primaryid$caseid$caseversion$i_f_code$event_dt$mfr_dt$init_fda_dt$fda_dt$rept_cod$auth_num$mfr_num$mfr_sndr$lit_ref$age$age_cod$age_grp$sex$e_sub$wt$wt_cod$rept_dt$to_mfr$occp_cod$reporter_country$occr_country
100138392$10013839$2$F$$20240716$20140316$20240726$EXP$$FI-009507513-1403FIN003898$MERCK$$37$YR$$M$Y$$$20240726$$HP$FI$FI
1002310548$10023105$48$F$20140101$20240626$20140320$20240715$EXP$$CA-ROCHE-1367988$ROCHE$$66$YR$E$F$Y$$$20240715$$MD$CA$CA
100313066$10031306$6$F$20130101$20240726$20140324$20240802$EXP$$JP-009507513-1403JPN009896$MERCK$Nomoto M, et al.. Two cases where it was difficult to control PT-INR because of concomitant use of aprepitant and Warfarin. The 66th Annual Congress of the Japan Society of Obstetrics and Gynecology. 2014;66(2):655$58$YR$$F$Y$53$KG$20240802$$MD$JP$JP
100445154$10044515$4$F$$20240429$20140328$20240922$EXP$$PHHY2014IT036115$NOVARTIS$De Tursi M, Carella C.. Lapatinib in second-line treatment for metastatic breast cancer: Rapid clinical benefit and long-term response.. TUMORI. 2013;99 (6):e261-3$55$YR$$F$Y$110$KG$20240922$$HP$IT$IT
100635983$10063598$3$F$20140319$20240715$20140407$20240725$EXP$$GB-BAXTER-2014BAX016322$BAXTER$$64$YR$$M$Y$89$KG$20240725$$MD$GB$GB
100689412$10068941$2$F$$20240808$20140409$20240812$EXP$$PHHY2014FR042860$NOVARTIS$Groh M, Masciocco G, Kirchner E, Kristen A, Pellegrini C,  Varnous S et al.. Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). JOURNAL OF HEART AND LUNG TRANSPLANTATION (F). 2014;1-9$22$YR$$M$Y$$$20240812$$HP$FR$FR
100863564$10086356$4$F$$20240923$20140418$20240926$EXP$$CA-ABBVIE-14K-028-1226276-00$ABBVIE$$56$YR$$M$Y$$$20240926$$PH$CA$CA
100878202$10087820$2$F$20140202$20240815$20140418$20240816$PER$$US-NAPPMUNDI-USA-2014-0110960$PURDUE$$46$YR$$M$Y$$$20240816$$CN$US$US
100895645$10089564$5$F$20131231$20240509$20140421$20240717$EXP$$CA-SA-2014SA048760$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240717$$HP$CA$CA
101009407$10100940$7$F$20131025$20141017$20140424$20240919$EXP$$JP-AMGEN-JPNSP2014029025$AMGEN$$77$YR$E$M$Y$50$KG$20240919$$MD$JP$JP
1015212333$10152123$33$F$20131205$20240909$20140505$20240916$EXP$$CA-ROCHE-1393055$ROCHE$$38$YR$A$F$Y$101$KG$20240916$$CN$CA$CA
1016133063$10161330$63$F$$20240822$20140509$20240830$EXP$$CA-ROCHE-1113310$ROCHE$$$$E$F$Y$63$KG$20240830$$HP$CA$CA
101705892$10170589$2$F$$20240902$20140513$20240911$EXP$$PHHY2014PL057371$NOVARTIS$Sawosz M, Cieciura T, Perkowska-Ptasinska A, Sikora P, Beck B, Chmura A, et al.. Late diagnosis of hyperoxaluria transplantation - case report. POSTEPY NAUK MEDYCZNYCH. 2014;XXVII (2):104-6$65$YR$$F$Y$$$20240911$$HP$PL$PL
1017130216$10171302$16$F$$20240926$20140514$20240930$EXP$$US-PFIZER INC-2014131046$PFIZER$$63$YR$$F$Y$$$20240930$$CN$US$US
101756879$10175687$9$F$20131206$20240827$20140516$20240902$EXP$$CA-ROCHE-1397863$ROCHE$$55$YR$A$F$Y$$$20240902$$CN$CA$CA
101815232$10181523$2$F$20140319$20240808$20140519$20240817$EXP$$GB-TEVA-481359ISR$TEVA$$64$YR$$M$Y$89$KG$20240817$$PH$GB$GB
101821132$10182113$2$F$$20240916$20140520$20240923$EXP$$US-Orion Corporation ORION PHARMA-ENT 2014-0065$ORION$Oyama G, Maling N. Rescue GPi-DBS for a Stroke-associated Hemiballism in a Patient with STN-DBS. Tremor and Other Hyperkinetic Movements 4. 2014 FEB 04;1-5.$38$YR$A$M$Y$$$20240923$$MD$US$
1020044031$10200440$31$F$20120730$20240808$20140528$20240816$EXP$$CA-ROCHE-1406066$ROCHE$$50$YR$A$F$Y$106.57$KG$20240816$$MD$CA$CA
1020569529$10205695$29$F$20131217$20240702$20140530$20240715$EXP$$CA-ROCHE-1409404$ROCHE$$63$YR$A$F$Y$$$20240715$$MD$CA$CA
102292016$10229201$6$F$20140317$20140804$20140611$20240918$EXP$$JP-AMGEN-JPNCT2014042668$AMGEN$$72$YR$E$M$Y$70$KG$20240918$$MD$JP$JP
1023164242$10231642$42$F$20120505$20240625$20140611$20240702$EXP$$PHHY2012CA036601$NOVARTIS$$55$YR$$F$Y$$$20240702$$HP$CA$CA
1023233522$10232335$22$F$20130801$20240911$20140612$20240918$EXP$$PHHY2013CA066835$NOVARTIS$$72$YR$$M$Y$$$20240918$$HP$CA$CA
1023843751$10238437$51$F$20161014$20240703$20140616$20240709$EXP$$PHHY2014CA073310$NOVARTIS$$72$YR$$M$Y$$$20240709$$HP$CA$CA
102554732$10255473$2$F$$20140715$20140624$20240918$EXP$$JP-AMGEN-JPNOT2014047247$AMGEN$Keiichiro Ono, et al. A study on nine cases of osteonecrosis of jaw associated with bisphosphonate drugs and denosumab. The 82nd Meeting of Japanese Society of Oral and Maxillofacial Surgeons in Kyushu Region. Jun 2014, 11.$$$$$Y$$$20240918$$MD$JP$JP
1026684121$10266841$21$F$20170720$20240806$20140630$20240814$EXP$$CA-ROCHE-1426159$ROCHE$$48$YR$A$F$Y$117$KG$20240814$$MD$CA$CA
102696365$10269636$5$F$20140130$20150113$20140701$20240920$EXP$$JP-AMGEN-JPNCT2014048847$AMGEN$$$$A$F$Y$55$KG$20240920$$MD$JP$JP
102714235$10271423$5$F$20130213$20160823$20140701$20240908$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-21151998$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$92$KG$20240909$$MD$JP$JP
102763263$10276326$3$F$$20240821$20140703$20240825$PER$$US-JNJFOC-20140702133$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240825$$LW$US$US
102790334$10279033$4$F$20130611$20240726$20140707$20240802$EXP$$JP-009507513-1403JPN011664$MERCK$Nomoto M.. Two cases where it was difficult to control PT-INR because of concomitant use of aprepitant and Warfarin. The 66th Annual Congress of the Japan Society of Obstetrics and Gynecology. 2014;66(2):655$33$YR$$F$Y$61$KG$20240802$$MD$JP$JP
1028518548$10285185$48$F$20140703$20240628$20140708$20240710$EXP$$CA-ROCHE-1267909$ROCHE$$49$YR$A$F$Y$79$KG$20240709$$HP$CA$CA
102857464$10285746$4$F$20131201$20171228$20140709$20240916$EXP$$US-ROCHE-1431150$ROCHE$$4$YR$C$M$Y$67.2$KG$20240916$$MD$US$US
1030948617$10309486$17$F$$20240820$20140717$20240824$EXP$$CA-ROCHE-1435384$ROCHE$$72$YR$E$M$Y$$$20240824$$HP$CA$CA
103094902$10309490$2$F$$20240718$20140717$20240730$EXP$$IT-MYLANLABS-2014S1016134$MYLAN$Leone MC, Muoio A, Caputo C, Galimberti D, Casali AM, Arioli D, et al. Hypersensitivity acute coronary syndromes. Italian-J-Med 2014; 8 (Suppl. 2) 72$$$$M$Y$$$20240730$$MD$IT$IT
1033431714$10334317$14$F$20140710$20240907$20140723$20240912$EXP$$PHHY2014IN087849$NOVARTIS$$35$YR$$F$Y$58$KG$20240912$$CN$IN$IN
1033834382$10338343$82$F$20120301$20240710$20140724$20240717$EXP$$CA-ROCHE-1098542$ROCHE$$44$YR$A$F$Y$83$KG$20240717$$HP$CA$CA
103487093$10348709$3$F$19880101$20240717$20140729$20240724$EXP$$PHHY2014BR088769$NOVARTIS$$$$$F$Y$88$KG$20240724$$CN$BR$BR
104092843$10409284$3$F$20140426$20141104$20140826$20240920$EXP$$JP-AMGEN-JPNSP2014064437$AMGEN$$93$YR$E$F$Y$$$20240920$$MD$JP$JP
104228452$10422845$2$F$$20240720$20140902$20240731$EXP$$US-AUROBINDO-AUR-APL-2014-09257$AUROBINDO$J B Cole, R L Gardner. Esophageal obstruction with pharmacobezoar: A complication of glucagon?. Clinical Toxicology. 2014;52 (7):793-794$43$YR$$M$Y$$$20240731$$HP$US$US
104473652$10447365$2$F$$20130722$20140911$20240814$PER$$US-BEH-2013037031$CSL BEHRING$$17$YR$T$M$Y$58.968$KG$20240814$$PH$US$US
104475582$10447558$2$F$$20140507$20140911$20240814$PER$$US-BEH-2014042510$CSL BEHRING$$3$MON$I$F$Y$$$20240814$$CN$US$US
104605112$10460511$2$F$$20240916$20140918$20240926$EXP$$DE-AUROBINDO-AUR-APL-2014-09603$AUROBINDO$$32$YR$$F$Y$82$KG$20240926$$MD$DE$DE
104658923$10465892$3$F$$20240701$20140922$20240709$EXP$$US-AUROBINDO-AUR-APL-2014-09851$AUROBINDO$Omar HR, Sprenker C, Karlnoski R, Mangar D, Camporesi EM. The use of isoproterenol and phenytoin to reverse torsade de pointes. American Journal of Emergency Medicine. 2014;32(6):683.e5-683.e7$31$YR$$F$Y$$$20240709$$MD$US$US
1046961217$10469612$17$F$20140521$20240704$20140923$20240712$EXP$$CA-ROCHE-1465579$ROCHE$$60$YR$A$M$Y$$$20240712$$MD$CA$CA
104802623$10480262$3$F$$20240821$20140929$20240903$EXP$$US-AUROBINDO-AUR-APL-2014-10231$AUROBINDO$Jacobs JC Jr, Shea KG, Oxford JT and Carey JL.. Fluoroquinolone use in a child associated with development of osteochondritis dissecans.. BMJ Case Rep.. 2014$10$YR$$F$Y$$$20240903$$HP$US$US
104989742$10498974$2$F$20140905$20240709$20141006$20240711$EXP$$US-BAUSCH-BL-2014-005847$BAUSCH AND LOMB$$60$YR$$F$Y$$$20240711$$CN$US$US
105131672$10513167$2$F$20140928$20240905$20141013$20240918$EXP$$IT-AUROBINDO-AUR-APL-2014-10775$AUROBINDO$$74$YR$$F$Y$$$20240918$$PH$IT$IT
105154135$10515413$5$F$20120101$20240913$20141014$20240925$EXP$$FR-AUROBINDO-AUR-APL-2014-10735$AUROBINDO$Rabenkogo A, Vigue MG, Jeziorski E. Drug reaction with eosinophilia and systemic symptoms. Arch Pediatr. 2014$9$YR$$F$Y$$$20240925$$HP$FR$FR
1052690063$10526900$63$F$20141119$20240611$20141020$20240709$EXP$$CA-ROCHE-1341517$ROCHE$$75$YR$E$M$Y$74$KG$20240705$$HP$CA$CA
1053317434$10533174$34$F$20140106$20240710$20141022$20240723$EXP$$CA-ROCHE-1477398$ROCHE$$70$YR$E$F$Y$60$KG$20240723$$CN$CA$CA
1054730627$10547306$27$F$20140701$20240730$20141028$20240812$EXP$$CA-ROCHE-1479164$ROCHE$$66$YR$E$F$Y$69$KG$20240812$$CN$CA$CA
105588752$10558875$2$F$20130222$20240720$20141101$20240730$EXP$$DE-AUROBINDO-AUR-APL-2014-11225$AUROBINDO$$1$DY$$M$Y$3.63$KG$20240730$$MD$DE$DE
105861382$10586138$2$F$$20240902$20141115$20240909$EXP$$PHHY2014PL149012$NOVARTIS$Boratyska M, Obremska M, Ma?ecki R, Gacka M, Magotta M, Kaminska D et al.,. Impact of immunosuppressive treatment on the cardiovascular system in patients after hand transplantation. TRANSPLANTATION PROCEEDINGS (F). 2014;46:2890-3$56$YR$$F$Y$$$20240909$$HP$PL$PL
105861463$10586146$3$F$$20240902$20141115$20240910$EXP$$PHHY2014PL148873$NOVARTIS$Boratyska M, Obremska M, Ma?ecki R, Gacka M, Magotta M, Kaminska D et al.. Impact of immunosuppressive treatment on the cardiovascular system in patients after hand transplantation. TRANSPLANTATION PROCEEDINGS (F). 2014;46:2890-3$44$YR$$M$Y$$$20240910$$HP$PL$PL
1059192433$10591924$33$F$20130101$20240619$20141119$20240709$EXP$$CA-ROCHE-1491761$ROCHE$$75$YR$E$F$Y$61$KG$20240701$$HP$CA$CA
105961863$10596186$3$F$$20240805$20141120$20240809$EXP$$PHHY2014FR151235$NOVARTIS$Pontoizeau C, Dangers L, Jarlier V, Luyt CE, Guiller E, Brossier F et al.. Ruling out false-positive urinary legionella pneumophila serogroup 1 and streptococcus pneumoniae antigen test results by heating urine. CLINICAL MICROBIOLOGY. 2014;52(12):4347-9$16$YR$$M$Y$$$20240809$$HP$FR$FR
105969356$10596935$6$F$20240620$20240722$20141120$20240726$EXP$$US-ARIAD-2014US003136$TAKEDA$$40$YR$$F$Y$$$20240726$$HP$US$US
105990492$10599049$2$F$$20240812$20141121$20240820$EXP$$PHHY2014PL148992$NOVARTIS$Arasiewicz H, Brzezinska-Wcisto L, Miziotek B, Michalska-Barikowska A. The use of ustekinumab in patients with psoriasis and coexisting renal or hepatic dysfunction-a report of two cases. PRZEGLAD DERMATOLOGICZNY. 2014;101:405-8$61$YR$$F$Y$$$20240820$$HP$PL$PL
1063107612$10631076$12$F$20010101$20240828$20141205$20240830$EXP$$US-PFIZER INC-2014330922$PFIZER$$60$YR$$F$Y$35.83$KG$20240830$$CN$US$US
106335902$10633590$2$F$20060101$20240710$20141205$20240714$PER$$US-JNJFOC-20141119885$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240715$$LW$US$US
106336653$10633665$3$F$20090101$20240624$20141205$20240701$PER$$US-JNJFOC-20141119044$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240701$$LW$US$US
106385914$10638591$4$F$20141125$20240726$20141208$20240730$EXP$$US-SHIRE-US201408456$TAKEDA$$10$YR$$M$Y$$$20240730$$HP$US$US
1064492227$10644922$27$F$20120801$20240628$20141211$20240710$EXP$$CA-ROCHE-1262889$ROCHE$$63$YR$A$M$Y$80$KG$20240710$$CN$CA$CA
106469444$10646944$4$F$$20240805$20141211$20240815$EXP$$PHHY2014FR157878$NOVARTIS$Guitard J, Guilbeau-Frugier C, Roussel M, Kamar N. An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis.. CLINICAL NEPHROLOGY. 2014;82(6):392-6$58$YR$$F$Y$$$20240815$$HP$FR$FR
106489364$10648936$4$F$$20240902$20141212$20240910$EXP$$PHHY2014BE158151$NOVARTIS$Nortier JL, Roumeguere T, Broeders N, Jayaswal A, Rorive S, Quackels T, et al.. Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropa. TRANSPLANT INTERNATIONAL. 2014;1-7$$$$F$Y$$$20240910$$HP$BE$BE
106734313$10673431$3$F$20130101$20240814$20141224$20240829$EXP$$DE-RANBAXY-2014R1-80826$RANBAXY$Schunemann M, Oette M. Fecal microbiota transplantation for clostridium difficile-associated colitis in a severely immunocompromized critically ill AIDS patients: A case report. AIDS. 2014;Mar 13; 28(5):798-799$54$YR$$M$Y$$$20240829$$HP$DE$DE
106777172$10677717$2$F$$20240905$20141229$20240913$EXP$$TR-ROCHE-1512965$ROCHE$Tufan H, Gencer B and Kara S Macular hole after intravitreal bevacizumab injection for choroidal neovascularisation. Clinical + experimental optometry : journal of the Australian Optometrical Association 2014 Mar 01;97(2):178-180.$78$YR$E$M$Y$$$20240913$$MD$TR$TR
106872518$10687251$8$F$20170101$20240703$20150102$20240715$EXP$$CA-ROCHE-1516335$ROCHE$$68$YR$E$M$Y$$$20240715$$MD$CA$CA
1069198854$10691988$54$F$20130404$20240826$20150106$20240903$EXP$$CA-ROCHE-1516574$ROCHE$$67$YR$E$M$Y$$$20240903$$MD$CA$CA
107123794$10712379$4$F$20110101$20240904$20150115$20240912$EXP$$CA-ROCHE-1521315$ROCHE$$65$YR$E$F$Y$$$20240912$$CN$CA$CA
107326623$10732662$3$F$20141125$20240716$20150123$20240729$EXP$GB-MHRA-EYC 00118928$GB-009507513-1501GBR007783$MERCK$$16$YR$$F$Y$40$KG$20240729$$HP$GB$GB
107327723$10732772$3$F$20141125$20240802$20150123$20240812$EXP$$GB-TEVA-535363ISR$TEVA$$16$YR$$F$Y$40$KG$20240812$$HP$GB$GB
107534343$10753434$3$F$$20240720$20150131$20240731$EXP$$ES-AUROBINDO-AUR-APL-2015-00750$AUROBINDO$Dr Monica Tarapues. Dronedarone and ventricular arrythmia. WHO pharmaceuticals newsletter. 2014;6:18-27$80$YR$$M$Y$$$20240731$$MD$ES$ES
107667143$10766714$3$F$20141114$20240902$20150205$20240905$EXP$$PHHY2015FR012809$NOVARTIS$$$$$$Y$$$20240905$$MD$FR$FR
107748282$10774828$2$F$20140801$20240702$20150209$20240708$PER$$US-AMGEN-USASL2015010934$AMGEN$$53$YR$A$F$Y$$$20240708$$CN$US$US
107838212$10783821$2$F$$20240923$20150210$20240927$EXP$$PHHY2015PL015582$NOVARTIS$Basak GW, Jedrzejczak WW, Labopin M, Schoemans H, Ljungman P, Kobbe G et al.. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. AMERICAN JOURNAL OF TRANSPLANTATION. 2015;XX:1-10$54$YR$$M$Y$$$20240927$$HP$PL$PL
107857083$10785708$3$F$$20240923$20150211$20240927$EXP$$PHHY2015PL015587$NOVARTIS$Basak GW, Wiktor-jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G et. al.. Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT.. AMERICAN JOURNAL OF TRANSPLANTATION.. 2015;15:1-10$17$YR$$F$Y$$$20240927$$HP$PL$PL
107859663$10785966$3$F$$20240909$20150211$20240913$EXP$$PHHY2015PL015561$NOVARTIS$Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoeman H, Ljungman P, Kobbe G, et al.,. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. AMERICAN JOURNAL OF TRANSPLANTATION. 2015;1-10$$$$M$Y$$$20240913$$HP$PL$PL
107860453$10786045$3$F$$20240923$20150211$20240930$EXP$$PHHY2015PL015568$NOVARTIS$Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoeman H, Ljungman P, Kobbe G, et al.,. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. AMERICAN JOURNAL OF TRANSPLANTATION. 2015;1-10$25$YR$$M$Y$$$20240930$$HP$PL$PL
107860512$10786051$2$F$$20240905$20150211$20240910$EXP$$PHHY2015PL015567$NOVARTIS$Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoeman H, Ljungman P, Kobbe G, et al.,. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. AMERICAN JOURNAL OF TRANSPLANTATION. 2015;1-10$39$YR$$M$Y$$$20240910$$HP$PL$PL
1078607314$10786073$14$F$20140812$20240910$20150211$20240924$EXP$$IN-INCYTE CORPORATION-2014IN002534$INCYTE$$$$$$Y$$$20240924$$CN$IN$IN
107930703$10793070$3$F$20140101$20240627$20150213$20240701$EXP$$US-Dyax Corp.-2015DX000047$TAKEDA$$$$$M$Y$96.161$KG$20240701$$MD$US$US
108153554$10815355$4$F$$20240808$20150218$20240812$EXP$$PHHY2015SK017881$NOVARTIS$Sykora T, Horakova J, Buzzasyova D, Sladekova M, Poczova M, Sufliarska S. Protothecal peritonitis in child after bone marrow transplantation: Case report and literature review of paediatric cases. NEW MICROBES AND NEW INFECTIONS. 2014;2(6):156-60$3$YR$$M$Y$$$20240812$$HP$SK$SK
1083036712$10830367$12$F$20150201$20240704$20150219$20240709$EXP$$FR-SA-2015SA019322$SANOFI AVENTIS$$46$YR$A$F$Y$85$KG$20240709$$MD$FR$FR
108619133$10861913$3$F$20150201$20150701$20150224$20240902$EXP$$JP-AMGEN-JPNSP2015016271$AMGEN$$81$YR$E$M$Y$$$20240902$$PH$JP$JP
1086486216$10864862$16$F$20180801$20240625$20150224$20240702$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK023439$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$BR$BR
1087204329$10872043$29$F$20150201$20240827$20150226$20240830$EXP$$US-JAZZ-2015-US-002582$JAZZ$$44$YR$$F$Y$$$20240830$$MD$US$US
108962542$10896254$2$F$$20240701$20150309$20240710$EXP$$AU-AUROBINDO-AUR-APL-2015-01787$AUROBINDO$Kango G P, Pazhvoor SK, Hewton C. Myoclonus associated with concomitant ciprofloxacin and oxycodone in an older patient. British Journal of Clinical Pharmacology. 2013;77:5:906-907$80$YR$$F$Y$$$20240710$$MD$AU$AU
109001062$10900106$2$F$20150201$20150302$20150310$20240901$EXP$$JP-AMGEN-JPNSP2015021348$AMGEN$$82$YR$E$M$Y$$$20240901$$MD$JP$JP
109016227$10901622$7$F$20150201$20240730$20150310$20240801$EXP$$DK-JNJFOC-20150303538$JOHNSON AND JOHNSON$$15$YR$T$M$Y$64.1$KG$20240801$$MD$DK$DK
109170872$10917087$2$F$20080101$20240729$20150316$20240802$PER$$US-JNJFOC-20150301456$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240802$$LW$US$US
109233193$10923319$3$F$20140201$20150624$20150318$20240905$EXP$$JP-AMGEN-JPNSP2015025104$AMGEN$$$$$$Y$$$20240904$$HP$JP$JP
109322525$10932252$5$F$19970101$20240717$20150320$20240723$PER$$US-JNJFOC-20150118645$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240723$$HP$US$US
109436003$10943600$3$F$$20240830$20150322$20240904$PER$$US-JNJFOC-20140815210$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$LW$US$US
109440332$10944033$2$F$$20240720$20150323$20240731$EXP$$US-AUROBINDO-AUR-APL-2015-02389$AUROBINDO$Miller C, Pleitez O, Anderson D, Mertens-Maxham D, Wade N. Asenapine (saphris): GC-MS method validation and the postmortem distribution of a new atypical antipsychotic medication.. Journal of Analytical Toxicology. 2013;37(8):559-564$38$YR$$F$Y$99$KG$20240731$$HP$US$US
1095268125$10952681$25$F$20141101$20240801$20150325$20240813$EXP$$CA-ROCHE-1555539$ROCHE$$63$YR$A$F$Y$$$20240813$$MD$CA$CA
1095711512$10957115$12$F$20230601$20240826$20150326$20240829$EXP$$US-PFIZER INC-2015102699$PFIZER$$74$YR$$F$Y$$$20240829$$CN$US$US
109739893$10973989$3$F$$20210719$20150401$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2015US-94558$RANBAXY$$$$$M$Y$$$20240702$$MD$US$US
109752886$10975288$6$F$20110727$20240802$20150401$20240805$EXP$$CZ-JNJFOC-20150321378$JOHNSON AND JOHNSON$$8$YR$C$M$Y$18$KG$20240805$$HP$CZ$CZ
1097587655$10975876$55$F$20140101$20240717$20150401$20240724$EXP$$PHHY2014CA142506$NOVARTIS$$81$YR$$F$Y$$$20240724$$HP$CA$CA
1098206366$10982063$66$F$20130101$20240702$20150403$20240716$EXP$$CA-ROCHE-1350337$ROCHE$$37$YR$A$F$Y$47$KG$20240716$$CN$CA$CA
109892232$10989223$2$F$20141021$20240716$20150406$20240726$EXP$$GB-AUROBINDO-AUR-APL-2015-02854$AUROBINDO$$42$YR$$F$Y$$$20240726$$PH$GB$GB
1098933910$10989339$10$F$20190114$20240917$20150406$20240920$EXP$$US-PFIZER INC-2015113764$PFIZER$$57$YR$$F$Y$113.4$KG$20240920$$CN$US$US
1099047574$10990475$74$F$20150312$20240925$20150406$20240927$EXP$$CA-ROCHE-1551832$ROCHE$$57$YR$A$M$Y$85.2$KG$20240927$$HP$CA$CA
1099223010$10992230$10$F$$20240903$20150406$20240910$EXP$$PHHY2015FR036316$NOVARTIS$Khanafer N, Neuraz A, Benet T, Cour M, Persat F, Labussiere H et al.. Acute graft-versus-host disease, invasive aspergillosis and Clostridium difficile colitis after peripheral blood stem cell transplantation: A complex network of causalities and a challenge for prevention. ANAEROBE. 2015;33:98-100$58$YR$$M$Y$$$20240910$$HP$FR$FR
1100310640$11003106$40$F$20141226$20240828$20150409$20240904$EXP$$PHHY2014CA170176$NOVARTIS$$61$YR$$M$Y$$$20240904$$HP$CA$CA
1100938115$11009381$15$F$20130101$20240831$20150410$20240912$EXP$$CA-ROCHE-1562570$ROCHE$$44$YR$A$F$Y$96$KG$20240912$$HP$CA$CA
1102019557$11020195$57$F$20120807$20240919$20150413$20240924$EXP$$CA-ROCHE-1137189$ROCHE$$46$YR$A$F$Y$95$KG$20240924$$CN$CA$CA
110206947$11020694$7$F$20140429$20240910$20150413$20240917$EXP$$CA-ROCHE-1396938$ROCHE$$18$YR$A$M$Y$$$20240917$$CN$CA$CA
1102430315$11024303$15$F$20121003$20240717$20150414$20240730$EXP$$CA-ROCHE-1538829$ROCHE$$49$YR$A$F$Y$94$KG$20240730$$MD$CA$CA
110462236$11046223$6$F$$20240831$20150418$20240913$EXP$$FR-AUROBINDO-AUR-APL-2015-03294$AUROBINDO$Nagham Khanafer, Antoine Neuraz, Thomas Benet , Martin Cour, Florence Persat, Helene Labussiere, Laurent Argaud, Mauricette Michallet, Philippe Vanhems. Acute graft-versus-host disease, invasive aspergillosis and Clostridium difficile colitis after peripheral blood stem cell transplantation: A complex network of causalities and a challenge for prevention.. Anaerobe. 2015;33:98-100$58$YR$$M$Y$$$20240913$$HP$FR$FR
110503163$11050316$3$F$$20150520$20150421$20240815$EXP$$US-BEH-2015050361$CSL BEHRING$$17$YR$T$F$Y$$$20240815$$CN$US$US
110580092$11058009$2$F$$20240905$20150423$20240917$EXP$$FR-Accord-030229$ACCORD$Khanafer N, Neuraz A, Benet T, Cour M, Persat F, Labussiere H, et al. Acute graft-versus-host disease, invasive aspergillosis and Clostridium difficile colitis after peripheral blood stem cell transplantation: A complex network of causalities and a challenge for prevention. Anaerobe. 2015 Mar 5;33:98-100.$58$YR$A$M$Y$$$20240917$$HP$FR$FR
1106955819$11069558$19$F$20211001$20240918$20150427$20240925$EXP$$BR-GLAXOSMITHKLINE INC.-BR2015GSK056220$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$BR$BR
110732242$11073224$2$F$20150201$20240716$20150428$20240726$EXP$NL-LRB-196371$NL-009507513-1504NLD021096$MERCK$$54$YR$$F$Y$83$KG$20240726$$HP$NL$NL
110734568$11073456$8$F$20150413$20240808$20150428$20240812$EXP$$US-SHIRE-US201503423$TAKEDA$$33$YR$$F$Y$$$20240812$$MD$US$US
1107812715$11078127$15$F$20150101$20240625$20150430$20240701$EXP$$PHHY2015CA047192$NOVARTIS$$65$YR$$F$Y$88$KG$20240701$$MD$CA$CA
110844169$11084416$9$F$$20240905$20150502$20240906$EXP$$PT-AUROBINDO-AUR-APL-2015-03877$AUROBINDO$Caldeira L, Varanda S, Machado A, Ferreira C, Carneiro G. et al.. Cognitive decline of medicamentous etiology. Acta Medica Portuguesa. 2014;27(2):266-268$68$YR$$F$Y$$$20240906$$MD$PT$PT
1110122511$11101225$11$F$20150101$20240729$20150508$20240731$EXP$$US-SHIRE-US201503872$TAKEDA$$$$$F$Y$77$KG$20240731$$MD$US$US
111149094$11114909$4$F$$20240909$20150515$20240921$EXP$$US-Accord-030706$ACCORD$Khajuria B, Khajuria M, Agrawal Y. Mycophenolate-Induced Posterior Reversible Encephalopathy Syndrome. Am J Ther. 30-Apr-2015.$29$YR$A$F$Y$$$20240921$$HP$US$US
111417284$11141728$4$F$20010101$20240917$20150525$20240922$PER$$US-JNJFOC-20140511722$JOHNSON AND JOHNSON$$$$C$M$Y$113.5$KG$20240923$$LW$US$US
111442895$11144289$5$F$20041101$20240904$20150526$20240913$EXP$$JP-ASTELLAS-2015JP010141$ASTELLAS$$57$YR$A$F$Y$46$KG$20240913$$PH$JP$JP
1114513410$11145134$10$F$20140521$20200203$20150528$20240715$EXP$$PHHY2014GB071137$NOVARTIS$$34$YR$$F$Y$$$20240715$$MD$GB$GB
111478123$11147812$3$F$$20240829$20150529$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2015R1-97709$RANBAXY$Chen J, Kong X, Sun X. Effect of selective laser trabeculoplasty on intraocular pressure in patients with glucocorticoid induced glaucoma. Chin J Exp Ophthalmol. 2014;Feb;32(2):168-71$32$YR$$F$Y$$$20240913$$HP$CN$CN
111612102$11161210$2$F$20130901$20240819$20150604$20240828$PER$$US-SA-2014SA075666$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240828$$CN$US$US
111657115$11165711$5$F$20150101$20240802$20150604$20240808$EXP$$US-JAZZ-2015-US-007934$JAZZ$$$$$M$Y$$$20240808$$CN$US$US
111657144$11165714$4$F$20150528$20240717$20150604$20240724$EXP$$US-JAZZ-2015-US-008022$JAZZ$$39$YR$$F$Y$$$20240723$$HP$US$US
1119006917$11190069$17$F$20211027$20240909$20150615$20240913$PER$$US-PFIZER INC-2015196944$PFIZER$$66$YR$$M$Y$$$20240913$$CN$US$US
1119150417$11191504$17$F$20150402$20240819$20150616$20240827$EXP$$CA-ROCHE-1582145$ROCHE$$22$YR$A$M$Y$55$KG$20240827$$CN$CA$CA
1119850320$11198503$20$F$$20240916$20150618$20240920$EXP$$CA-AMGEN-CANSP2015012893$AMGEN$$67$YR$E$F$Y$73$KG$20240920$$MD$CA$CA
112059695$11205969$5$F$20150617$20230413$20150622$20240808$EXP$$US-OTSUKA-2015_003971$OTSUKA$$59$YR$$M$Y$$$20240808$$PH$US$US
112206758$11220675$8$F$$20240909$20150626$20240916$EXP$$CA-ROCHE-1595276$ROCHE$$67$YR$E$F$Y$73$KG$20240916$$CN$CA$CA
112248472$11224847$2$F$$20240705$20150629$20240715$EXP$$DE-AUROBINDO-AUR-APL-2015-05363$AUROBINDO$$26$YR$$F$Y$56$KG$20240715$$MD$DE$DE
1123360937$11233609$37$F$20150921$20240617$20150702$20240709$EXP$$CA-ROCHE-1602464$ROCHE$$65$YR$E$F$Y$$$20240702$$MD$CA$CA
1123377219$11233772$19$F$20120128$20240718$20150702$20240726$EXP$$CA-ROCHE-1602529$ROCHE$$70$YR$E$M$Y$$$20240726$$CN$CA$CA
112383302$11238330$2$F$$20240705$20150704$20240715$EXP$$US-AUROBINDO-AUR-APL-2015-05700$AUROBINDO$Rankin, H; Zwicker, K; Trenor, CC... Caution is Recommended Prior to Sildenafil Use in Vascular Anomalies. Pediatr Blood Cancer. 2015$3$MON$$$Y$$$20240715$$MD$US$US
1124225727$11242257$27$F$20150318$20240909$20150707$20240917$EXP$$CA-ROCHE-1604437$ROCHE$$74$YR$E$F$Y$$$20240917$$CN$CA$CA
112535625$11253562$5$F$$20240913$20150709$20240924$EXP$$IT-AUROBINDO-AUR-APL-2015-05645$AUROBINDO$C.Tana, M.Alfieri, O. Arar, A. Benetti, C. Casali, F. Franco et al.,. An unusual case of severe pancolitis. Italian Journal of Medicine. 2015;9 (82):108$45$YR$$M$Y$$$20240924$$MD$IT$IT
1126087932$11260879$32$F$20230201$20240902$20150710$20240907$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK098504$GLAXOSMITHKLINE$$$$$$Y$$$20240907$$CN$BR$BR
112844342$11284434$2$F$$20240827$20150720$20240829$PER$$US-TAKEDA-2015TUS002793$TAKEDA$$$$$F$Y$76$KG$20240829$$MD$US$US
112874814$11287481$4$F$$20240916$20150721$20240918$EXP$$JP-SA-2015SA105283$SANOFI AVENTIS$Nakahara S, Kitamura K, Honma K, Yamamoto Y, Takenaka Y, Yasui T et al.. A case of nasopharyngeal cancer with febrile neutropenia followed by death during adjuvant chemotherapy.. Journal of Otolaryngology of Japan.. 2015;118(6):763-9$55$YR$A$M$Y$$$20240918$$MD$JP$JP
1131096044$11310960$44$F$20150914$20240812$20150726$20240819$EXP$$CA-ROCHE-1610105$ROCHE$$47$YR$A$F$Y$54$KG$20240819$$HP$CA$CA
1131105416$11311054$16$F$20160512$20240820$20150727$20240830$EXP$$CA-ROCHE-1612806$ROCHE$$64$YR$A$M$Y$113$KG$20240830$$MD$CA$CA
113161032$11316103$2$F$20150524$20240808$20150728$20240821$EXP$$GB-AUROBINDO-AUR-APL-2015-06635$AUROBINDO$$72$YR$$F$Y$65.31$KG$20240821$$MD$GB$GB
113261994$11326199$4$F$20150305$20240626$20150731$20240702$EXP$$PHHY2011CA01880$NOVARTIS$$54$YR$$M$Y$$$20240702$$HP$CA$CA
113635462$11363546$2$F$$20240905$20150811$20240916$EXP$$DE-AUROBINDO-AUR-APL-2015-06791$AUROBINDO$$$YR$$M$Y$0.375$KG$20240916$$MD$DE$DE
113636422$11363642$2$F$20150524$20240808$20150811$20240820$EXP$$GB-AUROBINDO-AUR-APL-2015-06241$AUROBINDO$$72$YR$$F$Y$66$KG$20240820$$CN$GB$GB
113815987$11381598$7$F$20150716$20240809$20150814$20240813$EXP$$NL-ABBVIE-15P-114-1442620-00$ABBVIE$$43$YR$$F$Y$$$20240813$$MD$NL$NL
1138286734$11382867$34$F$$20240819$20150814$20240827$EXP$$CA-PFIZER INC-2015267393$PFIZER$$60$YR$$F$Y$$$20240827$$CN$CA$CA
1142184215$11421842$15$F$20131113$20240730$20150827$20240808$EXP$$CA-ROCHE-1318626$ROCHE$$40$YR$A$F$Y$130$KG$20240808$$CN$CA$CA
114220992$11422099$2$F$$20240729$20150827$20240807$EXP$$US-Accord-033321$ACCORD$Yang Z, Loew T, Hammer RD. Association of long-term tacrolimus (FK506) therapy with abnormal megakaryocytosis, bone marrow fibrosis, and dyserythropoiesis. Clin Case Rep. 2015 Jul;3(7):664-8.$17$YR$T$M$Y$$$20240807$$HP$US$US
114450798$11445079$8$F$$20240909$20150902$20240913$EXP$NO-JNJFOC-20150820301$NO-JNJFOC-20150820301$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240913$$MD$NO$NO
1145717525$11457175$25$F$$20240819$20150904$20240822$EXP$$CA-AMGEN-CANSP2015088317$AMGEN$$60$YR$A$F$Y$$$20240822$$HP$CA$CA
114605236$11460523$6$F$20150501$20240723$20150904$20240730$EXP$$US-JAZZ-2015-US-012871$JAZZ$$37$YR$$M$Y$82.086$KG$20240730$$MD$US$US
114655687$11465568$7$F$20141017$20240924$20150907$20240930$EXP$$CA-ROCHE-1628386$ROCHE$$52$YR$A$M$Y$$$20241001$$MD$CA$CA
114725804$11472580$4$F$20140601$20240730$20150908$20240806$EXP$$US-JAZZ-2015-US-005644$JAZZ$$79$YR$$F$Y$$$20240806$$MD$US$US
1149087939$11490879$39$F$20140101$20240819$20150910$20240823$EXP$$CA-AMGEN-CANSP2015093585$AMGEN$$3$YR$C$F$Y$64$KG$20240823$$HP$CA$CA
114953978$11495397$8$F$20150826$20240812$20150911$20240820$EXP$$CA-ROCHE-1633071$ROCHE$$44$YR$A$M$Y$$$20240820$$MD$CA$CA
115014202$11501420$2$F$$20240822$20150914$20240829$PER$$US-AMGEN-USASP2015093296$AMGEN$$$$A$F$Y$$$20240828$$CN$US$US
1151574950$11515749$50$F$20050101$20240819$20150916$20240827$EXP$$CA-PFIZER INC-2015293060$PFIZER$$1$YR$$F$Y$64$KG$20240827$$MD$CA$CA
1151945687$11519456$87$F$20150901$20240916$20150918$20240920$EXP$$CA-AMGEN-CANSP2015095516$AMGEN$$43$YR$A$F$Y$97$KG$20240920$$HP$CA$CA
115282144$11528214$4$F$$20240821$20150921$20240902$EXP$$JP-Accord-033738$ACCORD$Nakahara S, Kitamura K, Honma K, Yamamoto Y, Takenaka Y, Yasui T et al. A Case of Nasopharyngeal Cancer with Febrile Neutropenia Followed by Death during Adjuvant Chemotherapy. Nihon Jibiinkoka Gakkai kaiho. 2015; 118(6):763-769$55$YR$A$M$Y$$$20240902$$MD$JP$JP
115366222$11536622$2$F$$20240718$20150922$20240725$EXP$$US-SHIRE-US201511758$TAKEDA$$$$$F$Y$$$20240725$$CN$US$US
115454636$11545463$6$F$20141222$20240626$20150924$20240709$EXP$$JP-AMGEN-JPNSP2015099089$AMGEN$$62$YR$A$F$Y$40$KG$20240708$$MD$JP$JP
115637325$11563732$5$F$20150916$20240809$20150928$20240816$EXP$$NL-ABBVIE-15P-114-1469003-00$ABBVIE$$43$YR$$F$Y$$$20240813$$MD$NL$NL
1156506855$11565068$55$F$$20240903$20150928$20240907$EXP$$CA-009507513-1509CAN012569$MERCK$$$$$F$Y$97$KG$20240907$$HP$CA$CA
1156866015$11568660$15$F$20150101$20240802$20150929$20240809$EXP$$CA-ROCHE-1458445$ROCHE$$23$YR$A$F$Y$127$KG$20240809$$MD$CA$CA
115737342$11573734$2$F$$20240913$20150929$20240918$EXP$$US-JAZZ-2015-US-014553$JAZZ$$$$$F$Y$$$20240918$$CN$US$US
115777744$11577774$4$F$20150506$20240911$20150930$20240927$EXP$$DK-ABBVIE-15P-044-1410049-00$ABBVIE$$51$YR$$M$Y$$$20240927$$HP$DK$DK
115799645$11579964$5$F$20150401$20240710$20150930$20240717$EXP$$US-JAZZ-2015-US-013800$JAZZ$$40$YR$$M$Y$158$KG$20240717$$CN$US$US
1161396013$11613960$13$F$20150827$20240814$20151008$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-067081$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240819$$MD$JP$JP
1161438013$11614380$13$F$20150701$20240723$20151009$20240727$EXP$$CA-ROCHE-1459625$ROCHE$$51$YR$A$F$Y$51$KG$20240727$$CN$CA$CA
116215038$11621503$8$F$20150810$20240729$20151013$20240801$EXP$$CA-ROCHE-1620457$ROCHE$$69$YR$E$F$Y$52$KG$20240801$$HP$CA$CA
1162632833$11626328$33$F$20150901$20240909$20151013$20240919$EXP$$CA-UCBSA-2015032127$UCB$$43$YR$$F$Y$68$KG$20240919$$CN$CA$CA
116311776$11631177$6$F$20140101$20240701$20151014$20240708$EXP$$US-JAZZ-2015-US-015995$JAZZ$$$$$M$Y$95$KG$20240708$$MD$US$US
1163606327$11636063$27$F$20151002$20240618$20151016$20240702$EXP$$CA-ROCHE-1646696$ROCHE$$20$YR$A$M$Y$$$20240702$$MD$CA$CA
116625958$11662595$8$F$20150501$20240704$20151027$20240716$EXP$$CA-ROCHE-1650804$ROCHE$$7$YR$C$M$Y$$$20240716$$CN$CA$CA
1168527113$11685271$13$F$$20240902$20151030$20240906$EXP$$DE-AstraZeneca-2015SF04662$ASTRAZENECA$$71$YR$$M$Y$$$20240906$$HP$FR$
1168789261$11687892$61$F$20150101$20240806$20151030$20240808$EXP$$PHHY2015CA139740$NOVARTIS$$44$YR$$F$Y$$$20240808$$CN$CA$CA
1169056712$11690567$12$F$$20240724$20151102$20240729$EXP$$US-PFIZER INC-2015371949$PFIZER$$70$YR$$F$Y$62$KG$20240729$$CN$US$US
1169665437$11696654$37$F$20160928$20240826$20151104$20240902$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK033029$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$BR$BR
116991995$11699199$5$F$20090101$20240920$20151104$20240925$EXP$$US-JAZZ-2015-US-017798$JAZZ$$$$$M$Y$138$KG$20240925$$MD$US$US
117006382$11700638$2$F$20150824$20240814$20151105$20240820$EXP$$US-SHIRE-US201513300$TAKEDA$$61$YR$$F$Y$$$20240820$$CN$US$US
1170499317$11704993$17$F$$20240918$20151106$20240920$EXP$$FR-BAUSCH-BL-2015-026253$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240920$$HP$FR$FR
117506095$11750609$5$F$$20240909$20151118$20240919$EXP$$PHHY2015PL150316$NOVARTIS$Boratynska M, Obremska M, Malecki R, Gacka M, Magott M, Kaminska D et al.. Impact of immunosuppressive treatment on the cardiovascular system in patients after hand transplantation. TRANSPLANTATION PROSEEDINGS. 2014;46(8):2890-3$56$YR$$F$Y$$$20240919$$HP$PL$PL
117516346$11751634$6$F$20150101$20240819$20151118$20240822$EXP$$US-JAZZ-2015-US-019310$JAZZ$$39$YR$$M$Y$79$KG$20240822$$MD$US$US
1176645740$11766457$40$F$20150902$20240805$20151123$20240813$EXP$$CA-ROCHE-GNE318259$ROCHE$$58$YR$A$F$Y$$$20240814$$CN$CA$CA
117754442$11775444$2$F$20020101$20240814$20151125$20240819$PER$$US-JNJFOC-20151105703$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240819$$HP$US$US
117755703$11775570$3$F$20060101$20240826$20151125$20240902$PER$$US-JNJFOC-20151105771$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240902$$LW$US$US
117756444$11775644$4$F$20060101$20240805$20151125$20240807$PER$$US-JNJFOC-20151104721$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$HP$US$US
117756673$11775667$3$F$20101012$20240904$20151125$20240912$EXP$$US-JNJFOC-20151104355$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240912$$HP$US$US
117759332$11775933$2$F$20130101$20240805$20151125$20240807$PER$$US-JNJFOC-20151104737$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240807$$LW$US$US
117760272$11776027$2$F$20140101$20240830$20151125$20240904$PER$$US-JNJFOC-20151100908$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240904$$LW$US$US
117761404$11776140$4$F$20150101$20240826$20151125$20240903$PER$$US-JNJFOC-20151105738$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240903$$LW$US$US
117761583$11776158$3$F$20050101$20240805$20151125$20240807$PER$$US-JNJFOC-20151105779$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240808$$LW$US$US
1177666119$11776661$19$F$20150602$20240703$20151125$20240710$EXP$$CA-ROCHE-1595569$ROCHE$$37$YR$A$F$Y$74$KG$20240710$$CN$CA$CA
1178262528$11782625$28$F$20140201$20240919$20151127$20240927$EXP$$CA-ROCHE-1668392$ROCHE$$55$YR$A$M$Y$78$KG$20240927$$MD$CA$CA
117870035$11787003$5$F$20150101$20230421$20151130$20240723$EXP$$US-OTSUKA-2015_015320$OTSUKA$$21$YR$$F$Y$$$20240723$$HP$US$US
117876904$11787690$4$F$20181001$20240909$20151130$20240913$EXP$$US-JAZZ-2015-US-020290$JAZZ$$37$YR$$F$Y$$$20240912$$HP$US$US
1180606218$11806062$18$F$20151201$20240717$20151207$20240724$EXP$$PHHY2015CA158998$NOVARTIS$$50$YR$$M$Y$$$20240724$$CN$CA$CA
118168213$11816821$3$F$20070806$20240722$20151210$20240725$PER$$US-JNJFOC-20151107889$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240725$$HP$US$US
118168815$11816881$5$F$20120501$20240913$20151210$20240919$PER$$US-JNJFOC-20151123608$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240919$$HP$US$US
118169902$11816990$2$F$$20240708$20151210$20240710$PER$$US-JNJFOC-20151107554$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$LW$US$US
118172974$11817297$4$F$20110101$20240805$20151210$20240808$EXP$$US-JNJFOC-20151110774$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240808$$HP$US$US
118174363$11817436$3$F$20120101$20240729$20151210$20240806$PER$$US-JNJFOC-20151108011$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240806$$LW$US$US
118175693$11817569$3$F$20090101$20240909$20151210$20240912$PER$$US-JNJFOC-20151115301$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240912$$LW$US$US
118175703$11817570$3$F$20100101$20240805$20151210$20240807$PER$$US-JNJFOC-20151115302$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240807$$LW$US$US
118176082$11817608$2$F$20130702$20240710$20151210$20240714$PER$$US-JNJFOC-20151117931$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240715$$LW$US$US
118176133$11817613$3$F$20100101$20240826$20151210$20240830$PER$$US-JNJFOC-20151117887$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240830$$HP$US$US
118178943$11817894$3$F$20020101$20240814$20151210$20240820$PER$$US-JNJFOC-20151111314$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240821$$LW$US$US
118183523$11818352$3$F$20140101$20240729$20151210$20240805$PER$$US-JNJFOC-20151109415$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240805$$LW$US$US
118183774$11818377$4$F$20020101$20240701$20151210$20240704$PER$$US-JNJFOC-20151115192$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240704$$LW$US$US
118184734$11818473$4$F$$20240729$20151210$20240805$PER$$US-JNJFOC-20151115310$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$LW$US$US
118185593$11818559$3$F$20050101$20240724$20151210$20240729$PER$$US-JNJFOC-20151115303$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240730$$HP$US$US
118186146$11818614$6$F$20060614$20240626$20151210$20240704$EXP$$US-JNJFOC-20151117877$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240704$$HP$US$US
118187843$11818784$3$F$20130101$20240917$20151210$20240925$PER$$US-JNJFOC-20151117942$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240925$$LW$US$US
118188344$11818834$4$F$20050101$20240715$20151210$20240717$PER$$US-JNJFOC-20151114005$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$LW$US$US
118189183$11818918$3$F$20040101$20240828$20151210$20240905$PER$$US-JNJFOC-20151110773$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240906$$LW$US$US
118191713$11819171$3$F$20110101$20240729$20151210$20240805$PER$$US-JNJFOC-20151104791$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240805$$LW$US$US
118198552$11819855$2$F$20060801$20240814$20151210$20240819$PER$$US-JNJFOC-20151110713$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20240819$$HP$US$US
118199022$11819902$2$F$$20240807$20151210$20240809$PER$$US-JNJFOC-20151201602$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$LW$US$US
118199433$11819943$3$F$20070101$20240724$20151210$20240731$PER$$US-JNJFOC-20151110114$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240801$$LW$US$US
1183887724$11838877$24$F$20151201$20240802$20151215$20240809$EXP$$CA-TAKEDA-2015TUS013643$TAKEDA$$50$YR$$F$Y$55$KG$20240809$$HP$CA$CA
118607414$11860741$4$F$$20240826$20151222$20240903$EXP$$PHHY2015FR167359$NOVARTIS$Garinet S, Tourret J, Barete S, Arzouk N, Meyer I, Frances C, et al.. Invasive cutaneous Neoscytalidium infections in renal transplant recipients: A series of five cases. BMC INFECTIOUS DISEASES. 2015;15 No. 1.:1-7$64$YR$$F$Y$$$20240903$$HP$FR$FR
118618419$11861841$9$F$20150101$20240808$20151222$20240814$EXP$$US-JAZZ-2015-US-021840$JAZZ$$$$$F$Y$$$20240814$$CN$US$US
1187110919$11871109$19$F$20141224$20240902$20151228$20240906$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2015JPN180189$VIIV$$$$$$Y$$$20240906$$MD$JP$JP
1189731574$11897315$74$F$20160101$20240724$20160108$20240802$EXP$$CA-ROCHE-1691132$ROCHE$$63$YR$A$M$Y$90$KG$20240802$$HP$CA$CA
119238123$11923812$3$F$$20240829$20160118$20240911$EXP$$PL-AUROBINDO-AUR-APL-2015-11650$AUROBINDO$M. Karczewskia,, H. Tomczak, I. Piechocka-Idasiak, L. Cichanska, Z. Adamska, and M. Stronka. Is multiresistant Klebsiella pneumoniae New Delhi metallobeta-lactamase (NDM-1) a new threat for kidney transplant recipients?.. Transplantation Proceedings. 2014;46:2409-10$56$YR$$M$Y$$$20240911$$HP$PL$PL
119331323$11933132$3$F$$20240812$20160121$20240822$EXP$$IT-ROCHE-1696760$ROCHE$Pistacchi M, Gioulis M, Zirillo M, Francavilla E and Marsala S. Cerebral toxoplasmosis in undifferentiated connective disease treated with mycophenolate mofetil: an unusual case report. DOI 10.1007/s13760-015-0595-9. Acta neurologica Belgica 2016 Jan 01;116 (4):633-636.$48$YR$A$F$Y$$$20240822$$HP$IT$IT
1193375738$11933757$38$F$$20240627$20160121$20240711$EXP$$CA-ROCHE-1434589$ROCHE$$$$E$F$Y$87$KG$20240711$$CN$CA$CA
119353853$11935385$3$F$20151201$20230421$20160121$20240723$PER$$US-OTSUKA-2015_016597$OTSUKA$$50$YR$$F$Y$$$20240723$$CN$US$US
119353993$11935399$3$F$20150101$20230421$20160121$20240723$PER$$US-OTSUKA-2015_016924$OTSUKA$$60$YR$$F$Y$$$20240723$$CN$US$US
119354403$11935440$3$F$20150101$20230421$20160121$20240723$PER$$US-OTSUKA-2015_017292$OTSUKA$$$$$F$Y$58.96$KG$20240723$$CN$US$US
119357773$11935777$3$F$20151101$20230705$20160121$20240723$PER$$US-OTSUKA-2015_015272$OTSUKA$$25$YR$$F$Y$$$20240723$$CN$US$US
119357804$11935780$4$F$20151101$20230421$20160121$20240723$PER$$US-OTSUKA-2015_014759$OTSUKA$$42$YR$$F$Y$$$20240723$$HP$US$US
119359923$11935992$3$F$20150101$20230421$20160121$20240723$PER$$US-OTSUKA-2016_000610$OTSUKA$$77$YR$$F$Y$$$20240723$$MD$US$US
119359954$11935995$4$F$20151101$20230421$20160121$20240723$PER$$US-OTSUKA-2016_000968$OTSUKA$$45$YR$$F$Y$99.8$KG$20240723$$CN$US$US
119771769$11977176$9$F$$20240909$20160129$20240913$EXP$$PHHY2016NO004749$NOVARTIS$Andersson H, Sem M, Lund MB, Aalokken TM, Gunther A, Walle-Hansen R et al.. Long term experience with rituximab in anti-synthetase syndrome related intestitial lung disease. RHEUMATOLOGY. 2015;54 (8):1420-8$37$YR$$M$Y$$$20240913$$HP$NO$NO
119810342$11981034$2$F$20151128$20240709$20160129$20240718$EXP$$IN-INCYTE CORPORATION-2016IN000455$INCYTE$$$$$$Y$$$20240718$$CN$IN$IN
119848093$11984809$3$F$20160121$20240829$20160201$20240905$EXP$$US-SHIRE-US201600732$TAKEDA$$58$YR$$F$Y$84$KG$20240905$$MD$US$US
119916012$11991601$2$F$20130401$20240708$20160203$20240710$PER$$US-JNJFOC-20160106408$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240710$$HP$US$US
119924492$11992449$2$F$$20160121$20160203$20240814$EXP$$US-BEH-2016058205$CSL BEHRING$$$$C$F$Y$52.164$KG$20240814$$PH$US$US
119957552$11995755$2$F$$20240724$20160203$20240801$PER$$US-SHIRE-US201600812$TAKEDA$$$$$F$Y$91$KG$20240801$$MD$US$US
119973633$11997363$3$F$$20160331$20160203$20240901$EXP$$JP-AMGEN-JPNSP2016011618$AMGEN$$$$$$Y$$$20240901$$MD$JP$JP
119991015$11999101$5$F$20151214$20240925$20160204$20240930$EXP$FR-AFSSAPS-NY20160127$FR-009507513-1602FRA001472$MERCK$$16$YR$$M$Y$58.3$KG$20240930$$MD$FR$FR
120095422$12009542$2$F$$20240826$20160205$20240828$PER$$US-PFIZER INC-2016009612$PFIZER$$65$YR$$F$Y$71.655$KG$20240828$$CN$US$US
120461232$12046123$2$F$20141014$20240904$20160209$20240909$EXP$$JP-009507513-1507JPN008873$MERCK$Inagaki, Y. Construction of the system of treatment for deep venous thrombosis with malignant tumor in Anjo Kosei Hospital. 13th the Japanese Society of Medical Oncology 2015 Annual Meeting. 2015;26 (Suppl. 7)$63$YR$$F$Y$$$20240909$$MD$JP$JP
120571002$12057100$2$F$20151010$20240916$20160209$20240923$PER$$US-ABBVIE-15P-163-1483034-00$ABBVIE$$33$YR$$F$Y$$$20240921$$MD$US$US
120585063$12058506$3$F$$20240912$20160210$20240923$EXP$NO-NOMAADVRE-NOMAADVRE-2016-21297$NO-Accord-037485$ACCORD$$37$YR$A$M$Y$$$20240923$$MD$NO$NO
120670033$12067003$3$F$20040401$20240703$20160210$20240710$PER$$US-JNJFOC-20160111185$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240710$$CN$US$US
120706705$12070670$5$F$$20240903$20160211$20240904$EXP$$JP-SA-2016SA024459$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240904$$MD$JP$JP
120708117$12070811$7$F$20160106$20240415$20160211$20240822$EXP$$US-AEGERION PHARMACEUTICAL INC.-AEGR002377$AEGERION$$68$YR$$F$Y$75.6$KG$20240822$$MD$US$US
120715845$12071584$5$F$$20240817$20160212$20240830$EXP$$FR-AUROBINDO-AUR-APL-2016-01450$AUROBINDO$Garinet S, Tourret J, Barete S, Arzouk N, Meyer I, Frances C, at al. Invasive cutaneous Neoscytalidium infections in renal transplant recipients: A series of five cases. BMC Infectious Diseases. 2015;15(1):535$64$YR$$F$Y$$$20240830$$MD$FR$FR
120721282$12072128$2$F$$20240705$20160212$20240715$EXP$$US-AUROBINDO-AUR-APL-2016-01087$AUROBINDO$Kim D, Benjamin L, Wysong A, Hovsepian D, Teng J.. Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone.. Dermatologic Therapy. 2015;28: No. 4:218-221$2$WK$$F$Y$$$20240715$$MD$US$US
1207524711$12075247$11$F$20160129$20240712$20160212$20240717$EXP$$CA-TAKEDA-2016TUS001984$TAKEDA$$36$YR$$F$Y$$$20240717$$CN$CA$CA
1207531619$12075316$19$F$$20240809$20160212$20240823$EXP$$CA-AUROBINDO-AUR-APL-2016-01463$AUROBINDO$Abidi S, Ursuliak Z, Morrison J, Teehan MD, Tibbo PG, Gardner DM.. Incidence of oculogyric crisis and long-term outcomes with second-generation antipsychotics in a first-episode psychosis program. Journal of Clinical Psychopharmacology. 2015;35(6):715-718$22$YR$$F$Y$$$20240823$$MD$CA$CA
1207560710$12075607$10$F$$20240815$20160213$20240829$EXP$$CA-AUROBINDO-AUR-APL-2016-01464$AUROBINDO$Gardner DM, Abidi S, Ursuliak Z, Morrison J, Teehan MD, Tibbo PG. Incidence of Oculogyric Crisis and Long-Term Outcomes With Second-Generation Antipsychotics in a First-Episode Psychosis Program. Journal of Clinical Psychopharmacology. 2015;35 (6):715-718$19$YR$$M$Y$$$20240829$$MD$CA$CA
1207627211$12076272$11$F$20141201$20240813$20160215$20240821$EXP$$CA-ROCHE-1709689$ROCHE$$35$YR$A$M$Y$72$KG$20240821$$HP$CA$CA
120783552$12078355$2$F$$20240626$20160216$20240704$EXP$$CA-ROCHE-1682119$ROCHE$$44$YR$A$M$Y$$$20240704$$CN$CA$CA
1207853044$12078530$44$F$20150101$20240819$20160216$20240827$EXP$$CA-ROCHE-1711280$ROCHE$$46$YR$A$F$Y$$$20240827$$MD$CA$CA
120814925$12081492$5$F$20150313$20240909$20160216$20240914$EXP$$FR-ROCHE-1710812$ROCHE$$47$YR$A$F$Y$70$KG$20240914$$MD$FR$FR
1208227816$12082278$16$F$20150204$20240729$20160217$20240806$EXP$$CA-ROCHE-1177020$ROCHE$$67$YR$E$F$Y$57$KG$20240806$$HP$CA$CA
120887287$12088728$7$F$$20240708$20160218$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-111620$RANBAXY$Rogier T, Gerfaud-Valentin M, Pouteil-Noble C, Taleb A, Guillet M, Noel A et al. Clinical efficacy of eculizumab as treatment of gemcitabine-induced thrombotic microangiopathy: A case report. Rev Med Interne. 2016;37(10):701-704$68$YR$$F$Y$$$20240723$$MD$FR$FR
1209149732$12091497$32$F$$20240715$20160218$20240724$EXP$$CA-PFIZER INC-2016085227$PFIZER$$65$YR$$F$Y$$$20240724$$CN$CA$CA
121201616$12120161$6$F$$20240913$20160226$20240918$PER$$US-PFIZER INC-2016093049$PFIZER$$63$YR$$F$Y$53.061$KG$20240918$$CN$US$US
121224337$12122433$7$F$$20240709$20160226$20240712$EXP$$CA-TAKEDA-2016TUS003384$TAKEDA$$15$YR$$F$Y$$$20240712$$MD$CA$CA
1212559019$12125590$19$F$20141001$20240708$20160229$20240722$EXP$$CA-ROCHE-1717659$ROCHE$$42$YR$A$F$Y$$$20240722$$MD$CA$CA
121330532$12133053$2$F$$20240715$20160301$20240722$EXP$$US-AUROBINDO-AUR-APL-2016-02158$AUROBINDO$Mowry JB, Spyker DA, Cantilena LR Jr, Bailey, JE, Ford M.. 2013 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):31st Annual Report. Clinical Toxicology. 2014;52(10):1032-1283$49$YR$$M$Y$$$20240722$$PH$US$US
1213337527$12133375$27$F$$20240715$20160301$20240722$EXP$$CA-AMGEN-CANSP2016018438$AMGEN$$65$YR$E$F$Y$$$20240722$$HP$CA$CA
121344752$12134475$2$F$$20240720$20160301$20240731$EXP$$US-AUROBINDO-AUR-APL-2016-02355$AUROBINDO$Mowry JB, Spyker DA, Cantilena LR Jr, Bailey, JE, Ford M... 2013 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):31st Annual Report. Clinical Toxicology. 2014;52:1032-1283$27$YR$$F$Y$$$20240731$$PH$US$US
121429342$12142934$2$F$$20240715$20160303$20240722$EXP$$US-AUROBINDO-AUR-APL-2016-02147$AUROBINDO$Mowry JB, Spyker DA, Cantilena LR Jr, Bailey, JE, Ford M... 2013 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):31st Annual Report. Clinical Toxicology. 2014;52:1032-1283$50$YR$$M$Y$$$20240722$$PH$US$US
121560505$12156050$5$F$$20240131$20160307$20240802$EXP$$NL-TEVA-640853ISR$TEVA$van Dijk R, Kremer AE, Smit W, van den Elzen B, van Gulik T, Gouma D, et al. Characterization and treatment of persistent hepatocellular secretory failure. Liver-Int 2015;35(4):1478-1488.; van Dijk R, Kremer AE, Smit W, van den Elzen B, van Gulik T, Gouma D, et al. Characterization and treatment of persistent hepatocellular secretory failure. Liver-Int 2015;35(4):1478-1488.; van Dijk R, Kremer AE, Smit W, van den Elzen B, van Gulik T, Gouma D, et al. Characterization and treatment of persiste...$31$YR$$F$Y$$$20240802$$HP$NL$NL
121569772$12156977$2$F$$20240807$20160307$20240816$EXP$$US-AUROBINDO-AUR-APL-2016-02754$AUROBINDO$Mowry JB, Spyker DA, Cantilena LR Jr, Bailey, JE, Ford M, Mcmillan N. 2013 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):31st Annual Report. Clinical Toxicology. 2014;52:1032-1283$87$YR$$F$Y$$$20240816$$PH$US$US
1215980210$12159802$10$F$$20240720$20160308$20240725$EXP$$CA-ASTELLAS-2016US008118$ASTELLAS$$15$YR$$F$Y$$$20240725$$CN$CA$CA
121686943$12168694$3$F$$20240809$20160310$20240814$EXP$$JP-SA-2016SA047269$SANOFI AVENTIS$Murakami J, Hori K, Okubo R, Miyagi K, Shiomi M, Uragami K et al.. A Case of Bilateral Pneumothorax after Chemotherapy for Uterine Leiomyosarcoma with Multiple Lung Metastases.. Gan to kagaku ryoho. Cancer + chemotherapy.. 2016;43(2):259-61$52$YR$A$F$Y$$$20240814$$MD$JP$JP
1216925610$12169256$10$F$20160101$20240708$20160310$20240715$EXP$$US-SHIRE-US201602604$TAKEDA$$$$$F$Y$90$KG$20240715$$HP$US$US
121703147$12170314$7$F$20130730$20240923$20160311$20240930$EXP$$CA-ROCHE-1247398$ROCHE$$56$YR$A$F$Y$90.9$KG$20240930$$CN$CA$CA
121708132$12170813$2$F$$20240807$20160311$20240817$EXP$$US-AUROBINDO-AUR-APL-2016-02930$AUROBINDO$Mowry JB, Spyker DA, Cantilena LR Jr, Bailey, JE, Ford M, Mcmillan N. 2013 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):31st Annual Report. Clinical Toxicology. 2014;52:1032-1283$58$YR$$M$Y$$$20240817$$PH$US$US
121793382$12179338$2$F$$20240720$20160315$20240731$EXP$$US-AUROBINDO-AUR-APL-2016-02569$AUROBINDO$Mowry JB, Spyker DA, Cantilena LR Jr, Bailey, JE, Ford M... 2013 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):31st Annual Report. Clinical Toxicology. 2014;52:1032-1283$27$YR$$M$Y$$$20240731$$PH$US$US
121828272$12182827$2$F$$20240720$20160316$20240731$EXP$$US-AUROBINDO-AUR-APL-2016-02426$AUROBINDO$Mowry JB, Spyker DA, Cantilena LR Jr, Bailey, JE, Ford M... 2013 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):31st Annual Report. Clinical Toxicology. 2014;52:1032-1283$61$YR$$M$Y$$$20240731$$PH$US$US
121835997$12183599$7$F$20160101$20240630$20160316$20240701$PER$$US-PFIZER INC-2016101978$PFIZER$$72$YR$$F$Y$$$20240701$$HP$US$US
121865012$12186501$2$F$$20240821$20160317$20240831$EXP$$US-AUROBINDO-AUR-APL-2016-03109$AUROBINDO$JAMES B. MOWRY , DANIEL A. SPYKER , LOUIS R. CANTILENA JR, NAYA MCMILLAN , MARSHA FORD. 2013 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):31st Annual Report. Clinical Toxicology. 2014;52:1032-1283$17$YR$$M$Y$$$20240831$$PH$US$US
121873604$12187360$4$F$$20240812$20160317$20240820$EXP$$US-SA-2016SA050106$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240820$$MD$US$SA
121896833$12189683$3$F$$20240807$20160318$20240817$EXP$$US-AUROBINDO-AUR-APL-2016-03292$AUROBINDO$JAMES B. MOWRY , DANIEL A. SPYKER , LOUIS R. CANTILENA JR, NAYA MCMILLAN , MARSHA FORD. 2013 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):31st Annual Report. Clinical Toxicology. 2014;52:1032-1283$42$YR$$M$Y$$$20240817$$PH$US$US
121898902$12189890$2$F$$20240807$20160318$20240816$EXP$$US-AUROBINDO-AUR-APL-2016-03318$AUROBINDO$Mowry JB, Spyker DA, Cantilena LR Jr, Bailey, JE, Ford M... 2013 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):31st Annual Report. Clinical Toxicology. 2014;52:1032-1283$54$YR$$F$Y$$$20240816$$PH$US$US
122050395$12205039$5$F$$20240726$20160323$20240802$EXP$$JP-009507513-1603JPN008869$MERCK$Okada N. Ifosfamide and etoposide chemotherapy may interact with warfarin, enhancing the warfarin-induced anticoagulant response. International Journal of Clinical Pharmacology and Therapeutics. 2016;54(1):58-61$15$YR$$M$Y$60$KG$20240802$$HP$JP$JP
122060243$12206024$3$F$20140101$20240816$20160323$20240823$EXP$$US-BIOGEN-2016BI00209612$BIOGEN$$39$YR$$F$Y$$$20240823$$CN$US$US
1220965359$12209653$59$F$20130101$20240920$20160325$20240925$EXP$$CA-ROCHE-1213265$ROCHE$$73$YR$E$F$Y$65$KG$20240925$$HP$CA$CA
122188054$12218805$4$F$20110701$20240625$20160329$20240708$PER$IE-HPRA-2016-026265$IE-DSJP-DSE-2016-110689$DAIICHI$$$$$M$Y$$$20240708$$CN$IE$IE
122493037$12249303$7$F$20141101$20240918$20160408$20240927$PER$$US-SHIRE-US201604155$TAKEDA$$76$YR$$F$Y$59$KG$20240927$$CN$US$US
122614065$12261406$5$F$$20240726$20160412$20240805$EXP$$JP-009507513-1604JPN006891$MERCK$Fukaya Y. Effects of concomitant use of aprepitant and an oral pyrimidine fluoride drug in patients on treatment with warfarin. Annual Meeting of Japanese Society of Pharmaceutical Oncology. 2026;P.189$70$YR$$F$Y$$$20240805$$HP$JP$JP
1226963213$12269632$13$F$20160410$20240709$20160414$20240715$EXP$$CO-SHIRE-CO201604454$TAKEDA$$17$YR$$M$Y$54$KG$20240715$$CN$CO$CO
122791233$12279123$3$F$$20230421$20160418$20240723$PER$$US-OTSUKA-2016_001504$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
122792575$12279257$5$F$20160101$20230421$20160418$20240723$PER$$US-OTSUKA-2016_002790$OTSUKA$$15$YR$$F$Y$$$20240723$$CN$US$US
122879782$12287978$2$F$20150701$20240712$20160420$20240722$EXP$$US-JAZZ-2015-US-011072$JAZZ$$24$YR$$F$Y$62.132$KG$20240722$$CN$US$US
1228924320$12289243$20$F$20160403$20240729$20160421$20240808$EXP$$CA-ROCHE-1745843$ROCHE$$67$YR$E$F$Y$77.1$KG$20240808$$CN$CA$CA
1229013127$12290131$27$F$20210101$20240906$20160421$20240911$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK011740$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$BR$BR
1229378941$12293789$41$F$20150608$20240815$20160421$20240820$EXP$$CA-ROCHE-1591315$ROCHE$$66$YR$E$F$Y$130$KG$20240820$$CN$CA$CA
122995742$12299574$2$F$$20240726$20160425$20240807$EXP$$US-AUROBINDO-AUR-APL-2016-04862$AUROBINDO$Shin-e Lin MD, Thomas Fernandez MD, Matthias Braehler MD, PhD. Subdural spread of local anesthetic mimicking cerebrovascular accident: A case report. Regional Anesthesia and Pain Medicine. 2015;40 (5)$53$YR$$F$Y$$$20240807$$MD$US$US
123031623$12303162$3$F$20140101$20240703$20160426$20240705$PER$$US-JNJFOC-20160404861$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240705$$LW$US$US
123032913$12303291$3$F$20010101$20240812$20160426$20240816$PER$$US-JNJFOC-20160406948$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240816$$LW$US$US
123034933$12303493$3$F$20081209$20240624$20160426$20240701$PER$$US-JNJFOC-20160411024$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240701$$HP$US$US
123168682$12316868$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115711$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$53$YR$$F$Y$$$20240719$$MD$NO$NO
123171352$12317135$2$F$$20240912$20160429$20240924$EXP$$PL-Accord-039806$ACCORD$Gawle-Krawczyk K, Stanczak-Bujnicka E, Matysiak M. Zespol odwracalnej encefalopatii u chlopca leczonego z powodu ostrej bialaczki limfoblastycznej. PEDIATRIA POLSKA 2016;91/2:168-171.$13$YR$T$M$Y$$$20240924$$HP$PL$PL
123172173$12317217$3$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115709$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$64$YR$$F$Y$$$20240719$$MD$NO$NO
123172182$12317218$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115694$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$59$YR$$M$Y$$$20240719$$MD$NO$NO
123172193$12317219$3$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115715$RANBAXY$Frost J, Loken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$52$YR$$M$Y$$$20240719$$MD$NO$NO
123172202$12317220$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115725$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$21$YR$$F$Y$$$20240719$$MD$NO$NO
123172213$12317221$3$F$$20240715$20160429$20240730$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115692$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;262:128-137$50$YR$$F$Y$$$20240730$$MD$NO$NO
123173632$12317363$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115746$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$63$YR$$F$Y$$$20240719$$MD$NO$NO
123173642$12317364$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115738$RANBAXY$Frost J, Loken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;262:128-137$52$YR$$M$Y$$$20240719$$MD$NO$NO
123173653$12317365$3$F$$20240715$20160429$20240730$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115731$RANBAXY$Frost J, Loken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$39$YR$$M$Y$$$20240730$$MD$NO$NO
123173672$12317367$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115744$RANBAXY$Frost J, Loken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$54$YR$$F$Y$$$20240719$$MD$NO$NO
123173712$12317371$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115737$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;262:128-137$40$YR$$M$Y$$$20240719$$MD$NO$NO
123173722$12317372$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115734$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;262:128-137$32$YR$$M$Y$$$20240719$$MD$NO$NO
123173732$12317373$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115730$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$56$YR$$M$Y$$$20240719$$MD$NO$NO
123173743$12317374$3$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115733$RANBAXY$Frost J, Loken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;262:128-137$28$YR$$M$Y$$$20240719$$MD$NO$NO
123173822$12317382$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115748$RANBAXY$Frost J, Loken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$50$YR$$M$Y$$$20240719$$MD$NO$NO
123173842$12317384$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115747$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$47$YR$$F$Y$$$20240719$$MD$NO$NO
123173852$12317385$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115750$RANBAXY$Frost J, Loken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$29$YR$$M$Y$$$20240719$$MD$NO$NO
123176132$12317613$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115727$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L.. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$40$YR$$M$Y$$$20240719$$MD$NO$NO
123176142$12317614$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115736$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;262;may:128-137$54$YR$$M$Y$$$20240719$$MD$NO$NO
123176153$12317615$3$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115729$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$39$YR$$F$Y$$$20240719$$MD$NO$NO
123176162$12317616$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115728$RANBAXY$Frost J, Lokken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May; 262:128-137$51$YR$$F$Y$$$20240719$$MD$NO$NO
123176182$12317618$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115755$RANBAXY$Frost J, Loken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$48$YR$$M$Y$$$20240719$$MD$NO$NO
123176192$12317619$2$F$$20240704$20160429$20240720$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-115722$RANBAXY$Frost J, Loken TN, Helland A, Nordrum IS, Slordal L. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths. Forensic Sci Int. 2016;May;262:128-137$66$YR$$F$Y$$$20240719$$MD$NO$NO
1233895917$12338959$17$F$20160502$20240730$20160505$20240802$PER$$US-PFIZER INC-2016243931$PFIZER$$59$YR$$F$Y$71.67$KG$20240802$$HP$US$US
123505473$12350547$3$F$20040101$20240816$20160510$20240822$EXP$$US-JAZZ-2015-US-013243$JAZZ$$$$$M$Y$$$20240822$$CN$US$US
123528916$12352891$6$F$20150904$20240722$20160510$20240730$EXP$$US-BIOGEN-2016BI00233196$BIOGEN$$51$YR$$F$Y$$$20240730$$CN$US$US
123541292$12354129$2$F$$20240826$20160511$20240830$EXP$$US-JAZZ-2015-US-012986$JAZZ$$$$$M$Y$$$20240830$$HP$US$US
123552724$12355272$4$F$20150101$20240911$20160511$20240919$EXP$$PHHY2013CA039946$NOVARTIS$$46$YR$$M$Y$$$20240919$$HP$CA$CA
1235731110$12357311$10$F$20160427$20240624$20160511$20240702$EXP$DE-GILEAD-2016-0211301$DE-GILEAD-2016-0211301$GILEAD$$77$YR$E$M$Y$75$KG$20240702$$MD$DE$DE
123580732$12358073$2$F$$20240802$20160512$20240807$PER$$US-AMGEN-USASL2016058866$AMGEN$$61$YR$A$M$Y$$$20240807$$CN$US$US
1238083420$12380834$20$F$20160401$20240904$20160518$20240911$EXP$$CA-ROCHE-1758483$ROCHE$$23$YR$A$F$Y$$$20240911$$MD$CA$CA
123868967$12386896$7$F$$20240809$20160519$20240813$EXP$$CA-PFIZER INC-2015113921$PFIZER$Yin Ming Kwan, B., Mandell D., Bernstein M, Krings, T.. A novel mechanism of toxic injury to the Papez circuit from chemotherapy. Journal of Clinical Neuroscience. 2015;22(4):760-762$16$YR$$$Y$$$20240813$$MD$CA$CA
123884234$12388423$4$F$20151021$20240705$20160520$20240712$EXP$$JP-TAKEDA-2016TJP002885$TAKEDA$$28$YR$$F$Y$58$KG$20240712$$MD$JP$JP
123889854$12388985$4$F$$20240822$20160520$20240903$EXP$$CA-GLAXOSMITHKLINE-CA2016GSK063913$Haleon PLC$$68$YR$$F$Y$$$20240903$$HP$CA$CA
1239193821$12391938$21$F$20160217$20240618$20160523$20240702$EXP$$CA-ROCHE-1760096$ROCHE$$64$YR$A$M$Y$$$20240702$$MD$CA$CA
1239599529$12395995$29$F$20160215$20240621$20160524$20240703$EXP$$CA-ROCHE-1760608$ROCHE$$80$YR$E$F$Y$$$20240703$$MD$CA$CA
1240670610$12406706$10$F$20111001$20240726$20160526$20240731$EXP$$US-JAZZ-JPI-P-018187$JAZZ$$60$YR$$M$Y$109$KG$20240731$$MD$US$US
1240791446$12407914$46$F$20190101$20240819$20160526$20240822$EXP$$PHHY2016CA070945$NOVARTIS$$43$YR$$F$Y$$$20240822$$MD$CA$CA
124100655$12410065$5$F$20160418$20240902$20160527$20240906$EXP$$DE-ROCHE-1764525$ROCHE$$45$YR$A$M$Y$99$KG$20240906$$MD$DE$DE
1241500917$12415009$17$F$20150101$20240913$20160530$20240921$EXP$$CA-ROCHE-1765541$ROCHE$$58$YR$A$F$Y$$$20240921$$MD$CA$CA
1241759016$12417590$16$F$20160412$20240917$20160530$20240919$EXP$$CA-TAKEDA-2016TUS006496$TAKEDA$$62$YR$$F$Y$$$20240919$$MD$CA$CA
124183633$12418363$3$F$20160418$20240830$20160531$20240911$EXP$$DE-AUROBINDO-AUR-APL-2016-06618$AUROBINDO$$45$YR$$M$Y$99$KG$20240911$$MD$DE$DE
1242381217$12423812$17$F$20160401$20240917$20160601$20240923$EXP$$CA-PFIZER INC-2016250580$PFIZER$$62$YR$$F$Y$$$20240923$$HP$CA$CA
124307085$12430708$5$F$19790101$20240918$20160602$20240920$PER$$US-PURDUE-USA-2016-0128336$PURDUE$$$$$M$Y$$$20240920$$CN$US$US
124314434$12431443$4$F$20140101$20240709$20160603$20240711$EXP$$US-JAZZ-2015-US-017432$JAZZ$$$$$M$Y$$$20240711$$CN$US$US
124398657$12439865$7$F$$20240910$20160606$20240913$EXP$$PHHY2016NL073198$NOVARTIS$Dos Santos CO, Zijlstra JG, Porte RJ, Kampinga GA, van Diepeningen AD, Sinha B et al.. Emerging pan-resistance in Trichosporon species: A case report.. BMC INFECTIOUS DISEASES. 2016;16(148):1-4$48$YR$$M$Y$$$20240913$$HP$NL$NL
124457384$12445738$4$F$20071105$20240904$20160608$20240906$PER$$US-JNJFOC-20160411993$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240906$$LW$US$US
1245713411$12457134$11$F$20151026$20240920$20160610$20240926$EXP$$PHJP2015JP023476$NOVARTIS$$56$YR$$M$Y$80$KG$20240927$$MD$JP$JP
1246198011$12461980$11$F$20160308$20240716$20160613$20240720$EXP$$CA-TAKEDA-2016TUS006414$TAKEDA$$61$YR$$M$Y$$$20240720$$HP$CA$CA
124645752$12464575$2$F$$20240829$20160614$20240910$EXP$$US-NOVOPROD-495616$NOVO NORDISK$$$$$M$Y$$$20240910$$CN$US$US
124764024$12476402$4$F$$20240815$20160617$20240820$EXP$$US-INCYTE CORPORATION-2016IN003550$INCYTE$$$$$$Y$$$20240820$$CN$US$US
124768003$12476800$3$F$$20240812$20160617$20240814$EXP$$US-PFIZER INC-2016297425$PFIZER$Repplinger, D.. Unique histopathology in severe iron toxicity treated with liver transplantation. Clinical Toxicology. 2016;54 (4):492-493$16$YR$$F$Y$$$20240814$$HP$US$US
1247952428$12479524$28$F$20151221$20240820$20160620$20240828$EXP$$CA-ROCHE-1777775$ROCHE$$59$YR$A$F$Y$93$KG$20240828$$CN$CA$CA
124809896$12480989$6$F$20160607$20240910$20160620$20240912$PER$$US-PFIZER INC-2016296946$PFIZER$$21$YR$$M$Y$77$KG$20240912$$MD$US$US
124825918$12482591$8$F$$20240923$20160620$20240927$EXP$$US-ARIAD PHARMACEUTICALS, INC-2016US006617$TAKEDA$$$$$M$Y$79$KG$20240927$$MD$US$US
1248289813$12482898$13$F$20150715$20240916$20160620$20240920$EXP$$PHHY2016CO012426$NOVARTIS$$67$YR$$F$Y$56$KG$20240920$$CN$CO$CO
124836362$12483636$2$F$$20240912$20160621$20240924$EXP$US-MLMSERVICE-20160602-0305267-1$US-Accord-041643$ACCORD$Menashy V, Levine A, Stoudt K, Mazurkiewicz R, Wagner I. Mycophenolate-induced posterior reversible encephalopathy syndrome.Journal of General Internal Medicine.2016; 31:2(1):S682.$18$YR$A$F$Y$$$20240924$$MD$US$US
1248405013$12484050$13$F$20160421$20240724$20160621$20240802$EXP$$CA-ROCHE-1778609$ROCHE$$72$YR$E$F$Y$$$20240802$$MD$CA$CA
1248745123$12487451$23$F$20140605$20240830$20160622$20240910$EXP$$CA-ROCHE-1778623$ROCHE$$56$YR$A$F$Y$$$20240910$$CN$CA$CA
124880532$12488053$2$F$$20240816$20160622$20240828$EXP$US-MLMSERVICE-20160602-0303115-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2016-00006$ALKEM$Millien VO, Santana LA, Kolpakchi A, Lu L.. Trading one for another: A case of de novo crohn^s disease after lung transplant.. Journal of General Internal Medicine.. 2016;31:2(1):S769$71$YR$$M$Y$$$20240828$$HP$US$US
124909083$12490908$3$F$20160414$20240726$20160623$20240801$PER$$US-BIOGEN-2016BI00251886$BIOGEN$$29$YR$$F$Y$$$20240801$$CN$US$US
124986963$12498696$3$F$$20240909$20160627$20240913$EXP$$US-JAZZ-2015-US-021634$JAZZ$$$$$M$Y$$$20240913$$CN$US$US
124987294$12498729$4$F$20100101$20240904$20160627$20240912$EXP$$US-JAZZ-2015-US-021545$JAZZ$$$$$M$Y$$$20240912$$MD$US$US
125020264$12502026$4$F$20150101$20240919$20160627$20240924$EXP$$JP-SA-2016SA114414$SANOFI AVENTIS$Ebisui C, Hamano R, Nushijima Y, Yanagisawa T, Okamura S, Fukuchi N, et al.. A Case of T1a Early Gastric Cancer That Metastasized to the Right Femoral Muscles Six Years and Seven Months after Radical Surgery.. Jpn J Cancer Chemother.. 2016;43(12):1893-5$49$YR$A$F$Y$$$20240924$$HP$JP$JP
1250687936$12506879$36$F$20140623$20240919$20160629$20240930$EXP$$CA-ROCHE-1783033$ROCHE$$34$YR$A$F$Y$97.7$KG$20240930$$CN$CA$CA
1251777410$12517774$10$F$20160101$20240806$20160630$20240813$EXP$$US-TAKEDA-2016MPI005855$TAKEDA$$$$$F$Y$$$20240813$$CN$US$US
1252363910$12523639$10$F$20140304$20240807$20160704$20240820$EXP$$CA-ROCHE-1786585$ROCHE$$55$YR$A$M$Y$68$KG$20240820$$CN$CA$CA
125238534$12523853$4$F$$20240909$20160704$20240910$EXP$$GR-ROCHE-1787700$ROCHE$$69$YR$E$F$Y$$$20240910$$MD$GR$GR
1252726715$12527267$15$F$20150511$20240624$20160705$20240709$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2016JPN092059$VIIV$$$$$$Y$$$20240709$$MD$JP$JP
125281084$12528108$4$F$20150330$20240820$20160705$20240828$EXP$$JP-PFIZER INC-3201825$PFIZER$Murakami, J.. A Case of Bilateral Pneumothorax after Chemotherapy for Uterine Leiomyosarcoma with Multiple Lung Metastases. Jpn J Cancer Chemother. 2016;43(2):259-261$52$YR$$F$Y$58$KG$20240828$$MD$JP$JP
125352242$12535224$2$F$$20151020$20160707$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2015US-105472$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
125389272$12538927$2$F$20150101$20150924$20160708$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2015US-104377$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
125389372$12538937$2$F$$20150924$20160708$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2015US-104394$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
125442152$12544215$2$F$20160529$20240808$20160711$20240821$EXP$$GB-AUROBINDO-AUR-APL-2016-08473$AUROBINDO$$76$YR$$M$Y$139$KG$20240821$$MD$GB$GB
125507112$12550711$2$F$$20170403$20160712$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-056641$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240708$$MD$JP$JP
125537969$12553796$9$F$20160616$20240719$20160713$20240724$EXP$$US-ABBVIE-16P-163-1670896-00$ABBVIE$$23$YR$$M$Y$$$20240724$$MD$US$US
1256069620$12560696$20$F$20141014$20240710$20160715$20240718$EXP$$CA-ROCHE-1794678$ROCHE$$55$YR$A$M$Y$$$20240718$$CN$CA$CA
125636746$12563674$6$F$20160627$20240911$20160715$20240920$EXP$$CA-TAKEDA-2016TUS011882$TAKEDA$$54$YR$$M$Y$$$20240920$$MD$CA$CA
125676773$12567677$3$F$20160711$20240905$20160718$20240910$EXP$$JP-SA-2016SA128799$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240911$$PH$JP$JP
125819903$12581990$3$F$$20240808$20160722$20240819$EXP$US-MLMSERVICE-20160503-0267171-1$US-STRIDES ARCOLAB LIMITED-2016SP003040$STRIDES$Kanth K, Solorzano G, Goldman M. Case report: PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents. Neurol Clin Pract. 2016;6(2):e17-e19$58$YR$$F$Y$$$20240819$$MD$US$US
125926679$12592667$9$F$20160101$20240719$20160726$20240723$PER$$US-PFIZER INC-2016323247$PFIZER$$54$YR$$F$Y$90.72$KG$20240723$$MD$US$US
1259270916$12592709$16$F$$20240916$20160726$20240919$PER$$US-PFIZER INC-2016336939$PFIZER$$82$YR$$F$Y$65$KG$20240919$$HP$US$US
125999405$12599940$5$F$$20240809$20160727$20240813$EXP$$US-PFIZER INC-2016356792$PFIZER$Hensley, M.. A Large Case Series of Acute Pediatric Methotrexate Ingestions: Significant Clinical Effects Are Rare.. Pediatric Emergency Care. 2016;32(10):682-684$$$$$Y$$$20240813$$HP$US$US
126007078$12600707$8$F$20160801$20240906$20160727$20240916$EXP$$CA-TAKEDA-2016TUS012992$TAKEDA$$62$YR$$F$Y$92$KG$20240916$$CN$CA$CA
1260155923$12601559$23$F$20141209$20240708$20160728$20240715$EXP$$PHHY2013CA096983$NOVARTIS$$64$YR$$F$Y$$$20240715$$MD$CA$CA
1260527210$12605272$10$F$20160701$20240724$20160729$20240729$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-060754$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240729$$MD$FR$FR
1260584817$12605848$17$F$20140523$20240912$20160729$20240917$EXP$$PHHY2014CA065852$NOVARTIS$$32$YR$$F$Y$$$20240917$$HP$CA$CA
1260592912$12605929$12$F$20150507$20211122$20160729$20240819$EXP$$JP-AMGEN-JPNCT2016098045$AMGEN$$87$YR$E$M$Y$$$20240819$$MD$JP$JP
1261220641$12612206$41$F$20150510$20240923$20160801$20240926$EXP$$PHHY2015CA089484$NOVARTIS$$40$YR$$F$Y$88$KG$20240926$$MD$CA$CA
126132752$12613275$2$F$20160529$20240808$20160802$20240821$EXP$$GB-AUROBINDO-AUR-APL-2016-09879$AUROBINDO$$76$YR$$M$Y$139$KG$20240821$$MD$GB$GB
1261461520$12614615$20$F$20160101$20240715$20160802$20240717$EXP$$US-PFIZER INC-2016022099$PFIZER$$66$YR$$F$Y$86$KG$20240717$$CN$US$US
1262095917$12620959$17$F$20151119$20240627$20160804$20240704$EXP$$PHHY2015CA153374$NOVARTIS$$68$YR$$M$Y$100.68$KG$20240704$$HP$CA$CA
1262260613$12622606$13$F$20160423$20240708$20160804$20240715$EXP$$US-ARIAD PHARMACEUTICALS, INC-2016US006716$TAKEDA$$63$YR$$F$Y$84$KG$20240715$$CN$US$US
1264877315$12648773$15$F$20180801$20240702$20160812$20240704$PER$$US-PFIZER INC-2016374798$PFIZER$$63$YR$$M$Y$$$20240704$$CN$US$US
126494458$12649445$8$F$$20240924$20160812$20240926$EXP$$CA-009507513-1608CAN005855$MERCK$$10$YR$$M$Y$$$20240926$$HP$CA$CA
1265982719$12659827$19$F$20220310$20240726$20160817$20240731$EXP$$US-SHIRE-2016DX000079$TAKEDA$$17$YR$$F$Y$61$KG$20240731$$HP$US$US
1267604339$12676043$39$F$$20240711$20160823$20240718$EXP$$CA-SA-2015SA146389$SANOFI AVENTIS$$43$YR$A$F$Y$96$KG$20240718$$MD$CA$CA
1267642215$12676422$15$F$20120510$20240801$20160823$20240807$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2016JPN119671$VIIV$$$$$$Y$$$20240807$$MD$JP$JP
1267647415$12676474$15$F$20120510$20240801$20160823$20240807$EXP$$JP-GLAXOSMITHKLINE-JP2016JPN119671$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$JP$JP
1267797120$12677971$20$F$20150327$20240717$20160823$20240723$EXP$$PHHY2015CO167185$NOVARTIS$$34$YR$$F$Y$57$KG$20240723$$CN$CO$CO
1268655311$12686553$11$F$20160701$20240730$20160825$20240805$EXP$$FR-MYLANLABS-2016M1035188$MYLAN$$76$YR$$F$Y$$$20240805$$HP$FR$FR
126869025$12686902$5$F$20151001$20240829$20160825$20240904$EXP$$US-JAZZ-2016-US-006844$JAZZ$$46$YR$$F$Y$$$20240904$$CN$US$US
126896475$12689647$5$F$$20240916$20160826$20240924$EXP$$ES-AUROBINDO-AUR-APL-2016-10934$AUROBINDO$Mart?n-Navarro JA, Petkov-Stoyanov V, Guti?rrez-S?nchez MJ, Pedraza-Cez?n YL.. Acute renal failure secondary to interstitial acute nephritis and Fanconi syndrome for metamizole and gemfibrozil. [Estonian].. Nefrologia. 2016;36: No. 3:321-23$49$YR$$M$Y$$$20240924$$MD$ES$ES
1269020033$12690200$33$F$$20240724$20160826$20240805$EXP$$CA-AMGEN-CANSP2016107911$AMGEN$$42$YR$A$F$Y$97$KG$20240805$$HP$CA$CA
126924095$12692409$5$F$20160126$20240705$20160828$20240712$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-006994$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240712$$CN$CA$CA
1269299313$12692993$13$F$20160407$20240716$20160829$20240724$EXP$$CA-ROCHE-1821507$ROCHE$$70$YR$E$M$Y$77$KG$20240724$$MD$CA$CA
1269489737$12694897$37$F$$20240724$20160829$20240731$EXP$$CA-PFIZER INC-2016406528$PFIZER$$42$YR$$F$Y$97$KG$20240731$$HP$CA$CA
126962955$12696295$5$F$$20240917$20160830$20240924$EXP$$CA-ROCHE-1821354$ROCHE$$10$YR$C$M$Y$$$20240924$$HP$CA$CA
1269688716$12696887$16$F$$20240822$20160830$20240830$EXP$$CA-Orion Corporation ORION PHARMA-TREX2016-1453$ORION$$60$YR$A$F$Y$$$20240830$$MD$CA$
126980304$12698030$4$F$20040101$20240729$20160830$20240805$PER$$US-JNJFOC-20160708718$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240805$$LW$US$US
126982503$12698250$3$F$20110101$20240722$20160830$20240726$EXP$$US-JNJFOC-20160728231$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$HP$US$US
126983153$12698315$3$F$20110101$20240724$20160830$20240726$PER$$US-JNJFOC-20160804331$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$HP$US$US
126997145$12699714$5$F$20090101$20240726$20160830$20240802$EXP$$US-BIOGEN-2009BI040939$BIOGEN$$$$$F$Y$$$20240802$$CN$US$US
1270058737$12700587$37$F$20160601$20240910$20160830$20240916$EXP$$CA-ROCHE-1821941$ROCHE$$38$YR$A$F$Y$97$KG$20240916$$HP$CA$CA
1270573726$12705737$26$F$$20240722$20160901$20240801$EXP$$CA-Orion Corporation ORION PHARMA-TREX2016-1512$ORION$$42$YR$A$F$Y$97$KG$20240801$$HP$CA$
127080168$12708016$8$F$$20240821$20160901$20240827$EXP$$CA-PFIZER INC-2016125504$PFIZER$Rizek, P. Bowel Ischemia in Refractory Status Epilepticus: Report of Two Cases and Review of the Literature.. Neurocritical Care. 2016;24 (1):128-131$58$YR$$F$Y$$$20240827$$MD$CA$CA
127086004$12708600$4$F$20160701$20240619$20160901$20240702$EXP$$US-PFIZER INC-2016409335$PFIZER$$35$YR$$M$Y$$$20240702$$PH$US$US
1271108410$12711084$10$F$$20240730$20160902$20240801$EXP$$US-PFIZER INC-2016407143$PFIZER$$85$YR$$F$Y$52.154$KG$20240801$$CN$US$US
1271617518$12716175$18$F$20160101$20240813$20160906$20240819$EXP$$PHHY2011CA67594$NOVARTIS$$62$YR$$M$Y$$$20240819$$CN$CA$CA
127169074$12716907$4$F$20160816$20240710$20160906$20240712$EXP$$CA-PFIZER INC-2016406331$PFIZER$$73$YR$$F$Y$$$20240712$$CN$CA$CA
1272267514$12722675$14$F$20160601$20240823$20160907$20240828$PER$$US-PFIZER INC-2016228092$PFIZER$$70$YR$$F$Y$75$KG$20240828$$MD$US$US
1272747540$12727475$40$F$20160609$20240807$20160909$20240816$EXP$$CA-ROCHE-1827432$ROCHE$$62$YR$A$F$Y$74$KG$20240816$$MD$CA$CA
127299453$12729945$3$F$20150518$20240712$20160909$20240717$EXP$$US-TAKEDA-2016TUS015120$TAKEDA$$43$YR$$F$Y$86.16$KG$20240717$$MD$US$US
1273291916$12732919$16$F$20160906$20240814$20160912$20240820$EXP$$PHHY2015CA163254$NOVARTIS$$66$YR$$M$Y$$$20240820$$CN$CA$CA
1273710827$12737108$27$F$20150617$20240905$20160913$20240912$EXP$$CA-ROCHE-1827996$ROCHE$$61$YR$A$F$Y$$$20240912$$CN$CA$CA
1275270020$12752700$20$F$20160906$20240814$20160916$20240822$EXP$$CA-ROCHE-1829312$ROCHE$$66$YR$E$M$Y$$$20240822$$CN$CA$CA
127527493$12752749$3$F$20151019$20240819$20160915$20240902$EXP$$US-ASTELLAS-2015US037117$ASTELLAS$$79$YR$E$M$Y$$$20240902$$CN$US$US
1277575011$12775750$11$F$20151201$20240702$20160923$20240706$EXP$$US-JAZZ-2016-US-010126$JAZZ$$50$YR$$M$Y$$$20240706$$CN$US$US
127759302$12775930$2$F$$20240809$20160923$20240816$EXP$$US-SA-2016SA173244$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240816$$HP$US$US
127787003$12778700$3$F$$20240711$20160926$20240724$EXP$DE-MLMSERVICE-20160818-0291594-1$DE-MACLEODS PHARMACEUTICALS US LTD-MAC2016003143$MACLEODS$$$$$$Y$$$20240724$$MD$DE$DE
127915416$12791541$6$F$20160701$20240805$20160929$20240806$EXP$$US-PFIZER INC-2016456339$PFIZER$$71$YR$$F$Y$$$20240806$$CN$US$US
127919804$12791980$4$F$20080101$20240814$20160929$20240819$PER$$US-JNJFOC-20160806454$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240819$$LW$US$US
127928243$12792824$3$F$20001101$20240909$20160929$20240912$PER$$US-JNJFOC-20160917029$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240912$$HP$US$US
127931643$12793164$3$F$$20240812$20160929$20240816$PER$$US-JNJFOC-20160915290$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$LW$US$US
127946173$12794617$3$F$$20240710$20160929$20240714$PER$$US-JNJFOC-20160917149$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$LW$US$US
127972683$12797268$3$F$$20240715$20160930$20240724$EXP$$CA-APOTEX-2016AP012414$APOTEX$$$$$M$Y$$$20240724$$HP$CA$CA
1279829612$12798296$12$F$$20240812$20160930$20240820$EXP$$CA-APOTEX-2016AP012482$APOTEX$$31$YR$$F$Y$71$KG$20240820$$CN$CA$CA
127984522$12798452$2$F$$20240724$20160930$20240731$EXP$$ES-MYLANLABS-2016M1040747$MYLAN$Garcia-Nunez I, Algaba-Marmol M-A, Barasona-Villarejo M-J, Suarez-Vergara M, Espinola-Gonzalez F, Reina-Ariza E-M. Kounis syndrome after levofloxacin intake: Clinical report and cross reactivity study. Allergy 2016;71 (Suppl. 102):524 abstr. 1597.$35$YR$$M$Y$$$20240731$$HP$ES$ES
128008037$12800803$7$F$$20240712$20161002$20240722$EXP$$CA-APOTEX-2016AP012426$APOTEX$$38$YR$$F$Y$54$KG$20240722$$HP$CA$CA
1280612810$12806128$10$F$20160601$20240620$20161004$20240704$EXP$$CA-GLAXOSMITHKLINE-CA2016GSK084842$Haleon PLC$$45$YR$$F$Y$$$20240704$$CN$CA$CA
1280942516$12809425$16$F$20160903$20240925$20161005$20240928$EXP$$CA-TAKEDA-2016TUS017672$TAKEDA$$63$YR$$M$Y$$$20240928$$CN$CA$CA
128154395$12815439$5$F$$20240909$20161005$20240921$EXP$$CA-UCBSA-2015027945$UCB$$60$YR$$F$Y$$$20240921$$MD$CA$CA
1282456426$12824564$26$F$20110101$20240822$20161007$20240829$EXP$$CA-PFIZER INC-2016464814$PFIZER$$68$YR$$F$Y$$$20240829$$HP$CA$CA
128364163$12836416$3$F$$20240919$20161011$20240923$EXP$$HU-PFIZER INC-2016468953$MYLAN$Dr. Ruszkai Zoltan. Serotonin: source of joy for one, racking brain and bustling to the other. Aneszteziologia es Intenziv Terapia. 2016;47(S2):47$$$$$Y$$$20240923$$MD$HU$HU
128521752$12852175$2$F$$20240709$20161017$20240716$EXP$$CA-GLAXOSMITHKLINE-CA2016GSK147895$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$HP$CA$CA
1285307620$12853076$20$F$20190319$20240906$20161017$20240920$EXP$$US-JAZZ-2016-US-014084$JAZZ$$60$YR$$F$Y$$$20240920$$HP$US$US
1286392214$12863922$14$F$20201231$20240801$20161019$20240806$EXP$$CA-TAKEDA-2016TUS018720$TAKEDA$$49$YR$$F$Y$$$20240806$$CN$CA$CA
1286453612$12864536$12$F$20130109$20240619$20161020$20240702$EXP$$CA-ROCHE-1843171$ROCHE$$61$YR$A$F$Y$$$20240702$$MD$CA$CA
128647923$12864792$3$F$20160831$20240708$20161020$20240715$EXP$$IT-AUROBINDO-AUR-APL-2016-12769$AUROBINDO$$69$YR$$M$Y$$$20240715$$PH$IT$IT
128672217$12867221$7$F$20160101$20240724$20161020$20240731$EXP$$US-JAZZ-2016-US-014683$JAZZ$$$$$F$Y$$$20240731$$HP$US$US
128718388$12871838$8$F$20180724$20240807$20161021$20240808$EXP$$US-NAPPMUNDI-USA-2016-0131959$PURDUE$$$$$F$Y$$$20240808$$CN$US$US
128744928$12874492$8$F$20160101$20240809$20161021$20240814$EXP$$US-JAZZ-2016-US-018557$JAZZ$$$$$F$Y$$$20240814$$CN$US$US
128771283$12877128$3$F$$20240710$20161024$20240717$PER$$US-BIOGEN-2016BI00306816$BIOGEN$$$$$F$Y$$$20240717$$CN$US$US
128772895$12877289$5$F$$20240709$20161024$20240712$EXP$$US-PFIZER INC-2016489046$PFIZER$Lu, B.. Facial manifestations of Epstein-Barr virus-related lymphoproliferative disease in childhood acute lymphoblastic leukemia in remission: Two atypical presentations. Pediatric Blood and Cancer. 2016;63 (11):2042-2045$16$YR$$M$Y$$$20240712$$HP$US$US
128808743$12880874$3$F$19980101$20240809$20161025$20240816$EXP$$US-JNJFOC-20151102759$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240816$$HP$US$US
128812873$12881287$3$F$20140101$20240722$20161025$20240725$EXP$$US-JNJFOC-20161003647$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240725$$HP$US$US
128813603$12881360$3$F$20040101$20240906$20161025$20240910$PER$$US-JNJFOC-20161004422$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240910$$HP$US$US
128823674$12882367$4$F$20150401$20240918$20161025$20240923$EXP$$AR-SA-2016SA062568$SANOFI AVENTIS$Pitoia F, SchmidtA, Bueno F, Abelleira E, Jerkovich F. Rare complications of multikinase  inhibitor treatment.. Endocrinol Metab. 2018;62(6):636-40$37$YR$A$F$Y$$$20240923$$MD$AR$AR
128830864$12883086$4$F$20161001$20240819$20161025$20240824$EXP$$CA-SHIRE-CA201615466$TAKEDA$$31$YR$$M$Y$$$20240824$$CN$CA$CA
128951323$12895132$3$F$20160315$20180812$20161029$20240925$PER$$JP-AMGEN-JPNNI2016151361$AMGEN$$61$YR$A$M$Y$$$20240925$$MD$JP$JP
1291173234$12911732$34$F$20180614$20240806$20161104$20240812$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK144075$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$BR$BR
129123934$12912393$4$F$$20240715$20161104$20240722$EXP$$IT-PFIZER INC-2016512605$PFIZER$Esposito, S.. A young infant with transient severe hypertriglyceridemia temporarily associated with meropenem administration: A case report and review of the literature. Medicine. 2016;95(38):e4872$75$DY$$F$Y$$$20240722$$MD$IT$IT
1291335236$12913352$36$F$$20240819$20161104$20240903$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-037942$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$95$KG$20240903$$CN$CA$CA
1291369431$12913694$31$F$20160106$20240711$20161104$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-053149$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240725$$CN$CA$CA
1291393911$12913939$11$F$$20240724$20161104$20240807$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091688$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240807$$HP$CA$CA
129139533$12913953$3$F$$20240820$20161104$20240830$EXP$$CA-APOTEX-2016AP013716$APOTEX$$68$YR$$F$Y$$$20240830$$HP$CA$CA
129172646$12917264$6$F$$20240701$20161107$20240705$EXP$$US-JAZZ-2016-US-017589$JAZZ$$$$$F$Y$$$20240705$$HP$US$US
129269573$12926957$3$F$20160401$20240919$20161108$20240924$EXP$$US-BIOGEN-2016BI00313972$BIOGEN$$58$YR$$F$Y$$$20240924$$CN$US$US
129393589$12939358$9$F$$20240827$20161114$20240902$EXP$$US-ARIAD-2016US007158$TAKEDA$$$$$M$Y$$$20240902$$CN$US$US
129403243$12940324$3$F$19990101$20240729$20161115$20240805$PER$$US-JNJFOC-20161102568$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240805$$HP$US$US
129405893$12940589$3$F$20090101$20240722$20161115$20240730$PER$$US-JNJFOC-20161103068$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240730$$LW$US$US
129406503$12940650$3$F$20130101$20240904$20161115$20240909$PER$$US-JNJFOC-20161103678$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240909$$LW$US$US
129410843$12941084$3$F$20120101$20240717$20161115$20240723$EXP$$US-JNJFOC-20161103224$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$HP$US$US
129411283$12941128$3$F$20100101$20240724$20161115$20240730$PER$$US-JNJFOC-20161103262$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240730$$LW$US$US
129414613$12941461$3$F$20010101$20240722$20161115$20240723$PER$$US-JNJFOC-20161104099$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240723$$LW$US$US
129418303$12941830$3$F$20020101$20240710$20161115$20240711$PER$$US-JNJFOC-20161106994$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240711$$LW$US$US
129419729$12941972$9$F$20110101$20240822$20161114$20240826$EXP$$US-JAZZ-JPI-P-019501$JAZZ$$33$YR$$F$Y$113.4$KG$20240826$$MD$US$US
1294337737$12943377$37$F$20220401$20240911$20161115$20240918$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK075816$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$BR$BR
129514353$12951435$3$F$20170101$20240918$20161116$20240926$EXP$$BR-AMGEN-BRASP2016160279$AMGEN$$68$YR$E$F$Y$$$20240926$$CN$BR$BR
1296129917$12961299$17$F$20161116$20240914$20161121$20240916$PER$$US-PFIZER INC-2016538805$PFIZER$$20$YR$$M$Y$$$20240916$$CN$US$US
129613843$12961384$3$F$20161104$20240815$20161121$20240820$PER$$US-TAKEDA-2016TUS020659$TAKEDA$$69$YR$$F$Y$70.3$KG$20240820$$CN$US$US
1296549415$12965494$15$F$20161001$20240704$20161122$20240711$EXP$$BR-TAKEDA-2016TUS021026$TAKEDA$$61$YR$$F$Y$70.9$KG$20240711$$CN$BR$BR
1296897413$12968974$13$F$$20240806$20161123$20240808$PER$$US-PFIZER INC-2016545465$PFIZER$$72$YR$$F$Y$56.689$KG$20240808$$CN$US$US
129698264$12969826$4$F$20140101$20240905$20161123$20240909$EXP$$PL-SA-2016SA207852$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240909$$MD$PL$PL
129703478$12970347$8$F$20161116$20240910$20161123$20240912$EXP$$IE-JNJFOC-20161124043$JOHNSON AND JOHNSON$$60$YR$A$M$Y$90$KG$20240913$$CN$IE$IE
129710083$12971008$3$F$20150901$20240808$20161123$20240814$EXP$$US-JAZZ-2015-US-002811$JAZZ$$27$YR$$F$Y$$$20240814$$HP$US$US
1297451218$12974512$18$F$20160411$20240618$20161125$20240709$EXP$$CA-ROCHE-1859271$ROCHE$$66$YR$E$F$Y$$$20240701$$CN$CA$CA
129756817$12975681$7$F$20161001$20240705$20161125$20240711$EXP$$BE-TAKEDA-2016TUS021324$TAKEDA$$22$YR$$M$Y$$$20240711$$MD$BE$BE
1298505611$12985056$11$F$$20240916$20161129$20240927$EXP$$CA-APOTEX-2016AP014805$APOTEX$$52$YR$$M$Y$$$20240927$$MD$CA$CA
129869052$12986905$2$F$$20161123$20161130$20240903$EXP$$GB-JNJFOC-20161125751$JOHNSON AND JOHNSON$$$$$M$Y$50$KG$20240903$$MD$GB$GB
129874665$12987466$5$F$20160101$20240820$20161130$20240822$EXP$$JP-SA-2016SA216666$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240822$$MD$JP$JP
1298794810$12987948$10$F$20160101$20240723$20161130$20240725$EXP$$US-BAXALTA-2016BLT008577$TAKEDA$$$$$F$Y$91$KG$20240725$$HP$US$US
129883493$12988349$3$F$$20240809$20161130$20240814$EXP$$US-JAZZ-2016-US-023123$JAZZ$$$$$F$Y$$$20240814$$CN$US$US
129902093$12990209$3$F$$20240814$20161201$20240821$EXP$$NL-009507513-1611NLD014254$ASPEN$$$$$$Y$$$20240821$$HP$NL$NL
129915484$12991548$4$F$20160101$20240820$20161201$20240827$EXP$$JP-SA-2016SA216682$SANOFI AVENTIS$Tanaka H, Kojima R, Hirasawa K, Takase S, Sato H, Okamoto I, et al. A Case of Sepsis Caused by Non-Occlusive Mesenteric Ischaemia Noted During Induction Chemotherapy. The 27th Annual Meeting of the Japan Society for Head and Neck Surgery/Scientifi. 2017;unknown:unknown$74$YR$E$M$Y$$$20240827$$MD$JP$JP
1299241841$12992418$41$F$20161123$20240903$20161202$20240916$EXP$$CA-ROCHE-1862239$ROCHE$$53$YR$A$F$Y$$$20240916$$CN$CA$CA
129967682$12996768$2$F$$20240823$20161204$20240902$EXP$$FR-ROCHE-1862935$ROCHE$Terrier B, Jachiet M, Samson M, Cottin V, Kahn JE, Guenno GE et al. Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss).. ARTHRITIS AND RHEUMATOLOGY. 2016;68(9):2274-82 ;//2016:2274-82.$53$YR$A$M$Y$$$20240902$$HP$FR$FR
129986262$12998626$2$F$$20240814$20161205$20240822$PER$$US-SHIRE-US201618499$TAKEDA$$43$YR$$F$Y$64$KG$20240822$$CN$US$US
130057965$13005796$5$F$20130101$20240628$20161207$20240705$EXP$$US-BIOGEN-2016BI00327021$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
1300991010$13009910$10$F$20140720$20240805$20161208$20240812$EXP$$PHHY2014IN084165$NOVARTIS$$34$YR$$F$Y$$$20240812$$CN$IN$IN
1301373014$13013730$14$F$20160101$20240816$20161209$20240823$EXP$$CA-TAKEDA-2016TUS018689$TAKEDA$$$$$M$Y$$$20240823$$MD$CA$CA
130168055$13016805$5$F$$20240712$20161212$20240726$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-129347$RANBAXY$Pfeiffer H, Herbst L, Schwarze B, Eckstein R, Weisbach V. Massive intoxication with rivaroxaban, phenprocoumon, and diclofenac A case report. Medicine (Baltimore). 2016;e5343 D$23$YR$$M$Y$74$KG$20240726$$MD$DE$DE
1301761515$13017615$15$F$20160801$20240828$20161212$20240902$EXP$$US-PFIZER INC-2016574841$PFIZER$$69$YR$$F$Y$90$KG$20240902$$CN$US$US
1302401122$13024011$22$F$20161101$20240918$20161213$20240926$EXP$$US-PFIZER INC-2016569208$PFIZER$$40$YR$$F$Y$$$20240926$$CN$US$US
1303206711$13032067$11$F$20161207$20240813$20161215$20240816$PER$$US-PFIZER INC-2016573674$PFIZER$$63$YR$$F$Y$$$20240816$$HP$US$US
130357264$13035726$4$F$20150729$20240701$20161216$20240703$PER$$US-PFIZER INC-2016570983$PFIZER$$70$YR$$F$Y$64.23$KG$20240703$$MD$US$US
1303730615$13037306$15$F$$20240723$20161216$20240730$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK140073$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$BR$BR
130481706$13048170$6$F$$20240725$20161220$20240729$EXP$IT-MINISAL02-387132$IT-MYLANLABS-2016M1055989$MYLAN$Giovannini M, Sarti L, Barni S, Pucci N, Novembre E, Mori F.. Anaphylaxis to Over-the-Counter Flurbiprofen in a Child. Pharmacology. 2016;99 (3-4):121-123$10$YR$$F$Y$$$20240729$$HP$IT$IT
130528976$13052897$6$F$20151106$20240821$20161222$20240831$EXP$$PHHY2015CA147774$NOVARTIS$$62$YR$$F$Y$$$20240831$$CN$CA$CA
1305805717$13058057$17$F$$20240821$20161223$20240829$EXP$$CA-APOTEX-2016AP015766$APOTEX$$65$YR$$F$Y$95$KG$20240829$$MD$CA$CA
1306035438$13060354$38$F$20161026$20240622$20161223$20240701$EXP$$SK-SA-2016SA205066$SANOFI AVENTIS$$39$YR$A$F$Y$54$KG$20240701$$MD$SK$SK
130604752$13060475$2$F$$20240910$20161224$20240921$EXP$$US-Accord-046729$ACCORD$Rattner P, Sutherland A. Aspergillus nidulans: A rare cause of invasive pulmonary aspergillosis resulting in diffuse alveolar haemorrhage. Chest. 2016; 150(4):157A.$25$YR$A$F$Y$$$20240921$$HP$US$US
130686232$13068623$2$F$$20240911$20161228$20240925$EXP$US-MLMSERVICE-20161207-0527858-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2016-00438$ALKEM$Rattner P, Sutherland A. Aspergillus nidulans: A rare cause of invasive pulmonary aspergillosis resulting in diffuse alveolar haemorrhage. Chest. 2016;150(4):157A$25$YR$$F$Y$$$20240925$$MD$US$US
1306917113$13069171$13$F$20210101$20240919$20161228$20240920$EXP$$US-PFIZER INC-2016477642$PFIZER$$67$YR$$F$Y$97.5$KG$20240920$$CN$US$US
130703192$13070319$2$F$$20161215$20161228$20240802$PER$$US-009507513-1612USA008925$MERCK$$$$$$Y$$$20240802$$PH$US$US
1307383419$13073834$19$F$20161220$20240903$20161229$20240909$EXP$$CA-TAKEDA-2016TUS023148$TAKEDA$$67$YR$$F$Y$$$20240909$$CN$CA$CA
130797526$13079752$6$F$20161123$20240905$20170103$20240911$EXP$$CA-TAKEDA-2016TUS021278$TAKEDA$$37$YR$$M$Y$$$20240911$$CN$CA$CA
130942016$13094201$6$F$$20240906$20170106$20240910$EXP$$JP-PFIZER INC-2016573932$PFIZER$Yoshikawa, T. Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan. Vaccine. 2016;34(41):4943-4947$40$YR$$M$Y$$$20240910$$MD$JP$JP
131083839$13108383$9$F$20170629$20240709$20170112$20240716$EXP$$PHJP2017JP000775$NOVARTIS$$43$YR$$M$Y$103.8$KG$20240716$$MD$JP$JP
1310930130$13109301$30$F$20140101$20240724$20170112$20240807$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-065623$BRISTOL MYERS SQUIBB$$12$YR$T$F$Y$64$KG$20240808$$CN$CA$CA
1310972324$13109723$24$F$$20240920$20170112$20240924$EXP$$US-PFIZER INC-2016491928$PFIZER$$43$YR$$F$Y$84$KG$20240924$$CN$US$US
1311073018$13110730$18$F$20160521$20240816$20170112$20240820$EXP$$CA-TAKEDA-2016TUS009032$TAKEDA$$78$YR$$M$Y$$$20240820$$CN$CA$CA
131134174$13113417$4$F$20161017$20240718$20170113$20240719$EXP$$HR-PFIZER INC-2017008927$PFIZER$$44$YR$$F$Y$61.5$KG$20240719$$MD$HR$HR
131178703$13117870$3$F$20060101$20240715$20170116$20240718$PER$$US-JNJFOC-20170104064$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240718$$LW$US$US
131181534$13118153$4$F$$20240909$20170116$20240912$PER$$US-JNJFOC-20161217230$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$LW$US$US
131269948$13126994$8$F$20161207$20240828$20170118$20240831$EXP$$US-JAZZ-2017-US-000592$JAZZ$$43$YR$$F$Y$$$20240831$$MD$US$US
131284813$13128481$3$F$$20240828$20170118$20240902$EXP$$US-JAZZ-2017-US-000359$JAZZ$$$$$F$Y$$$20240902$$MD$US$US
1312968311$13129683$11$F$20120101$20240729$20170119$20240731$EXP$$US-PFIZER INC-2017021999$PFIZER$$64$YR$$F$Y$$$20240731$$CN$US$US
1313146712$13131467$12$F$19970101$20240820$20170119$20240822$PER$$US-PFIZER INC-2017022444$PFIZER$$53$YR$$F$Y$63.5$KG$20240822$$CN$US$US
1313210712$13132107$12$F$20030101$20240903$20170119$20240906$EXP$$US-JAZZ-2017-US-000516$JAZZ$$$$$F$Y$$$20240905$$MD$US$US
131393334$13139333$4$F$20161201$20240917$20170123$20240919$EXP$$FR-PFIZER INC-2017020968$PFIZER$$72$YR$$F$Y$100$KG$20240919$$MD$FR$FR
1314326414$13143264$14$F$20160101$20240627$20170124$20240704$EXP$$FR-GLAXOSMITHKLINE-FR2016GSK093577$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$HP$FR$FR
1314533911$13145339$11$F$20161201$20240904$20170124$20240906$EXP$$PHHY2016CA180092$NOVARTIS$$57$YR$$M$Y$$$20240906$$CN$CA$CA
1314540423$13145404$23$F$$20240911$20170124$20240913$PER$$US-PFIZER INC-2017029857$PFIZER$$64$YR$$F$Y$$$20240913$$CN$US$US
1315873921$13158739$21$F$20161101$20240808$20170127$20240815$EXP$$CA-TAKEDA-2017TUS001663$TAKEDA$$47$YR$$F$Y$60$KG$20240815$$HP$CA$CA
131611662$13161166$2$F$$20240701$20170130$20240710$EXP$$US-AUROBINDO-AUR-APL-2017-28398$AUROBINDO$Mowry JB,Spyker AD, Brooks DE, Zimmerman A + Schauben JL. 2015 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):33rd Annual Report. Clinical Toxicology. 2016;54(10):924-1109$67$YR$$F$Y$$$20240710$$PH$US$US
1316446812$13164468$12$F$20170209$20240827$20170130$20240830$EXP$$CA-TAKEDA-2017TUS001775$TAKEDA$$65$YR$$F$Y$$$20240830$$HP$CA$CA
131653418$13165341$8$F$20170101$20240905$20170131$20240913$EXP$$CA-ROCHE-1887040$ROCHE$$66$YR$E$F$Y$$$20240913$$CN$CA$CA
131718608$13171860$8$F$20161116$20240717$20170201$20240718$PER$$US-PFIZER INC-2017040325$PFIZER$$67$YR$$M$Y$70$KG$20240718$$CN$US$US
131755385$13175538$5$F$20170113$20240812$20170201$20240823$PER$$US-INCYTE CORPORATION-2017IN000447$INCYTE$$$$$$Y$$$20240823$$MD$US$US
1317867413$13178674$13$F$20161013$20240806$20170202$20240814$EXP$$CA-ROCHE-1888270$ROCHE$$47$YR$A$F$Y$$$20240814$$HP$CA$CA
131833944$13183394$4$F$20161023$20240808$20170203$20240815$EXP$$GB-ABBVIE-17P-167-1856326-00$ABBVIE$$23$YR$$M$Y$$$20240809$$MD$GB$GB
131880145$13188014$5$F$$20240816$20170206$20240829$EXP$$US-AUROBINDO-AUR-APL-2017-29212$AUROBINDO$vlahovic L, Sweis R, Lowery E, Borys E, Biller J. Fulminant West Nile Virus (WNV) Encephalitis in a Double Bilateral Lung Transplant Recipient: Case report. Annals of Neurology. 2016;80 (20):S119-S120$51$YR$$F$Y$$$20240829$$HP$US$US
1319514218$13195142$18$F$20150801$20240813$20170207$20240821$EXP$$CA-ROCHE-1890133$ROCHE$$64$YR$A$F$Y$$$20240821$$CN$CA$CA
1319527633$13195276$33$F$20160606$20240712$20170208$20240726$EXP$$CA-ROCHE-1889780$ROCHE$$66$YR$E$M$Y$$$20240726$$CN$CA$CA
132054583$13205458$3$F$$20240924$20170209$20240927$EXP$$US-JAZZ-2017-US-001171$JAZZ$$$$$F$Y$$$20240927$$MD$US$US
1321121020$13211210$20$F$$20240828$20170209$20240830$EXP$$CA-PFIZER INC-2017057251$PFIZER$Acedillo, R.. Treatment of severe, refractory and rapidly evolving thrombotic thrombocytopenic purpura. BMJ Case Reports. 2016;2016:10.1136/bcr-2016-215491$36$YR$$M$Y$$$20240830$$MD$CA$CA
1321911926$13219119$26$F$20141126$20240718$20170210$20240731$EXP$$CA-ROCHE-1891382$ROCHE$$68$YR$E$M$Y$87$KG$20240731$$MD$CA$CA
1322723245$13227232$45$F$$20240911$20170213$20240917$EXP$$CA-PURDUE PHARMA-CAN-2017-0007437$PURDUE$Farrell B, Merkley V, Thompson W.. Managing polypharmacy in a 77-year-old woman with multiple prescribers. CMAJ. 2013;185(14):1240-1245$77$YR$$F$Y$$$20240917$$HP$DE$CA
1323021925$13230219$25$F$20160603$20240914$20170214$20240925$EXP$$PHHY2016CA090442$NOVARTIS$$39$YR$$M$Y$125$KG$20240925$$MD$CA$CA
132340785$13234078$5$F$20170202$20240801$20170215$20240807$EXP$$PHHY2017CO020740$NOVARTIS$$59$YR$$F$Y$48$KG$20240807$$CN$CO$CO
132372057$13237205$7$F$$20240719$20170215$20240723$EXP$$AU-PFIZER INC-2017024812$PFIZER$Sivakumar, J.. Proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia: Case review. International Journal of Physiology, Pathophysiology and Pharmacology. 2016;8(4):169-174$91$YR$$M$Y$$$20240723$$HP$AU$AU
132391973$13239197$3$F$19980901$20240716$20170216$20240723$EXP$$US-BIOGEN-2017BI00357726$BIOGEN$$54$YR$$F$Y$$$20240723$$CN$US$US
1324415024$13244150$24$F$20150928$20240917$20170217$20240919$EXP$$NL-SA-2015SA218820$SANOFI AVENTIS$$45$YR$A$F$Y$69$KG$20240919$$CN$FR$NL
1324493114$13244931$14$F$20170129$20240722$20170216$20240801$EXP$$CA-ROCHE-1894064$ROCHE$$40$YR$A$F$Y$$$20240801$$CN$CA$CA
1324649432$13246494$32$F$20130919$20240906$20170217$20240919$EXP$$GB-AUROBINDO-AUR-APL-2017-29423$AUROBINDO$$55$YR$$M$Y$$$20240919$$MD$GB$GB
1325085811$13250858$11$F$20170211$20240828$20170220$20240905$EXP$$CA-ROCHE-1895248$ROCHE$$67$YR$E$F$Y$$$20240905$$MD$CA$CA
132628292$13262829$2$F$20140101$20240703$20170223$20240705$PER$$US-JNJFOC-20151106470$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240705$$LW$US$US
1327376213$13273762$13$F$20160101$20240909$20170227$20240911$EXP$$US-PFIZER INC-2017077406$PFIZER$$61$YR$$F$Y$82$KG$20240911$$CN$US$US
132753736$13275373$6$F$20170101$20240910$20170228$20240918$EXP$$CA-ROCHE-1898517$ROCHE$$76$YR$E$M$Y$$$20240918$$CN$CA$CA
132754912$13275491$2$F$20150101$20240912$20170228$20240920$EXP$$US-BIOGEN-2017BI00362624$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
132807615$13280761$5$F$$20240916$20170301$20240927$EXP$$CA-BAXTER-2017BAX008935$BAXTER$$36$YR$$M$Y$$$20240927$$CN$CA$CA
132876213$13287621$3$F$20170112$20240923$20170302$20240930$EXP$$CA-ABBVIE-16P-028-1658076-00$ABBVIE$$30$YR$$F$Y$$$20240930$$MD$CA$CA
1328861118$13288611$18$F$$20240920$20170302$20240924$EXP$$US-PFIZER INC-2017079065$PFIZER$$67$YR$$F$Y$58.97$KG$20240924$$CN$US$US
1329228117$13292281$17$F$20170201$20240715$20170303$20240718$EXP$$CA-TAKEDA-2017TUS004521$TAKEDA$$41$YR$$F$Y$$$20240718$$CN$CA$CA
132937313$13293731$3$F$20170221$20240910$20170303$20240921$EXP$$US-TAKEDA-2017MPI001704$TAKEDA$$52$YR$$F$Y$57$KG$20240921$$CN$US$US
132950396$13295039$6$F$$20240708$20170303$20240717$EXP$FI-JNJFOC-20170226194$FI-JNJFOC-20170226194$JOHNSON AND JOHNSON$Karajamaki A, Lauri T, Ebeling T. Antipsychotic Drug Induced Hypoglycaemia and Hypothermia. Duodecim 2017;133 (3):301-4.$49$YR$A$M$Y$$$20240717$$MD$FI$FI
1329934721$13299347$21$F$20170201$20240715$20170306$20240723$EXP$$CA-PFIZER INC-2017096227$PFIZER$$42$YR$$F$Y$$$20240723$$CN$CA$CA
133027446$13302744$6$F$20170201$20240919$20170307$20240927$EXP$$CA-TAKEDA-2017TUS004312$TAKEDA$$44$YR$$M$Y$$$20240927$$HP$CA$CA
133034167$13303416$7$F$20170301$20240731$20170307$20240806$EXP$$US-INCYTE CORPORATION-2017IN001461$INCYTE$$$$$$Y$$$20240806$$HP$US$US
133038668$13303866$8$F$20210108$20240621$20170307$20240704$EXP$$CN-ROCHE-1727941$ROCHE$$66$YR$E$M$Y$60$KG$20240704$$CN$CN$CN
1330513111$13305131$11$F$20191001$20240724$20170308$20240727$EXP$$PHHY2017CA030045$NOVARTIS$$$$A$M$Y$$$20240727$$MD$CA$CA
133115383$13311538$3$F$$20240717$20170309$20240722$PER$$US-JNJFOC-20170300783$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240723$$HP$US$US
133115413$13311541$3$F$20060101$20240826$20170309$20240830$PER$$US-JNJFOC-20170300787$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240830$$HP$US$US
1331398616$13313986$16$F$20150702$20240925$20170309$20240927$EXP$$CA-TAKEDA-2015TUS017685$TAKEDA$$33$YR$$F$Y$$$20240927$$HP$CA$CA
1331730910$13317309$10$F$$20240718$20170310$20240730$EXP$$FI-AUROBINDO-AUR-APL-2017-30536$AUROBINDO$Karajamaki A, Lauri T, Ebeling T. Antipsychotic drug-induced hypoglycaemia and hypothermia.. Duodecim.. 2017;133(3):301-4$49$YR$$M$Y$$$20240730$$MD$FI$FI
133292673$13329267$3$F$20170224$20240725$20170313$20240730$EXP$$CA-JNJFOC-20170311792$JOHNSON AND JOHNSON$$71$YR$E$F$Y$54.48$KG$20240730$$HP$CA$CA
133401333$13340133$3$F$20160101$20240614$20170316$20240711$EXP$$US-ROCHE-1906461$ROCHE$$58$YR$A$F$Y$$$20240711$$CN$US$US
133481476$13348147$6$F$20080901$20240906$20170318$20240920$EXP$$FR-AUROBINDO-AUR-APL-2017-31221$AUROBINDO$Faucon A, Zamfir O, Dupouet L and Pruna A. Streptococcus pneumonia infection and positive blood culture with Francisella tularensis, in a renal transplant recipient.. Presse Medicale. 2011;40 (12):1199-1202$69$YR$$M$Y$$$20240920$$HP$FR$FR
133523656$13352365$6$F$$20240820$20170320$20240823$EXP$IT-MINISAL02-400110$IT-MYLANLABS-2017M1016663$MYLAN$Arena F, De Angelis LH, D Andrea MM, Cannatelli A, Fossati L, Di Pilato V, et al.. Infections caused by carbapenem-resistant Klebsiella pneumoniae with hypermucoviscous phenotype: A case report and literature review.. Virulence. 2017;8(8):1900-1908$52$YR$$M$Y$$$20240823$$HP$IT$IT
133528944$13352894$4$F$20170302$20240909$20170320$20240913$EXP$$FR-AMGEN-FRASP2017039373$AMGEN$$69$YR$E$M$Y$$$20240913$$MD$FR$FR
1335383319$13353833$19$F$20150101$20240923$20170321$20240926$PER$$US-PFIZER INC-2017110744$PFIZER$$63$YR$$F$Y$$$20240926$$CN$US$US
133575142$13357514$2$F$$20240708$20170322$20240716$EXP$$CA-APOTEX-2017AP008126$APOTEX$$48$YR$$F$Y$96$KG$20240716$$HP$CA$CA
1335763319$13357633$19$F$20170101$20240814$20170322$20240823$EXP$$CA-ROCHE-1909497$ROCHE$$40$YR$A$F$Y$154$KG$20240823$$CN$CA$CA
1335799324$13357993$24$F$20180101$20240912$20170322$20240912$PER$$US-PFIZER INC-2017124435$PFIZER$$65$YR$$M$Y$99.79$KG$20240912$$MD$US$US
133623342$13362334$2$F$$20240819$20170323$20240830$EXP$$HK-Accord-049360$ACCORD$Chung MM, Chan YC, Law Y, Cheng SW. Infectious anastomotic pseudoaneurysm complicating renal allograft: case report and review of literature. Int J Nephrol Renovasc Dis. 2017;10:55-60.$45$YR$A$M$Y$$$20240830$$HP$HK$HK
133639103$13363910$3$F$$20240814$20170323$20240819$EXP$$US-PFIZER INC-2017125443$PFIZER$Sussman, S.. A Teenager with Sulfasalazine-Associated DRESS Syndrome after the Introduction of Amoxicillin. Clinical Pediatrics. 2017;56(3):290-291$16$YR$$M$Y$$$20240819$$MD$US$US
1336455411$13364554$11$F$20080901$20240909$20170323$20240919$EXP$$PHHY2017FR041418$NOVARTIS$Faucon AL, Zamfir O, Dupouet L, Pruna A. Pneumococcal disease and bacteremic tularemia in a renal transplant patient. PRESSE MEDICALE. 2011;40 (12) Part 1:1199-202$69$YR$$M$Y$$$20240919$$HP$FR$FR
1338928821$13389288$21$F$20161121$20240806$20170331$20240816$EXP$$CA-ROCHE-1913940$ROCHE$$52$YR$A$F$Y$$$20240816$$MD$CA$CA
1339544711$13395447$11$F$20160526$20240912$20170403$20240924$EXP$$CA-ROCHE-1768365$ROCHE$$36$YR$A$M$Y$$$20240924$$CN$CA$CA
1339726221$13397262$21$F$20170320$20240923$20170403$20240927$EXP$$US-INCYTE CORPORATION-2017IN002413$INCYTE$$$$$$Y$$$20240927$$CN$US$US
1339894427$13398944$27$F$20160101$20240829$20170404$20240905$EXP$$PHHY2016CA109964$NOVARTIS$$59$YR$$M$Y$$$20240905$$CN$CA$CA
133991602$13399160$2$F$$20240823$20170404$20240902$EXP$$HK-ROCHE-1915320$ROCHE$Chung M, Chan Y, Law Y and Cheng S Infectious anastomotic pseudoaneurysm complicating renal allograft: case report and review of literature. Int J Nephrol Renovasc Dis 2017;10:55-60.$45$YR$A$M$Y$$$20240902$$MD$HK$HK
134008553$13400855$3$F$20150101$20240626$20170404$20240701$EXP$$US-INCYTE CORPORATION-2017IN002304$INCYTE$$$$$$Y$$$20240701$$HP$US$US
134088714$13408871$4$F$20031210$20240624$20170406$20240701$PER$$US-JNJFOC-20170224208$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20240701$$HP$US$US
134096702$13409670$2$F$20050101$20240722$20170406$20240726$PER$$US-JNJFOC-20151105639$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$HP$US$US
134104405$13410440$5$F$$20240717$20170406$20240719$PER$$US-JNJFOC-20170225616$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$HP$US$US
134104952$13410495$2$F$$20240722$20170406$20240725$PER$$US-JNJFOC-20170226938$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$LW$US$US
134105493$13410549$3$F$$20240911$20170406$20240919$PER$$US-JNJFOC-20170300317$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$LW$US$US
134105523$13410552$3$F$$20240826$20170406$20240830$PER$$US-JNJFOC-20170300319$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$LW$US$US
134106784$13410678$4$F$20110707$20240830$20170406$20240904$PER$$US-JNJFOC-20170307973$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240904$$LW$US$US
134107803$13410780$3$F$$20240814$20170406$20240819$PER$$US-JNJFOC-20170307966$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$LW$US$US
134108944$13410894$4$F$$20240830$20170406$20240904$PER$$US-JNJFOC-20170302218$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$LW$US$US
134111772$13411177$2$F$$20240911$20170406$20240913$PER$$US-JNJFOC-20170306744$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$LW$US$US
134111852$13411185$2$F$19970101$20240911$20170406$20240918$PER$$US-JNJFOC-20170306439$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240918$$LW$US$US
134112062$13411206$2$F$$20240911$20170406$20240913$PER$$US-JNJFOC-20170306573$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$LW$US$US
134113054$13411305$4$F$$20240814$20170406$20240816$PER$$US-JNJFOC-20170307035$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$LW$US$US
134113703$13411370$3$F$20070101$20240731$20170406$20240806$PER$$US-JNJFOC-20170304308$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240806$$HP$US$US
134114293$13411429$3$F$20060809$20240911$20170406$20240913$EXP$$US-JNJFOC-20170304648$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240913$$HP$US$US
134115193$13411519$3$F$$20240624$20170406$20240701$PER$$US-JNJFOC-20170304963$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$LW$US$US
134116743$13411674$3$F$20040813$20240624$20170406$20240701$PER$$US-JNJFOC-20170303443$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240701$$LW$US$US
134118155$13411815$5$F$20070301$20240910$20170406$20240913$PER$$US-JNJFOC-20170304271$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240913$$LW$US$US
134118323$13411832$3$F$$20240904$20170406$20240909$PER$$US-JNJFOC-20170304553$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$LW$US$US
134120162$13412016$2$F$$20240726$20170406$20240801$PER$$US-JNJFOC-20170317025$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$LW$US$US
134122062$13412206$2$F$20090813$20240826$20170406$20240829$PER$$US-JNJFOC-20170314772$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240829$$LW$US$US
134122123$13412212$3$F$$20240911$20170406$20240912$PER$$US-JNJFOC-20170314730$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$LW$US$US
134123074$13412307$4$F$20130727$20240918$20170406$20240925$PER$$US-JNJFOC-20170308052$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240925$$LW$US$US
134123202$13412320$2$F$$20240626$20170406$20240702$PER$$US-JNJFOC-20170308333$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$LW$US$US
134124492$13412449$2$F$$20240819$20170406$20240821$PER$$US-JNJFOC-20170308335$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$LW$US$US
134126062$13412606$2$F$$20240819$20170406$20240821$PER$$US-JNJFOC-20170308195$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$LW$US$US
134126664$13412666$4$F$20101119$20240814$20170406$20240820$PER$$US-JNJFOC-20170308951$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240821$$LW$US$US
134126692$13412669$2$F$$20240819$20170406$20240821$PER$$US-JNJFOC-20170308210$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$LW$US$US
134126894$13412689$4$F$19930913$20240731$20170406$20240806$PER$$US-JNJFOC-20170310077$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240807$$LW$US$US
134128264$13412826$4$F$20040101$20240626$20170406$20240703$EXP$$US-JNJFOC-20170308443$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20240703$$HP$US$US
134128394$13412839$4$F$20121024$20240726$20170406$20240802$EXP$$US-JNJFOC-20170309472$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240802$$HP$US$US
134128893$13412889$3$F$$20240819$20170406$20240822$PER$$US-JNJFOC-20170311398$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$LW$US$US
134135962$13413596$2$F$19990101$20240809$20170406$20240814$PER$$US-JNJFOC-20170317755$JOHNSON AND JOHNSON$$3$YR$C$M$Y$$$20240814$$LW$US$US
134144972$13414497$2$F$20170330$20240917$20170407$20240919$PER$$US-BIOGEN-2017BI00382324$BIOGEN$$50$YR$$F$Y$$$20240919$$CN$US$US
134174976$13417497$6$F$20220101$20240723$20170406$20240725$PER$$US-PFIZER INC-2017145047$PFIZER$$59$YR$$F$Y$$$20240725$$PH$US$US
134190223$13419022$3$F$20131004$20240801$20170407$20240805$PER$$US-JNJFOC-20170320438$JOHNSON AND JOHNSON$$25$YR$A$M$Y$118.04$KG$20240805$$LW$US$US
134191372$13419137$2$F$$20240715$20170407$20240718$PER$$US-JNJFOC-20170320613$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$LW$US$US
134193794$13419379$4$F$$20240909$20170407$20240912$PER$$US-JNJFOC-20170323500$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$LW$US$US
134194393$13419439$3$F$$20240625$20170407$20240710$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-134634$RANBAXY$Lai-Tiong F, Duval Y, Krabansky F. Gemcitabine-associated thrombotic microangiopathy in a patient with lung cancer: A case report. Oncology Letters. 2017;13 (3):1201-1203$63$YR$$M$Y$$$20240710$$HP$FR$FR
134296703$13429670$3$F$20170227$20240702$20170412$20240705$EXP$$CA-TAKEDA-2017TUS004425$TAKEDA$$52$YR$$F$Y$$$20240705$$CN$CA$CA
134344173$13434417$3$F$$20240916$20170412$20240923$EXP$$US-JAZZ-2017-US-004403$JAZZ$$$$$F$Y$$$20240923$$MD$US$US
1343997916$13439979$16$F$20120628$20240708$20170413$20240718$EXP$$CA-ROCHE-1918546$ROCHE$$61$YR$A$M$Y$70$KG$20240718$$MD$CA$CA
134410228$13441022$8$F$20120701$20240701$20170413$20240705$EXP$$US-JAZZ-2017-US-004639$JAZZ$$63$YR$$M$Y$$$20240705$$MD$US$US
134415962$13441596$2$F$$20240820$20170414$20240903$EXP$HK-MLMSERVICE-20170327-0662772-1$HK-ALKEM LABORATORIES LIMITED-HK-ALKEM-2017-00152$ALKEM$Chung MM, Chan YC, Law Y, Cheng SW.. Infectious anastomotic pseudoaneurysm complicating renal allograft: case report and review of literature. International Journal of Nephrology and Renovascular Disease. 2017;10:55-60$45$YR$$M$Y$$$20240903$$MD$HK$HK
134567857$13456785$7$F$$20240709$20170419$20240715$EXP$$US-PFIZER INC-2015393423$PFIZER$Hatem, N.. Meropenem: The new culprit in eosinophilic lung diseases. American Journal of Respiratory and Critical Care Medicine. 2015;191$51$YR$$F$Y$$$20240715$$MD$US$US
134588826$13458882$6$F$$20240621$20170419$20240702$EXP$$CA-APOTEX-2017AP010128$APOTEX$$36$YR$$M$Y$$$20240702$$HP$CA$CA
1345954914$13459549$14$F$$20240801$20170419$20240806$EXP$$AT-009507513-1704AUT007219$MERCK$Taylor N, Touzeau V, Geit M, Gisinger M, Egle A, Greil R, et al.. Raltegravir in Pregnancy: A Case Series Presentation.. International Journal of STD + AIDS. 2011;22(6):358-60$1$DY$$$Y$$$20240806$$MD$AT$AT
134692702$13469270$2$F$$20240828$20170421$20240903$EXP$$PHHY2016US168164$NOVARTIS$Osorio C, Caceres J, Curcio C, Silverberg M. A case of acute fibrinous and organizing pneumonia. CHEST. 2016;150 (4 Suppl 1):808A$53$YR$$F$Y$$$20240903$$HP$US$US
1347248911$13472489$11$F$20160101$20240920$20170424$20240930$EXP$$CA-PFIZER INC-2016402096$PFIZER$$62$YR$$F$Y$$$20240930$$HP$CA$CA
1348099111$13480991$11$F$20170410$20240723$20170425$20240726$EXP$$CA-TAKEDA-2017TUS008390$TAKEDA$$47$YR$$F$Y$$$20240726$$CN$CA$CA
134851584$13485158$4$F$20170409$20240910$20170426$20240919$EXP$$JP-AEGERION PHARMACEUTICAL, INC-AEGR003138$AEGERION$$$$$$Y$$$20240919$$MD$JP$JP
134886022$13488602$2$F$20060101$20240701$20170427$20240705$PER$$US-JNJFOC-20170427420$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240705$$LW$US$US
134892532$13489253$2$F$$20240807$20170427$20240812$PER$$US-JNJFOC-20170427423$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$LW$US$US
134896582$13489658$2$F$20041101$20240701$20170427$20240704$PER$$US-JNJFOC-20170427533$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240705$$LW$US$US
134898258$13489825$8$F$20170401$20240809$20170426$20240814$EXP$$CA-TAKEDA-2017TUS008524$TAKEDA$$66$YR$$M$Y$$$20240814$$CN$CA$CA
134903222$13490322$2$F$20020101$20240807$20170427$20240814$PER$$US-JNJFOC-20170427559$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240814$$LW$US$US
134903542$13490354$2$F$20110101$20240701$20170427$20240705$PER$$US-JNJFOC-20170427561$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$LW$US$US
134918202$13491820$2$F$$20240624$20170427$20240701$PER$$US-JNJFOC-20170427428$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$LW$US$US
134927952$13492795$2$F$20020101$20240701$20170427$20240704$PER$$US-JNJFOC-20170427426$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240705$$LW$US$US
134931242$13493124$2$F$20170404$20240821$20170427$20240831$EXP$$GB-AUROBINDO-AUR-APL-2017-32837$AUROBINDO$$80$YR$$F$Y$80$KG$20240831$$MD$GB$GB
135115732$13511573$2$F$$20240703$20170504$20240708$EXP$$CN-PFIZER INC-2017190524$PFIZER$Tang, Y.. Severe sclerosing cholangitis after Langerhans cell histiocytosis treated by liver transplantation. Medicine (United States). 2017;96(9):10.1097/MD.0000000000005994$37$YR$$M$Y$$$20240708$$MD$CN$CN
135137022$13513702$2$F$$20240905$20170504$20240917$EXP$$OM-Accord-051143$ACCORD$Rabah F, Beshlawi I, El-Naggari M, Al-Shidani A, Al-Nabhani D. Secondary hypertension post bone marrow transplant: A long winding road. Journal of Pediatric Hematology/Oncology. 2017;39(1):77-79$12$YR$T$F$Y$$$20240917$$MD$OM$OM
135213615$13521361$5$F$$20240726$20170508$20240731$PER$$US-PFIZER INC-2017199352$PFIZER$$68$YR$$F$Y$$$20240731$$CN$US$US
135316109$13531610$9$F$20170201$20240719$20170510$20240725$EXP$$PHHY2017CA025217$NOVARTIS$$48$YR$$F$Y$$$20240725$$MD$CA$CA
135364867$13536486$7$F$20170428$20240619$20170511$20240703$EXP$$CA-ROCHE-1931238$ROCHE$$42$YR$A$F$Y$$$20240703$$MD$CA$CA
1353777712$13537777$12$F$20230101$20240814$20170511$20240820$EXP$$US-JAZZ-JPI-P-019713$JAZZ$$$$$F$Y$98$KG$20240820$$HP$US$US
135415549$13541554$9$F$20150701$20240812$20170512$20240821$EXP$$PHHY2017PL068025$NOVARTIS$Banaszkiewicz M, Krzanowska K, Chowaniec E, Krzanowski M, Okon K, Sulowicz W. Coexistence of 2 malignant urogenital neoplasms: a testicular seminoma and adenocarcinoma of the prostate gland in a patient 1 year after kidney transplantation. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ. 2016;126(5):367-8$65$YR$$M$Y$$$20240821$$HP$PL$PL
135503859$13550385$9$F$20150101$20240809$20170516$20240814$EXP$$PHHY2015CO167075$NOVARTIS$$$$$F$Y$65$KG$20240814$$CN$CO$CO
1355364511$13553645$11$F$20170331$20240905$20170517$20240912$EXP$$CA-ROCHE-1935141$ROCHE$$43$YR$A$F$Y$$$20240912$$MD$CA$CA
135551604$13555160$4$F$20170403$20240716$20170517$20240730$EXP$$US-009507513-1705USA002200$MERCK$$76$YR$$F$Y$68.7$KG$20240730$$MD$US$US
1355762424$13557624$24$F$20170503$20240812$20170518$20240822$EXP$$JP-009507513-1705JPN001079J$MERCK$Katsume Y, Isawa T, Toi Y, Fukuda R,  Kondo Y, Sugawara S et al.. Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring. Internal Medicine. 2018;57:3157-3162$73$YR$$M$Y$60$KG$20240822$$MD$JP$JP
1355772818$13557728$18$F$$20240726$20170518$20240730$EXP$$US-PFIZER INC-2017212769$PFIZER$$71$YR$$F$Y$49$KG$20240730$$CN$US$US
135593203$13559320$3$F$20170101$20240910$20170518$20240918$EXP$$CA-ROCHE-1935665$ROCHE$$51$YR$A$M$Y$$$20240918$$MD$CA$CA
135614772$13561477$2$F$20161123$20240905$20170518$20240918$EXP$$IT-AUROBINDO-AUR-APL-2017-34067$AUROBINDO$$1$DY$$M$Y$3.43$KG$20240918$$CN$DE$DE
135617584$13561758$4$F$20160101$20240828$20170518$20240904$EXP$$US-JAZZ-2017-US-006146$JAZZ$$$$$F$Y$$$20240904$$MD$US$US
1356231523$13562315$23$F$20150821$20240715$20170519$20240723$EXP$$CA-ROCHE-1936490$ROCHE$$55$YR$A$F$Y$$$20240723$$CN$CA$CA
135683319$13568331$9$F$20161001$20240911$20170522$20240919$EXP$$US-AEGERION PHARMACEUTICAL, INC-AEGR003170$AEGERION$$44$YR$$F$Y$63$KG$20240919$$HP$US$US
135691349$13569134$9$F$20170310$20240903$20170522$20240913$EXP$$DE-Ipsen Biopharmaceuticals, Inc.-2017-04321$IPSEN$$59$YR$A$F$Y$55$KG$20240913$$MD$DE$DE
1357099511$13570995$11$F$$20240827$20170523$20240905$EXP$$CA-AUROBINDO-AUR-APL-2017-34294$AUROBINDO$Villeneuve E, Delisle MS, Wang JJ, Gosselin S. Management of a mixed overdose in the prehospital setting: A case report. Clinical Toxicology. 2017;55(5):511$71$YR$$F$Y$$$20240905$$MD$CA$CA
135714567$13571456$7$F$20200101$20240719$20170523$20240723$EXP$$US-PFIZER INC-2017217915$PFIZER$$63$YR$$F$Y$120.2$KG$20240723$$MD$US$US
135741643$13574164$3$F$20170401$20240801$20170523$20240807$EXP$$US-JAZZ-2017-US-005556$JAZZ$$32$YR$$F$Y$$$20240807$$CN$US$US
135773253$13577325$3$F$$20240723$20170524$20240729$EXP$$US-JAZZ-2017-US-006621$JAZZ$$$$$F$Y$$$20240729$$MD$US$US
135890939$13589093$9$F$$20240813$20170529$20240817$EXP$$JP-ROCHE-1847093$ROCHE$Ishikawa Y, Ishikawa K, Fujiwara M, and Kita Y. A case of progressive multifocal leukoencephalopathy (PML) during the treatment with multiple immunosuppressive drugs including rituximab (RTX) and mycophenolate mofetil (MMF) in refractory systemic lupus erythematosus (SLE).. The 72nd Kanagawa Rheumatism Medicine Association. 2017 Jul 08;:1-.$$$A$M$Y$54$KG$20240817$$MD$JP$JP
136016315$13601631$5$F$$20240919$20170601$20240925$EXP$$JP-PFIZER INC-2017057800$PFIZER$Wakiguchi, H.. Severe gluteal skin ulcers in an infant with juvenile dermatomyositis. Eur-J-Dermatol. 2016;26(2):192-193$16$YR$$F$Y$42.4$KG$20240925$$MD$JP$JP
136091602$13609160$2$F$20161217$20240704$20170602$20240720$EXP$IT-JNJFOC-20170126994$IT-JNJFOC-20170126994$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240719$$MD$IT$IT
136097704$13609770$4$F$20110101$20240909$20170602$20240913$EXP$$US-JAZZ-2017-US-007016$JAZZ$$32$YR$$F$Y$$$20240912$$CN$US$US
136143663$13614366$3$F$$20240715$20170606$20240722$EXP$$US-AUROBINDO-AUR-APL-2017-34897$AUROBINDO$Edwards LE, Hutchison LB, Hornik CD, Smith PB, Cotten CM, Bidegain M.. A case of infant delirium in the neonatal intensive careunit. Journal of Neonatal-Perinatal Medicine. 2017;10:119-123$6$MON$$M$Y$4.7$KG$20240722$$MD$US$US
1361548110$13615481$10$F$$20240821$20170606$20240827$EXP$$JP-PFIZER INC-2016487880$PFIZER$Hirai, I.. Weekly cisplatin, epirubicin, and paclitaxel induced a durable response in two cases of metastatic extramammary Paget^s disease. Melanoma Research. 2016;26(1) e87:153$65$YR$$M$Y$$$20240827$$MD$JP$JP
136212123$13621212$3$F$$20240821$20170607$20240902$EXP$$JP-Accord-045238$ACCORD$Hirai I, Funakoshi T. Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget^s disease. Journal of Dermatology. 2017;44(10):1148-51.$65$YR$E$M$Y$$$20240902$$MD$JP$JP
136244965$13624496$5$F$$20240708$20170608$20240712$EXP$$CA-AstraZeneca-2017SE59375$ASTRAZENECA$$$$$M$Y$$$20240712$$MD$CA$
136256813$13625681$3$F$$20240916$20170607$20240925$EXP$$US-JNJFOC-20170503266$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$LW$US$US
136256962$13625696$2$F$$20240626$20170607$20240702$PER$$US-JNJFOC-20170503457$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$LW$US$US
136264233$13626423$3$F$20091123$20240913$20170607$20240918$PER$$US-JNJFOC-20170416725$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240918$$LW$US$US
136265372$13626537$2$F$20050401$20240807$20170607$20240812$PER$$US-JNJFOC-20170427995$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20240812$$LW$US$US
136284757$13628475$7$F$20160601$20240812$20170608$20240821$EXP$$FR-PFIZER INC-2017247845$PFIZER$Garrigues, P.. Proton pump inhibitor-induced hypomagnesemia: A metabolic disorder not to be overlooked. 75th French Congress of Internal Medicine. 2017;38 (suppl 1):A150-A151$80$YR$$M$Y$98$KG$20240821$$MD$FR$FR
136306365$13630636$5$F$20170101$20240821$20170608$20240826$EXP$$CA-TAKEDA-2017TUS012387$TAKEDA$$$$$M$Y$$$20240826$$CN$CA$CA
136363763$13636376$3$F$$20240716$20170609$20240725$EXP$$GB-AUROBINDO-AUR-APL-2017-34948$AUROBINDO$$43$YR$$F$Y$$$20240725$$MD$GB$GB
1363703614$13637036$14$F$$20240814$20170609$20240822$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK085504$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$MD$CA$CA
136373143$13637314$3$F$20100101$20240823$20170609$20240903$EXP$$IT-AUROBINDO-AUR-APL-2012-04532$AUROBINDO$Barbera N, Busardo FP, Indorato F, Romano G.. The pathogenetic role of adulterants in 5 cases of drug addicts with a fatal outcome. Forensic Science International. 2013;227(1-3):74-6$26$YR$$M$Y$$$20240903$$HP$IT$IT
136441735$13644173$5$F$20170501$20240911$20170612$20240917$EXP$$US-SHIRE-US201712721$TAKEDA$$19$YR$$F$Y$$$20240917$$CN$US$US
136459864$13645986$4$F$$20240822$20170613$20240906$EXP$$US-AUROBINDO-AUR-APL-2017-35168$AUROBINDO$Simon MS, Westblade LF, Dziedziech A, Visone JE, Furman RR, Jenkins SG, et al. Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated with Rituximab and Chronic Lymphocytic Leukemia. Clin-Infect-Dis. 2017;65(7):1222-1225$81$YR$$M$Y$$$20240906$$MD$US$US
136471839$13647183$9$F$20170512$20240822$20170613$20240903$PER$$US-INCYTE CORPORATION-2017IN004399$INCYTE$$$$$$Y$$$20240903$$CN$US$US
136516693$13651669$3$F$20170501$20240827$20170614$20240903$EXP$$JP-JNJFOC-20170523559$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240903$$MD$JP$JP
136674014$13667401$4$F$$20240921$20170620$20240925$EXP$$CA-ROCHE-1951316$ROCHE$$62$YR$A$M$Y$113$KG$20240925$$HP$CA$CA
136677413$13667741$3$F$$20240909$20170620$20240920$EXP$$CA-Accord-052806$ACCORD$Tremblay C, Friedmann D. Kaposi Sarcoma Associated With Iatrogenic Immunosuppression: A Rare Complication of Bullous Pemphigoid Treatment. Journal of Cutaneous Medicine and Surgery. 2017;21(5):449-51$86$YR$E$M$Y$$$20240920$$MD$CA$CA
136691124$13669112$4$F$$20240911$20170620$20240919$EXP$$ES-AUROBINDO-AUR-APL-2017-35684$AUROBINDO$Recarey-Mayo A, Hermida-Ameijeiras A, Lopez-Paz JE, Calvo-Gomez C.. Thiazide diuretics induce sub-acute cutaneous lupus erythematosus.. Semergen Sociedad Espanola de Medicina Rural y Generalista. 2016;42(8):e174-6$72$YR$$F$Y$$$20240919$$HP$ES$ES
136733953$13673395$3$F$20170511$20240823$20170621$20240903$EXP$$BE-SAOL THERAPEUTICS-2017SAO01048$AMNEAL$$$$$$Y$$$20240903$$MD$BE$BE
1367822912$13678229$12$F$20170101$20240716$20170622$20240721$EXP$$PHHY2016CA012252$NOVARTIS$$56$YR$$F$Y$$$20240722$$HP$CA$CA
136912242$13691224$2$F$$20240812$20170626$20240821$PER$$US-ROCHE-721296$ROCHE$ADAMS B, Lazarchick J, Medina A, Willner I, Neville B, Murphy E, Stuart R and Costa L Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis. American Journal of Hematology 2020;85 (8):627-9.$42$YR$A$F$Y$$$20240821$$MD$US$US
136917558$13691755$8$F$$20240909$20170626$20240919$EXP$$PHHY2017ES092982$NOVARTIS$Sanchez VG, Pedregosa LE, Martos ML, Cano VR, Gonzalez ER, Mendoza AE et al.. Subacute polyneuropathy by pharmacological toxicity. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY. 2017;21:e232-3$6$YR$$F$Y$$$20240919$$HP$ES$ES
136917933$13691793$3$F$20161223$20240914$20170626$20240917$EXP$$US-NAPPMUNDI-USA-2017-0139553$PURDUE$$60$YR$$F$Y$$$20240917$$CN$US$US
136998647$13699864$7$F$20141001$20240625$20170629$20240709$EXP$$CA-ROCHE-1684427$ROCHE$$65$YR$E$F$Y$88$KG$20240708$$MD$CA$CA
137003022$13700302$2$F$$20240812$20170629$20240821$EXP$$CA-APOTEX-2017AP013304$APOTEX$$$$$$Y$$$20240821$$HP$CA$CA
137009974$13700997$4$F$$20240701$20170629$20240718$EXP$$NO-Horizon-PRO-0033-2017$AMGEN$Kishk OA, Kim I, Cheng C, Summan M, Munoz MA.. Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients. Pediatric Nephrology. 2024;39(3):1-5$21$YR$A$M$Y$$$20240718$$HP$NO$NO
1370316025$13703160$25$F$20170101$20240912$20170629$20240913$EXP$$US-PFIZER INC-2017142637$PFIZER$$78$YR$$F$Y$$$20240913$$CN$US$US
137047086$13704708$6$F$20170614$20240821$20170630$20240826$EXP$$IT-ABBVIE-17P-083-1983079-00$ABBVIE$$32$YR$$F$Y$$$20240826$$MD$IT$IT
1370644815$13706448$15$F$20170520$20240809$20170630$20240813$EXP$$CA-TAKEDA-2017TUS013681$TAKEDA$$66$YR$$M$Y$75$KG$20240813$$CN$CA$CA
137105902$13710590$2$F$$20240708$20170703$20240716$EXP$$CA-APOTEX-2017AP013576$APOTEX$$29$YR$$F$Y$57$KG$20240716$$HP$CA$CA
1371571717$13715717$17$F$$20240814$20170705$20240822$EXP$$CA-JNJFOC-20170625604$JOHNSON AND JOHNSON$$50$YR$A$F$Y$110$KG$20240822$$HP$CA$CA
137198982$13719898$2$F$20170619$20240711$20170705$20240717$PER$$US-BIOGEN-2017BI00423321$BIOGEN$$51$YR$$F$Y$$$20240717$$CN$US$US
1372081421$13720814$21$F$20170628$20240814$20170706$20240820$EXP$$CA-ROCHE-1959396$ROCHE$$45$YR$A$F$Y$86$KG$20240820$$CN$CA$CA
137266572$13726657$2$F$$20240726$20170707$20240815$EXP$$US-PFIZER INC-2017294372$MYLAN$$$$$F$Y$$$20240815$$CN$US$US
137309532$13730953$2$F$20080101$20240710$20170707$20240711$PER$$US-JNJFOC-20151104890$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240711$$LW$US$US
137386174$13738617$4$F$20090123$20230926$20170710$20240806$EXP$$US-SAOL THERAPEUTICS-2017SAO00261$AMNEAL$$19$YR$$F$Y$56.236$KG$20240806$$HP$US$US
137388683$13738868$3$F$20160101$20240823$20170710$20240906$EXP$$JP-SA-2017SA123092$SANOFI AVENTIS$Ozeki T, Fujimoto S, Miyamoto Y, Asano M, Fuchimoto Y, Wada S, et al.. A Case of Oesophagobronchial Fistula during Radiochemotherapy in a Patient with Squamous Cell Carcinoma of Lung.. The 56th ChugokuShikoku Regional Meeting of the Japanese Respiratory Society. 2016;unk:unk$72$YR$E$M$Y$$$20240906$$MD$JP$JP
137390412$13739041$2$F$20170402$20240212$20170710$20240806$EXP$$US-SAOL THERAPEUTICS-2017SAO00676$AMNEAL$$20$YR$$M$Y$$$20240806$$MD$US$US
137399832$13739983$2$F$$20240716$20170711$20240729$EXP$$NL-AUROBINDO-AUR-APL-2012-01431$AUROBINDO$Verwimp-Hoeks M. P. A.. Aprepitant quetiapine: a clinically significant drug interaction in a patient treated for head and neck cancer. Annals of Oncology. 2012;Vol: 23(3):801 - 2$44$YR$$M$Y$$$20240729$$HP$NL$NL
1374018511$13740185$11$F$$20240716$20170711$20240719$EXP$$CA-PFIZER INC-2017103610$PFIZER$$69$YR$$F$Y$62$KG$20240719$$MD$CA$CA
137419376$13741937$6$F$20170622$20240626$20170711$20240701$PER$$US-PFIZER INC-2017298881$PFIZER$$64$YR$$M$Y$$$20240701$$CN$US$US
1374567113$13745671$13$F$20160610$20240918$20170712$20240927$EXP$$AT-PFIZER INC-2017297258$PFIZER$$59$YR$$M$Y$68.5$KG$20240927$$MD$AT$AT
137457504$13745750$4$F$$20240823$20170712$20240829$EXP$$JP-PFIZER INC-2017298301$PFIZER$Ozeki, T.. Esophagobronchial Fistula in a Patient with Squamous Cell Carcinoma of the Lung: A Case Report.. Case Reports in Oncology. 2017;10 (2):553-557$72$YR$$M$Y$$$20240829$$MD$JP$JP
137479527$13747952$7$F$20170706$20240801$20170713$20240808$EXP$$CA-ROCHE-1962850$ROCHE$$11$YR$C$M$Y$91$KG$20240808$$CN$CA$CA
137510702$13751070$2$F$20170313$20230714$20170713$20240722$PER$$US-ASTELLAS-2017US011109$ASTELLAS$$64$YR$$F$Y$$$20240722$$CN$US$US
137512463$13751246$3$F$$20211112$20170713$20240722$PER$$US-ASTELLAS-2017US013006$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
137578104$13757810$4$F$20220918$20240910$20170717$20240917$EXP$$CA-ROCHE-1962285$ROCHE$$40$YR$A$F$Y$$$20240917$$CN$CA$CA
1376235320$13762353$20$F$20170703$20240828$20170718$20240830$EXP$$US-PFIZER INC-2017301253$PFIZER$$59$YR$$M$Y$61$KG$20240830$$CN$US$US
137625862$13762586$2$F$$20240823$20170718$20240904$EXP$$JP-Accord-053671$ACCORD$Ozeki T, Asano M, Fujimoto N, Nishimura J, Takada K, Miyamoto Y et al. Esophagobronchial Fistula in a Patient with Squamous Cell Carcinoma of the Lung: A Case Report. Case Reports in Oncology. 2017;10:553-557.$73$YR$$M$Y$$$20240904$$HP$JP$JP
137661992$13766199$2$F$20161221$20240916$20170719$20240921$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2017-NB-003979$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$94.6$KG$20240921$$MD$JP$JP
1377127120$13771271$20$F$20170613$20240821$20170720$20240830$EXP$$JP-AEGERION PHARMACEUTICAL, INC-AEGR003254$AEGERION$$$$$$Y$$$20240830$$MD$JP$JP
137724367$13772436$7$F$20170701$20240627$20170720$20240701$PER$$US-PFIZER INC-2017316207$PFIZER$$63$YR$$F$Y$$$20240701$$CN$US$US
137807415$13780741$5$F$20170601$20240725$20170724$20240730$PER$$US-PFIZER INC-2017320046$PFIZER$$70$YR$$F$Y$108.4$KG$20240730$$CN$US$US
137902122$13790212$2$F$$20240909$20170725$20240912$EXP$$DE-ADIENNEP-2017AD000233$ADIENNE PHARMA + BIOTECH$Goessling KL, Schipp C, Fischer U, Babor F, Koch G, Schuster FR et al. Hematopoietic stem cell transplantation in an infant with immunodeficiency, centromeric instability, and facial anomaly syndrome. Front Immunol. 2017; 8:JUN Article Number 773. doi: 10.3389/fimmu.2017.00773.$$$I$M$Y$$$20240911$$MD$DE$
137924813$13792481$3$F$$20240730$20170725$20240802$EXP$$CA-MYLANLABS-2017M1044161$MYLAN$$64$YR$$F$Y$69$KG$20240802$$HP$CA$CA
137948527$13794852$7$F$$20240717$20170726$20240718$EXP$$US-PFIZER INC-2017324851$PFIZER$$65$YR$$F$Y$79$KG$20240718$$CN$US$US
137984814$13798481$4$F$$20240716$20170727$20240726$EXP$$NL-AUROBINDO-AUR-APL-2013-09509$AUROBINDO$Dreijerink KM, Kampschreur LM, Lentjes EG, Lokhorst B, Zelissen PM. Atypical hypocortisolism. Endocrine Practice. 2013;19 (5):e112 - 4$36$YR$$M$Y$$$20240726$$MD$NL$NL
1380230923$13802309$23$F$20170101$20240925$20170728$20240930$PER$$US-PFIZER INC-2017328467$PFIZER$$55$YR$$F$Y$57$KG$20240930$$MD$US$US
138060928$13806092$8$F$20160315$20240910$20170728$20240919$EXP$$PHHY2016CA036453$NOVARTIS$$43$YR$$M$Y$$$20240919$$CN$CA$CA
1381361628$13813616$28$F$20170716$20240910$20170731$20240919$EXP$$CA-ROCHE-1971321$ROCHE$$22$YR$A$F$Y$$$20240919$$MD$CA$CA
1381458416$13814584$16$F$20161201$20240625$20170731$20240705$EXP$$CA-ROCHE-1971446$ROCHE$$47$YR$A$F$Y$$$20240705$$MD$CA$CA
1381731532$13817315$32$F$20160101$20240924$20170731$20240927$EXP$$PHHY2016CO148527$NOVARTIS$$$$$F$Y$64$KG$20240927$$CN$CO$CO
138238953$13823895$3$F$$20240805$20170802$20240814$PER$$US-PFIZER INC-2017330643$PFIZER$$54$YR$$F$Y$$$20240814$$HP$US$US
138259179$13825917$9$F$20170322$20240829$20170802$20240831$EXP$$ES-ABBVIE-17P-144-2054495-00$ABBVIE$$44$YR$$M$Y$$$20240831$$MD$ES$ES
138300333$13830033$3$F$20100901$20240903$20170803$20240907$EXP$$FR-ASTELLAS-2007EU002031$ASTELLAS$Petruzzo P, Testelin, S. Kanitakis, J. Badet, L. Lengele,B. Girbon,JP. Parmentier,H. Malcus,C. Morelon,E. Devauchelle,B. and Dubernard,JM. First Human Face Transplantation: 5 Years Outcomes. Transplantation 2012 Jan 01;93 (2):236-240.$38$YR$A$F$Y$$$20240907$$MD$FR$FR
138386437$13838643$7$F$20170426$20240830$20170807$20240906$EXP$$CA-ROCHE-1967731$ROCHE$$44$YR$A$F$Y$$$20240906$$CN$CA$CA
138484354$13848435$4$F$$20240729$20170809$20240731$PER$$US-PURDUE-USA-2017-0140025$PURDUE$$$$$F$Y$$$20240731$$CN$US$US
138540112$13854011$2$F$$20240812$20170810$20240824$EXP$US-MLMSERVICE-20170320-0527848-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2017-00212$ALKEM$Osorio C, Caceres J, Curcio C, Silverberg M.. A case of acute fibrinous and organizing pneumonia. Chest. 2016;150;4(1):808A$53$YR$$F$Y$$$20240825$$HP$US$US
138580192$13858019$2$F$$20240906$20170811$20240920$EXP$PL-ALKEM-001656$PL-ALKEM LABORATORIES LIMITED-PL-ALKEM-001656$ALKEM$Turno-Krecicka A, Tomczyk-Socha M, Zimny A.. Progressive outer retinal necrosis syndrome in the course of systemic lupus erythematosus.. Lupus. 2016;25(14):1610-1614$44$YR$$F$Y$$$20240920$$HP$PL$PL
138595579$13859557$9$F$20170801$20240916$20170811$20240919$PER$$US-PFIZER INC-2017041037$PFIZER$$22$YR$$M$Y$72.8$KG$20240919$$MD$US$US
1386274015$13862740$15$F$20170801$20240814$20170814$20240823$EXP$$CA-ROCHE-1977450$ROCHE$$57$YR$A$F$Y$$$20240823$$MD$CA$CA
138682402$13868240$2$F$20170101$20240816$20170815$20240822$PER$$US-BIOGEN-2017BI00445275$BIOGEN$$$$$F$Y$$$20240822$$MD$US$US
138821982$13882198$2$F$20170313$20240903$20170818$20240912$EXP$$FR-AMGEN-FRASP2017122508$AMGEN$$67$YR$E$F$Y$$$20240912$$HP$FR$FR
1388815624$13888156$24$F$20170703$20240729$20170821$20240803$EXP$$MX-SHIRE-MX201716592$TAKEDA$$32$YR$$F$Y$52$KG$20240803$$HP$MX$MX
138886015$13888601$5$F$20170101$20240829$20170821$20240904$EXP$$CA-TAKEDA-2017TUS013809$TAKEDA$$$$$F$Y$$$20240904$$CN$CA$CA
138918234$13891823$4$F$20170803$20240905$20170822$20240912$EXP$$CA-TAKEDA-2017TUS017469$TAKEDA$$54$YR$$F$Y$$$20240912$$MD$CA$CA
1389564416$13895644$16$F$$20240701$20170823$20240702$EXP$$US-PFIZER INC-2016603073$PFIZER$$70$YR$$F$Y$57$KG$20240702$$MD$US$US
1389956110$13899561$10$F$20160101$20240912$20170823$20240917$EXP$$US-JAZZ-2017-US-006627$JAZZ$$23$YR$$F$Y$$$20240917$$MD$US$US
139026213$13902621$3$F$20240101$20240710$20170824$20240717$PER$$US-PURDUE-USA-2017-0139156$PURDUE$$$$$F$Y$68.038$KG$20240717$$CN$US$US
139032143$13903214$3$F$$20240705$20170824$20240710$EXP$$PHHY2017DE124251$NOVARTIS$Kaysen A, Heintz-Buschart A, Muller EEL, Narayanasamy S, Wampach L, Laczny CC et al.. Integrated meta-omic analyses of the gastrointestinal tract microbiome in patients undergoing allogeneic hematopoietic stem cell transplantation. TRANSLATIONAL RESEARCH. 2017;186:79-94$63$YR$$F$Y$$$20240710$$HP$LU$DE
1390469912$13904699$12$F$20171101$20240829$20170825$20240904$PER$$US-PFIZER INC-2017368049$PFIZER$$64$YR$$F$Y$$$20240904$$HP$US$US
139063863$13906386$3$F$$20240917$20170825$20240920$EXP$$US-KAMADA LIMITED-2016US012337$TAKEDA$$$$$F$Y$$$20240920$$CN$US$US
1390640861$13906408$61$F$$20240905$20170825$20240913$EXP$$CA-009507513-0809CAN00001$MERCK$Harris M, Larsen G, Montaner JSG. Exacerbation of depression associated with starting raltegravir: a report of four cases.. AIDS. 2008;22(14):1890-2$54$YR$$M$Y$$$20240913$$HP$CA$CA
139095849$13909584$9$F$20171128$20240626$20170828$20240701$PER$$US-PFIZER INC-2017363494$PFIZER$$57$YR$$F$Y$52.16$KG$20240701$$CN$US$US
139107353$13910735$3$F$20151222$20240826$20170828$20240919$EXP$$US-ABBVIE-17P-163-1976194-00$ABBVIE$$44$YR$$F$Y$$$20240917$$MD$US$US
1391285324$13912853$24$F$20170815$20240627$20170828$20240704$EXP$$PHHY2017CA038696$NOVARTIS$$65$YR$$M$Y$$$20240705$$CN$CA$CA
139163412$13916341$2$F$20170804$20240701$20170829$20240708$EXP$$GB-AUROBINDO-AUR-APL-2017-39221$AUROBINDO$$59$YR$$F$Y$86$KG$20240708$$MD$GB$GB
139189563$13918956$3$F$20240101$20240711$20170830$20240717$PER$$US-AMGEN-USASP2017129081$AMGEN$$57$YR$A$F$Y$$$20240717$$CN$US$US
139244375$13924437$5$F$20231101$20240702$20170831$20240709$EXP$$PHHY2017CO127426$NOVARTIS$$60$YR$$F$Y$66$KG$20240709$$HP$CO$CO
139268323$13926832$3$F$20170701$20240726$20170901$20240801$EXP$$US-ASTELLAS-2017US027041$ASTELLAS$$82$YR$$M$Y$$$20240801$$CN$US$US
1392956911$13929569$11$F$20170816$20240805$20170901$20240807$EXP$$US-PFIZER INC-2017375987$PFIZER$$54$YR$$F$Y$59$KG$20240807$$MD$US$US
1392968213$13929682$13$F$$20240920$20170901$20240926$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-2697$ORION$$67$YR$E$F$Y$73$KG$20240926$$MD$CA$
139322148$13932214$8$F$$20240906$20170904$20240910$PER$$US-PFIZER INC-2017379021$PFIZER$$62$YR$$F$Y$$$20240910$$MD$US$US
139326284$13932628$4$F$20161206$20240823$20170904$20240902$EXP$$CA-ROCHE-1987447$ROCHE$$58$YR$A$M$Y$$$20240902$$MD$CA$CA
139380746$13938074$6$F$20170101$20240823$20170905$20240826$EXP$$US-JAZZ-2017-US-011312$JAZZ$$$$$F$Y$$$20240826$$MD$US$US
139396344$13939634$4$F$$20240822$20170906$20240824$PER$$US-ROCHE-1986431$ROCHE$Echenique I, Beltran D, Ramirez-Ruiz L, Najafian N and Agrawal N Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report. Transplantation proceedings 2017 Sep;49 (7):1560-1564.$71$YR$E$M$Y$$$20240824$$MD$US$US
1394022810$13940228$10$F$20170308$20240923$20170906$20240925$EXP$$PHHY2017AR131239$NOVARTIS$$58$YR$$F$Y$76$KG$20240925$$MD$AR$AR
139466603$13946660$3$F$20170719$20240903$20170907$20240904$EXP$$US-PURDUE-USA-2017-0140587$PURDUE$$72$YR$$M$Y$62$KG$20240904$$MD$US$US
139467249$13946724$9$F$20170901$20240816$20170907$20240821$EXP$$CA-TAKEDA-2017TUS016422$TAKEDA$$67$YR$$F$Y$$$20240821$$MD$CA$CA
139542363$13954236$3$F$$20240701$20170911$20240708$EXP$$IT-FERRINGPH-2017FE04277$FERRING$Di Paolo M, Bugelli V, Figus M, Fornaro S, Guidi B, Giannarelli C et al.. Acute myocardial infarction following off label retrobulbar injection of desmopressin for non-arteritic anterior ischemic optic neuropathy (NAION). Causal correlation or coincidence?. Rom J Leg Med. 2017;25:165-168$$$$$Y$$$20240708$$MD$IT$IT
139608004$13960800$4$F$$20240823$20170912$20240828$EXP$$PHHY2017SI133619$NOVARTIS$Kojc N, Rigler AA, Mlinsek G, Kovac D, Ferluga D, Arnol M.. Outcome of polyomavirus nephropathy in renal transplant patients: A single-center experience.. CLINICAL NEPHROLOGY. 2017;88:S109-14$59$YR$$M$Y$$$20240828$$HP$SI$SI
1396104132$13961041$32$F$20170511$20240903$20170912$20240910$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK035127$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$BR$BR
139645302$13964530$2$F$20160809$20240703$20170913$20240709$EXP$$CA-TAKEDA-2017TUS018464$TAKEDA$$36$YR$$F$Y$$$20240709$$CN$CA$CA
139713073$13971307$3$F$20160101$20240814$20170914$20240829$EXP$$US-ASTELLAS-2017US015000$ASTELLAS$$88$YR$E$M$Y$$$20240827$$CN$US$US
139734328$13973432$8$F$20170801$20240826$20170914$20240902$EXP$$US-PFIZER INC-2017394261$PFIZER$$58$YR$$M$Y$77$KG$20240902$$MD$US$US
139752302$13975230$2$F$20170707$20240909$20170914$20240913$PER$$US-ASTELLAS-2017US004872$ASTELLAS$$80$YR$E$M$Y$$$20240913$$CN$US$US
139774373$13977437$3$F$20160101$20240730$20170915$20240806$EXP$$US-JAZZ-2017-US-012008$JAZZ$$$$$F$Y$$$20240806$$MD$US$US
139777093$13977709$3$F$$20170911$20170915$20240822$EXP$CA-009507513-1709CAN006345$CA-009507513-1709CAN006345$MERCK$$59$YR$$F$Y$46$KG$20240822$$PH$CA$CA
139780223$13978022$3$F$20170418$20240821$20170914$20240829$EXP$$US-ASTELLAS-2017US023069$ASTELLAS$$84$YR$E$M$Y$$$20240829$$CN$US$US
139794552$13979455$2$F$20170405$20240830$20170914$20240905$EXP$$US-ASTELLAS-2017US010465$ASTELLAS$$70$YR$E$M$Y$$$20240905$$CN$US$US
139843572$13984357$2$F$20170207$20240711$20170918$20240715$EXP$$NO-MYLANLABS-2017M1058704$MYLAN$$56$YR$$F$Y$163$KG$20240715$$HP$NO$NO
139843974$13984397$4$F$20170504$20240904$20170918$20240906$EXP$$NO-MYLANLABS-2017M1058702$MYLAN$$56$YR$$F$Y$76$KG$20240906$$HP$NO$NO
1398548219$13985482$19$F$20110120$20240816$20170919$20240828$EXP$$CA-ROCHE-1991029$ROCHE$$47$YR$A$F$Y$41$KG$20240828$$CN$CA$CA
139859248$13985924$8$F$$20240722$20170919$20240724$PER$$US-PFIZER INC-2017401683$PFIZER$$74$YR$$F$Y$$$20240724$$MD$US$US
139941102$13994110$2$F$$20240909$20170920$20240920$PER$$US-Neurocrine Biosciences Inc.-2017NBI00576$NEUROCRINE BIOSCIENCES$$75$YR$$M$Y$$$20240921$$MD$US$US
139964313$13996431$3$F$20170905$20240719$20170921$20240726$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK146475$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$MD$CA$CA
139981835$13998183$5$F$$20240816$20170921$20240823$EXP$$US-PFIZER INC-2017403263$PFIZER$Echenique, I.. Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report. Transplantation Proceedings. 2017;49(7):1560-1564$71$YR$$M$Y$$$20240823$$MD$US$US
139983353$13998335$3$F$20170517$20240911$20170921$20240913$PER$$US-BIOGEN-2017BI00458275$BIOGEN$$46$YR$$F$Y$$$20240913$$MD$US$US
1399910913$13999109$13$F$20170914$20240718$20170922$20240729$EXP$$CA-ROCHE-1995903$ROCHE$$56$YR$A$M$Y$122$KG$20240729$$CN$CA$CA
1400296017$14002960$17$F$20171212$20240627$20170922$20240702$EXP$$CA-TAKEDA-2017TUS019399$TAKEDA$$52$YR$$M$Y$$$20240702$$HP$CA$CA
140070266$14007026$6$F$20170701$20240830$20170925$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2017-04741$LUPIN$$62$YR$$M$Y$65.76$KG$20240911$$CN$US$US
1401401514$14014015$14$F$$20240702$20170926$20240709$PER$$US-AMGEN-USASP2017143522$AMGEN$$66$YR$E$F$Y$66$KG$20240709$$MD$US$US
140144636$14014463$6$F$20140101$20240904$20170927$20240906$PER$$US-BIOGEN-2017BI00462114$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
140148289$14014828$9$F$20170101$20240726$20170927$20240726$EXP$$US-PFIZER INC-2017409332$PFIZER$$48$YR$$F$Y$77$KG$20240726$$CN$US$US
140157795$14015779$5$F$$20240911$20170927$20240913$EXP$$US-PFIZER INC-2017409675$PFIZER$Pelletier, J.. Neutropenic enterocolitis (typhlitis) in a pediatric renal transplant patient. A case report and review of the literature. Pediatric Transplantation. 2017;21(6):10.1111/petr.13022$15$YR$$M$Y$$$20240913$$MD$US$US
140182102$14018210$2$F$$20240816$20170928$20240829$EXP$$US-AUROBINDO-AUR-APL-2017-40793$AUROBINDO$Echenique IA, Beltran D, Ramirez-Ruiz L, Najafian N, Agrawal N.. Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.. Transplantation Proceedings. 2017;49(7):1560-64$71$YR$$M$Y$$$20240829$$MD$US$US
140281313$14028131$3$F$20170811$20240913$20171002$20240923$PER$$US-009507513-1709USA012651$MERCK$$75$YR$$F$Y$$$20240923$$CN$US$US
140298019$14029801$9$F$20170813$20240725$20171002$20240730$EXP$$GB-ABBVIE-17P-167-2114556-00$ABBVIE$$51$YR$$M$Y$$$20240727$$MD$GB$GB
1403227911$14032279$11$F$20150101$20240828$20171002$20240902$EXP$$US-PFIZER INC-2017424177$PFIZER$$68$YR$$F$Y$74.83$KG$20240902$$CN$US$US
140326377$14032637$7$F$$20240717$20171002$20240722$PER$$US-PFIZER INC-2017421865$PFIZER$$68$YR$$F$Y$$$20240722$$MD$US$US
1403529812$14035298$12$F$20051010$20240909$20171003$20240911$EXP$$US-PFIZER INC-2017425983$PFIZER$$46$YR$$M$Y$115.67$KG$20240911$$CN$US$US
140375203$14037520$3$F$20160409$20171207$20171004$20240905$PER$$JP-AMGEN-JPNCT2017149511$AMGEN$$80$YR$E$M$Y$55$KG$20240904$$MD$JP$JP
140442162$14044216$2$F$20170901$20240916$20171004$20240925$EXP$$US-BEH-2017084007$CSL BEHRING$$29$YR$A$F$Y$$$20240925$$MD$US$US
140443132$14044313$2$F$$20240726$20171004$20240801$EXP$$US-BIOGEN-2013BI098471$BIOGEN$$$$$M$Y$$$20240801$$CN$US$US
140561254$14056125$4$F$20170501$20240912$20171006$20240916$EXP$$CA-JNJFOC-20171004802$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240916$$HP$CA$CA
140608616$14060861$6$F$20160101$20240903$20171009$20240910$EXP$$PHHY2017CO060440$NOVARTIS$$$$$F$Y$64$KG$20240910$$CN$CO$CO
140664102$14066410$2$F$$20240916$20171009$20240919$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2017-BI-054176$BOEHRINGER INGELHEIM$Woron J, Marcin S. Pacjentka po probie samobojczej podjetej z powodu depresji i uporczywych szumow usznych. Medycyna Praktyczna, Psychiatria. 2017 Apr;53-54.$50$YR$A$F$Y$$$20240919$$HP$PL$PL
140676095$14067609$5$F$20150601$20240828$20171010$20240910$EXP$GB-MACLEODS PHARMACEUTICALS US LTD-MAC2017006181$GB-MACLEODS PHARMACEUTICALS US LTD-MAC2017006181$MACLEODS$$$$$$Y$$$20240910$$CN$GB$GB
1406897036$14068970$36$F$20180326$20240828$20171010$20240906$EXP$$CA-CELLTRION INC.-2017CA013585$CELLTRION$$$$$$Y$$$20240906$$CN$CA$CA
140723292$14072329$2$F$$20240819$20171011$20240902$EXP$$CA-APOTEX-2017AP019339$APOTEX$$45$YR$$F$Y$$$20240902$$CN$CA$CA
140853419$14085341$9$F$20060801$20240725$20171013$20240725$PER$$US-PFIZER INC-2017367514$PFIZER$$69$YR$$F$Y$63.492$KG$20240725$$MD$US$US
140853862$14085386$2$F$20150601$20240814$20171013$20240827$EXP$$GB-AUROBINDO-AUR-APL-2017-41546$AUROBINDO$$52$YR$$M$Y$105$KG$20240827$$CN$GB$GB
140933894$14093389$4$F$20170301$20240902$20171016$20240906$EXP$$PHHY2017FR148740$NOVARTIS$$37$YR$$F$Y$$$20240906$$PH$FR$FR
1409872113$14098721$13$F$20160916$20240625$20171017$20240703$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN156841$VIIV$$$$$$Y$$$20240703$$MD$JP$JP
140991495$14099149$5$F$20171002$20191021$20171017$20240902$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2017-BI-055664$BOEHRINGER INGELHEIM$$66$YR$E$F$Y$47$KG$20240902$$MD$DE$DE
141052553$14105255$3$F$20170101$20240716$20171018$20240726$EXP$$CA-009507513-1710CAN008394$MERCK$$24$YR$$F$Y$$$20240726$$PH$CA$CA
141105565$14110556$5$F$20170701$20240912$20171020$20240917$EXP$$DE-NAPPMUNDI-GBR-2017-0049836$PURDUE$$60$YR$$M$Y$$$20240917$$CN$DE$DE
1411302435$14113024$35$F$20160505$20240913$20171022$20240919$EXP$$PHHY2017CA152629$NOVARTIS$$27$YR$$F$Y$$$20240919$$CN$CA$CA
1411446719$14114467$19$F$20160101$20240724$20171023$20240726$EXP$$US-PFIZER INC-2017453141$PFIZER$$72$YR$$F$Y$53$KG$20240726$$CN$US$US
141163832$14116383$2$F$$20240819$20171023$20240822$EXP$$IN-SA-2017SA202695$SANOFI AVENTIS$Antony R, Krishna S, James J, Kunoor A, Vijayan M.. Case report on docetaxel-induced interstitial lung disease.. Asian Journal Pharmaceutical and Clinical  Research.. 2017;10(10):10-12$34$YR$A$F$Y$$$20240822$$PH$IN$IN
1411898310$14118983$10$F$20170922$20240830$20171024$20240903$EXP$$US-SHIRE-US201724065$TAKEDA$$60$YR$$M$Y$$$20240903$$CN$US$US
141190932$14119093$2$F$$20240815$20171024$20240829$EXP$$US-AUROBINDO-AUR-APL-2017-42177$AUROBINDO$Kamal M, Apewokin S, Anand M, Abu Jawdeh BG, Govil A, Sheikh MM et al.,. Late-Onset Allograft Aspergillosis in an HIV-Positive Renal Transplant Recipient: A Case Report. Transplantation Proceedings. 2017;49 (7):1570-73$21$YR$$M$Y$$$20240829$$MD$US$US
141217754$14121775$4$F$20171020$20240716$20171024$20240729$EXP$$US-009507513-1710USA011668$MERCK$$60$YR$$F$Y$$$20240729$$MD$US$US
141418085$14141808$5$F$$20240820$20171030$20240826$EXP$$CO-PFIZER INC-2017463343$PFIZER$Nieto-rios, J.. Malakoplakia after kidney transplantation: Case report and literature review.. Transplant Infectious Disease. 2017;19(5):10.1111/tid.12731$45$YR$$F$Y$$$20240826$$HP$CO$CO
1414484412$14144844$12$F$20140514$20240919$20171031$20240925$EXP$$US-SHIRE-US201726642$TAKEDA$$61$YR$$F$Y$$$20240925$$CN$US$US
141512022$14151202$2$F$$20240702$20171102$20240704$PER$$US-SHIRE-US201725370$TAKEDA$$$$$F$Y$$$20240704$$MD$US$US
1415832210$14158322$10$F$$20240920$20171103$20240926$EXP$$ES-PFIZER INC-2017469732$MYLAN$Osorio, S.. Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline.. Journal of Oncology Pharmacy Practice. 2017;1-3$63$YR$$F$Y$$$20240926$$MD$ES$ES
141590772$14159077$2$F$$20240816$20171106$20240828$EXP$$CO-Accord-060634$ACCORD$Nieto-Rios JF, Ramirez I, Zuluaga-Quintero M, Serna-Higuita LM, Gaviria-Gil F, Velez-Hoyos A. Malakoplakia after kidney transplantation: Case report and literature review. Transplant Infectious Disease. 2017;19(5):Article Number e12731.$45$YR$A$F$Y$$$20240828$$HP$CO$CO
141635603$14163560$3$F$$20240814$20171107$20240827$EXP$$US-AUROBINDO-AUR-APL-2017-43222$AUROBINDO$Fatima S, Mottola N. Case 5: A 7-year-old autistic boy with altered movements and mental status. Pediatrics in Review. 2017;38 (10):493$7$YR$$M$Y$$$20240827$$MD$US$US
141708504$14170850$4$F$19980101$20240806$20171108$20240812$PER$$US-BIOGEN-2013BI052143$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
1417327714$14173277$14$F$20170703$20240729$20171109$20240805$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-068337$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240805$$HP$DE$DE
1418543110$14185431$10$F$20170925$20240828$20171114$20240903$EXP$$CO-TAKEDA-2017TUS022249$TAKEDA$$67$YR$$M$Y$57$KG$20240903$$HP$CO$CO
141864593$14186459$3$F$20160601$20240913$20171114$20240920$EXP$$US-TAKEDA-2017TUS023195$TAKEDA$$36$YR$$F$Y$$$20240920$$CN$US$US
141871368$14187136$8$F$$20240715$20171114$20240723$EXP$$CA-AMGEN-CANSP2017170029$AMGEN$$64$YR$A$F$Y$$$20240723$$HP$CA$CA
1418835016$14188350$16$F$20170912$20240712$20171114$20240723$EXP$$JP-009507513-1710JPN001542J$MERCK$Yoneda K,Murakami Y,Tanaka O,Morisaki M,Wakahara K,Sato M,etal. 24 A case of advanced stage lung adenocarcinoma who developed refractory pancreatitis as an immune-related adverse event after administration of pembrolizumab. The 113th Japan Lung Cancer Society Chubu branch academic meeting. 12$45$YR$$M$Y$60$KG$20240723$$MD$JP$JP
1419064817$14190648$17$F$$20240819$20171115$20240827$EXP$$FR-PFIZER INC-2017484181$PFIZER$Tudesq, J.. Cytomegalovirus infection with retinitis after brentuximab vedotin treatment for CD30+ lymphoma. Open Forum Infectious Diseases. 2017;4 (2):1-3$43$YR$$M$Y$$$20240827$$MD$FR$FR
141940833$14194083$3$F$20170510$20240625$20171116$20240702$EXP$$BR-TAKEDA-2017TUS023003$TAKEDA$$54$YR$$F$Y$$$20240702$$CN$BR$BR
141995773$14199577$3$F$20171101$20240716$20171117$20240722$EXP$$US-JAZZ-2017-US-014953$JAZZ$$41$YR$$F$Y$$$20240722$$CN$US$US
142034354$14203435$4$F$20090519$20240705$20171120$20240711$EXP$DE-ROCHE-2022964$DE-ROCHE-2022964$ROCHE$$78$YR$E$M$Y$64$KG$20240711$$MD$DE$DE
142046889$14204688$9$F$20170808$20240730$20171120$20240803$EXP$$BE-GLAXOSMITHKLINE-BE2017GSK177076$GLAXOSMITHKLINE$$$$$$Y$$$20240803$$MD$BE$BE
1420640826$14206408$26$F$20150101$20240711$20171120$20240715$EXP$$US-PFIZER INC-2017498067$PFIZER$$80$YR$$F$Y$72.109$KG$20240715$$CN$US$US
142065245$14206524$5$F$$20240627$20171120$20240707$PER$$US-AMGEN-USASP2017173904$AMGEN$$62$YR$A$F$Y$90.2$KG$20240707$$HP$US$US
1421105520$14211055$20$F$20160101$20240717$20171121$20240722$EXP$$US-PFIZER INC-2017500276$PFIZER$$74$YR$$F$Y$68$KG$20240722$$CN$US$US
142189923$14218992$3$F$20100518$20240626$20171123$20240702$PER$$US-JNJFOC-20171012064$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240702$$LW$US$US
142200852$14220085$2$F$20090101$20240814$20171123$20240819$PER$$US-JNJFOC-20170923852$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240819$$LW$US$US
142201143$14220114$3$F$20020101$20240731$20171123$20240805$PER$$US-JNJFOC-20170923986$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240805$$LW$US$US
142201782$14220178$2$F$$20240624$20171123$20240701$PER$$US-JNJFOC-20171011126$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$LW$US$US
142241274$14224127$4$F$$20240919$20171126$20240925$EXP$IT-MINISAL02-437295$IT-MYLANLABS-2017M1073725$MYLAN$Ghio L, Natta W, Rossi P, Peruzzo L, Zanelli E, Gotelli S, et al.. Combined venlafaxine and olanzapine prescription in women with psychotic major depression: A case series. Case Reports in Medicine. 2011;1-4$59$YR$$F$Y$$$20240925$$HP$IT$IT
1422536111$14225361$11$F$20070101$20240819$20171127$20240821$PER$$US-PFIZER INC-2017506944$PFIZER$$67$YR$$F$Y$50$KG$20240821$$CN$US$US
142292204$14229220$4$F$20170301$20240923$20171128$20240924$EXP$FR-UCBSA-2017047307$FR-UCBSA-2017047307$UCB$$26$YR$$M$Y$72$KG$20240924$$HP$FR$FR
142302724$14230272$4$F$$20240911$20171128$20240920$EXP$$DE-MYLANLABS-2017M1074109$MYLAN$Hoppe J, Holderied A, Schafer H, Schonermarck U, Anders HJ, Fischereder M. Drug-induced cytochrome-P450 induction as therapy for calcineurin inhibitor intoxication. Transpl-Int 2017;30 (Suppl. 4):33 abstr. P30.$54$YR$$M$Y$$$20240920$$HP$DE$DE
142302814$14230281$4$F$$20240911$20171128$20240919$EXP$$DE-MYLANLABS-2017M1074094$MYLAN$Hoppe J, Holderied A, Schafer H, Schonermarck U, Anders HJ, Fischereder M. Drug-induced cytochrome-P450 induction as therapy for calcineurin inhibitor intoxication. Transpl-Int 2017;30 (Suppl. 4):33 abstr. P30.$56$YR$$M$Y$$$20240919$$MD$DE$DE
142304216$14230421$6$F$$20240815$20171128$20240821$EXP$$DE-PFIZER INC-2017505746$PFIZER$Serrano Sponton, L.. A Rare Case of Docetaxel-Induced Hydrocephalus Presenting with Gait Disturbances Mimicking and Coexisting with Taxane-Associated Polyneuropathy: The Relevance of Differential Diagnosis, Clinical Assessment, and Response to Ventriculoperitoneal Shunt.. Case Reports in Oncology. 2017;10:973-980$64$YR$$F$Y$$$20240821$$MD$DE$DE
142334256$14233425$6$F$20170101$20240905$20171129$20240912$EXP$$CA-PFIZER INC-2017510433$PFIZER$$67$YR$$M$Y$$$20240912$$MD$CA$CA
142338232$14233823$2$F$$20240830$20171129$20240903$EXP$$FR-MYLANLABS-2017M1074763$MYLAN$Tudesq J-J, Vincent L, Lebrun J, Hicheri Y, Gabellier L, Busetto T, et al. Cytomegalovirus infection with retinitis after brentuximab vedotin treatment for CD30+ lymphoma. Open-Forum-Infect-Dis 2017;4(2):ofx091.$44$YR$$M$Y$$$20240903$$HP$FR$FR
142358214$14235821$4$F$20170801$20240813$20171129$20240821$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK133797$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240821$$HP$CA$CA
142364452$14236445$2$F$$20240906$20171129$20240917$EXP$$FR-MYLANLABS-2017M1074863$MYLAN$Tudesq J-J, Vincent L, Lebrun J, Hicheri Y, Gabellier L, Busetto T, et al. Cytomegalovirus infection with retinitis after brentuximab vedotin treatment for CD30+ lymphoma. Open-Forum-Infect-Dis 2017;4(2):ofx091.$83$YR$$M$Y$$$20240917$$HP$FR$FR
142375672$14237567$2$F$20120101$20240812$20171129$20240821$EXP$$TW-SA-2017SA224217$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240821$$MD$TW$TW
1424139820$14241398$20$F$20160711$20240823$20171130$20240830$EXP$$CA-ROCHE-1797829$ROCHE$$62$YR$A$F$Y$53.5$KG$20240830$$CN$CA$CA
142452342$14245234$2$F$$20240716$20171202$20240726$EXP$$IT-AUROBINDO-AUR-APL-2017-44053$AUROBINDO$Rovera C, Esposito CM, Ciappolino V, Cattaneo D, Baldelli S, Clementi E, et al.. Quetiapine Induced Hypomania and its Association with Quetiapine/Norquetiapine Plasma Concentrations: Case Series of Bipolar Type 2 Patients. Drug Safety - Case Reports. 2017;4:13$28$YR$$F$Y$$$20240726$$HP$IT$IT
1424799222$14247992$22$F$20171101$20240821$20171204$20240823$EXP$$US-PFIZER INC-2017503910$PFIZER$$77$YR$$F$Y$91$KG$20240823$$CN$US$US
1424886315$14248863$15$F$20170808$20240730$20171204$20240805$EXP$$BE-PFIZER INC-2017514075$PFIZER$$1$WK$$M$Y$$$20240805$$MD$BE$BE
142490248$14249024$8$F$20170523$20240911$20171204$20240914$EXP$$MX-ABBVIE-17P-107-2178838-00$ABBVIE$$56$YR$$F$Y$$$20240914$$MD$MX$MX
142520094$14252009$4$F$$20240920$20171205$20240924$EXP$IT-MINISAL02-437800$IT-MYLANLABS-2017M1075934$MYLAN$Ghio L, Natta W, Rossi P, Peruzzo L, Zanelli E, Gotelli S et al.. Combined  venlafaxine and olanzapine prescription in women with psychotic major depression: A case series. Case Rep Med.. 2011$59$YR$$F$Y$$$20240924$$HP$IT$IT
1425344915$14253449$15$F$20150707$20240916$20171206$20240926$EXP$$FR-AUROBINDO-AUR-APL-2017-44327$AUROBINDO$Tudesq JJ, Vincent L, Lebrun J, Hicheri Y, Gabellier L, Busetto T et al.. Cytomegalovirus infection with retinitis after brentuximab vedotin treatment for CD30+ lymphoma. Open Forum Infectious Diseases. 2017;4(2):1-3$44$YR$$M$Y$$$20240926$$MD$FR$FR
1425464611$14254646$11$F$$20240710$20171206$20240711$PER$$US-PFIZER INC-2017518796$PFIZER$$56$YR$$F$Y$$$20240711$$MD$US$US
142584686$14258468$6$F$$20240917$20171207$20240919$PER$$US-PFIZER INC-2017520159$PFIZER$$61$YR$$F$Y$92.99$KG$20240919$$CN$US$US
142608093$14260809$3$F$20171101$20240823$20171207$20240828$PER$$US-JAZZ-2017-US-016148$JAZZ$$11$YR$$M$Y$$$20240828$$CN$US$US
142617423$14261742$3$F$$20240806$20171208$20240812$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-110295$BRISTOL MYERS SQUIBB$Franklin C, Rooms I, Fiedler M, Reis H, Milsch L, Herz S, et al. Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis. European Journal of Cancer 2017;86:248-56. doi:10.1016/j.ejca.2017.09.019$66$YR$E$F$Y$$$20240812$$HP$DE$DE
142625572$14262557$2$F$$20240830$20171208$20240909$EXP$$CA-AUROBINDO-AUR-APL-2017-44169$AUROBINDO$$41$YR$$F$Y$81.63$KG$20240909$$PH$CA$CA
1426271911$14262719$11$F$20170101$20240924$20171208$20240926$EXP$$US-PFIZER INC-2017523161$PFIZER$$60$YR$$M$Y$99.79$KG$20240926$$CN$US$US
142671926$14267192$6$F$20170211$20240807$20171211$20240817$EXP$$IT-AUROBINDO-AUR-APL-2017-44504$AUROBINDO$$45$YR$$M$Y$$$20240817$$MD$IT$IT
142715223$14271522$3$F$$20240911$20171211$20240916$EXP$$CA-PURDUE PHARMA-CAN-2017-0008154$PURDUE$$71$YR$$F$Y$$$20240917$$CN$CA$CA
142748093$14274809$3$F$$20240814$20171212$20240827$EXP$$ES-AUROBINDO-AUR-APL-2017-44634$AUROBINDO$$81$YR$$M$Y$$$20240827$$MD$ES$ES
1427835612$14278356$12$F$$20240918$20171212$20240925$EXP$$CA-PURDUE PHARMA-CAN-2017-0008147$PURDUE$$61$YR$$F$Y$70$KG$20240925$$CN$CA$CA
142803395$14280339$5$F$20161201$20240718$20171212$20240723$EXP$$US-JAZZ-2017-US-016349$JAZZ$$62$YR$$F$Y$$$20240723$$MD$US$US
142808116$14280811$6$F$20140808$20240829$20171213$20240911$EXP$$FR-AUROBINDO-AUR-APL-2017-45060$AUROBINDO$Tudesq J-J, Vincent L, Lebrun J, Hicheri Y, Gabellier L, Cartron G, et al. Cytomegalovirus infection with retinitis after brentuximab vedotin treatment for CD30 lymphoma. Open Forum Infectious Diseases. 2017;4(2):1-3$83$YR$$M$Y$$$20240911$$MD$FR$FR
142835005$14283500$5$F$20170301$20240916$20171214$20240926$EXP$$FR-AUROBINDO-AUR-APL-2017-45121$AUROBINDO$$27$YR$$M$Y$72$KG$20240926$$MD$FR$FR
142835578$14283557$8$F$$20240916$20171213$20240924$EXP$$PHHY2017ES184888$NOVARTIS$Osorio S, Escudero-Vilaplana V, Reguilon-Gallego L, Gomez-Centurion I, Diez JL, Ferrer-Marin F. Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2017;1-3$63$YR$$F$Y$$$20240924$$HP$ES$ES
142914807$14291480$7$F$20170917$20240315$20171215$20240704$EXP$$GB-TEVA-2017-GB-832356$TEVA$$29$YR$$F$Y$$$20240704$$HP$GB$GB
1429284722$14292847$22$F$$20240806$20171215$20240812$EXP$$LT-PFIZER INC-2017532771$MYLAN$Abramavicius, S.. Cisplatin-induced sudden cardiac death with hemodynamic collapse: A severe adverse drug reaction. Medicine. 2017;96 (48)$53$YR$$F$Y$$$20240812$$MD$LT$LT
142937363$14293736$3$F$$20240911$20171216$20240923$EXP$$US-Accord-061862$ACCORD$Joshi S, Khan D. Secondary immunodeficiency due to immunosuppressants for allergic contact dermatitis (ACD) from vascular clips. Annals of Allergy, Asthma and Immunology. 2017;119:5(1): S14-S15$44$YR$A$M$Y$$$20240923$$HP$US$US
142953015$14295301$5$F$$20240807$20171218$20240812$EXP$$US-SHIRE-US201732007$TAKEDA$$$$$F$Y$51$KG$20240812$$MD$US$US
142972705$14297270$5$F$$20240905$20171218$20240911$EXP$$JP-PFIZER INC-2017530697$PFIZER$Yamamoto, K.. Megakaryoblastic transformation of therapy-related myeloid neoplasms with concomitant MYC amplification on double minute chromosomes. International Journal of Hematology. 2017;106 (6):729-731$66$YR$$M$Y$$$20240911$$HP$JP$JP
142982163$14298216$3$F$$20240716$20171218$20240730$EXP$$JP-009507513-1712JPN001347$MERCK$Nawata K, et al. A case of the patient with gynecologic cancer experienced reduction of Warfarin effect after initiation of aprepitant treatment and the effect enhanced after addition of fosfluconazole. The 27th Annual Meeting of Japanese Society of Pharmaceutical Health care and Sc. 2017;854$$$$F$Y$$$20240730$$PH$JP$JP
142982914$14298291$4$F$$20240916$20171218$20240926$EXP$$PHHY2017US180797$NOVARTIS$Joshi SR, Khan D. Secondary immunodeficiency due to immunosuppressants for allergic contact dermatitis (ACD) from vascular clips. ANNALS OF ALLERGY, ASTHMA AND IMMUNOLOGY. 2017;119:5(1):S14-5$44$YR$$M$Y$$$20240926$$HP$US$US
143003174$14300317$4$F$20171207$20240705$20171219$20240716$EXP$$CA-ROCHE-2041428$ROCHE$$11$YR$C$M$Y$$$20240716$$CN$CA$CA
1430254913$14302549$13$F$20210201$20240702$20171219$20240705$EXP$$PHHY2017CA183277$NOVARTIS$$80$YR$$M$Y$$$20240705$$CN$CA$CA
1430839424$14308394$24$F$20171123$20240905$20171220$20240910$EXP$$CA-TAKEDA-2017TUS025842$TAKEDA$$50$YR$$F$Y$$$20240910$$HP$CA$CA
143094298$14309429$8$F$20170808$20240716$20171220$20240821$EXP$$BE-TEVA-2017-BE-832465$TEVA$$$$N$M$Y$0.3$KG$20240821$$MD$BE$BE
1430952046$14309520$46$F$20170101$20240909$20171220$20240916$EXP$$CA-CELLTRION INC.-2017CA005211$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
143114978$14311497$8$F$$20240722$20171221$20240805$EXP$$CA-UCBSA-2017051050$UCB$$60$YR$$F$Y$$$20240805$$HP$CA$CA
143130142$14313014$2$F$20171117$20240626$20171221$20240704$EXP$$ES-AUROBINDO-AUR-APL-2017-45698$AUROBINDO$$28$YR$$F$Y$$$20240704$$MD$ES$ES
143131877$14313187$7$F$$20240913$20171221$20240925$EXP$$IT-AUROBINDO-AUR-APL-2017-45776$AUROBINDO$Valeria C.Semkova D. When to start anticoagulation treatment after acute ischemic stroke?. Compendium of Medicine. 2017;7-10$80$YR$$M$Y$$$20240925$$MD$IT$IT
1431491912$14314919$12$F$20090101$20240918$20171221$20240930$EXP$$GR-ELI_LILLY_AND_COMPANY-GR201712006788$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240930$$MD$GR$GR
1431858921$14318589$21$F$20160101$20240716$20171222$20240729$EXP$$LT-009507513-1712LTU009307$MERCK$Abramavicius S, Zemaitis M, Pilvinis V, Kadusevicius E. Cisplatin-induced sudden cardiac death with hemodynamic collapse: A severe adverse drug reaction. Medicine. 2017;96(48):1-3$53$YR$$F$Y$$$20240729$$MD$LT$LT
143195325$14319532$5$F$$20240919$20171222$20240925$EXP$$ES-MYLANLABS-2017M1080723$MYLAN$Osorio S, Escudero Vilaplana V, Reguilon Gallego L, Gomez Centurion I, Diez JL, Ferrer Marin F. Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline. J-Oncol-Pharm-Pract. 2017;1-3$63$YR$$F$Y$$$20240925$$HP$ES$ES
143196283$14319628$3$F$$20240905$20171222$20240910$EXP$$JP-SA-2017SA249384$SANOFI AVENTIS$Yamamoto K, Yakushijin K, Inui Y, Kawamoto S, Kajimoto K, Hayashi Y et al.. Megaryoblastic transformation of therapy-related myeloid neoplasms with concomitant MYC amplification on double minute chromosomes.. Int J Hematol.. 2017;106 (6):729-31$66$YR$E$M$Y$$$20240910$$MD$JP$JP
143254624$14325462$4$F$20171220$20240715$20171226$20240720$EXP$$US-JAZZ-2017-US-017158$JAZZ$$29$YR$$F$Y$$$20240720$$MD$US$US
143255194$14325519$4$F$$20240716$20171226$20240722$EXP$$DE-MYLANLABS-2017M1081843$MYLAN$Mahmoudi M, Brenner T, Hatiboglu G, Burhenne J, Weiss J, Weigand M, et al. Substantial impairment of voriconazole clearance by high-dose meropenem in a patient with renal failure. Clin Infect Dis. 2017;65 (6):1033-1036$78$YR$$M$Y$$$20240722$$HP$DE$DE
143259375$14325937$5$F$20130301$20240715$20171226$20240721$EXP$$FR-MYLANLABS-2017M1082144$MYLAN$Reynaud Q, Dupont D, Nove-Josserand R, Durupt S, Persat F, Ader F, et al. Rare and unusual presentation of Cladophialophora infection in a pulmonary transplant cystic fibrosis patient. Transplant Infectious Disease. 2017;19(6):e12789$35$YR$$F$Y$$$20240719$$HP$FR$FR
143264052$14326405$2$F$$20240905$20171227$20240917$EXP$$JP-Accord-062336$ACCORD$Yamamoto K, Yakushijin K, Inui Y, Kawamoto S, Kajimoto K, Hayashi Y et al. Mega karyoblastic transformation of therapy-related myeloid neoplasms with concomitant MYC amplification on double minute chromosomes. International Journal of Hematology. 2017;106(6):729-731. DOI: 10.1007/s12185-017-2326-x.$66$YR$E$M$Y$$$20240917$$HP$JP$JP
143273436$14327343$6$F$20171201$20240911$20171227$20240916$PER$$US-PFIZER INC-2017544156$PFIZER$$48$YR$$F$Y$$$20240916$$CN$US$US
143301552$14330155$2$F$20170301$20240712$20171227$20240722$EXP$$DE-TEVA-2017-DE-836931$TEVA$$78$YR$$M$Y$84$KG$20240722$$HP$DE$DE
143312752$14331275$2$F$20160120$20240720$20171228$20240731$EXP$$DE-AUROBINDO-AUR-APL-2017-47446$AUROBINDO$$39$YR$$F$Y$$$20240731$$MD$DE$DE
143332212$14333221$2$F$20150601$20240828$20171228$20240904$EXP$$GB-TEVA-813953ACC$TEVA$$52$YR$$M$Y$105$KG$20240904$$CN$GB$GB
1433369118$14333691$18$F$20150707$20240830$20171228$20240903$EXP$$FR-MYLANLABS-2017M1082609$MYLAN$Tudesq J-J, Vincent L, Lebrun J, Hicheri Y, Gabellier L, Busetto T et al.. Cytomegalovirus infection with retinitis after brentuximab vedotin treatment for CD30 lymphoma.. Open Forum Infect Dis. 2017;4(2):91$44$YR$$M$Y$$$20240903$$MD$FR$FR
1433764136$14337641$36$F$20090101$20240909$20171229$20240913$EXP$$GR-MYLANLABS-2017M1082797$MYLAN$$62$YR$$F$Y$$$20240913$$MD$GR$GR
1434040915$14340409$15$F$20170901$20240731$20180101$20240805$EXP$$US-ARIAD PHARMACEUTICALS, INC-2017US009034$TAKEDA$$38$YR$$F$Y$152$KG$20240805$$CN$US$US
1434198914$14341989$14$F$20160101$20240912$20180102$20240918$EXP$$FR-MYLANLABS-2017M1083210$MYLAN$$84$YR$$F$Y$68$KG$20240918$$HP$FR$FR
1434258617$14342586$17$F$20160101$20240923$20180102$20240926$EXP$$FR-PFIZER INC-2017550561$PFIZER$$84$YR$$F$Y$68$KG$20240926$$CN$FR$FR
143432242$14343224$2$F$20171201$20240815$20180102$20240820$EXP$$US-JAZZ-2017-US-017342$JAZZ$$57$YR$$M$Y$$$20240820$$CN$US$US
1434327617$14343276$17$F$$20240821$20180102$20240827$EXP$$DE-PFIZER INC-2017550256$PFIZER$Kaschka, W.. The chemo brain: Severe cognitive decline following chemotherapy of breast cancer. New Horizons in Clinical Case Reports. 2017;2:4-6$43$YR$$F$Y$$$20240827$$HP$DE$DE
143437402$14343740$2$F$$20240729$20180102$20240802$EXP$$US-PFIZER INC-2016575174$PFIZER$Yang, Z.. Association of long-term tacrolimus (FK506) therapy with abnormal megakaryocytosis, bone marrow fibrosis, and dyserythropoiesis. Clinical Case Reports. 2015;3(7):664-668$17$YR$$M$Y$$$20240802$$MD$US$US
143456543$14345654$3$F$$20240809$20180103$20240819$EXP$$US-AUROBINDO-AUR-APL-2018-000625$AUROBINDO$Domingo L, Magdo HS, Day RW.. Acute Pulmonary Vasodilator Testing and Long-Term Clinical Course in Segmental Pulmonary Vascular Disease.. Pediatric Cardiology. 2017;1-8$1$YR$$F$Y$$$20240819$$MD$US$US
143462855$14346285$5$F$20160101$20240711$20180103$20240712$EXP$$FR-PFIZER INC-2018001178$PFIZER$$85$YR$$F$Y$60$KG$20240712$$MD$FR$FR
143479492$14347949$2$F$20160101$20240806$20180103$20240812$EXP$$LT-MYLANLABS-2017M1081956$MYLAN$Abramavicius S, Zemaitis M, Pilvinis V, Kadusevicius E. Cisplatin-induced sudden cardiac death with hemodynamic collapse: A severe adverse drug reaction. Medicine 2017;96(48):e8995.$53$YR$$F$Y$$$20240812$$MD$LT$LT
1434973914$14349739$14$F$20150901$20240922$20180104$20240926$EXP$$PHHY2017FR094682$NOVARTIS$Keribin P, Guerrot D, Jardin F, Moizan H. Osteonecrosis of the jaw in a patient presenting with post-transplantation lymphoproliferative disorder treated with rituximab: a case report. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY OFFICIAL JOURNAL OF THE AMERICAN ASSOC. 2017;75(12):2599-605$73$YR$$M$Y$$$20240926$$HP$FR$FR
143505716$14350571$6$F$$20240715$20180104$20240717$PER$$US-PFIZER INC-2018001919$PFIZER$$62$YR$$F$Y$$$20240717$$MD$US$US
143514182$14351418$2$F$$20240917$20180104$20240926$PER$$US-SHIRE-US201736731$TAKEDA$$$$$F$Y$55$KG$20240926$$HP$US$US
143515437$14351543$7$F$20150401$20240709$20180104$20240717$EXP$$DE-CELLTRION INC.-2017DE017345$CELLTRION$$$$$$Y$$$20240717$$MD$DE$DE
143520953$14352095$3$F$$20240709$20180104$20240715$EXP$$DE-MYLANLABS-2018M1000352$MYLAN$Pushkarevskaya A, Bidier M, Hartmann M, Enk A, Hadaschik E. Viral reactivation imitates relapse of pemphigus vulgaris in an immunosuppressed patient.. JDDG - Journal of the German Society of Dermatology. 2017;15(11):1144-1146$52$YR$$F$Y$$$20240715$$MD$DE$DE
143541298$14354129$8$F$20180516$20240813$20180105$20240819$EXP$$CA-TAKEDA-2017TUS027516$TAKEDA$$34$YR$$F$Y$$$20240819$$CN$CA$CA
143555185$14355518$5$F$20170808$20240716$20180105$20240727$EXP$$BE-SA-2018SA003378$SANOFI AVENTIS$$$$$M$Y$0.3$KG$20240727$$MD$BE$BE
143566563$14356656$3$F$20171121$20230712$20180105$20240715$EXP$FR-AFSSAPS-BS20170928$FR-LUNDBECK-DKLU2042173$LUNDBECK$$$$$$Y$$$20240715$$MD$FR$FR
143566625$14356662$5$F$20160101$20240722$20180105$20240725$EXP$$FR-MYLANLABS-2018M1000188$MYLAN$$85$YR$$F$Y$60$KG$20240725$$MD$FR$FR
143566645$14356664$5$F$$20240919$20180105$20240923$EXP$$SE-MYLANLABS-2018M1000133$MYLAN$$30$YR$$M$Y$$$20240923$$MD$SE$SE
143602613$14360261$3$F$20170426$20240716$20180106$20240725$EXP$$GB-AUROBINDO-AUR-APL-2018-000360$AUROBINDO$$68$YR$$F$Y$53.97$KG$20240725$$MD$GB$GB
143603303$14360330$3$F$$20240821$20180106$20240830$EXP$$DE-Accord-062607$ACCORD$Kaschka WP, Steyer J, Kaschka IN, Jandl M, Hodgkinson S. The chemo brain: Severe cognitive decline following chemotherapy of breast cancer. New Horizons in Clinical Case Reports. 2017;2:4-6.$43$YR$A$F$Y$$$20240830$$HP$DE$DE
143684292$14368429$2$F$$20240822$20180109$20240823$EXP$$DE-MYLANLABS-2017M1083338$MYLAN$Kaschka WP, Steyer J, Kaschka IN, Jandl M, Hodgkinson S. The chemo brain: Severe cognitive decline following chemotherapy of breast cancer. unknown 2017;2:4-6.$43$YR$$F$Y$$$20240823$$HP$DE$DE
143686776$14368677$6$F$20170725$20240723$20180109$20240725$EXP$$US-PFIZER INC-2017282201$PFIZER$$70$YR$$F$Y$61.23$KG$20240725$$CN$US$US
143705135$14370513$5$F$$20240709$20180110$20240711$PER$$US-PFIZER INC-2018005602$PFIZER$$72$YR$$F$Y$$$20240711$$MD$US$US
143705812$14370581$2$F$$20240814$20180110$20240827$EXP$$GB-AUROBINDO-AUR-APL-2016-11282$AUROBINDO$$78$YR$$F$Y$45.5$KG$20240827$$MD$GB$GB
143745723$14374572$3$F$20171215$20240715$20180111$20240722$EXP$$FR-AUROBINDO-AUR-APL-2018-001266$AUROBINDO$$70$YR$$F$Y$$$20240722$$MD$FR$FR
1437469320$14374693$20$F$20140301$20240806$20180111$20240808$EXP$$CA-ROCHE-1365965$ROCHE$$65$YR$E$F$Y$57$KG$20240808$$HP$CA$CA
143798092$14379809$2$F$20170403$20240814$20180112$20240826$EXP$$ES-AUROBINDO-AUR-APL-2018-002075$AUROBINDO$$30$YR$$M$Y$$$20240826$$MD$ES$ES
143804397$14380439$7$F$$20240709$20180112$20240716$EXP$$CA-GLAXOSMITHKLINE-CA2018GSK004947$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$MD$CA$CA
143811453$14381145$3$F$$20240715$20180112$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-000442$BRISTOL MYERS SQUIBB$Patel RJ, Liu MA, Amaraneni A, Sindhu SK. Rare side effect of adjuvant ipilimumab after surgical resection of melanoma: Guillain-Barre syndrome. BMJ Case Reports. 2017 Dec 13;2017:1-3. doi:10.1136/bcr-2017-221318.$71$YR$E$M$Y$$$20240719$$HP$US$US
1438320312$14383203$12$F$20090101$20240909$20180115$20240918$EXP$GR-EISAI EUROPE LTD-EC-2017-033791$GR-ROCHE-2052195$ROCHE$$62$YR$A$F$Y$$$20240918$$MD$GR$GR
143875772$14387577$2$F$$20240812$20180115$20240820$EXP$$US-SA-2017SA193628$SANOFI AVENTIS$$63$YR$A$F$Y$35.38$KG$20240820$$MD$US$US
1438980033$14389800$33$F$20171008$20240923$20180115$20240926$EXP$$PHHY2017CA153083$NOVARTIS$$59$YR$$M$Y$$$20240926$$CN$CA$CA
143911923$14391192$3$F$$20240814$20180116$20240827$EXP$$ES-AUROBINDO-AUR-APL-2018-002047$AUROBINDO$Sendra J, Alcoverro O.. Left Anterior Right Temporal Electrode Placement in Maintenance Electroconvulsive Therapy.. The Journal of ECT.. 2017;33 (1)::e1-e2$71$YR$$F$Y$$$20240827$$MD$ES$ES
143921113$14392111$3$F$$20240813$20180116$20240814$EXP$DE-JNJFOC-20171108993$DE-JNJFOC-20171108993$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$HP$DE$DE
1439728510$14397285$10$F$20171220$20240913$20180116$20240918$EXP$$DE-ABBVIE-18P-062-2217099-00$ABBVIE$$51$YR$$M$Y$86$KG$20240918$$MD$DE$DE
144008572$14400857$2$F$20170620$20240624$20180117$20240708$EXP$DE-FERRINGPH-2018FE00107$DE-FERRINGPH-2018FE00107$FERRING$$$$$$Y$$$20240708$$MD$DE$DE
1440101013$14401010$13$F$20171209$20240923$20180117$20240930$EXP$$CA-TAKEDA-2018TUS001007$TAKEDA$$81$YR$$F$Y$$$20240930$$CN$CA$CA
1440251017$14402510$17$F$$20240917$20180117$20240919$PER$$US-PFIZER INC-2018020230$PFIZER$$70$YR$$M$Y$106$KG$20240919$$CN$US$US
144101165$14410116$5$F$20171201$20240918$20180119$20240920$EXP$$US-PFIZER INC-2018024864$PFIZER$$61$YR$$F$Y$$$20240920$$CN$US$US
144103952$14410395$2$F$20170804$20240701$20180119$20240708$EXP$$GB-AUROBINDO-AUR-APL-2018-002105$AUROBINDO$$59$YR$$F$Y$86$KG$20240708$$MD$GB$GB
144111416$14411141$6$F$$20240822$20180119$20240828$EXP$$US-JAZZ-2018-US-001248$JAZZ$$$$$M$Y$$$20240828$$HP$US$US
1441261416$14412614$16$F$20180129$20240807$20180119$20240808$EXP$$US-PFIZER INC-2018024451$PFIZER$$69$YR$$F$Y$82$KG$20240808$$CN$US$US
144129115$14412911$5$F$20141001$20240813$20180119$20240816$EXP$$ES-ABBVIE-18P-144-2218839-00$ABBVIE$Ruiz de Morales JG, Munoz F, Hernando M. Successful treatment of common variable immunodeficiency-associated inflammatory bowel disease with ustekinumab. Journal of Crohn^s and Colitis. 2017;11(9):1154-5.$60$YR$$M$Y$$$20240816$$MD$ES$ES
144194485$14419448$5$F$20071001$20240820$20180122$20240823$EXP$$FR-MYLANLABS-2018M1004398$MYLAN$Salmon A, Debourgogne A, Vasbien M, Clement L, Collomb J, Plenat F et al.. Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature. Clinical Microbiology and Infection. 2010;16 (5):508-512$38$YR$$F$Y$$$20240823$$HP$FR$FR
144196939$14419693$9$F$$20240923$20180122$20240925$EXP$$US-PFIZER INC-2017512553$PFIZER$$20$YR$$M$Y$81.65$KG$20240925$$MD$US$US
144213523$14421352$3$F$$20240730$20180122$20240805$PER$$US-BIOGEN-2018BI00511851$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
1442354127$14423541$27$F$20170101$20240903$20180123$20240906$EXP$$US-PFIZER INC-2018027236$PFIZER$$81$YR$$F$Y$52$KG$20240906$$CN$US$US
144248264$14424826$4$F$$20230421$20180123$20240723$PER$$US-OTSUKA-BMS-2015-056650$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
144251732$14425173$2$F$$20240731$20180123$20240801$PER$$US-PFIZER INC-2018024106$PFIZER$$75$YR$$F$Y$92.99$KG$20240801$$CN$US$US
1443016613$14430166$13$F$20171222$20240924$20180123$20240925$EXP$$MX-ABBVIE-18P-107-2231913-00$ABBVIE$$57$YR$$F$Y$$$20240925$$MD$MX$MX
144328268$14432826$8$F$20171002$20240823$20180124$20240826$EXP$$CA-NAPPMUNDI-USA-2018-0142471$PURDUE$$66$YR$$M$Y$92.971$KG$20240826$$CN$US$US
144356372$14435637$2$F$20170826$20240621$20180125$20240705$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-161504$RANBAXY$$66$YR$$M$Y$$$20240705$$MD$SE$SE
144467236$14446723$6$F$$20240827$20180126$20240827$EXP$$PHHY2018AU009439$NOVARTIS$$$$$F$Y$$$20240827$$HP$AU$AU
1444905114$14449051$14$F$20180111$20240828$20180126$20240902$EXP$$CA-TAKEDA-2017TUS024839$TAKEDA$$67$YR$$F$Y$$$20240902$$HP$CA$CA
144528445$14452844$5$F$20171229$20240821$20180129$20240827$EXP$$DE-AEGERION PHARMACEUTICAL, INC-AEGR003555$AEGERION$$$$$$Y$$$20240827$$MD$DE$DE
144540166$14454016$6$F$$20240911$20180129$20240917$EXP$$GB-MYLANLABS-2018M1002396$MYLAN$Gonzaga-Lopez A, Munoz-Rodriguez J, Ruiz-Casado A.. Necrotising fasciitis in a patient treated with FOLFIRI-aflibercept for colorectal cancer.. Ann R Coll Surg Engl.. 2017;99(8):225-6$64$YR$$M$Y$$$20240917$$HP$GB$ES
144541855$14454185$5$F$20170601$20240715$20180129$20240718$EXP$DE-BFARM-18000495$DE-PFIZER INC-2018033498$PFIZER$$17$YR$$F$Y$68$KG$20240718$$MD$DE$DE
144572472$14457247$2$F$20171211$20240720$20180130$20240731$EXP$$ES-AUROBINDO-AUR-APL-2018-003357$AUROBINDO$$89$YR$$M$Y$$$20240731$$MD$ES$ES
1445851817$14458518$17$F$$20240814$20180130$20240823$EXP$$CA-APOTEX-2018AP005828$APOTEX$$76$YR$$F$Y$$$20240823$$MD$CA$CA
144728373$14472837$3$F$$20240624$20180201$20240701$EXP$$JP-AMGEN-JPNSP2018014089$AMGEN$Hyakudomi R, Yamamoto T, Takai K, Taniura T, Kishi T, Miyazaki Y, et al. A case of pulmonary tuberculosis occurred during the chemotherapy for locally advanced colon cancer. The 108th meeting of The Japanese Society of Gastroenterology Chugoku Branch. 2017;139$78$YR$E$M$Y$41.9$KG$20240701$$MD$JP$JP
1447328839$14473288$39$F$20171017$20240907$20180201$20240918$EXP$$CA-ROCHE-2065793$ROCHE$$51$YR$A$M$Y$86$KG$20240918$$CN$CA$CA
1447381732$14473817$32$F$20170101$20240830$20180201$20240904$EXP$$US-PFIZER INC-2018041621$PFIZER$$68$YR$$F$Y$49$KG$20240904$$CN$US$US
144738593$14473859$3$F$$20240919$20180201$20240923$EXP$$US-PFIZER INC-2018043111$PFIZER$$58$YR$$F$Y$$$20240923$$CN$US$US
144754424$14475442$4$F$20160823$20240715$20180201$20240718$EXP$$CA-TAKEDA-2018TUS002355$TAKEDA$$50$YR$$F$Y$$$20240718$$HP$CA$CA
144788987$14478898$7$F$$20240910$20180202$20240912$PER$$US-PFIZER INC-2018045432$PFIZER$$65$YR$$F$Y$$$20240912$$MD$US$US
144789155$14478915$5$F$$20240711$20180202$20240715$PER$$US-PFIZER INC-2018044193$PFIZER$$60$YR$$F$Y$$$20240715$$HP$US$US
144817105$14481710$5$F$20090101$20240916$20180202$20240923$PER$$US-JAZZ-2018-US-002118$JAZZ$$$$$M$Y$$$20240923$$CN$US$US
1448615510$14486155$10$F$20141001$20240820$20180205$20240826$EXP$$ES-MYLANLABS-2018M1004934$MYLAN$Ruiz De Morales, J., Munoz, F. and Hernando, M., Jose G... Successful treatment of common variable immunodeficiency-associated inflammatory bowel disease with Ustekinumab.. J. Crohn^s Colitis. 2017;11(9):1154-5$60$YR$$M$Y$$$20240826$$MD$ES$ES
144879876$14487987$6$F$$20240715$20180205$20240725$EXP$CA-LEO PHARMA-307183$CA-LEO Pharma-307183$LEO PHARM$$$$$M$Y$$$20240725$$CN$CA$CA
144921783$14492178$3$F$$20180202$20180206$20240923$EXP$$UG-MYLANLABS-2018M1007722$MYLAN$$$$$M$Y$2.5$KG$20240923$$HP$UG$UG
1449471011$14494710$11$F$20170101$20240628$20180206$20240704$EXP$$US-JAZZ-2018-US-002324$JAZZ$$$$$F$Y$$$20240704$$MD$US$US
1449585445$14495854$45$F$$20240716$20180207$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-007109$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240731$$CN$CA$CA
1449736924$14497369$24$F$20211201$20240726$20180207$20240802$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK066828$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$BR$BR
1450166941$14501669$41$F$$20240801$20180207$20240820$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-007157$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240820$$HP$CA$CA
145121734$14512173$4$F$20171124$20240711$20180209$20240716$EXP$$FR-PFIZER INC-2018051155$PFIZER$$21$YR$$F$Y$98$KG$20240716$$MD$FR$FR
145173562$14517356$2$F$$20240621$20180212$20240716$EXP$$LB-ROCHE-2071822$ROCHE$Salem R, Massoud R, Kanj S, Hamdan M, Salman R, Bazarbachi A. Progressive multifocal leukoencephalopathy in patients receiving rituximab and cyclophosphamide after haplo-identical T-cell replete transplantation and review of the literature. Current Research in Translational Medicine. 2017;65 (4):127-32. doi:10.1016/J.RETRAM.2017.10.002.$49$YR$A$F$Y$$$20240716$$HP$LB$LB
145173794$14517379$4$F$$20240920$20180212$20240926$EXP$$US-ROCHE-2065618$ROCHE$$42$YR$A$F$Y$$$20240926$$MD$US$US
1451773415$14517734$15$F$20161001$20240621$20180212$20240703$EXP$$CA-ROCHE-2067588$ROCHE$$30$YR$A$M$Y$100$KG$20240703$$MD$CA$CA
145242938$14524293$8$F$20180202$20240723$20180213$20240724$PER$$US-PFIZER INC-2017518308$PFIZER$$58$YR$$F$Y$107.9$KG$20240724$$CN$US$US
1452907417$14529074$17$F$20180101$20240911$20180214$20240916$EXP$$US-PFIZER INC-2018063855$PFIZER$$68$YR$$F$Y$61.224$KG$20240916$$MD$US$US
145308749$14530874$9$F$20110101$20240802$20180214$20240806$EXP$$FR-MYLANLABS-2018M1008542$MYLAN$M^Kada H, Perazzo H, Munteanu M, Ngo Y, Ramanujam N, Fautrel G, et al.. Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study.  Drug Induced Liver Injury Groupe Hospitalier Pitie-Salpetriere (DILI-GHPS) Group and Safer and Faster Evidence-based Translation (SAFE-T) Consortium. PLoS One.. 2012;7(8):e42418 (1-7)$31$YR$$F$Y$$$20240806$$MD$FR$FR
145318406$14531840$6$F$$20240816$20180214$20240826$EXP$$DE-MYLANLABS-2018M1009505$BIOCON$Kaschka WP, Kaschka J, Kaschka IN, Jandl Hodgkinson S. et al.. The chemo brain: Severe cognitive decline following chemotherapy of breast cancer.. New Horizons in Clinical Case Reports.. 2017;2:4-6$$$$$Y$$$20240826$$MD$DE$DE
145340467$14534046$7$F$20171001$20240819$20180215$20240821$EXP$$US-PFIZER INC-2018063220$PFIZER$$65$YR$$F$Y$45.36$KG$20240821$$CN$US$US
145345862$14534586$2$F$20160101$20240806$20180215$20240816$EXP$$FR-TEVA-2018-FR-856617$TEVA$$85$YR$$F$Y$60$KG$20240816$$MD$FR$FR
145349027$14534902$7$F$20180301$20240906$20180215$20240911$EXP$$CA-PFIZER INC-2016424376$PFIZER$$49$YR$$M$Y$$$20240911$$CN$CA$CA
145352876$14535287$6$F$$20240913$20180215$20240925$EXP$$IT-AUROBINDO-AUR-APL-2018-005488$AUROBINDO$Pelizzaro E, Natali N, Cuna V, Comai G, Baraldi O, La Manna G.. Could metformin associated lactic acidosis have a role in deposition of oxalates?. Blood Purification. 2017;44(3):183$65$YR$$M$Y$$$20240925$$HP$IT$IT
145353193$14535319$3$F$20171101$20240708$20180215$20240710$EXP$IE-HPRA-2017-032790$IE-PFIZER INC-2018064874$PFIZER$$49$YR$$M$Y$$$20240710$$MD$IE$IE
1453548223$14535482$23$F$$20240922$20180215$20240924$EXP$$CA-BIOVITRUM-2018CA0123$BIOVITRUM$$56$YR$$F$Y$$$20240924$$HP$CA$CA
145359603$14535960$3$F$20170510$20240808$20180215$20240818$EXP$$BE-AUROBINDO-AUR-APL-2018-007660$AUROBINDO$$28$YR$$F$Y$58$KG$20240818$$MD$BE$BE
145367483$14536748$3$F$20150419$20240906$20180215$20240919$EXP$$BE-TEVA-2018-BE-858044$TEVA$$71$YR$$M$Y$81.7$KG$20240916$$MD$BE$BE
145370647$14537064$7$F$20150901$20240807$20180215$20240813$EXP$$CA-TAKEDA-2015TUS015228$TAKEDA$$55$YR$$M$Y$$$20240813$$CN$CA$CA
1454430311$14544303$11$F$20170808$20240704$20180216$20240704$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-121039$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$88$KG$20240704$$HP$DE$DE
145464734$14546473$4$F$20160112$20240828$20180219$20240905$EXP$$CA-ROCHE-2074738$ROCHE$$43$YR$A$M$Y$99$KG$20240905$$MD$CA$CA
145465302$14546530$2$F$20180112$20240830$20180219$20240909$EXP$$ES-AUROBINDO-AUR-APL-2018-007917$AUROBINDO$$38$YR$$M$Y$$$20240909$$MD$ES$ES
145500153$14550015$3$F$20171101$20240916$20180219$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006496$ACADIA PHARMACEUTICALS$$67$YR$$F$Y$$$20240926$$CN$US$US
145526048$14552604$8$F$$20240920$20180220$20240926$EXP$$US-JAZZ-2017-US-017050$JAZZ$$$$$M$Y$$$20240926$$CN$US$US
145531504$14553150$4$F$$20240813$20180220$20240822$EXP$$CA-APOTEX-2018AP006538$APOTEX$$73$YR$$M$Y$$$20240822$$HP$CA$CA
1455810721$14558107$21$F$20180201$20240910$20180221$20240919$EXP$$PHHY2018DE025410$NOVARTIS$$61$YR$$F$Y$50$KG$20240919$$MD$DE$DE
145629373$14562937$3$F$20180110$20240830$20180222$20240909$EXP$$ES-AUROBINDO-AUR-APL-2018-008844$AUROBINDO$$34$YR$$F$Y$$$20240909$$MD$ES$ES
145651363$14565136$3$F$20171215$20240715$20180223$20240722$EXP$$FR-AUROBINDO-AUR-APL-2018-008964$AUROBINDO$$70$YR$$F$Y$$$20240722$$MD$FR$FR
145655882$14565588$2$F$20180122$20240821$20180223$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-009228$AUROBINDO$$65$YR$$M$Y$74$KG$20240831$$MD$ES$ES
145675962$14567596$2$F$$20240731$20180223$20240805$PER$$US-JNJFOC-20180216755$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$LW$US$US
145683819$14568381$9$F$$20240724$20180223$20240731$EXP$$CA-TAKEDA-2018TUS004077$TAKEDA$$$$$F$Y$$$20240731$$CN$CA$CA
145690043$14569004$3$F$$20240911$20180223$20240919$EXP$$CA-TAKEDA-2018TUS004315$TAKEDA$$$$$F$Y$$$20240919$$CN$CA$CA
145691272$14569127$2$F$$20240701$20180223$20240709$PER$$US-JNJFOC-20180216795$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$LW$US$US
145694293$14569429$3$F$$20240725$20180223$20240731$EXP$$NL-B.I. Pharmaceuticals,Inc./Ridgefield-2018-12-000696$BOEHRINGER INGELHEIM$Diercks GFH, Meijer JM, Bolling MC, Scholtens-Jaegers SMHJ, Bremer J, Horvath B.. Absence of Epidermal Antibodies in Stevens?Johnson Syndrome/ Toxic Epidermal Necrolysis Patients but Beware of Single Positive Results.. Dermatology Research and Practice. 2024;2024:1-5. doi:10.1155/2024/5504462.$36$YR$A$F$Y$$$20240731$$HP$NL$NL
145695693$14569569$3$F$20160101$20240820$20180224$20240831$EXP$$JP-Accord-063799$ACCORD$Tanaka H, Kojima R, Hirasawa K, Takase S, Sato H, Okamoto I, et al; A Case of Sepsis Caused by Non-Occlusive Mesenteric Ischaemia Noted During Induction Chemotherapy; The 27th Annual Meeting of the Japan Society for Head and Neck Surgery/Scientific Lectures (02, 03-Feb-2017)/Shinjuku-ku, Tokyo ()207/().$74$YR$E$M$Y$$$20240831$$HP$JP$JP
1457041412$14570414$12$F$20130101$20240816$20180226$20240826$EXP$$FR-009507513-1802FRA011139$MERCK$$78$YR$$F$Y$$$20240826$$CN$FR$FR
145716035$14571603$5$F$20171201$20240710$20180226$20240712$EXP$$US-PFIZER INC-2018076620$PFIZER$$45$YR$$F$Y$104.33$KG$20240712$$CN$US$US
1457292413$14572924$13$F$20200101$20240716$20180226$20240717$EXP$$US-PFIZER INC-2018080288$PFIZER$$90$YR$$F$Y$49$KG$20240717$$CN$US$US
1457467617$14574676$17$F$20150318$20240909$20180227$20240912$EXP$$PHHY2015CA035824$NOVARTIS$$74$YR$$F$Y$$$20240912$$CN$CA$CA
145794948$14579494$8$F$20170601$20240709$20180227$20240716$EXP$$US-JAZZ-2018-US-003502$JAZZ$$47$YR$$F$Y$89.796$KG$20240716$$HP$US$US
145798655$14579865$5$F$$20240814$20180228$20240821$PER$$US-AMGEN-USASP2018025843$AMGEN$$47$YR$A$F$Y$$$20240821$$HP$US$US
1458079315$14580793$15$F$20170823$20240917$20180228$20240925$EXP$$CA-ROCHE-2078309$ROCHE$$69$YR$E$F$Y$$$20240925$$CN$CA$CA
1458164313$14581643$13$F$20160921$20240711$20180228$20240718$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK151636$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$BR$BR
145848889$14584888$9$F$20180607$20240628$20180301$20240705$EXP$$CA-TAKEDA-2018TUS004851$TAKEDA$$37$YR$$M$Y$$$20240705$$CN$CA$CA
145927042$14592704$2$F$20171212$20240716$20180302$20240729$EXP$CH-SM-2018-00992$CH-009507513-1802CHE013558$MERCK$$43$YR$$F$Y$56$KG$20240729$$PH$CH$CH
1459618916$14596189$16$F$20130101$20240823$20180303$20240902$EXP$$FR-AUROBINDO-AUR-APL-2018-010542$AUROBINDO$$78$YR$$F$Y$$$20240902$$CN$FR$FR
145963373$14596337$3$F$$20240906$20180303$20240909$EXP$IT-PFIZER INC-2017500949$IT-GLAXOSMITHKLINE-IT2018032902$GLAXOSMITHKLINE$Milano A. Acinetobacter Baumannii multi drug resistance (MDR): pathogenic increasingly present in our departments and cause of deaths. SIMIT National Congress. Abstract 306 Pr:285$$$$$Y$$$20240909$$MD$IT$IT
1459743811$14597438$11$F$20171223$20240705$20180305$20240710$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-019075$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240710$$HP$DE$DE
1459770510$14597705$10$F$20160913$20240819$20180305$20240826$EXP$$CA-ROCHE-2082150$ROCHE$$66$YR$E$M$Y$70$KG$20240826$$CN$CA$CA
145993063$14599306$3$F$20170419$20240715$20180305$20240715$EXP$$DK-PFIZER INC-2018090503$PFIZER$$79$YR$$F$Y$170$KG$20240715$$MD$DK$DK
1459992311$14599923$11$F$20130101$20240731$20180305$20240802$EXP$$FR-AstraZeneca-2018SE27280$ASTRAZENECA$$73$YR$$F$Y$$$20240802$$MD$FR$
146019612$14601961$2$F$$20240621$20180306$20240705$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2018-01057$ALKEM$Todokoro D, Hoshino J, Yo A, Makimura K and et al.. Scedosporium apiospermum infectious scleritis following posterior subtenon triamcinolone acetonide injection: a case report and literature review. BMC Ophthalmology.. 2018;18(40):1-9$50$YR$$M$Y$$$20240705$$HP$JP$JP
146019622$14601962$2$F$$20240621$20180306$20240705$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2018-01058$ALKEM$Oh IK, Baek S, Huh K and Oh J.. Periocular abscess caused by Pseudallescheria boydii after a posterior subtenon injection of triamcinolone acetonide. Graefes Arch Clin Exp Ophthalmol.. 2007;245:164-6$62$YR$$F$Y$$$20240705$$HP$JP$JP
1460655617$14606556$17$F$20160622$20240819$20180307$20240827$EXP$$CA-ROCHE-2082859$ROCHE$$29$YR$A$F$Y$$$20240827$$PH$CA$CA
146072788$14607278$8$F$$20240923$20180307$20240925$PER$$US-PFIZER INC-2018091817$PFIZER$$47$YR$$F$Y$$$20240925$$HP$US$US
1461090326$14610903$26$F$20160101$20240629$20180308$20240905$EXP$$CA-ROCHE-2084104$ROCHE$$42$YR$A$F$Y$$$20240905$$MD$CA$CA
146117312$14611731$2$F$$20240902$20180308$20240904$PER$$US-PFIZER INC-2018093071$PFIZER$$82$YR$$F$Y$$$20240904$$HP$US$US
1461178414$14611784$14$F$20230301$20240727$20180308$20240729$EXP$$US-PFIZER INC-2018095782$PFIZER$$77$YR$$F$Y$76.66$KG$20240729$$MD$US$US
1461264321$14612643$21$F$20220101$20240701$20180308$20240807$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK167250$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$BR$BR
1461359649$14613596$49$F$20180101$20240826$20180308$20240903$EXP$$CA-CELLTRION INC.-2018CA018359$CELLTRION$$$$$$Y$$$20240903$$MD$CA$CA
146151186$14615118$6$F$$20240816$20180308$20240820$EXP$$JP-PFIZER INC-2018098153$PFIZER$Habuka, M.. Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case report. BMC Research Notes. 2018;11(1):165$46$YR$$F$Y$58.1$KG$20240820$$HP$JP$JP
1461567027$14615670$27$F$20180201$20240717$20180309$20240729$EXP$$CA-ROCHE-2085827$ROCHE$$11$YR$C$M$Y$$$20240729$$MD$CA$CA
146194964$14619496$4$F$20090519$20240629$20180309$20240708$EXP$$DE-AUROBINDO-AUR-APL-2018-012009$AUROBINDO$$78$YR$$M$Y$64$KG$20240708$$MD$DE$DE
146203817$14620381$7$F$20150101$20240903$20180309$20240909$EXP$$US-JAZZ-2018-US-004081$JAZZ$$$$$F$Y$$$20240909$$HP$US$US
146210212$14621021$2$F$$20240723$20180309$20240730$EXP$$US-TAKEDA-2018TUS005204$TAKEDA$$$$$F$Y$80.726$KG$20240730$$MD$US$US
146219464$14621946$4$F$20160101$20240715$20180310$20240724$EXP$$FR-AUROBINDO-AUR-APL-2018-012960$AUROBINDO$$85$YR$$F$Y$60$KG$20240724$$MD$FR$FR
146235354$14623535$4$F$$20240808$20180312$20240820$EXP$$BE-AUROBINDO-AUR-APL-2018-012532$AUROBINDO$Motaparthi K,De Montjoye L, Tromme I, Baeck M., Ross LC, Shevchenko A. Two cases of annular acute generalized exanthematous pustulosis induced by terbinafine.. European Journal of Dermatology. 2018;28 (2):236-8$63$YR$$M$Y$$$20240820$$MD$BE$BE
146235593$14623559$3$F$$20240904$20180312$20240917$EXP$$IT-AUROBINDO-AUR-APL-2018-012826$AUROBINDO$Giuri P, Montanari E, Milano A, Maccari S.. Acinetobacter Baumannii multi drug resistance (MDR): pathogen increasingly present in our departments and cause of deaths... Congresso Nazionale SIMIT.. 306 (10):285$$$E$F$Y$$$20240917$$MD$IT$IT
146245598$14624559$8$F$20170817$20240904$20180312$20240911$EXP$$PHHY2017CA171486$NOVARTIS$$51$YR$$M$Y$$$20240911$$CN$CA$CA
146272572$14627257$2$F$$20240807$20180312$20240816$EXP$$US-TAKEDA-2018TUS005886$TAKEDA$$$$$F$Y$$$20240816$$CN$US$US
1462981022$14629810$22$F$20180228$20240906$20180313$20240916$EXP$$DE-ROCHE-2087412$ROCHE$$43$YR$A$F$Y$$$20240916$$CN$DE$DE
146314739$14631473$9$F$$20240821$20180313$20240830$EXP$$CA-APOTEX-2018AP007487$APOTEX$$57$YR$$F$Y$$$20240830$$MD$CA$CA
146314809$14631480$9$F$$20240708$20180313$20240717$EXP$$CA-APOTEX-2018AP007495$APOTEX$$$$$M$Y$$$20240717$$HP$CA$CA
146339407$14633940$7$F$$20240715$20180314$20240722$EXP$$CA-AMGEN-CANSP2018033844$AMGEN$$34$YR$A$F$Y$$$20240722$$HP$CA$CA
146358538$14635853$8$F$$20240709$20180314$20240713$PER$$US-AMGEN-USASP2018033412$AMGEN$$64$YR$A$M$Y$$$20240712$$MD$US$US
146358962$14635896$2$F$20160601$20240716$20180314$20240726$EXP$$IT-AUROBINDO-AUR-APL-2018-014522$AUROBINDO$$25$YR$$M$Y$$$20240726$$MD$IT$IT
1463596216$14635962$16$F$20180320$20240816$20180314$20240828$EXP$$US-PFIZER INC-2018095803$PFIZER$$76$YR$$F$Y$73$KG$20240828$$CN$US$US
146365444$14636544$4$F$20070101$20240910$20180314$20240913$EXP$$JP-SA-2018SA047707$SANOFI AVENTIS$$4$MON$I$F$Y$14$KG$20240913$$MD$JP$JP
146424465$14642446$5$F$20161107$20240710$20180315$20240716$EXP$$ES-SA-2017SA255136$SANOFI AVENTIS$$32$YR$A$F$Y$57$KG$20240716$$MD$ES$ES
146435294$14643529$4$F$20170101$20240711$20180315$20240712$EXP$$FR-PFIZER INC-2018104433$PFIZER$$62$YR$$M$Y$65$KG$20240712$$MD$FR$FR
146484556$14648455$6$F$20240101$20240809$20180316$20240812$EXP$$US-PFIZER INC-2018105445$PFIZER$$71$YR$$F$Y$47.63$KG$20240812$$CN$US$US
146503955$14650395$5$F$20171124$20240809$20180316$20240820$EXP$$JP-SHIRE-JP201809590$TAKEDA$$55$YR$$M$Y$$$20240820$$MD$JP$JP
146516622$14651662$2$F$20171222$20240821$20180317$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-014640$AUROBINDO$$84$YR$$F$Y$$$20240831$$MD$ES$ES
146518093$14651809$3$F$20171215$20240715$20180317$20240718$EXP$$FR-AUROBINDO-AUR-APL-2018-015001$AUROBINDO$$70$YR$$F$Y$$$20240718$$MD$FR$FR
146538453$14653845$3$F$$20240909$20180319$20240910$PER$$US-PFIZER INC-2018112099$PFIZER$$85$YR$$F$Y$$$20240910$$CN$US$US
146551587$14655158$7$F$$20240911$20180319$20240918$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2018-BI-014441$BOEHRINGER INGELHEIM$$52$YR$A$F$Y$$$20240918$$HP$CA$CA
1465877234$14658772$34$F$20180206$20240918$20180320$20240921$EXP$$DE-ROCHE-2071555$ROCHE$$46$YR$A$F$Y$$$20240921$$CN$DE$DE
146589047$14658904$7$F$$20240708$20180320$20240712$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2018-18763$REGENERON$$$$$F$Y$$$20240712$$HP$CA$CA
1465980059$14659800$59$F$20180213$20240703$20180320$20240710$EXP$$US-SA-2018SA074660$SANOFI AVENTIS$$34$YR$A$F$Y$77.1$KG$20240710$$MD$US$US
146611159$14661115$9$F$20180319$20240829$20180320$20240904$PER$$US-PFIZER INC-2018116443$PFIZER$$70$YR$$M$Y$$$20240904$$PH$US$US
146630934$14663093$4$F$20180215$20240904$20180321$20240911$EXP$$CA-ROCHE-2092622$ROCHE$$51$YR$A$F$Y$$$20240911$$CN$CA$CA
146639936$14663993$6$F$$20240709$20180321$20240711$PER$$US-PFIZER INC-2018112503$PFIZER$$61$YR$$F$Y$100$KG$20240711$$MD$US$US
1466531063$14665310$63$F$20180101$20240909$20180321$20240916$EXP$$CA-CELLTRION INC.-2018CA018639$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
146659594$14665959$4$F$$20240819$20180321$20240823$EXP$FR-FRESENIUS KABI-FK201501848$FR-BIOMARINAP-FR-2018-117509$BIOMARIN$$$$$$Y$$$20240823$$CN$US$FR
146755822$14675582$2$F$$20240725$20180323$20240731$EXP$$US-SA-2018SA084238$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240731$$CN$US$US
146756313$14675631$3$F$20090311$20240726$20180323$20240809$EXP$$CA-PFIZER INC-2018118105$Haleon PLC$$61$YR$$M$Y$97$KG$20240808$$MD$CA$CA
146758884$14675888$4$F$$20240827$20180323$20240830$EXP$$JP-PFIZER INC-2018120066$PFIZER$Tawara, T.. A case report of progressive multifocal leukoencephalopathy during suteroid treatment of to ANCA-associated vasculitis. ISN FRONTIERS MEETINGS. 2018;10.1007/s13730-020-00482-w$80$YR$$F$Y$$$20240830$$MD$JP$JP
146774143$14677414$3$F$20170601$20240716$20180325$20240721$EXP$$DE-MYLANLABS-2018M1017270$MYLAN$$17$YR$$F$Y$68$KG$20240719$$MD$DE$DE
146783515$14678351$5$F$20071001$20240819$20180326$20240821$EXP$$FR-ROCHE-2088724$ROCHE$Salmon A, Debourgogne A, Vasbien M, Clement L, Collomb J, Plenat F. Disseminated Scopulariopsis brevicaulis infection in an allogenic stem cell recipient: case report and review of the literature. Clinical Microbiology and infection. 2010;16 (5):508-12.$38$YR$A$F$Y$$$20240821$$HP$FR$FR
146816233$14681623$3$F$20181119$20240903$20180326$20240906$PER$$US-JAZZ-2018-US-004947$JAZZ$$56$YR$$F$Y$$$20240906$$CN$US$US
146818652$14681865$2$F$$20240816$20180326$20240822$EXP$$CZ-SHIRE-CZ201811207$TAKEDA$$66$YR$$M$Y$$$20240822$$HP$CZ$CZ
146829234$14682923$4$F$$20240826$20180327$20240828$EXP$FR-FRESENIUS KABI-FK201501848$FR-ABBVIE-18S-056-2300263-00$ABBVIE$Debiec H, Valayannopoulos V, Boyer O, et al. Allo-Immune Membranous Nephropathy and Recombinant Aryl Sulfatase Replacement Therapy: A Need for Tolerance Induction Therapy. journal of the American Society of Nephrology. 2014;675-680.$5$YR$$M$Y$$$20240828$$HP$FR$FR
146837952$14683795$2$F$20130914$20240903$20180327$20240913$EXP$$FR-AUROBINDO-AUR-APL-2017-18344$AUROBINDO$Hentzien M, Lambert D, Limelette A, N^Guyen Y, Robbins A, Lebrun D et al.. Macroscopic amoxicillin crystalluria. Lancet. 2015;385(9984)::2296$62$YR$$F$Y$$$20240913$$MD$FR$FR
146857454$14685745$4$F$20160301$20240906$20180327$20240920$EXP$$DE-DSJP-DSE-2018-111332$DAIICHI$$82$YR$$F$Y$56$KG$20240920$$MD$DE$DE
1468801211$14688012$11$F$20120101$20240722$20180328$20240724$PER$$US-PFIZER INC-2018126575$PFIZER$$64$YR$$F$Y$74$KG$20240724$$CN$US$US
146886175$14688617$5$F$20170721$20240711$20180328$20240716$EXP$$FR-PFIZER INC-2018123180$PFIZER$$48$YR$$F$Y$101$KG$20240716$$MD$FR$FR
146919255$14691925$5$F$20171212$20240718$20180329$20240729$EXP$$GB-ROCHE-2072315$ROCHE$$67$YR$E$F$Y$$$20240729$$MD$GB$GB
1469227112$14692271$12$F$20180116$20240923$20180329$20240928$EXP$$US-ROCHE-2058394$ROCHE$$63$YR$A$F$Y$$$20240928$$CN$US$US
146926347$14692634$7$F$20170105$20240715$20180329$20240725$EXP$$CA-ROCHE-2098890$ROCHE$$76$YR$E$F$Y$$$20240725$$CN$CA$CA
146953134$14695313$4$F$20171201$20240816$20180329$20240821$EXP$$FR-PFIZER INC-2018123488$PFIZER$$31$YR$$M$Y$82$KG$20240821$$MD$FR$FR
1469894938$14698949$38$F$20180226$20240904$20180330$20240910$EXP$$DE-ROCHE-2096691$ROCHE$$50$YR$A$M$Y$70.9$KG$20240910$$CN$DE$DE
147003022$14700302$2$F$$20240822$20180330$20240903$EXP$$CA-MYLANLABS-2018M1019610$AUROBINDO$Hohl CM, Badke K, Zhao A, Wickham ME, Woo SA, Sivilotti MLA, et al. Prospective validation of clinical criteria to identify emergency department patients at high risk for adverse drug events.. AcadEmerg-Med. 2018;25:1015?1027$87$YR$$F$Y$$$20240903$$MD$CA$CA
147003042$14700304$2$F$$20240822$20180330$20240902$EXP$$CA-MYLANLABS-2018M1019609$AUROBINDO$Hohl CM, Badke K, Zhao A, Wickham ME, Woo SA, Sivilotti MLA, et al.. Prospective validation of clinical criteria to identify emergency department patients at high risk for adverse drug events.. AcadEmerg-Med. 2018;25:1015-1027$51$YR$$F$Y$$$20240902$$MD$CA$CA
1470101010$14701010$10$F$$20240628$20180330$20240702$EXP$$CA-BAUSCH-BL-2018-007773$BAUSCH AND LOMB$$25$YR$$M$Y$$$20240702$$HP$CA$CA
147021627$14702162$7$F$$20240902$20180401$20240910$EXP$$PHHY2018DK051146$NOVARTIS$Schmiegelow A, Klein M. Small bowel obstruction caused by immunosuppressive therapy after a liver transplant. UGESKR AEGER. 2014;176 (44)$53$YR$$F$Y$$$20240910$$HP$DK$DK
1470742630$14707426$30$F$20180315$20240814$20180403$20240815$EXP$$DE-ROCHE-2098104$ROCHE$$36$YR$A$F$Y$$$20240815$$CN$DE$DE
1470781411$14707814$11$F$$20240909$20180403$20240917$EXP$$CA-APOTEX-2018AP008705$APOTEX$$48$YR$$F$Y$106$KG$20240917$$PH$CA$CA
1470787237$14707872$37$F$20190507$20240918$20180403$20240924$EXP$$US-PFIZER INC-2017231089$PFIZER$$63$YR$$F$Y$$$20240924$$CN$US$US
147082523$14708252$3$F$$20240903$20180403$20240909$EXP$$PL-ROCHE-2081499$ROCHE$Karczewskia M, Tomczakb H, Idasiakc IP, Cichanskaa L, Adamskaa Z, Stronka M. Is Multiresistant Klebsiella pneumoniae New Delhi Metallobeta- Lactamase (NDM-1) a New Threat for Kidney Transplant Recipients?. TRANSPLANTATION PROCEEDINGS 2014;46:2409-2410.$56$YR$A$M$Y$$$20240909$$HP$PL$PL
147088188$14708818$8$F$$20240829$20180403$20240909$EXP$$CA-AUROBINDO-AUR-APL-2018-017893$AUROBINDO$Rebecca Zivanovic, Evan Wood, Seonaid Nolan. Naloxone Infusion in the Setting of an Unknown Ingestion: A Case Report. Canadian Journal of Addiction. 2016;7:19-24$55$YR$$F$Y$$$20240909$$MD$CA$CA
147096255$14709625$5$F$20120427$20240905$20180403$20240911$EXP$PL-EMA-20171025-TANEJAEVHP-161843308$PL-MYLANLABS-2018M1018820$MYLAN$Muras-Szwedziak K, ZawiasaBryszewska A, Bryszewski B, Strzelczyk J, Szwedziak K, Nowicki M et al.. Intervertebral disc aspergillosis in patient in short term after kidney transplantation.. Forum Nefrologiczne.. 2017;10(2):139-43$55$YR$$F$Y$$$20240911$$HP$PL$PL
147113765$14711376$5$F$20170123$20240708$20180403$20240710$EXP$$US-PFIZER INC-2018133957$PFIZER$$70$YR$$F$Y$59.4$KG$20240710$$CN$US$US
147138872$14713887$2$F$20160909$20240711$20180404$20240717$EXP$$PHJP2016JP037060$NOVARTIS$$40$YR$$F$Y$$$20240717$$MD$JP$JP
147142305$14714230$5$F$20180122$20240829$20180404$20240904$EXP$$JP-GLAXOSMITHKLINE-JP2018JPN012119$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$JP$JP
147154922$14715492$2$F$$20240919$20180404$20240926$EXP$$SE-MYLANLABS-2018M1020399$MYLAN$$67$YR$$M$Y$$$20240926$$CN$SE$SE
147177414$14717741$4$F$$20240723$20180404$20240731$PER$$US-SA-2018SA026107$SANOFI AVENTIS$$66$YR$E$F$Y$56.6$KG$20240731$$MD$US$US
147189322$14718932$2$F$20160811$20240707$20180405$20240710$EXP$$ES-BAUSCH-BL-2018-008112$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240710$$HP$ES$ES
1471939932$14719399$32$F$20180307$20240819$20180405$20240827$EXP$$DE-ROCHE-2090784$ROCHE$$31$YR$A$F$Y$$$20240827$$CN$DE$DE
1471942232$14719422$32$F$20180315$20240910$20180405$20240919$EXP$$DE-ROCHE-2102569$ROCHE$$43$YR$A$F$Y$$$20240919$$CN$DE$DE
1472122310$14721223$10$F$20130101$20240826$20180405$20240830$EXP$$FR-MYLANLABS-2018M1020692$MYLAN$$78$YR$$F$Y$$$20240830$$CN$FR$FR
147236447$14723644$7$F$20140101$20240909$20180405$20240913$EXP$$PT-MYLANLABS-2018M1021618$MYLAN$Lima Joana, Sousa M, Andrade P.. Postirradiation Multiple Minute Digitate Porokeratosis: Case Report.. Revista Portuguesa de Dermatologia e Venereologia. 2017;75(4):425-28$67$YR$$F$Y$$$20240913$$HP$PT$PT
1472658216$14726582$16$F$20180305$20240910$20180406$20240918$EXP$$CA-ROCHE-2086136$ROCHE$$48$YR$A$F$Y$70.31$KG$20240918$$HP$CA$CA
147311052$14731105$2$F$20171201$20240808$20180406$20240812$EXP$$US-TAKEDA-2018TUS008386$TAKEDA$$75$YR$$F$Y$63.492$KG$20240812$$CN$US$US
147313936$14731393$6$F$20160301$20240904$20180407$20240913$EXP$$DE-AUROBINDO-AUR-APL-2018-017927$AUROBINDO$$82$YR$$F$Y$56$KG$20240913$$MD$DE$DE
147314186$14731418$6$F$20000101$20240919$20180407$20240926$EXP$$SE-AUROBINDO-AUR-APL-2018-014472$AUROBINDO$$32$YR$$F$Y$39$KG$20240926$$MD$SE$SE
147314679$14731467$9$F$20170808$20240807$20180407$20240818$EXP$$BE-AUROBINDO-AUR-APL-2017-44076$AUROBINDO$$1$WK$$M$Y$0.3$KG$20240818$$MD$BE$BE
1473279714$14732797$14$F$$20240719$20180409$20240723$EXP$$US-PFIZER INC-2018140873$PFIZER$$47$YR$$F$Y$$$20240723$$CN$US$US
147333597$14733359$7$F$20220526$20240709$20180409$20240711$EXP$$US-SHIRE-US201812976$TAKEDA$$79$YR$$F$Y$$$20240711$$CN$US$US
147388014$14738801$4$F$20170301$20200303$20180409$20240715$EXP$$US-BIOGEN-2018BI00551975$BIOGEN$$62$YR$$F$Y$$$20240715$$CN$US$US
147399228$14739922$8$F$$20240925$20180410$20240926$PER$$US-PFIZER INC-2018145712$PFIZER$$72$YR$$F$Y$$$20240926$$CN$US$US
1474050830$14740508$30$F$20180315$20240724$20180410$20240727$EXP$$CA-ROCHE-2093315$ROCHE$$38$YR$A$F$Y$88$KG$20240727$$CN$CA$CA
147439067$14743906$7$F$$20240814$20180410$20240825$EXP$$IT-009507513-1804ITA001892$MERCK$Alfano G, Fontana F, Francesca D, Assirati G, Magistri P, Tarantino G, et al.. Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature. Transplantation Proceedings. 2018;50(3):905-9$42$YR$$F$Y$$$20240825$$MD$IT$IT
147441417$14744141$7$F$20161013$20240621$20180411$20240703$EXP$$CA-ROCHE-2104180$ROCHE$$46$YR$A$F$Y$$$20240703$$MD$CA$CA
147449344$14744934$4$F$$20240923$20180411$20240925$PER$$US-PFIZER INC-2018144085$PFIZER$$64$YR$$F$Y$$$20240925$$MD$US$US
147459892$14745989$2$F$$20240621$20180411$20240702$EXP$$TR-ROCHE-2104228$ROCHE$Ecen Yucel K, Bayraktar Ekincioglu A, Kilickap S and Erman M Clinical Pharmacy Practices in Oncology Patients Treated with Tyrosine Kinase Inhibitors. International Journal of Hematology and Oncology 2018;1 (28):53-60.$$$$$Y$$$20240702$$HP$TR$TR
1475144517$14751445$17$F$20171215$20240813$20180412$20240818$EXP$$PHHY2017CA180212$NOVARTIS$$35$YR$$F$Y$$$20240818$$MD$CA$CA
147518986$14751898$6$F$20180302$20191023$20180412$20240719$EXP$$JP-GLAXOSMITHKLINE-JP2018JPN058587$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$MD$JP$JP
147519672$14751967$2$F$20180305$20240821$20180412$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-019001$AUROBINDO$$61$YR$$M$Y$$$20240831$$MD$ES$ES
147534044$14753404$4$F$$20240718$20180412$20240731$EXP$$GB-ROCHE-1839849$ROCHE$$$$A$F$Y$$$20240731$$CN$GB$GB
147534594$14753459$4$F$$20240807$20180412$20240813$EXP$$US-ARIAD PHARMACEUTICALS, INC-2017US007854$TAKEDA$$$$$M$Y$86$KG$20240813$$CN$US$US
147547853$14754785$3$F$$20240828$20180413$20240912$EXP$DE-MYLANLABS-2017M1083338$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2017-02178$ALKEM$Kaschka WP, Steyer J, Kaschka IN, Jandl M. The chemo brain: Severe cognitive decline following chemotherapy of breast cancer. New Horizons in Clinical Case Reports.. 2017;2:4-6$43$YR$$F$Y$$$20240912$$HP$DE$DE
147549557$14754955$7$F$20160101$20240822$20180413$20240828$PER$$US-BIOGEN-2018BI00553540$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
147589653$14758965$3$F$20180406$20240826$20180413$20240902$EXP$$US-SHIRE-US201813948$TAKEDA$$58$YR$$F$Y$$$20240902$$CN$US$US
147641754$14764175$4$F$20170209$20240711$20180416$20240718$EXP$$FR-PFIZER INC-2018145158$PFIZER$$62$YR$$F$Y$84$KG$20240718$$MD$FR$FR
1476689619$14766896$19$F$20180404$20240805$20180417$20240813$EXP$$CO-ROCHE-2107157$ROCHE$$$$$F$Y$75$KG$20240813$$CN$CO$CO
147683348$14768334$8$F$20180408$20240729$20180417$20240731$EXP$$CA-TAKEDA-2018TUS009868$TAKEDA$$42$YR$$M$Y$$$20240731$$HP$CA$CA
147730897$14773089$7$F$$20240725$20180418$20240805$EXP$$CA-APOTEX-2018AP009876$APOTEX$$64$YR$$F$Y$$$20240805$$HP$CA$CA
147736295$14773629$5$F$$20240813$20180418$20240823$EXP$$GR-ROCHE-2105937$ROCHE$, Mylona M, Toskas P, Kouveletsou M, Theodosopoulos I, Toskas A, Liatis S. Pneumonia and brain abscess from Nocardia spp. in a patient with systemic lupus erythematosus.. 41st Annual Panhellenic Medical Conference, 2015;:10-13.$44$YR$A$F$Y$$$20240823$$HP$GR$GR
147758533$14775853$3$F$$20240906$20180418$20240925$EXP$$PHHY2018FR068008$NOVARTIS$Cyclosporine: fibroadenomas of the breast. LA REVUE PRESCRIRE. 2024;44(491):666$42$YR$$F$Y$$$20240925$$HP$FR$FR
147780127$14778012$7$F$20180205$20240620$20180419$20240702$EXP$$JP-AEGERION PHARMACEUTICAL, INC-AEGR003713$AEGERION$$$$$$Y$$$20240702$$MD$JP$JP
1477816322$14778163$22$F$20130101$20240826$20180419$20240902$EXP$$PHHY2017FR202265$NOVARTIS$$78$YR$$F$Y$$$20240902$$CN$FR$FR
1478151211$14781512$11$F$20170126$20240821$20180419$20240902$EXP$$CA-ROCHE-2107638$ROCHE$$34$YR$A$F$Y$105$KG$20240902$$MD$CA$CA
147892264$14789226$4$F$20180412$20240827$20180423$20240903$EXP$$PHHY2017CA095886$NOVARTIS$$37$YR$$F$Y$$$20240903$$MD$CA$CA
147946936$14794693$6$F$20180105$20240828$20180423$20240902$EXP$$CA-TAKEDA-2018TUS010954$TAKEDA$$11$YR$$F$Y$41.4$KG$20240902$$CN$CA$CA
1480008310$14800083$10$F$20171026$20240913$20180424$20240920$EXP$$CA-TAKEDA-2017TUS022707$TAKEDA$$41$YR$$F$Y$$$20240920$$CN$CA$CA
1480113831$14801138$31$F$20160101$20240715$20180424$20240718$EXP$$PHHY2016CA168430$NOVARTIS$$56$YR$$F$Y$$$20240718$$MD$CA$CA
1480122129$14801221$29$F$20180101$20240801$20180424$20240808$EXP$$CA-CELLTRION INC.-2018CA019333$CELLTRION$$$$$$Y$$$20240808$$CN$CA$CA
1480237510$14802375$10$F$20140101$20240810$20180424$20240813$PER$$US-PURDUE PHARMA-USA-2018-0142318$PURDUE$$$$$F$Y$$$20240813$$CN$US$US
148038413$14803841$3$F$20171115$20240621$20180425$20240709$EXP$$CA-ROCHE-2026236$ROCHE$$43$YR$A$F$Y$$$20240705$$CN$CA$CA
148044285$14804428$5$F$$20240729$20180425$20240731$PER$$US-PFIZER INC-2018168556$PFIZER$$57$YR$$F$Y$$$20240731$$MD$US$US
148045437$14804543$7$F$$20240814$20180425$20240827$EXP$$FR-AUROBINDO-AUR-APL-2018-020567$AUROBINDO$Chaumette B, Masson M, Barde M, Gay O, Gaillard R.. Switching from antipsychotics to aripiprazole and risk of agitation.. The Brain. 2018;44(1):88-90$20$YR$$F$Y$$$20240827$$HP$FR$FR
148052828$14805282$8$F$20140101$20240627$20180425$20240705$EXP$$AU-CELLTRION INC.-2018AU019342$CELLTRION$$$$$$Y$$$20240705$$MD$AU$AU
148106957$14810695$7$F$20160101$20240920$20180425$20240926$EXP$$CA-TAKEDA-2016TUS014244$TAKEDA$$$$$F$Y$$$20240926$$CN$CA$CA
148138006$14813800$6$F$$20240920$20180426$20240925$PER$$US-PFIZER INC-2018170624$PFIZER$$34$YR$$M$Y$$$20240925$$MD$US$US
148186242$14818624$2$F$$20240621$20180427$20240703$EXP$$ES-ROCHE-2114525$ROCHE$Zamorano I, Rubio C P. Evaluation of drug interactions in the treatment with oral cytostatic [Abstract number: DI015]. Int J Clin Pharm. 2016;38 (2):507-8.$$$$$Y$$$20240703$$HP$ES$ES
148236742$14823674$2$F$20180322$20240821$20180428$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-022312$AUROBINDO$$90$YR$$F$Y$60$KG$20240831$$MD$ES$ES
1482543012$14825430$12$F$20220204$20240724$20180430$20240730$EXP$$CA-TAKEDA-2017TUS008746$TAKEDA$$66$YR$$F$Y$$$20240730$$CN$CA$CA
148270776$14827077$6$F$20161201$20240913$20180430$20240925$EXP$$ES-AUROBINDO-AUR-APL-2018-022709$AUROBINDO$$64$YR$$F$Y$$$20240925$$MD$ES$ES
1482920922$14829209$22$F$20180224$20240904$20180430$20240905$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-037536$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$89$KG$20240905$$PH$FR$FR
148345795$14834579$5$F$$20240909$20180501$20240912$EXP$$IT-MYLANLABS-2018M1028021$MYLAN$Giuri P, Montanari E, Milano A, Maccari S.. Acinetobacter Baumannii multi drug resistance (MDR): pathogen increasingly present in our departments and cause of deaths.. Congresso Nazionale SIMIT. 306(10):285$$$E$F$Y$$$20240912$$MD$IT$IT
148369352$14836935$2$F$20170419$20240724$20180502$20240729$EXP$DK-DKMA-WBS-0008222$DK-MYLANLABS-2018M1027290$MYLAN$$79$YR$$F$Y$75$KG$20240729$$MD$DK$DK
148371722$14837172$2$F$20180327$20180425$20180502$20240903$EXP$$PL-JNJFOC-20180433478$JOHNSON AND JOHNSON$$86$YR$E$M$Y$75$KG$20240903$$MD$PL$PL
1483804816$14838048$16$F$20180301$20240909$20180502$20240913$EXP$$CA-TAKEDA-2018TUS012853$TAKEDA$$67$YR$$F$Y$$$20240913$$CN$CA$CA
1483815361$14838153$61$F$20151231$20240913$20180502$20240917$EXP$$CA-ROCHE-1696490$ROCHE$$31$YR$A$F$Y$198$KG$20240917$$HP$CA$CA
148391893$14839189$3$F$20171001$20240711$20180502$20240715$EXP$$FR-PFIZER INC-2018171240$PFIZER$$51$YR$$M$Y$72$KG$20240715$$MD$FR$FR
148401133$14840113$3$F$20170325$20240705$20180503$20240717$EXP$DE-CELGENE-DEU-2017039112$DE-Accord-066411$ACCORD$$78$YR$E$M$Y$84$KG$20240717$$HP$DE$DE
1484050511$14840505$11$F$20180118$20240904$20180503$20240906$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-038445$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240906$$MD$IT$IT
1484633322$14846333$22$F$20180801$20240821$20180504$20240827$EXP$$CA-ROCHE-2116316$ROCHE$$40$YR$A$F$Y$70$KG$20240827$$MD$CA$CA
148465908$14846590$8$F$$20240828$20180504$20240830$EXP$$US-PFIZER INC-2018182589$PFIZER$$71$YR$$F$Y$$$20240830$$CN$US$US
148490624$14849062$4$F$20180118$20240906$20180504$20240911$EXP$IT-MINISAL02-471408$IT-DSJP-DSE-2018-117647$DAIICHI$$$$$$Y$$$20240911$$MD$IT$IT
1485335875$14853358$75$F$20180101$20240911$20180507$20240920$EXP$$CA-CELLTRION INC.-2018CA018999$CELLTRION$$$$$$Y$$$20240920$$CN$CA$CA
148542522$14854252$2$F$20240827$20240827$20180507$20240902$PER$$US-SHIRE-US201817286$TAKEDA$$44$YR$$F$Y$$$20240902$$CN$US$US
148594324$14859432$4$F$20160601$20240716$20180508$20240726$EXP$$IT-AUROBINDO-AUR-APL-2018-007486$AUROBINDO$$25$YR$$M$Y$$$20240726$$MD$IT$IT
148601806$14860180$6$F$$20240917$20180508$20240925$EXP$$CZ-CELLTRION INC.-2018CZ019575$CELLTRION$Bortlik M, Machkova N, Hruba V, Lukas Jr. M, Duricova D, Malickova K et al. Efficacy of ustekinumab in a patient refractory to other biological treatment. Gastroenterologie a Hepatologie. 2018;72(1):47-49$$$$$Y$$$20240925$$MD$CZ$CZ
148602462$14860246$2$F$20150601$20240828$20180508$20240906$EXP$GB-MHRA-ADR 24182219$GB-Accord-066552$ACCORD$$52$YR$A$M$Y$105$KG$20240906$$CN$GB$GB
148675534$14867553$4$F$$20240809$20180508$20240819$EXP$$PHHY2017DE184444$NOVARTIS$Franklin C, Rooms I, Fiedler M, Reis H, Milsch L, Herz S et al.. Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis. EUROPEAN JOURNAL OF CANCER. 2017;86:248-56$66$YR$$F$Y$$$20240819$$HP$DE$DE
148693382$14869338$2$F$20050101$20240816$20180509$20240826$EXP$$FR-ABBVIE-18S-056-2347392-00$ABBVIE$$3$YR$$F$Y$$$20240826$$CN$FR$FR
148695232$14869523$2$F$$20240825$20180509$20240906$EXP$$AR-JNJFOC-20180504859$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$MD$AR$AR
1487390212$14873902$12$F$20000101$20240823$20180510$20240830$EXP$$US-BIOGEN-2014BI054571$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
1487660217$14876602$17$F$20180118$20240904$20180510$20240909$EXP$$IT-PFIZER INC-2018184915$PFIZER$$58$YR$$M$Y$$$20240909$$MD$IT$IT
148800222$14880022$2$F$$20240910$20180511$20240921$EXP$$US-Accord-066740$ACCORD$Akhter S, Krishnan P, Kaul P. Tigecycline-Associated Acute Pancreatitis. American Journal of Therapeutics. 2018;25(6):e749-50.$61$YR$A$M$Y$$$20240921$$MD$US$US
148807362$14880736$2$F$$20240710$20180511$20240720$EXP$$ES-AUROBINDO-AUR-APL-2018-025054$AUROBINDO$$50$YR$$M$Y$$$20240720$$MD$ES$ES
148819289$14881928$9$F$20170601$20240814$20180511$20240820$EXP$$US-JAZZ-2018-US-007045$JAZZ$$44$YR$$F$Y$$$20240820$$MD$US$US
1488589219$14885892$19$F$20180423$20240916$20180512$20240925$EXP$$DE-ROCHE-2122874$ROCHE$$41$YR$A$M$Y$$$20240925$$CN$DE$DE
1488603411$14886034$11$F$$20240813$20180512$20240816$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2018-BI-025498$BOEHRINGER INGELHEIM$$48$YR$A$F$Y$$$20240816$$HP$CA$CA
1489216915$14892169$15$F$$20240919$20180514$20240923$EXP$$US-PFIZER INC-2018193304$PFIZER$$67$YR$$F$Y$$$20240923$$CN$US$US
1489664945$14896649$45$F$20170804$20240924$20180515$20240927$EXP$$FR-PFIZER INC-2018195935$PFIZER$$1$DY$$M$Y$1.89$KG$20240927$$PH$FR$FR
148990072$14899007$2$F$$20240710$20180516$20240722$EXP$$DE-ROCHE-2122444$ROCHE$Kaysen A, Heintz-Buschart A, Muller E, Narayanasamy S, Wampach L, et al. Integrated meta-omic analyses of the gastrointestinal tract microbiome in patients undergoing allogeneic hematopoietic stem cell transplantation.. Translational Research.. 2017;186:79-94. doi:10.1016/j.trsl.2017.06.008.$63$YR$A$F$Y$$$20240722$$HP$DE$DE
1489955522$14899555$22$F$20130905$20240712$20180516$20240723$EXP$$CA-ROCHE-1275094$ROCHE$$60$YR$A$F$Y$53.5$KG$20240723$$HP$CA$CA
148996736$14899673$6$F$20170101$20240626$20180516$20240702$EXP$$BR-TAKEDA-2017TUS021624$TAKEDA$$$$$F$Y$57$KG$20240702$$CN$BR$BR
1489989319$14899893$19$F$20160115$20240812$20180516$20240816$EXP$$CA-ROCHE-2123349$ROCHE$$73$YR$E$F$Y$$$20240816$$MD$CA$CA
149009799$14900979$9$F$20180306$20240907$20180516$20240918$EXP$$JP-GLAXOSMITHKLINE-JP2018JPN082879$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$JP$JP
149037494$14903749$4$F$20170620$20240723$20180516$20240729$EXP$$FR-MYLANLABS-2018M1031973$MYLAN$$48$YR$$F$Y$101$KG$20240729$$MD$FR$FR
149080723$14908072$3$F$$20240809$20180517$20240816$EXP$$US-PFIZER INC-2018199210$PFIZER$Velez, M.. Immune-related myocarditis and conduction abnormalities secondary to combination immunotherapy treatment with ipilimumab/nivolumab in a patient with merkel cell carcinoma. Journal of the American College of Cardiology. 2018;71(11):A2617$69$YR$$F$Y$$$20240816$$HP$US$US
149084963$14908496$3$F$$20240812$20180517$20240823$EXP$$ZA-GLENMARK PHARMACEUTICALS-2018GMK035365$GLENMARK$Muranda AZ, Greeff L, Sathekge MM, Lengano T, Karusseit VOL.. Cryptococcoma of a transplanted kidney in a patient presenting with recurrent urinary tract infection: A case report.. BMC Nephrology.. 2018;19 (1):94$$$$$Y$$$20240823$$MD$ZA$ZA
149086002$14908600$2$F$20180402$20240808$20180517$20240820$EXP$$NL-AUROBINDO-AUR-APL-2018-025783$AUROBINDO$$58$YR$$M$Y$$$20240820$$MD$NL$NL
149122623$14912262$3$F$$20240812$20180518$20240824$EXP$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2018-03101$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2018-03101$ALKEM$Velez MG, Suero-Abreu G, Duma N, Gutierrez M, Singh TP.. Immune-related myocarditis and conduction abnormalities secondary to combination immunotherapy treatment with ipilimumab/nivolumab in a patient with merkel cell carcinoma. Journal of the American College of Cardiology. 2018;71(11):unk$69$YR$$F$Y$$$20240825$$HP$US$US
1491383910$14913839$10$F$$20240918$20180518$20240920$EXP$$US-PFIZER INC-2018199309$PFIZER$$75$YR$$F$Y$$$20240920$$CN$US$US
1491885843$14918858$43$F$20170810$20240912$20180521$20240920$EXP$$CA-CELLTRION INC.-2017CA011198$CELLTRION$$$$$$Y$$$20240920$$CN$CA$CA
1491931428$14919314$28$F$20170914$20240909$20180521$20240917$EXP$FR-AFSSAPS-PC20180352$FR-OTSUKA-2018_012300$OTSUKA$$0$YR$$M$Y$1.89$KG$20240917$$PH$FR$FR
1492008320$14920083$20$F$$20240809$20180521$20240819$EXP$$CA-OTSUKA-2018_011946$OTSUKA$$48$YR$$F$Y$$$20240819$$HP$CA$CA
149215929$14921592$9$F$$20240819$20180522$20240823$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-043890$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240823$$MD$CA$CA
149235296$14923529$6$F$20160101$20240902$20180522$20240905$EXP$$JP-PFIZER INC-2018203570$PFIZER$Tsuruda, Y.. Case Report of an Acute Focal Bacterial Nephritis Associated with Adjuvant Chemotherapy in Esophageal Cancer Patient. Gan to kagaku ryoho. Cancer + chemotherapy. 2017;44 (12):1476-1478$54$YR$$F$Y$38$KG$20240905$$HP$JP$JP
149249572$14924957$2$F$$20240214$20180522$20240809$PER$$US-MYLANLABS-2018M1030701$AUROBINDO$$83$YR$$F$Y$82$KG$20240809$$CN$US$US
149255964$14925596$4$F$20170914$20240908$20180522$20240912$EXP$FR-AFSSAPS-PC20180352$FR-BAUSCH-BL-2018-014230$BAUSCH AND LOMB$$1$DY$$M$Y$1.89$KG$20240912$$PH$FR$FR
1492875526$14928755$26$F$20170914$20240913$20180523$20240925$EXP$$FR-AUROBINDO-AUR-APL-2018-025734$AUROBINDO$$1$DY$$M$Y$1.89$KG$20240925$$PH$FR$FR
149303278$14930327$8$F$$20240828$20180523$20240828$EXP$$US-PFIZER INC-2018206674$PFIZER$$59$YR$$F$Y$99.79$KG$20240828$$CN$US$US
149319275$14931927$5$F$20180201$20240627$20180524$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2018-007581$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240723$$CN$US$US
149320048$14932004$8$F$20180101$20240815$20180524$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2018-007752$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
149322224$14932222$4$F$20230901$20240611$20180524$20240707$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2018-007973$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240707$$CN$US$US
1493226816$14932268$16$F$20190101$20240614$20180524$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2018-008044$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
149427042$14942704$2$F$20170301$20240814$20180528$20240820$EXP$$NL-AUROBINDO-AUR-APL-2018-027421$AUROBINDO$$78$YR$$M$Y$58$KG$20240820$$MD$NL$NL
149457292$14945729$2$F$$20240813$20180529$20240826$EXP$US-MACLEODS PHARMACEUTICALS US LTD-MAC2018013669$US-MACLEODS PHARMACEUTICALS US LTD-MAC2018013669$MACLEODS$Mazer-Amirshahi M, Porter R, Dewey K..Prolonged QRS Widening After Aripiprazole Overdose.Pediatric Emergency Care.2018;35(11):e209-e212$$$$$Y$$$20240826$$MD$US$US
1495053416$14950534$16$F$$20240712$20180530$20240718$EXP$$CA-ROCHE-2129535$ROCHE$$50$YR$A$M$Y$91.63$KG$20240718$$CN$CA$CA
149512135$14951213$5$F$20170101$20240911$20180530$20240919$EXP$$CO-ROCHE-2131504$ROCHE$$56$YR$A$F$Y$46$KG$20240919$$CN$CO$CO
149525456$14952545$6$F$20240801$20240828$20180530$20240830$EXP$$US-PFIZER INC-2017125407$PFIZER$$83$YR$$F$Y$51.701$KG$20240830$$CN$US$US
1495353140$14953531$40$F$20190107$20240912$20180530$20240920$EXP$$CA-CELLTRION INC.-2017CA007602$CELLTRION$$$$$$Y$$$20240920$$CN$CA$CA
149568516$14956851$6$F$20180329$20240708$20180531$20240718$EXP$$CA-ROCHE-2131801$ROCHE$$51$YR$A$F$Y$$$20240718$$PH$CA$CA
149569883$14956988$3$F$20090101$20240906$20180531$20240917$EXP$$PHHY2017GR180759$NOVARTIS$$62$YR$$F$Y$$$20240917$$MD$GR$GR
149590589$14959058$9$F$20170209$20240813$20180531$20240819$EXP$$FR-MYLANLABS-2018M1035281$MYLAN$$62$YR$$F$Y$84$KG$20240819$$MD$FR$FR
149640994$14964099$4$F$20180422$20240708$20180601$20240711$EXP$$CA-TAKEDA-2018TUS018449$TAKEDA$$32$YR$$M$Y$$$20240711$$MD$CA$CA
149675932$14967593$2$F$20180419$20240821$20180604$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-028545$AUROBINDO$$56$YR$$F$Y$$$20240831$$MD$ES$ES
149678316$14967831$6$F$20240201$20240919$20180604$20240923$EXP$$US-PFIZER INC-2018222803$PFIZER$$73$YR$$F$Y$68.04$KG$20240923$$CN$US$US
149680152$14968015$2$F$$20240912$20180604$20240917$EXP$$FR-MYLANLABS-2018M1033819$MYLAN$Zaworski J, Frimat M, Duval M, Saint-Jacques C, Bouderlique E, Glowacki F, et al. Vancomycin poisoning successfully treated with intermittent hemodialysis: A case report. Nephrol-Ther 2018;14(2):112-116.$43$YR$$M$Y$$$20240917$$HP$FR$FR
149690293$14969029$3$F$20180515$20240708$20180604$20240717$PER$$US-SA-2018SA143078$SANOFI AVENTIS$$52$YR$A$F$Y$61.234$KG$20240717$$MD$US$US
149695022$14969502$2$F$20180518$20180606$20180604$20240916$EXP$$AR-SA-2018SA141673$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$CN$AR$AR
149695885$14969588$5$F$$20240708$20180604$20240716$EXP$$CA-APOTEX-2018AP014918$APOTEX$$69$YR$$F$Y$$$20240716$$HP$CA$CA
1496974519$14969745$19$F$20170914$20240924$20180604$20240925$EXP$$FR-BAUSCH-BL-2018-015512$BAUSCH AND LOMB$$$$A$F$Y$77$KG$20240925$$PH$FR$FR
149706474$14970647$4$F$20170101$20240820$20180604$20240828$PER$$US-BIOGEN-2018BI00584165$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
1497068825$14970688$25$F$20170914$20210225$20180604$20240722$EXP$$FR-GLAXOSMITHKLINE-FR2018094658$GLAXOSMITHKLINE$$$$A$F$Y$77$KG$20240722$$PH$FR$FR
149711453$14971145$3$F$$20240712$20180604$20240718$EXP$$CA-JNJFOC-20180538274$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240718$$HP$CA$CA
149724843$14972484$3$F$20180401$20240717$20180605$20240724$EXP$$ES-AMGEN-ESPCT2018073195$AMGEN$$78$YR$E$M$Y$$$20240724$$MD$ES$ES
149786842$14978684$2$F$$20240904$20180606$20240916$EXP$$IE-AUROBINDO-AUR-APL-2018-028842$AUROBINDO$Bede, P.. Carbapenems and valproate: A consumptive relationship.. Epilepsia Open.. 2017;2 (1):107-111$24$YR$$F$Y$$$20240916$$HP$IE$IE
1497978416$14979784$16$F$$20240913$20180606$20240917$EXP$$US-PFIZER INC-2018231542$PFIZER$$61$YR$$F$Y$$$20240917$$CN$US$US
1498039115$14980391$15$F$20180101$20240910$20180606$20240916$EXP$$CA-TAKEDA-2018TUS003471$TAKEDA$$$$$M$Y$$$20240916$$CN$CA$CA
149822312$14982231$2$F$$20240816$20180607$20240828$EXP$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2018-03673$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2018-03673$ALKEM$Lu PC, Chang PY, Hsu YH, Chiu TL, Wang LS. Cerebral toxoplasmosis in a patient who had kidney transplant. International Journal of Antimicrobial Agents. 2017;50(2):S200$72$YR$$M$Y$$$20240828$$HP$TW$TW
149824557$14982455$7$F$20170501$20240715$20180607$20240717$PER$$US-PFIZER INC-2018220395$PFIZER$$41$YR$$F$Y$$$20240717$$CN$US$US
1498892414$14988924$14$F$20180527$20240918$20180608$20240923$EXP$$PHHY2018CA042982$NOVARTIS$$55$YR$$F$Y$$$20240923$$MD$CA$CA
149925022$14992502$2$F$$20240716$20180609$20240725$EXP$$GB-AUROBINDO-AUR-APL-2018-029576$AUROBINDO$$43$YR$$F$Y$$$20240725$$MD$GB$GB
1499254613$14992546$13$F$20171001$20240729$20180609$20240809$EXP$$DE-AUROBINDO-AUR-APL-2018-029953$AUROBINDO$Hess C, Kramer M, Wagner R, Madea B. Lethal injection with the muscle relaxant rocuronium. Romanian Journal of Legal Medicine. 2018;26:62-66$35$YR$$M$Y$73.7$KG$20240809$$MD$DE$DE
149926523$14992652$3$F$$20240911$20180609$20240919$EXP$$DE-TEVA-2018-DE-902120$TEVA$$73$YR$$F$Y$96$KG$20240919$$MD$DE$DE
1499476815$14994768$15$F$20200101$20240819$20180611$20240820$EXP$$US-PFIZER INC-2018231015$PFIZER$$69$YR$$F$Y$80$KG$20240820$$CN$US$US
149961333$14996133$3$F$20180109$20240711$20180611$20240715$EXP$$FR-PFIZER INC-2018236324$PFIZER$$59$YR$$M$Y$84$KG$20240715$$MD$FR$FR
150010142$15001014$2$F$20160610$20240919$20180612$20240925$EXP$$AT-MYLANLABS-2018M1038187$MYLAN$$59$YR$$M$Y$68.5$KG$20240925$$MD$AT$AT
1500190916$15001909$16$F$20171107$20240924$20180612$20240926$EXP$$DE-ABBVIE-18P-062-2237593-00$ABBVIE$$48$YR$$M$Y$$$20240926$$MD$DE$DE
150041442$15004144$2$F$20180129$20240814$20180613$20240820$EXP$$ES-AUROBINDO-AUR-APL-2018-030645$AUROBINDO$$63$YR$$F$Y$70$KG$20240820$$MD$ES$ES
150057595$15005759$5$F$$20240826$20180613$20240828$EXP$$JP-PFIZER INC-2018237633$PFIZER$Hiyama, Y.. Four Cases of Bacteremia Caused by Helicobacter cinaedi in the Urological Ward at About the Same Time. Hinyokika Kiyo (Acta Urologica Japonica). 2017;63(11):461-463$7$DEC$$M$Y$$$20240828$$MD$JP$JP
150093749$15009374$9$F$$20240918$20180614$20240925$EXP$$CA-TAKEDA-2018TUS019459$TAKEDA$$$$$M$Y$$$20240925$$CN$CA$CA
1500983320$15009833$20$F$$20240812$20180614$20240820$EXP$$CA-APOTEX-2018AP015326$APOTEX$$23$YR$$F$Y$$$20240820$$HP$CA$CA
150127564$15012756$4$F$$20240725$20180614$20240730$EXP$$FI-MYLANLABS-2018M1041648$MYLAN$Karajamaki A, Lauri T and Ebeling T.. Antipsychotic drug-induced hypoglycemia and hypothermia. Duodecim. 2017;133 (3):301-304$49$YR$$M$Y$$$20240730$$HP$FI$FI
150129334$15012933$4$F$20170227$20240715$20180614$20240725$EXP$$DE-TEVA-2018-DE-906485$TEVA$$63$YR$$F$Y$$$20240725$$HP$DE$DE
150131962$15013196$2$F$$20240709$20180614$20240711$EXP$$BE-MYLANLABS-2018M1039281$MYLAN$Vandenbriele C, Price S. QTc in the elderly. Eur-Heart-J 2018;39(16):1445.$76$YR$$F$Y$$$20240711$$HP$BE$BE
150144739$15014473$9$F$20161128$20240822$20180615$20240901$EXP$$CA-TAKEDA-2016TUS021409$TAKEDA$$22$YR$$M$Y$$$20240901$$CN$CA$CA
150155146$15015514$6$F$20160301$20240909$20180615$20240912$EXP$$DE-MYLANLABS-2018M1040108$MYLAN$$82$YR$$F$Y$56$KG$20240912$$MD$DE$DE
150158082$15015808$2$F$$20180703$20180615$20240805$EXP$$AU-ABBVIE-18P-008-2379375-00$ABBVIE$$41$YR$$F$Y$$$20240801$$MD$AU$AU
1501641522$15016415$22$F$20220415$20240701$20180615$20240702$PER$$US-PFIZER INC-2018240889$PFIZER$$65$YR$$M$Y$83.9$KG$20240702$$CN$US$US
1501756139$15017561$39$F$20171118$20240819$20180615$20240827$EXP$$CA-CELLTRION INC.-2018CA020634$CELLTRION$$$$$$Y$$$20240827$$CN$CA$CA
150180802$15018080$2$F$20170612$20240731$20180615$20240809$EXP$ES-AEMPS-350104$ES-TEVA-2018-ES-907526$TEVA$$86$YR$$M$Y$$$20240809$$MD$ES$ES
1502089111$15020891$11$F$20180511$20240904$20180618$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-055559$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240912$$MD$JP$JP
1502167426$15021674$26$F$$20240724$20180618$20240731$EXP$$CA-GLAXOSMITHKLINE-CA2018GSK106653$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$CA$CA
150270096$15027009$6$F$$20240912$20180619$20240921$EXP$$US-ROCHE-1993953$ROCHE$$40$YR$A$F$Y$$$20240921$$HP$US$US
150270932$15027093$2$F$$20240709$20180619$20240717$EXP$$GB-ROCHE-2107642$ROCHE$$$$A$F$Y$$$20240717$$CN$GB$GB
150280022$15028002$2$F$20080101$20240819$20180619$20240905$EXP$$BE-ASTELLAS-2017US028754$ASTELLAS$Darcis G, Van der Auwera G, Giot JP, Hayette MP, Tassin F, Estrada JA, et. al.. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy. BMC Infectious Diseases. 2017;17(1):478.$52$YR$A$F$Y$$$20240905$$HP$BE$BE
1503384014$15033840$14$F$20180515$20240802$20180619$20240807$EXP$$DE-ROCHE-2130154$ROCHE$$47$YR$A$F$Y$$$20240807$$CN$DE$DE
150338722$15033872$2$F$$20240723$20180620$20240729$PER$$US-BIOGEN-2018BI00596561$BIOGEN$$$$$F$Y$$$20240729$$CN$US$US
150346245$15034624$5$F$20180226$20240910$20180620$20240916$EXP$$BE-ROCHE-2083268$ROCHE$$81$YR$E$M$Y$64.8$KG$20240916$$MD$BE$BE
150411222$15041122$2$F$$20240829$20180621$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-176134$RANBAXY$Chan B, Chiew A. Endoscopic decontamination reduces risk of life threatening poisoning. Emerg Med Australas. 2018;30 (Suppl. 1):33-34$13$YR$$F$Y$$$20240913$$HP$AU$AU
150429934$15042993$4$F$$20240909$20180621$20240913$EXP$$GR-MYLANLABS-2018M1041120$MYLAN$Kourti, E. Persistent bacteremia from Bacillus cereus: An infectious challenge. 18th Panhellenic Congress of Infections (Book of Proceedings). 2018;80$85$YR$$F$Y$$$20240913$$MD$GR$GR
150433516$15043351$6$F$20170727$20240820$20180621$20240827$EXP$$DE-PFIZER INC-2018243851$PFIZER$$59$YR$$F$Y$$$20240827$$MD$DE$DE
150441072$15044107$2$F$$20240711$20180621$20240716$EXP$$ES-PURDUE PHARMA-GBR-2018-0056787$PURDUE$$69$YR$$M$Y$$$20240716$$MD$ES$ES
150442093$15044209$3$F$20170714$20240821$20180621$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-111552$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$77$KG$20240829$$MD$JP$JP
150461314$15046131$4$F$20170101$20240807$20180621$20240814$EXP$$FR-MYLANLABS-2018M1041746$MYLAN$$62$YR$$M$Y$65$KG$20240814$$MD$FR$FR
150534262$15053426$2$F$$20240919$20180622$20240923$EXP$$DE-MYLANLABS-2018M1042459$MYLAN$Lenz F. Nebenwirkungen der neuen Antidepressiva.. Psych up2date. 2017;11:493-504$35$YR$$M$Y$$$20240923$$MD$DE$DE
150587152$15058715$2$F$$20240823$20180625$20240905$EXP$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2018-04286$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2018-04286$ALKEM$Patel JD, Yampikulsakul P, Tunsupon P.. A patient with mycophenolate induced posterior reversible encephalopathy syndrome (pres). Journal of General Internal Medicine. 2018;33(2):431-432$36$YR$$F$Y$$$20240905$$HP$US$US
150660953$15066095$3$F$20170901$20240827$20180626$20240903$PER$$US-VERTEX PHARMACEUTICALS-2018-003888$VERTEX$$5$YR$$F$Y$$$20240903$$CN$US$US
150664404$15066440$4$F$$20240715$20180626$20240721$EXP$$GR-MYLANLABS-2018M1043582$MYLAN$Kiapidou S, Sinakos E, Chytiroglou P, Koustiani G, Kaprinis A, Akrviadis E et al.. Exposure to chemotherapeutic agents: an emerging cause of non?cirrhotic portal hypertension. . 2017 OCT;Volume 30, Supplemen:28-28.. Annals of Gastroenterology. 2017;30 (28):28$49$YR$$M$Y$$$20240719$$MD$GR$GR
150772238$15077223$8$F$20170808$20240801$20180627$20240805$EXP$$BE-MYLANLABS-2017M1077087$MYLAN$$1$WK$$M$Y$0.3$KG$20240805$$MD$BE$BE
150800705$15080070$5$F$20140327$20240802$20180627$20240808$EXP$$PHHY2013CA146598$NOVARTIS$$65$YR$$F$Y$$$20240808$$HP$CA$CA
150824115$15082411$5$F$20180129$20240814$20180628$20240820$EXP$$ES-AUROBINDO-AUR-APL-2018-032827$AUROBINDO$$63$YR$$F$Y$70$KG$20240820$$MD$ES$ES
1508376211$15083762$11$F$20170914$20240912$20180628$20240921$EXP$FR-AFSSAPS-PC20180352$FR-TEVA-2018-FR-918354$TEVA$$1$DY$$M$Y$1.89$KG$20240921$$PH$FR$FR
150896042$15089604$2$F$20171204$20240821$20180629$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-032753$AUROBINDO$$27$YR$$M$Y$$$20240831$$MD$ES$ES
150905393$15090539$3$F$20160101$20240910$20180629$20240912$EXP$$US-PFIZER INC-2018257840$PFIZER$$66$YR$$M$Y$118$KG$20240912$$MD$US$US
150969112$15096911$2$F$20180101$20240826$20180702$20240830$EXP$$US-JAZZ-2018-US-010223$JAZZ$$$$$F$Y$$$20240830$$CN$US$US
150978455$15097845$5$F$$20211026$20180702$20240710$PER$$US-PFM-2018-01686$PIERRE FABRE MEDICAMENT$$$$$M$Y$30$KG$20240710$$HP$US$US
150978833$15097883$3$F$$20220216$20180702$20240710$PER$$US-PFM-2018-02674$PIERRE FABRE MEDICAMENT$$$$$F$Y$14.966$KG$20240710$$MD$US$US
150981977$15098197$7$F$$20230421$20180702$20240808$PER$$US-OTSUKA-2018_017392$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
1510060035$15100600$35$F$20180503$20240625$20180703$20240702$EXP$$CA-CELLTRION INC.-2018CA020081$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
151034725$15103472$5$F$20170101$20240819$20180703$20240822$EXP$$FR-PFIZER INC-2018263515$PFIZER$$81$YR$$F$Y$57$KG$20240822$$MD$FR$FR
151039893$15103989$3$F$20161215$20240625$20180703$20240701$EXP$$AT-OTSUKA-2018_018284$OTSUKA$$27$YR$$F$Y$65$KG$20240701$$MD$AT$AT
1510415518$15104155$18$F$$20240829$20180703$20240904$EXP$$IN-PFIZER INC-2018162191$PFIZER$$67$YR$$F$Y$$$20240904$$CN$IN$IN
1510461019$15104610$19$F$$20240819$20180703$20240821$EXP$$CA-BAUSCH-BL-2018-018105$BAUSCH AND LOMB$$48$YR$$F$Y$$$20240821$$CN$CA$CA
151053495$15105349$5$F$$20240825$20180704$20240903$EXP$$US-ROCHE-2146325$ROCHE$$51$YR$A$M$Y$$$20240903$$CN$US$US
151054098$15105409$8$F$20181004$20240625$20180704$20240701$EXP$$CA-TAKEDA-2018TUS021213$TAKEDA$$69$YR$$F$Y$$$20240701$$HP$CA$CA
151059016$15105901$6$F$$20240822$20180704$20240903$EXP$$ES-ROCHE-2144936$ROCHE$Baran R, Baran R, Robert C, Sibaud V. Asymmetric acral spared phenomenon related to systemic anticancer therapies. Skin Appendage Disorders 2018;:1-5.$48$YR$A$F$Y$$$20240903$$HP$ES$ES
151059124$15105912$4$F$$20240905$20180704$20240909$EXP$$US-SHIRE-US201823596$TAKEDA$$$$$M$Y$$$20240909$$CN$US$US
1510737220$15107372$20$F$20180101$20240906$20180704$20240912$EXP$$CA-TAKEDA-2018TUS021103$TAKEDA$$$$$M$Y$$$20240912$$MD$CA$CA
151090335$15109033$5$F$20180210$20240820$20180705$20240824$EXP$$IT-ROCHE-2148662$ROCHE$$66$YR$E$M$Y$$$20240824$$MD$IT$IT
151120075$15112007$5$F$$20240813$20180705$20240819$EXP$$GR-MYLANLABS-2018M1047243$MYLAN$Mylona M, Panopoulos S, Karamanakos A, Kolyogeorgis P, Tossa.. Pneumonia and brain abscess from Nocardia spp. in a patient with systemic lupus erythematosus.. 18th Pan-Hellenic Congress of Infections. 2018;78-79$44$YR$$F$Y$$$20240819$$HP$GR$GR
151124065$15112406$5$F$$20240923$20180705$20240926$PER$$US-BIOGEN-2015BI001542$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
1511369145$15113691$45$F$20180305$20240909$20180706$20240918$EXP$$DE-ROCHE-2091662$ROCHE$$52$YR$A$M$Y$90$KG$20240918$$CN$DE$DE
1511437833$15114378$33$F$20180321$20240826$20180706$20240902$EXP$$DE-ROCHE-2107689$ROCHE$$46$YR$A$F$Y$$$20240902$$CN$DE$DE
151152032$15115203$2$F$20240708$20240805$20180706$20240808$EXP$$US-SHIRE-US201822729$TAKEDA$$77$YR$$F$Y$$$20240808$$CN$US$US
151180222$15118022$2$F$20180619$20240626$20180707$20240704$EXP$$ES-AUROBINDO-AUR-APL-2018-033913$AUROBINDO$$22$YR$$M$Y$83$KG$20240704$$MD$ES$ES
151184132$15118413$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063675$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal medicine. 2018 Jun 01;283(6):568-77.doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184142$15118414$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063674$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal medicine. 2018 Jun 01;283(6):568-77.doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184172$15118417$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063677$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal medicine. 2018 Jun 01;283(6):568-577.doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184242$15118424$2$F$$20240624$20180708$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-061099$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240702$$HP$US$US
151184252$15118425$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063678$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184262$15118426$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063676$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal medicine. 2018 Jun 01;283(6):568-77.doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184272$15118427$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063660$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184282$15118428$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063679$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184322$15118432$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063670$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184332$15118433$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063668$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184342$15118434$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063669$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184372$15118437$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063661$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184382$15118438$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063662$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184392$15118439$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063665$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184402$15118440$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063664$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184412$15118441$2$F$$20240624$20180708$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063663$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240702$$HP$US$US
151184422$15118442$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063667$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184472$15118447$2$F$$20240624$20180708$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063666$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240702$$HP$US$US
151184582$15118458$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063672$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal medicine. 2018 Jun 01;283(6):568-77.doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151184632$15118463$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063680$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal Medicine. 2018 Jun 01;283(6):568-77. doi:10.1111/joim.12744.$$$$$Y$$$20240702$$HP$US$US
151184642$15118464$2$F$$20240624$20180708$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-063673$BRISTOL MYERS SQUIBB$Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, et al. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. Journal of Internal medicine. 2018 Jun 01;283(6):568-77.doi:10.1111/joim.12744.$$$$$Y$$$20240701$$HP$US$US
151206782$15120678$2$F$20180228$20240702$20180709$20240706$EXP$FR-AFSSAPS-MP20181491$FR-SA-2018SA177287$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240706$$MD$FR$FR
151226259$15122625$9$F$20180101$20240916$20180709$20240920$EXP$$DE-ABBVIE-18K-062-2376349-00$ABBVIE$$76$YR$$M$Y$72$KG$20240920$$MD$DE$DE
151228802$15122880$2$F$$20240628$20180709$20240702$EXP$$ES-MYLANLABS-2018M1048145$MYLAN$$59$YR$$F$Y$$$20240702$$MD$ES$ES
1512401714$15124017$14$F$20170529$20240822$20180710$20240830$EXP$$CA-ROCHE-2151256$ROCHE$$63$YR$A$M$Y$97$KG$20240830$$CN$CA$CA
1512472431$15124724$31$F$20180620$20240812$20180710$20240816$EXP$$DE-ROCHE-2151780$ROCHE$$53$YR$A$F$Y$$$20240816$$CN$DE$DE
151277876$15127787$6$F$20180612$20240826$20180710$20240902$EXP$$CA-SHIRE-CA201823910$TAKEDA$$62$YR$$F$Y$127$KG$20240902$$CN$CA$CA
151296856$15129685$6$F$20180101$20240729$20180711$20240807$PER$$US-SA-2018SA181933$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$MD$US$US
151322497$15132249$7$F$20180101$20240709$20180711$20240716$EXP$$US-JAZZ-2018-US-010720$JAZZ$$$$$F$Y$$$20240716$$HP$US$US
1513416417$15134164$17$F$20140203$20240705$20180712$20240711$EXP$$PHHY2011CA43185$NOVARTIS$$$$A$F$Y$$$20240711$$MD$CA$CA
1513522924$15135229$24$F$20180526$20240912$20180712$20240921$EXP$$CA-CELLTRION INC.-2018CA019164$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
1513523134$15135231$34$F$20180416$20240809$20180712$20240816$EXP$$CA-CELLTRION INC.-2018CA019834$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
151391217$15139121$7$F$20180628$20240820$20180713$20240828$EXP$$CA-ROCHE-2154503$ROCHE$$21$YR$A$M$Y$$$20240828$$MD$CA$CA
151419645$15141964$5$F$20180226$20240919$20180713$20240923$EXP$$BE-PFIZER INC-2018282682$PFIZER$$81$YR$$M$Y$64.8$KG$20240923$$MD$BE$BE
151420612$15142061$2$F$$20240814$20180713$20240827$EXP$$ES-AUROBINDO-AUR-APL-2018-036026$AUROBINDO$$29$YR$$F$Y$$$20240827$$MD$ES$ES
151433292$15143329$2$F$20170703$20240821$20180713$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-035092$AUROBINDO$$67$YR$$M$Y$$$20240831$$MD$ES$ES
151434166$15143416$6$F$20170109$20240717$20180713$20240724$EXP$$DE-SA-2017SA018564$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240724$$HP$DE$DE
151481632$15148163$2$F$$20240702$20180716$20240704$EXP$$ES-PURDUE-GBR-2018-0057366$PURDUE$$59$YR$$F$Y$$$20240704$$MD$ES$ES
1514834528$15148345$28$F$20100101$20240924$20180716$20240927$EXP$$US-PFIZER INC-2018284082$PFIZER$$72$YR$$F$Y$$$20240927$$CN$US$US
151486523$15148652$3$F$$20240920$20180716$20240926$EXP$IT-EMA-DD-20180405-NEGIEVPROD-164731$IT-MYLANLABS-2018M1050421$MYLAN$Ferrajolo, C... Antidepressantinduced liver injury risk in Italy. Reactions Weekly. 2017;1665(1):5$56$YR$$F$Y$$$20240926$$MD$IT$IT
151489952$15148995$2$F$20161215$20240624$20180716$20240701$EXP$$AT-GLAXOSMITHKLINE-AT2018121519$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$HP$AT$AT
151513977$15151397$7$F$20171221$20240723$20180716$20240730$EXP$$CA-TAKEDA-2018TUS022061$TAKEDA$$32$YR$$F$Y$$$20240730$$CN$CA$CA
151535193$15153519$3$F$$20240712$20180717$20240717$EXP$$PHHY2018ES044707$NOVARTIS$$50$YR$$M$Y$$$20240717$$MD$ES$ES
151543049$15154304$9$F$20170610$20240730$20180717$20240802$EXP$ES-AEMPS-340160$ES-MYLANLABS-2018M1051081$MYLAN$$82$YR$$F$Y$$$20240802$$MD$ES$ES
151585928$15158592$8$F$20180615$20240730$20180718$20240805$EXP$$PHHY2018CO044525$NOVARTIS$$45$YR$$F$Y$60$KG$20240805$$CN$CO$CO
151606852$15160685$2$F$20071201$20240910$20180718$20240912$EXP$$ES-SANOFI-AVENTIS-2010SA012529$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240912$$MD$ES$ES
151633374$15163337$4$F$$20240912$20180719$20240913$EXP$$US-SHIRE-US201826048$TAKEDA$$$$$M$Y$$$20240913$$CN$US$US
151693642$15169364$2$F$20000101$20240920$20180720$20240930$EXP$SE-EMA-DD-20180103-NEGIEVPROD-092302$SE-TEVA-2018-SE-925370$TEVA$$32$YR$$F$Y$39$KG$20240930$$CN$SE$SE
151704283$15170428$3$F$$20240820$20180720$20240826$PER$$US-BIOGEN-2018BI00610627$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
151705312$15170531$2$F$20240716$20240723$20180720$20240726$PER$$US-TAKEDA-2018TUS022331$TAKEDA$$54$YR$$F$Y$$$20240726$$CN$US$US
151713716$15171371$6$F$20180301$20221014$20180720$20240828$EXP$$PHHY2018AU046705$NOVARTIS$$43$YR$$F$Y$$$20240828$$MD$AU$AU
151716199$15171619$9$F$20180601$20240913$20180720$20240918$EXP$$DE-ABBVIE-18K-062-2423271-00$ABBVIE$$84$YR$$F$Y$68$KG$20240918$$MD$DE$DE
151730912$15173091$2$F$$20240710$20180720$20240722$PER$$US-TAKEDA-2018TUS022510$TAKEDA$$$$$F$Y$82.54$KG$20240722$$MD$US$US
151733284$15173328$4$F$20171013$20240709$20180720$20240711$EXP$$CA-TAKEDA-2018TUS022397$TAKEDA$$72$YR$$M$Y$$$20240711$$MD$CA$CA
151775414$15177541$4$F$$20240916$20180720$20240923$EXP$$US-SHIRE-US201826291$TAKEDA$$$$$F$Y$65$KG$20240923$$HP$US$US
151795256$15179525$6$F$20180205$20240715$20180723$20240725$EXP$$DE-TEVA-2018-DE-926959$TEVA$$62$YR$$M$Y$91$KG$20240725$$MD$DE$DE
1517975720$15179757$20$F$20180111$20240919$20180723$20240923$EXP$$CA-ROCHE-2069964$ROCHE$$20$YR$A$F$Y$$$20240923$$CN$CA$CA
1518778211$15187782$11$F$20180626$20240722$20180724$20240725$EXP$$CA-ROCHE-2156405$ROCHE$$67$YR$E$F$Y$$$20240725$$CN$CA$CA
151946039$15194603$9$F$20180621$20240729$20180725$20240801$EXP$$DE-ROCHE-2141668$ROCHE$$35$YR$A$F$Y$$$20240801$$CN$DE$DE
1520044618$15200446$18$F$20180423$20240612$20180726$20240703$EXP$$DE-ROCHE-2126614$ROCHE$$41$YR$A$F$Y$54$KG$20240703$$CN$DE$DE
152026452$15202645$2$F$20171211$20240821$20180726$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-037579$AUROBINDO$$89$YR$$M$Y$$$20240831$$MD$ES$ES
152027703$15202770$3$F$20090101$20240718$20180726$20240729$EXP$$US-OTSUKA-2018_016899$OTSUKA$$$$$M$Y$$$20240729$$LW$US$US
152039157$15203915$7$F$20171106$20240711$20180726$20240717$EXP$$JP-LUNDBECK-DKLU2048119$LUNDBECK$$$$$$Y$$$20240717$$MD$JP$JP
152042742$15204274$2$F$$20240827$20180726$20240903$EXP$$PHHY2018CO056743$NOVARTIS$$$$$F$Y$$$20240903$$CN$CO$CO
152043114$15204311$4$F$$20240911$20180726$20240912$EXP$$IT-MYLANLABS-2018M1055088$MYLAN$Todeschini G.Tecchio C, Meneghini V, Pizzolo G, Veneri D, Zanotti R et al.. Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin. Leukemia. 1998;12 (2):144-49$70$YR$$$Y$$$20240912$$HP$IT$IT
152048215$15204821$5$F$20240612$20240808$20180726$20240815$EXP$$CA-SHIRE-CA201826903$TAKEDA$$71$YR$$M$Y$86$KG$20240815$$CN$CA$CA
1520586315$15205863$15$F$20180626$20240905$20180727$20240910$EXP$$CA-ROCHE-2159967$ROCHE$$40$YR$A$F$Y$$$20240910$$CN$CA$CA
152059085$15205908$5$F$$20240913$20180727$20240925$EXP$$PL-AUROBINDO-AUR-APL-2018-037405$AUROBINDO$Siwek M. Woron J.. A 65-year-old female patient suffering from recurrent depression with complex complications associated with irrational Polypharmacy.. Psychofarmacology in practice.. 2018;3:61-63$65$YR$$F$Y$$$20240925$$MD$PL$PL
152082822$15208282$2$F$$20240906$20180727$20240911$EXP$FR-EMA-DD-20180420-NEGIEVPROD-114056$FR-MYLANLABS-2018M1057023$MYLAN$Tudesq J, Vincent L, Lebrun J, Hicheri Y, Gabellier L, Busetto T et al. Cytomegalovirus infection with retinitis after brentuximab vedotin treatment for CD30+ lymphoma.. Open Forum Infect. Dis.. 2017;4(2):10$83$YR$$M$Y$$$20240911$$MD$FR$FR
152094613$15209461$3$F$20180201$20240821$20180727$20240830$EXP$FR-AFSSAPS-AN20180647$FR-TEVA-2018-FR-930980$TEVA$$70$YR$$F$Y$$$20240830$$PH$FR$FR
152120503$15212050$3$F$20171001$20240815$20180730$20240826$EXP$$PL-ROCHE-2160718$ROCHE$Pietraszewska K, Januszko- Giergielewicz B, Arlukowicz T, Jaroslawski J, Kozak L, Skutecki R, Kwella N and Adadynski L Acute pancreatitis after kidney transplantation-serious complication, therapeutic dilemmas - a case report and literature overview.. Nephrology and dialysis therapy Poland. 2018;22 (2):81-86.$61$YR$A$M$Y$$$20240826$$MD$PL$PL
152228408$15222840$8$F$20170801$20240709$20180731$20240709$EXP$PT-INFARMED-H201807-158$PT-JNJFOC-20180729490$JOHNSON AND JOHNSON$$48$YR$A$F$Y$77$KG$20240710$$HP$PT$PT
152228682$15222868$2$F$$20240911$20180731$20240917$EXP$$FR-MYLANLABS-2018M1055675$MYLAN$$72$YR$$F$Y$$$20240917$$MD$FR$FR
1522515861$15225158$61$F$20180101$20240913$20180801$20240923$EXP$$CA-CELLTRION INC.-2018CA020447$CELLTRION$$$$$$Y$$$20240923$$CN$CA$CA
1522648725$15226487$25$F$20180611$20240823$20180801$20240902$EXP$$DE-ROCHE-2162727$ROCHE$$40$YR$A$F$Y$$$20240902$$CN$DE$DE
152274637$15227463$7$F$20221113$20240722$20180801$20240801$EXP$$US-SHIRE-US201829120$TAKEDA$$73$YR$$M$Y$$$20240801$$CN$US$US
152291304$15229130$4$F$20170101$20240726$20180801$20240805$EXP$$JP-009507513-1807JPN012578$MERCK$$72$YR$$F$Y$41$KG$20240805$$MD$JP$JP
152302973$15230297$3$F$20140103$20230908$20180802$20240802$EXP$$US-Accord-067883$ACCORD$$64$YR$A$F$Y$$$20240802$$LW$US$US
152309632$15230963$2$F$20140201$20230623$20180802$20240802$EXP$$US-Accord-063218$ACCORD$$58$YR$A$F$Y$$$20240802$$LW$US$US
152309773$15230977$3$F$20131001$20230628$20180802$20240802$EXP$$US-Accord-063228$ACCORD$$57$YR$A$F$Y$$$20240802$$LW$US$US
152310062$15231006$2$F$$20240911$20180802$20240925$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2018-06062$ALKEM$Imafuku A, Tanaka K, Marui Y, Ubara Y, Takaichi K, Tomikawa S et al. Primary central nervous system post-transplant lymphoproliferative disorder diagnosed by peripheral facial nerve palsy. Internal medicine. 2018;57(13):1899-1903$62$YR$$M$Y$84$KG$20240925$$HP$JP$JP
1523378435$15233784$35$F$20180709$20240708$20180802$20240711$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK169298$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$BR$BR
1523392522$15233925$22$F$$20240923$20180802$20240926$EXP$$CA-BAUSCH-BL-2018-020551$BAUSCH AND LOMB$$69$YR$$F$Y$$$20240926$$HP$CA$CA
1523494940$15234949$40$F$20180220$20240907$20180803$20240910$EXP$$CA-ROCHE-2081120$ROCHE$$38$YR$A$F$Y$$$20240910$$CN$CA$CA
152351122$15235112$2$F$$20240319$20180803$20240730$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2017-01237$ALKEM$Trautmann A, Benoit S, Goebeler M and Stoevesandt J.. ^Treating Through^ Decision and Follow-up in Antibiotic Therapy-Associated Exanthemas. J Allergy Clin Immunol Pract. 2017;5(6):1650-1656$32$YR$$M$Y$$$20240730$$MD$DE$DE
152373367$15237336$7$F$$20240809$20180803$20240813$EXP$$PHHY2018GR060445$NOVARTIS$Lionaki, S, Tsakonas E, Androulaki A, Liapis G, Panayiotidis P, Zavos G et al. Primary hepatic burkitt lymphoma in a kidney transplant recipient. CASE REPORTS IN NEPHROLOGY. 2018$51$YR$$F$Y$$$20240813$$HP$GR$GR
152382014$15238201$4$F$$20240909$20180803$20240912$EXP$$BG-MYLANLABS-2018M1056714$MYLAN$Angelov. A, Vetkova, M, Atanasov. D, Encheva. P,Stoyanov. P, Polymorphic.. Polymorphic ventricular tachycardia due to prinzmetal angina.. Scripta Scientifica Vox Studentium - Supplementum.. 2018;1:103$76$YR$$M$Y$$$20240912$$MD$BG$BG
152396492$15239649$2$F$$20240812$20180803$20240820$EXP$$PHHY2016IE120240$NOVARTIS$Medani S, Wall C. Colchicine toxicity in renal patients - Are we paying attention?. CLINICAL NEPHROLOGY. 2016;86(2):100-5$46$YR$$M$Y$$$20240820$$HP$IE$IE
152404109$15240410$9$F$20171001$20240813$20180804$20240820$EXP$PL-GLAXOSMITHKLINE-PL2018GSK124794$PL-JNJFOC-20180731667$JOHNSON AND JOHNSON$Pietraszewska K, Januszko-giergielewicz B, Arlukowicz T, Jaroslawski J, Kozak L, Skutecki R, Pietraszewska K. Acute pancreatitis after kidney transplantation-serious complication, therapeutic dilemmas - a case report and literature overview. Nephrology and dialysis therapy Poland. 2018;22 (2):81-6.$61$YR$A$M$Y$$$20240820$$HP$PL$PL
152429905$15242990$5$F$20090101$20240819$20180806$20240828$EXP$$PHHY2017BE204453$NOVARTIS$Darcis G, Van der Auwera G, Giot JP, Hayette MP, Tassin F, Estrada JA et al.. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy. BMC INFECTIOUS DISEASES. 2017;17(1):478$52$YR$$F$Y$$$20240828$$HP$BE$BE
152447135$15244713$5$F$$20240808$20180806$20240812$EXP$$US-SHIRE-US201829063$TAKEDA$$$$$F$Y$$$20240812$$MD$US$US
1524473812$15244738$12$F$$20240921$20180806$20240926$EXP$$US-SHIRE-US201829650$TAKEDA$$$$$F$Y$97$KG$20240926$$CN$US$US
152471762$15247176$2$F$20080101$20240709$20180807$20240715$PER$$US-AMGEN-USASL2018105464$AMGEN$$53$YR$A$F$Y$$$20240715$$CN$US$US
152476693$15247669$3$F$20180129$20240715$20180807$20240724$EXP$$PL-TEVA-2018-PL-937264$TEVA$$24$YR$$F$Y$70$KG$20240724$$MD$PL$PL
1524791914$15247919$14$F$20180409$20240719$20180807$20240731$EXP$$DE-ROCHE-2131550$ROCHE$$38$YR$A$M$Y$$$20240731$$CN$DE$DE
1524970313$15249703$13$F$20170914$20210225$20180807$20240715$EXP$FR-EMA-DD-20180928-VSEVHPDD-105915$FR-SA-2018SA106385$SANOFI AVENTIS$$$$A$F$Y$77$KG$20240715$$MD$FR$FR
152504644$15250464$4$F$$20240919$20180807$20240923$EXP$$US-PFIZER INC-2018313103$PFIZER$Sierra, M.. Combined treatment with growth hormone and anastrozole in a pubertal male with growth hormone deficiency and low bone density due to chronic steroids use. Endocrine Reviews. 2018;39(2):1$21$YR$$M$Y$$$20240923$$MD$US$US
1525090317$15250903$17$F$20180710$20240814$20180807$20240821$EXP$$PHHY2017GT122446$NOVARTIS$$35$YR$$M$Y$80.726$KG$20240822$$CN$GT$GT
152549292$15254929$2$F$$20240815$20180808$20240822$EXP$$JP-SA-2018SA154146$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240822$$MD$JP$JP
152588843$15258884$3$F$20130101$20240724$20180809$20240730$PER$$US-BIOGEN-2014BI074150$BIOGEN$$$$$F$Y$$$20240730$$CN$US$US
152628612$15262861$2$F$20180408$20240916$20180810$20240926$EXP$$ES-AUROBINDO-AUR-APL-2018-040660$AUROBINDO$$81$YR$$M$Y$$$20240926$$PH$ES$ES
152636282$15263628$2$F$$20240502$20180810$20240802$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2018-00766$ALKEM$Willis T, Roper H, Rabb L. Lamotrigine poisoning presenting as seizures: a case of deliberate poisoning (Case Reports). Child Abuse + Neglect. 2007;31(1):85-88$12$DY$$M$Y$$$20240802$$HP$CA$CA
152636492$15263649$2$F$$20240502$20180810$20240802$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2018-00927$ALKEM$G. Briassoulis, P. Kalabalikis, M. Tamiolaki, T. Hatzis. Lamotrigine childhood overdose. Pediatric Neurology. 1998;19(3):239-242$2$YR$$M$Y$$$20240802$$HP$CA$CA
152636602$15263660$2$F$$20240502$20180810$20240802$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2018-00924$ALKEM$Thundiyil JG, Anderson IB, Stewart PJ, Olson KR.. Lamotrigine-induced seizures in a child: case report and literature review (Case Reports). Clinical Toxicology. 2007;45:169-172$19$MON$$M$Y$$$20240802$$HP$CA$CA
1526379734$15263797$34$F$20180508$20240701$20180810$20240716$EXP$$DE-ROCHE-2126374$ROCHE$$37$YR$A$F$Y$70$KG$20240716$$MD$DE$DE
152654558$15265455$8$F$$20240813$20180810$20240816$EXP$$AT-JNJFOC-20180807177$JOHNSON AND JOHNSON$$1$DY$N$$Y$2.1$KG$20240816$$MD$AT$AT
152663435$15266343$5$F$20180601$20240928$20180810$20240930$EXP$$US-PFIZER INC-2018317052$PFIZER$$50$YR$$F$Y$99.79$KG$20240930$$CN$US$US
1526881414$15268814$14$F$20090101$20240626$20180813$20240703$EXP$$DE-Orion Corporation ORION PHARMA-ENTC2009-0251$ORION$$68$YR$E$F$Y$53$KG$20240703$$MD$DE$
1526972043$15269720$43$F$20180101$20240719$20180813$20240729$EXP$$CA-CELLTRION INC.-2018CA018685$CELLTRION$$$$$$Y$$$20240729$$CN$CA$CA
152732722$15273272$2$F$20130201$20240916$20180813$20240923$EXP$$US-JAZZ-JPI-P-030354$JAZZ$$68$YR$$M$Y$127.27$KG$20240922$$CN$US$US
1527397110$15273971$10$F$$20240625$20180814$20240703$PER$$US-AMGEN-USASP2018110206$AMGEN$$63$YR$A$F$Y$$$20240703$$MD$US$US
152742383$15274238$3$F$20180501$20240905$20180814$20240918$EXP$$FR-AUROBINDO-AUR-APL-2018-040714$AUROBINDO$$13$YR$$M$Y$$$20240918$$MD$FR$FR
152744872$15274487$2$F$20180612$20240821$20180814$20240902$EXP$$ES-AUROBINDO-AUR-APL-2018-040829$AUROBINDO$$88$YR$$F$Y$$$20240902$$MD$ES$ES
152749663$15274966$3$F$$20240919$20180814$20240930$EXP$$US-AUROBINDO-AUR-APL-2018-040513$AUROBINDO$Sierra M, Ramirez M, Alvarado M, GonzalezRodriguez LA, GarcesDominguez A, NievesRivera F. Combined treatment with growth hormone and anastrozole in a pubertal male with growth hormone deficiency and low bone density due to chronic steroids use. Endocrine Reviews. 2018;39(2):1$18$YR$$M$Y$$$20240930$$MD$US$US
152823143$15282314$3$F$$20240808$20180816$20240813$EXP$$US-INCYTE CORPORATION-2018IN007301$INCYTE$$$$$$Y$$$20240814$$CN$US$US
1528422011$15284220$11$F$20170615$20240830$20180816$20240906$EXP$$CA-TAKEDA-2017TUS013388$TAKEDA$$41$YR$$F$Y$$$20240906$$HP$CA$CA
152859763$15285976$3$F$20150610$20231130$20180816$20240807$EXP$IT-MINISAL02-489258$IT-TEVA-2018-IT-942711$TEVA$$30$YR$$F$Y$$$20240807$$PH$IT$IT
1528637417$15286374$17$F$20171025$20240919$20180816$20240923$EXP$FR-AFSSAPS-AM20181050$FR-MYLANLABS-2018M1062163$MYLAN$$89$YR$$F$Y$68$KG$20240923$$PH$FR$FR
1528801710$15288017$10$F$20180813$20240820$20180817$20240826$PER$$US-PFIZER INC-2018332395$PFIZER$$67$YR$$F$Y$69$KG$20240826$$CN$US$US
1528971314$15289713$14$F$20160629$20240725$20180817$20240730$EXP$$AU-SA-2016SA147483$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240730$$HP$AU$AU
152910882$15291088$2$F$$20240826$20180817$20240828$PER$$US-SHIRE-US201831920$TAKEDA$$$$$M$Y$$$20240828$$MD$US$US
152971952$15297195$2$F$$20240820$20180820$20240827$EXP$$US-SA-2018SA221947$SANOFI AVENTIS$Liu C, Zhao Y, Yin Z, Hu T, Ren J, Wei J et al.. Right atrial epithelioid angiosarcoma with multiple pulmonary metastasis confirmed by multimodality imaging-guided pulmonary biopsy: A case report and literature review. A case report and literature review: Medicine (Baltimore). 2018;97(30):11588$35$YR$A$M$Y$$$20240827$$HP$CN$CN
152996518$15299651$8$F$20180815$20240702$20180821$20240711$EXP$$CA-ROCHE-2171420$ROCHE$$41$YR$A$F$Y$$$20240711$$CN$CA$CA
153003327$15300332$7$F$20180612$20240903$20180821$20240909$EXP$$CA-ROCHE-2172207$ROCHE$$55$YR$A$F$Y$$$20240909$$CN$CA$CA
153017552$15301755$2$F$$20240821$20180821$20240827$EXP$$CN-ELI_LILLY_AND_COMPANY-CN201808008666$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240827$$CN$IN$CN
153067985$15306798$5$F$$20240126$20180822$20240927$EXP$$PHHY2018CO076074$NOVARTIS$$$$$M$Y$74$KG$20240927$$CN$CO$CO
153080073$15308007$3$F$20230606$20240905$20180822$20240909$EXP$$US-SHIRE-US201831569$TAKEDA$$75$YR$$M$Y$$$20240909$$CN$US$US
153149838$15314983$8$F$20171001$20240809$20180824$20240821$EXP$$PL-AUROBINDO-AUR-APL-2018-043176$AUROBINDO$Pietraszewska K, Januszko-giergielewicz B, Arlukowicz T, Jaroslawski J, Kozak L, Skutecki R.. Acute pancreatitis after kidney transplantation - serious complication, therapeutic dilemmas - a case report and literature overview. Nephrology and dialysis therapy Poland. 2018;22(2):81-6$61$YR$$M$Y$$$20240821$$MD$PL$PL
1532061774$15320617$74$F$20180423$20240910$20180827$20240916$EXP$$CA-ROCHE-2172109$ROCHE$$71$YR$E$F$Y$51$KG$20240916$$HP$CA$CA
153225114$15322511$4$F$20070101$20240827$20180827$20240902$EXP$$PHHY2018SK080314$NOVARTIS$Urbancek S, Bielikova, M, Stovcik T. A Unique case of a Haemodialyasis Patient with a Severe Form of Psoriasis in the Biological Treatment with Secukinumab.. LIECBA DERMATOVENEROLOGICKYCH OCHORENI. 2018;2:1316-11$29$YR$$M$Y$$$20240902$$HP$SK$SK
153260424$15326042$4$F$$20240919$20180828$20240926$EXP$$RO-PFIZER INC-2018341751$MYLAN$Trifu, S.. The authenticity of the suicidal gesture in the crepuscular state. Buletinul Asociatiei Balint. 2018;20 (78):12-17$33$YR$$M$Y$$$20240926$$MD$RO$RO
153273003$15327300$3$F$20160625$20240717$20180828$20240729$EXP$$FR-ELI_LILLY_AND_COMPANY-FR201808008590$ELI LILLY AND CO$$22$YR$A$M$Y$85$KG$20240729$$CN$FR$FR
1532768418$15327684$18$F$20180101$20240909$20180828$20240918$EXP$$RU-BIOGEN-2018BI00624971$BIOGEN$$$$$F$Y$55$KG$20240918$$MD$RU$RU
153280983$15328098$3$F$20141001$20240716$20180828$20240723$EXP$$US-BIOGEN-2014BI106247$BIOGEN$$50$YR$$F$Y$$$20240723$$CN$US$US
153313243$15331324$3$F$20150522$20240630$20180829$20240905$EXP$$US-TEVA-2018-US-949344$TEVA$$$$$M$Y$$$20240905$$LW$US$US
1533150214$15331502$14$F$20190712$20240829$20180829$20240904$EXP$$US-TAKEDA-2018TUS025703$TAKEDA$$65$YR$$M$Y$$$20240904$$CN$US$US
1533183220$15331832$20$F$20160101$20240909$20180829$20240919$EXP$$RU-BIOGEN-2018BI00620933$BIOGEN$$23$YR$$F$Y$$$20240919$$MD$RU$RU
1533192114$15331921$14$F$$20240828$20180829$20240829$EXP$$US-PFIZER INC-2018345158$PFIZER$$26$YR$$M$Y$71.4$KG$20240829$$CN$US$US
153337143$15333714$3$F$20180821$20190605$20180830$20240912$EXP$$JP-GLAXOSMITHKLINE-JP2018JPN154589$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$JP$JP
1533537116$15335371$16$F$20171001$20240812$20180830$20240829$EXP$PHHY2018PL079008$PHHY2018PL079008$NOVARTIS$Pietraszewska K, JanuszkoGiergielewicz B, Arlukowicz T, Jaroslawski J, Kozak L, Skutecki R et al. Acute pancreatitis after kidney transplantationserious complication, therapeutic dilemmas a case report and literature overview.. NEPHROLOGY AND DIALYSIS THERAPY POLAND. 2018;22(2):81-6$61$YR$$M$Y$$$20240829$$HP$PL$PL
153354678$15335467$8$F$20210824$20240724$20180830$20240729$EXP$$US-SHIRE-US201833500$TAKEDA$$64$YR$$F$Y$$$20240729$$MD$US$US
1533649514$15336495$14$F$20180801$20240809$20180830$20240813$EXP$$CA-TAKEDA-2018TUS025977$TAKEDA$$65$YR$$F$Y$$$20240813$$CN$CA$CA
153369782$15336978$2$F$20160301$20240821$20180831$20240902$EXP$$ES-AUROBINDO-AUR-APL-2018-043436$AUROBINDO$$61$YR$$F$Y$$$20240902$$PH$ES$ES
153372424$15337242$4$F$20180802$20240913$20180831$20240925$EXP$$DE-AUROBINDO-AUR-APL-2018-043385$AUROBINDO$$51$YR$$M$Y$90$KG$20240925$$HP$DE$DE
153395808$15339580$8$F$$20240813$20180831$20240819$EXP$$US-SHIRE-US201833688$TAKEDA$$$$$F$Y$$$20240819$$CN$US$US
153402317$15340231$7$F$20180129$20240731$20180831$20240806$EXP$$JP-ABBVIE-18P-087-2471236-00$ABBVIE$$63$YR$$M$Y$73$KG$20240806$$MD$JP$JP
1534427912$15344279$12$F$20180802$20240920$20180903$20240926$EXP$$DE-PFIZER INC-2018354172$MYLAN$$51$YR$$M$Y$90$KG$20240926$$HP$DE$DE
153461452$15346145$2$F$20120719$20240912$20180904$20240920$EXP$$FR-TEVA-2018-FR-951179$TEVA$$67$YR$$F$Y$55$KG$20240920$$HP$FR$FR
1534651711$15346517$11$F$20180826$20240726$20180904$20240730$PER$$US-PFIZER INC-2018354256$PFIZER$$75$YR$$F$Y$92$KG$20240730$$CN$US$US
153465607$15346560$7$F$20180823$20240906$20180904$20240912$PER$$US-PFIZER INC-2018233490$PFIZER$$66$YR$$F$Y$60.317$KG$20240912$$CN$US$US
153516262$15351626$2$F$$20240710$20180905$20240718$PER$$US-JAZZ-2018-US-013322$JAZZ$$$$$F$Y$$$20240718$$CN$US$US
153541255$15354125$5$F$$20240916$20180906$20240925$EXP$$PHBS2004DE00723$NOVARTIS$Groll AH, Kolve H, Ehlert K, Paulussen M, Vormoor J. Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2004;53(1):113-4$14$YR$$F$Y$48$KG$20240925$$HP$DE$DE
153548018$15354801$8$F$20171102$20240913$20180906$20240924$EXP$$FR-AUROBINDO-AUR-APL-2018-044261$AUROBINDO$$79$YR$$M$Y$69$KG$20240924$$MD$FR$FR
1535500111$15355001$11$F$20180814$20240913$20180906$20240918$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-081714$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$69$KG$20240918$$PH$FR$FR
153567328$15356732$8$F$20210101$20240826$20180906$20240829$EXP$$US-PFIZER INC-2018346749$PFIZER$$73$YR$$F$Y$49.9$KG$20240829$$HP$US$US
153591217$15359121$7$F$20050615$20240708$20180907$20240712$EXP$$BR-BIOGEN-2018BI00627055$BIOGEN$$40$YR$$F$Y$54$KG$20240712$$HP$BR$BR
1536027310$15360273$10$F$20180601$20240622$20180907$20240709$EXP$$CA-ROCHE-2181138$ROCHE$$55$YR$A$F$Y$64.41$KG$20240705$$HP$CA$CA
153608082$15360808$2$F$20171030$20240916$20180907$20240924$EXP$$NL-AUROBINDO-AUR-APL-2018-044352$AUROBINDO$$$$$M$Y$$$20240924$$CN$NL$NL
153617484$15361748$4$F$20160101$20240722$20180907$20240731$EXP$$FR-PFIZER INC-2018355581$PFIZER$$22$YR$$M$Y$85$KG$20240731$$MD$FR$FR
153620365$15362036$5$F$20180721$20181211$20180907$20240830$EXP$$JP-GLAXOSMITHKLINE-JP2018JPN159115$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$JP$JP
153643774$15364377$4$F$20180101$20240827$20180909$20240904$EXP$$US-BIOGEN-2018BI00629617$BIOGEN$$$$$M$Y$$$20240904$$CN$US$US
153649032$15364903$2$F$20180101$20240814$20180910$20240827$EXP$$FR-AUROBINDO-AUR-APL-2018-044970$AUROBINDO$$6$DEC$$F$Y$$$20240827$$MD$FR$FR
1536896910$15368969$10$F$20231001$20240819$20180911$20240829$EXP$$DE-ROCHE-2182332$ROCHE$$54$YR$A$F$Y$60$KG$20240829$$MD$DE$DE
153694147$15369414$7$F$20180830$20240717$20180911$20240729$EXP$$CA-ROCHE-2182226$ROCHE$$79$YR$E$F$Y$65$KG$20240729$$CN$CA$CA
153695099$15369509$9$F$$20240919$20180911$20240924$PER$$US-PFIZER INC-2018361185$PFIZER$$30$YR$$M$Y$79$KG$20240924$$MD$US$US
153695394$15369539$4$F$20180721$20240904$20180911$20240906$PER$$US-PFIZER INC-2018363024$PFIZER$$65$YR$$F$Y$$$20240906$$PH$US$US
153699002$15369900$2$F$$20240729$20180911$20240809$EXP$$DE-AUROBINDO-AUR-APL-2018-045289$AUROBINDO$Lange-Asschenfeldt C, Blaeser I, Supprian T.. Bipolar switching after carbamazepine withdrawal. . ;86-7, 82-8. Pharmacopsychiatry. 2007;40 (2):86-7, 82-8$74$YR$$M$Y$$$20240809$$HP$DE$DE
1536991036$15369910$36$F$20181029$20240910$20180911$20240919$EXP$$CA-CELLTRION INC.-2018CA021546$CELLTRION$$$$$$Y$$$20240919$$CN$CA$CA
153699985$15369998$5$F$20171102$20240915$20180911$20240920$EXP$$FR-BAUSCH-BL-2018-024686$BAUSCH AND LOMB$$79$YR$$M$Y$69$KG$20240920$$MD$FR$FR
153765073$15376507$3$F$$20240705$20180912$20240709$EXP$$US-JAZZ-2018-US-013620$JAZZ$$$$$F$Y$$$20240709$$MD$US$US
153765533$15376553$3$F$$20240909$20180912$20240912$EXP$$DE-009507513-1808DEU013701$MERCK$Avsar Y, Cicinnati VR, Kabar I, Wolters H, Anthoni C, Schmidt HH et al.. Small bowel transplantation complicated by cytomegalovirus tissue invasive disease without viremia.. J Clin Virol. 2014;60(2):177-80$52$YR$$F$Y$$$20240912$$HP$DE$DE
153800892$15380089$2$F$20180408$20240905$20180913$20240909$EXP$$US-ASTELLAS-2018US017654$ASTELLAS$$74$YR$E$M$Y$$$20240909$$CN$US$US
153801114$15380111$4$F$20180327$20240718$20180913$20240726$EXP$$US-ASTELLAS-2018US017830$ASTELLAS$$70$YR$$M$Y$$$20240726$$CN$US$US
153814545$15381454$5$F$$20240923$20180913$20240925$PER$$US-PFIZER INC-2018360727$PFIZER$$63$YR$$F$Y$$$20240925$$CN$US$US
153832363$15383236$3$F$20171201$20240816$20180913$20240820$EXP$$PL-SHIRE-PL201834775$TAKEDA$$59$YR$$F$Y$$$20240820$$HP$PL$PL
153841968$15384196$8$F$$20240920$20180914$20240926$EXP$$CA-TAKEDA-2018TUS027181$TAKEDA$$$$$M$Y$$$20240926$$HP$CA$CA
153851183$15385118$3$F$20130207$20240626$20180914$20240703$EXP$$PHHY2018CA094804$NOVARTIS$$57$YR$$M$Y$$$20240703$$MD$CA$CA
153875755$15387575$5$F$20160401$20240624$20180914$20240709$EXP$$GB-TEVA-2018-GB-953703$TEVA$Robins AEM, Bowden DJ, Gelson WTH. Chronic genotype 1 hepatitis E infection from immunosuppression for ileo-colonic Crohn^s disease, Oxford Medical Case Reports, 2018;9(1)_278-281, DOI_ 10.1093_omcr_omy059; Robins AEM, Bowden DJ, Gelson WTH. Chronic genotype 1 hepatitis E infection from immunosuppression for ileo-colonic Crohn^s disease, Oxford Medical Case Reports, 2018;9(1)_278-281, DOI_ 10.1093_omcr_omy059; Robins A. Chronic genotype 1 hepatitis E infection from immunosuppression for ileo-...$33$YR$$M$Y$$$20240709$$MD$GB$GB
153878266$15387826$6$F$$20240802$20180914$20240809$EXP$$US-JAZZ-2018-US-013716$JAZZ$$$$$M$Y$$$20240809$$HP$US$US
153889783$15388978$3$F$$20240905$20180917$20240914$EXP$$FR-ROCHE-2171035$ROCHE$Altwegg R, Combes R L. Conti F et al.. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.. DIGESTIVE AND LIVER DISEASE. 2018;50 (7):668-674.$26$YR$A$M$Y$$$20240914$$HP$FR$FR
153900612$15390061$2$F$20180822$20240814$20180917$20240820$EXP$$ES-AUROBINDO-AUR-APL-2018-045908$AUROBINDO$$77$YR$$M$Y$71$KG$20240820$$MD$ES$ES
153924987$15392498$7$F$$20240909$20180917$20240912$EXP$$US-SHIRE-US201835182$TAKEDA$$$$$M$Y$120$KG$20240912$$HP$US$US
153935152$15393515$2$F$20180511$20240711$20180917$20240716$EXP$FR-AFSSAPS-MP20182017$FR-PFIZER INC-2018367993$PFIZER$$36$YR$$F$Y$54$KG$20240716$$MD$FR$FR
1539438850$15394388$50$F$20170601$20240903$20180918$20240910$EXP$$CA-ROCHE-2184987$ROCHE$$64$YR$A$F$Y$$$20240910$$CN$CA$CA
153945916$15394591$6$F$20160101$20240913$20180918$20240920$EXP$$US-BIOGEN-2018BI00632036$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
1539632934$15396329$34$F$20160101$20240814$20180918$20240823$EXP$$CA-JNJFOC-20180911207$JOHNSON AND JOHNSON$$54$YR$A$F$Y$76$KG$20240823$$HP$CA$CA
154036786$15403678$6$F$20180701$20240627$20180919$20240704$EXP$$BR-TAKEDA-2018TUS023442$TAKEDA$$29$YR$$F$Y$$$20240704$$CN$BR$BR
1540438514$15404385$14$F$20170101$20240829$20180919$20240904$EXP$$US-JAZZ-2018-US-013978$JAZZ$$$$$F$Y$$$20240904$$CN$US$US
1540594520$15405945$20$F$20180901$20240708$20180920$20240711$EXP$$US-PFIZER INC-2018377439$PFIZER$$72$YR$$M$Y$$$20240711$$CN$US$US
1541231710$15412317$10$F$20180428$20240730$20180921$20240808$EXP$$CA-ROCHE-2186860$ROCHE$$44$YR$A$F$Y$$$20240808$$MD$CA$CA
1541266434$15412664$34$F$20180204$20240917$20180921$20240926$EXP$$PHHY2018DE024042$NOVARTIS$$9$YR$$F$Y$50$KG$20240926$$MD$DE$DE
1541392913$15413929$13$F$20220330$20240919$20180921$20240926$EXP$$CA-TAKEDA-2018TUS022784$TAKEDA$$45$YR$$F$Y$$$20240926$$CN$CA$CA
154147738$15414773$8$F$20160816$20240918$20180921$20240925$EXP$$CA-TAKEDA-2018TUS020295$TAKEDA$$69$YR$$F$Y$$$20240925$$CN$CA$CA
154154922$15415492$2$F$$20240925$20180922$20240930$EXP$$US-TAKEDA-2018TUS027580$TAKEDA$$$$$F$Y$$$20240930$$CN$US$US
154158472$15415847$2$F$20080409$20240807$20180922$20240815$EXP$$US-JNJFOC-20170504717$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240815$$LW$US$US
154179765$15417976$5$F$20180124$20240904$20180924$20240913$EXP$$TR-ASTELLAS-2018US014031$ASTELLAS$$80$YR$E$M$Y$$$20240913$$MD$TR$TR
1542343026$15423430$26$F$20180606$20240621$20180925$20240705$EXP$$CA-ROCHE-2187539$ROCHE$$64$YR$A$F$Y$60$KG$20240705$$MD$CA$CA
154235484$15423548$4$F$$20240712$20180925$20240717$PER$$US-PFIZER INC-2018383148$PFIZER$$65$YR$$F$Y$77$KG$20240717$$CN$US$US
154251709$15425170$9$F$20180224$20240909$20180925$20240913$EXP$$FR-MYLANLABS-2018M1069546$MYLAN$$84$YR$$M$Y$89$KG$20240913$$PH$FR$FR
1542592810$15425928$10$F$20180605$20240918$20180925$20240927$EXP$$CA-PFIZER INC-2018258169$PFIZER$$69$YR$$F$Y$$$20240927$$CN$CA$CA
154272272$15427227$2$F$$20240919$20180925$20240924$EXP$$SE-MYLANLABS-2018M1070042$MYLAN$$26$YR$$M$Y$$$20240924$$MD$SE$SE
154287212$15428721$2$F$20170705$20240703$20180926$20240710$EXP$$NL-AUROBINDO-AUR-APL-2018-046919$AUROBINDO$$29$YR$$F$Y$$$20240710$$MD$NL$NL
154295147$15429514$7$F$20090101$20231216$20180926$20240712$EXP$$CO-ASTELLAS-2018US041840$ASTELLAS$$$$$M$Y$32$KG$20240712$$CN$CO$CO
1542984510$15429845$10$F$20221001$20240827$20180926$20240829$EXP$$CA-PFIZER INC-2016303618$PFIZER$$75$YR$$F$Y$$$20240829$$CN$CA$CA
1543145623$15431456$23$F$20170914$20240911$20180926$20240916$EXP$FR-AFSSAPS-PC20180352$FR-MYLANLABS-2018M1070214$MYLAN$$1$DY$$M$Y$1.89$KG$20240916$$PH$FR$FR
154332492$15433249$2$F$20180301$20240916$20180927$20240924$EXP$$ES-AUROBINDO-AUR-APL-2018-047163$AUROBINDO$$58$YR$$F$Y$$$20240924$$PH$ES$ES
154382076$15438207$6$F$20180923$20240801$20180928$20240805$EXP$$US-SHIRE-US201837495$TAKEDA$$59$YR$$F$Y$$$20240805$$CN$US$US
154385545$15438554$5$F$20150101$20240711$20180928$20240723$EXP$$CA-ROCHE-2190399$ROCHE$$60$YR$A$F$Y$$$20240723$$CN$CA$CA
154412214$15441221$4$F$$20240812$20180928$20240813$EXP$$US-SHIRE-US201837599$TAKEDA$$$$$F$Y$$$20240813$$CN$US$US
1544872213$15448722$13$F$20240101$20240701$20180929$20240708$EXP$$US-SA-2018SA270053$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240708$$CN$US$US
154493949$15449394$9$F$20180709$20240916$20181001$20240923$EXP$$CA-ROCHE-2190809$ROCHE$$10$YR$C$F$Y$49$KG$20240923$$CN$CA$CA
154521604$15452160$4$F$$20240717$20181001$20240725$EXP$$AT-PFIZER INC-2018385432$PFIZER$$$$E$M$Y$$$20240725$$MD$AT$AT
154540797$15454079$7$F$20140101$20240806$20181002$20240810$EXP$$US-TAKEDA-2018TUS028397$TAKEDA$$62$YR$$M$Y$74$KG$20240810$$HP$US$US
154551336$15455133$6$F$$20240723$20181002$20240725$EXP$$US-PFIZER INC-2017296843$PFIZER$$80$YR$$F$Y$$$20240725$$CN$US$US
154559343$15455934$3$F$$20240823$20181002$20240826$EXP$$CA-BAYER-2018-183512$BAYER$Auyeung J, Lee M. Successful treatment of stevens?Johnson syndrome with cyclosporine and corticosteroid/ Ciprofloxacin-Induced Stevens-Johnson Syndrome Treated with Cyclosporine: A Case Report. Canadian Journal of Hospital Pharmacy. 2018;71(4):272-275$66$YR$E$F$Y$66$KG$20240826$$PH$CA$CA
154576652$15457665$2$F$$20240905$20181003$20240918$EXP$$FR-AUROBINDO-AUR-APL-2018-009893$AUROBINDO$Portal A, Pernot S, Siauve N, Landi B, Lepere C, Colussi O, et al.. Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: Report of an effective new strategy. Clinics and Research in Hepatology and Gastroenterology. 2014;38(2):e23-e26$60$YR$$M$Y$$$20240918$$HP$FR$FR
154578633$15457863$3$F$$20240918$20181003$20240919$EXP$$US-SHIRE-US201837953$TAKEDA$$$$$M$Y$77$KG$20240919$$CN$US$US
154580857$15458085$7$F$20120101$20240912$20181003$20240923$EXP$CZ-NOVPHSZ-PHHY2018CZ099831$CZ-ROCHE-2191837$ROCHE$Kiss I. The treatment of the developed mCRC (metastatic colorectal cancer) in a nutshell. Farmakoterapie 2018;14 (3):305-480.$52$YR$A$F$Y$$$20240923$$MD$CZ$CZ
154589733$15458973$3$F$20160201$20240813$20181003$20240821$EXP$$PHHY2018SK071401$NOVARTIS$Valekova L. Hypomethylation therapy in patients with high-risk MDS - our experience. Hemotolagicke dni. 2018;25-7$62$YR$$M$Y$$$20240821$$HP$SK$SK
154603786$15460378$6$F$20180911$20240812$20181003$20240816$EXP$$US-ABBVIE-18P-163-2493051-00$ABBVIE$$30$YR$$M$Y$$$20240816$$MD$US$US
154605693$15460569$3$F$20180404$20240826$20181003$20240831$EXP$$DE-ABBVIE-18P-062-2319267-00$ABBVIE$$77$YR$$M$Y$75$KG$20240831$$MD$DE$DE
154616178$15461617$8$F$20230214$20240911$20181003$20240917$EXP$$US-SHIRE-US201837654$TAKEDA$$79$YR$$F$Y$70$KG$20240917$$CN$US$US
1546162111$15461621$11$F$$20240916$20181003$20240920$EXP$$US-SHIRE-US201838127$TAKEDA$$$$$F$Y$56$KG$20240920$$HP$US$US
154616664$15461666$4$F$$20240827$20181003$20240829$EXP$$US-SHIRE-US201837670$TAKEDA$$$$$F$Y$$$20240829$$CN$US$US
1546254711$15462547$11$F$20180918$20240916$20181004$20240917$EXP$$CA-ROCHE-2191998$ROCHE$$51$YR$A$F$Y$$$20240917$$CN$CA$CA
1546312521$15463125$21$F$20180920$20240806$20181004$20240814$EXP$$CA-ROCHE-2194192$ROCHE$$38$YR$A$F$Y$$$20240814$$CN$CA$CA
154635592$15463559$2$F$20180209$20240626$20181004$20240702$EXP$$BR-TAKEDA-2018TUS028666$TAKEDA$$18$YR$$F$Y$$$20240702$$CN$BR$BR
154681649$15468164$9$F$20160411$20240729$20181005$20240807$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN102704$VIIV$$$$$$Y$$$20240807$$MD$JP$JP
154702907$15470290$7$F$$20240705$20181005$20240708$EXP$$GR-PFIZER INC-2018392945$MYLAN$Despotopoulos, S.. Severe allergic reaction during angioplasty culminating to fatal acute stent thrombosis: An association with Kounis syndrome. Heart + Lung. 2018;1-3$50$YR$$M$Y$$$20240708$$HP$GR$GR
154704229$15470422$9$F$20150901$20240725$20181005$20240731$EXP$$US-JAZZ-2018-US-014635$JAZZ$$43$YR$$F$Y$$$20240731$$MD$US$US
154721742$15472174$2$F$$20240826$20181008$20240904$PER$$US-SHIRE-US201838363$TAKEDA$$$$$M$Y$$$20240904$$CN$US$US
154805593$15480559$3$F$20100101$20240909$20181010$20240917$EXP$$FR-ROCHE-2196436$ROCHE$Leibler C, Arnault J, Sayegh J, Montaudie H, Remy P. Ipilimumab for the treatment of advanced melanoma in six kidney transplant patients. American journal of transplantation. 2018;18 (12):3065-71.$57$YR$A$F$Y$$$20240917$$HP$FR$FR
154812512$15481251$2$F$20180528$20240916$20181010$20240921$EXP$$NL-AUROBINDO-AUR-APL-2018-048871$AUROBINDO$$73$YR$$F$Y$69$KG$20240921$$CN$NL$NL
154814203$15481420$3$F$$20240822$20181010$20240903$EXP$$CA-AUROBINDO-AUR-APL-2018-049493$AUROBINDO$Hohl CM, Badke K, Zhao A, Wickham ME, Woo SA, Sivilotti MLA et al.. Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug Events.. Academic Emergency Medicine.. 2018;25(9):1015-1026$58$YR$$M$Y$$$20240903$$MD$CA$CA
1548223613$15482236$13$F$$20240919$20181010$20240924$EXP$$CA-JNJFOC-20181009935$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240924$$MD$CA$CA
1548383516$15483835$16$F$20180901$20240715$20181010$20240717$EXP$$US-PFIZER INC-2018054936$PFIZER$$81$YR$$F$Y$71$KG$20240717$$CN$US$US
154841755$15484175$5$F$20181205$20240625$20181010$20240701$EXP$$CA-TAKEDA-2018TUS029233$TAKEDA$$71$YR$$F$Y$$$20240701$$MD$CA$CA
154842817$15484281$7$F$20180101$20240919$20181010$20240925$PER$$US-PFIZER INC-2016303725$PFIZER$$10$YR$$M$Y$19$KG$20240925$$MD$US$US
154865906$15486590$6$F$$20240904$20181011$20240916$EXP$$IT-AUROBINDO-AUR-APL-2018-049234$AUROBINDO$Rimoldi SG, Longhi E, Palazzin A, Savi C, Zambelli A, Mangini A et al... Role of chryseobacterium indologenes infection in a female with mediastinitis. Surgical Infections Case Reports. 2016;1(1):44-6$67$YR$$F$Y$$$20240916$$MD$IT$IT
154867372$15486737$2$F$20170101$20240715$20181011$20240718$EXP$$ES-PURDUE PHARMA-GBR-2018-0060068$PURDUE$$51$YR$$F$Y$$$20240718$$MD$ES$ES
1548675940$15486759$40$F$20180420$20240816$20181011$20240826$EXP$$CA-ROCHE-2113859$ROCHE$$24$YR$A$F$Y$$$20240826$$CN$CA$CA
154871554$15487155$4$F$$20240731$20181011$20240813$EXP$$CA-AUROBINDO-AUR-APL-2018-049507$AUROBINDO$Auyeung J, Lee M. Successful treatment of stevens?Johnson syndrome with cyclosporine and corticosteroid. Canadian Journal of Hospital Pharmacy. 2018;71(4):272-275$66$YR$$F$Y$66$KG$20240813$$PH$CA$CA
1548764319$15487643$19$F$20180804$20240822$20181011$20240909$EXP$$JP-LUNDBECK-DKLU2054678$LUNDBECK$$$$$$Y$$$20240909$$HP$JP$JP
1549137913$15491379$13$F$20180509$20240718$20181012$20240722$EXP$$CA-ROCHE-2124762$ROCHE$$47$YR$A$F$Y$$$20240722$$CN$CA$CA
154916414$15491641$4$F$$20240822$20181012$20240903$EXP$$CA-AUROBINDO-AUR-APL-2018-049509$AUROBINDO$Hohl CM, Badke K, Zhao A, Wickham ME, Woo SA, Sivilotti MLA et al.. Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug Events.. Academic Emergency Medicine. 2018;25(9):1015-26$97$YR$$F$Y$$$20240903$$MD$CA$CA
154920352$15492035$2$F$$20240705$20181012$20240720$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-187545$RANBAXY$$$$A$$Y$$$20240719$$HP$DE$DE
154922005$15492200$5$F$20140101$20240905$20181012$20240918$EXP$$FR-AUROBINDO-AUR-APL-2018-050085$AUROBINDO$$$$N$M$Y$1.92$KG$20240918$$MD$FR$FR
155001312$15500131$2$F$20170725$20231109$20181015$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-US-2018DEP000739$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$CN$US$US
155051667$15505166$7$F$20160504$20240913$20181016$20240921$EXP$$CA-ROCHE-2197046$ROCHE$$65$YR$E$F$Y$$$20240921$$MD$CA$CA
155080322$15508032$2$F$20140101$20240912$20181016$20240920$EXP$FR-AFSSAPS-CF20180407$FR-TEVA-2018-FR-964600$TEVA$$$$$M$Y$1.92$KG$20240920$$MD$FR$FR
1550856918$15508569$18$F$$20240925$20181016$20240930$EXP$$GB-MYLANLABS-2018M1075556$MYLAN$$$$$F$Y$97$KG$20240930$$HP$CA$CA
1551577813$15515778$13$F$20160522$20240624$20181017$20240702$EXP$$FR-AUROBINDO-AUR-APL-2018-049422$AUROBINDO$$50$YR$$F$Y$106$KG$20240702$$CN$FR$FR
155158182$15515818$2$F$20180813$20240814$20181017$20240821$EXP$$NL-AUROBINDO-AUR-APL-2018-050448$AUROBINDO$$50$YR$$M$Y$$$20240821$$PH$NL$NL
1551826322$15518263$22$F$20181011$20240802$20181017$20240805$PER$$US-PFIZER INC-2018414579$PFIZER$$63$YR$$F$Y$95$KG$20240805$$MD$US$US
155256573$15525657$3$F$20180401$20240711$20181018$20240717$EXP$$ES-MYLANLABS-2018M1077748$MYLAN$$78$YR$$M$Y$$$20240717$$MD$ES$ES
155269922$15526992$2$F$$20240711$20181020$20240716$EXP$$DE-AUROBINDO-AUR-APL-2017-34676$AUROBINDO$Mahmoudi M, Brenner T, Hatiboglu G, Burhenne J, Weiss J, Weigand MA.. Substantial impairment of voriconazole clearance by high-dose meropenem in a patient with renal failure. Cliniacal Infectious disease. 2017;65(6):1033-1036$78$YR$$M$Y$$$20240716$$HP$DE$DE
1553025610$15530256$10$F$20160601$20240705$20181018$20240710$PER$$US-PFIZER INC-2018418618$PFIZER$$62$YR$$F$Y$$$20240710$$CN$US$US
155323736$15532373$6$F$20180803$20211007$20181019$20240719$EXP$$JP-GLAXOSMITHKLINE-JP2018JPN013937$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$MD$JP$JP
155334944$15533494$4$F$$20240808$20181019$20240809$EXP$ES-TEVA-2018-ES-961390$ES-JNJFOC-20181024926$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240809$$HP$ES$ES
155347254$15534725$4$F$$20240826$20181022$20240904$EXP$$GB-ROCHE-2202298$ROCHE$$87$YR$E$F$Y$$$20240904$$CN$GB$GB
155353533$15535353$3$F$$20190121$20181022$20240814$EXP$$JP-AMGEN-JPNSP2018147070$AMGEN$$$$E$F$Y$$$20240813$$MD$JP$JP
155358217$15535821$7$F$20180101$20240701$20181022$20240703$EXP$$US-PFIZER INC-2018423714$PFIZER$$47$YR$$F$Y$$$20240703$$MD$US$US
155364956$15536495$6$F$20171001$20240816$20181022$20240823$EXP$$PL-PURDUE PHARMA-GBR-2018-0060506$PURDUE$Pietraszewska K, Januszko-giergielewicz B, Arlukowicz T, Jaroslawski J, Kozak L, Skutecki R.. Acute pancreatitis after kidney transplantation - serious complication, therapeutic dilemmas - a case report and literature overview.. Nephrology and dialysis therapy Poland. 2018;22(2):81-6$61$YR$$M$Y$$$20240823$$MD$PL$PL
155376092$15537609$2$F$$20240624$20181022$20240701$EXP$$US-VERTEX PHARMACEUTICALS-2018-007551$VERTEX$$$$$F$Y$$$20240701$$CN$US$US
1553817015$15538170$15$F$20160101$20240905$20181022$20240911$EXP$$RO-MYLANLABS-2018M1076181$MYLAN$Moloce AM, Aursulesei V, Petris AO, Costache II.. Supine hypertension and orthostatic hypotension - a management challenge. The Medical Surgical Journal / Revista Medico-Chirurgicala. 2018;122 (3):489-494$80$YR$$M$Y$$$20240911$$MD$RO$RO
155405172$15540517$2$F$20120427$20240912$20181023$20240923$EXP$PL-EMA-DD-20180423-TANEJAEVHP-173546$PL-Accord-073558$ACCORD$Katarzyna Muras-Szwedziak, Anna Zawiasa-Bryszewska, Bartosz Bryszewski, Janusz Strzelczyk, Krzysztof Szwedziak, Michal Nowicki, Ilona Kurnatowska. Intervertebral disc aspergillosis in a female patient after a kidney transplantation. Forum Nefrologiczne. 2017;10(2):139-143$55$YR$A$F$Y$$$20240923$$HP$PL$PL
155432043$15543204$3$F$$20220914$20181023$20240710$PER$$CA-PFM-2018-12619$PIERRE FABRE MEDICAMENT$$47$YR$$F$Y$$$20240710$$MD$CA$CA
155432124$15543212$4$F$20160919$20240919$20181023$20240926$EXP$$DE-PFIZER INC-2018427419$MYLAN$$84$YR$$M$Y$$$20240926$$MD$DE$DE
155451287$15545128$7$F$20120101$20240813$20181024$20240827$EXP$$FR-AUROBINDO-AUR-APL-2018-051070$AUROBINDO$Ray-Coquard I. Management of relapsed ovarian cancer in routine clinical practice: a case study. Expert Review of Anticancer Therapy. 2018;18(1):9-11$63$YR$$F$Y$$$20240827$$HP$FR$FR
155454256$15545425$6$F$20150829$20240904$20181024$20240915$EXP$$FR-AUROBINDO-AUR-APL-2018-001012$AUROBINDO$$41$YR$$M$Y$55$KG$20240915$$MD$FR$FR
155460993$15546099$3$F$$20240812$20181024$20240819$EXP$$PHHY2018ES129822$NOVARTIS$Redondo-Benito A, Curran A, Villar-Gomez A, Trallero-Araguas E, Fernandez-Codina A, Pinal-Fernandez I et al.. Opportunistic infections in patients with idiopathic inflammatory myopathies. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2018;21(2):487-96$43$YR$$F$Y$$$20240819$$HP$ES$ES
1554688611$15546886$11$F$$20240705$20181024$20240720$EXP$$CA-GLENMARK PHARMACEUTICALS-2018GMK037856$GLENMARK$$$$$$Y$$$20240720$$HP$CA$CA
155472748$15547274$8$F$$20240712$20181024$20240716$PER$$US-PFIZER INC-2018429365$PFIZER$$70$YR$$F$Y$$$20240716$$CN$US$US
1554817510$15548175$10$F$20171013$20240709$20181024$20240712$EXP$$CA-TAKEDA-2018TUS013242$TAKEDA$$72$YR$$M$Y$$$20240712$$HP$CA$CA
155486466$15548646$6$F$20061207$20240702$20181025$20240711$EXP$$ZA-AMGEN-ZAFSP2018148819$AMGEN$$61$YR$A$F$Y$70$KG$20240710$$MD$ZA$ZA
155503384$15550338$4$F$20180219$20190218$20181025$20240828$EXP$$JP-GLAXOSMITHKLINE-JP2018JPN043342$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$JP$JP
155535522$15553552$2$F$$20240904$20181026$20240911$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-090872$BRISTOL MYERS SQUIBB$Cuzzubbo S, Belin C, Chouahnia K, Baroudjian B, Duchemann B, Barlog C, et al. Assessing cognitive function in patients treated with immune checkpoint inhibitors: A feasibility study. Psycho?Oncology. 2018;27:1861-4. doi:10.1002/pon.4725.$74$YR$E$F$Y$$$20240911$$HP$FR$FR
1555543212$15555432$12$F$20160101$20240730$20181026$20240805$EXP$$CA-PFIZER INC-2018434110$MYLAN$$82$YR$$F$Y$$$20240805$$HP$CA$CA
155566548$15556654$8$F$20150101$20240701$20181026$20240710$EXP$$RO-AstraZeneca-2018SF35672$ASTRAZENECA$Moloce A, Aursulesei V, Petris AO, Costache I. Supine hypertension and orthostatic hypotension a management challenge. The Medical Surgical Journal 2018;122(3):489-494.$80$YR$$M$Y$$$20240710$$MD$RO$
155570307$15557030$7$F$$20240819$20181026$20240826$EXP$$PHHY2018CA133118$NOVARTIS$$52$YR$$F$Y$$$20240826$$HP$CA$CA
1555876415$15558764$15$F$20181018$20240627$20181029$20240722$EXP$$DE-ROCHE-2206440$ROCHE$$38$YR$A$F$Y$$$20240719$$CN$DE$DE
1556174934$15561749$34$F$20210501$20240909$20181029$20240916$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK201070$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$BR$BR
155631318$15563131$8$F$20180101$20240913$20181029$20240923$EXP$$CA-TAKEDA-2018TUS007694$TAKEDA$$$$$F$Y$$$20240923$$MD$CA$CA
155650084$15565008$4$F$20180413$20240718$20181030$20240724$EXP$$CA-ROCHE-2171481$ROCHE$$42$YR$A$F$Y$$$20240724$$HP$CA$CA
1556504312$15565043$12$F$20180830$20240801$20181030$20240807$EXP$$DE-ROCHE-2206420$ROCHE$$43$YR$A$F$Y$$$20240807$$CN$DE$DE
155651163$15565116$3$F$20140101$20240911$20181030$20240916$EXP$$CZ-MYLANLABS-2018M1080845$MYLAN$Hodacova, J.. Progress in the therapy of metastatic colorectal carcinoma.. FARMAKOTERAPIE. 2018;14(2):173-6$64$YR$$M$Y$$$20240916$$MD$CZ$CZ
1556561123$15565611$23$F$$20240822$20181030$20240831$EXP$$CA-CELLTRION INC.-2018CA023567$CELLTRION$$$$$$Y$$$20240831$$CN$CA$CA
1556561242$15565612$42$F$20180803$20240815$20181030$20240824$EXP$$CA-CELLTRION INC.-2018CA021365$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
1556825711$15568257$11$F$$20240813$20181030$20240820$PER$$US-AMGEN-USASP2018149668$AMGEN$$75$YR$E$F$Y$$$20240820$$MD$US$US
155686244$15568624$4$F$20181019$20240919$20181031$20240927$EXP$$US-BIOGEN-2018BI00650907$BIOGEN$$58$YR$$F$Y$$$20240927$$CN$US$US
1556892214$15568922$14$F$20180323$20240705$20181031$20240722$EXP$$DE-ROCHE-2098755$ROCHE$$45$YR$A$M$Y$$$20240719$$CN$DE$DE
155706842$15570684$2$F$20180914$20240829$20181031$20240906$EXP$$CH-AstraZeneca-2018SF39604$ASTRAZENECA$$$$$M$Y$75.1$KG$20240906$$MD$CH$
1557372610$15573726$10$F$20180901$20240909$20181101$20240911$EXP$$JP-ALEXION PHARMACEUTICALS INC.-A201813879$ALEXION PHARMACEUTICALS$$30$YR$$F$Y$$$20240911$$MD$JP$JP
1557391414$15573914$14$F$20180829$20240621$20181101$20240711$EXP$$DE-ROCHE-2194970$ROCHE$$42$YR$A$F$Y$$$20240711$$CN$DE$DE
1557553326$15575533$26$F$$20240820$20181101$20240823$EXP$$US-PFIZER INC-2018067898$PFIZER$$79$YR$$F$Y$$$20240823$$CN$US$US
1558063310$15580633$10$F$20171101$20240924$20181102$20240927$EXP$$JP-GILEAD-2018-0371002$GILEAD$$27$YR$A$M$Y$$$20240927$$MD$JP$JP
155890973$15589097$3$F$$20240706$20181106$20240717$EXP$$FR-AUROBINDO-AUR-APL-2018-053720$AUROBINDO$Abadie D, Durrieu G, Roussin A, Montastruc J.. Serious adverse drug reactions with tramadol: A 2010-2011 pharmacovigilance survey in France. Therapie. 2013;68(2):77-84$20$YR$$F$Y$$$20240717$$HP$FR$FR
155891172$15589117$2$F$20180917$20240720$20181106$20240730$EXP$$DE-AUROBINDO-AUR-APL-2018-053663$AUROBINDO$$53$YR$$M$Y$$$20240730$$CN$DE$DE
155893655$15589365$5$F$$20240716$20181106$20240720$EXP$$US-SHIRE-US201842381$TAKEDA$$$$$F$Y$100$KG$20240720$$MD$US$US
155924378$15592437$8$F$20181013$20240926$20181106$20240927$PER$$US-PFIZER INC-2018444074$PFIZER$$67$YR$$M$Y$77.098$KG$20240927$$CN$US$US
155944333$15594433$3$F$$20240805$20181107$20240813$EXP$$DE-NAPPMUNDI-GBR-2018-0061555$PURDUE$Hess C, Kramer M, Wagner R, Madea B. Lethal injection with the muscle relaxant rocuronium. Romanian Journal of Legal Medicine. 2018;26(1):62-6$35$YR$$M$Y$73.7$KG$20240813$$HP$DE$DE
155960772$15596077$2$F$20170427$20240716$20181108$20240725$EXP$$GB-AUROBINDO-AUR-APL-2018-015347$AUROBINDO$$68$YR$$F$Y$53.97$KG$20240725$$MD$GB$GB
1559666211$15596662$11$F$20180412$20240812$20181108$20240815$EXP$$DE-ROCHE-2111845$ROCHE$$29$YR$A$F$Y$$$20240815$$CN$DE$DE
155982328$15598232$8$F$$20240815$20181108$20240823$EXP$$AT-ROCHE-1065422$ROCHE$Taylor N, Touzeau V, Geit M, Gisinger M, Egle A, Greil R, et al. Raltegravir in pregnancy: A case series presentation. International Journal of STD and AIDS 2011;22 (6):358-360.$$$$$Y$$$20240823$$HP$AT$AT
155999202$15599920$2$F$20180712$20240821$20181108$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-053784$AUROBINDO$$64$YR$$F$Y$$$20240831$$PH$ES$ES
156022258$15602225$8$F$20180101$20240906$20181109$20240913$EXP$$US-TAKEDA-2018MPI015153$TAKEDA$$$$$F$Y$$$20240913$$MD$US$US
156041432$15604143$2$F$20170427$20240801$20181110$20240812$EXP$GB-MHRA-TPP4211855C968206YC1519128799944$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2018-02462$ALKEM$$68$YR$$F$Y$54$KG$20240812$$CN$GB$GB
156061732$15606173$2$F$20180201$20240822$20181112$20240904$EXP$FR-AFSSAPS-AN20180647$FR-Accord-091898$ACCORD$$70$YR$E$F$Y$$$20240903$$PH$FR$FR
156085294$15608529$4$F$20230517$20240723$20181112$20240726$EXP$$US-SHIRE-US201843545$TAKEDA$$7$YR$$M$Y$$$20240726$$CN$US$US
1560854020$15608540$20$F$20181101$20240729$20181112$20240731$EXP$$US-SHIRE-US201843774$TAKEDA$$26$YR$$F$Y$193$KG$20240731$$HP$US$US
156126102$15612610$2$F$20230901$20240723$20181113$20240731$EXP$$PHHY2018MX150720$NOVARTIS$$76$YR$$F$Y$72$KG$20240731$$CN$MX$MX
156139442$15613944$2$F$$20240906$20181113$20240912$EXP$FR-EMA-DD-20180612-ISHAEVHP-135723$FR-MYLANLABS-2018M1085634$MYLAN$Tudesq J-J, Vincent L, Lebrun J, Hicheri Y, Gabellier L, Busetto T et al.. Cytomegalovirus infection with retinitis after brentuximab vedotin treatment for CD30 lymphoma.. OFID. 2017$$$$M$Y$$$20240912$$MD$FR$FR
1561506831$15615068$31$F$20181107$20240805$20181114$20240813$EXP$$CA-ROCHE-2215064$ROCHE$$67$YR$E$M$Y$$$20240813$$CN$CA$CA
156161963$15616196$3$F$20230330$20240913$20181114$20240913$EXP$$AU-ROCHE-2212722$ROCHE$$67$YR$E$F$Y$$$20240913$$CN$AU$AU
156175982$15617598$2$F$20180730$20240711$20181114$20240716$EXP$FR-AFSSAPS-AM20181484$FR-PFIZER INC-2018460045$PFIZER$$67$YR$$M$Y$104$KG$20240716$$MD$FR$FR
156178473$15617847$3$F$20180821$20240711$20181114$20240716$EXP$FR-AFSSAPS-AM20181485$FR-PFIZER INC-2018460041$PFIZER$$68$YR$$M$Y$98$KG$20240716$$MD$FR$FR
156185515$15618551$5$F$$20240717$20181114$20240722$EXP$$US-PFIZER INC-2018453891$PFIZER$$69$YR$$F$Y$$$20240722$$CN$US$US
1562053748$15620537$48$F$20181031$20240909$20181115$20240917$EXP$$CA-CELLTRION INC.-2018CA023385$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
1562539716$15625397$16$F$20180313$20240709$20181116$20240801$EXP$$DE-ROCHE-2102589$ROCHE$$40$YR$A$F$Y$$$20240801$$CN$DE$DE
156264974$15626497$4$F$$20240702$20181116$20240710$EXP$$GB-AstraZeneca-2018SF50395$ASTRAZENECA$Murphy C.. Dexmedetomidine, high-flow nasal oxygen and sugammadex-reversal of rocuronium: overcoming anaesthetic challenges in a parturient with congenital muscular dystrophy presenting for caesarean section.. International Journal Of Obstetric Anesthesia. 2018 2018;34:108-12.$25$YR$$F$Y$61$KG$20240710$$HP$IE$
1562675142$15626751$42$F$$20240923$20181116$20240926$EXP$$CA-ABBVIE-18S-028-2552613-00$ABBVIE$$54$YR$$M$Y$$$20240926$$HP$CA$CA
156269413$15626941$3$F$$20240919$20181116$20240924$EXP$$DE-PFIZER INC-2018469218$MYLAN$$$$$M$Y$$$20240924$$CN$DE$DE
1562713619$15627136$19$F$$20240812$20181116$20240819$EXP$$BR-GLAXOSMITHKLINE-BR2018GSK188262$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$CN$BR$BR
156276298$15627629$8$F$20180802$20240621$20181116$20240703$EXP$$CA-AEGERION PHARMACEUTICAL, INC-AEGR003927$AEGERION$$$$$$Y$$$20240703$$MD$CA$CA
156284714$15628471$4$F$20181104$20240904$20181116$20240909$EXP$$IL-SHIRE-IL201841351$TAKEDA$$32$YR$$F$Y$$$20240909$$MD$IL$IL
156288215$15628821$5$F$$20240720$20181116$20240726$EXP$$CA-ASTELLAS-2018US048913$ASTELLAS$$10$YR$$M$Y$$$20240726$$CN$CA$CA
1562895011$15628950$11$F$$20240917$20181116$20240918$PER$$US-PFIZER INC-2018468367$PFIZER$$64$YR$$M$Y$$$20240918$$MD$US$US
156305834$15630583$4$F$20181001$20240621$20181119$20240703$EXP$$IT-BEH-2018096926$CSL BEHRING$$12$YR$T$M$Y$36$KG$20240703$$HP$IT$IT
156315809$15631580$9$F$20171229$20240823$20181119$20240828$EXP$$US-ARIAD PHARMACEUTICALS, INC-2017US009116$TAKEDA$$52$YR$$M$Y$$$20240828$$HP$US$US
156318603$15631860$3$F$$20240628$20181119$20240704$PER$$US-BIOGEN-2018BI00657836$BIOGEN$$$$$F$Y$$$20240704$$CN$US$US
156323284$15632328$4$F$20140106$20240906$20181119$20240910$EXP$$JO-ROCHE-2214686$ROCHE$Mustafa K, Qasem U, Al-Ryalat N and Bsisu I Rituximab-associated posterior reversible encephalopathy syndrome. International journal of rheumatic diseases 2019;22 (1):160-165.$36$YR$A$F$Y$$$20240910$$HP$JO$JO
156343608$15634360$8$F$20181027$20240809$20181119$20240812$EXP$$US-PFIZER INC-2017348979$PFIZER$$85$YR$$F$Y$81.63$KG$20240812$$CN$US$US
156345216$15634521$6$F$20220804$20240814$20181119$20240818$EXP$$PHHY2018CA157449$NOVARTIS$$57$YR$$F$Y$$$20240818$$HP$CA$CA
1563532824$15635328$24$F$$20240716$20181120$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-105928$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$68$KG$20240730$$CN$CA$CA
156398018$15639801$8$F$$20240809$20181120$20240819$EXP$$PHHY2018ES109845$NOVARTIS$Redondo-Benito A, Curran A, Villar-gomez A, Trallero-araguas E, Fernandez-codina A, Pinal-fernandez et al.. Opportunistic infections in patients with idiopathic inflammatory myopathies. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2018;21(2):487-96$58$YR$$F$Y$$$20240819$$HP$ES$ES
1564086815$15640868$15$F$$20240909$20181120$20240912$EXP$$CA-PURDUE PHARMA-CAN-2018-0009241$PURDUE$$42$YR$$F$Y$81$KG$20240912$$HP$CA$CA
1564151311$15641513$11$F$20181105$20240716$20181120$20240729$EXP$$CA-ROCHE-2217350$ROCHE$$65$YR$E$F$Y$105$KG$20240729$$MD$CA$CA
1564204714$15642047$14$F$20180413$20240913$20181121$20240923$EXP$$CA-TAKEDA-2017TUS020626$TAKEDA$$35$YR$$M$Y$$$20240923$$HP$CA$CA
156422652$15642265$2$F$20170201$20240826$20181121$20240903$EXP$FR-AFSSAPS-BX20182375$FR-ROCHE-2217271$ROCHE$$57$YR$A$F$Y$54$KG$20240903$$MD$FR$FR
1564285815$15642858$15$F$20171001$20240725$20181121$20240806$EXP$$CA-ROCHE-2217099$ROCHE$$54$YR$A$F$Y$$$20240806$$CN$CA$CA
156432932$15643293$2$F$20240701$20240716$20181121$20240724$PER$$US-SA-2018SA317583$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240724$$MD$US$US
156438509$15643850$9$F$$20240924$20181121$20240927$PER$$US-PFIZER INC-2018477008$PFIZER$$83$YR$$F$Y$$$20240927$$MD$US$US
1564443414$15644434$14$F$$20240917$20181121$20240918$EXP$$PT-AstraZeneca-2018SF50815$ASTRAZENECA$Not provided. Not provided. Not provided Not provided(Not provided):$54$YR$$F$Y$$$20240918$$MD$PT$
156453833$15645383$3$F$20151029$20240827$20181121$20240903$EXP$$US-SHIRE-US201844170$TAKEDA$$31$YR$$F$Y$$$20240903$$HP$US$US
156484244$15648424$4$F$$20240703$20181122$20240708$PER$$US-PFIZER INC-2018481160$PFIZER$$49$YR$$M$Y$$$20240708$$CN$US$US
156490434$15649043$4$F$20180801$20240815$20181122$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2018-010002$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240909$$CN$US$US
156503255$15650325$5$F$20170101$20240809$20181123$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093648$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240814$$MD$JP$JP
156507393$15650739$3$F$$20240701$20181123$20240702$EXP$$US-SHIRE-US201845355$TAKEDA$$$$$M$Y$$$20240702$$CN$US$US
156507592$15650759$2$F$20181103$20240720$20181123$20240801$EXP$$ES-AUROBINDO-AUR-APL-2018-056472$AUROBINDO$$19$YR$$F$Y$$$20240801$$MD$ES$ES
156508862$15650886$2$F$20181101$20240821$20181123$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-056468$AUROBINDO$$90$YR$$F$Y$$$20240831$$MD$ES$ES
1565187526$15651875$26$F$20210401$20240902$20181123$20240909$EXP$$BR-GLAXOSMITHKLINE-BR2018GSK210913$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$CN$BR$BR
1565562151$15655621$51$F$20180101$20240816$20181126$20240824$EXP$$CA-CELLTRION INC.-2018CA021406$CELLTRION$$$$$$Y$$$20240824$$CN$CA$CA
1565720114$15657201$14$F$$20240722$20181126$20240727$EXP$$CA-JNJFOC-20181128756$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240727$$HP$CA$CA
156574073$15657407$3$F$$20240924$20181126$20240926$EXP$$DE-SAKK-2018SA318070AA$SANOFI AVENTIS$Berger FK, Schwab N, Glanemann M, Bohle RM, Gartner B, Groesdonk HV.. Flavonifractor (Eubacterium) plautii bloodstream infection following acute cholecystitis. IDCases. 2018;14:1-3$69$YR$E$M$Y$$$20240926$$MD$DE$DE
156574943$15657494$3$F$20181116$20240918$20181126$20240923$EXP$$US-SHIRE-US201845232$TAKEDA$$15$YR$$M$Y$66$KG$20240923$$CN$US$US
156575322$15657532$2$F$20240819$20240819$20181126$20240826$EXP$$US-SHIRE-US201845506$TAKEDA$$71$YR$$F$Y$$$20240826$$HP$US$US
1565939010$15659390$10$F$20160224$20240822$20181127$20240903$EXP$$CA-ROCHE-2219895$ROCHE$$54$YR$A$M$Y$$$20240903$$CN$CA$CA
156598122$15659812$2$F$20180823$20240905$20181127$20240918$EXP$$FR-AUROBINDO-AUR-APL-2018-056547$AUROBINDO$$45$YR$$F$Y$56$KG$20240918$$MD$FR$FR
156599769$15659976$9$F$20180101$20240710$20181127$20240717$EXP$$US-JAZZ-2018-US-016983$JAZZ$$$$$F$Y$$$20240717$$CN$US$US
1566012444$15660124$44$F$20180101$20240904$20181127$20240914$EXP$$CA-CELLTRION INC.-2018CA018233$CELLTRION$$$$$$Y$$$20240914$$CN$CA$CA
1566400511$15664005$11$F$20171212$20240716$20181128$20240723$EXP$$CA-TAKEDA-2018TUS006976$TAKEDA$$73$YR$$F$Y$$$20240723$$MD$CA$CA
156659595$15665959$5$F$20150101$20240711$20181128$20240724$EXP$$US-SA-2015SA179868$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240724$$MD$US$US
156673765$15667376$5$F$20110401$20240813$20181128$20240814$PER$$US-PFIZER INC-2018483200$PFIZER$$48$YR$$F$Y$95$KG$20240814$$LW$US$US
156694223$15669422$3$F$$20240624$20181129$20240705$PER$$US-TAKEDA-2018TUS033645$TAKEDA$$$$$M$Y$$$20240705$$MD$US$US
156711392$15671139$2$F$20171201$20240821$20181129$20240830$EXP$FR-AFSSAPS-AN20181099$FR-TEVA-2018-FR-979283$TEVA$$67$YR$$M$Y$$$20240830$$PH$FR$FR
156747933$15674793$3$F$$20240826$20181130$20240906$EXP$$DE-Accord-094004$ACCORD$Berger FK, Schwab N, Glanemann M, Bohle RM, Gartner B, Groesdonk HV. Flavonifractor (Eubacterium) plautii bloodstream infection following acute cholecystitis. IDCases. 2018 Oct 28;14:e00461.$69$YR$E$M$Y$$$20240906$$HP$DE$DE
156750526$15675052$6$F$$20240923$20181130$20240925$PER$$US-PFIZER INC-2017548665$PFIZER$$43$YR$$F$Y$$$20240925$$MD$US$US
156752027$15675202$7$F$20150101$20240730$20181130$20240812$EXP$$FR-AUROBINDO-AUR-APL-2018-057549$AUROBINDO$Van De Wyngaert Z, Coppo P, Cervera P, Fabiani B, Lemonnier M.-P, Corre E et al... Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide (ICE) in relapsed or refractory peripheral t-cell lymphoma. HemaSphere. 2020;4(1):597- 8$55$YR$$M$Y$68$KG$20240812$$MD$FR$FR
1567738411$15677384$11$F$20181031$20240918$20181130$20240925$EXP$$CA-TAKEDA-2018TUS034228$TAKEDA$$38$YR$$M$Y$$$20240925$$MD$CA$CA
1568332842$15683328$42$F$20050101$20240823$20181204$20240911$EXP$$CA-CELLTRION INC.-2018CA024265$CELLTRION$$$$$$Y$$$20240911$$MD$CA$CA
156839158$15683915$8$F$20180207$20240628$20181204$20240710$EXP$$CA-ROCHE-2077487$ROCHE$$58$YR$A$M$Y$$$20240710$$CN$CA$CA
156873272$15687327$2$F$20171224$20240916$20181205$20240926$EXP$$ES-AUROBINDO-AUR-APL-2018-058110$AUROBINDO$$86$YR$$F$Y$$$20240926$$MD$ES$ES
1568854516$15688545$16$F$$20240724$20181205$20240726$EXP$$CA-BAUSCH-BL-2018-033498$BAUSCH AND LOMB$$40$YR$$F$Y$119$KG$20240726$$CN$CA$CA
156887168$15688716$8$F$20151013$20240905$20181205$20240912$EXP$$CA-ROCHE-2223022$ROCHE$$18$YR$A$M$Y$$$20240912$$CN$CA$CA
156888585$15688858$5$F$$20240904$20181205$20240917$EXP$$FR-AUROBINDO-AUR-APL-2018-058794$AUROBINDO$Aeschlimann FA, Fremond M, Duffy D, Rice GI, Charuel J, Bondet V et al.. A child with severe juvenile dermatomyositis treated with ruxolitinib.. BRAIN. 2018;141(11):1-5$13$YR$$F$Y$$$20240917$$HP$FR$FR
1568985215$15689852$15$F$20170120$20240912$20181205$20240917$PER$$US-PFIZER INC-2017398804$PFIZER$$74$YR$$M$Y$82$KG$20240917$$MD$US$US
156901912$15690191$2$F$$20240704$20181205$20240710$EXP$$NO-PFIZER INC-2018491821$PFIZER$$$$$M$Y$$$20240710$$MD$NO$NO
1569075313$15690753$13$F$20180424$20240929$20181205$20240930$EXP$$US-PFIZER INC-2018500066$PFIZER$$59$YR$$F$Y$99.773$KG$20240930$$MD$US$US
1569154516$15691545$16$F$20181021$20240730$20181205$20240806$EXP$$BR-TAKEDA-2018TUS031569$TAKEDA$$29$YR$$M$Y$55$KG$20240806$$CN$BR$BR
1569188811$15691888$11$F$20170101$20240923$20181205$20240924$EXP$$US-PFIZER INC-2018499891$PFIZER$$79$YR$$F$Y$$$20240924$$MD$US$US
1569271018$15692710$18$F$20181113$20240726$20181206$20240802$EXP$$CA-ROCHE-2220791$ROCHE$$45$YR$A$F$Y$$$20240802$$CN$CA$CA
1569539419$15695394$19$F$$20240916$20181206$20240924$EXP$$CA-PFIZER INC-2015052110$PFIZER$$67$YR$$F$Y$73$KG$20240924$$MD$CA$CA
1569541617$15695416$17$F$20170131$20240809$20181206$20240814$EXP$$CA-TAKEDA-2017TUS002829$TAKEDA$$30$YR$$F$Y$$$20240814$$CN$CA$CA
156955053$15695505$3$F$20150101$20240711$20181206$20240716$EXP$$FR-PFIZER INC-2018496548$PFIZER$$55$YR$$M$Y$68$KG$20240716$$MD$FR$FR
156959909$15695990$9$F$20200101$20240821$20181206$20240825$EXP$$PHHY2018CA173575$NOVARTIS$$$$A$M$Y$$$20240825$$CN$CA$CA
156984098$15698409$8$F$20181001$20240725$20181207$20240729$EXP$$US-PFIZER INC-2018498676$PFIZER$$73$YR$$F$Y$116$KG$20240729$$CN$US$US
156987984$15698798$4$F$$20240821$20181207$20240905$EXP$$CA-ASTELLAS-2018US051668$ASTELLAS$Bienz M, Tomaszewski M, McDonald EG. Severe pet-transmitted zoonosis in a patient with a compromised immune system. CMAJ 2018;190(45):E1332-6.$76$YR$E$M$Y$$$20240905$$MD$CA$CA
157000323$15700032$3$F$$20240911$20181207$20240917$EXP$$IN-PFIZER INC-2018503438$PFIZER$Narayanan, G.. Cytomegalovirus Retinitis Occurring as a Complication of HyperCVAD Chemotherapy: Report of Two Cases. Indian Journal of Medical and Paediatric Oncology. 2018;39 (4):548-550$16$YR$$M$Y$$$20240917$$HP$IN$IN
157053002$15705300$2$F$$20240730$20181210$20240812$EXP$$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2018-10688$ALKEM$Sim FH, Brunet DG and Conacher GN. Quetiapine associated with acute mental status changes. Canadian journal of psychiatry. 2000;45(3):299$62$YR$$M$Y$$$20240812$$HP$TW$TW
1570891011$15708910$11$F$$20240906$20181211$20240913$EXP$$PHHY2018GR152785$NOVARTIS$Xanthopoulos A. Decongestion in heart failure with normal blood pressure. PANHELLENIC CONGRESS CARDIOLOGY. 2018$68$YR$$F$Y$$$20240913$$HP$GR$GR
157096862$15709686$2$F$$20240807$20181211$20240821$EXP$$US-ELI_LILLY_AND_COMPANY-US201812002784$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240821$$CN$US$US
157105729$15710572$9$F$20181001$20240715$20181211$20240717$EXP$$US-PFIZER INC-2018503839$PFIZER$$62$YR$$F$Y$$$20240717$$CN$US$US
157138252$15713825$2$F$20180801$20240915$20181212$20240920$EXP$$SE-BAUSCH-BL-2018-027905$BAUSCH AND LOMB$$63$YR$$M$Y$$$20240920$$CN$SE$SE
1571473024$15714730$24$F$20181003$20240716$20181212$20240724$EXP$$CA-CELLTRION INC.-2018CA024563$CELLTRION$$$$$$Y$$$20240724$$HP$CA$CA
1571928319$15719283$19$F$20160101$20240704$20181213$20240709$EXP$$CA-TAKEDA-2016TUS019868$TAKEDA$$$$$F$Y$$$20240709$$CN$CA$CA
157201429$15720142$9$F$$20240821$20181213$20240823$EXP$$ES-MYLANLABS-2018M1091697$MYLAN$Truchuelo M, Vano-Galvan S, Perez B.. Unilateral taxane-induced onychopathy in a patient with a brain metastasis.. Dermatol Online J. 2009;15(7)$48$YR$$F$Y$$$20240823$$HP$ES$ES
1572029017$15720290$17$F$20181204$20240821$20181213$20240827$EXP$$US-SHIRE-US201848004$TAKEDA$$71$YR$$F$Y$82$KG$20240827$$MD$US$US
1572145913$15721459$13$F$20181019$20240709$20181214$20240724$EXP$$DE-ROCHE-2150140$ROCHE$$55$YR$A$F$Y$$$20240724$$CN$DE$DE
157215427$15721542$7$F$20190501$20240909$20181214$20240913$PER$$US-TAKEDA-2018MPI016893$TAKEDA$$62$YR$$M$Y$$$20240913$$HP$US$US
1572204015$15722040$15$F$20180424$20240903$20181214$20240912$EXP$$DE-ROCHE-2230488$ROCHE$$46$YR$A$F$Y$$$20240912$$CN$DE$DE
157271486$15727148$6$F$20220201$20240809$20181217$20240903$EXP$$PHEH2018US051755$NOVARTIS$$69$YR$$F$Y$$$20240903$$CN$US$US
157277879$15727787$9$F$20180901$20240625$20181217$20240701$PER$$US-PFIZER INC-2018393718$PFIZER$$64$YR$$F$Y$65.76$KG$20240701$$CN$US$US
157281949$15728194$9$F$20180409$20240722$20181217$20240802$EXP$$DE-ROCHE-2107033$ROCHE$$57$YR$A$F$Y$$$20240802$$CN$DE$DE
157313072$15731307$2$F$20180201$20240711$20181217$20240717$EXP$$ES-MYLANLABS-2018M1093732$MYLAN$$51$YR$$F$Y$$$20240717$$MD$ES$ES
157313932$15731393$2$F$20181213$20240909$20181217$20240910$EXP$$US-SHIRE-US201848548$TAKEDA$$15$YR$$M$Y$$$20240910$$CN$US$US
157323572$15732357$2$F$20181107$20240530$20181217$20240717$PER$$US-NOVOPROD-632873$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
1573329236$15733292$36$F$20180320$20240903$20181218$20240912$EXP$$DE-ROCHE-2097781$ROCHE$$46$YR$A$F$Y$$$20240912$$CN$DE$DE
1573600210$15736002$10$F$$20240913$20181218$20240918$EXP$$PHHY2018PT187175$NOVARTIS$Pereira L, Meng C, Guedes L, Marques S, Nunes A, Sampaio S et al.. Infective endocarditis in renal transplant recipients: one center^s experience. PORTUGUESE JOURNAL OF NEPHROLOGY AND HYPERTENSION. 2018;32 (4):337-41$39$YR$$F$Y$$$20240918$$HP$PT$PT
157382982$15738298$2$F$20180514$20240821$20181219$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-060226$AUROBINDO$$46$YR$$M$Y$$$20240831$$MD$ES$ES
1574043230$15740432$30$F$20200601$20240823$20181219$20240828$EXP$$PHHY2018AR026774$NOVARTIS$$52$YR$$F$Y$85$KG$20240828$$CN$AR$AR
157434388$15743438$8$F$20130123$20240919$20181220$20240930$EXP$$CA-ROCHE-2233229$ROCHE$$58$YR$A$F$Y$$$20240930$$CN$CA$CA
1574357815$15743578$15$F$$20240925$20181220$20240926$EXP$$US-PFIZER INC-2018521260$PFIZER$$69$YR$$F$Y$$$20240926$$CN$US$US
157458545$15745854$5$F$$20240828$20181220$20240904$EXP$$US-PFIZER INC-2018521906$PFIZER$Chen, J.. Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease. Journal of Oncology Pharmacy Practice. 2018;0(0):1-4$26$YR$$M$Y$$$20240904$$HP$US$US
1574973724$15749737$24$F$20181121$20240829$20181221$20240904$EXP$$DE-ROCHE-2234716$ROCHE$$48$YR$A$F$Y$$$20240904$$CN$DE$DE
157499983$15749998$3$F$$20240806$20181221$20240819$EXP$$US-CIPLA LTD.-2018US23819$CIPLA$Martinez-Rubio M, DeSalvo DJ, Karaviti LP.. Treating the Father With Testosterone Inadvertently Leads to Treating the Children: Can This Be Prevented?. Endocrine Reviews. 2018;39 (2):1$$$$$Y$$$20240819$$HP$US$US
157544962$15754496$2$F$20180301$20240717$20181224$20240726$EXP$$FR-AUROBINDO-AUR-APL-2018-061744$AUROBINDO$$75$YR$$F$Y$61$KG$20240726$$MD$FR$FR
1575599650$15755996$50$F$20180101$20240829$20181224$20240907$EXP$$CA-CELLTRION INC.-2018CA021298$CELLTRION$$$$$$Y$$$20240907$$CN$CA$CA
1575780534$15757805$34$F$20180709$20240919$20181225$20240928$EXP$$CA-CELLTRION INC.-2018CA021158$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
157582653$15758265$3$F$$20240828$20181225$20240909$EXP$$US-Accord-096898$ACCORD$Chen J, Ngo D, Rosenthal J. Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease. Journal of Oncology Pharmacy Practice. 2018.$26$YR$A$M$Y$$$20240909$$HP$US$US
1575939622$15759396$22$F$20180411$20240909$20181226$20240918$EXP$$DE-ROCHE-2113766$ROCHE$$40$YR$A$F$Y$$$20240918$$CN$DE$DE
1576034310$15760343$10$F$$20240708$20181226$20240715$EXP$$CA-BAYER-2018-236755$BAYER$$39$YR$A$F$Y$119$KG$20240715$$HP$CA$CA
157606409$15760640$9$F$20180501$20240813$20181226$20240815$EXP$$US-PFIZER INC-2018525603$PFIZER$$70$YR$$F$Y$82$KG$20240815$$CN$US$US
157622472$15762247$2$F$$20210422$20181226$20240703$PER$$PHEH2018US053896$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
157642172$15764217$2$F$20160919$20240920$20181227$20240926$EXP$$DE-TEVA-2018-DE-991640$TEVA$$84$YR$$M$Y$$$20240926$$MD$DE$DE
157678344$15767834$4$F$20210901$20240916$20181227$20240923$EXP$$US-JAZZ-2018-US-018308$JAZZ$$54$YR$$F$Y$$$20240923$$CN$US$US
157689322$15768932$2$F$20180803$20240821$20181228$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-059928$AUROBINDO$$48$YR$$F$Y$67.8$KG$20240831$$MD$ES$ES
157694084$15769408$4$F$20180801$20240913$20181228$20240925$EXP$$SE-AUROBINDO-AUR-APL-2018-051254$AUROBINDO$$63$YR$$M$Y$$$20240925$$CN$SE$SE
157729085$15772908$5$F$$20240715$20181228$20240718$EXP$$US-SHIRE-US201849284$TAKEDA$$$$$M$Y$$$20240718$$CN$US$US
157735992$15773599$2$F$$20240814$20181228$20240827$EXP$$US-AUROBINDO-AUR-APL-2018-062691$AUROBINDO$Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W.. 2016 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):34th Annual Report. Clinical Toxicology. 2017;55(10):1072?1254$14$YR$$F$Y$$$20240827$$MD$US$US
157741982$15774198$2$F$$20240715$20181229$20240722$EXP$$US-AUROBINDO-AUR-APL-2018-061145$AUROBINDO$Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W.. 2016 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS):34th Annual Report. Clinical Toxicology. 2017;55(10):1072?1254$55$YR$$M$Y$$$20240722$$MD$US$US
157745328$15774532$8$F$20180831$20210603$20181229$20240725$EXP$$JP-GLAXOSMITHKLINE-JP2018JPN215253$GLAXOSMITHKLINE$Yoshimura M, Mishima K, Ayano M, Kimoto Y, Mitoma H, Akahoshi K, et al. Investigation of the clinical course of SLE patients using Belimumab in the real world. The 64th Annual General Assembly and Scientific Meeting of the Japan College Rhe. 2020;489$$$$$Y$$$20240725$$MD$JP$JP
157753602$15775360$2$F$20181201$20240626$20181231$20240711$EXP$$CA-ROCHE-2235186$ROCHE$$58$YR$A$F$Y$$$20240711$$HP$CA$CA
1577580942$15775809$42$F$20170701$20240913$20181231$20240921$EXP$$CA-CELLTRION INC.-2017CA011303$CELLTRION$$$$$$Y$$$20240921$$CN$CA$CA
157768365$15776836$5$F$$20240822$20181231$20240827$EXP$$US-PFIZER INC-2018526616$PFIZER$$$$$F$Y$$$20240827$$CN$US$US
157795182$15779518$2$F$$20240906$20190101$20240920$EXP$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2018-04100$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2018-04100$ALKEM$Downie ML, Mulder J, Schneider R, Lim L, et al.. A curious case of growth failure and hypercalcemia: Questions. Pediatric Nephrology. 2018;33(6):991-993$14$YR$$M$Y$35$KG$20240920$$MD$CA$CA
157798352$15779835$2$F$$20210824$20190102$20240703$PER$$PHEH2018US055198$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
157807953$15780795$3$F$20181101$20240823$20190102$20240902$EXP$$US-SHIRE-US201850059$TAKEDA$$64$YR$$F$Y$88$KG$20240902$$MD$US$US
157809392$15780939$2$F$$20240912$20190102$20240926$EXP$US-MLMSERVICE-20171129-0982373-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2018-00087$ALKEM$Joshi S, Khan D. Secondary immunodeficiency due to immunosuppressants for allergic contact dermatitis (ACD) from vascular clips. Annals of Allergy, Asthma and Immunology. 2017;119:5(1):S14-S15$43$YR$$M$Y$$$20240926$$HP$US$US
157810762$15781076$2$F$$20240717$20190102$20240723$PER$$US-BIOGEN-2018BI00676007$BIOGEN$$$$$M$Y$$$20240723$$PH$US$US
1578562311$15785623$11$F$20171128$20240920$20190103$20240930$EXP$$PHHY2019JP000464$NOVARTIS$Hayashi M, Igarashi A, Suzuki T. A Case of Interstitial Pneumonia Developed during Administration of Secukinumab. Nishinihon Journal of Dermatology/ The 70th Annual Meeting of the Western Divisi. 2019;81 (3):264-265$66$YR$$M$Y$83$KG$20241001$$HP$JP$JP
1578563311$15785633$11$F$20120101$20240701$20190103$20240708$EXP$$US-JAZZ-2018-US-018787$JAZZ$$$$$F$Y$$$20240708$$MD$US$US
157861102$15786110$2$F$20180301$20240711$20190103$20240716$EXP$$FR-PFIZER INC-2018531710$PFIZER$$75$YR$$F$Y$61$KG$20240716$$MD$FR$FR
1578702419$15787024$19$F$20230705$20240709$20190103$20240716$EXP$$US-TAKEDA-2018TUS036993$TAKEDA$$69$YR$$F$Y$73$KG$20240716$$CN$US$US
1578997813$15789978$13$F$20181219$20240829$20190104$20240904$EXP$$US-PFIZER INC-2019005220$PFIZER$$83$YR$$F$Y$44$KG$20240904$$CN$US$US
157913104$15791310$4$F$$20240819$20190104$20240911$PER$$US-INCYTE CORPORATION-2018IN012149$INCYTE$$$$$$Y$$$20240911$$CN$US$US
1579259712$15792597$12$F$20220426$20240809$20190107$20240814$EXP$$US-SHIRE-US201900192$TAKEDA$$26$YR$$F$Y$$$20240814$$CN$US$US
157947646$15794764$6$F$20180514$20240917$20190107$20240919$EXP$$DE-ABBVIE-19K-062-2611399-00$ABBVIE$$69$YR$$F$Y$79$KG$20240919$$MD$DE$DE
157961263$15796126$3$F$$20240821$20190108$20240831$EXP$$US-AUROBINDO-AUR-APL-2019-000289$AUROBINDO$Bishop-Freeman SC, Hensel EM, Feaster MS, Wtnecker RE.. Degradation of Bupropion: Implications for Interpretation of Postmortem Case Data.. Journal of Analytical Toxicology. 2018;42(8):526-536$59$YR$$F$Y$$$20240831$$HP$US$US
1579666712$15796667$12$F$20180523$20240919$20190108$20240924$EXP$$DE-ROCHE-2137306$ROCHE$$49$YR$A$F$Y$$$20240924$$CN$DE$DE
1579892615$15798926$15$F$20181026$20240923$20190108$20240927$EXP$$BE-PFIZER INC-2018487316$PFIZER$$76$YR$$M$Y$77$KG$20240927$$MD$BE$BE
1580113212$15801132$12$F$20230124$20240830$20190109$20240904$EXP$$US-TAKEDA-2019MPI000225$TAKEDA$$81$YR$$F$Y$$$20240904$$HP$US$US
158013658$15801365$8$F$$20240624$20190109$20240704$EXP$CZ-EMA-DD-20180806-SHREYAEVHP-125259$CZ-SAMSUNG BIOEPIS-SB-2019-00020$SAMSUNG BIOEPIS$Bortlik M. Efficacy of ustekinumab in a patient refractory to other biological treatment. Gastroenterology of Hepatology. 2018 FEB 26;72(1):47-49.$33$YR$A$F$Y$$$20240704$$MD$CZ$CZ
158022758$15802275$8$F$$20240813$20190109$20240820$EXP$$CA-TAKEDA-2019TUS000552$TAKEDA$$$$$M$Y$$$20240820$$HP$CA$CA
158029287$15802928$7$F$20181101$20240807$20190109$20240813$PER$$US-PFIZER INC-2019006811$PFIZER$$81$YR$$F$Y$63.5$KG$20240813$$CN$US$US
158062549$15806254$9$F$20150101$20240808$20190110$20240814$PER$$US-PFIZER INC-2017401753$PFIZER$$25$YR$$F$Y$$$20240814$$HP$US$US
1580780610$15807806$10$F$$20240917$20190110$20240919$EXP$$US-PFIZER INC-2019012051$PFIZER$$53$YR$$F$Y$$$20240919$$CN$US$US
1581123735$15811237$35$F$20171204$20240728$20190111$20240805$EXP$$CA-CELLTRION INC.-2017CA017549$CELLTRION$$$$$$Y$$$20240805$$CN$CA$CA
158225162$15822516$2$F$20161201$20240711$20190114$20240715$EXP$$FR-PFIZER INC-2019013469$PFIZER$$51$YR$$F$Y$94$KG$20240715$$MD$FR$FR
1582336811$15823368$11$F$$20240722$20190114$20240726$PER$$US-PFIZER INC-2019015923$PFIZER$$75$YR$$M$Y$$$20240726$$CN$US$US
158234322$15823432$2$F$20030518$20240708$20190114$20240711$EXP$$DE-FERRINGPH-2003FE00441$FERRING$$$$$$Y$$$20240711$$MD$DE$DE
158235392$15823539$2$F$$20240828$20190114$20240904$EXP$$US-SA-2018SA397928$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240904$$HP$US$US
1582645056$15826450$56$F$20181101$20240812$20190115$20240820$EXP$$CA-CELLTRION INC.-2018CA024921$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
158265559$15826555$9$F$20181201$20211122$20190115$20240710$EXP$$CO-ASTELLAS-2018US043507$ASTELLAS$$88$YR$$M$Y$55$KG$20240710$$CN$CO$CO
158268262$15826826$2$F$20161201$20240719$20190115$20240725$EXP$$FR-INCYTE CORPORATION-2019IN000109$INCYTE$$$$$$Y$$$20240725$$MD$FR$FR
158283822$15828382$2$F$$20240927$20190115$20240930$EXP$$US-PFIZER INC-2019018458$PFIZER$$$$$F$Y$$$20240930$$MD$US$US
158331623$15833162$3$F$20220101$20220209$20190116$20240824$EXP$$US-SHIRE-US201901332$TAKEDA$$87$YR$$M$Y$$$20240824$$MD$US$US
1583318611$15833186$11$F$$20240906$20190116$20240909$EXP$$US-SHIRE-US201901514$TAKEDA$$$$$M$Y$$$20240909$$CN$US$US
1583660426$15836604$26$F$20190101$20240717$20190117$20240723$EXP$$CA-ROCHE-2246516$ROCHE$$56$YR$A$F$Y$$$20240723$$CN$CA$CA
158374894$15837489$4$F$20180801$20240711$20190117$20240712$EXP$$FR-PFIZER INC-2019016866$PFIZER$$57$YR$$F$Y$64$KG$20240712$$MD$FR$FR
1584065319$15840653$19$F$20190109$20240628$20190118$20240709$EXP$$CA-ROCHE-2247343$ROCHE$$30$YR$A$F$Y$$$20240709$$MD$CA$CA
1584151315$15841513$15$F$20211201$20240823$20190118$20240903$EXP$$DE-ROCHE-2131563$ROCHE$$40$YR$A$F$Y$80$KG$20240903$$CN$DE$DE
158442254$15844225$4$F$$20240729$20190118$20240801$EXP$$US-JAZZ-2019-US-000600$JAZZ$$$$$M$Y$$$20240801$$CN$US$US
158456402$15845640$2$F$20140101$20240913$20190119$20240922$EXP$$US-JNJFOC-20190109992$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20240922$$LW$US$US
1584726320$15847263$20$F$20180613$20240708$20190121$20240722$EXP$$DE-ROCHE-2141062$ROCHE$$50$YR$A$F$Y$49$KG$20240722$$CN$DE$DE
1584730712$15847307$12$F$20180618$20240617$20190121$20240704$EXP$$DE-ROCHE-2145717$ROCHE$$29$YR$A$F$Y$$$20240704$$CN$DE$DE
1584758415$15847584$15$F$20180613$20240823$20190121$20240902$EXP$$DE-ROCHE-2147123$ROCHE$$38$YR$A$F$Y$$$20240902$$MD$DE$DE
158482544$15848254$4$F$20230101$20240710$20190121$20240712$PER$$US-PFIZER INC-2017323736$PFIZER$$19$YR$$F$Y$$$20240712$$CN$US$US
158495973$15849597$3$F$20180101$20240902$20190121$20240919$EXP$$IT-ABBVIE-18P-083-2480350-00$ABBVIE$$67$YR$$F$Y$$$20240918$$MD$IT$IT
158511673$15851167$3$F$20180101$20240913$20190122$20240925$EXP$$IT-AUROBINDO-AUR-APL-2019-001567$AUROBINDO$$59$YR$$M$Y$119$KG$20240925$$MD$IT$IT
1585363711$15853637$11$F$20170420$20240819$20190122$20240822$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2018JPN167244$VIIV$$$$$$Y$$$20240822$$MD$JP$JP
158554938$15855493$8$F$20181213$20240914$20190122$20240924$EXP$$PHHY2019CA011031$NOVARTIS$$26$YR$$F$Y$69.7$KG$20240924$$MD$CA$CA
1585637917$15856379$17$F$20180101$20240731$20190123$20240808$EXP$$CA-CELLTRION INC.-2017CA017652$CELLTRION$$$$$$Y$$$20240808$$MD$CA$CA
1585658844$15856588$44$F$20190101$20240819$20190123$20240826$EXP$$CA-ROCHE-1765282$ROCHE$$43$YR$A$F$Y$$$20240826$$MD$CA$CA
158595933$15859593$3$F$$20240803$20190123$20240815$EXP$$DE-MYLANLABS-MK-6033440$MYLAN$Lange-Asschenfeldt C,Blaeser I,Supprian T.. Bipolar switching after carbamazepine withdrawal.. Pharmacopsychiatry. 2007;40 (2):86-87, 82-8$74$YR$$M$Y$$$20240815$$MD$DE$DE
1586228110$15862281$10$F$20180814$20240919$20190124$20240925$EXP$$FR-MYLANLABS-2019M1006901$MYLAN$$89$YR$$F$Y$69$KG$20240925$$PH$FR$FR
158645445$15864544$5$F$20180724$20240715$20190124$20240729$EXP$$FR-ELI_LILLY_AND_COMPANY-FR201901007340$ELI LILLY AND CO$$57$YR$A$F$Y$64$KG$20240729$$MD$FR$FR
1586559422$15865594$22$F$20190115$20240916$20190125$20240924$EXP$$CA-ROCHE-2249027$ROCHE$$43$YR$A$F$Y$$$20240924$$CN$CA$CA
158679647$15867964$7$F$$20240909$20190125$20240912$EXP$GR-EMA-20190312-AUTODUP-30663000$GR-MYLANLABS-2019M1007395$MYLAN$Zacharopoulou E, Internos I, Pantoula P, Veimou C, Moschovis D, ?echagias G. et al.. A Patient with Severe Ulcerative Colitis, Acute Complicated C. Difficile Infection, Bacteremia and Possible CMV Recurrence. Clinical Manifestations. 17 Panhellenic Congress of Idiopathic Inflammator Disea. 2018;62$22$YR$$M$Y$$$20240912$$MD$GR$GR
1586810417$15868104$17$F$20170101$20240625$20190125$20240701$EXP$$US-PFIZER INC-2019031756$PFIZER$$69$YR$$F$Y$88.45$KG$20240701$$CN$US$US
1586866410$15868664$10$F$20141217$20240701$20190125$20240705$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN176164$VIIV$$$$$$Y$$$20240705$$MD$JP$JP
1586892510$15868925$10$F$20141217$20240701$20190125$20240705$EXP$$JP-GLAXOSMITHKLINE-JP2017JPN176164$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$JP$JP
1588143612$15881436$12$F$$20240715$20190128$20240721$EXP$$PHHY2018CA019720$NOVARTIS$$40$YR$$M$Y$130$KG$20240722$$MD$CA$CA
158817415$15881741$5$F$20190512$20240829$20190128$20240902$EXP$$US-SHIRE-US201902798$TAKEDA$$63$YR$$F$Y$42.63$KG$20240902$$HP$US$US
1588236410$15882364$10$F$20211129$20240829$20190129$20240905$EXP$$US-SHIRE-US201902551$TAKEDA$$41$YR$$F$Y$$$20240905$$MD$US$US
158830049$15883004$9$F$20181001$20240828$20190129$20240905$EXP$$DE-ROCHE-2253335$ROCHE$$38$YR$A$M$Y$60$KG$20240905$$MD$DE$DE
158855305$15885530$5$F$20181001$20240617$20190129$20240712$EXP$$JP-009507513-1901JPN002361J$MERCK$Marusawa M, Takehara K, Kobe M, Fueki E, Saito Y, Watanabe G, et al.. 11 A case of eosinophilic fasciitis during pembrolizumab use. The 11th Kanto Regional Meeting of the Japanese Society of Allergology. 23$64$YR$$M$Y$62$KG$20240712$$MD$JP$JP
158865275$15886527$5$F$$20240911$20190129$20240911$EXP$$US-PFIZER INC-2019042270$PFIZER$$37$YR$$M$Y$$$20240911$$MD$US$US
158877092$15887709$2$F$20180608$20240812$20190130$20240817$EXP$FR-AFSSAPS-PV20181051$FR-ROCHE-2251356$ROCHE$$37$YR$A$F$Y$62$KG$20240817$$MD$FR$FR
158881117$15888111$7$F$$20240827$20190130$20240830$PER$$US-PFIZER INC-2019043960$PFIZER$$72$YR$$M$Y$$$20240830$$CN$US$US
158911239$15891123$9$F$$20240815$20190130$20240821$EXP$AT-EMA-DD-20180723-DEEPAKEVHPDD-103850$AT-MYLANLABS-2019M1008334$MYLAN$Taylor N, Touzeau V, Geit M, Gisinger M, Egle A, Greil R, et al... Raltegravir in Pregnancy: A Case Series Presentation... International Journal of STD + AIDS.. 2011;22(6):358-60$1$DY$$$Y$$$20240821$$MD$AT$AT
1589188413$15891884$13$F$20160906$20240911$20190130$20240919$EXP$$CA-TAKEDA-2016TUS018845$TAKEDA$$59$YR$$M$Y$$$20240919$$MD$CA$CA
1589465915$15894659$15$F$20190401$20240722$20190131$20240725$EXP$$US-PFIZER INC-2019044115$PFIZER$$73$YR$$M$Y$88$KG$20240725$$CN$US$US
158964333$15896433$3$F$20240813$20240814$20190131$20240815$EXP$$US-PFIZER INC-2019045820$PFIZER$$58$YR$$F$Y$$$20240815$$CN$US$US
158977635$15897763$5$F$$20240918$20190201$20240926$EXP$$PL-MYLANLABS-2019M1006235$MYLAN$Siwek M. Woron J.. A 65-year-old female patient suffering from recurrent depression with complex complications associated with irrational Polypharmacy. Psychofarmacology in practice.. Medycyna praktyczna - psychiatria.. 2018;3:61-63$65$YR$$F$Y$$$20240926$$MD$PL$PL
158990466$15899046$6$F$20181001$20210915$20190201$20240708$EXP$$JP-GLAXOSMITHKLINE-JP2018JPN196071$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$JP$JP
159009496$15900949$6$F$20050924$20240215$20190201$20240731$EXP$$US-GILEAD-2019-0387821$GILEAD$$59$YR$A$M$Y$84.807$KG$20240730$$LW$US$US
1590294012$15902940$12$F$20170301$20240814$20190202$20240816$EXP$$CA-TAKEDA-2017TUS007103$TAKEDA$$51$YR$$M$Y$$$20240816$$HP$CA$CA
159031929$15903192$9$F$20190604$20240704$20190202$20240712$EXP$$CA-TAKEDA-2019TUS003952$TAKEDA$$42$YR$$M$Y$$$20240712$$CN$CA$CA
159067724$15906772$4$F$20160101$20240916$20190204$20240917$EXP$$US-AstraZeneca-2018SF14255$ASTRAZENECA$$61$YR$$M$Y$104.4$KG$20240917$$LW$US$
159069227$15906922$7$F$20160809$20240729$20190204$20240731$EXP$$US-PFIZER INC-2016408295$PFIZER$$52$YR$$F$Y$104.31$KG$20240731$$CN$US$US
1590726015$15907260$15$F$20180101$20240729$20190204$20240731$EXP$$US-PFIZER INC-2019046708$PFIZER$$72$YR$$F$Y$65.2$KG$20240731$$MD$US$US
159139505$15913950$5$F$$20240705$20190204$20240710$PER$$US-PFIZER INC-2019051335$PFIZER$$62$YR$$F$Y$$$20240710$$CN$US$US
159171109$15917110$9$F$20170914$20240912$20190205$20240924$EXP$FR-AFSSAPS-PC20180352$FR-Accord-105712$ACCORD$$1$DY$N$M$Y$1.89$KG$20240924$$PH$FR$FR
159178135$15917813$5$F$$20240927$20190205$20240927$PER$$US-PFIZER INC-2019052081$PFIZER$$22$YR$$M$Y$$$20240927$$MD$US$US
1592377013$15923770$13$F$$20240917$20190206$20240921$EXP$$CA-ABBVIE-19K-028-2653534-00$ABBVIE$$50$YR$$F$Y$$$20240921$$HP$CA$CA
1592410011$15924100$11$F$20181116$20240720$20190206$20240731$EXP$$DE-AUROBINDO-AUR-APL-2019-005617$AUROBINDO$$$$E$F$Y$$$20240731$$MD$DE$DE
159277333$15927733$3$F$20180102$20240227$20190206$20240703$EXP$$CA-BAYER-2019-006922$BAYER$$27$YR$A$F$Y$90.703$KG$20240703$$MD$CA$CA
159293862$15929386$2$F$$20240722$20190206$20240730$PER$$US-SA-2019SA029810$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240730$$MD$US$US
159304077$15930407$7$F$$20240708$20190207$20240711$EXP$$CA-ABBVIE-19K-028-2655633-00$ABBVIE$$65$YR$$F$Y$$$20240711$$HP$CA$CA
159317696$15931769$6$F$20121201$20240813$20190207$20240820$EXP$$BR-BIOGEN-2018BI00609147$BIOGEN$$28$YR$$F$Y$70$KG$20240820$$CN$BR$BR
1593204460$15932044$60$F$$20240708$20190207$20240712$EXP$$CA-ABBVIE-19K-028-2651975-00$ABBVIE$$44$YR$$F$Y$97$KG$20240712$$HP$CA$CA
159322413$15932241$3$F$$20240705$20190207$20240708$PER$$US-PFIZER INC-2019056264$PFIZER$$70$YR$$F$Y$$$20240708$$CN$US$US
1593294828$15932948$28$F$$20240813$20190207$20240815$EXP$$CA-ABBVIE-19K-028-2655966-00$ABBVIE$$3$YR$$F$Y$64$KG$20240815$$CN$CA$CA
159330094$15933009$4$F$$20240822$20190207$20240826$EXP$$US-KYOWAKIRIN-2018BKK008777$KYOWA$$$$$$Y$$$20240826$$HP$US$US
159331074$15933107$4$F$$20240901$20190207$20240924$EXP$$US-KYOWAKIRIN-2019BKK000682$KYOWA$$$$$$Y$$$20240924$$HP$US$US
1593361710$15933617$10$F$20181027$20240808$20190207$20240813$EXP$$CA-TAKEDA-2018TUS031372$TAKEDA$$15$YR$$M$Y$$$20240813$$HP$CA$CA
159343973$15934397$3$F$20160201$20240903$20190207$20240909$EXP$$CA-TAKEDA-2016TUS003868$TAKEDA$$37$YR$$M$Y$$$20240909$$CN$CA$CA
159354174$15935417$4$F$$20240916$20190207$20240918$EXP$$US-AstraZeneca-2019SE11890$ASTRAZENECA$$$$$M$Y$$$20240918$$LW$US$
1593620912$15936209$12$F$20171106$20240722$20190208$20240801$EXP$$JP-AEGERION PHARMACEUTICAL, INC-AEGR003956$AEGERION$$$$$$Y$$$20240801$$MD$JP$JP
159388844$15938884$4$F$20180101$20240904$20190208$20240912$EXP$$US-SA-2019SA037039$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240912$$MD$US$US
1594375813$15943758$13$F$$20240919$20190210$20240925$PER$$US-AMGEN-USASP2019021260$AMGEN$$74$YR$E$F$Y$$$20240925$$HP$US$US
159449519$15944951$9$F$20180414$20240607$20190211$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2018-011162$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240701$$CN$US$US
159455652$15945565$2$F$$20240911$20190211$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011606$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
159474405$15947440$5$F$20190206$20240717$20190211$20240722$EXP$$CO-BIOMARINAP-CO-2019-121911$BIOMARIN$$$$$$Y$$$20240722$$CN$CO$CO
159474678$15947467$8$F$20191126$20240827$20190211$20240830$EXP$$US-PFIZER INC-2019062481$PFIZER$$68$YR$$M$Y$$$20240830$$CN$US$US
1594902210$15949022$10$F$20181213$20210922$20190212$20240708$EXP$$JP-GLAXOSMITHKLINE-JP2019JPN022198$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$JP$JP
159516558$15951655$8$F$20180101$20240816$20190211$20240821$EXP$$US-PFIZER INC-2019051083$PFIZER$$77$YR$$F$Y$$$20240821$$CN$US$US
159529594$15952959$4$F$20080101$20240918$20190212$20240923$EXP$$US-JAZZ-2018-US-008889$JAZZ$$52$YR$$M$Y$$$20240922$$CN$US$US
159537836$15953783$6$F$$20240819$20190212$20240830$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-073803$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240830$$MD$CA$CA
159542253$15954225$3$F$20181120$20240905$20190213$20240918$EXP$$FR-AUROBINDO-AUR-APL-2019-007257$AUROBINDO$$1$MON$$F$Y$1$KG$20240918$$MD$FR$FR
1595476416$15954764$16$F$20200101$20240918$20190213$20240926$EXP$$CA-ROCHE-2260675$ROCHE$$61$YR$A$M$Y$$$20240926$$MD$CA$CA
159572858$15957285$8$F$20181017$20240805$20190213$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-013302$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$63.3$KG$20240814$$MD$JP$JP
159589085$15958908$5$F$20180803$20240703$20190214$20240715$EXP$$CA-ROCHE-2262537$ROCHE$$58$YR$A$F$Y$$$20240715$$CN$CA$CA
159594146$15959414$6$F$20181129$20240709$20190214$20240715$EXP$$JP-GLAXOSMITHKLINE-JP2019JPN023325$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$MD$JP$JP
159610807$15961080$7$F$$20240630$20190214$20240701$PER$$US-PFIZER INC-2016552441$PFIZER$$35$YR$$M$Y$$$20240701$$MD$US$US
159615342$15961534$2$F$$20240725$20190214$20240807$EXP$$CA-MYLANLABS-2019M1012770$AUROBINDO$Pikard JL, Oliver D, Saraceno J, Groll D.. Lithium: contributor to movement disorder sensitivity after anoxic brain injury.. SAGE-Open-Med-Case-Rep. 2019;7$35$YR$$M$Y$$$20240807$$HP$CA$CA
159623025$15962302$5$F$$20240830$20190214$20240903$EXP$$US-PFIZER INC-2019065185$PFIZER$Patil, S.. Ibuprofen abuse-a case of rhabdomyolysis, hypokalemia, and hypophosphatemia with drug-induced mixed renal tubular acidosis.. Kidney international reports. 2018;3 (5):1237-1238$48$YR$$F$Y$$$20240903$$HP$US$US
159638204$15963820$4$F$$20240918$20190214$20240924$EXP$$DE-MYLANLABS-2019M1012741$MYLAN$Groll, A.. Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.. Journal of Antimicrobial Chemotherapy. 2004;53 (1):113-114$14$YR$$F$Y$48$KG$20240924$$HP$DE$DE
1596565215$15965652$15$F$20161101$20240913$20190215$20240920$EXP$$CA-TAKEDA-2016TUS023477$TAKEDA$$42$YR$$F$Y$$$20240920$$CN$CA$CA
159682342$15968234$2$F$$20240828$20190215$20240907$30DAY$$US-GLAXOSMITHKLINE-US2019019206$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$CN$US$US
159688252$15968825$2$F$20190130$20240924$20190215$20240930$EXP$$US-SHIRE-US201905079$TAKEDA$$62$YR$$F$Y$55$KG$20240930$$MD$US$US
159761199$15976119$9$F$$20240827$20190218$20240829$EXP$$US-PFIZER INC-2019062150$PFIZER$$75$YR$$F$Y$49.887$KG$20240829$$CN$US$US
159762863$15976286$3$F$20120401$20240813$20190218$20240814$PER$$US-PFIZER INC-2018523336$PFIZER$$75$YR$$F$Y$$$20240814$$LW$US$US
159776335$15977633$5$F$20170201$20240718$20190218$20240718$EXP$$PHHY2019DE036098$NOVARTIS$$64$YR$$M$Y$$$20240718$$HP$DE$DE
1597820813$15978208$13$F$20170115$20240701$20190218$20240709$EXP$$JP-ABBVIE-17K-087-2181146-00$ABBVIE$Maeda A, Tsujii Y, Yoshioka T, et al. A case of intractable duodenal ulcer possibly developed by PEG-J tube specifically for DUODOPA moved towards the side of anus. The 100th Annual Meeting of Japan Gastroenterological Endoscopy Society Kinki Chapter. 2018: 114-114.$40$YR$$F$Y$48$KG$20240709$$MD$JP$JP
159809543$15980954$3$F$$20240904$20190219$20240913$EXP$$CA-ASTELLAS-2019US006393$ASTELLAS$unk$23$YR$A$F$Y$$$20240913$$HP$CA$CA
159828842$15982884$2$F$$20240708$20190219$20240711$EXP$$US-SHIRE-US201905345$TAKEDA$$$$$F$Y$$$20240711$$HP$US$US
159841726$15984172$6$F$19990101$20240916$20190219$20240919$EXP$$US-009507513-0504USA04403$MERCK$$$$$F$Y$63.492$KG$20240919$$HP$US$US
159861513$15986151$3$F$$20240910$20190220$20240913$PER$$US-BIOGEN-2019BI00696574$BIOGEN$$$$$F$Y$$$20240913$$CN$US$US
1598776817$15987768$17$F$20150101$20240715$20190220$20240716$EXP$$US-PFIZER INC-2019063056$PFIZER$$72$YR$$F$Y$95$KG$20240716$$CN$US$US
159880043$15988004$3$F$20180825$20240910$20190220$20240911$EXP$$US-ABBVIE-19P-163-2672181-00$ABBVIE$$67$YR$$F$Y$$$20240911$$MD$US$US
1598900113$15989001$13$F$20190207$20240821$20190221$20240827$EXP$$US-TAKEDA-2019TUS007466$TAKEDA$$53$YR$$F$Y$$$20240827$$HP$US$US
159918673$15991867$3$F$$20240627$20190221$20240701$EXP$$DE-MYLANLABS-2019M1015330$MYLAN$Kaysen A, Heintz-Buschart A, Muller EEL, Narayanasamy S, Wampach L, Laczny CC et al. Integrated meta-omic analyses of the gastrointestinal tract microbiome in patients undergoing allogeneic hematopoietic stem cell transplantation. Translational Research. 2017;186:79-94$63$YR$$F$Y$$$20240701$$HP$DE$DE
159934239$15993423$9$F$20170802$20240729$20190222$20240806$EXP$$CA-ROCHE-2266627$ROCHE$$64$YR$A$F$Y$64$KG$20240806$$MD$CA$CA
1599554335$15995543$35$F$20180208$20240717$20190222$20240725$EXP$$PHHY2017CA111935$NOVARTIS$$50$YR$$F$Y$130$KG$20240725$$CN$CA$CA
159971328$15997132$8$F$20190201$20240917$20190222$20240919$EXP$$CA-TAKEDA-2019TUS007849$TAKEDA$$51$YR$$F$Y$$$20240919$$MD$CA$CA
1599792310$15997923$10$F$$20240813$20190222$20240819$EXP$$US-SHIRE-US201905833$TAKEDA$$$$$F$Y$93$KG$20240819$$CN$US$US
1599974917$15999749$17$F$$20240701$20190225$20240703$EXP$$US-PFIZER INC-2019082864$PFIZER$$77$YR$$F$Y$$$20240703$$CN$US$US
159997782$15999778$2$F$$20240806$20190225$20240807$PER$$US-PFIZER INC-2019083157$PFIZER$$70$YR$$F$Y$$$20240807$$HP$US$US
1600075420$16000754$20$F$20200110$20240823$20190225$20240923$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK124085$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$BR$BR
160042394$16004239$4$F$20210324$20240909$20190226$20240911$EXP$$US-SHIRE-US201906137$TAKEDA$$4$YR$$M$Y$$$20240911$$CN$US$US
160044347$16004434$7$F$20210201$20221101$20190226$20240925$EXP$$US-ROCHE-2269859$ROCHE$$37$YR$A$F$Y$96.16$KG$20240925$$CN$US$US
1600451528$16004515$28$F$20181201$20240723$20190226$20240730$EXP$$CA-ROCHE-2266633$ROCHE$$27$YR$A$F$Y$$$20240730$$CN$CA$CA
160057059$16005705$9$F$20190216$20240924$20190226$20240930$EXP$$BR-GLAXOSMITHKLINE-BR2019GSK033217$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$BR$BR
160057702$16005770$2$F$20190205$20240805$20190226$20240808$EXP$IT-MINISAL02-529388$IT-EMD Serono-E2B_90066472$EMD SERONO INC$$81$YR$E$F$Y$81$KG$20240808$$MD$IT$IT
160067743$16006774$3$F$20160101$20240724$20190226$20240730$EXP$$FR-MYLANLABS-2019M1016271$MYLAN$$22$YR$$M$Y$85$KG$20240730$$MD$FR$FR
160078473$16007847$3$F$20150501$20240812$20190226$20240820$EXP$$PHHY2019IT042315$NOVARTIS$Mendogni P, Henchi S, Morlacchi LC, Tosi D, Nosotti M, Tarsia P et al. Epstein-Barr viruse related post-transplant lymphoproliferative disorders in cystic fibrosis lung transplant recipients: A case series. TRANSPLANTATION PROCEEDINGS. 2019;51:194-7$17$YR$$M$Y$$$20240820$$HP$IT$IT
160083134$16008313$4$F$20170101$20240812$20190226$20240816$EXP$$PHHY2019IT042328$NOVARTIS$Mendogni P, Henchi S, Morlacchi LC, Tosi D, Nosotti M, Tarsia P et al.. Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders in Cystic Fibrosis Lung Transplant Recipients: A Case Series. TRANSPLANTATION PROCEEDINGS. 2019;51:194-7$26$YR$$F$Y$$$20240816$$HP$IT$IT
1600885418$16008854$18$F$$20230726$20190225$20240729$EXP$$CA-TEVA-2019-CA-1016510$TEVA$$43$YR$$F$Y$68$KG$20240729$$HP$CA$CA
160102555$16010255$5$F$20180101$20240301$20190225$20240702$EXP$$CA-ROCHE-2270952$ROCHE$$$$A$F$Y$70$KG$20240702$$MD$CA$CA
1601053014$16010530$14$F$$20240828$20190225$20240830$EXP$$US-PFIZER INC-2019068855$PFIZER$$75$YR$$F$Y$58.06$KG$20240830$$HP$US$US
160110603$16011060$3$F$$20240819$20190227$20240828$EXP$$CA-APOTEX-2019AP008297$APOTEX$$66$YR$$F$Y$$$20240828$$HP$CA$CA
160111675$16011167$5$F$20190215$20240815$20190227$20240822$EXP$$CA-PFIZER INC-2019084268$PFIZER$$26$YR$$F$Y$$$20240822$$CN$CA$CA
160137305$16013730$5$F$20190101$20240619$20190227$20240703$PER$$US-SA-2019SA055725$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240703$$MD$US$US
160152363$16015236$3$F$20180801$20240708$20190228$20240715$EXP$$GB-ABBVIE-19P-167-2680267-00$ABBVIE$$52$YR$$M$Y$$$20240711$$MD$GB$GB
1601530210$16015302$10$F$20180401$20240902$20190228$20240910$EXP$$DE-ROCHE-2130664$ROCHE$$54$YR$A$F$Y$$$20240910$$CN$DE$DE
160161078$16016107$8$F$20200901$20240807$20190228$20240812$PER$$US-BIOGEN-2019BI00702155$BIOGEN$$30$YR$$F$Y$$$20240812$$CN$US$US
1601685511$16016855$11$F$20180701$20240718$20190228$20240722$PER$$US-PFIZER INC-2019087019$PFIZER$$81$YR$$F$Y$47.619$KG$20240722$$CN$US$US
160181032$16018103$2$F$20180901$20240815$20190228$20240823$EXP$$US-MALLINCKRODT-T201901978$SPECGX$$61$YR$$M$Y$102$KG$20240823$$CN$US$US
160195154$16019515$4$F$$20190522$20190228$20240705$PER$$PHEH2019US008516$NOVARTIS$$$$$M$Y$$$20240705$$MD$US$US
160206273$16020627$3$F$$20240730$20190301$20240809$EXP$$CA-AUROBINDO-AUR-APL-2019-010520$AUROBINDO$$79$YR$$M$Y$82$KG$20240809$$HP$CA$CA
160206313$16020631$3$F$$20240822$20190301$20240903$EXP$$CA-AUROBINDO-AUR-APL-2018-049510$AUROBINDO$Hohl CM, Badke K, Zhao A, Wickham ME, Woo SA, Sivilotti MLA et al. Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug Events. Academic Emergency Medicine. 2018;25(9):1015-1026$92$YR$$F$Y$$$20240903$$MD$CA$CA
1602089027$16020890$27$F$$20240801$20190301$20240814$EXP$$CA-AUROBINDO-AUR-APL-2019-010743$AUROBINDO$Harris M, Larsen G, Montaner JSG.. Exacerbation of depression associated with starting raltegravir: a report of four cases. AIDS. 2008;22(14):1890-2$54$YR$$M$Y$$$20240814$$HP$CA$CA
160210862$16021086$2$F$$20240801$20190301$20240814$EXP$$CA-AUROBINDO-AUR-APL-2019-010442$AUROBINDO$$49$YR$$F$Y$80$KG$20240814$$HP$CA$CA
1602117926$16021179$26$F$$20240801$20190301$20240814$EXP$$CA-AUROBINDO-AUR-APL-2019-010077$AUROBINDO$$58$YR$$F$Y$$$20240814$$MD$CA$CA
160212352$16021235$2$F$20150426$20240905$20190301$20240918$EXP$$FR-AUROBINDO-AUR-APL-2019-009737$AUROBINDO$$67$YR$$F$Y$$$20240918$$MD$FR$FR
1602164624$16021646$24$F$$20240815$20190301$20240828$EXP$$CA-AUROBINDO-AUR-APL-2019-009941$AUROBINDO$$23$YR$$F$Y$$$20240828$$HP$CA$CA
160217718$16021771$8$F$$20240720$20190301$20240731$EXP$$CA-AUROBINDO-AUR-APL-2019-009985$AUROBINDO$$25$YR$$F$Y$$$20240731$$HP$CA$CA
160220529$16022052$9$F$$20240725$20190301$20240806$EXP$$CA-AUROBINDO-AUR-APL-2019-009889$AUROBINDO$$35$YR$$F$Y$$$20240806$$MD$CA$CA
1602251211$16022512$11$F$$20240829$20190301$20240909$EXP$$CA-AUROBINDO-AUR-APL-2019-010641$AUROBINDO$Pfeffer G, Mezei MM, Montaner JS, Li CC, Jitratkosol M, Cote HC. Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving HIV therapy. NEUROLOGY. 2009;73 (1):71-2$52$YR$$M$Y$$$20240909$$HP$CA$CA
1602253021$16022530$21$F$$20240904$20190301$20240915$EXP$$CA-AUROBINDO-AUR-APL-2019-009916$AUROBINDO$$40$YR$$M$Y$$$20240915$$HP$CA$CA
160225509$16022550$9$F$$20240801$20190301$20240814$EXP$$CA-AUROBINDO-AUR-APL-2019-010032$AUROBINDO$$60$YR$$F$Y$64$KG$20240814$$HP$CA$CA
1602261310$16022613$10$F$20181201$20240806$20190301$20240808$EXP$$CA-ROCHE-2264735$ROCHE$$60$YR$A$M$Y$$$20240808$$CN$CA$CA
1602263310$16022633$10$F$$20240819$20190301$20240829$EXP$$CA-AUROBINDO-AUR-APL-2019-010518$AUROBINDO$$$$$$Y$$$20240829$$HP$CA$CA
1602854312$16028543$12$F$20190101$20240801$20190304$20240808$EXP$$DE-ROCHE-2271569$ROCHE$$45$YR$A$F$Y$$$20240808$$CN$DE$DE
160333775$16033377$5$F$$20240924$20190305$20240930$EXP$$PT-ROCHE-2239984$ROCHE$Pereira L, Meng C, Guedes L, Marques S, Nunes A, Sampaio S. Infective endocarditis in renal transplant recipients: one center^s experience. Portuguese Journal of Nephrology and Hypertension. 2018;32 (4):337-41.$39$YR$A$F$Y$$$20240930$$HP$PT$PT
160344376$16034437$6$F$$20240917$20190305$20240919$EXP$$US-PFIZER INC-2019091886$PFIZER$$55$YR$$F$Y$$$20240919$$CN$US$US
160356609$16035660$9$F$$20240702$20190305$20240704$EXP$$US-PFIZER INC-2019091701$PFIZER$$67$YR$$F$Y$$$20240704$$CN$US$US
160361375$16036137$5$F$$20240923$20190305$20240927$EXP$$DE-MYLANLABS-2019M1018568$MYLAN$Avsar Y, Cicinnati VR, Kabar I, Wolters H, Anthoni C, Schmidt HH and Beckebaum S.. Small bowel transplantation complicated by cytomegalovirus tissue invasive disease without viremia.. J Clin Virol.. 2014;60(2):177-80$52$YR$$F$Y$$$20240927$$HP$DE$DE
160372133$16037213$3$F$$20240702$20190305$20240708$EXP$$DE-MYLANLABS-2019M1018743$MYLAN$Schneck E, Koch C, Arens C, Schiirg R, Zajonz T, Khaleeva A et al.. Obstetrics: Anesthesia in fetal surgery. Anasthesiol Intensivmed Notfallmed Schmerzther. 2017;52:204-13$$$I$$Y$$$20240708$$MD$DE$DE
160385203$16038520$3$F$$20240821$20190305$20240829$PER$$US-JAZZ-2019-US-003060$JAZZ$$$$$F$Y$$$20240829$$CN$US$US
160392576$16039257$6$F$20180830$20240906$20190306$20240909$EXP$$DE-ROCHE-2194690$ROCHE$$32$YR$A$F$Y$$$20240910$$CN$DE$DE
160406008$16040600$8$F$20180704$20240819$20190306$20240826$EXP$$JP-ABBVIE-19P-087-2692692-00$ABBVIE$$61$YR$$M$Y$76$KG$20240826$$MD$JP$JP
160433096$16043309$6$F$$20240815$20190306$20240821$EXP$$IT-MYLANLABS-2019M1020668$MYLAN$Mancianti N, Monaci G, Rollo F, Buracchi P, Guarnieri A, Di Luca M et al.. First case report of using Ofatumumab in kidney transplantation AB0 incompatible.. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nef. 2017;34:1-5$41$YR$$M$Y$$$20240821$$MD$IT$IT
1604592535$16045925$35$F$20190101$20240830$20190307$20240909$EXP$$CA-CELLTRION INC.-2019CA019169$CELLTRION$$$$$$Y$$$20240909$$CN$CA$CA
1604665313$16046653$13$F$20190301$20240705$20190307$20240807$EXP$$DE-ROCHE-2278394$ROCHE$$58$YR$A$F$Y$53$KG$20240807$$CN$DE$DE
1604674118$16046741$18$F$20181117$20240722$20190307$20240724$EXP$$US-PFIZER INC-2019091452$PFIZER$$81$YR$$F$Y$58.95$KG$20240724$$CN$US$US
160489633$16048963$3$F$20170101$20240812$20190307$20240816$EXP$$PHHY2019IT027060$NOVARTIS$Mendogni P, Henchi S, Morlacchi L, Tosi D, Nosotti M, Tarsia P et al. Epstein-Barr virus-related post-transplant lymphoproliferative disorders in cystic fibrosis lung transplant recipients: a case series. TRANSPLANTATION PROCEEDINGS. 2019;51:194-7$25$YR$$F$Y$$$20240816$$HP$IT$IT
160514553$16051455$3$F$20130101$20240904$20190308$20240918$EXP$$AR-ALKEM LABORATORIES LIMITED-AR-ALKEM-2019-02074$ALKEM$Galluzzo Mutti L, Alvarez M, Siminovich M, Perez C, Lucero B, Nieto M, Castanos C, Haag D, Boglione M.. Disseminated visceral Kaposi?s sarcoma in a pediatric bilateral lung transplant recipient.. Pediatric Transplantation. 2019;23(1):e13311$15$YR$$F$Y$$$20240918$$MD$AR$AR
160537627$16053762$7$F$$20240816$20190308$20240821$EXP$$HU-MYLANLABS-2019M1021507$MYLAN$Mangel KZ, Szilagyi M, Nemeth T, Nagy G.. Just a bit of conjunctivitis. Hungarian Rheumatology. 2018;2:111-112$77$YR$$F$Y$$$20240821$$MD$HU$HU
160573828$16057382$8$F$$20240702$20190311$20240703$PER$$US-PFIZER INC-2019022141$PFIZER$$61$YR$$F$Y$$$20240703$$MD$US$US
160595445$16059544$5$F$20180823$20240904$20190311$20240909$EXP$$CA-TAKEDA-2018TUS027474$TAKEDA$$36$YR$$M$Y$$$20240909$$MD$CA$CA
1606074348$16060743$48$F$20180129$20240709$20190312$20240718$EXP$$CA-CELLTRION INC.-2018CA017918$CELLTRION$$$$$$Y$$$20240718$$CN$CA$CA
1606205717$16062057$17$F$20181224$20240723$20190312$20240731$EXP$$DE-ROCHE-2278493$ROCHE$$61$YR$A$F$Y$$$20240731$$CN$DE$DE
1606257711$16062577$11$F$$20240805$20190312$20240812$EXP$$CA-PFIZER INC-2019102192$PFIZER$$39$YR$$F$Y$119.3$KG$20240812$$CN$CA$CA
160628406$16062840$6$F$20230201$20240814$20190312$20240821$PER$$US-BIOGEN-2019BI00707694$BIOGEN$$34$YR$$F$Y$$$20240821$$CN$US$US
160646177$16064617$7$F$$20240712$20190312$20240717$EXP$$CA-PFIZER INC-2014254855$PFIZER$Wong, J.. Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment. Pediatric Transplantation. 2014;18 (6):E200-E207$15$YR$$F$Y$$$20240717$$MD$CA$CA
1606562310$16065623$10$F$20210501$20240715$20190313$20240722$EXP$$BR-GLAXOSMITHKLINE-BR2018GSK006043$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$MD$BR$BR
160692694$16069269$4$F$20180802$20240919$20190313$20240926$EXP$$DE-MYLANLABS-2019M1018459$MYLAN$$51$YR$$M$Y$90$KG$20240926$$HP$DE$DE
160708292$16070829$2$F$$20240709$20190314$20240712$PER$$US-BIOGEN-2019BI00709817$BIOGEN$$$$$M$Y$$$20240712$$CN$US$US
160729722$16072972$2$F$$20240816$20190314$20240821$EXP$$HU-MYLANLABS-2019M1023163$MYLAN$Mangel KZ, Szil?gyi M, N?meth T, Nagy G.. JUST A SLIGH CONJUNCTIVITIS. Magyar Reumatologia. 2018;59(2):111-2$$$$$Y$$$20240821$$MD$HU$HU
160736772$16073677$2$F$$20240813$20190314$20240820$EXP$$CA-TAKEDA-2018TUS021144$TAKEDA$$$$$M$Y$$$20240820$$CN$CA$CA
160750535$16075053$5$F$20181210$20240626$20190315$20240711$EXP$$CA-ROCHE-2283621$ROCHE$$61$YR$A$F$Y$$$20240711$$CN$CA$CA
1607544613$16075446$13$F$$20240830$20190315$20240911$EXP$$CA-AUROBINDO-AUR-APL-2019-012901$AUROBINDO$$$$$F$Y$97$KG$20240911$$MD$CA$CA
160754736$16075473$6$F$20181001$20240828$20190315$20240904$EXP$$DE-ROCHE-2278716$ROCHE$$63$YR$A$F$Y$65$KG$20240904$$MD$DE$DE
160755332$16075533$2$F$$20240720$20190315$20240731$EXP$$CA-AUROBINDO-AUR-APL-2019-012883$AUROBINDO$$55$YR$$M$Y$$$20240731$$HP$CA$CA
160755344$16075534$4$F$$20240814$20190315$20240827$EXP$$CA-AUROBINDO-AUR-APL-2019-012888$AUROBINDO$$35$YR$$F$Y$$$20240827$$HP$CA$CA
160762619$16076261$9$F$$20240828$20190315$20240907$EXP$$CA-AUROBINDO-AUR-APL-2019-013441$AUROBINDO$$27$YR$$F$Y$$$20240907$$HP$CA$CA
160762629$16076262$9$F$$20240815$20190315$20240827$EXP$$CA-AUROBINDO-AUR-APL-2019-013338$AUROBINDO$$65$YR$$F$Y$$$20240827$$HP$CA$CA
160765439$16076543$9$F$$20240809$20190315$20240822$EXP$$CA-AUROBINDO-AUR-APL-2019-013548$AUROBINDO$$$$$M$Y$17$KG$20240822$$HP$CA$CA
160794592$16079459$2$F$20240722$20240719$20190315$20240725$EXP$$US-SHIRE-US201908422$TAKEDA$$14$YR$$M$Y$$$20240725$$CN$US$US
160796415$16079641$5$F$$20240715$20190315$20240722$EXP$$PHHY2019CA054482$NOVARTIS$$40$YR$$M$Y$130$KG$20240722$$MD$CA$CA
160799592$16079959$2$F$20150701$20240913$20190315$20240919$EXP$$AT-PFIZER INC-2019074545$PFIZER$$57$YR$$M$Y$70$KG$20240919$$MD$AT$AT
1608072717$16080727$17$F$$20240827$20190316$20240905$EXP$$CA-AUROBINDO-AUR-APL-2019-013413$AUROBINDO$$40$YR$$F$Y$113$KG$20240905$$HP$CA$CA
160809455$16080945$5$F$$20240827$20190316$20240905$EXP$$CA-AUROBINDO-AUR-APL-2019-013872$AUROBINDO$$57$YR$$M$Y$$$20240905$$HP$CA$CA
160811515$16081151$5$F$$20240812$20190316$20240822$EXP$$CA-AUROBINDO-AUR-APL-2019-013572$AUROBINDO$$50$YR$$M$Y$$$20240822$$HP$CA$CA
160811613$16081161$3$F$$20240813$20190316$20240826$EXP$$CA-AUROBINDO-AUR-APL-2019-013694$AUROBINDO$$64$YR$$M$Y$$$20240826$$HP$CA$CA
1608138312$16081383$12$F$$20240724$20190316$20240807$EXP$$CA-AUROBINDO-AUR-APL-2019-012872$AUROBINDO$$44$YR$$F$Y$63$KG$20240807$$MD$CA$CA
1608138910$16081389$10$F$$20240827$20190316$20240905$EXP$$CA-AUROBINDO-AUR-APL-2019-013165$AUROBINDO$$56$YR$$F$Y$$$20240905$$MD$CA$CA
1608139210$16081392$10$F$$20240726$20190316$20240807$EXP$$CA-AUROBINDO-AUR-APL-2019-012904$AUROBINDO$$10$YR$$M$Y$$$20240807$$HP$CA$CA
160814222$16081422$2$F$$20240903$20190316$20240912$EXP$$CA-AUROBINDO-AUR-APL-2019-013293$AUROBINDO$$53$YR$$F$Y$72$KG$20240912$$HP$CA$CA
1608291621$16082916$21$F$$20240729$20190318$20240808$EXP$$CA-TEVA-2019-CA-1022965$TEVA$$44$YR$$F$Y$97$KG$20240808$$MD$CA$CA
1608363410$16083634$10$F$20190215$20240717$20190318$20240729$EXP$$DE-ROCHE-2269918$ROCHE$$19$YR$A$F$Y$46$KG$20240729$$CN$DE$DE
160841434$16084143$4$F$$20240805$20190318$20240807$PER$$US-PFIZER INC-2019112413$PFIZER$$71$YR$$F$Y$$$20240807$$HP$US$US
160843153$16084315$3$F$$20240628$20190318$20240704$EXP$$GR-BAUSCH-BL-2019-008035$BAUSCH AND LOMB$Koliaki C, Siafarikas C, Tsakanikas A, Georgopoulou A, Mylona M. A young neutropenic patient with glycogen storage disease and diarrhea: An underlying infection or her pre-existing Crohn^s like disease. European Journal of Case Reports in Internal Medicine. 2019;6 (SUPPLEMENT 1):411. doi:10.12890/2019_V6Sup1$30$YR$$F$Y$$$20240704$$HP$GR$GR
160863274$16086327$4$F$20190211$20240726$20190318$20240731$EXP$$SK-SA-2019SA053054$SANOFI AVENTIS$$41$YR$A$F$Y$57$KG$20240731$$MD$SK$SK
160867338$16086733$8$F$20180130$20240726$20190318$20240919$EXP$$PHHY2019PT056283$NOVARTIS$$64$YR$$F$Y$87$KG$20240919$$MD$PT$PT
1608700910$16087009$10$F$$20240711$20190318$20240718$EXP$$CA-009507513-1903CAN006484$MERCK$$$$A$M$Y$$$20240718$$MD$CA$CA
1608735735$16087357$35$F$20181129$20240903$20190319$20240910$EXP$$CA-CELLTRION INC.-2018CA024738$CELLTRION$$$$$$Y$$$20240910$$CN$CA$CA
160895308$16089530$8$F$20181226$20240913$20190319$20240920$EXP$$FR-ABBVIE-19K-056-2703773-00$ABBVIE$$69$YR$$M$Y$90$KG$20240920$$MD$FR$FR
160898099$16089809$9$F$20180202$20231012$20190319$20240708$EXP$$JP-GLAXOSMITHKLINE-JP2018JPN144948$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$JP$JP
160908908$16090890$8$F$20180101$20240822$20190319$20240827$EXP$$US-PFIZER INC-2019111184$PFIZER$$59$YR$$M$Y$$$20240827$$CN$US$US
160922328$16092232$8$F$20190417$20240812$20190319$20240814$EXP$$US-SHIRE-US201908456$TAKEDA$$59$YR$$M$Y$$$20240814$$CN$US$US
160927073$16092707$3$F$20181126$20240903$20190319$20240911$EXP$$PT-CELLTRION INC.-2019PT018521$CELLTRION$$$$$$Y$$$20240911$$HP$PT$PT
160930782$16093078$2$F$$20240913$20190320$20240925$EXP$$PL-AUROBINDO-AUR-APL-2019-015460$AUROBINDO$Woron J.. Unwanted effects of psychotropic drug interactions with medicinal products and diet supplements containing plant extracts.. Psychiatria Polska.. 2018;52(6):983-996$$$A$$Y$$$20240925$$HP$PL$PL
1609528210$16095282$10$F$20191101$20240905$20190320$20240906$PER$$US-PFIZER INC-2019116288$PFIZER$$57$YR$$M$Y$$$20240906$$CN$US$US
160972122$16097212$2$F$20161114$20240828$20190320$20240904$EXP$$BR-TAKEDA-2017TUS010942$TAKEDA$$51$YR$$F$Y$$$20240904$$CN$BR$BR
160975904$16097590$4$F$$20240809$20190320$20240813$EXP$$US-SHIRE-US201909144$TAKEDA$$$$$M$Y$$$20240813$$HP$US$US
160976212$16097621$2$F$20240727$20240911$20190320$20240917$EXP$$US-SHIRE-US201908846$TAKEDA$$91$YR$$F$Y$$$20240917$$CN$US$US
160992369$16099236$9$F$$20240821$20190321$20240827$EXP$$PHHY2016CA096795$NOVARTIS$Acedillo RR, Govind M, Kashgary A, Clark WF. Treatment of severe, refractory and rapidly evolving thrombotic thrombocytopenic purpura. BMJ CASE REPORTS. 2016;1-3$36$YR$$M$Y$$$20240827$$HP$CA$CA
161034753$16103475$3$F$20180130$20240712$20190322$20240722$EXP$$PT-CELLTRION INC.-2019PT019530$CELLTRION$$$$$$Y$$$20240722$$MD$PT$PT
161040992$16104099$2$F$$20240815$20190322$20240827$EXP$ES-EMA-DD-20181114-ABDUL_J-093549$ES-Accord-114407$ACCORD$$58$YR$A$F$Y$$$20240827$$HP$ES$ES
1610453816$16104538$16$F$20190301$20240902$20190322$20240911$EXP$$DE-ROCHE-2288237$ROCHE$$60$YR$A$M$Y$$$20240911$$CN$DE$DE
161053022$16105302$2$F$20181217$20240708$20190322$20240709$EXP$FR-AFSSAPS-BX20190395$FR-JNJFOC-20190328640$JOHNSON AND JOHNSON$$49$YR$A$M$Y$64$KG$20240709$$MD$FR$FR
161054442$16105444$2$F$20170324$20240711$20190322$20240717$EXP$$FR-PFIZER INC-2019119540$PFIZER$$40$YR$$M$Y$82$KG$20240717$$MD$FR$FR
1610599610$16105996$10$F$20180530$20240701$20190322$20240705$EXP$$JP-ABBVIE-19P-087-2714996-00$ABBVIE$$54$YR$$M$Y$68$KG$20240705$$MD$JP$JP
161076742$16107674$2$F$$20240709$20190322$20240717$EXP$$CA-TAKEDA-2019TUS013865$TAKEDA$$$$$M$Y$$$20240717$$CN$CA$CA
161086264$16108626$4$F$20060701$20240829$20190323$20240910$EXP$SK-EMA-DD-20181115-SHUKLA_V-142809$SK-Accord-114301$ACCORD$$29$YR$A$M$Y$$$20240910$$HP$SK$SK
161109427$16110942$7$F$$20240712$20190325$20240717$EXP$$PT-AUROBINDO-AUR-APL-2019-016820$AUROBINDO$Rodrigues M, Monteiro M, Costa J, Messias A, Cardoso F, Dias L.. DOENCA ATEROEMBOLICA RENAL, UMA CONSEQUENCIA DA FIBRINOLISE E ANTICOAGULACAO. Online Magazine of Clinical Cases in Internal Medicine. 2019$79$YR$$M$Y$75$KG$20240717$$HP$PT$PT
161130692$16113069$2$F$20170101$20240811$20190325$20240819$EXP$$US-AMGEN-USASP2019045344$AMGEN$Alay M.; Michael B.; Koyamangalath K. et al.. Successful Salvage with Inotuzumab Ozogamicin in Relapsed/Refractory Lymphoid Blast Crisis of Chronic Myeloid Leukemia after Failure of Multiple Lines of Therapy Including Blinatumomab. Blood. 2018;132 (SUPPL_1):5452$$$$M$Y$$$20240819$$MD$US$US
161131754$16113175$4$F$20170501$20240801$20190325$20240807$EXP$$CA-PFIZER INC-2017217246$PFIZER$$70$YR$$F$Y$$$20240807$$CN$CA$CA
161163986$16116398$6$F$$20240814$20190326$20240827$EXP$$PT-AUROBINDO-AUR-APL-2019-002445$AUROBINDO$Fonseca NM, Navarro D, Gois M, Sousa H, Aires I, Nolasco F.. Streamlining diagnosis with urinary sediment microscopy: a case of deteriorating renal function in a kidney transplant patient.. Portuguese Journal of Nephrology and Hypertension.. 2018;32(4):381-4/389-92$71$YR$$M$Y$$$20240827$$MD$PT$PT
161169835$16116983$5$F$20190301$20240923$20190326$20240924$EXP$$US-PFIZER INC-2019124440$PFIZER$$50$YR$$F$Y$$$20240924$$CN$US$US
161170248$16117024$8$F$$20240905$20190326$20240909$EXP$$US-PFIZER INC-2019124975$PFIZER$$61$YR$$F$Y$49.887$KG$20240909$$HP$US$US
161197983$16119798$3$F$$20240813$20190326$20240819$PER$$US-SHIRE-US201909723$TAKEDA$$$$$M$Y$$$20240819$$CN$US$US
161200434$16120043$4$F$$20240701$20190326$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-030092$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240705$$MD$JP$JP
1612230927$16122309$27$F$20181018$20240904$20190327$20240913$EXP$$DE-ROCHE-2218327$ROCHE$$38$YR$A$F$Y$$$20240913$$CN$DE$DE
161232443$16123244$3$F$20240821$20240821$20190327$20240823$EXP$$US-KYOWAKIRIN-2019BKK004701$KYOWA$$$$$$Y$$$20240823$$MD$US$US
161255872$16125587$2$F$20160601$20240910$20190328$20240910$EXP$$AT-ROCHE-2255837$ROCHE$$57$YR$A$M$Y$70$KG$20240910$$MD$AT$AT
161259905$16125990$5$F$20181106$20240903$20190328$20240912$EXP$$DE-ROCHE-2214255$ROCHE$$63$YR$A$F$Y$$$20240912$$CN$DE$DE
1613130214$16131302$14$F$20170901$20240813$20190328$20240819$EXP$$PHHY2019ES065684$NOVARTIS$Ordonez-Fernandez L, Rodriguez-Ferreras A, Carriles C, Martinez-Torron A, Lazaro-Lopez E, Rosado-Maria MC. Pneumonia in a patient with kidney transplant treated with alirocumab and everolimus. FARMACIA HOSPITALARIA. 2019;43(2):74-6$45$YR$$M$Y$$$20240819$$HP$ES$ES
161313314$16131331$4$F$$20240911$20190328$20240918$EXP$$PHHY2019CA065565$NOVARTIS$$29$YR$$F$Y$$$20240919$$CN$CA$CA
161315604$16131560$4$F$20210301$20240816$20190328$20240828$PER$$US-INCYTE CORPORATION-2019IN002855$INCYTE$$$$$$Y$$$20240828$$CN$US$US
161331848$16133184$8$F$20170901$20240816$20190329$20240826$EXP$$ES-ROCHE-2289527$ROCHE$Rodriguez-Ferreras A, Carriles C, Martinez-Torron A, Lazaro- Lopez E, Rosado-Maria M. Pneumonia in a patient with kidney transplant treated with alirocumab and everolimus.. Farmacia Hospitalaria. 2019;43 (2):74-6. doi:10.7399/fh.11138.$45$YR$A$M$Y$$$20240826$$MD$ES$ES
161334938$16133493$8$F$20180101$20240724$20190329$20240729$EXP$$DE-ROCHE-2123584$ROCHE$$43$YR$A$F$Y$$$20240729$$CN$DE$DE
161335085$16133508$5$F$20190328$20240710$20190329$20240715$EXP$$CA-BIOGEN-2019BI00716272$BIOGEN$$51$YR$$F$Y$$$20240715$$CN$CA$CA
161346793$16134679$3$F$$20240826$20190331$20240830$EXP$$PHHY2019CA071777$NOVARTIS$$38$YR$$M$Y$$$20240830$$MD$CA$CA
161363695$16136369$5$F$20190321$20240709$20190329$20240711$EXP$$US-SHIRE-US201909725$TAKEDA$$62$YR$$F$Y$$$20240711$$MD$US$US
161364453$16136445$3$F$$20240821$20190329$20240822$EXP$$US-SHIRE-US201900407$TAKEDA$$$$$F$Y$$$20240822$$HP$US$US
161373187$16137318$7$F$20170401$20240812$20190330$20240823$EXP$$ES-AUROBINDO-AUR-APL-2019-016968$AUROBINDO$Ordonez-Fernandez L,Rodriguez-Ferreras A,Carriles C,Martinez-Torron A,Lazaro-Lopez E,Rosado-Maria MC. Pneumonia in a patient with kidney transplant treated with alirocumab and everolimus. Farmacia Hospitalaria. 2019;43(2):74-6$45$YR$$M$Y$$$20240823$$MD$ES$ES
1613766728$16137667$28$F$$20240823$20190401$20240830$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK072615$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$BR$BR
161395602$16139560$2$F$$20240809$20190401$20240815$EXP$DK-EMA-20140929-DEEPTISP-122416997$DK-ELI_LILLY_AND_COMPANY-DK201903015394$ELI LILLY AND CO$$17$YR$T$M$Y$$$20240815$$MD$DK$DK
161415503$16141550$3$F$20121230$20240826$20190401$20240828$EXP$FR-AFSSAPS-PO20190348$FR-UCBSA-2019012620$UCB$$0$YR$$F$Y$2.1$KG$20240828$$MD$FR$FR
1614203222$16142032$22$F$20180526$20240625$20190401$20240701$EXP$$FR-ABBVIE-18K-056-2481804-00$ABBVIE$$76$YR$$F$Y$71$KG$20240701$$MD$FR$FR
1614258010$16142580$10$F$$20240801$20190401$20240814$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-027232$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240814$$HP$CA$CA
161437906$16143790$6$F$$20240829$20190401$20240903$EXP$$US-SHIRE-US201910074$TAKEDA$$$$$F$Y$$$20240903$$CN$US$US
161447459$16144745$9$F$20180224$20240723$20190402$20240801$EXP$IT-MINISAL02-539116$IT-ROCHE-2293429$ROCHE$$65$YR$E$F$Y$68$KG$20240801$$MD$IT$IT
161467007$16146700$7$F$20181124$20200311$20190402$20240912$EXP$$JP-GLAXOSMITHKLINE-JP2019JPN055568$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$JP$JP
161489143$16148914$3$F$20190318$20240702$20190402$20240705$EXP$$CA-TAKEDA-2019TUS018528$TAKEDA$$59$YR$$M$Y$$$20240705$$CN$CA$CA
1615072611$16150726$11$F$20180102$20240724$20190403$20240731$EXP$$PHHY2019CA073819$NOVARTIS$$29$YR$$M$Y$$$20240731$$CN$CA$CA
1615399215$16153992$15$F$20210101$20240821$20190403$20240828$EXP$$US-PFIZER INC-2019139627$PFIZER$$69$YR$$F$Y$65.76$KG$20240828$$MD$US$US
161542092$16154209$2$F$20170101$20240809$20190403$20240819$EXP$$US-ROCHE-2288900$ROCHE$$56$YR$A$F$Y$94.35$KG$20240819$$CN$US$US
1615516629$16155166$29$F$20190301$20240812$20190403$20240817$EXP$$US-TAKEDA-2019TUS015567$TAKEDA$$58$YR$$F$Y$62$KG$20240817$$HP$US$US
161562322$16156232$2$F$$20190327$20190404$20240815$EXP$$JP-AMGEN-JPNSP2019051731$AMGEN$$9$DEC$E$F$Y$$$20240814$$HP$JP$JP
1615636312$16156363$12$F$20170420$20240806$20190404$20240812$EXP$$ES-SA-2017SA148451$SANOFI AVENTIS$$40$YR$A$F$Y$55$KG$20240812$$MD$ES$ES
161567712$16156771$2$F$20121230$20240829$20190404$20240906$EXP$FR-AFSSAPS-PO20190348$FR-TEVA-2019-FR-1032918$TEVA$$$$$F$Y$2.1$KG$20240906$$MD$FR$FR
161569465$16156946$5$F$20181020$20240716$20190404$20240729$EXP$$DE-ROCHE-2185103$ROCHE$$44$YR$A$F$Y$$$20240729$$CN$DE$DE
1615748119$16157481$19$F$$20240826$20190404$20240829$PER$$US-PFIZER INC-2019135811$PFIZER$$65$YR$$F$Y$56.689$KG$20240829$$MD$US$US
161590542$16159054$2$F$$20240814$20190404$20240819$EXP$DK-EMA-20140929-DEEPTISP-122416997$DK-SANOFI-AVENTIS-2013SA060213$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240819$$HP$DK$DK
161595908$16159590$8$F$$20240709$20190404$20240716$EXP$$CA-GLAXOSMITHKLINE-CA2019GSK052972$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$MD$CA$CA
1615994618$16159946$18$F$20170101$20240903$20190404$20240911$EXP$$CA-PFIZER INC-2018176610$PFIZER$$49$YR$$F$Y$$$20240911$$HP$CA$CA
161607873$16160787$3$F$$20240715$20190405$20240721$EXP$$PHHY2019CA070839$NOVARTIS$$47$YR$$M$Y$$$20240722$$MD$CA$CA
161616758$16161675$8$F$20180201$20240813$20190405$20240815$PER$$US-PFIZER INC-2019138806$PFIZER$$74$YR$$F$Y$104$KG$20240815$$CN$US$US
161624932$16162493$2$F$20190201$20240916$20190405$20240917$EXP$PHHY2019FR076868$PHHY2019FR076868$NOVARTIS$$60$YR$$F$Y$55$KG$20240918$$PH$FR$FR
161625074$16162507$4$F$20190329$20240711$20190405$20240717$PER$$US-BIOGEN-2019BI00719534$BIOGEN$$61$YR$$F$Y$$$20240717$$CN$US$US
161637345$16163734$5$F$$20240823$20190405$20240828$EXP$$CA-PFIZER INC-2019139534$MYLAN$$23$YR$$F$Y$$$20240828$$HP$CA$CA
161637419$16163741$9$F$19940101$20240911$20190405$20240913$EXP$$US-PFIZER INC-2019139971$PFIZER$$44$YR$$F$Y$91.63$KG$20240913$$CN$US$US
161638284$16163828$4$F$$20240823$20190405$20240828$EXP$$CA-PFIZER INC-2019139064$MYLAN$$23$YR$$F$Y$$$20240828$$HP$CA$CA
161656759$16165675$9$F$20170801$20240719$20190405$20240726$EXP$$PHHY2017CA018260$NOVARTIS$$67$YR$$F$Y$$$20240726$$CN$CA$CA
161661972$16166197$2$F$20190114$20240711$20190406$20240722$EXP$FR-AFSSAPS-MP20190156$FR-Accord-118361$ACCORD$$50$YR$A$F$Y$72.5$KG$20240722$$MD$FR$FR
161663505$16166350$5$F$20200502$20240826$20190406$20240829$EXP$$CA-ROCHE-2298686$ROCHE$$51$YR$A$M$Y$$$20240829$$CN$CA$CA
161691083$16169108$3$F$20190117$20240722$20190408$20240726$PER$$US-SHIRE-US201911391$TAKEDA$$35$YR$$F$Y$$$20240726$$CN$US$US
161723082$16172308$2$F$$20240817$20190409$20240829$EXP$IT-EMA-DD-20190301-KUMARSINGH_A-141913$IT-Accord-118674$ACCORD$Data migrated from the EudraVigilance E2B(R2) Literature repository$41$YR$A$M$Y$$$20240829$$MD$IT$IT
1617476240$16174762$40$F$20180101$20240909$20190409$20240917$EXP$$CA-CELLTRION INC.-2018CA023892$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
1617524513$16175245$13$F$20140101$20240905$20190409$20240910$PER$$US-JAZZ-2014-US-001128$JAZZ$$45$YR$$F$Y$$$20240910$$MD$US$US
161767832$16176783$2$F$$20240705$20190409$20240709$EXP$$GR-MYLANLABS-2019M1032636$MYLAN$Despotopoulos S, Roumeliotis A, Kounis NG, Tsigkas G, Hahalis G, Davlouros P.. Severe allergic reaction during angioplasty culminating to fatal acute stent thrombosis: An association with Kounis syndrome. Heart + Lung. 2018;1-3$50$YR$$M$Y$$$20240709$$HP$GR$GR
161775203$16177520$3$F$20190201$20240814$20190410$20240814$EXP$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033814$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033814$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240814$$PH$FR$FR
1618091712$16180917$12$F$20220301$20240812$20190410$20240815$EXP$$US-TAKEDA-2019TUS020674$TAKEDA$$77$YR$$F$Y$75$KG$20240815$$HP$US$US
161821069$16182106$9$F$20190317$20240909$20190411$20240912$EXP$$US-SHIRE-US201909236$TAKEDA$$23$YR$$F$Y$$$20240912$$CN$US$US
161822719$16182271$9$F$20190301$20240912$20190410$20240917$EXP$$US-JAZZ-2017-US-008546$JAZZ$$49$YR$$F$Y$$$20240917$$MD$US$US
161850322$16185032$2$F$$20240909$20190411$20240912$EXP$$FR-MYLANLABS-2019M1033363$MYLAN$Zehou O, Leibler C, Arnault J, Sayegh J, Montaudie H, Remy P et al.. Ipilimumab for the treatment of advanced melanoma in six kidney transplant patients.. American journal of transplantation. 2018;18(12):3065-71$57$YR$$F$Y$$$20240912$$HP$FR$FR
161861223$16186122$3$F$20180515$20240830$20190411$20240909$EXP$$IN-PFIZER INC-2019152253$PFIZER$Sharma, M.. Amiodarone induced delirium. Indian Journal of Psychiatry. 2019;61(9 supp 3):S553$71$YR$$F$Y$$$20240909$$HP$IN$IN
161864198$16186419$8$F$20161001$20240906$20190411$20240918$EXP$$NL-TEVA-2019-NL-1035151$TEVA$Cate IMR, Maten JV, Overbeek MJ, Holder JTT. Organising pneumonia and non-specific interstitial pneumonia as a late consequence of treatment with imatinib in a patient with chronic myeloid leukaemia. Ned Tijdschr Allergie, Astma, Klin Immunol. 2019;19: 22-27.; Cate IMR, Maten JV, Overbeek MJ, Holder JTT. Organising pneumonia and non-specific interstitial pneumonia as a late consequence of treatment with imatinib in a patient with chronic myeloid leukemia. Ned-Tijdschr-Voor-Allerg-Asthma 2019;...$68$YR$$M$Y$$$20240918$$HP$NL$NL
161906122$16190612$2$F$20180824$20240711$20190412$20240716$EXP$FR-AFSSAPS-PV20190166$FR-PFIZER INC-2019150559$PFIZER$$61$YR$$M$Y$78$KG$20240716$$MD$FR$FR
161924764$16192476$4$F$20190901$20240702$20190412$20240711$PER$$US-SA-2019SA100816$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240711$$MD$US$US
1619522211$16195222$11$F$20190401$20240816$20190415$20240826$EXP$$CA-ROCHE-2302802$ROCHE$$48$YR$A$M$Y$$$20240826$$CN$CA$CA
161957423$16195742$3$F$20190206$20240710$20190415$20240718$EXP$$JP-009507513-1902JPN000719J$MERCK$$73$YR$$F$Y$39$KG$20240718$$MD$JP$JP
161970884$16197088$4$F$20111101$20240813$20190415$20240814$PER$$US-PFIZER INC-2018533644$PFIZER$$42$YR$$F$Y$$$20240814$$LW$US$US
161980725$16198072$5$F$$20240715$20190415$20240806$EXP$$CA-PFIZER INC-2019154871$MYLAN$$55$YR$$M$Y$82$KG$20240806$$HP$CA$CA
161997273$16199727$3$F$$20190410$20190415$20240808$PER$$US-009507513-1904USA005365$MERCK$Afzal M, Shirai K.. Response to the Rechallenge With Talimogene Laherparepvec (T-VEC) After Ipilimumab/Nivolumab Treatment in Patient With Cutaneous Malignant Melanoma Who Initially Had a Progression on T-VEC With Pembrolizumab. Journal of Immunotherapy. 2019$83$YR$$M$Y$$$20240808$$HP$US$US
162010266$16201026$6$F$$20240814$20190416$20240821$EXP$$PL-SA-2019SA101741$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240821$$MD$PL$PL
162013624$16201362$4$F$20181101$20240808$20190416$20240815$EXP$$US-BIOGEN-2019BI00725880$BIOGEN$$73$YR$$M$Y$$$20240815$$CN$US$US
1620139315$16201393$15$F$20190222$20240806$20190416$20240811$EXP$$DE-ROCHE-2276118$ROCHE$$57$YR$A$F$Y$$$20240811$$CN$DE$DE
162055329$16205532$9$F$20190408$20240813$20190417$20240815$EXP$$CA-ROCHE-2304498$ROCHE$$48$YR$A$F$Y$$$20240815$$CN$CA$CA
162056854$16205685$4$F$$20240801$20190417$20240815$EXP$$CA-AUROBINDO-AUR-APL-2019-019693$AUROBINDO$$$$$F$Y$3$KG$20240815$$HP$CA$CA
162057037$16205703$7$F$$20240924$20190417$20240928$EXP$$CA-AUROBINDO-AUR-APL-2019-019628$AUROBINDO$$69$YR$$F$Y$$$20240928$$HP$CA$CA
1620576111$16205761$11$F$$20240904$20190417$20240913$EXP$$CA-AUROBINDO-AUR-APL-2019-009893$AUROBINDO$$32$YR$$M$Y$$$20240913$$HP$CA$CA
162062735$16206273$5$F$$20240725$20190417$20240807$EXP$$CA-AUROBINDO-AUR-APL-2019-019776$AUROBINDO$$53$YR$$F$Y$$$20240807$$HP$CA$CA
162078777$16207877$7$F$20181213$20240730$20190417$20240808$EXP$$CA-ROCHE-2305372$ROCHE$$30$YR$A$F$Y$$$20240808$$CN$CA$CA
162108037$16210803$7$F$20181212$20240823$20190418$20240903$EXP$$DE-AUROBINDO-AUR-APL-2019-001626$AUROBINDO$$$$A$F$Y$72$KG$20240903$$MD$DE$DE
162111323$16211132$3$F$$20240910$20190418$20240920$EXP$$CA-APOTEX-2019AP011797$APOTEX$$72$YR$$F$Y$$$20240920$$HP$CA$CA
162111804$16211180$4$F$20190409$20240719$20190418$20240725$EXP$$CA-ROCHE-2304500$ROCHE$$43$YR$A$F$Y$$$20240725$$CN$CA$CA
162111966$16211196$6$F$$20240819$20190418$20240829$EXP$$CA-APOTEX-2019AP011786$APOTEX$$53$YR$$F$Y$$$20240829$$HP$CA$CA
162113104$16211310$4$F$$20240821$20190418$20240831$EXP$$CA-AUROBINDO-AUR-APL-2019-020182$AUROBINDO$$31$YR$$M$Y$$$20240831$$CN$CA$CA
162120836$16212083$6$F$$20240829$20190418$20240903$EXP$$US-JAZZ-2018-US-001240$JAZZ$$$$$F$Y$$$20240903$$MD$US$US
162145898$16214589$8$F$20221101$20240913$20190418$20240917$EXP$$US-SHIRE-US201912618$TAKEDA$$15$YR$$M$Y$$$20240917$$CN$US$US
162147693$16214769$3$F$20170301$20240920$20190418$20240923$PER$$US-GILEAD-2019-0402876$GILEAD$$55$YR$A$M$Y$$$20240923$$LW$US$US
162152934$16215293$4$F$20131201$20240821$20190419$20240902$EXP$$FR-AUROBINDO-AUR-APL-2019-001854$AUROBINDO$Thibaud V, Rivalan J, Llamas F, Cherel M, Decaux O, Vigneau C.. Plasmacytoma-like post-kidney-transplant lymphoproliferative disorder confined to renal allograft and urinary tract:. A case report. Ne? phrologie + The?rapeutique.. 2018;14 (7):544-47$65$YR$$M$Y$$$20240902$$HP$FR$FR
1621537852$16215378$52$F$20180612$20240906$20190419$20240916$EXP$$CA-CELLTRION INC.-2018CA020116$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
162160513$16216051$3$F$$20240904$20190419$20240917$EXP$$ES-AUROBINDO-AUR-APL-2019-021219$AUROBINDO$Hern?ndez-Gu?o A, Bernabeu-Mart?nez MA, Mart?nez-Lazcano MT, Vera-Alvarez S. Dermatosis IgA lineal secundaria a vancomicina: descripci?n de un caso - Vancomycin-induced linear IgA bullous dermatosis: a case report. OFIL. 2019;29(1):58-60$84$YR$$M$Y$$$20240917$$MD$ES$ES
162163043$16216304$3$F$$20240720$20190419$20240731$EXP$$CA-AUROBINDO-AUR-APL-2019-020823$AUROBINDO$$55$YR$$M$Y$$$20240731$$CN$CA$CA
162163225$16216322$5$F$$20240720$20190419$20240731$EXP$$CA-AUROBINDO-AUR-APL-2019-020489$AUROBINDO$$31$YR$$F$Y$71$KG$20240731$$CN$CA$CA
162163686$16216368$6$F$$20240731$20190419$20240813$EXP$$CA-AUROBINDO-AUR-APL-2019-020522$AUROBINDO$$40$YR$$F$Y$$$20240813$$HP$CA$CA
162165498$16216549$8$F$$20240720$20190419$20240731$EXP$$CA-AUROBINDO-AUR-APL-2019-020660$AUROBINDO$$31$YR$$F$Y$71$KG$20240731$$CN$CA$CA
162170817$16217081$7$F$$20240720$20190419$20240731$EXP$$CA-AUROBINDO-AUR-APL-2019-020520$AUROBINDO$$25$YR$$M$Y$$$20240731$$HP$CA$CA
162184022$16218402$2$F$$20240926$20190419$20240930$PER$$US-PFIZER INC-2019165500$PFIZER$$80$YR$$M$Y$$$20240930$$HP$US$US
162190272$16219027$2$F$20190415$20240801$20190419$20240805$PER$$US-SHIRE-US201912907$TAKEDA$$58$YR$$F$Y$$$20240805$$HP$US$US
162196472$16219647$2$F$$20240706$20190420$20240717$EXP$$ES-AUROBINDO-AUR-APL-2019-021192$AUROBINDO$$48$YR$$F$Y$$$20240717$$MD$ES$ES
162196922$16219692$2$F$$20190408$20190420$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-037796$BRISTOL MYERS SQUIBB$Afzal MZ, Shirai K. Response to the Rechallenge With Talimogene Laherparepvec (T-VEC) After Ipilimumab/Nivolumab Treatment in Patient With Cutaneous Malignant Melanoma Who initially Had a Progression on T-VEC With Pembrolizumab. Journal of Immunotherapy 2019;42 (4):136-41.$83$YR$E$M$Y$$$20240816$$HP$US$US
1622007816$16220078$16$F$20161024$20240911$20190420$20240917$EXP$$CA-TAKEDA-2019TUS022520$TAKEDA$$45$YR$$M$Y$$$20240917$$HP$CA$CA
162220082$16222008$2$F$$20240909$20190422$20240920$EXP$$SG-Accord-122806$ACCORD$Goh KJ, Takano A, Koh MS, Tiew PY, Chong CS, Tay CK. A 53-Year-Old Man Presenting With Diplopia and Cavitary Lung Nodules. Chest. 2019;155(4):e107 - e112. DOI:10.1016/j.chest.2018.10.021$53$YR$A$M$Y$$$20240920$$MD$SG$SG
162228848$16222884$8$F$$20240806$20190422$20240808$PER$$US-PFIZER INC-2019167750$PFIZER$$61$YR$$F$Y$$$20240808$$PH$US$US
162250615$16225061$5$F$20190101$20240924$20190422$20240927$PER$$US-BIOGEN-2019BI00727582$BIOGEN$$60$YR$$F$Y$$$20240927$$CN$US$US
162262378$16226237$8$F$$20240626$20190423$20240701$EXP$$US-SHIRE-US201912731$TAKEDA$$$$$F$Y$110$KG$20240701$$CN$US$US
162270179$16227017$9$F$$20240812$20190423$20240821$EXP$$CA-APOTEX-2019AP012171$APOTEX$$52$YR$$F$Y$$$20240821$$HP$CA$CA
162281075$16228107$5$F$20030324$20240907$20190423$20240913$EXP$$US-NAPPMUNDI-USA-2019-0146552$PURDUE$$45$YR$$F$Y$$$20240913$$CN$US$US
162281104$16228110$4$F$20030324$20240907$20190423$20240913$PER$$US-NAPPMUNDI-USA-2019-0146553$PURDUE$$52$YR$$M$Y$$$20240913$$CN$US$US
1623176316$16231763$16$F$20180206$20240827$20190424$20240831$EXP$$JP-ABBVIE-19P-087-2756323-00$ABBVIE$$39$YR$$M$Y$$$20240831$$MD$JP$JP
1623230823$16232308$23$F$20190313$20240904$20190424$20240911$EXP$$PHHY2019DE091268$NOVARTIS$$$$E$F$Y$56.2$KG$20240911$$MD$DE$DE
162338952$16233895$2$F$$20240912$20190424$20240920$30DAY$$US-GLAXOSMITHKLINE-US2019AMR072226$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
1623624438$16236244$38$F$20190314$20240829$20190425$20240907$EXP$$DE-AUROBINDO-AUR-APL-2019-018189$AUROBINDO$$$$A$F$Y$98$KG$20240907$$MD$DE$DE
162375819$16237581$9$F$20180101$20240719$20190425$20240725$EXP$$CA-TAKEDA-2018TUS025487$TAKEDA$$$$$F$Y$$$20240725$$CN$CA$CA
162380882$16238088$2$F$$20240820$20190425$20240822$PER$$US-PFIZER INC-2019173428$PFIZER$$59$YR$$F$Y$$$20240822$$MD$US$US
162391592$16239159$2$F$20181221$20240730$20190425$20240808$PER$$US-SA-2019SA112770$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240808$$MD$US$US
162418644$16241864$4$F$20160628$20240702$20190426$20240715$EXP$$CA-ROCHE-2306886$ROCHE$$63$YR$A$F$Y$85$KG$20240715$$CN$CA$CA
162432136$16243213$6$F$$20240617$20190426$20240702$EXP$$CA-GLAXOSMITHKLINE-CA2019GSK072592$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$MD$CA$CA
1624474213$16244742$13$F$20170701$20240829$20190426$20240904$EXP$$CA-PFIZER INC-2017319203$PFIZER$$73$YR$$F$Y$$$20240904$$CN$CA$CA
162461084$16246108$4$F$20190228$20200911$20190426$20240702$EXP$$US-AKCEA THERAPEUTICS-2019IS001493$AKCEA THERAPEUTICS$$$$$$Y$$$20240702$$HP$US$US
162461792$16246179$2$F$20240601$20240725$20190426$20240731$EXP$$US-SHIRE-US201911000$TAKEDA$$27$YR$$$Y$$$20240731$$CN$US$US
162468812$16246881$2$F$$20240628$20190427$20240710$EXP$IE-EMA-DD-20190204-JAIN_H1-093606$IE-Accord-118601$ACCORD$$$$N$F$Y$1.5$KG$20240710$$HP$IE$IE
1624717714$16247177$14$F$20190201$20240821$20190427$20240828$EXP$$CA-CELLTRION INC.-2019CA019005$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
162481466$16248146$6$F$20170101$20240904$20190428$20240912$EXP$$PL-CELLTRION INC.-2019PL020660$CELLTRION$Wojcik, K.. Pixantrone therapy for refractory and relapsed diffuse large B-cell Lymphoma (DLBCL) after allogeneic stem cell transplantation-case report.. Onkologia w Praktyce Klinicznej-edukacja.. 2019;5 (suppl.B):B7-B10$$$$$Y$$$20240912$$HP$PL$PL
1624912019$16249120$19$F$20180322$20240911$20190429$20240921$EXP$$DE-ROCHE-2114383$ROCHE$$53$YR$A$F$Y$67$KG$20240921$$CN$DE$DE
162511853$16251185$3$F$$20240703$20190429$20240709$EXP$$IE-MYLANLABS-2019M1039092$MYLAN$Murphy C, Moriarty R. Dexmedetomidine, high-flow nasal oxygen and sugammadex-reversal of rocuronium: overcoming anaesthetic challenges in a parturient with congenital muscular dystrophy presenting for caesarean section. International Journal of Obstetric Anesthesia. 2018;34:108-12$$$N$F$Y$1.5$KG$20240709$$HP$IE$IE
1625120524$16251205$24$F$20190101$20240723$20190429$20240729$EXP$$US-PFIZER INC-2019176767$PFIZER$$83$YR$$F$Y$63$KG$20240729$$CN$US$US
162512853$16251285$3$F$$20240919$20190429$20240925$EXP$$DE-MYLANLABS-2019M1039128$MYLAN$$$$$M$Y$$$20240925$$CN$DE$DE
162514515$16251451$5$F$20190101$20240919$20190429$20240927$EXP$$US-CATALYST PHARMACEUTICALS, INC-2019CAT00098$CATALYST PHARMA$$$$$F$Y$63.492$KG$20240927$$CN$US$US
162522362$16252236$2$F$20231101$20231115$20190429$20240906$PER$$US-FARMAPROD-201903-0423$DOMPE FARMACEUTICI$$73$YR$E$M$Y$$$20240902$$CN$US$
162526044$16252604$4$F$20180501$20240919$20190429$20240925$EXP$$PT-MYLANLABS-2019M1040039$MYLAN$$37$YR$$M$Y$118$KG$20240925$$MD$PT$PT
162531992$16253199$2$F$$20240711$20190429$20240722$PER$$US-SA-2019SA115765$SANOFI AVENTIS$$$$A$M$Y$86.168$KG$20240721$$MD$US$US
1625335930$16253359$30$F$20180710$20240623$20190429$20240701$EXP$$CA-CELLTRION INC.-2018CA020124$CELLTRION$$$$$$Y$$$20240701$$HP$CA$CA
162538183$16253818$3$F$20190413$20240716$20190430$20240720$PER$$US-SHIRE-US201914069$TAKEDA$$60$YR$$M$Y$110.2$KG$20240720$$CN$US$US
162546953$16254695$3$F$20121230$20240829$20190430$20240909$EXP$FR-AFSSAPS-PO20190348$FR-Accord-124686$ACCORD$$0$DY$$F$Y$2.1$KG$20240909$$MD$FR$FR
162550077$16255007$7$F$$20240909$20190430$20240913$EXP$$GR-MYLANLABS-2019M1035410$MYLAN$Xanthopoulos, A. Decongestion in heart failure with normal blood pressure.. Panhellenic Congress of Cardiology. 2018$68$YR$$F$Y$$$20240913$$HP$GR$GR
162554582$16255458$2$F$$20240718$20190430$20240724$EXP$$US-KYOWAKIRIN-2019BKK006149$KYOWA$$$$$$Y$$$20240724$$CN$US$US
162572993$16257299$3$F$$20240802$20190430$20240806$EXP$$NO-MYLANLABS-2019M1041352$MYLAN$Wenche Rodseth Brede, Hege-Merete Krabseth, Lisbeth SolemMichelsen, Harald Aarset, John-Petter Jamt, and Lars Slordal.. A Wolf in Sheep^s Clothing... Journal of Analytical Toxicology.. 2018;1-2.$27$YR$$M$Y$$$20240806$$HP$NO$NO
1625804816$16258048$16$F$20171218$20240719$20190430$20240725$EXP$$CA-TAKEDA-2018TUS000383$TAKEDA$$57$YR$$M$Y$$$20240725$$CN$CA$CA
162586448$16258644$8$F$20180101$20240906$20190430$20240913$EXP$$PHHY2019SK093807$NOVARTIS$Miklo M. Neutropenic enterocolitis- not only in children. GASTROENTEROLOGIA PRE PRAX. 2019;18(1):25-30$55$YR$$F$Y$70$KG$20240913$$HP$SK$SK
1625929874$16259298$74$F$20180101$20240919$20190501$20240927$EXP$$CA-CELLTRION INC.-2019CA020672$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
1625934410$16259344$10$F$20190301$20240827$20190501$20240830$EXP$$CA-TAKEDA-2019TUS011619$TAKEDA$$39$YR$$M$Y$$$20240830$$CN$CA$CA
162593552$16259355$2$F$20190225$20240730$20190501$20240809$EXP$PT-INFARMED-B201903-581$PT-Accord-125278$ACCORD$$75$YR$E$F$Y$$$20240809$$HP$PT$PT
162594854$16259485$4$F$$20240822$20190501$20240904$EXP$$SE-Accord-124449$ACCORD$Parodis I, Dani L, Notarnicola A, Martenhed G, Fernstrom P, Matikas A, et al. G-CSF-induced aortitis: Two cases and review of the literature. Autoimmunity Reviews. 2019;18(6):615-20.$70$YR$E$F$Y$$$20240903$$HP$SE$SE
162614883$16261488$3$F$$20240719$20190501$20240801$EXP$$GB-AMGEN-GBRSP2019066836$AMGEN$Cooper N.; Provan D.; Scully M. et al.. Real world effectiveness of thrombopoietin receptor agonists (TRAs) in the management of immune thrombocytopenia (ITP) in the UK: results from a post hoc analysis of the TRAIT study. British Journal of Haematology. 2019;185 (Suppl 1):129$$$$$Y$$$20240801$$HP$GB$GB
162625998$16262599$8$F$20181203$20240716$20190502$20240718$EXP$$CA-TAKEDA-2019TUS000338$TAKEDA$$44$YR$$F$Y$$$20240718$$MD$CA$CA
1626467211$16264672$11$F$$20240903$20190502$20240905$EXP$$US-PFIZER INC-2019183756$PFIZER$$61$YR$$M$Y$$$20240905$$HP$US$US
162658115$16265811$5$F$20060430$20240628$20190502$20240701$EXP$$US-GILEAD-2019-0405254$GILEAD$$44$YR$A$F$Y$$$20240701$$LW$US$US
162667862$16266786$2$F$20190415$20240723$20190502$20240801$PER$$US-SA-2019SA116982$SANOFI AVENTIS$$50$YR$A$F$Y$89.8$KG$20240801$$MD$US$US
162668962$16266896$2$F$20190304$20240621$20190502$20240705$PER$$US-SA-2019SA117419$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240705$$CN$US$US
162683612$16268361$2$F$20170101$20240716$20190503$20240729$EXP$$FR-AUROBINDO-AUR-APL-2018-014184$AUROBINDO$$48$YR$$F$Y$101$KG$20240729$$MD$FR$FR
162704764$16270476$4$F$20120223$20240812$20190503$20240814$PER$$US-GILEAD-2019-0405400$GILEAD$$32$YR$A$M$Y$$$20240814$$LW$US$US
162724672$16272467$2$F$20171208$20240716$20190503$20240724$EXP$$JP-BAUSCH-BL-2019-011131$BAUSCH AND LOMB$$86$YR$$M$Y$65$KG$20240724$$HP$JP$JP
1627366225$16273662$25$F$20190101$20240807$20190506$20240814$EXP$$IL-ABBVIE-19K-082-2735071-00$ABBVIE$$67$YR$$M$Y$73$KG$20240814$$MD$IL$IL
162753678$16275367$8$F$20190427$20240816$20190504$20240821$EXP$$PHHY2019CA100468$NOVARTIS$$61$YR$$F$Y$$$20240821$$CN$CA$CA
1627575120$16275751$20$F$$20240819$20190506$20240826$EXP$$CA-GLAXOSMITHKLINE-CA2019GSK080005$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$HP$CA$CA
162763734$16276373$4$F$$20240909$20190506$20240911$EXP$$US-PFIZER INC-2019187447$PFIZER$Kang, M.. Varicella zoster virus encephalitis in solid organ transplant recipients: Case series and review of literature. Transplant Infectious Disease. 2019;21(2):10.1111/tid.13038$66$YR$$M$Y$$$20240911$$MD$US$US
162781683$16278168$3$F$20160811$20240723$20190506$20240729$EXP$$FR-MYLANLABS-2019M1042493$MYLAN$$41$YR$$M$Y$83$KG$20240729$$MD$FR$FR
1628028437$16280284$37$F$$20240909$20190507$20240916$EXP$$CA-GLAXOSMITHKLINE-CA2019GSK078216$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$CA$CA
162819696$16281969$6$F$$20240821$20190507$20240902$EXP$$CA-APOTEX-2019AP013055$APOTEX$$49$YR$$F$Y$$$20240902$$MD$CA$CA
1628343930$16283439$30$F$$20240819$20190507$20240826$EXP$$CA-GLAXOSMITHKLINE-CA2019GSK079995$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$CA$CA
1628418118$16284181$18$F$20180510$20240823$20190507$20240910$EXP$$CA-CELLTRION INC.-2018CA020161$CELLTRION$$$$$$Y$$$20240910$$CN$CA$CA
1628497121$16284971$21$F$20181012$20240830$20190508$20240906$EXP$$DE-ROCHE-2239868$ROCHE$$32$YR$A$F$Y$48.8$KG$20240906$$CN$DE$DE
162864113$16286411$3$F$20190410$20210708$20190508$20240710$PER$$PHEH2019US019373$NOVARTIS$$41$YR$$M$Y$$$20240710$$CN$US$US
162868128$16286812$8$F$20190404$20240716$20190508$20240720$EXP$$CA-TAKEDA-2019TUS027348$TAKEDA$$49$YR$$M$Y$$$20240720$$MD$CA$CA
162884968$16288496$8$F$$20240923$20190509$20240930$PER$$US-ALEXION PHARMACEUTICALS INC.-A201906721$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240930$$$US$US
1628853620$16288536$20$F$20190401$20240807$20190509$20240816$EXP$$CA-ROCHE-2314813$ROCHE$$26$YR$A$F$Y$$$20240816$$CN$CA$CA
162890402$16289040$2$F$20190506$20240826$20190509$20240902$PER$$US-SHIRE-US201915055$TAKEDA$$21$YR$$F$Y$$$20240902$$CN$US$US
1629001610$16290016$10$F$20190101$20240710$20190509$20240724$EXP$$FR-TEVA-2019-FR-1048095$TEVA$$40$YR$$M$Y$$$20240724$$LW$FR$FR
162900334$16290033$4$F$$20240916$20190509$20240920$EXP$$CA-BAYER-2019-087608$BAYER$$73$YR$E$F$Y$99$KG$20240920$$HP$CA$CA
1629110717$16291107$17$F$20200203$20240719$20190509$20240723$PER$$US-PFIZER INC-2019191024$PFIZER$$79$YR$$F$Y$48.08$KG$20240723$$CN$US$US
162917672$16291767$2$F$20180906$20240708$20190509$20240711$EXP$$AT-PFIZER INC-2019195539$PFIZER$$$$A$F$Y$$$20240711$$MD$AT$AT
1629743416$16297434$16$F$20190313$20240912$20190510$20240923$EXP$$DE-AUROBINDO-AUR-APL-2019-025099$AUROBINDO$$$$E$F$Y$56.2$KG$20240923$$MD$DE$DE
1629794014$16297940$14$F$20240130$20240828$20190510$20240830$EXP$$US-SHIRE-US201915286$TAKEDA$$52$YR$$F$Y$$$20240830$$MD$US$US
162981906$16298190$6$F$$20240911$20190510$20240923$EXP$$CA-APOTEX-2019AP013378$APOTEX$$63$YR$$M$Y$61$KG$20240923$$HP$CA$CA
162995352$16299535$2$F$$20240817$20190510$20240829$EXP$DK-EMA-DD-20190326-PRABHAKAR_D-132732$DK-Accord-126883$ACCORD$Ladekarl M,Villadsen G,Rudbeck A,Aagenaes ,Nielsen J,Dutoit S,Nordsmark?M. Advanced hepatocellular carcinoma in adolescence associated with?congenital cholestasis: A case description. Case Reports in Oncology 2013?Apr 6(1):98-103.$17$YR$T$M$Y$$$20240829$$HP$DK$DK
1630020731$16300207$31$F$20190409$20240718$20190510$20240724$EXP$$US-TAKEDA-2018TUS016219$TAKEDA$$61$YR$$F$Y$$$20240724$$CN$US$US
163035693$16303569$3$F$20190201$20240708$20190513$20240718$30DAY$$US-GLAXOSMITHKLINE-US2019082523$GLAXOSMITHKLINE$$60$YR$$M$Y$$$20240718$$CN$US$US
163043459$16304345$9$F$$20240813$20190513$20240816$PER$$US-PFIZER INC-2019198117$PFIZER$$67$YR$$M$Y$$$20240816$$CN$US$US
163054813$16305481$3$F$$20240731$20190513$20240810$EXP$$CA-TEVA-2019-CA-1050490$TEVA$$64$YR$$F$Y$$$20240810$$HP$CA$CA
163073835$16307383$5$F$20190101$20240717$20190514$20240730$EXP$$CA-ROCHE-2314189$ROCHE$$$$A$F$Y$$$20240730$$CN$CA$CA
163082938$16308293$8$F$20190424$20240924$20190514$20240927$EXP$$PHHY2019CA107032$NOVARTIS$$60$YR$$F$Y$$$20240927$$MD$CA$CA
163099366$16309936$6$F$$20240718$20190514$20240725$EXP$$GB-MYLANLABS-2019M1044769$MYLAN$Sarkar P, Dhileepan S.. Angiotensin converting enzyme inhibitor-associated angioedema: more common than recognized.. CLINICAL INTENSIVE CARE.. 2005;16 (1):37-42$75$YR$$F$Y$$$20240725$$HP$GB$GB
163109698$16310969$8$F$20171130$20240729$20190514$20240801$EXP$$CA-TAKEDA-2017TUS017156$TAKEDA$$38$YR$$F$Y$$$20240801$$CN$CA$CA
163121222$16312122$2$F$20190301$20240708$20190515$20240712$EXP$$CA-TAKEDA-2019TUS028894$TAKEDA$$39$YR$$M$Y$$$20240712$$MD$CA$CA
163130868$16313086$8$F$20140729$20240708$20190515$20240716$EXP$$CA-ROCHE-2317366$ROCHE$$61$YR$A$F$Y$$$20240716$$CN$CA$CA
163137155$16313715$5$F$$20240703$20190515$20240708$PER$$US-PFIZER INC-2019205708$PFIZER$$65$YR$$F$Y$$$20240708$$MD$US$US
1631400913$16314009$13$F$20201204$20240816$20190515$20240816$EXP$$US-PFIZER INC-2019178746$PFIZER$$82$YR$$F$Y$55.329$KG$20240816$$HP$US$US
163178032$16317803$2$F$20140101$20240807$20190516$20240813$PER$$US-JNJFOC-20190505060$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240813$$LW$US$US
163178074$16317807$4$F$20120101$20240918$20190516$20240926$PER$$US-JNJFOC-20190505110$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240926$$LW$US$US
163179412$16317941$2$F$$20240807$20190516$20240809$PER$$US-JNJFOC-20190504919$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$LW$US$US
163179502$16317950$2$F$$20240701$20190516$20240704$PER$$US-JNJFOC-20190505074$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$LW$US$US
163184012$16318401$2$F$$20240701$20190516$20240704$PER$$US-JNJFOC-20190505076$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240704$$LW$US$US
163184072$16318407$2$F$$20240701$20190516$20240704$PER$$US-JNJFOC-20190504916$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$LW$US$US
163199455$16319945$5$F$20170220$20240813$20190516$20240819$EXP$$CZ-PFIZER INC-2019201093$PFIZER$Kopecky, J.. Hepatic Injury Induced by a Single Dose of Nivolumab - a Case Report and Literature Review. Klinicka Onkologie. 2019;32(2):133-138$38$YR$$F$Y$$$20240819$$MD$CZ$CZ
163207393$16320739$3$F$20120830$20240916$20190516$20240922$PER$$US-JNJFOC-20190505012$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240922$$LW$US$US
163210002$16321000$2$F$$20240701$20190516$20240704$PER$$US-JNJFOC-20190505151$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$LW$US$US
163217442$16321744$2$F$$20240807$20190516$20240813$PER$$US-JNJFOC-20190505432$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$LW$US$US
163217452$16321745$2$F$$20240624$20190516$20240701$PER$$US-JNJFOC-20190505501$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240701$$LW$US$US
163218352$16321835$2$F$$20240910$20190516$20240917$EXP$DE-EMBRYOTOX-201905728$DE-GLAXOSMITHKLINE-DE2019086654$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$DE$DE
163220492$16322049$2$F$$20240624$20190516$20240701$PER$$US-JNJFOC-20190505551$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$LW$US$US
163224812$16322481$2$F$20020101$20240807$20190516$20240813$PER$$US-JNJFOC-20190505388$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240814$$LW$US$US
163226892$16322689$2$F$20190401$20240716$20190516$20240726$EXP$FR-AFSSAPS-PV20190263$FR-009507513-1905FRA006541$MERCK$$66$YR$$M$Y$115$KG$20240726$$MD$FR$FR
163227683$16322768$3$F$20060101$20240705$20190516$20240709$PER$$US-JNJFOC-20190505394$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$LW$US$US
163228652$16322865$2$F$$20240701$20190516$20240704$PER$$US-JNJFOC-20190505601$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$LW$US$US
1632344310$16323443$10$F$20190508$20240819$20190517$20240826$EXP$$CA-ROCHE-2319532$ROCHE$$66$YR$E$M$Y$$$20240826$$CN$CA$CA
163242753$16324275$3$F$$20240819$20190517$20240829$EXP$$CA-AUROBINDO-AUR-APL-2019-026129$AUROBINDO$$71$YR$$F$Y$$$20240829$$CN$CA$CA
163248486$16324848$6$F$$20240923$20190517$20240925$PER$$US-BIOGEN-2017BI00347658$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
163261015$16326101$5$F$20231201$20240717$20190517$20240724$EXP$$BR-TAKEDA-2019TUS029682$TAKEDA$$40$YR$$M$Y$$$20240724$$CN$BR$BR
1632735011$16327350$11$F$20170430$20240923$20190517$20240926$EXP$$CA-PFIZER INC-2017196519$PFIZER$$68$YR$$F$Y$$$20240926$$CN$CA$CA
163276649$16327664$9$F$$20240919$20190517$20240924$EXP$$PHJP2019JP005244$NOVARTIS$$36$YR$$F$Y$$$20240924$$MD$JP$JP
1632824915$16328249$15$F$20190508$20240912$20190518$20240918$EXP$$CA-TAKEDA-2019TUS030220$TAKEDA$$57$YR$$F$Y$113$KG$20240918$$HP$CA$CA
163287642$16328764$2$F$$20240813$20190519$20240816$EXP$$US-JNJFOC-20190510788$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240816$$LW$US$US
163287862$16328786$2$F$$20240703$20190519$20240709$PER$$US-JNJFOC-20190510871$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$LW$US$US
163288602$16328860$2$F$$20240807$20190519$20240814$PER$$US-JNJFOC-20190510796$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$LW$US$US
163289312$16328931$2$F$19970101$20240701$20190519$20240704$PER$$US-JNJFOC-20190510510$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240705$$LW$US$US
163289752$16328975$2$F$$20240807$20190519$20240812$PER$$US-JNJFOC-20190510758$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$LW$US$US
163292762$16329276$2$F$20150130$20240716$20190520$20240729$EXP$$US-009507513-1905USA006932$MERCK$$56$YR$$F$Y$80.5$KG$20240729$$MD$US$US
163310447$16331044$7$F$20191201$20240619$20190520$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011886$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240712$$CN$US$US
163335534$16333553$4$F$20190101$20240723$20190520$20240728$EXP$$CA-JNJFOC-20190523390$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$57.2$KG$20240728$$HP$CA$CA
1633390119$16333901$19$F$20190426$20240626$20190520$20240710$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK183050$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$BR$BR
1633490910$16334909$10$F$20170701$20240909$20190520$20240919$EXP$$PHHY2017CA165411$NOVARTIS$$43$YR$$F$Y$68.9$KG$20240919$$MD$CA$CA
163365082$16336508$2$F$$20240910$20190521$20240914$EXP$$CZ-ROCHE-2319261$ROCHE$Hodacova J. Duel of titans - specialized symposium of Sanofi Genzyme at PRAGUE ONCO 2019.. FARMAKOTERAPIE. 2019;2:202-205.$$$$F$Y$$$20240914$$HP$CZ$CZ
1633712712$16337127$12$F$20190301$20240729$20190521$20240801$PER$$US-PFIZER INC-2019209722$PFIZER$$63$YR$$F$Y$96.145$KG$20240801$$CN$US$US
1633848311$16338483$11$F$20180508$20240901$20190521$20240912$EXP$$DE-ROCHE-2322194$ROCHE$$56$YR$A$M$Y$83$KG$20240912$$MD$DE$DE
163405374$16340537$4$F$$20240720$20190522$20240801$EXP$$CA-AUROBINDO-AUR-APL-2019-027425$AUROBINDO$$8$YR$$F$Y$$$20240801$$MD$CA$CA
163405546$16340554$6$F$$20240720$20190522$20240731$EXP$$CA-AUROBINDO-AUR-APL-2019-027601$AUROBINDO$$69$YR$$F$Y$$$20240731$$HP$CA$CA
163415375$16341537$5$F$$20240829$20190522$20240909$EXP$$CA-AUROBINDO-AUR-APL-2019-027592$AUROBINDO$$63$YR$$M$Y$61$KG$20240909$$HP$CA$CA
163417887$16341788$7$F$20190201$20240911$20190522$20240916$EXP$$DE-ROCHE-2270829$ROCHE$$48$YR$A$F$Y$$$20240916$$CN$DE$DE
1634238515$16342385$15$F$$20240815$20190522$20240828$EXP$$CA-AUROBINDO-AUR-APL-2019-027417$AUROBINDO$$52$YR$$F$Y$$$20240828$$HP$CA$CA
163424356$16342435$6$F$20190401$20240801$20190522$20240906$PER$$US-INCYTE CORPORATION-2019IN003656$INCYTE$$$$$$Y$$$20240906$$CN$US$US
163450172$16345017$2$F$19950101$20240807$20190523$20240812$PER$$US-JNJFOC-20190514622$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240812$$LW$US$US
163451232$16345123$2$F$$20240701$20190523$20240705$PER$$US-JNJFOC-20190514681$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$LW$US$US
163451242$16345124$2$F$$20240916$20190523$20240922$PER$$US-JNJFOC-20190514509$JOHNSON AND JOHNSON$$$$$M$Y$$$20240922$$LW$US$US
163451252$16345125$2$F$$20240701$20190523$20240704$PER$$US-JNJFOC-20190513978$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$LW$US$US
163453002$16345300$2$F$$20240624$20190523$20240701$PER$$US-JNJFOC-20190514576$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$LW$US$US
163456712$16345671$2$F$$20240701$20190523$20240705$PER$$US-JNJFOC-20190514686$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$LW$US$US
163457962$16345796$2$F$$20240807$20190523$20240809$PER$$US-JNJFOC-20190514472$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$LW$US$US
163458528$16345852$8$F$20180323$20240821$20190523$20240827$EXP$$CA-ROCHE-2323442$ROCHE$$36$YR$A$F$Y$$$20240827$$CN$CA$CA
163461992$16346199$2$F$$20240827$20190523$20240905$EXP$$CA-AUROBINDO-AUR-APL-2019-028478$AUROBINDO$$50$YR$$F$Y$80$KG$20240905$$HP$CA$CA
163462937$16346293$7$F$$20240708$20190523$20240709$PER$$US-PFIZER INC-2019212053$PFIZER$$66$YR$$F$Y$$$20240709$$MD$US$US
1634731710$16347317$10$F$20190506$20240826$20190523$20240903$EXP$$CA-ROCHE-2320708$ROCHE$$60$YR$A$F$Y$$$20240903$$CN$CA$CA
163504552$16350455$2$F$$20240923$20190524$20240927$PER$$US-GLAXOSMITHKLINE-US2019AMR087839$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
163509945$16350994$5$F$20190506$20240717$20190524$20240730$EXP$$CA-ROCHE-2324405$ROCHE$$72$YR$E$M$Y$$$20240730$$CN$CA$CA
163524109$16352410$9$F$20190418$20240716$20190524$20240729$EXP$$DE-ROCHE-2324933$ROCHE$$36$YR$A$F$Y$$$20240729$$CN$DE$DE
163541522$16354152$2$F$$20240701$20190524$20240704$PER$$US-JNJFOC-20190517419$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$LW$US$US
163543252$16354325$2$F$20130101$20240624$20190524$20240701$PER$$US-JNJFOC-20190517132$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240701$$LW$US$US
163546728$16354672$8$F$20180101$20240910$20190524$20240916$EXP$$US-TAKEDA-2018TUS017561$TAKEDA$$$$$F$Y$89.796$KG$20240916$$MD$US$US
1635675924$16356759$24$F$20180328$20240829$20190527$20240905$EXP$$DE-ROCHE-2161436$ROCHE$$53$YR$A$F$Y$$$20240905$$CN$DE$DE
163574152$16357415$2$F$20190301$20240917$20190527$20240924$EXP$$US-GLAXOSMITHKLINE-US2019093307$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$US$US
163595614$16359561$4$F$$20240918$20190528$20240924$EXP$$US-BIOGEN-2019BI00742829$BIOGEN$$$$$F$Y$$$20240924$$CN$US$US
163600713$16360071$3$F$$20240911$20190528$20240919$PER$$US-ROCHE-2310255$ROCHE$Kang M, Aslam S Varicella zoster virus encephalitis in solid organ transplant recipients: Case series and review of literature.. Transplant Infectious Disease 2019 Apr;21 (2):1-6.$66$YR$E$M$Y$$$20240919$$HP$US$US
1636014919$16360149$19$F$20181002$20240809$20190528$20240814$EXP$$CA-ROCHE-2195293$ROCHE$$51$YR$A$F$Y$86.18$KG$20240814$$MD$CA$CA
163608024$16360802$4$F$20180101$20240703$20190528$20240712$EXP$$PT-AUROBINDO-AUR-APL-2019-028333$AUROBINDO$Branco FP, Brito CB, Luz G, Teixeira JA. Central venous catheter misplaced in the epidural space. BMJ Case Reports. 2019;12(4):E229295:1-2$56$YR$$M$Y$85$KG$20240712$$MD$PT$PT
1636200420$16362004$20$F$$20240718$20190528$20240723$EXP$$US-PFIZER INC-2019226757$PFIZER$$63$YR$$M$Y$117.93$KG$20240723$$CN$US$US
163624338$16362433$8$F$20190403$20240917$20190528$20240919$EXP$$US-PFIZER INC-2019227766$PFIZER$$77$YR$$M$Y$$$20240919$$CN$US$US
163629417$16362941$7$F$20180101$20240906$20190528$20240913$EXP$$PHHY2019PL109802$NOVARTIS$Gozdzik M, Grzejszczak P, Kurnatowska I. Treatment of posttransplant diabetes with linagliptin, evaluation of effectiveness and safety - a series of clinical cases. FORUM NEFROL. 2019;12(1):33-40$62$YR$$M$Y$$$20240913$$HP$PL$PL
1636621412$16366214$12$F$20180529$20240722$20190529$20240805$EXP$$DE-ROCHE-2326667$ROCHE$$41$YR$A$F$Y$61$KG$20240805$$MD$DE$DE
163675597$16367559$7$F$$20240627$20190529$20240702$PER$$US-PFIZER INC-2019228392$PFIZER$$69$YR$$M$Y$83.91$KG$20240702$$MD$US$US
1637019613$16370196$13$F$20170206$20240703$20190530$20240708$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN199674$VIIV$$$$$$Y$$$20240708$$MD$JP$JP
163715778$16371577$8$F$$20240821$20190530$20240827$PER$$US-PFIZER INC-2019208103$PFIZER$$65$YR$$F$Y$$$20240827$$CN$US$US
163722232$16372223$2$F$$20240816$20190530$20240828$EXP$$DE-Rare Disease Therapeutics, Inc.-2067591$NOVA LABORATORIES$$34$YR$$F$Y$$$20240828$$$DE$DE
163750953$16375095$3$F$$20190621$20190531$20240815$EXP$$JP-AMGEN-JPNSP2019085706$AMGEN$$$$$F$Y$$$20240814$$MD$JP$JP
163759846$16375984$6$F$$20240814$20190531$20240826$EXP$$CA-APOTEX-2019AP015208$APOTEX$$60$YR$$M$Y$$$20240826$$HP$CA$CA
163764538$16376453$8$F$20181201$20240817$20190531$20240826$EXP$$CA-ROCHE-2258818$ROCHE$$55$YR$A$F$Y$$$20240826$$CN$CA$CA
163781515$16378151$5$F$$20240715$20190531$20240722$PER$$US-GLAXOSMITHKLINE-US2019096520$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
163790585$16379058$5$F$$20240819$20190531$20240827$EXP$$US-TAKEDA-2019TUS031448$TAKEDA$$$$$M$Y$150.36$KG$20240827$$HP$US$US
163793838$16379383$8$F$$20240918$20190531$20240923$PER$$US-PFIZER INC-2019232880$PFIZER$$65$YR$$F$Y$$$20240923$$CN$US$US
163805984$16380598$4$F$20110901$20240918$20190601$20240927$EXP$IT-MACLEODS PHARMACEUTICALS US LTD-MAC2019021486$IT-MACLEODS PHARMACEUTICALS US LTD-MAC2019021486$MACLEODS$$$$$$Y$$$20240927$$CN$IT$IT
163806183$16380618$3$F$20110901$20240918$20190601$20240926$EXP$$IT-AUROBINDO-AUR-APL-2013-10064$AUROBINDO$Ginanneschi F, Volpi N, Giannini F, Rocchi R, Donati D, Margherita Aglian?, Paola Lorenzoni, Alessandro Rossi. Rhabdomyolysis in an elderly multitreated patient: Multiple drug interactions after statin withdrawal. Journal of the Neurological Sciences. 2013;1-4$72$YR$$M$Y$$$20240926$$HP$IT$IT
163806252$16380625$2$F$20170405$20240718$20190601$20240729$EXP$$FR-AUROBINDO-AUR-APL-2019-031255$AUROBINDO$$32$YR$$M$Y$82$KG$20240729$$MD$FR$FR
1638281117$16382811$17$F$20190101$20240819$20190603$20240826$EXP$$JP-ABBVIE-19S-087-2785090-00$ABBVIE$$48$YR$$F$Y$43$KG$20240826$$MD$JP$JP
163829922$16382992$2$F$20190314$20240918$20190603$20240919$EXP$$IT-TAKEDA-2019TEU006421$TAKEDA$$83$YR$$F$Y$60$KG$20240919$$HP$IT$IT
163830083$16383008$3$F$20171101$20240910$20190603$20240912$EXP$$US-PFIZER INC-2019232687$PFIZER$$11$MON$$M$Y$$$20240912$$MD$US$US
163834642$16383464$2$F$$20240726$20190603$20240730$PER$$US-PFIZER INC-2019235258$PFIZER$$64$YR$$F$Y$$$20240730$$CN$US$US
1638445825$16384458$25$F$20190306$20240703$20190603$20240708$EXP$$CA-TAKEDA-2019TUS030138$TAKEDA$$40$YR$$F$Y$$$20240708$$CN$CA$CA
163848807$16384880$7$F$20190602$20240903$20190603$20240904$EXP$$US-SHIRE-US201917934$TAKEDA$$46$YR$$F$Y$$$20240904$$MD$US$US
1638628019$16386280$19$F$20190723$20240802$20190603$20240813$EXP$$CA-TAKEDA-2019TUS033301$TAKEDA$$69$YR$$M$Y$$$20240813$$HP$CA$CA
163867286$16386728$6$F$$20240801$20190604$20240814$EXP$$CA-AUROBINDO-AUR-APL-2019-029812$AUROBINDO$$38$YR$$F$Y$54$KG$20240814$$HP$CA$CA
163884254$16388425$4$F$$20240706$20190604$20240716$EXP$$JP-ROCHE-2105381$ROCHE$Ebina K, Hashimoto M, Yamamoto W, Ohnishi A, Kabata D, Hirano T, Hara R, Katayama M, Yoshida S, Nagai K, Son Y, Amuro H, Akashi K, Fujimura T, Hirao M, Yamamoto K, Shintani A, Kumanogoh A and Yoshikawa H Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.. PLoS ONE 2018 Mar;13 (3):1-13.$$$$$Y$$$20240716$$HP$JP$JP
163898952$16389895$2$F$20170501$20240715$20190604$20240717$EXP$$ES-PURDUE-GBR-2019-0066872$PURDUE$$74$YR$$F$Y$$$20240717$$MD$ES$ES
163899352$16389935$2$F$$20240816$20190604$20240828$EXP$$DE-Rare Disease Therapeutics, Inc.-2067772$NOVA LABORATORIES$$$$$M$Y$$$20240828$$$DE$DE
163929655$16392965$5$F$$20240813$20190605$20240826$EXP$$CA-AUROBINDO-AUR-APL-2019-030680$AUROBINDO$$56$YR$$F$Y$$$20240826$$HP$CA$CA
163935572$16393557$2$F$20170405$20240711$20190605$20240715$EXP$$FR-PFIZER INC-2019235635$PFIZER$$32$YR$$M$Y$82$KG$20240715$$MD$FR$FR
163967544$16396754$4$F$20161208$20240726$20190606$20240805$EXP$$JP-009507513-1905JPN006220$MERCK$$74$YR$$M$Y$50$KG$20240805$$HP$JP$JP
163995234$16399523$4$F$20190501$20240812$20190606$20240822$PER$$US-INCYTE CORPORATION-2019IN005506$INCYTE$$$$$$Y$$$20240822$$CN$US$US
164005536$16400553$6$F$20190101$20240819$20190606$20240829$EXP$$US-CATALYST PHARMACEUTICALS, INC-2019CAT00172$CATALYST PHARMA$$$$$F$Y$87.528$KG$20240829$$CN$US$US
1640313018$16403130$18$F$20190401$20240717$20190607$20240729$EXP$$PHHY2018CO072743$NOVARTIS$$15$YR$$F$Y$53$KG$20240729$$CN$CO$CO
1640315116$16403151$16$F$20190101$20240723$20190607$20240729$EXP$$CA-ROCHE-2329495$ROCHE$$46$YR$A$F$Y$$$20240729$$CN$CA$CA
164037176$16403717$6$F$20181205$20240704$20190607$20240716$EXP$$CA-ROCHE-2333742$ROCHE$$19$YR$A$F$Y$$$20240716$$CN$CA$CA
164052672$16405267$2$F$$20240926$20190607$20240927$EXP$$US-PFIZER INC-2019242269$PFIZER$$72$YR$$M$Y$$$20240927$$MD$US$US
164056804$16405680$4$F$20050101$20240916$20190607$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US201905014778$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240927$$CN$US$US
1641175312$16411753$12$F$20191203$20240705$20190610$20240710$EXP$$US-SHIRE-US201918588$TAKEDA$$66$YR$$M$Y$$$20240710$$CN$US$US
164117792$16411779$2$F$20180319$20240724$20190610$20240730$EXP$$FR-MYLANLABS-2019M1053223$MYLAN$$75$YR$$F$Y$61$KG$20240730$$MD$FR$FR
1641276813$16412768$13$F$20180613$20240618$20190611$20240701$EXP$$CA-ROCHE-2334612$ROCHE$$42$YR$A$F$Y$$$20240701$$MD$CA$CA
164135873$16413587$3$F$$20240729$20190611$20240806$EXP$$US-ROCHE-2332471$ROCHE$$55$YR$A$F$Y$70.31$KG$20240806$$CN$US$US
164142083$16414208$3$F$$20240628$20190611$20240716$EXP$$PHHY2019AR132713$NOVARTIS$$$$$M$Y$$$20240716$$CN$AR$AR
164143598$16414359$8$F$20180101$20240911$20190611$20240919$EXP$$CA-TAKEDA-2018TUS006952$TAKEDA$$$$$F$Y$$$20240919$$CN$CA$CA
1641566614$16415666$14$F$20181101$20240701$20190611$20240710$PER$$US-SA-2019SA155215$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240710$$MD$US$US
1641673817$16416738$17$F$$20240716$20190611$20240730$EXP$$BR-GLAXOSMITHKLINE-BR2019GSK102514$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$BR$BR
164170994$16417099$4$F$20181220$20240729$20190611$20240801$EXP$$US-ABBVIE-19P-163-2812685-00$ABBVIE$$58$YR$$M$Y$$$20240801$$MD$US$US
1641850533$16418505$33$F$20180301$20240816$20190612$20240824$EXP$$CA-CELLTRION INC.-2018CA019337$CELLTRION$$$$$$Y$$$20240824$$CN$CA$CA
164198523$16419852$3$F$20190523$20240624$20190612$20240702$EXP$$KR-ALEXION PHARMACEUTICALS INC.-A201908630$ALEXION PHARMACEUTICALS$$56$YR$$M$Y$51$KG$20240702$$MD$KR$KR
164205854$16420585$4$F$20161227$20240723$20190612$20240725$EXP$$US-JNJFOC-20190608418$JOHNSON AND JOHNSON$$5$MON$I$M$Y$4.224$KG$20240725$$HP$US$US
164239272$16423927$2$F$20190314$20240911$20190613$20240924$EXP$IT-MINISAL02-552076$IT-TEVA-2019-IT-1060765$TEVA$$83$YR$$F$Y$60$KG$20240920$$PH$IT$IT
164251415$16425141$5$F$$20240916$20190613$20240923$EXP$$PT-MYLANLABS-2019M1054923$MYLAN$Pereira LAL, Meng C, Guedes L, Marques S, Nunes A, Sampaio S et al... Infective endocarditis in renal transplant recipients: one center^s experience.. Portuguese Journal of Nephrology and Hypertension.. 2018;32 (4):337-341$39$YR$$F$Y$$$20240923$$HP$PT$PT
164275582$16427558$2$F$20151209$20240711$20190613$20240712$EXP$$FR-PFIZER INC-2019253429$PFIZER$$35$YR$$F$Y$99$KG$20240712$$MD$FR$FR
164320794$16432079$4$F$$20240716$20190614$20240724$EXP$$CA-APOTEX-2019AP015597$APOTEX$$56$YR$$F$Y$$$20240724$$HP$CA$CA
164331502$16433150$2$F$20140212$20240715$20190614$20240723$PER$$US-JNJFOC-20170510686$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240722$$HP$US$US
164334752$16433475$2$F$19990101$20240731$20190614$20240806$PER$$US-JNJFOC-20150702913$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240806$$HP$US$US
164335792$16433579$2$F$20120208$20240729$20190614$20240806$PER$$US-JNJFOC-20170422723$JOHNSON AND JOHNSON$$15$YR$T$M$Y$96.4$KG$20240806$$HP$US$US
164339832$16433983$2$F$$20240822$20190614$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US201906001671$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240829$$CN$US$US
164346105$16434610$5$F$20171219$20240903$20190614$20240918$EXP$$US-ABBVIE-19P-163-2819883-00$ABBVIE$$23$YR$$M$Y$$$20240918$$MD$US$US
164353162$16435316$2$F$20161201$20240724$20190614$20240726$EXP$$FR-MYLANLABS-2019M1054965$MYLAN$$51$YR$$F$Y$94$KG$20240726$$MD$FR$FR
164372614$16437261$4$F$$20240830$20190615$20240910$EXP$$CA-AUROBINDO-AUR-APL-2019-032658$AUROBINDO$$78$YR$$F$Y$$$20240910$$HP$CA$CA
164380599$16438059$9$F$20190426$20200917$20190617$20240807$EXP$$JP-009507513-1906JPN000753J$MERCK$Katsu K, Muraki K, Murashima K, Nishioki T, Mimori Y, Sekiya M. 53 A case of large cell neuroendocrine carcinoma associated with type 1 diabetes and isolated ACTH deficiency due to pembrolizumab. The 176th meeting of the Kanto branch of the Japanese society for tuberculosis.. 30$72$YR$$M$Y$55$KG$20240807$$MD$JP$JP
1643937621$16439376$21$F$20230121$20240827$20190617$20240830$EXP$$US-SHIRE-US201919349$TAKEDA$$65$YR$$F$Y$$$20240830$$CN$US$US
1643950917$16439509$17$F$20200101$20240709$20190617$20240711$EXP$$US-PFIZER INC-2019251641$PFIZER$$69$YR$$F$Y$65.77$KG$20240711$$CN$US$US
164397402$16439740$2$F$20190517$20240708$20190617$20240710$EXP$$AT-PFIZER INC-2019250608$PFIZER$$$$A$M$Y$$$20240710$$MD$AT$AT
1644000915$16440009$15$F$$20240617$20190617$20240702$EXP$E2B_02373859$CA-ASSERTIO THERAPEUTICS, INC.-CA-2019DEP000563$ASSERTIO THERAPEUTICS$$43$YR$$F$Y$97$KG$20240702$$MD$CA$CA
164435972$16443597$2$F$$20240819$20190618$20240829$PER$$US-SHIRE-US201918603$TAKEDA$$$$$F$Y$61$KG$20240829$$CN$US$US
164438794$16443879$4$F$$20240724$20190618$20240807$EXP$$CA-AUROBINDO-AUR-APL-2019-033209$AUROBINDO$$53$YR$$F$Y$$$20240807$$HP$CA$CA
164438824$16443882$4$F$$20240726$20190618$20240806$EXP$$CA-AUROBINDO-AUR-APL-2019-033449$AUROBINDO$$15$YR$$F$Y$$$20240806$$HP$CA$CA
164439012$16443901$2$F$$20240814$20190618$20240827$EXP$$CA-AUROBINDO-AUR-APL-2019-033237$AUROBINDO$$45$YR$$M$Y$$$20240827$$HP$CA$CA
1644413910$16444139$10$F$$20240726$20190618$20240807$EXP$$CA-AUROBINDO-AUR-APL-2019-033469$AUROBINDO$$53$YR$$M$Y$69$KG$20240807$$HP$CA$CA
164449654$16444965$4$F$$20240813$20190618$20240827$EXP$$CA-AUROBINDO-AUR-APL-2019-033524$AUROBINDO$$47$YR$$F$Y$$$20240827$$HP$CA$CA
1644500917$16445009$17$F$$20240723$20190618$20240803$EXP$$CA-AUROBINDO-AUR-APL-2019-033389$AUROBINDO$$36$YR$$F$Y$$$20240803$$PH$CA$CA
164450478$16445047$8$F$$20240910$20190618$20240923$EXP$$CA-APOTEX-2019AP016526$APOTEX$$53$YR$$F$Y$$$20240923$$HP$CA$CA
164451536$16445153$6$F$$20240805$20190618$20240808$EXP$$US-PFIZER INC-2019254201$PFIZER$Pimentel, J.. Adrenal insufficiency due to combined inhaled corticosteroid and Azole agent. Hormone Research in Paediatrics. 2017;88 (Suppl 1):438-439$9$YR$$F$Y$$$20240808$$MD$US$US
1644632819$16446328$19$F$20220307$20240905$20190618$20240911$EXP$$CA-TAKEDA-2019TUS037895$TAKEDA$$42$YR$$F$Y$$$20240911$$MD$CA$CA
164470486$16447048$6$F$$20240711$20190618$20240715$EXP$$US-SHIRE-US201919173$TAKEDA$$$$$F$Y$86$KG$20240715$$HP$US$US
164472122$16447212$2$F$$20190610$20190618$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-057049$BRISTOL MYERS SQUIBB$A surgical case of unilateral acute pyothorax complicated by bilateral chylothorax during treatment for chronic myeloid leukaemia. The 36th Annual Meeting of the Japanese Association for Chest Surgery. 2019;P92-2.$29$YR$A$M$Y$$$20240913$$MD$JP$JP
164474532$16447453$2$F$$20240812$20190619$20240823$EXP$$CA-AUROBINDO-AUR-APL-2019-033673$AUROBINDO$$8$WK$$$Y$$$20240823$$HP$CA$CA
1645190411$16451904$11$F$$20240828$20190619$20240903$EXP$$PT-MYLANLABS-2019M1056256$MYLAN$Fonseca NM, Navarro D, Gois M, Sousa H, Aires I, Nolasco F.. Streamlining diagnosis with urinary sediment microscopy: a case of deteriorating renal function in a kidney transplant patient.. Portuguese Journal of Nephrology and Hypertension.. 2018;32 (4):381-4, 389-92$71$YR$$M$Y$$$20240903$$HP$PT$PT
164549423$16454942$3$F$$20240610$20190620$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2019-013139$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$HP$US$US
1645527727$16455277$27$F$20190101$20240905$20190620$20240914$EXP$$CA-CELLTRION INC.-2019CA019833$CELLTRION$$$$$$Y$$$20240914$$MD$CA$CA
164576919$16457691$9$F$20120101$20240726$20190620$20240731$EXP$$US-PFIZER INC-2019258247$MYLAN$$$$$F$Y$93.44$KG$20240731$$CN$US$US
1646010521$16460105$21$F$20190603$20240809$20190620$20240814$EXP$$US-SHIRE-US201920074$TAKEDA$$50$YR$$F$Y$71$KG$20240814$$MD$US$US
164619716$16461971$6$F$20190320$20240827$20190621$20240902$EXP$$JP-GLAXOSMITHKLINE-JP2019JPN109024$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$JP$JP
1646378813$16463788$13$F$20221117$20240905$20190621$20240905$PER$$US-PFIZER INC-2019267737$PFIZER$$54$YR$$M$Y$$$20240905$$CN$US$US
1646416410$16464164$10$F$$20220127$20190621$20240722$PER$$US-ASTELLAS-2018US052755$ASTELLAS$$83$YR$$M$Y$$$20240722$$MD$US$US
1646632912$16466329$12$F$20190221$20240627$20190622$20240709$EXP$$CA-ROCHE-2341170$ROCHE$$59$YR$A$F$Y$40$KG$20240709$$CN$CA$CA
164685113$16468511$3$F$$20240909$20190624$20240912$EXP$$CA-PFIZER INC-2019262435$PFIZER$$42$YR$$F$Y$$$20240912$$CN$CA$CA
164702383$16470238$3$F$$20240718$20190624$20240724$EXP$$US-JAZZ-2019-US-008459$JAZZ$$$$$M$Y$$$20240724$$CN$US$US
164705934$16470593$4$F$20180801$20200312$20190624$20240912$EXP$$JP-GLAXOSMITHKLINE-JP2019JPN112121$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$JP$JP
164711347$16471134$7$F$$20240717$20190624$20240718$EXP$$US-PFIZER INC-2019270537$PFIZER$$52$YR$$F$Y$$$20240718$$CN$US$US
164713744$16471374$4$F$$20240625$20190624$20240702$EXP$$JP-GILEAD-2019-0414913$GILEAD$$$$A$M$Y$$$20240702$$MD$JP$JP
164746788$16474678$8$F$20170101$20240827$20190625$20240830$EXP$$CA-TAKEDA-2017TUS012674$TAKEDA$$$$$F$Y$$$20240830$$CN$CA$CA
164752656$16475265$6$F$20190523$20240815$20190625$20240828$PER$$US-SA-2019SA170638$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240828$$MD$US$US
164767924$16476792$4$F$20190618$20240916$20190626$20240921$EXP$$DE-ABBVIE-19K-062-2829547-00$ABBVIE$$83$YR$$M$Y$97$KG$20240921$$MD$DE$DE
164780413$16478041$3$F$$20240724$20190626$20240803$EXP$$CA-AUROBINDO-AUR-APL-2019-035859$AUROBINDO$$61$YR$$F$Y$$$20240803$$MD$CA$CA
164789662$16478966$2$F$20190619$20240628$20190626$20240701$PER$$US-SHIRE-US201920238$TAKEDA$$64$YR$$F$Y$60$KG$20240701$$CN$US$US
164791502$16479150$2$F$20180907$20231115$20190626$20240806$EXP$$US-SAOL THERAPEUTICS-2018SAO01022$AMNEAL$$17$YR$$M$Y$$$20240806$$MD$US$US
1648015112$16480151$12$F$20180105$20240715$20190626$20240718$EXP$$CA-TAKEDA-2016TUS021628$TAKEDA$$43$YR$$M$Y$$$20240718$$HP$CA$CA
164805032$16480503$2$F$$20240625$20190626$20240701$EXP$$JP-DSJP-DSJ-2019-122105$DAIICHI$Satou C, Hashiguchi K, Iyama R, Kawasaki H, Kinoshita R, Kuwahara A, et al.. A case of adult invagination of intestine which occurred after EMR for large intestine polyp. Jt Met 113th Rg Met JSGE Kyusyu Div + 107th Rg Met Cont Med Ed JGES Kyusyu Ch. 2019;190$78$YR$$M$Y$$$20240701$$MD$JP$JP
164817672$16481767$2$F$$20240912$20190627$20240924$EXP$NL-MACLEODS PHARMACEUTICALS US LTD-MAC2019021774$NL-MACLEODS PHARMACEUTICALS US LTD-MAC2019021774$MACLEODS$Cate IMR, Maten JV, Overbeek MJ, Holder JTT..Organising pneumonia and non-specific interstitial pneumonia as a late consequence of treatment with imatinib in a patient with chronic myeloid leukaemia.Ned Tijdschr Allergie, Astma, Klin Immunol.2019;19:22-27$$$$$Y$$$20240924$$HP$NL$NL
164828352$16482835$2$F$20160918$20240904$20190627$20240911$EXP$$DE-JNJFOC-20190631078$JOHNSON AND JOHNSON$$20$YR$A$F$Y$54$KG$20240911$$MD$DE$DE
164828433$16482843$3$F$$20240815$20190627$20240827$EXP$$CA-AUROBINDO-AUR-APL-2019-035424$AUROBINDO$$26$YR$$M$Y$$$20240827$$HP$CA$CA
164830722$16483072$2$F$$20240624$20190627$20240704$EXP$$JP-STRIDES ARCOLAB LIMITED-2019SP005522$STRIDES$Furumi Y, Shimizu S, Ogawa Y, Hirose D, Takada Y, Kanetaka H et al.. A suspicious case of coagulation disorder caused by vitamin K deficiency associated with fasting and antibiotics.. Nippon Medical Journal. 2019;56(2):204-208$91$YR$$M$Y$$$20240704$$PH$JP$JP
1648356119$16483561$19$F$20220101$20240716$20190627$20240717$EXP$$US-PFIZER INC-2018230052$PFIZER$$76$YR$$F$Y$62$KG$20240717$$CN$US$US
164867074$16486707$4$F$$20240626$20190627$20240709$EXP$$CO-INCYTE CORPORATION-2018IN008617$INCYTE$$$$$$Y$$$20240709$$CN$CO$CO
164889914$16488991$4$F$$20240802$20190628$20240816$EXP$$CA-AUROBINDO-AUR-APL-2019-035550$AUROBINDO$$72$YR$$F$Y$$$20240816$$HP$CA$CA
164955663$16495566$3$F$$20240827$20190628$20240901$EXP$$US-SHIRE-US201920197$TAKEDA$$$$$F$Y$$$20240901$$HP$US$US
1649785111$16497851$11$F$20190605$20240910$20190628$20240912$EXP$$US-PFIZER INC-2019265512$PFIZER$$74$YR$$F$Y$85$KG$20240912$$CN$US$US
164979933$16497993$3$F$20240404$20240910$20190628$20240918$EXP$$CA-JNJFOC-20190625630$JOHNSON AND JOHNSON$$61$YR$A$F$Y$48$KG$20240918$$HP$CA$CA
164982652$16498265$2$F$$20240913$20190629$20240924$EXP$$NL-AUROBINDO-AUR-APL-2019-036262$AUROBINDO$Pinxterhuis TH, Out M, Van Den Broek R, et al.. Transient thyroiditis after parathyroidectomy for tertiary hyperparathyroidism.. Netherlands Journal of Medicine.. 2019;77:119-121$32$YR$$M$Y$$$20240924$$HP$NL$NL
164984362$16498436$2$F$20190603$20240624$20190629$20240702$EXP$$ES-AUROBINDO-AUR-APL-2019-036472$AUROBINDO$$44$YR$$F$Y$$$20240702$$MD$ES$ES
1649962113$16499621$13$F$20190613$20240709$20190701$20240715$EXP$$BR-GLAXOSMITHKLINE-BR2019AMR113910$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$MD$BR$BR
164997706$16499770$6$F$20160101$20240823$20190701$20240904$EXP$$SK-Accord-135126$ACCORD$Dvoroznakova M et al.. Life of a patient with hearth failure. When is the appropriate time for action.. 2016;1-3$53$YR$A$F$Y$$$20240904$$MD$SK$SK
165001574$16500157$4$F$20180123$20240725$20190701$20240729$EXP$$PHJP2019JP006683$NOVARTIS$$78$YR$$M$Y$$$20240729$$MD$JP$JP
165012582$16501258$2$F$$20240717$20190701$20240722$EXP$$CA-PFIZER INC-2019275607$MYLAN$$22$YR$$F$Y$$$20240722$$HP$CA$CA
165039722$16503972$2$F$20190322$20220222$20190701$20240703$PER$$PHEH2019US027517$NOVARTIS$$46$YR$$M$Y$$$20240703$$CN$US$US
165056712$16505671$2$F$20190624$20240716$20190701$20240723$PER$$US-SA-2019SA176880$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240723$$MD$US$US
1650723810$16507238$10$F$20190601$20240731$20190701$20240806$EXP$$US-PFIZER INC-2019273483$PFIZER$$61$YR$$F$Y$71.973$KG$20240806$$CN$US$US
1650785038$16507850$38$F$20190101$20240913$20190701$20240918$EXP$$BR-GLAXOSMITHKLINE-BR2019GSK041108$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$BR$BR
165096666$16509666$6$F$$20240720$20190702$20240731$EXP$$CA-AUROBINDO-AUR-APL-2019-036542$AUROBINDO$$32$YR$$F$Y$70$KG$20240731$$HP$CA$CA
165164544$16516454$4$F$20111017$20240909$20190702$20240913$EXP$$FR-MYLANLABS-2019M1060611$MYLAN$$41$YR$$F$Y$74$KG$20240913$$CN$FR$FR
1651821010$16518210$10$F$$20240826$20190702$20240829$PER$$US-PFIZER INC-2019282913$PFIZER$$75$YR$$F$Y$$$20240829$$CN$US$US
165200899$16520089$9$F$20160101$20240627$20190702$20240701$EXP$$CA-PFIZER INC-2019281673$PFIZER$Lewin, A.. Bacillus cereus infection in neonates and the absence of evidence for the role of banked human milk: Case reports and literature review. Infection Control and Hospital Epidemiology. 2019;40 (7):787-793$6$DY$$$Y$0.56$KG$20240701$$MD$CA$CA
1652241913$16522419$13$F$$20240830$20190703$20240906$EXP$$US-PFIZER INC-2019280984$PFIZER$$61$YR$$F$Y$$$20240906$$CN$US$US
165261742$16526174$2$F$$20240720$20190703$20240801$EXP$$CA-AUROBINDO-AUR-APL-2019-036480$AUROBINDO$$$$$$Y$$$20240801$$HP$CA$CA
165265219$16526521$9$F$20231001$20240724$20190703$20240731$EXP$$US-JAZZ-2019-US-009135$JAZZ$$65$YR$$F$Y$$$20240731$$MD$US$US
1652658013$16526580$13$F$20160901$20240626$20190703$20240701$EXP$$CA-TAKEDA-2016TUS016067$TAKEDA$$70$YR$$F$Y$$$20240701$$CN$CA$CA
165266393$16526639$3$F$$20240619$20190704$20240701$EXP$$CA-APOTEX-2019AP017328$APOTEX$$$$$M$Y$$$20240701$$MD$CA$CA
165305333$16530533$3$F$20160918$20240831$20190704$20240910$EXP$$DE-AUROBINDO-AUR-APL-2019-037278$AUROBINDO$$20$YR$$F$Y$54$KG$20240910$$MD$DE$DE
165309643$16530964$3$F$20190101$20240704$20190705$20240708$EXP$$CA-PFIZER INC-2019019743$PFIZER$$57$YR$$F$Y$$$20240708$$CN$CA$CA
165321712$16532171$2$F$$20240826$20190705$20240828$EXP$$US-BAYER-2019-126007$BAYER$$$$$$Y$$$20240828$$CN$US$US
1653267218$16532672$18$F$20161027$20240807$20190704$20240815$EXP$$CA-ROCHE-1994734$ROCHE$$79$YR$E$F$Y$51$KG$20240815$$CN$CA$CA
1653327111$16533271$11$F$$20240909$20190705$20240920$EXP$$PL-PFIZER INC-2019289284$PFIZER$Komorowska, A.. Cessation of empagliflozin treatment in a hospitalised patient with exacerbated heart failure and reduced ejection fraction. Folia Cardiologica. 2019;14(2):206-212$56$YR$$M$Y$120$KG$20240920$$MD$PL$PL
1653344912$16533449$12$F$20181001$20240903$20190704$20240909$EXP$$PHHY2018CO051727$NOVARTIS$$53$YR$$F$Y$70$KG$20240909$$CN$CO$CO
165335685$16533568$5$F$$20240813$20190705$20240815$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-064199$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240815$$MD$BR$BR
165339676$16533967$6$F$20190101$20240916$20190704$20240924$EXP$$DE-ABBVIE-19K-062-2843492-00$ABBVIE$$$$$M$Y$74$KG$20240924$$MD$DE$DE
165362432$16536243$2$F$$20240723$20190705$20240725$PER$$US-PFIZER INC-2019286283$PFIZER$$67$YR$$M$Y$$$20240725$$MD$US$US
165362944$16536294$4$F$$20240827$20190705$20240830$EXP$$US-PFIZER INC-2019287709$MYLAN$$$$$M$Y$$$20240830$$CN$US$US
165390722$16539072$2$F$$20240809$20190708$20240819$EXP$$PHHY2018BE056500$NOVARTIS$Verschelden G, Laethem JV, Velkeniers B, Ilsen B, Noeparast A, De Greve JD. Significant response to dabrafenib in a patient with erdheim-chester disease with BRAF V600E mutation. POLISH ARCHIVES OF INTERNAL MEDICINE. 2018;128(6):386-8$57$YR$$M$Y$$$20240819$$HP$BE$BE
165392606$16539260$6$F$20190101$20221012$20190708$20240925$EXP$DE-ROCHE-2348859$DE-ROCHE-2348859$ROCHE$Heger J, Eichenauer D, Kasper P, Boll B, Shimabukuro-Vornhagen A, and Kochanek M Fatal disseminated enterovirus infection in a patient with follicular lymphoma undergoing obinutuzumab maintenance therapy. European Journal of Haematology 2019;103 (3):268-71.$45$YR$A$F$Y$70$KG$20240925$$HP$DE$DE
165396256$16539625$6$F$$20240924$20190708$20240930$EXP$$US-SHIRE-US201920683AA$TAKEDA$$$$$F$Y$$$20240930$$CN$US$US
165400042$16540004$2$F$20180101$20240913$20190708$20240924$EXP$$IT-MYLANLABS-2019M1061388$MYLAN$$59$YR$$M$Y$119$KG$20240924$$HP$IT$IT
165410782$16541078$2$F$$20240912$20190708$20240917$EXP$$ES-MYLANLABS-2019M1062109$MYLAN$Los-Arcos I, Royuela M, Martin-Gomez MT, Alastruey-Izquierdo A, Sellares J, Perello M, et al. Phaeohyphomycosis caused by Medicopsis romeroi in solid organ transplant recipients: Report of two cases and comprehensive review of the literature. Transpl-Infect-Dis 2019;21:No. 3.$56$YR$$F$Y$$$20240917$$HP$ES$ES
165412703$16541270$3$F$20170501$20240729$20190708$20240731$PER$$US-INCYTE CORPORATION-2019IN006565$INCYTE$$$$$$Y$$$20240731$$HP$US$US
165427248$16542724$8$F$20190301$20240711$20190709$20240722$EXP$$CA-ROCHE-2348199$ROCHE$$52$YR$A$F$Y$$$20240722$$CN$CA$CA
165428463$16542846$3$F$20170401$20240821$20190709$20240902$EXP$$ES-Accord-116229$ACCORD$Ordonez-FernAndez L, Rodriguez-Ferreras A, Carriles C, Martinez-Torron A, Lazaro-Lopez E, Rosado-Maria MC. Pneumonia in a patient with kidney transplant treated with alirocumab and everolimus. Farm Hosp. 2019 Mar 1;43(2):74-76.$47$YR$A$M$Y$$$20240902$$HP$ES$ES
1654288938$16542889$38$F$20191009$20240828$20190709$20240905$EXP$$CA-CELLTRION INC.-2019CA019741$CELLTRION$$$$$$Y$$$20240905$$CN$CA$CA
165429209$16542920$9$F$20240512$20240924$20190709$20240930$EXP$$US-SHIRE-US201921815$TAKEDA$$58$YR$$F$Y$48$KG$20240930$$CN$US$US
1654295811$16542958$11$F$$20240903$20190709$20240912$EXP$$CA-AUROBINDO-AUR-APL-2019-037759$AUROBINDO$$37$YR$$M$Y$122$KG$20240912$$HP$CA$CA
165433359$16543335$9$F$$20240826$20190709$20240829$EXP$$US-SHIRE-US201920068$TAKEDA$$$$$F$Y$67.12$KG$20240829$$MD$US$US
165433794$16543379$4$F$$20240905$20190709$20240924$PER$$US-GLAXOSMITHKLINE-US2019121871$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
1654436811$16544368$11$F$20190101$20240704$20190709$20240708$EXP$$PHHY2019CA158000$NOVARTIS$$57$YR$$M$Y$$$20240708$$CN$CA$CA
165458113$16545811$3$F$20180316$20240916$20190709$20240923$EXP$$AT-OTSUKA-2019_023554$OTSUKA$$48$YR$$F$Y$$$20240923$$MD$AT$AT
165465364$16546536$4$F$$20210804$20190709$20240722$PER$$US-ASTELLAS-2019US000421$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
165468296$16546829$6$F$20190109$20210804$20190709$20240722$PER$$US-ASTELLAS-2019US001555$ASTELLAS$$87$YR$$M$Y$$$20240722$$CN$US$US
165473124$16547312$4$F$20190501$20211220$20190709$20240722$PER$$US-ASTELLAS-2019US020366$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
165505442$16550544$2$F$$20240827$20190710$20240906$EXP$$CA-AUROBINDO-AUR-APL-2019-037951$AUROBINDO$$26$YR$$F$Y$$$20240906$$HP$CA$CA
165506112$16550611$2$F$$20240817$20190710$20240828$EXP$$CA-AUROBINDO-AUR-APL-2019-038298$AUROBINDO$$32$YR$$F$Y$$$20240828$$HP$CA$CA
165506172$16550617$2$F$$20240817$20190710$20240828$EXP$$CA-AUROBINDO-AUR-APL-2019-038273$AUROBINDO$$61$YR$$F$Y$44$KG$20240828$$HP$CA$CA
165506332$16550633$2$F$$20240817$20190710$20240828$EXP$$CA-AUROBINDO-AUR-APL-2019-038427$AUROBINDO$$66$YR$$F$Y$$$20240828$$HP$CA$CA
165509562$16550956$2$F$$20240817$20190710$20240829$EXP$$CA-AUROBINDO-AUR-APL-2019-038303$AUROBINDO$$44$YR$$F$Y$$$20240829$$HP$CA$CA
165509592$16550959$2$F$$20240808$20190710$20240819$EXP$$CA-AUROBINDO-AUR-APL-2019-038325$AUROBINDO$$61$YR$$M$Y$81.646$KG$20240819$$CN$CA$CA
165510492$16551049$2$F$$20240817$20190710$20240828$EXP$$CA-AUROBINDO-AUR-APL-2019-038422$AUROBINDO$$72$YR$$F$Y$$$20240828$$HP$CA$CA
165510777$16551077$7$F$20180705$20220606$20190710$20240705$EXP$$JP-GLAXOSMITHKLINE-JP2018JPN239592$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$JP$JP
165553422$16555342$2$F$20160918$20240909$20190710$20240917$EXP$DE-EMA-DD-20190627-AGRAHARI_P-134139$DE-TEVA-2019-DE-1075017$TEVA$$20$YR$$F$Y$54$KG$20240917$$MD$DE$DE
1655547414$16555474$14$F$20210301$20240703$20190710$20240709$EXP$$US-PFIZER INC-2019290618$PFIZER$$80$YR$$F$Y$64.399$KG$20240709$$CN$US$US
165566656$16556665$6$F$20180927$20240816$20190711$20240823$EXP$$JP-ABBVIE-18P-087-2265705-00$ABBVIE$$65$YR$$M$Y$55$KG$20240823$$MD$JP$JP
165571312$16557131$2$F$$20240808$20190711$20240820$EXP$$CA-AUROBINDO-AUR-APL-2019-038434$AUROBINDO$$56$YR$$M$Y$93$KG$20240820$$HP$CA$CA
165572056$16557205$6$F$$20240911$20190711$20240913$EXP$$ES-MYLANLABS-2019M1063003$MYLAN$Ferrer Garrido G, Costilla Barriga L, De Rueda Ciller B, Rodriguez-Vigil Iturrate C, Villalba Montaner M, Salvador Ruperez E, et al.. A report of different purposes: Blinatumomab with previous debulking chemotherapy to reach or maintain response.. HemaSphere. 2018;2suppl 2:756$21$YR$$M$Y$$$20240913$$HP$ES$ES
165583626$16558362$6$F$20171120$20240905$20190711$20240910$EXP$$DE-MYLANLABS-2019M1063216$MYLAN$$$$A$M$Y$$$20240910$$MD$DE$DE
1655991520$16559915$20$F$20190601$20240923$20190711$20240926$EXP$$IL-ABBVIE-19K-082-2846787-00$ABBVIE$$70$YR$$M$Y$74$KG$20240926$$MD$IL$IL
165604616$16560461$6$F$$20240820$20190711$20240829$EXP$$CA-APOTEX-2019AP017854$APOTEX$$72$YR$$M$Y$$$20240829$$HP$CA$CA
165610563$16561056$3$F$20180724$20240722$20190711$20240725$EXP$$FR-MYLANLABS-2019M1063404$MYLAN$$57$YR$$F$Y$64$KG$20240725$$MD$FR$FR
165658455$16565845$5$F$20180206$20240905$20190712$20240909$EXP$$US-ABBVIE-18P-163-2250274-00$ABBVIE$$13$YR$$M$Y$36$KG$20240909$$MD$US$US
1656595116$16565951$16$F$20190701$20240729$20190712$20240801$EXP$$CA-TAKEDA-2019TUS042270$TAKEDA$$48$YR$$M$Y$$$20240801$$CN$CA$CA
165683939$16568393$9$F$20230112$20240923$20190712$20240927$EXP$$US-SHIRE-US201922565$TAKEDA$$37$YR$$F$Y$104$KG$20240927$$MD$US$US
1656890314$16568903$14$F$20190708$20240625$20190713$20240701$EXP$$CO-TAKEDA-2019TUS043264$TAKEDA$$59$YR$$F$Y$57$KG$20240701$$HP$CO$CO
165699206$16569920$6$F$$20240827$20190715$20240905$EXP$$CA-AUROBINDO-AUR-APL-2019-038920$AUROBINDO$$59$YR$$M$Y$$$20240905$$HP$CA$CA
165700984$16570098$4$F$$20240813$20190715$20240826$EXP$$CA-AUROBINDO-AUR-APL-2019-039056$AUROBINDO$$57$YR$$F$Y$$$20240826$$HP$CA$CA
165728499$16572849$9$F$20221106$20240715$20190715$20240717$EXP$$US-JAZZ-2019-US-009599$JAZZ$$38$YR$$F$Y$$$20240717$$MD$US$US
165743153$16574315$3$F$20181201$20240530$20190715$20240717$PER$$US-NOVOPROD-665156$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
165743292$16574329$2$F$20190211$20240530$20190715$20240717$PER$$US-NOVOPROD-647808$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
1657546418$16575464$18$F$$20240819$20190716$20240902$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-068760$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$69$KG$20240902$$CN$CA$CA
165822272$16582227$2$F$20190101$20190708$20190717$20240708$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-213816$RANBAXY$$$$A$M$Y$$$20240708$$CN$US$US
165841102$16584110$2$F$$20240906$20190717$20240917$EXP$$NL-ROCHE-2311387$ROCHE$, Vaessen N, Sijpkens Y and de Fijter J Unusual presentation of central nervous system manifestations of Varicella zoster virus vasculopathy in renal transplant recipients. Transplant Infectious Disease 2007;9 (3):237-240.$51$YR$A$F$Y$$$20240917$$HP$NL$NL
165841189$16584118$9$F$20190101$20240912$20190717$20240916$EXP$$US-PFIZER INC-2019296087$PFIZER$$62$YR$$F$Y$77.551$KG$20240916$$CN$US$US
165855677$16585567$7$F$20190709$20240912$20190717$20240917$EXP$$JP-GILEAD-2019-0417748$GILEAD$Ohya K, Imamura M, Teraoka Y, Morio K, Fujino H, Nakahara T et al.. Real-world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus-related decompensated cirrhosis. Hepatology Research. 2020;unk:unk$79$YR$E$M$Y$59.3$KG$20240917$$PH$JP$JP
1658622231$16586222$31$F$20190130$20240813$20190717$20240822$EXP$$PHHY2019DE121451$NOVARTIS$$68$YR$$F$Y$88.8$KG$20240822$$MD$DE$DE
165872046$16587204$6$F$20190101$20240919$20190717$20240926$PER$$US-SA-2019SA193123$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240926$$MD$US$US
1658844634$16588446$34$F$20190829$20240910$20190718$20240917$EXP$$CA-CELLTRION INC.-2018CA025224$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
165887177$16588717$7$F$$20240904$20190718$20240913$EXP$$PL-AUROBINDO-AUR-APL-2019-040965$AUROBINDO$Komorowska A, Lelonek M. Cessation of empagliflozin treatment in a hospitalised patient with exacerbated heart failure and reduced ejection fraction. Folia Cardiologica Excerpta. 2019;14(2):206-12$56$YR$$M$Y$120$KG$20240913$$MD$PL$PL
165896103$16589610$3$F$$20240724$20190718$20240805$EXP$$CA-AUROBINDO-AUR-APL-2019-040384$AUROBINDO$$69$YR$$F$Y$$$20240805$$HP$CA$CA
165914697$16591469$7$F$20240601$20240711$20190718$20240715$EXP$$US-PFIZER INC-2019306375$PFIZER$$60$YR$$F$Y$$$20240715$$CN$US$US
1659475012$16594750$12$F$20180524$20240821$20190718$20240826$EXP$$JP-GILEAD-2019-0418948$GILEAD$$46$YR$A$M$Y$$$20240826$$MD$JP$JP
165954335$16595433$5$F$$20240724$20190719$20240803$EXP$$CA-AUROBINDO-AUR-APL-2019-040388$AUROBINDO$$53$YR$$M$Y$107$KG$20240803$$HP$CA$CA
1659569519$16595695$19$F$$20240815$20190719$20240828$EXP$$CA-AUROBINDO-AUR-APL-2019-040311$AUROBINDO$$$$$F$Y$$$20240828$$MD$CA$CA
1659645118$16596451$18$F$20190723$20240814$20190719$20240819$EXP$$CA-ROCHE-2355382$ROCHE$$45$YR$A$F$Y$89$KG$20240819$$CN$CA$CA
165986453$16598645$3$F$20190520$20240722$20190719$20240727$EXP$$DE-ABBVIE-19P-062-2858911-00$ABBVIE$$60$YR$$M$Y$$$20240727$$MD$DE$DE
165988038$16598803$8$F$20190101$20240620$20190719$20240702$PER$$US-SA-2019SA193940$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240702$$MD$US$US
165993562$16599356$2$F$$20240903$20190719$20240905$EXP$$US-JAZZ-2019-US-009894$JAZZ$$$$$F$Y$$$20240905$$CN$US$US
1659962833$16599628$33$F$$20240724$20190720$20240806$EXP$$CA-AUROBINDO-AUR-APL-2019-040214$AUROBINDO$$$$$F$Y$$$20240806$$MD$CA$CA
1660071315$16600713$15$F$20190902$20240802$20190719$20240806$EXP$$US-PFIZER INC-2019307236$PFIZER$$79$YR$$F$Y$82$KG$20240806$$HP$US$US
1660174715$16601747$15$F$$20240909$20190719$20240916$EXP$$CA-GLAXOSMITHKLINE-CA2019AMR127715$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$CA$CA
166076296$16607629$6$F$$20240903$20190722$20240913$EXP$$CA-AUROBINDO-AUR-APL-2019-042343$AUROBINDO$$$$$M$Y$$$20240913$$MD$CA$CA
166080454$16608045$4$F$$20240827$20190722$20240904$EXP$$CA-APOTEX-2019AP018429$APOTEX$$78$YR$$M$Y$$$20240904$$HP$CA$CA
166080693$16608069$3$F$$20240904$20190722$20240916$EXP$$PL-MACLEODS PHARMACEUTICALS US LTD-MAC2019022162$MACLEODS$$$$$$Y$$$20240916$$MD$PL$PL
166080805$16608080$5$F$$20240708$20190722$20240716$EXP$$CA-APOTEX-2019AP018322$APOTEX$$72$YR$$F$Y$$$20240716$$HP$CA$CA
1660912313$16609123$13$F$$20240910$20190722$20240923$EXP$$CA-APOTEX-2019AP018499$APOTEX$$65$YR$$F$Y$$$20240923$$MD$CA$CA
166102512$16610251$2$F$$20240913$20190722$20240916$EXP$$PT-MYLANLABS-2019M1054932$MYLAN$Pereira L, Meng C, Guedes L, Marques S, Nunes A, Sampaio S et al.. Infective endocarditis in renal transplant recipients: one center^s experience. Portuguese Journal of Nephrology and Hypertension. 2018;32 (4):319-23$39$YR$$F$Y$$$20240916$$HP$PT$PT
166105562$16610556$2$F$$20240919$20190722$20240927$PER$$US-GLAXOSMITHKLINE-US2019130872$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
166136064$16613606$4$F$$20240813$20190723$20240827$EXP$$CA-AUROBINDO-AUR-APL-2019-041475$AUROBINDO$$75$YR$$M$Y$$$20240827$$HP$CA$CA
1661449714$16614497$14$F$$20240924$20190723$20240927$EXP$$US-PFIZER INC-2019304030$PFIZER$$66$YR$$F$Y$$$20240927$$HP$US$US
166149818$16614981$8$F$$20240805$20190723$20240807$EXP$$US-PFIZER INC-2019313908$PFIZER$$61$YR$$F$Y$$$20240807$$CN$US$US
166158826$16615882$6$F$$20240725$20190723$20240807$EXP$$CA-AUROBINDO-AUR-APL-2019-041090$AUROBINDO$$60$YR$$F$Y$$$20240807$$HP$CA$CA
166171204$16617120$4$F$20180928$20240919$20190723$20240925$EXP$$DE-MYLANLABS-2019M1067732$MYLAN$$77$YR$$F$Y$86$KG$20240925$$HP$DE$DE
166218483$16621848$3$F$$20230421$20190723$20240723$PER$$US-OTSUKA-2018_039615$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
166229584$16622958$4$F$$20240813$20190724$20240826$EXP$$CA-AUROBINDO-AUR-APL-2019-041663$AUROBINDO$$45$YR$$F$Y$$$20240826$$HP$CA$CA
166233462$16623346$2$F$$20240830$20190724$20240905$EXP$$US-KAMADA LIMITED-2018US012137$TAKEDA$$$$$M$Y$$$20240905$$CN$US$US
166237346$16623734$6$F$$20240813$20190724$20240827$EXP$$CA-AUROBINDO-AUR-APL-2019-041565$AUROBINDO$$57$YR$$F$Y$$$20240827$$HP$CA$CA
166237423$16623742$3$F$$20240813$20190724$20240827$EXP$$CA-AUROBINDO-AUR-APL-2019-041561$AUROBINDO$$34$YR$$F$Y$105$KG$20240827$$HP$CA$CA
166237484$16623748$4$F$$20240801$20190724$20240814$EXP$$CA-AUROBINDO-AUR-APL-2019-041535$AUROBINDO$$60$YR$$F$Y$$$20240814$$HP$CA$CA
166238143$16623814$3$F$$20240827$20190724$20240905$EXP$$CA-AUROBINDO-AUR-APL-2019-042064$AUROBINDO$$54$YR$$M$Y$$$20240905$$HP$CA$CA
1662446034$16624460$34$F$20190710$20240822$20190724$20240830$EXP$$DE-ROCHE-2355980$ROCHE$$34$YR$A$F$Y$$$20240830$$CN$DE$DE
1662541012$16625410$12$F$20200205$20240809$20190724$20240812$EXP$$US-PFIZER INC-2019313310$PFIZER$$69$YR$$M$Y$75.283$KG$20240812$$CN$US$US
166255134$16625513$4$F$$20240717$20190724$20240729$EXP$$CA-APOTEX-2019AP018593$APOTEX$$55$YR$$M$Y$$$20240729$$HP$CA$CA
1662838824$16628388$24$F$$20240917$20190724$20240921$EXP$$CA-ABBVIE-19K-028-2863507-00$ABBVIE$$40$YR$$F$Y$73$KG$20240921$$HP$CA$CA
1662844013$16628440$13$F$20190718$20240902$20190724$20240906$EXP$$AU-ABBVIE-19P-008-2714779-00$ABBVIE$$29$YR$$F$Y$$$20240906$$MD$AU$AU
166296419$16629641$9$F$20170619$20240903$20190725$20240909$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2018JPN152865$VIIV$$$$$$Y$$$20240909$$MD$JP$JP
166296668$16629666$8$F$20190530$20240830$20190725$20240906$EXP$FR-AFSSAPS-GR20191138$FR-GLAXOSMITHKLINE-FR2019133161$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$PH$FR$FR
1663094816$16630948$16$F$20151002$20240906$20190725$20240913$EXP$$PHHY2018CO055420$NOVARTIS$$58$YR$$F$Y$67$KG$20240913$$CN$CO$CO
166328253$16632825$3$F$20161027$20240724$20190725$20240730$EXP$$FR-MYLANLABS-2019M1068308$MYLAN$$26$YR$$M$Y$68$KG$20240730$$MD$FR$FR
1663455617$16634556$17$F$20190722$20240722$20190726$20240725$EXP$$CA-TAKEDA-2019TUS040094$TAKEDA$$34$YR$$F$Y$$$20240725$$MD$CA$CA
1663512210$16635122$10$F$20141219$20240701$20190726$20240705$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN160693$VIIV$Kikuchi T.. All the cases refer to anti-HIV treatments in the antiretroviral therapy (ART) years. Luncheon seminar held by Japanese Society for Sexually Transmitted Infections. 2016$$$$$Y$$$20240705$$MD$JP$JP
1663514410$16635144$10$F$20141219$20240701$20190726$20240705$EXP$$JP-GLAXOSMITHKLINE-JP2017JPN160693$GLAXOSMITHKLINE$Kikuchi T.. All the cases refer to anti-HIV treatments in the antiretroviral therapy (ART) years. Luncheon seminar held by Japanese Society for Sexually Transmitted Infections. 2016$$$$$Y$$$20240705$$MD$JP$JP
166375832$16637583$2$F$20180301$20230712$20190726$20240715$PER$$US-PERRIGO-18US014025$PERRIGO$$34$YR$$M$Y$65.76$KG$20240715$$CN$US$US
1663984116$16639841$16$F$$20240829$20190727$20240902$EXP$$CA-TAKEDA-2019TUS044967$TAKEDA$$$$$F$Y$$$20240902$$HP$CA$CA
166439722$16643972$2$F$$20240814$20190729$20240819$PER$$US-JNJFOC-20190729198$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20240819$$LW$US$US
166441622$16644162$2$F$$20190709$20190729$20240827$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2019-000508$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240827$$CN$US$US
1664642821$16646428$21$F$$20240923$20190730$20240926$PER$$US-PFIZER INC-2016565892$PFIZER$$15$YR$$M$Y$43$KG$20240926$$MD$US$US
166467373$16646737$3$F$20190724$20240625$20190730$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US201907014008$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240701$$CN$US$US
166468083$16646808$3$F$$20240826$20190730$20240905$EXP$$US-AUROBINDO-AUR-APL-2019-043403$AUROBINDO$Pilbeam K, Eidenschink B, Sulciner M, Luquette M, Neglia J, Chinnakotla S.. Success of chemotherapy and a liver transplant in a pediatric patient with hepatic angiosarcoma: A case report.. Pediatric Transplantation.. 2019;23(4):e13410$2$YR$$F$Y$$$20240905$$HP$US$US
166469166$16646916$6$F$20190624$20240828$20190730$20240905$EXP$$US-SHIRE-US201924325$TAKEDA$$87$YR$$M$Y$71.1$KG$20240905$$CN$US$US
166478416$16647841$6$F$20190601$20240927$20190730$20240930$PER$$US-GILEAD-2019-0420433$GILEAD$$37$YR$A$M$Y$61.587$KG$20240930$$LW$US$US
166481644$16648164$4$F$$20240906$20190730$20240916$EXP$$PHHY2019NL147337$NOVARTIS$Hovens M, Vaessen N, Sijpkens Y, Fijter DJ. Unusual presentation of central nervous system manifestations of Varicella zoster virus vasculopathy in renal transplant recipients. TRANSPLANT INFECTIOUS DISEASE. 2007;9(3):237-40$51$YR$$F$Y$$$20240916$$HP$NL$NL
1664898122$16648981$22$F$20190721$20240815$20190730$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-072687$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$86$KG$20240822$$MD$JP$JP
166504485$16650448$5$F$$20240827$20190731$20240905$EXP$$CA-AUROBINDO-AUR-APL-2019-042958$AUROBINDO$$75$YR$$F$Y$57$KG$20240905$$HP$CA$CA
166534785$16653478$5$F$20180903$20240711$20190731$20240718$EXP$$JP-GILEAD-2019-0420997$GILEAD$$37$YR$A$M$Y$$$20240718$$MD$JP$JP
166552148$16655214$8$F$20190101$20240809$20190801$20240820$EXP$$CA-ROCHE-2363090$ROCHE$$50$YR$A$F$Y$$$20240820$$CN$CA$CA
166564636$16656463$6$F$$20240718$20190801$20240722$EXP$$US-PFIZER INC-2019325408$PFIZER$$66$YR$$F$Y$$$20240722$$CN$US$US
166576673$16657667$3$F$$20230714$20190801$20240801$PER$$US-SEBELA IRELAND LIMITED-2019SEB00011$SEBELA$$$$$M$Y$$$20240801$$CN$US$US
166597853$16659785$3$F$$20240918$20190802$20240924$PER$$US-GLAXOSMITHKLINE-US2019AMR137438$GLAXOSMITHKLINE$$$$$M$Y$$$20240924$$CN$US$US
1665998021$16659980$21$F$20181102$20240711$20190802$20240717$EXP$$PHHY2018CA148831$NOVARTIS$$69$YR$$F$Y$$$20240717$$CN$CA$CA
166601512$16660151$2$F$$20240821$20190802$20240905$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-216166$RANBAXY$Rizzo G, Bussolin L, Genitori L, Zicca A, Messeri A, Lenge M, et al. The use of opioids in children receiving intrathecal baclofen therapy. Childs Nerv Syst. 2019;26-Apr; 35(7):1213-1218$13$YR$$F$Y$$$20240905$$HP$IT$IT
166606132$16660613$2$F$$20190722$20190802$20240924$EXP$$FR-ROCHE-GNE235932$ROCHE$Basse G. Infectious complications in renal transplant patients: 2 case reports. Reactions ;:-.;, Basse G, Ribes D, Kamar N, Esposito L and Rostaing L. (Pages : 6.) Life-threatening infections following rituximab therapy in renal transplant patients with mixed cryoglobulinemia.. Clinical Nephrology 2006;66:395-.;, Ribes D, Kamar N, Mehrenberger M, Esposito L, Guitard J, Lavayssiere L, Oksman F, Durand D, Dur D and Rostaing L. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplan$56$YR$A$F$Y$$$20240924$$MD$FR$FR
166628592$16662859$2$F$$20240909$20190802$20240917$EXP$$TR-ROCHE-2364480$ROCHE$Karacaglar E, Akgun A, Aytekin C, Aydinalp A, Sezgin A and Haldun Muderrisoglu I Successful Treatment of a Rare Complication in a Heart Transplant Recipient: Spontaneous Axillary Artery Bleeding. Experimental and Clinical Transplantation 2019 Jun;:421-4.$45$YR$A$F$Y$$$20240917$$MD$TR$TR
166643828$16664382$8$F$20170619$20240903$20190802$20240906$EXP$$JP-GILEAD-2018-0361029$GILEAD$$32$YR$A$M$Y$$$20240906$$MD$JP$JP
166648563$16664856$3$F$20150310$20230616$20190803$20240802$EXP$$US-Accord-069131$ACCORD$$63$YR$A$F$Y$$$20240802$$LW$US$US
166652873$16665287$3$F$20170201$20230721$20190803$20240802$EXP$$US-Accord-128756$ACCORD$$42$YR$A$F$Y$$$20240802$$LW$US$US
166652922$16665292$2$F$20161201$20230628$20190803$20240802$EXP$$US-Accord-129766$ACCORD$$64$YR$A$F$Y$$$20240802$$LW$US$US
166653845$16665384$5$F$20150101$20240719$20190803$20240723$PER$$US-GILEAD-2019-0421687$GILEAD$$42$YR$A$F$Y$$$20240723$$LW$US$US
1666588537$16665885$37$F$20190401$20240903$20190804$20240911$EXP$$CA-CELLTRION INC.-2018CA025312$CELLTRION$$$$$$Y$$$20240911$$CN$CA$CA
166667324$16666732$4$F$20161201$20230623$20190805$20240802$EXP$$US-Accord-105400$ACCORD$$57$YR$A$F$Y$$$20240802$$LW$US$US
166678324$16667832$4$F$$20240718$20190805$20240718$EXP$$IE-JNJFOC-20190721106$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$HP$IE$IE
166680365$16668036$5$F$$20190822$20190805$20240701$EXP$$US-AKCEA THERAPEUTICS-2019IS001636$AKCEA THERAPEUTICS$$$$$$Y$$$20240628$$MD$US$US
166701775$16670177$5$F$20171102$20240919$20190805$20240924$EXP$$FR-MYLANLABS-2019M1072729$MYLAN$$79$YR$$M$Y$69$KG$20240924$$MD$FR$FR
166702393$16670239$3$F$$20240820$20190805$20240826$PER$$US-BIOMARINAP-US-2019-124931$BIOMARIN$$$$$$Y$$$20240826$$CN$US$US
1667133721$16671337$21$F$20200907$20240909$20190806$20240918$EXP$$CO-TAKEDA-2019TUS046467$TAKEDA$$81$YR$$M$Y$60$KG$20240918$$HP$CO$CO
1667309613$16673096$13$F$20230101$20240717$20190806$20240719$EXP$$US-PFIZER INC-2018211378$PFIZER$$84$YR$$F$Y$$$20240719$$CN$US$US
166731116$16673111$6$F$20170516$20240703$20190806$20240705$EXP$$US-GILEAD-2019-0421706$GILEAD$$49$YR$A$F$Y$$$20240705$$LW$US$US
1667826312$16678263$12$F$20200101$20240826$20190807$20240829$EXP$$US-PFIZER INC-2019335013$PFIZER$$65$YR$$F$Y$$$20240829$$CN$US$US
1667920158$16679201$58$F$$20240809$20190807$20240816$EXP$$CA-GLAXOSMITHKLINE-CA2019AMR133655$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$CA$CA
1668168322$16681683$22$F$20180308$20240808$20190808$20240813$EXP$$DE-ROCHE-2242179$ROCHE$$31$YR$A$F$Y$70$KG$20240813$$CN$DE$DE
166840412$16684041$2$F$$20240708$20190808$20240711$EXP$$IT-PURDUE PHARMA-GBR-2019-0068817$PURDUE$Rizzo G, Leonardo B, Anna Z, Lorenzo G, Matteo L, Flavio G et.al. The use of opioids in children receiving intrathecal baclofen therapy.. Childs Nerv Syst. 2019;35(7):1213-1218$11$YR$$M$Y$$$20240711$$HP$IT$IT
166840423$16684042$3$F$$20240708$20190808$20240711$EXP$$IT-PURDUE-GBR-2019-0068816$PURDUE$Rizzo G, Leonardo B, Anna Z, Lorenzo G, Matteo L, Flavio G, Andrea M. The use of opioids in children receiving intrathecal baclofen therapy.. Childs Nerv Syst. 2019;35(7):1213-1218$13$YR$$F$Y$30.7$KG$20240711$$HP$IT$IT
166848993$16684899$3$F$$20240703$20190808$20240710$PER$$US-INCYTE CORPORATION-2019IN007880$INCYTE$$$$$$Y$$$20240710$$CN$US$US
166878423$16687842$3$F$20171025$20240919$20190809$20240927$EXP$FR-AFSSAPS-AM20181050$FR-EMD Serono-E2B_90055192$EMD SERONO INC$$89$YR$E$F$Y$68$KG$20240927$$PH$FR$FR
1668812113$16688121$13$F$20200101$20240715$20190809$20240723$EXP$$PHHY2019CL183733$NOVARTIS$$51$YR$$F$Y$$$20240723$$CN$CL$CL
166951698$16695169$8$F$20190924$20240829$20190813$20240905$EXP$$CO-TAKEDA-2019TUS047092$TAKEDA$$70$YR$$F$Y$82$KG$20240905$$CN$CO$CO
166979823$16697982$3$F$20180224$20240805$20190813$20240809$EXP$IT-MINISAL02-539116$IT-PFIZER INC-2019340925$PFIZER$$65$YR$$F$Y$68$KG$20240809$$MD$IT$IT
167002618$16700261$8$F$$20240805$20190814$20240812$EXP$$US-GLAXOSMITHKLINE-US2019143153$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
167005582$16700558$2$F$$20240829$20190814$20240909$EXP$$CA-AUROBINDO-AUR-APL-2019-046167$AUROBINDO$$68$YR$$F$Y$$$20240909$$HP$CA$CA
167027609$16702760$9$F$20190905$20240801$20190814$20240806$EXP$$US-SHIRE-US201922711$TAKEDA$$52$YR$$F$Y$136$KG$20240806$$HP$US$US
1670282742$16702827$42$F$$20240813$20190814$20240815$EXP$$CA-ABBVIE-19K-028-2888402-00$ABBVIE$$43$YR$$F$Y$97$KG$20240815$$HP$CA$CA
167030157$16703015$7$F$20190731$20240809$20190814$20240819$EXP$$CA-PFIZER INC-2019345299$PFIZER$$32$YR$$F$Y$$$20240819$$CN$CA$CA
167040413$16704041$3$F$$20240909$20190814$20240912$EXP$$GR-MYLANLABS-2019M1075182$MYLAN$Mpristogiannis, S. Fulminant meningitis from a panresistant strain of Acinetobacter baumannii.. 19th Panhellenic Congress of Infections.. 2019;91$48$YR$$F$Y$$$20240912$$MD$GR$GR
167057837$16705783$7$F$$20240812$20190815$20240819$EXP$$PHHY2019IT186073$NOVARTIS$Bottoni A, Sica F, Basilone A, Chiossi L, Damiano B, Ficele L et al.. Posterior reversible encephalopathy syndrome (PRES) in a Child with steroid-dependent nephrotic syndrome: A case report. ARCHIVES OF DISEASE IN CHILDHOOD. 2019;104(3):A357$6$YR$$M$Y$$$20240819$$HP$IT$IT
167058103$16705810$3$F$$20240820$20190815$20240830$EXP$$IT-TEVA-2019-IT-1093077$TEVA$$24$YR$$M$Y$$$20240830$$MD$IT$IT
1670780531$16707805$31$F$20160401$20240802$20190815$20240808$EXP$$US-PFIZER INC-2018360182$PFIZER$$66$YR$$M$Y$107$KG$20240808$$CN$US$US
167121692$16712169$2$F$$20240722$20190816$20240730$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-079527$BRISTOL MYERS SQUIBB$Tan JL, Mugwagwa AN, Cieslik L, Joshi R. Nivolumab-indluced myocarditis complicated by complete atrioventricular block in a patient with metastatic non-small cell lung cancer. BMJ Case Reports. 2019 Jul 11;12(7):1-4. doi:10.1136/bcr-201 9-229963.$74$YR$E$M$Y$$$20240730$$HP$AU$AU
167125068$16712506$8$F$20181101$20240913$20190816$20240919$EXP$$US-BIOGEN-2019BI00774185$BIOGEN$$32$YR$$F$Y$55.388$KG$20240919$$CN$US$US
167133254$16713325$4$F$20190101$20240718$20190818$20240725$EXP$$US-BIOGEN-2019BI00774687$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
167138658$16713865$8$F$20181001$20240802$20190819$20240807$EXP$$CA-TAKEDA-2018TUS032721$TAKEDA$$67$YR$$M$Y$$$20240807$$CN$CA$CA
167167822$16716782$2$F$$20240827$20190819$20240906$EXP$$CA-UCBSA-2019033727$UCB$$64$YR$$F$Y$$$20240906$$HP$CA$CA
167171893$16717189$3$F$$20240828$20190819$20240906$EXP$$CA-SHIRE-CA201926805$TAKEDA$$$$$$Y$$$20240906$$HP$CA$CA
167199748$16719974$8$F$$20240729$20190820$20240807$EXP$$US-PFIZER INC-2019355342$MYLAN$$$$$F$Y$70.31$KG$20240807$$CN$US$US
167227825$16722782$5$F$20171121$20240701$20190821$20240703$EXP$$JP-ABBVIE-17K-087-2181150-00$ABBVIE$$69$YR$$M$Y$63$KG$20240703$$MD$JP$JP
167234128$16723412$8$F$$20240801$20190821$20240814$EXP$$CA-AUROBINDO-AUR-APL-2019-054052$AUROBINDO$$72$YR$$F$Y$$$20240814$$HP$CA$CA
167234446$16723444$6$F$$20240731$20190821$20240813$EXP$$CA-AUROBINDO-AUR-APL-2019-053930$AUROBINDO$$52$YR$$F$Y$$$20240813$$HP$CA$CA
167236303$16723630$3$F$20190101$20240906$20190821$20240918$EXP$$US-INSMED, INC.-US-INS-19-02397$INSMED$$$$$F$Y$$$20240918$$HP$US$US
167249424$16724942$4$F$$20240702$20190821$20240704$PER$$US-PFIZER INC-2019358531$PFIZER$$69$YR$$F$Y$$$20240704$$CN$US$US
167254295$16725429$5$F$$20240709$20190821$20240711$EXP$$US-PFIZER INC-2019359748$PFIZER$$69$YR$$F$Y$$$20240711$$CN$US$US
167256247$16725624$7$F$20190621$20240913$20190821$20240923$EXP$$US-ROCHE-2374550$ROCHE$$72$YR$E$M$Y$$$20240923$$CN$US$US
167261112$16726111$2$F$20190716$20240719$20190821$20240724$EXP$FR-AFSSAPS-ST20191049$FR-ROCHE-2376383$ROCHE$$42$YR$A$M$Y$75$KG$20240724$$MD$FR$FR
167263689$16726368$9$F$$20240809$20190821$20240813$EXP$$CA-GLAXOSMITHKLINE-CA2019AMR149267$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$MD$CA$CA
1672804312$16728043$12$F$$20240819$20190822$20240831$EXP$$CA-AUROBINDO-AUR-APL-2019-054000$AUROBINDO$$53$YR$$F$Y$60$KG$20240831$$HP$CA$CA
1672808326$16728083$26$F$$20240827$20190822$20240906$EXP$$CA-AUROBINDO-AUR-APL-2019-054119$AUROBINDO$$56$YR$$M$Y$$$20240906$$HP$CA$CA
167281056$16728105$6$F$$20240814$20190822$20240826$EXP$$CA-AUROBINDO-AUR-APL-2019-010053$AUROBINDO$$32$YR$$M$Y$$$20240826$$HP$CA$CA
167286198$16728619$8$F$$20240815$20190822$20240828$EXP$$CA-AUROBINDO-AUR-APL-2019-054708$AUROBINDO$Linton B, Fu R, MacDonald PA, Ganjavi H.. Burning pain secondary to clozapine use: a case report.. ;. BMC-Psychiatry.. 2014;14:299$44$YR$$M$Y$$$20240828$$HP$CA$CA
167286419$16728641$9$F$$20240826$20190822$20240904$EXP$$CA-AUROBINDO-AUR-APL-2019-054419$AUROBINDO$$73$YR$$F$Y$$$20240904$$HP$CA$CA
167289232$16728923$2$F$$20240808$20190822$20240812$EXP$$AU-SA-2019SA230317$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240812$$CN$AU$AU
167290192$16729019$2$F$20240731$20240731$20190822$20240805$EXP$$US-KYOWAKIRIN-2019BKK013123$KYOWA$$$$$$Y$$$20240805$$HP$US$US
167308317$16730831$7$F$$20240812$20190822$20240813$EXP$$PHHY2019IT193133$NOVARTIS$Di Renzo B, Montanaro A, Spinelli A, Covella P, De Giorgi A, Flores A et al.. A case of septic shock with oliguric acute renal failure resolved with CVVHF coupled with cytosorb.. BLOOD PURIFICATION. 2019;47(4):11-2$72$YR$$M$Y$$$20240813$$HP$IT$IT
167309197$16730919$7$F$$20240807$20190822$20240816$PER$$US-INCYTE CORPORATION-2019IN008324$INCYTE$$$$$$Y$$$20240816$$CN$US$US
167327724$16732772$4$F$$20240829$20190823$20240909$EXP$$CA-AUROBINDO-AUR-APL-2019-055418$AUROBINDO$$40$YR$$F$Y$$$20240909$$HP$CA$CA
1673313513$16733135$13$F$20190624$20240626$20190823$20240701$EXP$$CA-TAKEDA-2019TUS039239$TAKEDA$$52$YR$$F$Y$$$20240701$$CN$CA$CA
167347566$16734756$6$F$$20240807$20190823$20240819$EXP$$CA-AUROBINDO-AUR-APL-2019-055308$AUROBINDO$$63$YR$$F$Y$$$20240819$$HP$CA$CA
1673573815$16735738$15$F$$20240708$20190823$20240715$PER$$US-PFIZER INC-2019361936$PFIZER$$65$YR$$F$Y$$$20240715$$CN$US$US
1673586813$16735868$13$F$20210731$20240918$20190823$20240920$EXP$$US-PFIZER INC-2019360210$PFIZER$$82$YR$$F$Y$55.329$KG$20240920$$CN$US$US
167360293$16736029$3$F$20170701$20190816$20190823$20240716$EXP$$US-AstraZeneca-2019SF19413$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
167362604$16736260$4$F$20190701$20240820$20190823$20240917$PER$$US-SA-2019SA228479$SANOFI AVENTIS$$52$YR$A$M$Y$97.5$KG$20240918$$MD$US$US
167365507$16736550$7$F$20160331$20240709$20190823$20240717$EXP$$CA-PFIZER INC-2019362664$PFIZER$$50$YR$$F$Y$$$20240717$$MD$CA$CA
167370075$16737007$5$F$20190812$20210617$20190823$20240717$EXP$$DE-EXELIXIS-XL18419023256$EXELIXIS$$66$YR$$F$Y$52$KG$20240717$$MD$DE$DE
167371254$16737125$4$F$20181207$20240716$20190823$20240719$EXP$$PHHY2019CA036661$NOVARTIS$$73$YR$$M$Y$$$20240719$$MD$CA$CA
167398607$16739860$7$F$$20240830$20190826$20240904$EXP$$AU-TAKEDA-2019TUS049364$TAKEDA$$$$$F$Y$$$20240904$$CN$AU$AU
167404622$16740462$2$F$$20240815$20190826$20240819$EXP$DK-EMA-20140929-DEEPTISP-122416997$DK-MYLANLABS-2019M1079239$MYLAN$Ladekarl M,Villadsen G,Rudbeck A,Aagen?s ?,Nielsen J,Dutoit S,Nordsmark M.. Advanced hepatocellular carcinoma in adolescence associated with congenital cholestasis: A case description.. Case Reports in Oncology. 2013;6(1):98-103$17$YR$$M$Y$$$20240819$$HP$DK$DK
167405454$16740545$4$F$$20240827$20190826$20240829$PER$$US-PFIZER INC-2019363324$PFIZER$$49$YR$$F$Y$123$KG$20240829$$CN$US$US
167412542$16741254$2$F$$20240823$20190826$20240907$EXP$$JP-JNJFOC-20190710531$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240907$$MD$JP$JP
167436522$16743652$2$F$$20240913$20190827$20240920$EXP$$IT-EMD Serono-9111423$EMD SERONO INC$$78$YR$E$M$Y$$$20240920$$CN$IT$IT
167445554$16744555$4$F$20190716$20240909$20190827$20240912$EXP$$JP-PFIZER INC-2019361270$PFIZER$$75$YR$$M$Y$58.4$KG$20240912$$MD$JP$JP
167453076$16745307$6$F$$20200722$20190827$20240701$EXP$$US-AKCEA THERAPEUTICS-2019IS001585$AKCEA THERAPEUTICS$$$$$$Y$$$20240701$$MD$US$US
1674822310$16748223$10$F$20190101$20240626$20190827$20240710$EXP$$CA-CELLTRION INC.-2019CA023974$CELLTRION$$$$$$Y$$$20240710$$CN$CA$CA
1674909139$16749091$39$F$20181210$20240910$20190828$20240918$EXP$$CA-CELLTRION INC.-2018CA024931$CELLTRION$$$$$$Y$$$20240918$$CN$CA$CA
167520433$16752043$3$F$20190710$20240829$20190828$20240904$EXP$$US-SHIRE-US201922998$TAKEDA$$67$YR$$F$Y$66$KG$20240904$$MD$US$US
167524118$16752411$8$F$20220829$20240903$20190828$20240906$EXP$$US-SHIRE-US201927782$TAKEDA$$37$YR$$F$Y$66$KG$20240906$$CN$US$US
167529415$16752941$5$F$20190819$20240905$20190829$20240909$PER$$US-BIOGEN-2019BI00779398$BIOGEN$$56$YR$$F$Y$$$20240909$$CN$US$US
1675445113$16754451$13$F$$20240816$20190829$20240820$EXP$$US-PFIZER INC-2019368412$PFIZER$$71$YR$$F$Y$66.213$KG$20240820$$MD$US$US
167547633$16754763$3$F$$20240919$20190829$20240926$PER$$US-AMGEN-USASP2019135527$AMGEN$$60$YR$A$F$Y$$$20240926$$MD$US$US
167559968$16755996$8$F$20190808$20240910$20190829$20240916$EXP$$US-TAKEDA-2019TUS050018$TAKEDA$$76$YR$$M$Y$73$KG$20240916$$MD$US$US
167582027$16758202$7$F$20180101$20240722$20190830$20240729$EXP$$US-GILEAD-2019-0425698$GILEAD$$57$YR$A$F$Y$$$20240729$$LW$US$US
167620973$16762097$3$F$20190801$20240828$20190830$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US201908011106$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240906$$CN$US$US
167641475$16764147$5$F$20190101$20240731$20190902$20240807$EXP$$US-TESARO-2019-TSO02417-US$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$US$US
167643683$16764368$3$F$20130604$20240906$20190902$20240911$EXP$$PHHY2019DE199186$NOVARTIS$$50$YR$$F$Y$$$20240911$$CN$DE$DE
1677081018$16770810$18$F$20181127$20240831$20190904$20240909$EXP$$AU-Ipsen Biopharmaceuticals, Inc.-2019-01031$IPSEN$$39$YR$A$F$Y$$$20240909$$MD$AU$AU
167708293$16770829$3$F$20150616$20200303$20190904$20240823$EXP$$JP-AMGEN-JPNCT2017008201$AMGEN$$62$YR$A$M$Y$$$20240823$$MD$JP$JP
167713023$16771302$3$F$20180101$20240710$20190904$20240715$EXP$$US-KYOWAKIRIN-2019BKK013681$KYOWA$$$$$$Y$$$20240715$$CN$US$US
167717293$16771729$3$F$20190501$20240806$20190904$20240813$EXP$$US-VERTEX PHARMACEUTICALS-2019-008324$VERTEX$$34$YR$$F$Y$59$KG$20240813$$MD$US$US
167738652$16773865$2$F$20190501$20240905$20190904$20240917$EXP$$FR-AUROBINDO-AUR-APL-2019-057511$AUROBINDO$$27$YR$$M$Y$97.6$KG$20240917$$MD$FR$FR
167747504$16774750$4$F$20180901$20240813$20190905$20240819$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2019JPN160587$VIIV$$$$$$Y$$$20240819$$MD$JP$JP
1677674315$16776743$15$F$20190828$20240718$20190905$20240725$EXP$$US-SA-2019SA247234$SANOFI AVENTIS$$12$YR$T$M$Y$48.9$KG$20240725$$MD$US$US
1677678118$16776781$18$F$$20240709$20190905$20240711$EXP$$CA-PFIZER INC-2019372202$PFIZER$$53$YR$$F$Y$53$KG$20240711$$HP$CA$CA
167774522$16777452$2$F$$20240911$20190905$20240913$EXP$$DE-MYLANLABS-2019M1083181$MYLAN$Romeike BF, Kim YJ, Steudel WI, Graf N.. Diffuse high-grade gliomas as second malignant neoplasms after radio-chemotherapy for pediatric malignancies (case 4).. child^s nervous system. 2007;23 (2):185-93$11$YR$$M$Y$$$20240913$$HP$DE$DE
1677875814$16778758$14$F$$20240709$20190906$20240716$EXP$$CA-Orion Corporation ORION PHARMA-TREX2019-3228$ORION$$53$YR$A$F$Y$53$KG$20240716$$HP$CA$
1678159213$16781592$13$F$20190704$20240716$20190906$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-070899$BRISTOL MYERS SQUIBB$Mizukoshi E. Management of immune-related adverse events (irAEs) with immune checkpoint inhibitors (ICIs). Japan Digestive Disease Week 2019. 2019;$54$YR$A$M$Y$58$KG$20240724$$MD$JP$JP
1678247947$16782479$47$F$20190701$20240904$20190906$20240919$EXP$$DE-Ascend Therapeutics US, LLC-2074123$ASCEND$$41$YR$$F$Y$40$KG$20240919$$$DE$DE
1678298620$16782986$20$F$20190702$20240918$20190906$20240925$EXP$$CA-TAKEDA-2018TUS032885$TAKEDA$$42$YR$$F$Y$$$20240925$$CN$CA$CA
1678302315$16783023$15$F$$20240910$20190906$20240911$EXP$$PHHY2019CA205793$NOVARTIS$$61$YR$$F$Y$70$KG$20240912$$HP$CA$CA
167837722$16783772$2$F$$20240813$20190908$20240826$EXP$$CA-AUROBINDO-AUR-APL-2019-058197$AUROBINDO$$46$YR$$F$Y$95$KG$20240826$$HP$CA$CA
167846864$16784686$4$F$20190301$20240909$20190909$20240919$EXP$$BG-ROCHE-2393259$ROCHE$Simova Y, Petrov I, Stanilov P. Sacubitril/valsartan use for a cardiotoxicity, associated with a chemoptherapy.. Cardio D. 2019;25(1):-.$60$YR$A$F$Y$$$20240919$$HP$BG$BG
167848292$16784829$2$F$$20240703$20190909$20240704$EXP$$US-KYOWAKIRIN-2019BKK013918$KYOWA$$$$$$Y$$$20240704$$CN$US$US
167851105$16785110$5$F$$20240724$20190909$20240805$EXP$$CA-AUROBINDO-AUR-APL-2014-00507$AUROBINDO$Farrell B, Shamji S, Ingar N.. Reducing fall risk while managing hypotension, pain, and poor sleep in an 83-year-old woman.. Can Fam Phys. 2013;59(12):1300 - 1305$83$YR$$F$Y$87$KG$20240805$$PH$CA$CA
1678537215$16785372$15$F$20190820$20240710$20190909$20240712$EXP$$PHHY2019AU208485$NOVARTIS$$8$YR$$M$Y$48$KG$20240712$$MD$AU$AU
1678555432$16785554$32$F$20190101$20240709$20190909$20240711$EXP$$US-PFIZER INC-2019384470$PFIZER$$91$YR$$F$Y$70$KG$20240711$$CN$US$US
167872675$16787267$5$F$$20240828$20190909$20240902$EXP$$US-PFIZER INC-2019386805$PFIZER$$77$YR$$F$Y$60.3$KG$20240902$$MD$US$US
167878603$16787860$3$F$20180901$20240813$20190909$20240819$EXP$$JP-GILEAD-2019-0427156$GILEAD$$21$YR$A$M$Y$$$20240819$$MD$JP$JP
167879166$16787916$6$F$20100722$20240802$20190909$20240806$EXP$$PHHY2019FR205615$NOVARTIS$Javelot M, Sergheraert J, Agbo-Godeau S, Levy-Weil F, Laurence S, Goudot P et al.. Rituximab as a trigger factor ofmedication-related osteonecrosis of the jaw- A case report. JOURNAL OF STOMATOLOGY, ORAL AND MAXILLOFACIAL SURGERY. 2019;1-15$69$YR$$F$Y$$$20240806$$HP$FR$FR
167885523$16788552$3$F$$20240812$20190910$20240814$EXP$$US-SA-2019SA250678$SANOFI AVENTIS$$$$E$M$Y$$$20240815$$MD$US$US
1678865411$16788654$11$F$$20240403$20190910$20240801$EXP$$CA-SA-2019SA249407$SANOFI AVENTIS$$44$YR$A$F$Y$68$KG$20240801$$HP$CA$CA
1678897811$16788978$11$F$20151216$20240729$20190910$20240806$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN098293$VIIV$$$$$$Y$$$20240806$$MD$JP$JP
1678898511$16788985$11$F$20151216$20240729$20190910$20240806$EXP$$JP-GLAXOSMITHKLINE-JP2017JPN098293$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$MD$JP$JP
1679022230$16790222$30$F$20190722$20240814$20190910$20240819$EXP$$PHHY2019DE186078$NOVARTIS$$$$E$F$Y$66$KG$20240819$$MD$DE$DE
167920243$16792024$3$F$20190101$20240726$20190910$20240802$EXP$$US-SA-2019SA250499$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240802$$CN$US$US
167929112$16792911$2$F$20181029$20240920$20190910$20240928$EXP$$DE-AUROBINDO-AUR-APL-2019-058961$AUROBINDO$$1$DY$$M$Y$2.055$KG$20240928$$MD$DE$DE
167937104$16793710$4$F$$20200229$20190911$20240917$EXP$$JP-GLAXOSMITHKLINE-JP2019JPN162000$GLAXOSMITHKLINE$$46$YR$$F$Y$48$KG$20240917$$MD$JP$JP
167957399$16795739$9$F$20180504$20240820$20190911$20240823$EXP$$CA-TAKEDA-2018TUS033814$TAKEDA$$42$YR$$M$Y$$$20240823$$CN$CA$CA
1679630715$16796307$15$F$20150514$20240820$20190911$20240828$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK059049$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$BR$BR
1679712952$16797129$52$F$20191016$20240830$20190911$20240909$EXP$$CA-CELLTRION INC.-2019CA023311$CELLTRION$$$$$$Y$$$20240909$$MD$CA$CA
1679774121$16797741$21$F$$20240911$20190912$20240920$EXP$$CA-TEVA-2019-CA-1104790$TEVA$$71$YR$$F$Y$69$KG$20240920$$HP$CA$CA
167981522$16798152$2$F$$20240813$20190912$20240827$EXP$$CA-AUROBINDO-AUR-APL-2019-058991$AUROBINDO$$63$YR$$M$Y$$$20240827$$HP$CA$CA
167981683$16798168$3$F$$20240723$20190912$20240802$EXP$$CA-AUROBINDO-AUR-APL-2019-059002$AUROBINDO$$73$YR$$M$Y$$$20240802$$HP$CA$CA
168022022$16802202$2$F$$20240904$20190912$20240913$EXP$$CA-TEVA-2019-CA-1042659$TEVA$$67$YR$$M$Y$101$KG$20240913$$HP$CA$CA
1680247612$16802476$12$F$20190716$20240709$20190912$20240718$EXP$$CA-ROCHE-2403595$ROCHE$$35$YR$A$F$Y$$$20240718$$HP$CA$CA
168027694$16802769$4$F$$20240813$20190912$20240826$EXP$$CA-AUROBINDO-AUR-APL-2019-058992$AUROBINDO$$76$YR$$M$Y$$$20240826$$HP$CA$CA
168036253$16803625$3$F$20100101$20231114$20190913$20240917$EXP$$US-MALLINCKRODT-T201901839$SPECGX$$$$$M$Y$84$KG$20240917$$CN$US$US
1680393929$16803939$29$F$$20240912$20190913$20240918$EXP$$CA-JNJFOC-20190905109$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240918$$MD$CA$CA
168050572$16805057$2$F$20190501$20240715$20190913$20240722$PER$$US-GLAXOSMITHKLINE-US2019162845$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240722$$CN$US$US
168087752$16808775$2$F$$20240817$20190916$20240829$EXP$$IT-Accord-154881$ACCORD$Di Renzo B, Montanaro A, Spinelli A, Covella P, De Giorgi A, Flores A et al. A case of septic shock with oliguric acute renal failure resolved with CVVHF coupled with cytosorb. Blood Purification. 2019;47(4):11-12. DOI: 10.1159/000500179$72$YR$E$M$Y$$$20240829$$HP$IT$IT
1681007413$16810074$13$F$$20240625$20190916$20240701$PER$$US-PFIZER INC-2019393944$PFIZER$$79$YR$$M$Y$99.32$KG$20240701$$CN$US$US
168114632$16811463$2$F$20190701$20240914$20190916$20240919$PER$$US-SA-2019SA251733$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240919$$MD$US$US
1681169210$16811692$10$F$$20240625$20190916$20240701$PER$$US-PFIZER INC-2019394973$PFIZER$$76$YR$$F$Y$$$20240701$$CN$US$US
168118392$16811839$2$F$20160701$20240909$20190916$20240913$EXP$FR-AFSSAPS-RN20161340$FR-MYLANLABS-2019M1085734$MYLAN$$41$YR$$F$Y$60$KG$20240913$$MD$FR$FR
168150488$16815048$8$F$20190805$20211012$20190917$20240711$EXP$$PHHY2019GB193786$NOVARTIS$$68$YR$$F$Y$$$20240711$$CN$GB$GB
1681532519$16815325$19$F$$20240812$20190917$20240819$EXP$$CA-JNJFOC-20190913993$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$HP$CA$CA
1681634915$16816349$15$F$20210412$20240731$20190917$20240806$EXP$$BR-GLAXOSMITHKLINE-BR2018GSK067759$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$HP$BR$BR
1681642116$16816421$16$F$20190429$20240823$20190917$20240902$EXP$$BR-GLAXOSMITHKLINE-BR2019GSK074154$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$BR$BR
168184734$16818473$4$F$$20240627$20190917$20240712$PER$$US-SA-2019SA257273$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240712$$MD$US$US
1681867324$16818673$24$F$20200731$20240919$20190917$20240925$EXP$$BR-GLAXOSMITHKLINE-BR2019GSK003150$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$BR$BR
1681899811$16818998$11$F$$20240911$20190917$20240913$PER$$US-PFIZER INC-2019397764$PFIZER$$65$YR$$M$Y$$$20240913$$CN$US$US
1681956613$16819566$13$F$$20240806$20190917$20240808$EXP$$US-TAKEDA-2019TUS052494$TAKEDA$$$$$F$Y$82$KG$20240808$$HP$US$US
1682106614$16821066$14$F$20191001$20240708$20190918$20240715$EXP$$US-GLAXOSMITHKLINE-US-2018TSO02047$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$US$US
1682330013$16823300$13$F$20190704$20240920$20190918$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-089467$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240930$$PH$JP$JP
168236002$16823600$2$F$$20240816$20190918$20240823$EXP$$DE-BAXTER-2019BAX018013$BAXTER$$$$N$M$Y$$$20240823$$HP$DE$DE
168260784$16826078$4$F$$20240801$20190919$20240814$EXP$$CA-AUROBINDO-AUR-APL-2019-059693$AUROBINDO$$44$YR$$M$Y$$$20240814$$HP$CA$CA
168261102$16826110$2$F$$20240801$20190919$20240814$EXP$$CA-AUROBINDO-AUR-APL-2019-059629$AUROBINDO$$49$YR$$F$Y$$$20240814$$HP$CA$CA
168267082$16826708$2$F$$20240720$20190919$20240731$EXP$$CA-AUROBINDO-AUR-APL-2019-059738$AUROBINDO$EL-GAALY S., ST. JOHN., DUNSMORE S. AND BOLTON J.M. ATYPICAL NEUROLEPTIC MALIGNANT SYNDROME WITH QUETIAPINE : A CASE REPORT AND REVIEW OF THE LITERATURE.. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2009;29(5):497-499$52$YR$$M$Y$$$20240731$$MD$CA$CA
1682679027$16826790$27$F$20190723$20240911$20190919$20240913$EXP$$CA-ROCHE-2372484$ROCHE$$63$YR$A$F$Y$$$20240913$$CN$CA$CA
168270139$16827013$9$F$$20240718$20190919$20240724$EXP$$CA-TAKEDA-2019TEU011026$TAKEDA$$72$YR$$M$Y$$$20240724$$HP$CA$CA
168296955$16829695$5$F$$20240909$20190919$20240912$EXP$$GR-MYLANLABS-2019M1087648$MYLAN$Kourtelesi E, Mermigis D, Panagiotidis K, Mantzouranis K, Georgakopoulou V, Tsiafaki Xet al.. Pneumonia from Legionella in a patient under treatment with adalimumab.. Panhellenic Pneumonological Conference.. 2018;13-16$63$YR$$M$Y$$$20240912$$HP$GR$GR
1682991010$16829910$10$F$20190702$20240626$20190919$20240702$EXP$$CO-INCYTE CORPORATION-2019IN007546$INCYTE$$$$$$Y$$$20240702$$CN$CO$CO
168315132$16831513$2$F$$20240724$20190920$20240805$EXP$$CA-AUROBINDO-AUR-APL-2019-059936$AUROBINDO$$60$YR$$M$Y$$$20240805$$HP$CA$CA
1683181220$16831812$20$F$20180828$20240716$20190920$20240723$EXP$$CA-ROCHE-2177467$ROCHE$$46$YR$A$M$Y$$$20240723$$CN$CA$CA
168345715$16834571$5$F$20160601$20240911$20190920$20240916$EXP$$CZ-MYLANLABS-2019M1086177$MYLAN$Liberko M.. Third-line disease stabilization of metastatic rectal cancer in a patient with adverse clinical course. Acta Medicinae. Case study in oncology. 2019;4:24-26$$$A$M$Y$$$20240916$$MD$CZ$CZ
168346928$16834692$8$F$20190101$20240909$20190920$20240916$EXP$$CA-PFIZER INC-2019401450$PFIZER$$42$YR$$F$Y$$$20240916$$HP$CA$CA
168353113$16835311$3$F$$20240806$20190920$20240812$EXP$$CO-AMGEN-COLSL2019152667$AMGEN$$82$YR$E$F$Y$$$20240811$$CN$CO$CO
1683637718$16836377$18$F$$20240805$20190921$20240808$EXP$$CA-AUROBINDO-AUR-APL-2019-059963$AUROBINDO$$53$YR$$M$Y$$$20240808$$MD$CA$CA
168378949$16837894$9$F$20190704$20240816$20190923$20240826$EXP$$CA-ROCHE-2412952$ROCHE$$62$YR$A$F$Y$114$KG$20240826$$MD$CA$CA
168382922$16838292$2$F$$20240913$20190923$20240923$EXP$$ES-AUROBINDO-AUR-APL-2019-061338$AUROBINDO$Perez-ricart A, Galicia-basart M, Comas-sugranes D, Cruzado-garrit JM, Segarra-medrano A, Montoro-ronsano JB.. Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism. Kidney Research and Clinical Practice. 2019;38(2):229-38$$$A$$Y$$$20240923$$HP$ES$ES
1684158121$16841581$21$F$$20240718$20190923$20240726$EXP$$CA-PFIZER INC-2019408591$PFIZER$$72$YR$$M$Y$$$20240726$$CN$CA$CA
168422332$16842233$2$F$$20191030$20190924$20240712$PER$$PHEH2019US039283$NOVARTIS$$$$$M$Y$$$20240712$$CN$US$US
1684238939$16842389$39$F$20180912$20240904$20190924$20240913$EXP$$CA-CELLTRION INC.-2018CA021828$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
168435942$16843594$2$F$$20240828$20190924$20240912$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-220970$RANBAXY$Mihaila RG, Sandu M. Liver infarction in a patient with Clostridium Difficile colitis. A possible connection?. J Gastrointestin Liver Dis. 2019;Jun; 28 (2):245-247$66$YR$$F$Y$$$20240912$$HP$RO$RO
1684494110$16844941$10$F$$20240731$20190924$20240805$EXP$$US-PFIZER INC-2019409206$PFIZER$$82$YR$$M$Y$79.365$KG$20240805$$CN$US$US
168462684$16846268$4$F$20200901$20240621$20190924$20240702$PER$$US-SA-2019SA262162$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240702$$MD$US$US
168462763$16846276$3$F$$20240826$20190924$20240918$PER$$US-SA-2019SA262446$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240918$$MD$US$US
168479183$16847918$3$F$20160701$20240829$20190924$20240912$EXP$$DE-CELLTRION INC.-2019DE025010$CELLTRION$Panning M, Basho K, Fahrner A and Neumann-Haefelin C. Chronic hepatitis E after kidney transplantation with an antibody response suggestive of reinfection: a case report. BMC infectious diseases. 2019;19(1):1-5$$$$$Y$$$20240912$$HP$DE$DE
168482692$16848269$2$F$$20240406$20190925$20240911$PER$$US-AUROBINDO-AUR-APL-2019-020979$AUROBINDO$$7$YR$$M$Y$$$20240911$$CN$US$US
168483823$16848382$3$F$$20190930$20190925$20240716$EXP$$US-AstraZeneca-2019SF21989$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
168492119$16849211$9$F$$20240726$20190925$20240807$EXP$$CA-AUROBINDO-AUR-APL-2019-062322$AUROBINDO$$60$YR$$F$Y$$$20240807$$HP$CA$CA
168511523$16851152$3$F$20240801$20240906$20190925$20240916$EXP$$US-GLAXOSMITHKLINE-US2019168152$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240916$$CN$US$US
168538553$16853855$3$F$20190814$20240624$20190926$20240709$EXP$$CA-ROCHE-2419188$ROCHE$$45$YR$A$F$Y$79$KG$20240705$$MD$CA$CA
168545279$16854527$9$F$$20240724$20190926$20240731$EXP$$CA-Orion Corporation ORION PHARMA-TREX2019-3630$ORION$$72$YR$E$M$Y$$$20240731$$MD$CA$
168560406$16856040$6$F$20231101$20240731$20190926$20240805$PER$$US-PFIZER INC-2019132294$PFIZER$$56$YR$$M$Y$$$20240805$$HP$US$US
1685729211$16857292$11$F$20190101$20240822$20190926$20240826$EXP$$JP-ABBVIE-19P-087-2925617-00$ABBVIE$$80$YR$$M$Y$40$KG$20240826$$CN$JP$JP
168573324$16857332$4$F$$20240717$20190926$20240723$EXP$$CA-PFIZER INC-2019409918$MYLAN$$63$YR$$F$Y$85$KG$20240723$$HP$CA$CA
168573435$16857343$5$F$$20240807$20190926$20240809$EXP$$CA-PFIZER INC-2019410534$PFIZER$$52$YR$$F$Y$$$20240809$$HP$CA$CA
168583085$16858308$5$F$$20240718$20190926$20240725$EXP$$CA-SHIRE-CA201900834AA$TAKEDA$$$$$M$Y$113$KG$20240725$$CN$CA$CA
168595367$16859536$7$F$20190101$20240912$20190927$20240921$EXP$$CA-ROCHE-2419054$ROCHE$$33$YR$A$F$Y$41.5$KG$20240921$$MD$CA$CA
168619262$16861926$2$F$$20240923$20190927$20240925$EXP$$DE-UCBSA-2019041233$UCB$Hoeltzenbein M, Slimi S, Fietz AK, Onken M, Dathe K, Schaefer C. Lacosamide use during pregnancy - An evaluation of the German embryotox database. 47th Conference of the European Teratology Society (ETS). Germany. Reproductive Toxicology. 2019;88:143-4$$$$$Y$$$20240925$$MD$DE$DE
168624402$16862440$2$F$$20240821$20190927$20240902$EXP$GR-EMA-DD-20190918-KHARE_I-085301$GR-Accord-155841$ACCORD$Rapti K, Aravantinou-Fatoorou E, Bakogoorgos M, Kenteopozidis N. AA41: LUNG ADENOCARCINOMA WITH EGFR MUTATION AND LONG-TERM RESPONSE ?TO IMMUNOTHERAPY, PRESENTATION OF A RARE CASE. 25th HELLENIC CONGRESS OF CLINICAL ONCOLOGY. 2019,18-20$82$YR$E$M$Y$$$20240902$$HP$GR$GR
168639912$16863991$2$F$$20240726$20190927$20240805$EXP$$US-VIIV HEALTHCARE LIMITED-US2019174627$VIIV$$$$$M$Y$$$20240805$$CN$US$US
168644289$16864428$9$F$20171121$20240815$20190928$20240823$EXP$$CN-ROCHE-1956374$ROCHE$$53$YR$A$M$Y$78$KG$20240823$$CN$CN$CN
168644572$16864457$2$F$$20240815$20190928$20240827$EXP$$IT-ROCHE-2413695$ROCHE$Di R, Montanaro A, Spinelli A, et al A case of septic shock with oliguric acute renal failure resolved with CVVHF coupled with cytosorb.. Blood Purification 2019;47 (0):11-.$72$YR$E$M$Y$$$20240827$$MD$IT$IT
168649186$16864918$6$F$20190917$20240809$20190929$20240813$EXP$$JP-TAKEDA-2019TJP022470$TAKEDA$Arii K. et al. The 107th General Meeting of the Japanese Society of Gastroenterology. JOURNAL OF JAPANESE SOCIETY OF GASTROENTEROLOGY. 2021;04:15-7$67$YR$$M$Y$$$20240813$$MD$JP$JP
1686643533$16866435$33$F$20190901$20240906$20190930$20240910$EXP$$US-GLAXOSMITHKLINE-US2019TSO170327$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$US$US
1686644719$16866447$19$F$$20240801$20190930$20240807$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK138459$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$BR$BR
168686019$16868601$9$F$$20240808$20190930$20240812$PER$$US-PFIZER INC-2019418989$PFIZER$$26$YR$$F$Y$$$20240812$$HP$US$US
168690044$16869004$4$F$$20240701$20190930$20240708$EXP$$CA-BAUSCH-BL-2019-055613$BAUSCH AND LOMB$$$$$F$Y$$$20240708$$CN$CA$CA
168690994$16869099$4$F$$20240819$20190930$20240822$EXP$$PHHY2019FR226489$NOVARTIS$$68$YR$$M$Y$$$20240822$$MD$FR$FR
168692015$16869201$5$F$20190909$20240712$20190930$20240717$EXP$$BE-ROCHE-2422500$ROCHE$$41$YR$A$F$Y$$$20240717$$MD$BE$BE
1687008016$16870080$16$F$20191101$20240830$20190930$20240917$PER$$US-INCYTE CORPORATION-2019IN008797$INCYTE$$$$$$Y$$$20240917$$CN$US$US
168703016$16870301$6$F$20190714$20240624$20190930$20240702$EXP$$PHHY2019BR167905$NOVARTIS$$43$YR$$M$Y$$$20240702$$CN$BR$BR
168728382$16872838$2$F$$20240821$20191001$20240828$EXP$$DE-PFIZER INC-2019418555$MYLAN$$55$YR$$M$Y$$$20240828$$CN$DE$DE
168728714$16872871$4$F$20170101$20240927$20191001$20240930$EXP$$US-GILEAD-2019-0430957$GILEAD$$62$YR$A$M$Y$$$20240930$$LW$US$US
1687393826$16873938$26$F$20190618$20240830$20191001$20240903$EXP$$DE-ROCHE-2348096$ROCHE$$51$YR$A$F$Y$$$20240903$$CN$DE$DE
1687770637$16877706$37$F$20180315$20240626$20191002$20240716$EXP$$DE-ROCHE-2095674$ROCHE$$59$YR$A$F$Y$$$20240716$$CN$DE$DE
168786082$16878608$2$F$20190901$20240905$20191002$20240923$PER$$US-SA-2019SA263573$SANOFI AVENTIS$$28$YR$A$F$Y$77.27$KG$20240923$$MD$US$US
168786543$16878654$3$F$20190901$20240909$20191002$20240917$PER$$US-SA-2019SA266412$SANOFI AVENTIS$$80$YR$E$F$Y$52.32$KG$20240918$$MD$US$US
168787812$16878781$2$F$20190919$20240708$20191002$20240716$PER$$US-SA-2019SA267200$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240716$$CN$US$US
1687967422$16879674$22$F$$20240906$20191003$20240913$EXP$$CA-Noden Pharma DAC-NOD-2019-000161$NODEN PHARMA$$61$YR$A$F$Y$70$KG$20240913$$HP$CA$
168802972$16880297$2$F$$20240701$20191003$20240708$EXP$$CA-AUROBINDO-AUR-APL-2019-063450$AUROBINDO$$32$YR$$F$Y$$$20240708$$HP$CA$CA
168812493$16881249$3$F$20190429$20240710$20191003$20240712$EXP$$US-SHIRE-US201915052$TAKEDA$$47$YR$$F$Y$$$20240712$$CN$US$US
168821934$16882193$4$F$20151215$20240716$20191003$20240724$EXP$$FR-ELI_LILLY_AND_COMPANY-FR201909014092$ELI LILLY AND CO$$56$YR$A$F$Y$61$KG$20240723$$CN$FR$FR
1688253518$16882535$18$F$$20240819$20191003$20240822$EXP$$CA-BAUSCH-BL-2019-055729$BAUSCH AND LOMB$$60$YR$$F$Y$61$KG$20240823$$CN$CA$CA
168825904$16882590$4$F$$20240731$20191003$20240813$EXP$$CA-AUROBINDO-AUR-APL-2019-063541$AUROBINDO$$28$YR$$F$Y$$$20240813$$HP$CA$CA
168826444$16882644$4$F$$20240731$20191003$20240811$EXP$$CA-AUROBINDO-AUR-APL-2019-063630$AUROBINDO$$46$YR$$F$Y$$$20240812$$HP$CA$CA
168840054$16884005$4$F$$20240731$20191004$20240813$EXP$$CA-AUROBINDO-AUR-APL-2019-063945$AUROBINDO$$54$YR$$F$Y$$$20240813$$HP$CA$CA
168841336$16884133$6$F$$20240731$20191004$20240813$EXP$$CA-AUROBINDO-AUR-APL-2019-063668$AUROBINDO$$44$YR$$F$Y$74$KG$20240813$$HP$CA$CA
168854113$16885411$3$F$$20240820$20191004$20240827$EXP$$BR-SA-2019SA269468$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240827$$HP$BR$BR
1688672066$16886720$66$F$$20240708$20191004$20240710$EXP$$CA-ABBVIE-19K-028-2946845-00$ABBVIE$$44$YR$$F$Y$97$KG$20240710$$HP$CA$CA
1688675019$16886750$19$F$20170531$20240913$20191004$20240925$EXP$$CA-TAKEDA-2019TUS027610$TAKEDA$$65$YR$$F$Y$$$20240925$$MD$CA$CA
1688691642$16886916$42$F$20210901$20240829$20191004$20240902$EXP$$US-GLAXOSMITHKLINE-US2019TSO170833$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
168874686$16887468$6$F$$20240705$20191004$20240716$EXP$$DE-AUROBINDO-AUR-APL-2019-063632$AUROBINDO$Mizera L, Klingel K, Gawaz M, Greulich S. Fatigue, shortness of breath and chest pain in a 31-year-old man with schizoaffective disorder. Der Internist. 2019;60(11):1209-1214$31$YR$$M$Y$110$KG$20240716$$MD$DE$DE
168879373$16887937$3$F$20240510$20240816$20191006$20240820$EXP$$US-SHIRE-US201932633$TAKEDA$$86$YR$$F$Y$$$20240820$$HP$US$US
1688902110$16889021$10$F$20190924$20240920$20191007$20240930$EXP$$JP-ASTELLAS-2019JP022159$ASTELLAS$Suzuki Y, Kitawaki T, Arai Y, Nakagawa S, Chonabayashi K, Nannya Y,et al. Concentration of gilteritinib in the cerebrospinal fluid of a patient with relapsed FLT3-ITD positive acute myeloid leukemia with optic nerve involvement. The Japanese Journal of Clinical Hematology. 2024;65(8): 727-31.$72$YR$E$F$Y$60$KG$20240930$$MD$JP$JP
168895692$16889569$2$F$$20240821$20191007$20240904$EXP$BR-MLMSERVICE-20190920-1970152-1$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2019-08546$ALKEM$Lima VACC, Gouv?a ALF, Menezes P, Santos JDF, Rochael MC, Carvalho FR et al.. Hemophagocytic lymphohistiocytosis, a rare condition in renal transplant - a case report. Jornal brasileiro de nefrologia : orgao oficial de Sociedades Brasileira e Latin. 2018;40(4):423-427$50$YR$$F$Y$$$20240904$$HP$BR$BR
1688961636$16889616$36$F$20120101$20240829$20191007$20240831$EXP$$DE-ROCHE-2190506$ROCHE$$39$YR$A$M$Y$67$KG$20240831$$CN$DE$DE
168908023$16890802$3$F$$20240913$20191007$20240916$PER$$US-PFIZER INC-2019429954$PFIZER$$56$YR$$F$Y$$$20240916$$CN$US$US
168922892$16892289$2$F$$20240715$20191007$20240723$PER$$US-SA-2019SA269631$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240723$$CN$US$US
1689349517$16893495$17$F$20190809$20240619$20191008$20240710$EXP$$DE-ROCHE-2358101$ROCHE$$49$YR$A$F$Y$$$20240710$$CN$DE$DE
168935582$16893558$2$F$20190301$20240911$20191008$20240919$EXP$$BG-ROCHE-2422471$ROCHE$, Simova Y, Stanilov P, Sacubitril/Valsartan in chemotherapy induced cardiotoxicity associated with a chemoptherapy. Cardio D. 2019;25:9-12.$60$YR$A$F$Y$$$20240919$$HP$BG$BG
168936152$16893615$2$F$20170405$20240725$20191008$20240731$EXP$$FR-MYLANLABS-2019M1092171$MYLAN$$32$YR$$M$Y$82$KG$20240731$$MD$FR$FR
168944666$16894466$6$F$$20240729$20191008$20240801$PER$$US-PFIZER INC-2019396566$PFIZER$$69$YR$$F$Y$$$20240801$$MD$US$US
168953313$16895331$3$F$20151215$20240711$20191008$20240715$EXP$$FR-PFIZER INC-2019425307$PFIZER$$60$YR$$F$Y$61$KG$20240715$$MD$FR$FR
168955663$16895566$3$F$20190920$20240918$20191008$20240920$EXP$$VN-PFIZER INC-2019432082$PFIZER$$5$WK$$F$Y$$$20240920$$HP$VN$VN
168958726$16895872$6$F$20220726$20240711$20191008$20240715$EXP$$US-SHIRE-US201932929$TAKEDA$$56$YR$$F$Y$$$20240715$$CN$US$US
168959144$16895914$4$F$20160101$20240627$20191008$20240710$EXP$$CA-MYLANLABS-2019M1094314$Steriscience PTE$Lewin A, Quach C, Rigourd V, Picaud J-C, Perreault T, Frange P, et al.. Bacillus cereus infection in neonates and the absence of evidence for the role of banked human milk: Case reports and literature review.. Infection Control and Hospital Epidemiology. 2019;40(7):787-793$6$DY$$$Y$0.56$KG$20240710$$MD$CA$CA
168963057$16896305$7$F$20170209$20240719$20191008$20240731$EXP$$FR-ELI_LILLY_AND_COMPANY-FR201803004026$ELI LILLY AND CO$$62$YR$A$F$Y$84$KG$20240731$$CN$FR$FR
1689765011$16897650$11$F$20190301$20240904$20191009$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-096760$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$66.6$KG$20240917$$MD$JP$JP
168977743$16897774$3$F$$20240812$20191009$20240822$EXP$$ES-AUROBINDO-AUR-APL-2019-065021$AUROBINDO$Requena S, Lozano AB, Caballero E, Garc?a F, Nieto MC, T?llez R et al,... Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain.. Journal of Antimicrobial Chemotherapy. 2019;74(5):1357?62$51$YR$$M$Y$$$20240822$$HP$ES$ES
168978553$16897855$3$F$20190926$20191023$20191009$20240717$EXP$$PT-SA-2019SA278260$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240717$$CN$PT$PT
168983852$16898385$2$F$$20240805$20191009$20240815$EXP$$DE-TEVA-2019-DE-1118962$TEVA$Hoeltzenbein M, Slimi S, Fietz A-K, Onken M, Dathe K, Schaefer C. #33 Lacosamide use during pregnancy - An evaluation of the German embryotox database. Reprod-Toxicol 2019; 88 143-144.; Hoeltzenbein M, Slimi S, Fietz A-K, Onken M, Dathe K, Schaefer C. #33 Lacosamide use during pregnancy - An evaluation of the German embryotox database. Reprod-Toxicol 2019;88:143-144 abstr. 33.$$$N$$Y$$$20240815$$HP$DE$DE
168989027$16898902$7$F$20180101$20240712$20191009$20240716$EXP$$US-PFIZER INC-2019430600$PFIZER$$77$YR$$F$Y$64$KG$20240716$$CN$US$US
169000586$16900058$6$F$$20240826$20191009$20240829$EXP$$US-JNJFOC-20190938576$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$HP$US$FR
169017984$16901798$4$F$20190930$20240906$20191010$20240909$EXP$$US-SHIRE-US201932276$TAKEDA$$70$YR$$F$Y$79.8$KG$20240909$$MD$US$US
169024034$16902403$4$F$$20240801$20191010$20240806$EXP$$US-SHIRE-US201932707$TAKEDA$$$$$F$Y$$$20240806$$CN$US$US
169033333$16903333$3$F$20170701$20240711$20191010$20240715$EXP$$FR-PFIZER INC-2019034662$PFIZER$$65$YR$$M$Y$91$KG$20240715$$MD$FR$FR
169060605$16906060$5$F$$20240829$20191010$20240909$EXP$$CA-AUROBINDO-AUR-APL-2019-065542$AUROBINDO$$46$YR$$M$Y$$$20240909$$HP$CA$CA
1690792123$16907921$23$F$20190926$20240813$20191011$20240819$EXP$$IL-ABBVIE-19K-082-2955109-00$ABBVIE$$59$YR$$M$Y$73$KG$20240819$$MD$IL$IL
1690804012$16908040$12$F$20190729$20240820$20191011$20240826$EXP$$IL-ABBVIE-19K-082-2956727-00$ABBVIE$$86$YR$$F$Y$60$KG$20240826$$MD$IL$IL
1690876413$16908764$13$F$$20240828$20191011$20240831$EXP$$US-SHIRE-US201933341$TAKEDA$$$$$F$Y$108$KG$20240831$$CN$US$US
169098742$16909874$2$F$$20240827$20191011$20240903$PER$$US-GLAXOSMITHKLINE-US2019AMR180470$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$CN$US$US
1691047921$16910479$21$F$20191201$20240924$20191011$20240930$EXP$$US-SHIRE-US201933807$TAKEDA$$57$YR$$F$Y$82$KG$20240930$$MD$US$US
169106424$16910642$4$F$20191002$20240918$20191012$20240920$PER$$US-SHIRE-US201933267$TAKEDA$$54$YR$$M$Y$79.36$KG$20240920$$HP$US$US
1691159032$16911590$32$F$20190219$20240821$20191013$20240829$EXP$$CA-CELLTRION INC.-2019CA017829$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
169116754$16911675$4$F$$20240814$20191013$20240821$EXP$$CA-AUROBINDO-AUR-APL-2019-065720$AUROBINDO$$83$YR$$M$Y$100$KG$20240821$$HP$CA$CA
169123185$16912318$5$F$$20240909$20191014$20240911$EXP$$US-SHIRE-US201933818$TAKEDA$$$$$F$Y$65$KG$20240911$$HP$US$US
169123982$16912398$2$F$20190309$20240827$20191014$20240905$EXP$FR-AFSSAPS-ST20191218$FR-TEVA-2019-FR-1120697$TEVA$$70$YR$$F$Y$$$20240905$$MD$FR$FR
1691261212$16912612$12$F$$20240801$20191014$20240814$EXP$$CA-AUROBINDO-AUR-APL-2019-065970$AUROBINDO$$34$YR$$F$Y$81$KG$20240814$$HP$CA$CA
169126214$16912621$4$F$$20240813$20191014$20240826$EXP$$CA-AUROBINDO-AUR-APL-2019-066300$AUROBINDO$$56$YR$$F$Y$80$KG$20240826$$HP$CA$CA
169130084$16913008$4$F$20121230$20240822$20191014$20240903$EXP$$FR-AUROBINDO-AUR-APL-2019-065796$AUROBINDO$$$$N$F$Y$2.1$KG$20240903$$MD$FR$FR
169130987$16913098$7$F$$20240903$20191014$20240912$EXP$$CA-AUROBINDO-AUR-APL-2019-066068$AUROBINDO$$62$YR$$F$Y$$$20240912$$HP$CA$CA
169133007$16913300$7$F$$20240720$20191014$20240801$EXP$$PT-AUROBINDO-AUR-APL-2019-066409$AUROBINDO$Fonseca T, Romero JM. Neuroleptic-induced ischemic colitis: clinical cases in a psychiatric hospital.. REVISTA ONLINE DE CASOS CLINICOS EM MEDICINA INTERNA (RCCMI).. 2019;1-3$47$YR$$M$Y$$$20240801$$MD$PT$PT
1691464537$16914645$37$F$20170105$20240903$20191014$20240906$EXP$$US-SHIRE-US201934029$TAKEDA$$51$YR$$F$Y$93$KG$20240906$$MD$US$US
169148866$16914886$6$F$$20240920$20191014$20240925$EXP$$CA-PFIZER INC-2019317807$PFIZER$$60$YR$$F$Y$$$20240925$$HP$CA$CA
169168453$16916845$3$F$$20240913$20191015$20240925$EXP$$DE-AUROBINDO-AUR-APL-2017-06751$AUROBINDO$Runge S, Mayerle J, Warnke C, Robinson D, Roser M, Felix SB, Friesecke S.. Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation?. Diabetes, Obesity and Metabolism. 2008;10(1):91-93$74$YR$$M$Y$$$20240925$$MD$DE$DE
169169738$16916973$8$F$20211204$20240718$20191015$20240724$EXP$$US-TAKEDA-2019TUS056439$TAKEDA$$19$YR$$M$Y$$$20240724$$HP$US$US
1691762110$16917621$10$F$20180101$20240723$20191015$20240729$EXP$$CA-TAKEDA-2018TUS007306$TAKEDA$$$$$F$Y$62.7$KG$20240729$$MD$CA$CA
169184888$16918488$8$F$20180101$20240729$20191015$20240802$EXP$$JP-GILEAD-2018-0362598$GILEAD$$52$YR$A$M$Y$$$20240802$$MD$JP$JP
1691894917$16918949$17$F$20210220$20240801$20191015$20240805$EXP$$US-PFIZER INC-2019064045$PFIZER$$76$YR$$F$Y$58.957$KG$20240805$$CN$US$US
1691905521$16919055$21$F$20180102$20240904$20191015$20240906$EXP$$PHHY2018CA089256$NOVARTIS$$71$YR$$F$Y$$$20240906$$MD$CA$CA
1691916516$16919165$16$F$$20240725$20191015$20240730$EXP$$US-PFIZER INC-2019444030$PFIZER$$70$YR$$F$Y$$$20240730$$CN$US$US
1691951316$16919513$16$F$$20240918$20191015$20240923$EXP$$CA-PFIZER INC-2019436652$PFIZER$$50$YR$$F$Y$118$KG$20240923$$HP$CA$CA
169204104$16920410$4$F$20190101$20240702$20191015$20240704$EXP$$CA-JNJFOC-20190541594$JOHNSON AND JOHNSON$$51$YR$A$F$Y$54.43$KG$20240704$$HP$CA$CA
169211388$16921138$8$F$20131001$20240729$20191015$20240801$EXP$$BE-PFIZER INC-2019442923$PFIZER$Apraxine, M.. Severe hypomagnesemia induced by proton pump inhibitors: description of two cases and review of the literature. Louvain Medical. 2019;138 (7):446-451$54$YR$$M$Y$$$20240801$$HP$BE$BE
1692179211$16921792$11$F$20190928$20240917$20191015$20240920$EXP$$US-SHIRE-US201933430$TAKEDA$$79$YR$$F$Y$52$KG$20240920$$HP$US$US
1692410517$16924105$17$F$20190101$20240904$20191016$20240905$EXP$$CA-PFIZER INC-2019440780$PFIZER$$61$YR$$M$Y$$$20240905$$HP$CA$CA
169252243$16925224$3$F$$20240701$20191016$20240718$EXP$$AT-Horizon-PRO-0225-2019$AMGEN$Kishk OA, Kim I, Cheng C, Summan M, Munoz MA.. Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients.. Pediatric Nephrology. 2024;39 (3):1-5$9$YR$C$F$Y$25$KG$20240718$$HP$AT$AT
169261797$16926179$7$F$20190517$20240815$20191016$20240823$EXP$$CA-ROCHE-2384927$ROCHE$$77$YR$E$M$Y$$$20240823$$CN$CA$CA
169273594$16927359$4$F$20160101$20240905$20191016$20240910$EXP$$PHHY2019CO082239$NOVARTIS$$$$$M$Y$97$KG$20240910$$CN$CO$CO
1692797414$16927974$14$F$20201030$20240813$20191017$20240824$EXP$$US-SHIRE-US201934583$TAKEDA$$46$YR$$F$Y$61.22$KG$20240824$$HP$US$US
169335226$16933522$6$F$20190325$20240910$20191018$20240912$EXP$$US-KYOWAKIRIN-2019BKK005147$KYOWA$$$$$$Y$$$20240912$$HP$US$US
169336022$16933602$2$F$$20191011$20191018$20240711$EXP$$GB-ASTELLAS-2019US040668$ASTELLAS$$$$$M$Y$$$20240711$$PH$GB$GB
169338615$16933861$5$F$20190101$20240819$20191018$20240827$EXP$$US-SA-2019SA267487$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240827$$HP$US$US
169362614$16936261$4$F$20181224$20240813$20191018$20240828$EXP$$US-INSMED, INC.-US-INS-19-03231$INSMED$$70$YR$$M$Y$$$20240828$$CN$US$US
169363098$16936309$8$F$$20240808$20191018$20240813$EXP$$CA-PFIZER INC-2019450641$PFIZER$$12$YR$$M$Y$$$20240813$$HP$CA$CA
1693810311$16938103$11$F$$20240802$20191019$20240807$EXP$$US-SHIRE-US201935104$TAKEDA$$$$$F$Y$79$KG$20240807$$CN$US$US
1693907920$16939079$20$F$20191007$20240709$20191020$20240717$EXP$$CA-CELLTRION INC.-2019CA024113$CELLTRION$$$$$$Y$$$20240717$$HP$CA$CA
1694143112$16941431$12$F$20191009$20240909$20191021$20240911$EXP$$US-SHIRE-US201934219$TAKEDA$$6$YR$$M$Y$$$20240911$$HP$US$US
1694423821$16944238$21$F$$20240816$20191022$20240826$EXP$$US-SHIRE-US201935446$TAKEDA$$$$$F$Y$$$20240826$$CN$US$US
169477613$16947761$3$F$$20240823$20191022$20240827$EXP$$US-JAZZ-2019-US-014398$JAZZ$$$$$F$Y$$$20240827$$CN$US$US
169487257$16948725$7$F$20170201$20240828$20191023$20240829$EXP$$US-NAPPMUNDI-USA-2019-0148303$PURDUE$$38$YR$$M$Y$$$20240829$$CN$US$US
169535053$16953505$3$F$20240601$20240726$20191023$20240807$PER$$US-SA-2019SA293817$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240807$$MD$US$US
169540885$16954088$5$F$$20240916$20191023$20240918$EXP$$US-SHIRE-US201934812$TAKEDA$$$$$F$Y$95.238$KG$20240918$$HP$US$US
1695479011$16954790$11$F$20190701$20240702$20191024$20240710$EXP$$NVSC2019CO013452$NOVARTIS$$29$YR$$M$Y$79$KG$20240710$$CN$CO$CO
1695696718$16956967$18$F$20190516$20240709$20191024$20240723$EXP$$DE-ROCHE-2370519$ROCHE$$26$YR$A$F$Y$57$KG$20240723$$MD$DE$DE
169585833$16958583$3$F$20201001$20240719$20191024$20240729$PER$$US-SA-2019SA289686$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240729$$MD$US$US
169587344$16958734$4$F$20190528$20240820$20191024$20240822$EXP$$ES-ABBVIE-19P-144-2970782-00$ABBVIE$$17$YR$$M$Y$$$20240821$$MD$ES$ES
169591242$16959124$2$F$$20240903$20191024$20240912$EXP$$CA-AUROBINDO-AUR-APL-2019-068850$AUROBINDO$$65$YR$$F$Y$88$KG$20240912$$HP$CA$CA
169599463$16959946$3$F$20191217$20240716$20191025$20240722$EXP$$CA-TAKEDA-2019TUS059822$TAKEDA$$64$YR$$M$Y$$$20240722$$MD$CA$CA
169620079$16962007$9$F$$20240905$20191025$20240910$EXP$$US-SHIRE-US201935636$TAKEDA$$$$$M$Y$104.3$KG$20240910$$HP$US$US
1696276815$16962768$15$F$20211017$20240920$20191025$20240927$EXP$$US-TAKEDA-2019TUS058698$TAKEDA$$71$YR$$F$Y$$$20240927$$HP$US$US
169629515$16962951$5$F$20190924$20240705$20191025$20240711$EXP$$CA-JNJFOC-20191025952$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240711$$HP$CA$CA
169632083$16963208$3$F$20151002$20240912$20191025$20240914$EXP$$US-TAKEDA-2019TUS059657$TAKEDA$$68$YR$$F$Y$97.959$KG$20240914$$HP$US$US
169632655$16963265$5$F$$20240827$20191025$20240830$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-102053$BRISTOL MYERS SQUIBB$Pluchart H, Ferrer L, Giovannini D, Tetaz R, Pinsolle J, Stephanov O, et al. Concomitant use of nivolumab and immunosuppressants in a renal transplant patient. Journal of Respiratory Diseases. 2019;(9):1064-8. doi:10.1016/j.rmr.2019.08.004.$71$YR$E$M$Y$$$20240830$$HP$FR$FR
169667922$16966792$2$F$20191022$20240821$20191028$20240823$PER$$US-SHIRE-US201936032$TAKEDA$$55$YR$$F$Y$55$KG$20240823$$CN$US$US
169673086$16967308$6$F$20211124$20240801$20191028$20240807$EXP$$US-SHIRE-US201936128$TAKEDA$$76$YR$$F$Y$$$20240807$$HP$US$US
169684274$16968427$4$F$20080101$20240913$20191029$20240925$EXP$$FR-AUROBINDO-AUR-APL-2019-061496$AUROBINDO$Rottembourg J, Menegaux F. Are oxyphil cells responsible for the ineffectiveness of cinacalcet hydrochloride in haemodialysis patients. Clinical Kidney Journal. 2019;12(3):433-436$3$DEC$$F$Y$56$KG$20240925$$HP$FR$FR
169685092$16968509$2$F$$20240903$20191029$20240915$EXP$$CA-AUROBINDO-AUR-APL-2019-068549$AUROBINDO$$70$YR$$F$Y$$$20240915$$HP$CA$CA
169690462$16969046$2$F$$20240912$20191029$20240926$EXP$FR-002147023-NVSC2019FR006062$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2019-08942$ALKEM$Poli E, Kounis I, Guettier C, Verstuyft C, Coilly A, Sobesky R et al.. Post-liver transplantation sinusoidal obstruction syndrome with refractory ascites induced by Mycophenolate Mofetil. Hepatology. 2020;71:1508-1510$41$YR$$M$Y$$$20240926$$MD$FR$FR
169698106$16969810$6$F$20190924$20240913$20191029$20240919$EXP$FR-AFSSAPS-MP20191337$FR-TAKEDA-2019TUS060175$TAKEDA$$68$YR$$M$Y$$$20240919$$HP$FR$FR
169704312$16970431$2$F$20190928$20240711$20191029$20240715$EXP$$CN-PFIZER INC-2019463216$PFIZER$$47$YR$$M$Y$$$20240715$$CN$CN$CN
169729912$16972991$2$F$$20240916$20191030$20240921$EXP$$CA-AUROBINDO-AUR-APL-2019-069283$AUROBINDO$$72$YR$$F$Y$$$20240921$$HP$CA$CA
169730437$16973043$7$F$20190101$20240716$20191030$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-218146$RANBAXY$$$$A$F$Y$$$20240731$$CN$US$US
169732575$16973257$5$F$$20240903$20191030$20240913$EXP$$CA-AUROBINDO-AUR-APL-2019-069313$AUROBINDO$$64$YR$$F$Y$$$20240913$$HP$CA$CA
169734259$16973425$9$F$20191019$20240717$20191030$20240719$EXP$$US-SHIRE-US201936016$TAKEDA$$30$YR$$M$Y$$$20240719$$MD$US$US
1697344022$16973440$22$F$$20240830$20191030$20240905$EXP$$US-SHIRE-US201936409$TAKEDA$$$$$M$Y$79$KG$20240905$$CN$US$US
169741786$16974178$6$F$20191008$20240926$20191030$20240930$EXP$$US-PFIZER INC-2019465570$PFIZER$$75$YR$$F$Y$68.04$KG$20240930$$CN$US$US
1697421015$16974210$15$F$20130101$20240705$20191030$20240709$EXP$$NVSC2019DE016816$NOVARTIS$$62$YR$$M$Y$119$KG$20240709$$CN$DE$DE
1697473115$16974731$15$F$20190428$20230609$20191030$20240901$EXP$$FR-ABBVIE-19K-056-2977950-00$ABBVIE$$68$YR$$M$Y$111$KG$20240901$$MD$FR$FR
169757442$16975744$2$F$20190101$20240919$20191030$20240926$EXP$$AT-PFIZER INC-2019465930$MYLAN$$47$YR$$F$Y$$$20240926$$MD$AT$AT
169763436$16976343$6$F$20180201$20240809$20191030$20240816$EXP$$CA-GLAXOSMITHKLINE-CA2019AMR195163$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$CA$CA
169776327$16977632$7$F$20240102$20240919$20191031$20240925$EXP$$US-SHIRE-US201936437$TAKEDA$$73$YR$$F$Y$50$KG$20240925$$HP$US$US
169787013$16978701$3$F$20190831$20240902$20191031$20240904$EXP$$DE-PFIZER INC-2019468695$PFIZER$$81$YR$$M$Y$65$KG$20240904$$MD$DE$DE
1697935924$16979359$24$F$20191009$20240730$20191031$20240806$EXP$$CA-ROCHE-2447688$ROCHE$$38$YR$A$F$Y$73$KG$20240806$$CN$CA$CA
169832836$16983283$6$F$$20240711$20191101$20240722$EXP$$NL-009507513-1910NLD014597$MERCK$van Wijk F, Waterval J, van Aerde K, Henriet SSV, Meijer FJA, Borra LC, et al.. Successful systemic and topical treatment of Mycobacterium abscessus otomastoiditis. Antimicrobial agents and chemotherapy. 2019$7$YR$$M$Y$$$20240719$$HP$NL$NL
1698341217$16983412$17$F$20231022$20240726$20191101$20240731$EXP$$US-SHIRE-US201936849$TAKEDA$$77$YR$$F$Y$81$KG$20240731$$CN$US$US
169842113$16984211$3$F$$20240214$20191101$20240906$PER$$US-FARMAPROD-201904-0601$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240902$$CN$US$
169843162$16984316$2$F$20190621$20230712$20191101$20240906$PER$$US-FARMAPROD-201906-0987$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240902$$CN$US$US
169843422$16984342$2$F$$20230919$20191101$20240906$PER$$US-FARMAPROD-201904-0628$DOMPE FARMACEUTICI$$72$YR$E$F$Y$58.967$KG$20240902$$CN$US$
169844842$16984484$2$F$$20230815$20191101$20240906$PER$$US-FARMAPROD-201907-1125$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240902$$CN$US$US
169861227$16986122$7$F$20200911$20240826$20191101$20240829$EXP$$US-SHIRE-US201936845$TAKEDA$$73$YR$$F$Y$90.703$KG$20240829$$HP$US$US
169874279$16987427$9$F$20220927$20240906$20191102$20240911$EXP$$US-SHIRE-US201936164$TAKEDA$$73$YR$$F$Y$56$KG$20240911$$CN$US$US
169876015$16987601$5$F$$20240717$20191104$20240722$EXP$$CA-Orion Corporation ORION PHARMA-TREX2019-4952$ORION$$48$YR$A$F$Y$$$20240722$$HP$CA$
1698784017$16987840$17$F$20190821$20240827$20191104$20240905$EXP$$CA-CELLTRION INC.-2019CA021069$CELLTRION$$$$$$Y$$$20240905$$MD$CA$CA
169879704$16987970$4$F$$20240918$20191104$20240923$EXP$$CA-Orion Corporation ORION PHARMA-TREX2019-5020$ORION$$55$YR$A$F$Y$$$20240923$$HP$CA$
169891838$16989183$8$F$20190101$20240909$20191104$20240911$EXP$$US-PFIZER INC-2019473185$PFIZER$$50$YR$$F$Y$82.55$KG$20240911$$HP$US$US
169894572$16989457$2$F$20141001$20240730$20191104$20240731$PER$$US-PFIZER INC-2019362389$PFIZER$$55$YR$$F$Y$$$20240731$$LW$US$US
1699162215$16991622$15$F$20190927$20240909$20191104$20240912$EXP$$CA-TAKEDA-2019TUS046035$TAKEDA$$78$YR$$F$Y$$$20240912$$HP$CA$CA
169920955$16992095$5$F$20181024$20240827$20191105$20240903$EXP$$CA-ROCHE-2463989$ROCHE$$56$YR$A$M$Y$$$20240903$$CN$CA$CA
1699530624$16995306$24$F$20180911$20240701$20191105$20240703$EXP$$US-SHIRE-US201936135$TAKEDA$$69$YR$$F$Y$70$KG$20240703$$HP$US$US
169964862$16996486$2$F$$20240912$20191106$20240919$PER$$US-TAKEDA-2019TUS062273$TAKEDA$$$$$F$Y$86$KG$20240919$$MD$US$US
1699671615$16996716$15$F$20190911$20240715$20191105$20240723$EXP$$NVSC2019CO022097$NOVARTIS$$60$YR$$F$Y$78$KG$20240723$$CN$CO$CO
1699865726$16998657$26$F$20130813$20240830$20191105$20240904$EXP$$PHHY2013CA054029$NOVARTIS$$47$YR$$F$Y$85$KG$20240904$$HP$CA$CA
1700086518$17000865$18$F$20190107$20240917$20191106$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-004968$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$46.6$KG$20240924$$MD$JP$JP
170019892$17001989$2$F$$20240913$20191106$20240918$EXP$$US-JAZZ-2019-US-015184$JAZZ$$$$$M$Y$$$20240918$$CN$US$US
170026908$17002690$8$F$20201119$20240815$20191107$20240820$EXP$$US-SHIRE-US201937868$TAKEDA$$71$YR$$M$Y$76.644$KG$20240820$$CN$US$US
170028083$17002808$3$F$$20240705$20191107$20240715$EXP$$IT-AUROBINDO-AUR-APL-2019-070552$AUROBINDO$Pietrafusa N, Ferretti A, Trivisano M, De Palma L, Calabrese C, Carfi Pavia G, et al. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy. Pediatric Drugs. 2019;21(4):283-290$3$YR$$F$Y$$$20240715$$MD$IT$IT
170035868$17003586$8$F$20170801$20240903$20191107$20240909$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2018JPN170314$VIIV$$$$$$Y$$$20240909$$MD$JP$JP
170077956$17007795$6$F$20240918$20240918$20191108$20240919$EXP$$US-SHIRE-US201937359$TAKEDA$$78$YR$$F$Y$76.83$KG$20240919$$HP$US$US
1700835827$17008358$27$F$20230819$20240828$20191108$20240903$EXP$$US-SHIRE-US201937990$TAKEDA$$65$YR$$F$Y$59.864$KG$20240903$$MD$US$US
170093952$17009395$2$F$20240716$20240827$20191108$20240904$EXP$$US-GLAXOSMITHKLINE-US2019196481$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240904$$CN$US$US
170124427$17012442$7$F$20201101$20240827$20191108$20240902$EXP$$EG-ROCHE-2456990$ROCHE$$43$YR$A$F$Y$100$KG$20240902$$CN$EG$EG
1701287512$17012875$12$F$20190715$20240918$20191109$20240925$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-095625$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$78$KG$20240925$$HP$DE$DE
170140874$17014087$4$F$$20240916$20191111$20240920$EXP$$CA-AMGEN-CANSP2019183869$AMGEN$$58$YR$A$F$Y$$$20240920$$HP$CA$CA
170151442$17015144$2$F$$20240705$20191111$20240710$EXP$$CA-SA-2019SA310801$SANOFI AVENTIS$$65$YR$E$M$Y$58$KG$20240710$$HP$CA$CA
1701551814$17015518$14$F$20191009$20240709$20191111$20240722$EXP$$DE-ROCHE-2120407$ROCHE$$51$YR$A$F$Y$$$20240722$$CN$DE$DE
170170509$17017050$9$F$20180614$20240805$20191111$20240814$EXP$$JP-GILEAD-2018-0352428$GILEAD$$41$YR$A$M$Y$$$20240814$$MD$JP$JP
170176722$17017672$2$F$$20240703$20191111$20240711$PER$$US-INCYTE CORPORATION-2019IN010945$INCYTE$$$$$$Y$$$20240711$$CN$US$US
1701800910$17018009$10$F$20190101$20240724$20191111$20240726$EXP$$US-PFIZER INC-2019485778$PFIZER$$72$YR$$F$Y$65.77$KG$20240726$$CN$US$US
170203048$17020304$8$F$$20240916$20191112$20240924$EXP$$CA-PFIZER INC-2019488038$PFIZER$$58$YR$$F$Y$$$20240924$$CN$CA$CA
1702039516$17020395$16$F$$20240715$20191112$20240722$EXP$$US-SHIRE-US201936803$TAKEDA$$$$$F$Y$91$KG$20240722$$HP$US$US
1702059826$17020598$26$F$20170519$20240827$20191112$20240831$EXP$$NVSC2016CO000444$NOVARTIS$$48$YR$$F$Y$74$KG$20240831$$CN$CO$CO
170210378$17021037$8$F$$20240820$20191112$20240823$EXP$$CA-PFIZER INC-2019484155$PFIZER$$54$YR$$F$Y$67$KG$20240823$$HP$CA$CA
1702115911$17021159$11$F$20190101$20240905$20191112$20240910$PER$$US-DSJP-DSU-2019-143675$DAIICHI$$$$$F$Y$$$20240910$$MD$US$US
170213212$17021321$2$F$20191014$20240823$20191112$20240828$PER$$US-PFIZER INC-2019485921$PFIZER$$47$YR$$F$Y$$$20240828$$HP$US$US
170215924$17021592$4$F$20191108$20240813$20191112$20240816$PER$$US-BAYER-2019-203741$BAYER$$38$YR$A$F$Y$$$20240816$$HP$US$US
170229172$17022917$2$F$20190101$20240828$20191112$20240830$EXP$$US-SHIRE-US201937095$TAKEDA$$$$$M$Y$$$20240830$$CN$US$US
170232886$17023288$6$F$$20240717$20191112$20240718$PER$$US-INCYTE CORPORATION-2019IN007502$INCYTE$$$$$$Y$$$20240718$$CN$US$US
1702341719$17023417$19$F$20190101$20240909$20191112$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-096166$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$54$KG$20240919$$MD$JP$JP
1702506614$17025066$14$F$20200211$20240917$20191113$20240924$EXP$$CA-TAKEDA-2019TUS064795$TAKEDA$$47$YR$$F$Y$$$20240924$$CN$CA$CA
170255063$17025506$3$F$$20240725$20191113$20240801$EXP$$CA-SA-2019SA304254$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240801$$HP$CA$CA
170256586$17025658$6$F$20191203$20240708$20191113$20240710$EXP$$US-PFIZER INC-2019486899$PFIZER$$73$YR$$F$Y$70.31$KG$20240710$$CN$US$US
170262406$17026240$6$F$20240630$20240812$20191113$20240813$EXP$$US-PFIZER INC-2019489527$PFIZER$$71$YR$$F$Y$56.689$KG$20240813$$CN$US$US
1702733820$17027338$20$F$20221105$20240805$20191113$20240809$EXP$$IN-PFIZER INC-2018043942$PFIZER$$61$YR$$F$Y$$$20240809$$CN$IN$IN
1703279514$17032795$14$F$$20240828$20191114$20240903$EXP$$US-TAKEDA-2019TUS064835$TAKEDA$$$$$F$Y$73$KG$20240903$$HP$US$US
170331334$17033133$4$F$$20240905$20191114$20240912$EXP$$US-ARIAD PHARMACEUTICALS, INC-2017US008704$TAKEDA$$$$$M$Y$$$20240912$$CN$US$US
170340805$17034080$5$F$20191111$20240712$20191114$20240716$EXP$$MX-ABBVIE-19P-107-2998376-00$ABBVIE$$58$YR$$F$Y$$$20240716$$MD$MX$MX
170348204$17034820$4$F$$20240920$20191115$20240925$EXP$$CA-Orion Corporation ORION PHARMA-TREX2019-5364$ORION$$58$YR$A$F$Y$$$20240925$$HP$CA$
170367498$17036749$8$F$20240725$20240729$20191115$20240802$EXP$$CA-PFIZER INC-2019494100$MYLAN$$72$YR$$M$Y$$$20240802$$CN$CA$CA
1703704413$17037044$13$F$20190301$20240910$20191115$20240912$EXP$$US-PFIZER INC-2019490210$PFIZER$$69$YR$$F$Y$103$KG$20240912$$CN$US$US
1703749216$17037492$16$F$$20240910$20191115$20240913$EXP$$US-SHIRE-US201938010$TAKEDA$$$$$F$Y$54$KG$20240913$$MD$US$US
170389455$17038945$5$F$20160101$20240628$20191115$20240704$EXP$$RO-SAKK-2018SA282653AA$SANOFI AVENTIS$Vasiliu O.. Therapeutic management of schizophrenia and substance use disorders dual diagnosis - clinical vignettes.. Romania Journal of Military Medicine. 2018;121 (2):26-34$80$YR$E$M$Y$$$20240704$$MD$RO$RO
170392882$17039288$2$F$$20240708$20191115$20240717$PER$$US-SA-2019SA313535$SANOFI AVENTIS$$$$A$F$Y$63$KG$20240717$$MD$US$US
1704008213$17040082$13$F$20190111$20240802$20191116$20240816$EXP$$PHHY2019GB207337$NOVARTIS$$8$YR$$F$Y$23.35$KG$20240816$$MD$GB$GB
170405728$17040572$8$F$20090115$20240627$20191117$20240704$EXP$$ZA-AMGEN-ZAFSP2017120475$AMGEN$$47$YR$A$M$Y$108$KG$20240704$$MD$ZA$ZA
170413843$17041384$3$F$$20240819$20191118$20240829$EXP$$CA-AUROBINDO-AUR-APL-2019-072786$AUROBINDO$$71$YR$$F$Y$$$20240829$$HP$CA$CA
170424568$17042456$8$F$20181101$20240703$20191118$20240705$EXP$$CH-PFIZER INC-2019498316$PFIZER$$78$YR$$M$Y$83$KG$20240705$$MD$CH$CH
170426642$17042664$2$F$$20240722$20191118$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-097026$BRISTOL MYERS SQUIBB$Matsubara S, Seki M, Suzuki S, Komori T, Takamori M. Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors. Journal for ImmunuoTherapy Of Cancer. 2019 Sep 18;7(1):1-7.doi:10.1186/s40425-019-0736-4.$57$YR$A$M$Y$$$20240725$$HP$JP$JP
170430282$17043028$2$F$$20240701$20191118$20240703$EXP$$US-KYOWAKIRIN-2019BKK017928$KYOWA$$$$$$Y$$$20240703$$HP$US$US
1704495619$17044956$19$F$$20240925$20191118$20240930$EXP$$CA-BAUSCH-BL-2019-058588$BAUSCH AND LOMB$Harris M, Larsen G, Montaner J. Exacerbation of depression associated with starting raltegravir: a report of four cases. AIDS. 2008;22 (14):1890-1892. doi:10.1097/QAD.0b013e32830e0169$54$YR$$M$Y$$$20241001$$HP$CA$CA
170450454$17045045$4$F$$20240726$20191118$20240807$PER$$US-SA-2019SA317874$SANOFI AVENTIS$$33$YR$A$F$Y$63.5$KG$20240807$$MD$US$US
170461124$17046112$4$F$20191105$20240709$20191119$20240718$EXP$$CA-ROCHE-2472181$ROCHE$$68$YR$E$F$Y$$$20240718$$CN$CA$CA
170481288$17048128$8$F$$20240705$20191119$20240709$PER$$US-PFIZER INC-2019465289$PFIZER$$66$YR$$M$Y$117.91$KG$20240709$$CN$US$US
170499956$17049995$6$F$20190101$20240919$20191119$20240923$EXP$$US-PFIZER INC-2019365382$PFIZER$$81$YR$$F$Y$$$20240923$$CN$US$US
170502362$17050236$2$F$$20240723$20191119$20240726$EXP$$CA-JNJFOC-20191113693$JOHNSON AND JOHNSON$$60$YR$A$M$Y$113$KG$20240726$$PH$CA$CA
170506072$17050607$2$F$$20191112$20191119$20240710$PER$$NVSC2019US014371$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
170509042$17050904$2$F$$20240826$20191120$20240904$EXP$$CA-AUROBINDO-AUR-APL-2019-073755$AUROBINDO$$48$YR$$M$Y$151$KG$20240904$$HP$CA$CA
170516214$17051621$4$F$$20240724$20191120$20240803$EXP$$CA-AUROBINDO-AUR-APL-2019-073673$AUROBINDO$$75$YR$$M$Y$$$20240803$$HP$CA$CA
1705168011$17051680$11$F$20190510$20240627$20191120$20240701$EXP$$ES-009507513-1911ESP005723$MERCK$Escudero-S?nchez R, Ruiz-Ruig?mez M, Fern?ndez-Fradejas J, Fern?ndez SG, Samperio MO, Yuste AC et al.. Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection. Journal of Clinical Medicine. 2020;10(1)$92$YR$$F$Y$46$KG$20240701$$MD$ES$ES
1705240714$17052407$14$F$20190101$20240716$20191120$20240723$EXP$$NVSC2019CO041409$NOVARTIS$$$$$F$Y$45$KG$20240723$$CN$CO$CO
1705309611$17053096$11$F$$20240920$20191120$20240926$PER$$US-PFIZER INC-2019495947$PFIZER$$73$YR$$F$Y$$$20240926$$CN$US$US
1705408211$17054082$11$F$20161021$20240819$20191120$20240821$EXP$$US-PFIZER INC-2019503746$PFIZER$$75$YR$$F$Y$62.132$KG$20240821$$CN$US$US
1705443718$17054437$18$F$20220511$20240823$20191120$20240827$EXP$$US-SHIRE-US201938009$TAKEDA$$77$YR$$F$Y$71$KG$20240827$$HP$US$US
1705519019$17055190$19$F$20190615$20240715$20191120$20240718$EXP$$CO-TAKEDA-2019TUS039355$TAKEDA$$40$YR$$F$Y$67$KG$20240718$$HP$CO$CO
170552035$17055203$5$F$$20240710$20191120$20240715$PER$$US-PFIZER INC-2019296852$PFIZER$$59$YR$$F$Y$$$20240715$$HP$US$US
1705563030$17055630$30$F$20180228$20240823$20191120$20240831$EXP$$CA-CELLTRION INC.-2018CA018822$CELLTRION$$$$$$Y$$$20240831$$CN$CA$CA
170583889$17058388$9$F$20190827$20240715$20191121$20240726$EXP$$DE-ROCHE-2453217$ROCHE$$53$YR$A$M$Y$$$20240726$$CN$DE$DE
170628476$17062847$6$F$$20240909$20191122$20240917$EXP$$CA-APOTEX-2019AP024849$APOTEX$$61$YR$$F$Y$70$KG$20240917$$HP$CA$CA
170644743$17064474$3$F$20180101$20240917$20191122$20240923$PER$$US-PFIZER INC-2019502573$PFIZER$$70$YR$$F$Y$90.703$KG$20240923$$CN$US$US
1706461827$17064618$27$F$$20240927$20191122$20240927$PER$$US-PFIZER INC-2019505060$PFIZER$$76$YR$$F$Y$44.45$KG$20240927$$CN$US$US
1706584711$17065847$11$F$$20240919$20191122$20240925$EXP$$PL-MYLANLABS-2019M1112189$MYLAN$Woron J, Siwek M.. Burning mouth syndrome as a consequence of undesired interactions of sertraline.. Practical medicine - psychiatry. 2019;3:62-63$56$YR$$F$Y$$$20240925$$MD$PL$PL
170669414$17066941$4$F$$20240724$20191123$20240730$EXP$$US-TAKEDA-2019TUS067366$TAKEDA$$$$$M$Y$$$20240730$$CN$US$US
170670974$17067097$4$F$$20240912$20191122$20240918$EXP$$ES-MYLANLABS-2019M1089196$MYLAN$Los-Arcos I, Royuela M, Martin-Gomez MT, Alastruey-Izquierdo A, Sellares J, Perello M et al.. Phaeohyphomycosis caused by Medicopsis romeroi in solid organ transplant recipients: Report of two cases and comprehensive review of the literature.. Transplant Infectious Disease. 2019;21 (3):e13072, 1-6$56$YR$$F$Y$$$20240918$$HP$ES$ES
170671776$17067177$6$F$$20240710$20191122$20240715$EXP$$DE-MYLANLABS-2019M1091536$MYLAN$Mizera L, Klingel K, Gawaz M, Greulich S.. Fatigue, breathlessness and chest pain in a 31-year-old man with schizoaffective disorder. Der Internist. 2019;60(11):1209-1214$$$$$Y$$$20240715$$HP$DE$DE
170679382$17067938$2$F$$20191114$20191122$20240711$PER$$NVSC2019US032757$NOVARTIS$$$$$M$Y$$$20240711$$CN$US$US
170681383$17068138$3$F$20180403$20240710$20191122$20240718$EXP$$DE-CELLTRION INC.-2019DE026643$CELLTRION$$$$$$Y$$$20240718$$MD$DE$DE
170682753$17068275$3$F$$20240816$20191123$20240822$EXP$$US-SHIRE-US201940268$TAKEDA$$$$$M$Y$97$KG$20240822$$CN$US$US
1706828911$17068289$11$F$20220328$20240919$20191123$20240925$EXP$$US-SHIRE-US201940308$TAKEDA$$66$YR$$F$Y$85$KG$20240925$$CN$US$US
1706903933$17069039$33$F$20190101$20240815$20191124$20240822$EXP$$CA-CELLTRION INC.-2019CA019786$CELLTRION$$$$$$Y$$$20240822$$CN$CA$CA
1707085550$17070855$50$F$$20240701$20191125$20240704$EXP$$US-SHIRE-US201940541$TAKEDA$$$$$F$Y$68$KG$20240704$$MD$US$US
170728323$17072832$3$F$$20240906$20191125$20240911$EXP$$NL-MYLANLABS-2019M1113168$MYLAN$Kang M, Aslam S. Varicella zoster virus encephalitis in solid organ transplant recipients: Case series and review of literature.. Transplant Infectious Disease. 2019;21 (2):1-6$51$YR$$F$Y$$$20240911$$HP$NL$NL
170730622$17073062$2$F$20190914$20191118$20191125$20240808$EXP$$AU-ASTELLAS-2019US046162$ASTELLAS$$60$YR$$F$Y$$$20240808$$CN$AU$AU
170732447$17073244$7$F$20190626$20240808$20191125$20240810$EXP$$GB-ABBVIE-19P-167-3013735-00$ABBVIE$$56$YR$$F$Y$$$20240810$$MD$GB$GB
1707400213$17074002$13$F$20180719$20240812$20191126$20240822$EXP$$DE-AUROBINDO-AUR-APL-2019-074127$AUROBINDO$$52$YR$$M$Y$$$20240822$$MD$DE$DE
1707475421$17074754$21$F$20150504$20240810$20191126$20240816$EXP$$US-SHIRE-US201940751$TAKEDA$$38$YR$$F$Y$89$KG$20240816$$HP$US$US
1707504930$17075049$30$F$$20240723$20191126$20240725$EXP$$US-PFIZER INC-2019492143$PFIZER$$82$YR$$F$Y$46.712$KG$20240725$$MD$US$US
170771475$17077147$5$F$$20240905$20191126$20240911$EXP$$CA-GLAXOSMITHKLINE-CA2019AMR175797$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$MD$CA$CA
1707853150$17078531$50$F$20191101$20240829$20191126$20240907$EXP$$CA-CELLTRION INC.-2019CA026646$CELLTRION$$$$$$Y$$$20240907$$CN$CA$CA
170786333$17078633$3$F$$20240725$20191127$20240805$EXP$$FR-Accord-161703$ACCORD$Hernandez M, Pochon C, Chastagner P, Droz D.. Long-term adverse effects of?acute myeloid leukemia treatment on odontogenesis in a child. International?Journal of Clinical Pediatric Dentistry. 2019,12(3):243-6.$9$YR$C$M$Y$$$20240805$$HP$FR$FR
1708219812$17082198$12$F$20220601$20240618$20191127$20240814$EXP$$PHHY2019CA030053$NOVARTIS$$66$YR$$F$Y$$$20240814$$MD$CA$CA
1708248414$17082484$14$F$20190610$20240904$20191127$20240905$EXP$$US-PFIZER INC-2019513280$PFIZER$$59$YR$$F$Y$95$KG$20240905$$CN$US$US
170830348$17083034$8$F$20190626$20240805$20191127$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-111757$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$64.5$KG$20240816$$MD$JP$JP
170837147$17083714$7$F$20191031$20240829$20191127$20240903$EXP$$US-SHIRE-US201940827$TAKEDA$$70$YR$$F$Y$$$20240903$$CN$US$US
170860074$17086007$4$F$$20240813$20191128$20240821$PER$$US-ROCHE-2485095$ROCHE$Rajpurkar M, Buck S, Lafferty J, Wakeling E, Ravindranath Y and Savasan S. Acquired pure red cell aplasia and acquired amegakaryocytic thrombocytopenia associated with clonal expansion of T-cell large granular lymphocytes in a patient with lipopolysaccharide-responsive beige-like anchor (LRBA) protein deficiency. Journal of Pediatric Hematology/Oncology 2019 Nov 01;41 (8):E542-E545.$16$YR$T$M$Y$$$20240821$$MD$US$US
170871644$17087164$4$F$$20240805$20191128$20240810$EXP$$PT-ROCHE-2475744$ROCHE$$73$YR$E$M$Y$$$20240810$$MD$PT$PT
1708893218$17088932$18$F$20230306$20240807$20191128$20240812$EXP$$US-SHIRE-US201940246$TAKEDA$$79$YR$$F$Y$113$KG$20240812$$CN$US$US
1708950911$17089509$11$F$20181007$20240820$20191128$20240823$EXP$$CA-TAKEDA-2018TUS029825$TAKEDA$$50$YR$$M$Y$$$20240823$$CN$CA$CA
170898873$17089887$3$F$$20240720$20191128$20240731$EXP$$CA-AUROBINDO-AUR-APL-2019-075917$AUROBINDO$$36$YR$$M$Y$$$20240731$$CN$CA$CA
170908238$17090823$8$F$$20240826$20191129$20240907$EXP$$CA-GLENMARK PHARMACEUTICALS-2019GMK044496$GLENMARK$$$$$$Y$$$20240907$$HP$CA$CA
1709086714$17090867$14$F$20181004$20240909$20191129$20240918$EXP$$CA-TAKEDA-2018TUS027544$TAKEDA$$27$YR$$M$Y$$$20240918$$MD$CA$CA
170917954$17091795$4$F$20190601$20240708$20191129$20240715$EXP$$DE-SA-2019SA329925$SANOFI AVENTIS$$35$YR$A$F$Y$112$KG$20240715$$CN$DE$DE
1709338821$17093388$21$F$20190821$20240916$20191129$20240919$EXP$$PHHY2019CA202243$NOVARTIS$$55$YR$$F$Y$$$20240919$$CN$CA$CA
170934813$17093481$3$F$$20211001$20191129$20240904$EXP$$NVSC2019ES050009$NOVARTIS$Sepulveda M, Montejo C, Llufriu S, Sola-Valls N, Reyes D, Martinez-Lapiscina EH et al.. Rebound of multiple sclerosis activity after fingolimod withdrawal due to planning pregnancy: Analysis of predisposing factors. MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2020;38:1-5$23$YR$$F$Y$$$20240904$$HP$ES$ES
1709412426$17094124$26$F$$20240917$20191129$20240923$EXP$$US-SHIRE-US201940921$TAKEDA$$$$$F$Y$95$KG$20240923$$CN$US$US
170959262$17095926$2$F$$20240711$20191202$20240722$EXP$$JP-ROCHE-2486251$ROCHE$$70$YR$E$M$Y$65$KG$20240722$$MD$JP$JP
170991622$17099162$2$F$20191011$20240731$20191202$20240807$PER$$US-BIOGEN-2019BI00755406$BIOGEN$$54$YR$$F$Y$$$20240807$$CN$US$US
1709971611$17099716$11$F$20190819$20240913$20191202$20240923$EXP$$CA-TAKEDA-2018TUS022153$TAKEDA$$54$YR$$M$Y$89$KG$20240923$$MD$CA$CA
170999764$17099976$4$F$$20240812$20191202$20240815$EXP$$US-PFIZER INC-2019514629$PFIZER$Rajpurkar, M.. Acquired Pure Red Cell Aplasia and Acquired Amegakaryocytic Thrombocytopenia Associated with Clonal Expansion of T-Cell Large Granular Lymphocytes in a Patient with Lipopolysaccharide-responsive Beige-like Anchor (LRBA) Protein Deficiency. Journal of Pediatric Hematology/Oncology. 2019;41 (8):e542-e545$16$YR$$M$Y$$$20240815$$MD$US$US
171008675$17100867$5$F$20191121$20240717$20191202$20240726$PER$$US-SA-2019SA330643$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240726$$CN$US$US
171050765$17105076$5$F$20191023$20240806$20191203$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-114701$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$71$KG$20240816$$MD$JP$JP
1710626024$17106260$24$F$20190101$20240709$20191203$20240711$PER$$US-DSJP-DSU-2019-145921$DAIICHI$$$$$F$Y$$$20240711$$CN$US$US
171072872$17107287$2$F$$20240806$20191203$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-116144$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$71$KG$20240814$$MD$JP$JP
1710832628$17108326$28$F$20220617$20240917$20191203$20240923$EXP$$US-SHIRE-US201941069$TAKEDA$$46$YR$$F$Y$64$KG$20240923$$HP$US$US
1710894711$17108947$11$F$20190101$20240806$20191204$20240812$EXP$$US-ROCHE-2325455$ROCHE$$58$YR$A$M$Y$131.54$KG$20240812$$CN$US$US
171090883$17109088$3$F$20190925$20240220$20191204$20240923$PER$$AT-ROCHE-2481138$ROCHE$$43$YR$A$F$Y$65$KG$20240923$$MD$AT$AT
171092084$17109208$4$F$$20240306$20191204$20240911$EXP$$CA-TEVA-2019-CA-1145585$TEVA$$44$YR$$F$Y$70$KG$20240911$$HP$CA$CA
1711049026$17110490$26$F$20091228$20240830$20191204$20240904$EXP$$US-PFIZER INC-2018475209$PFIZER$$56$YR$$F$Y$92$KG$20240904$$CN$US$US
171109094$17110909$4$F$$20240809$20191204$20240812$EXP$$NVSC2019IT055544$NOVARTIS$Peri AM, Verna M, Biffi S, Alagna L, Longhi B, Migliorino GM et al.. Combination Antifungal Therapy for Invasive Mold Infections Among Pediatric Patients with Hematological Malignancies: Data from A Real-Life Case-Series.. PATHOGENS AND IMMUNITY. 2019;4(2):180-94$10$YR$$M$Y$$$20240812$$HP$IT$IT
1711095323$17110953$23$F$20190809$20240531$20191204$20240702$EXP$$PHHY2019CA190608$NOVARTIS$$10$YR$$F$Y$$$20240702$$CN$CA$CA
171140982$17114098$2$F$$20240816$20191205$20240821$EXP$$US-SA-2019SA324450$SANOFI AVENTIS$Lum EL, Datta N, Beaird O, Zuckerman J, Bunnapradist S, Schaenman J.. Cutaneous Fungal Masses From Prior Environmental Injury Following Kidney Transplant: A Case Report.. Transplant Proc.. 2019;51(9):3087?91$72$YR$E$F$Y$$$20240821$$MD$US$US
171145262$17114526$2$F$$20240823$20191205$20240828$EXP$$PHHY2019ES027625$NOVARTIS$Sisinni L, Gasior M, Paz RD, Querol S, Bueno D, Fernandez L et al.. Unexpected High Incidence of Human Herpesvirus-6 Encephalitis after Naive T Cell-Depleted Graft of Haploidentical Stem Cell Transplantation in Pediatric Patients. BIOL. BLOOD MARROW TRANSPLANT. 2018;24(11):2316-23$13$YR$$M$Y$$$20240828$$HP$ES$ES
171149382$17114938$2$F$20190701$20240712$20191205$20240716$EXP$$US-GW PHARMA-201910USGW3680$JAZZ$$23$YR$$M$Y$$$20240716$$CN$US$US
1711544126$17115441$26$F$20120206$20240906$20191205$20240911$EXP$$PHHY2017CO043126$NOVARTIS$$61$YR$$F$Y$69$KG$20240911$$CN$CO$CO
1711859011$17118590$11$F$20211212$20240801$20191206$20240809$EXP$$PK-AMGEN-PAKSP2019202414$AMGEN$$19$YR$A$M$Y$49$KG$20240809$$CN$PK$PK
171200969$17120096$9$F$20210108$20240711$20191206$20240715$EXP$$US-SHIRE-US201942043$TAKEDA$$51$YR$$F$Y$113$KG$20240715$$HP$US$US
171219849$17121984$9$F$$20240905$20191206$20240909$PER$$US-PFIZER INC-2019528071$PFIZER$$64$YR$$F$Y$124.74$KG$20240909$$CN$US$US
171223986$17122398$6$F$20191101$20240905$20191206$20240913$PER$$US-VERTEX PHARMACEUTICALS-2019-011975$VERTEX$$12$YR$$M$Y$40$KG$20240913$$MD$US$US
1712324614$17123246$14$F$20210506$20240903$20191206$20240906$EXP$$US-SHIRE-US201941698$TAKEDA$$59$YR$$F$Y$108$KG$20240906$$CN$US$US
171247072$17124707$2$F$20191203$20240812$20191206$20240820$PER$$US-SA-2019SA338718$SANOFI AVENTIS$$50$YR$A$F$Y$67.13$KG$20240820$$MD$US$US
171261563$17126156$3$F$20190522$20240718$20191209$20240725$EXP$$GB-AUROBINDO-AUR-APL-2019-103226$AUROBINDO$$75$YR$$M$Y$68$KG$20240725$$MD$GB$GB
171276784$17127678$4$F$$20240809$20191209$20240823$EXP$US-MLMSERVICE-20191122-2054750-3$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2019-10609$ALKEM$Lum EL, Datta N, Beaird O, Zuckerman J, Bunnapradist S, Schaenman J.. Cutaneous Fungal Masses From Prior Environmental Injury Following Kidney Transplant: A Case Report. Transplantation Proceedings. 2019;51(9):3087-3091$63$YR$$M$Y$$$20240823$$MD$US$US
171276814$17127681$4$F$$20240819$20191209$20240902$EXP$US-MLMSERVICE-20191122-2054750-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2019-10570$ALKEM$Lum EL, Datta N, Beaird O, Zuckerman J et al. Cutaneous Fungal Masses From Prior Environmental Injury Following Kidney Transplant: A Case Report. Transplantation Proceedings. 2019;51(9):3087-3091$72$YR$$F$Y$$$20240902$$MD$US$US
171280076$17128007$6$F$$20240802$20191209$20240815$EXP$$CA-AUROBINDO-AUR-APL-2019-076009$AUROBINDO$$52$YR$$M$Y$$$20240815$$CN$CA$CA
171288382$17128838$2$F$$20240808$20191209$20240815$EXP$$US-GLENMARK PHARMACEUTICALS-2019GMK044703$GLENMARK$Lum EL, Datta N, Beaird O, Zuckerman J, Bunnapradist S, Schaenman J.. Cutaneous Fungal Masses From Prior Environmental Injury Following Kidney Transplant: A Case Report. Transplantation Proceedings. 2019;51 (9):3087-3091$$$$$Y$$$20240815$$MD$US$US
171293935$17129393$5$F$$20240716$20191209$20240718$PER$$US-PFIZER INC-2019528178$PFIZER$$70$YR$$F$Y$$$20240718$$CN$US$US
1712957612$17129576$12$F$$20240822$20191209$20240827$EXP$$US-PFIZER INC-2019529485$PFIZER$$71$YR$$F$Y$71.67$KG$20240827$$CN$US$US
1712990110$17129901$10$F$20211108$20240716$20191209$20240725$PER$$US-SA-2019SA174786$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240725$$HP$US$US
171305863$17130586$3$F$20190101$20240913$20191209$20240917$EXP$$US-ROCHE-2375570$ROCHE$$65$YR$E$F$Y$90.72$KG$20240917$$CN$US$US
1713066627$17130666$27$F$20191128$20240816$20191209$20240822$EXP$$US-SHIRE-US201942361$TAKEDA$$34$YR$$F$Y$74$KG$20240822$$MD$US$US
171311097$17131109$7$F$20191125$20240916$20191209$20240924$EXP$$CA-GILEAD-2019-0441705$GILEAD$$16$YR$T$F$Y$$$20240924$$MD$CA$CA
171330918$17133091$8$F$20240801$20240910$20191210$20240913$EXP$$US-SHIRE-US201941989$TAKEDA$$73$YR$$M$Y$88$KG$20240913$$HP$US$US
171340654$17134065$4$F$20210201$20240716$20191210$20240717$EXP$$US-SHIRE-US201942297$TAKEDA$$45$YR$$F$Y$74$KG$20240717$$CN$US$US
1713574035$17135740$35$F$$20240710$20191210$20240715$EXP$$CA-PFIZER INC-2019532008$MYLAN$$$$$M$Y$$$20240715$$HP$CA$CA
171364852$17136485$2$F$20190101$20240809$20191210$20240826$PER$$US-SA-2019SA338941$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240826$$MD$US$US
1713734333$17137343$33$F$20181110$20240915$20191210$20240923$EXP$$CA-CELLTRION INC.-2018CA024006$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
171391582$17139158$2$F$$20240626$20191211$20240704$EXP$$PT-AUROBINDO-AUR-APL-2019-104490$AUROBINDO$Carvalho J, Neves M, Marques R, Alves JD.. Report of a case of rituximab use in the treatment of immune refractory thrombocytopenic purpura to the 1st line medical therapy. Medicina Interna - Congressos Nacionais. 2019;25(Congresso):943$77$YR$$F$Y$$$20240704$$MD$PT$PT
171396952$17139695$2$F$$20240808$20191211$20240815$EXP$$US-GLENMARK PHARMACEUTICALS-2019GMK044702$GLENMARK$Lum EL, Datta N, Beaird O, Zuckerman J, Bunnapradist S, Schaenman J.. Cutaneous Fungal Masses From Prior Environmental Injury Following Kidney Transplant: A Case Report.. Transplantation Proceedings.. 2019;51(9):3087-3091$63$YR$$M$Y$$$20240815$$MD$US$US
171401137$17140113$7$F$20190716$20240823$20191211$20240827$EXP$$CA-TAKEDA-2019TUS068977$TAKEDA$$12$YR$$F$Y$$$20240827$$HP$CA$CA
171405843$17140584$3$F$20191203$20240827$20191211$20240905$30DAY$$US-GLAXOSMITHKLINE-US2019219217$GLAXOSMITHKLINE$$59$YR$$M$Y$$$20240905$$CN$US$US
171409875$17140987$5$F$20190101$20240904$20191211$20240905$EXP$$US-PFIZER INC-2019535131$PFIZER$$73$YR$$F$Y$68$KG$20240905$$CN$US$US
1714116329$17141163$29$F$20191024$20240613$20191211$20240704$EXP$$DE-ROCHE-2484360$ROCHE$$79$YR$E$F$Y$$$20240704$$CN$DE$DE
171422002$17142200$2$F$$20240716$20191211$20240723$EXP$$US-SHIRE-US201942193$TAKEDA$$$$$F$Y$$$20240723$$CN$US$US
1714248113$17142481$13$F$20200101$20240910$20191211$20240911$EXP$$US-PFIZER INC-2019535266$PFIZER$$72$YR$$F$Y$$$20240911$$CN$US$US
171432114$17143211$4$F$20170101$20240808$20191211$20240813$EXP$$US-INCYTE CORPORATION-2019IN010023$INCYTE$$$$$$Y$$$20240813$$MD$US$US
171449723$17144972$3$F$20190101$20240731$20191212$20240808$PER$$US-SA-2019SA340587$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240808$$CN$US$US
171450597$17145059$7$F$20190801$20240730$20191212$20240807$EXP$$US-SA-2019SA342338$SANOFI AVENTIS$$62$YR$A$F$Y$71.2$KG$20240807$$MD$US$US
171451307$17145130$7$F$20210123$20240812$20191212$20240815$EXP$$US-SHIRE-US201942263$TAKEDA$$33$YR$$F$Y$70$KG$20240815$$CN$US$US
171461625$17146162$5$F$$20240822$20191212$20240830$EXP$$FR-JNJFOC-20191206202$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240830$$HP$FR$FR
171467372$17146737$2$F$$20240828$20191212$20240910$EXP$$US-MYLANLABS-2019M1123770$AUROBINDO$Chen J, Ngo D, Rosenthal J.. Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease.. J-Oncol-Pharm-Pract. 2018;25(8):2027-2030$26$YR$$M$Y$$$20240910$$HP$US$US
171472263$17147226$3$F$20190301$20240912$20191212$20240918$EXP$$BG-MYLANLABS-2019M1122179$MYLAN$Simova Y, Stanilov P, Petrov I.. Sacubitril/Valsartan in chemotherapy-induced cardiotoxicity, associated with a chemoptherapy.. Cardio D.. 2019;25(1):9-12$60$YR$$F$Y$$$20240918$$HP$BG$BG
1714736311$17147363$11$F$20230118$20240818$20191212$20240821$EXP$$US-SHIRE-US201942634$TAKEDA$$65$YR$$M$Y$$$20240821$$MD$US$US
171475259$17147525$9$F$$20240618$20191212$20240709$EXP$$CA-ROCHE-2493207$ROCHE$$24$YR$A$M$Y$$$20240702$$MD$CA$CA
171478885$17147888$5$F$20190101$20240805$20191212$20240812$EXP$$US-009507513-1912USA000943$MERCK$$$$$M$Y$$$20240812$$CN$US$US
171480522$17148052$2$F$$20191220$20191212$20240711$PER$$NVSC2019US003992$NOVARTIS$$$$$M$Y$$$20240711$$CN$US$US
171501947$17150194$7$F$$20240828$20191213$20240903$EXP$$US-SHIRE-US201942628$TAKEDA$$$$$F$Y$70$KG$20240903$$HP$US$US
1715107314$17151073$14$F$20240605$20240713$20191213$20240722$EXP$$BR-GLAXOSMITHKLINE-BR2019AMR113919$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$BR$BR
171563013$17156301$3$F$20160101$20240603$20191216$20240703$30DAY$$US-GLAXOSMITHKLINE-US2019225173$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
171574552$17157455$2$F$20190101$20240916$20191216$20240919$EXP$$US-GW PHARMA-201912USGW4575$JAZZ$$$$$$Y$$$20240919$$CN$US$US
171583399$17158339$9$F$20201201$20240729$20191216$20240801$EXP$$US-PFIZER INC-2019537876$PFIZER$$89$YR$$M$Y$73.48$KG$20240801$$CN$US$US
1716079922$17160799$22$F$20190430$20240924$20191216$20240930$EXP$$PHHY2019CO104382$NOVARTIS$$80$YR$$F$Y$63$KG$20240930$$CN$CO$CO
171612592$17161259$2$F$$20240912$20191216$20240916$PER$$US-JAZZ-2019-US-017308$JAZZ$$$$$F$Y$$$20240916$$CN$US$US
171627652$17162765$2$F$$20191003$20191217$20240704$PER$$NVSC2019US005242$NOVARTIS$$$$$$Y$$$20240704$$MD$US$US
171636423$17163642$3$F$$20240709$20191217$20240715$EXP$CA-HEALTHCANVIG-E2B- 02608407$CA-GLAXOSMITHKLINE-CA2019227985$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$CA$CA
171642224$17164222$4$F$20240916$20240916$20191217$20240919$PER$$US-PFIZER INC-2019542529$PFIZER$$58$YR$$F$Y$68.04$KG$20240919$$CN$US$US
171650552$17165055$2$F$20191205$20240923$20191217$20240927$EXP$$NVSC2019CO071305$NOVARTIS$$76$YR$$F$Y$63$KG$20240927$$CN$CO$CO
171694007$17169400$7$F$20170620$20240725$20191218$20240815$EXP$$PHHY2017CA094886$NOVARTIS$$37$YR$$M$Y$$$20240815$$CN$CA$CA
171697222$17169722$2$F$20110101$20240823$20191218$20240829$PER$$US-JNJFOC-20191227069$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20240829$$LW$US$US
171697402$17169740$2$F$$20240826$20191218$20240830$PER$$US-JNJFOC-20191228415$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$LW$US$US
171698055$17169805$5$F$20240801$20240829$20191218$20240904$PER$$US-PFIZER INC-2018080185$PFIZER$$65$YR$$F$Y$$$20240904$$CN$US$US
171704465$17170446$5$F$20181207$20240924$20191218$20240926$EXP$$US-UCBSA-2019053129$UCB$$0$YR$$M$Y$3.3$KG$20240926$$HP$US$US
171731603$17173160$3$F$20191001$20240829$20191218$20240902$EXP$$US-JAZZ-2019-US-017552$JAZZ$$59$YR$$F$Y$$$20240902$$MD$US$US
171738593$17173859$3$F$20190101$20240829$20191219$20240830$PER$$US-PFIZER INC-2019544126$PFIZER$$78$YR$$F$Y$$$20240830$$CN$US$US
171742418$17174241$8$F$20230913$20240731$20191219$20240805$EXP$$US-SHIRE-US201943552$TAKEDA$$51$YR$$F$Y$63$KG$20240805$$HP$US$US
1717429612$17174296$12$F$20211104$20240918$20191219$20240923$EXP$$US-SHIRE-US201943406$TAKEDA$$60$YR$$F$Y$50$KG$20240923$$CN$US$US
171758306$17175830$6$F$20210702$20240731$20191219$20240802$EXP$$US-TAKEDA-2019TUS071284$TAKEDA$$76$YR$$M$Y$$$20240802$$CN$US$US
1717748117$17177481$17$F$20220501$20240906$20191219$20240913$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK050809$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$BR$BR
171778402$17177840$2$F$$20240624$20191219$20240705$EXP$$JP-TEVA-2019-JP-1153584$TEVA$Takeuchi M. Cytomegalovirus retinitis in posterior pole. Clinical ophthalmology. 2019;73(11):272-76; Takeuchi M. Cytomegalovirus retinitis in posterior pole. Clinical ophthalmology. 2019;73(11):272-76; Takeuchi M. Cytomegalovirus retinitis in posterior pole. Clinical ophthalmology. 2019;73(11):272-76$43$YR$$M$Y$$$20240705$$HP$JP$JP
171791304$17179130$4$F$20190711$20240911$20191219$20240917$EXP$FR-AFSSAPS-AN20190888$FR-MYLANLABS-2019M1124915$MYLAN$Pabst L, Lopes S, Mascaux C.. Non-small cell lung cancer: the role of immune checkpoint inhibitors in elderly patients, Clinical case study.. Cancer and the Immune System.. 2024;8 (2):79-85$72$YR$$M$Y$89$KG$20240917$$PH$FR$FR
171802002$17180200$2$F$20190101$20240723$20191220$20240819$EXP$$US-SA-2019SA197491$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240819$$MD$US$US
1718074031$17180740$31$F$20181008$20240708$20191220$20240716$EXP$$GB-ASPEN-GLO2019GB013478$ASPEN$$$$$$Y$$$20240716$$MD$GB$GB
171809323$17180932$3$F$$20240813$20191219$20240819$EXP$$CA-TAKEDA-2019TUS070384$TAKEDA$$$$$M$Y$$$20240819$$MD$CA$CA
1718143011$17181430$11$F$20191106$20240918$20191220$20240930$EXP$$JP-ABBVIE-19P-087-3204662-00$ABBVIE$$65$YR$$M$Y$96$KG$20240930$$MD$JP$JP
171835458$17183545$8$F$$20240819$20191220$20240823$EXP$$NVSC2019IT072244$NOVARTIS$Berlot G, Tomasini A, Zandona L, Leonardo E, Bussani R. Multi-organ dysfunction syndrome following infectious mononucleosis: Case study. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. 2019;12(11):13061-4$24$YR$$F$Y$$$20240823$$HP$IT$IT
171845049$17184504$9$F$$20240910$20191220$20240912$PER$$US-PFIZER INC-2019152032$PFIZER$$77$YR$$F$Y$59.41$KG$20240912$$CN$US$US
1718480515$17184805$15$F$20191201$20240820$20191220$20240826$EXP$$NVSC2019CO072770$NOVARTIS$$42$YR$$F$Y$66$KG$20240826$$CN$CO$CO
171867573$17186757$3$F$20191213$20240704$20191220$20240710$EXP$$DE-PFIZER INC-2019546317$PFIZER$$$$$$Y$$$20240710$$MD$DE$DE
171875434$17187543$4$F$$20240812$20191220$20240815$EXP$$IT-ROCHE-2502587$ROCHE$Berlot G, Tomasini A, Zandona L, Leonardo E and Bussani R Multi-organ dysfunction syndrome following infectious mononucleosis: Case study. International Journal of Clinical and Experimental Medicine 2019;12(11):13061-4.$24$YR$A$F$Y$$$20240815$$HP$IT$IT
171876385$17187638$5$F$20210510$20240813$20191220$20240816$EXP$$US-SHIRE-US201943804$TAKEDA$$57$YR$$F$Y$57$KG$20240816$$CN$US$US
171894052$17189405$2$F$$20240913$20191223$20240921$EXP$$US-ROCHE-2497152$ROCHE$Menashy V, Levine A, Stoudt K, Mazurkiewicz R and Wagner I Mycophenolate-induced posterior reversible encephalopathy syndrome. Journal of General Internal Medicine 2016 May;31(2):S682-.$18$YR$A$F$Y$$$20240921$$HP$US$US
171894864$17189486$4$F$20230222$20240816$20191223$20240821$EXP$$US-SHIRE-US201943971$TAKEDA$$18$YR$$M$Y$79$KG$20240821$$CN$US$US
171904202$17190420$2$F$$20240816$20191223$20240828$EXP$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2019-06842$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2019-06842$ALKEM$Giavina-Bianchi MH, Giavina-Bianchi P and Rizzo LV.. Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report. Einstein (Sao Paulo, Brazil). 2019;17(4):eRC4599$18$YR$$F$Y$$$20240828$$HP$BR$BR
171910912$17191091$2$F$$20240710$20191223$20240712$EXP$$ES-PFIZER INC-2019545454$PFIZER$$$$$F$Y$$$20240712$$MD$ES$ES
171911662$17191166$2$F$20190601$20240708$20191223$20240711$EXP$$AT-PFIZER INC-2019545480$PFIZER$$58$YR$$M$Y$$$20240711$$MD$AT$AT
171926693$17192669$3$F$20191101$20240701$20191223$20240709$PER$$US-SA-2019SA350011$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240709$$MD$US$US
1719325913$17193259$13$F$20200401$20240805$20191223$20240809$EXP$$DE-SHIRE-DE201944441$TAKEDA$$81$YR$$F$Y$85$KG$20240809$$HP$DE$DE
1719326510$17193265$10$F$$20240822$20191223$20240828$EXP$$US-SHIRE-US201943435$TAKEDA$$$$$M$Y$79$KG$20240828$$HP$US$US
1719352827$17193528$27$F$$20240812$20191223$20240814$EXP$$CA-BAUSCH-BL-2019-065992$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240815$$CN$CA$CA
171940332$17194033$2$F$$20200311$20191223$20240711$PER$$NVSC2019US077839$NOVARTIS$$$$$F$Y$$$20240711$$CN$US$US
171943826$17194382$6$F$20191211$20240718$20191224$20240723$EXP$$US-SHIRE-US201934761$TAKEDA$$71$YR$$M$Y$88$KG$20240723$$CN$US$US
171948505$17194850$5$F$20190702$20200911$20191224$20240709$EXP$$JP-GLAXOSMITHKLINE-JP2019JPN231639$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$JP$JP
171948513$17194851$3$F$$20240617$20191224$20240704$EXP$$CA-GLAXOSMITHKLINE-CA2019AMR127729$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$MD$CA$CA
171960618$17196061$8$F$$20240924$20191224$20240930$EXP$$US-SHIRE-US201944351$TAKEDA$$$$$F$Y$54$KG$20240930$$CN$US$US
171966606$17196660$6$F$$20240704$20191224$20240709$EXP$$CA-PFIZER INC-2019549933$PFIZER$$51$YR$$F$Y$60$KG$20240709$$HP$CA$CA
171966815$17196681$5$F$$20240704$20191224$20240709$EXP$$CA-PFIZER INC-2019551135$PFIZER$$60$YR$$F$Y$61$KG$20240709$$HP$CA$CA
171978313$17197831$3$F$20190101$20240726$20191224$20240802$EXP$$US-JAZZ-2019-US-017941$JAZZ$$$$$F$Y$$$20240802$$MD$US$US
171984622$17198462$2$F$$20240812$20191225$20240823$EXP$$IT-Accord-167048$ACCORD$Berlot G, Tomasini A, Zandona L, Leonardo E, Bussani R. Multi-organ dysfunction syndrome following infectious mononucleosis: Case study. International Journal of Clinical and Experimental Medicine. 2019;12(11): Article Number IJCEM0061180 (13061 - 13064).$24$YR$A$F$Y$$$20240823$$MD$IT$IT
171986447$17198644$7$F$$20240918$20191225$20240925$EXP$$CA-ROCHE-2498601$ROCHE$$43$YR$A$F$Y$68$KG$20240925$$HP$CA$CA
172002652$17200265$2$F$20140203$20240906$20191226$20240920$EXP$US-ROCHE-2217408$JO-ALKEM LABORATORIES LIMITED-JO-ALKEM-2019-01538$ALKEM$Mustafa KN, Qasem U, Al-Ryalat N and Bsisu IK. Rituximab-associated posterior reversible encephalopathy syndrome. International Journal of Rheumatic Disease. 2019;22(1):160-165$36$YR$$F$Y$$$20240920$$HP$JO$JO
172007772$17200777$2$F$20111021$20240723$20191226$20240726$EXP$$DK-MYLANLABS-2019M1128472$MYLAN$$72$YR$$F$Y$$$20240726$$MD$DK$DK
172014605$17201460$5$F$$20240624$20191226$20240703$EXP$$SK-PFIZER INC-2019545738$PFIZER$Olearova, A.. Drug induced myelosupression- serious pharmacotherapy issue. Farm Obzor. 2014;83:18$72$YR$$F$Y$70$KG$20240703$$MD$SK$SK
1720206421$17202064$21$F$20191209$20240814$20191226$20240825$EXP$$DE-ROCHE-2452624$ROCHE$$44$YR$A$F$Y$$$20240825$$CN$DE$DE
172020944$17202094$4$F$20191001$20240715$20191226$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US201912008750$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240722$$CN$US$US
172024902$17202490$2$F$20120101$20240911$20191226$20240916$EXP$AT-EMA-DD-20190515-SINGH_N3-104639$AT-MYLANLABS-2019M1120175$MYLAN$Vogl U.. Trifluridine/Tipiracil (Lonsurf).Colon cancer: stabilisation of disease. Krebs: hilfe. 2019;38-39.$79$YR$$F$Y$$$20240916$$MD$AT$AT
172031392$17203139$2$F$20190111$20240805$20191226$20240813$EXP$$JP-AstraZeneca-2019SF86168$ASTRAZENECA$$70$YR$$M$Y$78$KG$20240813$$MD$JP$
172045347$17204534$7$F$20131205$20240626$20191226$20240702$EXP$$US-JAZZ-2019-US-017119$JAZZ$$45$YR$$F$Y$88.888$KG$20240702$$HP$US$US
172045386$17204538$6$F$20110101$20240806$20191226$20240813$EXP$$US-JAZZ-2019-US-017909$JAZZ$$$$$F$Y$$$20240813$$CN$US$US
172046437$17204643$7$F$20190725$20240709$20191226$20240711$EXP$$CA-TAKEDA-2019TUS047228$TAKEDA$$73$YR$$F$Y$$$20240711$$MD$CA$CA
1720465027$17204650$27$F$20190813$20240909$20191226$20240917$EXP$$CA-CELLTRION INC.-2019CA024108$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
1720497921$17204979$21$F$20240306$20240905$20191227$20240910$EXP$$US-SHIRE-US201944748$TAKEDA$$44$YR$$F$Y$114$KG$20240910$$CN$US$US
172059082$17205908$2$F$$20240828$20191227$20240909$EXP$$US-GLENMARK PHARMACEUTICALS-2019GMK045064$GLENMARK$Chen J, Ngo D, Rosenthal J. Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease.. Journal of Oncology Pharmacy Practice. 2019;25 (8):2027-2030$$$$$Y$$$20240909$$HP$US$US
172059202$17205920$2$F$$20240910$20191227$20240924$EXP$SG-MLMSERVICE-20190405-1688588-1$SG-ALKEM LABORATORIES LIMITED-SG-ALKEM-2019-03533$ALKEM$Goh KJ, Takano A, Koh MS, Tiew PY, Chong CS, Tay CK.. A 53-Year-Old Man Presenting With Diplopia and Cavitary Lung Nodules. Chest. 2019;155(4):e107-e112$53$YR$$M$Y$$$20240924$$MD$SG$SG
172066222$17206622$2$F$$20240909$20191227$20240924$EXP$TR-MLMSERVICE-20190723-1863336-1$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2019-07049$ALKEM$Karacaglar E, Akgun AN, Aytekin C, Aydinalp A, Sezgin A, Haldun  Muderrisoglu I.. Successful Treatment of a Rare Complication in a Heart Transplant Recipient: Spontaneous Axillary Artery Bleeding. Experimental and Clinical Transplantation. 2019;17(3):421-424$45$YR$$F$Y$$$20240924$$MD$TR$TR
172074796$17207479$6$F$$20240911$20191227$20240916$EXP$$US-PFIZER INC-2019554263$PFIZER$$67$YR$$M$Y$$$20240916$$CN$US$US
172079948$17207994$8$F$$20240725$20191227$20240801$EXP$$CA-PFIZER INC-2019554322$MYLAN$$70$YR$$F$Y$$$20240801$$HP$CA$CA
172091512$17209151$2$F$$20240705$20191227$20240710$EXP$$CA-SA-2019SA354949$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240710$$HP$CA$CA
172097935$17209793$5$F$20190101$20240815$20191227$20240829$PER$$US-SA-2019SA351161$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240829$$MD$US$US
172099952$17209995$2$F$20080901$20240913$20191227$20240919$EXP$$FR-MYLANLABS-2019M1127620$MYLAN$Faucon A, Zamfir O, Dupouet L and Pruna A. Streptococcus pneumonia infection and positive blood culture with Francisella tularensis, in a renal transplant recipient. .. Presse Med. 2011;40(12):1199-1202$69$YR$$M$Y$$$20240919$$HP$FR$FR
172106562$17210656$2$F$$20240705$20191227$20240710$EXP$$CA-SA-2019SA355038$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240710$$MD$CA$CA
1721085832$17210858$32$F$20190101$20240731$20191227$20240808$EXP$$CA-CELLTRION INC.-2019CA027617$CELLTRION$$$$$$Y$$$20240808$$MD$CA$CA
172109969$17210996$9$F$$20240822$20191227$20240827$EXP$$US-SHIRE-US201945260$TAKEDA$$$$$F$Y$53.968$KG$20240827$$MD$US$US
1721106814$17211068$14$F$20210609$20240829$20191228$20240903$EXP$$US-SHIRE-US201945193$TAKEDA$$56$YR$$F$Y$102$KG$20240903$$HP$US$US
172118112$17211811$2$F$$20240705$20191230$20240710$EXP$$CA-SA-2019SA354995$SANOFI AVENTIS$$$$$F$Y$$$20240710$$HP$CA$CA
172118202$17211820$2$F$20180322$20240705$20191230$20240710$EXP$$CA-SA-2019SA354845$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240710$$PH$CA$CA
172118262$17211826$2$F$$20240705$20191230$20240710$EXP$$CA-SA-2019SA355015$SANOFI AVENTIS$$44$YR$A$F$Y$91$KG$20240710$$MD$CA$CA
1721245820$17212458$20$F$20191128$20240827$20191230$20240830$EXP$$US-SHIRE-US201945053$TAKEDA$$64$YR$$M$Y$130$KG$20240830$$HP$US$US
172128603$17212860$3$F$$20240910$20191230$20240924$EXP$US-MLMSERVICE-20190422-1712283-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2019-04064$ALKEM$Kang M, Aslam S.. Varicella zoster virus encephalitis in solid organ transplant recipients: Case series and review of literature. Transplant Infectious Disease. 2018;21(2):1-6$66$YR$$M$Y$$$20240924$$MD$US$US
172154132$17215413$2$F$$20240705$20191230$20240710$EXP$$CA-SA-2019SA354975$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240710$$HP$CA$CA
172161532$17216153$2$F$$20240705$20191230$20240710$EXP$$CA-SA-2019SA354908$SANOFI AVENTIS$$$$$F$Y$$$20240710$$MD$CA$CA
172161632$17216163$2$F$$20240705$20191230$20240710$EXP$$CA-SA-2019SA354866$SANOFI AVENTIS$$$$$M$Y$$$20240710$$HP$CA$CA
1721647514$17216475$14$F$$20240724$20191230$20240803$EXP$$CA-AUROBINDO-AUR-APL-2019-107046$AUROBINDO$$53$YR$$F$Y$$$20240803$$HP$CA$CA
172171686$17217168$6$F$$20240724$20191231$20240803$EXP$$CA-AUROBINDO-AUR-APL-2019-107039$AUROBINDO$$$$$F$Y$$$20240803$$HP$CA$CA
172173253$17217325$3$F$20101118$20240912$20191231$20240920$EXP$$NO-TEVA-2019-NO-1159797$TEVA$$33$YR$$M$Y$$$20240920$$MD$NO$NO
1721744310$17217443$10$F$$20240705$20191231$20240710$EXP$$US-SHIRE-US201944922$TAKEDA$$$$$M$Y$52$KG$20240710$$HP$US$US
172187774$17218777$4$F$20190101$20240722$20191231$20240729$PER$$US-VERTEX PHARMACEUTICALS-2019-011779$VERTEX$$$$$F$Y$$$20240729$$PH$US$US
1721976914$17219769$14$F$$20240828$20191231$20240903$EXP$$US-SHIRE-US201945039$TAKEDA$$$$$F$Y$65.76$KG$20240903$$CN$US$US
172201143$17220114$3$F$20151215$20240723$20191231$20240726$EXP$$FR-MYLANLABS-2019M1131937$MYLAN$$56$YR$$F$Y$61$KG$20240726$$MD$FR$FR
172217376$17221737$6$F$$20240911$20200101$20240919$EXP$$CA-ROCHE-2509684$ROCHE$$73$YR$E$M$Y$$$20240919$$CN$CA$CA
1722187624$17221876$24$F$20181217$20240709$20200101$20240722$EXP$$DE-ROCHE-2239412$ROCHE$$59$YR$A$F$Y$53$KG$20240722$$CN$DE$DE
172223962$17222396$2$F$$20240827$20200101$20240905$EXP$$FR-BAXTER-2019BAX026273$BAXTER$$47$YR$$F$Y$$$20240905$$HP$FR$FR
172226252$17222625$2$F$$20240829$20200102$20240905$EXP$$FR-ROCHE-2504557$ROCHE$Uzunov M. Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab. BRITISH JOURNAL OF HAEMATOLOGY 2019;:1-3.$47$YR$A$F$Y$$$20240906$$HP$FR$FR
172226612$17222661$2$F$20140101$20240812$20200102$20240818$EXP$$IN-BIOGEN-2019BI00822095$BIOGEN$$63$YR$$F$Y$$$20240818$$CN$IN$IN
1722324913$17223249$13$F$20180530$20240826$20200102$20240902$EXP$$US-SHIRE-US201945267$TAKEDA$$62$YR$$F$Y$70$KG$20240902$$CN$US$US
172236494$17223649$4$F$$20240820$20200102$20240823$EXP$$FR-ROCHE-2493394$ROCHE$, Pochon C, Chastagner P, Droz D. Long-term Adverse Effects of Acute Myeloid Leukemia Treatment on Odontogenesis in a Child. Doi: 10.5005/jp-journals-10005-1614. Int J Clin Pediatr Dent 2019;12 (3):243-6.$9$YR$C$M$Y$$$20240823$$HP$FR$FR
172237935$17223793$5$F$20190101$20240830$20200102$20240909$30DAY$$US-GLAXOSMITHKLINE-US2019AMR237673$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
172239702$17223970$2$F$20190301$20240909$20200102$20240916$EXP$$BG-MYLANLABS-2019M1126840$MYLAN$Simova Y, Petrov I, Stanilov P. Sacubitril/valsartan use for a cardiotoxicity, associated with a chemoptherapy.. Cardio D.. 2019;25(1)$60$YR$$F$Y$$$20240916$$HP$BG$BG
1722833329$17228333$29$F$20200113$20240904$20200103$20240910$EXP$$US-SHIRE-US201945601$TAKEDA$$75$YR$$M$Y$97$KG$20240910$$CN$US$US
172285869$17228586$9$F$20110701$20240821$20200103$20240823$EXP$$CA-Orion Corporation ORION PHARMA-TREX2020-0008$ORION$$69$YR$E$M$Y$76$KG$20240823$$HP$CA$
172294452$17229445$2$F$$20240911$20200103$20240913$PER$$US-JNJFOC-20200103081$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$LW$US$US
172295534$17229553$4$F$20150216$20240902$20200103$20240916$EXP$CZ-MYLANLABS-2019M1121241$CZ-ROCHE-2504938$ROCHE$The use of eribulin and vinorelbin in treating breast cancer ? two case studies. Onkologicka Revue. 2019;6 (6):78-80.$66$YR$E$F$Y$$$20240916$$MD$CZ$CZ
1722955410$17229554$10$F$20240401$20240729$20200103$20240805$EXP$$US-SHIRE-US201945544$TAKEDA$$52$YR$$F$Y$68$KG$20240805$$HP$US$US
1723083510$17230835$10$F$20210514$20240822$20200103$20240830$EXP$$US-SHIRE-US201945486$TAKEDA$$33$YR$$F$Y$91$KG$20240830$$HP$US$US
172318629$17231862$9$F$$20240821$20200103$20240822$EXP$$US-PFIZER INC-2020001669$PFIZER$$85$YR$$F$Y$$$20240822$$CN$US$US
1723198023$17231980$23$F$20190901$20240730$20200103$20240807$EXP$$US-GLAXOSMITHKLINE-US2019TSO170527$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
172320908$17232090$8$F$20200801$20240917$20200103$20240925$PER$$US-SA-2020SA001388$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240925$$CN$US$US
172323683$17232368$3$F$$20240802$20200103$20240813$PER$$US-SA-2019SA359378$SANOFI AVENTIS$$$$A$F$Y$77.11$KG$20240814$$MD$US$US
1723247215$17232472$15$F$20201105$20240913$20200103$20240918$EXP$$US-SHIRE-US201945055$TAKEDA$$64$YR$$F$Y$98$KG$20240918$$CN$US$US
172326116$17232611$6$F$20190101$20240627$20200103$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2019-017436$UNITED THERAPEUTICS$$$$$F$Y$83.447$KG$20240705$$$US$US
1723282129$17232821$29$F$$20240916$20200103$20240923$EXP$$CA-BAUSCH-BL-2019-066666$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240923$$CN$CA$CA
172328263$17232826$3$F$$20240925$20200103$20240930$EXP$$CA-PFIZER INC-2019561644$MYLAN$$61$YR$$M$Y$$$20240930$$HP$CA$CA
172336733$17233673$3$F$20190901$20240711$20200105$20240716$PER$$NVSC2019US085305$NOVARTIS$$$$A$M$Y$$$20240716$$HP$US$US
172341727$17234172$7$F$20191228$20240925$20200106$20240930$EXP$$US-SHIRE-US201945656$TAKEDA$$59$YR$$F$Y$$$20240930$$CN$US$US
1723486312$17234863$12$F$20180601$20240715$20200106$20240725$EXP$$DE-ROCHE-2151250$ROCHE$$47$YR$A$F$Y$$$20240725$$CN$DE$DE
172358262$17235826$2$F$$20240830$20200106$20240911$EXP$FR-EMA-20191219-AUTODUP-30960000$FR-Accord-168664$ACCORD$See underlying duplicates$47$YR$A$F$Y$$$20240911$$HP$FR$FR
172358413$17235841$3$F$$20240816$20200106$20240828$EXP$$JP-Accord-169212$ACCORD$Yokoyama K, Sakaeda S, Ishida R, Terao M, Morioka T, Tsuda B, et al, (Two Cases of Pneumocystis Pneumonia during Adjuvant Chemotherapy for  Breast Cancer). Gan To Kagaku Ryoho. 2019 Dec;46(12):1887-1890.$27$YR$A$F$Y$$$20240828$$HP$JP$JP
172364704$17236470$4$F$$20240822$20200106$20240827$EXP$$US-TAKEDA-2020TUS000556$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
1723650816$17236508$16$F$20191101$20240716$20200106$20240723$EXP$$US-VERTEX PHARMACEUTICALS-2019-013885$VERTEX$$21$YR$$F$Y$62$KG$20240723$$MD$US$US
172372895$17237289$5$F$$20240829$20200106$20240904$EXP$$JP-PFIZER INC-2020002296$PFIZER$Watanabe, H.. Pneumocystis jirovecii Pneumonia in a Patient with Breast Cancer Receiving Neoadjuvant Dose-dense Chemotherapy.. Internal medicine (Tokyo, Japan). 2020;59(7):987-990$38$YR$$F$Y$$$20240904$$HP$JP$JP
172390072$17239007$2$F$20191127$20240305$20200106$20240731$PER$$US-BAYER-2020-002250$BAYER$$19$YR$A$F$Y$$$20240731$$MD$US$US
1724090916$17240909$16$F$20160816$20240923$20200107$20240930$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK120535$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$BR$BR
172417572$17241757$2$F$20191121$20240711$20200107$20240715$EXP$FR-AFSSAPS-NC20191474$FR-PFIZER INC-2020001408$PFIZER$$30$YR$$M$Y$74$KG$20240715$$MD$FR$FR
172427276$17242727$6$F$20200101$20240701$20200107$20240708$PER$$US-BIOGEN-2020BI00824469$BIOGEN$$48$YR$$F$Y$$$20240708$$CN$US$US
172435032$17243503$2$F$$20240911$20200107$20240918$EXP$$CZ-MYLANLABS-2020M1000101$MYLAN$Sedo J.. Trifluridin/tipiracil in therapy of colorectal carcinoma.. Acta Medicinae. 2019;(14):28-29$70$YR$$M$Y$$$20240918$$MD$CZ$CZ
1724352734$17243527$34$F$20200102$20240918$20200107$20240923$EXP$$US-SHIRE-US202000215$TAKEDA$$51$YR$$M$Y$$$20240923$$CN$US$US
172441305$17244130$5$F$20180101$20240828$20200107$20240905$EXP$$US-BIOGEN-2019BI00822103$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
172443956$17244395$6$F$20150101$20240918$20200107$20240920$PER$$US-GILEAD-2020-0445064$GILEAD$$59$YR$A$M$Y$$$20240920$$LW$US$US
172444206$17244420$6$F$20141014$20240813$20200107$20240815$PER$$US-GILEAD-2020-0445065$GILEAD$$54$YR$A$M$Y$$$20240815$$LW$US$US
172450486$17245048$6$F$20171117$20231204$20200108$20240710$EXP$$CA-ROCHE-2513457$ROCHE$$81$YR$E$F$Y$69$KG$20240710$$CN$CA$CA
1724597348$17245973$48$F$20200101$20240826$20200108$20240904$EXP$$US-SHIRE-US202000231$TAKEDA$$42$YR$$F$Y$152$KG$20240904$$MD$US$US
172461207$17246120$7$F$20190601$20240717$20200108$20240726$EXP$$US-ROCHE-2514675$ROCHE$$42$YR$A$M$Y$104$KG$20240726$$CN$US$US
1724650313$17246503$13$F$20161227$20240711$20200108$20240715$EXP$$PHHY2016CA128302$NOVARTIS$$62$YR$$F$Y$$$20240715$$CN$CA$CA
172468619$17246861$9$F$$20240904$20200108$20240905$EXP$$US-PFIZER INC-2017547293$PFIZER$$74$YR$$M$Y$54$KG$20240905$$CN$US$US
172483332$17248333$2$F$$20240724$20200108$20240803$EXP$$CA-TEVA-2020-CA-1164869$TEVA$$44$YR$$F$Y$$$20240803$$HP$CA$CA
1724850015$17248500$15$F$20210112$20240920$20200108$20240926$EXP$$US-SHIRE-US202000081$TAKEDA$$77$YR$$F$Y$72$KG$20240926$$HP$US$US
172495326$17249532$6$F$20180101$20240704$20200108$20240710$EXP$$CA-TAKEDA-2018TUS010510$TAKEDA$$$$$F$Y$$$20240710$$CN$CA$CA
172497493$17249749$3$F$20160101$20240904$20200109$20240917$EXP$$CZ-AUROBINDO-AUR-APL-2020-001189$AUROBINDO$L. Lojkaskova. Linearni IgA bulozni dermatoza. Linear IgA bullous dermatosis. Case report. CESKO-SLOVENSKA DERMATOLOGIE. 2019;94(5):204-8$85$YR$$M$Y$64$KG$20240917$$MD$CZ$CZ
172501214$17250121$4$F$$20240909$20200109$20240917$EXP$$CA-ROCHE-2516277$ROCHE$$63$YR$A$F$Y$$$20240917$$HP$CA$CA
172504215$17250421$5$F$$20240913$20200109$20240923$EXP$$CA-ROCHE-2513880$ROCHE$$73$YR$E$M$Y$$$20240923$$HP$CA$CA
1725063224$17250632$24$F$20191115$20240809$20200109$20240813$EXP$$DE-ROCHE-2491834$ROCHE$$44$YR$A$F$Y$$$20240813$$CN$DE$DE
172517945$17251794$5$F$20190309$20240823$20200109$20240829$EXP$FR-AFSSAPS-ST20191218$FR-MYLANLABS-2020M1001599$MYLAN$$70$YR$$F$Y$$$20240829$$MD$FR$FR
172520072$17252007$2$F$20121230$20240827$20200109$20240903$EXP$FR-EMA-DD-20191003-SANDEVHP-150757$FR-MYLANLABS-2020M1001690$MYLAN$$$$N$F$Y$2.1$KG$20240903$$MD$FR$FR
172528164$17252816$4$F$20180911$20240906$20200109$20240916$EXP$$CA-TAKEDA-2020TUS001326$TAKEDA$$32$YR$$M$Y$$$20240916$$CN$CA$CA
172532227$17253222$7$F$20240101$20240722$20200109$20240729$EXP$$US-SA-2020SA004783$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240729$$MD$US$US
1725373842$17253738$42$F$$20240923$20200109$20240927$EXP$$US-SHIRE-US202000327$TAKEDA$$$$$F$Y$61$KG$20240927$$MD$US$US
172542134$17254213$4$F$$20240820$20200109$20240823$EXP$$DE-MYLANLABS-2020M1002102$MYLAN$Olaizola I, Ellger T, Young P, Bosebeck F, Evers S, Kellinghaus C.. Pregabalin-associated acute psychosis and epileptiform EEG-changes. Seizure. 2006;15:208-210$44$YR$$F$Y$$$20240823$$HP$DE$DE
172551102$17255110$2$F$$20240814$20200109$20240827$EXP$$FR-AUROBINDO-AUR-APL-2018-037185$AUROBINDO$Sarradin V, Dalenc F, Sibaud V, Tournier E, Roch? H.. Acute Generalized Exanthematous Pustulosis Induced by Docetaxel and Recurrent With Letrozole: A Case Report.. Clinical Breast Cancer.. 2018$63$YR$$F$Y$$$20240827$$MD$FR$FR
172557985$17255798$5$F$$20240814$20200110$20240824$EXP$$US-AMGEN-USASP2020002245$AMGEN$Dinardo, C.D.. Venetoclax in Combination with FLAG-IDA Chemotherapy (FLAG-V-I) for Fit, Relapsed/Refractory AML Patients: Interim Results of a Phase lb/2 Dose Escalation and Expansion Study. Blood. 2018;132 (Suppl-1)$$$$$Y$$$20240824$$MD$US$US
172570905$17257090$5$F$20230707$20240723$20200110$20240813$PER$$AU-TOLMAR, INC.-19AU000697$TOLMAR$$81$YR$$M$Y$$$20240813$$HP$AU$AU
172572376$17257237$6$F$20191203$20240905$20200110$20240909$EXP$$NVSC2019CH060794$NOVARTIS$$80$YR$$F$Y$66$KG$20240909$$MD$CH$CH
1725731410$17257314$10$F$20191223$20240917$20200110$20240919$EXP$$US-PFIZER INC-2020009993$PFIZER$$76$YR$$F$Y$74.03$KG$20240919$$CN$US$US
172577327$17257732$7$F$20131001$20240730$20200110$20240802$EXP$$BE-MYLANLABS-2020M1002409$MYLAN$Apraxine M, Levecque P, Druez P, Dahan K, Cambier JF, Lengele JP.. Severe hypomagnesemia induced by proton pump inhibitors: description of two cases and review of the literature. Louvain Medical. 2019;138 (7):446-51$54$YR$$M$Y$$$20240802$$HP$BE$BE
172594453$17259445$3$F$$20240829$20200110$20240903$EXP$$JP-BAUSCH-BL-2020-000108$BAUSCH AND LOMB$Watanabe H, Kitahara Y, Murakami Y, Nihashi F, Matsushima S, Eifuku T, Uto T, Sato J, Imokawa S, Suda T. Pneumocystis jirovecii Pneumonia in a Patient with Breast Cancer Receiving Neoadjuvant Dose-dense Chemotherapy.. Internal medicine. 2019;59(7):987-90. doi:10.2169/internalmedicine.3907-19$38$YR$$F$Y$$$20240903$$MD$JP$JP
172595064$17259506$4$F$20190906$20240826$20200110$20240830$PER$$US-SHIRE-US202000618$TAKEDA$$14$YR$$M$Y$47$KG$20240830$$CN$US$US
1725994015$17259940$15$F$$20240816$20200111$20240829$EXP$$LT-AUROBINDO-AUR-APL-2020-001762$AUROBINDO$KUNIGELIENA A, ALEKNA D, GUZEVICIUS M.. KLINIKINIS ATVEJIS: PACIENTO, SERGAN?IO ?IZOFRENIJA IR TURIN?IO TRANSPLANTUOTA INKSTA GYDYMO YPATUMAI (A clinical case: Treatment of a patient with schizophrenia and kidney transplant). SVEIKATOS MOKSLAI / HEALTH SCIENCES IN EASTERN EUROPE. 2019;29(6):132-135$32$YR$$M$Y$$$20240829$$MD$LT$LT
1726007019$17260070$19$F$20171222$20240709$20200111$20240713$EXP$$US-SHIRE-US201736609$TAKEDA$$47$YR$$F$Y$119$KG$20240713$$HP$US$US
172614216$17261421$6$F$20160101$20240808$20200113$20240816$EXP$$US-SA-2016SA019886$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240816$$CN$US$US
172626032$17262603$2$F$20191010$20240919$20200113$20240920$EXP$ES-AEMPS-578942$ES-009507513-2001ESP001801$MERCK$$57$YR$$M$Y$$$20240920$$MD$ES$ES
1726374310$17263743$10$F$20191231$20240903$20200113$20240904$EXP$$US-SHIRE-US202000579$TAKEDA$$68$YR$$M$Y$98$KG$20240904$$PH$US$US
172653294$17265329$4$F$$20240820$20200114$20240829$PER$$US-ROCHE-2519019$ROCHE$Singha A, Wert M. Strongyloides hyperinfection syndrome in a patient with systemic lupus erythematosus (SLE) and heart transplant.. American Journal of Respiratory and Critical Care Medicine. 2019;199 (9):A7494.$28$YR$A$F$Y$$$20240829$$HP$US$US
1726536615$17265366$15$F$$20240820$20200114$20240823$EXP$$US-SHIRE-US202000780$TAKEDA$$$$$M$Y$86$KG$20240823$$HP$US$US
1726577816$17265778$16$F$20200113$20240912$20200114$20240916$EXP$$US-SHIRE-US202000738$TAKEDA$$54$YR$$F$Y$56$KG$20240916$$CN$US$US
1726636516$17266365$16$F$20191201$20240816$20200114$20240823$EXP$$US-DSJP-DSU-2020-100367$DAIICHI$$47$YR$$M$Y$$$20240823$$CN$US$US
1726720112$17267201$12$F$20231225$20240722$20200114$20240729$EXP$$US-SHIRE-US202000868$TAKEDA$$77$YR$$M$Y$91$KG$20240729$$HP$US$US
172673782$17267378$2$F$$20240815$20200114$20240828$PER$$US-SA-2020SA005169$SANOFI AVENTIS$$$$E$M$Y$$$20240828$$MD$US$US
1726758712$17267587$12$F$20190101$20240826$20200114$20240829$PER$$US-BIOGEN-2018BI00664924$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
1727077440$17270774$40$F$$20240724$20200114$20240801$EXP$$US-SHIRE-US202001266$TAKEDA$$$$$F$Y$75$KG$20240801$$HP$US$US
172739364$17273936$4$F$$20240905$20200115$20240910$EXP$$CA-PFIZER INC-2020015731$PFIZER$$61$YR$$F$Y$$$20240910$$HP$CA$CA
172744546$17274454$6$F$20221123$20240819$20200115$20240826$EXP$$US-TAKEDA-2020TUS001598$TAKEDA$$69$YR$$F$Y$77.605$KG$20240826$$HP$US$US
172745716$17274571$6$F$20230801$20240627$20200115$20240701$EXP$$US-JAZZ-2020-US-000353$JAZZ$$52$YR$$F$Y$$$20240701$$HP$US$US
1727485210$17274852$10$F$20240402$20240726$20200116$20240801$EXP$$US-SHIRE-US202000980$TAKEDA$$25$YR$$F$Y$61$KG$20240801$$CN$US$US
172755409$17275540$9$F$$20240826$20200116$20240829$EXP$$US-SHIRE-US202001294$TAKEDA$$$$$F$Y$58$KG$20240829$$CN$US$US
172769743$17276974$3$F$20200622$20240620$20200116$20240703$EXP$DE-EMA-DD-20191223-NEGI_N-150855$DE-TEVA-2020-DE-1167152$TEVA$$60$YR$$F$Y$$$20240703$$MD$DE$DE
1727765410$17277654$10$F$20191201$20240726$20200116$20240802$EXP$$NVSC2020CO004428$NOVARTIS$$50$YR$$F$Y$80$KG$20240802$$CN$CO$CO
172788639$17278863$9$F$$20240918$20200116$20240920$EXP$$CA-PFIZER INC-2020013200$PFIZER$$46$YR$$M$Y$$$20240920$$HP$CA$CA
1728042716$17280427$16$F$20200612$20240923$20200117$20240930$EXP$$US-SHIRE-US202000988$TAKEDA$$50$YR$$M$Y$74$KG$20240930$$MD$US$US
1728222021$17282220$21$F$20190101$20240715$20200117$20240725$EXP$$CA-ROCHE-2522590$ROCHE$$38$YR$A$F$Y$$$20240725$$CN$CA$CA
1728269622$17282696$22$F$20191101$20240830$20200117$20240904$EXP$$US-SHIRE-US202001296$TAKEDA$$70$YR$$F$Y$70$KG$20240904$$HP$US$US
172832218$17283221$8$F$20200102$20240703$20200117$20240709$PER$$US-PFIZER INC-2020019606$PFIZER$$69$YR$$F$Y$77.098$KG$20240709$$CN$US$US
1728462813$17284628$13$F$20200101$20240920$20200117$20240927$EXP$$US-SHIRE-US202001092$TAKEDA$$2$YR$$M$Y$$$20240927$$CN$US$US
172859883$17285988$3$F$20180926$20240824$20200118$20240903$EXP$$CA-ROCHE-2463251$ROCHE$$41$YR$A$F$Y$$$20240903$$CN$CA$CA
172860673$17286067$3$F$$20240724$20200118$20240806$EXP$$CA-AUROBINDO-AUR-APL-2019-096157$AUROBINDO$$62$YR$$M$Y$113$KG$20240806$$HP$CA$CA
172876003$17287600$3$F$20180810$20240711$20200120$20240722$EXP$$JP-ABBVIE-20P-087-3235551-00$ABBVIE$$40$YR$$M$Y$$$20240718$$MD$JP$JP
172885115$17288511$5$F$$20240807$20200120$20240812$EXP$$US-PFIZER INC-2020021883$PFIZER$$70$YR$$F$Y$$$20240812$$HP$US$US
1728863826$17288638$26$F$$20240704$20200120$20240709$EXP$$IL-PFIZER INC-2018190864$PFIZER$$49$YR$$M$Y$$$20240709$$HP$IL$IL
1728967824$17289678$24$F$20221205$20240801$20200120$20240805$EXP$$US-SHIRE-US202001340$TAKEDA$$74$YR$$F$Y$102$KG$20240805$$HP$US$US
1729012416$17290124$16$F$20190801$20240823$20200120$20240830$EXP$$CO-TAKEDA-2019TUS049387$TAKEDA$$30$YR$$F$Y$68$KG$20240830$$HP$CO$CO
1729120141$17291201$41$F$20191015$20240819$20200121$20240827$EXP$$CA-CELLTRION INC.-2019CA025942$CELLTRION$$$$$$Y$$$20240827$$CN$CA$CA
172917602$17291760$2$F$$20240809$20200121$20240816$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR007263$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$HP$CA$CA
1729298817$17292988$17$F$20230101$20240703$20200121$20240711$EXP$$US-PFIZER INC-2019421384$PFIZER$$66$YR$$F$Y$108.86$KG$20240711$$CN$US$US
172930488$17293048$8$F$20170301$20240725$20200121$20240801$EXP$$PHHY2017CA048441$NOVARTIS$$30$YR$$M$Y$$$20240801$$MD$CA$CA
172937833$17293783$3$F$20190101$20240807$20200121$20240816$PER$$US-SA-2020SA014708$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240816$$HP$US$US
172961204$17296120$4$F$$20240905$20200121$20240912$EXP$$JP-PFIZER INC-2020023373$PFIZER$Yokoyama, K.. Two Cases of Pneumocystis Pneumonia during Adjuvant Chemotherapy for Breast Cancer.. Gan to kagaku ryoho. Cancer + chemotherapy 1890.. 2019;46(12):1887-1890$62$YR$$F$Y$$$20240912$$MD$JP$JP
172974238$17297423$8$F$20170817$20240717$20200122$20240724$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2019JPN011305$VIIV$$$$$$Y$$$20240724$$MD$JP$JP
172975563$17297556$3$F$20200101$20240805$20200121$20240808$EXP$$US-SHIRE-US202001954$TAKEDA$$60$YR$$F$Y$49$KG$20240808$$HP$US$US
172976063$17297606$3$F$20170101$20240828$20200122$20240912$EXP$KR-MLMSERVICE-20200102-2105458-1$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2020-00050$ALKEM$Kim KC, Choi HM, Yoon YE, Cho Y, Cho GY. A Case of Aspergillus Mural Endocarditis Presenting With Complete Atrioventricular Block after Liver-Kidney Transplantation.. Cardiovascular Imaging Case Reports. 2019;3(6):267-271$61$YR$$M$Y$$$20240912$$MD$KR$KR
1729803814$17298038$14$F$20231201$20240716$20200121$20240723$EXP$$CA-TAKEDA-2020TUS003290$TAKEDA$$75$YR$$M$Y$$$20240723$$CN$CA$CA
172985504$17298550$4$F$$20240905$20200121$20240912$EXP$$JP-PFIZER INC-2020023510$PFIZER$Yokoyama, K.. Two Cases of Pneumocystis Pneumonia during Adjuvant Chemotherapy for Breast Cancer.. Gan to kagaku ryoho. Cancer + chemotherapy 1890.. 2019;46(12):1887-1890$27$YR$$F$Y$$$20240912$$MD$JP$JP
1730078511$17300785$11$F$$20240826$20200122$20240903$EXP$$CA-JNJFOC-20200124582$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240904$$CN$CA$CA
173008193$17300819$3$F$$20240725$20200122$20240729$EXP$$CA-PFIZER INC-2020024875$PFIZER$$18$YR$$F$Y$59$KG$20240729$$HP$CA$CA
173009524$17300952$4$F$$20240910$20200122$20240912$PER$$US-PFIZER INC-2020029018$PFIZER$$66$YR$$F$Y$75.737$KG$20240912$$CN$US$US
173009714$17300971$4$F$$20240829$20200122$20240904$PER$$US-PFIZER INC-2020028713$PFIZER$$63$YR$$F$Y$$$20240904$$CN$US$US
173014834$17301483$4$F$20160901$20240829$20200122$20240903$EXP$$HU-MYLANLABS-2020M1005241$MYLAN$Zoltan K, Csaba B, Adrienne B, Tibor F. Tumor in the renal graft after translation. MAGYAR URILOGIA. 2019;3:98-102$78$YR$$F$Y$$$20240903$$HP$HU$HU
173034503$17303450$3$F$20200112$20240717$20200122$20240723$EXP$$US-INCYTE CORPORATION-2020IN000406$INCYTE$$$$$$Y$$$20240723$$CN$US$US
173052438$17305243$8$F$$20240729$20200123$20240730$EXP$$US-PFIZER INC-2020030146$PFIZER$$69$YR$$F$Y$56.7$KG$20240730$$CN$US$US
1730700532$17307005$32$F$$20240830$20200123$20240916$EXP$$CA-AUROBINDO-AUR-APL-2020-003529$AUROBINDO$$44$YR$$F$Y$97$KG$20240916$$MD$CA$CA
173072504$17307250$4$F$20190329$20240716$20200123$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-095441$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240723$$MD$JP$JP
1730725612$17307256$12$F$20190604$20240716$20200123$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-095443$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240725$$MD$JP$JP
1730775719$17307757$19$F$20180116$20240805$20200123$20240822$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK112839$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$MD$BR$BR
173098003$17309800$3$F$$20240627$20200123$20240701$EXP$$US-KYOWAKIRIN-2020BKK000649$KYOWA$$$$$$Y$$$20240701$$CN$US$US
173119462$17311946$2$F$20190101$20240530$20200123$20240717$PER$$US-NOVOPROD-700029$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
173120232$17312023$2$F$20190320$20240530$20200123$20240717$PER$$US-NOVOPROD-666525$NOVO NORDISK$$66$YR$$F$Y$71.202$KG$20240717$$CN$US$US
173122262$17312226$2$F$20190101$20240530$20200123$20240717$PER$$US-NOVOPROD-687035$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
173122612$17312261$2$F$20190101$20240530$20200123$20240717$PER$$US-NOVOPROD-689020$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
173130497$17313049$7$F$20191217$20240916$20200124$20240919$EXP$$DE-ABBVIE-20K-062-3245199-00$ABBVIE$$76$YR$$M$Y$74$KG$20240919$$MD$DE$DE
1731392317$17313923$17$F$20231228$20240725$20200124$20240801$EXP$$US-SHIRE-US202002370$TAKEDA$$76$YR$$F$Y$67.574$KG$20240801$$HP$US$US
173146463$17314646$3$F$20171101$20240902$20200124$20240905$EXP$$PL-MYLANLABS-2020M1007565$MYLAN$Piorek A, Pluzanski A, Krzakowski M.. ADVANCED SOLITARY FIBROUS TUMOUR OF THE PLEURA - A CASE REPORT AND LITERATURE REVIEW.. ONCOLOGY IN CLINICAL PRACTICE. 2019;15(3):185-189$55$YR$$F$Y$130$KG$20240905$$MD$PL$PL
1731465012$17314650$12$F$$20240809$20200124$20240813$EXP$$US-SHIRE-US202002390$TAKEDA$$$$$M$Y$77$KG$20240813$$MD$US$US
1731493712$17314937$12$F$20201217$20240708$20200124$20240710$EXP$$US-SHIRE-US202002317$TAKEDA$$65$YR$$F$Y$85$KG$20240710$$HP$US$US
173153164$17315316$4$F$20200101$20240806$20200124$20240809$EXP$$US-VERTEX PHARMACEUTICALS-2020-000763$VERTEX$$28$YR$$F$Y$$$20240809$$MD$US$US
173160614$17316061$4$F$$20240627$20200124$20240703$EXP$$US-TAKEDA-2018TUS027067$TAKEDA$$$$$M$Y$$$20240703$$CN$US$US
173170515$17317051$5$F$$20240813$20200124$20240819$EXP$$CA-TAKEDA-2020TUS004044$TAKEDA$$$$$F$Y$$$20240819$$CN$CA$CA
173174363$17317436$3$F$$20221102$20200124$20240723$PER$$US-OTSUKA-2019_029216$OTSUKA$$$$$M$Y$$$20240723$$PH$US$US
173186436$17318643$6$F$20190101$20240701$20200124$20240707$EXP$$BR-BIOGEN-2020BI00829529$BIOGEN$$$$$F$Y$45$KG$20240707$$CN$BR$BR
1732293249$17322932$49$F$20200106$20240723$20200127$20240801$EXP$$CA-ROCHE-2521131$ROCHE$$48$YR$A$M$Y$$$20240801$$CN$CA$CA
173235822$17323582$2$F$$20240624$20200127$20240703$EXP$$NL-AUROBINDO-AUR-APL-2020-003581$AUROBINDO$Oliveira dos Santos C, Zijlstra JG, Porte RJ, Kampinga GA, van Diepeningen AD, Sinha B, et al.. Emerging pan-resistance in Trichosporon species: A case report.. BMC Infectious Diseases.. 2016;16(1):148$48$YR$$M$Y$$$20240703$$MD$NL$NL
173237413$17323741$3$F$$20240725$20200127$20240730$EXP$$CA-Orion Corporation ORION PHARMA-TREX2020-0502$ORION$$18$YR$A$F$Y$59$KG$20240730$$MD$CA$
173241647$17324164$7$F$20240603$20240708$20200127$20240711$EXP$$US-SHIRE-US202003001$TAKEDA$$27$YR$$M$Y$120$KG$20240711$$HP$US$US
173246733$17324673$3$F$20180227$20240624$20200127$20240709$EXP$$CA-ROCHE-2530573$ROCHE$$41$YR$A$F$Y$$$20240705$$HP$CA$CA
1732468526$17324685$26$F$20200404$20240730$20200127$20240806$EXP$$US-SHIRE-US202003035$TAKEDA$$56$YR$$F$Y$60$KG$20240806$$HP$US$US
1732638614$17326386$14$F$$20240829$20200127$20240902$EXP$$US-PFIZER INC-2020033129$PFIZER$$71$YR$$F$Y$$$20240902$$CN$US$US
173271752$17327175$2$F$$20240909$20200127$20240916$EXP$GR-EMA-20160805-RPATEVHP-110249533$GR-MYLANLABS-2020M1008126$MYLAN$$69$YR$$F$Y$$$20240916$$MD$GR$GR
1732786714$17327867$14$F$20190101$20240904$20200127$20240911$EXP$$PHHY2019CA011353$NOVARTIS$$53$YR$$F$Y$$$20240911$$CN$CA$CA
173319582$17331958$2$F$20230601$20240504$20200127$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2019ARB001684$ARBOR$$15$YR$$M$Y$$$20240802$$MD$US$US
1733225531$17332255$31$F$20200813$20240919$20200128$20240925$EXP$$US-SHIRE-US202002586$TAKEDA$$71$YR$$F$Y$85$KG$20240925$$CN$US$US
173345802$17334580$2$F$20090101$20240717$20200128$20240722$PER$$US-JNJFOC-20200143981$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240722$$LW$US$US
1733518310$17335183$10$F$$20200722$20200128$20240702$EXP$$US-AKCEA THERAPEUTICS-2020IS001046$AKCEA THERAPEUTICS$$$$$$Y$$$20240701$$MD$US$US
1733534714$17335347$14$F$$20240712$20200128$20240719$EXP$$BR-GLAXOSMITHKLINE-BR2018GSK215886$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$MD$BR$BR
173357195$17335719$5$F$20190920$20240619$20200128$20240703$EXP$$CA-ROCHE-2535531$ROCHE$$63$YR$A$F$Y$$$20240703$$MD$CA$CA
173358884$17335888$4$F$$20240724$20200129$20240803$EXP$$CA-AUROBINDO-AUR-APL-2020-003930$AUROBINDO$$58$YR$$M$Y$$$20240803$$HP$CA$CA
173362172$17336217$2$F$20240601$20240703$20200128$20240708$EXP$$US-KYOWAKIRIN-2020BKK000887$KYOWA$$$$$$Y$$$20240708$$HP$US$US
173366135$17336613$5$F$20190426$20240826$20200129$20240829$EXP$$NVSC2020CO019505$NOVARTIS$$69$YR$$M$Y$93$KG$20240829$$CN$CO$CO
173379412$17337941$2$F$$20240724$20200129$20240806$EXP$$CA-AUROBINDO-AUR-APL-2020-003987$AUROBINDO$$34$YR$$F$Y$$$20240806$$HP$CA$CA
173385926$17338592$6$F$20240101$20240826$20200129$20240829$EXP$$CA-TAKEDA-2020TUS005441$TAKEDA$$$$$M$Y$$$20240829$$CN$CA$CA
173391442$17339144$2$F$$20240816$20200129$20240828$PER$$US-SA-2020SA022166$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240828$$MD$US$US
1733926511$17339265$11$F$20200101$20240627$20200129$20240701$PER$$US-PFIZER INC-2020039922$PFIZER$$81$YR$$F$Y$58.503$KG$20240701$$CN$US$US
173393818$17339381$8$F$$20240626$20200129$20240701$PER$$US-PFIZER INC-2020039104$PFIZER$$53$YR$$F$Y$88$KG$20240701$$CN$US$US
173426752$17342675$2$F$$20240919$20200129$20240924$EXP$$SE-MYLANLABS-2020M1010166$MYLAN$Rollof, J. Neurologic adverse effects during concomitant treatment with ciprofloxacin, NSAIDs, and chloroquine: possible drug interaction. Annals of pharmacotherapy. 1993;27 (9):1058-1059$68$YR$$F$Y$$$20240924$$HP$SE$SE
173448488$17344848$8$F$20180727$20240711$20200129$20240718$EXP$$JP-ABBVIE-19P-087-2663465-00$ABBVIE$$53$YR$$M$Y$$$20240718$$MD$JP$JP
1734747215$17347472$15$F$$20240910$20200130$20240911$EXP$$US-PFIZER INC-2020036680$PFIZER$$60$YR$$M$Y$$$20240911$$CN$US$US
1734821512$17348215$12$F$20191220$20240815$20200130$20240819$EXP$$US-PFIZER INC-2020039889$PFIZER$$65$YR$$F$Y$90.703$KG$20240819$$CN$US$US
173495003$17349500$3$F$$20240724$20200130$20240806$EXP$$CA-AUROBINDO-AUR-APL-2020-003964$AUROBINDO$$74$YR$$F$Y$$$20240806$$HP$CA$CA
173497202$17349720$2$F$20200118$20240716$20200130$20240725$PER$$US-SA-2020SA019545$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240725$$MD$US$US
1734972318$17349723$18$F$20180508$20240724$20200130$20240731$EXP$$DE-PFIZER INC-2019154747$MYLAN$$39$YR$$F$Y$70$KG$20240731$$MD$DE$DE
173498543$17349854$3$F$20190711$20240903$20200130$20240910$EXP$$BE-ABBVIE-20K-013-3255715-00$ABBVIE$$70$YR$$M$Y$72$KG$20240910$$MD$BE$BE
173503878$17350387$8$F$20200101$20240714$20200130$20240722$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2020-01886$IPSEN$$60$YR$A$F$Y$79.37$KG$20240722$$HP$CA$CA
1735079111$17350791$11$F$20190617$20240815$20200130$20240821$EXP$$IL-ABBVIE-19K-082-2853655-00$ABBVIE$$87$YR$$M$Y$85$KG$20240821$$MD$IL$IL
1735116711$17351167$11$F$20221004$20240808$20200130$20240812$EXP$$US-SHIRE-US202003357$TAKEDA$$55$YR$$F$Y$98.866$KG$20240812$$CN$US$US
173516442$17351644$2$F$20101118$20240911$20200130$20240913$EXP$$NO-MYLANLABS-2020M1011762$MYLAN$$$$A$M$Y$$$20240913$$MD$NO$NO
173516583$17351658$3$F$20190523$20201026$20200130$20240725$EXP$$DE-EXELIXIS-XL18419021498$EXELIXIS$$$$$$Y$$$20240725$$MD$DE$DE
173519737$17351973$7$F$$20240916$20200130$20240927$EXP$$CA-CIPHER-2020-CA-000076$CIPHER$$30$YR$A$F$Y$90$KG$20240927$$HP$CA$CA
1735234341$17352343$41$F$20200101$20240823$20200130$20240902$EXP$$CA-CELLTRION INC.-2020CA018631$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
1735248415$17352484$15$F$20220917$20240904$20200131$20240909$EXP$$US-SHIRE-US202003678$TAKEDA$$77$YR$$M$Y$103$KG$20240909$$HP$US$US
173529003$17352900$3$F$$20240828$20200131$20240912$EXP$US-ROCHE-2511459$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-00105$ALKEM$Schmitt NC, Richmon J, Quon H, Steen V, Pietsch K, Page BR.. Challenges in management of a patient with oropharyngeal carcinoma and scleroderma. Otolaryngology Case Reports. 2020;14:100144$70$YR$$M$Y$$$20240912$$MD$US$US
173535904$17353590$4$F$20061103$20240628$20200131$20240701$EXP$$US-GILEAD-2020-0448970$GILEAD$$41$YR$A$M$Y$$$20240701$$LW$US$US
173546645$17354664$5$F$20190101$20240729$20200131$20240730$EXP$$PHHY2019CH100574$NOVARTIS$$70$YR$$F$Y$$$20240730$$MD$CH$CH
1735543025$17355430$25$F$20210816$20240909$20200131$20240912$EXP$$US-SHIRE-US202003415$TAKEDA$$50$YR$$F$Y$115$KG$20240912$$CN$US$US
173562159$17356215$9$F$20190810$20240827$20200131$20240903$EXP$$CA-TAKEDA-2019TUS045562$TAKEDA$$34$YR$$F$Y$$$20240903$$HP$CA$CA
173562293$17356229$3$F$20191101$20210628$20200131$20240812$EXP$$TH-AstraZeneca-2020SE14040$ASTRAZENECA$$77$YR$$M$Y$$$20240812$$CN$TH$
1735637119$17356371$19$F$20210719$20240830$20200131$20240903$EXP$$US-SHIRE-US202003092$TAKEDA$$78$YR$$F$Y$63$KG$20240903$$CN$US$US
173564168$17356416$8$F$$20240909$20200131$20240916$EXP$$FR-MYLANLABS-2020M1010757$MYLAN$Hernandez M, Pochon C, Chastagner P, Droz D.. Long-term adverse effects of acute myeloid leukemia treatment on odontogenesis in a child. International Journal of Clinical Pediatric Dentistry. 2019;12(3):243-246$9$YR$$M$Y$$$20240916$$HP$FR$FR
1735889814$17358898$14$F$20210906$20240805$20200202$20240808$EXP$$US-SHIRE-US202003314$TAKEDA$$62$YR$$F$Y$54$KG$20240808$$CN$US$US
173589395$17358939$5$F$$20240701$20200202$20240718$EXP$$FR-CELLTRION INC.-2020FR017588$CELLTRION$Hernandez M, Pochon C, Chastagner P, Droz D. Long-term adverse effects of acute myeloid leukemia treatment on odontogenesis in a child.. International Journal of Clinical Pediatric Dentistry. 2019;12(3):243-6$$$$$Y$$$20240718$$MD$FR$FR
173599565$17359956$5$F$20090428$20240910$20200203$20240916$PER$$US-GILEAD-2020-0448795$GILEAD$$54$YR$A$M$Y$99.773$KG$20240916$$LW$US$US
173611562$17361156$2$F$$20240820$20200203$20240822$EXP$$CA-PFIZER INC-2020043381$PFIZER$$42$YR$$F$Y$176$KG$20240822$$HP$CA$CA
1736141313$17361413$13$F$$20240904$20200203$20240906$EXP$$US-PFIZER INC-2020043396$PFIZER$$71$YR$$F$Y$63.492$KG$20240906$$HP$US$US
173614318$17361431$8$F$20191201$20240715$20200203$20240717$PER$$US-PFIZER INC-2020043204$PFIZER$$68$YR$$F$Y$90.72$KG$20240717$$CN$US$US
173623588$17362358$8$F$$20240819$20200203$20240823$EXP$$US-SHIRE-US202003844$TAKEDA$$$$$M$Y$95$KG$20240823$$CN$US$US
173652324$17365232$4$F$$20240813$20200204$20240826$EXP$$CA-AUROBINDO-AUR-APL-2020-005255$AUROBINDO$$68$YR$$F$Y$$$20240826$$HP$CA$CA
173652442$17365244$2$F$$20240813$20200204$20240826$EXP$$CA-AUROBINDO-AUR-APL-2020-005098$AUROBINDO$$51$YR$$F$Y$$$20240826$$HP$CA$CA
173661878$17366187$8$F$20210106$20240626$20200204$20240703$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR016672$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$CA$CA
173665623$17366562$3$F$$20240827$20200204$20240829$EXP$$US-PFIZER INC-2020045329$PFIZER$$70$YR$$F$Y$$$20240829$$CN$US$US
173674542$17367454$2$F$$20240809$20200204$20240814$PER$$US-JNJFOC-20200203408$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$LW$US$US
173700622$17370062$2$F$$20240820$20200205$20240823$EXP$$CA-Orion Corporation ORION PHARMA-TREX2020-0635$ORION$$42$YR$A$F$Y$176$KG$20240823$$HP$CA$
173703566$17370356$6$F$20200127$20240703$20200205$20240709$EXP$$US-SHIRE-US202003864$TAKEDA$$57$YR$$M$Y$63$KG$20240709$$HP$US$US
173707252$17370725$2$F$20240806$20240904$20200205$20240913$EXP$$US-GLAXOSMITHKLINE-US2020014932$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240913$$CN$US$US
1737076361$17370763$61$F$20200129$20240708$20200205$20240711$EXP$$US-SHIRE-US202004220$TAKEDA$$3$YR$$M$Y$$$20240711$$MD$US$US
1737163217$17371632$17$F$20211107$20240815$20200205$20240820$EXP$$US-SHIRE-US202002867$TAKEDA$$58$YR$$F$Y$83$KG$20240820$$HP$US$US
1737275425$17372754$25$F$20180315$20240724$20200205$20240730$EXP$$DE-MYLANLABS-2020M1012929$MYLAN$$59$YR$$F$Y$$$20240730$$CN$DE$DE
173746332$17374633$2$F$$20240820$20200205$20240823$PER$$US-PFIZER INC-2020049745$PFIZER$$74$YR$$F$Y$$$20240823$$CN$US$US
173770259$17377025$9$F$20200222$20240923$20200206$20240925$EXP$$US-PFIZER INC-2020050446$PFIZER$$64$YR$$F$Y$$$20240925$$HP$US$US
173773643$17377364$3$F$$20240904$20200206$20240911$PER$$US-PFIZER INC-2020050048$PFIZER$$65$YR$$F$Y$$$20240911$$CN$US$US
1738481811$17384818$11$F$$20240812$20200206$20240814$EXP$$CA-BAUSCH-BL-2020-003444$BAUSCH AND LOMB$$59$YR$$F$Y$$$20240814$$MD$CA$CA
173882735$17388273$5$F$$20240821$20200207$20240823$EXP$$CA-PFIZER INC-2020050080$PFIZER$$46$YR$$M$Y$$$20240823$$HP$CA$CA
1738835526$17388355$26$F$$20240920$20200207$20240926$EXP$$US-SHIRE-US202004633$TAKEDA$$$$$F$Y$48$KG$20240926$$MD$US$US
1738840026$17388400$26$F$20200805$20240809$20200206$20240813$EXP$$US-SHIRE-US202003705$TAKEDA$$72$YR$$F$Y$81.63$KG$20240813$$HP$US$US
173890384$17389038$4$F$$20240923$20200206$20240926$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-009234$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240926$$MD$DE$DE
173900035$17390003$5$F$20200111$20240628$20200207$20240705$PER$$US-VERTEX PHARMACEUTICALS-2020-001999$VERTEX$$59$YR$$F$Y$$$20240705$$HP$US$US
173906514$17390651$4$F$20200112$20240802$20200207$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-000307$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240827$$CN$US$US
1739068212$17390682$12$F$$20240702$20200207$20240705$EXP$$US-SHIRE-US202004225$TAKEDA$$$$$M$Y$125$KG$20240705$$HP$US$US
173908875$17390887$5$F$$20240813$20200207$20240826$EXP$$CA-AUROBINDO-AUR-APL-2020-005362$AUROBINDO$$75$YR$$F$Y$$$20240826$$HP$CA$CA
173912453$17391245$3$F$$20240830$20200207$20240909$EXP$$CA-AUROBINDO-AUR-APL-2020-005398$AUROBINDO$$41$YR$$F$Y$81.646$KG$20240909$$PH$CA$CA
173916977$17391697$7$F$20210105$20240718$20200207$20240724$EXP$$US-SHIRE-US202003959$TAKEDA$$70$YR$$M$Y$106$KG$20240724$$CN$US$US
173917399$17391739$9$F$20220901$20240709$20200207$20240711$EXP$$US-SHIRE-US202004040$TAKEDA$$43$YR$$F$Y$47$KG$20240711$$HP$US$US
173917912$17391791$2$F$$20240711$20200207$20240716$EXP$$DE-MYLANLABS-2020M1013606$MYLAN$Mizera L, Klingel K, Gawaz M, Greulich S. Fatigue, breathlessness and chest pain in a 31-year-old man with schizoaffective disorder. Internist (Berl). 2019;60(11):1209-1214$31$YR$$M$Y$110$KG$20240716$$MD$DE$DE
173919116$17391911$6$F$$20240628$20200207$20240703$EXP$$US-SHIRE-US202004807$TAKEDA$$$$$F$Y$63$KG$20240703$$CN$US$US
1739278111$17392781$11$F$$20240628$20200207$20240701$EXP$$US-SHIRE-US202004254$TAKEDA$$$$$F$Y$87$KG$20240701$$HP$US$US
173934525$17393452$5$F$20230212$20240920$20200208$20240924$EXP$$US-SHIRE-US202005096$TAKEDA$$44$YR$$F$Y$49.887$KG$20240924$$CN$US$US
1739355222$17393552$22$F$20210630$20240904$20200208$20240911$EXP$$US-SHIRE-US202004908$TAKEDA$$55$YR$$M$Y$114$KG$20240911$$MD$US$US
1739369234$17393692$34$F$20200724$20240917$20200209$20240924$EXP$$US-SHIRE-US202004823$TAKEDA$$44$YR$$F$Y$82$KG$20240924$$HP$US$US
173941022$17394102$2$F$$20240705$20200210$20240716$EXP$$GB-ROCHE-2537630$ROCHE$$$$E$F$Y$$$20240716$$CN$GB$GB
173951415$17395141$5$F$20161001$20240910$20200210$20240919$EXP$$CA-ROCHE-2544742$ROCHE$$64$YR$A$F$Y$$$20240919$$CN$CA$CA
1739551041$17395510$41$F$20200101$20240712$20200210$20240722$EXP$$CA-CELLTRION INC.-2019CA028080$CELLTRION$$$$$$Y$$$20240722$$MD$CA$CA
173982463$17398246$3$F$$20240829$20200210$20240903$EXP$$FR-MYLANLABS-2020M1014112$MYLAN$Uzunov M, Demeret S, Quoc SN, Morel M, Bellanger A, Chavez H et al... Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab. BRITISH JOURNAL OF HAEMATOLOGY. 2019;1-3$47$YR$$F$Y$$$20240903$$HP$FR$FR
173992685$17399268$5$F$$20240801$20200211$20240814$EXP$$CA-AUROBINDO-AUR-APL-2020-006262$AUROBINDO$$59$YR$$F$Y$$$20240814$$MD$CA$CA
174000943$17400094$3$F$$20240906$20200211$20240918$EXP$$CN-Accord-172095$ACCORD$Chen X, Yang YM, Li B, Li XQ, Zhou C, Jin J et al. Acute generalized exanthematous pustulosis induced by mycophenolate mofetil: a case complicated with pemphigus foliaceus. Chinese medical journal. 2020;133(5):629-30.$46$YR$A$F$Y$$$20240918$$HP$CN$CN
174008254$17400825$4$F$20200131$20240815$20200211$20240822$EXP$$CA-ROCHE-2546211$ROCHE$$79$YR$E$M$Y$$$20240822$$CN$CA$CA
1740143912$17401439$12$F$20191030$20240716$20200211$20240724$EXP$$NVSC2020DE035485$NOVARTIS$$$$E$F$Y$64$KG$20240724$$MD$DE$DE
174029913$17402991$3$F$$20240708$20200211$20240709$EXP$$AT-PFIZER INC-2020049537$PFIZER$Wagner, S.. Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas. EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;1-8$$$$$Y$$$20240709$$HP$AT$AT
174038712$17403871$2$F$$20240717$20200211$20240726$PER$$US-AMGEN-USASP2020021768$AMGEN$Savage, K.. Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients. JAAD Case Reports. 2020;6 (2):99-102$$$$F$Y$$$20240726$$HP$US$US
174055454$17405545$4$F$$20240819$20200212$20240829$EXP$$CA-AUROBINDO-AUR-APL-2020-006432$AUROBINDO$$66$YR$$F$Y$95$KG$20240829$$HP$CA$CA
174056432$17405643$2$F$$20240801$20200212$20240813$EXP$$CA-AUROBINDO-AUR-APL-2020-006230$AUROBINDO$$$$$F$Y$$$20240813$$CN$CA$CA
174059905$17405990$5$F$$20240821$20200212$20240826$EXP$$CA-Orion Corporation ORION PHARMA-TREX2020-0751$ORION$$46$YR$A$M$Y$$$20240826$$HP$CA$
174061053$17406105$3$F$20191208$20240701$20200212$20240708$EXP$$IT-AUROBINDO-AUR-APL-2020-006586$AUROBINDO$$63$YR$$F$Y$$$20240708$$HP$IT$IT
174068982$17406898$2$F$$20240819$20200212$20240823$EXP$$NL-ROCHE-2542424$ROCHE$Dekker T, Balen MC, Vlasveld LT Hypercobalaminemia in myeloid and lymphoid malignancies. EUROPEAN JOURNAL OF HAEMATOLOGY 2020;:13365-.$68$YR$E$$Y$$$20240823$$HP$NL$NL
174069048$17406904$8$F$$20240827$20200212$20240906$EXP$$CA-AUROBINDO-AUR-APL-2020-006568$AUROBINDO$$54$YR$$F$Y$53$KG$20240906$$MD$CA$CA
1740700121$17407001$21$F$20210720$20240827$20200212$20240902$EXP$$US-SHIRE-US202005386$TAKEDA$$76$YR$$F$Y$78$KG$20240902$$HP$US$US
174078222$17407822$2$F$$20240627$20200212$20240702$EXP$$US-PFIZER INC-2020058827$PFIZER$$51$YR$$F$Y$$$20240702$$HP$US$US
174083964$17408396$4$F$$20240809$20200212$20240814$EXP$$NVSC2020PL035984$NOVARTIS$Kusnierz?Cabala B, Hawrylecka D, Mensah?Glanowska P, Piatkowska?Jakubas,Solnica B, Skotnicki A et al.. Neopterin and other inflammatory markers in the early period following allogeneic bone marrow transplantation: series of 3 cases. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ. 2009;119(11):756-9$43$YR$$M$Y$$$20240814$$HP$PL$PL
174084767$17408476$7$F$$20240719$20200212$20240723$EXP$$CA-PFIZER INC-2020056767$PFIZER$$31$YR$$F$Y$46$KG$20240723$$HP$CA$CA
174085957$17408595$7$F$20191204$20240815$20200212$20240821$EXP$$JP-009507513-1912JPN001896J$MERCK$Matsuo K, Nakajima M, Makimoto T, Kawaguchi T, Koide S, Wada M, et al.. JRA-9 (17) A case of immune checkpoint inhibitor-induced immune-related adverse event (irAE) myocarditis. The 123rd Chugoku Regional Meeting of the Japanese Society of Internal Medicine. 38$94$YR$$M$Y$46$KG$20240821$$MD$JP$JP
1740946211$17409462$11$F$20191223$20240909$20200212$20240916$EXP$GR-ROCHE-2528781$GR-ROCHE-2528781$ROCHE$$$$A$F$Y$60$KG$20240916$$CN$GR$GR
1741003923$17410039$23$F$20220627$20240809$20200212$20240815$EXP$$IN-PFIZER INC-2019392017$PFIZER$$38$YR$$M$Y$$$20240815$$CN$IN$IN
174101957$17410195$7$F$20200101$20240730$20200212$20240807$PER$$US-SA-2020SA035908$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240807$$MD$US$US
174102882$17410288$2$F$$20240719$20200212$20240730$PER$$US-SA-2020SA035306$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240730$$MD$US$US
1741049211$17410492$11$F$20240814$20240923$20200212$20240926$EXP$$US-TAKEDA-2020TUS009147$TAKEDA$$87$YR$$M$Y$$$20240926$$HP$US$US
174107635$17410763$5$F$$20240723$20200212$20240726$PER$$NVSC2020US035146$NOVARTIS$$$$$M$Y$$$20240726$$CN$US$US
174122487$17412248$7$F$20200306$20240910$20200213$20240919$30DAY$$US-GLAXOSMITHKLINE-US2020021624$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240919$$CN$US$US
174127525$17412752$5$F$$20240626$20200213$20240701$EXP$$US-SHIRE-US202005227$TAKEDA$$$$$M$Y$87$KG$20240701$$CN$US$US
174148536$17414853$6$F$20200723$20240912$20200213$20240918$EXP$$US-PFIZER INC-2020064377$PFIZER$$84$YR$$F$Y$$$20240918$$CN$US$US
1741485622$17414856$22$F$20190607$20240730$20200213$20240802$EXP$$CA-TAKEDA-2020TUS008062$TAKEDA$$15$YR$$F$Y$$$20240802$$HP$CA$CA
174148636$17414863$6$F$20210801$20240805$20200213$20240808$EXP$$US-SHIRE-US202005669$TAKEDA$$53$YR$$F$Y$81$KG$20240808$$CN$US$US
1741509517$17415095$17$F$20210629$20240702$20200213$20240709$EXP$$CA-TAKEDA-2020TUS008096$TAKEDA$$56$YR$$F$Y$$$20240709$$CN$CA$CA
1741550020$17415500$20$F$20160815$20240913$20200213$20240918$EXP$$US-SHIRE-US201945576$TAKEDA$$51$YR$$F$Y$78$KG$20240918$$HP$US$US
1741551225$17415512$25$F$20240530$20240913$20200213$20240919$EXP$$US-SHIRE-US202005065$TAKEDA$$81$YR$$F$Y$86$KG$20240919$$HP$US$US
1741811331$17418113$31$F$20200122$20240809$20200214$20240821$EXP$$DE-AUROBINDO-AUR-APL-2020-007406$AUROBINDO$$72$YR$$F$Y$64.8$KG$20240821$$MD$DE$DE
174181602$17418160$2$F$$20240829$20200214$20240909$EXP$$CA-AUROBINDO-AUR-APL-2020-007200$AUROBINDO$$41$YR$$F$Y$$$20240909$$HP$CA$CA
174187648$17418764$8$F$$20240719$20200214$20240725$EXP$$CA-Orion Corporation ORION PHARMA-TREX2020-0847$ORION$$31$YR$A$F$Y$46$KG$20240725$$HP$CA$
174188532$17418853$2$F$$20240624$20200214$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-236473$RANBAXY$$$$$F$Y$$$20240709$$CN$US$US
174194882$17419488$2$F$$20240806$20200214$20240808$EXP$$US-SHIRE-US202004865$TAKEDA$$$$$F$Y$$$20240808$$CN$US$US
174197154$17419715$4$F$20200211$20240726$20200214$20240801$PER$$US-BIOGEN-2019BI00768673$BIOGEN$$67$YR$$F$Y$$$20240801$$CN$US$US
174198143$17419814$3$F$$20240819$20200214$20240819$EXP$$AT-PFIZER INC-2020064125$PFIZER$$$$A$M$Y$$$20240819$$MD$AT$AT
174207525$17420752$5$F$20200101$20240903$20200214$20240909$EXP$$US-PFIZER INC-2020066668$PFIZER$$71$YR$$M$Y$$$20240909$$HP$US$US
174209163$17420916$3$F$$20240828$20200214$20240903$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR024037$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$MD$CA$CA
174224469$17422446$9$F$$20240909$20200215$20240912$EXP$$US-SHIRE-US202005824$TAKEDA$$$$$F$Y$50$KG$20240912$$HP$US$US
174225872$17422587$2$F$20191008$20240905$20200215$20240917$EXP$$NL-AUROBINDO-AUR-APL-2020-007379$AUROBINDO$$71$YR$$M$Y$$$20240917$$CN$NL$NL
1742310315$17423103$15$F$$20240912$20200217$20240918$EXP$$FR-AUROBINDO-AUR-APL-2020-006807$AUROBINDO$$71$YR$$M$Y$$$20240918$$MD$FR$FR
1742356343$17423563$43$F$20200212$20240905$20200217$20240912$EXP$$US-SHIRE-US202006022$TAKEDA$$54$YR$$F$Y$52$KG$20240912$$HP$US$US
174236363$17423636$3$F$$20240819$20200217$20240822$EXP$$US-SHIRE-US202006031$TAKEDA$$$$$M$Y$82.993$KG$20240822$$CN$US$US
174258352$17425835$2$F$$20240708$20200217$20240711$EXP$$AT-PFIZER INC-2020061938$PFIZER$$$$E$F$Y$$$20240711$$MD$AT$AT
174266745$17426674$5$F$20200204$20240910$20200217$20240913$EXP$$CA-ROCHE-2550767$ROCHE$$43$YR$A$F$Y$$$20240913$$CN$CA$CA
174272562$17427256$2$F$20190922$20240619$20200218$20240704$EXP$FR-AFSSAPS-AM20200124$FR-TEVA-2020-FR-1187184$TEVA$$87$YR$$M$Y$90$KG$20240704$$MD$FR$FR
174274054$17427405$4$F$$20240731$20200217$20240806$EXP$$CA-TAKEDA-2020TUS009545$TAKEDA$$$$$M$Y$$$20240806$$CN$CA$CA
1742753211$17427532$11$F$$20240909$20200217$20240917$EXP$$NVSC2020DE041400$NOVARTIS$Kasper P, Gobel H, Michels G. MTOR-induced pneumonitis in a 72-year-old patient after heart transplantation. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. 2020;145(3):189-94$72$YR$$M$Y$57.8$KG$20240917$$HP$DE$DE
174275334$17427533$4$F$20191103$20240829$20200218$20240912$EXP$$US-LUPIN PHARMACEUTICALS INC.-2020-00615$LUPIN$$$$$$Y$$$20240912$$CN$US$US
174278443$17427844$3$F$$20240822$20200217$20240826$EXP$$IT-MYLANLABS-2020M1018179$MYLAN$Berlot G, Tomasini A, Zandona L, Leonardo E and Bussani R. Multi-organ dysfunction syndrome following infectious mononucleosis: Case study. International Journal of Clinical and Experimental Medicine. 2019;12 (11):13061-13064$24$YR$$F$Y$$$20240826$$HP$IT$IT
174280867$17428086$7$F$20200208$20240812$20200217$20240813$EXP$$US-SHIRE-US202005788$TAKEDA$$27$YR$$M$Y$$$20240813$$HP$US$US
1742809114$17428091$14$F$20200212$20240806$20200217$20240808$EXP$$AU-SHIRE-AU202004394$TAKEDA$$39$YR$$M$Y$$$20240808$$HP$AU$AU
174282746$17428274$6$F$20191212$20240709$20200217$20240717$EXP$$CO-TOLMAR, INC.-19CO019662$TOLMAR$$78$YR$$M$Y$$$20240717$$HP$CO$CO
174287373$17428737$3$F$$20240807$20200217$20240821$EXP$E2B_02854790$CA-ASSERTIO THERAPEUTICS, INC.-CA-2020DEP000099$ASSERTIO THERAPEUTICS$$42$YR$$F$Y$126$KG$20240821$$HP$CA$CA
1742889351$17428893$51$F$20220529$20240828$20200218$20240905$EXP$$US-SHIRE-US202006248$TAKEDA$$62$YR$$F$Y$99$KG$20240905$$HP$US$US
174297938$17429793$8$F$20220701$20240917$20200218$20240919$EXP$$US-PFIZER INC-2020066436$PFIZER$$67$YR$$F$Y$61.23$KG$20240919$$HP$US$US
1743011510$17430115$10$F$20160301$20240701$20200218$20240703$PER$$US-PFIZER INC-2020045505$PFIZER$$78$YR$$M$Y$$$20240703$$CN$US$US
174302046$17430204$6$F$$20240819$20200218$20240821$EXP$$US-PFIZER INC-2020068066$PFIZER$$74$YR$$F$Y$72.562$KG$20240821$$CN$US$US
1743138850$17431388$50$F$20220428$20240910$20200218$20240912$PER$$US-PFIZER INC-2020072404$PFIZER$$87$YR$$F$Y$56.25$KG$20240912$$CN$US$US
174324278$17432427$8$F$20180611$20240821$20200218$20240826$EXP$$US-JAZZ-2020-US-002216$JAZZ$$28$YR$$M$Y$$$20240826$$MD$US$US
174325342$17432534$2$F$20191201$20240710$20200218$20240718$EXP$$JP-009507513-1912JPN003927J$MERCK$$72$YR$$M$Y$$$20240718$$MD$JP$JP
174327604$17432760$4$F$20200201$20240905$20200218$20240918$EXP$$IT-AUROBINDO-AUR-APL-2020-007948$AUROBINDO$$94$YR$$F$Y$$$20240918$$MD$IT$IT
174329694$17432969$4$F$20200129$20240920$20200219$20240926$EXP$IT-MINISAL02-604570$IT-TEVA-2020-IT-1187729$TEVA$$20$YR$$F$Y$$$20240926$$HP$IT$IT
1743429311$17434293$11$F$$20240702$20200219$20240704$PER$$US-PFIZER INC-2020073619$PFIZER$$76$YR$$F$Y$$$20240704$$CN$US$US
174345135$17434513$5$F$20181001$20240705$20200219$20240709$PER$$US-PFIZER INC-2020074161$PFIZER$$69$YR$$F$Y$81.2$KG$20240709$$CN$US$US
1743496214$17434962$14$F$20190813$20240904$20200219$20240910$EXP$$CA-TAKEDA-2019TUS058296$TAKEDA$$29$YR$$F$Y$$$20240910$$CN$CA$CA
174356972$17435697$2$F$20200101$20240909$20200219$20240917$EXP$$US-ROCHE-2549282$ROCHE$$46$YR$A$F$Y$62.6$KG$20240917$$CN$US$US
1743715011$17437150$11$F$$20240902$20200219$20240908$EXP$$NVSC2020FR043746$NOVARTIS$Hernandez M, Pochon C, Chastagner P, Droz D. Long-term adverse effects of acute myeloid leukemia treatment on odontogenesis in a child. INTERNATIONAL JOURNAL OF CLINICAL PEDIATRIC DENTISTRY. 2019;12(3):243-6$9$YR$$M$Y$$$20240908$$HP$FR$FR
174385454$17438545$4$F$$20240827$20200220$20240905$EXP$$CA-AUROBINDO-AUR-APL-2020-008012$AUROBINDO$$60$YR$$M$Y$$$20240905$$HP$CA$CA
174389455$17438945$5$F$20200217$20240709$20200220$20240718$PER$$JP-JAZZ-2020-JP-002395$JAZZ$$28$YR$$M$Y$60.8$KG$20240718$$MD$JP$JP
1743953013$17439530$13$F$20191223$20240813$20200220$20240814$EXP$$GB-ROCHE-2549653$ROCHE$$38$YR$A$M$Y$$$20240814$$MD$GB$GB
174403483$17440348$3$F$$20240627$20200220$20240702$PER$$US-JNJFOC-20200227704$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$LW$US$US
174405689$17440568$9$F$20200125$20240703$20200220$20240705$EXP$$US-PFIZER INC-2020074707$PFIZER$$84$YR$$F$Y$66.68$KG$20240705$$CN$US$US
174406323$17440632$3$F$$20240722$20200220$20240724$EXP$$AT-PFIZER INC-2020068434$PFIZER$$70$YR$$F$Y$$$20240724$$MD$AT$AT
1744076421$17440764$21$F$20200123$20240802$20200220$20240807$EXP$$IN-PFIZER INC-2020071864$PFIZER$$70$YR$$F$Y$50.1$KG$20240807$$CN$IN$IN
1744080613$17440806$13$F$$20240919$20200220$20240924$EXP$$IN-PFIZER INC-2019108818$PFIZER$$53$YR$$F$Y$$$20240924$$CN$IN$IN
1744194710$17441947$10$F$20200201$20240822$20200220$20240826$EXP$$US-SHIRE-US202005973$TAKEDA$$33$YR$$F$Y$122$KG$20240826$$CN$US$US
1744195616$17441956$16$F$20200211$20240812$20200220$20240814$EXP$$US-SHIRE-US202006374$TAKEDA$$70$YR$$M$Y$$$20240814$$CN$US$US
174420744$17442074$4$F$$20240820$20200220$20240826$EXP$$US-SHIRE-US202006599$TAKEDA$$$$$F$Y$56.68$KG$20240826$$HP$US$US
174422554$17442255$4$F$$20240906$20200220$20240911$EXP$$US-GILEAD-2020-0450835$GILEAD$$72$YR$E$F$Y$$$20240911$$HP$US$US
174422997$17442299$7$F$$20240716$20200220$20240718$EXP$$CA-NAPPMUNDI-CAN-2020-0010602$PURDUE$$82$YR$$F$Y$$$20240718$$HP$CA$CA
174423132$17442313$2$F$19981001$20240815$20200220$20240821$EXP$$IT-MYLANLABS-2020M1018156$MYLAN$Zerbi S, Saruggia M, Brambilla L, Lodeville D, Buccianti G.. Kaposi^s sarcoma in a patient with focal glomerulosclerosis. Journal of Nephrology.. 2001;14:299-303$59$YR$$M$Y$88.7$KG$20240821$$HP$IT$IT
174424763$17442476$3$F$$20220914$20200220$20240710$PER$$CA-PFM-2020-02005$PIERRE FABRE MEDICAMENT$$48$YR$$F$Y$$$20240710$$HP$CA$CA
174430775$17443077$5$F$20200212$20240827$20200221$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013771$BRISTOL MYERS SQUIBB$Kawata S, et al. A case of polyarthritis during nivolumab administration. The 236th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2022; 115$78$YR$E$M$Y$82.95$KG$20240905$$MD$JP$JP
1744315210$17443152$10$F$20191030$20240726$20200221$20240806$EXP$$DE-AUROBINDO-AUR-APL-2020-008950$AUROBINDO$$$$E$F$Y$64$KG$20240806$$MD$DE$DE
174442817$17444281$7$F$$20240909$20200221$20240916$PER$$US-AMGEN-USASP2020029545$AMGEN$$51$YR$A$F$Y$$$20240916$$MD$US$US
1744472823$17444728$23$F$20190513$20240923$20200221$20240926$EXP$$GR-009507513-2002GRC006773$MERCK$$$$A$F$Y$60$KG$20240926$$MD$GR$GR
174449992$17444999$2$F$20200208$20240819$20200221$20240829$30DAY$$US-GLAXOSMITHKLINE-US2020023490$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240829$$PH$US$US
174452237$17445223$7$F$$20240724$20200221$20240725$EXP$$US-PFIZER INC-2020077979$PFIZER$$69$YR$$F$Y$$$20240725$$CN$US$US
174452725$17445272$5$F$$20240812$20200221$20240815$PER$$US-PFIZER INC-2020078939$PFIZER$$71$YR$$M$Y$113.4$KG$20240815$$CN$US$US
174465198$17446519$8$F$$20240925$20200221$20240927$EXP$$US-SHIRE-US202006238$TAKEDA$$$$$F$Y$$$20240927$$HP$US$US
1744728418$17447284$18$F$20200201$20240904$20200221$20240911$EXP$$CA-PFIZER INC-2019453993$PFIZER$$32$YR$$F$Y$$$20240911$$CN$CA$CA
174475956$17447595$6$F$20080101$20240508$20200221$20240703$EXP$$CA-TEVA-2020-CA-1187711$TEVA$$53$YR$$M$Y$$$20240703$$MD$CA$CA
1744763110$17447631$10$F$20221128$20240716$20200221$20240724$EXP$$US-SHIRE-US202006854$TAKEDA$$72$YR$$F$Y$70$KG$20240724$$CN$US$US
174478444$17447844$4$F$20180206$20240625$20200221$20240708$EXP$$CA-ROCHE-2553502$ROCHE$$61$YR$A$M$Y$$$20240708$$CN$CA$CA
174490214$17449021$4$F$$20240827$20200224$20240905$EXP$$CA-AUROBINDO-AUR-APL-2020-008619$AUROBINDO$$12$YR$$M$Y$$$20240905$$HP$CA$CA
174493449$17449344$9$F$20211019$20240807$20200224$20240809$EXP$$US-SHIRE-US202006882$TAKEDA$$50$YR$$M$Y$64$KG$20240809$$HP$US$US
1745010739$17450107$39$F$$20240731$20200224$20240805$EXP$$CA-BIOVITRUM-2020CA0815$BIOVITRUM$$4$YR$$F$Y$64$KG$20240805$$HP$CA$CA
174517054$17451705$4$F$$20240905$20200224$20240914$PER$$US-SA-2020SA046246$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240914$$MD$US$US
174520516$17452051$6$F$$20240920$20200224$20240925$EXP$$US-SHIRE-US202006569$TAKEDA$$$$$F$Y$61$KG$20240925$$HP$US$US
174524313$17452431$3$F$$20200224$20200224$20240711$EXP$$NVSC2020GB046834$NOVARTIS$$$$$M$Y$$$20240711$$CN$GB$GB
174528219$17452821$9$F$20200210$20240718$20200224$20240722$EXP$$US-SHIRE-US202006373$TAKEDA$$12$YR$$M$Y$$$20240722$$CN$US$US
1745290911$17452909$11$F$20200128$20240830$20200224$20240903$EXP$$US-SHIRE-US202006817$TAKEDA$$55$YR$$F$Y$106$KG$20240903$$HP$US$US
174529445$17452944$5$F$20200215$20240805$20200224$20240807$EXP$$US-SHIRE-US202006627$TAKEDA$$48$YR$$F$Y$$$20240807$$MD$US$US
174546543$17454654$3$F$$20240830$20200225$20240906$EXP$$CA-ROCHE-2556362$ROCHE$$76$YR$E$F$Y$$$20240906$$CN$CA$CA
174550235$17455023$5$F$$20240729$20200225$20240808$EXP$$CA-AUROBINDO-AUR-APL-2020-008560$AUROBINDO$$48$YR$$F$Y$76$KG$20240808$$MD$CA$CA
174550534$17455053$4$F$$20240830$20200225$20240909$EXP$$CA-AUROBINDO-AUR-APL-2020-008777$AUROBINDO$$67$YR$$M$Y$$$20240909$$HP$CA$CA
174554263$17455426$3$F$20191009$20240715$20200225$20240724$EXP$$FR-AUROBINDO-AUR-APL-2020-009139$AUROBINDO$$55$YR$$M$Y$83$KG$20240724$$HP$FR$FR
174592352$17459235$2$F$$20240924$20200225$20240926$EXP$$DE-BAUSCH-BL-2020-005038$BAUSCH AND LOMB$$78$YR$$F$Y$$$20240926$$MD$DE$DE
1745926213$17459262$13$F$20240127$20240925$20200226$20240930$EXP$$IN-PFIZER INC-2019531336$PFIZER$$50$YR$$M$Y$$$20240930$$CN$IN$IN
1745949810$17459498$10$F$$20240822$20200226$20240829$EXP$$LT-MYLANLABS-2020M1020370$MYLAN$A. Kunigeliene, Alekna D, Guzevicius M. A case report: treatment of a patient with schizophrenia and a kindney transplant. Sveikatos mokslai/ Health sciences in Eastern Europe. 2019;29 (6):132-135$32$YR$$M$Y$$$20240829$$HP$LT$LT
174598342$17459834$2$F$20170101$20240712$20200225$20240716$EXP$$US-JAZZ-2020-US-002633$JAZZ$$$$$M$Y$$$20240716$$CN$US$US
174600875$17460087$5$F$20190101$20240710$20200226$20240722$EXP$$US-ROCHE-1883203$ROCHE$$65$YR$E$F$Y$$$20240722$$MD$US$US
174606439$17460643$9$F$20190513$20240920$20200226$20240928$EXP$$GR-AMGEN-GRCSP2020028536$AMGEN$$$$A$F$Y$60$KG$20240928$$CN$GR$GR
174614804$17461480$4$F$20190421$20240813$20200226$20240821$EXP$$BE-ABBVIE-20K-013-3293932-00$ABBVIE$$82$YR$$M$Y$62$KG$20240821$$MD$BE$BE
174625495$17462549$5$F$20190401$20240813$20200226$20240820$EXP$$CA-ROCHE-2555554$ROCHE$$43$YR$A$F$Y$67$KG$20240820$$CN$CA$CA
174631789$17463178$9$F$20200129$20240621$20200226$20240709$EXP$$CA-ROCHE-2554238$ROCHE$$33$YR$A$F$Y$$$20240705$$HP$CA$CA
174633317$17463331$7$F$20190328$20240702$20200226$20240708$PER$$US-BIOGEN-2019BI00718825$BIOGEN$$35$YR$$F$Y$$$20240708$$CN$US$US
1746349223$17463492$23$F$20180613$20240724$20200226$20240730$EXP$$DE-MYLANLABS-2020M1020608$MYLAN$$70$YR$$M$Y$$$20240730$$MD$DE$DE
174639275$17463927$5$F$20190901$20240807$20200226$20240818$EXP$$FR-AUROBINDO-AUR-APL-2020-009018$AUROBINDO$$81$YR$$F$Y$49$KG$20240818$$MD$FR$FR
1746435611$17464356$11$F$20190101$20240816$20200226$20240826$EXP$$US-ACORDA-ACO_163949_2020$ACORDA$$$$$F$Y$$$20240826$$CN$US$US
174645744$17464574$4$F$20240706$20240710$20200226$20240718$EXP$$CO-INCYTE CORPORATION-2019IN001637$INCYTE$$$$$$Y$$$20240718$$CN$CO$CO
1746515713$17465157$13$F$20190613$20231109$20200227$20240830$EXP$$FR-ABBVIE-20P-056-3292767-00$ABBVIE$$65$YR$$M$Y$65$KG$20240830$$MD$FR$FR
174673068$17467306$8$F$20240213$20240625$20200227$20240701$PER$$US-PFIZER INC-2020083254$PFIZER$$54$YR$$F$Y$94.331$KG$20240701$$HP$US$US
1746750210$17467502$10$F$$20240822$20200227$20240828$PER$$US-PFIZER INC-2020086266$PFIZER$$68$YR$$F$Y$71$KG$20240828$$CN$US$US
174679686$17467968$6$F$20181114$20240814$20200227$20240821$EXP$$DE-ROCHE-2254494$ROCHE$$33$YR$A$F$Y$$$20240821$$CN$DE$DE
174691882$17469188$2$F$$20240904$20200227$20240911$PER$$US-SA-2020SA051248$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240911$$MD$US$US
174713393$17471339$3$F$$20240809$20200227$20240813$EXP$$US-ROCHE-2556528$ROCHE$$$$E$F$Y$$$20240813$$MD$US$US
1747169714$17471697$14$F$20190808$20240818$20200228$20240821$EXP$$IL-ABBVIE-19K-082-3001148-00$ABBVIE$$83$YR$$F$Y$50$KG$20240821$$MD$IL$IL
174730546$17473054$6$F$20200210$20240809$20200228$20240816$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR032914$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$CA$CA
1747328930$17473289$30$F$20200215$20240826$20200228$20240903$EXP$$CA-CELLTRION INC.-2020CA018641$CELLTRION$$$$$$Y$$$20240903$$MD$CA$CA
174786154$17478615$4$F$$20240916$20200228$20240923$EXP$$FI-MYLANLABS-2020M1021260$MYLAN$Laatikainen O, Turpeinen M. Drug-related adverse events are prevented with knowledge. Physician^s journal. 2020;75(8):492-494$75$YR$$M$Y$$$20240923$$PH$FI$FI
174786976$17478697$6$F$20200203$20240718$20200228$20240720$EXP$$MX-ABBVIE-20K-107-3296389-00$ABBVIE$$59$YR$$M$Y$$$20240720$$MD$MX$MX
174803336$17480333$6$F$20180312$20240909$20200228$20240919$EXP$$CA-TAKEDA-2018TUS029240$TAKEDA$$32$YR$$M$Y$$$20240919$$CN$CA$CA
1748084430$17480844$30$F$20181212$20240826$20200301$20240903$EXP$$CA-CELLTRION INC.-2018CA025151$CELLTRION$$$$$$Y$$$20240903$$CN$CA$CA
1748169911$17481699$11$F$20200101$20240815$20200302$20240821$EXP$$US-SHIRE-US202007982$TAKEDA$$50$YR$$F$Y$113$KG$20240821$$HP$US$US
174817194$17481719$4$F$$20240828$20200302$20240904$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR033867$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$CA$CA
174818244$17481824$4$F$$20240904$20200302$20240915$EXP$$FR-AUROBINDO-AUR-APL-2019-106644$AUROBINDO$Hernandez M, Pochon C, Chastagner P, Droz D. Long-term Adverse Effects of Acute Myeloid Leukemia Treatment on Odontogenesis in a Child. Int J Clin  Pediatr Dent (International Journal of Clinical Pediatric Dentistry). 2019;12(3):243-46$9$YR$$M$Y$$$20240915$$MD$FR$FR
174824113$17482411$3$F$$20240809$20200302$20240816$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK203689$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$CA$CA
174825343$17482534$3$F$$20240809$20200302$20240821$EXP$$US-GLENMARK PHARMACEUTICALS-2020GMK046378$GLENMARK$Radow M.. A case of CMV colitis: Both a cause and consequence of acute renal allograft rejection.. 2019 Annual Scientific Meeting and Postgraduate Course of the American College. 2019;114:S1658-S1659$$$$$Y$$$20240821$$HP$US$US
174838062$17483806$2$F$20200108$20240903$20200302$20240906$EXP$$FI-AstraZeneca-2020SE29099$ASTRAZENECA$$51$YR$$M$Y$126$KG$20240906$$MD$FI$
1748467410$17484674$10$F$$20240708$20200302$20240715$EXP$$NVSC2020CA058057$NOVARTIS$$71$YR$$F$Y$$$20240715$$CN$CA$CA
1748548325$17485483$25$F$20200418$20240725$20200302$20240802$EXP$$CA-CELLTRION INC.-2020CA019839$CELLTRION$$$$$$Y$$$20240802$$HP$CA$CA
174861033$17486103$3$F$20190429$20240627$20200303$20240708$EXP$$CA-ROCHE-2560529$ROCHE$$40$YR$A$M$Y$$$20240708$$CN$CA$CA
174868012$17486801$2$F$$20240708$20200303$20240710$EXP$$US-GLAXOSMITHKLINE-US2020AMR035043$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$US$US
1748743819$17487438$19$F$$20240725$20200303$20240731$PER$$US-PFIZER INC-2020093357$PFIZER$$1$YR$$M$Y$10$KG$20240731$$MD$US$US
174882054$17488205$4$F$20200201$20240830$20200303$20240905$EXP$$NVSC2019GB017638$NOVARTIS$$$$A$F$Y$$$20240906$$CN$GB$GB
174908689$17490868$9$F$$20240823$20200303$20240902$EXP$$NVSC2020CA057529$NOVARTIS$$72$YR$$M$Y$$$20240902$$HP$CA$CA
174928234$17492823$4$F$20200101$20240624$20200304$20240708$EXP$$FR-AMGEN-FRASP2020035807$AMGEN$$77$YR$E$M$Y$77$KG$20240707$$MD$FR$FR
174929876$17492987$6$F$20191101$20240809$20200304$20240816$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR035947$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$CA$CA
174938983$17493898$3$F$$20240823$20200303$20240905$EXP$$US-AMNEAL PHARMACEUTICALS-2019-IPXL-00619$AMNEAL$$$$$M$Y$105$KG$20240905$$CN$US$US
174940756$17494075$6$F$20190811$20240909$20200303$20240917$EXP$$US-AMNEAL PHARMACEUTICALS-2019-IPXL-01653$AMNEAL$$64$YR$$F$Y$$$20240917$$CN$US$US
174943472$17494347$2$F$$20191223$20200304$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-232191$RANBAXY$$$$$M$Y$$$20240804$$CN$US$US
174951413$17495141$3$F$$20240813$20200304$20240821$EXP$$CA-APOTEX-2020AP008146$APOTEX$$88$YR$$F$Y$77$KG$20240821$$HP$CA$CA
174953062$17495306$2$F$$20240910$20200303$20240924$EXP$$CZ-ELI_LILLY_AND_COMPANY-CZ202002014261$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240924$$MD$CZ$CZ
1749555711$17495557$11$F$20191001$20240626$20200304$20240701$EXP$$US-PFIZER INC-2019531597$PFIZER$$67$YR$$M$Y$58.957$KG$20240701$$CN$US$US
174958654$17495865$4$F$$20240708$20200304$20240711$EXP$$AT-PFIZER INC-2020094788$PFIZER$Hartmann, B.. Case Report / Brentuximab Vedotin (Adcetris) - Psychiatric patient with advanced Hodgkin^s lymphoma. SPECTRUM ONKOLOGIE. 2020;(02):65$21$YR$$F$Y$$$20240711$$MD$AT$AT
1749589410$17495894$10$F$20190901$20240205$20200304$20240809$EXP$$NVSC2020IN060311$NOVARTIS$$71$YR$$F$Y$50$KG$20240809$$CN$IN$IN
1749605518$17496055$18$F$$20240822$20200304$20240828$EXP$$CA-PFIZER INC-2020092985$PFIZER$$51$YR$$F$Y$101$KG$20240828$$HP$CA$CA
1749857411$17498574$11$F$$20240919$20200304$20240924$EXP$$US-SHIRE-US202007885$TAKEDA$$$$$M$Y$59$KG$20240924$$MD$US$US
1749859611$17498596$11$F$20200225$20240726$20200304$20240730$EXP$$US-SHIRE-US202008189$TAKEDA$$21$YR$$M$Y$$$20240730$$CN$US$US
1749859713$17498597$13$F$20211219$20240725$20200304$20240730$EXP$$US-SHIRE-US202008056$TAKEDA$$71$YR$$F$Y$81$KG$20240730$$CN$US$US
1749921412$17499214$12$F$20240101$20240716$20200304$20240726$EXP$$US-TAKEDA-2020TUS012590$TAKEDA$$76$YR$$F$Y$$$20240726$$HP$US$US
1749987516$17499875$16$F$20220925$20240904$20200305$20240909$EXP$$US-KAMADA LIMITED-2020US001233$TAKEDA$$59$YR$$F$Y$78$KG$20240909$$HP$US$US
175002283$17500228$3$F$20240701$20240725$20200305$20240729$EXP$$GB-GLAXOSMITHKLINE-GB2020EME035909$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$HP$GB$GB
175008163$17500816$3$F$$20240909$20200305$20240916$EXP$$US-BIOGEN-2020BI00845917$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
1750085323$17500853$23$F$20200116$20240729$20200305$20240806$EXP$$CA-CELLTRION INC.-2020CA019771$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
175011023$17501102$3$F$$20240805$20200305$20240814$30DAY$$US-GLAXOSMITHKLINE-US2020035138$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
175011584$17501158$4$F$$20240828$20200305$20240904$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR036687$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$CA$CA
175018006$17501800$6$F$$20240903$20200305$20240905$PER$$US-PFIZER INC-2020098477$PFIZER$$71$YR$$F$Y$$$20240905$$CN$US$US
175021538$17502153$8$F$20200101$20240712$20200305$20240718$EXP$$US-VERTEX PHARMACEUTICALS-2020-004063$VERTEX$$$$$M$Y$$$20240718$$PH$US$US
1750604818$17506048$18$F$$20240822$20200306$20240829$EXP$$CA-Orion Corporation ORION PHARMA-TREX2020-1202$ORION$$51$YR$A$F$Y$101$KG$20240829$$HP$CA$
175070967$17507096$7$F$20200127$20240909$20200306$20240924$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-238555$RANBAXY$$79$YR$$F$Y$56$KG$20240924$$HP$DE$DE
1750785612$17507856$12$F$20220101$20240808$20200306$20240813$EXP$$US-SHIRE-US202008578$TAKEDA$$22$YR$$M$Y$118$KG$20240813$$CN$US$US
175083004$17508300$4$F$20060905$20240823$20200306$20240911$EXP$$US-SA-2020SA059365$SANOFI AVENTIS$$50$YR$A$M$Y$80.73$KG$20240911$$MD$US$US
175086894$17508689$4$F$20200101$20240718$20200306$20240719$EXP$$FR-AstraZeneca-2020SE30615$ASTRAZENECA$$77$YR$$M$Y$77$KG$20240719$$MD$FR$
175093753$17509375$3$F$20200302$20240726$20200306$20240806$PER$$US-SA-2020SA059233$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240806$$MD$US$US
1751014912$17510149$12$F$20191121$20240702$20200306$20240704$EXP$$US-PFIZER INC-2019548240$PFIZER$$71$YR$$M$Y$90.72$KG$20240704$$CN$US$US
1751175819$17511758$19$F$20190601$20240903$20200308$20240906$EXP$$NVSC2020CO024394$NOVARTIS$$61$YR$$F$Y$65$KG$20240906$$CN$CO$CO
175118025$17511802$5$F$20200101$20240712$20200306$20240715$EXP$FR-AFSSAPS-TS20200158$FR-PFIZER INC-2020100950$PFIZER$$77$YR$$M$Y$77$KG$20240715$$MD$FR$FR
1751423418$17514234$18$F$20200107$20240820$20200309$20240823$EXP$$US-SHIRE-US202008717$TAKEDA$$58$YR$$F$Y$81$KG$20240823$$MD$US$US
1751449235$17514492$35$F$$20240911$20200307$20240919$EXP$$US-SHIRE-US202008621$TAKEDA$$$$$F$Y$72$KG$20240919$$HP$US$US
175152873$17515287$3$F$20200101$20240628$20200309$20240708$EXP$FR-AFSSAPS-TS20200158$FR-TEVA-2020-FR-1195690$TEVA$$77$YR$$M$Y$77$KG$20240708$$MD$FR$FR
1751590911$17515909$11$F$20170601$20240820$20200309$20240823$EXP$$JP-GILEAD-2018-0359565$GILEAD$$41$YR$A$M$Y$$$20240823$$MD$JP$JP
175165615$17516561$5$F$20200101$20240625$20200309$20240705$EXP$$US-VERTEX PHARMACEUTICALS-2020-004356$VERTEX$$35$YR$$M$Y$54$KG$20240705$$HP$US$US
175179822$17517982$2$F$$20240809$20200309$20240815$EXP$$CZ-MYLANLABS-2020M1023608$MYLAN$Hugo J.. Treatment with secukinumab in case of patient with concomitant severe form of psoriasis and multiple sclerosis. ACTA MEDICINAE. 2019;8(15):56-8$30$YR$$F$Y$$$20240815$$HP$CZ$CZ
175198056$17519805$6$F$20200129$20240919$20200310$20240923$EXP$IT-MINISAL02-604570$IT-MYLANLABS-2020M1026130$MYLAN$$20$YR$$F$Y$$$20240923$$HP$IT$IT
175202314$17520231$4$F$20200205$20240914$20200310$20240922$EXP$$CZ-BIOGEN-2020BI00844527$BIOGEN$$46$YR$$F$Y$$$20240922$$MD$CZ$CZ
175205087$17520508$7$F$$20240819$20200309$20240823$PER$$US-BIOGEN-2020BI00845544$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
175216112$17521611$2$F$$20240820$20200310$20240822$EXP$$CA-PFIZER INC-2020101492$PFIZER$$44$YR$$M$Y$$$20240822$$HP$CA$CA
175219273$17521927$3$F$$20230802$20200310$20240906$PER$$US-FARMAPROD-201911-1748$DOMPE FARMACEUTICI$$$$E$F$Y$41.28$KG$20240902$$CN$US$US
175219282$17521928$2$F$$20231115$20200310$20240906$PER$$US-FARMAPROD-201911-1749$DOMPE FARMACEUTICI$$$$E$F$Y$80.74$KG$20240902$$CN$US$US
175220343$17522034$3$F$$20231205$20200310$20240906$PER$$US-FARMAPROD-202001-0005$DOMPE FARMACEUTICI$$$$E$M$Y$77.11$KG$20240902$$CN$US$US
175220373$17522037$3$F$20200101$20240223$20200310$20240906$PER$$US-FARMAPROD-202001-0010$DOMPE FARMACEUTICI$$85$YR$E$F$Y$70.3$KG$20240902$$CN$US$
175234793$17523479$3$F$20200201$20240912$20200310$20240916$PER$$US-PFIZER INC-2020044331$PFIZER$$52$YR$$F$Y$45.805$KG$20240916$$CN$US$US
175246683$17524668$3$F$$20240822$20200310$20240828$EXP$$IT-MYLANLABS-2020M1025354$MYLAN$Chinello M, Balter R, De Bortoli M, Vitale V, Zaccaron A, Bonetti E, et al.. Chronic graft-versus-host-disease-related polymyositis: A 17-months-old child with a rare and late complication of haematopoietic stem cell transplantation.. Mediterranean Journal of Hematology and Infectious Diseases. 2020;11:1:e2020002$6$MON$$F$Y$$$20240828$$MD$IT$IT
175248072$17524807$2$F$20220101$20240710$20200310$20240715$EXP$$US-TAKEDA-2020TUS013150$TAKEDA$$81$YR$$F$Y$$$20240715$$CN$US$US
175248319$17524831$9$F$20170101$20240802$20200311$20240808$EXP$$PHHY2017CA044470$NOVARTIS$$32$YR$$F$Y$$$20240808$$CN$CA$CA
175250456$17525045$6$F$20180101$20240904$20200311$20240907$EXP$$PHHY2018CA162782$NOVARTIS$$65$YR$$F$Y$$$20240907$$CN$CA$CA
175256212$17525621$2$F$20180101$20240905$20200311$20240918$EXP$$GB-AUROBINDO-AUR-APL-2020-011704$AUROBINDO$$31$YR$$F$Y$56$KG$20240918$$CN$GB$GB
1752588010$17525880$10$F$20230101$20240906$20200310$20240911$EXP$$US-SHIRE-US202008936$TAKEDA$$$$$M$Y$76$KG$20240911$$HP$US$US
175262413$17526241$3$F$20200201$20240620$20200310$20240708$PER$$US-BIOMARINAP-US-2020-128669$BIOMARIN$$$$$$Y$$$20240708$$CN$US$US
175273423$17527342$3$F$20200130$20240905$20200311$20240910$EXP$$CA-JNJFOC-20200300028$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240910$$HP$CA$CA
175277042$17527704$2$F$$20200226$20200311$20240711$EXP$$NVSC2020CA058783$NOVARTIS$$40$YR$$F$Y$$$20240711$$MD$CA$CA
175279033$17527903$3$F$$20240918$20200311$20240920$EXP$$CA-PFIZER INC-2020103695$PFIZER$$20$YR$$F$Y$61$KG$20240920$$HP$CA$CA
175284634$17528463$4$F$20191223$20240829$20200311$20240906$EXP$$JP-MYLANLABS-2020M1010254$MYLAN$$76$YR$$M$Y$56$KG$20240906$$MD$JP$JP
175290642$17529064$2$F$$20240823$20200311$20240830$EXP$$US-MYLANLABS-2020M1027638$MYLAN$Malik AH, Shetty S, Aronow WS. Clozapine-Associated Myocarditis: Is It Time to Start Monitoring. Am-J-Ther 2019;26(5):e666-e667.$19$YR$$M$Y$$$20240830$$MD$US$US
175292482$17529248$2$F$$20240820$20200312$20240823$EXP$$CA-Orion Corporation ORION PHARMA-TREX2020-1268$ORION$$44$YR$A$M$Y$$$20240823$$HP$CA$
1752949546$17529495$46$F$$20240903$20200311$20240913$EXP$$GB-MYLANLABS-2020M1026187$AUROBINDO$$53$YR$$M$Y$$$20240913$$MD$GB$GB
175305908$17530590$8$F$20200201$20240913$20200311$20240918$PER$$US-BIOGEN-2020BI00846719$BIOGEN$$70$YR$$F$Y$$$20240918$$CN$US$US
175318317$17531831$7$F$$20240816$20200312$20240822$EXP$$US-SHIRE-US202009180$TAKEDA$$$$$F$Y$59$KG$20240822$$CN$US$US
1753258415$17532584$15$F$$20240924$20200312$20240927$EXP$$US-SHIRE-US202009196$TAKEDA$$$$$M$Y$116$KG$20240927$$HP$US$US
175326083$17532608$3$F$20240101$20240916$20200312$20240918$EXP$$US-KYOWAKIRIN-2020BKK003671$KYOWA$$$$$$Y$$$20240918$$CN$US$US
175332049$17533204$9$F$$20240913$20200312$20240917$EXP$$CA-PFIZER INC-2020105908$PFIZER$$60$YR$$F$Y$$$20240917$$HP$CA$CA
175334485$17533448$5$F$$20240821$20200312$20240822$EXP$$US-PFIZER INC-2020108891$PFIZER$$54$YR$$F$Y$$$20240822$$CN$US$US
175348282$17534828$2$F$20200224$20240625$20200312$20240704$PER$$US-SA-2020SA061835$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240704$$MD$US$US
175348506$17534850$6$F$20190208$20240708$20200312$20240716$PER$$US-SA-2020SA064254$SANOFI AVENTIS$$34$YR$A$F$Y$149.96$KG$20240716$$MD$US$US
175355173$17535517$3$F$$20240611$20200313$20240711$EXP$$CA-ROCHE-2564055$ROCHE$$74$YR$E$F$Y$$$20240618$$HP$CA$CA
175359313$17535931$3$F$$20240918$20200313$20240923$EXP$$CA-Orion Corporation ORION PHARMA-TREX2020-1333$ORION$$20$YR$A$F$Y$61$KG$20240923$$HP$CA$
175363922$17536392$2$F$20200221$20240720$20200313$20240731$EXP$$DE-AUROBINDO-AUR-APL-2020-012587$AUROBINDO$$26$YR$$M$Y$85$KG$20240731$$MD$DE$DE
1753643642$17536436$42$F$20191003$20240626$20200313$20240704$EXP$$CA-CELLTRION INC.-2019CA025554$CELLTRION$$$$$$Y$$$20240704$$MD$CA$CA
175367672$17536767$2$F$$20240626$20200313$20240708$EXP$$GB-ROCHE-2561658$ROCHE$$$$A$M$Y$$$20240708$$CN$GB$GB
175382338$17538233$8$F$20200515$20240807$20200313$20240809$EXP$$NVSC2020CA072422$NOVARTIS$$38$YR$$F$Y$$$20240809$$MD$CA$CA
1754221032$17542210$32$F$20180511$20240815$20200314$20240823$EXP$$CA-CELLTRION INC.-2018CA020139$CELLTRION$$$$$$Y$$$20240823$$CN$CA$CA
1754222112$17542221$12$F$20200101$20240711$20200313$20240718$EXP$$US-ABBVIE-19K-163-3193854-00$ABBVIE$$$$$F$Y$66$KG$20240718$$CN$US$US
175422534$17542253$4$F$20120206$20240710$20200313$20240717$EXP$$US-JAZZ-2020-US-003445$JAZZ$$53$YR$$M$Y$$$20240717$$MD$US$US
175424766$17542476$6$F$20170526$20240822$20200314$20240830$EXP$$US-SHIRE-US202009782$TAKEDA$$69$YR$$F$Y$50$KG$20240830$$CN$US$US
175432399$17543239$9$F$$20240913$20200316$20240918$EXP$$CA-Orion Corporation ORION PHARMA-TREX2020-1385$ORION$$60$YR$A$F$Y$$$20240918$$HP$CA$
175438422$17543842$2$F$20191208$20240701$20200316$20240708$EXP$$IT-AUROBINDO-AUR-APL-2020-012542$AUROBINDO$$63$YR$$F$Y$$$20240708$$HP$IT$IT
175439014$17543901$4$F$20200101$20240821$20200316$20240905$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-240491$RANBAXY$$77$YR$$M$Y$77$KG$20240905$$MD$FR$FR
1754409410$17544094$10$F$$20240821$20200316$20240828$EXP$$LT-ROCHE-2564778$ROCHE$Kunigeeliene A, Kunigeeliene A, Alekna D, Guzevicius M. A case report: treatment of a patient with schizophrenia and a kindney transplant.. Sveikatos mokslai/ Health Sciences In Eastern Europe.. 2019;29 (6):132-5. doi:10.35988/sm-hs.2019.114.$32$YR$A$M$Y$$$20240828$$MD$LT$LT
175444374$17544437$4$F$$20240911$20200316$20240913$EXP$$DE-MYLANLABS-2020M1027208$MYLAN$Kasper P, Gobel H, Michels G.. mTOR-induced pneumonitis in a 72-year-old patient after heart transplantation. Dtsch-Med-Wochenschr. 2020;185:189-194$72$YR$$M$Y$57.8$KG$20240913$$HP$DE$DE
1754460613$17544606$13$F$$20240917$20200316$20240920$EXP$$US-SHIRE-US202009790$TAKEDA$$$$$F$Y$94$KG$20240920$$HP$US$US
1754465319$17544653$19$F$20180101$20240809$20200316$20240813$EXP$$US-PFIZER INC-2019332432$PFIZER$$73$YR$$F$Y$68.04$KG$20240813$$CN$US$US
1754513717$17545137$17$F$20201113$20240924$20200316$20240930$EXP$$US-SHIRE-US202009963$TAKEDA$$79$YR$$F$Y$75$KG$20240930$$CN$US$US
175459094$17545909$4$F$$20240716$20200316$20240718$PER$$US-PFIZER INC-2020111673$PFIZER$$51$YR$$F$Y$$$20240718$$CN$US$US
1754623222$17546232$22$F$$20240828$20200316$20240831$EXP$$US-SHIRE-US202009800$TAKEDA$$$$$F$Y$68$KG$20240831$$HP$US$US
1754650220$17546502$20$F$20210914$20240920$20200316$20240926$EXP$$US-SHIRE-US202009720$TAKEDA$$79$YR$$F$Y$103$KG$20240926$$CN$US$US
175472688$17547268$8$F$$20240625$20200316$20240701$EXP$$NVSC2020CA064933$NOVARTIS$$74$YR$$F$Y$$$20240701$$CN$CA$CA
1754804417$17548044$17$F$20190701$20240919$20200317$20240926$EXP$$CA-TAKEDA-2019TUS025167$TAKEDA$$46$YR$$F$Y$$$20240926$$HP$CA$CA
175483685$17548368$5$F$20181012$20240829$20200317$20240905$EXP$$CA-ROCHE-2566072$ROCHE$$48$YR$A$F$Y$$$20240905$$CN$CA$CA
175489078$17548907$8$F$20190101$20240725$20200317$20240801$PER$$US-BIOGEN-2019BI00700516$BIOGEN$$31$YR$$M$Y$$$20240801$$CN$US$US
1754971917$17549719$17$F$20240102$20240821$20200317$20240828$EXP$$US-SHIRE-US202010049$TAKEDA$$71$YR$$F$Y$113$KG$20240828$$CN$US$US
1755055916$17550559$16$F$20191104$20240816$20200317$20240827$EXP$$NVSC2020GB069762$NOVARTIS$$81$YR$$M$Y$$$20240827$$MD$GB$GB
1755108438$17551084$38$F$20240905$20240911$20200317$20240919$EXP$$US-SHIRE-US202009671$TAKEDA$$68$YR$$F$Y$31$KG$20240919$$CN$US$US
175514535$17551453$5$F$20220606$20240731$20200317$20240802$PER$$US-PFIZER INC-2020114857$PFIZER$$78$YR$$F$Y$68.04$KG$20240802$$CN$US$US
175527003$17552700$3$F$$20240910$20200317$20240912$EXP$$NVSC2020CA072149$NOVARTIS$$57$YR$$F$Y$60$KG$20240912$$CN$CA$CA
1755465411$17554654$11$F$$20240829$20200318$20240830$EXP$$NVSC2020US072932$NOVARTIS$$$$$F$Y$$$20240831$$CN$US$US
175546702$17554670$2$F$$20240801$20200318$20240814$EXP$$CA-AUROBINDO-AUR-APL-2020-013426$AUROBINDO$$47$YR$$F$Y$$$20240815$$HP$CA$CA
175563412$17556341$2$F$$20240903$20200318$20240912$PER$$US-SA-2020SA065432$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240912$$CN$US$US
175564037$17556403$7$F$20200101$20240627$20200318$20240712$PER$$US-SA-2020SA060933$SANOFI AVENTIS$$30$YR$A$F$Y$86.18$KG$20240712$$MD$US$US
175588562$17558856$2$F$20191118$20240903$20200318$20240906$EXP$$US-TAKEDA-2020TUS014010$TAKEDA$$43$YR$$F$Y$$$20240906$$MD$US$US
1755890310$17558903$10$F$20210101$20240918$20200319$20240925$EXP$$CO-ROCHE-2554415$ROCHE$$73$YR$E$F$Y$78$KG$20240925$$CN$CO$CO
1755894831$17558948$31$F$20140501$20240823$20200318$20240830$EXP$$US-SHIRE-US202010147$TAKEDA$$59$YR$$M$Y$107$KG$20240830$$CN$US$US
1755903329$17559033$29$F$20200101$20240625$20200319$20240703$EXP$$CA-CELLTRION INC.-2019CA025446$CELLTRION$$$$$$Y$$$20240703$$MD$CA$CA
175590364$17559036$4$F$20200301$20240712$20200319$20240716$EXP$$US-SA-2020SA069030$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240716$$MD$US$US
175594603$17559460$3$F$$20240909$20200319$20240912$EXP$$US-ADIENNEP-2020AD000168$ADIENNE PHARMA + BIOTECH$Burk CM, Coffey KE, Mace EM, Bostwick BL, Chinn IK, Coban-Akdemir ZH et all. Immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome with NK dysfunction and EBV-driven malignancy treated with stem cell transplantation. J Allergy Clin Immunol Pract. 2020 8:3 (1103-1106.e3) DOI: 10.1016/j.jaip.2019.08.040$34$MON$$F$Y$$$20240911$$MD$US$
175596303$17559630$3$F$$20240816$20200319$20240902$PER$$US-APOTEX-2019AP026720$APOTEX$$$$$M$Y$$$20240902$$CN$US$US
175610985$17561098$5$F$20221124$20240730$20200319$20240801$EXP$$US-SHIRE-US202009773$TAKEDA$$36$YR$$M$Y$$$20240801$$HP$US$US
1756114722$17561147$22$F$20200311$20240924$20200319$20240927$EXP$$US-SHIRE-US202010098$TAKEDA$$47$YR$$M$Y$$$20240927$$CN$US$US
1756139410$17561394$10$F$20200101$20240809$20200319$20240813$PER$$US-VERTEX PHARMACEUTICALS-2020-005537$VERTEX$$$$$F$Y$$$20240813$$MD$US$US
175616582$17561658$2$F$20191211$20240711$20200319$20240718$EXP$ES-AEMPS-605561$ES-PFIZER INC-2020112079$PFIZER$Mir-Ihara, P.. Drug reaction with eosinophilia and systemic symptoms in children. Allergy: European Journal of Allergy and Immunology. 2023;78(Suppl 111):684-5$12$YR$$F$Y$37$KG$20240718$$HP$ES$ES
1756209548$17562095$48$F$20190722$20240915$20200319$20240919$EXP$$IL-PFIZER INC-2018497680$PFIZER$$64$YR$$M$Y$72$KG$20240919$$HP$IL$IL
1756256715$17562567$15$F$20200304$20240730$20200319$20240805$EXP$$CO-SHIRE-CO202008892$TAKEDA$$12$YR$$F$Y$39$KG$20240805$$CN$CO$CO
1756390710$17563907$10$F$20211225$20240801$20200320$20240806$EXP$$US-SHIRE-US202010611$TAKEDA$$76$YR$$M$Y$104$KG$20240806$$HP$US$US
1756461813$17564618$13$F$20200129$20240731$20200320$20240803$EXP$$IL-ABBVIE-20K-082-3292782-00$ABBVIE$$68$YR$$F$Y$73$KG$20240803$$MD$IL$IL
1756466614$17564666$14$F$$20240805$20200320$20240809$EXP$$US-SHIRE-US202010580$TAKEDA$$$$$F$Y$59$KG$20240809$$HP$US$US
175648865$17564886$5$F$$20240829$20200320$20240904$EXP$$US-SHIRE-US202010578$TAKEDA$$$$$F$Y$69$KG$20240904$$CN$US$US
175666052$17566605$2$F$20240726$20240729$20200320$20240731$EXP$$US-KYOWAKIRIN-2020BKK004270$KYOWA$$$$$$Y$$$20240731$$HP$US$US
175667377$17566737$7$F$20191025$20240703$20200320$20240715$EXP$$GB-AEGERION PHARMACEUTICAL, INC-AEGR004746$AEGERION$$$$$$Y$$$20240715$$MD$GB$GB
1756762611$17567626$11$F$20201215$20240912$20200320$20240918$EXP$$US-SHIRE-US202010684$TAKEDA$$70$YR$$F$Y$64$KG$20240918$$HP$US$US
175684954$17568495$4$F$20020217$20240709$20200320$20240712$EXP$$ES-009507513-2003ESP007672$MERCK$$58$YR$$M$Y$$$20240712$$MD$ES$ES
175687395$17568739$5$F$$20240923$20200321$20240926$EXP$$US-SHIRE-US202010460$TAKEDA$$$$$F$Y$73$KG$20240926$$HP$US$US
1756910513$17569105$13$F$20200203$20240828$20200322$20240903$EXP$$US-SHIRE-US202010686$TAKEDA$$77$YR$$F$Y$58$KG$20240903$$CN$US$US
1756923120$17569231$20$F$20200227$20240628$20200322$20240703$EXP$$US-SHIRE-US202010795$TAKEDA$$56$YR$$F$Y$79$KG$20240703$$HP$US$US
1756930010$17569300$10$F$20240301$20240913$20200322$20240919$EXP$$US-SHIRE-US202010703$TAKEDA$$65$YR$$M$Y$125$KG$20240919$$HP$US$US
1757068522$17570685$22$F$20200224$20240820$20200323$20240829$EXP$$CA-ROCHE-2559985$ROCHE$$30$YR$A$F$Y$$$20240829$$HP$CA$CA
175709458$17570945$8$F$20210101$20240822$20200323$20240827$PER$$US-PFIZER INC-2020118708$PFIZER$$76$YR$$F$Y$$$20240827$$CN$US$US
175716017$17571601$7$F$$20240708$20200323$20240712$EXP$$CA-APOTEX-2020AP008858$APOTEX$$40$YR$$M$Y$130$KG$20240712$$MD$CA$CA
1757246719$17572467$19$F$20171005$20240808$20200323$20240814$EXP$$CO-TAKEDA-2020TUS014240$TAKEDA$$63$YR$$F$Y$85$KG$20240814$$HP$CO$CO
1757255527$17572555$27$F$$20240912$20200323$20240924$EXP$$US-SHIRE-US202010741$TAKEDA$$$$$F$Y$79$KG$20240924$$HP$US$US
1757264416$17572644$16$F$20190225$20240628$20200323$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-126530$BRISTOL MYERS SQUIBB$Nakamura K, Ashida A, Kiniwa Y, Okuyama R. Summary of adjuvant therapy for advanced malignant melanoma in our department. Skin Cancer. 2021;36(3):212-7.$53$YR$A$M$Y$90.6$KG$20240704$$MD$JP$JP
1757279220$17572792$20$F$20200226$20240911$20200323$20240913$EXP$$US-SHIRE-US202010404$TAKEDA$$48$YR$$M$Y$$$20240913$$MD$US$US
1757283412$17572834$12$F$20200314$20240823$20200323$20240827$EXP$$US-SHIRE-US202010734$TAKEDA$$53$YR$$M$Y$$$20240827$$CN$US$US
175749887$17574988$7$F$$20240813$20200324$20240821$EXP$$US-SHIRE-US202010924$TAKEDA$$$$$M$Y$78.912$KG$20240821$$HP$US$US
175751143$17575114$3$F$$20240806$20200324$20240813$EXP$$NVSC2020US072768$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
175768805$17576880$5$F$$20240717$20200324$20240718$EXP$$CA-PFIZER INC-2020120589$PFIZER$$49$YR$$F$Y$$$20240718$$HP$CA$CA
175775699$17577569$9$F$$20240815$20200324$20240820$EXP$$US-SHIRE-US202010641$TAKEDA$$$$$M$Y$92$KG$20240820$$HP$US$US
1757775112$17577751$12$F$$20240719$20200324$20240723$EXP$$US-SHIRE-US202011024$TAKEDA$$$$$M$Y$103$KG$20240723$$MD$US$US
1757846024$17578460$24$F$20200312$20240829$20200324$20240906$EXP$$CA-CELLTRION INC.-2020CA020670$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
1757861938$17578619$38$F$20200320$20240916$20200325$20240919$EXP$$US-SHIRE-US202011119$TAKEDA$$4$YR$$F$Y$$$20240919$$MD$US$US
175790643$17579064$3$F$20191101$20240819$20200325$20240823$PER$$US-BIOGEN-2019BI00817006$BIOGEN$$49$YR$$F$Y$$$20240823$$CN$US$US
175791003$17579100$3$F$$20240906$20200325$20240912$EXP$$CA-ROCHE-2571952$ROCHE$Downie M, Downie M M. A curious case of growth failure and hypercalcemia: Questions. Pediatric Nephrology. 2018;33 (6):991-3. doi:10.1007/s00467-017-3768-3.$14$YR$T$M$Y$35$KG$20240912$$MD$CA$CA
1757916938$17579169$38$F$20190509$20240821$20200325$20240829$EXP$$CA-CELLTRION INC.-2019CA021569$CELLTRION$$$$$$Y$$$20240829$$CN$CA$CA
1758022928$17580229$28$F$$20240716$20200325$20240722$EXP$$CA-BIOVITRUM-2020CA1335$BIOVITRUM$$52$YR$$F$Y$$$20240722$$MD$CA$CA
175809878$17580987$8$F$$20240826$20200325$20240829$PER$$US-PFIZER INC-2020124494$PFIZER$$80$YR$$M$Y$$$20240829$$MD$US$US
1758115529$17581155$29$F$20200301$20240718$20200325$20240723$EXP$$US-SHIRE-US202011080$TAKEDA$$45$YR$$F$Y$83$KG$20240723$$HP$US$US
175817454$17581745$4$F$20230414$20240718$20200325$20240723$EXP$$US-SHIRE-US202010920$TAKEDA$$69$YR$$M$Y$$$20240723$$CN$US$US
1758184317$17581843$17$F$$20240809$20200325$20240814$EXP$$US-SHIRE-US202011174$TAKEDA$$$$$M$Y$89$KG$20240814$$HP$US$US
175819297$17581929$7$F$$20240729$20200325$20240801$EXP$$US-SHIRE-US202011219$TAKEDA$$$$$F$Y$68$KG$20240801$$CN$US$US
175828192$17582819$2$F$20150101$20240802$20200325$20240809$PER$$US-JAZZ-2020-US-004027$JAZZ$$37$YR$$F$Y$$$20240809$$CN$US$US
1758308110$17583081$10$F$20200310$20240828$20200325$20240902$EXP$$CA-TAKEDA-2020TUS015002$TAKEDA$$34$YR$$F$Y$$$20240902$$MD$CA$CA
175836185$17583618$5$F$$20240717$20200326$20240722$EXP$$CA-Orion Corporation ORION PHARMA-TREX2020-1505$ORION$$49$YR$A$F$Y$$$20240723$$HP$CA$
1758365044$17583650$44$F$20181121$20240807$20200326$20240813$EXP$$US-SHIRE-US202010879$TAKEDA$$71$YR$$F$Y$56$KG$20240813$$CN$US$US
175839363$17583936$3$F$20190801$20240827$20200326$20240905$EXP$FR-AFSSAPS-AM20200368$FR-TEVA-2020-FR-1209074$TEVA$$66$YR$$F$Y$65$KG$20240905$$MD$FR$FR
175858588$17585858$8$F$$20240827$20200326$20240829$EXP$$US-PFIZER INC-2020127341$PFIZER$$32$YR$$M$Y$$$20240829$$CN$US$US
175881142$17588114$2$F$20200214$20240717$20200327$20240729$EXP$FR-AFSSAPS-LL20200416$FR-ELI_LILLY_AND_COMPANY-FR202003009206$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240729$$CN$FR$FR
175889089$17588908$9$F$$20220110$20200327$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR047606$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
1758974626$17589746$26$F$20211013$20240723$20200327$20240729$EXP$$US-SHIRE-US202011435$TAKEDA$$62$YR$$F$Y$48$KG$20240729$$CN$US$US
175911593$17591159$3$F$$20240628$20200327$20240702$PER$$US-PFIZER INC-2020128014$PFIZER$$69$YR$$M$Y$$$20240702$$CN$US$US
1759171810$17591718$10$F$$20240910$20200327$20240913$EXP$$US-SHIRE-US202011450$TAKEDA$$$$$F$Y$67$KG$20240913$$CN$US$US
175919343$17591934$3$F$$20240708$20200327$20240711$EXP$$AT-PFIZER INC-2020127634$PFIZER$Ozsvath, B.. Case Report / Brentuximab Vedotin (Adcetris) High-risk patient with advanced Hodgkin lymphoma.. SPECTRUM ONKOLOGIE. 2020;01:96$61$YR$$M$Y$$$20240711$$MD$AT$AT
175948503$17594850$3$F$$20240910$20200328$20240918$EXP$$NVSC2020CA085805$NOVARTIS$$51$YR$$M$Y$$$20240919$$CN$CA$CA
1759508118$17595081$18$F$20230116$20240814$20200328$20240820$EXP$$US-SHIRE-US202011520$TAKEDA$$89$YR$$F$Y$72$KG$20240820$$CN$US$US
175952632$17595263$2$F$20200112$20240627$20200328$20240702$EXP$$NVSC2020IN086006$NOVARTIS$$64$YR$$F$Y$$$20240702$$CN$IN$IN
1759586714$17595867$14$F$20200101$20240730$20200329$20240803$PER$$US-DSJP-DSU-2020-109065$DAIICHI$$$$$F$Y$$$20240803$$CN$US$US
175966272$17596627$2$F$20200131$20240717$20200330$20240729$EXP$$FR-AUROBINDO-AUR-APL-2020-015588$AUROBINDO$$64$YR$$M$Y$$$20240729$$PH$FR$FR
1759701914$17597019$14$F$$20240718$20200330$20240724$EXP$$CA-Orion Corporation ORION PHARMA-TREX2020-1563$ORION$$60$YR$A$F$Y$81$KG$20240724$$HP$CA$
175992933$17599293$3$F$$20240820$20200330$20240827$EXP$$NVSC2020CA085778$NOVARTIS$$66$YR$$F$Y$$$20240827$$CN$CA$CA
175995182$17599518$2$F$20120101$20240909$20200330$20240913$PER$$US-JNJFOC-20200341707$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240913$$LW$US$US
176001817$17600181$7$F$$20240801$20200330$20240806$PER$$US-PFIZER INC-2020131774$PFIZER$$79$YR$$M$Y$$$20240806$$HP$US$US
1760139013$17601390$13$F$20200324$20240806$20200331$20240807$EXP$$US-SHIRE-US202011861$TAKEDA$$4$YR$$M$Y$$$20240807$$CN$US$US
176020572$17602057$2$F$$20240906$20200331$20240908$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-016402$BOEHRINGER INGELHEIM$$55$YR$A$F$Y$$$20240908$$CN$AU$AU
1760275410$17602754$10$F$20160930$20240709$20200330$20240713$EXP$$JP-ABBVIE-18K-087-2424631-00$ABBVIE$$57$YR$$F$Y$$$20240713$$HP$JP$JP
176032527$17603252$7$F$$20240909$20200331$20240913$EXP$FR-EMA-DD-20200323-AGRAHARI_P-151601$FR-GLAXOSMITHKLINE-FR2020053609$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$FR$FR
1760658012$17606580$12$F$20210809$20240913$20200331$20240917$EXP$$US-SHIRE-US202011301$TAKEDA$$55$YR$$F$Y$95$KG$20240917$$HP$US$US
176068673$17606867$3$F$$20240819$20200331$20240822$EXP$$NVSC2020GR088407$NOVARTIS$Skalioti XN, Mantios E, Marinaki S, Pantazatou A, Apostolou O, Psyychogiou M et al.. Nocardia cyriacigeorgica infection in immunosuppresed patient. 20th PANHELLENIC CONGRESS ON INFECTIONS. 2020;17-20$75$YR$$M$Y$$$20240822$$HP$GR$GR
176080644$17608064$4$F$$20240801$20200401$20240807$30DAY$$US-GLAXOSMITHKLINE-US2020055838$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
176090344$17609034$4$F$$20240913$20200401$20240926$EXP$$IT-AUROBINDO-AUR-APL-2020-015895$AUROBINDO$Corti CG, Faiola S, Lanna MM, Castoldi F, Lista G, Nespoli LF et al.. Monochorionic diamniotic twin pregnancy complicated by discordant premature closure of ductus arteriosus. Clinical Case Reports. 2020;00:1-5$33$WK$$F$Y$2.021$KG$20240926$$MD$IT$IT
1760904911$17609049$11$F$20180920$20240909$20200401$20240920$EXP$$DE-AUROBINDO-AUR-APL-2020-016023$AUROBINDO$$$$A$F$Y$82$KG$20240920$$MD$DE$DE
1760913439$17609134$39$F$$20240923$20200401$20240927$EXP$$US-SHIRE-US202011949$TAKEDA$$$$$M$Y$104$KG$20240927$$CN$US$US
1760942710$17609427$10$F$20191001$20240723$20200401$20240727$EXP$$NVSC2019CA034498$NOVARTIS$$43$YR$$F$Y$$$20240727$$CN$CA$CA
176096242$17609624$2$F$20200201$20240708$20200401$20240710$EXP$$SE-PFIZER INC-2020122205$PFIZER$$75$YR$$F$Y$$$20240710$$CN$SE$SE
176105752$17610575$2$F$20200131$20240711$20200401$20240716$EXP$FR-AFSSAPS-LL20200416$FR-PFIZER INC-2020132608$PFIZER$$64$YR$$M$Y$$$20240716$$PH$FR$FR
176144563$17614456$3$F$$20240829$20200402$20240906$EXP$$FR-TEVA-2020-FR-1217622$TEVA$$71$YR$$M$Y$$$20240906$$HP$FR$FR
1761448412$17614484$12$F$20200101$20240903$20200402$20240910$EXP$$CA-CELLTRION INC.-2020CA019806$CELLTRION$$$$$$Y$$$20240910$$MD$CA$CA
1761505514$17615055$14$F$$20240701$20200402$20240704$PER$$US-PFIZER INC-2020136094$PFIZER$$85$YR$$F$Y$$$20240704$$CN$US$US
1761518610$17615186$10$F$$20240926$20200402$20240930$EXP$$US-PFIZER INC-2020133708$PFIZER$$68$YR$$F$Y$$$20240930$$CN$US$US
1761687818$17616878$18$F$$20240805$20200402$20240808$EXP$$US-SHIRE-US202008931$TAKEDA$$$$$F$Y$59$KG$20240808$$HP$US$US
176172976$17617297$6$F$20200101$20240812$20200402$20240814$PER$$US-BIOGEN-2020BI00832494$BIOGEN$$50$YR$$F$Y$$$20240814$$CN$US$US
176212496$17621249$6$F$20190901$20240730$20200403$20240806$EXP$$BE-TAKEDA-2020TUS016880$TAKEDA$$32$YR$$M$Y$115$KG$20240806$$MD$BE$BE
1762267120$17622671$20$F$20210122$20240905$20200403$20240911$EXP$$US-SHIRE-US202012166$TAKEDA$$72$YR$$F$Y$68$KG$20240911$$CN$US$US
176228325$17622832$5$F$20200101$20240905$20200403$20240917$PER$$US-PFIZER INC-2020137225$PFIZER$$68$YR$$F$Y$104.33$KG$20240917$$CN$US$US
176228836$17622883$6$F$20230418$20240712$20200403$20240716$EXP$$US-PFIZER INC-2020137195$PFIZER$$60$YR$$F$Y$88.889$KG$20240716$$CN$US$US
1762338221$17623382$21$F$20140530$20240920$20200403$20240930$EXP$$US-SHIRE-US202008310$TAKEDA$$57$YR$$F$Y$72$KG$20240930$$HP$US$US
176247766$17624776$6$F$20200305$20240918$20200404$20240930$EXP$$IT-INCYTE CORPORATION-2020IN003121$INCYTE$$$$$$Y$$$20240930$$MD$IT$IT
176253037$17625303$7$F$20200215$20240715$20200403$20240720$EXP$$US-JAZZ-2020-US-004635$JAZZ$$31$YR$$F$Y$$$20240720$$CN$US$US
176258518$17625851$8$F$20221201$20240910$20200404$20240913$EXP$$US-SHIRE-US202012444$TAKEDA$$68$YR$$F$Y$75$KG$20240913$$MD$US$US
176261482$17626148$2$F$$20240827$20200404$20240830$EXP$$DE-MYLANLABS-2020M1034354$MYLAN$Christofyllakis K... WALKING THE LINE BETWEEN TREATMENT BENEFIT AND TOXICITY IN LIMITEDSTAGE DLBCL OF THE ELDERLY: A CASE REPORT.. J. Geriatr. Oncol.. 2019;10 (Sup) (6):S5 - S14 abstr.$80$YR$$F$Y$$$20240830$$HP$DE$DE
176267726$17626772$6$F$20200321$20240916$20200405$20240925$EXP$$NVSC2020DE090459$NOVARTIS$$$$A$M$Y$127$KG$20240926$$CN$DE$DE
1762896822$17628968$22$F$$20230328$20200406$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR057933$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
176295443$17629544$3$F$$20240612$20200406$20240704$30DAY$$US-GLAXOSMITHKLINE-US2020057546$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
176311952$17631195$2$F$$20240723$20200406$20240801$PER$$US-APOTEX-2020AP009467$APOTEX$Elmassry M, Mantilla B, Mortagy M, Al Mahmoud AF, Nugent K. An extremely low ph survivor: A case of septic shock complicated with metformininduced severe lactic acidosis. DOI: 10.1136/jim-2020-SRM.417.. Journal of Investigative Medicine. 2020;68 (2):602$51$YR$$F$Y$$$20240801$$HP$US$US
1763164325$17631643$25$F$20200924$20240718$20200406$20240725$EXP$$US-SHIRE-US202012522$TAKEDA$$70$YR$$F$Y$134$KG$20240725$$HP$US$US
1763165819$17631658$19$F$$20240709$20200406$20240712$EXP$$US-SHIRE-US202012480$TAKEDA$$$$$F$Y$92$KG$20240712$$CN$US$US
1763241418$17632414$18$F$20200404$20240909$20200406$20240910$EXP$$US-SHIRE-US202012504$TAKEDA$$65$YR$$F$Y$80$KG$20240910$$CN$US$US
176327429$17632742$9$F$20200315$20240910$20200406$20240913$EXP$$US-SHIRE-US202012336$TAKEDA$$10$YR$$M$Y$$$20240913$$PH$US$US
1763292410$17632924$10$F$20200101$20240715$20200406$20240723$PER$$US-SA-2020SA086048$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240722$$MD$US$US
1763388217$17633882$17$F$20240910$20240910$20200406$20240917$EXP$$US-SHIRE-US202012481$TAKEDA$$82$YR$$F$Y$111$KG$20240917$$MD$US$US
176344693$17634469$3$F$$20240820$20200406$20240821$EXP$$NVSC2020CA091510$NOVARTIS$$49$YR$$F$Y$$$20240822$$HP$CA$CA
176362753$17636275$3$F$$20240513$20200407$20240828$EXP$$NVSC2020CA092105$NOVARTIS$$35$YR$$M$Y$$$20240828$$CN$CA$CA
176373644$17637364$4$F$$20240626$20200407$20240702$EXP$$US-SHIRE-US202012648$TAKEDA$$$$$F$Y$$$20240702$$CN$US$US
176394755$17639475$5$F$20190101$20240702$20200407$20240708$PER$$US-VERTEX PHARMACEUTICALS-2020-003784$VERTEX$$$$$F$Y$74$KG$20240708$$PH$US$US
176407443$17640744$3$F$20180207$20240729$20200407$20240802$EXP$$PHHY2018CA023490$NOVARTIS$$50$YR$$F$Y$$$20240802$$CN$CA$CA
1764108222$17641082$22$F$20201201$20240924$20200407$20240926$EXP$$US-SHIRE-US202012468$TAKEDA$$57$YR$$F$Y$113$KG$20240926$$HP$US$US
176420023$17642002$3$F$20200128$20240703$20200407$20240709$EXP$$ES-AUROBINDO-AUR-APL-2020-017185$AUROBINDO$$58$YR$$M$Y$$$20240709$$MD$ES$ES
1764206212$17642062$12$F$20190717$20240820$20200407$20240826$EXP$$CA-PFIZER INC-2018491917$PFIZER$$51$YR$$F$Y$84$KG$20240826$$MD$CA$CA
176431674$17643167$4$F$$20240730$20200408$20240805$EXP$$NVSJ2020JP004012$NOVARTIS$$24$YR$$$Y$$$20240805$$MD$JP$JP
1764586510$17645865$10$F$20230726$20240719$20200408$20240724$EXP$$US-SHIRE-US202012672$TAKEDA$$79$YR$$F$Y$81$KG$20240724$$CN$US$US
176459673$17645967$3$F$20240101$20240625$20200408$20240702$PER$$US-SA-2020SA084323$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240702$$MD$US$US
176460873$17646087$3$F$20200101$20240908$20200408$20240916$PER$$US-SA-2020SA088575$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240916$$CN$US$US
1764719212$17647192$12$F$$20240726$20200409$20240801$EXP$$US-SHIRE-US202012756$TAKEDA$$$$$M$Y$112$KG$20240801$$CN$US$US
176473923$17647392$3$F$20190928$20240729$20200408$20240730$PER$$US-BIOVITRUM-2019US3472$BIOVITRUM$$82$YR$$M$Y$$$20240730$$CN$US$US
176485758$17648575$8$F$$20240726$20200408$20240729$EXP$$CA-NAPPMUNDI-CAN-2020-0010830$PURDUE$$62$YR$$F$Y$$$20240729$$CN$CA$CA
176485797$17648579$7$F$20200304$20211221$20200409$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR057109$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
176485939$17648593$9$F$20200301$20240826$20200409$20240828$EXP$$US-SHIRE-US202012867$TAKEDA$$9$YR$$M$Y$$$20240828$$CN$US$US
176490744$17649074$4$F$$20240910$20200409$20240918$EXP$$NVSC2020CA094481$NOVARTIS$$48$YR$$F$Y$$$20240918$$CN$CA$CA
176496422$17649642$2$F$$20200317$20200408$20240723$PER$$US-NOVOPROD-719771$NOVO NORDISK$$57$YR$$F$Y$$$20240723$$PH$US$US
176506236$17650623$6$F$$20240815$20200409$20240827$EXP$LT-EMA-DD-20200325-PRABHAKAR_D-220501$LT-Accord-178411$ACCORD$KUNIGELIENA A, ALEKNA D, GUZEVICIUS M. KLINIKINIS ATVEJIS PACIENTO, SERGANCIO SIZOFRENIJA IR TURINCIO TRANSPLANTUOTA INKSTA, GYDYMO YPATUMAI. SVEIKATOS MOKSLAI HEALTH SCIENCES IN EASTERN EUROPE. 201929 6132135. DOI https doi.org10.35988smhs.2019.114.$32$YR$A$M$Y$$$20240827$$MD$LT$LT
176535187$17653518$7$F$$20240625$20200409$20240702$EXP$$NVSC2020CA096583$NOVARTIS$$66$YR$$F$Y$$$20240702$$CN$CA$CA
176536302$17653630$2$F$20240101$20240704$20200410$20240715$PER$$US-SA-2020SA089292$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240715$$MD$US$US
176544413$17654441$3$F$$20240705$20200410$20240715$EXP$$IT-AUROBINDO-AUR-APL-2020-017516$AUROBINDO$Liccioli G, Mori F, Parronchi P, Barni S, Capone M, Fili L, et al.. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting. Clin-Exp-Allergy. 2020;50(1):61-73$6$YR$$F$Y$$$20240715$$MD$IT$IT
176548587$17654858$7$F$20200307$20240718$20200410$20240722$EXP$$CA-PFIZER INC-2019321556$PFIZER$$52$YR$$F$Y$$$20240722$$CN$CA$CA
176550532$17655053$2$F$$20240812$20200410$20240821$PER$$US-SA-2020SA090460$SANOFI AVENTIS$$50$YR$A$F$Y$72.57$KG$20240821$$MD$US$US
1765634812$17656348$12$F$20220101$20240814$20200410$20240826$EXP$$CA-ROCHE-2579781$ROCHE$$54$YR$A$F$Y$$$20240826$$CN$CA$CA
1765720212$17657202$12$F$20190101$20240821$20200410$20240823$EXP$$FR-ABBVIE-20K-056-3359557-00$ABBVIE$$69$YR$$M$Y$59$KG$20240823$$MD$FR$FR
176573965$17657396$5$F$20120101$20240909$20200410$20240911$EXP$$US-NAPPMUNDI-USA-2020-0151426$PURDUE$$$$$M$Y$90.703$KG$20240911$$CN$US$US
1765763024$17657630$24$F$20181220$20240726$20200411$20240802$EXP$$DE-ROCHE-2248497$ROCHE$$58$YR$A$F$Y$$$20240802$$CN$DE$DE
1765788912$17657889$12$F$$20240830$20200411$20240903$EXP$$US-SHIRE-US202012930$TAKEDA$$$$$F$Y$77$KG$20240903$$MD$US$US
1765877333$17658773$33$F$$20240826$20200413$20240829$EXP$$CA-TAKEDA-2020TJP006975$TAKEDA$$78$YR$$F$Y$93$KG$20240829$$MD$CA$CA
1765894221$17658942$21$F$20190718$20240904$20200413$20240911$EXP$$DE-ROCHE-2360566$ROCHE$$32$YR$A$F$Y$$$20240911$$CN$DE$DE
1766033938$17660339$38$F$20210101$20240924$20200413$20240926$EXP$$US-PFIZER INC-2019268231$PFIZER$$76$YR$$F$Y$58.06$KG$20240926$$CN$US$US
176603959$17660395$9$F$20200501$20240719$20200413$20240724$EXP$$US-PFIZER INC-2020148725$PFIZER$$44$YR$$M$Y$$$20240724$$CN$US$US
176606713$17660671$3$F$$20240820$20200413$20240822$PER$$US-PFIZER INC-2016278746$PFIZER$$51$YR$$F$Y$73$KG$20240822$$CN$US$US
1766173612$17661736$12$F$20200409$20240809$20200413$20240814$EXP$$US-SHIRE-US202013059$TAKEDA$$15$YR$$M$Y$$$20240814$$CN$US$US
1766189436$17661894$36$F$20200923$20240805$20200413$20240809$EXP$$US-SHIRE-US202013186$TAKEDA$$47$YR$$F$Y$70$KG$20240809$$HP$US$US
176625517$17662551$7$F$$20240814$20200413$20240819$EXP$$US-SHIRE-US202013164$TAKEDA$$$$$F$Y$94$KG$20240819$$HP$US$US
176632622$17663262$2$F$$20240620$20200414$20240701$PER$$US-INCYTE CORPORATION-2020IN001815$INCYTE$$$$$$Y$$$20240701$$HP$US$US
176633792$17663379$2$F$$20240705$20200413$20240715$EXP$$IT-AUROBINDO-AUR-APL-2020-018198$AUROBINDO$Liccioli G, Mori F, Parronchi P, Capone M, Fili L, Barni S, et al.. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.. Clin-Exp-Allergy.. 2020;50(1):61-73$$$C$$Y$$$20240715$$MD$IT$IT
176660322$17666032$2$F$$20240904$20200414$20240910$EXP$$DE-MYLANLABS-2018M1029235$MYLAN$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al.. Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant recipients.. CERTAIN registry study. 2018;103(6):1-33$17$YR$$$Y$$$20240910$$HP$DE$DE
1766706237$17667062$37$F$$20240826$20200414$20240830$EXP$$CA-AstraZeneca-2020SE49789$ASTRAZENECA$$78$YR$$F$Y$93$KG$20240830$$MD$CA$
176672528$17667252$8$F$$20240715$20200414$20240717$EXP$$US-PFIZER INC-2019468541$PFIZER$$72$YR$$M$Y$$$20240717$$HP$US$US
176673312$17667331$2$F$$20240913$20200414$20240918$EXP$$DE-MYLANLABS-2020M1037334$MYLAN$Wobser M, Kneitz H, Broecker E-B, Becker J C.. Primary cutaneous diffuse large b-cell lymphoma, leg-type, treated with a modified r-chop immunochemotherapy - diagnostic and therapeutic challenges.. J Dtsch Dermatol Ges. 2011;9(3):204-210$81$YR$$M$Y$$$20240918$$HP$DE$DE
1766924813$17669248$13$F$20200114$20240801$20200415$20240802$EXP$$DE-ROCHE-2531723$ROCHE$$54$YR$A$F$Y$$$20240803$$CN$DE$DE
176693494$17669349$4$F$$20240913$20200415$20240918$EXP$$DE-MYLANLABS-2020M1037333$MYLAN$Wobser M, Kneitz H, Brocker E-B, Becker JC. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type, Treated With A Modified R-Chop Immunochemotherapy - Diagnostic And Therapeutic Challenges.. Journal Of The German Society Of Dermatology.. 2011;9(3):204-210$70$YR$$M$Y$$$20240918$$HP$DE$DE
176693663$17669366$3$F$$20240827$20200415$20240903$EXP$$DE-MYLANLABS-2020M1037331$MYLAN$Wobser M, Kneitz H, Brocker E-B, Becker JC.. Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - Diagnostic and therapeutic challenges.. JOURNAL OF THE GERMAN SOCIETY OF DERMATOLOGY. 2011;9(3):204-210$74$YR$$F$Y$$$20240903$$HP$DE$DE
1767072214$17670722$14$F$20200101$20240626$20200415$20240703$EXP$$US-SA-2020SA096126$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240703$$HP$US$US
1767105940$17671059$40$F$$20240910$20200415$20240920$EXP$$CA-PFIZER INC-2020133540$PFIZER$$78$YR$$F$Y$93$KG$20240920$$CN$CA$CA
176713802$17671380$2$F$$20240918$20200415$20240924$EXP$$HR-MYLANLABS-2019M1111560$MYLAN$Petric D, Peitl MV, Proloscic J, Peitl V.. Sertraline Induced Excessive Yawning.. Archives of Psychiatry Research. 2019;55 (1):85-88$42$YR$$F$Y$$$20240924$$MD$HR$HR
176715435$17671543$5$F$20200210$20240816$20200415$20240822$EXP$$CA-TAKEDA-2020TUS011019$TAKEDA$$68$YR$$M$Y$$$20240822$$CN$CA$CA
176746842$17674684$2$F$20170101$20240902$20200416$20240906$EXP$FR-AFSSAPS-NY20200001$NVSC2020FR099892$NOVARTIS$$43$YR$$M$Y$100$KG$20240906$$MD$FR$FR
1767608522$17676085$22$F$20200301$20240808$20200416$20240814$EXP$$US-SHIRE-US202013369$TAKEDA$$37$YR$$M$Y$$$20240814$$MD$US$US
176761413$17676141$3$F$20200212$20200414$20200416$20240911$EXP$$JP-SHIRE-JP202013312AA$TAKEDA$$19$YR$$M$Y$$$20240911$$CN$JP$JP
176762264$17676226$4$F$20120312$20240918$20200416$20240920$EXP$$US-GILEAD-2020-0458801$GILEAD$$46$YR$A$M$Y$$$20240920$$LW$US$US
1767976017$17679760$17$F$20200413$20240517$20200417$20240808$EXP$$US-SHIRE-US202013671$TAKEDA$$59$YR$$F$Y$72$KG$20240808$$CN$US$US
1768074029$17680740$29$F$$20240829$20200417$20240904$EXP$$CA-ANIPHARMA-2020-CA-000419$ANI$$78$YR$$F$Y$93$KG$20240904$$CN$CA$CA
1768122820$17681228$20$F$20190409$20240703$20200417$20240705$EXP$$US-SHIRE-US202013749$TAKEDA$$48$YR$$F$Y$86$KG$20240705$$MD$US$US
176834955$17683495$5$F$$20240722$20200420$20240725$EXP$$CA-Orion Corporation ORION PHARMA-TREX2020-1802$ORION$$63$YR$A$F$Y$$$20240725$$HP$CA$
176836212$17683621$2$F$$20240816$20200420$20240819$PER$$US-SHIRE-US202013887$TAKEDA$$$$$F$Y$88.435$KG$20240819$$HP$US$US
1768366029$17683660$29$F$20200913$20240724$20200420$20240729$EXP$$US-SHIRE-US202013831$TAKEDA$$71$YR$$F$Y$126$KG$20240729$$HP$US$US
176843006$17684300$6$F$20200403$20240702$20200420$20240708$EXP$$CA-TAKEDA-2020TUS011522$TAKEDA$$50$YR$$M$Y$$$20240708$$CN$CA$CA
1768463846$17684638$46$F$20210829$20240906$20200420$20240910$EXP$$US-SHIRE-US202013771$TAKEDA$$25$YR$$M$Y$$$20240910$$MD$US$US
176854552$17685455$2$F$$20240828$20200420$20240910$PER$$US-SA-2020SA101270$SANOFI AVENTIS$$$$A$M$Y$$$20240910$$CN$US$US
176860412$17686041$2$F$$20240805$20200420$20240808$EXP$$CO-AMGEN-COLSL2020062157$AMGEN$$57$YR$A$F$Y$$$20240808$$CN$CO$CO
176870657$17687065$7$F$$20240712$20200421$20240724$EXP$$CA-ROCHE-2587054$ROCHE$$76$YR$E$F$Y$$$20240724$$CN$CA$CA
176883609$17688360$9$F$20200313$20240710$20200421$20240814$EXP$$JP-009507513-2004JPN000945J$MERCK$Oka Y, Hamano Y, Nakamura R, Sawafuji T, Mabuchi K, Yamaguchi Y, et al.. 1. A case developed immune-related gastrooesophagitis caused by immune checkpoint inhibitor for non-small lung cancer. The 364th Kanto Chapter regular meeting of the Japan Gastroenterological endosco. 20$64$YR$$M$Y$59$KG$20240814$$MD$JP$JP
1768872210$17688722$10$F$20220507$20240808$20200421$20240813$EXP$$US-TAKEDA-2020TUS018752$TAKEDA$$59$YR$$M$Y$108$KG$20240813$$MD$US$US
1768892250$17688922$50$F$20200317$20240625$20200421$20240701$EXP$$US-SHIRE-US201942225$TAKEDA$$60$YR$$F$Y$108$KG$20240701$$MD$US$US
1768991720$17689917$20$F$20190101$20240828$20200421$20240902$EXP$$CA-TAKEDA-2019TUS070406$TAKEDA$$$$$F$Y$$$20240902$$MD$CA$CA
176905913$17690591$3$F$20200113$20240924$20200421$20240930$EXP$$US-SHIRE-US202005552$TAKEDA$$63$YR$$F$Y$78$KG$20240930$$CN$US$US
176922696$17692269$6$F$20200801$20240815$20200422$20240820$PER$$US-PFIZER INC-2020156942$PFIZER$$72$YR$$F$Y$76.19$KG$20240820$$CN$US$US
176923815$17692381$5$F$20200101$20240703$20200422$20240709$PER$$US-PFIZER INC-2020158785$PFIZER$$73$YR$$F$Y$$$20240709$$HP$US$US
1769240415$17692404$15$F$20080114$20240814$20200422$20240819$EXP$$US-SHIRE-US202014180$TAKEDA$$44$YR$$F$Y$62$KG$20240819$$MD$US$US
176925588$17692558$8$F$20210101$20240711$20200422$20240807$EXP$$US-VIIV HEALTHCARE LIMITED-US2020AMR068404$VIIV$$$$$M$Y$$$20240807$$CN$US$US
1769356644$17693566$44$F$20200408$20240702$20200422$20240703$EXP$$US-SHIRE-US202013982$TAKEDA$$8$YR$$M$Y$$$20240703$$MD$US$US
176936369$17693636$9$F$20200412$20240724$20200422$20240729$EXP$$US-SHIRE-US202014229$TAKEDA$$8$YR$$M$Y$$$20240729$$MD$US$US
1769458314$17694583$14$F$20180305$20240909$20200422$20240911$EXP$$US-PFIZER INC-2020133769$PFIZER$$60$YR$$F$Y$99.79$KG$20240911$$CN$US$US
176949982$17694998$2$F$$20240626$20200422$20240704$EXP$$US-AMGEN-USASL2020064931$AMGEN$$62$YR$A$M$Y$$$20240704$$CN$US$US
176963273$17696327$3$F$20150201$20240808$20200423$20240809$EXP$$US-NAPPMUNDI-USA-2020-0150295$PURDUE$$54$YR$$M$Y$$$20240809$$CN$US$US
176964654$17696465$4$F$$20240628$20200423$20240703$EXP$$US-NAPPMUNDI-USA-2020-0150931$PURDUE$$$$$M$Y$$$20240703$$CN$US$US
176972086$17697208$6$F$20200120$20240710$20200423$20240719$EXP$$JP-ROCHE-2587803$ROCHE$$71$YR$E$F$Y$43.6$KG$20240719$$MD$JP$JP
176992489$17699248$9$F$20150814$20240808$20200423$20240809$EXP$$US-GILEAD-2020-0460569$GILEAD$$48$YR$A$M$Y$$$20240809$$LW$US$US
177004025$17700402$5$F$20200101$20240831$20200423$20240902$EXP$$US-PFIZER INC-2020165441$PFIZER$$80$YR$$F$Y$$$20240902$$CN$US$US
1770125832$17701258$32$F$20180901$20240703$20200424$20240709$EXP$$CA-CELLTRION INC.-2018CA022761$CELLTRION$$$$$$Y$$$20240709$$CN$CA$CA
177026404$17702640$4$F$$20211102$20200423$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR065509$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
1770302113$17703021$13$F$20220606$20240822$20200423$20240827$EXP$$US-SHIRE-US202014353$TAKEDA$$74$YR$$F$Y$59$KG$20240827$$HP$US$US
177051287$17705128$7$F$20180101$20240904$20200424$20240906$PER$$US-PFIZER INC-2020163179$PFIZER$$65$YR$$F$Y$$$20240906$$CN$US$US
177052893$17705289$3$F$20151201$20240717$20200424$20240718$EXP$$US-GILEAD-2020-0460145$GILEAD$$64$YR$A$M$Y$$$20240718$$LW$US$US
177058152$17705815$2$F$$20240707$20200424$20240710$EXP$$IT-MYLANLABS-2020M1040782$MYLAN$Lerjefors L, Mainardi M, Antonini A, Carecchio M. Drug-induced negative myoclonus: A case report. Mov-Disord 2019;34 (Suppl. 2):S597 abstr. 1462.$83$YR$$F$Y$$$20240710$$HP$IT$IT
177071843$17707184$3$F$$20240731$20200424$20240812$EXP$$CN-Accord-179562$ACCORD$Xue J, Liu W, Shi F, Zheng J, Ma J. Pleural Effusion Due to Use of Pioglitazone: A Case Report. Metab Syndr Relat Disord. 2020 Apr;18(3):168-171.$76$YR$E$F$Y$$$20240812$$MD$CN$CN
177081167$17708116$7$F$20180301$20240702$20200425$20240715$EXP$$CA-ROCHE-2589275$ROCHE$$21$YR$A$M$Y$$$20240715$$CN$CA$CA
1770929125$17709291$25$F$20190729$20240910$20200426$20240917$EXP$$CA-CELLTRION INC.-2019CA023680$CELLTRION$$$$$$Y$$$20240918$$CN$CA$CA
177093883$17709388$3$F$$20240813$20200427$20240827$EXP$$CA-AUROBINDO-AUR-APL-2020-020203$AUROBINDO$$63$YR$$F$Y$$$20240827$$MD$CA$CA
177093892$17709389$2$F$$20240813$20200427$20240826$EXP$$CA-AUROBINDO-AUR-APL-2020-020258$AUROBINDO$$36$YR$$F$Y$$$20240826$$HP$CA$CA
177095012$17709501$2$F$$20240701$20200427$20240708$EXP$$PT-AUROBINDO-AUR-APL-2020-020485$AUROBINDO$Alpalh?o M, Antunes J, Soares-Almeida L, Correia TE, Filipe P.. Fixed drug eruption due to norfloxacin with cross-reactivity with ciprofloxacin: a case report.. Contact Dermatitis.. 2020$63$YR$$F$Y$$$20240708$$HP$PT$PT
177098432$17709843$2$F$20160101$20240911$20200427$20240919$EXP$$BR-BIOGEN-2016BI00315636$BIOGEN$$$$$M$Y$107$KG$20240919$$CN$BR$BR
1771091116$17710911$16$F$20230508$20240718$20200427$20240724$EXP$$US-SHIRE-US202014613$TAKEDA$$87$YR$$M$Y$79$KG$20240724$$CN$US$US
177111265$17711126$5$F$20190401$20240725$20200427$20240731$EXP$$DE-ROCHE-2576081$ROCHE$$62$YR$A$F$Y$68$KG$20240731$$MD$DE$DE
1771144810$17711448$10$F$20200301$20240830$20200427$20240919$PER$$CA-TOLMAR, INC.-20CA021089$TOLMAR$$72$YR$$M$Y$$$20240919$$CN$CA$CA
177115033$17711503$3$F$20140107$20240925$20200427$20240927$EXP$$JP-PFIZER INC-2014055869$PFIZER$$80$YR$$M$Y$68.1$KG$20240927$$MD$JP$JP
177117525$17711752$5$F$20161018$20240925$20200427$20240927$EXP$$JP-PFIZER INC-2017039347$PFIZER$$57$YR$$F$Y$45$KG$20240927$$MD$JP$JP
177127456$17712745$6$F$20200101$20240711$20200427$20240717$PER$$US-PFIZER INC-2020165950$PFIZER$$26$YR$$M$Y$$$20240717$$HP$US$US
177132166$17713216$6$F$$20240707$20200427$20240711$EXP$$IT-PFIZER INC-2020153095$MYLAN$Lerjefors, L.. Drug-induced negative myoclonus: A case report. Movement Disorder. 2019;34 (Suppl 2):S597$83$YR$$F$Y$$$20240711$$HP$IT$IT
1771586920$17715869$20$F$20210118$20240906$20200428$20240911$EXP$$US-SHIRE-US202014603$TAKEDA$$77$YR$$F$Y$39.91$KG$20240911$$HP$US$US
1771632821$17716328$21$F$20190501$20240704$20200428$20240718$EXP$$DE-ROCHE-2588771$ROCHE$$41$YR$A$F$Y$80$KG$20240718$$CN$DE$DE
177176615$17717661$5$F$20200329$20240709$20200428$20240710$EXP$$US-SHIRE-US202014381$TAKEDA$$58$YR$$F$Y$$$20240710$$MD$US$US
1771784923$17717849$23$F$20190706$20240627$20200428$20240705$EXP$$NVSC2019CO054686$NOVARTIS$$6$YR$$F$Y$$$20240705$$CN$CO$CO
177182446$17718244$6$F$20100316$20240918$20200428$20240920$PER$$US-GILEAD-2020-0461789$GILEAD$$56$YR$A$M$Y$$$20240920$$LW$US$US
177191898$17719189$8$F$$20240905$20200428$20240910$EXP$$US-SHIRE-US202014747$TAKEDA$$$$$F$Y$65$KG$20240910$$CN$US$US
177195659$17719565$9$F$20211027$20240723$20200428$20240726$EXP$$US-SHIRE-US202014758$TAKEDA$$75$YR$$F$Y$83.9$KG$20240726$$CN$US$US
1771958240$17719582$40$F$20160801$20240718$20200428$20240725$EXP$$PHHY2016CA125989$NOVARTIS$$70$YR$$M$Y$$$20240725$$CN$CA$CA
177201779$17720177$9$F$20190620$20240626$20200428$20240702$EXP$$CO-TAKEDA-2019TUS041907$TAKEDA$$34$YR$$M$Y$85$KG$20240702$$HP$CO$CO
177212702$17721270$2$F$$20190913$20200429$20240913$PER$$US-ROCHE-2386359$ROCHE$$$$$$Y$$$20240913$$HP$US$US
1772197110$17721971$10$F$20220821$20240725$20200429$20240730$EXP$$US-SHIRE-US202014789$TAKEDA$$49$YR$$F$Y$49$KG$20240730$$CN$US$US
177229663$17722966$3$F$$20240912$20200429$20240923$EXP$SE-EMA-DD-20200406-PRABHAKAR_D-112034$SE-Accord-179941$ACCORD$Bruchfeld A, Barany P, Hedstrom A, Stal P.. Fatal adenovirus hepatitis after rituximab therapy for ANCA-associated vasculitis.. Nephron. 2015129 Suppl 2:110. doi:10.1159/000381121$69$YR$E$M$Y$$$20240923$$HP$SE$SE
177235602$17723560$2$F$20190801$20240829$20200429$20240902$PER$$US-GILEAD-2020-0462379$GILEAD$$56$YR$A$M$Y$$$20240902$$LW$US$US
177250873$17725087$3$F$20180901$20240926$20200429$20240930$PER$$US-GILEAD-2020-0462306$GILEAD$$63$YR$A$M$Y$$$20240930$$LW$US$US
1772622518$17726225$18$F$20191202$20240919$20200429$20240927$EXP$$DE-AUROBINDO-AUR-APL-2020-020829$AUROBINDO$$$$A$F$Y$100.8$KG$20240928$$MD$DE$DE
177271537$17727153$7$F$$20240626$20200430$20240703$EXP$$CA-GLAXOSMITHKLINE-CA2020GSK073370$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$HP$CA$CA
1772780213$17727802$13$F$20220601$20240923$20200430$20240927$EXP$$US-SHIRE-US202014958$TAKEDA$$60$YR$$F$Y$118$KG$20240927$$CN$US$US
177279899$17727989$9$F$20220728$20240919$20200430$20240924$EXP$$US-SHIRE-US202014928$TAKEDA$$73$YR$$F$Y$71$KG$20240924$$HP$US$US
177283784$17728378$4$F$$20240816$20200430$20240820$EXP$$GR-SA-2020SA111164$SANOFI AVENTIS$Komitopoulou A, Goussetis E, Oikonomopoulou C, Paisiou A, Kaisari K, Ioannidou E, et al.. Toxoplasma gondii: How fatal is it in pediatric allogeneic bone marrow transplantation setting?. Transpl Infect Dis.. 2020;22(1):e13226$5$YR$C$M$Y$$$20240820$$MD$GR$GR
177299156$17729915$6$F$20190806$20240731$20200430$20240802$EXP$$US-GILEAD-2020-0462717$GILEAD$$61$YR$A$M$Y$$$20240802$$LW$US$US
1773017517$17730175$17$F$20200303$20240724$20200430$20240727$EXP$$CA-ROCHE-2566008$ROCHE$$31$YR$A$F$Y$$$20240727$$MD$CA$CA
177305856$17730585$6$F$$20240808$20200430$20240813$EXP$$NVSC2020AT116323$NOVARTIS$Haninger-Vacariu N, Aigner C, Kain R, Prohaszka Z, Gaggl M, Bbhmig GA et al.. Successful pregnancies during ongoing eculizumab therapy in two patients with complement mediated thrombotic microangiopathy. KIDNEY MEDICINE. 2020;2(2):213-7$3$DEC$$F$Y$$$20240813$$HP$AT$AT
1773061613$17730616$13$F$$20211215$20200430$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR072333$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
1773075123$17730751$23$F$$20240814$20200430$20240823$EXP$$NVSC2020CA113431$NOVARTIS$$71$YR$$F$Y$69$KG$20240823$$HP$CA$CA
1773170914$17731709$14$F$20050816$20240715$20200501$20240719$EXP$$US-SHIRE-US202015048$TAKEDA$$56$YR$$M$Y$75$KG$20240719$$CN$US$US
1773408411$17734084$11$F$$20240726$20200501$20240731$PER$$US-PFIZER INC-2019086897$PFIZER$$48$YR$$F$Y$$$20240731$$HP$US$US
177341252$17734125$2$F$$20240827$20200501$20240904$PER$$US-PFIZER INC-2020174208$PFIZER$$68$YR$$F$Y$$$20240904$$CN$US$US
177341279$17734127$9$F$$20240903$20200501$20240905$PER$$US-PFIZER INC-2020174632$PFIZER$$74$YR$$M$Y$$$20240905$$CN$US$US
1773500914$17735009$14$F$20190425$20240806$20200501$20240807$EXP$$US-SHIRE-US202014781$TAKEDA$$80$YR$$F$Y$55$KG$20240807$$CN$US$US
1773577110$17735771$10$F$$20240909$20200501$20240914$EXP$$CA-BAUSCH-BL-2020-012871$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240913$$CN$CA$CA
177398446$17739844$6$F$20200430$20240709$20200504$20240712$30DAY$$US-GLAXOSMITHKLINE-US2020074510$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240712$$MD$US$US
177403513$17740351$3$F$$20240912$20200504$20240916$PER$$US-PFIZER INC-2020177260$PFIZER$$48$YR$$F$Y$$$20240916$$CN$US$US
177408594$17740859$4$F$$20240826$20200504$20240830$EXP$$AU-PFIZER INC-2020176005$PFIZER$Crowhurst, T.. Progressive multifocal leukoencephalopathy in a lung transplant recipient presenting with memory impairment: Case report and literature review. Transplant infectious disease. 2020;22 (3):e13293$66$YR$$M$Y$$$20240830$$HP$AU$AU
177413902$17741390$2$F$$20240904$20200504$20240910$EXP$$DE-MYLANLABS-2018M1029236$MYLAN$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al.. Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant recipients, Certain registry study. TRANSPLANTATION. 2018;103 (6):1-33$8$YR$$$Y$$$20240910$$HP$DE$DE
177415413$17741541$3$F$20240830$20240903$20200504$20240905$EXP$$US-KYOWAKIRIN-2020BKK006848$KYOWA$$$$$$Y$$$20240905$$CN$US$US
177416619$17741661$9$F$20160101$20240702$20200504$20240709$EXP$$SE-SHIRE-SE202014877$TAKEDA$$$$$F$Y$76$KG$20240709$$CN$GB$SE
1774232834$17742328$34$F$20221128$20240917$20200504$20240923$EXP$$US-SHIRE-US202015321$TAKEDA$$69$YR$$F$Y$76$KG$20240923$$HP$US$US
1774269834$17742698$34$F$20200101$20240816$20200505$20240824$EXP$$CA-CELLTRION INC.-2019CA027883$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
177428332$17742833$2$F$$20240904$20200504$20240909$EXP$$DE-MYLANLABS-2018M1029378$MYLAN$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al... Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant recipients. CERTAIN registry study. 2018;1-33$2$YR$$$Y$$$20240909$$HP$DE$DE
177428456$17742845$6$F$20200216$20240926$20200505$20240930$EXP$$IT-ROCHE-2592735$ROCHE$$31$YR$A$F$Y$49$KG$20240930$$MD$IT$IT
1774308810$17743088$10$F$20200311$20240910$20200505$20240918$EXP$$CA-CELLTRION INC.-2020CA020622$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
177432902$17743290$2$F$$20240918$20200504$20240920$EXP$$PHHY2019CA097702$NOVARTIS$$$$E$F$Y$$$20240920$$CN$CA$CA
177437715$17743771$5$F$$20240628$20200505$20240710$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2020GSK075602$VIIV$$$$$$Y$$$20240710$$HP$CA$CA
177437825$17743782$5$F$$20240628$20200505$20240702$EXP$$CA-GLAXOSMITHKLINE-CA2020GSK075602$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$CA$CA
177439954$17743995$4$F$$20240820$20200505$20240828$EXP$$NVSC2020IT118169$NOVARTIS$Chinello M, Balter R, De Bortoli M, Vitale V, Zaccaron A, Bonetti E, et al.. Chronic graft-versus-host-disease-related polymyositis: A 17-months-old child with a rare and late complication of haematopoietic stem cell transplantation. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES. 2020;11(1)$6$MON$$F$Y$$$20240828$$HP$IT$IT
1774447851$17744478$51$F$20210323$20240821$20200505$20240827$EXP$$US-SHIRE-US202015186$TAKEDA$$81$YR$$F$Y$64$KG$20240827$$MD$US$US
177447336$17744733$6$F$$20240717$20200505$20240718$EXP$$US-PFIZER INC-2020179131$PFIZER$$65$YR$$F$Y$$$20240718$$CN$US$US
177447648$17744764$8$F$20200326$20240913$20200505$20240917$PER$$US-PFIZER INC-2020177765$PFIZER$$71$YR$$F$Y$81.65$KG$20240917$$CN$US$US
177448027$17744802$7$F$$20240814$20200505$20240816$PER$$US-PFIZER INC-2020177164$PFIZER$$71$YR$$F$Y$88$KG$20240816$$CN$US$US
177456385$17745638$5$F$$20240819$20200505$20240823$EXP$$CA-BAUSCH-BL-2020-012594$BAUSCH AND LOMB$$52$YR$$F$Y$$$20240823$$HP$CA$CA
177460847$17746084$7$F$20200425$20240823$20200505$20240829$EXP$$US-SHIRE-US202015317$TAKEDA$$37$YR$$M$Y$82$KG$20240829$$HP$US$US
177467512$17746751$2$F$20200324$20240710$20200505$20240718$EXP$$JP-009507513-2004JPN002450J$MERCK$$74$YR$$M$Y$43$KG$20240718$$MD$JP$JP
177475325$17747532$5$F$$20240703$20200505$20240705$EXP$$CA-BAUSCH-BL-2020-012898$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240705$$CN$CA$CA
1774824111$17748241$11$F$$20240813$20200505$20240816$EXP$$CA-TAKEDA-2020TUS021156$TAKEDA$$$$$F$Y$$$20240816$$MD$CA$CA
177488863$17748886$3$F$$20240906$20200505$20240911$EXP$$US-GILEAD-2020-0463403$GILEAD$$69$YR$E$M$Y$$$20240911$$HP$US$US
177489435$17748943$5$F$20150101$20240910$20200505$20240916$PER$$US-GILEAD-2020-0464136$GILEAD$$57$YR$A$M$Y$$$20240916$$LW$US$US
177492223$17749222$3$F$20170601$20240702$20200505$20240705$EXP$$US-GILEAD-2020-0463241$GILEAD$$49$YR$A$F$Y$$$20240705$$LW$US$US
177500742$17750074$2$F$$20240624$20200506$20240701$PER$$US-JNJFOC-20200502910$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$LW$US$US
177502736$17750273$6$F$20200101$20240909$20200506$20240912$EXP$$PR-PFIZER INC-2020180802$PFIZER$$68$YR$$F$Y$$$20240912$$HP$PR$PR
177517315$17751731$5$F$20200426$20240715$20200506$20240718$EXP$$US-SHIRE-US202015413$TAKEDA$$52$YR$$F$Y$$$20240718$$MD$US$US
177521305$17752130$5$F$20070322$20240705$20200506$20240708$EXP$$US-GILEAD-2020-0464326$GILEAD$$49$YR$A$M$Y$$$20240708$$LW$US$US
177528613$17752861$3$F$$20240703$20200506$20240705$EXP$$CA-BAUSCH-BL-2020-013000$BAUSCH AND LOMB$$59$YR$$M$Y$114$KG$20240705$$HP$CA$CA
177536312$17753631$2$F$20200414$20240720$20200507$20240726$EXP$$FR-AUROBINDO-AUR-APL-2020-022332$AUROBINDO$$28$YR$$F$Y$59$KG$20240726$$PH$FR$FR
1775435021$17754350$21$F$20220901$20240805$20200506$20240812$EXP$$US-SHIRE-US202015320$TAKEDA$$69$YR$$F$Y$76$KG$20240812$$HP$US$US
177544093$17754409$3$F$$20240711$20200506$20240716$EXP$$CA-PFIZER INC-2020175762$MYLAN$$59$YR$$F$Y$$$20240716$$HP$CA$CA
177547902$17754790$2$F$$20240719$20200507$20240730$EXP$$PL-AUROBINDO-AUR-APL-2020-021755$AUROBINDO$$23$YR$$M$Y$100$KG$20240730$$MD$PL$PL
177558976$17755897$6$F$$20240827$20200507$20240902$EXP$$US-TAKEDA-2018TUS033659$TAKEDA$$$$$M$Y$$$20240902$$CN$US$US
177564894$17756489$4$F$$20240710$20200507$20240716$EXP$$US-PFIZER INC-2020181199$PFIZER$$65$YR$$F$Y$$$20240716$$CN$US$US
177574563$17757456$3$F$20200415$20240717$20200507$20240723$EXP$$US-KYOWAKIRIN-2020BKK007114$KYOWA$$$$$$Y$$$20240723$$CN$US$US
1775766622$17757666$22$F$20230415$20240919$20200507$20240925$EXP$$US-SHIRE-US202015570$TAKEDA$$80$YR$$F$Y$81$KG$20240925$$CN$US$US
177580606$17758060$6$F$$20240819$20200507$20240826$EXP$$CA-JNJFOC-20200437410$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240826$$HP$CA$CA
177586645$17758664$5$F$20200217$20240705$20200508$20240715$EXP$$DE-AUROBINDO-AUR-APL-2020-021886$AUROBINDO$$$$E$F$Y$73.4$KG$20240715$$MD$DE$DE
177588753$17758875$3$F$20191004$20240702$20200508$20240705$PER$$US-GILEAD-2020-0463989$GILEAD$$37$YR$A$M$Y$$$20240705$$LW$US$US
177589965$17758996$5$F$$20240920$20200508$20240925$EXP$$US-SHIRE-US202015591$TAKEDA$$$$$M$Y$107$KG$20240925$$CN$US$US
177595296$17759529$6$F$20120201$20240823$20200508$20240828$PER$$US-GILEAD-2020-0464244$GILEAD$$57$YR$A$M$Y$$$20240828$$LW$US$US
1776066573$17760665$73$F$20201205$20240917$20200508$20240924$EXP$$US-SHIRE-US202015554$TAKEDA$$78$YR$$F$Y$78$KG$20240924$$HP$US$US
1776136020$17761360$20$F$20150311$20240827$20200508$20240830$EXP$$PHHY2014CA125377$NOVARTIS$$$$A$F$Y$$$20240830$$MD$CA$CA
177626156$17762615$6$F$20200505$20240813$20200509$20240816$EXP$$CA-TAKEDA-2019TUS035357$TAKEDA$$53$YR$$F$Y$$$20240816$$CN$CA$CA
1776313119$17763131$19$F$20130730$20240809$20200508$20240819$EXP$$PHHY2015CA169370$NOVARTIS$$71$YR$$F$Y$$$20240819$$CN$CA$CA
1776398940$17763989$40$F$20190101$20240819$20200510$20240827$EXP$$CA-CELLTRION INC.-2019CA022294$CELLTRION$$$$$$Y$$$20240827$$MD$CA$CA
1776405422$17764054$22$F$20200501$20240912$20200511$20240921$EXP$$CA-CELLTRION INC.-2020CA022150$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
177649665$17764966$5$F$20200507$20240820$20200511$20240827$EXP$$US-GLAXOSMITHKLINE-US2020078027$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
177659634$17765963$4$F$20191015$20240726$20200511$20240802$EXP$$CA-ROCHE-2451161$ROCHE$$27$YR$A$F$Y$$$20240802$$CN$CA$CA
177663672$17766367$2$F$$20240722$20200511$20240729$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR078627$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$HP$CA$CA
1776678928$17766789$28$F$20210107$20240912$20200511$20240918$EXP$$US-SHIRE-US202015722$TAKEDA$$58$YR$$F$Y$47$KG$20240918$$MD$US$US
1776679312$17766793$12$F$$20240815$20200511$20240821$EXP$$US-SHIRE-US202015682$TAKEDA$$$$$M$Y$95$KG$20240821$$HP$US$US
1776719912$17767199$12$F$$20240918$20200511$20240926$EXP$$US-SHIRE-US202015960$TAKEDA$$$$$F$Y$75$KG$20240926$$HP$US$US
1776784414$17767844$14$F$20190410$20240624$20200511$20240703$EXP$$AU-SHIRE-AU201912549$TAKEDA$$11$YR$$M$Y$33$KG$20240703$$HP$AU$AU
177685854$17768585$4$F$$20240830$20200512$20240830$EXP$$DE-ROCHE-2596368$ROCHE$Kasper P, Gobel H, Michels G.. mTOR-induced pneumonitis in a 72-year-old patient after heart transplantation. Dtsch-Med-Wochenschr 2020;185:189-194.$72$YR$E$M$Y$57.8$KG$20240830$$HP$DE$DE
177687303$17768730$3$F$20180913$20240913$20200512$20240926$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-01683$ALKEM$Werner C, Lupp A, Mtuka-Pardon G, Kloos C, Wolf G, Aschenbach R, Biermann A, Freesmeyer M, Seifert P.. Case report of a cystic parathyroidal adenoma with rapid growth induced by cinacalcet. BMC Endocrine Disorders. 2020;20:53$56$YR$$F$Y$60$KG$20240926$$HP$DE$DE
1776899413$17768994$13$F$20191201$20240808$20200512$20240809$EXP$$US-PFIZER INC-2020188417$PFIZER$$61$YR$$F$Y$$$20240809$$CN$US$US
177692842$17769284$2$F$$20240626$20200512$20240709$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02223$HIKMA$Elangovan C , Niazi M , Zeigler G , Shankar L. Elangovan C , Niazi M , Zeigler G , Shankar L. Reversible cerebral vasoconstriction syndrome precipitated by IV and oral steroids in a patient with new diagnosis of multiple sclerosis. Annals of Neurology. 2019;86:S140$28$YR$$F$Y$$$20240709$$MD$US$US
1776955019$17769550$19$F$20240413$20240917$20200512$20240923$EXP$$US-SHIRE-US202015958$TAKEDA$$39$YR$$F$Y$73$KG$20240923$$HP$US$US
177696305$17769630$5$F$$20240919$20200512$20240925$EXP$$US-SHIRE-US202015998$TAKEDA$$$$$M$Y$84$KG$20240925$$CN$US$US
177698149$17769814$9$F$20200101$20240917$20200512$20240920$EXP$$US-PFIZER INC-2020189154$PFIZER$$87$YR$$F$Y$$$20240920$$HP$US$US
1777038821$17770388$21$F$$20240821$20200512$20240828$EXP$$US-SHIRE-US202015448$TAKEDA$$$$$F$Y$$$20240828$$HP$US$US
1777039222$17770392$22$F$$20240716$20200512$20240720$EXP$$US-SHIRE-US202015703$TAKEDA$$$$$F$Y$66$KG$20240720$$HP$US$US
177703936$17770393$6$F$$20240813$20200512$20240815$EXP$$US-SHIRE-US202015704$TAKEDA$$$$$F$Y$59$KG$20240815$$MD$US$US
1777041211$17770412$11$F$20201001$20240822$20200512$20240828$EXP$$US-SHIRE-US202015845$TAKEDA$$59$YR$$F$Y$81$KG$20240828$$HP$US$US
177711715$17771171$5$F$$20240821$20200512$20240821$PER$$US-GILEAD-2020-0465787$GILEAD$$$$A$M$Y$$$20240821$$LW$US$US
177714886$17771488$6$F$20030201$20240827$20200512$20240828$EXP$$US-GILEAD-2020-0466395$GILEAD$$36$YR$A$F$Y$$$20240828$$LW$US$US
1777283827$17772838$27$F$$20240725$20200512$20240729$EXP$$NVSC2020CO128552$NOVARTIS$$$$$M$Y$70$KG$20240729$$CN$CO$CO
1777290320$17772903$20$F$20190301$20240905$20200512$20240912$EXP$$PHHY2019CA060714$NOVARTIS$$72$YR$$F$Y$$$20240912$$CN$CA$CA
177747579$17774757$9$F$$20240718$20200513$20240812$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-000073$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
177751745$17775174$5$F$20231001$20240624$20200513$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-000525$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240718$$CN$US$US
177754303$17775430$3$F$20200223$20240621$20200513$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-000828$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240716$$CN$US$US
177761894$17776189$4$F$20190501$20240607$20200513$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2019-013158$ACADIA PHARMACEUTICALS$$64$YR$$M$Y$$$20240701$$CN$US$US
177769746$17776974$6$F$20210411$20240613$20200513$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2019-013703$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$81$KG$20240708$$CN$US$US
177773855$17777385$5$F$20230221$20240617$20200513$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2019-014588$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240712$$CN$US$US
1777750710$17777507$10$F$20191101$20240624$20200513$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2019-014796$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$77$KG$20240718$$CN$US$US
1777756813$17777568$13$F$20191001$20240911$20200513$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2019-014937$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240923$$CN$US$US
1777796829$17777968$29$F$20221211$20240723$20200513$20240726$EXP$$US-SHIRE-US202016116$TAKEDA$$71$YR$$F$Y$88$KG$20240726$$MD$US$US
177779843$17777984$3$F$20230715$20240911$20200513$20240921$EXP$$US-ROCHE-2597699$ROCHE$$79$YR$E$F$Y$49.44$KG$20240921$$CN$US$US
177784328$17778432$8$F$20200225$20240917$20200513$20240924$EXP$$DE-MYLANLABS-2020M1046087$MYLAN$$$$E$F$Y$94$KG$20240924$$HP$DE$DE
177806102$17780610$2$F$20190601$20240910$20200513$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2019-013345$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240927$$CN$US$US
177833105$17783310$5$F$$20240701$20200514$20240703$EXP$$US-PFIZER INC-2020192234$PFIZER$$59$YR$$F$Y$84.37$KG$20240703$$CN$US$US
177835393$17783539$3$F$20240108$20240708$20200514$20240711$EXP$$US-KYOWAKIRIN-2020BKK007562$KYOWA$$$$$$Y$$$20240711$$HP$US$US
177842968$17784296$8$F$20240214$20240717$20200514$20240724$EXP$$PHHY2018DO124818$NOVARTIS$$76$YR$$F$Y$$$20240724$$CN$DO$DO
1778621632$17786216$32$F$20190301$20240910$20200513$20240918$EXP$$CA-CELLTRION INC.-2019CA019905$CELLTRION$$$$$$Y$$$20240918$$CN$CA$CA
177862788$17786278$8$F$20200217$20240820$20200514$20240827$EXP$$NVSC2020DE130796$NOVARTIS$$$$E$F$Y$72$KG$20240827$$HP$DE$DE
177868602$17786860$2$F$20200128$20240708$20200514$20240715$EXP$$ES-MYLANLABS-2020M1046347$MYLAN$$58$YR$$M$Y$$$20240715$$MD$ES$ES
1778801017$17788010$17$F$20190528$20240808$20200514$20240812$EXP$$CA-TAKEDA-2020TUS021977$TAKEDA$$51$YR$$M$Y$$$20240812$$CN$CA$CA
177893255$17789325$5$F$20120315$20240913$20200515$20240918$PER$$US-GILEAD-2020-0466940$GILEAD$$53$YR$A$F$Y$$$20240918$$LW$US$US
1778961416$17789614$16$F$20240717$20240924$20200515$20240930$EXP$$US-SHIRE-US202016272$TAKEDA$$34$YR$$F$Y$102$KG$20240930$$CN$US$US
1779249416$17792494$16$F$20150209$20240801$20200515$20240802$EXP$$US-SHIRE-US202016141$TAKEDA$$56$YR$$M$Y$89$KG$20240802$$HP$US$US
177925444$17792544$4$F$20200101$20240918$20200515$20240927$EXP$$US-VERTEX PHARMACEUTICALS-2020-006850$VERTEX$$$$$F$Y$52$KG$20240927$$MD$US$US
177936815$17793681$5$F$20220628$20240730$20200515$20240805$EXP$$NVSC2020CA132782$NOVARTIS$$58$YR$$M$Y$$$20240805$$CN$CA$CA
177951077$17795107$7$F$20170814$20240705$20200516$20240710$EXP$$CA-TAKEDA-2017TUS015806$TAKEDA$$38$YR$$F$Y$$$20240710$$CN$CA$CA
177966056$17796605$6$F$20200403$20240619$20200518$20240703$EXP$$CA-ROCHE-2580269$ROCHE$$26$YR$A$F$Y$100$KG$20240703$$HP$CA$CA
177966206$17796620$6$F$20210702$20240703$20200518$20240709$EXP$$US-SHIRE-US202016406$TAKEDA$$65$YR$$F$Y$90$KG$20240709$$HP$US$US
177968037$17796803$7$F$$20240801$20200518$20240814$EXP$$ES-AUROBINDO-AUR-APL-2020-024372$AUROBINDO$Mensa, J. et al. Neck infection after allogenic hematopoietic progenitors transplantation. Revista Espanola de Quimioterapia. 2020;33:2:130-6$65$YR$$F$Y$$$20240814$$MD$ES$ES
177973218$17797321$8$F$20200506$20240911$20200518$20240917$EXP$$NVSC2020CA097237$NOVARTIS$$56$YR$$M$Y$104.5$KG$20240917$$MD$CA$CA
177989102$17798910$2$F$20200510$20240814$20200518$20240820$EXP$$US-SHIRE-US202016403$TAKEDA$$26$YR$$M$Y$$$20240820$$PH$US$US
1779972326$17799723$26$F$20221215$20240913$20200518$20240919$EXP$$US-SHIRE-US202016558$TAKEDA$$39$YR$$F$Y$78$KG$20240919$$CN$US$US
1780030023$17800300$23$F$20200803$20240814$20200519$20240820$EXP$$US-SHIRE-US202016644$TAKEDA$$52$YR$$F$Y$57$KG$20240820$$MD$US$US
1780092838$17800928$38$F$20190101$20240704$20200518$20240830$EXP$$CA-CELLTRION INC.-2019CA025473$CELLTRION$$$$$$Y$$$20240830$$MD$CA$CA
1780101624$17801016$24$F$20200704$20240905$20200519$20240911$EXP$$US-SHIRE-US202016565$TAKEDA$$67$YR$$F$Y$115$KG$20240911$$HP$US$US
1780120522$17801205$22$F$20180305$20240816$20200519$20240826$EXP$$CA-CELLTRION INC.-2019CA019200$CELLTRION$$$$$$Y$$$20240826$$CN$CA$CA
178019897$17801989$7$F$20190517$20240822$20200519$20240827$EXP$$JP-ABBVIE-19S-087-2701045-00$ABBVIE$$52$YR$$F$Y$40$KG$20240827$$CN$JP$JP
178020433$17802043$3$F$20200226$20240913$20200519$20240918$EXP$$NVSC2020DE072480$NOVARTIS$$$$A$F$Y$63$KG$20240919$$MD$DE$DE
178032204$17803220$4$F$$20240913$20200519$20240923$EXP$$CA-TAKEDA-2020TUS022765$TAKEDA$$$$$M$Y$$$20240923$$CN$CA$CA
1780353416$17803534$16$F$20200707$20240829$20200519$20240904$EXP$$AU-PFIZER INC-2020191005$PFIZER$$55$YR$$F$Y$$$20240904$$HP$AU$AU
1780358640$17803586$40$F$$20240905$20200519$20240912$EXP$$US-SHIRE-US202015966$TAKEDA$$$$$F$Y$65$KG$20240912$$MD$US$US
1780359016$17803590$16$F$20230308$20240905$20200519$20240911$EXP$$US-SHIRE-US202016390$TAKEDA$$5$YR$$M$Y$15$KG$20240911$$CN$US$US
1780459813$17804598$13$F$20211203$20240923$20200519$20240925$EXP$$US-SHIRE-US202016643$TAKEDA$$83$YR$$M$Y$78$KG$20240925$$HP$US$US
1780504240$17805042$40$F$20200409$20240827$20200520$20240905$EXP$$CA-CELLTRION INC.-2020CA022407$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
178055128$17805512$8$F$20191121$20240816$20200520$20240823$EXP$$NVSC2020US133505$NOVARTIS$$74$YR$$M$Y$$$20240823$$MD$US$US
178068824$17806882$4$F$$20240625$20200520$20240701$PER$$US-PFIZER INC-2020199828$PFIZER$$68$YR$$F$Y$$$20240701$$MD$US$US
178109664$17810966$4$F$20200601$20240820$20200521$20240830$EXP$$US-009507513-2005USA006382$MERCK$$72$YR$$M$Y$76.19$KG$20240830$$HP$US$US
178118395$17811839$5$F$$20240724$20200521$20240801$PER$$US-SA-2020SA107924$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240801$$MD$US$US
1781190212$17811902$12$F$20150101$20240814$20200521$20240819$EXP$$CA-009507513-1606CAN010226$MERCK$$45$YR$$M$Y$81$KG$20240819$$HP$CA$CA
178126556$17812655$6$F$20190101$20240730$20200521$20240802$EXP$$CA-PFIZER INC-2019384479$PFIZER$$68$YR$$F$Y$$$20240802$$CN$CA$CA
178146395$17814639$5$F$$20240917$20200522$20240924$EXP$$US-GLAXOSMITHKLINE-US2020AMR086391$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$US$US
178164998$17816499$8$F$$20240806$20200522$20240807$EXP$$US-PFIZER INC-2020203122$PFIZER$$80$YR$$F$Y$58.97$KG$20240807$$CN$US$US
1781718012$17817180$12$F$20200210$20240827$20200522$20240902$EXP$$CA-TAKEDA-2020TUS009512$TAKEDA$$59$YR$$F$Y$$$20240902$$CN$CA$CA
178176753$17817675$3$F$20200505$20240722$20200522$20240726$EXP$$DE-ABBVIE-20K-062-3412453-00$ABBVIE$$50$YR$$M$Y$$$20240726$$MD$DE$DE
178190432$17819043$2$F$20200101$20240617$20200523$20240702$PER$$US-AstraZeneca-2020SE58439$ASTRAZENECA$$65$YR$$F$Y$$$20240702$$CN$US$
1781972534$17819725$34$F$20200504$20240724$20200524$20240729$EXP$$US-SHIRE-US202017119$TAKEDA$$69$YR$$F$Y$58$KG$20240729$$CN$US$US
178201248$17820124$8$F$20200217$20240828$20200525$20240906$EXP$$DE-AUROBINDO-AUR-APL-2020-025628$AUROBINDO$$$$E$F$Y$72$KG$20240906$$MD$DE$DE
1782028129$17820281$29$F$$20240718$20200525$20240723$EXP$$US-SHIRE-US202017132$TAKEDA$$$$$F$Y$58$KG$20240723$$CN$US$US
178203487$17820348$7$F$$20240712$20200525$20240723$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-025513$BOEHRINGER INGELHEIM$$57$YR$A$F$Y$$$20240719$$CN$CA$CA
178203516$17820351$6$F$20190901$20240906$20200525$20240913$EXP$$NVSC2020US133521$NOVARTIS$$64$YR$$F$Y$$$20240913$$MD$US$US
178203782$17820378$2$F$$20240918$20200525$20240925$EXP$$CA-ROCHE-2604402$ROCHE$$15$YR$T$F$Y$$$20240925$$HP$CA$CA
178206516$17820651$6$F$20110101$20240926$20200525$20240930$PER$$US-GILEAD-2020-0467084$GILEAD$$40$YR$A$M$Y$111.11$KG$20240930$$LW$US$US
178208286$17820828$6$F$20220609$20240828$20200525$20240902$EXP$$US-SHIRE-US202017257$TAKEDA$$73$YR$$F$Y$87$KG$20240902$$CN$US$US
178211443$17821144$3$F$$20240813$20200525$20240820$EXP$PL-MLMSERVICE-20200512-2299307-1$PL-SA-2020SA121887$SANOFI AVENTIS$Jankowski J, Jedynak P, Pazik J.. Pregnant woman with primary membranous nephropathy - case report.. Pol Med J.. 2020;48(284):105-7$21$YR$A$F$Y$$$20240820$$MD$PL$PL
178220968$17822096$8$F$20200520$20240919$20200526$20240923$EXP$$NVSC2020MX142224$NOVARTIS$$36$YR$$F$Y$107$KG$20240923$$CN$MX$MX
178221018$17822101$8$F$20200614$20240827$20200526$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-247940$RANBAXY$$73$YR$E$F$Y$$$20240911$$CN$US$US
178221133$17822113$3$F$$20200728$20200526$20240920$EXP$$NVSC2020PL142413$NOVARTIS$$$$$$Y$$$20240920$$MD$PL$PL
178224416$17822441$6$F$20210922$20240627$20200526$20240701$EXP$$US-SHIRE-US202016915$TAKEDA$$62$YR$$F$Y$$$20240701$$MD$US$US
1782263810$17822638$10$F$$20240826$20200526$20240902$EXP$$CA-AstraZeneca-2020SE67936$ASTRAZENECA$$65$YR$$F$Y$$$20240902$$MD$CA$
1782408516$17824085$16$F$20200922$20240919$20200526$20240924$EXP$$US-SHIRE-US202017345$TAKEDA$$25$YR$$F$Y$61$KG$20240924$$CN$US$US
1782488022$17824880$22$F$20200512$20240906$20200526$20240911$EXP$$US-SHIRE-US202017219$TAKEDA$$29$YR$$M$Y$$$20240911$$CN$US$US
1782663532$17826635$32$F$20180101$20240822$20200527$20240830$EXP$$CA-CELLTRION INC.-2018CA021352$CELLTRION$$$$$$Y$$$20240830$$CN$CA$CA
178271099$17827109$9$F$20181207$20240704$20200527$20240712$EXP$$AT-CELLTRION INC.-2020AT022577$CELLTRION$$$$$$Y$$$20240712$$MD$AT$AT
178279858$17827985$8$F$20200101$20240618$20200527$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001462$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
178282963$17828296$3$F$$20240723$20200527$20240730$PER$$US-SHIRE-US202017139$TAKEDA$$$$$F$Y$$$20240730$$HP$US$US
178284645$17828464$5$F$$20240910$20200527$20240917$PER$$US-PFIZER INC-2018298096$PFIZER$$67$YR$$F$Y$77.098$KG$20240917$$HP$US$US
178285427$17828542$7$F$20200501$20240708$20200527$20240710$PER$$US-PFIZER INC-2020208352$PFIZER$$65$YR$$M$Y$$$20240710$$HP$US$US
178290112$17829011$2$F$20190607$20240903$20200527$20240905$EXP$$US-UCBSA-2019034114$UCB$$25$YR$$M$Y$$$20240905$$PH$US$US
1782912031$17829120$31$F$20240503$20240722$20200527$20240729$EXP$$US-SHIRE-US202017476$TAKEDA$$63$YR$$M$Y$73$KG$20240729$$HP$US$US
178296262$17829626$2$F$$20240826$20200527$20240828$PER$$US-BIOVITRUM-2020US0503$BIOVITRUM$$70$YR$$F$Y$$$20240828$$MD$US$US
178308784$17830878$4$F$20200501$20240705$20200527$20240724$EXP$$DE-ROCHE-2608931$ROCHE$$46$YR$A$F$Y$65$KG$20240724$$MD$DE$DE
178312707$17831270$7$F$20170906$20240907$20200527$20240914$EXP$$CA-SA-2017SA169943$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240914$$HP$CA$CA
178314793$17831479$3$F$20200328$20240913$20200527$20240924$EXP$FR-AFSSAPS-AM20200588$FR-NOVOPROD-728979$NOVO NORDISK$$73$YR$$M$Y$80.6$KG$20240924$$MD$FR$FR
1783240919$17832409$19$F$20201101$20240819$20200528$20240827$EXP$$US-SHIRE-US202017512$TAKEDA$$66$YR$$M$Y$84$KG$20240827$$HP$US$US
178326943$17832694$3$F$20200104$20240711$20200528$20240712$EXP$$US-UCBSA-2020001680$UCB$$57$YR$$F$Y$$$20240712$$HP$US$US
1783658136$17836581$36$F$20220307$20240918$20200529$20240923$EXP$$US-SHIRE-US202017619$TAKEDA$$81$YR$$F$Y$63$KG$20240923$$HP$US$US
1783851337$17838513$37$F$20190101$20240923$20200528$20240926$EXP$$NVSC2020CO055412$NOVARTIS$$$$$F$Y$58$KG$20240926$$CN$CO$CO
1783957213$17839572$13$F$$20240713$20200529$20240715$EXP$$CA-PFIZER INC-2019497568$PFIZER$$37$YR$$M$Y$$$20240715$$MD$CA$CA
178402628$17840262$8$F$20090101$20240911$20200529$20240917$EXP$$PL-MYLANLABS-2020M1051899$MYLAN$Gowin, E, Januszkiewicz-Lewandowska D.. TP53 mutation in children with therapy-related myelodysplastic syndrome/acute myeloid leukemia after rhabdomyosarcoma treatment.. Palliative Medicine in Practice. 2020;14 (1):58-62$9$YR$$M$Y$$$20240917$$MD$PL$PL
178403493$17840349$3$F$$20240910$20200529$20240919$EXP$$CA-ROCHE-2606318$ROCHE$$47$YR$A$F$Y$117$KG$20240919$$CN$CA$CA
178405435$17840543$5$F$$20240813$20200529$20240815$EXP$$US-PFIZER INC-2020197597$PFIZER$$74$YR$$F$Y$$$20240815$$CN$US$US
1784062059$17840620$59$F$20140101$20240808$20200529$20240814$EXP$$CA-PFIZER INC-2020211017$PFIZER$$46$YR$$M$Y$$$20240814$$MD$CA$CA
1784109514$17841095$14$F$20200101$20240811$20200529$20240820$PER$$US-PFIZER INC-2020211716$PFIZER$$61$YR$$F$Y$$$20240820$$HP$US$US
178429695$17842969$5$F$$20240916$20200530$20240921$EXP$$CA-ROCHE-2606437$ROCHE$$42$YR$A$F$Y$81$KG$20240921$$HP$CA$CA
178434066$17843406$6$F$$20240814$20200530$20240819$EXP$$CA-ROCHE-2607077$ROCHE$$69$YR$E$M$Y$76$KG$20240819$$HP$CA$CA
1784528832$17845288$32$F$$20240807$20200601$20240812$EXP$$US-SHIRE-US202017777$TAKEDA$$$$$F$Y$77$KG$20240812$$MD$US$US
178460916$17846091$6$F$20200101$20240817$20200601$20240819$PER$$US-PFIZER INC-2020170745$PFIZER$$61$YR$$F$Y$$$20240819$$HP$US$US
178466869$17846686$9$F$$20240912$20200601$20240920$EXP$$CA-TAKEDA-2020TUS023975$TAKEDA$$$$$F$Y$$$20240920$$PH$CA$CA
178468953$17846895$3$F$$20240906$20200601$20240911$EXP$$US-GILEAD-2020-0469268$GILEAD$$55$YR$A$F$Y$$$20240911$$HP$US$US
1784699914$17846999$14$F$$20240712$20200601$20240716$EXP$$US-PFIZER INC-2020213427$PFIZER$$83$YR$$F$Y$$$20240716$$HP$US$US
178470709$17847070$9$F$20171030$20240812$20200601$20240816$EXP$$US-SHIRE-US202017856$TAKEDA$$50$YR$$F$Y$68$KG$20240816$$HP$US$US
178481337$17848133$7$F$20160818$20240718$20200601$20240724$EXP$$CA-TAKEDA-2017TUS011312$TAKEDA$$63$YR$$F$Y$$$20240724$$CN$CA$CA
1784817620$17848176$20$F$20200505$20240917$20200601$20240920$EXP$$US-TAKEDA-2020TUS024317$TAKEDA$$63$YR$$F$Y$78.4$KG$20240920$$HP$US$US
1784826928$17848269$28$F$20140101$20240808$20200602$20240816$EXP$$CA-CELLTRION INC.-2020CA022710$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
1784831615$17848316$15$F$20210301$20240626$20200602$20240701$EXP$$US-SHIRE-US202017793$TAKEDA$$74$YR$$F$Y$56$KG$20240701$$HP$US$US
178497299$17849729$9$F$20240101$20240909$20200602$20240911$EXP$$US-PFIZER INC-2020214533$PFIZER$$68$YR$$F$Y$70.76$KG$20240911$$CN$US$US
178505362$17850536$2$F$20190901$20240708$20200602$20240711$EXP$$AT-PFIZER INC-2020210738$PFIZER$$63$YR$$F$Y$58$KG$20240711$$MD$AT$AT
178505654$17850565$4$F$20200101$20240709$20200602$20240717$PER$$US-VERTEX PHARMACEUTICALS-2020-007101$VERTEX$$$$$F$Y$$$20240717$$PH$US$US
1785089823$17850898$23$F$20191212$20240913$20200602$20240919$EXP$$US-SHIRE-US202018053$TAKEDA$$53$YR$$F$Y$145$KG$20240919$$HP$US$US
178509675$17850967$5$F$$20240926$20200602$20240930$EXP$$US-PFIZER INC-2020214351$PFIZER$$70$YR$$F$Y$72.57$KG$20240930$$CN$US$US
1785097024$17850970$24$F$20200501$20240906$20200602$20240910$EXP$$US-SHIRE-US202017810$TAKEDA$$38$YR$$M$Y$$$20240910$$PH$US$US
1785168728$17851687$28$F$20230501$20240814$20200602$20240820$EXP$$US-SHIRE-US202018014$TAKEDA$$68$YR$$F$Y$77$KG$20240820$$CN$US$US
178536522$17853652$2$F$20200511$20240823$20200603$20240831$EXP$$BR-TAKEDA-2020TUS024275$TAKEDA$$47$YR$$F$Y$86$KG$20240831$$CN$BR$BR
178541016$17854101$6$F$$20240814$20200603$20240826$EXP$$DE-AUROBINDO-AUR-APL-2020-026304$AUROBINDO$Stefanou MI, Vittore D, Wolz I, Klingberg S, Wildgruber D.. Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia.. Frontiers in Psychiatry. 2020;11:318$29$YR$$M$Y$$$20240826$$MD$DE$DE
178542683$17854268$3$F$$20240809$20200603$20240821$EXP$ES-EMA-DD-20200525-GANGAL_S-105908$ES-Accord-183905$ACCORD$Mensa, J. et al... Neck infection after allogenic hematopoietic progenitors transplantation.. Revista de la Sociedad Espanola de Quimioterapia. 2020;33:2:130-136$65$YR$E$F$Y$$$20240821$$HP$ES$ES
178544554$17854455$4$F$20200521$20240712$20200603$20240718$PER$$US-SA-2020SA140704$SANOFI AVENTIS$$43$YR$A$F$Y$70.306$KG$20240718$$MD$US$US
1785460615$17854606$15$F$20200505$20240920$20200603$20240927$EXP$$NVSC2020GB140788$NOVARTIS$$9$YR$$F$Y$38$KG$20240927$$MD$GB$GB
178546097$17854609$7$F$$20240910$20200603$20240918$EXP$$NVSC2020CA153004$NOVARTIS$$56$YR$$F$Y$$$20240919$$CN$CA$CA
178547005$17854700$5$F$$20240828$20200603$20240909$EXP$$ES-MACLEODS PHARMACEUTICALS US LTD-MAC2020026660$MACLEODS$$$$$$Y$$$20240909$$HP$ES$ES
178549163$17854916$3$F$$20240731$20200603$20240805$PER$$US-PFIZER INC-2020104608$PFIZER$$70$YR$$M$Y$$$20240805$$MD$US$US
178556873$17855687$3$F$20201201$20240827$20200603$20240902$EXP$$US-PFIZER INC-2019289841$PFIZER$$72$YR$$F$Y$70.03$KG$20240902$$CN$US$US
178566013$17856601$3$F$$20240910$20200603$20240918$EXP$$NVSC2020CA153277$NOVARTIS$$53$YR$$M$Y$$$20240918$$CN$CA$CA
1785723610$17857236$10$F$20180101$20240812$20200603$20240815$EXP$$US-JAZZ-2020-US-007057$JAZZ$$$$$F$Y$$$20240815$$CN$US$US
1785889620$17858896$20$F$$20240826$20200604$20240903$EXP$$US-SHIRE-US202018368$TAKEDA$$$$$F$Y$50$KG$20240903$$HP$US$US
178599146$17859914$6$F$20200524$20240904$20200604$20240906$EXP$$US-SHIRE-US202018063$TAKEDA$$54$YR$$M$Y$$$20240906$$CN$US$US
178606893$17860689$3$F$20200501$20240813$20200604$20240827$PER$$US-SA-2020SA143421$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240827$$MD$US$US
178609674$17860967$4$F$$20240730$20200604$20240808$PER$$US-INCYTE CORPORATION-2020IN004975$INCYTE$$$$$$Y$$$20240808$$CN$US$US
1786205931$17862059$31$F$20220912$20240919$20200604$20240927$EXP$$US-SHIRE-US202018022$TAKEDA$$73$YR$$F$Y$53$KG$20240927$$MD$US$US
178630543$17863054$3$F$$20240710$20200604$20240718$EXP$$IT-BAUSCH-BL-2020-016069$BAUSCH AND LOMB$Muggeo P, Angarano R, Daniele R, Ingravallo G, Santoro N. BV-DHAP as salvage treatment for high risk adolescent Hodgkin lymphoma. Klinische Padiatrie. 2020;232(2):106-107. doi:10.1055/s-0040-1701898$15$YR$$M$Y$$$20240718$$MD$IT$IT
1786327612$17863276$12$F$20200101$20240726$20200605$20240807$EXP$$DE-ROCHE-2610228$ROCHE$$67$YR$E$F$Y$87$KG$20240807$$CN$DE$DE
178637538$17863753$8$F$20191119$20240730$20200605$20240802$EXP$$NO-TAKEDA-2020TUS024952$TAKEDA$$75$YR$$M$Y$$$20240802$$MD$NO$NO
1786386513$17863865$13$F$20190802$20240328$20200605$20240923$PER$$IT-ROCHE-2609084$ROCHE$$66$YR$E$F$Y$57$KG$20240923$$MD$IT$IT
178639058$17863905$8$F$20200529$20240917$20200605$20240922$EXP$$CA-ROCHE-2614946$ROCHE$$39$YR$A$F$Y$$$20240922$$CN$CA$CA
178655589$17865558$9$F$20230101$20240712$20200605$20240718$EXP$$US-PFIZER INC-2020220414$PFIZER$$80$YR$$F$Y$59.864$KG$20240718$$CN$US$US
178660606$17866060$6$F$20240717$20240724$20200605$20240730$30DAY$$US-GLAXOSMITHKLINE-US2020091750$GLAXOSMITHKLINE$$36$YR$$F$Y$$$20240730$$CN$US$US
178662837$17866283$7$F$20200527$20240717$20200605$20240726$PER$$US-VERTEX PHARMACEUTICALS-2020-011968$VERTEX$$31$YR$$F$Y$$$20240726$$PH$US$US
178663448$17866344$8$F$20210726$20240719$20200605$20240725$EXP$$US-SHIRE-US202017959$TAKEDA$$8$YR$$M$Y$$$20240725$$CN$US$US
1786640711$17866407$11$F$20200101$20240809$20200605$20240813$PER$$US-DSJP-DSU-2020-115383$DAIICHI$$$$$F$Y$$$20240813$$CN$US$US
178666915$17866691$5$F$20191201$20240628$20200605$20240712$PER$$US-SA-2020SA144439$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240712$$CN$US$US
178674693$17867469$3$F$$20240715$20200605$20240723$EXP$$NVSC2020CA156456$NOVARTIS$$61$YR$$F$Y$$$20240723$$HP$CA$CA
1786748914$17867489$14$F$20230112$20240918$20200605$20240925$EXP$$US-SHIRE-US202005189$TAKEDA$$81$YR$$F$Y$71$KG$20240925$$HP$US$US
178679042$17867904$2$F$$20240619$20200605$20240701$PER$$GB-AMGEN-GBRSP2020072249$AMGEN$$66$YR$E$F$Y$$$20240701$$CN$GB$GB
178681704$17868170$4$F$20180601$20240916$20200605$20240923$EXP$$BR-TAKEDA-2018TUS021397$TAKEDA$$36$YR$$F$Y$$$20240923$$CN$BR$BR
178688345$17868834$5$F$$20240913$20200607$20240926$EXP$$IT-AUROBINDO-AUR-APL-2020-026863$AUROBINDO$Galassi A, Perna F, De Nicola E, Moneghini L, Sganzaroli AB, Cozzolino M.. Calciphylaxis in a dialysis patient treated by intralesional and systemic sodium thiosulphate on top of multifactorial intervention. Clin-Kidney-J. 2019;12(4):546-549$70$YR$$M$Y$$$20240926$$MD$IT$IT
178691709$17869170$9$F$20210620$20240715$20200608$20240718$EXP$$US-SHIRE-US202018636$TAKEDA$$59$YR$$F$Y$67$KG$20240718$$HP$US$US
178692356$17869235$6$F$20170101$20240627$20200608$20240703$PER$$US-BIOGEN-2020BI00861504$BIOGEN$$$$$M$Y$$$20240703$$CN$US$US
178697956$17869795$6$F$20190404$20240704$20200608$20240715$EXP$$CA-ROCHE-2459831$ROCHE$$38$YR$A$F$Y$$$20240715$$HP$CA$CA
178704894$17870489$4$F$20200201$20240801$20200608$20240805$PER$$US-PFIZER INC-2020221694$PFIZER$$55$YR$$F$Y$$$20240805$$HP$US$US
1787059810$17870598$10$F$20240101$20240730$20200608$20240801$PER$$US-PFIZER INC-2020222309$PFIZER$$83$YR$$F$Y$80.74$KG$20240801$$HP$US$US
178706218$17870621$8$F$20200424$20240821$20200608$20240823$EXP$$CA-PFIZER INC-2020-07881$PFIZER$$66$YR$$M$Y$62.9$KG$20240823$$MD$CA$CA
178715214$17871521$4$F$20200525$20240905$20200608$20240910$EXP$$US-SHIRE-US202018626$TAKEDA$$15$YR$$M$Y$$$20240910$$CN$US$US
178716684$17871668$4$F$$20240726$20200608$20240813$EXP$$US-TEVA-2020-US-1245006$TEVA$$53$YR$$M$Y$124$KG$20240813$$LW$US$US
178716813$17871681$3$F$$20240702$20200608$20240717$EXP$$US-TEVA-2020-US-1244993$TEVA$$$$A$M$Y$$$20240717$$LW$US$US
1787363714$17873637$14$F$$20240909$20200609$20240919$EXP$$CA-APOTEX-2020AP011480$APOTEX$$$$$F$Y$$$20240919$$MD$CA$CA
178736432$17873643$2$F$$20240709$20200609$20240717$PER$$US-SHIRE-US202018827$TAKEDA$$$$$M$Y$77$KG$20240717$$MD$US$US
178738533$17873853$3$F$$20240724$20200609$20240805$EXP$$CA-AUROBINDO-AUR-APL-2020-027177$AUROBINDO$$69$YR$$F$Y$$$20240805$$HP$CA$CA
178738599$17873859$9$F$20180605$20240712$20200609$20240725$EXP$$DE-ROCHE-2316756$ROCHE$$68$YR$E$M$Y$$$20240725$$CN$DE$DE
178749497$17874949$7$F$$20240724$20200609$20240726$EXP$$US-PFIZER INC-2020222933$PFIZER$$42$YR$$F$Y$$$20240726$$CN$US$US
178756968$17875696$8$F$$20240809$20200609$20240816$EXP$$ES-ROCHE-2615833$ROCHE$Mensa J, Gutierrez C, Cardozo C, Fernandez L, Kestler M, Munoz P et al Neck infection after allogenic hematopoietic progenitors transplantation. DOI:10.37201/req/100.2019. Official journal of the spanish society of chemotherapy 2020;33 (2):130-6.$65$YR$E$F$Y$$$20240816$$HP$ES$ES
1787659620$17876596$20$F$20211225$20240911$20200609$20240917$EXP$$US-SHIRE-US202019030$TAKEDA$$57$YR$$F$Y$73$KG$20240917$$CN$US$US
178766816$17876681$6$F$20240101$20240926$20200609$20240930$PER$$US-PFIZER INC-2020224241$PFIZER$$69$YR$$F$Y$95.71$KG$20240930$$CN$US$US
178768042$17876804$2$F$$20240722$20200609$20240730$PER$$US-SA-2020SA147698$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240730$$CN$US$US
178769379$17876937$9$F$20240201$20240903$20200609$20240906$EXP$$US-SHIRE-US202018829$TAKEDA$$81$YR$$F$Y$51$KG$20240906$$HP$US$US
178779356$17877935$6$F$$20240711$20200609$20240714$EXP$$US-SHIRE-US202018913$TAKEDA$$$$$F$Y$57$KG$20240714$$HP$US$US
178781476$17878147$6$F$20110224$20240917$20200610$20240925$EXP$$US-SHIRE-US202019052$TAKEDA$$52$YR$$M$Y$87$KG$20240925$$HP$US$US
178784346$17878434$6$F$$20240828$20200610$20240906$EXP$$CA-APOTEX-2020AP011827$APOTEX$$65$YR$$F$Y$$$20240906$$HP$CA$CA
1787843815$17878438$15$F$20200212$20240920$20200610$20240930$EXP$$CA-CELLTRION INC.-2020CA019597$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
178788322$17878832$2$F$$20240911$20200610$20240925$EXP$PL-MLMSERVICE-20200520-2311889-1$PL-ALKEM LABORATORIES LIMITED-PL-ALKEM-2020-02533$ALKEM$Witkowskia G, Matejak-Gorska M, Durlik M.. Severe infection with skin necrosis of the leg after simultaneous pancreas and kidney transplantation. Case report. Transplantation Reports. 2020;5:100049$37$YR$$M$Y$$$20240925$$MD$PL$PL
178802304$17880230$4$F$$20240702$20200610$20240709$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-029164$BOEHRINGER INGELHEIM$Tomomi Hiraoka, Tsuyoshi Ishii, Nobuyuki Sato, Yuto Yamada, Ai Fujimoto, Takahisa Matsuda, Yoshinori Kikuchi, Naobumi Tochigi, Kazutoshi Shibuya; Case  A Case of Esophageal Cancer Diagnosed After Dabigatran-Induced Esophagitis; Gastroenterological Endoscopy; 2024; 66; 4; 403-410$72$YR$E$M$Y$70$KG$20240709$$MD$JP$JP
1788080718$17880807$18$F$20240101$20240701$20200610$20240703$PER$$US-PFIZER INC-2020226137$PFIZER$$93$YR$$F$Y$$$20240703$$CN$US$US
178809154$17880915$4$F$20200522$20240704$20200610$20240710$EXP$$BE-PFIZER INC-2020223083$PFIZER$$47$YR$$F$Y$76$KG$20240710$$MD$BE$BE
178821664$17882166$4$F$20200113$20240711$20200610$20240717$EXP$$DE-MYLANLABS-2020M1055454$MYLAN$$$$E$F$Y$80.6$KG$20240717$$MD$DE$DE
178824315$17882431$5$F$20200204$20240717$20200610$20240807$PER$$US-TOLMAR, INC.-20US021595$TOLMAR$$77$YR$$M$Y$$$20240807$$CN$US$US
178829205$17882920$5$F$20200113$20240706$20200611$20240717$EXP$$DE-AUROBINDO-AUR-APL-2020-028052$AUROBINDO$$$$E$F$Y$80.6$KG$20240717$$MD$DE$DE
178839736$17883973$6$F$$20240812$20200611$20240827$EXP$$CA-APOTEX-2018AP017451$APOTEX$$36$YR$$F$Y$$$20240827$$HP$CA$CA
178843133$17884313$3$F$$20240816$20200611$20240828$EXP$$DE-Accord-184905$ACCORD$Topp MS, Duell J, Guijarro AMA, Odin M, Nielsen T, Rajeswaran A et al.?Severe treatment-refractory T-cell-mediated immune skin toxicities observed?with obinutuzumab/rituximab-atezo-pola in two patients with follicular?lymphoma. Haematologica. 2020,105:e256-60.$68$YR$E$M$Y$$$20240828$$HP$DE$DE
1788441623$17884416$23$F$$20240710$20200611$20240710$EXP$$US-PFIZER INC-2020226058$PFIZER$$83$YR$$F$Y$76.2$KG$20240710$$CN$US$US
178845453$17884545$3$F$$20240909$20200611$20240916$EXP$$CA-GLAXOSMITHKLINE-CA2019GSK062133$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$CA$CA
1788463214$17884632$14$F$20180308$20240712$20200611$20240717$EXP$$CA-ROCHE-2102538$ROCHE$$72$YR$E$F$Y$100$KG$20240717$$HP$CA$CA
178854416$17885441$6$F$20200512$20240801$20200611$20240805$EXP$$US-SHIRE-US202019184$TAKEDA$$22$YR$$M$Y$$$20240805$$MD$US$US
178858432$17885843$2$F$$20240919$20200611$20240924$EXP$$IT-MYLANLABS-2020M1055537$MYLAN$Tana, C. An unusual case of severe pancolitis. Italian Journal of Medicine. 2015;9(S2):108$45$YR$$M$Y$$$20240924$$MD$IT$IT
178862704$17886270$4$F$20200113$20240710$20200611$20240718$EXP$$DE-AstraZeneca-2020SE72441$ASTRAZENECA$$$$E$F$Y$80$KG$20240718$$MD$DE$
178866933$17886693$3$F$20160123$20240822$20200612$20240906$EXP$$US-TEVA-2020-US-1247916$TEVA$$46$YR$$F$Y$92$KG$20240906$$LW$US$US
178874112$17887411$2$F$$20240716$20200612$20240726$EXP$$GB-BAXTER-2020BAX012153$BAXTER$$$$$F$Y$$$20240726$$HP$GB$GB
178876603$17887660$3$F$$20240724$20200612$20240808$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-249684$RANBAXY$Jain A. Imatinib Induced Blue Nails. Indian J Hematol Blood Transf. 2020;36(2):432-433$22$YR$$F$Y$$$20240808$$HP$IN$IN
1788874514$17888745$14$F$20210101$20240722$20200612$20240726$EXP$$US-SHIRE-US202019305$TAKEDA$$83$YR$$F$Y$81$KG$20240726$$HP$US$US
178888495$17888849$5$F$$20240814$20200612$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001883$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
178902368$17890236$8$F$20200212$20240910$20200612$20240912$EXP$$US-SHIRE-US202018875$TAKEDA$$71$YR$$M$Y$$$20240912$$PH$US$US
1789027941$17890279$41$F$20200607$20240909$20200612$20240912$EXP$$US-SHIRE-US202019220$TAKEDA$$58$YR$$M$Y$$$20240912$$MD$US$US
1789078411$17890784$11$F$20190101$20240917$20200612$20240920$EXP$$PHHY2019CA199932$NOVARTIS$$41$YR$$F$Y$$$20240920$$CN$CA$CA
1789128911$17891289$11$F$$20240708$20200612$20240718$EXP$$CA-APOTEX-2020AP011744$APOTEX$$71$YR$$M$Y$$$20240718$$HP$CA$CA
178917025$17891702$5$F$20160901$20240805$20200612$20240816$EXP$$US-TEVA-2020-US-1508898$TEVA$$70$YR$$F$Y$89.8$KG$20240816$$LW$US$US
1789186411$17891864$11$F$$20240826$20200612$20240829$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR096059$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$MD$CA$CA
178928355$17892835$5$F$20210413$20240805$20200613$20240814$EXP$$US-TEVA-2020-US-1247896$TEVA$$73$YR$$M$Y$90.7$KG$20240814$$LW$US$US
178929124$17892912$4$F$20150324$20240827$20200613$20240925$EXP$$US-TEVA-2020-US-1247798$TEVA$$65$YR$$M$Y$90.718$KG$20240925$$LW$US$US
1789403624$17894036$24$F$20200401$20240708$20200615$20240716$EXP$$GB-AUROBINDO-AUR-APL-2020-028517$AUROBINDO$$57$YR$$M$Y$$$20240716$$HP$GB$GB
178940488$17894048$8$F$20200101$20240716$20200615$20240718$EXP$$ZA-PFIZER INC-2019139125$PFIZER$$58$YR$$F$Y$85$KG$20240718$$MD$ZA$ZA
1789457716$17894577$16$F$20201007$20240904$20200615$20240911$EXP$$US-SHIRE-US202015328$TAKEDA$$29$YR$$F$Y$63$KG$20240911$$CN$US$US
1789613514$17896135$14$F$20231025$20240923$20200615$20240930$EXP$$US-SHIRE-US202019356$TAKEDA$$71$YR$$F$Y$54$KG$20240930$$HP$US$US
178966945$17896694$5$F$20200526$20240719$20200615$20240725$EXP$$NVSC2020DE165465$NOVARTIS$$$$E$F$Y$85$KG$20240725$$MD$DE$DE
178973233$17897323$3$F$20200401$20240830$20200615$20240905$PER$$US-PFIZER INC-2020229931$PFIZER$$55$YR$$F$Y$63.5$KG$20240905$$HP$US$US
178995125$17899512$5$F$$20240610$20200616$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001717$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
179006845$17900684$5$F$20200101$20220207$20200616$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR100033$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
179013409$17901340$9$F$$20210817$20200616$20240722$PER$$US-ASTELLAS-2020US017435$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
179019642$17901964$2$F$20200611$20240809$20200616$20240815$EXP$$US-GW PHARMA-202006USGW02120$JAZZ$$16$YR$$F$Y$45$KG$20240815$$CN$US$US
1790295328$17902953$28$F$20180523$20240802$20200617$20240807$EXP$$DE-ROCHE-2138885$ROCHE$$50$YR$A$F$Y$$$20240807$$CN$DE$DE
179035764$17903576$4$F$20200530$20240722$20200617$20240802$EXP$$CA-INTERCEPT-PM2020001272$INTERCEPT PHARMACEUTICALS$$49$YR$$F$Y$$$20240802$$CN$CA$CA
179038246$17903824$6$F$20180101$20240917$20200617$20240923$EXP$$CA-ROCHE-2429342$ROCHE$$56$YR$A$F$Y$$$20240923$$MD$CA$CA
179040008$17904000$8$F$20200101$20240716$20200617$20240728$EXP$$ZA-AMGEN-ZAFSP2020095822$AMGEN$$58$YR$A$F$Y$85$KG$20240728$$MD$ZA$ZA
179067995$17906799$5$F$20240101$20240719$20200617$20240723$EXP$$US-PFIZER INC-2020234921$PFIZER$$73$YR$$F$Y$$$20240723$$CN$US$US
179070235$17907023$5$F$20220601$20240708$20200617$20240710$PER$$US-PFIZER INC-2020234499$PFIZER$$45$YR$$F$Y$89.6$KG$20240710$$HP$US$US
179070925$17907092$5$F$$20240913$20200617$20240924$EXP$$CA-ROCHE-2623439$ROCHE$$31$YR$A$F$Y$46$KG$20240924$$HP$CA$CA
1790753110$17907531$10$F$20240502$20240924$20200617$20240927$EXP$$US-SHIRE-US202019757$TAKEDA$$66$YR$$F$Y$68$KG$20240927$$HP$US$US
1790912612$17909126$12$F$$20240718$20200617$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-046445$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240723$$HP$CA$CA
1791034213$17910342$13$F$20180313$20240701$20200617$20240709$EXP$$JP-ABBVIE-20P-087-3448447-00$ABBVIE$$75$YR$$M$Y$71.8$KG$20240709$$MD$JP$JP
1791078416$17910784$16$F$$20240801$20200618$20240809$EXP$$CA-ROCHE-2490897$ROCHE$$$$E$M$Y$$$20240809$$HP$CA$CA
179110174$17911017$4$F$$20240910$20200618$20240920$EXP$$CA-APOTEX-2020AP012181$APOTEX$$50$YR$$M$Y$$$20240920$$HP$CA$CA
179115912$17911591$2$F$20240620$20240725$20200618$20240731$EXP$$US-PFIZER INC-2020236821$PFIZER$$49$YR$$M$Y$$$20240731$$HP$US$US
1791194625$17911946$25$F$$20240805$20200618$20240808$EXP$$CA-PFIZER INC-2020236998$PFIZER$$$$$M$Y$$$20240808$$HP$CA$CA
1791450613$17914506$13$F$20200101$20240703$20200619$20240712$EXP$$ES-AUROBINDO-AUR-APL-2020-029179$AUROBINDO$Mederos-Luis E, Gonzalez-Perez R, Poza-Guedes P, AlavaCruz C, Matheu V, Sanchez-Machin I. Toxic epidermal necrolysis induced by cystic fibrosis transmembrane conductance regulator modulators.. 2021$39$YR$$M$Y$68$KG$20240712$$MD$ES$ES
1791498713$17914987$13$F$20230818$20240916$20200619$20240923$EXP$$US-SHIRE-US202019997$TAKEDA$$57$YR$$F$Y$57$KG$20240923$$CN$US$US
1791590710$17915907$10$F$20200101$20240703$20200619$20240705$EXP$$US-PFIZER INC-2020238338$PFIZER$$47$YR$$F$Y$$$20240705$$HP$US$US
1791606112$17916061$12$F$$20240906$20200619$20240911$EXP$$US-SHIRE-US202019470$TAKEDA$$$$$F$Y$79$KG$20240911$$MD$US$US
1791715911$17917159$11$F$$20240812$20200619$20240823$EXP$$CA-APOTEX-2020AP012201$APOTEX$$65$YR$$F$Y$69$KG$20240823$$HP$CA$CA
179174162$17917416$2$F$20180711$20240712$20200619$20240722$EXP$$JP-009507513-2001JPN002435J$MERCK$Mizuno K, Ishigami M, and Fujishiro M.. W2-7 Examination of hepatic function disorder: An immune-related adverse event due to immune checkpoint inhibitor. Kanzo, The 43rd Meeting of Western Branch of the Japan Society of Hepatology. 2019;60:A604$61$YR$$F$Y$$$20240722$$MD$JP$JP
1791769918$17917699$18$F$20230206$20240717$20200619$20240722$EXP$$US-SHIRE-US202019943$TAKEDA$$70$YR$$M$Y$91$KG$20240722$$CN$US$US
179178204$17917820$4$F$20160427$20240903$20200619$20240904$EXP$$US-GILEAD-2020-0474027$GILEAD$$30$YR$A$M$Y$$$20240904$$LW$US$US
179180677$17918067$7$F$20200610$20240821$20200619$20240824$EXP$$US-SHIRE-US202019897$TAKEDA$$67$YR$$F$Y$$$20240824$$CN$US$US
179188953$17918895$3$F$$20240827$20200619$20240829$PER$$US-PFIZER INC-2020238035$PFIZER$$72$YR$$F$Y$63.5$KG$20240829$$CN$US$US
179189223$17918922$3$F$20131101$20240730$20200619$20240731$PER$$US-PFIZER INC-2020125047$PFIZER$$57$YR$$F$Y$$$20240731$$LW$US$US
179193135$17919313$5$F$20180302$20240712$20200619$20240722$EXP$$JP-009507513-2001JPN002431J$MERCK$Mizuno K, Ishigami M, and Fujishiro M. W2-7 Examination of hepatic function disorder: An immune-related adverse event due to immune checkpoint inhibitor. Kanzo, The 23th Annual Meeting of Japan Society of Hepatology. 2019;60:A604$72$YR$$M$Y$$$20240722$$MD$JP$JP
179194402$17919440$2$F$$20240802$20200620$20240814$EXP$$CZ-AUROBINDO-AUR-APL-2020-029810$AUROBINDO$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E et al.. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia ? update of single center study.. Neoplasma.. 2017;64:5::762-769$58$YR$$F$Y$$$20240814$$HP$CZ$CZ
179195463$17919546$3$F$20200110$20240910$20200619$20240919$EXP$$US-BIOGEN-2020BI00831086$BIOGEN$$52$YR$$M$Y$$$20240919$$CN$US$US
179195612$17919561$2$F$$20240802$20200620$20240815$EXP$$CZ-AUROBINDO-AUR-APL-2020-029826$AUROBINDO$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al... Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia ? update of single center study.. Neoplasma.. 2017;64:5:762-769$24$YR$$F$Y$$$20240815$$HP$CZ$CZ
179195652$17919565$2$F$$20240802$20200620$20240814$EXP$$CZ-AUROBINDO-AUR-APL-2020-029815$AUROBINDO$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al.. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia ? update of single center study. Neoplasma. 2017;64:5:762-769$28$YR$$M$Y$$$20240814$$HP$CZ$CZ
179195672$17919567$2$F$$20240802$20200620$20240814$EXP$$CZ-AUROBINDO-AUR-APL-2020-029813$AUROBINDO$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E et al.. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia ? update of single center study. Neoplasma. 2017;64:5:762-69$50$YR$$M$Y$$$20240814$$HP$CZ$CZ
179195692$17919569$2$F$$20240803$20200620$20240816$EXP$$CZ-AUROBINDO-AUR-APL-2020-029835$AUROBINDO$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al.. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia ? update of single center study. Neoplasma. 2017;64:5:762-769$46$YR$$M$Y$$$20240816$$HP$CZ$CZ
179195712$17919571$2$F$$20240802$20200620$20240816$EXP$$CZ-AUROBINDO-AUR-APL-2020-029817$AUROBINDO$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al.. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia ? update of single center study.. Neoplasma.. 2017;64:5:762-769$27$YR$$F$Y$$$20240816$$HP$CZ$CZ
179195772$17919577$2$F$$20240802$20200620$20240815$EXP$$CZ-AUROBINDO-AUR-APL-2020-029821$AUROBINDO$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E et al... Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia ? update of single center study. Neoplasma. 2017;64:5:762-769$52$YR$$F$Y$$$20240815$$HP$CZ$CZ
179195832$17919583$2$F$$20240802$20200620$20240816$EXP$$CZ-AUROBINDO-AUR-APL-2020-029829$AUROBINDO$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al.. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia ? update of single center study. Neoplasma. 2017;64:5:762-769$25$YR$$M$Y$$$20240816$$HP$CZ$CZ
179195852$17919585$2$F$$20240802$20200620$20240815$EXP$$CZ-AUROBINDO-AUR-APL-2020-029823$AUROBINDO$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al.. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia ? update of single center study.. Neoplasma.. 2017;64(5):762-69$53$YR$$F$Y$$$20240815$$HP$CZ$CZ
179195872$17919587$2$F$$20240802$20200620$20240815$EXP$$CZ-AUROBINDO-AUR-APL-2020-029832$AUROBINDO$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al.. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study. Neoplasma. 2017;64(5):762-769$34$YR$$F$Y$$$20240815$$HP$CZ$CZ
1792031621$17920316$21$F$$20230531$20200620$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR099839$GLAXOSMITHKLINE$$$$$F$Y$51.71$KG$20240925$$HP$US$US
179204462$17920446$2$F$$20240906$20200620$20240912$EXP$$NVSC2020DE164278$NOVARTIS$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B, et al.. Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: an international CERTAIN registry study. TRANSPLANTATION. 2019;103(6):1224-33$2$YR$$$Y$$$20240912$$HP$DE$DE
1792093311$17920933$11$F$20200101$20240620$20200622$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001752$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
179210253$17921025$3$F$20150406$20240709$20200622$20240712$EXP$$US-GILEAD-2020-0474235$GILEAD$$49$YR$A$M$Y$$$20240712$$LW$US$US
179222014$17922201$4$F$20190101$20240903$20200622$20240904$PER$$US-GILEAD-2020-0473762$GILEAD$$71$YR$E$M$Y$$$20240904$$LW$US$US
179225999$17922599$9$F$20181001$20240828$20200622$20240905$EXP$$PHHY2019BR104059$NOVARTIS$$60$YR$$M$Y$63$KG$20240905$$CN$BR$BR
179226212$17922621$2$F$$20240919$20200622$20240923$PER$$US-SHIRE-US202020289$TAKEDA$$$$$F$Y$$$20240923$$MD$US$US
179231703$17923170$3$F$$20240725$20200622$20240806$EXP$E2B_02980168$CA-Accord-185752$ACCORD$$71$YR$E$M$Y$$$20240806$$HP$CA$CA
1792438223$17924382$23$F$20240902$20240909$20200622$20240916$EXP$$US-SHIRE-US202019900$TAKEDA$$37$YR$$M$Y$100$KG$20240916$$MD$US$US
179245867$17924586$7$F$20200510$20240916$20200622$20240920$EXP$$US-SHIRE-US202019923$TAKEDA$$5$YR$$M$Y$$$20240920$$MD$US$US
179253223$17925322$3$F$$20240625$20200622$20240709$EXP$$CA-ROCHE-2618356$ROCHE$$$$A$F$Y$$$20240709$$CN$CA$CA
179256508$17925650$8$F$20231227$20240710$20200623$20240715$EXP$$CA-TAKEDA-2020TUS025124$TAKEDA$$26$YR$$F$Y$$$20240715$$CN$CA$CA
1792587119$17925871$19$F$$20240827$20200622$20240904$EXP$$CA-JNJFOC-20200623650$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240904$$MD$CA$CA
179260289$17926028$9$F$$20240730$20200622$20240805$EXP$$US-SHIRE-US202020384$TAKEDA$$$$$F$Y$100$KG$20240805$$HP$US$US
1792605146$17926051$46$F$20201024$20240916$20200623$20240925$EXP$$US-SHIRE-US202020335$TAKEDA$$31$YR$$F$Y$49$KG$20240925$$CN$US$US
179262374$17926237$4$F$20200615$20240917$20200623$20240919$EXP$$CA-ROCHE-2628534$ROCHE$$31$YR$A$F$Y$$$20240919$$CN$CA$CA
179262644$17926264$4$F$$20240905$20200623$20240910$EXP$$US-INCYTE CORPORATION-2020IN005683$INCYTE$$$$$$Y$$$20240910$$CN$US$US
179262977$17926297$7$F$$20240805$20200623$20240816$EXP$$US-TEVA-2020-US-1790497$TEVA$$67$YR$$F$Y$$$20240816$$LW$US$US
179264323$17926432$3$F$$20240809$20200623$20240820$PER$$US-INCYTE CORPORATION-2020IN005841$INCYTE$$$$$$Y$$$20240820$$HP$US$US
179266845$17926684$5$F$$20240731$20200623$20240811$EXP$$CA-AUROBINDO-AUR-APL-2020-030144$AUROBINDO$$74$YR$$F$Y$$$20240812$$HP$CA$CA
1792671629$17926716$29$F$20200617$20240828$20200623$20240904$EXP$$US-SHIRE-US202016394$TAKEDA$$40$YR$$F$Y$113$KG$20240904$$PH$US$US
179277923$17927792$3$F$$20240906$20200623$20240920$EXP$CA-MLMSERVICE-20171026-0938301-1$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2020-02844$ALKEM$Claveau JS, LeBlanc R, Ahmad I, Ferreira J, Pistono AA, Bambace N, Bernard L, Cohen S, Delisle JS, Kiss T, Lachance S, Roy J. Cerebral adenovirus endotheliitis presenting as posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation. Bone Marrow Transplantation. 2017;52(10):1457-1459$60$YR$$M$Y$$$20240920$$HP$CA$CA
1792855031$17928550$31$F$20190101$20240730$20200623$20240807$EXP$$CA-CELLTRION INC.-2019CA021616$CELLTRION$$$$$$Y$$$20240807$$CN$CA$CA
1792928315$17929283$15$F$$20240909$20200623$20240914$EXP$$US-SHIRE-US202020370$TAKEDA$$$$$F$Y$57$KG$20240914$$CN$US$US
1792973115$17929731$15$F$20230901$20240722$20200623$20240724$EXP$$US-PFIZER INC-2020241742$PFIZER$$74$YR$$F$Y$$$20240724$$MD$US$US
179308733$17930873$3$F$20090101$20240712$20200623$20240715$EXP$$US-GILEAD-2020-0474590$GILEAD$$37$YR$A$M$Y$$$20240715$$LW$US$US
179309322$17930932$2$F$$20240820$20200623$20240826$EXP$GR-EMA-DD-20200609-SHAIK_I-161045$GR-MYLANLABS-2020M1057057$MYLAN$Pectasides D, Pectasides E, Papaxoinis G, Xiros N, Kamposioras K, Tountas N, et. methotrexate, paclitaxel, ifosfamide, and cisplatin in poor-risk nonseminomatous germ cell tumors. Urol. Oncol. Semin. Orig. Invest.. 2010;28:617?623$$$A$$Y$$$20240826$$MD$GR$GR
179310634$17931063$4$F$20230829$20240925$20200623$20240930$EXP$$US-SHIRE-US202020187$TAKEDA$$77$YR$$F$Y$$$20240930$$CN$US$US
179312746$17931274$6$F$20200610$20240719$20200623$20240725$EXP$$CA-TAKEDA-2019TUS051939$TAKEDA$$80$YR$$F$Y$72$KG$20240725$$CN$CA$CA
179321224$17932122$4$F$$20240815$20200624$20240828$EXP$$CA-AUROBINDO-AUR-APL-2020-030456$AUROBINDO$$9$YR$$F$Y$28$KG$20240828$$HP$CA$CA
179321955$17932195$5$F$$20240731$20200624$20240811$EXP$$CA-AUROBINDO-AUR-APL-2020-030176$AUROBINDO$$65$YR$$F$Y$69$KG$20240812$$HP$CA$CA
179322654$17932265$4$F$$20240716$20200623$20240723$EXP$$NVSC2020CA172766$NOVARTIS$$27$YR$$F$Y$$$20240723$$CN$CA$CA
1793279324$17932793$24$F$$20240718$20200624$20240805$EXP$$CA-AMGEN-CANSP2020098713$AMGEN$$$$$M$Y$$$20240805$$HP$CA$CA
179329285$17932928$5$F$$20240916$20200624$20240930$EXP$$CA-APOTEX-2017AP019645$APOTEX$$56$YR$$M$Y$$$20240930$$MD$CA$CA
1793298521$17932985$21$F$20200619$20240809$20200624$20240814$EXP$$US-SHIRE-US202020584$TAKEDA$$47$YR$$M$Y$$$20240814$$HP$US$US
179340846$17934084$6$F$20190701$20240923$20200623$20240930$EXP$$BE-TAKEDA-2017TUS001382$TAKEDA$$34$YR$$M$Y$80$KG$20240930$$HP$BE$BE
179342933$17934293$3$F$$20240610$20200624$20240914$EXP$$JP-TEVA-2020-JP-1790157$TEVA$Kataoka S, Nishikawa Y, Funakoshi T, Horimatsu T, Sakuragi M, Uchino E, et al. Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study. Int-J-Clin-Oncol 2024; 29 398-406.; Kataoka S, Nishikawa Y, Funakoshi T, Horimatsu T, Kondo N, Matsubara T, et al. Long-term survival and renal dysfunction in a patient with recurrent colorectal cancer treated with Bevacizumab. Clin-J-Gastroenterol 2020;13(3):316-319.; Kataoka...$66$YR$$M$Y$$$20240914$$HP$JP$JP
1793441514$17934415$14$F$$20240709$20200624$20240715$EXP$$US-KAMADA LIMITED-2020US003244$TAKEDA$$$$$M$Y$81$KG$20240715$$CN$US$US
179348445$17934844$5$F$20160101$20240903$20200624$20240904$EXP$$US-GILEAD-2020-0474662$GILEAD$$$$A$F$Y$$$20240904$$LW$US$US
179349813$17934981$3$F$$20240703$20200624$20240715$EXP$000736573$CA-Accord-186423$ACCORD$$61$YR$A$M$Y$$$20240715$$HP$CA$CA
1793661313$17936613$13$F$$20240625$20200624$20240704$EXP$000736566$CA-Accord-185852$ACCORD$$76$YR$E$F$Y$$$20240704$$CN$CA$CA
1793902916$17939029$16$F$20200924$20240903$20200625$20240913$EXP$$CN-ROCHE-2351223$ROCHE$$52$YR$A$M$Y$66$KG$20240913$$CN$CN$CN
179394433$17939443$3$F$20200602$20240702$20200624$20240710$EXP$$DE-PFIZER INC-2020242978$PFIZER$$$$$$Y$$$20240710$$MD$DE$DE
179397399$17939739$9$F$20200201$20240405$20200625$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR109145$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
1794043912$17940439$12$F$$20240916$20200624$20240923$EXP$$US-SHIRE-US202020556$TAKEDA$$$$$F$Y$100$KG$20240923$$HP$US$US
179409565$17940956$5$F$20190101$20240822$20200625$20240904$PER$$US-SA-2020SA148695$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240904$$MD$US$US
1794097812$17940978$12$F$20200101$20240621$20200624$20240701$EXP$$ES-VERTEX PHARMACEUTICALS-2020-012149$VERTEX$Mederos-Luis E, Gonzalez-Perez R, Poza-Guedes P, Alava-Cruz C, Matheu V, Sanchez-Machin I. Toxic epidermal necrolysis induced by cystic fibrosis transmembrane conductance regulator modulators. 2021$39$YR$$M$Y$68$KG$20240701$$MD$ES$ES
179414586$17941458$6$F$$20240710$20200624$20240712$EXP$$US-PFIZER INC-2020211199$PFIZER$$57$YR$$F$Y$$$20240712$$HP$US$US
1794326414$17943264$14$F$20200115$20240923$20200625$20240928$EXP$$IL-ABBVIE-20K-082-3284515-00$ABBVIE$$80$YR$$M$Y$65$KG$20240928$$MD$IL$IL
1794327026$17943270$26$F$20220901$20230718$20200625$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR108561$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
1794336018$17943360$18$F$20210401$20240722$20200625$20240724$EXP$$US-PFIZER INC-2020245116$PFIZER$$83$YR$$F$Y$$$20240724$$MD$US$US
1794375718$17943757$18$F$20201213$20240906$20200625$20240910$EXP$$US-SHIRE-US202020671$TAKEDA$$55$YR$$M$Y$92$KG$20240910$$HP$US$US
179440744$17944074$4$F$$20240701$20200625$20240712$EXP$CA-MHPD-E2B_02981925$CA-Accord-186537$ACCORD$$35$YR$$M$Y$$$20240712$$HP$CA$CA
179449026$17944902$6$F$$20240808$20200625$20240809$PER$$US-GILEAD-2020-0475791$GILEAD$$$$A$F$Y$$$20240809$$LW$US$US
1794541840$17945418$40$F$20200101$20240917$20200626$20240921$EXP$$CH-ABBVIE-20K-151-3275823-00$ABBVIE$$71$YR$$M$Y$108$KG$20240921$$MD$CH$CH
179469814$17946981$4$F$20200524$20240703$20200626$20240709$EXP$$TR-ROCHE-2630424$ROCHE$$30$YR$A$F$Y$57$KG$20240705$$MD$TR$TR
179474042$17947404$2$F$20191001$20240530$20200625$20240717$PER$$US-NOVOPROD-701218$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
179475042$17947504$2$F$20191101$20240530$20200625$20240717$PER$$US-NOVOPROD-705784$NOVO NORDISK$$63$YR$$M$Y$$$20240717$$CN$US$US
179480292$17948029$2$F$20200206$20240530$20200625$20240717$PER$$US-NOVOPROD-714453$NOVO NORDISK$$80$YR$$M$Y$$$20240717$$CN$US$US
179482163$17948216$3$F$$20200604$20200625$20240717$PER$$US-NOVOPROD-720266$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
1794825612$17948256$12$F$$20240918$20200626$20240923$PER$$US-AMGEN-USASP2020075304$AMGEN$$72$YR$E$F$Y$$$20240923$$MD$US$US
179487312$17948731$2$F$20200401$20240530$20200625$20240717$PER$$US-NOVOPROD-727092$NOVO NORDISK$$29$YR$$F$Y$$$20240717$$CN$US$US
179494679$17949467$9$F$20200101$20240823$20200626$20240830$EXP$$JP-ASTELLAS-2020JP008899$ASTELLAS$$25$YR$A$F$Y$$$20240830$$CN$JP$JP
179496908$17949690$8$F$20211031$20240916$20200625$20240920$EXP$$US-SHIRE-US202020769$TAKEDA$$78$YR$$F$Y$92$KG$20240920$$CN$US$US
1794978611$17949786$11$F$20200622$20240830$20200626$20240904$EXP$$US-PFIZER INC-2020246154$PFIZER$$71$YR$$F$Y$58.97$KG$20240904$$CN$US$US
1795042212$17950422$12$F$20230215$20240805$20200626$20240806$EXP$$US-SHIRE-US202020371$TAKEDA$$66$YR$$F$Y$86$KG$20240806$$HP$US$US
179504589$17950458$9$F$20200620$20240911$20200626$20240916$EXP$$US-SHIRE-US202020649$TAKEDA$$52$YR$$F$Y$44$KG$20240916$$CN$US$US
179505232$17950523$2$F$$20240909$20200626$20240912$EXP$$PL-MYLANLABS-2020M1057989$MYLAN$Witkowski G, et al.. Severe infection with skin necrosis of the leg after simultaneous pancreas and kidney transplantation. Case report.. Transplant. Reports. 2020;5:100049:No. 3$37$YR$$M$Y$$$20240912$$MD$PL$PL
179509995$17950999$5$F$20170101$20240726$20200626$20240801$EXP$$CO-ASTELLAS-2019US035438$ASTELLAS$$$$$F$Y$46$KG$20240801$$CN$CO$CO
1795144925$17951449$25$F$20191201$20240816$20200626$20240822$EXP$$NVSC2020CO001090$NOVARTIS$$41$YR$$F$Y$117$KG$20240822$$CN$CO$CO
179522956$17952295$6$F$20170412$20240918$20200627$20240927$EXP$$CA-TAKEDA-2018TUS020926$TAKEDA$$29$YR$$M$Y$$$20240927$$CN$CA$CA
179523588$17952358$8$F$20191201$20240916$20200626$20240919$PER$$US-PFIZER INC-2020030342$PFIZER$$68$YR$$M$Y$$$20240919$$CN$US$US
179525779$17952577$9$F$20200917$20240722$20200627$20240726$EXP$$CO-TAKEDA-2020TUS027305$TAKEDA$$29$YR$$F$Y$61$KG$20240726$$HP$CO$CO
1795333320$17953333$20$F$$20220404$20200628$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR108467$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
179549636$17954963$6$F$20190101$20240821$20200629$20240822$PER$$US-GILEAD-2020-0476204$GILEAD$$$$A$M$Y$$$20240822$$LW$US$US
179549697$17954969$7$F$$20240813$20200629$20240822$EXP$$CA-AUROBINDO-AUR-APL-2020-027331$AUROBINDO$$56$YR$$F$Y$$$20240822$$HP$CA$CA
1795599610$17955996$10$F$20200619$20240807$20200629$20240812$EXP$$US-PFIZER INC-2020222194$PFIZER$$67$YR$$F$Y$$$20240812$$LW$US$US
179560273$17956027$3$F$20200101$20240731$20200629$20240807$PER$$US-PFIZER INC-2017329914$PFIZER$$48$YR$$M$Y$$$20240807$$MD$US$US
179561516$17956151$6$F$20200101$20240923$20200629$20240926$EXP$$US-PFIZER INC-2020248661$PFIZER$$64$YR$$F$Y$$$20240926$$HP$US$US
179562676$17956267$6$F$$20240905$20200629$20240917$EXP$E2B_02934356$CA-Accord-187262$ACCORD$$$$$$Y$$$20240917$$CN$CA$CA
1795747513$17957475$13$F$$20240910$20200629$20240912$EXP$$US-PFIZER INC-2020246661$PFIZER$$69$YR$$F$Y$59.864$KG$20240912$$HP$US$US
179575424$17957542$4$F$20190402$20240813$20200629$20240814$PER$$US-GILEAD-2020-0476983$GILEAD$$60$YR$A$F$Y$$$20240814$$LW$US$US
1795860334$17958603$34$F$$20240822$20200630$20240829$EXP$$US-SHIRE-US202021042$TAKEDA$$$$$F$Y$109$KG$20240829$$HP$US$US
179589593$17958959$3$F$$20240702$20200630$20240712$EXP$DE-MACLEODS PHARMACEUTICALS US LTD-MAC2020026368$DE-MACLEODS PHARMACEUTICALS US LTD-MAC2020026368$MACLEODS$$$$$$Y$$$20240712$$MD$DE$DE
179604692$17960469$2$F$$20240808$20200630$20240812$EXP$$BE-MYLANLABS-V-DE-2007-1570$MYLAN$De Decker K. Fatal intoxication due to Tramadol alone. Case report and review of the literature. Forensic Sci. Int.. 2007$28$YR$$M$Y$$$20240812$$MD$BE$BE
1796059521$17960595$21$F$20200301$20240912$20200630$20240918$EXP$$US-GLAXOSMITHKLINE-US2020AMR111944$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$US$US
1796077212$17960772$12$F$20240211$20240809$20200630$20240813$EXP$$US-SHIRE-US202012410$TAKEDA$$46$YR$$F$Y$71$KG$20240813$$CN$US$US
179615445$17961544$5$F$$20240917$20200630$20240923$EXP$$CA-Orion Corporation ORION PHARMA-20_00009644$ORION$$50$YR$A$F$Y$$$20240923$$HP$CA$
179620793$17962079$3$F$$20240821$20200630$20240827$PER$$US-PFIZER INC-2020250148$PFIZER$$66$YR$$F$Y$$$20240827$$CN$US$US
179633667$17963366$7$F$$20240911$20200630$20240918$EXP$$NVSC2020CA182940$NOVARTIS$$50$YR$$M$Y$$$20240918$$CN$CA$CA
179637722$17963772$2$F$20200502$20240725$20200630$20240802$EXP$$BR-JNJFOC-20200521529$JOHNSON AND JOHNSON$$46$YR$A$F$Y$82$KG$20240802$$CN$BR$BR
1796442229$17964422$29$F$20201106$20240715$20200630$20240722$EXP$$US-SHIRE-US202021007$TAKEDA$$74$YR$$F$Y$66$KG$20240722$$HP$US$US
179646042$17964604$2$F$20200114$20240802$20200630$20240814$EXP$$US-SA-2020SA167990$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240814$$MD$US$US
1796498116$17964981$16$F$$20240627$20200630$20240702$EXP$$US-SHIRE-US202020777$TAKEDA$$$$$F$Y$77$KG$20240702$$HP$US$US
179653477$17965347$7$F$$20240820$20200630$20240824$EXP$$NVSC2020CA180005$NOVARTIS$$71$YR$$F$Y$$$20240824$$CN$CA$CA
179653574$17965357$4$F$20200625$20240829$20200630$20240903$EXP$$US-TAKEDA-2020TUS028189$TAKEDA$$58$YR$$M$Y$$$20240903$$CN$US$US
1796572224$17965722$24$F$20210101$20240731$20200701$20240807$EXP$$US-GLAXOSMITHKLINE-US2020AMR110548$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
1796630931$17966309$31$F$20211009$20240919$20200630$20240925$EXP$$US-SHIRE-US202021051$TAKEDA$$65$YR$$M$Y$76$KG$20240925$$MD$US$US
179663172$17966317$2$F$20200304$20240805$20200701$20240809$EXP$$ES-AMGEN-ESPSP2020103972$AMGEN$$58$YR$A$F$Y$52$KG$20240808$$CN$ES$ES
179666777$17966677$7$F$20200901$20240827$20200701$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001906$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240905$$CN$US$US
179688308$17968830$8$F$$20240902$20200701$20240917$EXP$CA-MHPD-E2B_02988422$CA-Accord-186566$ACCORD$$$$$$Y$$$20240917$$HP$CA$CA
1796883311$17968833$11$F$$20240719$20200701$20240731$EXP$E2B_02944156$CA-Accord-186751$ACCORD$$53$YR$A$M$Y$$$20240731$$HP$CA$CA
179688903$17968890$3$F$$20210720$20200701$20240710$PER$$US-PFM-2019-06417$PIERRE FABRE MEDICAMENT$$$$$F$Y$29$KG$20240710$$PH$US$US
179689643$17968964$3$F$$20230926$20200701$20240710$PER$$US-PFM-2019-06487$PIERRE FABRE MEDICAMENT$$$$$F$Y$14.1$KG$20240710$$PH$US$US
179689773$17968977$3$F$$20210427$20200701$20240710$PER$$US-PFM-2019-11457$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240710$$PH$US$US
179691723$17969172$3$F$$20210426$20200701$20240710$PER$$US-PFM-2020-03070$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.617$KG$20240710$$PH$US$US
179692063$17969206$3$F$20201002$20211029$20200701$20240710$PER$$US-PFM-2019-12487$PIERRE FABRE MEDICAMENT$$2$YR$$F$Y$16$KG$20240710$$PH$US$US
179692363$17969236$3$F$$20220407$20200701$20240710$PER$$US-PFM-2020-02148$PIERRE FABRE MEDICAMENT$$$$$F$Y$16.78$KG$20240710$$PH$US$US
179693033$17969303$3$F$$20210809$20200701$20240710$PER$$US-PFM-2020-03933$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.442$KG$20240710$$PH$US$US
179693414$17969341$4$F$$20220425$20200701$20240710$PER$$US-PFM-2020-03984$PIERRE FABRE MEDICAMENT$$$$$F$Y$12$KG$20240710$$PH$US$US
179693553$17969355$3$F$$20210813$20200701$20240710$PER$$US-PFM-2020-05931$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.431$KG$20240710$$PH$US$US
179722463$17972246$3$F$$20240916$20200702$20240924$PER$$US-AMGEN-USASP2020085832$AMGEN$$23$YR$A$F$Y$$$20240924$$MD$US$US
1797361713$17973617$13$F$20200530$20240724$20200702$20240731$EXP$$PHHY2019GB103345$NOVARTIS$$$$E$F$Y$$$20240731$$CN$GB$GB
179748197$17974819$7$F$20190221$20240730$20200702$20240801$EXP$$US-SHIRE-US202019038$TAKEDA$$36$YR$$F$Y$103$KG$20240801$$HP$US$US
1797483520$17974835$20$F$20220606$20240812$20200702$20240816$EXP$$US-SHIRE-US202019762$TAKEDA$$60$YR$$F$Y$107$KG$20240816$$HP$US$US
179752885$17975288$5$F$20190729$20240712$20200702$20240722$EXP$$CA-TAKEDA-2020TUS028431$TAKEDA$$69$YR$$M$Y$$$20240722$$CN$CA$CA
179757087$17975708$7$F$$20240729$20200702$20240731$EXP$$US-NAPPMUNDI-USA-2020-0153851$PURDUE$$$$$M$Y$$$20240731$$CN$US$US
1797640147$17976401$47$F$20200302$20240803$20200703$20240813$EXP$$GB-ROCHE-2606410$ROCHE$$54$YR$A$F$Y$63.5$KG$20240813$$MD$GB$GB
179774962$17977496$2$F$20200529$20240906$20200703$20240917$EXP$$CA-ABBVIE-20K-028-3468505-00$ABBVIE$$58$YR$$M$Y$$$20240917$$MD$CA$CA
179777055$17977705$5$F$20171001$20240827$20200703$20240828$EXP$$US-GILEAD-2020-0477677$GILEAD$$55$YR$A$M$Y$$$20240828$$LW$US$US
1798024531$17980245$31$F$20210223$20240905$20200703$20240911$EXP$$US-SHIRE-US202021434$TAKEDA$$62$YR$$F$Y$84$KG$20240911$$MD$US$US
1798032138$17980321$38$F$20200928$20240920$20200703$20240927$EXP$$US-SHIRE-US202021179$TAKEDA$$45$YR$$F$Y$58$KG$20240927$$HP$US$US
1798086211$17980862$11$F$20201228$20240920$20200704$20240927$EXP$$US-SHIRE-US202021428$TAKEDA$$66$YR$$M$Y$117.91$KG$20240927$$HP$US$US
1798185630$17981856$30$F$20200915$20240905$20200706$20240908$EXP$$CA-ROCHE-2634127$ROCHE$$46$YR$A$M$Y$$$20240908$$CN$CA$CA
1798255926$17982559$26$F$20200317$20240924$20200706$20240926$EXP$$DE-ROCHE-2636591$ROCHE$$51$YR$A$F$Y$$$20240926$$CN$DE$DE
179851339$17985133$9$F$$20240923$20200706$20240930$EXP$$US-SHIRE-US202021553$TAKEDA$$$$$F$Y$85.71$KG$20240930$$HP$US$US
179854866$17985486$6$F$20200629$20240812$20200706$20240815$EXP$$US-SHIRE-US202021212$TAKEDA$$40$YR$$F$Y$$$20240815$$MD$US$US
179860009$17986000$9$F$20240315$20240718$20200706$20240729$EXP$$CA-ROCHE-2408727$ROCHE$$46$YR$A$F$Y$$$20240729$$CN$CA$CA
179861762$17986176$2$F$20200401$20200601$20200706$20240723$PER$$US-NOVOPROD-726167$NOVO NORDISK$$52$YR$$F$Y$$$20240723$$MD$US$US
1798737419$17987374$19$F$$20240724$20200707$20240807$EXP$$CA-AUROBINDO-AUR-APL-2020-032129$AUROBINDO$Khazaka M, Laverdiere J, Bouchard A, Ferreira V, Mathieu A.. Identification of Possible Causative Agents in a Polymedicated Patient Presenting With Toxic Epidermal Necrolysis. Journal of Pharmacy Practice. 2020;1-5$75$YR$$F$Y$70$KG$20240807$$PH$CA$CA
179882128$17988212$8$F$20200101$20240827$20200707$20240909$EXP$$CA-UCBSA-2020017846$UCB$$$$$F$Y$$$20240909$$CN$CA$CA
179886186$17988618$6$F$$20240711$20200707$20240715$PER$$US-PFIZER INC-2020259312$PFIZER$$73$YR$$F$Y$$$20240715$$CN$US$US
179916785$17991678$5$F$$20240715$20200707$20240725$EXP$$CA-PFIZER INC-2017491690$PFIZER$$64$YR$$F$Y$$$20240725$$HP$CA$CA
179928604$17992860$4$F$20120401$20240827$20200708$20240828$EXP$$US-GILEAD-2020-0478404$GILEAD$$69$YR$E$M$Y$$$20240828$$LW$US$US
179933093$17993309$3$F$$20240709$20200708$20240716$EXP$$CA-APOTEX-2020AP013076$APOTEX$$61$YR$$F$Y$$$20240716$$HP$CA$CA
179949005$17994900$5$F$20090521$20240909$20200708$20240916$EXP$$US-GILEAD-2020-0478928$GILEAD$$56$YR$A$F$Y$$$20240916$$LW$US$US
1799533219$17995332$19$F$$20240903$20200708$20240905$EXP$$US-SHIRE-US202021901$TAKEDA$$$$$F$Y$139$KG$20240905$$CN$US$US
179972615$17997261$5$F$20171001$20240830$20200709$20240905$PER$$US-BIOGEN-2017BI00496366$BIOGEN$$45$YR$$F$Y$$$20240905$$CN$US$US
179986464$17998646$4$F$$20240719$20200709$20240724$EXP$$US-SHIRE-US202021959$TAKEDA$$$$$F$Y$77$KG$20240724$$CN$US$US
1799976825$17999768$25$F$$20240209$20200709$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR124042$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
180009097$18000909$7$F$$20240821$20200709$20240823$EXP$$CA-TAKEDA-2020TUS019534$TAKEDA$$$$$M$Y$$$20240823$$CN$CA$CA
1800211636$18002116$36$F$20201029$20240716$20200709$20240722$EXP$$US-SHIRE-US202022109$TAKEDA$$71$YR$$F$Y$82$KG$20240722$$HP$US$US
180022412$18002241$2$F$$20240826$20200709$20240830$PER$$US-JNJFOC-20200708917$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$LW$US$US
180032204$18003220$4$F$$20220105$20200709$20240722$PER$$US-ASTELLAS-2019US048332$ASTELLAS$$78$YR$$M$Y$$$20240722$$CN$US$US
180033693$18003369$3$F$$20240902$20200710$20240911$EXP$$SE-CELLTRION INC.-2020SE024042$CELLTRION$Bjellvi J., Edelvik A., Krysl D., Nilsson J., Zelano J., Odenstedt Herges H.. Super-refractory status epilepticus with persisting seizures and treatment- related complications: Case report. Epilepsy + Behavior 101. 2019$$$$$Y$$$20240911$$HP$SE$SE
180041818$18004181$8$F$$20221129$20200709$20240722$PER$$US-ASTELLAS-2020US021331$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
180047908$18004790$8$F$20200201$20240624$20200710$20240709$EXP$$CA-ROCHE-2638340$ROCHE$$21$YR$A$F$Y$$$20240705$$MD$CA$CA
1800754511$18007545$11$F$$20240909$20200710$20240912$EXP$$US-SHIRE-US202022071$TAKEDA$$$$$F$Y$56$KG$20240912$$HP$US$US
180092022$18009202$2$F$20200304$20231220$20200710$20240806$EXP$$US-SAOL THERAPEUTICS-2020SAO00083$AMNEAL$$69$YR$$M$Y$$$20240806$$CN$US$US
180095545$18009554$5$F$20070412$20240925$20200710$20240930$EXP$$US-GILEAD-2020-0481353$GILEAD$$44$YR$A$M$Y$$$20240930$$LW$US$US
180096939$18009693$9$F$$20240919$20200710$20240925$EXP$$US-SHIRE-US202022140$TAKEDA$$$$$F$Y$83.9$KG$20240925$$HP$US$US
1800974018$18009740$18$F$20221007$20240912$20200711$20240917$EXP$$US-SHIRE-US202022293$TAKEDA$$45$YR$$F$Y$86$KG$20240917$$CN$US$US
180099997$18009999$7$F$$20240916$20200710$20240924$EXP$$CA-BAUSCH-BL-2020-019419$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240924$$MD$CA$CA
180106395$18010639$5$F$20190301$20240725$20200710$20240802$EXP$$DE-ROCHE-2576052$ROCHE$$62$YR$A$F$Y$70$KG$20240802$$MD$DE$DE
180110172$18011017$2$F$$20240711$20200710$20240718$EXP$$NVSC2020CA193186$NOVARTIS$$69$YR$$F$Y$$$20240718$$CN$CA$CA
1801144655$18011446$55$F$20200125$20240919$20200712$20240928$EXP$$CA-CELLTRION INC.-2020CA019518$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
1801149724$18011497$24$F$20200311$20240710$20200713$20240716$EXP$$AT-ABBVIE-20K-009-3474636-00$ABBVIE$$60$YR$$M$Y$82$KG$20240716$$MD$AT$AT
1801164618$18011646$18$F$20221018$20240819$20200713$20240826$EXP$$US-SHIRE-US202022268$TAKEDA$$74$YR$$F$Y$63$KG$20240826$$CN$US$US
180117562$18011756$2$F$20190101$20240826$20200713$20240901$EXP$$BE-PFIZER INC-2020262409$PFIZER$$48$YR$$F$Y$$$20240901$$CN$BE$BE
180134587$18013458$7$F$$20240827$20200713$20240831$EXP$$US-SHIRE-US202022358$TAKEDA$$$$$F$Y$76$KG$20240831$$CN$US$US
180134873$18013487$3$F$20140101$20240801$20200713$20240812$PER$$US-GILEAD-2020-0482028$GILEAD$$34$YR$A$M$Y$$$20240812$$LW$US$US
180136382$18013638$2$F$20200501$20240701$20200713$20240703$EXP$FR-AFSSAPS-LL20200989$FR-PFIZER INC-2020266435$PFIZER$$59$YR$$M$Y$$$20240703$$MD$FR$FR
180143847$18014384$7$F$20200621$20240924$20200713$20240928$EXP$$US-SHIRE-US202022301$TAKEDA$$18$YR$$M$Y$$$20240928$$PH$US$US
180154104$18015410$4$F$$20240918$20200713$20240927$EXP$$FR-SA-2020SA177748$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240927$$PH$FR$FR
180159545$18015954$5$F$20191004$20240807$20200713$20240812$EXP$$CA-TAKEDA-2020TUS030057$TAKEDA$$54$YR$$F$Y$$$20240812$$CN$CA$CA
1801620128$18016201$28$F$20210101$20240911$20200714$20240919$EXP$$CA-CELLTRION INC.-2020CA019825$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
180174853$18017485$3$F$20190703$20240726$20200713$20240802$EXP$$DE-ROCHE-2576078$ROCHE$$62$YR$A$F$Y$68$KG$20240802$$MD$DE$DE
180175675$18017567$5$F$20190501$20240808$20200714$20240812$PER$$US-GILEAD-2020-0480736$GILEAD$$46$YR$A$M$Y$$$20240812$$LW$US$US
180176088$18017608$8$F$20120101$20240913$20200713$20240916$EXP$$US-GILEAD-2020-0481501$GILEAD$$47$YR$A$F$Y$$$20240916$$LW$US$US
1801768111$18017681$11$F$20190101$20240820$20200713$20240822$EXP$$CA-TAKEDA-2019TUS003281$TAKEDA$$70$YR$$F$Y$$$20240822$$HP$CA$CA
1801838424$18018384$24$F$20231113$20240906$20200714$20240912$EXP$$US-SHIRE-US202022411$TAKEDA$$65$YR$$F$Y$82$KG$20240912$$CN$US$US
180185397$18018539$7$F$20180522$20240820$20200714$20240827$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2019JPN130160$VIIV$$$$$$Y$$$20240827$$MD$JP$JP
180191512$18019151$2$F$20200601$20240909$20200714$20240916$EXP$$JP-SA-2020SA150231$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240917$$MD$JP$JP
180196296$18019629$6$F$20240222$20240705$20200714$20240710$30DAY$$US-GLAXOSMITHKLINE-US2020AMR128050$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240710$$CN$US$US
180197774$18019777$4$F$20200401$20240904$20200714$20240910$PER$$US-VERTEX PHARMACEUTICALS-2020-014318$VERTEX$$45$YR$$F$Y$$$20240910$$MD$US$US
180200016$18020001$6$F$20200601$20240626$20200714$20240722$PER$$US-INCYTE CORPORATION-2020IN005884$INCYTE$$$$$$Y$$$20240719$$CN$US$US
180231734$18023173$4$F$$20240918$20200714$20240918$EXP$$FR-TAKEDA-2020TJP014410$TAKEDA$$77$YR$$F$Y$$$20240918$$PH$FR$FR
180233773$18023377$3$F$$20240909$20200714$20240912$EXP$$CA-BAUSCH-BL-2020-019491$BAUSCH AND LOMB$$80$YR$$M$Y$$$20240912$$CN$CA$CA
180237014$18023701$4$F$20200117$20240715$20200715$20240725$EXP$$KR-GLAXOSMITHKLINE-KR2020GSK128741$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$KR$KR
1802374824$18023748$24$F$20190101$20240702$20200714$20240704$EXP$$US-PFIZER INC-2020064683$PFIZER$$62$YR$$F$Y$117.93$KG$20240704$$CN$US$US
180244138$18024413$8$F$20200609$20240716$20200714$20240724$EXP$$CA-TAKEDA-2020TUS015183$TAKEDA$$27$YR$$F$Y$$$20240724$$HP$CA$CA
180244578$18024457$8$F$20220801$20240917$20200714$20240923$EXP$$US-SHIRE-US202022466$TAKEDA$$67$YR$$F$Y$61$KG$20240923$$HP$US$US
1802525311$18025253$11$F$$20240903$20200715$20240905$EXP$$US-SHIRE-US202022657$TAKEDA$$$$$F$Y$65$KG$20240905$$HP$US$US
180253002$18025300$2$F$$20240827$20200715$20240829$EXP$$DE-MYLANLABS-2020M1064958$MYLAN$Witte H, Biersack H, Bernard V, Riecke A, Gebauer J, Lehnert H, Bubnoff N, Feller A, Gebauer N, Merz H.. Impact of treatment variability and clinicopathological characteristics on survival in patients with Epstein-Barr-Virus positive diffuse large B cell lymphoma.. British Society for Haematology.. 2020;189 (2):257-268$70$YR$$M$Y$$$20240829$$HP$DE$DE
1802534317$18025343$17$F$20221012$20240821$20200715$20240828$EXP$$US-SHIRE-US202022723$TAKEDA$$75$YR$$F$Y$61$KG$20240828$$HP$US$US
1802534720$18025347$20$F$$20240903$20200715$20240905$EXP$$US-SHIRE-US202022669$TAKEDA$$$$$F$Y$76$KG$20240905$$CN$US$US
180254012$18025401$2$F$$20240708$20200715$20240711$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2020EME125044$VIIV$$$$$$Y$$$20240711$$HP$GB$GB
180267017$18026701$7$F$$20240725$20200715$20240730$EXP$$US-SHIRE-US202022659$TAKEDA$$$$$F$Y$132$KG$20240730$$CN$US$US
180267223$18026722$3$F$$20240819$20200716$20240830$EXP$$CA-AUROBINDO-AUR-APL-2020-034119$AUROBINDO$$65$YR$$F$Y$60$KG$20240830$$HP$CA$CA
180277305$18027730$5$F$$20240823$20200715$20240906$EXP$$JP-SA-2020SA181807$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240906$$MD$JP$JP
1802920915$18029209$15$F$$20240905$20200715$20240911$EXP$$US-SHIRE-US202022656$TAKEDA$$$$$F$Y$83$KG$20240911$$CN$US$US
180294695$18029469$5$F$$20240715$20200715$20240718$EXP$$CA-BAUSCH-BL-2020-019407$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240718$$MD$CA$CA
180302846$18030284$6$F$20170101$20240827$20200715$20240829$PER$$US-GILEAD-2020-0482238$GILEAD$$$$A$F$Y$$$20240829$$LW$US$US
180311365$18031136$5$F$$20240924$20200715$20240928$EXP$$CA-AUROBINDO-AUR-APL-2019-094812$AUROBINDO$$69$YR$$F$Y$$$20240928$$HP$CA$CA
180312088$18031208$8$F$20200301$20240905$20200716$20240911$EXP$$NVSC2020BR181950$NOVARTIS$$18$YR$$M$Y$40$KG$20240911$$CN$BR$BR
180317293$18031729$3$F$$20240829$20200716$20240903$EXP$$DE-PFIZER INC-2020270718$PFIZER$Schulte-Kemna, L.. Eculizumab in chemotherapy-induced thrombotic microangiopathy. Clinical Nephrology - Case Studies. 2020;8(1):25-32$52$YR$$F$Y$$$20240903$$MD$DE$DE
1803266717$18032667$17$F$$20240904$20200716$20240910$EXP$$US-SHIRE-US202022688$TAKEDA$$$$$F$Y$78.91$KG$20240910$$HP$US$US
180326847$18032684$7$F$$20240919$20200716$20240925$EXP$$US-SHIRE-US202022840$TAKEDA$$$$$M$Y$97.51$KG$20240925$$HP$US$US
180331872$18033187$2$F$20200707$20240905$20200716$20240912$EXP$$NVSC2020DE196738$NOVARTIS$$63$YR$$M$Y$$$20240912$$MD$DE$DE
180335202$18033520$2$F$20200617$20240509$20200716$20240709$EXP$$US-BIOGEN-2020BI00896557$BIOGEN$$55$YR$$F$Y$111.1$KG$20240709$$CN$US$US
1803355522$18033555$22$F$20200712$20231215$20200717$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR131737$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240925$$CN$US$US
180338038$18033803$8$F$$20240918$20200716$20240924$EXP$$US-SHIRE-US202022855$TAKEDA$$$$$M$Y$95$KG$20240924$$HP$US$US
180338205$18033820$5$F$$20240708$20200716$20240711$EXP$$BR-GLAXOSMITHKLINE-BR2020AMR041673$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$BR$BR
1803496913$18034969$13$F$20200708$20240719$20200717$20240729$EXP$$IL-ABBVIE-20K-082-3484077-00$ABBVIE$$79$YR$$M$Y$63$KG$20240729$$MD$IL$IL
1803550114$18035501$14$F$20200616$20240730$20200717$20240805$EXP$$US-SHIRE-US202022627$TAKEDA$$60$YR$$F$Y$124$KG$20240805$$HP$US$US
1803578360$18035783$60$F$20220102$20240913$20200717$20240919$EXP$$US-SHIRE-US202022849$TAKEDA$$58$YR$$F$Y$58$KG$20240919$$HP$US$US
180364687$18036468$7$F$20200601$20240611$20200717$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-002096$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240705$$CN$US$US
180371946$18037194$6$F$20150101$20240808$20200717$20240809$PER$$US-GILEAD-2020-0482326$GILEAD$$$$A$M$Y$$$20240809$$LW$US$US
180372913$18037291$3$F$$20240823$20200717$20240830$EXP$$JP-PFIZER INC-2020270395$PFIZER$Toyama, S.. Localized scleroderma histologically characterized by liquefaction degeneration and upper dermis fibrosis: a possible association with chemotherapy. Clinical and Experimental Dermatology. 2020;45 (5):632-634$61$YR$$M$Y$$$20240830$$MD$JP$JP
1803836028$18038360$28$F$$20240917$20200718$20240924$EXP$$US-SHIRE-US202023192$TAKEDA$$$$$F$Y$98$KG$20240924$$CN$US$US
180387003$18038700$3$F$20200614$20240910$20200717$20240917$PER$$US-SA-2020SA184388$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240918$$MD$US$US
180394529$18039452$9$F$20200601$20240726$20200717$20240802$EXP$$CA-TAKEDA-2020TUS030820$TAKEDA$$74$YR$$M$Y$$$20240802$$HP$CA$CA
180402452$18040245$2$F$20200714$20240710$20200718$20240719$PER$$US-TAKEDA-2020TUS030977$TAKEDA$$67$YR$$F$Y$$$20240719$$MD$US$US
180402842$18040284$2$F$$20240918$20200717$20240927$EXP$$SG-TAKEDA-2020TUS030998$TAKEDA$$27$YR$$M$Y$$$20240927$$HP$SG$SG
1804194113$18041941$13$F$$20240910$20200720$20240920$EXP$$CA-APOTEX-2020AP013849$APOTEX$$72$YR$$F$Y$61$KG$20240920$$HP$CA$CA
180423383$18042338$3$F$20191119$20240715$20200720$20240722$EXP$$KR-GLAXOSMITHKLINE-KR2020GSK130397$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$MD$KR$KR
180428085$18042808$5$F$$20240726$20200720$20240806$EXP$E2B_02997619$CA-Accord-191142$ACCORD$$82$YR$E$F$Y$72$KG$20240806$$CN$CA$CA
180431905$18043190$5$F$$20240716$20200720$20240723$PER$$US-PFIZER INC-2020275720$PFIZER$$59$YR$$F$Y$$$20240723$$HP$US$US
180437156$18043715$6$F$$20240708$20200720$20240715$EXP$$CA-APOTEX-2020AP013843$APOTEX$$56$YR$$M$Y$$$20240715$$CN$CA$CA
180447859$18044785$9$F$$20240916$20200720$20240920$EXP$$CA-BAYER-2020-143505$BAYER$Khazaka M, Laverdiere J, Bouchard A, Ferreira V, Mathieu A. Identification of Possible Causative Agents in a Polymedicated Patient Presenting With Toxic Epidermal Necrolysis. Journal of Pharmacy Practice. 2020;1-5$75$YR$E$F$Y$70$KG$20240920$$PH$CA$CA
1804501112$18045011$12$F$20230614$20240717$20200720$20240723$EXP$$CA-TAKEDA-2020TUS010802$TAKEDA$$75$YR$$M$Y$93$KG$20240723$$CN$CA$CA
180450605$18045060$5$F$20221201$20240917$20200720$20240919$EXP$$US-PFIZER INC-2020276194$PFIZER$$64$YR$$F$Y$$$20240919$$HP$US$US
180452447$18045244$7$F$20150101$20240827$20200720$20240829$PER$$US-GILEAD-2020-0474897$GILEAD$$53$YR$A$F$Y$$$20240829$$LW$US$US
180464002$18046400$2$F$20200711$20240805$20200720$20240807$PER$$US-PFIZER INC-2019450816$PFIZER$$58$YR$$F$Y$65.77$KG$20240807$$CN$US$US
180466408$18046640$8$F$$20240806$20200721$20240812$EXP$$US-SHIRE-US202023191$TAKEDA$$$$$F$Y$66$KG$20240812$$CN$US$US
180466494$18046649$4$F$$20240829$20200720$20240902$EXP$$DE-SA-2020SA181750$SANOFI AVENTIS$SchulteKemna L, Reister B, Bettac L, Ludwig U, F?rst D, Mytilineos J et al.. Eculizumab in chemotherapy-induced thrombotic microangiopathy.. Clinical Nephrology - Case Studies. 2020;8(1):25-32$52$YR$A$F$Y$$$20240902$$MD$DE$DE
1804780320$18047803$20$F$$20240916$20200721$20240927$EXP$$CA-APOTEX-2020AP013830$APOTEX$$66$YR$$M$Y$70$KG$20240927$$HP$CA$CA
180499225$18049922$5$F$20200601$20240722$20200721$20240802$EXP$GB-ROCHE-2640471$GB-ROCHE-2640471$ROCHE$$39$YR$A$F$Y$$$20240802$$MD$GB$GB
180499652$18049965$2$F$$20240812$20200721$20240823$PER$$US-JNJFOC-20200726905$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$LW$US$US
180502453$18050245$3$F$$20240909$20200721$20240916$EXP$$BE-MYLANLABS-2020M1060671$MYLAN$Volon B, Willemart T, Haufroid V, Hantson P.. Recurrence of Serotonin Toxicity and Influence of Cytochrome 2D6 Polymorphism.. Primary Care Companion CNS Disorder.. 2019;21(6)$48$YR$$M$Y$$$20240916$$MD$BE$BE
1805091215$18050912$15$F$20180813$20240807$20200721$20240810$EXP$$DE-ROCHE-2646175$ROCHE$$55$YR$A$F$Y$36$KG$20240810$$CN$DE$DE
180511698$18051169$8$F$$20240920$20200721$20240926$EXP$$CA-JNJFOC-20200721895$JOHNSON AND JOHNSON$$12$YR$T$F$Y$64$KG$20240926$$HP$CA$CA
1805128415$18051284$15$F$20240708$20240729$20200722$20240801$EXP$$US-SHIRE-US202023358$TAKEDA$$59$YR$$F$Y$104$KG$20240801$$CN$US$US
1805193425$18051934$25$F$20211101$20240718$20200721$20240723$EXP$$US-SHIRE-US202023342$TAKEDA$$67$YR$$F$Y$47$KG$20240723$$MD$US$US
180519894$18051989$4$F$$20240913$20200721$20240919$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202007006247$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240919$$CN$FR$FR
180523574$18052357$4$F$20180101$20240808$20200722$20240809$PER$$US-GILEAD-2020-0480162$GILEAD$$$$A$F$Y$$$20240809$$LW$US$US
1805315850$18053158$50$F$20200710$20240702$20200722$20240715$EXP$$NVSJ2020JP006878$NOVARTIS$$23$MON$$F$Y$10.2$KG$20240715$$MD$JP$JP
180536604$18053660$4$F$$20240820$20200722$20240826$EXP$$US-TAKEDA-2018TUS029585$TAKEDA$$$$$M$Y$$$20240826$$CN$US$US
180540008$18054000$8$F$20200101$20240923$20200722$20240925$EXP$$US-PFIZER INC-2020278861$PFIZER$$71$YR$$F$Y$$$20240925$$HP$US$US
180540313$18054031$3$F$20240703$20240708$20200722$20240710$EXP$$US-PFIZER INC-2020279354$PFIZER$$69$YR$$M$Y$$$20240710$$CN$US$US
180551712$18055171$2$F$$20240627$20200722$20240709$EXP$$JP-SHIRE-JP202023039$TAKEDA$Hiraoka S. Multicenter survey on mesalamine intolerance in patients with ulcerative colitis. Journal of gastroenterology and hepatology. 2020$$$$$Y$$$20240709$$MD$JP$JP
1805534516$18055345$16$F$20221103$20240910$20200722$20240913$EXP$$US-SHIRE-US202023516$TAKEDA$$68$YR$$F$Y$79$KG$20240913$$MD$US$US
180554413$18055441$3$F$20200702$20200908$20200722$20240725$EXP$$US-AstraZeneca-2020SE90504$ASTRAZENECA$$28635$DY$$F$Y$47.6$KG$20240725$$MD$US$
1805570321$18055703$21$F$20230401$20240919$20200722$20240925$EXP$$US-SHIRE-US202023363$TAKEDA$$64$YR$$F$Y$70$KG$20240925$$HP$US$US
1805732518$18057325$18$F$20210218$20240913$20200723$20240917$EXP$$US-SHIRE-US202023364$TAKEDA$$69$YR$$F$Y$58$KG$20240917$$HP$US$US
180575313$18057531$3$F$$20240712$20200723$20240725$EXP$$IN-CIPLA LTD.-2020IN04883$CIPLA$Dravid AN, Gawali R, Betha TP, Sharma AK, Medisetty M, Natrajan K et al.. Two treatment strategies for management of Neurosymptomatic cerebrospinal fluid HIV escape in Pune, India. Medicine. 2020;99 (24):1 to 11$$$$$Y$$$20240725$$MD$IN$IN
180581402$18058140$2$F$$20240917$20200723$20240927$EXP$$PT-AUROBINDO-AUR-APL-2020-036035$AUROBINDO$$70$YR$$M$Y$$$20240927$$CN$PT$PT
1805825220$18058252$20$F$$20240625$20200723$20240705$EXP$$CA-GLENMARK PHARMACEUTICALS-2020GMK048757$GLENMARK$Khazaka M, Laverdiere J, Bouchard A, Ferreira V, Mathieu A.. Identification of possible causative agents in a polymedicated patient presenting with toxic epidermal necrolysis.. Journal of pharmacy practice.. 2020;1-5$$$$$Y$$$20240705$$PH$CA$CA
180584058$18058405$8$F$20170201$20240808$20200723$20240812$EXP$$NVSC2020IT205940$NOVARTIS$Botta C, Caruso N, Bossio S, Storino F, Console G, Martino M et al.. Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report. FRONTIERS IN ONCOLOGY. 2020;10(967):1-6$32$YR$$F$Y$$$20240812$$HP$IT$IT
180593184$18059318$4$F$20180101$20240701$20200723$20240716$EXP$$US-TEVA-2020-US-1804669$TEVA$$74$YR$$M$Y$160$KG$20240716$$LW$US$US
180608078$18060807$8$F$20190513$20240909$20200723$20240916$EXP$GR-EMA-DD-20200716-JAIN_H1-101540$GR-GLAXOSMITHKLINE-GR2020137722$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$GR$GR
180618789$18061878$9$F$20190201$20240913$20200723$20240918$EXP$$NVSC2020US206449$NOVARTIS$$75$YR$$M$Y$$$20240918$$CN$US$US
1806194116$18061941$16$F$20200630$20240912$20200723$20240914$EXP$$US-SHIRE-US202022844$TAKEDA$$15$YR$$M$Y$$$20240914$$CN$US$US
180623094$18062309$4$F$20200623$20240712$20200723$20240720$EXP$$CA-TAKEDA-2020TUS031526$TAKEDA$$53$YR$$M$Y$$$20240720$$CN$CA$CA
180632332$18063233$2$F$20240601$20240607$20200724$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-002193$ACADIA PHARMACEUTICALS$$65$YR$$M$Y$$$20240701$$CN$US$US
180632727$18063272$7$F$20210525$20240610$20200724$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-002196$ACADIA PHARMACEUTICALS$$86$YR$$F$Y$$$20240705$$CN$US$US
1806346518$18063465$18$F$20190702$20240905$20200724$20240916$EXP$$DE-ROCHE-2365577$ROCHE$$36$YR$A$F$Y$$$20240916$$CN$DE$DE
180640934$18064093$4$F$20110106$20240813$20200724$20240814$PER$$US-GILEAD-2020-0484590$GILEAD$$47$YR$A$M$Y$$$20240814$$LW$US$US
180655553$18065555$3$F$$20201007$20200724$20240701$EXP$$JP-SA-2020SA190936$SANOFI AVENTIS$$$$$$Y$$$20240702$$CN$JP$JP
180666385$18066638$5$F$$20240827$20200724$20240830$EXP$$US-SHIRE-US202023830$TAKEDA$$$$$F$Y$63$KG$20240830$$HP$US$US
1806665120$18066651$20$F$20200201$20240220$20200724$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR133960$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
1806668310$18066683$10$F$$20240916$20200724$20240918$EXP$$US-SHIRE-US202023351$TAKEDA$$$$$F$Y$68$KG$20240918$$CN$US$US
180667904$18066790$4$F$$20240919$20200724$20240924$EXP$$US-KAMADA LIMITED-2020US000620$TAKEDA$$$$$F$Y$60$KG$20240924$$HP$US$US
1806737214$18067372$14$F$20200423$20240704$20200724$20240705$EXP$$IT-ROCHE-2646589$ROCHE$$36$YR$A$F$Y$$$20240705$$MD$IT$IT
1806808110$18068081$10$F$20200909$20240710$20200725$20240716$EXP$$US-SHIRE-US202024004$TAKEDA$$61$YR$$F$Y$80$KG$20240716$$HP$US$US
180687315$18068731$5$F$20160101$20240827$20200724$20240828$PER$$US-GILEAD-2020-0476637$GILEAD$$43$YR$A$F$Y$$$20240828$$LW$US$US
180692864$18069286$4$F$20200101$20240307$20200725$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2020ARB000422$ARBOR$$$$$F$Y$$$20240802$$CN$US$US
1806967021$18069670$21$F$20200327$20240910$20200726$20240918$EXP$$CA-CELLTRION INC.-2020CA017847$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
180705752$18070575$2$F$$20240719$20200727$20240724$EXP$$US-KAMADA LIMITED-2020US001410$TAKEDA$$$$$F$Y$$$20240724$$HP$US$US
180721197$18072119$7$F$$20240722$20200727$20240724$PER$$US-PFIZER INC-2020284450$PFIZER$$78$YR$$F$Y$$$20240724$$CN$US$US
180724088$18072408$8$F$20170306$20240902$20200727$20240906$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN110774$VIIV$$33$YR$$M$Y$$$20240906$$MD$JP$JP
1807326356$18073263$56$F$20171203$20240802$20200727$20240807$EXP$$US-SHIRE-US202024012$TAKEDA$$50$YR$$F$Y$82$KG$20240807$$CN$US$US
1807359910$18073599$10$F$20200601$20240716$20200727$20240718$EXP$$US-SHIRE-US202023057$TAKEDA$$2$YR$$M$Y$$$20240718$$PH$US$US
1807365322$18073653$22$F$20200705$20240823$20200727$20240828$EXP$$US-SHIRE-US202023496$TAKEDA$$5$YR$$M$Y$$$20240828$$MD$US$US
180737527$18073752$7$F$20200909$20240826$20200727$20240903$EXP$$US-SHIRE-US202023756$TAKEDA$$37$YR$$F$Y$$$20240903$$CN$US$US
180741102$18074110$2$F$20200101$20240819$20200727$20240829$PER$$US-SA-2020SA193312$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240829$$MD$US$US
180744295$18074429$5$F$$20240820$20200727$20240822$PER$$US-PFIZER INC-2020284507$PFIZER$$65$YR$$F$Y$$$20240822$$CN$US$US
1807854218$18078542$18$F$20180522$20240819$20200728$20240822$EXP$$DE-ROCHE-2135467$ROCHE$$61$YR$A$M$Y$$$20240822$$CN$DE$DE
180788764$18078876$4$F$20080304$20240814$20200728$20240816$EXP$$US-GILEAD-2020-0485411$GILEAD$$43$YR$A$M$Y$$$20240816$$LW$US$US
180795444$18079544$4$F$20200324$20240827$20200728$20240909$EXP$$US-SA-2020SA194131$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240909$$MD$US$US
180800199$18080019$9$F$20190101$20240820$20200728$20240826$EXP$$NVSC2020NL207592$NOVARTIS$$70$YR$$F$Y$$$20240826$$HP$NL$NL
180803075$18080307$5$F$20200716$20240814$20200728$20240819$EXP$$AU-ABBVIE-20K-008-3494031-00$ABBVIE$$34$YR$$M$Y$$$20240819$$MD$AU$AU
180803127$18080312$7$F$20211121$20240724$20200728$20240730$EXP$$US-SHIRE-US202024142$TAKEDA$$64$YR$$M$Y$97$KG$20240730$$CN$US$US
180807775$18080777$5$F$20180515$20240816$20200728$20240824$EXP$$BR-TAKEDA-2018TUS028907$TAKEDA$$61$YR$$F$Y$$$20240824$$CN$BR$BR
1808117410$18081174$10$F$$20240909$20200728$20240919$EXP$$CA-APOTEX-2020AP012184$APOTEX$$56$YR$$F$Y$$$20240919$$HP$CA$CA
180811995$18081199$5$F$20200715$20240821$20200728$20240828$EXP$$US-SHIRE-US202024106$TAKEDA$$76$YR$$M$Y$79$KG$20240828$$CN$US$US
1808213213$18082132$13$F$20170929$20240722$20200729$20240726$EXP$$US-BIOGEN-2020BI00902664$BIOGEN$$63$YR$$F$Y$$$20240726$$CN$US$US
180826312$18082631$2$F$20200101$20240802$20200729$20240805$EXP$GB-MHRA-EYC 00225136$GB-SA-2020SA195249$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240804$$HP$GB$GB
180828703$18082870$3$F$$20240712$20200729$20240717$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-037604$BOEHRINGER INGELHEIM$$38$YR$A$M$Y$$$20240717$$MD$CA$CA
180838503$18083850$3$F$20200728$20240830$20200728$20240903$EXP$$US-INCYTE CORPORATION-2020IN007257$INCYTE$$$$$$Y$$$20240903$$CN$US$US
1808405222$18084052$22$F$20180927$20240902$20200729$20240910$EXP$$CA-CELLTRION INC.-2018CA023486$CELLTRION$$$$$$Y$$$20240910$$CN$CA$CA
180843226$18084322$6$F$20200221$20240812$20200729$20240814$PER$$US-GILEAD-2020-0486095$GILEAD$$32$YR$A$F$Y$$$20240814$$LW$US$US
180846138$18084613$8$F$20200101$20240717$20200728$20240720$EXP$$NVSC2020GB210814$NOVARTIS$$48$YR$$F$Y$$$20240719$$HP$GB$GB
180870545$18087054$5$F$$20240812$20200729$20240821$EXP$$CA-APOTEX-2020AP014300$APOTEX$$61$YR$$M$Y$$$20240821$$MD$CA$CA
1808772319$18087723$19$F$20211120$20240919$20200729$20240927$EXP$$US-SHIRE-US202023979$TAKEDA$$44$YR$$F$Y$79$KG$20240927$$HP$US$US
180882013$18088201$3$F$$20240917$20200729$20240923$EXP$$US-SHIRE-US202024337$TAKEDA$$$$$F$Y$102$KG$20240923$$MD$US$US
180886413$18088641$3$F$20200627$20240712$20200729$20240716$EXP$$GB-MYLANLABS-2020M1068098$MYLAN$$39$YR$$F$Y$$$20240716$$MD$GB$GB
180889028$18088902$8$F$20240304$20240807$20200729$20240813$EXP$$US-SHIRE-US202024273$TAKEDA$$21$YR$$M$Y$44$KG$20240813$$HP$US$US
1808902112$18089021$12$F$20230123$20240910$20200729$20240913$EXP$$US-SHIRE-US202024374$TAKEDA$$77$YR$$F$Y$60$KG$20240913$$CN$US$US
1808924012$18089240$12$F$20200101$20240822$20200729$20240827$EXP$$US-PFIZER INC-2020286408$PFIZER$$81$YR$$M$Y$58.97$KG$20240827$$CN$US$US
1809061627$18090616$27$F$20200723$20240905$20200730$20240913$EXP$$CA-CELLTRION INC.-2020CA023415$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
180927984$18092798$4$F$20200326$20240828$20200730$20240905$PER$$US-INCYTE CORPORATION-2020IN007024$INCYTE$$$$$$Y$$$20240905$$CN$US$US
180930197$18093019$7$F$$20220718$20200730$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR146103$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
180940533$18094053$3$F$$20240812$20200730$20240823$EXP$US-MLMSERVICE-20191122-2054301-1$US-STRIDES ARCOLAB LIMITED-2019SP012277$STRIDES$Rajpurkar M, Buck S, Lafferty J, Wakeling E, Ravindranath Y, Savasan S.. Acquired Pure Red Cell Aplasia and Acquired Amegakaryocytic Thrombocytopenia Associated with Clonal Expansion of T-Cell Large Granular Lymphocytes in a Patient with Lipopolysaccharide-responsive Beige-like Anchor (LRBA) Protein Deficiency.. Journal of Pediatric Hematology/Oncology. 2019;41(8):E542-E545$16$YR$$M$Y$$$20240823$$MD$US$US
180946325$18094632$5$F$20200601$20240713$20200731$20240717$EXP$$GB-AMGEN-GBRNI2020119064$AMGEN$$39$YR$A$F$Y$$$20240717$$MD$GB$GB
1809464614$18094646$14$F$$20240724$20200730$20240808$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005470$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$68$KG$20240808$$CN$CA$CA
1809515511$18095155$11$F$20210705$20240801$20200731$20240807$EXP$$US-SHIRE-US202024475$TAKEDA$$58$YR$$F$Y$73.01$KG$20240807$$CN$US$US
180952423$18095242$3$F$$20240731$20200731$20240808$EXP$$US-TORRENT-00010315$TORRENT$$25$YR$A$F$Y$$$20240808$$MD$US$US
1809532215$18095322$15$F$20230404$20240702$20200731$20240704$EXP$$US-SHIRE-US202024488$TAKEDA$$73$YR$$M$Y$81.54$KG$20240704$$HP$US$US
1809571426$18095714$26$F$20200723$20240710$20200731$20240720$EXP$$CA-CELLTRION INC.-2020CA024774$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
1809648833$18096488$33$F$20210301$20240917$20200731$20240924$EXP$$US-SHIRE-US202024645$TAKEDA$$55$YR$$F$Y$123$KG$20240924$$CN$US$US
180965212$18096521$2$F$$20240715$20200731$20240722$EXP$$FR-AUROBINDO-AUR-APL-2017-07620$AUROBINDO$Cottencin 0, Danel T, Goudemand M, Thomas P, Consoli SM. Catatonia recognition and treatment. Medical Science Monitor. 2009;15(8):CS129-CS131$54$YR$$F$Y$$$20240722$$HP$FR$FR
180967663$18096766$3$F$$20240729$20200730$20240731$PER$$US-PURDUE-USA-2020-0160111$PURDUE$$$$$M$Y$$$20240731$$CN$US$US
180970245$18097024$5$F$$20240701$20200731$20240712$EXP$000908164$CA-Accord-193115$ACCORD$$47$YR$A$F$Y$95$KG$20240712$$HP$CA$CA
180974436$18097443$6$F$20210420$20240821$20200731$20240826$EXP$$CA-TAKEDA-2020TUS032747$TAKEDA$$39$YR$$F$Y$$$20240826$$MD$CA$CA
180980714$18098071$4$F$20190101$20240919$20200731$20240920$EXP$$US-GILEAD-2020-0487495$GILEAD$$30$YR$A$M$Y$$$20240920$$LW$US$US
180983106$18098310$6$F$19980101$20240820$20200731$20240823$EXP$$US-GILEAD-2020-0486346$GILEAD$$42$YR$A$F$Y$$$20240823$$LW$US$US
180984167$18098416$7$F$$20240917$20200731$20240919$PER$$US-PFIZER INC-2020289798$PFIZER$$50$YR$$F$Y$$$20240919$$MD$US$US
180986335$18098633$5$F$20200301$20240917$20200731$20240924$EXP$$NVSC2020BR007607$NOVARTIS$$63$YR$$F$Y$63$KG$20240924$$CN$BR$BR
180994494$18099449$4$F$$20240705$20200731$20240710$EXP$$US-PURDUE-USA-2020-0160118$PURDUE$$$$$M$Y$$$20240710$$LW$US$US
1810117910$18101179$10$F$20210226$20240829$20200801$20240904$EXP$$US-SHIRE-US202024878$TAKEDA$$53$YR$$F$Y$85$KG$20240904$$CN$US$US
1810189418$18101894$18$F$20200415$20240812$20200802$20240820$EXP$$CA-CELLTRION INC.-2020CA021807$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
1810199811$18101998$11$F$20220105$20220616$20200803$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR146074$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240925$$CN$US$US
181021188$18102118$8$F$20230508$20240821$20200803$20240826$EXP$$US-SHIRE-US202024725$TAKEDA$$52$YR$$F$Y$131.51$KG$20240826$$CN$US$US
1810246420$18102464$20$F$20230124$20240801$20200803$20240805$EXP$$US-SHIRE-US202024961$TAKEDA$$71$YR$$F$Y$75$KG$20240805$$HP$US$US
181025752$18102575$2$F$$20240731$20200803$20240813$EXP$$US-Hikma Pharmaceuticals USA Inc.-US-H14001-20-51826$HIKMA$Saha BK, Bonnier A, Chong W. Saha BK, Bonnier A, Chong W. Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning. African Journal of Emergency Medicine.. 2020$25$YR$$F$Y$$$20240813$$HP$US$US
181028818$18102881$8$F$20181217$20240911$20200803$20240922$EXP$$ES-ASTELLAS-2020US023850$ASTELLAS$Cases-Corona C, Shabaka A, Gonzalez-Lopez A, Martin-Segarra O, Moreno De La Higuera MA, Lucena R. Fulminant emphysematous pyelonephritis by Candida glabrata in a kidney allograft. Nephron 2020;144(6):304-9.$56$YR$A$F$Y$$$20240922$$MD$ES$ES
181033633$18103363$3$F$20230401$20240911$20200803$20240912$PER$$US-PFIZER INC-2020292753$PFIZER$$34$YR$$F$Y$$$20240912$$CN$US$US
181039952$18103995$2$F$$20240730$20200803$20240807$EXP$$CA-AstraZeneca-2020SE94346$ASTRAZENECA$$23$YR$$F$Y$$$20240807$$MD$CA$
181040125$18104012$5$F$$20240702$20200803$20240708$EXP$$CA-PFIZER INC-2020289367$PFIZER$$75$YR$$F$Y$$$20240708$$HP$CA$CA
181046753$18104675$3$F$$20240709$20200803$20240718$EXP$$JP-AMGEN-JPNSP2020124319$AMGEN$Joko R, Nakata E, Kunisada T, Misawa H, Hasei J, Kure M, et al.. Treatment results of bone giant cell tumour occurrence in spine for which denosumab treatment was performed. J. Jpn. Orthop. Assoc./The 53rd AMTM of Jpn. Orthop. Assoc. [online]. 2020;94 (6):S1416$30$YR$A$F$Y$$$20240718$$MD$JP$JP
1810480614$18104806$14$F$20200316$20240704$20200804$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-059888$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$62$KG$20240710$$MD$JP$JP
181054562$18105456$2$F$20200426$20240702$20200804$20240709$EXP$$DE-AMGEN-DEUNI2020121919$AMGEN$$76$YR$E$F$Y$60$KG$20240709$$MD$DE$DE
181056288$18105628$8$F$$20240708$20200803$20240711$EXP$$DE-MYLANLABS-2020M1068331$MYLAN$Schinz K, Waldfahrer F, Wust W, Iro H. Agranulocytosis after use of metamizole-an underestimated risk. Laryngo-rhino-otologie. 2020$43$YR$$M$Y$$$20240711$$MD$DE$DE
1810704216$18107042$16$F$20210823$20240711$20200803$20240717$EXP$$US-SHIRE-US202024891$TAKEDA$$16$YR$$F$Y$78$KG$20240717$$CN$US$US
181072056$18107205$6$F$20191120$20240917$20200804$20240921$EXP$$AT-ABBVIE-20K-009-3473423-00$ABBVIE$$55$YR$$M$Y$122$KG$20240921$$MD$AT$AT
181086122$18108612$2$F$$20240731$20200804$20240807$EXP$$US-BAUSCH-BL-2020-021708$BAUSCH AND LOMB$Saha B, Bonnier A, Chong W. Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning. African Journal of Emergency Medicine. 2020;1-4. doi:10.1016/j.afjem.2020.06.014$25$YR$$F$Y$$$20240807$$HP$US$US
1810894611$18108946$11$F$20201106$20240910$20200804$20240912$EXP$$US-PFIZER INC-2020292804$PFIZER$$62$YR$$F$Y$106.14$KG$20240912$$CN$US$US
181090135$18109013$5$F$$20240717$20200804$20240719$PER$$US-PFIZER INC-2017184019$PFIZER$$74$YR$$F$Y$$$20240719$$CN$US$US
181090872$18109087$2$F$20191221$20240730$20200804$20240807$EXP$$CA-AstraZeneca-2020SE94906$ASTRAZENECA$$68$YR$$F$Y$90$KG$20240807$$MD$CA$
181102072$18110207$2$F$20200107$20240730$20200804$20240807$EXP$$CA-AstraZeneca-2020SE94402$ASTRAZENECA$$71$YR$$M$Y$81.6$KG$20240807$$MD$CA$
1811032112$18110321$12$F$$20240820$20200804$20240830$EXP$$CA-TEVA-2020-CA-1810052$TEVA$Khazaka M, Laverdiere J, Bouchard A, Ferreira V, Mathieu A. Identification of Possible Causative Agents in a Polymedicated Patient Presenting With Toxic Epidermal Necrolysis. J-Pharm-Pract 2020;:.; Khazaka M, Laverdiere J, Bouchard A, Ferreira V, Mathieu A. Identification of Possible Causative Agents in a Polymedicated Patient Presenting With Toxic Epidermal Necrolysis. J-Pharm-Pract 2020;:.; Khazaka M, Laverdiere J, Bouchard A, Ferreira V, Mathieu A. Identification of Possible Causative Agen...$75$YR$$F$Y$$$20240830$$HP$CA$CA
181106192$18110619$2$F$20200121$20240730$20200804$20240807$EXP$$CA-AstraZeneca-2020SE94781$ASTRAZENECA$$55$YR$$M$Y$75$KG$20240807$$MD$CA$
1811151017$18111510$17$F$20170101$20240923$20200804$20240926$EXP$$PHHY2017CA174529$NOVARTIS$$7$YR$$M$Y$$$20240926$$CN$CA$CA
1811151318$18111513$18$F$20170713$20240923$20200804$20240925$EXP$$PHHY2017CA175098$NOVARTIS$$6$YR$$M$Y$$$20240925$$MD$CA$CA
181117054$18111705$4$F$$20240913$20200804$20240924$EXP$$IT-AUROBINDO-AUR-APL-2020-011518$AUROBINDO$Foppiani L, Bottoni G, Piccardo A. Primary Hyperparathyroidism Manifesting with Severe Hypercalcemia in a Nonagenarian Man: Pitfall of Common Imaging Techniques, Localization by 18F-Choline Positron Emission Tomography/Computed Tomography and Successful Management with Calcimimetics. Acta-Med-Hradec-Kralove. 2019;62(4):156-160$90$YR$$M$Y$$$20240924$$MD$IT$IT
1811239115$18112391$15$F$$20240808$20200805$20240820$EXP$$CA-AUROBINDO-AUR-APL-2020-037641$AUROBINDO$Kattail D, Niec A.. Caregiver-fabricated illness in a child prescribed long-term opioids and benzodiazepines.. Journal of Opioid Management. 2020;16(2):155-159$11$YR$$M$Y$$$20240820$$MD$CA$CA
181124548$18112454$8$F$20111101$20240724$20200805$20240726$PER$$US-GILEAD-2020-0487528$GILEAD$$62$YR$A$M$Y$$$20240726$$LW$US$US
181139516$18113951$6$F$$20240807$20200805$20240809$PER$$US-PFIZER INC-2020295696$PFIZER$$76$YR$$F$Y$$$20240809$$CN$US$US
1811466230$18114662$30$F$20200726$20240906$20200805$20240911$EXP$$US-SHIRE-US202024879$TAKEDA$$42$YR$$M$Y$$$20240911$$CN$US$US
181146636$18114663$6$F$20200719$20240724$20200805$20240730$EXP$$US-SHIRE-US202024895$TAKEDA$$35$YR$$M$Y$$$20240730$$MD$US$US
1811472511$18114725$11$F$20181002$20240820$20200805$20240827$EXP$$DE-ROCHE-2195172$ROCHE$$52$YR$A$F$Y$67$KG$20240827$$CN$DE$DE
1811478014$18114780$14$F$$20240903$20200805$20240906$PER$$US-PFIZER INC-2020296161$PFIZER$$49$YR$$F$Y$$$20240906$$MD$US$US
1811551915$18115519$15$F$20210120$20240724$20200805$20240726$EXP$$US-SHIRE-US202025143$TAKEDA$$76$YR$$F$Y$68$KG$20240726$$HP$US$US
1811555420$18115554$20$F$20220116$20240904$20200805$20240909$EXP$$US-SHIRE-US202025230$TAKEDA$$41$YR$$F$Y$70$KG$20240909$$HP$US$US
1811563113$18115631$13$F$20240701$20240924$20200805$20240930$EXP$$US-SHIRE-US202025206$TAKEDA$$63$YR$$F$Y$91$KG$20240930$$MD$US$US
1811682417$18116824$17$F$$20240711$20200806$20240717$EXP$$US-SHIRE-US202025382$TAKEDA$$$$$F$Y$81$KG$20240717$$MD$US$US
1811682515$18116825$15$F$20191201$20240827$20200805$20240830$EXP$$CO-TAKEDA-2020TUS004693$TAKEDA$$64$YR$$M$Y$73$KG$20240830$$HP$CO$CO
181174136$18117413$6$F$20190605$20240730$20200806$20240809$EXP$$CA-009507513-2008CAN001403$MERCK$$85$YR$$M$Y$$$20240809$$CN$CA$CA
181175708$18117570$8$F$20191001$20240816$20200806$20240830$PER$$US-SA-2020SA202920$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240830$$MD$US$US
1811761423$18117614$23$F$20210806$20240613$20200806$20240709$EXP$$CA-ROCHE-2649787$ROCHE$$66$YR$E$M$Y$78$KG$20240628$$CN$CA$CA
181185096$18118509$6$F$$20240821$20200806$20240827$30DAY$$US-GLAXOSMITHKLINE-US2020143409$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$MD$US$US
181192293$18119229$3$F$20200301$20240816$20200806$20240822$EXP$$NVSC2020CA086112$NOVARTIS$$64$YR$$F$Y$$$20240822$$CN$CA$CA
1811962617$18119626$17$F$20200726$20240910$20200806$20240913$EXP$$US-SHIRE-US202024987$TAKEDA$$40$YR$$M$Y$$$20240913$$PH$US$US
181197032$18119703$2$F$20191128$20240715$20200806$20240722$EXP$$KR-GLAXOSMITHKLINE-KR2020GSK127100$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$MD$KR$KR
181197043$18119704$3$F$20200311$20240715$20200806$20240725$EXP$$KR-GLAXOSMITHKLINE-KR2020GSK127112$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$KR$KR
1811985725$18119857$25$F$20200921$20240823$20200806$20240829$EXP$$US-SHIRE-US202025411$TAKEDA$$39$YR$$F$Y$58.05$KG$20240829$$CN$US$US
181212102$18121210$2$F$$20240924$20200806$20240925$EXP$$US-PURDUE-USA-2020-0160471$PURDUE$$$$$F$Y$$$20240925$$CN$US$US
181221425$18122142$5$F$$20210526$20200806$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-062764$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$MD$JP$JP
181229272$18122927$2$F$$20240731$20200807$20240812$EXP$$US-Accord-194592$ACCORD$Multiple drugs; Various toxicities and lack of efficacy: case report. 2020.$25$YR$A$F$Y$$$20240812$$HP$US$US
181241982$18124198$2$F$20200729$20240828$20200807$20240903$EXP$$US-SHIRE-US202024988$TAKEDA$$14$YR$$M$Y$$$20240903$$CN$US$US
181261932$18126193$2$F$20110101$20240729$20200808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2020-037913$AUROBINDO$M^Kada H, Perazzo H, Munteanu M, Ngo Y, Ramanujam N, Poynard T, et al.. Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study. PLOS-One.. 2012;7(8):1-7 (e42418)$56$YR$$M$Y$$$20240808$$HP$FR$FR
1812707313$18127073$13$F$20211030$20240828$20200810$20240903$EXP$$US-SHIRE-US202025614$TAKEDA$$76$YR$$F$Y$78$KG$20240903$$CN$US$US
181282973$18128297$3$F$20220101$20240625$20200810$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-002371$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240719$$CN$US$US
181289298$18128929$8$F$$20240822$20200810$20240828$PER$$US-PFIZER INC-2019033607$PFIZER$$71$YR$$F$Y$$$20240828$$MD$US$US
1812906022$18129060$22$F$$20240826$20200810$20240828$PER$$US-PFIZER INC-2019343427$PFIZER$$66$YR$$M$Y$85$KG$20240828$$MD$US$US
1813044114$18130441$14$F$20210428$20240703$20200810$20240708$EXP$$US-SHIRE-US202025602$TAKEDA$$20$YR$$M$Y$68$KG$20240708$$CN$US$US
1813049710$18130497$10$F$20200725$20240916$20200810$20240919$EXP$$US-SHIRE-US202025514$TAKEDA$$19$YR$$M$Y$$$20240919$$CN$US$US
181305755$18130575$5$F$20200325$20240711$20200810$20240716$EXP$$NVSC2020DE220503$NOVARTIS$$51$YR$$F$Y$75$KG$20240716$$HP$DE$DE
181320124$18132012$4$F$20200727$20240814$20200811$20240826$PER$$US-SA-2020SA206775$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240826$$MD$US$US
181324237$18132423$7$F$20211019$20240829$20200811$20240903$EXP$$US-SHIRE-US202025603$TAKEDA$$63$YR$$M$Y$73$KG$20240903$$HP$US$US
181333293$18133329$3$F$20200301$20240905$20200811$20240910$PER$$US-AMGEN-USA-20200407596$AMGEN$$65$YR$E$F$Y$$$20240910$$HP$US$US
181340124$18134012$4$F$20230522$20240815$20200811$20240822$EXP$$BR-TAKEDA-2020TUS034016$TAKEDA$$43$YR$$F$Y$$$20240822$$CN$BR$BR
1813506910$18135069$10$F$$20220309$20200811$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR153913$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
181355533$18135553$3$F$20190908$20240806$20200811$20240807$EXP$$IL-SHIRE-IL201931054$TAKEDA$$40$YR$$F$Y$$$20240807$$HP$IL$IL
181361375$18136137$5$F$$20240708$20200811$20240710$PER$$US-PFIZER INC-2020305214$PFIZER$$63$YR$$F$Y$$$20240710$$HP$US$US
1813640321$18136403$21$F$20160201$20240904$20200811$20240909$EXP$$US-SHIRE-US202025843$TAKEDA$$47$YR$$F$Y$68$KG$20240909$$HP$US$US
181364323$18136432$3$F$20191201$20240710$20200811$20240717$EXP$$US-PFIZER INC-2020301039$MYLAN$$32$YR$$F$Y$77.09$KG$20240717$$CN$US$US
1813644212$18136442$12$F$20200730$20240903$20200811$20240905$EXP$$US-SHIRE-US202025502$TAKEDA$$17$YR$$M$Y$$$20240905$$MD$US$US
1813644310$18136443$10$F$20230418$20240918$20200811$20240923$EXP$$US-SHIRE-US202025404$TAKEDA$$4$YR$$M$Y$$$20240923$$CN$US$US
181369298$18136929$8$F$$20240924$20200811$20240930$EXP$$AU-TOLMAR, INC.-20AU022340$TOLMAR$$$$$M$Y$$$20240930$$HP$AU$AU
181378683$18137868$3$F$$20240708$20200811$20240713$PER$$US-SA-2020SA207946$SANOFI AVENTIS$$$$T$M$Y$$$20240713$$MD$US$US
1813822413$18138224$13$F$20200731$20240904$20200812$20240912$EXP$$CA-ROCHE-2656722$ROCHE$$48$YR$A$F$Y$$$20240912$$CN$CA$CA
181390766$18139076$6$F$20200717$20240916$20200812$20240923$EXP$$US-SHIRE-US202025878$TAKEDA$$65$YR$$M$Y$108$KG$20240923$$CN$US$US
1814174512$18141745$12$F$20210310$20240826$20200812$20240902$EXP$$US-TAKEDA-2020TUS034132$TAKEDA$$28$YR$$F$Y$127.6$KG$20240902$$HP$US$US
181423288$18142328$8$F$$20240903$20200813$20240913$EXP$$ES-ROCHE-2657950$ROCHE$Cases-Corona C, Shabaka A, Gonzalez-Lopez A, Martin-Segarra O, Moreno De La Higuera M, Lucena R. Fulminant Emphysematous Pyelonephritis by Candida glabrata in a Kidney Allograft.. Nephron clinical practice.. 2020;144 (6):304-9.$53$YR$A$F$Y$$$20240913$$HP$ES$ES
181428472$18142847$2$F$20200807$20240913$20200813$20240923$PER$$US-SA-2020SA209872$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240923$$MD$US$US
181446712$18144671$2$F$20200101$20240830$20200813$20240918$EXP$$US-SA-2020SA209598$SANOFI AVENTIS$$62$YR$A$F$Y$65.91$KG$20240918$$MD$US$US
1814497718$18144977$18$F$20220615$20240819$20200813$20240827$EXP$$US-SHIRE-US202026112$TAKEDA$$37$YR$$M$Y$98$KG$20240827$$CN$US$US
181450053$18145005$3$F$$20240809$20200813$20240814$EXP$$IT-SA-2020SA209915$SANOFI AVENTIS$Botta C, Caruso N, Bossio S, Storino F, Console G, Martino M et al.. Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib:A Case Report. Frontiers in oncology. 2020;10:unk$32$YR$A$F$Y$$$20240814$$HP$IT$IT
181453917$18145391$7$F$$20240708$20200813$20240715$EXP$$CA-BAUSCH-BL-2020-022191$BAUSCH AND LOMB$$56$YR$$F$Y$$$20240715$$CN$CA$CA
181465642$18146564$2$F$$20240803$20200813$20240807$PER$$US-PURDUE-USA-2020-0160950$PURDUE$$26$YR$$F$Y$$$20240807$$LW$US$US
1814764010$18147640$10$F$20201213$20240919$20200813$20240923$EXP$$US-SHIRE-US202025914$TAKEDA$$25$YR$$M$Y$$$20240923$$CN$US$US
1814845514$18148455$14$F$20200101$20240704$20200814$20240711$EXP$$CA-CELLTRION INC.-2020CA025149$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
181484878$18148487$8$F$20200901$20221129$20200814$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR152937$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
181485604$18148560$4$F$20200723$20240822$20200814$20240830$EXP$$US-Horizon-TEP-1199-2020$AMGEN$$70$YR$E$F$Y$$$20240829$$LW$US$US
181498452$18149845$2$F$20200417$20200916$20200814$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-245396$RANBAXY$$95$YR$E$F$Y$$$20240804$$CN$US$US
181498533$18149853$3$F$20200521$20200817$20200814$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-249655$RANBAXY$$80$YR$E$M$Y$$$20240804$$CN$US$US
181498542$18149854$2$F$$20200218$20200814$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-237969$RANBAXY$$$$A$F$Y$$$20240804$$HP$US$US
1815085112$18150851$12$F$$20240918$20200814$20240923$EXP$$US-SHIRE-US202026216$TAKEDA$$$$$M$Y$70$KG$20240923$$CN$US$US
1815085214$18150852$14$F$$20240916$20200814$20240924$EXP$$CA-ROCHE-2657379$ROCHE$$$$A$M$Y$$$20240924$$CN$CA$CA
1815128533$18151285$33$F$20210607$20240916$20200814$20240924$EXP$$US-SHIRE-US202026111$TAKEDA$$67$YR$$F$Y$57.143$KG$20240924$$HP$US$US
1815155117$18151551$17$F$$20240813$20200814$20240820$EXP$$US-SHIRE-US202026040$TAKEDA$$$$$F$Y$60$KG$20240820$$HP$US$US
181524512$18152451$2$F$20000701$20240911$20200814$20240914$EXP$$US-SA-200020149US$SANOFI AVENTIS$Koening, Andrew, Abruzzo JL,. Leflunomide Induced Fevers, Thrombocytosis, and Leukocytosis in Pts with Relapsing Polychondritis. J Rheumatol. 2002;29:192-4$50$YR$A$M$Y$$$20240914$$HP$US$US
181524778$18152477$8$F$$20240708$20200814$20240710$EXP$$US-SHIRE-US202026010$TAKEDA$$$$$M$Y$$$20240710$$CN$US$US
181526102$18152610$2$F$$20240715$20200814$20240726$EXP$$CA-ANIPHARMA-2020-CA-001554$ANI$$57$YR$$F$Y$$$20240726$$HP$CA$CA
1815277026$18152770$26$F$20201209$20240802$20200814$20240805$EXP$$US-DSJP-DSU-2020-123077$DAIICHI$$56$YR$$F$Y$$$20240805$$CN$US$US
1815304116$18153041$16$F$$20240718$20200815$20240723$EXP$$US-SHIRE-US202026217$TAKEDA$$$$$F$Y$80$KG$20240723$$HP$US$US
1815306618$18153066$18$F$20200727$20240916$20200815$20240918$EXP$$US-SHIRE-US202026120$TAKEDA$$7$YR$$M$Y$$$20240918$$CN$US$US
181535089$18153508$9$F$20181110$20240913$20200816$20240918$EXP$$PHHY2018CA160935$NOVARTIS$$23$YR$$F$Y$$$20240918$$CN$CA$CA
181564986$18156498$6$F$$20240827$20200817$20240924$EXP$$US-PFIZER INC-2020020721$PFIZER$$72$YR$$F$Y$49.9$KG$20240924$$CN$US$US
1815664625$18156646$25$F$$20240705$20200817$20240808$EXP$$NVSC2020CA224094$NOVARTIS$$44$YR$$F$Y$68$KG$20240808$$CN$CA$CA
1815808740$18158087$40$F$$20240909$20200817$20240912$EXP$$US-SHIRE-US202026115$TAKEDA$$$$$F$Y$57$KG$20240912$$MD$US$US
1815811721$18158117$21$F$20200821$20230428$20200817$20240926$PER$$US-GLAXOSMITHKLINE-US2020AMR160602$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240926$$CN$US$US
181581615$18158161$5$F$$20240919$20200817$20240924$EXP$$US-SHIRE-US202026271$TAKEDA$$$$$M$Y$75$KG$20240924$$CN$US$US
181589354$18158935$4$F$$20240802$20200817$20240820$EXP$$GR-ABBVIE-20K-066-3525853-00$ABBVIE$TORTMAN J, D^Sa S, Jurczak W, Lee H, Cull G, Owen R,et.al. Re-sults of a phase 3 randomized trial of zanubrutinib versus ibrutinib for patients with waldenstrom macroglobulinemia (WM). Hemasphere. 2020;4:S1,71$$$$$Y$$$20240820$$HP$GR$GR
181593942$18159394$2$F$$20240905$20200818$20240919$EXP$$IT-AUROBINDO-AUR-APL-2013-02119$AUROBINDO$Mameli C, Tadini G, Cattaneo D, Cerini C, Zuccotti GV.. Acute Generalized Exanthematous Pustulosis Induced by Paroxetine in an Adolescent Girl. Acta Derm Venereol. 2013;93:733-734$16$YR$$F$Y$$$20240919$$HP$IT$IT
1815965725$18159657$25$F$20220714$20240814$20200818$20240821$EXP$$US-SHIRE-US202026456$TAKEDA$$70$YR$$F$Y$119$KG$20240821$$HP$US$US
1816012111$18160121$11$F$$20240828$20200818$20240906$EXP$$CA-AUROBINDO-AUR-APL-2020-038692$AUROBINDO$$61$YR$$F$Y$$$20240906$$HP$CA$CA
1816041610$18160416$10$F$$20240920$20200817$20240925$EXP$$US-PFIZER INC-2020309755$PFIZER$$72$YR$$F$Y$47.6$KG$20240925$$CN$US$US
181646384$18164638$4$F$$20240918$20200819$20240927$EXP$$CA-APOTEX-2020AP015720$APOTEX$$69$YR$$M$Y$$$20240927$$CN$CA$CA
181646933$18164693$3$F$$20240903$20200818$20240905$EXP$$US-SHIRE-US202026329$TAKEDA$$$$$F$Y$79$KG$20240905$$CN$US$US
181653942$18165394$2$F$$20240730$20200818$20240802$EXP$$CA-AstraZeneca-2020SF03536$ASTRAZENECA$$53$YR$$M$Y$$$20240802$$MD$CA$
1816575410$18165754$10$F$$20240813$20200819$20240827$EXP$$CA-AUROBINDO-AUR-APL-2020-038667$AUROBINDO$$78$YR$$F$Y$93$KG$20240827$$HP$CA$CA
181660674$18166067$4$F$20200804$20240717$20200819$20240725$EXP$$DE-AUROBINDO-AUR-APL-2020-039415$AUROBINDO$$$$A$F$Y$90$KG$20240725$$MD$DE$DE
181678206$18167820$6$F$20191209$20211027$20200818$20240703$EXP$$NVSC2020US226125$NOVARTIS$$4$YR$$M$Y$$$20240703$$HP$US$US
1816870612$18168706$12$F$20171201$20240918$20200818$20240926$PER$$US-GLAXOSMITHKLINE-US2020AMR163546$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240926$$CN$US$US
181688665$18168866$5$F$$20240628$20200819$20240702$EXP$$US-PFIZER INC-2020158516$PFIZER$$81$YR$$F$Y$$$20240702$$HP$US$US
1816948825$18169488$25$F$20170101$20240703$20200819$20240709$EXP$$US-SHIRE-US202026301$TAKEDA$$$$$M$Y$$$20240709$$PH$US$US
181699772$18169977$2$F$20200701$20240723$20200819$20240724$EXP$$US-SHIRE-US202026139$TAKEDA$$37$YR$$F$Y$$$20240724$$CN$US$US
1817005213$18170052$13$F$20240722$20240723$20200819$20240725$EXP$$US-SHIRE-US202026452$TAKEDA$$81$YR$$F$Y$45$KG$20240725$$HP$US$US
181708738$18170873$8$F$$20240828$20200819$20240909$PER$$US-AMGEN-USASP2020133406$AMGEN$$79$YR$E$F$Y$58.06$KG$20240909$$CN$US$US
181710672$18171067$2$F$20200627$20200723$20200819$20240715$EXP$$NVSC2020GB207548$NOVARTIS$$39$YR$$F$Y$$$20240715$$MD$GB$GB
181714212$18171421$2$F$$20240809$20200819$20240820$EXP$$IT-BAXTER-2020BAX016307$BAXTER$$32$YR$$F$Y$$$20240820$$HP$IT$IT
181714333$18171433$3$F$$20240823$20200819$20240829$EXP$$JP-PFIZER INC-2020313458$PFIZER$Yoshida, A.. Tumour necrosis factor inhibitor-induced myositis in a patient with ulcerative colitis. Modern Rheumatology Case reports. 2020;10.1080/24725625.2020.1800958$60$YR$$M$Y$$$20240829$$HP$JP$JP
1817154618$18171546$18$F$20200101$20240731$20200819$20240806$EXP$$US-DSJP-DSU-2020-123405$DAIICHI$$$$$F$Y$105.1$KG$20240806$$CN$US$US
1817226813$18172268$13$F$20200115$20240731$20200820$20240806$EXP$$DE-ROCHE-2569226$ROCHE$$53$YR$A$F$Y$$$20240806$$CN$DE$DE
181736577$18173657$7$F$20200818$20240731$20200820$20240805$EXP$$US-SHIRE-US202026709$TAKEDA$$66$YR$$M$Y$79$KG$20240805$$HP$US$US
1817411345$18174113$45$F$20200101$20240904$20200820$20240912$EXP$$CA-CELLTRION INC.-2019CA027680$CELLTRION$$$$$$Y$$$20240912$$MD$CA$CA
1817421014$18174210$14$F$20190924$20240814$20200820$20240822$EXP$$CA-CELLTRION INC.-2019CA024084$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
1817425124$18174251$24$F$$20240919$20200820$20240925$EXP$$US-SHIRE-US202026693$TAKEDA$$$$$M$Y$64$KG$20240925$$HP$US$US
181745212$18174521$2$F$$20240801$20200820$20240813$EXP$E2B_03074036$CA-Accord-196039$ACCORD$$50$YR$A$F$Y$$$20240813$$HP$CA$CA
181745523$18174552$3$F$$20240826$20200820$20240905$30DAY$$US-GLAXOSMITHKLINE-US2020156596$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
181749698$18174969$8$F$20240901$20240917$20200820$20240920$EXP$$US-SHIRE-US202027055$TAKEDA$$70$YR$$M$Y$66$KG$20240920$$CN$US$US
181750173$18175017$3$F$$20240814$20200820$20240824$EXP$E2B_03078723$CA-Accord-196007$ACCORD$$44$YR$A$F$Y$$$20240824$$HP$CA$CA
1817573860$18175738$60$F$20130128$20240916$20200820$20240924$EXP$$US-SHIRE-US202026750$TAKEDA$$52$YR$$F$Y$59$KG$20240924$$HP$US$US
181762717$18176271$7$F$20200601$20240717$20200820$20240722$EXP$$CA-PFIZER INC-2020050451$PFIZER$$60$YR$$F$Y$$$20240722$$HP$CA$CA
181764097$18176409$7$F$20230217$20240919$20200820$20240923$EXP$$US-SHIRE-US202026432$TAKEDA$$12$YR$$M$Y$$$20240923$$CN$US$US
181770193$18177019$3$F$20200801$20240814$20200820$20240828$PER$$US-SA-2020SA221011$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240828$$MD$US$US
1817740132$18177401$32$F$20201101$20231030$20200820$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR166684$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
1817745220$18177452$20$F$20201201$20240906$20200821$20240911$EXP$$US-SHIRE-US202026782$TAKEDA$$72$YR$$F$Y$48$KG$20240911$$CN$US$US
181787462$18178746$2$F$20200804$20240910$20200820$20240917$EXP$$CA-JNJFOC-20200818103$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240917$$CN$CA$CA
181788966$18178896$6$F$$20240826$20200820$20240829$EXP$$CA-TAKEDA-2020TUS033733$TAKEDA$$$$$F$Y$$$20240829$$MD$CA$CA
181794552$18179455$2$F$$20240801$20200821$20240814$EXP$$CA-AUROBINDO-AUR-APL-2012-05443$AUROBINDO$Chow TW, Links KA, Masterman DL, Mendez MF, Vinters HV. A case of semantic variant primary progressive aphasia with severe insular atrophy. Neurocase: The Neural Basis of Cognition. 2012;18(6):450-456$58$YR$$M$Y$$$20240814$$MD$CA$CA
181796878$18179687$8$F$$20240918$20200821$20240930$EXP$000910468$CA-Accord-196242$ACCORD$$44$YR$A$F$Y$97$KG$20240930$$HP$CA$CA
1818012911$18180129$11$F$$20220426$20200821$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR167234$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
181801449$18180144$9$F$$20240819$20200821$20240824$EXP$$NVSC2020CA225240$NOVARTIS$$61$YR$$F$Y$$$20240824$$CN$CA$CA
181806778$18180677$8$F$$20230926$20200821$20240911$EXP$$NVSC2020US231376$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
181810137$18181013$7$F$$20240910$20200821$20240925$EXP$$CA-HLS-202001075$HLS THERAPEUTICS$$$$$M$Y$$$20240925$$HP$CA$CA
181811114$18181111$4$F$$20240808$20200821$20240813$EXP$$US-SHIRE-US202027051$TAKEDA$$$$$F$Y$74.83$KG$20240813$$CN$US$US
1818127522$18181275$22$F$20070101$20240911$20200821$20240918$EXP$$NVSC2017CA011902$NOVARTIS$$62$YR$$F$Y$$$20240918$$CN$CA$CA
1818136911$18181369$11$F$$20240910$20200821$20240917$EXP$$US-SHIRE-US202026912$TAKEDA$$$$$F$Y$79$KG$20240917$$CN$US$US
1818283813$18182838$13$F$20200529$20240809$20200821$20240815$EXP$$US-SHIRE-US202027181$TAKEDA$$62$YR$$F$Y$113$KG$20240815$$CN$US$US
1818316710$18183167$10$F$$20240801$20200822$20240813$EXP$$US-SHIRE-US202027001$TAKEDA$$$$$F$Y$78$KG$20240813$$HP$US$US
1818332637$18183326$37$F$20240308$20240920$20200822$20240930$EXP$$US-SHIRE-US202027133$TAKEDA$$52$YR$$M$Y$99$KG$20240930$$CN$US$US
181837598$18183759$8$F$20200728$20240911$20200822$20240918$EXP$$NVSC2020GB229683$NOVARTIS$$54$YR$$F$Y$$$20240918$$CN$GB$GB
1818398317$18183983$17$F$20200813$20220719$20200823$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR166714$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
1818424128$18184241$28$F$20230322$20240920$20200824$20240927$EXP$$US-SHIRE-US202027052$TAKEDA$$25$YR$$F$Y$58$KG$20240927$$MD$US$US
181844255$18184425$5$F$20200101$20240827$20200824$20240828$EXP$$US-PFIZER INC-2020324234$PFIZER$$73$YR$$F$Y$$$20240828$$CN$US$US
181845158$18184515$8$F$$20240820$20200824$20240828$EXP$$US-SHIRE-US202027040$TAKEDA$$$$$F$Y$131$KG$20240828$$CN$US$US
1818454247$18184542$47$F$20200601$20240920$20200824$20240930$EXP$$CA-CELLTRION INC.-2020CA023039$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
181846203$18184620$3$F$$20240805$20200824$20240813$EXP$$BR-CELLTRION INC.-2020BR025683$CELLTRION$$$$$$Y$$$20240813$$MD$BR$BR
181848865$18184886$5$F$20200215$20240820$20200824$20240830$EXP$$US-SHIRE-US202006718$TAKEDA$$61$YR$$M$Y$124$KG$20240830$$MD$US$US
181849083$18184908$3$F$$20240710$20200824$20240718$EXP$$CA-CELLTRION INC.-2020CA025417$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
181857392$18185739$2$F$$20240728$20200824$20240807$EXP$$GB-ROCHE-2281473$ROCHE$$$$A$F$Y$$$20240807$$CN$GB$GB
181861966$18186196$6$F$$20240822$20200824$20240830$EXP$$CA-APOTEX-2020AP016463$APOTEX$$$$$M$Y$$$20240830$$CN$CA$CA
1818707912$18187079$12$F$20220831$20240923$20200824$20240927$EXP$$US-SHIRE-US202027165$TAKEDA$$73$YR$$F$Y$79$KG$20240927$$CN$US$US
1818817511$18188175$11$F$20200815$20240726$20200824$20240731$EXP$$US-SHIRE-US202026844$TAKEDA$$20$YR$$M$Y$$$20240731$$MD$US$US
181881779$18188177$9$F$20200101$20240813$20200824$20240819$EXP$$US-SHIRE-US202026880$TAKEDA$$$$$M$Y$74.83$KG$20240819$$HP$US$US
1818831010$18188310$10$F$$20220415$20200824$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR165012$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
181884413$18188441$3$F$$20240722$20200824$20240730$EXP$$CA-MYLANLABS-2020M1072808$MYLAN$$48$YR$$F$Y$76$KG$20240730$$MD$CA$CA
1818939127$18189391$27$F$20190905$20240820$20200824$20240827$EXP$$US-SHIRE-US202027309$TAKEDA$$36$YR$$F$Y$145$KG$20240827$$HP$US$US
1818967711$18189677$11$F$20200812$20240702$20200825$20240708$EXP$$US-SHIRE-US202027270$TAKEDA$$75$YR$$F$Y$61$KG$20240708$$HP$US$US
181910533$18191053$3$F$20170701$20240322$20200824$20240710$PER$$US-ROCHE-2547997$ROCHE$$38$YR$A$F$Y$$$20240628$$CN$US$US
181910692$18191069$2$F$20200220$20231030$20200824$20240710$PER$$US-ROCHE-2561556$ROCHE$$60$YR$A$F$Y$$$20240628$$CN$US$US
1819129721$18191297$21$F$20200801$20240910$20200825$20240912$PER$$US-DSJP-DSU-2020-124161$DAIICHI$$50$YR$$M$Y$$$20240912$$CN$US$US
181914227$18191422$7$F$$20240916$20200824$20240925$EXP$$CA-CELLTRION INC.-2020CA025357$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
181918238$18191823$8$F$20190726$20240710$20200825$20240717$EXP$$PHHY2019BR179680$NOVARTIS$$49$YR$$M$Y$95$KG$20240717$$CN$BR$BR
1819188710$18191887$10$F$20200101$20240829$20200825$20240906$EXP$$PK-AMGEN-PAKSP2020001110$AMGEN$$48$YR$A$M$Y$78$KG$20240906$$CN$PK$PK
1819304215$18193042$15$F$$20240808$20200825$20240814$EXP$$US-SHIRE-US202027458$TAKEDA$$$$$F$Y$73.92$KG$20240814$$HP$US$US
181932035$18193203$5$F$$20240829$20200825$20240906$EXP$$CA-AstraZeneca-2020SF04261$ASTRAZENECA$$31$YR$$F$Y$71$KG$20240906$$MD$CA$
181934298$18193429$8$F$20200712$20240703$20200825$20240717$EXP$$BG-AstraZeneca-2020SF05712$ASTRAZENECA$$19$YR$$M$Y$$$20240717$$MD$BG$
1819406411$18194064$11$F$$20240910$20200825$20240927$EXP$$CA-ROCHE-2664629$ROCHE$$78$YR$E$F$Y$93$KG$20240927$$CN$CA$CA
181959883$18195988$3$F$20130207$20240819$20200826$20240826$EXP$$ZA-AMGEN-ZAFSP2020138599$AMGEN$$49$YR$A$F$Y$$$20240826$$MD$ZA$ZA
181968312$18196831$2$F$20190101$20240904$20200826$20240913$EXP$$US-SPECGX-T201906738$SPECGX$$$$$F$Y$$$20240913$$PH$US$US
1819814815$18198148$15$F$20230801$20240828$20200826$20240904$EXP$$US-PFIZER INC-2020328573$PFIZER$$77$YR$$F$Y$$$20240904$$CN$US$US
1819822312$18198223$12$F$20210330$20240730$20200826$20240803$EXP$$CA-ROCHE-2665018$ROCHE$$57$YR$A$M$Y$$$20240803$$CN$CA$CA
181990394$18199039$4$F$20200501$20240820$20200826$20240828$PER$$US-BIOMARINAP-US-2020-131850$BIOMARIN$$$$$$Y$$$20240828$$HP$US$US
1819908521$18199085$21$F$20180615$20240913$20200826$20240920$EXP$$US-SHIRE-US202027671$TAKEDA$$81$YR$$M$Y$106$KG$20240920$$HP$US$US
181992395$18199239$5$F$20180221$20240703$20200826$20240710$PER$$US-SA-2020SA227948$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240710$$MD$US$US
1819961112$18199611$12$F$20200806$20240718$20200826$20240722$EXP$$US-SHIRE-US202027537$TAKEDA$$58$YR$$M$Y$$$20240722$$CN$US$US
181996208$18199620$8$F$20200813$20240712$20200826$20240716$EXP$$US-SHIRE-US202027652$TAKEDA$$22$YR$$M$Y$$$20240716$$CN$US$US
1819994411$18199944$11$F$20200817$20240827$20200827$20240902$EXP$$US-SHIRE-US202027697$TAKEDA$$47$YR$$M$Y$111$KG$20240902$$CN$US$US
1820073121$18200731$21$F$20240208$20240827$20200827$20240830$EXP$$US-SHIRE-US202027604$TAKEDA$$50$YR$$F$Y$81$KG$20240830$$HP$US$US
1820077623$18200776$23$F$20200819$20240812$20200827$20240814$EXP$$US-SHIRE-US202027642$TAKEDA$$0$YR$$M$Y$$$20240814$$MD$US$US
1820114311$18201143$11$F$20230328$20240910$20200827$20240917$EXP$$US-SHIRE-US202027611$TAKEDA$$66$YR$$F$Y$67$KG$20240917$$CN$US$US
182016042$18201604$2$F$20191225$20240831$20200827$20240912$EXP$DE-BFARM-20008969$DE-Accord-197597$ACCORD$$71$YR$E$M$Y$74$KG$20240912$$PH$DE$DE
182021107$18202110$7$F$$20240904$20200827$20240905$PER$$US-PFIZER INC-2020328262$PFIZER$$74$YR$$F$Y$59.42$KG$20240905$$CN$US$US
1820302819$18203028$19$F$$20240910$20200827$20240914$EXP$$US-SHIRE-US202027636$TAKEDA$$$$$F$Y$63$KG$20240914$$HP$US$US
182035483$18203548$3$F$20191225$20240827$20200827$20240908$EXP$DE-MACLEODS PHARMACEUTICALS US LTD-MAC2020027796$DE-MACLEODS PHARMACEUTICALS US LTD-MAC2020027796$MACLEODS$$$$$$Y$$$20240906$$PH$DE$DE
182036438$18203643$8$F$20210801$20240712$20200827$20240717$EXP$$US-SHIRE-US202027723$TAKEDA$$52$YR$$F$Y$60.77$KG$20240717$$HP$US$US
182041209$18204120$9$F$20190803$20240918$20200827$20240925$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-067813$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$78$KG$20240925$$HP$DE$DE
1820439622$18204396$22$F$20200701$20240911$20200828$20240915$EXP$$US-SHIRE-US202027869$TAKEDA$$22$YR$$M$Y$$$20240915$$CN$US$US
1820454020$18204540$20$F$20190101$20240905$20200827$20240910$EXP$$NVSC2019CA045151$NOVARTIS$$66$YR$$F$Y$$$20240910$$CN$CA$CA
182050104$18205010$4$F$20240415$20240925$20200828$20240930$EXP$$US-SHIRE-US202027911$TAKEDA$$62$YR$$F$Y$$$20240930$$HP$US$US
182053989$18205398$9$F$$20240925$20200827$20240930$EXP$$US-SHIRE-US202027879$TAKEDA$$$$$F$Y$70$KG$20240930$$HP$US$US
1820565732$18205657$32$F$20190101$20240903$20200828$20240911$EXP$$CA-CELLTRION INC.-2019CA022271$CELLTRION$$$$$$Y$$$20240911$$CN$CA$CA
1820588111$18205881$11$F$20200505$20240903$20200828$20240906$EXP$$US-SHIRE-US202027930$TAKEDA$$69$YR$$M$Y$81.633$KG$20240906$$HP$US$US
182059585$18205958$5$F$20160601$20240821$20200827$20240826$EXP$$US-JAZZ-2020-US-010797$JAZZ$$34$YR$$M$Y$$$20240826$$CN$US$US
1820658224$18206582$24$F$20210101$20240627$20200828$20240703$EXP$$CA-CELLTRION INC.-2020CA020963$CELLTRION$$$$$$Y$$$20240703$$MD$CA$CA
182069363$18206936$3$F$20200820$20240910$20200828$20240922$PER$$US-BEH-2020121696$CSL BEHRING$$52$YR$A$F$Y$$$20240922$$HP$US$US
182076938$18207693$8$F$20210719$20240828$20200828$20240830$EXP$$US-PFIZER INC-2020333750$PFIZER$$68$YR$$F$Y$$$20240830$$HP$US$US
182077998$18207799$8$F$20200626$20240903$20200828$20240906$EXP$$US-INCYTE CORPORATION-2020IN006326$INCYTE$$$$$$Y$$$20240906$$CN$US$US
1820918421$18209184$21$F$20161018$20240826$20200828$20240902$EXP$$US-SHIRE-US202009777$TAKEDA$$34$YR$$F$Y$86$KG$20240902$$MD$US$US
182092813$18209281$3$F$$20240701$20200828$20240712$EXP$$US-THERATECHNOLOGIES INC.-2020-THE-TES-000193$Unknown Manufacturer$$$$$$Y$$$20240712$$CN$US$US
1820997937$18209979$37$F$20200101$20240904$20200829$20240913$EXP$$CA-CELLTRION INC.-2019CA026266$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
182108042$18210804$2$F$$20240726$20200830$20240802$EXP$$CA-AstraZeneca-2020SF07886$ASTRAZENECA$$1$DY$$$Y$2$KG$20240802$$MD$CA$
182112799$18211279$9$F$20240422$20240913$20200831$20240918$EXP$$US-SHIRE-US202027839$TAKEDA$$37$YR$$F$Y$98.86$KG$20240918$$HP$US$US
182122525$18212252$5$F$$20240708$20200831$20240711$EXP$$IE-PFIZER INC-2020329513$PFIZER$Keane, N.. A Surviving Case of Acanthamoeba Granulomatous Amebic Encephalitis in a Hematopoietic Stem Cell Transplant Recipient.. Am J Case Rep.. 2020;21:e923219-1 e923219-6$32$YR$$M$Y$$$20240711$$HP$IE$IE
182133472$18213347$2$F$20191225$20240903$20200831$20240911$EXP$$DE-TEVA-2020-DE-1822849$TEVA$$71$YR$$M$Y$74$KG$20240911$$PH$DE$DE
1821369710$18213697$10$F$$20240827$20200831$20240831$EXP$$US-SHIRE-US202027891$TAKEDA$$$$$F$Y$47$KG$20240831$$CN$US$US
1821372115$18213721$15$F$$20240918$20200831$20240924$EXP$$US-SHIRE-US202027963$TAKEDA$$$$$M$Y$64$KG$20240924$$HP$US$US
182141114$18214111$4$F$20200325$20240722$20200831$20240726$EXP$$DE-PFIZER INC-2020331519$PFIZER$$51$YR$$F$Y$75$KG$20240726$$HP$DE$DE
182141556$18214155$6$F$20200101$20240812$20200831$20240814$EXP$$US-PFIZER INC-2020003834$PFIZER$$66$YR$$M$Y$$$20240814$$HP$US$US
1821459621$18214596$21$F$20181012$20240826$20200831$20240902$EXP$$US-SHIRE-US202028126$TAKEDA$$37$YR$$F$Y$107$KG$20240902$$CN$US$US
182163242$18216324$2$F$20191225$20240904$20200901$20240916$EXP$$DE-MSNLABS-2020MSNSPO00335$MSN LABORATORIES$$$$$$Y$$$20240916$$PH$DE$DE
182166189$18216618$9$F$$20240903$20200901$20240910$EXP$$JP-ROCHE-2668873$ROCHE$$25$YR$A$F$Y$$$20240910$$CN$JP$JP
182166713$18216671$3$F$20200801$20240813$20200901$20240820$PER$$US-SA-2020SA234204$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240820$$MD$US$US
182174824$18217482$4$F$20170101$20240701$20200901$20240703$EXP$$US-MYLANLABS-2020M1075001$MYLAN$$$$$M$Y$90.71$KG$20240703$$LW$US$US
182178512$18217851$2$F$$20240726$20200901$20240802$EXP$$CA-AstraZeneca-2020SF07858$ASTRAZENECA$$46$YR$$M$Y$90$KG$20240802$$MD$CA$
182178598$18217859$8$F$20220111$20240809$20200901$20240813$EXP$$US-TAKEDA-2020TUS036641$TAKEDA$$70$YR$$F$Y$92$KG$20240813$$CN$US$US
182184233$18218423$3$F$$20240918$20200901$20240919$EXP$$US-PURDUE-USA-2020-0163703$PURDUE$$68$YR$$M$Y$$$20240919$$CN$US$US
182186582$18218658$2$F$20190101$20240916$20200901$20240919$PER$$US-PFIZER INC-2020336155$PFIZER$$60$YR$$F$Y$83.91$KG$20240919$$CN$US$US
182188343$18218834$3$F$$20240802$20200901$20240808$PER$$US-BIOGEN-2020BI00918126$BIOGEN$$$$$M$Y$$$20240808$$CN$US$US
1821906529$18219065$29$F$20211126$20240918$20200901$20240924$EXP$$US-SHIRE-US202028277$TAKEDA$$67$YR$$F$Y$63$KG$20240924$$HP$US$US
182199482$18219948$2$F$$20240909$20200902$20240917$PER$$US-SA-2020SA233773$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240918$$HP$US$US
182204742$18220474$2$F$20150306$20240730$20200902$20240808$EXP$$CA-ROCHE-1549700$ROCHE$$61$YR$A$F$Y$60$KG$20240808$$HP$CA$CA
182211535$18221153$5$F$20200720$20240911$20200902$20240917$PER$$US-AMGEN-USASP2020139435$AMGEN$$16$YR$T$M$Y$63.6$KG$20240917$$HP$US$US
1822122832$18221228$32$F$20240101$20240718$20200902$20240724$EXP$$US-SHIRE-US202028079$TAKEDA$$80$YR$$F$Y$102$KG$20240724$$CN$US$US
1822128017$18221280$17$F$20180830$20240806$20200902$20240812$EXP$$DE-ROCHE-2180826$ROCHE$$54$YR$A$F$Y$$$20240812$$CN$DE$DE
1822271619$18222716$19$F$20230401$20240823$20200902$20240830$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK089672$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$BR$BR
182228434$18222843$4$F$20200518$20240731$20200902$20240805$PER$$US-BAYER-2020-184408$BAYER$$18$YR$A$F$Y$56.689$KG$20240805$$MD$US$US
182231057$18223105$7$F$20240306$20240830$20200902$20240903$EXP$$US-SHIRE-US202028117$TAKEDA$$77$YR$$F$Y$78.91$KG$20240903$$HP$US$US
1822310715$18223107$15$F$20200825$20240910$20200902$20240912$EXP$$US-SHIRE-US202028276$TAKEDA$$72$YR$$M$Y$$$20240912$$PH$US$US
182232385$18223238$5$F$20200623$20240814$20200902$20240815$EXP$$US-PURDUE-USA-2020-0164289$PURDUE$$14$YR$$M$Y$$$20240815$$CN$US$US
182243752$18224375$2$F$20160311$20240709$20200902$20240710$EXP$$US-PURDUE-USA-2020-0164290$PURDUE$$26$YR$$M$Y$$$20240710$$CN$US$US
182250132$18225013$2$F$20200801$20240802$20200902$20240812$PER$$US-SA-2020SA237479$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240812$$CN$US$US
182251477$18225147$7$F$20240701$20240923$20200903$20240930$EXP$$US-SHIRE-US202028283$TAKEDA$$56$YR$$F$Y$51$KG$20240930$$CN$US$US
1822672923$18226729$23$F$20200824$20240625$20200903$20240702$EXP$$NVSJ2020JP008401$NOVARTIS$$1$YR$$F$Y$$$20240702$$MD$JP$JP
182270578$18227057$8$F$20200101$20240828$20200903$20240904$PER$$US-PFIZER INC-2020339647$PFIZER$$79$YR$$F$Y$79.38$KG$20240904$$CN$US$US
182274085$18227408$5$F$$20240813$20200903$20240827$EXP$$CA-SA-2020SA232464$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240827$$CN$CA$CA
1822747118$18227471$18$F$20180606$20240822$20200903$20240830$EXP$$CA-ROCHE-2655777$ROCHE$$33$YR$A$F$Y$88.4$KG$20240830$$CN$CA$CA
182281984$18228198$4$F$20200305$20240912$20200903$20240917$PER$$US-GILEAD-2020-0492958$GILEAD$$51$YR$A$M$Y$$$20240917$$LW$US$US
1822824812$18228248$12$F$20200628$20240924$20200903$20240926$EXP$$IL-ABBVIE-20K-082-3529698-00$ABBVIE$$$$$M$Y$72$KG$20240926$$MD$IL$IL
182283135$18228313$5$F$20200701$20240917$20200903$20240923$EXP$$NVSC2020CO240059$NOVARTIS$$41$YR$$M$Y$$$20240923$$CN$CO$CO
1822847618$18228476$18$F$20230914$20240912$20200903$20240918$EXP$$US-SHIRE-US202023058$TAKEDA$$87$YR$$M$Y$74$KG$20240918$$MD$US$US
1822849218$18228492$18$F$20210919$20221228$20200903$20240926$PER$$US-GLAXOSMITHKLINE-US2020AMR176075$GLAXOSMITHKLINE$$67$YR$$F$Y$70.2$KG$20240926$$MD$US$US
1822891123$18228911$23$F$20200822$20240802$20200903$20240805$EXP$$US-SHIRE-US202028585$TAKEDA$$12$YR$$M$Y$$$20240805$$MD$US$US
182290083$18229008$3$F$20191225$20240830$20200903$20240905$EXP$$DE-MYLANLABS-2020M1075330$MYLAN$$71$YR$$M$Y$74$KG$20240905$$PH$DE$DE
182291715$18229171$5$F$$20240910$20200903$20240912$PER$$US-PFIZER INC-2020127963$PFIZER$$67$YR$$F$Y$$$20240912$$CN$US$US
182302963$18230296$3$F$20200801$20240625$20200903$20240701$EXP$$US-JAZZ-2020-US-011462$JAZZ$$73$YR$$F$Y$$$20240701$$CN$US$US
182318082$18231808$2$F$$20240822$20200904$20240830$EXP$$CA-AstraZeneca-2020SF09792$ASTRAZENECA$$$$$$Y$$$20240830$$MD$CA$
182326314$18232631$4$F$20201101$20240805$20200904$20240807$EXP$$US-PFIZER INC-2020285734$PFIZER$$82$YR$$F$Y$79.38$KG$20240807$$CN$US$US
1823341946$18233419$46$F$$20240819$20200904$20240821$EXP$$CA-BAUSCH-BL-2020-025040$BAUSCH AND LOMB$$54$YR$$F$Y$$$20240822$$MD$CA$CA
182338552$18233855$2$F$20070101$20240926$20200904$20240927$EXP$$US-PURDUE PHARMA-USA-2020-0157163$PURDUE$$$$$F$Y$$$20240927$$LW$US$US
182346548$18234654$8$F$20200101$20240731$20200904$20240802$PER$$US-PFIZER INC-2020341633$PFIZER$$79$YR$$F$Y$75.75$KG$20240802$$HP$US$US
182361987$18236198$7$F$20200823$20240712$20200906$20240716$EXP$$TR-ROCHE-2667438$ROCHE$$19$YR$A$F$Y$95$KG$20240716$$MD$TR$TR
182377818$18237781$8$F$$20240815$20200907$20240821$EXP$$US-SHIRE-US202028696$TAKEDA$$$$$F$Y$52$KG$20240821$$HP$US$US
182384862$18238486$2$F$$20240905$20200907$20240909$PER$$US-BIOGEN-2019BI00689569$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
182386557$18238655$7$F$20200903$20240905$20200907$20240907$EXP$$US-SHIRE-US202029029$TAKEDA$$48$YR$$F$Y$$$20240907$$HP$US$US
182387005$18238700$5$F$$20240705$20200907$20240710$PER$$US-BIOGEN-2019BI00796042$BIOGEN$$$$$F$Y$$$20240710$$CN$US$US
1823878919$18238789$19$F$$20240808$20200907$20240814$EXP$$CA-TAKEDA-2020TUS037615$TAKEDA$$$$$M$Y$$$20240814$$HP$CA$CA
182395993$18239599$3$F$20200518$20240715$20200907$20240723$PER$$US-SA-2020SA242287$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240723$$MD$US$US
182403933$18240393$3$F$20200626$20200907$20200908$20240711$EXP$$DE-ASTELLAS-2020US030589$ASTELLAS$$77$YR$$M$Y$$$20240711$$CN$DE$DE
182405175$18240517$5$F$$20240912$20200908$20240919$EXP$$CA-APOTEX-2020AP017129$APOTEX$$32$YR$$F$Y$$$20240919$$MD$CA$CA
1824156718$18241567$18$F$$20240627$20200908$20240701$EXP$$US-SHIRE-US202028725$TAKEDA$$$$$M$Y$68.93$KG$20240701$$CN$US$US
1824261811$18242618$11$F$$20220429$20200908$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR176874$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
182427322$18242732$2$F$20200901$20240823$20200908$20240904$PER$$US-INCYTE CORPORATION-2020IN008612$INCYTE$$$$$$Y$$$20240904$$HP$US$US
182429135$18242913$5$F$20200128$20240702$20200908$20240703$EXP$$US-PURDUE-USA-2020-0164985$PURDUE$$31$YR$$M$Y$$$20240703$$CN$US$US
1824368624$18243686$24$F$20200809$20240711$20200908$20240716$EXP$$US-SHIRE-US202025065$TAKEDA$$66$YR$$M$Y$$$20240716$$PH$US$US
182439816$18243981$6$F$$20240708$20200908$20240712$EXP$$PHHY2019CO091095$NOVARTIS$$$$$M$Y$83$KG$20240712$$CN$CO$CO
182444166$18244416$6$F$20160815$20240628$20200908$20240703$EXP$$JP-JNJFOC-A-CH2018-167526$JOHNSON AND JOHNSON$$74$YR$E$M$Y$52.2$KG$20240703$$MD$JP$JP
182460033$18246003$3$F$$20240712$20200909$20240723$EXP$$IE-AUROBINDO-AUR-APL-2020-047239$AUROBINDO$Keane NA, Lane LM, Canniff E, Hare D, Doran S, Wallace E, et al.. A surviving case of acanthamoeba granulomatous amebic encephalitis in a hematopoietic stem cell transplant recipient. Am-J-Case-Rep. 2020;21:e923219-1 e923219-6$32$YR$$M$Y$$$20240723$$HP$IE$IE
182460373$18246037$3$F$$20200902$20200909$20240716$EXP$$US-AstraZeneca-2020SF13118$ASTRAZENECA$$63$YR$$F$Y$$$20240716$$CN$US$
182473972$18247397$2$F$$20200902$20200909$20240723$EXP$$US-AstraZeneca-2020SF14451$ASTRAZENECA$$7$YR$$M$Y$$$20240723$$HP$US$
1824772010$18247720$10$F$20200504$20240826$20200909$20240905$EXP$$JP-JNJFOC-20200902804$JOHNSON AND JOHNSON$$65$YR$E$F$Y$33$KG$20240905$$MD$JP$JP
182477866$18247786$6$F$20200827$20240830$20200909$20240904$EXP$$US-SHIRE-US202029094$TAKEDA$$31$YR$$M$Y$$$20240904$$CN$US$US
182494804$18249480$4$F$20200801$20240806$20200910$20240807$EXP$$US-ALEXION-A202012967$ALEXION PHARMACEUTICALS$$$$E$F$Y$$$20240807$$HP$US$US
182506686$18250668$6$F$20220523$20240726$20200910$20240731$EXP$$US-SHIRE-US202029152$TAKEDA$$66$YR$$F$Y$54$KG$20240731$$CN$US$US
182508006$18250800$6$F$20200224$20240717$20200910$20240725$EXP$$FR-ABBVIE-20K-056-3359175-00$ABBVIE$$75$YR$$M$Y$75$KG$20240725$$MD$FR$FR
182520532$18252053$2$F$$20231127$20200910$20240906$PER$$US-FARMAPROD-202007-0944$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240902$$CN$US$
182521374$18252137$4$F$$20230925$20200910$20240906$PER$$US-FARMAPROD-202004-0498$DOMPE FARMACEUTICI$$$$E$M$Y$72.57$KG$20240902$$CN$US$
182522172$18252217$2$F$$20231205$20200910$20240906$PER$$US-FARMAPROD-202005-0698$DOMPE FARMACEUTICI$$$$E$F$Y$61.23$KG$20240902$$CN$US$
182522212$18252221$2$F$20200515$20240328$20200910$20240906$PER$$US-FARMAPROD-202005-0702$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240902$$CN$US$
182523126$18252312$6$F$20210118$20231117$20200910$20240906$PER$$US-FARMAPROD-202006-0785$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240902$$CN$US$
182523742$18252374$2$F$20231123$20231128$20200910$20240906$PER$$US-FARMAPROD-202006-0893$DOMPE FARMACEUTICI$$66$YR$E$F$Y$$$20240902$$CN$US$
182527105$18252710$5$F$20200813$20240813$20200910$20240820$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR178631$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$MD$CA$CA
1825324910$18253249$10$F$20200902$20240730$20200910$20240801$EXP$$US-SHIRE-US202028881$TAKEDA$$5$YR$$M$Y$$$20240801$$HP$US$US
182544789$18254478$9$F$20230101$20240628$20200910$20240703$EXP$$US-PFIZER INC-2020349960$PFIZER$$64$YR$$F$Y$$$20240703$$CN$US$US
182550366$18255036$6$F$20230622$20240723$20200911$20240726$EXP$$US-SHIRE-US202029458$TAKEDA$$70$YR$$F$Y$$$20240726$$CN$US$US
182559882$18255988$2$F$20200101$20240719$20200910$20240729$EXP$$DK-ROCHE-2669109$ROCHE$$57$YR$A$M$Y$$$20240729$$MD$DK$DK
1825689911$18256899$11$F$20200817$20240722$20200911$20240729$EXP$$CA-TAKEDA-2019TUS064186$TAKEDA$$57$YR$$F$Y$$$20240729$$MD$CA$CA
1825692517$18256925$17$F$$20220817$20200911$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR179775$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$MD$US$US
182578235$18257823$5$F$$20240717$20200911$20240723$EXP$$BR-SHIRE-BR202029220$TAKEDA$$$$$M$Y$62$KG$20240723$$MD$BR$BR
1825794111$18257941$11$F$20200907$20240701$20200911$20240704$EXP$$US-PFIZER INC-2020351236$PFIZER$$67$YR$$F$Y$63.492$KG$20240704$$HP$US$US
182580845$18258084$5$F$20220918$20240723$20200911$20240726$EXP$$US-SHIRE-US202029536$TAKEDA$$44$YR$$F$Y$75.283$KG$20240726$$CN$US$US
1825869014$18258690$14$F$20190101$20240917$20200911$20240924$EXP$$CA-TAKEDA-2019TUS070593$TAKEDA$$$$$M$Y$$$20240924$$CN$CA$CA
182589445$18258944$5$F$20190101$20240628$20200911$20240704$EXP$$CA-JNJFOC-20191224040$JOHNSON AND JOHNSON$$13$YR$T$M$Y$62$KG$20240704$$HP$CA$CA
1825915210$18259152$10$F$$20240920$20200911$20240923$EXP$$US-PFIZER INC-2020352103$PFIZER$$72$YR$$F$Y$$$20240923$$CN$US$US
182593026$18259302$6$F$20220101$20240712$20200911$20240716$EXP$$US-PFIZER INC-2020351811$PFIZER$$83$YR$$M$Y$71.67$KG$20240716$$CN$US$US
1825952113$18259521$13$F$$20240819$20200912$20240821$EXP$$US-SHIRE-US202029558$TAKEDA$$$$$F$Y$63$KG$20240821$$HP$US$US
1825988412$18259884$12$F$20200831$20240725$20200912$20240731$EXP$$NVSC2020GB247330$NOVARTIS$$55$YR$$F$Y$$$20240731$$HP$GB$GB
182603496$18260349$6$F$20180810$20240806$20200914$20240811$EXP$$DE-ROCHE-2172076$ROCHE$$38$YR$A$F$Y$$$20240811$$CN$DE$DE
1826119717$18261197$17$F$20200806$20240730$20200914$20240805$EXP$$US-SHIRE-US202029579$TAKEDA$$33$YR$$M$Y$93.7$KG$20240805$$CN$US$US
182614442$18261444$2$F$$20240702$20200914$20240705$EXP$$NVSC2020CA247948$NOVARTIS$$$$A$M$Y$$$20240705$$CN$CA$CA
1826154115$18261541$15$F$20191128$20240826$20200914$20240903$EXP$$DE-ROCHE-2490647$ROCHE$$65$YR$E$F$Y$$$20240903$$CN$DE$DE
182616815$18261681$5$F$20200811$20240820$20200914$20240823$EXP$$GB-ROCHE-2674518$ROCHE$$37$YR$A$M$Y$$$20240823$$MD$GB$GB
1826330039$18263300$39$F$20211022$20240728$20200914$20240801$EXP$$US-SHIRE-US202028891$TAKEDA$$63$YR$$F$Y$90$KG$20240801$$MD$US$US
1826339010$18263390$10$F$$20240822$20200914$20240830$EXP$$US-SHIRE-US202029728$TAKEDA$$$$$F$Y$56$KG$20240830$$CN$US$US
1826343324$18263433$24$F$$20240809$20200914$20240815$EXP$$US-SHIRE-US202029751$TAKEDA$$$$$F$Y$102$KG$20240815$$CN$US$US
182637705$18263770$5$F$20170101$20240728$20200914$20240802$EXP$$CA-TAKEDA-2017TUS017465$TAKEDA$$$$$F$Y$$$20240802$$CN$CA$CA
182646906$18264690$6$F$$20240701$20200914$20240708$PER$$US-PFIZER INC-2020351858$PFIZER$$85$YR$$F$Y$$$20240708$$MD$US$US
1826556919$18265569$19$F$20200903$20240628$20200915$20240702$EXP$$US-SHIRE-US202029471$TAKEDA$$27$YR$$M$Y$$$20240702$$CN$US$US
1826572312$18265723$12$F$$20240812$20200915$20240815$EXP$$CA-BAUSCH-BL-2020-025875$BAUSCH AND LOMB$$61$YR$$F$Y$$$20240815$$CN$CA$CA
1826581324$18265813$24$F$20181024$20240919$20200915$20240926$EXP$$US-SHIRE-US202029809$TAKEDA$$15$YR$$F$Y$35$KG$20240926$$HP$US$US
1826601512$18266015$12$F$20210501$20240806$20200915$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-002807$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$75$KG$20240829$$CN$US$US
182664944$18266494$4$F$$20240724$20200915$20240803$EXP$$CA-AUROBINDO-AUR-APL-2020-047648$AUROBINDO$$53$YR$$F$Y$$$20240803$$HP$CA$CA
182668502$18266850$2$F$$20240816$20200915$20240826$30DAY$$US-GLAXOSMITHKLINE-US2020180972$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
1826745616$18267456$16$F$$20240903$20200915$20240915$EXP$CA-MHPD-E2B_03212224$CA-Accord-200778$ACCORD$$9$YR$C$M$Y$$$20240915$$HP$CA$CA
182681426$18268142$6$F$$20240801$20200915$20240805$PER$$US-PFIZER INC-2020351859$PFIZER$$76$YR$$F$Y$57.61$KG$20240805$$CN$US$US
182690822$18269082$2$F$$20240909$20200915$20240911$EXP$$CA-PFIZER INC-2020354658$PFIZER$$61$YR$$F$Y$65$KG$20240911$$HP$CA$CA
182697198$18269719$8$F$$20240909$20200915$20240912$EXP$$CA-BAUSCH-BL-2020-025906$BAUSCH AND LOMB$$48$YR$$F$Y$106$KG$20240912$$HP$CA$CA
182706239$18270623$9$F$$20240815$20200915$20240821$EXP$$US-TAKEDA-2019TUS062841$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
182714503$18271450$3$F$$20240813$20200916$20240826$EXP$$CA-AUROBINDO-AUR-APL-2020-047896$AUROBINDO$$$$$F$Y$$$20240826$$MD$CA$CA
1827147819$18271478$19$F$$20240911$20200916$20240927$EXP$$CA-JNJFOC-20200919284$Haleon PLC$$48$YR$$F$Y$68$KG$20240926$$HP$CA$CA
1827151816$18271518$16$F$20160101$20240822$20200916$20240902$EXP$$US-TEVA-2020-US-1828475$TEVA$$58$YR$$M$Y$117.93$KG$20240902$$CN$US$US
1827234230$18272342$30$F$20210512$20240904$20200916$20240910$EXP$$US-SHIRE-US202029762$TAKEDA$$67$YR$$F$Y$98$KG$20240910$$HP$US$US
182726432$18272643$2$F$20200609$20240809$20200916$20240814$30DAY$$US-GLAXOSMITHKLINE-US2020181846$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240814$$CN$US$US
1827377314$18273773$14$F$20200801$20240725$20200916$20240730$EXP$$US-SHIRE-US202030078$TAKEDA$$38$YR$$M$Y$$$20240730$$CN$US$US
1827458236$18274582$36$F$20210406$20240916$20200916$20240920$EXP$$US-SHIRE-US202029947$TAKEDA$$36$YR$$M$Y$46$KG$20240920$$HP$US$US
1827480013$18274800$13$F$$20240820$20200917$20240829$EXP$$CA-AMGEN-CANSP2020149852$AMGEN$$59$YR$A$F$Y$$$20240828$$HP$CA$CA
182750308$18275030$8$F$20180921$20240821$20200917$20240823$EXP$$FR-ABBVIE-19K-056-2704102-00$ABBVIE$$83$YR$$F$Y$51$KG$20240823$$MD$FR$FR
182755193$18275519$3$F$$20231129$20200916$20240730$EXP$$CA-AstraZeneca-2020SF16329$ASTRAZENECA$$55$YR$$M$Y$$$20240730$$MD$CA$
182755543$18275554$3$F$$20221129$20200917$20240726$EXP$$CA-AstraZeneca-2020SF17347$ASTRAZENECA$$72$YR$$F$Y$$$20240726$$MD$CA$
182756299$18275629$9$F$$20240719$20200917$20240730$EXP$E2B_03193921$CA-Accord-200560$ACCORD$$61$YR$A$F$Y$$$20240730$$HP$CA$CA
182760275$18276027$5$F$$20240729$20200917$20240806$EXP$$CA-APOTEX-2020AP017730$APOTEX$$70$YR$$F$Y$$$20240806$$MD$CA$CA
182768916$18276891$6$F$20200105$20240916$20200917$20240921$EXP$$DE-ABBVIE-20K-062-3570328-00$ABBVIE$$81$YR$$M$Y$80$KG$20240921$$MD$DE$DE
1827798112$18277981$12$F$20200827$20240916$20200917$20240924$EXP$$CA-TAKEDA-2020TUS036852$TAKEDA$$68$YR$$F$Y$$$20240924$$CN$CA$CA
1827819321$18278193$21$F$$20240808$20200917$20240813$EXP$$US-SHIRE-US202030225$TAKEDA$$$$$F$Y$104$KG$20240813$$HP$US$US
182786122$18278612$2$F$20200801$20240716$20200917$20240724$PER$$US-SA-2020SA253543$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240724$$MD$US$US
1827868727$18278687$27$F$20220211$20240920$20200917$20240927$EXP$$US-SHIRE-US202029830$TAKEDA$$60$YR$$M$Y$73$KG$20240927$$MD$US$US
1827870510$18278705$10$F$$20240626$20200917$20240701$EXP$$US-SHIRE-US202030219$TAKEDA$$$$$F$Y$55$KG$20240701$$MD$US$US
1827886413$18278864$13$F$$20240822$20200917$20240830$EXP$$US-SHIRE-US202029895$TAKEDA$$$$$F$Y$68$KG$20240830$$HP$US$US
1828000515$18280005$15$F$20210925$20240911$20200918$20240917$EXP$$US-SHIRE-US202030252$TAKEDA$$72$YR$$F$Y$88.889$KG$20240917$$HP$US$US
1828127941$18281279$41$F$20201123$20240716$20200918$20240718$EXP$$US-SHIRE-US202030251$TAKEDA$$82$YR$$F$Y$73$KG$20240718$$HP$US$US
182815987$18281598$7$F$20221122$20240910$20200918$20240916$EXP$$US-SHIRE-US202030076$TAKEDA$$67$YR$$F$Y$65$KG$20240916$$CN$US$US
182818884$18281888$4$F$$20220713$20200918$20240730$EXP$$CA-AstraZeneca-2020SF16414$ASTRAZENECA$$58$YR$$F$Y$$$20240730$$MD$CA$
1828314514$18283145$14$F$$20220607$20200918$20240830$EXP$$CA-AstraZeneca-2020SF18081$ASTRAZENECA$$62$YR$$F$Y$99$KG$20240830$$MD$CA$
182831604$18283160$4$F$20190101$20240715$20200918$20240722$EXP$$US-VERTEX PHARMACEUTICALS-2020-013883$VERTEX$$$$$F$Y$$$20240722$$MD$US$US
182832374$18283237$4$F$20200601$20240823$20200918$20240828$EXP$$US-PFIZER INC-2020298884$PFIZER$$63$YR$$F$Y$$$20240828$$HP$US$US
182832814$18283281$4$F$$20220530$20200918$20240726$EXP$$CA-AstraZeneca-2020SF17198$ASTRAZENECA$$56$YR$$M$Y$$$20240726$$MD$CA$
182832934$18283293$4$F$$20220530$20200918$20240726$EXP$$CA-AstraZeneca-2020SF17413$ASTRAZENECA$$68$YR$$F$Y$$$20240726$$MD$CA$
182833732$18283373$2$F$$20240726$20200918$20240801$EXP$$CA-AstraZeneca-2020SF18074$ASTRAZENECA$$77$YR$$M$Y$$$20240801$$MD$CA$
182843533$18284353$3$F$$20220530$20200918$20240730$EXP$$CA-AstraZeneca-2020SF16338$ASTRAZENECA$$67$YR$$F$Y$$$20240730$$MD$CA$
182845453$18284545$3$F$$20220713$20200918$20240726$EXP$$CA-AstraZeneca-2020SF16490$ASTRAZENECA$$64$YR$$M$Y$$$20240726$$MD$CA$
182846413$18284641$3$F$$20240205$20200918$20240726$EXP$$CA-AstraZeneca-2020SF16527$ASTRAZENECA$$70$YR$$M$Y$$$20240726$$MD$CA$
182846482$18284648$2$F$$20240415$20200918$20240718$EXP$$CA-AstraZeneca-2020SF18161$ASTRAZENECA$$69$YR$$F$Y$$$20240718$$MD$CA$
182847483$18284748$3$F$20150912$20240702$20200918$20240703$EXP$$US-PURDUE-USA-2020-0166969$PURDUE$$40$YR$$M$Y$$$20240703$$CN$US$US
182847983$18284798$3$F$$20221129$20200918$20240726$EXP$$CA-AstraZeneca-2020SF17013$ASTRAZENECA$$53$YR$$F$Y$$$20240726$$MD$CA$
182847994$18284799$4$F$$20221129$20200918$20240726$EXP$$CA-AstraZeneca-2020SF17200$ASTRAZENECA$$58$YR$$M$Y$$$20240726$$MD$CA$
1828567530$18285675$30$F$20240809$20240919$20200919$20240926$EXP$$US-SHIRE-US202030396$TAKEDA$$70$YR$$F$Y$88$KG$20240926$$MD$US$US
1828572728$18285727$28$F$20210205$20240828$20200918$20240903$EXP$$US-SHIRE-US202030321$TAKEDA$$63$YR$$F$Y$82$KG$20240903$$CN$US$US
182857884$18285788$4$F$$20240904$20200918$20240910$EXP$$US-SHIRE-US202030205$TAKEDA$$$$$F$Y$67$KG$20240910$$HP$US$US
182861078$18286107$8$F$20211225$20240701$20200919$20240703$EXP$$US-SHIRE-US202030476$TAKEDA$$45$YR$$F$Y$113$KG$20240703$$HP$US$US
1828822142$18288221$42$F$20220209$20240816$20200921$20240823$EXP$$US-SHIRE-US202030617$TAKEDA$$58$YR$$F$Y$47$KG$20240823$$CN$US$US
182888317$18288831$7$F$20240216$20240826$20200921$20240829$EXP$$US-SHIRE-US202030227$TAKEDA$$52$YR$$F$Y$68$KG$20240829$$CN$US$US
182892353$18289235$3$F$$20240708$20200921$20240716$EXP$$CA-AstraZeneca-2020SF15700$ASTRAZENECA$$42$YR$$F$Y$$$20240716$$MD$CA$
182901954$18290195$4$F$20190101$20240814$20200921$20240820$EXP$$US-JAZZ-2019-US-007907$JAZZ$$$$$M$Y$$$20240820$$MD$US$US
182909594$18290959$4$F$20220602$20240711$20200922$20240715$EXP$$US-SHIRE-US202030830$TAKEDA$$40$YR$$F$Y$$$20240715$$CN$US$US
1829139518$18291395$18$F$20200101$20240912$20200921$20240920$EXP$$CA-TAKEDA-2019TUS048447$TAKEDA$$$$$F$Y$$$20240920$$HP$CA$CA
1829167147$18291671$47$F$20240201$20240920$20200922$20240927$EXP$$US-SHIRE-US202030686$TAKEDA$$41$YR$$F$Y$95$KG$20240927$$CN$US$US
1829226715$18292267$15$F$20201212$20240904$20200922$20240911$EXP$$US-SHIRE-US202030729$TAKEDA$$38$YR$$F$Y$57$KG$20240911$$CN$US$US
1829391814$18293918$14$F$20240205$20240910$20200922$20240916$EXP$$US-SHIRE-US202030684$TAKEDA$$71$YR$$F$Y$63$KG$20240916$$CN$US$US
182956103$18295610$3$F$20200901$20200915$20200922$20240722$EXP$$US-AstraZeneca-2020SF04873$ASTRAZENECA$$709$MON$$M$Y$$$20240722$$HP$US$
1829617215$18296172$15$F$20221105$20240722$20200922$20240724$EXP$$US-SHIRE-US202030507$TAKEDA$$82$YR$$F$Y$82$KG$20240724$$CN$US$US
1829618525$18296185$25$F$20221228$20240729$20200922$20240801$EXP$$US-SHIRE-US202030553$TAKEDA$$79$YR$$M$Y$65$KG$20240801$$MD$US$US
1829745710$18297457$10$F$$20240626$20200923$20240704$EXP$$PT-AUROBINDO-AUR-APL-2020-048753$AUROBINDO$Araujo IM, Ferraro JL, Silva SC, Silva BC, Pereira VR, Brochado AI et al. QUANDO N?O ? S? HIPERTENS?O (When it^s just not hypertension). Portuguese Journal of Internal Medicine. 2020;27:19-19$55$YR$$M$Y$$$20240704$$MD$PT$PT
1829794925$18297949$25$F$20191217$20240813$20200923$20240821$EXP$$CA-CELLTRION INC.-2019CA027854$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
1829877412$18298774$12$F$20190104$20240708$20200923$20240716$EXP$$CA-CELLTRION INC.-2019CA017851$CELLTRION$$$$$$Y$$$20240716$$CN$CA$CA
182987944$18298794$4$F$$20240624$20200923$20240701$EXP$$CA-CELLTRION INC.-2020CA026305$CELLTRION$$$$$$Y$$$20240701$$HP$CA$CA
182988225$18298822$5$F$20210708$20240627$20200923$20240702$EXP$$US-SHIRE-US202030850$TAKEDA$$87$YR$$F$Y$55$KG$20240702$$CN$US$US
182988592$18298859$2$F$20200911$20240704$20200923$20240712$EXP$$JP-ROCHE-2679826$ROCHE$$73$YR$E$M$Y$$$20240712$$PH$JP$JP
182989154$18298915$4$F$20200701$20201224$20200922$20240916$EXP$$RU-SA-2020SA254834$SANOFI AVENTIS$$34$YR$A$F$Y$61$KG$20240916$$CN$RU$RU
1830014835$18300148$35$F$20230227$20240909$20200923$20240914$EXP$$US-SHIRE-US202030633$TAKEDA$$72$YR$$F$Y$78$KG$20240914$$HP$US$US
1830077721$18300777$21$F$20211006$20240729$20200923$20240805$EXP$$US-SHIRE-US202030886$TAKEDA$$76$YR$$F$Y$59$KG$20240805$$CN$US$US
1830080525$18300805$25$F$$20240916$20200923$20240920$EXP$$US-SHIRE-US202030950$TAKEDA$$$$$F$Y$88$KG$20240920$$CN$US$US
183016409$18301640$9$F$$20240709$20200923$20240716$EXP$$CA-GLAXOSMITHKLINE-CA2020186809$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$MD$CA$CA
183017862$18301786$2$F$$20240729$20200923$20240807$PER$$US-SA-2020SA254004$SANOFI AVENTIS$$13$YR$T$M$Y$27.211$KG$20240807$$MD$US$US
1830194711$18301947$11$F$$20240812$20200923$20240822$EXP$$CA-APOTEX-2020AP018305$APOTEX$$61$YR$$F$Y$$$20240822$$HP$CA$CA
183022634$18302263$4$F$20200101$20240906$20200923$20240912$PER$$US-VERTEX PHARMACEUTICALS-2020-014784$VERTEX$$$$$M$Y$95$KG$20240912$$HP$US$US
183024222$18302422$2$F$$20240712$20200923$20240722$EXP$$CA-CELLTRION INC.-2020CA026529$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
1830245115$18302451$15$F$20230326$20240816$20200923$20240822$EXP$$US-SHIRE-US202030767$TAKEDA$$69$YR$$F$Y$78$KG$20240822$$CN$US$US
1830245718$18302457$18$F$20200912$20240920$20200923$20240924$EXP$$US-SHIRE-US202030588$TAKEDA$$56$YR$$M$Y$$$20240924$$MD$US$US
1830246913$18302469$13$F$$20240705$20200923$20240709$EXP$$US-SHIRE-US202030765$TAKEDA$$$$$F$Y$81$KG$20240709$$HP$US$US
1830265010$18302650$10$F$20200820$20240724$20200923$20240801$EXP$$CA-ROCHE-2665968$ROCHE$$30$YR$A$F$Y$54.43$KG$20240801$$MD$CA$CA
1830300640$18303006$40$F$20200804$20240911$20200924$20240919$EXP$$CA-CELLTRION INC.-2020CA026239$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
183031224$18303122$4$F$$20240909$20200923$20240912$EXP$$US-BAYER-2020-193484$BAYER$$28$YR$A$F$Y$$$20240912$$HP$US$CA
1830358825$18303588$25$F$20220924$20240208$20200923$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR188732$GLAXOSMITHKLINE$$58$YR$$F$Y$48.53$KG$20240925$$CN$US$US
183038076$18303807$6$F$20200307$20240623$20200924$20240708$EXP$$EG-ROCHE-2681407$ROCHE$$36$YR$A$M$Y$90$KG$20240708$$CN$EG$EG
1830421839$18304218$39$F$20200101$20240829$20200924$20240906$EXP$$CA-CELLTRION INC.-2019CA027711$CELLTRION$$$$$$Y$$$20240906$$MD$CA$CA
183045518$18304551$8$F$20200101$20240918$20200923$20240920$PER$$US-PFIZER INC-2020365293$PFIZER$$49$YR$$F$Y$$$20240920$$CN$US$US
1830555310$18305553$10$F$20220105$20240627$20200923$20240701$EXP$$US-SHIRE-US202031045$TAKEDA$$77$YR$$F$Y$80.726$KG$20240701$$HP$US$US
1830580537$18305805$37$F$20200130$20240808$20200924$20240816$EXP$$CA-CELLTRION INC.-2020CA018773$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
183059637$18305963$7$F$$20240920$20200924$20240926$EXP$$US-SHIRE-US202031063$TAKEDA$$$$$F$Y$70$KG$20240926$$HP$US$US
183063798$18306379$8$F$20180814$20240725$20200923$20240801$EXP$$DE-ROCHE-2177964$ROCHE$$60$YR$A$F$Y$$$20240801$$CN$DE$DE
183069834$18306983$4$F$20190507$20240918$20200924$20240923$EXP$CH-SM-2019-13860$CH-MYLANLABS-2019M1052831$MYLAN$$59$YR$$M$Y$$$20240923$$MD$CH$CH
1830748510$18307485$10$F$20200123$20240822$20200924$20240829$EXP$$CA-SHIRE-CA202030664$TAKEDA$$60$YR$$M$Y$$$20240829$$CN$CA$CA
1830778537$18307785$37$F$20200914$20240920$20200924$20240926$EXP$$US-SHIRE-US202030669$TAKEDA$$45$YR$$F$Y$61$KG$20240926$$CN$US$US
183079284$18307928$4$F$20170101$20240905$20200924$20240909$EXP$$PL-009507513-2009POL007254$MERCK$Wachula E, Zemczak A, Lebiedzinska A, Gisterek I, Kos-Kudla B. Morphological heterogeneity of the neuroendoctrine cancer of pancreas (transformation from NEN G3 to NEN Gl) during the treatment with the CAP-TEM scheme (capecitabine and temozolomide). Onkologia w Praktyce Klinicznej - Edukacja. 2020;6 (Suppl 29):G23$32$YR$$M$Y$$$20240909$$HP$PL$PL
1830872812$18308728$12$F$20240408$20240911$20200924$20240918$EXP$$US-SHIRE-US202031120$TAKEDA$$51$YR$$F$Y$83$KG$20240918$$HP$US$US
183087954$18308795$4$F$$20240625$20200924$20240701$PER$$US-PFIZER INC-2020041570$PFIZER$$59$YR$$F$Y$$$20240701$$MD$US$US
1830895947$18308959$47$F$20220222$20240911$20200924$20240917$EXP$$US-SHIRE-US202030678$TAKEDA$$18$YR$$M$Y$43$KG$20240917$$MD$US$US
183093815$18309381$5$F$$20240621$20200925$20240701$PER$$US-SA-2020SA259691$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240701$$CN$US$US
183099986$18309998$6$F$$20240911$20200924$20240913$EXP$$US-PFIZER INC-2020366987$PFIZER$$60$YR$$M$Y$$$20240913$$CN$US$US
183100254$18310025$4$F$$20240906$20200924$20240911$EXP$$US-GILEAD-2020-0496049$GILEAD$$66$YR$E$M$Y$$$20240911$$MD$US$US
183102548$18310254$8$F$20050101$20240703$20200924$20240704$EXP$$US-PURDUE-USA-2020-0167717$PURDUE$$$$A$M$Y$$$20240704$$CN$US$US
183107803$18310780$3$F$$20240909$20200925$20240924$EXP$GB-MLMSERVICE-20210219-2736171-1$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2020-05876$ALKEM$Yaakub A, Htet ZM, Yardley Ball R, Karim M, Shah SN. Two simultaneous unusual complications after renal transplantation. British Journal of Dermatology. 2020;183(1):140$47$YR$$M$Y$$$20240924$$HP$GB$GB
183109232$18310923$2$F$20200923$20240729$20200925$20240807$PER$$US-SA-2020SA263766$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240807$$MD$US$US
183113939$18311393$9$F$20200307$20240716$20200925$20240719$EXP$$US-ABBVIE-20K-163-3577422-00$ABBVIE$$50$YR$$F$Y$196$KG$20240719$$MD$US$US
183114936$18311493$6$F$$20240708$20200925$20240716$EXP$$CA-APOTEX-2020AP018029$APOTEX$$72$YR$$M$Y$$$20240716$$HP$CA$CA
183118403$18311840$3$F$20200901$20201001$20200925$20240711$EXP$$DE-ASTELLAS-2020US033130$ASTELLAS$$76$YR$$M$Y$$$20240711$$CN$DE$DE
183124122$18312412$2$F$$20240903$20200925$20240910$PER$$US-GLAXOSMITHKLINE-US2020187874$GLAXOSMITHKLINE$$$$$F$Y$$$20240910$$CN$US$US
183125606$18312560$6$F$20191011$20240814$20200925$20240821$EXP$$PHHY2017CA190010$NOVARTIS$$58$YR$$M$Y$$$20240821$$CN$CA$CA
1831286223$18312862$23$F$20211225$20240716$20200925$20240719$EXP$$US-SHIRE-US202031185$TAKEDA$$40$YR$$F$Y$47$KG$20240719$$HP$US$US
1831304010$18313040$10$F$$20240814$20200925$20240823$EXP$$CA-APOTEX-2020AP018494$APOTEX$$53$YR$$M$Y$$$20240823$$HP$CA$CA
1831365611$18313656$11$F$$20240911$20200925$20240913$EXP$$US-PFIZER INC-2020371134$PFIZER$$70$YR$$F$Y$99.773$KG$20240913$$CN$US$US
183137297$18313729$7$F$$20240813$20200925$20240815$PER$$US-PFIZER INC-2020370472$PFIZER$$69$YR$$F$Y$$$20240815$$CN$US$US
183138586$18313858$6$F$20200101$20240710$20200925$20240716$EXP$$CA-JNJFOC-20200931206$JOHNSON AND JOHNSON$$14$YR$T$F$Y$59.02$KG$20240716$$HP$CA$CA
1831408426$18314084$26$F$20211111$20240827$20200925$20240903$EXP$$US-SHIRE-US202031082$TAKEDA$$53$YR$$F$Y$133$KG$20240903$$HP$US$US
1831420721$18314207$21$F$20180216$20240917$20200926$20240926$EXP$$CA-CELLTRION INC.-2018CA018338$CELLTRION$$$$$$Y$$$20240926$$CN$CA$CA
1831422320$18314223$20$F$20200907$20240701$20200925$20240704$EXP$$US-SHIRE-US202031230$TAKEDA$$39$YR$$F$Y$71$KG$20240704$$HP$US$US
183145403$18314540$3$F$20200915$20240708$20200925$20240805$EXP$$US-THERATECHNOLOGIES INC.-2020-THE-TES-000214$Unknown Manufacturer$$$$$$Y$$$20240805$$CN$US$US
183145788$18314578$8$F$20230915$20240628$20200926$20240704$EXP$$US-SHIRE-US202031264$TAKEDA$$60$YR$$F$Y$53$KG$20240704$$HP$US$US
183147654$18314765$4$F$20191205$20240715$20200925$20240723$EXP$$DE-TOLMAR, INC.-20DE023002$TOLMAR$$76$YR$$M$Y$93$KG$20240723$$CN$DE$DE
1832059527$18320595$27$F$$20240917$20200929$20240920$EXP$$US-SHIRE-US202031477$TAKEDA$$$$$F$Y$72$KG$20240920$$HP$US$US
1832104846$18321048$46$F$20220108$20240816$20200928$20240822$EXP$$US-SHIRE-US202031165$TAKEDA$$46$YR$$F$Y$85$KG$20240822$$CN$US$US
1832106012$18321060$12$F$$20240916$20200928$20240920$EXP$$US-SHIRE-US202031233$TAKEDA$$$$$F$Y$62$KG$20240920$$CN$US$US
183215352$18321535$2$F$20200826$20240924$20200928$20240927$EXP$IT-MINISAL02-633268$IT-BAYER-2020-201090$BAYER$$53$YR$A$M$Y$72$KG$20240927$$PH$IT$IT
183229212$18322921$2$F$$20240820$20200928$20240822$PER$$US-PFIZER INC-2020371550$PFIZER$$77$YR$$$Y$$$20240822$$CN$US$US
1832308112$18323081$12$F$$20240724$20200928$20240729$PER$$US-PFIZER INC-2018346987$PFIZER$$55$YR$$M$Y$$$20240729$$MD$US$US
183248502$18324850$2$F$20200526$20240912$20200929$20240916$EXP$$US-PFIZER INC-2020372899$PFIZER$$50$YR$$F$Y$$$20240916$$HP$US$US
183251575$18325157$5$F$20200901$20240906$20200929$20240912$PER$$US-VERTEX PHARMACEUTICALS-2020-019053$VERTEX$$19$YR$$F$Y$73$KG$20240912$$HP$US$US
1832562627$18325626$27$F$20170801$20240813$20200929$20240819$EXP$$NVSC2020CL059306$NOVARTIS$$55$YR$$F$Y$$$20240819$$CN$CL$CL
183268422$18326842$2$F$$20200916$20200929$20240802$EXP$$IE-JNJFOC-20200929319$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240802$$CN$IE$IE
183269343$18326934$3$F$20201201$20240903$20200929$20240920$PER$$AU-TOLMAR, INC.-20AU022913$TOLMAR$$68$YR$$M$Y$$$20240919$$CN$AU$AU
1832693624$18326936$24$F$20200225$20240827$20200930$20240905$EXP$$CA-CELLTRION INC.-2020CA019946$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
1832785119$18327851$19$F$20221208$20240906$20200929$20240911$EXP$$US-SHIRE-US202031719$TAKEDA$$40$YR$$F$Y$104$KG$20240911$$HP$US$US
1832999015$18329990$15$F$20190424$20240827$20200930$20240904$EXP$$CO-TAKEDA-2019TUS036869$TAKEDA$$36$YR$$F$Y$63$KG$20240904$$CN$CO$CO
1833007917$18330079$17$F$$20240701$20200930$20240703$EXP$$US-PFIZER INC-2020376975$PFIZER$$65$YR$$F$Y$$$20240703$$CN$US$US
1833060410$18330604$10$F$20200904$20240913$20200930$20240917$EXP$$US-SHIRE-US202031496$TAKEDA$$56$YR$$M$Y$$$20240917$$PH$US$US
183306786$18330678$6$F$20210406$20240911$20200930$20240913$EXP$$US-SHIRE-US202031441$TAKEDA$$31$YR$$F$Y$$$20240913$$CN$US$US
1833068524$18330685$24$F$20200920$20240830$20200930$20240903$EXP$$US-SHIRE-US202031501$TAKEDA$$80$YR$$F$Y$55$KG$20240903$$CN$US$US
183316488$18331648$8$F$20220223$20240912$20200930$20240919$EXP$$US-SHIRE-US202031790$TAKEDA$$73$YR$$F$Y$86$KG$20240919$$HP$US$US
183317707$18331770$7$F$$20240823$20200930$20240830$EXP$$CA-JNJFOC-20200941497$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240830$$CN$CA$CA
1833198916$18331989$16$F$20200701$20230414$20201001$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR194737$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
183332552$18333255$2$F$$20240801$20201001$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202009012672$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240806$$CN$US$US
183336062$18333606$2$F$$20240805$20201001$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-079405$BRISTOL MYERS SQUIBB$Pundole X, Jones AL, Tetzlaff MT, Williams MD, Murphy Jr WA, Otun A, et al. Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case report. Immunotherapy. 2020 Sep 09;12(17):1213-9. doi:10.2217/imt-2020-0108.$75$YR$E$M$Y$$$20240813$$HP$US$US
183340526$18334052$6$F$20200201$20240716$20201001$20240722$EXP$$CA-ROCHE-2687959$ROCHE$$57$YR$A$F$Y$$$20240722$$CN$CA$CA
183355644$18335564$4$F$20170101$20240805$20201001$20240809$EXP$$IE-AMGEN-IRLSP2020156889$AMGEN$$64$YR$A$F$Y$$$20240809$$CN$IE$IE
1833584617$18335846$17$F$20200901$20240905$20201001$20240909$PER$$US-PFIZER INC-2020363652$PFIZER$$40$YR$$M$Y$$$20240909$$MD$US$US
1833611919$18336119$19$F$20210831$20240823$20201001$20240831$EXP$$US-SHIRE-US202031356$TAKEDA$$70$YR$$F$Y$88$KG$20240831$$HP$US$US
1833705439$18337054$39$F$20200827$20240911$20201001$20240919$EXP$$CA-CELLTRION INC.-2020CA027390$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
183374582$18337458$2$F$20200924$20240904$20201002$20240911$EXP$$CA-ABBVIE-20K-028-3588662-00$ABBVIE$$78$YR$$F$Y$$$20240911$$MD$CA$CA
183377175$18337717$5$F$20120531$20231026$20201002$20240820$EXP$$US-ABBVIE-20K-163-3592046-00$ABBVIE$$28$YR$$M$Y$$$20240820$$HP$US$US
183383779$18338377$9$F$20231218$20240822$20201002$20240826$PER$$US-DSJP-DSU-2020-128618$DAIICHI$$47$YR$$F$Y$$$20240826$$MD$US$US
1833944214$18339442$14$F$20180705$20240725$20201002$20240801$EXP$$DE-ROCHE-2184047$ROCHE$$56$YR$A$F$Y$$$20240801$$CN$DE$DE
183397522$18339752$2$F$20200701$20240806$20201002$20240807$EXP$$US-PURDUE-USA-2020-0168698$PURDUE$$$$$F$Y$$$20240807$$CN$US$US
183399415$18339941$5$F$20221025$20240820$20201002$20240826$EXP$$US-SHIRE-US202031869$TAKEDA$$67$YR$$M$Y$$$20240826$$CN$US$US
1833994338$18339943$38$F$20210711$20240920$20201002$20240930$EXP$$US-SHIRE-US202032016$TAKEDA$$65$YR$$F$Y$91$KG$20240930$$HP$US$US
1834008814$18340088$14$F$20221231$20240827$20201002$20240830$EXP$$US-SHIRE-US202032030$TAKEDA$$66$YR$$F$Y$58$KG$20240830$$HP$US$US
183402132$18340213$2$F$$20240729$20201002$20240806$EXP$$CA-AstraZeneca-2020SF22644$ASTRAZENECA$$74$YR$$M$Y$$$20240806$$MD$CA$
183406343$18340634$3$F$20191225$20240903$20201002$20240910$EXP$DE-BOEHRINGERINGELHEIM-2020-BI-045494$DE-PURDUE-USA-2020-0168781$PURDUE$$71$YR$$M$Y$74$KG$20240910$$PH$DE$DE
1834127517$18341275$17$F$20220401$20240717$20201003$20240726$EXP$$US-SHIRE-US202032126$TAKEDA$$75$YR$$F$Y$83$KG$20240726$$CN$US$US
1834170933$18341709$33$F$20180910$20240809$20201005$20240816$EXP$$CA-CELLTRION INC.-2018CA023476$CELLTRION$$$$$$Y$$$20240816$$CN$CA$CA
183425999$18342599$9$F$20190101$20240820$20201005$20240829$EXP$$IL-ABBVIE-19K-082-2879414-00$ABBVIE$$51$YR$$$Y$83$KG$20240829$$MD$IL$IL
183429752$18342975$2$F$20200901$20240827$20201005$20240916$PER$$US-SA-2020SA271393$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240916$$CN$US$US
183432514$18343251$4$F$$20240720$20201005$20240801$EXP$$CA-ASTELLAS-2020US034175$ASTELLAS$$36$YR$$F$Y$$$20240801$$CN$CA$CA
183436588$18343658$8$F$20200922$20201118$20201005$20240702$EXP$$GB-AKCEA THERAPEUTICS-2020IS001490$AKCEA THERAPEUTICS$$$$$$Y$$$20240701$$MD$GB$GB
1834574711$18345747$11$F$20200929$20240826$20201005$20240828$EXP$$US-SHIRE-US202032173$TAKEDA$$39$YR$$M$Y$$$20240828$$MD$US$US
183463233$18346323$3$F$$20240905$20201005$20240910$EXP$$CA-TAKEDA-2020TEU009467$TAKEDA$$$$$M$Y$$$20240910$$HP$CA$CA
183464733$18346473$3$F$20200724$20240826$20201005$20240910$EXP$$DE-ABBVIE-20K-062-3594173-00$ABBVIE$$43$YR$$M$Y$110$KG$20240910$$MD$DE$DE
1834693915$18346939$15$F$$20240820$20201005$20240827$EXP$$US-SHIRE-US202032195$TAKEDA$$$$$F$Y$63$KG$20240827$$CN$US$US
183492436$18349243$6$F$20190401$20240626$20201006$20240701$EXP$$CA-TAKEDA-2019TUS024509$TAKEDA$$35$YR$$M$Y$$$20240701$$MD$CA$CA
183493145$18349314$5$F$20191015$20240716$20201006$20240723$EXP$$CO-TAKEDA-2019TUS059858$TAKEDA$$43$YR$$F$Y$45$KG$20240723$$CN$CO$CO
183499147$18349914$7$F$$20240814$20201006$20240822$EXP$$CA-JNJFOC-20200947923$JOHNSON AND JOHNSON$$31$YR$A$F$Y$71$KG$20240823$$CN$CA$CA
183500857$18350085$7$F$$20240909$20201006$20240917$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR174324$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$CA$CA
1835017917$18350179$17$F$$20240814$20201006$20240819$PER$$US-PFIZER INC-2020381976$PFIZER$$73$YR$$M$Y$90.718$KG$20240819$$HP$US$US
183505562$18350556$2$F$$20240729$20201006$20240806$EXP$$CA-AstraZeneca-2020SE06450$ASTRAZENECA$$61$YR$$F$Y$$$20240806$$MD$CA$
183513984$18351398$4$F$20200914$20240822$20201006$20240827$EXP$$US-SHIRE-US202030265$TAKEDA$$60$YR$$F$Y$61$KG$20240827$$CN$US$US
1835140120$18351401$20$F$$20240828$20201006$20240903$EXP$$US-SHIRE-US202031776$TAKEDA$$$$$F$Y$92$KG$20240903$$HP$US$US
1835140417$18351404$17$F$$20240911$20201006$20240924$EXP$$CA-APOTEX-2020AP018989$APOTEX$$60$YR$$F$Y$61$KG$20240924$$MD$CA$CA
1835227012$18352270$12$F$20211213$20240910$20201007$20240911$PER$$US-AMGEN-USASP2020160214$AMGEN$$30$YR$A$F$Y$$$20240911$$HP$US$US
1835301213$18353012$13$F$$20240910$20201007$20240914$EXP$$US-SHIRE-US202032343$TAKEDA$$$$$F$Y$68$KG$20240914$$MD$US$US
1835420840$18354208$40$F$20200605$20240911$20201006$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-080950$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$63$KG$20240918$$MD$JP$JP
183544372$18354437$2$F$$20240920$20201007$20240925$EXP$$US-KYOWAKIRIN-2020BKK015487$KYOWA$$$$$$Y$$$20240925$$HP$US$US
1835463415$18354634$15$F$$20240829$20201007$20240906$EXP$$BR-TAKEDA-2020TUS041591$TAKEDA$$$$$F$Y$$$20240906$$PH$BR$BR
183550156$18355015$6$F$$20240723$20201007$20240725$EXP$$US-PFIZER INC-2020383520$PFIZER$$67$YR$$M$Y$83.447$KG$20240725$$CN$US$US
183573449$18357344$9$F$20200927$20240703$20201008$20240708$EXP$$US-SHIRE-US202032504$TAKEDA$$6$YR$$M$Y$$$20240708$$CN$US$US
183577104$18357710$4$F$$20240906$20201007$20240911$EXP$$US-GILEAD-2020-0497490$GILEAD$$73$YR$E$M$Y$$$20240911$$MD$US$US
183588589$18358858$9$F$20220614$20240708$20201008$20240711$EXP$$US-SHIRE-US202032498$TAKEDA$$50$YR$$F$Y$85$KG$20240711$$HP$US$US
1835886110$18358861$10$F$20220405$20240923$20201008$20240930$EXP$$US-SHIRE-US202032403$TAKEDA$$74$YR$$F$Y$90$KG$20240930$$CN$US$US
183599092$18359909$2$F$$20240815$20201008$20240827$EXP$PT-EMA-DD-20200930-B8Q5M4-155050$PT-Accord-204512$ACCORD$Gago JP, et al.. Docetaxel : Various toxicities and septic shocks: case report. Reactions weekly. 2016 1617:99$63$YR$A$M$Y$$$20240827$$HP$PT$PT
183612569$18361256$9$F$20130601$20240802$20201008$20240806$EXP$$US-SHIRE-US202031926$TAKEDA$$12$YR$$M$Y$63$KG$20240806$$CN$US$US
1836125910$18361259$10$F$20180401$20240826$20201008$20240829$EXP$$IN-PFIZER INC-2019105859$PFIZER$$45$YR$$M$Y$80.4$KG$20240829$$CN$IN$IN
183626403$18362640$3$F$$20240729$20201008$20240815$EXP$$CA-AstraZeneca-2020SE00273$ASTRAZENECA$$48$YR$$M$Y$69$KG$20240815$$MD$CA$
1836277935$18362779$35$F$20201009$20240905$20201009$20240911$EXP$$US-SHIRE-US202032420$TAKEDA$$65$YR$$F$Y$86$KG$20240911$$HP$US$US
183631052$18363105$2$F$20200101$20240706$20201009$20240709$EXP$$US-KYOWAKIRIN-2020BKK016079$KYOWA$$$$$$Y$$$20240709$$HP$US$US
1836341713$18363417$13$F$20200220$20240709$20201008$20240718$EXP$$CA-CELLTRION INC.-2020CA019064$CELLTRION$$$$$$Y$$$20240718$$MD$CA$CA
183634839$18363483$9$F$20181125$20240919$20201009$20240926$EXP$$JP-ABBVIE-20P-087-3600385-00$ABBVIE$$73$YR$$M$Y$55$KG$20240926$$MD$JP$JP
183642123$18364212$3$F$20200101$20240808$20201009$20240820$PER$$US-SA-2020SA280539$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240820$$MD$US$US
1836501018$18365010$18$F$$20240729$20201009$20240801$EXP$$US-SHIRE-US202032919$TAKEDA$$$$$F$Y$109$KG$20240801$$HP$US$US
1836502637$18365026$37$F$$20240729$20201009$20240805$EXP$$US-SHIRE-US202032584$TAKEDA$$$$$F$Y$57$KG$20240805$$CN$US$US
183654038$18365403$8$F$20240207$20240726$20201009$20240731$EXP$$US-TAKEDA-2020TUS041776$TAKEDA$$72$YR$$F$Y$62$KG$20240731$$PH$US$US
183662428$18366242$8$F$20190101$20240718$20201009$20240724$EXP$$US-PFIZER INC-2020389681$PFIZER$$24$YR$$F$Y$$$20240724$$HP$US$US
183670935$18367093$5$F$$20240905$20201009$20240909$PER$$US-PFIZER INC-2020388443$PFIZER$$51$YR$$M$Y$104.33$KG$20240909$$CN$US$US
183674183$18367418$3$F$20240810$20240822$20201009$20240830$EXP$$US-SHIRE-US202032877$TAKEDA$$84$YR$$F$Y$91$KG$20240830$$CN$US$US
183681133$18368113$3$F$$20201002$20201009$20240717$EXP$$US-AstraZeneca-2020SF29608$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
183685995$18368599$5$F$20240109$20240730$20201010$20240805$EXP$$US-SHIRE-US202032933$TAKEDA$$52$YR$$F$Y$56$KG$20240805$$CN$US$US
1836870017$18368700$17$F$$20240724$20201010$20240727$EXP$$US-SHIRE-US202032920$TAKEDA$$$$$F$Y$97$KG$20240727$$CN$US$US
1836893525$18368935$25$F$20200611$20240402$20201011$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR197873$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
183691677$18369167$7$F$20200101$20240703$20201011$20240712$EXP$$JP-SA-2020SA278089$SANOFI AVENTIS$Iwatake S, Saitou Y, Sasano Y, Itou Y, Komori M.. A Case of Eosinophilic Sinusitis with Eosinophilic Granulomatous Vasculitis that Developed while Receiving Dupilumab.. Oto-Rhino-Laryngology Tokyo.. 2023;66(3):128-33.$43$YR$A$F$Y$53$KG$20240712$$MD$JP$JP
1837021966$18370219$66$F$20200101$20240910$20201012$20240917$EXP$$CA-CELLTRION INC.-2019CA026774$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
1837072814$18370728$14$F$20201007$20240906$20201012$20240909$EXP$$NVSC2020DE273972$NOVARTIS$$$$E$F$Y$87$KG$20240909$$MD$DE$DE
183708544$18370854$4$F$$20240917$20201012$20240919$EXP$$CA-ROCHE-2693854$ROCHE$$27$YR$A$F$Y$$$20240919$$CN$CA$CA
1837116436$18371164$36$F$$20240923$20201012$20240927$EXP$$CA-BAUSCH-BL-2019-025011$BAUSCH AND LOMB$$56$YR$$M$Y$$$20240927$$CN$CA$CA
183723193$18372319$3$F$20200801$20240627$20201012$20240703$EXP$$NVSC2020BR274093$NOVARTIS$$56$YR$$F$Y$$$20240703$$CN$BR$BR
183723388$18372338$8$F$20200922$20240710$20201012$20240712$PER$$US-PFIZER INC-2020391456$PFIZER$$69$YR$$F$Y$$$20240712$$CN$US$US
1837249315$18372493$15$F$20220101$20240826$20201012$20240829$EXP$$US-PFIZER INC-2020391067$PFIZER$$72$YR$$F$Y$$$20240829$$CN$US$US
183736473$18373647$3$F$$20230913$20201013$20240924$PER$$US-CELLTRION INC.-2019US019745$CELLTRION$$$$$$Y$$$20240924$$MD$US$US
1837425724$18374257$24$F$20210628$20240826$20201012$20240902$EXP$$US-SHIRE-US202033041$TAKEDA$$74$YR$$M$Y$105$KG$20240902$$HP$US$US
183742736$18374273$6$F$20210516$20240703$20201012$20240708$EXP$$US-SHIRE-US202033048$TAKEDA$$67$YR$$F$Y$65.76$KG$20240708$$CN$US$US
183748736$18374873$6$F$20100101$20240821$20201012$20240822$EXP$$US-GILEAD-2020-0498411$GILEAD$$$$A$F$Y$$$20240822$$LW$US$US
183749485$18374948$5$F$20200601$20240827$20201012$20240828$PER$$US-GILEAD-2020-0498407$GILEAD$$52$YR$A$M$Y$$$20240828$$LW$US$US
1837566614$18375666$14$F$20201001$20240628$20201013$20240709$PER$$US-ROCHE-2692405$ROCHE$$13$YR$T$M$Y$51$KG$20240705$$MD$US$US
1837663618$18376636$18$F$20210701$20220718$20201013$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR202719$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
183767594$18376759$4$F$20200801$20240705$20201013$20240708$EXP$$NL-JNJFOC-20201008680$JOHNSON AND JOHNSON$$$$$M$Y$106$KG$20240709$$MD$NL$NL
183770825$18377082$5$F$20240902$20240904$20201013$20240912$EXP$$US-TAKEDA-2020TUS042438$TAKEDA$$39$YR$$M$Y$64$KG$20240912$$MD$US$US
1837721212$18377212$12$F$20200917$20240830$20201013$20240904$EXP$$CA-TAKEDA-2020TUS042277$TAKEDA$$32$YR$$F$Y$$$20240904$$HP$CA$CA
183777568$18377756$8$F$20230530$20240705$20201013$20240708$EXP$$US-SHIRE-US202032431$TAKEDA$$78$YR$$M$Y$85.26$KG$20240708$$HP$US$US
1837863624$18378636$24$F$20200201$20240716$20201013$20240722$EXP$$JP-PFIZER INC-2020390357$PFIZER$$$$A$F$Y$40$KG$20240722$$CN$JP$JP
183786762$18378676$2$F$20201005$20201006$20201013$20240722$EXP$$TH-AstraZeneca-2020SF29442$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$TH$
183791676$18379167$6$F$20200101$20240812$20201014$20240820$EXP$$CA-CELLTRION INC.-2020CA023563$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
183791705$18379170$5$F$20211001$20240709$20201013$20240712$EXP$$US-AMGEN-USASP2020162487$AMGEN$$57$YR$A$F$Y$$$20240712$$HP$US$US
183792138$18379213$8$F$20240418$20240827$20201013$20240902$EXP$$US-TAKEDA-2020TUS042561$TAKEDA$$69$YR$$F$Y$$$20240902$$CN$US$US
183796387$18379638$7$F$$20240903$20201014$20240906$EXP$$US-SHIRE-US202033410$TAKEDA$$$$$M$Y$88$KG$20240906$$HP$US$US
183796395$18379639$5$F$20201007$20240816$20201014$20240822$EXP$$US-SHIRE-US202033399$TAKEDA$$43$YR$$F$Y$61$KG$20240822$$CN$US$US
1837964323$18379643$23$F$20220607$20240806$20201014$20240812$EXP$$US-SHIRE-US202033393$TAKEDA$$83$YR$$F$Y$56$KG$20240812$$MD$US$US
1838007713$18380077$13$F$20211228$20240827$20201014$20240902$EXP$$US-SHIRE-US202033392$TAKEDA$$49$YR$$F$Y$91$KG$20240902$$HP$US$US
1838010013$18380100$13$F$20201006$20240904$20201014$20240913$EXP$$CA-CELLTRION INC.-2020CA028863$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
183801459$18380145$9$F$20200101$20240619$20201014$20240703$EXP$$CA-INTERCEPT-PM2020002026$INTERCEPT PHARMACEUTICALS$$$$$F$Y$69.841$KG$20240703$$CN$CA$CA
1838156619$18381566$19$F$20221024$20240826$20201014$20240902$EXP$$US-SHIRE-US202033542$TAKEDA$$44$YR$$F$Y$106$KG$20240902$$HP$US$US
183818354$18381835$4$F$20200201$20240912$20201014$20240916$EXP$$US-PFIZER INC-2020393803$PFIZER$$59$YR$$F$Y$$$20240916$$HP$US$US
1838240416$18382404$16$F$20200902$20240627$20201014$20240702$EXP$$US-SHIRE-US202032882$TAKEDA$$78$YR$$F$Y$95$KG$20240702$$HP$US$US
1838241513$18382415$13$F$$20240809$20201014$20240815$EXP$$US-SHIRE-US202033217$TAKEDA$$$$$F$Y$49$KG$20240815$$HP$US$US
183825033$18382503$3$F$20201009$20240709$20201014$20240802$PER$$US-BIOGEN-2019BI00750492$BIOGEN$$22$YR$$F$Y$$$20240802$$CN$US$US
183836708$18383670$8$F$20210101$20240924$20201014$20240926$EXP$$US-PFIZER INC-2020394835$PFIZER$$89$YR$$F$Y$$$20240926$$CN$US$US
1838402311$18384023$11$F$$20240913$20201015$20240924$EXP$$PT-AUROBINDO-AUR-APL-2020-050545$AUROBINDO$Vilela M, Salazar T, Fernandes D, Maio C.. PE-227 QUANDO ALICE TOMOU SERTRALINA. Revista da sociedade portuguesa de medicina interna. 2020;27:478$67$YR$$F$Y$$$20240924$$MD$PT$PT
183841465$18384146$5$F$$20240906$20201014$20240912$EXP$$US-GILEAD-2020-0498782$GILEAD$$65$YR$E$M$Y$$$20240912$$MD$US$US
1838526527$18385265$27$F$20200101$20240731$20201014$20240807$EXP$$CA-CELLTRION INC.-2020CA026165$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
183852989$18385298$9$F$20190910$20240724$20201015$20240731$EXP$$CA-ROCHE-2411060$ROCHE$$38$YR$A$F$Y$127$KG$20240731$$CN$CA$CA
183857642$18385764$2$F$$20201007$20201015$20240724$EXP$$CA-AstraZeneca-2020SF30752$ASTRAZENECA$$30$YR$$F$Y$$$20240724$$MD$CA$
183857773$18385777$3$F$$20240813$20201015$20240826$EXP$$IE-ADVANZ PHARMA-202009009306$ADVANZ PHARMA$$$$$$Y$$$20240826$$MD$IE$IE
183857985$18385798$5$F$20200101$20240912$20201015$20240924$PER$$US-SA-2020SA287545$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240924$$MD$US$US
1838667515$18386675$15$F$$20240822$20201015$20240828$EXP$$US-SHIRE-US202033391$TAKEDA$$$$$F$Y$87$KG$20240828$$MD$US$US
1838667912$18386679$12$F$20240601$20240828$20201015$20240903$EXP$$US-SHIRE-US202033707$TAKEDA$$83$YR$$F$Y$66$KG$20240903$$CN$US$US
183866926$18386692$6$F$$20240823$20201015$20240828$PER$$US-PFIZER INC-2020332380$PFIZER$$73$YR$$F$Y$73.94$KG$20240828$$CN$US$US
1838691227$18386912$27$F$20200101$20240821$20201015$20240827$EXP$$US-PFIZER INC-2020399106$PFIZER$$75$YR$$F$Y$109$KG$20240827$$HP$US$US
183879842$18387984$2$F$$20201009$20201015$20240822$EXP$$US-AstraZeneca-2020SF32387$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
183882098$18388209$8$F$$20240718$20201015$20240722$EXP$$US-SHIRE-US202032791$TAKEDA$$$$$F$Y$112$KG$20240722$$CN$US$US
183882233$18388223$3$F$20200923$20240730$20201015$20240802$EXP$$US-SHIRE-US202033055$TAKEDA$$66$YR$$F$Y$$$20240802$$MD$US$US
183882424$18388242$4$F$20180910$20240827$20201015$20240902$EXP$$US-SHIRE-US202033282$TAKEDA$$62$YR$$M$Y$$$20240902$$CN$US$US
183886975$18388697$5$F$$20240906$20201015$20240912$EXP$$US-GILEAD-2020-0498797$GILEAD$$65$YR$E$M$Y$$$20240912$$MD$US$US
1838910733$18389107$33$F$20200101$20240823$20201016$20240830$EXP$$CA-CELLTRION INC.-2020CA025667$CELLTRION$$$$$$Y$$$20240830$$MD$CA$CA
183896905$18389690$5$F$20240829$20240904$20201015$20240906$EXP$$US-TAKEDA-2020TUS042926$TAKEDA$$74$YR$$F$Y$$$20240906$$CN$US$US
1839020321$18390203$21$F$20210729$20240801$20201015$20240806$EXP$$US-SHIRE-US202033497$TAKEDA$$52$YR$$F$Y$60$KG$20240806$$HP$US$US
1839035929$18390359$29$F$20200618$20240910$20201016$20240918$EXP$$CA-CELLTRION INC.-2020CA023645$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
183909866$18390986$6$F$20200901$20240916$20201015$20240923$EXP$$BE-ROCHE-2695633$ROCHE$$35$YR$A$F$Y$74$KG$20240923$$MD$BE$BE
183918969$18391896$9$F$20180524$20240704$20201016$20240712$EXP$$PHHY2018CA010806$NOVARTIS$$56$YR$$M$Y$$$20240712$$CN$CA$CA
183919766$18391976$6$F$20200101$20240917$20201016$20240926$EXP$$US-DSJP-DSU-2020-129491$DAIICHI$$$$$M$Y$$$20240926$$CN$US$US
183925175$18392517$5$F$20170803$20210129$20201016$20240722$EXP$$FR-VALIDUS PHARMACEUTICALS LLC-FR-2020VAL000818$VALIDUS$$$$$$Y$$$20240722$$HP$FR$FR
1839256813$18392568$13$F$20160224$20240822$20201016$20240830$EXP$$NVSC2016CA002679$NOVARTIS$$54$YR$$M$Y$$$20240830$$CN$CA$CA
183929692$18392969$2$F$$20201005$20201016$20240718$EXP$$CA-AstraZeneca-2020SF29460$ASTRAZENECA$$72$YR$$F$Y$$$20240718$$MD$CA$
1839339317$18393393$17$F$20200818$20240702$20201016$20240705$EXP$$CA-TAKEDA-2019TUS051994$TAKEDA$$57$YR$$F$Y$$$20240705$$CN$CA$CA
183934086$18393408$6$F$20080101$20240905$20201016$20240909$EXP$$US-GILEAD-2020-0499240$GILEAD$$53$YR$A$F$Y$$$20240909$$LW$US$US
183944602$18394460$2$F$$20240704$20201016$20240710$EXP$$GR-PFIZER INC-2020394364$PFIZER$Loutsidi, N-E.. CHYLOTHORAX AND PANCREATITIS IN A PATIENT WITH HODGKIN^S LYMPHOMA (HL) TREATED WITH BV/AVD. AN UNUSUAL CASE. 3rd GRECO-ISRAELI HEMATOLOGY MEETING, book of proceedings. 2020;58$42$YR$$F$Y$$$20240710$$MD$GR$GR
1839517416$18395174$16$F$20240702$20240903$20201017$20240909$EXP$$US-SHIRE-US202033140$TAKEDA$$72$YR$$F$Y$74$KG$20240909$$HP$US$US
183953636$18395363$6$F$20190912$20240802$20201017$20240805$PER$$US-GILEAD-2020-0499606$GILEAD$$54$YR$A$F$Y$$$20240805$$LW$US$US
183956722$18395672$2$F$$20240716$20201018$20240723$PER$$US-SA-2020SA290369$SANOFI AVENTIS$$$$E$M$Y$$$20240723$$MD$US$US
1839578015$18395780$15$F$$20240826$20201018$20240831$EXP$$US-SHIRE-US202033993$TAKEDA$$$$$M$Y$88$KG$20240831$$MD$US$US
1839592213$18395922$13$F$20240323$20240802$20201018$20240806$EXP$$US-SHIRE-US202022821$TAKEDA$$56$YR$$F$Y$56.7$KG$20240806$$HP$US$US
1839615734$18396157$34$F$20200612$20240819$20201019$20240827$EXP$$CA-CELLTRION INC.-2020CA023410$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
1839672013$18396720$13$F$$20240708$20201019$20240715$EXP$$CA-APOTEX-2020AP019726$APOTEX$$59$YR$$F$Y$$$20240715$$MD$CA$CA
183967903$18396790$3$F$20180101$20240814$20201019$20240826$EXP$$ES-AUROBINDO-AUR-APL-2020-051934$AUROBINDO$$67$YR$$M$Y$101$KG$20240826$$PH$ES$ES
1839706424$18397064$24$F$20201001$20240917$20201019$20240924$EXP$$US-SHIRE-US202034307$TAKEDA$$78$YR$$F$Y$60$KG$20240924$$MD$US$US
1839712112$18397121$12$F$20220401$20240905$20201019$20240910$EXP$$US-SHIRE-US202034212$TAKEDA$$55$YR$$F$Y$68$KG$20240910$$HP$US$US
1839714720$18397147$20$F$$20240903$20201019$20240906$EXP$$US-SHIRE-US202034168$TAKEDA$$$$$M$Y$80$KG$20240906$$MD$US$US
183976575$18397657$5$F$$20240903$20201019$20240905$EXP$$US-SHIRE-US202034096$TAKEDA$$$$$F$Y$$$20240905$$MD$US$US
183978922$18397892$2$F$$20240620$20201019$20240701$EXP$$CA-APOTEX-2020AP019604$APOTEX$$42$YR$$F$Y$87$KG$20240701$$HP$CA$CA
183980922$18398092$2$F$20190304$20240726$20201019$20240802$EXP$$CA-AstraZeneca-2020SF32902$ASTRAZENECA$$63$YR$$F$Y$$$20240802$$MD$CA$
1839945620$18399456$20$F$20230101$20240827$20201019$20240827$EXP$$US-PFIZER INC-2020139424$PFIZER$$69$YR$$F$Y$90.72$KG$20240827$$CN$US$US
183999486$18399948$6$F$$20240821$20201019$20240827$PER$$US-PFIZER INC-2020252663$PFIZER$$77$YR$$F$Y$55.34$KG$20240827$$CN$US$US
184024467$18402446$7$F$20230817$20240808$20201019$20240813$EXP$$US-SHIRE-US202033867$TAKEDA$$92$YR$$M$Y$82$KG$20240813$$HP$US$US
184030118$18403011$8$F$20210911$20240719$20201019$20240730$EXP$$US-SHIRE-US202034190$TAKEDA$$65$YR$$F$Y$68$KG$20240730$$HP$US$US
1840382814$18403828$14$F$20231208$20240918$20201020$20240925$EXP$$US-SHIRE-US202024331$TAKEDA$$63$YR$$F$Y$83$KG$20240925$$HP$US$US
184041194$18404119$4$F$20160101$20240731$20201020$20240812$EXP$$CA-Accord-205095$ACCORD$Pennou C, Javidi E, Lecours J, Belisle A, Davar S. Trichodysplasia spinulosa in a renal transplant patient: A case report of successful treatment. SAGE Open Medical Case Reports. 2020;8:1-4. DOI: 10.1177/2050313X20953039.$59$YR$A$M$Y$$$20240812$$MD$CA$CA
184043318$18404331$8$F$20201001$20240614$20201020$20240704$PER$$CA-TOLMAR, INC.-20CA023208$TOLMAR$$65$YR$$M$Y$92.3$KG$20240704$$CN$CA$CA
184043799$18404379$9$F$20201011$20240916$20201020$20240918$EXP$$US-SHIRE-US202034459$TAKEDA$$32$YR$$M$Y$$$20240918$$HP$US$US
184051244$18405124$4$F$20180101$20240815$20201020$20240819$EXP$$US-PFIZER INC-2020404266$PFIZER$$57$YR$$F$Y$$$20240819$$HP$US$US
1840655916$18406559$16$F$20200512$20240923$20201020$20240930$EXP$$NVSC2020DE280078$NOVARTIS$$$$A$F$Y$$$20240930$$HP$DE$DE
1840752116$18407521$16$F$$20240725$20201020$20240725$PER$$US-PFIZER INC-2020265662$PFIZER$$26$YR$$M$Y$$$20240725$$CN$US$US
184079652$18407965$2$F$$20240708$20201021$20240712$EXP$$FR-AUROBINDO-AUR-APL-2020-052674$AUROBINDO$Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M, et al.. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.. British Journal of Dermatology. 2013;168(3):555-562$55$YR$$M$Y$$$20240712$$HP$FR$FR
184084337$18408433$7$F$20200101$20240909$20201021$20240918$PER$$US-GILEAD-2020-0499673$GILEAD$$$$A$M$Y$$$20240918$$LW$US$US
184084767$18408476$7$F$20200201$20240830$20201021$20240906$EXP$$US-BIOGEN-2020BI00936623$BIOGEN$$38$YR$$M$Y$70.642$KG$20240906$$CN$US$US
184102472$18410247$2$F$$20201012$20201021$20240909$EXP$$US-KYOWAKIRIN-2020BKK016701$KYOWA$$$$$$Y$$$20240909$$HP$US$US
1841173910$18411739$10$F$20200903$20240814$20201021$20240821$EXP$$NVSC2020CH255075$NOVARTIS$$34$YR$$M$Y$74$KG$20240821$$MD$CH$CH
184128692$18412869$2$F$20200920$20240827$20201022$20240910$PER$$US-SA-2020SA288332$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240910$$MD$US$US
184131285$18413128$5$F$$20240715$20201022$20240722$EXP$$CA-BAUSCH-BL-2020-029891$BAUSCH AND LOMB$$$$$M$Y$38$KG$20240722$$CN$CA$CA
184132293$18413229$3$F$20190201$20240708$20201021$20240716$EXP$$CA-AstraZeneca-2020SF32857$ASTRAZENECA$$34$YR$$F$Y$$$20240716$$MD$CA$
184132616$18413261$6$F$$20240708$20201021$20240716$EXP$$CA-AstraZeneca-2020SF33600$ASTRAZENECA$$57$YR$$F$Y$$$20240716$$MD$CA$
184135754$18413575$4$F$20201001$20240911$20201022$20240926$EXP$$US-SA-2020SA289711$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240926$$MD$US$US
184145353$18414535$3$F$20201014$20240715$20201022$20240718$EXP$$CN-PFIZER INC-2020403660$PFIZER$$74$YR$$M$Y$58$KG$20240718$$CN$CN$CN
184158806$18415880$6$F$$20220907$20201022$20240905$EXP$$NVSC2020US278894$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
184160832$18416083$2$F$$20240729$20201022$20240806$EXP$$CA-AstraZeneca-2020SF33703$ASTRAZENECA$$75$YR$$F$Y$$$20240806$$MD$CA$
184162843$18416284$3$F$$20240708$20201022$20240716$EXP$$CA-AstraZeneca-2020SF34565$ASTRAZENECA$$71$YR$$F$Y$$$20240716$$MD$CA$
184167458$18416745$8$F$$20240918$20201022$20240925$EXP$$PT-MYLANLABS-2020M1088762$MYLAN$Vilela, M.. Quando Alice tomou sertralina. Medicina Interna - Congressos Nacionais, 26CNMI.. 2020;478$67$YR$$F$Y$$$20240925$$MD$PT$PT
1841677217$18416772$17$F$20190511$20240826$20201022$20240830$EXP$$JP-ABBVIE-20P-087-3598421-00$ABBVIE$$43$YR$$M$Y$68.9$KG$20240830$$MD$JP$JP
1841722712$18417227$12$F$20010101$20240904$20201022$20240906$EXP$$US-BAUSCH-BL-2020-030833$BAUSCH AND LOMB$$39$YR$$F$Y$77.18$KG$20240906$$CN$US$US
184178425$18417842$5$F$$20240913$20201022$20240918$EXP$$US-INCYTE CORPORATION-2020IN010284$INCYTE$$$$$$Y$$$20240918$$MD$US$US
1841879021$18418790$21$F$20210413$20220922$20201023$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR210785$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
1841907711$18419077$11$F$20170324$20240920$20201023$20240927$EXP$$AU-SA-2017SA080646$SANOFI AVENTIS$$47$YR$A$F$Y$192$KG$20240927$$HP$AU$AU
184197055$18419705$5$F$$20240813$20201023$20240821$EXP$$US-ROCHE-2701097$ROCHE$$76$YR$E$F$Y$$$20240821$$CN$US$US
184197343$18419734$3$F$$20220325$20201023$20240724$EXP$$CA-AstraZeneca-2020SF36872$ASTRAZENECA$$62$YR$$F$Y$69$KG$20240724$$MD$CA$
184201675$18420167$5$F$$20240812$20201023$20240821$EXP$$NVSC2020FR272415$NOVARTIS$Dubois M, Morel G, Tone A, Gaboriaud L, Gautier S, Lazrek M et al.. Meningoradiculite liee a une reactivation du virus varicelle-zona lors dun traitement par ixekizumab [Meningoradiculitis due to varicella zoster virus reactivation in a patient treated with ixekizumab]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE. 2020;147(10):667-71$51$YR$$F$Y$$$20240821$$HP$FR$FR
184202252$18420225$2$F$$20201017$20201023$20240724$EXP$$CA-AstraZeneca-2020SF36123$ASTRAZENECA$$59$YR$$M$Y$$$20240724$$MD$CA$
1842035913$18420359$13$F$$20240731$20201023$20240803$EXP$$PT-AUROBINDO-AUR-APL-2020-053338$AUROBINDO$Santos GM, Ilharco M, Moreira LB, Vieira MM, Coelho MS, Fevereiro MC, et al. CC12 - Acute generalised exanthematous putulosis- Um caso pouco comum.. Revista Portuguesa de Imunoalergologia.. 2020;28(2):54$68$YR$$F$Y$$$20240803$$MD$PT$PT
184219482$18421948$2$F$$20240905$20201023$20240906$PER$$US-PFIZER INC-2020409225$PFIZER$$$$$M$Y$$$20240906$$MD$US$US
184223077$18422307$7$F$$20240913$20201023$20240916$PER$$US-PFIZER INC-2020409845$PFIZER$$51$YR$$M$Y$$$20240916$$CN$US$US
184224172$18422417$2$F$20200908$20200911$20201023$20240903$EXP$$TR-JNJFOC-20200922462$JOHNSON AND JOHNSON$$$$$M$Y$71$KG$20240903$$MD$TR$TR
1842256324$18422563$24$F$20201020$20240722$20201023$20240726$EXP$$CA-PFIZER INC-2020409142$PFIZER$$45$YR$$F$Y$70$KG$20240726$$HP$CA$CA
184227073$18422707$3$F$$20240904$20201023$20240906$EXP$$US-PFIZER INC-2020410246$PFIZER$$65$YR$$F$Y$81.65$KG$20240906$$CN$US$US
184236063$18423606$3$F$$20240705$20201024$20240717$EXP$$PL-Accord-206041$ACCORD$Sikora-Skrabaka M, Copija A, Nowakowska-Zajdel E. Przerzuty raka piersi do jelita grubego-opis przypadku (Breast cancer metastasis to the colon-a case study). CLINICAL ONCOLOGY-EDUCATION. 2020;6:G12.$72$YR$E$F$Y$$$20240717$$HP$PL$PL
184238379$18423837$9$F$$20240812$20201024$20240821$EXP$$CA-APOTEX-2020AP020024$APOTEX$$63$YR$$M$Y$$$20240821$$HP$CA$CA
184277894$18427789$4$F$20200101$20240730$20201026$20240802$EXP$$US-VERTEX PHARMACEUTICALS-2020-020676$VERTEX$$$$$F$Y$$$20240802$$MD$US$US
1842880810$18428808$10$F$20190529$20240820$20201027$20240824$EXP$$IL-ABBVIE-20K-082-3620018-00$ABBVIE$$75$YR$$M$Y$68$KG$20240824$$MD$IL$IL
184291744$18429174$4$F$$20240813$20201026$20240816$EXP$$US-PFIZER INC-2020412835$PFIZER$Boozel, T.. WHAT ABOUT THE RASH? A CASE OF DISSEMINATED VARICELLA ZOSTER VIRUS LEADING TO ARDS. Chest. 2020;158 (4 Suppl):A2047-A2048$58$YR$$F$Y$$$20240816$$HP$US$US
184294843$18429484$3$F$$20240807$20201027$20240820$EXP$$FR-AUROBINDO-AUR-APL-2020-053561$AUROBINDO$Feuillet S, Meignin V, Briere J, Brice P, Rocha V, Socie G, et aL. Endobronchial epstein-barr virus associated post-transplant lymphoproliferative disorder in hematopoietic stem cell transplantation. Clinical Medicine: Case Reports. 2009;2009(2):11-15$39$YR$$M$Y$$$20240820$$HP$FR$FR
1843031732$18430317$32$F$20200101$20240920$20201026$20240930$EXP$$CA-CELLTRION INC.-2020CA020637$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
184305175$18430517$5$F$20191201$20240722$20201027$20240729$EXP$$NVSC2020AR004893$NOVARTIS$$60$YR$$F$Y$$$20240729$$CN$AR$AR
184309554$18430955$4$F$$20240828$20201027$20240903$EXP$$CA-GLAXOSMITHKLINE-CA2018GSK058548$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$MD$CA$CA
1843112210$18431122$10$F$20200201$20240723$20201027$20240730$PER$$US-BIOGEN-2020BI00842868$BIOGEN$$62$YR$$F$Y$$$20240730$$CN$US$US
184314848$18431484$8$F$$20220614$20201027$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR211741$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
1843207514$18432075$14$F$20210106$20240917$20201027$20240924$EXP$$CA-TAKEDA-2019TUS051749$TAKEDA$$73$YR$$M$Y$$$20240924$$MD$CA$CA
184328617$18432861$7$F$20210501$20240917$20201027$20240925$EXP$$CA-TAKEDA-2018TUS005993$TAKEDA$$50$YR$$F$Y$$$20240925$$MD$CA$CA
184334338$18433433$8$F$$20240919$20201027$20240925$EXP$$US-TAKEDA-US202034617$TAKEDA$$$$$F$Y$113.4$KG$20240925$$MD$US$US
1843369312$18433693$12$F$20200113$20240719$20201028$20240729$EXP$$CA-CELLTRION INC.-2020CA018074$CELLTRION$$$$$$Y$$$20240729$$HP$CA$CA
1843405082$18434050$82$F$20200330$20240722$20201027$20240729$EXP$$CO-SHIRE-CO202012111AA$TAKEDA$$16$YR$$F$Y$58$KG$20240729$$CN$CO$CO
184342957$18434295$7$F$$20240731$20201027$20240805$EXP$$CA-TAKEDA-2020TUS043948$TAKEDA$$$$$M$Y$$$20240805$$HP$CA$CA
184358148$18435814$8$F$20180101$20240823$20201028$20240828$EXP$$CA-TAKEDA-2018TUS033481$TAKEDA$$$$$F$Y$$$20240828$$MD$CA$CA
184360278$18436027$8$F$20170201$20240916$20201028$20240923$EXP$$CA-TAKEDA-2017TUS003350$TAKEDA$$60$YR$$M$Y$$$20240923$$MD$CA$CA
184361478$18436147$8$F$$20211228$20201028$20240702$EXP$$US-AKCEA THERAPEUTICS-2020IS001375$AKCEA THERAPEUTICS$$$$$$Y$$$20240701$$MD$US$US
1843651213$18436512$13$F$20200601$20240813$20201028$20240815$EXP$$US-PFIZER INC-2020417109$PFIZER$$51$YR$$F$Y$53.061$KG$20240815$$HP$US$US
184366679$18436667$9$F$20230215$20240708$20201028$20240711$EXP$$AU-TAKEDA-2020TUS021260$TAKEDA$$71$YR$$M$Y$$$20240711$$MD$AU$AU
1843671318$18436713$18$F$$20240813$20201028$20240820$EXP$$US-SHIRE-US202012013$TAKEDA$$$$$F$Y$$$20240820$$MD$US$US
1843723615$18437236$15$F$20221128$20240705$20201028$20240710$EXP$$US-TAKEDA-US202033837$TAKEDA$$69$YR$$M$Y$82$KG$20240710$$HP$US$US
1843731018$18437310$18$F$20130101$20240809$20201028$20240812$EXP$$US-SHIRE-US202007995$TAKEDA$$$$$F$Y$$$20240812$$HP$US$US
184380744$18438074$4$F$$20240925$20201028$20240930$EXP$$CA-TAKEDA-2020TUS012830$TAKEDA$$$$$F$Y$$$20240930$$MD$CA$CA
184395723$18439572$3$F$20200205$20240912$20201029$20240918$EXP$$JP-ALXN-A202015632AA$ALEXION PHARMACEUTICALS$$9$YR$$F$Y$$$20240918$$MD$JP$JP
184395903$18439590$3$F$20180101$20240728$20201029$20240729$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-265567$RANBAXY$Manjula G, Chandani S, Shivakantayya GM, Mithilesh S, Abhijit G. Fluoroquinolones Induced Bullous Fixed Drug Eruption. Eur J Clin Pharm. 2020;22(1):52-54$75$YR$$M$Y$$$20240729$$PH$IN$IN
184397802$18439780$2$F$$20240628$20201029$20240706$EXP$$CA-CELLTRION INC.-2020CA029210$CELLTRION$$$$$$Y$$$20240706$$HP$CA$CA
184399512$18439951$2$F$20180622$20240812$20201029$20240815$EXP$$CA-TAKEDA-2018TUS020768$TAKEDA$$53$YR$$M$Y$$$20240815$$CN$CA$CA
1844026212$18440262$12$F$20200101$20240905$20201029$20240919$EXP$$US-INSMED, INC.-US-INS-20-01857$INSMED$$$$$F$Y$$$20240919$$HP$US$US
184409143$18440914$3$F$$20240828$20201029$20240903$EXP$$US-TAKEDA-US202010066$TAKEDA$$$$$F$Y$$$20240903$$MD$US$US
1844118713$18441187$13$F$20200625$20240807$20201029$20240812$EXP$$CA-TAKEDA-2020TUS011901$TAKEDA$$37$YR$$F$Y$72$KG$20240812$$CN$CA$CA
184412813$18441281$3$F$20240530$20240628$20201029$20240703$EXP$$US-KYOWAKIRIN-2020BKK017485$KYOWA$$$$$$Y$$$20240703$$HP$US$US
184414054$18441405$4$F$20200101$20240712$20201029$20240717$EXP$$IT-MYLANLABS-2020M1089773$MYLAN$$$$$F$Y$$$20240717$$MD$US$US
1844193748$18441937$48$F$20200707$20240717$20201029$20240724$EXP$$CO-TAKEDA-CO202005608$TAKEDA$$28$YR$$F$Y$65$KG$20240724$$CN$CO$CO
184424826$18442482$6$F$20190301$20240829$20201029$20240919$PER$$CA-TOLMAR, INC.-20CA023545$TOLMAR$$76$YR$$M$Y$$$20240919$$CN$CA$CA
1844251341$18442513$41$F$20200903$20240828$20201029$20240905$EXP$$MX-TAKEDA-MX202029215$TAKEDA$$3$YR$$M$Y$38.5$KG$20240905$$CN$MX$MX
1844260041$18442600$41$F$20191216$20240918$20201029$20240923$EXP$$CO-SHIRE-CO201945261AA$TAKEDA$$36$YR$$F$Y$83$KG$20240923$$CN$CO$CO
184428594$18442859$4$F$20200816$20240712$20201029$20240718$PER$$US-BIOGEN-2020BI00915882$BIOGEN$$47$YR$$F$Y$$$20240718$$CN$US$US
1844289924$18442899$24$F$20200910$20240723$20201029$20240729$EXP$$CO-TAKEDA-2020TUS035894$TAKEDA$$55$YR$$F$Y$74$KG$20240729$$HP$CO$CO
184431177$18443117$7$F$20080903$20240814$20201029$20240821$EXP$$US-TAKEDA-2020TUS044796$TAKEDA$$46$YR$$M$Y$97$KG$20240821$$CN$US$US
184432793$18443279$3$F$$20240725$20201030$20240802$EXP$$US-ROCHE-2704614$ROCHE$$69$YR$E$M$Y$$$20240802$$CN$US$US
1844329929$18443299$29$F$20200929$20240829$20201030$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082328$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$71.4$KG$20240902$$MD$JP$JP
184445218$18444521$8$F$20200512$20240712$20201030$20240717$EXP$$CA-TAKEDA-2020TUS030720$TAKEDA$$24$YR$$F$Y$$$20240717$$HP$CA$CA
184446622$18444662$2$F$$20240814$20201030$20240820$EXP$$FR-ROCHE-2704207$ROCHE$Feuillet S, Meignin V B. Endobronchial epstein-barr virus associated post-transplant lymphoproliferative disorder in hematopoietic stem cell transplantation. Clin-Med-Case-Rep. 2009;2009 (2):11-5.$39$YR$A$M$Y$$$20240820$$HP$FR$FR
1844488216$18444882$16$F$20200401$20240723$20201030$20240730$EXP$$CA-SHIRE-CA202012983$TAKEDA$$71$YR$$M$Y$$$20240730$$MD$CA$CA
184454229$18445422$9$F$20201106$20240826$20201030$20240829$EXP$$CA-TAKEDA-2020TUS030840$TAKEDA$$78$YR$$F$Y$$$20240829$$MD$CA$CA
1844548627$18445486$27$F$20200906$20240918$20201030$20240926$EXP$$CA-TAKEDA-CA202016296$TAKEDA$$19$YR$$F$Y$$$20240926$$CN$CA$CA
1844578411$18445784$11$F$20171025$20240816$20201030$20240822$EXP$$CA-TAKEDA-2018TUS025340$TAKEDA$$63$YR$$F$Y$$$20240822$$MD$CA$CA
1844601719$18446017$19$F$20200101$20240725$20201030$20240730$EXP$$CA-TAKEDA-CA202026940$TAKEDA$$$$$M$Y$30$KG$20240730$$HP$CA$CA
1844679513$18446795$13$F$20200522$20240903$20201030$20240910$EXP$$CA-SHIRE-CA202017428$TAKEDA$$55$YR$$F$Y$62$KG$20240910$$CN$CA$CA
1844706618$18447066$18$F$20191030$20240627$20201030$20240705$EXP$$CA-TAKEDA-2020TUS012982$TAKEDA$$69$YR$$M$Y$$$20240705$$HP$CA$CA
184480942$18448094$2$F$20191124$20240717$20201030$20240724$EXP$$ES-ABBVIE-20K-144-3626408-00$ABBVIE$$38$YR$$M$Y$$$20240724$$MD$ES$ES
184487204$18448720$4$F$$20240913$20201030$20240920$EXP$$CA-SHIRE-CA202023618$TAKEDA$$$$$M$Y$$$20240920$$MD$CA$CA
184489129$18448912$9$F$20200101$20240829$20201030$20240905$PER$$US-PFIZER INC-2019464297$PFIZER$$2$YR$$M$Y$16$KG$20240905$$MD$US$US
1844899616$18448996$16$F$$20240716$20201030$20240722$EXP$$US-SHIRE-US202030698$TAKEDA$$$$$F$Y$88$KG$20240722$$CN$US$US
184490916$18449091$6$F$20200825$20240917$20201102$20240923$EXP$$JP-ABBVIE-20K-087-3597494-00$ABBVIE$$48$YR$$F$Y$$$20240923$$MD$JP$JP
184493134$18449313$4$F$20231029$20240715$20201030$20240717$EXP$$US-TAKEDA-2020TUS045020$TAKEDA$$53$YR$$F$Y$78$KG$20240717$$HP$US$US
184506898$18450689$8$F$20211001$20220322$20201102$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR216164$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
184516072$18451607$2$F$$20240816$20201102$20240828$EXP$FR-EMA-DD-20201023-SHUKLA_V-095619$FR-Accord-206875$ACCORD$Dubois M, Morel G, Tone A, Gaboriau L, Gautier S, Lazrek M, et al. Meningoradiculitis due to varicella zoster virus reactivation in a patient treated with ixekizumab. Ann-Dermatol-Venereol 2020;147(10):667-671.$51$YR$A$F$Y$$$20240828$$HP$FR$FR
1845194020$18451940$20$F$20240719$20240719$20201102$20240725$EXP$$CA-TAKEDA-2020TUS016097$TAKEDA$$62$YR$$M$Y$64.399$KG$20240725$$HP$CA$CA
1845199875$18451998$75$F$20200108$20240909$20201102$20240913$EXP$$MX-TAKEDA-MX202001174$TAKEDA$$7$YR$$M$Y$21$KG$20240913$$CN$MX$MX
184524782$18452478$2$F$20200401$20240724$20201102$20240731$PER$$US-BIOGEN-2020BI00859986$BIOGEN$$50$YR$$F$Y$$$20240731$$CN$US$US
1845298910$18452989$10$F$20200401$20240918$20201102$20240920$EXP$$IN-PFIZER INC-2020248921$PFIZER$$78$YR$$F$Y$$$20240920$$CN$IN$IN
1845335123$18453351$23$F$20200815$20240904$20201102$20240910$EXP$$CO-TAKEDA-CO202026484$TAKEDA$$40$YR$$F$Y$70$KG$20240910$$CN$CO$CO
1845351629$18453516$29$F$$20240830$20201102$20240905$EXP$$US-SHIRE-US202006114$TAKEDA$$$$$F$Y$$$20240905$$HP$US$US
184536272$18453627$2$F$20201009$20240712$20201102$20240717$PER$$US-INCYTE CORPORATION-2020IN010516$INCYTE$$$$$$Y$$$20240717$$PH$US$US
184539776$18453977$6$F$20201021$20240910$20201102$20240912$EXP$$US-TAKEDA-2020TUS044915$TAKEDA$$50$YR$$F$Y$$$20240912$$MD$US$US
1845403334$18454033$34$F$20220922$20240716$20201102$20240721$EXP$$US-TAKEDA-2020TUS044417$TAKEDA$$72$YR$$F$Y$63$KG$20240721$$HP$US$US
184546652$18454665$2$F$20200910$20201021$20201103$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-262909$RANBAXY$$17$YR$T$M$Y$$$20240702$$HP$US$US
184547706$18454770$6$F$20220613$20240906$20201102$20240913$EXP$$CO-TAKEDA-2020TUS046134$TAKEDA$$50$YR$$M$Y$60$KG$20240913$$CN$CO$CO
184555192$18455519$2$F$20240903$20240903$20201102$20240913$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202010011188$ELI LILLY AND CO$$79$YR$E$M$Y$95$KG$20240913$$CN$CN$CN
1845632017$18456320$17$F$20201026$20240905$20201103$20240909$EXP$$DE-ROCHE-2707219$ROCHE$$47$YR$A$F$Y$$$20240909$$CN$DE$DE
1845651012$18456510$12$F$20201121$20220415$20201103$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR217320$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
1845777311$18457773$11$F$20150101$20240904$20201103$20240909$EXP$$CA-TAKEDA-2015TUS016351$TAKEDA$$$$$F$Y$$$20240909$$CN$CA$CA
184586966$18458696$6$F$$20240807$20201103$20240812$EXP$$US-TAKEDA-US202003034$TAKEDA$$$$$F$Y$81$KG$20240812$$CN$US$US
1845895111$18458951$11$F$20200507$20240718$20201103$20240724$EXP$$CA-TAKEDA-2020TUS013538$TAKEDA$$32$YR$$M$Y$$$20240724$$MD$CA$CA
184594473$18459447$3$F$20240715$20240722$20201103$20240725$EXP$$US-TAKEDA-2020TUS046855$TAKEDA$$52$YR$$F$Y$$$20240725$$MD$US$US
1845952912$18459529$12$F$$20240702$20201103$20240704$EXP$$US-PFIZER INC-2020425133$PFIZER$$71$YR$$M$Y$$$20240704$$CN$US$US
184596626$18459662$6$F$20200616$20240917$20201103$20240925$EXP$$IE-SHIRE-IE202019904$TAKEDA$$52$YR$$F$Y$$$20240925$$CN$IE$IE
184597753$18459775$3$F$$20240806$20201103$20240808$EXP$$CA-TAKEDA-2020TUS039373$TAKEDA$$$$$M$Y$$$20240808$$CN$CA$CA
184604016$18460401$6$F$20190212$20240703$20201103$20240705$EXP$$CA-TAKEDA-2019TUS014011$TAKEDA$$84$YR$$F$Y$$$20240705$$CN$CA$CA
184607324$18460732$4$F$$20240905$20201104$20240918$EXP$$US-AUROBINDO-AUR-APL-2020-053924$AUROBINDO$Alhefzi M, Aycart MA, Bueno EM, Kueckelhaus M, Fischer S, Snook RJ, et al. Guillain-Barre syndrome associated with resistant cytomegalovirus infection after face transplantation. Transplant Infectious Disease. 2016;18(2):288-292$39$YR$$M$Y$$$20240918$$MD$US$US
1846106217$18461062$17$F$20191030$20240627$20201104$20240704$EXP$$BR-TAKEDA-BR202034395$TAKEDA$$5$YR$$M$Y$33$KG$20240704$$CN$BR$BR
184612029$18461202$9$F$20190729$20220502$20201104$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR218436$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
184614683$18461468$3$F$$20240902$20201104$20240913$EXP$ES-EMA-DD-20201029-PAWAR_P-112841$ES-Accord-207265$ACCORD$$56$YR$A$F$Y$$$20240913$$MD$ES$ES
1846148513$18461485$13$F$20240924$20240924$20201104$20240927$EXP$$CA-TAKEDA-2020TUS045608$TAKEDA$$61$YR$$F$Y$$$20240927$$CN$CA$CA
184642826$18464282$6$F$20200101$20240828$20201104$20240903$EXP$$JP-JAZZ-2020-JP-013437$JAZZ$$62$YR$$M$Y$84.5$KG$20240903$$MD$JP$JP
184643334$18464333$4$F$20210201$20240710$20201104$20240716$EXP$$BR-TAKEDA-2020TUS047524$TAKEDA$$11$YR$$M$Y$40$KG$20240716$$CN$BR$BR
1846442012$18464420$12$F$20171001$20240903$20201104$20240906$EXP$$CA-TAKEDA-2017TUS024481$TAKEDA$$50$YR$$F$Y$$$20240906$$MD$CA$CA
184645344$18464534$4$F$20090101$20240917$20201104$20240919$EXP$$US-PURDUE-USA-2020-0174412$PURDUE$$$$A$M$Y$$$20240919$$CN$US$US
184647543$18464754$3$F$20180401$20240712$20201104$20240724$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202010012964$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240724$$CN$ES$ES
1846487738$18464877$38$F$20200626$20240916$20201104$20240918$EXP$$DE-PFIZER INC-2020322945$PFIZER$$60$YR$$M$Y$96$KG$20240918$$HP$DE$DE
184656753$18465675$3$F$$20240726$20201105$20240730$PER$$US-AMGEN-USASP2020177621$AMGEN$$$$$$Y$$$20240730$$MD$US$US
184658488$18465848$8$F$$20240721$20201104$20240925$EXP$$FR-AUROBINDO-AUR-APL-2020-054013$AUROBINDO$$74$YR$$M$Y$61$KG$20240925$$MD$FR$FR
1846633724$18466337$24$F$20200101$20240708$20201104$20240717$EXP$$CA-CELLTRION INC.-2019CA028088$CELLTRION$$$$$$Y$$$20240717$$MD$CA$CA
1846643811$18466438$11$F$20120411$20220512$20201104$20240802$EXP$$JP-009507513-2011JPN001184$MERCK$$40$YR$$M$Y$$$20240802$$MD$JP$US
184664696$18466469$6$F$$20240704$20201105$20240718$EXP$$CA-CELLTRION INC.-2020CA030235$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
1846650124$18466501$24$F$20191001$20240822$20201104$20240829$EXP$$CA-CELLTRION INC.-2019CA027082$CELLTRION$$$$$$Y$$$20240829$$CN$CA$CA
184676625$18467662$5$F$$20240712$20201105$20240718$PER$$US-SA-2020SA309471$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240718$$MD$US$US
184677203$18467720$3$F$20200509$20240716$20201105$20240723$EXP$$US-TAKEDA-2020TUS045726$TAKEDA$$53$YR$$M$Y$93.44$KG$20240723$$CN$US$US
184678202$18467820$2$F$$20240729$20201105$20240801$EXP$$US-TAKEDA-2018TUS034542$TAKEDA$$$$$F$Y$$$20240801$$CN$US$US
184679023$18467902$3$F$20191001$20240913$20201105$20240920$EXP$FR-AFSSAPS-AN20201156$FR-TEVA-2020-FR-1844817$TEVA$$43$YR$$F$Y$63$KG$20240920$$PH$FR$FR
1846887543$18468875$43$F$20210531$20240720$20201105$20240724$EXP$$CL-TAKEDA-CL202029882$TAKEDA$$10$YR$$M$Y$43$KG$20240724$$HP$CL$CL
184691405$18469140$5$F$$20240716$20201105$20240718$PER$$US-PFIZER INC-2020428007$PFIZER$$66$YR$$F$Y$$$20240718$$CN$US$US
184694733$18469473$3$F$$20240920$20201105$20240930$EXP$$US-TAKEDA-2020TUS046042$TAKEDA$$$$$M$Y$$$20240930$$MD$US$US
1846985412$18469854$12$F$$20240910$20201105$20240914$EXP$$US-SHIRE-US202003279$TAKEDA$$$$$M$Y$79$KG$20240914$$HP$US$US
184700638$18470063$8$F$20200805$20240731$20201105$20240805$EXP$$CA-TAKEDA-2019TUS031036$TAKEDA$$48$YR$$F$Y$$$20240805$$MD$CA$CA
1847171224$18471712$24$F$20200601$20240716$20201105$20240719$EXP$$US-TAKEDA-2020TUS044458$TAKEDA$$27$YR$$M$Y$$$20240719$$MD$US$US
184718408$18471840$8$F$$20240910$20201105$20240918$EXP$$CA-CELLTRION INC.-2020CA030284$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
184722474$18472247$4$F$$20240710$20201106$20240715$EXP$$DE-AstraZeneca-2020SF43339$ASTRAZENECA$Malicek D, Wagner S, Kaiser S, Khandoga A, Meininger D. Severe shock condition with combined lactate and ketoacidosis in a patient following pancreatic left resection with metformin and dapagliflozin permanent therapy. Anaesthesiologie and Intensivmedizin 2020;61(10):472-478.$76$YR$$M$Y$$$20240715$$MD$DE$
1847296310$18472963$10$F$$20240716$20201106$20240725$EXP$$CA-APOTEX-2020AP021090$APOTEX$$57$YR$$F$Y$$$20240725$$HP$CA$CA
1847311510$18473115$10$F$$20240625$20201106$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-003351$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
184736513$18473651$3$F$$20240724$20201106$20240731$EXP$$CA-GLAXOSMITHKLINE-CA2018GSK142756$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$MD$CA$CA
184738364$18473836$4$F$$20240711$20201106$20240723$EXP$$DE-EMD Serono-9196420$EMD SERONO INC$Malicek D, Wagner S, Kaiser S, Meininger D, Khandoga A. Severe condition of shock with combined lactic and ketoacidosis in a patient after left-sided pancreas resection under permanent therapy with metformin and dapagliflozin. Anasthesiologie und Intensivmedizin. 2020 Oct 01;61(10): 472-478. doi:10.19224/ai2020.472.$76$YR$E$M$Y$100$KG$20240719$$MD$DE$DE
184739737$18473973$7$F$$20240711$20201106$20240716$EXP$$CA-TAKEDA-2020TUS037557$TAKEDA$$$$$F$Y$$$20240716$$CN$CA$CA
1847430025$18474300$25$F$20201015$20240628$20201106$20240703$EXP$$NVSC2020CO294933$NOVARTIS$$3$YR$$M$Y$17.6$KG$20240703$$MD$CO$CO
184744494$18474449$4$F$20180622$20210720$20201106$20240823$EXP$$JP-AMGEN-JPNCT2019119767$AMGEN$$85$YR$E$F$Y$$$20240823$$MD$JP$JP
184748212$18474821$2$F$20200301$20240912$20201106$20240919$PER$$US-VERTEX PHARMACEUTICALS-2020-012276$VERTEX$$25$YR$$M$Y$79$KG$20240919$$HP$US$US
184749144$18474914$4$F$$20240625$20201106$20240701$PER$$US-PFIZER INC-2020431585$PFIZER$$70$YR$$F$Y$$$20240701$$MD$US$US
1847502017$18475020$17$F$20191101$20240826$20201106$20240902$EXP$$CA-TAKEDA-2020TUS003561$TAKEDA$$63$YR$$M$Y$73$KG$20240902$$HP$CA$CA
1847519419$18475194$19$F$20240306$20240813$20201106$20240817$EXP$$US-SHIRE-US202004537$TAKEDA$$48$YR$$F$Y$91$KG$20240817$$HP$US$US
184752233$18475223$3$F$20200201$20240708$20201106$20240712$EXP$$US-SHIRE-US202013978$TAKEDA$$67$YR$$M$Y$$$20240712$$CN$US$US
184752823$18475282$3$F$20230808$20240906$20201107$20240912$EXP$$CA-TAKEDA-2020TUS047168$TAKEDA$$53$YR$$F$Y$$$20240912$$MD$CA$CA
1847536843$18475368$43$F$20200513$20240815$20201106$20240822$EXP$$CA-SHIRE-CA202017871$TAKEDA$$58$YR$$F$Y$94$KG$20240822$$CN$CA$CA
1847647115$18476471$15$F$$20240731$20201106$20240805$EXP$$CA-TAKEDA-2020TUS047226$TAKEDA$$$$$M$Y$$$20240805$$HP$CA$CA
1847647911$18476479$11$F$$20240913$20201106$20240924$EXP$$PL-AUROBINDO-AUR-APL-2020-052891$AUROBINDO$Woron J, Siwek M. ^B?le glowy jako dzialanie niepozadane interakcji sertraliny. [Headaches as an adverse reaction of sertraline interactions.]^. Medycyna Praktyczna-Psychiatria. 2020;5(76):53-54$32$YR$$F$Y$$$20240924$$MD$PL$PL
184765237$18476523$7$F$20200301$20240826$20201106$20240829$EXP$$US-SHIRE-US202012443$TAKEDA$$76$YR$$F$Y$$$20240829$$MD$US$US
184766234$18476623$4$F$20240301$20240718$20201107$20240725$EXP$$CA-TAKEDA-2020TUS046877$TAKEDA$$39$YR$$F$Y$$$20240725$$MD$CA$CA
1847668013$18476680$13$F$20180101$20240813$20201107$20240816$EXP$$CA-TAKEDA-2018TUS026278$TAKEDA$$$$$F$Y$$$20240816$$CN$CA$CA
184767503$18476750$3$F$$20240912$20201107$20240918$EXP$$CA-TAKEDA-2020TUS047117$TAKEDA$$$$$M$Y$$$20240918$$MD$CA$CA
184771279$18477127$9$F$20210302$20240824$20201107$20240828$EXP$$US-TAKEDA-2020TUS045382$TAKEDA$$32$YR$$M$Y$$$20240828$$MD$US$US
184787572$18478757$2$F$20200101$20201102$20201109$20240718$EXP$$TH-AstraZeneca-2020SF43681$ASTRAZENECA$$81$YR$$M$Y$$$20240718$$CN$TH$
184800452$18480045$2$F$$20240729$20201109$20240802$EXP$$JP-PFIZER INC-2020424985$PFIZER$Nemoto, C.. A case of Hashimoto^s disease manifested with exacerbation of skin eruptions and persistent viral reactivation during the course of drug-induced hypersensitivity syndrome. The 72nd Annual Meeting of the Western Division of Japanese Dermatological Assoc. 2020;72nd:134$65$YR$$M$Y$$$20240802$$MD$JP$JP
184805227$18480522$7$F$20200101$20240801$20201109$20240805$EXP$$US-PFIZER INC-2020435060$PFIZER$$42$YR$$F$Y$$$20240805$$HP$US$US
184805308$18480530$8$F$$20240819$20201109$20240821$EXP$$US-PFIZER INC-2020437486$PFIZER$$86$YR$$F$Y$$$20240821$$CN$US$US
184805892$18480589$2$F$20191001$20240909$20201109$20240911$EXP$FR-AFSSAPS-AN20201156$FR-PFIZER INC-2020428643$PFIZER$$43$YR$$F$Y$63$KG$20240911$$PH$FR$FR
184820073$18482007$3$F$$20210329$20201109$20240703$PER$$NVSC2020US296093$NOVARTIS$$$$$M$Y$$$20240703$$CN$US$US
1848336624$18483366$24$F$20201102$20240813$20201110$20240821$EXP$$CA-CELLTRION INC.-2020CA030336$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
184836569$18483656$9$F$20201001$20240806$20201109$20240823$PER$$US-INCYTE CORPORATION-2020IN009597$INCYTE$$$$$$Y$$$20240823$$CN$US$US
1848367819$18483678$19$F$20200310$20240729$20201109$20240806$EXP$$CA-CELLTRION INC.-2020CA020740$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
184838543$18483854$3$F$$20240819$20201110$20240826$EXP$$CA-JNJFOC-20201105030$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$CA$CA
1848446721$18484467$21$F$20180423$20240802$20201110$20240808$EXP$$DE-ROCHE-2116970$ROCHE$$55$YR$A$F$Y$$$20240808$$CN$DE$DE
1848466320$18484663$20$F$20201014$20240827$20201110$20240904$EXP$$EG-ROCHE-2707233$ROCHE$$30$YR$A$F$Y$65$KG$20240904$$CN$EG$EG
1848532618$18485326$18$F$20200611$20220926$20201110$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR219447$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
1848679610$18486796$10$F$20200818$20240627$20201110$20240701$EXP$$IL-ABBVIE-20K-082-3611703-00$ABBVIE$$73$YR$$F$Y$91$KG$20240701$$MD$IL$IL
184877072$18487707$2$F$20190814$20240906$20201110$20240910$EXP$$JP-LUNDBECK-DKLU3023553$LUNDBECK$$$$$$Y$$$20240910$$MD$JP$JP
184878482$18487848$2$F$20200301$20240917$20201111$20240925$EXP$$CA-JNJFOC-20200842454$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240925$$HP$CA$CA
184881402$18488140$2$F$$20240825$20201110$20240905$EXP$$US-JNJFOC-20201100147$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$HP$US$US
184896784$18489678$4$F$$20240706$20201111$20240719$EXP$DE-MACLEODS PHARMACEUTICALS US LTD-MAC2020029058$DE-MACLEODS PHARMACEUTICALS US LTD-MAC2020029058$MACLEODS$Malicek D, Wagner S, Kaiser S, Khandoga A, Meininger D..Severe condition of shock with combined lactic and ketoacidosis in a patient after left-sided pancreas resection under permanent therapy with metformin and dapagliflozin.Anasthesiologie und Intensivmedizin.2020;61(10):472-478$$$$$Y$$$20240719$$MD$DE$DE
184909926$18490992$6$F$20240101$20240723$20201111$20240726$EXP$$US-GW PHARMA-202011USGW03831$JAZZ$$8$YR$$M$Y$23.6$KG$20240726$$MD$US$US
1849183410$18491834$10$F$20080401$20240715$20201111$20240716$EXP$$US-NAPPMUNDI-USA-2020-0152657$PURDUE$$44$YR$$M$Y$$$20240716$$CN$US$US
1849198311$18491983$11$F$20201101$20240913$20201111$20240917$PER$$US-PFIZER INC-2020445740$PFIZER$$73$YR$$F$Y$$$20240917$$CN$US$US
184925884$18492588$4$F$20180402$20240819$20201111$20240822$EXP$$US-SHIRE-US201813013AA$TAKEDA$$11$YR$$F$Y$$$20240822$$MD$US$US
184928883$18492888$3$F$$20240812$20201112$20240824$EXP$$TW-Accord-207626$ACCORD$Chien SC, Chien SC, Hu TY. Rapid-onset acute respiratory distress syndrome after mastectomy in a breast cancer patient. 2020 Oct 23 99(43):e22795.$53$YR$A$F$Y$$$20240824$$MD$TW$TW
1849320612$18493206$12$F$20201012$20240812$20201111$20240815$EXP$$US-TAKEDA-2020TUS047536$TAKEDA$$50$YR$$M$Y$77.09$KG$20240815$$HP$US$US
184933144$18493314$4$F$$20240723$20201111$20240729$EXP$$CA-TAKEDA-2020TUS047996$TAKEDA$$$$$M$Y$$$20240729$$MD$CA$CA
184933366$18493336$6$F$20191126$20240702$20201111$20240705$EXP$$CA-TAKEDA-2020TUS041991$TAKEDA$$34$YR$$M$Y$$$20240705$$CN$CA$CA
1849343914$18493439$14$F$20210829$20240906$20201112$20240916$EXP$$US-TAKEDA-2020TUS045094$TAKEDA$$66$YR$$F$Y$56$KG$20240916$$CN$US$US
184935878$18493587$8$F$20171018$20240912$20201112$20240924$EXP$$CA-TAKEDA-2017TUS017833$TAKEDA$$47$YR$$F$Y$$$20240924$$CN$CA$CA
184936338$18493633$8$F$20180101$20240829$20201111$20240902$EXP$$CA-TAKEDA-2018TUS032985$TAKEDA$$$$$F$Y$$$20240902$$MD$CA$CA
1849383486$18493834$86$F$20200316$20240808$20201111$20240816$EXP$$CO-TAKEDA-CO202027224$TAKEDA$$6$YR$$F$Y$39.46$KG$20240816$$CN$CO$CO
184938427$18493842$7$F$20201201$20240711$20201111$20240718$EXP$$CA-TAKEDA-2020TUS047143$TAKEDA$$30$YR$$F$Y$$$20240718$$CN$CA$CA
1849388871$18493888$71$F$20200406$20240820$20201111$20240823$EXP$$CO-TAKEDA-CO202012933$TAKEDA$$41$YR$$F$Y$79$KG$20240823$$CN$CO$CO
184941002$18494100$2$F$20201005$20240910$20201112$20240918$EXP$$BR-TAKEDA-2020TUS032253$TAKEDA$$21$YR$$M$Y$88$KG$20240918$$CN$BR$BR
184941495$18494149$5$F$20240411$20240905$20201112$20240909$EXP$$CA-TAKEDA-2020TUS048168$TAKEDA$$74$YR$$F$Y$$$20240909$$MD$CA$CA
1849422310$18494223$10$F$20201211$20240815$20201112$20240821$EXP$$CA-TAKEDA-2020TUS048273$TAKEDA$$76$YR$$M$Y$$$20240821$$CN$CA$CA
184945272$18494527$2$F$$20240625$20201112$20240704$EXP$BE-EMA-DD-20201105-SHAIK_I-105217$BE-Accord-208073$ACCORD$Buttafuoco F, Peche R, Vander Elst B, Van Meerhaeghe A. Mycobacterium marinum infection causing extensive tissue destruction in a hypoxic COPD patient. Acta-Clin-Belg 2011 66(4) 315-317$52$YR$A$M$Y$$$20240704$$HP$BE$BE
1849471313$18494713$13$F$20180125$20240702$20201112$20240704$EXP$$CA-TAKEDA-2018TUS001293$TAKEDA$$57$YR$$M$Y$$$20240704$$HP$CA$CA
1849480316$18494803$16$F$20200911$20240820$20201112$20240826$EXP$$US-TAKEDA-US202033564$TAKEDA$$39$YR$$F$Y$68$KG$20240826$$CN$US$US
1849486522$18494865$22$F$20161012$20240905$20201112$20240911$EXP$$PHHY2018AR075623$NOVARTIS$$64$YR$$M$Y$88$KG$20240911$$MD$AR$AR
184964656$18496465$6$F$20191006$20221027$20201112$20240822$PER$$JP-AMGEN-JPNCT2020181410$AMGEN$$91$YR$E$M$Y$$$20240821$$MD$JP$JP
184975672$18497567$2$F$$20240705$20201112$20240718$EXP$$DE-IPCA LABORATORIES LIMITED-IPC-2020-DE-003388$IPCA$D. Malicek, S. Wagner, S. Kaiser et al. Severe condition of shock with combined lactic and ketoacidosis in a patient after left-sided pancreas resection under permanent therapy with metformin and dapagliflozin.. Anasth Intensivmed. 2020;61:472-478$$$$$Y$$$20240718$$MD$DE$DE
184977523$18497752$3$F$20150826$20240920$20201112$20240925$EXP$$DE-ABBVIE-15P-062-1463589-00$ABBVIE$$51$YR$$F$Y$$$20240925$$MD$DE$DE
1849831810$18498318$10$F$20180925$20240907$20201112$20240913$EXP$$CO-TAKEDA-2019TUS026457$TAKEDA$$48$YR$$F$Y$68$KG$20240913$$HP$CO$CO
1849836217$18498362$17$F$20200503$20240902$20201112$20240906$EXP$$CO-TAKEDA-CO202016045$TAKEDA$$43$YR$$F$Y$64$KG$20240906$$CN$CO$CO
1849841531$18498415$31$F$$20240912$20201112$20240920$EXP$$US-TAKEDA-2020TUS046519$TAKEDA$$$$$F$Y$160$KG$20240920$$MD$US$US
1849867833$18498678$33$F$20210426$20240723$20201112$20240729$EXP$$CO-TAKEDA-2020TUS048845$TAKEDA$$45$YR$$F$Y$65$KG$20240729$$CN$CO$CO
1849870413$18498704$13$F$20200319$20240729$20201112$20240801$EXP$$CA-TAKEDA-2020TUS014601$TAKEDA$$26$YR$$F$Y$$$20240801$$HP$CA$CA
1849871013$18498710$13$F$20190301$20240725$20201112$20240730$EXP$$CA-TAKEDA-2018TUS023570$TAKEDA$$40$YR$$F$Y$$$20240730$$MD$CA$CA
184987947$18498794$7$F$$20240712$20201112$20240716$EXP$$US-TAKEDA-2020TUS049028$TAKEDA$$$$$M$Y$136$KG$20240716$$CN$US$US
184990202$18499020$2$F$$20240802$20201112$20240806$PER$$US-TAKEDA-2020TUS047273$TAKEDA$$$$$M$Y$$$20240806$$HP$US$US
184996513$18499651$3$F$20120101$20240625$20201113$20240703$EXP$$DE-AUROBINDO-AUR-APL-2020-055856$AUROBINDO$Lehmann S, Kieliba T, Thevis M, Rothschild MA, Mercer-Chalmers-Bender K.. Fatalities associated with NPS stimulants in the Greater Cologne area.. International Journal of Legal Medicine. 2020;134(1):229-241$18$YR$$F$Y$$$20240703$$HP$DE$DE
1849983919$18499839$19$F$20200101$20240704$20201113$20240711$EXP$$CA-CELLTRION INC.-2020CA021953$CELLTRION$$$$$$Y$$$20240711$$CN$CA$CA
1850030523$18500305$23$F$20191102$20240909$20201113$20240912$EXP$$NVSC2020CO275671$NOVARTIS$$48$YR$$F$Y$78$KG$20240912$$CN$CO$CO
185006285$18500628$5$F$20200312$20240702$20201113$20240707$EXP$$CA-SHIRE-CA202023709$TAKEDA$$66$YR$$F$Y$$$20240707$$CN$CA$CA
185017978$18501797$8$F$$20240805$20201113$20240808$EXP$$US-TAKEDA-2019TUS073797$TAKEDA$$$$$F$Y$$$20240808$$CN$US$US
185020005$18502000$5$F$20240501$20240713$20201113$20240715$EXP$$US-PFIZER INC-2020304572$PFIZER$$30$YR$$F$Y$$$20240715$$CN$US$US
1850208215$18502082$15$F$20211206$20240916$20201113$20240920$EXP$$US-TAKEDA-US202017649$TAKEDA$$43$YR$$F$Y$90$KG$20240920$$HP$US$US
185021725$18502172$5$F$$20240923$20201113$20240925$EXP$$CA-TAKEDA-2020TUS042035$TAKEDA$$$$$F$Y$$$20240925$$MD$CA$CA
185022463$18502246$3$F$20200807$20201102$20201113$20240808$EXP$$US-AstraZeneca-2020SF07941$ASTRAZENECA$$23161$DY$$M$Y$99.8$KG$20240808$$PH$US$
185026437$18502643$7$F$20190827$20240823$20201113$20240827$EXP$$PHHY2019BR210764$NOVARTIS$$44$YR$$F$Y$$$20240827$$CN$BR$BR
1850293835$18502938$35$F$20200201$20240902$20201113$20240906$EXP$$CO-TAKEDA-CO202002801$TAKEDA$$54$YR$$F$Y$61$KG$20240906$$HP$CO$CO
185032765$18503276$5$F$20061207$20240702$20201113$20240708$EXP$$ZA-PFIZER INC-2018425342$PFIZER$$61$YR$$F$Y$70$KG$20240708$$MD$ZA$ZA
185034952$18503495$2$F$20190328$20240904$20201113$20240908$EXP$$CA-TAKEDA-2018TUS031747$TAKEDA$$25$YR$$M$Y$$$20240908$$MD$CA$CA
1850379925$18503799$25$F$20220101$20240801$20201113$20240807$EXP$$US-TAKEDA-US201936977$TAKEDA$$$$$F$Y$46$KG$20240807$$MD$US$US
185038032$18503803$2$F$20100201$20240704$20201113$20240712$EXP$$DE-PFIZER INC-2020442918$PFIZER$$70$YR$$M$Y$66$KG$20240712$$MD$DE$DE
1850407922$18504079$22$F$20210324$20240912$20201113$20240918$EXP$$US-TAKEDA-2020TUS048320$TAKEDA$$72$YR$$F$Y$85$KG$20240918$$HP$US$US
185043905$18504390$5$F$20191101$20240910$20201113$20240917$EXP$$US-ABBVIE-20K-163-3619264-00$ABBVIE$$63$YR$$M$Y$91$KG$20240917$$MD$US$US
185049127$18504912$7$F$$20240706$20201115$20240717$EXP$$DE-AUROBINDO-AUR-APL-2020-055698$AUROBINDO$Malicek D, Wagner S, Kaiser S, Khandoga A, Meininger D.. Severe condition of shock with combined lactic and ketoacidosis in a patient after left-sided pancreas resection under permanent therapy with metformin and dapagliflozin. Anasthesiologie und Intensivmedizin.. 2020;61(10):472-478$76$YR$$M$Y$100$KG$20240717$$MD$DE$DE
185052292$18505229$2$F$$20240910$20201116$20240919$EXP$NL-EMA-DD-20201105-KUMARVN_P-112409$NL-ROCHE-2713313$ROCHE$Bakker N, van Dijk JMC, Slart RHJA, Coppes MH,,van Imhoff GW, Verschuuren EAM. Extradural thoracic spinal cord compression: unusual initial presentation of post-transplant lymphoproliferative disorder. Journal of Heart and Lung Transplantation 27: No. 10 2008 Oct;:1165-1168.$44$YR$A$M$Y$$$20240919$$MD$NL$NL
1850625616$18506256$16$F$20190912$20240815$20201116$20240821$EXP$$CA-SHIRE-CA202019788$TAKEDA$$47$YR$$F$Y$$$20240821$$MD$CA$CA
1850627234$18506272$34$F$20210226$20240812$20201116$20240816$EXP$$CO-TAKEDA-CO201701754$TAKEDA$$36$YR$$M$Y$94$KG$20240816$$CN$CO$CO
185062736$18506273$6$F$20230801$20240722$20201116$20240726$EXP$$US-TAKEDA-2018TUS027710$TAKEDA$$54$YR$$F$Y$$$20240726$$HP$US$US
1850636947$18506369$47$F$20160901$20240829$20201116$20240905$EXP$$CA-TAKEDA-CA202003996$TAKEDA$$41$YR$$F$Y$$$20240905$$CN$CA$CA
1850637032$18506370$32$F$20200101$20240819$20201116$20240827$EXP$$US-SHIRE-US202015628$TAKEDA$$70$YR$$F$Y$63$KG$20240827$$MD$US$US
1850642112$18506421$12$F$20191004$20240917$20201116$20240919$EXP$$US-PFIZER INC-2020445187$PFIZER$$82$YR$$M$Y$78.458$KG$20240919$$CN$US$US
185064714$18506471$4$F$20201020$20240801$20201116$20240805$EXP$$US-PFIZER INC-2017125799$PFIZER$$79$YR$$F$Y$108.84$KG$20240805$$HP$US$US
185066387$18506638$7$F$20160101$20240716$20201116$20240718$EXP$$CA-TAKEDA-2016TUS019488$TAKEDA$$$$$F$Y$$$20240718$$CN$CA$CA
1850674038$18506740$38$F$20200801$20240827$20201116$20240831$EXP$$CO-TAKEDA-CO202025239$TAKEDA$$20$YR$$F$Y$100$KG$20240831$$CN$CO$CO
185067507$18506750$7$F$$20240919$20201116$20240924$EXP$$US-TAKEDA-US202032617$TAKEDA$$$$$F$Y$39$KG$20240924$$HP$US$US
185068926$18506892$6$F$$20240916$20201116$20240918$PER$$US-PFIZER INC-2020447423$PFIZER$$86$YR$$F$Y$$$20240918$$PH$US$US
1850798610$18507986$10$F$20210901$20240711$20201116$20240717$EXP$$CA-TAKEDA-2020TUS049723$TAKEDA$$69$YR$$F$Y$$$20240717$$CN$CA$CA
185084277$18508427$7$F$20200101$20240911$20201116$20240917$EXP$$PK-AMGEN-PAKSP2020135845$AMGEN$$59$YR$A$M$Y$$$20240917$$CN$PK$PK
185086552$18508655$2$F$$20240819$20201117$20240827$EXP$$GB-AMGEN-GBRSP2020185253$AMGEN$$83$YR$E$F$Y$$$20240827$$CN$GB$GB
185096985$18509698$5$F$$20240712$20201117$20240722$EXP$$US-GLAXOSMITHKLINE-US2020AMR224661$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$HP$US$US
185102038$18510203$8$F$$20240919$20201117$20240925$EXP$$PL-MYLANLABS-2020M1093870$MYLAN$Woron, J, Sivek, M. Headache as an adverse reaction of sertraline interaction. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2020;76(5):53-54$32$YR$$F$Y$$$20240925$$MD$PL$PL
1851064127$18510641$27$F$20200723$20240918$20201117$20240927$EXP$$CA-CELLTRION INC.-2020CA024748$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
1851108823$18511088$23$F$20201111$20240709$20201117$20240712$EXP$$US-TAKEDA-2020TUS050434$TAKEDA$$70$YR$$M$Y$$$20240712$$MD$US$US
185120832$18512083$2$F$$20240821$20201117$20240826$EXP$$NVSC2020DE305448$NOVARTIS$Seidel S, Kowalski T, Margold M, Baraniskin A, Schroers R, Martus P, et al.. HDMTX-based polychemotherapy including intraventricular therapy in elderly patients with primary CNS lymphoma: a single center series. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2020;13:1-12$$$E$$Y$$$20240826$$HP$DE$DE
1851259020$18512590$20$F$20200605$20240627$20201117$20240702$EXP$$CA-TAKEDA-CA202021864$TAKEDA$$43$YR$$F$Y$$$20240702$$CN$CA$CA
185127003$18512700$3$F$20201002$20240805$20201117$20240814$EXP$$US-TEVA-2020-US-1849262$TEVA$$18$YR$$F$Y$$$20240814$$MD$US$US
185127107$18512710$7$F$20201106$20240716$20201117$20240719$EXP$$US-SHIRE-US202012626$TAKEDA$$67$YR$$F$Y$$$20240719$$HP$US$US
1851277123$18512771$23$F$$20240704$20201117$20240709$EXP$$CA-TAKEDA-2020TUS048979$TAKEDA$$$$$M$Y$$$20240709$$HP$CA$CA
185129023$18512902$3$F$20191127$20240726$20201117$20240730$EXP$$CA-TAKEDA-2019TUS063538$TAKEDA$$40$YR$$F$Y$$$20240730$$MD$CA$CA
1851306726$18513067$26$F$20201104$20240706$20201117$20240709$EXP$$AU-TAKEDA-2020TUS049673$TAKEDA$$71$YR$$F$Y$$$20240709$$PH$AU$AU
185139955$18513995$5$F$$20240906$20201117$20240911$EXP$$US-GILEAD-2020-0504730$GILEAD$$78$YR$E$M$Y$$$20240911$$HP$US$US
185146952$18514695$2$F$20181026$20240905$20201117$20240917$EXP$$BE-AUROBINDO-AUR-APL-2018-056785$AUROBINDO$$76$YR$$M$Y$77$KG$20240917$$MD$BE$BE
185147244$18514724$4$F$20040101$20240813$20201118$20240814$EXP$$US-GILEAD-2020-0503143$GILEAD$$72$YR$E$M$Y$$$20240814$$LW$US$US
185159232$18515923$2$F$20200529$20240909$20201118$20240911$EXP$$DE-JNJFOC-20201111361$JOHNSON AND JOHNSON$$1$DY$N$F$Y$3.94$KG$20240911$$MD$DE$DE
1851680816$18516808$16$F$20200101$20240716$20201118$20240723$EXP$$NVSC2020CA226309$NOVARTIS$$62$YR$$F$Y$$$20240723$$CN$CA$CA
185168507$18516850$7$F$20220302$20240925$20201118$20240927$EXP$$CA-TAKEDA-2018TUS022277$TAKEDA$$37$YR$$F$Y$$$20240927$$CN$CA$CA
185173833$18517383$3$F$$20240813$20201118$20240815$EXP$$US-SHIRE-US202020276$TAKEDA$$$$$M$Y$$$20240815$$HP$US$US
185176443$18517644$3$F$20200101$20240715$20201118$20240720$EXP$$US-JAZZ-2020-US-015012$JAZZ$$$$$M$Y$$$20240720$$HP$US$US
185176463$18517646$3$F$20200101$20240822$20201118$20240828$EXP$$BR-TAKEDA-BR202002911$TAKEDA$$27$YR$$M$Y$86$KG$20240828$$CN$BR$BR
1851798314$18517983$14$F$20200601$20240819$20201118$20240821$EXP$$US-PFIZER INC-2020451142$PFIZER$$69$YR$$F$Y$$$20240821$$CN$US$US
185180422$18518042$2$F$20240101$20240627$20201118$20240702$EXP$$US-KYOWAKIRIN-2020BKK018922$KYOWA$$$$$$Y$$$20240702$$HP$US$US
185185714$18518571$4$F$$20240925$20201118$20240927$EXP$$US-TAKEDA-2020TUS048327$TAKEDA$$$$$M$Y$63$KG$20240927$$CN$US$US
1851876616$18518766$16$F$20221225$20240826$20201118$20240902$EXP$$US-SHIRE-US201935641$TAKEDA$$78$YR$$F$Y$68$KG$20240902$$CN$US$US
185201362$18520136$2$F$20200712$20240621$20201118$20240701$EXP$$BG-BAXTER-2020BAX022876$BAXTER$$19$YR$$M$Y$$$20240701$$CN$BG$BG
185212368$18521236$8$F$20190709$20240923$20201119$20240925$EXP$$CA-TAKEDA-2019TUS044461$TAKEDA$$29$YR$$F$Y$$$20240925$$CN$CA$CA
185222972$18522297$2$F$20150901$20240710$20201119$20240714$EXP$$FR-SA-2017SA264048$SANOFI AVENTIS$Keribin P, Guerrot D, Jardin F, Moizan H.. Osteonecrosis of the Jaw in a Patient Presenting With Post-Transplantation Lymphoproliferative Disorder Treated With Rituximab: A Case Report.. Journal of Oral and Maxillofacial Surgery.. 2017;UNK:1-7$73$YR$E$M$Y$$$20240714$$MD$FR$FR
1852342710$18523427$10$F$$20240628$20201119$20240702$PER$$US-PFIZER INC-2020407341$PFIZER$$68$YR$$F$Y$$$20240702$$CN$US$US
185235382$18523538$2$F$$20240924$20201119$20240926$EXP$$US-PURDUE-USA-2020-0164947$PURDUE$$40$YR$$M$Y$$$20240926$$CN$US$US
185238943$18523894$3$F$20240101$20240917$20201119$20240918$EXP$$US-PFIZER INC-2020455870$PFIZER$$72$YR$$F$Y$$$20240918$$CN$US$US
1852460316$18524603$16$F$20201102$20240903$20201119$20240908$EXP$$US-TAKEDA-2020TUS051651$TAKEDA$$23$YR$$M$Y$$$20240908$$CN$US$US
185246128$18524612$8$F$20200823$20240828$20201119$20240830$EXP$$CA-TAKEDA-2020TUS040083$TAKEDA$$54$YR$$F$Y$$$20240830$$MD$CA$CA
185259762$18525976$2$F$20200101$20240625$20201120$20240827$EXP$$BG-TEVA-2020-BG-1850060$TEVA$$19$YR$$M$Y$$$20240827$$CN$BG$BG
1852607214$18526072$14$F$$20220228$20201120$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR223837$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
185265796$18526579$6$F$20200901$20240720$20201120$20240724$EXP$$JP-TAKEDA-2020TJP025112$TAKEDA$$55$YR$$F$Y$37$KG$20240724$$MD$JP$JP
185265969$18526596$9$F$$20221214$20201120$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR228478$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
185269998$18526999$8$F$20191107$20240910$20201120$20240916$EXP$$CA-TAKEDA-2019TUS066436$TAKEDA$$45$YR$$M$Y$$$20240916$$CN$CA$CA
185270577$18527057$7$F$$20240826$20201120$20240902$EXP$$CA-JNJFOC-20201122318$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$HP$CA$CA
185270994$18527099$4$F$20201101$20240821$20201120$20240904$PER$$US-SA-2020SA324336$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240904$$MD$US$US
1852719614$18527196$14$F$20200201$20240703$20201120$20240708$EXP$$CA-TAKEDA-2020TUS010123$TAKEDA$$58$YR$$F$Y$$$20240708$$CN$CA$CA
185272646$18527264$6$F$20200618$20240710$20201120$20240712$EXP$$CA-TAKEDA-2020TUS023807$TAKEDA$$62$YR$$F$Y$$$20240712$$CN$CA$CA
185275496$18527549$6$F$20170101$20240806$20201120$20240809$EXP$$CA-TAKEDA-2017TUS006246$TAKEDA$$$$$F$Y$$$20240809$$MD$CA$CA
185279373$18527937$3$F$$20240918$20201120$20240924$EXP$$JP-JNJFOC-20201125904$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240924$$MD$JP$JP
185280754$18528075$4$F$20200101$20240914$20201120$20240925$EXP$$JP-ABBVIE-20K-087-3655100-00$ABBVIE$KIGUCHI T. Management of adverse reactions to Bruton^s tyrosine kinase inhibitor IBRUTINIB.$83$YR$$F$Y$$$20240925$$MD$JP$JP
1852870010$18528700$10$F$20190421$20240802$20201120$20240809$EXP$$CO-TAKEDA-2019TUS028136$TAKEDA$$33$YR$$F$Y$80$KG$20240809$$HP$CO$CO
1852942819$18529428$19$F$20200715$20240727$20201120$20240802$EXP$$CO-TAKEDA-CO202019063$TAKEDA$$41$YR$$M$Y$73$KG$20240802$$HP$CO$CO
185302793$18530279$3$F$$20240812$20201121$20240820$EXP$$US-TAKEDA-2020TUS050672$TAKEDA$$$$$F$Y$68.48$KG$20240820$$HP$US$US
185305156$18530515$6$F$20221024$20240702$20201121$20240704$EXP$$CA-TAKEDA-2020TUS035191$TAKEDA$$82$YR$$M$Y$$$20240704$$CN$CA$CA
185306002$18530600$2$F$$20240913$20201121$20240924$EXP$$PL-AUROBINDO-AUR-APL-2014-02616$AUROBINDO$Gosek P. Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy. Psychiatria Polska. 2014;48 (1):49 - 58$26$YR$$M$Y$$$20240924$$HP$PL$PL
1853062412$18530624$12$F$20231002$20240715$20201121$20240717$EXP$$CO-TAKEDA-2020TUS050585$TAKEDA$$39$YR$$F$Y$59$KG$20240717$$CN$CO$CO
185307658$18530765$8$F$20171214$20240724$20201121$20240801$EXP$$CA-TAKEDA-2018TUS003672$TAKEDA$$36$YR$$F$Y$$$20240801$$MD$CA$CA
1853175031$18531750$31$F$20191003$20240904$20201123$20240913$EXP$$CA-ROCHE-2436206$ROCHE$$44$YR$A$F$Y$$$20240913$$CN$CA$CA
185318153$18531815$3$F$20191101$20240806$20201123$20240811$EXP$$DE-ROCHE-2714079$ROCHE$$37$YR$A$F$Y$$$20240811$$MD$DE$DE
185346765$18534676$5$F$20230101$20240913$20201123$20240918$EXP$$US-BAUSCH-BL-2020-034097$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240918$$CN$US$US
185346782$18534678$2$F$20190509$20240710$20201123$20240715$PER$$US-BIOVITRUM-2020US6545$BIOVITRUM$$23$YR$$M$Y$$$20240715$$CN$US$US
1853575318$18535753$18$F$$20240830$20201123$20240905$EXP$$US-PFIZER INC-2020460067$PFIZER$$70$YR$$M$Y$$$20240905$$CN$US$US
1853623115$18536231$15$F$$20240826$20201124$20240903$EXP$$CA-ROCHE-2718688$ROCHE$$$$A$F$Y$$$20240903$$CN$CA$CA
185368794$18536879$4$F$20140101$20240723$20201124$20240725$PER$$US-GILEAD-2020-0504645$GILEAD$$$$A$F$Y$$$20240724$$LW$US$US
1853744725$18537447$25$F$20160916$20240918$20201124$20240926$EXP$$DE-AUROBINDO-AUR-APL-2020-057535$AUROBINDO$$52$YR$$F$Y$62$KG$20240926$$MD$DE$DE
185377462$18537746$2$F$$20240904$20201124$20240909$EXP$$DE-ROCHE-2718450$ROCHE$Seidel S, Seidel S, Kowalski T, Margold M, Baraniskin A, Schroers R, et al. HDMTX-based polychemotherapy including intraventricular therapy in elderly patients with primary CNS lymphoma: a single center series. Therapeutic. Advances in Neurological Disorders.. 2020;13:1-12.$$$$$Y$$$20240909$$HP$DE$DE
185384082$18538408$2$F$$20240830$20201124$20240909$EXP$$NL-AUROBINDO-08-AUR-02494$AUROBINDO$NICOLAI, J., GUNNING, B., LEROY, P.L., CEULEMANS, B., VLES, J.S.H.. Acute hepatic injury in four children with Dravet syndrome: valproic acid, topiramate or acetaminophen? Seizure.. European Journal Of Epilepsy. 2008;17- No. 1:92 - 97$3$YR$$F$Y$$$20240909$$HP$NL$NL
185400833$18540083$3$F$20201101$20240829$20201124$20240902$EXP$$US-JAZZ-2020-US-015502$JAZZ$$63$YR$$F$Y$$$20240902$$HP$US$US
185404504$18540450$4$F$$20240813$20201124$20240819$PER$$US-PFIZER INC-2020460795$PFIZER$$69$YR$$F$Y$$$20240819$$CN$US$US
185416743$18541674$3$F$20081201$20240829$20201124$20240903$EXP$$US-PURDUE-USA-2020-0164211$PURDUE$$46$YR$$M$Y$$$20240903$$CN$US$US
1854177018$18541770$18$F$20180613$20240722$20201124$20240727$EXP$DE-ROCHE-2141017$DE-BIOGEN-2020BI00948019$BIOGEN$$70$YR$$M$Y$$$20240727$$MD$DE$DE
1854236513$18542365$13$F$20200427$20240702$20201124$20240705$EXP$$CA-TAKEDA-2020TUS021015$TAKEDA$$55$YR$$F$Y$$$20240705$$MD$CA$CA
1854245141$18542451$41$F$20200101$20240816$20201125$20240824$EXP$$CA-CELLTRION INC.-2019CA023500$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
1854250138$18542501$38$F$20200813$20240830$20201124$20240906$EXP$$CO-SHIRE-CO202026803AA$TAKEDA$$22$YR$$F$Y$57$KG$20240906$$HP$CO$CO
185426709$18542670$9$F$$20240628$20201124$20240703$EXP$$CA-TAKEDA-2019TUS031311$TAKEDA$$$$$F$Y$$$20240703$$MD$CA$CA
1854299610$18542996$10$F$$20240909$20201124$20240911$EXP$$US-TAKEDA-2020TUS049533$TAKEDA$$$$$M$Y$93$KG$20240911$$CN$US$US
185434467$18543446$7$F$20200101$20240912$20201124$20240918$EXP$$BR-TAKEDA-BR202017839$TAKEDA$$$$$M$Y$38$KG$20240918$$CN$BR$BR
1854360120$18543601$20$F$20210915$20240729$20201124$20240801$EXP$$US-TAKEDA-2020TUS048146$TAKEDA$$57$YR$$F$Y$57$KG$20240801$$HP$US$US
1854375411$18543754$11$F$20170101$20240912$20201124$20240920$EXP$$CA-TAKEDA-2017TUS012453$TAKEDA$$$$$M$Y$$$20240920$$CN$CA$CA
1854379112$18543791$12$F$$20240719$20201124$20240725$EXP$$CA-TAKEDA-2019TUS066188$TAKEDA$$$$$F$Y$$$20240725$$CN$CA$CA
185438688$18543868$8$F$20220928$20240702$20201124$20240708$EXP$$US-TAKEDA-US201923493$TAKEDA$$66$YR$$M$Y$61$KG$20240708$$CN$US$US
1854387710$18543877$10$F$20190917$20240907$20201124$20240912$EXP$$CA-TAKEDA-2019TUS050506$TAKEDA$$36$YR$$M$Y$$$20240912$$HP$CA$CA
185439715$18543971$5$F$20200925$20240821$20201125$20240826$EXP$$FR-KYOWAKIRIN-2020BKK020147$KYOWA$$$$$$Y$$$20240826$$HP$FR$FR
185440432$18544043$2$F$$20240913$20201125$20240923$EXP$$JP-ASTELLAS-2020JP018214$ASTELLAS$Hirata Y, Sanada Y, Onishi Y, Okada N, Sakuma Y, Sada N. A case of post-liver transplant infant in which eosinophilic gastroenteritis was induced by tacrolimus. Japanese Journal of Pediatric Gastroenterology and Nutrition (The 47th Annual Meeting of Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition (2020.10.23-25)) 2020;34(special edi):62.$10$MON$I$M$Y$$$20240923$$MD$JP$JP
185449369$18544936$9$F$20201217$20240918$20201125$20240924$EXP$$CA-TAKEDA-2018TUS035874$TAKEDA$$25$YR$$F$Y$$$20240924$$CN$CA$CA
185450153$18545015$3$F$$20240827$20201125$20240903$EXP$$US-SHIRE-US202010825$TAKEDA$$$$$F$Y$$$20240903$$HP$US$US
185450173$18545017$3$F$20160101$20240926$20201125$20240930$EXP$$US-GILEAD-2020-0505312$GILEAD$$34$YR$A$M$Y$$$20240930$$LW$US$US
1854523410$18545234$10$F$20201029$20240910$20201125$20240916$EXP$$US-TAKEDA-2020TUS048836$TAKEDA$$65$YR$$F$Y$61$KG$20240916$$CN$US$US
185452439$18545243$9$F$20170523$20240724$20201125$20240726$EXP$$CA-TAKEDA-2016TUS019128$TAKEDA$$38$YR$$M$Y$$$20240726$$CN$CA$CA
185466914$18546691$4$F$$20240904$20201125$20240906$EXP$$US-PFIZER INC-2020466078$PFIZER$$75$YR$$F$Y$$$20240906$$CN$US$US
185470253$18547025$3$F$$20240710$20201125$20240715$PER$$US-PFIZER INC-2020171874$PFIZER$$56$YR$$F$Y$$$20240715$$HP$US$US
1854770913$18547709$13$F$20201126$20240813$20201125$20240815$EXP$$CA-TAKEDA-2020TUS051398$TAKEDA$$38$YR$$M$Y$$$20240815$$CN$CA$CA
1854774452$18547744$52$F$20190101$20240809$20201125$20240823$EXP$$US-TAKEDA-2020TUS049646$TAKEDA$$$$$M$Y$81$KG$20240823$$HP$US$US
185478702$18547870$2$F$$20240709$20201125$20240710$EXP$$US-PURDUE-USA-2020-0167400$PURDUE$$$$A$F$Y$$$20240710$$CN$US$US
185488523$18548852$3$F$20160101$20240730$20201126$20240808$EXP$$US-EMD Serono-9045300$EMD SERONO INC$$62$YR$A$F$Y$$$20240808$$CN$US$US
185489932$18548993$2$F$$20240729$20201126$20240807$EXP$$CA-APOTEX-2020AP022154$APOTEX$$64$YR$$F$Y$$$20240807$$MD$CA$CA
185494204$18549420$4$F$20200211$20240918$20201126$20240925$EXP$$BR-GLAXOSMITHKLINE-BR2019AMR166657$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$BR$BR
185498758$18549875$8$F$20191101$20240906$20201126$20240912$EXP$$CA-SHIRE-CA201942799$TAKEDA$$55$YR$$F$Y$44$KG$20240912$$CN$CA$CA
1854994010$18549940$10$F$$20240902$20201126$20240906$EXP$$CA-SHIRE-CA202002303AA$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
185500919$18550091$9$F$20160809$20240717$20201126$20240723$EXP$$CA-TAKEDA-2016TUS014182$TAKEDA$$41$YR$$F$Y$$$20240723$$HP$CA$CA
185501743$18550174$3$F$$20240725$20201126$20240729$EXP$$US-PFIZER INC-2020342938$PFIZER$$69$YR$$F$Y$$$20240729$$CN$US$US
185502894$18550289$4$F$20200213$20240731$20201126$20240805$EXP$$CA-TAKEDA-2019TUS061411$TAKEDA$$25$YR$$F$Y$$$20240805$$CN$CA$CA
1855049732$18550497$32$F$20210201$20240813$20201126$20240816$EXP$$US-PFIZER INC-2020323286$PFIZER$$88$YR$$F$Y$45.805$KG$20240816$$CN$US$US
185508562$18550856$2$F$20201119$20240819$20201126$20240829$PER$$US-SA-2020SA333096$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240829$$MD$US$US
185509455$18550945$5$F$20201103$20240710$20201126$20240712$EXP$$US-TAKEDA-2020TUS053167$TAKEDA$$18$YR$$M$Y$$$20240712$$CN$US$US
185512552$18551255$2$F$$20240621$20201126$20240702$PER$$US-SA-2020SA332871$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240702$$CN$US$US
1855127313$18551273$13$F$20200327$20240823$20201126$20240829$EXP$$US-SHIRE-US202014819$TAKEDA$$55$YR$$F$Y$$$20240829$$CN$US$US
185512906$18551290$6$F$20160113$20240908$20201126$20240914$EXP$$CA-TAKEDA-2016TUS000744$TAKEDA$$27$YR$$M$Y$$$20240914$$HP$CA$CA
185518794$18551879$4$F$$20240704$20201126$20240712$EXP$$CA-CELLTRION INC.-2020CA032195$CELLTRION$$$$$$Y$$$20240712$$HP$CA$CA
1855197415$18551974$15$F$20150401$20240801$20201126$20240808$EXP$$CA-ROCHE-1491427$ROCHE$$70$YR$E$F$Y$59$KG$20240808$$HP$CA$CA
185523833$18552383$3$F$$20240826$20201127$20240902$EXP$$US-INTERCEPT-PM2020002380$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
185532373$18553237$3$F$20240101$20240903$20201127$20240927$PER$$US-SA-2020SA341312$SANOFI AVENTIS$$16$YR$T$F$Y$87.528$KG$20240927$$MD$US$US
185532806$18553280$6$F$20200731$20240801$20201127$20240806$EXP$$CA-TAKEDA-2020TUS025465$TAKEDA$$19$YR$$M$Y$$$20240806$$HP$CA$CA
185534255$18553425$5$F$$20240823$20201127$20240829$EXP$$US-PFIZER INC-2020467130$PFIZER$$86$YR$$M$Y$$$20240829$$CN$US$US
1855354410$18553544$10$F$20201120$20240719$20201127$20240723$EXP$$US-TAKEDA-2020TUS052500$TAKEDA$$53$YR$$F$Y$$$20240723$$HP$US$US
1855358110$18553581$10$F$20201001$20240627$20201127$20240711$EXP$$DE-ROCHE-2716971$ROCHE$$33$YR$A$F$Y$$$20240711$$MD$DE$DE
1855394720$18553947$20$F$20210521$20240923$20201127$20240926$EXP$$US-TAKEDA-US202016162$TAKEDA$$69$YR$$F$Y$78$KG$20240926$$HP$US$US
185546067$18554606$7$F$20210726$20240814$20201127$20240819$EXP$$US-SHIRE-US202018495$TAKEDA$$36$YR$$F$Y$$$20240819$$HP$US$US
1855503614$18555036$14$F$20211023$20240918$20201127$20240926$EXP$$US-TAKEDA-2020TUS051644$TAKEDA$$80$YR$$F$Y$39$KG$20240926$$HP$US$US
1855534626$18555346$26$F$20201101$20240903$20201127$20240905$EXP$$US-TAKEDA-2020TUS051876$TAKEDA$$34$YR$$F$Y$82.5$KG$20240905$$HP$US$US
185554899$18555489$9$F$20210211$20240627$20201127$20240701$EXP$$US-SHIRE-US202003088$TAKEDA$$66$YR$$F$Y$70$KG$20240701$$CN$US$US
1855560011$18555600$11$F$$20240725$20201127$20240730$EXP$$US-SHIRE-US202021918$TAKEDA$$$$$F$Y$$$20240730$$HP$US$US
1855591722$18555917$22$F$20201118$20240917$20201127$20240926$EXP$$CA-CELLTRION INC.-2020CA024829$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
1855615825$18556158$25$F$20201118$20240906$20201128$20240916$EXP$$CA-CELLTRION INC.-2020CA032728$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
185562063$18556206$3$F$20201109$20201223$20201128$20240922$EXP$$JP-AMGEN-JPNSP2020192862$AMGEN$$94$YR$E$$Y$$$20240922$$PH$JP$JP
1855650212$18556502$12$F$$20240806$20201128$20240808$EXP$$US-TAKEDA-2020TUS053127$TAKEDA$$$$$F$Y$$$20240808$$MD$US$US
185566379$18556637$9$F$20200810$20240829$20201128$20240904$EXP$$CA-TAKEDA-CA202025297$TAKEDA$$63$YR$$F$Y$$$20240904$$HP$CA$CA
1855665611$18556656$11$F$$20240910$20201128$20240916$EXP$$US-TAKEDA-2020TUS051914$TAKEDA$$$$$M$Y$117$KG$20240916$$CN$US$US
1855665912$18556659$12$F$20201101$20240702$20201128$20240816$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-064561$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240816$$HP$CA$CA
185572445$18557244$5$F$$20240710$20201129$20240718$EXP$$AU-CELLTRION INC.-2020AU031120$CELLTRION$$$$$$Y$$$20240718$$HP$AU$AU
185573518$18557351$8$F$20151104$20240903$20201129$20240911$EXP$$ZA-AMGEN-ZAFSP2019045943$AMGEN$$49$YR$A$F$Y$$$20240911$$MD$ZA$ZA
185579339$18557933$9$F$$20240916$20201130$20240925$EXP$$PL-AUROBINDO-AUR-APL-2020-058562$AUROBINDO$Bosak M. 22-letnia pacjentka z uporczywymi napadami nie?wiadomo?ci (A 22-year-old female patient with persistent absence seizures). Medycyna praktyczna neurologia. 2020;65(5):71-74$22$YR$$F$Y$$$20240925$$MD$PL$PL
1855903030$18559030$30$F$20200101$20230710$20201130$20240926$EXP$$US-GLAXOSMITHKLINE-US2020AMR235317$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
185592872$18559287$2$F$20100101$20240801$20201130$20240805$EXP$$ZA-PFIZER INC-2020469222$PFIZER$$38$YR$$F$Y$55$KG$20240805$$MD$ZA$ZA
185594556$18559455$6$F$$20240909$20201130$20240911$PER$$US-PFIZER INC-2020466454$PFIZER$$57$YR$$F$Y$65.77$KG$20240911$$CN$US$US
1855949519$18559495$19$F$$20240911$20201130$20240917$EXP$$US-TAKEDA-2020TUS050400$TAKEDA$$$$$M$Y$85$KG$20240917$$CN$US$US
1855977015$18559770$15$F$$20240729$20201130$20240801$EXP$$US-TAKEDA-2020TUS052719$TAKEDA$$$$$F$Y$74$KG$20240801$$CN$US$US
185597914$18559791$4$F$20180913$20240822$20201130$20240828$EXP$$CA-TAKEDA-2020TUS053077$TAKEDA$$35$YR$$F$Y$$$20240828$$HP$CA$CA
1855999132$18559991$32$F$20191223$20240820$20201130$20240828$EXP$$CA-ROCHE-2512096$ROCHE$$36$YR$A$F$Y$99.79$KG$20240828$$CN$CA$CA
1856074726$18560747$26$F$20221028$20240917$20201130$20240923$EXP$$US-TAKEDA-2020TUS053145$TAKEDA$$74$YR$$F$Y$63$KG$20240923$$MD$US$US
185609004$18560900$4$F$$20240906$20201130$20240911$EXP$$US-GILEAD-2020-0505902$GILEAD$$71$YR$E$M$Y$$$20240911$$MD$US$US
185610575$18561057$5$F$$20240808$20201130$20240808$EXP$$NVSC2020SK313313$NOVARTIS$Pecova T, Adamicova K, Pec M, Kucerikova M. Kalcifikacia u hemodializovaneho pacienta [Calcifylaxis in a Patient on Hemodialysis]. LIECBA DERMATOVENEROLOGICKYCH OCHORENI. 2020;3(8):21-4$44$YR$$M$Y$145$KG$20240808$$HP$SK$SK
185612466$18561246$6$F$20201026$20240731$20201130$20240802$EXP$$US-TAKEDA-2020TUS053787$TAKEDA$$53$YR$$F$Y$$$20240802$$CN$US$US
1856126130$18561261$30$F$20200510$20240826$20201130$20240903$EXP$$DE-SHIRE-DE202016021AA$TAKEDA$$68$YR$$F$Y$$$20240903$$HP$DE$DE
185618187$18561818$7$F$$20240911$20201201$20240920$EXP$$CA-CELLTRION INC.-2020CA032696$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
1856236414$18562364$14$F$20201116$20240827$20201130$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-100480$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$56.4$KG$20240906$$MD$JP$JP
185633382$18563338$2$F$$20240913$20201201$20240925$EXP$$US-Accord-209231$ACCORD$Shrestha P, Garrahy I, Rahimian S. Eosinophilic granulomatosis with polyangiitis (EGPA) on remission with a new neuropathy: a rare case of mycophenolate induced primary CNS lymphoproliferative disease. J Community Hosp Intern Med Perspect. 2020 Oct 29;10(6):600-603.$81$YR$E$F$Y$$$20240925$$MD$US$US
1856367529$18563675$29$F$20220201$20240814$20201201$20240820$EXP$$US-TAKEDA-2020TUS052991$TAKEDA$$73$YR$$F$Y$54$KG$20240820$$HP$US$US
185636864$18563686$4$F$20200712$20240823$20201201$20240830$EXP$$BR-TAKEDA-BR202022848$TAKEDA$$57$YR$$F$Y$85$KG$20240830$$CN$BR$BR
185639832$18563983$2$F$20201101$20240716$20201201$20240717$EXP$$US-KYOWAKIRIN-2020BKK020397$KYOWA$$$$$$Y$$$20240717$$MD$US$US
185647328$18564732$8$F$20180320$20240703$20201201$20240708$EXP$$CA-TAKEDA-2018TUS016346$TAKEDA$$47$YR$$F$Y$$$20240708$$CN$CA$CA
1856539310$18565393$10$F$20230806$20240702$20201201$20240705$EXP$$US-TAKEDA-2020TUS053224$TAKEDA$$68$YR$$F$Y$65$KG$20240705$$CN$US$US
185654923$18565492$3$F$20240501$20240828$20201201$20240904$PER$$US-PFIZER INC-2020473130$PFIZER$$58$YR$$F$Y$$$20240904$$HP$US$US
1856580921$18565809$21$F$20200818$20240910$20201201$20240914$EXP$$CO-TAKEDA-CO202027177$TAKEDA$$12$YR$$M$Y$52$KG$20240914$$CN$CO$CO
185664537$18566453$7$F$$20240704$20201201$20240709$EXP$$AU-TAKEDA-2020TUS017640$TAKEDA$$$$$M$Y$$$20240709$$CN$AU$AU
185671854$18567185$4$F$$20240724$20201202$20240803$EXP$$US-AMGEN-USASP2020192976$AMGEN$$$$E$F$Y$$$20240803$$CN$US$US
185679405$18567940$5$F$20160106$20240625$20201202$20240703$EXP$$CA-CELLTRION INC.-2020CA032814$CELLTRION$$$$$$Y$$$20240703$$HP$CA$CA
185693377$18569337$7$F$20231101$20240723$20201202$20240801$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR235271$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$MD$CA$CA
185701455$18570145$5$F$20220117$20240723$20201202$20240802$EXP$$BR-TAKEDA-BR202009456$TAKEDA$$43$YR$$F$Y$64$KG$20240802$$MD$BR$BR
185704575$18570457$5$F$$20240919$20201202$20240923$PER$$US-PFIZER INC-2020231593$PFIZER$$72$YR$$F$Y$82.55$KG$20240923$$CN$US$US
1857151614$18571516$14$F$$20240814$20201202$20240816$EXP$$US-PFIZER INC-2020473473$PFIZER$$65$YR$$F$Y$$$20240816$$HP$US$US
185716144$18571614$4$F$$20240815$20201202$20240822$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR202190$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$CA$CA
1857178811$18571788$11$F$20220506$20240913$20201202$20240919$EXP$$TW-TAKEDA-TW202028156$TAKEDA$$34$YR$$M$Y$$$20240919$$HP$TW$TW
1857224419$18572244$19$F$20200924$20240813$20201202$20240819$EXP$$CO-TAKEDA-2020TUS041278$TAKEDA$$37$YR$$F$Y$66$KG$20240819$$CN$CO$CO
185722695$18572269$5$F$$20240806$20201202$20240809$EXP$$BR-TAKEDA-2020TUS053699$TAKEDA$$$$$F$Y$90$KG$20240809$$CN$BR$BR
185723909$18572390$9$F$20200725$20240709$20201202$20240715$EXP$$CA-TAKEDA-2020TUS033069$TAKEDA$$33$YR$$M$Y$$$20240715$$CN$CA$CA
185731196$18573119$6$F$20131111$20240718$20201203$20240723$EXP$$US-JNJFOC-20201146087$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240723$$LW$US$US
185731943$18573194$3$F$20201216$20240724$20201203$20240726$EXP$$CA-TAKEDA-2020TUS054550$TAKEDA$$48$YR$$M$Y$$$20240726$$CN$CA$CA
1857444015$18574440$15$F$$20240626$20201203$20240701$EXP$$US-TAKEDA-2020TUS051735$TAKEDA$$$$$M$Y$11$KG$20240701$$HP$US$US
185745234$18574523$4$F$$20240912$20201203$20240918$EXP$$SE-MYLANLABS-2020M1099328$MYLAN$Hegerius A.. WHO Pharmaceuticals Newsletter-No.5, 2020: Everolimus and osteonecrosis of the jaw (ONJ). WHO Pharmaceuticals Newsletter. 2020;5:11-18$65$YR$$M$Y$$$20240918$$HP$SE$SE
185750619$18575061$9$F$20240101$20240807$20201203$20240809$EXP$$US-PFIZER INC-2020473637$PFIZER$$75$YR$$F$Y$$$20240809$$CN$US$US
185751664$18575166$4$F$20190901$20240717$20201203$20240719$EXP$$FR-TAKEDA-FR202008245$TAKEDA$$57$YR$$F$Y$$$20240719$$HP$FR$FR
185752104$18575210$4$F$$20240726$20201203$20240731$EXP$$US-PFIZER INC-2020474013$MYLAN$$$$$$Y$$$20240731$$CN$US$US
185753916$18575391$6$F$20200101$20240809$20201203$20240814$EXP$$US-PFIZER INC-2020475749$PFIZER$$63$YR$$F$Y$47.17$KG$20240814$$CN$US$US
185756152$18575615$2$F$20201101$20240701$20201203$20240710$PER$$US-SA-2020SA346089$SANOFI AVENTIS$$67$YR$E$M$Y$97$KG$20240710$$MD$US$US
1857565313$18575653$13$F$20201008$20240822$20201203$20240830$EXP$$US-TAKEDA-US202028081$TAKEDA$$74$YR$$F$Y$41$KG$20240830$$HP$US$US
185757014$18575701$4$F$$20240805$20201203$20240812$PER$$US-PFIZER INC-2020477004$PFIZER$$58$YR$$F$Y$$$20240812$$CN$US$US
185759835$18575983$5$F$20201125$20240826$20201203$20240830$EXP$$US-TAKEDA-US201935391$TAKEDA$$72$YR$$F$Y$$$20240830$$HP$US$US
1857622710$18576227$10$F$$20240726$20201203$20240730$EXP$$US-PFIZER INC-2020473644$PFIZER$$68$YR$$F$Y$$$20240730$$CN$US$US
1857754313$18577543$13$F$20201121$20240901$20201203$20240904$EXP$$PK-AMGEN-PAKSP2020196679$AMGEN$$30$YR$A$M$Y$70$KG$20240904$$CN$PK$PK
1857792244$18577922$44$F$20200610$20240911$20201204$20240920$EXP$$CA-CELLTRION INC.-2020CA022875$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
1857818131$18578181$31$F$20200101$20240812$20201204$20240813$PER$$US-DSJP-DSU-2020-136157$DAIICHI$$$$$M$Y$$$20240813$$CN$US$US
185786995$18578699$5$F$20200601$20240623$20201204$20240711$EXP$$DE-ROCHE-2722144$ROCHE$$39$YR$A$F$Y$68$KG$20240711$$MD$DE$DE
1857878813$18578788$13$F$20170831$20240716$20201204$20240720$EXP$$CA-TAKEDA-2017TUS018876$TAKEDA$$53$YR$$F$Y$$$20240720$$HP$CA$CA
1857986324$18579863$24$F$20220707$20240729$20201204$20240805$EXP$$MX-TAKEDA-MX202012949$TAKEDA$$7$YR$$M$Y$20$KG$20240805$$CN$MX$MX
185801713$18580171$3$F$20200311$20240916$20201204$20240921$EXP$$DE-ABBVIE-20K-062-3675532-00$ABBVIE$$76$YR$$M$Y$74$KG$20240921$$MD$DE$DE
185804015$18580401$5$F$20201125$20240826$20201204$20240829$PER$$US-PFIZER INC-2020473172$PFIZER$$65$YR$$F$Y$$$20240829$$CN$US$US
185808385$18580838$5$F$20191011$20240731$20201204$20240805$EXP$$CA-TAKEDA-2019TUS052753$TAKEDA$$24$YR$$F$Y$52.3$KG$20240805$$HP$CA$CA
185809546$18580954$6$F$20180216$20240924$20201204$20240930$EXP$$JP-GILEAD-2019-0444028$GILEAD$$60$YR$A$M$Y$$$20240930$$MD$JP$JP
185815342$18581534$2$F$$20240628$20201204$20240708$EXP$$BE-MYLANLABS-2020M1098958$MYLAN$Buttafuoco F, Peche R, Vander Elst B, Van Meerhaeghe A. Mycobacterium marinum infection causing extensive tissue destruction in a hypoxic COPD patient. Acta-Clin-Belg. 2011;66(4):315-317$52$YR$$M$Y$$$20240708$$HP$BE$BE
185818435$18581843$5$F$20230630$20240823$20201204$20240830$EXP$$AU-TAKEDA-2020TUS055418$TAKEDA$$45$YR$$M$Y$$$20240830$$CN$AU$AU
185821313$18582131$3$F$$20240906$20201204$20240912$EXP$$US-GILEAD-2020-0507276$GILEAD$$72$YR$E$M$Y$$$20240912$$HP$US$US
185828752$18582875$2$F$20200514$20231128$20201205$20240701$EXP$$NVSC2020DE321855$NOVARTIS$$$$A$M$Y$$$20240701$$MD$DE$DE
1858346913$18583469$13$F$20200930$20240722$20201206$20240730$EXP$$CA-CELLTRION INC.-2020CA024299$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
1858353518$18583535$18$F$20200807$20240703$20201207$20240710$EXP$$CA-CELLTRION INC.-2020CA025162$CELLTRION$$$$$$Y$$$20240710$$CN$CA$CA
185845574$18584557$4$F$20151020$20221223$20201207$20240829$PER$$US-GILEAD-2020-0506981$GILEAD$$45$YR$A$M$Y$59.864$KG$20240829$$LW$US$US
185849934$18584993$4$F$20190219$20210126$20201207$20240709$EXP$$JP-GLAXOSMITHKLINE-JP2020JPN006628$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$JP$JP
185855017$18585501$7$F$20221201$20240626$20201207$20240701$EXP$$US-TAKEDA-2020TUS053112$TAKEDA$$47$YR$$M$Y$91$KG$20240701$$CN$US$US
185860702$18586070$2$F$$20240826$20201207$20240830$EXP$$NVSC2020DE297909$NOVARTIS$Ostendorf L, Burns M, Durek P, Heinz G, Heinrich F, Garantziotis P et al.. Targeting cd38 with daratumumab in refractory systemic lupus erythematosus. NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(12):1149-55$50$YR$$F$Y$$$20240830$$HP$DE$DE
1858616111$18586161$11$F$$20240904$20201207$20240906$EXP$$US-PFIZER INC-2020480247$PFIZER$$62$YR$$F$Y$62.14$KG$20240906$$HP$US$US
185862422$18586242$2$F$20201111$20240717$20201207$20240820$PER$$US-INCYTE CORPORATION-2020IN011522$INCYTE$$$$$$Y$$$20240820$$CN$US$US
1858639420$18586394$20$F$20201101$20240711$20201207$20240716$EXP$$CA-SA-2020SA349303$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240716$$MD$CA$CA
185869814$18586981$4$F$20201102$20240731$20201207$20240802$PER$$US-PFIZER INC-2020477546$PFIZER$$68$YR$$F$Y$91.99$KG$20240802$$MD$US$US
185874877$18587487$7$F$20190901$20240917$20201207$20240927$EXP$$CA-TAKEDA-2019TUS055085$TAKEDA$$31$YR$$F$Y$$$20240927$$CN$CA$CA
185875034$18587503$4$F$20200101$20240829$20201207$20240924$PER$$US-SA-2020SA350749$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240924$$CN$US$US
185876677$18587667$7$F$20230330$20240724$20201207$20240726$EXP$$US-TAKEDA-2015US004580$TAKEDA$$80$YR$$F$Y$64$KG$20240726$$MD$US$US
185878486$18587848$6$F$$20240724$20201207$20240725$PER$$US-PFIZER INC-2020481724$PFIZER$$48$YR$$F$Y$$$20240725$$HP$US$US
1858791811$18587918$11$F$20240220$20240828$20201207$20240903$EXP$$US-TAKEDA-2020TUS053884$TAKEDA$$73$YR$$F$Y$93$KG$20240903$$CN$US$US
185881093$18588109$3$F$20200614$20240904$20201207$20240906$EXP$$US-TAKEDA-US202019826$TAKEDA$$48$YR$$F$Y$65$KG$20240906$$HP$US$US
1858858642$18588586$42$F$20200101$20240723$20201208$20240731$EXP$$CA-CELLTRION INC.-2020CA018234$CELLTRION$$$$$$Y$$$20240731$$MD$CA$CA
185889002$18588900$2$F$$20240916$20201208$20240924$EXP$$US-TAKEDA-2020TUS055542$TAKEDA$$$$$M$Y$$$20240924$$CN$US$US
185890709$18589070$9$F$20180901$20240729$20201208$20240807$EXP$$US-ROCHE-2725482$ROCHE$$36$YR$A$F$Y$45.36$KG$20240807$$CN$US$US
185892282$18589228$2$F$$20240807$20201208$20240809$PER$$US-JNJFOC-20201207760$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$LW$US$US
185903187$18590318$7$F$20230101$20240702$20201208$20240705$EXP$$CA-TAKEDA-2019TUS049011$TAKEDA$$$$$F$Y$$$20240705$$CN$CA$CA
185907767$18590776$7$F$20170328$20240711$20201208$20240717$EXP$$PHHY2017CA049098$NOVARTIS$$8$YR$$F$Y$$$20240717$$CN$CA$CA
1859088026$18590880$26$F$20200101$20240708$20201208$20240709$EXP$$US-PFIZER INC-2020477090$PFIZER$$78$YR$$F$Y$61$KG$20240709$$CN$US$US
185912027$18591202$7$F$20210525$20240909$20201208$20240910$EXP$$US-TAKEDA-2020TUS053584$TAKEDA$$69$YR$$F$Y$61$KG$20240910$$MD$US$US
185912229$18591222$9$F$20201001$20240711$20201208$20240712$EXP$$US-PFIZER INC-2020481289$PFIZER$$94$YR$$M$Y$63.05$KG$20240712$$CN$US$US
185917102$18591710$2$F$$20240726$20201208$20240731$EXP$$US-PURDUE-USA-2020-0181893$PURDUE$$$$$M$Y$$$20240731$$CN$US$US
185919742$18591974$2$F$$20201104$20201208$20240701$30DAY$$BR-SA-2020SA351515$SANOFI AVENTIS$$$$$$Y$$$20240701$$PH$BR$BR
185921744$18592174$4$F$20200910$20240708$20201209$20240722$EXP$$JP-ALXN-A202013355AA$ALEXION PHARMACEUTICALS$$69$YR$$F$Y$$$20240722$$MD$JP$JP
1859247055$18592470$55$F$20200806$20240829$20201208$20240905$EXP$$BR-TAKEDA-BR202029221$TAKEDA$$34$YR$$F$Y$69$KG$20240905$$CN$BR$BR
1859337225$18593372$25$F$20200206$20240808$20201209$20240816$EXP$$CA-CELLTRION INC.-2020CA019338$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
1859421055$18594210$55$F$20201103$20240917$20201209$20240924$EXP$$US-TAKEDA-2020TUS054047$TAKEDA$$65$YR$$F$Y$$$20240924$$MD$US$US
185943253$18594325$3$F$$20240819$20201209$20240827$EXP$$US-BIOGEN-2020BI00954654$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
185944168$18594416$8$F$20191031$20240729$20201209$20240806$EXP$$DE-ROCHE-2493848$ROCHE$$32$YR$A$M$Y$$$20240806$$CN$DE$DE
185944476$18594447$6$F$20190701$20240905$20201209$20240913$EXP$$DE-JNJFOC-20200422024$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240913$$MD$DE$DE
185947486$18594748$6$F$20201128$20240818$20201209$20240820$EXP$$IL-ABBVIE-20K-082-3679847-00$ABBVIE$$69$YR$$M$Y$72$KG$20240820$$MD$IL$IL
185947919$18594791$9$F$20200101$20240716$20201209$20240718$EXP$$IN-PFIZER INC-2020478837$PFIZER$$51$YR$$F$Y$65.7$KG$20240718$$CN$IN$IN
185950384$18595038$4$F$20180907$20240829$20201209$20240909$EXP$$NVSC2020JP182361$NOVARTIS$Naya I, Sanada Y, Katano T, Miyahara G, Hirata Y, Yamada N et al.. Pregnancy outcomes following pediatric liver transplantation- A single-center experience in Japan. ANNALS OF TRANSPLANTATION. 2020;25$28$YR$$F$Y$41.3$KG$20240909$$HP$JP$JP
1859581910$18595819$10$F$20201130$20240822$20201209$20240830$EXP$$US-SHIRE-US202001363AA$TAKEDA$$45$YR$$F$Y$$$20240830$$HP$US$US
185960773$18596077$3$F$20190101$20240822$20201209$20240916$PER$$US-SA-2020SA353385$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240916$$MD$US$US
1859609317$18596093$17$F$20201118$20240807$20201209$20240814$EXP$$US-TAKEDA-2020TUS053778$TAKEDA$$61$YR$$F$Y$62$KG$20240814$$CN$US$US
1859610934$18596109$34$F$20180523$20240830$20201209$20240905$EXP$$DE-MYLANLABS-2020M1099630$MYLAN$$52$YR$$F$Y$62$KG$20240905$$CN$DE$DE
1859637819$18596378$19$F$20200101$20240829$20201209$20240904$EXP$$IN-PFIZER INC-2020481354$PFIZER$$61$YR$$F$Y$$$20240904$$CN$IN$IN
1859663125$18596631$25$F$20200822$20240801$20201209$20240807$EXP$$CO-TAKEDA-CO202028335$TAKEDA$$35$YR$$M$Y$95$KG$20240807$$CN$CO$CO
185969802$18596980$2$F$20201130$20240715$20201209$20240720$PER$$US-TAKEDA-2020TUS055756$TAKEDA$$62$YR$$F$Y$$$20240720$$MD$US$US
185976702$18597670$2$F$$20240910$20201210$20240918$PER$$US-SA-2020SA352456$SANOFI AVENTIS$$12$YR$T$F$Y$59$KG$20240918$$HP$US$US
1859813736$18598137$36$F$20200101$20240912$20201210$20240920$EXP$$CA-CELLTRION INC.-2020CA028233$CELLTRION$$$$$$Y$$$20240920$$MD$CA$CA
1860148818$18601488$18$F$20240314$20240819$20201210$20240827$EXP$$US-TAKEDA-US202028130$TAKEDA$$77$YR$$F$Y$45$KG$20240827$$CN$US$US
186015638$18601563$8$F$20201118$20240905$20201210$20240910$EXP$$US-TAKEDA-2020TUS055836$TAKEDA$$77$YR$$M$Y$104.3$KG$20240910$$CN$US$US
1860157610$18601576$10$F$20200207$20240725$20201210$20240729$EXP$$CA-TAKEDA-2019TUS009037$TAKEDA$$61$YR$$M$Y$$$20240729$$HP$CA$CA
1860158914$18601589$14$F$20220704$20240701$20201210$20240705$EXP$$AU-TAKEDA-2020TUS032446$TAKEDA$$75$YR$$F$Y$$$20240705$$MD$AU$AU
186021466$18602146$6$F$$20240724$20201210$20240726$EXP$$US-SHIRE-US201942315AA$TAKEDA$$$$$F$Y$$$20240726$$MD$US$US
186021824$18602182$4$F$$20240722$20201210$20240726$PER$$US-PFIZER INC-2020485378$PFIZER$$75$YR$$F$Y$79.38$KG$20240726$$CN$US$US
186030655$18603065$5$F$20200101$20240815$20201210$20240820$EXP$$US-JAZZ-2020-US-016199$JAZZ$$$$$F$Y$$$20240820$$MD$US$US
186037693$18603769$3$F$20190524$20240716$20201211$20240719$EXP$$CA-TAKEDA-2019TUS033073$TAKEDA$$51$YR$$F$Y$$$20240719$$CN$CA$CA
186051063$18605106$3$F$$20240717$20201211$20240723$PER$$US-INCYTE CORPORATION-2020IN012112$INCYTE$$$$$$Y$$$20240723$$CN$US$US
186054282$18605428$2$F$20201118$20201204$20201211$20240718$EXP$$US-AstraZeneca-2020SF63520$ASTRAZENECA$$260$DY$$M$Y$$$20240718$$CN$US$
186057082$18605708$2$F$$20240815$20201211$20240821$EXP$$US-TAKEDA-2019TUS061320$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
186057705$18605770$5$F$$20240906$20201211$20240912$EXP$$CA-TAKEDA-2019TUS064890$TAKEDA$$$$$M$Y$$$20240912$$MD$CA$CA
186058507$18605850$7$F$$20240702$20201211$20240706$EXP$$US-TAKEDA-2020TUS054660$TAKEDA$$$$$F$Y$54$KG$20240706$$CN$US$US
186060657$18606065$7$F$$20240913$20201211$20240916$EXP$$US-TAKEDA-US201941074$TAKEDA$$$$$F$Y$$$20240916$$MD$US$US
1860643212$18606432$12$F$20200630$20240829$20201211$20240919$PER$$CA-TOLMAR, INC.-20CA024251$TOLMAR$$62$YR$$M$Y$$$20240919$$CN$CA$CA
186070832$18607083$2$F$$20240913$20201211$20240917$PER$$US-PFIZER INC-2020488823$PFIZER$$52$YR$$F$Y$$$20240917$$HP$US$US
1860733433$18607334$33$F$20240221$20240701$20201211$20240705$EXP$$US-SHIRE-US202019069$TAKEDA$$72$YR$$F$Y$57$KG$20240705$$HP$US$US
1860737010$18607370$10$F$$20240924$20201211$20240926$PER$$US-PFIZER INC-2020487419$PFIZER$$64$YR$$F$Y$$$20240926$$HP$US$US
186074127$18607412$7$F$20200101$20240916$20201211$20240918$PER$$US-PFIZER INC-2020490242$PFIZER$$66$YR$$F$Y$54.422$KG$20240918$$CN$US$US
1860768912$18607689$12$F$20180925$20240702$20201211$20240708$EXP$$CA-TAKEDA-2019TUS040293$TAKEDA$$69$YR$$F$Y$$$20240708$$CN$CA$CA
186078476$18607847$6$F$20200101$20240923$20201211$20240925$EXP$$US-PFIZER INC-2020489332$PFIZER$$64$YR$$M$Y$$$20240925$$HP$US$US
1860784810$18607848$10$F$20200113$20240912$20201211$20240919$EXP$$CA-SHIRE-CA202025722$TAKEDA$$43$YR$$M$Y$$$20240919$$CN$CA$CA
186078602$18607860$2$F$$20240828$20201211$20240905$EXP$$CA-SHIRE-CA202026403$TAKEDA$$$$$F$Y$$$20240905$$CN$CA$CA
1860810219$18608102$19$F$20200515$20240903$20201212$20240909$EXP$$CA-SHIRE-CA202019465$TAKEDA$$53$YR$$F$Y$70$KG$20240909$$HP$CA$CA
186097659$18609765$9$F$$20240801$20201214$20240816$EXP$$CA-APOTEX-2020AP023720$APOTEX$$40$YR$$F$Y$73$KG$20240816$$HP$CA$CA
186103185$18610318$5$F$20200101$20240723$20201214$20240729$PER$$US-SA-2020SA355423$SANOFI AVENTIS$$52$YR$A$M$Y$81.64$KG$20240729$$MD$US$US
186103228$18610322$8$F$$20240716$20201214$20240729$EXP$$IE-ROCHE-2587279$ROCHE$$8$YR$C$M$Y$$$20240729$$HP$IE$IE
186110967$18611096$7$F$$20240819$20201214$20240821$EXP$$US-PFIZER INC-2020336643$PFIZER$$53$YR$$F$Y$$$20240821$$HP$US$US
186112256$18611225$6$F$$20240925$20201214$20240927$PER$$US-PFIZER INC-2020490321$PFIZER$$$$A$F$Y$$$20240927$$CN$US$US
186119002$18611900$2$F$20200101$20240904$20201214$20240912$EXP$$US-PFIZER INC-2020487631$PFIZER$$3$DEC$$F$Y$$$20240912$$CN$US$US
186123474$18612347$4$F$20200901$20240816$20201214$20240820$EXP$$CA-PFIZER INC-2020362885$PFIZER$$72$YR$$M$Y$$$20240820$$PH$CA$CA
1861482425$18614824$25$F$20221201$20240826$20201214$20240830$EXP$$US-TAKEDA-2020TUS056425$TAKEDA$$53$YR$$F$Y$75$KG$20240830$$HP$US$US
186149246$18614924$6$F$$20240910$20201214$20240912$EXP$$US-TAKEDA-2020TUS055671$TAKEDA$$$$$F$Y$$$20240912$$CN$US$US
1861496515$18614965$15$F$$20240812$20201214$20240815$EXP$$US-TAKEDA-2020TUS055908$TAKEDA$$$$$F$Y$77$KG$20240815$$HP$US$US
186149738$18614973$8$F$20190919$20240808$20201214$20240813$EXP$$CA-TAKEDA-2019TUS048276$TAKEDA$$35$YR$$F$Y$$$20240813$$MD$CA$CA
186149807$18614980$7$F$$20240923$20201214$20240930$EXP$$US-TAKEDA-2020TUS056352$TAKEDA$$$$$F$Y$87$KG$20240930$$HP$US$US
1861500110$18615001$10$F$20201116$20240905$20201215$20240919$EXP$$DE-AUROBINDO-AUR-APL-2020-060615$AUROBINDO$$$$E$F$Y$63$KG$20240919$$MD$DE$DE
186150037$18615003$7$F$$20240923$20201214$20240930$EXP$$US-TAKEDA-2020TUS036456$TAKEDA$$$$$F$Y$$$20240930$$MD$US$US
186150403$18615040$3$F$$20240913$20201214$20240918$EXP$$US-TAKEDA-2020TUS054086$TAKEDA$$$$$M$Y$133$KG$20240918$$CN$US$US
186150897$18615089$7$F$$20240806$20201214$20240812$EXP$$US-TAKEDA-2020TUS056297$TAKEDA$$$$$F$Y$105$KG$20240812$$HP$US$US
186151179$18615117$9$F$20220901$20240906$20201214$20240912$EXP$$US-TAKEDA-2020TUS056363$TAKEDA$$71$YR$$F$Y$73$KG$20240912$$CN$US$US
186151526$18615152$6$F$20200923$20240910$20201214$20240914$EXP$$CA-TAKEDA-2020TUS056880$TAKEDA$$40$YR$$F$Y$$$20240914$$CN$CA$CA
186151807$18615180$7$F$20211206$20240813$20201214$20240816$EXP$$BR-TAKEDA-2020TUS056161$TAKEDA$$47$YR$$M$Y$62$KG$20240816$$CN$BR$BR
186154024$18615402$4$F$$20240916$20201215$20240924$EXP$$CA-CELLTRION INC.-2020CA025466$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
186162416$18616241$6$F$$20211105$20201214$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR245540$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
186167953$18616795$3$F$20190326$20240622$20201215$20240705$EXP$$JP-TEVA-2020-JP-1858975$TEVA$Imai A. Cytomegalovirus retinitis occurs after administration of bendamustine. The 74th Annual Congress of Japan Clinical Ophthalmology. 2020;No information:No information; Imai A. Cytomegalovirus retinitis occurs after administration of bendamustine. The 74th Annual Congress of Japan Clinical Ophthalmology. 2020;No information:No information; Imai A. Cytomegalovirus retinitis occurs after administration of bendamustine. The 74th Annual Congress of Japan Clinical Ophthalmology. 2020;No inform...$68$YR$$M$Y$$$20240705$$HP$JP$JP
186169696$18616969$6$F$20190916$20240806$20201215$20240807$EXP$$US-TAKEDA-US201933808$TAKEDA$$57$YR$$F$Y$$$20240807$$MD$US$US
186173745$18617374$5$F$$20240805$20201215$20240808$EXP$$US-TAKEDA-2020TUS055988$TAKEDA$$$$$F$Y$106.58$KG$20240808$$CN$US$US
1861771332$18617713$32$F$20201203$20240627$20201215$20240701$EXP$$US-TAKEDA-2020TUS056488$TAKEDA$$62$YR$$F$Y$52$KG$20240701$$HP$US$US
1861814317$18618143$17$F$$20240918$20201215$20240923$EXP$$US-TAKEDA-2020TUS057242$TAKEDA$$$$$F$Y$95$KG$20240923$$HP$US$US
186182699$18618269$9$F$20200623$20240806$20201215$20240809$EXP$$JP-AstraZeneca-2020SF65584$ASTRAZENECA$Ishii S, et al. P-088 A case of platinum-sensitive recurrent ovarian cancer, in which drug-induced lung disorder due to Olaparib developed.. Journal of the Japan Society of Gynecologic Oncology 2021;39(3):256-.$75$YR$$F$Y$63$KG$20240809$$MD$JP$
186183393$18618339$3$F$$20240703$20201215$20240711$EXP$$IE-SA-2019SA038853$SANOFI AVENTIS$$$$N$F$Y$1.5$KG$20240711$$MD$IE$IE
1861900319$18619003$19$F$20210110$20240920$20201215$20240930$EXP$$CA-SHIRE-CA202012818$TAKEDA$$61$YR$$F$Y$$$20240930$$MD$CA$CA
186191183$18619118$3$F$$20240911$20201215$20240916$EXP$$US-TAKEDA-US202000960$TAKEDA$$$$$M$Y$$$20240916$$CN$US$US
186194479$18619447$9$F$20210101$20240703$20201215$20240708$EXP$$US-PFIZER INC-2020493900$PFIZER$$71$YR$$F$Y$63.96$KG$20240708$$MD$US$US
1861972719$18619727$19$F$20200805$20240918$20201215$20240927$EXP$$CA-TAKEDA-2020TUS030746$TAKEDA$$22$YR$$F$Y$$$20240927$$HP$CA$CA
1861985012$18619850$12$F$20210314$20240805$20201215$20240808$EXP$$US-SHIRE-US202016840$TAKEDA$$28$YR$$F$Y$63.5$KG$20240808$$MD$US$US
186198533$18619853$3$F$20240606$20240725$20201215$20240803$30DAY$$US-GLAXOSMITHKLINE-US2020242249$GLAXOSMITHKLINE$$63$YR$$M$Y$$$20240803$$CN$US$US
186198747$18619874$7$F$20201201$20240628$20201215$20240702$PER$$US-PFIZER INC-2020492785$PFIZER$$48$YR$$F$Y$73.48$KG$20240702$$HP$US$US
1862000011$18620000$11$F$20210101$20240820$20201215$20240826$EXP$$US-TAKEDA-2020TUS003534$TAKEDA$$$$$M$Y$68$KG$20240826$$MD$US$US
186200088$18620008$8$F$20210811$20240814$20201215$20240818$EXP$$US-TAKEDA-US202023119$TAKEDA$$11$YR$$M$Y$24$KG$20240818$$HP$US$US
1862028210$18620282$10$F$20100101$20240822$20201215$20240827$PER$$US-PFIZER INC-2020426369$PFIZER$$72$YR$$F$Y$77.11$KG$20240827$$CN$US$US
186209593$18620959$3$F$$20240729$20201215$20240801$EXP$$CA-BAYER-2020-270244$BAYER$$45$YR$A$F$Y$109$KG$20240801$$CN$CA$CA
186210686$18621068$6$F$20201210$20240819$20201216$20240823$EXP$$CA-TAKEDA-2020TUS057181$TAKEDA$$29$YR$$F$Y$$$20240823$$CN$CA$CA
1862195220$18621952$20$F$20200101$20240918$20201215$20240927$EXP$$CA-CELLTRION INC.-2020CA020605$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
186222403$18622240$3$F$$20240620$20201216$20240709$EXP$$GB-ROCHE-2711593$ROCHE$$$$E$M$Y$$$20240702$$CN$GB$GB
186227242$18622724$2$F$20201202$20240704$20201216$20240715$PER$$US-SA-2020SA357915$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240715$$MD$US$US
186236984$18623698$4$F$$20240918$20201216$20240925$EXP$$NVSC2020VE332638$NOVARTIS$$71$YR$$M$Y$$$20240925$$CN$VE$VE
1862385617$18623856$17$F$20200411$20240730$20201216$20240802$EXP$$CA-SHIRE-CA202013684$TAKEDA$$21$YR$$F$Y$$$20240802$$CN$CA$CA
186238574$18623857$4$F$20201218$20240711$20201216$20240712$EXP$$CA-TAKEDA-2020TUS035758$TAKEDA$$35$YR$$M$Y$$$20240712$$MD$CA$CA
1862385835$18623858$35$F$20210307$20240917$20201216$20240920$EXP$$CO-TAKEDA-CO202002304$TAKEDA$$31$YR$$F$Y$65$KG$20240920$$CN$CO$CO
186239115$18623911$5$F$20200928$20240628$20201216$20240724$PER$$CO-TOLMAR, INC.-20CO024309$TOLMAR$$73$YR$$M$Y$$$20240724$$CN$CO$CO
1862430723$18624307$23$F$20191108$20240704$20201216$20240709$EXP$$CO-TAKEDA-CO201932652$TAKEDA$$25$YR$$F$Y$57$KG$20240709$$CN$CO$CO
186244704$18624470$4$F$$20240724$20201216$20240726$EXP$$US-PURDUE-USA-2020-0183306$PURDUE$$$$E$M$Y$$$20240726$$LW$US$US
1862489211$18624892$11$F$20210210$20240924$20201216$20240927$EXP$$US-TAKEDA-2020TUS057027$TAKEDA$$69$YR$$F$Y$69$KG$20240927$$HP$US$US
186249755$18624975$5$F$20200707$20240819$20201216$20240822$EXP$$BR-TAKEDA-BR202011806$TAKEDA$$5$YR$$M$Y$21$KG$20240822$$CN$BR$BR
186256365$18625636$5$F$$20240815$20201216$20240821$EXP$$US-TAKEDA-2020TUS057271$TAKEDA$$$$$F$Y$104$KG$20240821$$CN$US$US
186261412$18626141$2$F$$20240828$20201216$20240901$EXP$IT-JNJFOC-20201220656$IT-JNJFOC-20201220656$JOHNSON AND JOHNSON$Bernardini N., Skroza N., Mambrin A., Tolino E., Anzalone A., Balduzzi V., et al. A tailored therapeutic approach for patients affected by multi-drug resistant psoriasis Giornale Italiano di Dermatologia e Venereologia 2020 155 511-512$30$YR$A$M$Y$$$20240902$$HP$IT$IT
1862641254$18626412$54$F$20200401$20240904$20201216$20240913$EXP$$CA-CELLTRION INC.-2020CA021805$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
186265367$18626536$7$F$20201124$20240828$20201217$20240902$EXP$$CA-SA-2020SA358807$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240902$$MD$CA$CA
186272525$18627252$5$F$$20240828$20201217$20240912$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR247241$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$CA$CA
1862735819$18627358$19$F$20210101$20230707$20201217$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR247183$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
1862820742$18628207$42$F$20201209$20240911$20201217$20240917$EXP$$IE-SHIRE-IE202027135$TAKEDA$$14$YR$$M$Y$$$20240917$$HP$IE$IE
186285002$18628500$2$F$$20240926$20201217$20240930$EXP$$DE-AMGEN-DEUSP2020203664$AMGEN$$57$YR$A$F$Y$79$KG$20240929$$MD$DE$DE
186287975$18628797$5$F$20240101$20240819$20201217$20240821$EXP$$US-PFIZER INC-2020497098$PFIZER$$70$YR$$F$Y$$$20240821$$HP$US$US
186288314$18628831$4$F$$20240820$20201217$20240822$PER$$US-PFIZER INC-2020496364$PFIZER$$70$YR$$M$Y$$$20240822$$CN$US$US
186292478$18629247$8$F$20030101$20240702$20201217$20240703$EXP$$US-PURDUE-USA-2020-0155477$PURDUE$$$$$F$Y$$$20240703$$CN$US$US
186297226$18629722$6$F$20201021$20240923$20201217$20240926$EXP$$US-TAKEDA-2020TUS057728$TAKEDA$$48$YR$$M$Y$103.86$KG$20240926$$CN$US$US
186298839$18629883$9$F$20221015$20240805$20201217$20240808$EXP$$US-TAKEDA-US202015957$TAKEDA$$50$YR$$F$Y$136$KG$20240808$$HP$US$US
1863126613$18631266$13$F$20200701$20240913$20201217$20240918$EXP$$US-JAZZ-2020-US-017060$JAZZ$$17$YR$$M$Y$54.9$KG$20240918$$MD$US$US
186325357$18632535$7$F$20200701$20240627$20201218$20240703$EXP$$NVSJ2020JP007185$NOVARTIS$$24$YR$$M$Y$$$20240703$$MD$JP$JP
186326135$18632613$5$F$20200101$20240904$20201218$20240913$EXP$$ES-AUROBINDO-AUR-APL-2020-061616$AUROBINDO$Machado M.. Invasive Pulmonary Aspergillosis in the COVID?19 era: An expected new entity.. Mycosis. 2020$60$YR$$F$Y$$$20240913$$MD$ES$ES
186326914$18632691$4$F$20201201$20240910$20201218$20240913$EXP$$US-TAKEDA-2017BLT001264$TAKEDA$$76$YR$$F$Y$$$20240913$$CN$US$US
186328459$18632845$9$F$20180523$20240729$20201218$20240731$EXP$$CA-TAKEDA-2018TUS012993$TAKEDA$$66$YR$$F$Y$$$20240731$$CN$CA$CA
1863471510$18634715$10$F$$20240805$20201218$20240809$PER$$US-AMGEN-USASP2020205421$AMGEN$$58$YR$A$M$Y$$$20240809$$MD$US$US
1863510010$18635100$10$F$$20240909$20201218$20240913$EXP$$CA-BAYER-2020-272491$BAYER$$65$YR$E$F$Y$69$KG$20240913$$HP$CA$CA
186358228$18635822$8$F$20211025$20240911$20201218$20240916$EXP$$CO-TAKEDA-CO202012596$TAKEDA$$57$YR$$M$Y$92$KG$20240916$$CN$CO$CO
186360984$18636098$4$F$$20240924$20201218$20240930$EXP$$CZ-MYLANLABS-2020M1103086$MYLAN$Kultan J.. Persistent effect of nivolumab even after cessation of treatment due to comorbidity.. Pharmacotherapy. 2020;16(5):654-657$67$YR$$M$Y$$$20240930$$HP$CZ$CZ
186365146$18636514$6$F$19920101$20240702$20201218$20240710$EXP$$US-PURDUE-USA-2020-0162680$PURDUE$$$$$M$Y$$$20240708$$LW$US$US
186365463$18636546$3$F$$20240701$20201218$20240703$EXP$$US-PURDUE-USA-2020-0173473$PURDUE$$$$$M$Y$$$20240703$$CN$US$US
1863662011$18636620$11$F$20201210$20240919$20201218$20240927$EXP$$US-TAKEDA-2020TUS058279$TAKEDA$$70$YR$$F$Y$74$KG$20240927$$HP$US$US
186367558$18636755$8$F$20210201$20240815$20201218$20240819$EXP$$US-SHIRE-US202028883$TAKEDA$$19$YR$$M$Y$$$20240819$$CN$US$US
1863809511$18638095$11$F$20190307$20240905$20201219$20240910$EXP$$US-TAKEDA-US202021642$TAKEDA$$82$YR$$F$Y$62$KG$20240910$$HP$US$US
1863828922$18638289$22$F$20200201$20240806$20201219$20240814$EXP$$CA-ROCHE-2714909$ROCHE$$40$YR$A$F$Y$$$20240814$$CN$CA$CA
1863860015$18638600$15$F$20191201$20240725$20201219$20240730$EXP$$CA-SHIRE-CA202019771$TAKEDA$$59$YR$$F$Y$$$20240730$$MD$CA$CA
186387352$18638735$2$F$$20240731$20201218$20240802$PER$$US-PFIZER INC-2020499263$PFIZER$$41$YR$$F$Y$$$20240802$$HP$US$US
186389765$18638976$5$F$20240101$20240912$20201218$20240917$PER$$US-PFIZER INC-2020500490$PFIZER$$65$YR$$F$Y$$$20240917$$CN$US$US
1863912217$18639122$17$F$20201214$20240704$20201218$20240712$EXP$$CA-ROCHE-2733115$ROCHE$$31$YR$A$M$Y$$$20240712$$CN$CA$CA
1863939814$18639398$14$F$$20240822$20201219$20240827$EXP$$US-TAKEDA-US201914260$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
186414853$18641485$3$F$20201110$20240814$20201221$20240822$EXP$$IT-EMD Serono-E2B_90081683$EMD SERONO INC$$45$YR$A$F$Y$90$KG$20240822$$MD$IT$IT
186424235$18642423$5$F$20200101$20240813$20201221$20240821$PER$$US-VERTEX PHARMACEUTICALS-2020-024763$VERTEX$$$$$M$Y$$$20240821$$MD$US$US
1864246717$18642467$17$F$20171113$20240729$20201221$20240803$EXP$$US-ROCHE-2734283$ROCHE$$62$YR$A$F$Y$70.31$KG$20240803$$MD$US$US
186430704$18643070$4$F$$20240813$20201221$20240814$PER$$US-PFIZER INC-2020499660$PFIZER$$65$YR$$M$Y$$$20240814$$CN$US$US
186431833$18643183$3$F$20201211$20240801$20201221$20240802$EXP$$FR-PFIZER INC-2020501841$PFIZER$$34$YR$$M$Y$90$KG$20240802$$MD$FR$FR
1864346616$18643466$16$F$20200101$20240919$20201221$20240924$EXP$$CA-PFIZER INC-2020498436$PFIZER$$68$YR$$M$Y$96$KG$20240924$$MD$CA$CA
186438763$18643876$3$F$$20240911$20201221$20240916$EXP$$GR-MYLANLABS-2020M1099179$MYLAN$Thomopoulou K, Sotiropoulos G, Manolakou S,. Complete pathological response (pcr) in patient with metastatic brca + pancreatic cancer following maintenance therapy with olaparib AA35.. 5th HELLENIC ONCOLOGY CONGRESS. 2020;29$39$YR$$F$Y$$$20240916$$MD$GR$GR
186449623$18644962$3$F$20220101$20240724$20201221$20240726$EXP$$US-PFIZER INC-2020500914$PFIZER$$70$YR$$F$Y$$$20240726$$CN$US$US
186451263$18645126$3$F$$20240724$20201221$20240730$PER$$US-PFIZER INC-2020503956$PFIZER$$58$YR$$F$Y$14.512$KG$20240730$$HP$US$US
186458132$18645813$2$F$$20240814$20201222$20240829$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-271954$RANBAXY$Schinz K, Waldfahrer F, Wust W, Iro H. Agranulocytosis after use of metamizole - An underestimated risk?. Laryngorhinootologie. 2020;99(10):707-712$43$YR$$M$Y$$$20240829$$MD$DE$DE
1864613334$18646133$34$F$20201101$20240828$20201222$20240906$EXP$$CA-CELLTRION INC.-2020CA034249$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
186464857$18646485$7$F$20201130$20240712$20201222$20240723$EXP$$ES-AUROBINDO-AUR-APL-2020-062008$AUROBINDO$Fernandez-Rubio B, Luque-Marquez R, Gil-Navarro MV. Probable ertapenem-induced encephalopathy; case report and suggested alternatives for chronic prostatitis. DARU, Journal of Pharmaceutical Sciences. 2022;30(1):159-163$64$YR$$M$Y$$$20240723$$PH$ES$ES
186470968$18647096$8$F$20201211$20240820$20201222$20240823$EXP$$CH-AMGEN-CHENI2020206731$AMGEN$$75$YR$E$M$Y$$$20240822$$MD$CH$CH
186486752$18648675$2$F$20200101$20240903$20201222$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-003935$ACADIA PHARMACEUTICALS$$$$$M$Y$77$KG$20240913$$CN$US$US
1864876413$18648764$13$F$20201001$20220519$20201222$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR250602$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
186493304$18649330$4$F$20200930$20240704$20201222$20240711$EXP$$BE-PFIZER INC-2020495765$PFIZER$$59$YR$$M$Y$88$KG$20240711$$MD$BE$BE
186495008$18649500$8$F$20201001$20240820$20201222$20240822$EXP$$CA-PFIZER INC-2020400825$PFIZER$$49$YR$$M$Y$$$20240822$$HP$CA$CA
186496738$18649673$8$F$$20240910$20201222$20240912$PER$$US-PFIZER INC-2020503896$PFIZER$$71$YR$$F$Y$97.959$KG$20240912$$CN$US$US
186497819$18649781$9$F$20201211$20240807$20201222$20240902$PER$$CA-TOLMAR, INC.-20CA024512$TOLMAR$$79$YR$$M$Y$$$20240902$$CN$CA$CA
1864985710$18649857$10$F$20200101$20240716$20201222$20240718$PER$$US-PFIZER INC-2020501195$PFIZER$$61$YR$$F$Y$92$KG$20240718$$HP$US$US
1865004111$18650041$11$F$20210114$20240903$20201222$20240905$EXP$$NVSC2020CA270252$NOVARTIS$$48$YR$$F$Y$43$KG$20240905$$CN$CA$CA
1865144314$18651443$14$F$20201201$20220812$20201223$20240925$EXP$$US-GLAXOSMITHKLINE-US2020AMR248245$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
186525394$18652539$4$F$20201105$20240704$20201223$20240708$EXP$$IT-ROCHE-2738504$ROCHE$$35$YR$A$F$Y$$$20240708$$MD$IT$IT
186526788$18652678$8$F$20201110$20240826$20201223$20240903$EXP$$NVSC2020BR338119$NOVARTIS$$58$YR$$F$Y$$$20240903$$CN$BR$BR
1865288113$18652881$13$F$20201208$20240822$20201223$20240827$EXP$$US-TAKEDA-2020TUS057536$TAKEDA$$65$YR$$F$Y$93$KG$20240827$$HP$US$US
186531425$18653142$5$F$20220718$20240722$20201222$20240731$PER$$US-SA-2020SA365659$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240731$$MD$US$US
186536613$18653661$3$F$20231025$20240829$20201223$20240904$EXP$$US-TAKEDA-2019TUS067495$TAKEDA$$78$YR$$F$Y$$$20240904$$HP$US$US
186536659$18653665$9$F$20190801$20240916$20201223$20240923$EXP$$CA-TAKEDA-2020TUS058939$TAKEDA$$64$YR$$M$Y$$$20240923$$CN$CA$CA
186536724$18653672$4$F$20201209$20240729$20201223$20240802$EXP$$US-TAKEDA-US202025953$TAKEDA$$71$YR$$M$Y$$$20240802$$CN$US$US
1865437715$18654377$15$F$20161003$20240910$20201223$20240917$EXP$$CA-TAKEDA-2020TUS032477$TAKEDA$$36$YR$$F$Y$$$20240917$$HP$CA$CA
186549125$18654912$5$F$20201101$20240802$20201223$20240808$EXP$$DE-PFIZER INC-2020500113$PFIZER$$71$YR$$F$Y$56$KG$20240808$$MD$DE$DE
186550142$18655014$2$F$$20240908$20201223$20240912$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202012010818$ELI LILLY AND CO$Komoriya K, et al..Refractory cardiogenic shock due to atomoxetine overdose rescued by venoarterial extracorporeal membrane oxygenation: A case report..Acute Medicine and Surgery 2024;11(1):.$30$YR$A$M$Y$$$20240912$$MD$JP$JP
1865580311$18655803$11$F$20170516$20240812$20201223$20240815$EXP$$CA-TAKEDA-2020TUS010309$TAKEDA$$68$YR$$M$Y$$$20240815$$MD$CA$CA
186561776$18656177$6$F$20201202$20240910$20201223$20240916$EXP$$US-TAKEDA-2020TUS058075$TAKEDA$$69$YR$$M$Y$106$KG$20240916$$MD$US$US
1865739113$18657391$13$F$$20240108$20201224$20240926$EXP$$US-GLAXOSMITHKLINE-US2020AMR251355$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
186575067$18657506$7$F$20211221$20220209$20201224$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR248442$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240925$$CN$US$US
186575104$18657510$4$F$20201201$20240712$20201224$20240722$EXP$$DE-ESPERIONTHERAPEUTICS-2020DEU05103$ESPERION THERAPEUTICS$$69$YR$$M$Y$90$KG$20240722$$MD$DE$DE
186585637$18658563$7$F$20070101$20240628$20201224$20240703$EXP$$JP-ABBVIE-19P-087-2676492-00$ABBVIE$$55$YR$$M$Y$$$20240703$$MD$JP$JP
186586092$18658609$2$F$20240612$20240716$20201223$20240717$PER$$US-TAKEDA-2020TUS058364$TAKEDA$$37$YR$$F$Y$$$20240717$$CN$US$US
1865915712$18659157$12$F$20200515$20240806$20201224$20240812$EXP$$IE-SHIRE-IE202016730$TAKEDA$$53$YR$$F$Y$$$20240812$$CN$IE$IE
1866029512$18660295$12$F$$20240723$20201224$20240729$EXP$$US-TAKEDA-2018TUS000519$TAKEDA$$$$$M$Y$$$20240729$$CN$US$US
1866069816$18660698$16$F$20200811$20240806$20201223$20240810$EXP$$CA-ROCHE-2659032$ROCHE$$45$YR$A$F$Y$$$20240810$$CN$CA$CA
186615254$18661525$4$F$20200601$20240724$20201224$20240725$EXP$$US-TAKEDA-US201846381$TAKEDA$$16$YR$$M$Y$$$20240725$$CN$US$US
1866164815$18661648$15$F$20200903$20240815$20201224$20240819$EXP$$CA-TAKEDA-2020TUS037954$TAKEDA$$60$YR$$F$Y$$$20240819$$HP$CA$CA
1866191515$18661915$15$F$20201115$20240918$20201224$20240923$EXP$$US-TAKEDA-2020TUS059128$TAKEDA$$28$YR$$M$Y$$$20240923$$PH$US$US
1866192415$18661924$15$F$20201217$20240903$20201224$20240909$EXP$$CA-TAKEDA-2020TUS058530$TAKEDA$$58$YR$$F$Y$$$20240909$$HP$CA$CA
186619589$18661958$9$F$20190601$20240723$20201224$20240725$EXP$$CA-TAKEDA-2019TUS035223$TAKEDA$$79$YR$$F$Y$$$20240725$$CN$CA$CA
186619704$18661970$4$F$$20240819$20201224$20240827$EXP$$US-TAKEDA-US202003397$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
1866197311$18661973$11$F$20200529$20240809$20201224$20240815$EXP$$US-SHIRE-US202012390AA$TAKEDA$$63$YR$$F$Y$65$KG$20240815$$HP$US$US
186619908$18661990$8$F$20201209$20240906$20201224$20240911$EXP$$US-TAKEDA-2020TUS057221$TAKEDA$$25$YR$$F$Y$90.24$KG$20240911$$CN$US$US
186619922$18661992$2$F$$20240726$20201224$20240731$EXP$$US-TAKEDA-2020TUS058990$TAKEDA$$$$$F$Y$$$20240731$$CN$US$US
1866292112$18662921$12$F$$20240717$20201224$20240724$EXP$$US-SHIRE-US202023967$TAKEDA$$$$$F$Y$$$20240724$$HP$US$US
1866341819$18663418$19$F$20201210$20240912$20201224$20240921$EXP$$US-SHIRE-US202021955$TAKEDA$$72$YR$$F$Y$71$KG$20240921$$MD$US$US
1866361822$18663618$22$F$20220309$20240720$20201224$20240724$EXP$$AU-TAKEDA-2020TUS048549$TAKEDA$$34$YR$$F$Y$$$20240724$$PH$AU$AU
1866462911$18664629$11$F$20210101$20220818$20201225$20240926$PER$$US-GLAXOSMITHKLINE-US2020AMR252197$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240926$$CN$US$US
1866505575$18665055$75$F$20201215$20240905$20201225$20240912$EXP$$IE-TAKEDA-IE202033806$TAKEDA$$18$YR$$M$Y$$$20240912$$HP$IE$IE
1866513127$18665131$27$F$20200319$20240910$20201225$20240913$EXP$$CO-TAKEDA-CO202010107$TAKEDA$$58$YR$$M$Y$82$KG$20240913$$CN$CO$CO
186652112$18665211$2$F$$20240328$20201225$20240801$EXP$GB-VELOXIS PHARMACEUTICALS-2020VELGB-000761$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2020-05381$ALKEM$Vergidis P, Rao A, Moore CB, Rautemaa-Richardson R, Sweeney LC, Morton M et.al.. Talaromycosis in a Renal Transplant Recipient Returning from South China. Transplant infectious disease: an official journal of the Transplantation Soci. 2020;Unk:e13447$53$YR$$F$Y$$$20240801$$MD$US$US
186652608$18665260$8$F$20200101$20240725$20201225$20240730$EXP$$JP-ABBVIE-20K-087-3680494-00$ABBVIE$$67$YR$$F$Y$$$20240730$$MD$JP$JP
186653186$18665318$6$F$20170801$20240709$20201225$20240711$EXP$$CA-TAKEDA-2017TUS016367$TAKEDA$$63$YR$$F$Y$$$20240711$$MD$CA$CA
1866546153$18665461$53$F$20200601$20240916$20201225$20240925$EXP$$CA-CELLTRION INC.-2019CA028595$CELLTRION$$$$$$Y$$$20240925$$MD$CA$CA
1866576535$18665765$35$F$20190101$20240918$20201226$20240927$EXP$$CA-CELLTRION INC.-2019CA022652$CELLTRION$$$$$$Y$$$20240927$$CN$CA$CA
1866590811$18665908$11$F$20201205$20240822$20201226$20240828$EXP$$DE-TAKEDA-2020TUS058318$TAKEDA$$36$YR$$M$Y$$$20240828$$HP$DE$DE
186662302$18666230$2$F$20200225$20240812$20201226$20240812$EXP$IT-MINISAL02-638110$NVSC2020IT277307$NOVARTIS$$32$YR$$F$Y$$$20240812$$MD$IT$IT
186670542$18667054$2$F$$20240906$20201228$20240919$EXP$$US-GLENMARK PHARMACEUTICALS-2020GMK051029$GLENMARK$Pacholec M, Sami F, Newell K, el Atrouni W.. Fatal disseminated Mycobacterium haemophilum infection involving the central nervous system in a renal transplant recipient.. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.. 2020;21$$$$$Y$$$20240919$$MD$US$US
1866706711$18667067$11$F$20160901$20240731$20201228$20240813$EXP$$FR-AUROBINDO-AUR-APL-2020-063076$AUROBINDO$$34$YR$$M$Y$79$KG$20240813$$HP$FR$FR
186682322$18668232$2$F$$20240816$20201228$20240828$EXP$$FR-AUROBINDO-AUR-APL-2020-063559$AUROBINDO$Vidil F.. Myositis case during chemotherapy with docetaxel. Abstracts - Discussed Posters 2017. Societe Francaise de Pharmacologie et de Therapeutique. 2017;(SUPPL.1) 21-5:31-31$43$YR$$M$Y$$$20240828$$HP$FR$FR
186686645$18668664$5$F$20201030$20240822$20201228$20240829$EXP$$US-GLAXOSMITHKLINE-US2020252589$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$HP$US$US
186687846$18668784$6$F$20201116$20240819$20201228$20240827$EXP$$US-ROCHE-2351904$ROCHE$$66$YR$E$F$Y$78.47$KG$20240827$$CN$US$US
1867046617$18670466$17$F$20201207$20240924$20201228$20240930$EXP$$US-TAKEDA-2020TUS060726$TAKEDA$$38$YR$$F$Y$85$KG$20240930$$HP$US$US
1867055932$18670559$32$F$20191212$20240617$20201228$20240701$EXP$$US-SHIRE-US201939853$TAKEDA$$39$YR$$F$Y$57$KG$20240701$$HP$US$US
186706659$18670665$9$F$20211023$20240911$20201228$20240912$EXP$$US-TAKEDA-US202032714$TAKEDA$$68$YR$$F$Y$$$20240912$$HP$US$US
186711064$18671106$4$F$20201207$20240829$20201228$20240904$PER$$US-PFIZER INC-2020506560$PFIZER$$65$YR$$F$Y$74.84$KG$20240904$$CN$US$US
186713997$18671399$7$F$$20240701$20201228$20240709$PER$$US-AMGEN-USASP2020211280$AMGEN$$69$YR$E$F$Y$$$20240708$$MD$US$US
1867141036$18671410$36$F$20190101$20240813$20201228$20240819$EXP$$CA-SHIRE-CA201926779$TAKEDA$$$$$F$Y$48$KG$20240819$$CN$CA$CA
1867142817$18671428$17$F$20210602$20240711$20201228$20240715$EXP$$US-TAKEDA-US202008057$TAKEDA$$55$YR$$F$Y$77$KG$20240715$$CN$US$US
186715996$18671599$6$F$20200101$20240909$20201229$20240927$PER$$AU-TOLMAR, INC.-20AU024375$TOLMAR$$$$$M$Y$$$20240927$$HP$AU$AU
186716164$18671616$4$F$20201001$20240904$20201229$20240912$PER$$US-SA-2020SA372767$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240912$$MD$US$US
186716615$18671661$5$F$$20240906$20201228$20240911$EXP$$US-GILEAD-2020-0510520$GILEAD$$62$YR$A$M$Y$$$20240911$$MD$US$US
186730358$18673035$8$F$20201202$20240816$20201229$20240827$EXP$$DE-ROCHE-2736178$ROCHE$$28$YR$A$F$Y$90$KG$20240827$$CN$DE$DE
186735897$18673589$7$F$$20240701$20201228$20240703$PER$$US-PFIZER INC-2020512249$PFIZER$$69$YR$$F$Y$$$20240703$$MD$US$US
186748797$18674879$7$F$20201015$20240830$20201229$20240904$EXP$$NVSC2020DE281312$NOVARTIS$$$$E$F$Y$57$KG$20240904$$MD$DE$DE
186755074$18675507$4$F$20220912$20240822$20201229$20240827$EXP$$US-TAKEDA-2020TUS060391$TAKEDA$$64$YR$$F$Y$86$KG$20240827$$HP$US$US
186755807$18675580$7$F$20230613$20240918$20201229$20240927$PER$$NVSC2020US338072$NOVARTIS$$53$YR$$M$Y$83.9$KG$20240927$$HP$US$US
186765119$18676511$9$F$20181024$20240729$20201229$20240805$EXP$$CA-TAKEDA-2018TUS032445$TAKEDA$$18$YR$$F$Y$$$20240805$$CN$CA$CA
186772116$18677211$6$F$20201112$20240813$20201229$20240820$EXP$$US-TAKEDA-2020TUS060851$TAKEDA$$61$YR$$M$Y$66.213$KG$20240820$$HP$US$US
1867731615$18677316$15$F$20200418$20240911$20201229$20240917$EXP$$CA-TAKEDA-2019TUS064338$TAKEDA$$69$YR$$M$Y$$$20240917$$CN$CA$CA
1867761920$18677619$20$F$20200101$20240819$20201229$20240822$EXP$$CA-PFIZER INC-2020389269$PFIZER$$32$YR$$F$Y$75.3$KG$20240822$$CN$CA$CA
186819832$18681983$2$F$$20240708$20201229$20240710$EXP$$US-PURDUE-USA-2020-0189697$PURDUE$$$$E$F$Y$$$20240710$$LW$US$US
1868230124$18682301$24$F$20200918$20240909$20201230$20240917$EXP$$CA-CELLTRION INC.-2020CA028228$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
1868432918$18684329$18$F$20201201$20240816$20201230$20240822$PER$$US-PFIZER INC-2020518241$PFIZER$$69$YR$$F$Y$72.562$KG$20240822$$HP$US$US
186844126$18684412$6$F$20191223$20240919$20201230$20240920$EXP$$US-PURDUE-USA-2020-0194162$PURDUE$$20$YR$$F$Y$$$20240920$$CN$US$US
186846302$18684630$2$F$$20240711$20201230$20240712$EXP$$JP-TAKEDA-2020TJP027817$TAKEDA$$$$$$Y$$$20240712$$MD$JP$JP
1868479619$18684796$19$F$20201101$20240902$20201230$20240904$EXP$$CA-TAKEDA-2020TUS027791$TAKEDA$$30$YR$$F$Y$$$20240904$$HP$CA$CA
1868485014$18684850$14$F$$20220831$20201230$20240925$PER$$US-GLAXOSMITHKLINE-US2020AMR253181$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
1868589925$18685899$25$F$20201101$20240802$20201231$20240810$EXP$$CA-CELLTRION INC.-2020CA025431$CELLTRION$$$$$$Y$$$20240810$$CN$CA$CA
186861234$18686123$4$F$$20240910$20201231$20240914$EXP$$GR-ROCHE-2740022$ROCHE$Papageorgiou G, Tsakatikas SA, Fioretzaki RG, Kosmas C. Notable response of a young adult with recurrent glioblastoma multiforme to vincristine-irinotecan-temozolomide and bevacizumab. Anti-cancer drugs 2020;:1-7.$28$YR$A$M$Y$$$20240914$$MD$GR$GR
186880209$18688020$9$F$20190704$20240729$20201231$20240801$EXP$$CA-TAKEDA-2019TUS039915$TAKEDA$$62$YR$$F$Y$$$20240801$$CN$CA$CA
1868824761$18688247$61$F$20210320$20240822$20201231$20240828$EXP$$US-TAKEDA-US202009233$TAKEDA$$62$YR$$F$Y$$$20240828$$HP$US$US
1868824813$18688248$13$F$20200806$20240829$20201231$20240906$EXP$$CA-TAKEDA-CA202030682$TAKEDA$$56$YR$$F$Y$$$20240906$$CN$CA$CA
186884686$18688468$6$F$20201224$20240827$20201231$20240830$EXP$$US-TAKEDA-2020TUS061124$TAKEDA$$84$YR$$F$Y$58$KG$20240830$$HP$US$US
186885643$18688564$3$F$20240101$20240801$20201231$20240808$PER$$US-BIOGEN-2020BI00961509$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
1868882814$18688828$14$F$20200101$20240920$20201231$20240927$EXP$$CA-TAKEDA-2020TUS028430$TAKEDA$$$$$F$Y$$$20240927$$HP$CA$CA
1868908510$18689085$10$F$20201219$20240730$20201231$20240805$EXP$$CO-TAKEDA-2020TUS061454$TAKEDA$$37$YR$$M$Y$72$KG$20240805$$CN$CO$CO
186891973$18689197$3$F$20201113$20240917$20201231$20240927$EXP$PT-INFARMED-T202012-234$PT-ELI_LILLY_AND_COMPANY-PT202012011694$ELI LILLY AND CO$$65$YR$E$F$Y$44$KG$20240927$$CN$PT$PT
186892318$18689231$8$F$20201201$20240716$20201231$20240718$EXP$ES-AEMPS-705027$ES-009507513-2012ESP012464$MERCK$Fernandez-Rubio B, Luque-Marquez R, Gil-Navarro M. Probable ertapenem-induced encephalopathy; case report and suggested alternatives for chronic prostatitis. DARU, Journal of Pharmaceutical Sciences. 2022$64$YR$$M$Y$$$20240718$$HP$ES$ES
1868930516$18689305$16$F$20201219$20240717$20201231$20240722$EXP$$CO-TAKEDA-2020TUS061421$TAKEDA$$26$YR$$F$Y$49$KG$20240722$$CN$CO$CO
186895198$18689519$8$F$20201113$20240916$20201231$20240921$EXP$$IE-TAKEDA-2020TUS051220$TAKEDA$$58$YR$$F$Y$$$20240921$$CN$IE$IE
186900483$18690048$3$F$$20240821$20201231$20240823$EXP$$US-PURDUE-USA-2020-0159684$PURDUE$$$$$M$Y$$$20240823$$CN$US$US
186906826$18690682$6$F$$20240916$20210101$20240920$EXP$$US-TAKEDA-2020TUS052251$TAKEDA$$$$$F$Y$$$20240920$$MD$US$US
1869090511$18690905$11$F$20240530$20240830$20210101$20240903$EXP$$US-TAKEDA-US202004681$TAKEDA$$54$YR$$F$Y$104$KG$20240903$$HP$US$US
1869091441$18690914$41$F$20210109$20240704$20210101$20240710$EXP$$CO-TAKEDA-CO201939388$TAKEDA$$56$YR$$F$Y$63$KG$20240710$$CN$CO$CO
1869091516$18690915$16$F$20240916$20240916$20210101$20240920$EXP$$US-TAKEDA-US201931832$TAKEDA$$60$YR$$F$Y$104$KG$20240920$$CN$US$US
1869096215$18690962$15$F$$20240910$20210101$20240920$EXP$E2B_03301666$CA-Accord-212773$ACCORD$$80$YR$E$M$Y$89$KG$20240920$$CN$CA$CA
186911198$18691119$8$F$$20240917$20210101$20240918$EXP$$US-TAKEDA-US202027920$TAKEDA$$$$$F$Y$$$20240918$$CN$US$US
1869136744$18691367$44$F$20200802$20240814$20210101$20240820$EXP$$CO-TAKEDA-CO202025830$TAKEDA$$18$YR$$F$Y$59$KG$20240820$$CN$CO$CO
1869161829$18691618$29$F$20200101$20240815$20210101$20240822$EXP$$CA-CELLTRION INC.-2019CA028209$CELLTRION$$$$$$Y$$$20240823$$MD$CA$CA
1869188846$18691888$46$F$20201126$20240809$20210102$20240817$EXP$$CA-CELLTRION INC.-2020CA033045$CELLTRION$$$$$$Y$$$20240817$$MD$CA$CA
186929352$18692935$2$F$20240101$20240621$20210104$20240705$PER$$US-SA-2020SA375232$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240705$$MD$US$US
186948303$18694830$3$F$$20240619$20210104$20240701$EXP$$CZ-PFIZER INC-2020507604$Haleon PLC$Chabova VC. Drug-induced kidney injury. Aktuality v Nefrologii. 2020;26(4):134-8.; Chabova VC. Drug-induced kidney injury. Aktuality v Nefrologii. 2020;26(4):134-8.$33$YR$$F$Y$$$20240626$$MD$CZ$CZ
1869533617$18695336$17$F$20210101$20240726$20210104$20240729$EXP$$US-PFIZER INC-2020490394$PFIZER$$84$YR$$F$Y$$$20240729$$MD$US$US
186955873$18695587$3$F$20201124$20240823$20210104$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2020-AMRX-03879$AMNEAL$$35$YR$$F$Y$119.73$KG$20240904$$MD$US$US
186957105$18695710$5$F$20200301$20240703$20210104$20240705$EXP$$US-PFIZER INC-2020518930$PFIZER$$61$YR$$F$Y$90.72$KG$20240705$$HP$US$US
186957132$18695713$2$F$$20240819$20210104$20240821$PER$$US-PFIZER INC-2020517646$PFIZER$$71$YR$$F$Y$$$20240821$$CN$US$US
1869576312$18695763$12$F$20190724$20240923$20210104$20240930$EXP$$CA-TAKEDA-2018TUS030456$TAKEDA$$62$YR$$M$Y$$$20240930$$HP$CA$CA
186973583$18697358$3$F$20201201$20240829$20210104$20240910$EXP$$US-NOVOPROD-777569$NOVO NORDISK$$$$E$F$Y$$$20240910$$CN$US$US
186980846$18698084$6$F$20201123$20240819$20210105$20240829$EXP$$DE-ROCHE-2741839$ROCHE$$39$YR$A$F$Y$60$KG$20240829$$MD$DE$DE
186983158$18698315$8$F$$20240912$20210104$20240914$EXP$$US-TAKEDA-US202024754$TAKEDA$$$$$F$Y$67$KG$20240914$$HP$US$US
186992742$18699274$2$F$20201103$20240710$20210105$20240718$PER$$US-SA-2020SA373809$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240718$$CN$US$US
187003432$18700343$2$F$$20240816$20210105$20240828$PER$$US-SA-2020SA373855$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240828$$MD$US$US
1870116811$18701168$11$F$20180517$20240808$20210105$20240813$EXP$$DE-ROCHE-2135208$ROCHE$$46$YR$A$F$Y$$$20240813$$CN$DE$DE
1870198615$18701986$15$F$20201001$20240916$20210105$20240924$EXP$$CA-SHIRE-CA202014144$TAKEDA$$62$YR$$F$Y$$$20240924$$CN$CA$CA
187022212$18702221$2$F$20240705$20240705$20210105$20240723$PER$$CA-TOLMAR, INC.-20CA024671$TOLMAR$$82$YR$$M$Y$$$20240722$$CN$CA$CA
1870317317$18703173$17$F$20180205$20240918$20210105$20240925$EXP$$US-TAKEDA-US202022132$TAKEDA$$51$YR$$M$Y$46$KG$20240925$$HP$US$US
1870365589$18703655$89$F$20191201$20240828$20210105$20240903$EXP$$MX-TAKEDA-2020TUS061520$TAKEDA$$8$YR$$M$Y$23$KG$20240903$$CN$MX$MX
187050825$18705082$5$F$$20240923$20210106$20240927$EXP$$CA-JNJFOC-20210102771$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240927$$CN$CA$CA
187051562$18705156$2$F$20240101$20240710$20210106$20240717$PER$$US-SA-2021SA003150$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240717$$MD$US$US
1870665214$18706652$14$F$20200714$20240620$20210106$20240702$EXP$$JP-ABBVIE-21K-087-3718106-00$ABBVIE$$69$YR$$F$Y$60.4$KG$20240702$$MD$JP$JP
1870680413$18706804$13$F$20150420$20240727$20210106$20240802$EXP$$CO-TAKEDA-CO201503739$TAKEDA$$47$YR$$M$Y$82$KG$20240802$$CN$CO$CO
187069383$18706938$3$F$20200101$20240820$20210106$20240830$PER$$US-SA-2021SA001625$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240830$$MD$US$US
187080703$18708070$3$F$20201223$20240903$20210106$20240920$PER$$CA-TOLMAR, INC.-20CA024665$TOLMAR$$75$YR$$M$Y$$$20240919$$CN$CA$CA
1870849015$18708490$15$F$20201001$20240919$20210106$20240930$EXP$$CA-TAKEDA-2020TUS038843$TAKEDA$$67$YR$$F$Y$$$20240930$$CN$CA$CA
1870871729$18708717$29$F$20220105$20240819$20210106$20240829$EXP$$US-TAKEDA-2021TUS000168$TAKEDA$$49$YR$$F$Y$91$KG$20240829$$HP$US$US
187092845$18709284$5$F$20201015$20240720$20210107$20240731$EXP$$DE-AUROBINDO-AUR-APL-2020-053938$AUROBINDO$$$$E$F$Y$57$KG$20240731$$MD$DE$DE
1871008014$18710080$14$F$20191231$20240802$20210106$20240809$EXP$$CA-CELLTRION INC.-2019CA028148$CELLTRION$$$$$$Y$$$20240809$$HP$CA$CA
187102274$18710227$4$F$20210208$20240801$20210106$20240806$PER$$US-AMGEN-USA-20200310645$AMGEN$$60$YR$A$F$Y$$$20240806$$HP$US$US
187102404$18710240$4$F$20201231$20240823$20210107$20240906$PER$$US-SA-2021SA000869$SANOFI AVENTIS$$15$YR$T$F$Y$45.5$KG$20240906$$MD$US$US
1871051815$18710518$15$F$20190101$20240903$20210107$20240909$EXP$$US-ROCHE-2571657$ROCHE$$52$YR$A$F$Y$125.19$KG$20240910$$CN$US$US
187106702$18710670$2$F$$20240718$20210107$20240726$PER$$US-SA-2021SA004526$SANOFI AVENTIS$$13$YR$T$F$Y$41$KG$20240726$$CN$US$US
187108628$18710862$8$F$20210104$20240822$20210107$20240829$EXP$$AU-ROCHE-2744520$ROCHE$$50$YR$A$F$Y$75$KG$20240829$$PH$AU$AU
1871288936$18712889$36$F$20201221$20240712$20210107$20240717$EXP$$CO-TAKEDA-CO202002296$TAKEDA$$36$YR$$F$Y$89$KG$20240717$$CN$CO$CO
187131872$18713187$2$F$$20240805$20210107$20240807$PER$$US-PFIZER INC-2021008071$PFIZER$$82$YR$$F$Y$$$20240807$$CN$US$US
187133724$18713372$4$F$20210215$20240904$20210107$20240910$EXP$$CA-TAKEDA-2020TUS042779$TAKEDA$$62$YR$$F$Y$$$20240910$$MD$CA$CA
1871424320$18714243$20$F$20201231$20240920$20210107$20240927$EXP$$CO-TAKEDA-2021TUS000680$TAKEDA$$29$YR$$M$Y$77$KG$20240927$$HP$CO$CO
187144048$18714404$8$F$20160916$20240924$20210107$20240930$EXP$$FR-TAKEDA-FR201729634$TAKEDA$$57$YR$$F$Y$58.3$KG$20240930$$HP$FR$FR
1871452230$18714522$30$F$$20240905$20210107$20240913$EXP$$CA-AstraZeneca-2021A001736$ASTRAZENECA$$80$YR$$M$Y$89.3$KG$20240913$$MD$CA$
1871461118$18714611$18$F$20200915$20240806$20210107$20240809$EXP$$CO-TAKEDA-2020TUS039447$TAKEDA$$19$YR$$M$Y$45$KG$20240809$$CN$CO$CO
1871508827$18715088$27$F$20201201$20240822$20210107$20240830$EXP$$CA-CELLTRION INC.-2020CA034916$CELLTRION$$$$$$Y$$$20240830$$PH$CA$CA
187168552$18716855$2$F$20190101$20240801$20210108$20240806$EXP$$CA-TAKEDA-2019TUS012261$TAKEDA$$$$$F$Y$$$20240806$$MD$CA$CA
187169835$18716983$5$F$20200501$20240801$20210108$20240805$PER$$US-PFIZER INC-2021008269$PFIZER$$43$YR$$F$Y$$$20240805$$HP$US$US
187172764$18717276$4$F$20201201$20240712$20210108$20240722$EXP$$DE-PFIZER INC-2021004604$MYLAN$$69$YR$$M$Y$90$KG$20240722$$CN$DE$DE
187177592$18717759$2$F$$20240827$20210108$20240828$EXP$$US-PURDUE PHARMA-USA-2021-0195906$PURDUE$$$$C$M$Y$$$20240828$$CN$US$US
187177622$18717762$2$F$$20240812$20210108$20240818$EXP$$IT-ROCHE-2745339$ROCHE$Quartuccio L, Isola M,Bruno D, Treppo E, Gigante L, Angelotti F, Capecchi R, Vitiello G, Cavallaro E, Tavoni A, Bosello S, Cammelli D, De Vita S and Gremese E Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study. Journal of Translational Autoimmunity 2020 Jan;3:-.$$$$$Y$$$20240819$$HP$IT$IT
187183762$18718376$2$F$20210101$20240917$20210108$20240926$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2021-000003$SK LIFE SCIENCE$$$$$$Y$$$20240926$$CN$US$US
1871840011$18718400$11$F$20201101$20240815$20210108$20240821$EXP$$US-TAKEDA-US202027940$TAKEDA$$14$YR$$M$Y$25$KG$20240821$$HP$US$US
187186837$18718683$7$F$20200718$20240918$20210108$20240921$EXP$$US-TAKEDA-US202024265$TAKEDA$$54$YR$$F$Y$$$20240921$$HP$US$US
187188304$18718830$4$F$$20240809$20210108$20240813$PER$$NVSC2021US000891$NOVARTIS$$67$YR$$F$Y$$$20240813$$CN$US$US
187189592$18718959$2$F$20201001$20201103$20210108$20240723$PER$$US-NOVOPROD-765955$NOVO NORDISK$$70$YR$$F$Y$$$20240723$$CN$US$US
187192145$18719214$5$F$$20240709$20210108$20240712$EXP$$US-JAZZ-2021-US-000140$JAZZ$$$$$F$Y$$$20240712$$CN$US$US
187220488$18722048$8$F$20201012$20240808$20210111$20240821$EXP$$DE-AUROBINDO-AUR-APL-2020-054433$AUROBINDO$$$$A$F$Y$80$KG$20240821$$MD$DE$DE
1872393111$18723931$11$F$20190822$20240829$20210111$20240830$EXP$DE-ROCHE-2464164$DE-ROCHE-2464164$ROCHE$$40$YR$A$F$Y$$$20240830$$CN$DE$DE
1872426638$18724266$38$F$$20240919$20210111$20240930$EXP$$CA-PFIZER INC-2020518156$PFIZER$$80$YR$$M$Y$89$KG$20240930$$CN$CA$CA
1872453813$18724538$13$F$20170101$20240709$20210111$20240710$EXP$$US-PFIZER INC-2021013532$PFIZER$$67$YR$$F$Y$$$20240710$$CN$US$US
1872458610$18724586$10$F$20201124$20240729$20210111$20240802$EXP$GB-ROCHE-2729221$GB-STRIDES ARCOLAB LIMITED-2021SP000146$STRIDES$$72$YR$$F$Y$60$KG$20240802$$MD$GB$GB
187247786$18724778$6$F$20201223$20240916$20210111$20240919$EXP$$US-TAKEDA-2021TUS001156$TAKEDA$$76$YR$$F$Y$$$20240919$$CN$US$US
1872578916$18725789$16$F$$20240725$20210111$20240730$EXP$$US-TAKEDA-US201920473$TAKEDA$$$$$M$Y$$$20240730$$HP$US$US
1872629822$18726298$22$F$$20240813$20210111$20240820$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-074585$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$89$KG$20240820$$HP$CA$CA
1872667523$18726675$23$F$20190530$20240809$20210111$20240816$EXP$$CO-TAKEDA-2019TUS038253$TAKEDA$$39$YR$$M$Y$58$KG$20240816$$CN$CO$CO
1872705430$18727054$30$F$20211004$20240830$20210111$20240905$EXP$$US-SHIRE-US202020662$TAKEDA$$35$YR$$M$Y$$$20240905$$HP$US$US
187276564$18727656$4$F$20201214$20240822$20210111$20240828$EXP$$DE-TAKEDA-2021TUS001377$TAKEDA$$9$DEC$$M$Y$65$KG$20240828$$MD$DE$DE
187279102$18727910$2$F$$20240627$20210111$20240701$PER$$US-PFIZER INC-2021015056$PFIZER$$70$YR$$M$Y$$$20240701$$CN$US$US
1872800017$18728000$17$F$20190528$20220608$20210111$20240821$EXP$$PHHY2019CH227578$NOVARTIS$$52$YR$$F$Y$$$20240821$$MD$CH$CH
187285634$18728563$4$F$20130801$20240905$20210112$20240910$PER$$US-GILEAD-2021-0511444$GILEAD$$32$YR$A$F$Y$$$20240910$$LW$US$US
187297359$18729735$9$F$20171001$20240703$20210112$20240711$EXP$$CA-TAKEDA-2017TUS021176$TAKEDA$$60$YR$$M$Y$94.331$KG$20240711$$CN$CA$CA
187299303$18729930$3$F$20170328$20240909$20210112$20240917$EXP$$CA-TAKEDA-2017TUS005126$TAKEDA$$49$YR$$F$Y$$$20240917$$CN$CA$CA
1873014516$18730145$16$F$20181211$20240926$20210112$20240930$EXP$$CA-TAKEDA-2018TUS028189$TAKEDA$$42$YR$$F$Y$$$20240930$$HP$CA$CA
1873068314$18730683$14$F$20211130$20240828$20210112$20240903$EXP$$CA-TAKEDA-2021TUS001337$TAKEDA$$68$YR$$F$Y$$$20240903$$HP$CA$CA
1873157026$18731570$26$F$$20240812$20210112$20240815$EXP$$US-SHIRE-US202019959$TAKEDA$$$$$F$Y$65$KG$20240815$$CN$US$US
1873183450$18731834$50$F$20200815$20240910$20210112$20240913$EXP$$CO-TAKEDA-CO202027035$TAKEDA$$38$YR$$F$Y$64.85$KG$20240913$$HP$CO$CO
187321527$18732152$7$F$20240703$20240814$20210112$20240815$EXP$$US-TAKEDA-2021TUS001887$TAKEDA$$76$YR$$M$Y$$$20240815$$MD$US$US
187322545$18732254$5$F$$20240806$20210113$20240815$EXP$$CA-JNJFOC-20210112531$JOHNSON AND JOHNSON$$82$YR$E$F$Y$72$KG$20240815$$HP$CA$CA
187323782$18732378$2$F$$20240827$20210113$20240905$EXP$$CA-AUROBINDO-AUR-APL-2021-001139$AUROBINDO$$15$YR$$F$Y$58$KG$20240905$$HP$CA$CA
1873300317$18733003$17$F$20201222$20240827$20210112$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-110813$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$68$KG$20240904$$MD$JP$JP
187332964$18733296$4$F$20201203$20240730$20210113$20240809$EXP$$US-ROCHE-2746397$ROCHE$$42$YR$A$F$Y$$$20240809$$CN$US$US
1873362711$18733627$11$F$$20240827$20210113$20240906$EXP$$CA-AUROBINDO-AUR-APL-2019-090562$AUROBINDO$$43$YR$$F$Y$$$20240906$$MD$CA$CA
187338929$18733892$9$F$$20240726$20210113$20240807$EXP$$CA-AUROBINDO-AUR-APL-2021-000752$AUROBINDO$$45$YR$$F$Y$95$KG$20240807$$HP$CA$CA
187342545$18734254$5$F$20200610$20220830$20210113$20240701$EXP$$CA-AKCEA THERAPEUTICS-2020IS001570$AKCEA THERAPEUTICS$$$$$$Y$$$20240701$$MD$CA$CA
1873576511$18735765$11$F$20210101$20240726$20210113$20240731$EXP$$CA-PFIZER INC-2021018341$PFIZER$$63$YR$$F$Y$102$KG$20240731$$HP$CA$CA
187361904$18736190$4$F$$20240913$20210113$20240916$PER$$US-PFIZER INC-2021020941$PFIZER$$79$YR$$F$Y$$$20240916$$CN$US$US
187364243$18736424$3$F$20210103$20240910$20210113$20240917$EXP$$BR-TAKEDA-2021TUS001784$TAKEDA$$6$YR$$M$Y$24$KG$20240917$$CN$BR$BR
1873688812$18736888$12$F$20220601$20240722$20210113$20240729$EXP$$US-JAZZ-2021-US-000271$JAZZ$$41$YR$$F$Y$$$20240729$$CN$US$US
1873723427$18737234$27$F$20200318$20230914$20210113$20240705$EXP$$NVSC2020MX138107$NOVARTIS$$49$YR$$M$Y$69$KG$20240705$$CN$MX$MX
1873833832$18738338$32$F$20190829$20240913$20210113$20240921$EXP$$CA-CELLTRION INC.-2019CA022284$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
187396767$18739676$7$F$20201017$20240702$20210114$20240708$EXP$$CA-TAKEDA-2021TUS002109$TAKEDA$$58$YR$$M$Y$$$20240708$$CN$CA$CA
1874024447$18740244$47$F$20181217$20240924$20210114$20240927$EXP$$IN-PFIZER INC-2018536543$PFIZER$$62$YR$$F$Y$70$KG$20240927$$CN$IN$IN
187407476$18740747$6$F$$20240716$20210114$20240719$EXP$$US-PFIZER INC-2020496292$PFIZER$$72$YR$$M$Y$$$20240719$$MD$US$US
187411705$18741170$5$F$20210403$20240903$20210114$20240909$EXP$$CA-TAKEDA-2021TUS002277$TAKEDA$$29$YR$$M$Y$$$20240909$$MD$CA$CA
187412234$18741223$4$F$20210401$20240805$20210114$20240812$EXP$$US-GLAXOSMITHKLINE-US2021004416$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
1874201317$18742013$17$F$$20230207$20210114$20240816$EXP$$CA-SA-2021SA006986$SANOFI AVENTIS$$80$YR$E$M$Y$89$KG$20240816$$MD$CA$CA
1874220821$18742208$21$F$20200101$20240920$20210114$20240926$EXP$$CA-BAUSCH-BL-2020-015826$BAUSCH AND LOMB$$63$YR$$F$Y$70.37$KG$20240927$$CN$CA$CA
1874242010$18742420$10$F$$20240911$20210114$20240912$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-075025$BOEHRINGER INGELHEIM$$45$YR$A$F$Y$95$KG$20240912$$HP$CA$CA
1874284616$18742846$16$F$$20240827$20210115$20240905$EXP$$CA-AUROBINDO-AUR-APL-2021-000871$AUROBINDO$$80$YR$$M$Y$89$KG$20240905$$HP$CA$CA
187432702$18743270$2$F$$20240910$20210115$20240919$EXP$$US-AUROBINDO-AUR-APL-2021-001204$AUROBINDO$Cobb WJ. 45-year-old man * fever * generalized rash * recent history of calcaneal osteomyelitis * Dx?. The Journal of Family Practice. 2020;69(7):353-356$45$YR$$M$Y$$$20240919$$MD$US$US
187433292$18743329$2$F$20200101$20201209$20210114$20240717$PER$$US-NOVOPROD-767118$NOVO NORDISK$$83$YR$$M$Y$$$20240717$$CN$US$US
187434603$18743460$3$F$20210101$20240917$20210115$20240922$EXP$$CA-BIOGEN-2021BI00966297$BIOGEN$$$$$F$Y$$$20240922$$CN$CA$CA
1874369218$18743692$18$F$20210601$20240731$20210115$20240809$EXP$$US-SA-2021SA010226$SANOFI AVENTIS$$74$YR$E$M$Y$46$KG$20240809$$MD$US$US
187437253$18743725$3$F$20200101$20210125$20210114$20240717$PER$$US-NOVOPROD-770102$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
187438613$18743861$3$F$20190101$20200626$20210114$20240717$PER$$US-NOVOPROD-738861$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
187444035$18744403$5$F$20181030$20240903$20210115$20240905$EXP$$DE-SHIRE-DE201842690$TAKEDA$$51$YR$$M$Y$$$20240905$$HP$DE$DE
187450578$18745057$8$F$20200821$20240802$20210115$20240806$EXP$$DE-ROCHE-2689159$ROCHE$$56$YR$A$M$Y$$$20240806$$MD$DE$DE
187453178$18745317$8$F$20220101$20240814$20210115$20240903$PER$$CA-TOLMAR, INC.-21CA024842$TOLMAR$$61$YR$$M$Y$$$20240902$$CN$CA$CA
187457167$18745716$7$F$20211201$20220404$20210115$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR002845$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240925$$MD$US$US
1874571713$18745717$13$F$$20220317$20210115$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR008151$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
187461386$18746138$6$F$$20240717$20210115$20240723$EXP$$US-TAKEDA-US202023687$TAKEDA$$$$$F$Y$$$20240723$$HP$US$US
1874633914$18746339$14$F$20191126$20240910$20210115$20240916$EXP$$CA-TAKEDA-2019TUS053737$TAKEDA$$28$YR$$M$Y$$$20240916$$CN$CA$CA
187463712$18746371$2$F$$20240724$20210115$20240726$EXP$$US-SHIRE-US202023860$TAKEDA$$$$$M$Y$$$20240726$$HP$US$US
1874697410$18746974$10$F$20240807$20240826$20210115$20240830$EXP$$BR-TAKEDA-BR202003300$TAKEDA$$12$YR$$M$Y$29$KG$20240830$$CN$BR$BR
187475774$18747577$4$F$20200201$20240802$20210115$20240809$EXP$$NVSC2021BR002584$NOVARTIS$$50$YR$$M$Y$$$20240809$$CN$BR$BR
1874770817$18747708$17$F$20170201$20240627$20210115$20240701$EXP$$CA-TAKEDA-2017TUS005066$TAKEDA$$72$YR$$F$Y$$$20240701$$CN$CA$CA
1874890522$18748905$22$F$20201218$20240826$20210116$20240830$EXP$$CO-TAKEDA-2020TUS038794$TAKEDA$$28$YR$$M$Y$77$KG$20240830$$CN$CO$CO
187490282$18749028$2$F$$20210112$20210116$20240812$EXP$$JP-AMGEN-JPNSP2021006674$AMGEN$$$$$$Y$$$20240812$$MD$JP$JP
1874933717$18749337$17$F$$20240830$20210116$20240904$EXP$$US-TAKEDA-2021TUS002147$TAKEDA$$$$$M$Y$69$KG$20240904$$CN$US$US
1875012810$18750128$10$F$20170412$20240814$20210118$20240819$EXP$$CA-TAKEDA-2017TUS005447$TAKEDA$$61$YR$$F$Y$$$20240819$$CN$CA$CA
187501469$18750146$9$F$20180101$20240628$20210118$20240706$EXP$$CA-TAKEDA-2018TUS029559$TAKEDA$$$$$M$Y$$$20240706$$CN$CA$CA
187503738$18750373$8$F$20201019$20240716$20210118$20240722$EXP$$CA-TAKEDA-2020TUS044847$TAKEDA$$67$YR$$F$Y$87$KG$20240722$$CN$CA$CA
1875076831$18750768$31$F$20180101$20240815$20210118$20240822$EXP$$CA-CELLTRION INC.-2018CA020023$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
187513028$18751302$8$F$20201015$20240708$20210118$20240710$EXP$$BE-ROCHE-2750805$ROCHE$$52$YR$A$M$Y$87$KG$20240710$$MD$BE$BE
187514424$18751442$4$F$$20240715$20210118$20240719$EXP$$US-GW PHARMA-202101USGW00101$JAZZ$$$$$M$Y$53.7$KG$20240719$$HP$US$US
187524308$18752430$8$F$20210107$20240619$20210118$20240710$PER$$CA-TOLMAR, INC.-21CA024848$TOLMAR$$75$YR$$M$Y$$$20240710$$CN$CA$CA
187528372$18752837$2$F$$20240912$20210118$20240916$EXP$$PHHY2018AU056206$NOVARTIS$$$$$M$Y$$$20240916$$MD$AU$AU
1875325824$18753258$24$F$20201211$20240729$20210118$20240805$EXP$$AT-TAKEDA-AT202030896$TAKEDA$$13$YR$$M$Y$31$KG$20240805$$CN$AT$AT
1875334634$18753346$34$F$20200626$20240714$20210118$20240717$EXP$$CA-TAKEDA-CA202021994$TAKEDA$$4$YR$$M$Y$25.7$KG$20240717$$HP$CA$CA
1875349647$18753496$47$F$$20240819$20210118$20240823$EXP$$CA-BAUSCH-BL-2021-001496$BAUSCH AND LOMB$$80$YR$$M$Y$89$KG$20240823$$CN$CA$CA
1875531014$18755310$14$F$20210601$20240722$20210119$20240730$EXP$$US-SHIRE-US202031010$TAKEDA$$64$YR$$F$Y$95$KG$20240730$$MD$US$US
187560892$18756089$2$F$$20240715$20210119$20240722$EXP$$NVSC2021CA008197$NOVARTIS$$44$YR$$M$Y$$$20240722$$CN$CA$CA
1875726511$18757265$11$F$20171208$20240626$20210119$20240702$EXP$$CA-TAKEDA-2018TUS000179$TAKEDA$$55$YR$$M$Y$$$20240702$$CN$CA$CA
1875728413$18757284$13$F$20210106$20240724$20210119$20240812$PER$$CA-TOLMAR, INC.-21CA024821$TOLMAR$$53$YR$$M$Y$$$20240812$$CN$CA$CA
1875810312$18758103$12$F$$20240819$20210119$20240823$EXP$$NVSC2021CA007904$NOVARTIS$$$$$M$Y$$$20240823$$HP$CA$CA
187582085$18758208$5$F$20190802$20240816$20210119$20240823$EXP$$CO-TAKEDA-CO201932344$TAKEDA$$30$YR$$F$Y$80$KG$20240823$$CN$CO$CO
1875952216$18759522$16$F$20210121$20240721$20210119$20240726$EXP$$CA-TAKEDA-CA202029322$TAKEDA$$67$YR$$F$Y$$$20240726$$CN$CA$CA
187609682$18760968$2$F$20210101$20240903$20210120$20240904$EXP$$US-CIPLA (EU) LIMITED-2021US00168$CIPLA$$$$$$Y$$$20240904$$CN$US$US
187621217$18762121$7$F$$20240910$20210120$20240918$EXP$$NVSC2021CA007926$NOVARTIS$$50$YR$$F$Y$$$20240918$$CN$CA$CA
1876283020$18762830$20$F$20200429$20240918$20210120$20240920$EXP$$US-TAKEDA-US202003872$TAKEDA$$57$YR$$F$Y$104$KG$20240920$$CN$US$US
1876408411$18764084$11$F$20211110$20240821$20210120$20240822$EXP$$US-TAKEDA-2021TUS001865$TAKEDA$$58$YR$$F$Y$61$KG$20240822$$MD$US$US
1876419210$18764192$10$F$$20240724$20210120$20240726$EXP$$US-TAKEDA-US202028980$TAKEDA$$$$$F$Y$$$20240726$$HP$US$US
187642006$18764200$6$F$20210101$20240820$20210120$20240826$EXP$$CO-TAKEDA-2021TUS003535$TAKEDA$$68$YR$$F$Y$60$KG$20240826$$CN$CO$CO
187643554$18764355$4$F$$20240702$20210120$20240704$PER$$US-PFIZER INC-2020367760$PFIZER$$76$YR$$M$Y$86.18$KG$20240704$$CN$US$US
187644335$18764433$5$F$20190101$20240626$20210120$20240702$EXP$$BR-BIOMARINAP-BR-2021-134416$BIOMARIN$$$$$$Y$$$20240702$$CN$BR$BR
187646403$18764640$3$F$20200810$20240808$20210120$20240813$EXP$$CA-TAKEDA-2020TUS024632$TAKEDA$$35$YR$$F$Y$$$20240813$$MD$CA$CA
187647005$18764700$5$F$$20240821$20210120$20240828$EXP$$US-TAKEDA-US202032127$TAKEDA$$$$$F$Y$$$20240828$$MD$US$US
187649582$18764958$2$F$$20240613$20210120$20240701$EXP$$JP-TEVA-2021-JP-1871402$TEVA$Yokoyama K, et al. A case of cytomegalovirus retinitis and generalized herpes zoster with persistent lymphopenia after bendamustine administration. The Japanese society of hematology. 2020; vol. 61(10); pp. 1518.; Yokoyama K, et al. A case of cytomegalovirus retinitis and generalized herpes zoster with persistent lymphopenia after bendamustine administration. The Japanese society of hematology. 2020; vol. 61(10); pp. 1518.; Yokoyama K, et al. A case of cytomegalovirus retinitis and generalize...$67$YR$$F$Y$$$20240701$$MD$JP$JP
187649885$18764988$5$F$20210111$20240723$20210121$20240728$EXP$$US-BIOGEN-2021BI00967248$BIOGEN$$58$YR$$F$Y$$$20240728$$CN$US$US
187650842$18765084$2$F$$20240925$20210120$20240927$EXP$$CA-PFIZER INC-2021024007$PFIZER$$70$YR$$M$Y$$$20240927$$CN$CA$CA
187652703$18765270$3$F$20201001$20240722$20210121$20240729$EXP$$US-GLAXOSMITHKLINE-US2021005893$GLAXOSMITHKLINE$$40$YR$$F$Y$55$KG$20240729$$CN$US$US
187659976$18765997$6$F$20221017$20240909$20210121$20240911$EXP$$US-KAMADA LIMITED-2021US000330$TAKEDA$$51$YR$$M$Y$63$KG$20240911$$CN$US$US
1876615413$18766154$13$F$20210110$20220308$20210120$20240926$PER$$US-GLAXOSMITHKLINE-US2021AMR008787$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240926$$CN$US$US
187667882$18766788$2$F$$20240822$20210121$20240905$EXP$DE-MLMSERVICE-20201105-2536298-1$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08351$ALKEM$Ostendorf L, Burns M, Durek P, Heinz GA, et.al.. Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus. New England Journal of Medicine. 2020;383 (12):1149-1155$32$YR$$F$Y$$$20240905$$MD$DE$DE
187667902$18766790$2$F$$20240605$20210121$20240807$EXP$$GR-ALKEM LABORATORIES LIMITED-GR-ALKEM-2020-09001$ALKEM$Toubanakis Ch, Batziou E, Sipsas N, Galanopoluos G, et.al. Acute pancreatitis after long-term therapy with mesalazine, and hyperamylasaemia associated with azathioprine in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol. 2003;15(8):933-4$19$YR$$M$Y$$$20240807$$HP$GR$GR
187670003$18767000$3$F$20201201$20240826$20210121$20240829$EXP$$DE-ROCHE-2754335$ROCHE$$34$YR$A$F$Y$57$KG$20240829$$MD$DE$DE
187675204$18767520$4$F$$20240801$20210121$20240807$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-003999$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$72$KG$20240807$$MD$CA$CA
187680466$18768046$6$F$$20240924$20210121$20240930$EXP$$US-TAKEDA-2021TUS003324$TAKEDA$$$$$F$Y$48$KG$20240930$$MD$US$US
187684488$18768448$8$F$20210112$20240828$20210121$20240829$EXP$$US-TAKEDA-US201933628$TAKEDA$$28$YR$$M$Y$$$20240829$$CN$US$US
187687862$18768786$2$F$$20240716$20210121$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202101005763$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240726$$CN$US$US
187694838$18769483$8$F$20201201$20240827$20210121$20240902$EXP$$CA-TAKEDA-2021TUS001202$TAKEDA$$36$YR$$F$Y$$$20240902$$CN$CA$CA
187696985$18769698$5$F$$20240813$20210121$20240819$EXP$$US-TAKEDA-US202009289$TAKEDA$$$$$F$Y$54$KG$20240819$$MD$US$US
1876985012$18769850$12$F$20191211$20240822$20210121$20240827$EXP$$CO-TAKEDA-2019TUS056071$TAKEDA$$59$YR$$M$Y$69$KG$20240827$$HP$CO$CO
1877111717$18771117$17$F$20211101$20220616$20210122$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR008445$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
187711267$18771126$7$F$20210701$20240705$20210121$20240713$PER$$NVSC2021US008977$NOVARTIS$$36$YR$$F$Y$$$20240713$$CN$US$US
187711775$18771177$5$F$20200301$20240910$20210121$20240911$EXP$$BE-PFIZER INC-2021042670$PFIZER$Jacobs, W.. Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19): autopsy reveals a ferroptosis signature.. ESC Heart Failure. 2020;7(6):3772-3781$48$YR$$M$Y$$$20240911$$HP$BE$BE
187737846$18773784$6$F$20190101$20240711$20210122$20240718$EXP$$CA-JNJFOC-20210117397$JOHNSON AND JOHNSON$$$$E$F$Y$68$KG$20240718$$CN$CA$CA
1877407817$18774078$17$F$20200910$20240924$20210122$20240927$EXP$$IN-PFIZER INC-2020259854$PFIZER$$26$YR$$F$Y$$$20240927$$CN$IN$IN
187756547$18775654$7$F$20210113$20240711$20210122$20240715$PER$$US-PFIZER INC-2021041288$PFIZER$$61$YR$$F$Y$52.154$KG$20240715$$CN$US$US
1877592210$18775922$10$F$20160101$20240822$20210122$20240830$EXP$$US-TAKEDA-US202032623$TAKEDA$$$$$F$Y$$$20240830$$MD$US$US
1877643317$18776433$17$F$20180329$20240705$20210122$20240711$EXP$$CA-TAKEDA-2018TUS008392$TAKEDA$$59$YR$$F$Y$$$20240711$$CN$CA$CA
187773459$18777345$9$F$20210128$20240909$20210123$20240914$EXP$$CA-TAKEDA-2020TUS030836$TAKEDA$$43$YR$$F$Y$$$20240914$$CN$CA$CA
187777487$18777748$7$F$20220301$20240815$20210122$20240820$PER$$US-PFIZER INC-2021044318$PFIZER$$51$YR$$F$Y$$$20240820$$HP$US$US
1877795049$18777950$49$F$20200108$20240905$20210123$20240911$EXP$$CA-TAKEDA-CA202001360$TAKEDA$$20$YR$$M$Y$55$KG$20240911$$CN$CA$CA
1877829823$18778298$23$F$$20240628$20210123$20240703$EXP$$US-SHIRE-US202010424AA$TAKEDA$$$$$F$Y$69$KG$20240703$$CN$US$US
1877953313$18779533$13$F$20191003$20240717$20210125$20240725$EXP$$MX-TAKEDA-MX201936858$TAKEDA$$47$YR$$M$Y$69$KG$20240725$$CN$MX$MX
1877961116$18779611$16$F$20200615$20240910$20210125$20240918$EXP$$CA-CELLTRION INC.-2020CA021881$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
187797067$18779706$7$F$$20240729$20210125$20240801$EXP$$US-TAKEDA-2021TUS003510$TAKEDA$$$$$M$Y$84$KG$20240801$$HP$US$US
1877999312$18779993$12$F$$20240819$20210125$20240822$EXP$$CA-BAUSCH-BL-2021-001290$BAUSCH AND LOMB$$45$YR$$F$Y$95$KG$20240822$$CN$CA$CA
187814934$18781493$4$F$$20240911$20210125$20240923$EXP$$CA-APOTEX-2021AP001499$APOTEX$$43$YR$$F$Y$$$20240923$$HP$CA$CA
1878300112$18783001$12$F$20210410$20240715$20210125$20240723$EXP$$CA-TOLMAR, INC.-21CA024954$TOLMAR$$76$YR$$M$Y$$$20240723$$CN$CA$CA
187831934$18783193$4$F$20200901$20240629$20210125$20240708$PER$$US-SA-2021SA018605$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240708$$MD$US$US
1878329718$18783297$18$F$20201124$20240910$20210125$20240920$EXP$$GB-TEVA-2021-GB-1870544$TEVA$$72$YR$$F$Y$60$KG$20240920$$MD$GB$GB
187840294$18784029$4$F$20210112$20240714$20210125$20240717$EXP$$IL-TAKEDA-IL202025751$TAKEDA$$$$A$F$Y$$$20240717$$HP$IL$IL
187840374$18784037$4$F$$20240905$20210125$20240909$PER$$US-PFIZER INC-2021050345$PFIZER$$69$YR$$F$Y$$$20240909$$HP$US$US
187840877$18784087$7$F$20210101$20240808$20210125$20240814$EXP$$US-PFIZER INC-2021044155$PFIZER$$56$YR$$F$Y$79.819$KG$20240814$$HP$US$US
187846523$18784652$3$F$$20240919$20210126$20240927$EXP$$CA-ROCHE-2753308$ROCHE$$48$YR$A$F$Y$$$20240927$$HP$CA$CA
187849426$18784942$6$F$$20240821$20210126$20240903$EXP$$US-SA-2021SA020894$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240903$$MD$US$US
1878494518$18784945$18$F$20210220$20240628$20210125$20240704$EXP$$CO-TAKEDA-2021TUS004638$TAKEDA$$53$YR$$M$Y$114$KG$20240704$$CN$CO$CO
187873882$18787388$2$F$20210118$20240718$20210126$20240724$EXP$$BR-TAKEDA-2021TUS004356$TAKEDA$$14$YR$$M$Y$$$20240724$$CN$BR$BR
187874497$18787449$7$F$20201228$20240624$20210126$20240703$EXP$$JP-009507513-2101JPN002295J$MERCK$Hirano S, Kojima A, Nakayama Y, Takeda T, Kishimoto T, Takahashi T, et al.. A case report of neuromyelitis optica spectrum disorder induced by pembrolizumab treatment for lung adenocarcinoma: a clinical and immunohistochemical study. BMC neurology. 2022;22(1):483$62$YR$$M$Y$$$20240703$$MD$JP$JP
187893439$18789343$9$F$20170929$20240722$20210125$20240805$EXP$$US-ACORDA-ACO_166229_2020$ACORDA$$63$YR$$F$Y$$$20240805$$MD$US$US
187893668$18789366$8$F$20200914$20240710$20210126$20240716$EXP$$IE-SHIRE-IE202032053$TAKEDA$$66$YR$$M$Y$$$20240716$$CN$IE$IE
187899497$18789949$7$F$20201201$20240719$20210126$20240722$EXP$$CA-TAKEDA-2020TUS057555$TAKEDA$$67$YR$$F$Y$65$KG$20240722$$MD$CA$CA
187904413$18790441$3$F$$20240829$20210126$20240830$EXP$$US-PURDUE-USA-2020-0186522$PURDUE$$$$C$F$Y$$$20240830$$LW$US$US
187906734$18790673$4$F$20191101$20240709$20210126$20240711$EXP$$US-TAKEDA-US202034547$TAKEDA$$66$YR$$F$Y$$$20240711$$HP$US$US
187908772$18790877$2$F$20180501$20240801$20210126$20240805$EXP$$US-TAKEDA-US201833859$TAKEDA$$67$YR$$F$Y$$$20240805$$MD$US$US
187910032$18791003$2$F$$20240812$20210126$20240903$PER$$CA-TOLMAR, INC.-21CA024817$TOLMAR$$$$$M$Y$$$20240903$$MD$CA$CA
1879110010$18791100$10$F$20201218$20240823$20210126$20240828$EXP$$CA-TAKEDA-2021TUS003351$TAKEDA$$57$YR$$F$Y$$$20240828$$MD$CA$CA
187917208$18791720$8$F$20201124$20240821$20210127$20240831$EXP$$DE-AUROBINDO-AUR-APL-2020-063799$AUROBINDO$$83$YR$$F$Y$62$KG$20240831$$MD$DE$DE
187918725$18791872$5$F$20201101$20240806$20210127$20240819$EXP$$FR-AUROBINDO-AUR-APL-2021-003134$AUROBINDO$$76$YR$$F$Y$50$KG$20240819$$MD$FR$FR
1879206025$18792060$25$F$20200204$20240909$20210127$20240917$EXP$$CA-CELLTRION INC.-2019CA027955$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
187928213$18792821$3$F$20240101$20240802$20210127$20240813$PER$$US-SA-2021SA022482$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240814$$CN$US$US
1879314124$18793141$24$F$20201120$20240816$20210127$20240821$EXP$$GB-ROCHE-2751663$ROCHE$$74$YR$E$F$Y$79.95$KG$20240821$$MD$GB$GB
187943014$18794301$4$F$20140922$20240704$20210127$20240705$EXP$$US-PURDUE-USA-2020-0200790$PURDUE$$30$YR$$M$Y$$$20240705$$CN$US$US
187950022$18795002$2$F$20240803$20240805$20210127$20240814$PER$$US-SA-2021SA021180$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240814$$CN$US$US
187953753$18795375$3$F$$20240726$20210127$20240731$EXP$$US-PURDUE-USA-2020-0199498$PURDUE$$$$$F$Y$$$20240731$$CN$US$US
187954342$18795434$2$F$20201001$20240827$20210127$20240906$30DAY$$US-GLAXOSMITHKLINE-US2021AMR009972$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240906$$CN$US$US
187957249$18795724$9$F$$20240912$20210127$20240918$EXP$$NVSC2021CO015636$NOVARTIS$$$$$M$Y$56$KG$20240918$$CN$CO$CO
1879647713$18796477$13$F$$20240827$20210127$20240905$EXP$$CA-AUROBINDO-AUR-APL-2021-002650$AUROBINDO$$52$YR$$M$Y$140$KG$20240905$$MD$CA$CA
187967873$18796787$3$F$$20240709$20210127$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2020-006170$ENDO$$$$A$F$Y$$$20240918$$CN$US$US
187970605$18797060$5$F$$20240829$20210127$20240903$EXP$$CA-JNJFOC-20210135541$JOHNSON AND JOHNSON$$65$YR$E$F$Y$95$KG$20240903$$HP$CA$CA
1879712525$18797125$25$F$20201027$20240911$20210128$20240919$EXP$$CA-CELLTRION INC.-2020CA030545$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
1879750010$18797500$10$F$20201231$20240816$20210127$20240830$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-277647$RANBAXY$$84$YR$E$F$Y$$$20240830$$CN$US$US
187978154$18797815$4$F$20201110$20240722$20210128$20240731$EXP$DE-PEI-PEI2021000684$DE-TEVA-2021-DE-1872954$TEVA$$55$YR$$M$Y$76$KG$20240731$$MD$DE$DE
187981543$18798154$3$F$$20240716$20210128$20240724$EXP$$CA-APOTEX-2021AP001825$APOTEX$$53$YR$$F$Y$$$20240724$$HP$CA$CA
187992472$18799247$2$F$20170701$20240923$20210128$20240925$EXP$PT-INFARMED-T202101-4$PT-BAYER-2021-029852$BAYER$$34$YR$A$F$Y$68$KG$20240925$$CN$PT$PT
1879997115$18799971$15$F$20200930$20240719$20210128$20240725$EXP$$NVSC2020CO271949$NOVARTIS$$33$YR$$F$Y$53$KG$20240725$$CN$CO$CO
188001353$18800135$3$F$20201201$20240711$20210128$20240716$EXP$$GB-PFIZER INC-2021044995$PFIZER$$72$YR$$F$Y$59.5$KG$20240716$$MD$GB$GB
188004712$18800471$2$F$$20240918$20210128$20240924$EXP$$US-JAZZ-2020-US-017444$JAZZ$$$$$F$Y$$$20240924$$CN$US$US
1880129912$18801299$12$F$20210901$20240805$20210128$20240813$EXP$$US-BIOMARINAP-US-2021-134423$BIOMARIN$$$$$$Y$$$20240813$$CN$US$US
1880154910$18801549$10$F$$20240626$20210128$20240701$PER$$US-PFIZER INC-2016303690$PFIZER$$62$YR$$F$Y$74.376$KG$20240701$$CN$US$US
188016329$18801632$9$F$$20240710$20210128$20240711$PER$$US-PFIZER INC-2021058455$PFIZER$$62$YR$$F$Y$102$KG$20240711$$HP$US$US
188025327$18802532$7$F$$20240819$20210129$20240829$EXP$$CA-AUROBINDO-AUR-APL-2021-003033$AUROBINDO$$74$YR$$M$Y$$$20240829$$MD$CA$CA
1880571935$18805719$35$F$20200101$20240829$20210129$20240907$EXP$$CA-CELLTRION INC.-2020CA033502$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
188060372$18806037$2$F$$20240804$20210128$20240806$EXP$$CA-PURDUE-USA-2020-0200634$PURDUE$$$$$M$Y$$$20240806$$LW$CA$CA
188068542$18806854$2$F$20201022$20240702$20210129$20240709$EXP$$CO-ASTELLAS-2020US033391$ASTELLAS$$43$YR$$F$Y$60$KG$20240709$$CN$CO$CO
188070832$18807083$2$F$20210118$20240802$20210128$20240807$EXP$$CA-JNJFOC-20210139476$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240807$$HP$CA$CA
188094063$18809406$3$F$$20240628$20210129$20240702$EXP$$US-PURDUE-USA-2020-0201407$PURDUE$$$$$M$Y$$$20240702$$CN$US$US
1880974421$18809744$21$F$20210101$20231128$20210129$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR013894$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
188100065$18810006$5$F$20210312$20211116$20210129$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR014256$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240926$$MD$US$US
188104242$18810424$2$F$20201201$20240806$20210129$20240808$EXP$$US-PFIZER INC-2021081254$PFIZER$$47$YR$$M$Y$$$20240808$$HP$US$US
188117343$18811734$3$F$$20211214$20210129$20240807$EXP$$CA-AstraZeneca-2021A018701$ASTRAZENECA$$53$YR$$M$Y$$$20240807$$MD$CA$
1881225466$18812254$66$F$20200101$20240830$20210129$20240913$EXP$$CA-AUROBINDO-AUR-APL-2021-002814$AUROBINDO$$80$YR$$M$Y$69$KG$20240913$$MD$CA$CA
188125319$18812531$9$F$20190403$20240828$20210130$20240903$EXP$$PHHY2019CA082849$NOVARTIS$$61$YR$$M$Y$$$20240903$$CN$CA$CA
188138048$18813804$8$F$$20240715$20210201$20240723$EXP$$CA-APOTEX-2021AP001830$APOTEX$$53$YR$$F$Y$54$KG$20240723$$MD$CA$CA
1881384934$18813849$34$F$20181211$20240909$20210201$20240917$EXP$$CA-CELLTRION INC.-2018CA025428$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
188140076$18814007$6$F$20200901$20210607$20210201$20240818$EXP$$JP-AMGEN-JPNSP2020203296$AMGEN$Yukari Morioka, Haruyuki Tanaka, Makoto Otani, Kouki Shibata, Masayuki Kubo, Atsushi Hasegawa, et al.. 40 Two Cases of Patients with Pure Red Cell Aplasia (PRCA) who Developed Anti-erythropoietin (Epo) Antibodies During Administration of Erythropoiesis Stimulating Agents (ESAs) and who Responded to Steroid Treatment. The 115th Annual Meeting of the Kinki Society of Hematology (June 5, 2021). 2021;34$80$YR$E$F$Y$$$20240818$$MD$JP$JP
188146482$18814648$2$F$$20210126$20210201$20240709$EXP$$DE-ASTELLAS-2021US003130$ASTELLAS$$$$$F$Y$$$20240709$$CN$DE$DE
188146733$18814673$3$F$20200501$20240629$20210201$20240711$EXP$DE-EMA-DD-20210115-KUMARVN_P-130101$DE-Accord-215970$ACCORD$$36$YR$A$F$Y$51.5$KG$20240711$$MD$DE$DE
188165518$18816551$8$F$20201218$20240702$20210201$20240703$EXP$$US-TAKEDA-2021TUS004091$TAKEDA$$67$YR$$F$Y$59$KG$20240703$$HP$US$US
188177447$18817744$7$F$20210113$20240808$20210201$20240813$EXP$$NVSC2021GB018335$NOVARTIS$$48$YR$$M$Y$$$20240813$$HP$GB$GB
1881779313$18817793$13$F$20211230$20240826$20210201$20240829$EXP$$US-TAKEDA-2021TUS004427$TAKEDA$$37$YR$$F$Y$66$KG$20240829$$HP$US$US
188183615$18818361$5$F$20210212$20240816$20210201$20240823$EXP$$CA-TAKEDA-2021TUS005383$TAKEDA$$24$YR$$F$Y$$$20240823$$CN$CA$CA
188193317$18819331$7$F$$20240828$20210201$20240902$EXP$$US-TAKEDA-US202008570$TAKEDA$$$$$F$Y$95$KG$20240902$$MD$US$US
188193356$18819335$6$F$$20240711$20210201$20240715$EXP$$US-TAKEDA-US202013833$TAKEDA$$$$$F$Y$82$KG$20240715$$HP$US$US
1881997522$18819975$22$F$20201016$20240822$20210202$20240830$EXP$$CA-CELLTRION INC.-2020CA029765$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
188200515$18820051$5$F$20200224$20240111$20210202$20240918$EXP$$NVSC2020CH085651$NOVARTIS$$50$YR$$F$Y$$$20240918$$MD$CH$CH
188208394$18820839$4$F$$20240821$20210202$20240828$EXP$$CA-GLAXOSMITHKLINE-CA2021AMR019343$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$CA$CA
1882194823$18821948$23$F$20200101$20240712$20210202$20240716$EXP$$CA-PFIZER INC-2020241561$PFIZER$$70$YR$$F$Y$85$KG$20240716$$MD$CA$CA
188224415$18822441$5$F$$20240117$20210202$20240731$EXP$$NVSC2021CA012850$NOVARTIS$$58$YR$$F$Y$$$20240731$$CN$CA$CA
188231038$18823103$8$F$20200101$20240617$20210202$20240709$EXP$$AT-ROCHE-2649703$ROCHE$$35$YR$A$F$Y$90$KG$20240703$$CN$AT$AT
188253918$18825391$8$F$20180901$20240723$20210202$20240726$EXP$$US-TAKEDA-US202029786$TAKEDA$$63$YR$$F$Y$$$20240726$$HP$US$US
188264473$18826447$3$F$$20240909$20210202$20240913$PER$$US-JAZZ-2021-US-001302$JAZZ$$$$$F$Y$$$20240913$$CN$US$US
188269523$18826952$3$F$20220828$20240830$20210202$20240904$EXP$$BR-TAKEDA-2021TUS005816$TAKEDA$$54$YR$$M$Y$$$20240904$$CN$BR$BR
1882774628$18827746$28$F$20210125$20240903$20210202$20240911$EXP$$CA-CELLTRION INC.-2020CA033255$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
188288612$18828861$2$F$$20210120$20210201$20240718$EXP$$IN-AstraZeneca-2021A010660$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$IN$
188333683$18833368$3$F$$20240909$20210203$20240920$EXP$$FR-AUROBINDO-AUR-APL-2021-004070$AUROBINDO$Mousseaux C, Dobosziewicz H, Rafat C, Frochot V, Letavernier E, Mercadal L, et al.. A new approach to the mechanism of renal toxicity of amoxicillin: about two cases and an experimental model.. J Nephrol Ther.. 2019;15:333-376$68$YR$$$Y$$$20240920$$MD$FR$FR
1883495716$18834957$16$F$20210119$20240912$20210203$20240916$EXP$$NVSC2021FR016129$NOVARTIS$$59$YR$$F$Y$57$KG$20240916$$MD$FR$FR
1883894014$18838940$14$F$20210101$20240626$20210203$20240701$PER$$US-PFIZER INC-2021089734$PFIZER$$60$YR$$F$Y$$$20240701$$HP$US$US
188424324$18842432$4$F$$20240902$20210203$20240915$EXP$$IR-JNJFOC-20210140987$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240916$$HP$IR$IR
1884275814$18842758$14$F$20210101$20240819$20210204$20240822$PER$$US-DSJP-DSU-2021-103291$DAIICHI$$$$$F$Y$$$20240822$$MD$US$US
188460628$18846062$8$F$$20240716$20210204$20240718$PER$$US-PFIZER INC-2021099110$PFIZER$$80$YR$$F$Y$$$20240718$$CN$US$US
1884769519$18847695$19$F$20190906$20240809$20210204$20240814$EXP$$US-SHIRE-US201938724AA$TAKEDA$$75$YR$$F$Y$48$KG$20240814$$HP$US$US
188481175$18848117$5$F$20240729$20240729$20210204$20240805$EXP$$US-SHIRE-US201924214$TAKEDA$$46$YR$$F$Y$$$20240805$$MD$US$US
188483782$18848378$2$F$20201101$20210309$20210204$20240826$EXP$$BE-BAYER-2021-025569$BAYER$$$$E$F$Y$$$20240826$$MD$BE$BE
188486579$18848657$9$F$$20240904$20210204$20240909$EXP$$US-PFIZER INC-2021090621$PFIZER$$74$YR$$F$Y$56.145$KG$20240909$$CN$US$US
188490043$18849004$3$F$20200101$20240708$20210205$20240717$PER$$US-SA-2021SA034176$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240717$$MD$US$US
188495673$18849567$3$F$20150705$20240718$20210205$20240731$EXP$$GB-AUROBINDO-AUR-APL-2020-021312$AUROBINDO$$78$YR$$F$Y$$$20240731$$MD$GB$GB
188505697$18850569$7$F$20210117$20240802$20210205$20240809$PER$$US-BIOGEN-2021BI00970092$BIOGEN$$45$YR$$F$Y$$$20240809$$CN$US$US
188514712$18851471$2$F$20200101$20240717$20210205$20240724$PER$$US-SA-2021SA035811$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240724$$MD$US$US
1885175412$18851754$12$F$20210801$20220930$20210205$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR028665$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
1885175819$18851758$19$F$20210101$20240730$20210205$20240807$EXP$$US-GLAXOSMITHKLINE-US2021AMR020670$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$HP$US$US
188518113$18851811$3$F$20200101$20240820$20210205$20240915$PER$$US-SA-2021SA034362$SANOFI AVENTIS$$57$YR$A$F$Y$63.946$KG$20240915$$MD$US$US
188526795$18852679$5$F$20240708$20240708$20210205$20240711$EXP$$US-TAKEDA-2021TUS005626$TAKEDA$$72$YR$$F$Y$72$KG$20240711$$MD$US$US
188537978$18853797$8$F$20200116$20240902$20210205$20240909$EXP$$JP-PFIZER INC-2020478240$PFIZER$Inoue, A.. Regimen switch to BRAF + MEK inhibitors for alleviation of adverse drug reactions in a patient with malignant melanoma.. The 36th Annual Meeting of the Japanese Skin Cancer Society (held online). 2021;B-5-5$44$YR$$F$Y$$$20240909$$MD$JP$JP
188547362$18854736$2$F$$20240811$20210205$20240819$EXP$$TR-JNJFOC-20210208467$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$TR$TR
188550313$18855031$3$F$$20240802$20210206$20240813$EXP$$US-ROCHE-2765019$ROCHE$$64$YR$A$F$Y$68$KG$20240813$$CN$US$US
188551012$18855101$2$F$20211026$20240709$20210206$20240716$EXP$$US-009507513-2101USA008134$MERCK$$59$YR$$M$Y$$$20240716$$CN$US$US
1885657113$18856571$13$F$$20240822$20210207$20240830$EXP$$US-TAKEDA-US202021449$TAKEDA$$$$$F$Y$145$KG$20240830$$CN$US$US
1885657638$18856576$38$F$20210124$20240923$20210207$20240927$EXP$$CO-TAKEDA-CO202025530$TAKEDA$$57$YR$$F$Y$70$KG$20240927$$HP$CO$CO
188565857$18856585$7$F$20210315$20240903$20210207$20240911$EXP$$CA-TAKEDA-2021TUS006960$TAKEDA$$37$YR$$F$Y$$$20240911$$CN$CA$CA
188566027$18856602$7$F$20210118$20240625$20210207$20240701$EXP$$CA-TAKEDA-2021TUS006942$TAKEDA$$42$YR$$M$Y$$$20240701$$HP$CA$CA
1885663159$18856631$59$F$20210126$20240905$20210207$20240911$EXP$$CO-TAKEDA-CO201945180$TAKEDA$$27$YR$$F$Y$78$KG$20240911$$HP$CO$CO
1885663213$18856632$13$F$20230220$20240923$20210207$20240930$EXP$$CA-TAKEDA-2021TUS005714$TAKEDA$$58$YR$$M$Y$$$20240930$$MD$CA$CA
188566435$18856643$5$F$20230701$20240918$20210207$20240926$EXP$$CA-TAKEDA-2020TUS016456$TAKEDA$$81$YR$$F$Y$$$20240926$$CN$CA$CA
1885664611$18856646$11$F$20181213$20240712$20210207$20240716$EXP$$CA-TAKEDA-2018TUS036038$TAKEDA$$31$YR$$F$Y$$$20240716$$CN$CA$CA
188567235$18856723$5$F$$20240916$20210207$20240919$EXP$$US-TAKEDA-2021TUS007003$TAKEDA$$$$$F$Y$67.57$KG$20240919$$HP$US$US
188576805$18857680$5$F$20210103$20240825$20210208$20240827$EXP$$EG-ROCHE-2759634$ROCHE$$23$YR$A$F$Y$47$KG$20240827$$CN$EG$EG
188600243$18860024$3$F$20201008$20240913$20210208$20240927$PER$$US-SA-2021SA038203$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240927$$MD$US$US
1886044817$18860448$17$F$$20240702$20210208$20240706$EXP$$US-TAKEDA-US202022121$TAKEDA$$$$$F$Y$$$20240706$$HP$US$US
1886070747$18860707$47$F$20210101$20240903$20210208$20240907$EXP$$CA-TAKEDA-2021TUS004751$TAKEDA$$$$$M$Y$72$KG$20240907$$CN$CA$CA
1886131011$18861310$11$F$$20240826$20210208$20240827$EXP$$NVSC2021US028125$NOVARTIS$$$$$M$Y$$$20240827$$CN$US$US
188617062$18861706$2$F$20180701$20240909$20210208$20240918$EXP$$NVSC2021CZ025348$NOVARTIS$Bartlova A. Pyoderma gangrenosum u tehotne pacientky -popis pripadu [Pyoderma gangrenosum in a pregnant patient. case report]. CESKO-SLOVENSKA DERMATOLOGIE. 2020;95(6):212-7$34$YR$$F$Y$$$20240918$$HP$CZ$CZ
188622652$18862265$2$F$20240101$20240917$20210209$20240919$PER$$US-PURDUE PHARMA-USA-2021-0197518$PURDUE$$$$$F$Y$86.18$KG$20240919$$CN$US$US
1886235534$18862355$34$F$20201211$20240909$20210208$20240918$EXP$$NVSC2020DE341763$NOVARTIS$$$$A$F$Y$60$KG$20240918$$HP$DE$DE
188639782$18863978$2$F$20201209$20240808$20210208$20240823$PER$$US-INCYTE CORPORATION-2020IN012972$INCYTE$$$$$$Y$$$20240823$$HP$US$US
188641358$18864135$8$F$20240601$20240620$20210209$20240701$PER$$US-SA-2021SA038040$SANOFI AVENTIS$$$$A$M$Y$131.09$KG$20240701$$MD$US$US
188657856$18865785$6$F$20200428$20240910$20210208$20240911$PER$$US-PFIZER INC-2020255002$PFIZER$$66$YR$$F$Y$88$KG$20240911$$CN$US$US
188658225$18865822$5$F$$20240912$20210208$20240916$PER$$US-PFIZER INC-2021108944$PFIZER$$58$YR$$F$Y$$$20240916$$CN$US$US
188674358$18867435$8$F$$20240806$20210209$20240813$EXP$$NVSC2020CO348869$NOVARTIS$$$$$F$Y$67$KG$20240813$$CN$CO$CO
1886820910$18868209$10$F$20170427$20240903$20210209$20240911$EXP$$CA-TAKEDA-2017TUS010861$TAKEDA$$81$YR$$F$Y$$$20240911$$MD$CA$CA
188688805$18868880$5$F$20150401$20240816$20210210$20240819$PER$$US-GILEAD-2021-0515312$GILEAD$$41$YR$A$M$Y$$$20240819$$LW$US$US
188699272$18869927$2$F$20161024$20240826$20210210$20240902$EXP$$CA-TAKEDA-2016TUS007899$TAKEDA$$45$YR$$M$Y$$$20240902$$CN$CA$CA
188700582$18870058$2$F$$20240724$20210209$20240802$EXP$$JP-LUNDBECK-DKLU2061562$LUNDBECK$$$$$$Y$$$20240802$$PH$JP$JP
188709135$18870913$5$F$20200805$20240830$20210209$20240904$PER$$US-BIOGEN-2020BI00909083$BIOGEN$$47$YR$$F$Y$$$20240904$$CN$US$US
188728415$18872841$5$F$20210101$20240703$20210210$20240705$EXP$$CA-TAKEDA-2020TUS002499$TAKEDA$$$$$M$Y$$$20240705$$MD$CA$CA
188728525$18872852$5$F$20220607$20240912$20210210$20240919$EXP$$CA-TAKEDA-2021TUS007113$TAKEDA$$21$YR$$F$Y$$$20240919$$CN$CA$CA
188730625$18873062$5$F$20180101$20240925$20210210$20240930$EXP$$PHHY2018CA076794$NOVARTIS$$60$YR$$F$Y$$$20240930$$CN$CA$CA
188734392$18873439$2$F$20201201$20240820$20210210$20240904$PER$$US-SA-2021SA044255$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240904$$MD$US$US
1887365911$18873659$11$F$20220106$20240913$20210210$20240920$EXP$$US-SHIRE-US202025019$TAKEDA$$66$YR$$F$Y$69$KG$20240920$$CN$US$US
188736912$18873691$2$F$$20240701$20210210$20240711$PER$$US-SA-2021SA042537$SANOFI AVENTIS$$60$YR$A$M$Y$94.8$KG$20240711$$MD$US$US
188743313$18874331$3$F$20160401$20240703$20210210$20240703$EXP$$GB-JNJFOC-20210210269$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240703$$PH$GB$GB
1887469016$18874690$16$F$$20240910$20210210$20240914$EXP$$US-TAKEDA-2021TUS006918$TAKEDA$$$$$F$Y$$$20240914$$CN$US$US
1887471715$18874717$15$F$20221007$20240823$20210210$20240829$EXP$$US-TAKEDA-2021TUS005170$TAKEDA$$67$YR$$F$Y$72.11$KG$20240829$$HP$US$US
188753383$18875338$3$F$$20240725$20210211$20240807$EXP$$FR-AUROBINDO-AUR-APL-2021-005523$AUROBINDO$$72$YR$$F$Y$$$20240807$$HP$FR$FR
188757352$18875735$2$F$$20240806$20210211$20240807$EXP$FR-SEATTLE GENETICS-2021SGN00340$FR-ROCHE-2766201$ROCHE$$72$YR$E$F$Y$$$20240807$$HP$FR$FR
1887605424$18876054$24$F$20200103$20240625$20210211$20240703$EXP$$CA-CELLTRION INC.-2020CA025103$CELLTRION$$$$$$Y$$$20240703$$HP$CA$CA
188765122$18876512$2$F$20200903$20240723$20210211$20240801$PER$$US-SA-2021SA040912$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240801$$MD$US$US
1887747313$18877473$13$F$20160301$20240723$20210211$20240726$EXP$$CA-TAKEDA-2016TUS004598$TAKEDA$$78$YR$$M$Y$84$KG$20240726$$CN$CA$CA
188775743$18877574$3$F$20240910$20240917$20210211$20240922$EXP$$US-TAKEDA-2021TUS008045$TAKEDA$$26$YR$$M$Y$81$KG$20240922$$HP$US$US
1887891316$18878913$16$F$$20240904$20210211$20240910$EXP$$US-TAKEDA-US202012457$TAKEDA$$$$$F$Y$49.8$KG$20240910$$CN$US$US
1887893764$18878937$64$F$20190522$20240906$20210211$20240913$EXP$$CO-TAKEDA-CO201917806$TAKEDA$$5$YR$$M$Y$17$KG$20240913$$MD$CO$CO
1888026313$18880263$13$F$20220630$20240705$20210211$20240710$EXP$$AU-TAKEDA-2021TUS007703$TAKEDA$$42$YR$$F$Y$$$20240710$$CN$AU$AU
188811492$18881149$2$F$$20240913$20210212$20240920$PER$$US-SA-2021SA046097$SANOFI AVENTIS$$$$A$M$Y$$$20240920$$HP$US$US
188814554$18881455$4$F$20180803$20240625$20210212$20240702$EXP$$CA-TAKEDA-2018TUS022762$TAKEDA$$56$YR$$F$Y$$$20240702$$CN$CA$CA
188829162$18882916$2$F$$20210202$20210212$20240703$EXP$$US-KYOWAKIRIN-2021BKK001714$KYOWA$$$$$$Y$$$20240703$$HP$COUNTRY NOT SPECIFIED$US
188829743$18882974$3$F$$20240808$20210212$20240817$PER$$US-SA-2021SA044360$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240817$$MD$US$US
188838934$18883893$4$F$20190101$20240828$20210211$20240905$EXP$$JP-JNJFOC-A-CH2019-194810$JOHNSON AND JOHNSON$$68$YR$E$F$Y$50.3$KG$20240905$$MD$JP$JP
1888412211$18884122$11$F$20210130$20220310$20210212$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR028524$GLAXOSMITHKLINE$$59$YR$$F$Y$94.785$KG$20240925$$HP$US$US
188861965$18886196$5$F$$20240827$20210212$20240903$EXP$$US-TAKEDA-2021TUS008338$TAKEDA$$$$$M$Y$58$KG$20240903$$HP$US$US
188862458$18886245$8$F$20201214$20240913$20210212$20240920$EXP$$CA-TAKEDA-CA202024371$TAKEDA$$72$YR$$M$Y$$$20240920$$CN$CA$CA
188864272$18886427$2$F$$20240918$20210212$20240924$EXP$$US-JAZZ-2021-US-002189$JAZZ$$$$$M$Y$$$20240924$$CN$US$US
188864382$18886438$2$F$$20240718$20210212$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013434$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240726$$HP$CA$CA
188870547$18887054$7$F$20190627$20221212$20210212$20240827$EXP$$NVSC2021RU028524$NOVARTIS$$68$YR$$M$Y$97$KG$20240827$$MD$RU$RU
188875713$18887571$3$F$$20240812$20210212$20240822$30DAY$$US-GLAXOSMITHKLINE-US2021AMR032640$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
1888786325$18887863$25$F$20200101$20240813$20210212$20240820$EXP$$CA-TAKEDA-CA202010037$TAKEDA$$$$$F$Y$40$KG$20240820$$HP$CA$CA
1888795812$18887958$12$F$20190530$20240816$20210212$20240822$EXP$$CA-TAKEDA-2019TUS021868$TAKEDA$$45$YR$$M$Y$$$20240822$$CN$CA$CA
1888797912$18887979$12$F$20210129$20240702$20210212$20240712$EXP$$NVSC2021US029326$NOVARTIS$$2$YR$$F$Y$9$KG$20240712$$MD$US$US
188885502$18888550$2$F$20201229$20240802$20210213$20240813$PER$$US-SA-2021SA045621$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240814$$MD$US$US
188900562$18890056$2$F$20240501$20240904$20210214$20240915$30DAY$$US-GLAXOSMITHKLINE-US2021033071$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240915$$CN$US$US
1889127123$18891271$23$F$20210101$20240825$20210215$20240902$EXP$$CA-CELLTRION INC.-2020CA032495$CELLTRION$$$$$$Y$$$20240902$$MD$CA$CA
1889329413$18893294$13$F$$20240912$20210215$20240918$EXP$$US-TAKEDA-2021TUS007748$TAKEDA$$$$$F$Y$76$KG$20240918$$CN$US$US
188935939$18893593$9$F$20211104$20240711$20210215$20240720$EXP$$CA-TAKEDA-2017TUS007720$TAKEDA$$74$YR$$F$Y$$$20240720$$CN$CA$CA
1889412814$18894128$14$F$20190101$20240821$20210215$20240828$EXP$$US-TAKEDA-US202020882$TAKEDA$$$$$F$Y$49.887$KG$20240828$$CN$US$US
188943142$18894314$2$F$20201001$20210204$20210215$20240827$EXP$$US-TAKEDA-2021TUS007611$TAKEDA$$68$YR$$M$Y$$$20240827$$CN$US$US
188952108$18895210$8$F$$20240731$20210215$20240805$PER$$US-PFIZER INC-2021130134$PFIZER$$76$YR$$F$Y$$$20240805$$HP$US$US
188952679$18895267$9$F$20240630$20240816$20210215$20240823$EXP$$US-TAKEDA-US202014206$TAKEDA$$75$YR$$F$Y$$$20240823$$MD$US$US
188954212$18895421$2$F$$20240821$20210215$20240828$EXP$$FR-MYLANLABS-2021M1008965$MYLAN$Vidil F. Myositis case during chemotherapy with docetaxel. Abstracts - Discussed Posters 2017.. Societe Francaise de Pharmacologie et de Therapeutique.. 2017;(SUPPL.1):21-50:31-31$43$YR$$M$Y$$$20240828$$HP$FR$FR
188958602$18895860$2$F$$20240318$20210216$20240910$EXP$DE-AMGEN-DEUSP2021005103$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-00314$ALKEM$$$$$M$Y$$$20240910$$PH$DE$DE
188959712$18895971$2$F$$20240917$20210216$20240925$EXP$$US-TAKEDA-2021TUS007243$TAKEDA$$$$$M$Y$$$20240925$$CN$US$US
1889637920$18896379$20$F$20200713$20240911$20210216$20240919$EXP$$CA-CELLTRION INC.-2020CA024497$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
1889641845$18896418$45$F$20201207$20240911$20210216$20240919$EXP$$CA-CELLTRION INC.-2020CA030514$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
188970333$18897033$3$F$$20231204$20210216$20240910$EXP$DE-GLENMARK PHARMACEUTICALS-2020GMK050447$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08509$ALKEM$Smits WJ, Feucht HH, Oellig F, Zollner B.. Infection of the orbita due to Delftia acidovorans after a cat scratch. Deutsche Medizinische Wochenschrift. 2020;145 (21):1559-1561$60$YR$$F$Y$$$20240910$$HP$DE$DE
1889811411$18898114$11$F$20220325$20240923$20210216$20240926$EXP$$CA-TAKEDA-2021TUS008603$TAKEDA$$44$YR$$M$Y$$$20240926$$HP$CA$CA
188984866$18898486$6$F$20230521$20240923$20210216$20240930$EXP$$US-GLAXOSMITHKLINE-US2021040327$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
188986623$18898662$3$F$20190301$20240813$20210216$20240828$30DAY$$US-GLAXOSMITHKLINE-US2021AMR041788$GLAXOSMITHKLINE$$53$YR$$F$Y$61.23$KG$20240828$$MD$US$US
1889918412$18899184$12$F$20200501$20240820$20210216$20240828$EXP$$US-TAKEDA-US202011084$TAKEDA$$66$YR$$M$Y$$$20240828$$CN$US$US
1890021314$18900213$14$F$20190813$20240621$20210216$20240710$EXP$$DE-ROCHE-2382596$ROCHE$$30$YR$A$F$Y$$$20240710$$CN$DE$DE
189006152$18900615$2$F$20140401$20231204$20210217$20240910$EXP$DE-AMAROX PHARMA GMBH-AMR2020DE01117$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2020-08280$ALKEM$Flother L, Avila-Castillo D, Burgdorff AM, Benndorf R. Capsaicin in the treatment of refractory neuropathic pain after mastectomy surgery: A case report.. Case Reports in Oncology. 2020;13:997-1001$62$YR$$F$Y$62$KG$20240910$$HP$DE$DE
189011666$18901166$6$F$$20240722$20210216$20240725$PER$$US-PFIZER INC-2021132139$PFIZER$$81$YR$$F$Y$93.89$KG$20240725$$CN$US$US
189012532$18901253$2$F$$20240724$20210217$20240803$EXP$$CA-AUROBINDO-AUR-APL-2021-006022$AUROBINDO$$57$YR$$M$Y$108$KG$20240803$$HP$CA$CA
189015028$18901502$8$F$$20240809$20210216$20240812$EXP$$US-PFIZER INC-2021142829$PFIZER$$75$YR$$F$Y$$$20240812$$CN$US$US
189017092$18901709$2$F$$20240906$20210217$20240909$EXP$$JP-JNJFOC-20210228593$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240909$$MD$JP$JP
189020192$18902019$2$F$20190913$20230821$20210217$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-261621$RANBAXY$$53$YR$A$F$Y$$$20240804$$CN$US$US
189024504$18902450$4$F$20160401$20240703$20210216$20240705$EXP$$GB-TAKEDA-2021TUS008775$TAKEDA$$68$YR$$M$Y$$$20240705$$MD$GB$GB
1890311410$18903114$10$F$20200901$20240717$20210216$20240723$EXP$$CA-JNJFOC-20201241140$JOHNSON AND JOHNSON$$38$YR$A$F$Y$96$KG$20240723$$CN$CA$CA
189042376$18904237$6$F$20170101$20240731$20210217$20240802$EXP$$CA-TAKEDA-2017TUS006596$TAKEDA$$$$$M$Y$$$20240802$$MD$CA$CA
189042609$18904260$9$F$20210209$20240628$20210217$20240708$EXP$$US-GLAXOSMITHKLINE-US2021AMR037112$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240708$$CN$US$US
1890487318$18904873$18$F$20230719$20240904$20210217$20240909$EXP$$CA-TAKEDA-2021TUS008627$TAKEDA$$36$YR$$F$Y$$$20240909$$CN$CA$CA
189049752$18904975$2$F$$20240708$20210217$20240716$EXP$$CA-TAKEDA-2019TUS020842$TAKEDA$$$$$M$Y$$$20240716$$CN$CA$CA
189051677$18905167$7$F$20170612$20240903$20210217$20240910$EXP$$CA-TAKEDA-2017TUS013433$TAKEDA$$49$YR$$F$Y$$$20240910$$CN$CA$CA
1890535719$18905357$19$F$20191021$20240723$20210217$20240726$EXP$$CA-TAKEDA-CA201927487$TAKEDA$$29$YR$$F$Y$60$KG$20240726$$HP$CA$CA
189056694$18905669$4$F$$20240816$20210217$20240820$EXP$$US-PFIZER INC-2021137226$PFIZER$Sheikh, T.. Glucocorticoid-induced cardiomyopathy: unexpected conclusion. BMJ Case Reports. 2020;13 (11):10.1136/bcr-2020-237173c$26$YR$$M$Y$$$20240820$$HP$US$US
1890568614$18905686$14$F$20210215$20240903$20210217$20240920$PER$$CA-TOLMAR, INC.-21CA025354$TOLMAR$$70$YR$$M$Y$$$20240919$$MD$CA$CA
1890588513$18905885$13$F$20240405$20240724$20210217$20240727$EXP$$US-SHIRE-US201942222AA$TAKEDA$$66$YR$$F$Y$$$20240727$$HP$US$US
189060569$18906056$9$F$20210208$20240709$20210217$20240716$EXP$$US-TAKEDA-2021TUS009142$TAKEDA$$76$YR$$M$Y$$$20240716$$MD$US$US
189061133$18906113$3$F$$20240722$20210217$20240725$EXP$$US-SHIRE-US202026934$TAKEDA$$$$$M$Y$$$20240725$$HP$US$US
189062142$18906214$2$F$$20240808$20210217$20240812$PER$$US-PFIZER INC-2020128275$PFIZER$$54$YR$$F$Y$91.63$KG$20240812$$CN$US$US
189062233$18906223$3$F$$20240724$20210217$20240729$EXP$$FR-PFIZER INC-2021120346$PFIZER$$72$YR$$F$Y$$$20240729$$HP$FR$FR
189067083$18906708$3$F$$20240826$20210218$20240903$EXP$$IT-ROCHE-2769551$ROCHE$Lapucci C, Frau J, Cocco E, Cavalla P, Vercellino M, Petracca M, Lanzillo R, Grossi P, Ferro M, Guaschino C, Zaffaroni M, Tazza F, Novi G, Uccelli A and Inglese M Short-term evaluation of alemtuzumab to ocrelizumab switch in MS patients with disease activity after alemtuzumab: An italian multicentric study (abstract P0161). Multiple Sclerosis Journal 2020 Dec;26 (3 SUPPL):195-96.$$$$$Y$$$20240903$$HP$IT$IT
189067115$18906711$5$F$$20240924$20210217$20240926$EXP$$US-PFIZER INC-2021143466$PFIZER$$74$YR$$F$Y$$$20240926$$CN$US$US
189083048$18908304$8$F$$20240828$20210218$20240903$EXP$$CA-JNJFOC-20210216275$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240903$$MD$CA$CA
1890838118$18908381$18$F$20220510$20240723$20210218$20240730$EXP$$CA-TAKEDA-2019TUS072754$TAKEDA$$76$YR$$F$Y$$$20240730$$CN$CA$CA
1890872919$18908729$19$F$20201201$20240806$20210218$20240808$EXP$$CA-TAKEDA-2020TUS053148$TAKEDA$$56$YR$$F$Y$58$KG$20240808$$CN$CA$CA
1890908810$18909088$10$F$20240318$20240813$20210218$20240814$EXP$$US-TAKEDA-2021TUS009702$TAKEDA$$68$YR$$F$Y$$$20240814$$HP$US$US
189104033$18910403$3$F$20210101$20240702$20210218$20240709$EXP$$US-SA-2021SA055590$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240709$$MD$US$US
1891065412$18910654$12$F$$20240925$20210218$20240930$EXP$$US-TAKEDA-US201944104$TAKEDA$$$$$F$Y$$$20240930$$HP$US$US
1891071821$18910718$21$F$$20240711$20210218$20240716$EXP$$US-TAKEDA-US202005946$TAKEDA$$$$$M$Y$64$KG$20240716$$HP$US$US
189111539$18911153$9$F$$20240819$20210218$20240821$EXP$$CA-PFIZER INC-2021160622$PFIZER$$65$YR$$F$Y$$$20240821$$HP$CA$CA
189112356$18911235$6$F$$20240626$20210218$20240702$EXP$$NVSJ2021JP002555$NOVARTIS$Ishigaki S, Ota Y, Nishina N, Kikuchi J, Hanaoka H, Otomo K et al.. A Case of Refractory Arthritis Accompanying Primary Sclerosing Cholangitis (PSC)-Related Enterocolitis. Proceedings of Kanto Rheumatology Conference/The 60th Kanto Rheumatology Confere. 2020;53:33-35$18$YR$$M$Y$$$20240703$$HP$JP$JP
189117485$18911748$5$F$20200101$20240923$20210218$20240925$EXP$$US-SHIRE-US202020943$TAKEDA$$59$YR$$F$Y$$$20240925$$HP$US$US
189119404$18911940$4$F$20210106$20240812$20210219$20240815$EXP$$IL-ABBVIE-21K-082-3776107-00$ABBVIE$$67$YR$$M$Y$111$KG$20240815$$MD$IL$IL
189123055$18912305$5$F$$20240819$20210218$20240823$EXP$$NVSC2021CA037003$NOVARTIS$$65$YR$$F$Y$69$KG$20240823$$HP$CA$CA
1891243911$18912439$11$F$$20240925$20210218$20240930$EXP$$US-TAKEDA-US202005307$TAKEDA$$$$$M$Y$105$KG$20240930$$HP$US$US
189125513$18912551$3$F$$20240916$20210218$20240923$EXP$$CA-BAUSCH-BL-2021-005174$BAUSCH AND LOMB$$51$YR$$F$Y$136$KG$20240923$$MD$CA$CA
189130989$18913098$9$F$$20240916$20210219$20240923$EXP$$CA-BAUSCH-BL-2021-005025$BAUSCH AND LOMB$$50$YR$$M$Y$$$20240923$$CN$CA$CA
189136319$18913631$9$F$20240101$20240725$20210218$20240729$EXP$$US-PFIZER INC-2021014091$PFIZER$$26$YR$$M$Y$$$20240729$$HP$US$US
189138927$18913892$7$F$20210205$20240912$20210219$20240916$PER$$NVSC2021US030602$NOVARTIS$$5$YR$$M$Y$$$20240916$$HP$US$US
1891464438$18914644$38$F$$20240916$20210218$20240930$EXP$$CA-BAUSCH-BL-2021-005026$BAUSCH AND LOMB$UNKNOWN, UNKNOWN. Unspecified Article. Unspecified Journal.$66$YR$$M$Y$70$KG$20240930$$CN$CA$CA
189152117$18915211$7$F$$20211229$20210219$20240926$PER$$US-GLAXOSMITHKLINE-US2021AMR047065$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
1891521417$18915214$17$F$20210215$20220602$20210219$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR046271$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240925$$CN$US$US
1891546013$18915460$13$F$20211001$20211129$20210219$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR047070$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240925$$CN$US$US
189155266$18915526$6$F$20181004$20240826$20210219$20240830$EXP$$CA-TAKEDA-2018TUS022708$TAKEDA$$56$YR$$F$Y$$$20240830$$CN$CA$CA
189157362$18915736$2$F$$20240816$20210219$20240822$EXP$$US-SA-2021SA043637$SANOFI AVENTIS$Sheikh T, Shuja H, Zaidi SR, Haque A.. Glucocorticoid-induced cardiomyopathy: Unexpected conclusion.. BMJ Case Reports.. 2020;13(11):e237173$26$YR$A$M$Y$$$20240822$$MD$US$US
189159073$18915907$3$F$20210112$20240904$20210219$20240906$EXP$$FR-ROCHE-2767968$ROCHE$$66$YR$E$F$Y$63$KG$20240906$$HP$FR$FR
189163559$18916355$9$F$$20240618$20210219$20240712$EXP$$CA-PFIZER INC-2021170755$MYLAN$$11$YR$$M$Y$$$20240712$$HP$CA$CA
189165645$18916564$5$F$20210101$20240919$20210219$20240925$EXP$$US-KYOWAKIRIN-2021BKK002385$KYOWA$$$$$$Y$$$20240925$$HP$US$US
1891700610$18917006$10$F$20210223$20240628$20210219$20240705$EXP$$CA-TAKEDA-2020TUS060926$TAKEDA$$70$YR$$M$Y$$$20240705$$HP$CA$CA
189170083$18917008$3$F$20240301$20240731$20210219$20240806$EXP$$BR-TAKEDA-BR202009994$TAKEDA$$42$YR$$M$Y$82$KG$20240806$$CN$BR$BR
1891726520$18917265$20$F$20181019$20240823$20210219$20240829$EXP$$US-SHIRE-US201933590AA$TAKEDA$$74$YR$$F$Y$63$KG$20240829$$CN$US$US
1891736111$18917361$11$F$20210722$20240906$20210219$20240913$EXP$$CA-TAKEDA-2021TUS009482$TAKEDA$$53$YR$$F$Y$$$20240913$$HP$CA$CA
189175595$18917559$5$F$20201201$20240916$20210219$20240918$PER$$US-PFIZER INC-2020092140$PFIZER$$73$YR$$F$Y$$$20240918$$CN$US$US
189175862$18917586$2$F$$20240822$20210219$20240829$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2021EME038028$VIIV$$$$$$Y$$$20240829$$HP$GB$GB
1891765510$18917655$10$F$20200402$20240711$20210219$20240715$EXP$$US-SHIRE-US202012301$TAKEDA$$49$YR$$F$Y$$$20240715$$CN$US$US
189179804$18917980$4$F$20190923$20240821$20210220$20240828$EXP$$CO-AMGEN-COLSL2019168682$AMGEN$$57$YR$A$M$Y$$$20240827$$CN$CO$CO
189181202$18918120$2$F$20110330$20240813$20210219$20240814$PER$$US-PFIZER INC-2020489699$PFIZER$$47$YR$$F$Y$$$20240814$$LW$US$US
1891906112$18919061$12$F$20181029$20240819$20210220$20240828$EXP$$CA-SHIRE-CA202001861$TAKEDA$$79$YR$$F$Y$$$20240828$$CN$CA$CA
189192724$18919272$4$F$20201201$20240729$20210220$20240731$EXP$$CA-TAKEDA-2020TUS045547$TAKEDA$$69$YR$$M$Y$$$20240731$$MD$CA$CA
189194244$18919424$4$F$$20240829$20210221$20240909$EXP$$JP-JNJFOC-20210204534$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240909$$MD$JP$JP
189197743$18919774$3$F$$20240822$20210221$20240903$EXP$$CA-AUROBINDO-AUR-APL-2018-049516$AUROBINDO$Hohl CM, Badke K, Zhao A, Wickham ME, Woo SA, Sivilotti MLA et al.. Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug Events.. Academic Emergency Medicine.. 2018;25(9):1015-1026$73$YR$$M$Y$$$20240903$$MD$CA$CA
189202767$18920276$7$F$$20240814$20210222$20240820$EXP$$CA-AUROBINDO-AUR-APL-2021-006601$AUROBINDO$$30$YR$$M$Y$$$20240820$$HP$CA$CA
189204083$18920408$3$F$$20240827$20210222$20240905$EXP$$CA-AUROBINDO-AUR-APL-2021-007133$AUROBINDO$$79$YR$$M$Y$$$20240905$$HP$CA$CA
189210842$18921084$2$F$$20210215$20210222$20240712$EXP$$NVSC2021GB037183$NOVARTIS$$$$$F$Y$$$20240712$$CN$GB$GB
189228838$18922883$8$F$20190801$20240812$20210222$20240816$EXP$$CA-TAKEDA-2019TUS049942$TAKEDA$$62$YR$$M$Y$$$20240816$$CN$CA$CA
189233684$18923368$4$F$20210201$20240912$20210222$20240918$EXP$$US-TAKEDA-2021TUS009853$TAKEDA$$38$YR$$F$Y$58$KG$20240918$$CN$US$US
1892413611$18924136$11$F$$20240806$20210222$20240818$EXP$$NVSC2021CO039095$NOVARTIS$$$$$F$Y$79$KG$20240818$$CN$CO$CO
1892428521$18924285$21$F$20200413$20240906$20210222$20240912$EXP$$US-TAKEDA-US202010807$TAKEDA$$40$YR$$F$Y$$$20240912$$HP$US$US
189243592$18924359$2$F$$20240816$20210222$20240820$EXP$$US-BAUSCH-BL-2021-005605$BAUSCH AND LOMB$Sheikh T, Shuja H, Zaidi S, Haque A. Glucocorticoid-induced cardiomyopathy: Unexpected conclusion. BMJ Case Reports. 2020;13:1-5. doi:10.1136/bcr-2020237173$26$YR$$M$Y$$$20240820$$MD$US$US
189245968$18924596$8$F$$20240809$20210222$20240813$PER$$US-PFIZER INC-2021167617$PFIZER$$61$YR$$F$Y$$$20240813$$HP$US$US
189246482$18924648$2$F$20150901$20240926$20210222$20240930$EXP$$DE-PFIZER INC-2021151087$PFIZER$$$$$$Y$$$20240930$$MD$DE$DE
1892507515$18925075$15$F$20210118$20240826$20210223$20240831$EXP$$CA-TAKEDA-2021TUS010240$TAKEDA$$50$YR$$F$Y$$$20240831$$MD$CA$CA
189251263$18925126$3$F$$20240716$20210222$20240729$EXP$$US-009507513-2102USA007506$MERCK$Winzent S, Dahl N, Hemenway M, Lovria R, Dorris K.. Concurrent use of aprepitant and ifosfamide in pediatric cancer patients. Neuro?Oncology. 2020;22 Suppl 3:iii424$7$YR$$F$Y$$$20240729$$HP$US$US
189251296$18925129$6$F$20210208$20240626$20210222$20240701$PER$$US-PFIZER INC-2021139164$PFIZER$$62$YR$$F$Y$77.7$KG$20240701$$CN$US$US
189262466$18926246$6$F$20240910$20240911$20210223$20240917$EXP$$CA-ROCHE-2773436$ROCHE$$54$YR$A$M$Y$$$20240917$$CN$CA$CA
189263835$18926383$5$F$$20210616$20210223$20240701$EXP$$US-AKCEA THERAPEUTICS-2020IS001607$AKCEA THERAPEUTICS$$$$$$Y$$$20240701$$MD$US$US
189267124$18926712$4$F$$20240811$20210223$20240821$EXP$$SA-AMGEN-SAUSP2021025378$AMGEN$Dada, R. Evaluation of fractionated ice as an alternative outpatient option for relapsed/refractory lymphomas. Bone Marrow Transplantation. 2020;55:519$$$$$Y$$$20240821$$MD$SA$SA
189275564$18927556$4$F$20201121$20240624$20210223$20240708$EXP$$JP-RECORDATI RARE DISEASES INC.-2021000643$RECORDATI$$$$$$Y$$$20240708$$MD$JP$JP
189276214$18927621$4$F$20240727$20240906$20210223$20240916$30DAY$$US-GLAXOSMITHKLINE-US2021AMR049796$GLAXOSMITHKLINE$$37$YR$$F$Y$$$20240916$$CN$US$US
189279672$18927967$2$F$20201230$20240905$20210223$20240913$EXP$$US-SA-2021SA060951$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240913$$MD$US$US
189283135$18928313$5$F$$20240823$20210223$20240828$EXP$$US-TAKEDA-2021TUS011453$TAKEDA$$$$$F$Y$92.517$KG$20240828$$CN$US$US
1892840522$18928405$22$F$20200318$20240725$20210223$20240731$EXP$$MX-TAKEDA-MX202010702$TAKEDA$$4$YR$$M$Y$18$KG$20240731$$HP$MX$MX
189286694$18928669$4$F$$20240621$20210223$20240703$PER$$NVSC2021US033958$NOVARTIS$$$$$M$Y$$$20240703$$CN$US$US
1892915618$18929156$18$F$20221201$20240815$20210223$20240821$PER$$US-BIOGEN-2021BI00981878$BIOGEN$$54$YR$$F$Y$$$20240821$$CN$US$US
1892919713$18929197$13$F$20210101$20240624$20210223$20240805$PER$$CA-TOLMAR, INC.-21CA025533$TOLMAR$$$$$M$Y$$$20240805$$CN$CA$CA
189292104$18929210$4$F$20210101$20240715$20210223$20240720$EXP$$US-AMGEN-USASP2021028015$AMGEN$$52$YR$A$M$Y$$$20240720$$HP$US$US
1892926816$18929268$16$F$20210319$20240918$20210223$20240924$EXP$$CO-TAKEDA-2021TUS010490$TAKEDA$$8$YR$$M$Y$27$KG$20240924$$MD$CO$CO
189313127$18931312$7$F$20191101$20240812$20210223$20240819$PER$$US-JAZZ-2020-US-016487$JAZZ$$55$YR$$F$Y$$$20240819$$MD$US$US
189323932$18932393$2$F$$20240827$20210223$20240906$EXP$$CA-AUROBINDO-AUR-APL-2019-089300$AUROBINDO$$81$YR$$F$Y$54$KG$20240906$$HP$CA$CA
189328413$18932841$3$F$$20240717$20210224$20240722$EXP$$CA-Orion Corporation ORION PHARMA-21_00013285$ORION$$69$YR$E$F$Y$$$20240719$$HP$CA$
1893357026$18933570$26$F$$20240826$20210224$20240907$EXP$$CA-GLENMARK PHARMACEUTICALS-2021GMK052211$GLENMARK$$$$$$Y$$$20240907$$HP$CA$CA
1893515520$18935155$20$F$$20240812$20210224$20240813$EXP$$US-TAKEDA-2020TUS053123$TAKEDA$$$$$F$Y$$$20240813$$HP$US$US
189354507$18935450$7$F$20200101$20240626$20210224$20240704$PER$$CA-TOLMAR, INC.-21CA025475$TOLMAR$$$$$M$Y$$$20240704$$CN$CA$CA
189356035$18935603$5$F$$20240712$20210224$20240716$EXP$$US-TAKEDA-2021TUS011776$TAKEDA$$$$$M$Y$132$KG$20240716$$HP$US$US
189357353$18935735$3$F$20200218$20240626$20210225$20240703$EXP$$AT-CELLTRION INC.-2021AT002176$CELLTRION$$$$$$Y$$$20240704$$MD$AT$AT
189357712$18935771$2$F$$20240726$20210225$20240805$PER$$US-SA-2021SA060775$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240805$$MD$US$US
189360384$18936038$4$F$20201201$20240729$20210224$20240801$EXP$$NVSC2021EG039466$NOVARTIS$$45$YR$$F$Y$70$KG$20240801$$CN$EG$EG
189361035$18936103$5$F$20210311$20240808$20210224$20240814$EXP$$US-TAKEDA-2021TUS011850$TAKEDA$$59$YR$$F$Y$59$KG$20240814$$CN$US$US
1893617725$18936177$25$F$20240627$20240722$20210224$20240725$EXP$$US-SHIRE-US201934474$TAKEDA$$30$YR$$F$Y$136$KG$20240725$$CN$US$US
189365004$18936500$4$F$20150302$20240726$20210225$20240819$PER$$CO-TOLMAR, INC.-2019CO003134$TOLMAR$$$$$$Y$$$20240819$$CN$CO$CO
1893661013$18936610$13$F$20200701$20240910$20210225$20240919$EXP$$ES-ROCHE-2769158$ROCHE$$13$YR$T$F$Y$32$KG$20240919$$MD$ES$ES
189366389$18936638$9$F$20210308$20240829$20210224$20240903$EXP$$US-JAZZ-2021-US-003051$JAZZ$$33$YR$$F$Y$$$20240903$$HP$US$US
189369783$18936978$3$F$$20240701$20210224$20240712$EXP$$US-TEVA-2021-US-1880022$TEVA$$$$E$M$Y$$$20240712$$LW$US$US
189378033$18937803$3$F$$20240923$20210224$20240930$EXP$$CA-BAUSCH-BL-2021-005925$BAUSCH AND LOMB$$56$YR$$M$Y$$$20240930$$HP$CA$CA
189380607$18938060$7$F$20210115$20240710$20210225$20240717$EXP$$NVSC2021MX040862$NOVARTIS$$55$YR$$F$Y$$$20240717$$CN$MX$MX
189396593$18939659$3$F$20191227$20240704$20210225$20240708$EXP$$CA-TAKEDA-2020TUS001385$TAKEDA$$66$YR$$F$Y$$$20240708$$CN$CA$CA
189397854$18939785$4$F$20200601$20240701$20210224$20240712$PER$$US-HORIZON THERAPEUTICS-HZN-2021-000553$AMGEN$Kishk O.A.; Kim I.; Cheng C.; Summan M.; Munoz M.A.. Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients. Pediatric Nephrology. 2024;39 (3):1-5$5$YR$C$M$Y$20$KG$20240712$$HP$US$US
189398224$18939822$4$F$$20240708$20210224$20240710$PER$$US-PFIZER INC-2021177456$PFIZER$$70$YR$$F$Y$84.807$KG$20240710$$CN$US$US
189408197$18940819$7$F$20230501$20240807$20210225$20240817$30DAY$$US-GLAXOSMITHKLINE-US2021AMR052873$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240817$$CN$US$US
1894125431$18941254$31$F$$20240627$20210225$20240702$EXP$$CA-ORGANON-1509CAN012569$ORGANON$$$$$F$Y$97$KG$20240702$$HP$CA$CA
1894180214$18941802$14$F$20190101$20240918$20210225$20240925$EXP$$CA-TAKEDA-2019TUS048316$TAKEDA$$$$$F$Y$$$20240925$$CN$CA$CA
1894204612$18942046$12$F$20200909$20240723$20210225$20240726$EXP$$CA-TAKEDA-2020TUS035484$TAKEDA$$53$YR$$M$Y$$$20240726$$CN$CA$CA
1894226213$18942262$13$F$20201001$20240909$20210225$20240913$EXP$$US-SHIRE-US201942005$TAKEDA$$59$YR$$F$Y$$$20240913$$HP$US$US
189423293$18942329$3$F$$20240912$20210225$20240918$EXP$$US-TAKEDA-2021TUS010863$TAKEDA$$$$$M$Y$81$KG$20240918$$MD$US$US
189427966$18942796$6$F$20210214$20240827$20210225$20240902$EXP$$GB-ROCHE-2774435$ROCHE$$63$YR$A$M$Y$80.1$KG$20240902$$MD$GB$GB
1894316915$18943169$15$F$20201201$20240622$20210226$20240717$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-000458$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240717$$CN$US$US
189436812$18943681$2$F$$20240816$20210226$20240828$EXP$$ES-AUROBINDO-AUR-APL-2021-008387$AUROBINDO$Sisinni L, Mozo Y, Bueno D, De Paz R, Lopez-Granados E, Perez-Martinez A.. Hemophagocytic syndrome after ex-vivo lymphodepleted hematopoietic transplantation.. Bone Marrow Transplant, 46 th Annual meeting of the european society for blood. 2020;55:614-615$2$YR$$M$Y$$$20240828$$MD$ES$ES
1894378156$18943781$56$F$$20240913$20210226$20240925$EXP$$GB-AUROBINDO-AUR-APL-2021-007676$AUROBINDO$$$$E$F$Y$$$20240925$$HP$GB$GB
189440124$18944012$4$F$$20240917$20210226$20240925$EXP$$ES-AUROBINDO-AUR-APL-2021-008388$AUROBINDO$Sisinni L, Mozo Y, Bueno D, De Paz R, Lopez-Granados E, Perez-Martinez A. Hemophagocytic syndrome after ex-vivo lymphodepleted hematopoietic transplantation.. Bone Marrow Transplant. 2020;55:614-615.$10$YR$$M$Y$$$20240925$$MD$ES$ES
189441042$18944104$2$F$20200313$20240805$20210226$20240809$EXP$ES-AEMPS-742330$ES-AMGEN-ESPSP2021031062$AMGEN$$39$YR$A$F$Y$53$KG$20240809$$CN$ES$ES
189443402$18944340$2$F$$20240720$20210226$20240730$EXP$$DE-AUROBINDO-AUR-APL-2021-007794$AUROBINDO$Zilles-Wegner D, Trost S, Walliser K, Saager L, Horn S, Ernst M.. Electroconvulsive therapy in pregnancy: case report and interdisciplinary treatment suggestions.. Der Nervenarzt. 2021;92(50):50-56$18$YR$$F$Y$$$20240730$$MD$DE$DE
189446074$18944607$4$F$$20240919$20210226$20240927$PER$$US-GLAXOSMITHKLINE-US2021051484$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
189448024$18944802$4$F$20060501$20240730$20210226$20240807$EXP$$US-JNJFOC-20210230297$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240807$$LW$US$US
1894488310$18944883$10$F$20191003$20240919$20210226$20240925$EXP$$CA-TAKEDA-2019TUS039434$TAKEDA$$50$YR$$F$Y$$$20240925$$HP$CA$CA
189451194$18945119$4$F$$20240729$20210226$20240801$EXP$$US-GW PHARMA-202102USGW00618$JAZZ$$$$$M$Y$$$20240731$$CN$US$US
189456273$18945627$3$F$20150601$20240703$20210226$20240710$EXP$GB-MHRA-ADR 23046048$GB-MHRA-ADR 23046048$ASPEN$$$$$$Y$$$20240710$$PH$GB$GB
189458449$18945844$9$F$$20240821$20210226$20240826$EXP$$CA-MYLANLABS-2021M1009886$MYLAN$$78$YR$$F$Y$93$KG$20240826$$CN$CA$CA
189458745$18945874$5$F$$20240906$20210226$20240919$EXP$$GB-ADVANZ PHARMA-202102001535$ADVANZ PHARMA$$$$$$Y$$$20240919$$MD$GB$GB
189462763$18946276$3$F$20010218$20240628$20210226$20240701$EXP$$US-PURDUE-USA-2021-0218985$PURDUE$$18$YR$$M$Y$$$20240701$$CN$US$US
189462808$18946280$8$F$$20240715$20210226$20240717$EXP$$CA-PURDUE-USA-2021-0220484$PURDUE$$63$YR$$F$Y$$$20240717$$HP$CA$CA
1894630311$18946303$11$F$20150101$20240809$20210226$20240814$EXP$$US-PFIZER INC-2019495416$PFIZER$$52$YR$$F$Y$83.9$KG$20240814$$CN$US$US
1894634923$18946349$23$F$20200402$20240808$20210226$20240815$EXP$$MX-TAKEDA-MX202012509$TAKEDA$$10$YR$$M$Y$54$KG$20240815$$CN$MX$MX
189464463$18946446$3$F$$20240802$20210226$20240816$EXP$$US-PURDUE-USA-2020-0210199$PURDUE$$$$$M$Y$$$20240816$$CN$US$US
189465512$18946551$2$F$$20210216$20210226$20240718$EXP$$RU-AstraZeneca-2021A065762$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$RU$
189465864$18946586$4$F$20240501$20240919$20210226$20240927$EXP$$US-TAKEDA-2021TUS012501$TAKEDA$$70$YR$$F$Y$58$KG$20240927$$CN$US$US
189467269$18946726$9$F$20200312$20240905$20210226$20240911$EXP$$CA-TAKEDA-2021TUS010712$TAKEDA$$73$YR$$M$Y$$$20240911$$HP$CA$CA
189469012$18946901$2$F$$20240808$20210226$20240808$EXP$$NVSC2021IT045280$NOVARTIS$Barbaro D, Lapi P, Viacava P, Torregrossa L. Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safe. BMJ CASE REPORTS. 2020;13(12):e236934$74$YR$$M$Y$$$20240808$$HP$IT$IT
189472455$18947245$5$F$20180701$20240829$20210227$20240910$EXP$$JP-ABBVIE-19P-087-2663630-00$ABBVIE$$38$YR$$M$Y$83$KG$20240910$$MD$JP$JP
1895000817$18950008$17$F$20191101$20240819$20210227$20240827$EXP$$NVSC2021HR042645$NOVARTIS$$56$YR$$F$Y$$$20240827$$MD$HR$HR
1895006919$18950069$19$F$20200624$20240923$20210228$20240925$EXP$$CA-ROCHE-2630979$ROCHE$$45$YR$A$F$Y$$$20240925$$CN$CA$CA
1895210520$18952105$20$F$20210216$20240918$20210301$20240927$EXP$$GB-TAKEDA-2021TUS010890$TAKEDA$$77$YR$$F$Y$$$20240927$$CN$GB$GB
189522075$18952207$5$F$20210701$20240816$20210301$20240822$EXP$$US-SA-2021SA066645$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240822$$CN$US$US
189522302$18952230$2$F$$20240624$20210301$20240701$EXP$$CA-BAUSCH-BL-2021-005951$BAUSCH AND LOMB$UNKNOWN. Unspecified Article. Unspecified Journal.$54$YR$$F$Y$$$20240701$$HP$CA$CA
189523268$18952326$8$F$$20211019$20210301$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR053818$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
189525802$18952580$2$F$20200101$20240813$20210301$20240815$EXP$$DE-ROCHE-2775645$ROCHE$Hollein A, Bojko P, Schulz S, Neitz J, Stotzer O, Pihusch R, Abedinpour F, Schmidt B, and Hentrich M Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study. Acta Oncologica 2021;60 (1):24-7.$42$YR$A$F$Y$$$20240815$$HP$DE$DE
189526233$18952623$3$F$20190101$20240822$20210301$20240903$EXP$$FR-AUROBINDO-AUR-APL-2021-008574$AUROBINDO$$65$YR$$M$Y$80$KG$20240903$$PH$FR$FR
1895343520$18953435$20$F$20201101$20230413$20210301$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR053880$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$HP$US$US
189538742$18953874$2$F$20191218$20240920$20210301$20240925$PER$$US-TAKEDA-2021TUS012825$TAKEDA$$59$YR$$F$Y$$$20240925$$HP$US$US
189544859$18954485$9$F$20210414$20240924$20210301$20240926$EXP$$CA-TAKEDA-2020TUS022680$TAKEDA$$44$YR$$M$Y$$$20240926$$MD$CA$CA
1895452213$18954522$13$F$20210101$20240627$20210301$20240701$EXP$$US-PFIZER INC-2021209297$PFIZER$$77$YR$$M$Y$$$20240701$$HP$US$US
189552012$18955201$2$F$$20240911$20210301$20240921$EXP$$DE-ROCHE-2775789$ROCHE$$$$$M$Y$$$20240921$$HP$DE$DE
189553073$18955307$3$F$$20240826$20210301$20240904$EXP$$US-PFIZER INC-2021201616$PFIZER$Vien, L.. Interstitial Emphysema as a Rare Radiographic Presentation of Bronchial Dehiscence after Lung Transplant. Case Reports in Pulmonology. 2020;10.1155/2020/8830361$66$YR$$M$Y$$$20240904$$MD$US$US
189553102$18955310$2$F$$20240904$20210301$20240910$EXP$$US-PFIZER INC-2021198584$PFIZER$Tsai, A.. Mesenteric venous thrombosis: A lethal complication of hyperglycemic crises. American Journal of Health-System Pharmacy. 2021;78 (2):105-107$44$YR$$M$Y$150$KG$20240910$$PH$US$US
1895542136$18955421$36$F$20240201$20240916$20210301$20240923$EXP$$US-TAKEDA-US202032013$TAKEDA$$77$YR$$F$Y$46$KG$20240923$$CN$US$US
1895568019$18955680$19$F$20210101$20240829$20210301$20240904$EXP$$IN-PFIZER INC-2021185884$PFIZER$$82$YR$$F$Y$$$20240904$$CN$IN$IN
189560492$18956049$2$F$$20240720$20210302$20240730$EXP$$DE-AUROBINDO-AUR-APL-2021-008335$AUROBINDO$Zilles-Wegner  D, Trost S, Walliser K, Saager L, Horn S, Ernst M. Elektrokonvulsionstherapie in der Schwangerschaft: Fallbericht und interdisziplinare Behandlungsvorschlage [Electroconvulsive therapy in pregnancy: case report and interdisciplinary treatment suggestions]. Nervenarzt. 2021;92 (1):50-56$18$YR$$F$Y$$$20240730$$HP$DE$DE
189560773$18956077$3$F$$20240906$20210301$20240913$EXP$$US-GILEAD-2021-0519008$GILEAD$$56$YR$A$M$Y$$$20240913$$HP$US$US
1895643216$18956432$16$F$20201209$20240823$20210302$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-016669$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$52$KG$20240829$$PH$JP$JP
189565683$18956568$3$F$$20240826$20210302$20240905$EXP$$US-AUROBINDO-AUR-APL-2021-007974$AUROBINDO$Vien LP, Marron RM, Charlie A, Kumaran M, Brown JC.. Interstitial Emphysema as a Rare Radiographic Presentation of Bronchial Dehiscence after Lung Transplant. Case Reports in Pulmonology. 2020;2020:1-5$66$YR$$M$Y$$$20240905$$MD$US$US
1895690038$18956900$38$F$20210101$20240910$20210302$20240919$EXP$$CA-CELLTRION INC.-2021CA002682$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
189571915$18957191$5$F$$20240712$20210302$20240722$PER$$US-SA-2021SA068578$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240720$$MD$US$US
189583156$18958315$6$F$$20240909$20210302$20240917$EXP$$CA-ROCHE-2773281$ROCHE$$65$YR$E$F$Y$72$KG$20240917$$HP$CA$CA
1895878331$18958783$31$F$$20240624$20210302$20240701$EXP$$CA-GLAXOSMITHKLINE-CA2021GSK053562$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$HP$CA$CA
1895930223$18959302$23$F$20210218$20240924$20210302$20240930$EXP$$US-TAKEDA-2021TUS011387$TAKEDA$$73$YR$$F$Y$91$KG$20240930$$MD$US$US
1895991334$18959913$34$F$$20240919$20210302$20240926$EXP$$CA-PURDUE-USA-2021-0223272$PURDUE$$53$YR$$M$Y$$$20240926$$HP$CA$CA
189601646$18960164$6$F$$20240820$20210302$20240827$EXP$$NVSC2021CA047361$NOVARTIS$$57$YR$$F$Y$$$20240827$$CN$CA$CA
1896104817$18961048$17$F$20200808$20240703$20210302$20240712$EXP$$CA-TAKEDA-2021TUS009072$TAKEDA$$25$YR$$F$Y$$$20240712$$MD$CA$CA
189610586$18961058$6$F$20240812$20240812$20210302$20240814$EXP$$US-TAKEDA-US201827633$TAKEDA$$67$YR$$F$Y$$$20240814$$MD$US$US
189625313$18962531$3$F$20090622$20240719$20210303$20240725$EXP$$US-TAKEDA-SPV1-2009-01370$TAKEDA$$2$YR$$M$Y$$$20240725$$CN$US$US
189625803$18962580$3$F$20240101$20240821$20210303$20240912$PER$$US-SA-2021SA070054$SANOFI AVENTIS$$66$YR$E$F$Y$70$KG$20240912$$MD$US$US
189626818$18962681$8$F$20200429$20240705$20210303$20240710$EXP$$US-TAKEDA-US202012222$TAKEDA$$6$YR$$M$Y$45$KG$20240710$$PH$US$US
189645836$18964583$6$F$$20240913$20210303$20240924$EXP$$US-AMNEAL PHARMACEUTICALS-2020-AMRX-03816$AMNEAL$$$$$F$Y$$$20240924$$CN$US$US
189648147$18964814$7$F$$20240629$20210303$20240701$EXP$$US-PFIZER INC-2021223632$PFIZER$$72$YR$$$Y$$$20240701$$CN$US$US
189648756$18964875$6$F$20190501$20240918$20210303$20240925$EXP$$CA-TAKEDA-2019TUS030146$TAKEDA$$39$YR$$M$Y$$$20240925$$CN$CA$CA
189648945$18964894$5$F$20200101$20240924$20210303$20240930$EXP$$US-AMNEAL PHARMACEUTICALS-2020-AMRX-01223$AMNEAL$$$$$F$Y$72.562$KG$20240930$$CN$US$US
189657802$18965780$2$F$$20240819$20210304$20240827$EXP$$CA-JNJFOC-20210247924$JOHNSON AND JOHNSON$$67$YR$E$M$Y$101$KG$20240827$$CN$CA$CA
189671432$18967143$2$F$$20240716$20210304$20240726$EXP$$US-GLAXOSMITHKLINE-US2021AMR056846$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$MD$US$US
1896758751$18967587$51$F$20150618$20240916$20210304$20240924$EXP$$CO-TAKEDA-CO201506588$TAKEDA$$12$YR$$M$Y$48$KG$20240924$$CN$CO$CO
1896814520$18968145$20$F$20201002$20240911$20210304$20240918$EXP$$BR-GLAXOSMITHKLINE-BR1976GSK000001$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$BR$BR
1896830417$18968304$17$F$20210424$20240725$20210304$20240731$EXP$$US-TAKEDA-2021TUS013750$TAKEDA$$60$YR$$M$Y$79$KG$20240731$$HP$US$US
1896872910$18968729$10$F$20190731$20240702$20210304$20240706$EXP$$US-TAKEDA-US201925513$TAKEDA$$13$YR$$M$Y$34$KG$20240706$$HP$US$US
1896937615$18969376$15$F$$20240715$20210304$20240716$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085933$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240716$$HP$CA$CA
189694599$18969459$9$F$20230227$20240909$20210304$20240913$EXP$$US-TAKEDA-2021TUS012105$TAKEDA$$20$YR$$M$Y$113$KG$20240913$$CN$US$US
1896970013$18969700$13$F$20210222$20240923$20210304$20240930$EXP$$US-SHIRE-US202031729$TAKEDA$$42$YR$$F$Y$$$20240930$$HP$US$US
189700814$18970081$4$F$20200101$20240703$20210304$20240708$PER$$US-VERTEX PHARMACEUTICALS-2020-018930$VERTEX$$57$YR$$F$Y$119$KG$20240708$$CN$US$US
1897008811$18970088$11$F$20200101$20240802$20210304$20240802$EXP$$US-PFIZER INC-2020290947$PFIZER$$70$YR$$F$Y$98.43$KG$20240802$$CN$US$US
189701314$18970131$4$F$$20240808$20210304$20240813$EXP$$US-TAKEDA-2021TUS013744$TAKEDA$$$$$F$Y$$$20240813$$HP$US$US
1897032022$18970320$22$F$20180507$20240715$20210305$20240723$EXP$$CA-ROCHE-2192256$ROCHE$$57$YR$A$F$Y$115$KG$20240723$$HP$CA$CA
1897035233$18970352$33$F$20200101$20240918$20210305$20240927$EXP$$CA-CELLTRION INC.-2020CA024894$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
189710362$18971036$2$F$20200101$20240801$20210304$20240809$EXP$$CA-009507513-2103CAN000692$MERCK$$3$DY$$F$Y$3$KG$20240809$$HP$CA$CA
189711132$18971113$2$F$$20240912$20210305$20240926$EXP$US-MLMSERVICE-20210212-2721451-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-00969$ALKEM$Shiroky J. Dermatopathology cinches the diagnosis for spor(E)adic fevers. Journal of General Internal Medicine. 2020;35(1):S440-41$63$YR$$F$Y$$$20240926$$HP$US$US
189713054$18971305$4$F$$20240821$20210305$20240827$EXP$$CA-BAUSCH-BL-2021-006678$BAUSCH AND LOMB$$65$YR$$F$Y$69$KG$20240827$$HP$CA$CA
1897224625$18972246$25$F$20190715$20240723$20210305$20240731$EXP$$CA-CELLTRION INC.-2019CA020435$CELLTRION$$$$$$Y$$$20240731$$CN$CA$CA
1897228022$18972280$22$F$$20240823$20210305$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-021130$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240902$$MD$JP$JP
1897232320$18972323$20$F$20210209$20240806$20210305$20240812$EXP$$CA-ROCHE-2776675$ROCHE$$31$YR$A$F$Y$$$20240812$$CN$CA$CA
189731593$18973159$3$F$20210101$20240805$20210305$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2021AMR054889$VIIV$$55$YR$$M$Y$$$20240815$$CN$US$US
189734064$18973406$4$F$20210201$20240722$20210305$20240724$EXP$$IN-PFIZER INC-2021211861$PFIZER$$62$YR$$F$Y$90$KG$20240724$$CN$IN$IN
189735794$18973579$4$F$20190101$20240628$20210305$20240705$PER$$US-VERTEX PHARMACEUTICALS-2021-003438$VERTEX$$$$$F$Y$56$KG$20240705$$MD$US$US
1897498555$18974985$55$F$20191205$20240805$20210305$20240807$EXP$$US-TAKEDA-US201942828$TAKEDA$$42$YR$$M$Y$124$KG$20240807$$HP$US$US
1897506114$18975061$14$F$20220620$20240812$20210306$20240820$EXP$$CA-CELLTRION INC.-2020CA021020$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
189751753$18975175$3$F$$20240904$20210306$20240909$PER$$NVSC2021US043141$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
189770907$18977090$7$F$20200821$20240822$20210306$20240829$EXP$$CA-ROCHE-2667371$ROCHE$$26$YR$A$F$Y$$$20240829$$HP$CA$CA
189772034$18977203$4$F$$20240906$20210306$20240918$EXP$$GB-Accord-218822$ACCORD$Yaakub A, Htet ZM, Yardley Ball R, Karim M, Shah SN. Two simultaneous unusual complications after renal transplantation. British Journal of Dermatology. 2020;183(1):140.$47$YR$A$M$Y$$$20240918$$MD$GB$GB
1897778112$18977781$12$F$20080101$20240905$20210306$20240909$EXP$$US-ORGANON-O2103USA000525$ORGANON$$$$$F$Y$92.98$KG$20240909$$MD$US$US
189779554$18977955$4$F$20190101$20240826$20210307$20240910$EXP$$US-TEVA-2021-US-1887159$TEVA$$76$YR$$M$Y$90.71$KG$20240910$$LW$US$US
1897846615$18978466$15$F$20210224$20220405$20210307$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR057510$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240926$$CN$US$US
189786894$18978689$4$F$$20220420$20210308$20240926$PER$$NVSC2021US047083$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
1897923612$18979236$12$F$20210105$20240828$20210308$20240910$EXP$$IL-ABBVIE-21K-082-3799764-00$ABBVIE$$77$YR$$M$Y$68$KG$20240910$$MD$IL$IL
189798205$18979820$5$F$20180813$20240815$20210308$20240821$EXP$$CA-TAKEDA-2019TUS050523$TAKEDA$$62$YR$$M$Y$$$20240821$$MD$CA$CA
1897988611$18979886$11$F$20170329$20240703$20210308$20240705$EXP$$CA-TAKEDA-2017TUS004089$TAKEDA$$42$YR$$F$Y$$$20240705$$HP$CA$CA
189799523$18979952$3$F$20210225$20240917$20210308$20240919$EXP$$US-TAKEDA-2021TUS013811$TAKEDA$$49$YR$$F$Y$89.8$KG$20240919$$HP$US$US
189800725$18980072$5$F$20200101$20240819$20210308$20240823$EXP$$NVSC2021DE051785$NOVARTIS$Hollein A, Bojko P, Schulz S, Neitz J, Stotzer O, Pihusch R et al. Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study. ACTA ONCOLOGICA. 2021;60(1):24-7$42$YR$$F$Y$$$20240823$$HP$DE$DE
1898029413$18980294$13$F$$20240702$20210308$20240704$EXP$$US-PFIZER INC-2019398419$PFIZER$$85$YR$$F$Y$47.619$KG$20240704$$CN$US$US
1898039213$18980392$13$F$$20240726$20210308$20240731$EXP$$US-TAKEDA-2021TUS014247$TAKEDA$$$$$F$Y$86$KG$20240731$$CN$US$US
189804785$18980478$5$F$$20240830$20210308$20240904$EXP$$US-PFIZER INC-2021235054$PFIZER$$74$YR$$F$Y$$$20240904$$CN$US$US
1898077354$18980773$54$F$20200101$20240829$20210308$20240905$EXP$$DE-PURDUE-USA-2021-0227914$PURDUE$$80$YR$$M$Y$69$KG$20240905$$HP$CA$CA
189811545$18981154$5$F$$20240925$20210308$20240930$EXP$$NVSC2021DE047306$NOVARTIS$Affeldt P, Di Cristanziano V, Grundmann F, Wirtz M, Kaiser R, Benzing T et al.. Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation. IMMUNITY INFLAMMATION AND DISEASE. 2021;9(2):513-20$$$$M$Y$$$20240930$$HP$DE$DE
189818793$18981879$3$F$$20240708$20210308$20240709$EXP$$CA-BAUSCH-BL-2021-007496$BAUSCH AND LOMB$$56$YR$$M$Y$$$20240709$$MD$CA$CA
189820695$18982069$5$F$20201201$20240826$20210308$20240902$EXP$$US-GLAXOSMITHKLINE-US2021055908$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
189825895$18982589$5$F$$20240816$20210308$20240821$EXP$$US-PFIZER INC-2021236278$PFIZER$$78$YR$$F$Y$$$20240821$$CN$US$US
1898273411$18982734$11$F$20210510$20240909$20210308$20240917$EXP$$CO-TAKEDA-CO202018048$TAKEDA$$29$YR$$M$Y$100$KG$20240917$$CN$CO$CO
189828473$18982847$3$F$$20240827$20210308$20240830$EXP$$NVSC2021GB048989$NOVARTIS$$$$E$M$Y$$$20240830$$CN$GB$GB
189846746$18984674$6$F$$20240830$20210309$20240906$EXP$$NVSC2021US024473$NOVARTIS$$$$$F$Y$$$20240906$$HP$US$US
189848915$18984891$5$F$20200918$20240710$20210309$20240716$EXP$$CA-TAKEDA-2020TUS038102$TAKEDA$$32$YR$$M$Y$$$20240716$$HP$CA$CA
189852692$18985269$2$F$20200301$20240905$20210309$20240916$PER$$US-SA-2021SA077773$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240916$$MD$US$US
189855382$18985538$2$F$$20210301$20210309$20240809$EXP$$DE-ASTELLAS-2021US007702$ASTELLAS$$77$YR$$M$Y$$$20240809$$CN$DE$DE
189860114$18986011$4$F$20210209$20240722$20210309$20240729$EXP$$US-ROCHE-2783613$ROCHE$$86$YR$E$F$Y$63.5$KG$20240729$$CN$US$US
189862043$18986204$3$F$20160101$20240627$20210309$20240705$EXP$CA-MLMSERVICE-20190621-1809769-1$CA-STRIDES ARCOLAB LIMITED-2021SP002632$STRIDES$Lewin A, Quach C, Rigourd V, Picaud JC, Perreault T, Frange P et al. Bacillus cereus infection in neonates and the absence of evidence for the role of banked human milk: Case reports and literature review. Infection Control and Hospital Epidemiology. 2019;40(7):787-793$6$DY$$$Y$0.56$KG$20240705$$MD$CA$CA
189866277$18986627$7$F$20240910$20240910$20210309$20240916$EXP$$US-TAKEDA-2021TUS015049$TAKEDA$$78$YR$$M$Y$115$KG$20240916$$HP$US$US
189866934$18986693$4$F$20210601$20240712$20210309$20240718$EXP$$CA-TAKEDA-CA202030848$TAKEDA$$66$YR$$F$Y$$$20240718$$CN$CA$CA
1898761312$18987613$12$F$20210211$20240807$20210309$20240902$PER$$CA-TOLMAR, INC.-21CA025587$TOLMAR$$82$YR$$M$Y$$$20240902$$CN$CA$CA
1898805212$18988052$12$F$20191216$20240909$20210309$20240916$EXP$$IE-SHIRE-IE201941832$TAKEDA$$18$YR$$F$Y$$$20240916$$MD$IE$IE
189883175$18988317$5$F$20220210$20240924$20210309$20240930$EXP$$US-SHIRE-US201843517AA$TAKEDA$$50$YR$$F$Y$72.5$KG$20240930$$HP$US$US
189883886$18988388$6$F$$20240925$20210309$20240927$EXP$$US-TAKEDA-US201835218$TAKEDA$$$$$F$Y$$$20240927$$HP$US$US
189893694$18989369$4$F$20210301$20240829$20210309$20240904$EXP$$US-JAZZ-2021-US-004005$JAZZ$$51$YR$$F$Y$$$20240904$$CN$US$US
1898938819$18989388$19$F$20200819$20240716$20210310$20240724$EXP$$CA-CELLTRION INC.-2020CA022863$CELLTRION$$$$$$Y$$$20240724$$HP$CA$CA
189896773$18989677$3$F$20200101$20240816$20210310$20240828$EXP$$DE-AUROBINDO-AUR-APL-2021-009574$AUROBINDO$Hollein A, Bojko P, Schulz S, Neitz J, Stotzer O, Pihusch R et al.. Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study.. Acta Oncologica. 2021;60 (1):24-27$42$YR$$F$Y$$$20240828$$MD$DE$DE
1899018212$18990182$12$F$20210224$20240822$20210310$20240904$EXP$$JP-ALXN-A202102896AA$ALEXION PHARMACEUTICALS$$0$YR$$F$Y$2.314$KG$20240904$$MD$JP$JP
189908023$18990802$3$F$20190730$20240718$20210310$20240728$EXP$$US-SA-2021SA079620$SANOFI AVENTIS$$55$YR$A$M$Y$62.5$KG$20240728$$MD$US$US
1899096515$18990965$15$F$$20240813$20210310$20240819$EXP$$US-TAKEDA-2021TUS015250$TAKEDA$$$$$M$Y$91$KG$20240819$$HP$US$US
189910204$18991020$4$F$$20240704$20210310$20240711$EXP$$JP-AMGEN-JPNSP2021033953$AMGEN$Tooya T.; Mukae J.; Kunuma R. et al.. Labile CD22 and CD19 expression in a case of Philadelphia chromosome-like acute lymphoblastic leukemia. Leukemia and Lymphoma. 2022;63 (13):3261-3264$19$YR$A$M$Y$$$20240711$$HP$JP$JP
189913344$18991334$4$F$20210301$20240910$20210310$20240912$EXP$$US-TAKEDA-US202010047$TAKEDA$$13$YR$$M$Y$$$20240912$$CN$US$US
189913834$18991383$4$F$20170921$20240716$20210310$20240718$EXP$$CA-TAKEDA-2017TUS016859$TAKEDA$$64$YR$$F$Y$$$20240718$$CN$CA$CA
189915164$18991516$4$F$20210305$20240923$20210310$20240927$EXP$$CA-TAKEDA-2021TUS013432$TAKEDA$$46$YR$$M$Y$$$20240927$$CN$CA$CA
189916846$18991684$6$F$20170801$20240803$20210310$20240809$EXP$$NVSC2020MX342854$NOVARTIS$$73$YR$$M$Y$84$KG$20240809$$CN$MX$MX
1899285711$18992857$11$F$$20240816$20210310$20240823$EXP$$US-TAKEDA-US202026654$TAKEDA$$$$$M$Y$96.599$KG$20240823$$HP$US$US
189936733$18993673$3$F$$20240905$20210310$20240909$EXP$$GB-PFIZER INC-2021240301$MYLAN$Sadik, A,Jelley M, Ward R. Depression with psychosis following pregabalin discontinuation. Progress in Neurology and Psychiatry. 2021;25 (1):19-22$74$YR$$F$Y$$$20240909$$HP$GB$GB
189937779$18993777$9$F$20210925$20211220$20210311$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR058836$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
189939093$18993909$3$F$$20240729$20210310$20240731$EXP$$CA-TAKEDA-CA202031565$TAKEDA$$$$$F$Y$$$20240731$$CN$CA$CA
189943084$18994308$4$F$20150706$20240918$20210311$20240925$EXP$$US-ROCHE-2417517$ROCHE$$63$YR$A$F$Y$$$20240926$$MD$US$US
1899692510$18996925$10$F$$20240911$20210311$20240917$EXP$$CA-TAKEDA-2020TUS018309$TAKEDA$$$$$F$Y$$$20240917$$HP$CA$CA
1899700117$18997001$17$F$20211101$20240909$20210311$20240917$EXP$$US-TAKEDA-US202025909$TAKEDA$$62$YR$$F$Y$$$20240917$$HP$US$US
189975777$18997577$7$F$20210308$20240719$20210311$20240723$EXP$$US-TAKEDA-2021TUS015583$TAKEDA$$13$YR$$M$Y$$$20240723$$PH$US$US
189977264$18997726$4$F$20190705$20240809$20210311$20240814$EXP$$CA-TAKEDA-2019TUS047136$TAKEDA$$32$YR$$F$Y$$$20240814$$MD$CA$CA
189981194$18998119$4$F$20210101$20240806$20210311$20240809$EXP$$US-PFIZER INC-2021257696$PFIZER$$57$YR$$M$Y$$$20240809$$HP$US$US
189981245$18998124$5$F$20200101$20240906$20210311$20240910$PER$$US-PFIZER INC-2021238337$PFIZER$$51$YR$$F$Y$$$20240910$$HP$US$US
189983066$18998306$6$F$$20240821$20210311$20240826$EXP$$US-TAKEDA-US201815553$TAKEDA$$$$$M$Y$$$20240826$$CN$US$US
1899859436$18998594$36$F$20210101$20240813$20210312$20240821$EXP$$CA-CELLTRION INC.-2020CA031084$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
189988865$18998886$5$F$20210304$20240911$20210311$20240912$EXP$$IL-TAKEDA-2021TUS014778$TAKEDA$$68$YR$$F$Y$$$20240912$$MD$IL$IL
189989674$18998967$4$F$20201114$20240819$20210312$20240829$EXP$$JP-ROCHE-2785620$ROCHE$Takemura N, Kirino S, Tsuchiya K, et al. A Case of Meningitis due to Immune-Related Adverse Event and Acute Renal Failure Developing after the Initiation of Atezolizumab + Bevacizumab Therapy for Multiple Hepatocellular Carcinoma.. The 667th Kanto Regional Meeting of the Japanese Society of Internal Medicine (held on web). 2021;:-.$24$YR$A$M$Y$120$KG$20240829$$MD$JP$JP
1899897210$18998972$10$F$$20240627$20210312$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-000621$ACADIA PHARMACEUTICALS$$$$$F$Y$63$KG$20240723$$CN$US$US
1899947416$18999474$16$F$20190617$20240812$20210311$20240815$EXP$$US-TAKEDA-US201919994$TAKEDA$$59$YR$$F$Y$$$20240815$$MD$US$US
1899973616$18999736$16$F$20191101$20240730$20210311$20240806$EXP$$HR-PFIZER INC-2021232245$PFIZER$$56$YR$$F$Y$$$20240806$$MD$HR$HR
190000272$19000027$2$F$$20240909$20210311$20240917$EXP$$CA-BAUSCH-BL-2021-007654$BAUSCH AND LOMB$$32$YR$$F$Y$109$KG$20240917$$CN$CA$CA
190004965$19000496$5$F$20191101$20240720$20210311$20240723$EXP$$HR-BAUSCH-BL-2021-007734$BAUSCH AND LOMB$$56$YR$$F$Y$$$20240723$$MD$HR$HR
1900120124$19001201$24$F$$20240702$20210312$20240717$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-283930$RANBAXY$$34$YR$$F$Y$81$KG$20240717$$CN$CA$CA
1900128217$19001282$17$F$20200101$20240717$20210311$20240726$EXP$$CA-CELLTRION INC.-2020CA033044$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
190016723$19001672$3$F$$20230719$20210312$20240906$PER$$US-FARMAPROD-202011-1576$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240902$$CN$US$
190018664$19001866$4$F$20210402$20240731$20210312$20240809$EXP$$CA-TAKEDA-2019TUS072463$TAKEDA$$55$YR$$F$Y$$$20240809$$CN$CA$CA
190018772$19001877$2$F$20210212$20240624$20210312$20240701$PER$$US-009507513-2102USA008534$MERCK$$62$YR$$M$Y$$$20240701$$HP$US$US
190021908$19002190$8$F$20200601$20240722$20210312$20240801$EXP$GB-MHRA-ADR 24509832$GB-Accord-219387$ACCORD$$36$YR$A$F$Y$$$20240801$$MD$GB$GB
190024594$19002459$4$F$$20240903$20210312$20240905$EXP$$US-TAKEDA-2017BLT002060$TAKEDA$$$$$M$Y$81$KG$20240905$$CN$US$US
190034175$19003417$5$F$$20240820$20210312$20240822$EXP$$US-TAKEDA-US202027593$TAKEDA$$$$$M$Y$73$KG$20240822$$HP$US$US
1900364617$19003646$17$F$20191101$20240903$20210312$20240912$EXP$$HR-ORGANON-O2103HRV001005$ORGANON$$56$YR$$F$Y$$$20240912$$MD$HR$HR
190037524$19003752$4$F$$20240724$20210312$20240729$EXP$$CA-PFIZER INC-2021257284$MYLAN$$40$YR$$F$Y$113$KG$20240729$$HP$CA$CA
190038453$19003845$3$F$$20240904$20210312$20240911$EXP$$CA-009507513-2103CAN002760$MERCK$unknown. unknown. unknown$52$YR$$M$Y$$$20240911$$HP$CA$CA
190038525$19003852$5$F$$20240903$20210312$20240909$EXP$$US-JAZZ-2021-US-004279$JAZZ$$$$$F$Y$$$20240909$$HP$US$US
1900398019$19003980$19$F$20191024$20240826$20210313$20240903$EXP$$CA-CELLTRION INC.-2019CA026363$CELLTRION$$$$$$Y$$$20240903$$CN$CA$CA
190045823$19004582$3$F$20200801$20210315$20210312$20240916$EXP$$RO-ROCHE-2782771$ROCHE$$62$YR$A$$Y$$$20240916$$MD$RO$RO
190046495$19004649$5$F$$20240708$20210312$20240710$EXP$$US-TAKEDA-2021TUS015215$TAKEDA$$$$$M$Y$91$KG$20240710$$CN$US$US
1900466316$19004663$16$F$20200528$20240815$20210312$20240822$EXP$$CA-TAKEDA-CA202013658$TAKEDA$$52$YR$$F$Y$$$20240822$$CN$CA$CA
190046677$19004667$7$F$20200616$20240813$20210312$20240816$EXP$$CA-SHIRE-CA202020152$TAKEDA$$55$YR$$M$Y$118$KG$20240816$$CN$CA$CA
190047373$19004737$3$F$20190717$20240729$20210312$20240731$EXP$$CA-TAKEDA-2019TUS041190$TAKEDA$$55$YR$$M$Y$$$20240731$$HP$CA$CA
190048042$19004804$2$F$20200423$20240904$20210312$20240911$EXP$$CA-009507513-2103CAN002500$MERCK$$60$YR$$M$Y$105$KG$20240911$$PH$CA$CA
190049748$19004974$8$F$20180627$20240731$20210313$20240807$EXP$$CA-TAKEDA-2018TUS020466$TAKEDA$$55$YR$$M$Y$$$20240807$$HP$CA$CA
190050683$19005068$3$F$$20210605$20210312$20240711$PER$$NVSC2021US058347$NOVARTIS$$$$$M$Y$$$20240711$$CN$US$US
190052623$19005262$3$F$$20240906$20210312$20240911$EXP$$US-GILEAD-2021-0520993$GILEAD$$26$YR$A$F$Y$$$20240911$$MD$US$US
190055933$19005593$3$F$20210302$20240809$20210313$20240815$EXP$$US-UCBSA-2021010669$UCB$$48$YR$$M$Y$$$20240815$$CN$US$US
190057235$19005723$5$F$$20240918$20210314$20240923$EXP$$GB-AMGEN-GBRSP2021038631$AMGEN$$70$YR$E$F$Y$$$20240923$$CN$GB$GB
1900628628$19006286$28$F$20200101$20240829$20210315$20240907$EXP$$CA-CELLTRION INC.-2019CA026379$CELLTRION$$$$$$Y$$$20240907$$MD$CA$CA
1900631229$19006312$29$F$20200323$20240911$20210315$20240919$EXP$$CA-CELLTRION INC.-2020CA021117$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
190065059$19006505$9$F$20210301$20240726$20210315$20240812$PER$$CA-TOLMAR, INC.-21CA025854$TOLMAR$$73$YR$$M$Y$$$20240812$$CN$CA$CA
190066109$19006610$9$F$20200101$20240612$20210315$20240704$PER$$CA-TOLMAR, INC.-21CA025873$TOLMAR$$$$$M$Y$$$20240704$$CN$CA$CA
190070072$19007007$2$F$20210204$20240724$20210315$20240806$EXP$$FR-AUROBINDO-AUR-APL-2021-009990$AUROBINDO$$77$YR$$F$Y$$$20240806$$MD$FR$FR
190070323$19007032$3$F$20210211$20240724$20210315$20240803$EXP$$FR-AUROBINDO-AUR-APL-2021-009986$AUROBINDO$$73$YR$$F$Y$$$20240803$$MD$FR$FR
1900750610$19007506$10$F$20180829$20240729$20210315$20240802$EXP$$PHHY2018CA095824$NOVARTIS$$71$YR$$F$Y$$$20240802$$MD$CA$CA
190076002$19007600$2$F$20210301$20240729$20210315$20240805$PER$$US-SA-2021SA086364$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240805$$MD$US$US
1900844811$19008448$11$F$20240225$20240917$20210315$20240919$PER$$US-BIOGEN-2021BI00989644$BIOGEN$$72$YR$$F$Y$$$20240919$$CN$US$US
1900847514$19008475$14$F$20191101$20240815$20210316$20240909$EXP$$HR-AMGEN-HRVSP2021035195$AMGEN$$56$YR$A$F$Y$$$20240909$$MD$HR$HR
190085203$19008520$3$F$20210129$20240904$20210315$20240909$EXP$$CA-009507513-2103CAN003057$MERCK$$75$YR$$F$Y$$$20240909$$CN$CA$CA
1900852411$19008524$11$F$20210305$20240827$20210315$20240830$EXP$$CA-TAKEDA-2021TUS005208$TAKEDA$$71$YR$$M$Y$$$20240830$$CN$CA$CA
190088075$19008807$5$F$20210717$20240821$20210315$20240826$EXP$$US-TAKEDA-2021TUS016254$TAKEDA$$56$YR$$F$Y$49$KG$20240826$$HP$US$US
190094752$19009475$2$F$$20240726$20210316$20240807$EXP$$CA-AUROBINDO-AUR-APL-2021-010249$AUROBINDO$$27$YR$$F$Y$$$20240807$$MD$CA$CA
1900966418$19009664$18$F$20210101$20240729$20210316$20240806$EXP$$CA-CELLTRION INC.-2019CA028687$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
190097199$19009719$9$F$20190101$20240627$20210315$20240704$EXP$$BR-TAKEDA-BR202015090$TAKEDA$$$$$M$Y$12$KG$20240704$$CN$BR$BR
190101622$19010162$2$F$$20240702$20210316$20240713$EXP$$GB-ROCHE-1836769$ROCHE$$$$A$M$Y$$$20240713$$CN$GB$GB
190105022$19010502$2$F$20210105$20240916$20210316$20240919$EXP$$BE-ABBVIE-21K-013-3817058-00$ABBVIE$$81$YR$$F$Y$67.1$KG$20240919$$MD$BE$BE
1901094617$19010946$17$F$20210517$20220630$20210315$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR060170$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
190122105$19012210$5$F$20200610$20240919$20210315$20240924$EXP$$NVSC2021DE056287$NOVARTIS$$$$A$F$Y$$$20240925$$HP$DE$DE
190122882$19012288$2$F$20210101$20210302$20210316$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-285751$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
1901242935$19012429$35$F$$20240708$20210315$20240710$EXP$$CA-TAKEDA-2021TJP006850$TAKEDA$$76$YR$$F$Y$$$20240710$$MD$CA$CA
1901255429$19012554$29$F$20220923$20240820$20210316$20240823$EXP$$US-TAKEDA-2021TUS016838$TAKEDA$$63$YR$$F$Y$66$KG$20240823$$MD$US$US
1901289513$19012895$13$F$20210305$20240815$20210315$20240816$EXP$$US-TAKEDA-2021TUS015562$TAKEDA$$33$YR$$M$Y$$$20240816$$PH$US$US
1901290957$19012909$57$F$20190628$20240801$20210316$20240808$EXP$$CA-ROCHE-2352498$ROCHE$$12$YR$T$M$Y$58$KG$20240808$$HP$CA$CA
190135273$19013527$3$F$20210216$20240701$20210316$20240711$PER$$US-SA-2021SA087488$SANOFI AVENTIS$$14$YR$T$F$Y$52.2$KG$20240711$$MD$US$US
1901454415$19014544$15$F$20180820$20240729$20210316$20240806$EXP$$DE-ROCHE-2202384$ROCHE$$50$YR$A$M$Y$95$KG$20240806$$CN$DE$DE
190146022$19014602$2$F$$20240724$20210317$20240803$EXP$$CA-AUROBINDO-AUR-APL-2021-010297$AUROBINDO$$40$YR$$F$Y$$$20240803$$HP$CA$CA
1901462313$19014623$13$F$$20240806$20210317$20240820$EXP$$CA-AUROBINDO-AUR-APL-2021-010416$AUROBINDO$$59$YR$$M$Y$115$KG$20240820$$MD$CA$CA
1901505017$19015050$17$F$20221020$20240703$20210316$20240709$EXP$$IN-PFIZER INC-2019147174$PFIZER$$50$YR$$F$Y$$$20240709$$CN$IN$IN
190151104$19015110$4$F$$20240708$20210317$20240722$EXP$$CA-APOTEX-2021AP005838$APOTEX$$42$YR$$F$Y$$$20240722$$HP$CA$CA
190151573$19015157$3$F$$20240814$20210316$20240820$EXP$$CA-TAKEDA-2019TUS048964$TAKEDA$$$$$M$Y$$$20240820$$PH$CA$CA
190152162$19015216$2$F$20210301$20240727$20210317$20240805$PER$$US-SA-2021SA090384$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240805$$MD$US$US
190158307$19015830$7$F$20210201$20240718$20210316$20240724$EXP$$CA-TAKEDA-2020TUS013302$TAKEDA$$87$YR$$F$Y$$$20240724$$CN$CA$CA
190169915$19016991$5$F$20201110$20240831$20210316$20240912$EXP$$EG-ROCHE-2790389$ROCHE$$26$YR$A$F$Y$85$KG$20240912$$MD$EG$EG
1901707717$19017077$17$F$$20240813$20210317$20240826$EXP$$CA-AUROBINDO-AUR-APL-2021-010196$AUROBINDO$$72$YR$$M$Y$$$20240826$$HP$CA$CA
190171822$19017182$2$F$$20240715$20210317$20240723$EXP$$CA-AUROBINDO-AUR-APL-2021-010280$AUROBINDO$$87$YR$$F$Y$$$20240723$$HP$CA$CA
190174073$19017407$3$F$$20240826$20210317$20240902$EXP$$US-BIOGEN-2020BI00950738$BIOGEN$$$$$F$Y$$$20240902$$CN$US$US
190175103$19017510$3$F$20210101$20240805$20210317$20240817$PER$$US-JNJFOC-20210309686$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240817$$CN$US$US
1901770310$19017703$10$F$20201117$20240807$20210316$20240812$EXP$$CA-TAKEDA-2020TUS010101$TAKEDA$$62$YR$$F$Y$$$20240812$$CN$CA$CA
190189145$19018914$5$F$20210101$20240622$20210317$20240701$PER$$US-SA-2021SA067361$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240701$$MD$US$US
190191756$19019175$6$F$20240818$20240818$20210317$20240820$EXP$$CA-TAKEDA-2021TUS015360$TAKEDA$$65$YR$$F$Y$$$20240820$$CN$CA$CA
190191802$19019180$2$F$$20240812$20210317$20240814$EXP$$US-PFIZER INC-2021256399$PFIZER$$69$YR$$F$Y$$$20240814$$CN$US$US
190193153$19019315$3$F$20210108$20240822$20210317$20240831$EXP$$US-AMNEAL PHARMACEUTICALS-2021-AMRX-00820$AMNEAL$$46$YR$$F$Y$92.063$KG$20240831$$MD$US$US
1902057637$19020576$37$F$20140101$20240903$20210317$20240906$EXP$$CO-TAKEDA-CO202033484$TAKEDA$$$$$M$Y$66$KG$20240906$$CN$CO$CO
190205985$19020598$5$F$$20240724$20210317$20240729$EXP$$US-PFIZER INC-2021263895$PFIZER$$51$YR$$F$Y$$$20240729$$CN$US$US
190209314$19020931$4$F$$20240913$20210317$20240924$EXP$$CA-ROCHE-2786247$ROCHE$$44$YR$A$F$Y$74$KG$20240924$$HP$CA$CA
190209734$19020973$4$F$$20240806$20210317$20240808$PER$$NVSC2021US061559$NOVARTIS$$$$$M$Y$$$20240808$$CN$US$US
190211119$19021111$9$F$20231213$20240910$20210317$20240919$EXP$$CA-TAKEDA-2020TUS033875$TAKEDA$$61$YR$$M$Y$$$20240919$$CN$CA$CA
190213147$19021314$7$F$$20240816$20210317$20240828$EXP$$CA-ROCHE-2786447$ROCHE$$62$YR$A$F$Y$88$KG$20240828$$HP$CA$CA
190215552$19021555$2$F$$20240819$20210317$20240824$EXP$$JP-ROCHE-2790951$ROCHE$$6$DEC$A$$Y$$$20240824$$MD$JP$JP
190219273$19021927$3$F$$20240720$20210317$20240725$PER$$US-SUNOVION-2021SUN000775$SUNOVION$$$$$$Y$$$20240725$$CN$US$US
190221376$19022137$6$F$20210304$20240617$20210317$20240701$EXP$$CA-ROCHE-2785924$ROCHE$$29$YR$A$M$Y$$$20240701$$MD$CA$CA
190241078$19024107$8$F$$20240725$20210317$20240730$EXP$$AU-PFIZER INC-2021240627$PFIZER$Gilhotra, R.. Granulomatous amebic encephalitis secondary to Acanthamoeba as a complication of combination immunosuppression in ulcerative colitis: A case report. Journal of Gastroenterology and Hepatology. 2020;35 (SUPPL 1):139-140$58$YR$$M$Y$$$20240730$$HP$AU$AU
1902451321$19024513$21$F$20210330$20240624$20210317$20240702$EXP$$CA-CELLTRION INC.-2021CA003450$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
1902563539$19025635$39$F$$20240722$20210318$20240726$EXP$$CA-PFIZER INC-2021284310$MYLAN$$76$YR$$F$Y$$$20240726$$CN$CA$CA
190256904$19025690$4$F$$20240717$20210318$20240726$PER$$US-SA-2021SA089375$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240726$$MD$US$US
1902680415$19026804$15$F$20210201$20240722$20210318$20240725$EXP$$US-PFIZER INC-2021261951$PFIZER$$79$YR$$F$Y$$$20240725$$HP$US$US
190268213$19026821$3$F$20210310$20240701$20210318$20240703$PER$$US-AMGEN-USASP2021038418$AMGEN$$78$YR$E$M$Y$$$20240703$$CN$US$US
190269546$19026954$6$F$20190522$20240626$20210318$20240703$EXP$NVSC2021PL058600$NVSC2021PL058600$NOVARTIS$$46$YR$$M$Y$$$20240703$$MD$PL$PL
190271349$19027134$9$F$20230422$20240710$20210318$20240711$EXP$$US-TAKEDA-2021TUS017425$TAKEDA$$6$YR$$M$Y$$$20240711$$PH$US$US
190271852$19027185$2$F$$20240715$20210318$20240717$EXP$$CA-BAUSCH-BL-2021-008349$BAUSCH AND LOMB$$42$YR$$F$Y$$$20240717$$CN$CA$CA
1902881319$19028813$19$F$20201202$20240916$20210319$20240926$EXP$$DE-AUROBINDO-AUR-APL-2021-011064$AUROBINDO$$58$YR$$F$Y$60$KG$20240926$$MD$DE$DE
190290836$19029083$6$F$20191101$20240627$20210318$20240701$EXP$$IN-PFIZER INC-2019218965$PFIZER$$56$YR$$F$Y$$$20240701$$CN$IN$IN
1903065013$19030650$13$F$20191027$20240802$20210319$20240809$EXP$$CO-TAKEDA-CO201937262$TAKEDA$$39$YR$$M$Y$60$KG$20240809$$HP$CO$CO
190308325$19030832$5$F$20211001$20240627$20210319$20240703$EXP$$US-TAKEDA-2021TUS015344$TAKEDA$$49$YR$$F$Y$90$KG$20240703$$CN$US$US
190313684$19031368$4$F$$20240729$20210319$20240805$EXP$$CA-APOTEX-2021AP006188$APOTEX$$58$YR$$M$Y$$$20240805$$HP$CA$CA
1903171711$19031717$11$F$20180901$20240723$20210319$20240726$EXP$$IN-PFIZER INC-2018354036$PFIZER$$64$YR$$F$Y$$$20240726$$CN$IN$IN
190317914$19031791$4$F$20210101$20240829$20210319$20240904$EXP$$IN-PFIZER INC-2021270029$PFIZER$$64$YR$$F$Y$$$20240904$$CN$IN$IN
1903267810$19032678$10$F$$20240912$20210319$20240913$EXP$$US-TAKEDA-US202023642$TAKEDA$$$$$F$Y$73$KG$20240913$$CN$US$US
1903410518$19034105$18$F$20210307$20240725$20210319$20240801$EXP$$US-TAKEDA-US202006151$TAKEDA$$29$YR$$F$Y$81$KG$20240801$$HP$US$US
1903463512$19034635$12$F$20240407$20240826$20210320$20240829$EXP$$US-TAKEDA-2021TUS015934$TAKEDA$$12$YR$$F$Y$39$KG$20240829$$CN$US$US
1903474515$19034745$15$F$20110824$20240718$20210320$20240724$EXP$$US-TAKEDA-2021TUS016443$TAKEDA$$49$YR$$F$Y$85$KG$20240724$$HP$US$US
1903480811$19034808$11$F$$20240712$20210320$20240717$EXP$$US-TAKEDA-2021TUS018140$TAKEDA$$$$$F$Y$63$KG$20240717$$CN$US$US
190353057$19035305$7$F$20200729$20240916$20210320$20240918$EXP$$US-TAKEDA-US202024643$TAKEDA$$71$YR$$F$Y$$$20240918$$HP$US$US
190362988$19036298$8$F$$20240903$20210322$20240917$EXP$$CA-AUROBINDO-AUR-APL-2021-011105$AUROBINDO$$54$YR$$F$Y$$$20240917$$HP$CA$CA
1903688110$19036881$10$F$20210119$20240731$20210322$20240808$EXP$$CA-CELLTRION INC.-2021CA003653$CELLTRION$$$$$$Y$$$20240808$$CN$CA$CA
190372105$19037210$5$F$$20240802$20210322$20240808$EXP$$US-JNJFOC-20210330336$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
190372717$19037271$7$F$20210301$20220504$20210322$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR064420$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240925$$CN$US$US
1903808821$19038088$21$F$20220101$20240731$20210322$20240802$EXP$$US-PFIZER INC-2021224349$PFIZER$$62$YR$$F$Y$$$20240802$$HP$US$US
190383633$19038363$3$F$20180101$20240808$20210322$20240813$EXP$$CA-TAKEDA-2018TUS020961$TAKEDA$$$$$F$Y$$$20240813$$CN$CA$CA
190384413$19038441$3$F$$20240916$20210322$20240923$EXP$$CA-BAUSCH-BL-2021-008563$BAUSCH AND LOMB$$69$YR$$M$Y$$$20240923$$CN$CA$CA
190386987$19038698$7$F$20200801$20240730$20210322$20240805$EXP$$HR-TAKEDA-2021TEU002541$TAKEDA$$56$YR$$F$Y$$$20240805$$CN$HR$HR
190387534$19038753$4$F$20240206$20240831$20210322$20240905$EXP$$IN-PFIZER INC-2021259830$PFIZER$$64$YR$$F$Y$$$20240905$$CN$IN$IN
1903899811$19038998$11$F$20220303$20240807$20210322$20240815$EXP$$US-GLAXOSMITHKLINE-US2020AMR143944$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$HP$US$US
1903937932$19039379$32$F$20221003$20240923$20210322$20240930$EXP$$US-TAKEDA-2021TUS017224$TAKEDA$$72$YR$$F$Y$73$KG$20240930$$CN$US$US
190394433$19039443$3$F$$20210325$20210322$20240710$EXP$$GB-ASTELLAS-2021US009965$ASTELLAS$$$$E$M$Y$$$20240710$$CN$GB$GB
190399632$19039963$2$F$20210204$20240805$20210322$20240812$EXP$$FR-ROCHE-2787480$ROCHE$$77$YR$E$F$Y$$$20240812$$MD$FR$FR
190400232$19040023$2$F$20200101$20240708$20210322$20240716$EXP$$AT-PFIZER INC-2021256349$PFIZER$$59$YR$$F$Y$$$20240716$$MD$AT$AT
190400957$19040095$7$F$20200901$20240711$20210323$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2020-017702$UNITED THERAPEUTICS$$61$YR$$F$Y$99.773$KG$20240719$$$US$US
190401512$19040151$2$F$$20240708$20210323$20240716$EXP$$GB-AUROBINDO-AUR-APL-2021-011379$AUROBINDO$$$$A$M$Y$$$20240716$$HP$GB$GB
190416127$19041612$7$F$$20240625$20210322$20240707$EXP$$CA-ROCHE-2787843$ROCHE$$$$A$F$Y$$$20240707$$CN$CA$CA
1904185813$19041858$13$F$20190415$20240807$20210322$20240812$EXP$$CA-TAKEDA-2019TUS026050$TAKEDA$$38$YR$$F$Y$$$20240812$$HP$CA$CA
190419992$19041999$2$F$$20210402$20210323$20240711$EXP$$NVSC2021US061554$NOVARTIS$$60$YR$$M$Y$$$20240711$$CN$US$US
1904201111$19042011$11$F$20181113$20240918$20210322$20240923$EXP$$CA-TAKEDA-2018TUS034306$TAKEDA$$74$YR$$F$Y$$$20240923$$CN$CA$CA
1904222217$19042222$17$F$$20240920$20210323$20240928$EXP$$CA-AUROBINDO-AUR-APL-2021-011206$AUROBINDO$$54$YR$$F$Y$$$20240928$$MD$CA$CA
190422812$19042281$2$F$20200901$20240626$20210322$20240703$EXP$$NVSC2021CO062574$NOVARTIS$$62$YR$$F$Y$$$20240703$$CN$CO$CO
190439082$19043908$2$F$$20240731$20210322$20240805$EXP$$CA-PFIZER INC-2021276981$MYLAN$$15$YR$$M$Y$127$KG$20240805$$HP$CA$CA
1904391515$19043915$15$F$20190101$20240918$20210322$20240920$EXP$$CA-BAUSCH-BL-2021-009360$BAUSCH AND LOMB$$72$YR$$F$Y$61$KG$20240920$$CN$CA$CA
1904415611$19044156$11$F$$20240715$20210322$20240722$EXP$$CA-BAUSCH-BL-2021-009346$BAUSCH AND LOMB$$57$YR$$F$Y$$$20240719$$CN$CA$CA
190459052$19045905$2$F$$20240903$20210323$20240912$PER$$US-SA-2021SA089685$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240912$$HP$US$US
190461054$19046105$4$F$$20240911$20210322$20240918$EXP$$CA-AstraZeneca-2021A151134$ASTRAZENECA$$65$YR$$M$Y$$$20240918$$MD$CA$
190465524$19046552$4$F$20210313$20240909$20210322$20240917$PER$$US-SA-2021SA095518$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240918$$MD$US$US
190466766$19046676$6$F$20210927$20240918$20210323$20240923$EXP$$US-TAKEDA-US201917836$TAKEDA$$27$YR$$M$Y$$$20240923$$HP$US$US
190475374$19047537$4$F$$20240911$20210323$20240916$EXP$$CA-009507513-2103CAN005658$MERCK$$59$YR$$M$Y$$$20240916$$PH$CA$CA
190480169$19048016$9$F$$20240921$20210323$20240925$EXP$$CA-ROCHE-2786589$ROCHE$$82$YR$E$F$Y$72$KG$20240925$$CN$CA$CA
190480604$19048060$4$F$$20240731$20210323$20240807$EXP$$US-JAZZ-2021-US-004943$JAZZ$$$$$F$Y$$$20240807$$HP$US$US
1904825519$19048255$19$F$20240419$20240830$20210323$20240903$EXP$$US-TAKEDA-US202015633$TAKEDA$$65$YR$$F$Y$$$20240903$$CN$US$US
1904867749$19048677$49$F$20191022$20240808$20210324$20240815$EXP$$CA-CELLTRION INC.-2019CA026312$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
190496564$19049656$4$F$20210317$20240718$20210323$20240725$PER$$US-BIOGEN-2021BI00993127$BIOGEN$$52$YR$$F$Y$$$20240725$$CN$US$US
190503214$19050321$4$F$20080616$20240910$20210324$20240919$EXP$$GB-AUROBINDO-AUR-APL-2021-011335$AUROBINDO$$22$YR$$F$Y$$$20240919$$PH$GB$GB
190504102$19050410$2$F$20080616$20240910$20210324$20240919$EXP$$GB-AUROBINDO-AUR-APL-2021-011354$AUROBINDO$$22$YR$$F$Y$$$20240919$$HP$GB$GB
190504783$19050478$3$F$20210223$20240725$20210324$20240806$EXP$$FR-AUROBINDO-AUR-APL-2021-011746$AUROBINDO$$57$YR$$F$Y$$$20240806$$MD$FR$FR
1905094729$19050947$29$F$20210101$20240726$20210323$20240805$EXP$$CA-CELLTRION INC.-2021CA003781$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
190513653$19051365$3$F$$20240710$20210324$20240720$EXP$$DE-AUROBINDO-AUR-APL-2021-011212$AUROBINDO$Paul LD, Welter-Luedeke J, Penzel S, Zangl A, Graw M.. Alpha-Pyrrolidinopentiothiophenone (alpha-PVT): A forensic case study including plasma concentrations.. Forensic Science International. 2021;321:1-17$44$YR$$M$Y$$$20240720$$MD$DE$DE
190518382$19051838$2$F$20210201$20240723$20210324$20240805$PER$$US-SA-2021SA097696$SANOFI AVENTIS$$55$YR$A$M$Y$84.36$KG$20240805$$MD$US$US
190529456$19052945$6$F$20201217$20240712$20210325$20240722$EXP$$CA-CELLTRION INC.-2020CA034856$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
1905335111$19053351$11$F$$20240807$20210324$20240812$EXP$$US-PFIZER INC-2020033170$PFIZER$$71$YR$$F$Y$63.5$KG$20240812$$CN$US$US
190534373$19053437$3$F$$20240827$20210325$20240905$EXP$$CA-AUROBINDO-AUR-APL-2021-011535$AUROBINDO$$59$YR$$M$Y$$$20240905$$MD$CA$CA
190538575$19053857$5$F$$20240702$20210324$20240704$EXP$$US-TAKEDA-2021TUS018535$TAKEDA$$$$$M$Y$20$KG$20240704$$CN$US$US
1905407331$19054073$31$F$20220906$20240703$20210325$20240715$EXP$$US-ROCHE-2797405$ROCHE$$49$YR$A$M$Y$$$20240715$$CN$US$US
190540762$19054076$2$F$$20240909$20210325$20240913$EXP$IT-PFIZER INC-2021188928$IT-ROCHE-2792986$ROCHE$$69$YR$E$F$Y$$$20240913$$HP$IT$IT
190541224$19054122$4$F$$20240724$20210325$20240805$EXP$$PL-AUROBINDO-AUR-APL-2021-009598$AUROBINDO$Sawczy?ska K.. 46-letnia kobieta z bolesnymi parestezjami dystalnych cz??ci ko?czyn.. MEDYCYNA PRAKTYCZNA - NEUROLOGIA.. 2020;66(6):84-86$46$YR$$F$Y$$$20240805$$MD$PL$PL
190567082$19056708$2$F$$20211209$20210325$20240710$PER$$CA-PFM-2021-02979$PIERRE FABRE MEDICAMENT$$65$YR$$F$Y$$$20240710$$MD$CA$CA
1905726315$19057263$15$F$20210301$20240830$20210325$20240906$EXP$$CA-OTSUKA-2020_032222$OTSUKA$$19$YR$$F$Y$$$20240906$$HP$CA$CA
190573217$19057321$7$F$20210415$20240730$20210325$20240809$EXP$$CA-TAKEDA-2021TUS016679$TAKEDA$$28$YR$$F$Y$$$20240809$$CN$CA$CA
190576414$19057641$4$F$$20240726$20210325$20240730$EXP$$US-PFIZER INC-2020077990$PFIZER$$77$YR$$M$Y$82.55$KG$20240730$$CN$US$US
190584314$19058431$4$F$20190916$20240903$20210325$20240909$EXP$$US-SA-2019SA271803$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240909$$HP$US$US
1905949443$19059494$43$F$20201116$20240712$20210326$20240722$EXP$$CA-CELLTRION INC.-2020CA027953$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
190599068$19059906$8$F$$20240827$20210326$20240905$EXP$$CA-APOTEX-2021AP006840$APOTEX$$62$YR$$M$Y$$$20240905$$HP$CA$CA
190606073$19060607$3$F$$20240724$20210326$20240808$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-287633$RANBAXY$Lei T, Tan F, Hou Z, Liu P, Zhao X, Liu H. Hepatitis B Virus Reactivation in Gastrointestinal Stromal Tumor Patients Treated With Imatinib.. Front Oncol. 2021;Jan10:596500$51$YR$$M$Y$$$20240808$$HP$CN$CN
190615292$19061529$2$F$20200101$20240904$20210325$20240910$EXP$$CA-009507513-2103CAN006649$MERCK$$79$YR$$M$Y$59$KG$20240910$$HP$CA$CA
1906212911$19062129$11$F$$20240726$20210326$20240730$EXP$$CA-TAKEDA-2020TUS057151$TAKEDA$$$$$F$Y$$$20240730$$MD$CA$CA
190621978$19062197$8$F$20210326$20240728$20210326$20240730$EXP$$CA-TAKEDA-2021TUS017594$TAKEDA$$31$YR$$M$Y$$$20240730$$HP$CA$CA
1906254014$19062540$14$F$$20240719$20210326$20240725$EXP$$US-SHIRE-US202008408$TAKEDA$$$$$M$Y$75$KG$20240725$$CN$US$US
190626503$19062650$3$F$20210219$20240722$20210326$20240725$EXP$$FR-PFIZER INC-2021311018$PFIZER$$59$YR$$F$Y$$$20240725$$MD$FR$FR
1906345216$19063452$16$F$20210223$20240702$20210326$20240712$EXP$$NVSC2021US056436$NOVARTIS$$3$MON$$F$Y$10.7$KG$20240712$$MD$US$US
190642667$19064266$7$F$20210126$20240905$20210326$20240909$EXP$$US-SHIRE-US202032419$TAKEDA$$67$YR$$F$Y$$$20240909$$CN$US$US
190644216$19064421$6$F$20210301$20240812$20210326$20240815$EXP$$DE-TAKEDA-2021TUS017045$TAKEDA$$25$YR$$F$Y$$$20240815$$HP$DE$DE
190649352$19064935$2$F$$20240909$20210326$20240910$EXP$$IT-009507513-2103ITA006245$MERCK$$69$YR$$F$Y$$$20240910$$HP$IT$IT
1906541530$19065415$30$F$20220601$20240913$20210327$20240920$EXP$$US-TAKEDA-2021TUS018157$TAKEDA$$35$YR$$F$Y$61$KG$20240920$$HP$US$US
190657428$19065742$8$F$20210407$20240723$20210327$20240729$EXP$$CA-TAKEDA-2021TUS017284$TAKEDA$$52$YR$$F$Y$$$20240729$$HP$CA$CA
190664954$19066495$4$F$20220101$20240708$20210328$20240711$PER$$US-SA-2021SA102041$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240711$$MD$US$US
190666769$19066676$9$F$20210304$20240716$20210328$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-028437$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$56.9$KG$20240722$$MD$JP$JP
190672323$19067232$3$F$20210227$20240725$20210329$20240806$EXP$$FR-AUROBINDO-AUR-APL-2021-012304$AUROBINDO$$67$YR$$F$Y$$$20240806$$MD$FR$FR
190673202$19067320$2$F$20190101$20240822$20210329$20240902$EXP$$FR-AUROBINDO-AUR-APL-2021-012212$AUROBINDO$$65$YR$$M$Y$80$KG$20240902$$PH$FR$FR
190679149$19067914$9$F$$20240917$20210329$20240920$PER$$US-PFIZER INC-2021200392$PFIZER$$67$YR$$F$Y$$$20240920$$CN$US$US
190687603$19068760$3$F$20171011$20240905$20210329$20240916$EXP$$CA-TAKEDA-2017TUS022659$TAKEDA$$56$YR$$M$Y$$$20240916$$CN$CA$CA
190688143$19068814$3$F$$20240703$20210329$20240708$EXP$$US-KYOWAKIRIN-2021BKK004721$KYOWA$$$$$$Y$$$20240708$$CN$US$US
190692475$19069247$5$F$$20240909$20210329$20240919$PER$$US-INCYTE CORPORATION-2021IN002476$INCYTE$$$$$$Y$$$20240919$$CN$US$US
1906999711$19069997$11$F$20210510$20240909$20210329$20240911$EXP$$US-TAKEDA-US202033062$TAKEDA$$43$YR$$F$Y$$$20240911$$HP$US$US
1907005510$19070055$10$F$20210531$20240826$20210329$20240828$EXP$$CA-TAKEDA-2021TUS019534$TAKEDA$$48$YR$$F$Y$$$20240828$$MD$CA$CA
1907088346$19070883$46$F$20210323$20240920$20210330$20240925$EXP$$CO-TAKEDA-2021TUS020067$TAKEDA$$65$YR$$M$Y$85$KG$20240925$$CN$CO$CO
190709453$19070945$3$F$20210106$20240816$20210330$20240828$EXP$$FR-AUROBINDO-AUR-APL-2021-012234$AUROBINDO$$47$YR$$F$Y$$$20240828$$MD$FR$FR
190710483$19071048$3$F$20210129$20240829$20210330$20240907$EXP$$FR-AUROBINDO-AUR-APL-2021-012533$AUROBINDO$$77$YR$$F$Y$55$KG$20240907$$MD$FR$FR
190722769$19072276$9$F$$20230803$20210330$20240731$EXP$$NVSC2021US064227$NOVARTIS$$$$$F$Y$91.61$KG$20240731$$CN$US$US
190723512$19072351$2$F$20190801$20240814$20210330$20240828$PER$$US-SA-2021SA099384$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240828$$MD$US$US
190726945$19072694$5$F$$20240722$20210330$20240726$EXP$$CA-PFIZER INC-2021318230$MYLAN$$19$YR$$F$Y$$$20240726$$HP$CA$CA
1907293416$19072934$16$F$$20240731$20210330$20240809$EXP$$US-GLAXOSMITHKLINE-US2021AMR071392$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
1907333610$19073336$10$F$20210419$20240919$20210330$20240923$EXP$$CA-TAKEDA-2020TUS017849$TAKEDA$$24$YR$$F$Y$$$20240923$$CN$CA$CA
190734542$19073454$2$F$$20240902$20210330$20240906$EXP$$NVSC2021PL065179$NOVARTIS$Szlauer-stefanska A, Kaminska-winciorek G. Patient with chronic cutaneous and mucosal forms of graft- versus-host disease. DERMATOLOGIA PO DYPLOMIE. 2024;2$30$YR$$M$Y$$$20240907$$HP$PL$PL
190736395$19073639$5$F$20151221$20240918$20210330$20240925$EXP$$CA-TAKEDA-2021TUS017815$TAKEDA$$45$YR$$M$Y$$$20240925$$MD$CA$CA
1907457310$19074573$10$F$$20240819$20210330$20240820$EXP$$US-TAKEDA-2020TUS044722$TAKEDA$$$$$M$Y$$$20240820$$HP$US$US
1907489011$19074890$11$F$20191224$20240812$20210331$20240820$EXP$$CA-CELLTRION INC.-2019CA026910$CELLTRION$$$$$$Y$$$20240820$$CN$CA$CA
1907521512$19075215$12$F$20210318$20240712$20210330$20240716$EXP$$AT-PFIZER INC-2021338379$PFIZER$$66$YR$$M$Y$68$KG$20240716$$HP$AT$AT
190753927$19075392$7$F$$20240912$20210330$20240917$EXP$$CA-TAKEDA-2019TUS027546$TAKEDA$$$$$F$Y$$$20240917$$CN$CA$CA
1907545123$19075451$23$F$20190522$20240624$20210331$20240701$EXP$$PL-AUROBINDO-AUR-APL-2021-012894$AUROBINDO$$46$YR$$M$Y$$$20240701$$MD$PL$PL
190757203$19075720$3$F$$20240720$20210331$20240801$EXP$$DE-AUROBINDO-AUR-APL-2021-012411$AUROBINDO$Hanisch F, Friedemann J, Piro J, Gutmann P.. Maintenance electroconvulsive therapy for comorbid pharmacotherapy- refractory obsessive-compulsive and schizoaffective disorder.. EUROPEAN JOURNAL OF MEDICAL RESEARCH. 2009;14(8):367-8$46$YR$$F$Y$$$20240801$$MD$DE$DE
1907659320$19076593$20$F$20210101$20240916$20210331$20240925$EXP$$CA-CELLTRION INC.-2021CA004314$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
190766643$19076664$3$F$$20240820$20210331$20240829$EXP$$CA-APOTEX-2021AP007258$APOTEX$$53$YR$$F$Y$$$20240829$$HP$CA$CA
190768183$19076818$3$F$20150605$20240909$20210331$20240912$EXP$$US-KYOWAKIRIN-2020BKK023156$KYOWA$$$$$$Y$$$20240912$$HP$US$US
190777664$19077766$4$F$$20240815$20210331$20240819$EXP$$US-SHIRE-US201936641$TAKEDA$$$$$F$Y$75$KG$20240819$$MD$US$US
1907844512$19078445$12$F$20190320$20240711$20210331$20240724$EXP$$DE-ROCHE-2348119$ROCHE$$61$YR$A$M$Y$$$20240724$$CN$DE$DE
190787587$19078758$7$F$20240521$20240911$20210331$20240916$EXP$$CA-TAKEDA-2020TUS056872$TAKEDA$$58$YR$$F$Y$$$20240916$$MD$CA$CA
190795914$19079591$4$F$$20240902$20210331$20240904$EXP$$DE-ORGANON-O2103DEU002256$ORGANON$Paul L D, Luedekea J W, Penzel S, Zangl A, Graw M. Alpha-Pyrrolidinopentiothiophenone (?-PVT): A forensic case study including plasma concentrations. Forensic Science International. 2021;321:1-17$44$YR$$M$Y$$$20240904$$MD$DE$DE
190802623$19080262$3$F$20210310$20240725$20210401$20240806$EXP$$FR-AUROBINDO-AUR-APL-2021-013251$AUROBINDO$$51$YR$$F$Y$$$20240806$$MD$FR$FR
1908038911$19080389$11$F$$20240916$20210331$20240920$EXP$$CA-TAKEDA-2020TUS040180$TAKEDA$$$$$F$Y$$$20240920$$HP$CA$CA
190804643$19080464$3$F$$20240806$20210401$20240813$PER$$US-SA-2021SA107902$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240814$$MD$US$US
190806966$19080696$6$F$$20240711$20210331$20240714$EXP$$US-SHIRE-US202000969$TAKEDA$$$$$F$Y$$$20240714$$CN$US$US
190816987$19081698$7$F$20190101$20240905$20210401$20240912$EXP$$DE-BIOGEN-2020BI00935695$BIOGEN$$$$$F$Y$60$KG$20240912$$CN$DE$DE
1908212512$19082125$12$F$20220211$20240716$20210401$20240813$PER$$CA-TOLMAR, INC.-21CA026296$TOLMAR$$78$YR$$M$Y$$$20240813$$MD$CA$CA
1908228010$19082280$10$F$20210101$20240724$20210401$20240730$PER$$US-BIOGEN-2021BI00995955$BIOGEN$$$$$F$Y$126.21$KG$20240730$$CN$US$US
1908293514$19082935$14$F$$20240826$20210401$20240830$EXP$$US-TAKEDA-2021TUS019120$TAKEDA$$$$$F$Y$54$KG$20240830$$CN$US$US
190829474$19082947$4$F$$20210619$20210401$20240710$PER$$NVSC2021US070655$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
190829787$19082978$7$F$$20240910$20210401$20240912$PER$$US-PFIZER INC-2021193338$PFIZER$$86$YR$$F$Y$$$20240912$$CN$US$US
190834252$19083425$2$F$$20240710$20210401$20240712$EXP$$ES-PFIZER INC-2021302476$PFIZER$$68$YR$$M$Y$$$20240712$$MD$ES$ES
1908377718$19083777$18$F$$20240821$20210401$20240906$EXP$$CA-ASTELLAS-2021US011449$ASTELLAS$$43$YR$A$F$Y$$$20240906$$HP$CA$CA
1908411013$19084110$13$F$20180402$20240815$20210401$20240820$EXP$$CA-TAKEDA-2018TUS016006$TAKEDA$$55$YR$$M$Y$$$20240820$$MD$CA$CA
190852072$19085207$2$F$$20240917$20210401$20240919$EXP$$CA-PFIZER INC-2021334840$PFIZER$$49$YR$$F$Y$58$KG$20240919$$HP$CA$CA
190852692$19085269$2$F$$20240725$20210402$20240802$PER$$US-SA-2021SA105997$SANOFI AVENTIS$$$$A$M$Y$$$20240802$$MD$US$US
1908559123$19085591$23$F$20210910$20240612$20210402$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-000957$ACADIA PHARMACEUTICALS$$63$YR$$F$Y$$$20240705$$CN$US$US
1908573627$19085736$27$F$20210101$20240717$20210402$20240726$EXP$$CA-CELLTRION INC.-2021CA004451$CELLTRION$$$$$$Y$$$20240726$$CN$CA$CA
190863292$19086329$2$F$$20240720$20210402$20240726$EXP$$CA-ASTELLAS-2021US011587$ASTELLAS$$59$YR$$M$Y$$$20240726$$CN$CA$CA
190866749$19086674$9$F$20221103$20240815$20210402$20240821$EXP$$US-TAKEDA-US202013925$TAKEDA$$15$YR$$M$Y$$$20240821$$HP$US$US
1908670611$19086706$11$F$20210107$20240904$20210402$20240911$EXP$$NVSC2021CA068461$NOVARTIS$$60$YR$$F$Y$94$KG$20240911$$MD$CA$CA
190869042$19086904$2$F$$20240917$20210402$20240920$EXP$$CA-Orion Corporation ORION PHARMA-21_00013871$ORION$$49$YR$A$F$Y$58$KG$20240920$$HP$CA$
1908740516$19087405$16$F$20220220$20240923$20210402$20240930$EXP$$US-TAKEDA-2021TUS018413$TAKEDA$$16$YR$$F$Y$99.7$KG$20240930$$HP$US$US
190875542$19087554$2$F$20210319$20240723$20210402$20240726$EXP$$BR-AstraZeneca-2021A224405$ASTRAZENECA$$20794$DY$$F$Y$$$20240726$$CN$BR$
1908767514$19087675$14$F$$20240919$20210402$20240925$EXP$$US-TAKEDA-2021TUS019116$TAKEDA$$$$$F$Y$124$KG$20240925$$CN$US$US
1908818422$19088184$22$F$20210402$20230515$20210402$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR072016$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
190882053$19088205$3$F$$20240722$20210402$20240724$EXP$$ES-PFIZER INC-2021332553$PFIZER$$$$A$F$Y$$$20240724$$MD$ES$ES
1908827820$19088278$20$F$$20240912$20210402$20240917$EXP$$US-TAKEDA-2017BLT003677$TAKEDA$$$$$F$Y$81$KG$20240917$$CN$US$US
190890773$19089077$3$F$$20240812$20210403$20240823$EXP$$CA-AUROBINDO-AUR-APL-2021-013386$AUROBINDO$$27$YR$$F$Y$$$20240823$$MD$CA$CA
1908972713$19089727$13$F$20190101$20240730$20210403$20240806$EXP$$US-TAKEDA-US202028152$TAKEDA$$$$$F$Y$56.68$KG$20240806$$HP$US$US
190900174$19090017$4$F$20210101$20240621$20210404$20240701$PER$$US-SA-2021SA107984$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240701$$MD$US$US
1909043013$19090430$13$F$$20240724$20210405$20240805$EXP$$CA-AUROBINDO-AUR-APL-2021-013082$AUROBINDO$$63$YR$$M$Y$$$20240805$$HP$CA$CA
190904832$19090483$2$F$$20240815$20210405$20240828$EXP$$CA-AUROBINDO-AUR-APL-2021-013698$AUROBINDO$$53$YR$$M$Y$$$20240828$$HP$CA$CA
1909086110$19090861$10$F$20210309$20240918$20210405$20240924$EXP$$CA-TAKEDA-2021TUS019006$TAKEDA$$78$YR$$F$Y$$$20240924$$HP$CA$CA
1909310111$19093101$11$F$20190710$20240710$20210405$20240716$EXP$$CA-SHIRE-CA201922159$TAKEDA$$34$YR$$M$Y$75$KG$20240716$$CN$CA$CA
190931374$19093137$4$F$20210325$20240627$20210405$20240702$EXP$$CA-TAKEDA-2021TUS020665$TAKEDA$$78$YR$$F$Y$$$20240702$$CN$CA$CA
1909387316$19093873$16$F$20220211$20240702$20210405$20240705$EXP$$AT-TAKEDA-2021TUS021307$TAKEDA$$9$YR$$M$Y$$$20240705$$CN$AT$AT
190939755$19093975$5$F$20230403$20240903$20210405$20240909$EXP$$US-SHIRE-US201911387$TAKEDA$$39$YR$$F$Y$55.78$KG$20240909$$CN$US$US
1909514012$19095140$12$F$$20240827$20210406$20240905$EXP$$CA-AUROBINDO-AUR-APL-2021-013616$AUROBINDO$$40$YR$$M$Y$140$KG$20240905$$HP$CA$CA
190956634$19095663$4$F$$20240729$20210406$20240806$EXP$$CA-APOTEX-2021AP007737$APOTEX$$51$YR$$M$Y$$$20240806$$HP$CA$CA
190957182$19095718$2$F$20210106$20240806$20210406$20240810$EXP$$FR-ROCHE-2796391$ROCHE$$47$YR$A$F$Y$$$20240810$$MD$FR$FR
190961192$19096119$2$F$$20240815$20210406$20240828$PER$$US-SA-2021SA113568$SANOFI AVENTIS$$$$A$M$Y$$$20240828$$MD$US$US
190964608$19096460$8$F$20180101$20240909$20210406$20240911$EXP$$IN-PFIZER INC-2018492835$PFIZER$$69$YR$$F$Y$$$20240911$$CN$IN$IN
190965597$19096559$7$F$$20240918$20210406$20240920$PER$$US-PFIZER INC-2018304049$PFIZER$$58$YR$$F$Y$$$20240920$$CN$US$US
1909736312$19097363$12$F$20190702$20240828$20210406$20240830$EXP$$CA-TAKEDA-2018TUS033274$TAKEDA$$72$YR$$M$Y$$$20240830$$MD$CA$CA
190974983$19097498$3$F$20210310$20240806$20210406$20240812$EXP$$FR-ROCHE-2801802$ROCHE$$51$YR$A$F$Y$$$20240812$$MD$FR$FR
1909770011$19097700$11$F$20200101$20240729$20210406$20240820$PER$$CA-TOLMAR, INC.-20CA024161$TOLMAR$$$$$M$Y$$$20240820$$CN$CA$CA
1909806022$19098060$22$F$20201130$20240821$20210406$20240827$EXP$$BR-TAKEDA-2020TUS059502$TAKEDA$$6$YR$$M$Y$27$KG$20240827$$CN$BR$BR
1909813626$19098136$26$F$20220109$20240809$20210406$20240815$EXP$$US-TAKEDA-2020TUS044861$TAKEDA$$62$YR$$F$Y$45$KG$20240815$$CN$US$US
190984275$19098427$5$F$20191125$20230131$20210406$20240829$EXP$$NVSC2021CA062375$NOVARTIS$$77$YR$$F$Y$87$KG$20240829$$MD$CA$CA
1909862017$19098620$17$F$20210510$20240809$20210406$20240814$EXP$$CA-TAKEDA-2021TUS011415$TAKEDA$$59$YR$$M$Y$$$20240814$$CN$CA$CA
190986468$19098646$8$F$$20240919$20210406$20240925$EXP$$CA-TAKEDA-2021TUS021316$TAKEDA$$72$YR$$M$Y$$$20240925$$HP$CA$CA
190986727$19098672$7$F$20231227$20240723$20210406$20240725$EXP$$CA-TAKEDA-2021TUS020321$TAKEDA$$42$YR$$M$Y$$$20240725$$CN$CA$CA
190986943$19098694$3$F$20210222$20240710$20210406$20240716$EXP$$NVSC2021IN073911$NOVARTIS$$58$YR$$F$Y$$$20240716$$CN$IN$IN
190991302$19099130$2$F$$20240812$20210406$20240813$EXP$$CA-BAUSCH-BL-2021-011582$BAUSCH AND LOMB$$$$$M$Y$$$20240813$$CN$CA$CA
1909914317$19099143$17$F$$20240801$20210406$20240805$EXP$$US-TAKEDA-US201849196$TAKEDA$$$$$M$Y$61$KG$20240805$$MD$US$US
190991678$19099167$8$F$20230701$20240830$20210406$20240903$EXP$$US-TAKEDA-2021TUS020956$TAKEDA$$58$YR$$F$Y$$$20240903$$HP$US$US
1909942027$19099420$27$F$20200116$20240726$20210407$20240805$EXP$$CA-CELLTRION INC.-2020CA018205$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
190996376$19099637$6$F$20180101$20240913$20210407$20240923$EXP$$FR-AUROBINDO-AUR-APL-2021-013810$AUROBINDO$Perrier M, Delemer B, Deguelte S, Legros V, Brixi H, Kianmanesh R, et al.. Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1/Zollinger Ellison syndrome patient.. Pancreatology.. 2021;21 (1):236-239$56$YR$$M$Y$$$20240923$$MD$FR$FR
190996877$19099687$7$F$20201201$20240627$20210406$20240709$EXP$$CA-ROCHE-2802685$ROCHE$$19$YR$A$F$Y$$$20240709$$CN$CA$CA
191002244$19100224$4$F$$20240828$20210407$20240910$EXP$DE-EMA-DD-20210405-PAWAR_P-143426$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-01674$ALKEM$Paul LD, Welter-Luedeke J, Penzel S, Zangl A, et al.. Alpha-Pyrrolidinopentiothiophenone (alpha-PVT): A forensic case study including plasma concentrations. Forensic Sci Int. 2021;321:110721$31$YR$$M$Y$$$20240910$$HP$DE$DE
191005703$19100570$3$F$$20240828$20210407$20240909$EXP$$CA-AUROBINDO-AUR-APL-2021-014383$AUROBINDO$$65$YR$$M$Y$$$20240909$$CN$CA$CA
191009632$19100963$2$F$$20210326$20210407$20240701$EXP$$ES-NOVOPROD-799422$NOVO NORDISK$De Lara Rodr?guez, Irene; Gonz?lez Navarro, Irene;Acosta Delgado, Domingo; D?niz Garc?a,Alejandro;Del Can S?nchez, Diego; Pi?ar Guti?rrez,Ana. MATERNAL-FETAL OUTCOMES IN PREGNANT TREATED WITH INSULIN DEGLUDEC. Medical News. 2020;54-56$$$A$F$Y$$$20240701$$MD$ES$ES
191012422$19101242$2$F$$20210326$20210407$20240702$EXP$$ES-NOVOPROD-800310$NOVO NORDISK$De Lara Rodr?guez, Irene; Gonz?lez Navarro, Irene;Acosta Delgado, Domingo; D?niz Garc?a,Alejandro;Del Can S?nchez, Diego; Pi?ar Guti?rrez,Ana. MATERNAL-FETAL OUTCOMES IN PREGNANT TREATED WITH INSULIN DEGLUDEC. Medical News. 2020;54-56$$$$$Y$$$20240702$$MD$ES$ES
191036189$19103618$9$F$$20240909$20210407$20240910$EXP$$US-PFIZER INC-2021349310$PFIZER$$56$YR$$F$Y$82.993$KG$20240910$$HP$US$US
1910416610$19104166$10$F$20210326$20240822$20210407$20240827$EXP$$BR-TAKEDA-2021TUS004655$TAKEDA$$35$YR$$M$Y$$$20240827$$CN$BR$BR
1910467020$19104670$20$F$20210405$20240924$20210407$20240926$EXP$$CA-ROCHE-2806134$ROCHE$$39$YR$A$F$Y$$$20240926$$CN$CA$CA
1910538748$19105387$48$F$$20240813$20210408$20240816$EXP$$CA-ABBVIE-21K-028-3851571-00$ABBVIE$$$$$F$Y$97$KG$20240816$$HP$CA$CA
1910607611$19106076$11$F$20191201$20240708$20210407$20240711$EXP$$US-TAKEDA-US202033627$TAKEDA$$55$YR$$F$Y$$$20240711$$HP$US$US
1910646626$19106466$26$F$20181010$20240710$20210407$20240720$EXP$$CA-CELLTRION INC.-2019CA020001$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
191080938$19108093$8$F$20171127$20240724$20210408$20240730$EXP$$CA-TAKEDA-2017TUS019603$TAKEDA$$22$YR$$F$Y$$$20240730$$CN$CA$CA
191090942$19109094$2$F$$20240807$20210408$20240813$EXP$$US-JAZZ-2021-US-004864$JAZZ$$$$$M$Y$$$20240813$$HP$US$US
191106783$19110678$3$F$$20240731$20210409$20240807$PER$$US-BIOGEN-2014BI046095$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
191108785$19110878$5$F$$20220621$20210409$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR073335$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
191113292$19111329$2$F$20210206$20240117$20210409$20240716$PER$$US-IGSA-BIG0013290$GRIFOLS$$35$YR$$M$Y$69.9$KG$20240716$$PH$US$US
1911136311$19111363$11$F$20210101$20240828$20210408$20240904$PER$$US-PFIZER INC-2021209697$PFIZER$$7$YR$$F$Y$$$20240904$$MD$US$US
191121144$19112114$4$F$$20240909$20210409$20240916$EXP$$CA-GLAXOSMITHKLINE-CA2021AMR077160$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$CA$CA
191121422$19112142$2$F$$20240724$20210409$20240730$PER$$CA-GLAXOSMITHKLINE-CA2021AMR077270$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$CA$CA
191129732$19112973$2$F$20191201$20240917$20210408$20240926$PER$$US-SA-2021SA111528$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240926$$MD$US$US
191132454$19113245$4$F$20190101$20240828$20210408$20240902$EXP$$NVSC2020BR001109$NOVARTIS$$$$$F$Y$63$KG$20240902$$CN$BR$BR
191145603$19114560$3$F$20200801$20240916$20210409$20240925$EXP$$NVSC2021DE042337$NOVARTIS$$$$$M$Y$$$20240925$$CN$DE$DE
191147203$19114720$3$F$20240701$20240809$20210409$20240815$PER$$US-PFIZER INC-2020373204$PFIZER$$52$YR$$F$Y$$$20240815$$HP$US$US
191159162$19115916$2$F$$20240822$20210409$20240829$EXP$$BR-TAKEDA-BR201924385$TAKEDA$$$$$M$Y$106$KG$20240829$$MD$BR$BR
191159616$19115961$6$F$20200101$20240725$20210409$20240730$EXP$$US-JNJFOC-20210400251$JOHNSON AND JOHNSON$$70$YR$E$F$Y$73.548$KG$20240731$$CN$US$US
191163602$19116360$2$F$20210405$20210405$20210409$20240711$EXP$$NVSC2021US078100$NOVARTIS$$26$YR$$F$Y$$$20240711$$CN$US$US
191172892$19117289$2$F$$20210326$20210409$20240701$EXP$$ES-NOVOPROD-802101$NOVO NORDISK$De Lara Rodr?guez, Irene; Gonz?lez Navarro, Irene;Acosta Delgado, Domingo; D?niz Garc?a,Alejandro;Del Can S?nchez, Diego; Pi?ar Guti?rrez,Ana. MATERNAL-FETAL OUTCOMES IN PREGNANT TREATED WITH INSULIN DEGLUDEC. Medical News. 2020;54-56$$$$F$Y$$$20240701$$MD$ES$ES
191172902$19117290$2$F$$20210326$20210409$20240701$EXP$$ES-NOVOPROD-802135$NOVO NORDISK$De Lara Rodr?guez, Irene; Gonz?lez Navarro, Irene;Acosta Delgado, Domingo; D?niz Garc?a,Alejandro;Del Can S?nchez, Diego; Pi?ar Guti?rrez,Ana. MATERNAL-FETAL OUTCOMES IN PREGNANT TREATED WITH INSULIN DEGLUDEC. Medical News. 2020;54-56$$$$F$Y$$$20240701$$MD$ES$ES
191172912$19117291$2$F$$20210326$20210409$20240701$EXP$$ES-NOVOPROD-802141$NOVO NORDISK$De Lara Rodr?guez, Irene; Gonz?lez Navarro, Irene;Acosta Delgado, Domingo; D?niz Garc?a,Alejandro;Del Can S?nchez, Diego; Pi?ar Guti?rrez,Ana. Maternal-Fetal Outcomes In Pregnant Treated With Insulin Degludec. Medical News. 2020;54-56$$$$F$Y$$$20240701$$MD$ES$ES
191172922$19117292$2$F$$20210326$20210409$20240701$EXP$$ES-NOVOPROD-802132$NOVO NORDISK$De Lara Rodr?guez, Irene; Gonz?lez Navarro, Irene;Acosta Delgado, Domingo; D?niz Garc?a,Alejandro;Del Can S?nchez, Diego; Pi?ar Guti?rrez,Ana. MATERNAL-FETAL OUTCOMES IN PREGNANT TREATED WITH INSULIN DEGLUDEC. Medical News. 2020;54-56$$$$F$Y$$$20240701$$MD$ES$ES
191176012$19117601$2$F$$20210329$20210409$20240723$EXP$$CA-AstraZeneca-2021A001134$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$CA$
1911784018$19117840$18$F$20200214$20240628$20210409$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-034289$BRISTOL MYERS SQUIBB$Nakamura K, Ashida A, Kiniwa Y, Okuyama R. Summary of adjuvant therapy for advanced malignant melanoma in our department. Skin Cancer. 2021;36(3):212-7.$63$YR$A$M$Y$$$20240704$$MD$JP$JP
191178459$19117845$9$F$20161001$20240624$20210409$20240705$EXP$$PHHY2016CA146558$NOVARTIS$$40$YR$$F$Y$$$20240705$$CN$CA$CA
1911867512$19118675$12$F$20201110$20240822$20210410$20240830$EXP$$IE-TAKEDA-2020TUS057895$TAKEDA$$69$YR$$F$Y$$$20240830$$HP$IE$IE
191186785$19118678$5$F$20230915$20240906$20210410$20240911$EXP$$AU-TAKEDA-2021TUS022829$TAKEDA$$45$YR$$F$Y$$$20240911$$CN$AU$AU
191195383$19119538$3$F$20210222$20240913$20210412$20240925$EXP$$FR-AUROBINDO-AUR-APL-2021-014876$AUROBINDO$$45$YR$$F$Y$85$KG$20240925$$MD$FR$FR
191195452$19119545$2$F$$20240909$20210412$20240917$EXP$$PL-AUROBINDO-AUR-APL-2021-014784$AUROBINDO$Szlauer-stefanska A, Kaminska-winciorek G. Patient with chronic cutaneous and mucosal forms of graft- versus-host disease. DERMATOLOGIA PO DYPLOMIE. 2024;2$30$YR$$M$Y$$$20240917$$MD$PL$PL
191200132$19120013$2$F$20210318$20240607$20210412$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-001071$ACADIA PHARMACEUTICALS$$64$YR$$M$Y$$$20240701$$CN$US$US
1912030123$19120301$23$F$20200508$20240814$20210412$20240822$EXP$$CA-CELLTRION INC.-2019CA028143$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
191204067$19120406$7$F$20210301$20240718$20210412$20240729$EXP$$DE-ROCHE-2800970$ROCHE$$44$YR$A$M$Y$130$KG$20240729$$MD$DE$DE
191208948$19120894$8$F$20190307$20240730$20210412$20240806$EXP$$CA-TAKEDA-2019TUS023487$TAKEDA$$17$YR$$F$Y$$$20240806$$CN$CA$CA
191222855$19122285$5$F$20200701$20240731$20210412$20240806$EXP$$EC-BIOGEN-2020BI00958233$BIOGEN$$32$YR$$F$Y$$$20240806$$CN$EC$EC
191226867$19122686$7$F$$20240819$20210412$20240822$EXP$$CA-BAUSCH-BL-2021-011864$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240822$$CN$CA$CA
1912392211$19123922$11$F$20201203$20240725$20210413$20240731$EXP$$DE-ROCHE-2760247$ROCHE$$30$YR$A$F$Y$$$20240731$$CN$DE$DE
1912427627$19124276$27$F$20200801$20240711$20210413$20240719$EXP$$CA-CELLTRION INC.-2020CA025687$CELLTRION$$$$$$Y$$$20240719$$HP$CA$CA
1912519210$19125192$10$F$20211220$20240815$20210412$20240816$EXP$$US-PFIZER INC-2021351013$PFIZER$$74$YR$$F$Y$148$KG$20240816$$CN$US$US
191252892$19125289$2$F$$20240819$20210412$20240821$EXP$$CA-BAUSCH-BL-2021-011806$BAUSCH AND LOMB$$$$$F$Y$$$20240821$$MD$CA$CA
191253242$19125324$2$F$$20240819$20210412$20240822$EXP$$CA-BAUSCH-BL-2021-011836$BAUSCH AND LOMB$$70$YR$$F$Y$50$KG$20240822$$CN$CA$CA
191253412$19125341$2$F$$20240819$20210412$20240823$EXP$$CA-BAUSCH-BL-2021-011867$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240823$$CN$CA$CA
191254472$19125447$2$F$$20240819$20210412$20240822$EXP$$CA-BAUSCH-BL-2021-011904$BAUSCH AND LOMB$$78$YR$$M$Y$83$KG$20240822$$PH$CA$CA
191260442$19126044$2$F$$20240715$20210413$20240718$EXP$$CA-BAUSCH-BL-2021-011714$BAUSCH AND LOMB$$45$YR$$F$Y$$$20240718$$CN$CA$CA
1912614518$19126145$18$F$20190529$20240905$20210413$20240911$EXP$$CA-TAKEDA-2021TUS003727$TAKEDA$$65$YR$$M$Y$$$20240911$$HP$CA$CA
1912618284$19126182$84$F$$20240923$20210412$20240930$EXP$$CA-BAUSCH-BL-2017-018617$BAUSCH AND LOMB$$44$YR$$F$Y$68$KG$20241001$$HP$CA$CA
191270054$19127005$4$F$20160629$20240815$20210412$20240819$EXP$$JP-JNJFOC-A-CH2019-185478$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240819$$MD$JP$JP
191289494$19128949$4$F$20210329$20240722$20210413$20240729$EXP$$CO-TAKEDA-2021TUS012956$TAKEDA$$56$YR$$F$Y$49$KG$20240729$$CN$CO$CO
191299722$19129972$2$F$$20240720$20210414$20240730$EXP$$DE-AUROBINDO-AUR-APL-2021-014979$AUROBINDO$Hanisch F, Friedemann J, Piro J, Gutmann P. Maintenance electroconvulsive therapy for comorbid pharmacotherapy- refractory obsessive-compulsive and schizoaffective disorder. Eur-J-Med-Res. 2009;14(8):367-368$46$YR$$F$Y$$$20240730$$HP$DE$DE
1913002115$19130021$15$F$20190918$20240704$20210414$20240715$EXP$$PL-AUROBINDO-AUR-APL-2021-014780$AUROBINDO$$62$YR$$M$Y$$$20240715$$MD$PL$PL
1913064924$19130649$24$F$20200427$20240829$20210414$20240907$EXP$$CA-CELLTRION INC.-2020CA022021$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
191307012$19130701$2$F$$20240819$20210413$20240822$EXP$$CA-BAUSCH-BL-2021-011937$BAUSCH AND LOMB$$$$$M$Y$$$20240822$$CN$CA$CA
191307356$19130735$6$F$20210101$20240717$20210413$20240724$EXP$$US-JAZZ-2021-US-006104$JAZZ$$$$$F$Y$$$20240723$$CN$US$US
191316794$19131679$4$F$$20240826$20210414$20240904$30DAY$$US-GLAXOSMITHKLINE-US2021079381$GLAXOSMITHKLINE$$$$$M$Y$$$20240904$$CN$US$US
191320108$19132010$8$F$20210201$20240913$20210413$20240917$PER$$US-PFIZER INC-2021299585$PFIZER$$57$YR$$F$Y$$$20240917$$CN$US$US
191327412$19132741$2$F$$20240715$20210413$20240717$EXP$$CA-BAUSCH-BL-2021-011834$BAUSCH AND LOMB$$$$$M$Y$$$20240717$$CN$CA$CA
191329642$19132964$2$F$$20240819$20210413$20240830$EXP$$CA-CIPHER-2021-CA-000811$CIPHER$$$$$F$Y$$$20240830$$HP$CA$CA
191338822$19133882$2$F$$20240813$20210414$20240822$EXP$$CA-APOTEX-2021AP008668$APOTEX$$55$YR$$F$Y$$$20240822$$MD$CA$CA
191339202$19133920$2$F$20190101$20210406$20210414$20240711$EXP$$GR-ASTELLAS-2021US013036$ASTELLAS$$72$YR$$M$Y$$$20240711$$CN$GR$GR
1913460410$19134604$10$F$$20240708$20210414$20240717$EXP$$CA-BAYER-2021-118599$BAYER$Author not available. Journal not available. Title not available. NA;NA:NA$11$YR$C$M$Y$$$20240717$$MD$CA$CA
1913463216$19134632$16$F$20201101$20240827$20210414$20240830$EXP$$US-JAZZ-2021-US-006420$JAZZ$$40$YR$$F$Y$97.959$KG$20240830$$MD$US$US
191347524$19134752$4$F$$20240718$20210414$20240724$PER$$US-BIOGEN-2021BI01000385$BIOGEN$$$$$F$Y$$$20240724$$CN$US$US
191356605$19135660$5$F$20210401$20240621$20210414$20240702$PER$$US-SA-2021SA120425$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240702$$MD$US$US
191357635$19135763$5$F$20190619$20240828$20210414$20240830$EXP$$CA-TAKEDA-2019TUS029064$TAKEDA$$60$YR$$M$Y$$$20240830$$MD$CA$CA
191357905$19135790$5$F$$20240813$20210414$20240816$EXP$$US-TAKEDA-US201912820$TAKEDA$$$$$M$Y$$$20240816$$HP$US$US
191358877$19135887$7$F$20210101$20240702$20210414$20240708$EXP$$US-PFIZER INC-2021354398$PFIZER$$78$YR$$M$Y$72.57$KG$20240708$$CN$US$US
191361732$19136173$2$F$$20240704$20210414$20240708$EXP$$CA-TAKEDA-2021TUS018075$TAKEDA$$$$$F$Y$$$20240708$$CN$CA$CA
1913618210$19136182$10$F$20131205$20240909$20210414$20240911$EXP$$PHHY2014CA052129$NOVARTIS$$38$YR$$F$Y$110$KG$20240911$$CN$CA$CA
191383056$19138305$6$F$20210601$20240910$20210414$20240917$EXP$$US-TAKEDA-2021TUS021676$TAKEDA$$57$YR$$F$Y$57$KG$20240917$$MD$US$US
191383459$19138345$9$F$20210324$20240823$20210415$20240830$EXP$$CA-ROCHE-2799504$ROCHE$$44$YR$A$F$Y$90$KG$20240830$$HP$CA$CA
1913873611$19138736$11$F$20211214$20240808$20210415$20240813$EXP$$CA-ROCHE-2807329$ROCHE$$70$YR$E$F$Y$$$20240813$$CN$CA$CA
1913927710$19139277$10$F$20191006$20240914$20210415$20240923$EXP$$NVSC2020CA005963$NOVARTIS$$29$YR$$F$Y$94$KG$20240923$$MD$CA$CA
191398554$19139855$4$F$$20240809$20210415$20240821$EXP$$CA-Accord-222484$ACCORD$Yim C, Hussein N, Arnason T. Capecitabine-induced hyperosmolar hyperglycaemic state. BMJ Case Rep. 2021 Mar 24;14(3):e241109.$72$YR$E$F$Y$50$KG$20240821$$HP$CA$CA
1914113016$19141130$16$F$20190101$20240718$20210415$20240724$EXP$$AU-TAKEDA-2021TUS000681$TAKEDA$$$$$F$Y$$$20240724$$MD$AU$AU
191411424$19141142$4$F$$20240816$20210415$20240821$EXP$$US-JAZZ-2021-US-006609$JAZZ$$$$$F$Y$77.098$KG$20240821$$CN$US$US
191414985$19141498$5$F$$20240701$20210415$20240703$EXP$$US-TAKEDA-US202003058$TAKEDA$$$$$M$Y$$$20240703$$CN$US$US
1914156814$19141568$14$F$20210409$20240829$20210415$20240830$EXP$$US-TAKEDA-2021TUS023961$TAKEDA$$47$YR$$M$Y$$$20240830$$PH$US$US
191419322$19141932$2$F$$20240703$20210415$20240718$EXP$$US-PHARMING-PHAUS2021000176$PHARMING GROUP$$$$$$Y$$$20240718$$CN$US$US
191430802$19143080$2$F$20210101$20240705$20210416$20240711$EXP$$NL-AUROBINDO-AUR-APL-2021-014967$AUROBINDO$$40$YR$$F$Y$77$KG$20240711$$MD$NL$NL
191433569$19143356$9$F$$20240829$20210416$20240902$EXP$$CA-TAKEDA-2019TUS058604$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
191437532$19143753$2$F$$20210318$20210415$20240709$PER$$US-AstraZeneca-2021A188546$ASTRAZENECA$$$$$F$Y$72.6$KG$20240709$$CN$US$
191437572$19143757$2$F$$20240731$20210415$20240814$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-290836$RANBAXY$De Enen NJ, Koens L, Jaspar EH, Vermeer MH, Williemze R, De Rie MA et al. Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma. Br J Dermatol. 2019;180:411-412$46$YR$$M$Y$$$20240814$$HP$NL$NL
191441794$19144179$4$F$20210222$20240903$20210416$20240905$EXP$$FR-ROCHE-2804955$ROCHE$$45$YR$A$F$Y$85$KG$20240905$$MD$FR$FR
191442482$19144248$2$F$$20240702$20210416$20240709$EXP$$BR-AUROBINDO-AUR-APL-2019-081593$AUROBINDO$Bugni VM, Terreri MTSLRA, Nunes NAC, Len CA, Barbosa CMPL, Hil?rio MOE.. S?ndrome DRESS e L?pus Eritematoso Sist?mico Juvenil em Menina de Dois Anos de Idade. Revista Brasileira De Reumatologia. 2008;48 (4):257-260$2$YR$$F$Y$$$20240709$$HP$BR$BR
1914458816$19144588$16$F$20210406$20240710$20210416$20240720$EXP$$CA-CELLTRION INC.-2020CA034775$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
1914491010$19144910$10$F$20200101$20240823$20210416$20240918$PER$$US-ASTELLAS-2021US010707$ASTELLAS$$54$YR$A$M$Y$$$20240918$$CN$US$US
1914507924$19145079$24$F$20200101$20240917$20210416$20240926$EXP$$CA-CELLTRION INC.-2020CA029298$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
1914577525$19145775$25$F$$20240916$20210416$20240926$EXP$$GB-TAKEDA-2021TUS023591$TAKEDA$$38$YR$$F$Y$$$20240926$$CN$GB$GB
191458256$19145825$6$F$20210315$20240715$20210416$20240718$EXP$$CA-TAKEDA-CA202002893$TAKEDA$$69$YR$$F$Y$$$20240718$$CN$CA$CA
1914589113$19145891$13$F$20210406$20240815$20210416$20240821$EXP$$CO-TAKEDA-2021TUS023996$TAKEDA$$28$YR$$F$Y$67$KG$20240821$$CN$CO$CO
191459254$19145925$4$F$$20240903$20210416$20240909$EXP$$DE-ABBVIE-21P-062-3862543-00$ABBVIE$$$$E$M$Y$$$20240909$$MD$DE$DE
191468443$19146844$3$F$20210402$20240906$20210416$20240912$EXP$$CO-TAKEDA-2021TUS023910$TAKEDA$$25$YR$$M$Y$48$KG$20240912$$CN$CO$CO
191481303$19148130$3$F$20190308$20240719$20210417$20240723$EXP$$FR-ABBVIE-19P-056-2703455-00$ABBVIE$$27$YR$$F$Y$$$20240723$$MD$FR$FR
1914880225$19148802$25$F$$20240830$20210416$20240904$EXP$$CA-ANIPHARMA-2021-CA-000457$ANI$$65$YR$$M$Y$$$20240904$$MD$CA$CA
1914910516$19149105$16$F$20210518$20240920$20210416$20240927$EXP$$US-TAKEDA-2021TUS022990$TAKEDA$$25$YR$$F$Y$68$KG$20240927$$CN$US$US
191492653$19149265$3$F$$20240815$20210416$20240912$PER$$US-SUNOVION-2021SUN001262$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
191496327$19149632$7$F$$20240816$20210417$20240820$EXP$$US-TAKEDA-US202008683$TAKEDA$$$$$F$Y$$$20240820$$HP$US$US
191496598$19149659$8$F$20210201$20240806$20210417$20240817$EXP$$US-AUROBINDO-AUR-APL-2021-015533$AUROBINDO$$42$YR$$F$Y$69.4$KG$20240817$$MD$US$US
1914989713$19149897$13$F$20240725$20240927$20210417$20240927$EXP$$US-TAKEDA-US202034595$TAKEDA$$79$YR$$F$Y$47.62$KG$20240927$$CN$US$US
1915008817$19150088$17$F$20200101$20240705$20210417$20240708$EXP$$NVSC2021AR082039$NOVARTIS$$3$YR$$M$Y$$$20240708$$CN$AR$AR
191501072$19150107$2$F$$20240828$20210417$20240902$EXP$$NVSC2021US022198$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
1915132429$19151324$29$F$20210101$20240919$20210419$20240927$EXP$$CA-CELLTRION INC.-2021CA005292$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
1915134819$19151348$19$F$20210325$20240809$20210419$20240816$EXP$$CA-CELLTRION INC.-2021CA005290$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
191515293$19151529$3$F$20210325$20240919$20210419$20240927$EXP$$US-INTERCEPT-PM2021001207$INTERCEPT PHARMACEUTICALS$$66$YR$$F$Y$$$20240927$$CN$US$US
191516983$19151698$3$F$20210215$20240904$20210419$20240909$EXP$FR-SEATTLE GENETICS-2021SGN01832$FR-ROCHE-2806225$ROCHE$$49$YR$A$F$Y$47$KG$20240909$$PH$FR$FR
191531588$19153158$8$F$$20240912$20210419$20240924$EXP$$CA-APOTEX-2021AP009030$APOTEX$$45$YR$$F$Y$95$KG$20240924$$HP$CA$CA
191531672$19153167$2$F$20200223$20240619$20210419$20240704$EXP$PL-URPL-1-1012-2020$PL-TEVA-2021-PL-1901734$TEVA$$55$YR$$F$Y$95$KG$20240704$$MD$PL$PL
1915324716$19153247$16$F$20210401$20220809$20210419$20240925$EXP$$US-GLAXOSMITHKLINE-US2021081789$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
191533428$19153342$8$F$$20220311$20210419$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR086018$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
191534915$19153491$5$F$20200218$20240919$20210419$20240924$EXP$$MX-TAKEDA-MX202007416$TAKEDA$$8$YR$$M$Y$22$KG$20240924$$CN$MX$MX
191536035$19153603$5$F$20141104$20240911$20210419$20240918$PER$$US-BIOGEN-2019BI00745799$BIOGEN$$38$YR$$F$Y$$$20240918$$CN$US$US
191537764$19153776$4$F$20210225$20240917$20210419$20240920$30DAY$$US-PFIZER INC-2021218145$PFIZER$$2$YR$$F$Y$15.51$KG$20240920$$CN$US$US
1915438423$19154384$23$F$20210401$20240626$20210419$20240701$EXP$$US-TAKEDA-2021TUS023615$TAKEDA$$35$YR$$M$Y$$$20240701$$CN$US$US
1915442810$19154428$10$F$$20240903$20210419$20240913$EXP$$HR-TEVA-2021-HR-1901716$TEVA$$56$YR$$F$Y$$$20240913$$MD$HR$HR
191560166$19156016$6$F$$20240829$20210419$20240829$EXP$$US-PFIZER INC-2021395544$PFIZER$$62$YR$$F$Y$74.83$KG$20240829$$CN$US$US
1915605517$19156055$17$F$20190918$20240730$20210419$20240808$EXP$$PL-PFIZER INC-2021369409$PFIZER$$62$YR$$M$Y$98$KG$20240808$$MD$PL$PL
191566543$19156654$3$F$20210226$20240725$20210419$20240805$EXP$$IL-ABBVIE-21K-082-3865015-00$ABBVIE$$81$YR$$F$Y$76$KG$20240805$$MD$IL$IL
1915747110$19157471$10$F$20221022$20240731$20210420$20240802$EXP$$US-TAKEDA-US202019029$TAKEDA$$78$YR$$M$Y$91$KG$20240802$$HP$US$US
191587977$19158797$7$F$$20240829$20210420$20240903$EXP$$US-TAKEDA-US202016467$TAKEDA$$$$$F$Y$$$20240903$$MD$US$US
191589069$19158906$9$F$20200610$20240911$20210420$20240919$EXP$$CA-TAKEDA-2019TUS053865$TAKEDA$$49$YR$$F$Y$$$20240919$$CN$CA$CA
1915906010$19159060$10$F$20210331$20240619$20210420$20240718$PER$$CA-TOLMAR, INC.-21CA026412$TOLMAR$$64$YR$$M$Y$$$20240718$$CN$CA$CA
191593605$19159360$5$F$$20240628$20210420$20240703$EXP$$US-JAZZ-2021-US-006896$JAZZ$$$$$F$Y$$$20240703$$CN$US$US
191597044$19159704$4$F$$20240819$20210420$20240823$EXP$$NVSC2021CA085300$NOVARTIS$$63$YR$$M$Y$$$20240823$$CN$CA$CA
191599382$19159938$2$F$20210404$20240801$20210421$20240826$PER$$PA-TOLMAR, INC.-21PA026464$TOLMAR$$59$YR$$M$Y$$$20240826$$CN$PA$PA
1916060615$19160606$15$F$20190316$20240910$20210421$20240918$EXP$$CA-CELLTRION INC.-2021CA005387$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
191618923$19161892$3$F$20210101$20240620$20210421$20240702$PER$$US-SA-2021SA127158$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240702$$MD$US$US
191632839$19163283$9$F$20201118$20240906$20210421$20240911$EXP$$US-TAKEDA-2021TUS023937$TAKEDA$$61$YR$$F$Y$94$KG$20240911$$CN$US$US
1916356814$19163568$14$F$$20240722$20210421$20240731$EXP$$CA-ROCHE-2814546$ROCHE$$$$A$F$Y$$$20240731$$HP$CA$CA
191636135$19163613$5$F$20210419$20240911$20210421$20240917$PER$$US-AMGEN-USASP2021060909$AMGEN$$55$YR$A$M$Y$$$20240916$$HP$US$US
191645425$19164542$5$F$$20240912$20210421$20240916$PER$$US-PFIZER INC-2021345529$PFIZER$$50$YR$$M$Y$77.11$KG$20240916$$CN$US$US
191649473$19164947$3$F$$20240808$20210421$20240815$EXP$$US-TAKEDA-2021TUS023764$TAKEDA$$$$$F$Y$132$KG$20240815$$MD$US$US
191675422$19167542$2$F$20210316$20240806$20210422$20240808$EXP$$FR-ROCHE-2807979$ROCHE$$82$YR$E$F$Y$$$20240808$$MD$FR$FR
191681763$19168176$3$F$$20240819$20210422$20240828$EXP$$CA-APOTEX-2021AP009429$APOTEX$$54$YR$$F$Y$59$KG$20240828$$CN$CA$CA
191687199$19168719$9$F$20190101$20240716$20210422$20240722$PER$$US-VERTEX PHARMACEUTICALS-2021-006228$VERTEX$$$$$F$Y$88$KG$20240722$$MD$US$US
191689022$19168902$2$F$$20240903$20210422$20240910$EXP$$DE-ABBVIE-21P-062-3869990-00$ABBVIE$$$$E$M$Y$$$20240910$$MD$DE$DE
191691693$19169169$3$F$20190610$20240812$20210422$20240814$EXP$$US-SHIRE-US201918971$TAKEDA$$38$YR$$F$Y$$$20240814$$MD$US$US
191698752$19169875$2$F$$20240813$20210422$20240821$EXP$$CA-APOTEX-2021AP010020$APOTEX$$60$YR$$M$Y$$$20240821$$MD$CA$CA
191700915$19170091$5$F$20191215$20240710$20210422$20240712$EXP$$US-ABBVIE-21K-163-3871792-00$ABBVIE$$40$YR$$M$Y$$$20240712$$MD$US$US
1917033810$19170338$10$F$20210101$20240703$20210422$20240709$PER$$US-PFIZER INC-2021405509$PFIZER$$76$YR$$F$Y$49.977$KG$20240709$$PH$US$US
191709493$19170949$3$F$$20240828$20210423$20240906$EXP$$CA-APOTEX-2021AP009485$APOTEX$$64$YR$$M$Y$$$20240906$$HP$CA$CA
191712478$19171247$8$F$20201201$20240627$20210423$20240702$EXP$$CA-ABBVIE-21K-028-3871882-00$ABBVIE$$68$YR$$F$Y$$$20240702$$CN$CA$CA
191717453$19171745$3$F$$20240819$20210423$20240828$EXP$$CA-APOTEX-2021AP009476$APOTEX$$$$$M$Y$$$20240828$$HP$CA$CA
1917176910$19171769$10$F$20210301$20240813$20210423$20240815$EXP$$JP-JNJFOC-20210436148$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240816$$MD$JP$JP
191720663$19172066$3$F$$20240819$20210423$20240828$EXP$$CA-APOTEX-2021AP009548$APOTEX$$78$YR$$M$Y$83$KG$20240828$$PH$CA$CA
191721023$19172102$3$F$$20240829$20210423$20240909$EXP$$CA-APOTEX-2021AP009502$APOTEX$$67$YR$$F$Y$$$20240909$$HP$CA$CA
191725002$19172500$2$F$20210330$20240808$20210423$20240820$PER$$US-SA-2021SA135222$SANOFI AVENTIS$$18$YR$A$M$Y$72.5$KG$20240820$$MD$US$US
191728702$19172870$2$F$$20240821$20210423$20240830$EXP$$CA-APOTEX-2021AP009642$APOTEX$$49$YR$$F$Y$$$20240830$$MD$CA$CA
1917329011$19173290$11$F$20210414$20240722$20210423$20240724$EXP$$US-TAKEDA-2021TUS015040$TAKEDA$$51$YR$$M$Y$127$KG$20240724$$HP$US$US
1917442218$19174422$18$F$$20240826$20210423$20240829$PER$$US-PFIZER INC-2021185392$PFIZER$$56$YR$$F$Y$63.96$KG$20240829$$CN$US$US
191748672$19174867$2$F$20210117$20240725$20210424$20240730$EXP$$IL-ABBVIE-21K-082-3867253-00$ABBVIE$$75$YR$$M$Y$67$KG$20240730$$MD$IL$IL
191749772$19174977$2$F$20210416$20240806$20210423$20240809$EXP$$CH-JNJFOC-20210144572$JOHNSON AND JOHNSON$$72$YR$E$F$Y$76$KG$20240809$$MD$CH$CH
1917679921$19176799$21$F$20200106$20240906$20210424$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-068617$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$73$KG$20240917$$MD$JP$JP
1917695910$19176959$10$F$$20240709$20210424$20240711$EXP$$NVSC2021US090560$NOVARTIS$$$$$M$Y$$$20240711$$CN$US$US
191774213$19177421$3$F$$20240702$20210425$20240709$EXP$$CA-JNJFOC-20210442039$JOHNSON AND JOHNSON$$62$YR$A$M$Y$69$KG$20240709$$HP$CA$CA
191778463$19177846$3$F$20210407$20240820$20210426$20240821$EXP$$FR-ROCHE-2816880$ROCHE$$71$YR$E$F$Y$$$20240821$$MD$FR$FR
1917803418$19178034$18$F$20200914$20240815$20210426$20240822$EXP$$CA-CELLTRION INC.-2020CA028756$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
191781237$19178123$7$F$20200228$20240802$20210426$20240809$EXP$$CA-CELLTRION INC.-2020CA020382$CELLTRION$$$$$$Y$$$20240809$$MD$CA$CA
191789532$19178953$2$F$20190704$20240827$20210426$20240830$EXP$$CA-TAKEDA-2019TUS044359$TAKEDA$$35$YR$$F$Y$$$20240830$$CN$CA$CA
191801213$19180121$3$F$$20240722$20210426$20240725$EXP$$KR-BAYER-2021-127749$BAYER$$$$$F$Y$$$20240725$$MD$KR$KR
1918016510$19180165$10$F$20210410$20240722$20210426$20240801$EXP$$US-AMICUS THERAPEUTICS, INC.-AMI_1300$AMICUS THERAPEUTICS$$44$YR$$F$Y$99.32$KG$20240801$$CN$US$US
191804825$19180482$5$F$$20240729$20210426$20240801$EXP$$CA-PFIZER INC-2021412054$PFIZER$$17$YR$$F$Y$49$KG$20240801$$HP$CA$CA
191806134$19180613$4$F$$20240909$20210426$20240916$EXP$$JP-AMGEN-JPNSP2021061659$AMGEN$NOMURA Hiroshi. Comparative analysis of dropout rate of the patients with osteoporosis associated with fresh vertebral fractures followed by romosozumab or oral bisphosphonates treatment. The Journal of Japan Osicoporosis Society. 2024;10 (1):69-79$83$YR$E$F$Y$$$20240916$$MD$JP$JP
191817824$19181782$4$F$20210901$20240722$20210426$20240724$EXP$$US-TAKEDA-US202023060$TAKEDA$$40$YR$$M$Y$$$20240724$$HP$US$US
1918185514$19181855$14$F$$20240913$20210426$20240923$EXP$$US-TAKEDA-US202005709$TAKEDA$$$$$M$Y$109$KG$20240923$$MD$US$US
191819039$19181903$9$F$20210502$20240916$20210426$20240924$EXP$$CA-TAKEDA-2020TUS035595$TAKEDA$$67$YR$$F$Y$$$20240924$$CN$CA$CA
191820347$19182034$7$F$$20240816$20210426$20240819$EXP$$US-PFIZER INC-2021406327$PFIZER$$81$YR$$F$Y$61.23$KG$20240819$$CN$US$US
191821553$19182155$3$F$20210423$20210510$20210427$20240830$EXP$$JP-TAKEDA-2021TJP019633$TAKEDA$$77$YR$$F$Y$$$20240830$$PH$JP$JP
191823953$19182395$3$F$$20240614$20210427$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-001270$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
1918310623$19183106$23$F$20210519$20240906$20210426$20240916$EXP$$CA-CELLTRION INC.-2020CA033431$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
191832125$19183212$5$F$$20240723$20210427$20240730$EXP$$US-ROCHE-2812295$ROCHE$$72$YR$E$F$Y$$$20240730$$CN$US$US
191833042$19183304$2$F$20240422$20240612$20210427$20240707$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-001283$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240707$$CN$US$US
1918344916$19183449$16$F$$20240830$20210427$20240913$EXP$$CA-AUROBINDO-AUR-APL-2021-015942$AUROBINDO$$43$YR$$F$Y$68$KG$20240913$$HP$CA$CA
191835267$19183526$7$F$$20240812$20210427$20240820$EXP$$CA-APOTEX-2021AP010156$APOTEX$$9$YR$$M$Y$$$20240820$$HP$CA$CA
191845934$19184593$4$F$20200101$20240819$20210427$20240821$EXP$$US-TAKEDA-US201944692$TAKEDA$$$$$F$Y$$$20240821$$HP$US$US
191846512$19184651$2$F$$20240820$20210427$20240823$EXP$$GB-TAKEDA-GB201942151$TAKEDA$$$$$F$Y$$$20240823$$CN$GB$GB
191847373$19184737$3$F$20240101$20240719$20210427$20240725$EXP$$US-SA-2021SA137325$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240725$$MD$US$US
191849402$19184940$2$F$$20240715$20210427$20240722$EXP$$US-AUROBINDO-AUR-APL-2021-015527$AUROBINDO$Edwards LE, Hutchison LB, Hornik CD, Smith PB, Cotten CM, Bidegain M.. A case of infant delirium in the neonatal intensive care unit. Journal of Neonatal-Perinatal Medicine. 2017;10(1):119-123$6$MON$$M$Y$4.7$KG$20240722$$MD$US$US
191852282$19185228$2$F$$20240812$20210427$20240817$PER$$US-SA-2021SA136546$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240817$$MD$US$US
191853507$19185350$7$F$20190813$20240911$20210427$20240916$EXP$$CA-TAKEDA-2018TUS033636$TAKEDA$$63$YR$$M$Y$$$20240916$$CN$CA$CA
191859828$19185982$8$F$20200927$20240822$20210427$20240827$EXP$$CO-SHIRE-CO202031850$TAKEDA$$37$YR$$M$Y$85$KG$20240827$$CN$CO$CO
1918644515$19186445$15$F$$20240825$20210427$20240828$EXP$$US-PFIZER INC-2021353334$PFIZER$$65$YR$$F$Y$$$20240828$$CN$US$US
191869046$19186904$6$F$$20240812$20210428$20240822$EXP$$CA-AUROBINDO-AUR-APL-2021-016664$AUROBINDO$$62$YR$$M$Y$$$20240822$$HP$CA$CA
191874314$19187431$4$F$20210415$20240726$20210427$20240731$EXP$$CO-TAKEDA-2021TUS026057$TAKEDA$$36$YR$$M$Y$80$KG$20240731$$CN$CO$CO
191881933$19188193$3$F$20210420$20210609$20210428$20240717$EXP$$CA-ASTELLAS-2021US014846$ASTELLAS$$72$YR$$F$Y$$$20240717$$CN$CA$CA
191883004$19188300$4$F$20210408$20240924$20210428$20240930$EXP$$NVSC2021CA088795$NOVARTIS$$54$YR$$M$Y$$$20240929$$MD$CA$CA
191884432$19188443$2$F$20201202$20240806$20210428$20240812$EXP$$FR-ROCHE-2817976$ROCHE$$67$YR$E$F$Y$50$KG$20240812$$MD$FR$FR
191887084$19188708$4$F$$20210723$20210428$20240711$PER$$NVSC2021US095687$NOVARTIS$$$$$$Y$$$20240711$$CN$US$US
191898484$19189848$4$F$$20240919$20210428$20240924$EXP$$US-TAKEDA-2020TUS056460$TAKEDA$$$$$F$Y$56.68$KG$20240924$$CN$US$US
1919067011$19190670$11$F$20201016$20240731$20210428$20240808$EXP$$CA-TAKEDA-2020TUS025468$TAKEDA$$69$YR$$M$Y$$$20240808$$PH$CA$CA
1919199517$19191995$17$F$20220601$20240821$20210428$20240827$EXP$$NVSC2020GB022293$NOVARTIS$$61$YR$$M$Y$$$20240827$$CN$GB$GB
1919244025$19192440$25$F$20210311$20240913$20210429$20240921$EXP$$CA-CELLTRION INC.-2020CA034162$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
1919252694$19192526$94$F$20180101$20240731$20210428$20240805$EXP$$US-PFIZER INC-2021432292$PFIZER$$72$YR$$F$Y$$$20240805$$CN$US$US
191927663$19192766$3$F$$20240820$20210429$20240902$EXP$$US-SA-2020SA181751$SANOFI AVENTIS$$69$YR$E$M$Y$72.73$KG$20240902$$MD$US$US
191938819$19193881$9$F$20190115$20240429$20210429$20240910$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-02219$ALKEM$$31$YR$$F$Y$99$KG$20240910$$HP$DE$DE
191942722$19194272$2$F$20240802$20240805$20210429$20240807$EXP$$US-TAKEDA-US201932387$TAKEDA$$42$YR$$F$Y$$$20240807$$CN$US$US
191946975$19194697$5$F$$20240716$20210429$20240724$EXP$$CA-ROCHE-2816619$ROCHE$$61$YR$A$F$Y$$$20240724$$CN$CA$CA
191949172$19194917$2$F$$20240829$20210429$20240907$EXP$$CA-AUROBINDO-AUR-APL-2020-031041$AUROBINDO$$38$YR$$F$Y$$$20240907$$HP$CA$CA
1919524211$19195242$11$F$20230320$20240803$20210429$20240808$EXP$$AU-TAKEDA-2020TUS002615$TAKEDA$$34$YR$$F$Y$$$20240808$$HP$AU$AU
191953464$19195346$4$F$20201102$20240918$20210429$20240924$EXP$$CA-TAKEDA-2018TUS021710$TAKEDA$$45$YR$$F$Y$$$20240924$$HP$CA$CA
191959284$19195928$4$F$$20240722$20210429$20240725$EXP$$CA-BAYER-2021-128260$BAYER$$57$YR$A$M$Y$108$KG$20240725$$HP$CA$CA
191961465$19196146$5$F$20180101$20240904$20210429$20240910$EXP$$PHHY2018CA151223$NOVARTIS$$35$YR$$F$Y$$$20240910$$CN$CA$CA
191963542$19196354$2$F$$20240923$20210429$20240930$EXP$$CA-TAKEDA-CA202024546$TAKEDA$$$$$F$Y$88$KG$20240930$$CN$CA$CA
1919647421$19196474$21$F$$20240924$20210429$20240930$EXP$$US-TAKEDA-US202028472$TAKEDA$$$$$F$Y$48$KG$20240930$$CN$US$US
191964906$19196490$6$F$20210101$20240909$20210429$20240912$EXP$$CA-TAKEDA-CA202008509$TAKEDA$$7$YR$$M$Y$$$20240912$$CN$CA$CA
191966623$19196662$3$F$20210101$20240909$20210429$20240920$PER$$US-INCYTE CORPORATION-2021IN002572$INCYTE$$$$$$Y$$$20240920$$CN$US$US
1919675918$19196759$18$F$20210430$20240717$20210429$20240725$EXP$$CA-ROCHE-2818302$ROCHE$$76$YR$E$F$Y$$$20240725$$CN$CA$CA
191968203$19196820$3$F$$20240820$20210430$20240827$EXP$$CA-ROCHE-2816677$ROCHE$$81$YR$E$F$Y$$$20240827$$MD$CA$CA
1919717713$19197177$13$F$$20240707$20210429$20240711$EXP$$IN-PFIZER INC-2020268843$PFIZER$$72$YR$$M$Y$$$20240711$$CN$IN$IN
1919730834$19197308$34$F$20210302$20240923$20210429$20240927$EXP$$CO-TAKEDA-CO201939795$TAKEDA$$49$YR$$M$Y$60$KG$20240927$$CN$CO$CO
191979267$19197926$7$F$20210401$20240612$20210429$20240704$PER$$CA-TOLMAR, INC.-21CA026476$TOLMAR$$86$YR$$M$Y$$$20240704$$CN$CA$CA
191986234$19198623$4$F$20211110$20240621$20210430$20240705$PER$$US-SA-2021SA143169$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240705$$MD$US$US
191989489$19198948$9$F$20210123$20240723$20210430$20240729$EXP$$CA-TAKEDA-2021TUS026397$TAKEDA$$40$YR$$F$Y$$$20240729$$HP$CA$CA
191995065$19199506$5$F$$20240923$20210430$20240926$EXP$$CA-TAKEDA-2021TUS026854$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
191995179$19199517$9$F$20210513$20240909$20210430$20240912$EXP$$CA-TAKEDA-2021TUS026869$TAKEDA$$28$YR$$M$Y$$$20240912$$CN$CA$CA
1919967113$19199671$13$F$20180115$20240803$20210430$20240810$EXP$$CA-CELLTRION INC.-2017CA017631$CELLTRION$$$$$$Y$$$20240810$$HP$CA$CA
1919971911$19199719$11$F$$20240903$20210430$20240904$EXP$$US-TAKEDA-US201932875$TAKEDA$$$$$F$Y$$$20240904$$MD$US$US
192001344$19200134$4$F$20240521$20240722$20210430$20240725$EXP$$US-SHIRE-US202033011$TAKEDA$$59$YR$$F$Y$$$20240725$$HP$US$US
192002543$19200254$3$F$20210312$20240708$20210430$20240717$EXP$ES-AEMPS-829432$ES-NOVOPROD-806667$NOVO NORDISK$$15$YR$$M$Y$52.5$KG$20240717$$MD$ES$ES
192003345$19200334$5$F$20210101$20240702$20210430$20240709$EXP$$US-SA-2021SA142414$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240709$$MD$US$US
192003766$19200376$6$F$20210314$20240719$20210430$20240730$EXP$$JP-ROCHE-2818196$ROCHE$$69$YR$E$F$Y$60$KG$20240730$$MD$JP$JP
1920047612$19200476$12$F$20210101$20240723$20210430$20240812$PER$$CA-TOLMAR, INC.-21CA025968$TOLMAR$$$$$M$Y$$$20240812$$CN$CA$CA
192005654$19200565$4$F$20210419$20240819$20210430$20240827$EXP$$CA-TAKEDA-2021TUS027105$TAKEDA$$58$YR$$M$Y$$$20240827$$CN$CA$CA
192006402$19200640$2$F$$20240722$20210430$20240726$EXP$$CA-APOTEX-2021AP010283$APOTEX$$44$YR$$M$Y$$$20240726$$HP$CA$CA
1920131323$19201313$23$F$20210417$20240906$20210430$20240910$EXP$$US-TAKEDA-2021TUS002216$TAKEDA$$60$YR$$F$Y$$$20240910$$CN$US$US
192014344$19201434$4$F$$20240628$20210430$20240706$EXP$$CA-TAKEDA-2020TUS040118$TAKEDA$$$$$F$Y$$$20240706$$CN$CA$CA
1920168423$19201684$23$F$20200901$20240828$20210430$20240904$EXP$$IN-PFIZER INC-2021011522$PFIZER$$68$YR$$F$Y$$$20240904$$CN$IN$IN
192020173$19202017$3$F$$20240911$20210502$20240916$EXP$$NVSC2021CO092405$NOVARTIS$$$$$M$Y$63$KG$20240916$$CN$CO$CO
192021415$19202141$5$F$20200626$20240903$20210430$20240909$EXP$$US-TAKEDA-US202021063$TAKEDA$$51$YR$$F$Y$$$20240909$$MD$US$US
192021874$19202187$4$F$20210418$20240921$20210430$20240925$EXP$$US-TAKEDA-2021TUS027051$TAKEDA$$32$YR$$M$Y$$$20240925$$MD$US$US
192026899$19202689$9$F$20200520$20240916$20210430$20240923$EXP$$CA-TAKEDA-2020TUS007608$TAKEDA$$80$YR$$F$Y$$$20240923$$CN$CA$CA
192027152$19202715$2$F$20201202$20240722$20210430$20240724$EXP$$FR-PFIZER INC-2021429672$PFIZER$$67$YR$$F$Y$50$KG$20240724$$MD$FR$FR
192032622$19203262$2$F$20240320$20240424$20210503$20240906$PER$$US-FARMAPROD-202104-0522$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240902$$CN$US$
1920361215$19203612$15$F$$20240906$20210430$20240911$EXP$$US-TAKEDA-US201934697$TAKEDA$$$$$F$Y$74$KG$20240911$$MD$US$US
1920518910$19205189$10$F$$20240820$20210503$20240823$EXP$$US-TAKEDA-2021TUS027365$TAKEDA$$$$$M$Y$65.76$KG$20240823$$HP$US$US
192056862$19205686$2$F$$20231019$20210503$20240906$PER$$US-FARMAPROD-202102-0167$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240902$$CN$US$US
192057462$19205746$2$F$20230902$20230905$20210503$20240906$PER$$US-FARMAPROD-202102-0192$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240902$$CN$US$
192057712$19205771$2$F$20240216$20240304$20210503$20240906$PER$$US-FARMAPROD-202102-0282$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240902$$CN$US$
192057872$19205787$2$F$20210225$20230831$20210503$20240906$PER$$US-FARMAPROD-202103-0307$DOMPE FARMACEUTICI$$59$YR$A$F$Y$102.06$KG$20240902$$CN$US$
192057933$19205793$3$F$20210302$20230728$20210503$20240906$PER$$US-FARMAPROD-202103-0313$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240902$$CN$US$
192062832$19206283$2$F$$20210426$20210503$20240723$EXP$$CA-AstraZeneca-2021A366919$ASTRAZENECA$$50$YR$$F$Y$$$20240723$$MD$CA$
192069404$19206940$4$F$$20240903$20210503$20240910$EXP$$BR-SHIRE-BR201842918AA$TAKEDA$$$$$M$Y$$$20240910$$MD$BR$BR
1920746218$19207462$18$F$20210101$20240821$20210503$20240827$PER$$US-PFIZER INC-2021204227$PFIZER$$49$YR$$F$Y$$$20240827$$CN$US$US
192076796$19207679$6$F$20210419$20220523$20210503$20240823$EXP$$ES-AKCEA THERAPEUTICS, INC.-2021IS001320$AKCEA THERAPEUTICS$Loreto Dominguez Senin, Sanchez Gomez, Borrachero Garro and Santos-Rubio MD. Severe Thrombocytopenia with Inotersen: 2 Case Reports and Review. Annals of Pharmacology and Pharmaceutics. 2021;6:2$$$$$Y$$$20240823$$MD$ES$ES
192083617$19208361$7$F$20180701$20240703$20210503$20240711$PER$$CA-TOLMAR, INC.-21CA026399$TOLMAR$$67$YR$$M$Y$100.23$KG$20240711$$CN$CA$CA
1920858611$19208586$11$F$20180614$20240925$20210504$20240927$EXP$$CA-TAKEDA-2018TUS013777$TAKEDA$$35$YR$$M$Y$$$20240927$$CN$CA$CA
192086612$19208661$2$F$$20210419$20210504$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-294208$RANBAXY$R Kollipara, C Reisz. Recognizing off-target drug effects in the gut and brain revisiting isotretinoin and depression. Clin Exp Dermatol. 2015;Mar(41):pp283-284$18$YR$$M$Y$58$KG$20240702$$HP$US$US
192088732$19208873$2$F$$20240820$20210503$20240903$PER$$US-SA-2021SA145288$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240903$$MD$US$US
192089692$19208969$2$F$$20210426$20210503$20240704$PER$$NVSC2021US094998$NOVARTIS$$$$$F$Y$$$20240704$$MD$US$US
192097202$19209720$2$F$$20240904$20210504$20240910$EXP$$CA-TAKEDA-2021TUS026991$TAKEDA$$$$$M$Y$$$20240910$$CN$CA$CA
192106998$19210699$8$F$20210301$20211216$20210504$20240926$EXP$$US-GLAXOSMITHKLINE-US2021093111$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240926$$CN$US$US
192108335$19210833$5$F$20210322$20240823$20210504$20240906$EXP$$US-ENDO PHARMACEUTICALS INC-2021-002703$ENDO$$$$A$M$Y$119.5$KG$20240906$$CN$US$US
192110477$19211047$7$F$20201013$20240722$20210501$20240725$EXP$$CA-ROCHE-2700463$ROCHE$$48$YR$A$F$Y$$$20240725$$CN$CA$CA
192111725$19211172$5$F$$20240902$20210504$20240912$EXP$DE-EMA-DD-20210405-PAWAR_P-143426$DE-TORRENT-00020087$TORRENT$$31$YR$A$M$Y$$$20240912$$MD$DE$DE
192113592$19211359$2$F$$20240920$20210501$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2021-007727$UNITED THERAPEUTICS$$$$$M$Y$64.853$KG$20240928$$$US$US
192114842$19211484$2$F$$20210429$20210504$20240718$EXP$$NVSC2021US097740$NOVARTIS$$$$$M$Y$$$20240718$$CN$US$US
1921155211$19211552$11$F$$20240529$20210504$20240812$EXP$$NVSC2021CO044672$NOVARTIS$$$$$F$Y$81.4$KG$20240812$$CN$CO$CO
192115598$19211559$8$F$20210701$20240731$20210504$20240802$EXP$$US-PFIZER INC-2021448490$PFIZER$$72$YR$$F$Y$$$20240802$$HP$US$US
192119603$19211960$3$F$$20240703$20210504$20240710$EXP$$US-GLAXOSMITHKLINE-US2021094064$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$US$US
1921313225$19213132$25$F$20190216$20240923$20210504$20240926$EXP$$CO-TAKEDA-CO202025698$TAKEDA$$11$YR$$F$Y$41$KG$20240926$$CN$CO$CO
192132332$19213233$2$F$20210407$20240703$20210504$20240709$EXP$$FR-PFIZER INC-2021440788$PFIZER$$$$E$F$Y$$$20240709$$MD$FR$FR
192136676$19213667$6$F$20210322$20220523$20210504$20240823$EXP$$ES-AKCEA THERAPEUTICS, INC.-2021IS001319$AKCEA THERAPEUTICS$Senin LD, Sanchez EG,  Borrachero CG, Santos-Rubio MD. Severe Thrombocytopenia with Inotersen: 2 Case Reports and Review. Annals of Pharmacology and Pharmaceutics. 2021;6 (1):1201$$$$$Y$$$20240823$$MD$ES$ES
1921472013$19214720$13$F$$20240801$20210505$20240815$EXP$$CA-AUROBINDO-AUR-APL-2021-017516$AUROBINDO$Lee C, Wanson A, Frangou S, Chong D, Halpape K.. Opioid toxicity due to CNS depressant polypharmacy: A case report. Ment Health Clin. 2021;11(2):70-74$47$YR$$F$Y$$$20240815$$PH$CA$CA
1921585211$19215852$11$F$20201001$20220531$20210505$20240925$EXP$$US-GLAXOSMITHKLINE-US2021095823$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
1921594516$19215945$16$F$20181101$20230907$20210505$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR095101$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$MD$US$US
192161894$19216189$4$F$20210317$20240906$20210505$20240914$EXP$$FR-ROCHE-2820811$ROCHE$$50$YR$A$F$Y$126$KG$20240914$$MD$FR$FR
1921764711$19217647$11$F$$20240819$20210505$20240822$EXP$$US-TAKEDA-US202021339$TAKEDA$$$$$M$Y$29.48$KG$20240822$$HP$US$US
192200458$19220045$8$F$20210401$20240723$20210505$20240805$EXP$$US-GW PHARMA-202104USGW02158$JAZZ$$53$YR$$M$Y$$$20240805$$CN$US$US
192202607$19220260$7$F$20210201$20240924$20210505$20240927$EXP$$US-SHIRE-US202030071$TAKEDA$$74$YR$$F$Y$$$20240927$$HP$US$US
1922091414$19220914$14$F$$20240816$20210506$20240820$EXP$$CA-ROCHE-2822808$ROCHE$$44$YR$A$F$Y$$$20240820$$MD$CA$CA
192214266$19221426$6$F$$20240911$20210506$20240913$EXP$$US-PFIZER INC-2021474607$PFIZER$Ravi, M.. High-dose methotrexate-induced epidermal necrosis in two pediatric patients. Pediatric dermatology. 2021;38 (3):659-663$5$YR$$F$Y$$$20240913$$HP$US$US
192216233$19221623$3$F$20210403$20240709$20210506$20240711$EXP$$CA-TAKEDA-2021TUS027691$TAKEDA$$60$YR$$M$Y$$$20240711$$MD$CA$CA
192218955$19221895$5$F$$20240711$20210506$20240717$PER$$US-BIOGEN-2020BI00959014$BIOGEN$$$$$F$Y$77$KG$20240717$$CN$US$US
192220733$19222073$3$F$$20210527$20210506$20240710$EXP$$DE-ASTELLAS-2021US016108$ASTELLAS$$77$YR$$M$Y$$$20240710$$CN$DE$DE
192223372$19222337$2$F$$20210430$20210506$20240718$EXP$$BR-ASTELLAS-2021US016343$ASTELLAS$De Sousa MV, de Siqueira Guida JP, de Castro Surita FG, Parpinelli MA, do Nascimento MLC, Mazzali M. Twin pregnancy after kidney transplantation: case report and systematic review. Brazilian Journal of Nephrology. 2021;43(1):121-7$32$YR$$F$Y$$$20240718$$HP$BR$BR
192227173$19222717$3$F$20190906$20240815$20210506$20240829$EXP$$CA-HLS-202000106$HLS THERAPEUTICS$$68$YR$A$F$Y$84$KG$20240829$$HP$CA$CA
192248572$19224857$2$F$$20240911$20210506$20240924$EXP$$US-MYLANLABS-2021M1026888$AUROBINDO$Ravi M, Ridpath A, Audino AN, Guinipero T, Chung C, Fernandez Faith E.. High-dose methotrexate-induced epidermal necrosis in two pediatric patients.. Pediatr-Dermatol. 2021$5$YR$$F$Y$$$20240924$$MD$US$US
192254128$19225412$8$F$$20240724$20210506$20240730$EXP$$PHHY2017CO055183$NOVARTIS$$$$$F$Y$80$KG$20240730$$CN$CO$CO
192255636$19225563$6$F$20201214$20240920$20210505$20240930$EXP$$DE-AUROBINDO-AUR-APL-2021-009900$AUROBINDO$$$$A$F$Y$$$20240930$$MD$DE$DE
192259923$19225992$3$F$20201203$20240829$20210505$20240830$PER$$US-ROCHE-2726539$ROCHE$$72$YR$E$F$Y$$$20240830$$MD$US$US
192264402$19226440$2$F$$20240827$20210506$20240903$PER$$US-JAZZ-2021-US-007891$JAZZ$$$$$F$Y$$$20240903$$CN$US$US
192264942$19226494$2$F$20210428$20240724$20210506$20240729$EXP$$US-TAKEDA-2020TUS053179$TAKEDA$$41$YR$$F$Y$$$20240729$$MD$US$US
192273592$19227359$2$F$20181218$20240826$20210507$20240905$PER$$US-SA-2021SA148264$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240905$$MD$US$US
1922752832$19227528$32$F$20210101$20240826$20210506$20240829$EXP$$CO-TAKEDA-CO202004467$TAKEDA$$9$YR$$M$Y$70$KG$20240829$$CN$CO$CO
192275952$19227595$2$F$20210413$20240621$20210507$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-001422$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240716$$CN$US$US
192279039$19227903$9$F$20201010$20240704$20210506$20240717$EXP$$CO-ROCHE-1744075$ROCHE$$45$YR$A$F$Y$60$KG$20240717$$CN$CO$CO
1922796910$19227969$10$F$20210401$20240909$20210507$20240911$PER$$US-BIOGEN-2021BI01003901$BIOGEN$$51$YR$$F$Y$$$20240911$$CN$US$US
192299434$19229943$4$F$20240809$20240816$20210506$20240822$EXP$$CA-JNJFOC-20210506761$JOHNSON AND JOHNSON$$77$YR$E$F$Y$65$KG$20240822$$HP$CA$CA
192301025$19230102$5$F$$20240719$20210506$20240724$EXP$$CA-AMGEN-CANSP2021069374$AMGEN$$55$YR$A$F$Y$$$20240723$$HP$CA$CA
192304534$19230453$4$F$20210201$20240620$20210506$20240701$PER$$US-SA-2021SA145519$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240701$$MD$US$US
1923088116$19230881$16$F$$20240819$20210507$20240823$EXP$$US-TAKEDA-US202032247$TAKEDA$$$$$F$Y$$$20240823$$CN$US$US
192308849$19230884$9$F$20190101$20240912$20210507$20240919$EXP$$JP-ABBVIE-19K-087-2874526-00$ABBVIE$$$$$M$Y$$$20240919$$CN$JP$JP
192312463$19231246$3$F$$20240812$20210507$20240814$EXP$$US-KYOWAKIRIN-2021BKK007112$KYOWA$$$$$$Y$$$20240814$$CN$US$US
192320218$19232021$8$F$$20240827$20210507$20240904$EXP$$CA-TAKEDA-2021TUS028574$TAKEDA$$$$$F$Y$$$20240904$$CN$CA$CA
192324208$19232420$8$F$$20240910$20210507$20240923$EXP$$CA-APOTEX-2021AP011547$APOTEX$$49$YR$$F$Y$$$20240923$$HP$CA$CA
192327494$19232749$4$F$$20240808$20210507$20240820$EXP$$PT-009507513-2105PRT001347$MERCK$Moreira I, Vilarica AS, Alves P. First report of a very rare complication in a case of nonsmall cell lung carcinoma. Breathe. 2021;17 (4):1-6$45$YR$$M$Y$$$20240820$$MD$PT$PT
1923303715$19233037$15$F$20190415$20240822$20210507$20240830$EXP$$DE-ROCHE-2367230$ROCHE$$37$YR$A$F$Y$73$KG$20240830$$CN$DE$DE
1923319711$19233197$11$F$20210311$20240621$20210507$20240709$EXP$$CA-ROCHE-2825490$ROCHE$$34$YR$A$F$Y$$$20240705$$MD$CA$CA
192349215$19234921$5$F$20210319$20240715$20210509$20240722$EXP$$US-SA-2021SA149513$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240722$$MD$US$US
192355972$19235597$2$F$$20240628$20210510$20240702$PER$$US-JNJFOC-20210512110$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$LW$US$US
192357333$19235733$3$F$$20240910$20210510$20240923$EXP$$CA-APOTEX-2021AP011405$APOTEX$$58$YR$$M$Y$$$20240923$$HP$CA$CA
192357538$19235753$8$F$20200501$20240701$20210510$20240710$EXP$$DE-AUROBINDO-AUR-APL-2021-000076$AUROBINDO$$36$YR$$F$Y$51.5$KG$20240710$$MD$DE$DE
192357692$19235769$2$F$20240701$20240808$20210510$20240815$EXP$$US-SA-2021SA149650$SANOFI AVENTIS$$$$A$F$Y$$$20240815$$MD$US$US
1923611721$19236117$21$F$$20240725$20210510$20240807$EXP$$CA-GLENMARK PHARMACEUTICALS-2021GMK053805$GLENMARK$Lee C, Wanson A, Frangou S, Chong D, Halpape K.. Opioid toxicity due to CNS depressant polypharmacy: A case report.. Ment Health Clin [Internet].. 2021;11 (2):70-4$$$$$Y$$$20240807$$PH$CA$CA
1923637111$19236371$11$F$20190801$20240703$20210510$20240716$EXP$$CA-ROCHE-2370837$ROCHE$$32$YR$A$F$Y$$$20240716$$CN$CA$CA
192365523$19236552$3$F$20210301$20240806$20210510$20240811$EXP$$FR-ROCHE-2793027$ROCHE$$58$YR$A$M$Y$$$20240811$$HP$FR$FR
192366766$19236676$6$F$20230401$20240815$20210510$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-001442$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$107$KG$20240909$$CN$US$US
1923782012$19237820$12$F$20171201$20240914$20210510$20240925$EXP$$PHHY2018CA056259$NOVARTIS$$59$YR$$M$Y$100$KG$20240925$$MD$CA$CA
192387912$19238791$2$F$20210301$20240712$20210510$20240801$PER$$US-SA-2021SA151718$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240719$$MD$US$US
1923926327$19239263$27$F$20210325$20240701$20210511$20240705$EXP$$CH-ABBVIE-21K-151-3845212-00$ABBVIE$$71$YR$$M$Y$81$KG$20240705$$MD$CH$CH
192393962$19239396$2$F$$20240905$20210510$20240913$EXP$$DE-TEVA-2021-DE-1908502$TEVA$$$$E$M$Y$$$20240913$$MD$DE$DE
192397682$19239768$2$F$20150609$20230720$20210511$20240802$EXP$$US-Accord-220492$ACCORD$$59$YR$A$F$Y$$$20240802$$LW$US$US
192397812$19239781$2$F$20181109$20230719$20210511$20240802$EXP$$US-Accord-220483$ACCORD$$53$YR$$F$Y$$$20240802$$LW$US$US
1924006010$19240060$10$F$$20240624$20210511$20240701$EXP$$CA-CELLTRION INC.-2021CA006101$CELLTRION$$$$$$Y$$$20240701$$HP$CA$CA
192402015$19240201$5$F$20210422$20240715$20210511$20240805$PER$$CA-TOLMAR, INC.-21CA026773$TOLMAR$$74$YR$$M$Y$$$20240802$$CN$CA$CA
1924024510$19240245$10$F$20200916$20240829$20210511$20240905$EXP$$DE-ROCHE-2680571$ROCHE$$36$YR$A$F$Y$$$20240905$$CN$DE$DE
192404723$19240472$3$F$$20240729$20210511$20240807$EXP$$CA-APOTEX-2021AP011507$APOTEX$$$$$M$Y$$$20240807$$CN$CA$CA
1924051113$19240511$13$F$20210428$20240711$20210511$20240720$EXP$$ZA-CELLTRION INC.-2021ZA006334$CELLTRION$$$$$$Y$$$20240720$$CN$ZA$ZA
192415435$19241543$5$F$20191111$20240722$20210511$20240725$EXP$$CA-TAKEDA-2019TUS062989$TAKEDA$$72$YR$$M$Y$$$20240725$$HP$CA$CA
1924185121$19241851$21$F$20180214$20240624$20210511$20240708$EXP$$CA-ROCHE-2824464$ROCHE$$62$YR$A$F$Y$112$KG$20240708$$CN$CA$CA
192418916$19241891$6$F$20210427$20240719$20210511$20240729$EXP$$PL-SA-2021SA150422$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$CN$PL$PL
192419062$19241906$2$F$$20240711$20210510$20240731$PER$$US-INCYTE CORPORATION-2021IN002836$INCYTE$$$$$$Y$$$20240731$$CN$US$US
192420623$19242062$3$F$20210317$20240725$20210510$20240730$EXP$$FR-PFIZER INC-2021461880$PFIZER$$50$YR$$F$Y$126$KG$20240730$$MD$FR$FR
192422627$19242262$7$F$20180101$20240916$20210511$20240923$EXP$$CA-TAKEDA-2018TUS026110$TAKEDA$$$$$M$Y$$$20240923$$CN$CA$CA
1924248512$19242485$12$F$20210729$20240719$20210511$20240724$EXP$$CA-TAKEDA-2018TUS022864$TAKEDA$$67$YR$$M$Y$$$20240724$$CN$CA$CA
1924306414$19243064$14$F$20210407$20240909$20210511$20240912$EXP$$CA-TAKEDA-2021TUS024675$TAKEDA$$85$YR$$F$Y$$$20240912$$CN$CA$CA
192431723$19243172$3$F$20210402$20240722$20210511$20240724$EXP$$FR-PFIZER INC-2021287484$PFIZER$$$$A$M$Y$$$20240724$$HP$FR$FR
192437114$19243711$4$F$$20240812$20210511$20240820$EXP$$CA-AstraZeneca-2021A394141$ASTRAZENECA$$66$YR$$F$Y$$$20240820$$MD$CA$
192438196$19243819$6$F$$20240712$20210511$20240716$EXP$$CA-TAKEDA-2021TUS028871$TAKEDA$$$$$F$Y$$$20240716$$CN$CA$CA
192438764$19243876$4$F$20200811$20230220$20210511$20240917$EXP$$FR-ABBVIE-21K-056-3895463-00$ABBVIE$$53$YR$$M$Y$92$KG$20240917$$MD$FR$FR
1924432014$19244320$14$F$$20240722$20210511$20240726$EXP$$US-TAKEDA-2021TUS017850$TAKEDA$$$$$F$Y$25$KG$20240726$$CN$US$US
1924449211$19244492$11$F$20210401$20240806$20210512$20240808$EXP$$RU-ROCHE-2827707$ROCHE$$46$YR$A$F$Y$51$KG$20240808$$MD$RU$RU
192445095$19244509$5$F$20210412$20240612$20210512$20240704$PER$$CA-TOLMAR, INC.-21CA026767$TOLMAR$$73$YR$$M$Y$$$20240704$$CN$CA$CA
192449917$19244991$7$F$20210401$20240818$20210511$20240822$EXP$$IN-PFIZER INC-2021117258$PFIZER$$64$YR$$F$Y$87$KG$20240822$$CN$IN$IN
192450064$19245006$4$F$20171001$20240807$20210512$20240814$PER$$US-SA-2021SA155233$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240814$$MD$US$US
1924675316$19246753$16$F$20190101$20240924$20210512$20240930$EXP$$US-TAKEDA-US202018638$TAKEDA$$$$$F$Y$$$20240930$$CN$US$US
1924678217$19246782$17$F$20210801$20240902$20210512$20240910$EXP$$US-SA-2021SA155891$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240910$$MD$US$US
192478795$19247879$5$F$$20240819$20210512$20240821$EXP$$US-PFIZER INC-2021222972$PFIZER$$69$YR$$F$Y$$$20240821$$HP$US$US
192483644$19248364$4$F$20240701$20240812$20210512$20240813$EXP$$US-PFIZER INC-2021480981$PFIZER$$60$YR$$F$Y$$$20240813$$CN$US$US
192489944$19248994$4$F$20240913$20240913$20210512$20240918$EXP$$US-SHIRE-US201918476AA$TAKEDA$$68$YR$$M$Y$$$20240918$$HP$US$US
192502974$19250297$4$F$$20240830$20210512$20240905$EXP$$US-TAKEDA-US202031208$TAKEDA$$$$$F$Y$122$KG$20240905$$CN$US$US
1925039915$19250399$15$F$20190110$20240815$20210512$20240824$EXP$$US-SHIRE-US201900876$TAKEDA$$69$YR$$F$Y$$$20240824$$CN$US$US
1925082848$19250828$48$F$20210101$20240701$20210513$20240709$EXP$$CA-CELLTRION INC.-2021CA004144$CELLTRION$$$$$$Y$$$20240709$$MD$CA$CA
192508505$19250850$5$F$20210301$20240804$20210512$20240807$EXP$$IL-ABBVIE-21K-082-3901792-00$ABBVIE$$84$YR$$F$Y$55$KG$20240807$$MD$IL$IL
192520123$19252012$3$F$20200901$20210429$20210513$20240827$EXP$$NVSC2021AU100234$NOVARTIS$$70$YR$$$Y$$$20240827$$MD$AU$AU
192539878$19253987$8$F$20230123$20240702$20210513$20240704$EXP$$CA-TAKEDA-2019TUS067197$TAKEDA$$76$YR$$M$Y$$$20240704$$MD$CA$CA
1925405411$19254054$11$F$20210422$20240731$20210513$20240809$PER$$US-SA-2021SA156470$SANOFI AVENTIS$$15$YR$T$M$Y$122$KG$20240809$$MD$US$US
192549965$19254996$5$F$$20240715$20210513$20240717$PER$$US-PFIZER INC-2020511183$PFIZER$$81$YR$$F$Y$$$20240717$$CN$US$US
192551466$19255146$6$F$$20240716$20210513$20240717$EXP$$US-TAKEDA-US202004124$TAKEDA$$$$$F$Y$$$20240717$$HP$US$US
192558006$19255800$6$F$20200618$20240807$20210513$20240812$EXP$$US-SHIRE-US201904270$TAKEDA$$41$YR$$M$Y$$$20240812$$CN$US$US
192559717$19255971$7$F$$20240709$20210513$20240711$EXP$$US-TAKEDA-US202032321$TAKEDA$$$$$F$Y$$$20240711$$HP$US$US
1925880411$19258804$11$F$20210516$20240724$20210514$20240729$EXP$$US-TAKEDA-2020TUS054040$TAKEDA$$62$YR$$F$Y$65$KG$20240729$$HP$US$US
192591225$19259122$5$F$20200101$20240722$20210514$20240724$EXP$$US-PFIZER INC-2021226042$PFIZER$$53$YR$$F$Y$95.25$KG$20240724$$CN$US$US
192593002$19259300$2$F$$20240724$20210514$20240726$EXP$$JP-BAYER-2021-139767$BAYER$$$$$M$Y$$$20240726$$MD$JP$JP
192593892$19259389$2$F$$20240724$20210514$20240726$EXP$$JP-BAYER-2021-139769$BAYER$$$$$M$Y$$$20240726$$MD$JP$JP
192597828$19259782$8$F$$20240709$20210514$20240711$PER$$US-PFIZER INC-2021494193$PFIZER$$88$YR$$F$Y$$$20240711$$CN$US$US
192599193$19259919$3$F$$20240805$20210514$20240807$PER$$US-PFIZER INC-2021516390$PFIZER$$78$YR$$F$Y$108.86$KG$20240807$$CN$US$US
1926034617$19260346$17$F$20210824$20220922$20210514$20240925$EXP$$US-GLAXOSMITHKLINE-US2021101380$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
192604526$19260452$6$F$$20240723$20210514$20240729$EXP$$US-JAZZ-2021-US-008328$JAZZ$$$$$F$Y$$$20240729$$CN$US$US
192604553$19260455$3$F$$20240808$20210514$20240818$EXP$$US-JAZZ-2021-US-008421$JAZZ$$$$$F$Y$$$20240818$$CN$US$US
192613953$19261395$3$F$$20240909$20210515$20240919$EXP$CA-UCBSA-2021021003$CA-UCBSA-2021021003$UCB$$56$YR$$F$Y$$$20240919$$HP$CA$CA
192615726$19261572$6$F$20191101$20240826$20210515$20240829$EXP$$US-TAKEDA-2021TUS030655$TAKEDA$$58$YR$$F$Y$60.32$KG$20240829$$HP$US$US
1926172913$19261729$13$F$20240615$20240726$20210515$20240801$EXP$$US-TAKEDA-US202024147$TAKEDA$$16$YR$$F$Y$40$KG$20240801$$HP$US$US
192631813$19263181$3$F$$20240313$20210517$20240910$EXP$DE-ARISTO PHARMA-LEVOM-LORA-PREG202103082$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-01157$ALKEM$Paul L, Welter-Luedeke J, Penzel S, Zangl A, et.al.. Alpha-Pyrrolidinopentiothiophenone (alpha-PVT): A forensic case study including plasma concentrations. Forensic Science International. 2021;321:1107-21$26$YR$$F$Y$$$20240910$$HP$DE$DE
192631842$19263184$2$F$$20240318$20210517$20240910$EXP$DE-SA-2021SA080390$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-01140$ALKEM$Paula LD, Welter-Luedeke J, Penzel S, Zangl A, et.al. Alpha-Pyrrolidinopentiothiophenone (?-PVT): A forensic case study including plasma concentrations. Forensic Science International. 2021;321:110721$40$YR$$M$Y$$$20240910$$HP$DE$DE
192631852$19263185$2$F$$20240319$20210517$20240910$EXP$DE-ARISTO PHARMA-LORA-PREG202103081$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-01154$ALKEM$Paul LD, Welter-Luedeke J, Penzel S, Zangl A, et.al.. Alpha-Pyrrolidinopentiothiophenone (alpha-PVT): A forensic case study including plasma concentrations. Forensic Science International. 2021;321:110721$34$YR$$F$Y$$$20240910$$HP$DE$DE
192631882$19263188$2$F$$20240319$20210517$20240910$EXP$DE-INDIVIOR EUROPE LIMITED-INDV-128594-2021$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-01146$ALKEM$Paul LD, Welter-Luedeke J, Penzel S, Zangl A, Graw M et al.. Alpha-Pyrrolidinopentiothiophenone (Alpha-PVT): A forensic case study including plasma concentrations.. Forensic Science International. 2021;321:110721$30$YR$$M$Y$$$20240910$$MD$DE$DE
192634242$19263424$2$F$20210308$20240807$20210517$20240809$EXP$$FR-ROCHE-2830298$ROCHE$$$$$F$Y$$$20240809$$HP$FR$FR
1926407212$19264072$12$F$20230110$20240722$20210517$20240725$EXP$$US-TAKEDA-2021TUS030121$TAKEDA$$83$YR$$F$Y$56$KG$20240725$$HP$US$US
192647007$19264700$7$F$20200418$20240807$20210517$20240809$EXP$$CA-ROCHE-2596053$ROCHE$$37$YR$A$F$Y$$$20240809$$CN$CA$CA
192650503$19265050$3$F$20210117$20240725$20210517$20240807$EXP$$AU-COLLEGIUM PHARMACEUTICAL, INC.-2021CGM00545$COLLEGIUM PHARMACEUTICAL$$61$YR$$F$Y$68.9$KG$20240807$$CN$AU$AU
192651479$19265147$9$F$20210506$20240910$20210517$20240912$EXP$$US-TAKEDA-US201937898$TAKEDA$$65$YR$$M$Y$$$20240912$$HP$US$US
1926523627$19265236$27$F$20200413$20240814$20210517$20240820$EXP$$US-TAKEDA-US202014653$TAKEDA$$78$YR$$M$Y$80$KG$20240820$$MD$US$US
192653024$19265302$4$F$$20240709$20210517$20240716$EXP$$CA-APOTEX-2021AP011545$APOTEX$$82$YR$$F$Y$72$KG$20240716$$HP$CA$CA
192657366$19265736$6$F$20180901$20240711$20210517$20240716$EXP$$PHHY2018CA108431$NOVARTIS$$43$YR$$F$Y$$$20240716$$CN$CA$CA
192657392$19265739$2$F$20210430$20240624$20210517$20240702$PER$$US-SA-2021SA161115$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240702$$MD$US$US
192664983$19266498$3$F$20210505$20240717$20210518$20240731$EXP$$BE-NOVOPROD-810668$NOVO NORDISK$$68$YR$$F$Y$74$KG$20240731$$MD$BE$BE
192668372$19266837$2$F$20210301$20240725$20210518$20240806$EXP$$FR-AUROBINDO-AUR-APL-2021-011745$AUROBINDO$$58$YR$$M$Y$$$20240806$$HP$FR$FR
192670313$19267031$3$F$20201005$20240812$20210517$20240820$EXP$$BE-PURDUE-USA-2021-0259179$PURDUE$$52$YR$$F$Y$85$KG$20240820$$MD$BE$BE
192678292$19267829$2$F$$20240731$20210517$20240805$EXP$$US-TAKEDA-2017BLT003931$TAKEDA$$$$$M$Y$$$20240805$$CN$US$US
192689102$19268910$2$F$$20240724$20210518$20240726$EXP$$JP-BAYER-2021-139766$BAYER$$$$$M$Y$$$20240726$$MD$JP$JP
192689122$19268912$2$F$$20240724$20210518$20240726$EXP$$JP-BAYER-2021-139320$BAYER$$$$$M$Y$$$20240726$$MD$JP$JP
1926960719$19269607$19$F$20210430$20230130$20210518$20240925$PER$$US-GLAXOSMITHKLINE-US2021103181$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
1926984017$19269840$17$F$20210102$20221123$20210518$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR104358$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
192698893$19269889$3$F$20210520$20240911$20210518$20240917$EXP$$CA-TAKEDA-2021TUS030544$TAKEDA$$25$YR$$F$Y$$$20240917$$CN$CA$CA
192701282$19270128$2$F$$20240722$20210518$20240726$PER$$US-PFIZER INC-2021330429$PFIZER$$69$YR$$F$Y$$$20240726$$CN$US$US
192705733$19270573$3$F$$20240729$20210518$20240802$EXP$$KR-BAYER-2021-138905$BAYER$$$$$F$Y$$$20240802$$CN$KR$KR
192707546$19270754$6$F$20211001$20240628$20210518$20240705$EXP$$US-TAKEDA-2021TUS029931$TAKEDA$$74$YR$$M$Y$129.25$KG$20240705$$HP$US$US
192710454$19271045$4$F$20170701$20240830$20210518$20240906$EXP$$HU-ROCHE-2830156$ROCHE$$51$YR$A$F$Y$$$20240906$$MD$HU$HU
1927115611$19271156$11$F$20200414$20240731$20210518$20240806$EXP$$CA-TAKEDA-2020TUS015153$TAKEDA$$54$YR$$F$Y$$$20240806$$MD$CA$CA
1927140518$19271405$18$F$20200916$20240820$20210518$20240822$EXP$$DE-ROCHE-2691736$ROCHE$$39$YR$A$F$Y$$$20240822$$CN$DE$DE
192730577$19273057$7$F$$20240716$20210519$20240813$PER$$CA-TOLMAR, INC.-21CA026960$TOLMAR$$$$$M$Y$$$20240813$$CN$CA$CA
192732923$19273292$3$F$$20240806$20210519$20240812$EXP$$NVSC2021MX105027$NOVARTIS$$$$$M$Y$$$20240812$$CN$MX$MX
192746364$19274636$4$F$$20240715$20210519$20240720$EXP$$NVSC2021AU106261$NOVARTIS$$$$$M$Y$$$20240719$$CN$AU$AU
192748968$19274896$8$F$20200101$20240827$20210519$20240829$EXP$$US-PFIZER INC-2021507929$PFIZER$$72$YR$$M$Y$$$20240829$$CN$US$US
192749249$19274924$9$F$$20240712$20210519$20240716$EXP$$US-PFIZER INC-2021509687$PFIZER$$69$YR$$F$Y$99.773$KG$20240716$$CN$US$US
192750702$19275070$2$F$$20210510$20210519$20240916$EXP$$BR-ROCHE-2829184$ROCHE$$$$A$M$Y$$$20240916$$MD$BR$BR
192750962$19275096$2$F$$20240827$20210519$20240830$PER$$US-PFIZER INC-2021330304$PFIZER$$65$YR$$F$Y$$$20240830$$CN$US$US
1927524042$19275240$42$F$$20240822$20210519$20240904$EXP$$CA-SA-2021SA164671$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240905$$MD$CA$CA
192752443$19275244$3$F$20221010$20240726$20210519$20240730$EXP$$CA-TAKEDA-2021TUS031291$TAKEDA$$34$YR$$M$Y$$$20240730$$MD$CA$CA
192753563$19275356$3$F$$20240821$20210519$20240827$EXP$$CA-TAKEDA-2021TUS030675$TAKEDA$$$$$F$Y$$$20240827$$MD$CA$CA
1927541014$19275410$14$F$20240603$20240903$20210519$20240905$EXP$$US-TAKEDA-US201911099$TAKEDA$$76$YR$$F$Y$$$20240905$$MD$US$US
1927595228$19275952$28$F$20200923$20240827$20210519$20240905$EXP$$AU-Ipsen Biopharmaceuticals, Inc.-2020-16574$IPSEN$$79$YR$E$M$Y$83$KG$20240905$$HP$AU$AU
192765712$19276571$2$F$20210308$20240725$20210519$20240726$EXP$$FR-PFIZER INC-2021527495$PFIZER$$$$$F$Y$$$20240726$$HP$FR$FR
192769698$19276969$8$F$$20240828$20210520$20240906$EXP$$CA-CELLTRION INC.-2021CA006662$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
192773144$19277314$4$F$20210429$20240830$20210519$20240923$PER$$US-SA-2021SA164537$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240923$$MD$US$US
1927750622$19277506$22$F$20210101$20240820$20210520$20240828$EXP$$CA-CELLTRION INC.-2021CA006774$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
192776263$19277626$3$F$20210101$20240701$20210520$20240710$PER$$US-SA-2021SA166971$SANOFI AVENTIS$$40$YR$A$M$Y$124.2$KG$20240710$$MD$US$US
192787483$19278748$3$F$$20210518$20210520$20240723$EXP$$CA-AstraZeneca-2021A440724$ASTRAZENECA$$$$$M$Y$$$20240723$$MD$CA$
192792782$19279278$2$F$$20210513$20210520$20240718$EXP$$US-AstraZeneca-2021A438462$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
192795615$19279561$5$F$20210324$20240913$20210520$20240919$EXP$$US-ROCHE-2010850$ROCHE$$80$YR$E$F$Y$75.75$KG$20240919$$CN$US$US
1927968612$19279686$12$F$20210507$20240722$20210520$20240725$EXP$$US-TAKEDA-2021TUS031869$TAKEDA$$25$YR$$M$Y$$$20240725$$CN$US$US
1928055644$19280556$44$F$20210101$20240825$20210521$20240903$EXP$$CA-CELLTRION INC.-2021CA001211$CELLTRION$$$$$$Y$$$20240903$$MD$CA$CA
192808677$19280867$7$F$$20240807$20210520$20240808$EXP$$US-TAKEDA-US202027814$TAKEDA$$$$$F$Y$$$20240808$$MD$US$US
192812173$19281217$3$F$$20240627$20210521$20240706$EXP$$CA-TEVA-2021-CA-1912488$TEVA$$82$YR$$F$Y$72$KG$20240706$$CN$CA$CA
1928143214$19281432$14$F$20200131$20240911$20210521$20240919$EXP$$CA-CELLTRION INC.-2020CA019010$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
192814583$19281458$3$F$$20240710$20210521$20240715$EXP$$US-BIOGEN-2021BI01012479$BIOGEN$$$$$M$Y$$$20240715$$HP$US$US
1928164812$19281648$12$F$20240521$20240911$20210520$20240912$EXP$$US-SHIRE-US202009350$TAKEDA$$77$YR$$F$Y$$$20240912$$HP$US$US
192818149$19281814$9$F$20210422$20240731$20210520$20240812$EXP$$US-BIOMARINAP-US-2021-136535$BIOMARIN$$$$$$Y$$$20240812$$CN$US$US
192822274$19282227$4$F$20150811$20240628$20210521$20240701$EXP$$US-GILEAD-2021-0531767$GILEAD$$59$YR$A$M$Y$$$20240701$$LW$US$US
1928224821$19282248$21$F$20191213$20240913$20210521$20240923$EXP$$CA-CELLTRION INC.-2021CA006806$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
192837746$19283774$6$F$20171013$20240718$20210520$20240723$EXP$$US-GILEAD-2021-0531589$GILEAD$$48$YR$A$F$Y$$$20240723$$LW$US$US
192844314$19284431$4$F$20190826$20240628$20210521$20240703$EXP$$CA-TAKEDA-2019TUS044764$TAKEDA$$38$YR$$F$Y$$$20240703$$CN$CA$CA
192855032$19285503$2$F$20210112$20240702$20210521$20240705$EXP$$US-BIOGEN-2021BI01013633$BIOGEN$$45$YR$$F$Y$$$20240705$$CN$US$US
192877598$19287759$8$F$$20240827$20210521$20240828$EXP$$US-TAKEDA-US202013826$TAKEDA$$$$$M$Y$$$20240828$$CN$US$US
1928788237$19287882$37$F$20200424$20240826$20210521$20240830$EXP$$US-TAKEDA-US202015119$TAKEDA$$38$YR$$F$Y$75$KG$20240830$$HP$US$US
192880303$19288030$3$F$20210514$20240923$20210521$20240926$EXP$$CA-TAKEDA-2021TUS027682$TAKEDA$$27$YR$$F$Y$$$20240926$$CN$CA$CA
192880775$19288077$5$F$20200115$20240712$20210522$20240722$PER$$US-SA-2021SA166992$SANOFI AVENTIS$$34$YR$A$M$Y$90.2$KG$20240722$$MD$US$US
1928836825$19288368$25$F$20210321$20240920$20210522$20240926$EXP$$US-TAKEDA-US202021763$TAKEDA$$41$YR$$F$Y$134$KG$20240926$$HP$US$US
1928893813$19288938$13$F$20210417$20240730$20210522$20240806$EXP$$NVSC2020BR141403$NOVARTIS$$58$YR$$F$Y$58$KG$20240806$$CN$BR$BR
192903835$19290383$5$F$20230731$20240816$20210522$20240821$EXP$$US-SHIRE-US202026930$TAKEDA$$76$YR$$F$Y$95.2$KG$20240821$$CN$US$US
1929130414$19291304$14$F$20181128$20240807$20210523$20240812$EXP$$CA-HLS-202005689$HLS THERAPEUTICS$$64$YR$A$M$Y$91$KG$20240812$$HP$CA$CA
192913312$19291331$2$F$20210512$20210512$20210523$20240705$PER$$US-SA-2021SA163210$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240705$$CN$US$US
192913885$19291388$5$F$$20240918$20210523$20240920$EXP$$NVSC2021US114684$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
192915597$19291559$7$F$20210101$20240918$20210523$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-048751$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240925$$MD$JP$JP
192921983$19292198$3$F$$20240910$20210524$20240916$EXP$$BE-ROCHE-2832936$ROCHE$Carmans L, Van Craenenbroeck A, Lagrou K, Deroose C, Sagaert X, Wolthuis A, Van Wijngaerden E and Kuypers D Disseminated histoplasmosis in a kidney liver transplant patient from a non-endemic area: A diagnostic challenge (Article number: e00971). IDCases 22 Elsevier Ltd. 2021 Jan;22:1-6.$63$YR$A$F$Y$$$20240916$$HP$BE$BE
1929225352$19292253$52$F$20210101$20240918$20210524$20240927$EXP$$CA-CELLTRION INC.-2021CA003749$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
192923926$19292392$6$F$20210504$20240724$20210524$20240802$EXP$$CO-ROCHE-2833442$ROCHE$$44$YR$A$F$Y$73$KG$20240802$$CN$CO$CO
192926752$19292675$2$F$20210202$20240711$20210524$20240720$EXP$$FR-AUROBINDO-AUR-APL-2021-021297$AUROBINDO$$$$$F$Y$$$20240720$$HP$FR$FR
192946982$19294698$2$F$20190820$20240820$20210524$20240823$EXP$$US-SHIRE-US201927420AA$TAKEDA$$58$YR$$F$Y$$$20240823$$CN$US$US
192950513$19295051$3$F$$20240715$20210524$20240719$EXP$$CA-BAUSCH-BL-2021-017123$BAUSCH AND LOMB$$63$YR$$F$Y$79$KG$20240719$$CN$CA$CA
192965424$19296542$4$F$$20240701$20210524$20240703$EXP$$US-PURDUE-USA-2020-0166319$PURDUE$$$$$M$Y$$$20240703$$CN$US$US
1929713514$19297135$14$F$20200111$20240921$20210524$20240930$EXP$$CA-ROCHE-2688331$ROCHE$$50$YR$A$F$Y$$$20240930$$CN$CA$CA
192982592$19298259$2$F$$20210211$20210525$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-283122$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
1929908630$19299086$30$F$20200101$20240812$20210525$20240820$EXP$$CA-CELLTRION INC.-2020CA029768$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
193000585$19300058$5$F$20201101$20240725$20210524$20240726$EXP$$US-UCBSA-2021022745$UCB$$28$YR$$F$Y$83.4$KG$20240726$$MD$US$US
193006724$19300672$4$F$$20240906$20210524$20240912$EXP$$US-GILEAD-2021-0532195$GILEAD$$86$YR$E$M$Y$$$20240912$$MD$US$US
193012403$19301240$3$F$20170118$20240730$20210524$20240801$EXP$$US-PURDUE-USA-2020-0173362$PURDUE$$59$YR$$M$Y$$$20240801$$CN$US$US
193024242$19302424$2$F$20201001$20240830$20210525$20240911$PER$$US-SA-2020SA324330$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240911$$PH$US$US
193026722$19302672$2$F$20210101$20240626$20210525$20240701$EXP$$US-VERTEX PHARMACEUTICALS-2021-004543$VERTEX$$$$$F$Y$$$20240701$$HP$US$US
1930336316$19303363$16$F$20170427$20240724$20210525$20240801$EXP$$CA-ROCHE-2835925$ROCHE$$23$YR$A$M$Y$$$20240801$$MD$CA$CA
1930389311$19303893$11$F$20210609$20240716$20210525$20240724$EXP$$CA-TAKEDA-2021TUS032086$TAKEDA$$52$YR$$M$Y$$$20240724$$HP$CA$CA
193040443$19304044$3$F$20210101$20220715$20210525$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-297905$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
193043706$19304370$6$F$20230117$20240718$20210525$20240725$EXP$$CA-TAKEDA-2021TUS031457$TAKEDA$$30$YR$$F$Y$$$20240725$$MD$CA$CA
1930481017$19304810$17$F$20190301$20240826$20210526$20240830$EXP$$JP-ABBVIE-21P-087-3921860-00$ABBVIE$$57$YR$$M$Y$66$KG$20240830$$MD$JP$JP
193051847$19305184$7$F$$20240730$20210526$20240823$PER$$CA-TOLMAR, INC.-21CA027138$TOLMAR$$$$$M$Y$$$20240823$$CN$CA$CA
193052097$19305209$7$F$$20240731$20210526$20240827$PER$$CA-TOLMAR, INC.-21CA027135$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
193054054$19305405$4$F$20200101$20240806$20210525$20240808$EXP$$US-PFIZER INC-2021546238$PFIZER$$59$YR$$F$Y$104.98$KG$20240808$$HP$US$US
1930608829$19306088$29$F$20200313$20240910$20210525$20240914$EXP$$CO-TAKEDA-CO202010417$TAKEDA$$41$YR$$F$Y$70$KG$20240914$$CN$CO$CO
1930613416$19306134$16$F$20220509$20240726$20210525$20240731$EXP$$AU-TAKEDA-2019TUS051915$TAKEDA$$31$YR$$F$Y$$$20240731$$HP$AU$AU
193072107$19307210$7$F$20210423$20240812$20210526$20240814$EXP$$ZA-TAKEDA-2021TUS026466$TAKEDA$$36$YR$$F$Y$$$20240814$$CN$ZA$ZA
193080727$19308072$7$F$20140903$20240806$20210526$20240822$EXP$$SE-ORGANON-1802SWE003501$ORGANON$Mallak FK, Kallner HK. Migration of a subdermal contraceptive implant into a subsegmental pulmonary artery and etonogestrel serum concentration over time - a case report.. The European Journal of Contraception + Reproductive Health Care. 2022$23$YR$$F$Y$48$KG$20240822$$HP$SE$SE
193102219$19310221$9$F$20220101$20240718$20210526$20240722$EXP$$IN-PFIZER INC-2021269979$PFIZER$$56$YR$$F$Y$$$20240722$$CN$IN$IN
1931075311$19310753$11$F$20230630$20240813$20210526$20240821$EXP$$CA-TAKEDA-2021TUS032128$TAKEDA$$73$YR$$F$Y$$$20240821$$MD$CA$CA
193109862$19310986$2$F$$20240720$20210526$20240801$EXP$$US-AUROBINDO-AUR-APL-2016-04471$AUROBINDO$San Gabriel MCP, Eddula-Changala B, Tan Y, Longshore CT.. Electroconvulsive in a Schizophrenic Patient with Neuroleptic Malignant Syndrome and Rhabdomyolysis. Journal of ECT. 2015;31(3):197-200$42$YR$$M$Y$$$20240801$$MD$US$US
193118595$19311859$5$F$20210101$20240903$20210527$20240910$PER$$US-AMGEN-USASP2021080097$AMGEN$$48$YR$A$F$Y$$$20240910$$HP$US$US
193128183$19312818$3$F$$20240716$20210527$20240725$EXP$$CA-APOTEX-2021AP012394$APOTEX$$$$$M$Y$$$20240725$$HP$CA$CA
1931290942$19312909$42$F$20200222$20240722$20210527$20240730$EXP$$CA-CELLTRION INC.-2020CA019939$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
193146972$19314697$2$F$20210517$20240816$20210527$20240826$PER$$US-SA-2021SA166586$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240826$$HP$US$US
193147382$19314738$2$F$20240622$20240703$20210527$20240715$PER$$US-SA-2021SA170740$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240715$$MD$US$US
193156463$19315646$3$F$20210501$20240703$20210527$20240709$30DAY$$US-GLAXOSMITHKLINE-US2021105198$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240709$$CN$US$US
193169272$19316927$2$F$$20240820$20210528$20240821$PER$$US-PURDUE-USA-2020-0187658$PURDUE$$$$$M$Y$$$20240821$$CN$US$US
1931705211$19317052$11$F$$20240729$20210527$20240806$EXP$$CA-ROCHE-2835670$ROCHE$$$$A$F$Y$$$20240806$$CN$CA$CA
193176255$19317625$5$F$20210601$20240617$20210528$20240711$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-001695$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$83$KG$20240711$$CN$US$US
1931833516$19318335$16$F$20210413$20240823$20210527$20240826$EXP$$PHHY2018CO200942$NOVARTIS$$53$YR$$M$Y$66$KG$20240826$$CN$CO$CO
1932229810$19322298$10$F$20210326$20240815$20210528$20240826$EXP$$CA-ROCHE-2838335$ROCHE$$49$YR$A$M$Y$$$20240826$$HP$CA$CA
193223226$19322322$6$F$20210426$20240911$20210528$20240918$EXP$$CA-TAKEDA-2021TUS032421$TAKEDA$$80$YR$$F$Y$96$KG$20240918$$CN$CA$CA
193230462$19323046$2$F$$20240808$20210528$20240816$PER$$US-SA-2021SA174369$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
193232832$19323283$2$F$$20240826$20210528$20240904$EXP$$CA-APOTEX-2021AP012423$APOTEX$$23$YR$$M$Y$$$20240904$$HP$CA$CA
193235433$19323543$3$F$20160101$20210521$20210528$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-115578$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
1932354519$19323545$19$F$$20240826$20210528$20240909$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-298347$RANBAXY$$$$A$F$Y$62.585$KG$20240909$$CN$US$US
193238582$19323858$2$F$20210202$20240726$20210528$20240801$EXP$$FR-ROCHE-2835115$ROCHE$$$$$F$Y$$$20240801$$HP$FR$FR
193248604$19324860$4$F$20210428$20240827$20210528$20240913$PER$$CA-TOLMAR, INC.-21CA026883$TOLMAR$$75$YR$$M$Y$$$20240913$$CN$CA$CA
193252188$19325218$8$F$$20240910$20210528$20240919$EXP$$NVSC2021CA113974$NOVARTIS$$50$YR$$M$Y$$$20240919$$CN$CA$CA
193258336$19325833$6$F$20230101$20240701$20210528$20240704$PER$$US-PFIZER INC-2021383456$PFIZER$$66$YR$$F$Y$72.57$KG$20240704$$CN$US$US
193258603$19325860$3$F$$20240715$20210528$20240717$EXP$$US-PFIZER INC-2021383602$PFIZER$$78$YR$$F$Y$$$20240717$$CN$US$US
193267143$19326714$3$F$20210422$20240725$20210528$20240808$EXP$$IT-ROCHE-2836121$ROCHE$$68$YR$E$F$Y$62$KG$20240808$$MD$IT$IT
193273202$19327320$2$F$$20240827$20210528$20240910$PER$$US-SA-2021SA170996$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240910$$MD$US$US
193276933$19327693$3$F$20210522$20240712$20210528$20240716$EXP$$IT-TAKEDA-2021TUS033369$TAKEDA$$3$YR$$M$Y$$$20240716$$CN$IT$IT
1932918218$19329182$18$F$$20240821$20210528$20240826$EXP$$CA-PFIZER INC-2021581506$PFIZER$$12$YR$$M$Y$45$KG$20240826$$HP$CA$CA
193295695$19329569$5$F$$20240910$20210528$20240919$EXP$$NVSC2021CA113985$NOVARTIS$$42$YR$$M$Y$$$20240919$$CN$CA$CA
193301052$19330105$2$F$20210312$20240711$20210528$20240715$EXP$$CN-PFIZER INC-2021550122$PFIZER$$89$YR$$F$Y$45$KG$20240715$$CN$CN$CN
193305257$19330525$7$F$20220701$20240806$20210528$20240808$EXP$$US-TAKEDA-US202030926$TAKEDA$$52$YR$$F$Y$61$KG$20240808$$HP$US$US
193328463$19332846$3$F$$20240724$20210528$20240801$PER$$US-PURDUE-USA-2020-0225971$PURDUE$$$$$M$Y$$$20240801$$CN$US$US
193328847$19332884$7$F$$20240717$20210529$20240723$EXP$$NVSC2020CO091645$NOVARTIS$$$$$F$Y$$$20240723$$CN$CO$CO
193352765$19335276$5$F$$20240702$20210529$20240704$PER$$US-PURDUE-USA-2020-0218102$PURDUE$$$$$M$Y$$$20240704$$CN$US$US
193369233$19336923$3$F$20200902$20240816$20210530$20240821$EXP$$US-UCBSA-2021023802$UCB$$27$YR$$F$Y$77.11$KG$20240821$$MD$US$US
193450909$19345090$9$F$$20240812$20210531$20240903$PER$$CA-TOLMAR, INC.-21CA027259$TOLMAR$$$$$M$Y$$$20240903$$CN$CA$CA
193454869$19345486$9$F$20210513$20240729$20210531$20240820$PER$$CA-TOLMAR, INC.-21CA027307$TOLMAR$$88$YR$$M$Y$$$20240820$$CN$CA$CA
193503242$19350324$2$F$20190401$20240621$20210531$20240708$EXP$$NL-ROCHE-2838437$ROCHE$Hussaarts K, Van Doorn L, Bins S, Sprengers D, De Bruijn P, Van Leeuwen R. Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma. Pharmaceuticals. 2021-Jan-01;14 (1):1-10. doi:10.3390/ph14010046.$65$YR$E$M$Y$$$20240708$$HP$NL$NL
193507113$19350711$3$F$20240101$20240813$20210531$20240821$PER$$US-SA-2021SA176247$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240821$$MD$US$US
193507672$19350767$2$F$$20240731$20210531$20240809$PER$$US-SA-2021SA177384$SANOFI AVENTIS$$$$A$F$Y$103.42$KG$20240809$$MD$US$US
1935125910$19351259$10$F$20211012$20240722$20210531$20240726$EXP$$AT-TAKEDA-2021TUS034189$TAKEDA$$60$YR$$F$Y$$$20240726$$MD$AT$AT
193513453$19351345$3$F$20210521$20240701$20210531$20240711$30DAY$$US-GLAXOSMITHKLINE-US2021109092$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240711$$CN$US$US
193520943$19352094$3$F$20201030$20240805$20210601$20240814$PER$$US-SA-2021SA180165$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240814$$MD$US$US
193527524$19352752$4$F$20210429$20231224$20210601$20240918$EXP$FR-AFSSAPS-AM20211330$FR-BAUSCH-BL-2021-018348$BAUSCH AND LOMB$$21$YR$$F$Y$70$KG$20240918$$MD$FR$FR
193527785$19352778$5$F$$20240906$20210531$20240912$EXP$$US-TAKEDA-2021TUS033009$TAKEDA$$$$$F$Y$125$KG$20240912$$HP$US$US
193529692$19352969$2$F$$20240724$20210531$20240729$EXP$$US-PFIZER INC-2021570641$PFIZER$$64$YR$$M$Y$$$20240729$$CN$US$US
193529952$19352995$2$F$20240622$20240703$20210601$20240716$EXP$$US-BIOMARINAP-US-2021-136743$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
193531426$19353142$6$F$$20240719$20210531$20240723$PER$$US-PFIZER INC-2021566661$PFIZER$$73$YR$$F$Y$$$20240723$$CN$US$US
193531918$19353191$8$F$20180101$20240906$20210531$20240913$EXP$$PHHY2018BR131344$NOVARTIS$$$$$F$Y$60$KG$20240913$$CN$BR$BR
193534432$19353443$2$F$20080101$20240709$20210531$20240710$PER$$US-PURDUE PHARMA-USA-2020-0153346$PURDUE$$$$$F$Y$$$20240710$$CN$US$US
193537813$19353781$3$F$20090101$20240821$20210531$20240822$PER$$US-NAPPMUNDI-USA-2020-0155044$PURDUE$$$$$F$Y$$$20240822$$CN$US$US
193543796$19354379$6$F$20201108$20240822$20210602$20240827$EXP$$IL-ABBVIE-20K-082-3646619-00$ABBVIE$$68$YR$$M$Y$$$20240827$$MD$IL$IL
193547938$19354793$8$F$20210729$20240705$20210531$20240709$EXP$$CA-TAKEDA-2021TUS029788$TAKEDA$$80$YR$$F$Y$$$20240709$$CN$CA$CA
193550134$19355013$4$F$$20240723$20210601$20240726$PER$$US-AMGEN-USASP2021082078$AMGEN$$$$$F$Y$$$20240726$$HP$US$US
193555307$19355530$7$F$$20240724$20210531$20240726$EXP$$US-PURDUE-USA-2020-0176597$PURDUE$$$$$M$Y$86$KG$20240726$$CN$US$US
193555372$19355537$2$F$20210401$20240621$20210601$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-001730$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240716$$CN$US$US
1935717412$19357174$12$F$20211213$20220426$20210601$20240925$EXP$$US-GLAXOSMITHKLINE-US2021113339$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
1935754313$19357543$13$F$20190710$20240920$20210602$20240930$EXP$$JP-ABBVIE-19P-087-2916460-00$ABBVIE$$76$YR$$M$Y$53.5$KG$20240930$$MD$JP$JP
193582393$19358239$3$F$$20240808$20210602$20240905$EXP$$US-BEH-2021132191$CSL BEHRING$$$$C$F$Y$$$20240905$$HP$US$US
1935825236$19358252$36$F$20210501$20240905$20210531$20240914$EXP$$CA-CELLTRION INC.-2021CA001343$CELLTRION$$$$$$Y$$$20240914$$MD$CA$CA
193599619$19359961$9$F$$20240812$20210601$20240815$EXP$$US-TAKEDA-US202008521$TAKEDA$$$$$F$Y$81$KG$20240815$$CN$US$US
1936030210$19360302$10$F$$20240716$20210601$20240725$EXP$$CA-APOTEX-2021AP012738$APOTEX$$75$YR$$F$Y$$$20240725$$HP$CA$CA
193610718$19361071$8$F$20201101$20240821$20210602$20240823$EXP$$IL-ABBVIE-21K-082-3928123-00$ABBVIE$$74$YR$$M$Y$65$KG$20240823$$MD$IL$IL
1936136011$19361360$11$F$20220601$20240724$20210601$20240727$EXP$$NVSC2021TH122255$NOVARTIS$$62$YR$$F$Y$$$20240727$$HP$TH$TH
193614498$19361449$8$F$20190901$20240704$20210601$20240715$EXP$$GB-SA-2019SA253956$SANOFI AVENTIS$$40$YR$A$F$Y$110$KG$20240715$$MD$GB$GB
193619903$19361990$3$F$20191201$20240816$20210601$20240821$EXP$$IT-PFIZER INC-2021560868$PFIZER$$43$YR$$F$Y$$$20240821$$MD$IT$IT
1936211135$19362111$35$F$20190512$20240916$20210601$20240920$EXP$$IN-PFIZER INC-2019512774$PFIZER$$66$YR$$F$Y$$$20240920$$CN$IN$IN
193621583$19362158$3$F$20210514$20240730$20210603$20240805$EXP$$US-BIOGEN-2021BI01016986$BIOGEN$$55$YR$$F$Y$$$20240805$$MD$US$US
193623172$19362317$2$F$$20240709$20210603$20240716$EXP$$CA-APOTEX-2021AP013071$APOTEX$$57$YR$$M$Y$$$20240716$$HP$CA$CA
193628322$19362832$2$F$$20240701$20210603$20240708$EXP$$CA-AUROBINDO-AUR-APL-2021-022442$AUROBINDO$$52$YR$$F$Y$$$20240708$$HP$CA$CA
1936442814$19364428$14$F$$20240826$20210602$20240907$EXP$$CA-GLENMARK PHARMACEUTICALS-2021GMK054175$GLENMARK$$$$$$Y$$$20240907$$MD$CA$CA
1936453721$19364537$21$F$$20240905$20210602$20240912$EXP$$CA-Covis Pharma GmbH-2021COV21042$COVIS PHARMA$$80$YR$E$M$Y$89.3$KG$20240912$$MD$CA$CA
193664222$19366422$2$F$20190808$20210521$20210603$20240703$EXP$$TR-TEVA-2021-TR-1919202$TEVA$$$$I$M$Y$$$20240703$$CN$TR$TR
193670665$19367066$5$F$20240821$20240821$20210603$20240826$EXP$$BR-SHIRE-BR202011700AA$TAKEDA$$30$YR$$M$Y$95$KG$20240826$$CN$BR$BR
1936710020$19367100$20$F$20201205$20240808$20210603$20240809$EXP$$CA-ROCHE-2840846$ROCHE$$44$YR$A$F$Y$$$20240809$$CN$CA$CA
1936748219$19367482$19$F$20201124$20240905$20210603$20240912$EXP$$CA-TAKEDA-2020TUS053772$TAKEDA$$59$YR$$M$Y$$$20240912$$HP$CA$CA
193680667$19368066$7$F$20190908$20240829$20210602$20240905$EXP$$US-AMGEN-USANI2019157175$AMGEN$$86$YR$E$M$Y$$$20240904$$MD$US$US
193685182$19368518$2$F$20210101$20240925$20210602$20240930$EXP$$US-SA-2021SA181675$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240930$$MD$US$US
193685503$19368550$3$F$20200903$20240916$20210602$20240926$EXP$$US-ROCHE-2674987$ROCHE$$32$YR$A$F$Y$72.57$KG$20240926$$CN$US$US
1936866214$19368662$14$F$20210326$20240708$20210602$20240715$EXP$$US-SA-2021SA178782$SANOFI AVENTIS$$53$YR$A$F$Y$90.9$KG$20240715$$HP$US$US
193695255$19369525$5$F$20200913$20240703$20210603$20240704$EXP$$NVSC2021DE124541$NOVARTIS$$$$A$F$Y$63$KG$20240704$$HP$DE$DE
1936996321$19369963$21$F$20200101$20240711$20210604$20240720$EXP$$CA-CELLTRION INC.-2020CA022936$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
193700892$19370089$2$F$20210413$20240805$20210604$20240813$EXP$$ES-AstraZeneca-2021A475913$ASTRAZENECA$$71$YR$$F$Y$$$20240813$$MD$ES$
193703197$19370319$7$F$20190314$20240712$20210604$20240718$EXP$$JP-ABBVIE-19P-087-2724698-00$ABBVIE$$75$YR$$M$Y$54$KG$20240718$$MD$JP$JP
193705622$19370562$2$F$$20240821$20210604$20240831$EXP$$US-AUROBINDO-AUR-APL-2019-076706$AUROBINDO$Ibrahim M, Omar B.. Ciprofloxacin-induced torsade de pointes. AMERICAN JOURNAL OF EMERGENCY MEDICINE. 2012;30 (1):252.E5-252.E9$65$YR$$M$Y$$$20240831$$MD$US$US
193710519$19371051$9$F$20210525$20240717$20210604$20240729$EXP$$DE-ROCHE-2673172$ROCHE$$25$YR$A$M$Y$$$20240729$$CN$DE$DE
193712492$19371249$2$F$20190101$20240912$20210604$20240926$EXP$BE-MLMSERVICE-20210513-2887647-1$BE-ALKEM LABORATORIES LIMITED-BE-ALKEM-2021-03072$ALKEM$Carmans L, Van Craenenbroeck A, Lagrou K, Deroose CM, Sagaert X, Wolthuis A et al.. Disseminated histoplasmosis in a kidney liver transplant patient from a non-endemic area: A diagnostic challenge. IDCases. 2020;22:e00971$63$YR$$F$Y$$$20240926$$MD$BE$BE
193713362$19371336$2$F$20190701$20240724$20210603$20240801$EXP$$IN-INCYTE CORPORATION-2019IN012181$INCYTE$$$$$$Y$$$20240801$$CN$IN$IN
1937154220$19371542$20$F$20210101$20240725$20210604$20240802$EXP$$CA-CELLTRION INC.-2021CA004830$CELLTRION$$$$$$Y$$$20240802$$HP$CA$CA
193720305$19372030$5$F$$20240726$20210603$20240805$EXP$$JP-009507513-2105JPN007247$MERCK$Hibino H, Makino Y, Sakiyama N, Makihara-Ando R, Hashimoto H, Akiyoshi T et al.. Exacerbation of atrioventricular block associated with concomitant use of amlodipine and aprepitant in a lung cancer patient: A case report.. International Journal of Clinical Pharmacology and Therapeutics.. 2021;59 (4):328-32$73$YR$$M$Y$91.9$KG$20240805$$PH$JP$JP
193725722$19372572$2$F$$20240711$20210604$20240722$EXP$$FR-AUROBINDO-AUR-APL-2021-022056$AUROBINDO$$$$$F$Y$$$20240722$$HP$FR$FR
193727672$19372767$2$F$$20240719$20210604$20240731$EXP$$PL-ROCHE-2705032$ROCHE$Sikora M, Sikora-Skrabaka M, Copija A, Nowakowska-Zajdel E. Metastasis of breast cancer to the colon - case report. ONCOLOGY IN CLINICAL PRACTICE - EDUCATION. CLINICAL ONCOLOGY-EDUCATION. 2020;G12 (6):$72$YR$E$F$Y$$$20240731$$HP$PL$PL
1937309511$19373095$11$F$20221128$20240710$20210604$20240718$PER$$CA-TOLMAR, INC.-21CA027388$TOLMAR$$81$YR$$M$Y$$$20240718$$CN$CA$CA
193731624$19373162$4$F$$20240722$20210604$20240731$EXP$HR-EMA-2021402-AUTODUP-1617319058078$HR-Accord-226839$ACCORD$$56$YR$A$F$Y$$$20240731$$MD$HR$HR
193731845$19373184$5$F$$20240801$20210604$20240805$EXP$$US-TAKEDA-2020TUS036318$TAKEDA$$$$$M$Y$$$20240805$$CN$US$US
1937321816$19373218$16$F$20200703$20240816$20210604$20240821$EXP$$GB-ROCHE-2660214$ROCHE$$75$YR$E$F$Y$56.9$KG$20240821$$MD$GB$GB
1937355915$19373559$15$F$20191021$20240812$20210603$20240816$EXP$$CA-TAKEDA-2019TUS019258$TAKEDA$$53$YR$$M$Y$$$20240816$$CN$CA$CA
193748322$19374832$2$F$$20240808$20210604$20240817$PER$$US-SA-2021SA184643$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240817$$MD$US$US
193748699$19374869$9$F$20220322$20240719$20210604$20240724$EXP$$CA-TAKEDA-2021TUS034907$TAKEDA$$49$YR$$F$Y$50$KG$20240724$$HP$CA$CA
193756825$19375682$5$F$$20240730$20210604$20240801$PER$$US-PFIZER INC-2021268547$PFIZER$$57$YR$$M$Y$$$20240801$$CN$US$US
193758552$19375855$2$F$20240724$20240725$20210604$20240730$EXP$$US-KYOWAKIRIN-2021BKK008819$KYOWA$$$$$$Y$$$20240730$$HP$US$US
193759473$19375947$3$F$20210416$20240912$20210604$20240917$PER$$US-BIOGEN-2021BI01016415$BIOGEN$$39$YR$$F$Y$$$20240917$$CN$US$US
193763396$19376339$6$F$20130101$20240821$20210605$20240831$EXP$$DE-AUROBINDO-AUR-APL-2021-022131$AUROBINDO$Wiemer-Kruel A.. Ketogenic diet therapy under special consideration of treatment of the myoclonic-astatic epilepsy.. Zeitschrift f?r Epileptologie. 2021;34:154?160$3$YR$$M$Y$$$20240831$$MD$DE$DE
193765962$19376596$2$F$$20240909$20210604$20240923$EXP$$CA-JNJFOC-20210606763$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240923$$MD$CA$CA
1937675712$19376757$12$F$20201106$20240718$20210604$20240724$EXP$$CO-TAKEDA-CO201912450$TAKEDA$$20$YR$$F$Y$57$KG$20240724$$CN$CO$CO
193767775$19376777$5$F$$20240715$20210604$20240716$PER$$US-PFIZER INC-2019164195$PFIZER$$62$YR$$F$Y$$$20240716$$CN$US$US
193767868$19376786$8$F$$20240812$20210604$20240816$EXP$$US-TAKEDA-2021TUS034852$TAKEDA$$$$$F$Y$73$KG$20240816$$HP$US$US
1937686945$19376869$45$F$20200304$20240909$20210605$20240917$EXP$$CA-CELLTRION INC.-2020CA020257$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
193772195$19377219$5$F$20210526$20240909$20210604$20240912$EXP$$US-TAKEDA-2021TUS035425$TAKEDA$$4$YR$$M$Y$$$20240912$$CN$US$US
193777182$19377718$2$F$20180101$20240812$20210605$20240823$EXP$$IT-Accord-223867$ACCORD$Fraticelli S, Bonometti A, Lucioni M, Capuano F, Meloni F, Arcaini L et al. Late-onset EBV-related post-transplant non-secreting plasma-cell neoplasms: Description of two cases. Leukemia Research.2021;100:Article Number 106493.$44$YR$A$F$Y$$$20240823$$HP$IT$IT
193784892$19378489$2$F$$20240702$20210606$20240711$PER$$US-SA-2021SA187107$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240711$$MD$US$US
193791586$19379158$6$F$20210601$20240618$20210607$20240702$PER$$US-SA-2021SA186467$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240702$$MD$US$US
193796205$19379620$5$F$20210101$20240719$20210607$20240725$PER$$US-SA-2021SA023086$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240725$$CN$US$US
1937976832$19379768$32$F$20200717$20240729$20210607$20240805$EXP$$CA-CELLTRION INC.-2020CA019237$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
1938085412$19380854$12$F$20210601$20240919$20210607$20240925$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2021JPN118466$VIIV$$$$$$Y$$$20240925$$HP$JP$JP
1938125820$19381258$20$F$20191219$20240910$20210607$20240916$EXP$$IT-ROCHE-2533393$ROCHE$$69$YR$E$F$Y$60$KG$20240916$$MD$IT$IT
193814862$19381486$2$F$$20240621$20210607$20240701$EXP$$NL-AUROBINDO-AUR-APL-2019-081835$AUROBINDO$Boumans D, De Vries PAM, Rikken NET, Laverman GD.. Prolonged hypocalcaemia after pamidronate infusion in Riedel^s thyroiditis associated hypoparathyroidism.. Netherlands Journal of Medici. 2013;71(8):442-443$50$YR$$F$Y$$$20240701$$HP$NL$NL
193815602$19381560$2$F$20210601$20240722$20210607$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202106001823$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240729$$CN$US$US
1938203350$19382033$50$F$20200901$20240829$20210607$20240905$EXP$$CO-TAKEDA-CO202026063$TAKEDA$$20$YR$$F$Y$75$KG$20240905$$CN$CO$CO
193822342$19382234$2$F$20210228$20210519$20210607$20240823$EXP$$US-ORPHANEU-2021001853$RECORDATI$$$$$$Y$$$20240823$$CN$US$US
193824583$19382458$3$F$$20240809$20210607$20240816$EXP$$NVSC2020DE286062$NOVARTIS$Ganzleben I, Geppert C, Osaba L, Hirschmann S, Nagel A, Atreya R et al.. Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2020;13:1-5$33$YR$$M$Y$$$20240816$$HP$DE$DE
193827183$19382718$3$F$20180101$20240820$20210607$20240822$EXP$$FR-TAKEDA-2021TUS035551$TAKEDA$$76$YR$$F$Y$$$20240822$$HP$FR$FR
193828102$19382810$2$F$$20240717$20210607$20240723$EXP$$US-TAKEDA-2021TUS035535$TAKEDA$$$$$M$Y$$$20240723$$CN$US$US
193830545$19383054$5$F$$20240903$20210607$20240906$EXP$$US-TAKEDA-US201913944$TAKEDA$$$$$F$Y$$$20240906$$CN$US$US
193835888$19383588$8$F$20210222$20240924$20210607$20240927$EXP$$AT-PFIZER INC-2021588827$PFIZER$$47$YR$$F$Y$58$KG$20240927$$MD$AT$AT
193843705$19384370$5$F$20210527$20240625$20210608$20240708$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003339$PAREXEL$$$$$$Y$$$20240708$$CN$US$US
193847426$19384742$6$F$20200504$20240730$20210608$20240806$EXP$$CA-ROCHE-2596715$ROCHE$$47$YR$A$M$Y$$$20240806$$CN$CA$CA
193851542$19385154$2$F$$20240916$20210608$20240927$EXP$$CA-APOTEX-2021AP013179$APOTEX$$72$YR$$F$Y$$$20240927$$MD$CA$CA
1938535319$19385353$19$F$20150826$20240702$20210607$20240709$EXP$$CO-TAKEDA-CO201511094$TAKEDA$$38$YR$$F$Y$60$KG$20240709$$CN$CO$CO
1938542527$19385425$27$F$20200807$20240819$20210607$20240822$EXP$$US-SHIRE-US202025784$TAKEDA$$64$YR$$F$Y$$$20240822$$HP$US$US
193860962$19386096$2$F$20140413$20240822$20210608$20240902$EXP$$NL-AUROBINDO-AUR-APL-2018-036031$AUROBINDO$Haarman MG, van Hunsel F, de Vries TW.. Adverse drug reactions of montelukast in children and adults.. Pharmacol-Res-Perspect. 2017;5(5)$72$YR$$F$Y$$$20240902$$PH$NL$NL
193861856$19386185$6$F$20210105$20240820$20210607$20240823$EXP$$US-JAZZ-2021-US-010155$JAZZ$$59$YR$$M$Y$$$20240823$$MD$US$US
193889482$19388948$2$F$20200101$20240724$20210607$20240806$PER$$US-SA-2021SA188789$SANOFI AVENTIS$$66$YR$E$F$Y$70$KG$20240806$$MD$US$US
193892794$19389279$4$F$20210316$20240910$20210607$20240918$EXP$$NVSJ2021JP006221$NOVARTIS$$12$YR$$M$Y$40.5$KG$20240918$$MD$JP$JP
193898564$19389856$4$F$20210101$20240830$20210608$20240903$EXP$$US-SA-2021SA189285$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240903$$MD$US$US
193899614$19389961$4$F$20190308$20240925$20210608$20240927$EXP$$CA-TAKEDA-2019TUS011917$TAKEDA$$52$YR$$F$Y$$$20240927$$MD$CA$CA
193900186$19390018$6$F$20211214$20240625$20210608$20240715$PER$$CA-TOLMAR, INC.-21CA027034$TOLMAR$$87$YR$$M$Y$$$20240715$$CN$CA$CA
193900696$19390069$6$F$20211119$20240913$20210608$20240920$EXP$$CA-TAKEDA-2021TUS035300$TAKEDA$$63$YR$$F$Y$$$20240920$$MD$CA$CA
193903158$19390315$8$F$20210505$20240715$20210608$20240805$PER$$CA-TOLMAR, INC.-20CA024092$TOLMAR$$76$YR$$M$Y$$$20240802$$CN$CA$CA
193908126$19390812$6$F$$20240830$20210608$20240904$EXP$$NVSC2021IT128378$NOVARTIS$Gallo M, Giampreti A, Eleftheriou G, Faraoni L, Gioia Contessa M, Butera R et al.. Successful 40-hour delayed acetylcysteine treatment in a severe acetaminophen acute hepatitis. CLINICAL TOXICOLOGY. 2021;59(6):559-60$55$YR$$F$Y$$$20240904$$HP$IT$IT
193912293$19391229$3$F$20210305$20240820$20210608$20240827$EXP$$DE-TAKEDA-2021TUS035143$TAKEDA$$30$YR$$F$Y$$$20240827$$HP$DE$DE
1939141714$19391417$14$F$20190703$20240923$20210608$20240930$EXP$$CA-TAKEDA-2019TUS041938$TAKEDA$$33$YR$$M$Y$$$20240930$$CN$CA$CA
193915436$19391543$6$F$$20240710$20210608$20240715$EXP$$CA-BAUSCH-BL-2021-019602$BAUSCH AND LOMB$$43$YR$$F$Y$96$KG$20240715$$HP$CA$CA
193920402$19392040$2$F$$20240703$20210608$20240709$EXP$$FR-PFIZER INC-2021603632$PFIZER$$$$$F$Y$$$20240709$$HP$FR$FR
1939290814$19392908$14$F$$20240731$20210609$20240813$EXP$$CA-AUROBINDO-AUR-APL-2021-022535$AUROBINDO$$65$YR$$M$Y$$$20240813$$MD$CA$CA
193932105$19393210$5$F$20200701$20240924$20210609$20240930$EXP$$ES-BIOGEN-2021BI01017804$BIOGEN$$13$YR$$F$Y$32$KG$20240930$$MD$ES$ES
193933174$19393317$4$F$$20240711$20210609$20240722$EXP$$CA-APOTEX-2021AP013304$APOTEX$$56$YR$$M$Y$$$20240722$$MD$CA$CA
193945026$19394502$6$F$$20240722$20210609$20240723$EXP$$US-TAKEDA-2021TUS035931$TAKEDA$$$$$F$Y$$$20240723$$HP$US$US
1939481312$19394813$12$F$20191017$20240628$20210609$20240703$EXP$$CA-TAKEDA-2019TUS054837$TAKEDA$$64$YR$$F$Y$$$20240703$$HP$CA$CA
193951577$19395157$7$F$20210101$20240806$20210609$20240808$EXP$$US-KYOWAKIRIN-2021BKK009180$KYOWA$$$$$$Y$$$20240808$$HP$US$US
193957239$19395723$9$F$20210618$20240920$20210609$20240927$EXP$$CA-TAKEDA-2021TUS029734$TAKEDA$$20$YR$$M$Y$$$20240927$$HP$CA$CA
1939588811$19395888$11$F$20200919$20240904$20210609$20240910$EXP$$US-TAKEDA-US202030350$TAKEDA$$68$YR$$F$Y$56$KG$20240910$$CN$US$US
193963732$19396373$2$F$$20240801$20210610$20240807$EXP$$IT-JNJFOC-20210618280$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240807$$HP$IT$IT
193976946$19397694$6$F$20150101$20240815$20210609$20240822$EXP$$JP-SAKK-2021SA188788AA$SANOFI AVENTIS$Fujisaki S, Takashina M, Tomita R, Sakurai K, Takayama T.. Long-Term Survival of Patient Having Advanced Esophageal Cancer with Cirrhosis after Overcoming Anastomotic Leakage, Purulent Osteomyelitis, Cervical Lymph Node Recurrence, and Systemic Edema-A Surgical Case.. Gan to kagaku ryoho. Cancer + chemotherapy.. 2022;49(1):91-3$69$YR$E$F$Y$47.5$KG$20240822$$MD$JP$JP
1939778210$19397782$10$F$20230812$20240802$20210610$20240807$EXP$$AU-TAKEDA-2021TUS036439$TAKEDA$$35$YR$$F$Y$$$20240807$$MD$AU$AU
1939781310$19397813$10$F$$20240711$20210610$20240722$EXP$$CA-APOTEX-2021AP013674$APOTEX$$40$YR$$M$Y$140$KG$20240722$$HP$CA$CA
193982295$19398229$5$F$20160628$20240717$20210610$20240722$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN063624$VIIV$$$$$$Y$$$20240722$$MD$JP$JP
1939908621$19399086$21$F$20200708$20240910$20210610$20240918$EXP$$CA-CELLTRION INC.-2021CA007913$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
1939945910$19399459$10$F$$20240913$20210610$20240917$PER$$US-PFIZER INC-2021641607$PFIZER$$72$YR$$F$Y$$$20240917$$CN$US$US
193995839$19399583$9$F$20220101$20220721$20210610$20240925$PER$$US-GLAXOSMITHKLINE-US2021121916$GLAXOSMITHKLINE$$42$YR$$F$Y$$$20240925$$CN$US$US
1939967230$19399672$30$F$20200527$20240627$20210610$20240703$EXP$$CA-TAKEDA-CA202018912$TAKEDA$$71$YR$$F$Y$$$20240703$$CN$CA$CA
193999152$19399915$2$F$20200928$20240913$20210610$20240918$EXP$$US-TAKEDA-US202032962$TAKEDA$$8$YR$$F$Y$$$20240918$$MD$US$US
193999806$19399980$6$F$20210101$20240828$20210610$20240829$EXP$$DE-TAKEDA-2021TUS034724$TAKEDA$$48$YR$$M$Y$$$20240829$$MD$DE$DE
194007042$19400704$2$F$20200101$20240611$20210610$20240702$PER$$US-TAKEDA-2021TUS035526$TAKEDA$$32$YR$$F$Y$67$KG$20240702$$MD$US$US
194008753$19400875$3$F$$20240809$20210610$20240820$PER$$US-SA-2021SA190519$SANOFI AVENTIS$$$$A$F$Y$90.71$KG$20240820$$MD$US$US
194014148$19401414$8$F$20210401$20240814$20210611$20240909$EXP$$US-THERATECHNOLOGIES INC.-2021-THE-TES-000132$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
194014524$19401452$4$F$20090101$20240920$20210611$20240924$EXP$$GR-AMGEN-GRCSP2018117725$AMGEN$$62$YR$A$F$Y$$$20240924$$MD$GR$GR
194017904$19401790$4$F$20200620$20240910$20210611$20240913$EXP$$AR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-053101$BRISTOL MYERS SQUIBB$Trimarchi H, Gianserra R, Lampo M, Monkowski M, Lodolo J. Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome. Clinical Kidney Journal. 2021;13(5):739-41. doi:10.1093/ckj/sfaa166.$24$YR$A$M$Y$75$KG$20240913$$MD$AR$AR
194018674$19401867$4$F$$20240724$20210611$20240803$EXP$$CA-AUROBINDO-AUR-APL-2021-024017$AUROBINDO$$56$YR$$M$Y$$$20240803$$HP$CA$CA
194019715$19401971$5$F$20210601$20240816$20210610$20240821$EXP$$US-TAKEDA-US202016943$TAKEDA$$63$YR$$F$Y$54$KG$20240821$$HP$US$US
194025233$19402523$3$F$$20240708$20210610$20240716$EXP$$JP-TAKEDA-2021TUS036163$TAKEDA$$6$DEC$$M$Y$$$20240716$$MD$JP$JP
194028598$19402859$8$F$$20240906$20210610$20240912$EXP$$NVSC2021DE126218$NOVARTIS$$77$YR$$F$Y$$$20240912$$HP$DE$DE
1940288610$19402886$10$F$20210604$20240719$20210611$20240723$EXP$$JP-ABBVIE-21K-087-3944526-00$ABBVIE$$81$YR$$F$Y$49$KG$20240723$$MD$JP$JP
1940290116$19402901$16$F$20200824$20240816$20210611$20240825$EXP$$CA-CELLTRION INC.-2020CA022430$CELLTRION$$$$$$Y$$$20240826$$MD$CA$CA
194029216$19402921$6$F$20210608$20240703$20210610$20240705$EXP$$CA-TAKEDA-2021TUS036416$TAKEDA$$22$YR$$F$Y$$$20240705$$CN$CA$CA
1940313225$19403132$25$F$20170101$20240723$20210610$20240726$EXP$$NVSC2021MX127013$NOVARTIS$$$$$F$Y$83$KG$20240726$$CN$MX$MX
194038204$19403820$4$F$$20240911$20210611$20240924$EXP$$CA-APOTEX-2021AP013579$APOTEX$$51$YR$$F$Y$136$KG$20240924$$MD$CA$CA
194052683$19405268$3$F$20210202$20240916$20210611$20240924$EXP$$CA-TAKEDA-2021TUS036332$TAKEDA$$42$YR$$M$Y$$$20240924$$MD$CA$CA
1940583911$19405839$11$F$20210605$20240819$20210611$20240821$EXP$$US-GW PHARMA-202106USGW02827$JAZZ$$50$YR$$F$Y$$$20240821$$HP$US$US
194060596$19406059$6$F$20200901$20240821$20210611$20240827$EXP$$US-ABBVIE-21K-163-3937700-00$ABBVIE$$77$YR$$F$Y$96$KG$20240827$$CN$US$US
1940617112$19406171$12$F$20201012$20240701$20210611$20240703$EXP$$IN-PFIZER INC-2018508446$PFIZER$$53$YR$$F$Y$$$20240703$$CN$IN$IN
194065292$19406529$2$F$20210201$20240731$20210611$20240827$PER$$CA-TOLMAR, INC.-21CA027109$TOLMAR$$68$YR$$M$Y$$$20240827$$CN$CA$CA
194066047$19406604$7$F$20200301$20240801$20210611$20240809$EXP$$US-SA-2021SA193230$SANOFI AVENTIS$$62$YR$A$F$Y$74.8$KG$20240809$$MD$US$US
1940670811$19406708$11$F$20210714$20240620$20210612$20240710$PER$$CA-TOLMAR, INC.-21CA027616$TOLMAR$$52$YR$$M$Y$$$20240710$$MD$CA$CA
194068998$19406899$8$F$20230101$20240822$20210611$20240910$PER$$CA-TOLMAR, INC.-21CA027169$TOLMAR$$$$$M$Y$$$20240910$$CN$CA$CA
1940709214$19407092$14$F$$20240712$20210611$20240716$EXP$$US-TAKEDA-2021TUS029486$TAKEDA$$$$$F$Y$108$KG$20240716$$HP$US$US
194071397$19407139$7$F$20210201$20240910$20210611$20240918$EXP$$CA-TAKEDA-2021TUS035052$TAKEDA$$62$YR$$M$Y$99$KG$20240918$$CN$CA$CA
1940717213$19407172$13$F$20190916$20240726$20210611$20240730$EXP$$US-TAKEDA-US201930769$TAKEDA$$54$YR$$F$Y$$$20240730$$HP$US$US
194072313$19407231$3$F$$20240627$20210612$20240709$EXP$$GB-ROCHE-2845521$ROCHE$$$$A$M$Y$$$20240709$$CN$GB$GB
194073979$19407397$9$F$20210601$20240918$20210611$20240927$EXP$$CA-TAKEDA-2021TUS005770$TAKEDA$$19$YR$$M$Y$$$20240927$$HP$CA$CA
194075927$19407592$7$F$20180928$20240826$20210611$20240830$EXP$$CA-TAKEDA-2018TUS021184$TAKEDA$$54$YR$$M$Y$$$20240830$$CN$CA$CA
194080277$19408027$7$F$20200901$20240820$20210611$20240830$EXP$$US-VERTEX PHARMACEUTICALS-2021-008765$VERTEX$$11$YR$$F$Y$38$KG$20240830$$MD$US$US
194082773$19408277$3$F$$20240802$20210611$20240813$PER$$US-SA-2021SA183185$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240814$$CN$US$US
194085929$19408592$9$F$20160101$20240917$20210612$20240919$EXP$$PHHY2016CA151033$NOVARTIS$$37$YR$$F$Y$$$20240919$$HP$CA$CA
194098544$19409854$4$F$$20240724$20210614$20240803$EXP$$CA-AUROBINDO-AUR-APL-2021-024030$AUROBINDO$$$$$M$Y$$$20240803$$MD$CA$CA
1940992510$19409925$10$F$20230620$20240815$20210614$20240830$PER$$CA-TOLMAR, INC.-21CA027666$TOLMAR$$80$YR$$M$Y$$$20240829$$CN$CA$CA
1940992813$19409928$13$F$20210527$20240705$20210614$20240712$PER$$CA-TOLMAR, INC.-21CA027665$TOLMAR$$63$YR$$M$Y$$$20240712$$MD$CA$CA
194102332$19410233$2$F$$20240627$20210614$20240703$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003362$PAREXEL$$$$$$Y$$$20240703$$CN$US$US
1941046622$19410466$22$F$20200911$20240919$20210614$20240928$EXP$$CA-CELLTRION INC.-2020CA027985$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
194109563$19410956$3$F$$20240916$20210614$20240925$EXP$$CA-APOTEX-2021AP013846$APOTEX$$65$YR$$M$Y$$$20240925$$MD$CA$CA
194118776$19411877$6$F$$20240711$20210614$20240723$EXP$$US-GLAXOSMITHKLINE-US2021122675$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
1941192515$19411925$15$F$20210601$20220815$20210614$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR124680$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
194122353$19412235$3$F$20190101$20240708$20210614$20240711$EXP$$DE-SA-2021SA196061$SANOFI AVENTIS$$61$YR$A$F$Y$55$KG$20240711$$HP$DE$DE
1941260014$19412600$14$F$20230301$20240716$20210614$20240723$EXP$$CA-ROCHE-2845683$ROCHE$$60$YR$A$M$Y$81.65$KG$20240723$$CN$CA$CA
194126082$19412608$2$F$$20240815$20210614$20240820$EXP$$CA-009507513-2106CAN003183$MERCK$unknown. unknown. unknown$51$YR$$M$Y$$$20240820$$HP$CA$CA
194133419$19413341$9$F$20191001$20240712$20210614$20240801$EXP$$US-SA-2021SA194434$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240719$$MD$US$US
194133954$19413395$4$F$$20240723$20210614$20240812$PER$$CA-TOLMAR, INC.-21CA027023$TOLMAR$$$$$M$Y$$$20240812$$CN$CA$CA
1941392833$19413928$33$F$20210101$20240920$20210615$20240930$EXP$$CA-CELLTRION INC.-2021CA003190$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
1941449111$19414491$11$F$20210401$20240627$20210615$20240724$PER$$CA-TOLMAR, INC.-21CA027857$TOLMAR$$71$YR$$M$Y$$$20240724$$CN$CA$CA
194145177$19414517$7$F$$20240702$20210615$20240723$PER$$CA-TOLMAR, INC.-21CA027745$TOLMAR$$$$$M$Y$$$20240722$$CN$CA$CA
194147397$19414739$7$F$$20240905$20210614$20240918$EXP$$GB-ADVANZ PHARMA-202106004165$ADVANZ PHARMA$$$$$$Y$$$20240918$$HP$GB$GB
194156633$19415663$3$F$$20240215$20210615$20240919$PER$$IR-ROCHE-2845481$ROCHE$Farhadi R, Mehrpisheh S, Ghaffari V, Haghshenas M and Ebadi A Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report. Journal of Medical Case Reports 2021;15 (1):1-5.;Zamaniyan M, Ebadi A, Aghajanpoor S, Rahmani Z, Haghshenas M and Azizi S Preterm delivery, maternal death, and vertical transmission in a pregnant woman with COVID-19 infection. DOI:10.1002/pd.5713.. Prenatal Diagn$22$YR$A$F$Y$$$20240919$$MD$IR$IR
194162126$19416212$6$F$$20240820$20210614$20240822$EXP$$US-TAKEDA-2021TUS010730$TAKEDA$$$$$F$Y$$$20240822$$MD$US$US
194168064$19416806$4$F$20210611$20240906$20210615$20240913$EXP$$CA-GLAXOSMITHKLINE-CA2021AMR128446$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$CA$CA
1941747025$19417470$25$F$20210101$20240906$20210614$20240916$EXP$$CA-CELLTRION INC.-2021CA008070$CELLTRION$$$$$$Y$$$20240916$$CN$CA$CA
194178623$19417862$3$F$20210923$20240828$20210615$20240902$EXP$$CA-TAKEDA-2020TUS030190$TAKEDA$$46$YR$$M$Y$$$20240902$$MD$CA$CA
194179324$19417932$4$F$$20240902$20210615$20240913$EXP$DE-EMA-2021417AUTODUP1618624258764$DE-Accord-227660$ACCORD$$$$E$M$Y$$$20240913$$MD$DE$DE
194188788$19418878$8$F$20160819$20240805$20210615$20240814$EXP$$CA-ROCHE-2264736$ROCHE$$32$YR$A$F$Y$96$KG$20240814$$CN$CA$CA
194189277$19418927$7$F$20210817$20240923$20210615$20240924$EXP$$US-PFIZER INC-2021458258$PFIZER$$59$YR$$F$Y$$$20240924$$HP$US$US
194189584$19418958$4$F$$20240819$20210615$20240821$EXP$$US-PFIZER INC-2021350215$PFIZER$$65$YR$$M$Y$$$20240821$$CN$US$US
1941915621$19419156$21$F$20191218$20240715$20210615$20240722$EXP$$GB-ROCHE-2621393$ROCHE$$76$YR$E$M$Y$73.5$KG$20240722$$MD$GB$GB
194194784$19419478$4$F$20190901$20240912$20210615$20240914$EXP$$DE-Ipsen Biopharmaceuticals, Inc.-2021-14630$IPSEN$$68$YR$E$M$Y$78$KG$20240914$$CN$DE$DE
194195005$19419500$5$F$$20240716$20210615$20240718$PER$$US-PFIZER INC-2021295080$PFIZER$$82$YR$$F$Y$$$20240718$$MD$US$US
1941988316$19419883$16$F$$20240718$20210615$20240726$EXP$$US-TAKEDA-US201922405$TAKEDA$$$$$F$Y$90$KG$20240726$$HP$US$US
1941994312$19419943$12$F$20210101$20240803$20210616$20240808$EXP$$US-SA-2021SA195993$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240808$$MD$US$US
194208352$19420835$2$F$$20240911$20210616$20240925$EXP$AR-MLMSERVICE-20210525-2909212-1$AR-ALKEM LABORATORIES LIMITED-AR-ALKEM-2021-03384$ALKEM$Trimarchi H, Gianserra R, Lampo M, Monkowski M, et al.. SARS-CoV-2 and atypical hemolytic uremic syndrome. Clinical Kidney Journal. 2021;13(5):731-741$24$YR$$M$Y$75$KG$20240925$$MD$AR$AR
1942086915$19420869$15$F$20210101$20240717$20210616$20240725$EXP$$CA-CELLTRION INC.-2021CA003978$CELLTRION$$$$$$Y$$$20240725$$MD$CA$CA
194209642$19420964$2$F$20210605$20240718$20210615$20240724$EXP$$US-TAKEDA-2021TUS036850$TAKEDA$$29$YR$$F$Y$77$KG$20240724$$HP$US$US
194211226$19421122$6$F$20200601$20240723$20210615$20240725$EXP$$CA-PFIZER INC-2021634333$PFIZER$$45$YR$$M$Y$93$KG$20240725$$HP$CA$CA
194213732$19421373$2$F$20200410$20240801$20210616$20240805$EXP$PL-URPL-2-484-2020$PL-JNJFOC-20210614473$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$PL$PL
194218112$19421811$2$F$$20240701$20210616$20240709$EXP$$US-AUROBINDO-AUR-APL-2019-076416$AUROBINDO$Leung N, Eirin A, Irazabal Mv, Maddox De, Gunderson Hd, Fervenza Fc,et.al.. Acute Kidney Injury In Patients With Inactive Cytochrome P450 Polymorphisms. Renal Failure. 2009;31(8)::749-52.$58$YR$$M$Y$$$20240709$$HP$US$US
194218602$19421860$2$F$$20240701$20210616$20240708$EXP$$US-AUROBINDO-AUR-APL-2019-086700$AUROBINDO$CHAUDHRY M, TARNEJA N, GUNDALE A, ROA D, LEVEY R. BONE MARROW SUPPRESSION: A SIDE EFFECT OF CIPROFLOXACIN THERAPY. AMERICAN JOURNAL OF THERAPEUTICS. 2010;17(5):E167-E168$50$YR$$F$Y$$$20240708$$MD$US$US
194228992$19422899$2$F$$20240809$20210616$20240815$EXP$$CA-GLAXOSMITHKLINE-CA2021AMR126204$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$HP$CA$CA
194230878$19423087$8$F$20180101$20240829$20210616$20240902$EXP$$CA-TAKEDA-2018TUS017956$TAKEDA$$$$$F$Y$$$20240902$$HP$CA$CA
194231304$19423130$4$F$20210101$20211203$20210616$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-057109$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240905$$MD$JP$JP
194232694$19423269$4$F$$20240826$20210616$20240829$PER$$US-PFIZER INC-2021561298$PFIZER$$67$YR$$M$Y$$$20240829$$MD$US$US
194237675$19423767$5$F$$20240814$20210616$20240817$EXP$$US-TAKEDA-US202007826$TAKEDA$$$$$F$Y$$$20240817$$HP$US$US
194250404$19425040$4$F$20191001$20240910$20210617$20240913$EXP$$US-ROCHE-2781634$ROCHE$$54$YR$A$F$Y$$$20240913$$MD$US$US
194251442$19425144$2$F$20090123$20240724$20210617$20240806$EXP$$FR-AUROBINDO-AUR-APL-2021-024049$AUROBINDO$Descamps V, Ranger-Rogez S.. DRESS syndrome. Joint Bone Spine. 2014;81(1):15-21$62$YR$$M$Y$$$20240806$$MD$FR$FR
194253272$19425327$2$F$$20240701$20210617$20240708$EXP$$IT-AUROBINDO-AUR-APL-2021-024488$AUROBINDO$Tuccori M, Guidi B, Carulli G, Blandizzi C, Del Tacca M, Di Paolo M.. Severe thrombocytopenia and haemolytic anaemia associated wtih ciprofloxacin: a case report with fatal outcome. Platelets. 2008;19(5):384-387$30$YR$$M$Y$$$20240708$$HP$IT$IT
194254936$19425493$6$F$20200814$20240718$20210617$20240726$EXP$$DE-AUROBINDO-AUR-APL-2020-050693$AUROBINDO$$68$YR$$F$Y$$$20240726$$MD$DE$DE
194257717$19425771$7$F$20200727$20240821$20210616$20240828$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2020-13630$IPSEN$$61$YR$A$F$Y$$$20240828$$MD$CA$CA
194267332$19426733$2$F$20210601$20240919$20210617$20240930$PER$$US-SA-2021SA197333$SANOFI AVENTIS$$8$YR$C$M$Y$23.8$KG$20240930$$MD$US$US
194271413$19427141$3$F$20200331$20240807$20210617$20240813$EXP$$CA-TAKEDA-2020TUS015752$TAKEDA$$41$YR$$F$Y$$$20240813$$HP$CA$CA
194271622$19427162$2$F$$20240701$20210617$20240708$EXP$$US-AUROBINDO-AUR-APL-2019-082564$AUROBINDO$KELESIDIS T, CANSECO E. QUINOLONE-INDUCED HYPOGLYCEMIA: A LIFE-THREATENING BUT POTENTIALLY REVERSIBLE SIDE EFFECT. AMERICAN JOURNAL OF MEDICINE. 2010;123(2):E5-E6$65$YR$$F$Y$$$20240708$$MD$US$US
194273667$19427366$7$F$20210901$20220209$20210617$20240925$PER$$US-GLAXOSMITHKLINE-US2021127224$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
194275216$19427521$6$F$20210101$20240701$20210616$20240705$EXP$$US-JAZZ-2021-US-010576$JAZZ$$$$$F$Y$$$20240705$$CN$US$US
1942916110$19429161$10$F$20181005$20240724$20210617$20240731$EXP$$CO-TAKEDA-2018TUS020360$TAKEDA$$50$YR$$M$Y$65$KG$20240731$$CN$CO$CO
194296125$19429612$5$F$20190201$20240830$20210617$20240906$EXP$$JP-BIOGEN-2019BI00781840$BIOGEN$$51$YR$$F$Y$54$KG$20240906$$MD$JP$JP
194296828$19429682$8$F$20210101$20240708$20210617$20240710$PER$$US-PFIZER INC-2021324001$PFIZER$$66$YR$$F$Y$$$20240710$$CN$US$US
194303883$19430388$3$F$$20240822$20210617$20240826$EXP$$US-JAZZ-2021-US-010781$JAZZ$$$$$F$Y$$$20240826$$CN$US$US
194304153$19430415$3$F$$20240627$20210617$20240702$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003358$PAREXEL$$$$$$Y$$$20240702$$CN$US$US
194304707$19430470$7$F$20210707$20240913$20210617$20240923$EXP$$CA-TAKEDA-2021TUS037905$TAKEDA$$66$YR$$F$Y$$$20240923$$CN$CA$CA
194306353$19430635$3$F$20210208$20240726$20210618$20240730$PER$$US-ROCHE-2767087$ROCHE$$74$YR$E$F$Y$$$20240730$$PH$US$US
1943129721$19431297$21$F$20200417$20240806$20210618$20240814$EXP$$CA-CELLTRION INC.-2020CA020017$CELLTRION$$$$$$Y$$$20240814$$MD$CA$CA
194319602$19431960$2$F$$20240917$20210617$20240920$EXP$$CA-PFIZER INC-2021671974$PFIZER$$59$YR$$M$Y$$$20240920$$MD$CA$CA
194320664$19432066$4$F$20200705$20240706$20210617$20240711$EXP$$IN-PFIZER INC-2020464010$PFIZER$$80$YR$$F$Y$$$20240711$$CN$IN$IN
1943350310$19433503$10$F$$20240828$20210617$20240902$EXP$$IN-PFIZER INC-2020388947$PFIZER$$36$YR$$M$Y$$$20240902$$CN$IN$IN
194347953$19434795$3$F$20210120$20240711$20210617$20240720$EXP$$FR-AUROBINDO-AUR-APL-2021-025511$AUROBINDO$$51$YR$$F$Y$$$20240720$$HP$FR$FR
194357807$19435780$7$F$20200820$20240817$20210618$20240823$EXP$$CA-CELLTRION INC.-2020CA027129$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
194385582$19438558$2$F$$20240801$20210619$20240813$EXP$IT-MACLEODS PHARMACEUTICALS US LTD-MAC2021031524$IT-MACLEODS PHARMACEUTICALS US LTD-MAC2021031524$MACLEODS$Gallo M, Giampreti A, Eleftheriou G, Faraoni L, Gioia Contessa M, Butera R et al.Successful 40-hour delayed acetylcysteine treatment in a severe acetaminophen acute hepatitis.Clinical Toxicology.2021;59(6):559-60$$$$$Y$$$20240813$$HP$IT$IT
194388573$19438857$3$F$$20240813$20210619$20240828$EXP$$CA-HLS-202107701$HLS THERAPEUTICS$$23$YR$A$F$Y$$$20240828$$HP$CA$CA
194390326$19439032$6$F$20210605$20240625$20210619$20240709$EXP$$CA-ROCHE-2846798$ROCHE$$45$YR$A$F$Y$$$20240709$$CN$CA$CA
194392862$19439286$2$F$$20240807$20210619$20240820$EXP$$IT-Accord-228382$ACCORD$Gallo M, Giampreti A, Eleftheriou G, Faraoni L, Gioia Contessa M, Butera R et al. Successful 40-hour delayed acetylcysteine treatment in a severe acetaminophen acute hepatitis. Clinical Toxicology. 2021;59(6):559-60.$55$YR$A$F$Y$$$20240820$$HP$IT$IT
194393008$19439300$8$F$20220101$20240704$20210618$20240709$EXP$$CA-PFIZER INC-2019539308$PFIZER$$35$YR$$F$Y$$$20240709$$CN$CA$CA
194397703$19439770$3$F$$20240729$20210620$20240807$EXP$$CA-APOTEX-2021AP014102$APOTEX$$97$YR$$F$Y$81$KG$20240807$$CN$CA$CA
194398123$19439812$3$F$20210603$20240819$20210620$20240827$PER$$CA-TOLMAR, INC.-21CA027850$TOLMAR$$74$YR$$M$Y$$$20240827$$CN$CA$CA
194405564$19440556$4$F$20210101$20240626$20210621$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-001987$ACADIA PHARMACEUTICALS$$$$$F$Y$54$KG$20240722$$CN$US$US
1944057742$19440577$42$F$20201031$20240920$20210621$20240930$EXP$$CA-CELLTRION INC.-2020CA027956$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
194408494$19440849$4$F$20210501$20240620$20210621$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-002013$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240712$$CN$US$US
1944102712$19441027$12$F$20180830$20240917$20210621$20240930$EXP$$DE-ROCHE-2183622$ROCHE$$49$YR$A$F$Y$$$20240930$$CN$DE$DE
194415418$19441541$8$F$20100101$20240905$20210621$20240910$EXP$$US-ORGANON-O2106USA001582$ORGANON$$$$$F$Y$$$20240910$$MD$US$US
194416433$19441643$3$F$20030101$20240827$20210621$20240830$EXP$$US-ORGANON-O2106USA001589$ORGANON$$$$$F$Y$$$20240830$$LW$US$US
1944166412$19441664$12$F$19990101$20240820$20210621$20240822$EXP$$US-ORGANON-O2106USA001587$ORGANON$$$$$F$Y$$$20240822$$MD$US$US
194420952$19442095$2$F$20160101$20240819$20210621$20240821$EXP$$KR-BAYER-2021-158760$BAYER$Choi S, Lee JY, Bae JS, Song HK, Lee JH, Kim Y.. Reversible cerebral vasoconstriction syndrome associated with levonorgestrel-releasing intrauterine system. Brain Sciences. 2021;11(5):Article number 601$35$YR$A$F$Y$$$20240821$$MD$KR$KR
194428153$19442815$3$F$$20240910$20210621$20240918$EXP$$NVSC2021CA133037$NOVARTIS$$69$YR$$F$Y$$$20240919$$CN$CA$CA
194431932$19443193$2$F$$20240902$20210621$20240917$EXP$$US-SA-2021SA201480$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240917$$MD$US$US
194432946$19443294$6$F$20240410$20240904$20210621$20240909$EXP$$CA-TAKEDA-2021TUS037493$TAKEDA$$54$YR$$F$Y$$$20240909$$HP$CA$CA
1944384321$19443843$21$F$20211207$20240920$20210621$20240926$EXP$$CO-TAKEDA-2021TUS037194$TAKEDA$$42$YR$$M$Y$70$KG$20240926$$MD$CO$CO
194439775$19443977$5$F$$20240910$20210621$20240924$EXP$$CA-HLS-202107746$HLS THERAPEUTICS$$23$YR$A$F$Y$$$20240924$$HP$CA$CA
194443387$19444338$7$F$20220401$20240822$20210621$20240827$EXP$$US-TAKEDA-US201926837$TAKEDA$$55$YR$$F$Y$$$20240827$$HP$US$US
194447609$19444760$9$F$20200221$20240821$20210621$20240826$EXP$$CA-TAKEDA-2019TUS066698$TAKEDA$$57$YR$$F$Y$$$20240826$$HP$CA$CA
194450892$19445089$2$F$$20240730$20210622$20240813$EXP$$IT-AUROBINDO-AUR-APL-2021-025700$AUROBINDO$Gallo M, Giampreti A, EleftherioG, Faraoni L, Contessa MG, Butera R et all. Successful 40-hour delayed acetylcysteine treatment in a severe acetaminophen acute hepatitis.. Clinical toxycology. 2021;59(6):559-60$55$YR$$F$Y$$$20240813$$HP$IT$IT
194454522$19445452$2$F$$20240701$20210622$20240709$PER$$US-SA-2021SA202034$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240709$$MD$US$US
194455943$19445594$3$F$20180714$20240704$20210622$20240712$EXP$$PT-CELLTRION INC.-2019PT019406$CELLTRION$$$$$$Y$$$20240712$$MD$PT$PT
1944565616$19445656$16$F$$20240812$20210622$20240819$EXP$$CA-GLAXOSMITHKLINE-CA2021131086$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$MD$CA$CA
194462737$19446273$7$F$$20240624$20210622$20240717$PER$$CA-TOLMAR, INC.-21CA027793$TOLMAR$$$$$M$Y$$$20240717$$CN$CA$CA
194464672$19446467$2$F$20210614$20240711$20210622$20240718$30DAY$$US-GLAXOSMITHKLINE-US2021130465$GLAXOSMITHKLINE$$63$YR$$M$Y$$$20240718$$CN$US$US
194465152$19446515$2$F$20210101$20240724$20210622$20240801$PER$$US-SA-2021SA088098$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240801$$MD$US$US
194471526$19447152$6$F$20210601$20240730$20210622$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-002220$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240822$$CN$US$US
194478844$19447884$4$F$20201008$20240917$20210622$20240925$EXP$$CA-TAKEDA-2019TUS000775$TAKEDA$$62$YR$$F$Y$$$20240925$$CN$CA$CA
194482973$19448297$3$F$$20240807$20210622$20240819$30DAY$$US-GLAXOSMITHKLINE-US2021133150$GLAXOSMITHKLINE$$$$$M$Y$$$20240819$$CN$US$US
194484185$19448418$5$F$$20240830$20210622$20240905$EXP$$CA-TAKEDA-2021TUS033730$TAKEDA$$$$$M$Y$$$20240905$$CN$CA$CA
194484806$19448480$6$F$20200522$20240806$20210622$20240810$EXP$$CA-TAKEDA-2020TUS020590$TAKEDA$$59$YR$$F$Y$$$20240810$$HP$CA$CA
194489856$19448985$6$F$20210101$20240806$20210622$20240809$PER$$US-AMGEN-USASP2021092876$AMGEN$$42$YR$A$M$Y$68.027$KG$20240808$$HP$US$US
194490535$19449053$5$F$20210101$20240916$20210622$20240923$EXP$$US-GW PHARMA-202106USGW02994$JAZZ$$$$$$Y$$$20240923$$CN$US$US
194490703$19449070$3$F$$20240827$20210622$20240830$EXP$$DE-MYLANLABS-2021M1035609$MYLAN$Schlegel, U.. Combined High-dosage polychemotherapy as efficient single therapy of primary cerebral lymphomas.. Current Neurology. 1998;25 (7):297-303$59$YR$$F$Y$$$20240830$$MD$DE$DE
1944972711$19449727$11$F$20210604$20240715$20210622$20240722$EXP$$CO-TAKEDA-2021TUS039108$TAKEDA$$50$YR$$M$Y$71$KG$20240722$$CN$CO$CO
1944987215$19449872$15$F$20210222$20240905$20210622$20240911$EXP$$CA-TAKEDA-2020TUS049360$TAKEDA$$84$YR$$M$Y$$$20240911$$MD$CA$CA
194499972$19449997$2$F$20210515$20240721$20210622$20240730$PER$$US-SA-2021SA204533$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240730$$MD$US$US
1945017415$19450174$15$F$20210421$20240625$20210622$20240701$EXP$$CA-TAKEDA-2021TUS017122$TAKEDA$$35$YR$$F$Y$$$20240701$$HP$CA$CA
1945048814$19450488$14$F$20210608$20240923$20210622$20240928$EXP$$CO-TAKEDA-2021TUS006255$TAKEDA$$30$YR$$M$Y$91$KG$20240928$$CN$CO$CO
194508574$19450857$4$F$$20240920$20210622$20240925$EXP$$US-JAZZ-2019-US-015021$JAZZ$$$$$F$Y$$$20240925$$CN$US$US
1945088117$19450881$17$F$20210101$20240817$20210623$20240822$EXP$$US-SA-2021SA203743$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240822$$MD$US$US
194516553$19451655$3$F$$20240726$20210623$20240807$EXP$$CA-AUROBINDO-AUR-APL-2021-025865$AUROBINDO$$59$YR$$M$Y$80$KG$20240807$$HP$CA$CA
194519262$19451926$2$F$20210220$20240726$20210623$20240807$EXP$$FR-AUROBINDO-AUR-APL-2021-014879$AUROBINDO$$$$A$F$Y$$$20240807$$MD$FR$FR
194527592$19452759$2$F$$20240813$20210623$20240828$EXP$$DE-ASTELLAS-2021US022517$ASTELLAS$Topp MS, Duell J, Guijarro AMA, Odin M, Nielsen T, Rajeswaran A et al. Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma. Haematologica 2020;105:e256-60.$68$YR$E$M$Y$$$20240827$$HP$DE$DE
194528385$19452838$5$F$20160101$20240905$20210623$20240917$EXP$$GB-Accord-228555$ACCORD$Abbas A, Zheng C, van Nispen tot Pannerden C, Newsholme W, Hilton R. Primary toxoplasmosis complicated by possible IRIS 15 years after renal transplantation. Clinical Infection in Practice. 2020 Article Number 100021:7-8.$26$YR$A$M$Y$$$20240917$$HP$GB$GB
1945299517$19452995$17$F$20210326$20240724$20210623$20240730$EXP$$US-PFIZER INC-2021601832$PFIZER$$83$YR$$M$Y$100.7$KG$20240730$$CN$US$US
194530132$19453013$2$F$20210603$20240722$20210623$20240731$PER$$US-SA-2021SA205524$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240731$$MD$US$US
194533177$19453317$7$F$20210909$20240704$20210623$20240709$EXP$$CA-TAKEDA-2021TUS038572$TAKEDA$$24$YR$$F$Y$$$20240709$$MD$CA$CA
19454468126$19454468$126$F$20180101$20240910$20210623$20240924$EXP$$CA-PFIZER INC-2019070530$PFIZER$$71$YR$$F$Y$69$KG$20240924$$MD$CA$CA
194545536$19454553$6$F$$20240715$20210623$20240717$EXP$FR-AFSSAPS-PP20210635$FR-TAKEDA-2021TEU005289$TAKEDA$$55$YR$$M$Y$70$KG$20240717$$HP$FR$FR
194547098$19454709$8$F$$20240819$20210623$20240827$EXP$$US-TAKEDA-2021TUS038740$TAKEDA$$$$$M$Y$81.633$KG$20240827$$CN$US$US
1945472918$19454729$18$F$20211201$20240812$20210623$20240819$EXP$$US-TAKEDA-US202030030$TAKEDA$$75$YR$$F$Y$61$KG$20240819$$HP$US$US
1945482817$19454828$17$F$$20240820$20210623$20240823$EXP$$CA-GLAXOSMITHKLINE-CA2021GSK133817$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$CA$CA
1945485018$19454850$18$F$$20240819$20210623$20240821$EXP$$US-PFIZER INC-2020328086$PFIZER$$55$YR$$M$Y$81.646$KG$20240821$$CN$US$US
1945485513$19454855$13$F$20210101$20240712$20210623$20240718$EXP$$FR-BAUSCH-BL-2021-022008$BAUSCH AND LOMB$$55$YR$$M$Y$70$KG$20240718$$MD$FR$FR
194549534$19454953$4$F$$20240830$20210623$20240904$EXP$$CA-ANIPHARMA-2021-CA-000905$ANI$$65$YR$$F$Y$69$KG$20240904$$HP$CA$CA
194549987$19454998$7$F$20201001$20240905$20210623$20240910$EXP$$US-TAKEDA-2021TUS001380$TAKEDA$$5$YR$$F$Y$21$KG$20240910$$HP$US$US
1945513910$19455139$10$F$20210308$20240702$20210623$20240715$EXP$$NVSC2021IE137411$NOVARTIS$$19$MON$$F$Y$10.3$KG$20240715$$MD$IE$IE
194565502$19456550$2$F$$20240715$20210624$20240723$EXP$$CA-AUROBINDO-AUR-APL-2021-025839$AUROBINDO$$87$YR$$F$Y$$$20240723$$HP$CA$CA
194565736$19456573$6$F$$20240827$20210624$20240906$EXP$$CA-AUROBINDO-AUR-APL-2021-026328$AUROBINDO$$60$YR$$M$Y$$$20240906$$HP$CA$CA
194572043$19457204$3$F$20220101$20240722$20210624$20240731$EXP$$US-ROCHE-2856393$ROCHE$$80$YR$E$M$Y$72.57$KG$20240731$$CN$US$US
1945724410$19457244$10$F$20210519$20240924$20210624$20240927$EXP$$NVSC2021DE124361$NOVARTIS$$$$A$F$Y$57$KG$20240927$$MD$DE$DE
1945820612$19458206$12$F$20210131$20240829$20210624$20240905$EXP$$CO-TAKEDA-2021TUS008211$TAKEDA$$47$YR$$F$Y$67$KG$20240905$$CN$CO$CO
1945823311$19458233$11$F$20200826$20240705$20210624$20240712$EXP$$NVSC2020CA240907$NOVARTIS$$86$YR$$F$Y$$$20240712$$CN$CA$CA
194583362$19458336$2$F$$20240729$20210624$20240805$EXP$$CA-MYLANLABS-2021M1036029$MYLAN$$31$YR$$F$Y$$$20240805$$HP$CA$CA
1945860318$19458603$18$F$20210101$20240911$20210624$20240912$EXP$$CA-PFIZER INC-2021438746$PFIZER$$38$YR$$F$Y$$$20240912$$MD$CA$CA
194593485$19459348$5$F$$20240823$20210624$20240823$PER$$US-PFIZER INC-2021354487$PFIZER$$78$YR$$F$Y$76.2$KG$20240823$$CN$US$US
194595693$19459569$3$F$20210615$20240909$20210624$20240911$EXP$$US-TAKEDA-2021TUS039137$TAKEDA$$1$YR$$M$Y$$$20240911$$CN$US$US
194599335$19459933$5$F$$20240813$20210625$20240826$EXP$$CA-AUROBINDO-AUR-APL-2021-026132$AUROBINDO$$18$YR$$F$Y$$$20240826$$MD$CA$CA
194600153$19460015$3$F$$20231123$20210625$20240726$EXP$$CA-AstraZeneca-2021A549893$ASTRAZENECA$$68$YR$$M$Y$$$20240726$$MD$CA$
194602705$19460270$5$F$20160915$20220517$20210625$20240826$PER$$JP-AMGEN-JPNCT2021097079$AMGEN$$57$YR$A$F$Y$$$20240825$$MD$JP$JP
1946050811$19460508$11$F$20210101$20240715$20210625$20240725$EXP$$DE-ROCHE-2851578$ROCHE$$57$YR$A$F$Y$$$20240725$$CN$DE$DE
194607636$19460763$6$F$$20240822$20210625$20240910$PER$$AU-TOLMAR, INC.-21AU027642$TOLMAR$$$$$M$Y$$$20240910$$CN$AU$AU
194608007$19460800$7$F$20240101$20240916$20210625$20240924$PER$$CA-TOLMAR, INC.-21CA028128$TOLMAR$$$$$M$Y$$$20240924$$CN$CA$CA
1946085633$19460856$33$F$$20240830$20210625$20240909$EXP$$GB-AUROBINDO-AUR-APL-2018-057916$AUROBINDO$$29$YR$$M$Y$$$20240909$$MD$GB$GB
194611434$19461143$4$F$20210530$20240806$20210625$20240810$EXP$$BR-TAKEDA-2021TUS039408$TAKEDA$$51$YR$$F$Y$$$20240810$$CN$BR$BR
194613702$19461370$2$F$$20240813$20210625$20240823$EXP$$DE-TEVA-2021-DE-1926578$TEVA$Topp MS, Duell J, Guijarro AMA, Odin M, Nielsen T, Rajeswaran A et al. Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma. Haematologica. 2020;105:e256-60. doi:10.3324/haematol.2019.233189; Topp MS, Duell J, Guijarro AMA, Odin M, Nielsen T, Rajeswaran A et al. Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients ...$68$YR$$M$Y$$$20240823$$HP$DE$DE
194614274$19461427$4$F$$20220228$20210625$20240809$EXP$$CA-AstraZeneca-2021A538608$ASTRAZENECA$$53$YR$$F$Y$$$20240809$$MD$CA$
194616636$19461663$6$F$20210530$20240718$20210625$20240724$EXP$$US-KYOWAKIRIN-2021BKK010628$KYOWA$$$$$$Y$$$20240724$$HP$US$US
194617215$19461721$5$F$20191120$20240626$20210625$20240701$EXP$$CA-TAKEDA-2019TUS042345$TAKEDA$$43$YR$$F$Y$$$20240701$$CN$CA$CA
194624757$19462475$7$F$20190530$20240725$20210625$20240731$EXP$$JP-GILEAD-2020-0506213$GILEAD$$5$DEC$A$M$Y$$$20240731$$MD$JP$JP
194626347$19462634$7$F$$20240809$20210625$20240816$EXP$$CA-AstraZeneca-2021A538724$ASTRAZENECA$$60$YR$$M$Y$$$20240816$$MD$CA$
1946272110$19462721$10$F$20231102$20240726$20210625$20240801$EXP$$US-TAKEDA-2021TUS039352$TAKEDA$$59$YR$$F$Y$$$20240801$$CN$US$US
194645128$19464512$8$F$20210601$20220114$20210626$20240925$EXP$$US-GLAXOSMITHKLINE-US2021137179$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240925$$CN$US$US
194646835$19464683$5$F$20190101$20240911$20210626$20240918$PER$$US-SA-2021SA209391$SANOFI AVENTIS$$75$YR$E$F$Y$46.82$KG$20240918$$MD$US$US
194646928$19464692$8$F$20240627$20240822$20210626$20240830$EXP$$CA-TAKEDA-2021TUS014421$TAKEDA$$77$YR$$F$Y$$$20240830$$MD$CA$CA
194647652$19464765$2$F$20201015$20240822$20210627$20240903$EXP$$GB-AUROBINDO-AUR-APL-2021-026684$AUROBINDO$$40$YR$$F$Y$67$KG$20240903$$PH$GB$GB
194649242$19464924$2$F$$20240827$20210627$20240905$EXP$$CA-AUROBINDO-AUR-APL-2021-026341$AUROBINDO$$37$YR$$M$Y$$$20240905$$MD$CA$CA
1946499214$19464992$14$F$$20240917$20210626$20240923$EXP$$US-SHIRE-US201924317AA$TAKEDA$$$$$F$Y$116$KG$20240923$$CN$US$US
194649936$19464993$6$F$20210526$20240625$20210626$20240703$EXP$$US-TAKEDA-2021TUS038586$TAKEDA$$65$YR$$M$Y$82$KG$20240703$$CN$US$US
194656433$19465643$3$F$$20240918$20210626$20240919$EXP$$DE-ROCHE-2856977$ROCHE$Ozdirik B, Jost-Brinkmann F, Savic LJ, Moh R, Tacke F, Ploner CJ, Roderburg C and Muller T Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review. Medicine 2021 Jun 18;100 (24):E26377-.$70$YR$E$F$Y$$$20240919$$HP$DE$DE
194659232$19465923$2$F$$20240821$20210625$20240824$PER$$US-AMGEN-USASP2021095054$AMGEN$$$$E$F$Y$$$20240824$$CN$US$US
194667318$19466731$8$F$20210610$20240704$20210628$20240723$PER$$CA-TOLMAR, INC.-21CA028068$TOLMAR$$72$YR$$M$Y$$$20240722$$CN$CA$CA
194670293$19467029$3$F$$20240717$20210628$20240718$EXP$$US-CIPLA LTD.-2021US04312$CIPLA$Menezes M, Orhurhu V, Quezado R, Shihab A.. Hematoma after a fluoroscopically guided sacroiliac joint injection: A case report. Interventional Pain Management Reports. 2021;5 (2):63 to 66$$$$$Y$$$20240718$$HP$US$US
194677978$19467797$8$F$$20211122$20210628$20240926$EXP$$US-GLAXOSMITHKLINE-US2021136057$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
194683579$19468357$9$F$20190101$20240821$20210628$20240902$EXP$$CA-TAKEDA-2019TUS011124$TAKEDA$$25$YR$$F$Y$$$20240902$$CN$CA$CA
194686582$19468658$2$F$$20210618$20210628$20240930$EXP$$GB-AKCEA THERAPEUTICS, INC.-2021IS001501$AKCEA THERAPEUTICS$$$$$$Y$$$20240930$$HP$GB$GB
194687939$19468793$9$F$20210801$20240829$20210628$20240904$PER$$US-PFIZER INC-2021578263$PFIZER$$57$YR$$F$Y$149.2$KG$20240904$$CN$US$US
1946899212$19468992$12$F$20210603$20240919$20210628$20240926$EXP$$CO-TAKEDA-2021TUS040150$TAKEDA$$26$YR$$F$Y$68$KG$20240926$$CN$CO$CO
1946902711$19469027$11$F$20210101$20240819$20210628$20240822$PER$$US-DSJP-DSU-2021-119418$DAIICHI$$$$$F$Y$96.8$KG$20240822$$CN$US$US
194692182$19469218$2$F$$20240819$20210628$20240822$EXP$$CA-BAUSCH-BL-2021-021374$BAUSCH AND LOMB$$54$YR$$F$Y$59$KG$20240822$$CN$CA$CA
194692499$19469249$9$F$$20240827$20210628$20240827$EXP$$CA-BAUSCH-BL-2021-021434$BAUSCH AND LOMB$$60$YR$$M$Y$$$20240827$$CN$CA$CA
194694046$19469404$6$F$$20220913$20210628$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR136036$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
194696233$19469623$3$F$$20240726$20210628$20240731$PER$$US-TAKEDA-2021TUS039761$TAKEDA$$$$$F$Y$59.41$KG$20240731$$CN$US$US
194696886$19469688$6$F$20210702$20240710$20210628$20240712$EXP$$CA-TAKEDA-2021TUS039973$TAKEDA$$76$YR$$F$Y$$$20240712$$CN$CA$CA
194697782$19469778$2$F$$20240821$20210628$20240822$EXP$$US-TAKEDA-US201935790$TAKEDA$$$$$F$Y$$$20240822$$CN$US$US
1946995512$19469955$12$F$20210805$20240919$20210628$20240925$EXP$$CA-TAKEDA-2021TUS040047$TAKEDA$$31$YR$$F$Y$$$20240925$$HP$CA$CA
194703058$19470305$8$F$20210706$20240807$20210628$20240809$EXP$$CA-TAKEDA-2021TUS039923$TAKEDA$$67$YR$$M$Y$$$20240809$$HP$CA$CA
194704146$19470414$6$F$$20240905$20210628$20240909$EXP$$US-PFIZER INC-2021531635$PFIZER$$63$YR$$M$Y$$$20240909$$CN$US$US
1947048135$19470481$35$F$20210203$20240909$20210629$20240917$EXP$$CA-CELLTRION INC.-2020CA029747$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
1947069415$19470694$15$F$20210621$20240902$20210628$20240909$EXP$$CO-TAKEDA-2021TUS039619$TAKEDA$$59$YR$$M$Y$84$KG$20240909$$CN$CO$CO
194707804$19470780$4$F$20210120$20240704$20210628$20240710$EXP$$FR-PFIZER INC-2021696315$PFIZER$$51$YR$$F$Y$$$20240710$$HP$FR$FR
194709444$19470944$4$F$20240701$20240801$20210628$20240805$EXP$$US-TAKEDA-2021TUS040027$TAKEDA$$53$YR$$F$Y$81$KG$20240805$$CN$US$US
194719824$19471982$4$F$$20240816$20210629$20240828$EXP$AU-MLMSERVICE-20210622-2960504-1$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-03940$ALKEM$Anderson M, Ying T, Wyburn K, Ferguson P, et.al. Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report. BMC Urology. 2021;21:87:1-6$75$YR$$M$Y$$$20240828$$MD$AU$AU
194721596$19472159$6$F$20190601$20240209$20210629$20240807$EXP$$NVSC2021CO121873$NOVARTIS$$58$YR$$F$Y$45$KG$20240807$$CN$CO$CO
194721777$19472177$7$F$20210101$20240704$20210629$20240709$EXP$$CA-Orion Corporation ORION PHARMA-21_00015010$ORION$$74$YR$E$M$Y$$$20240709$$MD$CA$
194742254$19474225$4$F$$20240731$20210630$20240807$EXP$$US-ROCHE-2859947$ROCHE$$74$YR$E$F$Y$$$20240807$$CN$US$US
1947436219$19474362$19$F$20210101$20240919$20210630$20240928$EXP$$CA-CELLTRION INC.-2021CA003890$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
194753565$19475356$5$F$$20240905$20210630$20240913$EXP$$CA-CELLTRION INC.-2021CA008630$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
1947574735$19475747$35$F$20210513$20240717$20210629$20240725$EXP$$CA-CELLTRION INC.-2021CA008402$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
194757784$19475778$4$F$$20240906$20210630$20240910$EXP$$JP-PFIZER INC-2021688629$PFIZER$Fujimoto, M.. A Case of Anaphylaxis Caused by Levofloxacin. Skin Research. 2020;19 (4):244-250$20$YR$$M$Y$$$20240910$$MD$JP$JP
194758816$19475881$6$F$$20240814$20210630$20240819$EXP$$AU-PFIZER INC-2021777631$PFIZER$Anderson, M.. Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report. BMC Urology. 2021;21(1):1-6$75$YR$$M$Y$$$20240819$$MD$AU$AU
1947689310$19476893$10$F$20210714$20240813$20210630$20240816$EXP$$CA-TAKEDA-2021TUS040611$TAKEDA$$62$YR$$M$Y$$$20240816$$CN$CA$CA
194778425$19477842$5$F$20240226$20240826$20210630$20240829$EXP$$US-TAKEDA-US201941283$TAKEDA$$55$YR$$F$Y$51$KG$20240829$$CN$US$US
194778544$19477854$4$F$$20240820$20210630$20240826$EXP$$DE-MYLANLABS-2021M1039037$MYLAN$Gruhn B et al.. Continuous complete molecular remission using three different monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with chemotherapy-refractory acute lymphoblastic leukemia... Bone Marrow Transplant.. 2019;54:543-44$$$I$$Y$$$20240826$$HP$DE$DE
1947785811$19477858$11$F$20210507$20240724$20210630$20240731$EXP$$DE-ROCHE-2858367$ROCHE$$45$YR$A$F$Y$$$20240731$$CN$DE$DE
194780177$19478017$7$F$$20240719$20210630$20240723$EXP$$US-PFIZER INC-2021743393$PFIZER$$71$YR$$F$Y$$$20240723$$CN$US$US
194780215$19478021$5$F$20130101$20240901$20210630$20240904$EXP$$US-PFIZER INC-2021746364$PFIZER$$57$YR$$M$Y$$$20240904$$CN$US$US
1947876816$19478768$16$F$20210210$20240704$20210630$20240709$EXP$$IN-PFIZER INC-2021087097$PFIZER$$54$YR$$F$Y$95$KG$20240709$$CN$IN$IN
194787747$19478774$7$F$20210101$20240703$20210630$20240709$EXP$$CA-PFIZER INC-2021070357$PFIZER$$74$YR$$M$Y$$$20240709$$CN$CA$CA
1947902514$19479025$14$F$20210605$20240715$20210630$20240719$EXP$$US-TAKEDA-US201916251$TAKEDA$$47$YR$$F$Y$84$KG$20240719$$CN$US$US
1947944410$19479444$10$F$20210611$20240919$20210630$20240930$EXP$$US-TAKEDA-US202004623$TAKEDA$$54$YR$$F$Y$56$KG$20240930$$CN$US$US
1947963615$19479636$15$F$20220516$20240731$20210630$20240807$EXP$$US-TAKEDA-2021TUS025417$TAKEDA$$54$YR$$F$Y$81$KG$20240807$$HP$US$US
194799282$19479928$2$F$20210607$20240813$20210630$20240829$PER$$US-BIOMARINAP-US-2021-137013$BIOMARIN$$$$$$Y$$$20240829$$CN$US$US
194800173$19480017$3$F$20210608$20240628$20210630$20240715$PER$$US-BIOMARINAP-US-2021-137049$BIOMARIN$$$$$$Y$$$20240715$$CN$US$US
194808295$19480829$5$F$20201124$20240911$20210701$20240921$EXP$$RO-AUROBINDO-AUR-APL-2021-026304$AUROBINDO$Petrescu C, Marian G, Sima CT, Dumitru CD, Focseneanu BD.. Psychiatric psychopathology in the context of multiple sclerosis ? diagnostic and therapeutic challenges. Psihiatru.ro.. 2021;64 (16):22-25$24$YR$$F$Y$$$20240921$$MD$RO$RO
194815417$19481541$7$F$$20240913$20210701$20240924$EXP$$PL-AUROBINDO-AUR-APL-2021-025457$AUROBINDO$Woron J, Siwek M. Chory na depresj? i z napadowym b?lem odbytu (proctalgia fugax) b?d?cym konsekwencj?  niekorzystnych interakcji lek?w.[Patient with depression and paroxysmal anal pain (proctalgia fugax), as a consequence of adverse drug interactions.]^. MEDYCYNA PRAKTYCZNA -PSYCHIATRIA.. 2021;80(3):57-59$26$YR$$M$Y$$$20240924$$MD$PL$PL
194822689$19482268$9$F$20220101$20240703$20210701$20240705$EXP$$US-PFIZER INC-2021382668$PFIZER$$80$YR$$F$Y$48.073$KG$20240705$$CN$US$US
194823753$19482375$3$F$20210301$20240912$20210701$20240926$PER$$US-SA-2021SA214291$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240926$$MD$US$US
194826042$19482604$2$F$$20240706$20210701$20240713$PER$$US-SA-2021SA213670$SANOFI AVENTIS$$$$A$F$Y$$$20240713$$MD$US$US
194826583$19482658$3$F$20210601$20240812$20210701$20240819$PER$$US-GLAXOSMITHKLINE-US2021139744$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240819$$MD$US$US
1948269113$19482691$13$F$20210616$20240624$20210701$20240701$EXP$$US-SA-2021SA214907$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240701$$MD$US$US
1948392714$19483927$14$F$20210106$20240819$20210701$20240823$EXP$$US-TAKEDA-2021TUS031839$TAKEDA$$81$YR$$F$Y$73$KG$20240823$$MD$US$US
1948420625$19484206$25$F$$20240627$20210701$20240705$EXP$$NVSC2021CA112987$NOVARTIS$$56$YR$$F$Y$$$20240705$$HP$CA$CA
1948472414$19484724$14$F$20210517$20240917$20210701$20240926$EXP$$NVSJ2021JP007656$NOVARTIS$$6$WK$$M$Y$5.2$KG$20240926$$MD$JP$JP
194850415$19485041$5$F$20200801$20240827$20210701$20240830$EXP$$IL-ABBVIE-21K-082-3968149-00$ABBVIE$$56$YR$$M$Y$112$KG$20240830$$MD$IL$IL
194875247$19487524$7$F$$20240712$20210702$20240716$EXP$$CA-TAKEDA-2015TUS016461$TAKEDA$$$$$M$Y$$$20240716$$CN$CA$CA
1948797310$19487973$10$F$20211126$20240920$20210702$20240925$EXP$$CA-TAKEDA-2021TUS040970$TAKEDA$$34$YR$$F$Y$$$20240925$$MD$CA$CA
1948818517$19488185$17$F$20210209$20240622$20210702$20240701$EXP$$US-TAKEDA-2021TUS038825$TAKEDA$$74$YR$$M$Y$$$20240701$$HP$US$US
194882472$19488247$2$F$20210202$20240714$20210702$20240718$EXP$$FR-PFIZER INC-2021667332$PFIZER$$62$YR$$M$Y$63$KG$20240718$$HP$FR$FR
194885196$19488519$6$F$20210222$20240621$20210702$20240709$EXP$$CN-ROCHE-2856623$ROCHE$$52$YR$A$F$Y$54$KG$20240701$$CN$CN$CN
194890872$19489087$2$F$20180904$20240726$20210703$20240803$EXP$$PT-AMGEN-PRTNI2021100326$AMGEN$$64$YR$A$F$Y$87$KG$20240803$$MD$PT$PT
194897234$19489723$4$F$20210216$20240701$20210704$20240708$EXP$$US-UCBSA-2021030473$UCB$$36$YR$$F$Y$70.31$KG$20240708$$HP$US$US
1949002525$19490025$25$F$20200101$20240718$20210705$20240726$EXP$$CA-CELLTRION INC.-2020CA022155$CELLTRION$$$$$$Y$$$20240727$$MD$CA$CA
194903569$19490356$9$F$20180515$20240808$20210705$20240820$EXP$$DE-AUROBINDO-AUR-APL-2021-027669$AUROBINDO$$47$YR$$F$Y$$$20240820$$MD$DE$DE
194905873$19490587$3$F$20220101$20240827$20210705$20240920$PER$$US-SA-2021SA218643$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240920$$MD$US$US
194905995$19490599$5$F$20210427$20240905$20210705$20240919$EXP$$FR-AUROBINDO-AUR-APL-2021-027744$AUROBINDO$$78$YR$$M$Y$68$KG$20240919$$HP$FR$FR
1949133110$19491331$10$F$20210627$20240723$20210705$20240729$EXP$$US-SA-2021SA218592$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240729$$MD$US$US
194928192$19492819$2$F$$20240821$20210705$20240904$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2021-04112$ALKEM$Pok PR, Mauras M, De Saint Leger MN, Kuhlmann E, et.al. Blood concentrations of clobazam and norclobazam in a lethal case involving clobazam, meprobamate and clorazepate. Leg Med. 2010;12:300-304$70$YR$$F$Y$$$20240904$$HP$CA$FR
1949355813$19493558$13$F$20220301$20230510$20210705$20240925$PER$$US-GLAXOSMITHKLINE-US2021141762$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
1949400716$19494007$16$F$20230110$20230707$20210705$20240926$PER$$US-GLAXOSMITHKLINE-US2021140775$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240926$$MD$US$US
1949415847$19494158$47$F$$20240521$20210705$20240805$EXP$$CA-GLAXOSMITHKLINE-CACH2021GSK000107$Haleon PLC$$36$YR$$F$Y$$$20240805$$HP$CA$CA
1949497017$19494970$17$F$20200301$20240729$20210706$20240806$EXP$$CA-CELLTRION INC.-2020CA021350$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
1949507622$19495076$22$F$20210626$20240904$20210706$20240912$EXP$$CA-CELLTRION INC.-2021CA009165$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
1949509024$19495090$24$F$20210101$20240911$20210706$20240919$EXP$$CA-CELLTRION INC.-2021CA009113$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
194954972$19495497$2$F$20180130$20240723$20210706$20240802$EXP$$PT-AUROBINDO-AUR-APL-2021-028554$AUROBINDO$$64$YR$$F$Y$87$KG$20240802$$MD$PT$PT
194955954$19495595$4$F$20210410$20240719$20210706$20240729$EXP$$GB-TEVA-2021-GB-1908892$TEVA$$65$YR$$M$Y$80$KG$20240729$$CN$GB$GB
194958694$19495869$4$F$20191225$20240624$20210706$20240705$EXP$$CA-ROCHE-2553478$ROCHE$$60$YR$A$F$Y$$$20240705$$CN$CA$CA
194972162$19497216$2$F$20210617$20240823$20210706$20240831$EXP$$US-AMNEAL PHARMACEUTICALS-2020-AMRX-00723$AMNEAL$$1$YR$$M$Y$17.098$KG$20240831$$CN$US$US
1949792512$19497925$12$F$20200628$20240722$20210706$20240729$EXP$$CA-TAKEDA-CA202007462$TAKEDA$$67$YR$$F$Y$56$KG$20240729$$CN$CA$CA
194981586$19498158$6$F$20190301$20240807$20210706$20240812$EXP$$US-SA-2017SA130862$SANOFI AVENTIS$$46$YR$A$M$Y$97.06$KG$20240812$$MD$US$US
194985036$19498503$6$F$$20240718$20210706$20240918$EXP$$CA-EXELIXIS-CABO-21039968$EXELIXIS$$47$YR$$M$Y$$$20240918$$MD$CA$CA
1949895464$19498954$64$F$20201001$20240924$20210707$20240930$EXP$$GB-Orion Corporation ORION PHARMA-21_00015106$ORION$$68$YR$E$F$Y$92$KG$20240930$$MD$GB$
194992083$19499208$3$F$$20240712$20210706$20240718$PER$$US-SA-2021SA212487$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240718$$CN$US$US
194993653$19499365$3$F$20211130$20240904$20210707$20240925$PER$$CA-TOLMAR, INC.-21CA028157$TOLMAR$$73$YR$$M$Y$$$20240925$$CN$CA$CA
195000343$19500034$3$F$$20240705$20210707$20240713$EXP$$RU-AUROBINDO-AUR-APL-2021-028765$AUROBINDO$Sharkov A, Dulac O, Gataullina S.. STXBP1 germline mutation and focal cortical dysplasia. Epileptic Disorders. 2021;23(1):143-147$2$YR$$M$Y$$$20240713$$HP$RU$RU
195002115$19500211$5$F$$20240630$20210706$20240704$EXP$$NVSC2021GB144429$NOVARTIS$$$$A$M$Y$$$20240704$$CN$GB$GB
195005864$19500586$4$F$20210423$20240724$20210706$20240801$EXP$$JP-ROCHE-2836742$ROCHE$$57$YR$A$M$Y$60$KG$20240801$$CN$JP$JP
195027415$19502741$5$F$$20240815$20210707$20240816$EXP$$US-TAKEDA-US202027192$TAKEDA$$$$$M$Y$$$20240816$$HP$US$US
1950398111$19503981$11$F$20201023$20240802$20210707$20240808$EXP$$CO-TAKEDA-CO202018040$TAKEDA$$43$YR$$M$Y$83$KG$20240808$$CN$CO$CO
1950458823$19504588$23$F$20200416$20240712$20210708$20240722$EXP$$CA-ROCHE-2489028$ROCHE$$11$YR$C$M$Y$42.3$KG$20240719$$HP$CA$CA
195052177$19505217$7$F$$20240827$20210707$20240830$EXP$$US-TAKEDA-US202008484$TAKEDA$$$$$F$Y$$$20240830$$MD$US$US
195052933$19505293$3$F$20210625$20240815$20210708$20240829$PER$$US-SA-2021SA223628$SANOFI AVENTIS$$35$YR$A$M$Y$104.32$KG$20240829$$MD$US$US
1950558510$19505585$10$F$20200725$20240830$20210708$20240906$EXP$$DE-ROCHE-2667359$ROCHE$$34$YR$A$F$Y$$$20240906$$CN$DE$DE
1950601926$19506019$26$F$20201123$20240725$20210708$20240801$EXP$$CA-CELLTRION INC.-2020CA031110$CELLTRION$$$$$$Y$$$20240801$$MD$CA$CA
195062063$19506206$3$F$20210101$20240705$20210708$20240718$PER$$US-SA-2021SA221877$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240718$$MD$US$US
195062824$19506282$4$F$20201001$20240815$20210708$20240821$EXP$$US-SA-2021SA224569$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240821$$MD$US$US
195063294$19506329$4$F$$20240819$20210708$20240823$EXP$$CA-BAYER-2021-167724$BAYER$$40$YR$A$F$Y$$$20240823$$HP$CA$CA
195069252$19506925$2$F$$20240708$20210708$20240716$EXP$$CA-AstraZeneca-2021A597625$ASTRAZENECA$$45$YR$$F$Y$$$20240716$$MD$CA$
195073883$19507388$3$F$20210227$20240630$20210708$20240709$EXP$$SG-JNJFOC-20210704767$JOHNSON AND JOHNSON$$73$YR$E$F$Y$50.2$KG$20240709$$MD$SG$SG
195078477$19507847$7$F$20210101$20240918$20210708$20240927$EXP$$US-ROCHE-2866001$ROCHE$$38$YR$A$F$Y$71.21$KG$20240927$$CN$US$US
195079474$19507947$4$F$20201015$20240725$20210708$20240731$EXP$$DE-MYLANLABS-2021M1039060$MYLAN$$$$E$F$Y$57$KG$20240731$$HP$DE$DE
195082727$19508272$7$F$20190918$20240708$20210708$20240715$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-113783$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$98$KG$20240715$$HP$PL$PL
195084827$19508482$7$F$$20220629$20210708$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR148259$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
195088393$19508839$3$F$$20240912$20210709$20240918$EXP$$DE-AUROBINDO-AUR-APL-2021-029113$AUROBINDO$Groll AH, Kolve H, Ehlert K, Paulussen M, Vormoor J.. Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2004;53(1):113-4$14$YR$$F$Y$48$KG$20240918$$HP$DE$DE
1950893212$19508932$12$F$20190208$20240912$20210709$20240921$EXP$$CA-CELLTRION INC.-2019CA019110$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
1950902720$19509027$20$F$20210620$20240717$20210708$20240725$EXP$$US-TAKEDA-2021TUS037676$TAKEDA$$86$YR$$M$Y$63$KG$20240725$$HP$US$US
1950907318$19509073$18$F$20201209$20240814$20210709$20240822$EXP$$CA-CELLTRION INC.-2020CA028473$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
195091823$19509182$3$F$$20240812$20210709$20240821$EXP$$CA-APOTEX-2021AP015647$APOTEX$$42$YR$$F$Y$$$20240821$$HP$CA$CA
195095989$19509598$9$F$20210701$20240618$20210709$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-002245$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240712$$CN$US$US
1950974628$19509746$28$F$20240108$20240830$20210708$20240904$EXP$$US-TAKEDA-US202018900$TAKEDA$$77$YR$$F$Y$75$KG$20240904$$HP$US$US
195101673$19510167$3$F$$20240829$20210709$20240906$EXP$$CA-APOTEX-2021AP014958$APOTEX$$72$YR$$M$Y$$$20240906$$HP$CA$CA
195101682$19510168$2$F$$20240820$20210709$20240830$EXP$$CA-APOTEX-2021AP015939$APOTEX$$55$YR$$M$Y$$$20240830$$HP$CA$CA
195103112$19510311$2$F$$20240910$20210709$20240920$EXP$$CA-APOTEX-2021AP015198$APOTEX$$58$YR$$F$Y$$$20240920$$HP$CA$CA
195110773$19511077$3$F$20150101$20240822$20210709$20240827$EXP$$US-JNJFOC-20210667016$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240827$$LW$US$US
195113245$19511324$5$F$$20240711$20210709$20240713$EXP$$US-ROCHE-2865331$ROCHE$$$$E$F$Y$$$20240713$$CN$US$US
195115047$19511504$7$F$20190101$20210910$20210709$20240709$EXP$$CO-ASTELLAS-2021US025034$ASTELLAS$$70$YR$$M$Y$$$20240709$$CN$CO$CO
1951175013$19511750$13$F$20190918$20240826$20210709$20240906$EXP$PL-002147023-NVSC2021PL140813$PL-STRIDES ARCOLAB LIMITED-2021SP007477$STRIDES$$62$YR$$M$Y$98$KG$20240906$$MD$PL$PL
195118556$19511855$6$F$20201116$20240726$20210709$20240801$EXP$$DE-MYLANLABS-2021M1038945$MYLAN$$$$E$F$Y$63$KG$20240801$$HP$DE$DE
195120533$19512053$3$F$20210501$20240628$20210709$20240703$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003411$PAREXEL$$$$$$Y$$$20240703$$HP$US$US
195121364$19512136$4$F$$20240806$20210709$20240816$EXP$$DE-SA-2021SA225234$SANOFI AVENTIS$$$$E$F$Y$$$20240816$$HP$DE$DE
1951214722$19512147$22$F$20200122$20240815$20210709$20240821$EXP$$DE-MYLANLABS-2021M1039063$MYLAN$$$$E$F$Y$64.8$KG$20240821$$MD$DE$DE
195131008$19513100$8$F$$20240807$20210709$20240812$PER$$US-PFIZER INC-2021785807$PFIZER$$71$YR$$F$Y$$$20240812$$HP$US$US
195135233$19513523$3$F$20210416$20240812$20210709$20240820$EXP$$DE-TAKEDA-2021TUS037441$TAKEDA$$29$YR$$F$Y$105$KG$20240820$$HP$DE$DE
195145122$19514512$2$F$20190430$20240627$20210710$20240702$EXP$$IT-AMGEN-ITANI2021102395$AMGEN$$38$YR$A$F$Y$60$KG$20240702$$MD$IT$IT
1951460612$19514606$12$F$20180515$20240813$20210709$20240820$EXP$$DE-PFIZER INC-2021819597$PFIZER$$47$YR$$F$Y$$$20240820$$MD$DE$DE
195146667$19514666$7$F$20191005$20240705$20210709$20240711$EXP$$CA-TAKEDA-2019TUS056196$TAKEDA$$14$YR$$M$Y$60$KG$20240711$$CN$CA$CA
195146873$19514687$3$F$20180101$20240820$20210709$20240822$EXP$$CA-PFIZER INC-2018094693$PFIZER$$63$YR$$M$Y$$$20240822$$CN$CA$CA
1951518910$19515189$10$F$20181001$20240712$20210709$20240716$EXP$$IN-PFIZER INC-2018433834$PFIZER$$36$YR$$M$Y$$$20240716$$CN$IN$IN
195153512$19515351$2$F$20210220$20240722$20210709$20240724$EXP$$FR-PFIZER INC-2021363690$PFIZER$$$$A$F$Y$$$20240724$$HP$FR$FR
195155462$19515546$2$F$20201201$20240921$20210709$20240926$EXP$$PL-BAUSCH-BL-2021-023615$BAUSCH AND LOMB$$49$YR$$M$Y$$$20240926$$MD$PL$PL
1951599010$19515990$10$F$$20210708$20210709$20240722$PER$$US-ASTELLAS-2021US017243$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
195160085$19516008$5$F$20210101$20210927$20210709$20240722$PER$$US-ASTELLAS-2021US017175$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
195160225$19516022$5$F$20191201$20220422$20210709$20240722$PER$$US-ASTELLAS-2021US016488$ASTELLAS$$64$YR$$M$Y$$$20240722$$CN$US$US
195160455$19516045$5$F$20210522$20211104$20210709$20240722$PER$$US-ASTELLAS-2021US019612$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
195160903$19516090$3$F$20210601$20210803$20210709$20240722$PER$$US-ASTELLAS-2021US022659$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
195161124$19516112$4$F$20210510$20210708$20210709$20240722$PER$$US-ASTELLAS-2021US022387$ASTELLAS$$87$YR$$M$Y$$$20240722$$CN$US$US
195161153$19516115$3$F$20210428$20210709$20210709$20240722$PER$$US-ASTELLAS-2021US022681$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
195161813$19516181$3$F$$20220405$20210709$20240722$PER$$US-ASTELLAS-2021US002431$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
195161955$19516195$5$F$20210101$20240129$20210709$20240722$PER$$US-ASTELLAS-2020US035025$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
195162073$19516207$3$F$$20210709$20210709$20240722$PER$$US-ASTELLAS-2021US022401$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
195162365$19516236$5$F$20210413$20210702$20210709$20240722$PER$$US-ASTELLAS-2021US021991$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
195163413$19516341$3$F$20210609$20210712$20210709$20240722$PER$$US-ASTELLAS-2021US022452$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
195163485$19516348$5$F$20201110$20210723$20210709$20240722$PER$$US-ASTELLAS-2021US013574$ASTELLAS$$82$YR$$M$Y$$$20240722$$MD$US$US
195165023$19516502$3$F$20200901$20221215$20210709$20240722$PER$$US-ASTELLAS-2020US036783$ASTELLAS$$72$YR$$F$Y$64.01$KG$20240722$$MD$US$US
195165413$19516541$3$F$20210629$20210913$20210709$20240722$PER$$US-ASTELLAS-2021US024580$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
195165853$19516585$3$F$$20210716$20210709$20240722$PER$$US-ASTELLAS-2021US024502$ASTELLAS$$$$$F$Y$$$20240722$$PH$US$US
195166043$19516604$3$F$20210613$20210820$20210709$20240722$PER$$US-ASTELLAS-2021US022965$ASTELLAS$$61$YR$$F$Y$64$KG$20240722$$MD$COUNTRY NOT SPECIFIED$US
195166215$19516621$5$F$$20210810$20210709$20240722$PER$$US-ASTELLAS-2021US023605$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
195166233$19516623$3$F$$20210810$20210709$20240722$PER$$US-ASTELLAS-2021US024082$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
195166686$19516668$6$F$20200323$20240808$20210709$20240815$EXP$$JP-ABBVIE-20P-087-3432618-00$ABBVIE$$56$YR$$M$Y$59$KG$20240815$$MD$JP$JP
195174313$19517431$3$F$$20220715$20210712$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-303093$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
195179022$19517902$2$F$20210509$20240708$20210712$20240715$EXP$$FR-AUROBINDO-AUR-APL-2021-028166$AUROBINDO$$60$YR$$M$Y$93$KG$20240715$$MD$FR$FR
195179712$19517971$2$F$20210202$20240720$20210712$20240731$EXP$$FR-AUROBINDO-AUR-APL-2021-029154$AUROBINDO$$62$YR$$M$Y$63$KG$20240731$$HP$FR$FR
195183952$19518395$2$F$$20240801$20210712$20240808$PER$$US-SA-2021SA224929$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240808$$MD$US$US
195188083$19518808$3$F$$20240715$20210712$20240724$EXP$$IT-ROCHE-2862695$ROCHE$$38$YR$A$F$Y$60$KG$20240724$$MD$IT$IT
195190003$19519000$3$F$20210601$20240703$20210712$20240712$PER$$US-SA-2021SA227016$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240712$$CN$US$US
195190462$19519046$2$F$20200601$20240911$20210712$20240917$PER$$US-SA-2021SA226592$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240918$$MD$US$US
195190853$19519085$3$F$20201201$20240909$20210712$20240920$EXP$$PL-ASTELLAS-2021US025102$ASTELLAS$$49$YR$A$M$Y$$$20240920$$MD$PL$PL
1951951430$19519514$30$F$$20240923$20210712$20240930$EXP$$CA-BAYER-2021-167750$BAYER$$43$YR$A$F$Y$97$KG$20240930$$HP$CA$CA
195196106$19519610$6$F$20201216$20240722$20210712$20240725$EXP$$CA-TAKEDA-2020TUS051946$TAKEDA$$70$YR$$F$Y$$$20240725$$CN$CA$CA
195201877$19520187$7$F$20210716$20240909$20210712$20240917$EXP$$CA-TAKEDA-2021TUS042940$TAKEDA$$67$YR$$M$Y$$$20240917$$CN$CA$CA
1952028310$19520283$10$F$20190101$20240807$20210712$20240814$EXP$$BR-TAKEDA-2021TUS006852$TAKEDA$$$$$F$Y$72$KG$20240814$$CN$BR$BR
195203643$19520364$3$F$20210325$20240823$20210712$20240903$EXP$$US-AMNEAL PHARMACEUTICALS-2021-AMRX-02592$AMNEAL$$51$YR$$F$Y$94.785$KG$20240903$$MD$US$US
195208203$19520820$3$F$20210201$20240716$20210712$20240718$EXP$$US-TAKEDA-2021TUS042963$TAKEDA$$48$YR$$F$Y$$$20240718$$CN$US$US
1952116812$19521168$12$F$20201111$20240810$20210712$20240816$EXP$$CO-TAKEDA-2020TUS050595$TAKEDA$$7$YR$$M$Y$20$KG$20240816$$CN$CO$CO
195229283$19522928$3$F$$20240816$20210713$20240822$PER$$US-BIOGEN-2019BI00801890$BIOGEN$$$$$M$Y$$$20240822$$CN$US$US
195236948$19523694$8$F$$20240917$20210712$20240924$EXP$$CA-ABBVIE-21K-028-3982799-00$ABBVIE$$67$YR$$F$Y$73$KG$20240924$$CN$CA$CA
195245902$19524590$2$F$20210618$20240821$20210713$20240828$EXP$$US-BEH-2021133711$CSL BEHRING$$89$YR$E$F$Y$$$20240828$$HP$US$US
195251612$19525161$2$F$$20240726$20210712$20240808$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-066036$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240808$$HP$CA$CA
195251738$19525173$8$F$20220429$20220615$20210712$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR147352$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
195265222$19526522$2$F$20210203$20240711$20210713$20240720$EXP$$FR-AUROBINDO-AUR-APL-2021-022047$AUROBINDO$$58$YR$$F$Y$$$20240720$$HP$FR$FR
195269717$19526971$7$F$20200622$20240710$20210713$20240715$EXP$$AT-ABBVIE-20K-009-3460577-00$ABBVIE$$72$YR$$M$Y$75$KG$20240715$$MD$AT$AT
1952804030$19528040$30$F$20220225$20240909$20210713$20240912$EXP$$US-TAKEDA-2021TUS039657$TAKEDA$$62$YR$$F$Y$85$KG$20240912$$MD$US$US
195283648$19528364$8$F$20160101$20240725$20210713$20240730$EXP$$CA-TAKEDA-2017TUS007549$TAKEDA$$$$$F$Y$$$20240730$$MD$CA$CA
195290953$19529095$3$F$20190903$20240701$20210713$20240703$EXP$$US-SHIRE-US201928993AA$TAKEDA$$19$YR$$M$Y$$$20240703$$HP$US$US
195299793$19529979$3$F$$20240708$20210713$20240712$EXP$$CA-APOTEX-2021AP016739$APOTEX$$45$YR$$F$Y$$$20240712$$CN$CA$CA
195302724$19530272$4$F$$20240701$20210713$20240702$PER$$US-AVEO ONCOLOGY-2021-AVEO-US003426$PAREXEL$$$$$$Y$$$20240702$$CN$US$US
195304823$19530482$3$F$20210801$20211102$20210713$20240925$PER$$US-GLAXOSMITHKLINE-US2021149304$GLAXOSMITHKLINE$$38$YR$$F$Y$$$20240925$$CN$US$US
195306352$19530635$2$F$$20220302$20210713$20240807$EXP$$CA-AstraZeneca-2021A597832$ASTRAZENECA$$$$$F$Y$$$20240807$$MD$CA$
1953131821$19531318$21$F$20190918$20240725$20210714$20240801$EXP$$PL-AUROBINDO-AUR-APL-2021-029367$AUROBINDO$$62$YR$$M$Y$98$KG$20240801$$MD$PL$PL
195343842$19534384$2$F$$20240702$20210714$20240710$EXP$$BR-AUROBINDO-09-AUR-09714$AUROBINDO$Bugni VM, Terreri MTSLRA, Nunes NAC, Len CA, Barbosa CMPL, Hilario MOE.. DRESS syndrome and juvenile systemic lupus erythematosus in a two year old girl. Revista Brasileira de Reumatologia (Brazilian Journal of Rheumatology). 2008;48:No.4:257-260$2$YR$$F$Y$$$20240710$$HP$BR$BR
195354345$19535434$5$F$20181116$20240726$20210713$20240801$EXP$$DE-MYLANLABS-2021M1040710$MYLAN$$$$E$F$Y$$$20240801$$MD$DE$DE
1953762311$19537623$11$F$20180601$20240911$20210713$20240924$EXP$$JP-ABBVIE-19P-087-2996101-00$ABBVIE$$48$YR$$M$Y$61$KG$20240924$$MD$JP$JP
195408312$19540831$2$F$20210221$20240719$20210713$20240726$EXP$$AU-ABBVIE-21K-008-3952982-00$ABBVIE$$9$YR$$F$Y$$$20240726$$CN$AU$AU
1954098130$19540981$30$F$20210101$20240806$20210714$20240813$EXP$$CA-CELLTRION INC.-2021CA008540$CELLTRION$$$$$$Y$$$20240813$$MD$CA$CA
195412836$19541283$6$F$$20240920$20210714$20240930$EXP$$PK-AMGEN-PAKSP2021106964$AMGEN$$13$YR$T$M$Y$$$20240930$$CN$PK$PK
195421133$19542113$3$F$20210502$20240913$20210714$20240924$EXP$$IT-AUROBINDO-AUR-APL-2021-029190$AUROBINDO$$47$YR$$M$Y$$$20240924$$MD$IT$IT
195435986$19543598$6$F$20220310$20240628$20210713$20240703$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003406$PAREXEL$$$$$$Y$$$20240703$$HP$US$US
195445699$19544569$9$F$$20240808$20210713$20240813$EXP$$US-SHIRE-US202023465$TAKEDA$$$$$F$Y$100$KG$20240813$$CN$US$US
195478323$19547832$3$F$20201025$20240720$20210714$20240730$EXP$$DE-AUROBINDO-AUR-APL-2021-029885$AUROBINDO$$61$YR$$M$Y$$$20240730$$MD$DE$DE
195497743$19549774$3$F$$20240807$20210714$20240808$EXP$$US-TAKEDA-2021TUS043858$TAKEDA$$$$$M$Y$$$20240808$$HP$US$US
195503722$19550372$2$F$20210101$20240906$20210715$20240912$EXP$$JP-ALXN-A202107730AA$ALEXION PHARMACEUTICALS$$44$YR$$F$Y$38.1$KG$20240912$$MD$JP$JP
195508169$19550816$9$F$20210813$20240626$20210715$20240705$EXP$$CA-TAKEDA-2021TUS043339$TAKEDA$$32$YR$$M$Y$$$20240705$$HP$CA$CA
1955137810$19551378$10$F$20210701$20230213$20210715$20240925$PER$$US-GLAXOSMITHKLINE-US2021150970$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240925$$CN$US$US
195515332$19551533$2$F$$20240719$20210715$20240802$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-303303$RANBAXY$Varghese A, Paul T, Kim H, Van Uum S, Vadas P, Azzola A. Effect of omalizumab  for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report. J Endocrine Soc. 2021;Apr-May 5 (S):A780$34$YR$$F$Y$$$20240802$$HP$CA$CA
195519524$19551952$4$F$20210501$20240718$20210715$20240722$EXP$$US-PUMA BIOTECHNOLOGY, LTD.-2021-PUM-US003423$PUMA$$$$$$Y$$$20240722$$HP$US$US
195523707$19552370$7$F$20230703$20240710$20210715$20240717$EXP$$CA-ROCHE-2867563$ROCHE$$47$YR$A$F$Y$119$KG$20240717$$CN$CA$CA
195525655$19552565$5$F$20210601$20240725$20210714$20240802$EXP$$US-SA-2021SA226514$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240802$$MD$US$US
195526574$19552657$4$F$20220101$20240726$20210714$20240807$PER$$US-SA-2021SA227826$SANOFI AVENTIS$$$$A$M$Y$$$20240807$$MD$US$US
195529438$19552943$8$F$20201224$20240824$20210715$20240827$EXP$$US-TAKEDA-2021TUS038962$TAKEDA$$27$YR$$F$Y$$$20240827$$HP$US$US
195529535$19552953$5$F$20210705$20240702$20210714$20240711$PER$$US-SA-2021SA228355$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240711$$MD$US$US
1955329150$19553291$50$F$20201001$20240916$20210714$20240924$EXP$$NVSC2021GB155461$NOVARTIS$$68$YR$$F$Y$92$KG$20240924$$MD$GB$GB
195559536$19555953$6$F$$20220304$20210714$20240925$PER$$US-GLAXOSMITHKLINE-US2021149276$GLAXOSMITHKLINE$$$$$F$Y$73.197$KG$20240925$$MD$US$US
195561863$19556186$3$F$$20240909$20210714$20240918$EXP$$NVSC2021SE157237$NOVARTIS$Hegerius A. Everolimus and osteonecrosis of the jaw (ONJ). WHO PHARMACEUTICALS NEWSLETTER. 2020;5:11-8$65$YR$$M$Y$$$20240918$$HP$SE$SE
195568786$19556878$6$F$20210101$20240911$20210715$20240918$EXP$$US-SHIRE-US202033083$TAKEDA$$$$$F$Y$$$20240918$$MD$US$US
1955736223$19557362$23$F$$20240918$20210715$20240927$EXP$$CA-PURDUE-USA-2021-0274962$PURDUE$$78$YR$$F$Y$93$KG$20240927$$MD$CA$CA
195592204$19559220$4$F$20200101$20240828$20210715$20240902$EXP$$US-KYOWAKIRIN-2021BKK012176$KYOWA$$$$$$Y$$$20240902$$HP$US$US
195608895$19560889$5$F$20201001$20211221$20210716$20240823$EXP$$BE-GLAXOSMITHKLINE-BE2021EME107756$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$BE$BE
195610824$19561082$4$F$20210101$20210709$20210716$20240702$EXP$$ES-NOVOPROD-828841$NOVO NORDISK$$55$YR$$M$Y$86$KG$20240702$$PH$ES$ES
195620449$19562044$9$F$20180319$20240625$20210714$20240712$EXP$$DE-ROCHE-2264299$ROCHE$$56$YR$A$F$Y$$$20240712$$CN$DE$DE
195630487$19563048$7$F$20190101$20240801$20210714$20240827$PER$$CA-TOLMAR, INC.-21CA027213$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
195631027$19563102$7$F$$20240806$20210714$20240828$PER$$CA-TOLMAR, INC.-21CA027256$TOLMAR$$$$$M$Y$$$20240828$$CN$CA$CA
195631528$19563152$8$F$20210101$20240720$20210714$20240723$PER$$US-PFIZER INC-2020488727$PFIZER$$77$YR$$F$Y$$$20240723$$CN$US$US
195637922$19563792$2$F$$20240912$20210716$20240923$PER$$US-SA-2021SA233899$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240923$$MD$US$US
195644232$19564423$2$F$$20240723$20210716$20240801$PER$$US-SA-2021SA232867$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240801$$MD$US$US
195644718$19564471$8$F$20200101$20240716$20210716$20240717$EXP$$IL-TAKEDA-2020TUS049995$TAKEDA$$$$A$F$Y$$$20240717$$HP$IL$IL
195646393$19564639$3$F$20210721$20240608$20210716$20240723$EXP$$CA-CELLTRION INC.-2021CA009638$CELLTRION$$$$$$Y$$$20240723$$CN$CA$CA
195650109$19565010$9$F$20210101$20240725$20210716$20240726$EXP$$US-PFIZER INC-2021753446$PFIZER$$5$YR$$M$Y$$$20240726$$CN$US$US
195651245$19565124$5$F$$20240814$20210714$20240821$EXP$$BR-TAKEDA-2021TUS043651$TAKEDA$$$$$F$Y$68$KG$20240821$$CN$BR$BR
1956664925$19566649$25$F$20200211$20240821$20210716$20240828$EXP$$MX-TAKEDA-MX202007299$TAKEDA$$9$YR$$M$Y$27$KG$20240828$$CN$MX$MX
195668318$19566831$8$F$20141010$20240916$20210716$20240927$EXP$$CA-ROCHE-2863229$ROCHE$$64$YR$A$F$Y$79$KG$20240927$$HP$CA$CA
195669614$19566961$4$F$$20240903$20210714$20240909$EXP$$CA-SHIRE-CA201935233AA$TAKEDA$$$$$M$Y$$$20240909$$CN$CA$CA
195670243$19567024$3$F$$20210907$20210714$20240730$EXP$$CA-AstraZeneca-2021A597867$ASTRAZENECA$$75$YR$$M$Y$$$20240730$$MD$CA$
195670276$19567027$6$F$$20240809$20210715$20240813$EXP$$CA-TAKEDA-2021TUS043876$TAKEDA$$$$$F$Y$$$20240813$$MD$CA$CA
1956706413$19567064$13$F$20210601$20240828$20210714$20240917$EXP$$US-SA-2021SA229928$SANOFI AVENTIS$$45$YR$A$M$Y$106.5$KG$20240917$$MD$US$US
195677773$19567777$3$F$$20210721$20210714$20240723$PER$$US-NOVOPROD-790408$NOVO NORDISK$$69$YR$$M$Y$$$20240723$$MD$US$US
195678265$19567826$5$F$20210601$20240731$20210716$20240806$PER$$US-BIOGEN-2021BI01025719$BIOGEN$$34$YR$$F$Y$$$20240806$$CN$US$US
195678782$19567878$2$F$20200101$20210105$20210714$20240723$PER$$US-NOVOPROD-777674$NOVO NORDISK$$74$YR$$F$Y$$$20240723$$CN$US$US
195679942$19567994$2$F$20210320$20210514$20210714$20240723$PER$$US-NOVOPROD-798511$NOVO NORDISK$$75$YR$$M$Y$$$20240723$$MD$US$US
195680837$19568083$7$F$20210813$20240910$20210716$20240918$EXP$$CA-TAKEDA-2021TUS044317$TAKEDA$$66$YR$$F$Y$$$20240918$$CN$CA$CA
195682772$19568277$2$F$20210519$20210520$20210714$20240723$PER$$US-NOVOPROD-816556$NOVO NORDISK$$81$YR$$M$Y$$$20240723$$CN$US$US
195683473$19568347$3$F$$20240701$20210715$20240708$PER$$US-AVEO ONCOLOGY-2021-AVEO-US003427$PAREXEL$$$$$$Y$$$20240708$$CN$US$US
1956855713$19568557$13$F$20230623$20240731$20210714$20240809$EXP$$US-JAZZ-2021-US-011862$JAZZ$$60$YR$$F$Y$$$20240809$$CN$US$US
195692357$19569235$7$F$20200601$20240715$20210716$20240722$EXP$$NVSC2020AR256199$NOVARTIS$$52$YR$$F$Y$$$20240722$$CN$AR$AR
195707316$19570731$6$F$$20240924$20210715$20240926$PER$$US-PFIZER INC-2019067132$PFIZER$$80$YR$$F$Y$$$20240926$$CN$US$US
195733223$19573322$3$F$$20240701$20210717$20240702$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003437$PAREXEL$$$$$$Y$$$20240702$$CN$US$US
1957345716$19573457$16$F$$20240923$20210717$20240927$EXP$$US-TAKEDA-2021TUS027347$TAKEDA$$$$$F$Y$50$KG$20240927$$HP$US$US
195734632$19573463$2$F$20060901$20240708$20210717$20240716$EXP$$ES-AUROBINDO-09-AUR-10105$AUROBINDO$Vives s, Batlle M, Montane E, Ribera J-M.. Rhabdomyolysis and renal failure secondary to interaction between simvastatin, ciclosporin A and risperidone in an allogeneic stem cell transplantation patient.. Medicina Clinica-Barc. 2008;131:17:676$54$YR$$M$Y$$$20240716$$HP$ES$ES
195736323$19573632$3$F$20171005$20240827$20210717$20240831$EXP$$US-SHIRE-US201726206$TAKEDA$$58$YR$$F$Y$$$20240831$$HP$US$US
195736395$19573639$5$F$20180101$20240807$20210717$20240810$EXP$$US-SHIRE-US201919338$TAKEDA$$65$YR$$F$Y$$$20240810$$CN$US$US
195736423$19573642$3$F$$20240814$20210717$20240820$EXP$$US-TAKEDA-2021TUS043335$TAKEDA$$$$$M$Y$$$20240820$$MD$US$US
195736729$19573672$9$F$20200811$20240730$20210717$20240801$EXP$$SE-TAKEDA-2021TUS041966$TAKEDA$$55$YR$$F$Y$$$20240801$$HP$SE$SE
195736787$19573678$7$F$20240329$20240918$20210717$20240923$EXP$$US-TAKEDA-2021TUS043779$TAKEDA$$59$YR$$F$Y$$$20240923$$CN$US$US
195737544$19573754$4$F$20171001$20240723$20210717$20240729$EXP$$FR-TAKEDA-FR201730711$TAKEDA$$62$YR$$F$Y$50$KG$20240729$$HP$FR$FR
195742113$19574211$3$F$$20240827$20210719$20240909$EXP$$US-AUROBINDO-AUR-APL-2021-029936$AUROBINDO$Ghayur A, Elahi Q, Patel C,Raj R.. Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy.. Endocrinology, Diabetes and Metabolism Case Reports.. 2021;2021(1):1-4.$68$YR$$M$Y$$$20240909$$MD$US$US
195745065$19574506$5$F$$20240710$20210719$20240730$PER$$AU-TOLMAR, INC.-21AU028709$TOLMAR$$$$$M$Y$$$20240729$$HP$AU$AU
195772814$19577281$4$F$$20240801$20210719$20240812$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-069347$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240812$$HP$CA$CA
1957735719$19577357$19$F$20210317$20240806$20210719$20240812$EXP$$US-TAKEDA-2021TUS026046$TAKEDA$$58$YR$$F$Y$$$20240812$$MD$US$US
195779136$19577913$6$F$20210101$20240830$20210719$20240905$EXP$$US-GW PHARMA-202107USGW03427$JAZZ$$$$$F$Y$80$KG$20240905$$MD$US$US
195779606$19577960$6$F$$20240827$20210719$20240902$EXP$$US-SHIRE-US201913151AA$TAKEDA$$$$$F$Y$$$20240902$$MD$US$US
1957803410$19578034$10$F$20200331$20240804$20210719$20240806$EXP$$US-TAKEDA-US202012113$TAKEDA$$73$YR$$F$Y$90$KG$20240806$$CN$US$US
195783382$19578338$2$F$20180121$20240712$20210720$20240722$EXP$$PT-CELLTRION INC.-2021PT009530$CELLTRION$$$$$$Y$$$20240722$$MD$PT$PT
195783846$19578384$6$F$20220128$20240807$20210719$20240809$EXP$$US-TAKEDA-US201903511$TAKEDA$$60$YR$$M$Y$117$KG$20240809$$CN$US$US
195786932$19578693$2$F$20240908$20240920$20210719$20240925$EXP$$US-TAKEDA-2021TUS044188$TAKEDA$$76$YR$$F$Y$$$20240925$$MD$US$US
195790492$19579049$2$F$20210401$20210528$20210719$20240717$PER$$US-NOVOPROD-818476$NOVO NORDISK$$56$YR$$M$Y$$$20240717$$CN$US$US
195797892$19579789$2$F$$20210129$20210719$20240717$PER$$US-NOVOPROD-781487$NOVO NORDISK$$$$E$F$Y$$$20240717$$MD$US$US
195797942$19579794$2$F$20210118$20210118$20210719$20240717$PER$$US-NOVOPROD-782046$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
195798022$19579802$2$F$20200807$20240827$20210720$20240904$EXP$$BG-CELLTRION INC.-2021BG002350$CELLTRION$$$$$$Y$$$20240904$$MD$BG$BG
195799592$19579959$2$F$$20210122$20210719$20240717$PER$$US-NOVOPROD-783830$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
195800312$19580031$2$F$$20210125$20210719$20240717$PER$$US-NOVOPROD-784177$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
195800722$19580072$2$F$$20240731$20210720$20240803$EXP$$PT-AUROBINDO-AUR-APL-2021-030374$AUROBINDO$Martins dos Santos G, Ilharco M, Bonito LM, et al.. Pustulose Exantem?tica Generalizada Aguda ? Um Caso Incomum.. Revista Online de Casos Cl?nicos em Medicina Interna.. 2021$68$YR$$F$Y$$$20240803$$MD$PT$PT
195802042$19580204$2$F$20210620$20240701$20210720$20240708$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003436$PAREXEL$$$$$$Y$$$20240708$$MD$US$US
195812799$19581279$9$F$20190901$20240726$20210719$20240801$EXP$$IN-INCYTE CORPORATION-2020IN013607$INCYTE$$$$$$Y$$$20240801$$CN$IN$IN
195817829$19581782$9$F$20180302$20240725$20210720$20240729$EXP$$CA-TAKEDA-2018TUS005739$TAKEDA$$67$YR$$F$Y$$$20240729$$CN$CA$CA
195827244$19582724$4$F$20210712$20240816$20210720$20240823$EXP$$AR-GLAXOSMITHKLINE-AR2021AMR153462$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$AR$AR
1958272627$19582726$27$F$20210101$20231227$20210720$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR152689$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
195827333$19582733$3$F$$20240703$20210720$20240708$EXP$$CA-PFIZER INC-2021862989$PFIZER$Sieffien, W.. Spinal myoclonus following spinal anaesthesia in a patient with restless legs syndrome.. Anesthesia Reports. 2021;9 (1):73-75$64$YR$$M$Y$$$20240708$$HP$CA$CA
195831847$19583184$7$F$20210112$20240826$20210720$20240910$EXP$$IL-ABBVIE-21K-082-3809483-00$ABBVIE$$81$YR$$M$Y$83$KG$20240910$$MD$IL$IL
195834983$19583498$3$F$$20210907$20210720$20240802$EXP$$CA-Covis Pharma GmbH-2021COV23274$COVIS PHARMA$$75$YR$E$M$Y$$$20240802$$CN$CA$CA
1958374317$19583743$17$F$20200226$20240724$20210720$20240730$EXP$$IN-PFIZER INC-2021087068$PFIZER$$76$YR$$F$Y$$$20240730$$CN$IN$IN
1958472023$19584720$23$F$20240819$20240905$20210720$20240909$EXP$$US-TAKEDA-2021TUS001452$TAKEDA$$79$YR$$F$Y$79$KG$20240909$$HP$US$US
1958492820$19584928$20$F$20210101$20240814$20210721$20240822$EXP$$CA-CELLTRION INC.-2020CA034798$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
195849357$19584935$7$F$20210615$20240729$20210720$20240801$EXP$$US-TAKEDA-2021TUS044079$TAKEDA$$75$YR$$M$Y$68$KG$20240801$$CN$US$US
1958680619$19586806$19$F$20190822$20240917$20210720$20240926$EXP$$CA-CELLTRION INC.-2019CA024211$CELLTRION$$$$$$Y$$$20240926$$CN$CA$CA
195873134$19587313$4$F$$20240717$20210721$20240723$EXP$$PT-AMGEN-PRTNI2021109054$AMGEN$$58$YR$A$F$Y$$$20240723$$MD$PT$PT
1958750513$19587505$13$F$20210127$20240904$20210721$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-016251$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$89.1$KG$20240917$$MD$JP$JP
195879655$19587965$5$F$$20240708$20210721$20240715$EXP$$CA-APOTEX-2021AP017815$APOTEX$$63$YR$$F$Y$79$KG$20240715$$HP$CA$CA
195883932$19588393$2$F$20160101$20240912$20210721$20240924$EXP$$EG-Accord-219333$ACCORD$Hashem HE, Ibrahim ZH. Atypical Presentation of Pediatric Systemic Lupus Erythematosus Complicated by Cryptococcal Meningitis. Case Rep Med. 2021 Feb 11;2021:6692767.$12$YR$T$F$Y$$$20240924$$MD$EG$EG
195886836$19588683$6$F$$20240816$20210721$20240820$PER$$US-PFIZER INC-2021344525$PFIZER$$68$YR$$M$Y$$$20240820$$MD$US$US
195887016$19588701$6$F$20221209$20240621$20210721$20240710$PER$$CA-TOLMAR, INC.-21CA027706$TOLMAR$$73$YR$$M$Y$$$20240710$$CN$CA$CA
195887674$19588767$4$F$$20240701$20210721$20240712$EXP$$JP-ROCHE-2873783$ROCHE$Mizuyama Y,  EP-18-8-1 A Case of Active Pulmonary Tuberculosis Developing during Preoperative Chemotherapy for HER2-Positive Breast Cancer.. The 29th Annual Meeting of The Japanese Breast Cancer Society(real meeting + on.. 2021;242:$68$YR$E$F$Y$$$20240712$$MD$JP$JP
1958876914$19588769$14$F$20210401$20240821$20210721$20240823$EXP$$JP-ABBVIE-21K-087-4000228-00$ABBVIE$$80$YR$$M$Y$56$KG$20240823$$MD$JP$JP
195890992$19589099$2$F$20201201$20240923$20210721$20240926$EXP$$PL-PFIZER INC-2021844173$PFIZER$$49$YR$$M$Y$$$20240926$$MD$PL$PL
195891813$19589181$3$F$20240701$20240724$20210721$20240726$EXP$$US-KYOWAKIRIN-2021BKK012408$KYOWA$$$$$$Y$$$20240726$$HP$US$US
195891822$19589182$2$F$$20240724$20210721$20240730$EXP$$US-KYOWAKIRIN-2021BKK012407$KYOWA$$$$$$Y$$$20240730$$HP$US$US
195896949$19589694$9$F$20200617$20240917$20210721$20240922$EXP$$JP-ABBVIE-21P-087-4001440-00$ABBVIE$$54$YR$$M$Y$64$KG$20240922$$MD$JP$JP
195899079$19589907$9$F$20171128$20240910$20210721$20240916$EXP$$CA-TAKEDA-2017TUS022226$TAKEDA$$46$YR$$M$Y$$$20240916$$HP$CA$CA
195899542$19589954$2$F$20200901$20240819$20210721$20240902$PER$$US-SA-2021SA237381$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240902$$CN$US$US
195908343$19590834$3$F$20240701$20240821$20210721$20240924$PER$$US-SA-2021SA234185$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240924$$CN$US$US
195908692$19590869$2$F$$20240724$20210721$20240801$PER$$US-SA-2021SA235718$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240801$$MD$US$US
195911004$19591100$4$F$20210716$20240722$20210721$20240725$EXP$$US-TAKEDA-2021TUS045514$TAKEDA$$9$YR$$M$Y$$$20240725$$CN$US$US
195912667$19591266$7$F$$20240719$20210721$20240807$PER$$CA-TOLMAR, INC.-21CA027390$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
195913274$19591327$4$F$20240716$20240716$20210721$20240717$EXP$$US-TAKEDA-US201936846$TAKEDA$$37$YR$$F$Y$$$20240717$$CN$US$US
195915712$19591571$2$F$20210505$20240702$20210721$20240710$PER$$US-INCYTE CORPORATION-2021IN005410$INCYTE$$$$$$Y$$$20240710$$CN$US$US
195917753$19591775$3$F$20210713$20240905$20210721$20240910$EXP$$US-JAZZ-2021-US-012835$JAZZ$$20$YR$$F$Y$$$20240910$$CN$US$US
195919633$19591963$3$F$20210706$20211004$20210722$20240820$EXP$$CA-AstraZeneca-2021A615702$ASTRAZENECA$$26709$DY$$M$Y$$$20240820$$MD$CA$
195920563$19592056$3$F$20200407$20240705$20210722$20240717$PER$$US-SA-2021SA238013$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240717$$MD$US$US
195924754$19592475$4$F$20131224$20240904$20210722$20240910$EXP$$US-JNJFOC-20210731021$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240910$$LW$US$US
195928958$19592895$8$F$20210101$20240711$20210722$20240720$EXP$$CA-CELLTRION INC.-2021CA009875$CELLTRION$$$$$$Y$$$20240720$$CN$CA$CA
195935012$19593501$2$F$$20240819$20210722$20240828$EXP$$CA-APOTEX-2021AP006250$APOTEX$$75$YR$$F$Y$$$20240828$$HP$CA$CA
195937212$19593721$2$F$$20240819$20210722$20240828$EXP$$CA-APOTEX-2021AP017758$APOTEX$$$$$M$Y$$$20240828$$CN$CA$CA
195942086$19594208$6$F$$20240722$20210722$20240731$PER$$US-SA-2021SA238877$SANOFI AVENTIS$$51$YR$A$F$Y$113.39$KG$20240731$$MD$US$US
195945024$19594502$4$F$$20240827$20210722$20240902$EXP$$CA-TAKEDA-2016TUS022925$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
195949233$19594923$3$F$20210701$20240918$20210722$20240926$EXP$$CA-TAKEDA-2021TUS044214$TAKEDA$$40$YR$$F$Y$$$20240926$$MD$CA$CA
195949589$19594958$9$F$20081107$20240627$20210722$20240701$EXP$$US-TAKEDA-US201942039$TAKEDA$$52$YR$$F$Y$66$KG$20240701$$HP$US$US
1959502213$19595022$13$F$20210522$20240816$20210722$20240823$EXP$$DE-PUMA BIOTECHNOLOGY, LTD.-2021-PUM-DE003909$PUMA$$$$$$Y$$$20240823$$HP$DE$DE
195950405$19595040$5$F$$20240805$20210722$20240813$EXP$$CO-INCYTE CORPORATION-2021IN006509$INCYTE$$$$$$Y$$$20240813$$CN$CO$CO
195951114$19595111$4$F$$20240705$20210723$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-002615$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
195952782$19595278$2$F$20240905$20240918$20210722$20240919$EXP$$US-KYOWAKIRIN-2021BKK012619$KYOWA$$$$$$Y$$$20240919$$HP$US$US
195957887$19595788$7$F$20130110$20240708$20210722$20240710$EXP$$JP-GILEAD-2015-0133986$GILEAD$$41$YR$A$M$Y$$$20240710$$MD$JP$JP
1959690115$19596901$15$F$20210708$20240823$20210723$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-071391$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$58.7$KG$20240904$$MD$JP$JP
195978699$19597869$9$F$20200729$20240704$20210723$20240711$EXP$$CA-JNJFOC-20210538721$JOHNSON AND JOHNSON$$39$YR$A$F$Y$73.094$KG$20240711$$HP$CA$CA
195982922$19598292$2$F$$20240828$20210723$20240906$EXP$$CA-APOTEX-2021AP020107$APOTEX$$$$$F$Y$$$20240906$$MD$CA$CA
1959858511$19598585$11$F$20210731$20211124$20210723$20240702$EXP$$US-DSJP-DSU-2021-123079$DAIICHI$$28$YR$$F$Y$65.306$KG$20240702$$CN$US$US
195997135$19599713$5$F$20191003$20240709$20210722$20240711$EXP$$US-TAKEDA-US201933049$TAKEDA$$65$YR$$F$Y$108$KG$20240711$$HP$US$US
195999003$19599900$3$F$$20240813$20210722$20240821$EXP$$CA-SA-2021SA240103$SANOFI AVENTIS$$80$YR$E$M$Y$89$KG$20240821$$CN$CA$CA
196026385$19602638$5$F$20210101$20240620$20210723$20240701$EXP$FR-EMA-DD-20210705-BISHT_P-153512$FR-INSMED, INC.-2021-08961-FR$INSMED$$$$$$Y$$$20240701$$MD$FR$FR
196026415$19602641$5$F$20210101$20240812$20210723$20240819$EXP$$US-PFIZER INC-2021376741$PFIZER$$75$YR$$F$Y$82.086$KG$20240819$$HP$US$US
1960267519$19602675$19$F$20160101$20240926$20210723$20240927$EXP$$US-PFIZER INC-2021605420$PFIZER$$85$YR$$F$Y$49.9$KG$20240927$$CN$US$US
196034484$19603448$4$F$$20240722$20210723$20240724$EXP$$CA-Orion Corporation ORION PHARMA-21_00015269$ORION$$52$YR$A$F$Y$$$20240724$$HP$CA$
196046894$19604689$4$F$$20240719$20210724$20240725$EXP$$US-TAKEDA-US202011088$TAKEDA$$$$$F$Y$56$KG$20240725$$CN$US$US
1960475227$19604752$27$F$20200319$20240729$20210724$20240805$EXP$$MX-TAKEDA-2021TUS006351$TAKEDA$$5$YR$$M$Y$12$KG$20240805$$CN$MX$MX
196056032$19605603$2$F$20210101$20240715$20210723$20240718$PER$$US-INCYTE CORPORATION-2021IN005762$INCYTE$$$$$$Y$$$20240718$$CN$US$US
196069116$19606911$6$F$20220101$20240724$20210725$20240801$PER$$US-AMGEN-USASP2021112257$AMGEN$$65$YR$A$F$Y$$$20240801$$HP$US$US
196069975$19606997$5$F$20210501$20240723$20210726$20240807$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-304470$RANBAXY$$73$YR$$M$Y$82.993$KG$20240807$$CN$US$US
196071906$19607190$6$F$20210101$20240617$20210726$20240702$EXP$FR-AFSSAPS-PP20210635$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-066861$ZYDUS PHARM$$$$$$Y$$$20240702$$MD$FR$FR
1960724130$19607241$30$F$20180701$20240909$20210726$20240917$EXP$$DE-ROCHE-2875564$ROCHE$$52$YR$A$F$Y$62$KG$20240917$$CN$DE$DE
196076603$19607660$3$F$$20220715$20210726$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-304691$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
196080032$19608003$2$F$20200501$20240806$20210726$20240811$EXP$$US-SA-2020SA117501$SANOFI AVENTIS$$70$YR$E$F$Y$76.5$KG$20240812$$MD$US$US
196082919$19608291$9$F$20190101$20240919$20210726$20240926$EXP$$US-BAYER-2021-178964$BAYER$$36$YR$A$F$Y$$$20240926$$CN$US$US
196083732$19608373$2$F$20210219$20240717$20210726$20240723$EXP$$DE-AMGEN-DEUSP2021112064$AMGEN$$$$$F$Y$$$20240723$$HP$DE$DE
196095112$19609511$2$F$$20210604$20210726$20240708$PER$$CA-TOLMAR, INC.-21CA027894$TOLMAR$$$$$M$Y$$$20240708$$CN$CA$CA
1960984413$19609844$13$F$20230403$20240801$20210726$20240806$EXP$$US-GW PHARMA-202107USGW03533$JAZZ$$18$YR$$F$Y$72.3$KG$20240806$$MD$US$US
196099822$19609982$2$F$20240101$20240711$20210726$20240715$EXP$$US-KYOWAKIRIN-2021BKK012614$KYOWA$$$$$$Y$$$20240715$$HP$US$US
196102094$19610209$4$F$20180526$20240815$20210726$20240819$EXP$$PHHY2018CA013995$NOVARTIS$$55$YR$$M$Y$$$20240819$$CN$CA$CA
196104288$19610428$8$F$$20240822$20210726$20240829$EXP$$US-TAKEDA-2021TUS045643$TAKEDA$$$$$M$Y$147$KG$20240829$$CN$US$US
196104653$19610465$3$F$20210101$20211012$20210726$20240722$EXP$$US-ORPHANEU-2021001671$RECORDATI$$$$$$Y$$$20240722$$CN$US$US
196106346$19610634$6$F$$20240828$20210726$20240905$EXP$$CA-APOTEX-2021AP020470$APOTEX$$66$YR$$F$Y$$$20240905$$HP$CA$CA
196114527$19611452$7$F$20220218$20240729$20210726$20240801$EXP$$CA-TAKEDA-2021TUS035639$TAKEDA$$71$YR$$F$Y$$$20240801$$CN$CA$CA
1961146013$19611460$13$F$20240419$20240619$20210726$20240701$PER$$US-PFIZER INC-2021075888$PFIZER$$78$YR$$F$Y$72.57$KG$20240701$$CN$US$US
196115115$19611511$5$F$20211201$20240730$20210726$20240802$PER$$US-PFIZER INC-2021890918$PFIZER$$60$YR$$F$Y$108.84$KG$20240802$$HP$US$US
1961215623$19612156$23$F$20201022$20240808$20210727$20240816$EXP$$CA-CELLTRION INC.-2020CA029570$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
1961354611$19613546$11$F$20210701$20230522$20210727$20240925$EXP$$US-GLAXOSMITHKLINE-US2021156363$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
196139412$19613941$2$F$$20240724$20210727$20240808$EXP$ES-EMA-DD-20201027-NEGI_N-123708$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-261507$RANBAXY$$64$YR$$F$Y$$$20240808$$HP$ES$ES
1961398167$19613981$67$F$20201001$20240924$20210727$20240930$EXP$$GB-MYLANLABS-2021M1045244$MYLAN$$68$YR$$F$Y$92$KG$20240930$$MD$GB$GB
1961452210$19614522$10$F$$20240714$20210727$20240715$EXP$$US-PFIZER INC-2017031811$PFIZER$$24$YR$$M$Y$$$20240715$$CN$US$US
196148272$19614827$2$F$$20240815$20210727$20240819$EXP$$CZ-MYLANLABS-2021M1044645$MYLAN$Kieslichova E Protus M, Nemcova D, Uchytilova E.. Single mutidrug resistant enterobacteriacae donor-derived infection in four solid organ transplant recipients. a case report.. BMC surg. 2019;19(1):111$32$YR$$M$Y$$$20240819$$HP$CZ$CZ
196154886$19615488$6$F$20200307$20240731$20210727$20240805$EXP$$US-ABBVIE-21K-163-4006190-00$ABBVIE$$51$YR$$F$Y$$$20240805$$MD$US$US
196160243$19616024$3$F$$20240724$20210727$20240731$EXP$$US-TAKEDA-2021TUS045907$TAKEDA$$$$$F$Y$$$20240731$$CN$US$US
196199634$19619963$4$F$20130101$20240722$20210727$20240801$EXP$$FR-JNJFOC-20170720478$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240802$$CN$FR$FR
196204752$19620475$2$F$20210708$20240724$20210728$20240726$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003458$PAREXEL$$$$$$Y$$$20240726$$CN$US$US
196226296$19622629$6$F$20181101$20240723$20210728$20240729$EXP$$CA-TAKEDA-2018TUS033440$TAKEDA$$57$YR$$F$Y$$$20240729$$MD$CA$CA
196236393$19623639$3$F$$20240822$20210729$20240903$EXP$$CA-AUROBINDO-AUR-APL-2018-049492$AUROBINDO$Hohl CM, Badke K, Zhao A, Wickham ME, Woo SA, Sivilotti MLA et al.. Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug Events. Academic Emergency Medicine. 2018;25(9):1015-1026$63$YR$$F$Y$$$20240903$$MD$CA$CA
196237237$19623723$7$F$20210725$20240827$20210728$20240902$EXP$$US-TAKEDA-2021TUS047154$TAKEDA$$29$YR$$M$Y$$$20240902$$PH$US$US
1962409323$19624093$23$F$20210624$20240909$20210729$20240917$EXP$$CA-CELLTRION INC.-2021CA009934$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
1962466817$19624668$17$F$20210801$20230331$20210729$20240926$PER$$US-GLAXOSMITHKLINE-US2021160072$GLAXOSMITHKLINE$$56$YR$$F$Y$168$KG$20240926$$HP$US$US
196248516$19624851$6$F$20200101$20240812$20210729$20240815$EXP$SE-002147023-NVSC2021SE133450$SE-ROCHE-2855741$ROCHE$Psaros Einberg A, Casswall TH, Arnell H, Nowak G, Mirazimi A, Sundin M and Fischler B Iatrogenic immunosuppression can lead to prolonged viral shedding and absent immune response to COVID-19. Acta Paediatrica, International Journal of Paediatrics 2021 Oct;110 (10):2810-1.$$$$F$Y$16.7$KG$20240815$$HP$SE$SE
196249505$19624950$5$F$$20240722$20210728$20240723$EXP$$CA-PFIZER INC-2021894423$PFIZER$$52$YR$$F$Y$$$20240723$$HP$CA$CA
196269774$19626977$4$F$20210325$20240723$20210729$20240727$EXP$$US-ROCHE-2878000$ROCHE$$71$YR$E$M$Y$$$20240727$$HP$US$US
1962801113$19628011$13$F$$20240805$20210729$20240814$EXP$$CA-BAYER-2021-183528$BAYER$$53$YR$A$M$Y$$$20240814$$HP$CA$CA
1962801420$19628014$20$F$20210618$20240813$20210728$20240817$EXP$$CO-TAKEDA-CO202019211$TAKEDA$$68$YR$$F$Y$70$KG$20240817$$HP$CO$CO
1962852221$19628522$21$F$20210801$20240814$20210729$20240820$EXP$$US-TAKEDA-2021TUS036434$TAKEDA$$57$YR$$F$Y$82$KG$20240820$$HP$US$US
196293656$19629365$6$F$$20240627$20210728$20240702$EXP$$CA-TAKEDA-2021TUS037371$TAKEDA$$$$$F$Y$$$20240702$$CN$CA$CA
196294106$19629410$6$F$20210902$20240829$20210729$20240902$EXP$$CA-TAKEDA-2020TUS023709$TAKEDA$$50$YR$$F$Y$$$20240902$$CN$CA$CA
196296663$19629666$3$F$$20240906$20210728$20240912$EXP$$US-GILEAD-2021-0541955$GILEAD$$78$YR$E$M$Y$$$20240912$$MD$US$US
196297885$19629788$5$F$$20240912$20210728$20240917$EXP$$US-PFIZER INC-2021895305$PFIZER$$64$YR$$F$Y$76.644$KG$20240917$$CN$US$US
196301047$19630104$7$F$20210101$20240820$20210729$20240823$EXP$$CO-TAKEDA-2021TUS025674$TAKEDA$$75$YR$$M$Y$80$KG$20240823$$CN$CO$CO
196301879$19630187$9$F$$20240926$20210728$20240930$EXP$$US-PFIZER INC-2021900860$PFIZER$$78$YR$$F$Y$$$20240930$$CN$US$US
196301902$19630190$2$F$$20240705$20210728$20240712$EXP$$PT-PFIZER INC-2021890005$PFIZER$$58$YR$$F$Y$$$20240712$$MD$PT$PT
196302312$19630231$2$F$$20240812$20210728$20240820$PER$$US-SA-2021SA243363$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
196303312$19630331$2$F$20210721$20240711$20210728$20240718$PER$$US-SA-2021SA244046$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240718$$MD$US$US
196305362$19630536$2$F$20210719$20240703$20210728$20240712$PER$$US-SA-2021SA244472$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240712$$MD$US$US
196307042$19630704$2$F$20230901$20240709$20210729$20240712$EXP$$US-KYOWAKIRIN-2021BKK012937$KYOWA$$$$$$Y$$$20240712$$HP$US$US
196307492$19630749$2$F$20240625$20240625$20210728$20240704$PER$$US-SA-2020SA265589$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240704$$MD$US$US
196308292$19630829$2$F$$20240913$20210729$20240926$EXP$$US-MYLANLABS-2021M1046794$AUROBINDO$Puing AG, Raghavan SS, Aleshin MA, Ho DY. Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis. Medical Mycology Case Reports. 2021;33:18-20$25$YR$$F$Y$$$20240926$$MD$US$US
196309852$19630985$2$F$20210727$20240815$20210729$20240822$EXP$$US-GLAXOSMITHKLINE-US2021161404$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
196310758$19631075$8$F$$20240821$20210729$20240903$EXP$03344059$CA-ICU MEDICAL, INC.-ICU2021CA00011$ICU MEDICAL$$80$YR$$M$Y$69$KG$20240903$$HP$CA$CA
1963367332$19633673$32$F$20210531$20240627$20210730$20240705$EXP$$CA-CELLTRION INC.-2021CA008235$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
196337563$19633756$3$F$20190101$20240806$20210729$20240812$EXP$$NVSC2021MX124791$NOVARTIS$$$$$F$Y$66$KG$20240812$$CN$MX$MX
196338692$19633869$2$F$20210701$20210726$20210730$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR161969$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240925$$CN$US$US
196341773$19634177$3$F$$20240906$20210729$20240913$EXP$$US-GILEAD-2021-0541922$GILEAD$$53$YR$A$F$Y$$$20240913$$MD$US$US
196347775$19634777$5$F$20200123$20240812$20210730$20240820$EXP$$FR-ABBVIE-20K-056-3487507-00$ABBVIE$$83$YR$$F$Y$58$KG$20240820$$MD$FR$FR
196349834$19634983$4$F$$20240912$20210730$20240920$EXP$$CA-CELLTRION INC.-2021CA009932$CELLTRION$$$$$$Y$$$20240920$$MD$CA$CA
196354415$19635441$5$F$$20240826$20210729$20240830$EXP$$CA-B.Braun Medical Inc.-2114426$B BRAUN$$80$YR$$M$Y$69$KG$20240830$$$CA$CA
1963544323$19635443$23$F$20210715$20240814$20210729$20240819$EXP$$CO-TAKEDA-CO202003635$TAKEDA$$35$YR$$M$Y$88$KG$20240819$$CN$CO$CO
196361394$19636139$4$F$$20240723$20210730$20240726$EXP$$NZ-GLAXOSMITHKLINE-NZ2021APC162450$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$NZ$NZ
196378048$19637804$8$F$20231201$20240813$20210729$20240819$EXP$$IN-PFIZER INC-2021902836$PFIZER$$60$YR$$M$Y$82$KG$20240819$$CN$IN$IN
196381664$19638166$4$F$20210101$20211014$20210730$20240914$EXP$$ZA-SA-2021SA152925$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240914$$MD$ZA$ZA
196381972$19638197$2$F$20210607$20240723$20210730$20240801$EXP$$DE-ROCHE-2876980$ROCHE$$42$YR$A$F$Y$$$20240801$$MD$DE$DE
196390173$19639017$3$F$20210713$20240730$20210729$20240812$PER$$US-SA-2021SA248390$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240812$$MD$US$US
1963913515$19639135$15$F$20210615$20240730$20210730$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061492$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$54.6$KG$20240807$$MD$JP$JP
196397248$19639724$8$F$20210701$20211124$20210730$20240926$EXP$$US-GLAXOSMITHKLINE-US2021158813$GLAXOSMITHKLINE$$61$YR$$F$Y$79.4$KG$20240926$$MD$US$US
196405512$19640551$2$F$20200101$20230710$20210729$20240715$PER$$US-PERRIGO-21US003741$PERRIGO$$$$$M$Y$88.435$KG$20240715$$CN$US$US
196420163$19642016$3$F$$20240819$20210730$20240822$PER$$US-PFIZER INC-2021598502$PFIZER$$53$YR$$F$Y$$$20240822$$HP$US$US
196423503$19642350$3$F$20210726$20240829$20210730$20240926$PER$$US-SA-2021SA251458$SANOFI AVENTIS$$41$YR$A$F$Y$102.05$KG$20240926$$MD$US$US
196424602$19642460$2$F$20180112$20240626$20210730$20240702$EXP$$BR-TAKEDA-2018TUS022578$TAKEDA$$61$YR$$F$Y$60$KG$20240702$$CN$BR$BR
196425353$19642535$3$F$$20240912$20210730$20240916$PER$$NVSC2021US162509$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
196445803$19644580$3$F$$20240812$20210802$20240829$PER$$CA-TOLMAR, INC.-21CA028743$TOLMAR$$$$$M$Y$$$20240829$$CN$CA$CA
196448702$19644870$2$F$$20240625$20210802$20240704$PER$$US-SA-2021SA250421$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240704$$CN$US$US
196464392$19646439$2$F$20230101$20240618$20210802$20240701$EXP$$US-TAKEDA-US201924028$TAKEDA$$$$$F$Y$$$20240701$$HP$US$US
196466049$19646604$9$F$20220206$20240731$20210802$20240802$EXP$$US-PFIZER INC-202100963343$PFIZER$$76$YR$$F$Y$40.82$KG$20240802$$CN$US$US
1964668618$19646686$18$F$20210315$20240826$20210802$20240902$EXP$$US-TAKEDA-2021TUS046770$TAKEDA$$49$YR$$M$Y$126$KG$20240902$$CN$US$US
196471262$19647126$2$F$20210528$20240919$20210802$20240924$EXP$CH-SM-2021-17098$CH-ROCHE-2879854$ROCHE$$68$YR$E$F$Y$70$KG$20240924$$PH$CH$CH
196473693$19647369$3$F$20210702$20240820$20210802$20240821$EXP$IT-MINISAL02-756343$IT-SAMSUNG BIOEPIS-SB-2021-17975$SAMSUNG BIOEPIS$$72$YR$E$F$Y$$$20240821$$MD$IT$IT
196474914$19647491$4$F$$20240716$20210802$20240718$PER$$US-PFIZER INC-2021504287$PFIZER$$43$YR$$F$Y$$$20240718$$CN$US$US
196475573$19647557$3$F$20240423$20240717$20210802$20240723$EXP$$CA-TAKEDA-2021TUS035754$TAKEDA$$81$YR$$F$Y$$$20240723$$MD$CA$CA
196476434$19647643$4$F$20210723$20240830$20210802$20240909$PER$$US-ORGANON-O2107USA002519$ORGANON$$18$YR$$F$Y$99.773$KG$20240909$$HP$US$US
1964864823$19648648$23$F$$20240909$20210802$20240913$EXP$$CA-MYLANLABS-2021M1045184$MYLAN$Farrell B, Merkley V, Thompson W. Managing polypharmacy in a 77-year-old woman with multiple prescribers.. CMAJ. 2013;185 (14):1240-1245$77$YR$$F$Y$$$20240913$$HP$CA$CA
196487825$19648782$5$F$$20240805$20210802$20240806$EXP$$US-TAKEDA-US201937505$TAKEDA$$$$$M$Y$$$20240806$$HP$US$US
1964881114$19648811$14$F$20201215$20240904$20210803$20240912$EXP$$CA-CELLTRION INC.-2020CA033417$CELLTRION$$$$$$Y$$$20240912$$MD$CA$CA
196496145$19649614$5$F$$20240710$20210802$20240712$PER$$US-PFIZER INC-2021767358$PFIZER$$78$YR$$M$Y$99.79$KG$20240712$$CN$US$US
196496838$19649683$8$F$20200101$20240905$20210803$20240914$EXP$$FR-CELLTRION INC.-2021FR010179$CELLTRION$Le M, Le Hingrat Q, Jaquet P, Wicky PH, Bunel V, Massias L et al.. Removal of Remdesivir^s Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19.. Antimicrobial Agents and Chemotherapy. 2020;64(11):E01521-20-$$$$$Y$$$20240914$$HP$FR$FR
196496854$19649685$4$F$$20240828$20210803$20240902$EXP$$CA-ROCHE-2876290$ROCHE$$48$YR$A$F$Y$70$KG$20240902$$HP$CA$CA
196517014$19651701$4$F$20210328$20240808$20210803$20240809$EXP$$US-TAKEDA-2021TUS048257$TAKEDA$$31$YR$$M$Y$$$20240809$$CN$US$US
196519372$19651937$2$F$20200101$20240827$20210803$20240830$EXP$FI-FIMEA-20213495$FI-BAYER-2021-183266$BAYER$$19$YR$A$M$Y$$$20240830$$CN$FI$FI
196519803$19651980$3$F$20200601$20240722$20210803$20240731$EXP$$GB-TEVA-2021-GB-1888642$TEVA$$39$YR$$F$Y$$$20240731$$MD$GB$GB
196520254$19652025$4$F$20210627$20240916$20210803$20240920$EXP$$US-TAKEDA-2021TUS034182$TAKEDA$$58$YR$$F$Y$70$KG$20240920$$MD$US$US
1965232426$19652324$26$F$$20240703$20210803$20240709$EXP$$US-TAKEDA-2021TUS021069$TAKEDA$$$$$F$Y$91$KG$20240709$$HP$US$US
196523332$19652333$2$F$20200501$20240729$20210803$20240805$EXP$$CA-TAKEDA-2020TUS014379$TAKEDA$$52$YR$$M$Y$$$20240805$$CN$CA$CA
196525343$19652534$3$F$20180401$20240816$20210803$20240828$PER$$US-SA-2021SA254759$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240828$$MD$US$US
196534942$19653494$2$F$$20210721$20210804$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-305634$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
196535007$19653500$7$F$$20240730$20210803$20240802$EXP$$NVSC2021CO169125$NOVARTIS$$$$$F$Y$$$20240802$$CN$CO$CO
196544552$19654455$2$F$$20240917$20210803$20240924$EXP$$NVSC2021CA168327$NOVARTIS$$$$$F$Y$$$20240924$$MD$CA$CA
1965449033$19654490$33$F$20210226$20240724$20210804$20240801$EXP$$CA-CELLTRION INC.-2020CA034165$CELLTRION$$$$$$Y$$$20240801$$MD$CA$CA
196559942$19655994$2$F$$20240816$20210804$20240829$PER$$US-SA-2021SA256820$SANOFI AVENTIS$$$$A$F$Y$$$20240829$$MD$US$US
196560162$19656016$2$F$$20240815$20210804$20240827$PER$$US-SA-2021SA255251$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240827$$CN$US$US
196560212$19656021$2$F$20190201$20240910$20210804$20240919$PER$$US-SA-2021SA256541$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240919$$HP$US$US
196562812$19656281$2$F$20210219$20240705$20210804$20240709$EXP$$DE-PFIZER INC-202100920185$PFIZER$$$$$F$Y$$$20240709$$HP$DE$DE
196568752$19656875$2$F$$20240723$20210804$20240801$PER$$US-SA-2021SA254016$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240801$$CN$US$US
196573092$19657309$2$F$$20240729$20210804$20240730$EXP$$NVSC2021PH175471$NOVARTIS$$$$$$Y$$$20240730$$CN$PH$PH
196574523$19657452$3$F$$20210929$20210804$20240712$EXP$$NVSC2021GB167202$NOVARTIS$$37$YR$$M$Y$$$20240712$$MD$GB$GB
196581532$19658153$2$F$20210101$20240821$20210805$20240905$PER$$US-SA-2021SA255843$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240905$$MD$US$US
196581624$19658162$4$F$20240601$20240802$20210805$20240808$PER$$US-SA-2021SA256995$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240808$$MD$US$US
1965826815$19658268$15$F$$20240912$20210804$20240918$EXP$$NVSC2021CA143482$NOVARTIS$$69$YR$$F$Y$$$20240919$$MD$CA$CA
1965841912$19658419$12$F$20191009$20240904$20210805$20240912$EXP$$US-AUROBINDO-AUR-APL-2021-033854$AUROBINDO$$54$YR$$F$Y$73.9$KG$20240912$$MD$US$US
1965850615$19658506$15$F$20200817$20240904$20210805$20240916$EXP$$US-AUROBINDO-AUR-APL-2021-033136$AUROBINDO$$76$YR$$M$Y$81$KG$20240916$$MD$US$US
196586192$19658619$2$F$20201026$20240709$20210805$20240711$EXP$$DE-ABBVIE-21K-062-4021450-00$ABBVIE$$43$YR$$F$Y$60$KG$20240711$$PH$DE$DE
196588194$19658819$4$F$20240723$20240802$20210804$20240807$EXP$$US-TAKEDA-2021TUS048389$TAKEDA$$78$YR$$M$Y$96$KG$20240807$$MD$US$US
196597342$19659734$2$F$20210701$20240828$20210804$20240912$PER$$US-SA-2021SA256072$SANOFI AVENTIS$$38$YR$A$F$Y$108.18$KG$20240912$$MD$US$US
1965991024$19659910$24$F$20170101$20240902$20210805$20240910$EXP$$CA-CELLTRION INC.-2017CA015117$CELLTRION$$$$$$Y$$$20240910$$CN$CA$CA
196613573$19661357$3$F$$20240906$20210805$20240916$30DAY$$US-GLAXOSMITHKLINE-US2021164766$GLAXOSMITHKLINE$$$$$M$Y$$$20240916$$CN$US$US
196619572$19661957$2$F$20180601$20230623$20210805$20240802$EXP$$US-Accord-207033$ACCORD$$43$YR$A$F$Y$99.79$KG$20240802$$LW$US$US
1966205612$19662056$12$F$20210101$20240904$20210805$20240905$EXP$$US-PFIZER INC-202100935351$PFIZER$$71$YR$$F$Y$69.388$KG$20240905$$HP$US$US
1966225413$19662254$13$F$20201018$20240801$20210805$20240806$EXP$$US-TAKEDA-US202026382$TAKEDA$$60$YR$$F$Y$122$KG$20240806$$HP$US$US
196624496$19662449$6$F$20160101$20240906$20210805$20240906$EXP$$US-PFIZER INC-2021847193$PFIZER$$65$YR$$F$Y$54.43$KG$20240906$$HP$US$US
196643835$19664383$5$F$20210701$20240911$20210805$20240913$EXP$$US-JAZZ-2021-US-013813$JAZZ$$26$YR$$M$Y$$$20240913$$CN$US$US
196648902$19664890$2$F$20190807$20231103$20210806$20240802$PER$$US-Accord-220436$ACCORD$$49$YR$A$F$Y$88$KG$20240802$$LW$US$US
196649363$19664936$3$F$20150701$20230721$20210806$20240802$EXP$$US-Accord-170513$ACCORD$$55$YR$A$F$Y$81.65$KG$20240802$$LW$US$US
196649392$19664939$2$F$20190101$20230721$20210806$20240802$EXP$$US-Accord-220459$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
196649452$19664945$2$F$20140711$20230728$20210806$20240802$EXP$$US-Accord-179971$ACCORD$$49$YR$A$F$Y$66.68$KG$20240802$$LW$US$US
196649542$19664954$2$F$20180101$20230721$20210806$20240802$PER$$US-Accord-220457$ACCORD$$55$YR$A$F$Y$$$20240802$$LW$US$US
196650254$19665025$4$F$20210727$20240610$20210806$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-002602$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240705$$CN$US$US
196655072$19665507$2$F$20180901$20231218$20210806$20240802$PER$$US-Accord-220442$ACCORD$$54$YR$A$F$Y$$$20240802$$LW$US$US
196655382$19665538$2$F$$20240916$20210806$20240930$EXP$US-MLMSERVICE-20210715-3000099-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-04776$ALKEM$Puing AG, Raghavan SS, Aleshin MA, Ho DY.. Hemophagocytic lymph histiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis. Medical Mycology Case Reports. 2021;33:18-20$25$YR$$F$Y$$$20240930$$MD$US$US
196655682$19665568$2$F$$20230915$20210806$20240802$PER$$US-Accord-220487$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
196655862$19665586$2$F$$20240402$20210806$20240802$PER$$US-Accord-220477$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
196657462$19665746$2$F$20161001$20230609$20210806$20240802$EXP$$US-Accord-204877$ACCORD$$59$YR$A$F$Y$68.95$KG$20240802$$LW$US$US
196657582$19665758$2$F$20200731$20231101$20210806$20240802$EXP$$US-Accord-220450$ACCORD$$37$YR$A$F$Y$$$20240802$$LW$US$US
196657742$19665774$2$F$20141001$20230616$20210806$20240802$EXP$$US-Accord-225115$ACCORD$$64$YR$A$F$Y$$$20240802$$LW$US$US
196658043$19665804$3$F$20210408$20240804$20210806$20240809$EXP$$IL-ABBVIE-21K-082-3876760-00$ABBVIE$$65$YR$$M$Y$78$KG$20240809$$MD$IL$IL
196659043$19665904$3$F$20210101$20240730$20210806$20240806$EXP$$US-BIOGEN-2021BI01035806$BIOGEN$$$$$F$Y$$$20240806$$HP$US$US
1966615432$19666154$32$F$20210101$20240828$20210806$20240906$EXP$$CA-CELLTRION INC.-2021CA008730$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
196665772$19666577$2$F$20210728$20210729$20210806$20240710$EXP$$CO-ASTELLAS-2021US029131$ASTELLAS$$$$$M$Y$$$20240710$$CN$CO$CO
196665782$19666578$2$F$$20210730$20210806$20240717$EXP$$PL-ASTELLAS-2021US029127$ASTELLAS$$$$$M$Y$1.2$KG$20240717$$HP$PL$PL
1966666351$19666663$51$F$20190716$20240812$20210806$20240816$EXP$$DE-MYLANLABS-2021M1048616$MYLAN$$79$YR$$F$Y$55$KG$20240816$$HP$DE$DE
1966693311$19666933$11$F$$20240919$20210806$20240926$EXP$$US-TAKEDA-US201938467$TAKEDA$$$$$F$Y$67$KG$20240926$$HP$US$US
1966696520$19666965$20$F$20230318$20240729$20210806$20240802$EXP$$CA-TAKEDA-2021TUS048927$TAKEDA$$69$YR$$F$Y$$$20240802$$HP$CA$CA
196670982$19667098$2$F$20181201$20230821$20210806$20240802$PER$$US-Accord-220456$ACCORD$$56$YR$A$F$Y$$$20240802$$LW$US$US
1966726810$19667268$10$F$$20240813$20210806$20240828$EXP$$US-ASTELLAS-2021US028062$ASTELLAS$$63$YR$A$M$Y$96.2$KG$20240823$$CN$US$US
196673762$19667376$2$F$20200101$20240909$20210806$20240920$EXP$$US-SA-2020SA022467$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240920$$MD$US$US
1966876913$19668769$13$F$20210201$20240821$20210806$20240910$PER$$CA-TOLMAR, INC.-21CA027514$TOLMAR$$76$YR$$M$Y$$$20240910$$CN$CA$CA
196691368$19669136$8$F$$20240716$20210806$20240717$EXP$$US-TAKEDA-US202015992$TAKEDA$$$$$F$Y$$$20240717$$HP$US$US
1966914227$19669142$27$F$20210101$20240731$20210806$20240805$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-083194$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$80$KG$20240805$$CN$ES$ES
196703402$19670340$2$F$20210204$20240503$20210806$20240806$EXP$$US-SAOL THERAPEUTICS-2021SAO00067$AMNEAL$$14$YR$$M$Y$29.478$KG$20240806$$MD$US$US
196704758$19670475$8$F$$20240912$20210806$20240924$EXP$$CA-APOTEX-2021AP028321$APOTEX$$75$YR$$F$Y$$$20240924$$HP$CA$CA
1967105313$19671053$13$F$20200415$20240918$20210806$20240925$EXP$$CA-TAKEDA-2020TUS018753$TAKEDA$$76$YR$$M$Y$$$20240925$$HP$CA$CA
196718646$19671864$6$F$20210301$20240805$20210806$20240815$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2021NBI04175$NEUROCRINE BIOSCIENCES$$73$YR$$F$Y$$$20240815$$HP$US$US
196728903$19672890$3$F$20191201$20211118$20210809$20240819$PER$$NVSC2021US155898$NOVARTIS$$23$YR$$F$Y$$$20240819$$CN$US$US
1967344241$19673442$41$F$20200623$20240904$20210809$20240913$EXP$$CA-CELLTRION INC.-2020CA022632$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
196737472$19673747$2$F$20140301$20230623$20210809$20240802$EXP$$US-Accord-169867$ACCORD$$61$YR$A$F$Y$90.72$KG$20240802$$LW$US$US
196737492$19673749$2$F$20151204$20230616$20210809$20240802$EXP$$US-Accord-169870$ACCORD$$54$YR$A$F$Y$114.76$KG$20240802$$LW$US$US
196745622$19674562$2$F$20200101$20240819$20210809$20240830$EXP$$US-NOVOPROD-835475$NOVO NORDISK$$65$YR$$M$Y$$$20240830$$CN$US$US
1967534217$19675342$17$F$20210501$20240809$20210809$20240816$EXP$$US-ABBVIE-21K-163-4029050-00$ABBVIE$$18$YR$$F$Y$61.2$KG$20240814$$MD$US$US
196753443$19675344$3$F$20210802$20240722$20210809$20240726$EXP$$US-SA-2021SA258695$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240726$$MD$US$US
196758555$19675855$5$F$$20210817$20210809$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR167039$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
196770137$19677013$7$F$20210901$20240801$20210809$20240806$EXP$$US-KYOWAKIRIN-2021BKK013396$KYOWA$$$$$$Y$$$20240806$$CN$US$US
196776852$19677685$2$F$20240601$20240731$20210809$20240812$EXP$$US-ROCHE-2882958$ROCHE$$83$YR$E$F$Y$$$20240812$$CN$US$US
196783402$19678340$2$F$$20240916$20210810$20240925$EXP$$CA-ROCHE-2882810$ROCHE$$64$YR$A$F$Y$100$KG$20240925$$HP$CA$CA
196786646$19678664$6$F$$20240828$20210809$20240830$PER$$US-PFIZER INC-2021800153$PFIZER$$34$YR$$F$Y$$$20240830$$HP$US$US
196793427$19679342$7$F$20210701$20211210$20210810$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR165469$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
196808797$19680879$7$F$20210730$20220222$20210810$20240712$EXP$$NVSC2021CA176734$NOVARTIS$$75$YR$$M$Y$$$20240712$$CN$CA$CA
196817304$19681730$4$F$$20240911$20210810$20240916$EXP$$IT-MYLANLABS-2021M1048719$MYLAN$Pro S, Ursitti F, Pruneddu GL, Di Capua M, Valeriani M. Childhood Onset Multifocal Motor Neuropathy with IgM Antibodies to Gangliosides GM1: A Case Report with Poor Outcome. Neuropediatrics. 2021$13$YR$$F$Y$$$20240916$$MD$IT$IT
1968190317$19681903$17$F$20200707$20240830$20210810$20240903$EXP$$US-TAKEDA-US202021861$TAKEDA$$72$YR$$F$Y$$$20240903$$CN$US$US
196820993$19682099$3$F$$20240710$20210811$20240715$EXP$$US-BIOGEN-2021BI01032413$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
1968216727$19682167$27$F$20210723$20240920$20210811$20240930$EXP$$CA-CELLTRION INC.-2020CA035127$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
196822299$19682229$9$F$20211026$20240801$20210810$20240806$EXP$$US-TAKEDA-US202012999$TAKEDA$$57$YR$$F$Y$$$20240806$$HP$US$US
196825802$19682580$2$F$20200901$20240822$20210810$20240827$EXP$$US-TAKEDA-US201835725$TAKEDA$$47$YR$$F$Y$$$20240827$$MD$US$US
196825834$19682583$4$F$20211001$20220601$20210811$20240925$PER$$US-GLAXOSMITHKLINE-US2021165523$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
196825928$19682592$8$F$20231201$20240913$20210810$20240923$EXP$$US-TAKEDA-US202014638$TAKEDA$$41$YR$$M$Y$63.5$KG$20240923$$HP$US$US
1968275913$19682759$13$F$20211004$20240801$20210810$20240806$EXP$$CA-TAKEDA-2021TUS023856$TAKEDA$$58$YR$$F$Y$$$20240806$$HP$CA$CA
1968315526$19683155$26$F$20210101$20240918$20210811$20240927$EXP$$CA-CELLTRION INC.-2021CA010755$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
1968397824$19683978$24$F$20210101$20240909$20210811$20240917$EXP$$CA-CELLTRION INC.-2021CA003763$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
1968412221$19684122$21$F$20210513$20240805$20210811$20240812$EXP$$CA-CELLTRION INC.-2021CA008357$CELLTRION$$$$$$Y$$$20240812$$HP$CA$CA
196844226$19684422$6$F$20210605$20240710$20210811$20240710$EXP$$ES-ROCHE-2886353$ROCHE$$40$YR$A$M$Y$89$KG$20240710$$MD$ES$ES
196845765$19684576$5$F$20161226$20240814$20210811$20240814$EXP$$CA-PFIZER INC-2017270136$PFIZER$$69$YR$$F$Y$54.422$KG$20240814$$HP$CA$CA
196848115$19684811$5$F$$20240813$20210811$20240823$EXP$$CA-APOTEX-2021AP028673$APOTEX$$60$YR$$M$Y$$$20240823$$HP$CA$CA
1968506911$19685069$11$F$20170615$20240731$20210811$20240805$EXP$$PHHY2017CO093869$NOVARTIS$$50$YR$$F$Y$$$20240805$$CN$CO$CO
196852649$19685264$9$F$20201117$20240913$20210811$20240920$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR005089$AEGERION$$41$YR$$F$Y$60.3$KG$20240920$$MD$US$US
196854744$19685474$4$F$$20240921$20210811$20240926$EXP$$CA-ROCHE-2883277$ROCHE$$57$YR$A$M$Y$$$20240926$$HP$CA$CA
1968578610$19685786$10$F$$20240828$20210811$20240901$EXP$$US-TAKEDA-2021TUS049865$TAKEDA$$$$$M$Y$78$KG$20240901$$MD$US$US
196867442$19686744$2$F$$20240815$20210811$20240820$EXP$$CA-009507513-2108CAN002277$MERCK$$79$YR$$F$Y$93$KG$20240820$$PH$CA$CA
196870114$19687011$4$F$20210301$20240817$20210811$20240821$EXP$$NVSC2021EG180248$NOVARTIS$$27$YR$$M$Y$$$20240821$$CN$EG$EG
196872203$19687220$3$F$$20240703$20210811$20240708$PER$$US-PFIZER INC-202100963228$PFIZER$$46$YR$$F$Y$$$20240708$$HP$US$US
1968731815$19687318$15$F$20230101$20240725$20210811$20240730$PER$$US-PFIZER INC-2021447711$PFIZER$$83$YR$$F$Y$52.62$KG$20240730$$CN$US$US
196875506$19687550$6$F$20210817$20240626$20210811$20240701$EXP$$CA-TAKEDA-2021TUS049777$TAKEDA$$20$YR$$F$Y$$$20240701$$CN$CA$CA
196878479$19687847$9$F$20210101$20240719$20210811$20240722$EXP$$US-PFIZER INC-2021556576$PFIZER$$54$YR$$F$Y$$$20240722$$HP$US$US
196885892$19688589$2$F$20210101$20240711$20210811$20240722$PER$$US-SA-2021SA263921$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240722$$MD$US$US
1968866519$19688665$19$F$20200801$20240814$20210812$20240821$EXP$$CA-CELLTRION INC.-2020CA021018$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
1968877313$19688773$13$F$20191114$20240716$20210812$20240724$EXP$$CA-CELLTRION INC.-2019CA025876$CELLTRION$$$$$$Y$$$20240724$$MD$CA$CA
1968969117$19689691$17$F$20200623$20240909$20210812$20240917$EXP$$CA-CELLTRION INC.-2020CA023753$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
196898033$19689803$3$F$$20240715$20210812$20240722$EXP$$US-BIOGEN-2021BI01037458$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
196909217$19690921$7$F$20210101$20240815$20210812$20240820$PER$$US-PFIZER INC-2021902936$PFIZER$$52$YR$$F$Y$64.399$KG$20240820$$HP$US$US
1969199210$19691992$10$F$20210720$20240625$20210812$20240702$EXP$$CA-TAKEDA-2021TUS046478$TAKEDA$$77$YR$$F$Y$$$20240702$$MD$CA$CA
196920295$19692029$5$F$$20240626$20210812$20240701$EXP$$US-TAKEDA-US201848675$TAKEDA$$$$$F$Y$$$20240701$$MD$US$US
1969215112$19692151$12$F$20210810$20240910$20210812$20240916$EXP$$CA-TAKEDA-2021TUS050292$TAKEDA$$27$YR$$F$Y$$$20240916$$CN$CA$CA
1969245612$19692456$12$F$20210401$20240730$20210812$20240805$EXP$$CO-TAKEDA-2021TUS028942$TAKEDA$$35$YR$$F$Y$58$KG$20240805$$CN$CO$CO
196924725$19692472$5$F$20210101$20240904$20210812$20240919$EXP$$US-SA-2021SA266955$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240919$$CN$US$US
196924963$19692496$3$F$20180101$20240710$20210812$20240715$EXP$$CA-TAKEDA-2018TUS006172$TAKEDA$$$$$F$Y$$$20240715$$MD$CA$CA
196927585$19692758$5$F$20230316$20240801$20210812$20240827$PER$$CA-TOLMAR, INC.-21CA027703$TOLMAR$$77$YR$$M$Y$$$20240827$$CN$CA$CA
196927647$19692764$7$F$20210830$20240724$20210812$20240812$PER$$CA-TOLMAR, INC.-21CA027712$TOLMAR$$75$YR$$M$Y$$$20240812$$CN$CA$CA
196934722$19693472$2$F$20210730$20240805$20210812$20240813$PER$$US-SA-2021SA265714$SANOFI AVENTIS$$7$YR$C$M$Y$26$KG$20240814$$HP$US$US
196936773$19693677$3$F$$20240906$20210812$20240911$EXP$$US-GILEAD-2021-0543127$GILEAD$$42$YR$A$F$Y$$$20240911$$MD$US$US
196937039$19693703$9$F$20200701$20240906$20210812$20240912$EXP$$US-GILEAD-2021-0543429$GILEAD$$63$YR$A$F$Y$52$KG$20240912$$MD$US$US
196937427$19693742$7$F$20220206$20240703$20210812$20240708$EXP$$CA-TAKEDA-2021TUS049730$TAKEDA$$41$YR$$F$Y$$$20240708$$CN$CA$CA
1969384414$19693844$14$F$20190101$20240924$20210812$20240927$EXP$$US-PFIZER INC-2021894319$PFIZER$$67$YR$$F$Y$88.435$KG$20240927$$HP$US$US
196943475$19694347$5$F$$20240704$20210813$20240712$EXP$$DE-CELLTRION INC.-2021DE010969$CELLTRION$Topp MS, Duell J, Guijarro AMA, Odin M, Nielsen T, Rajeswaran A et al.. Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma. Haematologica. 2020;105:e256-60$$$$$Y$$$20240712$$HP$DE$DE
1969437747$19694377$47$F$$20240920$20210813$20240925$EXP$$CA-ORGANON-O2108CAN000802$ORGANON$$44$YR$$F$Y$97$KG$20240925$$MD$CA$CA
1969448529$19694485$29$F$20201106$20240919$20210813$20240928$EXP$$CA-CELLTRION INC.-2020CA033050$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
196945153$19694515$3$F$$20240826$20210812$20240902$EXP$$CA-ROCHE-2885686$ROCHE$$83$YR$E$F$Y$$$20240902$$HP$CA$CA
196945492$19694549$2$F$$20240710$20210812$20240716$EXP$$ES-PFIZER INC-202100973060$PFIZER$$56$YR$$M$Y$$$20240716$$MD$ES$ES
196946249$19694624$9$F$20210526$20240918$20210812$20240924$EXP$$NVSJ2021JP011924$NOVARTIS$Goda S, Kimura Y, Ando Y and Shirabe H. A Patient Diagnosed with Drug-induced Interstitial Pneumonia with KL-6 increased after Treatment with Secukinumab for Pustular Psoriasis. Program (Abstracts) for the 489th Osaka Regional Meeting of Japanese Dermatologi. 2022;NP$64$YR$$F$Y$$$20240925$$MD$JP$JP
196950242$19695024$2$F$$20240719$20210813$20240729$PER$$US-SA-2021SA267434$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240729$$MD$US$US
196951492$19695149$2$F$$20240718$20210813$20240726$EXP$$CA-APOTEX-2021AP028814$APOTEX$$16$YR$$M$Y$$$20240726$$CN$CA$CA
1969530826$19695308$26$F$20230131$20240918$20210812$20240925$EXP$$US-SHIRE-US201727413$TAKEDA$$78$YR$$F$Y$71$KG$20240925$$MD$US$US
1969657511$19696575$11$F$$20240820$20210813$20240822$EXP$$US-SA-2021SA081226$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240822$$MD$US$US
1969793215$19697932$15$F$20210512$20240702$20210813$20240712$EXP$$CA-ROCHE-2887355$ROCHE$$52$YR$A$M$Y$$$20240712$$CN$CA$CA
196980125$19698012$5$F$20210901$20240625$20210812$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-002714$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$79$KG$20240719$$CN$US$US
196984413$19698441$3$F$20200101$20240809$20210813$20240813$EXP$$PT-SA-2021SA261597$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240813$$MD$PT$PT
196986103$19698610$3$F$20201109$20240311$20210813$20240910$EXP$DE-TEVA-2021-DE-1903068$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-02642$ALKEM$$$$$M$Y$$$20240910$$CN$DE$DE
1969997334$19699973$34$F$20201210$20240918$20210814$20240927$EXP$$CA-CELLTRION INC.-2020CA034730$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
197000152$19700015$2$F$20190805$20240816$20210814$20240826$EXP$$CA-ROCHE-2394128$ROCHE$$26$YR$A$F$Y$$$20240826$$CN$CA$CA
1970018617$19700186$17$F$20210226$20240905$20210813$20240916$EXP$$CO-TAKEDA-2021TUS014383$TAKEDA$$29$YR$$F$Y$73$KG$20240916$$CN$CO$CO
197004075$19700407$5$F$$20240730$20210813$20240801$EXP$$CA-TAKEDA-2020TUS006476$TAKEDA$$$$$F$Y$$$20240801$$MD$CA$CA
197012783$19701278$3$F$20210101$20240830$20210814$20240905$EXP$$US-009507513-2108USA003643$MERCK$$$$$M$Y$90.249$KG$20240905$$CN$US$US
197014747$19701474$7$F$20210728$20240716$20210813$20240722$EXP$$US-TAKEDA-2020TUS001736$TAKEDA$$72$YR$$F$Y$120$KG$20240722$$CN$US$US
1970165214$19701652$14$F$$20240923$20210814$20240928$EXP$$US-TAKEDA-2021TUS042409$TAKEDA$$$$$F$Y$73.92$KG$20240928$$CN$US$US
197020636$19702063$6$F$20210718$20240920$20210814$20240925$EXP$$US-SHIRE-US202028705$TAKEDA$$62$YR$$M$Y$$$20240925$$CN$US$US
197022442$19702244$2$F$$20240716$20210814$20240724$EXP$$NVSC2021US179594$NOVARTIS$$$$$M$Y$$$20240724$$CN$US$US
197025352$19702535$2$F$$20240705$20210815$20240715$PER$$US-SA-2021SA266992$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240715$$CN$US$US
1970264716$19702647$16$F$20210727$20240703$20210815$20240713$EXP$$GB-BAXTER-2021BAX024508$BAXTER$$52$YR$$F$Y$101$KG$20240713$$HP$GB$GB
197041923$19704192$3$F$$20220603$20210816$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR169017$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
197044408$19704440$8$F$20210726$20211215$20210816$20240925$PER$$US-GLAXOSMITHKLINE-US2021168208$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240925$$CN$US$US
197051843$19705184$3$F$20210601$20240920$20210816$20240923$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2021-72889$REGENERON$$$$$M$Y$$$20240923$$MD$US$US
197051924$19705192$4$F$20210101$20240625$20210816$20240703$PER$$US-VERTEX PHARMACEUTICALS-2021-012381$VERTEX$$$$$M$Y$$$20240703$$PH$US$US
197052255$19705225$5$F$$20240725$20210816$20240730$PER$$US-PFIZER INC-2021523068$PFIZER$$50$YR$$F$Y$$$20240730$$HP$US$US
197054534$19705453$4$F$$20240809$20210816$20240812$EXP$$US-PFIZER INC-202100999043$PFIZER$$59$YR$$F$Y$$$20240812$$CN$US$US
197059108$19705910$8$F$20230614$20240709$20210817$20240717$EXP$$CA-CELLTRION INC.-2020CA020735$CELLTRION$$$$$$Y$$$20240717$$MD$CA$CA
197063516$19706351$6$F$$20240705$20210817$20240720$EXP$$CA-GLENMARK PHARMACEUTICALS-2021GMK067288$GLENMARK$$$$$$Y$$$20240720$$MD$CA$CA
197066893$19706689$3$F$20210501$20220601$20210817$20240916$EXP$$AU-CELLTRION INC.-2021AU011069$CELLTRION$$$$$$Y$$$20240916$$MD$AU$AU
197067662$19706766$2$F$20201130$20240627$20210817$20240705$EXP$$DE-AUROBINDO-AUR-APL-2021-008586$AUROBINDO$$66$YR$$M$Y$70$KG$20240705$$MD$DE$DE
197076719$19707671$9$F$20160101$20240710$20210817$20240711$EXP$$US-ORGANON-O2108USA001329$ORGANON$$$$$M$Y$31$KG$20240711$$MD$US$US
197077602$19707760$2$F$$20240809$20210817$20240815$PER$$US-PFIZER INC-2021580937$PFIZER$$61$YR$$F$Y$70.748$KG$20240815$$HP$US$US
1970783210$19707832$10$F$20200801$20240820$20210817$20240826$EXP$$HR-MYLANLABS-2021M1051139$MYLAN$$56$YR$$F$Y$$$20240826$$MD$HR$HR
197079854$19707985$4$F$$20240805$20210816$20240806$EXP$$CA-ORGANON-1608CAN005855$ORGANON$unknown. unknown$10$YR$$M$Y$$$20240806$$HP$CA$CA
197082979$19708297$9$F$20210126$20240919$20210816$20240927$EXP$$CA-TAKEDA-2021TUS006577$TAKEDA$$58$YR$$M$Y$95$KG$20240927$$HP$CA$CA
1970877822$19708778$22$F$20220316$20240123$20210817$20240926$EXP$$US-GLAXOSMITHKLINE-US2021169148$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
197092205$19709220$5$F$20210101$20240911$20210817$20240916$EXP$$US-PFIZER INC-202101049558$PFIZER$$51$YR$$F$Y$$$20240916$$HP$US$US
197096583$19709658$3$F$$20240826$20210817$20240830$EXP$$KR-BAYER-2021-194337$BAYER$$$$A$F$Y$$$20240830$$HP$KR$KR
197116632$19711663$2$F$$20210727$20210817$20240911$PER$$US-TEVA-2021-US-1938856$TEVA$$38$YR$$F$Y$$$20240911$$CN$US$US
197117252$19711725$2$F$20210810$20240904$20210817$20240911$EXP$$US-TAKEDA-2021TUS050911$TAKEDA$$58$YR$$M$Y$$$20240911$$CN$US$US
197126623$19712662$3$F$20210506$20210812$20210816$20240916$EXP$$NVSC2021US184873$NOVARTIS$$66$YR$$M$Y$61.5$KG$20240916$$MD$US$US
1971342222$19713422$22$F$20210101$20240827$20210818$20240904$EXP$$CA-CELLTRION INC.-2021CA011180$CELLTRION$$$$$$Y$$$20240904$$CN$CA$CA
197153495$19715349$5$F$$20240823$20210818$20240828$EXP$$US-PFIZER INC-2020491548$PFIZER$$81$YR$$M$Y$$$20240828$$MD$US$US
1971537110$19715371$10$F$20190102$20240910$20210818$20240917$EXP$$CA-TAKEDA-2019TUS000279$TAKEDA$$71$YR$$F$Y$$$20240917$$HP$CA$CA
197154112$19715411$2$F$$20240826$20210818$20240904$EXP$$CA-APOTEX-2021AP032120$APOTEX$$53$YR$$F$Y$$$20240904$$HP$CA$CA
197157464$19715746$4$F$20201030$20211123$20210818$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-276919$RANBAXY$$61$YR$A$M$Y$$$20240804$$CN$US$US
197157482$19715748$2$F$20210721$20210729$20210818$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-293633$RANBAXY$$60$YR$A$M$Y$$$20240804$$CN$US$US
197161645$19716164$5$F$$20240821$20210818$20240827$PER$$US-PFIZER INC-2021593271$PFIZER$$83$YR$$F$Y$$$20240827$$CN$US$US
197164029$19716402$9$F$20231023$20240916$20210818$20240925$EXP$$CA-TAKEDA-2021TUS051426$TAKEDA$$31$YR$$F$Y$$$20240925$$HP$CA$CA
1971685811$19716858$11$F$$20240719$20210818$20240725$EXP$$CA-APOTEX-2021AP032109$APOTEX$$71$YR$$F$Y$$$20240725$$HP$CA$CA
197171922$19717192$2$F$$20210810$20210819$20240827$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-079155$BRISTOL MYERS SQUIBB$Muniz TP, Patriquin CJ, Saibil SD. Presumed complement-mediated, checkpoint inhibitor-induced, thrombotic microangiopathy in a patient with metastatic melanoma. BMJ Case Reports 2021;14(7):1-4.$74$YR$E$M$Y$$$20240827$$HP$CA$CA
197174203$19717420$3$F$20210721$20230926$20210819$20240717$EXP$FR-AFSSAPS-NY20213475$NVSC2021FR186510$NOVARTIS$$25$YR$$F$Y$52$KG$20240717$$MD$FR$FR
197192273$19719227$3$F$20210601$20240723$20210819$20240801$PER$$US-SA-2021SA271895$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240801$$MD$US$US
197193384$19719338$4$F$$20240627$20210818$20240703$EXP$$BR-TAKEDA-BR202009198$TAKEDA$$$$$M$Y$58$KG$20240703$$CN$BR$BR
197194423$19719442$3$F$20210810$20240702$20210818$20240703$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003497$PAREXEL$$$$$$Y$$$20240703$$CN$US$US
197202833$19720283$3$F$$20240828$20210818$20240903$EXP$$US-TAKEDA-US202016414$TAKEDA$$$$$F$Y$64$KG$20240903$$HP$US$US
197210804$19721080$4$F$$20240906$20210818$20240911$EXP$$US-GILEAD-2021-0544067$GILEAD$$73$YR$E$F$Y$$$20240911$$MD$US$US
197219293$19721929$3$F$20210821$20210826$20210818$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR171020$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
197227367$19722736$7$F$20181001$20240903$20210819$20240911$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2019JPN160576$VIIV$$$$$$Y$$$20240911$$MD$JP$JP
197228359$19722835$9$F$20210505$20240920$20210819$20240925$EXP$$US-TAKEDA-2021TUS051623$TAKEDA$$54$YR$$M$Y$$$20240924$$PH$US$US
197243434$19724343$4$F$$20240730$20210819$20240808$PER$$US-SA-2021SA273620$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240808$$MD$US$US
197244774$19724477$4$F$$20240919$20210819$20240930$EXP$$CA-TAKEDA-2021TUS051562$TAKEDA$$41$YR$$M$Y$$$20240930$$HP$CA$CA
1972488812$19724888$12$F$20210729$20240808$20210819$20240816$EXP$$JP-PFIZER INC-202101050522$PFIZER$Ishimaru, S.. Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial.. International Journal of Clinical Oncology. 2024;29(2):89-95$49$YR$$M$Y$60.5$KG$20240816$$MD$JP$JP
197252152$19725215$2$F$$20240830$20210819$20240903$EXP$$US-TAKEDA-2018TUS000599$TAKEDA$$$$$F$Y$$$20240903$$CN$US$US
197270553$19727055$3$F$20201201$20230822$20210819$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2020ARB001256$ARBOR$$7$YR$$F$Y$$$20240802$$CN$US$US
197271327$19727132$7$F$20220306$20240701$20210819$20240723$PER$$CA-TOLMAR, INC.-21CA028155$TOLMAR$$71$YR$$M$Y$$$20240723$$CN$CA$CA
197277139$19727713$9$F$20210801$20220121$20210819$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR172294$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240926$$CN$US$US
197277156$19727715$6$F$20210801$20210914$20210819$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR172814$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240925$$CN$US$US
197288828$19728882$8$F$20240419$20240918$20210820$20240923$EXP$$US-TAKEDA-US202000343$TAKEDA$$61$YR$$F$Y$$$20240923$$HP$US$US
197293743$19729374$3$F$20210816$20240823$20210820$20240827$PER$$US-ORGANON-O2108USA001372$ORGANON$$$$$M$Y$$$20240827$$CN$US$US
1972942210$19729422$10$F$20201201$20240917$20210820$20240919$EXP$$US-PFIZER INC-2021560131$PFIZER$$55$YR$$F$Y$$$20240919$$HP$US$US
197307804$19730780$4$F$$20240715$20210821$20240727$EXP$$NVSC2021EG181149$NOVARTIS$$$$$F$Y$$$20240727$$CN$EG$EG
1973081610$19730816$10$F$20210514$20230322$20210821$20240926$EXP$$NVSC2020CO263713$NOVARTIS$$55$YR$$F$Y$$$20240926$$CN$CO$CO
197311802$19731180$2$F$20210101$20240805$20210821$20240809$EXP$$ES-AMGEN-ESPSP2021129210$AMGEN$$50$YR$A$M$Y$76$KG$20240808$$CN$ES$ES
197312026$19731202$6$F$20210731$20240711$20210821$20240716$EXP$$US-TAKEDA-2021TUS051930$TAKEDA$$1$YR$$M$Y$$$20240716$$CN$US$US
1973145114$19731451$14$F$20200617$20240828$20210820$20240902$EXP$$CL-JNJFOC-20210830173$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240902$$CN$CL$CL
1973187622$19731876$22$F$20200101$20240924$20210820$20240930$EXP$$BR-TAKEDA-2021TUS004680$TAKEDA$$$$$M$Y$19$KG$20240930$$CN$BR$BR
197319654$19731965$4$F$20191017$20240821$20210820$20240822$EXP$$FR-TAKEDA-2021TUS051577$TAKEDA$$72$YR$$M$Y$$$20240822$$HP$FR$FR
1973227225$19732272$25$F$20210423$20240802$20210820$20240809$EXP$$CA-CELLTRION INC.-2021CA008613$CELLTRION$$$$$$Y$$$20240809$$HP$CA$CA
197327085$19732708$5$F$$20240916$20210823$20240925$EXP$$PL-CELLTRION INC.-2021PL011145$CELLTRION$Czyzewski K, Debski R, Wysocki M, and Styczynski J. Extracorporeal photopheresis in a one-year-old child with low body weight.. Acta Haematologica Polonica. 2021;52:142-44$$$$$Y$$$20240925$$HP$PL$PL
197328892$19732889$2$F$20210601$20240719$20210823$20240730$PER$$US-SA-2021SA274842$SANOFI AVENTIS$$41$YR$A$M$Y$104.32$KG$20240730$$MD$US$US
1973394717$19733947$17$F$20210806$20240918$20210823$20240927$EXP$$CA-CELLTRION INC.-2021CA011329$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
197345057$19734505$7$F$20200422$20240816$20210824$20240821$EXP$$DE-ROCHE-2615113$ROCHE$$59$YR$A$F$Y$$$20240821$$CN$DE$DE
1973476933$19734769$33$F$20200717$20240917$20210824$20240926$EXP$$CA-CELLTRION INC.-2020CA021657$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
1973548919$19735489$19$F$20210101$20240912$20210823$20240912$EXP$$CA-PFIZER INC-2020493705$PFIZER$$68$YR$$M$Y$82$KG$20240912$$MD$CA$CA
197361282$19736128$2$F$$20240621$20210824$20240705$PER$$US-SA-2021SA275946$SANOFI AVENTIS$$$$C$F$Y$$$20240705$$MD$US$US
1973670415$19736704$15$F$20210812$20221114$20210823$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR172297$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
197368833$19736883$3$F$$20240729$20210823$20240805$EXP$$CA-APOTEX-2021AP012461$APOTEX$$69$YR$$F$Y$$$20240805$$HP$CA$CA
197372666$19737266$6$F$20230701$20240713$20210823$20240718$EXP$$PHHY2019CA006434$NOVARTIS$$45$YR$$F$Y$$$20240718$$MD$CA$CA
197377043$19737704$3$F$20210101$20240105$20210823$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2021ARB000606$ARBOR$$$$$F$Y$$$20240802$$HP$US$US
197378037$19737803$7$F$20210510$20240912$20210823$20240914$EXP$$US-TAKEDA-2021TUS031826$TAKEDA$$54$YR$$M$Y$$$20240914$$CN$US$US
197385247$19738524$7$F$20220505$20240912$20210823$20240917$EXP$$MX-TAKEDA-2021TUS052253$TAKEDA$$11$YR$$M$Y$17$KG$20240917$$MD$MX$MX
197393104$19739310$4$F$20210301$20240625$20210824$20240701$PER$$US-PFIZER INC-2021670739$PFIZER$$37$YR$$M$Y$$$20240701$$HP$US$US
1973944913$19739449$13$F$20210317$20240813$20210824$20240815$EXP$$BE-ROCHE-2896686$ROCHE$$36$YR$A$F$Y$72$KG$20240815$$MD$BE$BE
197401895$19740189$5$F$20040101$20240730$20210824$20240805$EXP$$US-ORGANON-O2108USA001811$ORGANON$$$$$M$Y$14.7$KG$20240805$$HP$US$US
197402422$19740242$2$F$$20240712$20210824$20240717$EXP$$US-KYOWAKIRIN-2021BKK014200$KYOWA$$$$$$Y$$$20240717$$HP$US$US
197402485$19740248$5$F$$20230125$20210823$20240926$PER$$US-GLAXOSMITHKLINE-US2021173083$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
197403912$19740391$2$F$$20240731$20210824$20240809$PER$$US-INCYTE CORPORATION-2021IN007473$INCYTE$$$$$$Y$$$20240809$$CN$US$US
1974051725$19740517$25$F$20210101$20240708$20210824$20240711$EXP$$CA-TAKEDA-2021TUS047263$TAKEDA$$$$$M$Y$15$KG$20240711$$CN$CA$CA
1974092710$19740927$10$F$20200822$20240807$20210824$20240812$EXP$$US-TAKEDA-2020TUS036627$TAKEDA$$64$YR$$F$Y$84$KG$20240812$$CN$US$US
197414172$19741417$2$F$$20240702$20210825$20240702$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003508$PAREXEL$$$$$$Y$$$20240702$$HP$US$US
1974172226$19741722$26$F$20161220$20240828$20210825$20240906$EXP$$CA-CELLTRION INC.-2021CA011438$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
1974205822$19742058$22$F$20210805$20240918$20210824$20240920$EXP$$AU-PFIZER INC-202101070140$PFIZER$$72$YR$$F$Y$70.9$KG$20240920$$HP$AU$AU
1974211724$19742117$24$F$20190314$20240908$20210825$20240916$EXP$$CA-CELLTRION INC.-2019CA023382$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
197421637$19742163$7$F$20210801$20211110$20210825$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR174829$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
197422004$19742200$4$F$20240720$20240730$20210825$20240806$EXP$$US-AMGEN-USA-20190306145$AMGEN$$46$YR$A$F$Y$$$20240806$$HP$US$US
197423383$19742338$3$F$$20240812$20210825$20240819$EXP$$NVSC2021DE189072$NOVARTIS$Gambichler T, Patsinakidis N, Susok L, Segert MH, Doerler M. Primary cutaneous CD30 plus anaplastic large T cell lymphoma in a patient treated with cyclosporine for actinic reticuloid. CASE REPORTS IN DERMATOLOGICAL MEDICINE. 2020;1-5$58$YR$$M$Y$$$20240819$$HP$DE$DE
197426173$19742617$3$F$20210105$20240129$20210824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2021ARB000009$ARBOR$$7$YR$$F$Y$$$20240802$$HP$US$US
197427116$19742711$6$F$20210907$20240814$20210824$20240819$EXP$$CA-TAKEDA-2020TUS038276$TAKEDA$$62$YR$$F$Y$$$20240819$$CN$CA$CA
1974338414$19743384$14$F$20210815$20240918$20210824$20240927$PER$$NVSC2021US189341$NOVARTIS$$54$YR$$F$Y$$$20240927$$CN$US$US
197433963$19743396$3$F$20210821$20240920$20210825$20240927$EXP$$CA-GLAXOSMITHKLINE-CA2021AMR178159$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$CA$CA
197438722$19743872$2$F$$20240821$20210825$20240914$PER$$US-SA-2021SA277952$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240914$$MD$US$US
197439602$19743960$2$F$$20240911$20210825$20240920$30DAY$$US-GLAXOSMITHKLINE-US2021178095$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
1974405221$19744052$21$F$20210101$20240731$20210824$20240808$EXP$$CA-CELLTRION INC.-2020CA031881$CELLTRION$$$$$$Y$$$20240808$$MD$CA$CA
197451403$19745140$3$F$20210101$20231129$20210825$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2021ARB000297$ARBOR$$$$$F$Y$$$20240802$$CN$US$US
197453892$19745389$2$F$20240101$20240807$20210825$20240812$EXP$$US-KYOWAKIRIN-2021BKK014206$KYOWA$$$$$$Y$$$20240812$$HP$US$US
197456164$19745616$4$F$20180221$20240920$20210825$20240930$EXP$$CA-TAKEDA-2018TUS004858$TAKEDA$$46$YR$$F$Y$$$20240930$$CN$CA$CA
197463356$19746335$6$F$20210801$20211203$20210826$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR177099$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240925$$CN$US$US
197467185$19746718$5$F$20210730$20240917$20210826$20240923$EXP$$US-AMGEN-USASP2021129701$AMGEN$$57$YR$A$F$Y$$$20240923$$HP$US$US
197468678$19746867$8$F$$20240729$20210826$20240731$PER$$US-GILEAD-2021-0545463$GILEAD$$$$A$F$Y$$$20240731$$MD$US$US
197472609$19747260$9$F$20210713$20240904$20210825$20240925$PER$$CA-TOLMAR, INC.-21CA028850$TOLMAR$$86$YR$$M$Y$$$20240925$$CN$CA$CA
197474144$19747414$4$F$$20240625$20210825$20240709$EXP$$NVSC2021CA189190$NOVARTIS$$46$YR$$F$Y$$$20240709$$CN$CA$CA
1974750117$19747501$17$F$20210830$20240801$20210825$20240807$EXP$$CA-TAKEDA-2021TUS053060$TAKEDA$$24$YR$$F$Y$$$20240807$$MD$CA$CA
197477139$19747713$9$F$20210713$20240710$20210825$20240731$PER$$US-INCYTE CORPORATION-2021IN006413$INCYTE$$$$$$Y$$$20240731$$CN$US$US
197481632$19748163$2$F$20240820$20240820$20210825$20240914$PER$$US-SA-2021SA279754$SANOFI AVENTIS$$5$YR$C$M$Y$44.45$KG$20240914$$HP$US$US
1974839015$19748390$15$F$20210526$20240731$20210825$20240803$EXP$$IL-ABBVIE-21K-082-4047366-00$ABBVIE$$85$YR$$M$Y$78$KG$20240803$$MD$IL$IL
197485732$19748573$2$F$$20240823$20210825$20240916$PER$$US-SA-2021SA280709$SANOFI AVENTIS$$$$T$F$Y$$$20240916$$MD$US$US
197487593$19748759$3$F$$20240821$20210826$20240827$EXP$$US-PFIZER INC-202101065200$PFIZER$Winegarden, J.. Topical Ketamine with Other Adjuvants: Underutilized for Refractory Cancer Pain? A Case Series and Suggested Revision of the World Health Organization Stepladder for Cancer Pain. Journal of Palliative Medicine. 2020;23 (9):1167-1171$72$YR$$F$Y$$$20240827$$MD$US$US
197507247$19750724$7$F$20190918$20240828$20210826$20240910$EXP$$PL-TEVA-2021-PL-1944984$TEVA$$62$YR$$M$Y$98$KG$20240910$$MD$PL$PL
1975116912$19751169$12$F$20220410$20240730$20210826$20240803$EXP$$CA-ROCHE-2571924$ROCHE$$38$YR$A$F$Y$$$20240803$$CN$CA$CA
197511836$19751183$6$F$20200901$20240710$20210826$20240712$EXP$$BE-ROCHE-2888118$ROCHE$$40$YR$A$F$Y$79.59$KG$20240712$$MD$BE$BE
197518082$19751808$2$F$$20240720$20210827$20240723$EXP$$GB-UCBSA-2021039570$UCB$$$$$F$Y$$$20240723$$PH$GB$GB
197518929$19751892$9$F$20210131$20240918$20210826$20240926$EXP$$JP-ROCHE-2769964$ROCHE$$54$YR$A$F$Y$53$KG$20240926$$MD$JP$JP
197525678$19752567$8$F$20210728$20240730$20210826$20240802$PER$$US-PFIZER INC-2019199118$PFIZER$$59$YR$$F$Y$$$20240802$$CN$US$US
1975261141$19752611$41$F$20210101$20240823$20210827$20240830$EXP$$CA-CELLTRION INC.-2020CA031900$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
197529082$19752908$2$F$$20240501$20210827$20240830$PER$$US-Hikma Pharmaceuticals USA Inc.-US-H14001-21-02913$HIKMA$$$$$M$Y$$$20240829$$CN$US$US
1975299517$19752995$17$F$20210729$20240822$20210826$20240828$EXP$$US-TAKEDA-2021TUS049084$TAKEDA$$43$YR$$M$Y$$$20240828$$PH$US$US
197534042$19753404$2$F$20200817$20240904$20210827$20240910$EXP$$DE-AUROBINDO-AUR-APL-2021-035686$AUROBINDO$$47$YR$$F$Y$84$KG$20240910$$CN$DE$DE
197534232$19753423$2$F$$20240729$20210826$20240807$PER$$US-SA-2021SA280412$SANOFI AVENTIS$$$$T$M$Y$$$20240807$$MD$US$US
1975351610$19753516$10$F$20200601$20240918$20210827$20240925$EXP$$NVSC2020CA249725$NOVARTIS$$48$YR$$F$Y$$$20240925$$MD$CA$CA
197538713$19753871$3$F$$20240731$20210826$20240813$EXP$$CA-AUROBINDO-AUR-APL-2021-036119$AUROBINDO$$55$YR$$M$Y$$$20240813$$PH$CA$CA
197540049$19754004$9$F$$20230109$20210827$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR178404$GLAXOSMITHKLINE$$$$$F$Y$81.633$KG$20240925$$HP$US$US
1975441212$19754412$12$F$20210701$20240826$20210827$20240829$EXP$$CA-TAKEDA-2019TUS051256$TAKEDA$$74$YR$$F$Y$$$20240829$$MD$CA$CA
197550272$19755027$2$F$20210823$20240805$20210827$20240810$EXP$$US-SA-2021SA283642$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240810$$MD$US$US
197554052$19755405$2$F$20210501$20240627$20210827$20240705$EXP$$JP-AstraZeneca-2021A693570$ASTRAZENECA$$80$YR$$M$Y$$$20240705$$MD$JP$
197554513$19755451$3$F$$20240819$20210827$20240826$EXP$$GB-SA-2021SA279245$SANOFI AVENTIS$Babra D, Youn S, Devendra S.. Postural orthostatic tachycardia syndrome (POTS) occurring during treatment for breast cancer.. BMJ Case Rep.. 2021;14(8):1-5$58$YR$A$F$Y$$$20240826$$MD$GB$GB
197556257$19755625$7$F$$20240909$20210827$20240916$EXP$$CA-TAKEDA-2021TUS015644$TAKEDA$$$$$F$Y$$$20240916$$CN$CA$CA
1975566915$19755669$15$F$20240811$20240916$20210827$20240923$EXP$$US-TAKEDA-US202010379$TAKEDA$$61$YR$$F$Y$53$KG$20240923$$HP$US$US
197556853$19755685$3$F$$20210825$20210827$20240701$PER$$NVSC2021US191958$NOVARTIS$$$$$M$Y$$$20240701$$CN$US$US
197558212$19755821$2$F$20240801$20240819$20210827$20240822$EXP$$US-PFIZER INC-202101068553$PFIZER$$64$YR$$F$Y$$$20240822$$HP$US$US
197558593$19755859$3$F$$20211214$20210827$20240806$EXP$$JP-BIOGEN-2021BI01042726$BIOGEN$$$$I$M$Y$$$20240806$$MD$JP$JP
197566587$19756658$7$F$20200501$20240730$20210827$20240805$EXP$$CA-TAKEDA-CA202027565$TAKEDA$$75$YR$$F$Y$$$20240805$$CN$CA$CA
1975715931$19757159$31$F$20210101$20240821$20210828$20240829$EXP$$CA-CELLTRION INC.-2021CA011778$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
197588462$19758846$2$F$$20240725$20210829$20240803$EXP$$CA-TEVA-2021-CA-1945987$TEVA$$59$YR$$M$Y$$$20240803$$HP$CA$CA
197590505$19759050$5$F$20210813$20240621$20210827$20240708$EXP$$CH-ROCHE-2894592$ROCHE$$59$YR$A$F$Y$$$20240708$$CN$CH$CH
197591216$19759121$6$F$20191030$20240802$20210827$20240807$EXP$$DE-MYLANLABS-2021M1055425$MYLAN$$$$E$F$Y$64$KG$20240807$$MD$DE$DE
197591232$19759123$2$F$20210825$20240903$20210829$20240925$PER$$US-SA-2021SA283631$SANOFI AVENTIS$$78$YR$E$M$Y$68.03$KG$20240925$$MD$US$US
197594982$19759498$2$F$20210801$20210823$20210829$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR179287$GLAXOSMITHKLINE$$36$YR$$F$Y$$$20240925$$CN$US$US
197596772$19759677$2$F$$20240814$20210830$20240820$EXP$$CA-AUROBINDO-AUR-APL-2021-035912$AUROBINDO$$30$YR$$M$Y$$$20240820$$CN$CA$CA
1975986911$19759869$11$F$20230314$20240918$20210830$20240930$PER$$NVSC2021US195547$NOVARTIS$$63$YR$$F$Y$$$20240930$$CN$US$US
197601883$19760188$3$F$20210101$20210816$20210830$20240716$PER$$US-TEVA-2021-US-1944039$TEVA$$47$YR$$F$Y$83.46$KG$20240716$$CN$US$US
1976019320$19760193$20$F$20210101$20240729$20210830$20240805$EXP$$CA-CELLTRION INC.-2021CA001485$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
1976270017$19762700$17$F$20201202$20240906$20210830$20240913$EXP$$NVSC2020DE327506$NOVARTIS$$$$A$F$Y$60$KG$20240913$$MD$DE$DE
1976313614$19763136$14$F$20210721$20240723$20210830$20240728$EXP$$CA-ROCHE-2894766$ROCHE$$55$YR$A$M$Y$85$KG$20240728$$CN$CA$CA
197631432$19763143$2$F$$20240719$20210830$20240729$EXP$$CA-APOTEX-2021AP039385$APOTEX$$79$YR$$M$Y$$$20240729$$HP$CA$CA
197636636$19763663$6$F$20210801$20240807$20210830$20240812$EXP$$CA-TAKEDA-2021TUS053482$TAKEDA$$67$YR$$F$Y$61.22$KG$20240812$$CN$CA$CA
197638364$19763836$4$F$$20211006$20210830$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR177061$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
1976421114$19764211$14$F$20210820$20240904$20210830$20240909$EXP$$CA-TAKEDA-2021TUS038614$TAKEDA$$39$YR$$M$Y$$$20240909$$HP$CA$CA
197642304$19764230$4$F$20200514$20240626$20210830$20240702$EXP$$DE-MYLANLABS-2021M1056076$MYLAN$$$$E$F$Y$39$KG$20240702$$MD$DE$DE
197645627$19764562$7$F$20211028$20211126$20210831$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR181989$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240926$$CN$US$US
197646153$19764615$3$F$$20240910$20210830$20240920$EXP$$CA-APOTEX-2021AP039314$APOTEX$$49$YR$$F$Y$$$20240920$$HP$CA$CA
1976465618$19764656$18$F$20210818$20240727$20210831$20240805$EXP$$CA-CELLTRION INC.-2021CA011793$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
197646902$19764690$2$F$20150901$20240717$20210830$20240724$EXP$$US-JAZZ-2021-US-015612$JAZZ$$68$YR$$M$Y$$$20240723$$CN$US$US
197649762$19764976$2$F$20210716$20240722$20210830$20240730$EXP$$CA-EXELIXIS-CABO-21043469$EXELIXIS$$16$YR$$M$Y$89$KG$20240730$$MD$CA$CA
197653198$19765319$8$F$$20240725$20210830$20240730$PER$$US-PFIZER INC-202101069157$PFIZER$$70$YR$$F$Y$$$20240730$$HP$US$US
197653442$19765344$2$F$$20240702$20210831$20240704$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003537$PAREXEL$$$$$$Y$$$20240704$$PH$US$US
197653453$19765345$3$F$$20240724$20210831$20240726$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003529$PAREXEL$$$$$$Y$$$20240726$$CN$US$US
197654723$19765472$3$F$20210601$20240829$20210831$20240902$EXP$$US-KYOWAKIRIN-2021BKK014921$KYOWA$$$$$$Y$$$20240902$$HP$US$US
1976584410$19765844$10$F$20210701$20240909$20210830$20240921$30DAY$$US-UCBSA-2021040044$UCB$$59$YR$$F$Y$$$20240921$$CN$US$US
197663262$19766326$2$F$20240910$20240911$20210831$20240926$PER$$US-SA-2021SA284355$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240926$$CN$US$US
197665263$19766526$3$F$$20240906$20210830$20240912$EXP$$US-GILEAD-2021-0545843$GILEAD$$64$YR$A$M$Y$$$20240912$$HP$US$US
1976691645$19766916$45$F$20240308$20240916$20210830$20240920$EXP$$US-SHIRE-US201933018AA$TAKEDA$$33$YR$$F$Y$$$20240920$$MD$US$US
1976780816$19767808$16$F$20210612$20240815$20210830$20240819$EXP$$US-TAKEDA-2021TUS038279$TAKEDA$$70$YR$$F$Y$$$20240819$$HP$US$US
197685513$19768551$3$F$20171101$20240802$20210831$20240806$EXP$$US-TAKEDA-2021TUS053599$TAKEDA$$15$YR$$F$Y$75$KG$20240806$$CN$US$US
197697158$19769715$8$F$$20240808$20210831$20240813$EXP$$US-PFIZER INC-202101059094$PFIZER$$68$YR$$F$Y$108.86$KG$20240813$$CN$US$US
197701434$19770143$4$F$20210507$20240826$20210831$20240829$EXP$$IN-PFIZER INC-2018179846$PFIZER$$52$YR$$F$Y$$$20240829$$CN$IN$IN
1977025615$19770256$15$F$20210101$20240806$20210901$20240814$EXP$$CA-CELLTRION INC.-2021CA011928$CELLTRION$$$$$$Y$$$20240814$$HP$CA$CA
1977054828$19770548$28$F$20210601$20240910$20210901$20240918$EXP$$CA-CELLTRION INC.-2021CA010474$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
197709346$19770934$6$F$$20240925$20210831$20240925$PER$$US-PFIZER INC-202101012372$PFIZER$$36$YR$$F$Y$$$20240925$$CN$US$US
197711065$19771106$5$F$20210530$20240712$20210831$20240721$EXP$$FR-BAYER-2021-186282$BAYER$$90$YR$E$M$Y$85.5$KG$20240719$$MD$FR$FR
197714252$19771425$2$F$20210827$20240819$20210901$20240829$PER$$US-SA-2021SA287113$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240829$$MD$US$US
1977146618$19771466$18$F$20210727$20240911$20210831$20240913$EXP$$GB-PFIZER INC-202101064518$PFIZER$$52$YR$$F$Y$101$KG$20240913$$MD$GB$GB
1977202814$19772028$14$F$20211024$20240624$20210831$20240701$EXP$$CA-TAKEDA-2018MPI014438$TAKEDA$$67$YR$$F$Y$$$20240701$$CN$CA$CA
197721865$19772186$5$F$20210501$20240627$20210831$20240701$EXP$$US-PFIZER INC-202101034058$PFIZER$$73$YR$$F$Y$$$20240701$$HP$US$US
1977241010$19772410$10$F$20211126$20240711$20210831$20240715$EXP$$CA-TAKEDA-2021TUS053852$TAKEDA$$33$YR$$F$Y$$$20240715$$PH$CA$CA
1977259625$19772596$25$F$20210609$20240628$20210901$20240710$EXP$$CA-ROCHE-2900143$ROCHE$$45$YR$A$F$Y$$$20240710$$CN$CA$CA
197726318$19772631$8$F$20240315$20240828$20210831$20240919$PER$$CA-TOLMAR, INC.-21CA028079$TOLMAR$$74$YR$$M$Y$$$20240919$$CN$CA$CA
197726499$19772649$9$F$20240304$20240624$20210831$20240717$PER$$CA-TOLMAR, INC.-21CA028078$TOLMAR$$87$YR$$M$Y$$$20240717$$CN$CA$CA
197727928$19772792$8$F$$20240726$20210831$20240802$EXP$$US-ROCHE-2760014$ROCHE$$81$YR$E$M$Y$$$20240803$$CN$US$US
197728122$19772812$2$F$20210808$20240823$20210831$20240906$EXP$$CN-PFIZER INC-202101098623$PFIZER$$17$YR$$M$Y$44$KG$20240906$$CN$CN$CN
197731952$19773195$2$F$$20210820$20210901$20240801$EXP$$CA-AstraZeneca-2021A011507$ASTRAZENECA$$$$$F$Y$$$20240801$$MD$CA$
197735468$19773546$8$F$20190121$20240827$20210901$20240830$EXP$$DE-ROCHE-2370938$ROCHE$$46$YR$A$F$Y$$$20240830$$CN$DE$DE
1977378123$19773781$23$F$20201109$20240708$20210901$20240716$EXP$$CA-CELLTRION INC.-2020CA032028$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
197740376$19774037$6$F$20231005$20240827$20210901$20240829$EXP$$CA-TAKEDA-2019TUS021411$TAKEDA$$55$YR$$M$Y$$$20240829$$HP$CA$CA
197741762$19774176$2$F$20210730$20240719$20210901$20240725$EXP$$US-SA-2021SA286751$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240725$$CN$US$US
1977470613$19774706$13$F$$20240723$20210901$20240729$EXP$$US-TAKEDA-2021TUS053743$TAKEDA$$$$$F$Y$79$KG$20240729$$MD$US$US
197754682$19775468$2$F$$20210823$20210901$20240709$EXP$$DE-ASTELLAS-2021US032028$ASTELLAS$$$$$F$Y$$$20240709$$CN$DE$DE
197758443$19775844$3$F$$20210826$20210901$20240923$EXP$$NVSC2021IE197154$NOVARTIS$$$$$$Y$$$20240923$$PH$IE$IE
1977656410$19776564$10$F$$20240710$20210901$20240720$EXP$$CA-TEVA-2021-CA-1946589$TEVA$$19$YR$$F$Y$$$20240720$$HP$CA$CA
197774578$19777457$8$F$20220101$20240626$20210902$20240704$EXP$$CA-CELLTRION INC.-2021CA011997$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
197776603$19777660$3$F$20210701$20240919$20210902$20240926$EXP$$NVSC2021CO178152$NOVARTIS$$58$YR$$M$Y$70$KG$20240926$$CN$CO$CO
197778372$19777837$2$F$20210813$20240920$20210902$20240925$EXP$$US-JAZZ-2021-US-015940$JAZZ$$61$YR$$F$Y$$$20240925$$MD$US$US
197783972$19778397$2$F$$20210831$20210902$20240704$PER$$NVSC2021US198606$NOVARTIS$$$$$M$Y$$$20240704$$HP$US$US
197786033$19778603$3$F$20200101$20240626$20210902$20240704$EXP$$IT-AUROBINDO-AUR-APL-2021-037372$AUROBINDO$Dagna L, Ciceri F, Scarpellini P, et.al... Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19.. Clinical Microbiology and Infection. 2021;27:1190-1192$69$YR$$F$Y$$$20240704$$HP$IT$IT
197791322$19779132$2$F$20201016$20240627$20210902$20240702$EXP$$NVSC2020BR317790$NOVARTIS$$57$YR$$F$Y$$$20240703$$CN$BR$BR
197794644$19779464$4$F$20210801$20240808$20210902$20240816$PER$$US-SA-2021SA285333$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240816$$MD$US$US
1977959310$19779593$10$F$20210101$20240724$20210902$20240726$PER$$US-PFIZER INC-202101069065$PFIZER$$74$YR$$F$Y$$$20240726$$CN$US$US
197804243$19780424$3$F$$20240628$20210902$20240702$PER$$NVSC2021US198384$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
197804612$19780461$2$F$$20240923$20210902$20240924$EXP$$CA-PFIZER INC-202101089907$PFIZER$$$$$F$Y$$$20240924$$HP$CA$CA
197806919$19780691$9$F$20190201$20240717$20210902$20240718$EXP$$FR-TAKEDA-FR201924184$TAKEDA$$70$YR$$F$Y$60$KG$20240718$$HP$FR$FR
197831438$19783143$8$F$20210425$20240917$20210902$20240924$EXP$$NVSC2021CA114009$NOVARTIS$$91$YR$$F$Y$$$20240925$$CN$CA$CA
197831563$19783156$3$F$$20240912$20210903$20240924$EXP$$CA-APOTEX-2021AP042286$APOTEX$$52$YR$$F$Y$$$20240924$$HP$CA$CA
197836072$19783607$2$F$20210712$20240709$20210903$20240730$PER$$CA-TOLMAR, INC.-21CA028907$TOLMAR$$92$YR$$M$Y$$$20240730$$CN$CA$CA
197836747$19783674$7$F$20240409$20240730$20210903$20240823$PER$$CA-TOLMAR, INC.-21CA028914$TOLMAR$$90$YR$$M$Y$$$20240823$$CN$CA$CA
1978379822$19783798$22$F$20200325$20240715$20210903$20240724$EXP$$CA-CELLTRION INC.-2020CA021195$CELLTRION$$$$$$Y$$$20240724$$HP$CA$CA
197843733$19784373$3$F$$20240829$20210903$20240907$EXP$$CA-AUROBINDO-AUR-APL-2021-036302$AUROBINDO$$41$YR$$F$Y$$$20240907$$HP$CA$CA
197844238$19784423$8$F$20210101$20240910$20210903$20240927$EXP$$US-SA-2021SA287246$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240927$$MD$US$US
197844242$19784424$2$F$20210820$20240920$20210903$20240925$EXP$$US-SA-2021SA287140$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240925$$MD$US$US
197847664$19784766$4$F$20210101$20240813$20210903$20240821$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2021-21353$IPSEN$$53$YR$A$F$Y$$$20240821$$CN$US$US
197852814$19785281$4$F$$20240819$20210903$20240822$EXP$$GB-PFIZER INC-202101103328$PFIZER$Babra, D.. Postural orthostatic tachycardia syndrome (POTS) occurring during treatment for breast cancer. BMJ Case Reports. 2021;14 (8):1-5$58$YR$$F$Y$$$20240822$$MD$GB$GB
197853597$19785359$7$F$20210801$20240722$20210903$20240725$PER$$US-PFIZER INC-202101042097$PFIZER$$61$YR$$F$Y$$$20240725$$CN$US$US
1978537018$19785370$18$F$20190217$20240830$20210903$20240904$EXP$$IN-PFIZER INC-2019340109$PFIZER$$40$YR$$M$Y$$$20240904$$CN$IN$IN
197861256$19786125$6$F$20210129$20240816$20210903$20240823$EXP$$DE-ROCHE-2901914$ROCHE$$30$YR$A$F$Y$90$KG$20240823$$MD$DE$DE
197865032$19786503$2$F$20180911$20210827$20210903$20240709$EXP$$CO-ASTELLAS-2018US041312$ASTELLAS$$35$YR$$F$Y$64$KG$20240709$$CN$CO$CO
197870158$19787015$8$F$20240729$20240729$20210903$20240820$PER$$CA-TOLMAR, INC.-21CA028915$TOLMAR$$79$YR$$M$Y$$$20240820$$CN$CA$CA
197870645$19787064$5$F$20210715$20240809$20210903$20240904$PER$$CA-TOLMAR, INC.-21CA028965$TOLMAR$$78$YR$$M$Y$$$20240904$$CN$CA$CA
197878736$19787873$6$F$20210330$20240919$20210903$20240926$EXP$$CA-TAKEDA-2021TUS027749$TAKEDA$$26$YR$$F$Y$$$20240926$$CN$CA$CA
197881213$19788121$3$F$20210528$20240921$20210903$20240926$EXP$$DE-PFIZER INC-2021654366$MYLAN$$$$$$Y$$$20240926$$HP$DE$DE
1978842719$19788427$19$F$20201119$20240822$20210903$20240827$EXP$$US-TAKEDA-2020TUS058015$TAKEDA$$66$YR$$F$Y$$$20240827$$HP$US$US
197888713$19788871$3$F$20240426$20240716$20210904$20240717$EXP$$CA-TAKEDA-2021TUS008679$TAKEDA$$59$YR$$M$Y$92.8$KG$20240717$$PH$CA$CA
197889253$19788925$3$F$20240515$20240823$20210905$20240910$PER$$US-SA-2021SA289594$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240910$$MD$US$US
197890038$19789003$8$F$20220304$20240909$20210904$20240913$EXP$$US-TAKEDA-US202028915$TAKEDA$$59$YR$$F$Y$$$20240913$$HP$US$US
197893366$19789336$6$F$20201222$20240813$20210904$20240816$EXP$$NVSC2021DE194657$NOVARTIS$$$$A$F$Y$87.5$KG$20240816$$MD$DE$DE
197905124$19790512$4$F$20180101$20240812$20210906$20240829$PER$$CA-TOLMAR, INC.-21CA028919$TOLMAR$$$$$M$Y$$$20240829$$CN$CA$CA
1979126111$19791261$11$F$20190101$20240625$20210906$20240712$EXP$$DE-ROCHE-2266873$ROCHE$$50$YR$A$F$Y$$$20240712$$CN$DE$DE
197925012$19792501$2$F$20210826$20240702$20210906$20240710$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003541$PAREXEL$$$$$$Y$$$20240710$$CN$US$US
197932929$19793292$9$F$20180101$20240812$20210906$20240814$EXP$$US-SHIRE-US202012611$TAKEDA$$$$$F$Y$$$20240814$$HP$US$US
197936074$19793607$4$F$$20240725$20210906$20240730$EXP$$CA-PFIZER INC-202101097885$PFIZER$$26$YR$$F$Y$$$20240730$$HP$CA$CA
197937974$19793797$4$F$20211001$20211029$20210906$20240722$EXP$$US-RECORDATI RARE DISEASE INC.-2021003588$RECORDATI$$$$$$Y$$$20240722$$CN$US$US
197939068$19793906$8$F$20210810$20240726$20210907$20240731$EXP$$DE-ROCHE-2894800$ROCHE$$54$YR$A$F$Y$$$20240731$$CN$DE$DE
1979413812$19794138$12$F$20210601$20240912$20210907$20240926$PER$$CA-TOLMAR, INC.-21CA028407$TOLMAR$$68$YR$$M$Y$$$20240926$$CN$CA$CA
1979448518$19794485$18$F$20200602$20240813$20210907$20240821$EXP$$CA-CELLTRION INC.-2020CA022634$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
1979528112$19795281$12$F$20210928$20240913$20210906$20240926$PER$$CA-TOLMAR, INC.-21CA028771$TOLMAR$$82$YR$$M$Y$$$20240926$$CN$CA$CA
1979528716$19795287$16$F$20210628$20240917$20210906$20240925$PER$$CA-TOLMAR, INC.-21CA028519$TOLMAR$$60$YR$$M$Y$$$20240925$$CN$CA$CA
197958173$19795817$3$F$$20240829$20210907$20240909$PER$$US-AMGEN-USASP2021136646$AMGEN$$$$A$M$Y$$$20240909$$HP$US$US
197962242$19796224$2$F$$20240825$20210907$20240904$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202109001778$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240904$$CN$DE$JP
197962272$19796227$2$F$$20240825$20210907$20240903$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202109001685$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240903$$CN$DE$JP
197962912$19796291$2$F$$20240825$20210907$20240903$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202109001775$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240903$$CN$DE$JP
1979729321$19797293$21$F$20210808$20240923$20210901$20240925$EXP$$JP-TAKEDA-2021TJP073403$TAKEDA$$8$YR$$M$Y$20$KG$20240925$$CN$JP$JP
1979735313$19797353$13$F$$20240805$20210907$20240809$EXP$$CA-BAYER-2021-168079$BAYER$$43$YR$A$F$Y$$$20240809$$HP$CA$CA
197983745$19798374$5$F$20210412$20240729$20210907$20240731$EXP$$US-PFIZER INC-2021386202$PFIZER$$74$YR$$F$Y$68.04$KG$20240731$$CN$US$US
1979877110$19798771$10$F$20180509$20240923$20210907$20240927$EXP$$CO-INCYTE CORPORATION-2018IN005802$INCYTE$$$$$$Y$$$20240927$$CN$CO$CO
197987963$19798796$3$F$20200101$20240701$20210907$20240715$EXP$IT-ABBVIE-21K-083-4046843-00 (IT-ABBVIE-21K-083-4046843-00)$IT-IBIGEN-2021.10587$ISTITUTO BICHIMICO ITALIANO GIOVANNI LORENZINI (IBIGEN)$Dagna L, Ciceri F, Scarpellini P, et.al.. Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID 19. Clinical Microbiology and Infection. 2021;27:1190 1192.$69$YR$$F$Y$$$20240701$$HP$IT$
1979882219$19798822$19$F$20210510$20240729$20210907$20240802$EXP$$US-PFIZER INC-2021086471$PFIZER$$83$YR$$F$Y$$$20240802$$CN$US$US
197988595$19798859$5$F$20190918$20240828$20210907$20240909$EXP$PL-EMA-2021811AUTODUP1628639595048$PL-Accord-237462$ACCORD$$62$YR$A$M$Y$98$KG$20240909$$MD$PL$PL
1979915717$19799157$17$F$20191202$20240701$20210907$20240708$EXP$$DE-MYLANLABS-2021M1058946$MYLAN$$$$A$F$Y$100.8$KG$20240708$$HP$DE$DE
197991732$19799173$2$F$20240101$20240815$20210907$20240819$EXP$$US-KYOWAKIRIN-2021BKK015022$KYOWA$$$$$$Y$$$20240819$$HP$US$US
197995267$19799526$7$F$20240718$20240718$20210907$20240723$EXP$$US-TAKEDA-US202030310$TAKEDA$$77$YR$$F$Y$$$20240723$$CN$US$US
197996896$19799689$6$F$20210405$20240808$20210907$20240812$EXP$$AR-ROCHE-2894954$ROCHE$$9$YR$C$M$Y$$$20240812$$CN$AR$AR
1979974315$19799743$15$F$20160802$20240819$20210907$20240827$EXP$$PHHY2016CA107522$NOVARTIS$$53$YR$$F$Y$53$KG$20240827$$CN$CA$CA
198000102$19800010$2$F$$20240916$20210907$20240923$EXP$$PL-MYLANLABS-2021M1058358$MYLAN$Szlauer-stefanska A, Kaminska-winciorek G.. Patient with chronic cutaneous and mucosal forms of graft- versus-host disease.. DERMATOLOGIA PO DYPLOMIE. 2024;2$30$YR$$M$Y$$$20240923$$MD$PL$PL
198001606$19800160$6$F$20200301$20240702$20210908$20240705$EXP$$NVSC2020AT335486$NOVARTIS$$$$A$M$Y$$$20240705$$MD$AT$AT
1980084621$19800846$21$F$20210806$20230407$20210908$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR188698$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
198011656$19801165$6$F$20210801$20220301$20210908$20240909$EXP$$JP-SA-2021SA291534$SANOFI AVENTIS$$10$YR$C$M$Y$35.4$KG$20240910$$MD$JP$JP
198016826$19801682$6$F$$20240729$20210908$20240807$PER$$US-SA-2021SA293725$SANOFI AVENTIS$$3$YR$C$F$Y$17.69$KG$20240807$$MD$US$US
1980286817$19802868$17$F$20210701$20240903$20210908$20240910$EXP$$BR-GLAXOSMITHKLINE-BR2020AMR199041$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$PH$BR$BR
198033693$19803369$3$F$$20210507$20210908$20240710$PER$$US-PFM-2021-04539$PIERRE FABRE MEDICAMENT$Dowdy R, Mansour S, Cottle JH Mabe H, Weprin H, Yarborough L et al. Cardiac Arrest upon Induction of General Anesthesia. Anesthesia progress. 2020;68(1):38-44$27$YR$$M$Y$91$KG$20240710$$MD$US$US
198041017$19804101$7$F$$20240715$20210908$20240717$PER$$US-PFIZER INC-2021401307$PFIZER$$65$YR$$F$Y$$$20240717$$MD$US$US
198042422$19804242$2$F$20230801$20240206$20210908$20240906$PER$$US-FARMAPROD-202104-0560$DOMPE FARMACEUTICI$$58$YR$A$F$Y$$$20240902$$MD$US$
198045374$19804537$4$F$$20240722$20210908$20240725$EXP$$CA-PFIZER INC-202101109844$PFIZER$$63$YR$$F$Y$$$20240725$$HP$CA$CA
198048633$19804863$3$F$$20240926$20210908$20240930$PER$$US-PFIZER INC-2021701919$PFIZER$$69$YR$$F$Y$$$20240930$$CN$US$US
1980638121$19806381$21$F$20201123$20240905$20210909$20240913$EXP$$DE-ROCHE-2730131$ROCHE$$55$YR$A$F$Y$$$20240913$$CN$DE$DE
198064557$19806455$7$F$20201207$20240731$20210909$20240816$EXP$$JP-LUNDBECK-DKLU3025846$LUNDBECK$$$$$$Y$$$20240816$$MD$JP$JP
198068272$19806827$2$F$$20240809$20210909$20240813$EXP$$CA-ROCHE-2904906$ROCHE$$34$YR$A$M$Y$$$20240813$$CN$CA$CA
1980683519$19806835$19$F$20230921$20240919$20210908$20240924$EXP$$US-TAKEDA-2021TUS023644$TAKEDA$$75$YR$$F$Y$91$KG$20240924$$CN$US$US
198079863$19807986$3$F$$20240903$20210908$20240909$EXP$$DE-MYLANLABS-2021M1059500$MYLAN$$$$E$M$Y$$$20240909$$MD$DE$DE
1980831232$19808312$32$F$20201014$20240710$20210908$20240717$EXP$$MX-TAKEDA-MX202034386$TAKEDA$$7$YR$$M$Y$30$KG$20240717$$CN$MX$MX
1980961210$19809612$10$F$20220601$20240725$20210909$20240730$EXP$$US-PFIZER INC-2021830040$PFIZER$$87$YR$$F$Y$60.317$KG$20240730$$CN$US$US
1980963110$19809631$10$F$20231001$20240913$20210909$20240924$EXP$$CA-ROCHE-2786268$ROCHE$$37$YR$A$F$Y$$$20240924$$CN$CA$CA
198096382$19809638$2$F$20180301$20231006$20210908$20240710$PER$$US-ROCHE-2744096$ROCHE$$66$YR$E$F$Y$71.21$KG$20240628$$MD$US$US
1980977511$19809775$11$F$20220517$20240807$20210909$20240813$EXP$$CA-TAKEDA-2021TUS055305$TAKEDA$$62$YR$$M$Y$86.168$KG$20240813$$MD$CA$CA
198101443$19810144$3$F$20240501$20240611$20210909$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2021188764$VIIV$$64$YR$$M$Y$$$20240808$$PH$US$US
1981069812$19810698$12$F$20210805$20240628$20210909$20240710$EXP$$IN-INCYTE CORPORATION-2021IN007954$INCYTE$$$$$$Y$$$20240710$$CN$IN$IN
198109813$19810981$3$F$20210803$20240703$20210910$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-003030$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240726$$CN$US$US
198114062$19811406$2$F$$20240704$20210909$20240709$EXP$$CA-PFIZER INC-202101127022$PFIZER$$57$YR$$M$Y$$$20240709$$CN$CA$CA
198121873$19812187$3$F$$20240917$20210909$20240920$EXP$$US-KYOWAKIRIN-2021BKK015120$KYOWA$$$$$$Y$$$20240920$$HP$US$US
198122507$19812250$7$F$20180101$20240828$20210910$20240902$EXP$$CA-TAKEDA-2018TUS025443$TAKEDA$$$$$F$Y$$$20240902$$MD$CA$CA
198123226$19812322$6$F$$20240822$20210910$20240826$EXP$$CA-ROCHE-2901646$ROCHE$$$$A$F$Y$$$20240826$$HP$CA$CA
198125064$19812506$4$F$$20240830$20210910$20240909$EXP$$CA-TEVA-2021-CA-1949540$TEVA$$59$YR$$F$Y$$$20240909$$HP$CA$CA
198125367$19812536$7$F$20210101$20240710$20210910$20240720$EXP$$CA-CELLTRION INC.-2021CA012302$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
1981359712$19813597$12$F$20230701$20240703$20210909$20240708$EXP$$CA-TAKEDA-2021TUS043425$TAKEDA$$61$YR$$M$Y$$$20240708$$MD$CA$CA
198144443$19814444$3$F$20200801$20240919$20210909$20240924$EXP$$DE-MYLANLABS-2021M1059491$MYLAN$$$$$M$Y$$$20240924$$CN$DE$DE
1981449614$19814496$14$F$20191223$20240920$20210910$20240924$EXP$$AT-PFIZER INC-202101158368$PFIZER$$34$YR$$F$Y$$$20240924$$MD$AT$AT
1981455715$19814557$15$F$20210401$20240718$20210910$20240723$EXP$$IN-PFIZER INC-202100986953$PFIZER$$51$YR$$F$Y$$$20240723$$CN$IN$IN
198148083$19814808$3$F$20151111$20240703$20210909$20240709$EXP$$US-ARIAD-2015US005781$TAKEDA$$62$YR$$M$Y$97$KG$20240709$$HP$US$US
198151294$19815129$4$F$20240822$20240822$20210910$20240827$EXP$$US-SHIRE-US201935216AA$TAKEDA$$64$YR$$F$Y$58$KG$20240827$$HP$US$US
198153514$19815351$4$F$20210301$20240813$20210910$20240820$EXP$$US-PFIZER INC-202101139966$PFIZER$$60$YR$$F$Y$$$20240820$$CN$US$US
198157985$19815798$5$F$$20240620$20210910$20240703$EXP$$CA-TEVA-2021-CA-1949558$TEVA$$76$YR$$F$Y$$$20240703$$HP$CA$CA
1981590026$19815900$26$F$20191206$20240914$20210909$20240919$EXP$$CO-TAKEDA-CO201942846$TAKEDA$$3$YR$$M$Y$23.129$KG$20240919$$CN$CO$CO
198160164$19816016$4$F$20160824$20240923$20210910$20240925$EXP$$CA-TAKEDA-2016TUS020556$TAKEDA$$33$YR$$F$Y$$$20240925$$MD$CA$CA
1981617913$19816179$13$F$$20240823$20210909$20240827$EXP$$GB-TAKEDA-2021TUS048667$TAKEDA$$78$YR$$F$Y$$$20240827$$HP$GB$GB
198163503$19816350$3$F$$20240730$20210909$20240806$EXP$$US-JAZZ-2021-US-016505$JAZZ$$$$$F$Y$$$20240806$$MD$US$US
198166352$19816635$2$F$20210902$20240806$20210910$20240813$PER$$US-SA-2021SA295046$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240814$$MD$US$US
198170964$19817096$4$F$20230518$20240919$20210910$20240925$EXP$$US-TAKEDA-US202032678$TAKEDA$$56$YR$$F$Y$$$20240925$$MD$US$US
198174646$19817464$6$F$$20240729$20210910$20240812$PER$$US-BIOMARINAP-US-2021-138436$BIOMARIN$$$$$$Y$$$20240812$$CN$US$US
1981807613$19818076$13$F$$20240703$20210911$20240712$EXP$$CA-ROCHE-2904507$ROCHE$$$$A$F$Y$$$20240712$$MD$CA$CA
1981816012$19818160$12$F$$20240723$20210911$20240727$EXP$$US-SHIRE-US201942558AA$TAKEDA$$$$$F$Y$$$20240727$$CN$US$US
198187138$19818713$8$F$$20240826$20210912$20240905$EXP$$CA-TEVA-2020-CA-1865644$TEVA$$80$YR$$M$Y$89$KG$20240905$$HP$CA$CA
198192336$19819233$6$F$20190805$20240715$20210913$20240724$EXP$$DE-AUROBINDO-AUR-APL-2019-056667$AUROBINDO$$$$A$F$Y$57$KG$20240724$$MD$DE$DE
198195214$19819521$4$F$20210101$20240827$20210913$20240919$PER$$US-SA-2021SA298179$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240919$$MD$US$US
1982014529$19820145$29$F$20210101$20240916$20210913$20240924$EXP$$CA-CELLTRION INC.-2021CA012433$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
198208362$19820836$2$F$$20240906$20210913$20240930$PER$$US-SA-2021SA296517$SANOFI AVENTIS$$$$E$F$Y$72.12$KG$20240930$$MD$US$US
198214158$19821415$8$F$20210719$20240731$20210913$20240806$EXP$$US-ASTELLAS-2021US033811$ASTELLAS$$72$YR$$M$Y$$$20240806$$CN$US$US
198232235$19823223$5$F$20210826$20240828$20210913$20240902$EXP$$US-TAKEDA-2021TUS055851$TAKEDA$$64$YR$$M$Y$$$20240902$$MD$US$US
198236436$19823643$6$F$20210901$20240829$20210913$20240904$EXP$$US-INCYTE CORPORATION-2021IN006139$INCYTE$$$$$$Y$$$20240904$$CN$US$US
1982528510$19825285$10$F$20210101$20240628$20210913$20240705$EXP$$CA-OTSUKA-2021_031392$OTSUKA$$$$$M$Y$$$20240705$$MD$CA$CA
198253298$19825329$8$F$20231201$20240804$20210914$20240809$EXP$$US-SA-2021SA298703$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240809$$MD$US$US
1982548610$19825486$10$F$20210806$20240820$20210914$20240826$PER$$US-BIOGEN-2021BI01048189$BIOGEN$$56$YR$$M$Y$$$20240826$$CN$US$US
198262387$19826238$7$F$20190101$20240905$20210914$20240918$EXP$$BE-AUROBINDO-AUR-APL-2021-038835$AUROBINDO$Orazem M, Draulans C, Spaas M, Van Cutsem E, Debecker M, De Meerleer G, et al.. A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy.. Clinical Journal of Gastroenterology.. 2021;14(4):1121-1125$33$YR$$M$Y$$$20240918$$HP$BE$BE
1982639022$19826390$22$F$20210101$20240809$20210914$20240817$EXP$$CA-CELLTRION INC.-2021CA008619$CELLTRION$$$$$$Y$$$20240817$$MD$CA$CA
198271783$19827178$3$F$$20240903$20210914$20240909$EXP$$DE-MYLANLABS-2021M1058873$MYLAN$$$$E$M$Y$$$20240909$$MD$DE$DE
198277243$19827724$3$F$20210724$20240824$20210914$20240902$30DAY$$CA-TAKEDA-2021TUS029379$TAKEDA$$21$YR$$F$Y$$$20240902$$CN$CA$CA
198278647$19827864$7$F$20210301$20240730$20210914$20240802$EXP$$US-PFIZER INC-202101154273$PFIZER$$71$YR$$F$Y$72.12$KG$20240802$$CN$US$US
1982942611$19829426$11$F$20210906$20240808$20210914$20240814$EXP$$CA-TAKEDA-2021TUS056178$TAKEDA$$67$YR$$F$Y$$$20240814$$MD$CA$CA
1983035523$19830355$23$F$20210701$20240905$20210915$20240914$EXP$$CA-CELLTRION INC.-2021CA010285$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
198311246$19831124$6$F$20201001$20240905$20210915$20240913$EXP$$CA-ROCHE-2909439$ROCHE$$9$YR$C$M$Y$52$KG$20240913$$MD$CA$CA
198341012$19834101$2$F$$20240705$20210915$20240715$PER$$US-SA-2021SA303368$SANOFI AVENTIS$$$$A$F$Y$$$20240715$$MD$US$US
198349428$19834942$8$F$$20240826$20210915$20240902$EXP$$CA-AstraZeneca-2020SF34322$ASTRAZENECA$$71$YR$$M$Y$91$KG$20240902$$MD$CA$
1983505723$19835057$23$F$20200406$20240909$20210916$20240918$EXP$$CA-CELLTRION INC.-2020CA017968$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
1983517720$19835177$20$F$20220121$20240723$20210915$20240729$EXP$$IN-PFIZER INC-2020476509$PFIZER$$64$YR$$F$Y$35.3$KG$20240729$$CN$IN$IN
198369617$19836961$7$F$20180618$20240903$20210916$20240910$EXP$$JP-ABBVIE-19P-087-2906543-00$ABBVIE$$64$YR$$M$Y$61$KG$20240910$$MD$JP$JP
198370775$19837077$5$F$$20240715$20210915$20240723$EXP$$CA-AstraZeneca-2021A718876$ASTRAZENECA$NOT REPORTED. NOT REPORTED. NOT REPORTED NOT REPORTED(NOT REPORTED):$66$YR$$M$Y$70$KG$20240723$$MD$CA$
198377712$19837771$2$F$20210820$20240731$20210916$20240810$30DAY$$US-GLAXOSMITHKLINE-US2021193127$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240810$$CN$US$US
198401977$19840197$7$F$20200618$20240715$20210915$20240717$EXP$$US-TAKEDA-US202020230$TAKEDA$$61$YR$$F$Y$$$20240717$$CN$US$US
198402602$19840260$2$F$$20240828$20210916$20240904$EXP$$IT-AMGEN-ITASP2021139847$AMGEN$Ceechi N.; Giannotta J. A.; Capecchi M. et al.. EFFICACY OF THROMBOPOIETIN RECEPTOR AGONISTS IN EVANS SYNDROME: A SINGLE CENTER SERIES 2021. Hemisphere. 2021;5 (Suppl_2):546-547$54$YR$A$M$Y$$$20240904$$HP$IT$IT
198405518$19840551$8$F$20180626$20240723$20210915$20240725$EXP$$CA-TAKEDA-2018TUS021477$TAKEDA$$58$YR$$F$Y$$$20240725$$MD$CA$CA
198408699$19840869$9$F$20210301$20240708$20210916$20240729$PER$$CA-TOLMAR, INC.-21CA029664$TOLMAR$$76$YR$$M$Y$$$20240726$$CN$CA$CA
198415514$19841551$4$F$20240801$20240917$20210916$20240919$EXP$$IN-PFIZER INC-202101168773$PFIZER$$56$YR$$M$Y$62$KG$20240919$$CN$IN$IN
1984156913$19841569$13$F$20230714$20240709$20210916$20240712$EXP$$CA-PFIZER INC-2021039750$PFIZER$$63$YR$$F$Y$83.6$KG$20240712$$CN$CA$CA
198434264$19843426$4$F$$20240913$20210917$20240926$EXP$GB-MHRA-ADR 25879755$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2021-05818$ALKEM$Sadik A, Jelley M, Ward R.. Depression with psychosis following pregabalin discontinuation. Progress in Neurology and Psychiatry. 2021;25(1):19-22$74$YR$$F$Y$$$20240926$$MD$GB$GB
198435735$19843573$5$F$20210929$20211102$20210917$20240925$EXP$$US-GLAXOSMITHKLINE-US2021195565$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
198439392$19843939$2$F$$20240829$20210916$20240904$PER$$US-TAKEDA-2021TUS056168$TAKEDA$$$$$F$Y$81.633$KG$20240904$$CN$US$US
198447293$19844729$3$F$$20240905$20210917$20240910$EXP$$CA-Covis Pharma GmbH-2021COV20615$COVIS PHARMA$$63$YR$A$F$Y$79$KG$20240910$$CN$CA$CA
198449193$19844919$3$F$20200915$20240627$20210916$20240708$EXP$$CA-TAKEDA-2021TUS057031$TAKEDA$$28$YR$$F$Y$$$20240708$$CN$CA$CA
198455523$19845552$3$F$$20211001$20210917$20240709$EXP$$NL-ASTELLAS-2021US034428$ASTELLAS$$$$E$F$Y$$$20240709$$CN$NL$NL
198460953$19846095$3$F$20210101$20211004$20210917$20240710$EXP$$CO-ASTELLAS-2021US034561$ASTELLAS$$44$YR$$F$Y$48$KG$20240710$$CN$CO$CO
198464277$19846427$7$F$$20240812$20210917$20240814$EXP$$US-TAKEDA-US202003462$TAKEDA$$$$$F$Y$$$20240814$$HP$US$US
198469282$19846928$2$F$$20240725$20210917$20240731$EXP$$US-VIIV HEALTHCARE LIMITED-US2021196488$VIIV$$$$$M$Y$$$20240731$$CN$US$US
198470509$19847050$9$F$20220606$20240729$20210917$20240731$PER$$NVSC2021US209433$NOVARTIS$$77$YR$$F$Y$$$20240731$$CN$US$US
198492255$19849225$5$F$20210126$20240810$20210917$20240819$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-092555$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240819$$MD$DE$DE
198493349$19849334$9$F$20230220$20240827$20210918$20240830$EXP$$US-TAKEDA-2021TUS024022$TAKEDA$$54$YR$$F$Y$68$KG$20240830$$CN$US$US
198493513$19849351$3$F$20201214$20240704$20210917$20240709$EXP$$DE-MYLANLABS-2021M1053402$MYLAN$$$$A$F$Y$$$20240709$$HP$DE$DE
198496228$19849622$8$F$$20240705$20210917$20240712$EXP$$CA-AstraZeneca-2021A721982$ASTRAZENECA$Peterson W, Liederman Z, Baker J,Floros G,Martin R,Berger H,Meffe F, Teitel J, Sholzberg M. Hemorrhagic, thrombotic and obstetric complications of congenital dysfibrinogenemia in a previously asymptomatic woman. Thrombosis Research 2020;196:127-129.$35$YR$$F$Y$$$20240712$$HP$CA$
1984986511$19849865$11$F$20210101$20240826$20210917$20240903$EXP$$CA-TAKEDA-2021TUS057214$TAKEDA$$$$$F$Y$$$20240903$$MD$CA$CA
198498733$19849873$3$F$$20240814$20210917$20240816$EXP$$CA-TAKEDA-2021TUS057231$TAKEDA$$$$$$Y$$$20240816$$HP$CA$CA
198502123$19850212$3$F$$20211213$20210917$20240711$PER$$NVSC2021US210718$NOVARTIS$$$$$F$Y$$$20240711$$CN$US$US
198504082$19850408$2$F$20240827$20240827$20210918$20240830$EXP$$US-TAKEDA-US202012603$TAKEDA$$67$YR$$M$Y$$$20240830$$HP$US$US
198533062$19853306$2$F$20240101$20240625$20210919$20240704$PER$$US-SA-2021SA305739$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240704$$MD$US$US
1985374510$19853745$10$F$20210901$20240122$20210919$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR196909$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
198554273$19855427$3$F$20200106$20240625$20210920$20240704$PER$$US-SA-2021SA306815$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240704$$MD$US$US
198563148$19856314$8$F$20210914$20240903$20210920$20240906$EXP$$CA-TAKEDA-2020TUS057014$TAKEDA$$42$YR$$M$Y$$$20240906$$CN$CA$CA
198565478$19856547$8$F$$20240711$20210920$20240717$PER$$US-ROCHE-2914278$ROCHE$$36$YR$A$M$Y$$$20240717$$CN$US$US
198566226$19856622$6$F$$20240717$20210920$20240719$EXP$$US-TAKEDA-US201847865$TAKEDA$$$$$F$Y$$$20240719$$HP$US$US
198581472$19858147$2$F$20210518$20240820$20210921$20240821$EXP$FR-AFSSAPS-LY20217767$FR-UCBSA-2021043390$UCB$$33$YR$$F$Y$69$KG$20240821$$MD$FR$FR
198604902$19860490$2$F$20210901$20240823$20210921$20240909$PER$$US-SA-2021SA308627$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240909$$MD$US$US
198606983$19860698$3$F$20210715$20240904$20210920$20240906$EXP$$FR-TAKEDA-2021TUS057640$TAKEDA$$7$YR$$F$Y$$$20240906$$HP$FR$FR
1986119914$19861199$14$F$20201120$20240916$20210920$20240920$EXP$$CA-PFIZER INC-2020450692$PFIZER$$59$YR$$M$Y$113.4$KG$20240920$$MD$CA$CA
1986140514$19861405$14$F$20210827$20240904$20210920$20240906$EXP$$US-TAKEDA-2021TUS056910$TAKEDA$$29$YR$$M$Y$$$20240906$$PH$US$US
198614349$19861434$9$F$20200902$20240920$20210921$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-004140$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$60.5$KG$20240925$$MD$JP$JP
1986146225$19861462$25$F$20210309$20240729$20210920$20240801$EXP$$CA-PFIZER INC-2020460945$PFIZER$$40$YR$$F$Y$$$20240801$$HP$CA$CA
198615884$19861588$4$F$$20240904$20210921$20240907$EXP$$US-TAKEDA-US201937068$TAKEDA$$$$$F$Y$$$20240907$$HP$US$US
1986169410$19861694$10$F$$20240919$20210920$20240924$PER$$US-PFIZER INC-2021694886$PFIZER$$76$YR$$F$Y$77.098$KG$20240924$$CN$US$US
198617084$19861708$4$F$20210101$20240725$20210920$20240730$EXP$$US-PFIZER INC-202101060681$PFIZER$$72$YR$$F$Y$65.77$KG$20240730$$HP$US$US
1986204616$19862046$16$F$$20240913$20210921$20240918$EXP$$NVSC2021US213426$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
198625493$19862549$3$F$20210101$20240702$20210921$20240705$EXP$$US-PFIZER INC-2021677254$PFIZER$$72$YR$$F$Y$$$20240705$$HP$US$US
198649813$19864981$3$F$$20240808$20210921$20240819$EXP$$AU-PFIZER INC-202101211861$PFIZER$$$$A$M$Y$$$20240819$$MD$AU$AU
198654608$19865460$8$F$20210426$20240805$20210921$20240808$EXP$$US-TAKEDA-2021TUS029542$TAKEDA$$61$YR$$F$Y$92$KG$20240808$$CN$US$US
198657099$19865709$9$F$20210823$20240902$20210922$20240903$EXP$$ES-ROCHE-2910665$ROCHE$$54$YR$A$F$Y$$$20240903$$MD$ES$ES
1986625120$19866251$20$F$20210901$20240717$20210922$20240725$EXP$$CH-ABBVIE-21K-151-4084003-00$ABBVIE$$86$YR$$F$Y$$$20240725$$CN$CH$CH
198662853$19866285$3$F$20210903$20240829$20210921$20240830$EXP$$US-TAKEDA-2021TUS058410$TAKEDA$$1$YR$$M$Y$$$20240830$$PH$US$US
1986647517$19866475$17$F$20210803$20240626$20210922$20240717$EXP$$DE-ROCHE-2914332$ROCHE$$66$YR$E$M$Y$$$20240717$$CN$DE$DE
1986717310$19867173$10$F$$20240916$20210921$20240918$PER$$US-PFIZER INC-2021797409$PFIZER$$65$YR$$F$Y$$$20240918$$MD$US$US
198673062$19867306$2$F$$20210914$20210922$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-312076$RANBAXY$Beshay A, Petersen M, Rhoads JLW. Severe EGFR inhibitor-induced acneiform eruption responding to dapsone. Dermatol Online J. 2021;Jul;27(7):7 (1-3)$72$YR$$M$Y$$$20240702$$MD$US$US
198684014$19868401$4$F$20190101$20240802$20210921$20240809$EXP$$GB-SA-2019SA170318$SANOFI AVENTIS$$81$YR$E$M$Y$97.7$KG$20240809$$CN$GB$GB
198686114$19868611$4$F$20210101$20240814$20210922$20240816$EXP$$US-PFIZER INC-2021154711$PFIZER$$51$YR$$F$Y$$$20240816$$HP$US$US
1986866115$19868661$15$F$20210902$20240924$20210922$20240926$EXP$$US-TAKEDA-US201936856$TAKEDA$$5$YR$$M$Y$$$20240926$$CN$US$US
198687824$19868782$4$F$20210701$20240903$20210922$20240904$PER$$NVSC2021US213612$NOVARTIS$$54$YR$$M$Y$$$20240904$$CN$US$US
198692829$19869282$9$F$20191203$20240823$20210922$20240829$EXP$$MX-TAKEDA-MX201943942$TAKEDA$$6$YR$$M$Y$24$KG$20240829$$CN$MX$MX
198693755$19869375$5$F$$20240917$20210922$20240920$EXP$$US-SHIRE-US202011218$TAKEDA$$$$$F$Y$$$20240920$$HP$US$US
198693826$19869382$6$F$20220317$20240904$20210923$20240911$EXP$$CA-ABBVIE-21K-028-4090122-00$ABBVIE$$82$YR$$M$Y$$$20240911$$MD$CA$CA
1986973926$19869739$26$F$$20240919$20210922$20240927$EXP$$US-TAKEDA-2021TUS052249$TAKEDA$$$$$F$Y$69$KG$20240927$$MD$US$US
1987035822$19870358$22$F$20210913$20240829$20210923$20240907$EXP$$CA-CELLTRION INC.-2021CA012941$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
198703807$19870380$7$F$20240101$20240909$20210922$20240911$EXP$$US-PFIZER INC-2019311786$PFIZER$$70$YR$$F$Y$$$20240911$$CN$US$US
198704823$19870482$3$F$$20240903$20210922$20240913$EXP$$CA-TEVA-2019-CA-1116765$TEVA$$60$YR$$F$Y$61$KG$20240913$$MD$CA$CA
1987211012$19872110$12$F$20231124$20240805$20210923$20240812$EXP$$US-SA-2021SA310113$SANOFI AVENTIS$$10$YR$C$M$Y$34.47$KG$20240812$$MD$US$US
198729025$19872902$5$F$$20240919$20210922$20240923$PER$$US-PFIZER INC-2021702320$PFIZER$$52$YR$$F$Y$$$20240923$$HP$US$US
198731802$19873180$2$F$$20240801$20210922$20240805$EXP$$US-KYOWAKIRIN-2021BKK015712$KYOWA$$$$$$Y$$$20240805$$HP$US$US
198735785$19873578$5$F$$20240904$20210922$20240913$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-093972$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240913$$HP$CA$CA
198737609$19873760$9$F$20230101$20240820$20210923$20240827$EXP$$BR-GLAXOSMITHKLINE-BR2021AMR140433$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$BR$BR
198741752$19874175$2$F$$20240719$20210922$20240731$PER$$US-SA-2021SA308840$SANOFI AVENTIS$$$$A$F$Y$$$20240731$$MD$US$US
198743166$19874316$6$F$$20240723$20210922$20240730$PER$$US-SA-2021SA308690$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240730$$HP$US$US
198744002$19874400$2$F$20210725$20240918$20210923$20240927$PER$$US-SA-2021SA311834$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240927$$MD$US$US
1987459116$19874591$16$F$$20240830$20210922$20240904$EXP$$CA-ANIPHARMA-2021-CA-001419$ANI$$43$YR$$F$Y$$$20240904$$HP$CA$CA
198747166$19874716$6$F$20210101$20240822$20210923$20240828$PER$$US-PFIZER INC-202101056224$PFIZER$$52$YR$$F$Y$$$20240828$$HP$US$US
1987581835$19875818$35$F$20060101$20240911$20210924$20240918$EXP$$JP-SAKK-2021SA299449AA$SANOFI AVENTIS$$40$YR$A$M$Y$100$KG$20240918$$MD$JP$JP
198760772$19876077$2$F$$20210921$20210924$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR200525$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
198760793$19876079$3$F$$20220209$20210924$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR200624$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
198763753$19876375$3$F$$20210929$20210924$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR197169$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
1987771413$19877714$13$F$20220706$20240830$20210923$20240903$EXP$$US-TAKEDA-2021TUS051838$TAKEDA$$71$YR$$F$Y$82$KG$20240903$$HP$US$US
198779376$19877937$6$F$20211108$20240813$20210923$20240819$EXP$$CA-TAKEDA-2020TUS002069$TAKEDA$$64$YR$$F$Y$$$20240819$$MD$CA$CA
1987881911$19878819$11$F$20210901$20240917$20210924$20240920$EXP$$JP-TAKEDA-2021TJP090838$TAKEDA$$57$YR$$M$Y$$$20240920$$CN$JP$JP
198792882$19879288$2$F$$20240826$20210923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-003170$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
1987930935$19879309$35$F$20210101$20240717$20210923$20240725$EXP$$CA-CELLTRION INC.-2021CA012759$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
198796313$19879631$3$F$$20240708$20210924$20240717$EXP$$HR-PFIZER INC-202101197584$PFIZER$$63$YR$$M$Y$$$20240717$$MD$HR$HR
198797052$19879705$2$F$20210810$20240819$20210924$20240826$EXP$$JP-PFIZER INC-202101250718$PFIZER$$74$YR$$M$Y$69$KG$20240826$$PH$JP$JP
198798594$19879859$4$F$20210701$20211019$20210924$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR198838$GLAXOSMITHKLINE$$79$YR$$F$Y$$$20240925$$CN$US$US
198800572$19880057$2$F$$20240913$20210924$20240918$PER$$US-PFIZER INC-202101192251$PFIZER$$84$YR$$F$Y$46.72$KG$20240918$$CN$US$US
1988018617$19880186$17$F$20221109$20240903$20210925$20240911$EXP$$CA-CELLTRION INC.-2021CA000283$CELLTRION$$$$$$Y$$$20240911$$MD$CA$CA
198805582$19880558$2$F$$20240703$20210925$20240705$EXP$$US-TAKEDA-2021TUS059113$TAKEDA$$$$$F$Y$$$20240705$$CN$US$US
1988060625$19880606$25$F$20210101$20240909$20210925$20240917$EXP$$CA-CELLTRION INC.-2021CA008483$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
198809658$19880965$8$F$20210818$20240704$20210924$20240706$EXP$DE-BFARM-21009216$DE-INCYTE CORPORATION-2021IN008739$INCYTE$Andreas Edwin Juarso, Stefanie Entz, Florian Weissinger. Targeted therapy in intrahepatic cholangiocarcinoma$$$$$Y$$$20240706$$HP$DE$DE
1988105716$19881057$16$F$20210701$20240817$20210924$20240820$EXP$$US-JAZZ-2021-US-012636$JAZZ$$22$YR$$F$Y$$$20240820$$HP$US$US
198810593$19881059$3$F$20210203$20240703$20210924$20240710$EXP$$FR-PFIZER INC-2021603637$PFIZER$$58$YR$$F$Y$$$20240710$$HP$FR$FR
1988151122$19881511$22$F$20200501$20240822$20210925$20240829$EXP$$US-TAKEDA-US202015566$TAKEDA$$71$YR$$F$Y$$$20240829$$HP$US$US
198819089$19881908$9$F$19700101$20240919$20210924$20240919$PER$$US-PFIZER INC-202101191993$PFIZER$$85$YR$$F$Y$71.202$KG$20240919$$CN$US$US
1988191017$19881910$17$F$20200304$20240911$20210925$20240913$EXP$$CA-ROCHE-2567495$ROCHE$$52$YR$A$F$Y$$$20240913$$CN$CA$CA
1988191110$19881911$10$F$20200901$20240924$20210925$20240927$EXP$$DE-ROCHE-2909952$ROCHE$$26$YR$A$F$Y$$$20240928$$CN$DE$DE
198821874$19882187$4$F$20230828$20240815$20210924$20240819$EXP$$US-PFIZER INC-202100974923$PFIZER$$77$YR$$M$Y$$$20240819$$CN$US$US
198825794$19882579$4$F$20210801$20240614$20210924$20240725$PER$$US-SA-2021SA310088$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240725$$MD$US$US
198825992$19882599$2$F$20210101$20240702$20210924$20240709$PER$$US-SA-2021SA310599$SANOFI AVENTIS$$64$YR$A$M$Y$90.71$KG$20240709$$MD$US$US
198835066$19883506$6$F$20210608$20240903$20210926$20240911$EXP$$JP-ABBVIE-21K-087-3949221-00$ABBVIE$$87$YR$$F$Y$55$KG$20240911$$MD$JP$JP
198841542$19884154$2$F$$20240801$20210927$20240814$EXP$$CA-AUROBINDO-AUR-APL-2021-039738$AUROBINDO$$64$YR$$F$Y$92$KG$20240814$$HP$CA$CA
198841862$19884186$2$F$$20240719$20210927$20240730$PER$$US-SA-2021SA312375$SANOFI AVENTIS$$61$YR$A$F$Y$74.84$KG$20240730$$MD$US$US
198844234$19884423$4$F$$20240812$20210927$20240823$EXP$$CA-AUROBINDO-AUR-APL-2021-039889$AUROBINDO$$67$YR$$F$Y$77$KG$20240823$$HP$CA$CA
198854243$19885424$3$F$$20240905$20210927$20240914$EXP$$CA-TEVA-2020-CA-1832960$TEVA$$$$$M$Y$$$20240914$$CN$CA$CA
1988631415$19886314$15$F$20201011$20240909$20210927$20240917$EXP$$CA-ROCHE-2896992$ROCHE$$72$YR$E$M$Y$$$20240917$$CN$CA$CA
198863406$19886340$6$F$$20220119$20210928$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR201123$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
198863833$19886383$3$F$$20240830$20210928$20240902$PER$$NVSC2021US218627$NOVARTIS$$69$YR$$F$Y$$$20240902$$CN$US$US
1988713723$19887137$23$F$20210803$20240919$20210928$20240928$EXP$$CA-CELLTRION INC.-2021CA012872$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
198875492$19887549$2$F$20210101$20210913$20210928$20240725$EXP$$US-RECORDATI-2021002603$RECORDATI$$$$$$Y$$$20240725$$CN$US$US
198877316$19887731$6$F$20200101$20240701$20210928$20240705$EXP$$US-BIOGEN-2020BI00927312$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
198886125$19888612$5$F$20180601$20240716$20210927$20240723$EXP$$US-JNJFOC-20210941578$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240722$$LW$US$US
198897718$19889771$8$F$$20240613$20210927$20240715$EXP$$ZA-ROCHE-2620313$ROCHE$$58$YR$A$F$Y$$$20240715$$CN$ZA$ZA
198899159$19889915$9$F$20210928$20220314$20210928$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR201157$GLAXOSMITHKLINE$$48$YR$$F$Y$$$20240925$$CN$US$US
198902816$19890281$6$F$$20240715$20210928$20240822$EXP$$CA-Covis Pharma GmbH-2021COV20121$COVIS PHARMA$$72$YR$E$M$Y$$$20240822$$MD$CA$CA
198903486$19890348$6$F$20200814$20240725$20210928$20240731$EXP$$DE-MYLANLABS-2021M1040832$MYLAN$$68$YR$$F$Y$$$20240731$$HP$DE$DE
198904002$19890400$2$F$20210729$20240903$20210927$20240909$EXP$$CA-TAKEDA-2021TUS059120$TAKEDA$$17$YR$$F$Y$$$20240909$$MD$CA$CA
198905062$19890506$2$F$$20240827$20210928$20240828$EXP$$US-UCBSA-2021044367$UCB$$$$$F$Y$$$20240828$$CN$US$US
198905263$19890526$3$F$$20240926$20210927$20240930$EXP$$US-SHIRE-US201716098$TAKEDA$$$$$M$Y$$$20240930$$CN$US$US
198907607$19890760$7$F$20240801$20240802$20210927$20240808$EXP$$US-JAZZ-2021-US-017775$JAZZ$$52$YR$$M$Y$$$20240808$$CN$US$US
198908283$19890828$3$F$20230925$20240730$20210927$20240807$EXP$$BR-TAKEDA-2021TUS059415$TAKEDA$$42$YR$$F$Y$$$20240807$$CN$BR$BR
1989123114$19891231$14$F$20200306$20240816$20210928$20240823$EXP$$CO-SHIRE-CO202009165AA$TAKEDA$$46$YR$$M$Y$67$KG$20240823$$CN$CO$CO
198913303$19891330$3$F$20210101$20240726$20210928$20240801$PER$$US-AMGEN-USASP2021146062$AMGEN$$81$YR$E$F$Y$$$20240801$$MD$US$US
1989136116$19891361$16$F$20180828$20240722$20210927$20240730$EXP$$CA-CELLTRION INC.-2021CA013019$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
198914169$19891416$9$F$20210913$20240903$20210927$20240911$EXP$$NVSC2021GB214912$NOVARTIS$$60$YR$$F$Y$$$20240911$$HP$GB$GB
198917819$19891781$9$F$20210411$20240816$20210928$20240820$EXP$$US-ABBVIE-21K-163-4095719-00$ABBVIE$$32$YR$$M$Y$$$20240820$$MD$US$US
1989195037$19891950$37$F$20201030$20240717$20210928$20240722$EXP$$CA-TAKEDA-2020TUS047552$TAKEDA$$55$YR$$F$Y$53$KG$20240722$$CN$CA$CA
198927625$19892762$5$F$20170901$20240712$20210928$20240716$EXP$$FR-MYLANLABS-2021M1065888$MYLAN$$74$YR$$$Y$$$20240716$$LW$FR$FR
1989279921$19892799$21$F$20210919$20240808$20210928$20240813$EXP$$US-TAKEDA-2021TUS058048$TAKEDA$$66$YR$$F$Y$66$KG$20240813$$MD$US$US
198931047$19893104$7$F$20200301$20240620$20210929$20240704$EXP$$CO-SA-2021SA305087$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240704$$MD$CO$CO
198944179$19894417$9$F$20210918$20240710$20210928$20240715$EXP$$CA-TAKEDA-2021TUS059177$TAKEDA$$62$YR$$M$Y$$$20240715$$CN$CA$CA
198961693$19896169$3$F$$20240920$20210929$20240926$EXP$$CA-Orion Corporation ORION PHARMA-21_00015952$ORION$$33$YR$A$M$Y$$$20240926$$MD$CA$
1989637520$19896375$20$F$20200803$20240820$20210929$20240828$EXP$$US-TAKEDA-US202025303$TAKEDA$$74$YR$$F$Y$84$KG$20240828$$CN$US$US
198966643$19896664$3$F$$20220715$20210929$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-312313$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
198975319$19897531$9$F$20190926$20240828$20210930$20240905$EXP$$CA-CELLTRION INC.-2019CA025317$CELLTRION$$$$$$Y$$$20240905$$CN$CA$CA
198985336$19898533$6$F$20231214$20240719$20210930$20240725$EXP$$CA-TAKEDA-2021TUS059897$TAKEDA$$35$YR$$F$Y$$$20240725$$MD$CA$CA
198988833$19898883$3$F$$20240827$20210930$20240905$EXP$$CA-AUROBINDO-AUR-APL-2021-040636$AUROBINDO$$76$YR$$M$Y$$$20240905$$HP$CA$CA
198989852$19898985$2$F$20210801$20240920$20210929$20240927$EXP$$CA-TAKEDA-2020TUS020836$TAKEDA$$63$YR$$M$Y$$$20240927$$CN$CA$CA
1989909315$19899093$15$F$20210604$20240909$20210929$20240912$EXP$$US-TAKEDA-2017BLT002844$TAKEDA$$78$YR$$F$Y$47$KG$20240912$$HP$US$US
198991435$19899143$5$F$20210224$20240916$20210930$20240919$EXP$$DE-ABBVIE-21K-062-4099366-00$ABBVIE$$62$YR$$M$Y$67$KG$20240919$$MD$DE$DE
1989948621$19899486$21$F$20210323$20240819$20210929$20240826$EXP$$CA-ROCHE-2919964$ROCHE$$30$YR$A$F$Y$$$20240826$$CN$CA$CA
198995826$19899582$6$F$20210916$20240723$20210929$20240726$EXP$$US-TAKEDA-2021TUS059019$TAKEDA$$56$YR$$F$Y$$$20240726$$HP$US$US
199000096$19900009$6$F$20210924$20240712$20210929$20240716$EXP$$US-SHIRE-US201935831$TAKEDA$$32$YR$$F$Y$$$20240716$$HP$US$US
199001918$19900191$8$F$20210721$20240830$20210930$20240911$EXP$$ES-Accord-240005$ACCORD$$69$YR$E$M$Y$91$KG$20240911$$HP$ES$ES
199007497$19900749$7$F$20211012$20240822$20210929$20240827$EXP$$CA-TAKEDA-2021TUS059500$TAKEDA$$73$YR$$F$Y$$$20240827$$HP$CA$CA
1990103229$19901032$29$F$20210101$20240919$20210930$20240928$EXP$$CA-CELLTRION INC.-2021CA011481$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
199010966$19901096$6$F$20210824$20240628$20210930$20240703$PER$$US-PFIZER INC-202100977598$PFIZER$$80$YR$$M$Y$99.34$KG$20240703$$MD$US$US
199012338$19901233$8$F$20240801$20240808$20210930$20240812$PER$$US-PFIZER INC-2020006677$PFIZER$$51$YR$$F$Y$$$20240812$$CN$US$US
199018727$19901872$7$F$$20240826$20210929$20240828$EXP$$CA-ROCHE-2923400$ROCHE$$$$A$M$Y$$$20240828$$CN$CA$CA
199023133$19902313$3$F$20210101$20240626$20210930$20240705$PER$$US-SA-2021SA316601$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240705$$MD$US$US
199023186$19902318$6$F$20210101$20240909$20210930$20240914$EXP$$US-SA-2021SA316872$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240914$$MD$US$US
199024082$19902408$2$F$$20240719$20210930$20240801$PER$$US-SA-2021SA321340$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240801$$MD$US$US
199024963$19902496$3$F$20210924$20240828$20210930$20240923$PER$$US-SA-2021SA322421$SANOFI AVENTIS$$54$YR$A$F$Y$63.5$KG$20240923$$MD$US$US
199026025$19902602$5$F$20140101$20240906$20210930$20240909$PER$$US-GILEAD-2021-0550580$GILEAD$$$$A$M$Y$$$20240909$$LW$US$US
1990313412$19903134$12$F$$20240801$20211001$20240805$PER$$US-AMGEN-USASP2021151427$AMGEN$$50$YR$A$F$Y$$$20240805$$HP$US$US
199032773$19903277$3$F$$20240917$20211001$20240925$EXP$$CA-CELLTRION INC.-2021CA013121$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
1990342134$19903421$34$F$20210101$20240920$20211001$20240930$EXP$$CA-CELLTRION INC.-2021CA012750$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
199040217$19904021$7$F$20211101$20220428$20211001$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR204689$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240925$$CN$US$US
199042346$19904234$6$F$$20240710$20210930$20240730$EXP$$DE-ROCHE-2866589$ROCHE$$80$YR$E$M$Y$69$KG$20240730$$MD$CA$DE
1990439216$19904392$16$F$20190816$20240909$20210930$20240912$EXP$$US-TAKEDA-US201928352$TAKEDA$$3$YR$$M$Y$$$20240912$$MD$US$US
199044897$19904489$7$F$$20240812$20210930$20240819$EXP$$US-GW PHARMA-202109USGW04690$JAZZ$$$$$M$Y$$$20240818$$CN$US$US
199046862$19904686$2$F$20210101$20210916$20211001$20240722$EXP$$US-RECORDATI-2021003092$RECORDATI$$$$$$Y$$$20240722$$CN$US$US
1990494520$19904945$20$F$20210807$20240719$20210930$20240725$EXP$$AU-TAKEDA-2021TUS050693$TAKEDA$$61$YR$$M$Y$76$KG$20240725$$CN$AU$AU
199050583$19905058$3$F$20210915$20240625$20210930$20240701$EXP$$FR-SERVIER-S21010565$SERVIER$$$$$$Y$$$20240701$$MD$FR$FR
199052763$19905276$3$F$20210619$20240722$20211001$20240808$PER$$CA-TOLMAR, INC.-21CA028293$TOLMAR$$67$YR$$M$Y$$$20240808$$CN$CA$CA
199062684$19906268$4$F$20211018$20240912$20210930$20240918$EXP$$CA-TAKEDA-2021TUS053265$TAKEDA$$40$YR$$M$Y$$$20240918$$MD$CA$CA
199063312$19906331$2$F$20210101$20240802$20211001$20240812$PER$$US-SA-2021SA321498$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240812$$MD$US$US
199067699$19906769$9$F$$20240806$20210930$20240808$EXP$$US-TAKEDA-US201849572$TAKEDA$$$$$M$Y$$$20240808$$CN$US$US
1990689514$19906895$14$F$20211021$20240905$20210930$20240910$EXP$$CA-TAKEDA-2021TUS059927$TAKEDA$$50$YR$$M$Y$$$20240910$$CN$CA$CA
199073622$19907362$2$F$$20240701$20210930$20240710$PER$$US-INCYTE CORPORATION-2021IN008729$INCYTE$$$$$$Y$$$20240710$$HP$US$US
199078585$19907858$5$F$$20240911$20211001$20240916$EXP$$US-SHIRE-US202032081$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
199081803$19908180$3$F$20210401$20240717$20211001$20240722$PER$$US-PFIZER INC-202100932791$PFIZER$$71$YR$$F$Y$90.72$KG$20240722$$CN$US$US
1990933813$19909338$13$F$20211021$20230307$20211002$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR202009$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
1990936017$19909360$17$F$20210822$20240901$20211001$20240904$EXP$$IN-PFIZER INC-2018406273$PFIZER$$79$YR$$F$Y$$$20240904$$CN$IN$IN
1990958914$19909589$14$F$20230718$20240920$20211001$20240924$EXP$$US-PFIZER INC-2021545886$PFIZER$$87$YR$$F$Y$80.286$KG$20240924$$CN$US$US
1990991413$19909914$13$F$20210101$20240909$20211003$20240917$EXP$$NVSJ2021JP014247$NOVARTIS$$$$$F$Y$34.6$KG$20240917$$MD$JP$JP
199106766$19910676$6$F$$20240815$20211004$20240827$EXP$$CA-AUROBINDO-AUR-APL-2021-040700$AUROBINDO$$72$YR$$F$Y$61$KG$20240827$$HP$CA$CA
199118662$19911866$2$F$$20240909$20211004$20240919$EXP$$HR-STRIDES ARCOLAB LIMITED-2021SP028236$STRIDES$$63$YR$$M$Y$$$20240919$$MD$HR$HR
199123602$19912360$2$F$$20210920$20211004$20240823$EXP$$PT-AKCEA THERAPEUTICS, INC.-2021IS001719$AKCEA THERAPEUTICS$Marques J.H., Coelho J., Meneres M.J., Beirao J.M.. Progressive vitreous deposits during treatment with inotersen for hereditary ATTR amyloidosis. Amyloid. 2021$$$$$Y$$$20240823$$HP$PT$PT
199124054$19912405$4$F$20200810$20240820$20211004$20240822$EXP$$CA-ROCHE-2665098$ROCHE$$33$YR$A$F$Y$$$20240822$$HP$CA$CA
199124562$19912456$2$F$20190101$20240911$20211004$20240916$EXP$$BE-MYLANLABS-2021M1067594$MYLAN$Carmans L, Van Craenenbroeck A, Lagrou K, Deroose C, Sagaert X, Wolthuis A, et al.. Disseminated histoplasmosis in a kidney liver transplant patient from a non-endemic area: A diagnostic challenge. Elsevier Ltd. 2021;22 (e00971):1-6$63$YR$$F$Y$$$20240916$$HP$BE$BE
199128135$19912813$5$F$$20240628$20211004$20240702$PER$$US-PFIZER INC-2021855082$PFIZER$$57$YR$$M$Y$$$20240702$$CN$US$US
199128162$19912816$2$F$$20240705$20211004$20240709$PER$$US-PFIZER INC-2019340544$PFIZER$$65$YR$$F$Y$$$20240709$$CN$US$US
199128502$19912850$2$F$20210101$20240813$20211004$20240821$PER$$US-SA-2021SA322239$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240821$$MD$US$US
1991298210$19912982$10$F$20210504$20240909$20211004$20240912$PER$$US-PFIZER INC-202101126630$PFIZER$$65$YR$$M$Y$119.7$KG$20240912$$MD$US$US
199131006$19913100$6$F$20210927$20240705$20211004$20240709$EXP$$CA-TAKEDA-2021TUS006307$TAKEDA$$59$YR$$F$Y$$$20240709$$CN$CA$CA
1991320913$19913209$13$F$$20240806$20211004$20240812$EXP$$CZ-MYLANLABS-2021M1068490$MYLAN$Dolezalova I.. Brivaracetam and its clinical use. NEUROLOGY FOR PRACTICE. 2021;22(Suppl E):15-6, 18$20$YR$$F$Y$$$20240812$$MD$CZ$CZ
199171936$19917193$6$F$20190101$20240710$20211005$20240720$EXP$$CA-CELLTRION INC.-2021CA013411$CELLTRION$$$$$$Y$$$20240720$$CN$CA$CA
199173768$19917376$8$F$20210309$20240909$20211005$20240912$EXP$$CA-TAKEDA-2021TUS025932$TAKEDA$$13$YR$$F$Y$$$20240912$$CN$CA$CA
199184147$19918414$7$F$$20240910$20211005$20240918$EXP$$NVSC2021CA219063$NOVARTIS$$61$YR$$F$Y$70$KG$20240918$$CN$CA$CA
1991850313$19918503$13$F$20210921$20240914$20211004$20240919$EXP$$CO-TAKEDA-2021TUS059778$TAKEDA$$17$YR$$F$Y$22$KG$20240919$$CN$CO$CO
199188313$19918831$3$F$$20240709$20211004$20240809$EXP$$US-009507513-2110USA000180$MERCK$Shah S, Bremmer DN, Kline EG, Nicolau DP, Shields RK.. Ceftolozane/tazobactam for refractory P. aeruginosa endocarditis: A case report and pharmacokinetic analysis. Journal of Infection and Chemotherapy. 2021;1-4$48$YR$$M$Y$$$20240809$$HP$US$US
199189889$19918988$9$F$20210422$20240827$20211004$20240902$EXP$$JP-009507513-2110JPN000577$MERCK$$61$YR$$M$Y$92$KG$20240902$$MD$JP$JP
1991907021$19919070$21$F$20210801$20240921$20211005$20240924$EXP$$CA-PFIZER INC-202101110510$PFIZER$$55$YR$$F$Y$$$20240924$$HP$CA$CA
199191198$19919119$8$F$20210901$20240710$20211004$20240716$EXP$$AU-TAKEDA-2021TUS054218$TAKEDA$$44$YR$$F$Y$$$20240716$$HP$AU$AU
1992017710$19920177$10$F$$20240702$20211005$20240708$EXP$$CA-PFIZER INC-202101288909$PFIZER$Senaratne, J.. Plasma Exchange for Immune Checkpoint Inhibitor-Induced Myocarditis. CJC Open. 2021;3(3):379-382$69$YR$$M$Y$$$20240708$$MD$CA$CA
1992020615$19920206$15$F$20240701$20240831$20211005$20240902$EXP$$US-PFIZER INC-202101259504$PFIZER$$54$YR$$F$Y$$$20240902$$CN$US$US
199203022$19920302$2$F$20240704$20240711$20211005$20240715$EXP$$US-KYOWAKIRIN-2021BKK016387$KYOWA$$$$$$Y$$$20240715$$HP$US$US
199203043$19920304$3$F$$20211108$20211006$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR206682$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199205009$19920500$9$F$20190101$20240912$20211005$20240917$EXP$$US-PFIZER INC-2021503682$PFIZER$$60$YR$$M$Y$72.562$KG$20240917$$CN$US$US
199205698$19920569$8$F$20210706$20240812$20211005$20240814$PER$$US-PFIZER INC-2021862991$PFIZER$$82$YR$$M$Y$$$20240814$$CN$US$US
199209615$19920961$5$F$$20240911$20211006$20240918$30DAY$$US-GLAXOSMITHKLINE-US2021205519$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
199216625$19921662$5$F$$20240917$20211006$20240923$PER$$US-TAKEDA-2021TUS061217$TAKEDA$$$$$M$Y$$$20240923$$CN$US$US
199218622$19921862$2$F$20200901$20240823$20211005$20240918$PER$$US-SA-2021SA325032$SANOFI AVENTIS$$55$YR$A$F$Y$57.5$KG$20240918$$MD$US$US
199223122$19922312$2$F$20210101$20240715$20211005$20240723$EXP$$US-SA-2021SA328015$SANOFI AVENTIS$$$$A$M$Y$$$20240723$$MD$US$US
199224032$19922403$2$F$20201201$20240918$20211005$20240926$PER$$US-SA-2021SA322611$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240926$$MD$US$US
1992250824$19922508$24$F$20200624$20240913$20211005$20240920$EXP$$CA-TAKEDA-CA202021085$TAKEDA$$47$YR$$M$Y$82$KG$20240920$$HP$CA$CA
199227396$19922739$6$F$20220213$20240701$20211005$20240703$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003444$PAREXEL$$$$$$Y$$$20240703$$HP$US$US
199229055$19922905$5$F$$20240801$20211006$20240814$EXP$$FR-AUROBINDO-AUR-APL-2021-040892$AUROBINDO$Guitard J, Guilbeau-Frugier C, Roussel M, Kamar N.. An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis. Clinical Nephrology. 2014;82(6):392-396$58$YR$$F$Y$$$20240814$$MD$FR$FR
199229232$19922923$2$F$20210101$20240816$20211006$20240826$EXP$$US-ROCHE-2924284$ROCHE$$38$YR$A$F$Y$39.46$KG$20240826$$CN$US$US
1992295717$19922957$17$F$20210801$20240821$20211006$20240829$EXP$$CA-CELLTRION INC.-2021CA012222$CELLTRION$$$$$$Y$$$20240829$$PH$CA$CA
199238333$19923833$3$F$$20220121$20211005$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR206073$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$HP$US$US
1992411515$19924115$15$F$20210924$20240912$20211005$20240920$EXP$$CA-CELLTRION INC.-2021CA011617$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
199244992$19924499$2$F$20210930$20240730$20211006$20240801$EXP$$CA-TAKEDA-2021TUS061110$TAKEDA$$53$YR$$M$Y$$$20240801$$MD$CA$CA
199249463$19924946$3$F$20210705$20240905$20211006$20240911$EXP$$CA-JNJFOC-20210648570$JOHNSON AND JOHNSON$$5$YR$C$F$Y$12$KG$20240911$$HP$CA$CA
199252654$19925265$4$F$20210312$20240701$20211006$20240702$EXP$$US-TAKEDA-US202015545$TAKEDA$$48$YR$$F$Y$$$20240702$$HP$US$US
199259882$19925988$2$F$$20211004$20211007$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR207284$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199259897$19925989$7$F$20211212$20220121$20211007$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR206951$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
199261739$19926173$9$F$20240501$20240807$20211006$20240812$PER$$US-PFIZER INC-202101173583$PFIZER$$83$YR$$M$Y$95.254$KG$20240812$$CN$US$US
199271926$19927192$6$F$20220701$20230120$20211006$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR206692$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
199274742$19927474$2$F$$20211005$20211007$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR207465$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199279073$19927907$3$F$$20240913$20211007$20240925$EXP$$IT-AUROBINDO-AUR-APL-2021-041356$AUROBINDO$Panuccio V.; Tripepi R.; Lucisano S, Postorino A, Greve B, Sabattini E et all.. Does etelcalcetide reverse myelofibrotic bone changes due to hyperparathyroidism? a case report.. Nephrology Dialysis Transplantation.. 2021;36 (SUPPL_1):i448-i449$32$YR$$M$Y$$$20240925$$HP$IT$IT
1992792026$19927920$26$F$20210817$20240719$20211007$20240727$EXP$$CA-CELLTRION INC.-2021CA012332$CELLTRION$$$$$$Y$$$20240727$$MD$CA$CA
1992878111$19928781$11$F$20190214$20240830$20211007$20240905$EXP$$CA-TAKEDA-2019TUS007145$TAKEDA$$79$YR$$M$Y$$$20240905$$HP$CA$CA
199293582$19929358$2$F$$20240815$20211007$20240819$EXP$$US-PURDUE-USA-2021-0285671$PURDUE$$$$$M$Y$$$20240819$$CN$US$US
1992944122$19929441$22$F$20210822$20240827$20211007$20240829$PER$$US-PFIZER INC-202100929855$PFIZER$$74$YR$$F$Y$$$20240829$$CN$US$US
1992954712$19929547$12$F$20230616$20240829$20211007$20240904$EXP$$CA-PFIZER INC-202101287881$MYLAN$$58$YR$$F$Y$$$20240904$$HP$CA$CA
199299784$19929978$4$F$20190918$20240830$20211007$20240910$EXP$$PL-EMD Serono-E2B_90085374$EMD SERONO INC$$62$YR$A$M$Y$98$KG$20240911$$MD$PL$PL
199301543$19930154$3$F$20210727$20240911$20211007$20240920$EXP$$GB-TEVA-2021-GB-1964573$TEVA$$52$YR$$F$Y$101$KG$20240920$$MD$GB$GB
1993018619$19930186$19$F$$20240626$20211007$20240701$EXP$$US-TAKEDA-US202015061$TAKEDA$$$$$F$Y$104$KG$20240701$$HP$US$US
1993083534$19930835$34$F$20210701$20240709$20211008$20240718$EXP$$CA-CELLTRION INC.-2021CA005532$CELLTRION$$$$$$Y$$$20240718$$MD$CA$CA
199311386$19931138$6$F$20190319$20240704$20211007$20240709$EXP$$JP-ABBVIE-19P-087-2844826-00$ABBVIE$$55$YR$$M$Y$58$KG$20240709$$MD$JP$JP
199313782$19931378$2$F$20210923$20240703$20211008$20240705$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003617$PAREXEL$$$$$$Y$$$20240705$$HP$US$US
199314643$19931464$3$F$$20240909$20211008$20240911$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003544$PAREXEL$$$$$$Y$$$20240911$$CN$US$US
199314904$19931490$4$F$20210101$20240702$20211008$20240710$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003507$PAREXEL$$$$$$Y$$$20240710$$MD$US$US
1993228110$19932281$10$F$$20240916$20211008$20240927$EXP$$US-ROCHE-2927979$ROCHE$Douglas E, Jungquist R, Bouley A, Katz J and Lathi E. ACAPELLA: real-world experience with ocrelizumab - an observational study evaluating safety in patients with relapsing and progressive MS, year four data (abstract number: P795) DOI 10.1177/13524585211044667. Multiple Sclerosis Journal 2021 Oct;27 (2 SUP):656-7.$$$$$Y$$$20240927$$MD$US$US
199330173$19933017$3$F$$20240712$20211008$20240722$EXP$$CA-APOTEX-2021AP043827$APOTEX$$63$YR$$F$Y$58$KG$20240722$$HP$CA$CA
199335913$19933591$3$F$20240401$20240624$20211008$20240717$PER$$CA-TOLMAR, INC.-21CA028924$TOLMAR$$60$YR$$M$Y$$$20240717$$CN$CA$CA
199341622$19934162$2$F$$20240722$20211008$20240724$EXP$$FR-PFIZER INC-202101271934$PFIZER$$$$$F$Y$$$20240724$$HP$FR$FR
199343476$19934347$6$F$$20240912$20211008$20240924$EXP$$CA-APOTEX-2021AP043956$APOTEX$$73$YR$$F$Y$51$KG$20240924$$HP$CA$CA
199345877$19934587$7$F$$20240912$20211008$20240916$EXP$$US-PFIZER INC-2021402696$PFIZER$$72$YR$$F$Y$97.506$KG$20240916$$CN$US$US
199351525$19935152$5$F$20210319$20240801$20211008$20240806$EXP$$CA-TAKEDA-2021TUS018692$TAKEDA$$46$YR$$F$Y$$$20240806$$CN$CA$CA
199352043$19935204$3$F$$20240806$20211008$20240815$PER$$US-SA-2021SA330282$SANOFI AVENTIS$$$$E$F$Y$57.6$KG$20240815$$MD$US$US
199352716$19935271$6$F$20210901$20240802$20211008$20240809$PER$$US-SA-2021SA328576$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240809$$CN$US$US
1993541510$19935415$10$F$$20240820$20211008$20240822$EXP$$US-PFIZER INC-2018512864$PFIZER$$58$YR$$F$Y$114$KG$20240822$$MD$US$US
199364332$19936433$2$F$$20240805$20211008$20240813$EXP$$US-Sprout Pharmaceuticals, Inc.-2021SP000118$SPROUT PHARMACEUTICALS$$$$A$F$Y$65.83$KG$20240809$$CN$US$US
1993726613$19937266$13$F$20200417$20240829$20211010$20240902$EXP$$DE-ROCHE-2667286$ROCHE$$33$YR$A$F$Y$67$KG$20240902$$MD$DE$DE
1993756810$19937568$10$F$20211014$20220126$20211011$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR208040$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
199378982$19937898$2$F$$20240523$20211011$20240710$PER$$US-ROCHE-2828393$ROCHE$$$$C$F$Y$$$20240701$$MD$US$US
199388322$19938832$2$F$$20240806$20211011$20240819$EXP$$NVSC2021IE229350$NOVARTIS$$$$$F$Y$$$20240819$$MD$IE$IE
199393493$19939349$3$F$20210101$20240827$20211011$20240906$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202110003650$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240906$$CN$DE$BR
1993982410$19939824$10$F$20240801$20240920$20211012$20240927$EXP$$US-GLAXOSMITHKLINE-US2021AMR208536$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
199398827$19939882$7$F$$20221214$20211012$20240925$PER$$US-GLAXOSMITHKLINE-US2021207522$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199402374$19940237$4$F$$20240729$20211011$20240802$PER$$US-BIOGEN-2021BI01056190$BIOGEN$$$$$F$Y$$$20240802$$CN$US$US
199403775$19940377$5$F$20180217$20240828$20211012$20240904$EXP$$CA-ROCHE-2896058$ROCHE$$26$YR$A$F$Y$$$20240904$$CN$CA$CA
1994101013$19941010$13$F$20230103$20240802$20211011$20240806$EXP$$AU-TAKEDA-2019TUS069148$TAKEDA$$39$YR$$M$Y$$$20240806$$CN$AU$AU
1994103037$19941030$37$F$20201022$20240916$20211012$20240925$EXP$$CA-CELLTRION INC.-2020CA030197$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
199410392$19941039$2$F$20210615$20240831$20211012$20240903$EXP$$EG-ROCHE-2932141$ROCHE$$27$YR$A$F$Y$85$KG$20240903$$MD$EG$EG
1994186024$19941860$24$F$20210101$20240703$20211012$20240711$EXP$$CA-CELLTRION INC.-2021CA013235$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
199419393$19941939$3$F$20210101$20240827$20211012$20240923$PER$$US-MYOVANT SCIENCES GMBH-2021MYSCI0600276$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
199420893$19942089$3$F$20210701$20240730$20211012$20240828$PER$$US-MYOVANT SCIENCES GMBH-2021MYSCI0700022$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
199421066$19942106$6$F$19980101$20240905$20211012$20240910$EXP$$US-ORGANON-O2110USA000674$ORGANON$$$$$F$Y$$$20240910$$MD$US$US
199422124$19942212$4$F$20210529$20240828$20211012$20240902$EXP$$GB-ABBVIE-21K-167-4112947-00$ABBVIE$$65$YR$$M$Y$$$20240902$$MD$GB$GB
199425778$19942577$8$F$20210525$20240820$20211012$20240827$EXP$$JP-ROCHE-2926266$ROCHE$$53$YR$A$F$Y$$$20240827$$MD$JP$JP
199426969$19942696$9$F$20190804$20240910$20211012$20240917$EXP$$NVSC2021MX044883$NOVARTIS$$53$YR$$F$Y$73$KG$20240917$$CN$MX$MX
199427132$19942713$2$F$$20211006$20211012$20240719$EXP$$US-AstraZeneca-2021A763998$ASTRAZENECA$$$$$$Y$$$20240719$$HP$US$
199440252$19944025$2$F$$20210929$20211011$20240905$PER$$US-BAUSCH-BL-2021-033514$BAUSCH AND LOMB$$$$$F$Y$$$20240905$$CN$US$US
1994456911$19944569$11$F$20210507$20240715$20211012$20240721$EXP$FR-AFSSAPS-PP20210635$FR-MYLANLABS-2021M1067400$MYLAN$$55$YR$$M$Y$70$KG$20240719$$MD$FR$FR
1994546610$19945466$10$F$20180515$20240814$20211012$20240820$EXP$$DE-MYLANLABS-2021M1070837$MYLAN$$47$YR$$F$Y$$$20240820$$MD$DE$DE
199454837$19945483$7$F$$20220321$20211012$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR208738$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
1994568810$19945688$10$F$20220101$20240708$20211012$20240710$EXP$$US-PFIZER INC-2021684023$PFIZER$$55$YR$$F$Y$$$20240710$$CN$US$US
199460523$19946052$3$F$20201201$20240903$20211012$20240905$EXP$$US-JAZZ-2020-US-016302$JAZZ$$34$YR$$F$Y$$$20240905$$CN$US$US
199461243$19946124$3$F$20100101$20240820$20211012$20240823$EXP$$US-ORGANON-O2110USA000743$ORGANON$$$$$M$Y$$$20240823$$MD$US$US
1994657428$19946574$28$F$20210929$20240705$20211012$20240710$EXP$$US-TAKEDA-US202010531$TAKEDA$$63$YR$$F$Y$83$KG$20240710$$HP$US$US
199466116$19946611$6$F$20170531$20240812$20211012$20240815$EXP$$CA-TAKEDA-2017TUS013869$TAKEDA$$70$YR$$F$Y$$$20240815$$MD$CA$CA
1994689210$19946892$10$F$$20240813$20211013$20240815$EXP$$CA-TAKEDA-2021TUS059356$TAKEDA$$$$$M$Y$$$20240815$$CN$CA$CA
1994709611$19947096$11$F$$20240820$20211013$20240826$EXP$$US-TAKEDA-2021TUS062811$TAKEDA$$$$$M$Y$$$20240826$$CN$US$US
199471055$19947105$5$F$20100101$20240919$20211012$20240922$EXP$$US-ORGANON-O2110USA000740$ORGANON$$$$$F$Y$$$20240922$$HP$US$US
1994791117$19947911$17$F$20210930$20240806$20211013$20240813$EXP$$CA-CELLTRION INC.-2021CA013969$CELLTRION$$$$$$Y$$$20240813$$HP$CA$CA
199479667$19947966$7$F$20220628$20240822$20211013$20240910$PER$$CA-TOLMAR, INC.-21CA029200$TOLMAR$$80$YR$$M$Y$$$20240910$$CN$CA$CA
199480604$19948060$4$F$20211008$20211117$20211013$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR209273$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
199481732$19948173$2$F$$20211005$20211012$20240715$PER$$US-PFM-2021-09313$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240715$$HP$US$US
1994835217$19948352$17$F$20210713$20240903$20211012$20240906$EXP$$CO-TAKEDA-CO201849721$TAKEDA$$43$YR$$F$Y$69$KG$20240906$$CN$CO$CO
199484006$19948400$6$F$20210726$20240722$20211013$20240808$PER$$CA-TOLMAR, INC.-21CA029182$TOLMAR$$61$YR$$M$Y$$$20240808$$CN$CA$CA
199484887$19948488$7$F$20210721$20240909$20211013$20240909$EXP$$NVSC2021ES230761$NOVARTIS$$69$YR$$M$Y$91$KG$20240909$$HP$ES$ES
199491936$19949193$6$F$20080101$20240729$20211013$20240802$EXP$$US-ORGANON-O2110USA000864$ORGANON$$$$$F$Y$72.57$KG$20240802$$MD$US$US
199497746$19949774$6$F$20210114$20240922$20211013$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-054288$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240930$$MD$JP$JP
1995003913$19950039$13$F$20211002$20240619$20211013$20240703$EXP$$CA-ROCHE-2830094$ROCHE$$45$YR$A$F$Y$114.4$KG$20240703$$CN$CA$CA
199509375$19950937$5$F$20211001$20211105$20211014$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR210329$GLAXOSMITHKLINE$$48$YR$$F$Y$$$20240925$$CN$US$US
199510875$19951087$5$F$$20240325$20211013$20240717$EXP$$NVSC2021SK228648$NOVARTIS$Gura R. Prva skusenos? s ribociklibom mimo klinickeho skusania na Slovensku v lie?be postmenopauzalnej pacientky s HR positive, HER2- pokro?ilym/metastatickym karcinomom prsnika [The first experience with Ribociclib outside clinical trial in Slovakia in the therapy of postmenopausal patient with HR positive, HER2 negative advanced / metastatic breast cancer]. FARMAKOTERAPIA. 2021;32-4$64$YR$$F$Y$$$20240717$$HP$SK$SK
1995119813$19951198$13$F$20211101$20240627$20211013$20240704$EXP$$US-TAKEDA-2021TUS062693$TAKEDA$$61$YR$$F$Y$$$20240704$$CN$US$US
199512933$19951293$3$F$$20211004$20211013$20240715$PER$$US-PFM-2021-08395$PIERRE FABRE MEDICAMENT$Farshchian M, Potts GA. Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma. Australasian Journal of Dermatology. 2021;62:e580-e581$1$MON$$F$Y$$$20240715$$MD$US$US
199514687$19951468$7$F$20180305$20240919$20211014$20240927$EXP$$DE-AUROBINDO-AUR-APL-2021-041858$AUROBINDO$$52$YR$$M$Y$90$KG$20240927$$MD$DE$DE
1995162310$19951623$10$F$20211116$20221215$20211014$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR209956$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
199517794$19951779$4$F$$20240626$20211013$20240701$EXP$$US-PFIZER INC-202101294205$PFIZER$$37$YR$$M$Y$$$20240701$$CN$US$US
199518646$19951864$6$F$20210101$20240805$20211013$20240808$EXP$$US-PFIZER INC-202101162109$PFIZER$$73$YR$$M$Y$92.063$KG$20240808$$HP$US$US
1995207750$19952077$50$F$20210101$20240920$20211014$20240930$EXP$$CA-CELLTRION INC.-2021CA012894$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
199521658$19952165$8$F$20211003$20240826$20211013$20240829$EXP$$CO-TAKEDA-2021TUS031282$TAKEDA$$27$YR$$F$Y$48$KG$20240829$$CN$CO$CO
199522022$19952202$2$F$20211005$20240903$20211014$20240910$EXP$$US-VIIV HEALTHCARE LIMITED-US2021209363$VIIV$$60$YR$$F$Y$$$20240910$$CN$US$US
1995238011$19952380$11$F$20090101$20240910$20211013$20240913$EXP$$US-ORGANON-O2110USA000836$ORGANON$$$$$F$Y$$$20240913$$MD$US$US
1995245543$19952455$43$F$20211005$20240919$20211014$20240928$EXP$$CA-CELLTRION INC.-2021CA014012$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
199530003$19953000$3$F$20210203$20240914$20211014$20240919$EXP$$CA-TAKEDA-2021TUS062844$TAKEDA$$56$YR$$M$Y$$$20240919$$CN$CA$CA
1995304619$19953046$19$F$20211009$20240828$20211013$20240903$EXP$$AU-TAKEDA-2021TUS061140$TAKEDA$$72$YR$$M$Y$76$KG$20240903$$HP$AU$AU
199534127$19953412$7$F$20190101$20240814$20211014$20240830$PER$$CA-TOLMAR, INC.-21CA029023$TOLMAR$$$$$M$Y$$$20240829$$CN$CA$CA
199536377$19953637$7$F$$20240714$20211014$20240716$EXP$$CA-TAKEDA-2021TUS012998$TAKEDA$$$$$M$Y$$$20240716$$CN$CA$CA
199538552$19953855$2$F$20180904$20240730$20211013$20240805$EXP$$PT-MYLANLABS-2021M1071597$MYLAN$$64$YR$$F$Y$87$KG$20240805$$MD$PT$PT
199541729$19954172$9$F$20210930$20230530$20211014$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR209314$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
199541886$19954188$6$F$20211005$20240712$20211013$20240715$EXP$$US-TAKEDA-2021TUS063054$TAKEDA$$61$YR$$M$Y$$$20240715$$PH$US$US
1995419616$19954196$16$F$$20240806$20211014$20240813$EXP$$CO-INCYTE CORPORATION-2021IN009205$INCYTE$$$$$$Y$$$20240813$$CN$CO$CO
1995447410$19954474$10$F$$20240825$20211013$20240913$PER$$CA-TOLMAR, INC.-21CA029088$TOLMAR$$$$$M$Y$$$20240913$$CN$CA$CA
199546293$19954629$3$F$$20211116$20211014$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR211072$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199546857$19954685$7$F$20211005$20240919$20211014$20240923$EXP$$US-ABBVIE-21K-163-4112925-00$ABBVIE$$18$YR$$M$Y$42$KG$20240923$$MD$US$US
199551543$19955154$3$F$20170224$20240627$20211014$20240702$EXP$$ZA-PFIZER INC-202101229882$PFIZER$$59$YR$$F$Y$$$20240702$$MD$ZA$ZA
199553244$19955324$4$F$20190730$20240907$20211013$20240912$EXP$$CA-TAKEDA-2019TUS064229$TAKEDA$$37$YR$$F$Y$$$20240912$$MD$CA$CA
199553775$19955377$5$F$$20240722$20211013$20240726$EXP$$US-AMGEN-USASP2021155566$AMGEN$$$$A$F$Y$$$20240726$$HP$US$US
199553943$19955394$3$F$$20221101$20211014$20240924$EXP$$AU-ROCHE-2928298$ROCHE$McNeil T, Hannah R, Hui C-H and Qiao M. Disseminated enterovirus infection in a patient treated with obinutuzumab. Journal of medical virology 2021 Sep 30;94(2):439-441.$40$YR$A$F$Y$$$20240924$$MD$AU$AU
199559504$19955950$4$F$$20211117$20211014$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR210324$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199560002$19956000$2$F$$20240315$20211014$20240704$EXP$$GB-TEVA-2021-GB-1965014$TEVA$$34$YR$$F$Y$$$20240704$$CN$GB$GB
1995655819$19956558$19$F$20230131$20240801$20211014$20240806$EXP$$US-TAKEDA-US202023084$TAKEDA$$65$YR$$M$Y$$$20240806$$CN$US$US
199566222$19956622$2$F$20210722$20211008$20211014$20240917$PER$$NVSC2021US234564$NOVARTIS$$79$YR$$M$Y$111$KG$20240917$$MD$US$US
199572407$19957240$7$F$$20240625$20211014$20240701$EXP$$CA-TAKEDA-2021TUS057294$TAKEDA$$$$$F$Y$$$20240701$$MD$CA$CA
1995745911$19957459$11$F$20200929$20240716$20211014$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-097816$BRISTOL MYERS SQUIBB$Suzuki Y, Suzuki M, Ishiguro S. A case of mycophenolate mofetil administration for liver dysfunction developing as severe immune-related adverse event after administering immune checkpoint inhibitors. The Japanese Journal of Therapeutic Drug Monitoring. 2022 Jan 01;39(2):145.$75$YR$E$M$Y$64$KG$20240724$$MD$JP$JP
199582586$19958258$6$F$20201020$20220805$20211015$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR212424$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$MD$US$US
199594083$19959408$3$F$$20240627$20211015$20240701$PER$$US-PFIZER INC-2021401096$PFIZER$$79$YR$$F$Y$$$20240701$$CN$US$US
199602875$19960287$5$F$$20240729$20211015$20240731$PER$$US-PFIZER INC-2021727795$PFIZER$$74$YR$$M$Y$$$20240731$$CN$US$US
199605463$19960546$3$F$20200807$20240717$20211015$20240723$EXP$$CA-TAKEDA-2020TUS045802$TAKEDA$$51$YR$$M$Y$$$20240723$$CN$CA$CA
199605686$19960568$6$F$20220901$20240719$20211015$20240726$EXP$$US-TAKEDA-2021TUS063143$TAKEDA$$48$YR$$M$Y$$$20240726$$CN$US$US
199609543$19960954$3$F$20210101$20240820$20211016$20240902$PER$$US-SA-2021SA339425$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240902$$MD$US$US
199610214$19961021$4$F$20200917$20240904$20211016$20240912$EXP$$CA-TAKEDA-2020TUS038938$TAKEDA$$81$YR$$F$Y$$$20240912$$HP$CA$CA
199612132$19961213$2$F$$20240731$20211016$20240808$PER$$US-SA-2021SA339106$SANOFI AVENTIS$$$$E$M$Y$$$20240808$$CN$US$US
199615313$19961531$3$F$20211007$20240624$20211017$20240701$PER$$US-SA-2021SA337960$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240701$$MD$US$US
199617762$19961776$2$F$20200101$20211014$20211018$20240822$EXP$$AU-ABBVIE-21K-008-4121975-00$ABBVIE$$$$$F$Y$$$20240822$$CN$AU$AU
1996182236$19961822$36$F$20210918$20240919$20211018$20240928$EXP$$CA-CELLTRION INC.-2021CA013287$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
199619865$19961986$5$F$20210801$20240906$20211018$20240913$PER$$US-SA-2021SA341955$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240913$$MD$US$US
1996215319$19962153$19$F$20180212$20240816$20211018$20240824$EXP$$CA-CELLTRION INC.-2017CA012996$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
199624123$19962412$3$F$$20211111$20211018$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR210320$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199626022$19962602$2$F$$20240910$20211018$20240912$PER$$NVSC2021US237268$NOVARTIS$$$$$M$Y$$$20240912$$CN$US$US
199627026$19962702$6$F$20210901$20240529$20211018$20240809$EXP$$NVSJ2021JP016891$NOVARTIS$Hosoya R, Sakashita H, Yamada T, Sawada A, Kumagai T, Izumi M et al.. A Case of Left Ventricular Contractile Dysfunction with Complete Atrioventricular Block During Administraion of Dabrafenib Plus Trametinib in Wichi Treatment Was Able to Be Continued with Dabrafenib Alone. The Japan Lung Cancer Society. 2023;63:58-63$80$YR$$M$Y$$$20240809$$HP$JP$JP
1996281430$19962814$30$F$20190701$20240827$20211018$20240903$EXP$$DE-ROCHE-2351472$ROCHE$$41$YR$A$F$Y$40$KG$20240903$$CN$DE$DE
199631663$19963166$3$F$$20211110$20211018$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR213438$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199632886$19963288$6$F$$20240819$20211018$20240823$EXP$$ES-ROCHE-2937202$ROCHE$$$$$F$Y$$$20240823$$MD$ES$ES
199633643$19963364$3$F$20220208$20240626$20211018$20240702$30DAY$$US-GLAXOSMITHKLINE-US2021210531$GLAXOSMITHKLINE$$56$YR$$F$Y$51.26$KG$20240702$$CN$US$US
199634822$19963482$2$F$$20240912$20211018$20240920$EXP$$IN-MYLANLABS-2021M1073195$MYLAN$Ray S, Srijithesh PR, Kulkarni G, Alladi S. Prolonged magnesium sulphate infusion in the management of super-refractory status epilepticus in a probable GABA B Autoimmune Encephallitis. Ann-Indian-Acad-Neurol 2019;22 (Suppl.):S65 abstr. PP58/275.$28$YR$$F$Y$$$20240920$$HP$IN$IN
199638323$19963832$3$F$$20211115$20211018$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR212245$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199642872$19964287$2$F$$20240703$20211018$20240705$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003631$PAREXEL$$$$$$Y$$$20240705$$CN$US$US
199647294$19964729$4$F$$20240726$20211018$20240730$PER$$US-PFIZER INC-2021407646$PFIZER$$74$YR$$F$Y$$$20240730$$CN$US$US
199647793$19964779$3$F$$20240905$20211018$20240910$EXP$$GR-PFIZER INC-202101366957$PFIZER$Stavroulaki, G.. Hematopoietic stem cell transplantation in children with Fanconi anemia. 7th PANHELLENIC CONGRESS OF PEDIATRIC HEAMATOLOGY-ONCOLOGY, DEVELOPMENTS-DATA-PR. 2021$$$$$Y$$$20240910$$MD$GR$GR
199647875$19964787$5$F$$20221222$20211018$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR213469$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199649097$19964909$7$F$$20220420$20211018$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR214375$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
1996523413$19965234$13$F$20210721$20240830$20211018$20240903$EXP$$ES-PFIZER INC-202101321712$PFIZER$$69$YR$$M$Y$91$KG$20240903$$MD$ES$ES
199656915$19965691$5$F$20210414$20240626$20211018$20240701$PER$$US-PFIZER INC-2021433200$PFIZER$$70$YR$$F$Y$$$20240701$$CN$US$US
199657512$19965751$2$F$20201222$20240819$20211019$20240829$EXP$$DE-AUROBINDO-AUR-APL-2021-042294$AUROBINDO$$$$A$F$Y$87.5$KG$20240829$$MD$DE$DE
199666362$19966636$2$F$20210101$20240716$20211018$20240724$PER$$US-SA-2021SA341816$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240724$$MD$US$US
1996674331$19966743$31$F$20220716$20240722$20211018$20240724$EXP$$JP-TAKEDA-2021TJP105843$TAKEDA$$37$YR$$F$Y$42$KG$20240724$$MD$JP$JP
199684922$19968492$2$F$20211014$20240719$20211019$20240724$PER$$US-AMGEN-USASP2021159506$AMGEN$$75$YR$E$M$Y$$$20240724$$HP$US$US
199685684$19968568$4$F$20211007$20211201$20211019$20240913$PER$$US-ROCHE-2932650$ROCHE$$74$YR$E$F$Y$$$20240913$$CN$US$US
199689942$19968994$2$F$20180101$20240812$20211019$20240820$EXP$$CZ-MYLANLABS-2020M1070332$MYLAN$Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119$65$YR$$M$Y$$$20240820$$HP$CZ$CZ
199690866$19969086$6$F$20180822$20240719$20211019$20240724$EXP$$CA-PFIZER INC-202101317694$PFIZER$$42$YR$$M$Y$$$20240724$$MD$CA$CA
1996970010$19969700$10$F$20240828$20240829$20211019$20240902$EXP$$US-PFIZER INC-202101374818$PFIZER$$86$YR$$F$Y$$$20240902$$CN$US$US
199698373$19969837$3$F$20190820$20240909$20211019$20240917$EXP$$BR-TAKEDA-2020TUS008715$TAKEDA$$44$YR$$F$Y$$$20240917$$CN$BR$BR
199701302$19970130$2$F$$20240905$20211019$20240910$EXP$$GR-PFIZER INC-202101376533$PFIZER$Stavroulaki, G.. Hematopoietic stem cell transplantation in children with Fanconi anemia. 7th PANHELLENIC CONGRESS OF PEDIATRIC HEAMATOLOGY-ONCOLOGY, DEVELOPMENTS-DATA-PR. 2021$$$$$Y$$$20240910$$MD$GR$GR
199714293$19971429$3$F$$20211129$20211019$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR214371$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199714594$19971459$4$F$20210901$20211210$20211020$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR210336$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240925$$CN$US$US
1997261118$19972611$18$F$$20240919$20211019$20240926$EXP$$CA-TAKEDA-2021TUS000010$TAKEDA$$80$YR$$M$Y$89$KG$20240926$$HP$CA$CA
199734585$19973458$5$F$$20211216$20211020$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR215302$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$MD$US$US
199735235$19973523$5$F$20211008$20211122$20211020$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR212384$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
199736204$19973620$4$F$$20211117$20211020$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR214331$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199743743$19974374$3$F$$20240903$20211020$20240905$EXP$$GR-PFIZER INC-202101369744$PFIZER$Kotsoglanidou, K.. Cutaneous and invasive fungal infections in patients with hematology malignancies and neoplasms. 7th PANHELLENIC CONGRESS OF PEDIATRIC HEAMATOLOGY-ONCOLOGY. 2021$8$YR$$M$Y$$$20240905$$MD$GR$GR
1997448010$19974480$10$F$20230201$20240905$20211020$20240910$EXP$$US-PFIZER INC-202101342975$PFIZER$$84$YR$$M$Y$72.562$KG$20240910$$CN$US$US
199747552$19974755$2$F$20210101$20240628$20211020$20240710$EXP$$US-INSMED, INC.-2021-09354-US$INSMED$$$$$F$Y$$$20240710$$CN$US$US
199750788$19975078$8$F$20211011$20220624$20211020$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR213357$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
199750798$19975079$8$F$20220121$20220606$20211020$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR210316$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
199753343$19975334$3$F$$20240903$20211020$20240905$EXP$$GR-PFIZER INC-202101366448$PFIZER$Kotsoglanidou, K.. Cutaneous and invasive fungal infections in patients with hematology malignancies and neoplasms. 7th PANHELLENIC CONGRESS OF PEDIATRIC HEAMATOLOGY-ONCOLOGY. 2021$9$YR$$M$Y$$$20240905$$MD$GR$GR
1997539214$19975392$14$F$20200108$20240729$20211021$20240806$EXP$$CA-CELLTRION INC.-2019CA028264$CELLTRION$$$$$$Y$$$20240806$$MD$CA$CA
1997547713$19975477$13$F$20211001$20220722$20211021$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR215024$GLAXOSMITHKLINE$$50$YR$$F$Y$86.168$KG$20240925$$HP$US$US
1997550718$19975507$18$F$$20240722$20211020$20240725$PER$$US-PFIZER INC-202101333860$PFIZER$$48$YR$$F$Y$$$20240725$$CN$US$US
199757636$19975763$6$F$20190201$20240806$20211021$20240828$PER$$CA-TOLMAR, INC.-21CA029134$TOLMAR$$71$YR$$M$Y$$$20240828$$CN$CA$CA
199758856$19975885$6$F$$20220823$20211021$20240925$PER$$US-GLAXOSMITHKLINE-US2021215189$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199760205$19976020$5$F$20210727$20240911$20211021$20240924$EXP$$GB-ADVANZ PHARMA-202110006944$ADVANZ PHARMA$$$$$$Y$$$20240924$$HP$GB$GB
1997644212$19976442$12$F$$20240718$20211020$20240726$EXP$$CA-TAKEDA-2021TUS063242$TAKEDA$$53$YR$$F$Y$$$20240726$$HP$CA$CA
199768095$19976809$5$F$20210724$20240817$20211020$20240911$PER$$CA-TOLMAR, INC.-21CA029140$TOLMAR$$81$YR$$M$Y$$$20240911$$CN$CA$CA
199769064$19976906$4$F$20151101$20240702$20211021$20240711$EXP$$CA-ROCHE-1837567$ROCHE$$18$YR$A$F$Y$$$20240711$$CN$CA$CA
199772494$19977249$4$F$20150101$20240705$20211021$20240717$EXP$DE-MACLEODS PHARMA UK LTD-MAC2021033029$DE-MACLEODS PHARMA UK LTD-MAC2021033029$MACLEODS$$$$$$Y$$$20240717$$PH$DE$DE
1997779730$19977797$30$F$$20240906$20211020$20240909$EXP$$CA-PFIZER INC-202101352411$PFIZER$$27$YR$$F$Y$120$KG$20240909$$HP$CA$CA
199778048$19977804$8$F$20210924$20240821$20211020$20240823$EXP$$CA-TAKEDA-2021TUS064412$TAKEDA$$83$YR$$F$Y$$$20240823$$CN$CA$CA
199779192$19977919$2$F$20240801$20240906$20211020$20240912$EXP$$US-KYOWAKIRIN-2021BKK017312$KYOWA$$$$$$Y$$$20240912$$HP$US$US
199790474$19979047$4$F$20190203$20240702$20211021$20240723$PER$$AU-TOLMAR, INC.-21AU029321$TOLMAR$$71$YR$$M$Y$$$20240722$$HP$AU$AU
199791135$19979113$5$F$$20220527$20211021$20240926$EXP$$NVSC2021CO159712$NOVARTIS$$$$$F$Y$104$KG$20240926$$CN$CO$CO
1997911917$19979119$17$F$$20230405$20211021$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR214260$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199792654$19979265$4$F$20140411$20240731$20211021$20240809$EXP$$CA-ROCHE-2936599$ROCHE$$17$YR$T$F$Y$64$KG$20240809$$CN$CA$CA
199796892$19979689$2$F$20210101$20240904$20211020$20240913$PER$$US-SA-2021SA344540$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240913$$MD$US$US
199799392$19979939$2$F$20210811$20240805$20211021$20240812$PER$$US-SA-2021SA342647$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240812$$MD$US$US
199800966$19980096$6$F$$20240919$20211021$20240924$EXP$$GR-MYLANLABS-2021M1073786$MYLAN$Vasileios K, Eleni P, Stavros K, Panagiotis T, Gerasimos A, Panagiota C.. Patient with heatstroke and concomitant multiorgan failure under treatment with olanzapine and sertraline.. 5th National Resuscitation and Emergencies Conference. 2021$47$YR$$M$Y$$$20240924$$MD$GR$GR
1998049313$19980493$13$F$20210801$20240808$20211021$20240813$EXP$$US-SA-2021SA344514$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240813$$MD$US$US
199806466$19980646$6$F$20210701$20220210$20211022$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR216532$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
199808342$19980834$2$F$$20211013$20211021$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR212620$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199808904$19980890$4$F$20210911$20240716$20211021$20240721$EXP$$IN-PFIZER INC-2021666597$PFIZER$$77$YR$$F$Y$$$20240721$$CN$IN$IN
199809924$19980992$4$F$20210601$20240909$20211021$20240911$PER$$US-PFIZER INC-202100944358$PFIZER$$72$YR$$M$Y$111.13$KG$20240911$$CN$US$US
1998124138$19981241$38$F$20210101$20240918$20211022$20240927$EXP$$CA-CELLTRION INC.-2021CA014384$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
199822243$19982224$3$F$20211011$20211117$20211022$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR212270$GLAXOSMITHKLINE$$52$YR$$F$Y$77.56$KG$20240925$$MD$US$US
199822263$19982226$3$F$$20220314$20211022$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR213361$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199823988$19982398$8$F$20210101$20240813$20211022$20240830$PER$$CA-TOLMAR, INC.-21CA029284$TOLMAR$$$$$M$Y$$$20240830$$CN$CA$CA
199827462$19982746$2$F$$20211122$20211021$20240806$EXP$$US-AstraZeneca-2021A774296$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
199827542$19982754$2$F$$20211019$20211022$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR218145$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
1998284313$19982843$13$F$20211201$20221206$20211022$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR217898$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240925$$CN$US$US
199832786$19983278$6$F$20211012$20240903$20211021$20240905$EXP$$US-TAKEDA-US202026590$TAKEDA$$72$YR$$F$Y$$$20240905$$CN$US$US
199835126$19983512$6$F$20211001$20220222$20211022$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR215276$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240925$$CN$US$US
199835754$19983575$4$F$20210101$20211207$20211022$20240801$EXP$$US-RECORDATI-2021002832$RECORDATI$$$$$$Y$$$20240801$$CN$US$US
199839833$19983983$3$F$$20240807$20211021$20240809$EXP$$IN-PFIZER INC-202101365405$PFIZER$Biswas, A.. Successful multimodality management of extrarenal extracranial malignant rhabdoid tumour of the left sciatic nerve mimicking a neurofibroma. British Journal of Neurosurgery. 2021;1-5$5$YR$$F$Y$$$20240809$$MD$IN$IN
199843335$19984333$5$F$20190819$20240806$20211022$20240808$EXP$$CA-JNJFOC-20211038316$JOHNSON AND JOHNSON$$11$YR$C$F$Y$44$KG$20240808$$HP$CA$CA
199846529$19984652$9$F$20210928$20240923$20211021$20240928$EXP$$CA-TAKEDA-2020TUS022349$TAKEDA$$74$YR$$F$Y$$$20240928$$PH$CA$CA
1998492614$19984926$14$F$20210728$20240715$20211021$20240805$PER$$CA-TOLMAR, INC.-21CA029242$TOLMAR$$80$YR$$M$Y$$$20240802$$CN$CA$CA
1998560024$19985600$24$F$$20240828$20211021$20240911$EXP$$CA-Orion Corporation ORION PHARMA-21_00016192$ORION$$27$YR$A$F$Y$120$KG$20240911$$HP$CA$
1998562523$19985625$23$F$$20240819$20211021$20240827$EXP$$CA-AMGEN-CANSP2021164058$AMGEN$$43$YR$A$F$Y$$$20240827$$HP$CA$CA
199860087$19986008$7$F$20211012$20240726$20211022$20240807$PER$$US-TAKEDA-2021TUS063842$TAKEDA$$59$YR$$F$Y$46.259$KG$20240807$$CN$US$US
199860666$19986066$6$F$$20220602$20211022$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR218309$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199861037$19986103$7$F$20211001$20240913$20211022$20240923$EXP$$CA-TAKEDA-2021TUS065329$TAKEDA$$47$YR$$F$Y$$$20240923$$PH$CA$CA
199861076$19986107$6$F$20150101$20240709$20211022$20240710$EXP$DE-AMK-253746$DE-ORGANON-O2110DEU001483$ORGANON$$73$YR$$F$Y$81.2$KG$20240710$$PH$DE$DE
199863515$19986351$5$F$20210917$20240715$20211022$20240723$EXP$$US-UNITED THERAPEUTICS-UNT-2021-020844$UNITED THERAPEUTICS$$53$YR$$F$Y$49.887$KG$20240723$$$US$US
199869923$19986992$3$F$20210101$20240806$20211023$20240814$PER$$US-SA-2021SA348681$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240814$$CN$US$US
1998715514$19987155$14$F$20180901$20240711$20211023$20240717$EXP$$JP-ABBVIE-21P-087-4131956-00$ABBVIE$$73$YR$$M$Y$59.2$KG$20240717$$MD$JP$JP
199872243$19987224$3$F$$20240813$20211022$20240816$EXP$$CA-TAKEDA-2021TUS004087$TAKEDA$$$$$F$Y$$$20240816$$MD$CA$CA
1998748821$19987488$21$F$20200101$20240715$20211023$20240723$EXP$$CA-CELLTRION INC.-2020CA021218$CELLTRION$$$$$$Y$$$20240723$$MD$CA$CA
199876268$19987626$8$F$20210724$20240718$20211022$20240807$PER$$CA-TOLMAR, INC.-21CA029131$TOLMAR$$89$YR$$M$Y$$$20240807$$PH$CA$CA
199876684$19987668$4$F$20210727$20240828$20211022$20240903$EXP$$US-PFIZER INC-202100966063$PFIZER$$55$YR$$F$Y$70.295$KG$20240903$$CN$US$US
199880445$19988044$5$F$20211001$20240722$20211022$20240726$EXP$$JP-009507513-2110JPN001590J$MERCK$$62$YR$$M$Y$46$KG$20240726$$MD$JP$JP
1998807511$19988075$11$F$20210830$20240701$20211022$20240702$EXP$$US-TAKEDA-US201926862$TAKEDA$$74$YR$$F$Y$91$KG$20240702$$MD$US$US
199884803$19988480$3$F$20211010$20240918$20211023$20240926$PER$$US-TAKEDA-2021TUS063861$TAKEDA$$53$YR$$F$Y$$$20240926$$MD$US$US
199892997$19989299$7$F$20200225$20240911$20211025$20240921$EXP$$DE-AUROBINDO-AUR-APL-2021-043190$AUROBINDO$$$$E$F$Y$94$KG$20240921$$MD$DE$DE
199894989$19989498$9$F$20200814$20240626$20211025$20240718$EXP$$DE-ROCHE-2669444$ROCHE$$36$YR$A$F$Y$$$20240718$$CN$DE$DE
199897003$19989700$3$F$20211018$20240816$20211025$20240821$EXP$$GB-ABBVIE-21K-167-4131349-00$ABBVIE$$38$YR$$M$Y$$$20240821$$MD$GB$GB
199897063$19989706$3$F$20200501$20240729$20211025$20240805$EXP$$CZ-Ipsen Biopharmaceuticals, Inc.-2021-25727$IPSEN$$74$YR$E$F$Y$$$20240805$$MD$CZ$CZ
199898453$19989845$3$F$$20220715$20211025$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-315037$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
199900894$19990089$4$F$$20240921$20211025$20240925$PER$$US-BIOGEN-2020BI00834509$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
199902214$19990221$4$F$20200801$20220324$20211025$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR215308$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
199903622$19990362$2$F$$20211015$20211025$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR215396$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199905042$19990504$2$F$$20211018$20211025$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR216531$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
1999085525$19990855$25$F$20210101$20240912$20211025$20240920$EXP$$CA-CELLTRION INC.-2021CA004141$CELLTRION$$$$$$Y$$$20240920$$MD$CA$CA
199915836$19991583$6$F$20060314$20240918$20211025$20240924$EXP$$US-TAKEDA-2021TUS051659$TAKEDA$$44$YR$$F$Y$75$KG$20240924$$CN$US$US
199915935$19991593$5$F$20210101$20220209$20211025$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR216433$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199916815$19991681$5$F$20240401$20240716$20211025$20240718$PER$$US-PFIZER INC-2021470101$PFIZER$$56$YR$$M$Y$$$20240718$$HP$US$US
199918542$19991854$2$F$$20240720$20211025$20240729$PER$$US-SA-2021SA349606$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240729$$MD$US$US
199923433$19992343$3$F$20211011$20240912$20211025$20240923$EXP$$US-SA-2021SA348939$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240923$$MD$US$US
199928623$19992862$3$F$20210507$20231218$20211025$20240819$PER$$US-ENDO PHARMACEUTICALS INC-2021-011283$ENDO$$39$YR$$F$Y$58.957$KG$20240819$$MD$US$US
199928975$19992897$5$F$20150101$20240705$20211026$20240716$EXP$$DE-AUROBINDO-AUR-APL-2021-043189$AUROBINDO$$73$YR$$F$Y$81.2$KG$20240716$$PH$DE$DE
199932842$19993284$2$F$20211005$20211011$20211026$20240806$EXP$$RO-AstraZeneca-2021A691229$ASTRAZENECA$$5435$DY$$M$Y$45$KG$20240806$$MD$RO$
1999369011$19993690$11$F$20210909$20240705$20211025$20240710$EXP$$NVSC2021AT209927$NOVARTIS$$$$A$F$Y$$$20240710$$MD$AT$AT
199940378$19994037$8$F$20210701$20240813$20211026$20240830$PER$$CA-TOLMAR, INC.-21CA029332$TOLMAR$$75$YR$$M$Y$$$20240830$$CN$CA$CA
1999460214$19994602$14$F$20180601$20240830$20211026$20240902$EXP$$PHHY2018CO066052$NOVARTIS$$5$YR$$M$Y$38$KG$20240902$$CN$CO$CO
199958384$19995838$4$F$20201201$20240909$20211025$20240912$EXP$$US-INCYTE CORPORATION-2021IN009491$INCYTE$$$$$$Y$$$20240912$$CN$US$US
199959152$19995915$2$F$20211011$20211013$20211026$20240722$EXP$$US-ORPHANEU-2021004289$RECORDATI$$$$$$Y$$$20240722$$CN$US$US
199959523$19995952$3$F$$20211203$20211026$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR217395$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
199963253$19996325$3$F$$20240719$20211026$20240723$PER$$US-PFIZER INC-2021900073$PFIZER$$62$YR$$F$Y$$$20240723$$CN$US$US
199963775$19996377$5$F$$20240715$20211025$20240723$EXP$$GB-TAKEDA-2021TUS046730$TAKEDA$$$$$F$Y$$$20240723$$CN$GB$GB
199966624$19996662$4$F$$20240914$20211025$20240918$EXP$$IN-PFIZER INC-2018048440$PFIZER$$60$YR$$M$Y$$$20240918$$CN$IN$IN
199969166$19996916$6$F$$20220405$20211026$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR221002$GLAXOSMITHKLINE$$$$$F$Y$70.295$KG$20240925$$HP$US$US
199972132$19997213$2$F$$20240906$20211026$20240910$EXP$$CA-PFIZER INC-2021540155$PFIZER$$51$YR$$M$Y$$$20240910$$PH$CA$CA
199976125$19997612$5$F$20211009$20240702$20211026$20240709$EXP$$GB-Global Blood Therapeutics Inc-GB-GBT-21-03794$PFIZER$$23$YR$$M$Y$63$KG$20240709$$MD$GB$GB
199976244$19997624$4$F$$20240708$20211026$20240709$EXP$$US-TAKEDA-2021TUS015086$TAKEDA$$$$$F$Y$$$20240709$$MD$US$US
199977076$19997707$6$F$20190323$20240725$20211026$20240729$EXP$$DE-SHIRE-DE201913584$TAKEDA$$9$YR$$F$Y$15$KG$20240729$$MD$DE$DE
199977382$19997738$2$F$$20240621$20211026$20240702$PER$$US-SA-2021SA348600$SANOFI AVENTIS$$18$YR$A$F$Y$68.04$KG$20240702$$MD$US$US
1999910817$19999108$17$F$20210101$20240627$20211027$20240705$EXP$$CA-CELLTRION INC.-2021CA009207$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
199991115$19999111$5$F$$20240830$20211026$20240903$EXP$$US-TAKEDA-2021TUS064778$TAKEDA$$$$$M$Y$$$20240903$$CN$US$US
199991679$19999167$9$F$$20240805$20211026$20240807$EXP$$US-PFIZER INC-202101376554$PFIZER$$71$YR$$F$Y$48.98$KG$20240807$$MD$US$US
199992563$19999256$3$F$20210907$20240726$20211027$20240807$PER$$US-SA-2021SA351068$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240807$$MD$US$US
199992813$19999281$3$F$$20240903$20211026$20240911$EXP$$GR-PFIZER INC-202101366934$PFIZER$Lamprou, M.. TOXIC EPIDERMAL NECROLYSIS IN PEDIATRIC PATIENT WITH NON-HODGKIN B-CELL LYMPHOMA AND PRES ENCEPHALOPATHY. 7th PANHELLENIC CONGRESS OF PEDIATRIC HEAMATOLOGY-ONCOLOGY, DEVELOPMENTS-DATA-PR. 2021$12$YR$$M$Y$$$20240911$$MD$GR$GR
1999951714$19999517$14$F$20210803$20240920$20211027$20240930$EXP$$DE-CELLTRION INC.-2021DE014495$CELLTRION$$$$$$Y$$$20240930$$CN$DE$DE
200000522$20000052$2$F$20240701$20240716$20211027$20240723$PER$$US-SA-2021SA351941$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240723$$MD$US$US
2000045815$20000458$15$F$20210914$20240702$20211026$20240712$EXP$$DK-BAXTER-2021BAX032005$BAXTER$$62$YR$$F$Y$68.9$KG$20240712$$MD$DK$DK
200008234$20000823$4$F$20210601$20240723$20211027$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202110008803$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240729$$CN$US$US
200010723$20001072$3$F$20191201$20211222$20211027$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR217800$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
200014224$20001422$4$F$20220101$20240814$20211027$20240830$PER$$AU-TOLMAR, INC.-21AU029434$TOLMAR$$70$YR$$M$Y$$$20240829$$CN$AU$AU
200019062$20001906$2$F$$20211020$20211027$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR219307$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200021073$20002107$3$F$$20240910$20211027$20240930$PER$$CA-TOLMAR, INC.-21CA029307$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
200021543$20002154$3$F$$20211012$20211027$20240715$PER$$US-PFM-2021-08723$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240715$$HP$US$US
200022654$20002265$4$F$20211012$20240702$20211027$20240712$PER$$US-SA-2021SA351687$SANOFI AVENTIS$$67$YR$E$F$Y$94$KG$20240712$$MD$US$US
2000247915$20002479$15$F$20191001$20230616$20211027$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR217148$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240925$$CN$US$US
200025683$20002568$3$F$20200102$20240711$20211027$20240715$EXP$$CA-TAKEDA-2019TUS069766$TAKEDA$$22$YR$$F$Y$$$20240715$$CN$CA$CA
200025842$20002584$2$F$20150101$20240712$20211027$20240722$EXP$DE-AMK-253746$DE-TEVA-2021-DE-1967750$TEVA$$73$YR$$F$Y$81.2$KG$20240722$$PH$DE$DE
200029867$20002986$7$F$20210930$20240910$20211027$20240913$EXP$$BE-PFIZER INC-202101379709$PFIZER$$78$YR$$M$Y$76.9$KG$20240913$$MD$BE$BE
2000301919$20003019$19$F$20230114$20240722$20211027$20240726$EXP$$US-TAKEDA-2021TUS064904$TAKEDA$$56$YR$$F$Y$66$KG$20240726$$HP$US$US
200033772$20003377$2$F$$20240921$20211027$20240926$EXP$$GR-PFIZER INC-202101373376$MYLAN$Kalantzis, V.. Patient suffering from heatstroke and accompanying multi-organ failure on olanzapine and sertraline treatment. 5th National Resuscitation and Emergencies Conference. 2021$47$YR$$M$Y$$$20240926$$MD$GR$GR
200034747$20003474$7$F$20210419$20220310$20211028$20240905$EXP$$JP-SA-2021SA352491$SANOFI AVENTIS$$10$YR$C$M$Y$37.1$KG$20240906$$MD$JP$JP
200041373$20004137$3$F$$20240724$20211028$20240803$EXP$$CA-AUROBINDO-AUR-APL-2021-044274$AUROBINDO$$30$YR$$F$Y$$$20240803$$HP$CA$CA
200042925$20004292$5$F$20221027$20240904$20211028$20240925$PER$$CA-TOLMAR, INC.-21CA029350$TOLMAR$$72$YR$$M$Y$$$20240925$$CN$CA$CA
200044965$20004496$5$F$20211015$20240903$20211028$20240911$PER$$US-SA-2021SA352633$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240911$$MD$US$US
200053893$20005389$3$F$$20240305$20211028$20240923$PER$$RU-ROCHE-2941729$ROCHE$$24$YR$A$F$Y$$$20240923$$MD$RU$RU
200056769$20005676$9$F$$20220817$20211028$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR217367$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200060092$20006009$2$F$$20240828$20211028$20240919$PER$$CA-TOLMAR, INC.-21CA029554$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
200064978$20006497$8$F$$20220420$20211028$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR223352$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200065023$20006502$3$F$$20240628$20211028$20240704$EXP$$CA-GLAXOSMITHKLINE-CA2021220117$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$CA$CA
200065234$20006523$4$F$20210801$20240719$20211028$20240726$EXP$$US-ABBVIE-21K-163-4136148-00$ABBVIE$$43$YR$$F$Y$$$20240724$$MD$US$US
200066772$20006677$2$F$$20211018$20211028$20240808$EXP$$US-AstraZeneca-2021A782999$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
200067769$20006776$9$F$20200601$20220630$20211028$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR220167$GLAXOSMITHKLINE$$63$YR$$F$Y$73.923$KG$20240925$$HP$US$US
200070044$20007004$4$F$20211111$20220110$20211028$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR220095$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240925$$CN$US$US
2000706816$20007068$16$F$20200204$20240627$20211028$20240701$EXP$$US-SHIRE-US202004683$TAKEDA$$53$YR$$F$Y$49$KG$20240701$$CN$US$US
200071056$20007105$6$F$20211129$20240819$20211028$20240821$EXP$$US-TAKEDA-2021TUS065222$TAKEDA$$41$YR$$F$Y$$$20240820$$CN$US$US
2000752610$20007526$10$F$20190601$20230105$20211029$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR223255$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
200076418$20007641$8$F$20191001$20240826$20211029$20240919$PER$$CA-TOLMAR, INC.-21CA029476$TOLMAR$$64$YR$$M$Y$$$20240919$$CN$CA$CA
2000769014$20007690$14$F$20230613$20240923$20211028$20240930$EXP$$AU-TAKEDA-2021TUS065602$TAKEDA$$59$YR$$F$Y$$$20240930$$CN$AU$AU
200079539$20007953$9$F$20211201$20221109$20211028$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR219341$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
2000811910$20008119$10$F$20200930$20240701$20211028$20240702$EXP$$US-TAKEDA-US202023599$TAKEDA$$81$YR$$F$Y$$$20240702$$HP$US$US
200081555$20008155$5$F$$20240827$20211029$20240909$EXP$$FR-AUROBINDO-AUR-APL-2021-043490$AUROBINDO$$4$MON$$M$Y$2.1$KG$20240909$$HP$FR$FR
200083562$20008356$2$F$20210301$20211022$20211028$20240716$EXP$$CO-ASTELLAS-2021US040853$ASTELLAS$$42$YR$$F$Y$62$KG$20240716$$CN$CO$CO
200083683$20008368$3$F$$20211202$20211029$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR221570$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200084992$20008499$2$F$$20240731$20211029$20240813$EXP$$CA-AUROBINDO-AUR-APL-2021-044138$AUROBINDO$$67$YR$$F$Y$$$20240813$$HP$CA$CA
2000863325$20008633$25$F$20210823$20240820$20211029$20240828$EXP$$CA-CELLTRION INC.-2021CA014643$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
200087996$20008799$6$F$$20240918$20211028$20240920$EXP$$US-TAKEDA-2017BLT005843$TAKEDA$$$$$F$Y$$$20240920$$MD$US$US
200091587$20009158$7$F$$20220628$20211029$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR220096$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200093502$20009350$2$F$20210610$20240729$20211029$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-003573$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240821$$CN$US$US
2000943515$20009435$15$F$20210927$20240731$20211028$20240802$EXP$$NVSC2021RU223688$NOVARTIS$$59$YR$$F$Y$76$KG$20240803$$MD$RU$RU
200099294$20009929$4$F$20210703$20240826$20211028$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-110308$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$60.3$KG$20240903$$PH$JP$JP
200104599$20010459$9$F$$20240731$20211028$20240802$EXP$$IN-PFIZER INC-2019181716$PFIZER$$62$YR$$F$Y$35.828$KG$20240802$$CN$IN$IN
200110622$20011062$2$F$20211001$20240728$20211029$20240806$PER$$US-SA-2021SA352041$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240806$$MD$US$US
2001161017$20011610$17$F$20200401$20230425$20211029$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR221434$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
200116512$20011651$2$F$$20211025$20211029$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR221566$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200120177$20012017$7$F$20240228$20240816$20211029$20240823$EXP$$US-TAKEDA-US201936954$TAKEDA$$88$YR$$M$Y$79$KG$20240823$$CN$US$US
2001204210$20012042$10$F$$20240815$20211029$20240828$EXP$$CA-AUROBINDO-AUR-APL-2021-044257$AUROBINDO$$27$YR$$F$Y$120$KG$20240828$$HP$CA$CA
200121084$20012108$4$F$20211010$20240919$20211029$20240924$EXP$$CA-TAKEDA-2021TUS066016$TAKEDA$$36$YR$$M$Y$$$20240924$$CN$CA$CA
200127224$20012722$4$F$20210501$20240806$20211029$20240808$EXP$$US-PFIZER INC-202101453498$PFIZER$$67$YR$$M$Y$105.7$KG$20240808$$MD$US$US
200128356$20012835$6$F$$20240827$20211029$20240917$EXP$$CA-UCBSA-2021051083$UCB$$56$YR$$F$Y$$$20240917$$MD$CA$CA
2001341514$20013415$14$F$20211014$20240919$20211029$20240923$EXP$$US-TAKEDA-US202010259$TAKEDA$$66$YR$$M$Y$$$20240923$$MD$US$US
200137243$20013724$3$F$20210514$20240627$20211029$20240703$EXP$$CA-TAKEDA-2021TUS052616$TAKEDA$$23$YR$$F$Y$$$20240703$$MD$CA$CA
2001408930$20014089$30$F$20210101$20240913$20211029$20240923$EXP$$CA-CELLTRION INC.-2021CA011946$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
2001414511$20014145$11$F$20201007$20240910$20211029$20240918$EXP$$CA-CELLTRION INC.-2020CA029269$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
200169933$20016993$3$F$$20240724$20211030$20240805$EXP$$CA-AUROBINDO-AUR-APL-2021-044283$AUROBINDO$$67$YR$$M$Y$$$20240805$$HP$CA$CA
2001782710$20017827$10$F$20220713$20240904$20211101$20240925$PER$$CA-TOLMAR, INC.-21CA029582$TOLMAR$$74$YR$$M$Y$$$20240925$$CN$CA$CA
200178434$20017843$4$F$20180101$20240625$20211101$20240705$EXP$$CA-GLENMARK PHARMACEUTICALS-2021GMK068655$GLENMARK$Garneau B, Desharnais B, Beauchamp-Dore A, Lavall?e C, Mireault P, Lajeunesse A.. Challenges Related to Three Cases of Fatal Intoxication to Multiple Novel Synthetic Opioids.. Journal of Analytical Toxicology.. 2021;44(1):86-91$$$$$Y$$$20240705$$MD$CA$CA
2001818913$20018189$13$F$20190507$20240801$20211101$20240808$EXP$$CA-TAKEDA-2018TUS031609$TAKEDA$$32$YR$$F$Y$$$20240808$$CN$CA$CA
200184952$20018495$2$F$$20240924$20211101$20240930$EXP$$CA-TAKEDA-2021TUS066941$TAKEDA$$$$$M$Y$$$20240930$$CN$CA$CA
200189797$20018979$7$F$$20240723$20211101$20240726$EXP$$CA-TAKEDA-2018TUS034419$TAKEDA$$$$$F$Y$$$20240726$$CN$CA$CA
200192303$20019230$3$F$$20240702$20211101$20240716$PER$$US-TAKEDA-2021TUS065064$TAKEDA$$$$$M$Y$81$KG$20240716$$HP$US$US
2001925911$20019259$11$F$$20230227$20211101$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR224670$GLAXOSMITHKLINE$$$$$F$Y$95.7$KG$20240925$$HP$US$US
2001935214$20019352$14$F$20170701$20230515$20211101$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR224848$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
200194615$20019461$5$F$20210601$20220808$20211101$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR223939$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
2001947111$20019471$11$F$20211001$20220915$20211101$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR223372$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
200195403$20019540$3$F$$20220120$20211101$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR224025$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200198702$20019870$2$F$$20211022$20211101$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR221514$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200199285$20019928$5$F$20210819$20240807$20211101$20240809$PER$$US-PFIZER INC-202101078251$PFIZER$$48$YR$$F$Y$$$20240809$$PH$US$US
2002004314$20020043$14$F$20200811$20240917$20211101$20240923$EXP$$US-TAKEDA-US202022339$TAKEDA$$63$YR$$F$Y$$$20240923$$MD$US$US
2002016325$20020163$25$F$20210101$20240827$20211101$20240902$EXP$$US-TAKEDA-2021TUS067402$TAKEDA$$$$$F$Y$$$20240902$$MD$US$US
200204292$20020429$2$F$20210104$20240819$20211101$20240827$EXP$$US-TAKEDA-2021TUS000844$TAKEDA$$31$YR$$F$Y$$$20240827$$HP$US$US
2002052911$20020529$11$F$20210701$20240729$20211101$20240805$EXP$$BR-GLAXOSMITHKLINE-BR2020AMR106791$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$BR$BR
200212195$20021219$5$F$20211026$20240701$20211101$20240708$EXP$$US-TAKEDA-2021TUS067765$TAKEDA$$46$YR$$M$Y$$$20240708$$CN$US$US
2002140813$20021408$13$F$20210301$20240717$20211101$20240724$EXP$$US-JAZZ-2021-US-003384$JAZZ$$70$YR$$F$Y$$$20240724$$MD$US$US
200215859$20021585$9$F$20210101$20240725$20211101$20240731$EXP$$US-JAZZ-2021-US-015607$JAZZ$$$$$F$Y$$$20240731$$HP$US$US
2002178138$20021781$38$F$$20240905$20211101$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-113260$BRISTOL MYERS SQUIBB$Kunimasa K, Inoue T, Matsueda K, Kawamura T, Tamiya M, Nishino K. Cytokine release syndrome and immune-related pneumonitis associated with tumor progression in a pulmonary pleomorphic carcinoma treated with nivolumab plus ipilimumab treatment: a case report. JTO Clinical and Research Reports. 2022 Feb;3(2):1-5. doi:10.1016/j.jtocrr.2021.100272.$64$YR$A$F$Y$$$20240917$$MD$JP$JP
2002212216$20022122$16$F$20210807$20240920$20211102$20240930$EXP$$BE-CELLTRION INC.-2021BE014623$CELLTRION$$$$$$Y$$$20240930$$HP$BE$BE
200221295$20022129$5$F$$20240828$20211102$20240919$PER$$CA-TOLMAR, INC.-21CA029551$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
200226234$20022623$4$F$20211013$20240615$20211102$20240710$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-003661$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240710$$CN$US$US
200227963$20022796$3$F$$20211026$20211102$20240925$EXP$$US-TAKEDA-2021TUS067465$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
200229664$20022966$4$F$$20240912$20211102$20240923$PER$$US-SA-2020SA340115$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240923$$MD$US$US
2002319540$20023195$40$F$20210920$20240925$20211102$20240930$EXP$$AU-MYLANLABS-2021M1064996$MYLAN$$32$YR$$M$Y$$$20240930$$HP$AU$AU
200232794$20023279$4$F$$20220125$20211102$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR223887$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$HP$US$US
200233653$20023365$3$F$20180101$20240626$20211102$20240704$EXP$$CA-AUROBINDO-AUR-APL-2021-044311$AUROBINDO$Garneau B, Desharnais B, Beauchamp-Dor? A, Lavall?e C, Mireault P, Lajeunesse A.. Challenges Related to Three Cases of Fatal Intoxication to Multiple Novel Synthetic Opioids.. Journal of Analytical Toxicology.. 2021;44(1):86-91$29$YR$$M$Y$89$KG$20240704$$MD$CA$CA
200240393$20024039$3$F$20210101$20220322$20211102$20240722$EXP$$US-RECORDATI-2021003597$RECORDATI$$$$$$Y$$$20240722$$CN$US$US
200244168$20024416$8$F$20171101$20240724$20211102$20240801$EXP$$CA-TAKEDA-2017TUS024811$TAKEDA$$73$YR$$F$Y$$$20240801$$HP$CA$CA
200245755$20024575$5$F$20200101$20240820$20211102$20240821$EXP$$FR-TAKEDA-2021TUS065713$TAKEDA$$77$YR$$F$Y$$$20240821$$HP$FR$FR
200251969$20025196$9$F$20210911$20240906$20211102$20240911$EXP$$US-TAKEDA-2021TUS065998$TAKEDA$$5$YR$$M$Y$$$20240911$$HP$US$US
200253707$20025370$7$F$20170101$20240712$20211102$20240716$EXP$$CA-TAKEDA-2017TUS023910$TAKEDA$$$$$F$Y$$$20240716$$HP$CA$CA
2002567617$20025676$17$F$20210427$20240919$20211102$20240926$EXP$$AT-TAKEDA-2021TUS029738$TAKEDA$$55$YR$$F$Y$42.177$KG$20240926$$CN$AT$AT
200271442$20027144$2$F$20200617$20240707$20211103$20240716$PER$$US-SA-2021SA357280$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240716$$MD$US$US
200276093$20027609$3$F$$20240801$20211103$20240814$EXP$$CA-AUROBINDO-AUR-APL-2021-044177$AUROBINDO$$52$YR$$F$Y$$$20240814$$PH$CA$CA
200277167$20027716$7$F$20211001$20220106$20211103$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR223442$GLAXOSMITHKLINE$$73$YR$$F$Y$59$KG$20240925$$HP$US$US
2002773813$20027738$13$F$20191209$20240812$20211103$20240820$EXP$$CA-CELLTRION INC.-2019CA025083$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
200278473$20027847$3$F$20180101$20240627$20211103$20240711$EXP$CA-MLMSERVICE-20211014-3171576-1$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2021-06596$ALKEM$Garneau B, Desharnais B, Beauchamp-Dore A, Lavallee C, et.al. Challenges Related to Three Cases of Fatal Intoxication to Multiple Novel Synthetic Opioids. Journal of Analytical Toxicology. 2020;44(1):86-91$29$YR$$M$Y$89$KG$20240711$$MD$CA$CA
200279772$20027977$2$F$20210101$20240809$20211103$20240812$PER$$US-AMGEN-USASP2021170609$AMGEN$$60$YR$A$F$Y$$$20240812$$HP$US$US
2002809025$20028090$25$F$20200207$20240823$20211103$20240830$EXP$$CA-CELLTRION INC.-2020CA019100$CELLTRION$$$$$$Y$$$20240830$$MD$CA$CA
200284896$20028489$6$F$20200901$20220118$20211103$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR222304$GLAXOSMITHKLINE$$60$YR$$F$Y$55.9$KG$20240925$$MD$US$US
200286122$20028612$2$F$20211027$20240911$20211103$20240918$PER$$US-SA-2021SA360705$SANOFI AVENTIS$$9$YR$C$F$Y$19.5$KG$20240918$$MD$US$US
200290204$20029020$4$F$$20240917$20211103$20240923$EXP$$GR-ROCHE-2947057$ROCHE$Lamprou M,  TOXIC EPIDERMAL NECROLYSIS IN PEDIATRIC PATIENT WITH NON-HODGKIN B-CELL LYMPHOMA AND PRES ENCEPHALOPATHY. Annales Clinicae Paediatricae Universitatis Atheniensis, book of abstracts. 2023;73 (1):69.$12$YR$T$M$Y$$$20240923$$MD$GR$GR
2002912427$20029124$27$F$$20240702$20211103$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-114769$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240711$$MD$JP$JP
200295086$20029508$6$F$20211001$20220418$20211103$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR225263$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240925$$CN$US$US
200295927$20029592$7$F$20211012$20240718$20211103$20240724$EXP$$US-JAZZ-2021-US-019541$JAZZ$$$$$$Y$$$20240724$$HP$US$US
200296984$20029698$4$F$20210101$20240802$20211103$20240813$PER$$US-INCYTE CORPORATION-2021IN009985$INCYTE$$$$$$Y$$$20240813$$CN$US$US
2002983319$20029833$19$F$20210805$20240809$20211103$20240814$EXP$$CA-TAKEDA-2021TUS028045$TAKEDA$$31$YR$$F$Y$$$20240814$$CN$CA$CA
200299824$20029982$4$F$20240801$20240826$20211103$20240827$PER$$US-PFIZER INC-2021555622$PFIZER$$73$YR$$F$Y$$$20240827$$CN$US$US
200300993$20030099$3$F$20211001$20211103$20211103$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR224153$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
200302574$20030257$4$F$$20240816$20211103$20240821$EXP$$ES-PFIZER INC-202101410727$PFIZER$$$$$F$Y$$$20240821$$MD$ES$ES
200303238$20030323$8$F$20211202$20240723$20211103$20240729$EXP$$CA-TAKEDA-2021TUS058193$TAKEDA$$60$YR$$F$Y$$$20240729$$HP$CA$CA
2003068210$20030682$10$F$20211002$20240809$20211103$20240813$EXP$$US-DSJP-DSU-2021-136377$DAIICHI$$55$YR$$M$Y$$$20240813$$CN$US$US
200316325$20031632$5$F$20240125$20240906$20211103$20240913$EXP$$JP-ABBVIE-21K-087-4145008-00$ABBVIE$$70$YR$$F$Y$$$20240913$$HP$JP$JP
200317258$20031725$8$F$20200312$20240705$20211103$20240708$EXP$$CH-ABBVIE-20K-151-3587954-00$ABBVIE$$75$YR$$M$Y$115$KG$20240708$$MD$CH$CH
200318969$20031896$9$F$20210801$20240917$20211103$20240925$EXP$$FR-ABBVIE-21K-056-4138092-00$ABBVIE$$42$YR$$M$Y$$$20240925$$MD$FR$FR
200321035$20032103$5$F$$20240708$20211103$20240710$PER$$US-PFIZER INC-202101316005$PFIZER$$77$YR$$$Y$$$20240710$$CN$US$US
200322415$20032241$5$F$$20240916$20211103$20240917$EXP$GR-UCBSA-2021050580$GR-UCBSA-2021050580$UCB$$12$YR$$M$Y$$$20240917$$MD$GR$GR
200325703$20032570$3$F$$20240906$20211103$20240913$EXP$$US-GILEAD-2021-0555236$GILEAD$$40$YR$A$F$Y$$$20240913$$HP$US$US
2003312511$20033125$11$F$20200424$20240731$20211104$20240808$EXP$$CA-CELLTRION INC.-2020CA019558$CELLTRION$$$$$$Y$$$20240808$$MD$CA$CA
200333233$20033323$3$F$20200728$20220204$20211104$20240711$EXP$$ES-ASTELLAS-2021US042276$ASTELLAS$$$$$$Y$$$20240711$$CN$ES$ES
200337914$20033791$4$F$20210412$20240916$20211104$20240926$EXP$$NVSC2021CR250693$NOVARTIS$$75$YR$$M$Y$$$20240926$$CN$CR$CR
200345053$20034505$3$F$$20240808$20211104$20240812$EXP$$FR-MYLANLABS-2021M1079864$MYLAN$$74$YR$$M$Y$61$KG$20240812$$LW$FR$FR
200349803$20034980$3$F$20200225$20240701$20211104$20240707$EXP$$ZA-PFIZER INC-202101464824$PFIZER$$67$YR$$F$Y$$$20240707$$MD$ZA$ZA
2003505312$20035053$12$F$20210101$20240826$20211104$20240830$EXP$$CA-TAKEDA-2021TUS022053$TAKEDA$$67$YR$$F$Y$$$20240830$$CN$CA$CA
2003508117$20035081$17$F$20190705$20240918$20211104$20240926$EXP$$CA-TAKEDA-2021TUS068245$TAKEDA$$32$YR$$F$Y$$$20240926$$MD$CA$CA
200351317$20035131$7$F$20200528$20240803$20211104$20240812$EXP$$CA-TAKEDA-2020TUS020894$TAKEDA$$52$YR$$M$Y$$$20240812$$CN$CA$CA
200354817$20035481$7$F$$20240819$20211104$20240820$EXP$$US-PFIZER INC-202101440918$PFIZER$$69$YR$$F$Y$$$20240820$$CN$US$US
200357844$20035784$4$F$$20240911$20211104$20240919$EXP$$IT-CELLTRION INC.-2021IT014852$CELLTRION$Barbieri, M., Sorbara E., Cicala G., Santoro V., Cutroneo P., Franchina T., et al.. Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database. Drugs - Real World Outcomes.. 2021$$$$$Y$$$20240919$$HP$IT$IT
2003604810$20036048$10$F$20220112$20230306$20211105$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR223450$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
200362415$20036241$5$F$20210901$20240809$20211105$20240904$EXP$$US-ASTELLAS-2021US036396$ASTELLAS$$76$YR$E$M$Y$$$20240904$$CN$US$US
200362533$20036253$3$F$$20211208$20211105$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR224687$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200362546$20036254$6$F$$20220128$20211105$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR224014$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
200375084$20037508$4$F$$20220105$20211105$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR226016$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2003794312$20037943$12$F$20200524$20240830$20211105$20240904$EXP$$IT-MYLANLABS-2021M1079947$MYLAN$$62$YR$$M$Y$$$20240904$$MD$IT$IT
2003827317$20038273$17$F$20161111$20240702$20211105$20240704$EXP$$CA-TAKEDA-2016TUS023430$TAKEDA$$57$YR$$M$Y$$$20240704$$MD$CA$CA
200382783$20038278$3$F$$20240827$20211105$20240905$EXP$$US-TEVA-2021-US-1975631$TEVA$$85$YR$$F$Y$$$20240905$$LW$US$US
2003836017$20038360$17$F$20230619$20240827$20211105$20240902$EXP$$US-SHIRE-US202006410$TAKEDA$$67$YR$$F$Y$126$KG$20240902$$HP$US$US
2003837913$20038379$13$F$20211103$20221215$20211105$20240925$PER$$US-GLAXOSMITHKLINE-US2021224202$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240925$$CN$US$US
2003884315$20038843$15$F$$20240715$20211105$20240717$PER$$US-PFIZER INC-202101491081$PFIZER$$76$YR$$F$Y$$$20240717$$CN$US$US
200394135$20039413$5$F$$20240906$20211105$20240911$EXP$$US-GILEAD-2021-0555185$GILEAD$$64$YR$A$M$Y$$$20240911$$HP$US$US
200395909$20039590$9$F$20211023$20240813$20211106$20240813$EXP$$GB-ROCHE-2950984$ROCHE$$40$YR$A$M$Y$$$20240813$$MD$GB$GB
200396032$20039603$2$F$20211001$20240902$20211106$20240920$PER$$US-SA-2021SA360401$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240920$$MD$US$US
2003997922$20039979$22$F$20190101$20240813$20211106$20240823$EXP$$US-GLAXOSMITHKLINE-US2021AMR224831$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
200410147$20041014$7$F$20210801$20230602$20211107$20240926$PER$$US-GLAXOSMITHKLINE-US2021AMR225450$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240926$$CN$US$US
200414567$20041456$7$F$20210812$20240902$20211108$20240924$PER$$CA-TOLMAR, INC.-21CA029655$TOLMAR$$69$YR$$M$Y$$$20240923$$CN$CA$CA
200415034$20041503$4$F$20210814$20220125$20211108$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR227256$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
200420608$20042060$8$F$20211105$20220308$20211108$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR225244$GLAXOSMITHKLINE$$83$YR$$F$Y$$$20240926$$CN$US$US
200423664$20042366$4$F$$20240814$20211108$20240820$EXP$$CA-TAKEDA-2021TUS068414$TAKEDA$$$$$F$Y$$$20240820$$CN$CA$CA
2004241322$20042413$22$F$20201029$20240904$20211108$20240913$EXP$$CA-CELLTRION INC.-2020CA031117$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
200424184$20042418$4$F$$20240821$20211108$20240827$EXP$$CA-JNJFOC-20211103953$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240827$$HP$CA$CA
200424547$20042454$7$F$20220616$20231130$20211108$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR228652$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
200425173$20042517$3$F$20210819$20240905$20211108$20240925$PER$$CR-TOLMAR, INC.-21CR029867$TOLMAR$$81$YR$$M$Y$$$20240925$$CN$CR$CR
200425274$20042527$4$F$$20240614$20211108$20240704$PER$$CA-TOLMAR, INC.-21CA025766$TOLMAR$$$$$M$Y$$$20240704$$CN$CA$CA
200425498$20042549$8$F$20210101$20240825$20211108$20240902$PER$$CA-TOLMAR, INC.-21CA029843$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
2004256524$20042565$24$F$20190418$20240904$20211108$20240913$EXP$$CA-CELLTRION INC.-2019CA022937$CELLTRION$$$$$$Y$$$20240913$$CN$CA$CA
2004256830$20042568$30$F$20190405$20240808$20211108$20240815$EXP$$CA-CELLTRION INC.-2021CA008493$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
200425725$20042572$5$F$20210217$20240826$20211108$20240926$PER$$NL-TOLMAR, INC.-21NL029939$TOLMAR$$61$YR$$M$Y$$$20240926$$CN$NL$NL
200425813$20042581$3$F$$20240916$20211108$20240925$EXP$$CA-Orion Corporation ORION PHARMA-TREX2019-4323$ORION$$51$YR$A$M$Y$$$20240925$$HP$CA$
200427377$20042737$7$F$20211001$20220608$20211108$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR226105$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
200427442$20042744$2$F$20211020$20211102$20211108$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR227204$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240925$$CN$US$US
200428712$20042871$2$F$$20240822$20211108$20240830$EXP$$US-ROCHE-2903397$ROCHE$$77$YR$E$M$Y$$$20240830$$MD$US$US
2004312428$20043124$28$F$20211001$20240715$20211108$20240722$EXP$$NVSC2021MX235099$NOVARTIS$$23$YR$$M$Y$94$KG$20240722$$CN$MX$MX
200432442$20043244$2$F$$20240918$20211108$20240924$EXP$$CA-Orion Corporation ORION PHARMA-21_00016383$ORION$$68$YR$E$M$Y$$$20240924$$MD$CA$
2004326511$20043265$11$F$$20230703$20211108$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR225213$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2004332337$20043323$37$F$20200408$20240919$20211108$20240927$EXP$$CA-CELLTRION INC.-2020CA021489$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
2004363413$20043634$13$F$20210101$20240715$20211108$20240717$EXP$$US-PFIZER INC-202101456910$PFIZER$$68$YR$$F$Y$$$20240717$$CN$US$US
2004388513$20043885$13$F$20211012$20240905$20211108$20240911$EXP$$US-TAKEDA-2021TUS039456$TAKEDA$$65$YR$$F$Y$71.202$KG$20240911$$CN$US$US
200440002$20044000$2$F$$20240904$20211108$20240907$EXP$$US-TAKEDA-2021TUS066664$TAKEDA$$$$$F$Y$10$KG$20240907$$HP$US$US
200440435$20044043$5$F$$20220523$20211108$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR227254$GLAXOSMITHKLINE$$$$$F$Y$74.376$KG$20240925$$MD$US$US
2004419711$20044197$11$F$$20240910$20211108$20240912$PER$$US-PFIZER INC-2020343481$PFIZER$$74$YR$$F$Y$$$20240912$$MD$US$US
200443168$20044316$8$F$20210601$20221221$20211108$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR225542$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
2004452612$20044526$12$F$20230503$20240705$20211108$20240712$EXP$$US-TAKEDA-2021TUS066221$TAKEDA$$53$YR$$F$Y$109$KG$20240712$$CN$US$US
200446813$20044681$3$F$$20240917$20211108$20240920$EXP$$US-TAKEDA-2021TUS068934$TAKEDA$$$$$M$Y$$$20240920$$MD$US$US
200448743$20044874$3$F$$20240906$20211108$20240913$EXP$$US-GILEAD-2021-0555072$GILEAD$$70$YR$E$F$Y$$$20240913$$HP$US$US
2004489511$20044895$11$F$20210101$20240712$20211108$20240722$EXP$$JP-DSJP-DSJ-2021-118723$DAIICHI$Kamano M, Ootani Y, Kasahara C, Kasashima A, Tsukamoto F. Two cases of varices oesophageal in which pseudocirrhosis occurred during chemotherapy for breast cancer multiple metastases to liver. The 31st Annual Meeting of the Japanese Breast Cancer Society. 2023;154$55$YR$$F$Y$45$KG$20240722$$MD$JP$JP
200449413$20044941$3$F$20211005$20240723$20211108$20240725$EXP$$US-TAKEDA-2021TUS069280$TAKEDA$$42$YR$$M$Y$$$20240725$$PH$US$US
200449602$20044960$2$F$20140101$20211026$20211108$20240824$EXP$$CA-TAKEDA-2021TUS067108$TAKEDA$$24$YR$$F$Y$$$20240824$$CN$CA$CA
200456953$20045695$3$F$$20211203$20211108$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR226146$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200458743$20045874$3$F$$20211104$20211108$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR228778$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200459473$20045947$3$F$$20220127$20211108$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR226007$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200464089$20046408$9$F$$20230925$20211109$20240909$PER$$NVSC2021US254016$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
2004663311$20046633$11$F$$20240625$20211109$20240701$EXP$$PT-AUROBINDO-AUR-APL-2021-045720$AUROBINDO$Ferreira A, Pereira LC, Sousa, MB, Pardal N, Sobrosa PS, Mota RV et.al. Toxicidade a linezolide?a proposito de um caso clinico(Linezolid Toxicity - About a Clinical Case). Medicina Interna. 2021$80$YR$$M$Y$$$20240701$$MD$PT$PT
200470842$20047084$2$F$$20240718$20211109$20240723$EXP$$ES-AMGEN-ESPSP2021174309$AMGEN$$$$$F$Y$$$20240723$$HP$ES$ES
2004714223$20047142$23$F$20211030$20240812$20211109$20240926$PER$$US-GLAXOSMITHKLINE-US2021AMR227845$GLAXOSMITHKLINE$$39$YR$$F$Y$64$KG$20240926$$HP$US$US
2004736613$20047366$13$F$20211101$20230117$20211109$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR228660$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
2004861122$20048611$22$F$20211118$20240903$20211109$20240905$EXP$$IT-TAKEDA-2021TUS069299$TAKEDA$$6$YR$$M$Y$$$20240905$$CN$IT$IT
200502292$20050229$2$F$20190101$20211102$20211109$20240726$EXP$$AT-ASTELLAS-2021US042208$ASTELLAS$$$$N$M$Y$0.8$KG$20240726$$HP$AT$AT
2005118419$20051184$19$F$$20230918$20211110$20240926$PER$$US-GLAXOSMITHKLINE-US2021AMR226212$GLAXOSMITHKLINE$$$$$F$Y$61.23$KG$20240926$$HP$US$US
200517783$20051778$3$F$$20240906$20211110$20240912$EXP$$US-TAKEDA-2021TUS069336$TAKEDA$$$$$M$Y$125$KG$20240912$$MD$US$US
200522855$20052285$5$F$20240201$20240625$20211110$20240703$EXP$$US-SA-2021SA370609$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240703$$MD$US$US
200524033$20052403$3$F$$20211215$20211110$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR227263$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
2005263412$20052634$12$F$20200101$20221205$20211110$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR228984$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
200527402$20052740$2$F$$20240711$20211110$20240717$EXP$$NL-ALNYLAM PHARMACEUTICALS, INC.-ALN-2021-002858$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240717$$MD$NL$NL
2005323011$20053230$11$F$$20240729$20211110$20240801$EXP$$CA-PFIZER INC-202101493504$PFIZER$$24$YR$$F$Y$84$KG$20240801$$HP$CA$CA
200535156$20053515$6$F$20210623$20240906$20211110$20240920$EXP$$JP-DSJP-DSJ-2021-119877$DAIICHI$Hashimoto N, Igawa A. EP-0725 Usefulness of ENHERTU for HER2 positive metastatic recurrent breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;359$49$YR$$F$Y$52.2$KG$20240920$$MD$JP$JP
200540087$20054008$7$F$20090722$20240829$20211110$20240903$EXP$$US-TAKEDA-2021TUS067249$TAKEDA$$64$YR$$M$Y$62$KG$20240903$$CN$US$US
200544697$20054469$7$F$20220623$20240709$20211110$20240712$EXP$$CA-TAKEDA-2019TUS008497$TAKEDA$$59$YR$$F$Y$$$20240712$$HP$CA$CA
2005482014$20054820$14$F$20211206$20240911$20211110$20240917$EXP$$US-TAKEDA-2021TUS066427$TAKEDA$$67$YR$$F$Y$58$KG$20240917$$CN$US$US
200552395$20055239$5$F$20221001$20240709$20211110$20240712$EXP$$US-TAKEDA-2021TUS069435$TAKEDA$$48$YR$$M$Y$$$20240712$$CN$US$US
2005553825$20055538$25$F$20210730$20240813$20211110$20240817$EXP$$CO-TAKEDA-CO201944572$TAKEDA$$23$YR$$F$Y$54$KG$20240817$$HP$CO$CO
2005657812$20056578$12$F$20240429$20240822$20211111$20240824$EXP$$US-TAKEDA-US201725715$TAKEDA$$54$YR$$M$Y$$$20240824$$HP$US$US
2005668619$20056686$19$F$20210727$20240718$20211111$20240726$EXP$$CA-CELLTRION INC.-2021CA009944$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
200568263$20056826$3$F$$20220131$20211111$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR228697$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200569003$20056900$3$F$$20211214$20211111$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR228960$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200574236$20057423$6$F$20210809$20240815$20211111$20240820$EXP$$CO-TAKEDA-CO201909620$TAKEDA$$77$YR$$F$Y$49$KG$20240820$$CN$CO$CO
200575592$20057559$2$F$20210401$20211103$20211111$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR228701$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240925$$CN$US$US
2005767815$20057678$15$F$$20231115$20211111$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR227248$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$HP$US$US
2005797058$20057970$58$F$20200511$20240724$20211111$20240730$EXP$$CO-TAKEDA-CO202016718$TAKEDA$$11$YR$$M$Y$48$KG$20240730$$CN$CO$CO
2005799716$20057997$16$F$20221001$20240925$20211111$20240930$EXP$$US-TAKEDA-2021TUS070199$TAKEDA$$41$YR$$F$Y$$$20240930$$HP$US$US
200585523$20058552$3$F$$20240903$20211111$20240906$EXP$$CA-TAKEDA-2020TUS031649$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
200591874$20059187$4$F$20210819$20240710$20211111$20240711$EXP$$ES-TAKEDA-2021TUS068885$TAKEDA$$$$A$M$Y$$$20240711$$MD$ES$ES
200595185$20059518$5$F$20200101$20240701$20211111$20240708$EXP$$DE-MYLANLABS-2021M1081618$MYLAN$$77$YR$$F$Y$$$20240708$$MD$DE$DE
200597263$20059726$3$F$$20240906$20211111$20240913$EXP$$US-GILEAD-2021-0556114$GILEAD$$71$YR$E$F$Y$$$20240913$$HP$US$US
200599365$20059936$5$F$$20240202$20211111$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-000531$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
200604733$20060473$3$F$$20211104$20211112$20240926$PER$$NVSC2021US258142$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
200606598$20060659$8$F$$20240814$20211112$20240820$EXP$$CA-TAKEDA-2021TUS069979$TAKEDA$$$$$M$Y$$$20240820$$CN$CA$CA
2006138410$20061384$10$F$20210201$20221122$20211112$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR229089$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240925$$CN$US$US
2006188910$20061889$10$F$20211101$20220420$20211112$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR231813$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240926$$CN$US$US
2006203917$20062039$17$F$20220101$20230403$20211112$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR229304$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
200621394$20062139$4$F$20190101$20240911$20211112$20240919$EXP$$CA-TAKEDA-2019TUS070471$TAKEDA$$$$$M$Y$$$20240919$$CN$CA$CA
200622594$20062259$4$F$20231101$20240813$20211112$20240820$EXP$$US-GLAXOSMITHKLINE-US2021229167$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$US$US
200623403$20062340$3$F$20210101$20240823$20211112$20240828$EXP$$US-VERTEX PHARMACEUTICALS-2021-014343$VERTEX$$$$$M$Y$$$20240828$$CN$US$US
2006312412$20063124$12$F$20110801$20240806$20211112$20240808$EXP$$CA-JNJFOC-20210602895$JOHNSON AND JOHNSON$$25$YR$A$F$Y$74.8$KG$20240808$$HP$CA$CA
200634922$20063492$2$F$$20240812$20211112$20240816$EXP$$SK-MYLANLABS-2021M1081590$MYLAN$Sykora T, Horakova J, Buzzasyova D, Sladekova M, Poczova M, Sufliarska S. Protothecal peritonitis in child after bone marrow transplantation: Case report and literature review of paediatric cases.. New Microbes and New Infections.. 2014;2 (6):156-160$3$YR$$M$Y$$$20240816$$HP$SK$SK
200636347$20063634$7$F$$20240910$20211112$20240919$EXP$$CA-TAKEDA-2021TUS070711$TAKEDA$$$$$F$Y$$$20240919$$CN$CA$CA
200651853$20065185$3$F$$20240709$20211113$20240716$PER$$US-SA-2021SA373582$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240716$$CN$US$US
2006522012$20065220$12$F$20220201$20220913$20211113$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR230008$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
200652518$20065251$8$F$20211027$20220720$20211113$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR227854$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240925$$CN$US$US
2006529417$20065294$17$F$20220601$20230920$20211113$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR230031$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$MD$US$US
2006529515$20065295$15$F$20200601$20221214$20211113$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR229896$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
200654612$20065461$2$F$20130101$20240823$20211113$20240903$PER$$US-JNJFOC-20211105585$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240903$$LW$US$US
2006615719$20066157$19$F$20191129$20240801$20211114$20240808$EXP$$CA-CELLTRION INC.-2019CA027328$CELLTRION$$$$$$Y$$$20240808$$MD$CA$CA
200661632$20066163$2$F$20210101$20240702$20211114$20240710$PER$$US-SA-2021SA121465$SANOFI AVENTIS$$6$YR$C$F$Y$37.72$KG$20240710$$MD$US$US
200663853$20066385$3$F$20211008$20211214$20211115$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR230019$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
2006639614$20066396$14$F$20190101$20240628$20211115$20240706$EXP$$CA-CELLTRION INC.-2019CA019648$CELLTRION$$$$$$Y$$$20240706$$CN$CA$CA
200665802$20066580$2$F$$20240716$20211115$20240726$EXP$$JP-VALIDUS PHARMACEUTICALS LLC-JP-VDP-2021-014532$VALIDUS$Moue S, Sato Y, Yamaguchi Y, Fukudo S. OS6-5: A case of congestive cardiac failure during treatment of dehydration and renal impairment in a patient with persisting severe anorexia nervosa. Japanese Journal of Psychosomatic Internal Medicine. 2021;23:102$$$$$Y$$$20240726$$HP$JP$JP
2006658612$20066586$12$F$20180813$20240617$20211115$20240709$EXP$$DE-ROCHE-2171225$ROCHE$$27$YR$A$F$Y$$$20240705$$CN$DE$DE
200670136$20067013$6$F$$20220503$20211115$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR229876$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200678595$20067859$5$F$20211014$20240910$20211115$20240917$EXP$$CA-TAKEDA-2020TUS016241$TAKEDA$$30$YR$$F$Y$$$20240917$$CN$CA$CA
200679157$20067915$7$F$20240623$20240916$20211115$20240919$EXP$$AU-TAKEDA-2021TUS070328$TAKEDA$$83$YR$$M$Y$$$20240919$$MD$AU$AU
2006817229$20068172$29$F$20210705$20240820$20211115$20240827$EXP$$US-TAKEDA-2021TUS046501$TAKEDA$$54$YR$$F$Y$65$KG$20240827$$HP$US$US
200682254$20068225$4$F$$20240709$20211115$20240715$EXP$$CA-TAKEDA-2021TUS070038$TAKEDA$$$$$F$Y$$$20240715$$MD$CA$CA
2006827912$20068279$12$F$20170501$20230207$20211115$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR232759$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2006865824$20068658$24$F$20220701$20240920$20211115$20240927$EXP$$US-TAKEDA-2021TUS051052$TAKEDA$$82$YR$$F$Y$58.96$KG$20240927$$HP$US$US
200686993$20068699$3$F$20201101$20240805$20211115$20240811$EXP$$US-JAZZ-2021-US-020511$JAZZ$$54$YR$$M$Y$$$20240811$$CN$US$US
200688953$20068895$3$F$20211114$20211115$20211115$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR230024$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
200690123$20069012$3$F$$20240715$20211115$20240718$EXP$$SA-PFIZER INC-202101522874$PFIZER$Al-hwiesh, A.. Meropenem at Recommended Dose is a Potential Risk for Seizure in Hemodialysis Patient. Saudi Journal of Kidney Diseases and Transplantation. 2020;31 (6):1427-1431$65$YR$$F$Y$47$KG$20240718$$HP$SA$SA
200691596$20069159$6$F$$20240905$20211115$20240906$EXP$$US-TAKEDA-2021TUS050745$TAKEDA$$$$$M$Y$$$20240906$$HP$US$US
200692204$20069220$4$F$20210901$20240830$20211115$20240904$EXP$$US-PFIZER INC-202101572856$PFIZER$$54$YR$$F$Y$$$20240904$$HP$US$US
200693482$20069348$2$F$20180122$20240919$20211115$20240925$EXP$$US-TAKEDA-US201710671$TAKEDA$$4$YR$$M$Y$$$20240925$$CN$US$US
200693642$20069364$2$F$20210713$20240826$20211115$20240919$PER$$NL-TOLMAR, INC.-21NL030110$TOLMAR$$70$YR$$M$Y$$$20240919$$CN$NL$NL
200694942$20069494$2$F$$20240906$20211115$20240913$EXP$$JP-ABBVIE-21K-087-4162010-00$ABBVIE$$$$$$Y$$$20240913$$MD$JP$JP
200699812$20069981$2$F$$20240909$20211115$20240916$EXP$$CZ-MYLANLABS-2021M1082726$MYLAN$$13$MON$$M$Y$8$KG$20240916$$MD$CZ$CZ
2007036324$20070363$24$F$20210101$20240719$20211115$20240724$EXP$$CA-PFIZER INC-202101512635$PFIZER$$77$YR$$F$Y$67$KG$20240724$$HP$CA$CA
2007044812$20070448$12$F$20210101$20240912$20211115$20240916$EXP$$US-PFIZER INC-202101146924$PFIZER$$77$YR$$M$Y$$$20240916$$HP$US$US
200711213$20071121$3$F$$20240906$20211115$20240912$EXP$$US-GILEAD-2021-0556268$GILEAD$$61$YR$A$F$Y$$$20240912$$HP$US$US
2007125713$20071257$13$F$20210111$20240702$20211115$20240712$EXP$$NVSJ2021JP000838$NOVARTIS$$13$MON$$M$Y$8.2$KG$20240712$$MD$JP$JP
200717277$20071727$7$F$20210805$20240812$20211116$20240829$PER$$NL-TOLMAR, INC.-21NL029670$TOLMAR$$70$YR$$M$Y$$$20240829$$HP$NL$NL
2007203529$20072035$29$F$20210101$20240829$20211116$20240907$EXP$$CA-CELLTRION INC.-2021CA012716$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
2007283421$20072834$21$F$20210101$20240906$20211116$20240916$EXP$$CA-CELLTRION INC.-2021CA010994$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
2007309920$20073099$20$F$20220204$20240821$20211116$20240827$EXP$$US-GLAXOSMITHKLINE-US2021AMR231251$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$US$US
200731323$20073132$3$F$20211025$20240920$20211116$20240927$EXP$$KR-GLAXOSMITHKLINE-KR2021235207$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$KR$KR
200733836$20073383$6$F$20210903$20240603$20211116$20240708$PER$$CA-TOLMAR, INC.-21CA030254$TOLMAR$$73$YR$$M$Y$$$20240708$$CN$CA$CA
200739604$20073960$4$F$20211101$20240912$20211116$20240919$EXP$$CA-TAKEDA-2021TUS069962$TAKEDA$$75$YR$$F$Y$$$20240919$$CN$CA$CA
200739775$20073977$5$F$20200601$20240910$20211116$20240916$EXP$$CO-TAKEDA-2021TUS051548$TAKEDA$$57$YR$$F$Y$45$KG$20240916$$CN$CO$CO
2007423210$20074232$10$F$20210403$20240716$20211116$20240724$EXP$$US-TAKEDA-US202030491$TAKEDA$$74$YR$$F$Y$63$KG$20240724$$CN$US$US
2007441110$20074411$10$F$20210420$20240923$20211116$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR090747$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
200745494$20074549$4$F$$20240905$20211116$20240906$EXP$$CA-ROCHE-2955108$ROCHE$$58$YR$A$F$Y$$$20240906$$HP$CA$CA
200748426$20074842$6$F$20200101$20240701$20211116$20240708$EXP$$IT-MYLANLABS-2021M1082600$MYLAN$Dagna L, Ciceri F, Scarpellini P, et.al.. Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19.. Clinical Microbiology and Infection.. 2021;27:1190-1192.$69$YR$$F$Y$$$20240708$$HP$IT$IT
200751682$20075168$2$F$$20240815$20211116$20240828$PER$$US-SA-2021SA374628$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240828$$MD$US$US
200755572$20075557$2$F$$20240715$20211116$20240718$EXP$$CA-TAKEDA-2021TUS071386$TAKEDA$$$$$F$Y$$$20240718$$CN$CA$CA
200756652$20075665$2$F$20210525$20240827$20211116$20240905$EXP$$US-NOVOPROD-816787$NOVO NORDISK$$72$YR$$F$Y$$$20240905$$CN$US$US
200757173$20075717$3$F$20210520$20211014$20211116$20240717$PER$$US-NOVOPROD-824568$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$MD$US$US
200766174$20076617$4$F$$20240916$20211116$20240919$PER$$US-PFIZER INC-2018532484$PFIZER$$63$YR$$F$Y$$$20240919$$CN$US$US
200770093$20077009$3$F$$20240808$20211116$20240813$EXP$$US-INCYTE CORPORATION-2021IN010563$INCYTE$$$$$$Y$$$20240813$$CN$US$US
2007746822$20077468$22$F$20130730$20240815$20211116$20240822$EXP$$US-TAKEDA-2021TUS057810$TAKEDA$$54$YR$$F$Y$71$KG$20240822$$HP$US$US
200778822$20077882$2$F$20211007$20240719$20211116$20240730$EXP$$FR-AUROBINDO-AUR-APL-2021-046746$AUROBINDO$$44$YR$$M$Y$52$KG$20240730$$MD$FR$FR
200787952$20078795$2$F$$20211111$20211117$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR232948$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200792214$20079221$4$F$$20211115$20211117$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR231081$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2007932035$20079320$35$F$20201020$20240722$20211117$20240730$EXP$$CA-CELLTRION INC.-2021CA015379$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
2007947112$20079471$12$F$20200506$20240626$20211117$20240703$EXP$$NVSC2020CA157247$NOVARTIS$$52$YR$$M$Y$83.3$KG$20240703$$MD$CA$CA
200795137$20079513$7$F$$20240711$20211117$20240718$EXP$$NVSC2021BR259919$NOVARTIS$$$$$F$Y$$$20240718$$CN$BR$BR
200796657$20079665$7$F$20211018$20220525$20211117$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR232596$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
200801195$20080119$5$F$$20221130$20211117$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR231718$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2008089348$20080893$48$F$$20240918$20211117$20240927$EXP$$US-TAKEDA-2021TUS033682$TAKEDA$$$$$F$Y$60$KG$20240927$$HP$US$US
200816428$20081642$8$F$20210101$20240825$20211117$20240829$EXP$$IN-PFIZER INC-2021666309$PFIZER$$51$YR$$F$Y$52$KG$20240829$$CN$IN$IN
200817902$20081790$2$F$$20240802$20211117$20240812$EXP$$US-KYOWAKIRIN-2021BKK019123$KYOWA$$$$$$Y$$$20240812$$CN$US$US
200817982$20081798$2$F$20211103$20211103$20211117$20240723$PER$$US-BEH-2021137871$CSL BEHRING$$62$YR$A$M$Y$$$20240723$$CN$US$US
200818239$20081823$9$F$20211116$20240920$20211117$20240923$EXP$$JP-ABBVIE-21K-087-4163974-00$ABBVIE$$63$YR$$M$Y$64$KG$20240923$$MD$JP$JP
200821847$20082184$7$F$$20240909$20211117$20240911$EXP$$CA-ROCHE-2958804$ROCHE$$$$A$M$Y$$$20240911$$CN$CA$CA
200823022$20082302$2$F$$20240709$20211117$20240712$EXP$$ES-PFIZER INC-202101516315$PFIZER$$$$$F$Y$$$20240712$$HP$ES$ES
200829172$20082917$2$F$20210101$20240709$20211117$20240711$EXP$$US-KYOWAKIRIN-2021BKK019122$KYOWA$$$$$$Y$$$20240711$$HP$US$US
200832834$20083283$4$F$20240609$20240618$20211117$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-003811$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240712$$CN$US$US
200836467$20083646$7$F$20211001$20240611$20211118$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-003833$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240705$$CN$US$US
200845342$20084534$2$F$20180101$20211115$20211118$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR236185$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200845362$20084536$2$F$$20211112$20211118$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR235137$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200846008$20084600$8$F$20220703$20240918$20211118$20240927$EXP$$CA-CELLTRION INC.-2021CA015473$CELLTRION$$$$$$Y$$$20240927$$CN$CA$CA
200847192$20084719$2$F$$20240827$20211118$20240909$EXP$$FR-AUROBINDO-AUR-APL-2021-046946$AUROBINDO$$$$$M$Y$2.1$KG$20240909$$HP$FR$FR
200848954$20084895$4$F$20240101$20240718$20211118$20240720$EXP$$US-SHIRE-US201939061AA$TAKEDA$$$$$F$Y$$$20240720$$CN$US$US
2008504912$20085049$12$F$20210603$20240816$20211118$20240823$EXP$$CO-TAKEDA-2021TUS038508$TAKEDA$$46$YR$$M$Y$89$KG$20240823$$CN$CO$CO
200851292$20085129$2$F$$20211108$20211118$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR231035$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2008543213$20085432$13$F$20160201$20240808$20211118$20240815$EXP$$US-TAKEDA-2016BLT001703$TAKEDA$$61$YR$$F$Y$$$20240815$$CN$US$US
200854798$20085479$8$F$20210401$20220516$20211118$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR236131$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
200855548$20085554$8$F$20170922$20240730$20211118$20240802$EXP$$CA-TAKEDA-2021TUS023241$TAKEDA$$42$YR$$M$Y$$$20240802$$HP$CA$CA
200856142$20085614$2$F$$20240709$20211118$20240709$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003649$PAREXEL$$$$$$Y$$$20240709$$CN$US$US
200857352$20085735$2$F$$20240717$20211118$20240725$PER$$US-SA-2021SA301308$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240725$$PH$US$US
200857557$20085755$7$F$$20240625$20211118$20240701$EXP$$PT-PFIZER INC-202101544515$PFIZER$Ferreira, A.. Toxicidade a linezolide - a proposito de um caso clinico. Medicina Interna. 2021;76$80$YR$$M$Y$$$20240701$$MD$PT$PT
200860737$20086073$7$F$20220104$20240827$20211118$20240828$EXP$$US-TAKEDA-US202022426$TAKEDA$$78$YR$$F$Y$$$20240828$$MD$US$US
200861353$20086135$3$F$$20211221$20211118$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR232163$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200866402$20086640$2$F$$20211215$20211118$20240702$PER$$US-AstraZeneca-2021A807225$ASTRAZENECA$$$$$M$Y$129.3$KG$20240702$$CN$US$
2008714222$20087142$22$F$$20240722$20211118$20240726$EXP$$US-TAKEDA-2021TUS058101$TAKEDA$$$$$F$Y$88$KG$20240726$$HP$US$US
200871432$20087143$2$F$20210528$20240921$20211118$20240926$EXP$$DE-MYLANLABS-2021M1084153$MYLAN$$$$$$Y$$$20240926$$HP$DE$DE
200872012$20087201$2$F$20201203$20240816$20211118$20240829$PER$$US-SA-2021SA381595$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240829$$MD$US$US
200873152$20087315$2$F$$20240709$20211118$20240712$EXP$$CA-TAKEDA-2019TUS045899$TAKEDA$$$$$F$Y$$$20240712$$CN$CA$CA
200875682$20087568$2$F$20211007$20240711$20211118$20240715$EXP$FR-AFSSAPS-AN20214322$FR-PFIZER INC-202101530141$PFIZER$$44$YR$$M$Y$52$KG$20240715$$MD$FR$FR
2008802114$20088021$14$F$20210101$20240730$20211118$20240805$EXP$$JP-DSJP-DSJ-2021-133100$DAIICHI$Konno H, Terada K, Kudou C, Onji M, Yamaguchi A, Takahashi E, et al. EP-0650 Side effects of Trastuzumab Deruxtecan in our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society$$$$F$Y$71$KG$20240805$$MD$JP$JP
2008814522$20088145$22$F$20211008$20240913$20211118$20240923$EXP$$CA-CELLTRION INC.-2021CA015512$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
200882015$20088201$5$F$20211019$20220317$20211118$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR236126$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240926$$HP$US$US
200890547$20089054$7$F$20211001$20240710$20211119$20240717$EXP$$US-ABBVIE-21K-163-4127777-00$ABBVIE$$60$YR$$M$Y$$$20240717$$CN$US$US
200897576$20089757$6$F$20211101$20220120$20211119$20240926$PER$$US-GLAXOSMITHKLINE-US2021AMR236180$GLAXOSMITHKLINE$$63$YR$$F$Y$63.03$KG$20240926$$HP$US$US
2008991918$20089919$18$F$20211001$20240806$20211119$20240815$EXP$$US-GLAXOSMITHKLINE-US2021231094$GLAXOSMITHKLINE$$61$YR$$F$Y$67.574$KG$20240815$$HP$US$US
200903616$20090361$6$F$20240903$20240903$20211119$20240906$EXP$$US-TAKEDA-2021TUS069957$TAKEDA$$65$YR$$F$Y$$$20240906$$MD$US$US
200907519$20090751$9$F$20170717$20240718$20211119$20240723$EXP$$CA-TAKEDA-CA202020618$TAKEDA$$$$A$M$Y$$$20240723$$HP$CA$CA
2009103811$20091038$11$F$$20240830$20211119$20240904$EXP$$US-PFIZER INC-2021534670$PFIZER$$70$YR$$F$Y$104.33$KG$20240904$$CN$US$US
200911775$20091177$5$F$20220101$20240812$20211119$20240815$EXP$$CA-SHIRE-CA201847686AA$TAKEDA$$$$$F$Y$$$20240815$$CN$CA$CA
2009117811$20091178$11$F$20210718$20240816$20211119$20240821$EXP$$CO-TAKEDA-2021TUS045963$TAKEDA$$7$YR$$M$Y$23.2$KG$20240821$$CN$CO$CO
200912092$20091209$2$F$$20240813$20211119$20240819$EXP$$IT-MYLANLABS-2021M1084282$MYLAN$Tovo P, Garazzino S, Saglio F, Scolfaro C, Bustamante J, Badolato R. et al.. Successful Hematopoietic Stem Cell Transplantation in a Patient with Complete IFN-? Receptor 2 Deficiency: a Case Report and Literature Review.. Journal of Clinical Immunology. 2020;40:1191-1195$4$YR$$M$Y$$$20240819$$HP$IT$IT
200913817$20091381$7$F$20201103$20240628$20211119$20240703$EXP$$US-TAKEDA-2021TUS070071$TAKEDA$$36$YR$$F$Y$172$KG$20240703$$HP$US$US
2009195110$20091951$10$F$20160101$20240806$20211119$20240812$EXP$$AT-MYLANLABS-2021M1084525$MYLAN$Spitzwieser M. Case report relapsed multiple myeloma. Spectrum Onkologie.. 2021;64-65$50$YR$$M$Y$$$20240812$$MD$AT$AT
200920259$20092025$9$F$$20240717$20211119$20240718$EXP$$US-TAKEDA-US202030704$TAKEDA$$$$$F$Y$$$20240718$$CN$US$US
200923722$20092372$2$F$$20211113$20211119$20240905$EXP$$US-BAUSCH-BL-2021-037702$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240905$$MD$US$US
200923785$20092378$5$F$$20211215$20211119$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR227583$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200923996$20092399$6$F$20211101$20211228$20211119$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR234769$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240926$$CN$US$US
200924004$20092400$4$F$$20220119$20211119$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR235068$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2009251321$20092513$21$F$20210416$20240814$20211119$20240821$EXP$$CA-CELLTRION INC.-2021CA005403$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
2009288529$20092885$29$F$20200101$20240912$20211120$20240921$EXP$$CA-CELLTRION INC.-2020CA020879$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
200930557$20093055$7$F$20220208$20240906$20211120$20240911$EXP$$CA-TAKEDA-2021TUS073152$TAKEDA$$42$YR$$M$Y$$$20240911$$CN$CA$CA
200950945$20095094$5$F$20220303$20240618$20211122$20240709$PER$$CA-TOLMAR, INC.-21CA030365$TOLMAR$$73$YR$$M$Y$$$20240709$$CN$CA$CA
200952643$20095264$3$F$20211104$20240920$20211122$20240924$EXP$$KR-GLAXOSMITHKLINE-KR2021237927$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$KR$KR
200952947$20095294$7$F$20210501$20220517$20211122$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR235986$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
200960472$20096047$2$F$$20211118$20211122$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR239185$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
200960484$20096048$4$F$20211101$20211201$20211122$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR238361$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
200968043$20096804$3$F$$20240814$20211122$20240819$EXP$$US-TAKEDA-2021TUS071748$TAKEDA$$$$$F$Y$$$20240819$$HP$US$US
200969946$20096994$6$F$20220126$20220509$20211122$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR239136$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
200975426$20097542$6$F$20210801$20240727$20211122$20240805$PER$$US-SA-2021SA381790$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240805$$MD$US$US
200975434$20097543$4$F$$20240910$20211122$20240919$EXP$$CA-TAKEDA-2021TUS007443$TAKEDA$$$$$M$Y$$$20240919$$HP$CA$CA
200976638$20097663$8$F$20180101$20240628$20211122$20240703$EXP$$CA-TAKEDA-2018TUS025045$TAKEDA$$$$$F$Y$$$20240703$$CN$CA$CA
2009766514$20097665$14$F$20220429$20240809$20211122$20240814$EXP$$CA-TAKEDA-2020TUS033466$TAKEDA$$71$YR$$M$Y$$$20240814$$CN$CA$CA
200978705$20097870$5$F$20181001$20240731$20211122$20240802$EXP$$CA-TAKEDA-2019TUS007412$TAKEDA$$50$YR$$M$Y$$$20240802$$CN$CA$CA
200984835$20098483$5$F$20211102$20240920$20211122$20240930$EXP$$FR-Ipsen Biopharmaceuticals, Inc.-2021-28934$IPSEN$$6$YR$C$M$Y$16$KG$20240930$$MD$FR$FR
200985338$20098533$8$F$20210401$20240812$20211122$20240819$EXP$$CZ-MYLANLABS-2021M1062162$MYLAN$Krasenska M. Inhibitors of the cycline-dependent kinases 4/6 in the treatment of patients with breast cancer.. ONKOLOGICKA REVUE.. 2021;8(4):18-25$49$YR$$F$Y$$$20240819$$MD$CZ$CZ
200999444$20099944$4$F$20171218$20240704$20211123$20240710$EXP$$CA-TAKEDA-2021TUS074003$TAKEDA$$74$YR$$M$Y$$$20240710$$CN$CA$CA
2010008329$20100083$29$F$20210101$20240827$20211123$20240904$EXP$$CA-CELLTRION INC.-2021CA008317$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
2010044210$20100442$10$F$20211001$20240621$20211123$20240701$EXP$$CA-TAKEDA-2021TUS025113$TAKEDA$$50$YR$$F$Y$$$20240701$$CN$CA$CA
2010059018$20100590$18$F$20231120$20240918$20211123$20240927$EXP$$US-TAKEDA-US202034321$TAKEDA$$61$YR$$F$Y$40$KG$20240927$$HP$US$US
201006943$20100694$3$F$$20240803$20211123$20240816$EXP$$NL-AUROBINDO-AUR-APL-2009-00477$AUROBINDO$De Groot JWB, Gosselink ATM, Ottervanger JP.. ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ASSOCIATED WITH DICLOFENAC INDUCED ANAPHYLAXIS. American Journal of Critical Care.. 2009;18 (4):388,386-387$48$YR$$M$Y$$$20240816$$MD$NL$NL
201014502$20101450$2$F$$20240822$20211123$20240826$EXP$$US-JAZZ-2021-US-020668$JAZZ$$$$$F$Y$$$20240826$$CN$US$US
2010149610$20101496$10$F$20190101$20240814$20211123$20240819$EXP$$CA-TAKEDA-2019TUS009330$TAKEDA$$$$$M$Y$$$20240819$$CN$CA$CA
201015172$20101517$2$F$$20240715$20211123$20240720$EXP$$US-JAZZ-2021-US-020657$JAZZ$$$$$F$Y$$$20240720$$CN$US$US
201019207$20101920$7$F$20211118$20220419$20211123$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR240370$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240926$$CN$US$US
201025258$20102525$8$F$$20220825$20211123$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR237920$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
201025734$20102573$4$F$$20240826$20211123$20240902$EXP$$CA-GLAXOSMITHKLINE-CA2021AMR237774$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$HP$CA$CA
201027322$20102732$2$F$20210101$20240723$20211123$20240803$30DAY$$US-GLAXOSMITHKLINE-US2021236165$GLAXOSMITHKLINE$$$$$F$Y$$$20240803$$CN$US$US
201027374$20102737$4$F$20211113$20220407$20211123$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR240394$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
201028867$20102886$7$F$$20221007$20211123$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR237963$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
201036586$20103658$6$F$20210201$20240715$20211123$20240718$EXP$$NVSC2021CA262938$NOVARTIS$$53$YR$$F$Y$$$20240719$$CN$CA$CA
201037526$20103752$6$F$20240816$20240823$20211123$20240827$EXP$$US-PFIZER INC-2021605440$PFIZER$$87$YR$$M$Y$$$20240827$$HP$US$US
2010482310$20104823$10$F$$20240829$20211124$20240919$PER$$CA-TOLMAR, INC.-21CA030318$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
201062876$20106287$6$F$$20240916$20211124$20240917$PER$$US-BIOGEN-2020BI00893982$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
2010675113$20106751$13$F$20211101$20240213$20211124$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR241077$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240925$$CN$US$US
201070248$20107024$8$F$$20240726$20211124$20240802$EXP$$CA-ROCHE-2957415$ROCHE$$$$E$F$Y$$$20240802$$CN$CA$CA
201071084$20107108$4$F$20210801$20220420$20211124$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR239097$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
201071733$20107173$3$F$20211101$20211201$20211124$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR238602$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240925$$CN$US$US
201079792$20107979$2$F$20211019$20240709$20211124$20240711$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003652$PAREXEL$$$$$$Y$$$20240711$$CN$US$US
201088886$20108888$6$F$20201109$20240709$20211124$20240711$EXP$$CA-TAKEDA-2021TUS073982$TAKEDA$$52$YR$$M$Y$$$20240711$$MD$CA$CA
201093392$20109339$2$F$$20240620$20211124$20240702$PER$$US-TAKEDA-2021TUS072774$TAKEDA$$$$$F$Y$$$20240702$$CN$US$US
201106084$20110608$4$F$20210920$20240816$20211124$20240830$EXP$$FR-SERVIER-S21013052$SERVIER$$$$$$Y$$$20240830$$MD$FR$FR
201106095$20110609$5$F$20211102$20240919$20211124$20240930$EXP$$FR-SERVIER-S21013050$SERVIER$$$$$$Y$$$20240930$$MD$FR$FR
201108093$20110809$3$F$20200526$20240726$20211124$20240807$EXP$$DE-AUROBINDO-AUR-APL-2021-048176$AUROBINDO$$$$E$F$Y$85$KG$20240807$$MD$DE$DE
201113532$20111353$2$F$$20240717$20211125$20240723$EXP$$ES-AMGEN-ESPSP2021184272$AMGEN$$$$$F$Y$$$20240723$$MD$ES$ES
201114072$20111407$2$F$20160827$20240703$20211125$20240708$EXP$$CA-TAKEDA-2021TUS071258$TAKEDA$$59$YR$$F$Y$$$20240708$$CN$CA$CA
201132292$20113229$2$F$20210605$20211210$20211125$20240808$EXP$$US-AstraZeneca-2021A821412$ASTRAZENECA$$74$YR$$M$Y$68.5$KG$20240808$$HP$US$
201133555$20113355$5$F$20211130$20220112$20211125$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR242448$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
2011367122$20113671$22$F$20150101$20240905$20211125$20240910$EXP$$CA-ROCHE-1598789$ROCHE$$65$YR$E$F$Y$60$KG$20240910$$HP$CA$CA
201140702$20114070$2$F$20211001$20240718$20211125$20240722$EXP$$ES-AMGEN-ESPSP2021186787$AMGEN$$$$A$F$Y$$$20240722$$MD$ES$ES
201141674$20114167$4$F$$20240730$20211125$20240801$EXP$$CA-TAKEDA-2020TUS039104$TAKEDA$$$$$M$Y$$$20240801$$CN$CA$CA
201143248$20114324$8$F$20210101$20240906$20211125$20240910$PER$$US-PFIZER INC-202101488303$PFIZER$$71$YR$$F$Y$$$20240910$$HP$US$US
201143538$20114353$8$F$20200727$20240814$20211125$20240821$EXP$$CA-TAKEDA-2020TUS032029$TAKEDA$$57$YR$$F$Y$$$20240821$$MD$CA$CA
201143705$20114370$5$F$$20240815$20211125$20240821$EXP$$US-TAKEDA-2021TUS075054$TAKEDA$$$$$M$Y$$$20240821$$CN$US$US
201144452$20114445$2$F$$20240828$20211125$20240910$PER$$US-SA-2021SA382663$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240910$$MD$US$US
201145014$20114501$4$F$20210101$20240711$20211125$20240722$PER$$US-SA-2021SA382622$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240721$$MD$US$US
201147513$20114751$3$F$20220301$20240813$20211125$20240820$PER$$US-SA-2021SA388360$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240820$$MD$US$US
201147898$20114789$8$F$20140101$20240819$20211125$20240822$PER$$US-SA-2021SA388369$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240822$$PH$US$US
201148442$20114844$2$F$20210101$20240728$20211125$20240806$PER$$US-SA-2021SA385256$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240806$$CN$US$US
201151923$20115192$3$F$20210101$20240710$20211125$20240802$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-003890$ACADIA PHARMACEUTICALS$$$$$F$Y$44$KG$20240802$$CN$US$US
201151953$20115195$3$F$20210101$20240701$20211125$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-003894$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
2011526712$20115267$12$F$20210401$20240906$20211125$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-076915$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240911$$MD$JP$JP
201169555$20116955$5$F$20010101$20240912$20211126$20240917$PER$$US-PURDUE-USA-2021-0251351$PURDUE$$$$$M$Y$$$20240917$$CN$US$US
2011787611$20117876$11$F$20211001$20240918$20211126$20240927$EXP$$CA-CELLTRION INC.-2021CA016039$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
2011789915$20117899$15$F$$20240727$20211126$20240807$EXP$CA-MHPD-000929765$CA-Accord-245819$ACCORD$$$$$F$Y$$$20240807$$CN$CA$CA
201180382$20118038$2$F$20210201$20240927$20211126$20240930$EXP$FR-AFSSAPS-AN20214467$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-123855$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$59$KG$20240930$$MD$FR$FR
201183553$20118355$3$F$20200618$20240709$20211126$20240716$EXP$$CA-TAKEDA-2021TUS074638$TAKEDA$$62$YR$$F$Y$$$20240716$$CN$CA$CA
201186442$20118644$2$F$$20240624$20211126$20240702$30DAY$$US-GLAXOSMITHKLINE-US2021236251$GLAXOSMITHKLINE$$$$$M$Y$$$20240702$$CN$US$US
201186864$20118686$4$F$20240821$20240821$20211126$20240826$EXP$$CA-TAKEDA-2021TUS074803$TAKEDA$$59$YR$$F$Y$$$20240826$$CN$CA$CA
2011886210$20118862$10$F$20210901$20240809$20211126$20240814$EXP$$US-TAKEDA-2021TUS073731$TAKEDA$$84$YR$$F$Y$87.075$KG$20240814$$PH$US$US
2011891610$20118916$10$F$20190927$20240801$20211126$20240805$EXP$$DE-ROCHE-2445206$ROCHE$$41$YR$A$M$Y$$$20240805$$CN$DE$DE
201190435$20119043$5$F$$20240822$20211126$20240830$EXP$$CA-APOTEX-2021AP045619$APOTEX$$34$YR$$F$Y$130$KG$20240830$$HP$CA$CA
201191732$20119173$2$F$$20211116$20211126$20240926$PER$$US-GLAXOSMITHKLINE-US2021AMR237336$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
201193308$20119330$8$F$20211101$20220427$20211126$20240926$PER$$US-GLAXOSMITHKLINE-US2021AMR239092$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240926$$CN$US$US
201194296$20119429$6$F$20210927$20240910$20211126$20240912$EXP$$US-TAKEDA-2021TUS041121$TAKEDA$$61$YR$$F$Y$$$20240912$$HP$US$US
201195706$20119570$6$F$20201201$20220126$20211126$20240926$EXP$$NVSC2021MX266621$NOVARTIS$$33$YR$$M$Y$72$KG$20240926$$CN$MX$MX
201197345$20119734$5$F$20211010$20240918$20211126$20240927$EXP$$JP-JAZZ-2021-JP-020706$JAZZ$$61$YR$$M$Y$54.9$KG$20240927$$MD$JP$JP
201198152$20119815$2$F$$20240724$20211126$20240726$EXP$$US-TAKEDA-2020TUS032677$TAKEDA$$$$$M$Y$$$20240726$$CN$US$US
2012008814$20120088$14$F$20211109$20240827$20211126$20240829$EXP$$US-TAKEDA-2021TUS074872$TAKEDA$$15$YR$$M$Y$$$20240829$$PH$US$US
201202163$20120216$3$F$$20240704$20211126$20240710$EXP$$BE-PFIZER INC-202101581561$PFIZER$$57$YR$$F$Y$$$20240710$$MD$BE$BE
201205172$20120517$2$F$20211001$20240910$20211126$20240924$PER$$US-SA-2021SA387027$SANOFI AVENTIS$$67$YR$E$F$Y$74.966$KG$20240924$$MD$US$US
201209494$20120949$4$F$20211110$20240814$20211127$20240823$EXP$$JP-ROCHE-2963268$ROCHE$PRIVACY P, Kuwano A, Tanaka K, Nagasawa S, Morita Y, Yada M, et al. Immune thrombocytopenic purpura caused by combination therapy of atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: A case presentation. Liver. 2022;7 (63):335-341.$72$YR$E$M$Y$60.8$KG$20240823$$MD$JP$JP
2012095433$20120954$33$F$20211007$20240913$20211127$20240923$EXP$$CA-CELLTRION INC.-2021CA016089$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
201211885$20121188$5$F$20211101$20211216$20211127$20240926$PER$$US-GLAXOSMITHKLINE-US2021AMR242409$GLAXOSMITHKLINE$$38$YR$$F$Y$$$20240926$$CN$US$US
201212153$20121215$3$F$20210601$20220209$20211127$20240926$PER$$US-GLAXOSMITHKLINE-US2021AMR243012$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240926$$CN$US$US
201212385$20121238$5$F$$20220321$20211127$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR238362$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
201216062$20121606$2$F$$20211124$20211128$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR243364$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
201216072$20121607$2$F$$20211124$20211128$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR242871$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
201216315$20121631$5$F$20220801$20240816$20211128$20240820$EXP$$US-AMGEN-USASP2021186937$AMGEN$$59$YR$A$M$Y$$$20240820$$HP$US$US
201221552$20122155$2$F$$20240805$20211128$20240808$PER$$US-PURDUE-USA-2020-0251209$PURDUE$$$$A$M$Y$$$20240808$$LW$US$US
201222775$20122277$5$F$20130101$20240812$20211128$20240814$PER$$US-PURDUE-USA-2020-0152716$PURDUE$$$$$M$Y$99.79$KG$20240814$$CN$US$US
201227598$20122759$8$F$20210101$20240629$20211128$20240709$EXP$$JP-JNJFOC-20211146567$JOHNSON AND JOHNSON$$68$YR$E$M$Y$54$KG$20240710$$MD$JP$JP
201227855$20122785$5$F$20150101$20240808$20211128$20240822$EXP$$US-UCBSA-2015042300$UCB$$$$$F$Y$$$20240822$$CN$US$US
201227913$20122791$3$F$20211106$20231115$20211128$20240919$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-318141$RANBAXY$$64$YR$$F$Y$65$KG$20240919$$CN$AU$AU
201230059$20123005$9$F$20220621$20240806$20211129$20240828$PER$$CA-TOLMAR, INC.-21CA027587$TOLMAR$$64$YR$$M$Y$$$20240828$$CN$CA$CA
201231195$20123119$5$F$20230216$20240909$20211129$20240927$PER$$CA-TOLMAR, INC.-21CA030340$TOLMAR$$80$YR$$M$Y$$$20240927$$CN$CA$CA
201231952$20123195$2$F$$20211117$20211129$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-318406$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
201234592$20123459$2$F$$20240717$20211129$20240723$EXP$$ES-AMGEN-ESPSP2021187347$AMGEN$$$$$F$Y$$$20240723$$MD$ES$ES
201235654$20123565$4$F$20210507$20240805$20211129$20240808$EXP$$GB-AUROBINDO-AUR-APL-2021-048474$AUROBINDO$$17$YR$$F$Y$55$KG$20240808$$HP$GB$US
201241545$20124154$5$F$20211101$20211223$20211129$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR242773$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
2012415515$20124155$15$F$20211101$20230123$20211129$20240926$PER$$US-GLAXOSMITHKLINE-US2021AMR240572$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240926$$CN$US$US
201250517$20125051$7$F$20230418$20240924$20211129$20240926$PER$$US-PFIZER INC-202101662576$PFIZER$$71$YR$$F$Y$$$20240926$$CN$US$US
2012600319$20126003$19$F$20180403$20240826$20211129$20240830$EXP$$CO-TAKEDA-2018TUS009390$TAKEDA$$41$YR$$F$Y$64$KG$20240830$$HP$CO$CO
201261843$20126184$3$F$20210901$20240723$20211129$20240730$EXP$$ES-GLAXOSMITHKLINE-ES2021EME243960$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$ES$ES
2012623812$20126238$12$F$20191027$20240822$20211129$20240829$EXP$$MX-TAKEDA-MX201937883$TAKEDA$$12$YR$$M$Y$31$KG$20240829$$CN$MX$MX
201268276$20126827$6$F$20200101$20240906$20211129$20240913$EXP$$BR-TAKEDA-2020TUS035966$TAKEDA$$$$$F$Y$$$20240913$$CN$BR$BR
2012701810$20127018$10$F$20230130$20240907$20211129$20240910$EXP$$IN-PFIZER INC-2021860871$PFIZER$$61$YR$$F$Y$$$20240910$$CN$IN$IN
201277465$20127746$5$F$20150101$20240710$20211129$20240715$EXP$DE-AMK-253746$DE-MYLANLABS-2021M1088182$MYLAN$$73$YR$$F$Y$81.2$KG$20240715$$PH$DE$DE
201277474$20127747$4$F$20210703$20240909$20211129$20240912$EXP$$US-INCYTE CORPORATION-2021IN010946$INCYTE$$$$$$Y$$$20240912$$CN$US$US
201284966$20128496$6$F$20200512$20240908$20211130$20240914$EXP$$IE-SHIRE-IE202015764$TAKEDA$$40$YR$$M$Y$$$20240914$$MD$IE$IE
201287506$20128750$6$F$20210929$20240723$20211130$20240805$EXP$$JP-ROCHE-2960165$ROCHE$$37$YR$A$M$Y$65$KG$20240805$$MD$JP$JP
2012877310$20128773$10$F$20210101$20240911$20211130$20240919$PER$$CA-TOLMAR, INC.-21CA030383$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
2012878711$20128787$11$F$20230501$20240909$20211130$20240927$PER$$CA-TOLMAR, INC.-21CA030402$TOLMAR$$68$YR$$M$Y$$$20240927$$CN$CA$CA
201288047$20128804$7$F$20210915$20240619$20211130$20240710$PER$$CA-TOLMAR, INC.-21CA030420$TOLMAR$$79$YR$$M$Y$$$20240710$$CN$CA$CA
201291898$20129189$8$F$$20220506$20211130$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR243538$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$HP$US$US
201294695$20129469$5$F$$20220420$20211130$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR244218$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
2012954810$20129548$10$F$20220101$20240913$20211130$20240925$EXP$$US-INSMED, INC.-2021-10149-US$INSMED$$$$$$Y$$$20240925$$CN$US$US
201299688$20129968$8$F$$20240821$20211130$20240824$EXP$$US-TAKEDA-US202017792$TAKEDA$$$$$F$Y$$$20240824$$HP$US$US
201300818$20130081$8$F$20180920$20240708$20211130$20240710$EXP$$JP-ABBVIE-21P-087-4177077-00$ABBVIE$$75$YR$$M$Y$50$KG$20240710$$MD$JP$JP
201306089$20130608$9$F$20211028$20240709$20211130$20240711$EXP$$CA-TAKEDA-2021TUS075507$TAKEDA$$17$YR$$M$Y$$$20240711$$MD$CA$CA
2013064733$20130647$33$F$20211111$20240910$20211130$20240913$EXP$$IN-PFIZER INC-202101334861$PFIZER$$47$YR$$F$Y$68$KG$20240913$$CN$IN$IN
201310535$20131053$5$F$20211203$20220118$20211130$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR245134$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240926$$CN$US$US
201311783$20131178$3$F$$20240828$20211130$20240902$EXP$$CA-PFIZER INC-202101598974$PFIZER$$37$YR$$M$Y$$$20240902$$HP$CA$CA
2013120311$20131203$11$F$$20240924$20211130$20240926$PER$$US-PFIZER INC-2019330671$PFIZER$$71$YR$$F$Y$$$20240926$$HP$US$US
201312538$20131253$8$F$$20240820$20211130$20240822$EXP$$US-TAKEDA-US202009286$TAKEDA$$$$$F$Y$$$20240822$$CN$US$US
201314109$20131410$9$F$20211005$20240910$20211130$20240925$EXP$$CN-DSJP-DSE-2021-139237$DAIICHI$$77$YR$$F$Y$62$KG$20240925$$MD$CN$CN
201323013$20132301$3$F$$20240918$20211130$20240927$EXP$$GB-TEVA-2021-GB-1979277$TEVA$$$$$M$Y$$$20240927$$HP$GB$GB
2013269322$20132693$22$F$$20240823$20211130$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-128654$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240829$$MD$JP$JP
2013282230$20132822$30$F$20211105$20240902$20211130$20240910$EXP$$CA-CELLTRION INC.-2021CA016159$CELLTRION$$$$$$Y$$$20240910$$MD$CA$CA
2013288938$20132889$38$F$20210101$20240729$20211130$20240806$EXP$$CA-CELLTRION INC.-2021CA000583$CELLTRION$$$$$$Y$$$20240806$$MD$CA$CA
201332033$20133203$3$F$$20240918$20211201$20240930$EXP$$CA-APOTEX-2021AP045846$APOTEX$$65$YR$$F$Y$$$20240930$$HP$CA$CA
2013339327$20133393$27$F$20210901$20240719$20211201$20240729$EXP$$CA-CELLTRION INC.-2021CA013740$CELLTRION$$$$$$Y$$$20240729$$HP$CA$CA
201335145$20133514$5$F$20191101$20240730$20211201$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-251110$RANBAXY$$59$YR$$F$Y$79.365$KG$20240814$$CN$US$US
201337038$20133703$8$F$20230719$20240617$20211201$20240709$PER$$CA-TOLMAR, INC.-21CA030404$TOLMAR$$76$YR$$M$Y$$$20240709$$CN$CA$CA
2013375815$20133758$15$F$20200108$20240904$20211201$20240912$EXP$$CA-CELLTRION INC.-2021CA016194$CELLTRION$$$$$$Y$$$20240912$$MD$CA$CA
201339215$20133921$5$F$$20240715$20211201$20240719$EXP$$CA-AMGEN-CANSP2021186886$AMGEN$$56$YR$A$F$Y$$$20240719$$HP$CA$CA
201340166$20134016$6$F$20211026$20240723$20211201$20240726$EXP$$CA-ROCHE-2963901$ROCHE$$49$YR$A$F$Y$$$20240726$$CN$CA$CA
201350485$20135048$5$F$20211115$20220221$20211201$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR245339$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240925$$CN$US$US
201359719$20135971$9$F$20210422$20240705$20211201$20240710$EXP$$AT-TAKEDA-2021TUS031309$TAKEDA$$60$YR$$F$Y$54.875$KG$20240710$$CN$AT$AT
201364825$20136482$5$F$20210514$20240910$20211201$20240915$EXP$$ES-TAKEDA-2021TUS073968$TAKEDA$$1$YR$$M$Y$$$20240915$$HP$ES$ES
201365444$20136544$4$F$$20240916$20211201$20240918$PER$$US-PFIZER INC-2021885843$PFIZER$$75$YR$$F$Y$$$20240918$$CN$US$US
2013658629$20136586$29$F$20210101$20240918$20211201$20240924$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2021-26875$IPSEN$$78$YR$E$M$Y$$$20240924$$HP$CA$CA
201373167$20137316$7$F$$20240910$20211201$20240918$EXP$$CA-PFIZER INC-202101646914$PFIZER$$45$YR$$F$Y$95$KG$20240918$$HP$CA$CA
201375103$20137510$3$F$20211006$20240804$20211201$20240808$EXP$$IL-ABBVIE-21K-082-4178331-00$ABBVIE$$85$YR$$M$Y$63$KG$20240808$$MD$IL$IL
201380762$20138076$2$F$20120101$20240624$20211202$20240703$EXP$IT-EMA-DD-20211116-joon_u1-130205$IT-SAMSUNG BIOEPIS-SB-2021-27599$SAMSUNG BIOEPIS$Panebianco M, Salimbeni B, Roberto M and Marchetti P. An example of personalized treatment in hr+ her2+ long survivor breast cancer patient (Case report). Current Oncology 2021 Jun;28 (3):1980-7.$36$YR$A$F$Y$$$20240703$$HP$IT$IT
2013838118$20138381$18$F$$20240823$20211202$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-128633$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240830$$MD$JP$JP
2013849112$20138491$12$F$20211114$20240712$20211202$20240719$EXP$$US-HORIZON THERAPEUTICS-HZN-2021-007350$AMGEN$$76$YR$E$F$Y$$$20240719$$MD$US$US
201386133$20138613$3$F$20211016$20211214$20211202$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR202923$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$HP$US$US
201387006$20138700$6$F$$20240827$20211202$20240905$EXP$$CA-AUROBINDO-AUR-APL-2021-048914$AUROBINDO$$75$YR$$F$Y$$$20240905$$HP$CA$CA
2013911119$20139111$19$F$20221101$20240730$20211202$20240807$EXP$$CO-ROCHE-2958060$ROCHE$$36$YR$A$F$Y$57$KG$20240807$$CN$CO$CO
201391384$20139138$4$F$$20240703$20211202$20240705$EXP$$CA-TAKEDA-2020TUS000280$TAKEDA$$$$$F$Y$$$20240705$$MD$CA$CA
201396693$20139669$3$F$20211026$20211207$20211202$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR246475$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
201397352$20139735$2$F$$20240709$20211202$20240712$EXP$$ES-PFIZER INC-202101620513$PFIZER$$$$$F$Y$$$20240712$$MD$ES$ES
201399022$20139902$2$F$$20240729$20211202$20240802$EXP$$CA-SA-2021SA393494$SANOFI AVENTIS$$$$$F$Y$97$KG$20240802$$HP$CA$CA
2013991811$20139918$11$F$20211113$20240626$20211202$20240701$EXP$$US-PFIZER INC-202101648872$PFIZER$$76$YR$$F$Y$$$20240701$$HP$US$US
201399896$20139989$6$F$20211103$20240926$20211202$20240930$EXP$$VN-SA-2021SA368500$SANOFI AVENTIS$$1$YR$I$F$Y$10$KG$20240930$$HP$VN$VN
201400257$20140025$7$F$20200101$20240701$20211202$20240707$EXP$$CH-ABBVIE-20K-151-3598127-00$ABBVIE$$$$$M$Y$90$KG$20240707$$MD$CH$CH
201401393$20140139$3$F$$20240918$20211202$20240926$EXP$$US-ROCHE-2964598$ROCHE$$68$YR$E$F$Y$$$20240926$$CN$US$US
201407697$20140769$7$F$20210101$20240709$20211202$20240711$EXP$$CA-PFIZER INC-2021364344$PFIZER$$74$YR$$M$Y$$$20240711$$HP$CA$CA
201418936$20141893$6$F$$20240916$20211202$20240923$EXP$$GR-MYLANLABS-2021M1089258$MYLAN$Lamprou M, Kotsoglanidou K, Damianidou L, Antari V, Totikidis G, Papakonstantinou E.. Toxic epidermal necrolysis in a pediatric patient with non-hodgkin B-cell lymphoma of cell origin and pres encephalopathy. 7th PANHELLENIC CONGRESS OF PEDIATRIC HEAMATOLOGY-ONCOLOGY, DEVELOPMENTS-DATA. 2021;17-19$12$YR$$M$Y$$$20240923$$HP$GR$GR
201420452$20142045$2$F$$20240801$20211202$20240809$EXP$$ES-MYLANLABS-2021M1088532$BIOCON$$$$$$Y$$$20240809$$MD$ES$ES
201421617$20142161$7$F$$20240724$20211202$20240726$EXP$$CA-PFIZER INC-202101703293$PFIZER$$56$YR$$F$Y$$$20240726$$HP$CA$CA
201425282$20142528$2$F$$20240523$20211202$20240701$PER$$US-ROCHE-2897154$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
201425397$20142539$7$F$20210301$20240523$20211202$20240701$PER$$US-ROCHE-2936826$ROCHE$$35$YR$A$F$Y$20.41$KG$20240701$$CN$US$US
2014281032$20142810$32$F$20210101$20240919$20211202$20240928$EXP$$CA-CELLTRION INC.-2021CA010726$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
201433038$20143303$8$F$20220301$20240627$20211203$20240724$PER$$CA-TOLMAR, INC.-21CA030537$TOLMAR$$61$YR$$M$Y$$$20240724$$CN$CA$CA
201435737$20143573$7$F$$20240816$20211203$20240828$EXP$$PL-AUROBINDO-AUR-APL-2021-015466$AUROBINDO$Zajac-Spychala O, Pieczonka A, Janura-Szymanska J, Jonczyk-Potoczna K, Wachowiak J.. Multiple reactivations of viral infections followed by cerebral toxoplasmosis after allogeneic hematopoietic stem cell transplantation in an adolescent with Ph(+) acute lymphoblastic leukemia: A case report. TRANSPLANTATION PROCEEDINGS. 2021;1-5$17$YR$$F$Y$$$20240828$$MD$PL$PL
201436404$20143640$4$F$20211125$20240710$20211203$20240715$EXP$$CA-TAKEDA-2018TUS028707$TAKEDA$$38$YR$$F$Y$$$20240715$$CN$CA$CA
2014382524$20143825$24$F$20210101$20240704$20211203$20240711$EXP$$CA-CELLTRION INC.-2021CA009671$CELLTRION$$$$$$Y$$$20240711$$CN$CA$CA
2014401418$20144014$18$F$20210628$20240717$20211203$20240726$EXP$$CA-CELLTRION INC.-2021CA010202$CELLTRION$$$$$$Y$$$20240726$$HP$CA$CA
201441373$20144137$3$F$20200101$20240812$20211203$20240823$EXP$$PT-AUROBINDO-AUR-APL-2021-019869$AUROBINDO$$41$YR$$F$Y$$$20240823$$HP$PT$PT
201442182$20144218$2$F$$20240729$20211203$20240806$EXP$$ES-ROCHE-2963322$ROCHE$$$$$F$Y$$$20240806$$MD$ES$ES
2014438917$20144389$17$F$20220611$20240905$20211203$20240910$EXP$$US-TAKEDA-2020TUS045009$TAKEDA$$73$YR$$F$Y$90$KG$20240910$$HP$US$US
201444073$20144407$3$F$$20240710$20211203$20240717$EXP$$CA-APOTEX-2021AP045997$APOTEX$$27$YR$$F$Y$$$20240717$$MD$CA$CA
201444329$20144432$9$F$20211101$20240729$20211203$20240805$EXP$$CA-JAZZ-2021-CA-021285$JAZZ$$34$YR$$F$Y$$$20240805$$CN$CA$CA
2014527710$20145277$10$F$20220101$20240920$20211203$20240925$EXP$$IN-PFIZER INC-2019164749$PFIZER$$55$YR$$F$Y$$$20240925$$CN$IN$IN
201458553$20145855$3$F$20190326$20240903$20211203$20240905$EXP$$DE-ROCHE-2298255$ROCHE$$35$YR$A$F$Y$$$20240905$$CN$DE$DE
201458644$20145864$4$F$20180516$20240918$20211203$20240926$EXP$$DE-ROCHE-2148201$ROCHE$$42$YR$A$F$Y$$$20240926$$CN$DE$DE
2014651520$20146515$20$F$20200204$20240917$20211203$20240923$EXP$$IN-PFIZER INC-2020488270$PFIZER$$61$YR$$F$Y$$$20240923$$CN$IN$IN
201470593$20147059$3$F$20211101$20240705$20211203$20240712$EXP$$US-SA-2021SA393467$SANOFI AVENTIS$$58$YR$A$M$Y$97.52$KG$20240712$$MD$US$US
201472913$20147291$3$F$$20240710$20211203$20240718$PER$$US-SA-2021SA396515$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240718$$MD$US$US
2014779010$20147790$10$F$20210201$20240916$20211203$20240925$EXP$$CA-CELLTRION INC.-2021CA003125$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
2014823422$20148234$22$F$20210101$20240805$20211204$20240813$EXP$$CA-CELLTRION INC.-2021CA012618$CELLTRION$$$$$$Y$$$20240813$$MD$CA$CA
2014831610$20148316$10$F$20210101$20240918$20211204$20240928$EXP$$JP-UNITED THERAPEUTICS-UNT-2021-022062$UNITED THERAPEUTICS$$$$$F$Y$20.1$KG$20240928$$MD$JP$JP
201483656$20148365$6$F$$20240813$20211204$20240826$EXP$$CA-AUROBINDO-AUR-APL-2021-049467$AUROBINDO$Ghayur A, Elahi Q, Patel C, Raj R. Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy.. Endocrinology, Diabetes and Metabolism. 2021$68$YR$$M$Y$$$20240826$$MD$CA$CA
201483813$20148381$3$F$$20240813$20211204$20240826$EXP$$CA-AUROBINDO-AUR-APL-2021-049663$AUROBINDO$$65$YR$$F$Y$$$20240826$$HP$CA$CA
201484472$20148447$2$F$$20240801$20211204$20240814$EXP$$CA-AUROBINDO-AUR-APL-2021-049164$AUROBINDO$$86$YR$$M$Y$$$20240814$$HP$CA$CA
201484952$20148495$2$F$$20240813$20211205$20240826$EXP$$CA-AUROBINDO-AUR-APL-2021-049450$AUROBINDO$$45$YR$$F$Y$$$20240826$$CN$CA$CA
2014853519$20148535$19$F$20210101$20240814$20211204$20240821$EXP$$CA-CELLTRION INC.-2021CA013372$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
201490072$20149007$2$F$$20240805$20211204$20240813$PER$$US-SA-2021SA402934$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240813$$MD$US$US
201490163$20149016$3$F$$20240815$20211204$20240821$EXP$$CA-TEVA-2021-CA-1983164$TEVA$$68$YR$$M$Y$$$20240821$$HP$CA$CA
2014926114$20149261$14$F$$20240625$20211205$20240828$EXP$$NVSC2021CA274520$NOVARTIS$$77$YR$$F$Y$$$20240828$$HP$CA$CA
2015042536$20150425$36$F$20211125$20240911$20211206$20240920$EXP$$CA-CELLTRION INC.-2021CA016344$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
201513848$20151384$8$F$$20240702$20211206$20240704$EXP$$US-PFIZER INC-202101639073$PFIZER$$63$YR$$F$Y$265$KG$20240704$$CN$US$US
2015140910$20151409$10$F$20220527$20240827$20211206$20240902$EXP$$CA-TAKEDA-2021TUS071380$TAKEDA$$76$YR$$M$Y$$$20240902$$PH$CA$CA
201514338$20151433$8$F$$20240612$20211206$20240704$EXP$$US-GLAXOSMITHKLINE-US2021248040$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
201519952$20151995$2$F$20211001$20240709$20211206$20240712$EXP$$ES-PFIZER INC-202101636278$PFIZER$$$$A$F$Y$$$20240712$$MD$ES$ES
2015202415$20152024$15$F$20220101$20240919$20211206$20240924$EXP$$CA-PFIZER INC-202101646692$PFIZER$$65$YR$$F$Y$$$20240924$$CN$CA$CA
2015233415$20152334$15$F$$20240916$20211206$20240927$EXP$$CA-PFIZER INC-202101703556$PFIZER$$48$YR$$F$Y$68$KG$20240927$$HP$CA$CA
2015243726$20152437$26$F$20211201$20240908$20211206$20240913$EXP$$US-TAKEDA-US201937811$TAKEDA$$8$YR$$M$Y$$$20240913$$MD$US$US
2015346813$20153468$13$F$$20240913$20211206$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-130485$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240920$$MD$JP$JP
201540818$20154081$8$F$$20240724$20211207$20240801$EXP$$CA-CELLTRION INC.-2021CA016541$CELLTRION$$$$$$Y$$$20240801$$HP$CA$CA
201541556$20154155$6$F$$20240827$20211207$20240830$EXP$$US-ABBVIE-21K-163-4187327-00$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
201541812$20154181$2$F$$20240729$20211207$20240806$EXP$$ES-ROCHE-2967317$ROCHE$$$$$F$Y$$$20240806$$MD$ES$ES
201543124$20154312$4$F$20211122$20240628$20211207$20240702$EXP$$US-UCBSA-2021055840$UCB$$33$YR$$F$Y$$$20240702$$CN$US$US
201547042$20154704$2$F$20210101$20211130$20211207$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR247992$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
201548502$20154850$2$F$$20211201$20211207$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR248499$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
201549266$20154926$6$F$20211202$20240906$20211207$20240908$EXP$$TR-ROCHE-2972970$ROCHE$$34$YR$A$F$Y$83$KG$20240908$$MD$TR$TR
2015533921$20155339$21$F$20180101$20240301$20211207$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR247968$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2015549017$20155490$17$F$20240105$20240827$20211207$20240904$EXP$$US-TAKEDA-US202018978$TAKEDA$$67$YR$$M$Y$61$KG$20240904$$HP$US$US
201557075$20155707$5$F$20190319$20240910$20211207$20240914$EXP$$CA-TAKEDA-2018TUS035466$TAKEDA$$21$YR$$M$Y$$$20240914$$CN$CA$CA
201557779$20155777$9$F$$20240924$20211207$20240926$PER$$US-PFIZER INC-2020091710$PFIZER$$69$YR$$F$Y$63.039$KG$20240926$$HP$US$US
201558004$20155800$4$F$$20240802$20211207$20240806$EXP$$US-TAKEDA-2020TUS046608$TAKEDA$$$$$F$Y$45$KG$20240806$$CN$US$US
201559518$20155951$8$F$20210502$20240813$20211207$20240816$EXP$$CA-TAKEDA-2021TUS028792$TAKEDA$$56$YR$$M$Y$$$20240816$$MD$CA$CA
201568842$20156884$2$F$$20240709$20211207$20240712$EXP$$ES-PFIZER INC-202101651476$PFIZER$$$$$F$Y$$$20240712$$MD$ES$ES
2015742214$20157422$14$F$$20240916$20211207$20240919$EXP$$FR-ORGANON-1510FRA013864$ORGANON$$71$YR$$M$Y$$$20240919$$MD$FR$FR
201580284$20158028$4$F$$20240731$20211207$20240808$PER$$US-SA-2021SA397464$SANOFI AVENTIS$$49$YR$A$M$Y$54.43$KG$20240808$$MD$US$US
201583172$20158317$2$F$$20240701$20211207$20240710$PER$$US-SA-2021SA404903$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$MD$US$US
201586434$20158643$4$F$$20240904$20211207$20240916$EXP$$CA-AUROBINDO-AUR-APL-2021-049980$AUROBINDO$$40$YR$$F$Y$$$20240916$$MD$CA$CA
201586625$20158662$5$F$20211021$20240808$20211208$20240818$30DAY$$US-GLAXOSMITHKLINE-US2021249059$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240818$$MD$US$US
201593078$20159307$8$F$20190612$20240725$20211208$20240801$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK109018$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$BR$BR
201595313$20159531$3$F$20210101$20240701$20211208$20240710$PER$$US-SA-2021SA399468$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240710$$MD$US$US
201596337$20159633$7$F$20200713$20240725$20211208$20240805$EXP$$DE-ROCHE-2646852$ROCHE$$44$YR$A$F$Y$$$20240805$$CN$DE$DE
2015981622$20159816$22$F$20200706$20240628$20211208$20240708$EXP$$CA-CELLTRION INC.-2020CA022378$CELLTRION$$$$$$Y$$$20240708$$MD$CA$CA
201599447$20159944$7$F$$20220318$20211208$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR250935$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$MD$US$US
201602712$20160271$2$F$$20211201$20211208$20240701$PER$$US-SA-2021SA405926$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240701$$PH$US$US
2016091718$20160917$18$F$20201106$20240815$20211208$20240822$EXP$$DE-ROCHE-2726417$ROCHE$$35$YR$A$F$Y$139$KG$20240822$$CN$DE$DE
201611514$20161151$4$F$20210501$20240820$20211208$20240822$EXP$$FR-TAKEDA-2021TUS077182$TAKEDA$$64$YR$$M$Y$$$20240822$$MD$FR$FR
201612103$20161210$3$F$20180101$20240717$20211208$20240721$EXP$$PHHY2018CA102119$NOVARTIS$$$$A$F$Y$$$20240721$$CN$CA$CA
201612553$20161255$3$F$20171120$20240711$20211208$20240712$EXP$$FR-TAKEDA-FR201802923$TAKEDA$$75$YR$$F$Y$66$KG$20240712$$HP$FR$FR
201617069$20161706$9$F$20211015$20240722$20211208$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132275$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240729$$MD$JP$JP
2016182315$20161823$15$F$$20240902$20211208$20240906$EXP$$CA-PURDUE-USA-2021-0289847$PURDUE$$59$YR$$F$Y$$$20240906$$MD$CA$CA
2016190912$20161909$12$F$20100406$20240829$20211208$20240903$EXP$$US-TAKEDA-2021TUS076271$TAKEDA$$56$YR$$F$Y$72$KG$20240903$$HP$US$US
201622483$20162248$3$F$20210101$20240703$20211208$20240705$EXP$$US-PFIZER INC-202101688995$PFIZER$$55$YR$$F$Y$$$20240705$$HP$US$US
201628185$20162818$5$F$20211126$20240716$20211209$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132151$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$58.1$KG$20240724$$MD$JP$JP
2016339914$20163399$14$F$20210101$20240723$20211209$20240730$EXP$$CA-CELLTRION INC.-2021CA011027$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
201639119$20163911$9$F$20180222$20240802$20211209$20240813$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-07468$ALKEM$$57$YR$$M$Y$$$20240813$$CN$DE$DE
201639833$20163983$3$F$$20240913$20211209$20240924$EXP$$ES-AUROBINDO-AUR-APL-2021-050379$AUROBINDO$Rivas-prado L, Morales-ortega A, Allodi-de la Hoz S, Bernal-bello D, et al.. Hyperparathyroidism shows its hand: findings of osteitis fibrosa cystica.. The Lancet. 2021;397:1914$63$YR$$M$Y$$$20240924$$MD$ES$ES
201641493$20164149$3$F$$20240821$20211209$20240828$EXP$$CA-GLAXOSMITHKLINE-CA2021249199$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$CA$CA
201644313$20164431$3$F$20190523$20240917$20211209$20240925$EXP$$US-TAKEDA-US201930414$TAKEDA$$57$YR$$F$Y$81.63$KG$20240925$$HP$US$US
2016443812$20164438$12$F$20210928$20240717$20211209$20240722$EXP$$NVSC2021GB228578$NOVARTIS$$76$YR$$F$Y$$$20240722$$CN$GB$GB
2016502310$20165023$10$F$$20240715$20211209$20240718$PER$$US-PFIZER INC-202101523407$PFIZER$$78$YR$$F$Y$$$20240718$$CN$US$US
201655984$20165598$4$F$$20240710$20211209$20240715$EXP$$CA-TAKEDA-2021TUS077793$TAKEDA$$$$$M$Y$$$20240715$$CN$CA$CA
201662362$20166236$2$F$20210816$20240321$20211209$20240705$EXP$GB-MHRA-EYC 00262272$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2021-06424$ALKEM$$49$YR$$F$Y$47$KG$20240705$$CN$GB$GB
201662502$20166250$2$F$20210908$20240316$20211209$20240705$EXP$GB-MHRA-TPP14943945C6589193YC1631099022038$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2021-06098$ALKEM$$74$YR$$M$Y$98$KG$20240705$$MD$GB$GB
201675107$20167510$7$F$20210407$20240911$20211209$20240921$EXP$$JP-ABBVIE-21P-087-4191979-00$ABBVIE$$64$YR$$M$Y$69$KG$20240921$$MD$JP$JP
201677544$20167754$4$F$$20240802$20211210$20240809$PER$$US-SA-2021SA410633$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240809$$HP$US$US
201678375$20167837$5$F$20210101$20220426$20211210$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR249098$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
201679045$20167904$5$F$20211126$20220128$20211210$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR249073$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240925$$CN$US$US
201684926$20168492$6$F$$20220517$20211210$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR248959$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
201685088$20168508$8$F$20211117$20240905$20211210$20240917$EXP$$ES-AUROBINDO-AUR-APL-2021-050572$AUROBINDO$$56$YR$$M$Y$$$20240917$$MD$ES$ES
201686605$20168660$5$F$$20240720$20211210$20240801$EXP$$CZ-AUROBINDO-AUR-APL-2021-050105$AUROBINDO$Vanek J. Klinicke zkusenosti s novymi antipsychotiky (Clinical experience with new antipsychotics). Psychiatry for practice. 2021;22(3):143-148$27$YR$$F$Y$128.5$KG$20240801$$MD$CZ$CZ
2016869317$20168693$17$F$20210101$20240715$20211210$20240723$EXP$$CA-CELLTRION INC.-2021CA016936$CELLTRION$$$$$$Y$$$20240723$$HP$CA$CA
201688242$20168824$2$F$20210101$20240917$20211210$20240926$PER$$US-SA-2021SA406753$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240926$$MD$US$US
201691868$20169186$8$F$20210416$20240703$20211210$20240708$EXP$$CA-TAKEDA-2021TUS015642$TAKEDA$$33$YR$$M$Y$$$20240708$$CN$CA$CA
201691915$20169191$5$F$20220209$20240916$20211210$20240920$EXP$$CA-TAKEDA-2021TUS078008$TAKEDA$$38$YR$$F$Y$$$20240920$$MD$CA$CA
201695628$20169562$8$F$20211101$20240823$20211210$20240827$EXP$$US-JAZZ-2021-US-021725$JAZZ$$62$YR$$F$Y$$$20240827$$CN$US$US
201696124$20169612$4$F$20210101$20240807$20211210$20240814$EXP$$CA-CURRAX PHARMACEUTICALS-2021-014186$CURRAX PHARMACEUTICALS$$$$$F$Y$137.42$KG$20240814$$CN$CA$CA
201700602$20170060$2$F$20210527$20240711$20211210$20240716$EXP$$CN-PFIZER INC-202101676756$PFIZER$$66$YR$$M$Y$$$20240716$$CN$CN$CN
201700787$20170078$7$F$20211111$20240919$20211210$20240925$EXP$$JP-ABBVIE-21K-087-4192983-00$ABBVIE$$76$YR$$M$Y$$$20240925$$MD$JP$JP
2017020428$20170204$28$F$20211007$20240902$20211210$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-133007$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$63.1$KG$20240912$$MD$JP$JP
2017023711$20170237$11$F$20210101$20240911$20211210$20240913$EXP$$NVSC2021CA174029$NOVARTIS$$66$YR$$F$Y$$$20240913$$CN$CA$CA
201710009$20171000$9$F$20210101$20240709$20211210$20240716$EXP$$CA-TAKEDA-2021TUS037401$TAKEDA$$$$$F$Y$59$KG$20240716$$HP$CA$CA
201715249$20171524$9$F$20200401$20231212$20211210$20240805$EXP$$NVSC2020AR241136$NOVARTIS$$55$YR$$F$Y$$$20240805$$CN$AR$AR
201719502$20171950$2$F$20210101$20240828$20211210$20240917$PER$$US-SA-2021SA409000$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240918$$MD$US$US
201726462$20172646$2$F$20210914$20240708$20211211$20240717$EXP$$DK-TEVA-2021-DK-1984659$TEVA$$62$YR$$F$Y$68.9$KG$20240717$$MD$DK$DK
201731412$20173141$2$F$$20240724$20211211$20240725$EXP$$US-TAKEDA-2021TUS078425$TAKEDA$$$$$M$Y$$$20240725$$CN$US$US
2017346026$20173460$26$F$20201121$20240820$20211212$20240828$EXP$$CA-CELLTRION INC.-2020CA032288$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
2017372729$20173727$29$F$20210101$20240906$20211212$20240916$EXP$$CA-CELLTRION INC.-2021CA017002$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
2017374915$20173749$15$F$20210125$20240826$20211212$20240903$EXP$$CA-CELLTRION INC.-2021CA016922$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
201738947$20173894$7$F$20240706$20240706$20211213$20240726$PER$$CA-TOLMAR, INC.-21CA030661$TOLMAR$$73$YR$$M$Y$$$20240726$$HP$CA$CA
201745679$20174567$9$F$20211101$20240813$20211213$20240819$EXP$$CA-JNJFOC-20211165606$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240819$$HP$CA$CA
201747129$20174712$9$F$20200710$20240808$20211213$20240814$EXP$$DE-ROCHE-2653086$ROCHE$$51$YR$A$F$Y$127$KG$20240814$$CN$DE$DE
2017521034$20175210$34$F$20190412$20240918$20211213$20240927$EXP$$CA-CELLTRION INC.-2021CA016998$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
201754422$20175442$2$F$$20211208$20211213$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR252547$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
201757685$20175768$5$F$$20240812$20211213$20240815$EXP$$US-TAKEDA-2021TUS077635$TAKEDA$$$$$M$Y$$$20240815$$CN$US$US
201759077$20175907$7$F$20211124$20240817$20211213$20240820$EXP$$BE-PFIZER INC-202101725910$PFIZER$$78$YR$$M$Y$76.9$KG$20240820$$HP$BE$BE
201760846$20176084$6$F$20211022$20240814$20211213$20240822$EXP$$CA-TAKEDA-2021TUS064606$TAKEDA$$35$YR$$F$Y$$$20240822$$MD$CA$CA
201766262$20176626$2$F$20231210$20240703$20211213$20240705$EXP$$IN-PFIZER INC-202101699895$PFIZER$$57$YR$$M$Y$$$20240705$$CN$IN$IN
2017681712$20176817$12$F$20230519$20240705$20211213$20240713$EXP$$US-TAKEDA-2021TUS077847$TAKEDA$$61$YR$$F$Y$$$20240713$$CN$US$US
2017698013$20176980$13$F$20210803$20240722$20211213$20240726$EXP$$DE-PFIZER INC-202101269464$PFIZER$$66$YR$$M$Y$$$20240726$$CN$DE$DE
201773903$20177390$3$F$$20240821$20211213$20240823$PER$$NVSC2021US282757$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
201777152$20177715$2$F$20211127$20240830$20211213$20240920$PER$$US-SA-2021SA407987$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240920$$CN$US$US
201777227$20177722$7$F$$20240705$20211213$20240715$PER$$US-SA-2021SA409058$SANOFI AVENTIS$$18$YR$A$M$Y$73.4$KG$20240715$$MD$US$US
201778582$20177858$2$F$$20240812$20211213$20240816$EXP$$CA-BAUSCH-BL-2021-040767$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240816$$CN$CA$CA
201780053$20178005$3$F$20211130$20240801$20211213$20240808$PER$$US-SA-2021SA410132$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240808$$MD$US$US
201782714$20178271$4$F$20211116$20240819$20211213$20240823$EXP$$AU-ABBVIE-21K-008-4169490-00$ABBVIE$$35$YR$$M$Y$$$20240823$$MD$AU$AU
2017835038$20178350$38$F$20191204$20240911$20211213$20240918$EXP$$CA-CELLTRION INC.-2021CA017010$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
201784755$20178475$5$F$20130901$20240906$20211214$20240914$EXP$$ES-CELLTRION INC.-2021ES016628$CELLTRION$Lopez-Trascasa M, Alonso-Melgar, A, Melgosa-Hijosa, M et al. Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.. Frontiers in Immunology. 2021;12:1-8$$$$$Y$$$20240914$$HP$ES$ES
2017954715$20179547$15$F$20211111$20230405$20211214$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR206933$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240925$$CN$US$US
2017972011$20179720$11$F$20211206$20240903$20211214$20240906$EXP$$CA-TAKEDA-2021TUS078123$TAKEDA$$24$YR$$F$Y$$$20240906$$MD$CA$CA
2017991721$20179917$21$F$20220912$20240819$20211214$20240827$EXP$$US-TAKEDA-2021TUS077643$TAKEDA$$30$YR$$F$Y$98$KG$20240827$$CN$US$US
2018097218$20180972$18$F$20210603$20240729$20211214$20240806$EXP$$CA-ROCHE-2738558$ROCHE$$34$YR$A$M$Y$$$20240806$$CN$CA$CA
201811458$20181145$8$F$$20220527$20211214$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR250751$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2018164313$20181643$13$F$$20240802$20211214$20240807$EXP$$US-INCYTE CORPORATION-2021IN011383$INCYTE$$$$$$Y$$$20240807$$CN$US$US
201820982$20182098$2$F$$20240625$20211214$20240704$PER$$US-SA-2021SA412897$SANOFI AVENTIS$$$$A$F$Y$55$KG$20240704$$MD$US$US
2018466017$20184660$17$F$20200319$20240723$20211214$20240731$EXP$$CA-CELLTRION INC.-2020CA019728$CELLTRION$$$$$$Y$$$20240731$$MD$CA$CA
2018467319$20184673$19$F$20210101$20240813$20211214$20240821$EXP$$CA-CELLTRION INC.-2021CA017140$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
2018471825$20184718$25$F$20181128$20240704$20211214$20240711$EXP$$CA-CELLTRION INC.-2018CA024633$CELLTRION$$$$$$Y$$$20240711$$CN$CA$CA
201849744$20184974$4$F$20211001$20240807$20211214$20240822$EXP$$AU-BEH-2021139079$CSL BEHRING$$69$YR$E$M$Y$100.7$KG$20240822$$MD$AU$AU
201857016$20185701$6$F$20211130$20220906$20211215$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR253322$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240925$$CN$US$US
201857882$20185788$2$F$$20240906$20211215$20240921$EXP$$PT-CELLTRION INC.-2021PT016679$CELLTRION$Ravara M, Boneco T, Albuquerque M, Matos C, and Martins J et al. Posterior Reversible Encephalopathy Syndrome (PRES) (Abstract number 2683). Medicina Interna - Congressos Nacionais. 2021;2683:28CNMI$$$$$Y$$$20240921$$MD$PT$PT
201865225$20186522$5$F$20161101$20240726$20211215$20240805$EXP$$CA-TAKEDA-2018TUS026814$TAKEDA$$59$YR$$F$Y$$$20240805$$HP$CA$CA
2018665030$20186650$30$F$20210310$20240625$20211215$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-082575$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$58.4$KG$20240701$$MD$JP$JP
2018762812$20187628$12$F$20220101$20240905$20211215$20240909$EXP$$US-PFIZER INC-202101742470$PFIZER$$71$YR$$F$Y$81.65$KG$20240909$$CN$US$US
2018857011$20188570$11$F$$20240912$20211215$20240917$EXP$$US-PFIZER INC-2021092098$PFIZER$$83$YR$$F$Y$58.957$KG$20240917$$MD$US$US
201886853$20188685$3$F$20180601$20240722$20211215$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-097789$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$79$KG$20240730$$MD$JP$JP
2018984511$20189845$11$F$20211210$20240709$20211215$20240712$EXP$$CA-TAKEDA-2021TUS065155$TAKEDA$$66$YR$$F$Y$$$20240712$$CN$CA$CA
201899742$20189974$2$F$20211007$20240726$20211215$20240730$EXP$FR-AFSSAPS-AN20214322$FR-MYLANLABS-2021M1091798$MYLAN$$44$YR$$M$Y$52$KG$20240730$$MD$FR$FR
201915579$20191557$9$F$20210101$20220112$20211216$20240913$EXP$$PL-JNJFOC-20211233757$JOHNSON AND JOHNSON$$83$YR$E$F$Y$91$KG$20240913$$CN$PL$PL
201915922$20191592$2$F$$20240722$20211216$20240806$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-320622$RANBAXY$Townsend MJ, Hodi FS, Grover S. Infliximab for Steroid-Refractory Immune Checkpoint Inhibitor-Induced Acute Pancreatitis. ACG Case Rep J. 2023;10(3):E01018;1-4$73$YR$$M$Y$$$20240806$$MD$US$US
2019190322$20191903$22$F$20180919$20240912$20211216$20240920$EXP$$CA-CELLTRION INC.-2021CA015246$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
2019195564$20191955$64$F$20200225$20240820$20211216$20240827$EXP$$CA-CELLTRION INC.-2021CA017213$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
201919656$20191965$6$F$20211223$20240822$20211216$20240827$EXP$$US-TAKEDA-US202017265$TAKEDA$$62$YR$$M$Y$$$20240827$$MD$US$US
201930898$20193089$8$F$20211001$20240712$20211216$20240726$EXP$$CA-HLS-202108924$HLS THERAPEUTICS$$66$YR$E$M$Y$$$20240726$$PH$CA$CA
201933576$20193357$6$F$$20240129$20211216$20240812$EXP$$NVSC2021CO244047$NOVARTIS$$$$$F$Y$56$KG$20240812$$CN$CO$CO
201936117$20193611$7$F$$20240619$20211216$20240701$EXP$$CA-AMGEN-CANSP2021199666$AMGEN$$40$YR$A$F$Y$$$20240630$$HP$CA$CA
201938532$20193853$2$F$20211213$20240621$20211216$20240702$PER$$US-SA-2021SA417884$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240702$$MD$US$US
201943463$20194346$3$F$20180401$20240821$20211216$20240822$EXP$$FR-TAKEDA-FR201850769$TAKEDA$$61$YR$$M$Y$$$20240822$$HP$FR$FR
201956033$20195603$3$F$20211108$20240819$20211216$20240830$EXP$$US-ACORDA-ACO_171116_2021$ACORDA$$77$YR$$F$Y$$$20240830$$CN$US$US
201958413$20195841$3$F$20210917$20240709$20211216$20240718$EXP$FR-AFSSAPS-AM20213268$FR-TAKEDA-2021TEU010477$TAKEDA$$90$YR$$F$Y$56.5$KG$20240718$$HP$FR$FR
201959227$20195922$7$F$20190710$20240705$20211216$20240715$EXP$$CA-TAKEDA-2019TUS003291$TAKEDA$$33$YR$$F$Y$$$20240715$$HP$CA$CA
201969407$20196940$7$F$20211201$20220506$20211217$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR251072$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240925$$CN$US$US
201969607$20196960$7$F$20211005$20240710$20211217$20240730$PER$$CA-TOLMAR, INC.-21CA030780$TOLMAR$$69$YR$$M$Y$$$20240729$$CN$CA$CA
201971928$20197192$8$F$20190114$20240711$20211217$20240723$EXP$$DE-ROCHE-2425567$ROCHE$$46$YR$A$F$Y$$$20240723$$CN$DE$DE
2019793312$20197933$12$F$20230704$20240806$20211217$20240813$EXP$$CN-VIIV HEALTHCARE LIMITED-US2021APC252279$VIIV$$$$$$Y$$$20240813$$CN$CN$US
201983452$20198345$2$F$20211126$20240913$20211217$20240918$EXP$$US-SA-2021SA418747$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240918$$MD$US$US
2019846220$20198462$20$F$20211101$20230621$20211217$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR252620$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
201987444$20198744$4$F$20200920$20240820$20211217$20240904$EXP$$FR-SERVIER-S20011111$SERVIER$$$$$$Y$$$20240904$$MD$FR$FR
201990158$20199015$8$F$20200120$20240905$20211217$20240910$EXP$$DE-ROCHE-2560898$ROCHE$$59$YR$A$M$Y$$$20240910$$CN$DE$DE
201992257$20199225$7$F$20191201$20240912$20211217$20240918$EXP$$US-SHIRE-US202026032$TAKEDA$$59$YR$$M$Y$$$20240918$$HP$US$US
201995804$20199580$4$F$$20240708$20211217$20240709$EXP$$US-PFIZER INC-202101058748$PFIZER$$68$YR$$F$Y$$$20240709$$CN$US$US
202001172$20200117$2$F$20190101$20240822$20211217$20240904$EXP$$US-MYLANLABS-2021M1092030$AUROBINDO$Rosenblatt J, Leung A, Baneman E, Fuller R, Taimur S, Paniz-Mondolfi AE, et al.. Relapsed Babesia microti Infection following Allogeneic Hematopoietic Cell Transplantation in a Patient with B-cell Acute Lymphoblastic Leukemia: Case Report and Review of the Literature.. Open-Forum-Infect-Dis. 2021;8:9$64$YR$$F$Y$$$20240904$$MD$US$US
202004752$20200475$2$F$20170101$20240711$20211217$20240722$EXP$$FR-Merck Healthcare KGaA-9088327$MERCK KGAA$$68$YR$E$F$Y$$$20240718$$CN$FR$FR
202004915$20200491$5$F$20160201$20240829$20211217$20240903$EXP$$US-TAKEDA-US201803162$TAKEDA$$59$YR$$M$Y$165$KG$20240903$$HP$US$US
202005202$20200520$2$F$$20240911$20211217$20240914$EXP$$US-TAKEDA-2021TUS074683$TAKEDA$$$$$M$Y$49$KG$20240914$$HP$US$US
202008242$20200824$2$F$$20240709$20211217$20240712$EXP$$US-TAKEDA-2021TUS079105$TAKEDA$$$$$M$Y$$$20240712$$CN$US$US
2020108212$20201082$12$F$20210910$20240923$20211217$20240927$EXP$$DE-ROCHE-2917566$ROCHE$$42$YR$A$M$Y$$$20240928$$CN$DE$DE
2020108316$20201083$16$F$20211124$20240821$20211217$20240823$EXP$$CA-ROCHE-2970576$ROCHE$$37$YR$A$F$Y$$$20240823$$CN$CA$CA
2020251318$20202513$18$F$20210101$20240827$20211218$20240904$EXP$$CA-CELLTRION INC.-2021CA005531$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
202030623$20203062$3$F$20190101$20240624$20211218$20240722$PER$$US-009507513-2112USA003272$MERCK$$$$$F$Y$$$20240722$$CN$US$US
202031756$20203175$6$F$20211201$20220620$20211218$20240823$EXP$$NVSC2021CA279107$NOVARTIS$$67$YR$$M$Y$$$20240823$$CN$CA$CA
202032735$20203273$5$F$20210101$20240912$20211218$20240921$EXP$$CA-CELLTRION INC.-2021CA003909$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
202039472$20203947$2$F$20211201$20211208$20211219$20240701$PER$$US-SA-2021SA416277$SANOFI AVENTIS$$$$A$M$Y$$$20240701$$MD$US$US
202044422$20204442$2$F$20210427$20240130$20211220$20240711$EXP$FR-AFSSAPS-PV20213550$FR-TEVA-2021-FR-1987285$TEVA$$59$YR$$M$Y$75$KG$20240711$$MD$FR$FR
202048712$20204871$2$F$20240828$20240828$20211220$20240829$EXP$$US-TAKEDA-2021TUS005630$TAKEDA$$49$YR$$F$Y$$$20240829$$CN$US$US
202049444$20204944$4$F$$20240708$20211220$20240716$EXP$$DE-AUROBINDO-AUR-APL-2021-051828$AUROBINDO$$47$YR$$F$Y$62$KG$20240716$$PH$DE$DE
202054602$20205460$2$F$$20240828$20211220$20240914$PER$$US-SA-2021SA414831$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240914$$MD$US$US
202055192$20205519$2$F$20210101$20240816$20211220$20240823$PER$$US-BIOGEN-2021BI01078038$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
202057064$20205706$4$F$20230803$20240710$20211220$20240715$EXP$$US-TAKEDA-2021TUS067179$TAKEDA$$44$YR$$F$Y$64.85$KG$20240715$$CN$US$US
202060722$20206072$2$F$$20240712$20211220$20240719$PER$$US-JAZZ-2021-US-022274$JAZZ$$$$$F$Y$$$20240719$$CN$US$US
202062234$20206223$4$F$$20240910$20211220$20240919$EXP$$CA-APOTEX-2021AP046669$APOTEX$$50$YR$$F$Y$74$KG$20240919$$HP$CA$CA
202063202$20206320$2$F$20240101$20240801$20211220$20240810$PER$$US-SA-2021SA417289$SANOFI AVENTIS$$$$E$F$Y$$$20240810$$MD$US$US
202072145$20207214$5$F$20210914$20240704$20211220$20240709$EXP$$CA-TAKEDA-2021TUS058562$TAKEDA$$74$YR$$F$Y$$$20240709$$CN$CA$CA
202076465$20207646$5$F$$20240626$20211220$20240701$EXP$$CA-PFIZER INC-202101206122$PFIZER$$60$YR$$M$Y$$$20240701$$MD$CA$CA
2020767116$20207671$16$F$20210223$20240703$20211220$20240708$EXP$$DE-MYLANLABS-2021M1055606$MYLAN$$$$A$F$Y$60$KG$20240708$$HP$DE$DE
2020799010$20207990$10$F$$20240728$20211220$20240729$EXP$$US-PFIZER INC-2020365848$PFIZER$$1$YR$$M$Y$$$20240729$$MD$US$US
202092275$20209227$5$F$20220117$20220209$20211220$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR254561$GLAXOSMITHKLINE$$41$YR$$F$Y$$$20240925$$CN$US$US
202094676$20209467$6$F$20210825$20240710$20211221$20240718$EXP$$CA-TOLMAR, INC.-21CA029947$TOLMAR$$87$YR$$M$Y$$$20240718$$CN$CA$CA
2020950610$20209506$10$F$20200324$20240702$20211221$20240710$PER$$CA-TOLMAR, INC.-21CA028117$TOLMAR$$66$YR$$M$Y$$$20240710$$CN$CA$CA
202098954$20209895$4$F$20211201$20211229$20211221$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR256412$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
2021000732$20210007$32$F$20211206$20240917$20211221$20240926$EXP$$CA-CELLTRION INC.-2021CA017479$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
202100958$20210095$8$F$20201127$20240813$20211221$20240815$EXP$$CA-TAKEDA-CA202026539$TAKEDA$$68$YR$$F$Y$$$20240815$$CN$CA$CA
2021019120$20210191$20$F$20201210$20240628$20211221$20240706$EXP$$CA-CELLTRION INC.-2021CA015263$CELLTRION$$$$$$Y$$$20240706$$CN$CA$CA
202123303$20212330$3$F$20200526$20240802$20211221$20240807$EXP$$DE-MYLANLABS-2021M1093674$MYLAN$$$$E$F$Y$85$KG$20240807$$MD$DE$DE
202125058$20212505$8$F$20190101$20240717$20211221$20240719$EXP$$CA-PFIZER INC-2019055638$PFIZER$$44$YR$$F$Y$73.1$KG$20240719$$CN$CA$CA
202125484$20212548$4$F$20180119$20240821$20211221$20240827$PER$$US-BIOGEN-2018BI00513757$BIOGEN$$38$YR$$F$Y$$$20240827$$CN$US$US
202126764$20212676$4$F$$20220324$20211221$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR255948$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
202131312$20213131$2$F$20240812$20240812$20211221$20240821$PER$$US-SA-2021SA419214$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240821$$MD$US$US
202134342$20213434$2$F$20211011$20240823$20211221$20240828$EXP$$CN-PFIZER INC-202101760716$PFIZER$$67$YR$$F$Y$71$KG$20240828$$CN$CN$CN
202135583$20213558$3$F$$20240819$20211221$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202112007718$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240826$$CN$US$US
202142055$20214205$5$F$$20240822$20211221$20240826$EXP$$US-JAZZ-2021-US-022259$JAZZ$$$$$F$Y$98.86$KG$20240826$$HP$US$US
202144093$20214409$3$F$$20240906$20211221$20240913$EXP$$US-GILEAD-2021-0562385$GILEAD$$78$YR$E$F$Y$$$20240913$$HP$US$US
202145896$20214589$6$F$20210803$20240920$20211221$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-137200$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$48.5$KG$20240926$$PH$JP$JP
2021488913$20214889$13$F$20200201$20240720$20211222$20240808$PER$$CA-TOLMAR, INC.-21CA030846$TOLMAR$$67$YR$$M$Y$$$20240808$$CN$CA$CA
202148918$20214891$8$F$20230518$20240905$20211222$20240925$PER$$CA-TOLMAR, INC.-21CA030847$TOLMAR$$91$YR$$M$Y$$$20240925$$CN$CA$CA
202152055$20215205$5$F$20210731$20240628$20211222$20240706$EXP$$PT-CELLTRION INC.-2021PT017095$CELLTRION$$$$$$Y$$$20240706$$MD$PT$PT
202152103$20215210$3$F$20210101$20240710$20211222$20240718$PER$$US-SA-2021SA420930$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240718$$MD$US$US
202166796$20216679$6$F$$20240819$20211222$20240823$EXP$$NVSC2021CA288640$NOVARTIS$$60$YR$$M$Y$$$20240823$$MD$CA$CA
202167263$20216726$3$F$$20240919$20211222$20240925$EXP$$SI-MYLANLABS-2021M1094454$MYLAN$Razinger G, Grenc D, Pezdir T, Kranvogl R, Brvar M. Severe rhabdomyolysis and acute kidney failure due to synthetic opioid brorphine exposure in combination with chronic sertraline therapy. European Journal of Clinical Pharmacology. 2021;77(11):1759-1761$45$YR$$M$Y$$$20240925$$MD$SI$SI
202170955$20217095$5$F$$20240924$20211222$20240927$EXP$$GB-TAKEDA-2021TUS081166$TAKEDA$$$$$F$Y$$$20240927$$MD$GB$GB
202173256$20217325$6$F$$20240826$20211222$20240829$EXP$$US-PFIZER INC-202101772581$PFIZER$$43$YR$$F$Y$$$20240829$$CN$US$US
202175697$20217569$7$F$20211215$20240807$20211222$20240809$EXP$$GB-ROCHE-2985180$ROCHE$$23$YR$A$M$Y$68$KG$20240809$$MD$GB$GB
202176025$20217602$5$F$$20240826$20211222$20240829$EXP$$CA-BAYER-2021A268262$BAYER$$43$YR$A$F$Y$$$20240829$$CN$CA$CA
2021761816$20217618$16$F$20210909$20240926$20211222$20240930$EXP$$CA-ROCHE-2983797$ROCHE$$46$YR$A$M$Y$$$20240930$$CN$CA$CA
202181612$20218161$2$F$20230214$20240813$20211222$20240827$PER$$US-SA-2021SA424456$SANOFI AVENTIS$$62$YR$A$F$Y$83$KG$20240827$$MD$US$US
202187194$20218719$4$F$$20220216$20211222$20240910$PER$$NVSC2021US293382$NOVARTIS$$$$$F$Y$$$20240910$$CN$US$US
202187268$20218726$8$F$20211101$20240812$20211222$20240819$EXP$$US-SA-2021SA421043$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240819$$MD$US$US
2021914610$20219146$10$F$$20240827$20211222$20240830$EXP$$AU-TAKEDA-2021TUS080906$TAKEDA$$$$$F$Y$$$20240830$$CN$AU$AU
202191806$20219180$6$F$20211201$20220510$20211222$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR259509$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240925$$CN$US$US
202194102$20219410$2$F$$20210808$20211222$20240920$EXP$$US-NOVOPROD-878144$NOVO NORDISK$$$$A$M$Y$$$20240920$$CN$US$US
202195873$20219587$3$F$20211216$20240925$20211222$20240927$EXP$$IN-PFIZER INC-202101802088$PFIZER$$52$YR$$F$Y$$$20240927$$CN$IN$IN
202198625$20219862$5$F$$20240805$20211222$20240813$EXP$$US-SA-2021SA421644$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240813$$MD$US$US
202200995$20220099$5$F$20211201$20230814$20211222$20240906$PER$$US-FARMAPROD-202112-2324$DOMPE FARMACEUTICI$$69$YR$E$M$Y$131.09$KG$20240902$$CN$US$
202202173$20220217$3$F$20210507$20240805$20211223$20240808$EXP$$GB-AUROBINDO-AUR-APL-2021-051844$AUROBINDO$$17$YR$$F$Y$$$20240808$$HP$GB$US
202202593$20220259$3$F$20211108$20220207$20211223$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR256383$GLAXOSMITHKLINE$$58$YR$$F$Y$82.54$KG$20240925$$HP$US$US
2022029011$20220290$11$F$20201215$20240906$20211223$20240916$EXP$$CA-CELLTRION INC.-2020CA034794$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
202203149$20220314$9$F$$20240904$20211223$20240913$EXP$$CA-AUROBINDO-AUR-APL-2021-051987$AUROBINDO$$49$YR$$F$Y$91$KG$20240913$$HP$CA$CA
202203392$20220339$2$F$$20240731$20211223$20240813$EXP$$CA-AUROBINDO-AUR-APL-2021-052543$AUROBINDO$$65$YR$$F$Y$$$20240813$$HP$CA$CA
202203899$20220389$9$F$20240115$20240729$20211223$20240820$PER$$CA-TOLMAR, INC.-21CA030841$TOLMAR$$69$YR$$M$Y$$$20240820$$CN$CA$CA
202206463$20220646$3$F$20211008$20240723$20211223$20240812$PER$$CA-TOLMAR, INC.-21CA030881$TOLMAR$$90$YR$$M$Y$$$20240812$$CN$CA$CA
202206842$20220684$2$F$$20211220$20211223$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR260585$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
202207345$20220734$5$F$20211201$20240731$20211223$20240806$EXP$$CA-BAUSCH-BL-2021-041892$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240806$$CN$CA$CA
202207785$20220778$5$F$$20240805$20211223$20240808$EXP$$CA-AUROBINDO-AUR-APL-2021-052267$AUROBINDO$$53$YR$$M$Y$$$20240808$$MD$CA$CA
202209022$20220902$2$F$20211118$20240708$20211223$20240723$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-321495$RANBAXY$$40$YR$A$F$Y$$$20240723$$CN$CA$CA
202209793$20220979$3$F$$20240801$20211223$20240814$EXP$$CA-AUROBINDO-AUR-APL-2021-052213$AUROBINDO$$57$YR$$F$Y$$$20240814$$HP$CA$CA
202216346$20221634$6$F$20211105$20230720$20211223$20240926$PER$$US-GLAXOSMITHKLINE-US2021257825$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240926$$MD$US$US
202222653$20222265$3$F$$20220209$20211223$20240711$PER$$NVSC2021US294646$NOVARTIS$$$$$M$Y$$$20240711$$CN$US$US
2022251540$20222515$40$F$$20240730$20211223$20240813$EXP$$CA-ORGANON-1911CAN001744$ORGANON$$65$YR$$F$Y$69$KG$20240813$$HP$CA$CA
202225242$20222524$2$F$$20200707$20211223$20240805$EXP$$NVSC2020ES360639$NOVARTIS$$56$YR$$$Y$$$20240805$$HP$ES$ES
202225523$20222552$3$F$$20240628$20211223$20240701$PER$$US-PFIZER INC-202101692758$PFIZER$$80$YR$$M$Y$79.38$KG$20240701$$CN$US$US
2022259711$20222597$11$F$$20240624$20211223$20240701$PER$$US-PFIZER INC-202101782593$PFIZER$$65$YR$$F$Y$$$20240701$$MD$US$US
2022297310$20222973$10$F$$20240807$20211223$20240809$PER$$US-PFIZER INC-202101281186$PFIZER$$79$YR$$F$Y$$$20240809$$CN$US$US
202232452$20223245$2$F$$20240715$20211223$20240722$EXP$$ES-MYLANLABS-2021M1094264$BIOCON$$$$$$Y$$$20240719$$MD$ES$ES
202233687$20223368$7$F$20220101$20240911$20211223$20240919$EXP$$CA-TAKEDA-2021TUS081082$TAKEDA$$$$$M$Y$$$20240919$$HP$CA$CA
202234805$20223480$5$F$$20240821$20211223$20240827$EXP$$PL-MYLANLABS-2021M1094721$MYLAN$Zajac-Spychala O, Pieczonka A, Janura-Szymanska J, Jonczyk-Potoczna K, Wachowiak J.. Multiple Reactivations of Viral Infections Followed by Cerebral Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation in an Adolescent With Ph(+) Acute Lymphoblastic Leukemia: A Case Report... Transplantation Proceedings. 2021;53(4):1355-9$17$YR$$F$Y$$$20240827$$HP$PL$PL
202239882$20223988$2$F$20211108$20211209$20211223$20240827$EXP$$IE-BIOVITRUM-2021IE11403$BIOVITRUM$$245$DY$$F$Y$$$20240827$$HP$IE$IE
202241683$20224168$3$F$$20240801$20211223$20240805$EXP$$US-PFIZER INC-2020362151$PFIZER$$62$YR$$F$Y$$$20240805$$CN$US$US
202254544$20225454$4$F$$20240731$20211224$20240811$EXP$$CA-AUROBINDO-AUR-APL-2021-052542$AUROBINDO$$43$YR$$F$Y$$$20240812$$HP$CA$CA
202254876$20225487$6$F$20211201$20220517$20211224$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR259283$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
2022549714$20225497$14$F$20210521$20240801$20211224$20240808$EXP$$CA-CELLTRION INC.-2021CA008242$CELLTRION$$$$$$Y$$$20240808$$HP$CA$CA
202254984$20225498$4$F$$20240830$20211224$20240910$EXP$$CA-AUROBINDO-AUR-APL-2021-052223$AUROBINDO$$50$YR$$F$Y$74$KG$20240910$$HP$CA$CA
202257125$20225712$5$F$20211208$20220112$20211224$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR257691$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240926$$CN$US$US
202258522$20225852$2$F$20211101$20240910$20211224$20240917$EXP$$US-SA-2021SA426935$SANOFI AVENTIS$$46$YR$A$F$Y$77$KG$20240917$$MD$US$US
202261714$20226171$4$F$20211207$20240919$20211224$20240928$EXP$$JP-UNITED THERAPEUTICS-UNT-2021-025798$UNITED THERAPEUTICS$$7$YR$$F$Y$16.5$KG$20240928$$MD$JP$JP
202261846$20226184$6$F$20220106$20240703$20211224$20240709$EXP$$CA-TAKEDA-2021TUS081224$TAKEDA$$67$YR$$F$Y$$$20240709$$HP$CA$CA
2022688320$20226883$20$F$20211123$20240806$20211224$20240809$EXP$$DE-ROCHE-2967053$ROCHE$$45$YR$A$F$Y$69$KG$20240809$$CN$DE$DE
202268886$20226888$6$F$20190523$20240719$20211224$20240730$EXP$$DE-ROCHE-2326404$ROCHE$$38$YR$A$F$Y$$$20240730$$CN$DE$DE
202275268$20227526$8$F$20211201$20240731$20211224$20240801$EXP$$JP-ASTELLAS-2021JP024424$ASTELLAS$$7$DEC$$M$Y$63.4$KG$20240801$$CN$JP$JP
2022757115$20227571$15$F$20211201$20230728$20211224$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR258382$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240925$$CN$US$US
202278558$20227855$8$F$$20220620$20211224$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR260599$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2022806211$20228062$11$F$20210623$20240904$20211224$20240909$EXP$$US-INCYTE CORPORATION-2021IN011785$INCYTE$$$$$$Y$$$20240909$$CN$US$US
202281317$20228131$7$F$20191003$20240812$20211224$20240816$EXP$$BR-TAKEDA-BR201927597$TAKEDA$$41$YR$$M$Y$108$KG$20240816$$CN$BR$BR
202285006$20228500$6$F$20211201$20221103$20211225$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR258245$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
202286395$20228639$5$F$20230101$20240904$20211225$20240914$PER$$US-SA-2021SA422938$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240914$$MD$US$US
2022898343$20228983$43$F$20201101$20240910$20211225$20240912$EXP$$NVSC2021MX100243$NOVARTIS$$43$YR$$F$Y$66$KG$20240912$$CN$MX$MX
202303598$20230359$8$F$$20240813$20211227$20240815$EXP$$CA-ABBVIE-21K-028-4210017-00$ABBVIE$$44$YR$$F$Y$70$KG$20240815$$CN$CA$CA
202304464$20230446$4$F$20211216$20240724$20211227$20240802$EXP$$CA-CELLTRION INC.-2021CA017671$CELLTRION$$$$$$Y$$$20240802$$HP$CA$CA
2023074816$20230748$16$F$20220710$20240911$20211227$20240918$EXP$$US-ABBVIE-21K-163-4212226-00$ABBVIE$$60$YR$$F$Y$97$KG$20240918$$CN$US$US
202307613$20230761$3$F$20210917$20211214$20211227$20240712$EXP$$FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2021-014777$VALIDUS$$$$$$Y$$$20240712$$PH$FR$FR
2023106214$20231062$14$F$20211213$20240722$20211227$20240724$EXP$$ES-ROCHE-2981147$ROCHE$$48$YR$A$M$Y$$$20240724$$MD$ES$ES
202314993$20231499$3$F$$20240902$20211227$20240918$EXP$$NVSC2021TH286421$NOVARTIS$$58$YR$$F$Y$$$20240918$$MD$TH$TH
202315696$20231569$6$F$20211201$20220524$20211227$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR255950$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240925$$CN$US$US
202316584$20231658$4$F$$20240808$20211227$20240809$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003625$PAREXEL$$$$$$Y$$$20240809$$CN$US$US
202316644$20231664$4$F$$20240703$20211227$20240705$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003635$PAREXEL$$$$$$Y$$$20240705$$HP$US$US
202317155$20231715$5$F$20210101$20240725$20211227$20240726$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003605$PAREXEL$$$$$$Y$$$20240726$$HP$US$US
202319494$20231949$4$F$$20240905$20211227$20240917$EXP$CA-MHPD-E2B_03482536$CA-Accord-247901$ACCORD$$68$YR$E$F$Y$$$20240917$$HP$CA$CA
202327214$20232721$4$F$20210609$20240806$20211227$20240813$EXP$$BR-TAKEDA-2021TUS081564$TAKEDA$$64$YR$$F$Y$$$20240813$$CN$BR$BR
202330432$20233043$2$F$$20240917$20211227$20240920$EXP$$US-TAKEDA-US201722336$TAKEDA$$$$$F$Y$$$20240920$$HP$US$US
2023305818$20233058$18$F$20201126$20240813$20211227$20240816$EXP$$CA-PFIZER INC-2020417062$PFIZER$$30$YR$$F$Y$46$KG$20240816$$MD$CA$CA
202330603$20233060$3$F$$20240715$20211227$20240718$EXP$$CA-TAKEDA-2021TUS081494$TAKEDA$$$$$M$Y$$$20240718$$CN$CA$CA
2023306725$20233067$25$F$20211201$20240827$20211227$20240904$EXP$$CA-TAKEDA-2021TUS078401$TAKEDA$$54$YR$$F$Y$41$KG$20240904$$CN$CA$CA
2023322313$20233223$13$F$20221101$20240819$20211227$20240823$EXP$$AU-TAKEDA-2021TUS050980$TAKEDA$$66$YR$$M$Y$$$20240823$$CN$AU$AU
202332355$20233235$5$F$20240101$20240909$20211227$20240912$EXP$$US-PFIZER INC-202101540282$PFIZER$$70$YR$$F$Y$$$20240912$$CN$US$US
202333114$20233311$4$F$20210120$20240925$20211227$20240927$EXP$$CA-TAKEDA-2019TUS052022$TAKEDA$$69$YR$$M$Y$$$20240927$$HP$CA$CA
202334974$20233497$4$F$$20240808$20211227$20240812$EXP$$TH-TAKEDA-2021TUS081576$TAKEDA$$42$YR$$F$Y$$$20240812$$CN$TH$TH
202337534$20233753$4$F$20210818$20240619$20211227$20240701$PER$$US-SA-2021SA427030$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240701$$MD$US$US
202340078$20234007$8$F$$20240808$20211227$20240813$PER$$US-PFIZER INC-2021561233$PFIZER$$74$YR$$F$Y$$$20240813$$CN$US$US
202346634$20234663$4$F$20130213$20240627$20211227$20240701$PER$$US-PURDUE-USA-2020-0193409$PURDUE$$58$YR$$M$Y$$$20240701$$CN$US$US
202353687$20235368$7$F$20230227$20240710$20211228$20240730$PER$$CA-TOLMAR, INC.-21CA030905$TOLMAR$$73$YR$$M$Y$$$20240729$$CN$CA$CA
202353707$20235370$7$F$20230101$20240711$20211228$20240730$PER$$CA-TOLMAR, INC.-21CA030907$TOLMAR$$79$YR$$M$Y$$$20240729$$CN$CA$CA
202355572$20235557$2$F$$20240906$20211228$20240911$EXP$$US-TAKEDA-US201940926$TAKEDA$$$$$M$Y$$$20240911$$HP$US$US
202356272$20235627$2$F$20240801$20240920$20211228$20240930$EXP$$US-ROCHE-2935440$ROCHE$$67$YR$E$M$Y$86.18$KG$20240930$$MD$US$US
202358425$20235842$5$F$20190826$20240827$20211228$20240902$EXP$$IL-ABBVIE-19K-082-2991603-00$ABBVIE$$74$YR$$F$Y$89$KG$20240902$$MD$IL$IL
202359712$20235971$2$F$20210101$20240701$20211228$20240708$EXP$$US-UCBSA-2021059146$UCB$$$$$F$Y$3.68$KG$20240708$$HP$US$US
202360347$20236034$7$F$20220101$20221219$20211228$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR263728$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$HP$US$US
202362002$20236200$2$F$$20211222$20211228$20240717$EXP$$CA-ASTELLAS-2021US049491$ASTELLAS$$$$$M$Y$$$20240717$$CN$CA$CA
2023651144$20236511$44$F$20211209$20240925$20211228$20240930$EXP$$AR-MYLANLABS-2021M1092949$MYLAN$$64$YR$$F$Y$$$20240930$$CN$AR$AR
2023668722$20236687$22$F$20211201$20240419$20211228$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR262853$GLAXOSMITHKLINE$$84$YR$$F$Y$$$20240925$$CN$US$US
202370236$20237023$6$F$$20240909$20211228$20240916$EXP$$CA-ROCHE-2980780$ROCHE$$$$$F$Y$$$20240916$$HP$CA$CA
202370434$20237043$4$F$$20220419$20211228$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR259822$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
202374229$20237422$9$F$20211028$20240712$20211228$20240723$EXP$$DE-ROCHE-2987347$ROCHE$$33$YR$A$F$Y$$$20240723$$CN$DE$DE
202381372$20238137$2$F$$20240829$20211228$20240830$PER$$US-PURDUE-USA-2020-0286613$PURDUE$$$$$F$Y$$$20240830$$LW$US$US
202382029$20238202$9$F$20180222$20240808$20211228$20240815$EXP$$DE-MYLANLABS-2021M1094860$MYLAN$$57$YR$$M$Y$$$20240815$$CN$DE$DE
202392833$20239283$3$F$20170216$20240814$20211228$20240819$EXP$$US-TAKEDA-US201703711$TAKEDA$$73$YR$$M$Y$$$20240819$$CN$US$US
202401436$20240143$6$F$20220505$20240911$20211228$20240918$EXP$$IL-SHIRE-IL201902505AA$TAKEDA$$83$YR$$M$Y$$$20240918$$CN$IL$IL
202406392$20240639$2$F$19970501$20240917$20211228$20240920$PER$$US-PURDUE-USA-2020-0222377$PURDUE$$29$YR$$M$Y$$$20240920$$HP$US$US
2024157514$20241575$14$F$20220805$20240828$20211228$20240830$EXP$$CA-TAKEDA-2021TUS030169$TAKEDA$$31$YR$$F$Y$58.96$KG$20240830$$HP$CA$CA
202417112$20241711$2$F$20211107$20211214$20211228$20240903$EXP$$DE-JNJFOC-20211233268$JOHNSON AND JOHNSON$$$$$F$Y$55$KG$20240903$$MD$DE$DE
202421852$20242185$2$F$$20240923$20211228$20240924$PER$$US-PURDUE-USA-2020-0235600$PURDUE$$$$A$F$Y$$$20240924$$LW$US$US
202440526$20244052$6$F$20201029$20240711$20211228$20240723$EXP$$DE-ROCHE-2709521$ROCHE$$47$YR$A$M$Y$$$20240723$$CN$DE$DE
202442416$20244241$6$F$20210106$20240722$20211229$20240729$EXP$$CA-CELLTRION INC.-2020CA034973$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
202448917$20244891$7$F$20211201$20221118$20211229$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR261405$GLAXOSMITHKLINE$$57$YR$$F$Y$78.458$KG$20240925$$MD$US$US
202452176$20245217$6$F$$20240703$20211229$20240709$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003598$PAREXEL$$$$$$Y$$$20240709$$MD$US$US
202452387$20245238$7$F$$20240722$20211229$20240730$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003638$PAREXEL$$$$$$Y$$$20240730$$MD$US$US
202452433$20245243$3$F$20211218$20240725$20211229$20240726$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003620$PAREXEL$$$$$$Y$$$20240726$$CN$US$US
202453068$20245306$8$F$$20240922$20211229$20240926$EXP$$IN-PFIZER INC-2019401564$PFIZER$$63$YR$$F$Y$$$20240926$$CN$IN$IN
202457247$20245724$7$F$20220107$20240813$20211229$20240819$EXP$$CA-TAKEDA-2021TUS077344$TAKEDA$$19$YR$$F$Y$$$20240819$$CN$CA$CA
2024579515$20245795$15$F$20211111$20240731$20211229$20240807$EXP$$DE-ROCHE-2983819$ROCHE$$48$YR$A$M$Y$$$20240807$$CN$DE$DE
202458592$20245859$2$F$20240722$20240729$20211229$20240802$PER$$US-GLAXOSMITHKLINE-US2021263755$GLAXOSMITHKLINE$$87$YR$$M$Y$$$20240802$$CN$US$US
202458605$20245860$5$F$20211201$20220329$20211229$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR263735$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
2024630033$20246300$33$F$20220124$20240819$20211229$20240829$EXP$$US-TAKEDA-2021TUS036446$TAKEDA$$77$YR$$M$Y$84$KG$20240829$$CN$US$US
202463135$20246313$5$F$$20230322$20211229$20240813$EXP$$NVSC2018CH021112$NOVARTIS$$$$N$M$Y$$$20240813$$MD$CH$CH
202467722$20246772$2$F$20210601$20240717$20211229$20240724$EXP$$US-GLAXOSMITHKLINE-US2021263785$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240724$$CN$US$US
202467836$20246783$6$F$20211201$20220525$20211229$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR264204$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
202468002$20246800$2$F$20210917$20240814$20211229$20240821$EXP$IT-MINISAL02-791384$IT-MYLANLABS-2021M1095647$MYLAN$$62$YR$$F$Y$$$20240821$$MD$IT$IT
202471373$20247137$3$F$$20211221$20211229$20240719$EXP$$US-AstraZeneca-2021A892850$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
202472815$20247281$5$F$$20240808$20211229$20240812$EXP$$IT-MYLANLABS-2021M1096031$MYLAN$Dell^Orso G, Grossi A, Penco F, Caorsi R, Palmisani E, Terranova P, Schena F, Lupia M, Ricci E, Montalto S, Pierri F, Ceccherini I, Fioredda F, Dufour C, Gattorno M and Miano M. Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure. Frontiers in Immunology. 2021;12:1-8$25$YR$$F$Y$$$20240812$$HP$IT$IT
202475184$20247518$4$F$$20240726$20211229$20240806$PER$$US-SA-2021SA429933$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240806$$MD$US$US
202475712$20247571$2$F$$20240913$20211229$20240923$PER$$US-SA-2021SA431486$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240923$$MD$US$US
202486173$20248617$3$F$20210520$20240711$20211229$20240712$EXP$$US-PFIZER INC-202101512178$PFIZER$$72$YR$$F$Y$76.2$KG$20240712$$MD$US$US
202486332$20248633$2$F$$20240906$20211229$20240924$PER$$US-SA-2021SA432008$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240924$$MD$US$US
202488396$20248839$6$F$20230101$20240809$20211229$20240820$EXP$$US-SA-2021SA429974$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240820$$MD$US$US
202492197$20249219$7$F$20211207$20240904$20211229$20240905$EXP$$JP-PFIZER INC-202101852602$PFIZER$Iwamoto, S.. A case of cervical lymphatic malformation in a child, which was removed by surgical incision. The Pediatric Otorhinolaryngology Japan. 2023;44(2):316$4$YR$$M$Y$18.2$KG$20240905$$MD$JP$JP
202492778$20249277$8$F$$20240823$20211229$20240829$PER$$US-PFIZER INC-202101281469$PFIZER$$49$YR$$F$Y$$$20240829$$MD$US$US
202493844$20249384$4$F$20210101$20240726$20211229$20240731$PER$$US-PFIZER INC-202101285151$PFIZER$$58$YR$$F$Y$$$20240731$$HP$US$US
202493992$20249399$2$F$20210701$20240705$20211229$20240715$EXP$DK-DKMA-WBS-0092549$DK-TEVA-2021-DK-1991601$TEVA$$65$YR$$M$Y$56$KG$20240715$$MD$DK$DK
202498463$20249846$3$F$20210101$20210719$20211229$20240906$EXP$$KR-009507513-2112KOR009445$MERCK$$67$YR$$F$Y$76.8$KG$20240906$$MD$KR$KR
2025371511$20253715$11$F$20210201$20240912$20211230$20240920$EXP$$JP-ASTELLAS-2021JP025266$ASTELLAS$$35$YR$A$M$Y$$$20240920$$MD$JP$JP
202543872$20254387$2$F$$20240720$20211230$20240722$EXP$$CN-ROCHE-2985317$ROCHE$$53$YR$A$F$Y$62$KG$20240722$$MD$CN$CN
202543944$20254394$4$F$20211201$20240905$20211230$20240909$EXP$$CA-ROCHE-2988526$ROCHE$$40$YR$A$M$Y$$$20240909$$CN$CA$CA
202546562$20254656$2$F$$20240830$20211230$20240910$EXP$$CA-AUROBINDO-AUR-APL-2021-053300$AUROBINDO$$38$YR$$M$Y$93$KG$20240910$$HP$CA$CA
202546952$20254695$2$F$$20240812$20211230$20240817$PER$$US-SA-2021SA432074$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240817$$MD$US$US
2025508710$20255087$10$F$20220101$20240906$20211230$20240916$EXP$$CA-CELLTRION INC.-2021CA017939$CELLTRION$$$$$$Y$$$20240916$$CN$CA$CA
202557066$20255706$6$F$20211201$20220307$20211230$20240925$PER$$US-GLAXOSMITHKLINE-US2001AMR000035$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
2025733512$20257335$12$F$20130101$20240812$20211230$20240819$EXP$$CA-HLS-202003469$HLS THERAPEUTICS$$41$YR$A$M$Y$$$20240819$$HP$CA$CA
202573872$20257387$2$F$$20240712$20211230$20240717$EXP$$NVSC2021JM299243$NOVARTIS$$$$$F$Y$$$20240717$$CN$JM$JM
202576085$20257608$5$F$20210101$20240820$20211230$20240827$EXP$$BR-TAKEDA-BR202002189$TAKEDA$$47$YR$$F$Y$59$KG$20240827$$CN$BR$BR
202577966$20257796$6$F$20211112$20240912$20211230$20240916$EXP$$ES-PFIZER INC-202101865043$PFIZER$$63$YR$$F$Y$148$KG$20240916$$MD$ES$ES
202584014$20258401$4$F$$20240715$20211230$20240720$EXP$$US-TAKEDA-2017BLT002860$TAKEDA$$$$$F$Y$$$20240720$$MD$US$US
202608886$20260888$6$F$20211201$20240622$20211230$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-004298$ACADIA PHARMACEUTICALS$$65$YR$$M$Y$$$20240716$$CN$US$US
202624977$20262497$7$F$20180830$20240724$20211231$20240726$EXP$$CA-TAKEDA-2019TUS054841$TAKEDA$$51$YR$$F$Y$$$20240726$$CN$CA$CA
2026344622$20263446$22$F$20211201$20240329$20211231$20240925$EXP$$US-GLAXOSMITHKLINE-US2021AMR265596$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
202636304$20263630$4$F$20211201$20220127$20211231$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR260686$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
202648803$20264880$3$F$20240401$20240709$20211231$20240717$EXP$$NVSC2021CO297729$NOVARTIS$$69$YR$$F$Y$44$KG$20240717$$CN$CO$CO
202664777$20266477$7$F$20180123$20240920$20211231$20240926$EXP$$US-TAKEDA-US201802414$TAKEDA$$34$YR$$M$Y$$$20240926$$MD$US$US
202669026$20266902$6$F$$20240904$20211231$20240905$EXP$$CA-BAUSCH-BL-2021-042652$BAUSCH AND LOMB$$78$YR$$M$Y$$$20240905$$CN$CA$CA
202691953$20269195$3$F$$20240621$20220101$20240704$EXP$$CA-ROCHE-2983831$ROCHE$$$$A$F$Y$$$20240704$$HP$CA$CA
202693669$20269366$9$F$20180913$20240723$20220101$20240802$EXP$$DE-AUROBINDO-AUR-APL-2021-053536$AUROBINDO$$45$YR$$F$Y$84$KG$20240802$$CN$DE$DE
202749132$20274913$2$F$$20240805$20220102$20240806$PER$$US-PURDUE-USA-2020-0263543$PURDUE$$$$A$M$Y$$$20240806$$LW$US$US
202779343$20277934$3$F$20210101$20240701$20220103$20240710$PER$$US-SA-2021SA430567$SANOFI AVENTIS$$36$YR$A$F$Y$113$KG$20240710$$MD$US$US
202779562$20277956$2$F$$20240821$20220103$20240902$PER$$US-SA-2021SA435217$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240902$$MD$US$US
202783936$20278393$6$F$20211018$20240902$20220103$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-125375$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240909$$MD$JP$JP
2027856923$20278569$23$F$20211220$20240905$20220103$20240914$EXP$$CA-CELLTRION INC.-2021CA017883$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
2027875112$20278751$12$F$$20240819$20220103$20240828$EXP$$US-GLAXOSMITHKLINE-US2021AMR265560$GLAXOSMITHKLINE$$$$$F$Y$55.3$KG$20240828$$CN$US$US
202791703$20279170$3$F$20211101$20220211$20220103$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR264389$GLAXOSMITHKLINE$$62$YR$$F$Y$77.098$KG$20240925$$MD$US$US
202793307$20279330$7$F$20211222$20240917$20220103$20240925$EXP$$CA-JNJFOC-20211266712$JOHNSON AND JOHNSON$$75$YR$E$M$Y$61.5$KG$20240925$$HP$CA$CA
202794562$20279456$2$F$$20211227$20220103$20240926$EXP$$US-GLAXOSMITHKLINE-US2021AMR264421$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
2027982220$20279822$20$F$20210325$20240717$20220103$20240724$EXP$$CA-ROCHE-2800876$ROCHE$$24$YR$A$F$Y$$$20240724$$MD$CA$CA
202864415$20286441$5$F$20211101$20240913$20220103$20240924$EXP$$JP-JNJFOC-20211158987$JOHNSON AND JOHNSON$$27$YR$A$F$Y$39.7$KG$20240924$$PH$JP$JP
202887012$20288701$2$F$20210101$20211222$20220104$20240729$EXP$$US-RECORDATI-2021004905$RECORDATI$$$$$$Y$$$20240726$$CN$US$US
202887379$20288737$9$F$20170101$20240722$20220104$20240730$EXP$$CA-CELLTRION INC.-2017CA009737$CELLTRION$$$$$$Y$$$20240730$$CN$CA$CA
202889212$20288921$2$F$20211201$20211228$20220104$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR264427$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240925$$CN$US$US
2028897530$20288975$30$F$20190708$20240708$20220104$20240717$EXP$$CA-CELLTRION INC.-2021CA010438$CELLTRION$$$$$$Y$$$20240717$$HP$CA$CA
2028899011$20288990$11$F$20211201$20240702$20220104$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR265743$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240925$$CN$US$US
202890384$20289038$4$F$20211226$20220118$20220104$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR265581$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
202891362$20289136$2$F$$20240628$20220104$20240702$EXP$$GB-UCBSA-2021057571$UCB$$$$$F$Y$$$20240702$$CN$GB$GB
2028966710$20289667$10$F$$20240718$20220104$20240722$EXP$$CA-Orion Corporation ORION PHARMA-22_00017054$ORION$$64$YR$A$M$Y$80$KG$20240722$$HP$CA$
2029002311$20290023$11$F$$20240916$20220104$20240923$EXP$$CA-GLAXOSMITHKLINE-CA2021AMR262195$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$CA$CA
202909663$20290966$3$F$$20240904$20220104$20240906$EXP$$US-PFIZER INC-202101848490$PFIZER$Lynch, M.. Encephalopathy and myelopathy: unusual complications of intrathecal chemotherapy in an 18-year-old male with acute b-cell lymphoblastic leukemia.. PM and R. 2021;13:S205$18$YR$$M$Y$$$20240906$$MD$US$US
202912682$20291268$2$F$20210513$20240709$20220104$20240712$PER$$US-PFIZER INC-2021569221$PFIZER$$59$YR$$F$Y$68.027$KG$20240712$$HP$US$US
202914065$20291406$5$F$$20240820$20220104$20240823$PER$$US-PFIZER INC-202101035096$PFIZER$$36$YR$$M$Y$$$20240823$$HP$US$US
202914803$20291480$3$F$$20240910$20220104$20240912$PER$$US-PFIZER INC-202101146227$PFIZER$$60$YR$$F$Y$$$20240912$$HP$US$US
202914814$20291481$4$F$$20240722$20220104$20240724$PER$$US-PFIZER INC-202101208683$PFIZER$$64$YR$$F$Y$78.912$KG$20240724$$HP$US$US
202920666$20292066$6$F$$20240820$20220104$20240822$PER$$US-PFIZER INC-202101730462$PFIZER$$67$YR$$F$Y$$$20240822$$MD$US$US
202925754$20292575$4$F$$20240729$20220104$20240731$EXP$$CA-TAKEDA-2020TUS011755$TAKEDA$$$$$F$Y$$$20240731$$CN$CA$CA
2029401636$20294016$36$F$20240130$20240826$20220104$20240830$EXP$$US-TAKEDA-2022TUS000322$TAKEDA$$61$YR$$F$Y$61.5$KG$20240830$$MD$US$US
202962295$20296229$5$F$20210101$20240831$20220105$20240908$EXP$$CA-ABBVIE-22K-028-4218957-00$ABBVIE$$$$$F$Y$$$20240908$$CN$CA$CA
202968465$20296846$5$F$$20240730$20220105$20240806$PER$$US-ROCHE-2905381$ROCHE$$46$YR$A$M$Y$91.8$KG$20240806$$CN$US$US
202972526$20297252$6$F$20211227$20220425$20220105$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR001007$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
202973222$20297322$2$F$$20240920$20220105$20240923$PER$$US-ROCHE-2874337$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
2029736324$20297363$24$F$20230801$20240822$20220105$20240828$EXP$$US-GLAXOSMITHKLINE-US2022AMR001124$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
2029741524$20297415$24$F$20210101$20240904$20220105$20240912$EXP$$CA-CELLTRION INC.-2021CA014162$CELLTRION$$$$$$Y$$$20240912$$PH$CA$CA
202974272$20297427$2$F$20240817$20240826$20220105$20240830$PER$$US-ROCHE-2913523$ROCHE$$48$YR$A$M$Y$$$20240830$$CN$US$US
202982909$20298290$9$F$20211225$20240618$20220105$20240702$EXP$$CA-ROCHE-2992411$ROCHE$$38$YR$A$F$Y$$$20240702$$CN$CA$CA
202983238$20298323$8$F$$20240625$20220105$20240704$EXP$$NVSC2021CA297173$NOVARTIS$$59$YR$$F$Y$68$KG$20240705$$HP$CA$CA
202990043$20299004$3$F$$20240701$20220105$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202112013375$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240702$$CN$US$US
2029972619$20299726$19$F$20200501$20240905$20220105$20240910$EXP$$US-TAKEDA-US202018607$TAKEDA$$76$YR$$M$Y$$$20240910$$HP$US$US
203001278$20300127$8$F$20220101$20240725$20220105$20240729$EXP$$US-PFIZER INC-2019336963$PFIZER$$66$YR$$F$Y$$$20240729$$CN$US$US
203002052$20300205$2$F$$20240716$20220105$20240718$EXP$$US-PFIZER INC-202101852704$PFIZER$$39$YR$$F$Y$$$20240718$$HP$US$US
203021485$20302148$5$F$20160101$20240702$20220106$20240709$EXP$$US-BIOGEN-2022BI01083205$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
2030246725$20302467$25$F$20210101$20240723$20220106$20240731$EXP$$CA-CELLTRION INC.-2021CA001851$CELLTRION$$$$$$Y$$$20240731$$MD$CA$CA
2030262436$20302624$36$F$20211222$20240910$20220106$20240918$EXP$$CA-CELLTRION INC.-2021CA017956$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
203028736$20302873$6$F$20211231$20240828$20220106$20240902$EXP$$CA-ROCHE-2996738$ROCHE$$$$A$M$Y$$$20240902$$CN$CA$CA
203043156$20304315$6$F$$20240827$20220106$20240829$EXP$$CA-ROCHE-2996575$ROCHE$$$$A$F$Y$$$20240829$$MD$CA$CA
203053757$20305375$7$F$$20240916$20220106$20240918$PER$$US-PFIZER INC-2021616726$PFIZER$$59$YR$$M$Y$145.13$KG$20240918$$CN$US$US
2030596311$20305963$11$F$20210323$20240903$20220106$20240905$EXP$$CA-TAKEDA-2021TUS000189$TAKEDA$$31$YR$$F$Y$$$20240905$$MD$CA$CA
203059922$20305992$2$F$$20240808$20220106$20240812$EXP$$US-KYOWAKIRIN-2021BKK021929$KYOWA$$$$$$Y$$$20240812$$CN$US$US
203068583$20306858$3$F$20240528$20240610$20220106$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-004403$ACADIA PHARMACEUTICALS$$93$YR$$M$Y$$$20240705$$CN$US$US
2030729713$20307297$13$F$20211001$20240918$20220107$20240921$EXP$$DE-ROCHE-2944568$ROCHE$$51$YR$A$F$Y$$$20240921$$CN$DE$DE
203075242$20307524$2$F$$20240910$20220107$20240919$EXP$$IT-AUROBINDO-AUR-APL-2022-000211$AUROBINDO$Gatti M, Cojutti PG, Pascale R, Tonetti T, Laici C, Federico P, et al.. Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections. Antibiotics-(Basel). 2021;10(11):1311$74$YR$$M$Y$$$20240919$$HP$IT$IT
2030772018$20307720$18$F$20210101$20240918$20220107$20240927$EXP$$CA-CELLTRION INC.-2021CA016289$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
2030824315$20308243$15$F$20220301$20240820$20220107$20240826$EXP$$IN-PFIZER INC-202101857241$PFIZER$$65$YR$$F$Y$$$20240826$$CN$IN$IN
2030861917$20308619$17$F$20200709$20240717$20220107$20240722$EXP$$CA-ROCHE-2646458$ROCHE$$44$YR$A$F$Y$$$20240722$$CN$CA$CA
2030866913$20308669$13$F$20211024$20240722$20220107$20240729$EXP$$US-TAKEDA-2021TUS078209$TAKEDA$$84$YR$$F$Y$48.98$KG$20240729$$HP$US$US
203092749$20309274$9$F$20171004$20240910$20220107$20240912$EXP$$US-TAKEDA-US201726215$TAKEDA$$68$YR$$F$Y$69$KG$20240912$$MD$US$US
203092882$20309288$2$F$20211029$20240719$20220107$20240722$EXP$$JP-TAKEDA-2022TJP002009$TAKEDA$$88$YR$$M$Y$$$20240722$$MD$JP$JP
203094464$20309446$4$F$$20220318$20220107$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR002602$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$HP$US$US
203099818$20309981$8$F$20161017$20240628$20220107$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-095970$BRISTOL MYERS SQUIBB$Nakamura K, Ashida A, Kiniwa Y, Okuyama R. Summary of adjuvant therapy for advanced malignant melanoma in our department. Skin Cancer. 2021;36(3):212-7.$38$YR$A$M$Y$$$20240704$$MD$JP$JP
203101827$20310182$7$F$20211024$20240726$20220107$20240801$EXP$$IN-INCYTE CORPORATION-2020IN004702$INCYTE$$$$$$Y$$$20240801$$CN$IN$IN
2031034010$20310340$10$F$$20240702$20220107$20240705$EXP$$CA-TAKEDA-2021TUS057562$TAKEDA$$$$$F$Y$$$20240705$$CN$CA$CA
203103832$20310383$2$F$$20240909$20220107$20240910$EXP$$US-PFIZER INC-202101368308$PFIZER$$66$YR$$F$Y$$$20240910$$CN$US$US
2031153122$20311531$22$F$20191203$20240827$20220108$20240905$EXP$$CA-CELLTRION INC.-2019CA024039$CELLTRION$$$$$$Y$$$20240905$$MD$CA$CA
2031300115$20313001$15$F$$20240805$20220109$20240808$EXP$$PL-AUROBINDO-AUR-APL-2022-000371$AUROBINDO$Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51$29$YR$$F$Y$$$20240808$$MD$PL$PL
203132662$20313266$2$F$20210101$20240624$20220109$20240703$PER$$US-SA-2021SA434254$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240703$$MD$US$US
2031359413$20313594$13$F$20220117$20240815$20220109$20240821$EXP$$US-SA-2022SA001290$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240821$$MD$US$US
203137402$20313740$2$F$20211221$20240702$20220109$20240711$PER$$US-SA-2021SA436455$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240711$$MD$US$US
203141313$20314131$3$F$$20240816$20220109$20240827$PER$$US-SA-2022SA002509$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
203142943$20314294$3$F$$20240830$20220109$20240930$PER$$US-SA-2022SA005712$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240930$$MD$US$US
203144709$20314470$9$F$20200424$20240816$20220109$20240824$EXP$$CA-CELLTRION INC.-2020CA021959$CELLTRION$$$$$$Y$$$20240824$$HP$CA$CA
203145806$20314580$6$F$20211020$20240731$20220109$20240806$EXP$$IL-ABBVIE-22K-082-4222878-00$ABBVIE$$75$YR$$F$Y$68$KG$20240806$$MD$IL$IL
203146992$20314699$2$F$20190101$20211228$20220110$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-221822$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
203152752$20315275$2$F$20211223$20220103$20220110$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR000355$GLAXOSMITHKLINE$$39$YR$$M$Y$$$20240925$$CN$US$US
203154443$20315444$3$F$20211112$20240726$20220110$20240807$PER$$US-SA-2022SA004441$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240807$$MD$US$US
203159472$20315947$2$F$$20240910$20220110$20240919$EXP$$IT-AUROBINDO-AUR-APL-2022-000062$AUROBINDO$Gatti M, Cojutti PG, Pascale R, Tonetti T, Laici C, Dell^olio A, et al.. Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections.. Antibiotics-(Basel). 2021;10(11):1311$74$YR$$M$Y$$$20240919$$HP$IT$IT
2031663414$20316634$14$F$20161019$20240717$20220110$20240726$EXP$$CA-CELLTRION INC.-2021CA013400$CELLTRION$$$$$$Y$$$20240726$$HP$CA$CA
203179356$20317935$6$F$20210525$20240902$20220110$20240905$EXP$FR-AFSSAPS-AN20214761$FR-MYLANLABS-2022M1001321$MYLAN$$49$YR$$F$Y$$$20240905$$MD$FR$FR
203182062$20318206$2$F$20211201$20220106$20220110$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR003420$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240925$$CN$US$US
203187567$20318756$7$F$20220201$20220729$20220110$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR003524$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
203189203$20318920$3$F$$20240706$20220110$20240711$PER$$US-AMGEN-USASP2021209100$AMGEN$$60$YR$A$F$Y$$$20240711$$MD$US$US
203192346$20319234$6$F$$20240718$20220110$20240722$EXP$$US-PFIZER INC-2020163224$PFIZER$$65$YR$$M$Y$$$20240722$$HP$US$US
2031954413$20319544$13$F$20211229$20240812$20220110$20240820$EXP$$CA-CELLTRION INC.-2021CA018211$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
203198833$20319883$3$F$20220105$20220106$20220111$20240701$PER$$US-SA-2022SA007184$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240701$$CN$US$US
203200739$20320073$9$F$20220305$20220510$20220111$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR003386$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$MD$US$US
203213816$20321381$6$F$$20240722$20220111$20240801$EXP$CA-MHPD-E2B-03567457$CA-Accord-249780$ACCORD$$57$YR$A$F$Y$$$20240801$$CN$CA$CA
203219193$20321919$3$F$20020101$20220119$20220111$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR004138$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240925$$CN$US$US
2032218211$20322182$11$F$20220101$20230419$20220111$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR004126$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2032228123$20322281$23$F$20210101$20240611$20220111$20240830$EXP$$PL-TEVA-2021-PL-1996559$TEVA$Falls in an elderly person with multimorbidity; Justyna G. Upadki u starszej osoby z wielochorobowo ci . Medycyna po Dyplomie 2021-11; : 98-105.; Justyna G. Falls in an elderly person with multiple diseases. Medycyna po Dyplomie 2021-11; : 98-105.; Justyna G. Falls in an elderly person with multiple diseases. Medycyna po Dyplomie 2021-11; : 98-105.; Justyna G. Upadki u starszej osoby z wielochorobowo ci . Medycyna po Dyplomie 2021-11; : 98-105.$83$YR$$F$Y$91$KG$20240830$$HP$PL$PL
203227465$20322746$5$F$20240826$20240826$20220111$20240828$PER$$NVSC2022US003128$NOVARTIS$$24$YR$$F$Y$$$20240828$$CN$US$US
203232212$20323221$2$F$20210701$20210721$20220111$20240723$PER$$US-NOVOPROD-846185$NOVO NORDISK$$54$YR$$F$Y$$$20240723$$CN$US$US
203240354$20324035$4$F$20210501$20240822$20220111$20240827$EXP$$US-PFIZER INC-202101359033$PFIZER$$87$YR$$M$Y$83.91$KG$20240827$$HP$US$US
203244865$20324486$5$F$20211001$20240731$20220111$20240813$EXP$$US-MYOVANT SCIENCES GMBH-2021MYSCI1000580$SUNOVION$$$$$$Y$$$20240813$$CN$US$US
2032517035$20325170$35$F$20211231$20240909$20220111$20240917$EXP$$CA-CELLTRION INC.-2021CA018239$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
2032552012$20325520$12$F$20220124$20220920$20220112$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR003401$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
203255635$20325563$5$F$$20220309$20220112$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR003414$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$HP$US$US
203257004$20325700$4$F$20210101$20240702$20220112$20240705$PER$$US-GILEAD-2022-0564063$GILEAD$$57$YR$A$M$Y$$$20240705$$LW$US$US
203258734$20325873$4$F$20170728$20240704$20220112$20240710$EXP$$PHHY2017CO127955$NOVARTIS$$60$YR$$M$Y$64$KG$20240710$$CN$CO$CO
203260974$20326097$4$F$20211101$20240716$20220112$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2022-000359$UNITED THERAPEUTICS$$63$YR$$F$Y$$$20240725$$$US$US
203266214$20326621$4$F$20210501$20220325$20220112$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR002674$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
2032688610$20326886$10$F$20211215$20240830$20220112$20240911$EXP$$JP-ASTELLAS-2021JP024598$ASTELLAS$Koga T, Negishi T, Furubayashi N, Haraguchi Y, Nakamura M, Uchi H. 3 cases of severe skin disorders related to enfortumab vedotin. West Japan Urology Department, The 312th Annual Meeting of the the Japanese Urol. 2024;86(Ex.1): 52.$72$YR$E$M$Y$64$KG$20240911$$MD$JP$JP
2032717812$20327178$12$F$20190218$20240802$20220112$20240807$EXP$$JP-ABBVIE-22P-087-4229352-00$ABBVIE$$62$YR$$M$Y$$$20240807$$MD$JP$JP
203272685$20327268$5$F$20211206$20240704$20220112$20240709$EXP$$BE-PFIZER INC-202101866441$PFIZER$$71$YR$$M$Y$$$20240709$$MD$BE$BE
203272737$20327273$7$F$$20240812$20220112$20240813$PER$$NVSC2021US272732$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
203276017$20327601$7$F$$20221101$20220112$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR004546$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
203276432$20327643$2$F$20171101$20240815$20220112$20240826$EXP$$US-ROCHE-2066970$ROCHE$$66$YR$E$F$Y$78.93$KG$20240826$$CN$US$US
2032848313$20328483$13$F$20230207$20240807$20220112$20240812$EXP$$US-PFIZER INC-202101797734$PFIZER$$78$YR$$F$Y$56.236$KG$20240812$$CN$US$US
203292486$20329248$6$F$$20240725$20220112$20240730$EXP$$US-PFIZER INC-202101381081$PFIZER$$45$YR$$F$Y$93.878$KG$20240730$$HP$US$US
203293223$20329322$3$F$20230101$20240912$20220112$20240916$PER$$US-PFIZER INC-202101391626$PFIZER$$77$YR$$F$Y$$$20240916$$CN$US$US
203299977$20329997$7$F$$20240725$20220113$20240729$EXP$$CA-ROCHE-2983845$ROCHE$$$$A$F$Y$$$20240729$$CN$CA$CA
2033020522$20330205$22$F$20211216$20240903$20220113$20240910$EXP$$CA-CELLTRION INC.-2021CA017807$CELLTRION$$$$$$Y$$$20240910$$MD$CA$CA
203307342$20330734$2$F$$20240731$20220113$20240809$EXP$$US-GLAXOSMITHKLINE-US2022AMR004709$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$HP$US$US
203307455$20330745$5$F$20211011$20240319$20220113$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-116964$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$57$KG$20240704$$MD$JP$JP
203308667$20330866$7$F$20081020$20240718$20220113$20240723$EXP$$US-JNJFOC-20220114962$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240723$$LW$US$US
203309847$20330984$7$F$20201101$20240731$20220113$20240805$EXP$$US-SA-2022SA008099$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240805$$MD$US$US
203318863$20331886$3$F$20210701$20240829$20220113$20240904$EXP$$IN-PFIZER INC-2020375845$PFIZER$$69$YR$$F$Y$$$20240904$$CN$IN$IN
203318962$20331896$2$F$20211129$20240711$20220113$20240715$EXP$FR-AFSSAPS-BX202111389$FR-PFIZER INC-202200006623$PFIZER$$41$YR$$F$Y$$$20240715$$PH$FR$FR
2033190011$20331900$11$F$$20240730$20220113$20240801$EXP$$CA-PFIZER INC-202200015056$MYLAN$$27$YR$$F$Y$58.96$KG$20240801$$CN$CA$CA
2033194417$20331944$17$F$20210722$20240704$20220113$20240708$EXP$$CA-PFIZER INC-2021709649$PFIZER$$60$YR$$F$Y$69$KG$20240708$$HP$CA$CA
203321173$20332117$3$F$20210525$20240905$20220113$20240909$EXP$$FR-TAKEDA-2022TEU000220$TAKEDA$$49$YR$$F$Y$$$20240909$$HP$FR$FR
203323754$20332375$4$F$20200101$20240716$20220113$20240723$EXP$$CA-JNJFOC-20200948767$JOHNSON AND JOHNSON$$31$YR$A$F$Y$56.5$KG$20240722$$HP$CA$CA
2033344829$20333448$29$F$20211101$20240919$20220113$20240923$EXP$$US-PFIZER INC-202101882172$PFIZER$$74$YR$$F$Y$$$20240923$$CN$US$US
203334905$20333490$5$F$20220101$20240925$20220113$20240927$EXP$$US-PFIZER INC-202200021879$PFIZER$$78$YR$$F$Y$$$20240927$$CN$US$US
203336122$20333612$2$F$20220111$20240715$20220113$20240717$PER$$US-TAKEDA-2022TUS001970$TAKEDA$$74$YR$$M$Y$$$20240717$$MD$US$US
203338596$20333859$6$F$20210101$20240924$20220113$20240927$EXP$$US-PFIZER INC-2019135316$PFIZER$$71$YR$$F$Y$95.238$KG$20240927$$MD$US$US
203339148$20333914$8$F$20190805$20240906$20220113$20240919$EXP$$DE-TEVA-2022-DE-1997869$TEVA$$$$A$F$Y$115$KG$20240916$$HP$DE$DE
2033392514$20333925$14$F$20220114$20240828$20220113$20240830$PER$$US-DSJP-DSU-2022-101017$DAIICHI$$54$YR$$F$Y$$$20240830$$CN$US$US
203344813$20334481$3$F$$20240823$20220114$20240828$EXP$$CA-ROCHE-2838700$ROCHE$$55$YR$A$F$Y$$$20240828$$HP$CA$CA
203348708$20334870$8$F$20220101$20240705$20220114$20240710$EXP$$JP-ASTELLAS-2022JP000108$ASTELLAS$$87$YR$$M$Y$40.4$KG$20240710$$CN$JP$JP
2033490315$20334903$15$F$20211230$20240628$20220114$20240705$EXP$$CO-TAKEDA-2022TUS001731$TAKEDA$$36$YR$$F$Y$60$KG$20240705$$MD$CO$CO
2033498115$20334981$15$F$20210901$20240820$20220114$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323232$RANBAXY$$73$YR$$M$Y$129$KG$20240904$$HP$US$US
2033555240$20335552$40$F$20220111$20240629$20220114$20240705$EXP$$CO-TAKEDA-2021TUS035013$TAKEDA$$44$YR$$F$Y$62$KG$20240705$$CN$CO$CO
203361887$20336188$7$F$20210101$20240821$20220114$20240826$EXP$$US-PFIZER INC-202101843905$PFIZER$$60$YR$$F$Y$$$20240826$$HP$US$US
2033632519$20336325$19$F$20220203$20240828$20220114$20240903$EXP$$CA-OTSUKA-2021_015584$OTSUKA$$73$YR$$M$Y$$$20240903$$MD$CA$CA
203371736$20337173$6$F$$20240828$20220114$20240916$EXP$$US-SA-2021SA360239$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240916$$MD$US$US
203372573$20337257$3$F$$20240625$20220114$20240704$PER$$US-SA-2022SA008373$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$MD$US$US
203376043$20337604$3$F$20240101$20240904$20220114$20240928$PER$$US-SA-2022SA007703$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240928$$MD$US$US
2033763630$20337636$30$F$20220101$20240724$20220114$20240801$EXP$$CA-CELLTRION INC.-2022CA000316$CELLTRION$$$$$$Y$$$20240801$$CN$CA$CA
203376614$20337661$4$F$20211124$20240828$20220114$20240923$PER$$US-SA-2022SA007860$SANOFI AVENTIS$$57$YR$A$F$Y$73.48$KG$20240923$$MD$US$US
203376642$20337664$2$F$20220106$20240915$20220114$20240923$PER$$US-SA-2022SA007910$SANOFI AVENTIS$$10$YR$C$M$Y$30.2$KG$20240923$$MD$US$US
2033803414$20338034$14$F$20210101$20240702$20220115$20240712$PER$$US-JNJFOC-20220109809$JOHNSON AND JOHNSON$$77$YR$E$M$Y$86.26$KG$20240712$$CN$US$US
2033804512$20338045$12$F$20200806$20240919$20220115$20240928$EXP$$CA-CELLTRION INC.-2020CA023067$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
203380643$20338064$3$F$20211206$20240730$20220115$20240809$EXP$$JP-UNITED THERAPEUTICS-UNT-2022-000842$UNITED THERAPEUTICS$$6$YR$$M$Y$17.2$KG$20240809$$MD$JP$JP
203380668$20338066$8$F$20211201$20240725$20220115$20240802$EXP$$AU-ROCHE-2999462$ROCHE$$45$YR$A$F$Y$$$20240802$$MD$AU$AU
203386783$20338678$3$F$20211230$20240613$20220116$20240702$EXP$$CA-ROCHE-2994885$ROCHE$$45$YR$A$F$Y$$$20240702$$CN$CA$CA
2033884522$20338845$22$F$20211231$20240807$20220116$20240815$EXP$$CA-CELLTRION INC.-2021CA018460$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
203395142$20339514$2$F$20200819$20240813$20220117$20240821$PER$$DE-AMGEN-DEUNI2022003719$AMGEN$$81$YR$E$F$Y$$$20240820$$MD$DE$DE
2033968315$20339683$15$F$20200820$20240807$20220117$20240809$EXP$$DE-ROCHE-2745683$ROCHE$$44$YR$A$F$Y$$$20240809$$CN$DE$DE
203397242$20339724$2$F$$20220108$20220117$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323589$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
203402942$20340294$2$F$$20240909$20220117$20240918$30DAY$$US-GLAXOSMITHKLINE-US2022005663$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
203402973$20340297$3$F$$20220224$20220117$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR006460$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
203404002$20340400$2$F$$20220112$20220117$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR006553$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
203406227$20340622$7$F$$20240827$20220117$20240830$EXP$$CA-TAKEDA-2022TUS002190$TAKEDA$$$$$M$Y$$$20240830$$MD$CA$CA
203408833$20340883$3$F$$20240911$20220117$20240913$EXP$$US-PFIZER INC-202101770574$PFIZER$$76$YR$$F$Y$$$20240913$$CN$US$US
203409632$20340963$2$F$$20240701$20220117$20240710$PER$$US-SA-2022SA007614$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240710$$CN$US$US
2034141618$20341416$18$F$20230418$20240809$20220117$20240815$EXP$$US-TAKEDA-2022TUS002253$TAKEDA$$55$YR$$F$Y$72$KG$20240815$$HP$US$US
2034142810$20341428$10$F$20220825$20240724$20220117$20240731$EXP$$CA-TAKEDA-2021TUS050596$TAKEDA$$78$YR$$F$Y$$$20240731$$CN$CA$CA
203415925$20341592$5$F$20211206$20240815$20220117$20240823$EXP$$DE-TAKEDA-2021TUS078363$TAKEDA$$63$YR$$F$Y$$$20240823$$HP$DE$DE
203426536$20342653$6$F$20211001$20240730$20220117$20240801$EXP$$US-TAKEDA-2021TUS078147$TAKEDA$$75$YR$$F$Y$76$KG$20240801$$HP$US$US
203430703$20343070$3$F$20200710$20240722$20220117$20240729$EXP$$BR-TAKEDA-BR202022934$TAKEDA$$35$YR$$M$Y$93$KG$20240729$$MD$BR$BR
2034334222$20343342$22$F$20171101$20240916$20220117$20240924$EXP$$CA-CELLTRION INC.-2017CA016153$CELLTRION$$$$$$Y$$$20240924$$MD$CA$CA
203434578$20343457$8$F$20210301$20240917$20220118$20240925$EXP$$CA-JNJFOC-20210342640$JOHNSON AND JOHNSON$$52$YR$A$M$Y$121.5$KG$20240926$$HP$CA$CA
2034407810$20344078$10$F$20180901$20240819$20220118$20240824$EXP$$JP-ABBVIE-20P-087-3346443-00$ABBVIE$$71$YR$$M$Y$73$KG$20240824$$MD$JP$JP
2034415614$20344156$14$F$20211206$20240920$20220118$20240930$EXP$$CA-CELLTRION INC.-2021CA005070$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
203443423$20344342$3$F$20200825$20240822$20220118$20240829$EXP$$CN-GLAXOSMITHKLINE-CN2021APC159507$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$CN$CN
203443515$20344351$5$F$20190819$20240716$20220118$20240723$EXP$$JP-GLAXOSMITHKLINE-JP2022JPN007538$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$JP$JP
203444666$20344466$6$F$20211201$20221222$20220118$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR008008$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240925$$CN$US$US
203450204$20345020$4$F$$20240911$20220118$20240926$EXP$$CA-AMGEN-CANSP2022007873$AMGEN$$56$YR$A$F$Y$$$20240925$$HP$CA$CA
203450416$20345041$6$F$20180101$20240906$20220118$20240911$EXP$$PL-MYLANLABS-2019M1132242$MYLAN$Gozdzik M, Grzejszczak P, Kurnatowska I. Zastosowanie linagliptyny u chorych na cukrzyce potransplantacyjna. Ocena bezpieczenstwa i skutecznosci leczenia na podstawie opisu serii przypadkow klinicznych. FORUM NEFROLOGICZNE. 2019;12(1):33-40$62$YR$$M$Y$$$20240911$$HP$PL$PL
203451794$20345179$4$F$20240329$20240702$20220118$20240711$PER$$US-SA-2022SA013110$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240711$$MD$US$US
2034541610$20345416$10$F$20211231$20240906$20220118$20240912$EXP$$CA-ROCHE-2996745$ROCHE$$36$YR$A$F$Y$$$20240912$$CN$CA$CA
2034541910$20345419$10$F$20220108$20240731$20220118$20240801$EXP$$CA-ROCHE-3000379$ROCHE$$62$YR$A$F$Y$$$20240801$$CN$CA$CA
2034542114$20345421$14$F$20200821$20240903$20220118$20240905$EXP$$CA-ROCHE-3001731$ROCHE$$33$YR$A$F$Y$$$20240905$$CN$CA$CA
203459046$20345904$6$F$20220815$20240726$20220118$20240729$EXP$$US-TAKEDA-2022TUS002723$TAKEDA$$55$YR$$F$Y$93$KG$20240729$$MD$US$US
203460822$20346082$2$F$20211216$20240714$20220118$20240718$EXP$$GB-MYLANLABS-2022M1003208$MYLAN$$44$YR$$F$Y$$$20240718$$HP$GB$GB
203462632$20346263$2$F$$20240718$20220118$20240727$PER$$US-SA-2022SA010046$SANOFI AVENTIS$$$$E$F$Y$$$20240727$$MD$US$US
203464513$20346451$3$F$20210221$20240626$20220118$20240705$EXP$FR-AFSSAPS-TO20220054$FR-TEVA-2022-FR-1999500$TEVA$$76$YR$$F$Y$80$KG$20240705$$CN$FR$FR
203467224$20346722$4$F$20220110$20240730$20220118$20240801$EXP$$CA-ROCHE-3000527$ROCHE$$43$YR$A$F$Y$$$20240801$$CN$CA$CA
203472894$20347289$4$F$$20240702$20220118$20240709$EXP$$CA-OTSUKA-2021_020799$OTSUKA$$$$$F$Y$$$20240709$$HP$CA$CA
203475362$20347536$2$F$20220103$20220110$20220118$20240819$EXP$$CA-JAZZ-2022-CA-000072$JAZZ$$74$YR$$M$Y$$$20240819$$HP$CA$CA
203477695$20347769$5$F$20211201$20240903$20220118$20240905$EXP$$US-PFIZER INC-202101418300$PFIZER$$63$YR$$F$Y$$$20240905$$HP$US$US
203478562$20347856$2$F$20220104$20240729$20220118$20240730$EXP$$US-ROCHE-2999679$ROCHE$$48$YR$A$F$Y$$$20240730$$CN$US$US
203482483$20348248$3$F$20220108$20240927$20220119$20240930$EXP$$CA-ROCHE-3001426$ROCHE$$35$YR$A$M$Y$$$20240930$$CN$CA$CA
203482714$20348271$4$F$20200519$20220502$20220119$20240701$PER$$NVSC2022US004375$NOVARTIS$$31$YR$$F$Y$$$20240701$$CN$US$US
203484994$20348499$4$F$20211007$20240829$20220119$20240907$EXP$$BG-CELLTRION INC.-2022BG000297$CELLTRION$$$$$$Y$$$20240907$$MD$BG$BG
203488393$20348839$3$F$$20221005$20220119$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR008040$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
203488759$20348875$9$F$20191018$20240919$20220119$20240925$EXP$$AT-ABBVIE-20K-009-3279316-00$ABBVIE$$78$YR$$M$Y$77$KG$20240925$$MD$AT$AT
203490814$20349081$4$F$$20220223$20220119$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR004717$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
203492204$20349220$4$F$20220107$20220303$20220119$20240715$EXP$$ES-ASTELLAS-2022US001801$ASTELLAS$$$$$F$Y$$$20240715$$MD$ES$ES
203492512$20349251$2$F$20220106$20220111$20220119$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR005417$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240925$$CN$US$US
2034944816$20349448$16$F$20220218$20230921$20220119$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR004586$GLAXOSMITHKLINE$$76$YR$$F$Y$72$KG$20240926$$MD$US$US
203497492$20349749$2$F$$20240604$20220119$20240703$PER$$US-GW PHARMA-202201USGW00150$JAZZ$$$$$F$Y$$$20240703$$CN$US$US
203499552$20349955$2$F$$20220114$20220119$20240712$EXP$$BG-ASTELLAS-2022US001730$ASTELLAS$$79$YR$$M$Y$$$20240712$$MD$BG$BG
203500856$20350085$6$F$20210927$20240906$20220119$20240916$EXP$$DE-ROCHE-3003259$ROCHE$$37$YR$A$F$Y$72$KG$20240916$$MD$DE$DE
203501239$20350123$9$F$$20240310$20220119$20240807$EXP$$NVSC2022KW008171$NOVARTIS$$44$YR$$F$Y$$$20240807$$CN$KW$KW
203505095$20350509$5$F$20211230$20220406$20220119$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR007951$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
203505512$20350551$2$F$$20240718$20220119$20240727$PER$$US-SA-2022SA013755$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240727$$MD$US$US
203506742$20350674$2$F$$20240906$20220119$20240914$PER$$US-SA-2022SA015615$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$MD$US$US
203506985$20350698$5$F$$20240807$20220119$20240812$EXP$$US-PFIZER INC-202101741397$PFIZER$$68$YR$$F$Y$$$20240812$$CN$US$US
2035090410$20350904$10$F$20211001$20221214$20220119$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR008134$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
203512258$20351225$8$F$20191004$20240729$20220119$20240805$EXP$$CA-TAKEDA-CA202025974$TAKEDA$$50$YR$$M$Y$$$20240805$$MD$CA$CA
2035127522$20351275$22$F$20210101$20240715$20220119$20240718$EXP$$CA-TAKEDA-2021TUS066513$TAKEDA$$$$$M$Y$32$KG$20240718$$HP$CA$CA
2035152915$20351529$15$F$20201201$20240710$20220119$20240715$EXP$$IN-PFIZER INC-2021112981$PFIZER$$52$YR$$M$Y$98$KG$20240715$$CN$IN$IN
203517847$20351784$7$F$20231201$20240905$20220119$20240909$EXP$$US-PFIZER INC-202200050504$PFIZER$$73$YR$$F$Y$$$20240909$$CN$US$US
203536334$20353633$4$F$20220916$20230302$20220120$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR006612$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$HP$US$US
2035388928$20353889$28$F$20211001$20240815$20220120$20240823$EXP$$CA-CELLTRION INC.-2021CA017696$CELLTRION$$$$$$Y$$$20240823$$CN$CA$CA
203540167$20354016$7$F$20161213$20240716$20220120$20240726$EXP$$CA-ROCHE-2903060$ROCHE$$52$YR$A$F$Y$$$20240726$$CN$CA$CA
2035409820$20354098$20$F$20220101$20240729$20220120$20240805$EXP$$CA-CELLTRION INC.-2021CA016832$CELLTRION$$$$$$Y$$$20240805$$MD$CA$CA
203543072$20354307$2$F$20210101$20220113$20220120$20240711$EXP$$DE-ASTELLAS-2022US002038$ASTELLAS$$78$YR$$M$Y$$$20240711$$MD$DE$DE
203543154$20354315$4$F$$20240708$20220120$20240715$EXP$$CA-APOTEX-2021AP043534$APOTEX$$26$YR$$F$Y$47$KG$20240715$$HP$CA$CA
2035453714$20354537$14$F$20220207$20240826$20220120$20240905$EXP$$US-GLAXOSMITHKLINE-US2022AMR010124$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240905$$CN$US$US
203546517$20354651$7$F$20220101$20240806$20220120$20240810$EXP$$NVSC2021CA214951$NOVARTIS$$67$YR$$F$Y$$$20240810$$CN$CA$CA
203546687$20354668$7$F$20220114$20240913$20220120$20240916$EXP$$NVSC2022US009268$NOVARTIS$$71$YR$$M$Y$$$20240916$$CN$US$US
2035514415$20355144$15$F$20171208$20240917$20220120$20240927$EXP$FR-AFSSAPS-MA20180171$FR-GLAXOSMITHKLINE-FR2018010815$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$FR$FR
2035582213$20355822$13$F$20210101$20240919$20220120$20240926$EXP$$NVSC2021BR056872$NOVARTIS$$$$$F$Y$$$20240926$$CN$BR$BR
2035590926$20355909$26$F$20221105$20240801$20220120$20240807$EXP$$US-TAKEDA-2021TUS067832$TAKEDA$$69$YR$$F$Y$51$KG$20240807$$HP$US$US
203563053$20356305$3$F$20210125$20240729$20220120$20240801$EXP$$NVSC2021EG170096$NOVARTIS$$19$YR$$F$Y$$$20240801$$CN$EG$EG
2035631210$20356312$10$F$20211001$20240909$20220120$20240911$PER$$US-BIOGEN-2021BI01059624$BIOGEN$$41$YR$$M$Y$$$20240911$$CN$US$US
203563292$20356329$2$F$20220118$20240826$20220120$20240904$30DAY$$US-GLAXOSMITHKLINE-US2022009318$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240904$$CN$US$US
2035659020$20356590$20$F$$20240916$20220120$20240923$EXP$$CA-GLAXOSMITHKLINE-CA2022AMR006999$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$CA$CA
203569598$20356959$8$F$20210101$20240711$20220120$20240717$EXP$$NVSC2022US009182$NOVARTIS$$68$YR$$M$Y$108.8$KG$20240717$$HP$US$US
2035704411$20357044$11$F$$20240822$20220120$20240829$EXP$$CA-ROCHE-2733063$ROCHE$$$$A$F$Y$$$20240829$$CN$CA$CA
2035708011$20357080$11$F$20211130$20240911$20220120$20240918$EXP$$CO-TAKEDA-2022TUS003950$TAKEDA$$15$YR$$F$Y$60$KG$20240918$$CN$CO$CO
2035729414$20357294$14$F$20200113$20240916$20220120$20240917$EXP$$DE-ROCHE-2622320$ROCHE$$19$YR$A$F$Y$$$20240917$$CN$DE$DE
203573157$20357315$7$F$20211201$20240823$20220120$20240828$EXP$$US-PFIZER INC-202101288283$PFIZER$$67$YR$$M$Y$78.02$KG$20240828$$HP$US$US
203575743$20357574$3$F$20180101$20240906$20220120$20240918$EXP$$PL-EMD Serono-E2B_90086380$EMD SERONO INC$Gozdzik M, Grzejszczak P, Kurnatowska I. Treatment with linagliptin in patients with post-transplant diabetes mellitus. Assessment of treatment safety and effectiveness - a series of clinical cases. Forum Nefrologiczne. 2019;12(1): 33-40.$62$YR$A$M$Y$$$20240918$$MD$PL$PL
203577575$20357757$5$F$$20240823$20220120$20240902$EXP$$CA-ROCHE-3003963$ROCHE$$52$YR$A$F$Y$$$20240902$$CN$CA$CA
203578075$20357807$5$F$$20240708$20220120$20240726$EXP$$CA-FERRINGPH-2022FE00100$FERRING$Farrell B, Merkley V, Thompson W.. Managing polypharmacy in a 77-year-old woman with multiple prescribers. CMAJ. 2013;185:1240-1245$$$$$Y$$$20240726$$HP$CA$CA
203578183$20357818$3$F$20210821$20211220$20220120$20240717$PER$$US-NOVOPROD-847568$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
203580582$20358058$2$F$20200201$20211006$20220120$20240717$PER$$US-NOVOPROD-858953$NOVO NORDISK$$83$YR$$F$Y$$$20240717$$CN$US$US
203583329$20358332$9$F$20191219$20240917$20220120$20240919$EXP$$US-PFIZER INC-2020013145$PFIZER$$63$YR$$F$Y$69.841$KG$20240919$$CN$US$US
203585792$20358579$2$F$20210101$20210615$20220120$20240717$PER$$US-NOVOPROD-822652$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
203587802$20358780$2$F$20210629$20211008$20220120$20240717$PER$$US-NOVOPROD-835229$NOVO NORDISK$$41$YR$$F$Y$$$20240717$$MD$US$US
203589364$20358936$4$F$20211216$20240813$20220120$20240820$EXP$$US-SA-2022SA016246$SANOFI AVENTIS$$15$YR$T$M$Y$104.31$KG$20240820$$MD$US$US
203592475$20359247$5$F$20210101$20240802$20220121$20240808$EXP$$US-ABBVIE-22K-163-4243587-00$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
2035933110$20359331$10$F$20231229$20240607$20220121$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-004511$ACADIA PHARMACEUTICALS$$84$YR$$F$Y$42$KG$20240701$$CN$US$US
203594712$20359471$2$F$$20240708$20220121$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-004524$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
203595542$20359554$2$F$20211229$20220114$20220121$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR007983$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
203602595$20360259$5$F$20211123$20220726$20220121$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR011099$GLAXOSMITHKLINE$$81$YR$$F$Y$$$20240925$$CN$US$US
2036038419$20360384$19$F$20210401$20240828$20220121$20240906$EXP$$CA-CELLTRION INC.-2021CA004423$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
203606025$20360602$5$F$20220901$20240925$20220121$20240930$EXP$$US-AMGEN-USASP2022009065$AMGEN$$34$YR$A$F$Y$$$20240930$$HP$US$US
203606443$20360644$3$F$$20240726$20220121$20240807$PER$$US-SA-2022SA016478$SANOFI AVENTIS$$64$YR$E$F$Y$70.3$KG$20240807$$MD$US$US
203609932$20360993$2$F$20220101$20220119$20220121$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR011121$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
203620807$20362080$7$F$20180821$20240802$20220121$20240806$EXP$$US-TAKEDA-US201832436$TAKEDA$$60$YR$$F$Y$53$KG$20240806$$HP$US$US
203620885$20362088$5$F$20211214$20240829$20220121$20240830$EXP$$US-TAKEDA-2021TUS079570$TAKEDA$$19$YR$$M$Y$$$20240830$$CN$US$US
203621274$20362127$4$F$$20240702$20220121$20240708$PER$$US-BIOGEN-2020BI00871695$BIOGEN$$$$$F$Y$$$20240708$$CN$US$US
203623825$20362382$5$F$$20240807$20220121$20240813$EXP$$US-PFIZER INC-202101449222$PFIZER$$78$YR$$F$Y$$$20240813$$HP$US$US
203627003$20362700$3$F$$20240819$20220121$20240822$EXP$$NL-PFIZER INC-2021030590$PFIZER$Fransen, M.. Cutaneous Vasculitis Caused by Clindamycin. Dermatitis : contact, atopic, occupational, drug. Publish Ahead of Print. 2020;10.1097/DER.0000000000000665$24$YR$$M$Y$$$20240822$$MD$NL$NL
203629617$20362961$7$F$20221208$20240911$20220121$20240916$PER$$US-PFIZER INC-202101467554$PFIZER$$56$YR$$F$Y$$$20240916$$CN$US$US
203630197$20363019$7$F$20210101$20240810$20220121$20240814$EXP$$CA-BAUSCH-BL-2021-023980$BAUSCH AND LOMB$$57$YR$$F$Y$70.37$KG$20240815$$CN$CA$CA
203639705$20363970$5$F$$20240808$20220121$20240809$EXP$$GB-TAKEDA-2022TUS003458$TAKEDA$$$$$M$Y$$$20240809$$MD$GB$GB
2036455622$20364556$22$F$20210601$20240918$20220122$20240927$EXP$$CA-CELLTRION INC.-2021CA010541$CELLTRION$$$$$$Y$$$20240927$$PH$CA$CA
203648266$20364826$6$F$20211110$20240808$20220122$20240816$PER$$US-SA-2022SA018534$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240816$$MD$US$US
203648367$20364836$7$F$20190412$20240712$20220122$20240723$EXP$$CA-ROCHE-3000981$ROCHE$$43$YR$A$F$Y$128.7$KG$20240723$$CN$CA$CA
2036489011$20364890$11$F$20220113$20240911$20220122$20240919$EXP$$CA-CELLTRION INC.-2022CA000651$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
203648936$20364893$6$F$20231012$20240724$20220122$20240730$EXP$$GB-TAKEDA-2021TUS006184$TAKEDA$$59$YR$$M$Y$$$20240730$$PH$GB$GB
203651834$20365183$4$F$20220101$20240805$20220122$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2022-001138$UNITED THERAPEUTICS$$55$YR$$M$Y$74.966$KG$20240814$$$US$US
2036536718$20365367$18$F$20210629$20240826$20220122$20240902$EXP$$IT-TAKEDA-2021TUS042426$TAKEDA$$23$YR$$M$Y$$$20240902$$CN$IT$IT
2036546311$20365463$11$F$20230306$20240627$20220122$20240701$EXP$$AU-TAKEDA-2022TUS003169$TAKEDA$$27$YR$$F$Y$$$20240701$$HP$AU$AU
203655433$20365543$3$F$20240601$20240705$20220122$20240716$PER$$US-SA-2022SA016636$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
203672106$20367210$6$F$20220101$20220405$20220123$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR011092$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240926$$CN$US$US
203676452$20367645$2$F$$20240705$20220124$20240715$PER$$US-SA-2022SA018472$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240715$$MD$US$US
203682602$20368260$2$F$20180502$20220119$20220124$20240715$EXP$$TR-ASTELLAS-2022US002336$ASTELLAS$$74$YR$$M$Y$$$20240715$$MD$TR$TR
203684162$20368416$2$F$20140510$20240711$20220124$20240716$EXP$$US-TAKEDA-US-001029$TAKEDA$$41$YR$$M$Y$77$KG$20240716$$MD$US$US
203686142$20368614$2$F$$20240701$20220124$20240710$PER$$US-SA-2022SA019653$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240710$$MD$US$US
203687006$20368700$6$F$$20240916$20220124$20240920$EXP$$CA-BAUSCH-BL-2022-001541$BAUSCH AND LOMB$$53$YR$$F$Y$99$KG$20240920$$HP$CA$CA
203694893$20369489$3$F$20211025$20220217$20220124$20240712$PER$$JP-PFM-2021-12228$PIERRE FABRE MEDICAMENT$$4$MON$$F$Y$$$20240712$$MD$JP$JP
203695608$20369560$8$F$20171215$20240812$20220124$20240815$EXP$$CA-TAKEDA-2017TUS026295$TAKEDA$$72$YR$$F$Y$$$20240815$$CN$CA$CA
203697077$20369707$7$F$20210101$20240924$20220124$20240926$PER$$US-PFIZER INC-202101332556$PFIZER$$79$YR$$F$Y$$$20240926$$HP$US$US
203702686$20370268$6$F$$20240808$20220124$20240814$EXP$$CA-TAKEDA-2022TUS003765$TAKEDA$$$$$F$Y$$$20240814$$MD$CA$CA
203704923$20370492$3$F$$20220223$20220124$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR011071$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
203706612$20370661$2$F$20220116$20220120$20220124$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR011999$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
2037123913$20371239$13$F$20220523$20240805$20220124$20240809$EXP$$US-SHIRE-US202020458$TAKEDA$$66$YR$$M$Y$80$KG$20240809$$CN$US$US
203712624$20371262$4$F$$20230823$20220124$20240926$EXP$$NVSC2022CO013163$NOVARTIS$$$$$F$Y$$$20240926$$CN$CO$CO
203714249$20371424$9$F$20220114$20240806$20220124$20240812$EXP$$CA-TAKEDA-2022TUS003606$TAKEDA$$44$YR$$F$Y$$$20240812$$MD$CA$CA
203717333$20371733$3$F$20170915$20240823$20220124$20240830$EXP$$CA-TAKEDA-2017TUS021068$TAKEDA$$19$YR$$F$Y$$$20240830$$CN$CA$CA
2037187915$20371879$15$F$$20240729$20220124$20240731$EXP$$US-PFIZER INC-2021523962$PFIZER$$68$YR$$F$Y$80.726$KG$20240731$$CN$US$US
203723092$20372309$2$F$$20240903$20220124$20240907$PER$$US-AMGEN-USASP2022011085$AMGEN$$$$A$F$Y$$$20240907$$HP$US$US
203725323$20372532$3$F$20181101$20240903$20220125$20240912$EXP$$CA-ROCHE-2266538$ROCHE$$50$YR$A$F$Y$$$20240912$$CN$CA$CA
2037273511$20372735$11$F$20220101$20230105$20220125$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR012075$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
203728033$20372803$3$F$$20240925$20220125$20240927$EXP$$NVSC2022US009356$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
203728153$20372815$3$F$$20240819$20220125$20240823$EXP$$CA-BAUSCH-BL-2022-001494$BAUSCH AND LOMB$$57$YR$$F$Y$87$KG$20240823$$HP$CA$CA
203730935$20373093$5$F$20220119$20240219$20220125$20240905$PER$$NVSC2022US015518$NOVARTIS$$50$YR$$M$Y$$$20240905$$CN$US$US
203734513$20373451$3$F$20210111$20230525$20220125$20240712$EXP$$BG-ASTELLAS-2022US002033$ASTELLAS$$75$YR$$M$Y$$$20240712$$CN$BG$BG
203739354$20373935$4$F$20230925$20240624$20220125$20240703$EXP$$CO-TAKEDA-2022TUS004506$TAKEDA$$26$YR$$F$Y$53$KG$20240703$$CN$CO$CO
203740727$20374072$7$F$20220204$20240816$20220125$20240823$EXP$$CA-TAKEDA-2021TUS051418$TAKEDA$$55$YR$$M$Y$$$20240823$$HP$CA$CA
2037430414$20374304$14$F$20210811$20240911$20220125$20240919$EXP$$CA-TAKEDA-2021TUS052651$TAKEDA$$60$YR$$M$Y$$$20240919$$CN$CA$CA
203744403$20374440$3$F$$20240902$20220125$20240905$EXP$$US-PFIZER INC-202200087127$PFIZER$Sataloff, R.. Bilateral Sensorineural Hearing Loss in the Setting of Acute Methamphetamine Overdose. Ear, Nose and Throat Journal. 2021;10.1177/01455613211069353$28$YR$$M$Y$$$20240905$$MD$US$US
2037488411$20374884$11$F$20230601$20240627$20220125$20240708$PER$$US-SA-2022SA018409$SANOFI AVENTIS$$37$YR$A$F$Y$65.771$KG$20240708$$MD$US$US
203750383$20375038$3$F$$20240829$20220125$20240903$EXP$$US-TAKEDA-2021TUS009962$TAKEDA$$$$$F$Y$$$20240903$$HP$US$US
203752134$20375213$4$F$20240101$20240719$20220125$20240730$PER$$US-SA-2022SA020209$SANOFI AVENTIS$$58$YR$A$M$Y$81$KG$20240730$$MD$US$US
203753709$20375370$9$F$20230424$20240911$20220125$20240918$EXP$$CA-TAKEDA-2022TUS003795$TAKEDA$$53$YR$$F$Y$$$20240918$$MD$CA$CA
203755773$20375577$3$F$$20211202$20220125$20240925$EXP$$NVSC2021TH276092$NOVARTIS$$16$YR$$F$Y$$$20240925$$MD$TH$TH
203763503$20376350$3$F$20210903$20240702$20220125$20240708$EXP$$GB-JNJFOC-20211001943$JOHNSON AND JOHNSON$$32$YR$A$F$Y$114$KG$20240708$$MD$GB$GB
2037657217$20376572$17$F$20220101$20240815$20220125$20240827$PER$$US-SA-2022SA013833$SANOFI AVENTIS$$12$YR$T$M$Y$55.782$KG$20240827$$MD$US$US
2037724710$20377247$10$F$20220113$20240722$20220126$20240726$EXP$$CA-ROCHE-2998572$ROCHE$$29$YR$A$M$Y$$$20240726$$CN$CA$CA
2037744412$20377444$12$F$20220101$20240108$20220126$20240820$EXP$$CA-CELLTRION INC.-2021CA018244$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
203774566$20377456$6$F$20220121$20240828$20220126$20240830$PER$$NVSC2022US015499$NOVARTIS$$13$YR$$M$Y$$$20240830$$HP$US$US
203776732$20377673$2$F$$20240827$20220126$20240915$EXP$$US-SA-2022SA023115$SANOFI AVENTIS$$$$A$F$Y$$$20240915$$MD$US$US
2037773811$20377738$11$F$20220101$20230302$20220126$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR011996$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240926$$CN$US$US
203781562$20378156$2$F$20200201$20240909$20220126$20240913$EXP$$TR-ASTELLAS-2022US002543$ASTELLAS$$70$YR$E$M$Y$$$20240913$$MD$TR$TR
203782405$20378240$5$F$20230101$20240829$20220126$20240905$EXP$$US-JAZZ-2021-US-024731$JAZZ$$$$$F$Y$$$20240905$$CN$US$US
203788323$20378832$3$F$20220103$20240820$20220126$20240823$EXP$$US-PFIZER INC-202200073479$PFIZER$$40$YR$$F$Y$$$20240823$$HP$US$US
203797696$20379769$6$F$$20240903$20220126$20240905$EXP$$US-INCYTE CORPORATION-2022IN000734$INCYTE$$$$$$Y$$$20240905$$CN$US$US
203806962$20380696$2$F$20220101$20220124$20220127$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR014110$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240925$$CN$US$US
203806973$20380697$3$F$20211201$20220204$20220127$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR014527$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240925$$CN$US$US
203807634$20380763$4$F$$20240724$20220127$20240805$EXP$$CA-AUROBINDO-AUR-APL-2022-002203$AUROBINDO$$69$YR$$M$Y$92$KG$20240805$$HP$CA$CA
2038109813$20381098$13$F$20200330$20240726$20220127$20240802$EXP$$CA-CELLTRION INC.-2019CA028566$CELLTRION$$$$$$Y$$$20240803$$MD$CA$CA
203811524$20381152$4$F$20201105$20240918$20220127$20240920$PER$$US-BIOGEN-2021BI01005963$BIOGEN$$14$YR$$F$Y$$$20240920$$CN$US$US
2038150512$20381505$12$F$20220311$20240823$20220127$20240829$EXP$$CA-TAKEDA-2021TUS078576$TAKEDA$$61$YR$$F$Y$$$20240829$$CN$CA$CA
203818512$20381851$2$F$20220101$20220123$20220127$20240710$EXP$$RO-ASTELLAS-2022US002774$ASTELLAS$$65$YR$$M$Y$$$20240710$$CN$RO$RO
203825342$20382534$2$F$20210224$20240715$20220127$20240723$PER$$US-SA-2022SA021299$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240724$$MD$US$US
2038275214$20382752$14$F$20220112$20240917$20220127$20240925$EXP$$ZA-ROCHE-3004399$ROCHE$$34$YR$A$F$Y$$$20240925$$CN$ZA$ZA
203830042$20383004$2$F$$20240730$20220127$20240801$PER$$US-PFIZER INC-202101068449$PFIZER$$56$YR$$F$Y$$$20240801$$HP$US$US
203831483$20383148$3$F$20220101$20220224$20220127$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR013182$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240926$$MD$US$US
203853263$20385326$3$F$$20240904$20220127$20240906$EXP$$CA-PFIZER INC-202200120455$MYLAN$$34$YR$$M$Y$$$20240906$$HP$CA$CA
203875746$20387574$6$F$20201211$20240722$20220127$20240731$EXP$$CA-ROCHE-2739986$ROCHE$$38$YR$A$F$Y$$$20240731$$CN$CA$CA
203880603$20388060$3$F$20211201$20240809$20220128$20240817$PER$$US-SA-2022SA022575$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240817$$MD$US$US
203881337$20388133$7$F$20220101$20220707$20220128$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR015188$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
203891092$20389109$2$F$20180502$20240716$20220128$20240724$EXP$$TR-TOLMAR, INC.-22TR032616$TOLMAR$$74$YR$$M$Y$$$20240724$$MD$TR$TR
203892218$20389221$8$F$20230814$20240718$20220128$20240807$PER$$CA-TOLMAR, INC.-21CA030999$TOLMAR$$82$YR$$M$Y$$$20240807$$MD$CA$CA
203892264$20389226$4$F$$20240830$20220128$20240919$PER$$CA-TOLMAR, INC.-21CA031058$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
2038978013$20389780$13$F$$20240708$20220128$20240716$EXP$$CA-APOTEX-2022AP002382$APOTEX$$65$YR$$F$Y$34$KG$20240716$$HP$CA$CA
203905659$20390565$9$F$20211202$20240619$20220128$20240711$EXP$$ZA-ROCHE-3005299$ROCHE$$72$YR$E$F$Y$100$KG$20240711$$CN$ZA$ZA
203908307$20390830$7$F$20210719$20230427$20220128$20240807$EXP$$JP-GLAXOSMITHKLINE-JP2021JPN245786$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$JP$JP
203908572$20390857$2$F$20220106$20240814$20220128$20240821$EXP$FR-AFSSAPS-NT20220270$FR-ELI_LILLY_AND_COMPANY-FR202201008297$ELI LILLY AND CO$$58$YR$A$F$Y$56$KG$20240821$$CN$FR$FR
203909804$20390980$4$F$20190201$20240924$20220128$20240926$PER$$US-AMGEN-USASP2022013637$AMGEN$$70$YR$E$F$Y$$$20240926$$HP$US$US
203911382$20391138$2$F$20220122$20240912$20220128$20240917$EXP$$US-SA-2022SA026562$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240917$$MD$US$US
203912732$20391273$2$F$$20240726$20220128$20240805$PER$$US-SA-2022SA023337$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$MD$US$US
203916446$20391644$6$F$$20240623$20220128$20240701$PER$$US-PFIZER INC-202101882998$PFIZER$$75$YR$$F$Y$$$20240701$$CN$US$US
2039260211$20392602$11$F$20200218$20240918$20220128$20240925$EXP$$MX-TAKEDA-MX202007399$TAKEDA$$10$YR$$M$Y$37$KG$20240925$$CN$MX$MX
203932944$20393294$4$F$$20240624$20220128$20240703$PER$$US-INCYTE CORPORATION-2022IN000704$INCYTE$$$$$$Y$$$20240703$$CN$US$US
203935423$20393542$3$F$$20240823$20220128$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202201010174$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240904$$CN$US$US
203937527$20393752$7$F$20191014$20240726$20220128$20240802$EXP$$US-ABBVIE-21K-163-4215212-00$ABBVIE$$55$YR$$F$Y$$$20240802$$CN$US$US
203938553$20393855$3$F$20210903$20240828$20220129$20240914$EXP$$GB-ABBVIE-22K-167-4252081-00$ABBVIE$$40$YR$$F$Y$$$20240911$$MD$GB$GB
2039405115$20394051$15$F$20210101$20240814$20220129$20240822$EXP$$CA-CELLTRION INC.-2021CA003794$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
203941418$20394141$8$F$20220203$20240805$20220129$20240806$EXP$$JP-ABBVIE-22K-087-4252577-00$ABBVIE$$73$YR$$F$Y$47$KG$20240806$$MD$JP$JP
203949562$20394956$2$F$$20240701$20220130$20240716$EXP$$US-EMERGENT BIOSOLUTIONS CANADA INC.-22000014$EMERGENT BIOSOLUTIONS$Kummer RL, Kempainen RR, Olives TD, Leatherman JW, Prekker ME.. Naloxone-associated pulmonary edema following recreational opioid overdose: A case series.. Am J Emerg Med. 2022;53:41-3$20$YR$$$Y$$$20240716$$MD$US$US
203949572$20394957$2$F$$20240701$20220130$20240716$EXP$$US-EMERGENT BIOSOLUTIONS CANADA INC.-22000015$EMERGENT BIOSOLUTIONS$Kummer RL, Kempainen RR, Olives TD, Leatherman JW, Prekker ME.. Naloxone-associated pulmonary edema following recreational opioid overdose: A case series.. Am J Emerg Med. 2022;53:41-3$28$YR$$$Y$$$20240716$$MD$US$US
203949632$20394963$2$F$$20240701$20220130$20240716$EXP$$US-EMERGENT BIOSOLUTIONS CANADA INC.-22000016$EMERGENT BIOSOLUTIONS$Kummer RL, Kempainen RR, Olives TD, Leatherman JW, Prekker ME.. Naloxone-associated pulmonary edema following recreational opioid overdose: A case series.. Am J Emerg Med. 2022;53:41-3$33$YR$$$Y$$$20240716$$MD$US$US
203949682$20394968$2$F$$20240701$20220130$20240716$EXP$$US-EMERGENT BIOSOLUTIONS CANADA INC.-22000017$EMERGENT BIOSOLUTIONS$Kummer RL, Kempainen RR, Olives TD, Leatherman JW, Prekker ME. Naloxone-associated pulmonary edema following recreational opioid overdose: A case series. Am J Emerg Med. 2022;53:41-3$22$YR$$$Y$$$20240716$$MD$US$US
2040336810$20403368$10$F$20210701$20240717$20220131$20240725$EXP$$CA-ROCHE-3007132$ROCHE$$39$YR$A$F$Y$$$20240725$$CN$CA$CA
2040372524$20403725$24$F$20210501$20240906$20220131$20240916$EXP$$CA-CELLTRION INC.-2021CA012379$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
204040497$20404049$7$F$20211226$20240703$20220131$20240716$EXP$$DE-ROCHE-3005349$ROCHE$$44$YR$A$F$Y$$$20240716$$MD$DE$DE
204040758$20404075$8$F$20201224$20240813$20220131$20240815$EXP$$DE-ROCHE-2748054$ROCHE$$29$YR$A$F$Y$$$20240815$$CN$DE$DE
204041363$20404136$3$F$20220121$20240822$20220131$20240823$EXP$$IL-ROCHE-3009843$ROCHE$$51$YR$A$F$Y$$$20240823$$CN$IL$IL
204042403$20404240$3$F$$20240610$20220131$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000239$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
204043383$20404338$3$F$$20240613$20220131$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000309$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
204044364$20404436$4$F$20211101$20220218$20220131$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR013213$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240926$$CN$US$US
204044987$20404498$7$F$20220124$20240819$20220131$20240827$EXP$$CA-ROCHE-3014353$ROCHE$$47$YR$A$F$Y$$$20240827$$CN$CA$CA
204045793$20404579$3$F$$20240923$20220131$20240930$PER$$US-ROCHE-3007555$ROCHE$$51$YR$A$F$Y$$$20240929$$CN$US$US
204047092$20404709$2$F$$20240705$20220131$20240715$EXP$$BR-TAKEDA-2022TUS005479$TAKEDA$$$$$M$Y$$$20240715$$CN$BR$BR
2040539312$20405393$12$F$20230101$20240702$20220131$20240709$EXP$$US-JAZZ-2022-US-001300$JAZZ$$$$$F$Y$$$20240708$$CN$US$US
204054003$20405400$3$F$20180101$20240214$20220131$20240704$EXP$$DE-TEVA-2022-DE-2002692$TEVA$$77$YR$$M$Y$77$KG$20240704$$CN$DE$DE
204055666$20405566$6$F$20210828$20240715$20220131$20240717$EXP$$IN-PFIZER INC-2020353892$PFIZER$$77$YR$$F$Y$$$20240717$$CN$IN$IN
204055922$20405592$2$F$$20220126$20220131$20240902$EXP$$NVSC2022CN018729$NOVARTIS$$$$$$Y$$$20240902$$CN$CN$CN
204057705$20405770$5$F$20201216$20240904$20220131$20240905$EXP$$CA-ROCHE-2737569$ROCHE$$49$YR$A$F$Y$$$20240905$$CN$CA$CA
204058148$20405814$8$F$20200115$20240710$20220131$20240715$EXP$$CA-TAKEDA-2020TUS005749$TAKEDA$$67$YR$$M$Y$$$20240715$$MD$CA$CA
204062297$20406229$7$F$$20240702$20220131$20240704$EXP$$US-PFIZER INC-202101522915$PFIZER$$60$YR$$F$Y$52.154$KG$20240704$$HP$US$US
204065072$20406507$2$F$$20240725$20220131$20240807$PER$$US-SA-2022SA025583$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240807$$MD$US$US
204066132$20406613$2$F$20200901$20240918$20220131$20240926$EXP$$BR-TAKEDA-BR202002469$TAKEDA$$28$YR$$M$Y$110$KG$20240926$$MD$BR$BR
204067695$20406769$5$F$$20240827$20220131$20240829$EXP$$US-PFIZER INC-202101513629$PFIZER$$63$YR$$F$Y$$$20240829$$CN$US$US
204068698$20406869$8$F$20191217$20240917$20220131$20240924$EXP$$CA-TAKEDA-2022TUS005393$TAKEDA$$73$YR$$F$Y$$$20240924$$CN$CA$CA
2040765615$20407656$15$F$20201029$20240801$20220131$20240808$EXP$$CA-CELLTRION INC.-2020CA027973$CELLTRION$$$$$$Y$$$20240808$$HP$CA$CA
204079983$20407998$3$F$20200527$20240902$20220201$20240903$EXP$$JP-TAKEDA-2022TJP011213$TAKEDA$$17$YR$$M$Y$$$20240903$$MD$JP$JP
204083632$20408363$2$F$20220101$20240903$20220201$20240917$PER$$US-SA-2022SA026635$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240918$$MD$US$US
204084086$20408408$6$F$20211201$20220516$20220201$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR016106$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2040868410$20408684$10$F$20180901$20220909$20220201$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR015907$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$HP$US$US
204088504$20408850$4$F$20210101$20240802$20220201$20240815$EXP$$CA-AUROBINDO-AUR-APL-2022-002366$AUROBINDO$Naccarato M, Kweea F, Zaltzman J, Fong I. Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient: is it time for a priori tacrolimus dosage reduction?. AIDS (London, England). 2021;35(12):2065-2066$56$YR$$F$Y$58$KG$20240815$$PH$CA$CA
204088602$20408860$2$F$$20240801$20220201$20240814$EXP$$CA-AUROBINDO-AUR-APL-2022-002381$AUROBINDO$$41$YR$$F$Y$71$KG$20240814$$HP$CA$CA
2040886114$20408861$14$F$$20240830$20220201$20240910$EXP$$CA-AUROBINDO-AUR-APL-2022-002269$AUROBINDO$$65$YR$$F$Y$34$KG$20240910$$MD$CA$CA
204099802$20409980$2$F$$20240829$20220201$20240923$PER$$US-SA-2022SA027030$SANOFI AVENTIS$$30$YR$A$F$Y$79.3$KG$20240923$$MD$US$US
2041001411$20410014$11$F$20210101$20240703$20220201$20240718$EXP$$DE-ROCHE-2821514$ROCHE$$64$YR$A$F$Y$$$20240718$$CN$DE$DE
2041032210$20410322$10$F$20180123$20240819$20220201$20240822$EXP$$GB-MYLANLABS-2018M1006877$MYLAN$$29$YR$$F$Y$$$20240822$$MD$GB$GB
204103499$20410349$9$F$$20240904$20220201$20240912$EXP$$AU-JNJFOC-20220148770$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240912$$MD$AU$AU
204108087$20410808$7$F$20220912$20240711$20220201$20240719$EXP$$CA-TAKEDA-2020TUS055665$TAKEDA$$62$YR$$F$Y$$$20240719$$CN$CA$CA
2041087320$20410873$20$F$$20240917$20220201$20240925$EXP$$CA-PURDUE-USA-2022-0291043$PURDUE$$65$YR$$F$Y$34$KG$20240925$$HP$CA$CA
204118102$20411810$2$F$$20220125$20220201$20240824$EXP$$US-TAKEDA-2022TUS006008$TAKEDA$$$$$M$Y$$$20240824$$CN$US$US
204121745$20412174$5$F$20220110$20240805$20220201$20240816$EXP$$US-THERATECHNOLOGIES INC.-2022-THE-IBA-000015$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
204122598$20412259$8$F$$20240918$20220201$20240920$EXP$$US-PFIZER INC-202101361088$PFIZER$$70$YR$$F$Y$$$20240920$$CN$US$US
204125233$20412523$3$F$$20240906$20220201$20240911$EXP$$US-GILEAD-2022-0567547$GILEAD$$53$YR$A$M$Y$$$20240911$$HP$US$US
204126704$20412670$4$F$20230701$20240730$20220201$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202202000536$ELI LILLY AND CO$$78$YR$E$F$Y$52.154$KG$20240802$$CN$US$US
204141993$20414199$3$F$$20240801$20220201$20240814$EXP$$CA-AUROBINDO-AUR-APL-2022-002312$AUROBINDO$$52$YR$$F$Y$$$20240814$$HP$CA$CA
204142035$20414203$5$F$20230816$20240715$20220201$20240805$PER$$CA-TOLMAR, INC.-21CA030995$TOLMAR$$79$YR$$M$Y$$$20240802$$CN$CA$CA
204142494$20414249$4$F$20220117$20240812$20220202$20240815$EXP$$CA-ROCHE-3013391$ROCHE$$36$YR$A$F$Y$$$20240815$$CN$CA$CA
2041425111$20414251$11$F$20220126$20240910$20220202$20240919$EXP$$CA-ROCHE-3013923$ROCHE$$53$YR$A$M$Y$$$20240919$$CN$CA$CA
204142789$20414278$9$F$20220126$20240812$20220202$20240815$EXP$$CA-ROCHE-3014814$ROCHE$$41$YR$A$F$Y$$$20240815$$CN$CA$CA
204145295$20414529$5$F$20211125$20240702$20220202$20240711$EXP$$CA-ROCHE-3011128$ROCHE$$60$YR$A$F$Y$$$20240711$$CN$CA$CA
204148046$20414804$6$F$$20240731$20220202$20240811$EXP$$CA-AUROBINDO-AUR-APL-2022-002896$AUROBINDO$$37$YR$$F$Y$58$KG$20240812$$HP$CA$CA
204152914$20415291$4$F$$20221201$20220202$20240827$EXP$$TR-STRIDES ARCOLAB LIMITED-2022SP000883$STRIDES$Karasu S, Sinci KA, Yildiz Y, Gumus C, Tosun O. Chemotherapy-induced Pulmonary Toxicity Mimicking COVID-19 Pneumonia. Curr-Med-Imaging-Rev. 2021;17(12):1510-1512$53$YR$$M$Y$$$20240827$$HP$TR$TR
204153804$20415380$4$F$20220110$20240919$20220202$20240923$EXP$$CA-ROCHE-3015588$ROCHE$$31$YR$A$F$Y$$$20240923$$CN$CA$CA
204155002$20415500$2$F$20211209$20240710$20220202$20240722$EXP$$JP-009507513-2201JPN002251J$MERCK$$68$YR$$M$Y$56$KG$20240719$$MD$JP$JP
204155753$20415575$3$F$20210401$20240704$20220202$20240708$EXP$$NVSJ2021JP020787$NOVARTIS$Dobashi R, Ishihara S, Shimomura M, Tsunezuka H, Ikebe S, Taniguchi Y, et al.. A surgical case of intractable pneumothorax which developed during pazopanib treatment for pulmonary metastasis of osteosarcoma. Japanese Journal of Lung Cancer, the 62nd Annual Meeting of the Japan Lung Cance. 2021;61(6):740$31$YR$$M$Y$64.3$KG$20240709$$HP$JP$JP
204156363$20415636$3$F$$20220219$20220202$20240711$EXP$$DE-ASTELLAS-2022US003648$ASTELLAS$$87$YR$$M$Y$$$20240711$$CN$DE$DE
204156483$20415648$3$F$$20231009$20220202$20240806$PER$$NVSC2022US019582$NOVARTIS$$43$YR$$F$Y$$$20240806$$CN$US$US
204166503$20416650$3$F$$20240712$20220202$20240718$30DAY$$US-GLAXOSMITHKLINE-US2022AMR015035$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
2041689127$20416891$27$F$20211102$20240926$20220202$20240930$EXP$$CA-JNJFOC-20211142679$JOHNSON AND JOHNSON$$73$YR$E$F$Y$60$KG$20240930$$CN$CA$CA
2041750011$20417500$11$F$20210723$20240715$20220202$20240718$EXP$$CA-PFIZER INC-202100968377$PFIZER$$61$YR$$M$Y$126$KG$20240718$$HP$CA$CA
204178948$20417894$8$F$20220901$20240820$20220202$20240912$PER$$US-SA-2022SA026098$SANOFI AVENTIS$$69$YR$E$F$Y$90.703$KG$20240912$$MD$US$US
204179802$20417980$2$F$20220128$20240722$20220202$20240725$EXP$$US-TAKEDA-2022TUS006334$TAKEDA$$77$YR$$F$Y$$$20240725$$MD$US$US
2041800823$20418008$23$F$$20240920$20220202$20240927$EXP$$CA-TAKEDA-2022TUS004922$TAKEDA$Farrell B, Merkley V, Thompson W. Managing polypharmacy in a 77 year old woman with multiple prescribers. CMAJ. 2013;185(14):1240-50$77$YR$$F$Y$$$20240927$$MD$CA$CA
204185827$20418582$7$F$20211201$20240829$20220202$20240904$PER$$US-AMGEN-USASP2022015482$AMGEN$$69$YR$E$M$Y$$$20240904$$HP$US$US
204187213$20418721$3$F$20191220$20240710$20220202$20240717$EXP$$JP-ABBVIE-22P-087-4261463-00$ABBVIE$$66$YR$$M$Y$55$KG$20240717$$MD$JP$JP
2041898011$20418980$11$F$$20240826$20220203$20240902$EXP$$CA-TAKEDA-2022TUS006398$TAKEDA$$$$$M$Y$$$20240901$$MD$CA$CA
204190063$20419006$3$F$$20240905$20220203$20240917$EXP$$PT-CELLTRION INC.-2021PT017635$CELLTRION$Antunes D, Hundarova K, Carvalho MJ, et al.. IMPACT OF MULTIPLE SCLEROSIS ON THE OVARIAN FUNCTION OF WOMEN: ABOUT A CLINICAL CASE. Portuguese Obstetric and Gynecological Acta. 2021;15:93$$$$$Y$$$20240917$$MD$PT$PT
204190447$20419044$7$F$20220627$20240802$20220203$20240809$EXP$$CA-TAKEDA-2022TUS006605$TAKEDA$$62$YR$$M$Y$$$20240809$$CN$CA$CA
2041914311$20419143$11$F$20220101$20240910$20220203$20240920$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2022US000055$DECIPHERA PHARMACEUTICALS$$82$YR$E$M$Y$$$20240920$$MD$US$US
204193599$20419359$9$F$20230720$20240625$20220203$20240701$EXP$$CA-TAKEDA-2022TUS006003$TAKEDA$$44$YR$$M$Y$$$20240701$$HP$CA$CA
204194352$20419435$2$F$20170801$20220124$20220203$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR013922$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
204198756$20419875$6$F$20201101$20240924$20220203$20240928$EXP$$CO-TAKEDA-2020TUS014691$TAKEDA$$76$YR$$M$Y$76$KG$20240928$$CN$CO$CO
204202666$20420266$6$F$20220124$20240826$20220203$20240831$EXP$$DE-TAKEDA-2022TUS006270$TAKEDA$$32$YR$$M$Y$63$KG$20240831$$HP$DE$DE
2042027412$20420274$12$F$20200923$20240715$20220203$20240717$EXP$$CA-TAKEDA-2019TUS004510$TAKEDA$$69$YR$$M$Y$$$20240717$$CN$CA$CA
204204042$20420404$2$F$20181223$20220124$20220203$20240819$EXP$$JP-AMGEN-JPNCT2019183926$AMGEN$$79$YR$E$M$Y$$$20240819$$MD$JP$JP
204205654$20420565$4$F$$20220502$20220203$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR015823$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204205737$20420573$7$F$$20221025$20220203$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR017824$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
204212703$20421270$3$F$20220106$20240910$20220203$20240917$EXP$$US-VERTEX PHARMACEUTICALS-2022-001625$VERTEX$$7$YR$$F$Y$30$KG$20240917$$MD$US$US
204221624$20422162$4$F$20220109$20240802$20220203$20240805$EXP$$CA-ROCHE-3014840$ROCHE$$37$YR$A$F$Y$$$20240805$$CN$CA$CA
204223232$20422323$2$F$$20240712$20220203$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-000626$AURINIA PHARMACEUTICALS$$$$$F$Y$50.8$KG$20240731$$CN$US$US
204223793$20422379$3$F$$20220208$20220203$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR016117$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204225633$20422563$3$F$20211201$20240329$20220203$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-000832$AURINIA PHARMACEUTICALS$$60$YR$$F$Y$104.31$KG$20240731$$CN$US$US
204226543$20422654$3$F$20210801$20240711$20220203$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-000802$AURINIA PHARMACEUTICALS$$43$YR$$F$Y$$$20240731$$CN$US$US
204227382$20422738$2$F$$20240705$20220203$20240710$EXP$$IT-PFIZER INC-202200128757$PFIZER$$50$YR$$M$Y$$$20240710$$MD$IT$IT
204228367$20422836$7$F$20230912$20240916$20220203$20240920$EXP$$US-TAKEDA-US201735685$TAKEDA$$66$YR$$F$Y$85$KG$20240920$$CN$US$US
204230275$20423027$5$F$$20240702$20220203$20240704$EXP$$US-PFIZER INC-202200185685$PFIZER$$63$YR$$M$Y$$$20240704$$CN$US$US
204230762$20423076$2$F$20220106$20220126$20220203$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR007922$GLAXOSMITHKLINE$$58$YR$$F$Y$92$KG$20240925$$HP$US$US
2042345914$20423459$14$F$20220101$20240909$20220203$20240911$EXP$$US-PFIZER INC-202101604935$PFIZER$$66$YR$$F$Y$$$20240911$$HP$US$US
2042364229$20423642$29$F$20220101$20240913$20220203$20240923$EXP$$CA-CELLTRION INC.-2022CA001118$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
204237194$20423719$4$F$$20240827$20220203$20240904$EXP$$PT-CELLTRION INC.-2022PT000045$CELLTRION$Martins MM, Ferreira P, Maciel R, Costa C.. Vulvar herpes zoster infection: a rare and challenging diagnosis.. BMJ Case Rep. 2021;14(12):e246797$$$$$Y$$$20240904$$MD$PT$PT
2042373512$20423735$12$F$20210907$20240903$20220203$20240906$EXP$$JP-ABBVIE-22K-087-4261280-00$ABBVIE$$70$YR$$F$Y$29$KG$20240906$$MD$JP$JP
204269245$20426924$5$F$20200601$20240823$20220204$20240827$EXP$$JP-ROCHE-3015035$ROCHE$Tsuchiya R, Mishima K, Sasaki A, Homma T, Mizuno R, Uchida E, Shirahata M, Suzuki T, Adachi J and Nishikawa R Primary Central Nervous System Lymphoproliferative Disease associated with Administration of Mycophenolate Mofetil: A Case Report. Japanese Journal of Neurosurgery 2021;31:42-9.$69$YR$E$F$Y$$$20240827$$MD$JP$JP
204274233$20427423$3$F$20220101$20240703$20220204$20240712$EXP$$IE-EXELIXIS-CABO-21044144$EXELIXIS$$62$YR$$M$Y$$$20240712$$HP$IE$IE
204275683$20427568$3$F$20220201$20220216$20220204$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR017917$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
204276894$20427689$4$F$20240521$20240828$20220204$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000095$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240920$$CN$US$US
204281873$20428187$3$F$20200504$20240923$20220204$20240930$EXP$$CA-JNJFOC-20220201035$JOHNSON AND JOHNSON$$15$YR$T$F$Y$35$KG$20240930$$HP$CA$CA
2042833313$20428333$13$F$20210101$20240909$20220204$20240917$EXP$$CA-CELLTRION INC.-2021CA014128$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
2042937613$20429376$13$F$20200309$20240809$20220204$20240817$EXP$$CA-CELLTRION INC.-2021CA006139$CELLTRION$$$$$$Y$$$20240817$$MD$CA$CA
204297452$20429745$2$F$$20240819$20220204$20240827$EXP$$CA-APOTEX-2022AP002623$APOTEX$$40$YR$$F$Y$$$20240827$$HP$CA$CA
204297662$20429766$2$F$20220128$20220128$20220204$20240912$EXP$$JP-AstraZeneca-2022A055830$ASTRAZENECA$$63$YR$$M$Y$$$20240912$$MD$JP$
204298814$20429881$4$F$20210408$20240830$20220204$20240909$EXP$$JP-AstraZeneca-2021A804991$ASTRAZENECA$$62$YR$$M$Y$66$KG$20240909$$MD$JP$
2042993917$20429939$17$F$20140101$20240709$20220204$20240712$30DAY$$US-PFIZER INC-202200015586$PFIZER$$64$YR$$F$Y$$$20240712$$CN$US$US
204299502$20429950$2$F$20180924$20240916$20220204$20240925$EXP$$FR-SERVIER-S19003630$SERVIER$$$$$$Y$$$20240925$$MD$FR$FR
204302842$20430284$2$F$20200510$20240809$20220204$20240823$EXP$$FR-SERVIER-S20005376$SERVIER$$$$$$Y$$$20240823$$MD$FR$FR
204303796$20430379$6$F$20220121$20220429$20220204$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR017997$GLAXOSMITHKLINE$$78$YR$$F$Y$50$KG$20240925$$CN$US$US
204304163$20430416$3$F$20200309$20240718$20220204$20240802$EXP$$FR-SERVIER-S20007233$SERVIER$$$$$$Y$$$20240802$$MD$FR$FR
204304492$20430449$2$F$20200811$20240809$20220204$20240823$EXP$$FR-SERVIER-S20008562$SERVIER$$$$$$Y$$$20240823$$MD$FR$FR
204305262$20430526$2$F$20200707$20240906$20220204$20240920$EXP$$FR-SERVIER-S20009874$SERVIER$$$$$$Y$$$20240920$$MD$FR$FR
204305363$20430536$3$F$20200827$20201130$20220204$20240726$EXP$$FR-SERVIER-S20011010$SERVIER$$$$$$Y$$$20240726$$MD$FR$FR
204305473$20430547$3$F$20200825$20240813$20220204$20240828$EXP$$FR-SERVIER-S20010424$SERVIER$$$$$$Y$$$20240828$$MD$FR$FR
204305862$20430586$2$F$20201012$20240704$20220204$20240712$EXP$$FR-SERVIER-S20012077$SERVIER$$$$$$Y$$$20240712$$MD$FR$FR
204306416$20430641$6$F$20220602$20240820$20220204$20240822$EXP$$CA-TAKEDA-2022TUS004909$TAKEDA$$28$YR$$F$Y$$$20240822$$CN$CA$CA
204306492$20430649$2$F$20210128$20240903$20220204$20240918$EXP$$FR-SERVIER-S21004843$SERVIER$$$$$$Y$$$20240918$$MD$FR$FR
204307402$20430740$2$F$20201231$20240627$20220204$20240712$EXP$$FR-SERVIER-S21003106$SERVIER$$$$$$Y$$$20240712$$MD$FR$FR
204307583$20430758$3$F$20210217$20240905$20220204$20240920$EXP$$FR-SERVIER-S21004109$SERVIER$$5$YR$$F$Y$14.7$KG$20240920$$MD$FR$FR
204308282$20430828$2$F$20181116$20240903$20220204$20240918$EXP$$FR-SERVIER-S21006714$SERVIER$$$$$$Y$$$20240918$$MD$FR$FR
204308322$20430832$2$F$20170522$20240903$20220204$20240917$EXP$$FR-SERVIER-S21006533$SERVIER$$$$$$Y$$$20240917$$MD$FR$FR
204308352$20430835$2$F$20190611$20240627$20220204$20240712$EXP$$FR-SERVIER-S21006537$SERVIER$$$$$$Y$$$20240712$$MD$FR$FR
204308372$20430837$2$F$20210621$20240808$20220204$20240820$EXP$$US-SERVIER-S21006874$SERVIER$$$$$$Y$$$20240820$$MD$US$FR
204313943$20431394$3$F$20180416$20240819$20220204$20240820$PER$$US-GILEAD-2022-0567695$GILEAD$$54$YR$A$M$Y$$$20240820$$LW$US$US
2043148612$20431486$12$F$$20221130$20220204$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR017814$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204314886$20431488$6$F$20211201$20240708$20220204$20240712$EXP$$AT-TAKEDA-2022TUS007572$TAKEDA$$59$YR$$M$Y$$$20240712$$CN$AT$AT
2043179918$20431799$18$F$20220907$20240926$20220204$20240930$EXP$$US-PFIZER INC-2015409580$PFIZER$$88$YR$$F$Y$63.5$KG$20240930$$HP$US$US
204326064$20432606$4$F$$20240808$20220204$20240815$EXP$$IN-ROCHE-3017010$ROCHE$$61$YR$A$F$Y$$$20240815$$CN$IN$IN
204330362$20433036$2$F$$20240710$20220205$20240718$PER$$US-SA-2022SA030365$SANOFI AVENTIS$$$$A$M$Y$$$20240718$$MD$US$US
204330586$20433058$6$F$20200430$20240701$20220205$20240713$PER$$US-SA-2022SA030356$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240713$$MD$US$US
2043336211$20433362$11$F$20211019$20240912$20220205$20240921$EXP$$CA-CELLTRION INC.-2021CA018402$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
204334606$20433460$6$F$20211231$20240822$20220205$20240903$EXP$$CN-Accord-252689$ACCORD$$50$YR$A$F$Y$58$KG$20240903$$MD$CN$CN
204337693$20433769$3$F$20200106$20240716$20220205$20240723$EXP$$US-SA-2020SA057140$SANOFI AVENTIS$$59$YR$A$F$Y$61.2$KG$20240723$$MD$US$US
2043456812$20434568$12$F$20200704$20240719$20220206$20240724$EXP$$NVSC2020CA195583$NOVARTIS$$54$YR$$F$Y$$$20240724$$CN$CA$CA
204346193$20434619$3$F$$20240918$20220206$20240930$PER$$NVSC2022US025166$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
204353312$20435331$2$F$20220123$20240911$20220206$20240913$EXP$$CA-ROCHE-3011289$ROCHE$$42$YR$A$F$Y$$$20240913$$CN$CA$CA
204354764$20435476$4$F$20220131$20240821$20220206$20240910$EXP$$US-ABBVIE-22K-163-4265157-00$ABBVIE$$19$YR$$F$Y$$$20240910$$CN$US$US
204357583$20435758$3$F$20220124$20220607$20220207$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR018785$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240925$$CN$US$US
2043627813$20436278$13$F$20220207$20221116$20220207$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR020482$GLAXOSMITHKLINE$$36$YR$$F$Y$$$20240925$$HP$US$US
204366049$20436604$9$F$20220701$20220901$20220207$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR020269$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
204367742$20436774$2$F$20240627$20240709$20220207$20240712$EXP$$GB-TAKEDA-2022TUS007316$TAKEDA$$82$YR$$M$Y$$$20240712$$CN$GB$GB
204373743$20437374$3$F$$20220209$20220207$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR019670$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204375653$20437565$3$F$20240601$20240903$20220207$20240910$EXP$$US-GLAXOSMITHKLINE-US2022018782$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
204376536$20437653$6$F$$20240703$20220207$20240705$EXP$$CA-BAUSCH-BL-2022-003533$BAUSCH AND LOMB$$69$YR$$M$Y$92$KG$20240705$$CN$CA$CA
204379022$20437902$2$F$$20220203$20220207$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR020588$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204381552$20438155$2$F$20210801$20240313$20220207$20240910$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-06939$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-06939$ALKEM$$53$YR$$F$Y$$$20240910$$MD$DE$DE
204381572$20438157$2$F$$20230721$20220207$20240910$EXP$GB-MHRA-INP9AA56E25-F6FD-4FB8-B32D-3C60CF216ACA$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-00128$ALKEM$$86$YR$$M$Y$75$KG$20240910$$MD$GB$GB
204383562$20438356$2$F$$20240821$20220207$20240826$PER$$US-PFIZER INC-2021107063$PFIZER$$69$YR$$F$Y$$$20240826$$CN$US$US
204384564$20438456$4$F$20211119$20240702$20220207$20240723$EXP$$DE-ROCHE-3013701$ROCHE$$55$YR$A$F$Y$74$KG$20240723$$MD$DE$DE
204388235$20438823$5$F$$20240916$20220207$20240923$EXP$$US-TAKEDA-2020TUS024853$TAKEDA$$$$$F$Y$$$20240923$$MD$US$US
204388349$20438834$9$F$20221027$20240926$20220207$20240926$EXP$$US-PFIZER INC-202101863306$PFIZER$$78$YR$$F$Y$$$20240926$$CN$US$US
204388404$20438840$4$F$$20240723$20220207$20240725$PER$$US-PFIZER INC-202101207735$PFIZER$$65$YR$$F$Y$$$20240725$$CN$US$US
204392987$20439298$7$F$20191217$20240916$20220207$20240925$EXP$$DE-ROCHE-2554158$ROCHE$$65$YR$E$F$Y$$$20240925$$CN$DE$DE
2043972614$20439726$14$F$20200729$20240228$20220207$20240809$EXP$$NVSC2020DO224383$NOVARTIS$$52$YR$$F$Y$$$20240809$$CN$DO$DO
204397843$20439784$3$F$20220101$20220218$20220207$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR019414$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
204399433$20439943$3$F$$20220221$20220207$20240924$EXP$$NVSC2022PL023260$NOVARTIS$$50$YR$$M$Y$$$20240924$$MD$PL$PL
204400432$20440043$2$F$$20240809$20220207$20240810$EXP$$CA-B.Braun Medical Inc.-2124695$B BRAUN$$$$$F$Y$$$20240810$$$CA$CA
204411247$20441124$7$F$20220201$20220810$20220208$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR020306$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
204415965$20441596$5$F$$20220316$20220208$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR019389$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204423492$20442349$2$F$$20240819$20220208$20240821$EXP$$US-SA-2022SA037353$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240821$$MD$US$US
2044296110$20442961$10$F$$20230908$20220208$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR020298$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
204431757$20443175$7$F$20231001$20240919$20220208$20240924$EXP$$US-TAKEDA-2021TUS047984$TAKEDA$$62$YR$$F$Y$63$KG$20240924$$HP$US$US
204436008$20443600$8$F$$20240910$20220208$20240913$EXP$$NVSC2022US026740$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
2044363914$20443639$14$F$20210325$20240923$20220208$20240927$EXP$$NVSC2022DE026822$NOVARTIS$$$$E$F$Y$63$KG$20240927$$HP$DE$DE
2044369613$20443696$13$F$20220201$20240722$20220208$20240723$EXP$$CA-PFIZER INC-202200168115$PFIZER$$81$YR$$M$Y$69$KG$20240723$$MD$CA$CA
204437323$20443732$3$F$$20240918$20220208$20240923$EXP$$US-TAKEDA-2022TUS006787$TAKEDA$$$$$F$Y$$$20240923$$HP$US$US
204438733$20443873$3$F$20201201$20240624$20220208$20240701$PER$$US-SA-2022SA032734$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240701$$MD$US$US
204440642$20444064$2$F$20210127$20240726$20220208$20240805$PER$$US-SA-2022SA035668$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240805$$CN$US$US
204440985$20444098$5$F$20220101$20240724$20220208$20240730$EXP$$CA-PFIZER INC-202200156780$PFIZER$$60$YR$$F$Y$$$20240730$$CN$CA$CA
204441502$20444150$2$F$$20240806$20220208$20240814$PER$$US-SA-2022SA035311$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240814$$CN$US$US
204444855$20444485$5$F$20211228$20240723$20220208$20240730$EXP$$DE-TAKEDA-2021TUS083133$TAKEDA$$42$YR$$M$Y$$$20240730$$HP$DE$DE
204454653$20445465$3$F$$20240812$20220208$20240820$EXP$$IN-PFIZER INC-202200158138$PFIZER$Yadav, R.. Secondary Acute Promyelocytic Leukaemia in a Young Patient with Treated Breast Cancer.. Indian Journal of Hematology and Blood Transfusion. 2021;37(SUPPL 1):S37$40$YR$$F$Y$$$20240820$$MD$IN$IN
2044555925$20445559$25$F$20210908$20240902$20220208$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-015010$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$50.2$KG$20240910$$MD$JP$JP
204463396$20446339$6$F$$20240726$20220208$20240731$EXP$$CA-PURDUE-USA-2022-0291259$PURDUE$$50$YR$$F$Y$130$KG$20240731$$CN$CA$CA
204463865$20446386$5$F$20220104$20240711$20220208$20240716$EXP$$ES-PFIZER INC-202200152805$PFIZER$$51$YR$$M$Y$89$KG$20240716$$HP$ES$ES
204464693$20446469$3$F$$20240716$20220208$20240722$EXP$$US-GW PHARMA-202201USGW00493$JAZZ$$$$$M$Y$38.549$KG$20240722$$HP$US$US
204467373$20446737$3$F$$20240915$20220208$20240925$EXP$$JP-JNJFOC-20211046378$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$MD$JP$JP
2044684318$20446843$18$F$20210801$20240905$20220208$20240914$EXP$$CA-CELLTRION INC.-2021CA012604$CELLTRION$$$$$$Y$$$20240914$$CN$CA$CA
204468694$20446869$4$F$$20240815$20220208$20240816$EXP$$CA-ROCHE-3016380$ROCHE$$$$A$F$Y$$$20240816$$CN$CA$CA
2044698312$20446983$12$F$20220127$20240926$20220209$20240930$EXP$$PT-ROCHE-3017088$ROCHE$$52$YR$A$M$Y$$$20240930$$MD$PT$PT
204470472$20447047$2$F$$20240913$20220209$20240925$EXP$$ES-AUROBINDO-AUR-APL-2022-003380$AUROBINDO$Galvez-moreno M. A.; Herrera-martinez A. D.; Alcantara-laguna M. D. et al... PTHrP-induced hypercalcemia in paragangliomas: Tumor dedifferentiation as sign of bad prognosis. Endocrinologia. Diabetes y Nutricior. 2022;69 (1):73-75$61$YR$$M$Y$$$20240925$$HP$ES$ES
204474447$20447444$7$F$20220409$20220516$20220209$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR018935$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
204480222$20448022$2$F$20200901$20220206$20220209$20240712$EXP$$RO-ASTELLAS-2022US004689$ASTELLAS$$69$YR$$M$Y$$$20240712$$CN$RO$RO
204481155$20448115$5$F$20210101$20240829$20220209$20240907$EXP$$CA-CELLTRION INC.-2021CA000329$CELLTRION$$$$$$Y$$$20240907$$MD$CA$CA
2044826911$20448269$11$F$20200807$20240829$20220209$20240903$EXP$$DE-ROCHE-2658828$ROCHE$$38$YR$A$F$Y$$$20240903$$CN$DE$DE
204483742$20448374$2$F$$20240628$20220209$20240709$PER$$US-BAYER-2022A018692$BAYER$$42$YR$A$F$Y$$$20240709$$HP$US$US
204487366$20448736$6$F$20160421$20240924$20220209$20240927$EXP$$CA-TAKEDA-2021TUS064933$TAKEDA$$25$YR$$F$Y$$$20240927$$MD$CA$CA
204489467$20448946$7$F$20210118$20240925$20220209$20240930$EXP$$CA-PFIZER INC-2021056591$MYLAN$$68$YR$$F$Y$77.46$KG$20240930$$HP$CA$CA
204493492$20449349$2$F$20170311$20240905$20220209$20240909$EXP$$US-PFIZER INC-202200175476$PFIZER$$74$YR$$F$Y$$$20240909$$HP$US$US
2044972011$20449720$11$F$$20230418$20220209$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR019675$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204505758$20450575$8$F$20230706$20240809$20220209$20240813$EXP$$US-KYOWAKIRIN-2022BKK001256$KYOWA$$$$$$Y$$$20240813$$CN$US$US
204505808$20450580$8$F$20240801$20240903$20220209$20240906$EXP$$US-KYOWAKIRIN-2022BKK001255$KYOWA$$$$$$Y$$$20240906$$HP$US$US
204520923$20452092$3$F$$20220218$20220209$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR020293$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2045250430$20452504$30$F$20211223$20240828$20220210$20240906$EXP$$CA-CELLTRION INC.-2021CA018280$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
204530953$20453095$3$F$20220224$20240716$20220210$20240723$EXP$$CA-TAKEDA-2022TUS008052$TAKEDA$$25$YR$$F$Y$$$20240723$$HP$CA$CA
204537522$20453752$2$F$$20220203$20220210$20240701$PER$$US-SA-2022SA033984$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240701$$MD$US$US
204538254$20453825$4$F$20210101$20240801$20220210$20240805$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000041$PAREXEL$$$$$$Y$$$20240805$$MD$US$US
204538806$20453880$6$F$20220115$20240805$20220210$20240809$EXP$$US-BEH-2022141887$CSL BEHRING$$30$YR$A$M$Y$$$20240809$$HP$US$US
204543656$20454365$6$F$20210501$20240729$20220210$20240807$EXP$$US-JAZZ-2022-US-002414$JAZZ$$44$YR$$F$Y$$$20240807$$CN$US$US
204544938$20454493$8$F$$20220623$20220210$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR021292$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
204545353$20454535$3$F$20190926$20240717$20220210$20240722$EXP$$FR-TAKEDA-FR201945893$TAKEDA$$43$YR$$M$Y$$$20240722$$HP$FR$FR
2045482912$20454829$12$F$$20240814$20220210$20240819$EXP$$IN-PFIZER INC-2021211620$PFIZER$$63$YR$$F$Y$63.5$KG$20240819$$CN$IN$IN
204552577$20455257$7$F$20220110$20240924$20220210$20240926$EXP$$US-TAKEDA-2021TUS053479$TAKEDA$$58$YR$$F$Y$$$20240926$$MD$US$US
204552703$20455270$3$F$$20240805$20220210$20240813$EXP$$CA-BAYER-2022A016809$BAYER$$46$YR$A$F$Y$$$20240813$$CN$CA$CA
204552807$20455280$7$F$20220624$20240909$20220210$20240914$EXP$$CA-TAKEDA-2022TUS008969$TAKEDA$$21$YR$$F$Y$$$20240914$$MD$CA$CA
204555022$20455502$2$F$20210101$20240920$20220210$20240925$EXP$$US-KYOWAKIRIN-2022BKK001265$KYOWA$$$$$$Y$$$20240925$$HP$US$US
2045572917$20455729$17$F$20230117$20240725$20220210$20240729$EXP$$CA-ROCHE-2962257$ROCHE$$33$YR$A$F$Y$61.23$KG$20240729$$CN$CA$CA
2045735015$20457350$15$F$20190101$20240828$20220210$20240905$EXP$$IN-INCYTE CORPORATION-2022IN001196$INCYTE$$$$$$Y$$$20240905$$CN$IN$IN
2045746637$20457466$37$F$20200402$20240912$20220210$20240924$EXP$$CA-CELLTRION INC.-2020CA019659$CELLTRION$$$$$$Y$$$20240924$$MD$CA$CA
2045752511$20457525$11$F$20210711$20240815$20220210$20240822$EXP$$CA-CELLTRION INC.-2020CA033101$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
204576268$20457626$8$F$20211201$20240828$20220210$20240829$EXP$$NVSC2021GB055201$NOVARTIS$$57$YR$$M$Y$$$20240830$$CN$GB$GB
204578559$20457855$9$F$20220202$20240912$20220210$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000409$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240923$$CN$US$US
2045864654$20458646$54$F$20161025$20240805$20220211$20240807$EXP$$CO-TAKEDA-CO202014283$TAKEDA$$12$YR$$M$Y$67$KG$20240807$$HP$CO$CO
204598866$20459886$6$F$$20240726$20220211$20240805$EXP$$GB-ROCHE-3015742$ROCHE$$$$A$F$Y$$$20240805$$HP$GB$GB
204599397$20459939$7$F$20190109$20240725$20220211$20240801$EXP$$DE-ROCHE-2384130$ROCHE$$30$YR$A$M$Y$$$20240801$$CN$DE$DE
204601602$20460160$2$F$20191230$20240702$20220211$20240705$EXP$$CA-TAKEDA-2022TUS009315$TAKEDA$$46$YR$$F$Y$$$20240705$$MD$CA$CA
204604109$20460410$9$F$20170127$20240819$20220211$20240826$EXP$$CA-TAKEDA-2017TUS008648$TAKEDA$$56$YR$$F$Y$$$20240826$$HP$CA$CA
204604197$20460419$7$F$20220201$20240710$20220211$20240718$PER$$US-SA-2022SA043328$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240718$$MD$US$US
204604416$20460441$6$F$$20220916$20220211$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR018912$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2046112610$20461126$10$F$20210901$20240720$20220211$20240730$EXP$$US-ORG100014127-2021001098$HRA PHARMA$$62$YR$$M$Y$$$20240730$$CN$US$US
204611797$20461179$7$F$$20240718$20220211$20240722$EXP$$US-PHARMING-PHAUS2022000098$PHARMING GROUP$$$$$$Y$$$20240722$$CN$US$US
2046161918$20461619$18$F$20190825$20240819$20220211$20240822$EXP$$US-TAKEDA-US201928569$TAKEDA$$49$YR$$F$Y$$$20240822$$MD$US$US
204616857$20461685$7$F$20220209$20240911$20220211$20240916$EXP$$CO-TAKEDA-2021TUS039499$TAKEDA$$22$YR$$F$Y$62$KG$20240916$$CN$CO$CO
204619343$20461934$3$F$20220120$20240726$20220211$20240802$EXP$$US-ROCHE-3016178$ROCHE$$45$YR$A$F$Y$80.29$KG$20240802$$CN$US$US
204621323$20462132$3$F$$20220304$20220211$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR023134$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2046219613$20462196$13$F$20170101$20240704$20220211$20240711$EXP$$NVSC2022BR027975$NOVARTIS$$$$$M$Y$$$20240711$$CN$BR$BR
204622849$20462284$9$F$20210912$20240918$20220211$20240925$EXP$$CA-ROCHE-2646170$ROCHE$$30$YR$A$M$Y$$$20240925$$CN$CA$CA
204624542$20462454$2$F$$20220208$20220211$20240808$PER$$NVSC2022US029132$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
204626355$20462635$5$F$20180101$20240807$20220211$20240809$EXP$$CA-AstraZeneca-2022A063510$ASTRAZENECA$Garneau B, Desharnais B, Beauchamp-Dore A, Lavallee C, Mireault P, Lajeunesse A.. Challenges Related to Three Cases of Fatal Intoxication to Multiple Novel Synthetic Opioids. Journal of Analytical Toxicology 2019;19:86-91.$29$YR$$M$Y$89$KG$20240809$$HP$CA$
204628387$20462838$7$F$$20240909$20220211$20240913$EXP$$CA-BAUSCH-BL-2022-003911$BAUSCH AND LOMB$$66$YR$$F$Y$105$KG$20240913$$CN$CA$CA
204653712$20465371$2$F$$20220205$20220212$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR022516$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204653722$20465372$2$F$20220201$20220207$20220212$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR022394$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240925$$CN$US$US
2046544910$20465449$10$F$20211001$20240918$20220212$20240927$EXP$$CA-CELLTRION INC.-2021CA018122$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
204654693$20465469$3$F$20211029$20240704$20220212$20240712$EXP$$PT-CELLTRION INC.-2022PT001528$CELLTRION$$$$$$Y$$$20240712$$MD$PT$PT
2046572316$20465723$16$F$20220106$20240712$20220212$20240718$EXP$$IT-TAKEDA-2022TUS001729$TAKEDA$$9$YR$$M$Y$$$20240718$$CN$IT$IT
2046577222$20465772$22$F$20210101$20240725$20220212$20240802$EXP$$CA-CELLTRION INC.-2021CA018902$CELLTRION$$$$$$Y$$$20240802$$HP$CA$CA
204659914$20465991$4$F$20220101$20240904$20220212$20240905$EXP$$CA-ROCHE-3019753$ROCHE$$32$YR$A$M$Y$$$20240905$$HP$CA$CA
204660054$20466005$4$F$$20240813$20220212$20240819$EXP$$CA-ROCHE-3019754$ROCHE$$$$A$F$Y$$$20240819$$CN$CA$CA
204660074$20466007$4$F$20220108$20240712$20220212$20240718$EXP$$CA-ROCHE-2868607$ROCHE$$43$YR$A$F$Y$$$20240718$$CN$CA$CA
204660684$20466068$4$F$20220401$20240805$20220212$20240813$PER$$US-SA-2022SA043228$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240814$$MD$US$US
204662452$20466245$2$F$$20240830$20220213$20240911$PER$$US-SA-2022SA039467$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240911$$CN$US$US
2046670518$20466705$18$F$20211101$20240913$20220213$20240921$EXP$$CA-CELLTRION INC.-2021CA003377$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
2046794210$20467942$10$F$20220203$20221130$20220214$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR023313$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
204683743$20468374$3$F$20210101$20240812$20220214$20240824$EXP$NL-LRB-00785682$NL-Accord-253748$ACCORD$$16$YR$T$M$Y$$$20240824$$CN$NL$NL
204690254$20469025$4$F$20211101$20240808$20220214$20240815$EXP$$CA-GLAXOSMITHKLINE-CA2021251870$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$CN$CA$CA
204694168$20469416$8$F$20200409$20240815$20220214$20240816$EXP$$US-SHIRE-US202009819$TAKEDA$$62$YR$$F$Y$$$20240816$$HP$US$US
204695012$20469501$2$F$$20240812$20220214$20240816$EXP$$BE-TAKEDA-2022TUS009761$TAKEDA$$$$$F$Y$$$20240816$$MD$BE$BE
204697242$20469724$2$F$$20240806$20220214$20240808$PER$$US-PFIZER INC-202200080604$PFIZER$$67$YR$$F$Y$$$20240808$$HP$US$US
204698604$20469860$4$F$$20240715$20220214$20240717$PER$$US-PFIZER INC-2021684672$PFIZER$$78$YR$$F$Y$$$20240717$$CN$US$US
204698732$20469873$2$F$20240812$20240819$20220214$20240824$EXP$$BR-TAKEDA-2022TUS010011$TAKEDA$$43$YR$$F$Y$$$20240824$$CN$BR$BR
204698776$20469877$6$F$20211201$20240821$20220214$20240905$EXP$$FR-SERVIER-S21014516$SERVIER$$$$$$Y$$$20240905$$MD$FR$FR
204698808$20469880$8$F$20220201$20220706$20220214$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR023088$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
204703166$20470316$6$F$$20221101$20220214$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR024212$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204706077$20470607$7$F$20220131$20240722$20220214$20240726$EXP$$NVSC2022CL029016$NOVARTIS$$39$YR$$M$Y$86$KG$20240726$$CN$CL$CL
204711353$20471135$3$F$$20240725$20220214$20240729$EXP$$US-PFIZER INC-202200255740$PFIZER$$84$YR$$F$Y$$$20240729$$CN$US$US
204715613$20471561$3$F$20220720$20240807$20220214$20240816$PER$$US-SA-2021SA433806$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240816$$MD$US$US
204716182$20471618$2$F$$20240701$20220214$20240710$PER$$US-SA-2022SA046212$SANOFI AVENTIS$$$$E$M$Y$$$20240710$$MD$US$US
204717177$20471717$7$F$$20240829$20220214$20240902$EXP$$CA-PFIZER INC-2021755096$PFIZER$$61$YR$$F$Y$$$20240902$$HP$CA$CA
204717623$20471762$3$F$$20240913$20220214$20240923$PER$$US-SA-2022SA044382$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240923$$MD$US$US
204719396$20471939$6$F$20220209$20240722$20220214$20240726$EXP$$CA-TAKEDA-2022TUS009814$TAKEDA$$77$YR$$F$Y$$$20240726$$CN$CA$CA
204728117$20472811$7$F$$20240624$20220215$20240709$EXP$$PT-ABBVIE-22K-130-4269910-00$ABBVIE$$$$E$$Y$$$20240709$$MD$PT$PT
2047291134$20472911$34$F$20191107$20240829$20220215$20240906$EXP$$CA-CELLTRION INC.-2019CA026406$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
2047295834$20472958$34$F$20151101$20240926$20220215$20240928$EXP$$GB-ROCHE-3020555$ROCHE$$59$YR$A$M$Y$62$KG$20240928$$MD$GB$GB
2047320715$20473207$15$F$20220210$20240726$20220215$20240729$EXP$$NVSC2022US031692$NOVARTIS$$17$MON$$M$Y$11.2$KG$20240729$$MD$US$US
204732154$20473215$4$F$20220201$20220221$20220215$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR022498$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
204732316$20473231$6$F$20220201$20220428$20220215$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR025110$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
204732322$20473232$2$F$$20240802$20220215$20240808$PER$$US-GLAXOSMITHKLINE-US2022025089$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
204733304$20473330$4$F$20220201$20220422$20220215$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR025259$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240925$$CN$US$US
204733444$20473344$4$F$20211201$20240815$20220215$20240822$EXP$$DE-ROCHE-3021203$ROCHE$$50$YR$A$F$Y$65$KG$20240822$$MD$DE$DE
204741779$20474177$9$F$20220101$20240629$20220215$20240705$EXP$$CA-JNJFOC-20220228318$JOHNSON AND JOHNSON$$73$YR$E$M$Y$77$KG$20240705$$HP$CA$CA
204748673$20474867$3$F$20240101$20240904$20220215$20240906$EXP$$US-KYOWAKIRIN-2022BKK001569$KYOWA$$$$$$Y$$$20240906$$HP$US$US
204753465$20475346$5$F$$20240905$20220215$20240909$PER$$US-PFIZER INC-202101605893$PFIZER$$74$YR$$F$Y$$$20240909$$CN$US$US
204753907$20475390$7$F$20200206$20240726$20220215$20240731$EXP$$CA-TAKEDA-2019TUS060814$TAKEDA$$62$YR$$F$Y$$$20240731$$CN$CA$CA
2047549012$20475490$12$F$$20240704$20220215$20240715$EXP$$CA-ROCHE-3008246$ROCHE$$$$A$F$Y$$$20240715$$CN$CA$CA
2047587840$20475878$40$F$20220902$20240815$20220215$20240822$EXP$$US-TAKEDA-2021TUS082775$TAKEDA$$77$YR$$M$Y$79$KG$20240822$$CN$US$US
2047588214$20475882$14$F$20210808$20240902$20220215$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-018263$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$61$KG$20240912$$MD$JP$JP
204758946$20475894$6$F$$20220408$20220215$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR022370$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204760108$20476010$8$F$20220922$20240829$20220215$20240902$EXP$$DE-ROCHE-3022825$ROCHE$$28$YR$A$F$Y$$$20240902$$CN$DE$DE
204762297$20476229$7$F$$20240916$20220215$20240919$PER$$US-TAKEDA-2022TUS009646$TAKEDA$$$$$F$Y$$$20240919$$MD$US$US
2047724221$20477242$21$F$20201105$20240822$20220215$20240830$EXP$$CA-CELLTRION INC.-2020CA031887$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
2047729212$20477292$12$F$20211001$20240710$20220215$20240715$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-153056$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240715$$CN$CA$CA
204773744$20477374$4$F$20220207$20220303$20220215$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-326732$RANBAXY$$22$YR$A$F$Y$$$20240702$$HP$US$US
204774623$20477462$3$F$$20240805$20220216$20240808$EXP$$PL-AUROBINDO-AUR-APL-2022-004522$AUROBINDO$Dr Woron J, Dr Siwek M. Pharmacological treatment of obesity and drug interactions that are dangerous for health and life (Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lekow). MEDYCYNA PRAKTYCZNA - PSYCHIATRIA( PRACTICE MEDICINE - PSYCHIATRY). 2021;83(6):49-51$29$YR$$F$Y$$$20240808$$MD$PL$PL
204777793$20477779$3$F$20220120$20220316$20220216$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR024300$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
2047786523$20477865$23$F$20220101$20240919$20220216$20240928$EXP$$CA-CELLTRION INC.-2022CA001639$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
204779129$20477912$9$F$20221001$20221020$20220216$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR026420$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
204783588$20478358$8$F$20220128$20230130$20220216$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR022402$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$PH$US$US
204783922$20478392$2$F$20220101$20220214$20220216$20240712$EXP$$GB-ASTELLAS-2022US005665$ASTELLAS$$$$$M$Y$$$20240712$$HP$GB$GB
2047853745$20478537$45$F$20220101$20240917$20220216$20240926$EXP$$CA-CELLTRION INC.-2021CA018789$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
2047857113$20478571$13$F$20181020$20240826$20220216$20240903$EXP$$CA-CELLTRION INC.-2018CA023645$CELLTRION$$$$$$Y$$$20240903$$CN$CA$CA
204788543$20478854$3$F$20220131$20220324$20220216$20240930$EXP$$NVSC2020IN031009$NOVARTIS$$68$YR$$M$Y$$$20240930$$CN$IN$IN
204794844$20479484$4$F$20090101$20240620$20220216$20240710$PER$$US-GILEAD-2022-0569130$GILEAD$$46$YR$A$M$Y$78.458$KG$20240710$$LW$US$US
2047972413$20479724$13$F$$20240629$20220216$20240703$EXP$$IN-PFIZER INC-202200214991$PFIZER$$66$YR$$F$Y$$$20240703$$CN$IN$IN
204797539$20479753$9$F$$20240904$20220216$20240909$EXP$$CA-PFIZER INC-2020324281$PFIZER$$65$YR$$F$Y$72$KG$20240909$$HP$CA$CA
2047986120$20479861$20$F$20170706$20240627$20220216$20240705$EXP$$CA-CELLTRION INC.-2021CA008381$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
204799472$20479947$2$F$20220119$20240711$20220216$20240726$EXP$$FR-SERVIER-S22001411$SERVIER$$$$$$Y$$$20240726$$MD$FR$FR
204801316$20480131$6$F$20231101$20240924$20220216$20240930$EXP$$US-PFIZER INC-202101618264$PFIZER$$52$YR$$F$Y$$$20240930$$HP$US$US
204803526$20480352$6$F$20240808$20240829$20220216$20240902$EXP$$US-PFIZER INC-202101629951$PFIZER$$80$YR$$F$Y$$$20240902$$CN$US$US
204804876$20480487$6$F$20211101$20240917$20220216$20240919$PER$$US-PFIZER INC-2021289874$PFIZER$$69$YR$$F$Y$$$20240919$$CN$US$US
204805033$20480503$3$F$20220201$20240807$20220216$20240808$EXP$$US-TAKEDA-2022TUS007543$TAKEDA$$81$YR$$M$Y$$$20240808$$CN$US$US
204807047$20480704$7$F$20220122$20220406$20220216$20240927$EXP$$NVSC2022TW035353$NOVARTIS$$66$YR$$F$Y$$$20240927$$MD$TW$TW
204809012$20480901$2$F$$20240819$20220216$20240828$EXP$$CA-APOTEX-2022AP003216$APOTEX$$50$YR$$F$Y$$$20240828$$HP$CA$CA
204811597$20481159$7$F$$20240924$20220216$20240930$EXP$$US-TAKEDA-2022TUS010565$TAKEDA$$$$$F$Y$106$KG$20240930$$HP$US$US
2048116317$20481163$17$F$20220101$20240919$20220216$20240927$EXP$$US-TAKEDA-2022TUS009642$TAKEDA$$$$$$Y$$$20240927$$CN$US$US
204812493$20481249$3$F$$20240715$20220216$20240718$EXP$$CA-BAUSCH-BL-2022-004528$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240718$$CN$CA$CA
204816297$20481629$7$F$$20240923$20220216$20240926$EXP$$CA-PFIZER INC-202101598908$PFIZER$$75$YR$$F$Y$$$20240926$$HP$CA$CA
204820174$20482017$4$F$20220222$20240709$20220216$20240711$EXP$$CA-TAKEDA-2021TUS046001$TAKEDA$$36$YR$$F$Y$$$20240711$$MD$CA$CA
204821099$20482109$9$F$$20231120$20220216$20240729$EXP$$NVSC2021CA302395$NOVARTIS$$44$YR$$F$Y$68$KG$20240729$$CN$CA$CA
204822193$20482219$3$F$$20240710$20220216$20240718$EXP$$CA-APOTEX-2022AP003276$APOTEX$$53$YR$$F$Y$$$20240718$$HP$CA$CA
204828464$20482846$4$F$20220201$20220304$20220217$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR024423$GLAXOSMITHKLINE$$32$YR$$F$Y$$$20240925$$CN$US$US
2048284817$20482848$17$F$20220201$20230525$20220217$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR025088$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240926$$CN$US$US
204832834$20483283$4$F$20220125$20240703$20220217$20240709$EXP$$JP-ASTELLAS-2022JP001537$ASTELLAS$$85$YR$$F$Y$60.9$KG$20240709$$MD$JP$JP
204842665$20484266$5$F$20220126$20240924$20220217$20240926$EXP$$CA-ROCHE-3024934$ROCHE$$52$YR$A$F$Y$$$20240926$$CN$CA$CA
204844245$20484424$5$F$20220210$20240822$20220217$20240826$EXP$$TR-ROCHE-3027442$ROCHE$$31$YR$A$M$Y$73$KG$20240826$$MD$TR$TR
204844773$20484477$3$F$20210101$20240912$20220217$20240913$EXP$$US-PFIZER INC-202200276849$PFIZER$$64$YR$$F$Y$$$20240913$$HP$US$US
2048448434$20484484$34$F$20220211$20240913$20220217$20240916$EXP$$AR-MYLANLABS-2021M1074791$MYLAN$$18$YR$$F$Y$$$20240916$$CN$AR$AR
204846057$20484605$7$F$20220212$20240729$20220217$20240731$EXP$$US-TAKEDA-2022TUS010782$TAKEDA$$28$YR$$M$Y$$$20240731$$CN$US$US
204849864$20484986$4$F$$20240922$20220217$20240924$PER$$NVSC2022US036621$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
204850122$20485012$2$F$$20240905$20220217$20240918$PER$$US-SA-2022SA047873$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240918$$MD$US$US
204859748$20485974$8$F$$20240725$20220217$20240729$EXP$$CA-PFIZER INC-202200222287$PFIZER$$31$YR$$F$Y$$$20240729$$HP$CA$CA
2048649610$20486496$10$F$20190101$20240815$20220217$20240820$EXP$$US-SHIRE-US201907507$TAKEDA$$71$YR$$M$Y$94$KG$20240820$$HP$US$US
204866847$20486684$7$F$$20240717$20220217$20240724$EXP$$NVSC2022US035743$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
204868524$20486852$4$F$20220101$20240705$20220217$20240715$PER$$US-SA-2022SA048813$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240715$$MD$US$US
2048691021$20486910$21$F$20220209$20240925$20220217$20240926$EXP$$US-TAKEDA-2022TUS007307$TAKEDA$$60$YR$$M$Y$$$20240926$$CN$US$US
204870844$20487084$4$F$20210101$20240729$20220217$20240806$EXP$$CA-BEH-2021135164$CSL BEHRING$$57$YR$A$F$Y$86$KG$20240806$$HP$CA$CA
204870859$20487085$9$F$20200101$20240625$20220217$20240710$EXP$$DE-ABBVIE-22K-062-4277446-00$ABBVIE$$$$$M$Y$80$KG$20240710$$MD$DE$DE
204872705$20487270$5$F$20220120$20220531$20220217$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR024118$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240925$$CN$US$US
2048768211$20487682$11$F$20220801$20230118$20220218$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR024446$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240925$$CN$US$US
2048786312$20487863$12$F$20220425$20240920$20220218$20240926$EXP$$US-TAKEDA-2021TUS042264$TAKEDA$$54$YR$$M$Y$150$KG$20240926$$CN$US$US
204880517$20488051$7$F$$20220330$20220218$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR024413$GLAXOSMITHKLINE$$$$$F$Y$48.526$KG$20240925$$CN$US$US
204880758$20488075$8$F$$20240813$20220218$20240823$EXP$$CA-APOTEX-2022AP003249$APOTEX$$71$YR$$F$Y$69$KG$20240823$$HP$CA$CA
204881502$20488150$2$F$$20220208$20220218$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR023127$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204883369$20488336$9$F$20220101$20240906$20220218$20240916$EXP$$CA-CELLTRION INC.-2021CA018334$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
204883743$20488374$3$F$$20240715$20220218$20240722$EXP$$FR-AUROBINDO-AUR-APL-2022-004595$AUROBINDO$Laurent R et al. Drug monitoring for diagnosis of pharmacobezoar: a case report. FundamClin Pharmacol. 2021;35:195$51$YR$$F$Y$$$20240722$$HP$FR$FR
204885882$20488588$2$F$$20220209$20220218$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR024448$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204886887$20488688$7$F$$20240812$20220218$20240817$EXP$$NVSC2022GB035309$NOVARTIS$$$$A$F$Y$$$20240817$$CN$GB$GB
204887434$20488743$4$F$20220207$20240718$20220218$20240723$EXP$$US-SA-2022SA048678$SANOFI AVENTIS$$93$YR$E$F$Y$$$20240723$$MD$US$US
204888994$20488899$4$F$$20240911$20220218$20240923$EXP$$CA-APOTEX-2022AP003513$APOTEX$$29$YR$$M$Y$89$KG$20240923$$HP$CA$CA
204889043$20488904$3$F$20240701$20240709$20220218$20240717$PER$$US-SA-2022SA051216$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240717$$MD$US$US
2048913613$20489136$13$F$20211111$20240911$20220218$20240919$EXP$$CA-TAKEDA-2021TUS069049$TAKEDA$$44$YR$$F$Y$$$20240919$$MD$CA$CA
204894406$20489440$6$F$20211019$20240702$20220218$20240704$EXP$$IN-PFIZER INC-2021548414$PFIZER$$74$YR$$F$Y$$$20240704$$CN$IN$IN
2048970913$20489709$13$F$20220901$20240716$20220218$20240723$EXP$$US-TAKEDA-2021TUS043439$TAKEDA$$18$YR$$F$Y$177$KG$20240723$$CN$US$US
204897345$20489734$5$F$20210416$20240905$20220218$20240911$EXP$$CA-TAKEDA-2022TUS011104$TAKEDA$$3$YR$$M$Y$19$KG$20240911$$CN$CA$CA
204900902$20490090$2$F$20220204$20240918$20220218$20240923$PER$$US-SA-2022SA049947$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240923$$MD$US$US
204903682$20490368$2$F$$20240809$20220218$20240815$EXP$$GB-TAKEDA-2022TUS009749$TAKEDA$$$$E$F$Y$$$20240815$$CN$GB$GB
2049041210$20490412$10$F$$20240903$20220218$20240906$EXP$$CA-TAKEDA-2021TUS034993$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
204905182$20490518$2$F$20220128$20240813$20220218$20240816$EXP$$JP-009507513-2202JPN001919J$MERCK$$79$YR$$M$Y$$$20240816$$PH$JP$JP
204909172$20490917$2$F$$20240918$20220218$20240924$EXP$$US-AMGEN-USASP2022028093$AMGEN$$$$A$F$Y$$$20240924$$HP$US$US
204922373$20492237$3$F$$20240920$20220218$20240927$EXP$$US-TAKEDA-2022TUS011050$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
204925062$20492506$2$F$$20240801$20220219$20240814$EXP$$CA-AUROBINDO-AUR-APL-2022-004832$AUROBINDO$$$$$F$Y$52$KG$20240814$$MD$CA$CA
204927136$20492713$6$F$20190225$20240710$20220219$20240718$EXP$$PHHY2019CO073685$NOVARTIS$$42$YR$$F$Y$100$KG$20240718$$CN$CO$CO
204928257$20492825$7$F$20210115$20240731$20220219$20240801$EXP$$BE-ROCHE-3028269$ROCHE$$47$YR$A$F$Y$48$KG$20240801$$MD$BE$BE
204928412$20492841$2$F$$20240714$20220219$20240718$EXP$$CA-ROCHE-3029036$ROCHE$$$$A$F$Y$$$20240718$$CN$CA$CA
204929124$20492912$4$F$20000101$20240904$20220219$20240911$EXP$$US-SHIRE-US202030725$TAKEDA$$$$$F$Y$$$20240911$$HP$US$US
204937815$20493781$5$F$$20220525$20220221$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR025362$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
204938682$20493868$2$F$$20240821$20220221$20240904$PER$$US-SA-2022SA052335$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240904$$CN$US$US
2049392222$20493922$22$F$20220305$20240926$20220221$20240930$PER$$US-DSJP-DSU-2022-105982$DAIICHI$$16$YR$$F$Y$$$20240930$$MD$US$US
204939477$20493947$7$F$20220205$20240917$20220221$20240920$EXP$$JP-TAKEDA-2022TJP019418$TAKEDA$$6$YR$$M$Y$14.1$KG$20240920$$PH$JP$JP
204940602$20494060$2$F$20230101$20240703$20220221$20240708$EXP$$US-SHIRE-US201730226$TAKEDA$$$$$M$Y$$$20240708$$HP$US$US
2049414015$20494140$15$F$20220201$20230428$20220221$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR027165$GLAXOSMITHKLINE$$43$YR$$F$Y$$$20240925$$HP$US$US
204942398$20494239$8$F$20110802$20240723$20220221$20240727$EXP$$US-TAKEDA-2022TUS009753$TAKEDA$$58$YR$$M$Y$68$KG$20240727$$MD$US$US
204942413$20494241$3$F$20210501$20240726$20220221$20240801$EXP$$CA-BIOGEN-2021BI01033272$BIOGEN$$33$YR$$F$Y$$$20240801$$HP$CA$CA
204945839$20494583$9$F$20220124$20240801$20220221$20240807$EXP$$JP-ASTELLAS-2022JP001542$ASTELLAS$$68$YR$$M$Y$57$KG$20240807$$CN$JP$JP
204951107$20495110$7$F$20210301$20240717$20220221$20240724$EXP$$CA-TAKEDA-2021TUS017152$TAKEDA$$87$YR$$F$Y$$$20240724$$MD$CA$CA
204952876$20495287$6$F$20200101$20240820$20220221$20240822$EXP$$US-PFIZER INC-202200229476$PFIZER$$74$YR$$F$Y$$$20240822$$MD$US$US
204953422$20495342$2$F$$20240830$20220221$20240904$EXP$$US-PFIZER INC-202200276701$PFIZER$$61$YR$$F$Y$$$20240904$$CN$US$US
204955934$20495593$4$F$20220123$20240924$20220221$20240926$EXP$$CA-TAKEDA-2022TUS011630$TAKEDA$$38$YR$$M$Y$$$20240926$$CN$CA$CA
204958934$20495893$4$F$20201128$20240809$20220221$20240814$EXP$$CA-TAKEDA-2019TUS060093$TAKEDA$$39$YR$$F$Y$$$20240814$$CN$CA$CA
204958958$20495895$8$F$20220323$20240815$20220221$20240819$EXP$$CA-TAKEDA-2021TUS038742$TAKEDA$$27$YR$$M$Y$$$20240819$$HP$CA$CA
204959004$20495900$4$F$$20220623$20220221$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR029571$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2049630018$20496300$18$F$20220208$20240729$20220221$20240807$EXP$$IT-EMD Serono-9300419$EMD SERONO INC$$42$YR$A$F$Y$50$KG$20240807$$MD$IT$IT
204966456$20496645$6$F$20191223$20240917$20220221$20240926$EXP$$CA-TAKEDA-2019TUS002508$TAKEDA$$57$YR$$F$Y$$$20240926$$CN$CA$CA
204967693$20496769$3$F$20210101$20220128$20220221$20240716$EXP$$DE-ASTELLAS-2022US006131$ASTELLAS$$90$YR$$M$Y$$$20240716$$MD$DE$DE
2049708910$20497089$10$F$20221010$20240814$20220221$20240817$EXP$$US-TAKEDA-2022TUS011777$TAKEDA$$90$YR$$M$Y$68$KG$20240817$$HP$US$US
204973555$20497355$5$F$20220204$20240726$20220221$20240805$EXP$$BR-TAKEDA-2022TUS011444$TAKEDA$$28$YR$$M$Y$70$KG$20240805$$CN$BR$BR
204976188$20497618$8$F$$20240715$20220221$20240722$EXP$$FR-AUROBINDO-AUR-APL-2022-003854$AUROBINDO$Sastre, C,Baillif-Couniou V, Fabresse N,Ameline A,Kintz P,Gaulier J-M, et. al. Misuse of pregabalin: about seven cases of death in the Marseille region. Analytical + Clinical Toxicology. 2022;34(3):151-158$47$YR$$M$Y$$$20240722$$MD$FR$FR
204989437$20498943$7$F$20211206$20240903$20220222$20240905$EXP$$JP-TAKEDA-2022TJP020061$TAKEDA$$16$YR$$M$Y$23.9$KG$20240905$$MD$JP$JP
204990622$20499062$2$F$$20240715$20220222$20240723$PER$$US-SA-2022SA028760$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240723$$MD$US$US
204994543$20499454$3$F$20220101$20240626$20220222$20240703$PER$$US-BIOGEN-2022BI01098161$BIOGEN$$43$YR$$F$Y$$$20240703$$CN$US$US
205001185$20500118$5$F$20220201$20220308$20220222$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR029388$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240925$$CN$US$US
2050020714$20500207$14$F$20220113$20240911$20220222$20240912$EXP$$GB-MYLANLABS-2022M1003724$MYLAN$$58$YR$$M$Y$$$20240912$$CN$GB$GB
205004307$20500430$7$F$$20240821$20220222$20240828$EXP$$NVSC2022CO038494$NOVARTIS$$$$$F$Y$48$KG$20240828$$CN$CO$CO
205006002$20500600$2$F$20220212$20240625$20220222$20240703$PER$$US-SA-2022SA054284$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240703$$MD$US$US
205007756$20500775$6$F$20220210$20240906$20220222$20240912$EXP$$CA-TAKEDA-2021TUS017537$TAKEDA$$44$YR$$F$Y$$$20240912$$MD$CA$CA
205012827$20501282$7$F$20220211$20240716$20220222$20240718$PER$$NVSC2022US038720$NOVARTIS$$44$YR$$F$Y$$$20240718$$CN$US$US
205015508$20501550$8$F$$20240821$20220222$20240822$EXP$$US-PFIZER INC-202200257166$PFIZER$$78$YR$$M$Y$$$20240822$$CN$US$US
205018422$20501842$2$F$20210801$20220213$20220222$20240731$EXP$$TR-ASTELLAS-2022US006187$ASTELLAS$$64$YR$$M$Y$$$20240731$$MD$TR$TR
205022333$20502233$3$F$20220210$20240625$20220222$20240709$EXP$$TR-ROCHE-3027434$ROCHE$$27$YR$A$F$Y$60$KG$20240703$$MD$TR$TR
205026592$20502659$2$F$20240601$20240709$20220222$20240716$PER$$US-SA-2022SA053169$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240716$$MD$US$US
2050272712$20502727$12$F$20211201$20240624$20220222$20240702$EXP$$NVSC2022EG026840$NOVARTIS$$57$YR$$F$Y$80$KG$20240702$$CN$EG$EG
205028942$20502894$2$F$20220204$20240813$20220222$20240816$EXP$$JP-009507513-2202JPN002017J$MERCK$$78$YR$$M$Y$$$20240816$$PH$JP$JP
205035558$20503555$8$F$20200101$20240801$20220222$20240808$EXP$$CO-TAKEDA-2020TUS006276$TAKEDA$$27$YR$$F$Y$84$KG$20240808$$HP$CO$CO
205039393$20503939$3$F$20220212$20240813$20220222$20240820$EXP$$JP-009507513-2202JPN002953J$MERCK$$62$YR$$F$Y$$$20240820$$PH$JP$JP
205050629$20505062$9$F$$20240814$20220223$20240816$EXP$$CA-ROCHE-3029902$ROCHE$$$$A$F$Y$$$20240816$$MD$CA$CA
205057132$20505713$2$F$$20220221$20220223$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR032208$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
205058513$20505851$3$F$$20220323$20220223$20240711$EXP$$DE-ASTELLAS-2022US006651$ASTELLAS$$78$YR$$M$Y$$$20240711$$CN$DE$DE
205058682$20505868$2$F$20220201$20220215$20220223$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR028669$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
205059143$20505914$3$F$20210407$20220311$20220223$20240711$EXP$$GB-ASTELLAS-2022US006615$ASTELLAS$$74$YR$$M$Y$$$20240711$$MD$GB$GB
2050614828$20506148$28$F$$20240827$20220223$20240903$EXP$$US-TAKEDA-2021TUS034895$TAKEDA$$$$$F$Y$81$KG$20240903$$HP$US$US
205062267$20506226$7$F$20220217$20240906$20220223$20240916$30DAY$$US-GLAXOSMITHKLINE-US2022031546$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240916$$HP$US$US
205062886$20506288$6$F$$20240812$20220223$20240820$EXP$$CA-APOTEX-2017AP022153$APOTEX$$53$YR$$F$Y$53$KG$20240820$$HP$CA$CA
2050653830$20506538$30$F$20220113$20240820$20220223$20240824$EXP$$US-TAKEDA-2021TUS020198$TAKEDA$$62$YR$$F$Y$112$KG$20240824$$HP$US$US
2050684512$20506845$12$F$20220201$20220915$20220223$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR031291$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
205071629$20507162$9$F$20210704$20240913$20220223$20240918$EXP$$US-TAKEDA-2021TUS036982$TAKEDA$$5$YR$$F$Y$17$KG$20240918$$CN$US$US
2050720519$20507205$19$F$$20240904$20220223$20240926$EXP$$NVSC2022PT031088$NOVARTIS$Monteiro C, Dias B, Vaz-Patto M. Headache as an adverse reaction to the use of medication in the elderly: a pharmacovigilance study. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2021;18(5):1-11$$$E$$Y$$$20240926$$HP$PT$PT
205073852$20507385$2$F$$20240820$20220223$20240827$EXP$$US-PFIZER INC-202101654042$PFIZER$$56$YR$$F$Y$$$20240827$$HP$US$US
205075022$20507502$2$F$$20240702$20220223$20240711$PER$$US-SA-2022SA056896$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240711$$CN$US$US
2050754112$20507541$12$F$20211231$20240916$20220223$20240924$EXP$$DE-ROCHE-2353123$ROCHE$$52$YR$A$F$Y$$$20240924$$CN$DE$DE
2050770411$20507704$11$F$20190227$20240712$20220223$20240726$EXP$$DE-ROCHE-2284836$ROCHE$$24$YR$A$F$Y$75$KG$20240726$$CN$DE$DE
205086859$20508685$9$F$20220101$20240909$20220223$20240916$EXP$$JP-009507513-2202JPN000800J$MERCK$$83$YR$$F$Y$$$20240916$$MD$JP$JP
205089178$20508917$8$F$$20240916$20220223$20240919$EXP$$CA-PFIZER INC-202200281217$PFIZER$$66$YR$$F$Y$$$20240919$$HP$CA$CA
205090854$20509085$4$F$$20240809$20220223$20240814$EXP$$US-KYOWAKIRIN-2022BKK001908$KYOWA$$$$$$Y$$$20240814$$HP$US$US
205094632$20509463$2$F$20240624$20240628$20220224$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000551$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240723$$HP$US$US
205099205$20509920$5$F$$20220811$20220224$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR027448$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
205099532$20509953$2$F$$20220221$20220224$20240711$EXP$$DE-ASTELLAS-2022US006955$ASTELLAS$$84$YR$$M$Y$$$20240711$$CN$DE$DE
205100773$20510077$3$F$$20240812$20220224$20240819$EXP$$CA-APOTEX-2022AP003638$APOTEX$$52$YR$$F$Y$$$20240819$$HP$CA$CA
2051007815$20510078$15$F$20180412$20240626$20220224$20240704$EXP$$CA-CELLTRION INC.-2021CA018604$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
205100823$20510082$3$F$20220104$20240629$20220224$20240708$EXP$$ES-CELLTRION INC.-2022ES002206$CELLTRION$$$$$$Y$$$20240708$$HP$ES$ES
205106573$20510657$3$F$20220201$20240703$20220224$20240709$PER$$US-BIOGEN-2022BI01095784$BIOGEN$$54$YR$$F$Y$$$20240709$$CN$US$US
205106852$20510685$2$F$$20240918$20220224$20240920$PER$$NVSC2022US041919$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
205107867$20510786$7$F$20220101$20220912$20220224$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR029532$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240925$$CN$US$US
205111164$20511116$4$F$20220201$20220519$20220224$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR031411$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
205112628$20511262$8$F$20230113$20240723$20220224$20240812$PER$$CA-TOLMAR, INC.-21CA031106$TOLMAR$$83$YR$$M$Y$$$20240812$$CN$CA$CA
205113078$20511307$8$F$$20240916$20220224$20240920$EXP$$CA-Orion Corporation ORION PHARMA-22_00017671$ORION$$66$YR$E$F$Y$$$20240920$$HP$CA$
2051136710$20511367$10$F$20191107$20240814$20220224$20240816$EXP$$DE-ROCHE-2593716$ROCHE$$26$YR$A$F$Y$$$20240816$$CN$DE$DE
205114913$20511491$3$F$20240124$20240807$20220224$20240814$EXP$$CA-GLAXOSMITHKLINE-CA2022030249$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$HP$CA$CA
2051214825$20512148$25$F$20220611$20240816$20220224$20240820$EXP$$US-PAREXEL-2021-KAM-US003521$TAKEDA$$54$YR$$F$Y$92$KG$20240820$$HP$US$US
205128497$20512849$7$F$20240807$20240902$20220224$20240910$PER$$CA-TOLMAR, INC.-21CA028579$TOLMAR$$68$YR$$M$Y$$$20240910$$CN$CA$CA
205129648$20512964$8$F$$20240723$20220224$20240803$EXP$CA-MHPD-E2B_03676035$CA-Accord-254860$ACCORD$$56$YR$A$F$Y$$$20240803$$HP$CA$CA
205131744$20513174$4$F$20210101$20240912$20220224$20240923$EXP$$US-AMNEAL PHARMACEUTICALS-2021-AMRX-00976$AMNEAL$$$$$F$Y$$$20240923$$CN$US$US
2051319724$20513197$24$F$20220718$20240822$20220224$20240828$EXP$$US-PAREXEL-2021-KAM-US003583$TAKEDA$$63$YR$$F$Y$100$KG$20240828$$HP$US$US
205133013$20513301$3$F$$20240821$20220224$20240829$EXP$$CA-APOTEX-2022AP003792$APOTEX$$66$YR$$F$Y$$$20240829$$HP$CA$CA
205140567$20514056$7$F$20210101$20240710$20220224$20240717$EXP$$US-AMNEAL PHARMACEUTICALS-2021-AMRX-02697$AMNEAL$$$$$M$Y$$$20240717$$CN$US$US
205146157$20514615$7$F$20220101$20240909$20220224$20240919$EXP$$GB-ROCHE-3034943$ROCHE$$43$YR$A$F$Y$$$20240919$$MD$GB$GB
205150072$20515007$2$F$$20240904$20220224$20240913$PER$$US-SA-2022SA057543$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240913$$MD$US$US
205150662$20515066$2$F$$20240919$20220224$20240924$EXP$$US-KYOWAKIRIN-2022BKK001978$KYOWA$$$$$$Y$$$20240924$$HP$US$US
205151863$20515186$3$F$20240611$20240923$20220224$20240926$EXP$$US-PFIZER INC-202200282651$PFIZER$$42$YR$$F$Y$75.75$KG$20240926$$CN$US$US
205155635$20515563$5$F$20211223$20240624$20220224$20240702$EXP$$JP-JAZZ-2022-JP-004241$JAZZ$$50$YR$$M$Y$57.4$KG$20240702$$MD$JP$JP
205157659$20515765$9$F$$20240627$20220224$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000383$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
2051623622$20516236$22$F$20211105$20240715$20220225$20240724$EXP$$CA-CELLTRION INC.-2021CA018858$CELLTRION$$$$$$Y$$$20240724$$HP$CA$CA
2051649530$20516495$30$F$20211101$20240910$20220225$20240919$EXP$$CA-CELLTRION INC.-2021CA018416$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
205168204$20516820$4$F$$20240715$20220225$20240722$PER$$US-BIOGEN-2022BI01098770$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
2051686011$20516860$11$F$20211201$20240722$20220225$20240725$EXP$$US-ABBVIE-22K-163-4291504-00$ABBVIE$$75$YR$$M$Y$$$20240725$$CN$US$US
205170562$20517056$2$F$$20240905$20220225$20240911$EXP$$BR-TAKEDA-BR202014864$TAKEDA$$$$$M$Y$60$KG$20240911$$CN$BR$BR
205171658$20517165$8$F$20220201$20240720$20220225$20240725$EXP$$NVSC2022IN042022$NOVARTIS$$24$YR$$F$Y$$$20240725$$CN$IN$IN
205174136$20517413$6$F$20210101$20240807$20220225$20240819$EXP$$US-AMNEAL PHARMACEUTICALS-2022-AMRX-00468$AMNEAL$$$$$M$Y$49.887$KG$20240819$$CN$US$US
205175289$20517528$9$F$$20240812$20220225$20240817$EXP$$NVSC2022US042723$NOVARTIS$$$$$M$Y$$$20240817$$CN$US$US
2051758410$20517584$10$F$$20240821$20220225$20240823$EXP$$CA-Orion Corporation ORION PHARMA-22_00017684$ORION$$70$YR$E$M$Y$100$KG$20240823$$HP$CA$
205177707$20517770$7$F$20210501$20240725$20220225$20240813$PER$$CA-TOLMAR, INC.-21CA031251$TOLMAR$$76$YR$$M$Y$$$20240813$$CN$CA$CA
205179153$20517915$3$F$$20220218$20220225$20240925$EXP$$US-TAKEDA-2022TUS012369$TAKEDA$$$$$M$Y$$$20240925$$CN$US$US
2051815410$20518154$10$F$20200701$20240624$20220225$20240708$EXP$$CA-CURRAX PHARMACEUTICALS-2020-010841$CURRAX PHARMACEUTICALS$$56$YR$$F$Y$74.376$KG$20240708$$CN$CA$CA
205185302$20518530$2$F$20220201$20240626$20220225$20240705$PER$$US-SA-2022SA059252$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240705$$MD$US$US
2051881734$20518817$34$F$20221026$20240807$20220225$20240927$EXP$$US-PAREXEL-2021-KAM-US003563$TAKEDA$$53$YR$$F$Y$48$KG$20240927$$HP$US$US
2052003710$20520037$10$F$20190917$20240819$20220225$20240823$EXP$$MX-TAKEDA-MX201931065$TAKEDA$$11$YR$$M$Y$45$KG$20240823$$CN$MX$MX
2052054025$20520540$25$F$20220101$20240710$20220225$20240717$EXP$$CA-TAKEDA-2022TUS006938$TAKEDA$$$$$M$Y$$$20240717$$PH$CA$CA
205205705$20520570$5$F$$20240809$20220225$20240813$PER$$US-PFIZER INC-202200150710$PFIZER$$65$YR$$F$Y$$$20240813$$PH$US$US
205207392$20520739$2$F$20240701$20240701$20220225$20240703$EXP$$US-PFIZER INC-2021668130$PFIZER$$72$YR$$F$Y$$$20240703$$CN$US$US
2052124229$20521242$29$F$20210219$20240828$20220226$20240906$EXP$$CA-CELLTRION INC.-2021CA003343$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
2052134911$20521349$11$F$20220309$20240911$20220226$20240918$EXP$$CA-TAKEDA-2022TUS003141$TAKEDA$$44$YR$$M$Y$$$20240918$$CN$CA$CA
205216285$20521628$5$F$20220201$20240624$20220226$20240703$PER$$US-SA-2022SA063620$SANOFI AVENTIS$$29$YR$A$F$Y$58.9$KG$20240703$$MD$US$US
205236106$20523610$6$F$$20240625$20220228$20240709$EXP$$CA-GLENMARK PHARMACEUTICALS-2022GMK070813$GLENMARK$$$$$$Y$$$20240709$$CN$CA$CA
205238389$20523838$9$F$$20240726$20220228$20240803$EXP$$CA-TEVA-2022-CA-2012805$TEVA$$30$YR$$M$Y$84$KG$20240803$$HP$CA$CA
205239048$20523904$8$F$$20240815$20220228$20240822$EXP$$CA-TAKEDA-2022TUS012474$TAKEDA$$$$$M$Y$$$20240822$$HP$CA$CA
205248686$20524868$6$F$$20220909$20220228$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR034760$GLAXOSMITHKLINE$$$$$F$Y$41$KG$20240926$$CN$US$US
2052558028$20525580$28$F$20220101$20240722$20220228$20240726$PER$$US-BIOVITRUM-2022US02681$BIOVITRUM$$68$YR$$F$Y$$$20240726$$CN$US$US
2052592817$20525928$17$F$20210627$20240717$20220228$20240725$EXP$$CH-ABBVIE-21K-151-4014161-00$ABBVIE$$67$YR$$M$Y$113$KG$20240725$$MD$CH$CH
205259446$20525944$6$F$$20240816$20220228$20240821$EXP$$CA-TAKEDA-2022TUS012653$TAKEDA$$$$$F$Y$$$20240821$$MD$CA$CA
2052598810$20525988$10$F$20210101$20240820$20220228$20240904$EXP$$CA-SAMSUNG BIOEPIS-SB-2021-19762$SAMSUNG BIOEPIS$$36$YR$A$F$Y$75$KG$20240904$$CN$CA$CA
205260845$20526084$5$F$20220101$20240823$20220228$20240903$EXP$$CA-ROCHE-3033039$ROCHE$$21$YR$A$F$Y$$$20240903$$CN$CA$CA
205261112$20526111$2$F$$20240925$20220228$20240926$EXP$$US-PFIZER INC-202200317039$PFIZER$$75$YR$$F$Y$$$20240926$$CN$US$US
205267603$20526760$3$F$20220131$20220315$20220228$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR030402$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
2052694711$20526947$11$F$$20240628$20220228$20240702$PER$$US-PFIZER INC-2019295751$PFIZER$$68$YR$$M$Y$$$20240702$$MD$US$US
205271996$20527199$6$F$$20240829$20220228$20240903$EXP$$CA-TAKEDA-2022TUS012676$TAKEDA$$$$$F$Y$$$20240903$$CN$CA$CA
205272814$20527281$4$F$20200101$20240716$20220228$20240723$EXP$$US-BIOGEN-2021BI01067929$BIOGEN$$$$$F$Y$$$20240723$$CN$US$US
205277222$20527722$2$F$$20240813$20220228$20240828$EXP$$CA-HLS-202200400$HLS THERAPEUTICS$$66$YR$E$F$Y$$$20240828$$HP$CA$CA
205278513$20527851$3$F$20220215$20240626$20220228$20240705$PER$$US-SA-2022SA061316$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240705$$MD$US$US
2052810216$20528102$16$F$20220218$20240826$20220228$20240829$EXP$$AU-TAKEDA-2022TUS013266$TAKEDA$$23$YR$$F$Y$$$20240829$$CN$AU$AU
205282974$20528297$4$F$$20240807$20220228$20240816$PER$$US-SA-2022SA061365$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
205294833$20529483$3$F$$20220509$20220228$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR034375$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$MD$US$US
205295047$20529504$7$F$20210101$20240726$20220228$20240813$PER$$CA-TOLMAR, INC.-21CA031182$TOLMAR$$$$$M$Y$$$20240813$$CN$CA$CA
205297002$20529700$2$F$$20220222$20220301$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR033504$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
205298257$20529825$7$F$20220304$20220519$20220301$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR032001$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
2053006312$20530063$12$F$20240601$20240808$20220301$20240815$EXP$$US-GLAXOSMITHKLINE-US2022AMR033457$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$CN$US$US
2053010123$20530101$23$F$20210528$20240903$20220301$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-118426$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$58$KG$20240906$$MD$JP$JP
205301129$20530112$9$F$20210530$20240911$20220301$20240921$EXP$$CA-ROCHE-3030035$ROCHE$$44$YR$A$F$Y$$$20240921$$HP$CA$CA
205302185$20530218$5$F$20200923$20240902$20220301$20240924$PER$$CO-TOLMAR, INC.-20CO023274$TOLMAR$$80$YR$$M$Y$$$20240923$$CN$CO$CO
205302662$20530266$2$F$20220221$20240620$20220301$20240809$PER$$US-LUNDBECK-DKLU3045021$LUNDBECK$$$$$$Y$$$20240809$$HP$US$US
205305524$20530552$4$F$20190426$20240802$20220301$20240806$EXP$$US-KYOWAKIRIN-2022BKK002384$KYOWA$$$$$$Y$$$20240806$$HP$US$US
205307584$20530758$4$F$20211201$20240628$20220301$20240703$EXP$$NVSC2021RU301208$NOVARTIS$$64$YR$$F$Y$80$KG$20240703$$HP$RU$RU
205310447$20531044$7$F$20220214$20220620$20220301$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR031533$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
205310803$20531080$3$F$20080101$20240806$20220301$20240808$EXP$$US-ORGANON-O2203USA000028$ORGANON$$$$$F$Y$51.2$KG$20240808$$MD$US$US
205310819$20531081$9$F$20100101$20240702$20220301$20240705$EXP$$US-ORGANON-O2202USA002290$ORGANON$$$$$M$Y$$$20240705$$MD$US$US
205315262$20531526$2$F$20220201$20240708$20220301$20240716$PER$$US-SA-2022SA062235$SANOFI AVENTIS$$20$YR$A$M$Y$115.6$KG$20240716$$MD$US$US
205320276$20532027$6$F$20220101$20240701$20220301$20240705$EXP$$US-GW PHARMA-202202USGW00885$JAZZ$$37$YR$$F$Y$78.458$KG$20240705$$CN$US$US
205327616$20532761$6$F$$20240712$20220301$20240715$EXP$$US-ORGANON-O2202USA002287$ORGANON$$$$$M$Y$$$20240715$$MD$US$US
205329388$20532938$8$F$20000101$20240723$20220301$20240725$EXP$$US-ORGANON-O2202USA002336$ORGANON$$$$$F$Y$95.692$KG$20240725$$MD$US$US
2053339629$20533396$29$F$20210219$20240905$20220301$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-025440$BRISTOL MYERS SQUIBB$Yahiro C, Takai T, Nakatani S, Tanaka N, Goto A. Skin rash associated with combined cytotoxic chemotherapy and immunotherapy for cancer: a retrospective single-center case series. The Journal of Dermatology. 2022;1-7.doi:DOI: 10.1111/1346-8138.16614.$46$YR$A$M$Y$$$20240911$$MD$JP$JP
205336607$20533660$7$F$$20240726$20220301$20240730$PER$$US-PFIZER INC-202101106660$PFIZER$$68$YR$$F$Y$$$20240730$$CN$US$US
205337298$20533729$8$F$20190114$20240812$20220301$20240814$PER$$US-PFIZER INC-2019029808$PFIZER$$74$YR$$F$Y$$$20240814$$PH$US$US
2053403423$20534034$23$F$20180516$20240717$20220301$20240729$EXP$$DE-ROCHE-2129455$ROCHE$$73$YR$E$F$Y$$$20240729$$CN$DE$DE
205341115$20534111$5$F$20210824$20240625$20220301$20240701$EXP$$US-ABBVIE-21K-163-4077127-00$ABBVIE$$58$YR$$M$Y$77$KG$20240701$$CN$US$US
205341602$20534160$2$F$$20220222$20220301$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR033530$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
205343763$20534376$3$F$20211203$20240829$20220302$20240902$EXP$$BE-ROCHE-3037452$ROCHE$$39$YR$A$F$Y$71$KG$20240902$$MD$BE$BE
205344427$20534442$7$F$$20220715$20220302$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR035846$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2053447713$20534477$13$F$20220201$20240826$20220302$20240903$EXP$$CA-CELLTRION INC.-2022CA002481$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
2053464419$20534644$19$F$20200214$20240829$20220302$20240907$EXP$$CA-CELLTRION INC.-2019CA028256$CELLTRION$$$$$$Y$$$20240907$$MD$CA$CA
205346692$20534669$2$F$20211110$20220322$20220302$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-324447$RANBAXY$$25$YR$A$F$Y$$$20240702$$CN$US$US
205347822$20534782$2$F$$20240923$20220302$20240925$PER$$US-AMGEN-USASP2022035315$AMGEN$$51$YR$A$M$Y$$$20240924$$HP$US$US
2053479417$20534794$17$F$20190429$20240711$20220302$20240722$EXP$$CA-ROCHE-2317458$ROCHE$$39$YR$A$M$Y$$$20240722$$CN$CA$CA
205351189$20535118$9$F$20210101$20240723$20220302$20240731$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2022-05174$IPSEN$$64$YR$A$M$Y$$$20240731$$CN$US$US
205352869$20535286$9$F$20210812$20240627$20220302$20240710$EXP$$CA-ROCHE-2773435$ROCHE$$33$YR$A$M$Y$$$20240710$$CN$CA$CA
2053590611$20535906$11$F$20010101$20240809$20220302$20240813$EXP$$US-ORGANON-O2202USA002341$ORGANON$$$$$F$Y$$$20240813$$MD$US$US
205359468$20535946$8$F$20220221$20240729$20220302$20240801$EXP$$JP-ASTELLAS-2022JP003333$ASTELLAS$$61$YR$$M$Y$$$20240801$$MD$JP$JP
205361833$20536183$3$F$20220223$20220315$20220302$20240710$EXP$$DE-ASTELLAS-2022US007731$ASTELLAS$$$$$M$Y$$$20240710$$CN$DE$DE
205368652$20536865$2$F$$20240916$20220302$20240920$EXP$$CA-JNJFOC-20211158608$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240920$$PH$CA$CA
205370337$20537033$7$F$$20240827$20220302$20240829$PER$$NVSC2022US048808$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
205372987$20537298$7$F$20220307$20240730$20220302$20240805$EXP$$CA-TAKEDA-2022TUS013628$TAKEDA$$45$YR$$F$Y$$$20240805$$HP$CA$CA
205390077$20539007$7$F$20170729$20240708$20220302$20240712$EXP$$JP-JNJFOC-20210911063$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240712$$MD$JP$JP
2054006114$20540061$14$F$20210115$20240703$20220302$20240709$EXP$$IT-ROCHE-2815954$ROCHE$$50$YR$A$F$Y$48$KG$20240709$$MD$IT$IT
205401922$20540192$2$F$$20240709$20220302$20240712$EXP$$ES-PFIZER INC-202200294139$PFIZER$$$$A$F$Y$$$20240712$$MD$ES$ES
205404523$20540452$3$F$$20240912$20220302$20240922$EXP$$GR-JNJFOC-20211137979$JOHNSON AND JOHNSON$$$$$$Y$$$20240922$$HP$GR$GR
205406636$20540663$6$F$$20240724$20220302$20240729$EXP$$US-PFIZER INC-2021643050$PFIZER$$74$YR$$F$Y$104.3$KG$20240729$$CN$US$US
205406813$20540681$3$F$20220201$20220314$20220302$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR035040$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
205409855$20540985$5$F$20190711$20240711$20220302$20240715$EXP$$CA-TAKEDA-2019TUS041150$TAKEDA$$26$YR$$F$Y$$$20240715$$CN$CA$CA
205409987$20540998$7$F$$20240911$20220302$20240913$EXP$$US-PFIZER INC-202200300117$PFIZER$$71$YR$$M$Y$$$20240913$$CN$US$US
205413153$20541315$3$F$$20240820$20220302$20240822$PER$$US-PFIZER INC-2021750942$PFIZER$$63$YR$$M$Y$$$20240822$$HP$US$US
205413555$20541355$5$F$20210714$20240802$20220302$20240806$EXP$$JP-JNJFOC-20211025004$JOHNSON AND JOHNSON$$9$DEC$E$M$Y$$$20240806$$MD$JP$JP
205418245$20541824$5$F$20201124$20240819$20220302$20240827$EXP$$JP-DSJP-DSJ-2022-106612$DAIICHI$Anzai Y, Yukawa H, Kodera A, Ishibashi Y, Fujita S, Uemura M, et al.. EP-0667 Results of use of trastuzumab deruxtecan at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;344$56$YR$$F$Y$61$KG$20240827$$MD$JP$JP
205419854$20541985$4$F$20201005$20240819$20220302$20240827$EXP$$JP-DSJP-DSJ-2022-106605AA$DAIICHI$Anzai Y, Yukawa H, Kotera  A, Ishibashi Y, Fujita S, Uemura B et al.. EP-0667 Results of using Trastuzumab Deruxtecan at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;344$62$YR$$F$Y$57$KG$20240827$$MD$JP$JP
205422389$20542238$9$F$20210618$20240912$20220302$20240915$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-155987$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$45$KG$20240915$$MD$JP$JP
205422797$20542279$7$F$$20240812$20220302$20240819$EXP$$CA-PURDUE-USA-2022-0291797$PURDUE$$60$YR$$F$Y$$$20240819$$CN$CA$CA
205424535$20542453$5$F$$20240709$20220302$20240715$EXP$$GB-TAKEDA-2021TUS065007$TAKEDA$$$$$M$Y$$$20240715$$CN$GB$GB
2054254912$20542549$12$F$$20240916$20220302$20240930$EXP$$CA-CIPHER-2022-CA-000080$CIPHER$$54$YR$A$F$Y$$$20240930$$HP$CA$CA
205428316$20542831$6$F$$20240909$20220302$20240913$EXP$$CA-PFIZER INC-202200326871$PFIZER$$64$YR$$F$Y$$$20240913$$CN$CA$CA
2054352810$20543528$10$F$20220127$20240719$20220302$20240722$EXP$$NVSC2022DE048595$NOVARTIS$$51$YR$$M$Y$128$KG$20240722$$MD$DE$DE
2054390015$20543900$15$F$20220220$20230608$20220303$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR033931$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
205441833$20544183$3$F$20230621$20240705$20220303$20240716$PER$$US-SA-2022SA063508$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240716$$MD$US$US
205447395$20544739$5$F$20220208$20220315$20220303$20240712$EXP$$PL-ASTELLAS-2022US007823$ASTELLAS$$63$YR$$M$Y$$$20240712$$MD$PL$PL
205447492$20544749$2$F$$20211020$20220303$20240827$EXP$$DE-TAKEDA-2022TUS014203$TAKEDA$$$$A$M$Y$$$20240827$$CN$DE$DE
205448223$20544822$3$F$20050101$20240703$20220303$20240705$EXP$$US-ORGANON-O2203USA000161$ORGANON$$$$$M$Y$81.633$KG$20240705$$LW$US$US
205449292$20544929$2$F$20220201$20220301$20220303$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR038859$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240925$$CN$US$US
2054493415$20544934$15$F$20120201$20240711$20220303$20240716$EXP$$US-JAZZ-2022-US-004147$JAZZ$$58$YR$$M$Y$$$20240716$$HP$US$US
205452445$20545244$5$F$20010101$20240702$20220303$20240703$EXP$$US-ORGANON-O2203USA000146$ORGANON$$$$$M$Y$66.667$KG$20240703$$HP$US$US
2054552512$20545525$12$F$20220201$20230118$20220303$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR026462$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240926$$CN$US$US
205457282$20545728$2$F$20190101$20240920$20220303$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2022032533$VIIV$$$$$M$Y$$$20240929$$CN$US$US
205457524$20545752$4$F$20220330$20240921$20220303$20240924$EXP$$CA-TAKEDA-2022TUS013899$TAKEDA$$37$YR$$M$Y$$$20240924$$CN$CA$CA
2054580412$20545804$12$F$20000101$20240815$20220303$20240816$EXP$$US-ORGANON-O2203USA000178$ORGANON$$$$$F$Y$111.11$KG$20240816$$MD$US$US
205463236$20546323$6$F$20150801$20240919$20220303$20240923$EXP$$US-ORGANON-O2203USA000205$ORGANON$$$$$F$Y$$$20240923$$MD$US$US
2054701913$20547019$13$F$20220201$20230323$20220303$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR033901$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
2054727514$20547275$14$F$$20240916$20220303$20240920$EXP$$PT-ORGANON-O2202PRT001853$ORGANON$$$$E$$Y$$$20240920$$MD$PT$PT
205473099$20547309$9$F$20210101$20240809$20220303$20240813$PER$$US-PFIZER INC-202200317227$PFIZER$$76$YR$$F$Y$$$20240813$$HP$US$US
205474316$20547431$6$F$$20240912$20220303$20240917$PER$$US-PFIZER INC-202101075921$PFIZER$$77$YR$$F$Y$58.05$KG$20240917$$CN$US$US
205476664$20547666$4$F$20221210$20240926$20220303$20240930$EXP$$US-TAKEDA-2022TUS013816$TAKEDA$$1$YR$$M$Y$$$20240930$$CN$US$US
2054768311$20547683$11$F$20220201$20240902$20220303$20240904$EXP$$NVSC2021GB005506$NOVARTIS$$$$A$M$Y$$$20240904$$HP$GB$GB
205479056$20547905$6$F$20220226$20240724$20220303$20240725$EXP$$US-TAKEDA-2022TUS014242$TAKEDA$$4$YR$$M$Y$$$20240725$$PH$US$US
2054936718$20549367$18$F$20200214$20240902$20220303$20240910$EXP$$CA-CELLTRION INC.-2020CA019486$CELLTRION$$$$$$Y$$$20240910$$MD$CA$CA
205509806$20550980$6$F$$20220823$20220304$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR034654$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
205512855$20551285$5$F$20221011$20240729$20220304$20240806$PER$$CA-TOLMAR, INC.-21CA031334$TOLMAR$$74$YR$$M$Y$$$20240806$$CN$CA$CA
205513145$20551314$5$F$$20240903$20220304$20240913$EXP$$CA-CELLTRION INC.-2022CA002276$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
2055143610$20551436$10$F$20220101$20240819$20220304$20240821$EXP$$US-AMGEN-USASP2022037548$AMGEN$$$$A$F$Y$$$20240821$$HP$US$US
205517224$20551722$4$F$$20240903$20220304$20240906$EXP$$US-JAZZ-2022-US-006024$JAZZ$$$$$F$Y$$$20240906$$MD$US$US
205517289$20551728$9$F$20230401$20240829$20220304$20240902$EXP$$US-JAZZ-2022-US-005564$JAZZ$$52$YR$$F$Y$$$20240902$$HP$US$US
2055176117$20551761$17$F$20220201$20240815$20220304$20240823$EXP$$CA-CELLTRION INC.-2022CA002634$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
205522575$20552257$5$F$20230405$20230424$20220304$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR036963$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
205527275$20552727$5$F$20180101$20240726$20220304$20240731$EXP$$US-ORGANON-O2203USA000167$ORGANON$$$$$M$Y$$$20240731$$MD$US$US
205527892$20552789$2$F$20010101$20240924$20220304$20240926$EXP$$US-ORGANON-O2203USA000181$ORGANON$$$$$F$Y$$$20240926$$LW$US$US
2055280015$20552800$15$F$20220801$20230515$20220304$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR039102$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
205531476$20553147$6$F$20030101$20240809$20220304$20240813$EXP$$US-ORGANON-O2203USA000200$ORGANON$$$$$F$Y$40.74$KG$20240813$$MD$US$US
205531555$20553155$5$F$20220201$20240701$20220304$20240705$EXP$$FR-009507513-2203FRA000075$MERCK$$69$YR$$M$Y$84$KG$20240705$$MD$FR$FR
205532622$20553262$2$F$$20240821$20220304$20240829$EXP$$CO-MSNLABS-2022MSNLIT00183$MSN LABORATORIES$$$$$$Y$$$20240829$$HP$CO$CO
205534909$20553490$9$F$20211122$20240816$20220304$20240820$EXP$$AU-ABBVIE-21K-008-4213568-00$ABBVIE$$34$YR$$F$Y$$$20240820$$HP$AU$AU
205535926$20553592$6$F$20220101$20240909$20220304$20240911$PER$$US-PFIZER INC-202200214954$PFIZER$$61$YR$$F$Y$$$20240911$$CN$US$US
205544632$20554463$2$F$$20240812$20220304$20240822$EXP$NL-LRB-00792468$NL-TEVA-2022-NL-2012459$TEVA$$16$YR$$M$Y$$$20240822$$HP$NL$NL
2055451710$20554517$10$F$$20240923$20220304$20240930$EXP$$CA-BAUSCH-BL-2019-009925$BAUSCH AND LOMB$$61$YR$$F$Y$70$KG$20240930$$HP$CA$CA
205545356$20554535$6$F$20220110$20240611$20220304$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000707$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240705$$CN$US$US
205546698$20554669$8$F$20220201$20240815$20220304$20240821$EXP$$CA-TAKEDA-2021TUS032074$TAKEDA$$76$YR$$M$Y$$$20240821$$MD$CA$CA
205550226$20555022$6$F$$20240820$20220304$20240823$EXP$$FR-009507513-2203FRA001566$MERCK$Velev M, Puszkiel A, Blanchet B, de Percin S, Delanoy N, Medioni J et al... Association between olaparib exposure and early toxicity in brca-mutated ovarian cancer patients: Results from a retrospective multicenter study. Pharmaceuticals. 2021;14(8):1-16$$$$F$Y$$$20240823$$HP$FR$FR
205555553$20555555$3$F$20220101$20240815$20220304$20240820$EXP$$US-PFIZER INC-202200323235$PFIZER$$77$YR$$M$Y$$$20240820$$CN$US$US
205560987$20556098$7$F$20180905$20240823$20220304$20240826$EXP$$US-PURDUE PHARMA-USA-2021-0269704$PURDUE$$26$YR$$M$Y$$$20240826$$CN$US$US
205563489$20556348$9$F$$20240909$20220305$20240912$EXP$$NVSC2022US050170$NOVARTIS$$$$$M$Y$$$20240912$$CN$US$US
205564912$20556491$2$F$20070101$20240917$20220307$20240922$EXP$$US-ORGANON-O2203USA000361$ORGANON$$$$$F$Y$$$20240922$$LW$US$US
205564925$20556492$5$F$19990101$20240702$20220307$20240703$EXP$$US-ORGANON-O2203USA000342$ORGANON$$$$$F$Y$$$20240703$$MD$US$US
205567063$20556706$3$F$20100101$20240918$20220307$20240923$EXP$$US-ORGANON-O2203USA000357$ORGANON$$$$$M$Y$$$20240923$$MD$US$US
205568684$20556868$4$F$20220201$20220318$20220307$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR039044$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240926$$CN$US$US
2055687313$20556873$13$F$19990101$20240729$20220307$20240801$EXP$$US-ORGANON-O2203USA000249$ORGANON$$$$$F$Y$108.84$KG$20240801$$MD$US$US
205568964$20556896$4$F$20220101$20220606$20220307$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR037919$GLAXOSMITHKLINE$$45$YR$$F$Y$$$20240925$$CN$US$US
205572266$20557226$6$F$20090101$20240815$20220307$20240913$EXP$$US-ORGANON-O2203USA000330$ORGANON$$$$$M$Y$107.94$KG$20240913$$MD$US$US
205573743$20557374$3$F$20030101$20240827$20220307$20240829$EXP$$US-ORGANON-O2203USA000285$ORGANON$$$$$F$Y$$$20240829$$LW$US$US
205576768$20557676$8$F$20220118$20240625$20220307$20240703$EXP$$CN-ROCHE-3035932$ROCHE$$40$YR$A$M$Y$79$KG$20240704$$CN$CN$CN
2055774711$20557747$11$F$$20240918$20220307$20240926$EXP$$CA-ROCHE-3040580$ROCHE$$50$YR$A$M$Y$$$20240926$$CN$CA$CA
2055784822$20557848$22$F$20220301$20240723$20220307$20240724$EXP$$CA-ROCHE-2867521$ROCHE$$66$YR$E$F$Y$$$20240724$$MD$CA$CA
205580363$20558036$3$F$$20220304$20220307$20240705$PER$$NVSC2022US052936$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
205581175$20558117$5$F$$20240911$20220307$20240921$EXP$$FR-CELLTRION INC.-2022FR002407$CELLTRION$Drummond D, Thumerelle C, Roux A, Mordacq C, Frange P, Leruez-Ville M et al.. Severe COVID-19 evolving towards organizing pneumonia in a pediatric lung transplant recipient. Pediatric Pulmonology. 2022;57(2):583-585$$$$$Y$$$20240921$$MD$FR$FR
205581424$20558142$4$F$20060101$20240730$20220307$20240801$EXP$$US-ORGANON-O2203USA000310$ORGANON$$$$$F$Y$$$20240801$$MD$US$US
2055821213$20558212$13$F$20220101$20240625$20220307$20240704$EXP$$CO-SA-2022SA069912$SANOFI AVENTIS$$58$YR$A$F$Y$63$KG$20240704$$MD$CO$CO
205586243$20558624$3$F$20221207$20240611$20220307$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000516$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240705$$CN$US$US
205587353$20558735$3$F$20220201$20240828$20220307$20240919$PER$$US-SA-2022SA068186$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240919$$MD$US$US
2055901423$20559014$23$F$20110101$20240911$20220307$20240916$EXP$$US-ORGANON-O2203USA000259$ORGANON$$$$$F$Y$111.11$KG$20240916$$MD$US$US
205590772$20559077$2$F$$20240731$20220307$20240806$30DAY$$US-GLAXOSMITHKLINE-US2022040291$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$CN$US$US
205601577$20560157$7$F$20201224$20240705$20220307$20240710$EXP$$CA-PFIZER INC-2020456715$PFIZER$$71$YR$$M$Y$$$20240710$$MD$CA$CA
205603275$20560327$5$F$$20240826$20220307$20240827$EXP$$CA-PFIZER INC-202200332883$PFIZER$$64$YR$$F$Y$$$20240827$$HP$CA$CA
205604186$20560418$6$F$20201201$20240627$20220307$20240703$EXP$$DE-MYLANLABS-2022M1016364$MYLAN$$$$A$F$Y$65$KG$20240703$$MD$DE$DE
2056054410$20560544$10$F$20210731$20240920$20220307$20240924$EXP$$US-PFIZER INC-202100999984$PFIZER$$77$YR$$F$Y$$$20240924$$HP$US$US
205609886$20560988$6$F$20240130$20240715$20220307$20240717$EXP$$US-TAKEDA-US202020544$TAKEDA$$77$YR$$F$Y$$$20240717$$HP$US$US
205611564$20561156$4$F$$20240909$20220307$20240910$PER$$NVSC2022US052994$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
2056117913$20561179$13$F$20220101$20240724$20220307$20240729$PER$$US-PFIZER INC-202200317310$PFIZER$$66$YR$$F$Y$$$20240729$$HP$US$US
205611862$20561186$2$F$20220228$20240716$20220307$20240719$EXP$$US-TAKEDA-US201728784$TAKEDA$$58$YR$$M$Y$106$KG$20240719$$PH$US$US
205612167$20561216$7$F$$20240624$20220307$20240717$PER$$CA-TOLMAR, INC.-21CA031125$TOLMAR$$$$$M$Y$$$20240717$$CN$CA$CA
205614982$20561498$2$F$$20240712$20220307$20240722$PER$$US-INCYTE CORPORATION-2022IN002039$INCYTE$$$$$$Y$$$20240722$$CN$US$US
205617815$20561781$5$F$$20220503$20220307$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR040328$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
205617822$20561782$2$F$$20240909$20220307$20240911$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003596$PAREXEL$$$$$$Y$$$20240911$$CN$US$US
205617835$20561783$5$F$20220223$20221129$20220307$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR040166$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240925$$CN$US$US
205617979$20561797$9$F$$20240911$20220307$20240916$EXP$$US-TAKEDA-2022TUS013755$TAKEDA$$$$$M$Y$43$KG$20240916$$HP$US$US
205618662$20561866$2$F$$20240910$20220307$20240913$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003672$PAREXEL$$$$$$Y$$$20240913$$CN$US$US
205618702$20561870$2$F$$20240910$20220307$20240913$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003667$PAREXEL$$$$$$Y$$$20240913$$CN$US$US
205618762$20561876$2$F$20220101$20240730$20220307$20240731$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003722$PAREXEL$$$$$$Y$$$20240731$$CN$US$US
205618772$20561877$2$F$20211219$20240730$20220307$20240731$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003707$PAREXEL$$$$$$Y$$$20240731$$PH$US$US
205618782$20561878$2$F$20220118$20240730$20220307$20240731$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003725$PAREXEL$$$$$$Y$$$20240731$$CN$US$US
205618795$20561879$5$F$$20240910$20220307$20240918$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003729$PAREXEL$$$$$$Y$$$20240918$$HP$US$US
205618812$20561881$2$F$20220111$20240912$20220307$20240913$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003732$PAREXEL$$$$$$Y$$$20240913$$CN$US$US
205618822$20561882$2$F$$20240730$20220307$20240731$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003734$PAREXEL$$$$$$Y$$$20240731$$CN$US$US
205619162$20561916$2$F$20211011$20240725$20220307$20240726$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003619$PAREXEL$$$$$$Y$$$20240726$$CN$US$US
205619472$20561947$2$F$$20240909$20220307$20240911$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003588$PAREXEL$$$$$$Y$$$20240911$$CN$US$US
205619492$20561949$2$F$$20240724$20220307$20240726$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003585$PAREXEL$$$$$$Y$$$20240726$$CN$US$US
205619502$20561950$2$F$$20240909$20220307$20240910$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003584$PAREXEL$$$$$$Y$$$20240910$$CN$US$US
205619512$20561951$2$F$20210901$20240909$20220307$20240910$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003559$PAREXEL$$$$$$Y$$$20240910$$CN$US$US
205619542$20561954$2$F$$20240724$20220307$20240726$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003534$PAREXEL$$$$$$Y$$$20240726$$CN$US$US
205619632$20561963$2$F$$20240724$20220307$20240726$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003474$PAREXEL$$$$$$Y$$$20240726$$CN$US$US
205619962$20561996$2$F$20210928$20240725$20220307$20240726$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003644$PAREXEL$$$$$$Y$$$20240726$$CN$US$US
205620432$20562043$2$F$20211001$20240730$20220307$20240731$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003653$PAREXEL$$$$$$Y$$$20240731$$CN$US$US
205620723$20562072$3$F$20211013$20240910$20220307$20240913$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003654$PAREXEL$$$$$$Y$$$20240913$$HP$US$US
205620963$20562096$3$F$20210101$20240821$20220307$20240827$EXP$$US-PFIZER INC-202101025541$PFIZER$$52$YR$$F$Y$$$20240827$$HP$US$US
205621472$20562147$2$F$$20240910$20220307$20240913$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003658$PAREXEL$$$$$$Y$$$20240913$$CN$US$US
205627036$20562703$6$F$20190801$20240716$20220307$20240724$EXP$$CA-ROCHE-3036630$ROCHE$$45$YR$A$F$Y$$$20240724$$CN$CA$CA
205631154$20563115$4$F$20171214$20240722$20220307$20240729$EXP$$JP-ABBVIE-22P-087-4302947-00$ABBVIE$$75$YR$$M$Y$52.2$KG$20240729$$MD$JP$JP
205633664$20563366$4$F$$20240701$20220308$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000513$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
205634054$20563405$4$F$19980101$20240820$20220308$20240823$EXP$$US-ORGANON-O2203USA000692$ORGANON$$$$$F$Y$86.168$KG$20240823$$HP$US$US
2056346017$20563460$17$F$$20240722$20220308$20240725$EXP$$US-PFIZER INC-202200343835$PFIZER$$91$YR$$F$Y$63.492$KG$20240725$$MD$US$US
205638223$20563822$3$F$$20240808$20220308$20240826$PER$$US-SA-2022SA068986$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
205642944$20564294$4$F$20200313$20240904$20220308$20240912$EXP$$CA-CELLTRION INC.-2020CA020966$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
205643785$20564378$5$F$$20240923$20220308$20240927$EXP$$CA-ROCHE-3042748$ROCHE$$$$E$F$Y$68$KG$20240927$$MD$CA$CA
205645076$20564507$6$F$20120101$20240806$20220308$20240809$EXP$$US-ORGANON-O2203USA000497$ORGANON$$$$$M$Y$107.48$KG$20240809$$HP$US$US
205645239$20564523$9$F$20210101$20240622$20220308$20240702$EXP$$CA-INTERCEPT-PM2021003276$INTERCEPT PHARMACEUTICALS$$$$$F$Y$78$KG$20240702$$MD$CA$CA
2056456210$20564562$10$F$19990101$20240723$20220308$20240725$EXP$$US-ORGANON-O2203USA000496$ORGANON$$$$$F$Y$$$20240725$$MD$US$US
205646493$20564649$3$F$$20240731$20220308$20240802$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000031$PAREXEL$$$$$$Y$$$20240802$$CN$US$US
205646503$20564650$3$F$$20240731$20220308$20240801$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000024$PAREXEL$$$$$$Y$$$20240801$$CN$US$US
205646512$20564651$2$F$$20240801$20220308$20240802$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000053$PAREXEL$$$$$$Y$$$20240802$$CN$US$US
205646522$20564652$2$F$$20240731$20220308$20240801$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000022$PAREXEL$$$$$$Y$$$20240801$$CN$US$US
205646574$20564657$4$F$$20240801$20220308$20240802$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000060$PAREXEL$$$$$$Y$$$20240802$$CN$US$US
205646584$20564658$4$F$20220105$20240731$20220308$20240802$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000008$PAREXEL$$$$$$Y$$$20240802$$HP$US$US
205646814$20564681$4$F$20220131$20240801$20220308$20240807$EXP$$JP-ASTELLAS-2022JP002726$ASTELLAS$$77$YR$$M$Y$54$KG$20240807$$CN$JP$JP
205648917$20564891$7$F$20210210$20240924$20220308$20240927$EXP$$CA-TAKEDA-2019TUS038524$TAKEDA$$56$YR$$M$Y$$$20240927$$CN$CA$CA
2056508314$20565083$14$F$20200609$20240703$20220308$20240715$EXP$$IT-ROCHE-2669907$ROCHE$$48$YR$A$F$Y$$$20240715$$MD$IT$IT
205651982$20565198$2$F$$20240723$20220308$20240801$PER$$US-SA-2022SA070099$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240801$$MD$US$US
205652085$20565208$5$F$20060101$20240726$20220308$20240729$EXP$$US-ORGANON-O2203USA000760$ORGANON$$$$$F$Y$$$20240729$$LW$US$US
205653914$20565391$4$F$$20240923$20220308$20240927$EXP$$CA-TAKEDA-2019TUS073108$TAKEDA$$$$$F$Y$$$20240927$$CN$CA$CA
205655362$20565536$2$F$20211123$20240729$20220308$20240801$EXP$$AR-MYLANLABS-2022M1017566$MYLAN$$40$YR$$F$Y$$$20240801$$CN$AR$AR
205655965$20565596$5$F$20170619$20240919$20220308$20240926$EXP$$CA-TAKEDA-2017TUS007926$TAKEDA$$34$YR$$F$Y$$$20240926$$CN$CA$CA
205658983$20565898$3$F$20210101$20240911$20220308$20240920$PER$$NVSC2022US053800$NOVARTIS$$32$YR$$F$Y$108.6$KG$20240920$$CN$US$US
2056643212$20566432$12$F$20240624$20240805$20220308$20240808$EXP$$US-TAKEDA-2021TUS021863$TAKEDA$$71$YR$$F$Y$111$KG$20240808$$HP$US$US
205664352$20566435$2$F$20220217$20220225$20220308$20240725$EXP$$US-RECORDATI-2022000808$RECORDATI$$$$$$Y$$$20240725$$HP$US$US
205668246$20566824$6$F$20090101$20240925$20220308$20240927$EXP$$US-ORGANON-O2203USA000579$ORGANON$$$$$F$Y$146.94$KG$20240927$$MD$US$US
2056688010$20566880$10$F$20231121$20240911$20220308$20240916$EXP$$US-TAKEDA-US202033374$TAKEDA$$71$YR$$M$Y$$$20240916$$CN$US$US
2056692712$20566927$12$F$20190626$20240809$20220308$20240816$EXP$$CA-ROCHE-2973840$ROCHE$$39$YR$A$M$Y$175$KG$20240816$$CN$CA$CA
2056694010$20566940$10$F$20210324$20240626$20220308$20240703$EXP$$US-TAKEDA-2022TUS015241$TAKEDA$$63$YR$$F$Y$51.5$KG$20240703$$MD$US$CN
205671769$20567176$9$F$20210520$20240813$20220308$20240815$EXP$$DE-ROCHE-2867578$ROCHE$$31$YR$A$F$Y$$$20240815$$CN$DE$DE
2056741524$20567415$24$F$20191201$20240919$20220308$20240920$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-004186$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$80$KG$20240920$$CN$ES$ES
205675134$20567513$4$F$$20240918$20220308$20240925$EXP$$US-TAKEDA-US202022472$TAKEDA$$$$$F$Y$$$20240925$$HP$US$US
205675268$20567526$8$F$20211201$20240710$20220308$20240720$EXP$$BR-JNJFOC-20220260503$JOHNSON AND JOHNSON$$45$YR$A$M$Y$42$KG$20240719$$CN$BR$BR
2056759013$20567590$13$F$20210504$20240702$20220308$20240711$EXP$$CA-ROCHE-2824957$ROCHE$$67$YR$E$F$Y$78$KG$20240711$$HP$CA$CA
2056759710$20567597$10$F$20140927$20240624$20220308$20240704$EXP$$CA-ROCHE-1275068$ROCHE$$46$YR$A$M$Y$54.4$KG$20240704$$CN$CA$CA
205676849$20567684$9$F$$20240917$20220308$20240926$EXP$$GB-ROCHE-3039385$ROCHE$$74$YR$E$F$Y$$$20240926$$CN$GB$GB
205678764$20567876$4$F$$20240725$20220308$20240731$EXP$$US-PFIZER INC-202200149140$PFIZER$$75$YR$$F$Y$$$20240731$$HP$US$US
205682287$20568228$7$F$20190101$20240814$20220308$20240820$EXP$$CA-BAUSCH-BL-2019-061335$BAUSCH AND LOMB$$50$YR$$M$Y$$$20240820$$CN$CA$CA
205683394$20568339$4$F$$20240703$20220308$20240708$PER$$US-PFIZER INC-2021895202$PFIZER$$68$YR$$F$Y$$$20240708$$CN$US$US
205683992$20568399$2$F$20220216$20220727$20220308$20240911$EXP$$CO-TAKEDA-2022TUS014945$TAKEDA$$0$YR$$M$Y$$$20240911$$CN$CO$CO
205686568$20568656$8$F$$20240829$20220308$20240829$PER$$US-PFIZER INC-202100929323$PFIZER$$64$YR$$M$Y$$$20240829$$CN$US$US
2056871111$20568711$11$F$20220101$20240717$20220308$20240723$PER$$US-PFIZER INC-202200093841$PFIZER$$57$YR$$F$Y$$$20240723$$HP$US$US
205693745$20569374$5$F$20210923$20240813$20220308$20240820$EXP$$US-ABBVIE-22K-163-4302969-00$ABBVIE$$67$YR$$M$Y$$$20240820$$CN$US$US
205694352$20569435$2$F$20220201$20220307$20220309$20240701$PER$$US-AstraZeneca-2022A064849$ASTRAZENECA$$928$MON$$F$Y$107.5$KG$20240701$$CN$US$
205698714$20569871$4$F$20220301$20220408$20220309$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR039086$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240925$$CN$US$US
205700513$20570051$3$F$20070101$20240925$20220309$20240930$EXP$$US-ORGANON-O2203USA000770$ORGANON$$$$$M$Y$98.866$KG$20240930$$MD$US$US
2057017010$20570170$10$F$20210910$20240626$20220309$20240704$EXP$$CA-CELLTRION INC.-2021CA016382$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
205704473$20570447$3$F$$20220222$20220309$20240709$PER$$US-TEVA-2022-US-2012456$TEVA$$$$$F$Y$$$20240709$$CN$US$US
2057058210$20570582$10$F$19980101$20240717$20220309$20240719$EXP$$US-ORGANON-O2203USA000783$ORGANON$$$$$M$Y$138.32$KG$20240719$$MD$US$US
205706177$20570617$7$F$20100101$20240919$20220309$20240923$EXP$$US-ORGANON-O2203USA000766$ORGANON$$$$$F$Y$99.773$KG$20240923$$MD$US$US
205709823$20570982$3$F$$20240801$20220309$20240802$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000069$PAREXEL$$$$$$Y$$$20240802$$HP$US$US
205710002$20571000$2$F$20090101$20240911$20220309$20240913$EXP$$US-ORGANON-O2203USA000751$ORGANON$$$$$M$Y$$$20240913$$MD$US$US
205715684$20571568$4$F$$20240725$20220309$20240801$EXP$$US-GLAXOSMITHKLINE-US2022042384$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$HP$US$US
205715759$20571575$9$F$20220228$20221110$20220309$20240925$PER$$US-GLAXOSMITHKLINE-US2022042366$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$HP$US$US
205716166$20571616$6$F$20200101$20240717$20220309$20240719$EXP$$US-ORGANON-O2203USA000723$ORGANON$$$$$F$Y$$$20240719$$MD$US$US
2057200617$20572006$17$F$$20240919$20220309$20240924$EXP$$IN-ROCHE-3039499$ROCHE$$58$YR$A$F$Y$$$20240924$$MD$IN$IN
205722845$20572284$5$F$20220715$20240827$20220309$20240910$PER$$US-SA-2022SA073715$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240910$$MD$US$US
205724144$20572414$4$F$$20220629$20220309$20240925$PER$$US-GLAXOSMITHKLINE-US2022042497$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
205725173$20572517$3$F$$20240906$20220309$20240916$EXP$$JP-ROCHE-3043568$ROCHE$$6$DEC$A$F$Y$$$20240916$$MD$JP$JP
205726255$20572625$5$F$20060101$20240902$20220309$20240906$EXP$$US-ORGANON-O2203USA000805$ORGANON$$$$$M$Y$68.05$KG$20240906$$MD$US$US
2057265011$20572650$11$F$20210717$20231011$20220309$20240807$EXP$$NVSC2021IN219669$NOVARTIS$$59$YR$$F$Y$$$20240807$$CN$IN$IN
205729944$20572994$4$F$20220302$20240628$20220309$20240708$EXP$$US-DECIPHERA PHARMACEUTICALS LLC-2022US000183$DECIPHERA PHARMACEUTICALS$$61$YR$A$F$Y$$$20240708$$CN$US$US
2057308512$20573085$12$F$20000101$20240909$20220309$20240912$EXP$$US-ORGANON-O2203USA000722$ORGANON$$$$$F$Y$$$20240912$$MD$US$US
2057341411$20573414$11$F$20220301$20240808$20220309$20240814$EXP$$JP-PFIZER INC-202200365318$PFIZER$Ishimaru, S.. Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial. International Journal of Clinical Oncology. 2024;29(2):89-95$57$YR$$F$Y$53.95$KG$20240814$$MD$JP$JP
205736152$20573615$2$F$$20220307$20220309$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR043248$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
205738902$20573890$2$F$20190713$20240925$20220309$20240927$EXP$$DE-ABBVIE-22K-062-4308677-00$ABBVIE$$$$$$Y$$$20240927$$MD$DE$DE
205750083$20575008$3$F$20220301$20220413$20220310$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR043972$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240925$$MD$US$US
205753079$20575307$9$F$20150101$20240809$20220310$20240912$EXP$$US-ORGANON-O2203USA000915$ORGANON$$$$$F$Y$95.9$KG$20240912$$MD$US$US
205753732$20575373$2$F$$20240805$20220310$20240820$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2022-01696$ALKEM$Francis L, Bonilla E, Soforo E, Neupane H, et.al. Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin. Clin Rheumatol. 2008;27(1):129-31$66$YR$$M$Y$$$20240820$$HP$US$US
2057559122$20575591$22$F$20210901$20240813$20220310$20240821$EXP$$DE-ROCHE-2780112$ROCHE$$27$YR$A$F$Y$56$KG$20240821$$CN$DE$DE
2057579512$20575795$12$F$20180828$20240716$20220310$20240724$EXP$$CA-CELLTRION INC.-2018CA022388$CELLTRION$$$$$$Y$$$20240724$$CN$CA$CA
2057586912$20575869$12$F$$20240722$20220310$20240724$PER$$NVSC2022US055748$NOVARTIS$$$$$M$Y$$$20240724$$CN$US$US
205759204$20575920$4$F$$20240917$20220310$20240924$EXP$$US-TAKEDA-2020TUS055197$TAKEDA$$$$$F$Y$95$KG$20240924$$CN$US$US
205769302$20576930$2$F$$20220301$20220310$20240717$EXP$$PT-ASTELLAS-2022US008574$ASTELLAS$Luis T, Candeias C, Domingues S, Oliva-Teles N, Mota C, Reis CF. Partial tetrasomy 18 mosaicism: Pre and postnatal diagnosis of a unique pattern. Taiwanese Journal of Obstetrics and Gynecology. 2022;61(1):150-2$34$YR$$F$Y$$$20240717$$HP$PT$PT
205771144$20577114$4$F$$20220602$20220310$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR037609$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
205771673$20577167$3$F$20220205$20240628$20220310$20240709$EXP$$US-SA-2022SA073780$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240709$$MD$US$US
205774625$20577462$5$F$$20240701$20220310$20240703$EXP$$US-ORGANON-O2203USA000815$ORGANON$$$$$M$Y$$$20240703$$MD$US$US
205775884$20577588$4$F$20240201$20240717$20220310$20240719$EXP$$US-SHIRE-US202006320$TAKEDA$$61$YR$$F$Y$$$20240719$$CN$US$US
205777626$20577762$6$F$20210507$20240816$20220310$20240827$EXP$$CA-TAKEDA-2021TUS031413$TAKEDA$$38$YR$$F$Y$$$20240827$$MD$CA$CA
205778685$20577868$5$F$20220201$20240912$20220310$20240917$30DAY$$US-PFIZER INC-202200257508$PFIZER$$15$YR$$M$Y$28.58$KG$20240917$$CN$US$US
205778783$20577878$3$F$20220217$20240710$20220310$20240711$EXP$$BE-ROCHE-3039098$ROCHE$$39$YR$A$F$Y$59.4$KG$20240711$$MD$BE$BE
205780768$20578076$8$F$$20240828$20220310$20240904$PER$PT-SAKK-2022SA036611AA$PT-PFM-2022-01804$PIERRE FABRE MEDICAMENT$Monteiro C, Dias B, Vaz-Patto M. Headache as an adverse reaction to the use of medication in the elderly: a pharmacovigilance study. International Journal of Environmental Research and Public Heath. 2021;18(2674):1-11$$$$$Y$$$20240904$$HP$PT$PT
205781443$20578144$3$F$20200618$20240822$20220310$20240905$EXP$$FR-SERVIER-S22002378$SERVIER$$$$$$Y$$$20240905$$MD$FR$FR
205784414$20578441$4$F$20210304$20240920$20220310$20240926$EXP$$DE-ROCHE-2816935$ROCHE$$23$YR$A$F$Y$$$20240926$$CN$DE$DE
2057852314$20578523$14$F$20220101$20240703$20220310$20240705$EXP$$US-PFIZER INC-202200239069$PFIZER$$81$YR$$F$Y$$$20240705$$CN$US$US
205785665$20578566$5$F$$20240904$20220310$20240915$EXP$$JP-009507513-2203JPN000737J$MERCK$Higashiyama R, Yoshida T, Sakiyama N, Masuda K, Niino Y, Matsumoto Y, et al.. MO4-5 Safety of dosage switching of Pembrolizumab from 200mg Q3W to 400mg Q6W in advanced NSCLC patients. The 19th Annual Meeting of Japanese Society of Medical Oncology$62$YR$$M$Y$$$20240915$$MD$JP$JP
205786306$20578630$6$F$20220304$20240718$20220310$20240725$EXP$$CA-ROCHE-3043408$ROCHE$$33$YR$A$M$Y$$$20240725$$CN$CA$CA
205786318$20578631$8$F$20220217$20240610$20220310$20240709$EXP$$DE-ROCHE-3044552$ROCHE$$37$YR$A$F$Y$$$20240628$$CN$DE$DE
205787113$20578711$3$F$20120101$20240814$20220310$20240819$EXP$$US-ORGANON-O2203USA000851$ORGANON$$$$$M$Y$$$20240819$$LW$US$US
2057873113$20578731$13$F$20240517$20240918$20220310$20240925$EXP$$US-TAKEDA-2009BH015258$TAKEDA$$77$YR$$F$Y$73$KG$20240925$$MD$US$US
205787845$20578784$5$F$20190101$20240628$20220310$20240703$PER$$US-PFIZER INC-2021715370$PFIZER$$37$YR$$F$Y$$$20240703$$HP$US$US
205787916$20578791$6$F$$20240812$20220310$20240816$PER$$US-PFIZER INC-2021702083$PFIZER$$93$YR$$F$Y$$$20240816$$HP$US$US
205791857$20579185$7$F$20190901$20230804$20220310$20240912$EXP$$NVSC2019GB010527$NOVARTIS$$62$YR$$M$Y$$$20240912$$HP$GB$GB
205793616$20579361$6$F$$20240904$20220310$20240912$EXP$$JP-009507513-2203JPN000735J$MERCK$Higashiyama R, Yoshida T, Sakiyama N, Masuda K, Niino Y, Matsumoto Y, et al.. MO4-5 Safety of dosage switching of Pembrolizumab from 200mg Q3W to 400mg Q6W in advanced NSCLC patients. The 19th Annual Meeting of Japanese Society of Medical Oncology$73$YR$$F$Y$$$20240912$$MD$JP$JP
205796552$20579655$2$F$$20240720$20220310$20240729$PER$$US-SA-2022SA077356$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240729$$MD$US$US
205798583$20579858$3$F$20220213$20240924$20220310$20240927$EXP$$DE-PFIZER INC-202200355750$PFIZER$$75$YR$$F$Y$64$KG$20240927$$MD$DE$DE
2057994512$20579945$12$F$20210824$20240903$20220310$20240905$EXP$$JP-TAKEDA-2022TJP026490$TAKEDA$$8$YR$$M$Y$20.7$KG$20240905$$MD$JP$JP
205804498$20580449$8$F$20190101$20240617$20220311$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000543$ACADIA PHARMACEUTICALS$$$$$M$Y$97$KG$20240712$$CN$US$US
205805475$20580547$5$F$20170101$20240814$20220311$20240827$EXP$$PL-AUROBINDO-AUR-APL-2022-005667$AUROBINDO$Krzystanek M, Warchala A, Tredzbor B, Martyniak E, Skalacka K, Palasz A.. Amantadine in the treatment of sexual inactivity in schizophrenia patients taking atypical antipsychotics -the pilot case series study. Pharmaceuticals. 2021;14(10):1-11$42$YR$$M$Y$$$20240827$$MD$PL$PL
205806715$20580671$5$F$$20220509$20220311$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR040915$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
205806843$20580684$3$F$20220221$20220311$20220311$20240919$EXP$$IT-AKCEA THERAPEUTICS, INC.-2022IS001316$AKCEA THERAPEUTICS$$$$$$Y$$$20240918$$HP$IT$IT
2058144310$20581443$10$F$20211206$20240913$20220311$20240921$EXP$$CA-CELLTRION INC.-2021CA010897$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
205817138$20581713$8$F$20211208$20240808$20220311$20240812$EXP$$DE-TAKEDA-2022TUS015211$TAKEDA$$56$YR$$M$Y$$$20240812$$HP$DE$DE
205818493$20581849$3$F$$20240829$20220311$20240902$EXP$$CA-CHEPLA-1000037092$CHEPLAPHARM$$31$YR$$F$Y$71$KG$20240902$$CN$COUNTRY NOT SPECIFIED$CA
205819702$20581970$2$F$20220228$20240720$20220311$20240801$EXP$$US-Accord-257067$ACCORD$$27$YR$A$M$Y$$$20240801$$MD$US$US
205821126$20582112$6$F$$20240904$20220311$20240906$EXP$$JP-009507513-2203JPN000741J$MERCK$Higashiyama R, Yoshida T, Sakiyama N, Masuda K, Niino Y, Matsumoto Y, et al.. MO4-5 Safety of dosage switching of Pembrolizumab from 200mg Q3W to 400mg Q6W in advanced NSCLC patients. The 19th Annual Meeting of Japanese Society of Medical Oncology$73$YR$$M$Y$$$20240906$$MD$JP$JP
205822013$20582201$3$F$20220213$20240926$20220311$20240930$EXP$$DE-ROCHE-3042322$ROCHE$$75$YR$E$F$Y$64$KG$20240930$$MD$DE$DE
2058231213$20582312$13$F$20220525$20240711$20220311$20240715$EXP$$CA-TAKEDA-2022TUS015831$TAKEDA$$39$YR$$M$Y$$$20240715$$HP$CA$CA
2058271816$20582718$16$F$$20240826$20220311$20240828$PER$$US-PFIZER INC-2020387583$PFIZER$$65$YR$$F$Y$63$KG$20240828$$HP$US$US
2058274641$20582746$41$F$20220101$20240923$20220311$20240926$EXP$$IN-PFIZER INC-202200230812$PFIZER$$56$YR$$F$Y$83$KG$20240926$$CN$IN$IN
205829826$20582982$6$F$$20240823$20220311$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-036203$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240903$$MD$JP$JP
2058362320$20583623$20$F$20210415$20240724$20220311$20240729$EXP$$AT-PFIZER INC-2021832083$PFIZER$$60$YR$$M$Y$84$KG$20240729$$MD$AT$AT
205842573$20584257$3$F$20210901$20240917$20220311$20240925$EXP$$US-TAKEDA-2020TUS056471$TAKEDA$$31$YR$$M$Y$$$20240925$$CN$US$US
205843065$20584306$5$F$$20240703$20220311$20240709$EXP$$US-TAKEDA-2021TUS051903$TAKEDA$$$$$M$Y$88$KG$20240709$$CN$US$US
2058434310$20584343$10$F$20201006$20240916$20220311$20240920$EXP$$CA-TAKEDA-2020TUS048260$TAKEDA$$35$YR$$F$Y$$$20240920$$CN$CA$CA
205845633$20584563$3$F$$20240924$20220311$20240926$EXP$$CA-ROCHE-3045934$ROCHE$$$$A$F$Y$$$20240926$$MD$CA$CA
205847803$20584780$3$F$$20240801$20220311$20240809$EXP$$NVSC2022US056485$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
2058551114$20585511$14$F$20200629$20240821$20220312$20240829$EXP$$CA-CELLTRION INC.-2019CA028557$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
205857316$20585731$6$F$$20240823$20220312$20240901$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-036202$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240902$$MD$JP$JP
205860435$20586043$5$F$20220517$20220624$20220313$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR043122$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
205861484$20586148$4$F$20220201$20240807$20220313$20240809$EXP$$CA-ROCHE-2777407$ROCHE$$35$YR$A$F$Y$$$20240809$$CN$CA$CA
205867286$20586728$6$F$20210219$20240909$20220313$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-035097$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$57.3$KG$20240916$$MD$JP$JP
205868174$20586817$4$F$$20240819$20220314$20240823$EXP$$CA-AMGEN-CANSP2022043094$AMGEN$$$$$F$Y$$$20240822$$HP$CA$CA
205870923$20587092$3$F$$20240906$20220314$20240913$30DAY$$US-GLAXOSMITHKLINE-US2022044589$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
205871972$20587197$2$F$20211111$20240814$20220314$20240911$PER$$CA-TOLMAR, INC.-21CA031500$TOLMAR$$94$YR$$M$Y$$$20240911$$CN$CA$CA
205872807$20587280$7$F$$20240812$20220314$20240823$EXP$$ES-AUROBINDO-AUR-APL-2022-007764$AUROBINDO$Hernani R, Sancho A, Amat P, Hernandez-Boluda J, Perez A, Pinana J et al.. CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review.. Current Research in Translational Medicine. 2021;69 (4):1-5$56$YR$$M$Y$$$20240823$$HP$ES$ES
2058756711$20587567$11$F$20220227$20230227$20220314$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR045289$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
205876225$20587622$5$F$20210107$20221213$20220314$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR043202$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
205878333$20587833$3$F$20211117$20240711$20220314$20240715$PER$$US-AMGEN-USASP2022043869$AMGEN$$37$YR$A$F$Y$$$20240715$$HP$US$US
205887623$20588762$3$F$$20240203$20220314$20240812$EXP$$NVSC2021CO185718$NOVARTIS$$$$$F$Y$58$KG$20240812$$CN$CO$CO
205892505$20589250$5$F$20220201$20240701$20220314$20240708$EXP$$NVSC2022KW056810$NOVARTIS$$27$YR$$M$Y$$$20240708$$CN$KW$KW
205894286$20589428$6$F$$20240910$20220314$20240920$EXP$CA-MHPD-E2B_03761381$CA-Accord-256609$ACCORD$$75$YR$E$F$Y$$$20240920$$CN$CA$CA
205895124$20589512$4$F$20220309$20240918$20220314$20240926$PER$$NVSC2022US058797$NOVARTIS$$4$YR$$M$Y$19.5$KG$20240926$$CN$US$US
205895683$20589568$3$F$$20240628$20220314$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000610$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
205896118$20589611$8$F$20190301$20240626$20220314$20240717$EXP$$DE-ROCHE-2833665$ROCHE$$33$YR$A$F$Y$$$20240717$$CN$DE$DE
2058971511$20589715$11$F$$20230517$20220314$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR045291$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
205897397$20589739$7$F$20220503$20240904$20220314$20240909$EXP$$CA-TAKEDA-2022TUS016721$TAKEDA$$66$YR$$F$Y$$$20240909$$CN$CA$CA
205897852$20589785$2$F$20220201$20240715$20220314$20240724$EXP$$US-VIIV HEALTHCARE LIMITED-US2022045316$VIIV$$72$YR$$M$Y$$$20240724$$CN$US$US
205897973$20589797$3$F$20201231$20240715$20220314$20240722$EXP$$US-BIOGEN-2022BI01103950$BIOGEN$$15$YR$$F$Y$77.18$KG$20240722$$CN$US$US
205899495$20589949$5$F$$20220607$20220314$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR045435$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
205901143$20590114$3$F$20211101$20240906$20220314$20240914$EXP$$JP-ROCHE-3048544$ROCHE$Fukushima M, Tajima K, Sasaki R, Miuma S, Miyaaki H, Nakao K. A Case of Evans Syndrome Developing during Atezolizumab + Bevacizumab Combination Therapy for Hepatocellular Carcinoma.. The 26th Japan Association of Molecular Targeted Therapy for HCC. 2022;140:$86$YR$E$M$Y$$$20240914$$MD$JP$JP
2059054510$20590545$10$F$20210405$20240912$20220314$20240918$EXP$$NVSC2022FR058110$NOVARTIS$$$$E$F$Y$63$KG$20240918$$MD$FR$FR
205906408$20590640$8$F$20190701$20240916$20220314$20240918$EXP$$US-TAKEDA-US201932023$TAKEDA$$64$YR$$F$Y$$$20240918$$HP$US$US
205908133$20590813$3$F$20220211$20240805$20220314$20240806$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000074$PAREXEL$$$$$$Y$$$20240806$$MD$US$US
205908244$20590824$4$F$$20240911$20220314$20240926$PER$$US-SA-2022SA072970$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
205908762$20590876$2$F$20211101$20240627$20220314$20240706$PER$$US-SA-2022SA079893$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240706$$MD$US$US
205908852$20590885$2$F$$20240624$20220314$20240703$PER$$US-SA-2022SA080894$SANOFI AVENTIS$$$$A$M$Y$$$20240703$$MD$US$US
205909452$20590945$2$F$$20240723$20220314$20240730$PER$$US-SA-2022SA080331$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240730$$MD$US$US
2059108911$20591089$11$F$20230701$20240624$20220314$20240701$EXP$$US-JAZZ-2022-US-006527$JAZZ$$30$YR$$F$Y$$$20240701$$CN$US$US
205913422$20591342$2$F$$20240905$20220314$20240911$PER$$US-BEH-2022143216$CSL BEHRING$$$$E$F$Y$$$20240911$$HP$US$US
2059152717$20591527$17$F$20220303$20240801$20220314$20240808$EXP$$CA-OTSUKA-2022_011205$OTSUKA$$26$YR$$M$Y$$$20240808$$HP$CA$CA
205923294$20592329$4$F$$20240628$20220314$20240703$EXP$$US-AMGEN-USASP2022042518$AMGEN$$$$A$F$Y$$$20240703$$HP$US$US
205927975$20592797$5$F$$20220815$20220315$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR044670$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
205928123$20592812$3$F$20220201$20220715$20220315$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-327227$RANBAXY$$17$YR$T$M$Y$$$20240702$$HP$US$US
205928532$20592853$2$F$20210101$20220310$20220315$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR045279$GLAXOSMITHKLINE$$$$$M$Y$$$20240925$$CN$US$US
205928796$20592879$6$F$$20240611$20220315$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000618$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240707$$CN$US$US
205934324$20593432$4$F$$20240731$20220315$20240806$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000028$PAREXEL$$$$$$Y$$$20240806$$CN$US$US
205935709$20593570$9$F$$20240925$20220315$20240930$EXP$$US-ROCHE-2969837$ROCHE$$$$A$F$Y$$$20240930$$CN$US$US
2059361421$20593614$21$F$20220607$20240913$20220315$20240921$EXP$$CA-CELLTRION INC.-2022CA003056$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
205937462$20593746$2$F$20220306$20240912$20220315$20240913$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000076$PAREXEL$$$$$$Y$$$20240913$$CN$US$US
205939303$20593930$3$F$$20240904$20220315$20240913$30DAY$$US-GLAXOSMITHKLINE-US2022045520$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
205940248$20594024$8$F$$20240708$20220315$20240711$EXP$$CA-BAUSCH-BL-2022-006312$BAUSCH AND LOMB$$49$YR$$F$Y$91$KG$20240711$$HP$CA$CA
205943202$20594320$2$F$20220301$20240911$20220315$20240918$EXP$$US-BEH-2022143144$CSL BEHRING$$57$YR$A$F$Y$$$20240918$$HP$US$US
205956077$20595607$7$F$20221028$20240919$20220315$20240927$EXP$$CA-TAKEDA-2022TUS016406$TAKEDA$$74$YR$$M$Y$104.33$KG$20240927$$CN$CA$CA
205962114$20596211$4$F$$20240903$20220315$20240905$PER$$US-PFIZER INC-202200269165$PFIZER$$69$YR$$F$Y$$$20240905$$HP$US$US
205964467$20596446$7$F$20220301$20240816$20220315$20240819$EXP$$US-PFIZER INC-202200355137$PFIZER$$53$YR$$F$Y$$$20240819$$HP$US$US
205964912$20596491$2$F$$20240702$20220315$20240704$PER$$US-PFIZER INC-202200269101$PFIZER$$71$YR$$F$Y$$$20240704$$CN$US$US
205968072$20596807$2$F$$20240809$20220315$20240813$EXP$$US-KYOWAKIRIN-2022BKK003751$KYOWA$$$$$$Y$$$20240813$$HP$US$US
2059771820$20597718$20$F$20210930$20240819$20220315$20240827$EXP$$US-ROCHE-2922886$ROCHE$$31$YR$A$F$Y$68.04$KG$20240827$$CN$US$US
205977865$20597786$5$F$$20240715$20220315$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-035347$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240729$$HP$CA$CA
205978947$20597894$7$F$20211005$20240813$20220315$20240818$EXP$$IE-TAKEDA-2021TUS062786$TAKEDA$$46$YR$$M$Y$$$20240818$$PH$IE$IE
205980093$20598009$3$F$$20240701$20220315$20240705$EXP$$US-JAZZ-2022-US-007920$JAZZ$$$$$M$Y$$$20240705$$CN$US$US
205980112$20598011$2$F$$20240729$20220315$20240802$PER$$US-TAKEDA-2022TUS017317$TAKEDA$$$$$F$Y$86$KG$20240802$$MD$US$US
205982679$20598267$9$F$20220201$20240826$20220315$20240829$EXP$$US-PFIZER INC-202200378001$PFIZER$$59$YR$$F$Y$$$20240829$$HP$US$US
205984323$20598432$3$F$$20240926$20220315$20240930$PER$$US-PFIZER INC-202200348722$PFIZER$$57$YR$$F$Y$$$20240930$$HP$US$US
205988326$20598832$6$F$20220222$20240806$20220315$20240809$EXP$$JP-PFIZER INC-202200404514$PFIZER$$82$YR$$M$Y$50.3$KG$20240809$$MD$JP$JP
205989363$20598936$3$F$20211230$20240802$20220315$20240805$PER$$US-ROCHE-2994466$ROCHE$$39$YR$A$F$Y$$$20240805$$HP$US$US
205989907$20598990$7$F$20220101$20240809$20220315$20240813$EXP$$CA-TAKEDA-2022TUS017160$TAKEDA$$$$$M$Y$72$KG$20240813$$CN$CA$CA
205990033$20599003$3$F$$20240814$20220315$20240816$PER$$US-ROCHE-2956410$ROCHE$$22$YR$A$F$Y$$$20240816$$HP$US$US
205990827$20599082$7$F$20210901$20240625$20220315$20240702$EXP$$US-SA-2022SA075221$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240702$$MD$US$US
205990872$20599087$2$F$$20240815$20220315$20240827$PER$$US-SA-2022SA078854$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240827$$MD$US$US
205992422$20599242$2$F$20240806$20240829$20220315$20240923$PER$$US-SA-2022SA082399$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240923$$MD$US$US
205995763$20599576$3$F$$20240910$20220316$20240924$EXP$$AU-STRIDES ARCOLAB LIMITED-2022SP002649$STRIDES$Ennis S, Plit M, Malouf M.. Epstein-Barr virus associated smooth muscle neoplasm postlung transplantation. Transpl-Infect-Dis. 2022;24(1):e13756$$$A$F$Y$$$20240924$$MD$AU$AU
2059984518$20599845$18$F$20181001$20240730$20220316$20240805$PER$$US-BIOGEN-2022BI01104636$BIOGEN$$29$YR$$F$Y$$$20240805$$CN$US$US
2059994420$20599944$20$F$20210907$20240916$20220316$20240928$EXP$$CA-CELLTRION INC.-2021CA011204$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
206011822$20601182$2$F$$20220314$20220316$20240927$PER$$NVSC2022US060085$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
206021302$20602130$2$F$$20240625$20220316$20240708$PER$$CA-AMGEN-CANNI2022044598$AMGEN$$50$YR$A$F$Y$$$20240708$$MD$CA$CA
206023034$20602303$4$F$20210117$20240704$20220316$20240709$EXP$$IN-PFIZER INC-202100957596$PFIZER$$68$YR$$F$Y$66$KG$20240709$$CN$IN$IN
2060249414$20602494$14$F$20210309$20240911$20220316$20240913$EXP$$CA-ROCHE-2664362$ROCHE$$39$YR$A$F$Y$$$20240913$$CN$CA$CA
2060277413$20602774$13$F$20220101$20240720$20220316$20240722$EXP$$CA-PFIZER INC-202200383041$PFIZER$$68$YR$$M$Y$$$20240722$$HP$CA$CA
206027812$20602781$2$F$20220101$20240822$20220316$20240827$EXP$$US-PFIZER INC-202200397724$PFIZER$$61$YR$$F$Y$$$20240827$$CN$US$US
206029655$20602965$5$F$$20240909$20220316$20240918$EXP$$GB-ROCHE-3048282$ROCHE$$$$E$F$Y$$$20240918$$CN$GB$GB
2060319013$20603190$13$F$$20240715$20220316$20240720$EXP$$CA-AMGEN-CANSP2022042885$AMGEN$$$$$F$Y$97$KG$20240720$$HP$CA$CA
206035622$20603562$2$F$$20240920$20220316$20240925$EXP$$US-SHIRE-US201912374$TAKEDA$$$$$M$Y$$$20240925$$HP$US$US
206038573$20603857$3$F$$20240726$20220316$20240802$PER$$US-SA-2022SA082176$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240802$$CN$US$US
206042952$20604295$2$F$$20240719$20220316$20240730$PER$$US-SA-2022SA086000$SANOFI AVENTIS$$$$E$M$Y$$$20240730$$MD$US$US
206046328$20604632$8$F$$20240828$20220316$20240902$EXP$$CA-ROCHE-3034238$ROCHE$$59$YR$A$F$Y$68$KG$20240902$$MD$CA$CA
2060493136$20604931$36$F$$20240902$20220317$20240911$EXP$$PT-Noden Pharma DAC-NOD202203-000004$NODEN PHARMA$$$$E$$Y$$$20240911$$HP$PT$PT
206050413$20605041$3$F$20220207$20240812$20220317$20240813$EXP$FR-AFSSAPS-AN20220706$FR-ABBVIE-22K-056-4312699-00$ABBVIE$$78$YR$$F$Y$58$KG$20240813$$PH$FR$FR
206054733$20605473$3$F$$20240920$20220317$20240928$PER$$US-TAKEDA-2022TUS017852$TAKEDA$$$$$F$Y$76.19$KG$20240928$$HP$US$US
206059474$20605947$4$F$$20240624$20220317$20240702$EXP$$PT-AUROBINDO-AUR-APL-2020-028074$AUROBINDO$Sanches TAF, Madanelo I, Lourenco C, Martins L, Sousa H.. NEM TODOS OS MEDICAMENTOS SAO IGUAIS! RELATO DE CONTRA-INDICACOES E REACOES ADVERSAS (NOT ALL MEDICATIONS ARE THE SAME! REPORT OF CONTRAINDICATIONS AND ADVERSE REACTIONS). Revista Portuguesa de Medicina Geral e Familiar. 2020;11(29):407$67$YR$$M$Y$$$20240702$$MD$PT$PT
206077583$20607758$3$F$20220305$20240830$20220317$20240902$EXP$$CA-ROCHE-3052246$ROCHE$$46$YR$A$F$Y$$$20240902$$CN$CA$CA
2060789414$20607894$14$F$$20240823$20220317$20240828$PER$$US-PFIZER INC-202101442834$PFIZER$$81$YR$$F$Y$$$20240828$$MD$US$US
2060790611$20607906$11$F$$20240923$20220317$20240927$PER$$US-PFIZER INC-202200048610$PFIZER$$69$YR$$M$Y$$$20240927$$HP$US$US
206079145$20607914$5$F$$20240819$20220317$20240821$PER$$US-PFIZER INC-202200363705$PFIZER$$47$YR$$F$Y$$$20240821$$HP$US$US
206088329$20608832$9$F$$20240725$20220317$20240730$EXP$$US-TAKEDA-2021TUS066567$TAKEDA$$$$$F$Y$107$KG$20240730$$HP$US$US
206096494$20609649$4$F$$20240628$20220318$20240705$EXP$$DE-JNJFOC-20220325564$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$HP$DE$ES
206096513$20609651$3$F$$20240806$20220318$20240817$EXP$$CA-AUROBINDO-AUR-APL-2022-008336$AUROBINDO$$81$YR$$M$Y$$$20240817$$HP$CA$CA
2060995027$20609950$27$F$20220101$20240813$20220318$20240821$EXP$$CA-CELLTRION INC.-2022CA003239$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
206101884$20610188$4$F$20130201$20240830$20220318$20240903$EXP$$US-TAKEDA-2014BAX021014$TAKEDA$$18$YR$$M$Y$$$20240903$$CN$US$US
2061040318$20610403$18$F$20220720$20240809$20220318$20240816$EXP$$CA-CELLTRION INC.-2022CA003235$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
206111714$20611171$4$F$$20240819$20220318$20240827$EXP$$CA-PFIZER INC-202200403865$PFIZER$$$$$F$Y$$$20240827$$HP$CA$CA
2061118010$20611180$10$F$20221021$20240716$20220318$20240722$EXP$$CA-TAKEDA-2022TUS004808$TAKEDA$$69$YR$$F$Y$$$20240722$$CN$CA$CA
2061122011$20611220$11$F$20220221$20240909$20220318$20240917$EXP$$JP-ASTELLAS-2022JP004463$ASTELLAS$$73$YR$E$M$Y$61$KG$20240917$$PH$JP$JP
2061143414$20611434$14$F$20211129$20240628$20220318$20240703$EXP$$NVSC2022RU059262$NOVARTIS$$69$YR$$F$Y$$$20240703$$MD$RU$RU
206114502$20611450$2$F$$20240625$20220318$20240701$EXP$$JP-PFIZER INC-202200377295$PFIZER$Kato, A.. A case of multiple solar keratoses developed during long-term oral administration of voriconazole. Japanese Journal of Clinical Dermatology. 2022;76(2):113-116$48$YR$$M$Y$$$20240701$$HP$JP$JP
206115717$20611571$7$F$20240621$20240820$20220318$20240822$EXP$$US-PFIZER INC-202200426587$PFIZER$$63$YR$$F$Y$45.35$KG$20240822$$CN$US$US
206117695$20611769$5$F$20210605$20240628$20220318$20240702$EXP$$DE-PFIZER INC-202200386322$PFIZER$$$$A$F$Y$$$20240702$$MD$DE$DE
206118392$20611839$2$F$$20220228$20220318$20240710$EXP$$DE-ASTELLAS-2022US010211$ASTELLAS$$$$$M$Y$$$20240710$$PH$DE$DE
206128738$20612873$8$F$20190101$20240828$20220318$20240902$EXP$$US-JAZZ-2022-US-008212$JAZZ$$$$$M$Y$$$20240902$$HP$US$US
206130793$20613079$3$F$20220101$20240703$20220318$20240714$PER$$US-SA-2022SA086543$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240714$$MD$US$US
206131883$20613188$3$F$20210401$20240815$20220318$20240828$PER$$US-SA-2022SA088821$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240828$$CN$US$US
206132564$20613256$4$F$20220420$20240905$20220318$20240915$PER$$US-SA-2022SA087052$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240915$$MD$US$US
2061330231$20613302$31$F$$20240917$20220318$20240920$EXP$$CA-ABBVIE-22K-028-4316678-00$ABBVIE$$$$$F$Y$97$KG$20240920$$HP$CA$CA
2061333023$20613330$23$F$$20240813$20220318$20240815$EXP$$CA-ABBVIE-22K-028-4316655-00$ABBVIE$$$$$F$Y$97$KG$20240815$$MD$CA$CA
2061339726$20613397$26$F$20150901$20240917$20220319$20240920$EXP$$CA-ABBVIE-22K-028-4316671-00$ABBVIE$$43$YR$$F$Y$97$KG$20240920$$HP$CA$CA
206134196$20613419$6$F$20181206$20240911$20220319$20240920$EXP$$CA-AMGEN-CANCT2019092607$AMGEN$$60$YR$A$F$Y$$$20240919$$CN$CA$CA
206136953$20613695$3$F$$20240731$20220319$20240813$EXP$$CA-AUROBINDO-AUR-APL-2022-008298$AUROBINDO$$51$YR$$F$Y$60$KG$20240813$$HP$CA$CA
206140953$20614095$3$F$20220310$20240730$20220320$20240807$PER$$US-SA-2022SA087764$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240807$$MD$US$US
206141974$20614197$4$F$20240101$20240625$20220320$20240702$EXP$$PHHY2017CA009535$NOVARTIS$$41$YR$$F$Y$$$20240702$$CN$CA$CA
206144388$20614438$8$F$20220221$20240906$20220321$20240912$EXP$$US-GLAXOSMITHKLINE-US2021AMR254342$GLAXOSMITHKLINE$$38$YR$$F$Y$$$20240912$$CN$US$US
206146742$20614674$2$F$$20220316$20220321$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR048828$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
206151343$20615134$3$F$$20240813$20220321$20240826$EXP$$CA-AUROBINDO-AUR-APL-2022-008393$AUROBINDO$$40$YR$$F$Y$$$20240826$$HP$CA$CA
206151602$20615160$2$F$$20240813$20220321$20240826$EXP$$CA-AUROBINDO-AUR-APL-2022-008225$AUROBINDO$$49$YR$$M$Y$128$KG$20240826$$HP$CA$CA
206153783$20615378$3$F$$20240725$20220321$20240731$EXP$$CA-JNJFOC-20220333148$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$PH$CA$CA
206154738$20615473$8$F$$20240916$20220321$20240920$EXP$$CA-BAUSCH-BL-2022-006840$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240920$$HP$CA$CA
206154934$20615493$4$F$20210316$20240725$20220321$20240727$EXP$$DE-TAKEDA-2022TUS018359$TAKEDA$$10$YR$$F$Y$$$20240727$$HP$DE$DE
206158283$20615828$3$F$$20240729$20220321$20240808$EXP$$CA-AUROBINDO-AUR-APL-2022-009186$AUROBINDO$Leising J, Barr AM, Procyshyn RM, Ainsworth NJ, White RF, Honer W, et al.. High-Dose Fluvoxamine Augmentation to Clozapine in Treatment-Resistant Psychosis. J-Clin-Psychopharmacol. 2021;41(2):186-190$55$YR$$M$Y$$$20240809$$HP$CA$CA
206158368$20615836$8$F$20220311$20240712$20220321$20240716$EXP$$IT-TAKEDA-2022TUS017613$TAKEDA$$53$YR$$F$Y$$$20240716$$CN$IT$IT
206161496$20616149$6$F$20200101$20220601$20220321$20240710$EXP$$DE-ASTELLAS-2022US009967$ASTELLAS$$53$YR$$M$Y$61$KG$20240710$$MD$DE$DE
2061657338$20616573$38$F$$20240715$20220321$20240724$EXP$$CA-PFIZER INC-202200425777$PFIZER$$$$$F$Y$97$KG$20240724$$MD$CA$CA
2061679327$20616793$27$F$$20240917$20220321$20240919$EXP$$US-PFIZER INC-202200359979$PFIZER$$67$YR$$F$Y$81.633$KG$20240919$$CN$US$US
2061685310$20616853$10$F$20191029$20240913$20220321$20240918$EXP$$US-ALXN-A202203631$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
2061725010$20617250$10$F$20220101$20240911$20220321$20240913$30DAY$$US-PFIZER INC-202200183142$PFIZER$$14$YR$$M$Y$58.97$KG$20240913$$CN$US$US
206173324$20617332$4$F$$20240809$20220321$20240812$PER$$US-PFIZER INC-202200390063$PFIZER$$70$YR$$F$Y$$$20240812$$CN$US$US
206173646$20617364$6$F$$20240626$20220321$20240701$EXP$$US-PFIZER INC-202200376786$PFIZER$$71$YR$$F$Y$$$20240701$$CN$US$US
206179903$20617990$3$F$20220113$20220307$20220321$20240726$EXP$$FR-AstraZeneca-2022A106864$ASTRAZENECA$$19$YR$$M$Y$75$KG$20240726$$MD$FR$
206181854$20618185$4$F$20220205$20240708$20220321$20240711$EXP$$US-TAKEDA-2022TUS010037$TAKEDA$$54$YR$$M$Y$$$20240711$$HP$US$US
206184779$20618477$9$F$$20221025$20220321$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR049482$GLAXOSMITHKLINE$$$$$F$Y$78$KG$20240925$$MD$US$US
206185813$20618581$3$F$$20240626$20220322$20240703$EXP$$CA-APOTEX-2022AP004465$APOTEX$$52$YR$$F$Y$$$20240703$$HP$CA$CA
206190826$20619082$6$F$20210701$20240806$20220322$20240828$PER$$CA-TOLMAR, INC.-21CA031522$TOLMAR$$88$YR$$M$Y$$$20240828$$CN$CA$CA
2061913410$20619134$10$F$20220117$20240625$20220322$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000715$ACADIA PHARMACEUTICALS$$88$YR$$M$Y$63$KG$20240719$$CN$US$US
2061918316$20619183$16$F$20210101$20240905$20220322$20240913$EXP$$CA-CELLTRION INC.-2021CA014125$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
206192383$20619238$3$F$$20220408$20220322$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR048547$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
2061930017$20619300$17$F$20200808$20240912$20220322$20240917$EXP$$CO-TAKEDA-CO202026625$TAKEDA$$23$YR$$M$Y$46$KG$20240917$$HP$CO$CO
206193072$20619307$2$F$20200901$20240815$20220322$20240906$PER$$IT-TOLMAR, INC.-21IT031606$TOLMAR$$68$YR$$M$Y$$$20240906$$HP$IT$IT
206193262$20619326$2$F$20220301$20220316$20220322$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR049374$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240925$$CN$US$US
2061941618$20619416$18$F$20220103$20240723$20220322$20240731$EXP$$CN-TAKEDA-2022TUS005302$TAKEDA$$55$YR$$F$Y$45$KG$20240731$$MD$CN$CN
2061987720$20619877$20$F$20220301$20240827$20220322$20240911$EXP$$DE-EXELIXIS-XL18422050119$EXELIXIS$$$$$$Y$$$20240911$$MD$DE$DE
206200315$20620031$5$F$$20240819$20220322$20240826$EXP$$CA-AMGEN-CANSP2022047874$AMGEN$$42$YR$A$F$Y$81$KG$20240826$$HP$CA$CA
206200393$20620039$3$F$$20240823$20220322$20240828$EXP$$CA-Orion Corporation ORION PHARMA-22_00017956$ORION$$$$$F$Y$$$20240828$$HP$CA$
206201674$20620167$4$F$20220224$20240702$20220322$20240711$EXP$$CA-MYLANLABS-2022M1011765$BIOCON$$$$$$Y$$$20240711$$CN$CA$CA
206206603$20620660$3$F$20201101$20220418$20220322$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR050338$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240925$$CN$US$US
2062108518$20621085$18$F$$20240822$20220322$20240906$EXP$$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2022-015195$VALIDUS$$$$$$Y$$$20240906$$HP$CA$CA
206211084$20621108$4$F$$20240910$20220322$20240922$EXP$$CA-APOTEX-2022AP004770$APOTEX$$49$YR$$F$Y$96$KG$20240922$$HP$CA$CA
206217442$20621744$2$F$20211230$20220112$20220322$20240721$PER$$US-NOVOPROD-882638$NOVO NORDISK$$32$YR$$F$Y$$$20240721$$CN$US$US
206219752$20621975$2$F$$20220420$20220322$20240807$EXP$$CA-AstraZeneca-2022A115951$ASTRAZENECA$$$$$F$Y$$$20240807$$MD$CA$
206220615$20622061$5$F$20220328$20220411$20220322$20240721$PER$$US-NOVOPROD-894281$NOVO NORDISK$$75$YR$$F$Y$$$20240721$$MD$US$US
206224435$20622443$5$F$20220318$20240626$20220322$20240701$EXP$$US-PFIZER INC-2021855691$PFIZER$$42$YR$$F$Y$$$20240701$$CN$US$US
206225475$20622547$5$F$$20240918$20220322$20240925$PER$$NVSC2022US061183$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
206226385$20622638$5$F$$20240826$20220322$20240828$EXP$$NVSC2022US064400$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
206235637$20623563$7$F$$20240620$20220322$20240701$EXP$$CA-APOTEX-2022AP004490$APOTEX$$49$YR$$M$Y$128$KG$20240701$$HP$CA$CA
2062400410$20624004$10$F$$20240628$20220322$20240709$EXP$$US-JAZZ-2022-US-004727$JAZZ$$$$$F$Y$60$KG$20240709$$HP$US$US
206241043$20624104$3$F$20240501$20240625$20220322$20240704$PER$$US-SA-2022SA086767$SANOFI AVENTIS$$43$YR$A$F$Y$96.1$KG$20240704$$MD$US$US
2062477113$20624771$13$F$$20240720$20220323$20240801$EXP$$CA-Orion Corporation ORION PHARMA-22_00017976$ORION$$$$$F$Y$97$KG$20240801$$MD$CA$
206248152$20624815$2$F$$20240710$20220323$20240715$PER$$US-AMGEN-USASP2022049607$AMGEN$$$$A$F$Y$$$20240715$$HP$US$US
206251902$20625190$2$F$20220210$20240731$20220323$20240812$EXP$$US-Accord-257984$ACCORD$$65$YR$E$F$Y$$$20240812$$MD$US$US
206257842$20625784$2$F$$20240912$20220323$20240924$EXP$$CA-APOTEX-2022AP004796$APOTEX$$72$YR$$F$Y$85$KG$20240924$$HP$CA$CA
206258156$20625815$6$F$20211116$20240820$20220323$20240913$PER$$CA-TOLMAR, INC.-21CA031534$TOLMAR$$76$YR$$M$Y$$$20240913$$CN$CA$CA
206258189$20625818$9$F$20220401$20221122$20220323$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR051171$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
206261073$20626107$3$F$20220309$20220405$20220323$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-330519$RANBAXY$$21$YR$A$F$Y$$$20240702$$CN$US$US
206261593$20626159$3$F$20160101$20220315$20220323$20240717$EXP$$FR-ASTELLAS-2022US010674$ASTELLAS$$36$YR$$F$Y$$$20240717$$CN$NL$FR
206270153$20627015$3$F$$20240628$20220323$20240701$PER$$US-PFIZER INC-202200405583$PFIZER$$70$YR$$F$Y$$$20240701$$CN$US$US
206274725$20627472$5$F$20220601$20240813$20220323$20240819$EXP$$US-TAKEDA-2021TUS055416$TAKEDA$$61$YR$$M$Y$92.9$KG$20240819$$HP$US$US
206280617$20628061$7$F$20220101$20240911$20220323$20240920$EXP$$CA-TAKEDA-2022TUS018707$TAKEDA$$$$$M$Y$$$20240920$$MD$CA$CA
206280856$20628085$6$F$20220325$20240710$20220323$20240715$EXP$$US-PFIZER INC-202200406082$PFIZER$$62$YR$$F$Y$154.3$KG$20240715$$CN$US$US
206281426$20628142$6$F$$20240917$20220323$20240927$EXP$$JP-ROCHE-3053953$ROCHE$Hayashi M, Hayashi T, Kaneko R, Nishigami K, Sato Y, Nishikawa Y, Nakazaki N, et al. A Case of Multiple Hepatocellular Carcinoma Complicated with Severe Refractory Stasis Venous Ulcer of the Lower Extremities Repeatedly Responding to Angiogenesis Inhibitors. The 370th Kanto Regional Annual Meeting of the Japanese Society of Gastroenterology (held on web). 2022;:27-.$84$YR$E$M$Y$58$KG$20240927$$MD$JP$JP
206281926$20628192$6$F$20201222$20240805$20220323$20240806$EXP$$JP-SA-2022SA097193$SANOFI AVENTIS$$85$YR$E$F$Y$47.7$KG$20240807$$MD$JP$JP
206282342$20628234$2$F$20180824$20240628$20220323$20240821$EXP$$AR-ROCHE-3053641$ROCHE$$68$YR$E$F$Y$$$20240821$$CN$AR$AR
2062830014$20628300$14$F$20160101$20240809$20220323$20240829$EXP$$CA-ORGANON-1802CAN002229$ORGANON$$58$YR$$F$Y$$$20240829$$HP$CA$CA
2062845710$20628457$10$F$20220101$20240911$20220323$20240918$PER$$US-DSJP-DSU-2022-110162$DAIICHI$$$$$M$Y$$$20240918$$CN$US$US
206286013$20628601$3$F$$20240805$20220323$20240806$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000081$PAREXEL$$$$$$Y$$$20240806$$CN$US$US
206290766$20629076$6$F$$20220609$20220323$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR051186$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
206292824$20629282$4$F$20220201$20240910$20220323$20240912$EXP$$US-PFIZER INC-202200427363$PFIZER$$17$YR$$M$Y$$$20240912$$HP$US$US
206293969$20629396$9$F$$20240801$20220323$20240807$EXP$$PT-MYLANLABS-2022M1020906$MYLAN$Rodrigues S, Esteves VL. P065 ? Clinical Cases EUGLYCEMIC KETOACIDOSIS IN ELDERLY PATIENT ON EMPAGLIFLOZIN AND METFORMIN. Portuguese Journal of Diabetes. 2022;17 (1) Suppl:74$82$YR$$F$Y$$$20240807$$MD$PT$PT
206296882$20629688$2$F$$20240716$20220323$20240718$EXP$$PT-AMGEN-PRTSP2022049233$AMGEN$$$$$F$Y$$$20240718$$CN$PT$PT
206297273$20629727$3$F$$20240627$20220323$20240702$PER$$US-AMGEN-USASP2022051035$AMGEN$$$$A$F$Y$$$20240702$$HP$US$US
206300465$20630046$5$F$20190329$20240715$20220324$20240720$EXP$$PHHY2019CA077081$NOVARTIS$$31$YR$$F$Y$$$20240719$$CN$CA$CA
206304285$20630428$5$F$20211001$20240723$20220324$20240802$30DAY$$US-VIIV HEALTHCARE LIMITED-US2022AMR014683$VIIV$$48$YR$$M$Y$$$20240802$$CN$US$US
2063055317$20630553$17$F$20200130$20240913$20220324$20240921$EXP$$CA-CELLTRION INC.-2020CA021256$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
2063064813$20630648$13$F$20220309$20240729$20220324$20240805$EXP$$US-SA-2022SA097609$SANOFI AVENTIS$$29$YR$A$M$Y$71.2$KG$20240805$$MD$US$US
206306593$20630659$3$F$20220314$20240828$20220324$20240830$EXP$$JP-KYOWAKIRIN-2022AKK003884$KYOWA$$$$$$Y$$$20240830$$HP$JP$JP
206306613$20630661$3$F$20220121$20240628$20220324$20240708$30DAY$$US-GLAXOSMITHKLINE-US2022050457$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240708$$CN$US$US
206307312$20630731$2$F$$20220322$20220324$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR051675$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2063087814$20630878$14$F$20211123$20240623$20220324$20240701$EXP$$CA-CELLTRION INC.-2021CA013002$CELLTRION$$$$$$Y$$$20240701$$HP$CA$CA
206310823$20631082$3$F$20220120$20240904$20220324$20240911$EXP$$CA-ABBVIE-22K-028-4329868-00$ABBVIE$$41$YR$$M$Y$$$20240911$$MD$CA$CA
206311742$20631174$2$F$$20240816$20220324$20240826$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2022-001017$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
206314514$20631451$4$F$$20240910$20220324$20240920$EXP$$CA-APOTEX-2020AP007527$APOTEX$$64$YR$$M$Y$$$20240920$$HP$CA$CA
206315122$20631512$2$F$20200714$20220319$20220324$20240712$EXP$$RO-ASTELLAS-2022US010632$ASTELLAS$$79$YR$$M$Y$$$20240712$$CN$RO$RO
206319745$20631974$5$F$20220215$20240902$20220324$20240910$EXP$$DE-ROCHE-3056644$ROCHE$$57$YR$A$M$Y$$$20240910$$CN$DE$DE
2063211928$20632119$28$F$20240606$20240914$20220324$20240918$EXP$$IN-PFIZER INC-202101588624$PFIZER$$38$YR$$F$Y$$$20240918$$CN$IN$IN
206323863$20632386$3$F$20240518$20240910$20220324$20240912$EXP$$IN-PFIZER INC-2020414774$PFIZER$$71$YR$$F$Y$86.45$KG$20240912$$CN$IN$IN
2063245218$20632452$18$F$20210705$20240701$20220324$20240709$EXP$$CA-CELLTRION INC.-2021CA009903$CELLTRION$$$$$$Y$$$20240709$$CN$CA$CA
206325982$20632598$2$F$$20240823$20220324$20240829$EXP$$CA-ROCHE-3051073$ROCHE$$37$YR$A$F$Y$54$KG$20240829$$HP$CA$CA
206328132$20632813$2$F$$20220322$20220324$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR052694$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
2063322518$20633225$18$F$20200219$20240912$20220324$20240921$EXP$$CA-ROCHE-2560263$ROCHE$$34$YR$A$F$Y$$$20240921$$CN$CA$CA
2063324017$20633240$17$F$20160630$20240723$20220324$20240802$EXP$$CA-ROCHE-1978903$ROCHE$$63$YR$A$M$Y$61$KG$20240802$$MD$CA$CA
206332895$20633289$5$F$$20240819$20220324$20240828$EXP$$CA-PFIZER INC-202200454808$PFIZER$$42$YR$$F$Y$81$KG$20240828$$HP$CA$CA
206333937$20633393$7$F$20220811$20240801$20220324$20240808$EXP$$GB-TAKEDA-2021TUS017992$TAKEDA$$64$YR$$F$Y$71.2$KG$20240808$$HP$GB$GB
206335982$20633598$2$F$20210626$20240715$20220324$20240718$EXP$FR-AFSSAPS-AM20220648$FR-EMD Serono-E2B_90087278$EMD SERONO INC$$60$YR$A$F$Y$$$20240718$$MD$FR$FR
206336694$20633669$4$F$$20240730$20220324$20240806$EXP$$US-JAZZ-2022-US-009084$JAZZ$$$$$F$Y$$$20240806$$CN$US$US
206337952$20633795$2$F$$20240708$20220324$20240712$EXP$$PT-PFIZER INC-202200435713$PFIZER$$$$$F$Y$$$20240712$$CN$PT$PT
2063387021$20633870$21$F$20210324$20240725$20220324$20240731$EXP$$CA-ROCHE-2798675$ROCHE$$36$YR$A$F$Y$74.39$KG$20240731$$CN$CA$CA
206338786$20633878$6$F$$20240731$20220324$20240810$EXP$$US-JAZZ-2022-US-009076$JAZZ$$$$$F$Y$$$20240810$$MD$US$US
206339116$20633911$6$F$$20240719$20220324$20240724$EXP$$NVSC2022CO065011$NOVARTIS$$$$$F$Y$61$KG$20240724$$CN$CO$CO
206340838$20634083$8$F$20210315$20240920$20220324$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-036348$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$68$KG$20240927$$MD$JP$JP
206343713$20634371$3$F$20240701$20240809$20220325$20240813$PER$$US-AMGEN-USASP2022050871$AMGEN$$72$YR$E$F$Y$$$20240813$$HP$US$US
206344195$20634419$5$F$20211001$20240723$20220325$20240805$PER$$US-JNJFOC-20220350818$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240805$$CN$US$US
2063449224$20634492$24$F$20211222$20240905$20220325$20240914$EXP$$CA-CELLTRION INC.-2022CA001440$CELLTRION$$$$$$Y$$$20240914$$CN$CA$CA
206346896$20634689$6$F$20190730$20240731$20220325$20240807$EXP$$DE-ROCHE-2368907$ROCHE$$54$YR$A$F$Y$$$20240807$$CN$DE$DE
206347566$20634756$6$F$$20240809$20220325$20240812$EXP$$US-SHIRE-US201909945AA$TAKEDA$$$$$F$Y$$$20240812$$HP$US$US
206350712$20635071$2$F$$20240711$20220325$20240720$EXP$$PT-AUROBINDO-AUR-APL-2022-009720$AUROBINDO$$$$$F$Y$$$20240720$$HP$PT$PT
206353286$20635328$6$F$$20240923$20220325$20240926$EXP$$CA-ROCHE-3053199$ROCHE$$44$YR$A$F$Y$97$KG$20240926$$HP$CA$CA
2063552610$20635526$10$F$20211228$20240730$20220325$20240805$EXP$$CA-TAKEDA-2021TUS070498$TAKEDA$$51$YR$$F$Y$$$20240805$$MD$CA$CA
206358126$20635812$6$F$$20240625$20220325$20240708$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK013387$Haleon PLC$$$$$F$Y$$$20240705$$MD$CA$CA
206359262$20635926$2$F$20220201$20240709$20220325$20240716$EXP$$FR-TAKEDA-2022TUS018933$TAKEDA$$72$YR$$M$Y$82$KG$20240716$$HP$FR$FR
206364773$20636477$3$F$$20240724$20220325$20240731$EXP$$CA-GLAXOSMITHKLINE-CA2022AMR052463$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$CA$CA
206371116$20637111$6$F$20220223$20240826$20220325$20240829$EXP$$CA-ROCHE-3046276$ROCHE$$28$YR$A$M$Y$$$20240829$$CN$CA$CA
206376664$20637666$4$F$$20240719$20220325$20240726$EXP$$US-TAKEDA-2022TUS019723$TAKEDA$$$$$F$Y$$$20240726$$HP$US$US
206378744$20637874$4$F$20220101$20220323$20220325$20240723$EXP$$US-ORPHANEU-2022000983$RECORDATI$$$$$$Y$$$20240723$$HP$US$US
2063797511$20637975$11$F$20220101$20240920$20220325$20240925$PER$$US-DSJP-DSU-2022-110423$DAIICHI$$$$$F$Y$$$20240925$$HP$US$US
206380354$20638035$4$F$$20240910$20220325$20240920$EXP$$US-TAKEDA-US202025799$TAKEDA$$$$$M$Y$$$20240920$$CN$US$US
206384244$20638424$4$F$$20220325$20220325$20240805$EXP$$CA-Covis Pharma GmbH-2022COV00943$COVIS PHARMA$$62$YR$A$F$Y$69$KG$20240805$$$COUNTRY NOT SPECIFIED$CA
206385635$20638563$5$F$$20240918$20220325$20240920$EXP$$US-PFIZER INC-202200187070$PFIZER$$58$YR$$F$Y$$$20240920$$HP$US$US
2063864733$20638647$33$F$$20240919$20220325$20240927$EXP$$CA-TAKEDA-2021TUS063646$TAKEDA$$41$YR$$F$Y$$$20240927$$PH$CA$CA
206391937$20639193$7$F$20220725$20240710$20220326$20240716$EXP$$CO-TAKEDA-2022TUS020104$TAKEDA$$26$YR$$M$Y$49$KG$20240716$$CN$CO$CO
206392022$20639202$2$F$$20240722$20220326$20240726$EXP$$CA-JNJFOC-20220349045$JOHNSON AND JOHNSON$$72$YR$E$F$Y$65$KG$20240726$$PH$CA$CA
206396932$20639693$2$F$20210901$20240731$20220326$20240809$PER$$US-SA-2022SA094458$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240809$$MD$US$US
206396993$20639699$3$F$20220201$20240730$20220326$20240807$PER$$US-SA-2022SA094092$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240807$$MD$US$US
206397206$20639720$6$F$20220801$20230926$20220326$20240913$PER$$US-SA-2022SA092338$SANOFI AVENTIS$$20$YR$A$F$Y$65.76$KG$20240913$$MD$US$US
206397283$20639728$3$F$20220314$20240628$20220326$20240711$PER$$US-SA-2022SA093374$SANOFI AVENTIS$$10$YR$C$F$Y$48.6$KG$20240711$$CN$US$US
206397896$20639789$6$F$20240626$20240821$20220326$20240905$PER$$US-SA-2022SA092106$SANOFI AVENTIS$$62$YR$A$M$Y$95.238$KG$20240905$$MD$US$US
206400033$20640003$3$F$20220101$20240624$20220326$20240703$PER$$US-SA-2022SA095388$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240703$$MD$US$US
2064016511$20640165$11$F$20211101$20240724$20220327$20240819$PER$$AU-TOLMAR, INC.-21AU031799$TOLMAR$$76$YR$$M$Y$$$20240819$$HP$AU$AU
206403392$20640339$2$F$20211224$20240719$20220327$20240730$EXP$$US-ROCHE-3058260$ROCHE$$55$YR$A$M$Y$$$20240730$$CN$US$US
2064037210$20640372$10$F$20230501$20240725$20220327$20240801$PER$$US-SA-2022SA095389$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240801$$MD$US$US
206405322$20640532$2$F$$20240731$20220327$20240809$PER$$US-SA-2022SA096117$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
206414002$20641400$2$F$$20220321$20220328$20240711$EXP$$NVSC2022CA068094$NOVARTIS$$58$YR$$M$Y$$$20240711$$CN$CA$CA
206417065$20641706$5$F$$20240819$20220328$20240819$EXP$$CA-ORGANON-2004CAN002947$ORGANON$$$$$$Y$$$20240819$$HP$CA$CA
206420235$20642023$5$F$20211001$20240925$20220328$20240927$EXP$$NVSC2022DE069476$NOVARTIS$$45$YR$$F$Y$109$KG$20240927$$MD$DE$DE
206421872$20642187$2$F$$20240808$20220328$20240814$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2022-042735$REGENERON$$$$$M$Y$$$20240814$$CN$GB$GB
206423308$20642330$8$F$20211101$20230419$20220328$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR054779$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
206423793$20642379$3$F$$20240919$20220328$20240925$EXP$$NVSC2022US068765$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
2064249710$20642497$10$F$20220305$20240827$20220328$20240912$EXP$$US-SA-2022SA104447$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240912$$MD$US$US
2064259110$20642591$10$F$$20240625$20220328$20240702$EXP$$NVSC2022CA066190$NOVARTIS$$56$YR$$F$Y$$$20240702$$HP$CA$CA
206426062$20642606$2$F$$20220324$20220328$20240711$EXP$$DE-ASTELLAS-2022US011323$ASTELLAS$$66$YR$$M$Y$$$20240711$$CN$DE$DE
206426707$20642670$7$F$20150101$20240705$20220328$20240711$EXP$$US-JAZZ-2022-US-009062$JAZZ$$70$YR$$F$Y$$$20240711$$MD$US$US
206430545$20643054$5$F$$20240826$20220328$20240829$EXP$$CA-Orion Corporation ORION PHARMA-22_00018048$ORION$$42$YR$A$F$Y$81$KG$20240829$$HP$CA$
2064314013$20643140$13$F$20220101$20240909$20220328$20240914$EXP$$CA-TAKEDA-2022TUS015268$TAKEDA$$$$$F$Y$$$20240914$$HP$CA$CA
2064321613$20643216$13$F$20180522$20240916$20220328$20240920$EXP$$AT-MYLANLABS-2022M1021423$MYLAN$$37$YR$$F$Y$$$20240920$$MD$AT$AT
206433659$20643365$9$F$20220301$20220916$20220328$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR054392$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
206435567$20643556$7$F$20220324$20240906$20220328$20240911$EXP$$CA-TAKEDA-2022TUS017621$TAKEDA$$42$YR$$F$Y$$$20240911$$CN$CA$CA
206436413$20643641$3$F$20220312$20240709$20220328$20240720$EXP$$US-Accord-258595$ACCORD$$69$YR$E$M$Y$$$20240720$$MD$US$US
206436442$20643644$2$F$20220304$20230711$20220328$20240919$EXP$$US-Accord-258597$ACCORD$$61$YR$A$M$Y$$$20240919$$MD$US$US
206437232$20643723$2$F$$20240919$20220328$20240923$EXP$$US-SA-2022SA106040$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240923$$MD$US$US
206440785$20644078$5$F$20210101$20240909$20220328$20240911$PER$$US-PFIZER INC-202100963369$PFIZER$$76$YR$$F$Y$$$20240911$$HP$US$US
206440993$20644099$3$F$20220228$20240805$20220328$20240819$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2022-000161$SK LIFE SCIENCE$$$$$$Y$$$20240819$$CN$US$US
206449162$20644916$2$F$20210101$20240822$20220328$20240828$PER$$US-PFIZER INC-202200462880$PFIZER$$57$YR$$F$Y$$$20240828$$HP$US$US
206451652$20645165$2$F$20210101$20240902$20220328$20240911$PER$$US-SA-2022SA100284$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240911$$MD$US$US
206452116$20645211$6$F$20230421$20240822$20220328$20240823$PER$$US-ROCHE-3053554$ROCHE$$29$YR$A$M$Y$$$20240823$$CN$US$US
2064543213$20645432$13$F$$20240820$20220328$20240822$EXP$$US-PFIZER INC-202200452321$PFIZER$$60$YR$$M$Y$122.45$KG$20240822$$CN$US$US
2064543411$20645434$11$F$20220306$20240626$20220328$20240701$EXP$$US-PFIZER INC-202200440561$PFIZER$$70$YR$$F$Y$$$20240701$$CN$US$US
2064543612$20645436$12$F$20220901$20240903$20220328$20240905$EXP$$US-PFIZER INC-202200463800$PFIZER$$80$YR$$F$Y$79.38$KG$20240905$$CN$US$US
206457106$20645710$6$F$$20240708$20220328$20240715$PER$$US-SA-2022SA094909$SANOFI AVENTIS$$$$E$M$Y$$$20240715$$HP$US$US
206469016$20646901$6$F$20220301$20220427$20220329$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR054422$GLAXOSMITHKLINE$$58$YR$$F$Y$97.9$KG$20240926$$MD$US$US
206470326$20647032$6$F$20180308$20240906$20220329$20240917$EXP$$DE-ROCHE-2169507$ROCHE$$53$YR$A$F$Y$$$20240917$$CN$DE$DE
206472982$20647298$2$F$20220207$20240814$20220329$20240827$EXP$$FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2022-015287$VALIDUS$$$$$$Y$$$20240827$$PH$FR$FR
2064737910$20647379$10$F$20220525$20240923$20220329$20240927$EXP$$CA-TAKEDA-2022TUS018817$TAKEDA$$66$YR$$M$Y$89.1$KG$20240927$$CN$CA$CA
206475838$20647583$8$F$20220314$20240920$20220329$20240924$EXP$$JP-ASTELLAS-2022JP004563$ASTELLAS$$66$YR$E$M$Y$65.5$KG$20240924$$PH$JP$JP
206476138$20647613$8$F$$20240918$20220329$20240923$EXP$$CA-Orion Corporation ORION PHARMA-22_00018060$ORION$$46$YR$A$M$Y$$$20240923$$HP$CA$
2064848312$20648483$12$F$$20230207$20220329$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR054491$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
206486064$20648606$4$F$20240908$20240922$20220329$20240927$EXP$$US-TAKEDA-2022TUS020646$TAKEDA$$82$YR$$F$Y$90.249$KG$20240927$$MD$US$US
206492205$20649220$5$F$$20240628$20220329$20240702$EXP$$IN-PFIZER INC-202200445492$PFIZER$$69$YR$$F$Y$$$20240702$$CN$IN$IN
2064936714$20649367$14$F$20220319$20240613$20220329$20240702$EXP$$CA-ROCHE-3060651$ROCHE$$41$YR$A$F$Y$$$20240702$$HP$CA$CA
206493875$20649387$5$F$$20240722$20220329$20240724$EXP$$US-TAKEDA-2022TUS020603$TAKEDA$$$$$M$Y$132$KG$20240724$$CN$US$US
206501085$20650108$5$F$20230101$20240819$20220329$20240821$PER$$US-PFIZER INC-202101055712$PFIZER$$76$YR$$F$Y$$$20240821$$CN$US$US
206501275$20650127$5$F$$20240801$20220329$20240806$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000032$PAREXEL$$$$$$Y$$$20240806$$CN$US$US
206501293$20650129$3$F$$20240912$20220329$20240913$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000075$PAREXEL$$$$$$Y$$$20240913$$CN$US$US
2065040124$20650401$24$F$20210528$20240725$20220329$20240730$EXP$$US-TAKEDA-2021TUS036443$TAKEDA$$53$YR$$F$Y$50$KG$20240730$$HP$US$US
206506542$20650654$2$F$20220324$20240919$20220329$20240930$PER$$US-SA-2022SA105293$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240930$$HP$US$US
2065096222$20650962$22$F$20220105$20240809$20220329$20240827$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-161248$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$79$KG$20240827$$MD$DE$DE
2065150816$20651508$16$F$$20230619$20220330$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR053798$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
206517885$20651788$5$F$$20220808$20220330$20240925$PER$$US-GLAXOSMITHKLINE-US2022055939$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
206520439$20652043$9$F$20220301$20220826$20220330$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR055975$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
206520523$20652052$3$F$20200727$20240826$20220330$20240902$EXP$$CA-JNJFOC-20220353834$JOHNSON AND JOHNSON$$9$YR$C$M$Y$44$KG$20240902$$HP$CA$CA
206521555$20652155$5$F$20220316$20220520$20220330$20240914$EXP$$ZA-SA-2021SA228936$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240914$$MD$ZA$ZA
206522584$20652258$4$F$20220301$20220404$20220330$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR055526$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240926$$CN$US$US
2065294415$20652944$15$F$20220107$20221028$20220330$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR055661$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240925$$HP$US$US
206532947$20653294$7$F$20210901$20240829$20220330$20240909$EXP$$CA-AMGEN-CANNI2022005589$AMGEN$$25$YR$A$F$Y$$$20240909$$MD$CA$CA
206535333$20653533$3$F$20220322$20240806$20220330$20240814$PER$$US-SA-2022SA102161$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240814$$MD$US$US
2065389911$20653899$11$F$$20240806$20220330$20240809$PER$$US-PFIZER INC-202101742811$PFIZER$$71$YR$$F$Y$$$20240809$$CN$US$US
2065395017$20653950$17$F$20220101$20240730$20220330$20240801$EXP$$US-PFIZER INC-202200427163$PFIZER$$67$YR$$F$Y$83.01$KG$20240801$$HP$US$US
206540666$20654066$6$F$20240223$20240624$20220330$20240703$PER$$US-SA-2022SA069975$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240703$$MD$US$US
2065461813$20654618$13$F$$20240830$20220330$20240905$EXP$$IN-PFIZER INC-202200444611$PFIZER$$71$YR$$F$Y$80$KG$20240905$$CN$IN$IN
206548719$20654871$9$F$$20240904$20220330$20240906$EXP$$PT-ABBVIE-22K-130-4336747-00$ABBVIE$$$$E$$Y$$$20240906$$HP$PT$PT
206552012$20655201$2$F$20240715$20240716$20220330$20240719$EXP$$US-KYOWAKIRIN-2022BKK004195$KYOWA$$$$$$Y$$$20240719$$HP$US$US
206552274$20655227$4$F$20220301$20240920$20220330$20240925$EXP$$US-KYOWAKIRIN-2022BKK004395$KYOWA$$$$$$Y$$$20240925$$HP$US$US
206554912$20655491$2$F$20210101$20240923$20220330$20240925$PER$$US-PFIZER INC-202101034133$PFIZER$$67$YR$$F$Y$$$20240925$$HP$US$US
2065551710$20655517$10$F$20220108$20240909$20220330$20240912$EXP$$US-PAREXEL-2021-KAM-US003476$TAKEDA$$60$YR$$F$Y$64$KG$20240912$$MD$US$US
206557595$20655759$5$F$20210515$20240711$20220330$20240715$EXP$$US-TAKEDA-2022TUS020207$TAKEDA$$17$YR$$M$Y$$$20240715$$PH$US$US
206559266$20655926$6$F$$20240913$20220330$20240917$EXP$$US-JAZZ-2022-US-010024$JAZZ$$$$$F$Y$$$20240917$$CN$US$US
206563122$20656312$2$F$20211201$20220328$20220331$20240925$EXP$$NVSC2021IN301789$NOVARTIS$$20$YR$$M$Y$$$20240926$$CN$IN$IN
2065639827$20656398$27$F$20220101$20240813$20220331$20240820$EXP$$CA-CELLTRION INC.-2022CA003718$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
2065652017$20656520$17$F$20210505$20240909$20220331$20240917$EXP$$CA-CELLTRION INC.-2022CA003889$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
2065666613$20656666$13$F$20220316$20240829$20220331$20240907$EXP$$CA-CELLTRION INC.-2022CA003767$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
206571765$20657176$5$F$20200108$20240801$20220331$20240806$EXP$$DE-ROCHE-2573677$ROCHE$$29$YR$A$F$Y$$$20240806$$CN$DE$DE
2065726913$20657269$13$F$20210805$20240819$20220331$20240827$EXP$$CA-CELLTRION INC.-2020CA035134$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
206573223$20657322$3$F$$20240709$20220331$20240710$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000090$PAREXEL$$$$$$Y$$$20240710$$CN$US$US
206574002$20657400$2$F$$20240812$20220331$20240817$EXP$$PL-ROCHE-3060258$ROCHE$Zajac-Spychala O, Pieczonka A, Janura-Szymanska J, Jonczyk-Potoczna K, Wachowiak J. Multiple Reactivations of Viral Infections Followed by Cerebral Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation in an Adolescent With Ph(+) Acute Lymphoblastic Leukemia:. A Case Report. Transplant-Proc 2021;53(4):1355-1359.$17$YR$T$F$Y$$$20240817$$MD$PL$PL
206574982$20657498$2$F$$20220316$20220331$20240709$PER$$US-ASTELLAS-2022US010285$ASTELLAS$$75$YR$$F$Y$$$20240709$$CN$US$US
2065754615$20657546$15$F$20210225$20240816$20220331$20240824$EXP$$CA-CELLTRION INC.-2021CA003257$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
206575522$20657552$2$F$20220323$20240701$20220331$20240710$PER$$US-SA-2022SA105106$SANOFI AVENTIS$$4$YR$C$M$Y$22$KG$20240710$$MD$US$US
206577113$20657711$3$F$20220325$20230105$20220331$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR057284$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$HP$US$US
206577572$20657757$2$F$$20240805$20220331$20240808$EXP$$US-ASTELLAS-2022US011955$ASTELLAS$$$$$M$Y$$$20240808$$CN$US$US
2065797617$20657976$17$F$20190803$20240710$20220331$20240720$EXP$$CA-CELLTRION INC.-2019CA023364$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
206580792$20658079$2$F$$20240720$20220331$20240730$PER$$US-SA-2022SA110640$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240730$$MD$US$US
2065816211$20658162$11$F$20220301$20230628$20220331$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR057007$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240926$$CN$US$US
206583534$20658353$4$F$$20240715$20220331$20240723$PER$$US-SA-2022SA107160$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240723$$CN$US$US
206583802$20658380$2$F$$20240808$20220331$20240814$EXP$$US-GLAXOSMITHKLINE-US2022056620$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$US$US
206585132$20658513$2$F$20220127$20220321$20220331$20240730$EXP$$FR-AstraZeneca-2022A055776$ASTRAZENECA$$62$YR$$F$Y$74$KG$20240730$$MD$FR$
206589225$20658922$5$F$20220301$20240718$20220331$20240724$EXP$$NVSC2022CA072408$NOVARTIS$$74$YR$$M$Y$$$20240724$$CN$CA$CA
2065892610$20658926$10$F$20190501$20240711$20220331$20240722$PER$$US-XERIS PHARMACEUTICALS-2022XER00002$XERIS PHARMACEUTICALS$$46$YR$$M$Y$104.31$KG$20240719$$CN$US$US
206591053$20659105$3$F$20210101$20240724$20220331$20240802$PER$$US-SA-2022SA108459$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240802$$MD$US$US
206593163$20659316$3$F$$20220323$20220331$20240925$EXP$$US-TAKEDA-2022TUS020323$TAKEDA$$$$$M$Y$$$20240925$$CN$US$US
206596322$20659632$2$F$20220301$20220511$20220331$20240725$EXP$$ZA-BIOVITRUM-2022ZA04580$BIOVITRUM$$274$DY$$M$Y$7.5$KG$20240725$$MD$ZA$ZA
206598074$20659807$4$F$20220323$20240621$20220331$20240705$EXP$$CA-ROCHE-3063925$ROCHE$$43$YR$A$F$Y$$$20240705$$CN$CA$CA
206602678$20660267$8$F$20220221$20240814$20220331$20240823$EXP$$IN-INCYTE CORPORATION-2022IN002707$INCYTE$$$$$$Y$$$20240823$$CN$IN$IN
206603602$20660360$2$F$$20190606$20220331$20240830$PER$$US-JAZZ-2019-US-018561$JAZZ$$$$$M$Y$$$20240830$$CN$US$US
206606104$20660610$4$F$20190425$20240614$20220331$20240704$EXP$$DE-ROCHE-2327612$ROCHE$$31$YR$A$F$Y$$$20240704$$CN$DE$DE
2066078918$20660789$18$F$20200801$20240912$20220331$20240919$EXP$$CA-TAKEDA-2022TUS021531$TAKEDA$$73$YR$$M$Y$66$KG$20240919$$CN$CA$CA
206609629$20660962$9$F$20200625$20240827$20220331$20240830$EXP$$US-TAKEDA-2022TUS021535$TAKEDA$$67$YR$$F$Y$101$KG$20240830$$HP$US$US
206610582$20661058$2$F$$20220322$20220331$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-101619$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240704$$MD$JP$JP
206618477$20661847$7$F$20220319$20240821$20220401$20240823$EXP$$CA-ROCHE-3064889$ROCHE$$18$YR$A$F$Y$$$20240823$$CN$CA$CA
206619192$20661919$2$F$20220314$20220525$20220401$20240723$EXP$$US-ORPHANEU-2022001089$RECORDATI$$$$$$Y$$$20240723$$CN$US$US
2066243110$20662431$10$F$20210823$20240809$20220401$20240815$EXP$$CA-TAKEDA-2021TUS026254$TAKEDA$$30$YR$$F$Y$$$20240815$$CN$CA$CA
206624942$20662494$2$F$20221205$20240909$20220401$20240910$EXP$$US-UCBSA-2022017715$UCB$$49$YR$$F$Y$$$20240910$$CN$US$US
206629514$20662951$4$F$20220331$20230803$20220401$20240731$PER$$NVSC2022US074354$NOVARTIS$$50$YR$$M$Y$$$20240731$$HP$US$US
206634582$20663458$2$F$$20240725$20220401$20240726$EXP$$PT-ROCHE-3057039$ROCHE$$$$$F$Y$$$20240727$$HP$PT$PT
206635494$20663549$4$F$20220325$20240726$20220401$20240730$EXP$$US-GW PHARMA-202203USGW01629$JAZZ$$13$YR$$F$Y$21.4$KG$20240730$$CN$US$US
2066386639$20663866$39$F$$20240909$20220401$20240916$EXP$$CA-GLAXOSMITHKLINE-CA2020AMR124077$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$CA$CA
206639325$20663932$5$F$20200826$20240905$20220401$20240910$EXP$$FR-EMD Serono-E2B_90087375$EMD SERONO INC$$72$YR$E$M$Y$$$20240910$$MD$FR$FR
206640252$20664025$2$F$20190507$20240911$20220401$20240918$PER$$US-BIOVITRUM-2022US04455$BIOVITRUM$$49$YR$$F$Y$$$20240918$$CN$US$US
206643163$20664316$3$F$20220204$20240804$20220401$20240814$EXP$$JP-EMD Serono-9309176$EMD SERONO INC$$87$YR$E$M$Y$$$20240814$$MD$JP$JP
206644292$20664429$2$F$20180822$20240809$20220401$20240812$EXP$$CA-TAKEDA-2022TUS021816$TAKEDA$$74$YR$$F$Y$$$20240812$$MD$CA$CA
206646557$20664655$7$F$20200701$20240819$20220401$20240827$EXP$$CA-TAKEDA-2022TUS021463$TAKEDA$$88$YR$$M$Y$82$KG$20240827$$CN$CA$CA
2066477519$20664775$19$F$20240111$20240917$20220401$20240924$EXP$$GB-TAKEDA-2021TUS078183$TAKEDA$$64$YR$$M$Y$$$20240924$$CN$GB$GB
206647833$20664783$3$F$20210718$20240725$20220401$20240805$EXP$$ES-NOVOPROD-885556$NOVO NORDISK$$33$YR$$F$Y$69$KG$20240805$$CN$ES$ES
206649727$20664972$7$F$20230720$20240828$20220401$20240904$PER$$US-PFIZER INC-2021364367$PFIZER$$74$YR$$F$Y$76.553$KG$20240904$$CN$US$US
2066500820$20665008$20$F$20230101$20240807$20220401$20240819$EXP$$US-BIOGEN-2022BI01101932$BIOGEN$$75$YR$$F$Y$$$20240818$$CN$US$US
206654043$20665404$3$F$$20240708$20220402$20240711$PER$$US-AMGEN-USASP2022057068$AMGEN$$60$YR$A$F$Y$$$20240710$$MD$US$US
206654737$20665473$7$F$20210710$20240730$20220402$20240801$EXP$$RU-ROCHE-2953072$ROCHE$$72$YR$E$F$Y$68$KG$20240801$$MD$RU$RU
206658524$20665852$4$F$$20240917$20220402$20240924$EXP$$CA-TAKEDA-2022TUS002472$TAKEDA$$$$$F$Y$$$20240924$$CN$CA$CA
206664282$20666428$2$F$20220328$20240813$20220403$20240826$PER$$US-SA-2022SA109649$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240826$$MD$US$US
206665033$20666503$3$F$20181001$20240705$20220403$20240717$PER$$US-SA-2022SA112609$SANOFI AVENTIS$$43$YR$A$M$Y$84.82$KG$20240717$$MD$US$US
206666183$20666618$3$F$20220301$20240719$20220403$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-012655$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240722$$CN$US$US
206666242$20666624$2$F$$20240726$20220403$20240807$PER$$US-SA-2022SA108078$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240807$$MD$US$US
206668483$20666848$3$F$20190910$20240906$20220403$20240911$EXP$$NVSC2019DE060866$NOVARTIS$$$$A$F$Y$84$KG$20240911$$MD$DE$DE
206674366$20667436$6$F$20230331$20240618$20220404$20240709$PER$$CA-TOLMAR, INC.-21CA028387$TOLMAR$$78$YR$$M$Y$$$20240709$$CN$CA$CA
206675442$20667544$2$F$$20240731$20220404$20240801$EXP$$CA-BAUSCH-BL-2022-008138$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240801$$HP$CA$CA
2066781917$20667819$17$F$20240605$20240727$20220404$20240801$EXP$$US-TAKEDA-2021TUS078132$TAKEDA$$55$YR$$F$Y$59$KG$20240801$$CN$US$US
206681414$20668141$4$F$20211224$20220616$20220404$20240724$EXP$$JP-ORPHANEU-2022001211$RECORDATI$$$$$$Y$$$20240724$$MD$JP$JP
206681935$20668193$5$F$$20240703$20220404$20240709$EXP$$NVSC2022CO075219$NOVARTIS$$$$$M$Y$68$KG$20240709$$CN$CO$CO
2066843613$20668436$13$F$20220923$20240726$20220404$20240731$EXP$$US-SHIRE-US201912665$TAKEDA$$66$YR$$M$Y$100$KG$20240731$$HP$US$US
206684902$20668490$2$F$$20240711$20220404$20240718$EXP$$NL-MYLANLABS-2022M1024317$MYLAN$$$$$$Y$$$20240718$$CN$NL$NL
2066928913$20669289$13$F$20200101$20240925$20220404$20240930$EXP$$CA-PFIZER INC-202101587511$PFIZER$$47$YR$$F$Y$$$20240930$$HP$CA$CA
2066955812$20669558$12$F$$20240827$20220404$20240828$EXP$$US-TAKEDA-US202000175$TAKEDA$$$$$F$Y$$$20240828$$CN$US$US
206697677$20669767$7$F$20230801$20240626$20220404$20240701$EXP$$IN-PFIZER INC-2020248886$PFIZER$$64$YR$$F$Y$$$20240701$$CN$IN$IN
2067017412$20670174$12$F$20091105$20240627$20220404$20240702$EXP$$US-TAKEDA-2021TUS077358$TAKEDA$$17$YR$$M$Y$72$KG$20240702$$CN$US$US
206704957$20670495$7$F$20150101$20240808$20220404$20240814$EXP$$CA-ROCHE-1804535$ROCHE$$36$YR$A$F$Y$140$KG$20240814$$HP$CA$CA
2067072310$20670723$10$F$$20240912$20220404$20240918$EXP$$US-SHIRE-US201909490$TAKEDA$$$$$F$Y$72$KG$20240918$$CN$US$US
206707722$20670772$2$F$$20240808$20220404$20240812$EXP$$US-PFIZER INC-202101046806$PFIZER$$68$YR$$F$Y$$$20240812$$CN$US$US
2067123949$20671239$49$F$$20240919$20220404$20240930$EXP$$CA-PFIZER INC-202200422145$PFIZER$$44$YR$$F$Y$97$KG$20240930$$MD$CA$CA
2067147025$20671470$25$F$20210218$20240816$20220404$20240822$EXP$$US-TAKEDA-2022TUS021306$TAKEDA$$43$YR$$F$Y$61$KG$20240822$$CN$US$US
206714763$20671476$3$F$20210101$20240716$20220404$20240730$EXP$$GB-009507513-2204GBR000921$MERCK$Parikh S, Pettit L, AbdelGadir H. Severe hyponatremia in two patients with breast cancer caused by a low-dose cyclophosphamide and precipitated by aprepitant. BMJ Case Reports. 2022;15(3):1-4$54$YR$$F$Y$$$20240730$$MD$GB$GB
206715183$20671518$3$F$$20240729$20220404$20240801$EXP$$US-AMGEN-USASP2022056295$AMGEN$$$$E$M$Y$$$20240801$$HP$US$US
2067179412$20671794$12$F$20210413$20240902$20220405$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-011281$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$64.9$KG$20240909$$MD$JP$JP
206724723$20672472$3$F$20211026$20240705$20220405$20240712$EXP$$JP-ROCHE-3065362$ROCHE$$63$YR$A$M$Y$70$KG$20240712$$MD$JP$JP
206726262$20672626$2$F$20211002$20240705$20220405$20240724$PER$$CA-TOLMAR, INC.-21CA031978$TOLMAR$$73$YR$$M$Y$$$20240724$$CN$CA$CA
206726598$20672659$8$F$20211201$20240806$20220405$20240812$EXP$$CA-TAKEDA-2022TUS003027$TAKEDA$$17$YR$$M$Y$$$20240812$$CN$CA$CA
206732222$20673222$2$F$20220322$20220416$20220405$20240710$EXP$IT-MINISAL02-855938$IT-Accord-259607$ACCORD$$49$YR$A$F$Y$60$KG$20240710$$MD$IT$IT
206737122$20673712$2$F$20220303$20240715$20220405$20240720$EXP$$CA-TAKEDA-2022TUS021159$TAKEDA$$42$YR$$F$Y$$$20240720$$CN$CA$CA
206737539$20673753$9$F$20220109$20240705$20220405$20240710$EXP$$US-TAKEDA-2022TUS021493$TAKEDA$$69$YR$$F$Y$52$KG$20240710$$CN$US$US
206740279$20674027$9$F$20210616$20240807$20220405$20240814$EXP$$CA-TAKEDA-2022TUS021078$TAKEDA$$57$YR$$M$Y$$$20240814$$MD$CA$CA
206741305$20674130$5$F$$20220712$20220405$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR045325$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
206745524$20674552$4$F$$20240907$20220405$20240912$EXP$$NVSC2022CO076719$NOVARTIS$$$$$F$Y$60$KG$20240912$$CN$CO$CO
206747053$20674705$3$F$20220305$20240722$20220405$20240806$PER$$US-JNJFOC-20220404382$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20240807$$MD$US$US
206749006$20674900$6$F$$20240712$20220405$20240718$EXP$$CA-TAKEDA-2021TUS027981$TAKEDA$$$$$M$Y$89$KG$20240718$$CN$CA$CA
206750102$20675010$2$F$20201001$20240702$20220405$20240708$EXP$$US-TAKEDA-2022TUS021528$TAKEDA$$65$YR$$M$Y$$$20240708$$HP$US$US
2067506417$20675064$17$F$20220502$20240920$20220405$20240930$EXP$$US-TAKEDA-2022TUS021512$TAKEDA$$58$YR$$F$Y$103$KG$20240930$$HP$US$US
206751885$20675188$5$F$$20240823$20220405$20240827$EXP$$CA-PFIZER INC-202200473665$PFIZER$$44$YR$$F$Y$100$KG$20240827$$HP$CA$CA
206753045$20675304$5$F$$20240701$20220405$20240703$PER$$US-PFIZER INC-202101194235$PFIZER$$82$YR$$F$Y$$$20240703$$CN$US$US
206755184$20675518$4$F$20220318$20240822$20220405$20240828$EXP$$US-JAZZ-2022-US-010188$JAZZ$$54$YR$$M$Y$$$20240827$$CN$US$US
206757083$20675708$3$F$20220101$20240714$20220405$20240722$PER$$US-SA-2022SA113982$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240722$$MD$US$US
206757183$20675718$3$F$20211201$20240816$20220405$20240828$PER$$US-SA-2022SA114633$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240828$$MD$US$US
206760193$20676019$3$F$$20240717$20220405$20240725$PER$$US-SA-2022SA117448$SANOFI AVENTIS$$$$A$F$Y$59.8$KG$20240725$$MD$US$US
206760254$20676025$4$F$20220301$20240909$20220405$20240913$EXP$$IE-TAKEDA-2022TUS022416$TAKEDA$$69$YR$$M$Y$$$20240913$$HP$IE$IE
2067619510$20676195$10$F$20230201$20240703$20220405$20240708$EXP$$US-TAKEDA-2021TUS030127$TAKEDA$$33$YR$$F$Y$61$KG$20240708$$CN$US$US
206763656$20676365$6$F$20220310$20240813$20220405$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-012728$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240820$$CN$US$US
206763869$20676386$9$F$20220329$20240822$20220405$20240829$EXP$$GB-TAKEDA-2022TUS021636$TAKEDA$$76$YR$$M$Y$$$20240829$$HP$GB$GB
206767774$20676777$4$F$$20240709$20220406$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-331173$RANBAXY$Franzblau LE, Mauskar M, Wysocki CA. Macrophage Activation Syndrome Complicated by Toxic Epidermal Necrolysis Following SARSCoV- 2 mRNA Vaccination. J Clin Immunol. 2023;43(3):521- 524$23$YR$$F$Y$$$20240710$$HP$US$US
2067703315$20677033$15$F$$20240813$20220406$20240827$EXP$$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2022-015209$VALIDUS$$$$$$Y$$$20240827$$HP$CA$CA
206773157$20677315$7$F$20211005$20240829$20220406$20240830$EXP$$JP-ABBVIE-21K-087-4119977-00$ABBVIE$$77$YR$$M$Y$60$KG$20240830$$MD$JP$JP
206773214$20677321$4$F$$20240919$20220406$20240923$PER$$US-GILEAD-2022-0575606$GILEAD$$$$A$F$Y$$$20240923$$LW$US$US
2067740323$20677403$23$F$20220101$20240717$20220406$20240726$EXP$$CA-ROCHE-3063152$ROCHE$$41$YR$A$F$Y$$$20240726$$MD$CA$CA
206774814$20677481$4$F$20220328$20220705$20220406$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR058774$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240925$$CN$US$US
206779772$20677977$2$F$20200101$20240305$20220406$20240802$EXP$$US-Accord-247163$ACCORD$$42$YR$A$F$Y$68$KG$20240802$$LW$US$US
206784445$20678444$5$F$$20240805$20220406$20240813$EXP$$CA-BAYER-2022A046356$BAYER$$51$YR$A$F$Y$60$KG$20240813$$CN$CA$CA
206788665$20678866$5$F$20211026$20240904$20220406$20240908$EXP$$CA-ROCHE-2947834$ROCHE$$47$YR$A$F$Y$81.3$KG$20240908$$CN$CA$CA
206790746$20679074$6$F$20170413$20240826$20220406$20240828$EXP$$CA-TAKEDA-2017TUS007318$TAKEDA$$35$YR$$M$Y$$$20240828$$HP$CA$CA
206791152$20679115$2$F$$20220330$20220406$20240705$EXP$$JP-AMGEN-JPNSP2022059012$AMGEN$$$$$$Y$$$20240705$$MD$JP$JP
2067976917$20679769$17$F$20220630$20240701$20220406$20240703$EXP$$US-PFIZER INC-202101723435$PFIZER$$84$YR$$F$Y$71$KG$20240703$$CN$US$US
206797717$20679771$7$F$$20240814$20220406$20240820$EXP$$US-PFIZER INC-202101806514$PFIZER$$72$YR$$F$Y$78.92$KG$20240820$$CN$US$US
2067977512$20679775$12$F$20190914$20240827$20220406$20240830$EXP$$US-TAKEDA-US201931010$TAKEDA$$32$YR$$F$Y$58.957$KG$20240830$$HP$US$US
206801973$20680197$3$F$$20240820$20220406$20240821$EXP$$US-KYOWAKIRIN-2022BKK004568$KYOWA$$$$$$Y$$$20240821$$HP$US$US
206803143$20680314$3$F$20180101$20240920$20220406$20240925$EXP$$US-TAKEDA-2020TUS041021$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
206804918$20680491$8$F$20210917$20240613$20220406$20240705$EXP$$DE-ROCHE-2955599$ROCHE$$27$YR$A$F$Y$$$20240705$$CN$DE$DE
206806822$20680682$2$F$20220330$20240727$20220406$20240808$EXP$$US-MYOVANT SCIENCES IRELAND LIMITED-2022MYSCI0300824$SUNOVION$$$$$$Y$$$20240808$$CN$US$US
2068068319$20680683$19$F$20200623$20240812$20220406$20240815$EXP$$CO-TAKEDA-CO202021396$TAKEDA$$63$YR$$M$Y$70$KG$20240815$$HP$CO$CO
206807284$20680728$4$F$20220101$20240722$20220406$20240729$EXP$$CA-TAKEDA-CA201933765$TAKEDA$$67$YR$$F$Y$$$20240729$$CN$CA$CA
206809663$20680966$3$F$$20240918$20220406$20240920$PER$$US-PFIZER INC-202100929813$PFIZER$$68$YR$$F$Y$$$20240920$$CN$US$US
2068099526$20680995$26$F$20220310$20240903$20220406$20240910$EXP$$CA-TAKEDA-2021TUS069063$TAKEDA$$66$YR$$F$Y$44$KG$20240910$$HP$CA$CA
206810753$20681075$3$F$$20240816$20220406$20240823$PER$$US-009507513-2203USA010789$MERCK$Tushak Z, Restrepo VJ, Jang S, Holtz JE, Huston J, Jabbour G, et al.. Novel treatment of immune checkpoint inhibitor fulminant myocarditis with resolution of cardiogenic shock. Journal of the American College of Cardiology. 2022;79 (9):2697$72$YR$$F$Y$$$20240823$$HP$US$US
206813762$20681376$2$F$20210921$20240807$20220406$20240813$PER$$US-SA-2022SA116557$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240814$$MD$US$US
206819435$20681943$5$F$$20240829$20220407$20240907$EXP$$AU-CELLTRION INC.-2021AU019109$CELLTRION$$$$$$Y$$$20240907$$MD$AU$AU
206819442$20681944$2$F$$20240709$20220407$20240711$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000103$PAREXEL$$$$$$Y$$$20240711$$CN$US$US
206821804$20682180$4$F$20200318$20240808$20220407$20240818$EXP$$DE-AUROBINDO-AUR-APL-2022-011601$AUROBINDO$$49$YR$$M$Y$$$20240818$$CN$DE$DE
206822835$20682283$5$F$20220401$20220627$20220407$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR060021$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240925$$CN$US$US
2068234710$20682347$10$F$20211214$20240625$20220407$20240715$PER$$CA-TOLMAR, INC.-21CA032050$TOLMAR$$65$YR$$M$Y$$$20240715$$CN$CA$CA
206824415$20682441$5$F$20210223$20240731$20220407$20240807$EXP$$IL-ABBVIE-21K-082-3925200-00$ABBVIE$$65$YR$$F$Y$55$KG$20240807$$MD$IL$IL
206824665$20682466$5$F$$20240809$20220407$20240814$EXP$$CA-ROCHE-3067913$ROCHE$$$$A$F$Y$$$20240814$$CN$CA$CA
206827155$20682715$5$F$20190325$20240903$20220407$20240905$EXP$$US-GILEAD-2022-0576541$GILEAD$$65$YR$E$M$Y$$$20240905$$LW$US$US
206827896$20682789$6$F$20220325$20240628$20220407$20240710$EXP$$JP-NOVOPROD-905726$NOVO NORDISK$$11$YR$$F$Y$23.8$KG$20240710$$MD$JP$JP
206829648$20682964$8$F$20211101$20240903$20220407$20240910$EXP$$CA-CELLTRION INC.-2021CA018345$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
206830117$20683011$7$F$20220209$20240905$20220407$20240911$EXP$$CA-TAKEDA-2020TUS020039$TAKEDA$$78$YR$$M$Y$$$20240911$$CN$CA$CA
206830984$20683098$4$F$20200513$20240628$20220407$20240705$EXP$$CA-TAKEDA-2020TUS022500$TAKEDA$$17$YR$$M$Y$$$20240705$$CN$CA$CA
206831232$20683123$2$F$20200710$20240716$20220407$20240718$EXP$$US-TAKEDA-2022TUS021876$TAKEDA$$62$YR$$F$Y$79$KG$20240718$$CN$US$US
2068348711$20683487$11$F$20220101$20240911$20220407$20240916$EXP$$US-JAZZ-2022-US-009392$JAZZ$$$$$M$Y$$$20240916$$CN$US$US
206839344$20683934$4$F$$20240724$20220407$20240729$EXP$$CA-PFIZER INC-202200505793$MYLAN$$77$YR$$M$Y$$$20240729$$HP$CA$CA
206841932$20684193$2$F$$20240801$20220407$20240927$EXP$$CA-MYLANLABS-2022M1025464$MYLAN$$65$YR$$F$Y$$$20240927$$HP$CA$CA
206842432$20684243$2$F$20220320$20220323$20220407$20240724$EXP$$US-RECORDATI-2022001149$RECORDATI$$$$$$Y$$$20240724$$CN$US$US
2068433311$20684333$11$F$20220320$20240812$20220407$20240816$EXP$$US-TAKEDA-2021TUS078623$TAKEDA$$41$YR$$F$Y$95.24$KG$20240816$$HP$US$US
206843347$20684334$7$F$20210722$20240819$20220407$20240827$EXP$$US-TAKEDA-2022TUS021952$TAKEDA$$71$YR$$F$Y$61$KG$20240827$$CN$US$US
2068436716$20684367$16$F$20171110$20240923$20220407$20240930$EXP$$US-TAKEDA-2022TUS021922$TAKEDA$$33$YR$$F$Y$94$KG$20240930$$HP$US$US
206846083$20684608$3$F$20211118$20240801$20220407$20240805$PER$$US-PFIZER INC-202101795583$PFIZER$$71$YR$$F$Y$77.11$KG$20240805$$CN$US$US
206846179$20684617$9$F$$20240905$20220407$20240910$EXP$$US-TAKEDA-2022TUS021464$TAKEDA$$$$$F$Y$$$20240910$$MD$US$US
206846327$20684632$7$F$$20240805$20220407$20240808$PER$$US-PFIZER INC-202200005316$PFIZER$$60$YR$$F$Y$$$20240808$$HP$US$US
206850625$20685062$5$F$$20240809$20220407$20240813$PER$$US-PFIZER INC-202100997569$PFIZER$$78$YR$$F$Y$$$20240813$$HP$US$US
2068513510$20685135$10$F$20210505$20240826$20220407$20240830$EXP$$US-TAKEDA-2022TUS021794$TAKEDA$$81$YR$$M$Y$70$KG$20240830$$HP$US$US
206852287$20685228$7$F$20190913$20240730$20220407$20240812$EXP$$IN-INCYTE CORPORATION-2019IN009565$INCYTE$$$$$$Y$$$20240812$$CN$IN$IN
2068524915$20685249$15$F$20230408$20240909$20220407$20240913$EXP$$US-TAKEDA-2022TUS021810$TAKEDA$$73$YR$$F$Y$55$KG$20240913$$CN$US$US
206855265$20685526$5$F$20191223$20240904$20220407$20240906$EXP$$CA-TAKEDA-2019TUS067343$TAKEDA$$64$YR$$F$Y$$$20240906$$CN$CA$CA
206855896$20685589$6$F$20200109$20240809$20220407$20240815$EXP$$US-SHIRE-US201939150$TAKEDA$$8$YR$$M$Y$$$20240815$$CN$US$US
206856472$20685647$2$F$$20240909$20220407$20240912$EXP$$US-GILEAD-2022-0576520$GILEAD$$$$A$F$Y$$$20240912$$CN$US$US
206859156$20685915$6$F$$20240716$20220407$20240717$EXP$$US-PFIZER INC-202101098138$PFIZER$$65$YR$$M$Y$$$20240717$$CN$US$US
206859816$20685981$6$F$$20240917$20220407$20240917$PER$$US-PFIZER INC-202200037135$PFIZER$$63$YR$$F$Y$69.85$KG$20240917$$HP$US$US
206862734$20686273$4$F$$20240926$20220407$20240930$PER$$US-PFIZER INC-202101073791$PFIZER$$61$YR$$M$Y$$$20240930$$HP$US$US
206864713$20686471$3$F$20200101$20240708$20220407$20240722$EXP$$DE-ROCHE-3069114$ROCHE$$54$YR$A$F$Y$$$20240722$$CN$DE$DE
206865225$20686522$5$F$20220316$20240912$20220407$20240920$EXP$$US-BIOGEN-2022BI01107547$BIOGEN$$77$YR$$M$Y$68.4$KG$20240920$$HP$US$US
206866334$20686633$4$F$$20240730$20220407$20240807$PER$$US-SA-2022SA120351$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240807$$MD$US$US
206866782$20686678$2$F$20220301$20240814$20220407$20240828$PER$$US-SA-2022SA117481$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240828$$MD$US$US
206867552$20686755$2$F$$20240716$20220407$20240801$PER$$US-SA-2022SA118253$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240719$$MD$US$US
206870216$20687021$6$F$20210622$20240730$20220407$20240801$EXP$$JP-TAKEDA-2022TJP014652$TAKEDA$$17$YR$$F$Y$65.3$KG$20240801$$MD$JP$JP
2068713416$20687134$16$F$20200612$20240708$20220407$20240716$EXP$$CA-CELLTRION INC.-2020CA023437$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
2068725816$20687258$16$F$20220328$20230628$20220408$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR060215$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
206872688$20687268$8$F$20240124$20240622$20220408$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000960$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240716$$CN$US$US
2068752411$20687524$11$F$20240516$20240912$20220408$20240918$EXP$$US-TAKEDA-2022TUS022319$TAKEDA$$71$YR$$F$Y$$$20240918$$CN$US$US
2068771310$20687713$10$F$20220329$20240712$20220408$20240722$EXP$$CA-CELLTRION INC.-2022CA004277$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
206877303$20687730$3$F$20220312$20240701$20220408$20240706$EXP$$US-ABBVIE-22K-163-4350401-00$ABBVIE$$59$YR$$F$Y$131$KG$20240706$$CN$US$US
206878344$20687834$4$F$20220301$20240701$20220408$20240713$PER$$US-SA-2022SA118254$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240713$$MD$US$US
206880742$20688074$2$F$20220101$20220324$20220408$20240729$EXP$$US-RECORDATI-2022001213$RECORDATI$$$$$$Y$$$20240726$$CN$US$US
206882253$20688225$3$F$20220317$20240819$20220408$20240828$EXP$$CA-ROCHE-3063926$ROCHE$$31$YR$A$F$Y$87.6$KG$20240828$$HP$CA$CA
206883262$20688326$2$F$$20240626$20220408$20240705$EXP$$JP-AMGEN-JPNSP2022060646$AMGEN$$$$$$Y$$$20240705$$MD$JP$JP
206883994$20688399$4$F$$20240708$20220408$20240712$EXP$$CA-BAUSCH-BL-2022-008436$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240712$$CN$CA$CA
206885754$20688575$4$F$20220301$20240815$20220408$20240827$PER$$US-SA-2022SA122574$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240827$$MD$US$US
206885946$20688594$6$F$20220322$20231017$20220408$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR061739$GLAXOSMITHKLINE$$78$YR$$F$Y$56.372$KG$20240925$$CN$US$US
206886359$20688635$9$F$20240101$20240716$20220408$20240722$EXP$$CA-UCBSA-2022018967$UCB$$$$$F$Y$$$20240719$$CN$CA$CA
206889404$20688940$4$F$20220401$20220418$20220408$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR060940$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240925$$CN$US$US
206890922$20689092$2$F$20200401$20240830$20220408$20240903$EXP$$CA-TAKEDA-2022TUS021868$TAKEDA$$66$YR$$F$Y$$$20240903$$CN$CA$CA
206891747$20689174$7$F$20230101$20240912$20220408$20240926$PER$$CA-TOLMAR, INC.-21CA032094$TOLMAR$$$$$M$Y$$$20240926$$CN$CA$CA
2068938112$20689381$12$F$20200917$20240805$20220408$20240812$EXP$$US-TAKEDA-2022TUS023025$TAKEDA$$52$YR$$F$Y$122$KG$20240812$$HP$US$US
206895815$20689581$5$F$20220328$20240823$20220408$20240913$EXP$$US-SA-2022SA119482$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240913$$MD$US$US
206895907$20689590$7$F$20240119$20240827$20220408$20240829$EXP$$CA-TAKEDA-2022TUS021002$TAKEDA$$38$YR$$M$Y$$$20240829$$CN$CA$CA
206896878$20689687$8$F$20170425$20240913$20220408$20240920$EXP$$CA-TAKEDA-2020TUS038873$TAKEDA$$59$YR$$M$Y$97$KG$20240920$$PH$CA$CA
2068971919$20689719$19$F$20210630$20240822$20220408$20240830$EXP$$IT-TAKEDA-2021TUS042345$TAKEDA$$$$$M$Y$$$20240830$$CN$IT$IT
206898708$20689870$8$F$20220201$20240730$20220408$20240808$PER$$US-VERTEX PHARMACEUTICALS-2022-004799$VERTEX$$8$YR$$F$Y$31$KG$20240808$$MD$US$US
206898934$20689893$4$F$20220101$20240802$20220408$20240812$PER$$US-SA-2022SA122778$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240812$$MD$US$US
206902542$20690254$2$F$$20240803$20220408$20240808$EXP$$US-SA-2022SA122831$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240808$$MD$US$US
206903583$20690358$3$F$$20240916$20220408$20240923$EXP$$CA-BAYER-2022A045826$BAYER$$56$YR$A$F$Y$$$20240923$$HP$CA$CA
206908682$20690868$2$F$$20240722$20220408$20240729$EXP$$CA-JNJFOC-20180632396$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240729$$MD$CA$CA
206910935$20691093$5$F$20210605$20240701$20220408$20240708$EXP$$DE-MYLANLABS-2022M1025828$MYLAN$$$$A$F$Y$$$20240708$$MD$DE$DE
206912854$20691285$4$F$$20220517$20220408$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR061704$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
206913693$20691369$3$F$20120317$20240603$20220408$20240709$EXP$$FR-Ipsen Biopharmaceuticals, Inc.-2013-1137$IPSEN$$15$YR$T$M$Y$47.7$KG$20240709$$MD$FR$FR
206915243$20691524$3$F$20220101$20240909$20220408$20240912$EXP$$CA-ROCHE-3063117$ROCHE$$39$YR$A$F$Y$$$20240912$$CN$CA$CA
206917475$20691747$5$F$20211215$20240722$20220408$20240731$EXP$$JP-009507513-2203JPN001295J$MERCK$Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022$56$YR$$F$Y$51$KG$20240731$$MD$JP$JP
206919365$20691936$5$F$20201215$20240829$20220408$20240904$EXP$IE-GILEAD-2022-0574935$IE-GILEAD-2022-0574935$GILEAD$Roche D, Murray G, Hackett C, Tobin AM. A flexural exanthem following postexposure prophylaxis. Clinical + Experimental Dermatology.. 2022;unk:unk. doi:10.1111/ced.15131$27$YR$A$M$Y$$$20240904$$HP$IE$IE
206919706$20691970$6$F$$20240806$20220408$20240813$EXP$$US-ROCHE-3063707$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
206926958$20692695$8$F$$20240911$20220409$20240913$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-163130$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$70$KG$20240913$$HP$CA$CA
206928149$20692814$9$F$20220317$20240711$20220409$20240724$EXP$$DE-ROCHE-3064950$ROCHE$$60$YR$A$M$Y$73$KG$20240724$$MD$DE$DE
2069328416$20693284$16$F$20190801$20230210$20220410$20240903$EXP$$JP-TAKEDA-2022TJP038176$TAKEDA$$1$YR$$F$Y$$$20240903$$MD$JP$JP
2069330011$20693300$11$F$20200111$20240801$20220410$20240808$EXP$$CA-CELLTRION INC.-2020CA017876$CELLTRION$$$$$$Y$$$20240808$$MD$CA$CA
2069332919$20693329$19$F$20220101$20240919$20220410$20240928$EXP$$CA-CELLTRION INC.-2021CA018717$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
2069356314$20693563$14$F$20220402$20240723$20220411$20240726$EXP$$US-TAKEDA-US202017522$TAKEDA$$32$YR$$M$Y$$$20240726$$HP$US$US
206937762$20693776$2$F$$20240703$20220411$20240712$PER$$US-SA-2022SA122159$SANOFI AVENTIS$$$$A$F$Y$48.9$KG$20240712$$MD$US$US
2069379120$20693791$20$F$20220831$20240901$20220411$20240906$EXP$$CA-TAKEDA-2022TUS019271$TAKEDA$$67$YR$$M$Y$$$20240906$$CN$CA$CA
206939118$20693911$8$F$20220106$20240722$20220411$20240723$PER$$US-DSJP-DSU-2022-112349$DAIICHI$$80$YR$$F$Y$$$20240723$$CN$US$US
206939379$20693937$9$F$20201118$20240918$20220411$20240928$EXP$$CA-CELLTRION INC.-2020CA022272$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
206939522$20693952$2$F$20220401$20220408$20220411$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR062471$GLAXOSMITHKLINE$$38$YR$$F$Y$$$20240925$$CN$US$US
2069399116$20693991$16$F$20220801$20240611$20220411$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-000990$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240705$$CN$US$US
2069423827$20694238$27$F$20210102$20240820$20220411$20240827$EXP$$CA-ROCHE-2668934$ROCHE$$65$YR$E$F$Y$$$20240827$$MD$CA$CA
206945003$20694500$3$F$20220329$20240916$20220411$20240927$EXP$$US-Accord-260028$ACCORD$$64$YR$A$F$Y$$$20240927$$HP$US$US
206946787$20694678$7$F$20230508$20240805$20220411$20240827$PER$$CA-TOLMAR, INC.-21CA032135$TOLMAR$$62$YR$$M$Y$$$20240827$$CN$CA$CA
206952289$20695228$9$F$20181011$20240918$20220411$20240927$EXP$$CA-TAKEDA-2018TUS026014$TAKEDA$$28$YR$$F$Y$$$20240927$$HP$CA$CA
206952572$20695257$2$F$$20240912$20220411$20240913$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000110$PAREXEL$$$$$$Y$$$20240913$$CN$US$US
206953625$20695362$5$F$$20220620$20220411$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR058890$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$MD$US$US
2069536810$20695368$10$F$$20240730$20220411$20240801$PER$$US-PFIZER INC-202101665736$PFIZER$$68$YR$$F$Y$$$20240801$$MD$US$US
206954292$20695429$2$F$20220402$20240821$20220411$20240917$PER$$US-SA-2022SA120647$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240918$$MD$US$US
206958135$20695813$5$F$20220412$20240712$20220411$20240716$EXP$$CA-TAKEDA-2022TUS022169$TAKEDA$$30$YR$$M$Y$$$20240716$$CN$CA$CA
2069589010$20695890$10$F$20220404$20240626$20220411$20240702$EXP$$NVSC2022US080360$NOVARTIS$$55$YR$$F$Y$$$20240702$$CN$US$US
206959313$20695931$3$F$20220117$20240805$20220411$20240807$EXP$$NVSC2022DE080964$NOVARTIS$$$$E$F$Y$$$20240807$$HP$DE$DE
206959724$20695972$4$F$$20240917$20220411$20240923$EXP$$US-TAKEDA-2022TUS000975$TAKEDA$$$$$M$Y$$$20240923$$HP$US$US
206966932$20696693$2$F$$20240904$20220411$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-017898$BRISTOL MYERS SQUIBB$Aguilar-Gallardo JS, Das S, Reddy P, Mahmood K, Fox AL, Morningside MS. Clinically ambiguous hemorrhagic cardiac tamponade in the setting of apixaban. Journal of the American College of Cardiology. 2022 Mar 08;79(9 Suppl A):2626. doi:10.1016/S0735-1097(22)03617-8.$60$YR$A$F$Y$$$20240912$$HP$US$US
206969442$20696944$2$F$20220312$20220422$20220411$20240807$EXP$$US-AstraZeneca-2022A138684$ASTRAZENECA$$30309$DY$$M$Y$78.9$KG$20240807$$CN$US$
2069705311$20697053$11$F$20211001$20240820$20220411$20240822$EXP$$US-PFIZER INC-202200500657$PFIZER$$61$YR$$F$Y$129.27$KG$20240822$$CN$US$US
206973003$20697300$3$F$20220325$20240718$20220411$20240726$EXP$$CA-ROCHE-3065849$ROCHE$$36$YR$A$F$Y$$$20240726$$CN$CA$CA
206974383$20697438$3$F$20230101$20240926$20220411$20240930$PER$$US-PFIZER INC-202200080130$PFIZER$$68$YR$$F$Y$$$20240930$$HP$US$US
2069758813$20697588$13$F$20220421$20240917$20220411$20240923$EXP$$US-JAZZ-2022-US-011303$JAZZ$$49$YR$$F$Y$83$KG$20240923$$HP$US$US
206979253$20697925$3$F$$20240822$20220412$20240903$EXP$$US-AUROBINDO-AUR-APL-2022-011613$AUROBINDO$Franzblau L, Wysocki C.. TOXIC EPIDERMAL NECROLYSIS FOLLOWING MACROPHAGE ACTIVATION SYNDROME. Ann-Allergy-Asthma-Immunol. 2021;127 (Suppl.)(5):S66$23$YR$$F$Y$$$20240903$$MD$US$US
2069809513$20698095$13$F$20220101$20240916$20220412$20240919$EXP$$US-ABBVIE-22K-163-4354094-00$ABBVIE$$$$$M$Y$178$KG$20240919$$CN$US$US
2069815224$20698152$24$F$20200313$20240911$20220412$20240919$EXP$$CA-CELLTRION INC.-2020CA019822$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
206981599$20698159$9$F$20240501$20240827$20220412$20240904$EXP$$US-TAKEDA-2021TUS056035$TAKEDA$$75$YR$$M$Y$95$KG$20240904$$MD$US$US
206983886$20698388$6$F$$20240716$20220412$20240719$EXP$$DK-ORGANON-O2204DNK000831$ORGANON$Borresen SW, Klose M, Glintborg D, Watt T, Andersen MS, Feldt-Rasmussen U.  et al.. Approach to the patient with glucocorticoid-induced adrenal insufficiency.. The Journal of clinical endocrinology and metabolism.. 2022;107:2065-76$24$YR$$F$Y$$$20240719$$MD$DK$DK
2069840111$20698401$11$F$20190423$20240902$20220412$20240910$EXP$$DE-ROCHE-2308884$ROCHE$$50$YR$A$F$Y$$$20240910$$CN$DE$DE
206988103$20698810$3$F$20210701$20240718$20220412$20240723$EXP$$US-JNJFOC-20220418379$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240724$$LW$US$US
206989187$20698918$7$F$20220317$20240629$20220412$20240709$EXP$$GB-ROCHE-3070069$ROCHE$$68$YR$E$F$Y$57.6$KG$20240708$$MD$GB$GB
206992694$20699269$4$F$$20220701$20220412$20240709$EXP$$AU-ASTELLAS-2022US013075$ASTELLAS$$5$YR$$F$Y$$$20240709$$CN$AU$AU
206994878$20699487$8$F$20220101$20240725$20220412$20240730$EXP$$JP-009507513-2204JPN000300J$MERCK$Yoshida M, Hara R, Koichi M, Kawahara H, Sanada S, Takahashi Y, et al.. [O-59 A Case of RS3PE Syndrome During Treatment with Immune Checkpoint Inhibitor]. The 32nd Congress of the Chubu Rheumatism Association. 102$49$YR$$M$Y$$$20240730$$MD$JP$JP
206996957$20699695$7$F$$20240829$20220412$20240903$EXP$$US-MYLANLABS-2021M1037667$MYLAN$$$$$F$Y$76.2$KG$20240903$$CN$US$US
206998246$20699824$6$F$20210525$20240721$20220412$20240726$EXP$$IT-TAKEDA-2021TUS034217$TAKEDA$$16$YR$$M$Y$$$20240726$$CN$IT$IT
206998922$20699892$2$F$$20240806$20220412$20240814$EXP$$BR-TAKEDA-2021TUS068833$TAKEDA$$$$$M$Y$$$20240814$$CN$BR$BR
207001653$20700165$3$F$$20240919$20220412$20240926$EXP$$ES-PFIZER INC-202200513389$MYLAN$Barnes, M.. Acute eosinophilic pneumonia associated with antidepressant agents. Pharmacy World + Science. 1999;21(5):241-242$40$YR$$F$Y$$$20240926$$HP$ES$ES
207005255$20700525$5$F$20180510$20240814$20220412$20240820$EXP$$CA-TAKEDA-2018TUS021729$TAKEDA$$56$YR$$F$Y$$$20240820$$HP$CA$CA
207005503$20700550$3$F$$20240807$20220412$20240812$EXP$$CA-ROCHE-3072531$ROCHE$$$$A$M$Y$$$20240812$$CN$CA$CA
2070103929$20701039$29$F$20180214$20240913$20220412$20240923$EXP$$US-TAKEDA-2022TUS023374$TAKEDA$$16$YR$$F$Y$58$KG$20240923$$CN$US$US
207010823$20701082$3$F$20220320$20240918$20220412$20240926$PER$$US-SA-2022SA125212$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240926$$MD$US$US
207011432$20701143$2$F$20220101$20240808$20220412$20240820$PER$$US-SA-2022SA126134$SANOFI AVENTIS$$$$$F$Y$$$20240820$$CN$US$US
2070133211$20701332$11$F$$20240715$20220412$20240718$EXP$$US-TAKEDA-2022TUS024174$TAKEDA$$$$$F$Y$61$KG$20240718$$MD$US$US
207013693$20701369$3$F$$20240905$20220412$20240909$EXP$$CA-ROCHE-3069817$ROCHE$$$$$F$Y$$$20240909$$MD$CA$CA
207014106$20701410$6$F$20220506$20240816$20220412$20240823$EXP$$CA-TAKEDA-2020TUS040675$TAKEDA$$60$YR$$M$Y$$$20240823$$CN$CA$CA
2070159516$20701595$16$F$20221107$20240702$20220412$20240705$EXP$$US-TAKEDA-2022TUS023439$TAKEDA$$71$YR$$M$Y$88$KG$20240705$$HP$US$US
207016755$20701675$5$F$20211105$20240924$20220412$20240930$EXP$$US-TAKEDA-2021TUS069414$TAKEDA$$66$YR$$F$Y$$$20240930$$CN$US$US
207019875$20701987$5$F$20220301$20240628$20220412$20240708$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2022-010447$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240708$$CN$DE$DE
2070237512$20702375$12$F$20220617$20240814$20220412$20240816$EXP$$US-PFIZER INC-202101140648$PFIZER$$68$YR$$F$Y$80.29$KG$20240816$$CN$US$US
207029217$20702921$7$F$20220301$20240827$20220412$20240904$EXP$$US-GLAXOSMITHKLINE-US2022062486$GLAXOSMITHKLINE$$55$YR$$F$Y$81.633$KG$20240904$$MD$US$US
2070297514$20702975$14$F$20221115$20240815$20220413$20240822$PER$$US-ROCHE-3020130$ROCHE$$9$YR$C$M$Y$$$20240822$$CN$US$US
207036237$20703623$7$F$20220305$20240925$20220413$20240927$EXP$$NVSC2022AU083741$NOVARTIS$$2$YR$$F$Y$16$KG$20240927$$MD$AU$AU
207041665$20704166$5$F$20211129$20240828$20220413$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211202402$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$77.3$KG$20240906$$HP$US$US
207049854$20704985$4$F$$20220630$20220413$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR061740$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
207051026$20705102$6$F$20220623$20220822$20220413$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR014058$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
207052752$20705275$2$F$$20240917$20220413$20240923$EXP$$JP-009507513-2204JPN001185J$MERCK$$7$DEC$$$Y$$$20240923$$MD$JP$JP
207052986$20705298$6$F$20210824$20240719$20220413$20240722$EXP$$US-PFIZER INC-202101828675$PFIZER$$74$YR$$F$Y$77.098$KG$20240722$$MD$US$US
207054874$20705487$4$F$$20240905$20220413$20240910$EXP$$IN-PFIZER INC-202200560438$PFIZER$$73$YR$$F$Y$$$20240910$$CN$IN$IN
207056464$20705646$4$F$20210127$20240902$20220413$20240913$EXP$$JP-ROCHE-2781425$ROCHE$$71$YR$E$F$Y$49.4$KG$20240913$$MD$JP$JP
207056512$20705651$2$F$$20240917$20220413$20240920$EXP$$JP-009507513-2204JPN001203J$MERCK$$8$DEC$$$Y$$$20240920$$MD$JP$JP
207057442$20705744$2$F$20240701$20240729$20220413$20240801$EXP$$US-KYOWAKIRIN-2022BKK005100$KYOWA$$$$$$Y$$$20240801$$HP$US$US
2070574811$20705748$11$F$20220912$20240626$20220413$20240703$EXP$$CO-TAKEDA-2022TUS024386$TAKEDA$$10$YR$$M$Y$26$KG$20240703$$CN$CO$CO
207057992$20705799$2$F$$20240917$20220413$20240923$EXP$$JP-009507513-2204JPN001241J$MERCK$$$$E$$Y$$$20240923$$MD$JP$JP
207060312$20706031$2$F$$20240624$20220413$20240712$PER$$US-BIOMARINAP-US-2022-142628$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
207061802$20706180$2$F$$20240917$20220413$20240920$EXP$$JP-009507513-2204JPN001244J$MERCK$$$$E$$Y$$$20240920$$MD$JP$JP
207062072$20706207$2$F$$20240917$20220413$20240920$EXP$$JP-009507513-2204JPN001275J$MERCK$$$$E$$Y$$$20240920$$MD$JP$JP
207063169$20706316$9$F$20220106$20240627$20220413$20240702$EXP$$CA-PFIZER INC-202200530768$PFIZER$$54$YR$$F$Y$$$20240702$$HP$CA$CA
2070652910$20706529$10$F$20220509$20240827$20220413$20240829$EXP$$CA-TAKEDA-2022TUS024695$TAKEDA$$19$YR$$F$Y$$$20240829$$HP$CA$CA
207066902$20706690$2$F$$20240820$20220413$20240829$PER$$US-SA-2022SA127420$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240829$$MD$US$US
207069835$20706983$5$F$$20240814$20220413$20240816$PER$$US-PFIZER INC-202101041350$PFIZER$$61$YR$$F$Y$$$20240816$$CN$US$US
207072137$20707213$7$F$20210722$20240918$20220413$20240923$EXP$$DE-TAKEDA-2022TUS024099$TAKEDA$$56$YR$$F$Y$$$20240923$$HP$DE$DE
207073142$20707314$2$F$$20240917$20220413$20240920$EXP$$JP-009507513-2204JPN001231J$MERCK$$$$E$$Y$$$20240920$$MD$JP$JP
207073992$20707399$2$F$$20240917$20220413$20240923$EXP$$JP-009507513-2204JPN001169J$MERCK$$5$DEC$$$Y$$$20240923$$MD$JP$JP
207074082$20707408$2$F$$20240917$20220413$20240923$EXP$$JP-009507513-2204JPN001218J$MERCK$$8$DEC$$$Y$$$20240923$$MD$JP$JP
207074725$20707472$5$F$20231101$20240730$20220413$20240802$EXP$$US-PFIZER INC-202200056237$PFIZER$$59$YR$$F$Y$$$20240802$$HP$US$US
207074744$20707474$4$F$$20240816$20220413$20240821$PER$$US-PFIZER INC-202200064938$PFIZER$$58$YR$$F$Y$$$20240821$$HP$US$US
207074872$20707487$2$F$$20240917$20220413$20240923$EXP$$JP-009507513-2204JPN001168J$MERCK$$7$DEC$$$Y$$$20240923$$MD$JP$JP
207075182$20707518$2$F$$20240917$20220413$20240923$EXP$$JP-009507513-2204JPN001192J$MERCK$$8$DEC$$$Y$$$20240923$$MD$JP$JP
207075222$20707522$2$F$$20240917$20220413$20240923$EXP$$JP-009507513-2204JPN001214J$MERCK$$8$DEC$$$Y$$$20240923$$MD$JP$JP
2070755632$20707556$32$F$20210801$20240919$20220413$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200509332$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$57.5$KG$20240926$$MD$US$US
207081916$20708191$6$F$$20240826$20220414$20240827$EXP$$CA-ROCHE-3071608$ROCHE$$29$YR$A$F$Y$$$20240827$$HP$CA$CA
207085944$20708594$4$F$$20220513$20220414$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR063426$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2070867617$20708676$17$F$20220405$20240814$20220414$20240820$EXP$$US-TAKEDA-2022TUS023930$TAKEDA$$66$YR$$F$Y$10.431$KG$20240820$$HP$US$US
207088232$20708823$2$F$$20240917$20220414$20240920$EXP$$JP-009507513-2204JPN001229J$MERCK$$8$DEC$$$Y$$$20240920$$MD$JP$JP
207088372$20708837$2$F$$20240911$20220414$20240923$EXP$$FR-AUROBINDO-AUR-APL-2019-011535$AUROBINDO$Narjoux G, Clarenne J,Azzouz  B, Zeller PS, Slimano F, Bouch? O.. Nightmares and hallucinations with aprepitant and opium powder: a suspected drug?drug interaction.. British Journal of Clinical Pharmacology.. 2018$86$YR$$M$Y$$$20240923$$MD$FR$FR
207088442$20708844$2$F$$20240820$20220414$20240824$EXP$$CA-ROCHE-3073263$ROCHE$$$$$M$Y$$$20240824$$HP$CA$CA
207089499$20708949$9$F$$20240822$20220414$20240829$EXP$$NVSC2022US084644$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
2070915615$20709156$15$F$20220101$20240821$20220414$20240828$EXP$$JP-009507513-2203JPN001171J$MERCK$Inuzuka R, Maruyama S, Ogasawara A, Ikehara K, Ichiki T, Yoshida T, et al.. P-155 A Case of Prolonged Hypocalcaemia and Hypomagnesaemia After Lenvatinib + Pembrolizumab Combination Therapy for Corpus Uteri Carcinoma. Annual Meeting of Japanese Society of Pharmaceutical Oncology in 2024. 2024;380$59$YR$$F$Y$$$20240828$$PH$JP$JP
207092609$20709260$9$F$20220301$20240625$20220414$20240702$EXP$$BR-GLAXOSMITHKLINE-BR2019GSK051196$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$MD$BR$BR
207093169$20709316$9$F$$20240918$20220414$20240925$PER$$NVSC2022US084283$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
207094882$20709488$2$F$$20240705$20220414$20240712$EXP$$DK-AstraZeneca-2022A142458$ASTRAZENECA$Borresen SW, Klose M, Glintborg D, Watt T, Andersen MS, Feldt-Rasmussen U... Approach to the patient with glucocorticoid-induced adrenal insufficiency.. The Journal of clinical endocrinology and metabolism. 2022 2022;107:2065-76.$24$YR$$F$Y$$$20240712$$MD$DK$
207098329$20709832$9$F$$20240824$20220414$20240829$EXP$$IN-PFIZER INC-2020398597$PFIZER$$71$YR$$F$Y$$$20240829$$CN$IN$IN
207101452$20710145$2$F$20210101$20220411$20220414$20240711$EXP$DK-DKMA-WBS-0075323$NVSC2022DK081894$NOVARTIS$$47$YR$$F$Y$$$20240711$$PH$DK$DK
207102772$20710277$2$F$$20240719$20220414$20240729$EXP$$CO-INCYTE CORPORATION-2022IN003544$INCYTE$$$$$$Y$$$20240729$$CN$CO$CO
207104669$20710466$9$F$20210331$20240722$20220414$20240725$EXP$$US-TAKEDA-2022TUS025145$TAKEDA$$26$YR$$M$Y$$$20240725$$CN$US$US
2071061629$20710616$29$F$20220113$20240923$20220414$20240927$EXP$$CA-TAKEDA-2022TUS002476$TAKEDA$$47$YR$$F$Y$$$20240927$$CN$CA$CA
207106292$20710629$2$F$20200101$20240909$20220414$20240910$EXP$FR-AFSSAPS-AN20220942$FR-PFIZER INC-202200548844$PFIZER$$45$YR$$F$Y$62$KG$20240910$$MD$FR$FR
2071090710$20710907$10$F$20211122$20240812$20220414$20240819$EXP$$CA-TAKEDA-2022TUS024596$TAKEDA$$54$YR$$F$Y$$$20240819$$CN$CA$CA
207109088$20710908$8$F$20170101$20240809$20220414$20240813$EXP$$CA-TAKEDA-2017TUS013627$TAKEDA$$$$$F$Y$$$20240813$$HP$CA$CA
2071112753$20711127$53$F$20211014$20240822$20220414$20240829$EXP$$CA-TAKEDA-2021TUS064336$TAKEDA$$4$YR$$M$Y$18$KG$20240829$$HP$CA$CA
2071113020$20711130$20$F$$20240910$20220414$20240919$EXP$$CA-TAKEDA-2022TUS024666$TAKEDA$$71$YR$$F$Y$69$KG$20240919$$HP$CA$CA
207111973$20711197$3$F$20240901$20240920$20220414$20240930$PER$$US-MYOVANT SCIENCES GMBH-2022MYSCI0100040$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
207113195$20711319$5$F$20220412$20240725$20220414$20240805$30DAY$$US-GLAXOSMITHKLINE-US2022064034$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240804$$CN$US$US
2071139123$20711391$23$F$20210508$20240801$20220414$20240809$EXP$$NVSC2021IN113704$NOVARTIS$$18$YR$$F$Y$52$KG$20240809$$CN$IN$IN
207115313$20711531$3$F$20211001$20240906$20220414$20240910$PER$$US-PFIZER INC-202101277624$PFIZER$$54$YR$$F$Y$68.04$KG$20240910$$CN$US$US
207120007$20712000$7$F$20221111$20240716$20220414$20240723$EXP$$US-JAZZ-2022-US-011803$JAZZ$$45$YR$$M$Y$$$20240723$$CN$US$US
207122412$20712241$2$F$$20240806$20220414$20240816$EXP$$CA-BAXTER-2022BAX007821$BAXTER$$47$YR$$F$Y$111$KG$20240816$$HP$CA$CA
207122772$20712277$2$F$$20240917$20220415$20240920$EXP$$JP-009507513-2204JPN001193J$MERCK$$8$DEC$$$Y$$$20240920$$MD$JP$JP
207126429$20712642$9$F$20220101$20240916$20220415$20240925$EXP$$JP-009507513-2204JPN000976J$MERCK$$66$YR$$F$Y$35$KG$20240925$$MD$JP$JP
207126854$20712685$4$F$20220411$20220502$20220415$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR065146$GLAXOSMITHKLINE$$62$YR$$F$Y$92.517$KG$20240926$$HP$US$US
207127712$20712771$2$F$$20240917$20220415$20240920$EXP$$JP-009507513-2204JPN001223J$MERCK$$8$DEC$$$Y$$$20240920$$MD$JP$JP
207128372$20712837$2$F$20220401$20220414$20220415$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR065141$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
2071316611$20713166$11$F$20211025$20240622$20220415$20240701$EXP$$DE-PUMA BIOTECHNOLOGY, INC.-2021-PUM-DE004671$PUMA$$$$$$Y$$$20240701$$HP$DE$DE
2071325126$20713251$26$F$$20240923$20220415$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211209261$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240924$$MD$US$US
2071368415$20713684$15$F$$20240916$20220415$20240920$EXP$$US-TAKEDA-2021TUS050529$TAKEDA$$$$$F$Y$62$KG$20240920$$HP$US$US
207139925$20713992$5$F$20200101$20240626$20220415$20240717$EXP$$DE-ROCHE-2592614$ROCHE$$45$YR$A$F$Y$$$20240717$$CN$DE$DE
207140954$20714095$4$F$20220101$20240905$20220415$20240910$EXP$$CA-PFIZER INC-2021522782$PFIZER$$75$YR$$M$Y$70.31$KG$20240910$$MD$CA$CA
2071432316$20714323$16$F$20190605$20240626$20220415$20240703$EXP$$CA-TAKEDA-2018TUS023109$TAKEDA$$98$YR$$F$Y$$$20240703$$CN$CA$CA
2071435413$20714354$13$F$20211128$20240710$20220415$20240712$EXP$$US-TAKEDA-2021TUS043980$TAKEDA$$72$YR$$F$Y$90$KG$20240712$$CN$US$US
207151008$20715100$8$F$20210901$20240718$20220415$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210904570$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240722$$CN$US$US
2071684124$20716841$24$F$20220214$20240717$20220416$20240721$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20220204740$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240722$$MD$US$US
207170492$20717049$2$F$20240626$20240627$20220417$20240709$PER$$US-SA-2022SA127225$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240709$$MD$US$US
207174673$20717467$3$F$20220201$20240719$20220417$20240726$EXP$$US-UCBSA-2022020734$UCB$$72$YR$$F$Y$44$KG$20240726$$CN$US$US
2071762516$20717625$16$F$20210329$20240909$20220417$20240917$EXP$$CA-CELLTRION INC.-2021CA004826$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
207178223$20717822$3$F$$20220531$20220418$20240925$PER$$US-GLAXOSMITHKLINE-US2021AMR233509$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$MD$US$US
207179493$20717949$3$F$20220401$20220718$20220418$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR065030$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
2071800122$20718001$22$F$20211019$20240808$20220418$20240816$EXP$$CA-CELLTRION INC.-2021CA017640$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
207180957$20718095$7$F$$20240620$20220418$20240710$PER$$CA-TOLMAR, INC.-22CA032305$TOLMAR$$$$$M$Y$$$20240710$$CN$CA$CA
207181294$20718129$4$F$20220318$20240805$20220418$20240806$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000082$PAREXEL$$$$$$Y$$$20240806$$MD$US$US
207183944$20718394$4$F$20220624$20240828$20220418$20240902$PER$$US-AMGEN-USASP2022066563$AMGEN$$59$YR$A$F$Y$$$20240902$$HP$US$US
2071862821$20718628$21$F$20200731$20240822$20220418$20240829$EXP$$CA-TAKEDA-2022TUS024300$TAKEDA$$70$YR$$M$Y$$$20240829$$HP$CA$CA
207187092$20718709$2$F$20220412$20240716$20220418$20240722$PER$$US-SA-2022SA133033$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240722$$MD$US$US
207187244$20718724$4$F$$20220601$20220418$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR065145$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
207188392$20718839$2$F$$20220424$20220418$20240717$EXP$$PL-TEVA-2022-PL-2027519$TEVA$W J. Bol krzyza jako konsekwencja interakcjitadalafilu z sertralina stosowanych u chorego nadepresje. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2022; 85(2): 54-56. Polish.?W J. [Low back pain as a consequence of interactions of tadalafil with sertraline administered to a patient suffering from depression]. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA.2022; 85(2): 54-56. Polish.; W J. Low back pain as a consequence of interactions of tadalafil with sertraline administered to a patient suffering from depression....$31$YR$$M$Y$$$20240717$$MD$PL$PL
2071919613$20719196$13$F$$20240910$20220418$20240930$EXP$$CA-GLAXOSMITHKLINE-CACH2022AMR013792$Haleon PLC$$75$YR$$F$Y$70$KG$20240927$$HP$CA$CA
207202462$20720246$2$F$20240729$20240821$20220418$20240917$PER$$US-SA-2022SA134781$SANOFI AVENTIS$$24$YR$A$F$Y$62.27$KG$20240918$$MD$US$US
207202562$20720256$2$F$$20240719$20220418$20240730$PER$$US-SA-2022SA133728$SANOFI AVENTIS$$$$A$F$Y$$$20240730$$MD$US$US
207206419$20720641$9$F$20220305$20240722$20220418$20240729$EXP$$ES-PFIZER INC-202200514761$PFIZER$$56$YR$$M$Y$68.7$KG$20240729$$MD$ES$ES
207208385$20720838$5$F$20220330$20240910$20220418$20240917$EXP$$JP-009507513-2204JPN001021J$MERCK$$73$YR$$F$Y$$$20240917$$MD$JP$JP
207209182$20720918$2$F$$20220412$20220418$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR060968$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
207216192$20721619$2$F$$20240725$20220418$20240802$EXP$$US-JNJFOC-20220429386$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$LW$US$US
207216393$20721639$3$F$20211001$20240926$20220418$20240930$EXP$$DE-MYLANLABS-2022M1028257$MYLAN$$45$YR$$F$Y$109$KG$20240930$$MD$DE$DE
207219264$20721926$4$F$$20240724$20220418$20240726$EXP$$US-PFIZER INC-202101082107$PFIZER$$63$YR$$M$Y$115.67$KG$20240726$$CN$US$US
207219462$20721946$2$F$20220101$20240909$20220418$20240913$EXP$$AU-MYLANLABS-2022M1027655$MYLAN$$$$$M$Y$$$20240913$$HP$AU$AU
207220352$20722035$2$F$$20240917$20220418$20240923$EXP$$JP-009507513-2204JPN001276J$MERCK$$$$E$$Y$$$20240923$$MD$JP$JP
207220362$20722036$2$F$$20240917$20220418$20240923$EXP$$JP-009507513-2204JPN001277J$MERCK$$$$E$$Y$$$20240923$$MD$JP$JP
207224732$20722473$2$F$20200301$20220411$20220418$20240704$PER$$NVSC2022US082388$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
207225812$20722581$2$F$20220311$20240823$20220418$20240828$PER$$US-AMGEN-USASP2022060890$AMGEN$$80$YR$E$F$Y$$$20240827$$CN$US$US
207229814$20722981$4$F$$20240806$20220419$20240807$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000122$PAREXEL$$$$$$Y$$$20240807$$CN$US$US
2072318631$20723186$31$F$20200801$20240909$20220419$20240916$EXP$$CA-CELLTRION INC.-2020CA025642$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
2072347825$20723478$25$F$20210101$20240829$20220419$20240907$EXP$$CA-CELLTRION INC.-2021CA016843$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
207236015$20723601$5$F$$20240821$20220419$20240903$EXP$E2B_02413518$CA-ICU MEDICAL, INC.-ICU2022CA00018$ICU MEDICAL$$$$$$Y$$$20240903$$HP$CA$CA
2072367628$20723676$28$F$20211217$20240913$20220419$20240923$EXP$$CA-CELLTRION INC.-2021CA018375$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
207238153$20723815$3$F$$20220414$20220419$20240710$EXP$$DE-ASTELLAS-2022US014203$ASTELLAS$$$$$M$Y$$$20240710$$MD$DE$DE
207239885$20723988$5$F$20220301$20240906$20220419$20240913$EXP$$US-TAKEDA-2022TUS005169$TAKEDA$$60$YR$$F$Y$$$20240913$$HP$US$US
207240663$20724066$3$F$$20240719$20220419$20240729$PER$$US-TAKEDA-2022TUS025701$TAKEDA$$$$$F$Y$77.1$KG$20240729$$MD$US$US
207240697$20724069$7$F$20220512$20240919$20220419$20240927$EXP$$CA-TAKEDA-2016TUS020093$TAKEDA$$50$YR$$F$Y$$$20240927$$MD$CA$CA
207241705$20724170$5$F$$20240911$20220419$20240913$PER$$NVSC2022US090732$NOVARTIS$$$$$M$Y$$$20240913$$HP$US$US
207245433$20724543$3$F$$20240815$20220419$20240820$EXP$$GB-TAKEDA-2022TUS025995$TAKEDA$$$$$M$Y$$$20240820$$CN$GB$GB
2072518718$20725187$18$F$20210724$20240704$20220419$20240711$EXP$$AU-TAKEDA-2021TUS047261$TAKEDA$$72$YR$$M$Y$$$20240711$$CN$AU$AU
207252765$20725276$5$F$20191004$20240926$20220419$20240930$EXP$$CA-TAKEDA-2019TUS053398$TAKEDA$$54$YR$$F$Y$$$20240930$$CN$CA$CA
207253323$20725332$3$F$$20240903$20220419$20240904$EXP$$US-KYOWAKIRIN-2022BKK005437$KYOWA$$$$$$Y$$$20240904$$CN$US$US
207263342$20726334$2$F$20211001$20211214$20220419$20240806$EXP$$US-JAZZ-2021-US-019034$JAZZ$$25$YR$$F$Y$$$20240806$$MD$US$US
207263816$20726381$6$F$20210801$20240816$20220419$20240821$EXP$$US-JAZZ-2021-US-006603$JAZZ$$43$YR$$F$Y$$$20240821$$MD$US$US
207267426$20726742$6$F$20220217$20240808$20220419$20240814$PER$$US-JAZZ-2021-US-023309$JAZZ$$49$YR$$F$Y$$$20240814$$HP$US$US
2072694314$20726943$14$F$20220405$20240927$20220419$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-018249$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240930$$CN$US$US
207271954$20727195$4$F$$20240713$20220419$20240722$EXP$$US-GW PHARMA-2022-US-011691$JAZZ$$$$$F$Y$$$20240722$$CN$US$US
207279102$20727910$2$F$20220101$20240815$20220419$20240829$PER$$US-SA-2022SA136905$SANOFI AVENTIS$$13$YR$T$F$Y$62$KG$20240829$$MD$US$US
207283145$20728314$5$F$$20240903$20220420$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-020972$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240911$$PH$JP$JP
207286805$20728680$5$F$$20240718$20220420$20240729$EXP$$CA-APOTEX-2022AP006105$APOTEX$$32$YR$$M$Y$65$KG$20240729$$HP$CA$CA
207288193$20728819$3$F$20220327$20240910$20220420$20240916$EXP$$US-SA-2022SA137985$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240916$$MD$US$US
207291842$20729184$2$F$20211001$20240722$20220420$20240727$EXP$$NVSC2022CO067326$NOVARTIS$$74$YR$$M$Y$$$20240727$$CN$CO$CO
207297625$20729762$5$F$20220311$20240624$20220420$20240709$EXP$$BR-SA-2022SA134931$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240709$$HP$BR$BR
2072997617$20729976$17$F$$20240701$20220420$20240705$EXP$$US-PFIZER INC-202101803471$PFIZER$$53$YR$$F$Y$$$20240705$$CN$US$US
2073024234$20730242$34$F$$20240917$20220420$20240920$EXP$$IN-PFIZER INC-202200549802$PFIZER$$74$YR$$F$Y$59$KG$20240920$$CN$IN$IN
207310684$20731068$4$F$$20240715$20220420$20240718$EXP$$US-TAKEDA-US202006733$TAKEDA$$$$$F$Y$$$20240718$$HP$US$US
207313124$20731312$4$F$20220801$20240730$20220420$20240801$PER$$US-PFIZER INC-202101219973$PFIZER$$66$YR$$F$Y$$$20240801$$CN$US$US
207313777$20731377$7$F$$20240816$20220420$20240821$EXP$$US-TAKEDA-2022TUS022324$TAKEDA$$$$$F$Y$129$KG$20240821$$CN$US$US
207314223$20731422$3$F$$20240820$20220420$20240910$PER$$US-SA-2022SA135814$SANOFI AVENTIS$$$$E$F$Y$$$20240910$$MD$US$US
207314844$20731484$4$F$20200101$20240709$20220420$20240712$EXP$$CA-SHIRE-CA202011971AA$TAKEDA$$$$$M$Y$$$20240712$$CN$CA$CA
207319392$20731939$2$F$$20240709$20220420$20240713$EXP$$US-SA-2022SA139860$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240713$$CN$US$US
207320045$20732004$5$F$20230101$20240729$20220420$20240801$PER$$US-PFIZER INC-202200094157$PFIZER$$76$YR$$F$Y$$$20240801$$HP$US$US
2073211216$20732112$16$F$$20240712$20220420$20240717$EXP$$IN-PFIZER INC-202200569073$PFIZER$$77$YR$$F$Y$$$20240717$$CN$IN$IN
2073239816$20732398$16$F$20220101$20240909$20220420$20240910$EXP$$US-PFIZER INC-202200092582$PFIZER$$77$YR$$F$Y$$$20240910$$CN$US$US
207331127$20733112$7$F$20220410$20240701$20220421$20240802$EXP$$TW-TAKEDA-2022TUS026107$TAKEDA$$43$YR$$M$Y$$$20240802$$CN$TW$TW
207335535$20733553$5$F$20220313$20220906$20220421$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR063882$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
207336512$20733651$2$F$$20220401$20220421$20240824$EXP$$US-TAKEDA-2022TUS026380$TAKEDA$$$$$F$Y$$$20240824$$CN$US$US
207336542$20733654$2$F$20220101$20240709$20220421$20240715$EXP$$US-SA-2022SA135677$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240715$$MD$US$US
207336668$20733666$8$F$20220401$20221115$20220421$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR066822$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240925$$HP$US$US
207337523$20733752$3$F$20210601$20240805$20220421$20240814$EXP$$JP-ROCHE-2960923$ROCHE$$61$YR$A$F$Y$52.1$KG$20240814$$MD$JP$JP
207337723$20733772$3$F$$20240723$20220421$20240729$EXP$$US-TAKEDA-2021TUS009652$TAKEDA$$$$$M$Y$$$20240729$$CN$US$US
207337786$20733778$6$F$20180515$20240904$20220421$20240915$EXP$$DE-ROCHE-2135859$ROCHE$$51$YR$A$F$Y$$$20240915$$CN$DE$DE
207337906$20733790$6$F$20220416$20220705$20220421$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR066878$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240926$$CN$US$US
207339796$20733979$6$F$20220417$20220623$20220421$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR066281$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
207340502$20734050$2$F$$20240821$20220421$20240902$EXP$$CA-APOTEX-2022AP006218$APOTEX$$70$YR$$$Y$$$20240902$$MD$CA$CA
207340543$20734054$3$F$20220117$20240808$20220421$20240817$EXP$$DE-AUROBINDO-AUR-APL-2022-013747$AUROBINDO$$$$E$F$Y$$$20240817$$MD$DE$DE
207341372$20734137$2$F$$20220417$20220421$20240712$EXP$$PH-ASTELLAS-2022US014305$ASTELLAS$$$$$M$Y$$$20240712$$CN$PH$PH
2073458520$20734585$20$F$20231201$20240806$20220421$20240810$EXP$$US-KAMADA LIMITED-2017US014837$TAKEDA$$66$YR$$F$Y$67$KG$20240810$$HP$US$US
207350893$20735089$3$F$$20240903$20220421$20240904$EXP$$US-PFIZER INC-202200579494$PFIZER$$62$YR$$F$Y$$$20240904$$CN$US$US
207355909$20735590$9$F$20210901$20240628$20220421$20240716$PER$$CA-TOLMAR, INC.-22CA032460$TOLMAR$$58$YR$$M$Y$$$20240715$$CN$CA$CA
207355978$20735597$8$F$20220114$20240625$20220421$20240715$PER$$CA-TOLMAR, INC.-22CA032504$TOLMAR$$59$YR$$M$Y$$$20240715$$CN$CA$CA
207357904$20735790$4$F$$20240703$20220421$20240708$EXP$$US-TAKEDA-2022TUS026672$TAKEDA$$$$$F$Y$73$KG$20240708$$CN$US$US
2073591517$20735915$17$F$$20240906$20220421$20240910$PER$$US-PFIZER INC-202200126531$PFIZER$$55$YR$$F$Y$$$20240910$$CN$US$US
2073603521$20736035$21$F$20200203$20240813$20220421$20240820$EXP$$CA-TAKEDA-2022TUS024418$TAKEDA$$37$YR$$F$Y$55$KG$20240820$$MD$CA$CA
207360782$20736078$2$F$$20240811$20220421$20240820$EXP$$US-AMGEN-USASP2022066511$AMGEN$Accordino M. K.; Spivack J. H.; Ulene S. et al.. Continuous glucose monitoring and hyperglycemia during chemotherapy for early-stage breast cancer. Cancer research. 2022;82 (Suppl_4)$$$$$Y$$$20240820$$HP$US$US
207362225$20736222$5$F$20180312$20240819$20220421$20240823$EXP$$CA-TAKEDA-2018TUS035531$TAKEDA$$13$YR$$F$Y$$$20240823$$CN$CA$CA
207362447$20736244$7$F$$20240629$20220421$20240703$PER$$US-PFIZER INC-202200056369$PFIZER$$63$YR$$F$Y$$$20240703$$CN$US$US
207362505$20736250$5$F$20220901$20240918$20220421$20240924$EXP$$US-PFIZER INC-2020226493$PFIZER$$68$YR$$M$Y$$$20240924$$HP$US$US
2073625725$20736257$25$F$20180705$20240805$20220421$20240814$EXP$$CO-TAKEDA-CO201828597$TAKEDA$$33$YR$$F$Y$68$KG$20240814$$CN$CO$CO
207363742$20736374$2$F$$20240727$20220421$20240801$EXP$$IN-PFIZER INC-2021902811$PFIZER$$56$YR$$F$Y$$$20240801$$CN$IN$IN
2073642314$20736423$14$F$20200527$20240715$20220421$20240724$EXP$$DE-ROCHE-2614718$ROCHE$$33$YR$A$F$Y$67$KG$20240724$$CN$DE$DE
2073698710$20736987$10$F$$20240925$20220421$20240927$PER$$US-PFIZER INC-202200532619$PFIZER$$60$YR$$F$Y$$$20240927$$CN$US$US
207370258$20737025$8$F$$20240903$20220421$20240907$EXP$$US-TAKEDA-2022TUS026206$TAKEDA$$$$$F$Y$70$KG$20240907$$MD$US$US
207375012$20737501$2$F$$20240910$20220422$20240920$EXP$$CA-APOTEX-2022AP006357$APOTEX$$$$$F$Y$$$20240920$$MD$CA$CA
207377613$20737761$3$F$20220401$20220506$20220422$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR067596$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
2073800420$20738004$20$F$20210101$20240906$20220422$20240916$EXP$$CA-CELLTRION INC.-2021CA018650$CELLTRION$$$$$$Y$$$20240916$$CN$CA$CA
207383143$20738314$3$F$$20220425$20220422$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-333809$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
207386192$20738619$2$F$20220328$20240725$20220422$20240801$EXP$$FR-ROCHE-3078672$ROCHE$$$$$F$Y$$$20240801$$MD$FR$FR
2073887711$20738877$11$F$20220101$20240903$20220422$20240910$EXP$$CA-TAKEDA-2022TUS024111$TAKEDA$$$$$M$Y$$$20240910$$HP$CA$CA
207389905$20738990$5$F$20240409$20240805$20220422$20240807$EXP$$US-ROCHE-3030826$ROCHE$$81$YR$E$F$Y$58.9$KG$20240807$$CN$US$US
207393564$20739356$4$F$$20220825$20220422$20240925$EXP$$US-TAKEDA-2022TUS013477$TAKEDA$$$$$F$Y$$$20240925$$MD$US$US
207395079$20739507$9$F$$20240710$20220422$20240710$EXP$$US-PFIZER INC-202200575221$PFIZER$$57$YR$$M$Y$$$20240710$$HP$US$US
207395415$20739541$5$F$20220401$20220620$20220422$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR068054$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
207400062$20740006$2$F$$20240715$20220422$20240716$PER$$US-PFIZER INC-202200478125$PFIZER$$65$YR$$F$Y$$$20240716$$MD$US$US
207402748$20740274$8$F$20220418$20220729$20220422$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR068058$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$MD$US$US
207403832$20740383$2$F$20220401$20240708$20220422$20240723$EXP$$US-HARMONY BIOSCIENCES-2022HMY00721$HARMONY BIOSCIENCES$$$$$$Y$$$20240723$$PH$US$US
2074061314$20740613$14$F$20220411$20240620$20220422$20240705$EXP$$CA-ROCHE-2541664$ROCHE$$51$YR$A$M$Y$$$20240705$$MD$CA$CA
2074130111$20741301$11$F$$20240924$20220422$20240927$EXP$$CA-TEVA-2019-CA-1105603$TEVA$$53$YR$$M$Y$$$20240927$$MD$CA$CA
207413916$20741391$6$F$20201201$20240830$20220422$20240905$EXP$$US-PFIZER INC-202101461646$PFIZER$$85$YR$$F$Y$58.51$KG$20240905$$MD$US$US
207417855$20741785$5$F$$20240715$20220423$20240722$PER$$US-AMGEN-USASP2022070846$AMGEN$$65$YR$E$F$Y$$$20240722$$MD$US$US
207418748$20741874$8$F$20180201$20240828$20220423$20240905$EXP$$CA-ROCHE-2928948$ROCHE$$49$YR$A$F$Y$$$20240905$$MD$CA$CA
2074298518$20742985$18$F$20200804$20240828$20220425$20240905$EXP$$CA-CELLTRION INC.-2020CA022804$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
207430948$20743094$8$F$$20240620$20220425$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001154$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
207434473$20743447$3$F$20160301$20240822$20220425$20240829$EXP$$US-JNJFOC-20220445767$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240829$$LW$US$US
207435933$20743593$3$F$$20220606$20220425$20240923$EXP$$NVSC2022CA064646$NOVARTIS$$$$A$M$Y$$$20240923$$CN$CA$CA
207437785$20743778$5$F$$20240912$20220425$20240917$PER$$US-PFIZER INC-202200459550$PFIZER$$15$YR$$M$Y$$$20240917$$CN$US$US
207438642$20743864$2$F$$20240710$20220425$20240712$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000129$PAREXEL$$$$$$Y$$$20240712$$HP$US$US
207438707$20743870$7$F$20220101$20240801$20220425$20240807$EXP$$IN-PFIZER INC-202101266145$PFIZER$$73$YR$$F$Y$$$20240807$$CN$IN$IN
207439107$20743910$7$F$20211108$20240410$20220425$20240823$EXP$$JP-ROCHE-3080815$ROCHE$$73$YR$E$F$Y$53$KG$20240823$$MD$JP$JP
207440613$20744061$3$F$$20240621$20220425$20240702$EXP$$CA-APOTEX-2022AP006312$APOTEX$$61$YR$$F$Y$$$20240702$$HP$CA$CA
207441285$20744128$5$F$20170215$20240805$20220425$20240807$EXP$$DE-ROCHE-2879685$ROCHE$$41$YR$A$M$Y$$$20240807$$CN$DE$DE
207444317$20744431$7$F$20230130$20230622$20220425$20240925$EXP$$US-TAKEDA-2022TUS026345$TAKEDA$$47$YR$$F$Y$$$20240925$$HP$US$US
2074443214$20744432$14$F$$20240816$20220425$20240821$EXP$$US-TAKEDA-2022TUS026320$TAKEDA$$$$$M$Y$75$KG$20240821$$HP$US$US
207445212$20744521$2$F$$20240710$20220425$20240716$EXP$$JP-GLAXOSMITHKLINE-JP2022JPN067690$GLAXOSMITHKLINE$Tomikawa A, Fukuda M, Yasui M, Kawashima H, Hiraguri M. Comparison of the clinical course of 9 patients treated with and 13 patients not treated with mepolizumab for eosinophilic granulomatosis with polyangiitis (EGPA) at our department$$$$$Y$$$20240716$$MD$JP$JP
207445272$20744527$2$F$$20240710$20220425$20240716$EXP$$JP-GLAXOSMITHKLINE-JP2022JPN067688$GLAXOSMITHKLINE$Tomikawa A, Fukuda M, Yasui M, Kawashima H, Hiraguri M. Comparison of the clinical course of 9 patients treated with and 13 patients not treated with mepolizumab for eosinophilic polyangiitis granulomatosa EGPA in the reporting department$$$$$Y$$$20240716$$MD$JP$JP
207445789$20744578$9$F$20210723$20240823$20220425$20240902$PER$$DE-PUMA BIOTECHNOLOGY, INC.-2021-PUM-DE004327$PUMA$$$$$$Y$$$20240902$$HP$DE$DE
2074497610$20744976$10$F$20211207$20240731$20220425$20240807$EXP$$DE-ROCHE-3076505$ROCHE$$46$YR$A$F$Y$$$20240807$$CN$DE$DE
2074497816$20744978$16$F$20190910$20240708$20220425$20240716$EXP$$CA-ROCHE-2410974$ROCHE$$54$YR$A$F$Y$$$20240716$$CN$CA$CA
2074521412$20745214$12$F$20190101$20230525$20220425$20240912$EXP$$NVSC2022US095072$NOVARTIS$$$$$M$Y$127.01$KG$20240912$$CN$US$US
207452472$20745247$2$F$$20240705$20220425$20240709$PER$$US-PFIZER INC-202101276275$PFIZER$$63$YR$$F$Y$$$20240709$$CN$US$US
207453542$20745354$2$F$$20240725$20220425$20240731$EXP$$DE-MYLANLABS-2022M1029246$MYLAN$$81$YR$$F$Y$$$20240731$$CN$DE$DE
207453912$20745391$2$F$20200816$20240819$20220425$20240822$EXP$DE-CADRBFARM-2022291021$DE-TORRENT-00022372$TORRENT$$28$YR$A$M$Y$83$KG$20240822$$HP$DE$DE
207457395$20745739$5$F$$20240905$20220425$20240909$PER$$US-PFIZER INC-2021090268$PFIZER$$67$YR$$F$Y$$$20240909$$CN$US$US
2074588116$20745881$16$F$20220301$20240617$20220425$20240809$EXP$$NVSC2022AR026789$NOVARTIS$$57$YR$$F$Y$$$20240809$$CN$AR$AR
2074645722$20746457$22$F$20220227$20240802$20220425$20240807$PER$$US-PFIZER INC-2019177699$PFIZER$$58$YR$$M$Y$$$20240807$$CN$US$US
207464902$20746490$2$F$$20240711$20220425$20240715$PER$$US-PFIZER INC-202200285206$PFIZER$$64$YR$$F$Y$$$20240715$$HP$US$US
207464982$20746498$2$F$20210419$20240820$20220425$20240823$EXP$$US-TAKEDA-2022TUS027018$TAKEDA$$65$YR$$F$Y$$$20240823$$MD$US$US
2074707811$20747078$11$F$$20240904$20220425$20240906$PER$$US-PFIZER INC-2018342441$PFIZER$$78$YR$$F$Y$53$KG$20240906$$CN$US$US
207472792$20747279$2$F$20240501$20240808$20220425$20240820$PER$$US-SA-2022SA139111$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240820$$MD$US$US
207473302$20747330$2$F$20210114$20240730$20220425$20240807$PER$$US-SA-2022SA140704$SANOFI AVENTIS$$8$YR$C$M$Y$30.839$KG$20240807$$MD$US$US
207474265$20747426$5$F$20220223$20240711$20220425$20240722$PER$$US-SA-2022SA140751$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240722$$MD$US$US
207475122$20747512$2$F$$20240812$20220425$20240820$PER$$US-SA-2022SA143351$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240820$$MD$US$US
207475827$20747582$7$F$20221101$20240717$20220425$20240726$PER$$US-SA-2022SA142094$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240726$$MD$US$US
207476764$20747676$4$F$$20240722$20220425$20240731$PER$$US-SA-2022SA143278$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240731$$MD$US$US
207482026$20748202$6$F$20220412$20240925$20220426$20240930$EXP$$CA-ROCHE-3076589$ROCHE$$35$YR$A$F$Y$$$20240929$$CN$CA$CA
207482449$20748244$9$F$20210519$20221213$20220426$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR068573$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
207483309$20748330$9$F$20200401$20240903$20220426$20240905$EXP$$DE-ROCHE-2607169$ROCHE$$54$YR$A$F$Y$$$20240905$$CN$DE$DE
207483379$20748337$9$F$20210101$20240814$20220426$20240822$EXP$$CA-CELLTRION INC.-2021CA009093$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
207484307$20748430$7$F$20220501$20240819$20220426$20240821$EXP$$CA-ROCHE-3082009$ROCHE$$39$YR$A$F$Y$$$20240821$$CN$CA$CA
2074853612$20748536$12$F$20210115$20240711$20220426$20240720$EXP$$CA-CELLTRION INC.-2020CA034720$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
207485394$20748539$4$F$20210925$20240730$20220426$20240802$EXP$$JP-ABBVIE-22K-087-4369349-00$ABBVIE$$72$YR$$F$Y$49$KG$20240802$$MD$JP$JP
207485625$20748562$5$F$$20240720$20220426$20240722$EXP$$US-GILEAD-2022-0579151$GILEAD$$$$A$M$Y$$$20240722$$LW$US$US
2074862510$20748625$10$F$20210101$20240903$20220426$20240911$EXP$$CA-CELLTRION INC.-2020CA034994$CELLTRION$$$$$$Y$$$20240911$$MD$CA$CA
2074875220$20748752$20$F$20211114$20240814$20220426$20240821$EXP$$DE-BIOGEN-2021BI01078958$BIOGEN$$55$YR$$M$Y$$$20240821$$CN$DE$DE
207491243$20749124$3$F$20220324$20240814$20220426$20240821$EXP$$DE-TAKEDA-2022TUS025574$TAKEDA$$$$A$F$Y$58$KG$20240821$$HP$DE$DE
207494004$20749400$4$F$$20240821$20220426$20240826$EXP$$US-TAKEDA-2022TUS027358$TAKEDA$$$$$M$Y$$$20240826$$HP$US$US
207496813$20749681$3$F$20220405$20240726$20220426$20240802$EXP$$FR-Global Blood Therapeutics Inc-FR-GBT-22-02211$PFIZER$$16$YR$$M$Y$$$20240802$$MD$FR$FR
2074990315$20749903$15$F$20211020$20240517$20220426$20240712$EXP$$CN-DSJP-DSE-2021-135296$DAIICHI$$71$YR$$M$Y$60$KG$20240712$$MD$CN$CN
207499823$20749982$3$F$$20240708$20220426$20240710$EXP$$CA-TAKEDA-2020TUS007717$TAKEDA$$$$$F$Y$73$KG$20240710$$CN$CA$CA
207500992$20750099$2$F$$20240626$20220426$20240703$EXP$$US-SA-2022SA137427$SANOFI AVENTIS$$$$E$F$Y$$$20240703$$MD$US$US
207501068$20750106$8$F$$20240708$20220426$20240710$PER$$US-PFIZER INC-202200611561$PFIZER$$76$YR$$F$Y$$$20240710$$CN$US$US
207502137$20750213$7$F$$20240717$20220426$20240718$EXP$$US-PFIZER INC-202200574667$PFIZER$$24$YR$$M$Y$107.7$KG$20240718$$HP$US$US
2075052524$20750525$24$F$$20240911$20220426$20240912$PER$$US-PFIZER INC-2021444143$PFIZER$$73$YR$$F$Y$$$20240912$$MD$US$US
207506373$20750637$3$F$$20240628$20220426$20240701$PER$$US-PFIZER INC-202101328266$PFIZER$$72$YR$$F$Y$$$20240701$$CN$US$US
207507185$20750718$5$F$$20240805$20220426$20240807$PER$$US-PFIZER INC-202200589687$PFIZER$$43$YR$$F$Y$$$20240807$$HP$US$US
207507497$20750749$7$F$20231001$20240831$20220426$20240903$PER$$US-PFIZER INC-202200342383$PFIZER$$81$YR$$M$Y$$$20240903$$MD$US$US
207507508$20750750$8$F$$20240802$20220426$20240802$EXP$$US-PFIZER INC-202101110332$PFIZER$$73$YR$$F$Y$86.18$KG$20240802$$MD$US$US
207509464$20750946$4$F$20220601$20240821$20220426$20240823$EXP$$US-ROCHE-2900885$ROCHE$$84$YR$E$F$Y$$$20240823$$CN$US$US
2075107021$20751070$21$F$20220305$20240716$20220426$20240722$EXP$$GB-ROCHE-3081254$ROCHE$$68$YR$E$M$Y$84.05$KG$20240722$$MD$GB$GB
2075125410$20751254$10$F$20171124$20240903$20220426$20240906$EXP$$CA-TAKEDA-2017TUS023171$TAKEDA$$65$YR$$F$Y$$$20240906$$HP$CA$CA
2075143622$20751436$22$F$$20240913$20220426$20240918$PER$$US-PFIZER INC-2020510877$PFIZER$$68$YR$$F$Y$$$20240918$$CN$US$US
207517446$20751744$6$F$$20240716$20220426$20240722$EXP$$DK-MYLANLABS-2022M1029829$MYLAN$Borresen SW, Klose M, Glintborg D, Watt T, Andersen MS, Feldt-Rasmussen U. Approach to the patient with glucocorticoid-induced adrenal insufficiency.. The Journal of clinical endocrinology and metabolism. 2022;107(7):2065-2076$24$YR$$F$Y$$$20240722$$MD$DK$DK
2075178910$20751789$10$F$$20240828$20220426$20240904$PER$$US-PFIZER INC-202200333109$PFIZER$$70$YR$$F$Y$49.9$KG$20240904$$CN$US$US
207519387$20751938$7$F$$20240913$20220426$20240919$PER$$US-PFIZER INC-202101128214$PFIZER$$74$YR$$F$Y$$$20240919$$CN$US$US
207519518$20751951$8$F$$20240417$20220426$20240710$PER$$FR-ROCHE-2914049$ROCHE$$8$YR$C$F$Y$39.5$KG$20240628$$MD$FR$FR
207520282$20752028$2$F$$20240624$20220426$20240703$EXP$$US-BIOMARINAP-US-2022-142872$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
207522922$20752292$2$F$$20240725$20220426$20240802$EXP$$FR-ROCHE-3080266$ROCHE$$$$$F$Y$$$20240802$$MD$FR$FR
207532094$20753209$4$F$20140101$20240911$20220426$20240916$PER$$US-GILEAD-2022-0579239$GILEAD$$28$YR$A$F$Y$$$20240916$$LW$US$US
2075326725$20753267$25$F$$20240909$20220426$20240923$EXP$CA-JNJFOC-20220426663$CA-UCBSA-2022023347$UCB$$44$YR$$F$Y$97$KG$20240923$$CN$CA$CA
207547926$20754792$6$F$20220302$20240906$20220427$20240911$EXP$$CA-JNJFOC-20220313439$JOHNSON AND JOHNSON$$10$YR$C$M$Y$29$KG$20240911$$HP$CA$CA
207549635$20754963$5$F$20220413$20220919$20220427$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR069310$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
207552202$20755220$2$F$20220401$20220425$20220427$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR070098$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
2075522211$20755222$11$F$20240201$20240923$20220427$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR069404$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240925$$CN$US$US
2075535823$20755358$23$F$20221013$20240731$20220427$20240805$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-161982$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240805$$CN$US$US
207554189$20755418$9$F$20181213$20240809$20220427$20240819$EXP$$CN-ROCHE-2062618$ROCHE$$60$YR$A$F$Y$50$KG$20240819$$CN$CN$CN
207557488$20755748$8$F$20201212$20240806$20220427$20240812$EXP$$US-TAKEDA-2022TUS026733$TAKEDA$$37$YR$$M$Y$82$KG$20240812$$HP$US$US
207559862$20755986$2$F$$20240920$20220427$20240927$EXP$$CA-PFIZER INC-202200620270$PFIZER$$37$YR$$F$Y$$$20240927$$MD$CA$CA
207560213$20756021$3$F$20200101$20240814$20220427$20240828$EXP$$PL-AUROBINDO-AUR-APL-2021-054439$AUROBINDO$Krzystanek M, Warchala A, Tredzbor B, Martyniak E, Skalacka K, Palasz A.. Amantadine in the treatment of sexual inactivity in schizophrenia patients taking atypical antipsychotics-the pilot case series study.. Pharmaceuticals. 2021;14(10):1-11$33$YR$$M$Y$$$20240828$$MD$PL$PL
207560323$20756032$3$F$20180716$20240729$20220427$20240802$EXP$$CA-TAKEDA-2018TUS023687$TAKEDA$$47$YR$$M$Y$$$20240802$$CN$CA$CA
207561288$20756128$8$F$20220121$20240701$20220427$20240709$PER$$CA-TOLMAR, INC.-22CA032609$TOLMAR$$72$YR$$M$Y$$$20240709$$CN$CA$CA
207567448$20756744$8$F$20210101$20240919$20220427$20240923$EXP$$IN-PFIZER INC-202101048895$PFIZER$$46$YR$$F$Y$$$20240923$$CN$IN$IN
207568683$20756868$3$F$$20240826$20220427$20240829$EXP$$US-PFIZER INC-202200458608$PFIZER$$73$YR$$M$Y$92.99$KG$20240829$$CN$US$US
207576594$20757659$4$F$20220103$20240813$20220427$20240905$PER$$AU-TOLMAR, INC.-22AU033316$TOLMAR$$75$YR$$M$Y$$$20240905$$HP$AU$AU
207576605$20757660$5$F$20240314$20240701$20220427$20240723$PER$$CA-TOLMAR, INC.-22CA032703$TOLMAR$$87$YR$$M$Y$$$20240723$$CN$CA$CA
2075774711$20757747$11$F$$20240725$20220427$20240730$PER$$US-PFIZER INC-2021823166$PFIZER$$74$YR$$M$Y$$$20240730$$MD$US$US
207577839$20757783$9$F$20220201$20240710$20220427$20240730$PER$$CA-TOLMAR, INC.-22CA032775$TOLMAR$$61$YR$$M$Y$$$20240729$$CN$CA$CA
207581482$20758148$2$F$$20240920$20220427$20240924$PER$$US-PFIZER INC-202200483824$PFIZER$$77$YR$$$Y$$$20240924$$CN$US$US
2075833815$20758338$15$F$20210602$20240921$20220427$20240927$EXP$$CA-TAKEDA-2021TUS070392$TAKEDA$$17$YR$$F$Y$$$20240927$$CN$CA$CA
207583702$20758370$2$F$20220401$20240704$20220427$20240709$EXP$$FR-PFIZER INC-202200592265$PFIZER$$$$$F$Y$$$20240709$$MD$FR$FR
207585378$20758537$8$F$20220401$20230126$20220427$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR064597$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240925$$CN$US$US
207585949$20758594$9$F$20151201$20240625$20220427$20240701$EXP$$ES-MYLANLABS-2022M1029744$MYLAN$Marcos-Vadillo E, Carrascal-Laso L, Ramos-Gallego I,Gaedigk A, Garc?a-Berrocal B, Mayor-Toranzo E, et al et al.. Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a NewCYP2D6 Genotype. frontiers in psychiatry. 2022;12$60$YR$$M$Y$$$20240701$$HP$ES$ES
207587136$20758713$6$F$$20240722$20220427$20240724$EXP$$US-PFIZER INC-202200458439$PFIZER$$84$YR$$F$Y$$$20240724$$CN$US$US
207587862$20758786$2$F$20240802$20240805$20220427$20240807$EXP$$US-KYOWAKIRIN-2022BKK005799$KYOWA$$$$$$Y$$$20240807$$HP$US$US
2075885610$20758856$10$F$20240401$20240625$20220427$20240702$EXP$$US-JAZZ-2022-US-008187$JAZZ$$55$YR$$F$Y$$$20240702$$HP$US$US
207597237$20759723$7$F$$20231208$20220427$20240712$PER$PT-MYLANLABS-2022M1018770$PT-PFM-2022-03772$PIERRE FABRE MEDICAMENT$$$$E$$Y$$$20240712$$HP$PT$PT
207600123$20760012$3$F$20220326$20240805$20220427$20240806$PER$$US-AVEO ONCOLOGY-2022-AVEO-US000111$PAREXEL$$$$$$Y$$$20240806$$CN$US$US
207605489$20760548$9$F$20220105$20240617$20220428$20240709$PER$$CA-TOLMAR, INC.-22CA032369$TOLMAR$$81$YR$$M$Y$$$20240709$$CN$CA$CA
2076105215$20761052$15$F$20220209$20240730$20220428$20240801$EXP$$US-TAKEDA-2021TUS022373$TAKEDA$$45$YR$$F$Y$80$KG$20240801$$HP$US$US
207615553$20761555$3$F$$20240725$20220428$20240731$EXP$$CA-APOTEX-2022AP006566$APOTEX$$69$YR$$F$Y$$$20240731$$PH$CA$CA
207617854$20761785$4$F$20220401$20220615$20220428$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR070133$GLAXOSMITHKLINE$$47$YR$$F$Y$60.8$KG$20240925$$MD$US$US
2076178619$20761786$19$F$20210201$20240917$20220428$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-040295$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$46.8$KG$20240925$$MD$JP$JP
207619725$20761972$5$F$20220101$20240731$20220428$20240806$EXP$$US-ABBVIE-22K-163-4332342-00$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
207621492$20762149$2$F$$20240909$20220428$20240912$EXP$$SK-MYLANLABS-2022M1029395$MYLAN$ROSKOVA, E.. Unusual clinical Presentation of Aortic Stenosis - A Case Report.. Interna medicina.. 2019;9-9$84$YR$$F$Y$$$20240912$$MD$SK$SK
207623333$20762333$3$F$20240801$20240906$20220428$20240913$EXP$$US-GLAXOSMITHKLINE-US2022069297$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$US$US
207624072$20762407$2$F$$20240715$20220428$20240717$PER$$US-PFIZER INC-202200016769$PFIZER$$62$YR$$F$Y$$$20240717$$CN$US$US
207624093$20762409$3$F$20240201$20240725$20220428$20240730$EXP$$US-PFIZER INC-202200309254$PFIZER$$26$YR$$F$Y$$$20240730$$HP$US$US
207625134$20762513$4$F$20220408$20240814$20220428$20240819$PER$$US-PFIZER INC-202200342942$PFIZER$$54$YR$$F$Y$$$20240819$$CN$US$US
207630609$20763060$9$F$$20240514$20220428$20240701$EXP$$NVSC2022CA095089$NOVARTIS$$44$YR$$F$Y$68$KG$20240701$$HP$CA$CA
207631826$20763182$6$F$20220401$20240808$20220428$20240813$PER$$US-PFIZER INC-202200586682$PFIZER$$51$YR$$F$Y$$$20240813$$HP$US$US
207634262$20763426$2$F$20220101$20240725$20220428$20240730$PER$$US-PFIZER INC-202200483579$PFIZER$$38$YR$$F$Y$$$20240730$$HP$US$US
207634705$20763470$5$F$$20240910$20220428$20240912$EXP$$US-PFIZER INC-202200477153$PFIZER$$68$YR$$F$Y$78.93$KG$20240912$$MD$US$US
2076347117$20763471$17$F$20240526$20240731$20220428$20240802$EXP$$US-PFIZER INC-202200475640$PFIZER$$80$YR$$F$Y$$$20240802$$CN$US$US
2076355312$20763553$12$F$20220301$20240625$20220428$20240701$PER$$US-PFIZER INC-202200499102$PFIZER$$77$YR$$F$Y$55.34$KG$20240701$$CN$US$US
207635669$20763566$9$F$20220101$20240808$20220428$20240813$PER$$US-PFIZER INC-202200501081$PFIZER$$57$YR$$F$Y$$$20240813$$CN$US$US
207637126$20763712$6$F$20220418$20240920$20220428$20240925$EXP$$PHHY2018IN001416$NOVARTIS$$63$YR$$M$Y$62$KG$20240925$$CN$IN$IN
207638445$20763844$5$F$$20240828$20220428$20240904$PER$$US-PFIZER INC-202200049056$PFIZER$$71$YR$$M$Y$$$20240904$$CN$US$US
207638652$20763865$2$F$$20240815$20220428$20240819$EXP$$US-TAKEDA-US201927734$TAKEDA$$$$$M$Y$$$20240819$$HP$US$US
207640974$20764097$4$F$20240805$20240805$20220428$20240807$EXP$$US-PFIZER INC-202200341790$PFIZER$$74$YR$$F$Y$$$20240807$$CN$US$US
207640984$20764098$4$F$$20240711$20220428$20240716$PER$$US-PFIZER INC-202200334858$PFIZER$$66$YR$$F$Y$$$20240716$$CN$US$US
2076432610$20764326$10$F$20220504$20240919$20220428$20240926$EXP$$CA-TAKEDA-2022TUS027648$TAKEDA$$27$YR$$M$Y$$$20240926$$CN$CA$CA
207643754$20764375$4$F$20211213$20240906$20220428$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-026313$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$40$KG$20240913$$MD$JP$JP
207644074$20764407$4$F$20220419$20240619$20220428$20240709$EXP$$CA-ROCHE-3082000$ROCHE$$40$YR$A$F$Y$$$20240702$$CN$CA$CA
207648099$20764809$9$F$20220101$20240812$20220428$20240821$PER$$US-SA-2022SA138756$SANOFI AVENTIS$$53$YR$A$F$Y$91.1$KG$20240821$$HP$US$US
207650613$20765061$3$F$20220201$20240708$20220428$20240716$PER$$US-SA-2022SA142510$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240716$$MD$US$US
207651263$20765126$3$F$$20240719$20220428$20240726$PER$$US-SA-2022SA143760$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240726$$MD$US$US
207652762$20765276$2$F$20220117$20240904$20220428$20240913$PER$$US-SA-2022SA144267$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240913$$MD$US$US
207653242$20765324$2$F$20200101$20240709$20220428$20240716$PER$$US-SA-2022SA148929$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240716$$MD$US$US
207653512$20765351$2$F$20220301$20240903$20220428$20240924$PER$$US-SA-2022SA146658$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240924$$CN$US$US
207658038$20765803$8$F$20211201$20240806$20220428$20240809$PER$$US-PFIZER INC-202200452935$PFIZER$$67$YR$$F$Y$$$20240809$$HP$US$US
207658932$20765893$2$F$20240801$20240823$20220428$20240906$PER$$US-SA-2022SA147617$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240906$$MD$US$US
207660554$20766055$4$F$20220401$20240711$20220428$20240718$PER$$US-SA-2022SA007448$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240718$$MD$US$US
207662304$20766230$4$F$20230315$20240701$20220428$20240704$EXP$$US-PFIZER INC-202200434220$PFIZER$$80$YR$$F$Y$$$20240704$$CN$US$US
207666404$20766640$4$F$$20240616$20220428$20240711$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001220$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
207667533$20766753$3$F$20220401$20240812$20220429$20240821$PER$$US-SA-2022SA151590$SANOFI AVENTIS$$36$YR$A$F$Y$124.74$KG$20240821$$MD$US$US
207670986$20767098$6$F$20221001$20240704$20220429$20240711$EXP$$CA-TAKEDA-2020TUS040271$TAKEDA$$65$YR$$M$Y$$$20240711$$CN$CA$CA
207673442$20767344$2$F$20220405$20240919$20220429$20240924$EXP$$US-SA-2022SA151312$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240924$$MD$US$US
207674156$20767415$6$F$20230329$20240617$20220429$20240709$PER$$CA-TOLMAR, INC.-22CA032809$TOLMAR$$92$YR$$M$Y$$$20240709$$CN$CA$CA
207675612$20767561$2$F$$20240712$20220429$20240801$PER$$US-SA-2022SA150063$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240719$$CN$US$US
207681165$20768116$5$F$20181206$20240924$20220429$20240930$EXP$$CA-TAKEDA-2018TUS035521$TAKEDA$$67$YR$$M$Y$$$20240930$$CN$CA$CA
207683447$20768344$7$F$20220401$20220929$20220429$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR070681$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240925$$CN$US$US
207684852$20768485$2$F$$20220419$20220429$20240712$PER$$DE-PFM-2022-02598$PIERRE FABRE MEDICAMENT$Michaelis A, Dahnert I, Gebauer R, Paech C. Case report of a 4-year-old girl presenting cardiomyopathy due to a permanent junctional reciprocating tachycardia. Thieme E- Journals- The thoracic and cardiovascular surgeon. 2022;70:S67-S103$4$YR$$F$Y$$$20240712$$MD$DE$DE
207694828$20769482$8$F$$20240827$20220429$20240902$EXP$$CA-PURDUE-USA-2022-0293393$PURDUE$$34$YR$$F$Y$130$KG$20240902$$CN$CA$CA
207694864$20769486$4$F$$20240923$20220429$20240927$EXP$$CA-PURDUE-USA-2022-0293414$PURDUE$$45$YR$$F$Y$$$20240927$$CN$CA$CA
207694974$20769497$4$F$$20240918$20220429$20240920$EXP$$CA-PURDUE-USA-2022-0293394$PURDUE$$48$YR$$F$Y$30$KG$20240920$$CN$CA$CA
207696863$20769686$3$F$20211215$20240814$20220429$20240820$EXP$$FR-SERVIER-S22004384$SERVIER$$$$$$Y$$$20240820$$MD$FR$FR
2076971210$20769712$10$F$20220323$20240722$20220429$20240723$EXP$$BE-ROCHE-3081307$ROCHE$$25$YR$A$F$Y$107$KG$20240723$$MD$BE$BE
207698195$20769819$5$F$20220317$20240722$20220429$20240729$EXP$$US-VERTEX PHARMACEUTICALS-2022-006394$VERTEX$$51$YR$$F$Y$56$KG$20240729$$PH$US$US
207701772$20770177$2$F$20220404$20240709$20220429$20240720$EXP$$US-Accord-262081$ACCORD$$38$YR$A$M$Y$$$20240720$$HP$US$US
207703785$20770378$5$F$20220401$20220906$20220429$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR070706$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2077038315$20770383$15$F$20220601$20240923$20220429$20240927$EXP$$CO-TAKEDA-2022TUS028957$TAKEDA$$0$YR$$M$Y$8$KG$20240927$$HP$CO$CO
207706859$20770685$9$F$20220126$20240708$20220429$20240715$EXP$$CA-ROCHE-3086416$ROCHE$$37$YR$A$F$Y$$$20240715$$HP$CA$CA
207709263$20770926$3$F$$20240722$20220429$20240726$EXP$$NVSC2022US097785$NOVARTIS$$$$$M$Y$$$20240726$$CN$US$US
207710282$20771028$2$F$$20240827$20220429$20240829$PER$$US-PFIZER INC-202200175522$PFIZER$$64$YR$$M$Y$$$20240829$$CN$US$US
2077200613$20772006$13$F$20210925$20240820$20220501$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-015466$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$59.1$KG$20240829$$MD$JP$JP
207720502$20772050$2$F$$20240709$20220501$20240718$EXP$$US-JNJFOC-20220457417$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$LW$US$US
2077222314$20772223$14$F$20211117$20240808$20220502$20240815$EXP$$DE-ROCHE-2961391$ROCHE$$51$YR$A$M$Y$$$20240815$$CN$DE$DE
207722495$20772249$5$F$$20240920$20220502$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-127201$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240926$$MD$JP$JP
2077260811$20772608$11$F$20200916$20240904$20220502$20240913$EXP$$DE-ROCHE-2682102$ROCHE$$29$YR$A$F$Y$$$20240913$$CN$DE$DE
2077292416$20772924$16$F$$20240826$20220502$20240902$EXP$$US-TAKEDA-US201941509$TAKEDA$$$$$M$Y$76$KG$20240902$$HP$US$US
2077299613$20772996$13$F$20180831$20240827$20220502$20240829$EXP$$DE-ROCHE-2584024$ROCHE$$49$YR$A$F$Y$$$20240829$$CN$DE$DE
207735168$20773516$8$F$20220302$20240719$20220502$20240725$EXP$$CA-TAKEDA-2022TUS014180$TAKEDA$$51$YR$$F$Y$$$20240725$$HP$CA$CA
2077370113$20773701$13$F$20201128$20240708$20220502$20240717$EXP$$CA-ROCHE-2725651$ROCHE$$36$YR$A$M$Y$$$20240717$$CN$CA$CA
207737759$20773775$9$F$20220401$20221018$20220502$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR071187$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
207738522$20773852$2$F$20220401$20240717$20220502$20240718$EXP$$US-TAKEDA-US201703067$TAKEDA$$36$YR$$F$Y$$$20240718$$CN$US$US
207744563$20774456$3$F$20230531$20240711$20220502$20240718$EXP$$CA-GLAXOSMITHKLINE-CA2022070093$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$CA$CA
207750643$20775064$3$F$$20240909$20220502$20240914$EXP$$CA-ROCHE-3080767$ROCHE$$56$YR$A$F$Y$$$20240914$$HP$CA$CA
2077511513$20775115$13$F$20221201$20240703$20220502$20240705$EXP$$US-PFIZER INC-202200591499$PFIZER$$70$YR$$F$Y$82.1$KG$20240705$$CN$US$US
2077551515$20775515$15$F$20200803$20240902$20220502$20240906$EXP$$CO-TAKEDA-CO202025381$TAKEDA$$56$YR$$F$Y$78$KG$20240906$$CN$CO$CO
2077615513$20776155$13$F$20220211$20240724$20220502$20240730$EXP$$AT-PFIZER INC-202200643199$PFIZER$$75$YR$$F$Y$67$KG$20240730$$HP$AT$AT
207764475$20776447$5$F$$20240823$20220502$20240828$EXP$$CA-PURDUE-USA-2022-0293456$PURDUE$$59$YR$$F$Y$40$KG$20240828$$CN$CA$CA
207764634$20776463$4$F$$20240726$20220502$20240730$EXP$$US-PFIZER INC-202200411952$PFIZER$$64$YR$$F$Y$$$20240730$$HP$US$US
207768053$20776805$3$F$20220418$20240916$20220502$20240919$PER$$US-GILEAD-2022-0579192$GILEAD$$18$DY$N$F$Y$$$20240919$$HP$US$US
207769792$20776979$2$F$20220121$20240926$20220502$20240930$EXP$$IT-ROCHE-3088831$ROCHE$$32$YR$A$F$Y$49$KG$20240930$$MD$IT$IT
207771618$20777161$8$F$20221009$20240912$20220503$20240923$EXP$$CA-ROCHE-3084879$ROCHE$$55$YR$A$F$Y$$$20240923$$CN$CA$CA
207772062$20777206$2$F$20220420$20240716$20220503$20240725$EXP$$CA-ROCHE-3085369$ROCHE$$38$YR$A$M$Y$$$20240725$$CN$CA$CA
207772332$20777233$2$F$$20240807$20220503$20240814$PER$$US-SA-2022SA152378$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240814$$MD$US$US
2077746211$20777462$11$F$20220329$20240625$20220503$20240715$EXP$$DE-ROCHE-3087247$ROCHE$$29$YR$A$F$Y$$$20240715$$CN$DE$DE
207774637$20777463$7$F$20220426$20240703$20220503$20240711$EXP$$CA-ROCHE-3067047$ROCHE$$39$YR$A$M$Y$$$20240711$$CN$CA$CA
207774793$20777479$3$F$$20240715$20220503$20240722$PER$$US-SA-2022SA156106$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240722$$MD$US$US
207775022$20777502$2$F$20220301$20240718$20220503$20240726$PER$$US-SA-2022SA153001$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240726$$MD$US$US
207775983$20777598$3$F$20180101$20240924$20220503$20240930$EXP$$DE-TAKEDA-DE201803561$TAKEDA$$$$A$M$Y$77.5$KG$20240930$$HP$DE$DE
207777526$20777752$6$F$20220321$20240819$20220503$20240823$EXP$$CA-JNJFOC-20220457865$JOHNSON AND JOHNSON$$29$YR$A$F$Y$128$KG$20240823$$HP$CA$CA
207777707$20777770$7$F$20200722$20240921$20220503$20240927$EXP$$CO-TAKEDA-2020TUS028586$TAKEDA$$54$YR$$F$Y$64$KG$20240927$$CN$CO$CO
207779344$20777934$4$F$$20240822$20220503$20240828$EXP$$CA-Orion Corporation ORION PHARMA-22_00018622$ORION$$39$YR$A$M$Y$$$20240828$$HP$CA$
207783064$20778306$4$F$$20240701$20220503$20240703$EXP$$US-PFIZER INC-202101134508$PFIZER$$71$YR$$M$Y$$$20240703$$CN$US$US
2077839316$20778393$16$F$20210101$20240813$20220503$20240820$EXP$$CA-CELLTRION INC.-2021CA018142$CELLTRION$$$$$$Y$$$20240820$$CN$CA$CA
2077841624$20778416$24$F$20220330$20240827$20220503$20240902$EXP$$IN-PFIZER INC-202200617970$PFIZER$$54$YR$$F$Y$63.1$KG$20240902$$CN$IN$IN
207784422$20778442$2$F$20220117$20240814$20220503$20240820$EXP$$DE-MYLANLABS-2022M1032189$MYLAN$$$$E$F$Y$$$20240820$$HP$DE$DE
207784965$20778496$5$F$20210817$20240823$20220503$20240905$EXP$$US-AMNEAL PHARMACEUTICALS-2021-AMRX-03418$AMNEAL$$0$YR$$M$Y$14.512$KG$20240905$$CN$US$US
2077879913$20778799$13$F$20231111$20240912$20220503$20240919$EXP$$CA-TAKEDA-2022TUS006397$TAKEDA$$62$YR$$F$Y$$$20240919$$MD$CA$CA
207788523$20778852$3$F$$20240702$20220503$20240708$PER$$US-PFIZER INC-202200629879$PFIZER$$64$YR$$F$Y$81.633$KG$20240708$$CN$US$US
207789242$20778924$2$F$$20240702$20220503$20240703$PER$$NVSC2022US101599$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
207793692$20779369$2$F$20220401$20240812$20220503$20240820$PER$$US-SA-2022SA153306$SANOFI AVENTIS$$54$YR$A$M$Y$140.32$KG$20240820$$MD$US$US
207795483$20779548$3$F$$20240710$20220503$20240712$EXP$$CA-PURDUE-USA-2022-0293478$PURDUE$$55$YR$$F$Y$$$20240712$$CN$CA$CA
207795503$20779550$3$F$20220101$20240715$20220503$20240724$PER$$US-SA-2022SA152362$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240724$$MD$US$US
2077981414$20779814$14$F$20230208$20240924$20220503$20240926$EXP$$US-PFIZER INC-202200317164$PFIZER$$69$YR$$F$Y$$$20240926$$CN$US$US
207798194$20779819$4$F$20220301$20240821$20220503$20240827$PER$$US-PFIZER INC-202200456121$PFIZER$$61$YR$$F$Y$$$20240827$$HP$US$US
207799613$20779961$3$F$20240501$20240802$20220503$20240806$EXP$$US-PFIZER INC-2021470163$PFIZER$$54$YR$$M$Y$$$20240806$$HP$US$US
2078008818$20780088$18$F$20180501$20240805$20220503$20240817$EXP$$US-JAZZ-2022-US-014548$JAZZ$$57$YR$$F$Y$$$20240816$$CN$US$US
207801985$20780198$5$F$$20240807$20220503$20240815$PER$$US-SA-2022SA153748$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240815$$CN$US$US
207802123$20780212$3$F$20220422$20240709$20220503$20240711$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000109$PAREXEL$$$$$$Y$$$20240711$$HP$US$US
207803743$20780374$3$F$20220401$20220620$20220504$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR069989$GLAXOSMITHKLINE$$42$YR$$F$Y$$$20240925$$CN$US$US
207806887$20780688$7$F$20220401$20221004$20220504$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR072500$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
207806912$20780691$2$F$20220401$20220428$20220504$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR071879$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
207807354$20780735$4$F$20220401$20220606$20220504$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR072456$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
207809013$20780901$3$F$$20240904$20220504$20240905$PER$$NVSC2022US101755$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
207818789$20781878$9$F$20211123$20240904$20220504$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211107957$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240912$$MD$US$US
207824026$20782402$6$F$20211108$20240729$20220504$20240801$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2022-12037$IPSEN$$65$YR$E$F$Y$$$20240801$$CN$US$US
207824407$20782440$7$F$$20240617$20220504$20240709$EXP$$CA-ROCHE-3089504$ROCHE$$$$A$F$Y$$$20240701$$MD$CA$CA
207825364$20782536$4$F$20200519$20221017$20220504$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR072475$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240925$$CN$US$US
207825593$20782559$3$F$20220306$20240819$20220504$20240830$EXP$$JP-ROCHE-3089056$ROCHE$Yukishima T, Furuhashi K, Shimoyama K, Taki T, Azuma C, Yamazaki K, et al. Detailed tracking of antigen and antibody levels during coronavirus disease  2019 treatment in an immunosuppressed patient with anti-neutrophil  cytoplasmic autoantibody-associated vasculitis. Journal of Infection and Chemotherapy. 2024;30 (9):922-7. doi:10.1016/j.jiac.2024.02.004.$66$YR$E$F$Y$36.1$KG$20240830$$MD$JP$JP
207826897$20782689$7$F$$20240701$20220504$20240702$PER$$US-PFIZER INC-202200543920$PFIZER$$77$YR$$F$Y$$$20240702$$MD$US$US
207828067$20782806$7$F$20220101$20240808$20220504$20240814$EXP$$US-PFIZER INC-202200598757$PFIZER$$66$YR$$F$Y$$$20240814$$HP$US$US
2078284910$20782849$10$F$20220425$20240812$20220504$20240816$EXP$$CA-TAKEDA-2021TUS008254$TAKEDA$$55$YR$$F$Y$$$20240816$$CN$CA$CA
207830793$20783079$3$F$$20240919$20220504$20240925$EXP$$CA-CIPHER-2022-CA-000178$CIPHER$$$$$F$Y$$$20240925$$HP$CA$CA
207831056$20783105$6$F$20211019$20240902$20220504$20240904$EXP$$DE-ROCHE-3002670$ROCHE$$39$YR$A$F$Y$52$KG$20240904$$CN$DE$DE
2078319811$20783198$11$F$$20240827$20220504$20240902$EXP$$CA-TAKEDA-2022TUS028207$TAKEDA$$$$$F$Y$$$20240902$$MD$CA$CA
207838313$20783831$3$F$$20240705$20220504$20240710$EXP$$US-TAKEDA-US202007051$TAKEDA$$$$$M$Y$$$20240710$$MD$US$US
2078396414$20783964$14$F$$20240819$20220504$20240822$EXP$$US-TAKEDA-2022TUS027405$TAKEDA$$$$$M$Y$86$KG$20240822$$HP$US$US
207841646$20784164$6$F$20210819$20240710$20220504$20240712$EXP$$US-TAKEDA-2021TUS053010$TAKEDA$$47$YR$$F$Y$$$20240712$$CN$US$US
207842817$20784281$7$F$20210721$20240625$20220504$20240706$EXP$$CA-ROCHE-2877072$ROCHE$$40$YR$A$F$Y$$$20240706$$CN$CA$CA
207844902$20784490$2$F$20220124$20220428$20220504$20240911$EXP$FR-AFSSAPS-LL20221258$NVSC2022FR098634$NOVARTIS$$60$YR$$F$Y$$$20240911$$PH$FR$FR
207848413$20784841$3$F$$20240917$20220504$20240918$EXP$$US-PFIZER INC-202200108517$PFIZER$$75$YR$$F$Y$$$20240918$$CN$US$US
207851333$20785133$3$F$20211125$20240829$20220504$20240830$EXP$$NVSC2022GB098194$NOVARTIS$$63$YR$$M$Y$107.4$KG$20240830$$HP$GB$GB
207853472$20785347$2$F$$20240816$20220504$20240820$EXP$$US-JAZZ-2022-US-014025$JAZZ$$$$$F$Y$$$20240820$$MD$US$US
207858414$20785841$4$F$$20240723$20220504$20240724$PER$$US-ROCHE-2893742$ROCHE$$36$YR$A$M$Y$$$20240724$$CN$US$US
207864652$20786465$2$F$$20240712$20220505$20240726$PER$$US-ROCHE-2963621$ROCHE$$$$A$M$Y$$$20240726$$CN$US$US
207864913$20786491$3$F$20220429$20240805$20220505$20240806$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000117$PAREXEL$$$$$$Y$$$20240806$$MD$US$US
207865205$20786520$5$F$20220101$20240625$20220505$20240704$PER$$US-SA-2022SA158870$SANOFI AVENTIS$$31$YR$A$F$Y$72.562$KG$20240704$$MD$US$US
207866697$20786669$7$F$20220121$20240725$20220505$20240813$PER$$CA-TOLMAR, INC.-22CA032610$TOLMAR$$68$YR$$M$Y$$$20240813$$PH$CA$CA
207866813$20786681$3$F$20210413$20240906$20220505$20240916$EXP$$CA-ABBVIE-22K-028-4378096-00$ABBVIE$$66$YR$$F$Y$$$20240916$$MD$CA$CA
207866843$20786684$3$F$$20240725$20220505$20240805$PER$$US-SA-2022SA155836$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240805$$MD$US$US
207873473$20787347$3$F$20220426$20240716$20220505$20240725$EXP$$CA-CELLTRION INC.-2022CA005623$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
207878504$20787850$4$F$20220224$20240703$20220505$20240711$EXP$$CA-ROCHE-3090247$ROCHE$$23$YR$A$F$Y$$$20240711$$CN$CA$CA
207880815$20788081$5$F$20220218$20240718$20220505$20240725$EXP$$CA-ROCHE-3087279$ROCHE$$35$YR$A$F$Y$$$20240725$$CN$CA$CA
2078810224$20788102$24$F$20220101$20240920$20220505$20240930$EXP$$CA-CELLTRION INC.-2022CA002255$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
2078822714$20788227$14$F$20220514$20240805$20220505$20240807$EXP$$AU-TAKEDA-2022TUS029633$TAKEDA$$19$YR$$M$Y$$$20240807$$CN$AU$AU
207883485$20788348$5$F$20220429$20240709$20220505$20240712$EXP$$CA-TAKEDA-2022TUS023318$TAKEDA$$72$YR$$F$Y$$$20240712$$CN$CA$CA
207883555$20788355$5$F$20220226$20240808$20220505$20240904$PER$$CA-TOLMAR, INC.-22CA033191$TOLMAR$$72$YR$$M$Y$$$20240904$$CN$CA$CA
207889612$20788961$2$F$$20220429$20220505$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR072480$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
207890125$20789012$5$F$$20240813$20220505$20240826$EXP$$US-UCBSA-2021013593$UCB$$$$$F$Y$$$20240826$$HP$US$US
207890257$20789025$7$F$$20240805$20220505$20240807$PER$$US-AMGEN-USASP2022076767$AMGEN$$$$A$M$Y$$$20240807$$HP$US$US
207893318$20789331$8$F$20200907$20240909$20220505$20240911$EXP$$DE-ROCHE-2677813$ROCHE$$59$YR$A$M$Y$$$20240911$$CN$DE$DE
207893732$20789373$2$F$$20240814$20220505$20240828$PER$$US-SA-2022SA159166$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240828$$MD$US$US
207898802$20789880$2$F$20220225$20240722$20220505$20240723$EXP$$ES-ROCHE-3090970$ROCHE$$37$YR$A$M$Y$69$KG$20240723$$MD$ES$ES
207899012$20789901$2$F$20220428$20240829$20220505$20240910$PER$$US-SA-2022SA157191$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240910$$MD$US$US
207901218$20790121$8$F$20220401$20220908$20220505$20240926$EXP$$US-GLAXOSMITHKLINE-US2022071110$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
207902104$20790210$4$F$20150101$20240821$20220505$20240824$PER$$US-AMGEN-USASP2021210865$AMGEN$$42$YR$A$M$Y$$$20240824$$MD$US$US
207903073$20790307$3$F$$20240725$20220505$20240730$PER$$US-PFIZER INC-202101218698$PFIZER$$45$YR$$F$Y$71.21$KG$20240730$$CN$US$US
207906152$20790615$2$F$20201001$20240914$20220505$20240924$PER$$US-INCYTE CORPORATION-2022IN004056$INCYTE$$$$$$Y$$$20240924$$HP$US$US
207907573$20790757$3$F$20231223$20240809$20220505$20240812$EXP$$US-TAKEDA-US201842403$TAKEDA$$73$YR$$F$Y$$$20240812$$HP$US$US
207909276$20790927$6$F$$20240910$20220505$20240925$EXP$$CA-HLS-202200886$HLS THERAPEUTICS$$$$$F$Y$$$20240925$$HP$CA$CA
207911244$20791124$4$F$20220304$20240724$20220505$20240728$EXP$$NVSC2022CA065764$NOVARTIS$$42$YR$$M$Y$$$20240728$$CN$CA$CA
207911656$20791165$6$F$20220429$20240725$20220505$20240729$EXP$$US-TAKEDA-US201927236$TAKEDA$$67$YR$$M$Y$$$20240729$$CN$US$US
207912544$20791254$4$F$$20240904$20220505$20240906$EXP$$US-TAKEDA-2022TUS028105$TAKEDA$$$$$F$Y$$$20240906$$CN$US$US
207914014$20791401$4$F$$20240829$20220505$20240904$PER$$US-PFIZER INC-2021239831$PFIZER$$77$YR$$F$Y$$$20240904$$CN$US$US
207914784$20791478$4$F$20220301$20240709$20220505$20240716$EXP$$CA-JNJFOC-20220502980$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240716$$CN$CA$CA
207915059$20791505$9$F$20220101$20240717$20220505$20240722$EXP$$CA-PFIZER INC-202200634808$PFIZER$$51$YR$$F$Y$121$KG$20240722$$HP$CA$CA
207918844$20791884$4$F$20230101$20240916$20220505$20240924$PER$$US-SA-2022SA159701$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240924$$MD$US$US
207919806$20791980$6$F$20211207$20220330$20220505$20240903$EXP$$BR-JNJFOC-20220405509$JOHNSON AND JOHNSON$$66$YR$E$F$Y$60$KG$20240903$$MD$BR$BR
207920722$20792072$2$F$20220101$20240729$20220505$20240731$PER$$US-PFIZER INC-2019196288$PFIZER$$78$YR$$F$Y$77.11$KG$20240731$$CN$US$US
207921932$20792193$2$F$$20240813$20220505$20240815$EXP$$US-TAKEDA-2021TUS059881$TAKEDA$$$$$M$Y$$$20240815$$CN$US$US
207924637$20792463$7$F$20211101$20240716$20220506$20240719$EXP$$US-ABBVIE-22K-163-4380793-00$ABBVIE$$47$YR$$F$Y$$$20240719$$CN$US$US
207925072$20792507$2$F$20180101$20240624$20220506$20240701$EXP$$US-ABBVIE-22K-163-4382010-00$ABBVIE$$44$YR$$F$Y$$$20240628$$CN$US$US
207925153$20792515$3$F$20210714$20240826$20220506$20240830$EXP$$TR-ROCHE-3088302$ROCHE$$36$YR$A$F$Y$56$KG$20240830$$MD$TR$TR
2079335514$20793355$14$F$20220501$20240904$20220506$20240912$EXP$$CA-CELLTRION INC.-2022CA005934$CELLTRION$$$$$$Y$$$20240912$$MD$CA$CA
207934689$20793468$9$F$20210501$20240913$20220506$20240923$EXP$$DE-ROCHE-3085226$ROCHE$$34$YR$A$M$Y$67$KG$20240923$$CN$DE$DE
207935966$20793596$6$F$20220127$20240917$20220506$20240926$EXP$$CA-CELLTRION INC.-2021CA016652$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
207936934$20793693$4$F$20220501$20240702$20220506$20240711$EXP$$CA-ROCHE-3091063$ROCHE$$40$YR$A$M$Y$$$20240711$$CN$CA$CA
207937477$20793747$7$F$$20240916$20220506$20240924$EXP$$AU-TOLMAR, INC.-22AU033014$TOLMAR$$$$$M$Y$$$20240924$$CN$AU$AU
207939313$20793931$3$F$20230220$20240729$20220506$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001340$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240822$$CN$US$US
207939454$20793945$4$F$$20240102$20220506$20240923$PER$$US-ROCHE-3004637$ROCHE$$70$YR$E$F$Y$58.1$KG$20240923$$MD$US$US
207940362$20794036$2$F$$20240719$20220506$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-335370$RANBAXY$Dasgupta A, Tsay E, Federman N, Lechner MG, Su MA. Polyendocrine Autoimmunity and Diabetic Ketoacidosis Following Anti-PD-1 and Interferon apha. Pediatrics. 2022;Apr;149(4):e2021053363(1-5)$14$YR$$F$Y$$$20240802$$MD$US$US
207946214$20794621$4$F$20220426$20220610$20220506$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR073920$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
207949184$20794918$4$F$20220401$20220615$20220506$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR073929$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
207949242$20794924$2$F$$20240828$20220506$20240903$EXP$$CA-ROCHE-3090198$ROCHE$$$$$F$Y$$$20240903$$HP$CA$CA
207951723$20795172$3$F$20240701$20240730$20220506$20240801$EXP$$US-KYOWAKIRIN-2022BKK005978$KYOWA$$$$$$Y$$$20240801$$HP$US$US
207953264$20795326$4$F$$20240805$20220506$20240807$EXP$$US-TAKEDA-2022TUS008301$TAKEDA$$$$$F$Y$72.6$KG$20240807$$MD$US$US
2079542437$20795424$37$F$$20240918$20220506$20240924$EXP$$IL-PFIZER INC-2018171563$PFIZER$$42$YR$$M$Y$$$20240924$$HP$IL$IL
2079556415$20795564$15$F$20220127$20240827$20220506$20240902$EXP$$US-PAREXEL-2021-KAM-US003363$TAKEDA$$61$YR$$F$Y$120$KG$20240902$$HP$US$US
2079558713$20795587$13$F$20220322$20240918$20220506$20240927$EXP$$CA-CELLTRION INC.-2022CA006061$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
207957258$20795725$8$F$20220404$20240919$20220506$20240923$EXP$$BE-MYLANLABS-2022M1033268$MYLAN$$77$YR$$M$Y$80$KG$20240923$$HP$BE$BE
207959932$20795993$2$F$$20240718$20220506$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001350$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240812$$HP$US$US
207961616$20796161$6$F$20220201$20240702$20220506$20240723$PER$$CA-TOLMAR, INC.-22CA033024$TOLMAR$$71$YR$$M$Y$$$20240722$$CN$CA$CA
207961666$20796166$6$F$20220101$20240820$20220506$20240821$PER$$US-PFIZER INC-202200611454$PFIZER$$60$YR$$M$Y$$$20240821$$HP$US$US
207964904$20796490$4$F$$20240816$20220506$20240819$EXP$$US-TAKEDA-2022TUS028955$TAKEDA$$$$$M$Y$$$20240819$$HP$US$US
2079650312$20796503$12$F$20210801$20240903$20220506$20240910$EXP$$US-BIOGEN-2022BI01118878$BIOGEN$$62$YR$$F$Y$$$20240910$$CN$US$US
207966416$20796641$6$F$20220101$20240924$20220506$20240930$EXP$$US-PFIZER INC-202101732672$PFIZER$$87$YR$$F$Y$$$20240930$$MD$US$US
207967355$20796735$5$F$$20240801$20220506$20240805$PER$$US-PFIZER INC-202200239662$PFIZER$$71$YR$$F$Y$$$20240805$$CN$US$US
207968009$20796800$9$F$20180518$20240626$20220506$20240701$EXP$$CA-TAKEDA-2018TUS016200$TAKEDA$$71$YR$$F$Y$$$20240701$$CN$CA$CA
207968405$20796840$5$F$$20240805$20220506$20240807$PER$$US-PFIZER INC-202200091427$PFIZER$$67$YR$$F$Y$$$20240807$$MD$US$US
207968583$20796858$3$F$20240801$20240912$20220506$20240919$EXP$$CA-GLAXOSMITHKLINE-CA2022074135$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$CA$CA
207974266$20797426$6$F$20211201$20240910$20220506$20240913$EXP$$NVSC2022US103458$NOVARTIS$$48$YR$$M$Y$$$20240913$$CN$US$US
207974403$20797440$3$F$$20220728$20220506$20240830$PER$$NVSC2022US103897$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
207975113$20797511$3$F$$20230330$20220506$20240809$PER$$NVSC2022US104395$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
207982405$20798240$5$F$$20240722$20220507$20240730$EXP$$US-SA-2022SA161447$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240730$$CN$US$US
207985073$20798507$3$F$20220421$20240704$20220507$20240713$PER$$US-SA-2022SA160186$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240713$$MD$US$US
207985134$20798513$4$F$$20240815$20220507$20240829$PER$$US-SA-2022SA160888$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240829$$MD$US$US
207990453$20799045$3$F$20210901$20240806$20220507$20240809$EXP$$DE-ROCHE-3088596$ROCHE$$24$YR$A$F$Y$115$KG$20240809$$MD$DE$DE
207990464$20799046$4$F$$20240716$20220507$20240722$EXP$$US-AMGEN-USASP2022077024$AMGEN$$$$A$M$Y$$$20240722$$HP$US$US
2079933612$20799336$12$F$20210419$20240620$20220508$20240710$EXP$$DE-ROCHE-2836902$ROCHE$$48$YR$A$F$Y$$$20240710$$CN$DE$DE
2079945912$20799459$12$F$20190101$20240827$20220508$20240902$EXP$$US-ABBVIE-22K-163-4383816-00$ABBVIE$$$$$M$Y$74.389$KG$20240902$$CN$US$US
207994813$20799481$3$F$20220426$20240710$20220508$20240711$EXP$$BE-ROCHE-3090837$ROCHE$$44$YR$A$F$Y$57$KG$20240711$$MD$BE$BE
207994823$20799482$3$F$20220430$20240620$20220508$20240704$EXP$$CA-ROCHE-3092306$ROCHE$$50$YR$A$F$Y$$$20240704$$CN$CA$CA
207994988$20799498$8$F$20210303$20240926$20220508$20240930$EXP$$DE-ROCHE-2808618$ROCHE$$50$YR$A$F$Y$$$20240930$$CN$DE$DE
207996769$20799676$9$F$20220926$20240726$20220509$20240813$PER$$CA-TOLMAR, INC.-22CA033001$TOLMAR$$78$YR$$M$Y$$$20240813$$CN$CA$CA
207997133$20799713$3$F$$20240705$20220509$20240715$EXP$$ES-AUROBINDO-AUR-APL-2022-015400$AUROBINDO$Sturla Alvarez DA, Sanchez Marcos E, de Lucas Collantes C, Cantarin Extremera V, Soto Insuga V, Aparicio Lopez C.. Fanconi Syndrome Secondary to Sodium Valproate Therapy: Experience and Literature Review. Pediatric Neurology. 2022;130:53-59$3$YR$$F$Y$$$20240715$$MD$ES$ES
208003296$20800329$6$F$20210101$20221116$20220509$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR075006$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2080053110$20800531$10$F$20200212$20240909$20220509$20240918$EXP$$DE-ROCHE-2555937$ROCHE$$55$YR$A$F$Y$$$20240918$$CN$DE$DE
208006642$20800664$2$F$20160101$20240716$20220509$20240729$EXP$$GB-009507513-2205GBR002061$MERCK$Parikh S, Pettit L, AbdelGadir H.. Severe hyponatremia in two patients with breast cancer caused by a low-dose cyclophosphamide and precipitated by aprepitant.. BMJ Case Reports. 2022;15(3):1-4$70$YR$$F$Y$$$20240729$$MD$GB$GB
208012614$20801261$4$F$20230308$20240718$20220509$20240807$PER$$CA-TOLMAR, INC.-22CA033090$TOLMAR$$74$YR$$M$Y$$$20240807$$CN$CA$CA
208012726$20801272$6$F$20220219$20240807$20220509$20240904$PER$$CA-TOLMAR, INC.-22CA033070$TOLMAR$$72$YR$$M$Y$$$20240904$$CN$CA$CA
208012784$20801278$4$F$20220401$20240919$20220509$20240925$EXP$$BR-TAKEDA-2022TUS029594$TAKEDA$$37$YR$$M$Y$73$KG$20240925$$CN$BR$BR
208013322$20801332$2$F$$20240620$20220509$20240910$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02979$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02979$ALKEM$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. Journal of Psychoactive Drugs. 2023;55 (1):102-11$29$YR$$M$Y$$$20240910$$HP$DE$DE
208013332$20801333$2$F$$20240620$20220509$20240910$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02977$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02977$ALKEM$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. J Psychoactive Drugs. 2023;55 (1):102-111$41$YR$$M$Y$$$20240910$$HP$DE$DE
208013342$20801334$2$F$$20240620$20220509$20240910$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02978$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02978$ALKEM$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. Journal of Psychoactive Drugs. 2023;55(1):102-11$49$YR$$M$Y$$$20240910$$HP$DE$DE
208013352$20801335$2$F$$20240620$20220509$20240910$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02976$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02976$ALKEM$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. Journal of Psychoactive Drugs. 2023;55 (1):102-111$34$YR$$M$Y$$$20240910$$HP$DE$DE
208013382$20801338$2$F$$20240620$20220509$20240910$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02975$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02975$ALKEM$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. Journal of Psychoactive Drugs. 2023;55 (1):102-11$50$YR$$F$Y$$$20240910$$HP$DE$DE
208013392$20801339$2$F$$20240620$20220509$20240910$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02974$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02974$ALKEM$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. J Psychoactive Drugs. 2023;55(1):102-111$29$YR$$M$Y$$$20240910$$HP$DE$DE
208013412$20801341$2$F$$20240621$20220509$20240910$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02981$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02981$ALKEM$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. Journal of Psychoactive Drugs. 2023;55 (1):102-11$34$YR$$M$Y$$$20240910$$HP$DE$DE
208013422$20801342$2$F$$20240620$20220509$20240910$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02980$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02980$ALKEM$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. Journal of Psychoactive Drugs. 2023;55 (1):102-111$37$YR$$M$Y$$$20240910$$HP$DE$DE
208013442$20801344$2$F$$20240620$20220509$20240910$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02969$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02969$ALKEM$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. Journal of Psychoactive Drugs. 2023;55 (1):102-111$46$YR$$M$Y$$$20240910$$HP$DE$DE
208013492$20801349$2$F$$20240614$20220509$20240910$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-03642$ALKEM$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. Journal of Psychoactive Drugs. 2023;55 (1):102-111$34$YR$$F$Y$$$20240910$$HP$DE$DE
208013542$20801354$2$F$$20240621$20220509$20240910$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02971$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-02971$ALKEM$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. Journal of Psychoactive Drugs. 2023;55(1):102-111$20$YR$$M$Y$$$20240910$$HP$DE$DE
2080154818$20801548$18$F$20191120$20240801$20220509$20240807$EXP$$DE-MYLANLABS-2021M1038840$MYLAN$$62$YR$$F$Y$71$KG$20240807$$HP$DE$DE
2080189712$20801897$12$F$$20240716$20220509$20240723$EXP$$US-TAKEDA-2020TUS053182$TAKEDA$$$$$F$Y$$$20240723$$HP$US$US
2080274710$20802747$10$F$20220420$20240829$20220509$20240903$EXP$$US-TAKEDA-US201940714$TAKEDA$$54$YR$$F$Y$64$KG$20240903$$HP$US$US
208029462$20802946$2$F$20240721$20240726$20220509$20240805$30DAY$$US-GLAXOSMITHKLINE-US2022073800$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240805$$CN$US$US
208029982$20802998$2$F$$20240822$20220509$20240831$EXP$$BR-TAKEDA-2021TUS064700$TAKEDA$$$$$$Y$$$20240831$$CN$BR$BR
208030082$20803008$2$F$20190404$20240716$20220509$20240718$EXP$$FR-PFIZER INC-202200643184$PFIZER$$39$YR$$F$Y$46$KG$20240718$$MD$FR$FR
208030225$20803022$5$F$$20240815$20220509$20240822$EXP$$CA-TAKEDA-2022TUS030381$TAKEDA$$$$$M$Y$$$20240822$$CN$CA$CA
208030768$20803076$8$F$20230706$20240923$20220509$20240926$EXP$$IN-PFIZER INC-2021006350$PFIZER$$63$YR$$F$Y$$$20240926$$CN$IN$IN
208033628$20803362$8$F$20231003$20240813$20220509$20240816$EXP$$AU-TAKEDA-2022TUS030816$TAKEDA$$63$YR$$F$Y$$$20240816$$CN$AU$AU
2080336311$20803363$11$F$20210101$20240830$20220509$20240905$EXP$$NVSC2022AR001590$NOVARTIS$$$$$M$Y$$$20240905$$CN$AR$AR
208033662$20803366$2$F$20201215$20240924$20220509$20240930$EXP$$NVSC2022DE104033$NOVARTIS$$$$A$M$Y$$$20240930$$MD$DE$DE
208036395$20803639$5$F$20210101$20240801$20220509$20240807$EXP$$US-JAZZ-2022-US-014604$JAZZ$$$$$F$Y$$$20240807$$CN$US$US
208039088$20803908$8$F$20230401$20240730$20220509$20240805$EXP$$US-TAKEDA-2022TUS015943$TAKEDA$$65$YR$$M$Y$$$20240805$$HP$US$US
2080395011$20803950$11$F$$20240802$20220509$20240812$EXP$$US-TAKEDA-2022TUS030199$TAKEDA$$$$$F$Y$90$KG$20240812$$HP$US$US
2080414912$20804149$12$F$20220526$20240823$20220509$20240828$EXP$$US-GW PHARMA-2022-US-014462$JAZZ$$21$YR$$M$Y$136$KG$20240828$$CN$US$US
208044479$20804447$9$F$20210427$20240720$20220509$20240725$EXP$$NVSC2022IN105980$NOVARTIS$$67$YR$$F$Y$$$20240725$$CN$IN$IN
208045563$20804556$3$F$$20240828$20220509$20240830$EXP$$US-SHIRE-US201717507$TAKEDA$$$$$M$Y$$$20240830$$HP$US$US
208047477$20804747$7$F$20220422$20240730$20220509$20240802$EXP$$US-PFIZER INC-202200639268$PFIZER$$87$YR$$F$Y$68.04$KG$20240802$$CN$US$US
2080480916$20804809$16$F$20220101$20240729$20220509$20240802$EXP$$US-PFIZER INC-202200641760$PFIZER$$73$YR$$F$Y$87.08$KG$20240802$$CN$US$US
208048193$20804819$3$F$$20240711$20220509$20240720$EXP$$US-TAKEDA-2022TUS030739$TAKEDA$$$$$F$Y$64.3$KG$20240720$$MD$US$US
208049728$20804972$8$F$$20240826$20220509$20240828$EXP$$US-TAKEDA-US202033394$TAKEDA$$$$$M$Y$134$KG$20240828$$HP$US$US
208050483$20805048$3$F$$20240709$20220509$20240712$EXP$$US-PFIZER INC-202200390843$PFIZER$$44$YR$$M$Y$$$20240712$$HP$US$US
208051483$20805148$3$F$20210401$20240807$20220509$20240813$EXP$$US-JAZZ-2022-US-015196$JAZZ$$51$YR$$F$Y$$$20240813$$CN$US$US
208051853$20805185$3$F$$20240917$20220509$20240918$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000142$PAREXEL$$$$$$Y$$$20240918$$HP$US$US
2080518737$20805187$37$F$20220401$20240821$20220509$20240826$EXP$$JP-TAKEDA-2022TJP045629$TAKEDA$$58$YR$$F$Y$$$20240826$$CN$JP$JP
208055976$20805597$6$F$20220501$20220628$20220510$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR074961$GLAXOSMITHKLINE$$41$YR$$F$Y$$$20240925$$CN$US$US
208056092$20805609$2$F$$20240813$20220510$20240827$EXP$$CA-AUROBINDO-AUR-APL-2022-015763$AUROBINDO$$27$YR$$F$Y$$$20240827$$HP$CA$CA
208057482$20805748$2$F$20220308$20240814$20220510$20240906$PER$$CA-TOLMAR, INC.-22CA033398$TOLMAR$$65$YR$$M$Y$$$20240906$$CN$CA$CA
208059943$20805994$3$F$20220225$20240814$20220510$20240904$PER$$CO-TOLMAR, INC.-22CO033236$TOLMAR$$75$YR$$M$Y$$$20240904$$CN$CO$CO
208060203$20806020$3$F$$20240913$20220510$20240926$EXP$$JP-AUROBINDO-AUR-APL-2022-015527$AUROBINDO$Kitahara M, Hiroshima Y, Norose K, Hikosaka K, Kazumoto H, Uematsu N, et al. Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: A retrospective study and literature review. Transpl Infect Dis. 2021;23(6):e13726$53$YR$$F$Y$$$20240926$$HP$JP$JP
208063772$20806377$2$F$$20220505$20220510$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR075003$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
208071143$20807114$3$F$$20220519$20220510$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR075596$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
208082326$20808232$6$F$20210701$20220912$20220510$20240729$EXP$$US-RECORDATI-2022001791$RECORDATI$$$$$$Y$$$20240726$$CN$US$US
208093382$20809338$2$F$$20240704$20220510$20240712$EXP$$DE-PFIZER INC-202200641547$PFIZER$$$$E$M$Y$$$20240712$$MD$DE$DE
2080974511$20809745$11$F$$20240916$20220510$20240919$EXP$GB-NORGINE LIMITED-NOR202104286$NVSC2022GB106137$NOVARTIS$$$$E$F$Y$$$20240920$$HP$GB$GB
2081053017$20810530$17$F$20220601$20240412$20220510$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR074260$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
208105524$20810552$4$F$20220920$20240730$20220510$20240801$EXP$$US-PFIZER INC-202200630391$PFIZER$$61$YR$$M$Y$$$20240801$$HP$US$US
2081056069$20810560$69$F$20210617$20240829$20220510$20240904$EXP$$CO-TAKEDA-2021TUS039512$TAKEDA$$40$YR$$F$Y$64$KG$20240904$$CN$CO$CO
208105883$20810588$3$F$20220401$20240822$20220510$20240828$PER$$US-PFIZER INC-202200630173$PFIZER$$55$YR$$F$Y$$$20240828$$HP$US$US
2081069315$20810693$15$F$20220322$20240720$20220510$20240726$EXP$$FR-BAUSCH-BL-2022-008984$BAUSCH AND LOMB$$69$YR$$M$Y$94$KG$20240726$$HP$FR$FR
208108907$20810890$7$F$20240901$20240920$20220510$20240925$PER$$US-PFIZER INC-202200221003$PFIZER$$76$YR$$F$Y$$$20240925$$CN$US$US
208110716$20811071$6$F$$20240820$20220510$20240822$EXP$$US-PFIZER INC-202101790526$PFIZER$$71$YR$$M$Y$$$20240822$$CN$US$US
208110725$20811072$5$F$20221123$20240926$20220510$20240930$PER$$US-PFIZER INC-202200334395$PFIZER$$63$YR$$M$Y$$$20240930$$HP$US$US
208111355$20811135$5$F$$20240916$20220510$20240918$PER$$US-PFIZER INC-2019263133$PFIZER$$62$YR$$F$Y$$$20240918$$CN$US$US
2081115911$20811159$11$F$$20240801$20220510$20240805$PER$$US-PFIZER INC-202200214921$PFIZER$$80$YR$$F$Y$74.8$KG$20240805$$CN$US$US
208112314$20811231$4$F$$20240712$20220510$20240718$EXP$$US-TAKEDA-2022TUS009209$TAKEDA$$$$$M$Y$77$KG$20240718$$CN$US$US
2081228517$20812285$17$F$20210101$20240822$20220511$20240830$EXP$$CA-CELLTRION INC.-2021CA018433$CELLTRION$$$$$$Y$$$20240830$$PH$CA$CA
208127337$20812733$7$F$20221013$20240806$20220511$20240828$PER$$CA-TOLMAR, INC.-22CA033310$TOLMAR$$97$YR$$M$Y$$$20240828$$CN$CA$CA
208129194$20812919$4$F$$20240718$20220511$20240801$EXP$$US-UCBSA-2022011226$UCB$$$$$F$Y$$$20240801$$CN$US$US
208135732$20813573$2$F$20220417$20240721$20220511$20240726$EXP$$US-SA-2022SA168637$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240727$$MD$US$US
2081363416$20813634$16$F$20201101$20240712$20220511$20240724$EXP$$DE-ROCHE-2737956$ROCHE$$29$YR$A$F$Y$$$20240724$$CN$DE$DE
208138265$20813826$5$F$$20240711$20220511$20240730$PER$$CA-TOLMAR, INC.-22CA032687$TOLMAR$$$$$M$Y$$$20240729$$CN$CA$CA
208139093$20813909$3$F$20220502$20240717$20220511$20240723$EXP$$US-TAKEDA-US202019569$TAKEDA$$54$YR$$F$Y$$$20240723$$HP$US$US
208145703$20814570$3$F$$20210901$20220511$20240712$PER$$IL-PFM-2022-03544$PIERRE FABRE MEDICAMENT$Tal R, Yakov G, Lorber A. When answers cannot be found in the texbooks: Making ethical decisions regarding children with profound disabilities. Progress in pediatric cardiology. 2021;61$49$DY$$F$Y$$$20240712$$HP$IL$IL
2081477912$20814779$12$F$20220504$20240917$20220511$20240920$EXP$$CA-TAKEDA-2022TUS027799$TAKEDA$$84$YR$$F$Y$$$20240920$$HP$CA$CA
2081488410$20814884$10$F$$20240910$20220511$20240912$EXP$$US-PFIZER INC-202200682843$PFIZER$$64$YR$$F$Y$$$20240912$$MD$US$US
208149786$20814978$6$F$20220601$20240702$20220511$20240710$PER$$CA-TOLMAR, INC.-22CA033502$TOLMAR$$73$YR$$M$Y$72.562$KG$20240710$$CN$CA$CA
208150575$20815057$5$F$$20240910$20220511$20240912$EXP$$US-PFIZER INC-202101810072$PFIZER$$82$YR$$M$Y$$$20240912$$MD$US$US
208151052$20815105$2$F$$20240913$20220511$20240923$PER$$US-INCYTE CORPORATION-2022IN004356$INCYTE$$$$$$Y$$$20240923$$CN$US$US
208152104$20815210$4$F$20231201$20240820$20220511$20240822$EXP$$US-PFIZER INC-202200573006$PFIZER$$54$YR$$F$Y$$$20240822$$HP$US$US
208159205$20815920$5$F$$20240916$20220511$20240918$PER$$US-PFIZER INC-202101871895$PFIZER$$73$YR$$F$Y$$$20240918$$CN$US$US
208163395$20816339$5$F$20080409$20240725$20220511$20240803$EXP$$JP-ABBVIE-22K-087-4384457-00$ABBVIE$$40$YR$$M$Y$$$20240803$$CN$JP$JP
208167089$20816708$9$F$20210127$20240814$20220512$20240816$EXP$$DE-ROCHE-2771195$ROCHE$$37$YR$A$M$Y$$$20240816$$CN$DE$DE
208167363$20816736$3$F$20211111$20240814$20220512$20240911$PER$$CA-TOLMAR, INC.-21CA031454$TOLMAR$$79$YR$$M$Y$$$20240911$$CN$CA$CA
208167416$20816741$6$F$20230522$20240806$20220512$20240828$PER$$CA-TOLMAR, INC.-22CA033253$TOLMAR$$74$YR$$M$Y$$$20240828$$CN$CA$CA
208169152$20816915$2$F$$20240917$20220512$20240918$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000144$PAREXEL$$$$$$Y$$$20240918$$CN$US$US
2081705019$20817050$19$F$20210101$20240906$20220512$20240918$EXP$$US-INSMED, INC.-2021-09527-US$INSMED$$$$$F$Y$36.794$KG$20240918$$HP$US$US
208171612$20817161$2$F$$20240626$20220512$20240701$EXP$$DE-BIOVITRUM-2022DE05990$BIOVITRUM$Muench F, Krusche M, Sander LE, Rose T, Burmester GR, Schneider U. Macrophage activation syndrome in a patient with adult-onset Still^s disease following first COVID-19 vaccination with BNT162b2. BMC Rheumatology. 2021 Dec 28;5(1): 1-4. doi:10.1186/s41927-021-00237-9.$23$YR$$F$Y$$$20240701$$MD$DE$DE
208171793$20817179$3$F$20220401$20240620$20220512$20240710$EXP$$DE-ROCHE-3093957$ROCHE$$42$YR$A$F$Y$$$20240710$$CN$DE$DE
2081751510$20817515$10$F$20210101$20240715$20220512$20240723$EXP$$US-ABBVIE-21K-163-4108585-00$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
208178683$20817868$3$F$$20240628$20220512$20240707$PER$$US-AMGEN-USASP2022076007$AMGEN$$$$$F$Y$$$20240707$$CN$US$US
208182917$20818291$7$F$$20240918$20220512$20240926$EXP$PT-MYLANLABS-2022M1018770$PT-PFM-2022-04183$PIERRE FABRE MEDICAMENT$$$$E$$Y$$$20240926$$$PT$PT
208183592$20818359$2$F$$20240715$20220512$20240717$PER$$US-PFIZER INC-202200091573$PFIZER$$49$YR$$F$Y$$$20240717$$CN$US$US
208185422$20818542$2$F$$20240702$20220512$20240704$EXP$$US-KYOWAKIRIN-2022BKK006416$KYOWA$$$$$$Y$$$20240704$$CN$US$US
208187772$20818777$2$F$20220201$20220509$20220512$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR075671$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240925$$CN$US$US
2081935010$20819350$10$F$20230101$20240625$20220512$20240702$EXP$$US-SA-2022SA170558$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240702$$MD$US$US
208194722$20819472$2$F$$20240711$20220512$20240712$EXP$$FR-PFIZER INC-202200654065$PFIZER$$$$$F$Y$$$20240712$$MD$FR$FR
208197669$20819766$9$F$20180801$20240709$20220512$20240723$EXP$$DE-ROCHE-2249912$ROCHE$$49$YR$A$F$Y$$$20240723$$CN$DE$DE
2081994316$20819943$16$F$20220506$20240920$20220512$20240924$EXP$$US-TAKEDA-2022TUS031322$TAKEDA$$15$YR$$M$Y$$$20240924$$PH$US$US
208201787$20820178$7$F$20220327$20240903$20220512$20240906$EXP$$US-TAKEDA-2022TUS024870$TAKEDA$$58$YR$$M$Y$66$KG$20240906$$CN$US$US
208201798$20820179$8$F$20231219$20240628$20220512$20240703$EXP$$AU-TAKEDA-2021TUS014962$TAKEDA$$41$YR$$F$Y$$$20240703$$HP$AU$AU
2082018611$20820186$11$F$20220314$20240720$20220512$20240725$EXP$$AU-TAKEDA-2022TUS017908$TAKEDA$$20$YR$$M$Y$$$20240725$$HP$AU$AU
2082021711$20820217$11$F$$20240918$20220512$20240920$EXP$$US-PFIZER INC-202200278907$PFIZER$$61$YR$$F$Y$77.551$KG$20240920$$HP$US$US
208204288$20820428$8$F$$20240813$20220512$20240815$EXP$$US-PFIZER INC-202200418056$PFIZER$$70$YR$$F$Y$$$20240815$$CN$US$US
208205922$20820592$2$F$$20240829$20220512$20240904$PER$$US-PFIZER INC-2021081080$PFIZER$$73$YR$$F$Y$44.898$KG$20240904$$CN$US$US
208207322$20820732$2$F$20220101$20240627$20220512$20240701$PER$$US-PFIZER INC-202200434423$PFIZER$$32$YR$$F$Y$$$20240701$$HP$US$US
208208543$20820854$3$F$$20240816$20220512$20240820$PER$$US-PFIZER INC-202200434327$PFIZER$$48$YR$$F$Y$$$20240820$$HP$US$US
208209394$20820939$4$F$$20220801$20220512$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR076889$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
208210683$20821068$3$F$$20240918$20220512$20240919$PER$$US-PFIZER INC-202200270988$PFIZER$$46$YR$$F$Y$$$20240919$$HP$US$US
2082107213$20821072$13$F$20220415$20240722$20220512$20240724$EXP$$US-PFIZER INC-202200268711$PFIZER$$75$YR$$F$Y$$$20240724$$CN$US$US
208210813$20821081$3$F$$20240923$20220512$20240926$PER$$US-PFIZER INC-2020319193$PFIZER$$68$YR$$F$Y$$$20240926$$CN$US$US
208213434$20821343$4$F$20200101$20240723$20220512$20240725$PER$$US-PFIZER INC-202200463901$PFIZER$$58$YR$$F$Y$82.086$KG$20240725$$CN$US$US
208213843$20821384$3$F$$20240730$20220512$20240802$PER$$US-PFIZER INC-202200458337$PFIZER$$69$YR$$F$Y$$$20240802$$CN$US$US
208214483$20821448$3$F$$20240826$20220512$20240829$PER$$US-PFIZER INC-2019191135$PFIZER$$79$YR$$M$Y$$$20240829$$CN$US$US
208214843$20821484$3$F$$20240806$20220512$20240808$PER$$US-PFIZER INC-202200322981$PFIZER$$80$YR$$F$Y$$$20240808$$MD$US$US
208215339$20821533$9$F$20220101$20240716$20220512$20240722$PER$$US-PFIZER INC-202200343515$PFIZER$$66$YR$$M$Y$$$20240722$$HP$US$US
208215514$20821551$4$F$$20240722$20220512$20240724$PER$$US-PFIZER INC-202200471405$PFIZER$$75$YR$$F$Y$$$20240724$$CN$US$US
2082157110$20821571$10$F$$20240701$20220512$20240703$30DAY$$US-PFIZER INC-202200650599$PFIZER$$74$YR$$F$Y$$$20240703$$MD$US$US
208216092$20821609$2$F$20220101$20240903$20220512$20240920$PER$$AU-TOLMAR, INC.-22AU033560$TOLMAR$$$$$M$Y$$$20240919$$CN$AU$AU
208216356$20821635$6$F$20211206$20240729$20220512$20240801$EXP$$US-PFIZER INC-202200398012$PFIZER$$79$YR$$M$Y$61.23$KG$20240801$$CN$US$US
208216472$20821647$2$F$20211105$20240916$20220512$20240919$PER$$US-PFIZER INC-202101539496$PFIZER$$52$YR$$M$Y$$$20240919$$HP$US$US
208217372$20821737$2$F$$20240807$20220512$20240809$PER$$US-PFIZER INC-202200292949$PFIZER$$27$YR$$F$Y$$$20240809$$MD$US$US
208217656$20821765$6$F$$20240906$20220512$20240910$PER$$US-PFIZER INC-202200403641$PFIZER$$59$YR$$F$Y$$$20240910$$CN$US$US
2082179311$20821793$11$F$20220101$20240822$20220512$20240828$PER$$US-PFIZER INC-202200307693$PFIZER$$68$YR$$F$Y$63.5$KG$20240828$$CN$US$US
208220274$20822027$4$F$$20240916$20220512$20240919$PER$$US-PFIZER INC-202200501134$PFIZER$$53$YR$$F$Y$$$20240919$$HP$US$US
208220304$20822030$4$F$$20240805$20220512$20240807$PER$$US-AMGEN-USASP2022081691$AMGEN$$50$YR$A$F$Y$$$20240806$$HP$US$US
208221316$20822131$6$F$$20240722$20220512$20240724$PER$$US-PFIZER INC-202200551735$PFIZER$$64$YR$$M$Y$$$20240724$$HP$US$US
208221428$20822142$8$F$20240701$20240823$20220512$20240828$EXP$$US-PFIZER INC-2021549684$PFIZER$$70$YR$$F$Y$$$20240828$$CN$US$US
2082218719$20822187$19$F$20220101$20240925$20220512$20240927$EXP$$US-PFIZER INC-202200506858$PFIZER$$70$YR$$F$Y$77.11$KG$20240927$$CN$US$US
208235726$20823572$6$F$20230216$20240825$20220513$20240913$PER$$CA-TOLMAR, INC.-21CA031692$TOLMAR$$65$YR$$M$Y$$$20240913$$CN$CA$CA
208235845$20823584$5$F$20240905$20240905$20220513$20240925$PER$$CA-TOLMAR, INC.-22CA032441$TOLMAR$$73$YR$$M$Y$$$20240925$$CN$CA$CA
208239482$20823948$2$F$20220101$20240806$20220513$20240807$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000149$PAREXEL$$$$$$Y$$$20240807$$CN$US$US
208239707$20823970$7$F$20220201$20240626$20220513$20240704$EXP$$CA-CELLTRION INC.-2022CA003908$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
2082432910$20824329$10$F$20220401$20240903$20220513$20240907$EXP$$NVSC2022US109016$NOVARTIS$$56$YR$$F$Y$$$20240907$$CN$US$US
208244322$20824432$2$F$$20220511$20220513$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR077305$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
208248332$20824833$2$F$20220325$20220429$20220513$20240729$EXP$$US-RECORDATI-2022001398$RECORDATI$$$$$$Y$$$20240726$$CN$US$US
208249212$20824921$2$F$20220420$20220502$20220513$20240913$EXP$FR-AFSSAPS-NY20221360$FR-ASPEN-GLO2022FR002547$ASPEN$$$$$$Y$$$20240913$$MD$FR$FR
2082511325$20825113$25$F$20231126$20240827$20220513$20240904$EXP$$US-TAKEDA-2022TUS020913$TAKEDA$$69$YR$$F$Y$38$KG$20240904$$HP$US$US
208252602$20825260$2$F$20220501$20220510$20220513$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR076858$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
208255898$20825589$8$F$20220205$20240819$20220513$20240912$PER$$CA-TOLMAR, INC.-22CA032849$TOLMAR$$72$YR$$M$Y$$$20240912$$CN$CA$CA
208262892$20826289$2$F$$20220510$20220513$20240711$EXP$$ZA-ASTELLAS-2022US017343$ASTELLAS$$$$$M$Y$$$20240711$$HP$ZA$ZA
2082653010$20826530$10$F$20220429$20240830$20220513$20240906$EXP$$CO-TAKEDA-2022TUS027641$TAKEDA$$45$YR$$M$Y$57$KG$20240906$$CN$CO$CO
208266138$20826613$8$F$20220101$20240813$20220513$20240815$EXP$$US-PFIZER INC-202200598640$PFIZER$$22$YR$$M$Y$$$20240815$$HP$US$US
208269965$20826996$5$F$20230101$20240812$20220513$20240814$EXP$$US-PFIZER INC-202200596397$PFIZER$$69$YR$$M$Y$$$20240814$$CN$US$US
208273992$20827399$2$F$$20240906$20220513$20240911$PER$$US-PFIZER INC-2018065366$PFIZER$$68$YR$$F$Y$$$20240911$$MD$US$US
208274708$20827470$8$F$$20240822$20220513$20240829$EXP$$US-TAKEDA-2022TUS030311$TAKEDA$$$$$M$Y$$$20240829$$HP$US$US
2082773817$20827738$17$F$20200223$20240828$20220513$20240902$EXP$$US-TAKEDA-US202007690$TAKEDA$$51$YR$$F$Y$63$KG$20240902$$HP$US$US
208278712$20827871$2$F$$20240612$20220513$20240712$EXP$$PL-TEVA-2022-PL-2028143$TEVA$B M. Zaburzenia orientacji i pami ci u43-letniej kobiety. Med. Prakt. Neurologia. 2016;4: 55-60.; B M. Orientation and memory disturbances in a43-year-old woman. Med. Prakt. Neurologia. 2016;4: 55-60.; B M. Orientation and memory disturbances in a 43-year-old woman. Med. Prakt. Neurologia 2016; 4: 55-60.; Bosak M. Zaburzenia orientacji i pami ci u 43-letniej kobiety. Med. Prakt. Neurologia 2016; 4: 55-60.; Article Title:  Orientation and memory disturbances in a 43-year-old woman ;Journal Tit...$43$YR$$F$Y$$$20240712$$MD$PL$PL
208279242$20827924$2$F$$20240822$20220513$20240916$PER$$US-SA-2022SA164990$SANOFI AVENTIS$$$$A$M$Y$105.23$KG$20240916$$MD$US$US
208280932$20828093$2$F$$20240720$20220513$20240729$PER$$US-SA-2022SA163069$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240729$$MD$US$US
208281002$20828100$2$F$$20240722$20220513$20240731$PER$$US-SA-2022SA165419$SANOFI AVENTIS$$8$YR$C$F$Y$44.9$KG$20240731$$HP$US$US
208281093$20828109$3$F$$20240917$20220513$20240926$PER$$US-SA-2022SA164181$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240926$$MD$US$US
208281853$20828185$3$F$20220426$20240708$20220513$20240713$PER$$US-SA-2022SA163736$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240713$$MD$US$US
208282112$20828211$2$F$$20240805$20220513$20240814$PER$$US-SA-2022SA163520$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240814$$CN$US$US
208282674$20828267$4$F$$20240905$20220513$20240924$EXP$$US-SA-2022SA166302$SANOFI AVENTIS$$54$YR$A$F$Y$59.5$KG$20240924$$MD$US$US
208282859$20828285$9$F$20211215$20240708$20220513$20240716$PER$$US-SA-2022SA164640$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240716$$MD$US$US
2082839514$20828395$14$F$20220101$20240917$20220513$20240920$PER$$US-PFIZER INC-202200643398$PFIZER$$73$YR$$F$Y$$$20240920$$CN$US$US
208284304$20828430$4$F$20220101$20240827$20220513$20240829$EXP$$US-PFIZER INC-202200677095$PFIZER$$57$YR$$F$Y$$$20240829$$HP$US$US
208286974$20828697$4$F$$20240902$20220513$20240913$PER$$US-INCYTE CORPORATION-2022IN004479$INCYTE$$$$$$Y$$$20240913$$CN$US$US
2082898410$20828984$10$F$20220301$20240828$20220513$20240902$EXP$$BR-TAKEDA-2022TUS006040$TAKEDA$$61$YR$$F$Y$52$KG$20240902$$CN$BR$BR
208291644$20829164$4$F$20220101$20240903$20220513$20240925$PER$$US-SA-2022SA171393$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240925$$MD$US$US
208293132$20829313$2$F$$20240625$20220513$20240701$PER$$US-PFIZER INC-2020463909$PFIZER$$65$YR$$F$Y$$$20240701$$CN$US$US
208293237$20829323$7$F$20200101$20240918$20220513$20240923$PER$$US-PFIZER INC-202200433765$PFIZER$$61$YR$$F$Y$77.098$KG$20240923$$CN$US$US
208295808$20829580$8$F$20210101$20240629$20220513$20240703$EXP$$IN-PFIZER INC-202101500195$PFIZER$$58$YR$$M$Y$$$20240703$$CN$IN$IN
2082966613$20829666$13$F$20230601$20240826$20220513$20240829$EXP$$US-JAZZ-2022-US-012882$JAZZ$$52$YR$$F$Y$$$20240829$$CN$US$US
208297255$20829725$5$F$$20240729$20220513$20240731$EXP$$CA-PFIZER INC-202200655021$PFIZER$$$$$M$Y$$$20240731$$CN$CA$CA
2082983725$20829837$25$F$20190210$20240916$20220513$20240926$EXP$$DE-ROCHE-2188577$ROCHE$$48$YR$A$F$Y$128$KG$20240926$$CN$DE$DE
208301127$20830112$7$F$20170301$20240918$20220514$20240928$EXP$$CA-TAKEDA-CA201713728$TAKEDA$$45$YR$$F$Y$$$20240928$$CN$CA$CA
208304463$20830446$3$F$$20240817$20220514$20240830$PER$$US-SA-2022SA171429$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240830$$MD$US$US
208305773$20830577$3$F$20220325$20240716$20220514$20240725$PER$$US-SA-2022SA169196$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240725$$MD$US$US
2083060014$20830600$14$F$20210420$20240905$20220514$20240911$EXP$$IT-TAKEDA-2021TUS026279$TAKEDA$$66$YR$$F$Y$$$20240911$$CN$IT$IT
208308003$20830800$3$F$20180702$20240726$20220515$20240803$EXP$$DE-TEVA-2022-DE-2036245$TEVA$$35$YR$$F$Y$$$20240803$$CN$DE$DE
208314102$20831410$2$F$$20240815$20220516$20240828$EXP$$CA-AUROBINDO-AUR-APL-2022-016409$AUROBINDO$$69$YR$$F$Y$$$20240828$$PH$CA$CA
208315622$20831562$2$F$$20240821$20220516$20240902$EXP$$US-AUROBINDO-AUR-APL-2022-016543$AUROBINDO$Svoboda SA, Bisbee EL, Bender N, Motaparthi K.. Acute generalized exanthematous pustulosis sine pustules: A case series. JAAD-Case-Rep. 2022;23:24-26$38$YR$$F$Y$$$20240902$$MD$US$US
208318345$20831834$5$F$20220419$20240829$20220516$20240903$EXP$$DE-ROCHE-3094213$ROCHE$$32$YR$A$F$Y$70$KG$20240903$$MD$DE$DE
208318754$20831875$4$F$20220510$20240806$20220516$20240808$EXP$$CA-ROCHE-3092978$ROCHE$$63$YR$A$M$Y$$$20240808$$CN$CA$CA
208321573$20832157$3$F$$20240806$20220516$20240807$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000150$PAREXEL$$$$$$Y$$$20240807$$MD$US$US
208322062$20832206$2$F$$20220512$20220516$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR077468$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2083229619$20832296$19$F$20210320$20240621$20220516$20240702$EXP$$CA-TAKEDA-CA202034507$TAKEDA$$53$YR$$F$Y$54.431$KG$20240702$$HP$CA$CA
2083274738$20832747$38$F$20220101$20240912$20220516$20240921$EXP$$CA-CELLTRION INC.-2022CA006552$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
208328637$20832863$7$F$20231004$20240902$20220516$20240924$PER$$CA-TOLMAR, INC.-21CA031722$TOLMAR$$85$YR$$M$Y$$$20240923$$CN$CA$CA
208330084$20833008$4$F$20240905$20240905$20220516$20240906$EXP$$US-TAKEDA-US201911967$TAKEDA$$44$YR$$F$Y$$$20240906$$HP$US$US
208331723$20833172$3$F$20220328$20240813$20220516$20240821$EXP$$FR-AstraZeneca-2022A178110$ASTRAZENECA$$75$YR$$F$Y$55$KG$20240821$$MD$FR$
2083374012$20833740$12$F$20220513$20240924$20220516$20240930$EXP$$CA-TAKEDA-2022TUS032299$TAKEDA$$60$YR$$M$Y$$$20240930$$CN$CA$CA
208338102$20833810$2$F$20220413$20240723$20220516$20240726$EXP$ES-AEMPS-1175869$ES-PFIZER INC-202200683518$MYLAN$$62$YR$$M$Y$80$KG$20240726$$HP$ES$ES
208339526$20833952$6$F$$20240828$20220516$20240830$PER$$US-PFIZER INC-202200658807$PFIZER$$64$YR$$M$Y$110.75$KG$20240830$$CN$US$US
208340813$20834081$3$F$$20240830$20220516$20240906$EXP$$US-PFIZER INC-202101639365$PFIZER$$62$YR$$F$Y$$$20240906$$MD$US$US
2083409221$20834092$21$F$20230822$20240802$20220516$20240805$EXP$$AU-TAKEDA-2022TUS020909$TAKEDA$$32$YR$$F$Y$$$20240805$$CN$AU$AU
208341242$20834124$2$F$20220401$20240807$20220516$20240809$PER$$US-PFIZER INC-202200689281$PFIZER$$41$YR$$F$Y$$$20240809$$HP$US$US
2083422121$20834221$21$F$20211124$20240717$20220516$20240724$EXP$$US-TAKEDA-2021TUS045942$TAKEDA$$46$YR$$F$Y$66$KG$20240724$$HP$US$US
208342672$20834267$2$F$$20240717$20220516$20240723$EXP$$US-KYOWAKIRIN-2022BKK006969$KYOWA$$$$$$Y$$$20240723$$HP$US$US
208343384$20834338$4$F$$20240729$20220516$20240801$EXP$$US-TAKEDA-2022TUS032217$TAKEDA$$$$$F$Y$$$20240801$$MD$US$US
208345113$20834511$3$F$20210414$20240711$20220516$20240716$EXP$$CA-TAKEDA-CA202017469$TAKEDA$$57$YR$$M$Y$$$20240716$$CN$CA$CA
2083483117$20834831$17$F$20220506$20230922$20220516$20240912$EXP$$NVSC2022US112404$NOVARTIS$$34$YR$$F$Y$$$20240912$$CN$US$US
208351444$20835144$4$F$20220101$20240828$20220516$20240912$PER$$US-SA-2022SA172587$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240912$$MD$US$US
208351482$20835148$2$F$$20240903$20220516$20240912$PER$$US-SA-2022SA172710$SANOFI AVENTIS$$7$YR$C$F$Y$29$KG$20240912$$MD$US$US
208351693$20835169$3$F$$20240814$20220516$20240828$PER$$US-SA-2022SA171285$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240828$$MD$US$US
208355946$20835594$6$F$20220701$20240629$20220516$20240703$EXP$$US-INCYTE CORPORATION-2022IN004648$INCYTE$$$$$$Y$$$20240703$$MD$US$US
208356345$20835634$5$F$$20240808$20220516$20240812$PER$$US-PFIZER INC-202200574845$PFIZER$$36$YR$$F$Y$83.9$KG$20240812$$CN$US$US
208358628$20835862$8$F$20231101$20240703$20220516$20240710$EXP$$US-JAZZ-2022-US-016210$JAZZ$$32$YR$$M$Y$$$20240710$$MD$US$US
208359007$20835900$7$F$20200131$20240918$20220516$20240926$EXP$$DE-ROCHE-2557580$ROCHE$$59$YR$A$F$Y$$$20240926$$CN$DE$DE
208361665$20836166$5$F$$20240712$20220516$20240730$PER$$CA-TOLMAR, INC.-22CA033763$TOLMAR$$$$$M$Y$$$20240729$$CN$CA$CA
2083625426$20836254$26$F$20180914$20240918$20220516$20240927$EXP$$CA-CELLTRION INC.-2018CA022246$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
208364192$20836419$2$F$$20220513$20220517$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR078289$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2083644411$20836444$11$F$20240626$20240719$20220517$20240723$PER$$NVSC2022US112832$NOVARTIS$$62$YR$$M$Y$$$20240723$$CN$US$US
208364464$20836446$4$F$20220501$20220713$20220517$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR078124$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
208371773$20837177$3$F$20220501$20220527$20220517$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR078380$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240925$$CN$US$US
208373947$20837394$7$F$$20240725$20220517$20240731$EXP$$IN-ROCHE-3093753$ROCHE$$61$YR$A$F$Y$$$20240731$$CN$IN$IN
208377036$20837703$6$F$20220125$20240812$20220517$20240820$EXP$$DE-TAKEDA-2022TUS032182$TAKEDA$$59$YR$$M$Y$114$KG$20240820$$MD$DE$DE
208383003$20838300$3$F$20220501$20221018$20220517$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR078734$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
208383332$20838333$2$F$$20240725$20220517$20240728$EXP$$FR-ROCHE-3095299$ROCHE$$46$YR$A$F$Y$$$20240728$$MD$FR$FR
208386652$20838665$2$F$$20240624$20220517$20240701$EXP$$US-SA-2022SA177056$SANOFI AVENTIS$$56$YR$A$F$Y$56.689$KG$20240701$$MD$US$US
208387284$20838728$4$F$20220513$20240725$20220517$20240801$EXP$$US-GLAXOSMITHKLINE-US2022078113$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
208389446$20838944$6$F$$20240913$20220517$20240923$EXP$$US-TAKEDA-2021TUS063618$TAKEDA$$$$$F$Y$$$20240923$$CN$US$US
208399923$20839992$3$F$$20240821$20220517$20240823$EXP$$CA-ROCHE-3095731$ROCHE$$$$A$F$Y$$$20240823$$CN$CA$CA
2084015416$20840154$16$F$$20240809$20220517$20240812$EXP$$US-PFIZER INC-202200677350$PFIZER$$67$YR$$F$Y$116.12$KG$20240812$$CN$US$US
2084035910$20840359$10$F$20220609$20240807$20220517$20240812$EXP$$CA-TAKEDA-2021TUS042483$TAKEDA$$57$YR$$F$Y$$$20240812$$HP$CA$CA
208405047$20840504$7$F$20220322$20240904$20220517$20240925$PER$$CA-TOLMAR, INC.-22CA033669$TOLMAR$$83$YR$$M$Y$$$20240925$$CN$CA$CA
2084057710$20840577$10$F$20211201$20240813$20220517$20240830$PER$$CA-TOLMAR, INC.-21CA032228$TOLMAR$$60$YR$$M$Y$$$20240830$$HP$CA$CA
208407292$20840729$2$F$$20240808$20220517$20240813$EXP$$US-KYOWAKIRIN-2022BKK006558$KYOWA$$$$$$Y$$$20240813$$HP$US$US
2084077610$20840776$10$F$20220502$20240826$20220517$20240829$EXP$$US-PFIZER INC-202200655270$PFIZER$$74$YR$$F$Y$75.3$KG$20240829$$CN$US$US
208408376$20840837$6$F$$20240715$20220517$20240717$EXP$$US-PFIZER INC-202200503085$PFIZER$$76$YR$$F$Y$$$20240717$$CN$US$US
208410302$20841030$2$F$20220501$20240626$20220517$20240704$EXP$$US-JAZZ-2022-US-016305$JAZZ$$62$YR$$F$Y$$$20240704$$CN$US$US
208410836$20841083$6$F$20210101$20240628$20220517$20240704$PER$$US-PFIZER INC-202200499673$PFIZER$$23$YR$$F$Y$$$20240704$$HP$US$US
208411772$20841177$2$F$$20240726$20220517$20240801$EXP$$GB-INCYTE CORPORATION-2022IN004556$INCYTE$$$$$$Y$$$20240801$$HP$GB$GB
208415127$20841512$7$F$20211028$20240807$20220518$20240815$PER$$CA-TOLMAR, INC.-21CA031245$TOLMAR$$66$YR$$M$Y$$$20240815$$CN$CA$CA
2084212115$20842121$15$F$20180830$20240829$20220518$20240831$EXP$$DE-ROCHE-2190140$ROCHE$$42$YR$A$F$Y$$$20240831$$CN$DE$DE
208424523$20842452$3$F$$20240821$20220518$20240905$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-337207$RANBAXY$Marcos-Vadillo E, Carrascal-Laso L, Ramos-Gallego I, Gaedigk A, Garcia-Berrocal B, Mayor-Toranzo E, et al. Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype. Front Psychiatry. 2022;12; Feb:830608 (1-6)$$$$M$Y$$$20240905$$HP$ES$ES
208425579$20842557$9$F$20180504$20240619$20220518$20240710$EXP$$DE-ROCHE-2123188$ROCHE$$32$YR$A$F$Y$$$20240710$$CN$DE$DE
208425652$20842565$2$F$20220113$20240916$20220518$20240917$EXP$$BE-ROCHE-3022539$ROCHE$$37$YR$A$F$Y$74$KG$20240917$$MD$BE$BE
208435574$20843557$4$F$20220411$20240822$20220518$20240910$PER$$CA-TOLMAR, INC.-22CA034019$TOLMAR$$88$YR$$M$Y$$$20240910$$CN$CA$CA
208437532$20843753$2$F$$20240704$20220518$20240710$EXP$$FR-PFIZER INC-202200685625$PFIZER$$46$YR$$F$Y$$$20240710$$MD$FR$FR
208437903$20843790$3$F$20220101$20240809$20220518$20240814$EXP$$IN-PFIZER INC-202200715887$PFIZER$$69$YR$$F$Y$$$20240814$$CN$IN$IN
208439205$20843920$5$F$20210705$20240813$20220518$20240816$EXP$$US-TAKEDA-2021TUS047858$TAKEDA$$54$YR$$F$Y$81$KG$20240816$$CN$US$US
208442223$20844222$3$F$20240912$20240926$20220518$20240927$EXP$$US-PFIZER INC-202200726131$PFIZER$$84$YR$$M$Y$$$20240927$$CN$US$US
208446179$20844617$9$F$20240710$20240925$20220518$20240930$EXP$$US-TAKEDA-2022TUS031156$TAKEDA$$64$YR$$F$Y$$$20240930$$CN$US$US
208447404$20844740$4$F$$20240730$20220518$20240801$PER$$US-PFIZER INC-202200683976$PFIZER$$64$YR$$F$Y$$$20240801$$HP$US$US
208447446$20844744$6$F$20220601$20240826$20220518$20240829$PER$$US-PFIZER INC-202200670712$PFIZER$$42$YR$$F$Y$$$20240829$$CN$US$US
208452137$20845213$7$F$$20240913$20220518$20240917$PER$$US-PFIZER INC-202200667753$PFIZER$$74$YR$$F$Y$$$20240917$$CN$US$US
208454699$20845469$9$F$$20240903$20220518$20240905$EXP$$US-PFIZER INC-202200700413$PFIZER$$66$YR$$F$Y$$$20240905$$CN$US$US
208454712$20845471$2$F$$20240709$20220518$20240712$EXP$$US-PFIZER INC-202200701600$PFIZER$$59$YR$$F$Y$$$20240712$$HP$US$US
208455243$20845524$3$F$$20240708$20220518$20240712$EXP$$US-PFIZER INC-202200662113$PFIZER$$67$YR$$F$Y$58.97$KG$20240712$$CN$US$US
208455314$20845531$4$F$$20240916$20220518$20240919$PER$$US-PFIZER INC-202200657459$PFIZER$$59$YR$$F$Y$$$20240919$$HP$US$US
208455559$20845555$9$F$20220323$20240904$20220518$20240925$PER$$CA-TOLMAR, INC.-21CA031814$TOLMAR$$90$YR$$M$Y$$$20240925$$CN$CA$CA
208455795$20845579$5$F$$20240909$20220518$20240911$PER$$US-PFIZER INC-202200541496$PFIZER$$70$YR$$M$Y$$$20240911$$HP$US$US
208457907$20845790$7$F$20230221$20240902$20220518$20240923$PER$$CA-TOLMAR, INC.-22CA033683$TOLMAR$$60$YR$$M$Y$$$20240923$$CN$CA$CA
208458007$20845800$7$F$20220101$20240902$20220518$20240904$PER$$US-PFIZER INC-2019336966$PFIZER$$71$YR$$F$Y$52.16$KG$20240904$$MD$US$US
208458067$20845806$7$F$$20240923$20220518$20240924$PER$$US-PFIZER INC-2014033226$PFIZER$$71$YR$$M$Y$$$20240924$$CN$US$US
2084583613$20845836$13$F$20210616$20240626$20220518$20240704$EXP$$CN-TAKEDA-2022TUS003422$TAKEDA$$73$YR$$F$Y$58$KG$20240704$$MD$CN$CN
2084589211$20845892$11$F$20230808$20240827$20220518$20240902$EXP$$CA-TAKEDA-2022TUS032309$TAKEDA$$43$YR$$F$Y$$$20240902$$CN$CA$CA
208459015$20845901$5$F$$20230316$20220518$20240806$EXP$$JP-BIOGEN-2022BI01109100$BIOGEN$$$$$F$Y$9.15$KG$20240806$$MD$JP$JP
208459713$20845971$3$F$$20240816$20220518$20240821$EXP$$US-JAZZ-2022-US-016813$JAZZ$$$$$F$Y$$$20240821$$CN$US$US
208460245$20846024$5$F$20160701$20240710$20220518$20240711$EXP$$US-UCBSA-2022027521$UCB$$56$YR$$F$Y$$$20240711$$CN$US$US
208460915$20846091$5$F$$20240715$20220518$20240720$EXP$$NVSC2022MX114203$NOVARTIS$$$$$F$Y$47$KG$20240720$$CN$MX$MX
208464973$20846497$3$F$$20240910$20220518$20240920$EXP$$NVSC2022CA110813$NOVARTIS$$76$YR$$M$Y$$$20240920$$CN$CA$CA
208465142$20846514$2$F$$20240710$20220518$20240711$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000161$PAREXEL$$$$$$Y$$$20240711$$MD$US$US
208466195$20846619$5$F$20220506$20240806$20220518$20240807$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000157$PAREXEL$$$$$$Y$$$20240807$$CN$US$US
2084704824$20847048$24$F$20210611$20240625$20220519$20240703$EXP$$CA-CELLTRION INC.-2021CA010401$CELLTRION$$$$$$Y$$$20240703$$HP$CA$CA
2084709518$20847095$18$F$20191126$20240906$20220519$20240916$EXP$$CA-CELLTRION INC.-2019CA025618$CELLTRION$$$$$$Y$$$20240916$$CN$CA$CA
208473082$20847308$2$F$$20220512$20220519$20240709$EXP$$BR-ASTELLAS-2022US016385$ASTELLAS$$65$YR$$M$Y$$$20240709$$MD$BR$BR
2084761310$20847613$10$F$20201009$20240924$20220519$20240927$EXP$$DE-ROCHE-2695349$ROCHE$$23$YR$A$F$Y$$$20240927$$CN$DE$DE
2084840610$20848406$10$F$20230412$20240821$20220519$20240826$EXP$$US-KYOWAKIRIN-2022BKK007058$KYOWA$$$$$$Y$$$20240826$$HP$US$US
208485913$20848591$3$F$20220101$20220517$20220519$20240731$EXP$$US-RECORDATI-2022001971$RECORDATI$$$$$$Y$$$20240731$$MD$US$US
2084861412$20848614$12$F$20220101$20240909$20220519$20240916$EXP$$CA-CURRAX PHARMACEUTICALS LLC-CA-2022CUR021376$CURRAX PHARMACEUTICALS$$$$$F$Y$88.889$KG$20240916$$CN$CA$CA
208486322$20848632$2$F$20220502$20220505$20220519$20240809$EXP$$US-ORPHANEU-2022001998$RECORDATI$$$$$$Y$$$20240809$$CN$US$US
208486563$20848656$3$F$20230101$20240705$20220519$20240725$PER$$CA-TOLMAR, INC.-22CA033687$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
2084899712$20848997$12$F$20201024$20240918$20220519$20240919$EXP$$NVSC2021FR217849$NOVARTIS$$$$E$M$Y$80$KG$20240919$$MD$FR$FR
208493204$20849320$4$F$20211109$20240708$20220519$20240711$EXP$$US-KYOWAKIRIN-2022BKK006137$KYOWA$$$$$$Y$$$20240711$$CN$US$US
208494666$20849466$6$F$$20240614$20220519$20240702$PER$$CA-TOLMAR, INC.-22CA034104$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
208496286$20849628$6$F$20210601$20240808$20220519$20240814$EXP$$US-TAKEDA-2021TUS027371$TAKEDA$$78$YR$$F$Y$130$KG$20240814$$HP$US$US
208496403$20849640$3$F$20140416$20240926$20220519$20240930$PER$$US-BIOGEN-2020BI00866264$BIOGEN$$56$YR$$F$Y$$$20240930$$CN$US$US
208496582$20849658$2$F$20220307$20240903$20220519$20240913$EXP$FR-AFSSAPS-AN20221097$FR-TEVA-2022-FR-2037311$TEVA$$67$YR$$M$Y$74.9$KG$20240913$$PH$FR$FR
208497078$20849707$8$F$20160101$20240912$20220519$20240918$PER$$US-PFIZER INC-202200604856$PFIZER$$74$YR$$F$Y$117.93$KG$20240918$$MD$US$US
2084985714$20849857$14$F$20211123$20231207$20220519$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR078171$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
208500376$20850037$6$F$$20240918$20220519$20240923$PER$$US-PFIZER INC-202200708495$PFIZER$$53$YR$$F$Y$$$20240923$$CN$US$US
208509638$20850963$8$F$$20240909$20220519$20240913$EXP$$US-JAZZ-2022-US-011592$JAZZ$$$$$M$Y$$$20240912$$MD$US$US
208515562$20851556$2$F$$20240806$20220520$20240807$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000128$PAREXEL$$$$$$Y$$$20240807$$CN$US$US
208515887$20851588$7$F$20231009$20240906$20220520$20240925$PER$$CA-TOLMAR, INC.-22CA033840$TOLMAR$$74$YR$$M$Y$$$20240925$$CN$CA$CA
208522344$20852234$4$F$20220501$20220816$20220520$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR080982$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240926$$CN$US$US
208522475$20852247$5$F$20220515$20240804$20220520$20240812$EXP$$US-SA-2022SA177300$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240812$$MD$US$US
208523462$20852346$2$F$20220501$20220518$20220520$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR081056$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
2085241113$20852411$13$F$20220101$20240628$20220520$20240706$EXP$$CA-CELLTRION INC.-2022CA002778$CELLTRION$$$$$$Y$$$20240706$$MD$CA$CA
208526922$20852692$2$F$20220510$20240701$20220520$20240710$EXP$$NL-CELLTRION INC.-2022NL006596$CELLTRION$$$$$$Y$$$20240710$$MD$NL$NL
208527362$20852736$2$F$20220105$20240726$20220520$20240808$EXP$IT-SEATTLE GENETICS-2022SGN00326$IT-ROCHE-3098761$ROCHE$$45$YR$A$F$Y$58$KG$20240808$$CN$IT$IT
208533748$20853374$8$F$20160827$20240909$20220520$20240914$EXP$$CA-TAKEDA-2022TUS031624$TAKEDA$$25$YR$$F$Y$$$20240914$$CN$CA$CA
208539099$20853909$9$F$20220501$20221130$20220520$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR081070$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
208539115$20853911$5$F$20220516$20220817$20220520$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR080720$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
208541093$20854109$3$F$20220301$20240805$20220520$20240807$EXP$$US-UCBSA-2022028074$UCB$$70$YR$$F$Y$$$20240807$$CN$US$US
2085412613$20854126$13$F$20210101$20240904$20220520$20240910$EXP$$IN-PFIZER INC-202101566791$PFIZER$$70$YR$$F$Y$$$20240910$$CN$IN$IN
208545573$20854557$3$F$20220501$20240815$20220520$20240821$EXP$$CA-TAKEDA-CA202025048$TAKEDA$$50$YR$$F$Y$$$20240821$$CN$CA$CA
208547922$20854792$2$F$$20240629$20220520$20240704$EXP$$US-GW PHARMA-202110USGW04922$JAZZ$$$$$F$Y$34.467$KG$20240704$$CN$US$US
208550934$20855093$4$F$$20240724$20220520$20240729$EXP$$CA-PFIZER INC-202200717327$PFIZER$$53$YR$$M$Y$91$KG$20240729$$HP$CA$CA
208557339$20855733$9$F$$20240826$20220520$20240829$PER$$US-PFIZER INC-202200589623$PFIZER$$66$YR$$F$Y$$$20240829$$CN$US$US
2085584910$20855849$10$F$$20240701$20220520$20240704$EXP$$US-TAKEDA-2021TUS033791$TAKEDA$$$$$F$Y$137$KG$20240704$$HP$US$US
2085599711$20855997$11$F$20210609$20240910$20220520$20240916$EXP$$US-TAKEDA-2021TUS029782$TAKEDA$$51$YR$$M$Y$82$KG$20240916$$HP$US$US
208560292$20856029$2$F$$20240726$20220520$20240820$EXP$$CA-GILEAD-2022-0582362$GILEAD$$55$YR$A$F$Y$74$KG$20240820$$PH$CA$CA
208561527$20856152$7$F$20220101$20240829$20220520$20240910$EXP$$JP-009507513-2205JPN001799J$MERCK$$71$YR$$M$Y$$$20240910$$MD$JP$JP
208563342$20856334$2$F$20190603$20240827$20220520$20240909$PER$$US-SA-2022SA169867$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240909$$MD$US$US
208566632$20856663$2$F$$20240830$20220520$20240906$PER$$US-SA-2022SA168516$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240906$$MD$US$US
208570453$20857045$3$F$20211105$20240711$20220520$20240718$PER$$US-SA-2022SA179896$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240718$$MD$US$US
208571552$20857155$2$F$$20240715$20220520$20240718$PER$$US-SA-2022SA046757$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240718$$MD$US$US
208571852$20857185$2$F$$20240814$20220520$20240828$PER$$US-SA-2022SA180903$SANOFI AVENTIS$$$$A$M$Y$$$20240828$$MD$US$US
208571872$20857187$2$F$20201101$20240801$20220520$20240809$PER$$US-SA-2022SA178849$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240809$$MD$US$US
2085756313$20857563$13$F$20220504$20240918$20220520$20240928$EXP$$CZ-BAXTER-2022BAX010543$BAXTER$$67$YR$$F$Y$56$KG$20240928$$MD$CZ$CZ
208576335$20857633$5$F$20210101$20240916$20220521$20240924$EXP$$CA-CELLTRION INC.-2021CA009021$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
2085765812$20857658$12$F$20210115$20240913$20220521$20240923$EXP$$CA-CELLTRION INC.-2021CA017688$CELLTRION$$$$$$Y$$$20240923$$MD$CA$CA
2085766819$20857668$19$F$20220310$20240628$20220521$20240706$EXP$$CA-CELLTRION INC.-2022CA004573$CELLTRION$$$$$$Y$$$20240706$$HP$CA$CA
2085779414$20857794$14$F$20210721$20240725$20220521$20240803$EXP$$CA-CELLTRION INC.-2022CA007081$CELLTRION$$$$$$Y$$$20240803$$MD$CA$CA
208578572$20857857$2$F$$20240717$20220521$20240726$PER$$US-SA-2022SA183961$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
208580602$20858060$2$F$20220518$20240819$20220521$20240830$PER$$US-SA-2022SA183422$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240830$$CN$US$US
208580712$20858071$2$F$20220502$20240807$20220521$20240815$PER$$US-SA-2022SA180325$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240815$$MD$US$US
208581777$20858177$7$F$20211221$20240830$20220521$20240909$EXP$$CA-CELLTRION INC.-2021CA018667$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
208584313$20858431$3$F$20220510$20240806$20220521$20240812$EXP$$CA-TAKEDA-2022TUS033470$TAKEDA$$53$YR$$F$Y$$$20240812$$MD$CA$CA
208584329$20858432$9$F$$20240802$20220521$20240808$EXP$$CA-009507513-2205CAN005476$MERCK$$54$YR$$M$Y$$$20240808$$HP$CA$CA
208584999$20858499$9$F$20210412$20240902$20220521$20240904$EXP$$DE-ROCHE-2820552$ROCHE$$33$YR$A$F$Y$$$20240904$$CN$DE$DE
208588192$20858819$2$F$20220401$20240706$20220522$20240710$EXP$$US-AMGEN-USASP2022086908$AMGEN$$62$YR$A$F$Y$$$20240710$$HP$US$US
208592727$20859272$7$F$20210301$20240730$20220523$20240807$PER$$US-SA-2022SA082241$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240807$$HP$US$US
208593043$20859304$3$F$$20240706$20220523$20240715$PER$$US-SA-2022SA184339$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240715$$MD$US$US
208594387$20859438$7$F$20220514$20240711$20220523$20240716$EXP$$US-SA-2022SA181710$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240716$$MD$US$US
208596293$20859629$3$F$$20240819$20220523$20240828$PER$$US-SA-2022SA175796$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240828$$CN$US$US
208598356$20859835$6$F$20190806$20240708$20220523$20240726$EXP$$DE-ROCHE-2378872$ROCHE$$47$YR$A$F$Y$$$20240726$$CN$DE$DE
208599393$20859939$3$F$20220515$20220516$20220523$20240717$EXP$$AT-ASTELLAS-2022US017903$ASTELLAS$$75$YR$$M$Y$$$20240717$$CN$AT$AT
2086017010$20860170$10$F$$20240720$20220523$20240726$EXP$$CA-ASTELLAS-2022US017996$ASTELLAS$$43$YR$$F$Y$$$20240726$$CN$CA$CA
208606612$20860661$2$F$20210920$20240718$20220523$20240723$EXP$FR-AFSSAPS-BX20222449$FR-ROCHE-3095256$ROCHE$$36$YR$A$F$Y$54$KG$20240723$$MD$FR$FR
2086078419$20860784$19$F$20220501$20230920$20220523$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR080980$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240926$$CN$US$US
208610943$20861094$3$F$$20240708$20220523$20240716$EXP$$IT-CELLTRION INC.-2022IT006923$CELLTRION$Saffioti C, Mesini A, Caorsi R, Severino M, Gattorno M, Castagnola E.. Balamuthia mandrillaris infection: report of 1st autochthonous, fatal case in Italy.. European Journal of Clinical Microbiology + Infectious Diseases. 2022;41:685-7$$$$$Y$$$20240716$$HP$IT$IT
208616793$20861679$3$F$20190402$20240701$20220523$20240707$EXP$$CA-TAKEDA-2022TUS033095$TAKEDA$$66$YR$$M$Y$$$20240707$$CN$CA$CA
208616805$20861680$5$F$20210302$20240627$20220523$20240705$EXP$$DE-TAKEDA-2021TUS014762$TAKEDA$$29$YR$$F$Y$$$20240705$$CN$DE$DE
208620528$20862052$8$F$20220517$20240820$20220523$20240826$EXP$$US-OTSUKA-2022_028175$OTSUKA$$$$$M$Y$$$20240826$$CN$US$US
208625489$20862548$9$F$$20240805$20220523$20240813$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2022-13981$IPSEN$$53$YR$A$M$Y$$$20240813$$MD$US$US
208626446$20862644$6$F$20220422$20240613$20220523$20240702$PER$$CA-TOLMAR, INC.-22CA034221$TOLMAR$$76$YR$$M$Y$$$20240702$$CN$CA$CA
208629883$20862988$3$F$20210201$20220515$20220523$20240828$EXP$$NVSC2022AU115357$NOVARTIS$$55$YR$$F$Y$$$20240828$$MD$AU$AU
208632393$20863239$3$F$$20240903$20220523$20240905$PER$$US-PFIZER INC-202200308019$PFIZER$$91$YR$$M$Y$66.667$KG$20240905$$CN$US$US
2086326015$20863260$15$F$20180604$20240806$20220523$20240812$EXP$$DE-ROCHE-2252972$ROCHE$$56$YR$A$F$Y$50$KG$20240812$$CN$DE$DE
208636513$20863651$3$F$$20240730$20220523$20240808$PER$$US-SA-2022SA176828$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240808$$MD$US$US
208637642$20863764$2$F$20220501$20240731$20220523$20240809$PER$$US-SA-2022SA183105$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240809$$MD$US$US
208638277$20863827$7$F$20210422$20240826$20220523$20240828$EXP$$CA-TAKEDA-2021TUS026376$TAKEDA$$81$YR$$M$Y$$$20240828$$MD$CA$CA
208641223$20864122$3$F$20220301$20240726$20220523$20240806$EXP$$PT-ROCHE-3098005$ROCHE$$59$YR$A$F$Y$85$KG$20240806$$HP$PT$PT
208643182$20864318$2$F$$20240703$20220523$20240712$PER$$US-SA-2022SA185741$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240712$$MD$US$US
208645877$20864587$7$F$20200603$20240916$20220524$20240926$EXP$$DE-ROCHE-2704180$ROCHE$$57$YR$A$F$Y$$$20240926$$CN$DE$DE
2086460814$20864608$14$F$20220211$20240703$20220524$20240709$EXP$$IT-ROCHE-3101130$ROCHE$$51$YR$A$F$Y$48$KG$20240705$$MD$IT$IT
208646293$20864629$3$F$$20240724$20220524$20240801$PER$$US-ROCHE-3102033$ROCHE$$$$A$F$Y$$$20240801$$CN$US$US
208647594$20864759$4$F$20240603$20240828$20220524$20240903$EXP$$PK-AMGEN-PAKSP2022088522$AMGEN$$27$YR$A$F$Y$$$20240903$$CN$PK$PK
208655172$20865517$2$F$$20220523$20220524$20240711$EXP$$PH-ASTELLAS-2022US018560$ASTELLAS$$$$$M$Y$$$20240711$$CN$PH$PH
208656516$20865651$6$F$20191001$20240716$20220524$20240718$EXP$$CA-TAKEDA-2019TUS054574$TAKEDA$$79$YR$$F$Y$$$20240718$$CN$CA$CA
208656535$20865653$5$F$20240621$20240710$20220524$20240724$EXP$$NL-VER-202200051$VERITY PHARMACEUTICALS$$71$YR$E$M$Y$$$20240724$$CN$NL$NL
2086583119$20865831$19$F$20240401$20240912$20220524$20240916$EXP$$US-TAKEDA-2022TUS032250$TAKEDA$$44$YR$$F$Y$77$KG$20240916$$MD$US$US
2086596110$20865961$10$F$20220516$20240729$20220524$20240807$EXP$$US-JAZZ-2022-US-016646$JAZZ$$55$YR$$F$Y$38$KG$20240807$$CN$US$US
208661147$20866114$7$F$20020101$20240910$20220524$20240912$EXP$$US-PFIZER INC-202200739343$PFIZER$$47$YR$$F$Y$92.08$KG$20240912$$CN$US$US
2086632113$20866321$13$F$20220101$20240722$20220524$20240729$EXP$$JP-009507513-2205JPN001405J$MERCK$$72$YR$$M$Y$$$20240729$$MD$JP$JP
208665176$20866517$6$F$20150220$20240802$20220524$20240806$EXP$$US-TAKEDA-2022TUS033569$TAKEDA$$47$YR$$M$Y$133$KG$20240806$$HP$US$US
208667582$20866758$2$F$20220101$20240628$20220524$20240702$EXP$$US-PFIZER INC-202200744512$PFIZER$$56$YR$$F$Y$$$20240702$$HP$US$US
2086708224$20867082$24$F$20220501$20240923$20220524$20240925$PER$$US-DSJP-DSU-2022-110420$DAIICHI$$16$YR$$M$Y$$$20240925$$CN$US$US
208676304$20867630$4$F$20211202$20240730$20220524$20240803$EXP$$IT-TAKEDA-2021TUS077633$TAKEDA$$14$YR$$M$Y$$$20240803$$HP$IT$IT
208679215$20867921$5$F$$20240827$20220524$20240904$EXP$$NVSC2022AU113183$NOVARTIS$Gaekwad A, Thompson J. Sacubitiril/Valsartan Induced Symptomatic Myoclonus: A Case Report. BMJ-NEUROL-OPEN. 2024;4 (Suppl. 1):A62 abstr. 2440$75$YR$$M$Y$$$20240904$$HP$AU$AU
208685114$20868511$4$F$20160907$20240801$20220524$20240807$EXP$$JP-ABBVIE-22K-087-4407372-00$ABBVIE$$43$YR$$M$Y$$$20240807$$MD$JP$JP
208686076$20868607$6$F$$20240627$20220524$20240701$EXP$$US-PFIZER INC-202200334219$PFIZER$$81$YR$$M$Y$$$20240701$$CN$US$US
208686283$20868628$3$F$$20240805$20220524$20240807$EXP$$US-PFIZER INC-202200342740$PFIZER$$80$YR$$M$Y$78$KG$20240807$$CN$US$US
208696652$20869665$2$F$$20220520$20220525$20240711$EXP$$DE-ASTELLAS-2022US018804$ASTELLAS$$$$$M$Y$$$20240711$$CN$DE$DE
208697618$20869761$8$F$20211218$20240830$20220525$20240904$EXP$$US-ROCHE-3098672$ROCHE$$56$YR$A$F$Y$95.25$KG$20240904$$CN$US$US
208698126$20869812$6$F$$20240705$20220525$20240725$PER$$CA-TOLMAR, INC.-22CA034340$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
208698258$20869825$8$F$20210725$20240924$20220525$20240930$EXP$$US-TAKEDA-2021TUS048519$TAKEDA$$37$YR$$F$Y$87.982$KG$20240930$$CN$US$US
208698353$20869835$3$F$$20240826$20220525$20240919$PER$$AU-TOLMAR, INC.-22AU034409$TOLMAR$$$$$M$Y$$$20240919$$CN$AU$AU
208698385$20869838$5$F$20230330$20240815$20220525$20240906$PER$$CA-TOLMAR, INC.-22CA034381$TOLMAR$$68$YR$$M$Y$$$20240906$$CN$CA$CA
2087001610$20870016$10$F$20210623$20240920$20220525$20240926$EXP$$DE-ROCHE-2887751$ROCHE$$54$YR$A$F$Y$$$20240926$$CN$DE$DE
2087025411$20870254$11$F$20230430$20240717$20220525$20240718$PER$$NVSC2022US119789$NOVARTIS$$77$YR$$F$Y$$$20240718$$CN$US$US
2087037018$20870370$18$F$20190702$20240704$20220525$20240711$EXP$$CA-CELLTRION INC.-2021CA016010$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
2087069217$20870692$17$F$20180701$20240809$20220525$20240814$EXP$$CA-ROCHE-2147997$ROCHE$$38$YR$A$F$Y$$$20240814$$CN$CA$CA
208717602$20871760$2$F$20220518$20240807$20220525$20240814$EXP$$CN-TAKEDA-2022TUS034642$TAKEDA$$23$YR$$M$Y$$$20240814$$CN$CN$CN
208717884$20871788$4$F$$20240903$20220525$20240913$EXP$$CA-ASTELLAS-2022US018828$ASTELLAS$$$$N$$Y$$$20240913$$HP$CA$CA
2087215216$20872152$16$F$$20240924$20220525$20240927$EXP$$IN-ROCHE-3099231$ROCHE$$70$YR$E$F$Y$68$KG$20240927$$MD$IN$IN
208724077$20872407$7$F$20220522$20240702$20220525$20240715$EXP$$CA-ROCHE-3103852$ROCHE$$49$YR$A$F$Y$$$20240715$$CN$CA$CA
208729563$20872956$3$F$$20240919$20220525$20240920$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000179$PAREXEL$$$$$$Y$$$20240920$$CN$US$US
208731637$20873163$7$F$$20240819$20220525$20240822$EXP$$US-TAKEDA-2022TUS034757$TAKEDA$$$$$M$Y$$$20240822$$HP$US$US
208735478$20873547$8$F$20220101$20240904$20220525$20240913$EXP$$JP-009507513-2202JPN003001J$MERCK$Naito M, Mimatsu F, Yamauchi M, Sanemitsu Y, Muraoka J. p-1-100 A Case in which Lenvatinib Dose Reductions were required Multiple Times in a Short Time at Introduction of Pembrolizumab + Lenvatinib Therapy for Corpus Uteri Carcinoma. The Joint Meeting of the Kinki Pharmacist in 2023, the 25th Meeting of the Kinki. 227$71$YR$$F$Y$57$KG$20240913$$MD$JP$JP
208738002$20873800$2$F$20140101$20240709$20220525$20240716$PER$$US-BIOGEN-2020BI00901989$BIOGEN$$$$$F$Y$$$20240716$$CN$US$US
208740209$20874020$9$F$20220104$20240921$20220525$20240925$EXP$$CA-TAKEDA-2022TUS034906$TAKEDA$$79$YR$$F$Y$$$20240925$$CN$CA$CA
208741825$20874182$5$F$20221001$20240822$20220525$20240828$EXP$$IN-PFIZER INC-202200626238$PFIZER$$28$YR$$M$Y$$$20240828$$CN$IN$IN
208745579$20874557$9$F$$20240703$20220525$20240710$EXP$$US-JAZZ-2022-US-017262$JAZZ$$$$$F$Y$$$20240710$$CN$US$US
208748265$20874826$5$F$20230726$20240625$20220526$20240715$PER$$CA-TOLMAR, INC.-22CA034394$TOLMAR$$89$YR$$M$Y$$$20240715$$CN$CA$CA
208748489$20874848$9$F$20230828$20240729$20220526$20240821$PER$$CA-TOLMAR, INC.-22CA032564$TOLMAR$$85$YR$$M$Y$$$20240821$$CN$CA$CA
208752026$20875202$6$F$$20240701$20220526$20240710$EXP$$US-ROCHE-2021725$ROCHE$$$$E$M$Y$$$20240711$$MD$US$US
208753783$20875378$3$F$20220422$20240909$20220526$20240924$EXP$$CA-CELLTRION INC.-2022CA006314$CELLTRION$$$$$$Y$$$20240924$$CN$CA$CA
208754014$20875401$4$F$20220225$20240811$20220526$20240819$EXP$$CA-CELLTRION INC.-2022CA006852$CELLTRION$$$$$$Y$$$20240819$$MD$CA$CA
2087540324$20875403$24$F$20220101$20240724$20220526$20240801$EXP$$CA-CELLTRION INC.-2022CA005809$CELLTRION$$$$$$Y$$$20240801$$MD$CA$CA
208757422$20875742$2$F$20220501$20240917$20220526$20240918$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000135$PAREXEL$$$$$$Y$$$20240918$$CN$US$US
2087588116$20875881$16$F$20220101$20240909$20220526$20240917$EXP$$CA-CELLTRION INC.-2021CA019287$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
208761833$20876183$3$F$20211202$20240904$20220526$20240906$EXP$$CA-TAKEDA-2022TUS033816$TAKEDA$$68$YR$$M$Y$$$20240906$$MD$CA$CA
2087653011$20876530$11$F$20240401$20240722$20220526$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-034252$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$60.78$KG$20240723$$CN$US$US
2087674611$20876746$11$F$20220128$20240807$20220526$20240904$PER$$CA-TOLMAR, INC.-22CA032708$TOLMAR$$73$YR$$M$Y$$$20240904$$CN$CA$CA
208769142$20876914$2$F$$20220523$20220526$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR083232$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
208776143$20877614$3$F$$20240723$20220526$20240725$PER$$US-PFIZER INC-202200214805$PFIZER$$68$YR$$F$Y$90.703$KG$20240725$$CN$US$US
208776505$20877650$5$F$$20240910$20220526$20240924$EXP$$CA-APOTEX-2022AP008239$APOTEX$$54$YR$$M$Y$$$20240924$$HP$CA$CA
208780775$20878077$5$F$$20240919$20220526$20240923$PER$$US-BIOGEN-2022BI01126518$BIOGEN$$$$$F$Y$55.388$KG$20240923$$CN$US$US
208782475$20878247$5$F$20220101$20240911$20220526$20240912$PER$$US-DSJP-DSU-2022-117828$DAIICHI$$$$$M$Y$$$20240912$$CN$US$US
208783062$20878306$2$F$$20240625$20220526$20240705$EXP$$US-EMD Serono-9323629$EMD SERONO INC$AI-Moussally F, Tien J, Botero-Suraez C, Rajagopalan K. Euglycemic Ketoacidosis and Lactic Acidosis Associated With Metformin Toxicity. Cureus. 2024 May 01;doi:DOI 10.7759/cureus.60661.$67$YR$E$F$Y$$$20240705$$MD$US$US
2087954113$20879541$13$F$20220214$20240717$20220526$20240722$EXP$$CA-PFIZER INC-2021605880$PFIZER$$44$YR$$F$Y$115$KG$20240722$$MD$CA$CA
208797893$20879789$3$F$20220401$20240724$20220526$20240813$PER$$CA-TOLMAR, INC.-22CA034271$TOLMAR$$66$YR$$M$Y$$$20240813$$CN$CA$CA
208799692$20879969$2$F$$20240830$20220526$20240903$EXP$$US-TAKEDA-US202033651$TAKEDA$$$$$M$Y$$$20240903$$HP$US$US
208800384$20880038$4$F$$20240516$20220526$20240911$PER$$NVSC2022US009207$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
208817847$20881784$7$F$20220301$20240828$20220527$20240919$PER$$CA-TOLMAR, INC.-22CA033944$TOLMAR$$87$YR$$M$Y$$$20240919$$CN$CA$CA
208818757$20881875$7$F$20220501$20221007$20220527$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR084042$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240925$$CN$US$US
208820567$20882056$7$F$20220501$20220830$20220527$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR083816$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
208825413$20882541$3$F$20220101$20240823$20220527$20240923$PER$$CA-TOLMAR, INC.-22CA033692$TOLMAR$$69$YR$$M$Y$$$20240921$$CN$CA$CA
208826932$20882693$2$F$$20240918$20220527$20240930$EXP$$CA-APOTEX-2022AP008209$APOTEX$$75$YR$$F$Y$$$20240930$$HP$CA$CA
208827472$20882747$2$F$$20240820$20220527$20240823$EXP$$US-ABBVIE-22K-163-4411256-00$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
208828705$20882870$5$F$20220321$20240726$20220527$20240731$EXP$$CA-TAKEDA-2022TUS019198$TAKEDA$$71$YR$$F$Y$$$20240731$$HP$CA$CA
2088291711$20882917$11$F$20220522$20240724$20220527$20240730$EXP$$CA-UCBSA-2022029625$UCB$$37$YR$$F$Y$$$20240730$$HP$CA$CA
208832318$20883231$8$F$20220512$20240906$20220527$20240916$EXP$$CA-MYLANLABS-2022M1035080$BIOCON$$$$$$Y$$$20240916$$HP$CA$CA
208834114$20883411$4$F$$20240625$20220527$20240706$EXP$$CA-ROCHE-3104672$ROCHE$$$$A$M$Y$$$20240706$$CN$CA$CA
208835218$20883521$8$F$$20240805$20220527$20240806$EXP$$US-SHIRE-US201919457$TAKEDA$$$$$M$Y$78$KG$20240806$$HP$US$US
208836522$20883652$2$F$20240626$20240626$20220527$20240703$EXP$$CA-GLAXOSMITHKLINE-CA2022083251$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$HP$CA$CA
208839723$20883972$3$F$20240802$20240906$20220527$20240909$EXP$$US-PFIZER INC-202200760740$PFIZER$$67$YR$$F$Y$131.09$KG$20240909$$CN$US$US
208839997$20883999$7$F$20200529$20240628$20220527$20240705$EXP$$CO-TAKEDA-CO202017932$TAKEDA$$33$YR$$M$Y$79$KG$20240705$$HP$CO$CO
208840322$20884032$2$F$$20240703$20220527$20240708$PER$$US-PFIZER INC-202200766175$PFIZER$$56$YR$$F$Y$$$20240708$$HP$US$US
208840382$20884038$2$F$$20240828$20220527$20240904$PER$$US-PFIZER INC-202200761976$PFIZER$$73$YR$$F$Y$$$20240904$$CN$US$US
208840914$20884091$4$F$20220411$20240828$20220527$20240828$EXP$$US-PFIZER INC-202200762693$PFIZER$$41$YR$$M$Y$$$20240828$$CN$US$US
208842995$20884299$5$F$$20240626$20220527$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-07480$LUPIN$$$$$$Y$$$20240710$$CN$US$US
208844576$20884457$6$F$$20240910$20220527$20240920$EXP$$CA-OTSUKA-2022_028837$OTSUKA$$41$YR$$F$Y$$$20240920$$HP$CA$CA
208844997$20884499$7$F$20220101$20240721$20220527$20240726$EXP$$CA-TAKEDA-2022TUS034424$TAKEDA$$$$$M$Y$$$20240726$$CN$CA$CA
208846603$20884660$3$F$$20240925$20220527$20240926$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000178$PAREXEL$$$$$$Y$$$20240926$$MD$US$US
208847025$20884702$5$F$20220101$20240704$20220527$20240708$EXP$$US-PFIZER INC-202200761223$PFIZER$$60$YR$$F$Y$$$20240708$$HP$US$US
208853048$20885304$8$F$20220606$20240716$20220527$20240719$EXP$$CA-TAKEDA-2021TUS037735$TAKEDA$$73$YR$$M$Y$$$20240719$$CN$CA$CA
208863624$20886362$4$F$20220102$20220524$20220527$20240805$EXP$CH-SM-2022-10745$CH-009507513-2205CHE006735$MERCK$$$$$F$Y$$$20240805$$MD$CH$CH
208863887$20886388$7$F$20200101$20240730$20220527$20240802$EXP$$CA-BAUSCH-BL-2020-017421$BAUSCH AND LOMB$$66$YR$$M$Y$113.5$KG$20240802$$CN$CA$CA
208873752$20887375$2$F$$20240727$20220528$20240808$EXP$CA-MHPD-E2B_04006226$CA-Accord-264557$ACCORD$$10$YR$$M$Y$$$20240808$$HP$CA$CA
208884123$20888412$3$F$20240101$20240730$20220529$20240806$EXP$$US-SA-2022SA194413$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240806$$CN$US$US
208884564$20888456$4$F$20211028$20240801$20220529$20240807$EXP$$DE-ROCHE-3104113$ROCHE$$53$YR$A$F$Y$135$KG$20240807$$MD$DE$DE
208884719$20888471$9$F$20220201$20240815$20220529$20240906$PER$$CA-TOLMAR, INC.-22CA034328$TOLMAR$$62$YR$$M$Y$$$20240906$$CN$CA$CA
208884763$20888476$3$F$20220428$20240620$20220529$20240710$PER$$CA-TOLMAR, INC.-22CA034339$TOLMAR$$73$YR$$M$Y$$$20240710$$CN$CA$CA
208885399$20888539$9$F$$20240709$20220529$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-044526$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240716$$CN$US$US
2088854611$20888546$11$F$20170101$20240912$20220529$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-045581$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240919$$HP$US$US
2088890213$20888902$13$F$20220518$20240830$20220529$20240909$EXP$$CA-CELLTRION INC.-2022CA008092$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
208890025$20889002$5$F$20220310$20240913$20220530$20240917$EXP$$NVSC2021MX205617$NOVARTIS$$46$YR$$F$Y$58$KG$20240918$$CN$MX$MX
208891376$20889137$6$F$$20240626$20220530$20240705$EXP$$CA-JNJFOC-20220554044$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240705$$CN$CA$CA
208895332$20889533$2$F$$20240917$20220530$20240920$EXP$$JP-009507513-2205JPN002435J$MERCK$$7$DEC$$$Y$$$20240920$$MD$JP$JP
208896907$20889690$7$F$20201207$20240918$20220530$20240926$EXP$$DE-ROCHE-2735419$ROCHE$$26$YR$A$F$Y$$$20240926$$CN$DE$DE
2088987222$20889872$22$F$20220101$20240906$20220530$20240911$EXP$$US-PFIZER INC-202101506588$PFIZER$$75$YR$$F$Y$$$20240911$$MD$US$US
208902329$20890232$9$F$20210401$20240722$20220530$20240731$EXP$$DE-ROCHE-2880972$ROCHE$$38$YR$A$F$Y$$$20240731$$CN$DE$DE
208903485$20890348$5$F$$20240829$20220530$20240903$EXP$$CA-TAKEDA-2022TUS035787$TAKEDA$$$$$F$Y$$$20240903$$MD$CA$CA
2089092416$20890924$16$F$20220101$20240904$20220530$20240905$EXP$$CA-ROCHE-3107524$ROCHE$$52$YR$A$M$Y$$$20240905$$CN$CA$CA
208912555$20891255$5$F$20220101$20240924$20220530$20240926$EXP$$CA-JNJFOC-20220556739$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240926$$CN$CA$CA
208914442$20891444$2$F$$20240701$20220530$20240711$30DAY$$US-GLAXOSMITHKLINE-US2022084354$GLAXOSMITHKLINE$$$$$M$Y$$$20240711$$HP$US$US
208916304$20891630$4$F$$20240916$20220530$20240918$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000185$PAREXEL$$$$$$Y$$$20240918$$HP$US$US
2089172110$20891721$10$F$20210131$20240725$20220530$20240729$EXP$$US-TAKEDA-2021TUS007961$TAKEDA$$47$YR$$F$Y$$$20240729$$MD$US$US
208918145$20891814$5$F$20210614$20240725$20220530$20240730$EXP$$CA-PFIZER INC-202200742952$PFIZER$$45$YR$$F$Y$60$KG$20240730$$MD$CA$CA
208918353$20891835$3$F$20220301$20240705$20220530$20240710$EXP$IT-MINISAL02-869207$IT-PFIZER INC-202200757936$PFIZER$$32$YR$$M$Y$82$KG$20240710$$HP$IT$IT
208918982$20891898$2$F$$20240917$20220530$20240920$EXP$$JP-009507513-2205JPN002408J$MERCK$$7$DEC$$$Y$$$20240920$$MD$JP$JP
208919124$20891912$4$F$20210101$20240430$20220530$20240808$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-084590$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$58$KG$20240808$$CN$ES$ES
208919915$20891991$5$F$20240903$20240903$20220530$20240906$EXP$$CA-TAKEDA-2022TUS035272$TAKEDA$$43$YR$$M$Y$$$20240906$$CN$CA$CA
208924545$20892454$5$F$$20240813$20220531$20240906$PER$$CA-TOLMAR, INC.-22CA034196$TOLMAR$$$$$M$Y$$$20240906$$CN$CA$CA
208924817$20892481$7$F$20230627$20240815$20220531$20240906$PER$$CA-TOLMAR, INC.-22CA034501$TOLMAR$$83$YR$$M$Y$$$20240906$$CN$CA$CA
208924827$20892482$7$F$20230407$20240624$20220531$20240717$PER$$CA-TOLMAR, INC.-22CA034505$TOLMAR$$67$YR$$M$Y$$$20240717$$CN$CA$CA
208926445$20892644$5$F$20220511$20221122$20220531$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR083872$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240926$$MD$US$US
208926659$20892665$9$F$$20240923$20220531$20240927$EXP$$CA-ABBVIE-22K-028-4414704-00$ABBVIE$$54$YR$$M$Y$$$20240927$$HP$CA$CA
208928053$20892805$3$F$20220311$20240809$20220531$20240815$EXP$$FR-ABBVIE-22K-056-4414692-00$ABBVIE$$64$YR$$F$Y$75$KG$20240815$$MD$FR$FR
2089285614$20892856$14$F$20220101$20240907$20220531$20240916$EXP$$CA-CELLTRION INC.-2022CA006072$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
208929965$20892996$5$F$20220501$20230127$20220531$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR084492$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
208932087$20893208$7$F$$20240911$20220531$20240926$PER$$AU-TOLMAR, INC.-21AU032175$TOLMAR$$$$$M$Y$$$20240926$$HP$AU$AU
208932362$20893236$2$F$$20220526$20220531$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR085072$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2089342920$20893429$20$F$20220101$20240909$20220531$20240917$EXP$$CA-CELLTRION INC.-2021CA015879$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
208934756$20893475$6$F$20150317$20221024$20220531$20240807$EXP$$CA-ROCHE-1618053$ROCHE$$40$YR$A$F$Y$$$20240807$$MD$CA$CA
208936287$20893628$7$F$20220526$20240916$20220531$20240923$EXP$$CA-TAKEDA-2022TUS014272$TAKEDA$$45$YR$$F$Y$$$20240923$$CN$CA$CA
208937333$20893733$3$F$$20240813$20220531$20240826$EXP$$CA-AUROBINDO-AUR-APL-2022-018957$AUROBINDO$$37$YR$$F$Y$90$KG$20240826$$HP$CA$CA
2089393213$20893932$13$F$20240603$20240920$20220531$20240927$EXP$$US-TAKEDA-2022TUS035671$TAKEDA$$69$YR$$F$Y$$$20240927$$HP$US$US
2089442012$20894420$12$F$20211011$20240820$20220531$20240827$EXP$$US-TAKEDA-2021TUS067160$TAKEDA$$18$YR$$F$Y$43$KG$20240827$$CN$US$US
208948435$20894843$5$F$$20240808$20220531$20240930$PER$$US-PFIZER INC-202200576120$PFIZER$$65$YR$$M$Y$$$20240930$$CN$US$US
208948476$20894847$6$F$20190101$20240820$20220531$20240828$EXP$$JP-ORPHANEU-2022002245$RECORDATI$Youhei Tanaka. A case of Cushing^s disease caused by pituitary cancer that showed a favorable response to administration of temozolomide$$$$$Y$$$20240828$$MD$JP$JP
208949275$20894927$5$F$20220101$20240626$20220531$20240711$EXP$$AU-ROCHE-3105265$ROCHE$$36$YR$A$F$Y$$$20240711$$HP$AU$AU
208950862$20895086$2$F$20190911$20240918$20220531$20240926$EXP$$CA-TAKEDA-2022TUS020564$TAKEDA$$76$YR$$F$Y$$$20240926$$CN$CA$CA
208950956$20895095$6$F$20220112$20240716$20220531$20240720$EXP$$CN-TAKEDA-2022TUS036049$TAKEDA$$24$YR$$M$Y$50$KG$20240720$$MD$CN$CN
2089559514$20895595$14$F$20220101$20240816$20220531$20240820$EXP$$US-PFIZER INC-202200773813$PFIZER$$62$YR$$F$Y$$$20240820$$HP$US$US
2089584713$20895847$13$F$20210906$20240415$20220531$20240808$EXP$$NVSC2021PE210142$NOVARTIS$$57$YR$$F$Y$60$KG$20240808$$CN$PE$PE
208958946$20895894$6$F$20201230$20240724$20220531$20240730$EXP$$KR-OTSUKA-2021_010841$OTSUKA$$42$YR$$F$Y$$$20240730$$MD$KR$KR
208962912$20896291$2$F$$20240918$20220531$20240920$EXP$$CA-PFIZER INC-202200770960$PFIZER$$76$YR$$M$Y$$$20240920$$HP$CA$CA
2089652721$20896527$21$F$20220810$20240820$20220531$20240829$EXP$$CA-ROCHE-3024357$ROCHE$$77$YR$E$F$Y$55$KG$20240829$$HP$CA$CA
208968866$20896886$6$F$20210101$20230127$20220531$20240808$EXP$$US-OTSUKA-2022_029689$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
208970983$20897098$3$F$20220622$20240627$20220531$20240702$EXP$$CA-TAKEDA-2016TUS012844$TAKEDA$$67$YR$$M$Y$$$20240702$$HP$CA$CA
208979714$20897971$4$F$$20240711$20220531$20240718$EXP$$JP-009507513-2205JPN003212J$MERCK$$59$YR$$F$Y$$$20240718$$MD$JP$JP
208980025$20898002$5$F$20220516$20240726$20220531$20240731$EXP$$CA-JNJFOC-20220535450$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240731$$CN$CA$CA
208982002$20898200$2$F$20220101$20240916$20220531$20240919$EXP$$DE-ABBVIE-22K-062-4415079-00$ABBVIE$$$$$M$Y$$$20240919$$CN$DE$DE
208983967$20898396$7$F$20181026$20240729$20220601$20240803$EXP$$JP-ABBVIE-19P-087-2826177-00$ABBVIE$$71$YR$$M$Y$$$20240803$$MD$JP$JP
208984419$20898441$9$F$$20240801$20220601$20240815$EXP$$CA-AUROBINDO-AUR-APL-2022-018761$AUROBINDO$$54$YR$$M$Y$$$20240815$$HP$CA$CA
2089905415$20899054$15$F$20220801$20240718$20220601$20240801$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2022US000433$DECIPHERA PHARMACEUTICALS$$64$YR$A$M$Y$$$20240801$$HP$US$US
208990918$20899091$8$F$20160802$20240826$20220601$20240829$EXP$$CA-CHEPLA-2022004371$CHEPLAPHARM$$53$YR$$F$Y$53$KG$20240829$$CN$COUNTRY NOT SPECIFIED$CA
2089912515$20899125$15$F$20200101$20240830$20220601$20240909$EXP$$CA-CELLTRION INC.-2020CA027389$CELLTRION$$$$$$Y$$$20240909$$MD$CA$CA
208991952$20899195$2$F$$20240828$20220601$20240906$EXP$$CA-AUROBINDO-AUR-APL-2022-019154$AUROBINDO$$77$YR$$M$Y$83$KG$20240906$$HP$CA$CA
2089923423$20899234$23$F$20220101$20240725$20220601$20240802$EXP$$CA-CELLTRION INC.-2022CA001496$CELLTRION$$$$$$Y$$$20240802$$CN$CA$CA
208994672$20899467$2$F$$20240806$20220601$20240811$EXP$$GB-TAKEDA-2022TUS036236$TAKEDA$$$$$F$Y$$$20240811$$CN$GB$GB
208996052$20899605$2$F$$20240918$20220601$20240924$EXP$$CA-Orion Corporation ORION PHARMA-22_00019020$ORION$$76$YR$E$M$Y$$$20240924$$HP$CA$
208998492$20899849$2$F$$20220531$20220601$20240827$PER$$NVSC2022US125430$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
208999036$20899903$6$F$20220521$20240829$20220601$20240904$EXP$$NVSC2022US121777$NOVARTIS$$77$YR$$M$Y$$$20240904$$CN$US$US
209001164$20900116$4$F$20220814$20240730$20220601$20240801$PER$$US-PFIZER INC-202200776972$PFIZER$$51$YR$$F$Y$$$20240801$$CN$US$US
209004776$20900477$6$F$20210101$20230127$20220601$20240808$EXP$$US-OTSUKA-2022_029548$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
209017194$20901719$4$F$20231101$20240723$20220601$20240730$EXP$$NVSC2022CO125671$NOVARTIS$$57$YR$$F$Y$58$KG$20240730$$CN$CO$CO
209017472$20901747$2$F$$20240917$20220601$20240923$EXP$$JP-009507513-2205JPN002453J$MERCK$$$$E$$Y$$$20240923$$MD$JP$JP
209019926$20901992$6$F$20180128$20240717$20220601$20240718$EXP$$FR-TAKEDA-2022TUS035154$TAKEDA$$46$YR$$M$Y$$$20240718$$HP$FR$FR
209021224$20902122$4$F$$20240923$20220601$20240930$EXP$$US-SA-2022SA201196$SANOFI AVENTIS$$$$A$F$Y$81.6$KG$20240930$$MD$US$US
2090213119$20902131$19$F$20220622$20240903$20220601$20240906$EXP$$CA-TAKEDA-2022TUS033983$TAKEDA$$72$YR$$M$Y$$$20240906$$HP$CA$CA
209022214$20902221$4$F$20210901$20220610$20220601$20240802$EXP$$US-AstraZeneca-2022A172087$ASTRAZENECA$$808$MON$$M$Y$$$20240802$$CN$US$
209025092$20902509$2$F$$20240819$20220601$20240822$PER$$US-PFIZER INC-202200785295$PFIZER$$60$YR$$F$Y$$$20240822$$HP$US$US
2090252413$20902524$13$F$$20240705$20220601$20240708$EXP$$US-TAKEDA-2022TUS035024$TAKEDA$$$$$F$Y$$$20240708$$HP$US$US
2090264114$20902641$14$F$$20240916$20220601$20240919$EXP$$US-TAKEDA-2022TUS034920$TAKEDA$$$$$F$Y$79$KG$20240919$$HP$US$US
209027592$20902759$2$F$$20240826$20220601$20240904$EXP$$CA-ANIPHARMA-2022-CA-001068$ANI$$62$YR$$M$Y$$$20240904$$HP$CA$CA
209030425$20903042$5$F$$20240625$20220601$20240701$EXP$$CA-PFIZER INC-202200778490$PFIZER$Senderovich, H.. A case report on cannabinoid hyperemesis syndrome in palliative care: how good intentions can go wrong. Oncology research and treatment. 2022;45 (7-8):438-443$70$YR$$F$Y$$$20240701$$MD$CA$CA
209033805$20903380$5$F$$20240827$20220601$20240909$EXP$$CA-AUROBINDO-AUR-APL-2022-019078$AUROBINDO$$40$YR$$F$Y$96$KG$20240909$$HP$CA$CA
209035418$20903541$8$F$20220215$20240911$20220602$20240921$EXP$$DE-ROCHE-3105821$ROCHE$$27$YR$A$F$Y$$$20240921$$MD$DE$DE
209035693$20903569$3$F$20220101$20240917$20220602$20240924$EXP$$DE-BIOGEN-2022BI01127783$BIOGEN$$$$$F$Y$$$20240924$$MD$DE$DE
209036552$20903655$2$F$$20240812$20220602$20240814$PER$$NVSC2022US126338$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
209043279$20904327$9$F$20190517$20240823$20220602$20240902$EXP$$CA-ROCHE-2327396$ROCHE$$37$YR$A$F$Y$$$20240902$$CN$CA$CA
2090433410$20904334$10$F$20210101$20240907$20220602$20240913$EXP$$CA-BAUSCH-BL-2021-034883$BAUSCH AND LOMB$$25$YR$$F$Y$73.094$KG$20240913$$CN$CA$CA
209043365$20904336$5$F$20160604$20240822$20220602$20240829$EXP$$CA-CHEPLA-2021000874$CHEPLAPHARM$$65$YR$$F$Y$$$20240829$$HP$COUNTRY NOT SPECIFIED$CA
2090438212$20904382$12$F$20240501$20240714$20220602$20240715$EXP$$US-PFIZER INC-202200785443$PFIZER$$13$YR$$M$Y$$$20240715$$MD$US$US
209045752$20904575$2$F$$20220529$20220602$20240710$EXP$$BG-ASTELLAS-2022US019733$ASTELLAS$$60$YR$$F$Y$$$20240710$$MD$BG$BG
209045847$20904584$7$F$20210526$20240730$20220602$20240803$EXP$$DE-ROCHE-2839327$ROCHE$$42$YR$A$F$Y$$$20240803$$CN$DE$DE
209045892$20904589$2$F$$20240625$20220602$20240706$EXP$US-MACLEODS PHARMACEUTICALS US LTD-MAC2022035819$US-MACLEODS PHARMACEUTICALS US LTD-MAC2022035819$MACLEODS$$$$$$Y$$$20240706$$MD$US$US
209046102$20904610$2$F$$20220528$20220602$20240709$EXP$$BR-ASTELLAS-2022US019734$ASTELLAS$$$$$M$Y$$$20240709$$CN$BR$BR
209049392$20904939$2$F$$20240916$20220602$20240920$EXP$$CA-ORGANON-O2205CAN002541$ORGANON$$49$YR$$M$Y$$$20240920$$CN$CA$CA
209049872$20904987$2$F$20220101$20220518$20220602$20240723$EXP$$US-RECORDATI-2022000544$RECORDATI$$$$$$Y$$$20240723$$CN$US$US
209050239$20905023$9$F$20211126$20240819$20220602$20240826$EXP$$CA-TAKEDA-2021TUS083382$TAKEDA$$64$YR$$M$Y$$$20240826$$PH$CA$CA
2090628210$20906282$10$F$20220825$20240917$20220602$20240926$EXP$$CA-TAKEDA-2022TUS036298$TAKEDA$$30$YR$$M$Y$$$20240926$$HP$CA$CA
209063257$20906325$7$F$20210317$20240704$20220602$20240709$EXP$$CA-PFIZER INC-2021213919$PFIZER$$71$YR$$F$Y$72$KG$20240709$$HP$CA$CA
2090633016$20906330$16$F$20210511$20240912$20220602$20240912$EXP$$CA-PFIZER INC-2021111765$PFIZER$$73$YR$$F$Y$52$KG$20240912$$MD$CA$CA
209063472$20906347$2$F$$20240829$20220602$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202205010440$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240910$$CN$US$US
2090723812$20907238$12$F$20220101$20240807$20220602$20240813$EXP$$CA-TAKEDA-2022TUS025709$TAKEDA$$$$$F$Y$$$20240813$$CN$CA$CA
209072619$20907261$9$F$20220303$20240723$20220602$20240725$EXP$$US-TAKEDA-2022TUS015444$TAKEDA$$58$YR$$M$Y$$$20240725$$PH$US$US
209076733$20907673$3$F$20240823$20240902$20220602$20240905$EXP$$NVSC2022CO126650$NOVARTIS$$58$YR$$F$Y$$$20240905$$CN$CO$CO
2090798113$20907981$13$F$20220606$20240913$20220602$20240923$EXP$$CA-TAKEDA-2022TUS004040$TAKEDA$$67$YR$$F$Y$$$20240923$$HP$CA$CA
209080223$20908022$3$F$$20240910$20220602$20240913$EXP$$CA-ROCHE-3109890$ROCHE$$$$A$M$Y$$$20240913$$CN$CA$CA
2090807415$20908074$15$F$20220209$20240618$20220602$20240706$EXP$$DE-ROCHE-3026601$ROCHE$$49$YR$A$F$Y$$$20240706$$CN$DE$DE
209081284$20908128$4$F$$20240909$20220602$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001645$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
209081583$20908158$3$F$$20240624$20220602$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001682$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
209086243$20908624$3$F$20220401$20240807$20220603$20240810$PER$$US-AMGEN-USASP2022090123$AMGEN$$84$YR$E$F$Y$$$20240810$$CN$US$US
209090973$20909097$3$F$$20240911$20220603$20240919$EXP$$CA-JNJFOC-20210305287$JOHNSON AND JOHNSON$$10$YR$C$F$Y$44.946$KG$20240919$$HP$CA$CA
2090916719$20909167$19$F$20220501$20240827$20220603$20240904$EXP$$CA-CELLTRION INC.-2022CA008354$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
209099912$20909991$2$F$20220526$20220527$20220603$20240710$EXP$$BR-ASTELLAS-2022US019732$ASTELLAS$$95$YR$$M$Y$$$20240710$$CN$BR$BR
209101536$20910153$6$F$20220518$20240710$20220603$20240712$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000187$PAREXEL$$$$$$Y$$$20240712$$MD$US$US
209101883$20910188$3$F$20220512$20240816$20220603$20240823$EXP$$FR-JNJFOC-20220601940$JOHNSON AND JOHNSON$$29$YR$A$F$Y$62$KG$20240823$$MD$FR$FR
209102154$20910215$4$F$20220101$20240702$20220603$20240705$EXP$$CA-TAKEDA-2022TUS012287$TAKEDA$$$$$F$Y$$$20240705$$CN$CA$CA
209102424$20910242$4$F$$20220924$20220603$20240710$PER$$NVSC2022US127649$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
2091112312$20911123$12$F$20220401$20240903$20220603$20240905$EXP$$CA-ROCHE-2569834$ROCHE$$47$YR$A$F$Y$55$KG$20240905$$CN$CA$CA
2091132914$20911329$14$F$20200917$20240820$20220603$20240824$EXP$$US-PAREXEL-2021-KAM-US003337$TAKEDA$$67$YR$$F$Y$72$KG$20240824$$HP$US$US
209113303$20911330$3$F$20210520$20240621$20220603$20240709$EXP$$CA-ROCHE-3110535$ROCHE$$26$YR$A$F$Y$$$20240705$$HP$CA$CA
209114806$20911480$6$F$$20240827$20220603$20240829$PER$$US-PFIZER INC-2021064084$PFIZER$$74$YR$$F$Y$$$20240829$$CN$US$US
209115782$20911578$2$F$20220101$20220526$20220603$20240725$EXP$$US-RECORDATI-2022001675$RECORDATI$$$$$$Y$$$20240725$$CN$US$US
2091172714$20911727$14$F$20201102$20240801$20220603$20240803$EXP$$JP-ABBVIE-22K-087-4420717-00$ABBVIE$$70$YR$$F$Y$37$KG$20240803$$MD$JP$JP
209118553$20911855$3$F$20120718$20220809$20220603$20240909$EXP$$US-009507513-2206USA000773$MERCK$$$$$M$Y$$$20240909$$HP$US$US
209119598$20911959$8$F$20231211$20240810$20220603$20240813$EXP$$US-TAKEDA-2022TUS037028$TAKEDA$$81$YR$$F$Y$69$KG$20240813$$CN$US$US
2091214310$20912143$10$F$20170125$20240322$20220603$20240919$EXP$$PHHY2018IN073298$NOVARTIS$$62$YR$$M$Y$68$KG$20240919$$CN$IN$IN
209121457$20912145$7$F$20220531$20240703$20220603$20240705$EXP$$CA-TAKEDA-2022TUS013743$TAKEDA$$32$YR$$M$Y$$$20240705$$CN$CA$CA
209125524$20912552$4$F$20220309$20240724$20220603$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-050813$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$96.4$KG$20240730$$HP$US$US
2091264510$20912645$10$F$20230911$20240625$20220603$20240701$EXP$$CA-TAKEDA-2022TUS036910$TAKEDA$$69$YR$$F$Y$$$20240701$$HP$CA$CA
209126712$20912671$2$F$20220512$20240819$20220603$20240822$EXP$FR-AFSSAPS-DJ20221259$FR-ABBVIE-22K-056-4419642-00$ABBVIE$$67$YR$$F$Y$94$KG$20240822$$MD$FR$FR
209127203$20912720$3$F$20220221$20240717$20220603$20240721$EXP$$NO-MYLANLABS-2022M1042289$MYLAN$$69$YR$$M$Y$$$20240719$$MD$NO$NO
209127634$20912763$4$F$20220527$20240713$20220603$20240718$EXP$$CA-TAKEDA-2021TUS000979$TAKEDA$$30$YR$$F$Y$$$20240718$$CN$CA$CA
209128554$20912855$4$F$$20240919$20220603$20240920$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000190$PAREXEL$$$$$$Y$$$20240920$$CN$US$US
209128562$20912856$2$F$$20240808$20220603$20240809$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000167$PAREXEL$$$$$$Y$$$20240809$$HP$US$US
209130195$20913019$5$F$20220101$20240626$20220603$20240701$EXP$$CA-PFIZER INC-202200788907$PFIZER$$49$YR$$F$Y$$$20240701$$HP$CA$CA
2091304914$20913049$14$F$20220610$20240727$20220603$20240801$EXP$$AU-TAKEDA-2022TUS037168$TAKEDA$$38$YR$$M$Y$$$20240801$$CN$AU$AU
209132712$20913271$2$F$20220101$20240719$20220603$20240729$30DAY$$US-GLAXOSMITHKLINE-US2022085154$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
209135795$20913579$5$F$20210713$20240917$20220604$20240926$EXP$$GB-AUROBINDO-AUR-APL-2022-019779$AUROBINDO$$57$YR$$M$Y$$$20240926$$MD$GB$GB
209142285$20914228$5$F$20221009$20240909$20220604$20240926$EXP$$US-SA-2022SA187536$SANOFI AVENTIS$$22$YR$A$M$Y$59.87$KG$20240926$$MD$US$US
209143452$20914345$2$F$$20240918$20220604$20240927$PER$$US-SA-2022SA189816$SANOFI AVENTIS$$$$A$M$Y$$$20240927$$MD$US$US
209143653$20914365$3$F$20220101$20240904$20220604$20240914$PER$$US-SA-2022SA188505$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240914$$MD$US$US
209145132$20914513$2$F$20220519$20240703$20220604$20240712$PER$$US-SA-2022SA187229$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240712$$MD$US$US
209147932$20914793$2$F$20220501$20240830$20220604$20240913$PER$$US-SA-2022SA189953$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240913$$MD$US$US
209148084$20914808$4$F$20220521$20240919$20220604$20240930$PER$$US-SA-2022SA186984$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240930$$MD$US$US
209149304$20914930$4$F$$20240925$20220604$20240930$PER$$US-SA-2022SA196124$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240930$$MD$US$US
209151622$20915162$2$F$$20240731$20220604$20240808$PER$$US-SA-2022SA197897$SANOFI AVENTIS$$15$YR$T$F$Y$50.4$KG$20240808$$MD$US$US
209152826$20915282$6$F$20220224$20240626$20220604$20240701$PER$$US-SA-2022SA196658$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240701$$MD$US$US
209153223$20915322$3$F$$20240801$20220604$20240809$PER$$US-SA-2022SA201529$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240809$$MD$US$US
209153614$20915361$4$F$$20240710$20220604$20240722$PER$$US-SA-2022SA197621$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
209157743$20915774$3$F$$20240808$20220604$20240817$PER$$US-SA-2022SA198937$SANOFI AVENTIS$$$$A$M$Y$$$20240817$$MD$US$US
209159994$20915999$4$F$$20240807$20220604$20240816$PER$$US-SA-2022SA202000$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240816$$MD$US$US
209160953$20916095$3$F$20240101$20240628$20220604$20240703$PER$$US-SA-2022SA202326$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240703$$MD$US$US
209161062$20916106$2$F$$20240726$20220604$20240806$PER$$US-SA-2022SA205392$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240806$$MD$US$US
209165628$20916562$8$F$20201102$20240829$20220605$20240901$EXP$$DE-ROCHE-2723175$ROCHE$$28$YR$A$M$Y$$$20240901$$CN$DE$DE
209168822$20916882$2$F$$20240323$20220605$20240924$PER$$US-CELLTRION INC.-2022US008302$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
209170102$20917010$2$F$20220303$20240924$20220606$20240926$PER$$GT-TOLMAR, INC.-22GT034761$TOLMAR$$74$YR$$M$Y$$$20240926$$CN$GT$GT
209170805$20917080$5$F$20240315$20240704$20220606$20240725$PER$$CA-TOLMAR, INC.-22CA034596$TOLMAR$$83$YR$$M$Y$$$20240724$$CN$CA$CA
209170903$20917090$3$F$20211128$20240801$20220606$20240826$PER$$CO-TOLMAR, INC.-22CO034543$TOLMAR$$74$YR$$M$Y$$$20240826$$MD$CO$CO
209179963$20917996$3$F$20220514$20220616$20220606$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR088448$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240925$$CN$US$US
2091812722$20918127$22$F$20220927$20240412$20220606$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR087656$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240926$$PH$US$US
209183814$20918381$4$F$20200109$20240901$20220606$20240903$EXP$$US-SHIRE-US202000844$TAKEDA$$15$YR$$F$Y$$$20240903$$HP$US$US
209183823$20918382$3$F$20180401$20240827$20220606$20240829$EXP$$US-TAKEDA-US201837242$TAKEDA$$54$YR$$F$Y$$$20240829$$CN$US$US
209184423$20918442$3$F$20210517$20240924$20220606$20240926$EXP$$US-ABBVIE-22K-163-4421405-00$ABBVIE$$76$YR$$M$Y$89$KG$20240926$$MD$US$US
209184447$20918444$7$F$$20221104$20220606$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR087698$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
209184453$20918445$3$F$$20220614$20220606$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR087685$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
209184476$20918447$6$F$$20230427$20220606$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR087693$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
209190989$20919098$9$F$20150930$20240829$20220606$20240904$EXP$$US-JAZZ-2022-US-014694$JAZZ$$28$YR$$F$Y$$$20240904$$CN$US$US
2091921411$20919214$11$F$20221230$20240708$20220606$20240711$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-117088$BOEHRINGER INGELHEIM$$82$YR$E$M$Y$$$20240711$$CN$US$US
2092072623$20920726$23$F$20220520$20240918$20220606$20240925$EXP$$US-TAKEDA-US201914198$TAKEDA$$62$YR$$F$Y$$$20240925$$CN$US$US
209208524$20920852$4$F$20220301$20240917$20220606$20240923$EXP$$BR-GLAXOSMITHKLINE-BR2019GSK004973$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$BR$BR
209208865$20920886$5$F$$20240826$20220606$20240829$PER$$US-PFIZER INC-202200798847$PFIZER$$72$YR$$F$Y$$$20240829$$CN$US$US
209209482$20920948$2$F$20220101$20240626$20220606$20240701$EXP$$CA-PFIZER INC-2019033473$PFIZER$$46$YR$$F$Y$$$20240701$$CN$CA$CA
209214772$20921477$2$F$20200531$20240816$20220606$20240821$EXP$$US-UCBSA-2022030914$UCB$$0$YR$$F$Y$3.204$KG$20240821$$MD$US$US
209215185$20921518$5$F$20210401$20240710$20220606$20240716$EXP$$CA-BAUSCH-BL-2021-012638$BAUSCH AND LOMB$$78$YR$$M$Y$$$20240716$$CN$CA$CA
209217405$20921740$5$F$20210101$20240827$20220606$20240911$EXP$$US-ABBVIE-22K-163-4421762-00$ABBVIE$$$$$M$Y$69$KG$20240911$$CN$US$US
209221822$20922182$2$F$$20240913$20220607$20240926$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-05121$ALKEM$Seifert P, Greiser J, Winkens T, Lorenz K, et.al. Ectopic Retrolaryngeal Parathyroid Adenoma Detected by 18F-Ethylcholine PET/US Fusion Imaging. Clinical Nuclear Medicine. 2022;47 (2):182-184$68$YR$$F$Y$$$20240926$$MD$DE$DE
209223453$20922345$3$F$20201210$20240701$20220607$20240702$EXP$$JP-TAKEDA-2022TJP053412$TAKEDA$$20$YR$$M$Y$$$20240702$$MD$JP$JP
209224413$20922441$3$F$$20220812$20220607$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR088915$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2092294615$20922946$15$F$20230221$20240806$20220607$20240813$EXP$$CA-TAKEDA-2022TUS037195$TAKEDA$$55$YR$$F$Y$$$20240813$$CN$CA$CA
2092377511$20923775$11$F$$20240812$20220607$20240820$EXP$$CA-MYLANLABS-2021M1063461$BIOCON$$$$$$Y$$$20240820$$HP$CA$CA
209243547$20924354$7$F$20231201$20240812$20220607$20240814$EXP$$US-PFIZER INC-202200804133$PFIZER$$72$YR$$F$Y$$$20240814$$CN$US$US
209243815$20924381$5$F$$20240813$20220607$20240819$EXP$$US-JAZZ-2022-US-018573$JAZZ$$$$$F$Y$$$20240819$$MD$US$US
2092484712$20924847$12$F$20220526$20240811$20220607$20240812$EXP$$CA-PFIZER INC-202200771707$PFIZER$$58$YR$$F$Y$78$KG$20240812$$HP$CA$CA
2092517816$20925178$16$F$$20240923$20220607$20240926$PER$$US-PFIZER INC-202200789161$PFIZER$$69$YR$$F$Y$$$20240926$$CN$US$US
2092518110$20925181$10$F$20220504$20240918$20220607$20240924$EXP$$CZ-PFIZER INC-202200710574$PFIZER$$67$YR$$F$Y$56$KG$20240924$$HP$CZ$CZ
209253744$20925374$4$F$20231129$20240903$20220607$20240904$EXP$$US-PFIZER INC-202200804374$PFIZER$$57$YR$$F$Y$$$20240904$$HP$US$US
2092635617$20926356$17$F$20220601$20240924$20220607$20240927$EXP$$US-TAKEDA-2022TUS036686$TAKEDA$$17$YR$$M$Y$$$20240927$$MD$US$US
209267692$20926769$2$F$$20240824$20220607$20240830$EXP$$CO-TAKEDA-2022TUS037596$TAKEDA$$$$$M$Y$62$KG$20240830$$CN$CO$CO
2092715014$20927150$14$F$20220501$20240920$20220607$20240927$EXP$$CA-TAKEDA-2021TUS032714$TAKEDA$$41$YR$$M$Y$$$20240927$$HP$CA$CA
209271632$20927163$2$F$$20240918$20220607$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202206001722$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240923$$CN$US$US
209271974$20927197$4$F$20220517$20240905$20220607$20240926$PER$$CA-TOLMAR, INC.-22CA034739$TOLMAR$$81$YR$$M$Y$$$20240926$$CN$CA$CA
209275942$20927594$2$F$20220601$20240909$20220607$20240915$PER$$US-TAKEDA-2022TUS037050$TAKEDA$$72$YR$$F$Y$44$KG$20240915$$MD$US$US
2092858020$20928580$20$F$20170905$20240919$20220607$20240928$EXP$$CA-CELLTRION INC.-2022CA004577$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
2092872711$20928727$11$F$20220101$20240801$20220607$20240806$EXP$$US-UCBSA-2022010266$UCB$$$$$F$Y$86.168$KG$20240806$$CN$US$US
2092905810$20929058$10$F$20220426$20240916$20220608$20240924$EXP$$CA-CELLTRION INC.-2022CA006659$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
2092923814$20929238$14$F$20220101$20240809$20220608$20240817$EXP$$CA-CELLTRION INC.-2022CA006015$CELLTRION$$$$$$Y$$$20240817$$HP$CA$CA
209293402$20929340$2$F$20171006$20240715$20220608$20240722$EXP$$GB-AUROBINDO-AUR-APL-2022-020239$AUROBINDO$$43$YR$$F$Y$$$20240722$$HP$GB$GB
209295837$20929583$7$F$20200221$20240731$20220608$20240805$EXP$$MX-TAKEDA-MX202007734$TAKEDA$$52$YR$$F$Y$56$KG$20240805$$CN$MX$MX
209295907$20929590$7$F$20240501$20240823$20220608$20240828$EXP$$CA-SHIRE-CA201846647AA$TAKEDA$$54$YR$$M$Y$$$20240828$$MD$CA$CA
2092975215$20929752$15$F$20200902$20240913$20220608$20240921$EXP$$CA-CELLTRION INC.-2020CA027766$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
209308156$20930815$6$F$20240101$20240624$20220608$20240703$EXP$$IT-SA-2022SA197006$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240703$$HP$IT$IT
209311345$20931134$5$F$$20240808$20220608$20240812$EXP$$US-PFIZER INC-202200804816$PFIZER$$54$YR$$F$Y$$$20240812$$CN$US$US
209313283$20931328$3$F$20220401$20240830$20220608$20240909$EXP$$JP-009507513-2205JPN000732J$MERCK$$9$DEC$$M$Y$$$20240909$$MD$JP$JP
2093188116$20931881$16$F$20220523$20240918$20220608$20240920$EXP$$DE-PFIZER INC-202200808099$PFIZER$$80$YR$$M$Y$75$KG$20240920$$HP$DE$DE
2093254711$20932547$11$F$20220518$20240905$20220608$20240926$PER$$CA-TOLMAR, INC.-22CA034742$TOLMAR$$67$YR$$M$Y$$$20240926$$CN$CA$CA
2093257529$20932575$29$F$20180101$20240912$20220608$20240917$EXP$$IN-PFIZER INC-2017346566$PFIZER$$64$YR$$F$Y$72$KG$20240917$$CN$IN$IN
209325967$20932596$7$F$20220323$20240702$20220608$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-053520$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240710$$MD$JP$JP
209329787$20932978$7$F$$20240812$20220608$20240816$PER$$US-PFIZER INC-202200810111$PFIZER$$68$YR$$F$Y$$$20240816$$CN$US$US
209331034$20933103$4$F$$20240705$20220608$20240715$EXP$$CO-INCYTE CORPORATION-2021IN006473$INCYTE$$$$$$Y$$$20240715$$CN$CO$CO
209333513$20933351$3$F$20220324$20240917$20220608$20240919$EXP$$US-KYOWAKIRIN-2022BKK008644$KYOWA$$$$$$Y$$$20240919$$HP$US$US
209344307$20934430$7$F$$20240919$20220608$20240925$EXP$$PL-MYLANLABS-2022M1042545$MYLAN$Julia Nowowiejska, Anna Baran, Iwona Flisiak. Baboon syndrome.. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY.. 2022;39(2):413-415$74$YR$$M$Y$$$20240925$$MD$PL$PL
209347496$20934749$6$F$$20240916$20220608$20240921$EXP$$CA-ROCHE-3107908$ROCHE$$56$YR$A$F$Y$$$20240921$$HP$CA$CA
2093504310$20935043$10$F$20220404$20240918$20220608$20240927$EXP$$CA-CELLTRION INC.-2021CA012260$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
2093506829$20935068$29$F$20220101$20240723$20220608$20240730$EXP$$CA-CELLTRION INC.-2022CA008519$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
209351533$20935153$3$F$20220525$20240813$20220608$20240821$EXP$$CA-CELLTRION INC.-2022CA005804$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
209351847$20935184$7$F$20220516$20240614$20220608$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001722$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240709$$CN$US$US
209352138$20935213$8$F$20230418$20240617$20220608$20240709$PER$$CA-TOLMAR, INC.-22CA034834$TOLMAR$$65$YR$$M$Y$$$20240709$$CN$CA$CA
209352183$20935218$3$F$20221116$20240705$20220608$20240725$PER$$CA-TOLMAR, INC.-22CA034840$TOLMAR$$71$YR$$M$Y$$$20240724$$CN$CA$CA
209352193$20935219$3$F$$20240801$20220608$20240807$PER$$CA-TOLMAR, INC.-22CA034843$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
209354916$20935491$6$F$20230802$20240703$20220609$20240725$PER$$CA-TOLMAR, INC.-22CA034617$TOLMAR$$64$YR$$M$Y$$$20240724$$CN$CA$CA
209355337$20935533$7$F$20231122$20240704$20220609$20240725$PER$$CA-TOLMAR, INC.-22CA034660$TOLMAR$$87$YR$$M$Y$$$20240724$$CN$CA$CA
2093582622$20935826$22$F$20160505$20240904$20220609$20240913$EXP$$CA-CELLTRION INC.-2018CA022354$CELLTRION$$$$$$Y$$$20240913$$CN$CA$CA
2093605114$20936051$14$F$20210826$20240826$20220609$20240903$EXP$$CA-CELLTRION INC.-2021CA016102$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
209366954$20936695$4$F$20220830$20240704$20220609$20240725$PER$$CA-TOLMAR, INC.-22CA034595$TOLMAR$$78$YR$$M$Y$$$20240724$$CN$CA$CA
209372245$20937224$5$F$20220501$20240719$20220609$20240726$EXP$$US-ABBVIE-22K-163-4425713-00$ABBVIE$$67$YR$$F$Y$$$20240726$$CN$US$US
209373424$20937342$4$F$20220601$20220628$20220609$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR089020$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
2093735311$20937353$11$F$20201210$20240829$20220609$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-014554$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$62.2$KG$20240906$$MD$JP$JP
209374458$20937445$8$F$$20240807$20220609$20240813$EXP$$US-TAKEDA-US201926824$TAKEDA$$$$$F$Y$$$20240813$$HP$US$US
2093794525$20937945$25$F$$20240911$20220609$20240927$EXP$$CA-GLAXOSMITHKLINE-CACH2015AMR000012$Haleon PLC$$43$YR$$F$Y$96$KG$20240927$$HP$CA$CA
2093864611$20938646$11$F$20230101$20240806$20220609$20240808$EXP$$US-PFIZER INC-202200802631$PFIZER$$77$YR$$F$Y$81.179$KG$20240808$$CN$US$US
209390629$20939062$9$F$$20240920$20220609$20240925$EXP$PT-EMA-DD-20220524-216281-123433$PT-PFM-2022-04793$PIERRE FABRE MEDICAMENT$$$$E$$Y$$$20240924$$$PT$PT
2093940414$20939404$14$F$20220519$20240625$20220609$20240701$EXP$$AU-TAKEDA-2022TUS034354$TAKEDA$$29$YR$$F$Y$$$20240701$$HP$AU$AU
2093985910$20939859$10$F$20230301$20240903$20220609$20240920$PER$$CA-TOLMAR, INC.-22CA034769$TOLMAR$$94$YR$$M$Y$$$20240919$$CN$CA$CA
209398894$20939889$4$F$20220519$20240820$20220609$20240913$PER$$CA-TOLMAR, INC.-22CA034764$TOLMAR$$85$YR$$M$Y$$$20240913$$CN$CA$CA
209399324$20939932$4$F$20210115$20240829$20220609$20240911$EXP$$DE-JNJFOC-20220445312$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240912$$MD$DE$DE
209402085$20940208$5$F$$20240919$20220609$20240920$EXP$$CA-PFIZER INC-202200808443$PFIZER$$42$YR$$F$Y$$$20240920$$HP$CA$CA
209403713$20940371$3$F$$20231024$20220609$20240801$EXP$$NVSC2022US128591$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
209405213$20940521$3$F$20220525$20240722$20220609$20240726$EXP$$CO-UCBSA-2022031626$UCB$$39$YR$$F$Y$58$KG$20240726$$CN$CO$CO
209411708$20941170$8$F$20200710$20240515$20220609$20240802$EXP$$NVSJ2020JP362390$NOVARTIS$$23$MON$$F$Y$10.2$KG$20240802$$MD$JP$JP
209415722$20941572$2$F$$20240710$20220610$20240711$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000202$PAREXEL$$$$$$Y$$$20240711$$HP$US$US
209416044$20941604$4$F$20220101$20240807$20220610$20240815$EXP$$CA-CELLTRION INC.-2020CA019434$CELLTRION$$$$$$Y$$$20240815$$MD$CA$CA
2094186915$20941869$15$F$20201130$20240820$20220610$20240828$EXP$$CA-CELLTRION INC.-2020CA033557$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
209422362$20942236$2$F$20240628$20240628$20220610$20240703$EXP$$US-KYOWAKIRIN-2022BKK008557$KYOWA$$$$$$Y$$$20240703$$HP$US$US
209422587$20942258$7$F$$20221121$20220610$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR089991$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
209423152$20942315$2$F$$20220603$20220610$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR088570$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
209425983$20942598$3$F$$20240624$20220610$20240702$EXP$$CA-APOTEX-2022AP008817$APOTEX$$79$YR$$M$Y$82$KG$20240702$$HP$CA$CA
209426918$20942691$8$F$20220101$20240917$20220610$20240925$PER$$CA-TOLMAR, INC.-22CA034969$TOLMAR$$$$$M$Y$$$20240925$$CN$CA$CA
209428327$20942832$7$F$$20240914$20220610$20240919$EXP$$AU-TAKEDA-2022TUS038533$TAKEDA$$$$$M$Y$$$20240919$$CN$AU$AU
209429192$20942919$2$F$20220602$20240808$20220610$20240809$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000203$PAREXEL$$$$$$Y$$$20240809$$CN$US$US
209447445$20944744$5$F$20220401$20240703$20220610$20240709$EXP$$NVSC2022IN133447$NOVARTIS$$65$YR$$F$Y$$$20240709$$CN$IN$IN
2094477015$20944770$15$F$20240524$20240916$20220610$20240924$EXP$$US-TAKEDA-2021TUS069394$TAKEDA$$66$YR$$F$Y$83$KG$20240924$$HP$US$US
209454482$20945448$2$F$$20220607$20220610$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR064475$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
209454603$20945460$3$F$20220501$20240708$20220610$20240715$EXP$$AR-GLAXOSMITHKLINE-AR2022AMR088415$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$AR$AR
209455522$20945552$2$F$20220511$20220608$20220610$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR091053$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
209455552$20945555$2$F$$20240827$20220610$20240906$30DAY$$US-GLAXOSMITHKLINE-US2022090639$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$HP$US$US
209458006$20945800$6$F$$20240813$20220610$20240819$EXP$$US-SA-2022SA217330$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240819$$HP$US$US
2094605821$20946058$21$F$20220408$20240923$20220610$20240926$EXP$$US-TAKEDA-2022TUS038422$TAKEDA$$43$YR$$M$Y$$$20240926$$MD$US$US
209462786$20946278$6$F$20210515$20240722$20220610$20240729$EXP$$US-TAKEDA-2022TUS038606$TAKEDA$$76$YR$$M$Y$218$KG$20240729$$HP$US$US
209467803$20946780$3$F$$20240718$20220610$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20200210612$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240723$$MD$CA$CA
209468134$20946813$4$F$$20240625$20220610$20240701$EXP$$CA-TAKEDA-2022TUS038016$TAKEDA$$$$$M$Y$$$20240701$$MD$CA$CA
2094691316$20946913$16$F$20191101$20240820$20220610$20240827$EXP$$CA-TAKEDA-CA202001009$TAKEDA$$76$YR$$F$Y$$$20240827$$CN$CA$CA
209469528$20946952$8$F$20220402$20240911$20220610$20240917$EXP$$TH-TAKEDA-2022TUS030804$TAKEDA$$43$YR$$F$Y$$$20240917$$CN$TH$TH
209471344$20947134$4$F$$20220802$20220610$20240925$PER$$NVSC2022US134221$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
2094725617$20947256$17$F$$20240709$20220610$20240716$EXP$$US-JAZZ-2022-US-019723$JAZZ$$$$$F$Y$$$20240716$$CN$US$US
209473718$20947371$8$F$20210519$20240823$20220610$20240830$EXP$$JP-ABBVIE-21K-087-3922551-00$ABBVIE$$77$YR$$F$Y$43$KG$20240830$$MD$JP$JP
2094747716$20947477$16$F$20210330$20240822$20220610$20240830$EXP$$CA-CELLTRION INC.-2021CA004668$CELLTRION$$$$$$Y$$$20240830$$MD$CA$CA
2094770614$20947706$14$F$20210101$20240912$20220611$20240921$EXP$$CA-CELLTRION INC.-2021CA018163$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
209479634$20947963$4$F$20220601$20240806$20220611$20240814$EXP$$PR-ABBVIE-22K-131-4429044-00$ABBVIE$$77$YR$$F$Y$64$KG$20240814$$CN$PR$PR
209495103$20949510$3$F$$20240817$20220613$20240829$EXP$$PT-AUROBINDO-AUR-APL-2022-021429$AUROBINDO$Gon?alo V, Mariana S, Maria S?o P, Joana E, Patr?cia P.. A Misleading Angioedema: Case Report. Portuguese Journal of Pediatrics.. 2022;53(2):537-540$15$YR$$F$Y$$$20240829$$MD$PT$PT
209497412$20949741$2$F$$20220609$20220613$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR091039$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
209503716$20950371$6$F$$20240813$20220613$20240818$EXP$$CA-ROCHE-3113571$ROCHE$$50$YR$A$M$Y$70$KG$20240819$$HP$CA$CA
209503873$20950387$3$F$20211015$20240813$20220613$20240820$EXP$$US-TAKEDA-2021TUS064200$TAKEDA$$77$YR$$F$Y$$$20240820$$CN$US$US
2095044110$20950441$10$F$20220523$20230123$20220613$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR091197$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240926$$HP$US$US
209505002$20950500$2$F$$20240821$20220613$20240827$PER$$US-AMGEN-USASP2022100145$AMGEN$$67$YR$E$F$Y$$$20240827$$CN$US$US
2095063211$20950632$11$F$20210617$20240910$20220613$20240913$EXP$$CA-TAKEDA-2021TUS034346$TAKEDA$$22$YR$$M$Y$$$20240913$$HP$CA$CA
209509374$20950937$4$F$$20240708$20220613$20240710$EXP$$US-PFIZER INC-202200824789$PFIZER$$63$YR$$F$Y$$$20240710$$CN$US$US
209513034$20951303$4$F$20220708$20240923$20220613$20240926$EXP$$CA-TAKEDA-2018TUS022669$TAKEDA$$64$YR$$M$Y$$$20240926$$CN$CA$CA
209513168$20951316$8$F$20240913$20240916$20220613$20240918$EXP$$US-PFIZER INC-2019046103$PFIZER$$75$YR$$M$Y$$$20240918$$CN$US$US
209516094$20951609$4$F$$20240711$20220613$20240717$EXP$$CA-PFIZER INC-202200828228$MYLAN$$59$YR$$M$Y$115$KG$20240717$$MD$CA$CA
209521462$20952146$2$F$20220415$20240916$20220613$20240923$EXP$$CZ-MYLANLABS-2022M1041358$MYLAN$$67$YR$$F$Y$56$KG$20240923$$HP$CZ$CZ
209522183$20952218$3$F$20220602$20240730$20220613$20240805$EXP$$US-TAKEDA-US201801246$TAKEDA$$56$YR$$F$Y$$$20240805$$CN$US$US
2095225112$20952251$12$F$20211011$20240913$20220613$20240918$EXP$$IN-PFIZER INC-202200819586$PFIZER$$51$YR$$F$Y$$$20240918$$CN$IN$IN
209532232$20953223$2$F$20220402$20220610$20220613$20240830$EXP$IT-MINISAL02-872842$NVSC2022IT133949$NOVARTIS$$16$YR$$F$Y$$$20240830$$PH$IT$IT
209533896$20953389$6$F$20220610$20240925$20220613$20240926$PER$$NVSC2022US135272$NOVARTIS$$83$YR$$F$Y$$$20240926$$HP$US$US
209535604$20953560$4$F$20220401$20240819$20220613$20240821$EXP$$CA-ROCHE-3115556$ROCHE$$47$YR$A$F$Y$$$20240821$$CN$CA$CA
2095361116$20953611$16$F$20201203$20240918$20220613$20240927$EXP$$CA-CELLTRION INC.-2019CA022299$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
209537292$20953729$2$F$$20240812$20220613$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-053623$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240813$$CN$US$US
209541049$20954104$9$F$20220215$20240827$20220614$20240829$EXP$$JP-TAKEDA-2022TJP055474$TAKEDA$$22$YR$$M$Y$40$KG$20240829$$PH$JP$JP
2095414214$20954142$14$F$20220501$20240607$20220614$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001804$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240701$$CN$US$US
209544622$20954462$2$F$$20210713$20220614$20240715$PER$$US-PFM-2021-07433$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240715$$HP$US$US
209544632$20954463$2$F$$20210709$20220614$20240715$PER$$US-PFM-2021-07615$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240715$$HP$US$US
209544642$20954464$2$F$$20210719$20220614$20240715$PER$$US-PFM-2021-07618$PIERRE FABRE MEDICAMENT$$$$$M$Y$5$KG$20240715$$HP$US$US
209544652$20954465$2$F$$20210713$20220614$20240715$PER$$US-PFM-2021-07434$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240715$$HP$US$US
209544662$20954466$2$F$$20210715$20220614$20240715$PER$$US-PFM-2021-07616$PIERRE FABRE MEDICAMENT$$$$$F$Y$14$KG$20240715$$HP$US$US
209544672$20954467$2$F$$20210720$20220614$20240715$PER$$US-PFM-2021-07619$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240715$$HP$US$US
209544682$20954468$2$F$$20210719$20220614$20240715$PER$$US-PFM-2021-07617$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240715$$HP$US$US
209544692$20954469$2$F$$20210714$20220614$20240715$PER$$US-PFM-2021-07436$PIERRE FABRE MEDICAMENT$$$$I$F$Y$6$KG$20240715$$HP$US$US
209544702$20954470$2$F$$20210723$20220614$20240715$PER$$US-PFM-2021-07937$PIERRE FABRE MEDICAMENT$$$$$F$Y$3$KG$20240715$$HP$US$US
209544742$20954474$2$F$$20210730$20220614$20240715$PER$$US-PFM-2021-07813$PIERRE FABRE MEDICAMENT$$$$$F$Y$12$KG$20240715$$HP$US$US
209544772$20954477$2$F$$20210730$20220614$20240715$PER$$US-PFM-2021-07944$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.247$KG$20240715$$HP$US$US
209544782$20954478$2$F$$20210802$20220614$20240715$PER$$US-PFM-2021-07943$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240715$$HP$US$US
209544792$20954479$2$F$$20210802$20220614$20240715$PER$$US-PFM-2021-07941$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240715$$HP$US$US
209544802$20954480$2$F$$20210809$20220614$20240715$PER$$US-PFM-2021-08186$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240715$$HP$US$US
209544812$20954481$2$F$20210712$20210713$20220614$20240715$PER$$US-PFM-2021-07435$PIERRE FABRE MEDICAMENT$$2$YR$$F$Y$$$20240715$$HP$US$US
209544842$20954484$2$F$$20210730$20220614$20240715$PER$$US-PFM-2021-07814$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240715$$CN$US$US
209544852$20954485$2$F$$20210728$20220614$20240715$PER$$US-PFM-2021-07939$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240715$$HP$US$US
209544862$20954486$2$F$20210101$20220221$20220614$20240715$PER$$US-PFM-2021-07812$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240715$$PH$US$US
209544872$20954487$2$F$$20210812$20220614$20240715$PER$$US-PFM-2021-08171$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.27$KG$20240715$$HP$US$US
209544882$20954488$2$F$$20210802$20220614$20240715$PER$$US-PFM-2021-07942$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240715$$HP$US$US
209544902$20954490$2$F$$20210811$20220614$20240715$PER$$US-PFM-2021-08188$PIERRE FABRE MEDICAMENT$$$$$F$Y$43$KG$20240715$$HP$US$US
209544912$20954491$2$F$$20210811$20220614$20240715$PER$$US-PFM-2021-08187$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240715$$HP$US$US
209544922$20954492$2$F$$20211013$20220614$20240712$PER$$US-PFM-2021-10669$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.508$KG$20240712$$HP$US$US
209544932$20954493$2$F$$20211013$20220614$20240712$PER$$US-PFM-2021-10613$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209544942$20954494$2$F$$20211013$20220614$20240712$PER$$US-PFM-2021-10639$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209544952$20954495$2$F$$20211014$20220614$20240712$PER$$US-PFM-2021-10614$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240712$$HP$US$US
209544962$20954496$2$F$$20211015$20220614$20240712$PER$$US-PFM-2021-10615$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240712$$HP$US$US
209544972$20954497$2$F$$20211015$20220614$20240712$PER$$US-PFM-2021-10668$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240712$$HP$US$US
209544982$20954498$2$F$$20211019$20220614$20240712$PER$$US-PFM-2021-10608$PIERRE FABRE MEDICAMENT$$$$$$Y$8$KG$20240712$$HP$US$US
209544992$20954499$2$F$$20211019$20220614$20240712$PER$$US-PFM-2021-10618$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.442$KG$20240712$$HP$US$US
209545002$20954500$2$F$$20211021$20220614$20240712$PER$$US-PFM-2021-10604$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209545012$20954501$2$F$$20211021$20220614$20240712$PER$$US-PFM-2021-10602$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.29$KG$20240712$$HP$US$US
209545022$20954502$2$F$$20211021$20220614$20240712$PER$$US-PFM-2021-10603$PIERRE FABRE MEDICAMENT$$$$$F$Y$14$KG$20240712$$HP$US$US
209545034$20954503$4$F$$20220602$20220614$20240712$PER$$US-PFM-2021-10617$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
209545042$20954504$2$F$$20211025$20220614$20240712$PER$$US-PFM-2021-10681$PIERRE FABRE MEDICAMENT$$$$$F$Y$14.966$KG$20240712$$HP$US$US
209545052$20954505$2$F$$20211025$20220614$20240712$PER$$US-PFM-2021-10680$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.698$KG$20240712$$HP$US$US
209545062$20954506$2$F$$20211021$20220614$20240712$PER$$US-PFM-2021-10605$PIERRE FABRE MEDICAMENT$$$$$$Y$7$KG$20240712$$HP$US$US
209545072$20954507$2$F$$20211027$20220614$20240712$PER$$US-PFM-2021-10752$PIERRE FABRE MEDICAMENT$$$$$M$Y$17$KG$20240712$$HP$US$US
209545082$20954508$2$F$$20211026$20220614$20240712$PER$$US-PFM-2021-10711$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240712$$HP$US$US
209545092$20954509$2$F$$20211022$20220614$20240712$PER$$US-PFM-2021-10710$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.989$KG$20240712$$HP$US$US
209545102$20954510$2$F$$20211026$20220614$20240712$PER$$US-PFM-2021-10756$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.17$KG$20240712$$HP$US$US
209545112$20954511$2$F$$20211026$20220614$20240712$PER$$US-PFM-2021-10757$PIERRE FABRE MEDICAMENT$$$$$F$Y$16$KG$20240712$$HP$US$US
209545142$20954514$2$F$$20211026$20220614$20240712$PER$$US-PFM-2021-10758$PIERRE FABRE MEDICAMENT$$$$$F$Y$13$KG$20240712$$HP$US$US
209545152$20954515$2$F$$20211028$20220614$20240712$PER$$US-PFM-2021-10838$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240712$$HP$US$US
209545172$20954517$2$F$$20211027$20220614$20240712$PER$$US-PFM-2021-10837$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.989$KG$20240712$$HP$US$US
209545182$20954518$2$F$$20211026$20220614$20240712$PER$$US-PFM-2021-10760$PIERRE FABRE MEDICAMENT$$$$$F$Y$16$KG$20240712$$HP$US$US
209545192$20954519$2$F$$20211028$20220614$20240712$PER$$US-PFM-2021-10839$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240712$$HP$US$US
209545202$20954520$2$F$$20211029$20220614$20240712$PER$$US-PFM-2021-10882$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.524$KG$20240712$$HP$US$US
209545212$20954521$2$F$$20211029$20220614$20240712$PER$$US-PFM-2021-10840$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.397$KG$20240712$$HP$US$US
209545222$20954522$2$F$$20211029$20220614$20240712$PER$$US-PFM-2021-10881$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209545232$20954523$2$F$$20211101$20220614$20240712$PER$$US-PFM-2021-10876$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.327$KG$20240712$$HP$US$US
209545242$20954524$2$F$$20211101$20220614$20240712$PER$$US-PFM-2021-10854$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.39$KG$20240712$$HP$US$US
209545252$20954525$2$F$$20211103$20220614$20240712$PER$$US-PFM-2021-10997$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209545264$20954526$4$F$$20220810$20220614$20240712$PER$$US-PFM-2021-10853$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209545272$20954527$2$F$$20211101$20220614$20240712$PER$$US-PFM-2021-10852$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.576$KG$20240712$$HP$US$US
209545282$20954528$2$F$$20211110$20220614$20240712$PER$$US-PFM-2021-11230$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209545292$20954529$2$F$$20211108$20220614$20240712$PER$$US-PFM-2021-11143$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240712$$HP$US$US
209545302$20954530$2$F$$20220222$20220614$20240712$PER$$US-PFM-2021-11096$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209545312$20954531$2$F$$20220110$20220614$20240712$PER$$US-PFM-2021-11095$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209545322$20954532$2$F$20211008$20220225$20220614$20240712$PER$$US-PFM-2021-10998$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240712$$HP$US$US
209545332$20954533$2$F$$20211109$20220614$20240712$PER$$US-PFM-2021-11231$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
209545342$20954534$2$F$$20211116$20220614$20240712$PER$$US-PFM-2021-11409$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209545352$20954535$2$F$$20211116$20220614$20240712$PER$$US-PFM-2021-11410$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240712$$HP$US$US
209545362$20954536$2$F$$20211111$20220614$20240712$PER$$US-PFM-2021-11265$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209545372$20954537$2$F$$20211116$20220614$20240712$PER$$US-PFM-2021-11406$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240712$$HP$US$US
209545382$20954538$2$F$20211101$20211116$20220614$20240712$PER$$US-PFM-2021-11368$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$8$KG$20240712$$PH$US$US
209545392$20954539$2$F$$20211116$20220614$20240712$PER$$US-PFM-2021-11405$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209545402$20954540$2$F$$20211116$20220614$20240712$PER$$US-PFM-2021-11403$PIERRE FABRE MEDICAMENT$$$$$F$Y$19$KG$20240712$$HP$US$US
209545412$20954541$2$F$$20211119$20220614$20240712$PER$$US-PFM-2021-11516$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209545422$20954542$2$F$$20211118$20220614$20240712$PER$$US-PFM-2021-11490$PIERRE FABRE MEDICAMENT$$$$$M$Y$4$KG$20240712$$HP$US$US
209545452$20954545$2$F$$20211123$20220614$20240712$PER$$US-PFM-2021-11651$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240712$$HP$US$US
209545462$20954546$2$F$$20211122$20220614$20240712$PER$$US-PFM-2021-11637$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240712$$HP$US$US
209545472$20954547$2$F$$20211122$20220614$20240712$PER$$US-PFM-2021-11639$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209545482$20954548$2$F$$20211124$20220614$20240712$PER$$US-PFM-2021-11652$PIERRE FABRE MEDICAMENT$$$$$F$Y$14$KG$20240712$$HP$US$US
209545492$20954549$2$F$$20211124$20220614$20240712$PER$$US-PFM-2021-11653$PIERRE FABRE MEDICAMENT$$$$$M$Y$4$KG$20240712$$HP$US$US
209545502$20954550$2$F$$20211129$20220614$20240712$PER$$US-PFM-2021-11794$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209545512$20954551$2$F$20211125$20211129$20220614$20240712$PER$$US-PFM-2021-11793$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$11$KG$20240712$$HP$US$US
209545522$20954552$2$F$$20211129$20220614$20240712$PER$$US-PFM-2021-11764$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
209545542$20954554$2$F$$20211130$20220614$20240712$PER$$US-PFM-2021-11795$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209545552$20954555$2$F$$20211202$20220614$20240712$PER$$US-PFM-2021-11915$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209545582$20954558$2$F$$20211207$20220614$20240712$PER$$US-PFM-2021-12168$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
209545592$20954559$2$F$$20211206$20220614$20240712$PER$$US-PFM-2021-12123$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209545602$20954560$2$F$$20211207$20220614$20240712$PER$$US-PFM-2021-12167$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
209545612$20954561$2$F$$20211203$20220614$20240712$PER$$US-PFM-2021-11640$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209545632$20954563$2$F$$20211210$20220614$20240712$PER$$US-PFM-2021-12342$PIERRE FABRE MEDICAMENT$$$$$F$Y$12$KG$20240712$$HP$US$US
209545642$20954564$2$F$$20211210$20220614$20240712$PER$$US-PFM-2021-12456$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240712$$CN$US$US
209545652$20954565$2$F$20211209$20211210$20220614$20240712$PER$$US-PFM-2021-12214$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$11$KG$20240712$$PH$US$US
209545663$20954566$3$F$$20220621$20220614$20240712$PER$$US-PFM-2021-12411$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.608$KG$20240712$$HP$US$US
209545672$20954567$2$F$$20211215$20220614$20240712$PER$$US-PFM-2021-12413$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240712$$CN$US$US
209545682$20954568$2$F$20211214$20211216$20220614$20240712$PER$$US-PFM-2021-12457$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$10$KG$20240712$$HP$US$US
209545712$20954571$2$F$$20211220$20220614$20240712$PER$$US-PFM-2021-12552$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240712$$HP$US$US
209545722$20954572$2$F$$20211213$20220614$20240712$PER$$US-PFM-2021-12497$PIERRE FABRE MEDICAMENT$Wallington D, Schauer M, Bauler LD. Simultaneous presentation of thyroid storm and diabetic ketoacidosis in a previously healthy 21-year-old man. BMJ Case Rep. 2019;12(1):1-6$21$YR$$M$Y$$$20240712$$HP$US$US
209545732$20954573$2$F$$20211227$20220614$20240712$PER$$US-PFM-2021-12673$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209545744$20954574$4$F$$20231011$20220614$20240712$PER$$US-PFM-2021-12521$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.5$KG$20240712$$HP$US$US
209545752$20954575$2$F$$20211227$20220614$20240712$PER$$US-PFM-2021-12674$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240712$$HP$US$US
209545762$20954576$2$F$$20211228$20220614$20240712$PER$$US-PFM-2021-12723$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209545772$20954577$2$F$$20211230$20220614$20240712$PER$$US-PFM-2021-12804$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.442$KG$20240712$$HP$US$US
209545782$20954578$2$F$$20211229$20220614$20240712$PER$$US-PFM-2021-12753$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240712$$HP$US$US
209545793$20954579$3$F$$20220620$20220614$20240712$PER$$US-PFM-2022-00059$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.16$KG$20240712$$HP$US$US
209545802$20954580$2$F$$20220103$20220614$20240712$PER$$US-PFM-2022-00060$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209546609$20954660$9$F$$20240813$20220614$20240817$PER$$US-AMGEN-USASP2022101669$AMGEN$$56$YR$A$F$Y$87.5$KG$20240817$$CN$US$US
209550852$20955085$2$F$$20220610$20220614$20240710$EXP$$BG-ASTELLAS-2022US021259$ASTELLAS$$89$YR$$M$Y$$$20240710$$MD$BG$BG
209551112$20955111$2$F$$20210818$20220614$20240715$PER$$US-PFM-2021-08330$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240715$$HP$US$US
209551122$20955112$2$F$20210605$20210820$20220614$20240715$PER$$US-PFM-2021-08369$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240715$$PH$US$US
209551132$20955113$2$F$$20210819$20220614$20240715$PER$$US-PFM-2021-08328$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240715$$HP$US$US
209551142$20955114$2$F$$20210820$20220614$20240715$PER$$US-PFM-2021-08371$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240715$$HP$US$US
209551152$20955115$2$F$$20210902$20220614$20240715$PER$$US-PFM-2021-08877$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240715$$HP$US$US
209551162$20955116$2$F$$20210903$20220614$20240715$PER$$US-PFM-2021-08947$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240715$$HP$US$US
209551172$20955117$2$F$$20210820$20220614$20240715$PER$$US-PFM-2021-08370$PIERRE FABRE MEDICAMENT$$$$$M$Y$5$KG$20240715$$HP$US$US
209551182$20955118$2$F$$20210824$20220614$20240715$PER$$US-PFM-2021-08562$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240715$$HP$US$US
209551192$20955119$2$F$$20210825$20220614$20240715$PER$$US-PFM-2021-08648$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240715$$HP$US$US
209551202$20955120$2$F$$20210914$20220614$20240715$PER$$US-PFM-2021-09198$PIERRE FABRE MEDICAMENT$$$$$F$Y$3$KG$20240715$$HP$US$US
209551212$20955121$2$F$$20210903$20220614$20240715$PER$$US-PFM-2021-08946$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240715$$HP$US$US
209551222$20955122$2$F$$20220318$20220614$20240715$PER$$US-PFM-2021-09258$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.977$KG$20240715$$HP$US$US
209551232$20955123$2$F$20210701$20210803$20220614$20240715$PER$$US-PFM-2021-08272$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$$$20240715$$CN$US$US
209551252$20955125$2$F$$20220322$20220614$20240715$PER$$US-PFM-2021-08667$PIERRE FABRE MEDICAMENT$$$$$M$Y$11$KG$20240715$$HP$US$US
209551262$20955126$2$F$$20210903$20220614$20240715$PER$$US-PFM-2021-08995$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240715$$HP$US$US
209551272$20955127$2$F$$20210830$20220614$20240715$PER$$US-PFM-2021-08762$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240715$$HP$US$US
209551292$20955129$2$F$$20210825$20220614$20240715$PER$$US-PFM-2021-08647$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240715$$HP$US$US
209551302$20955130$2$F$$20210910$20220614$20240715$PER$$US-PFM-2021-09081$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.109$KG$20240715$$HP$US$US
209551312$20955131$2$F$$20210913$20220614$20240715$PER$$US-PFM-2021-09159$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240715$$HP$US$US
209551323$20955132$3$F$$20220418$20220614$20240715$PER$$US-PFM-2021-09257$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240715$$HP$US$US
209551382$20955138$2$F$$20210915$20220614$20240715$PER$$US-PFM-2021-09259$PIERRE FABRE MEDICAMENT$$$$$M$Y$5$KG$20240715$$HP$US$US
209551392$20955139$2$F$$20210917$20220614$20240715$PER$$US-PFM-2021-09322$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240715$$HP$US$US
209551402$20955140$2$F$$20210917$20220614$20240715$PER$$US-PFM-2021-09333$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240715$$HP$US$US
209551412$20955141$2$F$$20210920$20220614$20240715$PER$$US-PFM-2021-09373$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240715$$HP$US$US
209551422$20955142$2$F$$20210920$20220614$20240715$PER$$US-PFM-2021-09374$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.3$KG$20240715$$HP$US$US
209551432$20955143$2$F$$20210921$20220614$20240715$PER$$US-PFM-2021-09407$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240715$$HP$US$US
209551442$20955144$2$F$$20210922$20220614$20240715$PER$$US-PFM-2021-09451$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240715$$HP$US$US
209551452$20955145$2$F$$20210923$20220614$20240715$PER$$US-PFM-2021-09963$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240715$$HP$US$US
209551462$20955146$2$F$20210801$20210923$20220614$20240715$PER$$US-PFM-2021-09527$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240715$$HP$US$US
209551472$20955147$2$F$$20211001$20220614$20240715$PER$$US-PFM-2021-09889$PIERRE FABRE MEDICAMENT$$$$$M$Y$13.79$KG$20240715$$HP$US$US
209551482$20955148$2$F$$20211001$20220614$20240715$PER$$US-PFM-2021-09795$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240715$$HP$US$US
209551492$20955149$2$F$$20211005$20220614$20240715$PER$$US-PFM-2021-10009$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240715$$HP$US$US
209551502$20955150$2$F$$20210922$20220614$20240715$PER$$US-PFM-2021-09450$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240715$$HP$US$US
209551512$20955151$2$F$$20210928$20220614$20240715$PER$$US-PFM-2021-09699$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.299$KG$20240715$$HP$US$US
209551532$20955153$2$F$$20210924$20220614$20240715$PER$$US-PFM-2021-09587$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240715$$HP$US$US
209551552$20955155$2$F$$20211005$20220614$20240715$PER$$US-PFM-2021-10010$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240715$$HP$US$US
209551562$20955156$2$F$$20220324$20220614$20240715$PER$$US-PFM-2021-09331$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240715$$HP$US$US
209551572$20955157$2$F$20210101$20211008$20220614$20240712$PER$$US-PFM-2021-10122$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209551582$20955158$2$F$$20211101$20220614$20240715$PER$$US-PFM-2021-09697$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240715$$HP$US$US
209551592$20955159$2$F$$20211227$20220614$20240715$PER$$US-PFM-2021-09964$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240715$$HP$US$US
209551672$20955167$2$F$$20211011$20220614$20240712$PER$$US-PFM-2021-10221$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240712$$HP$US$US
209551682$20955168$2$F$$20211007$20220614$20240712$PER$$US-PFM-2021-10123$PIERRE FABRE MEDICAMENT$$$$$M$Y$12$KG$20240712$$HP$US$US
209551692$20955169$2$F$20211001$20211018$20220614$20240712$PER$$US-PFM-2021-10527$PIERRE FABRE MEDICAMENT$$4$MON$$F$Y$5$KG$20240712$$CN$US$US
209551702$20955170$2$F$$20211021$20220614$20240712$PER$$US-PFM-2021-10601$PIERRE FABRE MEDICAMENT$$$$$F$Y$27$KG$20240712$$HP$US$US
209551712$20955171$2$F$$20220120$20220614$20240712$PER$$US-PFM-2022-00581$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240712$$HP$US$US
209551722$20955172$2$F$$20211129$20220614$20240712$PER$$US-PFM-2021-10124$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$MD$US$US
209551732$20955173$2$F$$20211122$20220614$20240712$PER$$US-PFM-2021-10176$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209551792$20955179$2$F$$20220126$20220614$20240712$PER$$US-PFM-2022-00766$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240712$$HP$US$US
209551802$20955180$2$F$$20220126$20220614$20240712$PER$$US-PFM-2022-00765$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240712$$HP$US$US
209551812$20955181$2$F$$20220125$20220614$20240712$PER$$US-PFM-2022-00659$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209551822$20955182$2$F$$20220124$20220614$20240712$PER$$US-PFM-2022-00630$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240712$$HP$US$US
209551832$20955183$2$F$20220113$20220127$20220614$20240712$PER$$US-PFM-2022-00768$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240712$$HP$US$US
209551843$20955184$3$F$$20221228$20220614$20240712$PER$$US-PFM-2022-00839$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.859$KG$20240712$$HP$US$US
209551852$20955185$2$F$$20220131$20220614$20240712$PER$$US-PFM-2022-00841$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209551862$20955186$2$F$$20220131$20220614$20240712$PER$$US-PFM-2022-00840$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209551882$20955188$2$F$$20220201$20220614$20240712$PER$$US-PFM-2022-00881$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209551912$20955191$2$F$$20220131$20220614$20240712$PER$$US-PFM-2022-00842$PIERRE FABRE MEDICAMENT$$$$$$Y$7$KG$20240712$$HP$US$US
209551922$20955192$2$F$$20220202$20220614$20240712$PER$$US-PFM-2022-00919$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.669$KG$20240712$$HP$US$US
209551932$20955193$2$F$$20220203$20220614$20240712$PER$$US-PFM-2022-00981$PIERRE FABRE MEDICAMENT$$$$$M$Y$10$KG$20240712$$HP$US$US
209551942$20955194$2$F$$20220203$20220614$20240712$PER$$US-PFM-2022-00982$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209552002$20955200$2$F$$20220204$20220614$20240712$PER$$US-PFM-2022-00986$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.256$KG$20240712$$HP$US$US
209552012$20955201$2$F$$20220203$20220614$20240712$PER$$US-PFM-2022-00983$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240712$$HP$US$US
209552042$20955204$2$F$$20220203$20220614$20240712$PER$$US-PFM-2022-00984$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209552052$20955205$2$F$20220127$20220208$20220614$20240712$PER$$US-PFM-2022-01096$PIERRE FABRE MEDICAMENT$$2$YR$$M$Y$13$KG$20240712$$PH$US$US
209552062$20955206$2$F$$20220209$20220614$20240712$PER$$US-PFM-2022-01248$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240712$$HP$US$US
209552072$20955207$2$F$$20220210$20220614$20240712$PER$$US-PFM-2022-01207$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209552082$20955208$2$F$$20240401$20220614$20240712$PER$$US-PFM-2022-01249$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.4$KG$20240712$$HP$US$US
209552093$20955209$3$F$$20220902$20220614$20240712$PER$$US-PFM-2022-00985$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.5$KG$20240712$$HP$US$US
209552102$20955210$2$F$$20220208$20220614$20240712$PER$$US-PFM-2022-01094$PIERRE FABRE MEDICAMENT$$$$$M$Y$5$KG$20240712$$HP$US$US
209552112$20955211$2$F$$20220209$20220614$20240712$PER$$US-PFM-2022-01151$PIERRE FABRE MEDICAMENT$$$$$M$Y$12.245$KG$20240712$$HP$US$US
209552122$20955212$2$F$$20220207$20220614$20240712$PER$$US-PFM-2022-01024$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209552132$20955213$2$F$$20220211$20220614$20240712$PER$$US-PFM-2022-01206$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.524$KG$20240712$$PH$US$US
209552142$20955214$2$F$$20220216$20220614$20240712$PER$$US-PFM-2022-01385$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240712$$HP$US$US
209552152$20955215$2$F$$20220215$20220614$20240712$PER$$US-PFM-2022-01346$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.256$KG$20240712$$HP$US$US
209552162$20955216$2$F$$20220214$20220614$20240712$PER$$US-PFM-2022-01293$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.535$KG$20240712$$HP$US$US
209552172$20955217$2$F$$20220221$20220614$20240712$PER$$US-PFM-2022-01516$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240712$$HP$US$US
209552183$20955218$3$F$$20221005$20220614$20240712$PER$$US-PFM-2022-01515$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209552192$20955219$2$F$$20220217$20220614$20240712$PER$$US-PFM-2022-01480$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209552252$20955225$2$F$$20220222$20220614$20240712$PER$$US-PFM-2022-01679$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209552272$20955227$2$F$$20220223$20220614$20240712$PER$$US-PFM-2022-01588$PIERRE FABRE MEDICAMENT$$$$$F$Y$3$KG$20240712$$HP$US$US
209552283$20955228$3$F$$20230314$20220614$20240712$PER$$US-PFM-2022-01589$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.977$KG$20240712$$HP$US$US
209552292$20955229$2$F$$20220224$20220614$20240712$PER$$US-PFM-2022-01625$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240712$$HP$US$US
209552302$20955230$2$F$$20220303$20220614$20240712$PER$$US-PFM-2022-01868$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209552312$20955231$2$F$$20220224$20220614$20240712$PER$$US-PFM-2022-01624$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209552322$20955232$2$F$$20220303$20220614$20240712$PER$$US-PFM-2022-01867$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209552333$20955233$3$F$$20221017$20220614$20240712$PER$$US-PFM-2022-01869$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.66$KG$20240712$$HP$US$US
209552343$20955234$3$F$$20230523$20220614$20240712$PER$$US-PFM-2022-01866$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.249$KG$20240712$$HP$US$US
209552352$20955235$2$F$$20220301$20220614$20240712$PER$$US-PFM-2022-01792$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209552372$20955237$2$F$$20240513$20220614$20240712$PER$$US-PFM-2022-01964$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.79$KG$20240712$$HP$US$US
209552382$20955238$2$F$$20220307$20220614$20240712$PER$$US-PFM-2022-01965$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240712$$HP$US$US
209552392$20955239$2$F$$20220304$20220614$20240712$PER$$US-PFM-2022-01917$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209552402$20955240$2$F$20220209$20220304$20220614$20240712$PER$$US-PFM-2022-01918$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6$KG$20240712$$PH$US$US
209552412$20955241$2$F$$20220310$20220614$20240712$PER$$US-PFM-2022-02155$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.896$KG$20240712$$HP$US$US
209552422$20955242$2$F$$20220309$20220614$20240712$PER$$US-PFM-2022-02034$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240712$$HP$US$US
209552432$20955243$2$F$$20220310$20220614$20240712$PER$$US-PFM-2022-02156$PIERRE FABRE MEDICAMENT$$$$$F$Y$15$KG$20240712$$HP$US$US
209552442$20955244$2$F$$20220310$20220614$20240712$PER$$US-PFM-2022-02189$PIERRE FABRE MEDICAMENT$$$$$M$Y$5$KG$20240712$$HP$US$US
209552452$20955245$2$F$$20220309$20220614$20240712$PER$$US-PFM-2022-01989$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240712$$HP$US$US
209552462$20955246$2$F$$20220311$20220614$20240712$PER$$US-PFM-2022-02227$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209552482$20955248$2$F$$20220314$20220614$20240712$PER$$US-PFM-2022-02270$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240712$$HP$US$US
209552685$20955268$5$F$20220607$20220916$20220614$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR092153$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
209552792$20955279$2$F$$20220315$20220614$20240712$PER$$US-PFM-2022-02273$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.989$KG$20240712$$HP$US$US
209552812$20955281$2$F$20220201$20220315$20220614$20240712$PER$$US-PFM-2022-02272$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$$$20240712$$PH$US$US
209552832$20955283$2$F$$20220316$20220614$20240712$PER$$US-PFM-2022-02313$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240712$$HP$US$US
209552842$20955284$2$F$$20220317$20220614$20240712$PER$$US-PFM-2022-02390$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
209552852$20955285$2$F$$20220317$20220614$20240712$PER$$US-PFM-2022-02389$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209552863$20955286$3$F$$20220718$20220614$20240712$PER$$US-PFM-2022-02483$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240712$$HP$US$US
209552872$20955287$2$F$$20220318$20220614$20240712$PER$$US-PFM-2022-02471$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.163$KG$20240712$$HP$US$US
209552882$20955288$2$F$$20220321$20220614$20240712$PER$$US-PFM-2022-02535$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240712$$HP$US$US
209552892$20955289$2$F$$20220321$20220614$20240712$PER$$US-PFM-2022-02536$PIERRE FABRE MEDICAMENT$$$$$F$Y$12$KG$20240712$$HP$US$US
209552902$20955290$2$F$$20220322$20220614$20240712$PER$$US-PFM-2022-02539$PIERRE FABRE MEDICAMENT$$$$$M$Y$5$KG$20240712$$HP$US$US
209552923$20955292$3$F$$20221031$20220614$20240712$PER$$US-PFM-2022-02594$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.279$KG$20240712$$HP$US$US
209552932$20955293$2$F$$20220322$20220614$20240712$PER$$US-PFM-2022-02538$PIERRE FABRE MEDICAMENT$$$$$M$Y$5$KG$20240712$$HP$US$US
209552942$20955294$2$F$$20220322$20220614$20240712$PER$$US-PFM-2022-02537$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.256$KG$20240712$$HP$US$US
209552952$20955295$2$F$$20220318$20220614$20240712$PER$$US-PFM-2022-02473$PIERRE FABRE MEDICAMENT$$$$$M$Y$10$KG$20240712$$HP$US$US
209552962$20955296$2$F$$20220315$20220614$20240712$PER$$US-PFM-2022-02310$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209552972$20955297$2$F$$20220317$20220614$20240712$PER$$US-PFM-2022-02391$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209552982$20955298$2$F$$20220321$20220614$20240712$PER$$US-PFM-2022-02482$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.082$KG$20240712$$HP$US$US
209553042$20955304$2$F$$20220328$20220614$20240712$PER$$US-PFM-2022-02809$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209553052$20955305$2$F$$20220324$20220614$20240712$PER$$US-PFM-2022-02638$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240712$$HP$US$US
209553062$20955306$2$F$$20220324$20220614$20240712$PER$$US-PFM-2022-02639$PIERRE FABRE MEDICAMENT$$$$$F$Y$13$KG$20240712$$HP$US$US
209553072$20955307$2$F$$20220323$20220614$20240712$PER$$US-PFM-2022-02662$PIERRE FABRE MEDICAMENT$Afrin LB, Dempsey TT, Weinstock LB. Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?. Vaccines. 2022;10(1):127$$$$F$Y$$$20240712$$MD$US$US
209553082$20955308$2$F$$20220328$20220614$20240712$PER$$US-PFM-2022-02810$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
209553093$20955309$3$F$$20220705$20220614$20240712$PER$$US-PFM-2022-02887$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240712$$HP$US$US
209553102$20955310$2$F$$20220401$20220614$20240712$PER$$US-PFM-2022-02873$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209553112$20955311$2$F$$20220401$20220614$20240712$PER$$US-PFM-2022-02876$PIERRE FABRE MEDICAMENT$$$$$F$Y$14$KG$20240712$$HP$US$US
209553122$20955312$2$F$$20220401$20220614$20240712$PER$$US-PFM-2022-02875$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.605$KG$20240712$$HP$US$US
209553132$20955313$2$F$$20220329$20220614$20240712$PER$$US-PFM-2022-02813$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.46$KG$20240712$$HP$US$US
209553143$20955314$3$F$$20230330$20220614$20240712$PER$$US-PFM-2022-02877$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.977$KG$20240712$$HP$US$US
209553153$20955315$3$F$$20220525$20220614$20240712$PER$$US-PFM-2022-02484$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209560932$20956093$2$F$$20240419$20220614$20240710$PER$$US-PFM-2020-15311$PIERRE FABRE MEDICAMENT$$$$$F$Y$16.9$KG$20240710$$HP$US$US
209561216$20956121$6$F$20220629$20240806$20220614$20240812$EXP$$CA-TAKEDA-2022TUS026255$TAKEDA$$42$YR$$F$Y$$$20240812$$CN$CA$CA
209562832$20956283$2$F$20210520$20240731$20220614$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-340665$RANBAXY$$54$YR$$F$Y$53$KG$20240814$$CN$GB$GB
209570544$20957054$4$F$$20220803$20220614$20240710$PER$$US-PFM-2020-18037$PIERRE FABRE MEDICAMENT$$$$$F$Y$28$KG$20240710$$HP$US$US
209573064$20957306$4$F$$20221219$20220614$20240710$PER$$US-PFM-2021-04921$PIERRE FABRE MEDICAMENT$$$$$M$Y$12.599$KG$20240710$$HP$US$US
209574416$20957441$6$F$20211101$20240828$20220614$20240905$EXP$$US-ABBVIE-22K-163-4395158-00$ABBVIE$$81$YR$$M$Y$77$KG$20240905$$CN$US$US
209577022$20957702$2$F$$20220315$20220614$20240712$PER$$US-PFM-2022-02311$PIERRE FABRE MEDICAMENT$$$$$F$Y$13$KG$20240712$$HP$US$US
209577033$20957703$3$F$$20221006$20220614$20240712$PER$$US-PFM-2022-02540$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.617$KG$20240712$$HP$US$US
209577063$20957706$3$F$$20220608$20220614$20240712$PER$$US-PFM-2022-01095$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240712$$HP$US$US
209578899$20957889$9$F$20220610$20240718$20220614$20240719$PER$$US-PFIZER INC-PV202200000700$PFIZER$$77$YR$$M$Y$$$20240719$$CN$US$US
209580492$20958049$2$F$$20210426$20220614$20240710$PER$$US-PFM-2021-04068$PIERRE FABRE MEDICAMENT$Cano J, Zorio E, Mazzanti A, Arnau M, Trenor B, Priori SG et al. Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients. Frontiers in Pharmacology. 2020;11:1-19$2$YR$$F$Y$$$20240710$$HP$US$US
209580502$20958050$2$F$$20210427$20220614$20240710$PER$$US-PFM-2021-04295$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.07$KG$20240710$$HP$US$US
209580512$20958051$2$F$$20210427$20220614$20240710$PER$$US-PFM-2021-04282$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.27$KG$20240710$$HP$US$US
209580522$20958052$2$F$20210420$20210503$20220614$20240710$PER$$US-PFM-2021-04347$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.361$KG$20240710$$HP$US$US
209580532$20958053$2$F$$20210428$20220614$20240710$PER$$US-PFM-2021-04297$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240710$$HP$US$US
209580542$20958054$2$F$$20210427$20220614$20240710$PER$$US-PFM-2021-04296$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240710$$HP$US$US
209580552$20958055$2$F$$20210503$20220614$20240710$PER$$US-PFM-2021-04536$PIERRE FABRE MEDICAMENT$Miyake CY, Kim JJ, Tosur M, Howard TS, Pham TDN, Valdes So. Severe Hypoglycemia Associated With Oral Sotalol Use in Two Children. Heart Rhythm Case Reports. 2021;1-4$30$MON$$M$Y$12.7$KG$20240710$$MD$US$US
209580562$20958056$2$F$$20210430$20220614$20240710$PER$$US-PFM-2021-04265$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240710$$HP$US$US
209580572$20958057$2$F$$20210505$20220614$20240710$PER$$US-PFM-2021-04861$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240710$$HP$US$US
209580582$20958058$2$F$$20210426$20220614$20240710$PER$$US-PFM-2021-04273$PIERRE FABRE MEDICAMENT$$7$MON$$M$Y$$$20240710$$PH$US$US
209580592$20958059$2$F$$20210510$20220614$20240710$PER$$US-PFM-2021-04840$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240710$$HP$US$US
209580602$20958060$2$F$$20210507$20220614$20240710$PER$$US-PFM-2020-13348$PIERRE FABRE MEDICAMENT$Laube JG, Araujo TS, Taw LB. Integrative East-West medicine intervention for chronic daily headache: a case report and care perspective. Glob Adv Health Med. 2020;9:1-8$61$YR$$M$Y$$$20240710$$HP$US$US
209580612$20958061$2$F$$20210507$20220614$20240710$PER$$US-PFM-2021-04848$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240710$$HP$US$US
209580622$20958062$2$F$$20210504$20220614$20240710$PER$$US-PFM-2021-04348$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.599$KG$20240710$$HP$US$US
209580642$20958064$2$F$$20210506$20220614$20240710$PER$$US-PFM-2021-04851$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240710$$HP$US$US
209580652$20958065$2$F$20210509$20210510$20220614$20240710$PER$$US-PFM-2021-04841$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5$KG$20240710$$HP$US$US
209580662$20958066$2$F$$20210510$20220614$20240712$PER$$US-PFM-2022-03516$PIERRE FABRE MEDICAMENT$Sethi N, Funamoto K, Ingbar C, Mass P, Moak J, Wakai R et al. Noninvasive fetal electrocardiography in the diagnosis of long QT syndrome: A case series. Fetal diagnosis and therapy. 2020;47(9):711-6$$$I$$Y$$$20240712$$HP$US$US
209580672$20958067$2$F$$20210510$20220614$20240712$PER$$US-PFM-2022-03518$PIERRE FABRE MEDICAMENT$Sethi N, Funamoto K, Ingbar C, Mass P, Moak J, Wakai R et al. Noninvasive fetal electrocardiographyin the dignosis of long QT syndrome: A case series. Fetal diagnosis and therapy. 2020;47(9):711-6$$$I$$Y$$$20240712$$HP$US$US
209580682$20958068$2$F$$20210510$20220614$20240710$PER$$US-PFM-2021-04843$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240710$$HP$US$US
209580692$20958069$2$F$$20210510$20220614$20240710$PER$$US-PFM-2021-04842$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240710$$HP$US$US
209580732$20958073$2$F$$20210512$20220614$20240710$PER$$US-PFM-2021-04838$PIERRE FABRE MEDICAMENT$$$$$M$Y$3$KG$20240710$$HP$US$US
209580742$20958074$2$F$$20210514$20220614$20240710$PER$$US-PFM-2021-04834$PIERRE FABRE MEDICAMENT$$$$$F$Y$23$KG$20240710$$HP$US$US
209580752$20958075$2$F$$20210514$20220614$20240710$PER$$US-PFM-2021-04824$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240710$$HP$US$US
209580762$20958076$2$F$$20210517$20220614$20240710$PER$$US-PFM-2021-04993$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240710$$HP$US$US
209580782$20958078$2$F$$20210519$20220614$20240710$PER$$US-PFM-2021-05462$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.526$KG$20240710$$HP$US$US
209580792$20958079$2$F$$20210519$20220614$20240710$PER$$US-PFM-2021-05464$PIERRE FABRE MEDICAMENT$$$$$F$Y$29$KG$20240710$$HP$US$US
209580802$20958080$2$F$$20210513$20220614$20240710$PER$$US-PFM-2021-04835$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.256$KG$20240710$$HP$US$US
209580812$20958081$2$F$$20210517$20220614$20240710$PER$$US-PFM-2021-04866$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240710$$HP$US$US
209580822$20958082$2$F$$20210519$20220614$20240710$PER$$US-PFM-2021-05461$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240710$$HP$US$US
209580892$20958089$2$F$$20210519$20220614$20240710$PER$$US-PFM-2021-05465$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240710$$CN$US$US
209580902$20958090$2$F$$20210519$20220614$20240710$PER$$US-PFM-2021-05463$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240710$$HP$US$US
209580912$20958091$2$F$$20210520$20220614$20240715$PER$$US-PFM-2021-05879$PIERRE FABRE MEDICAMENT$$$$$M$Y$5$KG$20240715$$HP$US$US
209580922$20958092$2$F$$20210521$20220614$20240715$PER$$US-PFM-2021-05880$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240715$$HP$US$US
209580932$20958093$2$F$$20210521$20220614$20240715$PER$$US-PFM-2021-05881$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240715$$HP$US$US
209580942$20958094$2$F$$20210526$20220614$20240715$PER$$US-PFM-2021-06019$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240715$$HP$US$US
209580952$20958095$2$F$$20210524$20220614$20240715$PER$$US-PFM-2021-05883$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240715$$HP$US$US
209580962$20958096$2$F$$20210525$20220614$20240715$PER$$US-PFM-2021-05884$PIERRE FABRE MEDICAMENT$$$$$F$Y$3$KG$20240715$$HP$US$US
209580972$20958097$2$F$$20210525$20220614$20240710$PER$$US-PFM-2020-15385$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.399$KG$20240710$$HP$US$US
209580982$20958098$2$F$$20210525$20220614$20240710$PER$$US-PFM-2021-05524$PIERRE FABRE MEDICAMENT$Coleman M, Imundo JR, Cortez D, Cohen MH, Dhar P, Dalal G. Torsades de Pointes During Myringotomy in a Child with Congenital Long QT Syndrome: A Case Report. American Journal of Case Report. 2020;21$7$YR$$M$Y$26$KG$20240710$$HP$US$US
209581042$20958104$2$F$$20210813$20220614$20240710$PER$$US-PFM-2020-13522$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.823$KG$20240710$$PH$US$US
209581072$20958107$2$F$$20211029$20220614$20240710$PER$$US-PFM-2020-17314$PIERRE FABRE MEDICAMENT$$$$$F$Y$16$KG$20240710$$HP$US$US
209581102$20958110$2$F$$20211005$20220614$20240710$PER$$US-PFM-2020-16626$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.15$KG$20240710$$HP$US$US
209581332$20958133$2$F$$20210825$20220614$20240710$PER$$US-PFM-2020-17318$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$HP$US$US
209581422$20958142$2$F$20200827$20210816$20220614$20240710$PER$$US-PFM-2020-17936$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$10$KG$20240710$$HP$US$US
209581572$20958157$2$F$$20211005$20220614$20240710$PER$$US-PFM-2020-22571$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240710$$PH$US$US
209581602$20958160$2$F$$20211013$20220614$20240710$PER$$US-PFM-2020-20225$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240710$$PH$US$US
209581612$20958161$2$F$$20220119$20220614$20240710$PER$$US-PFM-2020-18003$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240710$$HP$US$US
209581622$20958162$2$F$$20210916$20220614$20240710$PER$$US-PFM-2020-20285$PIERRE FABRE MEDICAMENT$$$$$F$Y$13$KG$20240710$$HP$US$US
209581662$20958166$2$F$$20210528$20220614$20240715$PER$$US-PFM-2021-06021$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240715$$HP$US$US
209581672$20958167$2$F$$20210528$20220614$20240715$PER$$US-PFM-2021-06020$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240715$$HP$US$US
209581682$20958168$2$F$$20210601$20220614$20240715$PER$$US-PFM-2021-06022$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240715$$PH$US$US
209581692$20958169$2$F$$20210602$20220614$20240715$PER$$US-PFM-2021-05667$PIERRE FABRE MEDICAMENT$Faith F E, Cordisco M. Unrelenting facial segmental hemangiomas: A case series of late growth and recurrent ulcerations. Pediatric Dermatology. 2020;37:884-9$7$WK$$F$Y$$$20240715$$HP$US$US
209581712$20958171$2$F$$20210602$20220614$20240715$PER$$US-PFM-2021-05669$PIERRE FABRE MEDICAMENT$Faith F E, Cordisco M. Unrelenting facial segmental hemangiomas: A case series of late growth and recurrent ulcerations. Pediatric Dermatology. 2020;37:884-9$2$DY$$F$Y$$$20240715$$HP$US$US
209581722$20958172$2$F$$20210602$20220614$20240715$PER$$US-PFM-2021-05668$PIERRE FABRE MEDICAMENT$Faith F E, Cordisco M. Unrelenting facial segmental hemangiomas: A case series of late growth and recurrent ulcerations. Pediatric Dermatology. 2020;37:884-889$23$DY$$F$Y$$$20240715$$HP$US$US
209581732$20958173$2$F$$20210604$20220614$20240710$PER$$US-PFM-2021-05007$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240710$$HP$US$US
209581742$20958174$2$F$$20210712$20220614$20240710$PER$$US-PFM-2021-00415$PIERRE FABRE MEDICAMENT$$$$$M$Y$10$KG$20240710$$HP$US$US
209581752$20958175$2$F$$20210616$20220614$20240710$PER$$US-PFM-2021-00100$PIERRE FABRE MEDICAMENT$$$$$F$Y$20$KG$20240710$$HP$US$US
209581762$20958176$2$F$$20210615$20220614$20240715$PER$$US-PFM-2021-06216$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240715$$HP$US$US
209581772$20958177$2$F$20210512$20210616$20220614$20240715$PER$$US-PFM-2021-06215$PIERRE FABRE MEDICAMENT$$0$YR$$$Y$5$KG$20240715$$HP$US$US
209581782$20958178$2$F$$20210914$20220614$20240710$PER$$US-PFM-2021-00750$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240710$$HP$US$US
209581792$20958179$2$F$$20210831$20220614$20240710$PER$$US-PFM-2021-04298$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240710$$HP$US$US
209581802$20958180$2$F$$20211015$20220614$20240710$PER$$US-PFM-2021-04279$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.848$KG$20240710$$HP$US$US
209581812$20958181$2$F$$20220310$20220614$20240710$PER$$US-PFM-2021-00811$PIERRE FABRE MEDICAMENT$$$$$F$Y$12$KG$20240710$$HP$US$US
209581822$20958182$2$F$$20211129$20220614$20240710$PER$$US-PFM-2021-04839$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240710$$HP$US$US
209581872$20958187$2$F$$20210817$20220614$20240710$PER$$US-PFM-2021-04914$PIERRE FABRE MEDICAMENT$$$$$M$Y$10$KG$20240710$$HP$US$US
209581902$20958190$2$F$$20210819$20220614$20240710$PER$$US-PFM-2021-04922$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240710$$HP$US$US
209581913$20958191$3$F$$20220916$20220614$20240712$PER$$US-PFM-2022-03000$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.6$KG$20240712$$HP$US$US
209581922$20958192$2$F$$20211210$20220614$20240710$PER$$US-PFM-2021-04912$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240710$$HP$US$US
209581944$20958194$4$F$$20220620$20220614$20240710$PER$$US-PFM-2021-04862$PIERRE FABRE MEDICAMENT$$$$$F$Y$16.327$KG$20240710$$HP$US$US
209581952$20958195$2$F$$20210909$20220614$20240712$PER$$US-PFM-2022-03555$PIERRE FABRE MEDICAMENT$Johansen ML, Mahendran G, Lawley LP. Is prolonged monitoring necessary? An updated approach to infantile hemangioma treatment with oral propranolol. Pediatric dermatology. 2021;38(4):800-5$$$$$Y$$$20240712$$HP$US$US
209581962$20958196$2$F$$20220404$20220614$20240712$PER$$US-PFM-2022-02940$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
209581972$20958197$2$F$$20210916$20220614$20240712$PER$$US-PFM-2022-03517$PIERRE FABRE MEDICAMENT$Schweiger BM, Esakhan CL, Frishberg D, Grand K, Garg R, Sanchez-Lara PA. Pediatric Cushing syndrome: An early sign of an underling cancer predisposition syndrome. Am J Med Genet. 2021;185A:2824-8$5$MON$$M$Y$$$20240712$$HP$US$US
209581992$20958199$2$F$$20220404$20220614$20240712$PER$$US-PFM-2022-02937$PIERRE FABRE MEDICAMENT$$$$$M$Y$3$KG$20240712$$HP$US$US
209582002$20958200$2$F$$20220404$20220614$20240712$PER$$US-PFM-2022-02938$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.535$KG$20240712$$HP$US$US
209582012$20958201$2$F$$20220406$20220614$20240712$PER$$US-PFM-2022-03057$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.884$KG$20240712$$HP$US$US
209582022$20958202$2$F$$20220407$20220614$20240712$PER$$US-PFM-2022-03056$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209582032$20958203$2$F$$20220411$20220614$20240712$PER$$US-PFM-2022-03242$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
209582042$20958204$2$F$$20220411$20220614$20240712$PER$$US-PFM-2022-03241$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209582052$20958205$2$F$$20220407$20220614$20240712$PER$$US-PFM-2022-03137$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209582062$20958206$2$F$$20220411$20220614$20240712$PER$$US-PFM-2022-03240$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240712$$HP$US$US
209582072$20958207$2$F$$20220411$20220614$20240712$PER$$US-PFM-2022-03281$PIERRE FABRE MEDICAMENT$Feghali K, Atallah J, Norman C. Manifestations of thyroid disease post COVID-19 illness: Report of Hashimoto thyroiditis, Graves^ disease, and subacute thyroiditis. Journal of Clinical and Translational Endocrinology: Case Reports. 2021;22:100094$33$YR$$F$Y$$$20240712$$HP$US$US
209582082$20958208$2$F$$20220412$20220614$20240712$PER$$US-PFM-2022-03322$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240712$$HP$US$US
209582092$20958209$2$F$$20220414$20220614$20240712$PER$$US-PFM-2022-03497$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240712$$HP$US$US
209582102$20958210$2$F$$20220414$20220614$20240712$PER$$US-PFM-2022-03496$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209582113$20958211$3$F$$20220812$20220614$20240712$PER$$US-PFM-2022-03499$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209582152$20958215$2$F$$20210609$20220614$20240715$PER$$US-PFM-2021-06232$PIERRE FABRE MEDICAMENT$$$$$F$Y$16.59$KG$20240715$$HP$US$US
209582162$20958216$2$F$$20210610$20220614$20240715$PER$$US-PFM-2021-06230$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240715$$HP$US$US
209582172$20958217$2$F$$20220415$20220614$20240712$PER$$US-PFM-2022-03501$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.989$KG$20240712$$HP$US$US
209582182$20958218$2$F$$20210614$20220614$20240715$PER$$US-PFM-2021-06217$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240715$$HP$US$US
209582192$20958219$2$F$$20211011$20220614$20240715$PER$$US-PFM-2021-06231$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240715$$HP$US$US
209582202$20958220$2$F$$20220415$20220614$20240712$PER$$US-PFM-2022-03502$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209582212$20958221$2$F$20210430$20210608$20220614$20240715$PER$$US-PFM-2021-06234$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$8.934$KG$20240715$$PH$US$US
209582222$20958222$2$F$$20220419$20220614$20240712$PER$$US-PFM-2022-03591$PIERRE FABRE MEDICAMENT$$$$$M$Y$14$KG$20240712$$HP$US$US
209582233$20958223$3$F$20220101$20220517$20220614$20240712$PER$$US-PFM-2022-03753$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
209582243$20958224$3$F$$20220721$20220614$20240712$PER$$US-PFM-2022-03711$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209582362$20958236$2$F$$20210602$20220614$20240715$PER$$US-PFM-2021-06236$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240715$$HP$US$US
209582372$20958237$2$F$$20210601$20220614$20240715$PER$$US-PFM-2021-06235$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240715$$HP$US$US
209582392$20958239$2$F$$20210602$20220614$20240715$PER$$US-PFM-2021-06239$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240715$$HP$US$US
209582402$20958240$2$F$$20210607$20220614$20240715$PER$$US-PFM-2021-06247$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.27$KG$20240715$$HP$US$US
209582412$20958241$2$F$$20210602$20220614$20240715$PER$$US-PFM-2021-06237$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240715$$HP$US$US
209582422$20958242$2$F$$20210604$20220614$20240715$PER$$US-PFM-2021-06246$PIERRE FABRE MEDICAMENT$$$$$M$Y$11$KG$20240715$$HP$US$US
209582432$20958243$2$F$$20210607$20220614$20240715$PER$$US-PFM-2021-06401$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240715$$HP$US$US
209582442$20958244$2$F$$20210607$20220614$20240715$PER$$US-PFM-2021-06399$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240715$$HP$US$US
209582452$20958245$2$F$$20210607$20220614$20240715$PER$$US-PFM-2021-06248$PIERRE FABRE MEDICAMENT$$$$$M$Y$12$KG$20240715$$HP$US$US
209582462$20958246$2$F$$20220307$20220614$20240715$PER$$US-PFM-2021-06245$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240715$$HP$US$US
209582542$20958254$2$F$$20210607$20220614$20240715$PER$$US-PFM-2021-06403$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.168$KG$20240715$$HP$US$US
209582552$20958255$2$F$$20210616$20220614$20240715$PER$$US-PFM-2021-06409$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.202$KG$20240715$$HP$US$US
209582562$20958256$2$F$$20210616$20220614$20240715$PER$$US-PFM-2021-06412$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.141$KG$20240715$$HP$US$US
209582572$20958257$2$F$20210616$20210617$20220614$20240715$PER$$US-PFM-2021-06407$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6$KG$20240715$$HP$US$US
209582582$20958258$2$F$20210616$20210617$20220614$20240715$PER$$US-PFM-2021-06405$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6$KG$20240715$$HP$US$US
209582592$20958259$2$F$20210623$20210624$20220614$20240715$PER$$US-PFM-2021-06679$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6$KG$20240715$$HP$US$US
209582602$20958260$2$F$20210616$20210616$20220614$20240715$PER$$US-PFM-2021-06411$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6.259$KG$20240715$$HP$US$US
209582612$20958261$2$F$$20210629$20220614$20240715$PER$$US-PFM-2021-07062$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240715$$HP$US$US
209582622$20958262$2$F$$20210628$20220614$20240715$PER$$US-PFM-2021-06844$PIERRE FABRE MEDICAMENT$$$$$F$Y$3$KG$20240715$$HP$US$US
209582632$20958263$2$F$$20210630$20220614$20240715$PER$$US-PFM-2021-07063$PIERRE FABRE MEDICAMENT$$$$$M$Y$4$KG$20240715$$HP$US$US
209582702$20958270$2$F$$20210701$20220614$20240715$PER$$US-PFM-2021-07064$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240715$$HP$US$US
209582712$20958271$2$F$$20210701$20220614$20240715$PER$$US-PFM-2021-07066$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240715$$HP$US$US
209582722$20958272$2$F$$20210707$20220614$20240715$PER$$US-PFM-2021-07342$PIERRE FABRE MEDICAMENT$$$$$F$Y$21$KG$20240715$$HP$US$US
209582732$20958273$2$F$$20210702$20220614$20240715$PER$$US-PFM-2021-07137$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240715$$HP$US$US
209582742$20958274$2$F$$20210707$20220614$20240715$PER$$US-PFM-2021-07343$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240715$$HP$US$US
209582752$20958275$2$F$$20210707$20220614$20240715$PER$$US-PFM-2021-07346$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240715$$HP$US$US
209582762$20958276$2$F$$20210701$20220614$20240715$PER$$US-PFM-2021-07065$PIERRE FABRE MEDICAMENT$$$$$M$Y$5$KG$20240715$$HP$US$US
209582772$20958277$2$F$$20210708$20220614$20240715$PER$$US-PFM-2021-07340$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240715$$HP$US$US
209582782$20958278$2$F$$20210712$20220614$20240715$PER$$US-PFM-2021-07385$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240715$$HP$US$US
209582792$20958279$2$F$$20210709$20220614$20240715$PER$$US-PFM-2021-07356$PIERRE FABRE MEDICAMENT$$$$$M$Y$4$KG$20240715$$HP$US$US
209582902$20958290$2$F$$20210712$20220614$20240715$PER$$US-PFM-2021-07384$PIERRE FABRE MEDICAMENT$$$$$M$Y$10$KG$20240715$$HP$US$US
209582912$20958291$2$F$$20210714$20220614$20240715$PER$$US-PFM-2021-07432$PIERRE FABRE MEDICAMENT$$$$$M$Y$4$KG$20240715$$HP$US$US
209582922$20958292$2$F$$20211216$20220614$20240715$PER$$US-PFM-2021-07357$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240715$$HP$US$US
209582942$20958294$2$F$$20220103$20220614$20240712$PER$$US-PFM-2022-00061$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
209582952$20958295$2$F$$20220104$20220614$20240712$PER$$US-PFM-2022-00062$PIERRE FABRE MEDICAMENT$$$$$F$Y$13$KG$20240712$$HP$US$US
209582982$20958298$2$F$$20211129$20220614$20240715$PER$$US-PFM-2021-07355$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240715$$HP$US$US
209582992$20958299$2$F$$20220105$20220614$20240712$PER$$US-PFM-2022-00093$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240712$$HP$US$US
209583012$20958301$2$F$$20220106$20220614$20240712$PER$$US-PFM-2022-00110$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
209583022$20958302$2$F$$20220106$20220614$20240712$PER$$US-PFM-2022-00111$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.517$KG$20240712$$HP$US$US
209583032$20958303$2$F$$20220104$20220614$20240712$PER$$US-PFM-2022-00063$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240712$$HP$US$US
209583332$20958333$2$F$$20220106$20220614$20240712$PER$$US-PFM-2022-00118$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240712$$HP$US$US
209583342$20958334$2$F$$20220110$20220614$20240712$PER$$US-PFM-2022-00193$PIERRE FABRE MEDICAMENT$$$$$F$Y$13$KG$20240712$$HP$US$US
209583362$20958336$2$F$$20220110$20220614$20240712$PER$$US-PFM-2022-00194$PIERRE FABRE MEDICAMENT$$$$$M$Y$11$KG$20240712$$HP$US$US
209583372$20958337$2$F$$20220112$20220614$20240712$PER$$US-PFM-2022-00249$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240712$$HP$US$US
209583382$20958338$2$F$$20220111$20220614$20240712$PER$$US-PFM-2022-00275$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.431$KG$20240712$$HP$US$US
209583393$20958339$3$F$$20220926$20220614$20240712$PER$$US-PFM-2022-00250$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.2$KG$20240712$$HP$US$US
209583402$20958340$2$F$$20220113$20220614$20240712$PER$$US-PFM-2022-00276$PIERRE FABRE MEDICAMENT$$$$$F$Y$23$KG$20240712$$HP$US$US
209583412$20958341$2$F$$20220117$20220614$20240712$PER$$US-PFM-2022-00364$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
209583422$20958342$2$F$$20220117$20220614$20240712$PER$$US-PFM-2022-00448$PIERRE FABRE MEDICAMENT$Mitchell K, Weiner A, Ramsay P, Sahni M. Use of propranolol in the treatment of chylous effusions in infants. Pediatrics. 2021;148(1)$37$WK$$M$Y$$$20240712$$MD$US$US
209583432$20958343$2$F$$20220118$20220614$20240712$PER$$US-PFM-2022-00467$PIERRE FABRE MEDICAMENT$$$$$M$Y$18$KG$20240712$$HP$US$US
209585633$20958563$3$F$$20240812$20220614$20240815$EXP$$CA-ROCHE-2636333$ROCHE$$$$A$F$Y$$$20240815$$CN$CA$CA
209585719$20958571$9$F$20171114$20240823$20220614$20240827$EXP$$US-ROCHE-2602998$ROCHE$$67$YR$E$F$Y$102.06$KG$20240827$$CN$US$US
209591997$20959199$7$F$20160112$20240828$20220614$20240829$EXP$$US-TAKEDA-US201850858$TAKEDA$$69$YR$$F$Y$$$20240829$$HP$US$US
209596638$20959663$8$F$20180101$20240909$20220614$20240911$EXP$$US-SHIRE-US201925005AA$TAKEDA$$$$$F$Y$$$20240911$$HP$US$US
209596712$20959671$2$F$$20210512$20220614$20240710$PER$$US-PFM-2021-04837$PIERRE FABRE MEDICAMENT$$$$C$$Y$5$KG$20240710$$HP$US$US
209603623$20960362$3$F$20220202$20240624$20220615$20240701$EXP$$DK-CELLTRION INC.-2022DK008882$CELLTRION$$$$$$Y$$$20240701$$HP$DK$DK
209610122$20961012$2$F$$20220331$20220615$20240712$PER$$US-PFM-2022-02882$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
209610132$20961013$2$F$$20220331$20220615$20240712$PER$$US-PFM-2022-02879$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.524$KG$20240712$$HP$US$US
209610143$20961014$3$F$$20221010$20220615$20240712$PER$$US-PFM-2022-02886$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.789$KG$20240712$$HP$US$US
209610153$20961015$3$F$$20220908$20220615$20240712$PER$$US-PFM-2022-02881$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.97$KG$20240712$$HP$US$US
209612362$20961236$2$F$20220101$20220607$20220615$20240729$EXP$$US-RECORDATI-2022002643$RECORDATI$$$$$$Y$$$20240729$$CN$US$US
209613976$20961397$6$F$20220214$20240925$20220615$20240927$EXP$$CA-TAKEDA-2022TUS011325$TAKEDA$$52$YR$$F$Y$$$20240927$$HP$CA$CA
209614872$20961487$2$F$$20240730$20220615$20240803$EXP$$US-TAKEDA-US202026982$TAKEDA$$$$$F$Y$$$20240803$$HP$US$US
209621652$20962165$2$F$$20240702$20220615$20240712$EXP$$US-PFIZER INC-202200835801$MYLAN$$58$YR$$F$Y$$$20240712$$CN$US$US
209624292$20962429$2$F$20201116$20240826$20220615$20240910$EXP$$FR-SERVIER-S22006027$SERVIER$$$$$$Y$$$20240910$$MD$FR$FR
209625063$20962506$3$F$$20240829$20220615$20240905$EXP$$CA-GLAXOSMITHKLINE-CA2022091349$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$CA$CA
209633459$20963345$9$F$20180601$20240809$20220615$20240813$EXP$$CA-TAKEDA-2018TUS020978$TAKEDA$$52$YR$$M$Y$$$20240813$$CN$CA$CA
209636482$20963648$2$F$$20240909$20220615$20240910$EXP$$JP-PFIZER INC-PV202200001141$PFIZER$$$$$$Y$$$20240910$$PH$JP$JP
2096372710$20963727$10$F$20211001$20240904$20220615$20240909$EXP$$IN-PFIZER INC-2018443357$PFIZER$$57$YR$$M$Y$$$20240909$$CN$IN$IN
2096388710$20963887$10$F$20220607$20240824$20220615$20240828$EXP$$US-TAKEDA-2022TUS038238$TAKEDA$$60$YR$$F$Y$$$20240828$$CN$US$US
209639973$20963997$3$F$$20240730$20220615$20240805$EXP$$CA-TAKEDA-2022TUS039663$TAKEDA$$$$$M$Y$$$20240805$$MD$CA$CA
209640532$20964053$2$F$$20240712$20220615$20240716$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000213$PAREXEL$$$$$$Y$$$20240716$$CN$US$US
2096421226$20964212$26$F$20220222$20240726$20220615$20240731$EXP$$CO-TAKEDA-2022TUS012526$TAKEDA$$38$YR$$F$Y$68$KG$20240731$$CN$CO$CO
2096492210$20964922$10$F$20211101$20240816$20220616$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145669$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$$$20240821$$CN$US$US
209651943$20965194$3$F$$20240819$20220616$20240826$EXP$$IT-ROCHE-3116216$ROCHE$Ferreri A, Angelillo P, Erbella F, Cattaneo C, Verga L, Lleshi A, et al. Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma. Blood Advances. 2022;:-.$$$A$$Y$$$20240826$$MD$IT$IT
209652019$20965201$9$F$20220419$20240925$20220616$20240927$EXP$$CH-ABBVIE-22K-151-4397865-00$ABBVIE$$62$YR$$M$Y$80$KG$20240926$$MD$CH$CH
209652485$20965248$5$F$$20240823$20220616$20240828$EXP$$CA-ROCHE-3117103$ROCHE$$$$A$F$Y$$$20240828$$CN$CA$CA
209657274$20965727$4$F$20160401$20240828$20220616$20240829$EXP$$US-TAKEDA-US201738260$TAKEDA$$69$YR$$F$Y$$$20240829$$HP$US$US
209657942$20965794$2$F$20220526$20220610$20220616$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR092542$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
209660732$20966073$2$F$20220101$20240917$20220616$20240925$EXP$$US-TEVA-2022-US-2045033$TEVA$$64$YR$$F$Y$95.25$KG$20240925$$CN$US$US
209669404$20966940$4$F$$20240808$20220616$20240812$EXP$$US-TAKEDA-US202008558$TAKEDA$$$$$F$Y$$$20240812$$MD$US$US
209671753$20967175$3$F$20210901$20240716$20220616$20240723$EXP$$AT-TAKEDA-2022TUS014476$TAKEDA$$57$YR$$M$Y$$$20240723$$HP$AT$AT
209674184$20967418$4$F$$20240910$20220616$20240920$EXP$$CA-APOTEX-2022AP008908$APOTEX$$42$YR$$F$Y$$$20240920$$HP$CA$CA
209674522$20967452$2$F$$20240709$20220616$20240716$EXP$$CA-MYLANLABS-2022M1044945$MYLAN$$$$$M$Y$$$20240716$$HP$CA$CA
209676983$20967698$3$F$$20220719$20220616$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR093490$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2096801319$20968013$19$F$20210901$20240822$20220616$20240912$EXP$$NVSC2021CH285234$NOVARTIS$$62$YR$$F$Y$72$KG$20240912$$MD$CH$CH
209681064$20968106$4$F$20220101$20240729$20220616$20240730$EXP$$CA-TAKEDA-2022TUS001316$TAKEDA$$$$$F$Y$$$20240730$$CN$CA$CA
209681302$20968130$2$F$20211130$20220614$20220616$20240712$EXP$$NVSC2022IN054076$NOVARTIS$$50$YR$$M$Y$$$20240712$$CN$IN$IN
209684803$20968480$3$F$$20240919$20220616$20240920$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000214$PAREXEL$$$$$$Y$$$20240920$$CN$US$US
2096854424$20968544$24$F$20200101$20240910$20220616$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20201202827$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240911$$MD$US$US
209687702$20968770$2$F$$20240717$20220616$20240725$EXP$$US-GW PHARMA-202108USGW04001$JAZZ$$$$$M$Y$19.955$KG$20240724$$CN$US$US
209688308$20968830$8$F$20220419$20240903$20220616$20240904$EXP$$NVSC2022PL135830$NOVARTIS$$57$YR$$F$Y$66$KG$20240904$$MD$PL$PL
209689218$20968921$8$F$20220514$20240827$20220616$20240903$EXP$$US-AMGEN-USANI2022098034$AMGEN$$51$YR$A$F$Y$$$20240903$$MD$US$US
209696476$20969647$6$F$$20240909$20220616$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-054050$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$160.57$KG$20240916$$CN$US$US
209698592$20969859$2$F$20220527$20240711$20220616$20240722$PER$$US-SA-2022SA214297$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240722$$HP$US$US
209698743$20969874$3$F$$20240718$20220616$20240726$PER$$US-SA-2022SA209642$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240726$$MD$US$US
209699932$20969993$2$F$$20240627$20220616$20240706$PER$$US-SA-2022SA210273$SANOFI AVENTIS$$$$E$M$Y$$$20240706$$MD$US$US
209700435$20970043$5$F$20220101$20240716$20220616$20240723$PER$$US-SA-2022SA211377$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240723$$CN$US$US
209700506$20970050$6$F$20240205$20240712$20220616$20240801$EXP$$US-SA-2022SA210081$SANOFI AVENTIS$$14$YR$T$M$Y$53.5$KG$20240719$$MD$US$US
209706003$20970600$3$F$20240808$20240809$20220616$20240820$PER$$US-SA-2022SA222658$SANOFI AVENTIS$$41$YR$A$M$Y$77.11$KG$20240820$$MD$US$US
209707763$20970776$3$F$20220401$20240805$20220616$20240812$PER$$US-SA-2022SA213401$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240812$$MD$US$US
209708047$20970804$7$F$20200204$20240627$20220616$20240708$PER$$US-SA-2022SA213231$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240708$$MD$US$US
209708522$20970852$2$F$$20240718$20220616$20240726$PER$$US-SA-2022SA213603$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240726$$MD$US$US
209708586$20970858$6$F$20220101$20240813$20220616$20240820$PER$$US-SA-2022SA213137$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240820$$MD$US$US
209709964$20970996$4$F$20220608$20240903$20220616$20240912$PER$$US-SA-2022SA090341$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240912$$MD$US$US
2097100311$20971003$11$F$$20240711$20220616$20240718$EXP$$US-SA-2022SA220604$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240718$$HP$US$US
209710252$20971025$2$F$$20240723$20220616$20240801$PER$$US-SA-2022SA218859$SANOFI AVENTIS$$$$E$M$Y$$$20240801$$MD$US$US
209712825$20971282$5$F$20220501$20240710$20220616$20240801$PER$$US-SA-2022SA201880$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240719$$MD$US$US
2097136013$20971360$13$F$20200612$20240912$20220616$20240926$EXP$$CA-CELLTRION INC.-2020CA023417$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
209714015$20971401$5$F$$20240711$20220616$20240801$PER$$US-SA-2022SA218720$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240719$$MD$US$US
209719682$20971968$2$F$$20240730$20220616$20240808$PER$$US-SA-2022SA220296$SANOFI AVENTIS$$86$YR$E$F$Y$53.07$KG$20240808$$MD$US$US
209720413$20972041$3$F$$20240718$20220616$20240728$PER$$US-SA-2022SA226744$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240728$$MD$US$US
209720452$20972045$2$F$20210901$20240902$20220616$20240914$PER$$US-SA-2022SA225952$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240914$$MD$US$US
209721423$20972142$3$F$$20240621$20220616$20240702$PER$$US-SA-2022SA227660$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240702$$MD$US$US
209721452$20972145$2$F$20220519$20240805$20220616$20240814$PER$$US-SA-2022SA224442$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240814$$MD$US$US
2097294424$20972944$24$F$20201222$20240821$20220617$20240829$EXP$$CA-CELLTRION INC.-2020CA034896$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
209732944$20973294$4$F$$20240910$20220617$20240923$EXP$$CA-APOTEX-2022AP009160$APOTEX$$67$YR$$F$Y$73$KG$20240923$$HP$CA$CA
2097333414$20973334$14$F$20210101$20240823$20220617$20240902$EXP$$CA-CELLTRION INC.-2021CA012684$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
209734825$20973482$5$F$$20240925$20220617$20240927$PER$$NVSC2022US139242$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
209735088$20973508$8$F$20220401$20240821$20220617$20240910$PER$$CA-TOLMAR, INC.-22CA034896$TOLMAR$$77$YR$$M$Y$$$20240910$$CN$CA$CA
209735439$20973543$9$F$20210616$20240826$20220617$20240902$EXP$$CA-ROCHE-2712211$ROCHE$$53$YR$A$F$Y$$$20240902$$CN$CA$CA
209740252$20974025$2$F$20221201$20240725$20220617$20240801$EXP$$NVSC2021CA287152$NOVARTIS$$$$A$F$Y$$$20240801$$CN$CA$CA
209740472$20974047$2$F$$20220614$20220617$20240710$EXP$$DE-ASTELLAS-2022US021987$ASTELLAS$$$$$M$Y$$$20240710$$CN$DE$DE
209741882$20974188$2$F$20210918$20240826$20220617$20240910$EXP$$CA-SA-2022SA230561$SANOFI AVENTIS$$53$YR$A$M$Y$72.6$KG$20240910$$MD$CA$CA
2097457110$20974571$10$F$20220529$20240908$20220617$20240916$EXP$$CA-TAKEDA-2022TUS040182$TAKEDA$$56$YR$$F$Y$$$20240916$$CN$CA$CA
209748142$20974814$2$F$20220401$20240918$20220617$20240925$PER$$NVSC2022US134106$NOVARTIS$$31$YR$$F$Y$$$20240925$$CN$US$US
209750317$20975031$7$F$20200701$20230913$20220617$20240809$EXP$$NVSC2022EG017168$NOVARTIS$$53$YR$$F$Y$$$20240809$$CN$EG$EG
209752623$20975262$3$F$$20240801$20220617$20240805$EXP$$CA-ROCHE-3033909$ROCHE$$$$A$M$Y$$$20240805$$CN$CA$CA
2097551112$20975511$12$F$20221104$20240807$20220617$20240813$EXP$$US-TAKEDA-2022TUS032630$TAKEDA$$69$YR$$F$Y$66$KG$20240813$$HP$US$US
209759592$20975959$2$F$$20240731$20220617$20240801$EXP$$US-BAYER-2022A080602$BAYER$$$$$M$Y$$$20240801$$MD$US$US
209761435$20976143$5$F$20211201$20220823$20220617$20240725$EXP$$US-RECORDATI-2022000836$RECORDATI$$$$$$Y$$$20240725$$CN$US$US
209762974$20976297$4$F$$20240704$20220617$20240709$EXP$$CA-PFIZER INC-202200796979$PFIZER$$77$YR$$M$Y$89.1$KG$20240709$$CN$CA$CA
209763223$20976322$3$F$$20240909$20220617$20240919$EXP$$RU-BIOGEN-2022BI01097067$BIOGEN$$45$YR$$M$Y$$$20240919$$MD$RU$RU
209765367$20976536$7$F$$20240814$20220617$20240826$EXP$$US-LUPIN PHARMACEUTICALS INC.-2022-08685$LUPIN$$$$$$Y$$$20240826$$CN$US$US
209768124$20976812$4$F$20220324$20240719$20220617$20240723$EXP$$CA-TAKEDA-2021TUS066285$TAKEDA$$25$YR$$F$Y$$$20240723$$HP$CA$CA
2097691612$20976916$12$F$20201216$20240918$20220617$20240926$EXP$$CO-TAKEDA-2022TUS004532$TAKEDA$$64$YR$$F$Y$50$KG$20240926$$CN$CO$CO
209769525$20976952$5$F$$20240913$20220617$20240923$PER$$US-DSJP-DSU-2022-120712$DAIICHI$$$$$M$Y$$$20240923$$CN$US$US
209769865$20976986$5$F$20220511$20220812$20220617$20240711$EXP$$DE-ASTELLAS-2022US021547$ASTELLAS$$78$YR$$M$Y$$$20240711$$CN$DE$DE
209774512$20977451$2$F$20220501$20220615$20220617$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR094030$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
209774756$20977475$6$F$$20240719$20220618$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-055606$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240726$$CN$US$US
209776059$20977605$9$F$$20240910$20220618$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-056288$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240912$$HP$US$US
209777828$20977782$8$F$20200201$20240910$20220618$20240918$EXP$$CA-CELLTRION INC.-2022CA009497$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
209785982$20978598$2$F$20211217$20240905$20220618$20240916$PER$$US-SA-2022SA228407$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240916$$MD$US$US
209786145$20978614$5$F$20220101$20240718$20220618$20240725$PER$$US-SA-2022SA229186$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240725$$CN$US$US
209791414$20979141$4$F$20220521$20240618$20220619$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001879$ACADIA PHARMACEUTICALS$$70$YR$$F$Y$$$20240712$$CN$US$US
209793044$20979304$4$F$20220501$20240919$20220620$20240920$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000184$PAREXEL$$$$$$Y$$$20240920$$HP$US$US
209793707$20979370$7$F$20220301$20240807$20220620$20240810$EXP$$ES-ABBVIE-22K-144-4438743-00$ABBVIE$$75$YR$$F$Y$$$20240810$$MD$ES$ES
209794493$20979449$3$F$20220324$20240917$20220620$20240918$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000112$PAREXEL$$$$$$Y$$$20240918$$CN$US$US
209795352$20979535$2$F$20170829$20240724$20220620$20240801$EXP$$CA-ROCHE-3116479$ROCHE$$39$YR$A$F$Y$$$20240801$$MD$CA$CA
209795607$20979560$7$F$20211029$20240730$20220620$20240807$EXP$$NVSC2022US135330$NOVARTIS$$52$YR$$F$Y$51.3$KG$20240807$$MD$US$US
2097956813$20979568$13$F$20200430$20240830$20220620$20240909$EXP$$CA-CELLTRION INC.-2020CA028862$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
209799758$20979975$8$F$$20240727$20220620$20240801$EXP$$NVSC2022US140157$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
209799914$20979991$4$F$$20220810$20220620$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR093173$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$HP$US$US
209800923$20980092$3$F$20200601$20240920$20220620$20240920$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-052946$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240920$$CN$ES$ES
209802152$20980215$2$F$20200101$20240906$20220620$20240920$EXP$US-MLMSERVICE-20220531-3583040-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2022-06085$ALKEM$Ahmed A, Naji A, Zhang J, Raoufi M, Alhamar M, Salgia R, et al. Mantle Cell Lymphoma Presenting as Diarrhea in a Liver Transplant Recipient. ACG Case Reports Journal. 2021;8(7):e00635$63$YR$$M$Y$$$20240920$$MD$US$US
209805192$20980519$2$F$$20240910$20220620$20240917$EXP$$CA-APOTEX-2022AP009286$APOTEX$$48$YR$$F$Y$56$KG$20240917$$HP$CA$CA
209806888$20980688$8$F$20220606$20240822$20220620$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-060682$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240826$$CN$US$US
209811459$20981145$9$F$20210301$20240723$20220620$20240729$EXP$$IN-PFIZER INC-2021445341$PFIZER$$78$YR$$F$Y$$$20240729$$CN$IN$IN
2098125813$20981258$13$F$$20240827$20220620$20240830$PER$$US-PFIZER INC-PV202200005116$PFIZER$$75$YR$$F$Y$$$20240830$$HP$US$US
209812753$20981275$3$F$$20220222$20220620$20240722$PER$$US-ASTELLAS-2022US007080$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
209812773$20981277$3$F$$20220309$20220620$20240722$PER$$US-ASTELLAS-2022US009296$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
209812895$20981289$5$F$$20220503$20220620$20240722$PER$$US-ASTELLAS-2022US016602$ASTELLAS$$72$YR$$M$Y$$$20240722$$CN$US$US
209812943$20981294$3$F$$20210920$20220620$20240722$PER$$US-ASTELLAS-2021US035460$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
209812983$20981298$3$F$$20220120$20220620$20240722$PER$$US-ASTELLAS-2022US002485$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
209813003$20981300$3$F$$20211123$20220620$20240722$PER$$US-ASTELLAS-2021US045463$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
209813013$20981301$3$F$$20220112$20220620$20240722$PER$$US-ASTELLAS-2021US039083$ASTELLAS$$74$YR$$F$Y$$$20240722$$MD$US$US
209813063$20981306$3$F$$20211123$20220620$20240722$PER$$US-ASTELLAS-2021US045441$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
209813124$20981312$4$F$$20240809$20220620$20240814$PER$$US-PFIZER INC-PV202200004140$PFIZER$$43$YR$$F$Y$$$20240814$$HP$US$US
209815656$20981565$6$F$20220503$20221013$20220620$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR093709$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
209816633$20981663$3$F$$20240802$20220620$20240805$EXP$$CA-ROCHE-3120818$ROCHE$$$$A$F$Y$$$20240805$$CN$CA$CA
209819843$20981984$3$F$20220301$20240830$20220620$20240904$PER$$NVSC2022US138662$NOVARTIS$$22$YR$$F$Y$$$20240904$$CN$US$US
209821143$20982114$3$F$$20231130$20220620$20240721$PER$$US-NOVOPROD-921434$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
209821154$20982115$4$F$$20231130$20220620$20240721$PER$$US-NOVOPROD-921460$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
209829453$20982945$3$F$20070807$20240820$20220620$20240826$EXP$$CA-PFIZER INC-2020353249$MYLAN$$62$YR$$M$Y$$$20240826$$HP$CA$CA
209832552$20983255$2$F$$20240708$20220620$20240715$EXP$$GB-PFIZER INC-202200850945$PFIZER$$$$$F$Y$$$20240715$$MD$GB$GB
209838016$20983801$6$F$20220501$20240827$20220621$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001881$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240906$$CN$US$US
209851112$20985111$2$F$$20240910$20220621$20240930$PER$$AU-TOLMAR, INC.-22AU034999$TOLMAR$$$$$M$Y$$$20240930$$HP$AU$AU
2098525812$20985258$12$F$20200901$20240717$20220621$20240722$EXP$$NVSC2022CA140708$NOVARTIS$$37$YR$$F$Y$$$20240722$$CN$CA$CA
2098540114$20985401$14$F$20220101$20240801$20220621$20240809$EXP$$CA-CELLTRION INC.-2021CA018491$CELLTRION$$$$$$Y$$$20240809$$MD$CA$CA
209856512$20985651$2$F$20220601$20240809$20220621$20240816$EXP$$US-TAKEDA-2022TUS041106$TAKEDA$$68$YR$$M$Y$74.467$KG$20240816$$MD$US$US
209859174$20985917$4$F$20220609$20220718$20220621$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR094542$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240925$$CN$US$US
209859825$20985982$5$F$20220331$20240621$20220621$20240701$EXP$$DE-AUROBINDO-AUR-APL-2022-017452$AUROBINDO$$64$YR$$F$Y$85$KG$20240701$$MD$DE$DE
209860133$20986013$3$F$20220520$20220811$20220621$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR094253$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240925$$CN$US$US
209860576$20986057$6$F$20240101$20240814$20220621$20240822$EXP$$CA-CELLTRION INC.-2022CA009590$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
209860775$20986077$5$F$20220621$20240920$20220621$20240927$EXP$$CA-TAKEDA-2021TUS056500$TAKEDA$$60$YR$$M$Y$$$20240927$$MD$CA$CA
209866218$20986621$8$F$20240124$20240812$20220621$20240821$EXP$$CA-GLAXOSMITHKLINE-CA2022AMR095117$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$CA$CA
2098692316$20986923$16$F$20201219$20240719$20220621$20240724$EXP$$IN-PFIZER INC-2021064296$PFIZER$$66$YR$$M$Y$82.2$KG$20240724$$CN$IN$IN
209870554$20987055$4$F$$20240828$20220621$20240830$EXP$$CA-PFIZER INC-202200856409$PFIZER$$53$YR$$M$Y$$$20240830$$HP$CA$CA
2098705716$20987057$16$F$20220419$20240903$20220621$20240906$EXP$$PL-PFIZER INC-202200830492$PFIZER$$57$YR$$F$Y$66$KG$20240906$$MD$PL$PL
2098737714$20987377$14$F$$20240901$20220621$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-056703$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240904$$HP$US$US
209877636$20987763$6$F$$20240920$20220621$20240920$PER$$US-PFIZER INC-PV202200005525$PFIZER$$63$YR$$F$Y$79.819$KG$20240920$$CN$US$US
209878956$20987895$6$F$20220101$20240923$20220621$20240926$EXP$$US-PFIZER INC-202200857759$PFIZER$$74$YR$$M$Y$$$20240926$$HP$US$US
209881707$20988170$7$F$$20240914$20220621$20240916$EXP$$US-PFIZER INC-PV202200005524$PFIZER$$24$YR$$M$Y$$$20240916$$HP$US$US
209882373$20988237$3$F$20190301$20240718$20220621$20240724$EXP$$AT-ROCHE-2563804$ROCHE$$35$YR$A$F$Y$$$20240724$$CN$AT$AT
209883836$20988383$6$F$$20240909$20220621$20240917$EXP$$RO-TAKEDA-2019TEU003900$TAKEDA$$7$DY$$F$Y$$$20240917$$MD$RO$RO
2098867231$20988672$31$F$20230101$20240920$20220621$20240930$EXP$$CA-PFIZER INC-2018068761$PFIZER$$58$YR$$F$Y$$$20240930$$MD$CA$CA
2098869724$20988697$24$F$20210315$20240916$20220621$20240919$EXP$$IN-PFIZER INC-2021321044$PFIZER$$81$YR$$F$Y$48$KG$20240919$$CN$IN$IN
209890853$20989085$3$F$$20240710$20220621$20240712$EXP$$US-INCYTE CORPORATION-2022IN005916$INCYTE$$$$$$Y$$$20240712$$CN$US$US
209892135$20989213$5$F$20220612$20240911$20220621$20240913$EXP$$US-TAKEDA-2022TUS041355$TAKEDA$$9$YR$$M$Y$$$20240913$$CN$US$US
209895274$20989527$4$F$$20240826$20220621$20240830$EXP$$US-INCYTE CORPORATION-2022IN005842$INCYTE$$$$$$Y$$$20240830$$CN$US$US
209898623$20989862$3$F$$20240907$20220621$20240910$EXP$$US-PURDUE PHARMA-USA-2021-0289298$PURDUE$$43$YR$$M$Y$$$20240910$$CN$US$US
209904893$20990489$3$F$20231005$20240902$20220622$20240923$PER$$CA-TOLMAR, INC.-22CA034959$TOLMAR$$82$YR$$M$Y$$$20240923$$CN$CA$CA
2099072330$20990723$30$F$20191230$20240807$20220622$20240815$EXP$$CA-CELLTRION INC.-2019CA028714$CELLTRION$$$$$$Y$$$20240815$$MD$CA$CA
209907447$20990744$7$F$20210101$20240925$20220622$20240930$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2021-04735$IPSEN$$54$YR$A$M$Y$$$20240930$$CN$US$US
209908404$20990840$4$F$$20240821$20220622$20240831$EXP$$GB-AUROBINDO-AUR-APL-2022-022593$AUROBINDO$$$$$F$Y$$$20240831$$MD$GB$GB
209911752$20991175$2$F$20220419$20220609$20220622$20240729$EXP$$IN-RECORDATI-2022001798$RECORDATI$$$$$$Y$$$20240729$$MD$IN$IN
209913082$20991308$2$F$20220609$20240919$20220622$20240920$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000222$PAREXEL$$$$$$Y$$$20240920$$MD$US$US
209914062$20991406$2$F$$20240808$20220622$20240809$PER$$US-AVEO ONCOLOGY-2022-AVEO-US000218$PAREXEL$$$$$$Y$$$20240809$$HP$US$US
209917784$20991778$4$F$$20240718$20220622$20240725$EXP$$CA-APOTEX-2022AP009277$APOTEX$$61$YR$$F$Y$$$20240725$$HP$CA$CA
209922243$20992224$3$F$20220301$20240726$20220622$20240802$EXP$$CA-ABBVIE-22K-028-4441508-00$ABBVIE$$77$YR$$F$Y$$$20240802$$CN$CA$CA
209922639$20992263$9$F$20220601$20240807$20220622$20240815$PER$$IL-Blueprint Medicines Corporation-SP-IL-2022-001894$BLUEPRINT MEDICINES$$53$YR$A$F$Y$$$20240816$$HP$IL$IL
209923466$20992346$6$F$20220912$20240815$20220622$20240820$EXP$$CA-TAKEDA-2022TUS041426$TAKEDA$$53$YR$$M$Y$$$20240820$$CN$CA$CA
209925733$20992573$3$F$$20240628$20220622$20240702$PER$$NVSC2022US142797$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
209926305$20992630$5$F$$20240925$20220622$20240927$PER$$US-PFIZER INC-PV202200006970$PFIZER$$72$YR$$F$Y$$$20240927$$CN$US$US
209930612$20993061$2$F$20240827$20240827$20220622$20240830$EXP$$AU-TAKEDA-2022TUS001403$TAKEDA$$68$YR$$F$Y$$$20240830$$CN$AU$AU
209934622$20993462$2$F$20220601$20240808$20220622$20240809$PER$$US-AVEO ONCOLOGY-2022-AVEO-US000219$PAREXEL$$$$$$Y$$$20240809$$HP$US$US
2099394910$20993949$10$F$20230213$20240822$20220622$20240905$EXP$$US-UCBSA-2022034295$UCB$$53$YR$$F$Y$153$KG$20240905$$HP$US$US
2099434815$20994348$15$F$20230101$20240726$20220622$20240802$EXP$$IN-PFIZER INC-2020498078$PFIZER$$61$YR$$M$Y$67.2$KG$20240802$$CN$IN$IN
209944812$20994481$2$F$$20240820$20220622$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-055178$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240830$$CN$US$US
209953206$20995320$6$F$20220503$20240709$20220622$20240715$EXP$$CA-ROCHE-3121089$ROCHE$$43$YR$A$F$Y$$$20240715$$CN$CA$CA
2099536419$20995364$19$F$$20240923$20220622$20240927$EXP$$US-TAKEDA-2022TUS018945$TAKEDA$$$$$F$Y$59$KG$20240927$$HP$US$US
209953657$20995365$7$F$20211201$20240917$20220622$20240923$EXP$$US-JAZZ-2022-US-021014$JAZZ$$49$YR$$F$Y$$$20240923$$CN$US$US
2099540413$20995404$13$F$20200619$20240826$20220622$20240903$EXP$$CA-CELLTRION INC.-2020CA023665$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
209954356$20995435$6$F$$20240719$20220622$20240725$PER$$US-BIOGEN-2022BI01133429$BIOGEN$$$$$M$Y$$$20240725$$CN$US$US
2099662312$20996623$12$F$20220101$20240703$20220623$20240710$EXP$$CA-CELLTRION INC.-2022CA007121$CELLTRION$$$$$$Y$$$20240710$$MD$CA$CA
209969964$20996996$4$F$20220601$20220718$20220623$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR094555$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240925$$CN$US$US
209970996$20997099$6$F$20240227$20240924$20220623$20240926$EXP$$CA-ROCHE-3123686$ROCHE$$53$YR$A$F$Y$$$20240926$$CN$CA$CA
209971226$20997122$6$F$20210901$20240628$20220623$20240712$EXP$$CA-SAMSUNG BIOEPIS-SB-2022-02791$SAMSUNG BIOEPIS$$56$YR$A$F$Y$$$20240712$$CN$CA$CA
2099726612$20997266$12$F$20220620$20230711$20220623$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR093521$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240926$$CN$US$US
209974097$20997409$7$F$20220620$20220831$20220623$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR096249$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$MD$US$US
209977995$20997799$5$F$20220101$20240919$20220623$20240924$EXP$$CA-PFIZER INC-2018322635$PFIZER$$80$YR$$M$Y$$$20240924$$CN$CA$CA
209978053$20997805$3$F$20240101$20240826$20220623$20240829$EXP$$CA-PFIZER INC-202200857357$PFIZER$$78$YR$$M$Y$66.4$KG$20240829$$MD$CA$CA
2099824910$20998249$10$F$20221206$20240913$20220623$20240917$EXP$$NVSC2020CA222908$NOVARTIS$$48$YR$$F$Y$$$20240918$$CN$CA$CA
209982859$20998285$9$F$20220601$20230606$20220623$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR095809$GLAXOSMITHKLINE$$54$YR$$F$Y$50.7$KG$20240925$$MD$US$US
209986542$20998654$2$F$$20240805$20220623$20240812$EXP$$CA-GLAXOSMITHKLINE-CA2022095624$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$PH$CA$CA
209992904$20999290$4$F$$20240918$20220623$20240926$EXP$$CA-TAKEDA-2022TUS041648$TAKEDA$$$$$F$Y$$$20240926$$MD$CA$CA
2099948210$20999482$10$F$20220706$20240822$20220623$20240827$EXP$$CA-TAKEDA-2022TUS036626$TAKEDA$$23$YR$$M$Y$$$20240827$$CN$CA$CA
209995968$20999596$8$F$20220825$20240809$20220623$20240814$EXP$$CA-TAKEDA-2022TUS042203$TAKEDA$$66$YR$$M$Y$$$20240814$$MD$CA$CA
210003394$21000339$4$F$$20240822$20220623$20240826$EXP$$US-PFIZER INC-PV202200008041$PFIZER$$69$YR$$F$Y$$$20240826$$CN$US$US
210004813$21000481$3$F$$20240905$20220623$20240911$EXP$$CA-PURDUE-USA-2022-0294686$PURDUE$$$$$F$Y$$$20240911$$HP$CA$CA
210006285$21000628$5$F$20220322$20240722$20220623$20240729$EXP$$JP-009507513-2206JPN002178J$MERCK$Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022$67$YR$$F$Y$52$KG$20240729$$MD$JP$JP
210009055$21000905$5$F$20220201$20240617$20220624$20240711$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001947$ACADIA PHARMACEUTICALS$$84$YR$$F$Y$$$20240711$$CN$US$US
2100097716$21000977$16$F$20220611$20240920$20220624$20240926$EXP$$US-TAKEDA-2021TUS026888$TAKEDA$$84$YR$$F$Y$123$KG$20240926$$HP$US$US
210009816$21000981$6$F$$20240805$20220624$20240807$EXP$$NVSC2022US144142$NOVARTIS$$$$$M$Y$$$20240807$$CN$US$US
210012384$21001238$4$F$20220101$20240613$20220624$20240702$PER$$CR-TOLMAR, INC.-22CR032654$TOLMAR$$91$YR$$M$Y$$$20240702$$CN$CR$CR
210014813$21001481$3$F$20220613$20220628$20220624$20240715$EXP$$IT-ASTELLAS-2022US022777$ASTELLAS$$78$YR$$M$Y$$$20240715$$MD$IT$IT
210023902$21002390$2$F$20190312$20220622$20220624$20240715$EXP$$BG-ASTELLAS-2022US022674$ASTELLAS$$60$YR$$M$Y$$$20240715$$MD$BG$BG
210031907$21003190$7$F$20240226$20240913$20220624$20240918$EXP$$US-TAKEDA-2022TUS040971$TAKEDA$$66$YR$$M$Y$88$KG$20240918$$HP$US$US
210034985$21003498$5$F$$20240828$20220624$20240905$EXP$$CA-MYLANLABS-2022M1047757$BIOCON$$$$$$Y$$$20240905$$CN$CA$CA
2100377112$21003771$12$F$20210101$20240719$20220624$20240723$EXP$$CA-PFIZER INC-202200845720$PFIZER$$63$YR$$F$Y$79$KG$20240723$$HP$CA$CA
2100379216$21003792$16$F$20220614$20240715$20220624$20240718$EXP$$CA-PFIZER INC-202200468375$PFIZER$$31$YR$$F$Y$$$20240718$$HP$CA$CA
2100386414$21003864$14$F$20211125$20240718$20220624$20240731$EXP$$JP-ROCHE-2988814$ROCHE$$75$YR$E$M$Y$$$20240731$$MD$JP$JP
210040222$21004022$2$F$$20240820$20220624$20240823$EXP$$US-ABBVIE-22K-163-4444452-00$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
210041753$21004175$3$F$20220101$20240912$20220624$20240913$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000106$PAREXEL$$$$$$Y$$$20240913$$CN$US$US
210046192$21004619$2$F$$20240812$20220624$20240813$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000227$PAREXEL$$$$$$Y$$$20240813$$CN$US$US
210047034$21004703$4$F$$20240812$20220624$20240815$PER$$US-PFIZER INC-PV202200008825$PFIZER$$93$YR$$F$Y$$$20240815$$CN$US$US
210047135$21004713$5$F$20220608$20240705$20220624$20240711$EXP$$CN-TAKEDA-2022TUS041259$TAKEDA$$63$YR$$M$Y$70$KG$20240711$$MD$CN$CN
2100480117$21004801$17$F$20220502$20240722$20220624$20240725$EXP$$NVSC2022CH124893$NOVARTIS$$73$YR$$F$Y$58.2$KG$20240725$$MD$CH$CH
210049836$21004983$6$F$$20240722$20220624$20240726$EXP$$US-TAKEDA-US201911190$TAKEDA$$$$$F$Y$54.42$KG$20240726$$CN$US$US
2100532813$21005328$13$F$20211119$20240905$20220624$20240910$EXP$$US-TAKEDA-US202004562$TAKEDA$$23$YR$$F$Y$$$20240910$$HP$US$US
210055905$21005590$5$F$$20240801$20220624$20240805$EXP$$US-TAKEDA-2022TUS040487$TAKEDA$$$$$M$Y$111$KG$20240805$$HP$US$US
210060453$21006045$3$F$20220117$20240713$20220624$20240716$EXP$$FR-TAKEDA-2022TUS042325$TAKEDA$$40$YR$$M$Y$$$20240716$$HP$FR$FR
210060655$21006065$5$F$20220616$20240628$20220624$20240704$EXP$$CA-TAKEDA-2022TUS042210$TAKEDA$$55$YR$$F$Y$$$20240704$$MD$CA$CA
210061789$21006178$9$F$20000101$20240711$20220624$20240715$EXP$$US-TAKEDA-2022TUS040523$TAKEDA$$$$$F$Y$53$KG$20240715$$HP$US$US
210065257$21006525$7$F$20220618$20240917$20220624$20240924$EXP$$CA-TAKEDA-2022TUS041525$TAKEDA$$74$YR$$F$Y$$$20240924$$CN$CA$CA
210065535$21006553$5$F$20200506$20240827$20220624$20240904$EXP$$CA-CELLTRION INC.-2021CA001546$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
210065997$21006599$7$F$20210101$20240801$20220625$20240807$EXP$$US-ABBVIE-22K-163-4415942-00$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
210069149$21006914$9$F$$20240918$20220625$20240930$PER$$NVSC2022US144122$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
210069986$21006998$6$F$20190501$20240625$20220625$20240706$EXP$$CA-ROCHE-2348322$ROCHE$$47$YR$A$M$Y$$$20240706$$CN$CA$CA
2100706711$21007067$11$F$$20240712$20220625$20240720$EXP$$US-TAKEDA-2022TUS023989$TAKEDA$$$$$M$Y$58$KG$20240720$$MD$US$US
210077262$21007726$2$F$20220530$20220623$20220627$20240711$EXP$$DE-ASTELLAS-2022US022838$ASTELLAS$$81$YR$$M$Y$$$20240711$$MD$DE$DE
210079759$21007975$9$F$20200617$20240618$20220627$20240706$EXP$$DE-ROCHE-2632936$ROCHE$$55$YR$A$F$Y$$$20240706$$CN$DE$DE
210085952$21008595$2$F$$20240725$20220627$20240801$EXP$$US-JNJFOC-20220644273$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$LW$US$US
210088622$21008862$2$F$$20240913$20220627$20240926$EXP$$GB-CELLTRION INC.-2022GB009787$CELLTRION$$$$$$Y$$$20240926$$PH$GB$GB
210088744$21008874$4$F$20220429$20240802$20220627$20240807$EXP$$DE-TAKEDA-2022TUS042434$TAKEDA$$39$YR$$F$Y$65$KG$20240807$$HP$DE$DE
210089244$21008924$4$F$$20240724$20220627$20240729$EXP$$CA-JNJFOC-20220644458$JOHNSON AND JOHNSON$$65$YR$E$F$Y$34$KG$20240729$$CN$CA$CA
2100892723$21008927$23$F$20150901$20240923$20220627$20240927$EXP$$CA-JNJFOC-20220649922$JOHNSON AND JOHNSON$$43$YR$A$F$Y$70$KG$20240927$$HP$CA$CA
210091059$21009105$9$F$20220627$20240625$20220627$20240701$EXP$$CA-TAKEDA-2021TUS054048$TAKEDA$$74$YR$$F$Y$$$20240701$$CN$CA$CA
210095554$21009555$4$F$20181212$20240815$20220627$20240821$EXP$$DE-MYLANLABS-2022M1041886$MYLAN$$$$A$F$Y$72$KG$20240821$$MD$DE$DE
210097282$21009728$2$F$$20240923$20220627$20240924$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000231$PAREXEL$$$$$$Y$$$20240924$$HP$US$US
210098443$21009844$3$F$20220608$20240821$20220627$20240829$EXP$$US-TAKEDA-2022TUS010820$TAKEDA$$54$YR$$F$Y$91$KG$20240829$$MD$US$US
210106129$21010612$9$F$20220614$20240828$20220627$20240904$EXP$$IN-PFIZER INC-PV202200007066$PFIZER$$49$YR$$M$Y$$$20240904$$CN$IN$IN
210107328$21010732$8$F$20220620$20240904$20220627$20240909$EXP$$CA-PFIZER INC-202200634661$PFIZER$$64$YR$$M$Y$79$KG$20240909$$MD$CA$CA
210115126$21011512$6$F$20210812$20240812$20220627$20240822$EXP$$CA-TAKEDA-2021TUS058774$TAKEDA$$42$YR$$F$Y$$$20240822$$MD$CA$CA
210121409$21012140$9$F$20210615$20240816$20220627$20240823$EXP$$CO-TAKEDA-2021TUS039492$TAKEDA$$6$YR$$F$Y$21$KG$20240823$$CN$CO$CO
210126632$21012663$2$F$20220101$20240820$20220627$20240916$PER$$US-SA-2022SA227784$SANOFI AVENTIS$$25$YR$A$M$Y$102.04$KG$20240916$$MD$US$US
210128912$21012891$2$F$$20240812$20220627$20240820$PER$$US-SA-2022SA236157$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240820$$MD$US$US
210129973$21012997$3$F$20220101$20240711$20220627$20240801$PER$$US-SA-2022SA234005$SANOFI AVENTIS$$61$YR$A$M$Y$95.692$KG$20240719$$MD$US$US
210131872$21013187$2$F$$20240703$20220627$20240712$PER$$US-SA-2022SA234820$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240712$$MD$US$US
210132245$21013224$5$F$20220101$20240828$20220627$20240910$PER$$US-SA-2022SA237727$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240910$$MD$US$US
210132422$21013242$2$F$20220101$20240713$20220627$20240722$PER$$US-SA-2022SA234367$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240722$$MD$US$US
210133052$21013305$2$F$20240719$20240829$20220627$20240919$PER$$US-SA-2022SA239023$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240919$$CN$US$US
210133335$21013333$5$F$20220609$20240731$20220627$20240809$PER$$US-SA-2022SA235267$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240809$$MD$US$US
210136934$21013693$4$F$20220101$20240814$20220627$20240828$PER$$US-SA-2022SA238648$SANOFI AVENTIS$$66$YR$E$F$Y$45.8$KG$20240828$$MD$US$US
210137154$21013715$4$F$$20240722$20220627$20240730$PER$$US-SA-2022SA245385$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240730$$MD$US$US
210137377$21013737$7$F$$20240715$20220627$20240722$PER$$US-SA-2022SA242401$SANOFI AVENTIS$$$$A$M$Y$$$20240722$$MD$US$US
210138073$21013807$3$F$20240801$20240913$20220627$20240927$PER$$US-SA-2022SA241828$SANOFI AVENTIS$$6$YR$C$F$Y$64$KG$20240927$$MD$US$US
2101394821$21013948$21$F$20220101$20240724$20220627$20240802$EXP$$US-SA-2022SA239648$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240802$$MD$US$US
210140262$21014026$2$F$$20240723$20220627$20240801$PER$$US-SA-2022SA242518$SANOFI AVENTIS$$25$YR$A$F$Y$83$KG$20240801$$MD$US$US
2101416915$21014169$15$F$$20240823$20220627$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-063841$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240829$$MD$JP$JP
2101467215$21014672$15$F$20220101$20240625$20220628$20240702$EXP$$CA-CELLTRION INC.-2022CA005944$CELLTRION$$$$$$Y$$$20240703$$MD$CA$CA
210150628$21015062$8$F$20220527$20240801$20220628$20240806$EXP$$JP-ABBVIE-22K-087-4419196-00$ABBVIE$Nakagawa M, Inoue N, Takise S, Takayanagi M, Kubo T, Muroi H, et al. Buried bumper syndrome in percutaneous endoscopic gastrostomy with a jejunal extension tube in patients undergoing levodopa-carbidopa intestinal gel treatment. surg case rep. 2023;9(1):213.; Nakagawa M, Oishi H, Oaku Y, et al. O-64-4 A Case of Buried Bumper Syndrome Caused by DUODOPA PEG-J Tube. The 38th Annual Meeting of the Japanese Society for Clinical Nutrition and Metabolism (2023).; M Nakagawa ,H Oishi ,Y Oaku , et al....$71$YR$$M$Y$$$20240806$$MD$JP$JP
210152712$21015271$2$F$$20240902$20220628$20240905$EXP$$CO-SA-2022SA247516$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240905$$MD$CO$CO
2101536317$21015363$17$F$20220201$20240903$20220628$20240906$EXP$$CA-TAKEDA-2021TUS033023$TAKEDA$$28$YR$$F$Y$94$KG$20240906$$CN$CA$CA
210156095$21015609$5$F$20211201$20240731$20220628$20240805$EXP$$US-PFIZER INC-2019062183$PFIZER$$72$YR$$F$Y$67.13$KG$20240805$$MD$US$US
210156195$21015619$5$F$20220706$20240710$20220628$20240715$EXP$$CA-TAKEDA-2022TUS042500$TAKEDA$$40$YR$$F$Y$$$20240715$$HP$CA$CA
2101574119$21015741$19$F$20210316$20240910$20220628$20240918$EXP$$CA-CELLTRION INC.-2021CA004597$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
210158555$21015855$5$F$$20240911$20220628$20240921$EXP$CA-MHPD-E2B_04336577$CA-Accord-266935$ACCORD$$60$YR$A$M$Y$$$20240921$$CN$CA$CA
210164392$21016439$2$F$$20220627$20220628$20240715$EXP$$BG-ASTELLAS-2022US023156$ASTELLAS$$48$YR$$M$Y$$$20240715$$MD$BG$BG
210165473$21016547$3$F$$20240924$20220628$20240930$EXP$$US-TAKEDA-US202013595$TAKEDA$$$$$F$Y$$$20240930$$HP$US$US
210167714$21016771$4$F$20181024$20240725$20220628$20240731$EXP$$US-TAKEDA-US201843406$TAKEDA$$7$YR$$M$Y$29$KG$20240731$$MD$US$US
210173173$21017317$3$F$20210520$20240806$20220628$20240812$EXP$$US-PFIZER INC-PV202200006627$PFIZER$Rogers, R.. Broad antimicrobial resistance in a case of relapsing babesiosis successfully treated with tafenoquine. Clinical Infectious Diseases. 2022;10.1093/cid/ciac473$80$YR$$M$Y$$$20240812$$HP$US$US
210174312$21017431$2$F$$20220615$20220628$20240715$PER$$US-MYLANLABS-2022M1046416$BIOCON$$$$$F$Y$$$20240715$$$US$US
2101754420$21017544$20$F$20220628$20240916$20220628$20240919$PER$$US-PFIZER INC-202200763817$PFIZER$$83$YR$$M$Y$$$20240919$$MD$US$US
210178863$21017886$3$F$$20221114$20220628$20240802$EXP$$CA-Covis Pharma GmbH-2022COV01978$COVIS PHARMA$$71$YR$E$M$Y$$$20240802$$$COUNTRY NOT SPECIFIED$CA
210180422$21018042$2$F$20220101$20240912$20220628$20240917$EXP$$US-INCYTE CORPORATION-2022IN006359$INCYTE$$$$$$Y$$$20240917$$CN$US$US
210185764$21018576$4$F$$20240826$20220628$20240903$EXP$$CA-Covis Pharma GmbH-2021COV20934$COVIS PHARMA$$65$YR$E$F$Y$$$20240903$$MD$CA$CA
210186603$21018660$3$F$20220622$20220721$20220628$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR097773$GLAXOSMITHKLINE$$81$YR$$F$Y$$$20240925$$CN$US$US
2101866110$21018661$10$F$20220714$20230208$20220628$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR096734$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
210188283$21018828$3$F$20220603$20240731$20220628$20240802$EXP$FR-AFSSAPS-MP20222136$FR-MYLANLABS-2022M1048951$MYLAN$$51$YR$$F$Y$$$20240802$$MD$FR$FR
210189092$21018909$2$F$$20240809$20220628$20240814$EXP$$US-JAZZ-2022-US-019657$JAZZ$$$$$F$Y$$$20240814$$HP$US$US
2101895472$21018954$72$F$$20240919$20220628$20240930$EXP$$CA-PFIZER INC-2020321392$PFIZER$$41$YR$$F$Y$$$20240930$$PH$CA$CA
2101930010$21019300$10$F$20221021$20240918$20220628$20240930$PER$$NVSC2022US146930$NOVARTIS$$41$YR$$M$Y$88.5$KG$20240930$$CN$US$US
210199248$21019924$8$F$20230727$20240731$20220628$20240805$EXP$$US-JAZZ-2022-US-007926$JAZZ$$42$YR$$F$Y$$$20240804$$MD$US$US
210199268$21019926$8$F$20220503$20240815$20220628$20240822$EXP$$US-JAZZ-2022-US-007657$JAZZ$$59$YR$$F$Y$$$20240822$$CN$US$US
210199275$21019927$5$F$20240101$20240820$20220628$20240827$EXP$$US-JAZZ-2022-US-001519$JAZZ$$$$$F$Y$$$20240826$$MD$US$US
2101997260$21019972$60$F$20190716$20240927$20220628$20240930$EXP$$NVSC2019DE105910$NOVARTIS$$79$YR$$F$Y$56$KG$20240930$$HP$DE$DE
210202023$21020202$3$F$20220601$20240812$20220628$20240813$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000237$PAREXEL$$$$$$Y$$$20240813$$CN$US$US
210203093$21020309$3$F$$20240716$20220628$20240725$EXP$$JP-AMGEN-JPNSP2022109700$AMGEN$$$$$F$Y$$$20240725$$CN$JP$JP
210203292$21020329$2$F$20210101$20240829$20220628$20240918$EXP$$US-ABBVIE-21K-163-3977168-00$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
210203422$21020342$2$F$20220615$20240708$20220629$20240713$PER$$US-SA-2022SA246165$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240713$$MD$US$US
210205195$21020519$5$F$20140811$20240918$20220629$20240924$EXP$$US-JNJFOC-20220644432$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240924$$LW$US$US
210209245$21020924$5$F$20180217$20240808$20220629$20240811$EXP$$US-TAKEDA-2022TUS015003$TAKEDA$$38$YR$$F$Y$66.21$KG$20240811$$CN$US$US
2102094914$21020949$14$F$$20240823$20220629$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-063842$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240829$$MD$JP$JP
210209923$21020992$3$F$20220627$20220720$20220629$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR098477$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
210211267$21021126$7$F$20190625$20240829$20220629$20240905$EXP$$DE-ROCHE-2355987$ROCHE$$59$YR$A$F$Y$48$KG$20240905$$CN$DE$DE
210211576$21021157$6$F$20220206$20240606$20220629$20240709$EXP$$IT-ROCHE-3121760$ROCHE$$58$YR$A$M$Y$$$20240701$$MD$IT$IT
2102154719$21021547$19$F$20201001$20240702$20220629$20240705$EXP$$US-TAKEDA-US202033915$TAKEDA$$56$YR$$M$Y$$$20240705$$HP$US$US
210216108$21021610$8$F$$20240904$20220629$20240905$EXP$$CA-ROCHE-2769702$ROCHE$$$$A$M$Y$$$20240905$$CN$CA$CA
210220333$21022033$3$F$$20240916$20220629$20240926$EXP$$CA-APOTEX-2022AP009599$APOTEX$$53$YR$$F$Y$99$KG$20240926$$HP$CA$CA
210221428$21022142$8$F$20220614$20240709$20220629$20240711$EXP$$CH-ABBVIE-22K-151-4449685-00$ABBVIE$$$$E$M$Y$75$KG$20240711$$MD$CH$CH
210228362$21022836$2$F$$20240917$20220629$20240927$EXP$$JP-BAXTER-2022BAX013557$BAXTER$$$$$$Y$$$20240927$$PH$JP$JP
210231029$21023102$9$F$$20240916$20220629$20240919$EXP$$US-PFIZER INC-PV202200012006$PFIZER$$72$YR$$F$Y$$$20240919$$CN$US$US
21023228100$21023228$100$F$20220620$20240905$20220629$20240913$EXP$$DE-ROCHE-3127506$ROCHE$$54$YR$A$F$Y$$$20240913$$CN$DE$DE
210232303$21023230$3$F$20220623$20240802$20220629$20240807$EXP$$CA-ROCHE-3127516$ROCHE$$42$YR$A$M$Y$$$20240807$$CN$CA$CA
210234352$21023435$2$F$20220624$20240712$20220629$20240723$PER$$US-SA-2022SA250163$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240723$$MD$US$US
210238972$21023897$2$F$$20240916$20220629$20240925$EXP$$CA-TEVA-2022-CA-2049138$TEVA$$39$YR$$F$Y$$$20240925$$PH$CA$CA
210240732$21024073$2$F$$20240726$20220629$20240801$EXP$$US-KYOWAKIRIN-2022BKK009623$KYOWA$$$$$$Y$$$20240801$$HP$US$US
210254737$21025473$7$F$$20240701$20220630$20240717$EXP$$NVSC2022IT145954$NOVARTIS$Balestri R, Bortolotti R, Rech G, Girardelli CR, Zorzi MG, Magnano M. Treatment of oral erosive lichen planus with upadacitinib. JAMA DERMATOLOGY. 2022;158(4):457-8$45$YR$$F$Y$$$20240717$$HP$IT$IT
210256617$21025661$7$F$20200901$20240703$20220630$20240716$EXP$$EG-ROCHE-2725579$ROCHE$$43$YR$A$F$Y$85$KG$20240716$$CN$EG$EG
2102601419$21026014$19$F$20220101$20240913$20220630$20240921$EXP$$CA-CELLTRION INC.-2022CA007978$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
210260742$21026074$2$F$$20230619$20220630$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-061504$BRISTOL MYERS SQUIBB$Hamilton C, Nowicki T, Federman N. Severe immune checkpoint inhibitor associated hepatitis successfully treated with basiliximab. Pediatric Blood and Cancer. 2022 Jun 01;69(Suppl 2):S154-5.$22$YR$A$F$Y$$$20240708$$HP$US$US
210261308$21026130$8$F$$20230111$20220630$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR099073$GLAXOSMITHKLINE$$$$$F$Y$108$KG$20240925$$MD$US$US
210261913$21026191$3$F$20220614$20240612$20220630$20240709$EXP$$DE-ROCHE-3122778$ROCHE$$26$YR$A$F$Y$$$20240702$$CN$DE$DE
2102625513$21026255$13$F$20171201$20240827$20220630$20240903$EXP$$CA-ROCHE-2768094$ROCHE$$55$YR$A$M$Y$$$20240903$$CN$CA$CA
210262828$21026282$8$F$20240101$20240923$20220630$20240930$EXP$$US-TAKEDA-US201620618$TAKEDA$$69$YR$$F$Y$58$KG$20240930$$CN$US$US
2102628412$21026284$12$F$20240820$20240925$20220630$20240930$EXP$$US-TAKEDA-2021TUS034944$TAKEDA$$60$YR$$F$Y$105$KG$20240930$$MD$US$US
210264815$21026481$5$F$20220524$20240909$20220630$20240911$EXP$$CA-ROCHE-3128642$ROCHE$$33$YR$A$F$Y$$$20240911$$CN$CA$CA
210265992$21026599$2$F$20220601$20240813$20220630$20240820$PER$$US-SA-2022SA249072$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240820$$MD$US$US
210272493$21027249$3$F$20220101$20240911$20220630$20240913$PER$$US-PFIZER INC-PV202200011755$PFIZER$$78$YR$$F$Y$$$20240913$$HP$US$US
2102730521$21027305$21$F$20220407$20240919$20220630$20240925$EXP$$IN-PFIZER INC-2021016280$PFIZER$$65$YR$$F$Y$$$20240925$$CN$IN$IN
210274314$21027431$4$F$$20240715$20220630$20240808$EXP$$FR-AstraZeneca-2022A232415$ASTRAZENECA$$$$$M$Y$$$20240808$$MD$FR$
210276652$21027665$2$F$$20240708$20220630$20240715$EXP$$IE-PFIZER INC-202200903967$PFIZER$$$$$F$Y$$$20240715$$MD$IE$IE
210280079$21028007$9$F$20220101$20240130$20220630$20240807$EXP$$NVSC2022KW117577$NOVARTIS$$45$YR$$F$Y$$$20240807$$CN$KW$KW
210284065$21028406$5$F$$20240711$20220630$20240715$EXP$$CA-AstraZeneca-2022A226935$ASTRAZENECA$$58$YR$$F$Y$$$20240715$$MD$CA$
210287816$21028781$6$F$$20240627$20220630$20240705$EXP$$IT-MYLANLABS-2022M1048946$BIOCON$Balestri R, Bortolotti R, Rech G, Girardelli CR, Zorzi MG, Magnano M.. Treatment of Oral Erosive Lichen Planus With Upadacitinib. JAMA Dermatology. 2022;158 (4):457-458$$$$$Y$$$20240705$$MD$IT$IT
210288193$21028819$3$F$20220201$20240805$20220630$20240812$EXP$$JP-PFIZER INC-202200384961$PFIZER$$6$DEC$$M$Y$$$20240812$$MD$JP$JP
210294122$21029412$2$F$20220405$20240812$20220630$20240815$EXP$$CA-TAKEDA-2022TUS001030$TAKEDA$$53$YR$$M$Y$$$20240815$$MD$CA$CA
210306453$21030645$3$F$$20240731$20220701$20240803$PER$$US-ROCHE-3070947$ROCHE$$53$YR$A$M$Y$$$20240803$$CN$US$US
210310384$21031038$4$F$$20240822$20220701$20240823$EXP$$US-TAKEDA-US202008380$TAKEDA$$$$$F$Y$$$20240823$$HP$US$US
210312612$21031261$2$F$20220510$20240711$20220701$20240715$EXP$FR-AFSSAPS-LL20221869$FR-PFIZER INC-202200884838$PFIZER$$51$YR$$M$Y$$$20240715$$MD$FR$FR
2103141721$21031417$21$F$20220501$20240917$20220701$20240926$EXP$$CA-CELLTRION INC.-2022CA006956$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
210315607$21031560$7$F$20191015$20240716$20220701$20240731$EXP$$DE-ROCHE-2468265$ROCHE$$54$YR$A$F$Y$$$20240731$$CN$DE$DE
210319057$21031905$7$F$20220610$20240723$20220701$20240819$PER$$AU-TOLMAR, INC.-22AU035140$TOLMAR$$70$YR$$M$Y$$$20240814$$CN$AU$AU
210322733$21032273$3$F$$20240703$20220701$20240705$EXP$$CA-TAKEDA-2021TUS051481$TAKEDA$$$$$F$Y$$$20240705$$MD$CA$CA
210328293$21032829$3$F$20211101$20240723$20220701$20240731$EXP$$DE-ROCHE-3127680$ROCHE$$43$YR$A$F$Y$60$KG$20240731$$MD$DE$DE
210329587$21032958$7$F$20220628$20230831$20220701$20240813$EXP$$NVSC2022US150365$NOVARTIS$$50$YR$$M$Y$$$20240813$$CN$US$US
210330699$21033069$9$F$20220224$20240809$20220701$20240813$EXP$$JP-TAKEDA-2022TJP034945$TAKEDA$$50$YR$$M$Y$$$20240813$$PH$JP$JP
210331134$21033113$4$F$20220119$20240828$20220701$20240909$EXP$$JP-ASTELLAS-2022JP009769$ASTELLAS$$87$YR$E$M$Y$81$KG$20240909$$MD$JP$JP
210331237$21033123$7$F$20220604$20240626$20220701$20240702$EXP$$KR-009507513-2206KOR008466$MERCK$$54$YR$$F$Y$66.2$KG$20240702$$MD$KR$KR
210336425$21033642$5$F$20230426$20240925$20220701$20240926$PER$$US-PFIZER INC-PV202200011696$PFIZER$$62$YR$$F$Y$$$20240926$$CN$US$US
210336477$21033647$7$F$20220101$20240729$20220701$20240731$EXP$$US-PFIZER INC-PV202200011639$PFIZER$$51$YR$$F$Y$$$20240731$$HP$US$US
210341817$21034181$7$F$20220626$20240905$20220701$20240909$EXP$$US-PFIZER INC-PV202200012596$PFIZER$$70$YR$$F$Y$102$KG$20240909$$HP$US$US
210350127$21035012$7$F$20170817$20240827$20220701$20240829$EXP$$CA-TAKEDA-2017TUS019035$TAKEDA$$60$YR$$F$Y$$$20240829$$CN$CA$CA
210350992$21035099$2$F$20200801$20240823$20220701$20240826$EXP$$US-TAKEDA-2022TUS043845$TAKEDA$$59$YR$$M$Y$$$20240826$$MD$US$US
210355826$21035582$6$F$20211031$20240828$20220701$20240902$EXP$$US-JAZZ-2022-US-022244$JAZZ$$60$YR$$M$Y$$$20240902$$CN$US$US
210356576$21035657$6$F$20220101$20240716$20220701$20240723$EXP$$FR-VERTEX PHARMACEUTICALS-2022-009644$VERTEX$$$$$M$Y$3$KG$20240723$$MD$FR$FR
210356704$21035670$4$F$20140101$20240708$20220701$20240715$EXP$$FR-JNJFOC-20201030209$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240715$$MD$FR$CA
210358054$21035805$4$F$20171025$20240819$20220701$20240826$EXP$$CA-TAKEDA-2017TUS017396$TAKEDA$$37$YR$$F$Y$$$20240826$$CN$CA$CA
210359442$21035944$2$F$20220101$20240827$20220701$20240910$PER$$US-SA-2022SA257834$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240910$$MD$US$US
210359855$21035985$5$F$$20240902$20220701$20240905$EXP$$CA-BAUSCH-BL-2022-016425$BAUSCH AND LOMB$$43$YR$$F$Y$$$20240905$$CN$CA$CA
2103636427$21036364$27$F$20211118$20240915$20220702$20240924$EXP$$CA-CELLTRION INC.-2021CA018944$CELLTRION$$$$$$Y$$$20240924$$MD$CA$CA
2103643113$21036431$13$F$$20240724$20220702$20240807$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2022-050444$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$HP$CA$CA
2103643317$21036433$17$F$20211007$20240902$20220702$20240910$EXP$$CA-CELLTRION INC.-2021CA017411$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
210364564$21036456$4$F$20211201$20240819$20220702$20240823$EXP$$JP-ABBVIE-22P-087-4454113-00$ABBVIE$$62$YR$$M$Y$$$20240823$$MD$JP$JP
2103670218$21036702$18$F$20220629$20240920$20220702$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-066602$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240923$$CN$US$US
210368373$21036837$3$F$$20240611$20220702$20240720$EXP$$US-PAREXEL-2021-KAM-US003350$TAKEDA$$$$$F$Y$74.83$KG$20240720$$CN$US$US
210370392$21037039$2$F$20220601$20220629$20220702$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR100373$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240925$$CN$US$US
2103704718$21037047$18$F$20190511$20240722$20220702$20240729$EXP$$IT-SHIRE-IT201916936$TAKEDA$$77$YR$$F$Y$$$20240729$$CN$IT$IT
210373175$21037317$5$F$$20240712$20220703$20240718$EXP$$CA-ROCHE-2983782$ROCHE$$$$A$F$Y$$$20240718$$CN$CA$CA
2103760143$21037601$43$F$20220101$20240910$20220704$20240917$EXP$$CA-CELLTRION INC.-2022CA004127$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
210377282$21037728$2$F$$20240812$20220704$20240813$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000247$PAREXEL$$$$$$Y$$$20240813$$HP$US$US
210377754$21037775$4$F$20220601$20220909$20220704$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR100408$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
210378002$21037800$2$F$20220601$20240923$20220704$20240924$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000244$PAREXEL$$$$$$Y$$$20240924$$HP$US$US
210380198$21038019$8$F$20211130$20240913$20220704$20240921$EXP$$CA-CELLTRION INC.-2021CA018153$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
210380252$21038025$2$F$20220601$20240808$20220704$20240816$PER$$US-SA-2022SA253714$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240816$$MD$US$US
210383069$21038306$9$F$20220624$20240701$20220704$20240708$EXP$$US-SA-2022SA253074$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240708$$MD$US$US
210387902$21038790$2$F$$20240710$20220704$20240712$EXP$$ES-PFIZER INC-202200891587$PFIZER$$72$YR$$M$Y$$$20240712$$MD$ES$ES
210387982$21038798$2$F$20220501$20220628$20220704$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR096213$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
210388387$21038838$7$F$20220607$20240807$20220704$20240812$EXP$$JP-ASTELLAS-2022JP009756$ASTELLAS$$68$YR$$M$Y$60.7$KG$20240812$$MD$JP$JP
210391292$21039129$2$F$$20240915$20220704$20240920$EXP$$NVSC2022EG149314$NOVARTIS$$$$$F$Y$$$20240920$$CN$EG$EG
210391822$21039182$2$F$$20240716$20220704$20240723$EXP$$AR-GLAXOSMITHKLINE-AR2022AMR099769$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$AR$AR
210392273$21039227$3$F$20220601$20220804$20220704$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR100888$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$MD$US$US
210394137$21039413$7$F$20220308$20240717$20220704$20240726$PER$$US-VERTEX PHARMACEUTICALS-2021-019514$VERTEX$$8$YR$$M$Y$24$KG$20240726$$HP$US$US
210394303$21039430$3$F$$20240921$20220704$20240925$EXP$$NVSC2022EG151346$NOVARTIS$$$$$F$Y$$$20240925$$CN$EG$EG
210394942$21039494$2$F$20220501$20240910$20220704$20240917$EXP$$NVSC2022CA151066$NOVARTIS$$64$YR$$M$Y$$$20240918$$CN$CA$CA
210396072$21039607$2$F$20190101$20240820$20220704$20240823$EXP$$IT-ROCHE-3131125$ROCHE$Monti M, Cortesi P, Vespignani R, Bronico I, Gallio C, Flospergher M, Matteucci L and Frassineti G Takotsubo Syndrome (TTS) in Onco-Hematologic Patients: Retrospective Analysis and Focus on the Correlation or Not With Anticancer Drugs. Case Reports and Review of the Literature. Doi: 10.3389/fonc.2022.875391.. Frontiers in Oncology 2022 May 26;12:1-10.$80$YR$E$F$Y$$$20240823$$HP$IT$IT
210397813$21039781$3$F$20220301$20240923$20220704$20240928$EXP$$CA-JNJFOC-20220701735$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240928$$HP$CA$CA
210399184$21039918$4$F$20170301$20240815$20220704$20240819$EXP$$DE-TAKEDA-DE201738142$TAKEDA$$53$YR$$F$Y$$$20240819$$HP$DE$DE
210399324$21039932$4$F$20171108$20240716$20220704$20240717$EXP$$FR-TAKEDA-FR202000725$TAKEDA$$73$YR$$F$Y$$$20240717$$HP$FR$FR
210403036$21040303$6$F$20220601$20221202$20220704$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR100847$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$HP$US$US
210405374$21040537$4$F$20201201$20240626$20220704$20240705$PER$$US-SA-2022SA253716$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240705$$MD$US$US
210406719$21040671$9$F$20220608$20240718$20220704$20240726$EXP$$JP-009507513-2206JPN001570J$MERCK$Yumori A. A case of haemophagocytic syndrome and myocarditis after lenvatinib and pembrolizumab therapy for endometrial cancer. 2024 the Japanese Society of Medical Oncology Annual Meeting - The 21st Annivers. 2024$51$YR$$F$Y$60$KG$20240726$$MD$JP$JP
210407062$21040706$2$F$$20240725$20220704$20240726$EXP$$GR-ROCHE-3128124$ROCHE$$28$YR$A$F$Y$$$20240726$$MD$GR$GR
210410182$21041018$2$F$20211101$20240815$20220704$20240822$EXP$$GB-ABBVIE-22K-167-4310928-00$ABBVIE$$32$YR$$F$Y$129$KG$20240822$$HP$GB$GB
2104115816$21041158$16$F$20161213$20240802$20220705$20240807$EXP$$DE-ROCHE-2819268$ROCHE$$33$YR$A$M$Y$60.5$KG$20240807$$CN$DE$DE
210412727$21041272$7$F$20220101$20221219$20220705$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR100993$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240925$$CN$US$US
2104140211$21041402$11$F$20190611$20240620$20220705$20240704$EXP$$CA-ROCHE-2338523$ROCHE$$42$YR$A$F$Y$$$20240704$$HP$CA$CA
210414187$21041418$7$F$20220621$20240719$20220705$20240726$EXP$$JP-ARGENX-2022-ARGX-JP001081$ARGENX BVBA$$54$YR$$F$Y$39$KG$20240726$$MD$JP$JP
2104150113$21041501$13$F$20190101$20240717$20220705$20240718$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-093490$BOEHRINGER INGELHEIM$$58$YR$A$M$Y$83$KG$20240718$$CN$ES$ES
210416274$21041627$4$F$20190424$20240818$20220705$20240822$EXP$$DE-ROCHE-2498880$ROCHE$$45$YR$A$F$Y$55$KG$20240822$$MD$DE$DE
210421672$21042167$2$F$20210913$20240919$20220705$20240926$EXP$$NVSC2021IN228562$NOVARTIS$$68$YR$$F$Y$$$20240926$$CN$IN$IN
2104268917$21042689$17$F$20230313$20240826$20220705$20240830$EXP$$US-TAKEDA-2022TUS011138$TAKEDA$$52$YR$$F$Y$73$KG$20240830$$MD$US$US
210430874$21043087$4$F$20220501$20220915$20220705$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR101724$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
210432342$21043234$2$F$$20220628$20220705$20240715$EXP$$BG-ASTELLAS-2022US023457$ASTELLAS$$30$YR$$F$Y$$$20240715$$MD$BG$BG
2104337110$21043371$10$F$20220101$20240726$20220705$20240731$EXP$$US-PFIZER INC-202200917548$PFIZER$$61$YR$$F$Y$87.075$KG$20240731$$HP$US$US
2104372616$21043726$16$F$20220701$20240828$20220705$20240902$EXP$$NVSC2022CR152470$NOVARTIS$$57$YR$$F$Y$78$KG$20240902$$CN$CR$CR
210439043$21043904$3$F$20220518$20240226$20220705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2022-002252$SAREPTA THERAPEUTICS$$10$YR$$M$Y$$$20240702$$HP$US$US
2104435817$21044358$17$F$20220801$20240925$20220705$20240930$EXP$$US-PFIZER INC-PV202200013928$PFIZER$$82$YR$$F$Y$$$20240930$$CN$US$US
210449439$21044943$9$F$$20240701$20220705$20240704$EXP$$US-TAKEDA-2021TUS047822$TAKEDA$$$$$F$Y$84$KG$20240704$$HP$US$US
210450694$21045069$4$F$20220301$20240724$20220705$20240727$EXP$$FR-ABBVIE-22K-056-4322652-00$ABBVIE$$52$YR$$M$Y$$$20240727$$MD$FR$FR
2104509112$21045091$12$F$20220101$20240920$20220705$20240923$EXP$$CH-ABBVIE-22K-151-4454314-00$ABBVIE$$77$YR$$F$Y$73$KG$20240923$$MD$CH$CH
2104522421$21045224$21$F$20220423$20240910$20220705$20240918$EXP$$CA-CELLTRION INC.-2022CA008543$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
2104529114$21045291$14$F$20210519$20240804$20220706$20240807$EXP$$IL-ABBVIE-21K-082-3988531-00$ABBVIE$$76$YR$$M$Y$90$KG$20240807$$MD$IL$IL
2104535228$21045352$28$F$20220101$20240703$20220706$20240711$EXP$$CA-CELLTRION INC.-2022CA006272$CELLTRION$$$$$$Y$$$20240711$$MD$CA$CA
210454132$21045413$2$F$$20240729$20220706$20240807$EXP$$CA-APOTEX-2022AP009812$APOTEX$$76$YR$$F$Y$$$20240807$$HP$CA$CA
210454249$21045424$9$F$20201206$20240912$20220706$20240921$EXP$$DE-ROCHE-2735342$ROCHE$$25$YR$A$F$Y$65$KG$20240921$$MD$DE$DE
210455732$21045573$2$F$20220602$20240722$20220706$20240729$EXP$$CZ-JNJFOC-20220705134$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240729$$MD$CZ$CZ
2104605016$21046050$16$F$20210517$20240827$20220706$20240903$EXP$$CA-TAKEDA-2020TUS059226$TAKEDA$$21$YR$$F$Y$$$20240903$$CN$CA$CA
210468744$21046874$4$F$$20221114$20220706$20240730$EXP$$CA-AstraZeneca-2022A230109$ASTRAZENECA$$71$YR$$M$Y$$$20240730$$MD$CA$
2104713514$21047135$14$F$20210101$20240916$20220706$20240924$EXP$$CA-CELLTRION INC.-2020CA034441$CELLTRION$$$$$$Y$$$20240924$$MD$CA$CA
210476416$21047641$6$F$20240101$20240416$20220706$20240814$EXP$$NVSC2022GB075350$NOVARTIS$$$$A$M$Y$$$20240814$$CN$GB$GB
210478238$21047823$8$F$20221117$20240702$20220706$20240815$EXP$$CA-ROCHE-3128764$ROCHE$$34$YR$A$F$Y$$$20240815$$CN$CA$CA
210479126$21047912$6$F$20220219$20240719$20220706$20240725$EXP$$CA-TAKEDA-2022TUS012493$TAKEDA$$52$YR$$F$Y$$$20240725$$MD$CA$CA
2104822317$21048223$17$F$20220625$20240701$20220706$20240702$EXP$$US-TAKEDA-2022TUS044980$TAKEDA$$26$YR$$M$Y$$$20240702$$MD$US$US
2104836610$21048366$10$F$20181121$20240813$20220706$20240821$EXP$$RO-MYLANLABS-2022M1050385$BIOCON$Placinta CD, Gales L, Brotea-Mosoiu S. A case report of fulminant hepatitis due to docetaxel in breast cancer. Oncolog-Hematolog.ro. 2022;59(2):22-25$$$$$Y$$$20240821$$MD$RO$RO
2104851012$21048510$12$F$$20240801$20220706$20240805$EXP$$US-PFIZER INC-202101793046$PFIZER$$28$YR$$F$Y$72.57$KG$20240805$$MD$US$US
210485157$21048515$7$F$$20240905$20220706$20240912$EXP$$CA-TAKEDA-2022TUS044757$TAKEDA$$$$$F$Y$$$20240912$$MD$CA$CA
210485628$21048562$8$F$20191225$20240916$20220706$20240923$EXP$$NVSC2020IN026834$NOVARTIS$$65$YR$$F$Y$$$20240923$$CN$IN$IN
210485653$21048565$3$F$$20240906$20220706$20240912$EXP$$US-GILEAD-2022-0588296$GILEAD$$68$YR$E$M$Y$$$20240912$$HP$US$US
210491503$21049150$3$F$20220501$20240718$20220706$20240725$EXP$$RU-BIOGEN-2022BI01134893$BIOGEN$$44$YR$$F$Y$59$KG$20240725$$MD$RU$RU
2104944733$21049447$33$F$20220511$20240729$20220706$20240809$EXP$GB-MHRA-MIDB-9dff0444-8c8b-4f3a-8491-2708f9843ec8$GB-BAXTER-2022BAX013945$BAXTER$$49$YR$$M$Y$$$20240809$$HP$GB$GB
210496302$21049630$2$F$$20240729$20220706$20240807$EXP$$US-MYOVANT SCIENCES GMBH-2022MYSCI0600613$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
210496514$21049651$4$F$20180507$20240821$20220706$20240826$EXP$$CA-PFIZER INC-2018281439$MYLAN$$70$YR$$F$Y$75$KG$20240826$$MD$CA$CA
210498995$21049899$5$F$20220618$20240627$20220706$20240702$PER$$US-PFIZER INC-202200915603$PFIZER$$75$YR$$M$Y$96.36$KG$20240702$$CN$US$US
210499106$21049910$6$F$20220628$20240815$20220706$20240821$EXP$$US-JAZZ-2022-US-022553$JAZZ$$39$YR$$F$Y$$$20240821$$MD$US$US
210499762$21049976$2$F$$20220705$20220706$20240715$PER$$US-HLS-202200769$HLS THERAPEUTICS$$$$A$M$Y$$$20240715$$$COUNTRY NOT SPECIFIED$US
210500264$21050026$4$F$20210801$20240911$20220706$20240917$EXP$$US-GW PHARMA-2022-US-021974$JAZZ$$16$YR$$M$Y$55.8$KG$20240916$$CN$US$US
210502567$21050256$7$F$$20240801$20220706$20240805$EXP$$CA-ROCHE-3133269$ROCHE$$$$A$M$Y$$$20240805$$HP$CA$CA
210503249$21050324$9$F$20211201$20240724$20220707$20240729$EXP$$US-ABBVIE-22K-163-4457090-00$ABBVIE$$49$YR$$M$Y$$$20240729$$MD$US$US
210507502$21050750$2$F$20220601$20220705$20220707$20240709$PER$$NVSC2022US154032$NOVARTIS$$40$YR$$F$Y$$$20240710$$CN$US$US
210513402$21051340$2$F$20220630$20240724$20220707$20240802$30DAY$$US-GLAXOSMITHKLINE-US2022102613$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240802$$CN$US$US
2105156824$21051568$24$F$20211201$20240822$20220707$20240829$EXP$$CA-CELLTRION INC.-2021CA018414$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
210518456$21051845$6$F$20200930$20240826$20220707$20240830$EXP$$CA-SHIRE-CA202032843$TAKEDA$$57$YR$$F$Y$$$20240830$$CN$CA$CA
210521144$21052114$4$F$20220109$20240927$20220707$20240930$EXP$$PT-ROCHE-3127972$ROCHE$$19$YR$A$M$Y$$$20240930$$MD$PT$PT
2105215010$21052150$10$F$20220603$20240913$20220707$20240918$EXP$$US-PFIZER INC-202200930424$PFIZER$$75$YR$$F$Y$70.76$KG$20240918$$MD$US$US
210521817$21052181$7$F$20220601$20240924$20220707$20240926$PER$$US-AMGEN-USASP2022113517$AMGEN$$61$YR$A$F$Y$$$20240926$$HP$US$US
210525113$21052511$3$F$20181121$20240821$20220707$20240902$EXP$$RO-Accord-268449$ACCORD$Placinta C. Hepatita fulminanta postchimioterapie cu docetaxel in cancerul de san - prezentare de caz. Oncolog-Hematolog.ro. 2022;XVI, Nr. 59 (2/2022):22-25.$57$YR$A$F$Y$$$20240902$$HP$RO$RO
210528253$21052825$3$F$20180716$20240912$20220707$20240919$EXP$$CA-TAKEDA-2018TUS016978$TAKEDA$$40$YR$$M$Y$$$20240919$$CN$CA$CA
210537583$21053758$3$F$$20240913$20220707$20240916$EXP$$JP-AstraZeneca-2022A245705$ASTRAZENECA$$56$YR$$F$Y$$$20240916$$MD$JP$
210538222$21053822$2$F$20220405$20220629$20220707$20240801$EXP$$US-ORPHANEU-2022003114$RECORDATI$$$$$$Y$$$20240801$$CN$US$US
210541953$21054195$3$F$$20240821$20220707$20240827$PER$$US-PFIZER INC-PV202200016749$PFIZER$$67$YR$$F$Y$$$20240827$$MD$US$US
210542924$21054292$4$F$$20240814$20220707$20240819$EXP$$CA-ROCHE-3127242$ROCHE$$60$YR$A$M$Y$100$KG$20240819$$HP$CA$CA
210544507$21054450$7$F$20220605$20240912$20220707$20240919$EXP$$NVSC2022FR152637$NOVARTIS$$$$A$F$Y$60$KG$20240919$$MD$FR$FR
210545794$21054579$4$F$$20240722$20220707$20240722$EXP$$AU-ROCHE-3127335$ROCHE$$19$YR$A$M$Y$$$20240722$$CN$AU$AU
2105497527$21054975$27$F$20140101$20240802$20220707$20240807$EXP$$CA-ROCHE-1462689$ROCHE$$59$YR$A$M$Y$101$KG$20240807$$HP$CA$CA
2105510813$21055108$13$F$20240403$20240607$20220707$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-002094$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240701$$CN$US$US
210558692$21055869$2$F$20190312$20240719$20220708$20240725$EXP$$BG-AMGEN-BGRSP2022111767$AMGEN$$60$YR$A$M$Y$$$20240725$$MD$BG$BG
210561184$21056118$4$F$$20240802$20220708$20240815$EXP$$CA-AUROBINDO-AUR-APL-2022-025004$AUROBINDO$$48$YR$$M$Y$$$20240815$$HP$CA$CA
210561742$21056174$2$F$$20240701$20220708$20240708$EXP$$CA-AUROBINDO-AUR-APL-2022-024679$AUROBINDO$$80$YR$$M$Y$$$20240708$$CN$CA$CA
210562263$21056226$3$F$$20240801$20220708$20240813$EXP$$CA-AUROBINDO-AUR-APL-2022-024615$AUROBINDO$$85$YR$$M$Y$$$20240813$$HP$CA$CA
2105624510$21056245$10$F$$20240730$20220708$20240809$EXP$$CA-AUROBINDO-AUR-APL-2022-024605$AUROBINDO$Nowik CM, Gerrie AS, Wong J.. Conservative Management of Presumed Fetal Anemia Secondary to Maternal Chemotherapy for Acute Myeloid Leukemia. AJP. 2021;11(4):E137- E141$23$YR$$F$Y$$$20240809$$MD$CA$CA
2105624920$21056249$20$F$20230323$20240918$20220708$20240926$EXP$$CA-ROCHE-2936426$ROCHE$$41$YR$A$M$Y$$$20240926$$CN$CA$CA
210569859$21056985$9$F$20230501$20240910$20220708$20240912$PER$$US-DSJP-DSU-2022-123529$DAIICHI$$41$YR$$M$Y$$$20240913$$CN$US$US
210570994$21057099$4$F$20221208$20240903$20220708$20240906$EXP$$CA-TAKEDA-2022TUS031529$TAKEDA$$38$YR$$M$Y$$$20240906$$CN$CA$CA
210576006$21057600$6$F$20220101$20240810$20220708$20240812$EXP$$CA-PFIZER INC-202200868820$PFIZER$$71$YR$$F$Y$$$20240812$$HP$CA$CA
210577872$21057787$2$F$20220525$20240719$20220708$20240729$EXP$$US-SAMOHPHARM-2022003096$RECORDATI$$$$$$Y$$$20240729$$CN$US$US
210585134$21058513$4$F$20240201$20240911$20220708$20240918$EXP$$IN-GLAXOSMITHKLINE-IN2022APC103281$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$IN$IN
210585167$21058516$7$F$20211201$20230113$20220708$20240926$EXP$$US-GLAXOSMITHKLINE-US2022AMR103102$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
210585546$21058554$6$F$$20221208$20220708$20240925$EXP$$US-GLAXOSMITHKLINE-US2022AMR103120$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2105901412$21059014$12$F$20220705$20240808$20220708$20240813$PER$$US-PFIZER INC-202200485322$PFIZER$$82$YR$$F$Y$$$20240813$$CN$US$US
210591593$21059159$3$F$$20240715$20220708$20240716$PER$$US-PFIZER INC-PV202200018647$PFIZER$$79$YR$$F$Y$$$20240716$$PH$US$US
210591662$21059166$2$F$$20240723$20220708$20240730$EXP$$CA-Orion Corporation ORION PHARMA-22_00019465$ORION$$64$YR$A$F$Y$$$20240730$$HP$CA$
210596265$21059626$5$F$20211015$20240829$20220708$20240902$EXP$$CA-TAKEDA-2021TUS064916$TAKEDA$$88$YR$$F$Y$$$20240902$$HP$CA$CA
210597557$21059755$7$F$20200901$20240919$20220708$20240925$EXP$$PT-MYLANLABS-2022M1051192$MYLAN$Costa JFC.. PO 305 CONVERSIVE DISORDER: SEEING THE PATIENT BEYOND THE SYMPTOM. 2021;37(S6):63$47$YR$$F$Y$$$20240925$$MD$PT$PT
210598055$21059805$5$F$20220501$20240717$20220708$20240725$PER$$US-SA-2022SA251571$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240725$$MD$US$US
210598132$21059813$2$F$20220601$20240708$20220708$20240717$PER$$US-SA-2022SA254403$SANOFI AVENTIS$$13$YR$T$M$Y$61$KG$20240717$$MD$US$US
210598662$21059866$2$F$20240701$20240805$20220708$20240813$PER$$US-SA-2022SA262205$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240814$$MD$US$US
210599142$21059914$2$F$20240625$20240626$20220708$20240701$PER$$US-SA-2022SA252708$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240701$$HP$US$US
210599962$21059996$2$F$20220501$20240620$20220708$20240701$PER$$US-SA-2022SA259449$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240701$$MD$US$US
210600532$21060053$2$F$$20240726$20220708$20240805$PER$$US-SA-2022SA258355$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240805$$HP$US$US
210600875$21060087$5$F$20220620$20240816$20220708$20240830$PER$$US-SA-2022SA259176$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240830$$MD$US$US
210601693$21060169$3$F$20220623$20240807$20220708$20240814$PER$$US-SA-2022SA258491$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240814$$MD$US$US
210601872$21060187$2$F$$20240805$20220708$20240814$PER$$US-SA-2022SA263187$SANOFI AVENTIS$$79$YR$E$F$Y$81$KG$20240814$$MD$US$US
210602712$21060271$2$F$20220101$20240703$20220708$20240712$PER$$US-SA-2022SA263193$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240712$$MD$US$US
210602833$21060283$3$F$20240101$20240627$20220708$20240709$PER$$US-SA-2022SA262316$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240709$$MD$US$US
210610292$21061029$2$F$20220630$20240816$20220709$20240828$PER$$US-SA-2022SA262786$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240828$$MD$US$US
210617605$21061760$5$F$20220705$20240910$20220710$20240912$EXP$$CA-ROCHE-3134932$ROCHE$$38$YR$A$M$Y$$$20240912$$HP$CA$CA
210621403$21062140$3$F$20220621$20240722$20220711$20240729$EXP$$BG-JNJFOC-20220714209$JOHNSON AND JOHNSON$$66$YR$E$F$Y$75$KG$20240730$$MD$BG$BG
210623767$21062376$7$F$20211202$20240816$20220711$20240823$EXP$$CA-CELLTRION INC.-2021CA019171$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
210629854$21062985$4$F$20030101$20240722$20220711$20240726$EXP$$US-JNJFOC-20220715607$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240726$$LW$US$US
2106323910$21063239$10$F$20220620$20240716$20220711$20240721$EXP$$JP-TAKEDA-2022TJP062937$TAKEDA$$14$YR$$M$Y$47.9$KG$20240721$$MD$JP$JP
2106352722$21063527$22$F$20210317$20240812$20220711$20240813$EXP$$NVSC2021CH054242$NOVARTIS$$75$YR$$F$Y$74.2$KG$20240813$$MD$CH$CH
210635743$21063574$3$F$20200804$20240703$20220711$20240709$EXP$$CA-TAKEDA-2020TUS034349$TAKEDA$$75$YR$$F$Y$$$20240709$$CN$CA$CA
210637326$21063732$6$F$$20240726$20220711$20240801$EXP$$US-TAKEDA-2022TUS040443$TAKEDA$$$$$F$Y$44$KG$20240801$$CN$US$US
210639254$21063925$4$F$20220502$20240713$20220711$20240715$EXP$$FR-TAKEDA-2022TUS044585$TAKEDA$$77$YR$$M$Y$$$20240715$$HP$FR$FR
210639727$21063972$7$F$$20240909$20220711$20240911$EXP$$CA-BAYER-2022A094114$BAYER$$72$YR$E$F$Y$61$KG$20240911$$CN$CA$CA
2106411915$21064119$15$F$20220101$20240702$20220711$20240704$EXP$$CA-PFIZER INC-202200737791$PFIZER$$84$YR$$F$Y$91$KG$20240704$$HP$CA$CA
2106422910$21064229$10$F$20220601$20240909$20220711$20240912$PER$$US-BIOGEN-2022BI01132955$BIOGEN$$14$YR$$F$Y$$$20240912$$CN$US$US
2106489212$21064892$12$F$$20240719$20220711$20240724$EXP$$CA-PURDUE-USA-2022-0295017$PURDUE$$44$YR$$F$Y$97$KG$20240724$$MD$CA$CA
210654502$21065450$2$F$$20240719$20220711$20240726$PER$$US-JNJFOC-20220715520$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$LW$US$US
210656184$21065618$4$F$$20230202$20220711$20240925$EXP$$US-TAKEDA-2022TUS045539$TAKEDA$$$$$M$Y$$$20240925$$HP$US$US
210657943$21065794$3$F$$20240923$20220711$20240926$EXP$$PT-PFIZER INC-202200906371$MYLAN$Correia Costa, J.. Conversion Disorder: Seeing the patient beyond the symptom. Revista Portuguesa de Medicina Geral e Familiar. 2022;38(Supp):S63$47$YR$$F$Y$$$20240926$$MD$PT$PT
210660015$21066001$5$F$$20240718$20220711$20240722$PER$$US-PFIZER INC-PV202200018443$PFIZER$$79$YR$$F$Y$$$20240722$$CN$US$US
210665333$21066533$3$F$$20240822$20220711$20240919$PER$$US-SA-2022SA271211$SANOFI AVENTIS$$61$YR$A$M$Y$117.93$KG$20240919$$MD$US$US
2106678220$21066782$20$F$20220630$20240523$20220712$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR104248$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
210668183$21066818$3$F$20220601$20220811$20220712$20240926$PER$$US-GLAXOSMITHKLINE-US2022AMR104031$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240926$$CN$US$US
210671102$21067110$2$F$$20240813$20220712$20240827$EXP$$CA-AUROBINDO-AUR-APL-2022-024947$AUROBINDO$$27$YR$$F$Y$$$20240827$$MD$CA$CA
210673242$21067324$2$F$20220301$20220708$20220712$20240801$EXP$$US-RECORDATI-2022002006$RECORDATI$$$$$$Y$$$20240801$$CN$US$US
210673942$21067394$2$F$$20240813$20220712$20240826$EXP$$CA-AUROBINDO-AUR-APL-2022-024798$AUROBINDO$$49$YR$$M$Y$$$20240826$$HP$CA$CA
210674755$21067475$5$F$20240510$20240515$20220712$20240715$EXP$$US-KYOWAKIRIN-2022BKK010720$KYOWA$$$$$$Y$$$20240715$$HP$US$US
210675392$21067539$2$F$$20240701$20220712$20240708$EXP$$CA-AUROBINDO-AUR-APL-2022-024678$AUROBINDO$$80$YR$$M$Y$$$20240708$$CN$CA$CA
210675524$21067552$4$F$20201202$20240708$20220712$20240715$EXP$$US-SA-2022SA270478$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240715$$MD$US$US
210675692$21067569$2$F$$20240724$20220712$20240803$EXP$$CA-AUROBINDO-AUR-APL-2022-024811$AUROBINDO$$34$YR$$F$Y$$$20240803$$HP$CA$CA
210677555$21067755$5$F$20220701$20230323$20220712$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR104860$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
210681609$21068160$9$F$20210101$20240710$20220712$20240722$EXP$$CA-ROCHE-3131344$ROCHE$$67$YR$E$F$Y$$$20240722$$CN$CA$CA
210685579$21068557$9$F$20240320$20240910$20220712$20240916$EXP$$CA-TAKEDA-2020TUS046639$TAKEDA$$24$YR$$M$Y$$$20240916$$CN$CA$CA
210685902$21068590$2$F$20220301$20240623$20220712$20240708$EXP$$DE-ROCHE-3134887$ROCHE$$56$YR$A$M$Y$94$KG$20240708$$MD$DE$DE
210685932$21068593$2$F$$20240919$20220712$20240923$EXP$$CA-ROCHE-3136756$ROCHE$$31$YR$A$F$Y$$$20240923$$CN$CA$CA
210685959$21068595$9$F$20220614$20240715$20220712$20240729$EXP$$DE-ROCHE-3136746$ROCHE$$56$YR$A$F$Y$$$20240729$$CN$DE$DE
210686374$21068637$4$F$20220601$20220909$20220712$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR097029$GLAXOSMITHKLINE$$42$YR$$F$Y$$$20240925$$CN$US$US
210690402$21069040$2$F$$20211006$20220712$20240722$PER$$US-ASTELLAS-2021US038045$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210690412$21069041$2$F$$20211004$20220712$20240722$PER$$US-ASTELLAS-2021US037734$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
210690422$21069042$2$F$20210930$20211001$20220712$20240722$PER$$US-ASTELLAS-2021US037677$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
210690432$21069043$2$F$$20211004$20220712$20240722$PER$$US-ASTELLAS-2021US037724$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
210690442$21069044$2$F$20211002$20211004$20220712$20240722$PER$$US-ASTELLAS-2021US037733$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210690452$21069045$2$F$$20211006$20220712$20240722$PER$$US-ASTELLAS-2021US038107$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210690462$21069046$2$F$20210101$20211007$20220712$20240722$PER$$US-ASTELLAS-2021US038145$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210690472$21069047$2$F$20211005$20211005$20220712$20240722$PER$$US-ASTELLAS-2021US038060$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210690602$21069060$2$F$20210101$20211025$20220712$20240722$PER$$US-ASTELLAS-2021US040879$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210690612$21069061$2$F$$20211012$20220712$20240722$PER$$US-ASTELLAS-2021US039430$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210690622$21069062$2$F$$20211018$20220712$20240722$PER$$US-ASTELLAS-2021US039827$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210690632$21069063$2$F$20211001$20211025$20220712$20240722$PER$$US-ASTELLAS-2021US040849$ASTELLAS$$62$YR$$F$Y$$$20240722$$CN$US$US
210690642$21069064$2$F$$20211028$20220712$20240722$PER$$US-ASTELLAS-2021US039720$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210690652$21069065$2$F$20211001$20211014$20220712$20240722$PER$$US-ASTELLAS-2021US039407$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
210690662$21069066$2$F$20210101$20211018$20220712$20240722$PER$$US-ASTELLAS-2021US039511$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
210690672$21069067$2$F$20211001$20211013$20220712$20240722$PER$$US-ASTELLAS-2021US039133$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
210690682$21069068$2$F$20211001$20211006$20220712$20240722$PER$$US-ASTELLAS-2021US038112$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210690692$21069069$2$F$20210401$20211013$20220712$20240722$PER$$US-ASTELLAS-2021US039189$ASTELLAS$$68$YR$$M$Y$145$KG$20240722$$CN$US$US
210690702$21069070$2$F$20210101$20211105$20220712$20240722$PER$$US-ASTELLAS-2021US040909$ASTELLAS$$89$YR$$M$Y$$$20240722$$CN$US$US
210690712$21069071$2$F$$20211022$20220712$20240722$PER$$US-ASTELLAS-2021US040704$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210690722$21069072$2$F$$20211018$20220712$20240722$PER$$US-ASTELLAS-2021US039570$ASTELLAS$$64$YR$$F$Y$$$20240722$$CN$US$US
210690772$21069077$2$F$20200101$20211012$20220712$20240722$PER$$US-ASTELLAS-2021US038923$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
210690782$21069078$2$F$20200101$20211021$20220712$20240722$PER$$US-ASTELLAS-2021US038987$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
210690792$21069079$2$F$20210101$20211012$20220712$20240722$PER$$US-ASTELLAS-2021US039120$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210690802$21069080$2$F$$20211025$20220712$20240722$PER$$US-ASTELLAS-2021US040839$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210690812$21069081$2$F$$20211007$20220712$20240722$PER$$US-ASTELLAS-2021US038268$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210690822$21069082$2$F$20211001$20211018$20220712$20240722$PER$$US-ASTELLAS-2021US039593$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
210690832$21069083$2$F$$20211025$20220712$20240722$PER$$US-ASTELLAS-2021US040961$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210690842$21069084$2$F$$20211025$20220712$20240722$PER$$US-ASTELLAS-2021US040932$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210690852$21069085$2$F$$20211015$20220712$20240722$PER$$US-ASTELLAS-2021US039399$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210690862$21069086$2$F$20211001$20211022$20220712$20240722$PER$$US-ASTELLAS-2021US040775$ASTELLAS$$94$YR$$F$Y$$$20240722$$CN$US$US
210690872$21069087$2$F$20210901$20211213$20220712$20240722$PER$$US-ASTELLAS-2021US038274$ASTELLAS$$74$YR$$M$Y$$$20240722$$MD$US$US
210690882$21069088$2$F$20210901$20211104$20220712$20240722$PER$$US-ASTELLAS-2021US037651$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
210690892$21069089$2$F$20210101$20211015$20220712$20240722$PER$$US-ASTELLAS-2021US039586$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210690902$21069090$2$F$20210630$20211118$20220712$20240722$PER$$US-ASTELLAS-2021US038209$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
210690912$21069091$2$F$20211024$20211025$20220712$20240722$PER$$US-ASTELLAS-2021US040913$ASTELLAS$$90$YR$$M$Y$$$20240722$$CN$US$US
210690922$21069092$2$F$20210401$20211007$20220712$20240722$PER$$US-ASTELLAS-2021US038408$ASTELLAS$$62$YR$$M$Y$$$20240722$$CN$US$US
210690932$21069093$2$F$$20211018$20220712$20240722$PER$$US-ASTELLAS-2021US039624$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210690942$21069094$2$F$$20211007$20220712$20240722$PER$$US-ASTELLAS-2021US038273$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210690962$21069096$2$F$20211014$20211015$20220712$20240722$PER$$US-ASTELLAS-2021US039393$ASTELLAS$$74$YR$$M$Y$$$20240722$$MD$US$US
210690992$21069099$2$F$$20211019$20220712$20240722$PER$$US-ASTELLAS-2021US040037$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691002$21069100$2$F$$20211020$20220712$20240722$PER$$US-ASTELLAS-2021US040157$ASTELLAS$$$$$M$Y$$$20240722$$MD$US$US
210691012$21069101$2$F$$20211007$20220712$20240722$PER$$US-ASTELLAS-2021US038505$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210691022$21069102$2$F$$20211021$20220712$20240722$PER$$US-ASTELLAS-2021US040178$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210691032$21069103$2$F$20210701$20211012$20220712$20240722$PER$$US-ASTELLAS-2021US038899$ASTELLAS$$81$YR$$F$Y$$$20240722$$HP$US$US
210691042$21069104$2$F$20210901$20211112$20220712$20240722$PER$$US-ASTELLAS-2021US038393$ASTELLAS$$97$YR$$M$Y$$$20240722$$CN$US$US
210691052$21069105$2$F$20211001$20211011$20220712$20240722$PER$$US-ASTELLAS-2021US038630$ASTELLAS$$87$YR$$F$Y$$$20240722$$CN$US$US
210691062$21069106$2$F$20210901$20211025$20220712$20240722$PER$$US-ASTELLAS-2021US038520$ASTELLAS$$78$YR$$M$Y$$$20240722$$CN$US$US
210691072$21069107$2$F$$20211020$20220712$20240722$PER$$US-ASTELLAS-2021US040067$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691082$21069108$2$F$$20211217$20220712$20240722$PER$$US-ASTELLAS-2021US038733$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691092$21069109$2$F$$20211018$20220712$20240722$PER$$US-ASTELLAS-2021US039608$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
210691102$21069110$2$F$20211101$20211206$20220712$20240722$PER$$US-ASTELLAS-2021US047141$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
210691112$21069111$2$F$20211101$20211124$20220712$20240722$PER$$US-ASTELLAS-2021US045742$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691122$21069112$2$F$$20211124$20220712$20240722$PER$$US-ASTELLAS-2021US045730$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691132$21069113$2$F$$20211213$20220712$20240722$PER$$US-ASTELLAS-2021US048372$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
210691142$21069114$2$F$20211001$20211203$20220712$20240722$PER$$US-ASTELLAS-2021US047131$ASTELLAS$$53$YR$$F$Y$$$20240722$$CN$US$US
210691162$21069116$2$F$20211109$20211116$20220712$20240722$PER$$US-ASTELLAS-2021US044228$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
210691172$21069117$2$F$$20211115$20220712$20240722$PER$$US-ASTELLAS-2021US044080$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
210691182$21069118$2$F$$20211214$20220712$20240722$PER$$US-ASTELLAS-2021US048374$ASTELLAS$$58$YR$$M$Y$$$20240722$$CN$US$US
210691192$21069119$2$F$$20211103$20220712$20240722$PER$$US-ASTELLAS-2021US042531$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691202$21069120$2$F$$20211214$20220712$20240722$PER$$US-ASTELLAS-2021US048391$ASTELLAS$$90$YR$$M$Y$$$20240722$$CN$US$US
210691212$21069121$2$F$$20211216$20220712$20240722$PER$$US-ASTELLAS-2021US048806$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
210691222$21069122$2$F$$20211115$20220712$20240722$PER$$US-ASTELLAS-2021US044074$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210691232$21069123$2$F$$20211115$20220712$20240722$PER$$US-ASTELLAS-2021US044069$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
210691242$21069124$2$F$$20211214$20220712$20240722$PER$$US-ASTELLAS-2021US048398$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691252$21069125$2$F$$20211031$20220712$20240722$PER$$US-ASTELLAS-2021US041947$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691262$21069126$2$F$20211001$20211119$20220712$20240722$PER$$US-ASTELLAS-2021US045043$ASTELLAS$$67$YR$$M$Y$$$20240722$$CN$US$US
210691272$21069127$2$F$20211101$20211112$20220712$20240722$PER$$US-ASTELLAS-2021US043973$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
210691282$21069128$2$F$20210101$20211215$20220712$20240722$PER$$US-ASTELLAS-2021US048603$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691294$21069129$4$F$20211101$20211112$20220712$20240722$PER$$US-ASTELLAS-2021US043875$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691302$21069130$2$F$$20211116$20220712$20240722$PER$$US-ASTELLAS-2021US044374$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691314$21069131$4$F$$20220110$20220712$20240722$PER$$US-ASTELLAS-2021US048313$ASTELLAS$$89$YR$$F$Y$$$20240722$$CN$US$US
210691324$21069132$4$F$$20211207$20220712$20240722$PER$$US-ASTELLAS-2021US047450$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210691332$21069133$2$F$20211101$20211119$20220712$20240722$PER$$US-ASTELLAS-2021US045006$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
210691342$21069134$2$F$20211101$20211116$20220712$20240722$PER$$US-ASTELLAS-2021US044258$ASTELLAS$$73$YR$$M$Y$$$20240722$$CN$US$US
210691362$21069136$2$F$20211217$20220207$20220712$20240722$PER$$US-ASTELLAS-2021US048925$ASTELLAS$$73$YR$$M$Y$$$20240722$$CN$US$US
210691372$21069137$2$F$$20211028$20220712$20240722$PER$$US-ASTELLAS-2021US041913$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
210691382$21069138$2$F$20211215$20211216$20220712$20240722$PER$$US-ASTELLAS-2021US048695$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
210691402$21069140$2$F$$20211124$20220712$20240722$PER$$US-ASTELLAS-2021US045847$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691412$21069141$2$F$$20211101$20220712$20240722$PER$$US-ASTELLAS-2021US046071$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691432$21069143$2$F$20211206$20211214$20220712$20240722$PER$$US-ASTELLAS-2021US047216$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
210691442$21069144$2$F$$20211118$20220712$20240722$PER$$US-ASTELLAS-2021US044745$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691452$21069145$2$F$$20211222$20220712$20240722$PER$$US-ASTELLAS-2021US049499$ASTELLAS$$$$$F$Y$$$20240722$$HP$US$US
210691462$21069146$2$F$20211101$20220114$20220712$20240722$PER$$US-ASTELLAS-2022US000359$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691474$21069147$4$F$$20211110$20220712$20240722$PER$$US-ASTELLAS-2021US043535$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
210691482$21069148$2$F$20211110$20211110$20220712$20240722$PER$$US-ASTELLAS-2021US043557$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691492$21069149$2$F$$20211117$20220712$20240722$PER$$US-ASTELLAS-2021US044552$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
210691502$21069150$2$F$$20211108$20220712$20240722$PER$$US-ASTELLAS-2021US043205$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691512$21069151$2$F$$20211110$20220712$20240722$PER$$US-ASTELLAS-2021US041695$ASTELLAS$$79$YR$$M$Y$$$20240722$$CN$US$US
210691522$21069152$2$F$$20211129$20220712$20240722$PER$$US-ASTELLAS-2021US046267$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
210691532$21069153$2$F$$20211208$20220712$20240722$PER$$US-ASTELLAS-2021US047648$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691542$21069154$2$F$$20211029$20220712$20240722$PER$$US-ASTELLAS-2021US041801$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
210691562$21069156$2$F$20211101$20211123$20220712$20240722$PER$$US-ASTELLAS-2021US045401$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
210691572$21069157$2$F$20211101$20211206$20220712$20240722$PER$$US-ASTELLAS-2021US047272$ASTELLAS$$47$YR$$F$Y$$$20240722$$CN$US$US
210691582$21069158$2$F$20211129$20211129$20220712$20240722$PER$$US-ASTELLAS-2021US046270$ASTELLAS$$70$YR$$M$Y$$$20240722$$CN$US$US
210691632$21069163$2$F$$20211209$20220712$20240722$PER$$US-ASTELLAS-2021US047727$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691642$21069164$2$F$20211201$20211220$20220712$20240722$PER$$US-ASTELLAS-2021US049082$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691652$21069165$2$F$$20220106$20220712$20240722$PER$$US-ASTELLAS-2021US049223$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691662$21069166$2$F$$20211208$20220712$20240722$PER$$US-ASTELLAS-2021US047677$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
210691672$21069167$2$F$20211130$20211203$20220712$20240722$PER$$US-ASTELLAS-2021US047038$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691682$21069168$2$F$$20211109$20220712$20240722$PER$$US-ASTELLAS-2021US043444$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
210691692$21069169$2$F$20211203$20220111$20220712$20240722$PER$$US-ASTELLAS-2021US046933$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
210691702$21069170$2$F$$20211027$20220712$20240722$PER$$US-ASTELLAS-2021US041550$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691712$21069171$2$F$20211004$20220210$20220712$20240722$PER$$US-ASTELLAS-2021US043181$ASTELLAS$$79$YR$$M$Y$$$20240722$$CN$US$US
210691722$21069172$2$F$$20211109$20220712$20240722$PER$$US-ASTELLAS-2021US043358$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691733$21069173$3$F$$20221010$20220712$20240722$PER$$US-ASTELLAS-2021US042856$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
210691742$21069174$2$F$$20211129$20220712$20240722$PER$$US-ASTELLAS-2021US046276$ASTELLAS$$80$YR$$F$Y$50$KG$20240722$$CN$US$US
210691752$21069175$2$F$$20211129$20220712$20240722$PER$$US-ASTELLAS-2021US046273$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691764$21069176$4$F$20210901$20220124$20220712$20240722$PER$$US-ASTELLAS-2021US044839$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
210691772$21069177$2$F$20211101$20211217$20220712$20240722$PER$$US-ASTELLAS-2021US044834$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
210691782$21069178$2$F$20211020$20211026$20220712$20240722$PER$$US-ASTELLAS-2021US041230$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691792$21069179$2$F$$20211216$20220712$20240722$PER$$US-ASTELLAS-2021US048795$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
210691812$21069181$2$F$$20211210$20220712$20240722$PER$$US-ASTELLAS-2021US048075$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210691842$21069184$2$F$$20211130$20220712$20240722$PER$$US-ASTELLAS-2021US046455$ASTELLAS$$48$YR$$F$Y$$$20240722$$CN$US$US
210691852$21069185$2$F$$20211206$20220712$20240722$PER$$US-ASTELLAS-2021US046642$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691862$21069186$2$F$$20211207$20220712$20240722$PER$$US-ASTELLAS-2021US047728$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691872$21069187$2$F$$20211029$20220712$20240722$PER$$US-ASTELLAS-2021US041802$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210691882$21069188$2$F$20211101$20211119$20220712$20240722$PER$$US-ASTELLAS-2021US044821$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
210691892$21069189$2$F$20211025$20211029$20220712$20240722$PER$$US-ASTELLAS-2021US041890$ASTELLAS$$71$YR$$M$Y$49$KG$20240722$$CN$US$US
210691902$21069190$2$F$$20220210$20220712$20240722$PER$$US-ASTELLAS-2021US047834$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
210691922$21069192$2$F$$20211123$20220712$20240722$PER$$US-ASTELLAS-2021US045578$ASTELLAS$$82$YR$$M$Y$$$20240722$$PH$US$US
210691932$21069193$2$F$$20211210$20220712$20240722$PER$$US-ASTELLAS-2021US048063$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210691942$21069194$2$F$20211109$20211109$20220712$20240722$PER$$US-ASTELLAS-2021US043495$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691952$21069195$2$F$$20211220$20220712$20240722$PER$$US-ASTELLAS-2021US049055$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210691962$21069196$2$F$20211101$20220105$20220712$20240722$PER$$US-ASTELLAS-2021US046869$ASTELLAS$$68$YR$$M$Y$$$20240722$$CN$US$US
210691982$21069198$2$F$$20211215$20220712$20240722$PER$$US-ASTELLAS-2021US048574$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210691992$21069199$2$F$$20211203$20220712$20240722$PER$$US-ASTELLAS-2021US046928$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692002$21069200$2$F$$20211215$20220712$20240722$PER$$US-ASTELLAS-2021US048534$ASTELLAS$$$$$$Y$$$20240722$$CN$US$US
210692012$21069201$2$F$$20220114$20220712$20240722$PER$$US-ASTELLAS-2021US048973$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210692022$21069202$2$F$20211001$20211127$20220712$20240722$PER$$US-ASTELLAS-2021US044827$ASTELLAS$$67$YR$$M$Y$$$20240722$$CN$US$US
210692032$21069203$2$F$20211001$20211101$20220712$20240722$PER$$US-ASTELLAS-2021US042098$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692042$21069204$2$F$$20211101$20220712$20240722$PER$$US-ASTELLAS-2021US042072$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692062$21069206$2$F$$20211207$20220712$20240722$PER$$US-ASTELLAS-2021US047487$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
210692072$21069207$2$F$20211101$20211119$20220712$20240722$PER$$US-ASTELLAS-2021US044895$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210692092$21069209$2$F$$20211104$20220712$20240722$PER$$US-ASTELLAS-2021US042813$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692102$21069210$2$F$$20211123$20220712$20240722$PER$$US-ASTELLAS-2021US045342$ASTELLAS$$96$YR$$M$Y$$$20240722$$CN$US$US
210692114$21069211$4$F$$20211101$20220712$20240722$PER$$US-ASTELLAS-2021US042111$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
210692124$21069212$4$F$$20240619$20220712$20240722$PER$$US-ASTELLAS-2021US042107$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
210692132$21069213$2$F$$20211206$20220712$20240722$PER$$US-ASTELLAS-2021US045228$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
210692142$21069214$2$F$$20211208$20220712$20240722$PER$$US-ASTELLAS-2021US047623$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692152$21069215$2$F$$20211201$20220712$20240722$PER$$US-ASTELLAS-2021US046660$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210692164$21069216$4$F$$20211115$20220712$20240722$PER$$US-ASTELLAS-2021US044057$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210692172$21069217$2$F$$20211202$20220712$20240722$PER$$US-ASTELLAS-2021US046723$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692184$21069218$4$F$$20211210$20220712$20240722$PER$$US-ASTELLAS-2021US047932$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210692192$21069219$2$F$$20211123$20220712$20240722$PER$$US-ASTELLAS-2021US045458$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210692212$21069221$2$F$$20211028$20220712$20240722$PER$$US-ASTELLAS-2021US041694$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692222$21069222$2$F$20211111$20211112$20220712$20240722$PER$$US-ASTELLAS-2021US043984$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
210692232$21069223$2$F$$20211026$20220712$20240722$PER$$US-ASTELLAS-2021US041162$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210692242$21069224$2$F$$20211111$20220712$20240722$PER$$US-ASTELLAS-2021US043725$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210692262$21069226$2$F$20211027$20211028$20220712$20240722$PER$$US-ASTELLAS-2021US041684$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
210692272$21069227$2$F$$20211123$20220712$20240722$PER$$US-ASTELLAS-2021US045728$ASTELLAS$$91$YR$$F$Y$$$20240722$$CN$US$US
210692282$21069228$2$F$20211101$20211228$20220712$20240722$PER$$US-ASTELLAS-2021US044772$ASTELLAS$$93$YR$$F$Y$$$20240722$$CN$US$US
210692302$21069230$2$F$20210501$20211118$20220712$20240722$PER$$US-ASTELLAS-2021US044776$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
210692312$21069231$2$F$$20220103$20220712$20240722$PER$$US-ASTELLAS-2021US045729$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210692322$21069232$2$F$$20211206$20220712$20240722$PER$$US-ASTELLAS-2021US047290$ASTELLAS$$44$YR$$F$Y$$$20240722$$CN$US$US
210692332$21069233$2$F$20211119$20211202$20220712$20240722$PER$$US-ASTELLAS-2021US045213$ASTELLAS$$72$YR$$M$Y$$$20240722$$CN$US$US
210692342$21069234$2$F$$20211025$20220712$20240722$PER$$US-ASTELLAS-2021US040991$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692352$21069235$2$F$$20211112$20220712$20240722$PER$$US-ASTELLAS-2021US043986$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
210692362$21069236$2$F$$20211101$20220712$20240722$PER$$US-ASTELLAS-2021US042258$ASTELLAS$$14$YR$$F$Y$$$20240722$$CN$US$US
210692372$21069237$2$F$20210101$20220106$20220712$20240722$PER$$US-ASTELLAS-2021US047368$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692382$21069238$2$F$$20211101$20220712$20240722$PER$$US-ASTELLAS-2021US042120$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
210692392$21069239$2$F$20211101$20220105$20220712$20240722$PER$$US-ASTELLAS-2021US045209$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
210692482$21069248$2$F$$20220324$20220712$20240722$PER$$US-ASTELLAS-2022US003431$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210692492$21069249$2$F$$20220408$20220712$20240722$PER$$US-ASTELLAS-2022US013665$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692502$21069250$2$F$20220222$20220223$20220712$20240722$PER$$US-ASTELLAS-2022US007314$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
210692512$21069251$2$F$$20220315$20220712$20240722$PER$$US-ASTELLAS-2022US010119$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210692522$21069252$2$F$$20220127$20220712$20240722$PER$$US-ASTELLAS-2022US003289$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210692532$21069253$2$F$$20220307$20220712$20240722$PER$$US-ASTELLAS-2022US009088$ASTELLAS$$$$$F$Y$$$20240722$$MD$US$US
210692544$21069254$4$F$$20220308$20220712$20240722$PER$$US-ASTELLAS-2022US008968$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692554$21069255$4$F$$20220223$20220712$20240722$PER$$US-ASTELLAS-2022US007318$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
210692562$21069256$2$F$$20220111$20220712$20240722$PER$$US-ASTELLAS-2022US001250$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692572$21069257$2$F$$20220111$20220712$20240722$PER$$US-ASTELLAS-2022US001265$ASTELLAS$$76$YR$$F$Y$$$20240722$$MD$US$US
210692592$21069259$2$F$20220401$20220420$20220712$20240722$PER$$US-ASTELLAS-2022US013770$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
210692622$21069262$2$F$$20220513$20220712$20240722$PER$$US-ASTELLAS-2022US017870$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
210692632$21069263$2$F$20220101$20220111$20220712$20240722$PER$$US-ASTELLAS-2022US000392$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
210692642$21069264$2$F$$20220513$20220712$20240722$PER$$US-ASTELLAS-2022US017901$ASTELLAS$$82$YR$$M$Y$$$20240722$$MD$US$US
210692652$21069265$2$F$20220426$20220427$20220712$20240722$PER$$US-ASTELLAS-2022US016104$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210692662$21069266$2$F$20220101$20220124$20220712$20240722$PER$$US-ASTELLAS-2022US002785$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692672$21069267$2$F$20220426$20220610$20220712$20240722$PER$$US-ASTELLAS-2022US016038$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
210692684$21069268$4$F$$20220112$20220712$20240722$PER$$US-ASTELLAS-2022US001391$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
210692692$21069269$2$F$20220425$20220426$20220712$20240722$PER$$US-ASTELLAS-2022US015637$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
210692702$21069270$2$F$$20220124$20220712$20240722$PER$$US-ASTELLAS-2022US002866$ASTELLAS$$70$YR$$M$Y$$$20240722$$CN$US$US
210692712$21069271$2$F$$20220105$20220712$20240722$PER$$US-ASTELLAS-2022US000408$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692722$21069272$2$F$$20220113$20220712$20240722$PER$$US-ASTELLAS-2022US001529$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
210692734$21069273$4$F$$20220524$20220712$20240722$PER$$US-ASTELLAS-2022US019270$ASTELLAS$$94$YR$$F$Y$$$20240722$$CN$US$US
210692744$21069274$4$F$$20220112$20220712$20240722$PER$$US-ASTELLAS-2022US001346$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210692752$21069275$2$F$20220512$20220606$20220712$20240722$PER$$US-ASTELLAS-2022US016507$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
210692762$21069276$2$F$$20220426$20220712$20240722$PER$$US-ASTELLAS-2022US015763$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210692824$21069282$4$F$20220105$20220121$20220712$20240722$PER$$US-ASTELLAS-2022US000706$ASTELLAS$$69$YR$$F$Y$$$20240722$$CN$US$US
210692832$21069283$2$F$20211014$20220124$20220712$20240722$PER$$US-ASTELLAS-2022US000686$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
210692842$21069284$2$F$$20220406$20220712$20240722$PER$$US-ASTELLAS-2022US013628$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210692852$21069285$2$F$$20220406$20220712$20240722$PER$$US-ASTELLAS-2022US013212$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
210692862$21069286$2$F$$20220328$20220712$20240722$PER$$US-ASTELLAS-2022US011913$ASTELLAS$$$$E$$Y$$$20240722$$CN$US$US
210692872$21069287$2$F$$20220113$20220712$20240722$PER$$US-ASTELLAS-2022US001525$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692882$21069288$2$F$$20220127$20220712$20240722$PER$$US-ASTELLAS-2022US003503$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692892$21069289$2$F$$20220216$20220712$20240722$PER$$US-ASTELLAS-2022US006254$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210692902$21069290$2$F$20220101$20220128$20220712$20240722$PER$$US-ASTELLAS-2022US003610$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
210692914$21069291$4$F$$20220217$20220712$20240722$PER$$US-ASTELLAS-2022US006583$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
210692922$21069292$2$F$$20220223$20220712$20240722$PER$$US-ASTELLAS-2022US007356$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
210692932$21069293$2$F$$20220530$20220712$20240722$PER$$US-ASTELLAS-2022US019483$ASTELLAS$$53$YR$$F$Y$$$20240722$$CN$US$US
210692944$21069294$4$F$$20220223$20220712$20240722$PER$$US-ASTELLAS-2022US007345$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
210692952$21069295$2$F$20220201$20220216$20220712$20240722$PER$$US-ASTELLAS-2022US006229$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210692962$21069296$2$F$$20220331$20220712$20240722$PER$$US-ASTELLAS-2022US012254$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210692972$21069297$2$F$20220501$20220608$20220712$20240722$PER$$US-ASTELLAS-2022US019632$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
210692982$21069298$2$F$$20220411$20220712$20240722$PER$$US-ASTELLAS-2022US014142$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
210692992$21069299$2$F$$20220511$20220712$20240722$PER$$US-ASTELLAS-2022US017444$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
210693002$21069300$2$F$20220301$20220329$20220712$20240722$PER$$US-ASTELLAS-2022US011971$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
210693012$21069301$2$F$$20220105$20220712$20240722$PER$$US-ASTELLAS-2022US000391$ASTELLAS$$38$YR$$M$Y$$$20240722$$CN$US$US
210693022$21069302$2$F$20190101$20220524$20220712$20240722$PER$$US-ASTELLAS-2022US017425$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
210693032$21069303$2$F$20220101$20220427$20220712$20240722$PER$$US-ASTELLAS-2022US014145$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
210693042$21069304$2$F$$20220104$20220712$20240722$PER$$US-ASTELLAS-2022US000361$ASTELLAS$$75$YR$$F$Y$$$20240722$$HP$US$US
210693064$21069306$4$F$$20220322$20220712$20240722$PER$$US-ASTELLAS-2022US011080$ASTELLAS$$16$YR$$F$Y$$$20240722$$CN$US$US
210693072$21069307$2$F$$20220304$20220712$20240722$PER$$US-ASTELLAS-2022US008769$ASTELLAS$$8$DEC$$M$Y$$$20240722$$CN$US$US
210693084$21069308$4$F$20220203$20220204$20220712$20240722$PER$$US-ASTELLAS-2022US004590$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210693092$21069309$2$F$20220301$20220408$20220712$20240722$PER$$US-ASTELLAS-2022US008827$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
210693102$21069310$2$F$20220204$20220204$20220712$20240722$PER$$US-ASTELLAS-2022US004550$ASTELLAS$$91$YR$$F$Y$$$20240722$$CN$US$US
210693112$21069311$2$F$$20220304$20220712$20240722$PER$$US-ASTELLAS-2022US008766$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693122$21069312$2$F$20220301$20220323$20220712$20240722$PER$$US-ASTELLAS-2022US011170$ASTELLAS$$97$YR$$F$Y$$$20240722$$CN$US$US
210693132$21069313$2$F$$20220426$20220712$20240722$PER$$US-ASTELLAS-2022US015768$ASTELLAS$$90$YR$$M$Y$$$20240722$$CN$US$US
210693142$21069314$2$F$20220428$20220428$20220712$20240722$PER$$US-ASTELLAS-2022US016261$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693152$21069315$2$F$20220201$20220421$20220712$20240722$PER$$US-ASTELLAS-2022US015004$ASTELLAS$$59$YR$$F$Y$$$20240722$$CN$US$US
210693162$21069316$2$F$$20220111$20220712$20240722$PER$$US-ASTELLAS-2022US001079$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693172$21069317$2$F$20220113$20220117$20220712$20240722$PER$$US-ASTELLAS-2022US001820$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
210693182$21069318$2$F$20220314$20220315$20220712$20240722$PER$$US-ASTELLAS-2022US010128$ASTELLAS$$91$YR$$M$Y$$$20240722$$CN$US$US
210693192$21069319$2$F$20220301$20220304$20220712$20240722$PER$$US-ASTELLAS-2022US008768$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
210693202$21069320$2$F$$20220302$20220712$20240722$PER$$US-ASTELLAS-2022US008391$ASTELLAS$$48$YR$$F$Y$$$20240722$$CN$US$US
210693212$21069321$2$F$$20220505$20220712$20240722$PER$$US-ASTELLAS-2022US016857$ASTELLAS$$7$DEC$$F$Y$$$20240722$$CN$US$US
210693222$21069322$2$F$20220401$20220405$20220712$20240722$PER$$US-ASTELLAS-2022US012823$ASTELLAS$$68$YR$$F$Y$$$20240722$$CN$US$US
210693232$21069323$2$F$$20220617$20220712$20240722$PER$$US-ASTELLAS-2022US016263$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693252$21069325$2$F$$20220111$20220712$20240722$PER$$US-ASTELLAS-2022US001064$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693262$21069326$2$F$$20220513$20220712$20240722$PER$$US-ASTELLAS-2022US018022$ASTELLAS$$54$YR$$F$Y$$$20240722$$CN$US$US
210693272$21069327$2$F$20220501$20220509$20220712$20240722$PER$$US-ASTELLAS-2022US017373$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
210693282$21069328$2$F$20220515$20220517$20220712$20240722$PER$$US-ASTELLAS-2022US018217$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
210693292$21069329$2$F$$20220114$20220712$20240722$PER$$US-ASTELLAS-2022US001680$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210693302$21069330$2$F$20220201$20220302$20220712$20240722$PER$$US-ASTELLAS-2022US008313$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693312$21069331$2$F$$20220510$20220712$20240722$PER$$US-ASTELLAS-2022US017287$ASTELLAS$$8$DEC$$M$Y$$$20240722$$CN$US$US
210693352$21069335$2$F$$20220202$20220712$20240722$PER$$US-ASTELLAS-2022US004184$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
210693362$21069336$2$F$$20220228$20220712$20240722$PER$$US-ASTELLAS-2022US007923$ASTELLAS$$88$YR$$M$Y$$$20240722$$CN$US$US
210693372$21069337$2$F$$20220222$20220712$20240722$PER$$US-ASTELLAS-2022US007025$ASTELLAS$$65$YR$$F$Y$$$20240722$$CN$US$US
210693382$21069338$2$F$20220101$20220120$20220712$20240722$PER$$US-ASTELLAS-2022US002467$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
210693392$21069339$2$F$20220128$20220128$20220712$20240722$PER$$US-ASTELLAS-2022US004210$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210693402$21069340$2$F$$20220222$20220712$20240722$PER$$US-ASTELLAS-2022US007043$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210693412$21069341$2$F$20220512$20220512$20220712$20240722$PER$$US-ASTELLAS-2022US017723$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693422$21069342$2$F$20220201$20220225$20220712$20240722$PER$$US-ASTELLAS-2022US007910$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693432$21069343$2$F$$20220228$20220712$20240722$PER$$US-ASTELLAS-2022US007945$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693442$21069344$2$F$$20220117$20220712$20240722$PER$$US-ASTELLAS-2022US001831$ASTELLAS$$95$YR$$F$Y$$$20240722$$CN$US$US
210693452$21069345$2$F$20220202$20220203$20220712$20240722$PER$$US-ASTELLAS-2022US004398$ASTELLAS$$95$YR$$F$Y$$$20240722$$CN$US$US
210693462$21069346$2$F$20220125$20220302$20220712$20240722$PER$$US-ASTELLAS-2022US005479$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
210693472$21069347$2$F$$20220202$20220712$20240722$PER$$US-ASTELLAS-2022US004298$ASTELLAS$$70$YR$$M$Y$$$20240722$$CN$US$US
210693482$21069348$2$F$$20220329$20220712$20240722$PER$$US-ASTELLAS-2022US011959$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210693492$21069349$2$F$$20220422$20220712$20240722$PER$$US-ASTELLAS-2022US012601$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693502$21069350$2$F$$20220512$20220712$20240722$PER$$US-ASTELLAS-2022US017715$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210693512$21069351$2$F$$20220627$20220712$20240722$PER$$US-ASTELLAS-2022US016738$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
210693532$21069353$2$F$$20220211$20220712$20240722$PER$$US-ASTELLAS-2022US005654$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210693542$21069354$2$F$$20220118$20220712$20240722$PER$$US-ASTELLAS-2022US002054$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
210693552$21069355$2$F$$20220228$20220712$20240722$PER$$US-ASTELLAS-2022US007880$ASTELLAS$$89$YR$$M$Y$$$20240722$$CN$US$US
210693562$21069356$2$F$$20220401$20220712$20240722$PER$$US-ASTELLAS-2022US011077$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
210693572$21069357$2$F$$20220503$20220712$20240722$PER$$US-ASTELLAS-2022US016751$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
210693592$21069359$2$F$$20220301$20220712$20240722$PER$$US-ASTELLAS-2022US008208$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693659$21069365$9$F$20220509$20240819$20220712$20240826$EXP$$AU-TAKEDA-2022TUS031567$TAKEDA$$58$YR$$F$Y$$$20240826$$HP$AU$AU
210693662$21069366$2$F$$20220518$20220712$20240722$PER$$US-ASTELLAS-2022US018363$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693672$21069367$2$F$$20220215$20220712$20240722$PER$$US-ASTELLAS-2022US006085$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
210693682$21069368$2$F$$20220131$20220712$20240722$PER$$US-ASTELLAS-2022US003836$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693692$21069369$2$F$$20220426$20220712$20240722$PER$$US-ASTELLAS-2022US015914$ASTELLAS$$65$YR$$F$Y$$$20240722$$CN$US$US
210693702$21069370$2$F$$20220201$20220712$20240722$PER$$US-ASTELLAS-2022US003948$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
210693712$21069371$2$F$$20220427$20220712$20240722$PER$$US-ASTELLAS-2022US015833$ASTELLAS$$26$YR$$F$Y$$$20240722$$CN$US$US
210693722$21069372$2$F$$20220524$20220712$20240722$PER$$US-ASTELLAS-2022US019405$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693732$21069373$2$F$20210101$20220119$20220712$20240722$PER$$US-ASTELLAS-2022US002312$ASTELLAS$$73$YR$$M$Y$$$20240722$$CN$US$US
210693742$21069374$2$F$$20220214$20220712$20240722$PER$$US-ASTELLAS-2022US005870$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693752$21069375$2$F$$20220111$20220712$20240722$PER$$US-ASTELLAS-2022US001283$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693762$21069376$2$F$$20220111$20220712$20240722$PER$$US-ASTELLAS-2022US001268$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
210693772$21069377$2$F$$20220504$20220712$20240722$PER$$US-ASTELLAS-2022US016659$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210693782$21069378$2$F$$20220512$20220712$20240722$PER$$US-ASTELLAS-2022US017628$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693792$21069379$2$F$20220414$20220414$20220712$20240722$PER$$US-ASTELLAS-2022US014157$ASTELLAS$$93$YR$$F$Y$$$20240722$$CN$US$US
210693802$21069380$2$F$$20220512$20220712$20240722$PER$$US-ASTELLAS-2022US017629$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693812$21069381$2$F$$20220504$20220712$20240722$PER$$US-ASTELLAS-2022US016692$ASTELLAS$$59$YR$$F$Y$$$20240722$$CN$US$US
210693822$21069382$2$F$$20220120$20220712$20240722$PER$$US-ASTELLAS-2022US002328$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693832$21069383$2$F$20210101$20220214$20220712$20240722$PER$$US-ASTELLAS-2022US005832$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
210693842$21069384$2$F$$20220422$20220712$20240722$PER$$US-ASTELLAS-2022US015262$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693852$21069385$2$F$$20220126$20220712$20240722$PER$$US-ASTELLAS-2022US003159$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210693862$21069386$2$F$20220125$20220126$20220712$20240722$PER$$US-ASTELLAS-2022US003264$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210693872$21069387$2$F$$20220406$20220712$20240722$PER$$US-ASTELLAS-2022US014124$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693882$21069388$2$F$20220401$20220420$20220712$20240722$PER$$US-ASTELLAS-2022US014916$ASTELLAS$$91$YR$$F$Y$$$20240722$$CN$US$US
210693892$21069389$2$F$$20220414$20220712$20240722$PER$$US-ASTELLAS-2022US014323$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693902$21069390$2$F$$20220524$20220712$20240722$PER$$US-ASTELLAS-2022US019423$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693912$21069391$2$F$20220221$20220222$20220712$20240722$PER$$US-ASTELLAS-2022US007156$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210693942$21069394$2$F$$20220331$20220712$20240722$PER$$US-ASTELLAS-2022US012322$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
210693952$21069395$2$F$$20220329$20220712$20240722$PER$$US-ASTELLAS-2022US011996$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694002$21069400$2$F$$20220531$20220712$20240722$PER$$US-ASTELLAS-2022US020382$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694012$21069401$2$F$$20220411$20220712$20240722$PER$$US-ASTELLAS-2022US014095$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
210694022$21069402$2$F$$20220408$20220712$20240722$PER$$US-ASTELLAS-2022US012262$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
210694034$21069403$4$F$$20220317$20220712$20240722$PER$$US-ASTELLAS-2022US010690$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210694042$21069404$2$F$$20220326$20220712$20240722$PER$$US-ASTELLAS-2022US011522$ASTELLAS$$7$DEC$$F$Y$$$20240722$$CN$US$US
210694052$21069405$2$F$$20220614$20220712$20240722$PER$$US-ASTELLAS-2022US018970$ASTELLAS$$8$DEC$$F$Y$$$20240722$$CN$US$US
210694062$21069406$2$F$$20220309$20220712$20240722$PER$$US-ASTELLAS-2022US009576$ASTELLAS$$89$YR$$F$Y$$$20240722$$CN$US$US
210694072$21069407$2$F$$20220408$20220712$20240722$PER$$US-ASTELLAS-2022US011482$ASTELLAS$$92$YR$$M$Y$$$20240722$$CN$US$US
210694082$21069408$2$F$20220310$20220310$20220712$20240722$PER$$US-ASTELLAS-2022US009586$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694092$21069409$2$F$20220223$20220224$20220712$20240722$PER$$US-ASTELLAS-2022US007524$ASTELLAS$$44$YR$$F$Y$$$20240722$$CN$US$US
210694102$21069410$2$F$20211201$20220527$20220712$20240722$PER$$US-ASTELLAS-2022US019754$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694113$21069411$3$F$$20220815$20220712$20240722$PER$$US-ASTELLAS-2022US018912$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
210694122$21069412$2$F$$20220302$20220712$20240722$PER$$US-ASTELLAS-2022US008182$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
210694132$21069413$2$F$20220519$20220519$20220712$20240722$PER$$US-ASTELLAS-2022US018670$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
210694142$21069414$2$F$$20220224$20220712$20240722$PER$$US-ASTELLAS-2022US007533$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210694152$21069415$2$F$$20220301$20220712$20240722$PER$$US-ASTELLAS-2022US008178$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694162$21069416$2$F$$20220519$20220712$20240722$PER$$US-ASTELLAS-2022US018658$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
210694172$21069417$2$F$$20220422$20220712$20240722$PER$$US-ASTELLAS-2022US012472$ASTELLAS$$79$YR$$M$Y$$$20240722$$CN$US$US
210694184$21069418$4$F$$20220331$20220712$20240722$PER$$US-ASTELLAS-2022US009295$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
210694204$21069420$4$F$$20220211$20220712$20240722$PER$$US-ASTELLAS-2022US005691$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
210694212$21069421$2$F$20220201$20220325$20220712$20240722$PER$$US-ASTELLAS-2022US006584$ASTELLAS$$78$YR$$M$Y$$$20240722$$MD$US$US
210694223$21069422$3$F$20220729$20220815$20220712$20240722$PER$$US-ASTELLAS-2022US005676$ASTELLAS$$61$YR$$F$Y$$$20240722$$CN$US$US
210694232$21069423$2$F$$20220217$20220712$20240722$PER$$US-ASTELLAS-2022US006593$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
210694242$21069424$2$F$$20220328$20220712$20240722$PER$$US-ASTELLAS-2022US011783$ASTELLAS$$$$E$$Y$$$20240722$$CN$US$US
210694252$21069425$2$F$20220301$20220330$20220712$20240722$PER$$US-ASTELLAS-2022US012131$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694263$21069426$3$F$20220201$20220722$20220712$20240722$PER$$US-ASTELLAS-2022US016113$ASTELLAS$$70$YR$$M$Y$$$20240722$$CN$US$US
210694272$21069427$2$F$$20220422$20220712$20240722$PER$$US-ASTELLAS-2022US015541$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210694282$21069428$2$F$$20220317$20220712$20240722$PER$$US-ASTELLAS-2022US010406$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694292$21069429$2$F$20220401$20220419$20220712$20240722$PER$$US-ASTELLAS-2022US014572$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
210694302$21069430$2$F$20220401$20220425$20220712$20240722$PER$$US-ASTELLAS-2022US015449$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
210694312$21069431$2$F$$20220204$20220712$20240722$PER$$US-ASTELLAS-2022US004872$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210694322$21069432$2$F$$20220315$20220712$20240722$PER$$US-ASTELLAS-2022US010363$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210694332$21069433$2$F$$20220421$20220712$20240722$PER$$US-ASTELLAS-2022US015136$ASTELLAS$$99$YR$$F$Y$$$20240722$$CN$US$US
210694342$21069434$2$F$$20220331$20220712$20240722$PER$$US-ASTELLAS-2022US012324$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210694352$21069435$2$F$$20220421$20220712$20240722$PER$$US-ASTELLAS-2022US015125$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210694362$21069436$2$F$20220207$20220207$20220712$20240722$PER$$US-ASTELLAS-2022US004959$ASTELLAS$$78$YR$$M$Y$$$20240722$$CN$US$US
210694372$21069437$2$F$20030101$20220401$20220712$20240722$PER$$US-ASTELLAS-2022US010057$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694384$21069438$4$F$20220401$20220523$20220712$20240722$PER$$US-ASTELLAS-2022US012762$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
210694392$21069439$2$F$20220301$20220311$20220712$20240722$PER$$US-ASTELLAS-2022US009744$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
210694402$21069440$2$F$20220309$20220310$20220712$20240722$PER$$US-ASTELLAS-2022US009734$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
210694432$21069443$2$F$$20220119$20220712$20240722$PER$$US-ASTELLAS-2022US002310$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210694442$21069444$2$F$$20220401$20220712$20240722$PER$$US-ASTELLAS-2022US008956$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694452$21069445$2$F$$20220503$20220712$20240722$PER$$US-ASTELLAS-2022US016924$ASTELLAS$$74$YR$$F$Y$$$20240722$$HP$US$US
210694462$21069446$2$F$$20220201$20220712$20240722$PER$$US-ASTELLAS-2022US004025$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694472$21069447$2$F$$20220216$20220712$20240722$PER$$US-ASTELLAS-2022US006284$ASTELLAS$$60$YR$$M$Y$$$20240722$$CN$US$US
210694482$21069448$2$F$20220101$20220119$20220712$20240722$PER$$US-ASTELLAS-2022US002293$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210694492$21069449$2$F$20220112$20220112$20220712$20240722$PER$$US-ASTELLAS-2022US001341$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694502$21069450$2$F$20220416$20220418$20220712$20240722$PER$$US-ASTELLAS-2022US014933$ASTELLAS$$9$DEC$$F$Y$$$20240722$$CN$US$US
210694514$21069451$4$F$$20220527$20220712$20240722$PER$$US-ASTELLAS-2022US019761$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694524$21069452$4$F$$20220215$20220712$20240722$PER$$US-ASTELLAS-2022US006190$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210694532$21069453$2$F$$20220110$20220712$20240722$PER$$US-ASTELLAS-2022US001173$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210694544$21069454$4$F$$20220413$20220712$20240722$PER$$US-ASTELLAS-2022US014150$ASTELLAS$$56$YR$$F$Y$$$20240722$$CN$US$US
210694552$21069455$2$F$$20220502$20220712$20240722$PER$$US-ASTELLAS-2022US016324$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210694564$21069456$4$F$$20220106$20220712$20240722$PER$$US-ASTELLAS-2022US000572$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694572$21069457$2$F$20220401$20220607$20220712$20240722$PER$$US-ASTELLAS-2022US015828$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
210694582$21069458$2$F$$20220308$20220712$20240722$PER$$US-ASTELLAS-2022US008962$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210694592$21069459$2$F$$20220429$20220712$20240722$PER$$US-ASTELLAS-2022US016274$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694602$21069460$2$F$$20220216$20220712$20240722$PER$$US-ASTELLAS-2022US006328$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
210694612$21069461$2$F$$20220111$20220712$20240722$PER$$US-ASTELLAS-2022US001159$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
210694624$21069462$4$F$$20220502$20220712$20240722$PER$$US-ASTELLAS-2022US014141$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
210694632$21069463$2$F$$20220328$20220712$20240722$PER$$US-ASTELLAS-2022US011763$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210694642$21069464$2$F$20220202$20220202$20220712$20240722$PER$$US-ASTELLAS-2022US003965$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
210694652$21069465$2$F$$20220420$20220712$20240722$PER$$US-ASTELLAS-2022US014958$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
210694852$21069485$2$F$20220301$20220321$20220712$20240722$PER$$US-ASTELLAS-2022US010839$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210694862$21069486$2$F$$20220602$20220712$20240722$PER$$US-ASTELLAS-2022US018244$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
210694872$21069487$2$F$$20220209$20220712$20240722$PER$$US-ASTELLAS-2022US005309$ASTELLAS$$65$YR$$F$Y$$$20240722$$CN$US$US
210694882$21069488$2$F$$20220520$20220712$20240722$PER$$US-ASTELLAS-2022US018221$ASTELLAS$$95$YR$$M$Y$$$20240722$$CN$US$US
210694892$21069489$2$F$20220101$20220113$20220712$20240722$PER$$US-ASTELLAS-2022US001564$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
210694902$21069490$2$F$$20220610$20220712$20240722$PER$$US-ASTELLAS-2022US019264$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
210694912$21069491$2$F$$20220302$20220712$20240722$PER$$US-ASTELLAS-2022US008393$ASTELLAS$$64$YR$$F$Y$$$20240722$$CN$US$US
210694922$21069492$2$F$$20220301$20220712$20240722$PER$$US-ASTELLAS-2022US008128$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
210694932$21069493$2$F$$20220214$20220712$20240722$PER$$US-ASTELLAS-2022US005882$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210694942$21069494$2$F$$20220310$20220712$20240722$PER$$US-ASTELLAS-2022US009684$ASTELLAS$$35$YR$$M$Y$$$20240722$$CN$US$US
210694952$21069495$2$F$20220301$20220330$20220712$20240722$PER$$US-ASTELLAS-2022US012108$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
210694962$21069496$2$F$$20220519$20220712$20240722$PER$$US-ASTELLAS-2022US018621$ASTELLAS$$65$YR$$F$Y$$$20240722$$CN$US$US
210695062$21069506$2$F$$20220309$20220712$20240722$PER$$US-ASTELLAS-2022US009288$ASTELLAS$$69$YR$$M$Y$$$20240722$$HP$US$US
210695082$21069508$2$F$$20220128$20220712$20240722$PER$$US-ASTELLAS-2022US003833$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210695094$21069509$4$F$$20220309$20220712$20240722$PER$$US-ASTELLAS-2022US005140$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210695102$21069510$2$F$$20220301$20220712$20240722$PER$$US-ASTELLAS-2022US008036$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695112$21069511$2$F$$20220405$20220712$20240722$PER$$US-ASTELLAS-2022US010972$ASTELLAS$$78$YR$$M$Y$$$20240722$$CN$US$US
210695122$21069512$2$F$$20220310$20220712$20240722$PER$$US-ASTELLAS-2022US009721$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695132$21069513$2$F$$20220624$20220712$20240722$PER$$US-ASTELLAS-2022US019055$ASTELLAS$$$$$F$Y$$$20240722$$PH$US$US
210695142$21069514$2$F$20211101$20220131$20220712$20240722$PER$$US-ASTELLAS-2022US003827$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695152$21069515$2$F$$20220316$20220712$20240722$PER$$US-ASTELLAS-2022US008453$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
210695162$21069516$2$F$$20220505$20220712$20240722$PER$$US-ASTELLAS-2022US016831$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695172$21069517$2$F$20211201$20220118$20220712$20240722$PER$$US-ASTELLAS-2022US000990$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695182$21069518$2$F$20220401$20220418$20220712$20240722$PER$$US-ASTELLAS-2022US014810$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210695192$21069519$2$F$$20220504$20220712$20240722$PER$$US-ASTELLAS-2022US016808$ASTELLAS$$102$YR$$M$Y$$$20240722$$CN$US$US
210695202$21069520$2$F$$20220302$20220712$20240722$PER$$US-ASTELLAS-2022US008295$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210695212$21069521$2$F$$20220426$20220712$20240722$PER$$US-ASTELLAS-2022US015832$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695222$21069522$2$F$20211201$20220513$20220712$20240722$PER$$US-ASTELLAS-2022US017904$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
210695232$21069523$2$F$$20220223$20220712$20240722$PER$$US-ASTELLAS-2022US006687$ASTELLAS$$84$YR$$M$Y$$$20240722$$CN$US$US
210695242$21069524$2$F$20220401$20220408$20220712$20240722$PER$$US-ASTELLAS-2022US014093$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695252$21069525$2$F$20220501$20220527$20220712$20240722$PER$$US-ASTELLAS-2022US017905$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
210695262$21069526$2$F$20211101$20220406$20220712$20240722$PER$$US-ASTELLAS-2022US009515$ASTELLAS$$91$YR$$F$Y$$$20240722$$CN$US$US
210695272$21069527$2$F$20220401$20220411$20220712$20240722$PER$$US-ASTELLAS-2022US014090$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210695282$21069528$2$F$$20220208$20220712$20240722$PER$$US-ASTELLAS-2022US005118$ASTELLAS$$7$DEC$$F$Y$$$20240722$$CN$US$US
210695292$21069529$2$F$$20220218$20220712$20240722$PER$$US-ASTELLAS-2022US006670$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210695302$21069530$2$F$$20220309$20220712$20240722$PER$$US-ASTELLAS-2022US009501$ASTELLAS$$72$YR$$M$Y$$$20240722$$CN$US$US
210695313$21069531$3$F$20220101$20240321$20220712$20240722$PER$$US-ASTELLAS-2022US001403$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695322$21069532$2$F$$20220301$20220712$20240722$PER$$US-ASTELLAS-2022US008210$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695332$21069533$2$F$$20220505$20220712$20240722$PER$$US-ASTELLAS-2022US017078$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695364$21069536$4$F$$20220203$20220712$20240722$PER$$US-ASTELLAS-2022US004435$ASTELLAS$$66$YR$$M$Y$$$20240722$$CN$US$US
210695372$21069537$2$F$$20220110$20220712$20240722$PER$$US-ASTELLAS-2022US000955$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
210695382$21069538$2$F$$20220217$20220712$20240722$PER$$US-ASTELLAS-2022US003824$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695392$21069539$2$F$$20220128$20220712$20240722$PER$$US-ASTELLAS-2022US003658$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210695402$21069540$2$F$$20220505$20220712$20240722$PER$$US-ASTELLAS-2022US016882$ASTELLAS$$60$YR$$$Y$$$20240722$$CN$US$US
210695412$21069541$2$F$$20220420$20220712$20240722$PER$$US-ASTELLAS-2022US014843$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695422$21069542$2$F$$20220505$20220712$20240722$PER$$US-ASTELLAS-2022US016884$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695432$21069543$2$F$$20220111$20220712$20240722$PER$$US-ASTELLAS-2022US001242$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210695442$21069544$2$F$20220201$20220414$20220712$20240722$PER$$US-ASTELLAS-2022US011789$ASTELLAS$$67$YR$$M$Y$$$20240722$$CN$US$US
210695452$21069545$2$F$20220101$20220111$20220712$20240722$PER$$US-ASTELLAS-2022US001225$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210695462$21069546$2$F$$20220204$20220712$20240722$PER$$US-ASTELLAS-2022US004711$ASTELLAS$$73$YR$$M$Y$$$20240722$$CN$US$US
210695475$21069547$5$F$20230401$20230808$20220712$20240722$PER$$US-ASTELLAS-2022US016995$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
210695482$21069548$2$F$$20220105$20220712$20240722$PER$$US-ASTELLAS-2022US000514$ASTELLAS$$$$$M$Y$$$20240722$$HP$US$US
210695492$21069549$2$F$$20220105$20220712$20240722$PER$$US-ASTELLAS-2022US000477$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
210695502$21069550$2$F$$20220128$20220712$20240722$PER$$US-ASTELLAS-2022US003652$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210695512$21069551$2$F$$20220317$20220712$20240722$PER$$US-ASTELLAS-2022US010479$ASTELLAS$$68$YR$$M$Y$$$20240722$$CN$US$US
210695522$21069552$2$F$20191201$20220504$20220712$20240722$PER$$US-ASTELLAS-2022US014950$ASTELLAS$$66$YR$$F$Y$$$20240722$$CN$US$US
210695532$21069553$2$F$$20220302$20220712$20240722$PER$$US-ASTELLAS-2022US005799$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
210695554$21069555$4$F$20220301$20220325$20220712$20240722$PER$$US-ASTELLAS-2022US011560$ASTELLAS$$91$YR$$F$Y$$$20240722$$CN$US$US
210695562$21069556$2$F$$20220509$20220712$20240722$PER$$US-ASTELLAS-2022US017193$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
210695572$21069557$2$F$$20220128$20220712$20240722$PER$$US-ASTELLAS-2022US003638$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210695582$21069558$2$F$$20220317$20220712$20240722$PER$$US-ASTELLAS-2022US010559$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695592$21069559$2$F$$20220106$20220712$20240722$PER$$US-ASTELLAS-2022US000911$ASTELLAS$$8$DEC$$F$Y$$$20240722$$CN$US$US
210695602$21069560$2$F$$20220519$20220712$20240722$PER$$US-ASTELLAS-2022US016037$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
210695612$21069561$2$F$20220325$20220325$20220712$20240722$PER$$US-ASTELLAS-2022US011586$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
210695632$21069563$2$F$20220427$20220428$20220712$20240722$PER$$US-ASTELLAS-2022US016110$ASTELLAS$$87$YR$$M$Y$$$20240722$$CN$US$US
210695642$21069564$2$F$$20220401$20220712$20240722$PER$$US-ASTELLAS-2022US012540$ASTELLAS$$93$YR$$F$Y$$$20240722$$CN$US$US
210695662$21069566$2$F$20220501$20220520$20220712$20240722$PER$$US-ASTELLAS-2022US018897$ASTELLAS$$84$YR$$M$Y$$$20240722$$CN$US$US
210695672$21069567$2$F$20220504$20220523$20220712$20240722$PER$$US-ASTELLAS-2022US016107$ASTELLAS$$73$YR$$M$Y$$$20240722$$CN$US$US
210695682$21069568$2$F$20220501$20220511$20220712$20240722$PER$$US-ASTELLAS-2022US017483$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695692$21069569$2$F$$20220602$20220712$20240722$PER$$US-ASTELLAS-2022US020447$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695702$21069570$2$F$$20220506$20220712$20240722$PER$$US-ASTELLAS-2022US014496$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
210695722$21069572$2$F$$20220316$20220712$20240722$PER$$US-ASTELLAS-2022US010336$ASTELLAS$$$$$M$Y$$$20240722$$MD$US$US
210695732$21069573$2$F$$20220523$20220712$20240722$PER$$US-ASTELLAS-2022US016599$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
210695742$21069574$2$F$20220323$20220602$20220712$20240722$PER$$US-ASTELLAS-2022US015685$ASTELLAS$$69$YR$$M$Y$$$20240722$$CN$US$US
210695754$21069575$4$F$$20220526$20220712$20240722$PER$$US-ASTELLAS-2022US015210$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
210695762$21069576$2$F$$20220314$20220712$20240722$PER$$US-ASTELLAS-2022US009963$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210695772$21069577$2$F$$20220323$20220712$20240722$PER$$US-ASTELLAS-2022US011213$ASTELLAS$$$$$M$Y$$$20240722$$MD$US$US
210695782$21069578$2$F$$20220307$20220712$20240722$PER$$US-ASTELLAS-2022US008836$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
210695792$21069579$2$F$20220301$20220315$20220712$20240722$PER$$US-ASTELLAS-2022US010153$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210695802$21069580$2$F$$20220204$20220712$20240722$PER$$US-ASTELLAS-2022US004496$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
210695812$21069581$2$F$20220401$20220425$20220712$20240722$PER$$US-ASTELLAS-2022US014457$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
210695822$21069582$2$F$$20220311$20220712$20240722$PER$$US-ASTELLAS-2022US009762$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210695832$21069583$2$F$$20220401$20220712$20240722$PER$$US-ASTELLAS-2022US012511$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695842$21069584$2$F$20220510$20220511$20220712$20240722$PER$$US-ASTELLAS-2022US017471$ASTELLAS$$78$YR$$M$Y$$$20240722$$CN$US$US
210695855$21069585$5$F$20210101$20220414$20220712$20240722$PER$$US-ASTELLAS-2022US007639$ASTELLAS$$95$YR$$F$Y$$$20240722$$CN$US$US
210695862$21069586$2$F$$20220401$20220712$20240722$PER$$US-ASTELLAS-2022US012584$ASTELLAS$$69$YR$$M$Y$$$20240722$$CN$US$US
210695872$21069587$2$F$$20220520$20220712$20240722$PER$$US-ASTELLAS-2022US018893$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695882$21069588$2$F$20220301$20220406$20220712$20240722$PER$$US-ASTELLAS-2022US011424$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
210695892$21069589$2$F$$20220304$20220712$20240722$PER$$US-ASTELLAS-2022US008832$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210695902$21069590$2$F$$20220202$20220712$20240722$PER$$US-ASTELLAS-2022US004462$ASTELLAS$$62$YR$$F$Y$$$20240722$$CN$US$US
210696012$21069601$2$F$$20220217$20220712$20240722$PER$$US-ASTELLAS-2022US006645$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
210696022$21069602$2$F$$20220217$20220712$20240722$PER$$US-ASTELLAS-2022US006595$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
210696032$21069603$2$F$$20220107$20220712$20240722$PER$$US-ASTELLAS-2022US000886$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
210696042$21069604$2$F$$20220113$20220712$20240722$PER$$US-ASTELLAS-2022US002246$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
210696052$21069605$2$F$$20220308$20220712$20240722$PER$$US-ASTELLAS-2022US009090$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210696062$21069606$2$F$$20220308$20220712$20240722$PER$$US-ASTELLAS-2022US009122$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210696072$21069607$2$F$20200101$20220207$20220712$20240722$PER$$US-ASTELLAS-2022US002227$ASTELLAS$$37$YR$$M$Y$$$20240722$$CN$US$US
210696082$21069608$2$F$$20220216$20220712$20240722$PER$$US-ASTELLAS-2022US006369$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210696092$21069609$2$F$20220426$20220426$20220712$20240722$PER$$US-ASTELLAS-2022US015825$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210696102$21069610$2$F$$20220504$20220712$20240722$PER$$US-ASTELLAS-2022US017269$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210696112$21069611$2$F$$20220225$20220712$20240722$PER$$US-ASTELLAS-2022US007800$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210696122$21069612$2$F$$20220217$20220712$20240722$PER$$US-ASTELLAS-2022US006480$ASTELLAS$$70$YR$$F$Y$$$20240722$$HP$US$US
210696132$21069613$2$F$20220525$20220531$20220712$20240722$PER$$US-ASTELLAS-2022US020235$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210696142$21069614$2$F$20220301$20220318$20220712$20240722$PER$$US-ASTELLAS-2022US008457$ASTELLAS$$88$YR$$M$Y$$$20240722$$CN$US$US
210696152$21069615$2$F$$20220509$20220712$20240722$PER$$US-ASTELLAS-2022US017241$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
210696162$21069616$2$F$$20220210$20220712$20240722$PER$$US-ASTELLAS-2022US005469$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
210696172$21069617$2$F$$20220225$20220712$20240722$PER$$US-ASTELLAS-2022US007772$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210696182$21069618$2$F$$20220322$20220712$20240722$PER$$US-ASTELLAS-2022US011071$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210696192$21069619$2$F$$20220304$20220712$20240722$PER$$US-ASTELLAS-2022US008720$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210696202$21069620$2$F$$20220322$20220712$20240722$PER$$US-ASTELLAS-2022US011074$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210696212$21069621$2$F$$20220123$20220712$20240722$PER$$US-ASTELLAS-2022US005316$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210696222$21069622$2$F$$20220411$20220712$20240722$PER$$US-ASTELLAS-2022US013860$ASTELLAS$$50$YR$$F$Y$$$20240722$$CN$US$US
210696232$21069623$2$F$$20220407$20220712$20240722$PER$$US-ASTELLAS-2022US014028$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210696382$21069638$2$F$20220601$20220620$20220712$20240722$PER$$US-ASTELLAS-2022US022081$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
210696392$21069639$2$F$$20220615$20220712$20240722$PER$$US-ASTELLAS-2022US021999$ASTELLAS$$84$YR$$M$Y$$$20240722$$CN$US$US
210696402$21069640$2$F$20220601$20220623$20220712$20240722$PER$$US-ASTELLAS-2022US023062$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210696412$21069641$2$F$$20210729$20220712$20240722$PER$$US-ASTELLAS-2021US028772$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210696422$21069642$2$F$20210901$20210929$20220712$20240722$PER$$US-ASTELLAS-2021US037327$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
210696432$21069643$2$F$$20210810$20220712$20240722$PER$$US-ASTELLAS-2021US030503$ASTELLAS$$68$YR$$M$Y$$$20240722$$CN$US$US
210696442$21069644$2$F$$20211007$20220712$20240722$PER$$US-ASTELLAS-2021US025461$ASTELLAS$$92$YR$$F$Y$$$20240722$$CN$US$US
210696464$21069646$4$F$$20210803$20220712$20240722$PER$$US-ASTELLAS-2021US029555$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210696484$21069648$4$F$$20210930$20220712$20240722$PER$$US-ASTELLAS-2021US037415$ASTELLAS$$94$YR$$M$Y$$$20240722$$CN$US$US
210696492$21069649$2$F$$20220630$20220712$20240722$PER$$US-ASTELLAS-2022US023962$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210696502$21069650$2$F$$20210720$20220712$20240722$PER$$US-ASTELLAS-2021US027355$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210696512$21069651$2$F$$20210903$20220712$20240722$PER$$US-ASTELLAS-2021US033523$ASTELLAS$$$$E$$Y$$$20240722$$CN$US$US
210696524$21069652$4$F$$20210707$20220712$20240722$PER$$US-ASTELLAS-2021US025472$ASTELLAS$$63$YR$$F$Y$$$20240722$$CN$US$US
210696532$21069653$2$F$20210901$20210907$20220712$20240722$PER$$US-ASTELLAS-2021US033909$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210696544$21069654$4$F$$20210707$20220712$20240722$PER$$US-ASTELLAS-2021US025491$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
210696553$21069655$3$F$$20220727$20220712$20240722$PER$$US-ASTELLAS-2022US021301$ASTELLAS$$$$$F$Y$$$20240722$$MD$US$US
210696562$21069656$2$F$$20210727$20220712$20240722$PER$$US-ASTELLAS-2021US028336$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210696572$21069657$2$F$$20210728$20220712$20240722$PER$$US-ASTELLAS-2021US028518$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
210696582$21069658$2$F$20210701$20210720$20220712$20240722$PER$$US-ASTELLAS-2021US027343$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210696593$21069659$3$F$20220415$20220801$20220712$20240722$PER$$US-ASTELLAS-2022US023166$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
210696602$21069660$2$F$20210801$20210924$20220712$20240722$PER$$US-ASTELLAS-2021US034205$ASTELLAS$$72$YR$$M$Y$$$20240722$$CN$US$US
210696614$21069661$4$F$20210920$20211001$20220712$20240722$PER$$US-ASTELLAS-2021US035896$ASTELLAS$$48$YR$$F$Y$$$20240722$$CN$US$US
210696622$21069662$2$F$$20210806$20220712$20240722$PER$$US-ASTELLAS-2021US030204$ASTELLAS$$$$$F$Y$$$20240722$$HP$US$US
210696632$21069663$2$F$20210707$20210810$20220712$20240722$PER$$US-ASTELLAS-2021US030505$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
210696646$21069664$6$F$$20220726$20220712$20240722$PER$$US-ASTELLAS-2022US023031$ASTELLAS$$87$YR$$F$Y$$$20240722$$CN$US$US
210696663$21069666$3$F$$20220728$20220712$20240722$PER$$US-ASTELLAS-2022US021919$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210696672$21069667$2$F$$20210809$20220712$20240722$PER$$US-ASTELLAS-2021US030409$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
210696682$21069668$2$F$$20220606$20220712$20240722$PER$$US-ASTELLAS-2022US020761$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210696692$21069669$2$F$20210801$20210901$20220712$20240722$PER$$US-ASTELLAS-2021US033188$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
210696702$21069670$2$F$$20220614$20220712$20240722$PER$$US-ASTELLAS-2022US021933$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210696712$21069671$2$F$20210913$20210923$20220712$20240722$PER$$US-ASTELLAS-2021US034842$ASTELLAS$$101$YR$$F$Y$$$20240722$$CN$US$US
210696722$21069672$2$F$$20210720$20220712$20240722$PER$$US-ASTELLAS-2021US027381$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
210696732$21069673$2$F$$20210720$20220712$20240722$PER$$US-ASTELLAS-2021US027512$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210696742$21069674$2$F$20210808$20210818$20220712$20240722$PER$$US-ASTELLAS-2021US030230$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
210696752$21069675$2$F$20220601$20220602$20220712$20240722$PER$$US-ASTELLAS-2022US020469$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
210696762$21069676$2$F$20210801$20210913$20220712$20240722$PER$$US-ASTELLAS-2021US034832$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
210696942$21069694$2$F$20210901$20210928$20220712$20240722$PER$$US-ASTELLAS-2021US036915$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210696952$21069695$2$F$$20210929$20220712$20240722$PER$$US-ASTELLAS-2021US037025$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210696964$21069696$4$F$$20210929$20220712$20240722$PER$$US-ASTELLAS-2021US035562$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210696972$21069697$2$F$$20210816$20220712$20240722$PER$$US-ASTELLAS-2021US031149$ASTELLAS$$8$DEC$$F$Y$$$20240722$$CN$US$US
210696982$21069698$2$F$20210801$20211013$20220712$20240722$PER$$US-ASTELLAS-2021US035730$ASTELLAS$$6$YR$$M$Y$25$KG$20240722$$HP$US$US
210696992$21069699$2$F$20210601$20210929$20220712$20240722$PER$$US-ASTELLAS-2021US034514$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
210697002$21069700$2$F$$20210812$20220712$20240722$PER$$US-ASTELLAS-2021US031109$ASTELLAS$$89$YR$$F$Y$$$20240722$$CN$US$US
210697012$21069701$2$F$$20210917$20220712$20240722$PER$$US-ASTELLAS-2021US035272$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
210697022$21069702$2$F$20210801$20210817$20220712$20240722$PER$$US-ASTELLAS-2021US031778$ASTELLAS$$51$YR$$M$Y$$$20240722$$CN$US$US
210697032$21069703$2$F$20210630$20210701$20220712$20240722$PER$$US-ASTELLAS-2021US024644$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697042$21069704$2$F$20210701$20210805$20220712$20240722$PER$$US-ASTELLAS-2021US028540$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
210697052$21069705$2$F$$20210908$20220712$20240722$PER$$US-ASTELLAS-2021US034059$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
210697062$21069706$2$F$$20210928$20220712$20240722$PER$$US-ASTELLAS-2021US036736$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
210697072$21069707$2$F$20210601$20210803$20220712$20240722$PER$$US-ASTELLAS-2021US029549$ASTELLAS$$63$YR$$F$Y$$$20240722$$CN$US$US
210697082$21069708$2$F$20210801$20210921$20220712$20240722$PER$$US-ASTELLAS-2021US035618$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
210697092$21069709$2$F$$20210825$20220712$20240722$PER$$US-ASTELLAS-2021US031069$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697102$21069710$2$F$$20220614$20220712$20240722$PER$$US-ASTELLAS-2022US021763$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
210697112$21069711$2$F$20210712$20210719$20220712$20240722$PER$$US-ASTELLAS-2021US026166$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
210697122$21069712$2$F$20210801$20211021$20220712$20240722$PER$$US-ASTELLAS-2021US034963$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
210697132$21069713$2$F$$20210716$20220712$20240722$PER$$US-ASTELLAS-2021US026920$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210697142$21069714$2$F$20210810$20210810$20220712$20240722$PER$$US-ASTELLAS-2021US030398$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
210697154$21069715$4$F$$20210712$20220712$20240722$PER$$US-ASTELLAS-2021US026162$ASTELLAS$$66$YR$$F$Y$$$20240722$$CN$US$US
210697162$21069716$2$F$$20210902$20220712$20240722$PER$$US-ASTELLAS-2021US033372$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210697172$21069717$2$F$20210301$20211021$20220712$20240722$PER$$US-ASTELLAS-2021US037211$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210697182$21069718$2$F$20210722$20210806$20220712$20240722$PER$$US-ASTELLAS-2021US028090$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
210697192$21069719$2$F$20210101$20210922$20220712$20240722$PER$$US-ASTELLAS-2021US036033$ASTELLAS$$37$YR$$F$Y$$$20240722$$CN$US$US
210697202$21069720$2$F$$20210927$20220712$20240722$PER$$US-ASTELLAS-2021US036856$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
210697212$21069721$2$F$$20210714$20220712$20240722$PER$$US-ASTELLAS-2021US026203$ASTELLAS$$87$YR$$F$Y$$$20240722$$CN$US$US
210697222$21069722$2$F$20210701$20210810$20220712$20240722$PER$$US-ASTELLAS-2021US028080$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
210697232$21069723$2$F$$20210920$20220712$20240722$PER$$US-ASTELLAS-2021US035594$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697242$21069724$2$F$$20210902$20220712$20240722$PER$$US-ASTELLAS-2021US033371$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
210697252$21069725$2$F$20210701$20210729$20220712$20240722$PER$$US-ASTELLAS-2021US028683$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210697262$21069726$2$F$$20210727$20220712$20240722$PER$$US-ASTELLAS-2021US028326$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210697272$21069727$2$F$$20210902$20220712$20240722$PER$$US-ASTELLAS-2021US033254$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
210697284$21069728$4$F$$20210811$20220712$20240722$PER$$US-ASTELLAS-2021US030661$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
210697292$21069729$2$F$$20210908$20220712$20240722$PER$$US-ASTELLAS-2021US032072$ASTELLAS$$95$YR$$F$Y$$$20240722$$CN$US$US
210697303$21069730$3$F$20220515$20220812$20220712$20240722$PER$$US-ASTELLAS-2022US021760$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
210697312$21069731$2$F$$20210802$20220712$20240722$PER$$US-ASTELLAS-2021US029276$ASTELLAS$$64$YR$$F$Y$$$20240722$$CN$US$US
210697322$21069732$2$F$$20211005$20220712$20240722$PER$$US-ASTELLAS-2021US028217$ASTELLAS$$59$YR$$F$Y$$$20240722$$CN$US$US
210697332$21069733$2$F$$20210920$20220712$20240722$PER$$US-ASTELLAS-2021US035627$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
210697342$21069734$2$F$$20210923$20220712$20240722$PER$$US-ASTELLAS-2021US036023$ASTELLAS$$87$YR$$F$Y$$$20240722$$CN$US$US
210697352$21069735$2$F$$20210714$20220712$20240722$PER$$US-ASTELLAS-2021US026902$ASTELLAS$$$$$M$Y$$$20240722$$PH$US$US
210697364$21069736$4$F$20210601$20210825$20220712$20240722$PER$$US-ASTELLAS-2021US027268$ASTELLAS$$94$YR$$M$Y$$$20240722$$MD$US$US
210697372$21069737$2$F$20210101$20210813$20220712$20240722$PER$$US-ASTELLAS-2021US029551$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697382$21069738$2$F$$20220602$20220712$20240722$PER$$US-ASTELLAS-2022US020602$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
210697392$21069739$2$F$$20210803$20220712$20240722$PER$$US-ASTELLAS-2021US029553$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697402$21069740$2$F$20210209$20210902$20220712$20240722$PER$$US-ASTELLAS-2021US031311$ASTELLAS$$79$YR$$M$Y$$$20240722$$CN$US$US
210697412$21069741$2$F$20210901$20210922$20220712$20240722$PER$$US-ASTELLAS-2021US034684$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697422$21069742$2$F$$20210827$20220712$20240722$PER$$US-ASTELLAS-2021US032560$ASTELLAS$$95$YR$$F$Y$$$20240722$$CN$US$US
210697432$21069743$2$F$20210801$20210830$20220712$20240722$PER$$US-ASTELLAS-2021US032703$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
210697442$21069744$2$F$$20210902$20220712$20240722$PER$$US-ASTELLAS-2021US033300$ASTELLAS$$65$YR$$M$Y$$$20240722$$CN$US$US
210697452$21069745$2$F$$20220610$20220712$20240722$PER$$US-ASTELLAS-2022US021553$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
210697462$21069746$2$F$$20220606$20220712$20240722$PER$$US-ASTELLAS-2022US020760$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
210697472$21069747$2$F$20210901$20210916$20220712$20240722$PER$$US-ASTELLAS-2021US033299$ASTELLAS$$95$YR$$F$Y$$$20240722$$CN$US$US
210697482$21069748$2$F$$20210726$20220712$20240722$PER$$US-ASTELLAS-2021US028203$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697492$21069749$2$F$$20210809$20220712$20240722$PER$$US-ASTELLAS-2021US030291$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697502$21069750$2$F$$20210713$20220712$20240722$PER$$US-ASTELLAS-2021US026404$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
210697512$21069751$2$F$20210201$20210914$20220712$20240722$PER$$US-ASTELLAS-2021US034814$ASTELLAS$$21$YR$$F$Y$$$20240722$$CN$US$US
210697522$21069752$2$F$20210701$20210729$20220712$20240722$PER$$US-ASTELLAS-2021US028711$ASTELLAS$$90$YR$$M$Y$$$20240722$$CN$US$US
210697532$21069753$2$F$$20210707$20220712$20240722$PER$$US-ASTELLAS-2021US025456$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697542$21069754$2$F$20210601$20210706$20220712$20240722$PER$$US-ASTELLAS-2021US025451$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
210697552$21069755$2$F$$20220517$20220712$20240722$PER$$US-ASTELLAS-2022US018500$ASTELLAS$$90$YR$$M$Y$$$20240722$$CN$US$US
210697562$21069756$2$F$$20210706$20220712$20240722$PER$$US-ASTELLAS-2021US025313$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
210697572$21069757$2$F$$20210714$20220712$20240722$PER$$US-ASTELLAS-2021US026654$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210697582$21069758$2$F$$20210728$20220712$20240722$PER$$US-ASTELLAS-2021US028709$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210697592$21069759$2$F$$20220610$20220712$20240722$PER$$US-ASTELLAS-2022US021562$ASTELLAS$$$$$M$Y$$$20240722$$MD$US$US
210697602$21069760$2$F$$20210826$20220712$20240722$PER$$US-ASTELLAS-2021US032382$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
210697612$21069761$2$F$$20210824$20220712$20240722$PER$$US-ASTELLAS-2021US032075$ASTELLAS$$85$YR$$F$Y$$$20240722$$HP$US$US
210697622$21069762$2$F$20210721$20210819$20220712$20240722$PER$$US-ASTELLAS-2021US027783$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
210697632$21069763$2$F$$20210722$20220712$20240722$PER$$US-ASTELLAS-2021US027790$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697642$21069764$2$F$$20210802$20220712$20240722$PER$$US-ASTELLAS-2021US029197$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
210697652$21069765$2$F$$20210731$20220712$20240722$PER$$US-ASTELLAS-2021US029014$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697662$21069766$2$F$$20210802$20220712$20240722$PER$$US-ASTELLAS-2021US029227$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697682$21069768$2$F$20210701$20210706$20220712$20240722$PER$$US-ASTELLAS-2021US025312$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210697872$21069787$2$F$$20210902$20220712$20240722$PER$$US-ASTELLAS-2021US033379$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697882$21069788$2$F$$20210812$20220712$20240722$PER$$US-ASTELLAS-2021US031023$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210697894$21069789$4$F$$20211011$20220712$20240722$PER$$US-ASTELLAS-2021US035410$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
210697902$21069790$2$F$$20210823$20220712$20240722$PER$$US-ASTELLAS-2021US031068$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210697912$21069791$2$F$20220601$20220614$20220712$20240722$PER$$US-ASTELLAS-2022US021753$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
210697924$21069792$4$F$20210701$20210930$20220712$20240722$PER$$US-ASTELLAS-2021US034532$ASTELLAS$$61$YR$$F$Y$$$20240722$$CN$US$US
210697932$21069793$2$F$$20210927$20220712$20240722$PER$$US-ASTELLAS-2021US036675$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210697943$21069794$3$F$$20220922$20220712$20240722$PER$$US-ASTELLAS-2022US021128$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
210697952$21069795$2$F$$20220609$20220712$20240722$PER$$US-ASTELLAS-2022US021191$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
210697962$21069796$2$F$$20220620$20220712$20240722$PER$$US-ASTELLAS-2022US022574$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
210697972$21069797$2$F$20210801$20210817$20220712$20240722$PER$$US-ASTELLAS-2021US031253$ASTELLAS$$65$YR$$F$Y$$$20240722$$CN$US$US
210697982$21069798$2$F$$20220629$20220712$20240722$PER$$US-ASTELLAS-2022US023688$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210697992$21069799$2$F$$20210922$20220712$20240722$PER$$US-ASTELLAS-2021US035911$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210698002$21069800$2$F$20210901$20211012$20220712$20240722$PER$$US-ASTELLAS-2021US035926$ASTELLAS$$60$YR$$M$Y$$$20240722$$PH$US$US
210698012$21069801$2$F$$20210923$20220712$20240722$PER$$US-ASTELLAS-2021US036601$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
210698022$21069802$2$F$$20220613$20220712$20240722$PER$$US-ASTELLAS-2022US021710$ASTELLAS$$68$YR$$F$Y$$$20240722$$CN$US$US
210698032$21069803$2$F$20210101$20210917$20220712$20240722$PER$$US-ASTELLAS-2021US033441$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698303$21069830$3$F$$20220708$20220712$20240722$PER$$US-ASTELLAS-2022US021804$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
210698312$21069831$2$F$$20220623$20220712$20240722$PER$$US-ASTELLAS-2022US023059$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
210698322$21069832$2$F$$20210708$20220712$20240722$PER$$US-ASTELLAS-2021US025865$ASTELLAS$$7$DEC$$F$Y$$$20240722$$CN$US$US
210698334$21069833$4$F$20210927$20211019$20220712$20240722$PER$$US-ASTELLAS-2021US036718$ASTELLAS$$64$YR$$F$Y$$$20240722$$CN$US$US
210698342$21069834$2$F$20220607$20220608$20220712$20240722$PER$$US-ASTELLAS-2022US021064$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
210698362$21069836$2$F$$20210908$20220712$20240722$PER$$US-ASTELLAS-2021US033941$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
210698372$21069837$2$F$$20220628$20220712$20240722$PER$$US-ASTELLAS-2022US023525$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698382$21069838$2$F$20220531$20220602$20220712$20240722$PER$$US-ASTELLAS-2022US020522$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
210698392$21069839$2$F$$20210708$20220712$20240722$PER$$US-ASTELLAS-2021US025759$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
210698402$21069840$2$F$$20210921$20220712$20240722$PER$$US-ASTELLAS-2021US033934$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
210698412$21069841$2$F$$20220613$20220712$20240722$PER$$US-ASTELLAS-2022US021845$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698432$21069843$2$F$$20210830$20220712$20240722$PER$$US-ASTELLAS-2021US033146$ASTELLAS$$7$DEC$$F$Y$$$20240722$$CN$US$US
210698442$21069844$2$F$$20210907$20220712$20240722$PER$$US-ASTELLAS-2021US032450$ASTELLAS$$$$$M$Y$$$20240722$$PH$US$US
210698452$21069845$2$F$$20210831$20220712$20240722$PER$$US-ASTELLAS-2021US032997$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
210698462$21069846$2$F$$20220518$20220712$20240722$PER$$US-ASTELLAS-2022US018493$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
210698472$21069847$2$F$$20220629$20220712$20240722$PER$$US-ASTELLAS-2022US023705$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210698482$21069848$2$F$$20210913$20220712$20240722$PER$$US-ASTELLAS-2021US034619$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210698492$21069849$2$F$$20220606$20220712$20240722$PER$$US-ASTELLAS-2022US020796$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698502$21069850$2$F$$20210816$20220712$20240722$PER$$US-ASTELLAS-2021US031166$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
210698512$21069851$2$F$$20220609$20220712$20240722$PER$$US-ASTELLAS-2022US021196$ASTELLAS$$8$DEC$$F$Y$$$20240722$$CN$US$US
210698522$21069852$2$F$$20220629$20220712$20240722$PER$$US-ASTELLAS-2022US023730$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698532$21069853$2$F$$20220608$20220712$20240722$PER$$US-ASTELLAS-2022US021206$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698542$21069854$2$F$20210801$20210816$20220712$20240722$PER$$US-ASTELLAS-2021US031229$ASTELLAS$$69$YR$$F$Y$$$20240722$$HP$US$US
210698554$21069855$4$F$20210901$20211227$20220712$20240722$PER$$US-ASTELLAS-2021US036471$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
210698564$21069856$4$F$20210801$20210910$20220712$20240722$PER$$US-ASTELLAS-2021US033003$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
210698582$21069858$2$F$$20210827$20220712$20240722$PER$$US-ASTELLAS-2021US032558$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210698592$21069859$2$F$$20220606$20220712$20240722$PER$$US-ASTELLAS-2022US020895$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210698632$21069863$2$F$$20210921$20220712$20240722$PER$$US-ASTELLAS-2021US035756$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
210698644$21069864$4$F$20210601$20210920$20220712$20240722$PER$$US-ASTELLAS-2021US034039$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
210698652$21069865$2$F$20210901$20210921$20220712$20240722$PER$$US-ASTELLAS-2021US035748$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
210698672$21069867$2$F$$20210928$20220712$20240722$PER$$US-ASTELLAS-2021US037040$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210698682$21069868$2$F$$20210811$20220712$20240722$PER$$US-ASTELLAS-2021US030622$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698692$21069869$2$F$$20210811$20220712$20240722$PER$$US-ASTELLAS-2021US030651$ASTELLAS$$40$YR$$F$Y$$$20240722$$PH$US$US
210698704$21069870$4$F$$20210928$20220712$20240722$PER$$US-ASTELLAS-2021US037116$ASTELLAS$$7$DEC$$M$Y$$$20240722$$CN$US$US
210698712$21069871$2$F$20210701$20210817$20220712$20240722$PER$$US-ASTELLAS-2021US030111$ASTELLAS$$78$YR$$M$Y$$$20240722$$CN$US$US
210698722$21069872$2$F$$20210812$20220712$20240722$PER$$US-ASTELLAS-2021US029092$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698733$21069873$3$F$$20220727$20220712$20240722$PER$$US-ASTELLAS-2022US022307$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
210698742$21069874$2$F$$20210708$20220712$20240722$PER$$US-ASTELLAS-2021US025741$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
210698752$21069875$2$F$$20210722$20220712$20240722$PER$$US-ASTELLAS-2021US027794$ASTELLAS$$64$YR$$F$Y$$$20240722$$PH$US$US
210698762$21069876$2$F$20210801$20210806$20220712$20240722$PER$$US-ASTELLAS-2021US030161$ASTELLAS$$70$YR$$M$Y$$$20240722$$CN$US$US
210698773$21069877$3$F$20220606$20220712$20220712$20240722$PER$$US-ASTELLAS-2022US021473$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
210698782$21069878$2$F$$20220624$20220712$20240722$PER$$US-ASTELLAS-2022US023362$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210698792$21069879$2$F$$20210817$20220712$20240722$PER$$US-ASTELLAS-2021US031357$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
210698802$21069880$2$F$$20220614$20220712$20240722$PER$$US-ASTELLAS-2022US021772$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210698812$21069881$2$F$20210101$20210726$20220712$20240722$PER$$US-ASTELLAS-2021US028033$ASTELLAS$$55$YR$$F$Y$$$20240722$$CN$US$US
210698822$21069882$2$F$$20220613$20220712$20240722$PER$$US-ASTELLAS-2022US021802$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698852$21069885$2$F$$20211013$20220712$20240722$PER$$US-ASTELLAS-2021US030239$ASTELLAS$$97$YR$$M$Y$$$20240722$$CN$US$US
210698882$21069888$2$F$$20210701$20220712$20240722$PER$$US-ASTELLAS-2021US024993$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698892$21069889$2$F$$20210702$20220712$20240722$PER$$US-ASTELLAS-2021US025010$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698902$21069890$2$F$$20211001$20220712$20240722$PER$$US-ASTELLAS-2021US037539$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698912$21069891$2$F$$20210817$20220712$20240722$PER$$US-ASTELLAS-2021US031270$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698922$21069892$2$F$$20210818$20220712$20240722$PER$$US-ASTELLAS-2021US030245$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
210698932$21069893$2$F$20210801$20210818$20220712$20240722$PER$$US-ASTELLAS-2021US031361$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
210698942$21069894$2$F$$20220629$20220712$20240722$PER$$US-ASTELLAS-2022US023660$ASTELLAS$$$$$F$Y$61.69$KG$20240722$$CN$SE$US
210698952$21069895$2$F$$20220628$20220712$20240722$PER$$US-ASTELLAS-2022US023578$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
210698962$21069896$2$F$20210930$20211001$20220712$20240722$PER$$US-ASTELLAS-2021US037504$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210698972$21069897$2$F$20210701$20210726$20220712$20240722$PER$$US-ASTELLAS-2021US028165$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
210698982$21069898$2$F$$20210726$20220712$20240722$PER$$US-ASTELLAS-2021US028164$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
210698992$21069899$2$F$$20210804$20220712$20240722$PER$$US-ASTELLAS-2021US029606$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
210699002$21069900$2$F$$20210909$20220712$20240722$PER$$US-ASTELLAS-2021US034222$ASTELLAS$$66$YR$$M$Y$$$20240722$$CN$US$US
210699012$21069901$2$F$$20210910$20220712$20240722$PER$$US-ASTELLAS-2021US034450$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210699022$21069902$2$F$$20220610$20220712$20240722$PER$$US-ASTELLAS-2022US021509$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210699032$21069903$2$F$20210730$20210827$20220712$20240722$PER$$US-ASTELLAS-2021US029751$ASTELLAS$$65$YR$$F$Y$$$20240722$$CN$US$US
210699042$21069904$2$F$20210801$20210817$20220712$20240722$PER$$US-ASTELLAS-2021US031360$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699052$21069905$2$F$$20210817$20220712$20240722$PER$$US-ASTELLAS-2021US031273$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
210699082$21069908$2$F$$20210920$20220712$20240722$PER$$US-ASTELLAS-2021US031584$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210699092$21069909$2$F$$20210811$20220712$20240722$PER$$US-ASTELLAS-2021US030658$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
210699102$21069910$2$F$$20211001$20220712$20240722$PER$$US-ASTELLAS-2021US037502$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699112$21069911$2$F$$20210702$20220712$20240722$PER$$US-ASTELLAS-2021US024980$ASTELLAS$$6$DEC$$F$Y$$$20240722$$CN$US$US
210699122$21069912$2$F$20210101$20210702$20220712$20240722$PER$$US-ASTELLAS-2021US024956$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210699132$21069913$2$F$$20211001$20220712$20240722$PER$$US-ASTELLAS-2021US035830$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
210699142$21069914$2$F$$20210818$20220712$20240722$PER$$US-ASTELLAS-2021US031427$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699152$21069915$2$F$$20210723$20220712$20240722$PER$$US-ASTELLAS-2021US028135$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210699162$21069916$2$F$$20210820$20220712$20240722$PER$$US-ASTELLAS-2021US031756$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210699172$21069917$2$F$$20210921$20220712$20240722$PER$$US-ASTELLAS-2021US035868$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
210699182$21069918$2$F$20210719$20220315$20220712$20240722$PER$$US-ASTELLAS-2021US027207$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
210699192$21069919$2$F$20210715$20210729$20220712$20240722$PER$$US-ASTELLAS-2021US026923$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
210699212$21069921$2$F$20210701$20210728$20220712$20240722$PER$$US-ASTELLAS-2021US026204$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
210699222$21069922$2$F$$20220627$20220712$20240722$PER$$US-ASTELLAS-2022US021635$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210699232$21069923$2$F$$20210726$20220712$20240722$PER$$US-ASTELLAS-2021US028167$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699242$21069924$2$F$20210623$20210707$20220712$20240722$PER$$US-ASTELLAS-2021US025443$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
210699252$21069925$2$F$$20210819$20220712$20240722$PER$$US-ASTELLAS-2021US031679$ASTELLAS$$6$DEC$$F$Y$$$20240722$$CN$US$US
210699262$21069926$2$F$20210601$20210804$20220712$20240722$PER$$US-ASTELLAS-2021US028168$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
210699272$21069927$2$F$$20210818$20220712$20240722$PER$$US-ASTELLAS-2021US031628$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210699283$21069928$3$F$$20220706$20220712$20240722$PER$$US-ASTELLAS-2022US022086$ASTELLAS$$70$YR$$M$Y$$$20240722$$CN$US$US
210699292$21069929$2$F$$20210802$20220712$20240722$PER$$US-ASTELLAS-2021US029167$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
210699302$21069930$2$F$$20220617$20220712$20240722$PER$$US-ASTELLAS-2022US022345$ASTELLAS$$62$YR$$F$Y$$$20240722$$CN$US$US
210699312$21069931$2$F$20210930$20211115$20220712$20240722$PER$$US-ASTELLAS-2021US037164$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
210699322$21069932$2$F$$20220628$20220712$20240722$PER$$US-ASTELLAS-2022US023519$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699332$21069933$2$F$$20210709$20220712$20240722$PER$$US-ASTELLAS-2021US026108$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210699342$21069934$2$F$$20210904$20220712$20240722$PER$$US-ASTELLAS-2021US026079$ASTELLAS$$68$YR$$F$Y$$$20240722$$CN$US$US
210699354$21069935$4$F$20220421$20220602$20220712$20240722$PER$$US-ASTELLAS-2022US020630$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
210699362$21069936$2$F$$20220622$20220712$20240722$PER$$US-ASTELLAS-2022US022850$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
210699372$21069937$2$F$$20220602$20220712$20240722$PER$$US-ASTELLAS-2022US020616$ASTELLAS$$66$YR$$F$Y$$$20240722$$HP$US$US
210699382$21069938$2$F$20220601$20220613$20220712$20240722$PER$$US-ASTELLAS-2022US021636$ASTELLAS$$93$YR$$F$Y$$$20240722$$CN$US$US
210699422$21069942$2$F$$20210721$20220712$20240722$PER$$US-ASTELLAS-2021US027620$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
210699432$21069943$2$F$$20210805$20220712$20240722$PER$$US-ASTELLAS-2021US029927$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210699442$21069944$2$F$20210609$20210806$20220712$20240722$PER$$US-ASTELLAS-2021US029010$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
210699452$21069945$2$F$$20210811$20220712$20240722$PER$$US-ASTELLAS-2021US028990$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
210699462$21069946$2$F$$20210720$20220712$20240722$PER$$US-ASTELLAS-2021US027527$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699472$21069947$2$F$$20210706$20220712$20240722$PER$$US-ASTELLAS-2021US025309$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699485$21069948$5$F$$20221101$20220712$20240722$PER$$US-ASTELLAS-2021US030960$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699492$21069949$2$F$$20210917$20220712$20240722$PER$$US-ASTELLAS-2021US032990$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
210699502$21069950$2$F$20210101$20210805$20220712$20240722$PER$$US-ASTELLAS-2021US029966$ASTELLAS$$72$YR$$M$Y$$$20240722$$CN$US$US
210699512$21069951$2$F$$20210917$20220712$20240722$PER$$US-ASTELLAS-2021US035430$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210699522$21069952$2$F$$20210831$20220712$20240722$PER$$US-ASTELLAS-2021US032936$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699532$21069953$2$F$$20210723$20220712$20240722$PER$$US-ASTELLAS-2021US028146$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699542$21069954$2$F$$20210927$20220712$20240722$PER$$US-ASTELLAS-2021US036694$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210699554$21069955$4$F$$20211008$20220712$20240722$PER$$US-ASTELLAS-2021US033298$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210699562$21069956$2$F$$20210722$20220712$20240722$PER$$US-ASTELLAS-2021US028148$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
210699612$21069961$2$F$$20210720$20220712$20240722$PER$$US-ASTELLAS-2021US027335$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
210699622$21069962$2$F$20210701$20210720$20220712$20240722$PER$$US-ASTELLAS-2021US027296$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
210699632$21069963$2$F$$20210729$20220712$20240722$PER$$US-ASTELLAS-2021US028865$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699642$21069964$2$F$$20210914$20220712$20240722$PER$$US-ASTELLAS-2021US034947$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
210699652$21069965$2$F$$20210728$20220712$20240722$PER$$US-ASTELLAS-2021US028795$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210699662$21069966$2$F$20210101$20210825$20220712$20240722$PER$$US-ASTELLAS-2021US029970$ASTELLAS$$67$YR$$M$Y$$$20240722$$CN$US$US
210699672$21069967$2$F$$20210924$20220712$20240722$PER$$US-ASTELLAS-2021US036420$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
210699682$21069968$2$F$$20220606$20220712$20240722$PER$$US-ASTELLAS-2022US020898$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
210699692$21069969$2$F$$20210811$20220712$20240722$PER$$US-ASTELLAS-2021US030665$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699702$21069970$2$F$$20210812$20220712$20240722$PER$$US-ASTELLAS-2021US030735$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
210699712$21069971$2$F$20210801$20210927$20220712$20240722$PER$$US-ASTELLAS-2021US034949$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
210699722$21069972$2$F$20210801$20210817$20220712$20240722$PER$$US-ASTELLAS-2021US031359$ASTELLAS$$89$YR$$F$Y$$$20240722$$CN$US$US
210699732$21069973$2$F$$20211007$20220712$20240722$PER$$US-ASTELLAS-2021US036711$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
210699742$21069974$2$F$20210901$20211001$20220712$20240722$PER$$US-ASTELLAS-2021US036280$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
210699752$21069975$2$F$20210801$20210831$20220712$20240722$PER$$US-ASTELLAS-2021US033000$ASTELLAS$$97$YR$$F$Y$$$20240722$$CN$US$US
210699762$21069976$2$F$$20220628$20220712$20240722$PER$$US-ASTELLAS-2022US023434$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210699772$21069977$2$F$$20220629$20220712$20240722$PER$$US-ASTELLAS-2022US023692$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
210699782$21069978$2$F$20220622$20220623$20220712$20240722$PER$$US-ASTELLAS-2022US023066$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
210701372$21070137$2$F$20240708$20240708$20220712$20240711$EXP$$NVSC2022CA113120$NOVARTIS$$49$YR$$M$Y$$$20240711$$MD$CA$CA
210703082$21070308$2$F$20220515$20240812$20220712$20240814$EXP$FR-AFSSAPS-PP20220544$FR-ABBVIE-22K-056-4460530-00$ABBVIE$$68$YR$$F$Y$56$KG$20240814$$MD$FR$FR
2107080710$21070807$10$F$20240224$20240318$20220712$20240808$EXP$$NVSC2022CO025852$NOVARTIS$$82$YR$$F$Y$52$KG$20240808$$CN$CO$CO
210708882$21070888$2$F$$20240821$20220712$20240827$EXP$$US-TAKEDA-2022TUS031923$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
2107103219$21071032$19$F$20220710$20240806$20220712$20240810$EXP$$CA-ROCHE-3136854$ROCHE$$42$YR$A$F$Y$$$20240810$$CN$CA$CA
210711032$21071103$2$F$20220707$20240814$20220712$20240821$EXP$$US-SA-2022SA272196$SANOFI AVENTIS$$93$YR$E$F$Y$$$20240821$$CN$US$US
210711524$21071152$4$F$20220819$20240801$20220712$20240812$EXP$$CA-TAKEDA-2022TUS046544$TAKEDA$$29$YR$$M$Y$$$20240812$$CN$CA$CA
210712175$21071217$5$F$20220701$20240712$20220712$20240718$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000261$PAREXEL$$$$$$Y$$$20240718$$CN$US$US
210714194$21071419$4$F$20210101$20240906$20220712$20240927$PER$$US-MYOVANT SCIENCES GMBH-2022MYSCI0500264$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
210718403$21071840$3$F$$20231130$20220712$20240723$PER$$US-NOVOPROD-926916$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
210718553$21071855$3$F$$20231130$20220712$20240723$PER$$US-NOVOPROD-922924$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
210718646$21071864$6$F$20220218$20220701$20220712$20240723$PER$$US-NOVOPROD-915155$NOVO NORDISK$$72$YR$$M$Y$$$20240723$$CN$US$US
210718662$21071866$2$F$20220313$20220404$20220712$20240723$PER$$US-NOVOPROD-926870$NOVO NORDISK$$51$YR$$F$Y$$$20240723$$CN$US$US
210718943$21071894$3$F$$20220905$20220712$20240723$PER$$US-NOVOPROD-926950$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
210719264$21071926$4$F$20220325$20220331$20220712$20240723$PER$$US-NOVOPROD-907064$NOVO NORDISK$$59$YR$$F$Y$$$20240723$$CN$US$US
2107215715$21072157$15$F$20220101$20240916$20220712$20240923$EXP$$US-TAKEDA-US202028166$TAKEDA$$63$YR$$M$Y$211$KG$20240923$$HP$US$US
210727702$21072770$2$F$$20240701$20220712$20240709$EXP$$US-JNJFOC-20220718238$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$LW$US$US
210728097$21072809$7$F$20220711$20240829$20220712$20240903$EXP$$CA-TAKEDA-2022TUS045747$TAKEDA$$56$YR$$M$Y$$$20240903$$CN$CA$CA
210730173$21073017$3$F$$20240716$20220712$20240724$PER$$US-SA-2022SA269302$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240724$$MD$US$US
210730864$21073086$4$F$20220101$20240617$20220712$20240701$PER$$US-SA-2022SA271315$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240701$$MD$US$US
210731293$21073129$3$F$20220715$20240722$20220712$20240729$PER$$US-SA-2022SA273501$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240729$$HP$US$US
210731302$21073130$2$F$20220707$20240725$20220712$20240802$PER$$US-SA-2022SA272972$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240802$$MD$US$US
210731375$21073137$5$F$20240801$20240831$20220712$20240923$PER$$US-SA-2022SA275026$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240923$$CN$US$US
210736333$21073633$3$F$20220623$20220712$20220713$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR104515$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
210737224$21073722$4$F$20220705$20240710$20220713$20240717$EXP$$CA-ROCHE-3136799$ROCHE$$51$YR$A$F$Y$$$20240717$$CN$CA$CA
2107388512$21073885$12$F$20220601$20240819$20220713$20240822$EXP$$US-ABBVIE-22K-163-4461006-00$ABBVIE$$57$YR$$F$Y$$$20240822$$CN$US$US
210740522$21074052$2$F$20220601$20240712$20220713$20240718$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000251$PAREXEL$$$$$$Y$$$20240718$$CN$US$US
210745722$21074572$2$F$$20240912$20220713$20240918$EXP$$IT-AMGEN-ITASP2022116730$AMGEN$Musumeci G.; Muccioli S.; Giglio C. et.al.. The Importance of Intensive Lipid-Lowering Therapy After Acute Coronary Syndrome: Shifting the Paradigm to Improve Target Attainment. Giornale italiano di cardiologia. 2022;23 (7):553-561$$$$$Y$$$20240918$$MD$IT$IT
210746067$21074606$7$F$20190329$20240812$20220713$20240819$EXP$$CO-TAKEDA-2021TUS040112$TAKEDA$$40$YR$$M$Y$82$KG$20240819$$HP$CO$CO
210746969$21074696$9$F$20220705$20221114$20220713$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR104741$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240925$$CN$US$US
210748472$21074847$2$F$$20240812$20220713$20240814$PER$$NVSC2022US158794$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
210749913$21074991$3$F$$20240826$20220713$20240827$EXP$$US-TAKEDA-US201939219$TAKEDA$$$$$F$Y$$$20240827$$HP$US$US
210753068$21075306$8$F$$20230227$20220713$20240930$EXP$$NVSC2022CO058024$NOVARTIS$$$$$F$Y$65$KG$20240930$$CN$CO$CO
210754302$21075430$2$F$$20240715$20220713$20240717$EXP$$US-TAKEDA-2022TUS024500$TAKEDA$$$$$F$Y$$$20240717$$CN$US$US
2107559726$21075597$26$F$20220705$20240923$20220713$20240930$EXP$$IT-TAKEDA-2022TUS046672$TAKEDA$$3$YR$$M$Y$$$20240930$$HP$IT$IT
210762523$21076252$3$F$$20240918$20220713$20240927$PER$$US-MYOVANT SCIENCES GMBH-2022MYSCI0300714$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
210763395$21076339$5$F$20220404$20240724$20220713$20240822$PER$$US-MYOVANT SCIENCES GMBH-2022MYSCI0400125$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
210764088$21076408$8$F$20200101$20240903$20220713$20240908$EXP$$DE-ROCHE-2578105$ROCHE$$36$YR$A$F$Y$95$KG$20240908$$CN$DE$DE
210764614$21076461$4$F$20220603$20240731$20220713$20240802$EXP$$FR-MYLANLABS-2022M1078079$MYLAN$$51$YR$$F$Y$$$20240802$$MD$FR$FR
210765485$21076548$5$F$$20240722$20220713$20240727$EXP$$US-TAKEDA-2021TUS024637$TAKEDA$$$$$F$Y$68$KG$20240727$$HP$US$US
210765965$21076596$5$F$20220706$20240821$20220713$20240827$EXP$$IN-PFIZER INC-2019382891$PFIZER$$63$YR$$F$Y$70.3$KG$20240827$$CN$IN$IN
210770156$21077015$6$F$$20240829$20220713$20240903$EXP$$US-TAKEDA-US202033212$TAKEDA$$$$$F$Y$$$20240903$$MD$US$US
210770578$21077057$8$F$20240305$20240712$20220713$20240718$EXP$$US-TAKEDA-2022TUS046448$TAKEDA$$9$YR$$F$Y$24.03$KG$20240718$$CN$US$US
210771057$21077105$7$F$20220101$20240905$20220713$20240915$EXP$$US-UCBSA-2022038099$UCB$$$$$F$Y$$$20240915$$CN$US$US
210771513$21077151$3$F$20220515$20240815$20220713$20240826$EXP$FR-AFSSAPS-PP20220544$FR-009507513-2207FRA003270$MERCK$$68$YR$$F$Y$56$KG$20240826$$MD$FR$FR
210772667$21077266$7$F$20220101$20240810$20220713$20240814$PER$$US-BIOGEN-2022BI01138694$BIOGEN$$$$$M$Y$$$20240814$$CN$US$US
2107734012$21077340$12$F$20210623$20240812$20220713$20240814$EXP$$US-TAKEDA-2021TUS040593$TAKEDA$$45$YR$$F$Y$$$20240814$$CN$US$US
210773473$21077347$3$F$$20240918$20220713$20240920$EXP$$US-PFIZER INC-PV202200021240$PFIZER$$57$YR$$M$Y$$$20240920$$CN$US$US
2107765213$21077652$13$F$$20240806$20220713$20240807$EXP$$US-TAKEDA-2022TUS046438$TAKEDA$$$$$F$Y$86$KG$20240807$$HP$US$US
210777652$21077765$2$F$$20230801$20220713$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2021TASUS005251$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
210778442$21077844$2$F$20210401$20230912$20220713$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2021TASUS005160$VANDA PHARMACEUTICALS$$38$YR$$F$Y$$$20240723$$CN$US$US
210778822$21077882$2$F$$20230928$20220713$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2021TASUS005135$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
210780073$21078007$3$F$$20230316$20220713$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2021TASUS005369$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
210780454$21078045$4$F$20050101$20240920$20220713$20240927$EXP$$US-JNJFOC-20220718114$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240927$$LW$US$US
210780583$21078058$3$F$$20240529$20220713$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2021TASUS005325$VANDA PHARMACEUTICALS$$$$$F$Y$88.435$KG$20240723$$CN$US$US
210783983$21078398$3$F$20220624$20240808$20220713$20240811$EXP$$US-TAKEDA-2022TUS046369$TAKEDA$$5$YR$$M$Y$$$20240811$$CN$US$US
210784193$21078419$3$F$$20230803$20220713$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2022TASUS005751$VANDA PHARMACEUTICALS$$$$$M$Y$79.365$KG$20240723$$CN$US$US
210786056$21078605$6$F$20220401$20240807$20220713$20240813$EXP$$US-JAZZ-2021-US-026271$JAZZ$$32$YR$$M$Y$$$20240813$$MD$US$US
210788123$21078812$3$F$20220408$20240726$20220713$20240805$PER$$US-SA-2022SA276635$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240805$$MD$US$US
210788322$21078832$2$F$20220609$20240820$20220713$20240829$PER$$US-SA-2022SA276152$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240829$$MD$US$US
210789504$21078950$4$F$19960101$20240725$20220713$20240801$EXP$$US-JNJFOC-20220715583$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240802$$LW$US$US
210789673$21078967$3$F$20220706$20240813$20220713$20240815$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000265$PAREXEL$$$$$$Y$$$20240815$$CN$US$US
2107914421$21079144$21$F$20220101$20240919$20220714$20240928$EXP$$CA-CELLTRION INC.-2022CA006075$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
2107921711$21079217$11$F$20220623$20230918$20220714$20240925$PER$$US-GLAXOSMITHKLINE-US2022AMR104791$GLAXOSMITHKLINE$$79$YR$$F$Y$$$20240925$$CN$US$US
2107977010$21079770$10$F$20220101$20240821$20220714$20240828$PER$$US-BIOGEN-2022BI01095114$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
2108004612$21080046$12$F$20220704$20240815$20220714$20240824$EXP$$CA-CELLTRION INC.-2022CA009825$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
210801266$21080126$6$F$20231207$20240816$20220714$20240822$EXP$$US-SA-2022SA277529$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240822$$MD$US$US
2108032319$21080323$19$F$20210913$20240919$20220714$20240926$EXP$$CA-TAKEDA-2021TUS054368$TAKEDA$$60$YR$$F$Y$$$20240926$$HP$CA$CA
210803268$21080326$8$F$20220628$20240918$20220714$20240923$EXP$$CA-ROCHE-3139804$ROCHE$$33$YR$A$F$Y$$$20240923$$CN$CA$CA
2108118913$21081189$13$F$20220101$20240917$20220714$20240920$EXP$$US-ABBVIE-22K-163-4431698-00$ABBVIE$$26$YR$$M$Y$$$20240920$$CN$US$US
210815164$21081516$4$F$$20240807$20220714$20240809$EXP$$GB-ASTELLAS-2022US024727$ASTELLAS$$76$YR$$M$Y$$$20240809$$CN$GB$GB
210819362$21081936$2$F$20201101$20240724$20220714$20240801$EXP$$US-JNJFOC-20220718260$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240801$$LW$US$US
210819663$21081966$3$F$20210517$20240812$20220714$20240815$EXP$$DE-ROCHE-2834702$ROCHE$$44$YR$A$F$Y$63$KG$20240815$$MD$DE$DE
210821669$21082166$9$F$20210717$20240813$20220714$20240823$EXP$$BE-TEVA-2022-BE-2053238$TEVA$$73$YR$$F$Y$79.1$KG$20240823$$MD$BE$BE
210821696$21082169$6$F$$20240801$20220714$20240805$EXP$$US-TAKEDA-2021TUS048702$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
210825377$21082537$7$F$20220601$20240715$20220714$20240716$EXP$$US-TAKEDA-2022TUS046641$TAKEDA$$54$YR$$F$Y$59$KG$20240716$$HP$US$US
210827227$21082722$7$F$20130925$20240919$20220714$20240925$EXP$$US-TAKEDA-20131024CINRY5231$TAKEDA$$50$YR$$M$Y$$$20240925$$CN$US$US
210827272$21082727$2$F$20210713$20240725$20220714$20240803$EXP$$US-JNJFOC-20220718128$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240803$$LW$US$US
210827652$21082765$2$F$20220201$20220711$20220714$20240820$EXP$$NVSC2022MX081333$NOVARTIS$$31$YR$$M$Y$90$KG$20240820$$CN$MX$MX
210828572$21082857$2$F$$20220706$20220714$20240730$EXP$$CA-AstraZeneca-2022A248256$ASTRAZENECA$$57$YR$$F$Y$$$20240730$$MD$CA$
2108313417$21083134$17$F$20220101$20240705$20220714$20240710$EXP$$PE-PFIZER INC-PV202200011385$PFIZER$$68$YR$$M$Y$$$20240710$$CN$PE$PE
210834466$21083446$6$F$$20240902$20220714$20240909$EXP$$JP-PURDUE-USA-2022-0295172$PURDUE$Tsujikawa S, et al.. Abstract for The 2nd Annual meeting of Japan Society of Pain Clinicians. Kansai Chapter. 2021$47$YR$$M$Y$107$KG$20240909$$MD$JP$JP
210839564$21083956$4$F$20220412$20240730$20220714$20240801$EXP$$US-JAZZ-2022-US-011878$JAZZ$$50$YR$$F$Y$$$20240801$$MD$US$US
210840834$21084083$4$F$20220612$20240715$20220714$20240717$EXP$$US-JAZZ-2022-US-020320$JAZZ$$7$YR$$M$Y$$$20240717$$HP$US$US
210841542$21084154$2$F$20220428$20240719$20220714$20240724$EXP$$US-JAZZ-2022-US-014316$JAZZ$$14$YR$$F$Y$$$20240724$$MD$US$US
210843672$21084367$2$F$20220523$20240912$20220714$20240917$EXP$$US-JAZZ-2022-US-018346$JAZZ$$4$YR$$F$Y$$$20240917$$MD$US$US
210850039$21085003$9$F$20220101$20240809$20220714$20240817$PER$$US-SA-2022SA275955$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240817$$MD$US$US
210850075$21085007$5$F$20220201$20240807$20220714$20240815$PER$$US-SA-2022SA275933$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240815$$MD$US$US
210850642$21085064$2$F$$20240827$20220714$20240910$PER$$US-SA-2022SA275099$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240910$$MD$US$US
210850842$21085084$2$F$20220627$20240726$20220714$20240806$PER$$US-SA-2022SA276280$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240806$$MD$US$US
210851592$21085159$2$F$20220711$20240620$20220714$20240701$PER$$US-SA-2022SA279324$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240701$$MD$US$US
210853137$21085313$7$F$20220616$20240917$20220714$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-072980$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$43$KG$20240920$$MD$JP$JP
2108533213$21085332$13$F$20200919$20240828$20220714$20240905$EXP$$CA-CELLTRION INC.-2020CA027733$CELLTRION$$$$$$Y$$$20240905$$MD$CA$CA
210853383$21085338$3$F$20211128$20240201$20220714$20240716$PER$$US-EVOFEM BIOSCIENCES, INC.-2021-EVO-US003414$PAREXEL$$$$$$Y$$$20240617$$MD$US$US
210853633$21085363$3$F$$20240705$20220714$20240716$PER$$US-SA-2022SA277894$SANOFI AVENTIS$$$$A$F$Y$72.57$KG$20240716$$MD$US$US
210853884$21085388$4$F$$20240827$20220714$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-002287$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
210854497$21085449$7$F$20190101$20240715$20220715$20240722$EXP$$US-ABBVIE-22K-163-4465935-00$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
210856603$21085660$3$F$20220707$20240911$20220715$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2022US000568$DECIPHERA PHARMACEUTICALS$$44$YR$A$F$Y$$$20240927$$CN$US$US
210856722$21085672$2$F$20190801$20240625$20220715$20240703$EXP$$PHHY2019BR224036$NOVARTIS$$67$YR$$F$Y$$$20240703$$CN$BR$BR
210856983$21085698$3$F$20220701$20220817$20220715$20240925$PER$$US-GSK-US2022AMR105399$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
210858992$21085899$2$F$20220328$20240429$20220715$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2022-05647$ALKEM$$46$YR$$F$Y$$$20240723$$MD$FR$FR
210860514$21086051$4$F$20220101$20240711$20220715$20240801$EXP$$US-SA-2022SA280342$SANOFI AVENTIS$$80$YR$E$F$Y$66.22$KG$20240719$$MD$US$US
2108647314$21086473$14$F$20220312$20240720$20220715$20240724$EXP$$JP-TAKEDA-2022TJP030870$TAKEDA$$15$YR$$F$Y$43.8$KG$20240724$$MD$JP$JP
210865544$21086554$4$F$$20240828$20220715$20240903$EXP$$CA-JNJFOC-20220726715$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240903$$CN$CA$CA
2108659815$21086598$15$F$20220601$20240731$20220715$20240814$EXP$$CA-CELLTRION INC.-2022CA010618$CELLTRION$$$$$$Y$$$20240814$$MD$CA$CA
2108665516$21086655$16$F$20220101$20240904$20220715$20240913$EXP$$CA-CELLTRION INC.-2022CA011166$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
210872482$21087248$2$F$20190701$20240625$20220715$20240709$EXP$$CN-ROCHE-2060242$ROCHE$$56$YR$A$F$Y$55$KG$20240628$$CN$CN$CN
2108739413$21087394$13$F$20220629$20240628$20220715$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-069222$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240701$$PH$US$US
210877195$21087719$5$F$20220701$20240712$20220715$20240716$30DAY$$US-GSK-US2022106464$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240716$$CN$US$US
210878304$21087830$4$F$20230101$20240716$20220715$20240718$EXP$$US-KYOWAKIRIN-2022BKK010931$KYOWA$$$$$$Y$$$20240718$$HP$US$US
210881296$21088129$6$F$$20240918$20220715$20240919$PER$$NVSC2022US159944$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
210883154$21088315$4$F$20220601$20240624$20220715$20240701$EXP$$JP-009507513-2207JPN000294J$MERCK$Sakuma T, Yasui H, Mori Y, Kaido T, Yamada C, Fukui Y, et al.. C-19 A Case of Tracheal Chondritis Developed during Combination Therapy with Cytocide and Immune Checkpoint Inhibitors for Hypopharyngeal Cancer. The 140th Tokai Branch Meeting of the Japanese Society for Tuberculosis and Nont. 35$63$YR$$M$Y$$$20240701$$MD$JP$JP
210883602$21088360$2$F$20220221$20240916$20220715$20240920$EXP$$BE-ABBVIE-22K-013-4469508-00$ABBVIE$$74$YR$$M$Y$84$KG$20240920$$MD$BE$BE
210885039$21088503$9$F$$20240923$20220715$20240930$EXP$$US-TAKEDA-2022TUS047519$TAKEDA$$$$$F$Y$$$20240930$$HP$US$US
210885043$21088504$3$F$$20240828$20220715$20240902$EXP$$CA-TAKEDA-2019TUS046582$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
210885603$21088560$3$F$$20240828$20220715$20240905$EXP$$US-VERTEX PHARMACEUTICALS-2017-003785$VERTEX$$$$$F$Y$$$20240905$$CN$US$US
210885712$21088571$2$F$20210101$20240808$20220715$20240816$PER$$US-VERTEX PHARMACEUTICALS-2021-011538$VERTEX$$$$$F$Y$$$20240816$$CN$US$US
210887025$21088702$5$F$20230101$20240814$20220715$20240821$EXP$$US-ABBVIE-22K-163-4467764-00$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
210887416$21088741$6$F$20180626$20240829$20220715$20240902$EXP$$CA-TAKEDA-2022TUS040181$TAKEDA$$26$YR$$F$Y$$$20240902$$MD$CA$CA
210887763$21088776$3$F$20160527$20240815$20220715$20240820$EXP$$CA-PFIZER INC-2016290671$PFIZER$$62$YR$$F$Y$$$20240820$$MD$CA$CA
210892306$21089230$6$F$20220713$20240904$20220715$20240910$EXP$$AU-TAKEDA-2022TUS033870$TAKEDA$$47$YR$$M$Y$$$20240910$$CN$AU$AU
210897567$21089756$7$F$20220830$20240711$20220715$20240715$EXP$$CA-TAKEDA-2022TUS047194$TAKEDA$$29$YR$$F$Y$$$20240715$$CN$CA$CA
210899187$21089918$7$F$20211104$20240919$20220715$20240925$EXP$$CO-TAKEDA-2022TUS047383$TAKEDA$$41$YR$$M$Y$110$KG$20240925$$HP$CO$CO
2109003970$21090039$70$F$20200618$20240919$20220715$20240927$EXP$$US-TAKEDA-2020TUS059591$TAKEDA$$7$YR$$M$Y$32$KG$20240927$$CN$US$US
210906922$21090692$2$F$20220101$20240828$20220716$20240909$PER$$US-SA-2022SA279073$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240909$$MD$US$US
210907403$21090740$3$F$20220712$20240917$20220716$20240924$PER$$US-SA-2022SA280208$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240924$$MD$US$US
210910953$21091095$3$F$20220101$20240903$20220716$20240926$PER$$US-SA-2022SA281891$SANOFI AVENTIS$$58$YR$A$M$Y$108.18$KG$20240926$$MD$US$US
210911844$21091184$4$F$20200320$20240830$20220716$20240909$EXP$$CA-ROCHE-3133961$ROCHE$$53$YR$A$F$Y$$$20240909$$CN$CA$CA
210914045$21091404$5$F$$20240725$20220716$20240729$EXP$$US-SHIRE-US201937775AA$TAKEDA$$$$$F$Y$$$20240729$$MD$US$US
2109180114$21091801$14$F$20190304$20240902$20220717$20240905$EXP$$DE-ROCHE-3138496$ROCHE$$41$YR$A$M$Y$70$KG$20240905$$MD$DE$DE
2109211917$21092119$17$F$20240331$20240404$20220718$20240926$EXP$$US-GSK-US2022AMR105970$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
210921226$21092122$6$F$$20240903$20220718$20240912$EXP$$CA-ROCHE-3138423$ROCHE$$$$A$M$Y$$$20240912$$CN$CA$CA
210921583$21092158$3$F$20220713$20240703$20220718$20240708$EXP$$US-TAKEDA-2022TUS047744$TAKEDA$$1$YR$$F$Y$$$20240708$$CN$US$US
2109227316$21092273$16$F$20210701$20240805$20220718$20240812$EXP$$CA-CELLTRION INC.-2021CA011059$CELLTRION$$$$$$Y$$$20240812$$HP$CA$CA
210928485$21092848$5$F$20220701$20220901$20220718$20240925$PER$$US-GSK-US2022AMR106649$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
2109295419$21092954$19$F$20220101$20240912$20220718$20240921$EXP$$CA-CELLTRION INC.-2022CA006117$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
2109299413$21092994$13$F$20220701$20230607$20220718$20240926$EXP$$US-GSK-US2022AMR106619$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
210931633$21093163$3$F$20240629$20240730$20220718$20240809$30DAY$$US-GSK-US2022105555$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240809$$CN$US$US
210932285$21093228$5$F$20210220$20240620$20220718$20240703$EXP$$JP-ROCHE-3136138$ROCHE$$27$YR$A$F$Y$48$KG$20240704$$MD$JP$JP
2109346318$21093463$18$F$20220701$20240823$20220718$20240902$EXP$$US-GSK-US2022AMR107192$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240902$$CN$US$US
210934792$21093479$2$F$20240630$20240820$20220718$20240829$PER$$US-SA-2022SA271694$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240829$$MD$US$US
2109348113$21093481$13$F$20230606$20240702$20220718$20240710$EXP$$CA-TAKEDA-2022TUS047260$TAKEDA$$50$YR$$F$Y$$$20240710$$CN$CA$CA
210937852$21093785$2$F$20220701$20220714$20220718$20240925$PER$$US-GSK-US2022AMR106610$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
2109391411$21093914$11$F$$20240925$20220718$20240926$EXP$$CA-JNJFOC-20220726927$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240926$$HP$CA$CA
210944775$21094477$5$F$$20220923$20220718$20240925$PER$$US-GSK-US2022AMR106063$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
210944962$21094496$2$F$$20240724$20220718$20240730$PER$$US-VERTEX PHARMACEUTICALS-2022-010588$VERTEX$$$$$F$Y$$$20240730$$MD$US$US
210946469$21094646$9$F$20230925$20240916$20220718$20240918$EXP$$NVSC2022CA161138$NOVARTIS$$62$YR$$M$Y$104$KG$20240918$$MD$CA$CA
210946982$21094698$2$F$20240910$20240924$20220718$20240926$EXP$$US-TAKEDA-2022TUS047729$TAKEDA$$8$YR$$F$Y$$$20240926$$CN$US$US
210947916$21094791$6$F$20220701$20220915$20220718$20240926$EXP$$US-GSK-US2022AMR106595$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
210948032$21094803$2$F$20220316$20220713$20220718$20240926$EXP$$US-GSK-US2021AMR235149$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
210949024$21094902$4$F$20240610$20240827$20220718$20240830$EXP$$IN-PFIZER INC-2019138214$PFIZER$$73$YR$$F$Y$67.5$KG$20240830$$CN$IN$IN
210949847$21094984$7$F$20200201$20240801$20220718$20240807$EXP$$US-JAZZ-2022-US-019660$JAZZ$$32$YR$$F$Y$$$20240807$$HP$US$US
210951323$21095132$3$F$20220701$20220822$20220718$20240926$EXP$$US-GSK-US2022AMR106791$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
210954895$21095489$5$F$20220618$20220831$20220718$20240712$PER$$JP-PFM-2022-05477$PIERRE FABRE MEDICAMENT$$3$MON$$M$Y$$$20240712$$MD$JP$JP
2109557812$21095578$12$F$20220101$20240814$20220718$20240820$PER$$US-PFIZER INC-202200965708$PFIZER$$79$YR$$F$Y$99.79$KG$20240820$$CN$US$US
210961039$21096103$9$F$20240711$20240926$20220718$20240930$EXP$$US-TAKEDA-2021TUS024284$TAKEDA$$54$YR$$F$Y$$$20240930$$HP$US$US
210962294$21096229$4$F$20210812$20240911$20220718$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-123220$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240919$$MD$JP$JP
210962412$21096241$2$F$$20220706$20220718$20240731$EXP$$CA-Covis Pharma GmbH-2022COV02172$COVIS PHARMA$$71$YR$E$F$Y$$$20240731$$CN$CA$CA
210962422$21096242$2$F$$20220706$20220718$20240731$EXP$$CA-Covis Pharma GmbH-2022COV02167$COVIS PHARMA$$57$YR$A$F$Y$$$20240731$$CN$CA$CA
210963114$21096311$4$F$20220601$20240913$20220718$20240917$EXP$$US-GILEAD-2022-0581343$GILEAD$$23$YR$A$F$Y$$$20240917$$CN$US$US
210964583$21096458$3$F$$20240715$20220718$20240801$PER$$US-INCYTE CORPORATION-2022IN005718$INCYTE$$$$$$Y$$$20240801$$HP$US$US
210964727$21096472$7$F$20220713$20240627$20220718$20240701$PER$$NVSC2022US162302$NOVARTIS$$55$YR$$M$Y$$$20240701$$CN$US$US
210965196$21096519$6$F$20040415$20240820$20220718$20240822$EXP$$US-TAKEDA-2022TUS046017$TAKEDA$$43$YR$$M$Y$$$20240822$$CN$US$US
210965506$21096550$6$F$20230101$20240807$20220718$20240813$EXP$$US-INCYTE CORPORATION-2022IN006886$INCYTE$$$$$$Y$$$20240813$$CN$US$US
210966037$21096603$7$F$20180101$20240819$20220718$20240826$EXP$$NVSC2022RO161291$NOVARTIS$Placinta CD, Gales L, Brotea-Mosoiu S. Hepatita fulminanta postchimioterapie cu docetaxel in cancerul de san - prezentare de caz [A case report of fulminant hepatitis due to docetaxel in breast cancer]. ONCOLOG-HEMATOLOG.RO. 2022;16(59):22-5$57$YR$$F$Y$$$20240826$$HP$RO$RO
2109675111$21096751$11$F$$20240911$20220718$20240914$EXP$$GB-ROCHE-3138286$ROCHE$$7$YR$C$F$Y$$$20240914$$CN$GB$GB
210969452$21096945$2$F$$20240702$20220718$20240706$EXP$$US-ABBVIE-22K-163-4471794-00$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
2109721616$21097216$16$F$20230502$20240624$20220719$20240704$EXP$$US-GSK-US2022AMR104909$GLAXOSMITHKLINE$$63$YR$$F$Y$49.433$KG$20240704$$MD$US$US
210974885$21097488$5$F$20210801$20231009$20220719$20240822$PER$$NVSC2022US158763$NOVARTIS$$42$YR$$F$Y$$$20240822$$CN$US$US
210976276$21097627$6$F$$20240911$20220719$20240926$PER$$AU-TOLMAR, INC.-22AU035371$TOLMAR$$$$$M$Y$$$20240926$$CN$AU$AU
210978873$21097887$3$F$$20240704$20220719$20240710$EXP$$CA-TAKEDA-2022TUS047652$TAKEDA$$$$$F$Y$$$20240710$$MD$CA$CA
2109801317$21098013$17$F$20220711$20240826$20220719$20240902$EXP$$US-TAKEDA-2022TUS038264$TAKEDA$$57$YR$$F$Y$171$KG$20240902$$CN$US$US
210984748$21098474$8$F$20220613$20240707$20220719$20240715$EXP$$CA-ROCHE-3118008$ROCHE$$34$YR$A$F$Y$$$20240715$$CN$CA$CA
210985993$21098599$3$F$20220607$20240807$20220719$20240813$EXP$$FR-MYLANLABS-2022M1078844$MYLAN$$95$YR$$F$Y$$$20240813$$HP$FR$FR
2109881420$21098814$20$F$20220101$20240626$20220719$20240701$EXP$$CA-TAKEDA-2022TUS042687$TAKEDA$$$$$F$Y$30$KG$20240701$$CN$CA$CA
210988732$21098873$2$F$20220623$20240826$20220719$20240830$EXP$$US-BEH-2022147346$CSL BEHRING$$52$YR$A$M$Y$$$20240830$$CN$US$US
2109903613$21099036$13$F$$20240708$20220719$20240722$EXP$$CO-ROCHE-3142718$ROCHE$$47$YR$A$F$Y$60$KG$20240722$$CN$CO$CO
210990412$21099041$2$F$$20240828$20220719$20240902$EXP$$CA-TAKEDA-2020TUS007509$TAKEDA$$$$$M$Y$$$20240902$$CN$CA$CA
2109918443$21099184$43$F$$20240819$20220719$20240826$EXP$$CA-GSK-CA2020AMR262241$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$CA$CA
210993268$21099326$8$F$20210101$20240830$20220719$20240904$PER$$US-BIOGEN-2022BI01140016$BIOGEN$$$$$M$Y$$$20240904$$CN$US$US
2109943511$21099435$11$F$20220101$20240827$20220719$20240902$EXP$$IN-PFIZER INC-PV202200021039$PFIZER$$74$YR$$M$Y$50.75$KG$20240902$$CN$IN$IN
210994426$21099442$6$F$20211004$20240704$20220719$20240709$EXP$$CA-PFIZER INC-202101341128$PFIZER$$60$YR$$F$Y$83.1$KG$20240709$$MD$CA$CA
2109947226$21099472$26$F$20220101$20240628$20220719$20240702$EXP$$CA-PFIZER INC-PV202200016324$PFIZER$$62$YR$$F$Y$70.7$KG$20240702$$CN$CA$CA
2109967216$21099672$16$F$$20240923$20220719$20240930$EXP$$US-GSK-US2022AMR071397$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
2110024825$21100248$25$F$$20240904$20220719$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-076145$BRISTOL MYERS SQUIBB$Hyakudo T, Satouchi M, Hatori Y, Jyusou K, Yasuda Y, Ito S, et al. A case of clinical condition suggestive of cytokine release syndrome after ipilimumab/nivolumab administration for malignant pleural mesothelioma. The 119th Kansai Branch Meeting of the Japan Lung Cancer Society. 2024;45.$77$YR$E$M$Y$$$20240910$$MD$JP$JP
2110110217$21101102$17$F$20220930$20240802$20220719$20240805$EXP$$US-TAKEDA-2022TUS033592$TAKEDA$$70$YR$$F$Y$55$KG$20240805$$HP$US$US
211015703$21101570$3$F$20190101$20240806$20220719$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-076491$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$75.3$KG$20240813$$CN$US$US
211017694$21101769$4$F$20220128$20240813$20220719$20240821$EXP$$FR-AstraZeneca-2022A251782$ASTRAZENECA$$59$YR$$M$Y$59$KG$20240821$$MD$FR$
211020934$21102093$4$F$20220708$20240729$20220719$20240801$PER$$US-TAKEDA-2022TUS047615$TAKEDA$$32$YR$$M$Y$175$KG$20240801$$CN$US$US
211022513$21102251$3$F$20220407$20240808$20220719$20240830$EXP$$JP-009507513-2204JPN001020J$MERCK$Hikino K, Kudo A, Yamamoto Y, Makio S, Okawa M, Iida Y, et al.. P-196 Results of combination therapy with pembrolizumab and lenvatinib in our hospital.. The journal of gynecologic oncology/The 66th Annual Meeting of Japan Society of. 2024;42(3):403$66$YR$$F$Y$$$20240830$$MD$JP$JP
211025903$21102590$3$F$20220701$20240712$20220719$20240715$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000282$PAREXEL$$$$$$Y$$$20240716$$CN$US$US
211027943$21102794$3$F$$20240910$20220720$20240918$EXP$$PA-TOLMAR, INC.-22PA035364$TOLMAR$$$$$M$Y$$$20240918$$CN$PA$PA
211028677$21102867$7$F$20190228$20240918$20220720$20240925$EXP$$PHHY2019CA126596$NOVARTIS$$65$YR$$F$Y$110.5$KG$20240925$$MD$CA$CA
211031203$21103120$3$F$$20240725$20220720$20240730$PER$$US-AMGEN-USASP2022121106$AMGEN$$$$$F$Y$$$20240730$$HP$US$US
2110315611$21103156$11$F$20220518$20230302$20220720$20240925$EXP$$US-GSK-US2022AMR105964$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
211031693$21103169$3$F$20220401$20240910$20220720$20240913$EXP$$NVSC2022CA111221$NOVARTIS$$35$YR$$F$Y$$$20240913$$MD$CA$CA
2110360410$21103604$10$F$20210806$20240823$20220720$20240903$EXP$$CA-ROCHE-2897894$ROCHE$$55$YR$A$F$Y$$$20240903$$CN$CA$CA
211036282$21103628$2$F$20220712$20240913$20220720$20240921$EXP$$CA-CELLTRION INC.-2022CA011359$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
2110381013$21103810$13$F$20220407$20240731$20220720$20240802$EXP$$NVSC2022RU163975$NOVARTIS$$56$YR$$F$Y$72$KG$20240802$$MD$RU$RU
2110391111$21103911$11$F$20220711$20240704$20220720$20240708$EXP$$NVSJ2022JP094313$NOVARTIS$Hori Y, Niki M, Kawashima H, Kinoshita H, Murao K, Kubo Y et al.. Pyogenic Sternoclavicular Arthritis During Treatment with Secukinumab in Two Patients with Psoriatic Arthritis. The Japanese Journal of Dermatology/ The 122nd Annual Meeting of the Japanese De. 2023;(5)133:1392-1393$72$YR$$M$Y$$$20240709$$MD$JP$JP
211039608$21103960$8$F$20220101$20240913$20220720$20240919$EXP$$NVSC2022CA140047$NOVARTIS$$79$YR$$M$Y$$$20240919$$CN$CA$CA
211041849$21104184$9$F$20220717$20220930$20220720$20240926$EXP$$US-GSK-US2022AMR108116$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2110462913$21104629$13$F$$20240911$20220720$20240917$EXP$$US-PAREXEL-2021-KAM-US003548$TAKEDA$$$$$M$Y$89.79$KG$20240917$$HP$US$US
211046939$21104693$9$F$20211208$20240718$20220720$20240723$EXP$$IN-PFIZER INC-202101580226$PFIZER$$50$YR$$F$Y$67.8$KG$20240723$$CN$IN$IN
211047095$21104709$5$F$20220316$20240731$20220720$20240802$EXP$$IN-PFIZER INC-2020228487$PFIZER$$64$YR$$F$Y$70.4$KG$20240802$$CN$IN$IN
211048463$21104846$3$F$20220511$20240729$20220720$20240731$EXP$$DE-ROCHE-3138677$ROCHE$$78$YR$E$M$Y$$$20240731$$MD$DE$DE
211052543$21105254$3$F$20210101$20221009$20220720$20240801$EXP$$US-ORPHANEU-2022003322$RECORDATI$$$$$$Y$$$20240801$$CN$US$US
211055202$21105520$2$F$20130701$20240730$20220720$20240805$PER$$US-BIOGEN-2013BI079304$BIOGEN$$51$YR$$M$Y$$$20240805$$CN$US$US
211058823$21105882$3$F$$20240807$20220720$20240816$30DAY$$US-GSK-US2022107772$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
211059007$21105900$7$F$20220330$20240709$20220720$20240724$EXP$$DE-ROCHE-3071155$ROCHE$$56$YR$A$M$Y$$$20240724$$CN$DE$DE
2110607113$21106071$13$F$20220712$20240913$20220720$20240924$EXP$$US-BIOGEN-2022BI01140167$BIOGEN$$69$YR$$F$Y$61.2$KG$20240924$$CN$US$US
211060762$21106076$2$F$20220718$20240916$20220720$20240924$PER$$US-TAKEDA-2022TUS048545$TAKEDA$$$$$F$Y$$$20240924$$CN$US$US
211062912$21106291$2$F$$20240719$20220720$20240725$PER$$NVSC2022US163538$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
211065102$21106510$2$F$20220630$20240717$20220720$20240722$EXP$$US-KYOWAKIRIN-2022BKK011260$KYOWA$$$$$$Y$$$20240722$$CN$US$US
211070993$21107099$3$F$20200504$20240626$20220720$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200502308$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240705$$MD$US$US
211080842$21108084$2$F$$20240715$20220720$20240718$PER$$US-SA-2022SA282788$SANOFI AVENTIS$$$$A$M$Y$$$20240718$$CN$US$US
211081942$21108194$2$F$$20240722$20220720$20240730$PER$$US-SA-2022SA283149$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240730$$MD$US$US
211082814$21108281$4$F$20220101$20240709$20220720$20240717$PER$$US-SA-2022SA287932$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240717$$CN$US$US
211082822$21108282$2$F$20220401$20240917$20220720$20240923$PER$$US-SA-2022SA286369$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240923$$MD$US$US
211095353$21109535$3$F$20200101$20240717$20220721$20240719$EXP$$US-ABBVIE-22K-163-4475774-00$ABBVIE$$$$$M$Y$$$20240719$$CN$US$US
2110963010$21109630$10$F$20220701$20221116$20220721$20240925$PER$$US-GSK-US2022AMR107661$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
211098604$21109860$4$F$20181121$20240809$20220721$20240819$EXP$$RO-ROCHE-3138848$ROCHE$Placinta C, Gales L and Brotea-Mosoiu S A case report of fulminant hepatitis due to docetaxel in breast cancer.. Oncolog-Hematolog.ro 2022;59:22-25.$57$YR$A$F$Y$$$20240819$$MD$RO$RO
211101336$21110133$6$F$20220701$20230125$20220721$20240925$PER$$US-GSK-US2022AMR108208$GLAXOSMITHKLINE$$45$YR$$F$Y$$$20240925$$HP$US$US
2111038421$21110384$21$F$20180618$20240703$20220721$20240715$EXP$$CA-ROCHE-2142572$ROCHE$$65$YR$E$M$Y$$$20240715$$CN$CA$CA
211104942$21110494$2$F$20190401$20221216$20220721$20240727$EXP$DK-EMA-DD-20220531-6644993-182034$DK-Accord-270096$ACCORD$$57$YR$A$M$Y$$$20240727$$MD$DK$DK
211105432$21110543$2$F$20220709$20240730$20220721$20240805$EXP$$CA-TAKEDA-2022TUS048830$TAKEDA$$40$YR$$M$Y$$$20240805$$MD$CA$CA
211108498$21110849$8$F$20200314$20240715$20220721$20240720$EXP$$CO-TAKEDA-2020TUS016113$TAKEDA$$54$YR$$M$Y$62$KG$20240720$$CN$CO$CO
211108539$21110853$9$F$20230926$20240718$20220721$20240725$EXP$$US-TAKEDA-2021TUS042877$TAKEDA$$40$YR$$F$Y$68$KG$20240725$$MD$US$US
211113525$21111352$5$F$20200510$20240726$20220721$20240805$EXP$$CA-TAKEDA-CA202013250$TAKEDA$$49$YR$$F$Y$$$20240805$$CN$CA$CA
211115715$21111571$5$F$20220719$20240712$20220721$20240718$EXP$$CA-ROCHE-3144099$ROCHE$$43$YR$A$F$Y$$$20240718$$CN$CA$CA
211117042$21111704$2$F$$20220718$20220721$20240926$EXP$$US-GSK-US2022AMR000929$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
211121103$21112110$3$F$20220101$20240912$20220721$20240918$EXP$$JP-009507513-2207JPN001657J$MERCK$Iwai K, Kamibayashi J, Nishikawa K, Fukui Y, Kawahara N, Yamada Y, et al.. P-039 Usage experience of therapy with lenvatinib + pembrolizumab for corpus uteri carcinoma. The journal of the Japan Society of Gynecologic Oncology/The 66th Annual Meeting. 2024;42(3):364$62$YR$$F$Y$$$20240918$$MD$JP$JP
2111226226$21112262$26$F$20220117$20240822$20220721$20240827$EXP$$PK-PFIZER INC-202200173436$PFIZER$$54$YR$$F$Y$$$20240827$$CN$PK$PK
211125872$21112587$2$F$20211201$20240422$20220721$20240715$PER$$US-PERRIGO-21US032751$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
211129917$21112991$7$F$20210719$20240808$20220721$20240813$EXP$$DE-TAKEDA-2021TUS050750$TAKEDA$$30$YR$$M$Y$$$20240813$$HP$DE$DE
2111351113$21113511$13$F$20230112$20240828$20220721$20240902$EXP$$US-TAKEDA-2022TUS037979$TAKEDA$$77$YR$$M$Y$78.912$KG$20240902$$HP$US$US
2111351210$21113512$10$F$20220718$20240819$20220721$20240827$EXP$$CA-TAKEDA-2020TUS008975$TAKEDA$$81$YR$$F$Y$$$20240827$$CN$CA$CA
211136044$21113604$4$F$20220701$20240812$20220721$20240814$PER$$US-PFIZER INC-PV202200026404$PFIZER$$43$YR$$F$Y$$$20240814$$HP$US$US
211137813$21113781$3$F$20191014$20240907$20220721$20240912$EXP$$NVSC2019IN008979$NOVARTIS$$59$YR$$F$Y$$$20240912$$CN$IN$IN
211142356$21114235$6$F$20240320$20240725$20220721$20240730$EXP$$US-TAKEDA-2022TUS048629$TAKEDA$$70$YR$$F$Y$74$KG$20240730$$MD$US$US
211143367$21114336$7$F$20210708$20240805$20220721$20240808$EXP$$CO-TAKEDA-CO202008068$TAKEDA$$53$YR$$F$Y$60$KG$20240808$$HP$CO$CO
211147359$21114735$9$F$20220401$20240808$20220721$20240830$EXP$$JP-009507513-2207JPN001793J$MERCK$Izawa S, Matsumoto K, Taneda N, Kadowaki K, Fukaya K, Matsuzawa K, et al.. P10-1 Clinical presentation of 3 cases in which thyroid function abnormal observed within the first 3 months after the start of combination therapy with lenvatinib and pembrolizumab. 65th Annual Meeting of Japan Thyroid Associaton.. 89$65$YR$$F$Y$80$KG$20240830$$MD$JP$JP
211148256$21114825$6$F$20220711$20240719$20220721$20240723$PER$$US-PFIZER INC-PV202200027386$PFIZER$$52$YR$$F$Y$$$20240723$$HP$US$US
211156102$21115610$2$F$$20240706$20220721$20240715$PER$$US-SA-2022SA285856$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240715$$MD$US$US
211158346$21115834$6$F$$20240827$20220721$20240909$PER$$US-SA-2022SA288361$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240909$$MD$US$US
211158412$21115841$2$F$$20240626$20220721$20240705$PER$$US-SA-2022SA287925$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240705$$CN$US$US
211158865$21115886$5$F$$20240809$20220721$20240820$PER$$US-SA-2022SA288742$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240820$$HP$US$US
2111639213$21116392$13$F$20220325$20240813$20220721$20240821$EXP$$CA-CELLTRION INC.-2022CA009565$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
211164806$21116480$6$F$20220928$20240703$20220722$20240710$EXP$$JP-JNJFOC-20220662328$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$CN$JP$JP
211171065$21117106$5$F$20240822$20240822$20220722$20240910$PER$$CA-TOLMAR, INC.-22CA035479$TOLMAR$$94$YR$$M$Y$$$20240910$$CN$CA$CA
211171125$21117112$5$F$$20240822$20220722$20240910$PER$$CA-TOLMAR, INC.-22CA035491$TOLMAR$$$$$M$Y$$$20240910$$CN$CA$CA
211171714$21117171$4$F$$20240821$20220722$20240902$EXP$$US-GSK-US2022AMR109204$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$CN$US$US
211172712$21117271$2$F$20220525$20240125$20220722$20240830$PER$$US-CIPLA LTD.-2022US03581$CIPLA$$$$$$Y$$$20240830$$CN$US$US
211177234$21117723$4$F$20220712$20240827$20220722$20240831$EXP$$JP-AMGEN-JPNSP2022124269$AMGEN$$93$YR$E$F$Y$51$KG$20240831$$MD$JP$JP
211177942$21117794$2$F$20220613$20240909$20220722$20240921$EXP$$US-JNJFOC-20220731975$JOHNSON AND JOHNSON$$56$YR$A$M$Y$82.3$KG$20240921$$HP$US$US
211178284$21117828$4$F$20220705$20240808$20220722$20240813$EXP$$CA-ROCHE-3145534$ROCHE$$28$YR$A$F$Y$$$20240813$$MD$CA$CA
211180502$21118050$2$F$20220128$20240815$20220722$20240816$EXP$FR-AFSSAPS-LY20222205$FR-ROCHE-3138980$ROCHE$$59$YR$A$M$Y$59$KG$20240816$$PH$FR$FR
211181022$21118102$2$F$$20220720$20220722$20240717$EXP$$AT-ASTELLAS-2022US026081$ASTELLAS$$70$YR$$$Y$$$20240717$$CN$AT$AT
2111819218$21118192$18$F$20220720$20240625$20220722$20240704$EXP$$NVSC2022US165797$NOVARTIS$$63$YR$$F$Y$$$20240704$$CN$US$US
2111878911$21118789$11$F$20210804$20240712$20220722$20240716$EXP$$US-TAKEDA-2021TUS052988$TAKEDA$$35$YR$$F$Y$72$KG$20240716$$HP$US$US
211188872$21118887$2$F$20220601$20230808$20220722$20240715$PER$$US-PERRIGO-22US008350$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
211194484$21119448$4$F$20220630$20240725$20220722$20240730$EXP$$CA-TAKEDA-2022TUS049030$TAKEDA$$41$YR$$F$Y$$$20240730$$MD$CA$CA
2111944915$21119449$15$F$20210502$20240723$20220722$20240726$EXP$$CA-TAKEDA-2021TUS028813$TAKEDA$$55$YR$$F$Y$$$20240726$$CN$CA$CA
211194998$21119499$8$F$$20240911$20220722$20240917$EXP$$GB-TAKEDA-2022TUS008130$TAKEDA$$74$YR$$M$Y$$$20240917$$HP$GB$GB
211196876$21119687$6$F$$20240805$20220722$20240812$EXP$$US-JAZZ-2022-US-024387$JAZZ$$$$$F$Y$$$20240812$$MD$US$US
211198234$21119823$4$F$$20240906$20220722$20240911$EXP$$US-GILEAD-2022-0589410$GILEAD$$73$YR$E$M$Y$$$20240911$$HP$US$US
211201453$21120145$3$F$20210101$20240913$20220722$20240921$EXP$$US-ABBVIE-22K-163-4477544-00$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
211202627$21120262$7$F$20220715$20240903$20220722$20240905$EXP$$CA-ROCHE-3145560$ROCHE$$29$YR$A$F$Y$$$20240905$$CN$CA$CA
211203288$21120328$8$F$$20240711$20220722$20240716$EXP$$CA-TAKEDA-2022TUS048880$TAKEDA$$$$$F$Y$$$20240716$$MD$CA$CA
211204124$21120412$4$F$$20230113$20220722$20240925$EXP$$US-GSK-US2022AMR109340$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
211204513$21120451$3$F$20240701$20240715$20220722$20240722$EXP$$US-GSK-US2022AMR109247$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$HP$US$US
211206952$21120695$2$F$20220620$20240923$20220722$20240924$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000297$PAREXEL$$$$$$Y$$$20240924$$CN$US$US
211207842$21120784$2$F$20220601$20240812$20220722$20240813$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000253$PAREXEL$$$$$$Y$$$20240813$$CN$US$US
211207853$21120785$3$F$$20240712$20220722$20240715$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000301$PAREXEL$$$$$$Y$$$20240716$$MD$US$US
211214172$21121417$2$F$20220601$20240812$20220722$20240814$EXP$FR-AFSSAPS-AN20221648$FR-ABBVIE-22K-056-4479110-00$ABBVIE$$87$YR$$F$Y$48$KG$20240814$$PH$FR$FR
211215043$21121504$3$F$$20221101$20220722$20240715$EXP$$AU-ASTELLAS-2022US026045$ASTELLAS$$26$YR$$F$Y$$$20240715$$CN$AU$AU
2112156217$21121562$17$F$20220101$20240123$20220722$20240808$EXP$$NVSC2022CR167001$NOVARTIS$$59$YR$$F$Y$70$KG$20240808$$CN$CR$CR
2112161412$21121614$12$F$20220712$20240716$20220722$20240722$EXP$$US-JAZZ-2022-US-008065$JAZZ$$68$YR$$F$Y$$$20240722$$HP$US$US
2112161518$21121615$18$F$20210222$20240814$20220722$20240819$EXP$$IE-TAKEDA-2022TUS049329$TAKEDA$$70$YR$$F$Y$$$20240819$$CN$IE$IE
211220382$21122038$2$F$$20240813$20220722$20240826$PER$$US-SA-2022SA290150$SANOFI AVENTIS$$14$YR$T$M$Y$63.5$KG$20240826$$MD$US$US
211222374$21122237$4$F$20210410$20240920$20220722$20240930$EXP$$JP-ABBVIE-22P-087-4478597-00$ABBVIE$$48$YR$$M$Y$$$20240930$$MD$JP$JP
211222503$21122250$3$F$20220101$20220809$20220723$20240815$EXP$$CA-AstraZeneca-2022A239568$ASTRAZENECA$$69$YR$$F$Y$$$20240815$$MD$CA$
211228074$21122807$4$F$20220716$20240916$20220723$20240918$EXP$$NVSC2022US167116$NOVARTIS$$55$YR$$F$Y$$$20240918$$CN$US$US
211232392$21123239$2$F$20220718$20240624$20220724$20240703$PER$$US-SA-2022SA293740$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240703$$MD$US$US
211232523$21123252$3$F$$20240722$20220724$20240727$PER$$US-SA-2022SA293826$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240727$$CN$US$US
211235132$21123513$2$F$$20240718$20220724$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20200210635$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240722$$MD$CA$CA
211235142$21123514$2$F$$20240718$20220724$20240724$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20191103999$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240724$$HP$CA$CA
211237266$21123726$6$F$20231110$20240624$20220725$20240702$PER$$CA-TOLMAR, INC.-22CA035502$TOLMAR$$69$YR$$M$Y$$$20240702$$CN$CA$CA
211237334$21123733$4$F$$20240712$20220725$20240717$EXP$$CA-JNJFOC-20220742161$JOHNSON AND JOHNSON$$77$YR$E$M$Y$82$KG$20240717$$HP$CA$CA
211237642$21123764$2$F$20210901$20240712$20220725$20240723$EXP$$PT-AUROBINDO-AUR-APL-2022-028336$AUROBINDO$$59$YR$$F$Y$85$KG$20240723$$HP$PT$PT
211239712$21123971$2$F$20220624$20240913$20220725$20240917$EXP$$US-AMGEN-USASP2022125504$AMGEN$$62$YR$A$F$Y$$$20240917$$HP$US$US
211240042$21124004$2$F$20211201$20240723$20220725$20240801$PER$$US-SA-2022SA290677$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240801$$MD$US$US
211248035$21124803$5$F$$20230127$20220725$20240925$EXP$$US-TAKEDA-2022TUS048665$TAKEDA$$$$$M$Y$$$20240925$$CN$US$US
2112483827$21124838$27$F$20201225$20240924$20220725$20240930$EXP$$US-TAKEDA-2020TUS061489$TAKEDA$$49$YR$$F$Y$$$20240930$$HP$US$US
211249812$21124981$2$F$$20240904$20220725$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-076459$BRISTOL MYERS SQUIBB$Kommineni S, Hussain R, Bandarupalli T, Cook C. A unique case of aggressive hemorrhagic pericardial effusion causing cardiac tamponade in a patient with rheumatoid arthritis. American Journal of Respiratory and Critical Care Medicine. 2022 May;205(1):A1132. doi:10.1164/ajrccm-conference.2022.205.1.$73$YR$E$M$Y$$$20240911$$MD$US$US
2112500015$21125000$15$F$20220917$20240717$20220725$20240722$EXP$$AU-TAKEDA-2022TUS049494$TAKEDA$$35$YR$$M$Y$$$20240722$$HP$AU$AU
211250243$21125024$3$F$$20240724$20220725$20240806$EXP$$CA-MYLANLABS-2022M1079872$MYLAN$Okonkwo MC, Moeller A, McCoy K, Tulipan T, Coolen J. Clinical Conundrum: To Deliver or Not To Deliver a Patient With Pulmonary Edema and Preeclampsia. J-Obstet-Gynaecol-Can 2021;43(10):1170-1172.$29$YR$$F$Y$$$20240806$$MD$CA$CA
211251672$21125167$2$F$20170401$20240717$20220725$20240722$EXP$$FR-TAKEDA-FR202000727$TAKEDA$$46$YR$$M$Y$$$20240722$$HP$FR$FR
211251725$21125172$5$F$20240603$20240717$20220725$20240723$EXP$$AU-TAKEDA-2022TUS049882$TAKEDA$$61$YR$$F$Y$$$20240723$$CN$AU$AU
2112537218$21125372$18$F$20210713$20240813$20220725$20240820$EXP$$IN-PFIZER INC-2020121069$PFIZER$$59$YR$$F$Y$$$20240820$$CN$IN$IN
211255135$21125513$5$F$$20240716$20220725$20240722$EXP$$US-GW PHARMA-2022-US-024451$JAZZ$$$$$F$Y$$$20240722$$CN$US$US
211255756$21125575$6$F$20240101$20240823$20220725$20240828$EXP$$US-PFIZER INC-PV202200028118$PFIZER$$64$YR$$M$Y$$$20240828$$CN$US$US
211261537$21126153$7$F$$20240624$20220725$20240701$PER$$US-PFIZER INC-PV202200027928$PFIZER$$40$YR$$F$Y$$$20240701$$MD$US$US
211262535$21126253$5$F$$20221213$20220725$20240824$EXP$$US-TAKEDA-2022TUS018362$TAKEDA$$$$$F$Y$$$20240824$$HP$US$US
211262578$21126257$8$F$20230912$20240725$20220725$20240730$EXP$$US-PFIZER INC-PV202200028448$PFIZER$$57$YR$$F$Y$$$20240730$$CN$US$US
211263295$21126329$5$F$$20240819$20220725$20240827$PER$$US-BIOGEN-2021BI01029562$BIOGEN$$$$$M$Y$$$20240827$$CN$US$US
2112639712$21126397$12$F$20220501$20240708$20220725$20240711$EXP$$NVSC2022AR149304$NOVARTIS$$57$YR$$F$Y$$$20240711$$CN$AR$AR
211276889$21127688$9$F$$20240911$20220725$20240916$EXP$$US-PFIZER INC-202200157575$PFIZER$$66$YR$$F$Y$67.12$KG$20240916$$MD$US$US
211284794$21128479$4$F$20220601$20240704$20220725$20240709$EXP$$CA-TAKEDA-2022TUS049850$TAKEDA$$56$YR$$M$Y$$$20240709$$CN$CA$CA
211285147$21128514$7$F$$20240913$20220725$20240919$EXP$$NVSC2022US167086$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
211288015$21128801$5$F$20181206$20240809$20220725$20240814$EXP$$DE-ROCHE-3139236$ROCHE$$42$YR$A$F$Y$$$20240814$$MD$DE$DE
211289527$21128952$7$F$20220126$20240814$20220725$20240822$EXP$$DE-ROCHE-3139883$ROCHE$$43$YR$A$F$Y$$$20240822$$MD$DE$DE
211290297$21129029$7$F$20140222$20240722$20220725$20240730$EXP$$CA-ROCHE-3136323$ROCHE$$44$YR$A$F$Y$77$KG$20240730$$HP$CA$CA
211295714$21129571$4$F$20220101$20240726$20220726$20240805$EXP$$CA-ABBVIE-22K-028-4479364-00$ABBVIE$$$$$F$Y$$$20240805$$CN$CA$CA
211295733$21129573$3$F$20220811$20220816$20220726$20240925$PER$$US-GSK-US2022AMR110035$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
211296674$21129667$4$F$20220701$20240718$20220726$20240724$EXP$$NVSC2022DE167552$NOVARTIS$$81$YR$$F$Y$$$20240724$$CN$DE$DE
211296846$21129684$6$F$$20240705$20220726$20240710$30DAY$$US-GSK-US2022AMR109339$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
211298664$21129866$4$F$20211110$20240729$20220726$20240802$EXP$$NVSC2021CA265971$NOVARTIS$$26$YR$$M$Y$$$20240802$$CN$CA$CA
211301103$21130110$3$F$$20240812$20220726$20240823$EXP$CA-HEALTHCANVIG-E2B_05006510$CA-NOVOPROD-939418$NOVO NORDISK$$53$YR$$F$Y$60$KG$20240823$$HP$CA$CA
211302054$21130205$4$F$$20240911$20220726$20240924$EXP$$CA-APOTEX-2022AP010205$APOTEX$$60$YR$$M$Y$$$20240924$$HP$CA$CA
2113026915$21130269$15$F$20200519$20240920$20220726$20240930$EXP$$CA-CELLTRION INC.-2020CA021260$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
211303893$21130389$3$F$$20240916$20220726$20240923$EXP$$CA-TAKEDA-2020TUS022232$TAKEDA$$$$$M$Y$$$20240923$$CN$CA$CA
211306502$21130650$2$F$$20240826$20220726$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202207009637$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240828$$CN$US$US
211307196$21130719$6$F$$20240708$20220726$20240716$EXP$$IN-TAKEDA-2022TUS045448$TAKEDA$$$$$F$Y$$$20240716$$MD$IN$IN
211311083$21131108$3$F$20201029$20221114$20220726$20240710$PER$$JP-PFM-2020-20858$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6$KG$20240710$$MD$JP$JP
211311743$21131174$3$F$20220530$20240805$20220726$20240809$EXP$$GB-EXELIXIS-CABO-22049937$EXELIXIS$$13$YR$$M$Y$$$20240809$$MD$GB$GB
211312513$21131251$3$F$$20240801$20220726$20240809$EXP$$US-MYLANLABS-2022M1081083$MYLAN$Raghunandan S, Pauly M, Blum W, Qayed M, Dhodapkar M, Elkhalifa M, et al. BCMA CAR-T after allogeneic HCT induces remission in refractory plasmablastic lymphoma. Pediatr-Blood-Cancer 2022; 69 (Suppl.) S204-S205.$17$YR$$M$Y$$$20240809$$HP$US$US
211313598$21131359$8$F$$20240708$20220726$20240711$EXP$$US-BIOGEN-2022BI01141235$BIOGEN$$$$$M$Y$$$20240711$$CN$US$US
211315883$21131588$3$F$20220601$20240912$20220726$20240919$EXP$$US-GSK-US2022014751$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$US$US
211316266$21131626$6$F$$20240730$20220726$20240806$30DAY$$US-PFIZER INC-202200948627$PFIZER$$6$YR$$M$Y$21.315$KG$20240806$$MD$US$US
211317975$21131797$5$F$$20240904$20220726$20240906$EXP$$US-PFIZER INC-PV202200030052$PFIZER$$84$YR$$M$Y$70.307$KG$20240906$$CN$US$US
211322157$21132215$7$F$20220101$20240712$20220726$20240717$EXP$$DE-PFIZER INC-202200620313$PFIZER$$81$YR$$F$Y$78$KG$20240717$$HP$DE$DE
211322233$21132223$3$F$$20240904$20220726$20240910$EXP$$CA-PFIZER INC-202201000146$MYLAN$$45$YR$$F$Y$$$20240910$$HP$CA$CA
211323069$21132306$9$F$$20240906$20220726$20240912$EXP$$CA-TAKEDA-2020TUS042241$TAKEDA$$$$$F$Y$$$20240912$$CN$CA$CA
211323076$21132307$6$F$20220101$20240704$20220726$20240722$PER$$US-BEH-2022147645$CSL BEHRING$$90$YR$E$F$Y$$$20240722$$MD$US$US
211323103$21132310$3$F$20220718$20240718$20220726$20240724$EXP$$DE-TAKEDA-2022TUS049517$TAKEDA$$$$A$M$Y$$$20240724$$HP$DE$DE
211323855$21132385$5$F$$20240716$20220726$20240719$EXP$$US-TAKEDA-US201940730$TAKEDA$$$$$M$Y$$$20240719$$MD$US$US
211326356$21132635$6$F$20220507$20240903$20220726$20240910$EXP$$NVSC2022MX121331$NOVARTIS$$37$YR$$F$Y$59$KG$20240910$$CN$MX$MX
211326686$21132668$6$F$20220101$20240808$20220726$20240812$PER$$US-PFIZER INC-202200825356$PFIZER$$50$YR$$M$Y$$$20240812$$HP$US$US
211326746$21132674$6$F$$20240905$20220726$20240909$EXP$$US-PFIZER INC-PV202200029157$PFIZER$$78$YR$$F$Y$$$20240909$$CN$US$US
211332564$21133256$4$F$20240904$20240910$20220726$20240912$EXP$$US-TAKEDA-2022TUS016139$TAKEDA$$64$YR$$F$Y$$$20240912$$CN$US$US
2113325721$21133257$21$F$20210821$20240705$20220726$20240709$EXP$$US-TAKEDA-2021TUS061277$TAKEDA$$45$YR$$F$Y$74$KG$20240709$$MD$US$US
211334205$21133420$5$F$20220718$20240916$20220726$20240918$EXP$$US-TAKEDA-2022TUS048709$TAKEDA$$56$YR$$M$Y$$$20240918$$CN$US$US
211335165$21133516$5$F$20220721$20240813$20220726$20240826$PER$$US-TAKEDA-2022TUS049740$TAKEDA$$81$YR$$M$Y$$$20240826$$MD$US$US
211338107$21133810$7$F$20200604$20240823$20220726$20240828$EXP$$DE-ROCHE-2355935$ROCHE$$30$YR$A$F$Y$$$20240828$$CN$DE$DE
211344546$21134454$6$F$20191209$20240621$20220726$20240709$EXP$$CA-ROCHE-2506507$ROCHE$$44$YR$A$F$Y$$$20240705$$CN$CA$CA
211345062$21134506$2$F$20210701$20240913$20220726$20240921$EXP$$JP-ABBVIE-22K-087-4481955-00$ABBVIE$$70$YR$$F$Y$53$KG$20240919$$MD$JP$JP
211346213$21134621$3$F$$20220801$20220727$20240925$PER$$US-GSK-US2022AMR109516$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2113469014$21134690$14$F$20220701$20230818$20220727$20240926$EXP$$US-GSK-US2022AMR110362$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
211348233$21134823$3$F$20220718$20240704$20220727$20240710$EXP$$DE-ABBVIE-22K-062-4481001-00$ABBVIE$$57$YR$$F$Y$65$KG$20240710$$MD$DE$DE
211360784$21136078$4$F$20220725$20240904$20220727$20240909$EXP$$CA-ROCHE-3148526$ROCHE$$67$YR$E$M$Y$$$20240909$$CN$CA$CA
211362867$21136286$7$F$20220614$20240704$20220727$20240709$EXP$$NL-ROCHE-3142746$ROCHE$$58$YR$A$F$Y$65$KG$20240709$$MD$NL$NL
2113636810$21136368$10$F$20210927$20240620$20220727$20240808$EXP$$NVSC2022IN166159$NOVARTIS$$52$YR$$F$Y$$$20240808$$CN$IN$IN
211364763$21136476$3$F$$20240813$20220727$20240815$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000303$PAREXEL$$$$$$Y$$$20240815$$CN$US$US
211364843$21136484$3$F$$20220720$20220727$20240715$EXP$$HU-ASTELLAS-2022US023694$ASTELLAS$$53$YR$$M$Y$$$20240715$$CN$HU$HU
211367014$21136701$4$F$20220101$20240712$20220727$20240718$EXP$$US-SA-2022SA302235$SANOFI AVENTIS$$79$YR$E$F$Y$50$KG$20240718$$MD$US$US
211368222$21136822$2$F$20161201$20240627$20220727$20240703$EXP$$HR-MYLANLABS-2022M1080407$MYLAN$Mokos M, Basic-Jukic N.. Parotid metastases of cutaneous squamous cell carcinoma in renal transplant recipients: Case series and literature review.. Dermatol-Ther. 2021;34:3$45$YR$$M$Y$$$20240703$$HP$HR$HR
211368555$21136855$5$F$20220425$20240819$20220727$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-079464$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$50.5$KG$20240828$$MD$JP$JP
2113716611$21137166$11$F$20210301$20240815$20220727$20240821$EXP$$CO-TAKEDA-2022TUS050723$TAKEDA$$36$YR$$M$Y$84$KG$20240821$$CN$CO$CO
211374082$21137408$2$F$$20240909$20220727$20240918$EXP$$CA-APOTEX-2022AP010316$APOTEX$$22$YR$$F$Y$$$20240918$$PH$CA$CA
2113745614$21137456$14$F$20211022$20240828$20220727$20240903$EXP$$ZA-TAKEDA-2022TUS042901$TAKEDA$$75$YR$$M$Y$$$20240903$$MD$ZA$ZA
211380342$21138034$2$F$20210709$20220720$20220727$20240926$EXP$$US-GSK-US2021AMR166734$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
211380428$21138042$8$F$$20221115$20220727$20240926$EXP$$US-GSK-US2022081766$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
211381833$21138183$3$F$20220725$20240703$20220727$20240709$PER$$US-BIOGEN-2022BI01142592$BIOGEN$$63$YR$$F$Y$$$20240709$$CN$US$US
211386158$21138615$8$F$20220829$20240813$20220727$20240817$EXP$$CO-TAKEDA-2022TUS050721$TAKEDA$$62$YR$$F$Y$64$KG$20240817$$CN$CO$CO
2113873812$21138738$12$F$20220601$20240816$20220727$20240821$EXP$$NVSC2022EC166213$NOVARTIS$$71$YR$$F$Y$$$20240821$$CN$EC$EC
211388655$21138865$5$F$$20240415$20220727$20240808$EXP$$NVSC2022DO168500$NOVARTIS$$$$$F$Y$$$20240808$$CN$DO$DO
211390004$21139000$4$F$20220101$20240716$20220727$20240718$PER$$US-PFIZER INC-202200239873$PFIZER$$52$YR$$F$Y$$$20240718$$HP$US$US
211392226$21139222$6$F$$20240819$20220727$20240820$EXP$$US-PFIZER INC-PV202200030120$PFIZER$$70$YR$$F$Y$$$20240820$$CN$US$US
211392875$21139287$5$F$20210601$20240904$20220727$20240909$EXP$$CA-TAKEDA-2020TUS039278$TAKEDA$$61$YR$$F$Y$$$20240909$$CN$CA$CA
211398263$21139826$3$F$20220601$20240917$20220728$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-002238$ACADIA PHARMACEUTICALS$$88$YR$$F$Y$$$20240927$$CN$US$US
211398604$21139860$4$F$20220701$20220815$20220728$20240925$PER$$US-GSK-US2022AMR110542$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240925$$CN$US$US
211400162$21140016$2$F$$20240813$20220728$20240815$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000294$PAREXEL$$$$$$Y$$$20240815$$HP$US$US
211401333$21140133$3$F$20210101$20220830$20220728$20240925$PER$$US-GSK-US2022AMR110538$GLAXOSMITHKLINE$$39$YR$$F$Y$$$20240925$$CN$US$US
211403753$21140375$3$F$20220706$20240828$20220728$20240830$EXP$$CA-ROCHE-3144940$ROCHE$$38$YR$A$F$Y$$$20240830$$CN$CA$CA
211403768$21140376$8$F$20220724$20240716$20220728$20240729$EXP$$DE-ROCHE-3147687$ROCHE$$35$YR$A$F$Y$70$KG$20240729$$MD$DE$DE
211404674$21140467$4$F$20220801$20220902$20220728$20240925$PER$$US-GSK-US2022AMR111136$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
211404818$21140481$8$F$20220612$20240817$20220728$20240911$PER$$CA-TOLMAR, INC.-22CA035175$TOLMAR$$88$YR$$M$Y$$$20240911$$CN$CA$CA
2114076522$21140765$22$F$20200101$20240827$20220728$20240904$EXP$$CA-CELLTRION INC.-2020CA023439$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
211409134$21140913$4$F$$20240805$20220728$20240808$EXP$$CA-UCBSA-2022041976$UCB$$$$$F$Y$$$20240808$$CN$CA$CA
2114102724$21141027$24$F$20220101$20240912$20220728$20240923$EXP$$CA-JNJFOC-20220753178$JOHNSON AND JOHNSON$$63$YR$A$M$Y$107$KG$20240923$$HP$CA$CA
211410355$21141035$5$F$20210731$20240801$20220728$20240814$EXP$$JP-ROCHE-3145663$ROCHE$$61$YR$A$F$Y$35.2$KG$20240814$$MD$JP$JP
2114197619$21141976$19$F$20210212$20240830$20220728$20240909$EXP$$CA-TAKEDA-2021TUS008609$TAKEDA$$54$YR$$F$Y$$$20240909$$HP$CA$CA
211420737$21142073$7$F$20180429$20240619$20220728$20240703$EXP$$US-GSK-US2022GSK087906$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$US$US
211420913$21142091$3$F$20210701$20240806$20220728$20240812$EXP$$US-GSK-US2022111008$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$MD$US$US
211421935$21142193$5$F$$20240712$20220728$20240718$EXP$$US-TAKEDA-2022TUS050718$TAKEDA$$$$$F$Y$$$20240718$$CN$US$US
211430542$21143054$2$F$$20220727$20220728$20240904$EXP$$US-TAKEDA-2022TUS050982$TAKEDA$$52$YR$$M$Y$99$KG$20240904$$MD$US$US
211432034$21143203$4$F$20240901$20240925$20220728$20240927$PER$$US-PFIZER INC-PV202200031254$PFIZER$$71$YR$$M$Y$113.4$KG$20240927$$CN$US$US
211436685$21143668$5$F$20220707$20240702$20220728$20240705$EXP$$CA-PFIZER INC-202200828033$PFIZER$$73$YR$$M$Y$94$KG$20240705$$MD$CA$CA
2114369010$21143690$10$F$$20240910$20220728$20240916$EXP$$US-TAKEDA-2022TUS031138$TAKEDA$$$$$M$Y$$$20240916$$MD$US$US
211438182$21143818$2$F$20220601$20240911$20220728$20240915$EXP$$NVSC2022EG170659$NOVARTIS$$38$YR$$F$Y$$$20240916$$CN$EG$EG
211440285$21144028$5$F$$20230324$20220728$20240925$PER$$NVSC2022US170690$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
2114404315$21144043$15$F$20220718$20240920$20220728$20240924$EXP$$NVSC2022US170915$NOVARTIS$$57$YR$$F$Y$$$20240924$$CN$US$US
211441804$21144180$4$F$20220101$20240829$20220728$20240906$PER$$US-BIOGEN-2022BI01142692$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
211442334$21144233$4$F$$20240827$20220728$20240829$EXP$$ES-KYOWAKIRIN-2022BKK011818$KYOWA$$$$$$Y$$$20240829$$HP$ES$ES
211442392$21144239$2$F$$20240627$20220728$20240708$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202207002139$ELI LILLY AND CO$$17$YR$T$M$Y$$$20240708$$CN$AU$AU
211442813$21144281$3$F$$20240715$20220728$20240717$PER$$US-PFIZER INC-PV202200031176$PFIZER$$72$YR$$F$Y$$$20240717$$CN$US$US
2114430910$21144309$10$F$$20240903$20220728$20240905$EXP$$US-TAKEDA-2022TUS050399$TAKEDA$$$$$F$Y$$$20240905$$CN$US$US
2114446616$21144466$16$F$$20240709$20220728$20240711$PER$$US-PFIZER INC-2021650928$PFIZER$$53$YR$$F$Y$$$20240711$$CN$US$US
211451328$21145132$8$F$$20240731$20220729$20240826$PER$$CA-TOLMAR, INC.-22CA035557$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
211452005$21145200$5$F$$20240812$20220729$20240813$PER$$NVSC2022US171317$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
211452843$21145284$3$F$20220701$20220830$20220729$20240925$PER$$US-GSK-US2022AMR111584$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240925$$HP$US$US
211453805$21145380$5$F$20220418$20231006$20220729$20240909$PER$$NVSC2022US171198$NOVARTIS$$33$YR$$F$Y$$$20240909$$CN$US$US
211454472$21145447$2$F$$20240801$20220729$20240808$EXP$$US-STRIDES ARCOLAB LIMITED-2022SP009409$STRIDES$Raghunandan S, Pauly M, Blum W, Qayed M, Dhodapkar M, Elkhalifa M, et al.. BCMA CAR-T AFTER ALLOGENEIC HCT INDUCES REMISSION IN REFRACTORY PLASMABLASTIC LYMPHOMA.. Pediatric Blood and Cancer. 2022;69 (Suppl.):S204-S205$17$YR$$M$Y$$$20240808$$HP$US$US
2114552212$21145522$12$F$20220919$20240923$20220729$20240930$EXP$$US-GSK-US2022AMR111921$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
211456787$21145678$7$F$$20240726$20220729$20240730$EXP$$CA-ROCHE-3148520$ROCHE$$$$A$M$Y$$$20240730$$CN$CA$CA
211458806$21145880$6$F$20220101$20240702$20220729$20240704$EXP$$DE-ORGANON-O2207DEU002078$ORGANON$$53$YR$$M$Y$$$20240704$$MD$DE$DE
211461513$21146151$3$F$20120101$20240625$20220729$20240703$PER$$US-JNJFOC-20220752776$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240703$$LW$US$US
211462329$21146232$9$F$20220728$20240701$20220729$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-002423$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240725$$PH$US$US
2114661311$21146613$11$F$20230101$20230703$20220729$20240926$EXP$$US-GSK-US2022AMR112028$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
211466929$21146692$9$F$20200224$20240813$20220729$20240821$EXP$$CA-CELLTRION INC.-2019CA024947$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
211472355$21147235$5$F$$20240826$20220729$20240830$EXP$$CA-ROCHE-3147497$ROCHE$$67$YR$E$F$Y$$$20240830$$HP$CA$CA
211474672$21147467$2$F$20220726$20240822$20220729$20240828$30DAY$$US-GSK-US2022111782$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240828$$CN$US$US
2114759421$21147594$21$F$20220228$20240703$20220729$20240705$EXP$$US-GSK-US2022038147$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$US$US
211477143$21147714$3$F$20220607$20240707$20220729$20240715$EXP$$CA-ROCHE-3150306$ROCHE$$66$YR$E$F$Y$$$20240715$$CN$CA$CA
211479566$21147956$6$F$$20240826$20220729$20240828$PER$$NVSC2022US148896$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
2114818515$21148185$15$F$20220502$20240807$20220729$20240811$EXP$$DE-ROCHE-3145471$ROCHE$$30$YR$A$F$Y$$$20240811$$CN$DE$DE
211488193$21148819$3$F$20220618$20240708$20220729$20240711$EXP$$IN-PFIZER INC-PV202200032083$PFIZER$$60$YR$$F$Y$$$20240711$$CN$IN$IN
211490522$21149052$2$F$20220306$20220406$20220729$20240717$PER$$US-NOVOPROD-914411$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
211490772$21149077$2$F$20210101$20240823$20220729$20240903$EXP$$US-NOVOPROD-912657$NOVO NORDISK$$$$$M$Y$$$20240903$$CN$US$US
211492642$21149264$2$F$$20220328$20220729$20240717$PER$$US-NOVOPROD-916866$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
211496022$21149602$2$F$$20220330$20220729$20240717$PER$$US-NOVOPROD-931722$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
211497782$21149778$2$F$20211001$20220121$20220729$20240717$PER$$US-NOVOPROD-878225$NOVO NORDISK$$$$A$M$Y$$$20240717$$HP$US$US
211498056$21149805$6$F$20220613$20240806$20220729$20240807$EXP$$US-KYOWAKIRIN-2022BKK011848$KYOWA$$$$$$Y$$$20240807$$HP$US$US
211498752$21149875$2$F$$20220319$20220729$20240717$PER$$US-NOVOPROD-882950$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
211502402$21150240$2$F$20220114$20220114$20220729$20240717$PER$$US-NOVOPROD-907050$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
211503322$21150332$2$F$20211228$20220602$20220729$20240717$PER$$US-NOVOPROD-908827$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
211505574$21150557$4$F$20220314$20220418$20220729$20240717$PER$$US-NOVOPROD-935504$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
211506423$21150642$3$F$$20240311$20220729$20240717$PER$$US-NOVOPROD-936618$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
211506942$21150694$2$F$20220426$20220518$20220729$20240717$PER$$US-NOVOPROD-937771$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
211516883$21151688$3$F$20220728$20220728$20220730$20240717$PER$$US-HLS-202201319$HLS THERAPEUTICS$$64$YR$A$M$Y$$$20240717$$$COUNTRY NOT SPECIFIED$US
211518552$21151855$2$F$20220601$20240723$20220730$20240801$PER$$US-SA-2022SA292061$SANOFI AVENTIS$$42$YR$A$M$Y$95.7$KG$20240801$$MD$US$US
211522104$21152210$4$F$20220701$20240722$20220730$20240730$PER$$US-SA-2022SA299904$SANOFI AVENTIS$$8$YR$C$F$Y$26$KG$20240730$$CN$US$US
211522202$21152220$2$F$$20240827$20220730$20240905$PER$$US-SA-2022SA290877$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240905$$MD$US$US
211522294$21152229$4$F$20200101$20240712$20220730$20240801$PER$$US-SA-2022SA297196$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240719$$MD$US$US
211522623$21152262$3$F$$20240808$20220730$20240815$PER$$US-SA-2022SA298246$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240815$$MD$US$US
211523834$21152383$4$F$$20240802$20220730$20240813$PER$$US-SA-2022SA297197$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240814$$MD$US$US
211523954$21152395$4$F$20240501$20240627$20220730$20240712$PER$$US-SA-2022SA296640$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240712$$MD$US$US
211530466$21153046$6$F$20220101$20240715$20220730$20240722$PER$$US-SA-2022SA303275$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240720$$MD$US$US
211530593$21153059$3$F$20220725$20240909$20220730$20240917$PER$$US-SA-2022SA305434$SANOFI AVENTIS$$7$YR$C$M$Y$18.63$KG$20240918$$MD$US$US
211536577$21153657$7$F$20220101$20240708$20220801$20240710$EXP$$CA-UCBSA-2022040047$UCB$$$$$F$Y$$$20240710$$CN$CA$CA
2115379220$21153792$20$F$$20240207$20220801$20240925$EXP$$US-GSK-US2022AMR111971$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2115384311$21153843$11$F$20220725$20230511$20220801$20240925$EXP$$US-GSK-US2022AMR111663$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
211540753$21154075$3$F$20220718$20240924$20220801$20240925$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000310$PAREXEL$$$$$$Y$$$20240925$$MD$US$US
211542859$21154285$9$F$20160101$20240731$20220801$20240807$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-2022-078008$BRISTOL MYERS SQUIBB$Orlinger M. Case report relapsed multiple myeloma. Spectrum Onkologie. 2022;3:88-9.$50$YR$A$M$Y$$$20240807$$MD$AT$AT
211545083$21154508$3$F$20240720$20240724$20220801$20240731$EXP$$US-ROCHE-3147613$ROCHE$$84$YR$E$M$Y$$$20240731$$CN$US$US
211547112$21154711$2$F$$20240617$20220801$20240701$EXP$$ZA-PURACAP-ZA-2022EPCLIT01066$PURACAP$S omar.HAEMADSORPTION THERAPY FOR CALCIUM CHANNEL BLOCKER OVERDOSE: A CASE REPORT.Blood Purification.DEC-2021;50:33$3$DEC$$M$Y$$$20240701$$HP$ZA$ZA
211549199$21154919$9$F$20220701$20230206$20220801$20240926$EXP$$US-GSK-US2022AMR112389$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
211550463$21155046$3$F$$20240821$20220801$20240830$EXP$$CA-BAXTER-2022BAX016221$BAXTER$$82$YR$$F$Y$$$20240830$$PH$CA$CA
211551623$21155162$3$F$20220101$20240918$20220801$20240920$PER$$US-GBT-014732$PFIZER$$15$YR$$F$Y$$$20240920$$CN$US$US
2115524012$21155240$12$F$20220616$20240731$20220801$20240807$EXP$$CA-CELLTRION INC.-2022CA010755$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
211553488$21155348$8$F$20211201$20240916$20220801$20240925$EXP$$CA-ROCHE-3144984$ROCHE$$61$YR$A$F$Y$$$20240925$$CN$CA$CA
211556784$21155678$4$F$20170517$20230202$20220801$20240910$EXP$$PHHY2017CA075389$NOVARTIS$$44$YR$$M$Y$$$20240911$$CN$CA$CA
211556843$21155684$3$F$$20240916$20220801$20240919$EXP$$CA-BAYER-2022A045784$BAYER$$58$YR$A$F$Y$84$KG$20240919$$CN$CA$CA
211557082$21155708$2$F$$20220727$20220801$20240710$EXP$$DE-ASTELLAS-2022US027160$ASTELLAS$$$$$M$Y$$$20240710$$MD$DE$DE
2115573918$21155739$18$F$20220712$20240920$20220801$20240925$EXP$$NVSC2022IN172832$NOVARTIS$$76$YR$$F$Y$$$20240925$$CN$IN$IN
211558482$21155848$2$F$20220729$20240916$20220801$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-082760$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$112.99$KG$20240918$$CN$US$US
211559377$21155937$7$F$20220301$20240827$20220801$20240917$PER$$CA-TOLMAR, INC.-22CA035569$TOLMAR$$75$YR$$M$Y$$$20240917$$CN$CA$CA
211571253$21157125$3$F$20230128$20240807$20220801$20240812$EXP$$US-PFIZER INC-202201018473$PFIZER$$57$YR$$M$Y$$$20240812$$HP$US$US
211574724$21157472$4$F$20220101$20240806$20220801$20240811$EXP$$CA-PFIZER INC-202201015039$PFIZER$$54$YR$$F$Y$$$20240811$$HP$CA$CA
211577304$21157730$4$F$20220101$20240920$20220801$20240925$EXP$$CA-PFIZER INC-202201015499$PFIZER$$59$YR$$F$Y$$$20240925$$HP$CA$CA
2115785511$21157855$11$F$20210101$20240903$20220801$20240909$EXP$$NVSC2022EG172695$NOVARTIS$$56$YR$$F$Y$$$20240909$$CN$EG$EG
211579398$21157939$8$F$20220605$20240531$20220801$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-083121$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240829$$MD$JP$JP
211581995$21158199$5$F$$20240913$20220801$20240923$EXP$$CA-MYLANLABS-2022M1082445$BIOCON$$$$$$Y$$$20240923$$PH$CA$CA
211582643$21158264$3$F$20220728$20240715$20220801$20240717$PER$$US-PFIZER INC-202201021278$PFIZER$$53$YR$$F$Y$67.58$KG$20240717$$CN$US$US
211586352$21158635$2$F$$20240924$20220802$20240925$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000313$PAREXEL$$$$$$Y$$$20240925$$CN$US$US
211586372$21158637$2$F$20220718$20240813$20220802$20240815$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000308$PAREXEL$$$$$$Y$$$20240815$$MD$US$US
2115921314$21159213$14$F$20210201$20240823$20220802$20240902$EXP$$CA-CELLTRION INC.-2022CA008391$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
2115943711$21159437$11$F$20220728$20230113$20220802$20240925$PER$$US-GSK-US2022AMR113643$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
211594689$21159468$9$F$$20240913$20220802$20240913$PER$$US-PFIZER INC-PV202200010914$PFIZER$$40$YR$$M$Y$$$20240913$$CN$US$US
2115953725$21159537$25$F$20220609$20240625$20220802$20240704$EXP$$NVSJ2022JP092358$NOVARTIS$$9$MON$$M$Y$6.76$KG$20240704$$MD$JP$JP
2115958911$21159589$11$F$20220101$20240726$20220802$20240802$EXP$$CO-AMGEN-COLSL2022130917$AMGEN$$80$YR$E$M$Y$$$20240802$$CN$CO$CO
211597364$21159736$4$F$20210205$20240812$20220802$20240821$EXP$$CA-TAKEDA-2022TUS051913$TAKEDA$$51$YR$$F$Y$$$20240821$$MD$CA$CA
211597997$21159799$7$F$20210101$20240621$20220802$20240712$EXP$$DE-ROCHE-2848648$ROCHE$$54$YR$A$F$Y$$$20240712$$CN$DE$DE
211603683$21160368$3$F$20210616$20220803$20220802$20240814$EXP$$US-RECORDATI-2021004151$RECORDATI$$$$$$Y$$$20240814$$CN$US$US
211606023$21160602$3$F$20210915$20220921$20220802$20240913$EXP$$JP-GSK-JP2022JPN111864$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$JP$JP
211606205$21160620$5$F$20201101$20240919$20220802$20240927$EXP$$US-SAMOHPHARM-2022003616$RECORDATI$$$$$$Y$$$20240927$$CN$US$US
2116087115$21160871$15$F$20200928$20240813$20220802$20240814$EXP$$US-TAKEDA-2022TUS051236$TAKEDA$$42$YR$$M$Y$$$20240814$$PH$US$US
211610722$21161072$2$F$$20240724$20220802$20240730$EXP$$IN-PFIZER INC-PV202200033877$PFIZER$$53$YR$$M$Y$$$20240730$$CN$IN$IN
2116107721$21161077$21$F$$20240925$20220802$20240930$EXP$$US-PAREXEL-2021-KAM-US003595$TAKEDA$$$$$F$Y$51$KG$20240930$$HP$US$US
211610797$21161079$7$F$$20240809$20220802$20240812$EXP$$CA-ROCHE-3151398$ROCHE$$$$A$F$Y$$$20240812$$CN$CA$CA
2116156227$21161562$27$F$20211103$20240829$20220802$20240904$EXP$$IN-PFIZER INC-202101747857$PFIZER$$46$YR$$F$Y$88$KG$20240904$$CN$IN$IN
2116205217$21162052$17$F$20220722$20240823$20220802$20240830$EXP$$US-GSK-US2022AMR111687$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240830$$CN$US$US
211621163$21162116$3$F$20200601$20240913$20220802$20240921$EXP$$AR-ROCHE-2891506$ROCHE$$77$YR$E$F$Y$$$20240921$$CN$AR$AR
211633923$21163392$3$F$20220708$20240815$20220802$20240822$EXP$$US-ROCHE-3145880$ROCHE$$59$YR$A$F$Y$56.7$KG$20240822$$HP$US$US
2116345721$21163457$21$F$20211201$20240915$20220802$20240930$EXP$$CN-GILEAD-2022-0591948$GILEAD$$22$YR$A$F$Y$$$20240930$$MD$CN$CN
211634885$21163488$5$F$20210101$20240828$20220802$20240906$EXP$$CA-ANIPHARMA-2022-CA-001542$ANI$$84$YR$$M$Y$67$KG$20240906$$HP$CA$CA
211639634$21163963$4$F$$20240819$20220803$20240829$EXP$$CA-AUROBINDO-AUR-APL-2022-029914$AUROBINDO$$$$$F$Y$$$20240829$$CN$CA$CA
211640777$21164077$7$F$20220101$20240701$20220803$20240708$EXP$$DE-AUROBINDO-AUR-APL-2022-029878$AUROBINDO$$53$YR$$M$Y$$$20240708$$MD$DE$DE
2116410416$21164104$16$F$20220701$20240822$20220803$20240829$EXP$$US-GSK-US2022AMR113570$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$MD$US$US
2116416415$21164164$15$F$20211110$20240813$20220803$20240821$EXP$$CA-CELLTRION INC.-2021CA013743$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
2116442213$21164422$13$F$20220712$20240904$20220803$20240905$EXP$$NVSC2022US175021$NOVARTIS$$46$YR$$F$Y$$$20240905$$CN$US$US
211644242$21164424$2$F$20200305$20240809$20220803$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-074406$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240813$$CN$US$US
211645204$21164520$4$F$$20240808$20220803$20240826$EXP$$CA-GILEAD-2022-0592041$GILEAD$$46$YR$A$F$Y$$$20240826$$HP$CA$CA
211645913$21164591$3$F$$20240813$20220803$20240826$EXP$$CA-AUROBINDO-AUR-APL-2022-029456$AUROBINDO$$59$YR$$F$Y$$$20240826$$PH$CA$CA
211648549$21164854$9$F$20220626$20240905$20220803$20240906$EXP$$US-PFIZER INC-202200905724$PFIZER$$9$YR$$M$Y$27.256$KG$20240906$$CN$US$US
211651628$21165162$8$F$20180613$20240729$20220803$20240805$EXP$$DE-BIOGEN-2022BI01144030$BIOGEN$$50$YR$$F$Y$49$KG$20240805$$HP$DE$DE
211651784$21165178$4$F$$20240903$20220803$20240905$EXP$$US-SHIRE-US201910749$TAKEDA$$$$$F$Y$$$20240905$$HP$US$US
211658485$21165848$5$F$20220501$20240910$20220803$20240916$EXP$$CA-TAKEDA-2018TUS012526$TAKEDA$$76$YR$$F$Y$$$20240916$$PH$CA$CA
211663546$21166354$6$F$20230422$20240813$20220803$20240815$EXP$$US-ABBVIE-22K-163-4489684-00$ABBVIE$$77$YR$$F$Y$$$20240815$$CN$US$US
211669312$21166931$2$F$$20240719$20220803$20240722$EXP$$CA-JNJFOC-20220761073$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240722$$HP$CA$CA
2116700039$21167000$39$F$20220701$20240722$20220803$20240725$PER$$US-PFIZER INC-PV202200029482$PFIZER$$79$YR$$M$Y$$$20240725$$MD$US$US
211673004$21167300$4$F$$20240724$20220803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2022-028924$AUROBINDO$$$$$M$Y$98$KG$20240803$$HP$CA$CA
211673035$21167303$5$F$20220402$20240725$20220803$20240731$EXP$$US-TAKEDA-2022TUS025088$TAKEDA$$28$YR$$F$Y$$$20240731$$CN$US$US
211673055$21167305$5$F$20220601$20240702$20220803$20240712$EXP$$TR-BIOGEN-2022BI01135020$BIOGEN$$44$YR$$M$Y$80$KG$20240712$$MD$TR$TR
2116747211$21167472$11$F$20190103$20240722$20220803$20240725$EXP$$CA-TAKEDA-2022TUS044919$TAKEDA$$50$YR$$F$Y$$$20240725$$MD$CA$CA
211676317$21167631$7$F$$20240809$20220803$20240812$EXP$$US-PFIZER INC-PV202200033759$PFIZER$$67$YR$$F$Y$61.224$KG$20240812$$CN$US$US
211676352$21167635$2$F$$20240815$20220803$20240820$PER$$US-PFIZER INC-PV202200035469$PFIZER$$77$YR$$F$Y$$$20240820$$CN$US$US
211677092$21167709$2$F$20220711$20240910$20220803$20240914$EXP$$US-TAKEDA-2022TUS052294$TAKEDA$$34$YR$$M$Y$$$20240914$$MD$US$US
211681754$21168175$4$F$20220610$20220825$20220803$20240712$PER$$JP-PFM-2022-05297$PIERRE FABRE MEDICAMENT$$7$MON$$F$Y$7.2$KG$20240712$$MD$JP$JP
211682749$21168274$9$F$20220101$20240808$20220803$20240812$EXP$$US-PFIZER INC-PV202200035256$PFIZER$$44$YR$$M$Y$$$20240812$$CN$US$US
211685654$21168565$4$F$$20240802$20220803$20240806$EXP$$US-ROCHE-3153043$ROCHE$$67$YR$E$F$Y$$$20240806$$CN$US$US
2116856812$21168568$12$F$20220307$20240827$20220803$20240829$EXP$$BE-ROCHE-3152751$ROCHE$$58$YR$A$F$Y$84$KG$20240829$$MD$BE$BE
2116914411$21169144$11$F$20220701$20221222$20220804$20240925$EXP$$US-GSK-US2022AMR113861$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
211694484$21169448$4$F$20220524$20240625$20220804$20240703$EXP$PT-INFARMED-V202206-227$PT-TEVA-2022-PT-2060759$TEVA$$62$YR$$M$Y$$$20240703$$MD$PT$PT
2116950118$21169501$18$F$20220101$20240807$20220804$20240812$EXP$$CA-JNJFOC-20220423758$JOHNSON AND JOHNSON$$39$YR$A$M$Y$102$KG$20240812$$HP$CA$CA
211695295$21169529$5$F$20220701$20230314$20220804$20240925$EXP$$US-GSK-US2022AMR114599$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
211696515$21169651$5$F$20220701$20220816$20220804$20240925$PER$$US-GSK-US2022AMR114157$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
211697987$21169798$7$F$20220514$20240809$20220804$20240819$EXP$$GB-BAXTER-2022BAX016291$BAXTER$$49$YR$$M$Y$$$20240819$$PH$GB$GB
211700272$21170027$2$F$$20240809$20220804$20240820$EXP$$US-ROCHE-3149199$ROCHE$$68$YR$E$F$Y$$$20240821$$HP$US$US
211702806$21170280$6$F$20221109$20230602$20220804$20240925$PER$$US-GSK-US2022AMR114836$GLAXOSMITHKLINE$$54$YR$$F$Y$73.469$KG$20240925$$CN$US$US
2117048714$21170487$14$F$20200211$20240913$20220804$20240924$EXP$$DE-ROCHE-2564266$ROCHE$$49$YR$A$F$Y$61$KG$20240924$$CN$DE$DE
2117060826$21170608$26$F$20210520$20240718$20220804$20240727$EXP$$CA-CELLTRION INC.-2021CA008854$CELLTRION$$$$$$Y$$$20240727$$MD$CA$CA
211706892$21170689$2$F$$20240905$20220804$20240914$EXP$$CN-ABBVIE-22K-035-4492838-00$ABBVIE$$$$$$Y$$$20240911$$MD$CN$CN
211709104$21170910$4$F$$20240703$20220804$20240710$EXP$$CA-PFIZER INC-2020289416$PFIZER$$37$YR$$M$Y$$$20240710$$HP$CA$CA
211709762$21170976$2$F$$20240905$20220804$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-076166$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240911$$HP$US$US
2117111613$21171116$13$F$20220701$20230202$20220804$20240925$PER$$US-GSK-US2022AMR112142$GLAXOSMITHKLINE$$63$YR$$F$Y$59$KG$20240925$$MD$US$US
211716768$21171676$8$F$20211013$20240914$20220804$20240920$EXP$$NVSC2022IN172190$NOVARTIS$$68$YR$$F$Y$$$20240920$$CN$IN$IN
2117229916$21172299$16$F$20200302$20240903$20220804$20240911$EXP$$CO-TAKEDA-2018TUS007764$TAKEDA$$32$YR$$M$Y$78$KG$20240911$$CN$CO$CO
2117236013$21172360$13$F$20230113$20240717$20220804$20240718$EXP$$US-TAKEDA-2022TUS043883$TAKEDA$$11$YR$$M$Y$$$20240718$$PH$US$US
211724108$21172410$8$F$20200601$20240719$20220804$20240724$EXP$$NVSC2022US176380$NOVARTIS$$44$YR$$F$Y$62.2$KG$20240724$$CN$US$US
211724634$21172463$4$F$20220727$20240716$20220804$20240717$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000322$PAREXEL$$$$$$Y$$$20240717$$CN$US$US
211725964$21172596$4$F$20220626$20240910$20220804$20240912$EXP$$CA-ROCHE-3148443$ROCHE$$48$YR$A$F$Y$$$20240912$$CN$CA$CA
211726394$21172639$4$F$20200811$20240715$20220804$20240722$EXP$$CA-ROCHE-2660003$ROCHE$$33$YR$A$M$Y$$$20240722$$CN$CA$CA
2117271020$21172710$20$F$20200205$20240906$20220804$20240910$EXP$$DE-ROCHE-2569354$ROCHE$$26$YR$A$F$Y$$$20240910$$CN$DE$DE
2117293015$21172930$15$F$20220413$20240919$20220804$20240923$EXP$$AU-TAKEDA-2022TUS025842$TAKEDA$$69$YR$$F$Y$46$KG$20240923$$CN$AU$AU
2117293616$21172936$16$F$20220101$20240809$20220804$20240813$EXP$$CA-UCBSA-2022042891$UCB$$$$$F$Y$$$20240813$$CN$CA$CA
211729692$21172969$2$F$20220621$20240702$20220804$20240715$EXP$$US-BIOMARINAP-US-2022-144754$BIOMARIN$$$$$$Y$$$20240715$$CN$US$US
2117335138$21173351$38$F$20080101$20240911$20220804$20240917$EXP$$CA-AstraZeneca-2017SF10587$ASTRAZENECA$$53$YR$$M$Y$$$20240918$$MD$CA$
211743028$21174302$8$F$20220506$20240827$20220804$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-084922$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$60.8$KG$20240904$$MD$JP$JP
2117439019$21174390$19$F$20220101$20240708$20220804$20240716$EXP$$CA-CELLTRION INC.-2022CA010656$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
211744015$21174401$5$F$20220707$20240607$20220804$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-002354$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240701$$CN$US$US
211748072$21174807$2$F$$20230720$20220805$20240802$PER$$US-Accord-247152$ACCORD$$63$YR$A$M$Y$86.1$KG$20240802$$LW$US$US
211748112$21174811$2$F$20191101$20231215$20220805$20240802$EXP$$US-Accord-264736$ACCORD$$38$YR$A$F$Y$$$20240802$$LW$US$US
211749242$21174924$2$F$20220322$20230719$20220805$20240802$EXP$$US-Accord-247161$ACCORD$$36$YR$A$F$Y$84$KG$20240802$$LW$US$US
211749252$21174925$2$F$20200101$20230721$20220805$20240802$PER$$US-Accord-247162$ACCORD$$35$YR$A$F$Y$64$KG$20240802$$LW$US$US
211750662$21175066$2$F$$20240703$20220805$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-237697$RANBAXY$Hall R, Govindarajan A, Kumar M, Parker T, Heidari A. Omeprazole induced subacute cutanous lupus erythematosus. J Invest Med. 2020;68(1):A198 (457)$34$YR$$F$Y$$$20240718$$HP$US$US
211753167$21175316$7$F$20230101$20240917$20220805$20240930$EXP$$US-SA-2022SA319990$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240930$$MD$US$US
2117536216$21175362$16$F$20211108$20240827$20220805$20240904$EXP$$CA-CELLTRION INC.-2021CA016387$CELLTRION$$$$$$Y$$$20240904$$MD$CA$CA
211754344$21175434$4$F$$20240826$20220805$20240830$EXP$$JP-TAKEDA-2022TJP068826$TAKEDA$$55$YR$$F$Y$$$20240830$$MD$JP$JP
211756392$21175639$2$F$20220723$20240924$20220805$20240925$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000320$PAREXEL$$$$$$Y$$$20240925$$HP$US$US
211756462$21175646$2$F$$20240924$20220805$20240925$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000324$PAREXEL$$$$$$Y$$$20240925$$CN$US$US
2117575211$21175752$11$F$20220101$20240703$20220805$20240705$EXP$$CA-PFIZER INC-202201033060$PFIZER$$39$YR$$F$Y$$$20240705$$MD$CA$CA
211759043$21175904$3$F$$20240830$20220805$20240911$EXP$$CA-AUROBINDO-AUR-APL-2022-008767$AUROBINDO$$41$YR$$F$Y$$$20240911$$HP$CA$CA
211760574$21176057$4$F$20100416$20240625$20220805$20240703$EXP$$US-JNJFOC-20220806421$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240704$$LW$US$US
211761606$21176160$6$F$20220206$20240827$20220805$20240830$EXP$$BE-ROCHE-3152716$ROCHE$$47$YR$A$M$Y$113$KG$20240830$$MD$BE$BE
211768363$21176836$3$F$20220208$20240813$20220805$20240821$EXP$$FR-AstraZeneca-2022A268826$ASTRAZENECA$$57$YR$$M$Y$93.5$KG$20240821$$MD$FR$
2117686214$21176862$14$F$20220802$20240826$20220805$20240906$EXP$$JP-ASTELLAS-2022JP011900$ASTELLAS$Matsuda K, Kawahara T, Yamazaki T, Isoda B, Tanaka T, Tsuchiya H, et al. 2 cases of toxic epidermal necrolysis (TEN) developed during enfortumab vedotin (EV)therapy for metastatic bladder cancer. Japanese Journal of Urological Surgery,The 124th Japanese Urological Association Ibaraki local meeting (hybrid meeting) (2022.10.16). 2024;37(1): 6.$75$YR$E$M$Y$84$KG$20240906$$MD$JP$JP
2117717211$21177172$11$F$20231002$20240920$20220805$20240927$EXP$$CA-TAKEDA-2021TUS066662$TAKEDA$$39$YR$$M$Y$$$20240927$$HP$CA$CA
211777003$21177700$3$F$$20240906$20220805$20240910$PER$$US-PFIZER INC-202101162252$PFIZER$$76$YR$$F$Y$$$20240910$$CN$US$US
211779564$21177956$4$F$20220101$20240920$20220805$20240924$EXP$$US-TAKEDA-US202027056$TAKEDA$$$$$F$Y$$$20240924$$MD$US$US
211782452$21178245$2$F$20220201$20240903$20220805$20240906$EXP$$US-ORGANON-O2208USA000445$ORGANON$$26$YR$$F$Y$63.492$KG$20240906$$CN$US$US
211786029$21178602$9$F$20210101$20240701$20220805$20240705$EXP$$US-JAZZ-2022-US-012914$JAZZ$$$$$F$Y$$$20240705$$CN$US$US
211788062$21178806$2$F$$20240629$20220805$20240710$EXP$$CZ-INCYTE CORPORATION-2022IN007275$INCYTE$$$$$$Y$$$20240710$$MD$CZ$CZ
211792213$21179221$3$F$$20240815$20220805$20240819$EXP$$US-JAZZ-2022-US-021995$JAZZ$$$$$F$Y$$$20240819$$MD$US$US
2117935710$21179357$10$F$20220226$20240811$20220805$20240815$EXP$$IN-PFIZER INC-PV202200036468$PFIZER$$46$YR$$F$Y$$$20240815$$CN$IN$IN
2118005413$21180054$13$F$20220101$20240730$20220805$20240813$EXP$$US-JAZZ-2022-US-024299$JAZZ$$$$$M$Y$$$20240813$$CN$US$US
2118014216$21180142$16$F$20210101$20240729$20220806$20240805$EXP$$CA-CELLTRION INC.-2021CA000394$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
211803513$21180351$3$F$$20240730$20220806$20240806$PER$$US-GSK-US2022114202$GLAXOSMITHKLINE$$$$$M$Y$$$20240806$$CN$US$US
211805232$21180523$2$F$$20240819$20220806$20240902$PER$$US-SA-2022SA303728$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240902$$MD$US$US
211806023$21180602$3$F$20220726$20240717$20220806$20240725$PER$$US-SA-2022SA313065$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240725$$MD$US$US
211806892$21180689$2$F$20220701$20240705$20220806$20240715$PER$$US-SA-2022SA311385$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240715$$MD$US$US
211807723$21180772$3$F$$20240820$20220806$20240829$PER$$US-SA-2022SA308976$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240829$$CN$US$US
211808653$21180865$3$F$$20240628$20220806$20240709$PER$$US-SA-2022SA312292$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240709$$MD$US$US
211811072$21181107$2$F$$20240718$20220806$20240802$PER$$US-SA-2022SA308255$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240802$$MD$US$US
211814555$21181455$5$F$20240401$20240701$20220806$20240708$EXP$$US-SA-2022SA314607$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240708$$CN$US$US
211815062$21181506$2$F$$20240725$20220806$20240803$PER$$US-SA-2022SA314659$SANOFI AVENTIS$$$$A$M$Y$$$20240803$$MD$US$US
211815112$21181511$2$F$$20240620$20220806$20240701$PER$$US-SA-2022SA315953$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240701$$MD$US$US
211815143$21181514$3$F$$20240830$20220806$20240923$PER$$US-SA-2022SA310676$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240923$$MD$US$US
211815292$21181529$2$F$20220728$20240827$20220806$20240911$PER$$US-SA-2022SA314275$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240911$$MD$US$US
211815553$21181555$3$F$$20240624$20220806$20240703$PER$$US-SA-2022SA317685$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
211816232$21181623$2$F$20220101$20240726$20220806$20240731$PER$$US-SA-2022SA318177$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240731$$MD$US$US
211817042$21181704$2$F$20220101$20240708$20220806$20240715$PER$$US-SA-2022SA316198$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240715$$MD$US$US
211817053$21181705$3$F$20220701$20240621$20220806$20240703$PER$$US-SA-2022SA320889$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240703$$CN$US$US
211824213$21182421$3$F$$20221117$20220807$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-316650$RANBAXY$$14$YR$$M$Y$$$20240702$$CN$US$US
211827273$21182727$3$F$$20240801$20220808$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-347840$RANBAXY$Rafeq R, Salzman M. Use of Concentrated Insulin in the Management of Calcium Channel Blocker Overdose: A Case Report. J Pharm Pract. 2023;Jul 21; 36:1519-1522$73$YR$$F$Y$69.9$KG$20240816$$PH$US$US
211828038$21182803$8$F$20220611$20240909$20220808$20240918$PER$$US-SA-2022SA313942$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240918$$MD$US$US
2118298913$21182989$13$F$20220101$20240710$20220808$20240720$EXP$$CA-CELLTRION INC.-2022CA006826$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
2118312014$21183120$14$F$20191022$20240917$20220808$20240925$EXP$$CA-CELLTRION INC.-2019CA026306$CELLTRION$$$$$$Y$$$20240925$$CN$CA$CA
2118319413$21183194$13$F$20220701$20230413$20220808$20240925$EXP$$US-GSK-US2022AMR115815$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
2118337219$21183372$19$F$20220603$20240920$20220808$20240930$EXP$$CA-CELLTRION INC.-2022CA012611$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
211837213$21183721$3$F$20220701$20220817$20220808$20240930$EXP$$JP-JNJFOC-20220814473$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240930$$PH$JP$JP
211838336$21183833$6$F$20220322$20240624$20220808$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-085313$BRISTOL MYERS SQUIBB$Moku R, Ariga S, Oohara Y, Honma R, Noguti T, Taguti J et al. A case of repeated remission and aggravation of skin metastasis and enterocolitis during nivolumab + ipilimumab therapy in a patient with malignant melanoma. The 295th Hokkaido Regional Meeting of the Japanese Society of Internal Medicine. 2022;41.$70$YR$E$M$Y$67$KG$20240701$$MD$JP$JP
211839566$21183956$6$F$20181026$20240705$20220808$20240710$EXP$$PHHY2018CA145620$NOVARTIS$$36$YR$$F$Y$$$20240710$$CN$CA$CA
2118431112$21184311$12$F$$20240806$20220808$20240808$EXP$$US-TAKEDA-2021TUS029388$TAKEDA$$$$$F$Y$56$KG$20240808$$CN$US$US
211843982$21184398$2$F$20220101$20220725$20220808$20240801$EXP$$US-RECORDATI-2022002585$RECORDATI$$$$$$Y$$$20240801$$CN$US$US
211845304$21184530$4$F$$20230129$20220808$20240709$EXP$$AU-ASTELLAS-2022US027669$ASTELLAS$$43$YR$$M$Y$$$20240709$$CN$AU$AU
211849252$21184925$2$F$$20220725$20220808$20240823$EXP$$IT-AKCEA THERAPEUTICS, INC.-2022IS003861$AKCEA THERAPEUTICS$Severi D, Spina E, Iovino A, Nolano M, Manganelli F, et. al. A Case of Severe Increase of Liver Enzymes in a ATTRv Patient Treated with Inotersen. Wiley. 2022;S34$$$$$Y$$$20240823$$MD$IT$IT
211853995$21185399$5$F$$20221108$20220808$20240926$EXP$$US-GSK-US2022AMR115319$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
211854792$21185479$2$F$$20220804$20220808$20240712$EXP$$NVSC2022US177622$NOVARTIS$$$$$M$Y$$$20240712$$CN$US$US
211855694$21185569$4$F$20221017$20221117$20220808$20240925$PER$$US-GSK-US2022AMR114753$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240925$$CN$US$US
211858962$21185896$2$F$20220701$20240901$20220808$20240903$PER$$IL-KARYOPHARM-2022KPT000853$KARYOPHARM THERAPEUTICS$$55$YR$$F$Y$$$20240903$$MD$IL$IL
211864473$21186447$3$F$$20240814$20220808$20240817$EXP$$US-TAKEDA-US202011145$TAKEDA$$$$$M$Y$$$20240817$$CN$US$US
211864612$21186461$2$F$$20220930$20220808$20240711$PER$$NVSC2022US178730$NOVARTIS$$$$$F$Y$$$20240711$$CN$US$US
2118684810$21186848$10$F$20200701$20240625$20220808$20240702$EXP$$JP-GSK-JP2022JPN113990$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$MD$JP$JP
2118715524$21187155$24$F$20200801$20240809$20220808$20240814$EXP$$US-TAKEDA-US202028709$TAKEDA$$50$YR$$F$Y$$$20240814$$MD$US$US
211875363$21187536$3$F$20220503$20240725$20220808$20240802$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2022-083986$BRISTOL MYERS SQUIBB$$6$YR$C$F$Y$21$KG$20240802$$MD$FR$FR
211875902$21187590$2$F$$20220801$20220808$20240819$EXP$$US-AstraZeneca-2022A273934$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
211879705$21187970$5$F$20220401$20240823$20220809$20240910$PER$$CA-TOLMAR, INC.-22CA035801$TOLMAR$$71$YR$$M$Y$$$20240910$$CN$CA$CA
211886458$21188645$8$F$20210923$20240917$20220809$20240920$EXP$$JP-TAKEDA-2022TJP069190$TAKEDA$$7$YR$$F$Y$12.4$KG$20240920$$MD$JP$JP
211888144$21188814$4$F$20220601$20240716$20220809$20240717$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000327$PAREXEL$$$$$$Y$$$20240717$$MD$US$US
211888562$21188856$2$F$$20240705$20220809$20240708$PER$$NVSC2022US179042$NOVARTIS$$$$A$F$Y$$$20240708$$HP$US$US
2118895115$21188951$15$F$20220301$20240808$20220809$20240812$EXP$$CA-ASTELLAS-2022US009619$ASTELLAS$$66$YR$$M$Y$62$KG$20240812$$HP$CA$CA
2118912910$21189129$10$F$20210726$20240814$20220809$20240823$EXP$$CA-ROCHE-3150334$ROCHE$$25$YR$A$F$Y$$$20240823$$CN$CA$CA
211894286$21189428$6$F$20220101$20240704$20220809$20240710$EXP$$DE-MYLANLABS-2022M1084149$MYLAN$$53$YR$$M$Y$$$20240710$$MD$DE$DE
211894812$21189481$2$F$$20240731$20220809$20240812$EXP$CA-MHPD-E2B_04526677$CA-Accord-272738$ACCORD$$$$N$M$Y$$$20240812$$HP$CA$CA
211895789$21189578$9$F$$20240805$20220809$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-082262$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$77.11$KG$20240808$$HP$US$US
211896973$21189697$3$F$20220715$20240703$20220809$20240723$EXP$$DE-ROCHE-3153079$ROCHE$$46$YR$A$M$Y$$$20240723$$MD$DE$DE
211898632$21189863$2$F$$20230821$20220809$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-306468$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
211898773$21189877$3$F$20211201$20240812$20220809$20240827$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-329925$RANBAXY$$80$YR$E$M$Y$$$20240827$$CN$US$US
211899605$21189960$5$F$20220801$20221014$20220809$20240926$EXP$$US-GSK-US2022AMR116289$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
211899965$21189996$5$F$20221103$20240828$20220809$20240902$EXP$$CA-TAKEDA-2022TUS053740$TAKEDA$$30$YR$$F$Y$$$20240902$$MD$CA$CA
211901738$21190173$8$F$20220523$20240830$20220809$20240902$EXP$$NVSC2022RU179240$NOVARTIS$$40$YR$$F$Y$62$KG$20240902$$MD$RU$RU
211901953$21190195$3$F$20240722$20240722$20220809$20240730$EXP$$CA-TAKEDA-2020TUS025396$TAKEDA$$75$YR$$M$Y$$$20240730$$CN$CA$CA
211905943$21190594$3$F$20220721$20220822$20220809$20240717$EXP$$US-HLS-202201241$HLS THERAPEUTICS$$46$YR$A$$Y$$$20240717$$CN$US$US
211906027$21190602$7$F$20220701$20240830$20220809$20240904$EXP$$CA-TAKEDA-2022TUS011225$TAKEDA$$62$YR$$M$Y$$$20240904$$MD$CA$CA
211911962$21191196$2$F$20220319$20240918$20220809$20240926$EXP$$DE-SAMSUNG BIOEPIS-SB-2022-18958$SAMSUNG BIOEPIS$$68$YR$E$F$Y$$$20240926$$MD$DE$DE
2119130961$21191309$61$F$20220706$20240725$20220809$20240730$EXP$$CH-ABBVIE-22K-151-4497269-00$ABBVIE$$81$YR$$M$Y$61$KG$20240730$$MD$CH$CH
2119151622$21191516$22$F$20210101$20240821$20220809$20240828$EXP$$CA-TAKEDA-CA202015086$TAKEDA$$65$YR$$F$Y$$$20240828$$CN$CA$CA
211916772$21191677$2$F$20220101$20230713$20220809$20240826$EXP$$US-PHARMAAND-2022PHR00139$pharmaAND$$66$YR$$M$Y$74.376$KG$20240826$$CN$US$US
2119173916$21191739$16$F$20220701$20240905$20220809$20240906$EXP$$NVSC2022US179774$NOVARTIS$$45$YR$$M$Y$$$20240906$$CN$US$US
211918946$21191894$6$F$20200718$20240726$20220809$20240730$EXP$$US-TAKEDA-2022TUS053449$TAKEDA$$48$YR$$M$Y$$$20240730$$PH$US$US
211924126$21192412$6$F$20190916$20240813$20220809$20240816$EXP$$CA-TAKEDA-2019TUS054349$TAKEDA$$39$YR$$F$Y$$$20240816$$MD$CA$CA
211929252$21192925$2$F$$20240815$20220810$20240818$PER$$NVSC2022US180134$NOVARTIS$$$$$M$Y$$$20240818$$HP$US$US
211929708$21192970$8$F$$20240731$20220810$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-087025$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240802$$HP$US$US
2119367710$21193677$10$F$20220719$20240614$20220810$20240702$PER$$CA-TOLMAR, INC.-22CA035785$TOLMAR$$68$YR$$M$Y$$$20240702$$CN$CA$CA
2119367911$21193679$11$F$20230101$20240814$20220810$20240904$PER$$CA-TOLMAR, INC.-22CA035784$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
211938577$21193857$7$F$$20240726$20220810$20240803$EXP$$BR-CELLTRION INC.-2022BR012660$CELLTRION$$$$$$Y$$$20240803$$CN$BR$BR
211939874$21193987$4$F$$20240821$20220810$20240826$EXP$$US-SHIRE-US202009465$TAKEDA$$$$$F$Y$$$20240826$$MD$US$US
211942684$21194268$4$F$20240906$20240906$20220810$20240910$EXP$$CA-TAKEDA-2022TUS054083$TAKEDA$$49$YR$$F$Y$$$20240910$$CN$CA$CA
211947287$21194728$7$F$20220804$20240709$20220810$20240715$EXP$$US-JAZZ-2022-US-021466$JAZZ$$52$YR$$F$Y$$$20240715$$HP$US$US
211948395$21194839$5$F$20211207$20240903$20220810$20240905$EXP$$NVSC2021CA281044$NOVARTIS$$58$YR$$M$Y$$$20240905$$CN$CA$CA
211948733$21194873$3$F$20190101$20240815$20220810$20240820$EXP$$US-TAKEDA-US201920383$TAKEDA$$63$YR$$F$Y$$$20240820$$MD$US$US
211949922$21194992$2$F$20220101$20220808$20220810$20240926$EXP$$US-GSK-US2022AMR013087$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
211951532$21195153$2$F$$20240925$20220810$20240927$EXP$$ZA-PFIZER INC-202201043611$PFIZER$$22$YR$$F$Y$$$20240927$$MD$ZA$ZA
211953387$21195338$7$F$20220509$20240815$20220810$20240819$EXP$$NVSC2022CA111238$NOVARTIS$$66$YR$$M$Y$$$20240819$$CN$CA$CA
211954398$21195439$8$F$20240806$20240816$20220810$20240820$EXP$$US-TAKEDA-2021TUS049814$TAKEDA$$60$YR$$F$Y$54$KG$20240820$$HP$US$US
211955894$21195589$4$F$$20240821$20220810$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-086512$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$MD$JP$JP
2119565820$21195658$20$F$20210618$20240905$20220810$20240911$EXP$$US-TAKEDA-2022TUS053655AA$TAKEDA$$57$YR$$M$Y$$$20240911$$PH$US$US
2119570411$21195704$11$F$20220622$20240702$20220810$20240715$EXP$$US-THERATECHNOLOGIES INC.-2022-THE-IBA-000222$Unknown Manufacturer$$$$$$Y$$$20240715$$MD$US$US
211961848$21196184$8$F$$20240826$20220810$20240829$PER$$US-PFIZER INC-PV202200039622$PFIZER$$61$YR$$F$Y$107$KG$20240829$$PH$US$US
211962185$21196218$5$F$20190813$20240628$20220810$20240718$EXP$$DE-ROCHE-2398297$ROCHE$$44$YR$A$F$Y$$$20240718$$CN$DE$DE
211962817$21196281$7$F$$20240725$20220810$20240730$PER$$US-PFIZER INC-PV202200039934$PFIZER$$69$YR$$F$Y$$$20240730$$CN$US$US
211962866$21196286$6$F$20220122$20240628$20220810$20240706$EXP$$CA-TAKEDA-2022TUS012974$TAKEDA$$58$YR$$M$Y$$$20240706$$PH$CA$CA
211969232$21196923$2$F$20220316$20240723$20220810$20240725$EXP$$CA-PFIZER INC-202200440436$PFIZER$$64$YR$$F$Y$$$20240725$$HP$CA$CA
211970589$21197058$9$F$$20240701$20220810$20240705$PER$$US-BIOGEN-2022BI01142810$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
211972477$21197247$7$F$20240820$20240826$20220810$20240830$EXP$$US-TAKEDA-2022TUS054190$TAKEDA$$74$YR$$F$Y$88$KG$20240830$$CN$US$US
2119729523$21197295$23$F$20220719$20240917$20220810$20240923$EXP$$US-SA-2022SA322148$SANOFI AVENTIS$$29$YR$A$F$Y$134.71$KG$20240923$$MD$US$US
211973802$21197380$2$F$$20240620$20220810$20240702$PER$$US-SA-2022SA322692$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240702$$MD$US$US
211975792$21197579$2$F$$20240921$20220810$20240930$PER$$US-SA-2022SA322316$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240930$$MD$US$US
211976702$21197670$2$F$20220407$20220804$20220810$20240701$PER$$US-SA-2022SA327452$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240701$$MD$US$US
211977936$21197793$6$F$20220101$20240821$20220810$20240829$EXP$$JP-JAZZ-2022-JP-026140$JAZZ$$10$YR$$F$Y$15.5$KG$20240829$$PH$JP$JP
211978667$21197866$7$F$20220619$20240730$20220810$20240813$EXP$$CA-VER-202200231$VERITY PHARMACEUTICALS$$77$YR$E$M$Y$$$20240813$$CN$CA$CA
211981425$21198142$5$F$20240711$20240715$20220811$20240724$PER$$US-SA-2022SA322727$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240724$$CN$US$US
2119824610$21198246$10$F$$20240917$20220811$20240919$EXP$$US-TAKEDA-US202024096$TAKEDA$$$$$F$Y$75$KG$20240919$$CN$US$US
2119829611$21198296$11$F$20220801$20240110$20220811$20240926$PER$$US-GSK-US2022AMR117171$GLAXOSMITHKLINE$$43$YR$$F$Y$$$20240926$$CN$US$US
2119842519$21198425$19$F$20220801$20230914$20220811$20240926$EXP$$US-GSK-US2022AMR117384$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
211984413$21198441$3$F$20220111$20240910$20220811$20240919$EXP$$GB-AUROBINDO-AUR-APL-2022-030645$AUROBINDO$$67$YR$$M$Y$60$KG$20240919$$MD$GB$GB
2119884810$21198848$10$F$$20240828$20220811$20240904$EXP$$US-TAKEDA-2020TUS048837$TAKEDA$$$$$F$Y$126$KG$20240904$$HP$US$US
2119938715$21199387$15$F$20220817$20240917$20220811$20240924$EXP$$AU-TAKEDA-2022TUS054734$TAKEDA$$57$YR$$M$Y$$$20240924$$HP$AU$AU
211995544$21199554$4$F$$20220926$20220811$20240916$EXP$$NVSC2022DE180004$NOVARTIS$Kager J, Schneider J, Rasch S, Herhaus R, Verbeek M, Mogler C et al.. Fulminant adenoviral-induced hepatitis in immunosuppressed patients. VIRUSES. 2022;14(7):1-10$40$YR$$F$Y$$$20240916$$HP$DE$DE
2119974718$21199747$18$F$20220730$20240412$20220811$20240925$EXP$$US-GSK-US2022AMR116896$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
2119995328$21199953$28$F$20230404$20240829$20220811$20240905$EXP$$US-PAREXEL-2021-KAM-US003509$TAKEDA$$60$YR$$F$Y$78$KG$20240905$$HP$US$US
211999563$21199956$3$F$20210123$20220809$20220811$20240705$EXP$$CD-SA-2022SA330628$SANOFI AVENTIS$$52$YR$A$$Y$38$KG$20240705$$HP$CD$CD
2120001197$21200011$97$F$20220721$20240829$20220811$20240905$EXP$$CO-TAKEDA-2022TUS050243$TAKEDA$$3$YR$$M$Y$20$KG$20240905$$CN$CO$CO
2120007913$21200079$13$F$20240401$20240813$20220811$20240819$EXP$$IN-PFIZER INC-2019526976$PFIZER$$43$YR$$F$Y$$$20240819$$CN$IN$IN
212000836$21200083$6$F$20220101$20240702$20220811$20240704$EXP$$US-PFIZER INC-202201049862$PFIZER$$41$YR$$F$Y$$$20240704$$HP$US$US
2120050935$21200509$35$F$$20240916$20220811$20240923$EXP$$CA-BAUSCH-BL-2020-022260$BAUSCH AND LOMB$$41$YR$$F$Y$$$20240924$$CN$CA$CA
212005342$21200534$2$F$20240916$20240916$20220811$20240919$EXP$$US-BAXALTA-2016BLT009339$TAKEDA$$72$YR$$F$Y$$$20240919$$CN$US$US
212007345$21200734$5$F$$20240830$20220811$20240901$EXP$$CA-ROCHE-3158872$ROCHE$Mah J, Lieu A H. A case of disseminated strongyloidiasis after multiple courses of immunosuppression. Canadian Medical Association Journal. 2022-Jan-24;194 (3):E89-92. doi:10.1503/cmaj.211056.$71$YR$E$M$Y$$$20240901$$MD$CA$CA
212017113$21201711$3$F$$20240426$20220811$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-002030$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
212021125$21202112$5$F$$20240716$20220811$20240812$PER$$US-ANIPHARMA-2022-US-016098$ANI$$$$$M$Y$71.67$KG$20240812$$HP$US$US
2120223615$21202236$15$F$20190423$20240912$20220811$20240918$EXP$$US-TAKEDA-2022TUS054462$TAKEDA$$61$YR$$F$Y$48$KG$20240918$$HP$US$US
212023272$21202327$2$F$$20240903$20220811$20240905$EXP$$BG-AstraZeneca-2022A276278$ASTRAZENECA$$$$$F$Y$$$20240905$$MD$BG$
212023618$21202361$8$F$20230101$20240702$20220811$20240704$EXP$$US-PFIZER INC-PV202200041184$PFIZER$$61$YR$$F$Y$$$20240704$$HP$US$US
212024445$21202444$5$F$$20220728$20220811$20240723$PER$$US-OTSUKA-2022_032481$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
212024693$21202469$3$F$20200101$20220820$20220811$20240723$PER$$US-OTSUKA-2022_034409$OTSUKA$$$$$M$Y$136.08$KG$20240723$$CN$US$US
212024733$21202473$3$F$$20220905$20220811$20240723$PER$$US-OTSUKA-2022_035289$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
212026163$21202616$3$F$20211207$20230106$20220811$20240723$PER$$US-OTSUKA-2021_042603$OTSUKA$$74$YR$$M$Y$$$20240723$$CN$US$US
212027183$21202718$3$F$$20230405$20220811$20240723$PER$$US-OTSUKA-2022_022598$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
212027325$21202732$5$F$$20230127$20220811$20240723$PER$$US-OTSUKA-2022_028066$OTSUKA$$50$YR$$M$Y$$$20240723$$MD$US$US
212028293$21202829$3$F$$20230510$20220811$20240723$PER$$US-OTSUKA-2022_025713$OTSUKA$$77$YR$$F$Y$$$20240723$$MD$US$US
212028683$21202868$3$F$20210101$20220923$20220811$20240723$PER$$US-OTSUKA-2022_026116$OTSUKA$$$$$M$Y$63.49$KG$20240723$$MD$US$US
212028893$21202889$3$F$$20220711$20220811$20240723$PER$$US-OTSUKA-2022_027256$OTSUKA$$23$YR$$M$Y$$$20240723$$HP$US$US
212028963$21202896$3$F$20220504$20220711$20220811$20240723$PER$$US-OTSUKA-2022_027275$OTSUKA$$56$YR$$F$Y$$$20240723$$HP$US$US
212029002$21202900$2$F$20220101$20220809$20220811$20240925$EXP$$US-GSK-US2022AMR014763$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
212029093$21202909$3$F$$20220822$20220811$20240723$PER$$US-OTSUKA-2022_031851$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
212029175$21202917$5$F$20210201$20220912$20220811$20240723$EXP$$US-OTSUKA-2022_031157$OTSUKA$$39$YR$$F$Y$99.79$KG$20240723$$CN$US$US
212031143$21203114$3$F$$20220916$20220811$20240723$PER$$US-OTSUKA-2021_030437$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
2120327213$21203272$13$F$20220806$20240802$20220811$20240808$EXP$$US-TAKEDA-2022TUS054451$TAKEDA$$45$YR$$F$Y$$$20240808$$CN$US$US
212033204$21203320$4$F$20191023$20240716$20220811$20240722$EXP$$CA-TAKEDA-2019TUS055542$TAKEDA$$53$YR$$F$Y$$$20240722$$CN$CA$CA
212033409$21203340$9$F$$20240926$20220811$20240930$PER$$US-PFIZER INC-PV202200040091$PFIZER$$65$YR$$F$Y$$$20240930$$MD$US$US
212035275$21203527$5$F$$20240925$20220811$20240926$EXP$$CA-PFIZER INC-202201048475$PFIZER$$39$YR$$F$Y$$$20240926$$HP$CA$CA
212041954$21204195$4$F$$20240919$20220812$20240928$EXP$$CA-CELLTRION INC.-2022CA007780$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
2120502012$21205020$12$F$20220706$20230609$20220812$20240925$EXP$$US-GSK-US2022AMR117474$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2120508715$21205087$15$F$20210303$20240918$20220812$20240928$EXP$$CA-CELLTRION INC.-2022CA012860$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
212051169$21205116$9$F$$20240904$20220812$20240915$EXP$$CA-AUROBINDO-AUR-APL-2022-031841$AUROBINDO$Cvijovic K, Boon H, Jaeger W, Vohra S.. Polypharmacy, multiple natural health products and hepatotoxicity. CMAJ. 2022;183(14):1085-1089$53$YR$$F$Y$$$20240915$$MD$CA$CA
212051465$21205146$5$F$20221201$20240730$20220812$20240823$PER$$AU-TOLMAR, INC.-22AU035909$TOLMAR$$79$YR$$M$Y$$$20240823$$CN$AU$AU
2120516124$21205161$24$F$20220101$20240625$20220812$20240703$EXP$$CA-CELLTRION INC.-2022CA009168$CELLTRION$$$$$$Y$$$20240703$$MD$CA$CA
212062945$21206294$5$F$20221010$20221103$20220812$20240926$EXP$$US-GSK-US2022AMR117053$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
212067192$21206719$2$F$20220705$20220808$20220812$20240930$EXP$$TW-JNJFOC-20220824764$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240930$$MD$TW$TW
212068493$21206849$3$F$$20240821$20220812$20240828$EXP$$BR-GSK-BR2022AMR117465$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$BR$BR
212068556$21206855$6$F$20220310$20230616$20220812$20240926$EXP$$US-GSK-US2022AMR060861$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
212073086$21207308$6$F$20190112$20240703$20220812$20240717$EXP$$JP-AMRYT PHARMACEUTICALS DAC-AEGR004374$AEGERION$$$$$$Y$$$20240717$$MD$JP$JP
212076452$21207645$2$F$$20240815$20220812$20240828$PER$$US-SA-2022SA326318$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240828$$MD$US$US
212077224$21207722$4$F$20220808$20240715$20220812$20240723$PER$$US-SA-2022SA329902$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240723$$MD$US$US
212078545$21207854$5$F$$20240923$20220812$20240926$PER$$US-PFIZER INC-202101377241$PFIZER$$78$YR$$F$Y$$$20240926$$MD$US$US
212079475$21207947$5$F$20220101$20240711$20220812$20240712$EXP$$US-PFIZER INC-PV202200041176$PFIZER$$68$YR$$F$Y$$$20240712$$CN$US$US
212083013$21208301$3$F$$20240801$20220812$20240805$PER$$US-PFIZER INC-2019137570$PFIZER$$87$YR$$F$Y$92.53$KG$20240805$$CN$US$US
212084689$21208468$9$F$20190401$20240814$20220812$20240821$EXP$$DE-TAKEDA-DE201945782$TAKEDA$$56$YR$$M$Y$$$20240821$$HP$DE$DE
212085277$21208527$7$F$$20240815$20220812$20240822$EXP$$US-JAZZ-2022-US-021116$JAZZ$$$$$M$Y$$$20240822$$HP$US$US
2120866712$21208667$12$F$20220101$20240912$20220812$20240916$PER$$US-PFIZER INC-202200463926$PFIZER$$42$YR$$M$Y$$$20240916$$HP$US$US
2120871412$21208714$12$F$20191112$20240813$20220812$20240819$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2022-002701$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240819$$MD$JP$JP
212091905$21209190$5$F$$20240820$20220813$20240830$EXP$$CA-APOTEX-2022AP010906$APOTEX$$50$YR$$F$Y$96$KG$20240830$$HP$CA$CA
2120920514$21209205$14$F$20210101$20240912$20220813$20240920$EXP$$CA-CELLTRION INC.-2021CA010073$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
2120929132$21209291$32$F$20211201$20240902$20220813$20240910$EXP$$CA-CELLTRION INC.-2021CA018355$CELLTRION$$$$$$Y$$$20240910$$MD$CA$CA
212097604$21209760$4$F$$20240813$20220813$20240815$EXP$$CA-ABBVIE-22K-028-4497739-00$ABBVIE$$60$YR$$F$Y$$$20240815$$HP$CA$CA
212098245$21209824$5$F$20220701$20240826$20220813$20240829$EXP$$US-TAKEDA-2022TUS055672$TAKEDA$$22$YR$$M$Y$$$20240829$$CN$US$US
212099214$21209921$4$F$20230502$20230503$20220813$20240905$EXP$$NVSC2022US183373$NOVARTIS$$48$YR$$M$Y$74.84$KG$20240905$$CN$US$US
212101792$21210179$2$F$$20240712$20220814$20240717$PER$$NVSC2022US182579$NOVARTIS$$$$$F$Y$$$20240717$$HP$US$US
2121050626$21210506$26$F$20210108$20240624$20220815$20240702$EXP$$CA-CELLTRION INC.-2020CA033714$CELLTRION$$$$$$Y$$$20240702$$MD$CA$CA
212105185$21210518$5$F$$20240909$20220815$20240921$EXP$$CA-GLENMARK PHARMACEUTICALS-2022GMK073631$GLENMARK$$$$$$Y$$$20240921$$HP$CA$CA
212105932$21210593$2$F$20201201$20240729$20220815$20240821$PER$$CO-TOLMAR, INC.-22CO035224$TOLMAR$$60$YR$$M$Y$$$20240821$$CN$CO$CO
212106109$21210610$9$F$20220721$20240814$20220815$20240904$PER$$CA-TOLMAR, INC.-22CA035832$TOLMAR$$73$YR$$M$Y$$$20240904$$CN$CA$CA
212110645$21211064$5$F$$20240819$20220815$20240821$PER$$US-DSJP-DSU-2022-128429$DAIICHI$$$$$F$Y$$$20240821$$CN$US$US
212111025$21211102$5$F$20180101$20240826$20220815$20240902$EXP$$US-AMGEN-USASL2022120363$AMGEN$$64$YR$A$F$Y$$$20240902$$CN$US$US
2121142711$21211427$11$F$$20240625$20220815$20240708$EXP$$CA-ROCHE-3154993$ROCHE$$$$A$F$Y$$$20240708$$CN$CA$CA
212114543$21211454$3$F$$20240902$20220815$20240905$EXP$$JP-EXELIXIS-CABO-22054879$EXELIXIS$$60$YR$$M$Y$$$20240905$$MD$JP$JP
212115269$21211526$9$F$20211201$20240508$20220815$20240926$EXP$$US-GSK-US2021AMR155042$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
212120122$21212012$2$F$$20240710$20220815$20240715$EXP$$ES-PFIZER INC-202201023012$PFIZER$Guillen Sarmiento, C.. Pustulosis exantematica aguda generalizada en un paciente con micosis fungoide. A proposito de un caso. LXIII Congreso Nacional de la SEHH -XXXVII Congreso Nacional de la SETH Pamplona. 2021;384-385$19$YR$$M$Y$$$20240715$$HP$ES$ES
212120426$21212042$6$F$$20240812$20220815$20240816$EXP$$US-PFIZER INC-2021078219$PFIZER$$82$YR$$F$Y$85.73$KG$20240816$$CN$US$US
212122747$21212274$7$F$20220101$20240904$20220815$20240906$30DAY$$US-PFIZER INC-202201032669$PFIZER$$13$YR$$M$Y$46.27$KG$20240906$$CN$US$US
212127782$21212778$2$F$20211001$20220809$20220815$20240709$EXP$$BR-ASTELLAS-2022US028630$ASTELLAS$$49$YR$$M$Y$$$20240709$$MD$BR$BR
212128523$21212852$3$F$20220803$20240916$20220815$20240925$EXP$$JP-GILEAD-2022-0593017$GILEAD$$14$YR$T$M$Y$$$20240925$$PH$JP$JP
212130609$21213060$9$F$$20240923$20220815$20240930$EXP$$NVSC2020CA362693$NOVARTIS$$43$YR$$F$Y$96$KG$20240930$$CN$CA$CA
212131694$21213169$4$F$$20240813$20220815$20240910$PER$$US-INCYTE CORPORATION-2022IN006767$INCYTE$$$$$$Y$$$20240910$$MD$US$US
212132004$21213200$4$F$$20240729$20220815$20240731$PER$$US-PFIZER INC-202201053960$PFIZER$$65$YR$$F$Y$65.77$KG$20240731$$CN$US$US
212132615$21213261$5$F$20220808$20240823$20220815$20240827$EXP$$CA-PFIZER INC-202201049516$PFIZER$$65$YR$$F$Y$97$KG$20240827$$HP$CA$CA
212133966$21213396$6$F$$20240701$20220815$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-088389$BRISTOL MYERS SQUIBB$Sasa N, et al. A case of suspected protein-losing gastroenteropathy by capsule endoscopy in a patient with immune checkpoint inhibitor-induced enteritis. The 168th Tohoku Branch Meeting of the Japan Gastroenterological Endoscopy Society. 2022;76.$8$DEC$E$M$Y$68.2$KG$20240705$$MD$JP$JP
212134002$21213400$2$F$20151105$20220811$20220815$20240829$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-GBR-2016043221$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240829$$HP$GB$GB
2121364210$21213642$10$F$20220130$20240804$20220816$20240806$EXP$$NVSJ2022JP002392$NOVARTIS$$$$A$F$Y$$$20240806$$MD$JP$JP
212136494$21213649$4$F$20231201$20240627$20220816$20240706$PER$$US-SA-2022SA332431$SANOFI AVENTIS$$15$YR$T$M$Y$87.4$KG$20240706$$MD$US$US
212138262$21213826$2$F$$20240719$20220816$20240731$PER$$US-SA-2022SA329183$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240731$$MD$US$US
212144005$21214400$5$F$20210101$20240906$20220816$20240916$EXP$$JP-009507513-2208JPN001329J$MERCK$Komatsu D, Kubota K, Soejima Y. [S12-1 A Case of Microsatellite Instability (MSI)-high Intrahepatic Cholangiocarcinoma with Intraperitoneal Rupture After Successful Treatment with Pembrolizumab]. The 77th General Meeting of the Japanese Society of Gastroenterological Surgery. 795$72$YR$$M$Y$$$20240916$$MD$JP$JP
2121450914$21214509$14$F$20220801$20230620$20220816$20240925$EXP$$US-GSK-US2022AMR117430$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
212146794$21214679$4$F$$20230308$20220816$20240925$PER$$US-GSK-US2022AMR117971$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
212149164$21214916$4$F$20220803$20240816$20220816$20240820$EXP$$CA-ROCHE-3157792$ROCHE$$46$YR$A$F$Y$$$20240820$$CN$CA$CA
212149188$21214918$8$F$20220726$20240816$20220816$20240821$EXP$$CA-ROCHE-3158113$ROCHE$$58$YR$A$F$Y$$$20240821$$CN$CA$CA
212149203$21214920$3$F$20220601$20240924$20220816$20240927$EXP$$DE-ROCHE-3156537$ROCHE$$53$YR$A$F$Y$$$20240928$$MD$DE$DE
212150014$21215001$4$F$20220701$20240809$20220816$20240813$EXP$$US-BIOGEN-2022BI01147393$BIOGEN$$67$YR$$M$Y$$$20240813$$CN$US$US
212150907$21215090$7$F$20210616$20240924$20220816$20240927$EXP$$DE-ROCHE-2858142$ROCHE$$58$YR$A$F$Y$$$20240927$$CN$DE$DE
212151844$21215184$4$F$$20220915$20220816$20240712$EXP$$DE-ASTELLAS-2022US028625$ASTELLAS$$80$YR$$M$Y$$$20240712$$MD$DE$DE
212153563$21215356$3$F$$20220811$20220816$20240701$PER$$US-SA-2022SA336096$SANOFI AVENTIS$$$$$F$Y$$$20240701$$CN$US$US
212153764$21215376$4$F$$20240723$20220816$20240812$PER$$AU-TOLMAR, INC.-2019AU008369$TOLMAR$$$$$M$Y$$$20240812$$CN$AU$AU
212155243$21215524$3$F$$20240709$20220816$20240721$30DAY$$US-GSK-US2022117536$GLAXOSMITHKLINE$$$$$M$Y$$$20240721$$CN$US$US
212155564$21215556$4$F$$20240709$20220816$20240710$PER$$US-PFIZER INC-PV202200042288$PFIZER$$75$YR$$F$Y$$$20240710$$CN$US$US
212155785$21215578$5$F$20240401$20240808$20220816$20240812$PER$$NVSC2022US184355$NOVARTIS$$23$YR$$M$Y$$$20240812$$CN$US$US
212156396$21215639$6$F$20220801$20221013$20220816$20240925$EXP$$US-GSK-US2022AMR118513$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
212156418$21215641$8$F$20220708$20230202$20220816$20240925$EXP$$US-GSK-US2022AMR117886$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
212156607$21215660$7$F$20220802$20240724$20220816$20240726$EXP$$CA-TAKEDA-2022TUS055952$TAKEDA$$27$YR$$F$Y$$$20240726$$CN$CA$CA
212157312$21215731$2$F$20200206$20240709$20220816$20240717$EXP$$BE-ABBVIE-20K-013-3293940-00$ABBVIE$$81$YR$$F$Y$$$20240716$$MD$BE$BE
212157546$21215754$6$F$$20240710$20220816$20240715$EXP$$CA-BAUSCH-BL-2022-020017$BAUSCH AND LOMB$$60$YR$$F$Y$68$KG$20240715$$HP$CA$CA
2121600520$21216005$20$F$$20240925$20220816$20240927$PER$$NVSC2022US184347$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
212161383$21216138$3$F$20220212$20240702$20220816$20240709$EXP$$US-GSK-US2022AMR117476$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$PH$US$US
2121616717$21216167$17$F$$20240912$20220816$20240923$EXP$CA-MHPD-E2B_05173067$CA-Accord-272521$ACCORD$$40$YR$A$F$Y$96$KG$20240923$$HP$CA$CA
2121625819$21216258$19$F$$20240906$20220816$20240910$PER$$US-PFIZER INC-PV202200042731$PFIZER$$79$YR$$M$Y$$$20240910$$MD$US$US
212164299$21216429$9$F$20220601$20240722$20220816$20240729$EXP$$US-TAKEDA-2021TUS053376$TAKEDA$$38$YR$$F$Y$67$KG$20240729$$CN$US$US
2121647612$21216476$12$F$$20240701$20220816$20240704$EXP$$US-PFIZER INC-PV202200043701$PFIZER$$63$YR$$F$Y$75.283$KG$20240704$$CN$US$US
212167142$21216714$2$F$20210701$20240610$20220816$20240710$PER$$US-ROCHE-2871466$ROCHE$$64$YR$A$M$Y$$$20240628$$CN$US$US
212175343$21217534$3$F$20220101$20240731$20220816$20240808$PER$$JP-AMGEN-JPNSP2022138280$AMGEN$$68$YR$E$F$Y$$$20240808$$MD$JP$JP
212178764$21217876$4$F$$20221208$20220816$20240827$EXP$$NVSC2022AU183547$NOVARTIS$$$$$F$Y$35$KG$20240827$$MD$AU$AU
212181842$21218184$2$F$$20240716$20220816$20240719$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000334$PAREXEL$$$$$$Y$$$20240719$$HP$US$US
212183383$21218338$3$F$20200816$20240625$20220816$20240702$EXP$$NVSC2022DE183535$NOVARTIS$$72$YR$$F$Y$48$KG$20240702$$MD$DE$DE
212188742$21218874$2$F$$20240812$20220816$20240815$EXP$$GB-DSJP-DSE-2022-128649$DAIICHI$$$$$F$Y$$$20240815$$MD$GB$GB
212192723$21219272$3$F$20240806$20240806$20220817$20240828$PER$$CA-TOLMAR, INC.-22CA035986$TOLMAR$$66$YR$$M$Y$$$20240828$$CN$CA$CA
212194683$21219468$3$F$$20240924$20220817$20240927$PER$$NVSC2022US185238$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
212197218$21219721$8$F$$20240813$20220817$20240815$EXP$$US-TAKEDA-US202009859$TAKEDA$$$$$F$Y$$$20240815$$MD$US$US
2122006914$21220069$14$F$$20240916$20220817$20240923$EXP$$CA-BAUSCH-BL-2022-020142$BAUSCH AND LOMB$$4$YR$$M$Y$18$KG$20240923$$HP$CA$CA
2122026916$21220269$16$F$20220101$20240821$20220817$20240829$EXP$$CA-CELLTRION INC.-2022CA004256$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
212205824$21220582$4$F$20220822$20240829$20220817$20240903$EXP$$US-TAKEDA-2022TUS056630$TAKEDA$$62$YR$$F$Y$68.98$KG$20240903$$CN$US$US
212205893$21220589$3$F$$20240707$20220817$20240709$EXP$$US-TAKEDA-2021TUS028095$TAKEDA$$$$$F$Y$$$20240709$$MD$US$US
212206795$21220679$5$F$$20240826$20220817$20240830$EXP$$CA-ROCHE-3160407$ROCHE$$79$YR$E$M$Y$$$20240830$$HP$CA$CA
212207807$21220780$7$F$20220801$20221205$20220817$20240925$PER$$US-GSK-US2022AMR118969$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240925$$CN$US$US
212211442$21221144$2$F$20161104$20240731$20220817$20240805$EXP$$CA-JNJFOC-20220825361$JOHNSON AND JOHNSON$$42$YR$A$M$Y$72$KG$20240805$$HP$CA$CA
2122114613$21221146$13$F$20220419$20240823$20220817$20240829$EXP$$US-TAKEDA-2022TUS031549$TAKEDA$$42$YR$$F$Y$96$KG$20240829$$HP$US$US
212211607$21221160$7$F$$20240813$20220817$20240819$EXP$$US-TAKEDA-2022TUS043039$TAKEDA$$$$$F$Y$48$KG$20240819$$CN$US$US
212212542$21221254$2$F$$20220811$20220817$20240710$EXP$$DE-ASTELLAS-2022US028896$ASTELLAS$$$$$M$Y$$$20240710$$CN$DE$DE
212219652$21221965$2$F$20210913$20211123$20220817$20240715$PER$$IT-PFM-2021-09791$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$9$KG$20240715$$MD$IT$IT
212219662$21221966$2$F$20211012$20211118$20220817$20240712$PER$$JP-PFM-2021-10472$PIERRE FABRE MEDICAMENT$$19$MON$$F$Y$$$20240712$$PH$JP$JP
212220144$21222014$4$F$20220531$20240923$20220817$20240927$EXP$$NVSC2022FR185453$NOVARTIS$$54$YR$$M$Y$99$KG$20240927$$PH$FR$FR
212226466$21222646$6$F$$20240912$20220817$20240921$EXP$$CA-PIRAMAL CRITICAL CARE LIMITED-2022-PEL-000433$PIRAMAL$$$$$$Y$$$20240921$$HP$CA$CA
212226492$21222649$2$F$$20240715$20220817$20240717$EXP$$US-DSJP-DSU-2022-128654$DAIICHI$$$$$F$Y$$$20240717$$CN$US$US
212227144$21222714$4$F$$20240918$20220817$20240927$EXP$$CA-GSK-CA2022118396$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$HP$CA$CA
212227343$21222734$3$F$$20240626$20220817$20240711$EXP$$US-LUPIN PHARMACEUTICALS INC.-2022-10426$LUPIN$$$$$$Y$$$20240711$$CN$US$US
212227852$21222785$2$F$20220808$20240731$20220817$20240806$PER$$US-SA-2022SA329779$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240806$$MD$US$US
212231983$21223198$3$F$$20240911$20220817$20240913$EXP$$CA-ROCHE-3159060$ROCHE$$$$A$F$Y$$$20240913$$CN$CA$CA
2122323410$21223234$10$F$20220205$20240816$20220817$20240827$EXP$$DE-ROCHE-3157012$ROCHE$$55$YR$A$F$Y$93$KG$20240827$$MD$DE$DE
212235773$21223577$3$F$$20240624$20220817$20240708$EXP$$US-LUPIN PHARMACEUTICALS INC.-2022-10440$LUPIN$$$$$$Y$$$20240708$$CN$US$US
212236906$21223690$6$F$20210721$20240827$20220817$20240830$EXP$$CA-PFIZER INC-2021606305$PFIZER$$80$YR$$M$Y$71$KG$20240830$$MD$CA$CA
212241709$21224170$9$F$20061023$20240910$20220817$20240913$EXP$$US-TAKEDA-2022TUS043874$TAKEDA$$55$YR$$F$Y$69$KG$20240913$$CN$US$US
212241983$21224198$3$F$$20240918$20220817$20240930$PER$$US-TAKEDA-2022TUS056854$TAKEDA$$$$$F$Y$98.866$KG$20240930$$CN$US$US
212244123$21224412$3$F$20220101$20240628$20220817$20240704$EXP$$JP-009507513-2203JPN000190J$MERCK$$75$YR$$F$Y$$$20240704$$MD$JP$JP
212249893$21224989$3$F$20100101$20230927$20220817$20240808$EXP$$US-OTSUKA-2022_023200$OTSUKA$$$$$F$Y$136.53$KG$20240808$$CN$US$US
212252678$21225267$8$F$20230501$20240627$20220817$20240706$PER$$US-SA-2022SA334274$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240706$$MD$US$US
212256425$21225642$5$F$20180701$20240904$20220818$20240917$EXP$$ES-AUROBINDO-AUR-APL-2022-032123$AUROBINDO$$64$YR$$M$Y$$$20240917$$MD$ES$ES
2122567725$21225677$25$F$20210210$20240827$20220818$20240904$EXP$$CA-CELLTRION INC.-2021CA002314$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
212259143$21225914$3$F$20220707$20240722$20220818$20240805$EXP$$HU-JNJFOC-20220833215$JOHNSON AND JOHNSON$$62$YR$A$M$Y$148.5$KG$20240805$$MD$HU$HU
212259325$21225932$5$F$$20240814$20220818$20240906$PER$$AU-TOLMAR, INC.-22AU035989$TOLMAR$$$$$M$Y$$$20240906$$CN$AU$AU
2122597912$21225979$12$F$20220101$20240916$20220818$20240925$EXP$$CA-CELLTRION INC.-2022CA012183$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
212262883$21226288$3$F$20201217$20230920$20220818$20240921$PER$$US-CIPLA LTD.-2022US00567$CIPLA$$$$$$Y$$$20240921$$CN$US$US
212265356$21226535$6$F$20220801$20240712$20220818$20240717$EXP$$US-BIOGEN-2022BI01148158$BIOGEN$$51$YR$$F$Y$$$20240717$$CN$US$US
212265536$21226553$6$F$20220801$20221114$20220818$20240925$PER$$US-GSK-US2022AMR119501$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
2122665216$21226652$16$F$20211218$20240710$20220818$20240715$EXP$$US-TAKEDA-2021TUS083309$TAKEDA$$67$YR$$M$Y$$$20240715$$MD$US$US
212269173$21226917$3$F$$20240708$20220818$20240718$EXP$$FR-CELLTRION INC.-2022FR013332$CELLTRION$Camus V, Dubois S, Lepretre S, Jardin F, and Tilly H. Prolonged third complete remission after busulfan, thiotepa, and autologous stem cell transplant in a primary central nervous system lymphoma patient. Clinical Case Reports. 2018;6 (8):1418-1421$$$$$Y$$$20240718$$HP$FR$FR
2122703625$21227036$25$F$20220101$20240802$20220818$20240810$EXP$$CA-CELLTRION INC.-2022CA013235$CELLTRION$$$$$$Y$$$20240810$$MD$CA$CA
212276654$21227665$4$F$$20240628$20220818$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-10437$LUPIN$$$$$$Y$$$20240718$$CN$US$US
212278905$21227890$5$F$20230824$20240724$20220818$20240727$EXP$$US-TAKEDA-2022TUS056588$TAKEDA$$46$YR$$F$Y$60.77$KG$20240727$$CN$US$US
2122810113$21228101$13$F$20220514$20240722$20220818$20240726$EXP$$GB-MYLANLABS-2022M1086689$MYLAN$$49$YR$$M$Y$$$20240726$$PH$GB$GB
212283135$21228313$5$F$20220801$20221014$20220818$20240926$PER$$US-GSK-US2022AMR119478$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240926$$CN$US$US
212287628$21228762$8$F$20220729$20240815$20220818$20240819$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000336$PAREXEL$$$$$$Y$$$20240819$$HP$US$US
212289558$21228955$8$F$20180701$20240909$20220818$20240912$EXP$$ES-009507513-2208ESP004207$MERCK$$64$YR$$M$Y$$$20240912$$MD$ES$ES
212289779$21228977$9$F$20201101$20240901$20220818$20240903$EXP$$DE-ROCHE-2580084$ROCHE$$34$YR$A$F$Y$95$KG$20240903$$MD$DE$DE
212290899$21229089$9$F$20220815$20240905$20220818$20240909$EXP$$CA-ROCHE-3162483$ROCHE$$31$YR$A$F$Y$$$20240909$$CN$CA$CA
212292069$21229206$9$F$20190101$20240919$20220818$20240926$EXP$$US-ABBVIE-22K-163-4506432-00$ABBVIE$$74$YR$$M$Y$93$KG$20240926$$CN$US$US
212293313$21229331$3$F$20201111$20240719$20220818$20240726$EXP$$IL-ABBVIE-21K-082-3843477-00$ABBVIE$$69$YR$$M$Y$$$20240726$$MD$IL$IL
212293417$21229341$7$F$20201103$20240724$20220818$20240729$EXP$$US-ABBVIE-22K-163-4503076-00$ABBVIE$$48$YR$$M$Y$110.68$KG$20240729$$MD$US$US
212295392$21229539$2$F$$20210506$20220818$20240710$PER$$IT-PFM-2021-04433$PIERRE FABRE MEDICAMENT$Milano A. Hypoglycemic coma during treatment with propranolol. European Journal of Pediatric Dermatology. 2020;30(4):233-4$10$MON$$M$Y$$$20240710$$MD$IT$IT
212296456$21229645$6$F$$20240924$20220818$20240925$PER$$US-PFIZER INC-202200204182$PFIZER$$56$YR$$F$Y$$$20240925$$HP$US$US
2122978314$21229783$14$F$20220310$20240807$20220818$20240812$EXP$$US-TAKEDA-2022TUS019038$TAKEDA$$46$YR$$F$Y$79$KG$20240812$$HP$US$US
212299232$21229923$2$F$$20240820$20220818$20240913$PER$$US-SA-2022SA332716$SANOFI AVENTIS$$$$A$F$Y$85$KG$20240913$$MD$US$US
212299333$21229933$3$F$20240801$20240826$20220818$20240919$PER$$US-SA-2022SA335366$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240919$$MD$US$US
212300423$21230042$3$F$$20240729$20220818$20240807$PER$$US-SA-2022SA336207$SANOFI AVENTIS$$61$YR$A$F$Y$78$KG$20240807$$MD$US$US
212300472$21230047$2$F$$20240626$20220818$20240705$PER$$US-SA-2022SA337494$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240705$$CN$US$US
212300758$21230075$8$F$20240917$20240920$20220818$20240927$PER$$US-SA-2022SA338056$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240927$$MD$US$US
212302294$21230229$4$F$$20240916$20220818$20240919$EXP$$CA-TAKEDA-2022TUS057064$TAKEDA$$$$$M$Y$$$20240919$$CN$CA$CA
212308374$21230837$4$F$20220801$20240326$20220819$20240926$PER$$US-GSK-US2022AMR120011$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240926$$CN$US$US
212310953$21231095$3$F$$20240909$20220819$20240920$EXP$$ES-ASTELLAS-2022US029217$ASTELLAS$$64$YR$A$M$Y$$$20240920$$MD$ES$ES
212311316$21231131$6$F$$20240828$20220819$20240904$EXP$$CA-ROCHE-3160308$ROCHE$$73$YR$E$F$Y$$$20240904$$HP$CA$CA
212311603$21231160$3$F$$20240702$20220819$20240717$EXP$$AU-ROCHE-3162369$ROCHE$$77$YR$E$M$Y$85$KG$20240717$$MD$AU$AU
212312862$21231286$2$F$20240101$20240919$20220819$20240930$PER$$US-SA-2022SA336471$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240930$$MD$US$US
212313515$21231351$5$F$20220801$20221104$20220819$20240925$PER$$US-GSK-US2022AMR120071$GLAXOSMITHKLINE$$48$YR$$F$Y$$$20240925$$CN$US$US
212319204$21231920$4$F$$20221104$20220819$20240926$PER$$US-GSK-US2022AMR120076$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
212322264$21232226$4$F$20220701$20240711$20220819$20240718$PER$$US-BIOGEN-2022BI01143308$BIOGEN$$47$YR$$F$Y$$$20240718$$CN$US$US
212322357$21232235$7$F$20220901$20221122$20220819$20240925$EXP$$US-GSK-US2022AMR120678$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2123224112$21232241$12$F$20220906$20240913$20220819$20240921$EXP$$CA-CELLTRION INC.-2022CA006861$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
212322896$21232289$6$F$20220307$20240718$20220819$20240726$EXP$$CN-ROCHE-1559827$ROCHE$$44$YR$A$M$Y$55$KG$20240726$$CN$CN$CN
212323203$21232320$3$F$$20240711$20220819$20240722$EXP$$AU-ROCHE-3162624$ROCHE$$$$E$F$Y$$$20240719$$PH$AU$AU
2123234627$21232346$27$F$20240420$20240830$20220819$20240906$EXP$$US-GSK-US2022AMR120147$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$HP$US$US
212323813$21232381$3$F$20220329$20240916$20220819$20240923$EXP$$BE-ROCHE-3164341$ROCHE$$37$YR$A$F$Y$74$KG$20240923$$MD$BE$BE
212324328$21232432$8$F$20190703$20240813$20220819$20240815$EXP$$DE-ROCHE-2367101$ROCHE$$42$YR$A$F$Y$69.8$KG$20240815$$CN$DE$DE
212325628$21232562$8$F$20210101$20240628$20220819$20240705$EXP$$US-ABBVIE-22K-163-4509170-00$ABBVIE$$$$$F$Y$70$KG$20240705$$CN$US$US
212327373$21232737$3$F$20220101$20240905$20220819$20240917$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2022-002458$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240918$$HP$US$US
212329043$21232904$3$F$$20240906$20220819$20240910$EXP$$US-PFIZER INC-202201067998$PFIZER$$48$YR$$F$Y$$$20240910$$HP$US$US
212329893$21232989$3$F$20200108$20240903$20220819$20240909$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2020JPN184891$VIIV$$$$$$Y$$$20240909$$MD$JP$JP
212330948$21233094$8$F$20200513$20240815$20220819$20240821$EXP$$CA-TAKEDA-2021TUS012990$TAKEDA$$49$YR$$F$Y$$$20240821$$HP$CA$CA
2123316315$21233163$15$F$20240301$20240920$20220819$20240925$EXP$$CA-ROCHE-3164137$ROCHE$$35$YR$A$F$Y$66$KG$20240925$$CN$CA$CA
212333654$21233365$4$F$$20240918$20220819$20240920$EXP$$CA-PFIZER INC-2020271906$PFIZER$$32$YR$$F$Y$$$20240920$$HP$CA$CA
212333932$21233393$2$F$20220114$20240822$20220819$20240829$EXP$$US-TAKEDA-2022TUS057307$TAKEDA$$61$YR$$M$Y$$$20240829$$CN$US$US
212335784$21233578$4$F$$20240904$20220819$20240911$EXP$$CA-TAKEDA-2018TUS032132$TAKEDA$$$$$M$Y$$$20240911$$CN$CA$CA
2123381613$21233816$13$F$20240601$20240909$20220819$20240916$EXP$$US-TAKEDA-US201827730$TAKEDA$$71$YR$$F$Y$48$KG$20240916$$HP$US$US
212343585$21234358$5$F$20220101$20240729$20220819$20240805$EXP$$US-JAZZ-2022-US-027073$JAZZ$$$$$M$Y$$$20240805$$CN$US$US
212344233$21234423$3$F$20220802$20240815$20220820$20240819$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000342$PAREXEL$$$$$$Y$$$20240819$$MD$US$US
212348304$21234830$4$F$20220817$20240903$20220820$20240906$EXP$$US-TAKEDA-US201701661$TAKEDA$$26$YR$$M$Y$$$20240906$$CN$US$US
212353013$21235301$3$F$20190801$20240801$20220821$20240808$EXP$$US-SA-2022SA343159$SANOFI AVENTIS$$66$YR$E$M$Y$87.99$KG$20240808$$MD$US$US
212356332$21235633$2$F$$20240918$20220821$20240927$PER$$US-SA-2022SA338249$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240927$$MD$US$US
212356454$21235645$4$F$20211101$20240624$20220821$20240703$PER$$US-SA-2022SA339405$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240703$$MD$US$US
212356937$21235693$7$F$20220101$20240909$20220821$20240915$EXP$$US-SA-2022SA342463$SANOFI AVENTIS$$$$E$F$Y$$$20240915$$MD$US$US
212358105$21235810$5$F$20220418$20240702$20220821$20240722$EXP$$DE-ROCHE-3159139$ROCHE$$32$YR$A$F$Y$57$KG$20240722$$MD$DE$DE
212358483$21235848$3$F$20210801$20240708$20220821$20240713$EXP$$JP-ABBVIE-21K-087-4145645-00$ABBVIE$$46$YR$$F$Y$70$KG$20240713$$MD$JP$JP
212361983$21236198$3$F$20211201$20240726$20220822$20240813$PER$$GT-TOLMAR, INC.-22GT035902$TOLMAR$$77$YR$$M$Y$$$20240813$$CN$GT$GT
212362153$21236215$3$F$20220809$20240715$20220822$20240722$PER$$US-BIOGEN-2020BI00948863$BIOGEN$$69$YR$$M$Y$$$20240722$$CN$US$US
212362555$21236255$5$F$$20240916$20220822$20240917$PER$$US-BIOGEN-2020BI00913905$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
212364025$21236402$5$F$$20240910$20220822$20240920$EXP$CA-MHPD-E2B_05323624$CA-Accord-274291$ACCORD$$65$YR$E$F$Y$69$KG$20240920$$HP$CA$CA
212370917$21237091$7$F$$20240701$20220822$20240708$EXP$$CA-AUROBINDO-AUR-APL-2022-033021$AUROBINDO$$41$YR$$F$Y$$$20240708$$HP$CA$CA
2123743811$21237438$11$F$$20240801$20220822$20240806$EXP$$US-PFIZER INC-PV202200046202$PFIZER$$76$YR$$F$Y$53.515$KG$20240806$$CN$US$US
2123784838$21237848$38$F$20220123$20240912$20220822$20240918$EXP$$US-PAREXEL-2021-KAM-US003628$TAKEDA$$65$YR$$F$Y$64$KG$20240918$$HP$US$US
212379706$21237970$6$F$20231121$20240624$20220822$20240702$30DAY$$US-GSK-US2022120177$GLAXOSMITHKLINE$$80$YR$$M$Y$$$20240702$$CN$US$US
2123807224$21238072$24$F$20220801$20240628$20220822$20240705$EXP$$US-GSK-US2022120062$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$HP$US$US
212381365$21238136$5$F$20220401$20220915$20220822$20240712$EXP$$FR-ASTELLAS-2022US029833$ASTELLAS$$60$YR$$M$Y$$$20240712$$MD$FR$FR
2123820310$21238203$10$F$20220501$20240712$20220822$20240724$EXP$$CA-ROCHE-3114584$ROCHE$$64$YR$A$F$Y$56$KG$20240724$$HP$CA$CA
212382737$21238273$7$F$20220101$20240920$20220822$20240925$EXP$$CA-PFIZER INC-202201067959$PFIZER$$59$YR$$F$Y$$$20240925$$HP$CA$CA
2123827618$21238276$18$F$20201012$20240912$20220822$20240913$EXP$$AU-MYLANLABS-2020M1088413$MYLAN$$60$YR$$M$Y$$$20240913$$HP$AU$AU
212382944$21238294$4$F$$20240918$20220822$20240923$EXP$$CA-Orion Corporation ORION PHARMA-20_00009987$ORION$$32$YR$A$F$Y$$$20240923$$HP$CA$
2123831410$21238314$10$F$20220210$20240718$20220822$20240723$EXP$$CA-ROCHE-3027612$ROCHE$$33$YR$A$F$Y$$$20240723$$CN$CA$CA
212383915$21238391$5$F$20220124$20240626$20220822$20240702$EXP$$CA-TAKEDA-2022TUS048924$TAKEDA$$42$YR$$M$Y$$$20240702$$CN$CA$CA
2123848613$21238486$13$F$20220101$20240717$20220822$20240722$EXP$$IN-PFIZER INC-PV202200045780$PFIZER$$52$YR$$F$Y$$$20240722$$CN$IN$IN
212384962$21238496$2$F$20220801$20240723$20220822$20240730$EXP$$AR-GSK-AR2022AMR120631$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$AR$AR
212385019$21238501$9$F$20220629$20240614$20220822$20240828$EXP$$CA-GSK-CA2022119472$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$CA$CA
212385908$21238590$8$F$20220401$20230227$20220822$20240926$EXP$$US-GSK-US2022120126$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
212387612$21238761$2$F$$20240918$20220822$20240920$EXP$$CA-PFIZER INC-2019484285$PFIZER$$36$YR$$F$Y$$$20240920$$HP$CA$CA
212388236$21238823$6$F$20220201$20240822$20220822$20240830$EXP$$IL-ABBVIE-22K-082-4408906-00$ABBVIE$$69$YR$$F$Y$78$KG$20240830$$MD$IL$IL
212392703$21239270$3$F$20220819$20240709$20220822$20240710$PER$$US-PFIZER INC-202201074548$PFIZER$$66$YR$$F$Y$57.61$KG$20240710$$CN$US$US
212393373$21239337$3$F$20220731$20240815$20220822$20240819$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000348$PAREXEL$$$$$$Y$$$20240819$$MD$US$US
212397993$21239799$3$F$20220101$20240810$20220822$20240814$EXP$$CA-TAKEDA-2022TUS057287$TAKEDA$$$$$F$Y$$$20240814$$CN$CA$CA
212403794$21240379$4$F$20211010$20240829$20220822$20240906$EXP$$CA-AstraZeneca-2022A069552$ASTRAZENECA$$66$YR$$F$Y$$$20240906$$MD$CA$
212406702$21240670$2$F$$20240626$20220823$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-10547$LUPIN$$$$$$Y$$$20240712$$CN$US$US
2124069116$21240691$16$F$$20240920$20220823$20240926$EXP$$US-TAKEDA-2021TUS030376$TAKEDA$$$$$F$Y$77$KG$20240926$$HP$US$US
212407337$21240733$7$F$$20240812$20220823$20240827$EXP$$CA-AUROBINDO-AUR-APL-2022-032524$AUROBINDO$$44$YR$$F$Y$97$KG$20240827$$MD$CA$CA
212407968$21240796$8$F$20220620$20240731$20220823$20240808$EXP$$CA-JNJFOC-20220740457$JOHNSON AND JOHNSON$$59$YR$A$F$Y$49$KG$20240808$$HP$CA$CA
2124083411$21240834$11$F$20220101$20240823$20220823$20240831$EXP$$CA-CELLTRION INC.-2022CA008654$CELLTRION$$$$$$Y$$$20240831$$HP$CA$CA
212413926$21241392$6$F$20220810$20240620$20220823$20240710$PER$$CA-TOLMAR, INC.-22CA036107$TOLMAR$$84$YR$$M$Y$$$20240710$$CN$CA$CA
212416385$21241638$5$F$20220223$20240725$20220823$20240805$EXP$$BE-ROCHE-3137098$ROCHE$$66$YR$E$F$Y$68$KG$20240805$$MD$BE$BE
212417373$21241737$3$F$$20230405$20220823$20240828$EXP$$US-BIOCODEX2-2022000273$BIOCODEX$$$$$F$Y$28.4$KG$20240827$$CN$US$US
212417454$21241745$4$F$$20240906$20220823$20240917$EXP$DE-MLMSERVICE-20220803-3712892-1$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-08713$ALKEM$Kager J, Schneider J, Rasch S, Herhaus P, Verbeek M, Mogler C, Heim A, Frosner G, Hoffmann D, Schmid M, Lahmer T. Fulminant Adenoviral-Induced Hepatitis in Immunosuppressed Patients.. Viruses. 2022;14(7):1459$40$YR$$F$Y$$$20240917$$MD$DE$DE
212419558$21241955$8$F$20220704$20240708$20220823$20240711$EXP$$US-ABBVIE-22K-163-4495914-00$ABBVIE$$63$YR$$M$Y$108$KG$20240711$$CN$US$US
212423654$21242365$4$F$20210615$20230308$20220823$20240715$EXP$$NVSC2022US186939$NOVARTIS$$57$YR$$F$Y$$$20240715$$CN$US$US
2124249928$21242499$28$F$20220514$20240726$20220823$20240808$EXP$GB-MHRA-MIDB-9dff0444-8c8b-4f3a-8491-2708f9843ec8$GB-ROCHE-3127919$ROCHE$$49$YR$A$M$Y$$$20240808$$PH$GB$GB
212427623$21242762$3$F$20220701$20240917$20220823$20240920$EXP$$CA-TAKEDA-2022TUS057198$TAKEDA$$55$YR$$F$Y$$$20240920$$CN$CA$CA
212427692$21242769$2$F$$20240918$20220823$20240923$EXP$$CA-Orion Corporation ORION PHARMA-TREX2019-5627$ORION$$36$YR$A$F$Y$$$20240923$$HP$CA$
212427984$21242798$4$F$$20240625$20220823$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-094269$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240701$$HP$US$US
212428055$21242805$5$F$20240622$20240712$20220823$20240717$EXP$$US-SHIRE-US201726766$TAKEDA$$54$YR$$F$Y$73$KG$20240717$$HP$US$US
212428257$21242825$7$F$20211201$20240702$20220823$20240708$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2022-23895$IPSEN$$60$YR$A$F$Y$$$20240708$$HP$US$US
212428612$21242861$2$F$20220629$20240806$20220823$20240808$PER$$US-PFIZER INC-PV202200047311$PFIZER$$50$YR$$F$Y$$$20240808$$CN$US$US
212428676$21242867$6$F$$20240829$20220823$20240904$PER$$US-PFIZER INC-PV202200047231$PFIZER$$69$YR$$F$Y$$$20240904$$CN$US$US
212428705$21242870$5$F$$20240718$20220823$20240722$PER$$US-PFIZER INC-PV202200047252$PFIZER$$83$YR$$F$Y$$$20240722$$CN$US$US
212430662$21243066$2$F$$20220819$20220823$20240925$EXP$$US-GSK-US2022AMR046780$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
212430843$21243084$3$F$20220512$20221110$20220823$20240926$EXP$$US-GSK-US2022AMR080869$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
212431135$21243113$5$F$20211201$20240621$20220823$20240701$EXP$$US-BAYER-2022A112792$BAYER$$31$YR$A$F$Y$47.619$KG$20240701$$CN$US$US
212431208$21243120$8$F$20220801$20230113$20220823$20240925$EXP$$US-GSK-US2022AMR120777$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2124312110$21243121$10$F$20191007$20240704$20220823$20240712$EXP$$CA-ROCHE-2860538$ROCHE$$42$YR$A$F$Y$$$20240712$$CN$CA$CA
212432619$21243261$9$F$$20240820$20220823$20240902$EXP$$CA-Waylis Therapeutics LLC-ATNAHS20211107918$Waylis$Farrell B, Farrell B. Managing polypharmacy in a 77-year-old woman with multiple prescribers. Canadian Medical Association Journal. 2013;185 (14):1240-5. doi:10.1503 /cmaj.122012$77$YR$E$F$Y$$$20240830$$HP$CA$CA
212433573$21243357$3$F$20220114$20221121$20220823$20240724$EXP$$US-RECORDATI-2022001097$RECORDATI$$$$$$Y$$$20240724$$CN$US$US
212433806$21243380$6$F$$20240823$20220823$20240902$EXP$$CA-APOTEX-2022AP011383$APOTEX$$71$YR$$F$Y$$$20240902$$HP$CA$CA
2124413913$21244139$13$F$20220101$20240828$20220823$20240830$PER$$US-DSJP-DSU-2022-128665$DAIICHI$$$$$F$Y$$$20240830$$CN$US$US
212441832$21244183$2$F$$20240913$20220823$20240916$PER$$NVSC2022US185861$NOVARTIS$$$$$F$Y$$$20240916$$MD$US$US
212441867$21244186$7$F$20220101$20240709$20220823$20240712$PER$$US-AMGEN-USASP2022142254$AMGEN$$51$YR$A$M$Y$$$20240712$$HP$US$US
212444145$21244414$5$F$20221006$20240815$20220823$20240819$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000356$PAREXEL$$$$$$Y$$$20240819$$MD$US$US
212446439$21244643$9$F$20200301$20240806$20220823$20240821$EXP$$US-TEVA-2022-US-2067315$TEVA$$89$YR$$M$Y$61.24$KG$20240821$$LW$US$US
212446592$21244659$2$F$20200101$20240722$20220823$20240726$PER$$US-VERTEX PHARMACEUTICALS-2022-010999$VERTEX$$$$$F$Y$$$20240726$$MD$US$US
212449015$21244901$5$F$$20240830$20220823$20240905$EXP$$CA-ROCHE-3165667$ROCHE$$$$A$F$Y$$$20240905$$CN$CA$CA
2124491220$21244912$20$F$$20240715$20220823$20240718$EXP$$CA-ORGANON-O2206CAN002029$ORGANON$$76$YR$$F$Y$$$20240718$$MD$CA$CA
2124499310$21244993$10$F$20200101$20240911$20220823$20240917$EXP$$CA-BAUSCH-BL-2020-009920$BAUSCH AND LOMB$$24$YR$$M$Y$$$20240917$$CN$CA$CA
212451102$21245110$2$F$20211118$20230829$20220823$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2021ARB001516$ARBOR$$8$YR$$F$Y$$$20240802$$HP$US$US
2124518210$21245182$10$F$20220728$20240723$20220823$20240724$EXP$$JP-TAKEDA-2022TJP070418$TAKEDA$$22$YR$$F$Y$37$KG$20240724$$MD$JP$JP
2124543713$21245437$13$F$20220401$20240416$20220824$20240925$EXP$$US-GSK-US2022AMR120609$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
212455848$21245584$8$F$20220729$20230105$20220824$20240926$PER$$US-GSK-US2022AMR120693$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240926$$CN$US$US
212456176$21245617$6$F$20220630$20240918$20220824$20240923$EXP$$CA-ROCHE-3162482$ROCHE$$66$YR$E$M$Y$$$20240923$$CN$CA$CA
212458675$21245867$5$F$$20240624$20220824$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-058611$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240702$$MD$JP$JP
212459109$21245910$9$F$20220808$20240819$20220824$20240904$EXP$$JP-009507513-2208JPN001549J$MERCK$Nagai T. OS-037 A Case of Corpus Uteri Carcinoma in which Fulminant Myocarditis occurred and life-saving impossible during Combination Therapy with Pembrolizumab and Lenvatinib. The 65th Annual Meeting of Japan Society of Gynecologic Oncology.. 2023;41(3):43$51$YR$$F$Y$49.5$KG$20240904$$MD$JP$JP
2124606511$21246065$11$F$20210525$20240912$20220824$20240916$EXP$$NVSC2022FR183385$NOVARTIS$$$$E$M$Y$85$KG$20240916$$MD$FR$FR
2124624624$21246246$24$F$20220524$20240702$20220824$20240705$EXP$$US-TAKEDA-2022TUS030322$TAKEDA$$33$YR$$F$Y$86$KG$20240705$$MD$US$US
212462732$21246273$2$F$$20240801$20220824$20240814$EXP$$CA-AUROBINDO-AUR-APL-2022-032475$AUROBINDO$$85$YR$$M$Y$$$20240814$$HP$CA$CA
212465662$21246566$2$F$20220701$20220819$20220824$20240926$PER$$US-GSK-US2022AMR122074$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240926$$CN$US$US
2124668831$21246688$31$F$20210101$20240712$20220824$20240722$EXP$$CA-CELLTRION INC.-2021CA011066$CELLTRION$$$$$$Y$$$20240722$$CN$CA$CA
212468352$21246835$2$F$20180723$20240723$20220824$20240729$EXP$$CA-TAKEDA-CA201828649$TAKEDA$$25$YR$$F$Y$40$KG$20240729$$MD$CA$CA
212470776$21247077$6$F$20220101$20240715$20220824$20240718$EXP$$US-AMGEN-USASP2022144201$AMGEN$$56$YR$A$F$Y$$$20240718$$HP$US$US
212473032$21247303$2$F$$20240904$20220824$20240906$PER$$US-PFIZER INC-PV202200049240$PFIZER$$68$YR$$M$Y$$$20240906$$HP$US$US
212473989$21247398$9$F$20230701$20240327$20220824$20240812$EXP$$NVSC2022AR187758$NOVARTIS$$46$YR$$F$Y$$$20240812$$CN$AR$AR
212476314$21247631$4$F$$20240815$20220824$20240816$EXP$$CA-ROCHE-2634718$ROCHE$$52$YR$A$M$Y$$$20240817$$CN$CA$CA
212478792$21247879$2$F$$20240814$20220824$20240823$EXP$$US-ROCHE-3165952$ROCHE$$$$A$F$Y$$$20240823$$CN$US$US
2124802911$21248029$11$F$20190201$20240921$20220824$20240923$EXP$$CA-PFIZER INC-2019060143$PFIZER$$47$YR$$F$Y$$$20240923$$MD$CA$CA
212480984$21248098$4$F$20220522$20220919$20220824$20240926$EXP$$US-GSK-US2022AMR080953$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2124813414$21248134$14$F$$20240712$20220824$20240717$EXP$$NVSC2022AU025466$NOVARTIS$$$$$F$Y$$$20240717$$CN$AU$AU
2124815813$21248158$13$F$20220425$20240919$20220824$20240924$EXP$$MX-TAKEDA-2022TUS058112$TAKEDA$$59$YR$$F$Y$$$20240924$$CN$MX$MX
212483734$21248373$4$F$20211111$20240823$20220824$20240828$EXP$$NVSC2022CA002071$NOVARTIS$$47$YR$$M$Y$$$20240828$$MD$CA$CA
212485624$21248562$4$F$20220203$20240704$20220824$20240710$EXP$$BE-PFIZER INC-202200945543$PFIZER$$66$YR$$F$Y$68$KG$20240710$$MD$BE$BE
212486486$21248648$6$F$20210803$20240819$20220824$20240826$EXP$$AT-TAKEDA-2021TUS049819$TAKEDA$$37$YR$$F$Y$$$20240826$$CN$AT$AT
212489062$21248906$2$F$20220811$20240805$20220824$20240816$EXP$$US-MYOVANT SCIENCES GMBH-2022MYSCI0800199$SUNOVION$$$$$$Y$$$20240816$$CN$US$US
212493132$21249313$2$F$20220414$20231128$20220824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB001061$ARBOR$$4$YR$$M$Y$$$20240802$$CN$US$US
212495037$21249503$7$F$20210805$20240703$20220824$20240708$EXP$$CA-TAKEDA-CA202022740$TAKEDA$$66$YR$$M$Y$64$KG$20240708$$MD$CA$CA
212497612$21249761$2$F$20210830$20230817$20220824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2021ARB001032$ARBOR$$7$YR$$F$Y$$$20240802$$CN$US$US
212500102$21250010$2$F$20220408$20240606$20220824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB001012$ARBOR$$6$YR$$F$Y$$$20240802$$CN$US$US
212500192$21250019$2$F$20220414$20240312$20220824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB001062$ARBOR$$8$YR$$F$Y$$$20240802$$HP$US$US
212506669$21250666$9$F$20201028$20240826$20220824$20240901$EXP$$IL-ABBVIE-20K-082-3687836-00$ABBVIE$$68$YR$$M$Y$89$KG$20240901$$MD$IL$IL
212512422$21251242$2$F$20220721$20240627$20220825$20240709$EXP$$CA-ROCHE-3162583$ROCHE$$51$YR$A$M$Y$$$20240708$$CN$CA$CA
212516207$21251620$7$F$20231201$20240808$20220825$20240812$EXP$$CA-UCBSA-2022050140$UCB$$59$YR$$M$Y$$$20240812$$CN$CA$CA
2125180720$21251807$20$F$20220603$20240802$20220825$20240809$EXP$$CA-CELLTRION INC.-2022CA007244$CELLTRION$$$$$$Y$$$20240809$$MD$CA$CA
212520353$21252035$3$F$$20240626$20220825$20240703$EXP$$ES-AMGEN-ESPSP2022143331$AMGEN$Cabrero-de Las Heras S.; Losa F.; Hernandez-yague X. et al.. Luminex-based analysis of serum CXC chemokines showing their usefulness as prognostic and/or predictive biomarkers in metastatic colorectal cancer patients. Cancer research. 2022;82 (12)$$$$$Y$$$20240703$$HP$ES$ES
2125211113$21252111$13$F$20221214$20240918$20220825$20240923$EXP$$US-TAKEDA-2021TUS058454$TAKEDA$$72$YR$$F$Y$117$KG$20240923$$HP$US$US
2125233220$21252332$20$F$20220820$20240820$20220825$20240827$EXP$$CO-TAKEDA-2022TUS037167$TAKEDA$$38$YR$$F$Y$70$KG$20240827$$CN$CO$CO
212527664$21252766$4$F$20220614$20240627$20220825$20240703$EXP$$CN-TAKEDA-2022TUS058460$TAKEDA$$26$YR$$M$Y$55$KG$20240703$$MD$CN$CN
212528142$21252814$2$F$20210701$20220822$20220825$20240925$PER$$US-GSK-US2022AMR122670$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
212529712$21252971$2$F$$20240925$20220825$20240927$EXP$$US-KYOWAKIRIN-2022BKK013388$KYOWA$$$$$$Y$$$20240927$$HP$US$US
212529816$21252981$6$F$19790101$20240626$20220825$20240701$EXP$$US-PFIZER INC-PV202200049338$PFIZER$$75$YR$$M$Y$$$20240701$$CN$US$US
212530113$21253011$3$F$$20240904$20220825$20240912$EXP$$GR-CELLTRION INC.-2022GR013781$CELLTRION$Evdokia P.. Leukoencephalopathy in a patient with RA treated with rituximab and methotrexate. SPRING DAYS OF RHEUMATOLOGY. 2022$$$$$Y$$$20240912$$HP$GR$GR
212530503$21253050$3$F$20220701$20240711$20220825$20240717$EXP$$NVSC2022IN189927$NOVARTIS$$60$YR$$F$Y$64$KG$20240717$$CN$IN$IN
212531566$21253156$6$F$20220511$20240704$20220825$20240712$EXP$$JP-UNITED THERAPEUTICS-UNT-2022-019086$UNITED THERAPEUTICS$$7$YR$$M$Y$18$KG$20240712$$MD$JP$JP
2125325621$21253256$21$F$20240328$20240917$20220825$20240920$EXP$$US-TAKEDA-US201936141$TAKEDA$$75$YR$$F$Y$80$KG$20240920$$HP$US$US
212538964$21253896$4$F$$20240705$20220825$20240708$PER$$NVSC2022US189837$NOVARTIS$$$$$F$Y$$$20240708$$CN$US$US
2125394918$21253949$18$F$20221104$20240720$20220825$20240725$EXP$$IN-PFIZER INC-2019459080$PFIZER$$50$YR$$F$Y$76.8$KG$20240725$$CN$IN$IN
212540215$21254021$5$F$$20240909$20220825$20240914$EXP$$CA-ROCHE-3165545$ROCHE$$62$YR$A$F$Y$$$20240914$$HP$CA$CA
212540458$21254045$8$F$$20240830$20220825$20240905$EXP$$US-PFIZER INC-202201090526$PFIZER$$79$YR$$F$Y$53.52$KG$20240905$$CN$US$US
2125415917$21254159$17$F$20220801$20240628$20220825$20240705$EXP$$CA-GSK-CA2022089114$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$HP$CA$CA
212541703$21254170$3$F$20220801$20240821$20220825$20240826$EXP$$AU-ROCHE-3167377$ROCHE$$63$YR$A$F$Y$$$20240826$$CN$AU$AU
212544092$21254409$2$F$20220529$20220816$20220825$20240809$EXP$$GB-AstraZeneca-2022A291411$ASTRAZENECA$$51$YR$$F$Y$64$KG$20240809$$MD$GB$
212549612$21254961$2$F$$20240823$20220825$20240829$EXP$$US-INCYTE CORPORATION-2022IN008037$INCYTE$$$$$$Y$$$20240829$$CN$US$US
2125499710$21254997$10$F$20181106$20240712$20220825$20240717$EXP$$US-TAKEDA-US201843658$TAKEDA$$57$YR$$F$Y$$$20240717$$MD$US$US
212551672$21255167$2$F$20220706$20240913$20220825$20240923$PER$$US-INCYTE CORPORATION-2022IN007922$INCYTE$$$$$$Y$$$20240923$$MD$US$US
2125532016$21255320$16$F$20230227$20240918$20220825$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-095532$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240920$$CN$US$US
212558468$21255846$8$F$20200515$20240919$20220825$20240925$EXP$$CA-JNJFOC-20200935558$JOHNSON AND JOHNSON$$10$YR$C$F$Y$47$KG$20240925$$CN$CA$CA
212560143$21256014$3$F$$20220922$20220825$20240911$EXP$$NVSJ2022JP096092$NOVARTIS$$$$$$Y$$$20240911$$PH$JP$JP
212560417$21256041$7$F$20220613$20240919$20220825$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-092000$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240930$$MD$JP$JP
2125634023$21256340$23$F$20220701$20240811$20220825$20240819$EXP$$CA-CELLTRION INC.-2022CA012107$CELLTRION$$$$$$Y$$$20240819$$MD$CA$CA
2125646818$21256468$18$F$20211019$20240707$20220826$20240713$EXP$$CA-CELLTRION INC.-2021CA017929$CELLTRION$$$$$$Y$$$20240713$$HP$CA$CA
2125661317$21256613$17$F$20200201$20240710$20220826$20240716$EXP$$PE-AMGEN-PERSP2022146618$AMGEN$$53$YR$A$F$Y$42.5$KG$20240716$$CN$PE$PE
2125698416$21256984$16$F$20231019$20240906$20220826$20240916$EXP$$CA-CELLTRION INC.-2020CA035044$CELLTRION$$$$$$Y$$$20240916$$CN$CA$CA
212570092$21257009$2$F$20180101$20220815$20220826$20240916$EXP$$US-NOVOPROD-950934$NOVO NORDISK$$65$YR$$F$Y$$$20240916$$CN$US$US
212571202$21257120$2$F$20211001$20240805$20220826$20240808$EXP$$US-BIOGEN-2022BI01150643$BIOGEN$$64$YR$$M$Y$$$20240808$$CN$US$US
2125720210$21257202$10$F$20211001$20240716$20220826$20240723$EXP$$CA-ROCHE-2930206$ROCHE$$49$YR$A$M$Y$$$20240723$$CN$CA$CA
212572632$21257263$2$F$$20230707$20220826$20240923$EXP$$NVSC2022US191218$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
2125733221$21257332$21$F$20210101$20240627$20220826$20240705$EXP$$CA-CELLTRION INC.-2021CA010710$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
212575382$21257538$2$F$20220801$20220822$20220826$20240925$PER$$US-GSK-US2022AMR122571$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
212577219$21257721$9$F$20211217$20240709$20220826$20240717$EXP$$CO-TAKEDA-2021TUS081185$TAKEDA$$67$YR$$F$Y$49$KG$20240717$$HP$CO$CO
212585412$21258541$2$F$$20220819$20220826$20240712$EXP$$DE-ASTELLAS-2022US030109$ASTELLAS$$58$YR$$F$Y$$$20240712$$MD$DE$DE
212587536$21258753$6$F$$20240624$20220826$20240709$EXP$E2B_05429152$CA-ASSERTIO THERAPEUTICS, INC.-CA-2022AST000139$ASSERTIO THERAPEUTICS$$44$YR$$F$Y$97$KG$20240709$$MD$CA$CA
212588702$21258870$2$F$20161025$20240914$20220826$20240920$EXP$$GB-MYLANLABS-2022M1088483$MYLAN$$55$YR$$M$Y$$$20240920$$HP$GB$GB
2125887718$21258877$18$F$20220501$20240807$20220826$20240814$EXP$$CA-CELLTRION INC.-2022CA013994$CELLTRION$$$$$$Y$$$20240814$$HP$CA$CA
212590976$21259097$6$F$$20240626$20220826$20240701$EXP$$US-TAKEDA-2021TUS038116$TAKEDA$$$$$M$Y$22$KG$20240701$$MD$US$US
212592895$21259289$5$F$$20240625$20220826$20240701$PER$$US-PFIZER INC-PV202200051304$PFIZER$$75$YR$$M$Y$$$20240701$$HP$US$US
212594422$21259442$2$F$20220801$20240905$20220826$20240912$EXP$$GB-ABBVIE-22K-167-4517702-00$ABBVIE$$60$YR$$M$Y$$$20240912$$CN$GB$GB
212597762$21259776$2$F$20220722$20240722$20220826$20240723$EXP$$US-TAKEDA-2022TUS059223$TAKEDA$$58$YR$$M$Y$$$20240723$$MD$US$US
212599883$21259988$3$F$$20240826$20220826$20240830$EXP$$ES-MYLANLABS-2022M1088894$MYLAN$Adrian CG, Ivan QCE,  Richard B, Idoia MM, Cristina AP, Manuel SIJ et al.. Mogamulizumab in the treatment of advanced mycosis fungoides and Sezary syndrome: Report of four cases.. LXIII National Congress of the SEHH-XXXVII National Congress of the SETH Pamplon. 2021;373-374$73$YR$$M$Y$$$20240830$$HP$ES$ES
212600772$21260077$2$F$$20240828$20220826$20240910$EXP$$US-TARO PHARMACEUTICALS USA INC.-2022TAR01052$TARO$$$$$$Y$$$20240910$$CN$US$US
212601712$21260171$2$F$$20240913$20220826$20240917$EXP$$NVSC2021AU230498$NOVARTIS$$$$$F$Y$$$20240917$$CN$AU$AU
212602273$21260227$3$F$$20240724$20220826$20240801$EXP$$GB-TAKEDA-2022TUS059086$TAKEDA$$$$$M$Y$$$20240801$$CN$GB$GB
2126039911$21260399$11$F$$20240815$20220826$20240825$EXP$$CA-BAXTER-2022BAX017696$BAXTER$$71$YR$$F$Y$69$KG$20240825$$CN$CA$CA
212604575$21260457$5$F$20200308$20240805$20220826$20240808$EXP$$US-TAKEDA-US202012033$TAKEDA$$63$YR$$F$Y$$$20240808$$HP$US$US
212605973$21260597$3$F$$20240918$20220826$20240923$EXP$$US-PFIZER INC-PV202200051439$PFIZER$$81$YR$$F$Y$$$20240923$$CN$US$US
212608283$21260828$3$F$20190101$20230108$20220826$20240823$EXP$$CZ-Accord-267436$ACCORD$Batko S. Coordination of clinical oncology, radiation oncology and surgery in the treatment of a patient with tumours in GIT. FARMAKOTERAPIE. 2022;18(6):756-760.$35$YR$A$M$Y$$$20240823$$MD$CZ$CZ
212608903$21260890$3$F$$20230315$20220826$20240718$EXP$$ES-ALXN-A202210138$ALEXION PHARMACEUTICALS$Villamarin M, Marquez-Algaba E, Esperalba J, Perello M, Los Arcos I, Campany D et.al. Preliminary Clinical Experience of Molnupiravir to Prevent Progression of COVID-19 in Kidney Transplant Recipients. Transplantation. 2022;00:1-5$35$YR$$M$Y$$$20240718$$MD$ES$ES
212609634$21260963$4$F$20190101$20240821$20220826$20240827$EXP$$AR-BIOMARINAP-AR-2022-145157$BIOMARIN$$$$$$Y$$$20240827$$CN$AR$AR
212611048$21261104$8$F$20210101$20240828$20220826$20240905$EXP$$US-BIOGEN-2022BI01150145$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
212616744$21261674$4$F$$20240912$20220827$20240921$EXP$$CA-CELLTRION INC.-2022CA013893$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
212626355$21262635$5$F$20220809$20240725$20220828$20240731$EXP$$AU-JNJFOC-20220840875$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240731$$MD$AU$AU
2126335112$21263351$12$F$20220801$20230208$20220829$20240925$EXP$$US-GSK-US2022AMR123718$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
212641993$21264199$3$F$$20240716$20220829$20240717$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000351$PAREXEL$$$$$$Y$$$20240717$$HP$US$US
212642105$21264210$5$F$20220119$20240311$20220829$20240710$PER$$TR-ROCHE-3031211$ROCHE$$42$YR$A$M$Y$86$KG$20240628$$MD$TR$TR
2126429510$21264295$10$F$20220801$20230109$20220829$20240926$PER$$US-GSK-US2022AMR124053$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240926$$CN$US$US
2126437416$21264374$16$F$20220101$20240821$20220829$20240904$EXP$$CA-UCBSA-2022043163$UCB$$$$$F$Y$$$20240904$$CN$CA$CA
2126459422$21264594$22$F$20220601$20240416$20220829$20240925$EXP$$US-GSK-US2022AMR124171$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
212649302$21264930$2$F$$20220819$20220829$20240712$EXP$$DE-ASTELLAS-2022US030107$ASTELLAS$$77$YR$$M$Y$$$20240712$$MD$DE$DE
212650712$21265071$2$F$20220406$20240705$20220829$20240715$EXP$IT-MINISAL02-881391$IT-TEVA-2022-IT-2067608$TEVA$$14$YR$$M$Y$49$KG$20240715$$PH$IT$IT
212650759$21265075$9$F$20190716$20240820$20220829$20240830$EXP$$DE-TEVA-2022-DE-2067652$TEVA$$79$YR$$F$Y$56$KG$20240830$$HP$DE$DE
212650863$21265086$3$F$20220607$20220909$20220829$20240710$EXP$$BR-ASTELLAS-2022US030263$ASTELLAS$$74$YR$$M$Y$64$KG$20240710$$PH$BR$BR
2126517112$21265171$12$F$$20240911$20220829$20240921$EXP$CA-MHPD-E2B_05055351$CA-Accord-275415$ACCORD$$65$YR$E$F$Y$34$KG$20240921$$HP$CA$CA
212658827$21265882$7$F$20221001$20230210$20220829$20240711$EXP$$NVSC2022CA190993$NOVARTIS$$47$YR$$F$Y$104.31$KG$20240711$$MD$CA$CA
2126615910$21266159$10$F$$20240812$20220829$20240816$PER$$US-PFIZER INC-PV202200046243$PFIZER$$70$YR$$F$Y$$$20240816$$CN$US$US
212666813$21266681$3$F$20220301$20240822$20220829$20240829$EXP$$AU-ROCHE-3169112$ROCHE$$39$YR$A$M$Y$85$KG$20240829$$HP$AU$AU
212666916$21266691$6$F$$20240703$20220829$20240709$PER$$US-PFIZER INC-PV202200051050$PFIZER$$71$YR$$F$Y$80.55$KG$20240709$$MD$US$US
212667138$21266713$8$F$20220716$20240624$20220829$20240705$EXP$$CA-ROCHE-3168716$ROCHE$$41$YR$A$F$Y$$$20240705$$CN$CA$CA
212667866$21266786$6$F$20210101$20240826$20220829$20240907$EXP$$US-GLENMARK PHARMACEUTICALS-2022GMK072458$GLENMARK$$$$$$Y$$$20240907$$CN$US$US
2126700115$21267001$15$F$20220805$20240918$20220829$20240920$EXP$$US-TAKEDA-2022TUS059057$TAKEDA$$56$YR$$M$Y$$$20240920$$PH$US$US
212670612$21267061$2$F$20191230$20240910$20220829$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200100843$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$110$KG$20240911$$HP$US$US
2126722011$21267220$11$F$20220101$20230131$20220829$20240718$EXP$$US-DSJP-DSU-2022-131157$DAIICHI$$$$$F$Y$61.678$KG$20240718$$CN$US$US
212672464$21267246$4$F$$20240916$20220829$20240919$EXP$$GB-MYLANLABS-2022M1089276$MYLAN$$$$A$M$Y$$$20240919$$MD$GB$GB
212672726$21267272$6$F$20220801$20240820$20220829$20240827$EXP$$AR-GSK-AR2022AMR123459$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$AR$AR
212673732$21267373$2$F$20220602$20220822$20220829$20240925$EXP$$US-GSK-US2022AMR034841$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2126737515$21267375$15$F$20230226$20230605$20220829$20240926$EXP$$US-GSK-US2022AMR062351$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
2126741011$21267410$11$F$20220801$20240722$20220829$20240724$EXP$$US-PFIZER INC-202201095392$PFIZER$$62$YR$$F$Y$$$20240724$$PH$US$US
2126756916$21267569$16$F$20220822$20240820$20220829$20240821$EXP$$GB-MYLANLABS-2022M1089171$MYLAN$$38$YR$$M$Y$$$20240821$$CN$GB$GB
212676413$21267641$3$F$20130101$20220922$20220829$20240916$EXP$$FR-TAKEDA-2022TUS059232$TAKEDA$$$$$F$Y$$$20240916$$MD$FR$FR
212677248$21267724$8$F$20220824$20240923$20220829$20240930$EXP$$US-TAKEDA-2022TUS059956$TAKEDA$$65$YR$$F$Y$$$20240930$$MD$US$US
212678576$21267857$6$F$$20240712$20220829$20240805$EXP$$US-THERATECHNOLOGIES INC.-2022-THE-TES-000234$Unknown Manufacturer$$$$$$Y$$$20240805$$CN$US$US
212682414$21268241$4$F$20220801$20240903$20220830$20240909$EXP$$CA-JNJFOC-20220832022$JOHNSON AND JOHNSON$$75$YR$E$F$Y$49$KG$20240909$$CN$CA$CA
212683296$21268329$6$F$20230507$20240628$20220830$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-002922$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240723$$CN$US$US
212688142$21268814$2$F$20211215$20230811$20220830$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2022TAR00409$TARO$$$$$$Y$$$20240808$$CN$US$US
212691847$21269184$7$F$20220825$20240917$20220830$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-097401$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$80$KG$20240920$$MD$JP$JP
212692414$21269241$4$F$20220721$20240910$20220830$20240912$EXP$$CA-ROCHE-3169436$ROCHE$$30$YR$A$F$Y$$$20240912$$MD$CA$CA
2126930613$21269306$13$F$20220801$20230419$20220830$20240925$EXP$$US-GSK-US2022AMR124711$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
212694055$21269405$5$F$$20240821$20220830$20240826$EXP$$CA-TAKEDA-2022TUS011890$TAKEDA$$$$$F$Y$$$20240826$$CN$CA$CA
212694246$21269424$6$F$20220826$20240716$20220830$20240718$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000368$PAREXEL$$$$$$Y$$$20240718$$HP$US$US
212696043$21269604$3$F$20220601$20220822$20220830$20240926$EXP$$US-TAKEDA-2022TUS059104$TAKEDA$$37$YR$$M$Y$$$20240926$$CN$US$US
2126985522$21269855$22$F$20240201$20240711$20220830$20240718$EXP$$NVSC2022CO194860$NOVARTIS$$46$YR$$F$Y$83$KG$20240718$$CN$CO$CO
212698592$21269859$2$F$20220601$20240820$20220830$20240826$30DAY$$US-GSK-US2022124680$GLAXOSMITHKLINE$$45$YR$$M$Y$$$20240826$$CN$US$US
212699182$21269918$2$F$20220228$20220826$20220830$20240926$EXP$$US-GSK-US2021AMR227857$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
212700035$21270003$5$F$20220401$20221209$20220830$20240926$EXP$$US-GSK-US2022AMR062201$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
212700134$21270013$4$F$20220401$20221025$20220830$20240926$EXP$$US-GSK-US2022AMR068055$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
212704862$21270486$2$F$20210501$20240816$20220830$20240827$EXP$$US-NOVOPROD-951419$NOVO NORDISK$$59$YR$$F$Y$$$20240827$$CN$US$US
212705938$21270593$8$F$20231122$20240724$20220830$20240729$PER$$US-PFIZER INC-PV202200053063$PFIZER$$66$YR$$M$Y$$$20240729$$CN$US$US
212706004$21270600$4$F$20220801$20240717$20220830$20240722$PER$$US-PFIZER INC-202201093558$PFIZER$$77$YR$$M$Y$$$20240722$$CN$US$US
212709434$21270943$4$F$20220801$20240723$20220830$20240904$PER$$US-LUNDBECK-DKLU3051411$LUNDBECK$$$$$$Y$$$20240904$$CN$US$US
212709882$21270988$2$F$20240111$20240703$20220830$20240705$EXP$$IN-PFIZER INC-PV202200052319$PFIZER$$50$YR$$F$Y$$$20240705$$CN$IN$IN
212713335$21271333$5$F$20240229$20240627$20220830$20240701$EXP$$AU-TAKEDA-2022TUS059801$TAKEDA$$46$YR$$F$Y$$$20240701$$CN$AU$AU
212714294$21271429$4$F$20220801$20240710$20220830$20240722$EXP$$JP-009507513-2208JPN003192J$MERCK$$$$A$F$Y$$$20240719$$MD$JP$JP
2127145511$21271455$11$F$20210314$20240816$20220830$20240820$EXP$$US-TAKEDA-2022TUS059985$TAKEDA$$34$YR$$M$Y$$$20240820$$CN$US$US
212718869$21271886$9$F$20220217$20240804$20220830$20240809$EXP$$IL-ABBVIE-22K-082-4518385-00$ABBVIE$$78$YR$$M$Y$$$20240809$$MD$IL$IL
212718893$21271889$3$F$20220609$20240909$20220830$20240912$EXP$$GB-ABBVIE-22K-167-4519727-00$ABBVIE$$66$YR$$M$Y$$$20240912$$MD$GB$GB
212719842$21271984$2$F$$20240731$20220830$20240802$EXP$$US-ABBVIE-22K-163-4518777-00$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
212720792$21272079$2$F$20210101$20230816$20220830$20240829$PER$$US-AMERICAN REGENT INC-2022000695$AMERICAN REGENT$$$$$F$Y$110$KG$20240829$$MD$US$US
212723438$21272343$8$F$20220101$20240725$20220830$20240730$EXP$$US-ABBVIE-22K-163-4522268-00$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
212725524$21272552$4$F$20220821$20240718$20220830$20240725$EXP$$JP-JAZZ-2022-JP-028100$JAZZ$$51$YR$$M$Y$54$KG$20240725$$MD$JP$JP
2127264213$21272642$13$F$20220614$20240911$20220830$20240917$EXP$$JP-TAKEDA-2022TJP071751$TAKEDA$$25$YR$$F$Y$56.9$KG$20240917$$MD$JP$JP
212727685$21272768$5$F$20220824$20240629$20220831$20240723$PER$$CA-TOLMAR, INC.-22CA036336$TOLMAR$$80$YR$$M$Y$$$20240723$$CN$CA$CA
212729313$21272931$3$F$$20240624$20220831$20240702$EXP$$FR-CELLTRION INC.-2022FR013887$CELLTRION$Brue A, Amatore F, Rossi P, Delaporte E. Paradoxical reaction to rituximab prescribed for cryoglobulinemic vasculitis. Annales de Dermatologie et de Venereologie - FMC. 2021;8:A310-1.$$$$$Y$$$20240702$$HP$FR$FR
2127296613$21272966$13$F$20220501$20240911$20220831$20240918$EXP$$NVSC2022HR148377$NOVARTIS$$76$YR$$F$Y$60$KG$20240918$$CN$HR$HR
212729869$21272986$9$F$20220101$20240909$20220831$20240917$EXP$$CA-CELLTRION INC.-2022CA008114$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
212732027$21273202$7$F$20200702$20240715$20220831$20240717$EXP$$US-TAKEDA-2022TUS060050$TAKEDA$$2$YR$$F$Y$$$20240717$$HP$US$US
212732348$21273234$8$F$20230101$20230914$20220831$20240812$EXP$$NVSC2022US194188$NOVARTIS$$62$YR$$F$Y$$$20240812$$CN$US$US
212732435$21273243$5$F$$20240909$20220831$20240919$EXP$$NVSJ2022JP096346$NOVARTIS$Takuro Someya, Seisuke Sayama, Naoya Akiba, Ayumi Kanatani, Tatsuya Fujii, Mari Ichinose, et al.. A Case of Thrombocytopenia and Severe Infection in a Neonate, following Immune Thrombocytopenia-Complicated Pregnancy Successfully Treated with Eltrombopag. Kanto Journal of Obstetrics and Gynecology/The 143rd Meeting of the Kanto Societ. 2022;59:220$$$N$$Y$2.64$KG$20240919$$HP$JP$JP
212734702$21273470$2$F$$20220824$20220831$20240710$EXP$$DE-ASTELLAS-2022US028753$ASTELLAS$$80$YR$$M$Y$$$20240710$$MD$DE$DE
212736359$21273635$9$F$$20240906$20220831$20240910$EXP$$US-PFIZER INC-202200821498$PFIZER$$79$YR$$F$Y$$$20240910$$CN$US$US
212739144$21273914$4$F$$20240626$20220831$20240701$EXP$$GR-PFIZER INC-PV202200045934$PFIZER$Mpakosi, A.. A fatal neonatal case of fungemia due to Exophiala dermatitidis-case report and literature review. BMC Pediatrics. 2022;22(1):482$27$WK$$M$Y$0.81$KG$20240701$$HP$GR$GR
2127393525$21273935$25$F$20220101$20240819$20220831$20240822$EXP$$US-PFIZER INC-PV202200053990$PFIZER$$71$YR$$F$Y$54.43$KG$20240822$$CN$US$US
212740544$21274054$4$F$20220707$20240828$20220831$20240831$EXP$$CN-TAKEDA-2022TUS059498$TAKEDA$$57$YR$$M$Y$60$KG$20240831$$MD$CN$CN
212741607$21274160$7$F$20220101$20240923$20220831$20240926$EXP$$CA-PFIZER INC-202201097841$PFIZER$$72$YR$$F$Y$$$20240926$$HP$CA$CA
2127423118$21274231$18$F$20220812$20240812$20220831$20240819$EXP$$US-JAZZ-2022-US-024957$JAZZ$$38$YR$$F$Y$$$20240819$$CN$US$US
2127424312$21274243$12$F$20220729$20240628$20220831$20240709$EXP$$CN-ROCHE-3167690$ROCHE$$68$YR$E$M$Y$79$KG$20240703$$MD$CN$CN
212743802$21274380$2$F$20210501$20240923$20220831$20240928$EXP$$US-ABBVIE-21K-163-4034745-00$ABBVIE$$79$YR$$F$Y$$$20240928$$CN$US$US
212745282$21274528$2$F$$20230816$20220831$20240829$PER$$US-AMERICAN REGENT INC-2022000665$AMERICAN REGENT$$$$$F$Y$66.213$KG$20240829$$LW$US$US
212745553$21274555$3$F$$20240701$20220831$20240709$EXP$$CA-AstraZeneca-2020SF25671$ASTRAZENECA$$61$YR$$F$Y$$$20240709$$MD$CA$
212745914$21274591$4$F$$20240726$20220831$20240731$EXP$$CA-PFIZER INC-202201090019$PFIZER$$52$YR$$F$Y$$$20240731$$HP$CA$CA
212746127$21274612$7$F$20240415$20240710$20220831$20240711$EXP$$US-TAKEDA-US202019111$TAKEDA$$47$YR$$F$Y$78$KG$20240711$$CN$US$US
2127468812$21274688$12$F$20200901$20240627$20220831$20240702$EXP$$US-TAKEDA-2022TUS060272$TAKEDA$$29$YR$$M$Y$$$20240702$$PH$US$US
212749403$21274940$3$F$$20240703$20220831$20240709$EXP$$US-INCYTE CORPORATION-2022IN008244$INCYTE$$$$$$Y$$$20240709$$CN$US$US
212750863$21275086$3$F$20220523$20231214$20220831$20240710$PER$$VN-ROCHE-3167312$ROCHE$$33$YR$A$M$Y$68$KG$20240628$$MD$VN$VN
212751376$21275137$6$F$20210825$20240917$20220831$20240919$EXP$$ES-TAKEDA-2022TUS059836$TAKEDA$$67$YR$$M$Y$$$20240919$$HP$ES$ES
2127562717$21275627$17$F$20220101$20240920$20220831$20240925$EXP$$CA-PFIZER INC-202200996558$PFIZER$$53$YR$$M$Y$$$20240925$$HP$CA$CA
212759962$21275996$2$F$20220104$20240628$20220831$20240706$PER$$US-ABBVIE-22K-163-4303454-00$ABBVIE$$48$YR$$M$Y$74.842$KG$20240704$$CN$US$US
212784964$21278496$4$F$$20240903$20220831$20240904$EXP$$US-TAKEDA-US202022182$TAKEDA$$$$$M$Y$$$20240904$$MD$US$US
212785009$21278500$9$F$20200323$20240812$20220831$20240819$EXP$$CA-CELLTRION INC.-2019CA025129$CELLTRION$$$$$$Y$$$20240819$$MD$CA$CA
212786732$21278673$2$F$20210101$20240902$20220901$20240923$PER$$CO-TOLMAR, INC.-22CO036375$TOLMAR$$$$$M$Y$$$20240923$$CN$CO$CO
212786814$21278681$4$F$$20240712$20220901$20240730$PER$$CA-TOLMAR, INC.-22CA036330$TOLMAR$$$$$M$Y$$$20240729$$CN$CA$CA
212787073$21278707$3$F$20220817$20240916$20220901$20240925$EXP$$DE-AUROBINDO-AUR-APL-2022-034448$AUROBINDO$$60$YR$$M$Y$94.5$KG$20240925$$MD$DE$DE
212789545$21278954$5$F$20211020$20240703$20220901$20240926$PER$$US-GSK-US2022AMR125994$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240926$$CN$US$US
212789725$21278972$5$F$20220108$20240806$20220901$20240812$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-CHN-20220104222$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$71$KG$20240812$$CN$CN$CN
212791126$21279112$6$F$20220721$20240823$20220901$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-098175$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240829$$MD$JP$JP
2127942025$21279420$25$F$20220716$20240711$20220901$20240717$EXP$$US-SHIRE-US202025690$TAKEDA$$75$YR$$F$Y$58$KG$20240717$$MD$US$US
212794534$21279453$4$F$$20240807$20220901$20240822$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-352936$RANBAXY$Smith SS, Cernaro N, Tonti E. Eosinophilic pustular folliculitis due to naltrexone: A case report. J Am Pharmacists Assoc. 2022;62(6):1925-1928$20$YR$$F$Y$$$20240822$$HP$US$US
212794843$21279484$3$F$20220801$20240718$20220901$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-097744$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$144.7$KG$20240729$$PH$US$US
212796223$21279622$3$F$$20240820$20220901$20240830$EXP$$CA-APOTEX-2022AP012020$APOTEX$$61$YR$$F$Y$$$20240830$$HP$CA$CA
212800665$21280066$5$F$20220801$20221019$20220901$20240925$EXP$$US-GSK-US2022AMR125955$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2128007324$21280073$24$F$20200721$20240924$20220901$20240928$EXP$$CO-TAKEDA-CO202016083$TAKEDA$$9$YR$$M$Y$50$KG$20240928$$CN$CO$CO
212801847$21280184$7$F$20181008$20240708$20220901$20240712$EXP$$IE-TAKEDA-2022TUS059256$TAKEDA$$74$YR$$M$Y$$$20240712$$HP$GB$GB
2128028115$21280281$15$F$20220101$20240705$20220901$20240705$EXP$$CA-PFIZER INC-202200738491$PFIZER$$72$YR$$F$Y$77$KG$20240705$$MD$CA$CA
212803022$21280302$2$F$20220101$20220823$20220901$20240809$EXP$$FR-AstraZeneca-2022A292294$ASTRAZENECA$$55$YR$$F$Y$56$KG$20240809$$MD$FR$
212803463$21280346$3$F$$20240801$20220901$20240805$EXP$$US-PFIZER INC-PV202200006019$PFIZER$$50$YR$$F$Y$$$20240805$$HP$US$US
2128038813$21280388$13$F$20220101$20240906$20220901$20240906$EXP$$CA-PFIZER INC-202201103258$PFIZER$$58$YR$$M$Y$$$20240906$$HP$CA$CA
212803987$21280398$7$F$$20240725$20220901$20240731$EXP$$US-GSK-US2022AMR125547$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$US$US
212804759$21280475$9$F$20220701$20240829$20220901$20240830$EXP$$NVSC2022US196383$NOVARTIS$$23$YR$$M$Y$$$20240830$$HP$US$US
2128274512$21282745$12$F$20230718$20240712$20220901$20240716$PER$$NVSC2022US196016$NOVARTIS$$19$YR$$F$Y$52$KG$20240716$$CN$US$US
2128298814$21282988$14$F$20230131$20240905$20220901$20240911$EXP$$CO-TAKEDA-2022TUS050133$TAKEDA$$26$YR$$M$Y$70$KG$20240911$$CN$CO$CO
212838689$21283868$9$F$$20230811$20220901$20240824$EXP$$US-TAKEDA-2022TUS058725$TAKEDA$$$$$F$Y$$$20240824$$HP$US$US
2128412613$21284126$13$F$$20240703$20220902$20240708$EXP$$US-TAKEDA-US202007315$TAKEDA$$$$$F$Y$91$KG$20240708$$HP$US$US
2128421015$21284210$15$F$20220801$20231205$20220902$20240926$EXP$$US-GSK-US2022AMR124054$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
212842433$21284243$3$F$20240510$20240517$20220902$20240923$PER$$GT-TOLMAR, INC.-22GT036339$TOLMAR$$68$YR$$M$Y$$$20240923$$CN$GT$GT
212845855$21284585$5$F$20220801$20221201$20220902$20240925$PER$$US-GSK-US2022AMR125541$GLAXOSMITHKLINE$$60$YR$$F$Y$60.1$KG$20240925$$MD$US$US
212846214$21284621$4$F$20220801$20220902$20220902$20240925$EXP$$US-GSK-US2022AMR118532$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
212848574$21284857$4$F$20220801$20221110$20220902$20240925$PER$$US-GSK-US2022AMR126073$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240925$$CN$US$US
212857792$21285779$2$F$$20220830$20220902$20240717$EXP$$AT-ASTELLAS-2022US031095$ASTELLAS$$72$YR$$F$Y$$$20240717$$MD$AT$AT
212858365$21285836$5$F$$20240716$20220902$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2022-098929$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$68$KG$20240729$$CN$CA$CA
212859532$21285953$2$F$$20240822$20220902$20240827$EXP$$CA-TAKEDA-2022TUS060198$TAKEDA$$$$$M$Y$$$20240827$$CN$CA$CA
212861384$21286138$4$F$20220101$20220922$20220902$20240925$EXP$$US-GSK-US2022AMR017961$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
2128616910$21286169$10$F$20220728$20240731$20220902$20240806$EXP$$CA-JNJFOC-20220855576$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240806$$HP$CA$CA
212861777$21286177$7$F$20220705$20240813$20220902$20240815$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000291$PAREXEL$$$$$$Y$$$20240815$$HP$US$US
212862588$21286258$8$F$$20240723$20220902$20240725$EXP$$US-PFIZER INC-PV202200055165$PFIZER$$57$YR$$F$Y$$$20240725$$CN$US$US
2128674420$21286744$20$F$20210504$20240702$20220902$20240711$EXP$$CA-ROCHE-2832524$ROCHE$$47$YR$A$F$Y$$$20240711$$CN$CA$CA
2128702014$21287020$14$F$20220816$20240724$20220902$20240731$EXP$$NVSC2022PE188909$NOVARTIS$$68$YR$$F$Y$$$20240731$$CN$PE$PE
2128717713$21287177$13$F$20220101$20240813$20220902$20240816$EXP$$CA-PFIZER INC-202101161184$PFIZER$$65$YR$$F$Y$78$KG$20240816$$CN$CA$CA
212875392$21287539$2$F$20220101$20240814$20220902$20240827$PER$$US-ABBVIE-22K-163-4499974-00$ABBVIE$$$$$M$Y$60$KG$20240827$$CN$US$US
212877498$21287749$8$F$20230101$20240822$20220902$20240830$EXP$$US-ABBVIE-22K-163-4484853-00$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
212884342$21288434$2$F$$20240801$20220902$20240805$EXP$$CA-PFIZER INC-202201113761$MYLAN$$91$YR$$M$Y$$$20240805$$HP$CA$CA
212894973$21289497$3$F$$20240820$20220902$20240822$EXP$$US-TAKEDA-2022TUS061064$TAKEDA$$$$$F$Y$$$20240822$$MD$US$US
212895323$21289532$3$F$20220815$20240628$20220902$20240701$EXP$$US-TAKEDA-2022TUS061220$TAKEDA$$75$YR$$M$Y$$$20240701$$HP$US$US
212895504$21289550$4$F$20200118$20240830$20220902$20240906$EXP$$NVSC2020CA023529$NOVARTIS$$59$YR$$M$Y$$$20240906$$CN$CA$CA
2128978932$21289789$32$F$20201103$20240907$20220902$20240913$EXP$$CO-TAKEDA-2020TUS048912$TAKEDA$$30$YR$$F$Y$50$KG$20240913$$HP$CO$CO
212898075$21289807$5$F$$20240918$20220902$20240927$EXP$$CA-APOTEX-2022AP012107$APOTEX$$4$YR$$M$Y$18$KG$20240927$$HP$CA$CA
2129038412$21290384$12$F$20220801$20240705$20220902$20240708$EXP$$NVSC2022AR197543$NOVARTIS$$70$YR$$M$Y$$$20240708$$CN$AR$AR
2129039511$21290395$11$F$$20240813$20220902$20240816$EXP$$US-TAKEDA-2022TUS060554$TAKEDA$$$$$F$Y$$$20240816$$HP$US$US
2129045710$21290457$10$F$20220830$20240715$20220903$20240718$EXP$$US-TAKEDA-2022TUS061039$TAKEDA$$55$YR$$F$Y$$$20240718$$CN$US$US
2129047920$21290479$20$F$20220401$20240904$20220903$20240912$EXP$$CA-CELLTRION INC.-2022CA008712$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
2129064115$21290641$15$F$20220101$20240821$20220903$20240829$EXP$$CA-CELLTRION INC.-2022CA012309$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
212910303$21291030$3$F$20210914$20240627$20220903$20240703$EXP$$NVSC2021MX214735$NOVARTIS$$84$YR$$F$Y$50$KG$20240703$$CN$MX$MX
212910723$21291072$3$F$20220801$20240816$20220903$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2022-019979$UNITED THERAPEUTICS$$32$YR$$F$Y$$$20240824$$$US$US
212910909$21291090$9$F$$20240912$20220903$20240919$EXP$$CA-TAKEDA-2022TUS018446$TAKEDA$$$$$M$Y$$$20240919$$CN$CA$CA
212912012$21291201$2$F$$20240802$20220903$20240805$PER$$NVSC2022US196332$NOVARTIS$$$$A$F$Y$$$20240805$$HP$US$US
2129128711$21291287$11$F$$20240726$20220903$20240803$EXP$$CA-CELLTRION INC.-2020CA035246$CELLTRION$$$$$$Y$$$20240803$$HP$CA$CA
212917128$21291712$8$F$$20240828$20220903$20240910$EXP$$US-ABBVIE-22K-163-4525961-00$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
212921093$21292109$3$F$20220315$20220909$20220904$20240930$EXP$$JP-JNJFOC-20220900949$JOHNSON AND JOHNSON$$96$YR$E$F$Y$$$20240930$$CN$JP$JP
212924563$21292456$3$F$20220101$20240903$20220905$20240909$EXP$$CA-JNJFOC-20220615574$JOHNSON AND JOHNSON$$13$YR$T$M$Y$31$KG$20240909$$HP$CA$CA
212926082$21292608$2$F$20181201$20220829$20220905$20240715$EXP$$BG-ASTELLAS-2022US031104$ASTELLAS$$65$YR$$M$Y$$$20240715$$MD$BG$BG
212926736$21292673$6$F$20220823$20240627$20220905$20240709$EXP$$CA-ROCHE-3167713$ROCHE$$38$YR$A$F$Y$$$20240709$$MD$CA$CA
2129277811$21292778$11$F$20220821$20240820$20220905$20240821$EXP$$US-UCBSA-2022051054$UCB$$24$YR$$F$Y$$$20240821$$CN$US$US
212931578$21293157$8$F$20221201$20240918$20220905$20240925$EXP$$ZA-TAKEDA-2022TUS060712$TAKEDA$$63$YR$$F$Y$$$20240925$$HP$ZA$ZA
212938942$21293894$2$F$$20240723$20220905$20240730$EXP$$CA-APOTEX-2022AP012086$APOTEX$$68$YR$$M$Y$$$20240730$$MD$CA$CA
2129397911$21293979$11$F$20220901$20240703$20220905$20240710$EXP$$CA-GSK-CA2022125436$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$HP$CA$CA
212940302$21294030$2$F$$20240627$20220905$20240704$EXP$$US-009507513-2208USA011476$MERCK$Sandooja R, Higgins A, Simha V, Dhanasekaran M. Marked Hypoleptinemia precedes Overt Fat Loss in Immune Checkpoint Inhibitor-induced Acquired Generalized Lipodystrophy. Journal of Clinical Lipidology. 2022;16(3):e42$66$YR$$F$Y$$$20240704$$MD$US$US
212942446$21294244$6$F$20210101$20240521$20220905$20240809$EXP$$NVSC2021PA015414$NOVARTIS$$53$YR$$F$Y$$$20240809$$CN$PA$PA
212942775$21294277$5$F$20220121$20240626$20220905$20240709$EXP$$NL-ROCHE-3172680$ROCHE$$28$YR$A$F$Y$68$KG$20240628$$MD$NL$NL
212942984$21294298$4$F$20220901$20220921$20220905$20240926$PER$$US-GSK-US2022AMR127483$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240926$$HP$US$US
212943332$21294333$2$F$$20240717$20220905$20240718$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000387$PAREXEL$$$$$$Y$$$20240718$$CN$US$US
212943783$21294378$3$F$20220823$20240819$20220905$20240820$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000370$PAREXEL$$$$$$Y$$$20240820$$CN$US$US
2129442313$21294423$13$F$20220901$20240918$20220905$20240924$EXP$$US-TAKEDA-2022TUS060669$TAKEDA$$63$YR$$M$Y$$$20240924$$CN$US$US
212944632$21294463$2$F$20220723$20240813$20220905$20240815$EXP$FR-AFSSAPS-NC20222667$FR-JNJFOC-20220900807$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240816$$MD$FR$FR
212944823$21294482$3$F$20180915$20240808$20220905$20240815$EXP$$FR-009507513-2208FRA004501$MERCK$Farina A, Villagran-Garcia M, Lundahl Ciano-Petersen N, Vogrig A, Muniz-Castrillo S, Joubert B, et al.. HU ANTIBODIES AUTOIMMUNITY AND IMMUNE CHECKPOINT INHIBITORS. European Journal of Neurology - ePosters. 2022;29 Suppl 1:817$74$YR$$F$Y$$$20240815$$HP$FR$FR
212947416$21294741$6$F$$20240625$20220905$20240705$EXP$$CA-GLENMARK PHARMACEUTICALS-2022GMK074708$GLENMARK$$$$$$Y$$$20240705$$HP$CA$CA
212948917$21294891$7$F$$20240918$20220905$20240926$PER$$NVSC2022US199818$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
212949567$21294956$7$F$20220802$20240805$20220905$20240822$EXP$$JP-009507513-2208JPN000617J$MERCK$Nozaki M, Tomita R, Yano T, Nishiyama M, Kobayashi S, Minato R, et al.. Case Award 2 A Case of Metastatic Renal Cell Carcinoma in which Acute Cholecystitis Developed During Combination Therapy with Pembrolizumab and Lenvatinib. The 114th Shikoku Regional Meeting of the Japanese Urological Association. 27$46$YR$$M$Y$$$20240822$$MD$JP$JP
212951867$21295186$7$F$20220804$20240716$20220905$20240721$EXP$$JP-TAKEDA-2022TJP071854$TAKEDA$$4$YR$$M$Y$13.9$KG$20240721$$HP$JP$JP
212953366$21295336$6$F$20201007$20240813$20220905$20240819$EXP$$IL-ABBVIE-20K-082-3694850-00$ABBVIE$$73$YR$$M$Y$$$20240819$$MD$IL$IL
212954344$21295434$4$F$20220615$20240711$20220905$20240716$EXP$$FR-PFIZER INC-202201089085$PFIZER$$$$A$F$Y$71$KG$20240716$$MD$FR$FR
212954892$21295489$2$F$20220823$20240722$20220905$20240728$PER$$US-AMGEN-USASP2022149047$AMGEN$$77$YR$E$F$Y$$$20240728$$CN$US$US
212956977$21295697$7$F$20220801$20221128$20220906$20240926$PER$$US-GSK-US2022AMR127512$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240926$$CN$US$US
212959819$21295981$9$F$$20230501$20220906$20240925$PER$$US-GSK-US2022AMR127494$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
212959823$21295982$3$F$$20240116$20220906$20240925$PER$$US-GSK-US2022AMR127435$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$MD$US$US
212960569$21296056$9$F$20220201$20240702$20220906$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-090475$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240704$$HP$US$US
212960662$21296066$2$F$20210601$20220902$20220906$20240829$EXP$$NVSC2022AU199077$NOVARTIS$$52$YR$$F$Y$$$20240829$$MD$AU$AU
212961932$21296193$2$F$$20220902$20220906$20240712$EXP$$GB-ASTELLAS-2022US031727$ASTELLAS$$$$E$M$Y$$$20240712$$CN$GB$GB
212969632$21296963$2$F$20220601$20240814$20220906$20240821$EXP$FR-AFSSAPS-DJ20221539$FR-SA-2022SA367403$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240821$$MD$FR$FR
212973643$21297364$3$F$20210501$20240925$20220906$20240927$EXP$$FR-TAKEDA-2022TUS061634$TAKEDA$$58$YR$$F$Y$$$20240927$$HP$FR$FR
212973902$21297390$2$F$$20240410$20220906$20240814$EXP$$CA-TEVA-2022-CA-2069374$TEVA$$65$YR$$F$Y$69$KG$20240814$$HP$CA$CA
212973924$21297392$4$F$$20240617$20220906$20240702$EXP$$US-INSMED, INC.-2022-02418-US$INSMED$$$$$M$Y$$$20240702$$CN$US$US
212980472$21298047$2$F$$20240730$20220906$20240805$EXP$$NVSC2022US199306$NOVARTIS$$$$$M$Y$$$20240804$$CN$US$US
212981624$21298162$4$F$$20240627$20220906$20240701$PER$$US-PFIZER INC-202101864113$PFIZER$$76$YR$$F$Y$47.619$KG$20240701$$CN$US$US
212982213$21298221$3$F$$20240913$20220906$20240917$PER$$US-PFIZER INC-PV202200057064$PFIZER$$69$YR$$F$Y$$$20240917$$CN$US$US
212989983$21298998$3$F$$20240809$20220906$20240813$PER$$US-PFIZER INC-PV202200055385$PFIZER$$72$YR$$F$Y$$$20240813$$CN$US$US
2129900220$21299002$20$F$$20240827$20220906$20240830$EXP$$US-PFIZER INC-202201110425$PFIZER$$74$YR$$F$Y$68.95$KG$20240830$$CN$US$US
212990092$21299009$2$F$$20240717$20220906$20240722$EXP$$CA-TAKEDA-2022TUS061289$TAKEDA$$14$YR$$F$Y$$$20240722$$HP$CA$CA
212995002$21299500$2$F$20180918$20240705$20220906$20240718$EXP$$DE-ROCHE-2332587$ROCHE$$50$YR$A$F$Y$82$KG$20240718$$CN$DE$DE
2130044312$21300443$12$F$$20231204$20220907$20240926$EXP$$US-GSK-US2022127786$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
213007082$21300708$2$F$20200915$20240708$20220907$20240710$EXP$$DE-TAKEDA-2022TUS061795$TAKEDA$$56$YR$$M$Y$$$20240710$$MD$DE$DE
213008572$21300857$2$F$$20240918$20220907$20240923$PER$$NVSC2022US201682$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
213009507$21300950$7$F$20220909$20240703$20220907$20240716$EXP$$US-BIOCODEX2-2022001171$BIOCODEX$$31$YR$$M$Y$92.1$KG$20240711$$CN$US$US
213011717$21301171$7$F$20221001$20221011$20220907$20240925$EXP$$US-GSK-US2022AMR127424$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
213015297$21301529$7$F$$20240920$20220907$20240927$EXP$$CA-TAKEDA-2022TUS026996$TAKEDA$$$$$F$Y$$$20240927$$CN$CA$CA
213019382$21301938$2$F$$20240704$20220907$20240711$EXP$$CA-MYLANLABS-2022M1090962$BIOCON$$$$$$Y$$$20240711$$CN$CA$CA
213022538$21302253$8$F$20221102$20240911$20220907$20240917$EXP$$CA-TAKEDA-2022TUS062251$TAKEDA$$26$YR$$M$Y$$$20240917$$HP$CA$CA
213026323$21302632$3$F$$20220908$20220907$20240716$EXP$$AE-ASTELLAS-2022US031914$ASTELLAS$$74$YR$$M$Y$$$20240716$$MD$AE$AE
213030443$21303044$3$F$20220825$20240708$20220907$20240711$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202208011033$ELI LILLY AND CO$$94$YR$E$F$Y$40$KG$20240711$$PH$JP$JP
2130310014$21303100$14$F$20191212$20240821$20220907$20240828$EXP$$IT-ROCHE-2704595$ROCHE$$40$YR$A$F$Y$$$20240828$$MD$IT$IT
213033633$21303363$3$F$$20240815$20220907$20240820$EXP$$US-INCYTE CORPORATION-2022IN007679$INCYTE$$$$$$Y$$$20240820$$CN$US$US
213035829$21303582$9$F$20220828$20231117$20220907$20240911$EXP$$NVSC2022US197342$NOVARTIS$$50$YR$$F$Y$$$20240911$$CN$US$US
213035905$21303590$5$F$$20240807$20220907$20240813$EXP$$IN-PFIZER INC-2020102354$PFIZER$$41$YR$$F$Y$$$20240813$$CN$IN$IN
213037452$21303745$2$F$20200926$20240624$20220907$20240704$EXP$$IN-INCYTE CORPORATION-2020IN013682$INCYTE$$$$$$Y$$$20240704$$CN$IN$IN
213039648$21303964$8$F$20220826$20240717$20220907$20240724$EXP$$US-JAZZ-2022-US-028720$JAZZ$$40$YR$$F$Y$$$20240724$$HP$US$US
213043943$21304394$3$F$20220429$20231023$20220907$20240906$PER$$US-FARMAPROD-202108-1351$DOMPE FARMACEUTICI$$70$YR$E$F$Y$76.2$KG$20240902$$CN$US$
213044232$21304423$2$F$20230825$20230829$20220907$20240906$PER$$US-FARMAPROD-202108-1366$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240902$$CN$US$
213044792$21304479$2$F$$20231211$20220907$20240906$PER$$US-FARMAPROD-202108-1454$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240902$$CN$US$
213048213$21304821$3$F$20220101$20240911$20220907$20240916$EXP$$CA-PFIZER INC-202201057624$PFIZER$$66$YR$$F$Y$$$20240916$$PH$CA$CA
213048958$21304895$8$F$20240613$20240816$20220907$20240821$EXP$$US-TAKEDA-2022TUS062073$TAKEDA$$73$YR$$M$Y$$$20240821$$HP$US$US
2130550810$21305508$10$F$20220824$20240903$20220908$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-099028$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240911$$CN$US$US
2130577514$21305775$14$F$20220823$20240701$20220908$20240707$EXP$$JP-ARGENX-2022-ARGX-JP001666$ARGENX BVBA$$$$$$Y$$$20240707$$MD$JP$JP
213058204$21305820$4$F$$20240812$20220908$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2022US000746$DECIPHERA PHARMACEUTICALS$$61$YR$A$F$Y$$$20240905$$CN$US$US
2130583819$21305838$19$F$20221101$20240621$20220908$20240925$EXP$$US-GSK-US2022AMR128284$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
213072205$21307220$5$F$20211201$20230413$20220908$20240926$EXP$$US-GSK-US2021AMR264900$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
213074702$21307470$2$F$$20240816$20220908$20240819$PER$$US-PFIZER INC-202201139591$PFIZER$$$$$F$Y$$$20240819$$MD$US$US
213075314$21307531$4$F$20221008$20240919$20220908$20240926$EXP$$CA-TAKEDA-2022TUS062348$TAKEDA$$35$YR$$F$Y$$$20240926$$HP$CA$CA
213076625$21307662$5$F$20220907$20240709$20220908$20240712$PER$$US-PFIZER INC-PV202200010770$PFIZER$$61$YR$$F$Y$$$20240712$$HP$US$US
213084982$21308498$2$F$20220904$20220906$20220908$20240925$PER$$US-GSK-US2022AMR129294$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
2130850010$21308500$10$F$20221001$20230515$20220908$20240925$EXP$$US-GSK-US2022AMR129316$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2130869522$21308695$22$F$20220812$20240911$20220908$20240921$EXP$$US-ROCHE-3175906$ROCHE$$67$YR$E$F$Y$180$KG$20240921$$MD$US$US
213090883$21309088$3$F$$20240917$20220908$20240920$EXP$$GB-GSK-GB2021EME267605$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$GB$GB
213091339$21309133$9$F$$20240906$20220908$20240911$EXP$$US-TAKEDA-2022TUS013589$TAKEDA$$$$$M$Y$150$KG$20240911$$HP$US$US
213103573$21310357$3$F$$20240731$20220909$20240803$PER$$NVSC2022US199756$NOVARTIS$$$$$F$Y$$$20240803$$MD$US$US
213104552$21310455$2$F$$20240816$20220909$20240821$PER$$NVSC2022US201919$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
2131069616$21310696$16$F$20220101$20240911$20220909$20240920$EXP$$CA-CELLTRION INC.-2022CA010226$CELLTRION$$$$$$Y$$$20240920$$MD$CA$CA
213108214$21310821$4$F$20210101$20240704$20220909$20240725$PER$$CA-TOLMAR, INC.-22CA036416$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
213109682$21310968$2$F$20231213$20240119$20220909$20240906$PER$$US-FARMAPROD-202112-2267$DOMPE FARMACEUTICI$$88$YR$E$F$Y$$$20240902$$CN$US$
213110053$21311005$3$F$$20240214$20220909$20240906$PER$$US-FARMAPROD-202112-2352$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240902$$CN$US$
213111402$21311140$2$F$20231201$20231222$20220909$20240906$PER$$US-FARMAPROD-202201-0106$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240902$$CN$US$
213112323$21311232$3$F$$20230824$20220909$20240906$PER$$US-FARMAPROD-202202-0200$DOMPE FARMACEUTICI$$$$E$F$Y$67.13$KG$20240902$$CN$US$
213112444$21311244$4$F$20220914$20230818$20220909$20240906$PER$$US-FARMAPROD-202202-0265$DOMPE FARMACEUTICI$$86$YR$E$F$Y$$$20240902$$CN$US$
213117422$21311742$2$F$20240101$20240223$20220909$20240906$PER$$US-FARMAPROD-202203-0381$DOMPE FARMACEUTICI$$85$YR$E$M$Y$72.57$KG$20240902$$CN$US$
213118382$21311838$2$F$20220101$20231024$20220909$20240906$PER$$US-FARMAPROD-202203-0504$DOMPE FARMACEUTICI$$80$YR$E$F$Y$66.22$KG$20240902$$CN$US$
213118472$21311847$2$F$$20230712$20220909$20240906$PER$$US-FARMAPROD-202203-0561$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240902$$CN$US$
213118872$21311887$2$F$$20240528$20220909$20240906$PER$$US-FARMAPROD-202203-0549$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240902$$CN$US$US
213121622$21312162$2$F$20220423$20230815$20220909$20240906$PER$$US-FARMAPROD-202204-0742$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240902$$CN$US$
213122692$21312269$2$F$20230913$20230915$20220909$20240906$PER$$US-FARMAPROD-202205-0907$DOMPE FARMACEUTICI$$76$YR$E$F$Y$61.23$KG$20240902$$CN$US$
213122762$21312276$2$F$20240401$20240418$20220909$20240906$PER$$US-FARMAPROD-202205-0910$DOMPE FARMACEUTICI$$73$YR$E$F$Y$44.45$KG$20240902$$CN$US$
213123414$21312341$4$F$20190829$20240820$20220909$20240822$EXP$$IT-MYLANLABS-2022M1091731$MYLAN$Cetta I, Messina R, Colombo B, Filippi M. Myocardial infarction in a patient with migraine and triptan overuse treated with anti-CGRP receptor monoclonal antibody: a case report. J-Neurol 2022;269(9):5170-5172.$55$YR$$M$Y$110$KG$20240822$$HP$IT$IT
213123425$21312342$5$F$$20231215$20220909$20240906$PER$$US-FARMAPROD-202205-0974$DOMPE FARMACEUTICI$$68$YR$E$F$Y$47.17$KG$20240902$$CN$US$
213123722$21312372$2$F$20240124$20240126$20220909$20240906$PER$$US-FARMAPROD-202206-1013$DOMPE FARMACEUTICI$$63$YR$A$M$Y$$$20240902$$CN$US$
213124872$21312487$2$F$20240311$20240315$20220909$20240906$PER$$US-FARMAPROD-202206-1151$DOMPE FARMACEUTICI$$30$YR$A$F$Y$$$20240904$$CN$US$
213125662$21312566$2$F$$20230905$20220909$20240906$PER$$US-FARMAPROD-202207-1225$DOMPE FARMACEUTICI$$$$E$F$Y$54.43$KG$20240904$$CN$US$
213128325$21312832$5$F$$20240724$20220909$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-10883$LUPIN$$$$$$Y$$$20240813$$CN$US$US
213128723$21312872$3$F$20220810$20220830$20220909$20240709$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202208016050$ELI LILLY AND CO$$77$YR$E$F$Y$40$KG$20240709$$MD$FR$FR
213132652$21313265$2$F$$20240726$20220909$20240801$PER$$NVSC2022US199262$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
213133293$21313329$3$F$$20230901$20220909$20240902$PER$$US-ASTELLAS-2021US045718$ASTELLAS$$51$YR$A$M$Y$$$20240830$$CN$US$US
213135413$21313541$3$F$20210101$20231212$20220909$20240902$PER$$US-ASTELLAS-2022US009751$ASTELLAS$$87$YR$E$M$Y$$$20240830$$CN$US$US
213139373$21313937$3$F$$20220926$20220909$20240711$EXP$$DE-ASTELLAS-2022US031896$ASTELLAS$$63$YR$$F$Y$$$20240711$$CN$DE$DE
2131419113$21314191$13$F$20191019$20240922$20220909$20240928$EXP$$CA-TAKEDA-CA201939100$TAKEDA$$56$YR$$F$Y$$$20240928$$CN$CA$CA
213142022$21314202$2$F$20210909$20231003$20220909$20240906$PER$$US-FARMAPROD-202109-1658$DOMPE FARMACEUTICI$$65$YR$E$F$Y$$$20240902$$CN$US$
213142612$21314261$2$F$$20230929$20220909$20240906$PER$$US-FARMAPROD-202109-1725$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240902$$CN$US$
213143313$21314331$3$F$20230427$20231115$20220909$20240906$EXP$$US-FARMAPROD-202110-1795$DOMPE FARMACEUTICI$$47$YR$A$F$Y$81.65$KG$20240902$$MD$US$
213144266$21314426$6$F$20200318$20240821$20220909$20240824$EXP$$US-TAKEDA-US202004724$TAKEDA$$59$YR$$F$Y$$$20240824$$CN$US$US
213145008$21314500$8$F$$20240822$20220909$20240827$EXP$$US-PFIZER INC-PV202200059565$PFIZER$$60$YR$$F$Y$$$20240827$$CN$US$US
213145875$21314587$5$F$20220101$20240826$20220909$20240829$PER$$US-PFIZER INC-PV202200059519$PFIZER$$59$YR$$F$Y$$$20240829$$HP$US$US
213148142$21314814$2$F$$20230929$20220909$20240906$PER$$US-FARMAPROD-202111-2041$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240902$$CN$US$
213148275$21314827$5$F$$20240724$20220909$20240729$EXP$$US-PFIZER INC-PV202200060388$PFIZER$$89$YR$$F$Y$72.562$KG$20240729$$CN$US$US
213149124$21314912$4$F$20201201$20240903$20220909$20240916$EXP$$CA-HLS-202002985$HLS THERAPEUTICS$$74$YR$E$F$Y$$$20240916$$HP$CA$CA
2131511817$21315118$17$F$20200101$20240705$20220909$20240709$EXP$$US-PFIZER INC-202201139363$PFIZER$$88$YR$$M$Y$64.86$KG$20240709$$CN$US$US
213152153$21315215$3$F$20220826$20240829$20220909$20240911$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2022-097459$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240911$$MD$DE$DE
213152682$21315268$2$F$$20230720$20220909$20240906$PER$$US-FARMAPROD-202111-2066$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240902$$CN$US$
213155392$21315539$2$F$20220422$20220831$20220909$20240801$EXP$$US-RECORDATI-2022001816$RECORDATI$$$$$$Y$$$20240801$$CN$US$US
213158205$21315820$5$F$20220802$20240708$20220909$20240718$EXP$$BR-CELLTRION INC.-2022BR014557$CELLTRION$$$$$$Y$$$20240718$$CN$BR$BR
213158815$21315881$5$F$$20240624$20220910$20240701$EXP$$CA-CELLTRION INC.-2022CA014266$CELLTRION$$$$$$Y$$$20240701$$HP$CA$CA
213160006$21316000$6$F$20211018$20240717$20220910$20240724$EXP$$NVSC2021GB239129$NOVARTIS$$63$YR$$F$Y$56$KG$20240724$$CN$GB$GB
213160303$21316030$3$F$20220901$20220921$20220910$20240925$PER$$US-GSK-US2022AMR129381$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240925$$CN$US$US
2131610912$21316109$12$F$20200101$20240802$20220910$20240809$EXP$$CA-CELLTRION INC.-2019CA027695$CELLTRION$$$$$$Y$$$20240809$$MD$CA$CA
2131620915$21316209$15$F$20220101$20240830$20220910$20240909$EXP$$CA-CELLTRION INC.-2022CA010076$CELLTRION$$$$$$Y$$$20240909$$MD$CA$CA
213164026$21316402$6$F$20220901$20221101$20220910$20240926$PER$$US-GSK-US2022AMR129428$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240926$$CN$US$US
213164372$21316437$2$F$20210101$20220906$20220910$20240925$EXP$$US-GSK-US2022AMR129306$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
213165624$21316562$4$F$20220101$20240807$20220911$20240815$PER$$US-SA-2022SA241754$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240815$$MD$US$US
213165952$21316595$2$F$20220101$20240903$20220911$20240925$PER$$US-SA-2022SA336376$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240925$$MD$US$US
213166162$21316616$2$F$20210323$20240625$20220911$20240704$PER$$US-SA-2022SA340607$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240704$$MD$US$US
213167522$21316752$2$F$20220801$20240625$20220911$20240704$PER$$US-SA-2022SA347378$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240704$$MD$US$US
213167622$21316762$2$F$20220801$20240628$20220911$20240708$PER$$US-SA-2022SA347603$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240708$$MD$US$US
213167723$21316772$3$F$$20240815$20220911$20240827$PER$$US-SA-2022SA342139$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240827$$MD$US$US
213175232$21317523$2$F$20220101$20240806$20220911$20240814$PER$$US-SA-2022SA214175$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240814$$MD$US$US
213176732$21317673$2$F$$20240722$20220911$20240730$PER$$US-SA-2022SA354074$SANOFI AVENTIS$$$$A$F$Y$$$20240730$$MD$US$US
213177152$21317715$2$F$$20240624$20220911$20240703$PER$$US-SA-2022SA351799$SANOFI AVENTIS$$59$YR$A$M$Y$86$KG$20240703$$MD$US$US
213178842$21317884$2$F$20240101$20240906$20220911$20240913$PER$$US-SA-2022SA355419$SANOFI AVENTIS$$51$YR$A$M$Y$61.2$KG$20240913$$MD$US$US
213180207$21318020$7$F$20220101$20240705$20220911$20240712$EXP$$US-SA-2022SA357918$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240712$$MD$US$US
213181112$21318111$2$F$20220803$20240821$20220911$20240904$PER$$US-SA-2022SA355905$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240904$$MD$US$US
213181132$21318113$2$F$$20240725$20220911$20240803$PER$$US-SA-2022SA353938$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240803$$MD$US$US
213181172$21318117$2$F$20220801$20240829$20220911$20240923$PER$$US-SA-2022SA357036$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240923$$CN$US$US
213181866$21318186$6$F$20240101$20240820$20220911$20240828$EXP$$US-SA-2022SA355442$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240828$$MD$US$US
213182012$21318201$2$F$20220824$20240817$20220911$20240830$PER$$US-SA-2022SA358056$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240830$$MD$US$US
213183202$21318320$2$F$$20240821$20220911$20240904$PER$$US-SA-2022SA355663$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240904$$MD$US$US
213183955$21318395$5$F$20240401$20240709$20220911$20240717$PER$$US-SA-2022SA358647$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240717$$MD$US$US
213184102$21318410$2$F$$20240809$20220911$20240817$PER$$US-SA-2022SA357940$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240817$$MD$US$US
213184332$21318433$2$F$$20240619$20220911$20240701$PER$$US-SA-2022SA356586$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240701$$MD$US$US
213184922$21318492$2$F$20220821$20240801$20220911$20240812$PER$$US-SA-2022SA352463$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240812$$MD$US$US
213185045$21318504$5$F$$20240909$20220911$20240912$EXP$$PT-ORGANON-O2209PRT000434$ORGANON$Gomes LM, Silva MA, Portugues AS, Cunha C.. OP 52 | A DIAGNOSIS MASKED BY THE PANDEMIC: A CASE REPORT OF ORGANIZING PNEUMONIA. Rev Port Med Geral Fam. 2022;38:S49$65$YR$$F$Y$$$20240912$$HP$PT$PT
213185092$21318509$2$F$20220101$20240629$20220911$20240708$PER$$US-SA-2022SA356525$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240708$$MD$US$US
213185524$21318552$4$F$20230612$20240621$20220911$20240705$PER$$US-SA-2022SA360064$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240705$$CN$US$US
213186852$21318685$2$F$20240701$20240725$20220911$20240805$PER$$US-SA-2022SA360789$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
213187722$21318772$2$F$$20240726$20220911$20240806$PER$$US-SA-2022SA362292$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240806$$MD$US$US
213187892$21318789$2$F$$20240705$20220911$20240713$PER$$US-SA-2022SA361932$SANOFI AVENTIS$$$$E$F$Y$$$20240713$$HP$US$US
213187932$21318793$2$F$$20240804$20220911$20240813$PER$$US-SA-2022SA361280$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
213188192$21318819$2$F$$20240703$20220911$20240710$PER$$US-SA-2022SA361416$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$CN$US$US
213188343$21318834$3$F$$20240702$20220911$20240709$PER$$US-SA-2022SA361082$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240709$$CN$US$US
213189064$21318906$4$F$$20240709$20220911$20240714$PER$$US-SA-2022SA360276$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240714$$CN$US$US
213189392$21318939$2$F$20220813$20240829$20220911$20240905$PER$$US-SA-2022SA359719$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240905$$HP$US$US
213191224$21319122$4$F$20240101$20240903$20220911$20240918$PER$$US-SA-2022SA368576$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240918$$MD$US$US
213191253$21319125$3$F$20220712$20240729$20220911$20240807$PER$$US-SA-2022SA360585$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240807$$HP$US$US
213191963$21319196$3$F$20220701$20240717$20220911$20240725$PER$$US-SA-2022SA362123$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240725$$MD$US$US
213192742$21319274$2$F$$20240627$20220911$20240706$PER$$US-SA-2022SA362553$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240706$$MD$US$US
213197142$21319714$2$F$20230101$20240828$20220911$20240909$PER$$US-SA-2022SA364938$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240909$$MD$US$US
213197282$21319728$2$F$$20240729$20220911$20240807$PER$$US-SA-2022SA363278$SANOFI AVENTIS$$$$A$F$Y$64$KG$20240807$$MD$US$US
213198533$21319853$3$F$20220713$20240706$20220911$20240715$PER$$US-SA-2022SA367770$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240715$$MD$US$US
213198562$21319856$2$F$$20240710$20220911$20240718$PER$$US-SA-2022SA369497$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240718$$CN$US$US
213200212$21320021$2$F$20240101$20240716$20220911$20240724$PER$$US-SA-2022SA369074$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240724$$MD$US$US
213200754$21320075$4$F$$20240701$20220911$20240710$PER$$US-SA-2022SA330130$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240710$$MD$US$US
213201742$21320174$2$F$20240601$20240701$20220911$20240710$PER$$US-SA-2022SA371941$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240710$$MD$US$US
213202695$21320269$5$F$20220905$20240821$20220911$20240904$PER$$US-SA-2022SA373282$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240904$$MD$US$US
213205479$21320547$9$F$20220801$20240730$20220912$20240809$EXP$$US-PHARMAESSENTIA CORPORATION-US-2022-PEC-000790$PHARMAESSENTIA$$$$$M$Y$$$20240809$$CN$US$US
213207137$21320713$7$F$20210101$20240710$20220912$20240722$EXP$$CA-CELLTRION INC.-2021CA000524$CELLTRION$$$$$$Y$$$20240722$$MD$CA$CA
213207387$21320738$7$F$$20240906$20220912$20240919$EXP$$PT-AUROBINDO-AUR-APL-2022-035813$AUROBINDO$Gomes LM, Silva MA, Portugu?s AS, Cunha C.. Um diagnostico mascarado pela pandemia: Um relato de caso de pneumonia organizativa [PO 52 - A diagnosis masked by the pandemic: an organizing pneumonia case report].. PORTUGUESE MAGAZINE OF GENERAL AND FAMILIAR MEDICINE. 2022;38(49):51$65$YR$$F$Y$$$20240919$$MD$PT$PT
213210494$21321049$4$F$20220701$20240925$20220912$20240930$EXP$$NVSC2022DO156736$NOVARTIS$$48$YR$$M$Y$72.562$KG$20240930$$HP$DO$DO
213212258$21321225$8$F$20220601$20240916$20220912$20240925$EXP$$CZ-UCBSA-2022052936$UCB$$$$A$M$Y$$$20240925$$MD$CZ$CZ
213212298$21321229$8$F$20210118$20240830$20220912$20240903$EXP$$DE-ROCHE-2887300$ROCHE$$35$YR$A$F$Y$56$KG$20240903$$MD$DE$DE
213214174$21321417$4$F$20220818$20240722$20220912$20240725$EXP$$US-TAKEDA-2022TUS063144$TAKEDA$$14$YR$$M$Y$$$20240725$$CN$US$US
2132144512$21321445$12$F$20211001$20240628$20220912$20240706$EXP$$CA-CELLTRION INC.-2021CA017366$CELLTRION$$$$$$Y$$$20240706$$HP$CA$CA
2132159814$21321598$14$F$20220101$20240822$20220912$20240830$EXP$$CA-CELLTRION INC.-2022CA005870$CELLTRION$$$$$$Y$$$20240830$$MD$CA$CA
213216057$21321605$7$F$20220708$20240912$20220912$20240921$EXP$$CA-CELLTRION INC.-2022CA010027$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
213218382$21321838$2$F$$20240722$20220912$20240802$PER$$NVSC2022US204056$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
2132210912$21322109$12$F$20220902$20240822$20220912$20240826$EXP$$CA-ROCHE-3174918$ROCHE$$37$YR$A$F$Y$$$20240826$$CN$CA$CA
213221738$21322173$8$F$20210301$20240627$20220912$20240703$EXP$$NVSC2022IN204454$NOVARTIS$$68$YR$$F$Y$$$20240703$$CN$IN$IN
213222572$21322257$2$F$$20240918$20220912$20240923$EXP$$NVSC2022CO183304$NOVARTIS$$$$$M$Y$68$KG$20240923$$CN$CO$CO
213223922$21322392$2$F$$20240911$20220912$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-103261$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240917$$CN$US$US
213225262$21322526$2$F$20211207$20220907$20220912$20240926$EXP$$US-GSK-US2021AMR257720$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
213226703$21322670$3$F$$20240729$20220912$20240806$EXP$$US-JNJFOC-20220917609$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$LW$US$US
213229064$21322906$4$F$$20240628$20220912$20240703$EXP$$US-ABBVIE-22K-163-4400748-00$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
213230854$21323085$4$F$$20240809$20220912$20240816$EXP$$US-JAZZ-2022-US-026564$JAZZ$$$$$M$Y$$$20240815$$CN$US$US
213231404$21323140$4$F$20220908$20240809$20220912$20240814$EXP$$AU-TAKEDA-2022TUS063016$TAKEDA$$56$YR$$M$Y$$$20240814$$CN$AU$AU
213232833$21323283$3$F$$20240716$20220912$20240726$EXP$$US-ABBVIE-21K-163-4011231-00$ABBVIE$$$$$M$Y$$$20240726$$MD$US$US
213234914$21323491$4$F$20220801$20240725$20220912$20240731$EXP$$PR-ABBVIE-22K-131-4535090-00$ABBVIE$$56$YR$$M$Y$77$KG$20240731$$CN$PR$PR
213237012$21323701$2$F$$20240715$20220912$20240722$PER$$NVSC2022US204173$NOVARTIS$$$$$F$Y$$$20240722$$CN$US$US
213239257$21323925$7$F$$20240627$20220912$20240702$EXP$$US-JAZZ-2022-US-028905$JAZZ$$$$$F$Y$$$20240702$$MD$US$US
213242955$21324295$5$F$20211020$20240809$20220912$20240814$EXP$$US-TAKEDA-2021TUS044773$TAKEDA$$69$YR$$F$Y$56.7$KG$20240814$$CN$US$US
213243317$21324331$7$F$20220704$20240912$20220912$20240919$EXP$$NVSC2022FR204730$NOVARTIS$$$$E$M$Y$72$KG$20240919$$MD$FR$FR
213247036$21324703$6$F$20220907$20240815$20220912$20240816$EXP$$US-TAKEDA-2022TUS063483$TAKEDA$$31$YR$$M$Y$$$20240816$$CN$US$US
213249354$21324935$4$F$20180606$20240718$20220912$20240723$PER$$US-JNJFOC-20220918877$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240723$$LW$US$US
213250447$21325044$7$F$20180701$20240909$20220912$20240911$EXP$$ES-MYLANLABS-2022M1092522$MYLAN$$64$YR$$M$Y$$$20240911$$MD$ES$ES
2132574925$21325749$25$F$20200415$20240729$20220913$20240806$EXP$$CA-CELLTRION INC.-2019CA027206$CELLTRION$$$$$$Y$$$20240806$$MD$CA$CA
213257746$21325774$6$F$20220101$20240704$20220913$20240710$EXP$$CA-CELLTRION INC.-2022CA006142$CELLTRION$$$$$$Y$$$20240710$$MD$CA$CA
213258794$21325879$4$F$20220905$20240701$20220913$20240723$PER$$CA-TOLMAR, INC.-22CA036486$TOLMAR$$81$YR$$M$Y$$$20240723$$CN$CA$CA
2132594813$21325948$13$F$20220606$20240701$20220913$20240711$EXP$$CN-GILEAD-2022-0597069$GILEAD$$61$YR$A$M$Y$$$20240711$$MD$CN$CN
2132601719$21326017$19$F$20240627$20240627$20220913$20240702$PER$$NVSC2022US205088$NOVARTIS$$44$YR$$F$Y$$$20240702$$CN$US$US
213262843$21326284$3$F$$20240729$20220913$20240807$PER$$US-SA-2022SA372271$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240807$$CN$US$US
213266414$21326641$4$F$$20240705$20220913$20240717$EXP$$IT-AUROBINDO-AUR-APL-2022-035836$AUROBINDO$Berloffa S, Dosi C, Tascini B, Fossati B, Lupetti I, Masi G... Neuroleptic Malignant Syndrome in Children with Autism Spectrum Disorder (ASD): A Case Report and Brief.. Children-Basel.. 2021;8(12):0001-7$16$YR$$M$Y$$$20240717$$HP$IT$IT
213266689$21326668$9$F$20220101$20240909$20220913$20240917$EXP$$CA-CELLTRION INC.-2022CA008993$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
2132669512$21326695$12$F$20220720$20240909$20220913$20240917$EXP$$CA-CELLTRION INC.-2022CA010110$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
213269254$21326925$4$F$20220817$20240830$20220913$20240909$EXP$$JP-ROCHE-3174966$ROCHE$$63$YR$A$F$Y$71.8$KG$20240909$$MD$JP$JP
213269848$21326984$8$F$20190514$20240711$20220913$20240720$EXP$$CA-CELLTRION INC.-2019CA021591$CELLTRION$$$$$$Y$$$20240720$$CN$CA$CA
213270207$21327020$7$F$20220301$20240904$20220913$20240926$PER$$CA-TOLMAR, INC.-22CA036440$TOLMAR$$66$YR$$M$Y$$$20240926$$CN$CA$CA
213271498$21327149$8$F$20210412$20240730$20220913$20240805$EXP$$NVSC2021IN121395$NOVARTIS$$57$YR$$F$Y$$$20240805$$CN$IN$IN
213272357$21327235$7$F$20220628$20240724$20220913$20240731$EXP$$DE-ROCHE-3131260$ROCHE$$38$YR$A$F$Y$91$KG$20240731$$MD$DE$DE
213273993$21327399$3$F$20220103$20230929$20220913$20240712$EXP$GB-MHRA-ADR 26970377$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-05917$ALKEM$$$$A$M$Y$$$20240712$$MD$GB$GB
213274064$21327406$4$F$20210107$20230811$20220913$20240712$EXP$GB-MHRA-ADR 25215298$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-06214$ALKEM$$$$A$M$Y$99$KG$20240712$$MD$GB$GB
213274163$21327416$3$F$20190501$20230720$20220913$20240712$EXP$GB-MHRA-ADR 25136467$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-05918$ALKEM$$$$A$M$Y$$$20240712$$MD$GB$GB
213274172$21327417$2$F$20181019$20230814$20220913$20240712$EXP$GB-MHRA-ADR 27019799$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-06567$ALKEM$$56$YR$$F$Y$110.8$KG$20240712$$MD$GB$GB
213279002$21327900$2$F$20081101$20240708$20220913$20240715$EXP$$GB-AUROBINDO-AUR-APL-2022-035875$AUROBINDO$$18$YR$$F$Y$55$KG$20240715$$PH$GB$GB
213281056$21328105$6$F$20220501$20221122$20220913$20240926$EXP$$US-GSK-US2022AMR090542$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
213281089$21328108$9$F$20220301$20230703$20220913$20240925$EXP$$US-GSK-US2022AMR029481$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
213281132$21328113$2$F$20220601$20220908$20220913$20240925$EXP$$US-GSK-US2022AMR097628$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
213282027$21328202$7$F$$20240621$20220913$20240709$EXP$$CA-ROCHE-3175613$ROCHE$$$$A$M$Y$$$20240704$$CN$CA$CA
213282744$21328274$4$F$20220101$20240820$20220913$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-10965$LUPIN$$$$$$Y$$$20240906$$CN$US$US
213285247$21328524$7$F$20220501$20240715$20220913$20240726$EXP$$US-BIOCODEX2-2022000608$BIOCODEX$$10$YR$$M$Y$31.8$KG$20240724$$CN$US$US
213285477$21328547$7$F$$20230605$20220913$20240919$PER$$NVSC2022US176272$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
213287346$21328734$6$F$$20230510$20220913$20240824$EXP$$US-TAKEDA-2022TUS063482$TAKEDA$$$$$M$Y$$$20240824$$CN$US$US
2132882810$21328828$10$F$20231003$20240903$20220913$20240906$EXP$$CA-TAKEDA-2018TUS007970$TAKEDA$$85$YR$$M$Y$90$KG$20240906$$HP$CA$CA
213288577$21328857$7$F$20160601$20240823$20220913$20240827$EXP$$US-PFIZER INC-202201147438$PFIZER$$58$YR$$F$Y$56.7$KG$20240827$$CN$US$US
213288939$21328893$9$F$$20240703$20220913$20240712$EXP$$CA-ROCHE-3178291$ROCHE$$$$A$M$Y$$$20240712$$CN$CA$CA
213289879$21328987$9$F$20240115$20240910$20220913$20240911$EXP$$US-PFIZER INC-PV202200062086$PFIZER$$93$YR$$F$Y$43.084$KG$20240911$$CN$US$US
213290612$21329061$2$F$$20240807$20220913$20240808$PER$$NVSC2022US205516$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
213291074$21329107$4$F$20220905$20221008$20220913$20240711$EXP$$CH-ASTELLAS-2022US032178$ASTELLAS$$60$YR$$F$Y$$$20240711$$MD$CH$CH
2132916616$21329166$16$F$20220101$20240920$20220913$20240925$EXP$$CA-PFIZER INC-202201014474$PFIZER$$35$YR$$F$Y$$$20240925$$MD$CA$CA
213293014$21329301$4$F$$20240816$20220913$20240820$EXP$$CA-ROCHE-3178303$ROCHE$$$$A$M$Y$$$20240820$$MD$CA$CA
213295098$21329509$8$F$20230623$20240916$20220913$20240923$EXP$$AU-TAKEDA-2022TUS063825$TAKEDA$$51$YR$$F$Y$$$20240923$$CN$AU$AU
213297273$21329727$3$F$$20240905$20220913$20240909$PER$$NVSC2022US205639$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
213300424$21330042$4$F$$20240712$20220913$20240715$PER$$US-PFIZER INC-PV202200062188$PFIZER$$45$YR$$F$Y$$$20240715$$CN$US$US
213303372$21330337$2$F$20220908$20240910$20220913$20240910$EXP$$ZA-PFIZER INC-PV202200060688$PFIZER$$52$YR$$F$Y$135$KG$20240910$$HP$ZA$ZA
213307366$21330736$6$F$20220301$20240913$20220913$20240923$EXP$$US-BIOGEN-2022BI01153868$BIOGEN$$67$YR$$F$Y$$$20240923$$CN$US$US
213310047$21331004$7$F$20230413$20240701$20220914$20240723$PER$$CA-TOLMAR, INC.-22CA036467$TOLMAR$$78$YR$$M$Y$$$20240723$$CN$CA$CA
213310098$21331009$8$F$20220901$20240719$20220914$20240726$PER$$CA-TOLMAR, INC.-22CA036468$TOLMAR$$80$YR$$M$Y$$$20240726$$CN$CA$CA
213310262$21331026$2$F$$20240822$20220914$20240826$EXP$$JP-TAKEDA-2022TJP072600$TAKEDA$$35$YR$$M$Y$$$20240826$$MD$JP$JP
213310426$21331042$6$F$20230418$20240708$20220914$20240729$PER$$CA-TOLMAR, INC.-22CA036529$TOLMAR$$76$YR$$M$Y$$$20240726$$CN$CA$CA
213310574$21331057$4$F$20220101$20221012$20220914$20240913$PER$$US-ROCHE-3175539$ROCHE$$41$YR$A$F$Y$72.57$KG$20240913$$CN$US$US
213316902$21331690$2$F$20220101$20220928$20220914$20240723$EXP$$CA-AstraZeneca-2022A313503$ASTRAZENECA$$89$YR$$M$Y$$$20240723$$CN$CA$
213318733$21331873$3$F$$20240903$20220914$20240911$EXP$$GB-AUROBINDO-AUR-APL-2022-034777$AUROBINDO$$$$$M$Y$$$20240911$$MD$GB$GB
213318822$21331882$2$F$20220722$20240703$20220914$20240711$EXP$IT-MINISAL02-882841$IT-TEVA-2022-IT-2071148$TEVA$$12$YR$$F$Y$44$KG$20240711$$PH$IT$IT
213321598$21332159$8$F$20220908$20240726$20220914$20240802$EXP$$NVSC2022US206295$NOVARTIS$$39$YR$$M$Y$92.971$KG$20240802$$CN$US$US
213324014$21332401$4$F$20220709$20240829$20220914$20240902$EXP$$DE-TAKEDA-2022TUS063585$TAKEDA$$$$$M$Y$$$20240902$$CN$DE$DE
213328252$21332825$2$F$$20240826$20220914$20240829$PER$$US-PFIZER INC-PV202200062234$PFIZER$$44$YR$$F$Y$$$20240829$$CN$US$US
2133287314$21332873$14$F$20220101$20240820$20220914$20240823$EXP$$CA-PFIZER INC-202201091316$PFIZER$$54$YR$$F$Y$103$KG$20240823$$HP$CA$CA
213330677$21333067$7$F$$20240920$20220914$20240924$PER$$US-PFIZER INC-PV202200062969$PFIZER$$69$YR$$F$Y$49.44$KG$20240924$$CN$US$US
2133326827$21333268$27$F$20200901$20240403$20220914$20240808$EXP$$NVSC2022GT205839$NOVARTIS$$49$YR$$F$Y$$$20240808$$CN$GT$GT
213334763$21333476$3$F$20220120$20240914$20220914$20240918$EXP$$IT-ROCHE-3177794$ROCHE$$52$YR$A$F$Y$$$20240918$$MD$IT$IT
213338933$21333893$3$F$$20240821$20220914$20240823$PER$$US-PFIZER INC-2020387359$PFIZER$$76$YR$$F$Y$58.06$KG$20240823$$CN$US$US
213339685$21333968$5$F$$20240702$20220914$20240708$PER$$US-PFIZER INC-PV202200063151$PFIZER$$79$YR$$F$Y$67.13$KG$20240708$$CN$US$US
213339738$21333973$8$F$$20240725$20220914$20240731$PER$$US-PFIZER INC-PV202200063169$PFIZER$$75$YR$$M$Y$$$20240731$$CN$US$US
213340684$21334068$4$F$20220901$20240722$20220914$20240726$PER$$US-BIOGEN-2022BI01154931$BIOGEN$$31$YR$$F$Y$$$20240726$$CN$US$US
2133410214$21334102$14$F$20220911$20240918$20220914$20240926$EXP$$NVSC2022US207587$NOVARTIS$$53$YR$$M$Y$$$20240926$$CN$US$US
2133438611$21334386$11$F$20220801$20240822$20220914$20240826$EXP$$CA-TAKEDA-2022TUS047319$TAKEDA$$41$YR$$F$Y$$$20240826$$CN$CA$CA
213344323$21334432$3$F$20240601$20240817$20220914$20240901$PER$$US-SUNOVION-2022SUN002652$LUPIN$$$$$$Y$$$20240901$$CN$US$US
213348623$21334862$3$F$20220801$20240806$20220914$20240809$EXP$$JP-BAUSCH-BL-2022-021427$BAUSCH AND LOMB$Akai N, Yoshida A, Okuzawa M, Hashimoto T, Fujisawa R, Ito K, Sato T. P13-18 A case of giant cell arteritis that developed during Brodalumab therapy for psoriasis arthropathica. The Japanese Journal of Dermatology; The 123rd Annual Meeting of the Japanese De. 2024;134(5):1525.$83$YR$$F$Y$$$20240809$$MD$JP$JP
213350233$21335023$3$F$$20240718$20220914$20240723$EXP$$US-JNJFOC-20220922063$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240723$$LW$US$US
213351722$21335172$2$F$$20240315$20220915$20240914$EXP$$JP-TEVA-2022-JP-2072172$TEVA$Nakayama H, Satou K, Anzai K, Watanabe O, takai S, Sugai Y. Long-term effect of biochemical response to ursodeoxycholic acid and pemafibrate switching from bezafibrate in patients with primary biliary cholangitis due to renal dysfunction. Acta Hepatologica Japonica. 2022;63(8):392-4; Nakayama H, Satou K, Anzai K, Watanabe O, takai S, Sugai Y. Long-term effect of biochemical response to ursodeoxycholic acid and pemafibrate switching from bezafibrate in patients with primary biliary cholangitis...$$$E$M$Y$$$20240914$$HP$JP$JP
213353157$21335315$7$F$20220901$20221109$20220915$20240925$EXP$$US-GSK-US2022AMR131891$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2133531615$21335316$15$F$20220901$20230804$20220915$20240926$EXP$$US-GSK-US2022AMR131715$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
213353502$21335350$2$F$20220901$20240808$20220915$20240812$PER$$NVSC2022US206409$NOVARTIS$$25$YR$$F$Y$$$20240812$$CN$US$US
213358032$21335803$2$F$$20240807$20220915$20240813$EXP$$US-KYOWAKIRIN-2022BKK014380$KYOWA$$$$$$Y$$$20240813$$CN$US$US
2133585512$21335855$12$F$20220829$20230825$20220915$20240903$EXP$$NVSC2022US206467$NOVARTIS$$43$YR$$F$Y$$$20240903$$CN$US$US
213358712$21335871$2$F$$20220822$20220915$20240827$PER$$US-009507513-2208USA008800$MERCK$$$$$F$Y$$$20240827$$CN$US$US
213358924$21335892$4$F$$20240808$20220915$20240821$EXP$$CA-AUROBINDO-AUR-APL-2022-033793$AUROBINDO$unknown. unknown. unknown$55$YR$$M$Y$$$20240821$$MD$CA$CA
2133591914$21335919$14$F$$20240919$20220915$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-096367$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240920$$MD$US$US
213361069$21336106$9$F$$20240815$20220915$20240819$PER$$NVSC2022US207917$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
2133659610$21336596$10$F$20210101$20240626$20220915$20240704$EXP$$CA-CELLTRION INC.-2020CA030515$CELLTRION$$$$$$Y$$$20240704$$MD$CA$CA
213366913$21336691$3$F$20220101$20240823$20220915$20240902$EXP$$CA-TAKEDA-2022TUS047839$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
2133720017$21337200$17$F$20220601$20240626$20220915$20240926$EXP$$US-GSK-US2022AMR092982$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
213372842$21337284$2$F$$20240916$20220915$20240923$EXP$$US-AMGEN-USASP2022155924$AMGEN$Salem P. A.; Jabboury K .W.; Mccallum W. G. et al.. Personalized multimodality therapy with immune checkpoint inhibitors, chemotherapy, and targeted treatment (ICTriplex) in advanced/refractory cancer. Journal of Clinical Oncology. 2022;40 (SUPPL_16):e14590-e14590$$$$$Y$$$20240923$$HP$US$US
2133741118$21337411$18$F$20221013$20240913$20220915$20240923$EXP$$CA-TAKEDA-2022TUS061966$TAKEDA$$57$YR$$F$Y$$$20240923$$CN$CA$CA
213378232$21337823$2$F$20220701$20240730$20220915$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202209005104$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240802$$CN$US$US
213386713$21338671$3$F$20200709$20220905$20220915$20240821$EXP$$CA-AstraZeneca-2021A366998$ASTRAZENECA$$63$YR$$M$Y$$$20240821$$MD$CA$
213391658$21339165$8$F$20220421$20240729$20220915$20240802$EXP$$NVSC2022ZA154191$NOVARTIS$$27$YR$$M$Y$$$20240802$$CN$ZA$ZA
213391713$21339171$3$F$20240729$20240805$20220915$20240806$EXP$$IN-PFIZER INC-PV202200064033$PFIZER$$61$YR$$F$Y$$$20240806$$CN$IN$IN
213393092$21339309$2$F$20190101$20240819$20220915$20240830$PER$$US-SA-2022SA372203$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240830$$MD$US$US
213394364$21339436$4$F$20240501$20240620$20220915$20240701$PER$$US-SA-2022SA374848$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240701$$MD$US$US
213394795$21339479$5$F$20220101$20240731$20220915$20240808$PER$$US-SA-2022SA374558$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240808$$HP$US$US
213395013$21339501$3$F$20220905$20240913$20220915$20240923$PER$$US-SA-2022SA182266$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240923$$MD$US$US
213396042$21339604$2$F$20220901$20240802$20220915$20240812$PER$$US-SA-2022SA377322$SANOFI AVENTIS$$37$YR$A$M$Y$96.6$KG$20240812$$MD$US$US
213397854$21339785$4$F$20240201$20240912$20220915$20240922$PER$$US-SA-2022SA381561$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240922$$MD$US$US
213400307$21340030$7$F$20220831$20240625$20220915$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003058$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240719$$CN$US$US
213400793$21340079$3$F$$20240906$20220915$20240914$EXP$$NL-ROCHE-3179600$ROCHE$Sogbein O, Gamilla-Crudo AKN, Mujtaba MA, Hussain SA. Transplant Graft TMA Injury Post COVID-19 Vaccination.. American Journal of Kidney Diseases. 2022;79(4 SUPPL 2):S31-.$48$YR$A$M$Y$$$20240914$$HP$NL$NL
213406797$21340679$7$F$20220417$20240917$20220916$20240920$EXP$$JP-TAKEDA-2022TJP072862$TAKEDA$$14$YR$$F$Y$36$KG$20240920$$MD$JP$JP
213410043$21341004$3$F$20240101$20240626$20220916$20240705$PER$$US-SA-2022SA383878$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
2134108410$21341084$10$F$20210816$20240724$20220916$20240803$EXP$$ES-AUROBINDO-AUR-APL-2022-036213$AUROBINDO$$70$YR$$M$Y$$$20240803$$MD$ES$ES
2134109730$21341097$30$F$20220101$20240912$20220916$20240921$EXP$$CA-CELLTRION INC.-2022CA014263$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
213411948$21341194$8$F$20220101$20240911$20220916$20240926$PER$$US-SA-2022SA374089$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240926$$MD$US$US
213413142$21341314$2$F$$20240730$20220916$20240805$EXP$$JP-AMGEN-JPNSP2022155888$AMGEN$$$$$$Y$$$20240805$$MD$JP$JP
213413189$21341318$9$F$20220222$20240918$20220916$20240925$EXP$$DE-ROCHE-3056413$ROCHE$$45$YR$A$M$Y$87$KG$20240925$$MD$DE$DE
213414204$21341420$4$F$20160101$20240923$20220916$20240930$EXP$$CA-TAKEDA-2016TUS008019$TAKEDA$$$$$M$Y$$$20240930$$CN$CA$CA
213416924$21341692$4$F$20220909$20240718$20220916$20240807$PER$$CA-TOLMAR, INC.-22CA036564$TOLMAR$$79$YR$$M$Y$$$20240807$$CN$CA$CA
213416934$21341693$4$F$20230310$20240704$20220916$20240725$PER$$CO-TOLMAR, INC.-22CO036512$TOLMAR$$83$YR$$M$Y$$$20240724$$CN$CO$CO
213421937$21342193$7$F$20240815$20240815$20220916$20240828$EXP$$US-TAKEDA-2022TUS064301$TAKEDA$$52$YR$$F$Y$100$KG$20240828$$CN$US$US
213423594$21342359$4$F$20220809$20240729$20220916$20240731$EXP$$ES-CELLTRION INC.-2022ES014426$CELLTRION$$$$$$Y$$$20240731$$MD$ES$ES
213427252$21342725$2$F$20220823$20240806$20220916$20240811$EXP$$US-JNJFOC-20220858221$JOHNSON AND JOHNSON$$19$YR$A$F$Y$$$20240811$$MD$US$US
213429258$21342925$8$F$20220912$20240828$20220916$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-107364$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$62$KG$20240903$$MD$JP$JP
2134309119$21343091$19$F$20221206$20240725$20220916$20240730$PER$$US-PFIZER INC-PV202200065025$PFIZER$$75$YR$$F$Y$46.712$KG$20240730$$CN$US$US
213433823$21343382$3$F$$20221004$20220916$20240712$EXP$$IT-ASTELLAS-2022US032994$ASTELLAS$$44$YR$$F$Y$$$20240712$$MD$IT$IT
213440945$21344094$5$F$20220626$20240909$20220916$20240919$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2022-000478$SK LIFE SCIENCE$$$$$$Y$$$20240919$$CN$US$US
213441646$21344164$6$F$20230114$20240904$20220916$20240918$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2022-000552$SK LIFE SCIENCE$$$$$$Y$$$20240918$$CN$US$US
213450554$21345055$4$F$20220801$20240627$20220916$20240703$EXP$$JP-009507513-2209JPN001297J$MERCK$$8$DEC$$M$Y$$$20240703$$MD$JP$JP
2134564010$21345640$10$F$20220901$20240801$20220916$20240811$EXP$$US-JAZZ-2022-US-029566$JAZZ$$15$YR$$M$Y$$$20240811$$MD$US$US
213457384$21345738$4$F$$20240909$20220916$20240912$EXP$$CA-PFIZER INC-202201156734$PFIZER$$79$YR$$M$Y$$$20240912$$HP$CA$CA
213460942$21346094$2$F$$20240701$20220917$20240710$PER$$US-SA-2022SA383603$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240710$$MD$US$US
2134610531$21346105$31$F$20220101$20240920$20220917$20240930$EXP$$CA-CELLTRION INC.-2022CA007348$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
213461527$21346152$7$F$20220701$20240909$20220917$20240917$EXP$$CA-CELLTRION INC.-2022CA007253$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
213463927$21346392$7$F$20170101$20240826$20220917$20240828$EXP$$US-TAKEDA-US201711465$TAKEDA$$$$$M$Y$$$20240828$$CN$US$US
213464934$21346493$4$F$$20240731$20220917$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-10983$LUPIN$$$$$$Y$$$20240820$$CN$US$US
213471907$21347190$7$F$$20240821$20220919$20240903$EXP$$CA-ROCHE-1895786$ROCHE$$44$YR$A$F$Y$97$KG$20240903$$CN$CA$CA
213473575$21347357$5$F$20181110$20240710$20220919$20240712$EXP$$PHHY2019CA011019$NOVARTIS$$69$YR$$F$Y$69.5$KG$20240712$$MD$CA$CA
213478199$21347819$9$F$20221105$20230228$20220919$20240926$EXP$$US-GSK-US2022AMR133179$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2134783717$21347837$17$F$20220923$20240823$20220919$20240903$EXP$$AU-ROCHE-3177854$ROCHE$$27$YR$A$F$Y$$$20240903$$HP$AU$AU
213479248$21347924$8$F$20220915$20240801$20220919$20240805$PER$$NVSC2022US211016$NOVARTIS$$39$YR$$F$Y$$$20240805$$CN$US$US
213479435$21347943$5$F$20220901$20221108$20220919$20240926$PER$$US-GSK-US2022AMR133338$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240926$$CN$US$US
213479492$21347949$2$F$20210118$20240912$20220919$20240917$EXP$$DE-ROCHE-2893276$ROCHE$$30$YR$A$F$Y$56$KG$20240917$$MD$DE$DE
213479862$21347986$2$F$$20240821$20220919$20240830$EXP$$US-VIIV HEALTHCARE LIMITED-US2022130529$VIIV$$$$$M$Y$$$20240830$$HP$US$US
213479974$21347997$4$F$20180406$20240806$20220919$20240810$EXP$$CA-TAKEDA-2018TUS005308$TAKEDA$$68$YR$$F$Y$$$20240810$$CN$CA$CA
213481444$21348144$4$F$20220831$20240617$20220919$20240702$EXP$$JP-ROCHE-3181375$ROCHE$$73$YR$E$M$Y$46.4$KG$20240702$$MD$JP$JP
213484333$21348433$3$F$20211201$20240909$20220919$20240909$EXP$$ES-ROCHE-3180958$ROCHE$$33$YR$A$F$Y$$$20240910$$MD$ES$ES
213486222$21348622$2$F$$20240823$20220919$20240911$PER$$US-SA-2022SA379633$SANOFI AVENTIS$$$$A$F$Y$$$20240911$$MD$US$US
213486722$21348672$2$F$20210101$20240916$20220919$20240923$EXP$$US-ASTELLAS-2022US032907$ASTELLAS$$78$YR$E$M$Y$78$KG$20240923$$CN$US$US
213487038$21348703$8$F$20220701$20231118$20220919$20240717$EXP$$RO-ASTELLAS-2022US032734$ASTELLAS$$70$YR$$M$Y$$$20240717$$CN$RO$RO
213488592$21348859$2$F$20211203$20220915$20220919$20240923$EXP$FR-AFSSAPS-GR20222016$NVSC2022FR208607$NOVARTIS$$60$YR$$F$Y$55.3$KG$20240923$$MD$FR$FR
2134900619$21349006$19$F$20220905$20240104$20220919$20240926$EXP$$US-GSK-US2022AMR132786$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
213490835$21349083$5$F$$20240823$20220919$20240826$PER$$NVSC2022US210927$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
213491542$21349154$2$F$$20240819$20220919$20240828$EXP$$CA-GSK-CA2022132546$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$CA$CA
213491709$21349170$9$F$20230621$20230809$20220919$20240926$EXP$$US-GSK-US2022AMR088567$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2134923010$21349230$10$F$$20240919$20220919$20240926$EXP$$CA-ROCHE-3181761$ROCHE$$$$A$M$Y$$$20240926$$MD$CA$CA
213493085$21349308$5$F$20190924$20240916$20220919$20240923$EXP$$FR-MYLANLABS-2022M1093838$MYLAN$Rocanieres P, Lamure S, Geny C, Faillie JL, Hillaire-Buys D, Bres V. Parkinson^s disease progression in a patient with multiple myeloma treated with ixazomib. Fundamental and Clinical Pharmacology. 36:146$68$YR$$M$Y$$$20240923$$MD$FR$FR
2134931611$21349316$11$F$20220915$20240701$20220919$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-107259$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240709$$CN$US$US
213494176$21349417$6$F$20220404$20240715$20220919$20240723$EXP$$CA-CELLTRION INC.-2022CA014906$CELLTRION$$$$$$Y$$$20240723$$HP$CA$CA
213496572$21349657$2$F$$20240705$20220919$20240710$EXP$$IT-PFIZER INC-202201118634$PFIZER$Berloffa, S.. Neuroleptic malignant syndrome in children with autism spectrum disorder (Asd) A case report and brief.. Children-Basel.. 2021;8(12):0001-7$16$YR$$M$Y$$$20240710$$HP$IT$IT
213498522$21349852$2$F$20210201$20240808$20220919$20240809$EXP$FR-AFSSAPS-ST20222059$NVSC2022FR208742$NOVARTIS$$83$YR$$M$Y$$$20240809$$MD$FR$FR
2134988912$21349889$12$F$20220101$20240807$20220919$20240814$EXP$$CA-OTSUKA-2022_044543$OTSUKA$$$$$M$Y$$$20240814$$HP$CA$CA
213499466$21349946$6$F$20220101$20240910$20220919$20240912$EXP$$US-PFIZER INC-PV202200065215$PFIZER$$42$YR$$F$Y$$$20240912$$HP$US$US
213500482$21350048$2$F$20240307$20240911$20220919$20240919$EXP$$GB-ROCHE-3179832$ROCHE$$55$YR$A$F$Y$$$20240919$$HP$GB$GB
2135016910$21350169$10$F$$20240909$20220919$20240912$EXP$$US-TAKEDA-2022TUS065377$TAKEDA$$$$$F$Y$60$KG$20240912$$CN$US$US
213504264$21350426$4$F$$20240710$20220919$20240714$PER$$NVSC2022US211415$NOVARTIS$$$$$F$Y$$$20240714$$CN$US$US
213507022$21350702$2$F$$20220914$20220919$20240824$EXP$$US-TAKEDA-2022TUS065420$TAKEDA$$$$$M$Y$$$20240824$$HP$US$US
2135077211$21350772$11$F$20220801$20240509$20220919$20240813$EXP$$NVSC2022BR178516$NOVARTIS$$55$YR$$F$Y$51$KG$20240813$$CN$BR$BR
213512029$21351202$9$F$20190101$20240806$20220919$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-191810$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$$$20240813$$CN$US$US
213514103$21351410$3$F$20220909$20240829$20220919$20240911$PER$$US-SA-2022SA379026$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240911$$HP$US$US
213515718$21351571$8$F$20230804$20240729$20220919$20240802$EXP$$US-JAZZ-2022-US-010041$JAZZ$$49$YR$$F$Y$59.42$KG$20240802$$MD$US$US
213518282$21351828$2$F$20191109$20240717$20220919$20240729$EXP$$CA-AMGEN-CANCT2019203815$AMGEN$$42$YR$A$F$Y$$$20240729$$CN$CA$CA
213519574$21351957$4$F$20220913$20240626$20220920$20240709$EXP$$CA-ROCHE-3180691$ROCHE$$48$YR$A$F$Y$$$20240709$$CN$CA$CA
2135235214$21352352$14$F$20240101$20240905$20220920$20240909$EXP$$NVSC2020CO323350$NOVARTIS$$$$$F$Y$45$KG$20240909$$CN$CO$CO
213533118$21353311$8$F$20191223$20240726$20220920$20240802$EXP$$CA-ROCHE-2483634$ROCHE$$46$YR$A$M$Y$80$KG$20240802$$HP$CA$CA
213533484$21353348$4$F$$20240320$20220920$20240925$EXP$$US-GSK-US2022AMR133186$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
213535339$21353533$9$F$20220101$20240816$20220920$20240822$EXP$$US-SA-2022SA387483$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240822$$MD$US$US
213537504$21353750$4$F$20050101$20221019$20220920$20240716$EXP$$DE-ASTELLAS-2022US033327$ASTELLAS$$72$YR$$F$Y$$$20240716$$MD$DE$DE
213537592$21353759$2$F$$20220915$20220920$20240711$EXP$$IT-ASTELLAS-2022US033114$ASTELLAS$$54$YR$$M$Y$$$20240711$$MD$IT$IT
213538152$21353815$2$F$$20240819$20220920$20240821$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000420$PAREXEL$$$$$$Y$$$20240821$$CN$US$US
213538606$21353860$6$F$20220801$20221214$20220920$20240926$PER$$US-GSK-US2022AMR131835$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240926$$CN$US$US
213539434$21353943$4$F$20230522$20230531$20220920$20240925$EXP$$US-GSK-US2022AMR133324$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
213539445$21353944$5$F$20220831$20221213$20220920$20240926$PER$$US-GSK-US2022AMR133701$GLAXOSMITHKLINE$$63$YR$$F$Y$53.515$KG$20240926$$MD$US$US
2135396310$21353963$10$F$20220921$20240905$20220920$20240912$EXP$$CA-TAKEDA-2022TUS065766$TAKEDA$$41$YR$$F$Y$$$20240912$$CN$CA$CA
213542013$21354201$3$F$20181201$20240722$20220920$20240730$EXP$$NVSC2022BG209975$NOVARTIS$$65$YR$$M$Y$$$20240730$$MD$BG$BG
213542722$21354272$2$F$$20240801$20220920$20240805$EXP$$US-TAKEDA-2022TUS065463$TAKEDA$$$$$M$Y$$$20240805$$CN$US$US
213545824$21354582$4$F$$20240812$20220920$20240814$PER$$US-PFIZER INC-202101559615$PFIZER$$75$YR$$F$Y$$$20240814$$CN$US$US
213547452$21354745$2$F$20210101$20240911$20220920$20240918$EXP$$US-GSK-US2022AMR133018$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$US$US
213549493$21354949$3$F$$20240717$20220920$20240725$PER$$NVSC2022US211460$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
213549537$21354953$7$F$20220901$20240816$20220920$20240823$EXP$$US-GSK-US2022133793$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$US$US
213551172$21355117$2$F$$20240711$20220920$20240715$EXP$$CA-BAUSCH-BL-2022-021997$BAUSCH AND LOMB$$$$$$Y$$$20240715$$MD$CA$CA
213551379$21355137$9$F$20220520$20240802$20220920$20240809$EXP$$AT-BIOGEN-2022BI01151074$BIOGEN$$52$YR$$M$Y$78$KG$20240809$$MD$AT$AT
213551682$21355168$2$F$20190101$20240704$20220920$20240710$EXP$$CA-GSK-CA2018GSK220867$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$CA$CA
213552395$21355239$5$F$20220828$20240830$20220920$20240911$EXP$$JP-ROCHE-3180864$ROCHE$Nonaka T, Kamiya N, Ishikawa H, Hirayama Y, Teruya Y, Yanai M. A Case of Combined Small Cell Lung Cancer in Which Haemophagocytic Syndrome and Autoimmune Thrombocytopenia Developed after Atezolizumab Administration.. The 61st Annual Meeting of the Chugoku/Shikoku Branch of the Japan Lung Cancers.. 2023;98.$79$YR$E$M$Y$60$KG$20240911$$MD$JP$JP
213554379$21355437$9$F$20220830$20240918$20220920$20240924$EXP$$CA-PFIZER INC-202200925382$PFIZER$$19$YR$$F$Y$84$KG$20240924$$MD$CA$CA
213559622$21355962$2$F$$20221122$20220920$20240827$PER$$US-ABBVIE-4127929$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
213560602$21356060$2$F$$20240912$20220920$20240916$PER$$US-PFIZER INC-PV202200066722$PFIZER$$53$YR$$F$Y$$$20240916$$HP$US$US
2135638817$21356388$17$F$20100803$20240910$20220920$20240919$EXP$$CA-JNJFOC-20211120858$JOHNSON AND JOHNSON$$53$YR$A$M$Y$79$KG$20240919$$HP$CA$CA
213567073$21356707$3$F$20220501$20240813$20220920$20240821$EXP$$FR-AstraZeneca-2022A313979$ASTRAZENECA$$77$YR$$F$Y$$$20240821$$MD$FR$
213568385$21356838$5$F$$20240718$20220920$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2022-108051$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$63$KG$20240730$$MD$CA$CA
213569155$21356915$5$F$20151201$20240710$20220920$20240718$EXP$$IT-CELLTRION INC.-2022IT014989$CELLTRION$Zattarin E, Nichetti F, Ligorio F, Mazzeo L, Lobefaro R, Fuca G, et al.. Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin. Frontiers in Oncology. 2022;12:925551:01-09$$$$$Y$$$20240718$$HP$IT$IT
213569942$21356994$2$F$20220401$20240926$20220921$20240930$EXP$$IT-ROCHE-3181800$ROCHE$$38$YR$A$M$Y$90$KG$20240929$$MD$IT$IT
213571845$21357184$5$F$20200112$20240816$20220921$20240826$EXP$$CA-CELLTRION INC.-2022CA015180$CELLTRION$$$$$$Y$$$20240826$$CN$CA$CA
213573425$21357342$5$F$20220925$20230227$20220921$20240925$PER$$US-GSK-US2022AMR131934$GLAXOSMITHKLINE$$48$YR$$F$Y$$$20240925$$CN$US$US
213573843$21357384$3$F$20210201$20240806$20220921$20240820$EXP$$FR-AUROBINDO-AUR-APL-2022-037587$AUROBINDO$$83$YR$$M$Y$$$20240820$$MD$FR$FR
213574082$21357408$2$F$$20240923$20220921$20240927$EXP$$DE-AUROBINDO-AUR-APL-2022-037231$AUROBINDO$$60$YR$$F$Y$67$KG$20240927$$PH$DE$DE
213577442$21357744$2$F$20220401$20240714$20220921$20240716$EXP$$IL-TAKEDA-IL202025637$TAKEDA$$38$YR$$F$Y$$$20240716$$MD$IL$IL
2135783311$21357833$11$F$20220909$20240808$20220921$20240816$EXP$$CA-ROCHE-3181874$ROCHE$$22$YR$A$F$Y$$$20240816$$MD$CA$CA
2135785311$21357853$11$F$20240715$20240715$20220921$20240722$EXP$$CA-GSK-CA2022AMR134303$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$HP$CA$CA
213582347$21358234$7$F$20220407$20240721$20220921$20240724$EXP$$FR-TAKEDA-2022TUS065751$TAKEDA$$27$YR$$M$Y$$$20240724$$HP$FR$FR
213584602$21358460$2$F$20201115$20240724$20220921$20240731$EXP$$DE-AMGEN-DEUSP2022160901$AMGEN$$81$YR$E$M$Y$70$KG$20240731$$PH$DE$DE
213592183$21359218$3$F$20220201$20240213$20220921$20240717$EXP$CH-SM-2022-15785$NVSC2022CH110211$NOVARTIS$Schaeffer S, Lutz C, Dobbie M, Terracciano LM, Matter M, Vosbeck J, et al.. Ribociclib-induced liver injury: a case report. FRONT-ONCOL. 2023;13 (1256783)$41$YR$$F$Y$$$20240717$$HP$CH$CH
213603088$21360308$8$F$20220915$20240918$20220921$20240923$EXP$$US-TAKEDA-2022TUS065848$TAKEDA$$8$YR$$M$Y$$$20240923$$CN$US$US
2136035017$21360350$17$F$20221108$20240920$20220921$20240927$EXP$$CA-GSK-CA2022AMR133664$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$HP$CA$CA
2136051919$21360519$19$F$20230101$20240823$20220921$20240828$PER$$US-PFIZER INC-PV202200067217$PFIZER$$78$YR$$F$Y$$$20240828$$CN$US$US
2136065913$21360659$13$F$20230326$20240815$20220921$20240821$EXP$$CA-TAKEDA-2022TUS066058$TAKEDA$$46$YR$$M$Y$$$20240821$$CN$CA$CA
2136112411$21361124$11$F$20220408$20240710$20220921$20240716$EXP$$CA-MYLANLABS-2022M1043729$BIOCON$$$$$$Y$$$20240716$$CN$CA$CA
2136120814$21361208$14$F$20220613$20240822$20220921$20240828$EXP$$US-TAKEDA-2022TUS059155$TAKEDA$$47$YR$$F$Y$77$KG$20240828$$HP$US$US
213618884$21361888$4$F$$20240801$20220922$20240814$EXP$$CA-AUROBINDO-AUR-APL-2022-037540$AUROBINDO$Harris M, Larsen G, Montaner J. Exacerbation of depression associated with starting raltegravir: A report of four cases. AIDS. 2008;22(14):1890-1892$44$YR$$M$Y$$$20240814$$MD$CA$CA
213619778$21361977$8$F$20220907$20230316$20220922$20240926$PER$$US-GSK-US2022AMR133207$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240926$$CN$US$US
213625912$21362591$2$F$20220821$20240705$20220922$20240715$EXP$DK-DKMA-WBS-1001089$DK-TEVA-2022-DK-2074808$TEVA$$81$YR$$M$Y$$$20240715$$MD$DK$DK
2136276913$21362769$13$F$20211201$20240704$20220922$20240710$EXP$$NVSC2022CO143835$NOVARTIS$$38$YR$$F$Y$68$KG$20240711$$CN$CO$CO
213629182$21362918$2$F$$20220920$20220922$20240711$EXP$$GR-ASTELLAS-2022US033703$ASTELLAS$$77$YR$$M$Y$$$20240711$$CN$GR$GR
2136325718$21363257$18$F$20221226$20240806$20220922$20240808$EXP$$DE-ROCHE-3179258$ROCHE$$61$YR$A$M$Y$$$20240808$$MD$DE$DE
213633755$21363375$5$F$20220101$20240909$20220922$20240913$EXP$$US-ABBVIE-22K-163-4372312-00$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
213634633$21363463$3$F$$20240812$20220922$20240820$EXP$$US-TAKEDA-2022TUS029766$TAKEDA$$$$$F$Y$$$20240820$$CN$US$US
2136361113$21363611$13$F$20230311$20240731$20220922$20240808$EXP$$US-GSK-US2022AMR133163$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
213636183$21363618$3$F$$20240823$20220922$20240828$EXP$$IN-ROCHE-3181012$ROCHE$Reddy S, Tyagi M, Behera S and Pappuru R Cytomegalovirus retinitis in a patient of granulomatosis with polyangiitis on long-term immunosuppressants. DOI: 10.1136/bcr-2020-236632. BMJ Case Reports 2021 Feb 04;14 (2):1-3.$69$YR$E$M$Y$$$20240828$$HP$IN$IN
213638369$21363836$9$F$20220101$20240729$20220922$20240813$EXP$$US-INSMED, INC.-2022-02576-US$INSMED$$$$$$Y$$$20240813$$HP$US$US
213640595$21364059$5$F$20220912$20240917$20220922$20240920$EXP$$JP-TAKEDA-2022TJP073850$TAKEDA$$45$YR$$M$Y$47.3$KG$20240920$$MD$JP$JP
213640642$21364064$2$F$$20240628$20220922$20240703$30DAY$$US-GSK-US2022AMR131331$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$MD$US$US
213641016$21364101$6$F$20191230$20240815$20220922$20240821$EXP$$IN-PFIZER INC-2020344927$PFIZER$$56$YR$$F$Y$59.3$KG$20240821$$CN$IN$IN
213642857$21364285$7$F$20220101$20240912$20220922$20240916$EXP$$US-PFIZER INC-202201177365$PFIZER$$42$YR$$F$Y$$$20240916$$HP$US$US
213643182$21364318$2$F$20220401$20220915$20220922$20240926$EXP$$US-GSK-US2022AMR070642$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
213643235$21364323$5$F$20220607$20240628$20220922$20240722$EXP$$DE-ROCHE-3183851$ROCHE$$36$YR$A$F$Y$61$KG$20240722$$MD$DE$DE
2136438411$21364384$11$F$20220213$20240705$20220922$20240708$EXP$$JP-ASTELLAS-2022JP002896$ASTELLAS$$72$YR$$M$Y$$$20240708$$PH$JP$JP
213644994$21364499$4$F$20211114$20230723$20220922$20240726$EXP$$US-JNJFOC-20220937375$JOHNSON AND JOHNSON$$42$YR$A$F$Y$85$KG$20240726$$HP$US$US
2136462712$21364627$12$F$20211101$20240918$20220922$20240923$EXP$$AU-TAKEDA-2022TUS066420$TAKEDA$$84$YR$$F$Y$$$20240923$$HP$AU$AU
213647996$21364799$6$F$20211127$20240905$20220922$20240910$EXP$$NVSC2021GB253490$NOVARTIS$$41$YR$$F$Y$$$20240910$$CN$GB$GB
213650512$21365051$2$F$20220304$20220504$20220922$20240709$EXP$$DE-ASTELLAS-2022US013604$ASTELLAS$$66$YR$$M$Y$$$20240709$$CN$DE$DE
213651852$21365185$2$F$20220914$20240919$20220922$20240926$EXP$$CA-GSK-CA2022133757$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CA$CA
2136535415$21365354$15$F$20220101$20240814$20220922$20240819$PER$$US-PFIZER INC-PV202200068451$PFIZER$$59$YR$$F$Y$$$20240819$$HP$US$US
2136563412$21365634$12$F$20220311$20240709$20220922$20240715$EXP$$CO-TAKEDA-2022TUS017944$TAKEDA$$38$YR$$F$Y$46$KG$20240715$$CN$CO$CO
2136566812$21365668$12$F$20240909$20240911$20220922$20240916$EXP$$US-JAZZ-2022-US-009069$JAZZ$$62$YR$$F$Y$$$20240916$$MD$US$US
213658335$21365833$5$F$20220906$20240719$20220922$20240725$EXP$$AU-SA-2022SA388807$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240725$$MD$AU$AU
2136613210$21366132$10$F$20220916$20240917$20220922$20240923$EXP$$US-JAZZ-2022-US-016495$JAZZ$$43$YR$$F$Y$$$20240923$$CN$US$US
213664418$21366441$8$F$20220101$20240826$20220922$20240827$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-193680$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240827$$CN$CA$CA
213665537$21366553$7$F$20220901$20221208$20220923$20240926$PER$$US-GSK-US2022AMR135052$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240926$$CN$US$US
213666178$21366617$8$F$20220907$20240719$20220923$20240730$EXP$$JP-ROCHE-3180444$ROCHE$Yamakawa T K. Pj-058-2 Study on neuromyelitis optica spectrum disorder accompanied by severe complication during administration of satralizumab.. The 65th Annual Meeting of the Japanese Society of Neurology / The 19th Asian Oceanian Congress of Neurology (AOCN 2024).. 2024;487.$41$YR$A$M$Y$64.3$KG$20240730$$MD$JP$JP
213666524$21366652$4$F$20220913$20240717$20220923$20240813$PER$$CA-TOLMAR, INC.-22CA036595$TOLMAR$$76$YR$$M$Y$$$20240813$$CN$CA$CA
213667642$21366764$2$F$20220101$20240904$20220923$20240917$PER$$US-SA-2022SA385137$SANOFI AVENTIS$$63$YR$A$M$Y$65.7$KG$20240918$$MD$US$US
213667663$21366766$3$F$$20240626$20220923$20240708$PER$$US-SA-2022SA387091$SANOFI AVENTIS$$44$YR$A$M$Y$86.6$KG$20240708$$MD$US$US
213668332$21366833$2$F$$20240829$20220923$20240924$PER$$US-SA-2022SA388214$SANOFI AVENTIS$$32$YR$A$M$Y$90.7$KG$20240924$$MD$US$US
213668352$21366835$2$F$$20240709$20220923$20240717$PER$$US-SA-2022SA382072$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
213670102$21367010$2$F$20220801$20240908$20220923$20240916$PER$$US-SA-2022SA386326$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240916$$HP$US$US
213670153$21367015$3$F$20220902$20240705$20220923$20240715$PER$$US-SA-2022SA384820$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240715$$MD$US$US
213670313$21367031$3$F$$20240830$20220923$20240905$EXP$$CA-ROCHE-3184406$ROCHE$$$$A$M$Y$$$20240905$$CN$CA$CA
213670453$21367045$3$F$$20240828$20220923$20240904$PER$$US-SA-2022SA385213$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240904$$MD$US$US
213670605$21367060$5$F$20220901$20231227$20220923$20240925$PER$$US-GSK-US2022AMR133696$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
213671365$21367136$5$F$20220101$20240918$20220923$20240923$EXP$$US-SA-2022SA389782$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240923$$MD$US$US
213672132$21367213$2$F$20220425$20240819$20220923$20240912$PER$$US-SA-2022SA389132$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240912$$MD$US$US
213672862$21367286$2$F$$20240827$20220923$20240902$PER$$US-SA-2022SA388174$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240902$$CN$US$US
2136762512$21367625$12$F$$20240216$20220923$20240926$EXP$$US-GSK-US2022AMR134883$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
213678133$21367813$3$F$20180904$20240827$20220923$20240830$EXP$$PHHY2018CA094482$NOVARTIS$$47$YR$$F$Y$$$20240830$$MD$CA$CA
213680152$21368015$2$F$$20240826$20220923$20240923$PER$$US-SA-2022SA390164$SANOFI AVENTIS$$$$A$M$Y$80.45$KG$20240923$$MD$US$US
213684053$21368405$3$F$$20240801$20220923$20240814$EXP$$CA-AUROBINDO-AUR-APL-2022-037541$AUROBINDO$$53$YR$$F$Y$53$KG$20240814$$HP$CA$CA
213686377$21368637$7$F$20201129$20240916$20220923$20240918$EXP$$IL-ABBVIE-4128685$ABBVIE$$82$YR$$M$Y$$$20240918$$MD$IL$IL
213687204$21368720$4$F$$20240910$20220923$20240917$PER$$US-ROCHE-3180406$ROCHE$$$$A$M$Y$$$20240917$$CN$US$US
2136896621$21368966$21$F$20211101$20240719$20220923$20240727$EXP$$CA-CELLTRION INC.-2021CA018152$CELLTRION$$$$$$Y$$$20240727$$HP$CA$CA
213690135$21369013$5$F$20220818$20240916$20220923$20240919$EXP$$CA-BIOGEN-2022BI01150081$BIOGEN$$36$YR$$F$Y$$$20240919$$HP$CA$CA
213693742$21369374$2$F$$20240814$20220923$20240818$PER$$NVSC2022US214955$NOVARTIS$$$$$F$Y$$$20240818$$CN$US$US
213699137$21369913$7$F$20220821$20240917$20220923$20240925$EXP$$US-GSK-US2022134444$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
2137037911$21370379$11$F$20240206$20240920$20220923$20240927$EXP$$US-TAKEDA-US202023476$TAKEDA$$69$YR$$F$Y$$$20240927$$HP$US$US
213712583$21371258$3$F$20240101$20240926$20220923$20240930$EXP$$CA-PFIZER INC-202201182182$PFIZER$$44$YR$$F$Y$$$20240930$$HP$CA$CA
213713592$21371359$2$F$$20240731$20220923$20240806$PER$$US-BIOGEN-2022BI01156135$BIOGEN$$$$$M$Y$$$20240806$$MD$US$US
213716404$21371640$4$F$$20240724$20220923$20240801$PER$$US-SA-2022SA393703$SANOFI AVENTIS$$6$YR$C$M$Y$40.816$KG$20240801$$MD$US$US
213716654$21371665$4$F$20190827$20240827$20220923$20240830$EXP$$US-SHIRE-US202025522$TAKEDA$$1$YR$$F$Y$$$20240830$$CN$US$US
213717394$21371739$4$F$$20240711$20220923$20240716$EXP$$US-JAZZ-2022-US-030409$JAZZ$$$$$F$Y$$$20240716$$HP$US$US
2137215013$21372150$13$F$20220505$20240701$20220923$20240710$EXP$$CN-GILEAD-2022-0593259$GILEAD$$48$YR$A$F$Y$$$20240710$$MD$CN$CN
213726583$21372658$3$F$20220919$20240813$20220924$20240826$PER$$US-SA-2022SA393823$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240826$$MD$US$US
213727854$21372785$4$F$20211006$20240916$20220924$20240920$EXP$$NVSC2022EG216410$NOVARTIS$$55$YR$$M$Y$74$KG$20240920$$CN$EG$EG
213729466$21372946$6$F$20220801$20240716$20220924$20240723$EXP$$NVSC2022MX215088$NOVARTIS$$65$YR$$M$Y$61$KG$20240723$$CN$MX$MX
213729702$21372970$2$F$20220101$20240702$20220924$20240707$EXP$$US-ABBVIE-22K-163-4514546-00$ABBVIE$$$$$M$Y$$$20240707$$CN$US$US
213730872$21373087$2$F$$20240813$20220924$20240821$PER$$US-ABBVIE-4129766$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
2137356719$21373567$19$F$20210928$20240812$20220925$20240820$EXP$$CA-CELLTRION INC.-2021CA016841$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
213736692$21373669$2$F$20220101$20240827$20220926$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-002176$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$CN$US$US
213737334$21373733$4$F$20220101$20240904$20220926$20240907$EXP$$NVSC2021CA003047$NOVARTIS$$72$YR$$F$Y$$$20240907$$MD$CA$CA
213737737$21373773$7$F$20220901$20230131$20220926$20240925$EXP$$US-GSK-US2022AMR136231$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
213737749$21373774$9$F$20220901$20230310$20220926$20240925$PER$$US-GSK-US2022AMR134341$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
213738582$21373858$2$F$$20240716$20220926$20240726$EXP$$NL-AUROBINDO-AUR-APL-2022-038884$AUROBINDO$Schutte T, Tellingen AV, van den Broek  J, Brink  MT, van Agtmael-Boerrigter MG.. Topiramate intoxications + hemodialysis - Literature review and the first case report of a massive suicidal intoxication treated with hemodialysis.. Toxicology Reports.. 2022;9:1639-1646.$41$YR$$F$Y$65$KG$20240726$$MD$NL$NL
2137426124$21374261$24$F$20220101$20240830$20220926$20240909$EXP$$CA-CELLTRION INC.-2022CA013812$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
213742664$21374266$4$F$20240620$20240703$20220926$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202209010702$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240708$$CN$US$US
213744898$21374489$8$F$20230104$20240715$20220926$20240805$PER$$CA-TOLMAR, INC.-22CA036663$TOLMAR$$82$YR$$M$Y$$$20240802$$CN$CA$CA
213745704$21374570$4$F$20210531$20240805$20220926$20240816$EXP$$JP-NOVOPROD-819651$NOVO NORDISK$Yuya Ito, et.al.. Successful perinatal management of a woman with congenital factor XIII deficiency using recombinant factor XIII :A case report and literature review. Journal of Obstetrics and Gynaecology Research. 2024;50:262-265$4$DEC$$F$Y$59.8$KG$20240816$$MD$JP$JP
213747112$21374711$2$F$$20240712$20220926$20240723$EXP$$CA-AUROBINDO-AUR-APL-2022-038380$AUROBINDO$Olteanu C, Shear NH, Burnett M, Hashimoto R, Jeschke MG, Dodiuk-gad RP et al. Retrospective Study of Patients With SJS/TEN Treated at a Tertiary Burn Unit in Canada: Overview of 17 Years of Treatment. Journal of Cutaneous Medicine and Surgery. 2021;25(3):271-280.$69$YR$$F$Y$$$20240723$$HP$CA$CA
213750632$21375063$2$F$$20240712$20220926$20240726$EXP$$CA-AUROBINDO-AUR-APL-2022-038375$AUROBINDO$Olteanu C, Shear NH, Burnett M, Hashimoto R, Jeschke MG et al... Retrospective Study of Patients With SJS/TEN Treated at a Tertiary Burn Unit in Canada. Journal of Cutaneous Medicine and Surgery. 2021;25(3):271-280$72$YR$$M$Y$$$20240726$$HP$CA$CA
213751422$21375142$2$F$$20240712$20220926$20240723$EXP$$CA-AUROBINDO-AUR-APL-2022-038484$AUROBINDO$Olteanu C, Shear NH, Burnett M, Hashimoto R, Jeschke MG, Dodiuk-gad RP et al. Retrospective Study of Patients With SJS/TEN Treated at a Tertiary Burn Unit in Canada: Overview of 17 Years of Treatment. Journal of Cutaneous Medicine and Surgery. 2021;25(3):271-280$72$YR$$M$Y$$$20240723$$HP$CA$CA
2137525612$21375256$12$F$20210801$20240716$20220926$20240718$EXP$$JP-TAKEDA-2022TJP073997$TAKEDA$$33$YR$$F$Y$49.9$KG$20240718$$PH$JP$JP
2137537310$21375373$10$F$20220525$20240429$20220926$20240806$EXP$$CZ-UCBSA-2022056285$UCB$$$$A$M$Y$$$20240806$$MD$CZ$CZ
2137539315$21375393$15$F$20210101$20240627$20220926$20240705$EXP$$CA-CELLTRION INC.-2021CA019060$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
213754625$21375462$5$F$20220101$20240730$20220926$20240805$EXP$$US-BIOGEN-2022BI01156526$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
213756254$21375625$4$F$20220626$20240729$20220926$20240807$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202207000200$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240807$$CN$JP$JP
213758046$21375804$6$F$20191201$20240822$20220926$20240827$EXP$$US-TAKEDA-US202010262$TAKEDA$$52$YR$$M$Y$$$20240827$$HP$US$US
213758582$21375858$2$F$20220801$20220913$20220926$20240827$PER$$US-ABBVIE-4128932$ABBVIE$$43$YR$$F$Y$$$20240827$$CN$US$US
213761652$21376165$2$F$20220916$20220922$20220926$20240925$EXP$$US-GSK-US2022AMR137041$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
213769463$21376946$3$F$19900101$20240903$20220926$20240905$EXP$$ZA-PFIZER INC-PV202200067836$PFIZER$$77$YR$$F$Y$81$KG$20240905$$MD$ZA$ZA
213774062$21377406$2$F$$20240704$20220926$20240710$EXP$$DE-PFIZER INC-202201185645$PFIZER$$81$YR$$M$Y$70$KG$20240710$$PH$DE$DE
213775626$21377562$6$F$20211020$20240719$20220926$20240725$EXP$$CA-TAKEDA-2019TUS050030$TAKEDA$$54$YR$$F$Y$$$20240725$$HP$CA$CA
213778516$21377851$6$F$$20240925$20220926$20240930$EXP$$US-TAKEDA-2022TUS065696$TAKEDA$$$$$F$Y$72.12$KG$20240930$$CN$US$US
213780708$21378070$8$F$20220511$20240626$20220926$20240704$EXP$$CA-CELLTRION INC.-2022CA006107$CELLTRION$$$$$$Y$$$20240704$$MD$CA$CA
213780784$21378078$4$F$$20240819$20220926$20240821$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000428$PAREXEL$$$$$$Y$$$20240821$$HP$US$US
213780852$21378085$2$F$$20240717$20220926$20240719$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000429$PAREXEL$$$$$$Y$$$20240719$$CN$US$US
2137814415$21378144$15$F$20151014$20240913$20220926$20240918$EXP$$US-TAKEDA-2022TUS051533$TAKEDA$$61$YR$$M$Y$77$KG$20240918$$HP$US$US
213783202$21378320$2$F$$20240712$20220927$20240723$EXP$$CA-AUROBINDO-AUR-APL-2022-038254$AUROBINDO$Olteanu C, Shear NH, Burnett M, Hashimoto R, Jeschke MG, Dodiuk-gad RP et al. Retrospective Study of Patients With SJS/TEN 2 Treated at a Tertiary Burn Unit in Canada: Overview of 17 Years of Treatment.. Journal of Cutaneous Medicine and Surgery. 2021;25(3):271-280$69$YR$$F$Y$$$20240723$$HP$CA$CA
213784652$21378465$2$F$$20240716$20220927$20240726$EXP$$GB-AUROBINDO-AUR-APL-2022-037757$AUROBINDO$$$$$M$Y$$$20240726$$PH$GB$GB
213785695$21378569$5$F$20220816$20240704$20220927$20240712$EXP$$DE-CELLTRION INC.-2022DE015056$CELLTRION$$$$$$Y$$$20240712$$MD$DE$DE
213788555$21378855$5$F$20220916$20240726$20220927$20240813$PER$$CA-TOLMAR, INC.-22CA036692$TOLMAR$$69$YR$$M$Y$$$20240813$$CN$CA$CA
213791082$21379108$2$F$20200613$20240919$20220927$20240925$EXP$$NVSC2022BR020693$NOVARTIS$$60$YR$$M$Y$$$20240925$$CN$BR$BR
213792024$21379202$4$F$20201115$20240815$20220927$20240815$EXP$DE-ADRED-07540-02$DE-PFIZER INC-202201167771$PFIZER$$81$YR$$M$Y$70$KG$20240815$$PH$DE$DE
213793316$21379331$6$F$20220403$20240910$20220927$20240923$EXP$$US-BIOCODEX2-2022000415$BIOCODEX$$$$$F$Y$7.8$KG$20240919$$CN$US$US
213794394$21379439$4$F$20210629$20240828$20220927$20240909$EXP$$DE-AUROBINDO-AUR-APL-2022-037799$AUROBINDO$$78$YR$$M$Y$$$20240909$$PH$DE$DE
213800235$21380023$5$F$20220101$20221027$20220927$20240709$EXP$$BR-ASTELLAS-2022US032802$ASTELLAS$$77$YR$$F$Y$$$20240709$$CN$BR$BR
213803572$21380357$2$F$$20240717$20220927$20240718$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000430$PAREXEL$$$$$$Y$$$20240718$$CN$US$US
213804084$21380408$4$F$$20240729$20220927$20240801$EXP$$CA-APOTEX-2022AP013250$APOTEX$$62$YR$$F$Y$72$KG$20240801$$HP$CA$CA
213805363$21380536$3$F$$20240923$20220927$20240930$EXP$$FR-AMGEN-FRASP2022162294$AMGEN$Touzeau; C.. Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma. Blood. 2023$$$$$Y$$$20240930$$HP$FR$FR
213805518$21380551$8$F$$20240717$20220927$20240718$30DAY$$US-PFIZER INC-PV202200056750$PFIZER$$43$YR$$F$Y$$$20240718$$CN$US$US
213807322$21380732$2$F$20210629$20240903$20220927$20240913$EXP$$DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-22-58884$HIKMA$$78$YR$$M$Y$$$20240913$$PH$DE$DE
2138083010$21380830$10$F$$20240715$20220927$20240722$EXP$$CA-BAUSCH-BL-2022-022212$BAUSCH AND LOMB$$62$YR$$F$Y$72$KG$20240719$$CN$CA$CA
213810412$21381041$2$F$$20240919$20220927$20240924$EXP$$CA-JNJFOC-20220939826$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$HP$CA$CA
213811305$21381130$5$F$20190101$20240905$20220927$20240911$EXP$$US-ABBVIE-22K-163-4518673-00$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
213812325$21381232$5$F$20221129$20240628$20220927$20240704$EXP$$CA-JNJFOC-20220903538$JOHNSON AND JOHNSON$$1$DEC$$M$Y$29.2$KG$20240704$$HP$CA$CA
213813452$21381345$2$F$20220831$20240905$20220927$20240909$EXP$$CA-PFIZER INC-202201179734$PFIZER$$68$YR$$F$Y$$$20240909$$MD$CA$CA
2138159822$21381598$22$F$20220623$20240909$20220927$20240911$EXP$$FR-GILEAD-2022-0586805$GILEAD$$$$E$F$Y$72$KG$20240911$$MD$FR$FR
213819885$21381988$5$F$$20240903$20220927$20240906$EXP$$US-TAKEDA-2022TUS067788$TAKEDA$$$$$F$Y$$$20240906$$MD$US$US
2138204411$21382044$11$F$20200501$20240905$20220927$20240910$EXP$$US-TAKEDA-US201944272$TAKEDA$$30$YR$$F$Y$70$KG$20240910$$HP$US$US
213823372$21382337$2$F$20220520$20240901$20220927$20240916$EXP$$ES-ROCHE-3185569$ROCHE$$58$YR$A$M$Y$72.5$KG$20240916$$MD$ES$ES
213824546$21382454$6$F$$20240626$20220927$20240708$EXP$$US-ROCHE-3183857$ROCHE$$64$YR$A$F$Y$136.08$KG$20240708$$CN$US$US
213824864$21382486$4$F$20240304$20240902$20220927$20240912$EXP$$AU-ROCHE-2914113$ROCHE$$42$YR$A$F$Y$$$20240912$$PH$AU$AU
213827782$21382778$2$F$$20240701$20220927$20240710$PER$$US-SA-2022SA390253$SANOFI AVENTIS$$61$YR$A$F$Y$72$KG$20240710$$MD$US$US
213828833$21382883$3$F$20220914$20240903$20220927$20240912$PER$$US-SA-2022SA394502$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240912$$MD$US$US
213828852$21382885$2$F$$20240722$20220927$20240731$PER$$US-SA-2022SA389413$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240731$$CN$US$US
213831402$21383140$2$F$20210106$20240815$20220927$20240828$PER$$US-SA-2022SA397489$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240828$$MD$US$US
213831452$21383145$2$F$$20240801$20220927$20240809$PER$$US-SA-2022SA396304$SANOFI AVENTIS$$$$$M$Y$$$20240809$$MD$US$US
213832743$21383274$3$F$$20240725$20220927$20240731$EXP$$US-ABBVIE-4130255$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
213833397$21383339$7$F$20220105$20240925$20220927$20240927$EXP$$FR-ABBVIE-22K-056-4253866-00$ABBVIE$$75$YR$$M$Y$71$KG$20240927$$MD$FR$FR
2138341411$21383414$11$F$$20240726$20220927$20240805$EXP$$US-JAZZ-2022-US-030346$JAZZ$$$$$F$Y$67$KG$20240803$$HP$US$US
2138372620$21383726$20$F$20210720$20240805$20220928$20240813$EXP$$CA-CELLTRION INC.-2021CA014597$CELLTRION$$$$$$Y$$$20240813$$HP$CA$CA
213837459$21383745$9$F$20220801$20240723$20220928$20240819$PER$$CA-TOLMAR, INC.-22CA036655$TOLMAR$$65$YR$$M$Y$$$20240814$$CN$CA$CA
213838202$21383820$2$F$$20240716$20220928$20240726$EXP$$NL-AUROBINDO-AUR-APL-2022-038767$AUROBINDO$Schutte T, Tellingen AV, van den Broek J, ten Brink M, van Agtmael-Boerrigter MG.. Topiramate intoxications + hemodialysis - Literature review and the first case report of a massive suicidal intoxication treated with hemodialysis.. Toxicology Reports.. 2022;9:1639-46$41$YR$$F$Y$65$KG$20240726$$MD$NL$NL
213847333$21384733$3$F$$20240629$20220928$20240704$PER$$US-HETERO-HET2022US02213$HETERO$$$$$$Y$$$20240704$$CN$US$US
213848193$21384819$3$F$$20240723$20220928$20240725$PER$$US-PFIZER INC-PV202200071395$PFIZER$$58$YR$$F$Y$$$20240725$$CN$US$US
213848773$21384877$3$F$20221224$20240808$20220928$20240809$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000225$PAREXEL$$$$$$Y$$$20240809$$CN$US$US
213848853$21384885$3$F$20210101$20240812$20220928$20240813$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000233$PAREXEL$$$$$$Y$$$20240813$$MD$US$US
213849215$21384921$5$F$20220101$20240923$20220928$20240924$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000305$PAREXEL$$$$$$Y$$$20240924$$CN$US$US
213849573$21384957$3$F$20220723$20240815$20220928$20240819$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000309$PAREXEL$$$$$$Y$$$20240819$$MD$US$US
213849743$21384974$3$F$20220901$20240819$20220928$20240821$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000402$PAREXEL$$$$$$Y$$$20240821$$MD$US$US
2138500710$21385007$10$F$20220922$20240703$20220928$20240705$EXP$$CA-TAKEDA-2021TUS068329$TAKEDA$$37$YR$$M$Y$$$20240705$$CN$CA$CA
213851103$21385110$3$F$20220801$20221031$20220928$20240926$PER$$US-GSK-US2022AMR136035$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240926$$CN$US$US
213851492$21385149$2$F$20220801$20220920$20220928$20240925$PER$$US-GSK-US2022AMR135585$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240925$$CN$US$US
213853003$21385300$3$F$20201209$20240909$20220928$20240911$EXP$$ES-AUROBINDO-AUR-APL-2022-038976$AUROBINDO$$90$YR$$F$Y$$$20240911$$MD$ES$ES
213853072$21385307$2$F$$20240818$20220928$20240827$EXP$$CA-JNJFOC-20220954415$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$HP$CA$CA
2138540910$21385409$10$F$20220901$20240918$20220928$20240927$EXP$$CA-MYLANLABS-2022M1097236$BIOCON$$$$$$Y$$$20240927$$CN$CA$CA
213854572$21385457$2$F$20230101$20240812$20220928$20240815$EXP$$US-ABBVIE-4131152$ABBVIE$$75$YR$$F$Y$$$20240815$$CN$US$US
213855535$21385553$5$F$20220312$20240710$20220928$20240711$EXP$$ES-ROCHE-3187734$ROCHE$$41$YR$A$M$Y$89$KG$20240711$$MD$ES$ES
2138557513$21385575$13$F$20220920$20240716$20220928$20240724$EXP$$CA-ROCHE-3188567$ROCHE$$53$YR$A$F$Y$$$20240724$$CN$CA$CA
213856232$21385623$2$F$$20220922$20220928$20240715$EXP$$HR-ASTELLAS-2022US034152$ASTELLAS$$43$YR$$M$Y$$$20240715$$HP$HR$HR
213856355$21385635$5$F$20190701$20240429$20220928$20240814$EXP$$PHHY2019PE174225$NOVARTIS$$63$YR$$F$Y$70$KG$20240814$$CN$PE$PE
213856523$21385652$3$F$20220528$20240701$20220928$20240706$EXP$$IT-ABBVIE-4132307$ABBVIE$$55$YR$$F$Y$71$KG$20240706$$MD$IT$IT
213856823$21385682$3$F$20190805$20240903$20220928$20240909$EXP$$DE-LABORATORIOS LICONSA S.A.-2004DE03006$INSUD PHARMA$$$$A$F$Y$115$KG$20240909$$HP$DE$DE
213857646$21385764$6$F$20220601$20221109$20220928$20240716$EXP$$DE-ASTELLAS-2022US034235$ASTELLAS$$$$E$M$Y$$$20240716$$CN$DE$DE
213858033$21385803$3$F$20240501$20240710$20220928$20240715$PER$$US-PFIZER INC-202201191411$PFIZER$$69$YR$$M$Y$$$20240715$$HP$US$US
213858563$21385856$3$F$20210110$20240917$20220928$20240919$EXP$$FR-ABBVIE-4132080$ABBVIE$$63$YR$$F$Y$$$20240919$$MD$FR$FR
213858723$21385872$3$F$$20221015$20220928$20240731$EXP$$NVSJ2022JP098043$NOVARTIS$Itabashi Y, Sakurabayashi K, Shinoda K, Okuma S, Muramatsu M, Kawamura T et al.. Bypass surgery with greater saphenous vein grafts in a patient with enlarged superficial artery aneurysms of the brachial and femoral arteries after cadaveric renal transplantation. PROGRAM AND ABSTRACTS FOR THE 37TH JAPANESE SOCIETY OF RENAL TRANSPLANTATION AND. 2022;110$37$YR$$M$Y$$$20240731$$HP$JP$JP
213858974$21385897$4$F$$20230612$20220928$20240911$EXP$$NVSC2022CA218166$NOVARTIS$$44$YR$$M$Y$$$20240911$$CN$CA$CA
213860985$21386098$5$F$20220101$20240729$20220928$20240918$EXP$$US-UCBSA-2022056419$UCB$$$$$F$Y$93.107$KG$20240918$$HP$US$US
213861834$21386183$4$F$20220809$20240809$20220928$20240816$EXP$$ES-ROCHE-3184676$ROCHE$$85$YR$E$M$Y$61.7$KG$20240816$$MD$ES$ES
213867413$21386741$3$F$20210101$20240729$20220928$20240801$PER$$US-ABBVIE-22K-163-4523874-00$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
213868045$21386804$5$F$20220718$20240813$20220928$20240822$EXP$$DE-TAKEDA-2022TUS067605$TAKEDA$$49$YR$$M$Y$75$KG$20240822$$HP$DE$DE
2138690818$21386908$18$F$20220616$20240911$20220928$20240913$EXP$$US-TAKEDA-US202017082$TAKEDA$$29$YR$$F$Y$$$20240913$$HP$US$US
213869329$21386932$9$F$20230116$20240827$20220928$20240902$EXP$$AU-TAKEDA-2022TUS067600$TAKEDA$$71$YR$$F$Y$$$20240902$$HP$AU$AU
213870643$21387064$3$F$20220104$20240918$20220928$20240926$EXP$$ES-ROCHE-3188999$ROCHE$$28$YR$A$M$Y$72$KG$20240926$$MD$ES$ES
213873673$21387367$3$F$$20240826$20220928$20240829$EXP$$US-TAKEDA-2022TUS067824$TAKEDA$$$$$F$Y$$$20240829$$CN$US$US
2138755012$21387550$12$F$20220804$20240705$20220928$20240711$EXP$$IN-PFIZER INC-PV202200071354$PFIZER$$42$YR$$F$Y$$$20240711$$CN$IN$IN
213876113$21387611$3$F$20220201$20240910$20220928$20240917$PER$$US-GSK-US2022AMR134909$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240917$$CN$US$US
213876423$21387642$3$F$$20230205$20220928$20240911$EXP$$NVSC2022CA218124$NOVARTIS$$76$YR$$M$Y$$$20240911$$CN$CA$CA
213878212$21387821$2$F$$20240709$20220928$20240717$EXP$$US-TAKEDA-US202002657$TAKEDA$$$$$M$Y$67.574$KG$20240717$$HP$US$US
213880493$21388049$3$F$20220920$20240730$20220928$20240808$PER$$US-SA-2022SA393523$SANOFI AVENTIS$$10$DY$N$F$Y$$$20240808$$MD$US$US
213881774$21388177$4$F$20220809$20240805$20220928$20240808$EXP$$ES-PFIZER INC-202201174238$PFIZER$$85$YR$$M$Y$61.7$KG$20240808$$MD$ES$ES
213881785$21388178$5$F$20210909$20240815$20220928$20240823$EXP$$JP-PFIZER INC-202201137263$PFIZER$$51$YR$$F$Y$60$KG$20240823$$MD$JP$JP
213886125$21388612$5$F$$20240710$20220928$20240724$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2022-113202$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$68$KG$20240724$$HP$CA$CA
213888942$21388894$2$F$20220816$20240927$20220929$20240930$EXP$$IN-PFIZER INC-202200759704$PFIZER$$49$YR$$F$Y$$$20240930$$CN$IN$IN
213889439$21388943$9$F$20201101$20231221$20220929$20240925$PER$$US-GSK-US2022AMR135017$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
213890168$21389016$8$F$20220919$20240924$20220929$20240926$EXP$$CA-ROCHE-3188618$ROCHE$$43$YR$A$F$Y$$$20240926$$CN$CA$CA
213893193$21389319$3$F$20220910$20221010$20220929$20240925$PER$$US-GSK-US2022AMR131931$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
2138938718$21389387$18$F$20220901$20240808$20220929$20240926$EXP$$US-GSK-US2022AMR139097$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
213894953$21389495$3$F$$20240820$20220929$20240828$EXP$$CA-TOLMAR, INC.-22CA036750$TOLMAR$$$$$M$Y$$$20240828$$CN$CA$CA
213894979$21389497$9$F$20220921$20240724$20220929$20240813$PER$$CA-TOLMAR, INC.-22CA036765$TOLMAR$$70$YR$$M$Y$$$20240813$$CN$CA$CA
213895618$21389561$8$F$20201110$20240903$20220929$20240910$EXP$$FR-TERSERA THERAPEUTICS LLC-2022TRS004033$TERSERA THERAPEUTICS$$$$$$Y$$$20240910$$MD$FR$FR
2138957315$21389573$15$F$20220917$20240815$20220929$20240820$EXP$$US-TAKEDA-2022TUS006800$TAKEDA$$58$YR$$M$Y$131.5$KG$20240820$$HP$US$US
213896472$21389647$2$F$20210201$20240813$20220929$20240822$EXP$FR-AFSSAPS-ST20222059$FR-TEVA-2022-FR-2077270$TEVA$$83$YR$$M$Y$$$20240822$$MD$FR$FR
213903633$21390363$3$F$20190901$20240906$20220929$20240919$EXP$$DE-AUROBINDO-AUR-APL-2022-038388$AUROBINDO$$$$E$F$Y$99$KG$20240919$$MD$DE$DE
213905882$21390588$2$F$$20240911$20220929$20240919$EXP$$DE-STRIDES ARCOLAB LIMITED-2022SP012429$STRIDES$Hoppe JM, Holderied A, Schonermarck U, Vielhauer V, Anders H-J, Fischereder M.. Drug-induced CYP induction as therapy for tacrolimus intoxication.. Clinical Nephrology - Case Studies.. 2022;10(1):42-46$56$YR$$M$Y$$$20240919$$MD$DE$DE
213907633$21390763$3$F$$20240719$20220929$20240726$EXP$$NVSC2022US220208$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
2139076611$21390766$11$F$$20240621$20220929$20240709$EXP$$CA-ROCHE-3189638$ROCHE$$$$A$F$Y$$$20240705$$MD$CA$CA
213908338$21390833$8$F$$20240719$20220929$20240723$PER$$US-PFIZER INC-PV202200072351$PFIZER$$65$YR$$M$Y$$$20240723$$HP$US$US
213916338$21391633$8$F$$20240710$20220929$20240712$PER$$US-PFIZER INC-PV202200073133$PFIZER$$60$YR$$M$Y$$$20240712$$MD$US$US
213917553$21391755$3$F$20220701$20221011$20220929$20240926$EXP$$US-GSK-US2022AMR104345$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2139188212$21391882$12$F$20220916$20231228$20220929$20240731$EXP$$NVSC2022JP220473$NOVARTIS$$57$YR$$M$Y$56.2$KG$20240731$$HP$JP$JP
213922147$21392214$7$F$20230927$20240913$20220929$20240923$EXP$$CA-TAKEDA-2022TUS067567$TAKEDA$$79$YR$$M$Y$$$20240923$$CN$CA$CA
213922662$21392266$2$F$$20240919$20220929$20240930$EXP$$CA-UCBSA-2022057182$UCB$$$$$F$Y$$$20240930$$HP$CA$CA
213923996$21392399$6$F$20221115$20240905$20220929$20240912$EXP$$US-ABBVIE-22K-163-4349899-00$ABBVIE$$44$YR$$M$Y$$$20240912$$CN$US$US
213924014$21392401$4$F$$20240823$20220929$20240902$EXP$$US-TEVA-2022-US-2076331$TEVA$Antony M,Chaurasia A,Gopal N,Kozel Z,Linehan M,Ball M Risk of Tumor Recurrence, Functional Decline, and Metastatic Disease of Renal Transplant in Recipients with Hereditary Kidney Cancer: A Case Series. American Journal of Transplantation 22 (Suppl.): 965 (plus Poster) abstr. C213., Jun 2022; Antony M, Chaurasia A, Gopal N, Linehan M, Ball M. Indications for and Outcomes of Renal Transplant in Patients With Hereditary Renal Cancer: A Case Series. Am-J-Kidney-Dis 2022; 79 (Suppl.) (4): S92.; A...$$$$$Y$$$20240902$$HP$US$US
213925442$21392544$2$F$$20240827$20220929$20240904$EXP$$CA-PFIZER INC-202201188382$PFIZER$$55$YR$$F$Y$$$20240904$$HP$CA$CA
213925783$21392578$3$F$20220922$20240801$20220929$20240807$EXP$$IT-TAKEDA-2022TUS068363$TAKEDA$$$$A$M$Y$$$20240807$$CN$IT$IT
213927512$21392751$2$F$20220901$20240716$20220929$20240724$PER$$US-SA-2022SA393414$SANOFI AVENTIS$$57$YR$A$F$Y$72.12$KG$20240724$$MD$US$US
213927905$21392790$5$F$20220101$20240626$20220929$20240705$PER$$US-SA-2022SA233487$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240705$$MD$US$US
213928802$21392880$2$F$$20240823$20220929$20240917$PER$$US-SA-2022SA400971$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240918$$MD$US$US
213931692$21393169$2$F$20190101$20240821$20220929$20240822$EXP$$US-PURDUE PHARMA-USA-2022-0296864$PURDUE$$$$$M$Y$$$20240822$$LW$US$US
213932423$21393242$3$F$20220508$20240916$20220929$20240917$EXP$$CA-GILEAD-2022-0599522$GILEAD$$2$YR$C$M$Y$11$KG$20240917$$HP$CA$CA
213934657$21393465$7$F$20230101$20240620$20220929$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003015$ACADIA PHARMACEUTICALS$$58$YR$$F$Y$54$KG$20240712$$CN$US$US
2139350510$21393505$10$F$20200101$20240627$20220929$20240708$EXP$$PE-AMGEN-PERSP2022167838$AMGEN$$63$YR$A$F$Y$$$20240708$$CN$PE$PE
213938509$21393850$9$F$20220901$20230808$20220930$20240926$EXP$$US-GSK-US2022AMR136984$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
213939304$21393930$4$F$20160101$20240810$20220930$20240816$EXP$$NVSC2022EG218836$NOVARTIS$$$$$F$Y$80$KG$20240816$$CN$EG$EG
213940132$21394013$2$F$20210625$20240628$20220930$20240705$EXP$$JP-ABBVIE-21K-087-4183789-00$ABBVIE$$90$YR$$F$Y$$$20240705$$MD$JP$JP
213941527$21394152$7$F$20220901$20221223$20220930$20240926$EXP$$US-GSK-US2022AMR136378$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
213944483$21394448$3$F$20230601$20240719$20220930$20240724$EXP$$US-KYOWAKIRIN-2022BKK015175$KYOWA$$$$$$Y$$$20240724$$HP$US$US
213947902$21394790$2$F$$20240626$20220930$20240702$EXP$$GR-BRISTOL-MYERS SQUIBB COMPANY-2022-109075$BRISTOL MYERS SQUIBB$Mpakosi A, Siopi M, Demetriou M, Falaina V, Theodoraki M, Meletiadis J. A fatal neonatal case of fungemia due to exophiala dermatitidis-case report and literature review. BMC Pediatrics. 2022 Aug 10;22(482):1-9. doi:10.1186/s12887-022-03518-5.$27$WK$I$M$Y$0.81$KG$20240702$$HP$GR$GR
213948364$21394836$4$F$20220918$20240918$20220930$20240927$PER$$NVSC2022US220291$NOVARTIS$$38$YR$$F$Y$$$20240927$$CN$US$US
2139495213$21394952$13$F$20220101$20240912$20220930$20240920$EXP$$CA-CELLTRION INC.-2022CA008724$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
2139514812$21395148$12$F$20220922$20230512$20220930$20240925$EXP$$US-GSK-US2022AMR136550$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
213952606$21395260$6$F$20201125$20240716$20220930$20240729$EXP$$DE-ROCHE-2735102$ROCHE$$30$YR$A$F$Y$$$20240729$$CN$DE$DE
2139549817$21395498$17$F$$20240913$20220930$20240917$EXP$$GB-JNJFOC-20220954407$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240917$$MD$GB$GB
213957367$21395736$7$F$$20240903$20220930$20240911$EXP$$CA-ROCHE-3172688$ROCHE$$26$YR$A$F$Y$$$20240911$$CN$CA$CA
213965223$21396522$3$F$$20231121$20220930$20240824$EXP$$US-TAKEDA-2022TUS069083$TAKEDA$$$$$F$Y$$$20240824$$CN$US$US
2139653711$21396537$11$F$20190501$20240904$20220930$20240909$EXP$$PHHY2019GB101628$NOVARTIS$$30$YR$$M$Y$$$20240909$$CN$GB$GB
213967512$21396751$2$F$$20240723$20220930$20240731$EXP$$US-SA-2022SA402357$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240731$$MD$US$US
213968553$21396855$3$F$$20240729$20220930$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-11441$LUPIN$$$$$F$Y$$$20240817$$CN$US$US
213972588$21397258$8$F$20220101$20240919$20220930$20240925$EXP$$CA-TAKEDA-2022TUS036446$TAKEDA$$$$$F$Y$$$20240925$$CN$CA$CA
213973094$21397309$4$F$$20240729$20220930$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-11432$LUPIN$$$$$$Y$$$20240818$$CN$US$US
213973534$21397353$4$F$$20240715$20220930$20240722$EXP$$US-TAKEDA-2022TUS068988$TAKEDA$$$$$F$Y$$$20240722$$MD$US$US
213975552$21397555$2$F$$20240819$20220930$20240823$EXP$$IN-PFIZER INC-PV202200068783$PFIZER$Pyare, R.. Tofacitinib in Scleritis: A Case Series. Ocular Immunology and Inflammation. 2022;10.1080/09273948.2022.2113805$41$YR$$F$Y$$$20240823$$HP$IN$IN
213980573$21398057$3$F$20220922$20240628$20220930$20240712$PER$$US-SA-2022SA398381$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240712$$MD$US$US
213981133$21398113$3$F$20220916$20240910$20220930$20240919$PER$$US-SA-2022SA397239$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240919$$MD$US$US
213981382$21398138$2$F$$20240705$20220930$20240714$PER$$US-SA-2022SA396782$SANOFI AVENTIS$$$$E$M$Y$$$20240714$$CN$US$US
213981854$21398185$4$F$$20240710$20220930$20240718$PER$$US-SA-2022SA402388$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240718$$MD$US$US
21398273100$21398273$100$F$20210812$20240919$20220930$20240926$EXP$$CA-TAKEDA-2022TUS069270$TAKEDA$$40$YR$$F$Y$$$20240926$$CN$CA$CA
213984686$21398468$6$F$$20240703$20220930$20240705$EXP$$CA-BAUSCH-BL-2022-022821$BAUSCH AND LOMB$$60$YR$$M$Y$$$20240705$$HP$CA$CA
2139860710$21398607$10$F$20220101$20240911$20220930$20240920$EXP$$CA-CELLTRION INC.-2022CA012157$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
213987378$21398737$8$F$20211029$20240724$20221001$20240801$EXP$$CA-CELLTRION INC.-2021CA010727$CELLTRION$$$$$$Y$$$20240801$$MD$CA$CA
213987502$21398750$2$F$$20240828$20221001$20240906$EXP$$CA-AUROBINDO-AUR-APL-2022-039693$AUROBINDO$$$$$F$Y$94$KG$20240906$$MD$CA$CA
2139942310$21399423$10$F$20220423$20240802$20221001$20240807$EXP$$US-TAKEDA-2022TUS030974$TAKEDA$$58$YR$$F$Y$58$KG$20240807$$CN$US$US
213995962$21399596$2$F$20200827$20240913$20221001$20240917$EXP$$DE-ABBVIE-20K-062-3561289-00$ABBVIE$$44$YR$$F$Y$$$20240917$$MD$DE$DE
213996923$21399692$3$F$20210629$20240904$20221001$20240911$EXP$$DE-TEVA-2022-DE-2077083$TEVA$$78$YR$$M$Y$$$20240911$$PH$DE$DE
214001282$21400128$2$F$$20220926$20221002$20240911$EXP$$NVSC2022CA217954$NOVARTIS$$62$YR$$F$Y$$$20240911$$CN$CA$CA
214002912$21400291$2$F$20210101$20240820$20221002$20240828$EXP$$JP-AMGEN-JPNSP2020049701$AMGEN$$9$DEC$E$F$Y$$$20240828$$CN$JP$JP
214003287$21400328$7$F$20220904$20240610$20221002$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003051$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240705$$CN$US$US
214003609$21400360$9$F$20200828$20240903$20221002$20240911$EXP$$CA-CELLTRION INC.-2020CA027562$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
214005122$21400512$2$F$$20240709$20221003$20240718$EXP$$DE-AUROBINDO-AUR-APL-2022-039305$AUROBINDO$$35$YR$$M$Y$110$KG$20240718$$PH$DE$DE
214006103$21400610$3$F$20220101$20240906$20221003$20240916$PER$$US-ABBVIE-4134182$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
214006122$21400612$2$F$$20240718$20221003$20240726$EXP$$CA-APOTEX-2022AP013640$APOTEX$$46$YR$$F$Y$$$20240726$$HP$CA$CA
214008012$21400801$2$F$$20240712$20221003$20240718$EXP$DE-ADRED-08329-01$DE-SA-2022SA401166$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240718$$PH$DE$DE
2140081011$21400810$11$F$$20240725$20221003$20240729$EXP$$NVSC2022CO222038$NOVARTIS$$$$$M$Y$$$20240729$$CN$CO$CO
214008344$21400834$4$F$20201201$20240905$20221003$20240911$EXP$$DE-ROCHE-2640196$ROCHE$$42$YR$A$M$Y$$$20240911$$CN$DE$DE
214009893$21400989$3$F$20220901$20221011$20221003$20240926$PER$$US-GSK-US2022AMR139445$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240926$$CN$US$US
214009907$21400990$7$F$20220601$20230113$20221003$20240926$EXP$$US-GSK-US2022AMR138591$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
214012132$21401213$2$F$20220101$20220901$20221003$20240801$EXP$$US-RECORDATI-2022004205$RECORDATI$$$$$$Y$$$20240801$$CN$US$US
214013092$21401309$2$F$$20240722$20221003$20240731$EXP$$CA-APOTEX-2022AP013605$APOTEX$$81$YR$$M$Y$72$KG$20240731$$HP$CA$CA
214013988$21401398$8$F$20220328$20240703$20221003$20240708$EXP$$JP-TAKEDA-2022TJP052114$TAKEDA$$11$YR$$F$Y$23$KG$20240708$$PH$JP$JP
214014412$21401441$2$F$$20240715$20221003$20240723$EXP$$CA-APOTEX-2022AP013613$APOTEX$$37$YR$$M$Y$79$KG$20240723$$HP$CA$CA
2140145620$21401456$20$F$20211220$20240711$20221003$20240720$EXP$$CA-CELLTRION INC.-2021CA018374$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
214018273$21401827$3$F$$20240710$20221003$20240717$EXP$$NVSC2022US221983$NOVARTIS$$$$$M$Y$$$20240717$$MD$US$US
214020825$21402082$5$F$20221024$20240815$20221003$20240820$EXP$$CA-TAKEDA-2021TUS041342$TAKEDA$$30$YR$$F$Y$$$20240820$$CN$CA$CA
214021108$21402110$8$F$20220701$20240814$20221003$20240820$EXP$$US-ABBVIE-22K-163-4499679-00$ABBVIE$$91$YR$$M$Y$$$20240820$$CN$US$US
214021668$21402166$8$F$20220922$20240708$20221003$20240715$EXP$$CA-ROCHE-3191450$ROCHE$$33$YR$A$M$Y$$$20240715$$CN$CA$CA
214023123$21402312$3$F$20210629$20240902$20221003$20240911$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202209012952$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240911$$CN$DE$DE
2140238310$21402383$10$F$20220926$20240827$20221003$20240901$EXP$$US-ABBVIE-4134949$ABBVIE$$73$YR$$F$Y$119$KG$20240901$$CN$US$US
214024277$21402427$7$F$20230101$20240730$20221003$20240802$EXP$$US-PFIZER INC-202201197104$PFIZER$$64$YR$$F$Y$87.54$KG$20240802$$HP$US$US
214025356$21402535$6$F$20210303$20240619$20221003$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-114530$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$68.95$KG$20240703$$HP$US$US
214026673$21402667$3$F$$20240807$20221003$20240822$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2022AST001900$ASSERTIO THERAPEUTICS$$75$YR$$F$Y$70$KG$20240822$$HP$CA$CA
214028252$21402825$2$F$$20220922$20221003$20240802$EXP$$FR-RECORDATI-2022004725$RECORDATI$$$$$$Y$$$20240802$$MD$FR$FR
214028442$21402844$2$F$20220912$20240919$20221003$20240923$PER$$US-BIOGEN-2022BI01151275$BIOGEN$$60$YR$$F$Y$$$20240923$$CN$US$US
214029873$21402987$3$F$20220823$20240829$20221003$20240903$EXP$$US-TAKEDA-2022TUS026680$TAKEDA$$56$YR$$F$Y$$$20240903$$MD$US$US
214031116$21403111$6$F$20221001$20230221$20221003$20240926$EXP$$US-GSK-US2022AMR092404$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
214031312$21403131$2$F$20210101$20220926$20221003$20240925$EXP$$US-GSK-US2021AMR218148$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
214033498$21403349$8$F$20220929$20240904$20221003$20240905$EXP$$NVSC2022US221305$NOVARTIS$$62$YR$$M$Y$$$20240905$$CN$US$US
214035712$21403571$2$F$20220101$20240812$20221003$20240824$EXP$$GB-UCBSA-2022057739$UCB$$$$$F$Y$$$20240824$$CN$GB$GB
214036332$21403633$2$F$$20240729$20221003$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-11507$LUPIN$$$$$M$Y$$$20240815$$CN$US$US
214037156$21403715$6$F$$20240830$20221003$20240906$PER$$US-PHARMING-PHAUS2022000678$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
214038553$21403855$3$F$$20220928$20221003$20240925$EXP$$US-TAKEDA-2022TUS069528$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
2140400311$21404003$11$F$$20240913$20221003$20240919$EXP$$GB-TAKEDA-2022TUS069787$TAKEDA$$35$YR$$M$Y$$$20240919$$MD$GB$GB
214040988$21404098$8$F$20230929$20240826$20221003$20240829$EXP$$US-TAKEDA-US201931737$TAKEDA$$61$YR$$F$Y$$$20240829$$MD$US$US
214041684$21404168$4$F$20220801$20240712$20221003$20240722$EXP$$US-PFIZER INC-PV202200072733$PFIZER$$71$YR$$M$Y$$$20240722$$CN$US$US
214041707$21404170$7$F$$20240716$20221003$20240722$EXP$$IN-PFIZER INC-PV202200073967$PFIZER$$57$YR$$F$Y$$$20240722$$CN$IN$IN
214041715$21404171$5$F$20220627$20240703$20221003$20240708$EXP$$DE-PFIZER INC-PV202200073631$PFIZER$$66$YR$$F$Y$73$KG$20240708$$HP$DE$DE
214042782$21404278$2$F$$20240905$20221003$20240915$PER$$US-SA-2022SA351689$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240915$$MD$US$US
2140432110$21404321$10$F$20221030$20240724$20221003$20240729$EXP$$US-SA-2022SA405220$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240729$$MD$US$US
214043744$21404374$4$F$20200901$20240821$20221003$20240905$PER$$US-SA-2022SA405410$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240905$$MD$US$US
214045345$21404534$5$F$20190101$20240923$20221003$20240926$EXP$$CA-PFIZER INC-2018449650$PFIZER$$63$YR$$F$Y$$$20240926$$CN$CA$CA
214049988$21404998$8$F$$20240913$20221003$20240920$EXP$$US-TAKEDA-2022TUS069901$TAKEDA$$$$$F$Y$78$KG$20240920$$CN$US$US
214050122$21405012$2$F$20210316$20240808$20221004$20240809$EXP$$IT-ABBVIE-21K-083-3846948-00$ABBVIE$$35$YR$$F$Y$$$20240809$$MD$IT$IT
214051258$21405125$8$F$$20240815$20221004$20240829$EXP$$CA-AUROBINDO-AUR-APL-2022-040127$AUROBINDO$Wiseman D, Samoukovic G, Durcan L, Malhame I. Serotonin Syndrome After Treatment of Nausea and Vomiting in Pregnancy. Obstetrics and gynecology. 2022;140(4):696?9$35$YR$$F$Y$$$20240829$$MD$CA$CA
214051456$21405145$6$F$20220901$20240808$20221004$20240814$EXP$$US-GSK-US2022139266$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$US$US
214052486$21405248$6$F$20190826$20240826$20221004$20240829$EXP$$CA-ROCHE-3189830$ROCHE$$77$YR$E$M$Y$72$KG$20240829$$CN$CA$CA
214055243$21405524$3$F$20231101$20240910$20221004$20240917$EXP$$NVSC2022MX222279$NOVARTIS$$37$YR$$F$Y$63$KG$20240917$$CN$MX$MX
2140558611$21405586$11$F$20220301$20240830$20221004$20240909$EXP$$CA-CELLTRION INC.-2022CA006306$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
214056502$21405650$2$F$$20240831$20221004$20240910$EXP$$FR-AUROBINDO-AUR-APL-2022-039569$AUROBINDO$Mora-Soize C, Carsin-Vu A, Caby G, Belkessa N, Marcus C, Soize S. Recurrent massive hemoptysis from distal  pulmonary pseudoaneurysms complicating  invasive aspergillosis in a teenager.. Radiology case reports. 2022;17(10):3897-3902$15$YR$$F$Y$$$20240910$$MD$FR$FR
214057042$21405704$2$F$20201209$20240916$20221004$20240923$EXP$ES-AEMPS-1260903$ES-TEVA-2022-ES-2079294$TEVA$$90$YR$$F$Y$$$20240923$$MD$ES$ES
214062385$21406238$5$F$$20240823$20221004$20240828$PER$$US-PFIZER INC-PV202200074012$PFIZER$$79$YR$$F$Y$$$20240828$$CN$US$US
214062468$21406246$8$F$$20240916$20221004$20240918$PER$$US-PFIZER INC-PV202200075817$PFIZER$$91$YR$$F$Y$73.016$KG$20240918$$CN$US$US
214065574$21406557$4$F$20220901$20240708$20221004$20240801$EXP$$US-ABBVIE-22K-163-4474182-00$ABBVIE$$61$YR$$M$Y$$$20240801$$CN$US$US
214066202$21406620$2$F$$20220923$20221004$20240809$EXP$$US-ROCHE-2397443$ROCHE$$43$YR$A$F$Y$$$20240809$$MD$US$US
2140676113$21406761$13$F$20221021$20240920$20221004$20240927$EXP$$CA-TAKEDA-2022TUS069358$TAKEDA$$67$YR$$F$Y$$$20240927$$HP$CA$CA
214070052$21407005$2$F$20240728$20240823$20221004$20240827$EXP$$NVSC2022MX223500$NOVARTIS$$48$YR$$F$Y$56$KG$20240827$$CN$MX$MX
214076213$21407621$3$F$20220601$20221021$20221004$20240925$EXP$$US-GSK-US2022AMR100291$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
214076813$21407681$3$F$20220925$20240716$20221004$20240718$EXP$$US-INCYTE CORPORATION-2022IN009483$INCYTE$$$$$$Y$$$20240718$$CN$US$US
2140808711$21408087$11$F$20210101$20240905$20221004$20240910$EXP$$IN-PFIZER INC-2021675025$PFIZER$$53$YR$$F$Y$69$KG$20240909$$CN$IN$IN
2140815610$21408156$10$F$20221026$20240808$20221004$20240814$EXP$$CA-OTSUKA-2022_031010$OTSUKA$$20$YR$$F$Y$$$20240814$$HP$CA$CA
214083406$21408340$6$F$20220927$20240916$20221004$20240924$EXP$$CA-JNJFOC-20220958319$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240924$$HP$CA$CA
214087835$21408783$5$F$20220901$20221114$20221004$20240925$PER$$US-GSK-US2022AMR138617$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240925$$CN$US$US
214089042$21408904$2$F$$20240819$20221004$20240828$PER$$US-SA-2022SA400220$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
214090163$21409016$3$F$20240703$20240725$20221004$20240802$PER$$US-SA-2022SA400985$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240802$$CN$US$US
214091022$21409102$2$F$$20240802$20221004$20240812$PER$$US-SA-2022SA407054$SANOFI AVENTIS$$$$T$F$Y$26.85$KG$20240812$$MD$US$US
214092576$21409257$6$F$20210811$20240807$20221004$20240812$EXP$$JP-ABBVIE-4138468$ABBVIE$$59$YR$$M$Y$$$20240812$$MD$JP$JP
2140967820$21409678$20$F$20221116$20240905$20221004$20240914$EXP$$CA-CELLTRION INC.-2022CA007228$CELLTRION$$$$$$Y$$$20240914$$MD$CA$CA
214098386$21409838$6$F$$20240726$20221005$20240803$EXP$$BR-CELLTRION INC.-2022BR015968$CELLTRION$$$$$$Y$$$20240803$$CN$BR$BR
214104645$21410464$5$F$20191203$20240415$20221005$20240809$EXP$$FR-ORGANON-O2210FRA000157$ORGANON$$20$YR$$F$Y$54$KG$20240809$$MD$FR$FR
214110134$21411013$4$F$$20240920$20221005$20240925$EXP$$BR-PFIZER INC-202201188651$PFIZER$Ferreira, G.. Refractory Hypernatremia and Osmotic Demyelination Syndrome After Liver Transplantation: A Case Report. Transplantation Proceedings. 2022;54(5):1376-1379$39$YR$$M$Y$59$KG$20240925$$MD$BR$BR
214117602$21411760$2$F$20210719$20240709$20221005$20240716$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202209010528$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240716$$CN$DE$DE
214118788$21411878$8$F$20240818$20240909$20221005$20240912$EXP$$US-PFIZER INC-PV202200076286$PFIZER$$64$YR$$F$Y$80.74$KG$20240912$$CN$US$US
214123176$21412317$6$F$20190101$20240918$20221005$20240918$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-084158$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240918$$CN$ES$ES
214127643$21412764$3$F$20220901$20240620$20221005$20240701$PER$$US-SA-2022SA403417$SANOFI AVENTIS$$26$YR$A$F$Y$68.946$KG$20240701$$HP$US$US
214127912$21412791$2$F$20220701$20240916$20221005$20240925$PER$$US-SA-2022SA408060$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240925$$MD$US$US
214136432$21413643$2$F$$20240716$20221006$20240724$EXP$$JP-AMGEN-JPNNI2022171908$AMGEN$Isohata N, Endo S, Endo H, Nemoto T, Suzushino S, Soeda N, et al.. Results of pre-operative chemotherapy for local advanced colon cancer in our hospital.. The 77th General Meeting of the Japanese Society of Gastroenterological Surgery. 2022;420$$$A$$Y$$$20240724$$MD$JP$JP
2141421113$21414211$13$F$20221006$20240722$20221006$20240729$EXP$$US-GSK-US2022141277$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
2141461311$21414613$11$F$20220901$20240829$20221006$20240905$EXP$$DE-ROCHE-3189691$ROCHE$$65$YR$E$M$Y$68$KG$20240905$$MD$DE$DE
2141473513$21414735$13$F$$20240820$20221006$20240827$EXP$$CA-ROCHE-3188997$ROCHE$$76$YR$E$F$Y$$$20240827$$HP$CA$CA
2141508024$21415080$24$F$20200407$20240826$20221006$20240903$EXP$$CA-CELLTRION INC.-2021CA018788$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
214152219$21415221$9$F$20220914$20240724$20221006$20240730$PER$$US-SA-2022SA406749$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240730$$MD$US$US
214152272$21415227$2$F$20220101$20240722$20221006$20240802$PER$$US-SA-2022SA406624$SANOFI AVENTIS$$26$YR$A$F$Y$56.6$KG$20240802$$MD$US$US
214152286$21415228$6$F$20211101$20240717$20221006$20240725$PER$$US-SA-2022SA405857$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240725$$MD$US$US
2141546717$21415467$17$F$20220927$20240523$20221006$20240926$EXP$$US-GSK-US2022AMR140699$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
214155312$21415531$2$F$$20240821$20221006$20240828$PER$$US-ABBVIE-4140702$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
2141568514$21415685$14$F$20211115$20240905$20221006$20240913$EXP$$CA-CELLTRION INC.-2021CA018105$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
214157598$21415759$8$F$20211231$20240719$20221006$20240729$EXP$$CN-ROCHE-3189186$ROCHE$$69$YR$E$F$Y$47$KG$20240729$$CN$CN$CN
214159216$21415921$6$F$$20240805$20221006$20240813$EXP$$CA-BAYER-2022A135224$BAYER$$3$YR$C$F$Y$64$KG$20240813$$HP$CA$CA
214159822$21415982$2$F$$20240814$20221006$20240828$PER$$US-SA-2022SA404396$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240828$$MD$US$US
214159872$21415987$2$F$20220316$20240708$20221006$20240711$EXP$$JP-GILEAD-2022-0600077$GILEAD$$70$YR$E$M$Y$$$20240711$$MD$JP$JP
214160717$21416071$7$F$20190109$20240716$20221006$20240730$EXP$$DE-ROCHE-2245571$ROCHE$$52$YR$A$F$Y$86$KG$20240730$$CN$DE$DE
214166732$21416673$2$F$20220703$20231101$20221006$20240930$PER$$US-PERRIGO-22US010501$PERRIGO$$$$$M$Y$$$20240930$$CN$US$US
214167295$21416729$5$F$$20240716$20221006$20240718$EXP$$JP-PFIZER INC-PV202200071753$PFIZER$Fukumoto, K.. A case of diffuse large B-cell lymphoma complicated by haemophagocytic syndrome in a patient under treatment for rheumatoid arthritis. The 31st Congress of the Kinki Rheumatism Association. 2022;31st:102$73$YR$$F$Y$$$20240718$$HP$JP$JP
214169884$21416988$4$F$20180401$20240725$20221006$20240729$EXP$$CA-TAKEDA-2018TUS013663$TAKEDA$$35$YR$$F$Y$$$20240729$$CN$CA$CA
2141727410$21417274$10$F$$20240805$20221006$20240806$EXP$CZ-UCBSA-2022058588$CZ-UCBSA-2022058588$UCB$$20$YR$$F$Y$$$20240806$$MD$CZ$CZ
214176825$21417682$5$F$20220801$20240623$20221006$20240702$PER$$US-SA-2022SA406166$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240702$$MD$US$US
214176876$21417687$6$F$20221004$20240912$20221006$20240916$EXP$$US-PFIZER INC-PV202200076636$PFIZER$$76$YR$$F$Y$$$20240916$$CN$US$US
2141779413$21417794$13$F$20220609$20240828$20221006$20240904$PER$$PR-PFIZER INC-202200809717$PFIZER$$67$YR$$F$Y$$$20240904$$MD$PR$PR
214180214$21418021$4$F$20220708$20240909$20221006$20240916$EXP$$BR-GSK-BR2021AMR011188$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$BR$BR
214180362$21418036$2$F$20210607$20240823$20221006$20240902$EXP$$FR-VIIV HEALTHCARE LIMITED-FR2022EME114073$VIIV$$$$$$Y$$$20240902$$MD$FR$FR
214182174$21418217$4$F$$20240809$20221006$20240815$EXP$$US-TAKEDA-2022TUS061133$TAKEDA$$$$$F$Y$128$KG$20240815$$HP$US$US
214186199$21418619$9$F$20210127$20240826$20221006$20240830$EXP$$JP-GSK-JP2022JPN141540$GLAXOSMITHKLINE$Ito M, Hosotani Y, Yoshimura A, Gomi F, Fukunaga K. 1: A case of keratitis with detection of HSV1, HHV6, and HHV7 in a patient with immunodeficiency after allogeneic haematopoietic stem cell transplant. Ophthalmology. 2022;64:898$$$$$Y$$$20240830$$MD$JP$JP
214187667$21418766$7$F$$20240827$20221006$20240830$EXP$$US-TAKEDA-2022TUS033557$TAKEDA$$$$$F$Y$53$KG$20240830$$HP$US$US
214190225$21419022$5$F$$20240719$20221006$20240724$EXP$$CA-PFIZER INC-202201204325$PFIZER$$66$YR$$F$Y$$$20240724$$HP$CA$CA
214198015$21419801$5$F$20220925$20240913$20221006$20240918$EXP$$US-ABBVIE-4141421$ABBVIE$$77$YR$$M$Y$74$KG$20240918$$CN$US$US
214199913$21419991$3$F$$20240723$20221007$20240802$PER$$US-SA-2022SA403799$SANOFI AVENTIS$$$$A$F$Y$$$20240802$$MD$US$US
214200026$21420002$6$F$20220913$20240802$20221007$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003146$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240827$$CN$US$US
2142041717$21420417$17$F$20170905$20240905$20221007$20240914$EXP$$CA-CELLTRION INC.-2022CA010300$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
214204545$21420454$5$F$20220911$20240730$20221007$20240808$EXP$$IT-BAXTER-2022BAX020808$BAXTER$$68$YR$$M$Y$80$KG$20240808$$HP$IT$IT
214205244$21420524$4$F$$20240805$20221007$20240808$EXP$$US-ABBVIE-4141614$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
2142061220$21420612$20$F$20220101$20240802$20221007$20240809$EXP$$CA-CELLTRION INC.-2022CA009904$CELLTRION$$$$$$Y$$$20240809$$MD$CA$CA
214212307$21421230$7$F$20220815$20240720$20221007$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-116622$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$60.3$KG$20240726$$MD$JP$JP
214212822$21421282$2$F$$20240906$20221007$20240912$EXP$$JP-AMGEN-JPNSP2022172220$AMGEN$$$$$$Y$$$20240912$$MD$JP$JP
214214659$21421465$9$F$20231001$20240628$20221007$20240704$EXP$$CA-TAKEDA-2022TUS054545$TAKEDA$$73$YR$$F$Y$$$20240704$$CN$CA$CA
214215662$21421566$2$F$20220926$20240916$20221007$20240923$PER$$US-SA-2022SA404384$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240923$$HP$US$US
214215964$21421596$4$F$$20240816$20221007$20240821$EXP$$US-TAKEDA-2022TUS070797$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
214216705$21421670$5$F$20220805$20221115$20221007$20240703$EXP$$ES-ASTELLAS-2022US031631$ASTELLAS$$62$YR$$F$Y$$$20240703$$MD$ES$ES
214217212$21421721$2$F$20220101$20240703$20221007$20240712$PER$$US-SA-2022SA410480$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240712$$MD$US$US
2142181711$21421817$11$F$20220215$20240725$20221007$20240729$EXP$$JP-ASTELLAS-2022JP014683$ASTELLAS$$57$YR$$M$Y$53.8$KG$20240729$$MD$JP$JP
214219847$21421984$7$F$20200601$20240730$20221007$20240805$EXP$$CO-TAKEDA-2020TUS025217$TAKEDA$$39$YR$$F$Y$46$KG$20240805$$CN$CO$CO
214221432$21422143$2$F$$20240809$20221007$20240813$EXP$$US-CHEPLA-3000025783$CHEPLAPHARM$$$$$F$Y$$$20240813$$MD$COUNTRY NOT SPECIFIED$US
2142224914$21422249$14$F$20220926$20231113$20221007$20240925$EXP$$US-GSK-US2022AMR140064$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
214223742$21422374$2$F$$20240815$20221007$20240824$30DAY$$US-VIIV HEALTHCARE LIMITED-US2022139349$VIIV$$$$$M$Y$$$20240824$$HP$US$US
214224919$21422491$9$F$20220101$20240710$20221007$20240712$PER$$US-PFIZER INC-PV202200077421$PFIZER$$65$YR$$F$Y$$$20240712$$CN$US$US
214224972$21422497$2$F$20221005$20240904$20221007$20240906$PER$$US-PFIZER INC-PV202200034036$PFIZER$$80$YR$$F$Y$$$20240906$$MD$US$US
214224983$21422498$3$F$$20240802$20221007$20240805$PER$$US-PFIZER INC-2021494920$PFIZER$$56$YR$$F$Y$$$20240805$$HP$US$US
214225036$21422503$6$F$20240101$20240923$20221007$20240926$PER$$US-PFIZER INC-PV202200059690$PFIZER$$60$YR$$F$Y$$$20240926$$CN$US$US
214227262$21422726$2$F$$20240628$20221007$20240702$PER$$US-PFIZER INC-PV202200078022$PFIZER$$68$YR$$F$Y$$$20240702$$MD$US$US
214227403$21422740$3$F$$20240724$20221007$20240725$PER$$US-PFIZER INC-PV202200077229$PFIZER$$77$YR$$M$Y$$$20240725$$CN$US$US
214235368$21423536$8$F$20220921$20240819$20221007$20240820$PER$$NVSC2022US226892$NOVARTIS$$45$YR$$M$Y$$$20240820$$HP$US$US
214236306$21423630$6$F$$20240918$20221007$20240930$PER$$NVSC2022US225761$NOVARTIS$$38$YR$$F$Y$$$20240930$$CN$US$US
214239473$21423947$3$F$$20240717$20221007$20240719$PER$$US-PFIZER INC-202201208452$PFIZER$$47$YR$$M$Y$$$20240719$$PH$US$US
214243463$21424346$3$F$20220801$20240715$20221007$20240718$EXP$$US-GW PHARMA-2022-US-027252$JAZZ$$13$YR$$F$Y$80$KG$20240718$$CN$US$US
214243938$21424393$8$F$20220101$20240802$20221007$20240807$EXP$$CA-PFIZER INC-202201205588$PFIZER$$24$YR$$M$Y$85.9$KG$20240807$$MD$CA$CA
2142505031$21425050$31$F$20220901$20240911$20221008$20240918$EXP$$CA-CELLTRION INC.-2021CA012296$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
2142540115$21425401$15$F$20221004$20240924$20221008$20240930$EXP$$NVSC2022US226867$NOVARTIS$$54$YR$$F$Y$$$20240930$$CN$US$US
214256974$21425697$4$F$20211218$20240829$20221008$20240904$EXP$$JP-ABBVIE-4145324$ABBVIE$$53$YR$$M$Y$91$KG$20240904$$MD$JP$JP
214259093$21425909$3$F$20220701$20240823$20221008$20240902$EXP$$GB-TEVA-2022-GB-2080222$TEVA$$64$YR$$F$Y$59$KG$20240902$$MD$GB$GB
214259634$21425963$4$F$20170101$20240925$20221008$20240930$EXP$$NVSC2022AR217692$NOVARTIS$$$$$F$Y$$$20240929$$CN$AR$AR
214261164$21426116$4$F$20220908$20240718$20221008$20240729$EXP$$DE-ROCHE-3195504$ROCHE$$47$YR$A$M$Y$$$20240729$$CN$DE$DE
214261532$21426153$2$F$$20240716$20221008$20240725$EXP$$DE-TEVA-2022-DE-2080552$TEVA$$35$YR$$M$Y$110$KG$20240725$$PH$DE$DE
214313653$21431365$3$F$$20240724$20221009$20240802$PER$$US-SA-2022SA407748$SANOFI AVENTIS$$$$A$F$Y$$$20240802$$MD$US$US
214314042$21431404$2$F$20220707$20240702$20221009$20240711$PER$$US-SA-2022SA406809$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240711$$MD$US$US
214318828$21431882$8$F$$20240813$20221009$20240819$EXP$$US-TAKEDA-2022TUS071716$TAKEDA$$$$$M$Y$89.34$KG$20240819$$CN$US$US
214325142$21432514$2$F$20221005$20240705$20221010$20240715$PER$$US-SA-2022SA411907$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240715$$MD$US$US
214325433$21432543$3$F$$20240812$20221010$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003149$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
214325795$21432579$5$F$20221001$20221102$20221010$20240925$PER$$US-GSK-US2022AMR142624$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
214331483$21433148$3$F$20220911$20221006$20221010$20240712$EXP$$IT-ASTELLAS-2022US035479$ASTELLAS$$78$YR$$M$Y$$$20240712$$MD$IT$IT
214332577$21433257$7$F$20220901$20221206$20221010$20240925$PER$$US-GSK-US2022AMR141371$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
214337344$21433734$4$F$$20240820$20221010$20240913$PER$$US-SA-2022SA411014$SANOFI AVENTIS$$57$YR$A$M$Y$90$KG$20240913$$MD$US$US
214338702$21433870$2$F$20220817$20240918$20221010$20240926$EXP$$FR-AUROBINDO-AUR-APL-2022-040541$AUROBINDO$$65$YR$$M$Y$61.4$KG$20240926$$PH$FR$FR
214339205$21433920$5$F$20220915$20240718$20221010$20240727$EXP$$CA-CELLTRION INC.-2022CA016123$CELLTRION$$$$$$Y$$$20240727$$CN$CA$CA
214342202$21434220$2$F$20190327$20240807$20221010$20240812$EXP$$CA-TAKEDA-2016TUS022378$TAKEDA$$66$YR$$M$Y$$$20240812$$CN$CA$CA
214342464$21434246$4$F$20230101$20240712$20221010$20240717$EXP$$US-ABBVIE-4145463$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
214345864$21434586$4$F$$20240807$20221010$20240808$PER$$NVSC2022US227958$NOVARTIS$$$$$F$Y$$$20240808$$HP$US$US
214347533$21434753$3$F$20221002$20240625$20221010$20240705$EXP$$US-VIIV HEALTHCARE LIMITED-US2022142040$VIIV$$43$YR$$F$Y$$$20240705$$PH$US$US
214347637$21434763$7$F$$20240902$20221010$20240905$EXP$$NVSC2021CO178661$NOVARTIS$$$$$M$Y$86$KG$20240905$$CN$CO$CO
214347759$21434775$9$F$20220101$20240626$20221010$20240704$EXP$$CA-CELLTRION INC.-2022CA011270$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
214348882$21434888$2$F$$20240719$20221010$20240723$EXP$$NVSC2022HR222802$NOVARTIS$$43$YR$$M$Y$$$20240723$$HP$HR$HR
214348905$21434890$5$F$$20240910$20221010$20240913$EXP$$NVSC2022CA223879$NOVARTIS$$80$YR$$M$Y$$$20240913$$HP$CA$CA
214351283$21435128$3$F$20221011$20240717$20221010$20240723$EXP$$CA-TAKEDA-2022TUS071268$TAKEDA$$68$YR$$M$Y$$$20240723$$CN$CA$CA
214351638$21435163$8$F$20181004$20240919$20221010$20240923$EXP$$DE-ROCHE-2400697$ROCHE$$62$YR$A$F$Y$$$20240923$$CN$DE$DE
214352152$21435215$2$F$$20240806$20221010$20240808$PER$$US-PFIZER INC-PV202200079056$PFIZER$$61$YR$$F$Y$$$20240808$$CN$US$US
214352383$21435238$3$F$$20240722$20221010$20240730$EXP$$DE-TEVA-2022-DE-2080715$TEVA$$56$YR$$M$Y$$$20240730$$PH$DE$DE
214352847$21435284$7$F$20220801$20240827$20221010$20240909$PER$$US-SA-2022SA406486$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240909$$MD$US$US
214354004$21435400$4$F$$20240702$20221010$20240705$EXP$$CA-TAKEDA-2021TUS061668$TAKEDA$$$$$F$Y$$$20240705$$CN$CA$CA
2143547411$21435474$11$F$20221201$20240729$20221010$20240801$EXP$$US-JAZZ-2022-US-031513$JAZZ$$33$YR$$F$Y$$$20240801$$MD$US$US
214354775$21435477$5$F$20180801$20240716$20221010$20240723$EXP$$US-JAZZ-2022-US-031570$JAZZ$$67$YR$$M$Y$$$20240723$$MD$US$US
214355855$21435585$5$F$20220530$20230222$20221010$20240925$EXP$$US-GSK-US2022AMR093000$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
214357592$21435759$2$F$20200814$20240812$20221010$20240821$PER$$US-SA-2022SA408528$SANOFI AVENTIS$$11$YR$C$F$Y$27.664$KG$20240821$$MD$US$US
2143576717$21435767$17$F$20230101$20240702$20221010$20240708$EXP$$US-UCBSA-2022044245$UCB$$$$$F$Y$70$KG$20240708$$HP$US$US
214360282$21436028$2$F$$20240711$20221010$20240712$EXP$$NVSC2022PH228517$NOVARTIS$$$$$M$Y$$$20240712$$CN$PH$PH
2143608818$21436088$18$F$20190101$20240713$20221010$20240716$EXP$$US-INCYTE CORPORATION-2022IN009497$INCYTE$$$$$$Y$$$20240716$$MD$US$US
214363095$21436309$5$F$20200101$20240627$20221010$20240702$EXP$$US-ABBVIE-22K-163-4515205-00$ABBVIE$$$$$F$Y$136$KG$20240702$$CN$US$US
214364385$21436438$5$F$$20240711$20221010$20240724$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2022-113412$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$68$KG$20240724$$HP$CA$CA
214365667$21436566$7$F$20220612$20240806$20221010$20240809$EXP$$US-ABBVIE-22K-163-4461193-00$ABBVIE$$71$YR$$F$Y$65.77$KG$20240809$$CN$US$US
2143660816$21436608$16$F$20220101$20240924$20221010$20240927$EXP$$CA-PFIZER INC-202200625639$PFIZER$$55$YR$$F$Y$68$KG$20240927$$CN$CA$CA
214366816$21436681$6$F$20230412$20240822$20221010$20240823$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-172220$BOEHRINGER INGELHEIM$$57$YR$A$F$Y$$$20240823$$CN$US$US
214367228$21436722$8$F$20230821$20240805$20221010$20240809$EXP$$US-JAZZ-2022-US-009520$JAZZ$$48$YR$$F$Y$$$20240809$$MD$US$US
214369295$21436929$5$F$20220908$20240722$20221010$20240725$EXP$$ES-PFIZER INC-202201201779$PFIZER$$59$YR$$M$Y$74$KG$20240725$$MD$ES$ES
214370689$21437068$9$F$20220831$20240721$20221010$20240725$EXP$$FR-BAUSCH-BL-2022-023331$BAUSCH AND LOMB$$71$YR$$F$Y$50$KG$20240725$$HP$FR$FR
214371568$21437156$8$F$$20240910$20221010$20240916$EXP$$US-TAKEDA-2022TUS052102$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
214374575$21437457$5$F$$20240923$20221011$20240925$PER$$NVSC2022US228534$NOVARTIS$$$$$M$Y$$$20240925$$HP$US$US
2143749134$21437491$34$F$20220101$20240919$20221011$20240928$EXP$$CA-CELLTRION INC.-2022CA006018$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
214376583$21437658$3$F$20220506$20240905$20221011$20240917$EXP$$IT-AUROBINDO-AUR-APL-2022-041405$AUROBINDO$$79$YR$$F$Y$$$20240917$$MD$IT$IT
2143776917$21437769$17$F$20220101$20240717$20221011$20240725$EXP$$CA-CELLTRION INC.-2022CA002339$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
214377848$21437784$8$F$20221001$20230424$20221011$20240925$PER$$US-GSK-US2022AMR142588$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
2143803815$21438038$15$F$20220904$20240911$20221011$20240913$EXP$$US-GSK-US2022AMR142675$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$US$US
214381652$21438165$2$F$20190710$20240725$20221011$20240727$EXP$$IT-ABBVIE-19K-083-3201537-00$ABBVIE$$42$YR$$M$Y$$$20240727$$MD$IT$IT
214385684$21438568$4$F$$20240820$20221011$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-11755$LUPIN$$$$$M$Y$$$20240906$$CN$US$US
2144004118$21440041$18$F$20220101$20240701$20221011$20240703$EXP$$US-PFIZER INC-PV202200080232$PFIZER$$69$YR$$F$Y$47.6$KG$20240703$$CN$US$US
214404813$21440481$3$F$20211216$20240723$20221011$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2022-AMRX-01617$AMNEAL$$68$YR$$M$Y$$$20240806$$MD$US$US
214406522$21440652$2$F$20220617$20240718$20221011$20240725$EXP$$JP-AstraZeneca-2022A340991$ASTRAZENECA$$88$YR$$M$Y$61$KG$20240725$$MD$JP$
214409612$21440961$2$F$$20240911$20221011$20240912$PER$$NVSC2022US227446$NOVARTIS$$$$A$F$Y$$$20240912$$CN$US$US
214414173$21441417$3$F$20220929$20240626$20221011$20240705$PER$$US-SA-2022SA408124$SANOFI AVENTIS$$50$YR$A$F$Y$82.55$KG$20240705$$MD$US$US
2144180620$21441806$20$F$20200803$20240808$20221011$20240809$EXP$$NVSC2020CH269352$NOVARTIS$$72$YR$$F$Y$77.5$KG$20240809$$MD$CH$CH
214425286$21442528$6$F$20221007$20221230$20221011$20240925$PER$$US-GSK-US2022AMR144053$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240925$$CN$US$US
214425415$21442541$5$F$20221008$20240918$20221011$20240930$PER$$NVSC2022US229109$NOVARTIS$$60$YR$$F$Y$$$20240930$$CN$US$US
214430273$21443027$3$F$$20221021$20221012$20240925$PER$$US-GSK-US2022AMR142026$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
214432402$21443240$2$F$$20240815$20221012$20240826$PER$$US-JNJFOC-20221012793$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240826$$HP$US$US
2144326014$21443260$14$F$20211210$20240912$20221012$20240921$EXP$$CA-CELLTRION INC.-2021CA019244$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
214436892$21443689$2$F$$20240801$20221012$20240810$PER$$US-SA-2022SA407761$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240810$$MD$US$US
214438103$21443810$3$F$20220107$20240819$20221012$20240827$EXP$$US-Axsome Therapeutics, Inc.-E2B_00000335$AXSOME THERAPEUTICS$$4$MON$I$F$Y$5.301$KG$20240827$$$COUNTRY NOT SPECIFIED$US
214440365$21444036$5$F$20220627$20240708$20221012$20240710$EXP$$NVSC2022DE226368$NOVARTIS$$66$YR$$F$Y$73$KG$20240710$$HP$DE$DE
214440569$21444056$9$F$20220301$20240905$20221012$20240912$EXP$$CA-TAKEDA-2022TUS017553$TAKEDA$$64$YR$$F$Y$101$KG$20240912$$CN$CA$CA
2144449919$21444499$19$F$20240530$20240628$20221012$20240703$EXP$$NVSC2022CO178466$NOVARTIS$$41$YR$$M$Y$72$KG$20240703$$CN$CO$CO
214445563$21444556$3$F$20190801$20240827$20221012$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-358388$RANBAXY$$60$YR$A$F$Y$$$20240911$$CN$US$US
2144499812$21444998$12$F$20221201$20231211$20221012$20240926$EXP$$US-GSK-US2022AMR145700$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
214451273$21445127$3$F$20220930$20240705$20221012$20240709$EXP$$DE-TAKEDA-2022TUS072288$TAKEDA$$18$YR$$F$Y$$$20240709$$CN$DE$DE
2144538710$21445387$10$F$20180529$20240828$20221012$20240905$EXP$$CA-CELLTRION INC.-2022CA002805$CELLTRION$$$$$$Y$$$20240905$$MD$CA$CA
214456952$21445695$2$F$$20221007$20221012$20240711$EXP$$GR-ASTELLAS-2022US032979$ASTELLAS$$78$YR$$M$Y$$$20240711$$MD$GR$GR
2144576714$21445767$14$F$20230111$20240913$20221012$20240925$EXP$$AU-TAKEDA-2022TUS072347$TAKEDA$$81$YR$$F$Y$$$20240925$$MD$AU$AU
214462922$21446292$2$F$20210421$20221006$20221012$20240925$EXP$$US-GSK-US2021AMR102521$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
214464422$21446442$2$F$$20240627$20221012$20240703$EXP$$US-TAKEDA-2022TUS073012$TAKEDA$$$$$M$Y$86$KG$20240703$$MD$US$US
214464475$21446447$5$F$$20240715$20221012$20240722$EXP$$US-SA-2022SA417646$SANOFI AVENTIS$$$$A$M$Y$$$20240722$$MD$US$US
214464585$21446458$5$F$20191210$20240708$20221012$20240710$EXP$$CA-TAKEDA-2022TUS071698$TAKEDA$$74$YR$$M$Y$$$20240710$$CN$CA$CA
2144648517$21446485$17$F$20221001$20240514$20221012$20240925$PER$$US-GSK-US2022AMR143119$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
214466868$21446686$8$F$20221201$20240717$20221012$20240722$EXP$$US-PFIZER INC-PV202200061097$PFIZER$$81$YR$$F$Y$$$20240722$$CN$US$US
2144688917$21446889$17$F$$20240830$20221012$20240906$EXP$$US-PFIZER INC-PV202200080750$PFIZER$$64$YR$$F$Y$70.31$KG$20240906$$CN$US$US
214472217$21447221$7$F$20220101$20240905$20221012$20240911$EXP$$JP-009507513-2210JPN000491J$MERCK$Ozawa R, Kato M, Tanase Y, Uno M, Ishikawa M, Kato T, et al.. P-70-3 Experience with lenvatinib and pembrolizumab for corpus uteri carcinoma. Acta Obstetrica et Gynaecologica Japonica The 75th Annual Congress of the Japan. 2023;75(S):S520$72$YR$$F$Y$$$20240911$$MD$JP$JP
214473912$21447391$2$F$$20240809$20221012$20240819$PER$$US-INCYTE CORPORATION-2022IN009569$INCYTE$$$$$$Y$$$20240819$$CN$US$US
2144739213$21447392$13$F$20221002$20240814$20221012$20240826$PER$$US-INCYTE CORPORATION-2022IN009571$INCYTE$$$$$$Y$$$20240826$$CN$US$US
2144760010$21447600$10$F$20230601$20240911$20221012$20240916$EXP$$US-PFIZER INC-202200804890$PFIZER$$65$YR$$F$Y$77.56$KG$20240916$$MD$US$US
214476704$21447670$4$F$$20240723$20221012$20240729$EXP$$JP-ABBVIE-21P-087-4145344-00$ABBVIE$$74$YR$$M$Y$$$20240729$$MD$JP$JP
214482669$21448266$9$F$20220805$20240914$20221012$20240923$EXP$$US-CELLTRION INC.-2022US014127$CELLTRION$$$$$$Y$$$20240923$$CN$US$US
214490253$21449025$3$F$20221001$20221014$20221013$20240925$PER$$US-GSK-US2022AMR143190$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
214493534$21449353$4$F$20220923$20221103$20221013$20240925$PER$$US-GSK-US2022AMR146704$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240925$$CN$US$US
214493842$21449384$2$F$20230101$20240808$20221013$20240813$EXP$$US-ABBVIE-4152194$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
214498203$21449820$3$F$$20240809$20221013$20240904$PER$$CA-TOLMAR, INC.-22CA036874$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
214498423$21449842$3$F$20240729$20240809$20221013$20240813$EXP$$US-TAKEDA-2022TUS065389$TAKEDA$$11$YR$$M$Y$$$20240813$$HP$US$US
214498952$21449895$2$F$20220914$20221011$20221013$20240925$PER$$US-GSK-US2022AMR145872$GLAXOSMITHKLINE$$48$YR$$M$Y$$$20240925$$CN$US$US
214500735$21450073$5$F$20220627$20240706$20221013$20240717$EXP$$DE-AUROBINDO-AUR-APL-2022-041883$AUROBINDO$$66$YR$$F$Y$73$KG$20240717$$HP$DE$DE
214501954$21450195$4$F$$20240829$20221013$20240903$EXP$$PT-MYLANLABS-2022M1112905$MYLAN$Costa L, Lopes S, Carvalho I, Morgado C, Lopes M, Machado C, et al.. Epilepsy and ataxia: the hidden infection.. European Journal of Neurology. 2022;29(1):728$72$YR$$F$Y$$$20240903$$MD$PT$PT
214503252$21450325$2$F$20220101$20240911$20221013$20240917$EXP$$CA-ABBVIE-4152371$ABBVIE$$$$$F$Y$$$20240917$$CN$CA$CA
2145056214$21450562$14$F$20220101$20240708$20221013$20240710$PER$$US-DSJP-DSU-2022-136292$DAIICHI$$$$$F$Y$$$20240710$$HP$US$US
2145095910$21450959$10$F$20200101$20240910$20221013$20240917$EXP$$US-ABBVIE-4147793$ABBVIE$$80$YR$$M$Y$54$KG$20240917$$CN$US$US
214509684$21450968$4$F$20220901$20240915$20221013$20240923$EXP$$NL-TAKEDA-2022TUS072071$TAKEDA$$44$YR$$F$Y$$$20240923$$HP$NL$NL
214511733$21451173$3$F$20221001$20221020$20221013$20240925$EXP$$US-GSK-US2022AMR026420$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2145117810$21451178$10$F$20211101$20230601$20221013$20240925$EXP$$US-GSK-US2021AMR226039$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
214511873$21451187$3$F$20220201$20221102$20221013$20240926$EXP$$US-GSK-US2022AMR073634$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
214512072$21451207$2$F$$20240904$20221013$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-120088$BRISTOL MYERS SQUIBB$Peth D, Reddy A. Atypical presentation of cardiac tamponade secondary to loculated pericardial effusion. Chest. 2022 Oct;162(4S):110A. doi:10.1016/j.chest.2022.08.075.$75$YR$E$M$Y$$$20240911$$HP$US$US
214516083$21451608$3$F$$20240620$20221013$20240701$PER$$US-PFIZER INC-202101771221$PFIZER$$73$YR$$F$Y$$$20240701$$HP$US$US
214525202$21452520$2$F$20220508$20240701$20221013$20240716$EXP$$DE-ROCHE-3196202$ROCHE$$72$YR$E$F$Y$109.5$KG$20240716$$MD$DE$DE
214525326$21452532$6$F$20220101$20240613$20221013$20240702$EXP$$DE-ROCHE-3197550$ROCHE$$41$YR$A$F$Y$68$KG$20240702$$MD$DE$DE
214525474$21452547$4$F$20191105$20240708$20221013$20240725$EXP$$DE-ROCHE-2865526$ROCHE$$26$YR$A$F$Y$$$20240725$$CN$DE$DE
214525542$21452554$2$F$20220201$20240902$20221013$20240909$EXP$$DE-ROCHE-3156869$ROCHE$$45$YR$A$F$Y$56$KG$20240909$$MD$DE$DE
214525634$21452563$4$F$$20240822$20221013$20240829$EXP$$CA-ROCHE-3197382$ROCHE$$41$YR$A$F$Y$$$20240829$$CN$CA$CA
214530414$21453041$4$F$20210210$20240806$20221013$20240811$EXP$$DE-ROCHE-2798162$ROCHE$$55$YR$A$F$Y$$$20240811$$CN$DE$DE
214530493$21453049$3$F$$20240809$20221013$20240820$EXP$$CA-ROCHE-3198980$ROCHE$$72$YR$E$F$Y$$$20240820$$CN$CA$CA
214531923$21453192$3$F$$20240722$20221013$20240726$EXP$$US-JAZZ-2022-US-030552$JAZZ$$$$$F$Y$$$20240726$$CN$US$US
2145320312$21453203$12$F$$20240910$20221013$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-119562$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$56.7$KG$20240911$$HP$US$US
214532842$21453284$2$F$$20240829$20221013$20240916$PER$$US-BIOMARINAP-US-2022-146064$BIOMARIN$$$$$$Y$$$20240916$$CN$US$US
214535283$21453528$3$F$20220106$20240710$20221013$20240711$EXP$$SE-PFIZER INC-202201210277$PFIZER$$62$YR$$M$Y$125.7$KG$20240711$$MD$SE$SE
214536586$21453658$6$F$20220911$20240813$20221013$20240816$EXP$$IT-PFIZER INC-202201201802$PFIZER$$68$YR$$M$Y$80$KG$20240816$$HP$IT$IT
214539093$21453909$3$F$20231001$20240814$20221013$20240828$PER$$US-SA-2022SA413131$SANOFI AVENTIS$$40$YR$A$F$Y$119.7$KG$20240828$$MD$US$US
2145397010$21453970$10$F$$20240805$20221013$20240815$PER$$US-SA-2022SA417622$SANOFI AVENTIS$$65$YR$E$M$Y$97.506$KG$20240815$$HP$US$US
214542072$21454207$2$F$20240802$20240806$20221013$20240813$EXP$$US-TAKEDA-2022TUS072258$TAKEDA$$53$YR$$F$Y$$$20240813$$CN$US$US
214544862$21454486$2$F$$20240718$20221013$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210203227$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240726$$MD$CA$CA
2145452110$21454521$10$F$20210128$20240903$20221013$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-054287$BRISTOL MYERS SQUIBB$Toda M, Suzuki S, Iwada T. A case of effective ipilimumab + nivolumab + CBDCA + PTX therapy for sarcomatoid carcinoma of the left lung with brain metastases leading to complete response. Japanese Journal of Lung Cancer. 2021;61(6):708.$60$YR$A$F$Y$$$20240910$$MD$JP$JP
214545375$21454537$5$F$$20240922$20221013$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-120380$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240930$$MD$JP$JP
214545493$21454549$3$F$$20240701$20221013$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003243$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
214546625$21454662$5$F$20211120$20240710$20221013$20240712$EXP$$JP-TAKEDA-2022TJP075309$TAKEDA$$6$YR$$M$Y$10.9$KG$20240712$$MD$JP$JP
214546675$21454667$5$F$$20240801$20221013$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2022-023871$UNITED THERAPEUTICS$$$$$F$Y$79.365$KG$20240810$$$US$US
214547812$21454781$2$F$$20240701$20221014$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-357693$RANBAXY$$$$$$Y$$$20240711$$CN$US$US
214548433$21454843$3$F$20240515$20240613$20221014$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003215$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240708$$CN$US$US
2145507153$21455071$53$F$20211201$20240902$20221014$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-121095$BRISTOL MYERS SQUIBB$Ohara G, Shiraish Y, Hara S, Kurata T, Ohe Y. Occurrence state of adverse drug reactions due to chemotherapy including ipilimumab + nivolumab in mito kyodo general hospital. The 49th Ibaraki Society for Lung Cancer Program. 2022;7.$71$YR$E$F$Y$49.4$KG$20240912$$MD$JP$JP
2145546716$21455467$16$F$20220101$20240912$20221014$20240920$EXP$$CA-CELLTRION INC.-2022CA010018$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
214554895$21455489$5$F$20221001$20221229$20221014$20240926$PER$$US-GSK-US2022AMR146894$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240926$$CN$US$US
2145603725$21456037$25$F$20220617$20240906$20221014$20240916$EXP$$CA-CELLTRION INC.-2022CA010131$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
2145612715$21456127$15$F$20211028$20240701$20221014$20240709$EXP$$CA-CELLTRION INC.-2021CA018764$CELLTRION$$$$$$Y$$$20240709$$MD$CA$CA
214561319$21456131$9$F$20220101$20240916$20221014$20240920$EXP$$CA-PFIZER INC-202200804545$PFIZER$$49$YR$$F$Y$$$20240920$$MD$CA$CA
214563595$21456359$5$F$$20240801$20221014$20240809$PER$$US-SA-2022SA418372$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240809$$MD$US$US
214564173$21456417$3$F$20221001$20221027$20221014$20240925$PER$$US-GSK-US2022AMR146651$GLAXOSMITHKLINE$$84$YR$$F$Y$$$20240925$$CN$US$US
2145654610$21456546$10$F$20210101$20240916$20221014$20240920$EXP$$CA-TAKEDA-2021TUS034183$TAKEDA$$$$$M$Y$38$KG$20240920$$CN$CA$CA
214566429$21456642$9$F$20220701$20240703$20221014$20240715$EXP$$CA-ROCHE-3168329$ROCHE$$20$YR$A$F$Y$$$20240715$$CN$CA$CA
214567462$21456746$2$F$$20240920$20221014$20240924$PER$$NVSC2022US229374$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
214568896$21456889$6$F$20220301$20240712$20221014$20240716$EXP$$AT-ROCHE-3200093$ROCHE$$58$YR$A$M$Y$78$KG$20240716$$MD$AT$AT
2145699212$21456992$12$F$20230815$20240809$20221014$20240813$EXP$$US-TAKEDA-2022TUS073762$TAKEDA$$31$YR$$M$Y$$$20240813$$PH$US$US
2145705915$21457059$15$F$20220502$20240819$20221014$20240821$EXP$$NVSC2022CH102093$NOVARTIS$$58$YR$$F$Y$55.5$KG$20240821$$MD$CH$CH
214574542$21457454$2$F$20160817$20240817$20221014$20240828$EXP$PT-EMA-2022815-AUTODUP-1660591687498$PT-Accord-281424$ACCORD$$39$YR$A$F$Y$91$KG$20240828$$MD$PT$PT
214575434$21457543$4$F$20220901$20240802$20221014$20240807$EXP$$CA-TAKEDA-2018TUS012864$TAKEDA$$64$YR$$F$Y$$$20240807$$CN$CA$CA
214576775$21457677$5$F$20220720$20240813$20221014$20240814$EXP$$FR-AstraZeneca-2022A339229$ASTRAZENECA$$76$YR$$M$Y$86.3$KG$20240814$$MD$FR$
2145777410$21457774$10$F$20220101$20240830$20221014$20240904$EXP$$US-PFIZER INC-PV202200082238$PFIZER$$50$YR$$F$Y$$$20240904$$HP$US$US
214583007$21458300$7$F$$20240916$20221014$20240919$PER$$US-PFIZER INC-PV202200082337$PFIZER$$59$YR$$F$Y$$$20240919$$CN$US$US
214584993$21458499$3$F$20240626$20240716$20221014$20240722$EXP$$IN-PFIZER INC-PV202200080860$PFIZER$$66$YR$$F$Y$68$KG$20240722$$CN$IN$IN
214588758$21458875$8$F$20220901$20240826$20221014$20240903$PER$$US-SA-2022SA421019$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240903$$MD$US$US
214588764$21458876$4$F$20240501$20240802$20221014$20240807$EXP$$US-SA-2022SA421315$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240807$$CN$US$US
214592777$21459277$7$F$20220101$20240626$20221014$20240702$EXP$$CA-TAKEDA-2022TUS048201$TAKEDA$$$$$M$Y$$$20240702$$CN$CA$CA
214595646$21459564$6$F$$20240828$20221014$20240904$PER$$US-PFIZER INC-PV202200081716$PFIZER$$74$YR$$F$Y$$$20240904$$CN$US$US
214596279$21459627$9$F$20220905$20240813$20221014$20240820$EXP$$CA-TAKEDA-2022TUS064573$TAKEDA$$66$YR$$F$Y$$$20240820$$MD$CA$CA
214598157$21459815$7$F$20240531$20240813$20221014$20240820$EXP$$CA-TAKEDA-2022TUS073464$TAKEDA$$51$YR$$F$Y$$$20240820$$CN$CA$CA
214598447$21459844$7$F$20220504$20240918$20221014$20240927$EXP$$CZ-TEVA-2022-CZ-2816136$TEVA$$67$YR$$F$Y$56$KG$20240927$$MD$CZ$CZ
2146069220$21460692$20$F$20220322$20240920$20221015$20240930$EXP$$CA-CELLTRION INC.-2022CA004048$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
214610362$21461036$2$F$$20240905$20221015$20240914$PER$$US-SA-2022SA418347$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240914$$MD$US$US
2146158215$21461582$15$F$20230105$20240913$20221015$20240921$EXP$$CA-CELLTRION INC.-2022CA016493$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
214626994$21462699$4$F$20201001$20240718$20221017$20240723$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-084345$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$63$KG$20240719$$CN$ES$ES
214627284$21462728$4$F$20221001$20221121$20221017$20240925$PER$$US-GSK-US2022AMR142641$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
214630053$21463005$3$F$20220101$20240918$20221017$20240925$EXP$$US-ABBVIE-4156940$ABBVIE$$73$YR$$F$Y$63.5$KG$20240925$$CN$US$US
214636184$21463618$4$F$$20240920$20221017$20240926$EXP$$US-TAKEDA-US202014850$TAKEDA$$$$$M$Y$$$20240926$$HP$US$US
214637182$21463718$2$F$20220401$20240723$20221017$20240801$PER$$US-SA-2022SA420737$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240801$$MD$US$US
214637897$21463789$7$F$20221006$20240903$20221017$20240911$EXP$$CA-ROCHE-3198142$ROCHE$$63$YR$A$M$Y$$$20240911$$MD$CA$CA
214643793$21464379$3$F$20200101$20240807$20221017$20240808$EXP$$US-UCBSA-2022059654$UCB$$$$$M$Y$$$20240808$$CN$US$US
2146439731$21464397$31$F$20201217$20240705$20221017$20240713$EXP$$CA-CELLTRION INC.-2021CA003999$CELLTRION$$$$$$Y$$$20240713$$HP$CA$CA
214644038$21464403$8$F$20200121$20240919$20221017$20240930$EXP$$DE-ROCHE-2543270$ROCHE$$51$YR$A$F$Y$62$KG$20240930$$CN$DE$DE
214644258$21464425$8$F$20211001$20240730$20221017$20240731$EXP$$AT-ROCHE-3200098$ROCHE$$27$YR$A$F$Y$58$KG$20240731$$MD$AT$AT
214644397$21464439$7$F$20201101$20240825$20221017$20240829$EXP$$AT-ROCHE-3200343$ROCHE$$45$YR$A$F$Y$89.9$KG$20240829$$MD$AT$AT
214647745$21464774$5$F$20221001$20230210$20221017$20240925$PER$$US-GSK-US2022AMR148161$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
214650553$21465055$3$F$20220820$20221005$20221017$20240916$EXP$$US-NOVOPROD-966646$NOVO NORDISK$$64$YR$$M$Y$$$20240916$$HP$US$US
214654033$21465403$3$F$$20240718$20221017$20240722$PER$$US-PFIZER INC-2018362704$PFIZER$$52$YR$$F$Y$$$20240722$$HP$US$US
2146557811$21465578$11$F$20200318$20230914$20221017$20240710$EXP$$NVSC2020MX362902$NOVARTIS$$49$YR$$M$Y$69$KG$20240710$$CN$MX$MX
214657518$21465751$8$F$$20240718$20221017$20240723$PER$$US-PFIZER INC-PV202200082853$PFIZER$$82$YR$$F$Y$$$20240723$$CN$US$US
214658084$21465808$4$F$$20240809$20221017$20240816$EXP$$CA-GSK-CA2022AMR145846$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$HP$CA$CA
214660093$21466009$3$F$$20240905$20221017$20240909$EXP$$FR-MYLANLABS-2022M1114695$MYLAN$Mora-Soize C, Carsin-Vu A, Caby GM, Belkessa N, Marcus C, Soize S. Recurrent massive hemoptysis from distal pulmonary pseudoaneurysms complicating invasive aspergillosis in a teenager. Radiology case reports. 2022;17(10):3897-3902$15$YR$$F$Y$$$20240909$$MD$FR$FR
214661698$21466169$8$F$20070101$20240919$20221017$20240924$EXP$$US-PFIZER INC-PV202200082652$PFIZER$$56$YR$$M$Y$$$20240924$$CN$US$US
214661704$21466170$4$F$$20240711$20221017$20240712$EXP$$US-PFIZER INC-PV202200081691$PFIZER$$57$YR$$F$Y$$$20240712$$CN$US$US
214662772$21466277$2$F$$20240806$20221017$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-11985$LUPIN$$$$$$Y$$$20240821$$CN$US$US
214670223$21467022$3$F$20240704$20240711$20221017$20240716$PER$$US-ABBVIE-4145135$ABBVIE$$76$YR$$M$Y$$$20240716$$CN$US$US
214671698$21467169$8$F$$20240905$20221017$20240910$EXP$$CA-TAKEDA-2022TUS028057$TAKEDA$$$$$F$Y$$$20240910$$HP$CA$CA
214673794$21467379$4$F$$20240809$20221017$20240814$EXP$$CA-TAKEDA-2022TUS074209$TAKEDA$$$$$M$Y$$$20240814$$MD$CA$CA
214675612$21467561$2$F$20240716$20240723$20221017$20240725$EXP$$US-TAKEDA-2022TUS073855$TAKEDA$$82$YR$$M$Y$57$KG$20240725$$MD$US$US
214675633$21467563$3$F$$20240821$20221017$20240827$PER$$US-BIOGEN-2022BI01162023$BIOGEN$$$$$M$Y$$$20240827$$CN$US$US
214678479$21467847$9$F$20220101$20240829$20221017$20240903$EXP$$CA-PFIZER INC-202201006148$PFIZER$$34$YR$$F$Y$$$20240903$$HP$CA$CA
214681383$21468138$3$F$$20240711$20221017$20240723$PER$$US-VERTEX PHARMACEUTICALS-2022-014164$VERTEX$$$$$M$Y$$$20240723$$MD$US$US
2146852811$21468528$11$F$20220811$20240624$20221017$20240704$EXP$$US-BEH-2022148730$CSL BEHRING$$29$YR$A$F$Y$99.773$KG$20240704$$HP$US$US
214690215$21469021$5$F$20221101$20240731$20221018$20240802$EXP$$IT-TAKEDA-2022TUS074363$TAKEDA$$80$YR$$F$Y$$$20240802$$HP$IT$IT
214690248$21469024$8$F$20221004$20230413$20221018$20240925$EXP$$US-GSK-US2022AMR149012$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
2146975811$21469758$11$F$$20240813$20221018$20240816$EXP$$CA-ABBVIE-4133161$ABBVIE$$43$YR$$F$Y$96$KG$20240816$$HP$CA$CA
214699665$21469966$5$F$20210604$20240826$20221018$20240829$EXP$$US-TAKEDA-US202018290$TAKEDA$$57$YR$$F$Y$$$20240829$$MD$US$US
214699949$21469994$9$F$20220801$20240712$20221018$20240723$EXP$$CA-CELLTRION INC.-2022CA008109$CELLTRION$$$$$$Y$$$20240723$$MD$CA$CA
214701854$21470185$4$F$20220810$20221227$20221018$20240925$EXP$$US-GSK-US2022AMR147394$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
214708353$21470835$3$F$20220604$20240720$20221018$20240729$EXP$$FR-AUROBINDO-AUR-APL-2022-042982$AUROBINDO$$65$YR$$M$Y$$$20240729$$MD$FR$FR
214708702$21470870$2$F$$20240730$20221018$20240806$EXP$$US-SA-2022SA424053$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240806$$MD$US$US
214710756$21471075$6$F$20200513$20240827$20221018$20240830$EXP$$CA-ROCHE-2603241$ROCHE$$46$YR$A$F$Y$82.8$KG$20240830$$CN$CA$CA
214713323$21471332$3$F$20211001$20240701$20221018$20240702$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-131765$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$68$KG$20240702$$CN$ES$ES
214716754$21471675$4$F$20220501$20240701$20221018$20240703$PER$$US-PFIZER INC-PV202200083430$PFIZER$$70$YR$$F$Y$56.689$KG$20240703$$CN$US$US
2147197410$21471974$10$F$20200110$20240910$20221018$20240916$EXP$$CA-TAKEDA-2022TUS065706$TAKEDA$$85$YR$$M$Y$$$20240916$$CN$CA$CA
214719812$21471981$2$F$20230904$20240710$20221018$20240718$EXP$$US-ABBVIE-4147537$ABBVIE$$69$YR$$M$Y$$$20240718$$CN$US$US
214725959$21472595$9$F$20220101$20240827$20221018$20240923$PER$$US-SA-2022SA424151$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240923$$CN$US$US
214727077$21472707$7$F$20221007$20240830$20221018$20240830$PER$$NVSC2022US233930$NOVARTIS$$31$YR$$F$Y$$$20240830$$CN$US$US
214727172$21472717$2$F$20220801$20240814$20221018$20240820$EXP$$CA-TAKEDA-2022TUS074041$TAKEDA$$68$YR$$M$Y$$$20240820$$CN$CA$CA
214727476$21472747$6$F$$20240627$20221018$20240701$PER$$US-PFIZER INC-202201237047$PFIZER$$77$YR$$F$Y$$$20240701$$MD$US$US
214727607$21472760$7$F$20160127$20240925$20221018$20240927$EXP$$CA-TAKEDA-2022TUS074432$TAKEDA$$38$YR$$F$Y$$$20240927$$CN$CA$CA
214728299$21472829$9$F$20221012$20240923$20221018$20240930$EXP$$IN-PFIZER INC-PV202200005476$PFIZER$$64$YR$$M$Y$$$20240930$$CN$IN$IN
214731297$21473129$7$F$20191211$20240829$20221018$20240903$EXP$$CA-TAKEDA-2022TUS073927$TAKEDA$$54$YR$$F$Y$$$20240903$$HP$CA$CA
214733262$21473326$2$F$$20240816$20221018$20240823$EXP$$BR-TAKEDA-2022TUS074560$TAKEDA$$$$$$Y$$$20240823$$CN$BR$BR
214734802$21473480$2$F$$20240820$20221018$20240826$EXP$$IT-MYLANLABS-2022M1114720$MYLAN$Cetta I, Messina R, Colombo B, Filippi M. Myocardial infarction in a patient with migraine and triptan overuse treated with anti-CGRP receptor monoclonal antibody: a case report. Journal of Neurology. 2022;269(9):5170-5172$54$YR$$M$Y$$$20240826$$HP$IT$IT
2147359312$21473593$12$F$20220101$20240711$20221018$20240715$EXP$$IN-PFIZER INC-PV202200008764$PFIZER$$62$YR$$F$Y$65$KG$20240715$$CN$IN$IN
214737667$21473766$7$F$20221205$20240814$20221018$20240820$EXP$$CA-TAKEDA-2022TUS065545$TAKEDA$$59$YR$$M$Y$$$20240820$$HP$CA$CA
214740385$21474038$5$F$$20240722$20221018$20240726$EXP$$US-TAKEDA-2021TUS048851$TAKEDA$$$$$F$Y$72$KG$20240726$$CN$US$US
214742194$21474219$4$F$20221012$20240717$20221018$20240725$30DAY$$US-GSK-US2022146809$GLAXOSMITHKLINE$$41$YR$$M$Y$$$20240725$$PH$US$US
214742582$21474258$2$F$20220818$20240902$20221018$20240906$EXP$$DE-ABBVIE-4157613$ABBVIE$$67$YR$$F$Y$$$20240906$$HP$DE$DE
2147453212$21474532$12$F$20200114$20240924$20221018$20240926$EXP$$US-TAKEDA-2022TUS074737$TAKEDA$$27$YR$$M$Y$$$20240926$$MD$US$US
214749523$21474952$3$F$20221003$20240711$20221019$20240716$EXP$$JP-TAKEDA-2022TJP075641$TAKEDA$$7$YR$$F$Y$19$KG$20240716$$MD$JP$JP
214749882$21474988$2$F$$20240701$20221019$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-359031$RANBAXY$$$$$M$Y$$$20240711$$HP$US$US
2147508618$21475086$18$F$20200601$20240917$20221019$20240921$EXP$$DE-ABBVIE-4153526$ABBVIE$$80$YR$$M$Y$69$KG$20240921$$HP$DE$DE
214751205$21475120$5$F$20210825$20240916$20221019$20240918$EXP$$DE-ROCHE-2965893$ROCHE$$33$YR$A$F$Y$$$20240918$$CN$DE$DE
2147512110$21475121$10$F$20160101$20240827$20221019$20240904$EXP$$DE-ROCHE-3159749$ROCHE$$54$YR$A$F$Y$$$20240904$$CN$DE$DE
214752363$21475236$3$F$20221001$20221021$20221019$20240925$PER$$US-GSK-US2022AMR144130$GLAXOSMITHKLINE$$42$YR$$F$Y$$$20240925$$CN$US$US
214754924$21475492$4$F$$20240821$20221019$20240828$EXP$$DE-ROCHE-2750910$ROCHE$$52$YR$A$M$Y$$$20240828$$CN$DE$DE
214755547$21475554$7$F$20220701$20240912$20221019$20240921$EXP$$CA-CELLTRION INC.-2022CA007509$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
214757633$21475763$3$F$20220903$20240820$20221019$20240823$EXP$$US-ABBVIE-4149317$ABBVIE$$67$YR$$F$Y$$$20240823$$MD$US$US
214760145$21476014$5$F$$20240808$20221019$20240813$EXP$$US-TAKEDA-2022TUS072741$TAKEDA$$$$$M$Y$$$20240813$$CN$US$US
214760402$21476040$2$F$20221017$20221017$20221019$20240925$PER$$US-GSK-US2022AMR149683$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240925$$CN$US$US
214763213$21476321$3$F$20200827$20240705$20221019$20240726$EXP$$DE-ROCHE-2713477$ROCHE$$48$YR$A$F$Y$$$20240726$$CN$DE$DE
214763655$21476365$5$F$20210601$20240902$20221019$20240905$EXP$$DE-ROCHE-2904400$ROCHE$$36$YR$A$F$Y$$$20240905$$CN$DE$DE
214770985$21477098$5$F$20220804$20240725$20221019$20240807$EXP$$BE-ROCHE-3195134$ROCHE$$49$YR$A$F$Y$62.8$KG$20240807$$MD$BE$BE
2147758815$21477588$15$F$20200101$20240814$20221019$20240822$EXP$$CA-CELLTRION INC.-2020CA021044$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
214786423$21478642$3$F$20240501$20240808$20221019$20240816$PER$$US-SA-2022SA419687$SANOFI AVENTIS$$$$A$F$Y$81.64$KG$20240816$$MD$US$US
214787722$21478772$2$F$20221007$20240723$20221019$20240729$EXP$$US-SA-2022SA427049$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240729$$MD$US$US
214797669$21479766$9$F$20220101$20240625$20221019$20240709$EXP$$CO-BIOMARINAP-CO-2022-146274$BIOMARIN$$$$$$Y$$$20240709$$CN$CO$CO
214802092$21480209$2$F$20221001$20240703$20221019$20240712$PER$$US-SA-2022SA428876$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240712$$MD$US$US
214803653$21480365$3$F$20221001$20240911$20221019$20240913$EXP$$CA-PFIZER INC-202101577066$PFIZER$$25$YR$$F$Y$53$KG$20240913$$MD$CA$CA
214808105$21480810$5$F$20240101$20240903$20221019$20240925$PER$$US-SA-2022SA424371$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240925$$MD$US$US
214809434$21480943$4$F$20160101$20240910$20221019$20240912$EXP$$US-PFIZER INC-202201236824$PFIZER$$75$YR$$F$Y$71.655$KG$20240912$$CN$US$US
214817677$21481767$7$F$20201013$20240919$20221020$20240923$EXP$$DE-ROCHE-2829644$ROCHE$$30$YR$A$F$Y$$$20240923$$CN$DE$DE
214821394$21482139$4$F$20220301$20240906$20221020$20240912$EXP$$CA-ABBVIE-4154897$ABBVIE$$$$$$Y$$$20240912$$MD$CA$CA
214825645$21482564$5$F$$20240705$20221020$20240715$EXP$$CA-TAKEDA-2019TUS014926$TAKEDA$$$$$F$Y$$$20240715$$CN$CA$CA
214827893$21482789$3$F$$20240726$20221020$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-12309$LUPIN$$$$$$Y$$$20240815$$CN$US$US
214828443$21482844$3$F$20221001$20221108$20221020$20240925$PER$$US-GSK-US2022AMR149740$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$MD$US$US
214830762$21483076$2$F$$20240421$20221020$20240924$PER$$US-CELLTRION INC.-2022US009597$CELLTRION$$$$$$Y$$$20240924$$HP$US$US
214832712$21483271$2$F$$20240820$20221020$20240827$EXP$$US-GSK-US2022AMR149779$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
2148333811$21483338$11$F$20200122$20240920$20221020$20240930$EXP$$CA-CELLTRION INC.-2019CA027869$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
214838572$21483857$2$F$$20231222$20221020$20240924$PER$$US-CELLTRION INC.-2022US009725$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
214839337$21483933$7$F$20200101$20240708$20221020$20240712$EXP$$CA-BAUSCH-BL-2020-022764$BAUSCH AND LOMB$$31$YR$$M$Y$93.978$KG$20240712$$CN$CA$CA
214840205$21484020$5$F$20211201$20240904$20221020$20240906$EXP$$US-TAKEDA-2022TUS014673$TAKEDA$$60$YR$$F$Y$$$20240906$$CN$US$US
214841114$21484111$4$F$20220101$20240620$20221020$20240702$PER$$US-SA-2022SA419973$SANOFI AVENTIS$$13$YR$T$M$Y$68.03$KG$20240702$$MD$US$US
214842142$21484214$2$F$20220901$20240726$20221020$20240805$PER$$US-SA-2022SA421965$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240805$$MD$US$US
214847862$21484786$2$F$$20240730$20221020$20240731$EXP$$US-PFIZER INC-PV202200086141$PFIZER$$78$YR$$F$Y$$$20240731$$CN$US$US
214848222$21484822$2$F$$20221014$20221020$20240715$EXP$$DE-ASTELLAS-2022US037050$ASTELLAS$$$$$F$Y$$$20240715$$MD$DE$DE
214851203$21485120$3$F$$20240702$20221020$20240705$EXP$$US-PFIZER INC-202201215321$PFIZER$Grewal, S.. STATUS ASTHMATICUS COMPLICATED BY RHABDOMYOLYSIS. Chest. 2022;162(4 Suppl):A706-A707$21$YR$$M$Y$$$20240705$$HP$US$US
214853183$21485318$3$F$20221015$20240626$20221020$20240702$PER$$US-PFIZER INC-202201241855$PFIZER$$45$YR$$F$Y$$$20240702$$HP$US$US
214854595$21485459$5$F$$20240805$20221020$20240812$PER$$US-PFIZER INC-202201239805$PFIZER$$75$YR$$M$Y$95.25$KG$20240812$$CN$US$US
214856397$21485639$7$F$20170609$20240808$20221020$20240812$EXP$$CA-TAKEDA-2022TUS073906$TAKEDA$$57$YR$$F$Y$$$20240812$$MD$CA$CA
2148567611$21485676$11$F$20220101$20240821$20221020$20240828$EXP$$US-GSK-US2022AMR148251$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
2148567716$21485677$16$F$20220201$20240216$20221020$20240926$EXP$$US-GSK-US2022AMR026444$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
214857765$21485776$5$F$20220101$20240816$20221020$20240823$EXP$$IN-BIOGEN-2022BI01162354$BIOGEN$$52$YR$$F$Y$$$20240823$$CN$IN$IN
214859525$21485952$5$F$20220101$20240827$20221020$20240830$EXP$$CA-PFIZER INC-202200949751$PFIZER$$40$YR$$F$Y$$$20240830$$HP$CA$CA
214861418$21486141$8$F$20220207$20240920$20221020$20240926$EXP$$IN-PFIZER INC-202101797727$PFIZER$$58$YR$$M$Y$65$KG$20240926$$CN$IN$IN
2148625715$21486257$15$F$$20240722$20221020$20240725$EXP$$US-TAKEDA-2022TUS065259$TAKEDA$$$$$F$Y$78.005$KG$20240725$$HP$US$US
2148669716$21486697$16$F$$20240722$20221020$20240724$PER$$US-DSJP-DSU-2022-137939$DAIICHI$$$$$F$Y$$$20240724$$CN$US$US
214868423$21486842$3$F$$20240820$20221020$20240822$PER$$US-PFIZER INC-2019298255$PFIZER$$80$YR$$F$Y$$$20240822$$MD$US$US
214871545$21487154$5$F$20220919$20240910$20221020$20240917$EXP$$AU-TAKEDA-2022TUS076624$TAKEDA$$77$YR$$F$Y$$$20240917$$CN$AU$AU
214872134$21487213$4$F$$20240710$20221020$20240716$EXP$$IT-MYLANLABS-2022M1115831$MYLAN$Berloffa S, Dosi C, Tascini B, Fossati B, Lupetti I, Masi G.. Neuroleptic Malignant Syndrome in Children with Autism Spectrum Disorder (ASD):  A case report and brief review of recent literature. Children-(Basel). 2021;8No.12:0001-7$16$YR$$M$Y$$$20240716$$HP$IT$IT
214873145$21487314$5$F$20221003$20240813$20221020$20240816$PER$$US-BIOGEN-2022BI01163557$BIOGEN$$53$YR$$F$Y$$$20240816$$CN$US$US
214876152$21487615$2$F$20220921$20240822$20221020$20240829$EXP$$NVSC2022KR234593$NOVARTIS$$68$YR$$F$Y$$$20240829$$MD$KR$KR
214881054$21488105$4$F$20221007$20240610$20221020$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003506$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240705$$CN$US$US
214882448$21488244$8$F$20210123$20240812$20221020$20240820$EXP$$CA-CELLTRION INC.-2020CA034695$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
214885352$21488535$2$F$$20240412$20221021$20240924$PER$$US-CELLTRION INC.-2022US005446$CELLTRION$$$$$$Y$$$20240924$$HP$US$US
214891569$21489156$9$F$20220913$20240918$20221021$20240927$EXP$$CA-CELLTRION INC.-2022CA006298$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
214893135$21489313$5$F$20221114$20240906$20221021$20240913$EXP$$US-ABBVIE-4168778$ABBVIE$$77$YR$$F$Y$60.781$KG$20240913$$CN$US$US
214895454$21489545$4$F$20220722$20240711$20221021$20240720$EXP$$FR-CELLTRION INC.-2022FR016541$CELLTRION$$$$$$Y$$$20240720$$MD$FR$FR
214898013$21489801$3$F$20221012$20240913$20221021$20240918$PER$$NVSC2022US234239$NOVARTIS$$33$YR$$F$Y$$$20240918$$CN$US$US
214898294$21489829$4$F$$20240906$20221021$20240911$EXP$$US-TAKEDA-2022TUS075281$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
214898826$21489882$6$F$20220902$20240625$20221021$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003498$ACADIA PHARMACEUTICALS$$64$YR$$M$Y$$$20240705$$CN$US$US
214901912$21490191$2$F$$20240321$20221021$20240924$PER$$US-CELLTRION INC.-2022US013037$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
214901922$21490192$2$F$$20240312$20221021$20240924$PER$$US-CELLTRION INC.-2022US010648$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
214902373$21490237$3$F$20220701$20240610$20221021$20240703$EXP$$DE-ROCHE-3203047$ROCHE$$55$YR$A$F$Y$$$20240703$$MD$DE$DE
214905285$21490528$5$F$20221010$20240807$20221021$20240813$EXP$$CA-CELLTRION INC.-2022CA015800$CELLTRION$$$$$$Y$$$20240813$$CN$CA$CA
214914267$21491426$7$F$20220801$20240710$20221021$20240712$EXP$$CA-UCBSA-2022032906$UCB$$75$YR$$F$Y$$$20240712$$HP$CA$CA
214914843$21491484$3$F$20240101$20240925$20221021$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202210009323$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240927$$MD$US$US
2149149614$21491496$14$F$20230215$20240807$20221021$20240809$EXP$$AU-TAKEDA-2022TUS077060$TAKEDA$$48$YR$$F$Y$$$20240809$$HP$AU$AU
214920372$21492037$2$F$20220105$20221018$20221021$20240926$EXP$$US-GSK-US2021AMR250603$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
214924502$21492450$2$F$$20240814$20221021$20240828$PER$$US-SA-2022SA426482$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240828$$MD$US$US
214926169$21492616$9$F$$20240805$20221021$20240813$EXP$$US-PFIZER INC-202200661329$PFIZER$$$$E$M$Y$92.99$KG$20240813$$CN$US$US
214926847$21492684$7$F$20210303$20240716$20221021$20240730$EXP$$DE-ROCHE-2831972$ROCHE$$58$YR$A$F$Y$$$20240730$$CN$DE$DE
214927342$21492734$2$F$20220101$20240723$20221021$20240731$PER$$US-SA-2022SA433170$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240731$$MD$US$US
214927774$21492777$4$F$20220707$20240613$20221021$20240702$EXP$$DE-ROCHE-3151343$ROCHE$$32$YR$A$F$Y$$$20240702$$CN$DE$DE
2149292112$21492921$12$F$$20240916$20221021$20240918$PER$$US-PFIZER INC-PV202200086536$PFIZER$$67$YR$$F$Y$$$20240918$$CN$US$US
214929753$21492975$3$F$$20240822$20221021$20240902$EXP$$CA-APOTEX-2022AP014318$APOTEX$$41$YR$$F$Y$66$KG$20240902$$HP$CA$CA
214931112$21493111$2$F$20221011$20240827$20221021$20240905$EXP$$US-EMD Serono-9342578$EMD SERONO INC$$67$YR$E$F$Y$$$20240905$$CN$US$US
214935154$21493515$4$F$$20240913$20221021$20240916$PER$$US-PFIZER INC-2021882150$PFIZER$$53$YR$$F$Y$89.796$KG$20240916$$CN$US$US
214938064$21493806$4$F$$20240729$20221021$20240731$PER$$US-PFIZER INC-PV202200086364$PFIZER$$67$YR$$F$Y$$$20240731$$CN$US$US
214940277$21494027$7$F$20220101$20240723$20221021$20240730$EXP$$NVSC2022US236987$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
214940695$21494069$5$F$20220613$20240913$20221021$20240918$EXP$$CA-TAKEDA-2022TUS069289$TAKEDA$$11$YR$$M$Y$$$20240918$$CN$CA$CA
214943648$21494364$8$F$20230529$20240919$20221021$20240925$EXP$$AU-TAKEDA-2022TUS077075$TAKEDA$$45$YR$$F$Y$$$20240925$$HP$AU$AU
2149468610$21494686$10$F$20220522$20240910$20221021$20240911$EXP$$PL-ROCHE-3181021$ROCHE$$66$YR$E$F$Y$76$KG$20240911$$MD$PL$PL
214947293$21494729$3$F$20220101$20240809$20221021$20240819$PER$$US-SA-2022SA422708$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240819$$MD$US$US
214948423$21494842$3$F$$20240729$20221021$20240807$PER$$US-SA-2022SA427414$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240807$$MD$US$US
214949182$21494918$2$F$$20240216$20221022$20240924$PER$$US-CELLTRION INC.-2022US009112$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
214949212$21494921$2$F$$20240509$20221022$20240924$PER$$US-CELLTRION INC.-2022US009397$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
2149596623$21495966$23$F$20210101$20240916$20221022$20240925$EXP$$CA-CELLTRION INC.-2021CA013331$CELLTRION$$$$$$Y$$$20240925$$MD$CA$CA
214961962$21496196$2$F$20230101$20240919$20221022$20240928$PER$$US-ABBVIE-4142982$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
214968483$21496848$3$F$$20240916$20221022$20240925$PER$$US-ABBVIE-4151956$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
2149769918$21497699$18$F$20220101$20240623$20221024$20240701$EXP$$CA-CELLTRION INC.-2022CA015773$CELLTRION$$$$$$Y$$$20240701$$MD$CA$CA
214977612$21497761$2$F$$20240628$20221024$20240712$EXP$$PL-SA-2022SA431640$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240712$$MD$PL$PL
2149779831$21497798$31$F$20220101$20240918$20221024$20240927$EXP$$CA-CELLTRION INC.-2022CA015778$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
214978188$21497818$8$F$20221001$20240919$20221024$20240928$EXP$$CA-CELLTRION INC.-2022CA011975$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
2149784012$21497840$12$F$20220101$20240819$20221024$20240827$EXP$$CA-CELLTRION INC.-2022CA010297$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
2149788116$21497881$16$F$20220901$20240911$20221024$20240919$EXP$$CA-CELLTRION INC.-2021CA019128$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
214981157$21498115$7$F$20220101$20240910$20221024$20240918$EXP$$CA-CELLTRION INC.-2021CA017676$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
214981623$21498162$3$F$$20240927$20221024$20240930$PER$$NVSC2022US236601$NOVARTIS$$$$$F$Y$63.3$KG$20240930$$HP$US$US
214981823$21498182$3$F$$20240702$20221024$20240710$EXP$$GB-TAKEDA-2022TUS077059$TAKEDA$$$$$F$Y$$$20240710$$CN$GB$GB
214982005$21498200$5$F$20220314$20240819$20221024$20240829$EXP$$JP-ASTELLAS-2022JP015348$ASTELLAS$$82$YR$E$M$Y$80$KG$20240828$$MD$JP$JP
214989648$21498964$8$F$$20240819$20221024$20240826$EXP$$CA-BAUSCH-BL-2022-023860$BAUSCH AND LOMB$Kattail D, Niec A. Caregiver-fabricated illness in a child prescribed long-term opioids and benzodiazepines. Journal of Opioid Management. 2020;16 (2):155-159. doi:DOI:10.5055/jom.2020.0562$11$YR$$M$Y$$$20240826$$MD$CA$CA
214997813$21499781$3$F$20220901$20240916$20221024$20240918$PER$$US-PFIZER INC-PV202200032339$PFIZER$$68$YR$$F$Y$$$20240918$$CN$US$US
214998499$21499849$9$F$20240729$20240808$20221024$20240813$EXP$$US-PFIZER INC-PV202200087155$PFIZER$$71$YR$$M$Y$74.83$KG$20240813$$CN$US$US
214999303$21499930$3$F$20240625$20240708$20221024$20240709$EXP$$US-PFIZER INC-PV202200088453$PFIZER$$80$YR$$M$Y$$$20240709$$HP$US$US
2149996815$21499968$15$F$20211201$20240717$20221024$20240719$EXP$$US-PFIZER INC-PV202200003341$PFIZER$$66$YR$$M$Y$69.853$KG$20240719$$CN$US$US
215004164$21500416$4$F$$20240917$20221025$20240924$EXP$$US-GSK-US2022150541$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$US$US
2150048011$21500480$11$F$20220918$20240815$20221025$20240822$EXP$$NVSC2022MX227644$NOVARTIS$$38$YR$$M$Y$54$KG$20240822$$CN$MX$MX
2150125822$21501258$22$F$20220101$20240918$20221025$20240927$EXP$$CA-CELLTRION INC.-2022CA007980$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
215012618$21501261$8$F$$20240718$20221025$20240723$EXP$$US-PFIZER INC-202200714053$PFIZER$$72$YR$$F$Y$87.4$KG$20240723$$MD$US$US
2150126212$21501262$12$F$19900101$20240924$20221025$20240927$EXP$$US-PFIZER INC-2020321184$PFIZER$$63$YR$$F$Y$63.5$KG$20240927$$MD$US$US
2150126312$21501263$12$F$$20240812$20221025$20240812$EXP$$US-PFIZER INC-2019505750$PFIZER$$55$YR$$F$Y$$$20240812$$HP$US$US
215015355$21501535$5$F$20220710$20240903$20221025$20240909$EXP$$GR-BIOGEN-2022BI01161818$BIOGEN$$54$YR$$F$Y$60$KG$20240909$$MD$GR$GR
215015503$21501550$3$F$20221018$20240822$20221025$20240829$EXP$$CA-ROCHE-2968700$ROCHE$$37$YR$A$M$Y$$$20240829$$HP$CA$CA
215016867$21501686$7$F$20200903$20240812$20221025$20240821$EXP$$DE-ROCHE-2819403$ROCHE$$48$YR$A$F$Y$93$KG$20240821$$CN$DE$DE
215017303$21501730$3$F$20221201$20240619$20221025$20240710$EXP$$DE-ROCHE-3205782$ROCHE$$49$YR$A$F$Y$60$KG$20240710$$MD$DE$DE
215019676$21501967$6$F$$20240926$20221025$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-125750$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$73.03$KG$20240928$$CN$US$US
215021939$21502193$9$F$20221001$20230512$20221025$20240926$PER$$US-GSK-US2022AMR151946$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240926$$CN$US$US
215024728$21502472$8$F$$20240803$20221025$20240805$EXP$$CA-ROCHE-3205288$ROCHE$$67$YR$E$F$Y$34$KG$20240805$$HP$CA$CA
2150373716$21503737$16$F$20220501$20240918$20221025$20240926$EXP$$NVSC2022EG237300$NOVARTIS$$42$YR$$F$Y$$$20240926$$CN$EG$EG
215037883$21503788$3$F$$20221104$20221025$20240923$PER$$NVSC2022US238385$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
215039039$21503903$9$F$20221118$20240911$20221025$20240918$EXP$$US-GSK-US2022AMR152920$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$US$US
215040087$21504008$7$F$$20240918$20221025$20240925$PER$$NVSC2022US239678$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
215040706$21504070$6$F$20211007$20240627$20221025$20240718$EXP$$DE-ROCHE-2941944$ROCHE$$55$YR$A$F$Y$$$20240718$$CN$DE$DE
215042312$21504231$2$F$20220205$20240914$20221025$20240927$EXP$$CN-DSJP-DSE-2022-114499$DAIICHI$$85$YR$$F$Y$65$KG$20240927$$MD$CN$CN
215047034$21504703$4$F$20221018$20240827$20221025$20240909$EXP$$US-MYOVANT SCIENCES GMBH-2022MYSCI0900168$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
215049257$21504925$7$F$20221001$20240819$20221025$20240821$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000470$PAREXEL$$$$$$Y$$$20240821$$MD$US$US
2150569114$21505691$14$F$20220101$20240911$20221026$20240919$EXP$$CA-CELLTRION INC.-2022CA011054$CELLTRION$$$$$$Y$$$20240919$$CN$CA$CA
215058274$21505827$4$F$20220701$20240811$20221026$20240817$PER$$US-SA-2022SA367672$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240817$$MD$US$US
215063722$21506372$2$F$20221003$20221021$20221026$20240925$PER$$US-GSK-US2022AMR152989$GLAXOSMITHKLINE$$33$YR$$F$Y$$$20240925$$CN$US$US
2150656516$21506565$16$F$20220502$20240910$20221026$20240918$EXP$$CA-CELLTRION INC.-2022CA008662$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
215066163$21506616$3$F$$20240726$20221026$20240807$PER$$US-SA-2022SA430035$SANOFI AVENTIS$$$$A$F$Y$58.05$KG$20240807$$MD$US$US
215069082$21506908$2$F$20211201$20240819$20221026$20240828$PER$$US-ABBVIE-4165705$ABBVIE$$18$YR$$F$Y$$$20240828$$CN$US$US
215072737$21507273$7$F$20221019$20230119$20221026$20240925$PER$$US-GSK-US2022AMR151984$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$MD$US$US
215073395$21507339$5$F$20221110$20240828$20221026$20240919$PER$$US-SA-2022SA428950$SANOFI AVENTIS$$58$YR$A$F$Y$77.11$KG$20240919$$MD$US$US
215073875$21507387$5$F$20221014$20221209$20221026$20240813$EXP$$NVSC2022US235569$NOVARTIS$$26$YR$$F$Y$$$20240813$$CN$US$US
215074284$21507428$4$F$20231211$20240807$20221026$20240816$PER$$US-SA-2022SA434271$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240816$$MD$US$US
215074422$21507442$2$F$$20240918$20221026$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127171$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$68$YR$E$F$Y$$$20240925$$HP$US$US
215074622$21507462$2$F$$20240918$20221026$20240922$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127172$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$59$YR$A$M$Y$$$20240923$$HP$US$US
215075178$21507517$8$F$$20240715$20221026$20240717$PER$$US-PFIZER INC-PV202200089796$PFIZER$$65$YR$$F$Y$63.492$KG$20240717$$CN$US$US
215075375$21507537$5$F$$20240919$20221026$20240923$PER$$US-PFIZER INC-PV202200089657$PFIZER$$75$YR$$F$Y$$$20240923$$CN$US$US
2150779612$21507796$12$F$$20240905$20221026$20240913$EXP$$CA-CELLTRION INC.-2021CA019371$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
2150783411$21507834$11$F$20220101$20240924$20221026$20240926$EXP$$US-PFIZER INC-2020446894$PFIZER$$80$YR$$F$Y$63.96$KG$20240926$$CN$US$US
215080166$21508016$6$F$20220922$20240708$20221026$20240717$EXP$$JP-009507513-2210JPN002642J$MERCK$$71$YR$$F$Y$$$20240717$$MD$JP$JP
215081358$21508135$8$F$$20240828$20221026$20240904$EXP$$CA-ANIPHARMA-2021-CA-000205$ANI$$71$YR$$M$Y$$$20240904$$MD$CA$CA
215081402$21508140$2$F$$20240918$20221026$20240922$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127176$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$45$YR$A$F$Y$$$20240923$$HP$US$US
215081412$21508141$2$F$$20240918$20221026$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127183$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$68$YR$E$M$Y$$$20240924$$HP$US$US
215081782$21508178$2$F$$20240918$20221026$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127175$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$59$YR$A$M$Y$$$20240924$$HP$US$US
215081982$21508198$2$F$$20240918$20221026$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127174$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$65$YR$E$M$Y$$$20240925$$HP$US$US
215082002$21508200$2$F$$20240918$20221026$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127173$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$64$YR$A$F$Y$$$20240925$$HP$US$US
215083032$21508303$2$F$$20240918$20221026$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127184$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$74$YR$E$M$Y$$$20240924$$HP$US$US
215083144$21508314$4$F$20210803$20240814$20221026$20240821$EXP$$CO-AMGEN-COLSL2021038543$AMGEN$$54$YR$A$F$Y$$$20240821$$CN$CO$CO
215085035$21508503$5$F$$20221025$20221026$20240808$PER$$US-OTSUKA-2022_043517$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
2150864817$21508648$17$F$20220101$20240705$20221026$20240709$EXP$$CA-PFIZER INC-202201236939$PFIZER$$70$YR$$F$Y$78$KG$20240709$$HP$CA$CA
215087105$21508710$5$F$20240712$20240713$20221026$20240722$EXP$$IN-TAKEDA-2022TUS077106$TAKEDA$$33$YR$$M$Y$$$20240722$$CN$IN$IN
215087152$21508715$2$F$$20240918$20221026$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127185$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$69$YR$E$M$Y$$$20240924$$HP$US$US
215087502$21508750$2$F$$20240918$20221026$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127186$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$53$YR$A$F$Y$$$20240924$$HP$US$US
215088715$21508871$5$F$20240301$20240814$20221026$20240820$EXP$$US-GW PHARMA-2022-US-033395$JAZZ$$6$YR$$F$Y$17.234$KG$20240820$$CN$US$US
215091522$21509152$2$F$$20240708$20221026$20240712$PER$$US-ABBVIE-4171702$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
215093313$21509331$3$F$$20240729$20221026$20240731$EXP$$CA-ROCHE-3206991$ROCHE$$$$A$F$Y$76.2$KG$20240731$$CN$CA$CA
215094232$21509423$2$F$$20240918$20221026$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127182$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$51$YR$A$F$Y$$$20240924$$HP$US$US
215094812$21509481$2$F$$20240918$20221026$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127177$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$59$YR$A$M$Y$$$20240925$$HP$US$US
215101876$21510187$6$F$$20240905$20221026$20240909$EXP$$US-JAZZ-2022-US-027208$JAZZ$$$$$M$Y$$$20240909$$MD$US$US
215102009$21510200$9$F$$20240813$20221026$20240819$EXP$$US-JAZZ-2022-US-007394$JAZZ$$$$$M$Y$106.58$KG$20240819$$MD$US$US
2151026921$21510269$21$F$20230509$20240920$20221026$20240923$EXP$$US-JAZZ-2022-US-019505$JAZZ$$60$YR$$M$Y$$$20240923$$CN$US$US
2151027613$21510276$13$F$20231016$20240827$20221026$20240830$EXP$$US-JAZZ-2022-US-027913$JAZZ$$47$YR$$F$Y$$$20240830$$HP$US$US
215102965$21510296$5$F$20221116$20240913$20221026$20240918$EXP$$US-JAZZ-2022-US-028007$JAZZ$$44$YR$$M$Y$$$20240918$$CN$US$US
215105163$21510516$3$F$20220101$20240801$20221026$20240808$EXP$$US-JAZZ-2022-US-013408$JAZZ$$$$$F$Y$$$20240808$$MD$US$US
215105863$21510586$3$F$$20240730$20221026$20240805$EXP$$US-TAKEDA-2018TUS003270$TAKEDA$$$$$F$Y$$$20240805$$HP$US$US
215108303$21510830$3$F$20210701$20240822$20221026$20240830$EXP$$CA-CELLTRION INC.-2021CA016618$CELLTRION$$$$$$Y$$$20240830$$MD$CA$CA
215108632$21510863$2$F$$20240918$20221026$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127181$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$56$YR$A$F$Y$$$20240924$$HP$US$US
215108812$21510881$2$F$$20240918$20221026$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127180$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$56$YR$A$M$Y$$$20240924$$HP$US$US
2151100617$21511006$17$F$20220101$20240625$20221027$20240703$EXP$$CA-CELLTRION INC.-2022CA008870$CELLTRION$$$$$$Y$$$20240703$$HP$CA$CA
215112232$21511223$2$F$$20240918$20221027$20240922$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127178$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$53$YR$A$M$Y$$$20240923$$HP$US$US
215112287$21511228$7$F$20221221$20230404$20221027$20240925$PER$$US-GSK-US2022AMR154591$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
215112482$21511248$2$F$$20240918$20221027$20240922$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-127179$BRISTOL MYERS SQUIBB$Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, et al. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances. 2023 Jan 24;7(2):236-45. doi:10.1182/bloodadvances.2022007496.$69$YR$E$M$Y$$$20240923$$HP$US$US
215113085$21511308$5$F$20221001$20221109$20221027$20240925$PER$$US-GSK-US2022AMR142566$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
215114395$21511439$5$F$20221016$20240906$20221027$20240920$PER$$US-SA-2022SA432628$SANOFI AVENTIS$$72$YR$E$M$Y$89.35$KG$20240920$$MD$US$US
215116562$21511656$2$F$$20240905$20221027$20240906$EXP$$CA-ROCHE-3207751$ROCHE$$77$YR$E$F$Y$$$20240906$$HP$CA$CA
215118298$21511829$8$F$20221001$20230124$20221027$20240926$EXP$$US-GSK-US2022AMR149024$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
215122575$21512257$5$F$20230921$20240823$20221027$20240910$PER$$CA-TOLMAR, INC.-22CA037171$TOLMAR$$64$YR$$M$Y$$$20240910$$CN$CA$CA
215122646$21512264$6$F$20230628$20240716$20221027$20240813$PER$$CA-TOLMAR, INC.-22CA037192$TOLMAR$$66$YR$$M$Y$$$20240813$$CN$CA$CA
215124272$21512427$2$F$$20240801$20221027$20240810$PER$$US-ABBVIE-4172928$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
215129015$21512901$5$F$20190801$20240923$20221027$20240927$EXP$$US-ABBVIE-4176229$ABBVIE$$71$YR$$F$Y$59.874$KG$20240927$$CN$US$US
215129023$21512902$3$F$20220701$20240731$20221027$20240805$EXP$$CN-TAKEDA-2022TUS077289$TAKEDA$$26$YR$$F$Y$50$KG$20240805$$MD$CN$CN
2151290815$21512908$15$F$20210526$20240731$20221027$20240807$EXP$$CA-CELLTRION INC.-2020CA035048$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
215130662$21513066$2$F$$20240722$20221027$20240723$PER$$NVSC2022US238165$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
215131098$21513109$8$F$20190101$20240917$20221027$20240927$EXP$$DE-ROCHE-2724759$ROCHE$$48$YR$A$F$Y$$$20240927$$CN$DE$DE
215131314$21513131$4$F$20190101$20240812$20221027$20240827$EXP$$US-ASTELLAS-2021US021229$ASTELLAS$$69$YR$E$M$Y$$$20240826$$CN$US$US
215131806$21513180$6$F$20211202$20231212$20221027$20240724$EXP$$US-SA-2022SA024057$SANOFI AVENTIS$$78$YR$E$F$Y$70.3$KG$20240724$$HP$US$US
215132565$21513256$5$F$20150330$20240801$20221027$20240808$EXP$$US-GSK-US2022152979$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
215132653$21513265$3$F$20200414$20240816$20221027$20240822$EXP$$NVSC2020CO090718$NOVARTIS$$48$YR$$F$Y$52$KG$20240822$$CN$CO$CO
2151337812$21513378$12$F$20220101$20240820$20221027$20240828$EXP$$CA-CELLTRION INC.-2022CA014136$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
215135232$21513523$2$F$20220822$20221021$20221027$20240926$EXP$$US-GSK-US2022AMR084968$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
215138122$21513812$2$F$20240703$20240703$20221027$20240712$PER$$US-SA-2022SA438908$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240712$$MD$US$US
215139497$21513949$7$F$$20240809$20221027$20240809$PER$$US-PFIZER INC-PV202200090111$PFIZER$$78$YR$$F$Y$$$20240809$$CN$US$US
215142395$21514239$5$F$20220101$20240701$20221027$20240707$PER$$US-SA-2022SA440101$SANOFI AVENTIS$$54$YR$A$M$Y$68$KG$20240708$$MD$US$US
2151445017$21514450$17$F$20210709$20240905$20221027$20240910$EXP$$CA-HLS-202108187$HLS THERAPEUTICS$$33$YR$A$F$Y$74$KG$20240910$$HP$CA$CA
215147373$21514737$3$F$20220411$20240710$20221027$20240711$EXP$$DE-TAKEDA-2022TUS078207$TAKEDA$$16$YR$$F$Y$63$KG$20240711$$HP$DE$DE
2151476520$21514765$20$F$$20240718$20221027$20240726$EXP$$CA-PFIZER INC-PV202200083172$PFIZER$Austin, E.. Acute thiamine deficiency as a complication of insulin euglycemic therapy for an amlodipine overdose.. Clinical Toxicology. 2022;60 (SUPPL 2):124$15$YR$$F$Y$54$KG$20240726$$HP$CA$CA
215147674$21514767$4$F$20221008$20240809$20221027$20240816$EXP$$CN-TAKEDA-2022TUS077892$TAKEDA$$54$YR$$F$Y$53$KG$20240816$$MD$CN$CN
215148929$21514892$9$F$20150728$20240716$20221027$20240726$EXP$$CA-ROCHE-3207469$ROCHE$$47$YR$A$F$Y$$$20240726$$MD$CA$CA
215151033$21515103$3$F$20220328$20240722$20221027$20240729$EXP$$GB-VERTEX PHARMACEUTICALS-2022-015924$VERTEX$$10$YR$$M$Y$$$20240729$$MD$GB$GB
215152389$21515238$9$F$20221001$20240802$20221027$20240807$EXP$$US-PFIZER INC-PV202200090184$PFIZER$$80$YR$$F$Y$$$20240807$$CN$US$US
2151530719$21515307$19$F$20211229$20240829$20221027$20240904$EXP$$CA-PFIZER INC-202200163359$PFIZER$$28$YR$$F$Y$62$KG$20240904$$HP$CA$CA
2151555411$21515554$11$F$$20240628$20221027$20240703$EXP$$CA-AstraZeneca-2020SF15804$ASTRAZENECA$$53$YR$$M$Y$$$20240703$$MD$CA$
215156072$21515607$2$F$20240418$20240718$20221027$20240724$EXP$$US-KYOWAKIRIN-2022BKK016624$KYOWA$$$$$$Y$$$20240724$$HP$US$US
215157388$21515738$8$F$20221001$20240802$20221027$20240808$PER$$US-BIOGEN-2022BI01164625$BIOGEN$$16$YR$$F$Y$$$20240808$$MD$US$US
215157835$21515783$5$F$20220715$20240912$20221027$20240915$EXP$$FI-TAKEDA-2022TUS079012$TAKEDA$$55$YR$$F$Y$$$20240915$$HP$FI$FI
215168416$21516841$6$F$20220130$20240920$20221028$20240926$EXP$$DE-ROCHE-3016491$ROCHE$$48$YR$A$M$Y$$$20240926$$CN$DE$DE
215168754$21516875$4$F$$20240730$20221028$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003413$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
215169352$21516935$2$F$$20240916$20221028$20240917$PER$$US-ORGANON-O2210USA001988$ORGANON$VanDolah H, Crossley JR, Kim HJ. Three Cases of Uncommon Medication-Induced Osteonecrosis of Temporal Bone. Otolaryngology-Head and Neck Surgery. 2022;167(1S):P245-6$69$YR$$M$Y$$$20240917$$HP$US$US
215169472$21516947$2$F$20240101$20240723$20221028$20240801$PER$$US-SA-2022SA440335$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240801$$MD$US$US
215170107$21517010$7$F$20220909$20240722$20221028$20240729$EXP$$AU-JNJFOC-20221053061$JOHNSON AND JOHNSON$$82$YR$E$M$Y$94.3$KG$20240730$$MD$AU$AU
2151735514$21517355$14$F$20210723$20240719$20221028$20240730$EXP$$DE-ROCHE-2886686$ROCHE$$46$YR$A$F$Y$$$20240730$$CN$DE$DE
215175084$21517508$4$F$20220901$20240820$20221028$20240830$EXP$$US-ROCHE-3205671$ROCHE$$100$YR$E$F$Y$$$20240830$$CN$US$US
215177104$21517710$4$F$20210112$20240827$20221028$20240903$EXP$$CA-ROCHE-3026954$ROCHE$$29$YR$A$F$Y$$$20240903$$CN$CA$CA
2151780910$21517809$10$F$20220804$20240813$20221028$20240816$PER$$US-BIOGEN-2022BI01145340$BIOGEN$$72$YR$$F$Y$$$20240816$$CN$US$US
215178863$21517886$3$F$$20240726$20221028$20240815$EXP$$US-LUPIN PHARMACEUTICALS INC.-2022-12384$LUPIN$$$$$$Y$$$20240815$$CN$US$US
215184845$21518484$5$F$20220101$20240710$20221028$20240720$EXP$$CA-CELLTRION INC.-2022CA012732$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
2151892614$21518926$14$F$20230101$20240816$20221028$20240823$PER$$US-ABBVIE-4176980$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
215189303$21518930$3$F$$20240729$20221028$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-12564$LUPIN$$$$$$Y$$$20240818$$CN$US$US
215191503$21519150$3$F$20200101$20240710$20221028$20240715$EXP$$US-ABBVIE-22K-163-4488953-00$ABBVIE$$$$$M$Y$135$KG$20240715$$CN$US$US
215193034$21519303$4$F$20220825$20240918$20221028$20240925$PER$$NVSC2022US241743$NOVARTIS$$50$YR$$F$Y$$$20240925$$CN$US$US
215193103$21519310$3$F$20221007$20221107$20221028$20240723$EXP$$AU-AstraZeneca-2022A354987$ASTRAZENECA$$29065$DY$$M$Y$$$20240723$$CN$AU$
215195884$21519588$4$F$20221013$20240802$20221028$20240812$EXP$$US-VIIV HEALTHCARE LIMITED-US2022151392$VIIV$$34$YR$$M$Y$$$20240812$$HP$US$US
215196165$21519616$5$F$20211112$20240918$20221028$20240926$EXP$$CA-TAKEDA-2021TUS059932$TAKEDA$$54$YR$$M$Y$$$20240926$$MD$CA$CA
2151969218$21519692$18$F$20220311$20240923$20221028$20240927$EXP$$CO-TAKEDA-2021TUS025708$TAKEDA$$67$YR$$F$Y$84$KG$20240927$$CN$CO$CO
215202663$21520266$3$F$$20240617$20221028$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-360067$RANBAXY$Sastre C, Baillif-Couniou V, Fabresse N, Ameline A, Kintz P, Gaulier J-M, et al. Pregabalin misuse: About seven cases of death in the region of Marseille. Toxic Analyt Clinique. 2022;34(3):151-158$47$YR$$M$Y$$$20240702$$HP$FR$FR
215203025$21520302$5$F$$20240905$20221028$20240906$PER$$US-PFIZER INC-202200730015$PFIZER$$79$YR$$F$Y$$$20240906$$CN$US$US
2152063115$21520631$15$F$20221201$20240727$20221028$20240731$EXP$$CO-TAKEDA-2022TUS079697$TAKEDA$$83$YR$$F$Y$62$KG$20240731$$CN$CO$CO
215208416$21520841$6$F$20230823$20240706$20221028$20240715$EXP$$IN-PFIZER INC-2019203899$PFIZER$$61$YR$$M$Y$$$20240715$$CN$IN$IN
2152084312$21520843$12$F$20210101$20240731$20221028$20240731$EXP$$CA-PFIZER INC-2021082277$PFIZER$$76$YR$$F$Y$47$KG$20240731$$MD$CA$CA
215209745$21520974$5$F$$20240702$20221028$20240704$EXP$$US-TAKEDA-US202025859$TAKEDA$$$$$F$Y$83$KG$20240704$$CN$US$US
215217372$21521737$2$F$$20221020$20221028$20240720$EXP$$NVSC2022CO223363$NOVARTIS$$$$$F$Y$$$20240719$$CN$CO$CO
215218834$21521883$4$F$$20240703$20221028$20240705$EXP$$CA-BAUSCH-BL-2022-024406$BAUSCH AND LOMB$$52$YR$$M$Y$$$20240705$$CN$CA$CA
2152225622$21522256$22$F$20220101$20240713$20221028$20240723$EXP$$CA-CELLTRION INC.-2022CA001536$CELLTRION$$$$$$Y$$$20240723$$MD$CA$CA
2152252028$21522520$28$F$20220101$20240826$20221029$20240903$EXP$$CA-CELLTRION INC.-2022CA017927$CELLTRION$$$$$$Y$$$20240903$$MD$CA$CA
215225326$21522532$6$F$20220726$20240829$20221029$20240907$EXP$$CA-CELLTRION INC.-2021CA013108$CELLTRION$$$$$$Y$$$20240907$$MD$CA$CA
2152279710$21522797$10$F$20210422$20240913$20221029$20240923$EXP$$CA-CELLTRION INC.-2020CA022702$CELLTRION$$$$$$Y$$$20240923$$CN$CA$CA
2152291411$21522914$11$F$20211201$20240808$20221029$20240816$EXP$$CA-CELLTRION INC.-2021CA018259$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
215230779$21523077$9$F$$20240911$20221029$20240920$EXP$$CA-CELLTRION INC.-2022CA017502$CELLTRION$$$$$$Y$$$20240920$$CN$CA$CA
215231956$21523195$6$F$20220101$20240802$20221029$20240808$EXP$$US-ABBVIE-22K-163-4318747-00$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
215234279$21523427$9$F$20220629$20240909$20221029$20240917$EXP$$CA-CELLTRION INC.-2022CA015349$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
215238959$21523895$9$F$20221026$20240920$20221029$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2022-025982$UNITED THERAPEUTICS$$71$YR$$M$Y$75.737$KG$20240926$$$US$US
215240423$21524042$3$F$20240601$20240726$20221029$20240801$PER$$US-ABBVIE-22K-163-4446770-00$ABBVIE$$79$YR$$F$Y$$$20240801$$CN$US$US
215241052$21524105$2$F$20221019$20240828$20221029$20240910$PER$$US-SA-2022SA434253$SANOFI AVENTIS$$13$YR$T$F$Y$82.086$KG$20240910$$CN$US$US
215243523$21524352$3$F$$20240801$20221029$20240806$PER$$NVSC2022US244107$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
2152453416$21524534$16$F$20180214$20240909$20221029$20240916$EXP$$CA-CELLTRION INC.-2018CA017854$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
215246395$21524639$5$F$20221017$20240725$20221030$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-12572$LUPIN$$$$$$Y$$$20240813$$PH$US$US
215248812$21524881$2$F$$20240703$20221030$20240712$PER$$US-SA-2022SA437382$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
2152533012$21525330$12$F$20201030$20240904$20221030$20240905$EXP$$NVSC2022DE243757$NOVARTIS$$$$A$F$Y$$$20240905$$MD$DE$DE
2152535313$21525353$13$F$20230101$20240216$20221030$20240814$EXP$$NVSC2022PE242600$NOVARTIS$$$$$F$Y$$$20240814$$CN$PE$PE
215258207$21525820$7$F$20220101$20240726$20221031$20240731$EXP$$CO-ABBVIE-4181149$ABBVIE$$$$$M$Y$68$KG$20240731$$CN$CO$CO
215260623$21526062$3$F$20220815$20240829$20221031$20240902$EXP$$NVSC2022GB241433$NOVARTIS$$81$YR$$M$Y$$$20240902$$CN$GB$GB
215262443$21526244$3$F$20221019$20240918$20221031$20240920$EXP$$US-BAUSCH-BL-2022-024446$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240920$$CN$US$US
215267524$21526752$4$F$20220101$20240813$20221031$20240821$EXP$$BR-JNJFOC-20221050539$JOHNSON AND JOHNSON$$37$YR$A$M$Y$82$KG$20240821$$CN$BR$BR
215267832$21526783$2$F$$20240912$20221031$20240926$EXP$$AU-SAMSUNG BIOEPIS-SB-2022-27002$SAMSUNG BIOEPIS$$42$YR$A$F$Y$94$KG$20240926$$HP$AU$AU
2152708921$21527089$21$F$20220926$20240806$20221031$20240814$EXP$$CO-ROCHE-3196490$ROCHE$$12$YR$T$M$Y$49$KG$20240814$$CN$CO$CO
215271536$21527153$6$F$20240424$20240919$20221031$20240925$EXP$$NVSC2022CO240511$NOVARTIS$$84$YR$$F$Y$$$20240925$$CN$CO$CO
215274433$21527443$3$F$20221001$20240923$20221031$20240930$EXP$$CA-JNJFOC-20221011739$JOHNSON AND JOHNSON$$40$YR$A$M$Y$92$KG$20240929$$HP$CA$CA
215274524$21527452$4$F$$20240702$20221031$20240708$EXP$$CA-TAKEDA-2022TUS079498$TAKEDA$$$$$F$Y$$$20240708$$MD$CA$CA
215275404$21527540$4$F$$20240711$20221031$20240720$EXP$$ES-CELLTRION INC.-2022ES017804$CELLTRION$Serra Font S, Lopez-Granados L, Sisinni L, Serna Berna JV, Martinez Martinez L, Fernandez de Gamarra-Martinez E, et al.. Chronic hypogammaglobulinemia after allogeneic stem cell transplantation and their treatment with subcutaneous immunoglobulin in pediatric patients.. An-Pediatr. 2022;97(2):103-111$$$$$Y$$$20240720$$HP$ES$ES
215275637$21527563$7$F$20221028$20240806$20221031$20240808$EXP$$US-TAKEDA-2022TUS079769$TAKEDA$$13$YR$$M$Y$$$20240808$$MD$US$US
215276213$21527621$3$F$$20230122$20221031$20240709$EXP$$AU-ASTELLAS-2022US038357$ASTELLAS$$44$YR$$F$Y$$$20240709$$CN$AU$AU
215280045$21528004$5$F$20221022$20240830$20221031$20240903$EXP$$TW-TAKEDA-2022TUS079814$TAKEDA$$37$YR$$M$Y$$$20240903$$CN$TW$TW
215281025$21528102$5$F$$20240903$20221031$20240911$EXP$$ES-CELLTRION INC.-2022ES017814$CELLTRION$Serra Font S, Lopez-Granados L, Sisinni L, Serna Berna JV, Martinez Martinez L, Fernandez de Gamarra-Martinez E, et al.. Chronic hypogammaglobulinemia after allogeneic stem cell transplantation and their treatment with subcutaneous immunoglobulin in pediatric patients. An-Pediatr. 2022;97(2):103-111$$$$$Y$$$20240911$$HP$ES$ES
2152830611$21528306$11$F$20220804$20240920$20221031$20240927$EXP$$NVSC2022KR183930$NOVARTIS$$68$YR$$F$Y$$$20240927$$MD$KR$KR
2152848611$21528486$11$F$20211206$20240725$20221031$20240801$EXP$$US-GSK-US2021AMR260588$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
215285209$21528520$9$F$20191212$20240903$20221031$20240909$EXP$$IT-MYLANLABS-2022M1118901$MYLAN$$40$YR$$F$Y$$$20240909$$MD$IT$IT
215285913$21528591$3$F$$20230121$20221031$20240709$EXP$$AU-ASTELLAS-2022US037302$ASTELLAS$$64$YR$$F$Y$$$20240709$$CN$AU$AU
2152866410$21528664$10$F$20200522$20240809$20221031$20240813$EXP$$AU-TAKEDA-AU202017394$TAKEDA$$58$YR$$M$Y$$$20240813$$CN$AU$AU
2152894113$21528941$13$F$20220513$20240719$20221031$20240723$EXP$$AR-MYLANLABS-2022M1036720$MYLAN$$19$YR$$M$Y$$$20240723$$CN$AR$AR
215289463$21528946$3$F$$20240820$20221031$20240827$PER$$US-PFIZER INC-202201262805$PFIZER$$48$YR$$F$Y$$$20240827$$HP$US$US
2152954410$21529544$10$F$20220101$20240730$20221031$20240802$PER$$US-PFIZER INC-PV202200092062$PFIZER$$63$YR$$F$Y$$$20240802$$HP$US$US
215296917$21529691$7$F$$20240717$20221031$20240722$PER$$US-PFIZER INC-PV202200092235$PFIZER$$58$YR$$M$Y$105.23$KG$20240722$$HP$US$US
215298762$21529876$2$F$$20230222$20221031$20240705$PER$$NVSC2022US244595$NOVARTIS$$$$$M$Y$$$20240705$$CN$US$US
215298813$21529881$3$F$$20240903$20221031$20240905$PER$$US-PFIZER INC-PV202200093028$PFIZER$$72$YR$$F$Y$$$20240905$$CN$US$US
215301013$21530101$3$F$20170601$20240712$20221031$20240715$EXP$$FR-TAKEDA-FR201738214$TAKEDA$$77$YR$$F$Y$$$20240715$$HP$FR$FR
215309523$21530952$3$F$20221020$20240624$20221031$20240703$PER$$US-SA-2022SA436209$SANOFI AVENTIS$$65$YR$E$F$Y$107.9$KG$20240703$$MD$US$US
215309673$21530967$3$F$20220614$20240702$20221031$20240709$PER$$US-SA-2022SA439147$SANOFI AVENTIS$$54$YR$A$F$Y$83.77$KG$20240709$$MD$US$US
215310402$21531040$2$F$$20240910$20221031$20240920$PER$$US-SA-2022SA438284$SANOFI AVENTIS$$$$C$F$Y$$$20240920$$MD$US$US
215314302$21531430$2$F$$20240819$20221031$20240826$EXP$$US-TAKEDA-2022TUS079782$TAKEDA$$$$$F$Y$87.54$KG$20240826$$CN$US$US
215314873$21531487$3$F$$20240910$20221031$20240919$EXP$$IT-AUROBINDO-AUR-APL-2022-044835$AUROBINDO$De Vito A, Fiore V, Urru V, Bozzi E, Geremia N, Princic E, et al.. Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report.. The Brazilian Journal of Infectious Diseases. 2022;26(5):102701$21$YR$$M$Y$55$KG$20240919$$HP$IT$IT
215315364$21531536$4$F$20190924$20240910$20221031$20240926$EXP$FR-AFSSAPS-MP20191337$FR-BRISTOL-MYERS SQUIBB COMPANY-2022-128167$BRISTOL MYERS SQUIBB$Rocanieres P, Lamure S, Geny C, Faillie J, Hillaire-Buys D, Bres V. Parkinson^s disease progression in a patient with multiple myeloma treated with ixazomib. Fundamental and Clinical Pharmacology. 2022; 36:146 doi:10.1111/fcp.12789.$68$YR$E$M$Y$$$20240927$$HP$FR$FR
215316242$21531624$2$F$20221001$20240820$20221031$20240821$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000483$PAREXEL$$$$$$Y$$$20240821$$CN$US$US
215322279$21532227$9$F$20221026$20230320$20221101$20240926$EXP$$US-GSK-US2022AMR155526$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
215323485$21532348$5$F$20220901$20240717$20221101$20240725$EXP$$NVSC2022BR243092$NOVARTIS$$43$YR$$F$Y$$$20240725$$HP$BR$BR
2153275510$21532755$10$F$$20240828$20221101$20240904$EXP$$CA-TERSERA THERAPEUTICS LLC-2021TRS000668$TERSERA THERAPEUTICS$$$$$$Y$$$20240904$$MD$CA$CA
215329703$21532970$3$F$$20240726$20221101$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-12590$LUPIN$$$$$$Y$$$20240817$$CN$US$US
215329872$21532987$2$F$$20240705$20221101$20240710$EXP$$JP-ASTELLAS-2022JP015892$ASTELLAS$$27$YR$$F$Y$$$20240710$$MD$JP$JP
215335174$21533517$4$F$$20240725$20221101$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-12642$LUPIN$$35$YR$$M$Y$$$20240814$$CN$US$US
215337226$21533722$6$F$$20240828$20221101$20240906$EXP$$CA-BAUSCHBL-BL-2019-061339$BAUSCH AND LOMB$$71$YR$$F$Y$69$KG$20240906$$CN$CA$CA
2153428318$21534283$18$F$20220928$20240801$20221101$20240809$EXP$$CN-GILEAD-2022-0602968$GILEAD$$45$YR$A$F$Y$$$20240809$$MD$CN$CN
215343493$21534349$3$F$20240701$20240812$20221101$20240819$EXP$$CA-GSK-CA2019AMR194664$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$HP$CA$CA
215343703$21534370$3$F$$20230712$20221101$20240925$EXP$$US-GSK-US2022AMR155602$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
215344737$21534473$7$F$$20240708$20221101$20240709$EXP$$CA-ORGANON-2006CAN004403$ORGANON$$57$YR$$F$Y$$$20240709$$HP$CA$CA
215363647$21536364$7$F$$20240809$20221101$20240813$PER$$US-PFIZER INC-202200458752$PFIZER$$90$YR$$F$Y$58.957$KG$20240813$$MD$US$US
215363653$21536365$3$F$$20240725$20221101$20240725$PER$$US-PFIZER INC-PV202200094000$PFIZER$$86$YR$$F$Y$$$20240725$$CN$US$US
215364922$21536492$2$F$$20240820$20221101$20240826$EXP$$US-TAKEDA-2022TUS079832$TAKEDA$$$$$M$Y$66.21$KG$20240826$$CN$US$US
215372075$21537207$5$F$$20240904$20221101$20240905$EXP$$CA-BAUSCH-BL-2022-024417$BAUSCH AND LOMB$$83$YR$$M$Y$$$20240905$$CN$CA$CA
215374924$21537492$4$F$$20240828$20221101$20240903$EXP$$CA-AstraZeneca-2020SF14127$ASTRAZENECA$$41$YR$$F$Y$$$20240903$$MD$CA$
215376742$21537674$2$F$20240101$20240716$20221101$20240722$PER$$US-SA-2022SA444873$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240721$$MD$US$US
215377942$21537794$2$F$20240826$20240827$20221101$20240909$PER$$US-SA-2022SA444344$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240909$$CN$US$US
2153790711$21537907$11$F$$20240718$20221101$20240724$EXP$$CA-TAKEDA-2022TUS077306$TAKEDA$$15$YR$$F$Y$54$KG$20240724$$HP$CA$CA
215381105$21538110$5$F$20200101$20240917$20221101$20240923$EXP$$US-ORGANON-O2210USA002452$ORGANON$$$$$F$Y$22.766$KG$20240923$$LW$US$US
215386303$21538630$3$F$20221025$20240815$20221102$20240828$PER$$US-SA-2022SA444632$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240828$$MD$US$US
215386332$21538633$2$F$20220101$20240710$20221102$20240717$PER$$US-SA-2022SA446389$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240717$$CN$US$US
2153887928$21538879$28$F$20221021$20240808$20221102$20240815$EXP$$CA-CELLTRION INC.-2022CA018237$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
2153896519$21538965$19$F$20211229$20240830$20221102$20240909$EXP$$CA-CELLTRION INC.-2021CA018820$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
215390463$21539046$3$F$20220805$20240906$20221102$20240916$EXP$$CA-CELLTRION INC.-2022CA013646$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
2153968510$21539685$10$F$$20240709$20221102$20240712$PER$$US-BIOGEN-2022BI01166433$BIOGEN$$$$$M$Y$$$20240712$$CN$US$US
215397093$21539709$3$F$$20240717$20221102$20240722$EXP$$US-TAKEDA-2022TUS078822$TAKEDA$$$$$F$Y$$$20240722$$CN$US$US
215400034$21540003$4$F$20220922$20240710$20221102$20240711$EXP$$GB-ROCHE-3207963$ROCHE$$58$YR$A$F$Y$70$KG$20240711$$MD$GB$GB
215400736$21540073$6$F$20221010$20240918$20221102$20240927$EXP$$CN-ROCHE-1767890$ROCHE$$58$YR$A$M$Y$60$KG$20240927$$CN$CN$CN
215402386$21540238$6$F$20220801$20240904$20221102$20240913$EXP$$DE-ROCHE-3206002$ROCHE$$42$YR$A$M$Y$$$20240913$$CN$DE$DE
215402613$21540261$3$F$20221005$20240809$20221102$20240813$EXP$FR-AFSSAPS-PV20221450$FR-ROCHE-3207304$ROCHE$$79$YR$E$F$Y$66$KG$20240813$$MD$FR$FR
215405204$21540520$4$F$20221228$20240911$20221102$20240912$PER$$NVSC2022US246461$NOVARTIS$$43$YR$$M$Y$$$20240912$$CN$US$US
215412574$21541257$4$F$$20240716$20221102$20240724$EXP$$CA-AstraZeneca-2020SF10883$ASTRAZENECA$$54$YR$$F$Y$54$KG$20240724$$MD$CA$
215414193$21541419$3$F$$20240730$20221102$20240805$EXP$$US-PFIZER INC-PV202200094504$PFIZER$$66$YR$$F$Y$$$20240804$$CN$US$US
215418803$21541880$3$F$$20240726$20221102$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-12748$LUPIN$$$$$$Y$$$20240815$$CN$US$US
215419813$21541981$3$F$$20240726$20221102$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-12753$LUPIN$$$$$$Y$$$20240817$$CN$US$US
215422385$21542238$5$F$$20240731$20221102$20240805$PER$$US-PFIZER INC-PV202200067626$PFIZER$$63$YR$$F$Y$$$20240805$$HP$US$US
215422615$21542261$5$F$20240101$20240924$20221102$20240926$EXP$$US-PFIZER INC-PV202200094149$PFIZER$$58$YR$$M$Y$$$20240926$$CN$US$US
215424602$21542460$2$F$$20240912$20221102$20240924$EXP$AU-TGA-0000735847$AU-SAMSUNG BIOEPIS-SB-2022-27009$SAMSUNG BIOEPIS$Kayes T, Bonnichsen M, Willmann L, Lorenzo A, Das A, El-Haddad C. Menetrier^s disease exacerbating ulcerative colitis and relieved by gastrectomy. BMJ-Open Gastroenterology. 2021;8:NO.1:$21$YR$A$F$Y$$$20240924$$HP$AU$AU
215429112$21542911$2$F$$20240708$20221102$20240710$PER$$US-ABBVIE-4149944$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
2154292116$21542921$16$F$20221020$20240822$20221102$20240828$EXP$$MX-TAKEDA-2022TUS079866$TAKEDA$$11$YR$$F$Y$$$20240828$$CN$MX$MX
215432974$21543297$4$F$20220901$20240917$20221102$20240924$EXP$$EG-ROCHE-3208474$ROCHE$$44$YR$A$M$Y$70$KG$20240924$$CN$EG$EG
2154343010$21543430$10$F$20220101$20240712$20221102$20240729$PER$$US-KARYOPHARM-2022KPT001206$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240729$$CN$US$US
215434393$21543439$3$F$$20240626$20221102$20240816$EXP$$FR-AMGEN-FRASP2022186188$AMGEN$Overman M.J;. Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: The phase 11 CheckMate 142 study. Journal for Immunotherapy of Cancer. 2024;12 (5):1-8$$$$$Y$$$20240816$$HP$FR$FR
215434883$21543488$3$F$20210101$20240906$20221102$20240913$EXP$$NL-MYLANLABS-2022M1119711$MYLAN$Sogbein O, Gamilla-Crudo AKN, Mujtaba MA, Hussain SA.. Transplant Graft TMA Injury Post COVID-19 Vaccination.. American Journal of Kidney Diseases. 2022;79(4 Suppl 2:S31$48$YR$$M$Y$$$20240913$$HP$NL$NL
215437262$21543726$2$F$$20240828$20221102$20240906$PER$$US-ABBVIE-22K-163-4469819-00$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
215438573$21543857$3$F$20220805$20240711$20221102$20240717$EXP$$IT-BIOGEN-2022BI01166206$BIOGEN$$31$YR$$F$Y$70$KG$20240717$$MD$IT$IT
215442264$21544226$4$F$$20240808$20221102$20240823$EXP$$US-TEVA-2022-US-2822620$TEVA$$68$YR$$F$Y$$$20240823$$LW$US$US
215443942$21544394$2$F$$20240903$20221102$20240924$PER$$US-MYOVANT SCIENCES GMBH-2022MYSCI0800467$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
215450484$21545048$4$F$$20240726$20221103$20240729$PER$$NVSC2022US246973$NOVARTIS$$$$$M$Y$$$20240729$$CN$US$US
215450912$21545091$2$F$$20240913$20221103$20240925$EXP$$US-AUROBINDO-AUR-APL-2022-045786$AUROBINDO$VanDolah H, Crossley JR, Kim HJ. Three Cases of Uncommon Medication- Induced Osteonecrosis of Temporal Bone. Otolaryngology - Head and Neck Surgery. 2022;167(1):P245-6.$84$YR$$F$Y$$$20240925$$MD$US$US
215451008$21545100$8$F$$20240808$20221103$20240821$EXP$$CA-AUROBINDO-AUR-APL-2022-045790$AUROBINDO$Austin E, Maratta C. Acute thiamine deficiency as a complication of insulin euglycemic therapy for an amlodipine overdose. Clinical Toxicology. 2022;60(2):124$15$YR$$F$Y$54$KG$20240821$$MD$CA$CA
215451015$21545101$5$F$$20240823$20221103$20240904$EXP$$CA-BAXTER-2022BAX023125$BAXTER$$60$YR$$F$Y$$$20240904$$HP$CA$CA
215451372$21545137$2$F$20220501$20240903$20221103$20240920$PER$$CA-TOLMAR, INC.-22CA037232$TOLMAR$$82$YR$$M$Y$$$20240919$$CN$CA$CA
2154517714$21545177$14$F$20150303$20240909$20221103$20240918$EXP$$CA-JNJFOC-20221061054$JOHNSON AND JOHNSON$$52$YR$A$F$Y$86$KG$20240918$$HP$CA$CA
215452458$21545245$8$F$20221201$20230407$20221103$20240926$EXP$$US-GSK-US2022AMR157248$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2154524728$21545247$28$F$20210609$20240820$20221103$20240828$EXP$$IE-SHIRE-IE202009941$TAKEDA$$7$YR$$M$Y$$$20240828$$HP$IE$IE
215453593$21545359$3$F$$20240911$20221103$20240920$EXP$$CA-CELLTRION INC.-2022CA017807$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
215455393$21545539$3$F$$20240815$20221103$20240819$EXP$$NVSC2022US241858$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
215459053$21545905$3$F$$20240628$20221103$20240703$EXP$$US-VIIV HEALTHCARE LIMITED-US2022153508$VIIV$$$$$M$Y$$$20240703$$HP$US$US
215462017$21546201$7$F$20230121$20240717$20221103$20240722$EXP$$US-KYOWAKIRIN-2022BKK017022$KYOWA$$$$$$Y$$$20240722$$PH$US$US
215462875$21546287$5$F$$20240903$20221103$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-131199$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240906$$MD$JP$JP
215465143$21546514$3$F$20221017$20240705$20221103$20240715$PER$$US-SA-2022SA444913$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240715$$MD$US$US
215465427$21546542$7$F$20220101$20240808$20221103$20240813$EXP$$US-ABBVIE-4149180$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
215468682$21546868$2$F$20221005$20240705$20221103$20240715$PER$$US-SA-2022SA452759$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240715$$MD$US$US
215482042$21548204$2$F$20220501$20221101$20221103$20240926$EXP$$US-GSK-US2022AMR084994$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
215483662$21548366$2$F$$20240625$20221103$20240701$PER$$US-PFIZER INC-PV202200093912$PFIZER$$73$YR$$F$Y$$$20240701$$CN$US$US
215484732$21548473$2$F$20220331$20240715$20221103$20240718$EXP$FR-AFSSAPS-NY20222821$FR-KYOWAKIRIN-2022BKK017042$KYOWA$$$$$$Y$$$20240718$$MD$FR$FR
215487743$21548774$3$F$$20240726$20221103$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-12850$LUPIN$$$$$$Y$$$20240816$$CN$US$US
215491193$21549119$3$F$$20240821$20221103$20240911$PER$$US-MYOVANT SCIENCES GMBH-2022MYSCI0800623$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
215493644$21549364$4$F$20220101$20240815$20221103$20240819$PER$$US-PFIZER INC-202201269365$PFIZER$$72$YR$$F$Y$68.04$KG$20240819$$CN$US$US
215495302$21549530$2$F$20211201$20240822$20221103$20240918$PER$$US-MYOVANT SCIENCES GMBH-2022MYSCI0900481$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
215498013$21549801$3$F$$20240904$20221103$20240909$EXP$$IN-PFIZER INC-PV202200094211$PFIZER$$46$YR$$M$Y$$$20240909$$CN$IN$IN
215499803$21549980$3$F$20221026$20240711$20221103$20240717$PER$$US-SA-2022SA446118$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240717$$MD$US$US
215501082$21550108$2$F$$20240701$20221103$20240710$PER$$US-SA-2022SA454434$SANOFI AVENTIS$$4$YR$C$M$Y$29.12$KG$20240710$$MD$US$US
215502563$21550256$3$F$20220911$20240809$20221103$20240813$EXP$$IT-PFIZER INC-202201272053$PFIZER$$68$YR$$M$Y$80$KG$20240813$$MD$IT$IT
2155040210$21550402$10$F$20220913$20240805$20221103$20240808$EXP$$US-TAKEDA-2022TUS070330$TAKEDA$$68$YR$$F$Y$59$KG$20240808$$CN$US$US
215505432$21550543$2$F$$20240826$20221103$20240903$EXP$$CA-AstraZeneca-2022A358677$ASTRAZENECA$$52$YR$$F$Y$$$20240903$$MD$CA$
215505957$21550595$7$F$$20240716$20221103$20240723$EXP$$US-MYOVANT SCIENCES GMBH-2022MYSCI1000049$MYOVANT SCIENCES$$$$$M$Y$$$20240723$$CN$US$US
215506003$21550600$3$F$20220809$20240802$20221103$20240830$PER$$US-MYOVANT SCIENCES GMBH-2022MYSCI0900078$SUNOVION$$$$$$Y$$$20240830$$MD$US$US
215512349$21551234$9$F$20220101$20240702$20221104$20240709$EXP$$CO-JNJFOC-20220410794$JOHNSON AND JOHNSON$$56$YR$A$M$Y$60$KG$20240709$$HP$CO$CO
215514248$21551424$8$F$$20240627$20221103$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001082$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
215515222$21551522$2$F$20200111$20240709$20221103$20240715$PER$$US-INCYTE CORPORATION-2022IN010420$INCYTE$$$$$$Y$$$20240715$$CN$US$US
215518054$21551805$4$F$$20230801$20221104$20240712$PER$$CA-PFM-2021-11907$PIERRE FABRE MEDICAMENT$$53$YR$$M$Y$$$20240712$$CN$CA$CA
215519376$21551937$6$F$20221027$20240816$20221104$20240822$EXP$$US-SA-2022SA454115$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240822$$MD$US$US
2155196363$21551963$63$F$20220922$20240918$20221104$20240925$EXP$$CN-SA-2022SA403885$SANOFI AVENTIS$$65$YR$E$M$Y$71.5$KG$20240925$$CN$CN$CN
2155247810$21552478$10$F$20220101$20240814$20221104$20240821$EXP$$CA-CELLTRION INC.-2022CA005439$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
2155297213$21552972$13$F$20220101$20240919$20221104$20240927$EXP$$CA-TAKEDA-2022TUS081846$TAKEDA$$$$$M$Y$$$20240927$$HP$CA$CA
215530932$21553093$2$F$$20240703$20221104$20240720$EXP$$GB-CELLTRION INC.-2022GB017929$CELLTRION$$$$$$Y$$$20240720$$PH$GB$GB
215532267$21553226$7$F$$20240909$20221104$20240913$EXP$$CA-BAUSCH-BL-2022-024793$BAUSCH AND LOMB$$67$YR$$F$Y$73$KG$20240913$$MD$CA$CA
215536055$21553605$5$F$$20240701$20221104$20240706$EXP$$ES-AUROBINDO-AUR-APL-2022-046511$AUROBINDO$Rico-Nieto A, Falces-Romero I.. Osteoarticular infection due to dalbavancin-resistant Staphylococci: Description of two cases.. Med-Clin-Barc. 2021;156(11):577-578$60$YR$$M$Y$$$20240706$$MD$ES$ES
215536786$21553678$6$F$20161026$20240711$20221104$20240720$EXP$$CA-CELLTRION INC.-2022CA018534$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
215538018$21553801$8$F$20220919$20240822$20221104$20240828$EXP$$CA-TAKEDA-2022TUS066522$TAKEDA$$11$YR$$M$Y$$$20240828$$HP$CA$CA
215539532$21553953$2$F$$20240627$20221104$20240711$EXP$$US-CIPLA LTD.-2022US06449$CIPLA$Erickson JBS.. Albuterol-associated hallucinations: A case report and literature review. Journal of clinical psychopharmacology. 2022;42(6):597 to 600$$$$$Y$$$20240711$$PH$US$US
215540614$21554061$4$F$20211108$20240626$20221104$20240709$EXP$$CA-ROCHE-2959658$ROCHE$$20$YR$A$M$Y$$$20240709$$HP$CA$CA
215544282$21554428$2$F$$20240729$20221104$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-12893$LUPIN$$$$$$Y$$$20240818$$CN$US$US
215545652$21554565$2$F$$20240807$20221104$20240812$EXP$$US-PFIZER INC-PV202200096037$PFIZER$$61$YR$$F$Y$$$20240812$$HP$US$US
2155456611$21554566$11$F$20220316$20240802$20221104$20240807$PER$$US-PFIZER INC-202200455074$PFIZER$$74$YR$$F$Y$130$KG$20240807$$CN$US$US
215547089$21554708$9$F$20210101$20240821$20221104$20240830$EXP$$JP-JNJFOC-20220457301$JOHNSON AND JOHNSON$$78$YR$E$M$Y$55.2$KG$20240830$$MD$JP$JP
215547775$21554777$5$F$20220801$20240724$20221104$20240727$EXP$$US-ABBVIE-22K-163-4521049-00$ABBVIE$$71$YR$$F$Y$78.017$KG$20240727$$CN$US$US
215552667$21555266$7$F$20240322$20240709$20221104$20240716$EXP$$CA-TAKEDA-2022TUS081126$TAKEDA$$56$YR$$F$Y$$$20240716$$MD$CA$CA
215556776$21555677$6$F$$20240624$20221104$20240705$EXP$$CA-ROCHE-3165760$ROCHE$$$$A$M$Y$$$20240705$$CN$CA$CA
215557586$21555758$6$F$20220903$20240920$20221104$20240925$EXP$$US-ASTELLAS-2022US036208$ASTELLAS$$73$YR$E$M$Y$$$20240925$$CN$US$US
2155587013$21555870$13$F$20221026$20240823$20221104$20240827$EXP$$US-TAKEDA-2022TUS047820$TAKEDA$$57$YR$$F$Y$53$KG$20240827$$HP$US$US
2155591316$21555913$16$F$20220717$20240801$20221104$20240806$EXP$$US-TAKEDA-2022TUS025952$TAKEDA$$63$YR$$F$Y$77$KG$20240806$$HP$US$US
215559278$21555927$8$F$20210225$20240920$20221104$20240926$EXP$$US-TAKEDA-2020TUS053427$TAKEDA$$70$YR$$F$Y$54$KG$20240926$$MD$US$US
215561204$21556120$4$F$20220901$20240729$20221104$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-12927$LUPIN$$$$$$Y$$$20240815$$CN$US$US
215561866$21556186$6$F$20221001$20240927$20221104$20240930$EXP$$NVSC2022US247551$NOVARTIS$$63$YR$$F$Y$$$20240930$$CN$US$US
215561983$21556198$3$F$$20240725$20221104$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-12930$LUPIN$$$$$$Y$$$20240814$$CN$US$US
2155621410$21556214$10$F$20201231$20240709$20221104$20240716$EXP$$CA-TAKEDA-2021TUS019371$TAKEDA$$64$YR$$F$Y$$$20240716$$PH$CA$CA
215572084$21557208$4$F$$20240724$20221105$20240725$PER$$NVSC2022US247782$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
215573242$21557324$2$F$$20240906$20221105$20240910$PER$$NVSC2022US242339$NOVARTIS$$$$$F$Y$$$20240910$$CN$US$US
2155736819$21557368$19$F$20220101$20240902$20221105$20240910$EXP$$CA-CELLTRION INC.-2022CA011651$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
2155746615$21557466$15$F$20220505$20240902$20221105$20240910$EXP$$CA-CELLTRION INC.-2022CA008722$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
2155761311$21557613$11$F$20221026$20240816$20221106$20240826$EXP$$CA-CELLTRION INC.-2022CA018628$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
215578407$21557840$7$F$20220901$20240827$20221106$20240906$EXP$$US-BIOGEN-2022BI01166846$BIOGEN$$40$YR$$F$Y$$$20240906$$CN$US$US
215578632$21557863$2$F$$20240717$20221106$20240718$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000496$PAREXEL$$$$$$Y$$$20240718$$CN$US$US
215580375$21558037$5$F$20221024$20240829$20221107$20240919$PER$$CA-TOLMAR, INC.-22CA037236$TOLMAR$$72$YR$$M$Y$$$20240919$$CN$CA$CA
215581942$21558194$2$F$$20240913$20221107$20240920$EXP$$US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-59328$HIKMA$$69$YR$$M$Y$$$20240920$$MD$US$US
215584052$21558405$2$F$$20240806$20221107$20240819$EXP$$JP-ROCHE-3213426$ROCHE$$8$DEC$E$M$Y$$$20240819$$MD$JP$JP
215584295$21558429$5$F$20221121$20230206$20221107$20240925$PER$$US-GSK-US2022AMR160075$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
215586598$21558659$8$F$20221030$20240723$20221107$20240726$EXP$$JP-TAKEDA-2022TJP076583$TAKEDA$$61$YR$$F$Y$$$20240726$$MD$JP$JP
215587984$21558798$4$F$20221101$20221117$20221107$20240925$PER$$US-GSK-US2022AMR161083$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
2155926015$21559260$15$F$20230101$20240919$20221107$20240926$PER$$US-GSK-US2022AMR159964$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
215593319$21559331$9$F$20230412$20240905$20221107$20240912$PER$$CA-TOLMAR, INC.-22CA037280$TOLMAR$$65$YR$$M$Y$$$20240912$$CN$CA$CA
215593374$21559337$4$F$20220701$20240827$20221107$20240904$PER$$CA-TOLMAR, INC.-22CA037295$TOLMAR$$76$YR$$M$Y$$$20240904$$CN$CA$CA
215593439$21559343$9$F$20221001$20240828$20221107$20240905$PER$$CA-TOLMAR, INC.-22CA037306$TOLMAR$$70$YR$$M$Y$$$20240905$$CN$CA$CA
215593562$21559356$2$F$20170901$20221101$20221107$20240925$PER$$US-GSK-US2022AMR158693$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240925$$CN$US$US
2155950117$21559501$17$F$$20240711$20221107$20240717$EXP$$PT-MYLANLABS-2022M1121485$MYLAN$Bertao MI, Gaudencio M, Carvalho A, Barreiro I, Silva RS, Mascarenhas R, Gon?alves A et al. IM n.? 2426 Sunburn... and not only!. Congresses of the Portuguese Society of Internal Medicine: 28th National Congres. 2022;28(Sup 1):2112$79$YR$$M$Y$$$20240717$$MD$PT$PT
2155960311$21559603$11$F$20220101$20240910$20221107$20240912$PER$$US-DSJP-DSU-2022-140040$DAIICHI$$$$$M$Y$$$20240912$$CN$US$US
215597179$21559717$9$F$20230101$20240829$20221107$20240909$PER$$US-DSJP-DSU-2022-139805$DAIICHI$$$$$M$Y$$$20240909$$MD$US$US
215597195$21559719$5$F$20230807$20240625$20221107$20240702$EXP$$JP-ARGENX-2022-ARGX-JP002306$ARGENX BVBA$$45$YR$$F$Y$73.4$KG$20240702$$PH$JP$JP
215598563$21559856$3$F$20221014$20240903$20221107$20240912$30DAY$$US-GSK-US2022156105$GLAXOSMITHKLINE$$53$YR$$F$Y$99.79$KG$20240912$$CN$US$US
215601892$21560189$2$F$20240716$20240717$20221107$20240729$EXP$$GB-INTERCEPT-PM2022001963$INTERCEPT PHARMACEUTICALS$$76$YR$$F$Y$$$20240729$$HP$GB$GB
215604832$21560483$2$F$20220201$20240722$20221107$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202210013232$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240802$$CN$US$US
215608627$21560862$7$F$$20240813$20221107$20240816$EXP$$US-TAKEDA-2021TUS066465$TAKEDA$$$$$F$Y$$$20240816$$HP$US$US
215612113$21561211$3$F$20221101$20240904$20221107$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-130765$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240906$$CN$US$US
215613913$21561391$3$F$$20240822$20221107$20240830$EXP$$CA-GALDERMA-CA2022014945$GALDERMA$$$$$$Y$$$20240830$$HP$CA$CA
215614635$21561463$5$F$20221028$20240702$20221107$20240704$EXP$$CN-TAKEDA-2022TUS081386$TAKEDA$$28$YR$$M$Y$69$KG$20240704$$MD$CN$CN
215619094$21561909$4$F$20190311$20240813$20221107$20240819$EXP$$CA-TAKEDA-2019TUS017782$TAKEDA$$20$YR$$F$Y$$$20240819$$CN$CA$CA
2156236411$21562364$11$F$20221107$20240624$20221107$20240701$EXP$$CA-Taiho Oncology Inc-2022-002002$TAIHO ONCOLOGY INC$$65$YR$E$F$Y$$$20240701$$CN$CA$CA
215623895$21562389$5$F$$20240920$20221107$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-029896$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240927$$MD$JP$JP
215624535$21562453$5$F$20211006$20240821$20221107$20240828$EXP$$IN-PFIZER INC-202101844052$PFIZER$$66$YR$$F$Y$60.5$KG$20240828$$CN$IN$IN
215625183$21562518$3$F$$20240906$20221107$20240912$EXP$$CA-TAKEDA-2022TUS042443$TAKEDA$$$$$M$Y$$$20240912$$CN$CA$CA
215626804$21562680$4$F$20220623$20230626$20221107$20240720$EXP$$NVSJ2022JP100423$NOVARTIS$Taniguchi Y, Tamiya A, Yanagisawa A, Shimaya M, Kawakami M, Inagaki Y et al.. Cerebral infarction after treatment with dabrafenib plus trametinib for BRAF-V600E-positive non-small cell lung cancer: A case report. THORACIC CANCER. 2023;14:1201-3$65$YR$$M$Y$$$20240719$$MD$JP$JP
215629002$21562900$2$F$20220917$20240701$20221107$20240711$EXP$IT-MINISAL02-891204$IT-BAXTER-2022BAX023269$BAXTER$$9$YR$$M$Y$29$KG$20240711$$PH$IT$IT
215630242$21563024$2$F$20200101$20240820$20221107$20240829$PER$$US-SA-2022SA448619$SANOFI AVENTIS$$35$YR$A$F$Y$61.224$KG$20240829$$MD$US$US
215630512$21563051$2$F$20240701$20240730$20221107$20240807$PER$$US-SA-2022SA452001$SANOFI AVENTIS$$26$YR$A$F$Y$140.6$KG$20240807$$MD$US$US
215631033$21563103$3$F$20220801$20240910$20221107$20240919$PER$$US-SA-2022SA449304$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240919$$MD$US$US
215631123$21563112$3$F$20240625$20240625$20221107$20240703$PER$$US-SA-2022SA448014$SANOFI AVENTIS$$$$E$F$Y$$$20240703$$MD$US$US
215631142$21563114$2$F$20221013$20240819$20221107$20240828$PER$$US-SA-2022SA452155$SANOFI AVENTIS$$51$YR$A$F$Y$74.84$KG$20240828$$MD$US$US
215631683$21563168$3$F$$20240909$20221107$20240917$PER$$US-SA-2022SA454204$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240918$$MD$US$US
215631712$21563171$2$F$$20240729$20221107$20240806$PER$$US-SA-2022SA454486$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240806$$MD$US$US
215632512$21563251$2$F$$20240802$20221107$20240812$PER$$US-SA-2022SA455700$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240812$$MD$US$US
215633732$21563373$2$F$20210301$20221031$20221108$20240807$PER$$NVSC2022US246148$NOVARTIS$$28$YR$$F$Y$$$20240807$$HP$US$US
2156346027$21563460$27$F$20220101$20240905$20221108$20240913$EXP$$CA-CELLTRION INC.-2022CA011427$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
215635156$21563515$6$F$$20240716$20221108$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2022-132360$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240731$$MD$CA$CA
215637034$21563703$4$F$$20240826$20221108$20240902$EXP$$US-TAKEDA-US201942933$TAKEDA$$$$$M$Y$$$20240902$$CN$US$US
215642016$21564201$6$F$20221201$20230601$20221108$20240926$PER$$US-GSK-US2022AMR161244$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240926$$MD$US$US
215643589$21564358$9$F$20210101$20240701$20221108$20240706$EXP$$US-ABBVIE-22K-163-4255085-00$ABBVIE$$61$YR$$F$Y$$$20240706$$CN$US$US
215644762$21564476$2$F$20220401$20240911$20221108$20240920$PER$$US-ABBVIE-22K-163-4502055-00$ABBVIE$$64$YR$$F$Y$54$KG$20240920$$CN$US$US
215644983$21564498$3$F$$20240731$20221108$20240806$EXP$$BR-TAKEDA-2022TUS082146$TAKEDA$$$$$M$Y$$$20240806$$CN$BR$BR
215645299$21564529$9$F$20221001$20240801$20221108$20240801$30DAY$$US-PFIZER INC-202201256491$PFIZER$$3$YR$$F$Y$10.43$KG$20240801$$HP$US$US
2156500712$21565007$12$F$20200408$20240821$20221108$20240829$EXP$$CA-CELLTRION INC.-2020CA018924$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
215653366$21565336$6$F$20221019$20240709$20221108$20240712$EXP$$CA-TAKEDA-2022TUS078388$TAKEDA$$66$YR$$F$Y$75.74$KG$20240712$$HP$CA$CA
2156564019$21565640$19$F$20220909$20240731$20221108$20240809$EXP$$US-BAXTER-2022BAX023353$BAXTER$$81$YR$$F$Y$54.3$KG$20240809$$MD$US$US
215656662$21565666$2$F$20180814$20240911$20221108$20240918$EXP$$CA-TAKEDA-2022TUS082498$TAKEDA$$28$YR$$F$Y$$$20240918$$MD$CA$CA
215657085$21565708$5$F$20221129$20240821$20221108$20240826$EXP$$CA-TAKEDA-2022TUS080092$TAKEDA$$43$YR$$F$Y$$$20240826$$HP$CA$CA
2156571527$21565715$27$F$20220412$20240716$20221108$20240722$EXP$$GB-ROCHE-3212340$ROCHE$$65$YR$E$M$Y$89.2$KG$20240722$$MD$GB$GB
215659572$21565957$2$F$$20240820$20221108$20240821$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000500$PAREXEL$$$$$$Y$$$20240821$$CN$US$US
215659892$21565989$2$F$20210101$20240826$20221108$20240827$EXP$$US-UCBSA-2022063677$UCB$$$$$F$Y$$$20240827$$CN$US$US
215661674$21566167$4$F$$20240923$20221108$20240927$EXP$$US-JAZZ-2022-US-034540$JAZZ$$$$$F$Y$$$20240927$$HP$US$US
2156627830$21566278$30$F$$20240822$20221108$20240827$EXP$$US-JAZZ-2022-US-034486$JAZZ$$$$$F$Y$$$20240826$$HP$US$US
215663042$21566304$2$F$$20240917$20221108$20240927$EXP$$US-APOTEX-2022AP014951$APOTEX$VanDolah H, Crossley JR, Kim HJ.. Three Cases of Uncommon Medication- Induced Osteonecrosis of Temporal Bone. Otolaryngology - Head and Neck Surgery. 2022;167 (Suppl 1):P245-P246$60$YR$$M$Y$$$20240927$$HP$US$US
215665062$21566506$2$F$$20240917$20221108$20240926$EXP$$US-APOTEX-2022AP014950$APOTEX$VanDolah H, Crossley JR, Kim HJ.. Three Cases of Uncommon Medication- Induced Osteonecrosis of Temporal Bone. Otolaryngology - Head and Neck Surgery. 2022;167 (Suppl 1):P245-P246$69$YR$$M$Y$$$20240926$$HP$US$US
215665123$21566512$3$F$20221006$20240829$20221108$20240904$EXP$$NVSC2022CR017208$NOVARTIS$$49$YR$$M$Y$$$20240904$$CN$CR$CR
215671522$21567152$2$F$$20240708$20221108$20240716$PER$$US-SA-2022SA451590$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
215671982$21567198$2$F$$20240829$20221108$20240909$PER$$US-SA-2022SA069280$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240909$$CN$US$US
215672605$21567260$5$F$$20240819$20221108$20240821$EXP$$US-TAKEDA-US201606907$TAKEDA$$$$$F$Y$$$20240821$$HP$US$US
215673152$21567315$2$F$$20240621$20221108$20240703$PER$$US-SA-2022SA457727$SANOFI AVENTIS$$$$A$M$Y$$$20240703$$MD$US$US
215673612$21567361$2$F$$20240625$20221108$20240704$PER$$US-SA-2022SA457612$SANOFI AVENTIS$$$$I$M$Y$16.78$KG$20240704$$MD$US$US
215674888$21567488$8$F$20181201$20240802$20221108$20240809$EXP$$BG-MYLANLABS-2022M1122472$MYLAN$$65$YR$$M$Y$$$20240809$$MD$BG$BG
215675538$21567553$8$F$20220101$20240704$20221108$20240711$EXP$$JP-009507513-2211JPN000536J$MERCK$Yoshida Y, Inoue T, Nakamura H, Omune K, Kondo N, Miyata H. 67 A case of focal glomerulosclerosis during chemotherapy (lenvatinib and pembrolizumab) for corpus uteri carcinoma. The 240th Kinki Regional Meeting of The Japanese Society of Internal Medicine$72$YR$$F$Y$47$KG$20240711$$MD$JP$JP
215675583$21567558$3$F$$20240725$20221108$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13110$LUPIN$$$$$$Y$$$20240814$$CN$US$US
215678392$21567839$2$F$$20240814$20221108$20240819$EXP$$IN-PFIZER INC-2019395963$PFIZER$$66$YR$$M$Y$$$20240819$$CN$IN$IN
215678904$21567890$4$F$$20240813$20221108$20240814$EXP$$US-PFIZER INC-PV202200098696$PFIZER$$75$YR$$F$Y$$$20240814$$CN$US$US
215683352$21568335$2$F$$20240716$20221108$20240721$EXP$$FR-MYLANLABS-2022M1123095$MYLAN$Maroni A, Savary L, Deho A, Tanase A, Dossier C, Dauger S, et al. Malignant arterial hypertension in a 2-month-old girl: Etiological diagnosis and treatment. Arch-Pediatr 2022;29(7):537-539.$2$MON$$F$Y$$$20240719$$HP$FR$FR
215683559$21568355$9$F$20230101$20240729$20221108$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-129781$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240805$$HP$US$US
215685124$21568512$4$F$$20240823$20221108$20240903$PER$$US-AGIOS-2211US03170$AGIOS PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
215687202$21568720$2$F$$20240722$20221108$20240725$PER$$US-ABBVIE-4191341$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
2156877416$21568774$16$F$20230101$20240722$20221108$20240730$EXP$$CA-CELLTRION INC.-2022CA006897$CELLTRION$$$$$$Y$$$20240730$$MD$CA$CA
215688364$21568836$4$F$20220911$20240709$20221108$20240717$EXP$$IT-CELLTRION INC.-2022IT018145$CELLTRION$$$$$$Y$$$20240718$$HP$IT$IT
215689265$21568926$5$F$$20240708$20221108$20240711$EXP$$US-TAKEDA-2022TUS011192$TAKEDA$$$$$M$Y$$$20240711$$CN$US$US
2156923020$21569230$20$F$20221025$20240813$20221109$20240826$EXP$$US-UCBSA-2022064212$UCB$$26$YR$$M$Y$64.4$KG$20240826$$MD$US$US
215693965$21569396$5$F$20230203$20240806$20221109$20240828$PER$$CA-TOLMAR, INC.-22CA037113$TOLMAR$$83$YR$$M$Y$$$20240828$$CN$CA$CA
215696543$21569654$3$F$$20240820$20221109$20240827$EXP$$US-AMGEN-USASP2022190071$AMGEN$Renavikar, P.S.. Characteristics of HPC(A) Products Obtained from Donors with SARS-Cov-2 Infection and Transplant outcome. Transfusion. 2022;62 (2):89A-90A$62$YR$A$M$Y$$$20240827$$HP$US$US
215697508$21569750$8$F$$20240724$20221109$20240806$EXP$$CA-AUROBINDO-AUR-APL-2022-046741$AUROBINDO$$$$$F$Y$$$20240806$$HP$CA$CA
215698802$21569880$2$F$$20240712$20221109$20240715$EXP$$KR-ORGANON-O2211KOR000472$ORGANON$$23$YR$$F$Y$$$20240715$$HP$KR$KR
2157015710$21570157$10$F$$20240801$20221109$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-134539$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$55.79$KG$20240805$$CN$US$US
2157017923$21570179$23$F$20190701$20240916$20221109$20240923$EXP$$US-TAKEDA-US202006434$TAKEDA$$28$YR$$F$Y$$$20240923$$CN$US$US
215701812$21570181$2$F$20180530$20240916$20221109$20240918$EXP$$DE-ROCHE-2148280$ROCHE$$20$YR$A$F$Y$$$20240918$$CN$DE$DE
2157036412$21570364$12$F$20230612$20240903$20221109$20240905$EXP$$NVSC2022AU066944$NOVARTIS$$58$YR$$F$Y$$$20240905$$CN$AU$AU
215704835$21570483$5$F$20230516$20240806$20221109$20240812$EXP$$US-TAKEDA-2022TUS083177$TAKEDA$$50$YR$$F$Y$51$KG$20240812$$HP$US$US
215706418$21570641$8$F$$20240821$20221109$20240902$EXP$$CA-AUROBINDO-AUR-APL-2022-046700$AUROBINDO$$36$YR$$F$Y$$$20240902$$MD$CA$CA
215708024$21570802$4$F$20211231$20240819$20221109$20240829$EXP$$JP-ASTELLAS-2022JP001012$ASTELLAS$$73$YR$E$M$Y$59.5$KG$20240827$$HP$JP$JP
215708954$21570895$4$F$20221014$20240628$20221109$20240706$EXP$$CA-CELLTRION INC.-2022CA018679$CELLTRION$$$$$$Y$$$20240706$$HP$CA$CA
215709055$21570905$5$F$20221028$20221227$20221109$20240925$PER$$US-GSK-US2022AMR158174$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
2157090612$21570906$12$F$20221029$20231009$20221109$20240926$EXP$$US-GSK-US2022AMR159835$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
215713253$21571325$3$F$$20230706$20221109$20240824$EXP$$US-TAKEDA-2022TUS035998$TAKEDA$$$$$M$Y$$$20240824$$MD$US$US
215715992$21571599$2$F$$20240702$20221109$20240708$EXP$$US-GSK-US2022141955$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
215716813$21571681$3$F$$20240709$20221109$20240712$EXP$$US-GW PHARMA-2022-US-034497$JAZZ$$$$$F$Y$$$20240711$$CN$US$US
2157185615$21571856$15$F$20230101$20240826$20221109$20240909$EXP$$CA-UCBSA-2022060360$UCB$$$$$F$Y$$$20240909$$CN$CA$CA
2157223713$21572237$13$F$20221101$20240816$20221109$20240822$EXP$$CA-TAKEDA-2022TUS082079$TAKEDA$$66$YR$$F$Y$$$20240822$$MD$CA$CA
215728476$21572847$6$F$$20240710$20221109$20240711$PER$$US-PFIZER INC-PV202200098892$PFIZER$$54$YR$$F$Y$$$20240711$$MD$US$US
215728624$21572862$4$F$20221104$20240822$20221109$20240828$PER$$US-PFIZER INC-202201283703$PFIZER$$54$YR$$F$Y$$$20240828$$HP$US$US
215730349$21573034$9$F$$20240729$20221109$20240731$EXP$$US-PFIZER INC-2021213831$PFIZER$$74$YR$$F$Y$65.77$KG$20240731$$CN$US$US
215730787$21573078$7$F$20220809$20240902$20221109$20240909$EXP$$IT-PFIZER INC-202201218973$PFIZER$$57$YR$$F$Y$68$KG$20240909$$MD$IT$IT
215731662$21573166$2$F$20210721$20240909$20221109$20240916$EXP$$ES-FreseniusKabi-FK202201907$FRESENIUS KABI$$69$YR$E$M$Y$91$KG$20240916$$HP$ES$ES
215735433$21573543$3$F$20221103$20240705$20221109$20240715$PER$$US-SA-2022SA460364$SANOFI AVENTIS$$33$YR$A$M$Y$72.5$KG$20240715$$MD$US$US
215735663$21573566$3$F$$20240624$20221109$20240703$PER$$US-SA-2022SA460886$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240703$$MD$US$US
215735902$21573590$2$F$$20240717$20221109$20240724$EXP$$US-TAKEDA-2022TUS017182$TAKEDA$$$$$F$Y$$$20240724$$CN$US$US
215736086$21573608$6$F$20240618$20240909$20221109$20240916$EXP$$US-ABBVIE-4192637$ABBVIE$$59$YR$$M$Y$$$20240916$$CN$US$US
215737715$21573771$5$F$20220817$20240730$20221109$20240809$EXP$$CN-Accord-285578$ACCORD$$49$YR$A$F$Y$53.9$KG$20240809$$MD$CN$CN
215737877$21573787$7$F$20220823$20240925$20221109$20240927$EXP$$US-TAKEDA-US202022763$TAKEDA$$62$YR$$F$Y$170$KG$20240927$$HP$US$US
2157382110$21573821$10$F$20221105$20240916$20221109$20240920$EXP$$US-TAKEDA-2022TUS083394$TAKEDA$$3$YR$$M$Y$18$KG$20240920$$HP$US$US
2157387113$21573871$13$F$20220105$20240917$20221109$20240920$EXP$$CH-ABBVIE-4185802$ABBVIE$$78$YR$$M$Y$116$KG$20240920$$MD$CH$CH
215739976$21573997$6$F$$20240701$20221109$20240702$PER$$NVSC2022US252612$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
215745424$21574542$4$F$$20240807$20221109$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-135310$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240813$$HP$US$US
215745742$21574574$2$F$$20240719$20221109$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-362718$RANBAXY$SINGH S, PURI C, B KARKOWSKY W. ONE MORE FEATHER IN THE CAP (DECITABINE): YET ANOTHER CASE OF CHEMOTHERAPY INDUCED LUNG INJURY. Chest. 2022;162(Suppl 4):A1780$79$YR$$F$Y$$$20240802$$HP$US$US
2157464815$21574648$15$F$$20240729$20221109$20240801$EXP$$US-TAKEDA-2022TUS073992$TAKEDA$$$$$F$Y$56$KG$20240801$$HP$US$US
215749512$21574951$2$F$20221001$20221031$20221110$20240925$PER$$US-GSK-US2022AMR158629$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
215753426$21575342$6$F$$20240726$20221110$20240919$EXP$$CA-AUROBINDO-AUR-APL-2022-046720$AUROBINDO$$43$YR$$F$Y$68$KG$20240919$$HP$CA$CA
215763506$21576350$6$F$20220101$20240722$20221110$20240724$EXP$$US-UCBSA-2022063771$UCB$$$$$F$Y$$$20240724$$CN$US$US
2157639615$21576396$15$F$20220101$20240828$20221110$20240905$EXP$$CA-CELLTRION INC.-2022CA004584$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
2157661714$21576617$14$F$$20240730$20221110$20240803$EXP$$NVSC2022US251415$NOVARTIS$$$$$M$Y$145.15$KG$20240803$$CN$US$US
215766224$21576622$4$F$$20240920$20221110$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-134935$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240927$$MD$JP$JP
215768013$21576801$3$F$$20240729$20221110$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13196$LUPIN$$$$$$Y$$$20240815$$CN$US$US
215768567$21576856$7$F$20230101$20240627$20221110$20240702$EXP$$CA-UCBSA-2022064012$UCB$$$$$M$Y$$$20240702$$CN$CA$CA
215769383$21576938$3$F$20221001$20221118$20221110$20240925$PER$$US-GSK-US2022AMR158050$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240925$$CN$US$US
2157694816$21576948$16$F$20220214$20240715$20221110$20240717$EXP$$US-TAKEDA-2022TUS013420$TAKEDA$$63$YR$$F$Y$100$KG$20240717$$MD$US$US
215771693$21577169$3$F$$20240715$20221110$20240717$PER$$NVSC2022US252055$NOVARTIS$$$$$M$Y$$$20240717$$CN$US$US
215772602$21577260$2$F$20220301$20221104$20221110$20240715$EXP$$BG-ASTELLAS-2022US039725$ASTELLAS$$76$YR$$M$Y$$$20240715$$MD$BG$BG
215773473$21577347$3$F$20221005$20221028$20221110$20240711$PER$$JP-PFM-2022-07491$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$$$20240711$$MD$JP$JP
215774237$21577423$7$F$20220201$20240730$20221110$20240805$EXP$$NVSC2022US252791$NOVARTIS$$43$YR$$M$Y$$$20240804$$CN$US$US
215777742$21577774$2$F$$20240917$20221110$20240926$EXP$$IT-CELLTRION INC.-2022IT018471$CELLTRION$Giudice, A.. Oral Lichenoid reaction:an uncommon side efect of rituximab. Case Reports in Dentistry. 2019;1-3$$$$$Y$$$20240926$$HP$IT$IT
215779363$21577936$3$F$$20240816$20221110$20240819$EXP$$US-PFIZER INC-PV202200099707$PFIZER$$60$YR$$M$Y$147.39$KG$20240819$$CN$US$US
215779465$21577946$5$F$$20240814$20221110$20240819$PER$$US-PFIZER INC-PV202200099754$PFIZER$$67$YR$$M$Y$$$20240819$$CN$US$US
215781734$21578173$4$F$$20240819$20221110$20240822$EXP$$NVSC2021CA224553$NOVARTIS$$60$YR$$M$Y$$$20240822$$HP$CA$CA
215782219$21578221$9$F$20221102$20240715$20221110$20240720$EXP$$NVSC2022US252281$NOVARTIS$$67$YR$$F$Y$$$20240719$$CN$US$US
215782284$21578228$4$F$20220101$20240815$20221110$20240823$EXP$$RU-VERTEX PHARMACEUTICALS-2022-015230$VERTEX$$$$$M$Y$18$KG$20240823$$MD$RU$RU
215785526$21578552$6$F$20210821$20240719$20221110$20240723$EXP$$US-UCBSA-2022063399$UCB$$66$YR$$F$Y$$$20240723$$CN$US$US
215786772$21578677$2$F$20220926$20221102$20221110$20240807$EXP$$AE-AstraZeneca-2022A362494$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$AE$
215789293$21578929$3$F$20240501$20240731$20221110$20240808$PER$$US-SA-2022SA458937$SANOFI AVENTIS$$18$YR$A$F$Y$56.6$KG$20240808$$MD$US$US
215789835$21578983$5$F$20221022$20240821$20221110$20240913$PER$$US-SA-2022SA457271$SANOFI AVENTIS$$86$YR$E$M$Y$65.3$KG$20240913$$MD$US$US
215790022$21579002$2$F$20221031$20221101$20221110$20240830$PER$$US-SA-2022SA455067$SANOFI AVENTIS$$$$$$Y$$$20240830$$CN$US$US
215790234$21579023$4$F$20220628$20240705$20221110$20240715$PER$$US-SA-2022SA457301$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240715$$MD$US$US
215790383$21579038$3$F$$20240822$20221110$20240920$PER$$US-SA-2022SA455917$SANOFI AVENTIS$$54$YR$A$F$Y$50.91$KG$20240920$$MD$US$US
215793718$21579371$8$F$20220101$20240927$20221110$20240927$EXP$$CA-PFIZER INC-202201282700$PFIZER$$72$YR$$F$Y$$$20240927$$MD$CA$CA
215794812$21579481$2$F$$20240724$20221110$20240802$PER$$US-TAKEDA-2022TUS082891$TAKEDA$$$$$M$Y$91$KG$20240802$$HP$US$US
215796986$21579698$6$F$$20240726$20221110$20240802$EXP$$US-TAKEDA-2022TUS083710$TAKEDA$$$$$F$Y$89.342$KG$20240802$$CN$US$US
215797627$21579762$7$F$20220101$20240807$20221110$20240812$EXP$$US-PFIZER INC-PV202200100135$PFIZER$$65$YR$$F$Y$$$20240812$$CN$US$US
215802394$21580239$4$F$$20240807$20221110$20240809$EXP$$NVSJ2022JP100636$NOVARTIS$$$$A$F$Y$$$20240809$$MD$JP$JP
215803584$21580358$4$F$20221101$20240815$20221110$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003564$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240909$$CN$US$US
215805325$21580532$5$F$20220101$20240819$20221110$20240822$PER$$US-ABBVIE-4194919$ABBVIE$$$$$M$Y$109$KG$20240822$$CN$US$US
215806135$21580613$5$F$20190401$20240913$20221111$20240925$EXP$$PT-AUROBINDO-AUR-APL-2022-047581$AUROBINDO$Branco A.R.; Araujo P.T.; Andrade A. Fernando Lemos;Diogo Portugal 9 Alves;Pedro Pinto et.al... Difficult-to-control hypercalcemia- about a case of primary hyperparathyroidism. 28th National Internal Medicine Congress- Abstract book. Portuguese society of i. 2022;914$81$YR$$F$Y$$$20240925$$MD$PT$PT
215806665$21580666$5$F$$20240904$20221111$20240926$PER$$CA-TOLMAR, INC.-22CA037357$TOLMAR$$$$$M$Y$$$20240926$$CN$CA$CA
215811517$21581151$7$F$20211126$20240627$20221111$20240702$EXP$$NVSC2022US250308$NOVARTIS$$48$YR$$F$Y$$$20240702$$CN$US$US
215811533$21581153$3$F$$20240702$20221111$20240710$EXP$$CA-CELLTRION INC.-2022CA018458$CELLTRION$$$$$$Y$$$20240710$$HP$CA$CA
215811646$21581164$6$F$$20240916$20221111$20240919$PER$$US-BIOGEN-2022BI01117889$BIOGEN$$$$$F$Y$$$20240919$$CN$US$US
2158118217$21581182$17$F$20221103$20240722$20221111$20240726$EXP$$CO-TAKEDA-2022TUS073222$TAKEDA$$3$YR$$M$Y$17$KG$20240726$$CN$CO$CO
215812184$21581218$4$F$$20240819$20221111$20240821$EXP$$CA-ROCHE-3216148$ROCHE$$$$A$F$Y$$$20240821$$CN$CA$CA
215812318$21581231$8$F$20220101$20240918$20221111$20240926$EXP$$CA-ROCHE-3212865$ROCHE$$4$YR$C$M$Y$35.6$KG$20240926$$HP$CA$CA
215812535$21581253$5$F$20221101$20230103$20221111$20240926$PER$$US-GSK-US2022AMR160873$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240926$$CN$US$US
215812777$21581277$7$F$$20240910$20221111$20240917$EXP$$CA-ROCHE-3216205$ROCHE$$46$YR$A$F$Y$$$20240917$$CN$CA$CA
215812846$21581284$6$F$20220817$20240828$20221111$20240830$EXP$$NVSC2022CA076954$NOVARTIS$$67$YR$$M$Y$$$20240830$$CN$CA$CA
215813233$21581323$3$F$$20240830$20221111$20240926$PER$$US-SA-2022SA463713$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
215815089$21581508$9$F$$20240829$20221111$20240905$EXP$$BR-TAKEDA-2022TUS076418$TAKEDA$$$$$M$Y$$$20240905$$CN$BR$BR
215817802$21581780$2$F$20221102$20240828$20221111$20240925$PER$$US-SA-2022SA464917$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240925$$MD$US$US
215820505$21582050$5$F$$20240905$20221111$20240912$EXP$$CA-TAKEDA-2021TUS049391$TAKEDA$$$$$F$Y$$$20240912$$CN$CA$CA
215822496$21582249$6$F$$20240829$20221111$20240909$EXP$$CA-AUROBINDO-AUR-APL-2020-047584$AUROBINDO$$62$YR$$M$Y$$$20240909$$HP$CA$CA
215822586$21582258$6$F$20220201$20240807$20221111$20240809$EXP$$NVSC2022JP254254$NOVARTIS$$58$YR$$F$Y$$$20240809$$HP$JP$JP
215829094$21582909$4$F$20220525$20240926$20221111$20240930$EXP$$DE-ROCHE-3131925$ROCHE$$39$YR$A$F$Y$$$20240930$$CN$DE$DE
215829325$21582932$5$F$20210910$20240619$20221111$20240701$EXP$AU-STRIDES ARCOLAB LIMITED-2022SP014973$AU-STRIDES ARCOLAB LIMITED-2022SP014973$STRIDES$Courtney A, Ong J, Lucas M, Rueter K.. CHALLENGES IN DIAGNOSING DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS IN A MEDICALLY COMPLEX INFANT.. Internal Medicine Journal. 2022;52(5):5$2$YR$$F$Y$5$KG$20240701$$MD$AU$AU
215830655$21583065$5$F$20191114$20240829$20221111$20240905$EXP$$DE-ROCHE-2510022$ROCHE$$49$YR$A$F$Y$$$20240905$$CN$DE$DE
215832903$21583290$3$F$20220927$20221222$20221111$20240925$EXP$$US-GSK-US2022AMR037116$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2158330713$21583307$13$F$20230908$20240918$20221111$20240925$EXP$$CA-GSK-CA2022AMR165665$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$PH$CA$CA
215833172$21583317$2$F$20220901$20240816$20221111$20240823$EXP$$US-GSK-US2022140555$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$US$US
2158340110$21583401$10$F$20220701$20240702$20221111$20240704$EXP$$NVSC2022JP253668$NOVARTIS$$68$YR$$F$Y$42.4$KG$20240704$$HP$JP$JP
2158351512$21583515$12$F$$20240913$20221111$20240920$EXP$$US-TAKEDA-2022TUS009967$TAKEDA$$$$$M$Y$49$KG$20240920$$MD$US$US
215840536$21584053$6$F$20221024$20240926$20221111$20240930$EXP$$US-PFIZER INC-202201292667$PFIZER$$50$YR$$F$Y$$$20240930$$HP$US$US
215843155$21584315$5$F$20191216$20240826$20221111$20240903$EXP$$CA-ROCHE-2565247$ROCHE$$61$YR$A$F$Y$$$20240903$$CN$CA$CA
215843644$21584364$4$F$20210101$20240814$20221111$20240821$PER$$US-BIOGEN-2022BI01158346$BIOGEN$$$$$M$Y$$$20240821$$CN$US$US
215845632$21584563$2$F$20220101$20240918$20221111$20240923$EXP$$US-PFIZER INC-202200744934$PFIZER$$63$YR$$F$Y$$$20240923$$HP$US$US
215846242$21584624$2$F$$20240912$20221111$20240919$EXP$$GB-TAKEDA-2022TUS028427$TAKEDA$$$$$F$Y$$$20240919$$CN$GB$GB
215847374$21584737$4$F$$20240822$20221111$20240828$EXP$$IN-PFIZER INC-PV202200031402$PFIZER$$62$YR$$F$Y$$$20240828$$CN$IN$IN
215848153$21584815$3$F$$20240731$20221111$20240802$EXP$$IN-PFIZER INC-PV202200100999$PFIZER$$66$YR$$F$Y$$$20240802$$CN$IN$IN
215848176$21584817$6$F$20191212$20240902$20221111$20240905$EXP$$IT-PFIZER INC-202200800478$PFIZER$$40$YR$$F$Y$$$20240905$$MD$IT$IT
215848212$21584821$2$F$20220822$20240628$20221111$20240702$EXP$IT-MINISAL02-892668$IT-PFIZER INC-202201283971$PFIZER$$16$YR$$M$Y$$$20240702$$PH$IT$IT
215848442$21584844$2$F$$20240820$20221111$20240901$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-133987$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$69.4$KG$20240902$$CN$US$US
215848552$21584855$2$F$$20240807$20221111$20240816$EXP$$PT-AstraZeneca-2022A363948$ASTRAZENECA$sa S, Alves S, Lagarteira J, Pera R, Ceriz T, Batouxas C, Blanco M. Purpura Trombocitopenica Trombotica: varios espectros da doenca. Medicina Interna - Congressos Nacionais - Livro de Resumos 2022;1152.$64$YR$$F$Y$$$20240816$$MD$PT$
2158493118$21584931$18$F$$20240923$20221111$20240927$EXP$$CA-ORGANON-2012CAN013366$ORGANON$$44$YR$$F$Y$97$KG$20240927$$HP$CA$CA
215851072$21585107$2$F$20220819$20240712$20221111$20240717$PER$$US-ABBVIE-4195333$ABBVIE$$66$YR$$F$Y$$$20240717$$CN$US$US
215852574$21585257$4$F$20170401$20240726$20221111$20240808$EXP$$US-NOVOPROD-872581$NOVO NORDISK$$69$YR$$F$Y$58.05$KG$20240808$$MD$US$US
2158561020$21585610$20$F$20220101$20240906$20221111$20240910$PER$$US-DSJP-DSU-2022-140433$DAIICHI$$$$$F$Y$$$20240910$$CN$US$US
2158597913$21585979$13$F$20220901$20240705$20221111$20240711$EXP$$GR-TAKEDA-2022TUS082193$TAKEDA$$44$YR$$F$Y$$$20240711$$CN$GR$GR
215864697$21586469$7$F$$20240701$20221112$20240708$EXP$$PT-AUROBINDO-AUR-APL-2022-046940$AUROBINDO$Rocha, A.T.G.A.F, Sim?es, P,  Sousa, M, Rodrigues, F, Ceriz, T, Tome E et al. n.? 2716 - DRESS CODE PARA CIRURGIA ORTOPEDICA? INDUZIDO POR ANTIBIOTICO.. Medicina Interna ? Congressos Nacionais, 28 CNMI. 2022;28:1228$52$YR$$M$Y$$$20240708$$MD$PT$PT
215866392$21586639$2$F$$20221027$20221113$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202211003156$ELI LILLY AND CO$$$$$$Y$$$20240828$$MD$US$US
215866943$21586694$3$F$$20240701$20221113$20240706$EXP$$ES-AUROBINDO-AUR-APL-2022-046099$AUROBINDO$Rico-Nieto A, Falces-Romero I.. Osteoarticular infection due to dalbavancin-resistant Staphylococci: Description of two cases. Med-Clin-Barc. 2021;156(11):577-578.$46$YR$$F$Y$$$20240706$$HP$ES$ES
215868276$21586827$6$F$20200403$20240816$20221113$20240827$EXP$$CA-AMGEN-CANCT2019128569$AMGEN$$57$YR$A$F$Y$$$20240827$$CN$CA$CA
2158734115$21587341$15$F$20220101$20240814$20221114$20240821$EXP$$CA-CELLTRION INC.-2022CA016354$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
215875428$21587542$8$F$20220101$20240801$20221114$20240808$EXP$$CA-CELLTRION INC.-2022CA018398$CELLTRION$$$$$$Y$$$20240808$$HP$CA$CA
215878205$21587820$5$F$20181001$20240613$20221114$20240709$EXP$$DE-ROCHE-2313768$ROCHE$$54$YR$A$M$Y$$$20240705$$CN$DE$DE
215878645$21587864$5$F$20191104$20240612$20221114$20240703$EXP$$DE-ROCHE-2482054$ROCHE$$45$YR$A$F$Y$$$20240703$$CN$DE$DE
215880133$21588013$3$F$$20240715$20221114$20240722$EXP$$FR-AUROBINDO-AUR-APL-2022-047414$AUROBINDO$Sastre C, Baillif-Couniou V, Fabresse N, Ameline A, Kintz P, Gaulier J-M, et al... Pregabalin misuse: About seven cases of death in the region of Marseille.. Toxic-Analyt-Clinique. 2022;34(3):151-158$47$YR$$M$Y$$$20240722$$MD$FR$FR
2158808618$21588086$18$F$20221101$20240910$20221114$20240913$EXP$$US-PFIZER INC-PV202200099063$PFIZER$$75$YR$$F$Y$$$20240913$$CN$US$US
215881512$21588151$2$F$20221026$20221104$20221114$20240802$EXP$$US-ORPHANEU-2022005670$RECORDATI$$$$$$Y$$$20240802$$CN$US$US
2158906411$21589064$11$F$20190301$20240725$20221114$20240806$EXP$$DE-AUROBINDO-AUR-APL-2022-047538$AUROBINDO$$$$A$F$Y$64$KG$20240806$$MD$DE$DE
2158909816$21589098$16$F$20220101$20240625$20221114$20240704$EXP$$US-INSMED-2022-01985-USAA$INSMED$$$$$M$Y$$$20240704$$CN$US$US
215893747$21589374$7$F$20211209$20240917$20221114$20240924$EXP$$NVSC2022IN252902$NOVARTIS$$35$YR$$F$Y$$$20240924$$CN$IN$IN
215894092$21589409$2$F$$20240911$20221114$20240913$EXP$$NVSC2022CA251220$NOVARTIS$$80$YR$$M$Y$$$20240913$$HP$CA$CA
215894316$21589431$6$F$$20240910$20221114$20240918$EXP$$NVSC2022CA250900$NOVARTIS$$61$YR$$M$Y$$$20240918$$HP$CA$CA
215895782$21589578$2$F$$20221109$20221114$20240926$EXP$$US-GSK-US2022AMR092332$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2158993910$21589939$10$F$20220101$20240922$20221114$20240925$30DAY$$US-PFIZER INC-PV202200098825$PFIZER$$11$YR$$F$Y$$$20240925$$CN$US$US
2159029011$21590290$11$F$20220627$20240718$20221114$20240722$EXP$$CH-ABBVIE-4195633$ABBVIE$$73$YR$$M$Y$68$KG$20240722$$MD$CH$CH
215904644$21590464$4$F$$20240820$20221114$20240827$EXP$$CA-ROCHE-3215219$ROCHE$$65$YR$E$F$Y$$$20240827$$HP$CA$CA
215905314$21590531$4$F$$20230531$20221114$20240925$EXP$$US-TAKEDA-2022TUS014345$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
215906449$21590644$9$F$20220301$20240906$20221114$20240917$EXP$$US-TAKEDA-2022TUS031063$TAKEDA$$34$YR$$M$Y$68$KG$20240917$$HP$US$US
215907515$21590751$5$F$20220701$20240920$20221114$20240925$EXP$$JP-PFIZER INC-202201270419$PFIZER$$43$YR$$M$Y$$$20240925$$MD$JP$JP
215907625$21590762$5$F$20220428$20240910$20221114$20240913$EXP$$IN-PFIZER INC-202200649615$PFIZER$$63$YR$$M$Y$65$KG$20240913$$CN$IN$IN
215909383$21590938$3$F$20230413$20240911$20221114$20240923$EXP$$CA-TAKEDA-2022TUS084196$TAKEDA$$84$YR$$M$Y$$$20240923$$MD$CA$CA
215916374$21591637$4$F$$20240903$20221114$20240910$EXP$$GB-TAKEDA-2020TUS057990$TAKEDA$$$$$F$Y$$$20240910$$CN$GB$GB
215919688$21591968$8$F$20220622$20240723$20221114$20240731$EXP$$JP-PFIZER INC-PV202200102559$PFIZER$$39$YR$$F$Y$53$KG$20240731$$MD$JP$JP
215920252$21592025$2$F$$20240801$20221114$20240802$EXP$$US-TAKEDA-2022TUS045944$TAKEDA$$$$$F$Y$$$20240802$$MD$US$US
2159212312$21592123$12$F$20231201$20240809$20221114$20240814$EXP$$NVSC2022MX200391$NOVARTIS$$48$YR$$F$Y$90$KG$20240814$$CN$MX$MX
215922448$21592244$8$F$$20230621$20221114$20240924$EXP$$NVSC2022US252650$NOVARTIS$$$$$M$Y$$$20240924$$CN$US$US
215923343$21592334$3$F$$20240805$20221114$20240809$EXP$$BR-BIOMARINAP-BR-2021-137688$BIOMARIN$$$$$$Y$$$20240809$$CN$BR$BR
215924766$21592476$6$F$20211130$20240710$20221114$20240722$EXP$$DE-ROCHE-2997866$ROCHE$$47$YR$A$F$Y$$$20240722$$CN$DE$DE
215933799$21593379$9$F$$20240830$20221114$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-137245$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240909$$PH$US$US
215938418$21593841$8$F$$20240819$20221115$20240821$PER$$NVSC2022US253714$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
215940422$21594042$2$F$20221014$20221107$20221115$20240802$EXP$$US-ORPHANEU-2022005719$RECORDATI$$$$$$Y$$$20240802$$CN$US$US
215941063$21594106$3$F$$20240725$20221115$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13422$LUPIN$$$$$$Y$$$20240813$$CN$US$US
2159454413$21594544$13$F$20200527$20240827$20221115$20240904$EXP$$CA-CELLTRION INC.-2020CA019653$CELLTRION$$$$$$Y$$$20240904$$MD$CA$CA
215947572$21594757$2$F$20220623$20240809$20221115$20240814$EXP$$US-TAKEDA-2022TUS045599$TAKEDA$$64$YR$$F$Y$$$20240814$$CN$US$US
2159476610$21594766$10$F$$20240621$20221115$20240709$EXP$$CA-ROCHE-3218792$ROCHE$$$$A$F$Y$$$20240705$$CN$CA$CA
215947709$21594770$9$F$$20240924$20221115$20240928$EXP$$CA-ROCHE-3218754$ROCHE$$$$A$F$Y$$$20240928$$CN$CA$CA
215949333$21594933$3$F$$20240821$20221115$20240828$EXP$$BR-TAKEDA-2022TUS084834$TAKEDA$$$$$M$Y$$$20240828$$CN$BR$BR
215949777$21594977$7$F$20220101$20240829$20221115$20240829$EXP$$CA-PFIZER INC-202201292571$PFIZER$$47$YR$$M$Y$$$20240829$$HP$CA$CA
2159501018$21595010$18$F$20210112$20240912$20221115$20240920$EXP$$CA-CELLTRION INC.-2021CA018316$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
215955275$21595527$5$F$20210316$20240725$20221115$20240801$EXP$$DE-ROCHE-2811595$ROCHE$$44$YR$A$F$Y$$$20240801$$CN$DE$DE
215957032$21595703$2$F$20220101$20240715$20221115$20240722$EXP$$US-ABBVIE-4200240$ABBVIE$$$$$M$Y$76.203$KG$20240722$$CN$US$US
215958402$21595840$2$F$$20221109$20221115$20240711$EXP$$BG-ASTELLAS-2022US040352$ASTELLAS$$68$YR$$M$Y$$$20240711$$MD$BG$BG
215959373$21595937$3$F$20221122$20240712$20221115$20240716$EXP$$CA-TAKEDA-2022TUS084285$TAKEDA$$19$YR$$F$Y$$$20240716$$CN$CA$CA
215960594$21596059$4$F$$20221212$20221115$20240904$EXP$$NVSJ2022JP101116$NOVARTIS$Imi T, Nanya Y, Zaimoku Y, Maruyama H, Hosokawa A, Yoshida A, et al.. Low incidence of MDS-related gene mutations in patients with long-standing AA refractory to IST. Program and Abstracts for The 84th Annual Meeting of the Japanese Society of Hem. 2022;OS3-4C-3$$$$$Y$$$20240904$$HP$JP$JP
215962218$21596221$8$F$$20240726$20221115$20240729$PER$$NVSC2022US256221$NOVARTIS$$$$$F$Y$$$20240729$$HP$US$US
215964457$21596445$7$F$20210101$20240903$20221115$20240905$EXP$$US-PFIZER INC-202101847221$PFIZER$$68$YR$$F$Y$$$20240905$$HP$US$US
215964753$21596475$3$F$$20240725$20221115$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13351$LUPIN$$$$$$Y$$$20240815$$PH$US$US
215965073$21596507$3$F$$20240729$20221115$20240802$PER$$US-PFIZER INC-202200825511$PFIZER$$52$YR$$F$Y$$$20240802$$HP$US$US
215967122$21596712$2$F$20220606$20240904$20221115$20240912$EXP$$CZ-ROCHE-3125432$ROCHE$$70$YR$E$M$Y$68$KG$20240912$$HP$CZ$CZ
215968082$21596808$2$F$$20240911$20221115$20240919$EXP$$CA-MYLANLABS-2022M1124296$BIOCON$$$$$$Y$$$20240919$$CN$CA$CA
215969393$21596939$3$F$$20240904$20221115$20240906$PER$$NVSC2022US256082$NOVARTIS$$$$$M$Y$$$20240906$$CN$US$US
215969429$21596942$9$F$20220222$20240828$20221115$20240903$EXP$$CA-TAKEDA-2022TUS012810$TAKEDA$$60$YR$$M$Y$$$20240903$$CN$CA$CA
2159750520$21597505$20$F$20221018$20240828$20221115$20240903$EXP$$US-TAKEDA-2022TUS085072$TAKEDA$$6$YR$$M$Y$$$20240903$$MD$US$US
215980968$21598096$8$F$20221023$20240918$20221115$20240926$EXP$$US-TAKEDA-2022TUS083755$TAKEDA$$26$YR$$F$Y$$$20240926$$CN$US$US
215987844$21598784$4$F$20221101$20240702$20221115$20240711$PER$$US-SA-2022SA468417$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240711$$MD$US$US
215990814$21599081$4$F$$20240820$20221115$20240828$EXP$$CA-TEVA-2022-CA-2825000$TEVA$$44$YR$$F$Y$97$KG$20240828$$HP$CA$CA
215991892$21599189$2$F$$20240917$20221115$20240919$EXP$$NVSC2022US254710$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
215994532$21599453$2$F$$20240722$20221115$20240727$EXP$$NVSC2022US255965$NOVARTIS$$$$$M$Y$$$20240727$$CN$US$US
215999875$21599987$5$F$20221122$20221202$20221116$20240925$PER$$US-GSK-US2022AMR167971$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240925$$CN$US$US
215999972$21599997$2$F$$20240823$20221116$20240904$EXP$$CA-BAXTER-2022BAX024112$BAXTER$$60$YR$$F$Y$$$20240904$$HP$CA$CA
216000237$21600023$7$F$20220601$20240819$20221116$20240912$PER$$CA-TOLMAR, INC.-22CA037129$TOLMAR$$75$YR$$M$Y$$$20240912$$CN$CA$CA
2160045013$21600450$13$F$20221114$20240918$20221116$20240925$PER$$NVSC2022US257776$NOVARTIS$$8$YR$$F$Y$45$KG$20240925$$CN$US$US
216004643$21600464$3$F$20221103$20221103$20221116$20240903$EXP$$ES-JNJFOC-20221111738$JOHNSON AND JOHNSON$$$$$F$Y$71$KG$20240903$$MD$ES$ES
216008563$21600856$3$F$$20240725$20221116$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13300$LUPIN$$$$$$Y$$$20240814$$PH$US$US
216009093$21600909$3$F$20221101$20221116$20221116$20240925$PER$$US-GSK-US2022AMR166096$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
216009543$21600954$3$F$$20240725$20221116$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13346$LUPIN$$$$$$Y$$$20240813$$PH$US$US
216009557$21600955$7$F$20220621$20240826$20221116$20240830$EXP$$US-JNJFOC-20221123252$JOHNSON AND JOHNSON$$76$YR$E$F$Y$82.63$KG$20240830$$HP$US$US
216011904$21601190$4$F$20220101$20240802$20221116$20240802$EXP$$CA-PFIZER INC-202200547563$PFIZER$$64$YR$$M$Y$$$20240802$$HP$CA$CA
216012186$21601218$6$F$20220101$20240827$20221116$20240903$EXP$$CA-PFIZER INC-202200934699$PFIZER$$47$YR$$F$Y$64$KG$20240903$$MD$CA$CA
216013383$21601338$3$F$20170616$20240818$20221116$20240823$EXP$$PHHY2017CA169320$NOVARTIS$$38$YR$$F$Y$$$20240823$$CN$CA$CA
2160160410$21601604$10$F$20210501$20240709$20221116$20240716$EXP$$US-TAKEDA-2022TUS084679$TAKEDA$$47$YR$$F$Y$$$20240716$$CN$US$US
216016327$21601632$7$F$$20240712$20221116$20240718$EXP$$CA-ROCHE-2927110$ROCHE$$$$A$M$Y$$$20240718$$CN$CA$CA
216016544$21601654$4$F$20240607$20240815$20221116$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202211007319$ELI LILLY AND CO$$90$YR$E$M$Y$$$20240820$$MD$US$US
216018144$21601814$4$F$$20240725$20221116$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13440$LUPIN$$$$$$Y$$$20240815$$CN$US$US
216019943$21601994$3$F$20220301$20221214$20221116$20240926$EXP$$US-GSK-US2022AMR048373$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
216024153$21602415$3$F$20221102$20240725$20221116$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13477$LUPIN$$$$$$Y$$$20240815$$CN$US$US
216025573$21602557$3$F$$20240725$20221116$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13472$LUPIN$$$$$$Y$$$20240813$$CN$US$US
216025935$21602593$5$F$20230601$20240722$20221116$20240729$EXP$$US-JAZZ-2022-US-035247$JAZZ$$32$YR$$F$Y$$$20240729$$CN$US$US
216026296$21602629$6$F$20181002$20240702$20221116$20240711$EXP$$US-INTERCEPT-PM2022001769$INTERCEPT PHARMACEUTICALS$$61$YR$$F$Y$$$20240711$$CN$US$US
216029352$21602935$2$F$20221030$20240820$20221116$20240911$EXP$$US-SA-2022SA471096$SANOFI AVENTIS$$63$YR$A$M$Y$87.27$KG$20240911$$MD$US$US
216033242$21603324$2$F$$20240718$20221116$20240726$EXP$$CA-APOTEX-2022AP015363$APOTEX$$38$YR$$M$Y$$$20240726$$HP$CA$CA
216034477$21603447$7$F$20220401$20240814$20221116$20240819$EXP$$CA-TAKEDA-2022TUS085323$TAKEDA$$3$YR$$F$Y$$$20240819$$HP$CA$CA
216037492$21603749$2$F$20220501$20240725$20221116$20240801$EXP$$US-PFIZER INC-202200875981$PFIZER$$84$YR$$F$Y$$$20240801$$CN$US$US
216037633$21603763$3$F$$20240823$20221116$20240826$PER$$NVSC2022US257857$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
2160383110$21603831$10$F$20190612$20240722$20221116$20240726$EXP$$CA-TAKEDA-2019TUS048689$TAKEDA$$53$YR$$F$Y$$$20240726$$HP$CA$CA
216040445$21604044$5$F$20221001$20240701$20221116$20240705$EXP$$US-ABBVIE-22K-163-4529371-00$ABBVIE$$24$YR$$F$Y$$$20240705$$CN$US$US
216040774$21604077$4$F$20221014$20240917$20221116$20240930$EXP$$VN-TAKEDA-2022TUS079100$TAKEDA$$63$YR$$M$Y$65$KG$20240930$$CN$VN$VN
216046015$21604601$5$F$$20240715$20221116$20240719$EXP$$NVSC2021CA225101$NOVARTIS$$82$YR$$F$Y$72$KG$20240719$$CN$CA$CA
216051173$21605117$3$F$$20240906$20221116$20240909$PER$$NVSC2022US258272$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
216051435$21605143$5$F$20220601$20240822$20221116$20240830$EXP$$DE-MYLANLABS-2022M1128478$BIOCON$$$$$$Y$$$20240830$$MD$DE$DE
216051804$21605180$4$F$$20240923$20221116$20240926$EXP$$TO-TAKEDA-2022TUS084370$TAKEDA$$$$$M$Y$55$KG$20240926$$CN$TO$TO
216053523$21605352$3$F$20220921$20240617$20221116$20240701$EXP$$JP-ROCHE-3219872$ROCHE$PRIVACY P, Narahara K.. Untreated Diffuse Large B-Cell Lymphoma in which ARDS and Tumor Lysis Syndrome Developed after Polatuzumab Vedotin Treatment.. The 13th Annual Meeting of the Japanese Society of Hematology Kyushu Association. 2023;14:-.$71$YR$E$F$Y$43.6$KG$20240701$$MD$JP$JP
216053782$21605378$2$F$$20240717$20221116$20240725$PER$$US-SA-2022SA466672$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240725$$MD$US$US
216053938$21605393$8$F$20190522$20240621$20221116$20240710$EXP$$DE-ROCHE-2348966$ROCHE$$42$YR$A$F$Y$54$KG$20240710$$CN$DE$DE
216056827$21605682$7$F$20220101$20240808$20221116$20240816$EXP$$JP-009507513-2208JPN004432J$MERCK$Morita J, Sugiyama D, Mori S, Ogushi Y, Kadokawa Y, Inoue T, et al.. O-028 Comparative study of adverse events of IO + IO combination therapy and IO + TKI combination therapy for metastatic renal cancer at Showa University Hospital. The 88th Annual Meeting of the Eastern Section of Japanese Urological Associatio. 210$7$DEC$$M$Y$$$20240816$$MD$JP$JP
216062333$21606233$3$F$$20240903$20221117$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-136439$BRISTOL MYERS SQUIBB$K. Ozone et al. Ovarian hyperstimulation syndrome developing after oocyte retrieval performed under dasatinib administration as induction therapy for Ph-positive acute lymphoblastic leukemia. The 680th Kanto Regional Meeting Sponsored by the Kanto Branch of the Japanese Society of Internal Medicine (Programs and Abstracts). 2022; 68.$27$YR$A$F$Y$47$KG$20240913$$MD$JP$JP
2160643911$21606439$11$F$20221104$20240814$20221117$20240821$EXP$$BR-CELLTRION INC.-2022BR019300$CELLTRION$$$$$$Y$$$20240821$$HP$BR$BR
216065872$21606587$2$F$$20240620$20221117$20240701$EXP$$CA-APOTEX-2022AP015444$APOTEX$$60$YR$$F$Y$$$20240701$$HP$CA$CA
216066192$21606619$2$F$$20240819$20221117$20240823$EXP$$AU-TAKEDA-2021TUS064391$TAKEDA$$$$$F$Y$$$20240823$$CN$AU$AU
216071869$21607186$9$F$$20240809$20221117$20240813$PER$$US-PFIZER INC-PV202200104352$PFIZER$$63$YR$$F$Y$$$20240813$$MD$US$US
216072712$21607271$2$F$20220601$20240820$20221117$20240822$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000521$PAREXEL$$$$$$Y$$$20240822$$CN$US$US
216073482$21607348$2$F$$20240521$20221117$20240812$EXP$$IE-TEVA-2022-IE-2826020$TEVA$Carthy B, McQuaid SE. Acute peri-orbital inflammation associated with intravenous bisphosphonate therapy in a patient with primary hyperparathyroidism. Ir-J-Med-Sci 2022;191 (Suppl. 4):S115 abstr. P80.; Carthy B, McQuaid SE. Acute peri-orbital inflammation associated with intravenous bisphosphonate therapy in a patient with primary hyperparathyroidism. Ir-J-Med-Sci 2022;191 (Suppl. 4):S115 abstr. P80.$62$YR$$M$Y$$$20240812$$HP$IE$IE
216076622$21607662$2$F$$20240920$20221117$20240923$PER$$NVSC2022US257039$NOVARTIS$$$$$F$Y$$$20240923$$HP$US$US
216077159$21607715$9$F$20221101$20230425$20221117$20240925$PER$$US-GSK-US2022AMR167191$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240925$$CN$US$US
216077674$21607767$4$F$20221105$20240720$20221117$20240808$PER$$CA-TOLMAR, INC.-22CA037413$TOLMAR$$89$YR$$M$Y$$$20240808$$CN$CA$CA
216079408$21607940$8$F$20230701$20231204$20221117$20240926$EXP$$US-GSK-US2022AMR164631$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2160814614$21608146$14$F$20220218$20240523$20221117$20240925$EXP$$US-GSK-US2022AMR031521$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
216084535$21608453$5$F$20220101$20240731$20221117$20240802$PER$$US-PFIZER INC-PV202200027942$PFIZER$$64$YR$$F$Y$$$20240802$$CN$US$US
216087573$21608757$3$F$$20221107$20221117$20240914$EXP$$AU-TEVA-2022-AU-2027186$TEVA$Allnutt KJ, Vogrin S, Li J, Goh MS, Brennand S, Davenport R, et al. A long term cohort study of acitretin for prevention of keratinocyte carcinoma in solid organ transplant recipients. Australas J Dermatol. 2022;63(2): e121-e126.; Allnutt KJ, Vogrin S, Li J, Goh MS, Brennand S, Davenport R, et al. A long term cohort study of acitretin for prevention of keratinocyte carcinoma in solid organ transplant recipients. Australas J Dermatol. 2022;63(2): e121-e126.; Allnutt KJ, Vogrin S, Li J, Goh MS,...$$$A$$Y$$$20240914$$HP$AU$AU
216090688$21609068$8$F$20230814$20240828$20221117$20240910$EXP$$US-THERATECHNOLOGIES INC.-2022-THE-TES-000228$THERATECHNOLOGIES$$$$$$Y$$$20240910$$CN$US$US
216091332$21609133$2$F$20220101$20240805$20221117$20240807$EXP$$CA-PFIZER INC-202201300465$PFIZER$$8$YR$$M$Y$$$20240807$$MD$CA$CA
216091847$21609184$7$F$20230922$20240717$20221117$20240723$EXP$$IN-PFIZER INC-2019357635$PFIZER$$66$YR$$F$Y$$$20240723$$CN$IN$IN
216096195$21609619$5$F$20210801$20240801$20221117$20240808$EXP$$BR-TAKEDA-2022TUS002842$TAKEDA$$2$YR$$M$Y$18$KG$20240808$$CN$BR$BR
216097882$21609788$2$F$$20240826$20221117$20240902$EXP$$CA-APOTEX-2022AP015414$APOTEX$$52$YR$$M$Y$$$20240902$$HP$CA$CA
216098325$21609832$5$F$20221113$20240731$20221117$20240806$EXP$$CA-TAKEDA-2022TUS085626$TAKEDA$$74$YR$$M$Y$$$20240806$$CN$CA$CA
216098745$21609874$5$F$$20240910$20221117$20240918$EXP$$IN-EMD Serono-9365683$EMD SERONO INC$$61$YR$A$M$Y$65$KG$20240918$$CN$IN$IN
216098809$21609880$9$F$20221103$20240703$20221117$20240704$EXP$$CN-TAKEDA-2022TUS085224$TAKEDA$$65$YR$$F$Y$62$KG$20240704$$MD$CN$CN
216106982$21610698$2$F$$20240701$20221117$20240704$EXP$$US-TAKEDA-2022TUS085653$TAKEDA$$$$$M$Y$93.651$KG$20240704$$MD$US$US
216107158$21610715$8$F$20200710$20240830$20221117$20240903$EXP$$IT-ROCHE-2900232$ROCHE$$48$YR$A$F$Y$$$20240903$$MD$IT$IT
2161073115$21610731$15$F$20200101$20240715$20221117$20240718$PER$$US-ROCHE-3217821$ROCHE$$63$YR$A$M$Y$60.4$KG$20240718$$CN$US$US
216107725$21610772$5$F$20211019$20240902$20221117$20240910$EXP$$DE-ROCHE-3141547$ROCHE$$38$YR$A$F$Y$$$20240910$$CN$DE$DE
216109534$21610953$4$F$$20240926$20221117$20240930$EXP$$CA-TEVA-2022-CA-2826003$TEVA$$44$YR$$F$Y$97$KG$20240930$$HP$CA$CA
216109955$21610995$5$F$$20240923$20221117$20240926$PER$$US-PFIZER INC-PV202200103704$PFIZER$$78$YR$$F$Y$$$20240926$$CN$US$US
216110492$21611049$2$F$20210102$20240710$20221117$20240718$EXP$$JP-JAZZ-2021-JP-000135$JAZZ$$56$YR$$M$Y$66$KG$20240718$$MD$JP$JP
216111973$21611197$3$F$$20240726$20221117$20240807$PER$$US-SA-2022SA469303$SANOFI AVENTIS$$$$A$F$Y$106.14$KG$20240807$$MD$US$US
216115892$21611589$2$F$20221001$20240614$20221117$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003694$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240709$$CN$US$US
216121062$21612106$2$F$20220101$20240715$20221118$20240723$PER$$US-ABBVIE-22K-163-4374552-00$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
216123158$21612315$8$F$20221101$20230420$20221118$20240925$PER$$US-GSK-US2022AMR166092$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
216127298$21612729$8$F$20221101$20230626$20221118$20240925$EXP$$US-GSK-US2022AMR171053$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
216129097$21612909$7$F$20240628$20240722$20221118$20240724$EXP$$CA-TAKEDA-2022TUS085726$TAKEDA$$23$YR$$F$Y$$$20240724$$MD$CA$CA
2161299914$21612999$14$F$20220101$20240909$20221118$20240917$EXP$$CA-CELLTRION INC.-2022CA012449$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
216130188$21613018$8$F$20221117$20240710$20221118$20240712$PER$$NVSC2022US259843$NOVARTIS$$20$YR$$F$Y$$$20240712$$HP$US$US
2161340512$21613405$12$F$20131118$20240605$20221118$20240709$EXP$$CA-ROCHE-3220864$ROCHE$$57$YR$A$F$Y$$$20240704$$CN$CA$CA
2161360018$21613600$18$F$20221215$20240715$20221118$20240717$EXP$$US-KAMADA LIMITED-2017US016718$TAKEDA$$62$YR$$M$Y$59$KG$20240717$$HP$US$US
216137444$21613744$4$F$20221025$20240627$20221118$20240704$EXP$$US-SA-2022SA474302$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240704$$MD$US$US
216144996$21614499$6$F$20220101$20240722$20221118$20240731$EXP$$DE-NOVOPROD-965076$NOVO NORDISK$$77$YR$$M$Y$87$KG$20240731$$CN$DE$DE
216145043$21614504$3$F$20220812$20240906$20221118$20240918$EXP$FR-AFSSAPS-AN20222365$FR-NOVOPROD-978464$NOVO NORDISK$$66$YR$$F$Y$78$KG$20240918$$PH$FR$FR
216146026$21614602$6$F$$20240919$20221118$20240926$EXP$$CA-TAKEDA-2022TUS085073$TAKEDA$$$$$M$Y$88$KG$20240926$$CN$CA$CA
216146132$21614613$2$F$20221017$20240828$20221118$20240904$PER$$US-PFIZER INC-202201309393$PFIZER$$47$YR$$F$Y$$$20240904$$HP$US$US
2161467620$21614676$20$F$20210123$20240815$20221118$20240821$EXP$$DE-TAKEDA-2021TUS005562$TAKEDA$$60$YR$$M$Y$$$20240821$$CN$DE$DE
216148033$21614803$3$F$$20240725$20221118$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13517$LUPIN$$$$$$Y$$$20240813$$PH$US$US
216148213$21614821$3$F$$20240819$20221118$20240822$EXP$$US-JAZZ-2022-US-035228$JAZZ$$$$$M$Y$$$20240822$$MD$US$US
2161487325$21614873$25$F$$20240916$20221118$20240919$EXP$$US-PFIZER INC-PV202200105156$PFIZER$$73$YR$$F$Y$68.04$KG$20240919$$CN$US$US
216150482$21615048$2$F$20220601$20221115$20221118$20240925$EXP$$US-GSK-US2022AMR092924$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
216150643$21615064$3$F$$20240725$20221118$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13550$LUPIN$$$$$$Y$$$20240813$$CN$US$US
216152882$21615288$2$F$20210101$20240906$20221118$20240911$EXP$$NL-VELOXIS PHARMACEUTICALS, INC.-2022-VEL-00576$VELOXIS PHARMACEUTICALS$Sogbein O, Gamilla-Crudo AKN, Mujtaba M A, Hussain S A. Transplant Graft TMA Injury Post COVID-19 Vaccination.. American Journal of Kidney Diseases. 2022;79(4 Suppl 2):S31$48$YR$$M$Y$$$20240911$$HP$NL$NL
216157576$21615757$6$F$$20240715$20221118$20240819$EXP$$CA-AstraZeneca-2020SF02347$ASTRAZENECA$$72$YR$$M$Y$$$20240819$$MD$CA$
216157687$21615768$7$F$20200716$20240729$20221118$20240806$EXP$$DE-ROCHE-2666315$ROCHE$$51$YR$A$F$Y$$$20240806$$CN$DE$DE
216157752$21615775$2$F$$20240909$20221118$20240912$PER$$NVSC2022US258905$NOVARTIS$$$$$F$Y$$$20240912$$MD$US$US
2161587913$21615879$13$F$20200601$20240731$20221118$20240812$EXP$$CA-BAXTER-2022BAX015873$BAXTER$$80$YR$$M$Y$69$KG$20240812$$CN$DE$DE
216159616$21615961$6$F$19991101$20240627$20221118$20240702$EXP$$IT-MYLANLABS-2022M1126602$MYLAN$$58$YR$$M$Y$68$KG$20240702$$MD$IT$IT
216161332$21616133$2$F$20211221$20221107$20221118$20240805$EXP$$HR-ELI_LILLY_AND_COMPANY-HR202211003594$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240805$$CN$HR$HR
216161392$21616139$2$F$20200101$20221107$20221118$20240805$EXP$$HR-ELI_LILLY_AND_COMPANY-HR202211003597$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240805$$CN$HR$HR
216164452$21616445$2$F$$20240905$20221118$20240915$PER$$US-ABBVIE-4172775$ABBVIE$$$$$M$Y$$$20240915$$CN$US$US
216166642$21616664$2$F$20221029$20240812$20221118$20240815$PER$$US-SA-2022SA469505$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240815$$MD$US$US
2161748517$21617485$17$F$20201014$20240703$20221119$20240710$EXP$$CA-CELLTRION INC.-2022CA019268$CELLTRION$$$$$$Y$$$20240710$$CN$CA$CA
216176792$21617679$2$F$$20240807$20221119$20240813$PER$$US-SA-2022SA474394$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240813$$MD$US$US
216177212$21617721$2$F$$20240701$20221119$20240708$EXP$$PT-AUROBINDO-AUR-APL-2022-048754$AUROBINDO$Rocha A. et al.. P n.? 2716 - DRESS CODE PARA CIRURGIA ORTOPEDICA ? INDUZIDO POR ANTIBIOTICO. 28.? Congresso Nacional de Medicina Interna.  1228.. Livro de Resumos, Posters/Casos cl?nicos,. 1228$52$YR$$M$Y$$$20240708$$MD$PT$PT
216182392$21618239$2$F$$20240720$20221119$20240731$EXP$$FR-AUROBINDO-AUR-APL-2020-060763$AUROBINDO$Sastre C, Baillif-Couniou V, Gaulier J, Allorge D, Piercecchi M, Leonetti G. Usage d?tourn? de la pr?gabaline : ? propos de trois cas de d?c?s en r?gion marseillaise (Misuse of the pregabalin: about three cases of death in the region Marseille). Toxicologie Analytique et Clinique (Analytical and Clinical Toxicology). 2020;32 (Suppl.4):S33-34$51$YR$$F$Y$$$20240731$$MD$FR$FR
216182853$21618285$3$F$20210629$20240831$20221119$20240912$EXP$DE-BFARM-22006832$DE-Accord-286752$ACCORD$$78$YR$E$M$Y$$$20240912$$PH$DE$DE
216183125$21618312$5$F$20221021$20240830$20221119$20240904$EXP$$NVSC2022RU259634$NOVARTIS$$67$YR$$F$Y$60$KG$20240904$$MD$RU$RU
216183292$21618329$2$F$$20240912$20221119$20240913$PER$$NVSC2022US258020$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
216183753$21618375$3$F$$20240828$20221119$20240829$PER$$NVSC2022US260915$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
216191224$21619122$4$F$20190730$20240904$20221120$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-115349$BRISTOL MYERS SQUIBB$Manaka K, Sato J, Takeuchi M, Watanabe K, kage H, kawai T, et al. Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufficiency. Scientific Reports 2021;11:1-10. doi: 10.1038/S41598-021-91032-6$77$YR$E$F$Y$$$20240913$$MD$JP$JP
216194805$21619480$5$F$20211213$20240716$20221121$20240718$EXP$$JP-TAKEDA-2022TJP076393$TAKEDA$$61$YR$$F$Y$42.2$KG$20240718$$MD$JP$JP
216196273$21619627$3$F$$20240829$20221121$20240909$EXP$$JP-ROCHE-3221511$ROCHE$$$$E$M$Y$$$20240909$$MD$JP$JP
216197832$21619783$2$F$20220501$20240716$20221121$20240724$EXP$$BG-TOLMAR, INC.-22BG037448$TOLMAR$$68$YR$$M$Y$$$20240724$$MD$BG$BG
2161980017$21619800$17$F$20221101$20240118$20221121$20240925$EXP$$US-GSK-US2022AMR170162$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
216198655$21619865$5$F$20221101$20240715$20221121$20240723$EXP$$CA-CELLTRION INC.-2022CA008165$CELLTRION$$$$$$Y$$$20240723$$MD$CA$CA
216199304$21619930$4$F$20220721$20240725$20221121$20240802$EXP$$NVSC2022GB194522$NOVARTIS$$61$YR$$F$Y$$$20240802$$CN$GB$GB
216199975$21619997$5$F$20221101$20221214$20221121$20240925$PER$$US-GSK-US2022167367$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240925$$CN$US$US
2162014112$21620141$12$F$20220101$20240912$20221121$20240920$EXP$$CA-CELLTRION INC.-2022CA009896$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
216203952$21620395$2$F$20211123$20240827$20221121$20240827$EXP$$GB-UCBSA-2022065507$UCB$$39$YR$$F$Y$73$KG$20240827$$HP$GB$GB
216204322$21620432$2$F$20220101$20240903$20221121$20240910$EXP$$NVSC2022EG244008$NOVARTIS$$$$$M$Y$108$KG$20240910$$CN$EG$EG
216205702$21620570$2$F$$20221116$20221121$20240712$EXP$$GR-ASTELLAS-2022US041271$ASTELLAS$$$$$M$Y$$$20240712$$MD$GR$GR
216212107$21621210$7$F$$20240918$20221121$20240928$EXP$$US-CELLTRION INC.-2022US019165$CELLTRION$$$$$$Y$$$20240928$$HP$US$US
216212894$21621289$4$F$20240203$20240914$20221121$20240923$EXP$$CA-GSK-CA2022170944$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$CA$CA
216214844$21621484$4$F$20221107$20240725$20221121$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13648$LUPIN$$$$$$Y$$$20240815$$CN$US$US
2162150411$21621504$11$F$20221118$20240826$20221121$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-140436$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240904$$CN$US$US
216216815$21621681$5$F$20220201$20240906$20221121$20240909$EXP$$US-PFIZER INC-PV202200106233$PFIZER$$76$YR$$M$Y$$$20240909$$CN$US$US
216219443$21621944$3$F$$20240828$20221121$20240829$EXP$$CA-ANIPHARMA-2019-CA-001103$ANI$$72$YR$$M$Y$$$20240829$$CN$CA$CA
216220348$21622034$8$F$20201113$20240823$20221121$20240828$EXP$$NVSC2020IN328776$NOVARTIS$$49$YR$$F$Y$$$20240828$$CN$IN$IN
216223472$21622347$2$F$20220815$20240726$20221121$20240805$PER$$US-SA-2022SA475305$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240805$$MD$US$US
216225375$21622537$5$F$20191205$20240918$20221121$20240925$EXP$$CA-GSK-CA2022AMR170136$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$CA$CA
2162257625$21622576$25$F$$20240829$20221121$20240903$EXP$$US-JAZZ-2022-US-033860$JAZZ$$$$$F$Y$$$20240903$$HP$US$US
216227374$21622737$4$F$$20240910$20221121$20240916$PER$$US-PHARMING-PHAUS2022000790$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
216228774$21622877$4$F$$20240905$20221121$20240912$PER$$US-AGIOS-2211US03183$AGIOS PHARMACEUTICALS$$$$$F$Y$91.61$KG$20240912$$CN$US$US
216230264$21623026$4$F$20240701$20240805$20221121$20240807$EXP$$US-PFIZER INC-PV202200106231$PFIZER$$67$YR$$M$Y$$$20240807$$CN$US$US
216235292$21623529$2$F$20220701$20240722$20221121$20240723$EXP$$AT-ROCHE-3222344$ROCHE$$56$YR$A$F$Y$55$KG$20240723$$MD$AT$AT
216235462$21623546$2$F$$20240822$20221121$20240827$EXP$$US-TAKEDA-2018TUS035927$TAKEDA$$$$$M$Y$$$20240827$$CN$US$US
216235503$21623550$3$F$20230101$20240715$20221121$20240723$EXP$$US-ABBVIE-22K-163-4469312-00$ABBVIE$$$$$M$Y$$$20240723$$PH$US$US
2162355722$21623557$22$F$20200826$20240806$20221121$20240813$EXP$$CA-ROCHE-2668350$ROCHE$$68$YR$E$M$Y$96$KG$20240813$$HP$CA$CA
2162355819$21623558$19$F$20191030$20240826$20221121$20240830$EXP$$CA-ROCHE-2478785$ROCHE$$15$YR$T$F$Y$$$20240830$$CN$CA$CA
216237584$21623758$4$F$$20240924$20221121$20240930$PER$$US-PFIZER INC-PV202200095939$PFIZER$$66$YR$$F$Y$29.206$KG$20240930$$MD$US$US
2162455920$21624559$20$F$20211210$20240903$20221121$20240906$EXP$$FR-GILEAD-2022-0605947$GILEAD$$$$A$F$Y$74$KG$20240906$$MD$FR$FR
216246415$21624641$5$F$$20240904$20221121$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-140164$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240906$$MD$JP$JP
216246972$21624697$2$F$20220304$20221118$20221122$20240814$EXP$$NVSC2022KR261409$NOVARTIS$$66$YR$$M$Y$$$20240814$$MD$KR$KR
216247102$21624710$2$F$20220901$20240814$20221122$20240818$PER$$NVSC2022US259185$NOVARTIS$$31$YR$$F$Y$$$20240818$$CN$US$US
216247836$21624783$6$F$20221108$20230306$20221122$20240802$EXP$$US-ORPHANEU-2022005766$RECORDATI$$$$$$Y$$$20240802$$CN$US$US
216254102$21625410$2$F$20220101$20240624$20221122$20240702$EXP$$CA-CELLTRION INC.-2022CA012628$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
216254775$21625477$5$F$20221115$20240926$20221122$20240930$EXP$$NVSJ2022JP101575$NOVARTIS$$$$A$M$Y$$$20240930$$CN$JP$JP
216257523$21625752$3$F$$20240701$20221122$20240705$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-191639$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$$$20240705$$CN$US$US
216257864$21625786$4$F$20221116$20240906$20221122$20240916$30DAY$$US-GSK-US2022170363$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240916$$CN$US$US
2162585136$21625851$36$F$20221115$20240924$20221122$20240927$EXP$$MX-TAKEDA-2022TUS037870$TAKEDA$$45$YR$$F$Y$$$20240927$$CN$MX$MX
216258563$21625856$3$F$20190101$20240826$20221122$20240904$EXP$$FR-AUROBINDO-AUR-APL-2022-048580$AUROBINDO$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the ?le-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxicologie Analytique et Clinique. 2022;438:1-6$$$$M$Y$$$20240904$$HP$FR$FR
2162612811$21626128$11$F$20161013$20240815$20221122$20240820$EXP$$US-PAREXEL-2021-KAM-US003507$TAKEDA$$54$YR$$F$Y$135$KG$20240820$$HP$US$US
216268127$21626812$7$F$20221101$20230324$20221122$20240925$PER$$US-GSK-US2022AMR173040$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
216271492$21627149$2$F$20221001$20240827$20221122$20240831$EXP$$US-ABBVIE-4208360$ABBVIE$$66$YR$$F$Y$$$20240831$$CN$US$US
216276182$21627618$2$F$$20221115$20221122$20240712$EXP$$MY-ASTELLAS-2022US041190$ASTELLAS$$72$YR$$M$Y$$$20240712$$MD$MY$MY
216276315$21627631$5$F$20210701$20240925$20221122$20240927$30DAY$$US-PFIZER INC-202201173949$PFIZER$$13$YR$$M$Y$46.27$KG$20240927$$HP$US$US
216277982$21627798$2$F$$20240823$20221122$20240904$PER$$US-ABBVIE-22K-163-4444111-00$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
2162807111$21628071$11$F$20100101$20240827$20221122$20240902$EXP$$US-PFIZER INC-202200396704$PFIZER$$65$YR$$M$Y$77.098$KG$20240902$$CN$US$US
216284363$21628436$3$F$20221001$20221227$20221122$20240911$EXP$$HR-ALXN-A202214298$ALEXION PHARMACEUTICALS$$10$YR$$F$Y$37$KG$20240911$$MD$HR$HR
216285012$21628501$2$F$20220615$20240723$20221122$20240731$EXP$$DE-ROCHE-3222411$ROCHE$$35$YR$A$F$Y$$$20240731$$MD$DE$DE
216285742$21628574$2$F$20221009$20240813$20221122$20240815$EXP$$CA-ROCHE-3223110$ROCHE$$58$YR$A$F$Y$$$20240815$$CN$CA$CA
216286257$21628625$7$F$20240619$20240803$20221122$20240809$EXP$$GR-TAKEDA-2022TUS086459$TAKEDA$$34$YR$$F$Y$$$20240809$$CN$GR$GR
216286645$21628664$5$F$20181022$20240814$20221122$20240816$EXP$$DE-ROCHE-2489331$ROCHE$$44$YR$A$F$Y$$$20240816$$CN$DE$DE
216289322$21628932$2$F$$20240715$20221122$20240722$PER$$US-SA-2022SA469754$SANOFI AVENTIS$$49$YR$A$F$Y$88.4$KG$20240723$$MD$US$US
216290433$21629043$3$F$20230101$20240815$20221122$20240828$PER$$US-SA-2022SA427974$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240828$$MD$US$US
216291604$21629160$4$F$$20240830$20221122$20240927$PER$$US-SA-2022SA474838$SANOFI AVENTIS$$14$YR$T$M$Y$88$KG$20240927$$MD$US$US
216291895$21629189$5$F$20210801$20240923$20221122$20240930$EXP$$IN-PFIZER INC-2020426091$PFIZER$$65$YR$$F$Y$$$20240930$$CN$IN$IN
216292603$21629260$3$F$20200602$20240926$20221122$20240927$EXP$$FR-TAKEDA-2022TUS088181$TAKEDA$$64$YR$$M$Y$$$20240927$$HP$FR$FR
216293322$21629332$2$F$20220327$20221118$20221122$20240926$EXP$$US-GSK-US2022AMR057673$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
216293615$21629361$5$F$20220101$20240911$20221122$20240917$EXP$$US-ABBVIE-22K-163-4509446-00$ABBVIE$$$$$F$Y$98$KG$20240917$$CN$US$US
216295549$21629554$9$F$$20240822$20221122$20240826$EXP$$US-TAKEDA-2022TUS050858$TAKEDA$$$$$M$Y$64.853$KG$20240826$$HP$US$US
216296398$21629639$8$F$20220513$20240719$20221122$20240724$EXP$$IN-PFIZER INC-202101112221$PFIZER$$70$YR$$F$Y$72.8$KG$20240724$$CN$IN$IN
2163017015$21630170$15$F$20221114$20240827$20221122$20240902$EXP$$US-JAZZ-2022-US-005776$JAZZ$$52$YR$$F$Y$$$20240902$$MD$US$US
216302433$21630243$3$F$$20240723$20221122$20240730$EXP$$GB-BIOGEN-2022BI01170880$BIOGEN$$$$A$F$Y$$$20240730$$CN$GB$GB
216303316$21630331$6$F$$20240805$20221122$20240815$EXP$$CA-GLENMARK PHARMACEUTICALS-2022GMK076599$GLENMARK$$$$$$Y$$$20240815$$HP$CA$CA
216303796$21630379$6$F$20190205$20240910$20221122$20240926$EXP$$JP-LUNDBECK-DKLU3054836$LUNDBECK$$$$$$Y$$$20240926$$MD$JP$JP
216304294$21630429$4$F$$20240802$20221122$20240816$EXP$$TH-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-363099$RANBAXY$Thammongkolchai T, Termsarasab P.. Catatonia secondary to clozapine withdrawal: A case report.. J Neurol Sci. 2023;DEC15 455:120865$53$YR$$F$Y$$$20240816$$HP$TH$TH
216305004$21630500$4$F$20221101$20240820$20221123$20240822$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000519$PAREXEL$$$$$$Y$$$20240822$$CN$US$US
216305632$21630563$2$F$$20240810$20221123$20240817$PER$$US-SA-2022SA475815$SANOFI AVENTIS$$$$A$M$Y$93.7$KG$20240817$$MD$US$US
216308194$21630819$4$F$$20240708$20221123$20240715$EXP$$PT-AUROBINDO-AUR-APL-2022-048719$AUROBINDO$Trigo AF, Ramos AR, Alves RV, Santos P, Lobos AV.. P n.? 1213 Acyclovir Nephrotoxicity: a Reminder of How Important Prevention Is. Congressos da Sociedade Portuguesa de Medicina interna: 28.?. Congresso Nacional de Medicina Interna - Livro de resumos. 2022;28(Sup1):778.$23$YR$$M$Y$$$20240715$$MD$PT$PT
216310084$21631008$4$F$20200101$20240726$20221123$20240813$PER$$CO-TOLMAR, INC.-22CO037562$TOLMAR$$$$$M$Y$78$KG$20240813$$CN$CO$CO
216310312$21631031$2$F$$20240717$20221123$20240725$PER$$US-SA-2022SA475208$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240725$$MD$US$US
216310344$21631034$4$F$$20240905$20221123$20240918$EXP$$FR-AUROBINDO-AUR-APL-2022-048602$AUROBINDO$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the ?le-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxicologie Analytique et Clinique. 2022;438:1-6$68$YR$$F$Y$$$20240918$$HP$FR$FR
216311754$21631175$4$F$20190101$20240907$20221123$20240913$EXP$$US-ABBVIE-22K-163-4437559-00$ABBVIE$$$$$F$Y$64$KG$20240913$$CN$US$US
216312662$21631266$2$F$20221001$20240820$20221123$20240821$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000501$PAREXEL$$$$$$Y$$$20240821$$CN$US$US
216313334$21631333$4$F$20221108$20240812$20221123$20240815$EXP$$CA-BIOGEN-2022BI01170826$BIOGEN$$67$YR$$F$Y$$$20240815$$PH$CA$CA
216313732$21631373$2$F$20220101$20240710$20221123$20240716$EXP$$US-SA-2022SA418387$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240717$$MD$US$US
216314143$21631414$3$F$$20240701$20221123$20240711$EXP$$JP-ROCHE-3222618$ROCHE$Yamamoto R, Yamahara E H. 02 A case where one course of concomitant therapy with atezolizumab + bevacizumab was performed for unresectable hepatocellular carcinoma (HCC), followed by conversion resection even though the patient was complicated by tumour lysis syndro. The 140th Regular Meeting of the Japanese Society of Gastroenterology Tokai Bran.. 2024;83.$78$YR$E$M$Y$$$20240711$$MD$JP$JP
2163158416$21631584$16$F$20220101$20240726$20221123$20240803$EXP$$CA-CELLTRION INC.-2022CA019606$CELLTRION$$$$$$Y$$$20240803$$HP$CA$CA
216316597$21631659$7$F$20220906$20230705$20221123$20240926$EXP$$US-GSK-US2022AMR170126$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
2163166012$21631660$12$F$20221101$20240520$20221123$20240925$PER$$US-GSK-US2022AMR171138$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
216318352$21631835$2$F$$20221116$20221123$20240925$PER$$US-GSK-US2022AMR171071$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
216319277$21631927$7$F$20220309$20240819$20221123$20240829$PER$$US-SA-2022SA474890$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240829$$MD$US$US
216321304$21632130$4$F$$20240616$20221123$20240704$EXP$$GR-ROCHE-3222447$ROCHE$M. D, A. Mpitsani , C. Chatzidimitriou , et al. The combination venetoclax-obinutuzumab as 1st-line therapy in patients with chronic lymphocytic leukemia-data from daily clinical practice-the experience of one center. Haema 2022;13(1):390-392.$$$E$$Y$$$20240704$$MD$GR$GR
2163239217$21632392$17$F$20220607$20240812$20221123$20240816$EXP$$CA-TAKEDA-2022TUS068430$TAKEDA$$33$YR$$F$Y$$$20240816$$CN$CA$CA
216328143$21632814$3$F$20240401$20240926$20221123$20240930$PER$$US-SA-2022SA473860$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240929$$CN$US$US
2163300916$21633009$16$F$20221215$20240903$20221123$20240909$EXP$$CA-TAKEDA-2022TUS086279$TAKEDA$$63$YR$$M$Y$$$20240909$$HP$CA$CA
216331143$21633114$3$F$20200101$20221117$20221123$20240802$EXP$$US-ORPHANEU-2022005812$RECORDATI$$$$$$Y$$$20240802$$CN$US$US
216331464$21633146$4$F$20220801$20240903$20221123$20240905$PER$$US-PFIZER INC-202201318829$PFIZER$$70$YR$$F$Y$58.97$KG$20240905$$CN$US$US
2163328311$21633283$11$F$20230701$20240905$20221123$20240912$EXP$$BR-GSK-BR2022AMR170828$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$BR$BR
216333203$21633320$3$F$20220101$20240917$20221123$20240923$EXP$$CA-PFIZER INC-202200661431$PFIZER$$54$YR$$F$Y$93$KG$20240923$$HP$CA$CA
216333437$21633343$7$F$20220101$20240711$20221123$20240717$EXP$$CA-PFIZER INC-202201303095$PFIZER$$29$YR$$F$Y$$$20240717$$MD$CA$CA
216333624$21633362$4$F$20221019$20240723$20221123$20240726$EXP$$US-GSK-US2022GSK171580$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$MD$US$US
216333645$21633364$5$F$20221101$20230202$20221123$20240926$EXP$$US-GSK-US2022AMR171857$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
216334596$21633459$6$F$20221018$20240718$20221123$20240801$EXP$$US-UCBSA-2022061947$UCB$$18$YR$$M$Y$49.4$KG$20240801$$CN$US$US
216338344$21633834$4$F$20221001$20240911$20221123$20240919$EXP$$PL-TAKEDA-2022TUS086903$TAKEDA$$38$YR$$F$Y$$$20240919$$CN$PL$PL
2163406413$21634064$13$F$20221001$20240704$20221123$20240709$EXP$$IN-PFIZER INC-PV202200109457$PFIZER$$76$YR$$F$Y$70$KG$20240709$$CN$IN$IN
216340793$21634079$3$F$20211223$20240730$20221123$20240802$EXP$$GB-PFIZER INC-PV202200108106$PFIZER$$$$A$F$Y$70$KG$20240802$$HP$GB$GB
216341027$21634102$7$F$20220501$20240730$20221123$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-141912$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240801$$CN$US$US
216343322$21634332$2$F$20221101$20240812$20221123$20240816$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2022-149145$REGENERON$$$$$M$Y$$$20240816$$CN$US$US
216351454$21635145$4$F$20210101$20240919$20221123$20240923$EXP$$GR-MYLANLABS-2022M1095743$MYLAN$Papavasileiou V, Niotis G, Milas G, Issaris V, Antonopoulou A, Tsaousopoulou E, Georgiou A. USE OF ACTIVATED CHARCOAL IN SERTRALINE OVERDOSE. 48th ANNUAL PANHELLENIC MEDICAL CONGRESS, Book of proceedings. 2022;343$24$YR$$F$Y$60$KG$20240923$$MD$GR$GR
216357712$21635771$2$F$20221101$20240902$20221123$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-140650$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$59.1$KG$20240911$$MD$JP$JP
216357993$21635799$3$F$20220801$20240725$20221123$20240730$EXP$$NVSJ2022JP101538$NOVARTIS$$$$A$F$Y$$$20240730$$MD$JP$JP
2163592017$21635920$17$F$20230101$20240906$20221123$20240916$EXP$$CA-CELLTRION INC.-2022CA019741$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
2163605813$21636058$13$F$20221121$20240822$20221123$20240823$EXP$$US-TAKEDA-2022TUS088260$TAKEDA$$78$YR$$F$Y$$$20240823$$CN$US$US
216361624$21636162$4$F$20220328$20240911$20221123$20240918$EXP$$US-SA-2022SA480285$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240918$$MD$US$US
216361776$21636177$6$F$20240625$20240819$20221124$20240826$EXP$$US-GSK-US2022AMR173957$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$US$US
216362305$21636230$5$F$20180312$20240904$20221124$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-115351$BRISTOL MYERS SQUIBB$Manaka K, Sato J, Takeuchi M, Watanabe K, Kage H, Kawai T, et al. Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufciency. Scientific Reports. 2021;11(11617)1-10.doi:10.1038/s41598-021-91032-6.$86$YR$E$M$Y$$$20240912$$MD$JP$JP
216362744$21636274$4$F$20220101$20240805$20221124$20240810$EXP$$US-ABBVIE-22K-163-4408335-00$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
216363566$21636356$6$F$20221101$20230224$20221124$20240925$PER$$US-GSK-US2022AMR171926$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
216364266$21636426$6$F$20211022$20240821$20221124$20240826$EXP$$CA-ROCHE-3224497$ROCHE$$60$YR$A$F$Y$$$20240826$$CN$CA$CA
216370534$21637053$4$F$20221125$20240628$20221124$20240706$EXP$$AT-CELLTRION INC.-2022AT018486$CELLTRION$$$$$$Y$$$20240706$$MD$AT$AT
216370795$21637079$5$F$20220101$20240711$20221124$20240717$PER$$US-BIOGEN-2022BI01167408$BIOGEN$$$$$F$Y$$$20240717$$CN$US$US
216373884$21637388$4$F$20221012$20240926$20221124$20240930$EXP$$IT-ROCHE-3224663$ROCHE$$33$YR$A$F$Y$49$KG$20240930$$MD$IT$IT
216379264$21637926$4$F$20180216$20240714$20221124$20240716$EXP$$IL-TAKEDA-IL201807595$TAKEDA$$44$YR$$F$Y$68$KG$20240716$$MD$IL$IL
216379452$21637945$2$F$20220908$20240813$20221124$20240823$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-002538$AURINIA PHARMACEUTICALS$$38$YR$$F$Y$$$20240823$$HP$US$US
216379972$21637997$2$F$20221117$20240905$20221124$20240910$EXP$$NVSC2022CA262155$NOVARTIS$$52$YR$$M$Y$$$20240910$$MD$CA$CA
216380272$21638027$2$F$$20240916$20221124$20240926$PER$$US-GSK-US2022AMR170866$GLAXOSMITHKLINE$$$$$M$Y$$$20240926$$CN$US$US
216381232$21638123$2$F$20221001$20240701$20221124$20240705$PER$$US-ABBVIE-4163661$ABBVIE$$72$YR$$F$Y$$$20240705$$CN$US$US
216381463$21638146$3$F$$20240815$20221124$20240824$PER$$US-ABBVIE-4177139$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
216384754$21638475$4$F$$20240910$20221124$20240919$EXP$$JP-AMGEN-JPNSP2022201561$AMGEN$Shizuka Kobayashi, Kentaro Tanaka, Junichi Hoshino, Shigeko Hara, Akifumi Kushiyama, Yoshihide Tanaka, Shuta Motonishi, Ken Sakai, Takashi Ozawa. Synergistic deterioration of prognosis associated with decreased grip strength and hyporesponse to erythropoiesis-stimulating agents in patients undergoing hemodialysis. Renal Failure. 2022;44$$$$F$Y$$$20240919$$MD$JP$JP
216385192$21638519$2$F$$20240729$20221124$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13710$LUPIN$$$$$$Y$$$20240817$$CN$US$US
216385792$21638579$2$F$20221117$20240822$20221124$20240823$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000527$PAREXEL$$$$$$Y$$$20240823$$CN$US$US
216386052$21638605$2$F$20221106$20240717$20221124$20240718$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000548$PAREXEL$$$$$$Y$$$20240718$$CN$US$US
216387555$21638755$5$F$$20240702$20221124$20240704$EXP$$US-PFIZER INC-PV202200109472$PFIZER$$63$YR$$F$Y$$$20240704$$CN$US$US
216388852$21638885$2$F$20221101$20240713$20221124$20240722$PER$$US-SA-2022SA479842$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240720$$CN$US$US
216389012$21638901$2$F$$20240827$20221124$20240919$PER$$US-SA-2022SA478200$SANOFI AVENTIS$$56$YR$A$F$Y$97.959$KG$20240919$$MD$US$US
216392098$21639209$8$F$20211101$20240729$20221124$20240805$EXP$$BR-GSK-BR2022AMR012082$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$BR$BR
216395123$21639512$3$F$20150319$20240911$20221124$20240916$EXP$$US-TAKEDA-US201502588$TAKEDA$$9$YR$$M$Y$40.36$KG$20240916$$MD$US$US
2163951312$21639513$12$F$20240505$20240715$20221124$20240717$EXP$$US-TAKEDA-US201832200$TAKEDA$$57$YR$$M$Y$66$KG$20240717$$MD$US$US
216396062$21639606$2$F$20220101$20240719$20221124$20240730$EXP$$US-RECORDATI-2022006005$RECORDATI$$$$$$Y$$$20240730$$CN$US$US
2164004723$21640047$23$F$20221101$20240731$20221124$20240809$EXP$$US-JAZZ-2022-US-021212$JAZZ$$45$YR$$F$Y$$$20240809$$HP$US$US
216400557$21640055$7$F$20220101$20240919$20221124$20240925$EXP$$US-HORIZON THERAPEUTICS-HZN-2022-001424$AMGEN$$51$YR$A$F$Y$107$KG$20240925$$MD$US$US
2164009014$21640090$14$F$20221120$20240904$20221124$20240909$EXP$$CA-TAKEDA-2022TUS088912$TAKEDA$$50$YR$$M$Y$$$20240909$$CN$CA$CA
216400912$21640091$2$F$20220601$20240814$20221124$20240823$PER$$US-ABBVIE-4164606$ABBVIE$$54$YR$$F$Y$$$20240823$$CN$US$US
2164016824$21640168$24$F$20220301$20240920$20221124$20240925$EXP$$CA-PFIZER INC-202200123248$PFIZER$$56$YR$$F$Y$133$KG$20240925$$MD$CA$CA
216405082$21640508$2$F$$20240729$20221124$20240806$PER$$US-SA-2022SA481892$SANOFI AVENTIS$$$$A$F$Y$58.957$KG$20240806$$MD$US$US
216405695$21640569$5$F$20231201$20240715$20221124$20240719$EXP$$US-ABBVIE-4176677$ABBVIE$$26$YR$$F$Y$$$20240719$$CN$US$US
216409813$21640981$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365800$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$12$YR$$F$Y$$$20240702$$MD$US$US
216409823$21640982$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365802$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$15$YR$$M$Y$$$20240702$$MD$US$US
216409833$21640983$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365810$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$14$YR$$M$Y$$$20240702$$MD$US$US
216409853$21640985$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365807$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$14$YR$$M$Y$$$20240702$$MD$US$US
216409863$21640986$3$F$$20230717$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365815$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$15$YR$$M$Y$$$20240702$$MD$US$US
216409883$21640988$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365812$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$12$YR$$M$Y$$$20240702$$MD$US$US
216410103$21641010$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365805$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$15$YR$$M$Y$$$20240702$$MD$US$US
216411225$21641122$5$F$20221115$20240920$20221125$20240924$PER$$NVSC2022US263523$NOVARTIS$$31$YR$$F$Y$108$KG$20240924$$CN$US$US
216411753$21641175$3$F$$20230717$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365819$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$17$YR$$M$Y$$$20240702$$MD$US$US
216411763$21641176$3$F$$20230717$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365816$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$15$YR$$M$Y$$$20240702$$MD$US$US
216412325$21641232$5$F$20170101$20240826$20221125$20240905$EXP$$FR-AUROBINDO-AUR-APL-2022-049466$AUROBINDO$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxicologie Analytique et Clinique. 2022;438:1-6$53$YR$$F$Y$$$20240905$$MD$FR$FR
216413143$21641314$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365771$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$14$YR$$M$Y$$$20240702$$MD$US$US
216413343$21641334$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365769$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$14$YR$$F$Y$$$20240702$$MD$US$US
216413373$21641337$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365767$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$15$YR$$M$Y$$$20240702$$MD$US$US
216413383$21641338$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365762$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$14$YR$$M$Y$$$20240702$$MD$US$US
216413393$21641339$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365765$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$15$YR$$M$Y$$$20240702$$MD$US$US
216413403$21641340$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365766$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$13$YR$$M$Y$$$20240702$$MD$US$US
216413413$21641341$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365733$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$15$YR$$F$Y$$$20240702$$MD$US$US
216413423$21641342$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365770$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$15$YR$$M$Y$$$20240702$$MD$US$US
216414156$21641415$6$F$20220101$20240703$20221125$20240710$EXP$$CA-CELLTRION INC.-2022CA011598$CELLTRION$$$$$$Y$$$20240710$$MD$CA$CA
216414763$21641476$3$F$$20230715$20221125$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365775$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$16$YR$$M$Y$$$20240702$$MD$US$US
2164160913$21641609$13$F$20220101$20240912$20221125$20240921$EXP$$CA-CELLTRION INC.-2022CA001341$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
216416702$21641670$2$F$$20240529$20221125$20240729$EXP$$NVSC2022FR263670$NOVARTIS$$$$$M$Y$$$20240730$$HP$FR$FR
216418963$21641896$3$F$20230101$20240722$20221125$20240730$EXP$$US-SA-2022SA483835$SANOFI AVENTIS$$73$YR$E$M$Y$83.914$KG$20240730$$MD$US$US
216420325$21642032$5$F$20190328$20240830$20221125$20240906$EXP$$DE-ROCHE-2698406$ROCHE$$56$YR$A$F$Y$$$20240906$$CN$DE$DE
216420342$21642034$2$F$$20221121$20221125$20240925$PER$$US-GSK-US2022AMR174766$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
216423544$21642354$4$F$$20240910$20221125$20240918$EXP$$NVSC2022CA263684$NOVARTIS$$56$YR$$F$Y$$$20240918$$CN$CA$CA
216424139$21642413$9$F$20220329$20240917$20221125$20240919$EXP$$NVSC2022GB096972$NOVARTIS$$50$YR$$F$Y$$$20240919$$CN$GB$GB
216425665$21642566$5$F$20230120$20240716$20221125$20240722$EXP$$CA-TAKEDA-2022TUS004338$TAKEDA$$83$YR$$F$Y$$$20240722$$CN$CA$CA
216427098$21642709$8$F$20070101$20240729$20221125$20240806$EXP$$PA-BIOGEN-2022BI01166110$BIOGEN$$$$$F$Y$47.2$KG$20240806$$CN$PA$PA
216428092$21642809$2$F$20230101$20240702$20221125$20240710$PER$$US-SA-2022SA483162$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240710$$MD$US$US
216428735$21642873$5$F$20221117$20240920$20221125$20240926$PER$$US-GSK-US2022175034$GLAXOSMITHKLINE$$61$YR$$M$Y$$$20240926$$CN$US$US
216428743$21642874$3$F$$20240726$20221125$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13751$LUPIN$$$$$$Y$$$20240816$$CN$US$US
216430684$21643068$4$F$20240723$20240812$20221125$20240821$PER$$US-SA-2022SA482051$SANOFI AVENTIS$$65$YR$E$F$Y$84.82$KG$20240821$$MD$US$US
216434004$21643400$4$F$$20240820$20221125$20240826$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365160$RANBAXY$Bernasconi L, Schicchi A, Pirozzolo R, Negrini V, Scaravaggi G, Lonati D et al. Coronary thrombosis after European adder bite in a patient on dual antiplatelet therapy: A case report. Toxicon. 2022;Nov 5:online ahead of print$62$YR$$M$Y$$$20240826$$HP$IT$IT
216435142$21643514$2$F$20220101$20240715$20221125$20240723$PER$$US-SA-2022SA483693$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240723$$MD$US$US
216435302$21643530$2$F$20200630$20240624$20221125$20240701$PER$$US-ABBVIE-4163027$ABBVIE$$62$YR$$M$Y$$$20240701$$CN$US$US
216435562$21643556$2$F$20220417$20240716$20221125$20240727$EXP$$US-ABBVIE-22K-163-4414588-00$ABBVIE$$71$YR$$F$Y$70.306$KG$20240727$$CN$US$US
216437489$21643748$9$F$20221222$20240906$20221125$20240916$EXP$$US-UCBSA-2022067251$UCB$$4$YR$$F$Y$$$20240916$$CN$US$US
2164375212$21643752$12$F$20210705$20240923$20221125$20240927$EXP$$CO-TAKEDA-CO202032443$TAKEDA$$47$YR$$F$Y$75$KG$20240927$$CN$CO$CO
216438912$21643891$2$F$$20240823$20221125$20240827$EXP$$US-JAZZ-2022-US-019831$JAZZ$$$$$F$Y$$$20240827$$CN$US$US
2164426510$21644265$10$F$20190916$20240920$20221125$20240925$EXP$$CA-TAKEDA-2018TUS024000$TAKEDA$$80$YR$$F$Y$54.6$KG$20240925$$CN$CA$CA
216447532$21644753$2$F$20210528$20240705$20221125$20240712$PER$$US-INCYTE CORPORATION-2022IN011179$INCYTE$$$$$$Y$$$20240712$$MD$US$US
216448418$21644841$8$F$20220324$20240718$20221125$20240724$EXP$$BR-TAKEDA-BR202020262$TAKEDA$$11$YR$$M$Y$30$KG$20240724$$HP$BR$BR
216449202$21644920$2$F$20240201$20240702$20221125$20240703$PER$$US-PURDUE-USA-2022-0298015$PURDUE$$67$YR$$M$Y$117.93$KG$20240703$$CN$US$US
216456764$21645676$4$F$20220831$20240725$20221126$20240730$EXP$$US-AMGEN-USASP2022201337$AMGEN$$34$YR$A$F$Y$53.35$KG$20240730$$HP$US$US
2164632815$21646328$15$F$20210101$20240919$20221126$20240928$EXP$$CA-CELLTRION INC.-2021CA008348$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
216464687$21646468$7$F$20230102$20240708$20221126$20240710$EXP$$US-TAKEDA-2022TUS001281$TAKEDA$$44$YR$$F$Y$75$KG$20240710$$HP$US$US
216469412$21646941$2$F$20220822$20240703$20221127$20240711$EXP$IT-MINISAL02-892668$IT-TEVA-2022-IT-2827615$TEVA$$16$YR$$M$Y$$$20240711$$PH$IT$IT
216473053$21647305$3$F$20221101$20230201$20221127$20240925$PER$$US-GSK-US2022AMR168711$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
216473197$21647319$7$F$20240101$20240826$20221127$20240912$EXP$$US-SA-2022SA483152$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240912$$MD$US$US
216473466$21647346$6$F$20220101$20240906$20221127$20240912$EXP$$US-ABBVIE-22K-163-4503114-00$ABBVIE$$65$YR$$F$Y$$$20240912$$CN$US$US
216474703$21647470$3$F$20220608$20240716$20221128$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-061577$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$76.5$KG$20240729$$MD$JP$JP
216474765$21647476$5$F$20220311$20240806$20221128$20240808$EXP$$CA-TAKEDA-2022TUS027839$TAKEDA$$28$YR$$M$Y$$$20240808$$MD$CA$CA
2164750214$21647502$14$F$20221128$20240823$20221128$20240829$EXP$$US-GSK-US2022AMR173023$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$US$US
216475734$21647573$4$F$20200101$20240312$20221128$20240809$EXP$$NVSC2022PA264116$NOVARTIS$$$$$F$Y$86.168$KG$20240809$$CN$PA$PA
2164783610$21647836$10$F$20221118$20240808$20221128$20240819$EXP$$CA-ROCHE-3225423$ROCHE$$25$YR$A$F$Y$$$20240819$$CN$CA$CA
216478584$21647858$4$F$20221117$20240627$20221128$20240712$EXP$$FR-SERVIER-S22012049$SERVIER$$$$$$Y$$$20240712$$MD$FR$FR
216480525$21648052$5$F$20220621$20240116$20221128$20240923$PER$$MX-ROCHE-3225321$ROCHE$$66$YR$E$F$Y$$$20240923$$MD$MX$MX
216481162$21648116$2$F$$20240725$20221128$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13763$LUPIN$$$$$$Y$$$20240813$$CN$US$US
216483856$21648385$6$F$20220922$20240703$20221128$20240708$EXP$$CA-TAKEDA-2022TUS088241$TAKEDA$$66$YR$$F$Y$$$20240708$$CN$CA$CA
216484582$21648458$2$F$20170612$20240731$20221128$20240805$EXP$$CA-TAKEDA-2022TUS088302$TAKEDA$$9$YR$$F$Y$$$20240805$$CN$CA$CA
2164858820$21648588$20$F$20220101$20240814$20221128$20240821$EXP$$CA-CELLTRION INC.-2022CA006856$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
216490556$21649055$6$F$20211111$20240703$20221128$20240709$EXP$$CA-TAKEDA-2022TUS034195$TAKEDA$$16$YR$$F$Y$$$20240709$$MD$CA$CA
2164908710$21649087$10$F$20190515$20240717$20221128$20240729$EXP$$CA-ROCHE-2322596$ROCHE$$24$YR$A$F$Y$$$20240729$$MD$CA$CA
216490913$21649091$3$F$$20230322$20221128$20240925$PER$$US-GSK-US2022AMR176828$GLAXOSMITHKLINE$$$$$F$Y$63.946$KG$20240925$$CN$US$US
216491905$21649190$5$F$20221117$20230113$20221128$20240925$PER$$US-GSK-US2022AMR174620$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
216492618$21649261$8$F$$20240925$20221128$20240930$EXP$$US-SHIRE-US201938794$TAKEDA$$$$$M$Y$145$KG$20240930$$HP$US$US
216494486$21649448$6$F$20221101$20221223$20221128$20240925$EXP$$US-GSK-US2022AMR175744$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
216495595$21649559$5$F$$20240625$20221128$20240704$PER$$US-SA-2022SA484820$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240704$$MD$US$US
216495822$21649582$2$F$$20240705$20221128$20240713$PER$$US-SA-2022SA485253$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240713$$MD$US$US
216496242$21649624$2$F$20220930$20240816$20221128$20240826$PER$$US-SA-2022SA485128$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240826$$HP$US$US
216496512$21649651$2$F$$20240829$20221128$20240904$PER$$US-SA-2022SA484584$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240904$$CN$US$US
216498072$21649807$2$F$20220901$20240703$20221128$20240712$EXP$IT-MINISAL02-893414$IT-TEVA-2022-IT-2828561$TEVA$$12$YR$$F$Y$42$KG$20240712$$PH$IT$IT
2164997611$21649976$11$F$20221101$20240913$20221128$20240920$EXP$$US-BEH-2022152302$CSL BEHRING$$47$YR$A$F$Y$$$20240920$$CN$US$US
216500103$21650010$3$F$$20240705$20221128$20240711$EXP$$CA-TAKEDA-2022TUS088937$TAKEDA$$$$$M$Y$$$20240711$$CN$CA$CA
2165011612$21650116$12$F$20220101$20240701$20221128$20240703$EXP$$US-PFIZER INC-PV202200109386$PFIZER$$75$YR$$F$Y$83.2$KG$20240703$$CN$US$US
216503406$21650340$6$F$$20240724$20221128$20240729$PER$$US-PFIZER INC-PV202200109186$PFIZER$$78$YR$$F$Y$$$20240729$$CN$US$US
2165043116$21650431$16$F$20230201$20240502$20221128$20240926$PER$$US-GSK-US2022AMR176048$GLAXOSMITHKLINE$$43$YR$$F$Y$$$20240926$$MD$US$US
216504573$21650457$3$F$$20240912$20221128$20240912$EXP$$US-PFIZER INC-PV202200109688$PFIZER$$61$YR$$F$Y$$$20240912$$CN$US$US
216505155$21650515$5$F$20221123$20240925$20221128$20240930$EXP$$AU-Ipsen Biopharmaceuticals, Inc.-2022-32073$IPSEN$$67$YR$E$F$Y$49$KG$20240930$$HP$AU$AU
216505819$21650581$9$F$20221012$20240806$20221128$20240809$EXP$$US-PFIZER INC-PV202200110531$PFIZER$$71$YR$$F$Y$49.887$KG$20240809$$CN$US$US
216506806$21650680$6$F$20230203$20240809$20221128$20240814$EXP$$CA-TAKEDA-2020TUS000013$TAKEDA$$47$YR$$M$Y$$$20240814$$HP$CA$CA
216508275$21650827$5$F$20220101$20240912$20221128$20240926$PER$$US-SA-2022SA486102$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240926$$MD$US$US
216510425$21651042$5$F$20221117$20230208$20221128$20240926$EXP$$US-GSK-US2022AMR174792$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
216511136$21651113$6$F$20240720$20240914$20221128$20240916$EXP$$CA-PFIZER INC-202201317031$PFIZER$$74$YR$$F$Y$$$20240916$$HP$CA$CA
2165163426$21651634$26$F$20220131$20240924$20221128$20240927$EXP$$IN-PFIZER INC-PV202200109975$PFIZER$$58$YR$$F$Y$56.03$KG$20240927$$CN$IN$IN
2165179411$21651794$11$F$20201010$20240827$20221128$20240828$EXP$$US-TAKEDA-2022TUS090446$TAKEDA$$59$YR$$M$Y$$$20240828$$PH$US$US
216521222$21652122$2$F$$20240708$20221128$20240715$EXP$$AT-PFIZER INC-202201325777$PFIZER$$68$YR$$F$Y$$$20240715$$MD$AT$AT
216522197$21652219$7$F$20220101$20240711$20221128$20240718$PER$$US-SA-2022SA485756$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240718$$MD$US$US
216526742$21652674$2$F$$20240822$20221128$20240828$PER$$US-BAUSCH-BL-2022-026035$BAUSCH AND LOMB$$$$$M$Y$$$20240828$$PH$US$US
216529484$21652948$4$F$$20240719$20221128$20240724$EXP$$CA-PFIZER INC-202100999364$PFIZER$$58$YR$$M$Y$$$20240724$$MD$CA$CA
216533129$21653312$9$F$20221102$20240620$20221128$20240703$EXP$$CA-ROCHE-3226126$ROCHE$$40$YR$A$F$Y$$$20240703$$MD$CA$CA
216537357$21653735$7$F$20221120$20240614$20221129$20240702$PER$$CA-TOLMAR, INC.-22CA037635$TOLMAR$$62$YR$$M$Y$$$20240702$$CN$CA$CA
216539822$21653982$2$F$$20240827$20221129$20240905$PER$$US-ABBVIE-22K-163-4483029-00$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
216540085$21654008$5$F$$20240913$20221129$20240918$EXP$$PT-AUROBINDO-AUR-APL-2022-049795$AUROBINDO$Oliveira D, Garcia S, Pereira L, Magalhaes J, Costa L, Frazao J, et al. THE ROLE OF TERIPARATIDE ON ATYPICAL FEMORAL FRACTURE AFTER PROLONGED USE OF BISPHOSPHONATES. Porto Biomedical Journal. 2022;9(3):253$65$YR$$M$Y$$$20240918$$MD$PT$PT
216544555$21654455$5$F$20220101$20240716$20221129$20240723$EXP$$US-SA-2022SA486263$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240723$$MD$US$US
216545922$21654592$2$F$$20240627$20221129$20240705$EXP$$US-NOVOPROD-983258$NOVO NORDISK$$56$YR$$F$Y$$$20240705$$CN$US$US
216548815$21654881$5$F$$20240822$20221129$20240826$EXP$$CA-TAKEDA-2022TUS084457$TAKEDA$$$$$M$Y$$$20240826$$CN$CA$CA
216554583$21655458$3$F$20190122$20221124$20221129$20240716$EXP$$BG-ASTELLAS-2022US042152$ASTELLAS$$65$YR$$M$Y$$$20240716$$MD$BG$BG
216555149$21655514$9$F$$20240813$20221129$20240819$EXP$$NVSC2021CL091869$NOVARTIS$$50$YR$$F$Y$$$20240819$$CN$CL$CL
216557672$21655767$2$F$$20240830$20221129$20240911$EXP$PT-EMA-2022915-AUTODUP-1663273203554$PT-Accord-288097$ACCORD$$72$YR$E$F$Y$$$20240911$$MD$PT$PT
216557934$21655793$4$F$20220730$20221129$20221129$20240909$EXP$$FR-MYLANLABS-2022M1132160$MYLAN$$30$YR$$M$Y$$$20240909$$CN$FR$FR
216558814$21655881$4$F$$20240828$20221129$20240830$EXP$$US-KYOWAKIRIN-2022BKK018410$KYOWA$$$$$$Y$$$20240830$$HP$US$US
216560526$21656052$6$F$20221213$20240917$20221129$20240924$EXP$$CA-TAKEDA-2022TUS089678$TAKEDA$$70$YR$$F$Y$$$20240924$$CN$CA$CA
216563202$21656320$2$F$$20240725$20221129$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13814$LUPIN$$$$$$Y$$$20240813$$CN$US$US
216565819$21656581$9$F$20211120$20240320$20221129$20240808$EXP$$NVSC2022MX276378$NOVARTIS$$45$YR$$F$Y$86$KG$20240808$$CN$MX$MX
216567202$21656720$2$F$$20240830$20221129$20240910$PER$$US-SA-2022SA451780$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240910$$MD$US$US
216567603$21656760$3$F$20221011$20240828$20221129$20240925$PER$$US-SA-2022SA486345$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240925$$CN$US$US
216570346$21657034$6$F$20221101$20240807$20221129$20240815$EXP$$US-GSK-US2022170079$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$CN$US$US
216570395$21657039$5$F$$20240916$20221129$20240923$EXP$$CA-GSK-CA2022AMR175035$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$CA$CA
216570584$21657058$4$F$$20240724$20221129$20240731$EXP$$CA-GSK-CA2022AMR176737$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$CA$CA
216572123$21657212$3$F$20190703$20240801$20221129$20240807$EXP$$CA-TAKEDA-2022TUS089963$TAKEDA$$76$YR$$F$Y$$$20240807$$CN$CA$CA
216572857$21657285$7$F$20230208$20240822$20221129$20240828$EXP$$US-TAKEDA-2022TUS057391$TAKEDA$$42$YR$$F$Y$55.78$KG$20240828$$CN$US$US
216576844$21657684$4$F$20200717$20240813$20221129$20240821$PER$$US-SA-2022SA488136$SANOFI AVENTIS$$7$YR$C$M$Y$41$KG$20240821$$MD$US$US
216579368$21657936$8$F$20220101$20240802$20221129$20240812$EXP$$JP-009507513-2211JPN002681J$MERCK$$6$DEC$$F$Y$$$20240812$$MD$JP$JP
216587032$21658703$2$F$20220601$20240730$20221129$20240808$EXP$$NVSC2022BR265605$NOVARTIS$$55$YR$$F$Y$$$20240808$$CN$BR$BR
216590347$21659034$7$F$20200101$20240723$20221129$20240729$EXP$$US-HORIZON THERAPEUTICS-HZN-2022-009121$AMGEN$$70$YR$E$F$Y$$$20240728$$MD$US$US
216593439$21659343$9$F$20221003$20240907$20221129$20240912$EXP$$CO-BIOGEN-2022BI01160222$BIOGEN$$7$YR$$F$Y$31$KG$20240912$$CN$CO$CO
216595452$21659545$2$F$$20240710$20221129$20240716$PER$$US-ABBVIE-4217329$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
216597132$21659713$2$F$20220924$20221118$20221129$20240806$EXP$$US-RECORDATI-2022006017$RECORDATI$$$$$$Y$$$20240806$$CN$US$US
216597866$21659786$6$F$$20240917$20221129$20240926$EXP$$NVSC2022CA264457$NOVARTIS$$54$YR$$F$Y$$$20240926$$HP$CA$CA
216598239$21659823$9$F$20220101$20240822$20221130$20240826$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000556$PAREXEL$$$$$$Y$$$20240826$$CN$US$US
216603933$21660393$3$F$$20240816$20221130$20240830$PER$$US-SA-2022SA485856$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240830$$MD$US$US
216607923$21660792$3$F$20220101$20240628$20221130$20240704$EXP$$JP-009507513-2211JPN002917J$MERCK$$7$DEC$$F$Y$$$20240704$$MD$JP$JP
2166087631$21660876$31$F$20220420$20240913$20221130$20240923$EXP$$CA-CELLTRION INC.-2022CA007357$CELLTRION$$$$$$Y$$$20240923$$MD$CA$CA
216609414$21660941$4$F$$20240910$20221130$20240919$EXP$$BR-CELLTRION INC.-2022BR020104$CELLTRION$$$$$$Y$$$20240919$$CN$BR$BR
216610503$21661050$3$F$$20240805$20221130$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13873$LUPIN$$$$$$Y$$$20240820$$CN$US$US
216612872$21661287$2$F$$20221123$20221130$20240710$EXP$$AU-ASTELLAS-2022US042286$ASTELLAS$$$$$M$Y$$$20240710$$MD$AU$AU
216616717$21661671$7$F$20221101$20230616$20221130$20240926$PER$$US-GSK-US2022AMR177597$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240926$$CN$US$US
216617513$21661751$3$F$$20240704$20221130$20240725$EXP$$JP-AMGEN-JPNSP2022203748$AMGEN$Kamiya T.; Yamashita M.; Fujimura J.. Inotuzumab ozogamicin successfully controlled the TCF3-HLF-positive acute lymphoblastic leukemia before hematopoietic cell transplantation. The Japanese Journal of Pediatric Hematology/Oncology. 2022;59 (4):S67$4$YR$C$F$Y$$$20240725$$MD$JP$JP
216618652$21661865$2$F$$20240802$20221130$20240809$EXP$$JP-AMGEN-JPNSP2022204165$AMGEN$$$$A$M$Y$$$20240809$$MD$JP$JP
216618905$21661890$5$F$20220913$20240918$20221130$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-143051$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240926$$MD$JP$JP
216622336$21662233$6$F$20220101$20240731$20221130$20240805$EXP$$CA-PFIZER INC-202201332500$PFIZER$$28$YR$$M$Y$$$20240805$$MD$CA$CA
216623813$21662381$3$F$$20240815$20221130$20240822$EXP$$CA-TAKEDA-2021TUS023982$TAKEDA$$49$YR$$F$Y$$$20240822$$HP$CA$CA
216628332$21662833$2$F$20220101$20240725$20221130$20240805$PER$$US-SA-2022SA487341$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240805$$MD$US$US
216628972$21662897$2$F$20220805$20240722$20221130$20240725$EXP$$IT-PFIZER INC-202201333750$PFIZER$$31$YR$$F$Y$70$KG$20240725$$MD$IT$IT
216629023$21662902$3$F$$20240909$20221130$20240918$EXP$$IT-MYLANLABS-2022M1134118$MYLAN$Rodrigues, D. Gemella morbillorum subdural empyema and hematoma complicating acute sinusitis. Neuroradiology Journal. 2010;23(SUPPL 1):406$10$YR$$F$Y$$$20240918$$HP$IT$IT
216629772$21662977$2$F$20220101$20240716$20221130$20240722$PER$$US-SA-2022SA486638$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240722$$MD$US$US
216630153$21663015$3$F$20230215$20240826$20221130$20240904$EXP$$CA-GSK-CA2022175912$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$CA$CA
2166360810$21663608$10$F$20221028$20240715$20221130$20240720$EXP$$US-JAZZ-2022-US-034444$JAZZ$$42$YR$$F$Y$$$20240720$$HP$US$US
216640118$21664011$8$F$20200305$20240924$20221130$20240926$EXP$$US-TAKEDA-2022TUS091607$TAKEDA$$25$YR$$M$Y$$$20240926$$PH$US$US
216645527$21664552$7$F$20221110$20240724$20221130$20240730$EXP$$ES-PFIZER INC-202201333682$PFIZER$$71$YR$$F$Y$51.4$KG$20240730$$MD$ES$ES
216648415$21664841$5$F$$20240719$20221130$20240722$PER$$US-DSJP-DSU-2022-143225$DAIICHI$$$$$M$Y$$$20240722$$MD$US$US
216655867$21665586$7$F$20230501$20240716$20221201$20240724$PER$$CA-TOLMAR, INC.-22CA037684$TOLMAR$$78$YR$$M$Y$$$20240724$$CN$CA$CA
216657817$21665781$7$F$20230506$20240808$20221201$20240813$EXP$$BR-CELLTRION INC.-2022BR020155$CELLTRION$$$$$$Y$$$20240813$$CN$BR$BR
2166579118$21665791$18$F$20220101$20240822$20221201$20240829$EXP$$CA-CELLTRION INC.-2022CA016594$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
216658554$21665855$4$F$20220101$20240917$20221201$20240925$PER$$US-SA-2022SA489699$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240925$$MD$US$US
216662373$21666237$3$F$20221121$20221209$20221201$20240925$PER$$US-GSK-US2022AMR177554$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240925$$CN$US$US
216662825$21666282$5$F$20221027$20221229$20221201$20240925$EXP$$US-GSK-US2002AMR000061$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
2166646419$21666464$19$F$20220516$20240905$20221201$20240909$EXP$$CH-ABBVIE-22K-151-4499914-00$ABBVIE$$88$YR$$M$Y$75$KG$20240909$$MD$CH$CH
2166659914$21666599$14$F$$20240822$20221201$20240828$EXP$$BR-TAKEDA-2022TUS057450$TAKEDA$$$$$F$Y$87$KG$20240828$$MD$BR$BR
216667303$21666730$3$F$$20240918$20221201$20240927$PER$$NVSC2022US277928$NOVARTIS$$$$$M$Y$$$20240927$$MD$US$US
2166680914$21666809$14$F$20220222$20240906$20221201$20240912$EXP$$CA-CELLTRION INC.-2022CA005512$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
216670157$21667015$7$F$20221102$20240619$20221201$20240704$EXP$$DE-ROCHE-3224795$ROCHE$$61$YR$A$M$Y$90$KG$20240704$$MD$DE$DE
216670403$21667040$3$F$$20240718$20221201$20240729$EXP$DE-BFARM-22007669$DE-Accord-288245$ACCORD$$56$YR$A$M$Y$$$20240729$$PH$DE$DE
216671228$21667122$8$F$20220425$20240909$20221201$20240917$EXP$$DE-ROCHE-3088007$ROCHE$$53$YR$A$F$Y$$$20240917$$CN$DE$DE
216673782$21667378$2$F$20170101$20240816$20221201$20240826$PER$$US-ABBVIE-4171978$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
216674306$21667430$6$F$20220801$20240830$20221201$20240906$EXP$$DE-BIOGEN-2022BI01166158$BIOGEN$$59$YR$$F$Y$$$20240906$$CN$DE$DE
216675102$21667510$2$F$$20240806$20221201$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13917$LUPIN$$$$$$Y$$$20240827$$HP$US$US
216677423$21667742$3$F$20221101$20240913$20221201$20240917$EXP$$US-PFIZER INC-PV202200113789$PFIZER$$56$YR$$F$Y$$$20240917$$HP$US$US
216677822$21667782$2$F$$20240816$20221201$20240819$PER$$US-PFIZER INC-PV202200114662$PFIZER$$$$$$Y$$$20240819$$CN$US$US
2166778423$21667784$23$F$20220101$20240711$20221201$20240717$PER$$US-PFIZER INC-PV202200113940$PFIZER$$75$YR$$F$Y$78.02$KG$20240717$$CN$US$US
216679155$21667915$5$F$$20240730$20221201$20240801$EXP$$JP-ABBVIE-4219647$ABBVIE$Watanabe E. O22-6 Two cases of rheumatoid arthritis complicated by malignant tumour with elevated KL-6. The 37th Annual Meeting of the Japanese Society for Clinical Rheumatology and Related Research. 2022. 215-215.; E Watanabe. O22-6 Two cases of rheumatoid arthritis complicated by malignant tumour with elevated KL-6. The 37th Annual Meeting of the Japanese Society for Clinical Rheumatology and Related Research. 2022. 215-215.$49$YR$$F$Y$$$20240801$$MD$JP$JP
2166838610$21668386$10$F$20221110$20240724$20221201$20240726$EXP$$CA-TAKEDA-2022TUS090977$TAKEDA$$31$YR$$F$Y$$$20240726$$CN$CA$CA
216686502$21668650$2$F$$20240913$20221201$20240923$PER$$US-SA-2022SA489043$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240923$$MD$US$US
2166888610$21668886$10$F$20230928$20240917$20221201$20240923$EXP$$US-TAKEDA-2022TUS092527$TAKEDA$$58$YR$$F$Y$54$KG$20240923$$CN$US$US
2166892110$21668921$10$F$20220701$20240905$20221201$20240909$EXP$$US-JAZZ-2022-US-016543$JAZZ$$29$YR$$F$Y$$$20240909$$MD$US$US
216689562$21668956$2$F$$20240805$20221201$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13882$LUPIN$$$$$$Y$$$20240828$$CN$US$US
216693564$21669356$4$F$20221219$20240924$20221201$20240930$EXP$$NVSC2022US279585$NOVARTIS$$75$YR$$F$Y$86.6$KG$20240930$$HP$US$US
216696093$21669609$3$F$20221101$20240806$20221201$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202212000045$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240820$$CN$US$US
216702374$21670237$4$F$20220101$20240710$20221201$20240712$EXP$$US-PFIZER INC-PV202200115258$PFIZER$$75$YR$$F$Y$$$20240712$$CN$US$US
216704493$21670449$3$F$$20240829$20221201$20240911$EXP$$AU-ASTELLAS-2022US042511$ASTELLAS$Shivasabesan G. Disseminated Aspergillus lentulus Infection in a Heart Transplant Recipient: A Case Report. Clinical Infectious Diseases. 2022;75(7): 1235-8. doi:10.1093/cid/ciac205.$72$YR$E$F$Y$$$20240911$$HP$AU$AU
216706956$21670695$6$F$20221006$20240625$20221202$20240703$EXP$$CA-CELLTRION INC.-2022CA005249$CELLTRION$$$$$$Y$$$20240703$$MD$CA$CA
216709723$21670972$3$F$$20240725$20221202$20240808$PER$$US-SA-2022SA486449$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240808$$MD$US$US
216715003$21671500$3$F$20210101$20240909$20221202$20240911$EXP$$US-GBT-017346$PFIZER$$9$YR$$F$Y$$$20240911$$CN$US$US
216716612$21671661$2$F$$20240615$20221202$20240710$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003884$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
2167167112$21671671$12$F$20191216$20240816$20221202$20240824$EXP$$CA-CELLTRION INC.-2018CA021859$CELLTRION$$$$$$Y$$$20240824$$HP$CA$CA
216718746$21671874$6$F$20221101$20230130$20221202$20240925$PER$$US-GSK-US2022AMR178508$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
216720733$21672073$3$F$20221201$20240923$20221202$20240926$PER$$US-BIOGEN-2022BI01165543$BIOGEN$$58$YR$$F$Y$$$20240926$$CN$US$US
216721466$21672146$6$F$20230201$20240918$20221202$20240925$PER$$NVSC2022US278258$NOVARTIS$$29$YR$$F$Y$$$20240925$$MD$US$US
216722663$21672266$3$F$20221101$20221207$20221202$20240926$PER$$US-GSK-US2022AMR178691$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240926$$CN$US$US
216724203$21672420$3$F$20221007$20240719$20221202$20240725$EXP$$CA-TAKEDA-2022TUS089506$TAKEDA$$10$YR$$M$Y$26.304$KG$20240725$$CN$CA$CA
2167295413$21672954$13$F$20220101$20240820$20221202$20240828$EXP$$CA-CELLTRION INC.-2022CA006524$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
216730512$21673051$2$F$20240810$20240823$20221202$20240828$EXP$$NVSC2022IN277711$NOVARTIS$$65$YR$$F$Y$$$20240828$$CN$IN$IN
2167306317$21673063$17$F$$20240923$20221202$20240925$EXP$$CA-ORGANON-2012CAN013177$ORGANON$$43$YR$$F$Y$68$KG$20240925$$MD$CA$CA
2167310314$21673103$14$F$$20240923$20221202$20240926$EXP$$CA-ORGANON-2012CAN012673$ORGANON$$43$YR$$F$Y$68$KG$20240925$$HP$CA$CA
216734755$21673475$5$F$20220601$20240807$20221202$20240812$EXP$$CA-SHIRE-CA202016469$TAKEDA$$71$YR$$F$Y$76$KG$20240812$$CN$CA$CA
216735363$21673536$3$F$20240827$20240912$20221202$20240917$EXP$$US-PAREXEL-2021-KAM-US003615$TAKEDA$$72$YR$$M$Y$52.15$KG$20240917$$MD$US$US
216737177$21673717$7$F$20240401$20240629$20221202$20240702$PER$$US-PFIZER INC-202201343857$PFIZER$$61$YR$$F$Y$50.8$KG$20240702$$CN$US$US
216737842$21673784$2$F$$20221201$20221202$20240923$EXP$$NVSC2022IE279682$NOVARTIS$$$$$$Y$$$20240923$$PH$IE$IE
216744458$21674445$8$F$$20240821$20221202$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-147108$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240828$$HP$US$US
216746216$21674621$6$F$20160901$20240826$20221202$20240912$EXP$$US-SA-2022SA017489$SANOFI AVENTIS$$60$YR$A$F$Y$153.29$KG$20240912$$MD$US$US
216746294$21674629$4$F$20240101$20240920$20221202$20240924$EXP$$US-GBT-017587$PFIZER$$20$YR$$F$Y$$$20240924$$CN$US$US
216747302$21674730$2$F$$20240903$20221202$20240927$PER$$US-SA-2022SA492251$SANOFI AVENTIS$$$$A$M$Y$$$20240927$$MD$US$US
216747383$21674738$3$F$20200601$20240717$20221202$20240726$PER$$US-SA-2022SA492982$SANOFI AVENTIS$$$$A$F$Y$$$20240727$$MD$US$US
216748042$21674804$2$F$20221001$20240717$20221202$20240725$PER$$US-SA-2022SA491707$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240725$$MD$US$US
216755213$21675521$3$F$$20240708$20221202$20240717$EXP$$US-GW PHARMA-2022-US-036689$JAZZ$$$$$M$Y$$$20240717$$CN$US$US
2167581410$21675814$10$F$20220919$20240911$20221202$20240920$EXP$$US-THERATECHNOLOGIES INC.-2022-THE-TES-000296$THERATECHNOLOGIES$$$$$$Y$$$20240920$$CN$US$US
216758185$21675818$5$F$20220101$20240821$20221202$20240909$EXP$$US-THERATECHNOLOGIES INC.-2022-THE-TES-000361$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
216758665$21675866$5$F$20180808$20240625$20221202$20240702$EXP$$NVSC2022DE275829$NOVARTIS$$26$YR$$F$Y$93$KG$20240703$$MD$DE$DE
216760763$21676076$3$F$$20240711$20221202$20240717$EXP$$US-KYOWAKIRIN-2022BKK018650$KYOWA$$$$$$Y$$$20240717$$HP$US$US
216761559$21676155$9$F$20221121$20240821$20221202$20240827$EXP$$CO-TAKEDA-2022TUS093065$TAKEDA$$24$YR$$F$Y$59$KG$20240827$$CN$CO$CO
216763924$21676392$4$F$20220101$20230131$20221202$20240711$PER$$SK-PFM-2022-08363$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$6.2$KG$20240711$$MD$SK$SK
216764323$21676432$3$F$20210101$20240830$20221202$20240906$EXP$$BR-BIOMARINAP-BR-2022-147105$BIOMARIN$$$$$$Y$$$20240906$$CN$BR$BR
2167654812$21676548$12$F$$20240923$20221202$20240926$EXP$$CA-ORGANON-O2211CAN002590$ORGANON$$40$YR$$F$Y$73$KG$20240926$$HP$CA$CA
216772156$21677215$6$F$20230401$20240527$20221203$20240926$EXP$$NVSC2022CO212826$NOVARTIS$$24$YR$$F$Y$54$KG$20240926$$CN$CO$CO
2167763315$21677633$15$F$20220101$20240829$20221203$20240906$EXP$$CA-CELLTRION INC.-2022CA005434$CELLTRION$$$$$$Y$$$20240906$$MD$CA$CA
2167788113$21677881$13$F$20221101$20240731$20221203$20240806$EXP$$NVSC2020CA231809$NOVARTIS$$83$YR$$M$Y$$$20240806$$MD$CA$CA
216780306$21678030$6$F$$20240711$20221203$20240715$PER$$NVSC2022US279396$NOVARTIS$$$$$M$Y$$$20240715$$CN$US$US
216780666$21678066$6$F$20220406$20240918$20221203$20240926$EXP$$NVSC2022US279836$NOVARTIS$$87$YR$$F$Y$$$20240926$$CN$US$US
216781573$21678157$3$F$20221110$20221128$20221203$20240923$EXP$$NVSC2022US276879$NOVARTIS$$$$$$Y$$$20240923$$CN$US$US
2167845113$21678451$13$F$20231025$20240917$20221203$20240924$EXP$$CA-JNJFOC-20221204470$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240924$$CN$CA$CA
216784662$21678466$2$F$$20240726$20221203$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13966$LUPIN$$$$$$Y$$$20240815$$CN$US$US
216785047$21678504$7$F$$20240729$20221203$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14067$LUPIN$$$$$$Y$$$20240822$$CN$US$US
216788014$21678801$4$F$$20240806$20221204$20240814$PER$$US-SA-2022SA492981$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240814$$MD$US$US
216795767$21679576$7$F$20221108$20240826$20221205$20240829$EXP$$JP-TAKEDA-2022TJP078186$TAKEDA$$57$YR$$F$Y$40.9$KG$20240829$$MD$JP$JP
216797232$21679723$2$F$20240901$20240916$20221205$20240919$EXP$$US-KYOWAKIRIN-2022BKK018701$KYOWA$$$$$$Y$$$20240919$$HP$US$US
2167979510$21679795$10$F$20221101$20230718$20221205$20240925$PER$$US-GSK-US2022AMR178484$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
216801016$21680101$6$F$20200101$20240718$20221205$20240723$EXP$$CA-BAUSCH-BL-2020-009737$BAUSCH AND LOMB$$52$YR$$M$Y$108.96$KG$20240723$$CN$CA$CA
216802856$21680285$6$F$$20240910$20221205$20240920$EXP$$CA-APOTEX-2022AP016102$APOTEX$$30$YR$$M$Y$84$KG$20240920$$HP$CA$CA
216802943$21680294$3$F$$20240709$20221205$20240715$PER$$US-AMGEN-USASP2022209658$AMGEN$$68$YR$E$F$Y$$$20240715$$MD$US$US
216808192$21680819$2$F$20221101$20221130$20221205$20240925$PER$$US-GSK-US2022AMR180619$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
216810172$21681017$2$F$20221115$20240814$20221205$20240826$PER$$US-SA-2022SA491746$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240826$$MD$US$US
216811753$21681175$3$F$$20240831$20221205$20240903$EXP$$TH-TAKEDA-2020TUS033858$TAKEDA$$$$$F$Y$$$20240903$$CN$TH$TH
216812423$21681242$3$F$20220601$20240816$20221205$20240821$PER$$NVSC2022US281922$NOVARTIS$$43$YR$$F$Y$$$20240821$$CN$US$US
216813473$21681347$3$F$20221101$20240715$20221205$20240717$EXP$$US-TAKEDA-2022TUS092128$TAKEDA$$63$YR$$F$Y$91$KG$20240717$$CN$US$US
216814382$21681438$2$F$20220101$20240709$20221205$20240718$PER$$US-SA-2022SA490806$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240718$$MD$US$US
216815194$21681519$4$F$20220601$20240920$20221205$20240927$EXP$$CA-TAKEDA-2022TUS092202$TAKEDA$$62$YR$$F$Y$$$20240927$$MD$CA$CA
216817612$21681761$2$F$20221001$20240919$20221205$20240927$EXP$$US-SA-2022SA494568$SANOFI AVENTIS$$62$YR$A$M$Y$83.914$KG$20240927$$MD$US$US
216822664$21682266$4$F$$20240624$20221205$20240702$EXP$$PT-CELLTRION INC.-2022PT020079$CELLTRION$Jardim AL, Moreira S, Russo DL, et al. Chronic diarrhea as a manifestation of intestinal amyloidosis.. 28th National Internal Medicine Congress.. 156$$$$$Y$$$20240702$$MD$PT$PT
216823408$21682340$8$F$20181030$20240828$20221205$20240903$EXP$$DE-ROCHE-2210359$ROCHE$$29$YR$A$M$Y$$$20240903$$CN$DE$DE
216824443$21682444$3$F$$20221207$20221205$20240805$EXP$$US-MYLANLABS-2020458682$MYLAN$$$$$F$Y$$$20240805$$CN$US$US
216825572$21682557$2$F$20221102$20240919$20221205$20240920$EXP$FR-AFSSAPS-AM20222444$FR-PFIZER INC-202201344330$PFIZER$$30$YR$$F$Y$60$KG$20240920$$MD$FR$FR
216825722$21682572$2$F$$20240820$20221205$20240826$EXP$$CA-APOTEX-2022AP016109$APOTEX$$74$YR$$F$Y$$$20240826$$HP$CA$CA
2168267311$21682673$11$F$20221101$20240830$20221205$20240905$EXP$$US-ABBVIE-4187235$ABBVIE$$$$$F$Y$64$KG$20240905$$CN$US$US
2168268717$21682687$17$F$20220829$20240912$20221205$20240925$EXP$$CA-HLS-202202054$HLS THERAPEUTICS$$56$YR$A$M$Y$$$20240925$$CN$CA$CA
216827172$21682717$2$F$20211210$20240912$20221205$20240924$EXP$$FR-SERVIER-S22012330$SERVIER$$$$$$Y$$$20240924$$MD$FR$FR
2168277212$21682772$12$F$20220101$20240911$20221205$20240916$EXP$$CA-TAKEDA-2022TUS082675$TAKEDA$$$$$F$Y$17$KG$20240916$$HP$CA$CA
216831823$21683182$3$F$$20240909$20221205$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14066$LUPIN$$$$$$Y$$$20240921$$CN$US$US
216836395$21683639$5$F$$20240718$20221205$20240723$EXP$$US-TAKEDA-2022TUS014216$TAKEDA$$$$$F$Y$$$20240723$$CN$US$US
216838204$21683820$4$F$20220101$20221130$20221205$20240808$EXP$$US-OTSUKA-2022_053538$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
21684576122$21684576$122$F$20200601$20240919$20221205$20240926$EXP$$CA-PFIZER INC-202201346146$PFIZER$$80$YR$$M$Y$69$KG$20240926$$MD$CA$CA
216846763$21684676$3$F$20240701$20240722$20221205$20240727$PER$$US-ABBVIE-4223266$ABBVIE$$41$YR$$F$Y$102$KG$20240727$$CN$US$US
216847873$21684787$3$F$20100329$20240911$20221205$20240915$EXP$$US-JNJFOC-20221205567$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240916$$LW$US$US
216849102$21684910$2$F$$20240916$20221205$20240925$EXP$$PT-PIRAMAL CRITICAL CARE LIMITED-2022-PEL-000709$PIRAMAL$Oliveira D.C., Carvalho S., Parra C., Lopes N., Santos A. et al.. Diffuse Alveolar Hemorrhage - differential diagnosis. POSTERS | CLINICAL CASES. 0509$$$$$Y$$$20240925$$HP$PT$PT
216849467$21684946$7$F$$20240829$20221205$20240906$EXP$$DE-CELLTRION INC.-2022DE020299$CELLTRION$Schmidt K, Skusa R, Grobmann A.. Fatal neurological side effect of anti-CD20 antibody treatment. Internal Medicine. 2023;64 (2):193-6$$$$$Y$$$20240906$$HP$DE$DE
216856564$21685656$4$F$20221127$20240801$20221206$20240807$EXP$$US-TAKEDA-2021TUS070878$TAKEDA$$1$YR$$M$Y$$$20240807$$MD$US$US
216858332$21685833$2$F$20230101$20240625$20221206$20240702$PER$$US-ABBVIE-4181183$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
216858903$21685890$3$F$20221101$20240815$20221206$20240821$PER$$US-BIOGEN-2022BI01173085$BIOGEN$$46$YR$$F$Y$$$20240821$$CN$US$US
216859653$21685965$3$F$20221101$20240622$20221206$20240705$PER$$US-SA-2022SA494552$SANOFI AVENTIS$$48$YR$A$M$Y$100$KG$20240705$$MD$US$US
2168602313$21686023$13$F$20221212$20230802$20221206$20240926$EXP$$US-GSK-US2022AMR180720$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
216860476$21686047$6$F$20200922$20240919$20221206$20240930$EXP$$DE-ROCHE-2714563$ROCHE$$37$YR$A$F$Y$$$20240930$$CN$DE$DE
2168631822$21686318$22$F$$20240916$20221206$20240920$EXP$$CA-AMGEN-CANSP2022208115$AMGEN$$36$YR$A$F$Y$$$20240920$$HP$CA$CA
216863312$21686331$2$F$$20240718$20221206$20240726$PER$$US-SA-2022SA495014$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240726$$MD$US$US
216863523$21686352$3$F$20240101$20240909$20221206$20240912$EXP$$US-ABBVIE-4224603$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
2168661715$21686617$15$F$20200610$20240806$20221206$20240810$EXP$$CA-ROCHE-2620656$ROCHE$$36$YR$A$M$Y$$$20240810$$CN$CA$CA
216866376$21686637$6$F$20240719$20240814$20221206$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-148602$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240816$$HP$US$US
216867455$21686745$5$F$20220301$20240815$20221206$20240821$EXP$$US-TAKEDA-2022TUS092134$TAKEDA$$50$YR$$F$Y$79.3$KG$20240821$$CN$CA$CA
216868122$21686812$2$F$20210315$20231010$20221206$20240712$EXP$GB-MHRA-ADR 24802006$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-09278$ALKEM$$$$A$F$Y$73$KG$20240712$$MD$GB$GB
2168691211$21686912$11$F$20190919$20240830$20221206$20240903$EXP$$US-TAKEDA-US201931534$TAKEDA$$79$YR$$F$Y$$$20240903$$MD$US$US
216869632$21686963$2$F$20221007$20240904$20221206$20240910$EXP$$CA-UCBSA-2022068764$UCB$$37$YR$$F$Y$$$20240910$$MD$CA$CA
216870218$21687021$8$F$20231023$20240626$20221206$20240702$EXP$$NVSC2022US283080$NOVARTIS$$75$YR$$F$Y$$$20240702$$CN$US$US
216872812$21687281$2$F$20220331$20221202$20221206$20240926$EXP$$US-GSK-US2022AMR061012$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
216874194$21687419$4$F$20220610$20240712$20221206$20240717$EXP$$CA-TAKEDA-2021TUS028996$TAKEDA$$28$YR$$F$Y$46.5$KG$20240717$$CN$CA$CA
216874775$21687477$5$F$20211201$20240729$20221206$20240801$EXP$$DE-ROCHE-3128762$ROCHE$$50$YR$A$F$Y$71$KG$20240801$$MD$DE$DE
216874933$21687493$3$F$$20240805$20221206$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14034$LUPIN$$$$$$Y$$$20240829$$CN$US$US
216875323$21687532$3$F$20221128$20240807$20221206$20240812$PER$$NVSC2022US277978$NOVARTIS$$44$YR$$F$Y$$$20240812$$CN$US$US
216876107$21687610$7$F$20221125$20240809$20221206$20240813$EXP$$RU-JNJFOC-20221205440$JOHNSON AND JOHNSON$$$$A$F$Y$49$KG$20240813$$HP$RU$RU
216878902$21687890$2$F$$20240823$20221206$20240829$PER$$NVSC2022US282988$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
2168799615$21687996$15$F$20220125$20240801$20221206$20240807$EXP$$CA-OTSUKA-2022_003829$OTSUKA$$38$YR$$F$Y$$$20240807$$MD$CA$CA
216881032$21688103$2$F$$20240702$20221206$20240708$PER$$US-ABBVIE-4174346$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
216882972$21688297$2$F$$20240718$20221206$20240808$PER$$US-PFIZER INC-PV202200117288$PFIZER$$51$YR$$F$Y$$$20240808$$HP$US$US
216883324$21688332$4$F$20181201$20240731$20221206$20240802$EXP$$BG-AMGEN-BGRSP2022207668$AMGEN$$65$YR$E$M$Y$$$20240802$$MD$BG$BG
216884374$21688437$4$F$20221001$20240822$20221206$20240829$EXP$$CO-TAKEDA-2022TUS093366$TAKEDA$$43$YR$$M$Y$97$KG$20240829$$CN$CO$CO
2168844814$21688448$14$F$20221201$20240925$20221206$20240926$EXP$$US-PFIZER INC-PV202200117136$PFIZER$$76$YR$$F$Y$$$20240926$$CN$US$US
2168861514$21688615$14$F$20220901$20240816$20221206$20240821$EXP$$US-JAZZ-2022-US-023133$JAZZ$$71$YR$$F$Y$$$20240821$$CN$US$US
216886682$21688668$2$F$$20240904$20221206$20240906$PER$$US-PFIZER INC-PV202200117052$PFIZER$$59$YR$$M$Y$$$20240906$$CN$US$US
216887833$21688783$3$F$20220101$20221207$20221206$20240806$EXP$$US-RECORDATI-2022006457$RECORDATI$$$$$$Y$$$20240806$$CN$US$US
216888502$21688850$2$F$20221128$20240905$20221206$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-148375$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$94.3$KG$20240906$$CN$US$US
216890057$21689005$7$F$20221129$20240924$20221206$20240926$EXP$$NVSC2022US279833$NOVARTIS$$40$YR$$F$Y$$$20240926$$CN$US$US
216891262$21689126$2$F$$20240822$20221206$20240827$EXP$$US-TAKEDA-2021TUS073555$TAKEDA$$$$$M$Y$$$20240827$$CN$US$US
216893437$21689343$7$F$20090901$20240703$20221206$20240710$EXP$$CA-ANIPHARMA-2020-CA-001604$ANI$$72$YR$$F$Y$$$20240710$$CN$CA$CA
216893784$21689378$4$F$$20240814$20221206$20240817$EXP$$US-TAKEDA-2022TUS080277$TAKEDA$$$$$F$Y$$$20240817$$MD$US$US
216896342$21689634$2$F$$20240711$20221206$20240717$EXP$$US-ABBVIE-4225958$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
216897743$21689774$3$F$20220822$20240916$20221206$20240925$EXP$$CA-VER-202200631$VERITY PHARMACEUTICALS$$84$YR$E$M$Y$$$20240925$$CN$CA$CA
216898322$21689832$2$F$20220106$20240703$20221206$20240709$EXP$$SE-MYLANLABS-2022M1134650$MYLAN$$62$YR$$M$Y$125.7$KG$20240709$$MD$SE$SE
2168991910$21689919$10$F$$20240712$20221206$20240712$PER$$NVSC2022US283543$NOVARTIS$$$$$F$Y$$$20240712$$CN$US$US
2168999810$21689998$10$F$20221101$20240909$20221206$20240912$EXP$$US-JAZZ-2022-US-036929$JAZZ$$49$YR$$F$Y$$$20240912$$CN$US$US
216900826$21690082$6$F$20200225$20240911$20221206$20240917$PER$$US-ABBVIE-4176917$ABBVIE$$73$YR$$F$Y$53$KG$20240917$$CN$US$US
2169066914$21690669$14$F$20190101$20240724$20221206$20240731$EXP$$US-ABBVIE-4181298$ABBVIE$$$$$M$Y$115.66$KG$20240731$$CN$US$US
216907525$21690752$5$F$$20240822$20221206$20240829$30DAY$$US-GSK-US2022177844$GLAXOSMITHKLINE$$$$$M$Y$$$20240829$$CN$US$US
216910833$21691083$3$F$20210401$20240814$20221207$20240821$EXP$DE-CADRBFARM-2022311186$DE-ABBVIE-4225143$ABBVIE$$84$YR$$M$Y$70$KG$20240821$$MD$DE$DE
216911118$21691111$8$F$20220705$20240813$20221207$20240814$EXP$$JP-ABBVIE-4225065$ABBVIE$$14$YR$$M$Y$$$20240814$$MD$JP$JP
216914382$21691438$2$F$$20221128$20221207$20240925$PER$$US-GSK-US2022AMR178687$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2169159810$21691598$10$F$20221121$20240624$20221207$20240701$EXP$$US-SA-2022SA496106$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240701$$MD$US$US
2169163713$21691637$13$F$20221110$20240909$20221207$20240917$EXP$$CA-CELLTRION INC.-2022CA000873$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
216918304$21691830$4$F$20221101$20231019$20221207$20240925$PER$$US-GSK-US2022179129$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240925$$CN$US$US
216918513$21691851$3$F$20190101$20221220$20221207$20240913$EXP$$BG-ROCHE-3230716$ROCHE$$51$YR$A$F$Y$$$20240913$$MD$BG$BG
216919365$21691936$5$F$20170920$20240724$20221207$20240729$EXP$$CA-JNJFOC-20220316897$JOHNSON AND JOHNSON$$39$YR$A$F$Y$45$KG$20240729$$HP$CA$CA
216921052$21692105$2$F$$20240711$20221207$20240718$EXP$$US-AMGEN-USASP2022210311$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
2169217210$21692172$10$F$20200213$20240809$20221207$20240812$EXP$$IT-ROCHE-2698057$ROCHE$$67$YR$E$M$Y$$$20240812$$MD$IT$IT
216922756$21692275$6$F$20220214$20240731$20221207$20240807$EXP$$CA-CELLTRION INC.-2022CA010245$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
216924197$21692419$7$F$20220316$20240712$20221207$20240719$EXP$$JP-EXELIXIS-CABO-22051400$EXELIXIS$Nomura M, Kaneyama A, Sawada T, Nomura M, Saito T, Sudo Y, et al.. A case of nivolumab/cabozantinib combined therapy successfully responded for advanced renal cell carcinoma associated with mestases to the bones.. The 87th Annual Meeting of the Eastern Section of Japanese Urological. 2022;328$45$YR$$F$Y$$$20240719$$MD$JP$JP
216924403$21692440$3$F$$20240821$20221207$20240827$EXP$$JP-PFIZER INC-202201343772$PFIZER$Kurisu, N.. Vitreoretinal Lymphoma in a Patient with Rheumatoid Arthritis with a History of Methotrexate-associated Lymphoproliferative Disorders. Ocular Immunology and Inflammation. 2022;10.1080/09273948.2022.2144384$68$YR$$F$Y$$$20240827$$MD$JP$JP
216926812$21692681$2$F$20200116$20230821$20221207$20240712$EXP$GB-MHRA-ADR 27302474$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-10287$ALKEM$$58$YR$$F$Y$85.3$KG$20240712$$MD$GB$GB
216926842$21692684$2$F$20181217$20231003$20221207$20240712$EXP$GB-MHRA-ADR 27290593$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-10301$ALKEM$$38$YR$$F$Y$$$20240712$$MD$GB$GB
216926853$21692685$3$F$20190815$20231107$20221207$20240712$EXP$GB-MHRA-ADR 27290929$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-10196$ALKEM$$40$YR$$M$Y$92.3$KG$20240712$$MD$GB$GB
216926983$21692698$3$F$20201117$20230814$20221207$20240712$EXP$GB-MHRA-ADR 27285861$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-10094$ALKEM$$39$YR$$F$Y$62$KG$20240712$$MD$GB$GB
216927012$21692701$2$F$20180801$20230825$20221207$20240712$EXP$GB-MHRA-ADR 27285115$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-10088$ALKEM$$38$YR$$M$Y$85$KG$20240712$$MD$GB$GB
216927897$21692789$7$F$20221101$20230308$20221207$20240925$EXP$$US-GSK-US2022AMR180706$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2169289932$21692899$32$F$20220101$20240917$20221207$20240924$EXP$$CA-TAKEDA-2022TUS082295$TAKEDA$$$$$F$Y$$$20240924$$HP$CA$CA
216929667$21692966$7$F$$20240717$20221207$20240725$EXP$$CA-ROCHE-3230048$ROCHE$$$$A$F$Y$$$20240725$$CN$CA$CA
216931544$21693154$4$F$20191017$20240823$20221207$20240827$EXP$$US-TAKEDA-US201935386$TAKEDA$$63$YR$$F$Y$$$20240827$$MD$US$US
216933393$21693339$3$F$$20240718$20221207$20240729$PER$$US-SA-2022SA485977$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240729$$HP$US$US
216937602$21693760$2$F$20240701$20240806$20221207$20240813$EXP$$CA-GSK-CA2022163518$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$CA$CA
2169408412$21694084$12$F$$20240730$20221207$20240802$EXP$$US-PFIZER INC-PV202200118456$PFIZER$$79$YR$$F$Y$$$20240802$$HP$US$US
216941094$21694109$4$F$$20240710$20221207$20240718$EXP$$DK-CELLTRION INC.-2022DK020330$CELLTRION$Filikci Z, Jensen RM, Sellebjerg FT. Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis. BMJ Case Rep. 2022;15 (11):1-2$$$$$Y$$$20240718$$MD$DK$DK
216944583$21694458$3$F$$20240822$20221207$20240904$PER$$US-SA-2022SA494887$SANOFI AVENTIS$$3$YR$C$M$Y$26.5$KG$20240904$$CN$US$US
216944987$21694498$7$F$$20240628$20221207$20240702$EXP$$US-PFIZER INC-PV202200118123$PFIZER$$67$YR$$F$Y$$$20240702$$CN$US$US
216946334$21694633$4$F$20220101$20240727$20221207$20240801$EXP$$IN-PFIZER INC-PV202200118174$PFIZER$$59$YR$$M$Y$$$20240801$$CN$IN$IN
2169586114$21695861$14$F$20221001$20240917$20221207$20240923$EXP$$US-JAZZ-2022-US-018391$JAZZ$$44$YR$$F$Y$$$20240923$$CN$US$US
216959943$21695994$3$F$20141201$20240823$20221207$20240829$EXP$$US-009507513-2211USA006387$MERCK$$54$YR$$M$Y$$$20240829$$HP$US$US
2169649514$21696495$14$F$20221101$20240829$20221207$20240906$EXP$$CA-CELLTRION INC.-2022CA020625$CELLTRION$$$$$$Y$$$20240906$$MD$CA$CA
216968934$21696893$4$F$20230503$20231108$20221208$20240712$PER$$NVSC2022US278430$NOVARTIS$$28$YR$$F$Y$$$20240712$$CN$US$US
216969663$21696966$3$F$$20240828$20221208$20240905$EXP$$CA-APOTEX-2022AP016321$APOTEX$$50$YR$$F$Y$70$KG$20240905$$MD$CA$CA
2169744510$21697445$10$F$20230629$20240206$20221208$20240926$EXP$$US-GSK-US2022AMR181855$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
216975474$21697547$4$F$20221129$20230111$20221208$20240925$PER$$US-GSK-US2022AMR183495$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
216977316$21697731$6$F$20200401$20240725$20221208$20240801$EXP$$DE-ROCHE-2702437$ROCHE$$67$YR$E$M$Y$$$20240801$$CN$DE$DE
216977742$21697774$2$F$$20240821$20221208$20240828$PER$$US-ABBVIE-4226724$ABBVIE$$$$$M$Y$$$20240828$$MD$US$US
216978693$21697869$3$F$20210209$20230821$20221208$20240712$EXP$GB-MHRA-ADR 25787454$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-10953$ALKEM$$$$A$M$Y$94.2$KG$20240712$$MD$GB$GB
216978862$21697886$2$F$20191009$20230927$20221208$20240712$EXP$GB-MHRA-ADR 27285713$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-10091$ALKEM$$$$A$F$Y$82.9$KG$20240712$$MD$GB$GB
216978922$21697892$2$F$20180131$20231003$20221208$20240712$EXP$GB-MHRA-ADR 25623051$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-10312$ALKEM$$37$YR$$M$Y$82.2$KG$20240712$$MD$GB$GB
2169827418$21698274$18$F$20220524$20240819$20221208$20240831$EXP$$CA-UCBSA-2022031791$UCB$$50$YR$$F$Y$$$20240831$$CN$CA$CA
216983072$21698307$2$F$20221109$20240703$20221208$20240725$PER$$CA-TOLMAR, INC.-22CA037475$TOLMAR$$83$YR$$M$Y$$$20240724$$CN$CA$CA
2169833011$21698330$11$F$20221101$20240801$20221208$20240805$PER$$NVSC2022US282891$NOVARTIS$$31$YR$$M$Y$$$20240805$$CN$US$US
216985903$21698590$3$F$20220915$20240917$20221208$20240927$EXP$$FR-AUROBINDO-AUR-APL-2022-051686$AUROBINDO$$72$YR$$M$Y$$$20240927$$CN$FR$FR
216986562$21698656$2$F$$20221202$20221208$20240909$EXP$$NVSC2022PH283867$NOVARTIS$$$$$$Y$$$20240909$$CN$PH$PH
216990006$21699000$6$F$$20240814$20221208$20240906$PER$$AU-TOLMAR, INC.-22AU037489$TOLMAR$$$$$M$Y$$$20240906$$HP$AU$AU
216991492$21699149$2$F$20220822$20240626$20221208$20240708$EXP$IT-MINISAL02-892668$IT-Accord-289726$ACCORD$$16$YR$T$M$Y$$$20240708$$PH$IT$IT
216996545$21699654$5$F$20221114$20240906$20221208$20240911$EXP$$AU-TAKEDA-2022TUS091688$TAKEDA$$39$YR$$M$Y$$$20240911$$CN$AU$AU
2169974617$21699746$17$F$20240311$20240917$20221208$20240920$PER$$US-PFIZER INC-202200611506$PFIZER$$75$YR$$F$Y$102.09$KG$20240920$$MD$US$US
216997933$21699793$3$F$$20240715$20221208$20240718$EXP$$US-ABBVIE-4227877$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
216998523$21699852$3$F$$20240703$20221208$20240715$EXP$PL-EMA-DD-20221101-6644991-081210$PL-Accord-290287$ACCORD$Styczynski, T.. Double transformation of relapsing juvenile myelomonocytic leukemia to refractory acute myeloid leukemia. Acta Haematologica Polonica. 2022 53 4:295-297. doi 10.5603 AHP.A2022.0038$6$YR$C$M$Y$$$20240715$$HP$PL$PL
2169996418$21699964$18$F$20221224$20240910$20221208$20240916$EXP$$US-TAKEDA-2022TUS071968$TAKEDA$$61$YR$$F$Y$122$KG$20240916$$CN$US$US
217000605$21700060$5$F$20191025$20240611$20221208$20240709$EXP$$DE-ROCHE-2469863$ROCHE$$55$YR$A$M$Y$$$20240628$$CN$DE$DE
217002722$21700272$2$F$$20240917$20221208$20240919$EXP$$US-SA-2022SA498044$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240919$$MD$US$US
2170032815$21700328$15$F$20221230$20240705$20221208$20240710$EXP$$IN-PFIZER INC-2020166058$PFIZER$$75$YR$$F$Y$$$20240710$$CN$IN$IN
217009349$21700934$9$F$20221230$20240814$20221208$20240819$EXP$$CA-TAKEDA-2022TUS093588$TAKEDA$$36$YR$$M$Y$$$20240819$$MD$CA$CA
2170112610$21701126$10$F$$20240905$20221208$20240909$EXP$$US-PFIZER INC-PV202200118259$PFIZER$$75$YR$$F$Y$$$20240909$$CN$US$US
2170122811$21701228$11$F$20210517$20240814$20221208$20240820$EXP$$CA-TAKEDA-2022TUS094951$TAKEDA$$57$YR$$F$Y$$$20240820$$CN$CA$CA
217013085$21701308$5$F$20210519$20240911$20221208$20240916$EXP$$US-TAKEDA-US202033273$TAKEDA$$40$YR$$M$Y$43$KG$20240916$$CN$US$US
217013855$21701385$5$F$20191205$20240905$20221208$20240913$EXP$$DE-ROCHE-3235788$ROCHE$$43$YR$A$F$Y$84$KG$20240913$$CN$DE$DE
2170257815$21702578$15$F$20221128$20240124$20221208$20240926$EXP$$US-GSK-US2022AMR178552$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
217026414$21702641$4$F$20211201$20240710$20221209$20240715$EXP$$JP-TAKEDA-2022TJP078452$TAKEDA$$42$YR$$M$Y$59.4$KG$20240715$$MD$JP$JP
217029636$21702963$6$F$20210423$20240801$20221209$20240807$EXP$$CA-JNJFOC-20210508355$JOHNSON AND JOHNSON$$67$YR$E$F$Y$91$KG$20240807$$HP$CA$CA
217030307$21703030$7$F$20230425$20240621$20221209$20240702$PER$$US-ABBVIE-4193803$ABBVIE$$$$$F$Y$87$KG$20240702$$CN$US$US
217033486$21703348$6$F$$20240806$20221209$20240815$PER$$US-SA-2022SA500009$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240815$$MD$US$US
2170365413$21703654$13$F$$20240909$20221209$20240920$EXP$$CA-ORGANON-2011CAN012730$ORGANON$$44$YR$$F$Y$97$KG$20240920$$HP$CA$CA
2170366318$21703663$18$F$20220101$20240814$20221209$20240822$EXP$$CA-CELLTRION INC.-2022CA016753$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
217037577$21703757$7$F$$20240917$20221209$20240927$EXP$$JP-009507513-2212JPN000178J$MERCK$$60$YR$$F$Y$$$20240927$$MD$JP$JP
217037614$21703761$4$F$$20221228$20221209$20240925$PER$$US-GSK-US2022AMR184193$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$PH$US$US
217039974$21703997$4$F$$20240823$20221209$20240825$EXP$$CA-ROCHE-3233465$ROCHE$$45$YR$A$F$Y$46$KG$20240825$$HP$CA$CA
217043162$21704316$2$F$20220201$20221207$20221209$20240712$EXP$$BG-ASTELLAS-2022US043614$ASTELLAS$$72$YR$$M$Y$$$20240712$$MD$BG$BG
217047117$21704711$7$F$20240515$20240822$20221209$20240827$EXP$$US-TAKEDA-2022TUS073112$TAKEDA$$76$YR$$F$Y$$$20240827$$CN$US$US
217047563$21704756$3$F$20220101$20240829$20221209$20240906$30DAY$$US-GSK-US2022178645$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
2170493613$21704936$13$F$20240327$20240910$20221209$20240913$EXP$$CA-TAKEDA-2018TUS035572$TAKEDA$$69$YR$$M$Y$$$20240913$$HP$CA$CA
217054854$21705485$4$F$$20240906$20221209$20240912$EXP$$CA-TAKEDA-2021TUS082040$TAKEDA$$$$$M$Y$$$20240912$$HP$CA$CA
217056188$21705618$8$F$20220101$20240801$20221209$20240809$PER$$US-SA-2022SA500023$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240809$$MD$US$US
217057452$21705745$2$F$$20240916$20221209$20240923$EXP$$US-GSK-US2022AMR024215$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$US$US
217057536$21705753$6$F$20221202$20240806$20221209$20240813$EXP$$CA-GSK-CA2022AMR181779$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CA$CA
217057666$21705766$6$F$20221101$20240906$20221209$20240913$EXP$$CA-GSK-CA2022167102$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$CA$CA
217060615$21706061$5$F$20220930$20240829$20221209$20240905$EXP$$BR-TAKEDA-2022TUS071019$TAKEDA$$45$YR$$F$Y$$$20240905$$CN$BR$BR
217062762$21706276$2$F$$20240726$20221209$20240805$EXP$$US-VIIV HEALTHCARE LIMITED-US2022GSK178989$VIIV$$$$$$Y$$$20240805$$PH$US$US
217066192$21706619$2$F$$20221202$20221209$20240823$EXP$$US-AstraZeneca-2022A397599$ASTRAZENECA$$$$T$M$Y$$$20240823$$MD$US$
217070332$21707033$2$F$$20240725$20221209$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14133$LUPIN$$$$$$Y$$$20240813$$CN$US$US
217071129$21707112$9$F$20221104$20240701$20221209$20240704$EXP$$US-PFIZER INC-PV202200094368$PFIZER$$73$YR$$F$Y$75.283$KG$20240704$$CN$US$US
217072982$21707298$2$F$20240823$20240903$20221209$20240904$EXP$$US-KYOWAKIRIN-2022BKK018988$KYOWA$$$$$$Y$$$20240904$$HP$US$US
217074136$21707413$6$F$20230616$20240909$20221209$20240913$EXP$$CA-TAKEDA-2022TUS093824$TAKEDA$$26$YR$$F$Y$$$20240913$$MD$CA$CA
217075315$21707531$5$F$$20240821$20221209$20240823$EXP$$NVSC2022US286030$NOVARTIS$$$$$M$Y$$$20240823$$CN$US$US
2170781111$21707811$11$F$20171001$20240916$20221209$20240918$EXP$$CA-ORGANON-1904CAN006316$ORGANON$$65$YR$$F$Y$$$20240918$$MD$CA$CA
217081119$21708111$9$F$$20240913$20221209$20240919$EXP$$NVSC2022US285818$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
217081933$21708193$3$F$20221101$20240927$20221210$20240927$PER$$NVSC2022US286014$NOVARTIS$$23$YR$$M$Y$$$20240927$$CN$US$US
217082012$21708201$2$F$$20240712$20221210$20240801$PER$$US-SA-2022SA499873$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240719$$MD$US$US
217082334$21708233$4$F$20220329$20240828$20221210$20240905$EXP$$CA-CELLTRION INC.-2022CA001286$CELLTRION$$$$$$Y$$$20240905$$MD$CA$CA
217082425$21708242$5$F$$20240918$20221210$20240930$PER$$NVSC2022US285089$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
217085402$21708540$2$F$20221028$20221208$20221210$20240912$EXP$$NVSC2022US286401$NOVARTIS$$49$YR$$F$Y$$$20240912$$HP$US$US
217086345$21708634$5$F$20221207$20240816$20221210$20240823$EXP$$CO-TAKEDA-2022TUS095585$TAKEDA$$32$YR$$F$Y$41$KG$20240823$$CN$CO$CO
217087363$21708736$3$F$20220103$20240926$20221210$20240927$EXP$$FR-TAKEDA-2022TUS093069$TAKEDA$$70$YR$$M$Y$$$20240927$$HP$FR$FR
2170882019$21708820$19$F$20220101$20240801$20221210$20240808$EXP$$CA-CELLTRION INC.-2022CA004200$CELLTRION$$$$$$Y$$$20240808$$MD$CA$CA
217091874$21709187$4$F$20210101$20240808$20221210$20240814$EXP$$CA-CELLTRION INC.-2020CA035114$CELLTRION$$$$$$Y$$$20240814$$MD$CA$CA
217092974$21709297$4$F$$20240710$20221210$20240715$EXP$$US-AMGEN-USASP2022212275$AMGEN$$63$YR$A$F$Y$$$20240715$$HP$US$US
217103476$21710347$6$F$20221101$20240808$20221211$20240815$EXP$$US-ABBVIE-4231473$ABBVIE$$67$YR$$M$Y$$$20240815$$CN$US$US
217103596$21710359$6$F$20220929$20240820$20221211$20240827$EXP$$AU-CELLTRION INC.-2022AU020741$CELLTRION$$$$$$Y$$$20240827$$MD$AU$AU
217103702$21710370$2$F$$20240807$20221211$20240808$PER$$NVSC2022US286199$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
2171056112$21710561$12$F$20240714$20240924$20221212$20240930$EXP$$US-PAREXEL-2021-KAM-US003547$TAKEDA$$71$YR$$F$Y$71$KG$20240930$$HP$US$US
2171068810$21710688$10$F$20220801$20240826$20221212$20240829$EXP$$CA-ROCHE-3236244$ROCHE$$45$YR$A$F$Y$$$20240829$$CN$CA$CA
217111665$21711166$5$F$20240910$20240910$20221212$20240925$PER$$US-SA-2022SA500427$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240925$$MD$US$US
2171125516$21711255$16$F$20210927$20240910$20221212$20240919$EXP$$CA-ROCHE-2672399$ROCHE$$50$YR$A$M$Y$$$20240919$$CN$CA$CA
217113286$21711328$6$F$20221105$20240903$20221212$20240912$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-22-022964$AKEBIA THERAPEUTICS$$74$YR$$M$Y$62.3$KG$20240912$$MD$JP$JP
217113583$21711358$3$F$20221206$20240828$20221212$20240909$PER$$US-AMGEN-USASP2022212780$AMGEN$$11$YR$C$F$Y$$$20240908$$MD$US$US
217114807$21711480$7$F$20221201$20240628$20221212$20240705$PER$$US-BIOGEN-2022BI01173856$BIOGEN$$57$YR$$F$Y$$$20240705$$CN$US$US
217116053$21711605$3$F$20230112$20240723$20221212$20240807$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-366959$RANBAXY$$65$YR$E$M$Y$$$20240807$$CN$CA$CA
217117732$21711773$2$F$$20221207$20221212$20240913$EXP$$NVSC2022HU285797$NOVARTIS$$$$$$Y$$$20240913$$MD$HU$HU
217117795$21711779$5$F$$20240625$20221212$20240709$EXP$$IN-ROCHE-3235137$ROCHE$$67$YR$E$F$Y$$$20240709$$CN$IN$IN
217118093$21711809$3$F$20220101$20240712$20221212$20240717$EXP$$US-AMGEN-USASP2022212654$AMGEN$$50$YR$A$F$Y$$$20240717$$HP$US$US
217119783$21711978$3$F$$20240725$20221212$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14162$LUPIN$$$$$$Y$$$20240815$$PH$US$US
217120104$21712010$4$F$$20240919$20221212$20240930$EXP$$CA-ROCHE-3235418$ROCHE$$47$YR$A$F$Y$$$20240930$$CN$CA$CA
217121012$21712101$2$F$$20240725$20221212$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14175$LUPIN$$$$$$Y$$$20240815$$CN$US$US
217124163$21712416$3$F$$20240813$20221212$20240827$EXP$$CA-AUROBINDO-AUR-APL-2022-051393$AUROBINDO$$61$YR$$M$Y$76$KG$20240827$$HP$CA$CA
217125657$21712565$7$F$20220101$20240906$20221212$20240912$EXP$$CA-JNJFOC-20211146611$JOHNSON AND JOHNSON$$52$YR$A$F$Y$123.3$KG$20240912$$PH$CA$CA
217125952$21712595$2$F$$20240904$20221212$20240909$EXP$$US-TAKEDA-2021TUS002739$TAKEDA$$$$$F$Y$$$20240909$$CN$US$US
217126124$21712612$4$F$$20240801$20221212$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2022-148895$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$96$KG$20240814$$HP$CA$CA
217126575$21712657$5$F$20230302$20240920$20221212$20240925$EXP$$CA-TAKEDA-2022TUS094700$TAKEDA$$48$YR$$F$Y$$$20240925$$HP$CA$CA
217127596$21712759$6$F$20220101$20240730$20221212$20240808$PER$$US-SA-2022SA501772$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240808$$MD$US$US
217133692$21713369$2$F$$20240730$20221212$20240813$EXP$$US-RISINGPHARMA-US-2022RISLIT00520$RISING PHARMACEUTICALS$Maunoo Lee.Intravenous acetaminophen associated with acute liver failure.BMJ case reports.22-NOV-2022;15:e251305$7$DEC$A$F$Y$$$20240813$$HP$US$US
2171347516$21713475$16$F$20190110$20240918$20221212$20240925$EXP$$US-TAKEDA-2021TUS027945$TAKEDA$$53$YR$$F$Y$60$KG$20240925$$HP$US$US
217135837$21713583$7$F$20220101$20240731$20221212$20240731$EXP$$CA-PFIZER INC-202101565462$PFIZER$$69$YR$$M$Y$86$KG$20240731$$MD$CA$CA
217135887$21713588$7$F$20240318$20240923$20221212$20240926$EXP$$US-TAKEDA-US202032196$TAKEDA$$17$YR$$F$Y$$$20240926$$CN$US$US
217137004$21713700$4$F$$20240917$20221212$20240919$PER$$US-PFIZER INC-PV202200120868$PFIZER$$55$YR$$F$Y$$$20240919$$CN$US$US
217137063$21713706$3$F$20221129$20240829$20221212$20240904$EXP$$US-PFIZER INC-202201362812$PFIZER$$57$YR$$M$Y$$$20240904$$HP$US$US
217138139$21713813$9$F$20221012$20240714$20221212$20240715$EXP$$CA-PFIZER INC-202201087509$PFIZER$$30$YR$$F$Y$$$20240715$$HP$CA$CA
217138474$21713847$4$F$20180101$20240911$20221212$20240923$EXP$$CA-TAKEDA-2018TUS033182$TAKEDA$$$$$F$Y$$$20240923$$HP$CA$CA
217141085$21714108$5$F$20220101$20240903$20221212$20240905$PER$$US-BIOGEN-2022BI01174585$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
217142892$21714289$2$F$20220804$20240712$20221212$20240718$EXP$$BE-MYLANLABS-2022M1136846$BIOCON$$$$$$Y$$$20240718$$MD$BE$BE
2171432117$21714321$17$F$20190728$20240829$20221212$20240904$EXP$$US-TAKEDA-US201925323$TAKEDA$$77$YR$$F$Y$$$20240904$$HP$US$US
217143743$21714374$3$F$20221202$20240726$20221212$20240729$EXP$$JP-009507513-2212JPN000789J$MERCK$$82$YR$$F$Y$53$KG$20240729$$MD$JP$JP
217146042$21714604$2$F$20221111$20240826$20221212$20240829$EXP$$CA-ROCHE-3239693$ROCHE$$57$YR$A$M$Y$83$KG$20240829$$CN$CA$CA
217147992$21714799$2$F$20200501$20240731$20221212$20240809$PER$$US-SA-2022SA498776$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240809$$MD$US$US
217150645$21715064$5$F$20181211$20240905$20221212$20240912$EXP$$US-ABBVIE-22K-163-4517113-00$ABBVIE$$37$YR$$M$Y$68.038$KG$20240912$$CN$US$US
2171570412$21715704$12$F$$20240729$20221212$20240801$EXP$$US-PFIZER INC-PV202200120222$PFIZER$$83$YR$$M$Y$$$20240801$$CN$US$US
217158054$21715805$4$F$20190515$20240729$20221212$20240805$EXP$$JP-OTSUKA-2022_054324$OTSUKA$$47$YR$$M$Y$$$20240805$$MD$JP$JP
217182756$21718275$6$F$20221128$20240718$20221212$20240727$EXP$$US-JAZZ-2022-US-037206$JAZZ$$22$YR$$F$Y$$$20240727$$CN$US$US
217184007$21718400$7$F$20240529$20240729$20221212$20240806$EXP$$BR-CELLTRION INC.-2022BR020862$CELLTRION$$$$$$Y$$$20240806$$CN$BR$BR
217186389$21718638$9$F$20221125$20240711$20221213$20240730$PER$$CA-TOLMAR, INC.-22CA037821$TOLMAR$$71$YR$$M$Y$72.562$KG$20240729$$CN$CA$CA
217186395$21718639$5$F$20221128$20240611$20221213$20240718$PER$$CA-TOLMAR, INC.-22CA037822$TOLMAR$$76$YR$$M$Y$$$20240718$$CN$CA$CA
217188004$21718800$4$F$20221226$20240912$20221213$20240918$EXP$$US-ABBVIE-4233041$ABBVIE$$83$YR$$F$Y$$$20240918$$CN$US$US
217188983$21718898$3$F$$20240731$20221213$20240814$PER$$US-SA-2022SA502493$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
217190232$21719023$2$F$$20240606$20221213$20240919$PER$$US-ALVOGEN-2022088531$ALVOGEN$$$$$$Y$$$20240919$$CN$US$US
217194232$21719423$2$F$$20240814$20221213$20240820$EXP$$FR-Orion Corporation ORION PHARMA-TREX2022-0321$ORION$Dubois M, Morel G. Meningoradiculitis due to varicella zoster virus reactivation in a patient treated with ixekizumab. Ann-Dermatol- Venereol. 2020;147(10):667-71.$51$YR$A$F$Y$$$20240820$$MD$FR$
2171943516$21719435$16$F$20190523$20240626$20221213$20240708$PER$$US-ROCHE-3232005$ROCHE$$65$YR$E$F$Y$97.52$KG$20240708$$LW$US$US
217195826$21719582$6$F$20221206$20240827$20221213$20240830$EXP$$BG-ROCHE-3236712$ROCHE$$69$YR$E$M$Y$72$KG$20240830$$MD$BG$BG
217197914$21719791$4$F$20221001$20240612$20221213$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004037$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240705$$CN$US$US
217198905$21719890$5$F$20220101$20240925$20221213$20240930$EXP$$SE-TAKEDA-2022TUS095251$TAKEDA$$$$$M$Y$$$20240930$$HP$SE$SE
217200952$21720095$2$F$20220301$20240702$20221213$20240709$EXP$$DE-AMGEN-DEUSP2022214639$AMGEN$$14$YR$T$M$Y$66$KG$20240708$$MD$DE$DE
217203137$21720313$7$F$20221201$20230607$20221213$20240926$EXP$$US-GSK-US2022AMR184378$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
217205573$21720557$3$F$20211201$20240916$20221213$20240926$EXP$$PL-AUROBINDO-AUR-APL-2022-052630$AUROBINDO$Korzeniowska K., Malesza K., Miciak-Lawicka E., Jablecka A et. al. Hyperkalemia and renal dysfunction aftersimultaneous the use of sacubitril, valsartan and dapagliflozin- case report and litareture review. GERIATRICS.. 2022;3:171-178$91$YR$$F$Y$$$20240926$$MD$PL$PL
217205853$21720585$3$F$20220901$20240802$20221213$20240809$EXP$$US-SA-2022SA503810$SANOFI AVENTIS$$69$YR$E$M$Y$72.5$KG$20240809$$MD$US$US
217208943$21720894$3$F$20220901$20240625$20221213$20240715$EXP$$DE-ROCHE-3239607$ROCHE$$55$YR$A$M$Y$100$KG$20240715$$MD$DE$DE
217210522$21721052$2$F$20221001$20240704$20221213$20240707$EXP$FR-AFSSAPS-PS20222442$FR-ROCHE-3235618$ROCHE$$68$YR$E$F$Y$56$KG$20240707$$MD$FR$FR
217211842$21721184$2$F$20160101$20221206$20221213$20240830$EXP$$NVSC2022MX275350$NOVARTIS$$$$$F$Y$45$KG$20240830$$CN$MX$MX
217212533$21721253$3$F$20240601$20240731$20221213$20240812$PER$$US-SA-2022SA502830$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240812$$MD$US$US
217213147$21721314$7$F$20220101$20240904$20221213$20240911$EXP$$US-GSK-US2020TSO013870$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$MD$US$US
217213635$21721363$5$F$20220101$20240722$20221213$20240726$EXP$$US-SA-2022SA503395$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240726$$MD$US$US
217214592$21721459$2$F$20220201$20221210$20221213$20240716$EXP$$RO-ASTELLAS-2022US044073$ASTELLAS$$58$YR$$M$Y$$$20240716$$MD$RO$RO
217215432$21721543$2$F$$20240916$20221213$20240925$EXP$$FR-NOVITIUMPHARMA-2022FRNVP00346$NOVITIUM PHARMA$Jonathan Toutain.Severe Vaso-Occlusive and Ocular Decompression Retinopathy Revealing a Sickle Cell Trait in a Patient with Herpetic Uveitis.Ocular Immunology and Inflammation.28-NOV-2022;NA:1-4$24$YR$A$M$Y$$$20240925$$HP$FR$FR
217219595$21721959$5$F$$20240902$20221213$20240905$EXP$$JP-PFIZER INC-202201349984$PFIZER$Itagaki, T.. Two Cases of Therapy-Related Myeloid Neoplasms after Docetaxel with Cyclophosphamide Therapy for Breast Cancer. Gan to Kagaku Ryoho [Japanese Journal of Cancer + Chemotherapy]. 2022;49 (11):1263-1266$71$YR$$F$Y$$$20240905$$HP$JP$JP
217219655$21721965$5$F$20221125$20240709$20221213$20240715$EXP$$US-ABBVIE-4232830$ABBVIE$$66$YR$$F$Y$70$KG$20240715$$CN$US$US
217219913$21721991$3$F$20200101$20240826$20221213$20240903$EXP$$CA-ANIPHARMA-2021-CA-001847$ANI$$77$YR$$M$Y$$$20240903$$CN$CA$CA
2172234014$21722340$14$F$20210601$20240827$20221213$20240902$EXP$$US-PFIZER INC-PV202200120421$PFIZER$$75$YR$$F$Y$76.2$KG$20240902$$CN$US$US
217227417$21722741$7$F$20211201$20240708$20221213$20240715$EXP$$CA-TAKEDA-2022TUS096310$TAKEDA$$67$YR$$F$Y$62$KG$20240715$$MD$CA$CA
217228524$21722852$4$F$$20240726$20221213$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14226$LUPIN$$$$$$Y$$$20240815$$CN$US$US
217232453$21723245$3$F$20221205$20240730$20221213$20240802$EXP$$CA-TAKEDA-CA202006053$TAKEDA$$28$YR$$F$Y$$$20240802$$CN$CA$CA
217232596$21723259$6$F$$20240815$20221213$20240819$PER$$NVSC2022US288873$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
217232994$21723299$4$F$20221019$20240705$20221213$20240708$EXP$$JP-DSJP-DSJ-2022-143611$DAIICHI$$64$YR$$M$Y$65$KG$20240708$$MD$JP$JP
217235293$21723529$3$F$$20240814$20221213$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-150046$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240822$$HP$US$US
217241974$21724197$4$F$$20240904$20221213$20240930$PER$$US-SA-2022SA503313$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240930$$MD$US$US
217242224$21724222$4$F$20210101$20240801$20221213$20240806$EXP$$US-BIOGEN-2022BI01172705$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
217252902$21725290$2$F$20221111$20240809$20221214$20240815$EXP$$BR-CELLTRION INC.-2022BR020916$CELLTRION$$$$$$Y$$$20240815$$HP$BR$BR
217254572$21725457$2$F$$20221202$20221214$20240701$EXP$$ES-NOVOPROD-988572$NOVO NORDISK$Carrasco exposito. Emicizumab for the treatment of acquired haemophilia after failure of several lines and severe haemorrhagic complication. XXXVIII National congress of the spanish society of thrombosis and haemostasis$76$YR$$F$Y$$$20240701$$MD$ES$ES
217255883$21725588$3$F$20211001$20240702$20221214$20240704$EXP$$NVSC2022GB004743$NOVARTIS$$$$E$F$Y$$$20240704$$HP$GB$GB
217258773$21725877$3$F$$20240726$20221214$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14270$LUPIN$$$$$$Y$$$20240815$$CN$US$US
2172630810$21726308$10$F$20230123$20240911$20221214$20240913$PER$$NVSC2022US288631$NOVARTIS$$50$YR$$M$Y$$$20240913$$CN$US$US
217266212$21726621$2$F$20220101$20240731$20221214$20240809$PER$$US-SA-2022SA504794$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
217266378$21726637$8$F$20220101$20240827$20221214$20240829$PER$$US-SA-2022SA505480$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240829$$MD$US$US
217266412$21726641$2$F$$20240729$20221214$20240808$PER$$US-SA-2022SA505277$SANOFI AVENTIS$$$$C$M$Y$$$20240808$$MD$US$US
217272175$21727217$5$F$$20221221$20221214$20240711$PER$$JP-PFM-2022-08691$PIERRE FABRE MEDICAMENT$Ogawa T. Oral propranolol treatment in infantile hemangioma - Cooperation between dermatology and pediatrics$4$MON$$M$Y$$$20240711$$HP$JP$JP
217274024$21727402$4$F$20191203$20240806$20221214$20240812$EXP$$CA-TAKEDA-2019TUS069329$TAKEDA$$74$YR$$F$Y$$$20240812$$CN$CA$CA
217276295$21727629$5$F$20220307$20240805$20221214$20240819$EXP$$FR-SERVIER-S22012430$SERVIER$$$$$$Y$$$20240819$$MD$FR$FR
2172790415$21727904$15$F$20230317$20240917$20221214$20240924$EXP$$AU-TAKEDA-2022TUS095293$TAKEDA$$64$YR$$M$Y$$$20240924$$HP$AU$AU
217281873$21728187$3$F$$20240823$20221214$20240828$EXP$$US-TAKEDA-2022TUS095297$TAKEDA$$$$$F$Y$$$20240828$$CN$US$US
217287059$21728705$9$F$20221212$20240827$20221214$20240829$EXP$$US-TAKEDA-2022TUS094822$TAKEDA$$0$YR$$M$Y$$$20240829$$PH$US$US
217287353$21728735$3$F$20221001$20240702$20221214$20240706$EXP$$US-ABBVIE-4196300$ABBVIE$$74$YR$$F$Y$$$20240706$$CN$US$US
217288348$21728834$8$F$20220414$20240801$20221214$20240807$EXP$$IN-PFIZER INC-202101022363$PFIZER$$65$YR$$F$Y$67$KG$20240807$$CN$IN$IN
2172901310$21729013$10$F$20210714$20240913$20221214$20240917$PER$$US-BIOGEN-2022BI01167229$BIOGEN$$56$YR$$F$Y$$$20240917$$CN$US$US
217291956$21729195$6$F$20200201$20240807$20221214$20240811$EXP$$DE-ROCHE-2586448$ROCHE$$41$YR$A$F$Y$$$20240811$$CN$DE$DE
217293949$21729394$9$F$20210702$20240909$20221214$20240910$EXP$$US-TAKEDA-US202028733$TAKEDA$$33$YR$$F$Y$$$20240910$$HP$US$US
217294423$21729442$3$F$$20240705$20221214$20240709$EXP$$US-PFIZER INC-PV202200123040$PFIZER$$77$YR$$M$Y$$$20240709$$CN$US$US
217295587$21729558$7$F$$20240821$20221214$20240823$EXP$$US-PFIZER INC-PV202200122065$PFIZER$$70$YR$$F$Y$77.098$KG$20240823$$CN$US$US
217301042$21730104$2$F$$20240904$20221214$20240912$PER$$US-SA-2022SA506852$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240912$$MD$US$US
2173013814$21730138$14$F$20230304$20240910$20221214$20240919$EXP$$US-BEH-2022152950$CSL BEHRING$$9$YR$C$M$Y$$$20240919$$HP$US$US
217301784$21730178$4$F$20221120$20230403$20221214$20240918$PER$$US-ROCHE-3234946$ROCHE$$12$YR$T$M$Y$$$20240918$$CN$US$US
217304983$21730498$3$F$$20240702$20221215$20240724$PER$$CA-TOLMAR, INC.-22CA037885$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
217305142$21730514$2$F$$20221212$20221215$20240925$PER$$US-GSK-US2022AMR186530$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
217305913$21730591$3$F$20191026$20240828$20221215$20240910$PER$$US-SA-2022SA506790$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240910$$MD$US$US
217306854$21730685$4$F$20230101$20240705$20221215$20240715$PER$$US-SA-2022SA505341$SANOFI AVENTIS$$53$YR$A$F$Y$95$KG$20240715$$MD$US$US
217308489$21730848$9$F$$20240910$20221215$20240914$EXP$$CA-ROCHE-3242869$ROCHE$$$$A$F$Y$$$20240914$$CN$CA$CA
217308686$21730868$6$F$20230101$20240709$20221215$20240716$EXP$$US-ABBVIE-4200656$ABBVIE$$67$YR$$F$Y$54$KG$20240716$$CN$US$US
217312014$21731201$4$F$20240517$20240718$20221215$20240727$EXP$$US-ABBVIE-4236446$ABBVIE$$79$YR$$M$Y$$$20240727$$MD$US$US
217314253$21731425$3$F$$20240725$20221215$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14263$LUPIN$$$$$$Y$$$20240813$$CN$US$US
217316112$21731611$2$F$$20221207$20221215$20240923$EXP$$NVSC2022DK286509$NOVARTIS$$$$$$Y$$$20240923$$MD$DK$DK
2173176117$21731761$17$F$20220101$20240816$20221215$20240826$EXP$$CA-CELLTRION INC.-2022CA021037$CELLTRION$$$$$$Y$$$20240826$$CN$CA$CA
217318899$21731889$9$F$20221201$20231208$20221215$20240925$PER$$US-GSK-US2022AMR186241$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
2173198011$21731980$11$F$20221201$20240304$20221215$20240926$PER$$US-GSK-US2022AMR185947$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240926$$CN$US$US
217320232$21732023$2$F$$20221209$20221215$20240712$EXP$$PL-ASTELLAS-2022US044393$ASTELLAS$$$$$M$Y$$$20240712$$PH$PL$PL
217322644$21732264$4$F$$20230711$20221215$20240925$EXP$$US-TAKEDA-2022TUS095429$TAKEDA$$$$$F$Y$$$20240925$$MD$US$US
217325173$21732517$3$F$$20240913$20221215$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-368867$RANBAXY$Toutain J, Fares S, Cochereau I, Gargouri MA, Titah C. Severe Vaso-Occlusive and Ocular Decompression Retinopathy Revealing a Sickle Cell Trait in a Patient with Herpetic Uveitis. Ocul Immunol Inflamm. 2024;Nov 28;32 (6):1079-1082$24$YR$$M$Y$$$20240927$$MD$FR$FR
217326428$21732642$8$F$20210601$20240909$20221215$20240913$EXP$$CO-TAKEDA-2021TUS038815$TAKEDA$$39$YR$$M$Y$84$KG$20240913$$CN$CO$CO
217328972$21732897$2$F$$20240815$20221215$20240822$EXP$$GB-JNJFOC-20220914334$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$GB$GB
217329623$21732962$3$F$$20240809$20221215$20240816$PER$$US-SA-2022SA506966$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240816$$MD$US$US
217330843$21733084$3$F$$20240717$20221215$20240726$PER$$US-SA-2022SA505272$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240726$$MD$US$US
217333256$21733325$6$F$20221130$20240801$20221215$20240808$EXP$$CA-CELLTRION INC.-2022CA020790$CELLTRION$$$$$$Y$$$20240808$$CN$CA$CA
217334013$21733401$3$F$$20240730$20221215$20240802$EXP$$ES-MYLANLABS-2022M1138304$MYLAN$$75$YR$$M$Y$$$20240802$$MD$ES$ES
217337894$21733789$4$F$20221203$20240909$20221215$20240916$EXP$$CA-TAKEDA-2021TUS012788$TAKEDA$$29$YR$$F$Y$$$20240916$$MD$CA$CA
217340144$21734014$4$F$20220210$20240719$20221215$20240729$EXP$$DE-PUMA BIOTECHNOLOGY, INC.-2022-PUM-DE000385$PUMA$$$$$$Y$$$20240729$$HP$DE$DE
217342874$21734287$4$F$$20240903$20221215$20240912$PER$$US-SA-2022SA506844$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$MD$US$US
217344558$21734455$8$F$$20240820$20221215$20240823$EXP$$US-TAKEDA-2022TUS074023$TAKEDA$$$$$F$Y$70.3$KG$20240823$$CN$US$US
217346015$21734601$5$F$$20240723$20221215$20240729$EXP$$US-ABBVIE-4237978$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
2173493412$21734934$12$F$20220101$20240902$20221215$20240905$EXP$$IN-PFIZER INC-PV202200122718$PFIZER$$66$YR$$F$Y$$$20240905$$CN$IN$IN
2173503210$21735032$10$F$$20240628$20221215$20240702$EXP$$US-PFIZER INC-PV202200103526$PFIZER$$76$YR$$F$Y$$$20240702$$CN$US$US
217351723$21735172$3$F$20201101$20240805$20221215$20240813$EXP$FR-AFSSAPS-AM20222440$FR-TEVA-2022-FR-2835488$TEVA$$73$YR$$F$Y$79$KG$20240813$$MD$FR$FR
217353528$21735352$8$F$20231226$20240717$20221215$20240722$EXP$$CA-ROCHE-3240799$ROCHE$$37$YR$A$M$Y$$$20240722$$MD$CA$CA
2173572611$21735726$11$F$20221209$20240919$20221215$20240925$EXP$$CO-TAKEDA-2022TUS096810$TAKEDA$$32$YR$$F$Y$60$KG$20240925$$CN$CO$CO
217357864$21735786$4$F$20230101$20240918$20221215$20240924$EXP$$US-ABBVIE-4234247$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
217360046$21736004$6$F$$20240819$20221215$20240903$EXP$$CA-CIPHER-2022-CA-000863$CIPHER$$41$YR$A$F$Y$$$20240903$$HP$CA$CA
217361696$21736169$6$F$20220101$20240624$20221215$20240701$EXP$$DE-CELLTRION INC.-2022DE020873$CELLTRION$$$$$$Y$$$20240701$$MD$DE$DE
2173617814$21736178$14$F$20220707$20240726$20221215$20240805$EXP$$CA-CELLTRION INC.-2022CA011864$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
2173637810$21736378$10$F$20211207$20240716$20221215$20240924$EXP$$JP-TAKEDA-2022TJP060888$TAKEDA$$55$YR$$F$Y$34$KG$20240924$$HP$JP$JP
217367835$21736783$5$F$$20240701$20221216$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-151010$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240709$$MD$JP$JP
2173715119$21737151$19$F$20221201$20240206$20221216$20240926$EXP$$US-GSK-US2022AMR186245$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
2173729319$21737293$19$F$20230101$20240918$20221216$20240926$EXP$$US-TAKEDA-2022TUS093551$TAKEDA$$62$YR$$M$Y$73$KG$20240926$$HP$US$US
217376716$21737671$6$F$20200101$20240813$20221216$20240823$EXP$$FR-AUROBINDO-AUR-APL-2022-052646$AUROBINDO$Boignard A, Augier C, Kheng M, Epaulard O, Germi R.. Letermovir use to treat complex cytomegalovirus reactivations in two heart transplant recipients.. Antiviral Therapy.. 2022;27(6):1-5$50$YR$$F$Y$$$20240823$$HP$FR$FR
217377413$21737741$3$F$20200401$20240726$20221216$20240807$EXP$$DE-AUROBINDO-AUR-APL-2021-011797$AUROBINDO$$$$E$F$Y$54$KG$20240807$$MD$DE$DE
217377515$21737751$5$F$$20240820$20221216$20240830$EXP$$CA-AUROBINDO-AUR-APL-2022-052277$AUROBINDO$PRIVACY P, Khayyam A, Auer R, Robinson C, Rajput A. Evolving resting head tremor in parkinsonism. Clinicopathological study of a case. Parkinsonism and Related Disorders. 2021;86:1-4$77$YR$$M$Y$$$20240830$$HP$CA$CA
217380996$21738099$6$F$20220701$20240812$20221216$20240820$EXP$$US-ABBVIE-4236225$ABBVIE$$66$YR$$M$Y$74.842$KG$20240820$$CN$US$US
217387367$21738736$7$F$20190522$20240821$20221216$20240822$EXP$$DE-ROCHE-2393454$ROCHE$$63$YR$A$F$Y$$$20240822$$CN$DE$DE
217388523$21738852$3$F$$20240723$20221216$20240805$EXP$$US-CIPLA LTD.-2022US07155$CIPLA$Kilcrease C, Agwu AL, Yusuf H, Park J, Powell A, James L et al.. Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series. AIDS Research and Therapy. 2022;19 (56):1 to 6$$$$$Y$$$20240805$$HP$US$US
217389972$21738997$2$F$$20240725$20221216$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14361$LUPIN$$$$$$Y$$$20240813$$CN$US$US
217393228$21739322$8$F$$20240708$20221216$20240709$PER$$US-PFIZER INC-PV202200121849$PFIZER$$74$YR$$F$Y$66.667$KG$20240709$$CN$US$US
217393634$21739363$4$F$$20240910$20221216$20240918$EXP$$CA-ROCHE-3243656$ROCHE$$59$YR$A$M$Y$$$20240918$$HP$CA$CA
217393692$21739369$2$F$$20240813$20221216$20240826$EXP$$CA-AUROBINDO-AUR-APL-2022-052113$AUROBINDO$$$$$F$Y$$$20240826$$HP$CA$CA
217399613$21739961$3$F$20221108$20240716$20221216$20240723$EXP$$US-GSK-US2022183510$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
217400152$21740015$2$F$$20240729$20221216$20240802$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2022-082529$REGENERON$$$$$M$Y$$$20240802$$CN$US$US
217404872$21740487$2$F$$20240806$20221216$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14342$LUPIN$$$$$$Y$$$20240822$$CN$US$US
217408749$21740874$9$F$20220926$20240801$20221216$20240805$EXP$$US-UCBSA-2022060943$UCB$$2$YR$$M$Y$$$20240805$$CN$US$US
217409203$21740920$3$F$20180507$20240814$20221216$20240821$EXP$$BR-TAKEDA-2018TUS020021$TAKEDA$$34$YR$$F$Y$$$20240821$$CN$BR$BR
217409607$21740960$7$F$20210519$20240628$20221216$20240702$EXP$$DE-PFIZER INC-202201365786$PFIZER$$$$A$M$Y$$$20240702$$MD$DE$DE
217409772$21740977$2$F$$20221208$20221216$20240806$EXP$$FR-RECORDATI-2022006629$RECORDATI$Dormoy A, Haissaguerre M, Vitellius G, Cao CD, Geslot A, Drui D, et.al. Efficacy and safety of osilodrostat in paraneoplastic Cushing^s syndrome: a real-world multicenter study in France. Oxford University Press on behalf of the Endocrine Society. 2022;1-35$$$$$Y$$$20240806$$HP$FR$FR
2174101710$21741017$10$F$20221206$20240908$20221216$20240918$PER$$US-INCYTE CORPORATION-2022IN011994$INCYTE$$$$$$Y$$$20240918$$CN$US$US
217411835$21741183$5$F$20220719$20240902$20221216$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-116523$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240910$$MD$JP$JP
217412805$21741280$5$F$$20240925$20221216$20240930$EXP$$US-PFIZER INC-202200296303$PFIZER$$80$YR$$M$Y$77.11$KG$20240930$$CN$US$US
217416872$21741687$2$F$20200723$20240726$20221216$20240801$EXP$$DE-MYLANLABS-2022M1139386$MYLAN$$$$E$F$Y$73$KG$20240801$$HP$DE$DE
217423103$21742310$3$F$$20240910$20221216$20240918$EXP$$AU-BAUSCHBL-BL-2022-009787$BAUSCH AND LOMB$Ennis S, Plit M, Malouf M. Epstein-Barr virus associated smooth muscle neoplasm postlung transplantation. Transplant Infectious Disease. 2022;24 (1):1-2. doi:10.1111/tid.13756$43$YR$$F$Y$$$20240918$$HP$AU$AU
2174248817$21742488$17$F$20210101$20240829$20221216$20240907$EXP$$CA-CELLTRION INC.-2021CA016745$CELLTRION$$$$$$Y$$$20240907$$MD$CA$CA
2174269012$21742690$12$F$20220101$20240909$20221217$20240917$EXP$$CA-CELLTRION INC.-2022CA005499$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
2174278618$21742786$18$F$20221201$20240719$20221217$20240729$EXP$$CA-CELLTRION INC.-2022CA021274$CELLTRION$$$$$$Y$$$20240729$$HP$CA$CA
2174335611$21743356$11$F$20220101$20240911$20221217$20240919$EXP$$CA-CELLTRION INC.-2022CA001392$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
217434284$21743428$4$F$$20240730$20221217$20240801$PER$$NVSC2022US289714$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
217439876$21743987$6$F$20221017$20240710$20221217$20240715$EXP$$AU-TAKEDA-2022TUS056231$TAKEDA$$36$YR$$F$Y$$$20240715$$HP$AU$AU
217440142$21744014$2$F$$20221208$20221217$20240715$EXP$$GR-ASTELLAS-2022US043908$ASTELLAS$$35$YR$$F$Y$$$20240715$$MD$GR$GR
217445152$21744515$2$F$20221201$20240911$20221218$20240917$EXP$$US-BEH-2022153133$CSL BEHRING$$29$YR$A$F$Y$$$20240917$$HP$US$US
2174453426$21744534$26$F$20220402$20240907$20221218$20240917$EXP$$CA-CELLTRION INC.-2022CA006651$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
217446063$21744606$3$F$20221209$20240822$20221218$20240823$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000588$PAREXEL$$$$$$Y$$$20240823$$CN$US$US
217449519$21744951$9$F$20221201$20230601$20221219$20240925$PER$$US-GSK-US2022AMR187319$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
2174497119$21744971$19$F$20190319$20240805$20221219$20240813$EXP$$CA-ROCHE-2384958$ROCHE$$70$YR$E$F$Y$$$20240813$$CN$CA$CA
2174502815$21745028$15$F$20220101$20240821$20221219$20240829$EXP$$CA-CELLTRION INC.-2022CA006206$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
217451742$21745174$2$F$20221016$20240625$20221219$20240715$PER$$CA-TOLMAR, INC.-22CA037845$TOLMAR$$83$YR$$M$Y$$$20240715$$CN$CA$CA
217451766$21745176$6$F$20221203$20240614$20221219$20240702$PER$$CA-TOLMAR, INC.-22CA037891$TOLMAR$$77$YR$$M$Y$$$20240702$$CN$CA$CA
217455586$21745558$6$F$$20240801$20221219$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2022-155037$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$97$KG$20240813$$HP$CA$CA
217456135$21745613$5$F$20220313$20240829$20221219$20240830$EXP$$JP-TAKEDA-2022TJP079092$TAKEDA$$2$YR$$F$Y$10.2$KG$20240830$$MD$JP$JP
217457022$21745702$2$F$$20240729$20221219$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-154535$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240801$$CN$US$US
217457682$21745768$2$F$20220701$20240625$20221219$20240703$30DAY$$US-GSK-US2022185033$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240703$$CN$US$US
217460143$21746014$3$F$20220101$20240729$20221219$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14377$LUPIN$$$$$$Y$$$20240815$$CN$US$US
217462033$21746203$3$F$$20240711$20221219$20240715$EXP$$US-BIOGEN-2022BI01176238$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
217463092$21746309$2$F$20221124$20240703$20221219$20240705$EXP$$CA-BIOGEN-2022BI01175778$BIOGEN$$60$YR$$F$Y$$$20240705$$CN$CA$CA
217464372$21746437$2$F$$20240725$20221219$20240731$EXP$$CA-TAKEDA-2022TUS095138$TAKEDA$$$$$M$Y$$$20240731$$CN$CA$CA
217465284$21746528$4$F$20221205$20240820$20221219$20240821$EXP$$FR-TAKEDA-2022TUS098171$TAKEDA$$55$YR$$M$Y$$$20240821$$HP$FR$FR
2174664222$21746642$22$F$20240401$20240717$20221219$20240809$EXP$$NVSC2022BR291046$NOVARTIS$$67$YR$$F$Y$61$KG$20240809$$CN$BR$BR
217467116$21746711$6$F$20230308$20240918$20221219$20240923$EXP$$CA-TAKEDA-2022TUS096812$TAKEDA$$76$YR$$M$Y$$$20240923$$MD$CA$CA
217468722$21746872$2$F$$20240625$20221219$20240702$PER$$US-SA-2022SA510047$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240702$$MD$US$US
217468762$21746876$2$F$$20240712$20221219$20240801$PER$$US-SA-2022SA508451$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240719$$MD$US$US
217469184$21746918$4$F$20201101$20240709$20221219$20240718$PER$$US-SA-2022SA509930$SANOFI AVENTIS$$53$YR$A$M$Y$107.95$KG$20240718$$MD$US$US
217469972$21746997$2$F$$20240729$20221219$20240806$PER$$US-SA-2022SA509844$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240806$$MD$US$US
217473142$21747314$2$F$20220101$20240905$20221219$20240914$PER$$US-ABBVIE-4202241$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
217474116$21747411$6$F$20220809$20230914$20221219$20240925$EXP$$US-GSK-US2021AMR219134$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
217475612$21747561$2$F$$20240917$20221219$20240923$EXP$$CA-TAKEDA-2022TUS096745$TAKEDA$$$$$F$Y$$$20240923$$CN$CA$CA
217475647$21747564$7$F$$20240906$20221219$20240911$EXP$$PK-AMGEN-PAKSP2020213652$AMGEN$$22$YR$A$F$Y$50$KG$20240911$$CN$PK$PK
217476913$21747691$3$F$20240907$20240907$20221219$20240910$30DAY$$US-VIIV HEALTHCARE LIMITED-US2022AMR185724$VIIV$$30$YR$$M$Y$$$20240910$$CN$US$US
217478874$21747887$4$F$$20240814$20221219$20240820$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2022-146105$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$120$KG$20240820$$CN$DE$DE
217479637$21747963$7$F$20220501$20240717$20221219$20240727$30DAY$$US-VIIV HEALTHCARE LIMITED-US2022AMR185734$VIIV$$53$YR$$M$Y$$$20240727$$MD$US$US
217480897$21748089$7$F$$20240715$20221219$20240723$PER$$US-SA-2022SA508718$SANOFI AVENTIS$$$$E$F$Y$$$20240723$$MD$US$US
217481122$21748112$2$F$$20240829$20221219$20240904$EXP$$TW-PFIZER INC-PV202200124177$PFIZER$$$$$F$Y$$$20240904$$CN$TW$TW
217482187$21748218$7$F$20230215$20230717$20221219$20240830$PER$$NVSC2022US292711$NOVARTIS$$44$YR$$F$Y$$$20240830$$CN$US$US
217483169$21748316$9$F$20210504$20240921$20221219$20240923$EXP$$CA-PFIZER INC-2021354576$PFIZER$$64$YR$$M$Y$$$20240923$$MD$CA$CA
2174837610$21748376$10$F$$20240811$20221219$20240813$PER$$US-PFIZER INC-2020492677$PFIZER$$85$YR$$F$Y$49.887$KG$20240813$$CN$US$US
2174841617$21748416$17$F$20221204$20240701$20221219$20240702$EXP$$US-TAKEDA-2022TUS096507$TAKEDA$$27$YR$$M$Y$$$20240702$$HP$US$US
217489994$21748999$4$F$20221110$20240918$20221219$20240924$EXP$$US-TAKEDA-2022TUS093556$TAKEDA$$13$YR$$M$Y$$$20240924$$CN$US$US
217492362$21749236$2$F$$20240718$20221219$20240728$PER$$US-SA-2022SA510201$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240728$$MD$US$US
2174964712$21749647$12$F$$20240829$20221219$20240904$EXP$$US-PAREXEL-2021-KAM-US003610$TAKEDA$$$$$F$Y$63$KG$20240904$$MD$US$US
217500462$21750046$2$F$20220814$20240920$20221219$20240924$EXP$FR-AFSSAPS-AN20222554$FR-BAUSCH-BL-2022-027561$BAUSCH AND LOMB$$34$YR$$F$Y$78.9$KG$20240924$$PH$FR$FR
217507944$21750794$4$F$20220626$20240827$20221219$20240830$EXP$$US-ABBVIE-4241644$ABBVIE$$77$YR$$F$Y$76$KG$20240830$$CN$US$US
217511212$21751121$2$F$20221204$20240710$20221220$20240712$EXP$$US-GBT-018670$PFIZER$$50$YR$$F$Y$$$20240712$$CN$US$US
217512483$21751248$3$F$20221207$20240725$20221220$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14363$LUPIN$$$$$$Y$$$20240815$$CN$US$US
217513383$21751338$3$F$$20240725$20221220$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14391$LUPIN$$$$$$Y$$$20240813$$CN$US$US
2175140714$21751407$14$F$20221201$20240621$20221220$20240926$EXP$$US-GSK-US2022AMR187250$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
217514412$21751441$2$F$$20240807$20221220$20240813$EXP$$US-ABBVIE-4242150$ABBVIE$$$$$F$Y$$$20240813$$MD$US$US
217514642$21751464$2$F$20240801$20240903$20221220$20240912$PER$$US-SA-2022SA510856$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240912$$MD$US$US
217518368$21751836$8$F$$20240715$20221220$20240719$PER$$NVSC2022US293108$NOVARTIS$$$$$M$Y$$$20240719$$CN$US$US
2175199010$21751990$10$F$$20240925$20221220$20240927$EXP$$CA-JNJFOC-20221229613$JOHNSON AND JOHNSON$$78$YR$E$F$Y$93$KG$20240927$$CN$CA$CA
217520538$21752053$8$F$20220101$20240628$20221220$20240703$EXP$$JP-009507513-2212JPN001909J$MERCK$Motoshima T, Manabe S, Kurahashi T, Murakami H, Yatsuda S, Yoshii D, et al.. ICCJ2-6 A case of fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC)successfully treated with pembrolizumab and lenvatinib. The 61st Annual Meeting of Japan Society of Clinical Oncology. 2023;206$54$YR$$M$Y$$$20240703$$MD$JP$JP
217520834$21752083$4$F$20221201$20240726$20221220$20240801$EXP$$JP-009507513-2212JPN001926J$MERCK$$72$YR$$M$Y$$$20240801$$MD$JP$JP
217522063$21752206$3$F$20221116$20240911$20221220$20240919$EXP$$BR-CELLTRION INC.-2022BR020915$CELLTRION$$$$$$Y$$$20240919$$CN$BR$BR
2175234315$21752343$15$F$20210101$20240823$20221220$20240902$EXP$$CA-CELLTRION INC.-2021CA018073$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
217523682$21752368$2$F$$20240805$20221220$20240814$EXP$$CA-BAXTER-2022BAX030790$BAXTER$$52$YR$$M$Y$$$20240814$$HP$CA$CA
2175279912$21752799$12$F$$20240916$20221220$20240923$EXP$$US-TAKEDA-2021TUS046872$TAKEDA$$$$$F$Y$45$KG$20240923$$MD$US$US
217530963$21753096$3$F$20240101$20240806$20221220$20240813$EXP$$US-ABBVIE-4242496$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
217531054$21753105$4$F$20221201$20230109$20221220$20240925$PER$$US-GSK-US2022AMR188824$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
217531069$21753106$9$F$20230123$20230724$20221220$20240926$EXP$$US-GSK-US2022AMR180673$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
2175310711$21753107$11$F$20221201$20230718$20221220$20240925$PER$$US-GSK-US2022AMR187800$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240925$$CN$US$US
217534952$21753495$2$F$$20240828$20221220$20240903$PER$$US-SA-2022SA509327$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240903$$MD$US$US
217537134$21753713$4$F$$20240717$20221220$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-155594$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240719$$HP$US$US
217540535$21754053$5$F$$20240715$20221220$20240718$EXP$$CA-TAKEDA-2022TUS051945$TAKEDA$$$$$F$Y$$$20240718$$MD$CA$CA
217541262$21754126$2$F$$20240814$20221220$20240828$PER$$US-SA-2022SA508491$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240828$$MD$US$US
217541755$21754175$5$F$20230606$20240730$20221220$20240802$EXP$$CA-TAKEDA-2022TUS097819$TAKEDA$$26$YR$$F$Y$$$20240802$$MD$CA$CA
217542584$21754258$4$F$$20240725$20221220$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14440$LUPIN$$$$$$Y$$$20240813$$CN$US$US
217543893$21754389$3$F$20221026$20240809$20221220$20240812$EXP$$US-PFIZER INC-PV202200126397$PFIZER$$65$YR$$M$Y$$$20240812$$HP$US$US
217546758$21754675$8$F$20230101$20240820$20221220$20240822$EXP$$US-PFIZER INC-PV202200126753$PFIZER$$75$YR$$F$Y$73.923$KG$20240822$$CN$US$US
217551227$21755122$7$F$20240213$20240909$20221220$20240917$EXP$$US-TAKEDA-2022TUS096925$TAKEDA$$43$YR$$F$Y$$$20240917$$CN$US$US
217553662$21755366$2$F$20221130$20240903$20221220$20240911$PER$$US-SA-2022SA511859$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240911$$MD$US$US
2175541011$21755410$11$F$20190101$20240816$20221220$20240830$EXP$$US-AMICUS THERAPEUTICS, INC.-AMI_1568$AMICUS THERAPEUTICS$$$$$F$Y$54.422$KG$20240830$$CN$US$US
217562056$21756205$6$F$20221201$20240626$20221220$20240701$EXP$$US-JAZZ-2022-US-013159$JAZZ$$53$YR$$F$Y$$$20240701$$MD$US$US
217564262$21756426$2$F$20221128$20221130$20221220$20240813$PER$$US-AstraZeneca-2022A396308$ASTRAZENECA$$29175$DY$$M$Y$74.8$KG$20240813$$CN$US$
217567252$21756725$2$F$$20221207$20221220$20240815$EXP$$US-AstraZeneca-2022A350315$ASTRAZENECA$$65$YR$$F$Y$85.3$KG$20240815$$MD$US$
217572212$21757221$2$F$$20240807$20221220$20240815$PER$$US-SA-2022SA510907$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240815$$MD$US$US
217573496$21757349$6$F$20180320$20240917$20221220$20240924$EXP$$DE-GILEAD-2022-0581736$GILEAD$$46$YR$A$F$Y$$$20240924$$CN$DE$DE
217573848$21757384$8$F$20220928$20240716$20221220$20240726$EXP$$JP-009507513-2210JPN002709J$MERCK$$56$YR$$F$Y$$$20240726$$MD$JP$JP
217574192$21757419$2$F$$20240718$20221220$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20200300168$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240726$$MD$CA$CA
217579253$21757925$3$F$$20240725$20221221$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14448$LUPIN$$$$$$Y$$$20240813$$CN$US$US
217579554$21757955$4$F$$20240820$20221221$20240828$EXP$$CA-JNJFOC-20221232631$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240828$$CN$CA$CA
217580244$21758024$4$F$20221101$20240724$20221221$20240731$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-34213$IPSEN$$30$YR$A$M$Y$$$20240731$$CN$CA$CA
217582405$21758240$5$F$20220706$20240829$20221221$20240913$EXP$$BR-JNJFOC-20221231311$JOHNSON AND JOHNSON$$50$YR$A$F$Y$67$KG$20240913$$CN$BR$BR
2175824516$21758245$16$F$20201104$20240919$20221221$20240927$EXP$$CA-CELLTRION INC.-2020CA031460$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
217582472$21758247$2$F$20221201$20240715$20221221$20240723$EXP$$NVSC2022BR291384$NOVARTIS$$51$YR$$M$Y$$$20240723$$CN$BR$BR
217587442$21758744$2$F$$20240821$20221221$20240822$PER$$NVSC2022US294771$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
217588202$21758820$2$F$20220101$20240822$20221221$20240823$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000594$PAREXEL$$$$$$Y$$$20240823$$CN$US$US
217590426$21759042$6$F$20220914$20240902$20221221$20240906$EXP$$DE-ROCHE-3187400$ROCHE$$32$YR$A$F$Y$$$20240906$$CN$DE$DE
217590453$21759045$3$F$$20240730$20221221$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14478$LUPIN$$$$$$Y$$$20240815$$CN$US$US
2175940018$21759400$18$F$20180801$20240703$20221221$20240708$EXP$$NVSC2022AR281092$NOVARTIS$$54$YR$$M$Y$$$20240708$$CN$AR$AR
217596204$21759620$4$F$20181121$20240909$20221221$20240924$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-14143$ALKEM$$$$A$M$Y$$$20240924$$MD$DE$DE
217596646$21759664$6$F$20211125$20240710$20221221$20240725$EXP$$DE-ROCHE-3121042$ROCHE$$48$YR$A$F$Y$73$KG$20240725$$MD$DE$DE
2175974322$21759743$22$F$20200101$20240627$20221221$20240705$EXP$$CA-CELLTRION INC.-2021CA016846$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
217598492$21759849$2$F$20221119$20240729$20221221$20240803$EXP$$US-ABBVIE-4244263$ABBVIE$$68$YR$$M$Y$$$20240803$$CN$US$US
217598572$21759857$2$F$$20221215$20221221$20240925$PER$$US-GSK-US2022AMR188694$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
217601316$21760131$6$F$20220601$20240929$20221221$20240930$EXP$$CA-PFIZER INC-202201087924$PFIZER$$62$YR$$F$Y$$$20240930$$HP$CA$CA
217601543$21760154$3$F$$20240730$20221221$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14525$LUPIN$$$$$$Y$$$20240815$$CN$US$US
217601665$21760166$5$F$20181121$20240909$20221221$20240920$EXP$$DE-AUROBINDO-AUR-APL-2022-053790$AUROBINDO$$$$A$M$Y$$$20240920$$MD$DE$DE
217602753$21760275$3$F$$20240729$20221221$20240801$EXP$$US-TAKEDA-2022TUS098018$TAKEDA$$$$$M$Y$$$20240801$$HP$US$US
217604812$21760481$2$F$$20240912$20221221$20240919$EXP$$US-MYLANLABS-2020M1106567$MYLAN$Bower R, Balinski A, Padilla L. Acute liver failure associated with therapeutic doses of intravenous acetaminophen. Am-J-Gastroenterol 2020;115 (Suppl.):S1306 abstr. S2467.$67$YR$$F$Y$$$20240919$$MD$US$US
217605274$21760527$4$F$$20240912$20221221$20240923$EXP$$GB-TAKEDA-2022TUS088441$TAKEDA$$$$$F$Y$$$20240923$$HP$GB$GB
2176058114$21760581$14$F$20221213$20240826$20221221$20240827$EXP$$AU-TAKEDA-2022TUS081727$TAKEDA$$77$YR$$M$Y$$$20240827$$CN$AU$AU
217607376$21760737$6$F$20221101$20240903$20221221$20240910$EXP$$JP-009507513-2212JPN002009J$MERCK$$61$YR$$F$Y$$$20240910$$MD$JP$JP
2176118511$21761185$11$F$20220101$20240807$20221221$20240812$EXP$$CA-PFIZER INC-202201307706$PFIZER$$46$YR$$F$Y$$$20240812$$MD$CA$CA
217615104$21761510$4$F$$20240813$20221221$20240819$EXP$$US-JAZZ-2021-US-019279$JAZZ$$$$$F$Y$$$20240819$$MD$US$US
217615396$21761539$6$F$20220101$20240726$20221221$20240731$EXP$$CA-TAKEDA-2022TUS098091$TAKEDA$$$$$F$Y$$$20240731$$CN$CA$CA
217616353$21761635$3$F$20221201$20240729$20221221$20240806$PER$$US-SA-2022SA511693$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240806$$MD$US$US
217616526$21761652$6$F$$20240911$20221221$20240917$EXP$$US-TAKEDA-US202034236$TAKEDA$$$$$F$Y$$$20240917$$HP$US$US
217616882$21761688$2$F$20240731$20240801$20221221$20240813$PER$$US-SA-2022SA513447$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240814$$MD$US$US
217617332$21761733$2$F$$20240912$20221221$20240922$PER$$US-SA-2022SA512406$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240922$$MD$US$US
217618286$21761828$6$F$20220101$20240709$20221221$20240715$EXP$$US-SA-2022SA513139$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240715$$MD$US$US
217620764$21762076$4$F$$20240717$20221221$20240722$EXP$$CA-OTSUKA-2022_055272$OTSUKA$$$$$M$Y$$$20240722$$HP$CA$CA
217621695$21762169$5$F$$20240715$20221221$20240719$EXP$$CA-AMGEN-CANSP2022216949$AMGEN$$50$YR$A$F$Y$110$KG$20240719$$MD$CA$CA
2176222014$21762220$14$F$20221216$20240807$20221221$20240808$EXP$$PL-ROCHE-3245677$ROCHE$$41$YR$A$F$Y$73$KG$20240808$$MD$PL$PL
217625028$21762502$8$F$20230801$20240911$20221221$20240917$EXP$$US-PFIZER INC-202100966716$PFIZER$$67$YR$$M$Y$104.33$KG$20240917$$MD$US$US
2176271014$21762710$14$F$20221214$20240920$20221221$20240926$EXP$$IT-TAKEDA-2022TUS098654$TAKEDA$$60$YR$$F$Y$$$20240926$$CN$IT$IT
217627374$21762737$4$F$$20240718$20221221$20240729$PER$$US-INCYTE CORPORATION-2022IN012217$INCYTE$$$$$$Y$$$20240729$$CN$US$US
217628602$21762860$2$F$20220101$20240905$20221221$20240916$PER$$US-BIOGEN-2022BI01176005$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
217629503$21762950$3$F$20221215$20240628$20221221$20240712$PER$$US-SA-2022SA514109$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240712$$MD$US$US
217629893$21762989$3$F$$20240813$20221221$20240816$EXP$$IN-PFIZER INC-202201384980$PFIZER$Sethi, J.. A Case of Esophageal Mucormycosis.. American Journal of Gastroenterology. 2022;117(2):355-355$56$YR$$M$Y$$$20240816$$MD$IN$IN
217631249$21763124$9$F$20220101$20240923$20221221$20240926$EXP$$CA-PFIZER INC-202200321424$PFIZER$$71$YR$$F$Y$94$KG$20240926$$MD$CA$CA
217631744$21763174$4$F$20221211$20230308$20221221$20240724$EXP$$IL-RECORDATI-2022001394$RECORDATI$$$$$$Y$$$20240724$$MD$IL$IL
217631825$21763182$5$F$$20240719$20221221$20240730$PER$$US-SA-2022SA512523$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240730$$MD$US$US
217636354$21763635$4$F$$20240702$20221222$20240710$EXP$$PK-AMGEN-PAKSP2021211121$AMGEN$$40$YR$A$M$Y$$$20240710$$CN$PK$PK
217642886$21764288$6$F$20220101$20240812$20221222$20240816$EXP$$CA-JNJFOC-20221244206$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240816$$HP$CA$CA
217643293$21764329$3$F$$20240730$20221222$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14588$LUPIN$$$$$$Y$$$20240817$$CN$US$US
217643833$21764383$3$F$20221001$20240702$20221222$20240710$EXP$$US-SA-2022SA512005$SANOFI AVENTIS$$64$YR$A$F$Y$92.5$KG$20240710$$MD$US$US
217643883$21764388$3$F$20200921$20240719$20221222$20240724$EXP$$IL-ABBVIE-21K-082-3858756-00$ABBVIE$$63$YR$$M$Y$95$KG$20240724$$MD$IL$IL
217645852$21764585$2$F$20221214$20240913$20221222$20240923$EXP$$BR-CELLTRION INC.-2022BR021460$CELLTRION$$$$$$Y$$$20240923$$CN$BR$BR
217647763$21764776$3$F$$20240627$20221222$20240712$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-369818$RANBAXY$Oliveira C, Caldas F, Goncalves M. Catatonia induced by abrupt discontinuation of clozapine-case report. Eur Psychiatry. 2021;Jul-Sep; 31 (3):100482$34$YR$$M$Y$$$20240712$$HP$PT$PT
217649532$21764953$2$F$$20221219$20221222$20240709$EXP$$NL-ASTELLAS-2022US045150$ASTELLAS$$$$E$M$Y$$$20240709$$CN$NL$NL
217651442$21765144$2$F$$20240730$20221222$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14585$LUPIN$$$$$$Y$$$20240815$$CN$US$US
217651453$21765145$3$F$$20240725$20221222$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14586$LUPIN$$$$$$Y$$$20240815$$PH$US$US
217651913$21765191$3$F$20221212$20240725$20221222$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14587$LUPIN$$$$$$Y$$$20240813$$CN$US$US
217652475$21765247$5$F$20221213$20230118$20221222$20240926$PER$$US-GSK-US2022AMR187502$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240926$$CN$US$US
217653102$21765310$2$F$$20240725$20221222$20240731$30DAY$$US-GSK-US2022190642$GLAXOSMITHKLINE$$$$$M$Y$$$20240731$$CN$US$US
2176542232$21765422$32$F$20220101$20240821$20221222$20240827$EXP$$NVSC2022US295468$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
217654763$21765476$3$F$$20240917$20221222$20240927$PER$$US-GSK-US2022AMR186465$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
217657683$21765768$3$F$$20240730$20221222$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14627$LUPIN$$$$$$Y$$$20240815$$HP$US$US
217658082$21765808$2$F$20220701$20240912$20221222$20240919$EXP$$US-GSK-US2022189709$GLAXOSMITHKLINE$$55$YR$$F$Y$88.435$KG$20240919$$CN$US$US
217659014$21765901$4$F$20210609$20240805$20221222$20240820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-155667$BRISTOL MYERS SQUIBB$Yoshimura K, et al. A case of malignant transformation of mature teratoma to squamous cell carcinoma showing significant response to nivolumab. Journal of the Japan Society of Gynecologic Oncology. 2022; 40(3): 285$52$YR$A$F$Y$49.7$KG$20240820$$MD$JP$JP
217659732$21765973$2$F$20231201$20240718$20221222$20240724$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2022188709$VIIV$$$$$$Y$$$20240724$$CN$CA$CA
217659894$21765989$4$F$$20240625$20221222$20240702$EXP$$CA-GSK-CA2022187845$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$CA$CA
217663366$21766336$6$F$20180901$20240725$20221222$20240801$EXP$$DE-ROCHE-2573596$ROCHE$$40$YR$A$F$Y$111$KG$20240801$$CN$DE$DE
217664847$21766484$7$F$20180201$20240717$20221222$20240719$EXP$$US-DSJP-DSU-2022-146377$DAIICHI$$49$YR$$F$Y$$$20240719$$CN$US$US
2176650516$21766505$16$F$20220101$20240926$20221222$20240930$PER$$US-PFIZER INC-PV202200129350$PFIZER$$65$YR$$F$Y$71.202$KG$20240930$$MD$US$US
217667326$21766732$6$F$20221101$20240715$20221222$20240717$EXP$$US-PFIZER INC-PV202200128436$PFIZER$$94$YR$$M$Y$$$20240717$$MD$US$US
217667488$21766748$8$F$20240101$20240911$20221222$20240913$EXP$$US-PFIZER INC-PV202200128171$PFIZER$$78$YR$$F$Y$57.61$KG$20240913$$CN$US$US
217667516$21766751$6$F$20220101$20240729$20221222$20240801$EXP$$CA-PFIZER INC-202101813183$PFIZER$$74$YR$$M$Y$$$20240801$$MD$CA$CA
217667823$21766782$3$F$$20240904$20221222$20240913$EXP$$OM-PFIZER INC-202201378867$PFIZER$Kalbani, K.. Bilateral serous retinal detachment: An initial presentation of mixed phenotype acute leukemia in an adult. Oman Journal of Ophthalmology. 2022;15(3):356-359$60$YR$$F$Y$$$20240913$$MD$OM$OM
217667865$21766786$5$F$20230414$20240920$20221222$20240924$EXP$$US-PFIZER INC-PV202200127815$PFIZER$$84$YR$$F$Y$$$20240924$$CN$US$US
217669533$21766953$3$F$20181127$20240717$20221222$20240722$PER$$US-PFIZER INC-202201387463$PFIZER$$75$YR$$F$Y$$$20240722$$MD$US$US
217672353$21767235$3$F$$20240628$20221222$20240711$PER$$US-SA-2022SA513510$SANOFI AVENTIS$$$$T$M$Y$$$20240711$$MD$US$US
217673582$21767358$2$F$$20240719$20221222$20240731$PER$$US-SA-2022SA514981$SANOFI AVENTIS$$$$A$F$Y$$$20240731$$CN$US$US
217675602$21767560$2$F$20221101$20240910$20221222$20240919$EXP$$US-ORPHANEU-2022006781$RECORDATI$$$$$$Y$$$20240919$$CN$US$US
2176779512$21767795$12$F$20220819$20240906$20221222$20240912$EXP$$JP-PFIZER INC-PV202200068661$PFIZER$Nakamura, S.. Two intractable lymphatic malformations treated with Sirolimus. The 126th Annual Meeting of the Japan Pediatric Society. 2023;127(2):363$5$YR$$F$Y$13.5$KG$20240912$$MD$JP$JP
217678005$21767800$5$F$20220101$20240829$20221222$20240904$EXP$$CA-PFIZER INC-202200489907$PFIZER$$61$YR$$F$Y$97$KG$20240904$$MD$CA$CA
217688102$21768810$2$F$$20240718$20221222$20240723$PER$$US-PURDUE PHARMA-USA-2022-0295712$PURDUE$$$$$M$Y$$$20240723$$CN$US$US
217688486$21768848$6$F$$20240918$20221222$20240926$PER$$NVSC2022US294976$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
217689013$21768901$3$F$20221126$20240627$20221222$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004187$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240723$$HP$US$US
217692004$21769200$4$F$20240501$20240621$20221222$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004119$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240716$$CN$US$US
217692234$21769223$4$F$20221107$20240703$20221222$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004020$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240726$$CN$US$US
217693993$21769399$3$F$20221217$20240910$20221223$20240919$PER$$US-SA-2022SA515268$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240919$$MD$US$US
217694775$21769477$5$F$20221208$20240806$20221223$20240828$PER$$CA-TOLMAR, INC.-22CA037964$TOLMAR$$62$YR$$M$Y$$$20240828$$CN$CA$CA
217695253$21769525$3$F$$20240827$20221223$20240918$PER$$US-SA-2022SA515223$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240918$$MD$US$US
217695432$21769543$2$F$$20240810$20221223$20240816$PER$$US-SA-2022SA514792$SANOFI AVENTIS$$50$YR$A$M$Y$81.64$KG$20240816$$MD$US$US
217696125$21769612$5$F$20210713$20240716$20221223$20240724$EXP$$CA-CELLTRION INC.-2022CA009533$CELLTRION$$$$$$Y$$$20240724$$HP$CA$CA
217696152$21769615$2$F$$20221213$20221223$20240925$PER$$US-GSK-US2022AMR187233$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
217698044$21769804$4$F$20240916$20240917$20221223$20240926$EXP$$CA-ROCHE-3249425$ROCHE$$46$YR$A$F$Y$$$20240926$$CN$CA$CA
217703303$21770330$3$F$$20240710$20221223$20240713$PER$$NVSC2022US292915$NOVARTIS$$$$$F$Y$$$20240713$$CN$US$US
217704452$21770445$2$F$$20240826$20221223$20240905$PER$$US-ABBVIE-4200436$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
2177046714$21770467$14$F$20231101$20240702$20221223$20240709$EXP$$US-VIIV HEALTHCARE LIMITED-US2022AMR188679$VIIV$$$$$$Y$$$20240709$$CN$US$US
217706483$21770648$3$F$20221207$20240902$20221223$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-157110$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$68.7$KG$20240911$$MD$JP$JP
217709374$21770937$4$F$$20240821$20221223$20240826$EXP$$GB-TAKEDA-2022TUS098507$TAKEDA$$49$YR$$M$Y$$$20240826$$HP$GB$GB
217717462$21771746$2$F$$20221220$20221223$20240925$EXP$$US-GSK-US2022AMR038944$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2177185919$21771859$19$F$20200729$20240829$20221223$20240907$EXP$$CA-CELLTRION INC.-2022CA018370$CELLTRION$$$$$$Y$$$20240907$$MD$CA$CA
217718697$21771869$7$F$20220913$20240723$20221223$20240725$EXP$$NVSC2022KR295002$NOVARTIS$$65$YR$$F$Y$54.3$KG$20240725$$MD$KR$KR
217723007$21772300$7$F$$20240913$20221223$20240916$PER$$NVSC2022US297291$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
217724564$21772456$4$F$$20240727$20221223$20240805$PER$$US-SA-2022SA516917$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240805$$HP$US$US
217725465$21772546$5$F$$20240715$20221223$20240723$EXP$$CA-PFIZER INC-202201389168$PFIZER$$50$YR$$F$Y$110$KG$20240723$$MD$CA$CA
217725804$21772580$4$F$20230313$20240731$20221223$20240809$EXP$$BR-TAKEDA-2022TUS092538$TAKEDA$$50$YR$$F$Y$$$20240809$$CN$BR$BR
2177270114$21772701$14$F$20190101$20240910$20221223$20240913$30DAY$$US-PFIZER INC-PV202200124535$PFIZER$$50$YR$$F$Y$$$20240913$$CN$US$US
217727282$21772728$2$F$$20240729$20221223$20240809$EXP$$AU-MAYNE PHARMA-2022MYN001483$MAYNE$$$$$$Y$$$20240809$$HP$AU$AU
217728073$21772807$3$F$20220725$20240702$20221223$20240723$EXP$$DE-ROCHE-3249949$ROCHE$$54$YR$A$F$Y$$$20240723$$MD$DE$DE
217729444$21772944$4$F$20220622$20240712$20221223$20240717$EXP$$CA-TAKEDA-2022TUS099206$TAKEDA$$20$YR$$F$Y$$$20240717$$CN$CA$CA
217730382$21773038$2$F$$20240806$20221223$20240815$PER$$US-SA-2022SA515526$SANOFI AVENTIS$$16$YR$T$F$Y$62$KG$20240815$$MD$US$US
217730562$21773056$2$F$$20240705$20221223$20240709$EXP$$CA-TAKEDA-2022TUS098785$TAKEDA$$$$$F$Y$$$20240709$$MD$CA$CA
217731556$21773155$6$F$20221217$20240909$20221223$20240912$EXP$$CA-ROCHE-3247237$ROCHE$$60$YR$A$F$Y$$$20240912$$CN$CA$CA
2177320215$21773202$15$F$$20240819$20221223$20240827$EXP$$US-TAKEDA-2022TUS100632$TAKEDA$$$$$F$Y$74$KG$20240827$$MD$US$US
217733773$21773377$3$F$$20240710$20221223$20240716$EXP$$CA-TAKEDA-2022TUS099069$TAKEDA$$69$YR$$F$Y$$$20240716$$HP$CA$CA
217737272$21773727$2$F$20221007$20240725$20221223$20240729$PER$$US-ABBVIE-4207681$ABBVIE$$72$YR$$M$Y$$$20240729$$CN$US$US
217737976$21773797$6$F$$20240924$20221223$20240930$EXP$$CA-BAUSCHBL-2022BNL002964$BAUSCH AND LOMB$$52$YR$$M$Y$$$20240930$$HP$CA$CA
217738683$21773868$3$F$20211224$20240913$20221223$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-057450$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240924$$MD$JP$JP
2177393023$21773930$23$F$20220905$20240720$20221223$20240724$EXP$$IN-PFIZER INC-PV202200127042$PFIZER$$40$YR$$F$Y$$$20240724$$CN$IN$IN
2177400911$21774009$11$F$20220101$20240924$20221223$20240930$EXP$$JP-009507513-2207JPN001680J$MERCK$Nakai H, Ohnisi M, Makiyama T, Inazumi H, Shiomi H, Kato E, et al.. O3-4 A case of corpus uteri carcinoma in which ICI was re-administered after steroid treatment for myocarditis due to pembrolizumab. The 9th Japanese Heart Failure Society. 44$45$YR$$F$Y$56.4$KG$20240930$$MD$JP$JP
217740992$21774099$2$F$20220101$20240918$20221223$20240924$PER$$US-JAZZ-2022-US-004540$JAZZ$$59$YR$$F$Y$$$20240924$$MD$US$US
217743835$21774383$5$F$20191118$20240624$20221224$20240701$EXP$$NVSC2022DE217553$NOVARTIS$$40$YR$$F$Y$$$20240701$$CN$DE$DE
2177445810$21774458$10$F$20221214$20240704$20221224$20240710$EXP$$CO-TAKEDA-2022TUS099392$TAKEDA$$19$YR$$F$Y$43$KG$20240710$$CN$CO$CO
217748587$21774858$7$F$$20240802$20221224$20240808$EXP$$NVSC2022US296426$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
2177488211$21774882$11$F$20221128$20231219$20221224$20240926$EXP$$US-GSK-US2022AMR191263$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
217750062$21775006$2$F$$20240720$20221225$20240729$EXP$$FR-AUROBINDO-AUR-APL-2022-055219$AUROBINDO$Meyer G, Jumeau P, Fichter A, Kel C-L, Michel B, Javelot H.. Quetiapine and hypersexuality: Two case reports. Therapie. 2022;77(3):381-384$34$YR$$M$Y$$$20240729$$HP$FR$FR
217750198$21775019$8$F$20190718$20240820$20221225$20240829$EXP$$DE-ROCHE-2380184$ROCHE$$30$YR$A$F$Y$$$20240829$$CN$DE$DE
217750456$21775045$6$F$20230224$20240829$20221225$20240905$EXP$$CA-VER-202200670$VERITY PHARMACEUTICALS$$69$YR$E$M$Y$$$20240905$$CN$CA$CA
217751433$21775143$3$F$$20240814$20221225$20240826$EXP$$DE-MACLEODS PHARMACEUTICALS US LTD-MAC2022038897$MACLEODS$$$$$$Y$$$20240826$$CN$DE$DE
217752416$21775241$6$F$20221123$20240830$20221225$20240905$EXP$$US-ABBVIE-4244773$ABBVIE$$0$YR$$$Y$5$KG$20240905$$HP$US$US
217752642$21775264$2$F$20221205$20221221$20221225$20240712$EXP$$IT-ASTELLAS-2022US044842$ASTELLAS$$76$YR$$M$Y$$$20240712$$MD$IT$IT
217755873$21775587$3$F$20230110$20240816$20221226$20240827$PER$$US-SA-2022SA514734$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240827$$MD$US$US
217757762$21775776$2$F$$20240814$20221226$20240829$PER$$US-SA-2022SA516893$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240829$$MD$US$US
217760266$21776026$6$F$20210809$20240717$20221226$20240725$EXP$$CA-CELLTRION INC.-2021CA012563$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
217764246$21776424$6$F$20221201$20230307$20221226$20240925$PER$$US-GSK-US2022AMR192460$GLAXOSMITHKLINE$$41$YR$$F$Y$55.329$KG$20240925$$MD$US$US
217765892$21776589$2$F$$20240725$20221226$20240805$PER$$US-SA-2022SA505319$SANOFI AVENTIS$$$$A$F$Y$$$20240803$$MD$US$US
217765923$21776592$3$F$$20240714$20221226$20240722$PER$$US-SA-2022SA504957$SANOFI AVENTIS$$$$A$M$Y$$$20240722$$MD$US$US
217767797$21776779$7$F$20200915$20240911$20221226$20240923$EXP$$FR-AUROBINDO-AUR-APL-2022-054745$AUROBINDO$$84$YR$$F$Y$50$KG$20240923$$MD$FR$FR
217767892$21776789$2$F$20220101$20240726$20221226$20240729$PER$$US-AMGEN-USASP2022220789$AMGEN$$23$YR$A$M$Y$$$20240729$$HP$US$US
217768057$21776805$7$F$20220826$20240726$20221226$20240802$EXP$$CA-TAKEDA-2022TUS043540$TAKEDA$$66$YR$$F$Y$$$20240802$$CN$CA$CA
217769755$21776975$5$F$20220901$20240828$20221226$20240905$EXP$$CA-ROCHE-3250057$ROCHE$$37$YR$A$M$Y$$$20240905$$CN$CA$CA
217769846$21776984$6$F$20221101$20240827$20221226$20240830$EXP$$DE-TAKEDA-2022TUS100048$TAKEDA$$57$YR$$F$Y$$$20240830$$HP$DE$DE
217770777$21777077$7$F$20221201$20230306$20221226$20240926$EXP$$US-GSK-US2022AMR191928$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
217770992$21777099$2$F$$20221219$20221226$20240806$EXP$$IT-RECORDATI-2022006884$RECORDATI$Antonini S, Brunetti A, Zampetti B, Boeris D, Saladino A, Cozzi RC. Osilodrostat in Cushing^s disease: the management of its efficacy and the pitfalls of post-surgical results. Endocrinology, Diabetes and Metabolisim Case Reports. 2022$$$$$Y$$$20240806$$HP$IT$IT
217771275$21777127$5$F$$20240711$20221226$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2022-158185$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240716$$CN$CA$CA
2177728312$21777283$12$F$20221201$20240703$20221226$20240710$EXP$$US-GSK-US2022191871$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$US$US
217777039$21777703$9$F$$20240716$20221226$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2022-158239$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$95$KG$20240729$$HP$CA$CA
217779763$21777976$3$F$$20240904$20221226$20240908$EXP$$DE-ROCHE-3250408$ROCHE$$$$$F$Y$$$20240908$$CN$DE$DE
217780433$21778043$3$F$20221101$20240808$20221226$20240813$EXP$$CA-GSK-CA2022AMR192426$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CA$CA
217780713$21778071$3$F$20211002$20230717$20221226$20240926$EXP$$US-GSK-US2021AMR200609$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
217781226$21778122$6$F$20211222$20240906$20221226$20240913$EXP$$US-PAREXEL-2021-KAM-US003410$TAKEDA$$51$YR$$F$Y$100$KG$20240913$$HP$US$US
2177824615$21778246$15$F$20170321$20240919$20221226$20240928$EXP$$CA-CELLTRION INC.-2021CA015039$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
2177830115$21778301$15$F$20220101$20240822$20221226$20240830$EXP$$CA-CELLTRION INC.-2022CA005483$CELLTRION$$$$$$Y$$$20240830$$MD$CA$CA
217783804$21778380$4$F$20240701$20240904$20221226$20240930$EXP$$US-SA-2022SA519515$SANOFI AVENTIS$$$$E$F$Y$59.8$KG$20240930$$MD$US$US
2177853212$21778532$12$F$20231101$20240702$20221226$20240709$EXP$$US-JNJFOC-20221251343$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240709$$CN$US$US
217789826$21778982$6$F$$20240727$20221226$20240801$EXP$$NVSC2022AU064340$NOVARTIS$$$$$F$Y$$$20240801$$HP$AU$AU
217791465$21779146$5$F$$20240919$20221226$20240923$EXP$$US-TAKEDA-2022TUS099748$TAKEDA$$$$$M$Y$76$KG$20240923$$HP$US$US
217794348$21779434$8$F$$20240716$20221226$20240723$EXP$$IN-TAKEDA-2022TUS099201$TAKEDA$$$$$M$Y$$$20240723$$MD$IN$IN
2177976113$21779761$13$F$$20240701$20221226$20240705$EXP$$US-JAZZ-2022-US-021135$JAZZ$$$$$F$Y$$$20240705$$CN$US$US
2177977011$21779770$11$F$20110207$20240711$20221226$20240718$EXP$$US-JAZZ-2022-US-005475$JAZZ$$43$YR$$F$Y$$$20240718$$MD$US$US
217797978$21779797$8$F$$20240821$20221226$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-158107$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240827$$MD$JP$JP
217798836$21779883$6$F$20220101$20240705$20221226$20240709$EXP$$CA-PFIZER INC-202200583969$PFIZER$$33$YR$$F$Y$$$20240709$$MD$CA$CA
2177999111$21779991$11$F$$20240610$20221226$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004207$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
217801073$21780107$3$F$$20221219$20221226$20240706$PER$$US-TEVA-2022-US-2839245$TEVA$$51$YR$$F$Y$77.11$KG$20240706$$CN$US$US
2178029610$21780296$10$F$20220930$20240809$20221227$20240817$EXP$$MX-TAKEDA-2022TUS070627$TAKEDA$$46$YR$$M$Y$$$20240817$$CN$MX$MX
2178058711$21780587$11$F$20220510$20240718$20221227$20240726$EXP$$CA-CELLTRION INC.-2022CA007513$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
217806173$21780617$3$F$20220905$20240905$20221227$20240918$EXP$$PT-AUROBINDO-AUR-APL-2022-054910$AUROBINDO$Costa A, Faustino C, Correia F, Chave V, Almeida J... Sindrome hemofagocitico - quando pensar nesta entidade? a proposito de um caso clinico (abstract number: PO-0184 - (2479)).. Doencas oncologicas.552.. 552$50$YR$$F$Y$$$20240918$$MD$PT$PT
217807769$21780776$9$F$20210101$20240805$20221227$20240812$EXP$$CA-CELLTRION INC.-2021CA005641$CELLTRION$$$$$$Y$$$20240812$$HP$CA$CA
2178094012$21780940$12$F$20221214$20240901$20221227$20240909$EXP$$US-BEH-2022153474$CSL BEHRING$$29$YR$A$F$Y$91$KG$20240909$$CN$US$US
217809606$21780960$6$F$$20240821$20221227$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-158080$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240829$$MD$JP$JP
217812122$21781212$2$F$$20240910$20221227$20240919$EXP$$RO-AUROBINDO-AUR-APL-2022-052553$AUROBINDO$Borc?u D-A, Grama A, Filimon I, Marcu C, Pop TL.. Abcesul splenic ? cauz? neobi?nuit? de febr? la sugar (Splenic abscess ? unusual cause of fever in an infant). Pediatru.ro.. 2022;67(3):35-40.$14$MON$$F$Y$$$20240919$$MD$RO$RO
217815225$21781522$5$F$20240618$20240805$20221227$20240807$EXP$$US-TAKEDA-2019TUS044578$TAKEDA$$82$YR$$F$Y$$$20240807$$CN$US$US
217816112$21781611$2$F$20220814$20240918$20221227$20240927$EXP$$FR-AUROBINDO-AUR-APL-2022-054820$AUROBINDO$$34$YR$$F$Y$78.9$KG$20240927$$PH$FR$FR
217818273$21781827$3$F$$20240909$20221227$20240913$EXP$$CA-ROCHE-3250735$ROCHE$$67$YR$E$F$Y$$$20240913$$HP$CA$CA
217823792$21782379$2$F$20220101$20221222$20221227$20240806$EXP$$US-RECORDATI-2022006989$RECORDATI$$$$$$Y$$$20240806$$CN$US$US
217828864$21782886$4$F$$20230216$20221227$20240711$PER$$US-PFM-2022-07768$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.259$KG$20240711$$CN$US$US
217829972$21782997$2$F$20200123$20240913$20221227$20240927$PER$$US-SA-2022SA520688$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240927$$MD$US$US
217830012$21783001$2$F$20221111$20221220$20221227$20240806$EXP$$US-ORPHANEU-2022006972$RECORDATI$$$$$$Y$$$20240806$$CN$US$US
217834734$21783473$4$F$20220111$20240708$20221227$20240709$PER$$US-PFIZER INC-202200597737$PFIZER$$81$YR$$F$Y$$$20240709$$CN$US$US
217835052$21783505$2$F$$20240726$20221227$20240731$PER$$US-PFIZER INC-202201378289$PFIZER$$55$YR$$F$Y$$$20240731$$HP$US$US
217835752$21783575$2$F$$20240731$20221227$20240808$PER$$US-SA-2022SA520603$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240808$$CN$US$US
2178369513$21783695$13$F$$20240821$20221227$20240827$PER$$US-PFIZER INC-PV202200129544$PFIZER$$70$YR$$F$Y$$$20240827$$MD$US$US
217837073$21783707$3$F$$20240918$20221227$20240919$PER$$US-PFIZER INC-PV202200129751$PFIZER$$56$YR$$M$Y$$$20240919$$MD$US$US
217837124$21783712$4$F$$20240909$20221227$20240911$PER$$US-PFIZER INC-PV202200129316$PFIZER$$68$YR$$F$Y$$$20240911$$MD$US$US
217837167$21783716$7$F$$20240725$20221227$20240730$PER$$US-PFIZER INC-PV202200129394$PFIZER$$79$YR$$F$Y$$$20240730$$CN$US$US
2178386211$21783862$11$F$$20240905$20221227$20240909$EXP$$US-PFIZER INC-PV202200130170$PFIZER$$70$YR$$F$Y$50.794$KG$20240909$$CN$US$US
217840287$21784028$7$F$20220501$20240723$20221227$20240726$PER$$US-PFIZER INC-202200501451$PFIZER$$63$YR$$F$Y$$$20240726$$CN$US$US
217842923$21784292$3$F$20220101$20240702$20221227$20240710$EXP$$CL-BIOMARINAP-CL-2022-147629$BIOMARIN$$$$$$Y$$$20240710$$CN$CL$CL
217844625$21784462$5$F$$20240919$20221227$20240926$EXP$$CA-Orion Corporation ORION PHARMA-21_00014068$ORION$$59$YR$A$F$Y$68$KG$20240926$$HP$CA$
2178448715$21784487$15$F$20240101$20240805$20221227$20240809$EXP$$US-PFIZER INC-202201384474$PFIZER$$74$YR$$M$Y$95.25$KG$20240809$$CN$US$US
217846028$21784602$8$F$20220101$20240920$20221227$20240925$EXP$$CA-PFIZER INC-202200063616$PFIZER$$64$YR$$F$Y$77$KG$20240925$$HP$CA$CA
2178462814$21784628$14$F$20190712$20240903$20221227$20240913$EXP$$CA-ASTELLAS-2022US045360$ASTELLAS$$10$YR$C$M$Y$36$KG$20240913$$HP$CA$CA
217846708$21784670$8$F$20220101$20240809$20221227$20240813$EXP$$CA-PFIZER INC-202200989863$PFIZER$$54$YR$$F$Y$100$KG$20240813$$HP$CA$CA
217848976$21784897$6$F$20221219$20240916$20221227$20240921$EXP$$CA-TAKEDA-2022TUS100600$TAKEDA$$64$YR$$F$Y$$$20240921$$HP$CA$CA
2178501324$21785013$24$F$20220731$20240925$20221227$20240930$EXP$$IN-PFIZER INC-PV202200128997$PFIZER$$70$YR$$F$Y$$$20240930$$CN$IN$IN
217850213$21785021$3$F$20220101$20240807$20221227$20240812$EXP$$US-PFIZER INC-202201389423$PFIZER$$75$YR$$F$Y$47.63$KG$20240812$$CN$US$US
217850873$21785087$3$F$$20240723$20221227$20240725$EXP$$US-PFIZER INC-202201389181$PFIZER$$89$YR$$M$Y$68.04$KG$20240725$$CN$US$US
2178535417$21785354$17$F$20230207$20240729$20221227$20240805$EXP$$CA-OTSUKA-2022_055823$OTSUKA$$82$YR$$F$Y$$$20240805$$MD$CA$CA
217855848$21785584$8$F$20220128$20240730$20221227$20240801$EXP$$NVSJ2022JP276676$NOVARTIS$$9$YR$$F$Y$29.8$KG$20240802$$MD$JP$JP
217857674$21785767$4$F$$20240917$20221227$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-002800$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
2178612115$21786121$15$F$20221220$20240912$20221228$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-159591$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240913$$MD$US$US
217864322$21786432$2$F$20190701$20240819$20221228$20240823$PER$$US-BIOGEN-2019BI00781372$BIOGEN$$82$YR$$F$Y$$$20240823$$CN$US$US
217864872$21786487$2$F$20220601$20240624$20221228$20240717$PER$$CO-TOLMAR, INC.-22CO038038$TOLMAR$$73$YR$$M$Y$$$20240717$$CN$CO$CO
217864892$21786489$2$F$20240728$20240801$20221228$20240826$PER$$CO-TOLMAR, INC.-22CO035112$TOLMAR$$84$YR$$M$Y$$$20240826$$CN$CO$CO
217866622$21786662$2$F$$20221219$20221228$20240829$EXP$$JP-TERSERA THERAPEUTICS LLC-2022TRS005927$TERSERA THERAPEUTICS$$$$$$Y$$$20240829$$PH$JP$JP
217868508$21786850$8$F$$20240807$20221228$20240813$EXP$$CA-ROCHE-2907640$ROCHE$$44$YR$A$M$Y$$$20240813$$CN$CA$CA
2178691119$21786911$19$F$20220101$20240718$20221228$20240726$EXP$$CA-CELLTRION INC.-2022CA006508$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
217870995$21787099$5$F$$20240708$20221228$20240712$EXP$$NVSC2022US296414$NOVARTIS$$$$$M$Y$$$20240712$$CN$US$US
2178710716$21787107$16$F$20220101$20240630$20221228$20240709$EXP$$CA-CELLTRION INC.-2022CA008688$CELLTRION$$$$$$Y$$$20240709$$MD$CA$CA
217872158$21787215$8$F$20221216$20240819$20221228$20240901$EXP$$US-UCBSA-2022071831$UCB$$14$YR$$M$Y$$$20240901$$CN$US$US
2178729012$21787290$12$F$20221201$20240506$20221228$20240926$EXP$$US-GSK-US2022AMR188677$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
217874373$21787437$3$F$$20240717$20221228$20240725$PER$$US-AMGEN-USASP2022224126$AMGEN$$79$YR$E$F$Y$$$20240725$$MD$US$US
217874499$21787449$9$F$$20240807$20221228$20240809$EXP$$US-PAREXEL-2021-KAM-US003475$TAKEDA$$$$$F$Y$87$KG$20240809$$HP$US$US
217874692$21787469$2$F$20221026$20221221$20221228$20240806$EXP$$US-ORPHANEU-2022007008$RECORDATI$$$$$$Y$$$20240806$$CN$US$US
217874892$21787489$2$F$$20240805$20221228$20240807$PER$$NVSC2022US299167$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
217877883$21787788$3$F$20221027$20240819$20221228$20240827$PER$$US-SA-2022SA521359$SANOFI AVENTIS$$75$YR$E$F$Y$54.4$KG$20240827$$MD$US$US
217878123$21787812$3$F$$20240710$20221228$20240718$PER$$US-SA-2022SA518979$SANOFI AVENTIS$$$$A$F$Y$47.6$KG$20240718$$MD$US$US
217878536$21787853$6$F$20170801$20240717$20221228$20240725$EXP$$NVSC2022IN044420$NOVARTIS$$43$YR$$M$Y$$$20240725$$CN$IN$IN
217886184$21788618$4$F$20221204$20240906$20221228$20240912$EXP$$CA-TAKEDA-2022TUS101883$TAKEDA$$30$YR$$M$Y$$$20240912$$MD$CA$CA
217886904$21788690$4$F$20190801$20240902$20221228$20240904$EXP$$CA-PFIZER INC-202201392201$PFIZER$Mah, J.. A case of disseminated strongyloidiasis after multiple courses of immunosuppression. CMAJ. Canadian Medical Association Journal. 2022;194(3):E89-E92$71$YR$$M$Y$$$20240904$$MD$CA$CA
217890233$21789023$3$F$20221110$20240923$20221228$20240925$PER$$US-AMGEN-USASP2022214402$AMGEN$$70$YR$E$F$Y$64.853$KG$20240924$$HP$US$US
2178925715$21789257$15$F$20220901$20240925$20221228$20240928$EXP$$CA-ROCHE-2385327$ROCHE$$62$YR$A$M$Y$$$20240928$$HP$CA$CA
217895669$21789566$9$F$20240221$20240905$20221228$20240909$EXP$$IN-PFIZER INC-202200445238$PFIZER$$64$YR$$F$Y$65$KG$20240909$$CN$IN$IN
217896872$21789687$2$F$20200101$20240731$20221228$20240808$PER$$US-ABBVIE-22K-163-4408878-00$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
217899039$21789903$9$F$20221208$20240215$20221228$20240806$EXP$$NVSC2022TW294826$NOVARTIS$$79$YR$$M$Y$79.4$KG$20240806$$MD$TW$TW
2178998214$21789982$14$F$20220422$20240827$20221228$20240902$EXP$$IN-PFIZER INC-202101276693$PFIZER$$55$YR$$F$Y$$$20240902$$CN$IN$IN
2179011613$21790116$13$F$20040101$20240626$20221228$20240708$EXP$$BR-MYLANLABS-2022M1146388$MYLAN$$$$$F$Y$65$KG$20240708$$CN$BR$BR
217901693$21790169$3$F$20230101$20240730$20221228$20240731$EXP$$US-PFIZER INC-PV202200131263$PFIZER$$64$YR$$F$Y$$$20240731$$CN$US$US
217902652$21790265$2$F$$20240820$20221228$20240822$EXP$$US-KYOWAKIRIN-2022BKK020229$KYOWA$$$$$$Y$$$20240822$$HP$US$US
217908252$21790825$2$F$$20240826$20221228$20240911$PER$$US-ABBVIE-4198782$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
217914454$21791445$4$F$$20240703$20221228$20240709$EXP$$DE-ABBVIE-22K-062-4490488-00$ABBVIE$$$$$$Y$$$20240709$$CN$DE$DE
217915083$21791508$3$F$$20240618$20221228$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004408$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
2179163217$21791632$17$F$20240701$20240919$20221228$20240930$EXP$$US-ROCHE-3252457$ROCHE$$61$YR$A$M$Y$$$20240930$$CN$US$US
2179168911$21791689$11$F$20221221$20240826$20221229$20240829$EXP$$NVSC2022CA285265$NOVARTIS$$52$YR$$F$Y$$$20240829$$CN$CA$CA
217921955$21792195$5$F$20220801$20240627$20221229$20240702$EXP$$CA-UCBSA-2022072409$UCB$$29$YR$$F$Y$$$20240702$$CN$CA$CA
217922479$21792247$9$F$20221201$20230616$20221229$20240926$EXP$$US-GSK-US2022AMR191270$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2179230411$21792304$11$F$20220101$20240703$20221229$20240708$EXP$$US-UCBSA-2022064433$UCB$$$$$F$Y$84.354$KG$20240708$$CN$US$US
217924855$21792485$5$F$20221201$20240920$20221229$20240930$EXP$$GR-UCBSA-2022072889$UCB$$56$YR$$F$Y$56$KG$20240930$$MD$GR$GR
217927273$21792727$3$F$20220822$20240918$20221229$20240923$EXP$$JP-EXELIXIS-CABO-22059281$EXELIXIS$$71$YR$$M$Y$$$20240923$$MD$JP$JP
217927324$21792732$4$F$20220712$20240725$20221229$20240801$EXP$$NVSC2021AR184503$NOVARTIS$$63$YR$$F$Y$$$20240801$$CN$AR$AR
217929082$21792908$2$F$20220101$20240805$20221229$20240813$PER$$US-SA-2022SA523045$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240814$$MD$US$US
2179323916$21793239$16$F$20200824$20240815$20221229$20240822$EXP$$CA-CELLTRION INC.-2020CA020627$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
217932512$21793251$2$F$20220814$20240923$20221229$20240927$EXP$FR-AFSSAPS-AN20222554$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-086122$ZYDUS PHARM$$$$$$Y$$$20240927$$PH$FR$FR
217932725$21793272$5$F$20221201$20240823$20221229$20240918$PER$$US-SA-2022SA523539$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240918$$CN$US$US
2179332910$21793329$10$F$$20240805$20221229$20240812$EXP$$JP-009507513-2211JPN001806J$MERCK$Muroi H, Nakajima M, Kubo R, Inoue N, Nakagawa M, Morita S, et al.. P20-06 Treatment outcome of unresectable advanced recurrent esophageal cancer. The 77th Annual Meeting of the Japan Esophageal Society. 240$76$YR$$M$Y$$$20240812$$MD$JP$JP
217933415$21793341$5$F$20220504$20240818$20221229$20240828$EXP$$DE-PUMA BIOTECHNOLOGY, INC.-2022-PUM-DE001197$PUMA$$$$$$Y$$$20240828$$HP$DE$DE
217934843$21793484$3$F$20220101$20240814$20221229$20240820$EXP$$NVSC2022BR200374$NOVARTIS$$43$YR$$F$Y$93.5$KG$20240820$$CN$BR$BR
217936224$21793622$4$F$$20240702$20221229$20240712$EXP$$PT-TEVA-2022-PT-2840419$TEVA$Oliveira CM, Gomes L, Martins PS, Portela C, Caldas F, Goncalves M. Catatonia induced by abrupt discontinuation of clozapine-case report. Psiquiatria Biologica, Volume 31, Issue 3, Jul-Sep 2024.; Oliveira C, Caldas F, Goncalves M. Catatonia induced by abrupt discontinuation of clozapine -case report. Eur-Psychiatry 2021; 64 (Suppl.) S544-S545.; Oliveira C, Caldas F, Goncalves M. Catatonia induced by abrupt discontinuation of clozapine -case report. Eur-Psychiatry 2021;64 (Suppl. 1):S544-S545 ...$34$YR$$M$Y$$$20240712$$HP$PT$PT
217937015$21793701$5$F$20220101$20240904$20221229$20240913$PER$$US-UNITED THERAPEUTICS-UNT-2022-031852$UNITED THERAPEUTICS$$$$$F$Y$81.633$KG$20240913$$$US$US
217937042$21793704$2$F$20190501$20240821$20221229$20240831$PER$$US-ABBVIE-22K-163-4514905-00$ABBVIE$$56$YR$$M$Y$$$20240831$$CN$US$US
217937493$21793749$3$F$20240723$20240723$20221229$20240820$EXP$$CA-GSK-CA2022192457$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$HP$CA$CA
217937945$21793794$5$F$20231129$20240826$20221229$20240905$EXP$$CA-VER-202200671$VERITY PHARMACEUTICALS$$66$YR$E$M$Y$$$20240905$$CN$CA$CA
217938534$21793853$4$F$20221207$20230112$20221229$20240913$PER$$US-ROCHE-3241409$ROCHE$$27$YR$A$F$Y$52.16$KG$20240913$$CN$US$US
217940824$21794082$4$F$20230101$20230208$20221229$20240709$EXP$$BR-ASTELLAS-2022US045644$ASTELLAS$$78$YR$$M$Y$$$20240709$$CN$BR$BR
217944536$21794453$6$F$$20240916$20221229$20240918$EXP$$NVSC2022US300132$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
217944977$21794497$7$F$20220101$20240722$20221229$20240728$EXP$$NL-ABBVIE-4252480$ABBVIE$$76$YR$$M$Y$$$20240728$$CN$NL$NL
217950212$21795021$2$F$20220524$20240722$20221229$20240729$EXP$$NVSC2022DE131134$NOVARTIS$$52$YR$$M$Y$$$20240730$$MD$DE$DE
217954092$21795409$2$F$20221207$20240913$20221229$20240918$EXP$$US-INCYTE CORPORATION-2022IN012665$INCYTE$$$$$$Y$$$20240918$$CN$US$US
2179600120$21796001$20$F$20211128$20240923$20221229$20240927$EXP$$IN-PFIZER INC-202101807146$PFIZER$$70$YR$$F$Y$$$20240927$$CN$IN$IN
2179600212$21796002$12$F$20221220$20240821$20221229$20240826$EXP$$CA-PFIZER INC-202201393517$PFIZER$$75$YR$$F$Y$$$20240826$$MD$CA$CA
217960355$21796035$5$F$$20240828$20221229$20240902$EXP$$US-JAZZ-2021-US-014243$JAZZ$$$$$F$Y$$$20240902$$CN$US$US
217961459$21796145$9$F$20220101$20240722$20221229$20240727$EXP$$US-BIOGEN-2022BI01177401$BIOGEN$$$$$F$Y$$$20240727$$CN$US$US
217963705$21796370$5$F$20221216$20240905$20221229$20240909$EXP$$US-TAKEDA-2022TUS101478$TAKEDA$$8$YR$$F$Y$$$20240909$$CN$US$US
2179662610$21796626$10$F$20220302$20240816$20221229$20240826$EXP$$CA-CELLTRION INC.-2022CA004351$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
217966329$21796632$9$F$20240525$20240731$20221229$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004232$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240823$$CN$US$US
2179664410$21796644$10$F$20221220$20240620$20221229$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004449$ACADIA PHARMACEUTICALS$$86$YR$$F$Y$$$20240712$$CN$US$US
2179673522$21796735$22$F$20221121$20240915$20221230$20240919$EXP$$SA-ROCHE-3226020$ROCHE$$1$YR$I$M$Y$9.75$KG$20240919$$CN$SA$SA
2179680510$21796805$10$F$20221205$20240611$20221230$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004258$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240705$$CN$US$US
217968893$21796889$3$F$$20240716$20221230$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004276$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
2179725513$21797255$13$F$20211014$20240802$20221230$20240809$EXP$$CA-CELLTRION INC.-2021CA013061$CELLTRION$$$$$$Y$$$20240809$$MD$CA$CA
217972832$21797283$2$F$20221001$20240724$20221230$20240731$PER$$US-ABBVIE-4208296$ABBVIE$$56$YR$$F$Y$$$20240731$$CN$US$US
217977064$21797706$4$F$$20240918$20221230$20240927$EXP$$ZA-AMGEN-ZAFSP2022225000$AMGEN$$39$YR$A$F$Y$$$20240927$$CN$ZA$ZA
217977674$21797767$4$F$20221201$20230113$20221230$20240925$PER$$US-GSK-US2022AMR193629$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240925$$CN$US$US
217978213$21797821$3$F$20221114$20240718$20221230$20240726$EXP$$DE-TAKEDA-2022TUS101691$TAKEDA$$74$YR$$M$Y$$$20240726$$CN$DE$DE
217978973$21797897$3$F$20221101$20240715$20221230$20240722$EXP$$CA-ROCHE-3254341$ROCHE$$53$YR$A$M$Y$$$20240722$$CN$CA$CA
217978984$21797898$4$F$20220119$20240710$20221230$20240724$EXP$$DE-ROCHE-3015696$ROCHE$$30$YR$A$F$Y$$$20240724$$CN$DE$DE
217979012$21797901$2$F$20221201$20240903$20221230$20240903$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000612$PAREXEL$$$$$$Y$$$20240903$$CN$US$US
217979315$21797931$5$F$20201109$20240725$20221230$20240805$EXP$$DE-ROCHE-3115428$ROCHE$$52$YR$A$M$Y$$$20240805$$CN$DE$DE
217979833$21797983$3$F$20220923$20240827$20221230$20240901$EXP$$RU-JNJFOC-20221258676$JOHNSON AND JOHNSON$$$$A$F$Y$63$KG$20240901$$HP$RU$RU
217980639$21798063$9$F$$20240710$20221230$20240715$EXP$$CA-TAKEDA-2021TUS044724$TAKEDA$$$$$F$Y$$$20240715$$HP$CA$CA
217985272$21798527$2$F$$20221227$20221230$20240925$PER$$US-GSK-US2022AMR193546$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
217988506$21798850$6$F$20220101$20240627$20221230$20240705$EXP$$JP-009507513-2210JPN004212J$MERCK$$58$YR$$F$Y$$$20240705$$MD$JP$JP
217989955$21798995$5$F$20221201$20240815$20221230$20240828$PER$$US-SA-2022SA524313$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240828$$CN$US$US
217990213$21799021$3$F$20200701$20240807$20221230$20240812$EXP$$CA-TAKEDA-2020TUS035502$TAKEDA$$42$YR$$M$Y$$$20240812$$MD$CA$CA
217991172$21799117$2$F$20090526$20240706$20221230$20240710$EXP$FR-EMA-DD-20190301-chopra_i-171726$FR-BAUSCH-BL-2022-028086$BAUSCH AND LOMB$$71$YR$$F$Y$84$KG$20240710$$MD$FR$FR
217994765$21799476$5$F$20231010$20240701$20221230$20240703$EXP$$US-TAKEDA-2022TUS102044$TAKEDA$$13$YR$$F$Y$42.17$KG$20240703$$CN$US$US
2179956111$21799561$11$F$20221121$20240708$20221230$20240710$EXP$$JP-GSK-JP2022183767$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$JP$JP
217997297$21799729$7$F$20221219$20240906$20221230$20240913$EXP$$CO-TAKEDA-2022TUS103710$TAKEDA$$30$YR$$M$Y$63$KG$20240913$$CN$CO$CO
217998482$21799848$2$F$20221019$20240806$20221230$20240813$EXP$$CA-TAKEDA-2022TUS080958$TAKEDA$$65$YR$$M$Y$$$20240813$$CN$CA$CA
217999042$21799904$2$F$$20240812$20221230$20240820$PER$$US-SA-2022SA524558$SANOFI AVENTIS$$$$E$F$Y$131.54$KG$20240820$$MD$US$US
2179991012$21799910$12$F$20221226$20240703$20221230$20240710$EXP$$US-ABBVIE-4254439$ABBVIE$$58$YR$$M$Y$$$20240710$$CN$US$US
218000259$21800025$9$F$20220401$20240924$20221230$20240930$EXP$$CA-PFIZER INC-202201393540$PFIZER$$49$YR$$M$Y$$$20240929$$HP$CA$CA
218001043$21800104$3$F$$20240724$20221230$20240801$PER$$US-SA-2022SA523851$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240801$$CN$US$US
218001533$21800153$3$F$$20240718$20221230$20240720$PER$$US-AMGEN-USASP2022224788$AMGEN$$$$A$M$Y$$$20240720$$HP$US$US
218001955$21800195$5$F$20221001$20240823$20221230$20240827$EXP$$CA-TAKEDA-2022TUS103065$TAKEDA$$18$YR$$F$Y$$$20240827$$CN$CA$CA
218003362$21800336$2$F$$20240805$20221230$20240814$PER$$US-SA-2022SA521484$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240814$$MD$US$US
218005502$21800550$2$F$20221210$20240910$20221230$20240919$PER$$US-INCYTE CORPORATION-2022IN012576$INCYTE$$$$$$Y$$$20240919$$CN$US$US
218007952$21800795$2$F$20220101$20240701$20221230$20240705$PER$$US-ABBVIE-4252320$ABBVIE$$61$YR$$M$Y$$$20240705$$CN$US$US
218013336$21801333$6$F$20200201$20240903$20221230$20240906$EXP$$CA-TAKEDA-2020TUS009694$TAKEDA$$72$YR$$M$Y$$$20240906$$CN$CA$CA
218013857$21801385$7$F$20231213$20240820$20221230$20240827$EXP$$US-VIIV HEALTHCARE LIMITED-US2022AMR191786$VIIV$$$$$$Y$$$20240827$$CN$US$US
2180186111$21801861$11$F$20221120$20240702$20221230$20240709$EXP$$US-JAZZ-2022-US-031753$JAZZ$$39$YR$$F$Y$$$20240709$$MD$US$US
218025596$21802559$6$F$20221110$20240722$20221231$20240730$EXP$$CA-CELLTRION INC.-2022CA008717$CELLTRION$$$$$$Y$$$20240730$$MD$CA$CA
218026269$21802626$9$F$20220101$20240804$20221231$20240812$EXP$$CA-CELLTRION INC.-2022CA017168$CELLTRION$$$$$$Y$$$20240812$$HP$CA$CA
218032684$21803268$4$F$20220301$20240919$20230101$20240925$EXP$$US-ABBVIE-4254049$ABBVIE$$79$YR$$F$Y$82$KG$20240925$$CN$US$US
2180346310$21803463$10$F$20240701$20240725$20230101$20240730$EXP$$GB-ABBVIE-4254744$ABBVIE$$43$YR$$F$Y$$$20240730$$HP$GB$GB
218042153$21804215$3$F$20220101$20240724$20230102$20240802$PER$$US-SA-2022SA524047$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240802$$MD$US$US
218043143$21804314$3$F$$20240626$20230102$20240703$EXP$$CA-APOTEX-2022AP017339$APOTEX$$49$YR$$F$Y$$$20240703$$MD$CA$CA
218047063$21804706$3$F$$20240722$20230102$20240731$PER$$US-SA-2022SA524748$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240731$$MD$US$US
218049313$21804931$3$F$20240722$20240820$20230102$20240821$PER$$NVSC2022US301939$NOVARTIS$$13$YR$$M$Y$103$KG$20240821$$HP$US$US
218049336$21804933$6$F$20221201$20240702$20230102$20240710$EXP$$PE-ROCHE-3255016$ROCHE$$43$YR$A$F$Y$$$20240710$$CN$PE$PE
218050323$21805032$3$F$20231201$20240827$20230102$20240909$EXP$$US-SA-2022SA525187$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240909$$MD$US$US
218050792$21805079$2$F$$20240905$20230102$20240911$EXP$$CA-ROCHE-3254982$ROCHE$$37$YR$A$F$Y$63$KG$20240911$$HP$CA$CA
218053642$21805364$2$F$$20240718$20230102$20240727$EXP$$GB-ROCHE-1761479$ROCHE$$74$YR$E$M$Y$$$20240727$$CN$GB$GB
218053652$21805365$2$F$20221201$20240703$20230102$20240708$PER$$US-ABBVIE-4222300$ABBVIE$$81$YR$$F$Y$$$20240708$$CN$US$US
218055523$21805552$3$F$20221215$20240826$20230102$20240828$EXP$$NVSC2022US301956$NOVARTIS$$44$YR$$M$Y$$$20240828$$CN$US$US
218056327$21805632$7$F$$20240910$20230102$20240917$EXP$$US-PAREXEL-2021-KAM-US003597$TAKEDA$$$$$F$Y$158$KG$20240917$$CN$US$US
218056377$21805637$7$F$20221212$20240917$20230102$20240919$EXP$$CA-TAKEDA-2022TUS103600$TAKEDA$$62$YR$$F$Y$$$20240919$$HP$CA$CA
2180586911$21805869$11$F$20211018$20240902$20230102$20240906$EXP$$CA-TAKEDA-2021TUS064698$TAKEDA$$74$YR$$F$Y$60$KG$20240906$$CN$CA$CA
218063487$21806348$7$F$20220511$20240808$20230102$20240822$EXP$GB-CELLTRION INC.-2022GB010821$GB-TEVA-2022-GB-2838969$TEVA$$49$YR$$M$Y$$$20240822$$PH$GB$GB
218064405$21806440$5$F$20180601$20240722$20230102$20240726$EXP$$CA-TAKEDA-2018TUS020028$TAKEDA$$51$YR$$M$Y$$$20240726$$CN$CA$CA
218067613$21806761$3$F$20221227$20240814$20230102$20240819$EXP$$DE-JNJFOC-20221263183$JOHNSON AND JOHNSON$$82$YR$E$M$Y$66$KG$20240819$$MD$DE$DE
2180699610$21806996$10$F$20210922$20240730$20230102$20240806$EXP$$US-JAZZ-2022-US-034211$JAZZ$$75$YR$$M$Y$$$20240806$$MD$US$US
218070083$21807008$3$F$20231220$20240620$20230102$20240704$PER$$US-TAKEDA-2022TUS099704$TAKEDA$$66$YR$$F$Y$$$20240704$$HP$US$US
2180718015$21807180$15$F$20221201$20240809$20230102$20240814$EXP$$CA-ROCHE-3254933$ROCHE$$26$YR$A$F$Y$68.04$KG$20240814$$HP$CA$CA
218078796$21807879$6$F$20231213$20240820$20230103$20240828$EXP$$US-JNJFOC-20221264501$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240828$$CN$US$US
218079112$21807911$2$F$20220908$20240718$20230103$20240802$PER$$US-SA-2023SA000654$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240802$$MD$US$US
218087163$21808716$3$F$20240727$20240827$20230103$20240902$EXP$$US-GSK-US2022196000$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
218088243$21808824$3$F$$20240731$20230103$20240805$EXP$$PT-AUROBINDO-AUR-APL-2022-056182$AUROBINDO$Alves, H, Silva T.C, Machete, M, Pereira, C, Balhana S, Noronha C et al. O homem das cavern(om)as: epilepsia temporal como etiologia de alucina??es auditivovisuais. Medicina Interna ? Congressos Nacionais, 28 CNMI. 2022;1112:P n. 2298$70$YR$$M$Y$$$20240805$$MD$PT$PT
218090134$21809013$4$F$$20240808$20230103$20240812$EXP$$US-TAKEDA-2022TUS035640$TAKEDA$$$$$M$Y$$$20240812$$HP$US$US
218091913$21809191$3$F$20161201$20240916$20230103$20240926$EXP$$FR-AUROBINDO-AUR-APL-2022-056420$AUROBINDO$$72$YR$$F$Y$100$KG$20240926$$MD$FR$FR
218092603$21809260$3$F$20220105$20240815$20230103$20240829$PER$$US-SA-2023SA001564$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240829$$MD$US$US
218094544$21809454$4$F$20221201$20240812$20230103$20240821$PER$$US-SA-2023SA000708$SANOFI AVENTIS$$39$YR$A$F$Y$133.36$KG$20240821$$MD$US$US
218096363$21809636$3$F$$20240726$20230103$20240729$EXP$$US-TAKEDA-2022TUS101700$TAKEDA$$$$$M$Y$$$20240729$$CN$US$US
218098152$21809815$2$F$20221221$20221229$20230103$20240827$EXP$$TR-ORGANON-O2301TUR000096$ORGANON$$5$YR$$M$Y$24$KG$20240827$$CN$TR$TR
218101713$21810171$3$F$20221119$20240716$20230103$20240722$EXP$$GR-ABBVIE-4256008$ABBVIE$$72$YR$$F$Y$70$KG$20240719$$MD$GR$GR
218103507$21810350$7$F$20221218$20240913$20230103$20240920$EXP$$DE-ABBVIE-4255780$ABBVIE$$70$YR$$M$Y$83$KG$20240920$$MD$DE$DE
218103582$21810358$2$F$20201026$20240920$20230103$20240930$EXP$$CA-TAKEDA-2019TUS040179$TAKEDA$$34$YR$$F$Y$$$20240930$$MD$CA$CA
2181071910$21810719$10$F$$20240813$20230103$20240816$PER$$US-PFIZER INC-PV202200134035$PFIZER$$80$YR$$F$Y$88.2$KG$20240816$$CN$US$US
218108128$21810812$8$F$$20240820$20230103$20240827$EXP$$US-SA-2023SA000818$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240827$$CN$US$US
218111945$21811194$5$F$20210521$20240924$20230103$20240926$EXP$$DE-ROCHE-2843479$ROCHE$$51$YR$A$F$Y$$$20240926$$CN$DE$DE
218113719$21811371$9$F$20221001$20240711$20230103$20240715$EXP$$US-PFIZER INC-2020449512$PFIZER$$85$YR$$F$Y$66.67$KG$20240715$$CN$US$US
2181142822$21811428$22$F$20221219$20240920$20230103$20240925$EXP$$CA-PFIZER INC-202201401044$PFIZER$$72$YR$$F$Y$$$20240925$$HP$CA$CA
218114683$21811468$3$F$20240222$20240807$20230103$20240816$PER$$US-SA-2022SA374716$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240816$$MD$US$US
2181177318$21811773$18$F$20221217$20240826$20230103$20240831$EXP$$CO-TAKEDA-2022TUS095459$TAKEDA$$29$YR$$M$Y$47$KG$20240831$$CN$CO$CO
218118332$21811833$2$F$20220101$20240829$20230103$20240903$PER$$US-SA-2023SA001485$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240903$$CN$US$US
218120344$21812034$4$F$20221101$20240809$20230103$20240814$EXP$$US-ABBVIE-4217071$ABBVIE$$76$YR$$M$Y$$$20240814$$CN$US$US
218123145$21812314$5$F$19660101$20240829$20230103$20240902$EXP$$US-PFIZER INC-2021498153$PFIZER$$32$YR$$F$Y$72.109$KG$20240902$$HP$US$US
218123422$21812342$2$F$20220701$20240826$20230103$20240906$EXP$$JP-AMICUS-AMI_2159AA$AMICUS THERAPEUTICS$$78$YR$$F$Y$45$KG$20240906$$MD$JP$JP
218127274$21812727$4$F$20221212$20240705$20230103$20240711$EXP$$IT-PFIZER INC-202300000841$PFIZER$$45$YR$$F$Y$65$KG$20240711$$MD$IT$IT
218130962$21813096$2$F$$20240820$20230103$20240823$EXP$$US-JAZZ-2022-US-038721$JAZZ$$$$$F$Y$$$20240823$$CN$US$US
218131463$21813146$3$F$$20240926$20230103$20240927$EXP$$CA-MYLANLABS-2023M1000409$MYLAN$$2$YR$$F$Y$12$KG$20240927$$HP$CA$CA
218134175$21813417$5$F$$20240801$20230103$20240808$EXP$$BR-CELLTRION INC.-2022BR021926$CELLTRION$$$$$$Y$$$20240808$$CN$BR$BR
218138197$21813819$7$F$20221201$20230330$20230104$20240926$EXP$$US-GSK-US2022AMR194712$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2181392715$21813927$15$F$20200508$20240917$20230104$20240926$EXP$$CA-CELLTRION INC.-2020CA023262$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
2181415110$21814151$10$F$20221226$20240918$20230104$20240927$PER$$NVSC2023US001068$NOVARTIS$$13$YR$$F$Y$47$KG$20240927$$CN$US$US
218149277$21814927$7$F$$20240815$20230104$20240827$EXP$$CA-AUROBINDO-AUR-APL-2022-056925$AUROBINDO$Okonkwo MC, Moeller A, McCoy K, Tulipan T, Coolen J.. Clinical conundrum: To deliver or not to deliver a patient with pulmonary edema and preeclampsia.. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA. 2021;43(10):1170-2$29$YR$$F$Y$$$20240827$$HP$CA$CA
218150013$21815001$3$F$$20240723$20230104$20240806$EXP$AU-MACLEODS PHARMACEUTICALS US LTD-MAC2022039038$AU-MACLEODS PHARMACEUTICALS US LTD-MAC2022039038$MACLEODS$$$$$$Y$$$20240806$$MD$GB$GB
218153774$21815377$4$F$20180321$20240621$20230104$20240712$EXP$$DE-ROCHE-2097775$ROCHE$$47$YR$A$F$Y$63$KG$20240712$$CN$DE$DE
218157313$21815731$3$F$20220728$20240805$20230104$20240817$EXP$$CN-Accord-294642$ACCORD$$52$YR$A$F$Y$60$KG$20240817$$MD$CN$CN
218158002$21815800$2$F$$20240708$20230104$20240711$PER$$US-ABBVIE-22K-163-4443216-00$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
218158173$21815817$3$F$20221216$20240628$20230104$20240711$EXP$$US-THERATECHNOLOGIES INC.-2022-THE-TES-000416$Unknown Manufacturer$$$$$$Y$$$20240711$$CN$US$US
218160223$21816022$3$F$20210724$20230130$20230104$20240925$EXP$$US-GSK-US2021AMR165538$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
218161427$21816142$7$F$$20240827$20230104$20240909$EXP$$CA-AUROBINDO-AUR-APL-2022-056958$AUROBINDO$Haubrich K, Mammen C, Sekirov I, Mitchell H. Mycobacterium fortuitum peritoneal dialysisrelated peritonitis in a child: A case report and review of the literature. JAMMI. 2022;7(2):125-130$9$YR$$M$Y$$$20240909$$PH$CA$CA
218163309$21816330$9$F$$20240813$20230104$20240820$EXP$$NVSC2022CO302224$NOVARTIS$$$$$M$Y$$$20240820$$CN$CO$CO
218164802$21816480$2$F$$20240807$20230104$20240819$EXP$$CA-AUROBINDO-AUR-APL-2022-056942$AUROBINDO$$79$YR$$F$Y$65$KG$20240819$$HP$CA$CA
218166034$21816603$4$F$$20240911$20230104$20240919$EXP$$CA-AUROBINDO-AUR-APL-2022-057349$AUROBINDO$$68$YR$$F$Y$$$20240919$$HP$CA$CA
218166383$21816638$3$F$20220901$20240911$20230104$20240921$EXP$$CA-JNJFOC-20230104035$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240921$$CN$CA$CA
218170643$21817064$3$F$20230627$20240708$20230104$20240729$PER$$CO-TOLMAR, INC.-22CO038176$TOLMAR$$76$YR$$M$Y$64$KG$20240726$$CN$CO$CO
2181708812$21817088$12$F$20220101$20240916$20230104$20240919$EXP$$US-PFIZER INC-202300002195$PFIZER$$70$YR$$F$Y$128.37$KG$20240919$$CN$US$US
218172602$21817260$2$F$$20240803$20230104$20240805$EXP$$CA-ROCHE-3256324$ROCHE$$47$YR$A$F$Y$60$KG$20240805$$HP$CA$CA
2181731813$21817318$13$F$20221125$20240924$20230104$20240925$PER$$NVSC2023US001491$NOVARTIS$$40$YR$$F$Y$$$20240925$$CN$US$US
218185993$21818599$3$F$20221227$20230306$20230104$20240814$EXP$$NVSC2023US001575$NOVARTIS$$82$YR$$M$Y$$$20240814$$CN$US$US
218186603$21818660$3$F$20231201$20240730$20230104$20240806$EXP$$NVSC2022MX302608$NOVARTIS$$40$YR$$F$Y$80$KG$20240806$$CN$MX$MX
218188796$21818879$6$F$$20240726$20230104$20240730$EXP$$US-TAKEDA-2023TUS000570$TAKEDA$$$$$M$Y$116$KG$20240730$$CN$US$US
218189279$21818927$9$F$20221227$20240627$20230104$20240702$EXP$$US-PAREXEL-2021-KAM-US003438$TAKEDA$$55$YR$$M$Y$98$KG$20240702$$CN$US$US
2181899115$21818991$15$F$20221225$20240916$20230104$20240923$EXP$$CA-TAKEDA-2022TUS083010$TAKEDA$$40$YR$$F$Y$$$20240923$$CN$CA$CA
218189979$21818997$9$F$20230203$20240916$20230104$20240923$EXP$$CA-TAKEDA-2023TUS000626$TAKEDA$$30$YR$$F$Y$$$20240923$$CN$CA$CA
218191028$21819102$8$F$20240424$20240702$20230104$20240708$EXP$$US-JAZZ-2022-US-013108$JAZZ$$40$YR$$F$Y$$$20240708$$CN$US$US
218191805$21819180$5$F$20190101$20240829$20230104$20240903$EXP$$FR-MYLANLABS-2022M1148782$MYLAN$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, Lorin de la Grandmaison G, Mayer C, Alvarez JC, Langrand J. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Analytical and Clinical Toxicology. 2022;438:1-6$68$YR$$F$Y$$$20240903$$HP$FR$FR
218192136$21819213$6$F$20221225$20240813$20230104$20240820$PER$$US-PFIZER INC-PV202200132391$PFIZER$$80$YR$$F$Y$61.9$KG$20240820$$CN$US$US
218195133$21819513$3$F$$20240819$20230104$20240830$PER$$US-SA-2023SA001573$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240830$$MD$US$US
218195452$21819545$2$F$$20240725$20230104$20240803$PER$$US-SA-2023SA001057$SANOFI AVENTIS$$$$E$F$Y$$$20240803$$MD$US$US
218197165$21819716$5$F$20221218$20240725$20230104$20240813$PER$$US-LUNDBECK-DKLU3056185$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
218200513$21820051$3$F$$20240628$20230104$20240704$EXP$$US-BIOGEN-2023BI01178897$BIOGEN$$$$$F$Y$$$20240704$$CN$US$US
218201123$21820112$3$F$$20240725$20230105$20240813$PER$$US-LUPIN LIMITED-2022-14612$LUPIN$$$$$$Y$$$20240813$$CN$US$US
2182014511$21820145$11$F$20220101$20240705$20230105$20240712$EXP$$CA-CELLTRION INC.-2022CA008163$CELLTRION$$$$$$Y$$$20240713$$MD$CA$CA
218202182$21820218$2$F$$20240720$20230105$20240731$EXP$$CA-AUROBINDO-AUR-APL-2022-057279$AUROBINDO$$15$YR$$M$Y$127$KG$20240731$$HP$CA$CA
218204043$21820404$3$F$$20240723$20230105$20240801$PER$$US-SA-2023SA002016$SANOFI AVENTIS$$$$T$M$Y$$$20240801$$MD$US$US
218205683$21820568$3$F$$20240729$20230105$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14642$LUPIN$$$$$$Y$$$20240826$$CN$US$US
218205803$21820580$3$F$$20240726$20230105$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14625$LUPIN$$$$$$Y$$$20240815$$CN$US$US
218205832$21820583$2$F$$20240730$20230105$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14653$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218205883$21820588$3$F$$20240730$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14606$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218206456$21820645$6$F$20220904$20240701$20230105$20240723$PER$$CA-TOLMAR, INC.-22CA038103$TOLMAR$$64$YR$$M$Y$$$20240723$$CN$CA$CA
218206592$21820659$2$F$20221231$20230103$20230105$20240926$PER$$US-GSK-US2023AMR000303$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240926$$CN$US$US
218209044$21820904$4$F$$20240812$20230105$20240816$PER$$US-BIOGEN-2022BI01088697$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
2182097523$21820975$23$F$20220101$20240813$20230105$20240821$EXP$$CA-CELLTRION INC.-2022CA022140$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
218209982$21820998$2$F$$20240730$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14646$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218209992$21820999$2$F$$20240729$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14655$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218210013$21821001$3$F$$20240727$20230105$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14681$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218210044$21821004$4$F$$20240727$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14643$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218210062$21821006$2$F$$20240730$20230105$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14683$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218210103$21821010$3$F$$20240813$20230105$20240826$EXP$$CA-AUROBINDO-AUR-APL-2022-057270$AUROBINDO$$72$YR$$M$Y$$$20240826$$HP$CA$CA
218210516$21821051$6$F$20230101$20230113$20230105$20240925$EXP$$US-GSK-US2023AMR000331$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
218210603$21821060$3$F$$20240727$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14702$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218210663$21821066$3$F$$20240730$20230105$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14678$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218210713$21821071$3$F$$20240730$20230105$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14679$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218210733$21821073$3$F$$20240730$20230105$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14628$LUPIN$$$$$$Y$$$20240815$$CN$US$US
218210753$21821075$3$F$$20240725$20230105$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14692$LUPIN$$$$$$Y$$$20240813$$PH$US$US
218210763$21821076$3$F$$20240727$20230105$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14690$LUPIN$$$$$M$Y$$$20240816$$CN$US$US
2182159214$21821592$14$F$20200430$20240724$20230105$20240729$EXP$$US-TAKEDA-2023TUS000900$TAKEDA$$31$YR$$M$Y$$$20240729$$PH$US$US
218216014$21821601$4$F$20210101$20240822$20230105$20240827$EXP$$US-ABBVIE-4258043$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
218216802$21821680$2$F$$20240918$20230105$20240925$EXP$$CA-TAKEDA-2022TUS087834$TAKEDA$$$$$F$Y$$$20240925$$CN$CA$CA
218219525$21821952$5$F$$20240918$20230105$20240924$PER$$NVSC2023US001862$NOVARTIS$$$$$M$Y$$$20240924$$CN$US$US
218221262$21822126$2$F$20221201$20240624$20230105$20240701$PER$$US-ABBVIE-4218318$ABBVIE$$39$YR$$M$Y$92.986$KG$20240701$$CN$US$US
218221579$21822157$9$F$$20230222$20230105$20240805$PER$$NVSC2023US002036$NOVARTIS$$$$$M$Y$$$20240804$$CN$US$US
218222023$21822202$3$F$$20240819$20230105$20240829$EXP$$CA-AUROBINDO-AUR-APL-2022-057427$AUROBINDO$$56$YR$$F$Y$$$20240829$$HP$CA$CA
218222703$21822270$3$F$$20240725$20230105$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15090$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218223255$21822325$5$F$20230101$20240808$20230105$20240820$30DAY$$US-GSK-US2023000392$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240820$$CN$US$US
218223903$21822390$3$F$$20240917$20230105$20240930$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2022195891$VIIV$$$$$$Y$$$20240930$$PH$CA$CA
218223983$21822398$3$F$20211201$20230413$20230105$20240926$EXP$$US-GSK-US2021AMR266340$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
218223997$21822399$7$F$20220621$20230607$20230105$20240926$EXP$$US-GSK-US2022AMR083973$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
218224523$21822452$3$F$$20240727$20230105$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14714$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218224543$21822454$3$F$$20240727$20230105$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14756$LUPIN$$$$$$Y$$$20240818$$PH$US$US
218224553$21822455$3$F$$20240727$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14748$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218224563$21822456$3$F$$20240725$20230105$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14707$LUPIN$$$$$$Y$$$20240813$$CN$US$US
218224612$21822461$2$F$$20240725$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14766$LUPIN$$$$$$Y$$$20240817$$HP$US$US
218224873$21822487$3$F$$20240727$20230105$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14793$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218224912$21822491$2$F$$20240725$20230105$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14905$LUPIN$$$$$$Y$$$20240813$$PH$US$US
218224953$21822495$3$F$$20240727$20230105$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14902$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218224982$21822498$2$F$$20240806$20230105$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14884$LUPIN$$$$$$Y$$$20240827$$CN$US$US
218225063$21822506$3$F$$20240727$20230105$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14800$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218225642$21822564$2$F$$20240727$20230105$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14939$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218225652$21822565$2$F$$20240725$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14832$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218225672$21822567$2$F$$20240727$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14804$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218225694$21822569$4$F$20221201$20240725$20230105$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14831$LUPIN$$$$$$Y$$$20240814$$CN$US$US
218225723$21822572$3$F$$20240727$20230105$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14711$LUPIN$$$$$$Y$$$20240816$$PH$US$US
218225734$21822573$4$F$$20240725$20230105$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14802$LUPIN$$$$$$Y$$$20240814$$CN$US$US
218225765$21822576$5$F$$20240725$20230105$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14803$LUPIN$$$$$$Y$$$20240813$$PH$US$US
2182262611$21822626$11$F$20221214$20240919$20230105$20240926$EXP$$NVSC2022CO103010$NOVARTIS$$51$YR$$F$Y$49$KG$20240926$$CN$CO$CO
218226284$21822628$4$F$$20240712$20230105$20240718$EXP$$NVSC2023US001916$NOVARTIS$$$$$M$Y$$$20240718$$MD$US$US
218226393$21822639$3$F$$20240725$20230105$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15002$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218226474$21822647$4$F$$20240725$20230105$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14943$LUPIN$$$$$$Y$$$20240814$$CN$US$US
218226493$21822649$3$F$$20240727$20230105$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14940$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218226513$21822651$3$F$20221201$20240725$20230105$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14946$LUPIN$$$$$$Y$$$20240813$$CN$US$US
218226532$21822653$2$F$$20240727$20230105$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14910$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218226544$21822654$4$F$20221226$20240727$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14908$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218226593$21822659$3$F$$20240725$20230105$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14947$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218226612$21822661$2$F$$20240725$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14976$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218227393$21822739$3$F$$20240725$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14916$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218227402$21822740$2$F$$20240725$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14982$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218227423$21822742$3$F$$20240725$20230105$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15010$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218227453$21822745$3$F$$20240725$20230105$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15008$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218228258$21822825$8$F$20221001$20240731$20230105$20240805$EXP$$NVSC2022RU302832$NOVARTIS$$66$YR$$F$Y$85$KG$20240805$$MD$RU$RU
218228602$21822860$2$F$20240801$20240823$20230105$20240903$PER$$US-ABBVIE-22K-163-4509189-00$ABBVIE$$27$YR$$M$Y$$$20240903$$CN$US$US
218228786$21822878$6$F$$20240715$20230105$20240716$EXP$$IT-ROCHE-3247284$ROCHE$$47$YR$A$M$Y$$$20240716$$MD$IT$IT
218231503$21823150$3$F$$20240725$20230105$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15003$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218231673$21823167$3$F$20180517$20240814$20230105$20240827$EXP$$DE-AUROBINDO-AUR-APL-2022-056676$AUROBINDO$$46$YR$$F$Y$$$20240827$$MD$DE$DE
218231683$21823168$3$F$$20240725$20230105$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15043$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218232923$21823292$3$F$20220913$20240715$20230105$20240717$EXP$$PL-PFIZER INC-202300002620$PFIZER$$74$YR$$M$Y$81$KG$20240717$$MD$PL$PL
2182335322$21823353$22$F$20220224$20240918$20230105$20240925$EXP$$US-TAKEDA-2022TUS014101$TAKEDA$$43$YR$$F$Y$94$KG$20240925$$HP$US$US
218236524$21823652$4$F$20240918$20240919$20230105$20240920$PER$$US-PFIZER INC-PV202200081752$PFIZER$$70$YR$$F$Y$$$20240920$$CN$US$US
218236602$21823660$2$F$$20240920$20230105$20240926$PER$$US-PFIZER INC-PV202300000874$PFIZER$$76$YR$$F$Y$$$20240926$$CN$US$US
218237143$21823714$3$F$$20240924$20230105$20240925$PER$$US-PFIZER INC-202201108897$PFIZER$$56$YR$$F$Y$58.5$KG$20240925$$CN$US$US
218237408$21823740$8$F$20230911$20240715$20230105$20240720$EXP$$CA-TAKEDA-2022TUS031204$TAKEDA$$59$YR$$M$Y$$$20240720$$CN$CA$CA
218238535$21823853$5$F$$20240725$20230105$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15004$LUPIN$$$$$$Y$$$20240813$$CN$US$US
2182389910$21823899$10$F$20220811$20240705$20230105$20240708$EXP$$CA-PFIZER INC-202200165581$PFIZER$$86$YR$$F$Y$60.6$KG$20240708$$MD$CA$CA
218239312$21823931$2$F$20230101$20240819$20230105$20240828$PER$$US-ABBVIE-4229143$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
218240593$21824059$3$F$$20240725$20230105$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15037$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218248192$21824819$2$F$$20240909$20230105$20240911$EXP$$CA-BAUSCH-BL-2023-000195$BAUSCH AND LOMB$$61$YR$$F$Y$86$KG$20240911$$PH$CA$CA
218251988$21825198$8$F$20220501$20240905$20230105$20240918$EXP$$US-JAZZ-2022-US-016665$JAZZ$$35$YR$$F$Y$$$20240918$$HP$US$US
218255413$21825541$3$F$20230120$20240902$20230105$20240910$EXP$$CZ-Blueprint Medicines Corporation-SP-CZ-2023-000030$BLUEPRINT MEDICINES$$17$YR$T$M$Y$116$KG$20240910$$MD$CZ$CZ
2182565411$21825654$11$F$$20240624$20230105$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004327$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
218259152$21825915$2$F$$20240823$20230106$20240903$PER$$US-ABBVIE-4218259$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
2182598116$21825981$16$F$20220101$20240904$20230106$20240912$EXP$$CA-CELLTRION INC.-2022CA021388$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
218260812$21826081$2$F$20200805$20240813$20230106$20240821$EXP$$DE-BIOGEN-2023BI01178694$BIOGEN$$47$YR$$M$Y$$$20240821$$CN$DE$DE
218261494$21826149$4$F$20221208$20240725$20230106$20240903$PER$$CO-TOLMAR, INC.-22CO038116$TOLMAR$$68$YR$$M$Y$$$20240903$$CN$CO$CO
218261694$21826169$4$F$20221201$20240718$20230106$20240722$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000621$PAREXEL$$$$$$Y$$$20240722$$HP$US$US
218262223$21826222$3$F$20220101$20240727$20230106$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14715$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218266206$21826620$6$F$20200415$20240722$20230106$20240725$EXP$$US-TAKEDA-2023TUS001605$TAKEDA$$4$YR$$M$Y$$$20240725$$CN$US$US
218266253$21826625$3$F$$20240725$20230106$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15040$LUPIN$$$$$$Y$$$20240813$$CN$US$US
218266365$21826636$5$F$20230105$20240903$20230106$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-002144$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$73$KG$20240903$$HP$US$US
218266433$21826643$3$F$20220101$20240725$20230106$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15048$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218267084$21826708$4$F$$20240726$20230106$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15052$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218269184$21826918$4$F$20220101$20240702$20230106$20240708$EXP$$NL-ABBVIE-4189716$ABBVIE$$$$E$M$Y$$$20240708$$CN$NL$NL
218270242$21827024$2$F$$20240725$20230106$20240806$EXP$$CA-AUROBINDO-AUR-APL-2022-057468$AUROBINDO$$40$YR$$F$Y$$$20240806$$HP$CA$CA
218271085$21827108$5$F$20230331$20240717$20230106$20240722$PER$$US-AMGEN-USASP2022227764$AMGEN$$50$YR$A$F$Y$$$20240722$$HP$US$US
2182713021$21827130$21$F$20220101$20240916$20230106$20240925$EXP$$CA-CELLTRION INC.-2021CA018723$CELLTRION$$$$$$Y$$$20240925$$MD$CA$CA
2182882029$21828820$29$F$20191109$20240920$20230106$20240926$EXP$$US-TAKEDA-2023TUS000945$TAKEDA$$38$YR$$M$Y$$$20240926$$MD$US$US
218288596$21828859$6$F$$20230427$20230106$20240926$PER$$US-GSK-US2023AMR000793$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
2182892122$21828921$22$F$20221201$20240904$20230106$20240911$EXP$$US-GSK-US2022AMR194826$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$US$US
218290963$21829096$3$F$20220710$20230825$20230106$20240806$EXP$$US-AstraZeneca-2022A420911$ASTRAZENECA$$25596$DY$$M$Y$93$KG$20240806$$CN$US$
218296212$21829621$2$F$$20240701$20230106$20240710$PER$$US-SA-2023SA005272$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240710$$MD$US$US
218296966$21829696$6$F$20190404$20240705$20230106$20240717$EXP$$DE-ROCHE-2302028$ROCHE$$31$YR$A$M$Y$$$20240717$$CN$DE$DE
218299264$21829926$4$F$20220617$20240719$20230106$20240723$PER$$US-ABBVIE-4259067$ABBVIE$$45$YR$$F$Y$92.079$KG$20240723$$MD$US$US
2183019310$21830193$10$F$20230518$20240913$20230106$20240921$EXP$$CA-TAKEDA-2023TUS001090$TAKEDA$$21$YR$$F$Y$$$20240921$$HP$CA$CA
218305762$21830576$2$F$20220101$20240812$20230106$20240821$PER$$US-SA-2023SA005572$SANOFI AVENTIS$$40$YR$A$M$Y$87$KG$20240821$$MD$US$US
218306772$21830677$2$F$20240701$20240703$20230106$20240709$PER$$US-SA-2023SA004763$SANOFI AVENTIS$$44$YR$A$F$Y$86.1$KG$20240709$$MD$US$US
218308914$21830891$4$F$20220801$20240906$20230106$20240912$EXP$$GB-TAKEDA-2023TUS001302$TAKEDA$$29$YR$$F$Y$$$20240912$$CN$GB$GB
218312528$21831252$8$F$20210309$20240910$20230106$20240912$EXP$$US-PFIZER INC-202300004553$PFIZER$$78$YR$$F$Y$74.83$KG$20240912$$CN$US$US
218312823$21831282$3$F$$20240828$20230106$20240830$EXP$$US-PFIZER INC-2021832299$PFIZER$$89$YR$$M$Y$$$20240830$$HP$US$US
218313313$21831331$3$F$20221227$20240822$20230106$20240822$EXP$$NVSC2023DE002795$NOVARTIS$$82$YR$$M$Y$66$KG$20240822$$MD$DE$DE
218313644$21831364$4$F$$20240828$20230106$20240906$EXP$$CA-APOTEX-2023AP000073$APOTEX$$66$YR$$F$Y$$$20240906$$HP$CA$CA
218313922$21831392$2$F$20221130$20240705$20230106$20240715$EXP$IT-MINISAL02-900873$IT-TEVA-2022-IT-2842142$TEVA$$13$YR$$M$Y$43$KG$20240715$$PH$IT$IT
2183141113$21831411$13$F$20230809$20240917$20230106$20240924$EXP$$CA-TAKEDA-2021TUS040704$TAKEDA$$79$YR$$M$Y$$$20240924$$CN$CA$CA
218315754$21831575$4$F$20240701$20240717$20230106$20240722$PER$$US-PFIZER INC-PV202300002701$PFIZER$$47$YR$$F$Y$$$20240722$$PH$US$US
218316464$21831646$4$F$20221122$20230823$20230106$20240724$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2022USL00804$UPSHER-SMITH$$60$YR$$F$Y$77.098$KG$20240724$$CN$US$US
2183166710$21831667$10$F$20171212$20240703$20230106$20240710$EXP$$NVSC2022DE301429$NOVARTIS$$38$YR$$F$Y$57.5$KG$20240710$$CN$DE$DE
218316923$21831692$3$F$$20240917$20230106$20240925$EXP$$CA-JNJFOC-20230106684$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240925$$CN$CA$CA
218320577$21832057$7$F$20220915$20240718$20230106$20240723$EXP$$JP-009507513-2209JPN002554J$MERCK$Inakami K, Fujita N, Iguchi C, Enomoto Y, Minohata J, Sata A, et al.. Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report. Journal of Medical Case Reports. 2024;18(214):1-6$43$YR$$F$Y$$$20240723$$MD$JP$JP
218320862$21832086$2$F$$20240725$20230106$20240726$EXP$$US-TAKEDA-2023TUS001708$TAKEDA$$$$$F$Y$$$20240726$$CN$US$US
218321035$21832103$5$F$$20240726$20230106$20240806$PER$$US-SA-2023SA005455$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240806$$MD$US$US
218321103$21832110$3$F$$20240919$20230106$20240920$PER$$NVSC2023US002794$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
218331867$21833186$7$F$20230104$20240913$20230106$20240923$EXP$$CA-HLS-202300026$HLS THERAPEUTICS$$62$YR$A$M$Y$$$20240923$$PH$CA$CA
218332104$21833210$4$F$20220801$20240917$20230106$20240926$EXP$$BR-CELLTRION INC.-2022BR022133$CELLTRION$$$$$$Y$$$20240926$$CN$BR$BR
218333283$21833328$3$F$20220101$20240731$20230107$20240807$EXP$$CA-CELLTRION INC.-2022CA009715$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
218334905$21833490$5$F$20211001$20240830$20230107$20240909$EXP$$ES-CELLTRION INC.-2022ES022130$CELLTRION$$$$$$Y$$$20240909$$MD$ES$ES
218336103$21833610$3$F$$20240814$20230107$20240827$EXP$$CA-AUROBINDO-AUR-APL-2022-057652$AUROBINDO$$61$YR$$F$Y$74$KG$20240827$$HP$CA$CA
218338782$21833878$2$F$20170101$20240814$20230108$20240827$EXP$$PL-AUROBINDO-AUR-APL-2023-000667$AUROBINDO$Krzystanek M, Warchala A, Tredzbor B, Martyniak E, Skalacka K, Palasz A. Amantadine in the treatment of sexual inactivity in schizophrenia patients taking atypical antipsychotics -the pilot case series study. Pharmaceuticals. 2021;14(10) 947:1-11.$42$YR$$M$Y$$$20240827$$MD$PL$PL
218340057$21834005$7$F$20220114$20240812$20230108$20240814$PER$$US-ROCHE-3008870$ROCHE$$44$YR$A$M$Y$97.52$KG$20240814$$CN$US$US
218340403$21834040$3$F$20220221$20240716$20230108$20240718$PER$$US-ROCHE-3035468$ROCHE$$61$YR$A$M$Y$$$20240718$$HP$US$US
218342623$21834262$3$F$20220817$20240802$20230108$20240806$PER$$US-ROCHE-3170009$ROCHE$$11$YR$C$M$Y$$$20240806$$CN$US$US
218345122$21834512$2$F$20240829$20240830$20230108$20240906$PER$$US-ROCHE-2970858$ROCHE$$51$YR$A$M$Y$$$20240906$$CN$US$US
218345784$21834578$4$F$20220324$20240814$20230108$20240816$PER$$US-ROCHE-3063868$ROCHE$$40$YR$A$M$Y$$$20240816$$CN$US$US
218346372$21834637$2$F$$20240709$20230108$20240711$PER$$US-ROCHE-3200366$ROCHE$$49$YR$A$$Y$$$20240711$$CN$US$US
218349155$21834915$5$F$$20240910$20230109$20240913$EXP$$US-PFIZER INC-PV202300002381$PFIZER$$79$YR$$F$Y$$$20240913$$CN$US$US
218350379$21835037$9$F$20180407$20240813$20230109$20240819$EXP$$US-TAKEDA-US201813864$TAKEDA$$9$YR$$M$Y$62$KG$20240819$$MD$US$US
218350393$21835039$3$F$20221228$20240808$20230109$20240811$PER$$NVSC2023US002973$NOVARTIS$$72$YR$$F$Y$$$20240811$$CN$US$US
218351899$21835189$9$F$20220101$20240920$20230109$20240924$EXP$$NVSC2023US002154$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
218352045$21835204$5$F$20221201$20230328$20230109$20240926$PER$$US-GSK-US2023AMR001149$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240926$$CN$US$US
218353953$21835395$3$F$$20240903$20230109$20240903$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000002$PAREXEL$$$$$$Y$$$20240903$$MD$US$US
218356323$21835632$3$F$20230105$20240702$20230109$20240711$EXP$$CA-ROCHE-3257468$ROCHE$$42$YR$A$F$Y$$$20240711$$CN$CA$CA
218356444$21835644$4$F$$20240912$20230109$20240920$EXP$$CA-TAKEDA-2022TUS095982$TAKEDA$$$$$M$Y$$$20240920$$MD$CA$CA
218357225$21835722$5$F$$20240619$20230109$20240702$EXP$GB-ROCHE-3256583$GB-ROCHE-3256583$ROCHE$$$$A$M$Y$$$20240702$$MD$GB$GB
218357653$21835765$3$F$20230104$20240730$20230109$20240807$PER$$US-SA-2023SA005688$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240807$$CN$US$US
218359592$21835959$2$F$$20240714$20230109$20240801$PER$$US-SA-2022SA418126$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240719$$MD$US$US
218360726$21836072$6$F$20220212$20231019$20230109$20240824$EXP$$US-TAKEDA-2022TUS081862$TAKEDA$$13$YR$$M$Y$$$20240824$$HP$US$US
218362123$21836212$3$F$20221228$20240725$20230109$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-14979$LUPIN$$$$$$Y$$$20240813$$CN$US$US
2183631013$21836310$13$F$$20240906$20230109$20240912$EXP$$NVSC2023US001938$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
218363534$21836353$4$F$$20240702$20230109$20240708$PER$$US-BIOGEN-2023BI01179767$BIOGEN$$$$$F$Y$$$20240708$$CN$US$US
218366632$21836663$2$F$$20240821$20230109$20240829$PER$$US-SA-2023SA005210$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240829$$MD$US$US
2183685112$21836851$12$F$20230501$20240916$20230109$20240926$PER$$US-GSK-US2023AMR001102$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240926$$CN$US$US
218368974$21836897$4$F$$20240816$20230109$20240819$PER$$NVSC2023US003925$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
218371484$21837148$4$F$20220901$20240919$20230109$20240926$EXP$$CA-GSK-CA2023001135$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$CA$CA
2183715314$21837153$14$F$20230103$20240801$20230109$20240805$EXP$$CA-GSK-CA2023AMR001562$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$PH$CA$CA
218371707$21837170$7$F$20221115$20240820$20230109$20240827$EXP$$CA-GSK-CA2022AMR174098$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$HP$CA$CA
218371768$21837176$8$F$20230101$20240807$20230109$20240808$EXP$$US-UCBSA-2023000655$UCB$$75$YR$$M$Y$122.45$KG$20240808$$CN$US$US
218371792$21837179$2$F$20230103$20240712$20230109$20240716$EXP$$US-UCBSA-2023000723$UCB$$46$YR$$F$Y$$$20240716$$HP$US$US
218372062$21837206$2$F$$20230103$20230109$20240716$EXP$$BG-ASTELLAS-2023US000632$ASTELLAS$$30$YR$$F$Y$$$20240716$$MD$BG$BG
218372124$21837212$4$F$20230103$20240808$20230109$20240809$EXP$$US-UCBSA-2023000834$UCB$$69$YR$$M$Y$$$20240809$$CN$US$US
218372209$21837220$9$F$$20240913$20230109$20240923$PER$$US-PHARMING-PHAUS2023000028$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
218372432$21837243$2$F$20221101$20240807$20230109$20240816$PER$$US-SA-2023SA006080$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240816$$MD$US$US
218373452$21837345$2$F$$20230102$20230109$20240920$EXP$$NVSC2023DE002419$NOVARTIS$$$$$$Y$$$20240920$$PH$DE$DE
2183744213$21837442$13$F$20230210$20240724$20230109$20240730$EXP$$CA-TAKEDA-2022TUS002422$TAKEDA$$24$YR$$F$Y$$$20240730$$MD$CA$CA
218374574$21837457$4$F$20210101$20240718$20230109$20240723$EXP$$US-PFIZER INC-PV202300002937$PFIZER$$54$YR$$F$Y$$$20240723$$HP$US$US
218374756$21837475$6$F$20220901$20240822$20230109$20240827$PER$$US-PFIZER INC-PV202200133515$PFIZER$$68$YR$$F$Y$$$20240827$$MD$US$US
218375203$21837520$3$F$$20240910$20230109$20240911$PER$$US-PFIZER INC-PV202300002059$PFIZER$$56$YR$$F$Y$$$20240911$$CN$US$US
218375377$21837537$7$F$$20240701$20230109$20240703$PER$$US-PFIZER INC-PV202300002252$PFIZER$$78$YR$$F$Y$$$20240703$$CN$US$US
218375759$21837575$9$F$20221223$20240621$20230109$20240702$EXP$$US-JNJFOC-20221261205$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240702$$PH$US$US
2183776810$21837768$10$F$20220601$20230613$20230109$20240926$EXP$$BG-AKCEA THERAPEUTICS, INC.-2022IS004281$AKCEA THERAPEUTICS$$$$$$Y$$$20240926$$CN$BG$BG
218379399$21837939$9$F$$20240919$20230109$20240924$PER$$US-PFIZER INC-PV202300002940$PFIZER$$71$YR$$M$Y$$$20240924$$CN$US$US
218380306$21838030$6$F$20221001$20240730$20230109$20240822$PER$$CA-TOLMAR, INC.-22CA038252$TOLMAR$$83$YR$$M$Y$$$20240822$$CN$CA$CA
218380337$21838033$7$F$20221229$20240711$20230109$20240729$PER$$CA-TOLMAR, INC.-22CA038254$TOLMAR$$71$YR$$M$Y$$$20240729$$CN$CA$CA
218380357$21838035$7$F$20221230$20240806$20230109$20240828$PER$$CA-TOLMAR, INC.-22CA038280$TOLMAR$$68$YR$$M$Y$$$20240828$$CN$CA$CA
218380635$21838063$5$F$$20240729$20230109$20240801$EXP$$CA-PFIZER INC-202200221285$PFIZER$$66$YR$$F$Y$$$20240801$$HP$CA$CA
218382567$21838256$7$F$$20240716$20230109$20240722$PER$$US-PFIZER INC-PV202300004228$PFIZER$$72$YR$$F$Y$$$20240722$$HP$US$US
218384432$21838443$2$F$$20240815$20230109$20240827$EXP$$US-ROCHE-3198957$ROCHE$$76$YR$E$M$Y$$$20240827$$CN$US$US
218385906$21838590$6$F$$20240918$20230109$20240923$EXP$$IN-PFIZER INC-202200560277$PFIZER$$63$YR$$F$Y$51.8$KG$20240923$$CN$IN$IN
218386196$21838619$6$F$20220829$20240924$20230109$20240930$EXP$$US-TAKEDA-2022TUS059050$TAKEDA$$75$YR$$F$Y$$$20240929$$CN$US$US
218386972$21838697$2$F$$20240819$20230109$20240829$PER$$US-SA-2023SA006310$SANOFI AVENTIS$$38$YR$A$M$Y$70$KG$20240829$$MD$US$US
218387205$21838720$5$F$20220701$20240724$20230109$20240730$EXP$$AT-MYLANLABS-2023M1000928$MYLAN$$$$E$F$Y$59$KG$20240730$$MD$AT$AT
218390593$21839059$3$F$20221227$20240822$20230109$20240826$EXP$$DE-BAUSCH-BL-2023-000316$BAUSCH AND LOMB$$82$YR$$M$Y$66$KG$20240826$$MD$DE$DE
2183917713$21839177$13$F$20220603$20240920$20230109$20240927$EXP$$US-TAKEDA-2022TUS043327$TAKEDA$$4$YR$$F$Y$21$KG$20240927$$CN$US$US
2183944018$21839440$18$F$20230309$20240801$20230109$20240811$EXP$$US-JAZZ-2022-US-033507$JAZZ$$45$YR$$F$Y$$$20240811$$HP$US$US
218395656$21839565$6$F$20221228$20240823$20230109$20240827$PER$$NVSC2023US004007$NOVARTIS$$10$YR$$F$Y$47.3$KG$20240828$$HP$US$US
218396533$21839653$3$F$20220901$20230501$20230109$20240710$EXP$$AU-ASTELLAS-2023US000685$ASTELLAS$$28$YR$$M$Y$$$20240710$$MD$AU$AU
218401068$21840106$8$F$$20240717$20230110$20240724$EXP$$CA-ROCHE-3256787$ROCHE$$26$YR$A$F$Y$51$KG$20240724$$MD$CA$CA
218403738$21840373$8$F$$20240313$20230110$20240808$EXP$$NVSC2023US004578$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
218407302$21840730$2$F$$20240910$20230110$20240911$PER$$NVSC2023US004002$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
218408543$21840854$3$F$20201106$20230105$20230110$20240827$EXP$$NVSC2020CN329824$NOVARTIS$$55$YR$$M$Y$77.5$KG$20240827$$MD$CN$CN
218408573$21840857$3$F$$20240725$20230110$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15044$LUPIN$$$$$$Y$$$20240816$$PH$US$US
218412246$21841224$6$F$$20240920$20230110$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-063811$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$45$KG$20240927$$MD$JP$JP
2184143918$21841439$18$F$20221201$20240917$20230110$20240926$EXP$$CA-CELLTRION INC.-2022CA021764$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
218414783$21841478$3$F$20240808$20240808$20230110$20240812$EXP$$US-TAKEDA-2022TUS036892$TAKEDA$$61$YR$$F$Y$$$20240812$$HP$US$US
2184148332$21841483$32$F$20220101$20240722$20230110$20240729$EXP$$CA-PFIZER INC-202201049502$PFIZER$$42$YR$$F$Y$42.63$KG$20240729$$MD$CA$CA
218414874$21841487$4$F$20221201$20240624$20230110$20240701$30DAY$$US-PFIZER INC-202200510501$PFIZER$$9$YR$$F$Y$27.22$KG$20240701$$MD$US$US
218415509$21841550$9$F$20230320$20240708$20230110$20240711$EXP$$CA-TAKEDA-2023TUS001755$TAKEDA$$64$YR$$M$Y$$$20240711$$CN$CA$CA
218416453$21841645$3$F$$20240725$20230110$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15046$LUPIN$$$$$$Y$$$20240817$$CN$US$US
2184165314$21841653$14$F$20220815$20240910$20230110$20240916$EXP$$GB-MYLANLABS-2022M1087676$MYLAN$$49$YR$$F$Y$$$20240916$$MD$GB$GB
218416597$21841659$7$F$20220616$20240729$20230110$20240801$EXP$$CA-TAKEDA-2022TUS041439$TAKEDA$$43$YR$$F$Y$$$20240801$$HP$CA$CA
218416733$21841673$3$F$$20240725$20230110$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15047$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218417373$21841737$3$F$$20240725$20230110$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15051$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218418662$21841866$2$F$$20230104$20230110$20240926$EXP$$US-GSK-US2023AMR001118$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
218419104$21841910$4$F$20200212$20240827$20230110$20240906$EXP$$JP-EXELIXIS-CABO-23059443$EXELIXIS$$78$YR$$M$Y$82.95$KG$20240906$$MD$JP$JP
2184199111$21841991$11$F$20220601$20240626$20230110$20240703$EXP$$US-SA-2023SA007646$SANOFI AVENTIS$$29$YR$A$F$Y$113.3$KG$20240703$$MD$US$US
218422652$21842265$2$F$20220623$20240718$20230110$20240724$EXP$$CA-TAKEDA-2022TUS039676$TAKEDA$$43$YR$$F$Y$$$20240724$$CN$CA$CA
2184227610$21842276$10$F$$20240923$20230110$20240926$EXP$$CA-ORGANON-O2301CAN000350$ORGANON$$$$$F$Y$$$20240926$$HP$CA$CA
218423813$21842381$3$F$$20240911$20230110$20240918$EXP$$CA-AstraZeneca-2021A575332$ASTRAZENECA$$51$YR$$F$Y$136$KG$20240918$$MD$CA$
218425542$21842554$2$F$20240821$20240830$20230110$20240912$PER$$US-SA-2023SA006900$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240912$$MD$US$US
218427703$21842770$3$F$$20240726$20230110$20240726$PER$$US-PFIZER INC-202300005772$PFIZER$$70$YR$$F$Y$56.7$KG$20240726$$CN$US$US
218428453$21842845$3$F$$20240923$20230110$20240926$PER$$US-BIOGEN-2023BI01179700$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
218431842$21843184$2$F$20221001$20240705$20230110$20240709$EXP$$DE-PFIZER INC-202300009539$PFIZER$$61$YR$$F$Y$56$KG$20240709$$HP$DE$DE
218436744$21843674$4$F$20220101$20230209$20230110$20240806$EXP$$US-RECORDATI-2022006508$RECORDATI$$$$$$Y$$$20240806$$CN$US$US
218438584$21843858$4$F$$20240715$20230110$20240722$PER$$US-SA-2023SA005950$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240722$$HP$US$US
218438766$21843876$6$F$20191129$20240710$20230110$20240715$EXP$$AT-ABBVIE-20K-009-3471380-00$ABBVIE$$64$YR$$M$Y$98$KG$20240715$$MD$AT$AT
218440253$21844025$3$F$20230101$20240722$20230110$20240727$EXP$$CA-TAKEDA-2022TUS005373$TAKEDA$$$$$F$Y$$$20240727$$CN$CA$CA
2184412111$21844121$11$F$$20240918$20230110$20240930$EXP$$CA-TAKEDA-2022TUS005891$TAKEDA$$$$$F$Y$$$20240930$$CN$CA$CA
218445663$21844566$3$F$$20240920$20230110$20240930$PER$$US-MYLANLABS-2022M1142590$MYLAN$$$$$F$Y$$$20240930$$CN$US$US
2184459628$21844596$28$F$20221107$20240917$20230110$20240917$EXP$$AU-MYLANLABS-2022M1125562$MYLAN$$64$YR$$F$Y$$$20240917$$HP$AU$AU
218455743$21845574$3$F$20220219$20240717$20230111$20240726$EXP$FR-AFSSAPS-TO20223642$FR-TEVA-2023-FR-2843273$TEVA$$15$YR$$M$Y$$$20240726$$MD$FR$FR
218461149$21846114$9$F$$20240628$20230111$20240701$EXP$$NVSC2023US005514$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
218461844$21846184$4$F$20221201$20240903$20230111$20240903$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000007$PAREXEL$$$$$$Y$$$20240903$$CN$US$US
218463634$21846363$4$F$$20240710$20230111$20240716$EXP$$CA-ROCHE-3259849$ROCHE$$$$A$F$Y$$$20240716$$MD$CA$CA
218468243$21846824$3$F$$20240919$20230111$20240923$EXP$$US-TAKEDA-2023TUS003074$TAKEDA$$$$$F$Y$$$20240923$$HP$US$US
218470187$21847018$7$F$20221225$20240624$20230111$20240701$EXP$$US-GSK-US2023001975$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$US$US
218470316$21847031$6$F$20220904$20240813$20230111$20240823$EXP$$US-TAKEDA-US202015473$TAKEDA$$21$YR$$M$Y$$$20240823$$HP$US$US
218471062$21847106$2$F$$20240727$20230111$20240811$EXP$$US-LUPIN PHARMACEUTICALS INC.-2023-00037$LUPIN$$$$$$Y$$$20240811$$CN$US$US
218471852$21847185$2$F$$20240820$20230111$20240826$EXP$$DE-MYLANLABS-2023M1002185$MYLAN$$32$YR$$M$Y$$$20240826$$MD$DE$DE
218474107$21847410$7$F$20240716$20240815$20230111$20240827$PER$$US-SA-2023SA007578$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240827$$MD$US$US
218474242$21847424$2$F$$20240806$20230111$20240813$PER$$US-SA-2023SA008889$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240814$$MD$US$US
218474662$21847466$2$F$20230106$20240827$20230111$20240919$PER$$US-SA-2023SA008690$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240919$$MD$US$US
218477663$21847766$3$F$20220712$20240812$20230111$20240823$EXP$$IL-ABBVIE-4168101$ABBVIE$$73$YR$$M$Y$80$KG$20240823$$MD$IL$IL
218478243$21847824$3$F$20221101$20240717$20230111$20240725$PER$$US-SA-2023SA008311$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240725$$MD$US$US
218478433$21847843$3$F$$20240726$20230111$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00012$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218478527$21847852$7$F$20220127$20240820$20230111$20240822$EXP$$NVSC2022IT022203$NOVARTIS$$49$YR$$F$Y$$$20240822$$HP$IT$IT
218479483$21847948$3$F$$20240727$20230111$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00013$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218480273$21848027$3$F$$20240726$20230111$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00020$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218480583$21848058$3$F$$20240726$20230111$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00024$LUPIN$$$$$$Y$$$20240816$$CN$US$US
2184820312$21848203$12$F$20230106$20240803$20230111$20240808$EXP$$IN-PFIZER INC-PV202200062594$PFIZER$$65$YR$$M$Y$78.1$KG$20240808$$CN$IN$IN
218485804$21848580$4$F$$20240731$20230111$20240806$EXP$$US-PFIZER INC-PV202300003074$PFIZER$Miao, J.. Levofloxacin Associated Bullous Pemphigoid in a Hemodialysis Patient After Kidney Transplant Failure. The American Journal of Case Reports. 2022;23:e938476$27$YR$$F$Y$$$20240806$$HP$US$US
218485894$21848589$4$F$$20240727$20230111$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00025$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218487345$21848734$5$F$$20240727$20230111$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00028$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218487423$21848742$3$F$$20240726$20230111$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00029$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218487603$21848760$3$F$$20240726$20230111$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00030$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218487723$21848772$3$F$$20240726$20230111$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00034$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218488034$21848803$4$F$$20240726$20230111$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00035$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218488063$21848806$3$F$20221201$20240711$20230111$20240723$PER$$US-SA-2023SA008872$SANOFI AVENTIS$$56$YR$A$M$Y$138$KG$20240723$$MD$US$US
218488582$21848858$2$F$$20240729$20230111$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00038$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218488662$21848866$2$F$$20240726$20230111$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00036$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218488684$21848868$4$F$$20240905$20230111$20240910$EXP$$US-PFIZER INC-202300011838$PFIZER$Bharath, S.. Pearls + Oy-sters: Status Epilepticus and Cerebral Edema From Hyperammonemia Due to Disseminated Ureaplasma and Mycoplasma Species. Neurology. 2022;10.1212/WNL.0000000000206778.$57$YR$$M$Y$$$20240910$$MD$US$US
218488816$21848881$6$F$20180822$20240710$20230111$20240717$EXP$$JP-ABBVIE-4145184$ABBVIE$$57$YR$$M$Y$$$20240717$$MD$JP$JP
218489103$21848910$3$F$$20240726$20230111$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00040$LUPIN$$$$$$Y$$$20240813$$CN$US$US
218491369$21849136$9$F$20221003$20240731$20230111$20240802$EXP$$US-PFIZER INC-PV202200121979$PFIZER$$72$YR$$F$Y$77.098$KG$20240802$$CN$US$US
218491955$21849195$5$F$20221201$20240808$20230111$20240812$PER$$US-PFIZER INC-202300010856$PFIZER$$66$YR$$F$Y$54.61$KG$20240812$$PH$US$US
218493552$21849355$2$F$20240508$20240828$20230111$20240829$EXP$$US-PFIZER INC-PV202300006133$PFIZER$$90$YR$$M$Y$$$20240829$$CN$US$US
218493952$21849395$2$F$$20240717$20230111$20240718$EXP$$BG-ABBVIE-4264635$ABBVIE$$30$YR$$F$Y$$$20240718$$MD$BG$BG
218496203$21849620$3$F$$20240625$20230111$20240702$EXP$$US-TAKEDA-2022TUS065734$TAKEDA$$$$$F$Y$87.07$KG$20240702$$HP$US$US
218496423$21849642$3$F$20210607$20240918$20230111$20240924$EXP$$CA-TAKEDA-2022TUS010893$TAKEDA$$36$YR$$F$Y$$$20240924$$MD$CA$CA
218501632$21850163$2$F$20230110$20240820$20230111$20240830$PER$$US-SA-2023SA010433$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240830$$MD$US$US
218502125$21850212$5$F$20211228$20240722$20230111$20240729$EXP$$CO-TAKEDA-CO202026817$TAKEDA$$19$YR$$F$Y$53$KG$20240729$$CN$CO$CO
218502463$21850246$3$F$20210101$20240804$20230111$20240807$EXP$$IL-ABBVIE-22K-082-4485941-00$ABBVIE$$77$YR$$M$Y$70$KG$20240807$$MD$IL$IL
2185056327$21850563$27$F$20221109$20240903$20230111$20240917$EXP$$CA-HLS-202300057$HLS THERAPEUTICS$$56$YR$A$M$Y$$$20240917$$CN$CA$CA
218509997$21850999$7$F$20210428$20240918$20230111$20240928$EXP$$CA-CELLTRION INC.-2021CA006393$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
218510292$21851029$2$F$20221213$20240822$20230111$20240823$EXP$$US-AVEO ONCOLOGY-2022-AVEO-US000609$PAREXEL$$$$$$Y$$$20240823$$CN$US$US
2185118410$21851184$10$F$$20240711$20230112$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2023-000603$UNITED THERAPEUTICS$$$$$F$Y$119.86$KG$20240720$$$US$US
218513715$21851371$5$F$$20230417$20230112$20240925$PER$$US-GSK-US2023AMR001945$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
218514534$21851453$4$F$20230101$20240808$20230112$20240810$EXP$$US-ABBVIE-4265359$ABBVIE$$81$YR$$M$Y$$$20240810$$CN$US$US
218516663$21851666$3$F$$20240726$20230112$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00026$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218516783$21851678$3$F$$20240727$20230112$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00067$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218518084$21851808$4$F$$20240912$20230112$20240920$30DAY$$US-GSK-US2023002229$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
2185181913$21851819$13$F$20210108$20240705$20230112$20240801$EXP$$GB-ABBVIE-4266248$ABBVIE$$$$A$M$Y$$$20240801$$MD$GB$GB
218518212$21851821$2$F$20231001$20240718$20230112$20240722$EXP$$PHHY2018CO092219$NOVARTIS$$48$YR$$F$Y$62$KG$20240722$$CN$CO$CO
218520674$21852067$4$F$20221101$20240624$20230112$20240701$EXP$$AT-CELLTRION INC.-2023AT000126$CELLTRION$$$$$$Y$$$20240702$$MD$AT$AT
218523617$21852361$7$F$20221001$20240805$20230112$20240827$PER$$CA-TOLMAR, INC.-22CA038226$TOLMAR$$69$YR$$M$Y$$$20240827$$CN$CA$CA
218523622$21852362$2$F$20221227$20240709$20230112$20240730$PER$$CO-TOLMAR, INC.-22CO038207$TOLMAR$$88$YR$$M$Y$$$20240730$$CN$CO$CO
218524085$21852408$5$F$20230120$20240705$20230112$20240709$EXP$$CA-TAKEDA-2023TUS003441$TAKEDA$$65$YR$$M$Y$$$20240709$$CN$CA$CA
2185241610$21852416$10$F$$20240906$20230112$20240911$EXP$$US-TAKEDA-2017BLT005572$TAKEDA$$$$$F$Y$65$KG$20240911$$CN$US$US
218526943$21852694$3$F$$20240726$20230112$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00041$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218527584$21852758$4$F$20211217$20240904$20230112$20240918$EXP$$JP-ASTELLAS-2023JP000109$ASTELLAS$$66$YR$E$M$Y$66$KG$20240918$$MD$JP$JP
218527765$21852776$5$F$20221205$20230406$20230112$20240923$PER$$US-ABBVIE-4229997$ABBVIE$$76$YR$$F$Y$58.9$KG$20240923$$CN$US$US
218529925$21852992$5$F$20210521$20240718$20230112$20240726$EXP$$CA-TAKEDA-2022TUS008609$TAKEDA$$70$YR$$M$Y$$$20240726$$CN$CA$CA
218530012$21853001$2$F$$20240727$20230112$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00022$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218530395$21853039$5$F$$20230301$20230112$20240722$EXP$$NVSC2023US006373$NOVARTIS$$$$$F$Y$$$20240722$$CN$US$US
2185323211$21853232$11$F$$20240909$20230112$20240916$EXP$$CA-TAKEDA-2023TUS002786$TAKEDA$$$$$F$Y$$$20240916$$CN$CA$CA
2185336914$21853369$14$F$20220927$20240822$20230112$20240829$EXP$$CA-CELLTRION INC.-2022CA001493$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
218534182$21853418$2$F$$20240703$20230112$20240714$PER$$US-SA-2023SA010836$SANOFI AVENTIS$$$$A$F$Y$$$20240714$$MD$US$US
218535402$21853540$2$F$$20240729$20230112$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00054$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218535432$21853543$2$F$20221001$20230105$20230112$20240827$PER$$US-ABBVIE-4260483$ABBVIE$$46$YR$$F$Y$$$20240827$$CN$US$US
218535653$21853565$3$F$$20240727$20230112$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00062$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218537493$21853749$3$F$$20240727$20230112$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00069$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218537578$21853757$8$F$20190801$20240711$20230112$20240723$EXP$$DE-ROCHE-2634666$ROCHE$$18$YR$A$F$Y$$$20240723$$CN$DE$DE
218538133$21853813$3$F$$20240722$20230112$20240725$PER$$NVSC2023US006994$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
218540084$21854008$4$F$$20240727$20230112$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00081$LUPIN$$$$$$Y$$$20240817$$PH$US$US
218540364$21854036$4$F$20220809$20240723$20230112$20240729$PER$$US-BIOGEN-2022BI01147010$BIOGEN$$13$YR$$M$Y$$$20240729$$CN$US$US
2185410712$21854107$12$F$20220908$20240730$20230112$20240802$EXP$$US-TAKEDA-2022TUS075087$TAKEDA$$45$YR$$F$Y$66$KG$20240802$$HP$US$US
218541803$21854180$3$F$$20240727$20230112$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00095$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218542292$21854229$2$F$$20240730$20230112$20240801$PER$$US-PFIZER INC-202201063047$PFIZER$$66$YR$$F$Y$64.1$KG$20240801$$PH$US$US
218545082$21854508$2$F$20230106$20240823$20230112$20240829$PER$$US-009507513-2301USA001765$MERCK$$73$YR$$F$Y$$$20240829$$CN$US$US
218547272$21854727$2$F$$20240727$20230112$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00055$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218547593$21854759$3$F$$20240727$20230112$20240818$PER$$US-LUPIN LIMITED-2023-00096$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218547806$21854780$6$F$20230721$20240828$20230112$20240905$EXP$$US-TAKEDA-2023TUS003850$TAKEDA$$60$YR$$M$Y$$$20240905$$CN$US$US
218548308$21854830$8$F$20230108$20240715$20230112$20240719$EXP$$HR-TAKEDA-2023TUS003521$TAKEDA$$26$YR$$F$Y$$$20240719$$HP$HR$HR
2185508111$21855081$11$F$$20240722$20230112$20240723$PER$$US-PFIZER INC-PV202300006058$PFIZER$$75$YR$$M$Y$90.99$KG$20240723$$MD$US$US
218554314$21855431$4$F$$20240815$20230112$20240819$PER$$US-AMGEN-USASP2023003053$AMGEN$$47$YR$A$F$Y$$$20240819$$HP$US$US
218556452$21855645$2$F$$20240802$20230112$20240808$EXP$$NVSC2023CA003067$NOVARTIS$$49$YR$$F$Y$$$20240808$$MD$CA$CA
218557986$21855798$6$F$20130101$20240912$20230112$20240921$EXP$$BR-CELLTRION INC.-2023BR000211$CELLTRION$$$$$$Y$$$20240921$$CN$BR$BR
218558418$21855841$8$F$20240618$20240724$20230112$20240727$EXP$$CA-ROCHE-2975521$ROCHE$$41$YR$A$F$Y$$$20240727$$CN$CA$CA
218558533$21855853$3$F$$20240925$20230112$20240926$PER$$NVSC2023US006694$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
218558823$21855882$3$F$20221001$20240620$20230112$20240702$EXP$$CA-HLS-202202360$HLS THERAPEUTICS$$39$YR$A$M$Y$$$20240702$$MD$CA$CA
218559353$21855935$3$F$20191007$20240828$20230112$20240829$EXP$$US-TAKEDA-US201939118$TAKEDA$$11$YR$$M$Y$$$20240829$$HP$US$US
2185626810$21856268$10$F$20231208$20240813$20230112$20240819$EXP$$US-JAZZ-2023-US-000248$JAZZ$$51$YR$$F$Y$$$20240819$$CN$US$US
218565219$21856521$9$F$20221201$20240621$20230112$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004416$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240716$$CN$US$US
218566002$21856600$2$F$20190101$20240709$20230112$20240712$PER$$US-ABBVIE-22K-163-4420125-00$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
218567832$21856783$2$F$$20240828$20230113$20240829$EXP$$NVSC2023AU006395$NOVARTIS$$$$$M$Y$$$20240829$$HP$AU$AU
218570876$21857087$6$F$20210108$20240705$20230113$20240710$EXP$$GB-SA-2023SA010969$SANOFI AVENTIS$$$$A$M$Y$$$20240710$$CN$GB$GB
218571845$21857184$5$F$20230104$20240719$20230113$20240729$EXP$$CA-CELLTRION INC.-2023CA000671$CELLTRION$$$$$$Y$$$20240729$$HP$CA$CA
218572322$21857232$2$F$$20230110$20230113$20240920$EXP$$NVSC2023CN006935$NOVARTIS$$$$$$Y$$$20240920$$CN$CN$CN
218572742$21857274$2$F$$20240708$20230113$20240716$EXP$$BR-CELLTRION INC.-2023BR000318$CELLTRION$$$$$$Y$$$20240716$$CN$BR$BR
2185739410$21857394$10$F$20230101$20240910$20230113$20240917$EXP$$US-GSK-US2023AMR004027$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$US$US
218574265$21857426$5$F$$20240912$20230113$20240925$EXP$$CA-CELLTRION INC.-2023CA000435$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
218574298$21857429$8$F$20230109$20240710$20230113$20240723$EXP$$NVSC2023GB005558$NOVARTIS$$58$YR$$F$Y$$$20240723$$CN$GB$GB
218578703$21857870$3$F$$20240729$20230113$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00097$LUPIN$$$$$$Y$$$20240821$$CN$US$US
218579694$21857969$4$F$$20240729$20230113$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00118$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218579898$21857989$8$F$$20240821$20230113$20240828$EXP$$BR-CELLTRION INC.-2022BR021958$CELLTRION$$$$$$Y$$$20240828$$CN$BR$BR
218580702$21858070$2$F$$20240710$20230113$20240711$30DAY$$US-GSK-US2023003968$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
218582783$21858278$3$F$20221216$20240708$20230113$20240717$PER$$US-SA-2023SA012595$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240717$$MD$US$US
218584737$21858473$7$F$20220101$20240813$20230113$20240819$EXP$$US-BIOGEN-2022BI01160892$BIOGEN$$$$$F$Y$$$20240819$$CN$US$US
218585035$21858503$5$F$20230101$20240829$20230113$20240923$PER$$US-SA-2023SA012985$SANOFI AVENTIS$$12$YR$T$F$Y$82.91$KG$20240923$$MD$US$US
218586454$21858645$4$F$$20240628$20230113$20240712$PER$$US-SA-2023SA013137$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240712$$MD$US$US
218587958$21858795$8$F$20230101$20240716$20230113$20240725$EXP$$US-EMD Serono-9376923$EMD SERONO INC$$58$YR$A$M$Y$$$20240725$$CN$US$US
218588684$21858868$4$F$20211221$20240716$20230113$20240726$EXP$$JP-ROCHE-3263294$ROCHE$Sekiguchi Y, Sekiguchi Y, Kobayashi Y, Nishimura Y, Kanda H, Kawamura M, Kobayashi K A Case of Bladder Cancer Developing Immune-related Thrombocytopenia after Combined Therapy with Radiation and Atezolizumab.. The 683rd Kanto Regional Meeting of the Japanese Society of Internal Medicine. 2022;:-.$84$YR$E$F$Y$45$KG$20240726$$MD$JP$JP
218589724$21858972$4$F$20221201$20240708$20230113$20240712$EXP$$NVSC2023EG006453$NOVARTIS$$65$YR$$F$Y$$$20240712$$CN$EG$EG
218592422$21859242$2$F$$20240727$20230113$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00039$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218592683$21859268$3$F$$20240727$20230113$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00068$LUPIN$$$$$$Y$$$20240816$$CN$US$US
218593542$21859354$2$F$$20240829$20230113$20240907$30DAY$$US-GSK-US2023002765$GLAXOSMITHKLINE$$$$$M$Y$$$20240907$$CN$US$US
218594565$21859456$5$F$$20240729$20230113$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00126$LUPIN$$$$$$Y$$$20240817$$PH$US$US
218594572$21859457$2$F$$20240729$20230113$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00132$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218594833$21859483$3$F$$20240729$20230113$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00128$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218595233$21859523$3$F$$20240729$20230113$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00150$LUPIN$$$$$$Y$$$20240818$$PH$US$US
2185954710$21859547$10$F$20220101$20240627$20230113$20240701$EXP$$US-PFIZER INC-PV202300006906$PFIZER$$78$YR$$F$Y$61.224$KG$20240701$$HP$US$US
218595493$21859549$3$F$20220101$20240729$20230113$20240801$EXP$$CA-PFIZER INC-202300004828$PFIZER$$67$YR$$M$Y$$$20240801$$HP$CA$CA
218596573$21859657$3$F$$20240823$20230113$20240916$PER$$US-SA-2023SA013005$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
218598673$21859867$3$F$20230101$20240729$20230113$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00127$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218599143$21859914$3$F$20230101$20240729$20230113$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00131$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218601114$21860111$4$F$$20240729$20230113$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-005598$BRISTOL MYERS SQUIBB$Kataoka Y, et al. A case of anaplastic thyroid cancer transformation during nivolumab therapy for advanced lung adenocarcinoma. Japanese Journal of Lung Cancer. 2022;62(6).$71$YR$E$M$Y$$$20240805$$MD$JP$JP
218601328$21860132$8$F$20240719$20240719$20230113$20240724$EXP$$US-SHIRE-US201827123$TAKEDA$$66$YR$$F$Y$51$KG$20240724$$CN$US$US
218604243$21860424$3$F$$20240730$20230113$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00135$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218604552$21860455$2$F$$20240729$20230113$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00138$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218605286$21860528$6$F$20230110$20240813$20230113$20240816$EXP$$DE-TAKEDA-2023TUS004171$TAKEDA$$38$YR$$F$Y$$$20240816$$CN$DE$DE
2186053210$21860532$10$F$20230101$20240729$20230113$20240805$EXP$$NVSC2023KR007059$NOVARTIS$$$$A$F$Y$$$20240806$$CN$KR$KR
218606062$21860606$2$F$$20220630$20230113$20240721$PER$$US-NOVOPROD-936154$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
218606144$21860614$4$F$20210907$20240829$20230113$20240905$EXP$$DE-ROCHE-3120776$ROCHE$$57$YR$A$M$Y$$$20240905$$CN$DE$DE
218607452$21860745$2$F$20220901$20220912$20230113$20240721$PER$$US-NOVOPROD-981346$NOVO NORDISK$$55$YR$$F$Y$$$20240721$$CN$US$US
218607753$21860775$3$F$20220926$20230126$20230113$20240721$PER$$US-NOVOPROD-983477$NOVO NORDISK$$64$YR$$F$Y$$$20240721$$CN$US$US
218608462$21860846$2$F$20221002$20230206$20230113$20240721$PER$$US-NOVOPROD-988521$NOVO NORDISK$$39$YR$$F$Y$$$20240721$$CN$US$US
218608616$21860861$6$F$20180715$20240701$20230113$20240708$EXP$PT-INFARMED-J202203-882$PT-MYLANLABS-2023M1003270$MYLAN$$32$YR$$F$Y$$$20240708$$MD$PT$PT
218609792$21860979$2$F$$20240823$20230113$20240828$PER$$US-PFIZER INC-PV202300002259$PFIZER$$62$YR$$F$Y$$$20240828$$CN$US$US
218610002$21861000$2$F$$20240708$20230113$20240710$PER$$US-PFIZER INC-PV202300004992$PFIZER$$75$YR$$F$Y$$$20240710$$CN$US$US
218610613$21861061$3$F$20220101$20240809$20230113$20240816$EXP$$CA-GSK-CA2023AMR002400$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$CA$CA
218612064$21861206$4$F$$20240919$20230113$20240924$PER$$US-PFIZER INC-PV202300004925$PFIZER$$68$YR$$F$Y$$$20240924$$MD$US$US
218613615$21861361$5$F$20211002$20240716$20230113$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-002524$BRISTOL MYERS SQUIBB$Iwamuro M, Tanaka T, Kono Y, Kawano S, Okada H. Multiple white plaques in the esophagus: a possible case of esophageal mucosal alteration associated with immune-related adverse events of immune checkpoint inhibitors. Cureus. 2022 Dec 19;14(12):1-10. doi:10.7759/cureus.32710.$58$YR$A$F$Y$49.4$KG$20240724$$MD$JP$JP
218620504$21862050$4$F$20160101$20240828$20230113$20240902$EXP$$US-ABBVIE-4268943$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
218620753$21862075$3$F$20220101$20240701$20230113$20240710$EXP$$BR-CELLTRION INC.-2023BR000457$CELLTRION$$$$$$Y$$$20240710$$CN$BR$BR
218621615$21862161$5$F$20221201$20240725$20230113$20240801$EXP$$US-ABBVIE-4268957$ABBVIE$$73$YR$$F$Y$$$20240801$$CN$US$US
218624169$21862416$9$F$20220101$20240814$20230114$20240823$EXP$$CA-CELLTRION INC.-2023CA000781$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
218624777$21862477$7$F$20221119$20240808$20230114$20240812$EXP$$NVSC2023US007403$NOVARTIS$$51$YR$$F$Y$$$20240812$$CN$US$US
218627603$21862760$3$F$20220201$20240828$20230114$20240903$EXP$$NVSC2023BR007496$NOVARTIS$$50$YR$$F$Y$160$KG$20240903$$CN$BR$BR
218631378$21863137$8$F$20220829$20240729$20230115$20240730$EXP$$NVSC2022CH253253$NOVARTIS$$77$YR$$F$Y$73$KG$20240730$$MD$CH$CH
2186338511$21863385$11$F$20221215$20240829$20230115$20240906$EXP$$CA-CELLTRION INC.-2022CA018312$CELLTRION$$$$$$Y$$$20240906$$MD$CA$CA
218634143$21863414$3$F$20181009$20240731$20230115$20240813$EXP$$US-AUROBINDO-AUR-APL-2023-001590$AUROBINDO$Miao J, Gibson LE, Craici IM.. Levofloxacin-Associated Bullous Pemphigoid in a Hemodialysis Patient After Kidney Transplant Failure.. American Journal of case reports. 2022;23:e938476$27$YR$$F$Y$66$KG$20240813$$MD$US$US
218634214$21863421$4$F$20230105$20240903$20230115$20240903$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000017$PAREXEL$$$$$$Y$$$20240903$$HP$US$US
218637386$21863738$6$F$20220101$20240910$20230116$20240919$EXP$$US-ABBVIE-4269168$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
218637693$21863769$3$F$$20240906$20230116$20240910$PER$$US-BIOGEN-2023BI01180856$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
2186437010$21864370$10$F$$20240920$20230116$20240927$EXP$$US-TAKEDA-US201942294$TAKEDA$$$$$F$Y$66$KG$20240927$$HP$US$US
218644013$21864401$3$F$$20240729$20230116$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00154$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218644097$21864409$7$F$20230319$20230605$20230116$20240926$PER$$US-GSK-US2023AMR004522$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240926$$CN$US$US
218644634$21864463$4$F$20221201$20240715$20230116$20240729$EXP$$DE-ROCHE-3264687$ROCHE$$36$YR$A$F$Y$$$20240729$$MD$DE$DE
218645154$21864515$4$F$20190603$20240903$20230116$20240910$EXP$$DE-ROCHE-2332952$ROCHE$$41$YR$A$F$Y$57$KG$20240910$$CN$DE$DE
218646203$21864620$3$F$$20240727$20230116$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00111$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218649883$21864988$3$F$20220601$20240814$20230116$20240821$PER$$US-BIOGEN-2023BI01181219$BIOGEN$$47$YR$$F$Y$$$20240821$$CN$US$US
2186499715$21864997$15$F$20220501$20240805$20230116$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-005274$BRISTOL MYERS SQUIBB$Hayashi M, Yoshida S, Koori N, Horie K, Yatsuduka K, Mutou J, et al. A case of cutaneous arteritis developing during immune checkpoint inhibitor therapy for pulmonary adenocarcinoma. The 75th Ehime Regional Meeting of Japanese Dermatological Association. 2022;17.$42$YR$A$M$Y$$$20240816$$MD$JP$JP
218650812$21865081$2$F$$20240729$20230116$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00163$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218650925$21865092$5$F$20230101$20230209$20230116$20240925$PER$$US-GSK-US2023AMR005548$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
218659176$21865917$6$F$20230101$20240725$20230116$20240802$EXP$$US-SA-2023SA013632$SANOFI AVENTIS$$62$YR$A$M$Y$81.64$KG$20240802$$MD$US$US
218660232$21866023$2$F$$20240913$20230116$20240925$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2023002554$VIIV$$$$$$Y$$$20240925$$MD$CA$CA
218660272$21866027$2$F$20220628$20230111$20230116$20240926$EXP$$US-GSK-US2022AMR104812$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
218661053$21866105$3$F$20230101$20240719$20230116$20240729$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2023-015567$REGENERON$$$$$M$Y$$$20240729$$CN$GB$GB
2186647513$21866475$13$F$$20240913$20230116$20240918$30DAY$$US-PFIZER INC-PV202300006190$PFIZER$$11$YR$$F$Y$31.3$KG$20240918$$CN$US$US
218667102$21866710$2$F$$20240729$20230116$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00133$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218667444$21866744$4$F$$20240729$20230116$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00155$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218670122$21867012$2$F$$20240730$20230116$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00173$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218670682$21867068$2$F$$20240729$20230116$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00202$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218672387$21867238$7$F$20190301$20240924$20230116$20240926$EXP$$CA-ROCHE-2306680$ROCHE$$38$YR$A$F$Y$$$20240926$$CN$CA$CA
218673305$21867330$5$F$20240904$20240904$20230116$20240910$EXP$$CA-TAKEDA-2023TUS004421$TAKEDA$$28$YR$$F$Y$$$20240910$$CN$CA$CA
218673963$21867396$3$F$$20240916$20230116$20240925$EXP$$US-TAKEDA-2021TUS040032$TAKEDA$$$$$F$Y$73$KG$20240925$$HP$US$US
218675835$21867583$5$F$$20240909$20230116$20240911$PER$$US-AMGEN-USASP2023005745$AMGEN$$$$A$F$Y$$$20240911$$HP$US$US
218676533$21867653$3$F$$20240910$20230116$20240918$EXP$$NVSC2023CA005880$NOVARTIS$$66$YR$$F$Y$$$20240918$$CN$CA$CA
218679137$21867913$7$F$$20240904$20230116$20240906$EXP$$US-JAZZ-2022-US-005179$JAZZ$$$$$M$Y$$$20240906$$HP$US$US
218681686$21868168$6$F$20221020$20240712$20230116$20240718$EXP$$JP-ABBVIE-4232852$ABBVIE$$75$YR$$M$Y$57$KG$20240718$$MD$JP$JP
2186828711$21868287$11$F$20211201$20240903$20230116$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323092$RANBAXY$$68$YR$$M$Y$102.04$KG$20240918$$CN$US$US
218684232$21868423$2$F$$20240729$20230116$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00151$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218685192$21868519$2$F$20221217$20240802$20230117$20240806$EXP$$US-ABBVIE-4270341$ABBVIE$$63$YR$$M$Y$$$20240806$$CN$US$US
2186859621$21868596$21$F$20220707$20240906$20230117$20240916$EXP$$DE-ROCHE-3136763$ROCHE$$51$YR$A$F$Y$$$20240916$$CN$DE$DE
218687332$21868733$2$F$$20240822$20230117$20240831$EXP$$CA-BAXTER-2023BAX010443$BAXTER$$63$YR$$M$Y$$$20240831$$HP$CA$CA
218688343$21868834$3$F$$20240716$20230117$20240725$PER$$US-SA-2023SA014956$SANOFI AVENTIS$$$$C$F$Y$$$20240725$$MD$US$US
218688877$21868887$7$F$20220101$20240701$20230117$20240705$PER$$US-BIOGEN-2022BI01147346$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
2186930319$21869303$19$F$20210412$20240920$20230117$20240926$EXP$$US-TAKEDA-2023TUS004634$TAKEDA$$65$YR$$F$Y$85$KG$20240926$$MD$US$US
218694073$21869407$3$F$20220701$20240712$20230117$20240717$EXP$$US-ABBVIE-4272529$ABBVIE$$52$YR$$F$Y$$$20240717$$CN$US$US
218694615$21869461$5$F$$20230206$20230117$20240926$EXP$$US-GSK-US2023AMR005664$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
218696795$21869679$5$F$20220308$20240626$20230117$20240717$EXP$$DE-ROCHE-3265622$ROCHE$$40$YR$A$F$Y$$$20240717$$CN$DE$DE
218697733$21869773$3$F$$20240827$20230117$20240830$EXP$$NVSC2023CA009197$NOVARTIS$$85$YR$$M$Y$$$20240830$$CN$CA$CA
218700355$21870035$5$F$$20240624$20230117$20240702$EXP$$CZ-CELLTRION INC.-2023CZ000384$CELLTRION$Osovska M, Janikova A, Kren L, Mareckova A.. Chronic benign cd8 plus proliferation: a rare affection that can mimic a lymphoma relapse. CASE REPORTS IN HEMATOLOGY. 2019;2019(4932616):1-4$$$$$Y$$$20240702$$HP$CZ$CZ
2187005117$21870051$17$F$20220605$20240828$20230117$20240904$EXP$$US-TAKEDA-US202031560$TAKEDA$$70$YR$$F$Y$90$KG$20240904$$HP$US$US
218701473$21870147$3$F$$20240620$20230117$20240702$PER$$US-SA-2023SA015517$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240702$$MD$US$US
2187022020$21870220$20$F$20220708$20240909$20230117$20240917$EXP$$CA-CELLTRION INC.-2022CA012050$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
218704852$21870485$2$F$$20240729$20230117$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00161$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218704902$21870490$2$F$$20240730$20230117$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00253$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218704913$21870491$3$F$$20240729$20230117$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00214$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218704922$21870492$2$F$$20240730$20230117$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00227$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218704932$21870493$2$F$$20240730$20230117$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00224$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218706844$21870684$4$F$$20240730$20230117$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00269$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218707673$21870767$3$F$$20240730$20230117$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00228$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218708276$21870827$6$F$20221030$20240805$20230117$20240808$EXP$$NVSC2023DE009409$NOVARTIS$$$$A$F$Y$69$KG$20240808$$MD$DE$DE
218710282$21871028$2$F$$20240730$20230117$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00231$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218710524$21871052$4$F$20230101$20240708$20230117$20240712$EXP$$JP-ASTELLAS-2023JP000149$ASTELLAS$$$$$M$Y$$$20240712$$CN$JP$JP
218712057$21871205$7$F$$20240919$20230117$20240927$EXP$$CA-JNJFOC-20230129886$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240927$$MD$CA$CA
218712275$21871227$5$F$20221114$20240808$20230117$20240814$EXP$$CA-TAKEDA-2023TUS003225$TAKEDA$$74$YR$$F$Y$$$20240814$$MD$CA$CA
218714282$21871428$2$F$$20240815$20230117$20240821$EXP$$US-SA-2023SA015766$SANOFI AVENTIS$$75$YR$E$F$Y$118.8$KG$20240821$$MD$US$US
218715155$21871515$5$F$20221221$20240705$20230117$20240715$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2023003768$VIIV$$$$$$Y$$$20240715$$HP$CA$CA
218715755$21871575$5$F$20230106$20240923$20230117$20240925$EXP$$CA-ROCHE-3265898$ROCHE$$39$YR$A$F$Y$$$20240925$$CN$CA$CA
218717515$21871751$5$F$$20240702$20230117$20240708$PER$$US-BIOGEN-2019BI00816921$BIOGEN$$$$$F$Y$$$20240708$$CN$US$US
2187191413$21871914$13$F$$20240801$20230117$20240916$PER$$US-PFIZER INC-PV202300006744$PFIZER$$80$YR$$F$Y$46.712$KG$20240916$$CN$US$US
218719185$21871918$5$F$20230101$20240703$20230117$20240704$PER$$US-PFIZER INC-PV202300006212$PFIZER$$73$YR$$F$Y$$$20240704$$HP$US$US
218719237$21871923$7$F$$20240718$20230117$20240722$PER$$US-PFIZER INC-PV202300006940$PFIZER$$80$YR$$F$Y$$$20240722$$CN$US$US
218719833$21871983$3$F$$20240729$20230117$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00255$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218720353$21872035$3$F$20220922$20240701$20230117$20240703$EXP$$ES-PFIZER INC-202300016806$PFIZER$$69$YR$$M$Y$59.65$KG$20240703$$MD$ES$ES
218720683$21872068$3$F$20220926$20240730$20230117$20240805$EXP$$GR-MYLANLABS-2023M1002902$MYLAN$$87$YR$$M$Y$60$KG$20240805$$MD$GR$GR
218721916$21872191$6$F$$20240910$20230117$20240911$PER$$US-PFIZER INC-PV202300007709$PFIZER$$64$YR$$F$Y$$$20240911$$MD$US$US
2187255211$21872552$11$F$$20240904$20230117$20240906$PER$$US-PFIZER INC-PV202300006216$PFIZER$$85$YR$$F$Y$54.4$KG$20240906$$CN$US$US
218725573$21872557$3$F$$20240724$20230117$20240729$PER$$US-PFIZER INC-PV202300006565$PFIZER$$63$YR$$F$Y$$$20240729$$MD$US$US
218726033$21872603$3$F$$20240729$20230117$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00215$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218728543$21872854$3$F$$20240724$20230117$20240729$EXP$$JP-PFIZER INC-PV202300006065$PFIZER$Akao, T.. A case of drug-induced hypersensitivity syndrome associated acute kidney injury that developed diffuse perivasculitis. The 683rd Kanto Regional Meeting of The Japanese Society of Internal Medicine. 2022;683rd$54$YR$$F$Y$$$20240729$$HP$JP$JP
218730753$21873075$3$F$20210902$20240821$20230117$20240823$EXP$IT-MINISAL02-904048$IT-009507513-2301ITA005113$MERCK$$70$YR$$M$Y$68$KG$20240823$$MD$IT$IT
2187320310$21873203$10$F$$20240827$20230117$20240830$EXP$$US-PFIZER INC-PV202300008479$PFIZER$$71$YR$$F$Y$$$20240830$$CN$US$US
2187330913$21873309$13$F$20211210$20240905$20230117$20240912$EXP$$US-TAKEDA-2021TUS080643$TAKEDA$$51$YR$$F$Y$56.789$KG$20240912$$MD$US$US
218734003$21873400$3$F$20200401$20240802$20230117$20240808$EXP$$DE-MYLANLABS-2023M1003579$MYLAN$$$$E$F$Y$54$KG$20240808$$MD$DE$DE
2187342012$21873420$12$F$20210812$20240829$20230117$20240902$EXP$$CA-TAKEDA-2021TUS024601$TAKEDA$$63$YR$$M$Y$$$20240902$$HP$CA$CA
218735343$21873534$3$F$$20240807$20230117$20240817$EXP$CA-MHPD-E2B_05874083$CA-Accord-295917$ACCORD$$65$YR$E$F$Y$$$20240817$$HP$CA$CA
218738702$21873870$2$F$20220610$20221017$20230117$20240723$PER$$US-NOVOPROD-956043$NOVO NORDISK$$74$YR$$F$Y$$$20240723$$MD$US$US
218739592$21873959$2$F$20220821$20220927$20230117$20240723$PER$$US-NOVOPROD-979174$NOVO NORDISK$$59$YR$$F$Y$$$20240723$$CN$US$US
218741357$21874135$7$F$20230109$20240808$20230117$20240812$EXP$$ES-BAUSCH-BL-2023-000814$BAUSCH AND LOMB$$66$YR$$M$Y$101$KG$20240812$$MD$ES$ES
218746882$21874688$2$F$20220925$20240709$20230117$20240719$EXP$$AE-AstraZeneca-2023A005606$ASTRAZENECA$$44$YR$$F$Y$111$KG$20240719$$MD$AE$
218750712$21875071$2$F$20221010$20240626$20230117$20240703$EXP$$DE-CELLTRION INC.-2023DE000422$CELLTRION$$$$$$Y$$$20240704$$MD$DE$DE
218751264$21875126$4$F$20230103$20240903$20230117$20240903$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000009$PAREXEL$$$$$$Y$$$20240903$$CN$US$US
218753792$21875379$2$F$$20240716$20230118$20240723$PER$$US-SA-2023SA016283$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240723$$MD$US$US
218754182$21875418$2$F$$20240718$20230118$20240722$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000023$PAREXEL$$$$$$Y$$$20240722$$CN$US$US
218755377$21875537$7$F$$20240904$20230118$20240913$EXP$$CA-AUROBINDO-AUR-APL-2021-044159$AUROBINDO$$41$YR$$F$Y$$$20240913$$MD$CA$CA
218759172$21875917$2$F$$20240730$20230118$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00170$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218760613$21876061$3$F$$20240730$20230118$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00260$LUPIN$$$$$$Y$$$20240819$$CN$US$US
2187615310$21876153$10$F$20220425$20240828$20230118$20240905$EXP$$CA-CELLTRION INC.-2022CA022246$CELLTRION$$$$$$Y$$$20240905$$MD$CA$CA
218762422$21876242$2$F$$20240730$20230118$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00309$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218763189$21876318$9$F$20220201$20240830$20230118$20240906$EXP$$DE-ROCHE-3113934$ROCHE$$25$YR$A$F$Y$90$KG$20240906$$MD$DE$DE
218763582$21876358$2$F$$20240731$20230118$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00302$LUPIN$$$$$$Y$$$20240820$$CN$US$US
218766993$21876699$3$F$$20240730$20230118$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00241$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218767683$21876768$3$F$20220408$20240624$20230118$20240702$EXP$$FR-CELLTRION INC.-2023FR000418$CELLTRION$$$$$$Y$$$20240702$$CN$FR$FR
2187683010$21876830$10$F$20210108$20240605$20230118$20240906$EXP$$GB-CELLTRION INC.-2023GB000659$CELLTRION$$$$$$Y$$$20240906$$MD$GB$GB
218768762$21876876$2$F$$20240730$20230118$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00267$LUPIN$$$$$$Y$$$20240817$$CN$US$US
2187707111$21877071$11$F$$20240513$20230118$20240926$PER$$US-GSK-US2023AMR002412$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
218771193$21877119$3$F$20170106$20240814$20230118$20240820$EXP$$NVSC2023CA006917$NOVARTIS$$39$YR$$M$Y$$$20240820$$MD$CA$CA
218777726$21877772$6$F$20221101$20240812$20230118$20240821$EXP$$EG-ROCHE-3265353$ROCHE$$41$YR$A$F$Y$$$20240821$$CN$EG$EG
218777762$21877776$2$F$$20240905$20230118$20240917$EXP$$US-Accord-295946$ACCORD$Bharath SP, Pang H, Kaderi T, Rampolla R, Chen T, Gezalian M, et al. Pearls +amp; Oy-sters: Status Epilepticus and Cerebral Edema From Hyperammonemia Due to Disseminated Ureaplasma and Mycoplasma Species. Neurology. 2022;100(15):727-31.$57$YR$A$M$Y$$$20240917$$MD$US$US
218778802$21877880$2$F$20220726$20240723$20230118$20240730$EXP$$CA-TAKEDA-2022TUS051014$TAKEDA$$29$YR$$M$Y$$$20240730$$MD$CA$CA
218783067$21878306$7$F$20230101$20240816$20230118$20240821$EXP$$US-SA-2023SA017395$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240821$$MD$US$US
218783092$21878309$2$F$$20240905$20230118$20240918$EXP$$US-AUROBINDO-AUR-APL-2023-001123$AUROBINDO$Bharath SP, Pang H, Kaderi T, Rampolla R, Chen T, Gezalian M, et al.. Pearls + Oy-sters: Status Epilepticus and Cerebral Edema From Hyperammonemia Due to Disseminated Ureaplasma and Mycoplasma Species.. Neurology. 2022;100(15):727-31$57$YR$$M$Y$$$20240918$$MD$US$US
218784552$21878455$2$F$$20240730$20230118$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00256$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218785603$21878560$3$F$20201001$20240920$20230118$20240926$EXP$$BR-TAKEDA-BR202004284$TAKEDA$$7$YR$$M$Y$22$KG$20240926$$CN$BR$BR
218786402$21878640$2$F$$20240703$20230118$20240714$PER$$US-SA-2023SA015008$SANOFI AVENTIS$$$$A$M$Y$220$KG$20240714$$MD$US$US
218786914$21878691$4$F$20210311$20240627$20230118$20240709$EXP$$CA-ROCHE-2794986$ROCHE$$35$YR$A$F$Y$$$20240709$$CN$CA$CA
218787202$21878720$2$F$$20240710$20230118$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US201907001516$ELI LILLY AND CO$$45$YR$A$F$Y$66.667$KG$20240802$$CN$US$US
218787338$21878733$8$F$20221201$20240712$20230118$20240722$EXP$$NVSC2022AR301799$NOVARTIS$$47$YR$$F$Y$$$20240722$$CN$AR$AR
2187877019$21878770$19$F$20191010$20240725$20230118$20240731$EXP$$IN-PFIZER INC-2019114247$PFIZER$$70$YR$$F$Y$70$KG$20240731$$CN$IN$IN
218790973$21879097$3$F$$20240809$20230118$20240813$EXP$$US-PFIZER INC-PV202300007671$PFIZER$$68$YR$$F$Y$$$20240813$$CN$US$US
218798296$21879829$6$F$$20240625$20230118$20240701$PER$$US-AMGEN-USASP2023007824$AMGEN$$73$YR$E$F$Y$$$20240701$$CN$US$US
218803943$21880394$3$F$$20240923$20230118$20240924$EXP$$US-TAKEDA-2023TUS005578$TAKEDA$$$$$F$Y$$$20240924$$CN$US$US
218804433$21880443$3$F$20230103$20230111$20230118$20240911$PER$$US-TEVA-2023-US-2844499$TEVA$$19$YR$$$Y$$$20240911$$CN$US$US
218807125$21880712$5$F$20221030$20240813$20230118$20240819$EXP$$FR-MYLANLABS-2023M1003472$MYLAN$$71$YR$$F$Y$$$20240819$$MD$FR$FR
218808393$21880839$3$F$$20240710$20230118$20240716$EXP$$CA-BAUSCH-BL-2023-000570$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240716$$HP$CA$CA
218811234$21881123$4$F$$20240910$20230118$20240918$EXP$$IT-CELLTRION INC.-2023IT000606$CELLTRION$Bernardini N, Skroza N, Mambrin A, Tolino E, Anzalone A, Balduzzi V, et al.. A tailored therapeutic approach for patients affected by multi-drug resistant psoriasis. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. 2020;155(4):511-512$$$$$Y$$$20240918$$HP$IT$IT
218811262$21881126$2$F$$20240822$20230118$20240831$PER$$US-ABBVIE-4241661$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
218811533$21881153$3$F$$20240718$20230118$20240726$EXP$$BR-CELLTRION INC.-2023BR000884$CELLTRION$$$$$$Y$$$20240726$$HP$BR$BR
218811784$21881178$4$F$20221118$20240624$20230118$20240701$EXP$$DE-CELLTRION INC.-2023DE000479$CELLTRION$$$$$$Y$$$20240702$$MD$DE$DE
218814562$21881456$2$F$$20240923$20230119$20240926$EXP$$CA-ROCHE-3266318$ROCHE$$48$YR$A$F$Y$$$20240926$$HP$CA$CA
218814942$21881494$2$F$$20240808$20230119$20240814$EXP$$BR-CELLTRION INC.-2023BR000880$CELLTRION$$$$$$Y$$$20240814$$CN$BR$BR
218815284$21881528$4$F$20230101$20230210$20230119$20240925$PER$$US-GSK-US2023AMR006831$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
2188186310$21881863$10$F$20230903$20240612$20230119$20240909$EXP$$US-GSK-US2023AMR006393$GLAXOSMITHKLINE$$63$YR$$F$Y$72.562$KG$20240909$$CN$US$US
218820732$21882073$2$F$$20240729$20230119$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00313$LUPIN$$$$$$Y$$$20240818$$CN$US$US
218820962$21882096$2$F$$20240730$20230119$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00301$LUPIN$$$$$$Y$$$20240817$$CN$US$US
2188235215$21882352$15$F$20201201$20240821$20230119$20240829$EXP$$CA-CELLTRION INC.-2020CA033459$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
218830092$21883009$2$F$20221129$20240716$20230119$20240723$EXP$$ES-ROCHE-3264959$ROCHE$$69$YR$E$M$Y$59.65$KG$20240723$$MD$ES$ES
218831664$21883166$4$F$20210101$20240812$20230119$20240819$EXP$$US-ABBVIE-4274528$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
218832003$21883200$3$F$20221201$20240909$20230119$20240912$EXP$$GB-ABBVIE-4274559$ABBVIE$$67$YR$$M$Y$$$20240912$$HP$GB$GB
218840903$21884090$3$F$20220901$20240918$20230119$20240923$EXP$$NVSC2023AT011521$NOVARTIS$$$$A$F$Y$$$20240923$$MD$AT$AT
218841883$21884188$3$F$20220101$20240813$20230119$20240819$EXP$$DE-BIOGEN-2023BI01181842$BIOGEN$$$$$F$Y$$$20240819$$CN$DE$DE
218842552$21884255$2$F$$20230119$20230119$20240924$PER$$US-ABBVIE-4275728$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
218843322$21884332$2$F$$20240730$20230119$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00312$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218843992$21884399$2$F$$20230113$20230119$20240807$EXP$$US-RECORDATI-2023000211$RECORDATI$$$$$$Y$$$20240807$$MD$US$US
218844114$21884411$4$F$$20240805$20230119$20240807$EXP$$US-ROCHE-3267602$ROCHE$$56$YR$A$M$Y$$$20240807$$CN$US$US
2188441410$21884414$10$F$20221105$20240715$20230119$20240723$EXP$$CA-ROCHE-3266654$ROCHE$$39$YR$A$F$Y$$$20240723$$CN$CA$CA
218844532$21884453$2$F$$20240730$20230119$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00300$LUPIN$$$$$$Y$$$20240819$$CN$US$US
2188446912$21884469$12$F$$20240925$20230119$20240930$EXP$$US-PFIZER INC-PV202300010620$PFIZER$$72$YR$$F$Y$78.458$KG$20240930$$CN$US$US
218850462$21885046$2$F$20220719$20240704$20230119$20240709$EXP$FR-AFSSAPS-PP2023000054$FR-PFIZER INC-202300018969$PFIZER$$60$YR$$F$Y$115$KG$20240709$$PH$FR$FR
218850554$21885055$4$F$20200605$20240716$20230119$20240725$PER$$US-AMGEN-USASP2023007581$AMGEN$$66$YR$E$M$Y$$$20240725$$HP$US$US
218853142$21885314$2$F$20240531$20240830$20230119$20240912$PER$$US-SA-2023SA017762$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240912$$MD$US$US
218853654$21885365$4$F$20221201$20240904$20230119$20240926$PER$$US-SA-2023SA019296$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240926$$CN$US$US
218854203$21885420$3$F$20240830$20240830$20230119$20240910$PER$$US-SA-2023SA018822$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240910$$CN$US$US
218858642$21885864$2$F$$20240712$20230119$20240716$PER$$US-AMGEN-USASP2022228024$AMGEN$$$$A$F$Y$$$20240716$$HP$US$US
218860117$21886011$7$F$$20240822$20230119$20240829$EXP$$US-JAZZ-2022-US-037114$JAZZ$$$$$F$Y$$$20240829$$CN$US$US
2188601219$21886012$19$F$20210505$20240909$20230119$20240913$EXP$$US-JAZZ-2022-US-033558$JAZZ$$50$YR$$F$Y$$$20240913$$HP$US$US
218862026$21886202$6$F$$20240828$20230119$20240905$EXP$$CA-AstraZeneca-2021A794630$ASTRAZENECA$$41$YR$$F$Y$$$20240905$$MD$CA$
218866246$21886624$6$F$20221223$20240724$20230119$20240730$EXP$$ES-PFIZER INC-202300019712$PFIZER$$47$YR$$F$Y$53$KG$20240730$$MD$ES$ES
218867382$21886738$2$F$20221223$20240701$20230119$20240707$EXP$$NVSC2023IN010538$NOVARTIS$$49$YR$$M$Y$$$20240707$$CN$IN$IN
218867706$21886770$6$F$20220325$20240717$20230119$20240729$EXP$$JP-AstraZeneca-2023A009504$ASTRAZENECA$Yoshizaki C, Yoshida Y, Nohmi S, Go Y, Kusakado R, Kawamura S, Inoue D, Kabasawa N, Yamaguchi F. EGFR-TKI-induced Factor V deficiency in a patient with advanced non-small cell lung cancer: The first case report. Lung Cancer 2024;194:1-3.$61$YR$$M$Y$67$KG$20240729$$MD$JP$
218868564$21886856$4$F$$20240920$20230119$20240924$EXP$$US-GW PHARMA-2023-US-000940$JAZZ$$$$$F$Y$$$20240923$$CN$US$US
218871362$21887136$2$F$$20240718$20230119$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-007962$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240726$$HP$CA$CA
218871906$21887190$6$F$20210101$20240813$20230119$20240820$EXP$$CA-CELLTRION INC.-2021CA008334$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
218875427$21887542$7$F$20221201$20240729$20230120$20240807$EXP$$US-TAKEDA-2022TUS094110$TAKEDA$$53$YR$$F$Y$$$20240807$$CN$US$US
218875652$21887565$2$F$$20240802$20230120$20240813$EXP$$US-NOVOPROD-1013480$NOVO NORDISK$$$$A$F$Y$$$20240813$$CN$US$US
218876906$21887690$6$F$$20240904$20230120$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-007776$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240906$$MD$US$US
218878745$21887874$5$F$20210906$20240905$20230120$20240909$EXP$$CA-ROCHE-2902529$ROCHE$$36$YR$A$F$Y$$$20240909$$CN$CA$CA
218881104$21888110$4$F$20230101$20240710$20230120$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-008937$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$72.57$KG$20240715$$CN$US$US
218881632$21888163$2$F$20230106$20240920$20230120$20240924$PER$$US-AMGEN-USASP2023006111$AMGEN$$$$$M$Y$$$20240924$$CN$US$US
218882984$21888298$4$F$20240429$20240805$20230120$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004506$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240828$$CN$US$US
218884842$21888484$2$F$20230109$20240923$20230120$20240927$EXP$$DE-ABBVIE-4275925$ABBVIE$$78$YR$$F$Y$67$KG$20240927$$HP$DE$DE
218885473$21888547$3$F$20220915$20240715$20230120$20240720$EXP$$DE-JNJFOC-20230131656$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240719$$HP$DE$DE
218885982$21888598$2$F$$20240729$20230120$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00303$LUPIN$$$$$$Y$$$20240817$$PH$US$US
218886233$21888623$3$F$$20240730$20230120$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00311$LUPIN$$$$$$Y$$$20240819$$CN$US$US
218888783$21888878$3$F$$20240730$20230120$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00353$LUPIN$$$$$$Y$$$20240821$$CN$US$US
218889415$21888941$5$F$20201009$20240820$20230120$20240828$EXP$$US-TAKEDA-2022TUS025469$TAKEDA$$58$YR$$M$Y$$$20240828$$CN$US$US
2188894820$21888948$20$F$20230420$20240704$20230120$20240710$EXP$$NVSC2023BR006369$NOVARTIS$$68$YR$$F$Y$$$20240710$$CN$BR$BR
218889887$21888988$7$F$20240204$20240813$20230120$20240820$EXP$$US-TAKEDA-2021TUS065385$TAKEDA$$5$YR$$M$Y$14$KG$20240820$$CN$US$US
218892492$21889249$2$F$20220701$20240925$20230120$20240927$PER$$NVSC2023US011683$NOVARTIS$$60$YR$$F$Y$$$20240927$$CN$US$US
218893202$21889320$2$F$20230101$20240709$20230120$20240710$EXP$FR-AFSSAPS-NT2023000024$FR-ROCHE-3268351$ROCHE$$73$YR$E$M$Y$$$20240710$$PH$FR$FR
218897913$21889791$3$F$$20240826$20230120$20240829$PER$$US-PFIZER INC-PV202300010717$PFIZER$$40$YR$$F$Y$$$20240829$$HP$US$US
218897959$21889795$9$F$20231201$20240711$20230120$20240716$EXP$$US-PFIZER INC-PV202300011046$PFIZER$$79$YR$$F$Y$$$20240716$$CN$US$US
218897997$21889799$7$F$20230118$20240829$20230120$20240903$EXP$$US-PFIZER INC-PV202300011798$PFIZER$$86$YR$$F$Y$55.329$KG$20240903$$CN$US$US
218898344$21889834$4$F$20230124$20240918$20230120$20240925$EXP$$CA-TAKEDA-2022TUS077874$TAKEDA$$78$YR$$F$Y$$$20240925$$MD$CA$CA
218899064$21889906$4$F$20221231$20230223$20230120$20240712$EXP$$IT-ASTELLAS-2023US001859$ASTELLAS$$67$YR$$M$Y$$$20240712$$MD$IT$IT
218900102$21890010$2$F$20240703$20240703$20230120$20240710$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2023006322$VIIV$$$$$$Y$$$20240710$$HP$CA$CA
218901874$21890187$4$F$20210303$20240809$20230120$20240813$PER$$US-AMGEN-USASP2023009313$AMGEN$$59$YR$A$F$Y$$$20240813$$HP$US$US
218903323$21890332$3$F$$20240723$20230120$20240726$EXP$$IN-PFIZER INC-PV202200084616$PFIZER$$57$YR$$F$Y$$$20240726$$CN$IN$IN
218903764$21890376$4$F$20221001$20240709$20230120$20240711$EXP$$US-PFIZER INC-PV202300010338$PFIZER$$79$YR$$F$Y$$$20240711$$HP$US$US
218904868$21890486$8$F$$20240729$20230120$20240801$EXP$$CA-TAKEDA-2023TUS006175$TAKEDA$$$$$M$Y$$$20240801$$CN$CA$CA
218908716$21890871$6$F$20190508$20240703$20230120$20240708$EXP$$PHHY2019CA042009$NOVARTIS$$53$YR$$F$Y$$$20240708$$CN$CA$CA
218915117$21891511$7$F$$20240801$20230120$20240806$EXP$$CA-PFIZER INC-202300024599$PFIZER$$53$YR$$F$Y$$$20240806$$HP$CA$CA
218918573$21891857$3$F$$20240731$20230120$20240802$PER$$NVSC2023US012349$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
218921775$21892177$5$F$20240501$20240725$20230120$20240730$EXP$$US-JAZZ-2022-US-035353$JAZZ$$22$YR$$F$Y$$$20240730$$HP$US$US
218924764$21892476$4$F$20220101$20240822$20230120$20240828$EXP$$IN-PFIZER INC-202300026757$PFIZER$$28$YR$$M$Y$$$20240828$$CN$IN$IN
218924973$21892497$3$F$20240826$20240916$20230120$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-009296$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240917$$CN$US$US
218925232$21892523$2$F$20230101$20240708$20230120$20240710$EXP$$US-PFIZER INC-PV202300011952$PFIZER$$61$YR$$F$Y$$$20240710$$CN$US$US
218927162$21892716$2$F$$20230116$20230120$20240711$EXP$$IT-ASTELLAS-2023US001856$ASTELLAS$$$$$M$Y$$$20240711$$MD$IT$IT
218927424$21892742$4$F$20230105$20240716$20230120$20240718$EXP$$DE-JNJFOC-20230122683$JOHNSON AND JOHNSON$$55$YR$A$M$Y$60$KG$20240718$$MD$DE$DE
218929343$21892934$3$F$$20240903$20230120$20240906$PER$$US-JAZZ-2022-US-036828$JAZZ$$$$$F$Y$$$20240905$$CN$US$US
218931175$21893117$5$F$20230111$20240719$20230121$20240802$EXP$$BR-CELLTRION INC.-2023BR001104$CELLTRION$$$$$$Y$$$20240802$$CN$BR$BR
2189318110$21893181$10$F$20240507$20240917$20230121$20240926$EXP$$CA-TAKEDA-2022TUS068713$TAKEDA$$48$YR$$F$Y$$$20240926$$HP$CA$CA
218932982$21893298$2$F$20230114$20240923$20230121$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202301009005$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240926$$CN$US$US
218934626$21893462$6$F$20201005$20240826$20230121$20240902$EXP$$CA-TAKEDA-2020TUS044398$TAKEDA$$47$YR$$F$Y$$$20240902$$MD$CA$CA
218936482$21893648$2$F$20220912$20240522$20230121$20240807$EXP$$US-AUROBINDO-AUR-APL-2022-038519$AUROBINDO$$51$YR$$F$Y$$$20240807$$MD$US$US
218942792$21894279$2$F$$20240624$20230121$20240701$EXP$$US-AUROBINDO-AUR-APL-2022-043571$AUROBINDO$$63$YR$$M$Y$$$20240701$$HP$US$US
218944098$21894409$8$F$20210108$20240705$20230121$20240715$EXP$$GB-AUROBINDO-AUR-APL-2023-002079$AUROBINDO$$$$A$M$Y$$$20240715$$MD$GB$GB
218949524$21894952$4$F$20220114$20240715$20230122$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-051453$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240722$$MD$JP$JP
218951005$21895100$5$F$20220101$20240625$20230122$20240701$EXP$$CL-JNJFOC-20230123455$JOHNSON AND JOHNSON$$41$YR$A$F$Y$58$KG$20240701$$CN$CL$CL
218952872$21895287$2$F$20120901$20240729$20230123$20240802$EXP$$JP-SA-2023SA018197$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240802$$MD$JP$JP
2189531010$21895310$10$F$20220801$20240726$20230123$20240731$EXP$$CA-ABBVIE-4169541$ABBVIE$$63$YR$$F$Y$63.6$KG$20240731$$MD$CA$CA
2189541017$21895410$17$F$20230101$20240801$20230123$20240808$EXP$$US-GSK-US2023AMR008609$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
218960003$21896000$3$F$$20240723$20230123$20240730$EXP$$BR-CELLTRION INC.-2023BR000963$CELLTRION$$$$$$Y$$$20240731$$CN$BR$BR
218960293$21896029$3$F$$20240730$20230123$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00382$LUPIN$$$$$$Y$$$20240819$$PH$US$US
218961638$21896163$8$F$20210702$20240730$20230123$20240803$EXP$$DE-ROCHE-2873049$ROCHE$$52$YR$A$F$Y$$$20240803$$CN$DE$DE
2189616810$21896168$10$F$20230101$20230310$20230123$20240926$EXP$$US-GSK-US2023AMR008605$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
218961902$21896190$2$F$20230113$20240726$20230123$20240801$EXP$$BR-CELLTRION INC.-2023BR000965$CELLTRION$$$$$$Y$$$20240801$$CN$BR$BR
218962056$21896205$6$F$20230112$20240911$20230123$20240918$EXP$$US-TAKEDA-2023TUS006729$TAKEDA$$59$YR$$F$Y$$$20240918$$HP$US$US
218962074$21896207$4$F$20230101$20230314$20230123$20240926$PER$$US-GSK-US2023AMR007912$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240926$$MD$US$US
218964002$21896400$2$F$$20240722$20230123$20240729$EXP$$BR-CELLTRION INC.-2023BR001081$CELLTRION$$$$$$Y$$$20240730$$CN$BR$BR
218964062$21896406$2$F$20240917$20240917$20230123$20240920$EXP$$US-SHIRE-US202026056$TAKEDA$$69$YR$$F$Y$$$20240920$$MD$US$US
218964239$21896423$9$F$$20240808$20230123$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-009495$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240809$$MD$US$US
218964373$21896437$3$F$$20240730$20230123$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00316$LUPIN$$$$$$Y$$$20240819$$CN$US$US
2189652511$21896525$11$F$20230906$20240922$20230123$20240930$EXP$$US-TAKEDA-US201940052$TAKEDA$$79$YR$$F$Y$81$KG$20240930$$CN$US$US
2189657623$21896576$23$F$20230109$20240710$20230123$20240716$EXP$$MX-TAKEDA-2023TUS005959$TAKEDA$$3$YR$$M$Y$17$KG$20240716$$HP$MX$MX
218966455$21896645$5$F$20220101$20240626$20230123$20240702$EXP$$FR-UCBSA-2023002776$UCB$$20$YR$$F$Y$45$KG$20240702$$MD$FR$FR
218967289$21896728$9$F$$20240916$20230123$20240917$PER$$NVSC2023US011351$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
218968753$21896875$3$F$20240301$20240705$20230123$20240716$EXP$$US-SA-2023SA023283$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240716$$MD$US$US
218971175$21897117$5$F$20221101$20230717$20230123$20240926$EXP$$US-GSK-US2023AMR008558$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
218973612$21897361$2$F$$20240820$20230123$20240822$PER$$US-PFIZER INC-2021175998$PFIZER$$64$YR$$F$Y$$$20240822$$CN$US$US
218974426$21897442$6$F$20160101$20240726$20230123$20240731$PER$$US-PFIZER INC-2020128181$PFIZER$$61$YR$$F$Y$74.84$KG$20240731$$MD$US$US
218975805$21897580$5$F$$20240730$20230123$20240731$EXP$$US-PFIZER INC-202101870171$PFIZER$$75$YR$$F$Y$57.143$KG$20240731$$CN$US$US
218976113$21897611$3$F$$20230129$20230123$20240710$EXP$$AU-ASTELLAS-2023US002028$ASTELLAS$$22$YR$$F$Y$$$20240710$$CN$AU$AU
218976317$21897631$7$F$20230228$20240712$20230123$20240719$EXP$$CA-OTSUKA-2018_034738$OTSUKA$$25$YR$$F$Y$$$20240719$$MD$CA$CA
218976793$21897679$3$F$$20240726$20230123$20240807$PER$$US-SA-2023SA023297$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240807$$MD$US$US
218977283$21897728$3$F$$20240729$20230123$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00341$LUPIN$$$$$$Y$$$20240817$$CN$US$US
218977382$21897738$2$F$$20240822$20230123$20240906$PER$$US-SA-2023SA022308$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240906$$MD$US$US
218977452$21897745$2$F$$20240814$20230123$20240829$PER$$US-SA-2023SA008664$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240829$$MD$US$US
218978227$21897822$7$F$20230101$20240817$20230123$20240826$PER$$US-SA-2023SA022820$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240826$$CN$US$US
218979257$21897925$7$F$20230213$20240806$20230123$20240809$PER$$US-PFIZER INC-PV202300012711$PFIZER$$76$YR$$M$Y$95.238$KG$20240809$$CN$US$US
218980003$21898000$3$F$20190716$20240805$20230123$20240808$PER$$US-BIOGEN-2019BI00769545$BIOGEN$$36$YR$$F$Y$$$20240808$$CN$US$US
218980033$21898003$3$F$20230101$20240729$20230123$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00338$LUPIN$$$$$$Y$$$20240818$$CN$US$US
2189812112$21898121$12$F$20230523$20240812$20230123$20240813$EXP$$GB-UCBSA-2023003009$UCB$$63$YR$$F$Y$$$20240813$$CN$GB$GB
218981873$21898187$3$F$$20240726$20230123$20240730$EXP$$GB-UCBSA-2023003036$UCB$$$$$F$Y$$$20240730$$CN$GB$GB
218982203$21898220$3$F$$20240704$20230123$20240709$EXP$$CA-PFIZER INC-2021829914$PFIZER$$55$YR$$M$Y$$$20240709$$HP$CA$CA
218985459$21898545$9$F$20221026$20240628$20230123$20240708$EXP$$NVSC2022RU249770$NOVARTIS$$55$YR$$F$Y$60.2$KG$20240708$$MD$RU$RU
218990207$21899020$7$F$20230428$20240918$20230123$20240920$EXP$$CA-TAKEDA-2023TUS007815$TAKEDA$$79$YR$$F$Y$$$20240920$$HP$CA$CA
218993403$21899340$3$F$20220401$20230118$20230123$20240717$PER$$US-NOVOPROD-990265$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
218993603$21899360$3$F$$20230518$20230123$20240717$PER$$US-NOVOPROD-990817$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
218995456$21899545$6$F$$20240715$20230123$20240718$EXP$$US-TAKEDA-2023TUS006886$TAKEDA$$$$$M$Y$76.19$KG$20240718$$CN$US$US
218995642$21899564$2$F$20220609$20220620$20230123$20240717$PER$$US-NOVOPROD-953906$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
218995902$21899590$2$F$$20240628$20230123$20240702$EXP$$US-ABBVIE-4277592$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
2189980821$21899808$21$F$$20240905$20230123$20240909$EXP$$US-PFIZER INC-PV202300012606$PFIZER$$80$YR$$F$Y$56.236$KG$20240909$$CN$US$US
218999202$21899920$2$F$$20230929$20230123$20240716$PER$$US-NOVOPROD-1001574$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
218999502$21899950$2$F$$20221109$20230123$20240716$PER$$US-NOVOPROD-1001777$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
218999922$21899992$2$F$$20221130$20230123$20240716$PER$$US-NOVOPROD-1002057$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
218999992$21899999$2$F$20220710$20220711$20230123$20240717$PER$$US-NOVOPROD-958305$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
219004712$21900471$2$F$20220501$20221007$20230123$20240717$PER$$US-NOVOPROD-968350$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
219006042$21900604$2$F$20220901$20221026$20230123$20240717$PER$$US-NOVOPROD-973297$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
219006904$21900690$4$F$20220301$20221113$20230123$20240717$PER$$US-NOVOPROD-976667$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
219007312$21900731$2$F$20220827$20220831$20230123$20240717$PER$$US-NOVOPROD-977447$NOVO NORDISK$$75$YR$$M$Y$$$20240717$$CN$US$US
219007394$21900739$4$F$20220601$20220908$20230123$20240717$PER$$US-NOVOPROD-977539$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
219008343$21900834$3$F$$20230802$20230123$20240717$PER$$US-NOVOPROD-980536$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
219008452$21900845$2$F$20200801$20220919$20230123$20240717$PER$$US-NOVOPROD-980984$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
219008592$21900859$2$F$20220803$20220805$20230123$20240717$PER$$US-NOVOPROD-978524$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
219008772$21900877$2$F$20220601$20221116$20230123$20240717$PER$$US-NOVOPROD-982133$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
219009063$21900906$3$F$$20230530$20230123$20240717$PER$$US-NOVOPROD-982993$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
219011883$21901188$3$F$20220101$20240426$20230123$20240717$PER$$US-NOVOPROD-989744$NOVO NORDISK$$$$A$F$Y$$$20240717$$PH$US$US
219011932$21901193$2$F$$20221017$20230123$20240717$PER$$US-NOVOPROD-989967$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
219012102$21901210$2$F$$20220627$20230123$20240717$PER$$US-NOVOPROD-931006$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
219012834$21901283$4$F$20240101$20240806$20230123$20240812$EXP$$US-GW PHARMA-2022-US-032068$JAZZ$$$$$M$Y$12.245$KG$20240812$$MD$US$US
219015492$21901549$2$F$$20240905$20230123$20240906$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000040$PAREXEL$$$$$$Y$$$20240906$$CN$US$US
2190163015$21901630$15$F$20230101$20240828$20230124$20240906$EXP$$CA-CELLTRION INC.-2023CA001352$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
219016542$21901654$2$F$$20240702$20230124$20240711$PER$$US-SA-2023SA023481$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240711$$MD$US$US
219018362$21901836$2$F$$20240731$20230124$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00371$LUPIN$$$$$$Y$$$20240820$$HP$US$US
219018542$21901854$2$F$$20240624$20230124$20240702$EXP$$IT-CELLTRION INC.-2023IT001001$CELLTRION$$$$$$Y$$$20240702$$MD$IT$IT
219018792$21901879$2$F$$20240624$20230124$20240701$EXP$$GR-CELLTRION INC.-2023GR001003$CELLTRION$$$$$$Y$$$20240702$$MD$GR$GR
219018852$21901885$2$F$$20240729$20230124$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00373$LUPIN$$$$$$Y$$$20240817$$PH$US$US
219018932$21901893$2$F$$20240624$20230124$20240701$EXP$$DE-CELLTRION INC.-2023DE001042$CELLTRION$$$$$$Y$$$20240702$$MD$DE$DE
219018963$21901896$3$F$$20240729$20230124$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00377$LUPIN$$$$$$Y$$$20240818$$CN$US$US
2190190116$21901901$16$F$20221028$20240726$20230124$20240805$EXP$$CA-CELLTRION INC.-2022CA010743$CELLTRION$$$$$$Y$$$20240805$$MD$CA$CA
219019172$21901917$2$F$$20240729$20230124$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00380$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219019558$21901955$8$F$$20240919$20230124$20240923$PER$$NVSC2023US013668$NOVARTIS$$$$$F$Y$$$20240923$$HP$US$US
219019693$21901969$3$F$$20240731$20230124$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00381$LUPIN$$$$$$Y$$$20240820$$CN$US$US
219020365$21902036$5$F$20221115$20240912$20230124$20240917$EXP$$GB-ABBVIE-4279133$ABBVIE$$82$YR$$F$Y$$$20240917$$HP$GB$GB
2190215710$21902157$10$F$20230118$20240807$20230124$20240814$PER$$US-ALXN-A202300656$ALEXION PHARMACEUTICALS$$57$YR$$F$Y$$$20240814$$CN$US$US
219022243$21902224$3$F$$20240906$20230124$20240920$EXP$US-MLMSERVICE-20230102-4019688-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-00242$ALKEM$Bharath SP, Pang H, Kaderi T, Rampolla R, Chen T, Gezalian M, et al.. Pearls + Oy-sters: Status Epilepticus and Cerebral Edema From Hyperammonemia Due to Disseminated Ureaplasma and Mycoplasma Species. Neurology. 2022;100(15):727-31$57$YR$$M$Y$$$20240920$$MD$US$US
2190236210$21902362$10$F$20230120$20240523$20230124$20240926$EXP$$US-GSK-US2023AMR008577$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
219025254$21902525$4$F$$20240711$20230124$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-010242$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$85.275$KG$20240717$$CN$US$US
219025424$21902542$4$F$$20240821$20230124$20240826$EXP$$US-TAKEDA-2021TUS079340$TAKEDA$$$$$M$Y$84$KG$20240826$$HP$US$US
219025445$21902544$5$F$$20230421$20230124$20240925$PER$$US-GSK-US2023AMR008606$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2190259915$21902599$15$F$20190719$20240905$20230124$20240913$EXP$$CA-CELLTRION INC.-2019CA023358$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
2190276110$21902761$10$F$20221226$20240801$20230124$20240805$EXP$$NVSC2022BR301592$NOVARTIS$$60$YR$$F$Y$70$KG$20240805$$CN$BR$BR
219029089$21902908$9$F$$20240913$20230124$20240924$EXP$$CA-TAKEDA-2023TUS007798$TAKEDA$$$$$F$Y$$$20240924$$CN$CA$CA
219034292$21903429$2$F$20170419$20230117$20230124$20240828$PER$$US-SA-2023SA024230$SANOFI AVENTIS$$$$$$Y$$$20240828$$CN$US$US
219037042$21903704$2$F$20230101$20240827$20230124$20240830$PER$$US-BIOGEN-2022BI01129630$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
219037285$21903728$5$F$20230101$20240813$20230124$20240821$EXP$$US-SA-2023SA025324$SANOFI AVENTIS$$58$YR$A$F$Y$103$KG$20240821$$MD$US$US
219037409$21903740$9$F$20230101$20240819$20230124$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202301000894$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240827$$CN$US$US
219037706$21903770$6$F$20230118$20240722$20230124$20240730$EXP$$US-GSK-US2023008630$GLAXOSMITHKLINE$$40$YR$$F$Y$$$20240730$$CN$US$US
219039093$21903909$3$F$$20240822$20230124$20240829$EXP$$CA-ROCHE-3267835$ROCHE$$44$YR$A$F$Y$63$KG$20240829$$MD$CA$CA
219039457$21903945$7$F$20240911$20240911$20230124$20240920$EXP$$CA-GSK-CA2023AMR007435$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CA$CA
219040084$21904008$4$F$$20240806$20230124$20240809$EXP$$US-PFIZER INC-PV202300014004$PFIZER$$72$YR$$M$Y$103.85$KG$20240809$$MD$US$US
219040228$21904022$8$F$20221101$20240920$20230124$20240924$EXP$$US-PFIZER INC-PV202300013534$PFIZER$$67$YR$$F$Y$86.18$KG$20240924$$CN$US$US
219043696$21904369$6$F$20240425$20240705$20230124$20240710$EXP$$CA-TAKEDA-2023TUS006637$TAKEDA$$44$YR$$M$Y$$$20240710$$CN$CA$CA
219046122$21904612$2$F$20140901$20240626$20230124$20240703$PER$$US-BIOGEN-2014BI099878$BIOGEN$$55$YR$$F$Y$$$20240703$$CN$US$US
219046653$21904665$3$F$$20240626$20230124$20240701$PER$$US-PFIZER INC-2016308570$PFIZER$$$$$F$Y$$$20240701$$CN$US$US
219047206$21904720$6$F$20221119$20240919$20230124$20240926$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202301007306AA$ELI LILLY AND CO$$28$YR$A$M$Y$69$KG$20240926$$CN$JP$JP
219048163$21904816$3$F$$20240826$20230124$20240827$PER$$NVSC2023US012482$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
219053635$21905363$5$F$$20240819$20230124$20240822$EXP$$NVSC2021CA315860$NOVARTIS$$77$YR$$F$Y$$$20240822$$HP$CA$CA
219056423$21905642$3$F$20230101$20240822$20230124$20240902$PER$$US-SA-2023SA023212$SANOFI AVENTIS$$64$YR$A$M$Y$88.8$KG$20240902$$MD$US$US
219059192$21905919$2$F$$20240624$20230124$20240701$EXP$$DE-CELLTRION INC.-2023DE001010$CELLTRION$$$$$$Y$$$20240702$$CN$DE$DE
219061574$21906157$4$F$20230123$20240905$20230124$20240911$EXP$$US-TAKEDA-US201805710$TAKEDA$$67$YR$$F$Y$$$20240911$$HP$US$US
219061603$21906160$3$F$$20240718$20230124$20240722$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000042$PAREXEL$$$$$$Y$$$20240722$$HP$US$US
219063597$21906359$7$F$20230110$20240823$20230125$20240911$EXP$$US-BEH-2023154393$CSL BEHRING$$45$YR$A$F$Y$$$20240911$$HP$US$US
219063919$21906391$9$F$20230101$20240731$20230125$20240805$EXP$$US-PFIZER INC-202200037322$PFIZER$$74$YR$$M$Y$103.8$KG$20240805$$MD$US$US
219066143$21906614$3$F$$20240801$20230125$20240808$EXP$$BR-CELLTRION INC.-2023BR001418$CELLTRION$$$$$$Y$$$20240808$$CN$BR$BR
219066323$21906632$3$F$$20240624$20230125$20240701$EXP$$IT-CELLTRION INC.-2023IT000511$CELLTRION$$$$$$Y$$$20240702$$MD$IT$IT
219067822$21906782$2$F$$20240710$20230125$20240718$EXP$$JP-ALXN-A202300711AA$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$PH$JP$JP
219069995$21906999$5$F$$20240905$20230125$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2022-032404$UNITED THERAPEUTICS$$$$$F$Y$64.399$KG$20240914$$$US$US
219071983$21907198$3$F$$20240730$20230125$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00466$LUPIN$$$$$$Y$$$20240819$$CN$US$US
219073336$21907333$6$F$20221219$20240820$20230125$20240827$EXP$$CA-ROCHE-3270988$ROCHE$$59$YR$A$F$Y$$$20240827$$CN$CA$CA
219074274$21907427$4$F$$20240729$20230125$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00409$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219075733$21907573$3$F$$20240729$20230125$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00460$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219076013$21907601$3$F$$20240730$20230125$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00461$LUPIN$$$$$$Y$$$20240817$$CN$US$US
219076413$21907641$3$F$$20240729$20230125$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00467$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219076615$21907661$5$F$$20240619$20230125$20240701$EXP$CA-MHPD-E2B-05807662$CA-Accord-297339$ACCORD$$58$YR$A$M$Y$$$20240701$$HP$CA$CA
219078127$21907812$7$F$20230109$20240819$20230125$20240822$EXP$$US-SA-2023SA025351$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240822$$MD$US$US
219078423$21907842$3$F$20230119$20240726$20230125$20240802$EXP$$IN-GSK-IN2023APC009088$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$IN$IN
2190786319$21907863$19$F$20230118$20240920$20230125$20240925$EXP$$CA-GSK-CA2023AMR006751$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$CA$CA
219078666$21907866$6$F$$20240916$20230125$20240919$EXP$$US-AMGEN-USASP2022228289$AMGEN$$$$A$M$Y$$$20240919$$HP$US$US
219079562$21907956$2$F$$20240727$20230125$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00493$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219079852$21907985$2$F$$20240809$20230125$20240816$EXP$$CA-GSK-CA2023009530$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$HP$CA$CA
219081058$21908105$8$F$20220101$20240912$20230125$20240916$EXP$$NVSC2022BR235334$NOVARTIS$$$$$F$Y$54.3$KG$20240916$$CN$BR$BR
219082089$21908208$9$F$20220101$20240712$20230125$20240717$EXP$$CA-PFIZER INC-202201346099$PFIZER$$66$YR$$M$Y$$$20240717$$MD$CA$CA
219083803$21908380$3$F$$20240729$20230125$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00471$LUPIN$$$$$$Y$$$20240818$$PH$US$US
2190857812$21908578$12$F$$20240906$20230125$20240910$30DAY$$US-PFIZER INC-202300030681$PFIZER$$8$YR$$M$Y$20.7$KG$20240910$$CN$US$US
219086892$21908689$2$F$$20240814$20230125$20240816$EXP$$US-PFIZER INC-PV202300014727$PFIZER$$77$YR$$F$Y$$$20240816$$CN$US$US
219088103$21908810$3$F$$20230117$20230125$20240715$PER$$IT-PFM-2021-05612$PIERRE FABRE MEDICAMENT$Ramla MK, Goffredo B, Giustini F, Pisani M, Cairoli S, Simeoli R et al. The importance of free digoxin serum concentrations Case report of an infant treated for digoxin poisoning. Clinical Toxicology. 2021;59:574-5$54$DY$$M$Y$$$20240715$$HP$IT$IT
219090933$21909093$3$F$$20240903$20230125$20240905$EXP$$US-JAZZ-2023-US-001028$JAZZ$$$$$F$Y$$$20240905$$MD$US$US
219094482$21909448$2$F$$20240913$20230125$20240917$PER$$US-PFIZER INC-202300031967$PFIZER$$53$YR$$F$Y$$$20240917$$HP$US$US
219095654$21909565$4$F$$20240903$20230125$20240906$EXP$$US-PFIZER INC-202200815885$PFIZER$$74$YR$$F$Y$$$20240906$$CN$US$US
219096302$21909630$2$F$20240601$20240708$20230125$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-011400$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240712$$HP$US$US
219096373$21909637$3$F$20220121$20240917$20230125$20240923$EXP$$CA-INCYTE CORPORATION-2023IN000531$INCYTE$$$$$$Y$$$20240923$$HP$CA$CA
219096668$21909666$8$F$20221227$20240710$20230125$20240716$EXP$$BR-GSK-BR2020AMR110371$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$BR$BR
219096724$21909672$4$F$20230224$20240822$20230125$20240828$EXP$$CA-TAKEDA-2023TUS008310$TAKEDA$$64$YR$$M$Y$74.8$KG$20240828$$CN$CA$CA
219096873$21909687$3$F$20200101$20240813$20230125$20240819$EXP$$FI-MYLANLABS-202200357756$MYLAN$Koskimaki, J.. Withdrawal from long-term use of unusually high-dose oxazepam. Case Reports in Psychiatry. 2021;1-4$60$YR$$F$Y$$$20240819$$MD$FI$FI
219097122$21909712$2$F$20230101$20240708$20230125$20240710$EXP$$US-ABBVIE-4282763$ABBVIE$$71$YR$$M$Y$$$20240710$$CN$US$US
219097725$21909772$5$F$$20240924$20230125$20240926$EXP$$US-TAKEDA-US202016828$TAKEDA$$$$$F$Y$$$20240926$$HP$US$US
219097855$21909785$5$F$20220101$20240701$20230125$20240707$EXP$$US-ABBVIE-4282695$ABBVIE$$$$$F$Y$$$20240707$$CN$US$US
219099017$21909901$7$F$$20240809$20230125$20240815$30DAY$$US-PFIZER INC-202300029535$PFIZER$$15$YR$$M$Y$58.957$KG$20240815$$HP$US$US
219099603$21909960$3$F$20230101$20240918$20230125$20240925$PER$$NVSC2023US012513$NOVARTIS$$$$$$Y$$$20240925$$HP$US$US
219099793$21909979$3$F$$20240828$20230125$20240829$PER$$NVSC2023US016911$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
219109844$21910984$4$F$20230101$20240829$20230125$20240905$EXP$$CA-ABBVIE-4282885$ABBVIE$$$$$M$Y$$$20240905$$HP$CA$CA
219110813$21911081$3$F$$20240911$20230125$20240913$PER$$NVSC2023US015166$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
219112347$21911234$7$F$20220101$20240705$20230125$20240709$PER$$US-PFIZER INC-202300035965$PFIZER$$84$YR$$M$Y$108.86$KG$20240709$$CN$US$US
219112397$21911239$7$F$$20240805$20230125$20240809$EXP$$US-JAZZ-2022-US-032907$JAZZ$$$$$F$Y$$$20240809$$CN$US$US
219116624$21911662$4$F$20220827$20240819$20230125$20240820$EXP$$FR-PFIZER INC-PV202300012655$PFIZER$$63$YR$$M$Y$85$KG$20240820$$HP$FR$FR
2191184110$21911841$10$F$20230101$20240711$20230125$20240722$PER$$US-XERIS PHARMACEUTICALS-2023XER00017$XERIS PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
219125773$21912577$3$F$20220401$20240912$20230125$20240917$EXP$$US-JAZZ-2022-US-022017$JAZZ$$44$YR$$F$Y$$$20240917$$CN$US$US
219125806$21912580$6$F$20180101$20240823$20230125$20240826$EXP$$US-JAZZ-2022-US-033829$JAZZ$$46$YR$$M$Y$$$20240826$$MD$US$US
219137352$21913735$2$F$20230111$20240805$20230125$20240813$EXP$$BR-CELLTRION INC.-2023BR001440$CELLTRION$$$$$$Y$$$20240813$$CN$BR$BR
219137504$21913750$4$F$20221220$20240807$20230125$20240813$EXP$$BR-CELLTRION INC.-2023BR001447$CELLTRION$$$$$$Y$$$20240814$$CN$BR$BR
219145722$21914572$2$F$20230125$20240715$20230126$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-012074$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240718$$CN$US$US
2191458613$21914586$13$F$20230101$20240723$20230126$20240731$EXP$$CA-CELLTRION INC.-2023CA001826$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
219147003$21914700$3$F$$20240809$20230126$20240815$EXP$$BR-CELLTRION INC.-2023BR001570$CELLTRION$$$$$$Y$$$20240815$$CN$BR$BR
2191490413$21914904$13$F$20210317$20240912$20230126$20240923$EXP$$DE-ROCHE-2798517$ROCHE$$40$YR$A$F$Y$$$20240923$$CN$DE$DE
219149232$21914923$2$F$20230116$20240910$20230126$20240920$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023AMR009508$VIIV$$33$YR$$M$Y$$$20240920$$CN$US$US
2191520211$21915202$11$F$20221023$20240626$20230126$20240702$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-191966$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240702$$CN$US$US
219152218$21915221$8$F$20231101$20231127$20230126$20240924$EXP$$NVSC2023US016814$NOVARTIS$$76$YR$$M$Y$$$20240924$$HP$US$US
219152572$21915257$2$F$$20240819$20230126$20240826$EXP$$US-TAKEDA-2023TUS009177$TAKEDA$$$$$F$Y$$$20240826$$CN$US$US
2191528910$21915289$10$F$20210130$20240921$20230126$20240926$EXP$$US-SA-2021SA244977$SANOFI AVENTIS$$60$YR$A$F$Y$55.8$KG$20240926$$HP$US$US
219153187$21915318$7$F$$20240624$20230126$20240703$PER$$US-SA-2023SA026342$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240703$$MD$US$US
219153592$21915359$2$F$20220101$20240821$20230126$20240827$EXP$$CA-ROCHE-3108004$ROCHE$$28$YR$A$M$Y$103$KG$20240827$$CN$CA$CA
219154845$21915484$5$F$$20240823$20230126$20240828$EXP$$NVSC2023US015470$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
219155356$21915535$6$F$20200915$20240918$20230126$20240924$EXP$$FR-MYLANLABS-2023M1005735$MYLAN$$84$YR$$F$Y$50$KG$20240924$$MD$FR$FR
219156084$21915608$4$F$$20240712$20230126$20240716$EXP$$US-PFIZER INC-202300029719$PFIZER$Bowman, L.. Tacrolimus Toxicity Due to Unrecognized Significance of Nirmatrelvir-Ritonavir Interaction in a Case Series of Solid Organ Transplant Recipients. JACCP Journal of the American College of Clinical Pharmacy. 2022;5(12):1352-1353$53$YR$$M$Y$73$KG$20240716$$PH$US$US
219156104$21915610$4$F$$20240712$20230126$20240716$EXP$$US-PFIZER INC-202300029720$PFIZER$Bowman, L.. Tacrolimus Toxicity Due to Unrecognized Significance of Nirmatrelvir-Ritonavir Interaction in a Case Series of Solid Organ Transplant Recipients. JACCP Journal of the American College of Clinical Pharmacy. 2022;5(12):1352-1353$75$YR$$F$Y$52$KG$20240716$$PH$US$US
219156114$21915611$4$F$$20240712$20230126$20240716$EXP$$US-PFIZER INC-202300029718$PFIZER$Bowman, L.. Tacrolimus Toxicity Due to Unrecognized Significance of Nirmatrelvir-Ritonavir Interaction in a Case Series of Solid Organ Transplant Recipients. JACCP Journal of the American College of Clinical Pharmacy. 2022;5(12):1352-1353$60$YR$$M$Y$84$KG$20240716$$PH$US$US
2191593411$21915934$11$F$20221214$20240712$20230126$20240718$EXP$$MX-TAKEDA-2022TUS101825$TAKEDA$$6$YR$$M$Y$$$20240718$$MD$MX$MX
219161694$21916169$4$F$$20240906$20230126$20240910$EXP$$NVSC2021DE315861$NOVARTIS$$77$YR$$F$Y$$$20240910$$HP$DE$DE
219162263$21916226$3$F$20220101$20240618$20230126$20240701$PER$$US-PFIZER INC-PV202300013694$PFIZER$$42$YR$$F$Y$$$20240701$$HP$US$US
219164392$21916439$2$F$20230106$20230127$20230126$20240723$EXP$$CA-AstraZeneca-2023A016208$ASTRAZENECA$$23307$DY$$F$Y$$$20240723$$CN$CA$
219165034$21916503$4$F$20221207$20240802$20230126$20240808$EXP$$JP-009507513-2301JPN002296J$MERCK$$62$YR$$F$Y$$$20240808$$MD$JP$JP
2191667812$21916678$12$F$$20240821$20230126$20240829$EXP$$CA-ASTELLAS-2022US042185$ASTELLAS$$19$YR$A$M$Y$98$KG$20240829$$MD$CA$CA
219169872$21916987$2$F$20220101$20230123$20230126$20240715$EXP$$BE-ASTELLAS-2023US002784$ASTELLAS$$70$YR$$M$Y$$$20240715$$MD$BE$BE
219173332$21917333$2$F$$20240701$20230126$20240703$PER$$NVSC2023US017775$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
219173915$21917391$5$F$20221224$20240809$20230126$20240816$EXP$$BR-CELLTRION INC.-2023BR001591$CELLTRION$$$$$$Y$$$20240816$$HP$BR$BR
219174493$21917449$3$F$$20240802$20230126$20240809$EXP$$BR-CELLTRION INC.-2023BR001610$CELLTRION$$$$$$Y$$$20240809$$CN$BR$BR
219177152$21917715$2$F$$20240917$20230127$20240918$PER$$US-AMGEN-USASP2023013261$AMGEN$$$$A$F$Y$$$20240918$$HP$US$US
2191773516$21917735$16$F$20230215$20240816$20230127$20240826$EXP$$CA-CELLTRION INC.-2023CA001936$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
219178135$21917813$5$F$$20240830$20230127$20240907$EXP$$BR-CELLTRION INC.-2023BR001567$CELLTRION$$$$$$Y$$$20240907$$CN$BR$BR
219178774$21917877$4$F$20231215$20240828$20230127$20240919$PER$$CA-TOLMAR, INC.-23CA038382$TOLMAR$$50$YR$$M$Y$$$20240919$$CN$CA$CA
219179944$21917994$4$F$20221025$20230403$20230127$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGNX-22-00798$ULTRAGENYX PHARMACEUTICAL$$2$YR$$F$Y$$$20240905$$CN$US$US
219180486$21918048$6$F$20240101$20240805$20230127$20240815$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000026$DECIPHERA PHARMACEUTICALS$$66$YR$A$F$Y$$$20240815$$HP$US$US
2191808918$21918089$18$F$20221230$20240719$20230127$20240729$EXP$$US-ROCHE-3272067$ROCHE$$33$YR$A$M$Y$$$20240729$$CN$US$US
219181092$21918109$2$F$20230101$20230120$20230127$20240807$EXP$$US-RECORDATI-2023000396$RECORDATI$$$$$$Y$$$20240807$$CN$US$US
219181386$21918138$6$F$20230124$20240701$20230127$20240703$EXP$$JP-ARGENX-2023-ARGX-JP000230$ARGENX BVBA$$48$YR$$F$Y$87$KG$20240703$$MD$JP$JP
219182362$21918236$2$F$$20240822$20230127$20240902$EXP$$NL-AUROBINDO-AUR-APL-2023-003166$AUROBINDO$Daliparty VM, Chhetri S, Talib S, Dendi P.. Babesia microti infection with low-grade parasitemia causing ARDS in an immunocompetent patient.. Chest. 2022;162(4):A875$49$YR$$F$Y$$$20240902$$HP$NL$NL
219182552$21918255$2$F$20221101$20240806$20230127$20240809$EXP$$DE-ROCHE-3272549$ROCHE$$53$YR$A$F$Y$59$KG$20240809$$MD$DE$DE
219182595$21918259$5$F$20220608$20240731$20230127$20240802$EXP$$DE-ROCHE-3119198$ROCHE$$44$YR$A$M$Y$$$20240802$$CN$DE$DE
219183333$21918333$3$F$$20240729$20230127$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00476$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219186285$21918628$5$F$20230213$20240809$20230127$20240813$EXP$$CA-TAKEDA-2022TUS101904$TAKEDA$$55$YR$$F$Y$$$20240813$$CN$CA$CA
219186922$21918692$2$F$20221223$20240907$20230127$20240917$EXP$$FI-Vifor (International) Inc.-VIT-2023-00486$VIFOR$$41$YR$$M$Y$$$20240917$$CN$FI$FI
219187616$21918761$6$F$$20240714$20230127$20240717$EXP$$PK-AMGEN-PAKSP2023013796$AMGEN$$68$YR$E$F$Y$$$20240717$$CN$PK$PK
219188322$21918832$2$F$$20240911$20230127$20240918$PER$$US-SA-2022SA520249$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240918$$MD$US$US
219189323$21918932$3$F$20230101$20240820$20230127$20240824$EXP$$US-ABBVIE-4282788$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
219190852$21919085$2$F$20230123$20240917$20230127$20240923$PER$$US-SA-2023SA029422$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240923$$MD$US$US
219192174$21919217$4$F$$20240807$20230127$20240812$PER$$US-BIOGEN-2023BI01183685$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
219193238$21919323$8$F$20231128$20240708$20230127$20240710$EXP$$CA-TAKEDA-2023TUS009079$TAKEDA$$60$YR$$F$Y$$$20240710$$MD$CA$CA
219193937$21919393$7$F$$20240910$20230127$20240913$EXP$$US-TAKEDA-US202020260$TAKEDA$$$$$F$Y$79$KG$20240913$$CN$US$US
219193953$21919395$3$F$20180704$20240710$20230127$20240712$EXP$$CA-TAKEDA-2018TUS020509$TAKEDA$$81$YR$$F$Y$$$20240712$$CN$CA$CA
219194382$21919438$2$F$$20240624$20230127$20240702$PER$$US-TAKEDA-2023TUS007628$TAKEDA$$$$$F$Y$61$KG$20240702$$MD$US$US
219194594$21919459$4$F$$20230328$20230127$20240925$PER$$US-GSK-US2023AMR008608$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
219196552$21919655$2$F$20220301$20230123$20230127$20240925$EXP$$US-GSK-US2022AMR043230$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
219196782$21919678$2$F$20220607$20230124$20230127$20240926$EXP$$US-GSK-US2022AMR091072$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
219197337$21919733$7$F$20230110$20240801$20230127$20240808$EXP$$CA-TAKEDA-2023TUS003829$TAKEDA$$33$YR$$M$Y$$$20240808$$CN$CA$CA
219197845$21919784$5$F$$20230614$20230127$20240711$PER$$US-PFM-2022-06721$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.878$KG$20240711$$HP$US$US
219198234$21919823$4$F$20230119$20240810$20230127$20240828$EXP$$US-GSK-US2023006957$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240828$$HP$US$US
219202478$21920247$8$F$$20240722$20230127$20240731$EXP$$US-TAKEDA-2022TUS089572$TAKEDA$$$$$F$Y$$$20240731$$MD$US$US
219203152$21920315$2$F$$20240917$20230127$20240919$EXP$$US-PFIZER INC-PV202300016595$PFIZER$$79$YR$$M$Y$$$20240919$$CN$US$US
219204759$21920475$9$F$20220719$20240903$20230127$20240909$EXP$$US-TAKEDA-US201944618$TAKEDA$$34$YR$$F$Y$102$KG$20240909$$CN$US$US
219204857$21920485$7$F$$20240918$20230127$20240930$PER$$NVSC2023US014549$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
219204924$21920492$4$F$$20240924$20230127$20240926$PER$$US-PFIZER INC-PV202300017494$PFIZER$$71$YR$$F$Y$$$20240926$$CN$US$US
219205933$21920593$3$F$20211027$20240909$20230127$20240911$EXP$$GB-ROCHE-3272461$ROCHE$$30$YR$A$M$Y$82.6$KG$20240911$$MD$GB$GB
219205993$21920599$3$F$20220101$20240710$20230127$20240712$PER$$US-PFIZER INC-PV202300014957$PFIZER$$81$YR$$F$Y$$$20240712$$MD$US$US
219207545$21920754$5$F$20221221$20240620$20230127$20240701$EXP$$AT-PFIZER INC-202300038627$PFIZER$$72$YR$$M$Y$$$20240701$$MD$AT$AT
2192105711$21921057$11$F$20220516$20240903$20230127$20240906$EXP$$PL-PFIZER INC-202200830493$PFIZER$$58$YR$$F$Y$66$KG$20240906$$MD$PL$PL
219210833$21921083$3$F$20200420$20240820$20230127$20240828$EXP$$CA-TAKEDA-CA202014132$TAKEDA$$34$YR$$M$Y$73$KG$20240828$$CN$CA$CA
2192115522$21921155$22$F$$20240822$20230127$20240902$EXP$$CA-AstraZeneca-2021A294924$ASTRAZENECA$$65$YR$$M$Y$96$KG$20240903$$MD$CA$
219213828$21921382$8$F$$20240902$20230127$20240927$EXP$$CA-ORGANON-O2301CAN002055$ORGANON$$44$YR$$F$Y$97$KG$20240927$$MD$CA$CA
219214223$21921422$3$F$20190726$20230124$20230127$20240911$PER$$NVSC2023US016913$NOVARTIS$$60$YR$$M$Y$$$20240911$$CN$US$US
2192160611$21921606$11$F$$20240916$20230127$20240923$EXP$$CA-BAUSCH-BL-2023-001022$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240924$$HP$CA$CA
219216202$21921620$2$F$$20240909$20230127$20240910$EXP$$CA-BAUSCH-BL-2023-001421$BAUSCH AND LOMB$$5$MON$$F$Y$$$20240910$$CN$CA$CA
219219107$21921910$7$F$20221201$20240805$20230127$20240812$EXP$$JP-009507513-2301JPN000902J$MERCK$Yao S, Yokoi S, Kakiuchi T, Maeda H, Goi T. EP-0492 A Case of Early TNBC Successfully Treated Although Pembrolizumab Continuation was Difficult Due to irAE. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 300$69$YR$$F$Y$$$20240812$$MD$JP$JP
219219502$21921950$2$F$20221219$20240805$20230127$20240812$EXP$$BR-CELLTRION INC.-2023BR001376$CELLTRION$$$$$$Y$$$20240812$$CN$BR$BR
219220832$21922083$2$F$20230101$20230123$20230128$20240925$PER$$US-GSK-US2023AMR010154$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240925$$CN$US$US
219220914$21922091$4$F$$20240918$20230128$20240925$PER$$NVSC2023US015324$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
219221584$21922158$4$F$$20240830$20230128$20240904$EXP$$NVSC2023US016861$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
219222086$21922208$6$F$20230214$20231004$20230128$20240925$PER$$US-GSK-US2023AMR009451$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240925$$CN$US$US
219222296$21922229$6$F$$20240905$20230128$20240913$EXP$$CA-CELLTRION INC.-2021CA019387$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
2192236524$21922365$24$F$20220101$20240716$20230128$20240724$EXP$$CA-CELLTRION INC.-2022CA010777$CELLTRION$$$$$$Y$$$20240724$$MD$CA$CA
2192237428$21922374$28$F$20220801$20240911$20230128$20240919$EXP$$CA-CELLTRION INC.-2022CA012997$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
219224253$21922425$3$F$20221028$20240624$20230128$20240702$EXP$$IT-CELLTRION INC.-2023IT001427$CELLTRION$$$$$$Y$$$20240702$$MD$IT$IT
219227856$21922785$6$F$20221201$20240814$20230128$20240821$EXP$$BR-CELLTRION INC.-2023BR001571$CELLTRION$$$$$$Y$$$20240821$$CN$BR$BR
219228464$21922846$4$F$20230116$20240802$20230128$20240810$EXP$$BR-CELLTRION INC.-2023BR001728$CELLTRION$$$$$$Y$$$20240810$$CN$BR$BR
219232673$21923267$3$F$20220101$20240819$20230129$20240827$EXP$$CA-CELLTRION INC.-2022CA006390$CELLTRION$$$$$$Y$$$20240827$$MD$CA$CA
219233412$21923341$2$F$$20240724$20230129$20240727$EXP$$NVSC2023US019083$NOVARTIS$$$$$M$Y$$$20240727$$CN$US$US
219236035$21923603$5$F$20230121$20230208$20230130$20240926$EXP$$US-GSK-US2023AMR010134$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
219239713$21923971$3$F$$20240822$20230130$20240826$PER$$NVSC2023US019836$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
2192401018$21924010$18$F$20220101$20240905$20230130$20240916$EXP$$US-INSMED-2022-02612-USAA$INSMED$$$$$M$Y$$$20240916$$CN$US$US
219241503$21924150$3$F$20221201$20240808$20230130$20240815$EXP$$US-SA-2022SA520855$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240815$$CN$US$US
219244139$21924413$9$F$20230120$20230519$20230130$20240925$EXP$$US-GSK-US2023AMR011759$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
219244614$21924461$4$F$$20240805$20230130$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00558$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219244784$21924478$4$F$$20240830$20230130$20240902$EXP$$US-TAKEDA-US202033077$TAKEDA$$$$$F$Y$$$20240902$$HP$US$US
219245302$21924530$2$F$$20240812$20230130$20240820$30DAY$$US-GSK-US2023008668$GLAXOSMITHKLINE$$$$$F$Y$$$20240820$$CN$US$US
219246327$21924632$7$F$$20240710$20230130$20240711$EXP$$US-UCBSA-2023003620$UCB$$$$$F$Y$$$20240711$$CN$GB$GB
219246595$21924659$5$F$20221013$20240704$20230130$20240712$EXP$$DE-CELLTRION INC.-2023DE001527$CELLTRION$$$$$$Y$$$20240712$$MD$DE$DE
219247736$21924773$6$F$20230120$20240815$20230130$20240817$PER$$NVSC2023US017570$NOVARTIS$$51$YR$$M$Y$$$20240817$$HP$US$US
219248093$21924809$3$F$$20240703$20230130$20240712$PER$$US-SA-2023SA029234$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240712$$MD$US$US
219248125$21924812$5$F$20220701$20240801$20230130$20240814$PER$$US-SA-2023SA029018$SANOFI AVENTIS$$75$YR$E$M$Y$81$KG$20240814$$MD$US$US
219249342$21924934$2$F$20220501$20240709$20230130$20240723$EXP$$DE-AUROBINDO-AUR-APL-2023-003399$AUROBINDO$$1$DY$$F$Y$2.36$KG$20240719$$MD$DE$DE
219252013$21925201$3$F$$20240905$20230130$20240918$EXP$$FR-AUROBINDO-AUR-APL-2023-003677$AUROBINDO$Benchalal, M... Anaphylactic shock secondary to intravenous administration of folinic acid: a first report.. Annals of Oncology. 2002;13 (3):480-481$80$YR$$M$Y$$$20240918$$HP$FR$FR
219253147$21925314$7$F$20200601$20240822$20230130$20240829$EXP$$NVSC2020AT185641$NOVARTIS$$$$E$F$Y$$$20240829$$MD$AT$AT
219254145$21925414$5$F$20230101$20240307$20230130$20240806$EXP$$NVSC2023CO018803$NOVARTIS$$40$YR$$F$Y$87$KG$20240806$$CN$CO$CO
219255942$21925594$2$F$$20240722$20230130$20240727$EXP$$GR-TAKEDA-2023TUS009578$TAKEDA$$63$YR$$M$Y$$$20240727$$CN$GR$GR
219256473$21925647$3$F$$20240716$20230130$20240724$EXP$$CA-AstraZeneca-2023A024039$ASTRAZENECA$$65$YR$$F$Y$34$KG$20240724$$MD$CA$
219256775$21925677$5$F$20221201$20240717$20230130$20240726$PER$$US-SA-2023SA030479$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240726$$MD$US$US
219257016$21925701$6$F$20221126$20240910$20230130$20240916$EXP$$IT-TAKEDA-2022TUS052305$TAKEDA$$$$$F$Y$$$20240916$$CN$IT$IT
219258865$21925886$5$F$20230123$20240827$20230130$20240905$EXP$$US-TAKEDA-2023TUS008675$TAKEDA$$62$YR$$F$Y$$$20240905$$CN$US$US
219259322$21925932$2$F$$20240730$20230130$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00496$LUPIN$$$$$$Y$$$20240817$$CN$US$US
219259802$21925980$2$F$$20240729$20230130$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00504$LUPIN$$$$$$Y$$$20240817$$PH$US$US
219260473$21926047$3$F$$20240802$20230130$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00505$LUPIN$$$$$$Y$$$20240820$$CN$US$US
219260942$21926094$2$F$$20240730$20230130$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00506$LUPIN$$$$$$Y$$$20240819$$CN$US$US
219262123$21926212$3$F$20180517$20240821$20230130$20240827$EXP$$DE-MYLANLABS-2023M1008399$MYLAN$$46$YR$$F$Y$$$20240827$$CN$DE$DE
219262433$21926243$3$F$$20240802$20230130$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00509$LUPIN$$$$$$Y$$$20240827$$PH$US$US
219265472$21926547$2$F$$20240802$20230130$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00513$LUPIN$$$$$$Y$$$20240820$$CN$US$US
219267034$21926703$4$F$20230106$20240718$20230130$20240720$EXP$$NVSC2023CH016463$NOVARTIS$$$$A$F$Y$$$20240719$$MD$CH$CH
219268824$21926882$4$F$$20240919$20230130$20240924$PER$$US-PFIZER INC-PV202300007776$PFIZER$$69$YR$$F$Y$$$20240924$$MD$US$US
219268834$21926883$4$F$$20240715$20230130$20240718$PER$$US-PFIZER INC-PV202300016340$PFIZER$$51$YR$$F$Y$$$20240718$$CN$US$US
219270212$21927021$2$F$20221201$20240828$20230130$20240905$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2022-002856$SAREPTA THERAPEUTICS$$18$YR$$M$Y$95.084$KG$20240906$$HP$US$US
219271269$21927126$9$F$$20240807$20230130$20240811$EXP$$NVSC2023US019768$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
219272666$21927266$6$F$20221003$20240918$20230130$20240927$EXP$$JP-PFIZER INC-PV202200084035$PFIZER$$16$MON$$M$Y$7.4$KG$20240927$$MD$JP$JP
219273632$21927363$2$F$20230101$20240806$20230130$20240816$PER$$US-SA-2023SA030252$SANOFI AVENTIS$$63$YR$A$F$Y$67$KG$20240816$$MD$US$US
219274313$21927431$3$F$20180705$20240627$20230130$20240704$EXP$$JP-JNJFOC-20230152298$JOHNSON AND JOHNSON$$35$YR$A$F$Y$39.2$KG$20240704$$MD$JP$JP
219277009$21927700$9$F$$20240905$20230130$20240910$PER$$US-PFIZER INC-202300040027$PFIZER$$63$YR$$M$Y$$$20240910$$HP$US$US
219279833$21927983$3$F$20230106$20240920$20230130$20240925$EXP$$CA-ROCHE-3272283$ROCHE$$45$YR$A$M$Y$$$20240925$$CN$CA$CA
219280873$21928087$3$F$$20240925$20230130$20240928$EXP$$CA-ROCHE-3271292$ROCHE$$89$YR$E$M$Y$$$20240928$$CN$CA$CA
219281517$21928151$7$F$20220401$20240729$20230130$20240803$EXP$$CA-ROCHE-3270060$ROCHE$$41$YR$A$F$Y$$$20240803$$CN$CA$CA
219281732$21928173$2$F$$20240917$20230130$20240923$EXP$$CA-ROCHE-3274285$ROCHE$$73$YR$E$F$Y$81$KG$20240923$$HP$CA$CA
219281894$21928189$4$F$20211227$20240712$20230130$20240716$EXP$$GB-ROCHE-3273070$ROCHE$$42$YR$A$F$Y$97.1$KG$20240716$$MD$GB$GB
219286486$21928648$6$F$$20240624$20230130$20240703$EXP$$JP-ABBVIE-4288986$ABBVIE$$71$YR$$F$Y$28$KG$20240703$$MD$JP$JP
219289374$21928937$4$F$20221222$20240712$20230131$20240716$EXP$$US-TAKEDA-2022TUS004943$TAKEDA$$12$YR$$M$Y$45$KG$20240716$$CN$US$US
219289589$21928958$9$F$$20230502$20230131$20240828$PER$$NVSC2023US016721$NOVARTIS$$$$$M$Y$$$20240828$$CN$US$US
2192922611$21929226$11$F$20221214$20240901$20230131$20240909$EXP$$US-BEH-2023154558$CSL BEHRING$$15$YR$T$F$Y$55.329$KG$20240909$$CN$US$US
219292763$21929276$3$F$$20240805$20230131$20240816$EXP$$US-LUPIN PHARMACEUTICALS INC.-2023-00507$LUPIN$$$$$$Y$$$20240816$$CN$US$US
219293876$21929387$6$F$20230201$20240814$20230131$20240821$EXP$$US-ORPHANEU-2023000408$RECORDATI$$$$$$Y$$$20240821$$CN$US$US
219296734$21929673$4$F$20230301$20240729$20230131$20240806$PER$$US-SA-2023SA030771$SANOFI AVENTIS$$64$YR$A$M$Y$97.52$KG$20240806$$MD$US$US
219297012$21929701$2$F$$20240722$20230131$20240731$PER$$US-SA-2023SA032496$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240731$$CN$US$US
219297032$21929703$2$F$20220901$20240726$20230131$20240805$PER$$US-SA-2023SA031497$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240805$$MD$US$US
219297384$21929738$4$F$$20240719$20230131$20240722$EXP$$NVSC2022FR297065$NOVARTIS$$$$A$M$Y$79$KG$20240722$$MD$FR$FR
219299083$21929908$3$F$$20240805$20230131$20240807$PER$$US-AMGEN-USASP2023013610$AMGEN$$64$YR$A$M$Y$$$20240807$$HP$US$US
219299874$21929987$4$F$20230119$20240715$20230131$20240722$30DAY$$US-GSK-US2023010259$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240722$$CN$US$US
2193004810$21930048$10$F$20230101$20231006$20230131$20240925$PER$$US-GSK-US2023AMR012515$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
219302573$21930257$3$F$$20240805$20230131$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00508$LUPIN$$$$$$Y$$$20240822$$CN$US$US
2193030813$21930308$13$F$20230101$20240819$20230131$20240912$EXP$$US-GSK-US2023AMR011652$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$US$US
2193040911$21930409$11$F$20231101$20240719$20230131$20240726$EXP$$US-BIOGEN-2023BI01184547$BIOGEN$$65$YR$$F$Y$$$20240726$$CN$US$US
219304649$21930464$9$F$20220717$20240914$20230131$20240920$EXP$$CA-TAKEDA-CA202031480$TAKEDA$$13$YR$$M$Y$55$KG$20240920$$HP$CA$CA
219304658$21930465$8$F$20230627$20240712$20230131$20240716$EXP$$US-TAKEDA-2022TUS010430$TAKEDA$$69$YR$$F$Y$93$KG$20240716$$CN$US$US
219305482$21930548$2$F$$20230124$20230131$20240709$EXP$$BR-ASTELLAS-2023US003040$ASTELLAS$$$$$M$Y$$$20240709$$MD$BR$BR
219306432$21930643$2$F$$20230124$20230131$20240919$EXP$$NVSC2023HU017439$NOVARTIS$$$$$$Y$$$20240919$$MD$HU$HU
219307172$21930717$2$F$20230113$20240819$20230131$20240827$EXP$$BR-CELLTRION INC.-2023BR001586$CELLTRION$$$$$$Y$$$20240827$$HP$BR$BR
219311383$21931138$3$F$20230202$20240719$20230131$20240723$EXP$$CA-TAKEDA-2023TUS009863$TAKEDA$$64$YR$$M$Y$$$20240723$$CN$CA$CA
219312372$21931237$2$F$$20240806$20230131$20240810$EXP$$US-TAKEDA-2023TUS010222$TAKEDA$$$$$M$Y$$$20240810$$CN$US$US
219312619$21931261$9$F$20240411$20240703$20230131$20240708$EXP$$US-KYOWAKIRIN-2023BKK001420$KYOWA$$$$$$Y$$$20240708$$CN$US$US
219313102$21931310$2$F$20150101$20230122$20230131$20240710$EXP$$AU-ASTELLAS-2021US039773$ASTELLAS$Williams T, Kaazan P, Slack T, Tallis C, Borowsky J, Martin N. Ileal pouch adenocarcinoma following ileal pouch-anal anastomosis in a transplant recipient. Internal Medicine Journal. 2022;52 (8):1448-9$24$YR$$M$Y$$$20240710$$HP$AU$AU
219313504$21931350$4$F$20230112$20240903$20230131$20240923$EXP$$US-GSK-US2023011056$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$US$US
219315094$21931509$4$F$$20240802$20230131$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00524$LUPIN$$$$$$Y$$$20240820$$CN$US$US
219315573$21931557$3$F$$20240802$20230131$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00529$LUPIN$$$$$$Y$$$20240820$$CN$US$US
219315673$21931567$3$F$$20240731$20230131$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00526$LUPIN$$$$$$Y$$$20240820$$CN$US$US
219316712$21931671$2$F$$20240727$20230131$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00534$LUPIN$$$$$$Y$$$20240816$$CN$US$US
219316722$21931672$2$F$$20240730$20230131$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00531$LUPIN$$$$$$Y$$$20240819$$CN$US$US
219317002$21931700$2$F$$20240802$20230131$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00536$LUPIN$$$$$$Y$$$20240821$$CN$US$US
219317082$21931708$2$F$$20230124$20230131$20240903$EXP$$NVSC2023CA017042$NOVARTIS$$$$$F$Y$$$20240903$$CN$CA$CA
2193175213$21931752$13$F$20221101$20240717$20230131$20240723$EXP$$US-JAZZ-2023-US-001784$JAZZ$$23$YR$$F$Y$$$20240723$$CN$US$US
219320016$21932001$6$F$$20240812$20230131$20240820$EXP$$CA-JNJFOC-20230149335$JOHNSON AND JOHNSON$$65$YR$E$F$Y$69$KG$20240820$$HP$CA$CA
219320307$21932030$7$F$20201201$20240905$20230131$20240909$EXP$$US-PFIZER INC-2020460091$PFIZER$$66$YR$$F$Y$$$20240909$$CN$US$US
219321176$21932117$6$F$20211020$20240722$20230131$20240725$EXP$$JP-ABBVIE-4288461$ABBVIE$$68$YR$$M$Y$62.7$KG$20240725$$MD$JP$JP
219322926$21932292$6$F$$20240920$20230131$20240925$PER$$US-PFIZER INC-PV202300017542$PFIZER$$76$YR$$F$Y$$$20240925$$CN$US$US
219323575$21932357$5$F$20220101$20240911$20230131$20240916$EXP$$BE-MYLANLABS-2023M1009857$MYLAN$Manczak B, Verdier MC, Dewulf JP, Lemaitre F, Haufroid V, Hantson P. LACTIC ACIDOSIS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION POTENTIALLY RELATED TO LETERMOVIR. British Journal of Clinical Pharmacology. 2023;89(5):1686-1689$53$YR$$F$Y$$$20240916$$MD$BE$BE
219327235$21932723$5$F$20230116$20240816$20230131$20240817$EXP$$NVSC2023US016601$NOVARTIS$$65$YR$$F$Y$$$20240817$$CN$US$US
219327382$21932738$2$F$$20240801$20230131$20240810$PER$$US-SA-2023SA032819$SANOFI AVENTIS$$$$A$M$Y$88.45$KG$20240810$$MD$US$US
219330754$21933075$4$F$$20240909$20230131$20240911$EXP$$CA-BAUSCH-BL-2023-001418$BAUSCH AND LOMB$$31$MON$$$Y$$$20240911$$HP$CA$CA
219331653$21933165$3$F$$20240920$20230131$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-039254$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240927$$MD$JP$JP
219334652$21933465$2$F$20200101$20240719$20230201$20240726$EXP$$BR-JNJFOC-20230151498$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$56$KG$20240726$$CN$BR$BR
219334803$21933480$3$F$$20240715$20230201$20240723$EXP$$CA-JNJFOC-20230151298$JOHNSON AND JOHNSON$$14$YR$T$F$Y$$$20240722$$CN$CA$CA
2193372810$21933728$10$F$20220101$20240828$20230201$20240906$EXP$$CA-CELLTRION INC.-2022CA005921$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
219338132$21933813$2$F$20221204$20240729$20230201$20240802$EXP$FR-AFSSAPS-ST2023000088$FR-ROCHE-3275708$ROCHE$$76$YR$E$F$Y$48$KG$20240802$$PH$FR$FR
219339228$21933922$8$F$20230101$20240821$20230201$20240829$PER$$CA-TOLMAR, INC.-23CA038420$TOLMAR$$70$YR$$M$Y$$$20240829$$CN$CA$CA
219339282$21933928$2$F$20221101$20240710$20230201$20240729$PER$$NL-TOLMAR, INC.-23NL038372$TOLMAR$$78$YR$$M$Y$$$20240729$$CN$NL$NL
219339988$21933998$8$F$20230124$20240919$20230201$20240924$EXP$$NVSC2023US017884$NOVARTIS$$48$YR$$F$Y$$$20240924$$CN$US$US
219341125$21934112$5$F$20230223$20240917$20230201$20240927$EXP$$FR-AUROBINDO-AUR-APL-2023-003640$AUROBINDO$Pujol T, Souques C, Collarino R, Baudouin E, Keravec H, Houdre J et al. DRESS syndrome secondaire a une antibiotherapie par ceftriaxone (DRESS syndrome secondary to ceftriaxone antibiotic  therapy). LA REVUE DE GERIATRIE. 2022;47(9):473-9$88$YR$$F$Y$$$20240927$$MD$FR$FR
219342695$21934269$5$F$$20240911$20230201$20240919$EXP$$CA-CELLTRION INC.-2023CA001843$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
219342928$21934292$8$F$20230124$20240915$20230201$20240916$EXP$$CA-PFIZER INC-202300037962$PFIZER$$65$YR$$M$Y$$$20240916$$HP$CA$CA
219343413$21934341$3$F$$20240727$20230201$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00525$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219343533$21934353$3$F$20221001$20240808$20230201$20240809$PER$$NVSC2023US018270$NOVARTIS$$59$YR$$F$Y$$$20240809$$CN$US$US
2193448716$21934487$16$F$20230101$20240924$20230201$20240927$EXP$$CA-PFIZER INC-202300023744$PFIZER$$55$YR$$F$Y$86$KG$20240927$$MD$CA$CA
219345205$21934520$5$F$$20240830$20230201$20240903$PER$$US-PFIZER INC-202300038447$PFIZER$$44$YR$$F$Y$$$20240903$$CN$US$US
219345235$21934523$5$F$$20240805$20230201$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00570$LUPIN$$$$$$Y$$$20240827$$CN$US$US
219347397$21934739$7$F$20220920$20240805$20230201$20240812$EXP$$NVSC2023CN019651$NOVARTIS$$59$YR$$F$Y$55$KG$20240812$$HP$CN$CN
2193476912$21934769$12$F$20211028$20240816$20230201$20240820$EXP$$CA-TAKEDA-2023TUS010848$TAKEDA$$64$YR$$F$Y$$$20240820$$HP$CA$CA
219348372$21934837$2$F$$20240808$20230201$20240815$EXP$$BR-CELLTRION INC.-2023BR001938$CELLTRION$$$$$$Y$$$20240815$$CN$BR$BR
219352277$21935227$7$F$$20240904$20230201$20240909$PER$$NVSC2023US017575$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
219352603$21935260$3$F$$20240805$20230201$20240807$EXP$$US-TAKEDA-2022TUS004268$TAKEDA$$$$$F$Y$$$20240807$$CN$US$US
219353125$21935312$5$F$20220102$20240920$20230201$20240930$EXP$$US-GSK-US2022003458$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240930$$CN$US$US
219354502$21935450$2$F$$20240823$20230201$20240905$PER$$US-SA-2023SA032073$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240905$$MD$US$US
219354904$21935490$4$F$20221216$20240808$20230201$20240820$PER$$US-SA-2023SA032514$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240820$$MD$US$US
219356235$21935623$5$F$20211001$20240711$20230201$20240716$EXP$$US-SA-2023SA035770$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240716$$MD$US$US
219358198$21935819$8$F$20230510$20240807$20230201$20240812$EXP$$NVSC2023US017380$NOVARTIS$$64$YR$$M$Y$$$20240812$$CN$US$US
219363285$21936328$5$F$20230101$20240806$20230201$20240812$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-002910$AURINIA PHARMACEUTICALS$$22$YR$$F$Y$$$20240812$$HP$US$US
219365373$21936537$3$F$$20240830$20230201$20240905$EXP$$US-KYOWAKIRIN-2023BKK001475$KYOWA$$$$$$Y$$$20240905$$HP$US$US
219366787$21936678$7$F$$20240802$20230201$20240808$EXP$$CA-TAKEDA-2023TUS009185$TAKEDA$$$$$F$Y$$$20240808$$CN$CA$CA
219368213$21936821$3$F$$20240730$20230201$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00555$LUPIN$$$$$$Y$$$20240817$$CN$US$US
2193682216$21936822$16$F$20220101$20240924$20230201$20240927$EXP$$US-PFIZER INC-PV202300018668$PFIZER$$74$YR$$F$Y$$$20240927$$CN$US$US
219368334$21936833$4$F$$20240730$20230201$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00556$LUPIN$$$$$$Y$$$20240819$$CN$US$US
219369334$21936933$4$F$$20240805$20230201$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00597$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219369753$21936975$3$F$$20240726$20230201$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00596$LUPIN$$$$$$Y$$$20240816$$CN$US$US
219376074$21937607$4$F$20180727$20240828$20230201$20240830$EXP$$CA-JNJFOC-20230142839$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240830$$HP$CA$CA
219377002$21937700$2$F$$20240705$20230201$20240710$EXP$$IT-PFIZER INC-202300044338$PFIZER$$59$YR$$M$Y$$$20240710$$MD$IT$IT
2193776713$21937767$13$F$20231201$20240909$20230201$20240912$EXP$$US-TAKEDA-2022TUS091934$TAKEDA$$63$YR$$F$Y$62$KG$20240912$$CN$US$US
219379872$21937987$2$F$$20240905$20230201$20240917$EXP$$US-INCYTE CORPORATION-2021IN005019$INCYTE$Puar A, Donegan D, Helft P, Kuhar M, Webster J, Rao M, et al.. Hyperphosphatemic Tumoral Calcinosis With Pemigatinib Use. AACE Clinical Case Reports. 2022;8:217-220$$$$$Y$$$20240917$$MD$US$US
219381438$21938143$8$F$$20240220$20230201$20240718$EXP$$US-Taiho Oncology Inc-2022-003440$TAIHO ONCOLOGY INC$$67$YR$E$F$Y$$$20240718$$CN$US$US
219383417$21938341$7$F$$20240924$20230201$20240926$PER$$US-PFIZER INC-PV202300019834$PFIZER$$72$YR$$F$Y$70.3$KG$20240926$$CN$US$US
219383467$21938346$7$F$20230113$20240814$20230201$20240821$EXP$$DE-TAKEDA-2023TUS010687$TAKEDA$$34$YR$$F$Y$58$KG$20240821$$MD$DE$DE
219392973$21939297$3$F$20240819$20240829$20230201$20240904$EXP$$CA-ABBVIE-4290860$ABBVIE$$49$YR$$M$Y$$$20240904$$CN$CA$CA
219393184$21939318$4$F$20220101$20240711$20230201$20240717$EXP$$US-ABBVIE-4290546$ABBVIE$$$$$F$Y$72$KG$20240717$$CN$US$US
219400916$21940091$6$F$20230101$20240704$20230201$20240712$EXP$$FR-ALXN-A202300126$ALEXION PHARMACEUTICALS$$36$YR$$F$Y$61$KG$20240712$$MD$FR$FR
219409044$21940904$4$F$20230401$20240910$20230202$20240921$EXP$$CA-UCBSA-2023001896$UCB$$57$YR$$M$Y$$$20240921$$HP$CA$CA
219427552$21942755$2$F$20230101$20230130$20230202$20240925$PER$$US-GSK-US2023AMR014650$GLAXOSMITHKLINE$$85$YR$$F$Y$$$20240925$$CN$US$US
219428344$21942834$4$F$$20240717$20230202$20240726$EXP$$FR-AUROBINDO-AUR-APL-2022-055506$AUROBINDO$$$$A$M$Y$79$KG$20240726$$MD$FR$FR
219428384$21942838$4$F$$20240912$20230202$20240916$PER$$NVSC2023US020791$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
219429954$21942995$4$F$20200520$20240909$20230202$20240924$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-249485$RANBAXY$$45$YR$A$F$Y$$$20240924$$CN$US$US
219432773$21943277$3$F$20230101$20240729$20230202$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00592$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219433072$21943307$2$F$20221221$20240705$20230202$20240715$EXP$IT-MINISAL02-904502$IT-TEVA-2023-IT-2849627$TEVA$$12$YR$$M$Y$32$KG$20240715$$PH$IT$IT
219433322$21943332$2$F$20230118$20240702$20230202$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202301008801$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240708$$CN$US$US
219433514$21943351$4$F$20230130$20240717$20230202$20240724$EXP$$US-TAKEDA-2023TUS010817$TAKEDA$$79$YR$$M$Y$$$20240724$$MD$US$US
2194340312$21943403$12$F$$20240916$20230202$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-144842$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240920$$MD$JP$JP
219435115$21943511$5$F$20230114$20240830$20230202$20240919$PER$$CA-TOLMAR, INC.-23CA038486$TOLMAR$$74$YR$$M$Y$$$20240919$$CN$CA$CA
219435398$21943539$8$F$20230314$20240726$20230202$20240731$EXP$$US-TAKEDA-2021TUS056527$TAKEDA$$39$YR$$M$Y$101$KG$20240731$$CN$US$US
219435842$21943584$2$F$20190101$20210128$20230202$20240726$EXP$$NVSC2021AR025020$NOVARTIS$$$$$M$Y$$$20240726$$CN$AR$AR
2194368614$21943686$14$F$20230114$20240830$20230202$20240903$EXP$$NVSC2023US017703$NOVARTIS$$40$YR$$F$Y$$$20240904$$CN$US$US
219440272$21944027$2$F$$20240719$20230202$20240827$PER$$NVSC2023US023564$NOVARTIS$$$$$M$Y$$$20240827$$CN$US$US
219442932$21944293$2$F$$20240821$20230202$20240902$EXP$$PL-Accord-298440$ACCORD$Czarny J, Andrzejewska M, Zajac-Spychala O, Latos-Grazynska E, Pastorczak A, Wypyszczak K, et al. Successful Treatment of Large B-Cell Lymphoma in a Child with Compound Heterozygous Mutation in the +lt;i+gt;ATM+lt;/i+gt; Gene. Int J Mol Sci. 2023 Jan 6; 24(2): 1099.$7$YR$C$F$Y$$$20240902$$HP$PL$PL
219442993$21944299$3$F$20210101$20240715$20230202$20240722$EXP$DE-EMBRYOTOX-202118043$DE-UCBSA-2023003586$UCB$$1$DY$$F$Y$2.36$KG$20240722$$MD$DE$DE
219444799$21944479$9$F$20221211$20240718$20230202$20240723$EXP$$US-TAKEDA-2022TUS039899$TAKEDA$$9$YR$$M$Y$25$KG$20240723$$CN$US$US
219447547$21944754$7$F$20230918$20240722$20230202$20240729$EXP$$GB-GSK-GB2023EME013268$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$HP$GB$GB
219447907$21944790$7$F$$20240712$20230202$20240716$EXP$$NVSC2023CA018004$NOVARTIS$$63$YR$$M$Y$$$20240716$$HP$CA$CA
219448803$21944880$3$F$20221227$20240823$20230202$20240827$EXP$$DE-MYLANLABS-2023M1010681$MYLAN$$82$YR$$M$Y$66$KG$20240827$$MD$DE$DE
219450075$21945007$5$F$20200101$20240913$20230202$20240920$EXP$$CA-BAUSCH-BL-2020-005788$BAUSCH AND LOMB$$32$YR$$F$Y$$$20240920$$CN$CA$CA
219453606$21945360$6$F$$20240626$20230202$20240701$PER$$US-PFIZER INC-PV202200120409$PFIZER$$79$YR$$F$Y$68.027$KG$20240701$$CN$US$US
2194561712$21945617$12$F$$20240724$20230202$20240729$PER$$US-PFIZER INC-PV202300005001$PFIZER$$77$YR$$F$Y$$$20240729$$CN$US$US
219456853$21945685$3$F$$20240813$20230202$20240821$PER$$US-SA-2023SA031492$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240821$$CN$US$US
219456912$21945691$2$F$20230101$20240628$20230202$20240712$PER$$US-SA-2023SA034682$SANOFI AVENTIS$$27$YR$A$F$Y$74.84$KG$20240712$$MD$US$US
219458268$21945826$8$F$$20240627$20230202$20240701$EXP$$US-PFIZER INC-PV202200126934$PFIZER$$73$YR$$F$Y$$$20240701$$CN$US$US
219458322$21945832$2$F$$20240711$20230202$20240801$PER$$US-SA-2023SA036031$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240719$$MD$US$US
219458833$21945883$3$F$20221101$20240910$20230202$20240916$PER$$US-SA-2023SA036575$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240916$$MD$US$US
219459483$21945948$3$F$$20240820$20230202$20240828$PER$$US-SA-2023SA036311$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240828$$CN$US$US
219460496$21946049$6$F$20221130$20240710$20230202$20240717$EXP$$JP-009507513-2212JPN000834J$MERCK$$72$YR$$M$Y$169.4$KG$20240717$$MD$JP$JP
219461487$21946148$7$F$20230123$20240710$20230202$20240717$EXP$$US-JAZZ-2023-US-002420$JAZZ$$41$YR$$M$Y$$$20240717$$CN$US$US
219464536$21946453$6$F$20230101$20240719$20230202$20240724$EXP$$US-PFIZER INC-PV202300019888$PFIZER$$78$YR$$F$Y$$$20240724$$CN$US$US
219466395$21946639$5$F$20221214$20240729$20230202$20240808$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-34438$IPSEN$$78$YR$E$F$Y$$$20240808$$MD$CA$CA
219468652$21946865$2$F$$20240830$20230202$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-015737$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240904$$HP$US$US
219468836$21946883$6$F$20191223$20240711$20230202$20240717$EXP$$CA-TAKEDA-2019TUS060860$TAKEDA$$71$YR$$F$Y$$$20240717$$HP$CA$CA
219472917$21947291$7$F$20230131$20240809$20230202$20240814$EXP$$CA-TAKEDA-2021TUS025393$TAKEDA$$75$YR$$M$Y$$$20240814$$CN$CA$CA
219472992$21947299$2$F$20190601$20240719$20230202$20240724$EXP$$US-SHIRE-US201943283AA$TAKEDA$$47$YR$$F$Y$$$20240724$$CN$US$US
219475583$21947558$3$F$$20240620$20230202$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000114$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
219475656$21947565$6$F$20220729$20240918$20230202$20240928$EXP$$CA-CELLTRION INC.-2022CA013300$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
219476566$21947656$6$F$20230101$20240911$20230203$20240921$EXP$$CA-ROCHE-3272944$ROCHE$$36$YR$A$F$Y$$$20240921$$CN$CA$CA
219476696$21947669$6$F$20230504$20240722$20230203$20240808$PER$$CA-TOLMAR, INC.-23CA038449$TOLMAR$$81$YR$$M$Y$$$20240808$$CN$CA$CA
219476778$21947677$8$F$20221201$20240823$20230203$20240912$PER$$CA-TOLMAR, INC.-23CA038467$TOLMAR$$84$YR$$M$Y$$$20240912$$CN$CA$CA
219477128$21947712$8$F$20221001$20240726$20230203$20240803$EXP$$CA-CELLTRION INC.-2022CA018165$CELLTRION$$$$$$Y$$$20240803$$HP$CA$CA
219479145$21947914$5$F$20200914$20240814$20230203$20240822$EXP$ES-AEMPS-1324466$ES-ABBVIE-4293568$ABBVIE$$74$YR$$M$Y$59$KG$20240822$$PH$ES$ES
2194811521$21948115$21$F$20230101$20240916$20230203$20240924$EXP$$CA-CELLTRION INC.-2023CA001715$CELLTRION$$$$$$Y$$$20240924$$CN$CA$CA
219483143$21948314$3$F$20240601$20240729$20230203$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202301011654$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240820$$CN$US$US
219484103$21948410$3$F$$20240712$20230203$20240723$EXP$$US-TAKEDA-2023TUS010623$TAKEDA$$$$$F$Y$$$20240723$$HP$US$US
219484302$21948430$2$F$$20240809$20230203$20240817$EXP$$BR-CELLTRION INC.-2023BR002267$CELLTRION$$$$$$Y$$$20240817$$CN$BR$BR
219485804$21948580$4$F$20240528$20240816$20230203$20240821$EXP$$US-TAKEDA-US202027099$TAKEDA$$75$YR$$F$Y$$$20240821$$HP$US$US
219485834$21948583$4$F$$20240729$20230203$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00608$LUPIN$$$$$$Y$$$20240817$$CN$US$US
219485983$21948598$3$F$$20240730$20230203$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00612$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219486793$21948679$3$F$$20240805$20230203$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00618$LUPIN$$$$$$Y$$$20240817$$CN$US$US
219487222$21948722$2$F$20221231$20240705$20230203$20240715$EXP$IT-MINISAL02-904565$IT-TEVA-2023-IT-2851098$TEVA$$13$YR$$M$Y$43$KG$20240715$$PH$IT$IT
219487413$21948741$3$F$$20230206$20230203$20240709$EXP$$BR-ASTELLAS-2023US003400$ASTELLAS$$51$YR$$F$Y$$$20240709$$MD$BR$BR
219490954$21949095$4$F$$20240808$20230203$20240815$EXP$$GB-CELLTRION INC.-2023GB002262$CELLTRION$$$$$$Y$$$20240815$$CN$GB$GB
219491918$21949191$8$F$20230202$20240830$20230203$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-016081$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240904$$CN$US$US
219492633$21949263$3$F$$20240805$20230203$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00619$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219494753$21949475$3$F$$20240729$20230203$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00654$LUPIN$$$$$$Y$$$20240818$$PH$US$US
219494834$21949483$4$F$20230123$20240820$20230203$20240822$EXP$$US-SA-2023SA038970$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240822$$MD$US$US
219494933$21949493$3$F$$20240727$20230203$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00664$LUPIN$$$$$$Y$$$20240816$$PH$US$US
219495403$21949540$3$F$$20240805$20230203$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00665$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219498593$21949859$3$F$$20240630$20230203$20240830$EXP$$GB-SA-2022SA238475$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240830$$MD$GB$GB
219498722$21949872$2$F$$20240809$20230203$20240815$EXP$$BR-CELLTRION INC.-2023BR002254$CELLTRION$$$$$$Y$$$20240815$$CN$BR$BR
219500718$21950071$8$F$20230101$20230317$20230203$20240925$PER$$US-GSK-US2023AMR014577$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
2195018614$21950186$14$F$20220804$20240917$20230203$20240921$EXP$$NVSC2022MX180271$NOVARTIS$$68$YR$$F$Y$56$KG$20240921$$CN$MX$MX
219502023$21950202$3$F$$20240923$20230203$20240930$EXP$$UA-TAKEDA-2023TUS010400$TAKEDA$$$$$F$Y$$$20240930$$MD$UA$UA
219503943$21950394$3$F$20230119$20240701$20230203$20240711$EXP$$JP-UCBSA-2023005367$UCB$$21$YR$$M$Y$$$20240711$$MD$JP$JP
219504559$21950455$9$F$20230101$20240807$20230203$20240812$EXP$$CA-TAKEDA-2023TUS011972$TAKEDA$$22$YR$$M$Y$$$20240812$$MD$CA$CA
219505096$21950509$6$F$$20240918$20230203$20240926$PER$$NVSC2023US023409$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
219505447$21950544$7$F$$20240913$20230203$20240922$EXP$$US-TAKEDA-US202002724$TAKEDA$$$$$F$Y$74$KG$20240922$$HP$US$US
219506333$21950633$3$F$20220629$20240918$20230203$20240925$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-002937$AURINIA PHARMACEUTICALS$$19$YR$$F$Y$$$20240925$$HP$US$US
219508113$21950811$3$F$20230121$20240727$20230203$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00627$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219508272$21950827$2$F$$20240806$20230203$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00629$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219508443$21950844$3$F$$20240805$20230203$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00682$LUPIN$$$$$$Y$$$20240829$$CN$US$US
219509742$21950974$2$F$$20240805$20230203$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00681$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219509822$21950982$2$F$$20240806$20230203$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00631$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219510027$21951002$7$F$$20240803$20230203$20240805$EXP$$CA-PFIZER INC-202300046945$PFIZER$$67$YR$$F$Y$34$KG$20240805$$HP$CA$CA
219510163$21951016$3$F$20221204$20240716$20230203$20240718$EXP$FR-AFSSAPS-ST2023000088$FR-PFIZER INC-202300044451$PFIZER$$76$YR$$F$Y$48$KG$20240718$$PH$FR$FR
219510373$21951037$3$F$$20240805$20230203$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00709$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219510733$21951073$3$F$$20240727$20230203$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00628$LUPIN$$$$$$Y$$$20240818$$PH$US$US
2195117115$21951171$15$F$20231213$20240808$20230203$20240820$EXP$$NVSC2022CO134728$NOVARTIS$$59$YR$$M$Y$65$KG$20240820$$CN$CO$CO
219514583$21951458$3$F$20240101$20240906$20230203$20240916$PER$$US-SA-2023SA038424$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
219514924$21951492$4$F$$20240731$20230203$20240808$EXP$$US-SA-2023SA032887$SANOFI AVENTIS$$58$YR$A$M$Y$73.93$KG$20240808$$MD$US$US
219515983$21951598$3$F$$20240814$20230203$20240819$EXP$$US-PFIZER INC-202300047945$PFIZER$$76$YR$$F$Y$110.22$KG$20240819$$CN$US$US
219517437$21951743$7$F$20221201$20231116$20230203$20240925$EXP$$US-GSK-US2022AMR154486$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
219517458$21951745$8$F$20220830$20240807$20230203$20240809$EXP$$DE-TAKEDA-2022TUS101247$TAKEDA$$45$YR$$F$Y$119$KG$20240809$$MD$DE$DE
219518832$21951883$2$F$20220401$20230130$20230203$20240926$EXP$$US-GSK-US2022AMR075032$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
219520456$21952045$6$F$$20240819$20230203$20240822$EXP$$US-PFIZER INC-PV202300020394$PFIZER$$78$YR$$M$Y$$$20240822$$CN$US$US
219520515$21952051$5$F$20240709$20240710$20230203$20240712$EXP$$US-PFIZER INC-PV202300020403$PFIZER$$74$YR$$F$Y$$$20240712$$CN$US$US
219521396$21952139$6$F$20220118$20240812$20230203$20240816$EXP$$DE-PFIZER INC-202200623242$PFIZER$$57$YR$$F$Y$59$KG$20240816$$HP$DE$DE
2195228011$21952280$11$F$20230608$20240904$20230203$20240909$EXP$$CA-TAKEDA-2022TUS099966$TAKEDA$$59$YR$$F$Y$$$20240909$$MD$CA$CA
219523876$21952387$6$F$$20240910$20230203$20240919$EXP$$CA-ROCHE-3273315$ROCHE$$$$A$M$Y$$$20240919$$CN$CA$CA
219526703$21952670$3$F$20231123$20240813$20230203$20240820$EXP$$BR-CELLTRION INC.-2023BR002266$CELLTRION$$$$$$Y$$$20240820$$CN$BR$BR
2195278010$21952780$10$F$20230130$20240926$20230204$20240930$EXP$$NVSC2023US022308$NOVARTIS$$37$YR$$F$Y$$$20240929$$CN$US$US
219528042$21952804$2$F$20230127$20230228$20230204$20240717$PER$$NVSC2023US021335$NOVARTIS$$41$YR$$M$Y$$$20240717$$CN$US$US
219528332$21952833$2$F$$20240829$20230204$20240830$PER$$NVSC2023US019743$NOVARTIS$$$$A$F$Y$$$20240830$$MD$US$US
219531494$21953149$4$F$20221010$20240917$20230204$20240923$EXP$$AU-TAKEDA-2022TUS073337$TAKEDA$$27$YR$$M$Y$$$20240923$$MD$AU$AU
219531966$21953196$6$F$20220703$20240801$20230204$20240814$EXP$$FR-AUROBINDO-AUR-APL-2023-004257$AUROBINDO$Lazaridoun I, Calvani J, Annabi E, Moins-Teisserenc H, Ta AV, Rivet J etl... Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with S?zary syndrome. Journal of The european academiy of dermatorogy ? vebereology. 2023;00:1-3$49$YR$$M$Y$58$KG$20240814$$MD$FR$FR
219536442$21953644$2$F$$20240912$20230204$20240918$EXP$$NVSC2023CA023064$NOVARTIS$$$$A$F$Y$$$20240918$$HP$CA$CA
2195393210$21953932$10$F$$20240730$20230204$20240801$PER$$NVSC2023US022555$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
219543342$21954334$2$F$20220101$20240730$20230204$20240811$EXP$$US-ACORDA-ACO_173591_2022$ACORDA$$$$$F$Y$$$20240811$$CN$US$US
219545312$21954531$2$F$$20240806$20230205$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00626$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219545452$21954545$2$F$$20240806$20230205$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00630$LUPIN$$$$$$Y$$$20240827$$CN$US$US
219545493$21954549$3$F$$20240806$20230205$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00710$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219550977$21955097$7$F$20230420$20230424$20230206$20240925$PER$$US-GSK-US2023AMR014547$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
219550983$21955098$3$F$20230101$20230227$20230206$20240925$PER$$US-GSK-US2023AMR015693$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
219551394$21955139$4$F$20210101$20240905$20230206$20240906$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000064$PAREXEL$$$$$$Y$$$20240906$$CN$US$US
219552854$21955285$4$F$20230201$20240625$20230206$20240709$EXP$$CA-ROCHE-3278442$ROCHE$$30$YR$A$F$Y$$$20240709$$CN$CA$CA
219553947$21955394$7$F$20210428$20240816$20230206$20240819$EXP$$CA-ROCHE-2823000$ROCHE$$26$YR$A$F$Y$$$20240819$$CN$CA$CA
219554873$21955487$3$F$$20240807$20230206$20240814$PER$$US-SA-2023SA039418$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240814$$CN$US$US
219555843$21955584$3$F$$20240702$20230206$20240709$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-215649$BOEHRINGER INGELHEIM$$59$YR$A$F$Y$$$20240709$$CN$CA$CA
219557564$21955756$4$F$$20240827$20230206$20240909$EXP$$BR-CELLTRION INC.-2023BR002721$CELLTRION$$$$$$Y$$$20240909$$CN$BR$BR
219557863$21955786$3$F$20130206$20240621$20230206$20240709$EXP$$CA-ROCHE-1205735$ROCHE$$68$YR$E$F$Y$83.1$KG$20240705$$HP$CA$CA
219558825$21955882$5$F$20190101$20240716$20230206$20240723$EXP$$CA-ROCHE-2908773$ROCHE$$56$YR$A$F$Y$$$20240723$$CN$CA$CA
219561623$21956162$3$F$20230101$20240913$20230206$20240920$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-216802$BOEHRINGER INGELHEIM$$66$YR$E$F$Y$$$20240920$$CN$US$US
219561754$21956175$4$F$$20240910$20230206$20240918$EXP$$CA-CELLTRION INC.-2023CA002132$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
219562562$21956256$2$F$20221201$20240701$20230206$20240709$PER$$US-SA-2023SA038856$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240709$$MD$US$US
219567903$21956790$3$F$20201001$20240806$20230206$20240817$EXP$$CO-VER-202300006$VERITY PHARMACEUTICALS$$66$YR$E$M$Y$$$20240817$$CN$CO$CO
219568022$21956802$2$F$$20240718$20230206$20240724$EXP$$US-PFIZER INC-PV202300017950$PFIZER$$$$$F$Y$$$20240724$$CN$US$US
219575534$21957553$4$F$$20240828$20230206$20240907$EXP$$GB-TEVA-2023-GB-2851429$TEVA$$35$YR$$M$Y$$$20240907$$MD$GB$GB
219576366$21957636$6$F$20200101$20240826$20230206$20240829$EXP$$DE-PFIZER INC-202300040780$PFIZER$$40$YR$$F$Y$$$20240829$$CN$DE$DE
219576493$21957649$3$F$$20240807$20230206$20240809$EXP$$CA-PFIZER INC-202300051311$PFIZER$$32$YR$$M$Y$$$20240809$$HP$CA$CA
219577464$21957746$4$F$$20240805$20230206$20240813$PER$$US-SA-2023SA039280$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240814$$MD$US$US
219577598$21957759$8$F$20230119$20240826$20230206$20240902$EXP$$JP-GSK-JP2023017605$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$JP$JP
219578062$21957806$2$F$$20240819$20230206$20240826$EXP$$CA-GSK-CA2023013626$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$CA$CA
219578263$21957826$3$F$20240601$20240814$20230206$20240821$EXP$$CA-GSK-CA2023016392$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$CA$CA
219578585$21957858$5$F$$20240705$20230206$20240715$EXP$$CA-CELLTRION INC.-2023CA002170$CELLTRION$$$$$$Y$$$20240715$$HP$CA$CA
2195787815$21957878$15$F$20230309$20240826$20230206$20240830$EXP$$US-TAKEDA-2021TUS059588$TAKEDA$$66$YR$$F$Y$118$KG$20240830$$HP$US$US
219578913$21957891$3$F$20221119$20240726$20230206$20240801$EXP$$GR-MYLANLABS-2023M1010997$MYLAN$$72$YR$$F$Y$70$KG$20240801$$MD$GR$GR
219579172$21957917$2$F$$20240717$20230206$20240725$PER$$US-SA-2023SA040368$SANOFI AVENTIS$$90$YR$E$M$Y$$$20240725$$MD$US$US
219579752$21957975$2$F$$20240701$20230206$20240703$EXP$$US-PFIZER INC-202100934537$PFIZER$$67$YR$$M$Y$$$20240703$$CN$US$US
2195800810$21958008$10$F$20230128$20240808$20230206$20240813$EXP$$NVSC2023US022328$NOVARTIS$$48$YR$$F$Y$$$20240813$$CN$US$US
219580369$21958036$9$F$20200101$20240628$20230206$20240709$PER$$US-SA-2023SA040255$SANOFI AVENTIS$$43$YR$A$F$Y$71.66$KG$20240709$$MD$US$US
219580798$21958079$8$F$20220607$20240731$20230206$20240802$EXP$$NVSC2022RU198550$NOVARTIS$$57$YR$$F$Y$67$KG$20240802$$MD$RU$RU
219581772$21958177$2$F$20240101$20240925$20230206$20240930$PER$$US-PFIZER INC-PV202200010044$PFIZER$$49$YR$$F$Y$$$20240930$$MD$US$US
219587675$21958767$5$F$$20240922$20230206$20240925$PER$$US-PFIZER INC-2020306156$PFIZER$$73$YR$$F$Y$97.52$KG$20240925$$CN$US$US
219590043$21959004$3$F$$20240708$20230206$20240711$EXP$$US-PFIZER INC-PV202300015804$PFIZER$$77$YR$$F$Y$90.068$KG$20240711$$MD$US$US
2195926714$21959267$14$F$20230128$20240921$20230206$20240925$EXP$$NVSC2023EG021982$NOVARTIS$$52$YR$$F$Y$$$20240925$$CN$EG$EG
219593612$21959361$2$F$20230129$20240912$20230206$20240916$EXP$$CA-ROCHE-3277451$ROCHE$$59$YR$A$F$Y$$$20240916$$CN$CA$CA
219595593$21959559$3$F$$20240909$20230206$20240911$EXP$$US-PFIZER INC-PV202300023536$PFIZER$$76$YR$$F$Y$56.689$KG$20240911$$MD$US$US
2195997414$21959974$14$F$20230101$20240910$20230206$20240919$EXP$$CA-JNJFOC-20220453305$JOHNSON AND JOHNSON$$70$YR$E$F$Y$73$KG$20240919$$HP$CA$CA
219600127$21960012$7$F$$20240827$20230206$20240905$EXP$$BR-CELLTRION INC.-2023BR002470$CELLTRION$$$$$$Y$$$20240905$$PH$BR$BR
219601062$21960106$2$F$20221101$20240702$20230207$20240709$EXP$$CA-JNJFOC-20221246747$JOHNSON AND JOHNSON$$14$YR$T$M$Y$84$KG$20240709$$HP$CA$CA
2196027814$21960278$14$F$20220107$20240816$20230207$20240823$EXP$$CA-ROCHE-3000311$ROCHE$$52$YR$A$F$Y$$$20240823$$CN$CA$CA
219605138$21960513$8$F$20221201$20240816$20230207$20240823$EXP$$CA-CELLTRION INC.-2023CA002678$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
219605256$21960525$6$F$20230101$20240717$20230207$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000185$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240809$$CN$US$US
219605606$21960560$6$F$20230127$20240815$20230207$20240822$EXP$$BR-CELLTRION INC.-2023BR002406$CELLTRION$$$$$$Y$$$20240823$$CN$BR$BR
219606407$21960640$7$F$20200724$20230127$20230207$20240711$EXP$$US-ROCHE-3277296$ROCHE$$$$$$Y$$$20240711$$MD$US$US
219606633$21960663$3$F$$20240802$20230207$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00688$LUPIN$$$$$$Y$$$20240821$$CN$US$US
219606762$21960676$2$F$$20240910$20230207$20240921$EXP$$CA-APOTEX-2023AP002663$APOTEX$$72$YR$$M$Y$$$20240921$$HP$CA$CA
219607477$21960747$7$F$$20240918$20230207$20240926$EXP$$JP-009507513-2301JPN004118J$MERCK$Suzuki K, Shinohara H, Saito K,  Miura A, Kato T.. A Case of Unresectable Thoracic Esophageal Cancer Responding Well to Multimodal Therapy Including 5-FU plus CDDP plus Pembrolizumab. Japanese Journal of Cancer and Chemotherapy. 2023;50(13):1665-7$51$YR$$M$Y$$$20240926$$MD$JP$JP
219608413$21960841$3$F$$20240802$20230207$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00642$LUPIN$$$$$$Y$$$20240827$$CN$US$US
219608672$21960867$2$F$$20240626$20230207$20240702$EXP$$US-GSK-US2023016299$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$HP$US$US
219611837$21961183$7$F$$20230906$20230207$20240925$PER$$US-GSK-US2023AMR016278$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
219611953$21961195$3$F$$20240711$20230207$20240720$EXP$$US-ABBVIE-4296269$ABBVIE$$$$$M$Y$108.86$KG$20240720$$CN$US$US
219612063$21961206$3$F$$20240802$20230207$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00689$LUPIN$$$$$$Y$$$20240820$$CN$US$US
219614173$21961417$3$F$$20240802$20230207$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00716$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219614473$21961447$3$F$$20240802$20230207$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00717$LUPIN$$$$$$Y$$$20240820$$CN$US$US
219614622$21961462$2$F$$20240802$20230207$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00719$LUPIN$$$$$$Y$$$20240822$$PH$US$US
219614676$21961467$6$F$20230407$20230626$20230207$20240925$PER$$US-GSK-US2023AMR010405$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240925$$HP$US$US
2196152710$21961527$10$F$20230130$20230803$20230207$20240925$PER$$US-GSK-US2023AMR017224$GLAXOSMITHKLINE$$62$YR$$F$Y$73$KG$20240925$$MD$US$US
219615332$21961533$2$F$20090101$20240806$20230207$20240807$EXP$$FI-ORGANON-1910FIN008696$ORGANON$$$$E$M$Y$$$20240807$$CN$FI$FI
2196162310$21961623$10$F$20221009$20240725$20230207$20240731$EXP$$NVSC2022CA230499$NOVARTIS$$57$YR$$F$Y$$$20240731$$CN$CA$CA
219616382$21961638$2$F$20221101$20240816$20230207$20240826$EXP$$CA-ROCHE-3277529$ROCHE$$44$YR$A$M$Y$$$20240826$$CN$CA$CA
219616936$21961693$6$F$20230101$20240805$20230207$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-017735$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240814$$HP$US$US
219618374$21961837$4$F$$20240729$20230207$20240801$PER$$US-AMGEN-USASP2023020342$AMGEN$$$$A$M$Y$$$20240801$$HP$US$US
2196194313$21961943$13$F$20240201$20240916$20230207$20240923$EXP$$BR-GSK-BR2022AMR174944$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$BR$BR
2196194610$21961946$10$F$20220101$20240723$20230207$20240730$EXP$$CA-GSK-CA2022AMR154528$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$CA$CA
219619523$21961952$3$F$20230101$20240906$20230207$20240913$EXP$$IN-GSK-IN2023APC015568$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$IN$IN
2196195710$21961957$10$F$20240214$20240831$20230207$20240905$EXP$$CA-GSK-CA2023AMR014565$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$CA$CA
219622633$21962263$3$F$20220101$20240809$20230207$20240818$EXP$$JP-009507513-2210JPN002704J$MERCK$$71$YR$$F$Y$$$20240818$$MD$JP$JP
219625042$21962504$2$F$20221129$20240702$20230207$20240709$EXP$$ES-MYLANLABS-2023M1012137$MYLAN$$69$YR$$M$Y$59.65$KG$20240709$$MD$ES$ES
219625472$21962547$2$F$$20230131$20230207$20240709$EXP$$BR-ASTELLAS-2023US003968$ASTELLAS$$29$YR$$M$Y$$$20240709$$MD$BR$BR
219626332$21962633$2$F$20221204$20240717$20230207$20240725$EXP$$FR-AMGEN-FRASP2023016812$AMGEN$$76$YR$E$F$Y$48$KG$20240725$$PH$FR$FR
2196264610$21962646$10$F$20230130$20240706$20230207$20240709$EXP$$PK-AMGEN-PAKSP2022215720$AMGEN$$21$YR$A$M$Y$65$KG$20240708$$CN$PK$PK
219626802$21962680$2$F$20220101$20230111$20230207$20240807$EXP$$JP-RECORDATI-2023000134$RECORDATI$$$$$$Y$$$20240807$$MD$JP$JP
219628114$21962811$4$F$20210101$20240821$20230207$20240823$EXP$$FR-MYLANLABS-2023M1013010$MYLAN$Dufayet L., Deveaux M., Cheze M., Charuel L., Ludes B., Fortel I., Lorin de la Grandmaison G., Mayer C., Alvarez JC., Langrand J... Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the ?le-de-France Toxic Death Surveillance System (DCTOX-IdF). Analytical and Clinical Toxicology. 2022;438:1-6$38$YR$$M$Y$$$20240823$$HP$FR$FR
219631849$21963184$9$F$$20240725$20230207$20240730$PER$$US-PFIZER INC-PV202300023236$PFIZER$$67$YR$$F$Y$$$20240730$$CN$US$US
219632293$21963229$3$F$$20240626$20230207$20240711$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000082$DECIPHERA PHARMACEUTICALS$$59$YR$A$F$Y$$$20240711$$CN$US$US
219633588$21963358$8$F$20240201$20240829$20230207$20240902$EXP$$US-PFIZER INC-202300011547$PFIZER$$82$YR$$F$Y$60.771$KG$20240902$$CN$US$US
219637082$21963708$2$F$20230202$20240828$20230207$20240909$PER$$US-SA-2023SA042057$SANOFI AVENTIS$$15$YR$T$F$Y$57.1$KG$20240909$$MD$US$US
219637573$21963757$3$F$20230101$20240820$20230207$20240829$PER$$US-SA-2023SA042322$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240829$$MD$US$US
219647542$21964754$2$F$$20240924$20230207$20240927$EXP$$US-TAKEDA-US202016699$TAKEDA$$$$$F$Y$$$20240927$$MD$US$US
219647552$21964755$2$F$$20230130$20230207$20240806$EXP$$FR-JNJFOC-20230165438$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240807$$MD$FR$FR
219650832$21965083$2$F$$20240715$20230207$20240719$EXP$$NVSC2023CA020995$NOVARTIS$$55$YR$$F$Y$$$20240719$$CN$CA$CA
219653613$21965361$3$F$20230101$20240813$20230208$20240820$EXP$$BR-CELLTRION INC.-2023BR002482$CELLTRION$$$$$$Y$$$20240820$$CN$BR$BR
219653622$21965362$2$F$20221201$20240808$20230208$20240815$EXP$CH-SM-2023-10535$CH-CHEPLA-2023001512$CHEPLAPHARM$$67$YR$$F$Y$$$20240813$$PH$COUNTRY NOT SPECIFIED$CH
219654013$21965401$3$F$20221229$20240813$20230208$20240820$EXP$$BR-CELLTRION INC.-2022BR021540$CELLTRION$$$$$$Y$$$20240820$$CN$BR$BR
219654454$21965445$4$F$$20240806$20230208$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00699$LUPIN$$$$$$Y$$$20240829$$CN$US$US
2196548110$21965481$10$F$20161101$20240815$20230208$20240820$EXP$$CA-JNJFOC-20221203410$JOHNSON AND JOHNSON$$55$YR$A$F$Y$96$KG$20240820$$HP$CA$CA
219655073$21965507$3$F$20230119$20240806$20230208$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00732$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219655242$21965524$2$F$$20240802$20230208$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00733$LUPIN$$$$$$Y$$$20240827$$CN$US$US
219655492$21965549$2$F$$20240802$20230208$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00739$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219655793$21965579$3$F$$20240806$20230208$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00758$LUPIN$$$$$$Y$$$20240827$$CN$US$US
219656092$21965609$2$F$20221022$20240814$20230208$20240822$EXP$$BR-CELLTRION INC.-2023BR002496$CELLTRION$$$$$$Y$$$20240822$$CN$BR$BR
219656594$21965659$4$F$20200101$20240628$20230208$20240704$EXP$$CA-JNJFOC-20230209386$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240704$$LW$CA$CA
219656717$21965671$7$F$20230411$20240826$20230208$20240919$PER$$CA-TOLMAR, INC.-23CA038504$TOLMAR$$83$YR$$M$Y$$$20240919$$CN$CA$CA
219656728$21965672$8$F$20230116$20240827$20230208$20240917$PER$$CA-TOLMAR, INC.-23CA038523$TOLMAR$$61$YR$$M$Y$$$20240917$$CN$CA$CA
219657149$21965714$9$F$20220501$20231024$20230208$20240925$PER$$US-GSK-US2022124229$GLAXOSMITHKLINE$$71$YR$$F$Y$74.83$KG$20240925$$CN$US$US
219657272$21965727$2$F$$20240904$20230208$20240918$EXP$$US-CIPLA LTD.-2023US00416$CIPLA$Agrawal A, Chong GY, Fidler ME, Cramer II CH, Amer H, Bentall AJ.. Early post-transplant recurrence of ANCA vasculitis while on belatacept maintenance immunosuppression.. Journal of nephrology. 2023$$$$$Y$$$20240918$$HP$US$US
219657554$21965755$4$F$20190816$20240719$20230208$20240723$EXP$$CA-JNJFOC-20220944840$JOHNSON AND JOHNSON$$73$YR$E$F$Y$70.37$KG$20240723$$PH$CA$CA
219657894$21965789$4$F$$20230201$20230208$20240829$PER$$NVSC2023US024083$NOVARTIS$$$$$M$Y$$$20240829$$MD$US$US
219660052$21966005$2$F$20221118$20240808$20230208$20240815$EXP$$BR-CELLTRION INC.-2022BR019969$CELLTRION$$$$$$Y$$$20240815$$HP$BR$BR
219662846$21966284$6$F$20230412$20240624$20230208$20240701$EXP$$CA-TAKEDA-2023TUS012958$TAKEDA$$19$YR$$M$Y$$$20240701$$CN$CA$CA
219664664$21966466$4$F$$20240904$20230208$20240905$PER$$NVSC2023US023812$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
219667035$21966703$5$F$20211101$20240725$20230208$20240801$EXP$$US-SA-2023SA043291$SANOFI AVENTIS$$17$YR$A$M$Y$89.31$KG$20240801$$MD$US$US
219667233$21966723$3$F$$20240726$20230208$20240805$PER$$US-SA-2023SA043705$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240805$$MD$US$US
219667672$21966767$2$F$20230101$20230131$20230208$20240709$EXP$$BR-ASTELLAS-2023US003966$ASTELLAS$$50$YR$$F$Y$$$20240709$$MD$BR$BR
219668197$21966819$7$F$$20230406$20230208$20240807$PER$$NVSC2023US025404$NOVARTIS$$$$$M$Y$$$20240807$$CN$US$US
219668574$21966857$4$F$20220101$20240628$20230208$20240703$PER$$US-AMGEN-USASP2022228622$AMGEN$$58$YR$A$M$Y$$$20240703$$HP$US$US
219670643$21967064$3$F$20211201$20240724$20230208$20240802$PER$$US-SA-2023SA043942$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240802$$MD$US$US
219670772$21967077$2$F$$20240827$20230208$20240828$EXP$$CA-PFIZER INC-202300051658$PFIZER$$61$YR$$M$Y$$$20240828$$HP$CA$CA
219671093$21967109$3$F$$20240716$20230208$20240724$EXP$$CA-ROCHE-3280432$ROCHE$$36$YR$A$F$Y$95$KG$20240724$$CN$CA$CA
219672124$21967212$4$F$20210810$20240305$20230208$20240717$EXP$$NVSC2023CA026470$NOVARTIS$Watts C, Nadori K. Elevated transaminases and development of cardiomyopathy in a 32-year-old woman with metastatic breast cancer after treatment with ribociclib followed by palbociclib. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2023;29(4):962-6$32$YR$$F$Y$$$20240717$$HP$CA$CA
2196742910$21967429$10$F$20220101$20240826$20230208$20240829$EXP$$CA-PFIZER INC-202101780915$PFIZER$$59$YR$$F$Y$$$20240829$$CN$CA$CA
219675554$21967555$4$F$$20240724$20230208$20240729$EXP$$US-PFIZER INC-PV202300024108$PFIZER$$35$YR$$F$Y$$$20240729$$CN$US$US
219675833$21967583$3$F$20150918$20240918$20230208$20240923$EXP$$PHHY2015CA115064$NOVARTIS$$71$YR$$M$Y$$$20240923$$HP$CA$CA
2196770111$21967701$11$F$20230131$20240911$20230208$20240912$EXP$$NVSC2023US022596$NOVARTIS$$39$YR$$F$Y$$$20240912$$CN$US$US
219677393$21967739$3$F$$20240802$20230208$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00718$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219677573$21967757$3$F$$20240731$20230208$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00738$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219677733$21967773$3$F$$20240806$20230208$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00741$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219679063$21967906$3$F$$20240806$20230208$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00762$LUPIN$$$$$$Y$$$20240828$$PH$US$US
219679392$21967939$2$F$20220501$20230131$20230208$20240927$EXP$$NVSC2023BR025856$NOVARTIS$$$$A$F$Y$$$20240927$$MD$BR$BR
219679413$21967941$3$F$20230101$20240918$20230208$20240930$EXP$$GB-JNJFOC-20230209839$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240929$$HP$GB$GB
219680184$21968018$4$F$$20240903$20230208$20240908$EXP$$JP-009507513-2302JPN000033J$MERCK$$77$YR$$M$Y$$$20240908$$MD$JP$JP
219680573$21968057$3$F$$20240806$20230208$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00760$LUPIN$$$$$$Y$$$20240902$$CN$US$US
2196824111$21968241$11$F$20230101$20240919$20230208$20240923$PER$$US-DSJP-DSU-2023-104868$DAIICHI$$$$$M$Y$$$20240923$$CN$US$US
219682545$21968254$5$F$$20240909$20230208$20240911$EXP$$US-TAKEDA-US202015988$TAKEDA$$$$$F$Y$$$20240911$$HP$US$US
219682592$21968259$2$F$20230106$20240808$20230208$20240816$EXP$CH-SM-2023-10547$CH-009507513-2302CHE000496$MERCK$$54$YR$$F$Y$$$20240816$$MD$CH$CH
219683529$21968352$9$F$$20240716$20230208$20240718$EXP$$US-PFIZER INC-PV202300021639$PFIZER$$35$YR$$M$Y$$$20240718$$HP$US$US
219683994$21968399$4$F$$20240628$20230208$20240702$PER$$PR-PFIZER INC-202300053389$PFIZER$$56$YR$$F$Y$$$20240702$$HP$PR$PR
219684265$21968426$5$F$20230202$20240709$20230208$20240715$EXP$$CA-TAKEDA-2023TUS013112$TAKEDA$$56$YR$$M$Y$$$20240715$$CN$CA$CA
219684584$21968458$4$F$$20240903$20230208$20240912$EXP$$JP-009507513-2302JPN000035J$MERCK$$65$YR$$M$Y$$$20240912$$MD$JP$JP
219686072$21968607$2$F$20170101$20240729$20230208$20240802$EXP$$FR-MYLANLABS-2023M1013578$MYLAN$Dufayet L., Deveaux M., Cheze M., Charuel L., Ludes B., Fortel I., Lorin de la Grandmaison G., Mayer C., Alvarez JC., Langrand J... Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF)Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF).. Analytical and Clinical Toxicology.. 2022;438:1-6$45$YR$$M$Y$$$20240802$$HP$FR$FR
219689094$21968909$4$F$20221223$20240710$20230208$20240715$PER$$US-BAYER-2023A014403$BAYER$$52$YR$A$F$Y$$$20240715$$CN$US$US
219690362$21969036$2$F$$20240729$20230208$20240801$PER$$NVSC2023US023465$NOVARTIS$$$$$M$Y$$$20240802$$CN$US$US
219696453$21969645$3$F$$20240828$20230208$20240905$EXP$$CA-TAKEDA-2023TUS012187$TAKEDA$$62$YR$$F$Y$$$20240905$$MD$CA$CA
219697066$21969706$6$F$20220101$20240624$20230208$20240701$EXP$$JP-JAZZ-2023-JP-003073$JAZZ$$58$YR$$M$Y$84.4$KG$20240701$$MD$JP$JP
219698684$21969868$4$F$20220404$20240822$20230208$20240830$EXP$$CA-CELLTRION INC.-2022CA008351$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
219699182$21969918$2$F$$20240815$20230208$20240823$EXP$$BR-CELLTRION INC.-2023BR002622$CELLTRION$$$$$$Y$$$20240823$$CN$BR$BR
219699384$21969938$4$F$20240724$20240815$20230208$20240821$EXP$$BR-CELLTRION INC.-2023BR002647$CELLTRION$$$$$$Y$$$20240821$$CN$BR$BR
219701383$21970138$3$F$20230129$20240815$20230209$20240823$EXP$$BR-CELLTRION INC.-2023BR002585$CELLTRION$$$$$$Y$$$20240823$$CN$BR$BR
219702503$21970250$3$F$$20230202$20230209$20240802$PER$$NVSC2022US276899$NOVARTIS$$$$$M$Y$$$20240802$$CN$US$US
219704473$21970447$3$F$20230101$20230130$20230209$20240731$EXP$$US-NOVOPROD-1020001$NOVO NORDISK$$54$YR$$F$Y$329$KG$20240731$$MD$US$US
219705133$21970513$3$F$20220101$20240822$20230209$20240827$EXP$SE-MPA-2022-018778$SE-TAKEDA-2023TUS013431$TAKEDA$$37$YR$$M$Y$100$KG$20240827$$HP$SE$SE
219705463$21970546$3$F$$20240729$20230209$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00952$LUPIN$$$$$$Y$$$20240818$$CN$US$US
219705913$21970591$3$F$$20240730$20230209$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00770$LUPIN$$$$$$Y$$$20240819$$CN$US$US
219706353$21970635$3$F$20221203$20240624$20230209$20240701$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-376692$RANBAXY$$94$YR$$F$Y$$$20240701$$CN$GB$GB
219706623$21970662$3$F$$20240806$20230209$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00759$LUPIN$$$$$$Y$$$20240827$$CN$US$US
219707253$21970725$3$F$$20240806$20230209$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00769$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219707542$21970754$2$F$20230223$20240917$20230209$20240926$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-017719$BRISTOL MYERS SQUIBB$Pujol T, Souques C, Collarino R, Baudouin E, Keravec H, Houdre J, et al. DRESS syndrome secondary to ceftriaxone antibiotic therapy. Rev Geriatr. 2022 Nov;47(9):473-9.$88$YR$E$F$Y$$$20240926$$HP$FR$FR
219707942$21970794$2$F$$20240806$20230209$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00786$LUPIN$$$$$$Y$$$20240821$$CN$US$US
219709123$21970912$3$F$$20240806$20230209$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00761$LUPIN$$$$$$Y$$$20240821$$CN$US$US
219710517$21971051$7$F$20220101$20240822$20230209$20240830$EXP$$CA-CELLTRION INC.-2022CA022058$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
219712163$21971216$3$F$$20230202$20230209$20240909$PER$$NVSC2023US027671$NOVARTIS$$$$$$Y$$$20240909$$MD$US$US
219712344$21971234$4$F$20230127$20240722$20230209$20240730$30DAY$$US-GSK-US2023014270$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240730$$CN$US$US
219712465$21971246$5$F$$20240917$20230209$20240919$EXP$$CA-ROCHE-3282456$ROCHE$$$$A$F$Y$$$20240919$$CN$CA$CA
219713393$21971339$3$F$$20240727$20230209$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00807$LUPIN$$$$$$Y$$$20240816$$CN$US$US
219713958$21971395$8$F$20190503$20240627$20230209$20240702$EXP$$CA-TAKEDA-2020TUS021033$TAKEDA$$50$YR$$M$Y$$$20240702$$HP$CA$CA
219715548$21971554$8$F$20230208$20230622$20230209$20240925$PER$$US-GSK-US2023AMR017310$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240925$$HP$US$US
219715559$21971555$9$F$20230208$20230925$20230209$20240925$EXP$$US-GSK-US2023AMR017316$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
219718633$21971863$3$F$20210801$20230424$20230209$20240925$PER$$US-GSK-US2023AMR016405$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240925$$CN$US$US
219723712$21972371$2$F$$20240830$20230209$20240907$EXP$$NVSC2022AU139755$NOVARTIS$Cohen A, Sugo E, Chacko B. Isolated cerebral toxoplasmosis 17 years post renal transplant. TRANSPLANT INFECTIOUS DISEASE. 2022;24(4):e13880(1-3)$59$YR$$F$Y$$$20240907$$HP$AU$AU
219725102$21972510$2$F$20010301$20240802$20230209$20240807$EXP$$US-MYLANLABS-2023M1013638$MYLAN$$18$YR$$M$Y$86.18$KG$20240807$$CN$US$US
2197272917$21972729$17$F$20010101$20240920$20230209$20240920$EXP$$US-PFIZER INC-PV202300025035$PFIZER$$70$YR$$F$Y$79.819$KG$20240920$$CN$US$US
219727444$21972744$4$F$$20240703$20230209$20240708$PER$$US-PFIZER INC-PV202300025369$PFIZER$$64$YR$$F$Y$$$20240708$$MD$US$US
219727832$21972783$2$F$$20240731$20230209$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00453$LUPIN$$$$$$Y$$$20240820$$CN$US$US
219727933$21972793$3$F$20230101$20240827$20230209$20240830$EXP$$CA-PFIZER INC-202200358367$PFIZER$$72$YR$$F$Y$$$20240830$$MD$CA$CA
2197279512$21972795$12$F$20220101$20240918$20230209$20240924$EXP$$CA-PFIZER INC-202200809795$PFIZER$$61$YR$$M$Y$82$KG$20240924$$HP$CA$CA
219728062$21972806$2$F$20220708$20230206$20230209$20240822$EXP$IT-MINISAL02-907739$IT-BIOGEN-2023BI01186376$BIOGEN$$48$YR$$M$Y$$$20240822$$MD$IT$IT
2197281642$21972816$42$F$20230120$20240919$20230209$20240927$EXP$$CA-UCBSA-2023003574$UCB$$57$YR$$F$Y$$$20240927$$CN$CA$CA
219729152$21972915$2$F$$20240920$20230209$20240924$EXP$$CN-PFIZER INC-PV202300022815$PFIZER$Su, Y.. Fatal multisystem inflammatory syndrome in a 78-year-old adult after severe COVID-19 pneumonia during 2022 Omicron variant epidemic in Shanghai, China. Journal of Infection and Public Health. 2023;16(3):418-421$78$YR$$F$Y$$$20240924$$HP$CN$CN
219731999$21973199$9$F$20230101$20240828$20230209$20240911$EXP$$CA-UCBSA-2023006133$UCB$$$$$M$Y$$$20240911$$CN$CA$CA
219734493$21973449$3$F$20230101$20240710$20230209$20240801$PER$$US-SA-2023SA044910$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240719$$MD$US$US
219735185$21973518$5$F$$20240809$20230209$20240813$PER$$US-PFIZER INC-PV202300024151$PFIZER$$78$YR$$F$Y$$$20240813$$CN$US$US
219735227$21973522$7$F$$20240913$20230209$20240916$PER$$US-PFIZER INC-PV202300025055$PFIZER$$84$YR$$F$Y$$$20240916$$HP$US$US
219736744$21973674$4$F$20230203$20240704$20230209$20240712$EXP$$CA-ROCHE-3280341$ROCHE$$62$YR$A$M$Y$$$20240712$$CN$CA$CA
219738473$21973847$3$F$$20240823$20230209$20240828$EXP$$CA-AMGEN-CANSL2023019256$AMGEN$$51$YR$A$F$Y$$$20240828$$CN$CA$CA
219738752$21973875$2$F$20230112$20240808$20230209$20240814$EXP$CH-SM-2023-10690$CH-GSK-CH2023017011$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$CH$CH
219738839$21973883$9$F$20230308$20240808$20230209$20240814$EXP$$CA-GSK-CA2023017271$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$HP$CA$CA
219740186$21974018$6$F$20230412$20240918$20230209$20240926$EXP$$NVSC2023US022131$NOVARTIS$$38$YR$$F$Y$$$20240926$$CN$US$US
219740626$21974062$6$F$20200501$20240809$20230209$20240813$EXP$$DE-ROCHE-2616300$ROCHE$$49$YR$A$F$Y$$$20240813$$CN$DE$DE
219743487$21974348$7$F$20210402$20240724$20230209$20240730$EXP$$IN-PFIZER INC-2021113860$PFIZER$$53$YR$$F$Y$77.5$KG$20240730$$CN$IN$IN
2197514916$21975149$16$F$20240701$20240827$20230209$20240904$EXP$$US-GSK-US2023AMR017455$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240904$$CN$US$US
219753622$21975362$2$F$$20240701$20230210$20240710$EXP$$US-AUROBINDO-AUR-APL-2023-005243$AUROBINDO$Poondru S, Joseph A, Harding JC, Sundaramoorthi H, Mehta-Shah N, Green P, et al.. Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy.. Case Reports in Oncology. 2022;15(3):918-26$51$YR$$F$Y$$$20240710$$MD$US$US
2197566516$21975665$16$F$20211125$20240913$20230210$20240918$EXP$$MX-TAKEDA-2021TUS077428$TAKEDA$$56$YR$$F$Y$$$20240918$$CN$MX$MX
2197570010$21975700$10$F$20220104$20240829$20230210$20240906$EXP$$NVSC2023US027348$NOVARTIS$$21$YR$$M$Y$$$20240906$$CN$US$US
2197602010$21976020$10$F$$20230731$20230210$20240925$PER$$US-GSK-US2023AMR017449$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
219760623$21976062$3$F$$20240823$20230210$20240827$EXP$$CA-JNJFOC-20230216783$JOHNSON AND JOHNSON$$36$YR$A$F$Y$68$KG$20240827$$HP$CA$CA
2197624612$21976246$12$F$20220101$20240917$20230210$20240926$EXP$$CA-CELLTRION INC.-2022CA014067$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
219763872$21976387$2$F$20230202$20240912$20230210$20240920$EXP$$CA-CELLTRION INC.-2022CA019462$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
219764753$21976475$3$F$$20240806$20230210$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00789$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219765823$21976582$3$F$20230131$20240920$20230210$20240930$PER$$US-SA-2023SA041641$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240930$$MD$US$US
219768643$21976864$3$F$$20240806$20230210$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00803$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219768722$21976872$2$F$20221201$20240620$20230210$20240704$PER$$US-SA-2023SA046732$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240704$$MD$US$US
219768913$21976891$3$F$$20240806$20230210$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00804$LUPIN$$$$$$Y$$$20240902$$CN$US$US
219769123$21976912$3$F$$20240806$20230210$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00806$LUPIN$$$$$$Y$$$20240821$$CN$US$US
219769284$21976928$4$F$$20240820$20230210$20240828$EXP$$CA-ROCHE-3281370$ROCHE$$46$YR$A$M$Y$$$20240828$$CN$CA$CA
219769463$21976946$3$F$$20240806$20230210$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00808$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219769513$21976951$3$F$$20240805$20230210$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00809$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219769673$21976967$3$F$$20240805$20230210$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00811$LUPIN$$$$$$Y$$$20240821$$CN$US$US
219769712$21976971$2$F$$20240805$20230210$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00815$LUPIN$$$$$$Y$$$20240818$$CN$US$US
2197698618$21976986$18$F$20230101$20240815$20230210$20240821$EXP$$NVSC2023US026297$NOVARTIS$$47$YR$$F$Y$$$20240821$$CN$US$US
219769927$21976992$7$F$20221226$20240809$20230210$20240816$EXP$$CA-CELLTRION INC.-2023CA002845$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
219771092$21977109$2$F$$20240717$20230210$20240725$PER$$US-SA-2023SA047332$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240725$$MD$US$US
219773646$21977364$6$F$20230120$20240828$20230210$20240923$PER$$CA-TOLMAR, INC.-23CA038595$TOLMAR$$82$YR$$M$Y$$$20240923$$CN$CA$CA
219773703$21977370$3$F$20221001$20240715$20230210$20240805$PER$$CO-TOLMAR, INC.-23CO038584$TOLMAR$$71$YR$$M$Y$81$KG$20240802$$CN$CO$CO
219775033$21977503$3$F$$20240910$20230210$20240917$PER$$US-SA-2023SA046362$SANOFI AVENTIS$$13$YR$T$M$Y$45.9$KG$20240918$$MD$US$US
219775672$21977567$2$F$$20240717$20230210$20240724$EXP$$FR-MYLANLABS-2023M1013316$MYLAN$Duburcq T, Goutay J, Preau S, Mugnier A, Rousse N, Moussa MD, et al. Venoarterial Extracorporeal Membrane Oxygenation in Severe Drug Intoxication: A Retrospective Comparison of Survivors and Nonsurvivors. ASAIO-J 2022;68(7):907-913.$$$$$Y$$$20240724$$HP$FR$FR
219776843$21977684$3$F$$20240805$20230210$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00785$LUPIN$$$$$$Y$$$20240827$$CN$US$US
219777557$21977755$7$F$20240617$20240911$20230210$20240919$EXP$$CA-TAKEDA-2022TUS095226$TAKEDA$$38$YR$$F$Y$$$20240919$$MD$CA$CA
219779632$21977963$2$F$$20240730$20230210$20240802$EXP$$CA-PFIZER INC-202300062205$PFIZER$$$$N$$Y$$$20240802$$HP$CA$CA
219780753$21978075$3$F$20220525$20230405$20230210$20240815$EXP$$PH-OTSUKA-2023_003324$OTSUKA$$31$YR$$M$Y$$$20240815$$CN$PH$PH
219780973$21978097$3$F$$20240806$20230210$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00826$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219781183$21978118$3$F$$20240806$20230210$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00829$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219781522$21978152$2$F$$20240806$20230210$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00821$LUPIN$$$$$$Y$$$20240827$$CN$US$US
219781532$21978153$2$F$$20240806$20230210$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00831$LUPIN$$$$$$Y$$$20240822$$PH$US$US
219781983$21978198$3$F$$20240806$20230210$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00854$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219783545$21978354$5$F$20220820$20240723$20230210$20240729$PER$$US-BIOGEN-2022BI01150289$BIOGEN$$55$YR$$F$Y$$$20240729$$CN$US$US
219784042$21978404$2$F$20230104$20240712$20230210$20240721$EXP$HR-ABBVIE-4288862$HR-ROCHE-3282033$ROCHE$$77$YR$E$F$Y$$$20240721$$MD$HR$HR
219784282$21978428$2$F$20230101$20240829$20230210$20240927$PER$$US-SA-2023SA040721$SANOFI AVENTIS$$53$YR$A$M$Y$111.36$KG$20240927$$MD$US$US
219784373$21978437$3$F$$20240730$20230210$20240805$EXP$$CA-PFIZER INC-202300060498$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219784583$21978458$3$F$$20240730$20230210$20240805$EXP$$CA-PFIZER INC-202300060337$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219789162$21978916$2$F$$20240820$20230210$20240826$EXP$$US-TAKEDA-2023TUS013129$TAKEDA$$$$$M$Y$$$20240826$$CN$US$US
219789212$21978921$2$F$$20240924$20230210$20240930$EXP$$GB-MYLANLABS-2023M1014077$MYLAN$$35$YR$$M$Y$$$20240930$$MD$GB$GB
219790767$21979076$7$F$20230131$20240911$20230210$20240917$EXP$$AU-ABBVIE-4302149$ABBVIE$$35$YR$$M$Y$100$KG$20240917$$MD$AU$AU
219791014$21979101$4$F$$20240815$20230210$20240819$PER$$US-PFIZER INC-PV202300025093$PFIZER$$86$YR$$F$Y$$$20240819$$CN$US$US
219794425$21979442$5$F$$20240625$20230210$20240705$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK078558$GLENMARK$$$$$$Y$$$20240705$$HP$CA$CA
219797305$21979730$5$F$$20240913$20230210$20240919$EXP$$US-INCYTE CORPORATION-2023IN001284$INCYTE$$$$$$Y$$$20240919$$CN$US$US
219798628$21979862$8$F$20230101$20240907$20230210$20240913$EXP$$JP-009507513-2301JPN003901J$MERCK$$63$YR$$F$Y$$$20240913$$MD$JP$JP
219801314$21980131$4$F$$20240717$20230210$20240724$EXP$$US-JAZZ-2023-US-003058$JAZZ$$$$$F$Y$$$20240723$$MD$US$US
219801918$21980191$8$F$$20240918$20230210$20240930$PER$$NVSC2023US026903$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
2198027110$21980271$10$F$20220926$20240910$20230210$20240918$EXP$$CA-CELLTRION INC.-2023CA003012$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
219803606$21980360$6$F$$20240918$20230211$20240920$PER$$NVSC2023US024701$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
219805992$21980599$2$F$20230204$20240816$20230211$20240819$PER$$NVSC2023US028877$NOVARTIS$$5$YR$$F$Y$$$20240819$$HP$US$US
2198072412$21980724$12$F$20230129$20240917$20230211$20240923$EXP$$US-TAKEDA-2021TUS079754$TAKEDA$$84$YR$$M$Y$90$KG$20240923$$HP$US$US
219807534$21980753$4$F$20220501$20240807$20230211$20240812$EXP$$CA-TAKEDA-2020TUS049927$TAKEDA$$74$YR$$M$Y$$$20240812$$CN$CA$CA
219807767$21980776$7$F$20220101$20240816$20230211$20240821$EXP$$US-TAKEDA-2022TUS012540$TAKEDA$$48$YR$$F$Y$92$KG$20240821$$CN$US$US
219809654$21980965$4$F$$20240724$20230211$20240801$EXP$$US-AMGEN-USASP2023021806$AMGEN$$$$A$F$Y$$$20240801$$HP$US$US
219810036$21981003$6$F$20230119$20240820$20230211$20240821$PER$$NVSC2023US028883$NOVARTIS$$37$YR$$F$Y$$$20240821$$CN$US$US
219810782$21981078$2$F$20230201$20240702$20230211$20240704$PER$$NVSC2023US030452$NOVARTIS$$39$YR$$F$Y$$$20240704$$CN$US$US
219811503$21981150$3$F$$20240705$20230211$20240709$PER$$NVSC2023US030122$NOVARTIS$$87$YR$$M$Y$$$20240709$$CN$US$US
219813132$21981313$2$F$20220428$20240808$20230211$20240822$EXP$$US-UCBSA-2023006952$UCB$$17$YR$$F$Y$$$20240822$$CN$US$US
219813444$21981344$4$F$$20240119$20230211$20240909$EXP$$NVSC2023CA027071$NOVARTIS$$56$YR$$M$Y$$$20240909$$CN$CA$CA
2198143611$21981436$11$F$$20240927$20230211$20240930$EXP$$NVSC2023US028128$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
219814484$21981448$4$F$20220913$20240704$20230211$20240710$EXP$$CA-TAKEDA-2023TUS013982$TAKEDA$$59$YR$$M$Y$$$20240710$$CN$CA$CA
219816186$21981618$6$F$$20240806$20230212$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00838$LUPIN$$$$$$Y$$$20240821$$CN$US$US
219816324$21981632$4$F$$20240806$20230212$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00847$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219816423$21981642$3$F$$20240806$20230212$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00918$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219816472$21981647$2$F$$20240806$20230212$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00846$LUPIN$$$$$$Y$$$20240902$$CN$US$US
219817436$21981743$6$F$$20240725$20230212$20240805$PER$$US-SA-2023SA046739$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240805$$MD$US$US
2198205518$21982055$18$F$20230101$20240716$20230213$20240724$EXP$$CA-CELLTRION INC.-2023CA002531$CELLTRION$$$$$$Y$$$20240724$$MD$CA$CA
219823224$21982322$4$F$$20230710$20230213$20240925$PER$$US-GSK-US2023AMR017318$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
219824352$21982435$2$F$$20240701$20230213$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-376962$RANBAXY$$$$$F$Y$$$20240711$$CN$US$US
219826069$21982606$9$F$$20240715$20230213$20240725$EXP$$CA-AMGEN-CANSP2022228789$AMGEN$$43$YR$A$F$Y$$$20240724$$HP$CA$CA
219826248$21982624$8$F$$20240910$20230213$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-020421$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240912$$HP$US$US
219826874$21982687$4$F$$20231130$20230213$20240925$PER$$US-GSK-US2023AMR018970$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
219826899$21982689$9$F$$20230727$20230213$20240925$PER$$US-GSK-US2023AMR019334$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$MD$US$US
219828273$21982827$3$F$$20240806$20230213$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00845$LUPIN$$$$$$Y$$$20240828$$CN$US$US
2198308611$21983086$11$F$$20240910$20230213$20240918$EXP$$NVSC2023CA026446$NOVARTIS$$72$YR$$F$Y$$$20240918$$CN$CA$CA
2198322312$21983223$12$F$20231001$20240626$20230213$20240704$EXP$$US-TAKEDA-2022TUS040764$TAKEDA$$42$YR$$M$Y$$$20240704$$MD$US$US
219834548$21983454$8$F$20221201$20240516$20230213$20240814$EXP$$NVSC2022PE300244$NOVARTIS$$88$YR$$F$Y$$$20240814$$CN$PE$PE
219834898$21983489$8$F$20230101$20240731$20230213$20240808$EXP$$NL-ABBVIE-4304391$ABBVIE$$$$E$M$Y$$$20240808$$CN$NL$NL
219835603$21983560$3$F$20230101$20240927$20230213$20240928$EXP$$JP-ABBVIE-4305957$ABBVIE$$75$YR$$F$Y$56$KG$20240928$$MD$JP$JP
219837165$21983716$5$F$20230101$20240723$20230213$20240731$PER$$US-SA-2023SA046822$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240731$$MD$US$US
2198387410$21983874$10$F$20220923$20240815$20230213$20240823$EXP$$CA-TAKEDA-2023TUS014587$TAKEDA$$1$YR$$M$Y$$$20240823$$HP$CA$CA
219840517$21984051$7$F$20200124$20240708$20230213$20240716$EXP$$CA-TAKEDA-2020TUS005454$TAKEDA$$66$YR$$M$Y$$$20240716$$HP$CA$CA
219843542$21984354$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300059141$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
2198456413$21984564$13$F$20220512$20240913$20230213$20240920$EXP$$CA-TAKEDA-2022TUS032464$TAKEDA$$59$YR$$M$Y$$$20240920$$HP$CA$CA
219847212$21984721$2$F$$20240730$20230213$20240802$EXP$$CA-PFIZER INC-202300059112$PFIZER$$$$$F$Y$$$20240802$$HP$CA$CA
219847262$21984726$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300059124$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219847272$21984727$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300059142$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219847292$21984729$2$F$$20240730$20230213$20240802$EXP$$CA-PFIZER INC-202300059136$PFIZER$$$$$F$Y$$$20240802$$HP$CA$CA
219847362$21984736$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300059139$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219847578$21984757$8$F$20230101$20240724$20230213$20240802$PER$$US-SA-2023SA047433$SANOFI AVENTIS$$51$YR$A$F$Y$73$KG$20240802$$HP$US$US
219849143$21984914$3$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060314$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219849222$21984922$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300059135$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219849282$21984928$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060270$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219849362$21984936$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060471$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219849392$21984939$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060419$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219849877$21984987$7$F$20230701$20240904$20230213$20240909$PER$$US-AMGEN-USASP2023023902$AMGEN$$58$YR$A$M$Y$$$20240909$$HP$US$US
219851683$21985168$3$F$20230101$20240809$20230213$20240814$EXP$$US-PFIZER INC-202300062176$PFIZER$$75$YR$$F$Y$$$20240814$$HP$US$US
219851852$21985185$2$F$$20240824$20230213$20240905$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202302001465$ELI LILLY AND CO$Sugihara N, et al..A case of bullous pemphigoid developing after ixekizumab therapy for pityriasis rubra pilaris.The 39th Annual Meeting of the Japanese Society for Psoriasis Research 2024;:.$81$YR$E$M$Y$$$20240905$$CN$COUNTRY NOT SPECIFIED$JP
2198527312$21985273$12$F$20221201$20240322$20230213$20240814$EXP$$NVSC2023BR008004$NOVARTIS$$65$YR$$F$Y$62$KG$20240814$$CN$BR$BR
219854093$21985409$3$F$20230203$20240723$20230213$20240730$EXP$$CA-TAKEDA-2023TUS014593$TAKEDA$$51$YR$$F$Y$$$20240730$$PH$CA$CA
219857845$21985784$5$F$$20240828$20230213$20240830$EXP$$US-JAZZ-2023-US-002745$JAZZ$$$$$F$Y$$$20240830$$HP$US$US
219860782$21986078$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060496$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219860792$21986079$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060488$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219860803$21986080$3$F$$20240814$20230213$20240815$EXP$$CA-PFIZER INC-202300060636$PFIZER$$$$$$Y$$$20240815$$HP$CA$CA
219861244$21986124$4$F$$20240802$20230213$20240807$EXP$$HU-MYLANLABS-2023M1015001$MYLAN$Kiraly P.. Clinical history of a patient diagnosed with monomorphic epiteliotrophic intestinal T-cell lymphoma.. Hematology - Transfuziology. 2023;3:117-121$41$YR$$M$Y$$$20240807$$MD$HU$HU
219861852$21986185$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300062049$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219861862$21986186$2$F$$20240730$20230213$20240802$EXP$$CA-PFIZER INC-202300062226$PFIZER$$$$N$$Y$$$20240802$$HP$CA$CA
219861882$21986188$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060556$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219861892$21986189$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060567$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219861912$21986191$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300061881$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219861922$21986192$2$F$$20240730$20230213$20240802$EXP$$CA-PFIZER INC-202300062221$PFIZER$$$$N$$Y$$$20240802$$HP$CA$CA
219861932$21986193$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300062202$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219861943$21986194$3$F$$20240815$20230213$20240815$EXP$$CA-PFIZER INC-202300060721$PFIZER$$$$N$$Y$$$20240815$$HP$CA$CA
219861952$21986195$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060769$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219861962$21986196$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060779$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219861972$21986197$2$F$$20240730$20230213$20240802$EXP$$CA-PFIZER INC-202300062171$PFIZER$$$$N$$Y$$$20240802$$HP$CA$CA
219862002$21986200$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060434$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219862012$21986201$2$F$$20240730$20230213$20240802$EXP$$CA-PFIZER INC-202300060232$PFIZER$$$$$$Y$$$20240802$$HP$CA$CA
219862022$21986202$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060552$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219862042$21986204$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300062022$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219862052$21986205$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060765$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219862062$21986206$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300062188$PFIZER$$$$$$Y$$$20240805$$HP$CA$CA
219862072$21986207$2$F$$20240730$20230213$20240802$EXP$$CA-PFIZER INC-202300062055$PFIZER$$$$N$$Y$$$20240802$$HP$CA$CA
219862092$21986209$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300062038$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219862102$21986210$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060739$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219862122$21986212$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060576$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
219866342$21986634$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300060743$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219866494$21986649$4$F$20210101$20240710$20230213$20240715$EXP$$US-PFIZER INC-PV202300025556$PFIZER$$75$YR$$F$Y$$$20240715$$CN$US$US
219866532$21986653$2$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300061931$PFIZER$$$$N$$Y$$$20240805$$HP$CA$CA
219866574$21986657$4$F$$20240730$20230213$20240805$EXP$$CA-PFIZER INC-202300062014$PFIZER$$$$N$$Y$$$20240805$$CN$CA$CA
219868663$21986866$3$F$20240701$20240723$20230213$20240816$EXP$$US-THERATECHNOLOGIES INC.-2022-THE-TES-000389$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
219869079$21986907$9$F$$20240626$20230213$20240701$EXP$$CA-BAUSCH-BL-2023-002316$BAUSCH AND LOMB$$19$YR$$M$Y$98$KG$20240701$$CN$CA$CA
219870414$21987041$4$F$$20240913$20230213$20240917$PER$$NVSC2023US030477$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
219870862$21987086$2$F$$20240826$20230213$20240903$EXP$$BR-CELLTRION INC.-2023BR003023$CELLTRION$$$$$$Y$$$20240903$$CN$BR$BR
219872296$21987229$6$F$$20240802$20230213$20240805$EXP$$CA-ROCHE-2626433$ROCHE$$$$A$F$Y$$$20240805$$CN$CA$CA
219872335$21987233$5$F$20211118$20240915$20230213$20240923$EXP$$CA-JNJFOC-20211135325$JOHNSON AND JOHNSON$$8$YR$C$F$Y$37.6$KG$20240923$$HP$CA$CA
219873253$21987325$3$F$20221201$20240826$20230214$20240829$EXP$$BR-CELLTRION INC.-2023BR002652$CELLTRION$$$$$$Y$$$20240829$$CN$BR$BR
219873672$21987367$2$F$$20240820$20230214$20240827$EXP$$BR-CELLTRION INC.-2023BR002886$CELLTRION$$$$$$Y$$$20240827$$CN$BR$BR
219874749$21987474$9$F$20231001$20240612$20230214$20240707$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000268$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240707$$CN$US$US
219875963$21987596$3$F$$20240822$20230214$20240830$EXP$$BR-CELLTRION INC.-2023BR003013$CELLTRION$$$$$$Y$$$20240830$$CN$BR$BR
219876102$21987610$2$F$20230203$20240821$20230214$20240828$EXP$$BR-CELLTRION INC.-2023BR002987$CELLTRION$$$$$$Y$$$20240828$$CN$BR$BR
219876142$21987614$2$F$20190101$20240718$20230214$20240729$EXP$$RO-AUROBINDO-AUR-APL-2023-006117$AUROBINDO$$64$YR$$F$Y$$$20240729$$MD$RO$RO
219876362$21987636$2$F$$20240906$20230214$20240926$EXP$$US-SA-2023SA048792$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240926$$MD$US$US
219878034$21987803$4$F$$20240806$20230214$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00853$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219878233$21987823$3$F$$20240822$20230214$20240829$EXP$$BR-CELLTRION INC.-2023BR002248$CELLTRION$$$$$$Y$$$20240829$$CN$BR$BR
219878346$21987834$6$F$$20240806$20230214$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00855$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219878643$21987864$3$F$$20240806$20230214$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00875$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219878835$21987883$5$F$$20240917$20230214$20240924$EXP$$NVSC2023CA027756$NOVARTIS$$65$YR$$F$Y$$$20240924$$CN$CA$CA
219879263$21987926$3$F$$20240806$20230214$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00882$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219879346$21987934$6$F$$20240704$20230214$20240712$EXP$$SE-CELLTRION INC.-2023SE002773$CELLTRION$Kinch A, Furebring M, Chryssanthou E, Hallbook H. Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient. Medical Mycology Case Reports. 2023;39:26-30$$$$$Y$$$20240712$$HP$SE$SE
219879772$21987977$2$F$$20240727$20230214$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00921$LUPIN$$$$$$Y$$$20240818$$PH$US$US
2198800112$21988001$12$F$20230101$20240709$20230214$20240711$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-214569$BOEHRINGER INGELHEIM$$63$YR$A$F$Y$63$KG$20240711$$CN$US$US
219881103$21988110$3$F$$20240726$20230214$20240809$EXP$AU-MLMSERVICE-20230123-4049628-1$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-01152$ALKEM$Roberts MB, Lee J, Murphy MC, Kim AY, et.al.. Case 37-2022: A 55-Year-Old Man with Fatigue, Weight Loss, and Pulmonary Nodules. The New England Journal of Medicine. 2022;387(23):2172-83$55$YR$$M$Y$$$20240809$$MD$AU$AU
219883162$21988316$2$F$20230201$20240813$20230214$20240819$EXP$$US-ABBVIE-4306728$ABBVIE$$38$YR$$M$Y$$$20240819$$CN$US$US
219884025$21988402$5$F$20230101$20240816$20230214$20240904$PER$$CA-TOLMAR, INC.-23CA038536$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
219884486$21988448$6$F$20230209$20240822$20230214$20240824$EXP$$US-TAKEDA-2023TUS015876$TAKEDA$$4$YR$$M$Y$$$20240824$$CN$US$US
219885018$21988501$8$F$20230101$20240813$20230214$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-020290$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240816$$HP$US$US
2198870413$21988704$13$F$20221013$20240830$20230214$20240905$EXP$$CA-ROCHE-3202956$ROCHE$$19$YR$A$F$Y$$$20240905$$CN$CA$CA
219887183$21988718$3$F$20230126$20240704$20230214$20240712$EXP$$PL-CELLTRION INC.-2023PL002764$CELLTRION$$$$$$Y$$$20240712$$MD$PL$PL
219889503$21988950$3$F$20220501$20240627$20230214$20240703$EXP$$IT-MYLANLABS-2023M1014378$MYLAN$$47$YR$$M$Y$$$20240703$$MD$IT$IT
219890256$21989025$6$F$$20230403$20230214$20240925$PER$$US-GSK-US2023AMR021095$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
219890435$21989043$5$F$$20240828$20230214$20240902$EXP$$CA-JNJFOC-20230220718$JOHNSON AND JOHNSON$$80$YR$E$M$Y$89$KG$20240902$$HP$CA$CA
219890629$21989062$9$F$20230201$20230914$20230214$20240926$EXP$$US-GSK-US2023AMR022085$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
2198907114$21989071$14$F$$20240808$20230214$20240814$EXP$$US-GSK-US2022AMR078162$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$US$US
2198912315$21989123$15$F$20230201$20240801$20230214$20240830$EXP$$US-BEH-2023155162$CSL BEHRING$$40$YR$A$F$Y$$$20240830$$HP$US$US
219892512$21989251$2$F$20230211$20230724$20230214$20240823$PER$$US-Emmaus Medical, Inc.-EMM202302-000028$EMMAUS LIFE SCIENCES$$43$YR$A$M$Y$$$20240823$$CN$US$
219894874$21989487$4$F$$20240923$20230214$20240927$EXP$$US-TAKEDA-2023TUS015038$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
219896302$21989630$2$F$20240612$20240613$20230214$20240705$EXP$$US-BEH-2023155268$CSL BEHRING$$80$YR$E$M$Y$82.086$KG$20240705$$CN$US$US
219897112$21989711$2$F$$20240820$20230214$20240827$EXP$$BR-CELLTRION INC.-2023BR002876$CELLTRION$$$$$$Y$$$20240827$$CN$BR$BR
219897432$21989743$2$F$20210101$20240820$20230214$20240827$EXP$$BR-CELLTRION INC.-2023BR002975$CELLTRION$$$$$$Y$$$20240827$$CN$BR$BR
219898373$21989837$3$F$20221201$20240731$20230214$20240731$EXP$$CA-PFIZER INC-202300063571$PFIZER$$35$YR$$F$Y$$$20240731$$HP$CA$CA
219898682$21989868$2$F$20230201$20240906$20230214$20240910$EXP$$US-PFIZER INC-202300065560$PFIZER$$74$YR$$F$Y$$$20240910$$HP$US$US
219899312$21989931$2$F$$20240730$20230214$20240802$EXP$$CA-PFIZER INC-202300060718$PFIZER$$$$N$$Y$$$20240802$$HP$CA$CA
219900415$21990041$5$F$20221201$20240925$20230214$20240930$PER$$US-PFIZER INC-PV202300026374$PFIZER$$54$YR$$F$Y$71.202$KG$20240930$$HP$US$US
219903732$21990373$2$F$20230303$20240719$20230214$20240802$EXP$$HK-ROCHE-3282075$ROCHE$$62$YR$A$M$Y$$$20240802$$MD$HK$HK
219903804$21990380$4$F$$20230927$20230214$20240909$PER$$NVSC2023US032095$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
219904073$21990407$3$F$20230205$20240723$20230214$20240801$EXP$$JP-JAZZ-2023-JP-003356$JAZZ$$51$YR$$M$Y$78$KG$20240801$$HP$JP$JP
219904398$21990439$8$F$20230414$20240917$20230214$20240925$EXP$$CA-TAKEDA-2023TUS014023$TAKEDA$$81$YR$$F$Y$$$20240925$$HP$CA$CA
219905797$21990579$7$F$20211026$20240726$20230214$20240731$PER$$US-PFIZER INC-PV202300026582$PFIZER$$78$YR$$F$Y$$$20240731$$MD$US$US
219905943$21990594$3$F$$20240625$20230214$20240702$EXP$$CA-TAKEDA-2022TUS050779$TAKEDA$$$$$F$Y$$$20240702$$CN$CA$CA
2199073827$21990738$27$F$20230117$20240925$20230214$20240928$EXP$$US-TAKEDA-2023TUS014199$TAKEDA$$36$YR$$F$Y$69.841$KG$20240928$$HP$US$US
219910053$21991005$3$F$$20240716$20230214$20240724$PER$$US-SA-2023SA049284$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240724$$HP$US$US
219910084$21991008$4$F$$20240730$20230214$20240806$PER$$US-SA-2023SA049396$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240806$$MD$US$US
219911272$21991127$2$F$$20240730$20230214$20240807$PER$$US-SA-2023SA049629$SANOFI AVENTIS$$$$T$F$Y$$$20240807$$MD$US$US
219912655$21991265$5$F$20230111$20240701$20230214$20240709$EXP$$JP-JAZZ-2023-JP-003384$JAZZ$$61$YR$$M$Y$54$KG$20240709$$MD$JP$JP
219913336$21991333$6$F$20230306$20240916$20230214$20240919$EXP$$CA-TAKEDA-2022TUS074414$TAKEDA$$38$YR$$F$Y$$$20240919$$CN$CA$CA
219914317$21991431$7$F$20221001$20240912$20230214$20240920$EXP$$JP-009507513-2302JPN000854J$MERCK$$84$YR$$F$Y$53$KG$20240920$$MD$JP$JP
219914935$21991493$5$F$$20240830$20230214$20240906$EXP$$BR-CELLTRION INC.-2022BR019668$CELLTRION$$$$$$Y$$$20240906$$CN$BR$BR
219916714$21991671$4$F$$20240822$20230214$20240830$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202205001394$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240830$$CN$BR$BR
219917222$21991722$2$F$20230105$20240911$20230214$20240916$EXP$FR-AFSSAPS-AN2023000081$FR-MYLANLABS-2023M1014888$MYLAN$$23$YR$$M$Y$$$20240916$$MD$FR$FR
2199199011$21991990$11$F$20230708$20240710$20230214$20240724$EXP$$JP-LUNDBECK-DKLU3058119$LUNDBECK$$$$$$Y$$$20240724$$PH$JP$JP
219920665$21992066$5$F$$20240725$20230214$20240730$EXP$$US-AMGEN-USASP2023024466$AMGEN$$$$A$F$Y$$$20240730$$HP$US$US
219920675$21992067$5$F$20220101$20240821$20230214$20240830$EXP$$US-ABBVIE-4300278$ABBVIE$$$$$F$Y$97.975$KG$20240828$$CN$US$US
2199248011$21992480$11$F$$20240916$20230215$20240924$EXP$$CA-CELLTRION INC.-2023CA003170$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
219927732$21992773$2$F$$20240806$20230215$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00856$LUPIN$$$$$$Y$$$20240902$$CN$US$US
219932206$21993220$6$F$20220401$20240724$20230215$20240730$EXP$$NVSC2022GB103223$NOVARTIS$$$$E$F$Y$$$20240730$$CN$GB$GB
219932213$21993221$3$F$$20240726$20230215$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00955$LUPIN$$$$$$Y$$$20240822$$CN$US$US
219932372$21993237$2$F$$20240806$20230215$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00957$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219932682$21993268$2$F$20230203$20240806$20230215$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00990$LUPIN$$$$$$Y$$$20240902$$CN$US$US
219933255$21993325$5$F$20230209$20240805$20230215$20240808$PER$$US-BIOGEN-2023BI01187789$BIOGEN$$30$YR$$F$Y$$$20240808$$CN$US$US
219933819$21993381$9$F$20170220$20240709$20230215$20240712$EXP$$US-ABBVIE-4235532$ABBVIE$$70$YR$$F$Y$73$KG$20240712$$PH$US$US
219934125$21993412$5$F$20230214$20240819$20230215$20240901$EXP$$JP-UCBSA-2023007233$UCB$$5$YR$$M$Y$15$KG$20240901$$MD$JP$JP
2199392512$21993925$12$F$20221219$20240122$20230215$20240925$EXP$$US-GSK-US2023AMR023248$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
219940155$21994015$5$F$$20240625$20230215$20240703$EXP$$GB-CELLTRION INC.-2023GB002650$CELLTRION$$$$$$Y$$$20240703$$HP$GB$GB
2199412010$21994120$10$F$20240501$20240808$20230215$20240814$EXP$$NVSC2022CO144701$NOVARTIS$$70$YR$$F$Y$74$KG$20240814$$CN$CO$CO
219944819$21994481$9$F$20220101$20230926$20230215$20240926$EXP$$US-GSK-US2022AMR017970$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
219945792$21994579$2$F$20180104$20240829$20230215$20240904$EXP$$BE-ABBVIE-18K-013-3106334-00$ABBVIE$$70$YR$$M$Y$$$20240904$$HP$BE$BE
2199469313$21994693$13$F$$20240626$20230215$20240701$EXP$$US-PFIZER INC-202300068548$PFIZER$$76$YR$$F$Y$79.38$KG$20240701$$CN$US$US
219948263$21994826$3$F$$20240726$20230215$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01181$LUPIN$$$$$$Y$$$20240817$$CN$US$US
2199503811$21995038$11$F$$20240705$20230215$20240709$EXP$$US-TAKEDA-US202026085$TAKEDA$$$$$F$Y$98$KG$20240709$$HP$US$US
219950609$21995060$9$F$20220912$20240815$20230215$20240829$EXP$$US-UCBSA-2022059048$UCB$$10$YR$$F$Y$41$KG$20240829$$CN$US$US
219951402$21995140$2$F$$20240809$20230215$20240812$PER$$NVSC2023US030993$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
219953526$21995352$6$F$20221101$20240806$20230215$20240808$PER$$US-PFIZER INC-PV202300028022$PFIZER$$68$YR$$M$Y$92.971$KG$20240808$$CN$US$US
219956593$21995659$3$F$20240101$20240731$20230215$20240809$PER$$US-SA-2023SA051954$SANOFI AVENTIS$$61$YR$A$F$Y$85.261$KG$20240809$$MD$US$US
2199600010$21996000$10$F$20181220$20240722$20230215$20240727$EXP$$JP-ABBVIE-4306363$ABBVIE$$70$YR$$M$Y$74$KG$20240727$$MD$JP$JP
219960086$21996008$6$F$20221121$20240628$20230215$20240707$EXP$$JP-009507513-2211JPN003249J$MERCK$$74$YR$$M$Y$$$20240707$$MD$JP$JP
219960274$21996027$4$F$$20240823$20230215$20240904$EXP$$CA-BAXTER-2023BAX012617$BAXTER$$$$$$Y$$$20240904$$HP$CA$CA
2199607916$21996079$16$F$$20240628$20230215$20240701$EXP$$NVSC2023US034223$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
219960953$21996095$3$F$$20240709$20230215$20240711$EXP$$NVSC2023CA028634$NOVARTIS$$$$$F$Y$$$20240711$$HP$CA$CA
219962245$21996224$5$F$$20240904$20230215$20240910$EXP$$US-TAKEDA-2021TUS036705$TAKEDA$$$$$M$Y$67$KG$20240910$$HP$US$US
219963509$21996350$9$F$20221212$20240821$20230215$20240903$EXP$$NVSC2021CA218588$NOVARTIS$$56$YR$$F$Y$$$20240903$$CN$CA$CA
219967284$21996728$4$F$20230213$20240918$20230215$20240920$PER$$NVSC2023US034379$NOVARTIS$$51$YR$$F$Y$$$20240920$$CN$US$US
219968605$21996860$5$F$20230101$20240904$20230215$20240909$EXP$$US-BEH-2023155276$CSL BEHRING$$66$YR$E$F$Y$$$20240909$$CN$US$US
219969992$21996999$2$F$20230131$20240826$20230215$20240903$EXP$$BR-CELLTRION INC.-2023BR003132$CELLTRION$$$$$$Y$$$20240903$$CN$BR$BR
219970256$21997025$6$F$$20240812$20230215$20240822$PER$$US-AMGEN-USASP2023025970$AMGEN$$$$A$M$Y$$$20240822$$HP$US$US
219970463$21997046$3$F$$20230210$20230215$20240805$EXP$$UY-ABBVIE-4306749$ABBVIE$$$$$$Y$$$20240805$$MD$UY$UY
219972652$21997265$2$F$$20240627$20230216$20240705$PER$$US-ABBVIE-4308559$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
219973309$21997330$9$F$20230209$20240910$20230216$20240918$EXP$$US-BIOGEN-2023BI01187588$BIOGEN$$74$YR$$M$Y$$$20240918$$CN$US$US
219974895$21997489$5$F$$20240623$20230216$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000289$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
2199752111$21997521$11$F$20221220$20240808$20230216$20240816$EXP$$CA-CELLTRION INC.-2023CA000552$CELLTRION$$$$$$Y$$$20240816$$CN$CA$CA
219975583$21997558$3$F$$20240717$20230216$20240813$PER$$AU-TOLMAR, INC.-23AU038690$TOLMAR$$$$$M$Y$$$20240813$$CN$AU$AU
2199765112$21997651$12$F$20210101$20240815$20230216$20240822$EXP$$CA-TAKEDA-2021TUS069066$TAKEDA$$$$$F$Y$24$KG$20240822$$CN$CA$CA
219976802$21997680$2$F$$20240826$20230216$20240903$EXP$$BR-CELLTRION INC.-2023BR003159$CELLTRION$$$$$$Y$$$20240903$$CN$BR$BR
219979542$21997954$2$F$$20240802$20230216$20240828$PER$$US-PHARMING-PHAUS2023000122$PHARMING GROUP$$$$$$Y$$$20240807$$CN$US$US
219980724$21998072$4$F$20230201$20230306$20230216$20240925$PER$$US-GSK-US2023AMR024392$GLAXOSMITHKLINE$$41$YR$$F$Y$$$20240925$$CN$US$US
2199813920$21998139$20$F$20221228$20240826$20230216$20240909$EXP$$US-UCBSA-2023003464$UCB$$0$YR$$F$Y$$$20240909$$CN$US$US
219981453$21998145$3$F$$20240829$20230216$20240909$EXP$$CA-AUROBINDO-AUR-APL-2022-018720$AUROBINDO$$25$YR$$F$Y$$$20240909$$HP$CA$CA
219985313$21998531$3$F$20220101$20240827$20230216$20240829$PER$$US-AMGEN-USASP2022228832$AMGEN$$$$A$M$Y$$$20240829$$HP$US$US
219987553$21998755$3$F$$20240806$20230216$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01043$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219987917$21998791$7$F$20230130$20240718$20230216$20240724$EXP$$JP-ARGENX-2023-ARGX-JP000406$ARGENX BVBA$$$$E$F$Y$52$KG$20240724$$MD$JP$JP
219990604$21999060$4$F$20221212$20240919$20230216$20240923$EXP$$US-TAKEDA-2022TUS097707$TAKEDA$$5$YR$$M$Y$$$20240923$$CN$US$US
219991444$21999144$4$F$$20240827$20230216$20240923$PER$$US-SA-2023SA053189$SANOFI AVENTIS$$56$YR$A$F$Y$54.422$KG$20240923$$MD$US$US
219991542$21999154$2$F$20230211$20240921$20230216$20240930$PER$$US-SA-2023SA051126$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240930$$MD$US$US
219992643$21999264$3$F$$20240813$20230216$20240821$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2023-021738$BRISTOL MYERS SQUIBB$Margarit-Soler A, Deya-Martinez A, Canizales JT, Vlagea A, Garcia-Garcia A, Marsal J, et al. Case report: challenges in immune reconstitution following hematopoietic stem cell transplantation for ctla-4 insufficiency-like primary immune regulatory disorders. Frontiers In Immunology. 2022 Dec 27;13:1-10. doi:10.3389/fimmu.2022.1070068.$21$YR$A$M$Y$$$20240821$$HP$ES$ES
219994452$21999445$2$F$$20240730$20230216$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-00965$LUPIN$$$$$$Y$$$20240819$$CN$US$US
219994683$21999468$3$F$$20240726$20230216$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01044$LUPIN$$$$$$Y$$$20240816$$CN$US$US
219994943$21999494$3$F$$20240726$20230216$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01045$LUPIN$$$$$$Y$$$20240817$$CN$US$US
219995326$21999532$6$F$20230101$20240926$20230216$20240930$PER$$US-PFIZER INC-202300068885$PFIZER$$70$YR$$F$Y$51.71$KG$20240930$$CN$US$US
219996812$21999681$2$F$$20240806$20230216$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01060$LUPIN$$$$$$Y$$$20240828$$CN$US$US
219997889$21999788$9$F$20230315$20240821$20230216$20240827$EXP$$US-TAKEDA-2023TUS016785$TAKEDA$$1$YR$$M$Y$10$KG$20240827$$CN$US$US
2200017514$22000175$14$F$20210701$20240807$20230216$20240813$EXP$$IN-PFIZER INC-202200820850$PFIZER$$66$YR$$F$Y$46.7$KG$20240813$$CN$IN$IN
220001965$22000196$5$F$$20240815$20230216$20240820$EXP$$US-PFIZER INC-PV202300030209$PFIZER$$73$YR$$F$Y$$$20240820$$CN$US$US
220002355$22000235$5$F$$20240801$20230216$20240807$EXP$$US-JAZZ-2023-US-003519$JAZZ$$$$$M$Y$$$20240807$$CN$US$US
220002638$22000263$8$F$20210101$20240822$20230216$20240827$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-001212$AMGEN$$51$YR$A$F$Y$$$20240827$$MD$US$US
220002845$22000284$5$F$20220718$20240719$20230216$20240726$EXP$$US-BAXTER-2023BAX012844$BAXTER$$74$YR$$F$Y$70.9$KG$20240726$$MD$US$US
220003727$22000372$7$F$$20240820$20230216$20240827$PER$$US-PFIZER INC-PV202300029894$PFIZER$$57$YR$$F$Y$$$20240827$$CN$US$US
220004615$22000461$5$F$20230109$20240719$20230216$20240726$EXP$$US-ABBVIE-4307160$ABBVIE$$70$YR$$F$Y$107$KG$20240726$$CN$US$US
220004853$22000485$3$F$20230823$20240827$20230216$20240829$EXP$$CA-ROCHE-3287067$ROCHE$$47$YR$A$F$Y$$$20240829$$CN$CA$CA
220005035$22000503$5$F$20230101$20240715$20230216$20240722$PER$$US-SA-2023SA049635$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240722$$MD$US$US
220005762$22000576$2$F$$20240711$20230216$20240715$EXP$$FR-PFIZER INC-202201381912$PFIZER$$$$A$M$Y$79$KG$20240715$$HP$FR$FR
220006227$22000622$7$F$20230404$20240828$20230216$20240902$EXP$$US-HORIZON THERAPEUTICS-HZN-2021-003947$AMGEN$$73$YR$E$M$Y$$$20240901$$MD$US$US
220006425$22000642$5$F$$20240625$20230216$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-022796$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240701$$HP$US$US
220008227$22000822$7$F$20210101$20240820$20230216$20240822$EXP$$IN-PFIZER INC-202101761148$PFIZER$$64$YR$$F$Y$73.7$KG$20240822$$CN$IN$IN
220008943$22000894$3$F$$20240806$20230216$20240807$EXP$$CN-AstraZeneca-2018SF20548$ASTRAZENECA$$47$YR$$M$Y$$$20240807$$MD$CA$
220009033$22000903$3$F$20220715$20240624$20230216$20240702$EXP$$JP-AstraZeneca-2023A006240$ASTRAZENECA$$52$YR$$F$Y$66$KG$20240702$$MD$JP$
220012233$22001223$3$F$$20240819$20230216$20240826$EXP$$JP-GSK-JP2023JPN023598$GLAXOSMITHKLINE$Ito M, Yoshimura A, Fukunaga K, Hosotani Y, Gomi F. O096: 2 cases of HSV-1 and HHV-7 positive keratitis after HSCT. Japan Cornea Conference 2023/The 47th General Meeting of Japan Cornea Society/Th. 90$$$$$Y$$$20240826$$MD$JP$JP
220015613$22001561$3$F$$20240724$20230216$20240730$EXP$$FR-MYLANLABS-2023M1014616$MYLAN$$$$A$M$Y$79$KG$20240730$$MD$FR$FR
220020792$22002079$2$F$$20240826$20230216$20240903$EXP$$BR-CELLTRION INC.-2023BR003244$CELLTRION$$$$$$Y$$$20240903$$CN$BR$BR
220021533$22002153$3$F$20221201$20240612$20230217$20240702$PER$$CA-TOLMAR, INC.-23CA038618$TOLMAR$$73$YR$$M$Y$$$20240702$$CN$CA$CA
220021555$22002155$5$F$20230101$20240912$20230217$20240927$PER$$CA-TOLMAR, INC.-23CA038627$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
220023163$22002316$3$F$$20240806$20230217$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01084$LUPIN$$$$$$Y$$$20240828$$CN$US$US
2200234310$22002343$10$F$20230518$20231208$20230217$20240925$EXP$$US-GSK-US2023AMR022815$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
220024549$22002454$9$F$20200318$20240809$20230217$20240816$EXP$$CA-CELLTRION INC.-2022CA006882$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
2200246052$22002460$52$F$20230213$20240913$20230217$20240920$EXP$$CO-TAKEDA-2023TUS016897$TAKEDA$$30$YR$$F$Y$49$KG$20240920$$CN$CO$CO
220024969$22002496$9$F$20220301$20240701$20230217$20240709$EXP$$US-JNJFOC-20230224053$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240709$$HP$US$US
220025466$22002546$6$F$20221231$20240830$20230217$20240904$EXP$$CA-JNJFOC-20230106558$JOHNSON AND JOHNSON$$34$YR$A$M$Y$117$KG$20240904$$CN$CA$CA
220025942$22002594$2$F$20230127$20240827$20230217$20240904$EXP$$BR-CELLTRION INC.-2023BR003243$CELLTRION$$$$$$Y$$$20240904$$CN$BR$BR
220028206$22002820$6$F$$20240809$20230217$20240904$PER$$CA-TOLMAR, INC.-23CA038652$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
220028292$22002829$2$F$$20240811$20230217$20240903$PER$$CA-TOLMAR, INC.-23CA038693$TOLMAR$$$$$M$Y$$$20240903$$CN$CA$CA
220028354$22002835$4$F$20230115$20240902$20230217$20240923$PER$$CO-TOLMAR, INC.-23CO038685$TOLMAR$$75$YR$$M$Y$$$20240923$$CN$CO$CO
2200293127$22002931$27$F$20221201$20240802$20230217$20240810$EXP$$CA-CELLTRION INC.-2023CA000337$CELLTRION$$$$$$Y$$$20240810$$CN$CA$CA
220031353$22003135$3$F$20221107$20240820$20230217$20240822$EXP$$FR-TAKEDA-2023TUS015833$TAKEDA$$78$YR$$F$Y$$$20240822$$HP$FR$FR
220033012$22003301$2$F$$20240821$20230217$20240830$EXP$$ES-MSNLABS-2023MSNLIT00235$MSN LABORATORIES$Margarit-Soler A, Deya-Martinez A, Canizales JT, Vlagea A, Garcia-Garcia A, Marsal J et al..Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders..Frontiers in Immunology.2022;13:1070068$$$$$Y$$$20240830$$MD$ES$ES
220034844$22003484$4$F$20221201$20240730$20230217$20240805$EXP$$NVSC2023DE033681$NOVARTIS$$$$A$F$Y$$$20240805$$MD$DE$DE
2200352610$22003526$10$F$20221218$20240625$20230217$20240703$EXP$$DE-AUROBINDO-AUR-APL-2023-006458$AUROBINDO$$72$YR$$M$Y$65$KG$20240703$$MD$DE$DE
220035548$22003554$8$F$20220914$20240717$20230217$20240719$EXP$$DE-AMGEN-DEUNI2022186607$AMGEN$$76$YR$E$F$Y$$$20240719$$HP$DE$DE
220035613$22003561$3$F$20220301$20230310$20230217$20240716$EXP$$RO-ASTELLAS-2023US005568$ASTELLAS$$68$YR$$M$Y$$$20240716$$CN$RO$RO
2200382310$22003823$10$F$20231026$20240725$20230217$20240731$EXP$$CA-TAKEDA-2022TUS071697$TAKEDA$$68$YR$$F$Y$$$20240731$$MD$CA$CA
220041348$22004134$8$F$20230101$20240625$20230217$20240702$EXP$$US-SA-2023SA054247$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240702$$MD$US$US
220041652$22004165$2$F$20240801$20240827$20230217$20240923$PER$$US-SA-2023SA054169$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240923$$MD$US$US
220043842$22004384$2$F$$20240711$20230217$20240716$EXP$$CA-ROCHE-3287336$ROCHE$$$$A$M$Y$$$20240716$$CN$CA$CA
220044022$22004402$2$F$$20240816$20230217$20240829$PER$$US-SA-2023SA055408$SANOFI AVENTIS$$$$T$M$Y$65.77$KG$20240829$$MD$US$US
220045832$22004583$2$F$$20240709$20230217$20240715$PER$$US-BIOGEN-2023BI01188255$BIOGEN$$$$$M$Y$$$20240715$$CN$US$US
220048159$22004815$9$F$20230420$20240924$20230217$20240930$EXP$$CA-GSK-CA2023AMR024827$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$CA$CA
220048526$22004852$6$F$20220201$20230615$20230217$20240926$EXP$$US-GSK-US2022AMR035675$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
220048552$22004855$2$F$20220201$20230213$20230217$20240925$EXP$$US-GSK-US2022AMR046020$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
220048983$22004898$3$F$20230213$20240917$20230217$20240920$EXP$$US-PFIZER INC-202300069121$PFIZER$$82$YR$$M$Y$52.16$KG$20240920$$CN$US$US
2200505010$22005050$10$F$20221129$20240731$20230217$20240802$EXP$$NVSC2022RU279492$NOVARTIS$$45$YR$$F$Y$73$KG$20240802$$MD$RU$RU
220051133$22005113$3$F$$20240619$20230217$20240702$EXP$$PT-MSNLABS-2023MSNLIT00225$MSN LABORATORIES$Viana S, Ferreira S, Cunha J, Martins J.MULTIPLE MYELOMA AND END-STAGE RENAL FAILURE - IS IT POSSIBLE TO GET OFF OF DIALYSIS?.European Journal of Case Reports in Internal Medicine.2023;10:432$$$$$Y$$$20240702$$MD$PT$PT
220052082$22005208$2$F$20230209$20240911$20230217$20240913$PER$$US-AMGEN-USASP2023024443$AMGEN$$66$YR$E$M$Y$$$20240912$$CN$US$US
220052765$22005276$5$F$20230203$20240624$20230217$20240701$EXP$$US-TAKEDA-2023TUS014537$TAKEDA$$36$YR$$F$Y$$$20240701$$CN$US$US
220054072$22005407$2$F$$20240912$20230217$20240925$PER$$US-SA-2023SA054995$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240925$$MD$US$US
220056882$22005688$2$F$$20240806$20230217$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01107$LUPIN$$$$$$Y$$$20240827$$CN$US$US
220057223$22005722$3$F$$20240725$20230217$20240806$PER$$US-SA-2023SA052256$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240806$$CN$US$US
220057244$22005724$4$F$20230202$20240806$20230217$20240815$EXP$$JP-RADIUS HEALTH, INC.-2023JP000738$RADIUS PHARM$$87$YR$$F$Y$$$20240815$$MD$JP$JP
220057312$22005731$2$F$$20240807$20230217$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01095$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220057504$22005750$4$F$$20240625$20230217$20240701$PER$$US-PFIZER INC-PV202300031961$PFIZER$$71$YR$$F$Y$98.413$KG$20240701$$CN$US$US
2200589725$22005897$25$F$$20240722$20230217$20240729$EXP$$FR-GSK-FR2022EME147839$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$FR$FR
220063572$22006357$2$F$20230115$20240705$20230217$20240715$EXP$IT-MINISAL02-907120$IT-TEVA-2023-IT-2856184$TEVA$$12$YR$$M$Y$33$KG$20240715$$PH$IT$IT
220063784$22006378$4$F$20230223$20240924$20230217$20240927$EXP$$FR-MYE-2023M1015719AA$MYLAN$Pujol T, Souques C, Collarino R, Baudouin E, Keravec H, Houdre J, Laaraj F, Duron E et al.. DRESS syndrome secondary to ceftriaxone antibiotic therapy. Rev Geriatr. 2022;47(9):473-479$88$YR$$F$Y$$$20240927$$HP$FR$FR
220064304$22006430$4$F$20210521$20240801$20230217$20240808$EXP$$NVSC2023US017202$NOVARTIS$$70$YR$$F$Y$$$20240808$$MD$US$US
220065325$22006532$5$F$$20240920$20230217$20240920$PER$$US-PFIZER INC-PV202300030293$PFIZER$$70$YR$$F$Y$$$20240920$$CN$US$US
220065352$22006535$2$F$$20240726$20230217$20240730$PER$$US-PFIZER INC-202101275008$PFIZER$$43$YR$$M$Y$$$20240730$$MD$US$US
220067352$22006735$2$F$$20230202$20230217$20240927$EXP$$IT-AKCEA THERAPEUTICS, INC.-2023IS001141$AKCEA THERAPEUTICS$$$$$$Y$$$20240927$$CN$IT$IT
2200681211$22006812$11$F$$20240925$20230217$20240926$EXP$$CA-HLS-202300194$HLS THERAPEUTICS$$$$A$M$Y$$$20240926$$PH$CA$CA
220068523$22006852$3$F$$20240314$20230217$20240919$PER$$JP-ROCHE-3284575$ROCHE$$4$DEC$A$F$Y$$$20240919$$PH$JP$JP
220068913$22006891$3$F$$20240812$20230217$20240819$EXP$$DE-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00100$VELOXIS PHARMACEUTICALS$Boss K, Konik M, Brasen JH, Schmitz J, Jurgens C, Kribben A, et al. COVID-19 associated acute transplant failure after AB0-incompatible living donor kidney transplantation - a case report. BMC Nephrology. 2023;24:19:1-5$34$YR$$M$Y$$$20240819$$HP$DE$DE
220069675$22006967$5$F$20230101$20240918$20230217$20240924$EXP$$US-JAZZ-2023-US-002143$JAZZ$$60$YR$$F$Y$$$20240924$$HP$US$US
220069695$22006969$5$F$20230106$20240722$20230217$20240729$EXP$$US-JAZZ-2023-US-003731$JAZZ$$42$YR$$F$Y$71.53$KG$20240729$$CN$US$US
220069836$22006983$6$F$20211011$20240701$20230217$20240709$EXP$$JP-BAUSCH-BL-2020-008503$BAUSCH AND LOMB$Monden S, Matsumoto H, Osawa K, Oshimo T, Yo S, Osawa M, Handa O, Eiji U, Shiotani A. 18 A case of ileal ulcer caused by an interleukin-17 receptor A monoclonal antibody (Brodalumab). The 119th Annual Meeting of the Chugoku Branch of the Japanese Society of Gastroenterology. 2023 JUN 25;24:73.$36$YR$$F$Y$$$20240709$$MD$JP$JP
2200718810$22007188$10$F$20230202$20240905$20230217$20240914$EXP$$CA-CELLTRION INC.-2023CA003632$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
220072519$22007251$9$F$20220301$20240807$20230217$20240814$EXP$$CA-CELLTRION INC.-2022CA006610$CELLTRION$$$$$$Y$$$20240814$$CN$CA$CA
220072653$22007265$3$F$20211006$20240711$20230217$20240722$EXP$$CA-CELLTRION INC.-2021CA016364$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
220073255$22007325$5$F$20220101$20240723$20230218$20240729$EXP$$US-ABBVIE-4310520$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
220074729$22007472$9$F$20230119$20240913$20230218$20240920$EXP$$DE-ABBVIE-4310580$ABBVIE$$71$YR$$M$Y$83$KG$20240920$$MD$DE$DE
220075444$22007544$4$F$20221101$20240726$20230218$20240803$EXP$$AU-CELLTRION INC.-2023AU003522$CELLTRION$$$$$$Y$$$20240803$$MD$AU$AU
220075489$22007548$9$F$$20240715$20230218$20240717$PER$$NVSC2023US035817$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
220075686$22007568$6$F$20220101$20240811$20230218$20240819$EXP$$CA-CELLTRION INC.-2022CA007971$CELLTRION$$$$$$Y$$$20240819$$MD$CA$CA
2200769214$22007692$14$F$20221101$20240821$20230218$20240829$EXP$$CA-CELLTRION INC.-2022CA018934$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
220076943$22007694$3$F$$20240806$20230218$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01109$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220077092$22007709$2$F$$20240807$20230218$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01127$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220078463$22007846$3$F$20220101$20240626$20230218$20240702$EXP$$NVSC2023RO034339$NOVARTIS$$68$YR$$F$Y$$$20240702$$CN$RO$RO
220079252$22007925$2$F$20220101$20240820$20230218$20240831$EXP$$US-Accord-300353$ACCORD$Abu Jawdeh BG, Nguyen MC, Ryan MS, Vikram HR. Case report: Emphysematous pyelonephritis associated with kidney allograft abscess formation. Frontiers in Medicine. 2022;9:1066512$49$YR$A$F$Y$$$20240831$$MD$US$US
220079462$22007946$2$F$20230101$20240724$20230218$20240727$EXP$$US-ABBVIE-4311093$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
220079989$22007998$9$F$20230212$20240822$20230218$20240826$EXP$$NVSC2023BD018149$NOVARTIS$$63$YR$$M$Y$62$KG$20240826$$CN$BD$BD
220082593$22008259$3$F$$20240727$20230219$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01093$LUPIN$$$$$$Y$$$20240818$$CN$US$US
220085898$22008589$8$F$$20240916$20230219$20240925$EXP$$CA-ROCHE-3145286$ROCHE$$$$A$M$Y$$$20240925$$CN$CA$CA
220086932$22008693$2$F$$20240814$20230219$20240820$EXP$$US-ABBVIE-22K-163-4405016-00$ABBVIE$$$$$F$Y$$$20240820$$MD$US$US
220088632$22008863$2$F$20230205$20240718$20230220$20240721$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-021236$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240722$$HP$FR$FR
220088744$22008874$4$F$$20230521$20230220$20240920$EXP$$NVSC2023CN036009$NOVARTIS$$$$$$Y$$$20240920$$CN$CN$CN
220091802$22009180$2$F$20230101$20240729$20230220$20240805$PER$$US-SA-2023SA056584$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240805$$MD$US$US
220092252$22009225$2$F$$20240729$20230220$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01185$LUPIN$$$$$$Y$$$20240819$$CN$US$US
2200931514$22009315$14$F$20230406$20240214$20230220$20240926$EXP$$US-GSK-US2023025417$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
2200931611$22009316$11$F$20230201$20230821$20230220$20240925$EXP$$US-GSK-US2023AMR025281$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2200937116$22009371$16$F$20191204$20240904$20230220$20240913$EXP$$CA-CELLTRION INC.-2022CA006010$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
220094113$22009411$3$F$20230205$20240724$20230220$20240806$EXP$$US-UCBSA-2023008442$UCB$$61$YR$$M$Y$$$20240807$$HP$US$US
220094876$22009487$6$F$20230228$20240816$20230220$20240823$EXP$$US-GSK-US2023024383$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$HP$US$US
220097363$22009736$3$F$20230125$20240827$20230220$20240905$EXP$$BR-CELLTRION INC.-2023BR003467$CELLTRION$$$$$$Y$$$20240905$$CN$BR$BR
220097896$22009789$6$F$20230902$20240829$20230220$20240903$EXP$$CA-TAKEDA-2023TUS017889$TAKEDA$$41$YR$$F$Y$$$20240903$$CN$CA$CA
220098944$22009894$4$F$20230209$20240805$20230220$20240807$EXP$$CA-ROCHE-3281259$ROCHE$$41$YR$A$F$Y$$$20240807$$CN$CA$CA
2201001110$22010011$10$F$20230207$20240701$20230220$20240708$EXP$$JP-ARGENX-2023-ARGX-JP000495$ARGENX BVBA$$45$YR$$F$Y$74$KG$20240708$$MD$JP$JP
220102072$22010207$2$F$20221205$20230207$20230220$20240821$EXP$$IT-AstraZeneca-2023A031192$ASTRAZENECA$$4$YR$$M$Y$$$20240821$$MD$IT$
220102145$22010214$5$F$20240602$20240729$20230220$20240801$EXP$$US-TAKEDA-2023TUS017760$TAKEDA$$43$YR$$M$Y$$$20240801$$MD$US$US
220103205$22010320$5$F$$20230411$20230220$20240925$PER$$US-GSK-US2023AMR027373$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
220103212$22010321$2$F$$20230215$20230220$20240716$EXP$$RO-ASTELLAS-2023US005767$ASTELLAS$$42$YR$$F$Y$$$20240716$$CN$RO$RO
220104333$22010433$3$F$$20240624$20230220$20240709$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-379309$RANBAXY$Yu N, Ye S, Yang Z, Chen Z, Zhang C. Disseminated Cunninghamella Elegans Infection Diagnosed by Mngs During Induction Therapy in a Child With Intermediate-risk Acute Lymphoblastic Leukemia: A Case Report and Review of Literature. J Pediatr Hematol Oncol. 2023;Mar;45 (2):e266-e271$14$YR$$F$Y$$$20240709$$MD$CN$CN
220106173$22010617$3$F$$20240718$20230220$20240724$EXP$$NVSC2023CO036398$NOVARTIS$$$$$F$Y$57$KG$20240724$$CN$CO$CO
220106593$22010659$3$F$$20240820$20230220$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-023406$BRISTOL MYERS SQUIBB$Nonaka K, Kimura M, Aso K, Komori Y, Ueda K, Fujimori N, et al. A case of suspected irAE pancreatitis due to nivolumab. The 340th Kyushu Regional Meeting of the Japanese Society of Internal Medicine. 2023;47.$39$YR$A$M$Y$$$20240828$$MD$JP$JP
2201077711$22010777$11$F$20211216$20240802$20230220$20240807$EXP$$CN-TAKEDA-2022TUS060674$TAKEDA$$63$YR$$F$Y$49$KG$20240807$$CN$CN$CN
220110034$22011003$4$F$20190101$20240820$20230220$20240829$PER$$US-SA-2023SA055879$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240829$$CN$US$US
220110293$22011029$3$F$$20240807$20230220$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01206$LUPIN$$$$$$Y$$$20240829$$PH$US$US
220110588$22011058$8$F$20230101$20240903$20230220$20240928$PER$$US-SA-2023SA055305$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240928$$MD$US$US
220110879$22011087$9$F$20170516$20240717$20230220$20240723$EXP$$CA-TAKEDA-2021TUS029348$TAKEDA$$68$YR$$M$Y$$$20240723$$CN$CA$CA
220111872$22011187$2$F$$20240625$20230220$20240705$PER$$US-SA-2023SA054713$SANOFI AVENTIS$$$$C$M$Y$65.76$KG$20240705$$MD$US$US
220112123$22011212$3$F$$20240902$20230220$20240912$30DAY$$GB-ELI_LILLY_AND_COMPANY-GB202302003554$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240912$$MD$GB$GB
220112573$22011257$3$F$$20240813$20230220$20240814$EXP$$CA-PFIZER INC-202300066441$PFIZER$$74$YR$$M$Y$$$20240814$$HP$CA$CA
220112952$22011295$2$F$20240701$20240702$20230220$20240708$EXP$$CA-TAKEDA-2022TUS049278$TAKEDA$$51$YR$$M$Y$$$20240708$$MD$CA$CA
220113704$22011370$4$F$20231205$20240529$20230220$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-002769$AURINIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240731$$CN$US$US
220113962$22011396$2$F$$20240827$20230220$20240904$EXP$$BR-CELLTRION INC.-2023BR003573$CELLTRION$$$$$$Y$$$20240904$$CN$BR$BR
220114233$22011423$3$F$$20240216$20230220$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-002665$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
220114284$22011428$4$F$20221222$20240513$20230220$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-002784$AURINIA PHARMACEUTICALS$$37$YR$$M$Y$$$20240731$$CN$US$US
220114902$22011490$2$F$20170201$20240823$20230220$20240829$EXP$$CA-TAKEDA-2017TUS002839$TAKEDA$$22$YR$$F$Y$$$20240829$$MD$CA$CA
220115422$22011542$2$F$$20240712$20230220$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-002782$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
220115502$22011550$2$F$$20240305$20230220$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-002796$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
220115852$22011585$2$F$$20240126$20230220$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-002759$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
220116893$22011689$3$F$$20240829$20230220$20240904$PER$$US-PFIZER INC-2018120052$PFIZER$$75$YR$$F$Y$$$20240904$$CN$US$US
220117373$22011737$3$F$20220701$20240606$20230220$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-002095$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240731$$CN$US$US
220117656$22011765$6$F$$20240729$20230220$20240809$EXP$$US-ROCHE-3286798$ROCHE$$67$YR$E$M$Y$$$20240809$$CN$US$US
220118449$22011844$9$F$20220101$20240718$20230220$20240723$EXP$$CA-PFIZER INC-202200269315$PFIZER$$69$YR$$F$Y$93$KG$20240723$$MD$CA$CA
220118492$22011849$2$F$$20240715$20230220$20240722$PER$$US-PFIZER INC-PV202300031269$PFIZER$$44$YR$$F$Y$$$20240722$$CN$US$US
220118923$22011892$3$F$20240109$20240311$20230220$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-002355$AURINIA PHARMACEUTICALS$$20$YR$$M$Y$$$20240731$$CN$US$US
220119733$22011973$3$F$20230124$20240725$20230220$20240726$EXP$FR-AFSSAPS-AM2023000128$FR-PFIZER INC-202300067487$PFIZER$$65$YR$$F$Y$$$20240726$$PH$FR$FR
220122887$22012288$7$F$$20230410$20230220$20240926$EXP$$US-GSK-US2023AMR023236$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
220122945$22012294$5$F$$20240905$20230220$20240927$EXP$$US-SA-2023SA055196$SANOFI AVENTIS$$35$YR$A$F$Y$63.5$KG$20240927$$MD$US$US
220123002$22012300$2$F$$20240209$20230220$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-002349$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
220124463$22012446$3$F$$20230217$20230220$20240724$PER$$NVSC2023US038953$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
220125834$22012583$4$F$$20240702$20230220$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-002412$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
2201276010$22012760$10$F$20221019$20240917$20230220$20240925$EXP$$IE-TAKEDA-2022TUS077611$TAKEDA$$21$YR$$F$Y$70.8$KG$20240925$$CN$IE$IE
220128154$22012815$4$F$$20231127$20230220$20240919$PER$$ES-ROCHE-3285425$ROCHE$$27$YR$A$F$Y$$$20240919$$CN$ES$ES
2201283621$22012836$21$F$20220401$20240904$20230220$20240911$EXP$$US-TAKEDA-2021TUS059000$TAKEDA$$65$YR$$F$Y$81$KG$20240911$$HP$US$US
220128952$22012895$2$F$$20240709$20230220$20240711$EXP$$CA-PFIZER INC-202300070262$PFIZER$$48$YR$$F$Y$$$20240711$$HP$CA$CA
220130143$22013014$3$F$20210410$20240719$20230220$20240724$EXP$GB-MHRA-EYC 00249253$GB-MYLANLABS-2021M1026338$MYLAN$$65$YR$$M$Y$80$KG$20240724$$CN$GB$GB
220132303$22013230$3$F$$20240226$20230220$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-002760$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
220134792$22013479$2$F$$20240822$20230220$20240903$PER$$US-INCYTE CORPORATION-2023IN001560$INCYTE$$$$$$Y$$$20240903$$CN$US$US
220139364$22013936$4$F$20240607$20240612$20230221$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000369$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240705$$CN$US$US
220139714$22013971$4$F$20230217$20240821$20230221$20240827$PER$$US-BIOGEN-2023BI01188853$BIOGEN$$59$YR$$F$Y$$$20240827$$CN$US$US
220143425$22014342$5$F$$20240812$20230221$20240820$EXP$$CA-BAXTER-2023BAX013294$BAXTER$$43$YR$$M$Y$$$20240820$$HP$CA$CA
220144413$22014441$3$F$$20240807$20230221$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01205$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220145932$22014593$2$F$$20240807$20230221$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01209$LUPIN$$$$$$Y$$$20240830$$CN$US$US
220146762$22014676$2$F$20220101$20240820$20230221$20240901$EXP$$US-GLENMARK PHARMACEUTICALS-2023GMK078898$GLENMARK$Abu Jawdeh BG, Nguyen MC, Ryan MS, Vikram HR.. Case report: Emphysematous pyelonephritis associated with kidney allograft abscess formation.. Frontiers in Medicine.. 2022;9:1066512$$$$$Y$$$20240901$$MD$US$US
220147867$22014786$7$F$20230205$20240716$20230221$20240724$EXP$$NVSC2023IL036122$NOVARTIS$$$$$F$Y$6.9$KG$20240724$$MD$IL$IL
220148192$22014819$2$F$20221204$20240722$20230221$20240731$EXP$FR-AFSSAPS-ST2023000088$FR-TEVA-2023-FR-2857025$TEVA$$76$YR$$F$Y$48$KG$20240731$$PH$FR$FR
220150127$22015012$7$F$20221115$20240620$20230221$20240705$EXP$$DE-ROCHE-3289682$ROCHE$$65$YR$E$M$Y$$$20240705$$MD$DE$DE
220150802$22015080$2$F$$20240806$20230221$20240814$PER$$US-SA-2023SA057482$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240814$$MD$US$US
220151672$22015167$2$F$$20230217$20230221$20240722$EXP$$NVSC2023US039263$NOVARTIS$$$$$M$Y$79.83$KG$20240722$$CN$US$US
220152639$22015263$9$F$20210317$20240628$20230221$20240703$EXP$$AU-TAKEDA-2021TUS017932$TAKEDA$$49$YR$$F$Y$$$20240703$$MD$AU$AU
220153177$22015317$7$F$20221101$20240723$20230221$20240729$EXP$$US-TAKEDA-2022TUS091408$TAKEDA$$22$YR$$M$Y$59$KG$20240729$$HP$US$US
220157286$22015728$6$F$20210625$20240628$20230221$20240708$EXP$$CA-CELLTRION INC.-2021CA004123$CELLTRION$$$$$$Y$$$20240708$$MD$CA$CA
220159664$22015966$4$F$20181201$20240813$20230221$20240822$EXP$$US-INSMED, INC.-2023-00062-US$INSMED$$61$YR$$M$Y$$$20240822$$HP$US$US
220161393$22016139$3$F$$20240813$20230221$20240823$EXP$$US-TAKEDA-2022TUS042221$TAKEDA$$$$$M$Y$$$20240823$$MD$US$US
220161717$22016171$7$F$20180101$20240824$20230221$20240829$EXP$$PHHY2019IN082004$NOVARTIS$$$$$F$Y$$$20240829$$CN$IN$IN
220162064$22016206$4$F$20230206$20240712$20230221$20240715$EXP$$US-UCBSA-2023008002$UCB$$63$YR$$M$Y$$$20240715$$HP$US$US
220163713$22016371$3$F$$20240903$20230221$20240909$EXP$$GB-BEH-2023155531$CSL BEHRING$$$$E$M$Y$$$20240909$$HP$GB$GB
2201638010$22016380$10$F$$20240904$20230221$20240910$EXP$$US-TAKEDA-2023TUS004473$TAKEDA$$$$$F$Y$54$KG$20240910$$MD$US$US
220165104$22016510$4$F$$20240822$20230221$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202302008781$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240829$$CN$US$US
220165304$22016530$4$F$$20240702$20230221$20240704$EXP$$CA-TAKEDA-2022TUS042498$TAKEDA$$$$$F$Y$$$20240704$$CN$CA$CA
2201667411$22016674$11$F$$20240821$20230221$20240827$PER$$US-PFIZER INC-PV202200113058$PFIZER$$54$YR$$F$Y$$$20240827$$CN$US$US
220166922$22016692$2$F$20230101$20240729$20230221$20240826$PER$$US-SUNOVION-2023SUN000264$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
220167123$22016712$3$F$$20240830$20230221$20240902$PER$$NVSC2023US039852$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
220167168$22016716$8$F$20230101$20240904$20230221$20240906$EXP$$US-PFIZER INC-PV202300031605$PFIZER$$76$YR$$F$Y$$$20240906$$CN$US$US
220167387$22016738$7$F$$20240829$20230221$20240904$PER$$US-PFIZER INC-PV202300031875$PFIZER$$66$YR$$F$Y$68.934$KG$20240904$$CN$US$US
220167663$22016766$3$F$20170621$20240924$20230221$20240930$EXP$$CA-TAKEDA-2023TUS017506$TAKEDA$$43$YR$$M$Y$$$20240930$$MD$CA$CA
220167852$22016785$2$F$20230212$20230217$20230221$20240819$EXP$$US-RECORDATI-2023000943$RECORDATI$$$$$$Y$$$20240819$$CN$US$US
220168873$22016887$3$F$$20240807$20230221$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01235$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220169653$22016965$3$F$$20240807$20230221$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01241$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220169933$22016993$3$F$20230101$20240626$20230221$20240702$EXP$$JP-009507513-2302JPN000609J$MERCK$$$$$M$Y$$$20240702$$MD$JP$JP
220170183$22017018$3$F$$20240807$20230221$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01267$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220170395$22017039$5$F$20221114$20240902$20230221$20240910$EXP$FR-AFSSAPS-AM2023000128$FR-JNJFOC-20230234207$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240910$$PH$FR$FR
220171193$22017119$3$F$$20240729$20230221$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01275$LUPIN$$$$$$Y$$$20240817$$CN$US$US
220171967$22017196$7$F$20210101$20240911$20230221$20240925$EXP$$CO-INCYTE CORPORATION-2023IN001660$INCYTE$$$$$$Y$$$20240925$$CN$CO$CO
2201728312$22017283$12$F$20230405$20240830$20230221$20240909$EXP$$CA-TAKEDA-2023TUS013853$TAKEDA$$24$YR$$F$Y$$$20240909$$HP$CA$CA
2201747910$22017479$10$F$$20240920$20230221$20240926$EXP$$US-JAZZ-2023-US-004035$JAZZ$$$$$M$Y$$$20240926$$CN$US$US
220176155$22017615$5$F$$20240809$20230221$20240813$EXP$$SK-TAKEDA-2023TUS015511$TAKEDA$$10$YR$$M$Y$$$20240813$$HP$SK$SK
220177463$22017746$3$F$20230201$20240722$20230221$20240724$PER$$US-PFIZER INC-PV202300031933$PFIZER$$57$YR$$F$Y$$$20240724$$HP$US$US
2201791614$22017916$14$F$20230906$20240813$20230221$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-024782$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240820$$HP$US$US
220180116$22018011$6$F$20210101$20240708$20230221$20240713$EXP$$US-JAZZ-2022-US-035173$JAZZ$$62$YR$$M$Y$$$20240713$$CN$US$US
220185526$22018552$6$F$20230607$20240724$20230222$20240727$EXP$$NVSC2021CA069666$NOVARTIS$$68$YR$$M$Y$$$20240727$$CN$CA$CA
220186803$22018680$3$F$$20240829$20230222$20240924$PER$$US-SA-2023SA057792$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$MD$US$US
220189865$22018986$5$F$20230201$20240827$20230222$20240904$EXP$$BR-CELLTRION INC.-2023BR003548$CELLTRION$$$$$$Y$$$20240904$$CN$BR$BR
220190972$22019097$2$F$20220201$20240905$20230222$20240910$EXP$$DE-ROCHE-3290561$ROCHE$$33$YR$A$F$Y$85$KG$20240910$$MD$DE$DE
220191473$22019147$3$F$$20240725$20230222$20240729$PER$$NVSC2023US040720$NOVARTIS$$$$$M$Y$$$20240729$$CN$US$US
220191712$22019171$2$F$$20240701$20230222$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-378977$RANBAXY$$$$$M$Y$$$20240711$$CN$US$US
220191859$22019185$9$F$$20240830$20230222$20240911$EXP$$CA-AUROBINDO-AUR-APL-2020-034096$AUROBINDO$$41$YR$$F$Y$$$20240911$$MD$CA$CA
2201930112$22019301$12$F$20210429$20240912$20230222$20240919$EXP$$IT-TAKEDA-2021TUS028169$TAKEDA$$64$YR$$F$Y$$$20240919$$CN$IT$IT
220193216$22019321$6$F$20221023$20240712$20230222$20240722$EXP$$CA-CELLTRION INC.-2022CA019022$CELLTRION$$$$$$Y$$$20240722$$CN$CA$CA
220194232$22019423$2$F$$20230210$20230222$20240809$EXP$$US-RECORDATI-2023000769$RECORDATI$$$$$$Y$$$20240809$$CN$US$US
220194322$22019432$2$F$$20230210$20230222$20240809$EXP$$US-RECORDATI RARE DISEASE INC.-2023000827$RECORDATI$$$$$$Y$$$20240809$$CN$US$US
2201945613$22019456$13$F$20221229$20240906$20230222$20240913$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-000516$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240913$$MD$JP$JP
2201956913$22019569$13$F$20230210$20240925$20230222$20240930$EXP$$NVSC2023US035544$NOVARTIS$$66$YR$$M$Y$$$20240930$$CN$US$US
2201964510$22019645$10$F$20220805$20240730$20230222$20240809$EXP$$JP-INSMED-2022-02191-JPAA$INSMED$$78$YR$$F$Y$47.4$KG$20240809$$CN$JP$JP
220196685$22019668$5$F$20230101$20240716$20230222$20240718$PER$$US-AMGEN-USASP2023030403$AMGEN$$$$$F$Y$$$20240718$$HP$US$US
220196698$22019669$8$F$20200326$20240826$20230222$20240828$EXP$$CA-TAKEDA-2020TUS016203$TAKEDA$$38$YR$$M$Y$$$20240828$$CN$CA$CA
220197558$22019755$8$F$$20240627$20230222$20240704$EXP$$GB-TAKEDA-2023TUS017326$TAKEDA$$$$$F$Y$$$20240704$$CN$GB$GB
220197564$22019756$4$F$20240124$20240731$20230222$20240807$EXP$$BR-TAKEDA-2023TUS017995$TAKEDA$$37$YR$$F$Y$$$20240807$$CN$BR$BR
220200223$22020022$3$F$20230213$20240723$20230222$20240725$EXP$$US-TAKEDA-2022TUS056695$TAKEDA$$15$YR$$M$Y$44$KG$20240725$$CN$US$US
220204596$22020459$6$F$20230101$20240801$20230222$20240813$PER$$US-SA-2023SA055988$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240814$$MD$US$US
2202051911$22020519$11$F$20230302$20240816$20230222$20240821$EXP$$US-OTSUKA-2023_004634$OTSUKA$$77$YR$$M$Y$80.29$KG$20240821$$MD$US$US
220205886$22020588$6$F$$20240909$20230222$20240910$EXP$$US-PFIZER INC-PV202300033805$PFIZER$$59$YR$$M$Y$$$20240910$$MD$US$US
220205959$22020595$9$F$20230501$20240625$20230222$20240701$PER$$US-PFIZER INC-PV202300032896$PFIZER$$51$YR$$F$Y$$$20240701$$CN$US$US
220206385$22020638$5$F$$20240820$20230222$20240826$EXP$$ES-MYLANLABS-2023M1017793$MYLAN$Margarit-Soler A, Deya-Martinez A, Canizales JT, Vlagea A, Garcia-Garcia A, Marsal J et al.. Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders.. Front Immunol.. 2022;13:1-10$21$YR$$M$Y$$$20240826$$MD$ES$ES
220206892$22020689$2$F$20230201$20230215$20230222$20240819$EXP$$US-RECORDATI-2023000923$RECORDATI$$$$$$Y$$$20240819$$CN$US$US
220208128$22020812$8$F$20230216$20240627$20230222$20240709$PER$$US-ROCHE-3291347$ROCHE$$13$YR$T$M$Y$61.69$KG$20240705$$HP$US$US
220210813$22021081$3$F$$20240620$20230222$20240701$PER$$US-SA-2023SA058404$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240701$$MD$US$US
220213004$22021300$4$F$20230201$20240916$20230222$20240920$EXP$$US-AMGEN-USASP2023029369$AMGEN$$52$YR$A$F$Y$$$20240919$$CN$US$US
220215923$22021592$3$F$$20240808$20230222$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01287$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220216566$22021656$6$F$20230201$20240816$20230222$20240823$PER$$US-BIOGEN-2023BI01189329$BIOGEN$$59$YR$$F$Y$$$20240823$$CN$US$US
220216963$22021696$3$F$$20240801$20230222$20240807$EXP$$US-OTSUKA-2023_004619$OTSUKA$$$$$M$Y$97.52$KG$20240807$$CN$US$US
220217156$22021715$6$F$$20240802$20230222$20240812$EXP$$US-JAZZ-2023-US-003919$JAZZ$$$$$F$Y$$$20240812$$CN$US$US
220218498$22021849$8$F$$20240912$20230222$20240918$EXP$$US-TAKEDA-2022TUS006418$TAKEDA$$$$$F$Y$84$KG$20240918$$HP$US$US
220219722$22021972$2$F$$20240807$20230222$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01310$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220220034$22022003$4$F$20221109$20240322$20230222$20240814$EXP$$NVSC2022BR257686$NOVARTIS$$73$YR$$F$Y$$$20240814$$CN$BR$BR
220220403$22022040$3$F$$20240813$20230222$20240819$EXP$$CZ-MYLANLABS-2023M1011264$MYLAN$Hugo J.. Treatment of atopic dermatitis in a patient with autism spectrum disorder- case report.. FARMAKOTERAPEUTICKA REVUE.. 2022;7(6):576 - 578$24$YR$$M$Y$$$20240819$$MD$CZ$CZ
220221172$22022117$2$F$$20240807$20230222$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01350$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220223232$22022323$2$F$20190101$20240725$20230222$20240731$EXP$$RO-MYLANLABS-2023M1017853$MYLAN$$64$YR$$F$Y$$$20240731$$MD$RO$RO
220224352$22022435$2$F$20220805$20240807$20230222$20240815$EXP$$CN-JNJFOC-20230232646$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240815$$HP$CN$CN
2202303212$22023032$12$F$20221016$20240905$20230222$20240914$EXP$$CA-CELLTRION INC.-2022CA007701$CELLTRION$$$$$$Y$$$20240914$$MD$CA$CA
2202317512$22023175$12$F$$20240722$20230223$20240731$EXP$$US-GSK-US2023AMR028800$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$CN$US$US
220232023$22023202$3$F$$20230221$20230223$20240805$PER$$NVSC2023US041457$NOVARTIS$$$$$M$Y$$$20240805$$CN$US$US
220233562$22023356$2$F$$20240830$20230223$20240909$EXP$$BR-CELLTRION INC.-2023BR003752$CELLTRION$$$$$$Y$$$20240909$$PH$BR$BR
2202359810$22023598$10$F$20221201$20240627$20230223$20240704$EXP$$NVSC2023US038077$NOVARTIS$$74$YR$$M$Y$$$20240704$$CN$US$US
220236924$22023692$4$F$20221112$20240917$20230223$20240924$EXP$$JP-ROCHE-3290559$ROCHE$$64$YR$A$M$Y$75$KG$20240924$$MD$JP$JP
220237413$22023741$3$F$20211120$20240903$20230223$20240906$PER$$US-ROCHE-3007205$ROCHE$$15$YR$T$F$Y$$$20240906$$CN$US$US
220240005$22024000$5$F$$20240716$20230223$20240717$EXP$$US-ROCHE-3291594$ROCHE$$$$E$F$Y$$$20240717$$CN$US$US
220240132$22024013$2$F$$20240731$20230223$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01219$LUPIN$$$$$$Y$$$20240820$$CN$US$US
220240553$22024055$3$F$$20240808$20230223$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01281$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220248605$22024860$5$F$20230101$20240817$20230223$20240826$EXP$$CA-CELLTRION INC.-2022CA012676$CELLTRION$$$$$$Y$$$20240826$$MD$CA$CA
220248953$22024895$3$F$$20230216$20230223$20240925$EXP$$US-TAKEDA-2023TUS018106$TAKEDA$$$$$M$Y$$$20240925$$CN$US$US
220251202$22025120$2$F$$20240808$20230223$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01307$LUPIN$$$$$$Y$$$20240902$$CN$US$US
220251756$22025175$6$F$$20240808$20230223$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01308$LUPIN$$$$$$Y$$$20240902$$CN$US$US
220254062$22025406$2$F$20220513$20240904$20230223$20240906$PER$$US-ROCHE-3098152$ROCHE$$38$YR$A$F$Y$$$20240906$$PH$US$US
220254779$22025477$9$F$20211129$20240710$20230223$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-026752$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240718$$CN$US$US
220255952$22025595$2$F$$20240923$20230223$20240925$PER$$US-ROCHE-3130640$ROCHE$$75$YR$E$M$Y$$$20240925$$HP$US$US
220259533$22025953$3$F$20230210$20240730$20230223$20240806$EXP$$US-SA-2023SA061201$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240806$$MD$US$US
220259964$22025996$4$F$20220701$20240725$20230223$20240730$PER$$US-ROCHE-3134390$ROCHE$$45$YR$A$F$Y$55.34$KG$20240730$$CN$US$US
220261083$22026108$3$F$$20240809$20230223$20240813$PER$$US-ROCHE-3131805$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
220261466$22026146$6$F$$20240813$20230223$20240815$EXP$$SK-ROCHE-3289997$ROCHE$Dobsinska V, Svec P H. Adult patient with chronic inflammatory bowel disease and inborn error of immunity: hematopoietic stem cell transplantation as an option for curative treatment. PEDIATRIA PRE PRAX.. 2022;23(6):242-246.$18$YR$A$M$Y$$$20240815$$MD$SK$SK
220262652$22026265$2$F$$20240724$20230223$20240801$PER$$US-SA-2023SA061479$SANOFI AVENTIS$$$$E$F$Y$$$20240801$$MD$US$US
220263262$22026326$2$F$$20240923$20230223$20240930$PER$$US-ROCHE-3167064$ROCHE$$$$A$F$Y$$$20240930$$CN$US$US
2202644015$22026440$15$F$20240701$20240701$20230223$20240712$EXP$$CA-OTSUKA-2022_049589$OTSUKA$$28$YR$$M$Y$$$20240712$$HP$CA$CA
220266644$22026664$4$F$$20240808$20230223$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01349$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220266793$22026679$3$F$20220830$20240911$20230223$20240917$PER$$US-ROCHE-3182493$ROCHE$$58$YR$A$F$Y$$$20240917$$CN$US$US
220266963$22026696$3$F$$20240821$20230223$20240831$EXP$$PT-AUROBINDO-AUR-APL-2017-11209$AUROBINDO$Serra D, Goncalo M, Mariano A, Figueiredo A.. Pustular psoriasis and drug-induced pustulosis.. Giornale Italiano di Dermatologia e Venereologia. 2011;146(2):155-158$65$YR$$F$Y$$$20240831$$MD$PT$PT
220266982$22026698$2$F$20230214$20240829$20230223$20240906$EXP$$BR-CELLTRION INC.-2023BR003731$CELLTRION$$$$$$Y$$$20240906$$PH$BR$BR
220267677$22026767$7$F$20230207$20240912$20230223$20240917$EXP$$US-TAKEDA-2023TUS017687$TAKEDA$$76$YR$$M$Y$105$KG$20240917$$HP$US$US
220269062$22026906$2$F$$20240702$20230223$20240709$EXP$$DE-AUROBINDO-AUR-APL-2023-007738$AUROBINDO$Bulut K, Markova A, Canbay AE, Schmidt WE, Kahraman A.. Whipple^s disease-a rare and challenging complication in a patient with Crohn^s disease.. Z-Gastroenterol. 2022;60(4):598-601$30$YR$$M$Y$$$20240709$$MD$DE$DE
220271963$22027196$3$F$20230815$20240722$20230223$20240723$EXP$$GB-ROCHE-3291786$ROCHE$$45$YR$A$F$Y$$$20240723$$HP$GB$GB
220275247$22027524$7$F$20221002$20240910$20230223$20240917$EXP$$JP-AstraZeneca-2023A040318$ASTRAZENECA$Yamazaki N, et al.. 152 Two cases in which olaparib was successfully resumed after suspension due to drug-induced interstitial pneumonia during the treatment.. Modern Trends in Obstetrics + Gynecology 2024;73(S):S69.$58$YR$$F$Y$53$KG$20240917$$MD$JP$
220277136$22027713$6$F$20210301$20240906$20230223$20240911$EXP$$NVSC2023AR035073$NOVARTIS$$58$YR$$F$Y$60$KG$20240911$$MD$AR$AR
2202771410$22027714$10$F$20220615$20240829$20230223$20240903$EXP$$CN-TAKEDA-2022TUS073291$TAKEDA$$58$YR$$M$Y$62$KG$20240903$$CN$CN$CN
220279625$22027962$5$F$$20240702$20230223$20240709$EXP$$PT-MYLANLABS-2023M1015062$MYLAN$Martins de Sousa Ciria Leandra, Figueiredo CR, Ventura S, Almeida M, Martins LS. Late Onset of Pneumocystis jirovecii Pneumonia in Kidney Transplant: How Long is too Long in Opportunistic Infection Prophylaxis?. Portuguese Journal of Nephrology + Hypertension. 2022;36(4):233-236$45$YR$$M$Y$$$20240709$$MD$PT$PT
220279713$22027971$3$F$$20230222$20230223$20240829$EXP$$US-KYOWAKIRIN-2023BKK002756$KYOWA$Stern R, Levi DS,  Gales B,  Rutsch F, Salusky IB.. Correspondence on ^Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI)^ by Ferreira et al.. Genetics in Medicine.. 2021;23 (10):2006-2007$$$$$Y$$$20240829$$HP$US$US
2202798010$22027980$10$F$$20240809$20230223$20240819$EXP$$NVSC2023SK038153$NOVARTIS$Dobsinska V, Svec P, Horakova J, Ostro R, Pozdechova M, Bodova I et al.. Dospely pacient s chronickym zapalovym ochorenim creva a vrodenou imunodeficienciou: transplantacia krvotvornych buniek ako moznost kurativnej liecby [Adult patient with chronic inflammatory bowel disease and inborn error of immunity: hematopoietic stem cell transplantation as an option for curative treatment]. PEDIATRIA PRE PRAX. 2022;23(6):242-6$10$YR$$M$Y$$$20240819$$HP$SK$SK
220280752$22028075$2$F$$20240808$20230223$20240817$PER$$US-ROCHE-3220953$ROCHE$$$$A$F$Y$$$20240817$$CN$US$US
220283995$22028399$5$F$20200101$20240806$20230223$20240807$EXP$$US-TAKEDA-US202031266$TAKEDA$$46$YR$$F$Y$$$20240807$$HP$US$US
220287053$22028705$3$F$$20240715$20230223$20240717$PER$$US-PFIZER INC-PV202300033020$PFIZER$$60$YR$$F$Y$$$20240717$$CN$US$US
220287374$22028737$4$F$20230201$20230407$20230223$20240925$PER$$US-GSK-US2023AMR029162$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
220288135$22028813$5$F$20230127$20240913$20230223$20240919$EXP$$US-VERTEX PHARMACEUTICALS-2023-002725$VERTEX$$36$YR$$M$Y$74$KG$20240919$$MD$US$US
2202893014$22028930$14$F$20230908$20240812$20230223$20240819$EXP$$US-TAKEDA-2023TUS018551$TAKEDA$$7$YR$$M$Y$16$KG$20240819$$HP$US$US
220289432$22028943$2$F$$20240830$20230223$20240920$PER$$US-SA-2023SA060770$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240920$$MD$US$US
220289782$22028978$2$F$$20240904$20230223$20240919$PER$$US-SA-2023SA060731$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240919$$MD$US$US
220289898$22028989$8$F$20230620$20240723$20230223$20240729$EXP$$GB-MYLANLABS-2023M1018587$MYLAN$$50$YR$$M$Y$$$20240729$$MD$GB$GB
220291563$22029156$3$F$$20240808$20230223$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01360$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220293082$22029308$2$F$20221101$20240729$20230223$20240807$PER$$US-SA-2023SA057383$SANOFI AVENTIS$$11$YR$C$M$Y$54.8$KG$20240807$$MD$US$US
220293435$22029343$5$F$$20230501$20230223$20240820$EXP$$CA-AstraZeneca-2023A040259$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$CA$
220298172$22029817$2$F$20220805$20240807$20230223$20240819$EXP$$CN-TAKEDA-2023TUS019313$TAKEDA$$56$YR$$F$Y$$$20240819$$HP$CN$CN
220298467$22029846$7$F$20220101$20240807$20230223$20240812$EXP$$CA-PFIZER INC-202201064047$PFIZER$$65$YR$$F$Y$$$20240812$$HP$CA$CA
220299372$22029937$2$F$20230218$20240812$20230223$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-027182$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240814$$CN$US$US
2203059318$22030593$18$F$20240301$20240815$20230223$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-002086$JAZZ$$60$YR$$F$Y$$$20240822$$MD$US$US
220307438$22030743$8$F$$20240822$20230223$20240828$EXP$$CA-TAKEDA-2023TUS008203$TAKEDA$$43$YR$$F$Y$97$KG$20240828$$HP$CA$CA
220307612$22030761$2$F$$20230221$20230223$20240806$PER$$NVSC2023US041595$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
220308258$22030825$8$F$$20240919$20230223$20240923$EXP$$US-PFIZER INC-2021136851$PFIZER$$73$YR$$F$Y$65.76$KG$20240923$$CN$US$US
220308467$22030846$7$F$$20240823$20230223$20240829$PER$$US-PFIZER INC-202300077984$PFIZER$$65$YR$$F$Y$$$20240829$$CN$US$US
220310074$22031007$4$F$20220101$20240821$20230223$20240822$EXP$$JP-BEH-2023155595$CSL BEHRING$$5$DEC$A$M$Y$$$20240822$$MD$JP$JP
220310123$22031012$3$F$20230214$20240626$20230223$20240703$EXP$$NVSJ2023JP003366$NOVARTIS$$88$YR$$F$Y$61$KG$20240703$$MD$JP$JP
220310952$22031095$2$F$20230112$20240618$20230223$20240703$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-380157$RANBAXY$$23$YR$$F$Y$56$KG$20240703$$CN$DE$DE
220311442$22031144$2$F$20220101$20240626$20230223$20240701$EXP$$JP-SA-2023SA053487$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240702$$MD$JP$JP
220311976$22031197$6$F$20230214$20240716$20230223$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000402$ACADIA PHARMACEUTICALS$$68$YR$$F$Y$$$20240809$$CN$US$US
220312352$22031235$2$F$20230127$20240725$20230223$20240803$EXP$FR-AFSSAPS-PV2023000166$FR-BAXTER-2023BAX013348$BAXTER$$10$YR$$F$Y$54$KG$20240803$$MD$FR$FR
220313184$22031318$4$F$20230101$20240701$20230223$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000439$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240725$$CN$US$US
220314143$22031414$3$F$20200701$20240917$20230224$20240920$EXP$$PHHY2019CA135746$NOVARTIS$$51$YR$$F$Y$$$20240920$$CN$CA$CA
220314412$22031441$2$F$$20240704$20230224$20240712$EXP$$IT-CELLTRION INC.-2023IT002765$CELLTRION$$$$$$Y$$$20240712$$MD$IT$IT
220315543$22031554$3$F$20230206$20240806$20230224$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01311$LUPIN$$$$$$Y$$$20240822$$CN$US$US
220316269$22031626$9$F$20230301$20240502$20230224$20240925$PER$$US-GSK-US2023AMR025259$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$PH$US$US
220316354$22031635$4$F$20231011$20240923$20230224$20240926$EXP$$US-BAUSCH-BL-2023-002835$BAUSCH AND LOMB$$68$YR$$F$Y$$$20240926$$CN$US$US
220318757$22031875$7$F$20220801$20240618$20230224$20240709$PER$$CA-TOLMAR, INC.-23CA038723$TOLMAR$$71$YR$$M$Y$$$20240709$$HP$CA$CA
220319066$22031906$6$F$20210608$20240821$20230224$20240828$EXP$$DE-ROCHE-2903570$ROCHE$$35$YR$A$F$Y$$$20240828$$CN$DE$DE
220320053$22032005$3$F$$20230425$20230224$20240919$EXP$$NVSC2023GB036864$NOVARTIS$$$$$$Y$$$20240919$$MD$GB$GB
220320273$22032027$3$F$20220701$20230228$20230224$20240716$EXP$$RO-ASTELLAS-2023US006263$ASTELLAS$$71$YR$$M$Y$$$20240716$$MD$RO$RO
220321092$22032109$2$F$$20240729$20230224$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01290$LUPIN$$$$$$Y$$$20240818$$CN$US$US
220323066$22032306$6$F$$20240918$20230224$20240927$PER$$NVSC2023US043116$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
220323246$22032324$6$F$$20240712$20230224$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-027296$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240716$$CN$US$US
220324342$22032434$2$F$$20240807$20230224$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01353$LUPIN$$$$$$Y$$$20240822$$CN$US$US
2203254713$22032547$13$F$20230126$20240802$20230224$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-026965$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240809$$HP$US$US
220325767$22032576$7$F$$20240829$20230224$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-026944$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240903$$HP$US$US
220326594$22032659$4$F$$20240807$20230224$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01358$LUPIN$$$$$$Y$$$20240827$$CN$US$US
220327582$22032758$2$F$20220202$20240815$20230224$20240822$EXP$$CA-TAKEDA-2022TUS005944$TAKEDA$$35$YR$$F$Y$$$20240822$$CN$CA$CA
220328182$22032818$2$F$20230101$20230220$20230224$20240819$EXP$$US-RECORDATI-2023001013$RECORDATI$$$$$$Y$$$20240819$$CN$US$US
220328352$22032835$2$F$$20240626$20230224$20240703$EXP$$BE-OTSUKA-2021_031340$OTSUKA$$$$$F$Y$70$KG$20240703$$MD$BE$BE
220328992$22032899$2$F$20230215$20230215$20230224$20240925$PER$$US-GSK-US2023AMR026749$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
220329555$22032955$5$F$$20240819$20230224$20240827$EXP$$US-ABBVIE-4317063$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
220329824$22032982$4$F$$20230222$20230224$20240724$PER$$NVSC2023US042738$NOVARTIS$$$$$M$Y$$$20240724$$CN$US$US
220331222$22033122$2$F$20230217$20240918$20230224$20240930$PER$$NVSC2023US043218$NOVARTIS$$$$$$Y$$$20240930$$HP$US$US
2203317412$22033174$12$F$20210613$20240710$20230224$20240717$EXP$$CO-TAKEDA-2021TUS039567$TAKEDA$$60$YR$$F$Y$72$KG$20240717$$CN$CO$CO
220334059$22033405$9$F$$20240709$20230224$20240715$EXP$$US-PFIZER INC-PV202200053165$PFIZER$$68$YR$$F$Y$$$20240715$$CN$US$US
220334616$22033461$6$F$20221101$20240719$20230224$20240729$EXP$$AU-TAKEDA-2022TUS089989$TAKEDA$$23$YR$$F$Y$$$20240729$$CN$AU$AU
220336545$22033654$5$F$20230122$20240710$20230224$20240715$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-001381$JAZZ$$17$YR$$M$Y$$$20240714$$CN$US$US
220336759$22033675$9$F$20230101$20240923$20230224$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-024688$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$93.89$KG$20240926$$CN$US$US
220337583$22033758$3$F$$20240809$20230224$20240812$EXP$$SK-JNJFOC-20230241355$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240812$$MD$SK$SK
220337645$22033764$5$F$20230215$20240823$20230224$20240903$EXP$$JP-BAXTER-2023BAX013687$BAXTER$$28$YR$$M$Y$61$KG$20240903$$HP$JP$JP
220339443$22033944$3$F$$20240807$20230224$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01417$LUPIN$$$$$$Y$$$20240829$$CN$US$US
220339584$22033958$4$F$$20240807$20230224$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01407$LUPIN$$$$$$Y$$$20240827$$CN$US$US
220339724$22033972$4$F$$20240808$20230224$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01413$LUPIN$$$$$$Y$$$20240902$$CN$US$US
2203481712$22034817$12$F$20210101$20240912$20230224$20240920$EXP$$CA-TAKEDA-2021TUS038233$TAKEDA$$$$$F$Y$54$KG$20240920$$MD$CA$CA
220349496$22034949$6$F$20240218$20240906$20230224$20240909$EXP$$US-PFIZER INC-2019232728$PFIZER$$71$YR$$M$Y$$$20240909$$CN$US$US
220352024$22035202$4$F$20240701$20240812$20230224$20240827$EXP$$US-GSK-US2023026574$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
220352356$22035235$6$F$20230201$20240702$20230224$20240708$PER$$US-PFIZER INC-PV202300025246$PFIZER$$71$YR$$F$Y$$$20240708$$MD$US$US
220353135$22035313$5$F$$20240923$20230224$20240930$EXP$$IN-TAKEDA-2021TUS040080$TAKEDA$$$$$F$Y$$$20240930$$MD$IN$IN
2203540317$22035403$17$F$20181212$20240820$20230224$20240827$EXP$$IN-PFIZER INC-2019366383$PFIZER$$43$YR$$F$Y$$$20240827$$CN$IN$IN
220356315$22035631$5$F$20230201$20240910$20230224$20240916$EXP$$DE-PFIZER INC-PV202300023827$PFIZER$$64$YR$$F$Y$80$KG$20240916$$MD$DE$DE
220357105$22035710$5$F$20180807$20240916$20230224$20240918$EXP$$DE-ROCHE-2932715$ROCHE$$52$YR$A$F$Y$$$20240918$$CN$DE$DE
220358845$22035884$5$F$20230909$20240729$20230224$20240731$EXP$$US-TAKEDA-2023TUS020362$TAKEDA$$84$YR$$F$Y$$$20240731$$CN$US$US
220360173$22036017$3$F$20200629$20240923$20230224$20240926$EXP$$US-TAKEDA-2023TUS020017$TAKEDA$$26$YR$$M$Y$$$20240926$$MD$US$US
220360394$22036039$4$F$20210401$20230319$20230224$20240913$EXP$$QA-INCYTE CORPORATION-2023IN001965$INCYTE$$$$$$Y$$$20240913$$MD$QA$QA
220361952$22036195$2$F$$20240726$20230225$20240730$PER$$NVSC2023US044028$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
220362882$22036288$2$F$20220901$20230223$20230225$20240722$EXP$$NVSC2023US042991$NOVARTIS$$61$YR$$M$Y$78.912$KG$20240722$$CN$US$US
2203632616$22036326$16$F$20220616$20240712$20230225$20240722$EXP$$CA-CELLTRION INC.-2022CA007612$CELLTRION$$$$$$Y$$$20240722$$MD$CA$CA
220363435$22036343$5$F$20230101$20240711$20230225$20240720$EXP$$CA-CELLTRION INC.-2022CA018309$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
220363533$22036353$3$F$20230101$20240715$20230225$20240722$EXP$$US-UCBSA-2023008982$UCB$$80$YR$$F$Y$$$20240719$$HP$US$US
220363702$22036370$2$F$$20240913$20230225$20240925$EXP$$PL-AUROBINDO-AUR-APL-2023-008155$AUROBINDO$Olejarz M.; Szczepanek-parulska E.; Antosik P.. Tumoral calcinosis in the periarticular soft tissue of the left shoulder joint secondary to end stage renal disease. Polish Archives of Internal Medicine. 2022;132 (12):1-2$60$YR$$F$Y$$$20240925$$MD$PL$PL
220364189$22036418$9$F$20230106$20240529$20230225$20240812$EXP$$NVSC2023AR043430$NOVARTIS$$50$YR$$F$Y$$$20240812$$CN$AR$AR
220364645$22036464$5$F$20230101$20240918$20230225$20240924$PER$$NVSC2023US044041$NOVARTIS$$55$YR$$M$Y$$$20240924$$CN$US$US
220371713$22037171$3$F$20230201$20240621$20230226$20240702$PER$$US-SA-2023SA063288$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240702$$MD$US$US
2203733811$22037338$11$F$20170502$20240722$20230226$20240723$EXP$$CA-JNJFOC-20220925029$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240723$$HP$CA$CA
220375644$22037564$4$F$20200101$20240911$20230227$20240923$EXP$$JP-JNJFOC-20221149272$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240923$$CN$JP$JP
220376776$22037677$6$F$$20230330$20230227$20240926$EXP$$US-GSK-US2023AMR029200$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
220378256$22037825$6$F$$20240913$20230227$20240918$EXP$$US-TAKEDA-2023TUS019009$TAKEDA$$$$$F$Y$113$KG$20240918$$CN$US$US
220380262$22038026$2$F$20220801$20240702$20230227$20240724$PER$$CA-TOLMAR, INC.-23CA038769$TOLMAR$$72$YR$$M$Y$$$20240724$$CN$CA$CA
220381029$22038102$9$F$20230201$20230608$20230227$20240925$EXP$$US-GSK-US2023AMR028513$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
220381704$22038170$4$F$$20240709$20230227$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-027677$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$79.38$KG$20240715$$HP$US$US
220381783$22038178$3$F$20221001$20230316$20230227$20240801$EXP$$AU-ABBVIE-4318266$ABBVIE$$69$YR$$F$Y$$$20240801$$MD$AU$AU
220381963$22038196$3$F$$20240730$20230227$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01419$LUPIN$$$$$$Y$$$20240819$$CN$US$US
220384373$22038437$3$F$20230128$20240725$20230227$20240803$30DAY$$US-GSK-US2023028389$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240803$$CN$US$US
220384932$22038493$2$F$20221118$20240815$20230227$20240828$PER$$US-SA-2023SA063289$SANOFI AVENTIS$$5$YR$C$F$Y$31.75$KG$20240828$$MD$US$US
220385103$22038510$3$F$20230201$20240710$20230227$20240717$PER$$US-SA-2023SA061571$SANOFI AVENTIS$$55$YR$A$F$Y$65$KG$20240717$$MD$US$US
220385434$22038543$4$F$20230131$20240920$20230227$20240923$EXP$$AU-TAKEDA-2023TUS019532$TAKEDA$$53$YR$$F$Y$$$20240923$$HP$AU$AU
220385553$22038555$3$F$20230201$20240722$20230227$20240724$EXP$$US-TAKEDA-2023TUS020451$TAKEDA$$57$YR$$M$Y$$$20240724$$PH$US$US
220386595$22038659$5$F$$20240807$20230227$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01453$LUPIN$$$$$$Y$$$20240830$$CN$US$US
220386903$22038690$3$F$20210217$20240829$20230227$20240911$EXP$$CA-UCBSA-2023009637$UCB$$21$YR$$F$Y$$$20240911$$CN$CA$CA
220387317$22038731$7$F$$20240903$20230227$20240905$EXP$$CA-TAKEDA-2021TUS026079$TAKEDA$$$$$M$Y$$$20240905$$CN$CA$CA
220391102$22039110$2$F$20221221$20240917$20230227$20240923$EXP$$CA-ROCHE-3253306$ROCHE$$67$YR$E$F$Y$$$20240923$$CN$CA$CA
220392503$22039250$3$F$$20240808$20230227$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01301$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220393083$22039308$3$F$$20240808$20230227$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01450$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220393235$22039323$5$F$20221129$20240724$20230227$20240805$PER$$US-JNJFOC-20230254809$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240805$$HP$US$US
220393344$22039334$4$F$$20240807$20230227$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01451$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220393352$22039335$2$F$20230101$20230215$20230227$20240819$EXP$$US-RECORDATI-2023000951$RECORDATI$$$$$$Y$$$20240819$$CN$US$US
2203933611$22039336$11$F$20230201$20240808$20230227$20240814$EXP$$US-GSK-US2023AMR031027$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$US$US
220393607$22039360$7$F$20190801$20230620$20230227$20240925$EXP$$US-GSK-US2023AMR029199$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
220395642$22039564$2$F$$20240717$20230227$20240726$PER$$US-SA-2023SA062855$SANOFI AVENTIS$$60$YR$A$M$Y$61$KG$20240726$$MD$US$US
220397882$22039788$2$F$$20240626$20230227$20240701$PER$$US-PFIZER INC-PV202300034540$PFIZER$$66$YR$$F$Y$$$20240701$$CN$US$US
220398094$22039809$4$F$$20240629$20230227$20240702$PER$$US-PFIZER INC-PV202300036415$PFIZER$$71$YR$$F$Y$$$20240702$$MD$US$US
220399953$22039995$3$F$20230201$20240919$20230227$20240923$EXP$$US-PFIZER INC-2018135197$PFIZER$$72$YR$$F$Y$76$KG$20240923$$CN$US$US
220400187$22040018$7$F$20220422$20240806$20230227$20240814$EXP$$CA-CELLTRION INC.-2022CA006050$CELLTRION$$$$$$Y$$$20240814$$HP$CA$CA
220400492$22040049$2$F$20230120$20240705$20230227$20240716$EXP$$BE-CELLTRION INC.-2023BE004316$CELLTRION$$$$$$Y$$$20240716$$MD$BE$BE
220401229$22040122$9$F$20220613$20240717$20230227$20240720$EXP$$US-ABBVIE-4319423$ABBVIE$$81$YR$$M$Y$85$KG$20240720$$HP$US$US
220402144$22040214$4$F$20230221$20240806$20230227$20240809$PER$$US-PFIZER INC-PV202200059901$PFIZER$$63$YR$$F$Y$$$20240809$$CN$US$US
220402548$22040254$8$F$$20240822$20230227$20240826$EXP$$US-PFIZER INC-202200726272$PFIZER$$70$YR$$F$Y$70.748$KG$20240826$$CN$US$US
220402764$22040276$4$F$20221114$20240905$20230227$20240913$EXP$$FR-CELLTRION INC.-2023FR004270$CELLTRION$$$$$$Y$$$20240913$$PH$FR$FR
220403302$22040330$2$F$20240715$20240719$20230227$20240725$PER$$US-BEH-2023155720$CSL BEHRING$$61$YR$A$F$Y$$$20240725$$CN$US$US
220403802$22040380$2$F$20230216$20240909$20230227$20240913$EXP$$CA-TAKEDA-2023TUS019363$TAKEDA$$28$YR$$M$Y$$$20240913$$MD$CA$CA
220403823$22040382$3$F$$20240808$20230227$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01452$LUPIN$$$$$$Y$$$20240904$$CN$US$US
220404033$22040403$3$F$$20240808$20230227$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01454$LUPIN$$$$$$Y$$$20240828$$CN$US$US
2204042011$22040420$11$F$20230120$20240919$20230227$20240930$EXP$$CA-ROCHE-3294334$ROCHE$$42$YR$A$F$Y$$$20240930$$PH$CA$CA
220409003$22040900$3$F$20221114$20240829$20230227$20240905$EXP$$FR-MYLANLABS-2023M1020418$BIOCON$$$$$$Y$$$20240906$$PH$FR$FR
220409148$22040914$8$F$20230706$20240923$20230227$20240927$EXP$$US-PFIZER INC-PV202300037650$PFIZER$$80$YR$$M$Y$82.55$KG$20240927$$LW$US$US
220409533$22040953$3$F$$20240812$20230227$20240820$PER$$US-SA-2023SA064923$SANOFI AVENTIS$$$$A$F$Y$108$KG$20240820$$MD$US$US
220410093$22041009$3$F$$20240716$20230227$20240719$EXP$$GB-LABORATORIOS LICONSA S.A.-2302GB00904$INSUD PHARMA$Lazenbury A, De Chellis A, Singh J, Illingworth MA. A Case Report of Suspected Omeprazole-Induced Psychosis in a 6-Year-Old Girl with Acute Disseminated Encephalomyelitis. Dev-Med-Child-Neurol. 2023;65 (Suppl. 1):23$6$YR$$F$Y$$$20240719$$MD$GB$GB
220410674$22041067$4$F$20221201$20240718$20230227$20240725$EXP$$IT-EMD Serono-9385223$EMD SERONO INC$$39$YR$A$F$Y$58$KG$20240725$$MD$IT$IT
220411103$22041110$3$F$$20240726$20230227$20240801$EXP$$GT-BIOGEN-2023BI01189504$BIOGEN$$$$$F$Y$67$KG$20240801$$CN$GT$GT
220411556$22041155$6$F$20230219$20240829$20230227$20240905$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-004418$JAZZ$$7$YR$$F$Y$21$KG$20240905$$CN$US$US
220411564$22041156$4$F$20221201$20240912$20230227$20240919$EXP$$JP-JNJFOC-20230259625$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240919$$MD$JP$JP
220412494$22041249$4$F$$20240808$20230227$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01491$LUPIN$$$$$$Y$$$20240829$$CN$US$US
220413143$22041314$3$F$$20240727$20230227$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01489$LUPIN$$$$$$Y$$$20240816$$PH$US$US
220413612$22041361$2$F$$20230213$20230227$20240903$PER$$US-JNJFOC-20230257665$JOHNSON AND JOHNSON$$$$$F$Y$83$KG$20240903$$MD$US$US
220414554$22041455$4$F$$20240710$20230227$20240718$PER$$US-SA-2023SA064726$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240718$$MD$US$US
220415293$22041529$3$F$$20240817$20230227$20240829$PER$$US-SA-2023SA064525$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240829$$MD$US$US
220418495$22041849$5$F$20220213$20240918$20230227$20240926$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2023-000144$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$68$KG$20240926$$MD$DE$DE
220418786$22041878$6$F$$20240919$20230227$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-004142$JAZZ$$$$$F$Y$52.163$KG$20240924$$CN$US$US
220418805$22041880$5$F$20230219$20240708$20230227$20240712$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-004375$JAZZ$$61$YR$$M$Y$$$20240712$$CN$US$US
220422473$22042247$3$F$$20240701$20230227$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-379710$RANBAXY$$$$A$M$Y$$$20240711$$MD$US$US
220422605$22042260$5$F$20220522$20240611$20230227$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000486$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240705$$CN$US$US
220425955$22042595$5$F$20230223$20231115$20230228$20240710$PER$$IN-ROCHE-3294032$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$IN$IN
220427802$22042780$2$F$20220104$20230220$20230228$20240830$EXP$$NVSC2023CN040924$NOVARTIS$$68$YR$$F$Y$60$KG$20240830$$HP$CN$CN
220429212$22042921$2$F$20200701$20240812$20230228$20240818$PER$$US-SA-2023SA065131$SANOFI AVENTIS$$$$A$F$Y$$$20240818$$MD$US$US
220430598$22043059$8$F$$20240823$20230228$20240827$EXP$$NVSC2023US040728$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
220430647$22043064$7$F$$20240729$20230228$20240815$EXP$$JP-009507513-2302JPN002968J$MERCK$Kanazawa H, Komatsu S, Konishi T, Soga K, Shimomura K, Ikeda J, et al.. DP-005-8 Postoperative irAE-related anastomotic stenosis following curative gastrectomy in a gastric cancer patient with severe irAE: Review of literatures. The 95th Annual Meeting of the Japanese Gastric Cancer Association. 248$61$YR$$M$Y$$$20240815$$MD$JP$JP
220430834$22043083$4$F$$20240725$20230228$20240806$EXP$GR-SEATTLE GENETICS-2023SGN01642$GR-ROCHE-3292375$ROCHE$$63$YR$A$F$Y$$$20240806$$MD$GR$GR
220432384$22043238$4$F$$20240911$20230228$20240926$EXP$$US-CIPLA LTD.-2023US01096$CIPLA$Tamarelli C, Hosanagar A. Phenibut Use in a Patient Prescribed Gabapentinoids. Pain Medicine. 2021;22 (3):761 to 762$$$$$Y$$$20240926$$MD$US$US
220432863$22043286$3$F$$20240808$20230228$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01492$LUPIN$$$$$$Y$$$20240829$$CN$US$US
220432912$22043291$2$F$$20240808$20230228$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01422$LUPIN$$$$$$Y$$$20240829$$CN$US$US
220433174$22043317$4$F$20230101$20240717$20230228$20240722$EXP$$US-UCBSA-2023009538$UCB$$40$YR$$M$Y$$$20240719$$HP$US$US
220433423$22043342$3$F$20230101$20240827$20230228$20240906$EXP$$US-ORPHANEU-2023001096$RECORDATI$$$$$$Y$$$20240906$$CN$US$US
220436332$22043633$2$F$$20240723$20230228$20240802$EXP$$PR-STERISCIENCE B.V.-2023-ST-000920$Steriscience PTE$Ortiz Velez I, Gener E, Quiles-Cruz C, Roman-Velez N, Rodriguez KP, Rosado-Jimenez M, et al. The Challenge of multi-organism lung infection with human immunodeficiency virus. Am-J-Med-Sci. 2023;365(Suppl. 1):S160-S161$57$YR$$M$Y$$$20240802$$HP$US$US
220437163$22043716$3$F$$20240808$20230228$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01474$LUPIN$$$$$$Y$$$20240902$$CN$US$US
220437338$22043733$8$F$20190101$20240918$20230228$20240927$EXP$$CA-CELLTRION INC.-2019CA021815$CELLTRION$$$$$$Y$$$20240927$$CN$CA$CA
220437936$22043793$6$F$$20240708$20230228$20240718$EXP$$ES-AUROBINDO-AUR-APL-2023-008554$AUROBINDO$FJ MR, Ruiz RG, Puchades AM... Olmesartan Associated Enteropathy as an Inflammatory Bowel Disease Mimicker in a Patient With Hidradenitis Suppurativa. Actas Dermo-sifiliograficas.. 2023;1-5$65$YR$$M$Y$$$20240718$$MD$ES$ES
220438123$22043812$3$F$$20240731$20230228$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01488$LUPIN$$$$$$Y$$$20240820$$CN$US$US
2204446518$22044465$18$F$20090101$20240814$20230228$20240827$EXP$$GB-OTSUKA-2023_004968$OTSUKA$$37$YR$$M$Y$$$20240827$$CN$GB$GB
220445452$22044545$2$F$$20240808$20230228$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01542$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220446233$22044623$3$F$20220923$20240913$20230228$20240917$EXP$$CA-ABBVIE-4272434$ABBVIE$$81$YR$$M$Y$$$20240917$$CN$CA$CA
220450023$22045002$3$F$20240815$20240815$20230228$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202302012438$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240903$$CN$US$US
220450253$22045025$3$F$20220101$20240717$20230228$20240724$PER$$US-PFIZER INC-PV202300034762$PFIZER$$25$YR$$M$Y$$$20240724$$HP$US$US
220451612$22045161$2$F$$20240625$20230228$20240704$EXP$$ES-TAKEDA-2023TUS020387$TAKEDA$$60$YR$$M$Y$$$20240704$$MD$ES$ES
220451662$22045166$2$F$20230101$20240805$20230228$20240807$PER$$US-PFIZER INC-PV202300037561$PFIZER$$63$YR$$F$Y$$$20240807$$HP$US$US
220451782$22045178$2$F$$20240808$20230228$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01569$LUPIN$$$$$$Y$$$20240829$$CN$US$US
220453345$22045334$5$F$20200330$20240821$20230228$20240822$EXP$$FR-ABBVIE-21K-056-4094495-00$ABBVIE$$79$YR$$M$Y$55$KG$20240822$$MD$FR$FR
220454174$22045417$4$F$20230101$20240703$20230228$20240715$EXP$$CA-TAKEDA-2023TUS019945$TAKEDA$$75$YR$$F$Y$$$20240715$$MD$CA$CA
2204542611$22045426$11$F$20220101$20240906$20230228$20240912$EXP$$IN-PFIZER INC-PV202200126094$PFIZER$$55$YR$$F$Y$$$20240911$$CN$IN$IN
220454342$22045434$2$F$20230201$20240917$20230228$20240925$PER$$US-SA-2023SA064397$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240925$$HP$US$US
220454552$22045455$2$F$$20240814$20230228$20240819$PER$$US-PFIZER INC-202300068584$PFIZER$$76$YR$$F$Y$$$20240819$$CN$US$US
220454845$22045484$5$F$$20240823$20230228$20240903$EXP$$US-TAKEDA-2023TUS010572$TAKEDA$$$$$F$Y$44$KG$20240903$$MD$US$US
220454854$22045485$4$F$20230210$20240909$20230228$20240911$PER$$US-BIOGEN-2023BI01190289$BIOGEN$$68$YR$$F$Y$$$20240911$$CN$US$US
220455072$22045507$2$F$20201013$20240821$20230228$20240828$EXP$$US-SHIRE-US202033899$TAKEDA$$54$YR$$M$Y$87.52$KG$20240828$$CN$US$US
2204559912$22045599$12$F$$20240723$20230228$20240729$EXP$$PL-MYLANLABS-2023M1021490$MYLAN$Woron J.Siwek M. Rhabdomyolysis as a result of doxylamine interaction with other drugs. PRACTICAL MEDICINE-PSYCHIATRY. 2023;90(1):51-52$64$YR$$F$Y$$$20240729$$MD$PL$PL
220456102$22045610$2$F$$20230224$20230228$20240923$EXP$$NVSC2023AU043978$NOVARTIS$$$$$$Y$$$20240923$$MD$AU$AU
2204562617$22045626$17$F$$20240826$20230228$20240829$PER$$US-PFIZER INC-PV202300033081$PFIZER$$63$YR$$F$Y$63$KG$20240829$$MD$US$US
220457013$22045701$3$F$$20240224$20230228$20240807$EXP$$NVSC2023US040938$NOVARTIS$$$$$F$Y$50.35$KG$20240807$$CN$US$US
220457364$22045736$4$F$$20240813$20230228$20240816$PER$$US-PFIZER INC-PV202300037570$PFIZER$$77$YR$$F$Y$$$20240816$$MD$US$US
2204575111$22045751$11$F$20230210$20240925$20230228$20240930$PER$$US-PFIZER INC-PV202300034300$PFIZER$$71$YR$$F$Y$$$20240930$$CN$US$US
220459656$22045965$6$F$20231207$20240909$20230228$20240912$EXP$$CA-TAKEDA-2023TUS018937$TAKEDA$$72$YR$$M$Y$$$20240912$$CN$CA$CA
220460904$22046090$4$F$$20240722$20230228$20240806$EXP$$CA-MYLANLABS-2023M1017809$MYLAN$$65$YR$$F$Y$69$KG$20240806$$HP$CA$CA
220461808$22046180$8$F$20230205$20240729$20230228$20240801$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-004551$JAZZ$$65$YR$$F$Y$$$20240801$$CN$US$US
220462339$22046233$9$F$$20240918$20230228$20240920$PER$$US-PFIZER INC-PV202300035706$PFIZER$$77$YR$$F$Y$$$20240920$$HP$US$US
220466514$22046651$4$F$20210101$20240717$20230228$20240729$EXP$$US-NOVOPROD-1024958$NOVO NORDISK$$$$$F$Y$$$20240729$$CN$US$US
220467642$22046764$2$F$20230110$20240701$20230228$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-375211$RANBAXY$$63$YR$A$F$Y$$$20240711$$MD$US$US
220472083$22047208$3$F$20210801$20230224$20230301$20240719$PER$$NVSC2023US045617$NOVARTIS$$58$YR$$M$Y$81.65$KG$20240719$$CN$US$US
220472675$22047267$5$F$20221214$20240819$20230301$20240911$PER$$US-009507513-2302USA000522$MERCK$$69$YR$$M$Y$$$20240911$$CN$US$US
220473172$22047317$2$F$$20240725$20230301$20240802$PER$$US-SA-2023SA067346$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240802$$CN$US$US
220474134$22047413$4$F$$20240918$20230301$20240925$PER$$NVSC2023US046809$NOVARTIS$$56$YR$$M$Y$$$20240925$$CN$US$US
220474475$22047447$5$F$$20240805$20230301$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-029184$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240807$$HP$US$US
220474632$22047463$2$F$$20230227$20230301$20240720$PER$$NVSC2023US046104$NOVARTIS$$71$YR$$F$Y$$$20240719$$CN$US$US
220474927$22047492$7$F$20230103$20240822$20230301$20240828$EXP$$JP-009507513-2301JPN001062J$MERCK$$74$YR$$F$Y$$$20240828$$MD$JP$JP
220476053$22047605$3$F$$20240730$20230301$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01546$LUPIN$$$$$$Y$$$20240819$$CN$US$US
220476313$22047631$3$F$20230217$20240807$20230301$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01562$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220483073$22048307$3$F$20230201$20230320$20230301$20240925$PER$$US-GSK-US2023AMR030341$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240925$$HP$US$US
220483468$22048346$8$F$20220202$20240904$20230301$20240905$EXP$$BE-ROCHE-3123641$ROCHE$$44$YR$A$F$Y$78$KG$20240905$$MD$BE$BE
220483849$22048384$9$F$$20240711$20230301$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-028762$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240717$$HP$US$US
220484683$22048468$3$F$$20240808$20230301$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01561$LUPIN$$$$$$Y$$$20240828$$PH$US$US
220485062$22048506$2$F$$20240705$20230301$20240710$EXP$$CA-GSK-CA2023021106$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$PH$CA$CA
220485142$22048514$2$F$20220201$20230224$20230301$20240925$EXP$$US-GSK-US2022AMR026283$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
220486155$22048615$5$F$20230105$20240910$20230301$20240918$EXP$$BR-TAKEDA-2023TUS020019$TAKEDA$$37$YR$$F$Y$$$20240918$$CN$BR$BR
220488863$22048886$3$F$$20240827$20230301$20240829$EXP$$US-PFIZER INC-PV202300039333$PFIZER$$75$YR$$M$Y$$$20240829$$CN$US$US
220488954$22048895$4$F$$20240627$20230301$20240701$PER$$US-PFIZER INC-PV202300038143$PFIZER$$52$YR$$F$Y$$$20240701$$CN$US$US
220489043$22048904$3$F$20221201$20240808$20230301$20240812$PER$$US-PFIZER INC-202300080000$PFIZER$$87$YR$$F$Y$34.467$KG$20240812$$CN$US$US
220490355$22049035$5$F$20230215$20240812$20230301$20240816$EXP$$NVSC2023EG044792$NOVARTIS$$15$YR$$M$Y$100$KG$20240816$$CN$EG$EG
220491064$22049106$4$F$20230223$20240729$20230301$20240802$EXP$$BR-EMD Serono-9365722$EMD SERONO INC$$45$YR$A$F$Y$$$20240802$$CN$BR$BR
220491873$22049187$3$F$$20240702$20230301$20240705$PER$$NVSC2023US047255$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
220492516$22049251$6$F$20240301$20240802$20230301$20240810$EXP$$CA-TAKEDA-2023TUS020577$TAKEDA$$67$YR$$M$Y$$$20240810$$CN$CA$CA
220497902$22049790$2$F$$20240702$20230301$20240704$PER$$US-PFIZER INC-PV202300036334$PFIZER$$62$YR$$F$Y$$$20240704$$CN$US$US
220498612$22049861$2$F$$20240904$20230301$20240906$EXP$$CA-PFIZER INC-202300081250$PFIZER$$20$MON$$F$Y$13$KG$20240906$$HP$CA$CA
220501003$22050100$3$F$$20240909$20230301$20240918$PER$$US-SA-2023SA067150$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240918$$MD$US$US
220501632$22050163$2$F$20220101$20240729$20230301$20240806$PER$$US-SA-2023SA066717$SANOFI AVENTIS$$$$A$M$Y$$$20240806$$MD$US$US
220502882$22050288$2$F$20230105$20240723$20230301$20240805$EXP$FR-AFSSAPS-PV2023000190$FR-ELI_LILLY_AND_COMPANY-FR202302011296$ELI LILLY AND CO$$9$YR$C$M$Y$$$20240805$$CN$FR$FR
2205038212$22050382$12$F$$20240918$20230301$20240925$EXP$$CA-ROCHE-3290671$ROCHE$$43$YR$A$F$Y$96$KG$20240925$$HP$CA$CA
220504208$22050420$8$F$20231208$20240830$20230301$20240910$EXP$$CA-TAKEDA-2022TUS063392$TAKEDA$$43$YR$$M$Y$$$20240910$$MD$CA$CA
2205042326$22050423$26$F$20220627$20240814$20230301$20240815$EXP$$NZ-MYLANLABS-2023M1022979$MYLAN$$70$YR$$F$Y$$$20240815$$HP$NZ$NZ
220504292$22050429$2$F$$20240718$20230301$20240726$EXP$$CA-AstraZeneca-2020SF17944$ASTRAZENECA$$68$YR$$F$Y$$$20240726$$MD$CA$
220505823$22050582$3$F$20240130$20240710$20230301$20240723$EXP$$SG-ROCHE-3292679$ROCHE$$74$YR$E$M$Y$$$20240723$$CN$SG$SG
220507206$22050720$6$F$20230101$20240801$20230301$20240805$EXP$$US-TAKEDA-2016BLT007110$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
220509417$22050941$7$F$$20240918$20230301$20240925$PER$$NVSC2023US047641$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
220510043$22051004$3$F$20221207$20230228$20230301$20240715$PER$$NVSC2023US047331$NOVARTIS$$58$YR$$F$Y$$$20240715$$CN$US$US
2205134616$22051346$16$F$20220801$20240808$20230301$20240812$EXP$$JP-TAKEDA-2023TJP002595$TAKEDA$$2$YR$$M$Y$11.5$KG$20240812$$CN$JP$JP
220513616$22051361$6$F$20240305$20240906$20230301$20240911$EXP$$US-INCYTE CORPORATION-2023IN001881$INCYTE$$$$$$Y$$$20240911$$CN$US$US
2205144922$22051449$22$F$20230101$20240724$20230301$20240727$EXP$$CH-ABBVIE-4323294$ABBVIE$$75$YR$$M$Y$96$KG$20240727$$MD$CH$CH
220514905$22051490$5$F$20221111$20240913$20230301$20240923$EXP$$JP-ABBVIE-4324052$ABBVIE$$54$YR$$M$Y$$$20240923$$MD$JP$JP
220515918$22051591$8$F$20221201$20240723$20230301$20240729$EXP$$US-BIOGEN-2023BI01189517$BIOGEN$$57$YR$$M$Y$$$20240729$$CN$US$US
220516253$22051625$3$F$20221101$20230314$20230302$20240927$EXP$$NVSC2023FR044451$NOVARTIS$$64$YR$$F$Y$76$KG$20240927$$MD$FR$FR
220517862$22051786$2$F$$20240806$20230302$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01490$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220520279$22052027$9$F$20230222$20240802$20230302$20240814$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000177$DECIPHERA PHARMACEUTICALS$$68$YR$A$M$Y$$$20240814$$CN$US$US
220520512$22052051$2$F$20230101$20240703$20230302$20240708$EXP$$US-ABBVIE-4325177$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
220521012$22052101$2$F$$20240904$20230302$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-030437$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240905$$HP$US$US
220521904$22052190$4$F$20230202$20240618$20230302$20240709$PER$$CA-TOLMAR, INC.-23CA038810$TOLMAR$$76$YR$$M$Y$$$20240709$$CN$CA$CA
220522693$22052269$3$F$$20240807$20230302$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01547$LUPIN$$$$$$Y$$$20240828$$HP$US$US
220523052$22052305$2$F$$20240619$20230302$20240710$PER$$CA-TOLMAR, INC.-23CA038849$TOLMAR$$$$$M$Y$$$20240710$$CN$CA$CA
220525665$22052566$5$F$20221001$20240918$20230302$20240921$EXP$$DE-ROCHE-3296029$ROCHE$$35$YR$A$F$Y$67$KG$20240921$$MD$DE$DE
220526067$22052606$7$F$20230201$20230725$20230302$20240925$PER$$US-GSK-US2023AMR029357$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240925$$CN$US$US
220526144$22052614$4$F$20230215$20240705$20230302$20240711$EXP$$CA-JNJFOC-20230143916$JOHNSON AND JOHNSON$$12$YR$T$F$Y$38.3$KG$20240711$$HP$CA$CA
220528513$22052851$3$F$20230205$20240918$20230302$20240930$PER$$NVSC2023US042979$NOVARTIS$$36$YR$$F$Y$$$20240930$$CN$US$US
220530443$22053044$3$F$20230220$20230220$20230302$20240805$EXP$$AU-JNJFOC-20230247927$JOHNSON AND JOHNSON$$29$YR$A$F$Y$85$KG$20240806$$HP$AU$AU
220530528$22053052$8$F$20230201$20240829$20230302$20240907$EXP$$US-GSK-US2023029824$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240907$$CN$US$US
220530537$22053053$7$F$$20240922$20230302$20240926$EXP$$US-GSK-US2023AMR029797$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
220530727$22053072$7$F$$20230705$20230302$20240926$EXP$$US-GSK-US2023AMR029968$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
220531403$22053140$3$F$20220101$20240529$20230302$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2023-002826$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240718$$$US$US
220533233$22053323$3$F$$20240708$20230302$20240721$EXP$US-MLMSERVICE-20230213-4100053-1$US-MYLANLABS-2023M1021022$MYLAN$Kim HJ, Brill D, Giuliari GP. Occlusive Cytomegalovirus Panuveitis following Intravitreal Dexamethasone Implant. Retin-Cases-Brief-Rep 2023.$60$YR$$M$Y$$$20240719$$MD$US$US
2205354924$22053549$24$F$20230101$20240717$20230302$20240725$EXP$$CA-CELLTRION INC.-2023CA002183$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
220536732$22053673$2$F$20221201$20240703$20230302$20240705$EXP$FR-AFSSAPS-CF2023000120$FR-GSK-FR2023032894$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$FR$FR
220537928$22053792$8$F$20230204$20240925$20230302$20240927$EXP$$CH-ABBVIE-4321414$ABBVIE$$72$YR$$M$Y$70$KG$20240927$$MD$CH$CH
2205384111$22053841$11$F$20231001$20240724$20230302$20240731$EXP$$CA-ROCHE-3298017$ROCHE$$53$YR$A$F$Y$$$20240731$$CN$CA$CA
220539024$22053902$4$F$20230101$20240723$20230302$20240725$EXP$$US-UCBSA-2023010577$UCB$$$$$M$Y$77$KG$20240725$$HP$US$US
220539073$22053907$3$F$20230110$20240909$20230302$20240909$EXP$$NVSC2023DE047697$NOVARTIS$$45$YR$$M$Y$79$KG$20240909$$MD$DE$DE
220540223$22054022$3$F$$20240807$20230302$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01652$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220542497$22054249$7$F$$20240924$20230302$20240930$PER$$US-PFIZER INC-PV202300036724$PFIZER$$68$YR$$F$Y$$$20240930$$CN$US$US
2205425910$22054259$10$F$20231204$20240913$20230302$20240917$EXP$$US-PFIZER INC-202300083518$PFIZER$$64$YR$$F$Y$$$20240917$$HP$US$US
220542678$22054267$8$F$20230101$20240701$20230302$20240703$EXP$$US-PFIZER INC-PV202300036438$PFIZER$$48$YR$$F$Y$$$20240703$$HP$US$US
220544633$22054463$3$F$20220809$20240814$20230302$20240828$PER$$US-SA-2023SA065407$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240828$$MD$US$US
220544655$22054465$5$F$$20240807$20230302$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-004750$JAZZ$$$$$M$Y$58$KG$20240813$$CN$US$US
220544873$22054487$3$F$$20240827$20230302$20240919$PER$$US-SA-2023SA067800$SANOFI AVENTIS$$$$A$F$Y$70.7$KG$20240919$$MD$US$US
220545312$22054531$2$F$$20240708$20230302$20240715$PER$$US-SA-2023SA068696$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240715$$MD$US$US
220545473$22054547$3$F$20180601$20240709$20230302$20240715$PER$$US-SA-2023SA068489$SANOFI AVENTIS$$$$A$F$Y$$$20240715$$MD$US$US
220545522$22054552$2$F$$20240802$20230302$20240808$EXP$$CA-PFIZER INC-202300087539$PFIZER$$50$YR$$M$Y$$$20240808$$MD$CA$CA
220545566$22054556$6$F$20230214$20240709$20230302$20240715$EXP$$DE-PFIZER INC-202300088504$PFIZER$$65$YR$$M$Y$$$20240715$$HP$DE$DE
220545732$22054573$2$F$20230226$20240701$20230302$20240710$PER$$US-SA-2023SA069123$SANOFI AVENTIS$$74$YR$E$M$Y$96.6$KG$20240710$$MD$US$US
220546393$22054639$3$F$$20240718$20230302$20240727$PER$$US-SA-2023SA069559$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240727$$MD$US$US
220549235$22054923$5$F$20231212$20240712$20230302$20240716$30DAY$$US-GSK-US2023029307$GLAXOSMITHKLINE$$36$YR$$F$Y$$$20240716$$HP$US$US
220551474$22055147$4$F$20230201$20230320$20230302$20240925$EXP$$US-GSK-US2023AMR032606$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2205528513$22055285$13$F$$20240923$20230302$20240927$EXP$$US-PFIZER INC-PV202300039395$PFIZER$$80$YR$$F$Y$$$20240927$$MD$US$US
220553092$22055309$2$F$$20240805$20230302$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01656$LUPIN$$$$$$Y$$$20240822$$CN$US$US
2205535713$22055357$13$F$$20240924$20230302$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-030269$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240927$$HP$US$US
220553933$22055393$3$F$$20240722$20230302$20240725$EXP$$ES-PFIZER INC-202300083755$PFIZER$$$$$M$Y$$$20240725$$MD$ES$ES
220554873$22055487$3$F$$20240808$20230302$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01630$LUPIN$$$$$$Y$$$20240903$$PH$US$US
220555333$22055533$3$F$$20230227$20230302$20240807$PER$$NVSC2023US046903$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
220556213$22055621$3$F$20220429$20240819$20230302$20240821$EXP$$US-TAKEDA-2022TUS017351$TAKEDA$$45$YR$$F$Y$$$20240821$$HP$US$US
220556292$22055629$2$F$20231001$20240701$20230302$20240708$EXP$$US-GSK-US2023032642$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$HP$US$US
220556622$22055662$2$F$20230201$20240731$20230302$20240802$EXP$$US-PFIZER INC-202300089938$PFIZER$$65$YR$$M$Y$$$20240802$$HP$US$US
220559892$22055989$2$F$20230131$20240821$20230302$20240828$EXP$DE-PEI-CADR2023315030$DE-009507513-2302DEU008950$MERCK$$80$YR$$F$Y$75$KG$20240828$$CN$DE$DE
220560615$22056061$5$F$20230101$20240708$20230302$20240712$EXP$$JP-009507513-2302JPN003175J$MERCK$$69$YR$$M$Y$$$20240712$$MD$JP$JP
220562563$22056256$3$F$$20230301$20230302$20240814$PER$$NVSC2023US048371$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
220563839$22056383$9$F$20180701$20240912$20230302$20240921$EXP$$JP-ABBVIE-19P-087-2692593-00$ABBVIE$$62$YR$$M$Y$87$KG$20240921$$MD$JP$JP
220565237$22056523$7$F$$20240620$20230302$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-003827$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
220566613$22056661$3$F$$20230228$20230302$20240906$EXP$$JP-NOVOPROD-1026829$NOVO NORDISK$$55$YR$$F$Y$80$KG$20240906$$HP$JP$JP
220567763$22056776$3$F$$20240628$20230303$20240702$EXP$$JP-TAKEDA-2023TJP002774$TAKEDA$$53$YR$$F$Y$$$20240702$$MD$JP$JP
220567943$22056794$3$F$20240614$20240614$20230303$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000544$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240709$$CN$US$US
220569015$22056901$5$F$20220101$20240917$20230303$20240926$EXP$$CA-CELLTRION INC.-2022CA021203$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
220569724$22056972$4$F$$20240812$20230303$20240820$EXP$$CA-APOTEX-2023AP004024$APOTEX$$65$YR$$F$Y$34$KG$20240820$$HP$CA$CA
2205703914$22057039$14$F$20220101$20240830$20230303$20240904$EXP$$CA-TAKEDA-2022TUS063257$TAKEDA$$$$$F$Y$24$KG$20240904$$HP$CA$CA
220571716$22057171$6$F$20230201$20240821$20230303$20240912$PER$$CA-TOLMAR, INC.-23CA038857$TOLMAR$$85$YR$$M$Y$$$20240912$$CN$CA$CA
220571746$22057174$6$F$20230206$20240809$20230303$20240904$PER$$CA-TOLMAR, INC.-23CA038874$TOLMAR$$77$YR$$M$Y$$$20240904$$CN$CA$CA
220574472$22057447$2$F$20221201$20240813$20230303$20240822$EXP$$US-ROCHE-3291419$ROCHE$$52$YR$A$M$Y$127.01$KG$20240822$$CN$US$US
220574753$22057475$3$F$$20240628$20230303$20240702$EXP$$JP-TAKEDA-2023TJP002783$TAKEDA$$40$YR$$F$Y$$$20240702$$MD$JP$JP
220575382$22057538$2$F$$20240727$20230303$20240811$EXP$$US-LUPIN PHARMACEUTICALS INC.-2023-01667$LUPIN$$$$$$Y$$$20240811$$CN$US$US
220575795$22057579$5$F$20220628$20240913$20230303$20240917$EXP$$US-TAKEDA-2022TUS062719$TAKEDA$$47$YR$$F$Y$154.19$KG$20240917$$HP$US$US
220576233$22057623$3$F$$20240716$20230303$20240718$EXP$$PT-ROCHE-3276718$ROCHE$de Sousa C, Figueiredo CR, Ventura S, Almeida M and Martins LS. Late onset of pneumocystis jirovecii pneumonia in kidney transplant: How long is too long in opportunistic infection prophylaxis. Doi: 10.32932/pjnh.2023.01.217.. Portuguese journal of nephrology and hypertension 2022;36 (4):233-6.$45$YR$A$M$Y$$$20240718$$HP$PT$PT
220576302$22057630$2$F$$20230228$20230303$20240819$EXP$$US-RECORDATI-2023001198$RECORDATI$$$$$$Y$$$20240819$$HP$US$US
220577433$22057743$3$F$20230224$20240912$20230303$20240913$EXP$$NVSC2023SA048672$NOVARTIS$$2$YR$$F$Y$6$KG$20240913$$HP$SA$SA
220577533$22057753$3$F$$20240807$20230303$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01570$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220577683$22057768$3$F$$20240807$20230303$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01607$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220577973$22057797$3$F$20230201$20240807$20230303$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01637$LUPIN$$$$$$Y$$$20240828$$CN$US$US
2205795917$22057959$17$F$20230329$20240912$20230303$20240918$EXP$$CO-TAKEDA-2023TUS018632$TAKEDA$$33$YR$$F$Y$52.3$KG$20240918$$CN$CO$CO
220584054$22058405$4$F$$20240730$20230303$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01629$LUPIN$$$$$$Y$$$20240821$$CN$US$US
220587455$22058745$5$F$$20240801$20230303$20240806$EXP$$CN-ROCHE-3297525$ROCHE$$69$YR$E$M$Y$$$20240806$$MD$CN$CN
220589093$22058909$3$F$$20230228$20230303$20240712$PER$$NVSC2023US048135$NOVARTIS$$$$$M$Y$$$20240712$$CN$US$US
220589854$22058985$4$F$20231101$20240703$20230303$20240718$EXP$$US-THERATECHNOLOGIES INC.-2022-THE-TES-000420$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
220589862$22058986$2$F$$20230301$20230303$20240819$EXP$$US-RECORDATI-2023001197$RECORDATI$$$$$$Y$$$20240819$$CN$US$US
220590042$22059004$2$F$$20240726$20230303$20240730$PER$$US-PFIZER INC-PV202300038033$PFIZER$$60$YR$$M$Y$$$20240730$$CN$US$US
220590103$22059010$3$F$20230101$20240723$20230303$20240729$PER$$US-PFIZER INC-PV202300040581$PFIZER$$73$YR$$F$Y$55.34$KG$20240729$$CN$US$US
2205916828$22059168$28$F$20240309$20240912$20230303$20240918$EXP$$US-TAKEDA-2023TUS008345$TAKEDA$$61$YR$$F$Y$107$KG$20240918$$HP$US$US
220593434$22059343$4$F$20220513$20240701$20230303$20240703$PER$$US-TAKEDA-2023TUS019448$TAKEDA$$36$YR$$F$Y$65$KG$20240703$$HP$US$US
220594485$22059448$5$F$20220606$20240807$20230303$20240813$EXP$$CA-TAKEDA-2022TUS033066$TAKEDA$$44$YR$$M$Y$$$20240813$$HP$CA$CA
220597032$22059703$2$F$$20240629$20230303$20240708$PER$$US-SA-2023SA070223$SANOFI AVENTIS$$$$C$F$Y$$$20240708$$MD$US$US
220597632$22059763$2$F$$20240906$20230303$20240917$PER$$US-SA-2023SA071312$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
220597842$22059784$2$F$20230218$20240711$20230303$20240717$EXP$$US-SA-2023SA070171$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240717$$MD$US$US
220598024$22059802$4$F$$20240727$20230303$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01634$LUPIN$$$$$$Y$$$20240817$$CN$US$US
220602453$22060245$3$F$$20240805$20230303$20240806$PER$$US-PFIZER INC-PV202300038158$PFIZER$$88$YR$$F$Y$$$20240806$$CN$US$US
220602474$22060247$4$F$$20240730$20230303$20240805$PER$$US-PFIZER INC-PV202200081499$PFIZER$$71$YR$$F$Y$$$20240805$$CN$US$US
2206052015$22060520$15$F$20230201$20240814$20230303$20240820$EXP$$CA-UCBSA-2023005961$UCB$$28$YR$$F$Y$$$20240820$$CN$CA$CA
220605764$22060576$4$F$20220510$20240830$20230303$20240904$EXP$$JP-DSJP-DSJ-2023-101558$DAIICHI$Hasegawa Y, Kanai A, Terashita C, Nakayama Y, Mizuno Y. EP-0735 Review in cases of administration of Trastuzumab Deruxtecan for advanced recurrent breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;361$58$YR$$F$Y$59.7$KG$20240904$$MD$JP$JP
220610029$22061002$9$F$$20240913$20230303$20240919$EXP$CA-JAZZ PHARMACEUTICALS-2023-CA-004886$CA-JAZZ PHARMACEUTICALS-2023-CA-004886$JAZZ$$$$$M$Y$$$20240919$$MD$CA$CA
220610134$22061013$4$F$20221101$20240830$20230303$20240906$EXP$$US-BAUSCHBL-2023BNL001583$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240906$$CN$US$US
220610354$22061035$4$F$20210322$20240724$20230303$20240725$PER$$US-GILEAD-2023-0618802$GILEAD$$26$YR$A$F$Y$$$20240725$$LW$US$US
220611124$22061112$4$F$$20240717$20230303$20240722$PER$$US-GILEAD-2023-0618805$GILEAD$$$$A$M$Y$$$20240719$$LW$US$US
220613672$22061367$2$F$20210917$20240808$20230304$20240813$EXP$$IL-ABBVIE-4132246$ABBVIE$$84$YR$$F$Y$63$KG$20240813$$MD$IL$IL
2206140115$22061401$15$F$20220401$20240814$20230304$20240821$EXP$$CA-CELLTRION INC.-2022CA009479$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
220614092$22061409$2$F$20230301$20230301$20230304$20240715$PER$$NVSC2023US050197$NOVARTIS$$56$YR$$F$Y$$$20240715$$CN$US$US
220615025$22061502$5$F$20220816$20240701$20230304$20240703$EXP$$JP-ABBVIE-4135262$ABBVIE$Shirakura D, Kunisaki R, Kurimura K, Haruyama S, Nakamori Y, Matsubayashi M et al. O9-2 A case of Cerebellar haemorrhage neonatal thought to be caused by impaired vitamin K absorption due to the short intestine of a mother with Crohn^s disease. The 14th Annual Meeting of Japanese Society for Inflammatory Bowel Disease. 2023:139-139.; Shirakura D, Kunisaki R, Kurimura K, et al. O9-2 A case of Cerebellar haemorrhage neonatal thought to be caused by impaired vitamin K absorption due to the short...$0$YR$$M$Y$4.188$KG$20240703$$MD$JP$JP
220615064$22061506$4$F$20170427$20240829$20230304$20240914$EXP$$BE-ABBVIE-20K-013-3350846-00$ABBVIE$$69$YR$$M$Y$$$20240914$$HP$BE$BE
2206155310$22061553$10$F$20221011$20240724$20230304$20240801$EXP$$CA-CELLTRION INC.-2022CA017397$CELLTRION$$$$$$Y$$$20240801$$MD$CA$CA
220616413$22061641$3$F$20210601$20240627$20230304$20240701$EXP$$JP-ABBVIE-22K-087-4268124-00$ABBVIE$$52$YR$$F$Y$69$KG$20240701$$MD$JP$JP
220617442$22061744$2$F$20200709$20240704$20230304$20240708$EXP$$FR-ABBVIE-21K-056-4019055-00$ABBVIE$$81$YR$$M$Y$98$KG$20240708$$MD$FR$FR
220618122$22061812$2$F$$20230224$20230304$20240829$PER$$NVSC2023US045086$NOVARTIS$$$$$F$Y$$$20240829$$HP$US$US
220618233$22061823$3$F$20230106$20240826$20230304$20240902$EXP$$DE-ABBVIE-4274042$ABBVIE$$41$YR$$M$Y$104$KG$20240902$$HP$DE$DE
2206193114$22061931$14$F$20240601$20240703$20230304$20240925$EXP$$US-GSK-US2023AMR033313$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
220619962$22061996$2$F$20221001$20230228$20230304$20240727$EXP$$NVSC2023US047571$NOVARTIS$$82$YR$$F$Y$$$20240727$$CN$US$US
220620519$22062051$9$F$20220421$20240806$20230304$20240813$EXP$$CA-CELLTRION INC.-2022CA008484$CELLTRION$$$$$$Y$$$20240813$$HP$CA$CA
2206217110$22062171$10$F$20221011$20240828$20230304$20240909$EXP$$US-UCBSA-2022059240$UCB$$10$YR$$F$Y$$$20240909$$CN$US$US
220622703$22062270$3$F$$20240822$20230305$20240827$PER$$NVSC2023US049906$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
2206227210$22062272$10$F$20230222$20240711$20230305$20240715$EXP$$NVSC2023US048999$NOVARTIS$$58$YR$$F$Y$$$20240715$$CN$US$US
220625703$22062570$3$F$20220101$20240910$20230306$20240916$EXP$$US-AMGEN-USASP2023035750$AMGEN$$77$YR$E$F$Y$$$20240916$$CN$US$US
220625977$22062597$7$F$20230724$20240923$20230306$20240927$EXP$$US-TAKEDA-US202006116$TAKEDA$$48$YR$$F$Y$100$KG$20240927$$MD$US$US
220627473$22062747$3$F$20230201$20240815$20230306$20240824$EXP$$BR-CELLTRION INC.-2023BR004549$CELLTRION$$$$$$Y$$$20240824$$CN$BR$BR
220627723$22062772$3$F$$20240716$20230306$20240717$EXP$$US-TAKEDA-US201705264$TAKEDA$$$$$M$Y$$$20240717$$CN$US$US
220628513$22062851$3$F$$20240902$20230306$20240916$EXP$$BR-CELLTRION INC.-2023BR004657$CELLTRION$$$$$$Y$$$20240916$$CN$BR$BR
220629833$22062983$3$F$20230404$20240809$20230306$20240823$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000188$DECIPHERA PHARMACEUTICALS$$66$YR$A$M$Y$$$20240823$$CN$US$US
220629953$22062995$3$F$$20240812$20230306$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000583$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
2206308412$22063084$12$F$20220324$20240828$20230306$20240903$EXP$$DE-ROCHE-3140387$ROCHE$$66$YR$E$M$Y$66$KG$20240903$$MD$DE$DE
220631513$22063151$3$F$20230216$20240910$20230306$20240918$EXP$$BR-CELLTRION INC.-2023BR004551$CELLTRION$$$$$$Y$$$20240918$$CN$BR$BR
220631627$22063162$7$F$20230224$20240826$20230306$20240830$EXP$$US-TAKEDA-2023TUS020864$TAKEDA$$40$YR$$F$Y$142$KG$20240830$$HP$US$US
220631714$22063171$4$F$$20240826$20230306$20240829$EXP$$US-TAKEDA-2023TUS022675$TAKEDA$$$$$M$Y$$$20240829$$MD$US$US
220632072$22063207$2$F$20230212$20240902$20230306$20240911$EXP$$BR-CELLTRION INC.-2023BR004557$CELLTRION$$$$$$Y$$$20240911$$CN$BR$BR
220632804$22063280$4$F$$20240730$20230306$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01643$LUPIN$$$$$$Y$$$20240830$$CN$US$US
220632906$22063290$6$F$20230417$20240722$20230306$20240725$EXP$$CA-TAKEDA-2022TUS064568$TAKEDA$$25$YR$$M$Y$$$20240725$$MD$CA$CA
220634943$22063494$3$F$$20240808$20230306$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01646$LUPIN$$$$$$Y$$$20240829$$PH$US$US
220636788$22063678$8$F$$20240829$20230306$20240903$EXP$$US-TAKEDA-2023TUS022402$TAKEDA$$$$$F$Y$68$KG$20240903$$MD$US$US
220637122$22063712$2$F$$20240806$20230306$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01670$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220637453$22063745$3$F$20221201$20240828$20230306$20240905$EXP$$US-BIOGEN-2023BI01190696$BIOGEN$$62$YR$$M$Y$$$20240905$$CN$US$US
220637595$22063759$5$F$$20240917$20230306$20240926$EXP$$US-ROCHE-3296841$ROCHE$$$$E$F$Y$$$20240927$$CN$US$US
2206380011$22063800$11$F$$20240812$20230306$20240824$EXP$$GB-ROCHE-3247867$ROCHE$$$$E$F$Y$$$20240824$$CN$GB$GB
220638173$22063817$3$F$$20240628$20230306$20240710$EXP$CA-MHPD-001024306$CA-Accord-302702$ACCORD$$15$YR$T$F$Y$54$KG$20240710$$HP$CA$CA
220638577$22063857$7$F$20230212$20240812$20230306$20240820$EXP$$CA-ROCHE-3297017$ROCHE$$37$YR$A$M$Y$$$20240820$$CN$CA$CA
220639045$22063904$5$F$$20240206$20230306$20240808$EXP$$NVSC2023US047157$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
220639274$22063927$4$F$$20240716$20230306$20240726$EXP$$PL-AUROBINDO-AUR-APL-2023-009586$AUROBINDO$J.Woro?, Siwek M.. Rhabdomyolysis as a result of doxylamine interaction with other medications. Practical Medicine: Psychiatry. 2023;90 (1):51-52$64$YR$$F$Y$$$20240726$$MD$PL$PL
220639673$22063967$3$F$$20240807$20230306$20240809$PER$$NVSC2023US050469$NOVARTIS$$$$$F$Y$$$20240809$$HP$US$US
220640103$22064010$3$F$20211001$20240712$20230306$20240722$EXP$$DE-CELLTRION INC.-2023DE004341$CELLTRION$$$$$$Y$$$20240722$$MD$DE$DE
220641024$22064102$4$F$$20240916$20230306$20240920$PER$$NVSC2023US049477$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
220641283$22064128$3$F$20230127$20240715$20230306$20240718$EXP$$GR-009507513-2302GRC005714$MERCK$$67$YR$$M$Y$92$KG$20240718$$MD$GR$GR
220641536$22064153$6$F$$20240918$20230306$20240930$PER$$NVSC2023US051126$NOVARTIS$$$$$F$Y$93$KG$20240930$$CN$US$US
220641863$22064186$3$F$$20240903$20230306$20240912$EXP$$BR-CELLTRION INC.-2023BR004573$CELLTRION$$$$$$Y$$$20240912$$CN$BR$BR
220642433$22064243$3$F$$20230226$20230306$20240815$EXP$$PH-OTSUKA-2023_005308$OTSUKA$$$$$F$Y$$$20240815$$CN$PH$PH
220642972$22064297$2$F$$20240910$20230306$20240920$EXP$$CA-APOTEX-2023AP004383$APOTEX$$$$$M$Y$$$20240920$$HP$CA$CA
220643042$22064304$2$F$20220101$20240715$20230306$20240716$EXP$$CA-PFIZER INC-202201332303$PFIZER$$92$YR$$M$Y$$$20240716$$CN$CA$CA
220644912$22064491$2$F$20230101$20240913$20230306$20240918$EXP$$US-VIIV HEALTHCARE LIMITED-US2023AMR032013$VIIV$$$$$M$Y$$$20240918$$CN$US$US
220645874$22064587$4$F$20230228$20240813$20230306$20240819$EXP$$CA-ROCHE-3300724$ROCHE$$33$YR$A$M$Y$$$20240819$$CN$CA$CA
220649697$22064969$7$F$$20240909$20230306$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-031723$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240911$$CN$US$US
220650113$22065011$3$F$$20240730$20230306$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01706$LUPIN$$$$$$Y$$$20240817$$CN$US$US
220650645$22065064$5$F$20230704$20240920$20230306$20240925$EXP$$GB-MYLANLABS-2023M1023116$MYLAN$$56$YR$$M$Y$$$20240925$$MD$GB$GB
220651063$22065106$3$F$$20230307$20230306$20240930$PER$$NVSC2023US047842$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
220652602$22065260$2$F$20200101$20240905$20230306$20240913$PER$$US-SA-2023SA071973$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240913$$HP$US$US
220654715$22065471$5$F$20230314$20240829$20230306$20240903$EXP$$CA-TAKEDA-2023TUS022103$TAKEDA$$44$YR$$F$Y$$$20240903$$HP$CA$CA
220656442$22065644$2$F$$20240806$20230306$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01669$LUPIN$$$$$$Y$$$20240902$$CN$US$US
220656846$22065684$6$F$$20240724$20230306$20240805$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-032579$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240806$$HP$CA$CA
220657353$22065735$3$F$$20240712$20230306$20240717$PER$$NVSC2023US047066$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
220657372$22065737$2$F$$20240805$20230306$20240812$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-00231$AMNEAL$$$$$F$Y$$$20240812$$CN$US$US
2206576110$22065761$10$F$20240201$20240910$20230306$20240912$EXP$$US-PFIZER INC-PV202300041395$PFIZER$$92$YR$$M$Y$$$20240912$$CN$US$US
220657746$22065774$6$F$20230101$20240718$20230306$20240723$PER$$US-PFIZER INC-202300092599$PFIZER$$34$YR$$M$Y$$$20240723$$HP$US$US
220658584$22065858$4$F$20221130$20240813$20230306$20240820$EXP$$JP-ABBVIE-4325985$ABBVIE$$74$YR$$M$Y$$$20240820$$MD$JP$JP
220660016$22066001$6$F$$20240925$20230306$20240930$EXP$$US-PAREXEL-2021-KAM-US003331$TAKEDA$$$$$F$Y$45$KG$20240930$$MD$US$US
220661013$22066101$3$F$$20240703$20230306$20240709$EXP$$SK-MYLANLABS-2023M1014006$MYLAN$Dobsinska V,  Svec P, Horakova J, Ostro R, Pozdechova M, Bodova I, et al. Adult patient with chronic inflammatory bowel disease and inborn error of immunity: hematopoietic stem cell transplantation as an option for curative treatment.. PEDIATRIA PRE PRAX. 2022;23(6):242-246$10$YR$$M$Y$$$20240709$$MD$SK$SK
220661705$22066170$5$F$20230101$20240828$20230306$20240830$PER$$NVSC2023US047470$NOVARTIS$$36$YR$$F$Y$$$20240830$$CN$US$US
220661745$22066174$5$F$$20240719$20230306$20240724$EXP$$BG-TAKEDA-2022TUS000487$TAKEDA$$$$$F$Y$$$20240724$$CN$BG$BG
220663122$22066312$2$F$$20240724$20230306$20240726$EXP$$CA-TAKEDA-2023TUS023286$TAKEDA$$$$$F$Y$$$20240726$$MD$CA$CA
220665539$22066553$9$F$20230215$20240718$20230306$20240722$EXP$$US-TAKEDA-2023TUS023062$TAKEDA$$22$YR$$M$Y$$$20240722$$MD$US$US
220665596$22066559$6$F$20230207$20240830$20230306$20240904$PER$$NVSC2023US048116$NOVARTIS$$66$YR$$F$Y$$$20240904$$CN$US$US
220670623$22067062$3$F$$20240826$20230306$20240902$EXP$$US-BIOGEN-2023BI01191104$BIOGEN$$$$$F$Y$$$20240902$$CN$US$US
220670892$22067089$2$F$$20240610$20230306$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000585$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
220672207$22067220$7$F$20230105$20240912$20230307$20240920$EXP$$BR-CELLTRION INC.-2023BR004748$CELLTRION$$$$$$Y$$$20240920$$CN$BR$BR
220672503$22067250$3$F$20230128$20240903$20230307$20240911$EXP$$BR-CELLTRION INC.-2023BR004781$CELLTRION$$$$$$Y$$$20240911$$CN$BR$BR
220672602$22067260$2$F$$20240903$20230307$20240911$EXP$$BR-CELLTRION INC.-2023BR004656$CELLTRION$$$$$$Y$$$20240911$$CN$BR$BR
220672877$22067287$7$F$20230101$20240709$20230307$20240730$PER$$CA-TOLMAR, INC.-23CA038942$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
220673472$22067347$2$F$20230225$20240718$20230307$20240719$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000150$PAREXEL$$$$$$Y$$$20240719$$MD$US$US
220674605$22067460$5$F$20190901$20240802$20230307$20240809$EXP$$US-SA-2023SA073211$SANOFI AVENTIS$$74$YR$E$F$Y$95$KG$20240809$$MD$US$US
220675165$22067516$5$F$20230816$20240628$20230307$20240702$EXP$$US-TAKEDA-2022TUS022952$TAKEDA$$18$YR$$M$Y$$$20240702$$MD$US$US
220675942$22067594$2$F$20230303$20240710$20230307$20240715$EXP$$TW-ABBVIE-4329253$ABBVIE$$31$YR$$F$Y$37$KG$20240715$$CN$TW$TW
2206761410$22067614$10$F$20200827$20240910$20230307$20240918$EXP$$CA-CELLTRION INC.-2022CA018979$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
220680904$22068090$4$F$$20240805$20230307$20240827$PER$$AU-TOLMAR, INC.-23AU038915$TOLMAR$$$$$M$Y$$$20240827$$HP$AU$AU
220681483$22068148$3$F$$20240903$20230307$20240912$EXP$$BR-CELLTRION INC.-2023BR004637$CELLTRION$$$$$$Y$$$20240912$$CN$BR$BR
220685233$22068523$3$F$20220912$20240627$20230307$20240704$EXP$$JP-009507513-2302JPN003795J$MERCK$$77$YR$$M$Y$$$20240704$$MD$JP$JP
2206867312$22068673$12$F$20230101$20240913$20230307$20240926$EXP$$US-DSJP-DSU-2023-108790$DAIICHI$$$$$F$Y$85$KG$20240926$$CN$US$US
220689223$22068922$3$F$20230201$20240806$20230307$20240808$PER$$US-GBT-020527$PFIZER$$21$YR$$F$Y$63$KG$20240808$$HP$US$US
220691152$22069115$2$F$$20240814$20230307$20240827$EXP$$US-AMNEAL PHARMACEUTICALS-2022-AMRX-01002$AMNEAL$$$$$F$Y$101.59$KG$20240827$$CN$US$US
220691437$22069143$7$F$20230227$20240917$20230307$20240919$EXP$$CA-ROCHE-3301757$ROCHE$$43$YR$A$M$Y$$$20240919$$CN$CA$CA
220691889$22069188$9$F$$20240904$20230307$20240906$EXP$$US-PFIZER INC-PV202300040101$PFIZER$$76$YR$$F$Y$72.562$KG$20240906$$CN$US$US
220693333$22069333$3$F$$20240715$20230307$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2022-AMRX-02049$AMNEAL$$$$$M$Y$$$20240720$$CN$US$US
2206938518$22069385$18$F$20230201$20240808$20230307$20240814$EXP$$US-GSK-US2023AMR033314$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$US$US
220695433$22069543$3$F$20240814$20240828$20230307$20240912$PER$$US-SA-2023SA072716$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240912$$MD$US$US
220696032$22069603$2$F$20240709$20240822$20230307$20240905$PER$$US-SA-2023SA072912$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240905$$MD$US$US
220698172$22069817$2$F$$20240903$20230307$20240912$EXP$$BR-CELLTRION INC.-2023BR004804$CELLTRION$$$$$$Y$$$20240912$$CN$BR$BR
2207019711$22070197$11$F$20231001$20240831$20230307$20240920$EXP$$US-SA-2023SA074485$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240920$$MD$US$US
2207027211$22070272$11$F$20200305$20240920$20230307$20240926$EXP$$CO-TAKEDA-CO202005012$TAKEDA$$24$YR$$F$Y$76$KG$20240926$$CN$CO$CO
220704118$22070411$8$F$$20240705$20230307$20240708$EXP$$NVSC2023US051070$NOVARTIS$$$$$F$Y$$$20240708$$CN$US$US
220704758$22070475$8$F$20230204$20240701$20230307$20240705$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-004996$JAZZ$$34$YR$$M$Y$$$20240705$$MD$US$US
2207084310$22070843$10$F$20230130$20240918$20230307$20240928$EXP$$JP-BAXTER-2023BAX014458$BAXTER$$37$YR$$M$Y$55.4$KG$20240928$$HP$JP$JP
220708855$22070885$5$F$$20240828$20230307$20240904$PER$$US-PFIZER INC-PV202300039619$PFIZER$$67$YR$$F$Y$90.26$KG$20240904$$HP$US$US
2207089710$22070897$10$F$20210405$20240912$20230307$20240918$EXP$$US-TAKEDA-US202028577$TAKEDA$$14$YR$$M$Y$58$KG$20240918$$HP$US$US
220715285$22071528$5$F$$20240826$20230307$20240903$EXP$$SE-MYLANLABS-2023M1023272$MYLAN$Krstic A, Rezayee F, Saft L, Hammarsjo A, Svenberg P, Barbany G.. Case Report: Whole genome sequencing identifies CCDC88C as a novel JAK2 fusion partner in pediatric T-cell acute lymphoblastic leukemia. Front Pediatr. 2023;10:1082986$7$YR$$M$Y$$$20240903$$HP$SE$SE
220715453$22071545$3$F$20230101$20240820$20230307$20240827$PER$$US-PFIZER INC-PV202300019578$PFIZER$$52$YR$$F$Y$$$20240827$$HP$US$US
220716245$22071624$5$F$$20240726$20230307$20240731$PER$$US-PFIZER INC-PV202300043772$PFIZER$$50$YR$$M$Y$$$20240731$$CN$US$US
220717794$22071779$4$F$$20240729$20230307$20240805$EXP$$JP-JNJFOC-20230313697$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240805$$MD$JP$JP
220718062$22071806$2$F$$20240903$20230307$20240913$EXP$$BR-CELLTRION INC.-2023BR004808$CELLTRION$$$$$$Y$$$20240913$$CN$BR$BR
220718088$22071808$8$F$20210111$20240806$20230307$20240814$EXP$$CA-CELLTRION INC.-2020CA031761$CELLTRION$$$$$$Y$$$20240814$$MD$CA$CA
220718682$22071868$2$F$$20240808$20230307$20240809$PER$$US-BEH-2023156089$CSL BEHRING$$$$A$M$Y$$$20240809$$CN$US$US
220718875$22071887$5$F$20230101$20240301$20230307$20240813$EXP$$NVSC2022GB204733$NOVARTIS$$$$A$F$Y$$$20240813$$CN$GB$GB
220720242$22072024$2$F$$20240904$20230308$20240912$EXP$$BR-CELLTRION INC.-2023BR004907$CELLTRION$$$$$$Y$$$20240912$$CN$BR$BR
220720342$22072034$2$F$20230227$20240904$20230308$20240912$EXP$$BR-CELLTRION INC.-2023BR004803$CELLTRION$$$$$$Y$$$20240912$$CN$BR$BR
220720712$22072071$2$F$$20240808$20230308$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01672$LUPIN$$$$$$Y$$$20240829$$CN$US$US
220720922$22072092$2$F$20230202$20240906$20230308$20240916$EXP$$BR-CELLTRION INC.-2023BR004840$CELLTRION$$$$$$Y$$$20240916$$CN$BR$BR
220722313$22072231$3$F$$20240809$20230308$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01696$LUPIN$$$$$$Y$$$20240829$$CN$US$US
220722383$22072238$3$F$$20240808$20230308$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01690$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220725512$22072551$2$F$20230101$20240711$20230308$20240715$30DAY$$US-GSK-US2023033835$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
220725723$22072572$3$F$$20240726$20230308$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01708$LUPIN$$$$$$Y$$$20240822$$CN$US$US
2207265211$22072652$11$F$20220927$20240920$20230308$20240930$EXP$$CA-CELLTRION INC.-2022CA016999$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
220726633$22072663$3$F$$20240806$20230308$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01710$LUPIN$$$$$$Y$$$20240822$$PH$US$US
220726945$22072694$5$F$20230227$20240830$20230308$20240906$EXP$$CA-GSK-CA2023032697$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$HP$CA$CA
2207282917$22072829$17$F$20220101$20240711$20230308$20240720$EXP$$CA-CELLTRION INC.-2022CA006534$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
220728805$22072880$5$F$$20230831$20230308$20240710$PER$$IN-ROCHE-3299718$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$IN$IN
220728913$22072891$3$F$20240101$20240923$20230308$20240924$EXP$$US-TAKEDA-2023TUS022463$TAKEDA$$43$YR$$M$Y$102$KG$20240924$$MD$US$US
2207293013$22072930$13$F$20200801$20240917$20230308$20240923$EXP$$CA-TAKEDA-CA202024935$TAKEDA$$55$YR$$F$Y$$$20240923$$HP$CA$CA
220729312$22072931$2$F$20220101$20240827$20230308$20240830$EXP$$US-ABBVIE-4247544$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
220729515$22072951$5$F$$20240812$20230308$20240821$EXP$$GB-JNJFOC-20230307149$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$MD$GB$GB
220730433$22073043$3$F$$20240729$20230308$20240805$EXP$$US-AMGEN-USASP2023037365$AMGEN$$80$YR$E$F$Y$$$20240805$$MD$US$US
220730567$22073056$7$F$$20240812$20230308$20240823$EXP$$GB-JNJFOC-20230307064$JOHNSON AND JOHNSON$$2$DEC$$M$Y$$$20240823$$MD$GB$GB
220731925$22073192$5$F$$20240812$20230308$20240821$EXP$$GB-JNJFOC-20230304549$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$MD$GB$GB
220732464$22073246$4$F$20210912$20240924$20230308$20240930$EXP$$JP-ABBVIE-4329751$ABBVIE$$56$YR$$F$Y$52$KG$20240929$$MD$JP$JP
2207331116$22073311$16$F$20221001$20240729$20230308$20240812$EXP$$US-UCBSA-2022065522$UCB$$33$YR$$F$Y$58.5$KG$20240812$$CN$US$US
220733234$22073323$4$F$$20240702$20230308$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-033059$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240703$$HP$US$US
2207339411$22073394$11$F$20230301$20230626$20230308$20240925$EXP$$US-GSK-US2023AMR035356$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
220733995$22073399$5$F$20220501$20240719$20230308$20240726$EXP$$US-GSK-US2022AMR051646$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
220734093$22073409$3$F$$20240909$20230308$20240916$EXP$$CA-GSK-CA2023033319$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$CA$CA
220735214$22073521$4$F$$20230310$20230308$20240905$EXP$$NVSC2023GB052487$NOVARTIS$$$$$$Y$$$20240905$$MD$GB$GB
220735235$22073523$5$F$20230214$20240322$20230308$20240814$EXP$$NVSC2023BR050232$NOVARTIS$$62$YR$$F$Y$70$KG$20240814$$CN$BR$BR
220735294$22073529$4$F$20210826$20240718$20230308$20240726$EXP$$JP-ROCHE-3077653$ROCHE$$74$YR$E$M$Y$$$20240726$$MD$JP$JP
220735873$22073587$3$F$20230101$20240626$20230308$20240702$EXP$$US-ABBVIE-4331348$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
220735985$22073598$5$F$20230101$20240913$20230308$20240919$EXP$$CA-PFIZER INC-202300092099$PFIZER$$22$YR$$F$Y$$$20240919$$HP$CA$CA
220737002$22073700$2$F$20230101$20240821$20230308$20240823$EXP$$CA-PFIZER INC-2021839775$PFIZER$$82$YR$$F$Y$$$20240823$$CN$CA$CA
220737125$22073712$5$F$20230131$20240703$20230308$20240709$EXP$$IN-PFIZER INC-PV202300042631$PFIZER$$46$YR$$F$Y$$$20240709$$CN$IN$IN
220739362$22073936$2$F$$20240801$20230308$20240812$EXP$$NVSC2023FR050190$NOVARTIS$$$$A$M$Y$$$20240812$$MD$FR$FR
220739393$22073939$3$F$$20240819$20230308$20240828$EXP$$NVSC2023ES049325$NOVARTIS$Margarit-Soler A, Deya-Martinez A, Canizales J, Vlagea A, Garcia-Garcia A, Marsal J. Case report: challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary imune regulatory disorders. FRONTIERS IN IMMUNOLOGY. 2022;13:1-10$21$YR$$M$Y$$$20240828$$HP$ES$ES
220740432$22074043$2$F$20230303$20240903$20230308$20240905$EXP$$CA-ROCHE-3302604$ROCHE$$28$YR$A$F$Y$$$20240905$$CN$CA$CA
220741333$22074133$3$F$20220615$20240627$20230308$20240705$EXP$$JP-009507513-2302JPN003793J$MERCK$$73$YR$$M$Y$$$20240705$$MD$JP$JP
220742544$22074254$4$F$20230119$20240626$20230308$20240702$EXP$$JP-009507513-2303JPN000433J$MERCK$$7$DEC$$F$Y$$$20240702$$MD$JP$JP
220745272$22074527$2$F$20240807$20240816$20230308$20240821$EXP$$CA-HLS-202300579$HLS THERAPEUTICS$$38$YR$A$M$Y$$$20240821$$MD$CA$CA
220745523$22074552$3$F$$20240703$20230308$20240709$EXP$$CA-Covis Pharma GmbH-2023COV00513$COVIS PHARMA$$72$YR$E$M$Y$$$20240709$$CN$CA$CA
220745673$22074567$3$F$20230213$20240821$20230308$20240826$PER$$US-PFIZER INC-PV202300040976$PFIZER$$64$YR$$F$Y$$$20240826$$HP$US$US
220745763$22074576$3$F$20230101$20240628$20230308$20240708$PER$$US-PFIZER INC-202300091915$PFIZER$$68$YR$$F$Y$61.23$KG$20240708$$CN$US$US
220745844$22074584$4$F$20231201$20240827$20230308$20240828$EXP$$US-PFIZER INC-PV202300043100$PFIZER$$73$YR$$F$Y$$$20240828$$CN$US$US
220746055$22074605$5$F$20230101$20240703$20230308$20240704$PER$$US-PFIZER INC-202300092864$PFIZER$$48$YR$$F$Y$$$20240704$$HP$US$US
220746513$22074651$3$F$$20240715$20230308$20240723$PER$$US-VERTEX PHARMACEUTICALS-2023-003285$VERTEX$$$$$M$Y$$$20240723$$MD$US$US
220747273$22074727$3$F$$20240730$20230308$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01744$LUPIN$$$$$$Y$$$20240819$$CN$US$US
220748714$22074871$4$F$20221101$20230329$20230308$20240813$EXP$$NVSC2023US053438$NOVARTIS$$33$YR$$F$Y$90.7$KG$20240813$$HP$US$US
220748802$22074880$2$F$$20240726$20230308$20240805$PER$$US-SA-2023SA073107$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240805$$MD$US$US
220748992$22074899$2$F$20230217$20240620$20230308$20240703$PER$$US-SA-2023SA071406$SANOFI AVENTIS$$32$YR$A$F$Y$68.94$KG$20240703$$MD$US$US
220749322$22074932$2$F$20230101$20240910$20230308$20240919$PER$$US-SA-2023SA074714$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
220749583$22074958$3$F$$20240806$20230308$20240814$PER$$US-SA-2023SA072417$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240814$$MD$US$US
220749736$22074973$6$F$20230201$20240802$20230308$20240812$PER$$US-SA-2023SA075060$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240812$$MD$US$US
220751724$22075172$4$F$$20240725$20230308$20240729$EXP$$CA-ROCHE-3299306$ROCHE$$$$A$F$Y$$$20240729$$HP$CA$CA
220752573$22075257$3$F$$20240722$20230308$20240729$PER$$NVSC2023US053391$NOVARTIS$$$$$F$Y$$$20240729$$HP$US$US
220752943$22075294$3$F$$20240710$20230308$20240718$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-032436$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240718$$HP$CA$CA
220755312$22075531$2$F$$20240710$20230308$20240717$EXP$$CA-MYLANLABS-2023M1022452$MYLAN$$$$$F$Y$$$20240717$$HP$CA$CA
220758629$22075862$9$F$20230404$20240808$20230308$20240819$EXP$$IN-INCYTE CORPORATION-2023IN002266$INCYTE$$$$$$Y$$$20240819$$CN$IN$IN
220760062$22076006$2$F$20220610$20240718$20230308$20240718$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-223741$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$57.5$KG$20240719$$MD$JP$JP
220760542$22076054$2$F$$20240906$20230308$20240916$EXP$$BR-CELLTRION INC.-2023BR004844$CELLTRION$$$$$$Y$$$20240916$$CN$BR$BR
220762425$22076242$5$F$20181120$20240710$20230309$20240715$EXP$$PHHY2018CO200874$NOVARTIS$$63$YR$$M$Y$99$KG$20240715$$CN$CO$CO
220763323$22076332$3$F$$20240809$20230309$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01751$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220764913$22076491$3$F$$20230314$20230309$20240925$PER$$US-GSK-US2023AMR035227$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
220765617$22076561$7$F$20220715$20240918$20230309$20240925$EXP$$CH-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-181960$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$83$KG$20240925$$CN$CH$CH
220765782$22076578$2$F$$20230228$20230309$20240925$PER$$US-GSK-US2023AMR033370$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
220766353$22076635$3$F$$20240809$20230309$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01761$LUPIN$$$$$$Y$$$20240830$$CN$US$US
220767114$22076711$4$F$$20240809$20230309$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01745$LUPIN$$$$$$Y$$$20240829$$CN$US$US
220767492$22076749$2$F$20230208$20240806$20230309$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01765$LUPIN$$$$$$Y$$$20240829$$CN$US$US
220767572$22076757$2$F$$20240806$20230309$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01764$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220767714$22076771$4$F$20230119$20240806$20230309$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01749$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220768693$22076869$3$F$$20240809$20230309$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01770$LUPIN$$$$$$Y$$$20240831$$CN$US$US
220768914$22076891$4$F$$20240710$20230309$20240717$EXP$$DE-CELLTRION INC.-2023IT004614$CELLTRION$Caorsi R, Rusmini M, Volpi S, Chiesa S, Pastorino C, Sementa AR et al.. CD70 deficiency due to a novel mutation in a patient with severe chronic EBV infection presenting as a periodic fever.. Front. Immunol.. 2018$$$$$Y$$$20240718$$MD$DE$IT
220769074$22076907$4$F$$20240904$20230309$20240916$EXP$$FR-AUROBINDO-AUR-APL-2023-009863$AUROBINDO$Jeantin L, Plu I, Mar Amador MD, Maillart E, Lanternier F, Pourcher V, et al... Pearls + Oy-sters: Spinal Cord Candidiasis Linked to CARD9 Deficiency Masquerading as a Longitudinally Extensive Transverse Myelitis.. American Academy of Neurology. 2022;99(11):475-9$55$YR$$M$Y$$$20240916$$MD$FR$FR
220769162$22076916$2$F$20230119$20240705$20230309$20240715$EXP$IT-MINISAL02-907112$IT-TEVA-2023-IT-2857144$TEVA$$12$YR$$F$Y$42$KG$20240715$$PH$IT$IT
220770665$22077066$5$F$20230303$20230424$20230309$20240925$PER$$US-GSK-US2023AMR035791$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240925$$CN$US$US
220770935$22077093$5$F$$20230824$20230309$20240925$PER$$US-GSK-US2023AMR016380$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
220772252$22077225$2$F$$20240626$20230309$20240716$PER$$CA-TOLMAR, INC.-23CA038898$TOLMAR$$$$$M$Y$$$20240715$$CN$CA$CA
220772478$22077247$8$F$$20240903$20230309$20240913$EXP$$US-BIOGEN-2023BI01191828$BIOGEN$$$$$F$Y$$$20240913$$CN$US$US
220772603$22077260$3$F$$20240712$20230309$20240717$EXP$$BR-TAKEDA-2023TUS023881$TAKEDA$$$$$F$Y$$$20240717$$CN$BR$BR
220773666$22077366$6$F$20230209$20240923$20230309$20240925$EXP$$NVSC2023SA050835$NOVARTIS$$1$YR$$F$Y$$$20240925$$HP$SA$SA
220774088$22077408$8$F$$20240722$20230309$20240805$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-033042$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240805$$PH$CA$CA
2207741710$22077417$10$F$20220801$20240826$20230309$20240902$EXP$$NVSC2022AR212866$NOVARTIS$$56$YR$$F$Y$$$20240902$$CN$AR$AR
220775463$22077546$3$F$20210101$20240912$20230309$20240921$EXP$$CA-CELLTRION INC.-2021CA017931$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
2207761310$22077613$10$F$$20240917$20230309$20240919$EXP$$CA-ROCHE-3303074$ROCHE$$$$A$F$Y$$$20240919$$CN$CA$CA
2207763310$22077633$10$F$20230427$20240712$20230309$20240718$EXP$$AU-TAKEDA-2023TUS024329$TAKEDA$$33$YR$$F$Y$$$20240718$$CN$AU$AU
2207771710$22077717$10$F$20240513$20240829$20230309$20240905$EXP$$CA-GSK-CA2023035308$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$CA$CA
2207773413$22077734$13$F$$20240205$20230309$20240925$EXP$$US-GSK-US2022AMR035639$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
220778054$22077805$4$F$$20240626$20230309$20240716$PER$$CA-TOLMAR, INC.-23CA038945$TOLMAR$$$$$M$Y$$$20240715$$CN$CA$CA
220782732$22078273$2$F$20210301$20240710$20230309$20240716$EXP$$US-ABBVIE-4325323$ABBVIE$$67$YR$$M$Y$75$KG$20240716$$CN$US$US
220783892$22078389$2$F$$20240820$20230309$20240916$PER$$US-SA-2023SA073800$SANOFI AVENTIS$$$$C$F$Y$$$20240916$$MD$US$US
220783994$22078399$4$F$$20240627$20230309$20240710$PER$$US-SA-2023SA074516$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240710$$MD$US$US
220784263$22078426$3$F$$20240624$20230309$20240703$PER$$US-SA-2023SA074191$SANOFI AVENTIS$$$$A$M$Y$132$KG$20240703$$MD$US$US
220785444$22078544$4$F$20221101$20240708$20230309$20240717$PER$$US-SA-2023SA076992$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240717$$CN$US$US
220785637$22078563$7$F$20230306$20240809$20230309$20240814$PER$$US-SA-2023SA076341$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240814$$MD$US$US
220785652$22078565$2$F$$20240815$20230309$20240828$PER$$US-SA-2023SA076231$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
220787105$22078710$5$F$$20240828$20230309$20240912$PER$$US-SA-2023SA075484$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240912$$MD$US$US
220789012$22078901$2$F$$20240815$20230309$20240821$PER$$US-AMGEN-USASP2023038454$AMGEN$$60$YR$A$F$Y$$$20240821$$CN$US$US
220789486$22078948$6$F$20220101$20240814$20230309$20240821$EXP$$BR-GSK-BR2022AMR097482$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$BR$BR
220791563$22079156$3$F$$20240801$20230309$20240805$PER$$US-PFIZER INC-PV202300041246$PFIZER$$55$YR$$F$Y$$$20240805$$CN$US$US
220792516$22079251$6$F$20220801$20240816$20230309$20240821$EXP$$US-TAKEDA-2022TUS038861$TAKEDA$$75$YR$$F$Y$56$KG$20240821$$HP$US$US
220794118$22079411$8$F$$20240906$20230309$20240913$EXP$$US-TAKEDA-2021TUS063244$TAKEDA$$$$$M$Y$99$KG$20240913$$HP$US$US
220796842$22079684$2$F$20171117$20240705$20230309$20240711$EXP$$CA-TAKEDA-2023TUS023725$TAKEDA$$52$YR$$F$Y$$$20240711$$MD$CA$CA
220797773$22079777$3$F$$20240830$20230309$20240904$EXP$$GB-ROCHE-3303019$ROCHE$$14$YR$T$F$Y$$$20240904$$CN$GB$GB
220805912$22080591$2$F$$20240730$20230309$20240827$PER$$US-MYOVANT SCIENCES GMBH-2022MYSCI1000503$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
220807504$22080750$4$F$20220101$20240805$20230309$20240812$EXP$$US-JAZZ-2022-US-033158$JAZZ$$$$$F$Y$$$20240812$$CN$US$US
220809153$22080915$3$F$$20240719$20230309$20240725$EXP$$CA-PFIZER INC-202300099583$PFIZER$$73$YR$$M$Y$$$20240725$$HP$CA$CA
220817683$22081768$3$F$20230201$20240918$20230310$20240930$EXP$$NVSC2023US050711$NOVARTIS$$75$YR$$M$Y$$$20240930$$CN$US$US
220817715$22081771$5$F$20220101$20240827$20230310$20240903$EXP$$CA-ROCHE-2881994$ROCHE$$62$YR$A$F$Y$98.7$KG$20240903$$HP$CA$CA
220817806$22081780$6$F$$20240702$20230310$20240712$EXP$$FR-ROCHE-2952394$ROCHE$$21$YR$A$M$Y$56$KG$20240712$$MD$FR$FR
220818013$22081801$3$F$$20240806$20230310$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01766$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220818602$22081860$2$F$$20240726$20230310$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01773$LUPIN$$$$$$Y$$$20240816$$CN$US$US
220818703$22081870$3$F$$20240821$20230310$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15158$LUPIN$$$$$$Y$$$20240909$$CN$US$US
220819243$22081924$3$F$$20240705$20230310$20240709$EXP$$US-GSK-US2023033899$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$US$US
220820504$22082050$4$F$20221101$20240722$20230310$20240727$EXP$$US-ABBVIE-4334443$ABBVIE$$75$YR$$F$Y$$$20240727$$CN$US$US
220821197$22082119$7$F$$20240913$20230310$20240916$EXP$$CA-ROCHE-3305558$ROCHE$$$$A$F$Y$$$20240916$$MD$CA$CA
220823134$22082313$4$F$$20240724$20230310$20240805$EXP$$CA-AUROBINDO-AUR-APL-2023-010545$AUROBINDO$Mellor K, Khan N, Iatan I, Tran K. NOT FOR THE FAINT OF HEART: A CASE REPORT OF BRADYCARDIA INDUCED HYPERTENSION.. J-Hypertens. 2023;41 (1):e350$66$YR$$M$Y$$$20240805$$HP$CA$CA
220826295$22082629$5$F$20230201$20240920$20230310$20240925$EXP$$NVSC2023US051376$NOVARTIS$$39$YR$$F$Y$$$20240925$$CN$US$US
220827313$22082731$3$F$20230223$20230411$20230310$20240925$PER$$US-GSK-US2023AMR034548$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240925$$HP$US$US
220828622$22082862$2$F$20220101$20240701$20230310$20240705$EXP$$US-ABBVIE-4331944$ABBVIE$$75$YR$$F$Y$$$20240705$$CN$US$US
220829904$22082990$4$F$$20240726$20230310$20240806$EXP$$IT-AUROBINDO-AUR-APL-2023-009978$AUROBINDO$Ricciardulli S, Lattanzi L, Barbuti M, Ceravolo R, Perugi G.. Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report.. International clinical psychopharmacology. 2023;38(2):117-20$69$YR$$F$Y$$$20240806$$MD$IT$IT
220830972$22083097$2$F$$20240712$20230310$20240717$EXP$$NVSC2023US052263$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
220833502$22083350$2$F$$20240809$20230310$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01778$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220833654$22083365$4$F$20230404$20240828$20230310$20240830$EXP$$CA-TAKEDA-2022TUS077057$TAKEDA$$76$YR$$M$Y$92$KG$20240830$$CN$CA$CA
220833666$22083366$6$F$20210316$20240724$20230310$20240730$EXP$$CA-TAKEDA-2023TUS025005$TAKEDA$$37$YR$$F$Y$$$20240730$$HP$CA$CA
220835923$22083592$3$F$$20240730$20230310$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01846$LUPIN$$$$$$Y$$$20240819$$CN$US$US
220836859$22083685$9$F$$20240923$20230310$20240926$EXP$$US-PFIZER INC-PV202300044759$PFIZER$$68$YR$$F$Y$113.47$KG$20240926$$HP$US$US
220837663$22083766$3$F$$20240820$20230310$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01932$LUPIN$$$$$$Y$$$20240906$$CN$US$US
220839615$22083961$5$F$20211201$20240918$20230310$20240920$EXP$$US-PFIZER INC-202300102884$PFIZER$$76$YR$$F$Y$75.75$KG$20240920$$HP$US$US
220840897$22084089$7$F$20240101$20240812$20230310$20240819$EXP$$US-MYLANLABS-2023M1025736$MYLAN$$$$$F$Y$99.79$KG$20240819$$CN$US$US
220841952$22084195$2$F$20221209$20240904$20230310$20240927$PER$$US-MYOVANT SCIENCES GMBH-2022MYSCI1200351$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
220842153$22084215$3$F$$20240906$20230310$20240927$PER$$US-MYOVANT SCIENCES GMBH-2022MYSCI1200360$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
220842982$22084298$2$F$$20240722$20230310$20240725$EXP$$CA-TAKEDA-2021TUS026348$TAKEDA$$$$$F$Y$$$20240725$$MD$CA$CA
220843032$22084303$2$F$20230223$20240910$20230310$20240913$EXP$$GB-BAYER-2023A025818$BAYER$$57$YR$A$F$Y$$$20240913$$CN$GB$GB
220844962$22084496$2$F$$20240809$20230310$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01847$LUPIN$$$$$$Y$$$20240829$$CN$US$US
220845002$22084500$2$F$$20240812$20230310$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01849$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220845283$22084528$3$F$$20240726$20230310$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01894$LUPIN$$$$$$Y$$$20240817$$CN$US$US
220845823$22084582$3$F$$20240809$20230310$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01959$LUPIN$$$$$$Y$$$20240831$$CN$US$US
220846057$22084605$7$F$$20240920$20230310$20240924$EXP$$US-PFIZER INC-PV202300042745$PFIZER$$74$YR$$F$Y$$$20240924$$CN$US$US
2208469612$22084696$12$F$$20240618$20230310$20240701$EXP$$CA-SA-2023SA077793$SANOFI AVENTIS$$43$YR$A$F$Y$96$KG$20240701$$HP$CA$CA
220847103$22084710$3$F$$20240812$20230310$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01899$LUPIN$$$$$$Y$$$20240904$$CN$US$US
220848764$22084876$4$F$20210128$20240905$20230310$20240909$EXP$$DE-ROCHE-2769102$ROCHE$$31$YR$A$F$Y$98$KG$20240910$$MD$DE$DE
220848975$22084897$5$F$20220425$20240918$20230310$20240926$EXP$$DE-ROCHE-3088167$ROCHE$$34$YR$A$F$Y$$$20240926$$CN$DE$DE
220851652$22085165$2$F$20230227$20240726$20230310$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01848$LUPIN$$$$$$Y$$$20240816$$CN$US$US
220852126$22085212$6$F$20220714$20240916$20230310$20240926$EXP$$DE-PFIZER INC-202300105154$PFIZER$$71$YR$$M$Y$$$20240926$$HP$DE$DE
220852492$22085249$2$F$20230301$20240717$20230310$20240722$EXP$$DE-TAKEDA-2023TUS023421$TAKEDA$$46$YR$$M$Y$$$20240722$$HP$DE$DE
220853254$22085325$4$F$20240207$20240709$20230310$20240723$EXP$$US-VERTEX PHARMACEUTICALS-2023-003465$VERTEX$$$$$M$Y$$$20240723$$CN$US$US
2208544913$22085449$13$F$20230302$20240701$20230310$20240705$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-005534$JAZZ$$48$YR$$F$Y$83$KG$20240705$$CN$US$US
2208552617$22085526$17$F$20160205$20240917$20230310$20240925$EXP$$NVSC2016CL016543$NOVARTIS$$59$YR$$F$Y$69.5$KG$20240925$$MD$CL$CL
220856063$22085606$3$F$20220929$20240806$20230310$20240815$PER$$US-SA-2023SA076731$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240815$$MD$US$US
220856732$22085673$2$F$20240601$20240717$20230310$20240726$PER$$US-SA-2023SA077352$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240726$$MD$US$US
220857368$22085736$8$F$20230301$20240729$20230310$20240802$EXP$$US-SA-2023SA076941$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240802$$MD$US$US
220860524$22086052$4$F$$20240912$20230310$20240918$EXP$$CA-MYLANLABS-2023M1025833$MYLAN$$61$YR$$F$Y$70$KG$20240918$$HP$CA$CA
220862433$22086243$3$F$$20240904$20230310$20240906$PER$$US-PFIZER INC-PV202300045701$PFIZER$$84$YR$$M$Y$$$20240906$$CN$US$US
220864584$22086458$4$F$20221215$20240829$20230312$20240902$EXP$$NVSC2023US052269$NOVARTIS$$33$YR$$F$Y$$$20240902$$CN$US$US
220865272$22086527$2$F$$20240710$20230312$20240712$PER$$NVSC2023US054632$NOVARTIS$$$$$M$Y$$$20240712$$CN$US$US
220865542$22086554$2$F$$20230307$20230312$20240919$EXP$$NVSC2023HU056140$NOVARTIS$$$$$$Y$$$20240919$$MD$HU$HU
220865572$22086557$2$F$$20230309$20230312$20240801$PER$$NVSC2023US056957$NOVARTIS$$$$$F$Y$69.4$KG$20240801$$CN$US$US
220867803$22086780$3$F$$20240729$20230312$20240730$PER$$NVSC2023US052707$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
220868506$22086850$6$F$20230109$20240806$20230312$20240809$PER$$NVSC2023US055764$NOVARTIS$$75$YR$$F$Y$$$20240809$$CN$US$US
220868573$22086857$3$F$$20240918$20230312$20240925$PER$$NVSC2023US055439$NOVARTIS$$69$YR$$F$Y$$$20240925$$CN$US$US
2208720514$22087205$14$F$20221208$20240625$20230313$20240709$PER$$US-ROCHE-3304416$ROCHE$$6$YR$C$M$Y$$$20240705$$CN$US$US
220878583$22087858$3$F$$20240812$20230313$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01887$LUPIN$$$$$$Y$$$20240901$$CN$US$US
220878912$22087891$2$F$$20240904$20230313$20240910$EXP$$CA-TAKEDA-2022TUS057295$TAKEDA$$$$$F$Y$$$20240910$$MD$CA$CA
220879242$22087924$2$F$$20240812$20230313$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01914$LUPIN$$$$$$Y$$$20240829$$CN$US$US
2208807211$22088072$11$F$20230228$20240710$20230313$20240712$EXP$$US-TAKEDA-US201935156$TAKEDA$$59$YR$$M$Y$64$KG$20240712$$CN$US$US
220882153$22088215$3$F$$20240812$20230313$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01844$LUPIN$$$$$$Y$$$20240830$$CN$US$US
220882323$22088232$3$F$$20240708$20230313$20240715$EXP$$NVSC2023MX056404$NOVARTIS$$$$$F$Y$65$KG$20240715$$CN$MX$MX
220882832$22088283$2$F$20200101$20240812$20230313$20240818$EXP$$US-ROCHE-3302444$ROCHE$$40$YR$A$F$Y$47.63$KG$20240819$$CN$US$US
220885483$22088548$3$F$$20240805$20230313$20240809$EXP$$US-ROCHE-3306273$ROCHE$$55$YR$A$F$Y$$$20240809$$CN$US$US
220886887$22088688$7$F$20230301$20240709$20230313$20240716$30DAY$$US-GSK-US2023037513$GLAXOSMITHKLINE$$76$YR$$F$Y$300$KG$20240716$$CN$US$US
220891488$22089148$8$F$20221227$20240917$20230313$20240923$EXP$$BE-VERTEX PHARMACEUTICALS-2023-003515$VERTEX$$63$YR$$F$Y$56$KG$20240923$$MD$BE$BE
220891723$22089172$3$F$20221018$20240709$20230313$20240716$EXP$$BR-GSK-BR2022AMR137125$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$BR$BR
220891864$22089186$4$F$20240101$20240807$20230313$20240812$EXP$$US-ABBVIE-4337145$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
220894475$22089447$5$F$20230101$20240731$20230313$20240807$EXP$$US-ABBVIE-4336774$ABBVIE$$$$$F$Y$$$20240807$$MD$US$US
220895194$22089519$4$F$20000101$20240821$20230313$20240828$PER$$US-BIOGEN-2023BI01186793$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
220896383$22089638$3$F$$20240820$20230313$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01888$LUPIN$$$$$$Y$$$20240909$$CN$US$US
220896702$22089670$2$F$$20240726$20230313$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01916$LUPIN$$$$$$Y$$$20240822$$CN$US$US
220896772$22089677$2$F$$20240909$20230313$20240914$EXP$$PH-TAKEDA-2023TUS024658$TAKEDA$$$$$M$Y$$$20240914$$CN$PH$PH
220897214$22089721$4$F$$20240918$20230313$20240924$PER$$NVSC2023US054331$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
220897754$22089775$4$F$$20240812$20230313$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01886$LUPIN$$$$$$Y$$$20240830$$CN$US$US
220897832$22089783$2$F$$20240812$20230313$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01915$LUPIN$$$$$$Y$$$20240901$$CN$US$US
2208982512$22089825$12$F$20230410$20240910$20230313$20240916$EXP$$AU-TAKEDA-2023TUS025882$TAKEDA$$70$YR$$F$Y$$$20240916$$CN$AU$AU
220898443$22089844$3$F$$20240812$20230313$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01905$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220898683$22089868$3$F$$20240730$20230313$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01937$LUPIN$$$$$$Y$$$20240818$$CN$US$US
220898933$22089893$3$F$$20240812$20230313$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01947$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220899582$22089958$2$F$$20240911$20230313$20240916$EXP$$US-TAKEDA-2023TUS025752$TAKEDA$$$$$M$Y$$$20240916$$CN$US$US
220900152$22090015$2$F$$20240812$20230313$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01980$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220900425$22090042$5$F$$20240812$20230313$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01953$LUPIN$$$$$$Y$$$20240830$$CN$US$US
2209007211$22090072$11$F$20230101$20240718$20230313$20240724$EXP$$US-BIOGEN-2023BI01192628$BIOGEN$$$$$F$Y$$$20240724$$CN$US$US
2209018114$22090181$14$F$20220311$20240819$20230313$20240824$EXP$$US-PAREXEL-2021-KAM-US003538$TAKEDA$$60$YR$$F$Y$77$KG$20240824$$HP$US$US
220903872$22090387$2$F$20230303$20240924$20230313$20240926$PER$$US-DSJP-DSU-2023-109028$DAIICHI$$28$YR$$F$Y$$$20240926$$CN$US$US
220904686$22090468$6$F$$20240904$20230313$20240910$EXP$$US-TAKEDA-2019TUS031961$TAKEDA$$$$$M$Y$$$20240910$$CN$US$US
220908173$22090817$3$F$20220101$20240830$20230313$20240903$EXP$$RU-JNJFOC-20230331095$JOHNSON AND JOHNSON$$84$YR$E$$Y$$$20240903$$CN$RU$RU
220908682$22090868$2$F$$20240805$20230314$20240814$EXP$$CA-BAXTER-2023BAX015238$BAXTER$$9$DEC$$M$Y$$$20240814$$CN$CA$CA
220909892$22090989$2$F$$20230306$20230314$20240803$EXP$$NVSC2023US052847$NOVARTIS$$$$$F$Y$$$20240803$$CN$US$US
220910005$22091000$5$F$20181001$20230717$20230314$20240925$PER$$US-GSK-US2023AMR038169$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240925$$CN$US$US
220914104$22091410$4$F$$20240812$20230314$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01948$LUPIN$$$$$$Y$$$20240831$$CN$US$US
220914125$22091412$5$F$20230307$20240628$20230314$20240702$EXP$$US-ABBVIE-4338559$ABBVIE$$64$YR$$F$Y$$$20240702$$CN$US$US
220914739$22091473$9$F$20180201$20240723$20230314$20240806$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-02601$ALKEM$$51$YR$$F$Y$$$20240806$$CN$DE$DE
220914785$22091478$5$F$$20240822$20230314$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-036447$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240826$$CN$US$US
220914833$22091483$3$F$20090101$20240905$20230314$20240919$EXP$$PL-AUROBINDO-AUR-APL-2023-011070$AUROBINDO$E Gowin, Januszkiewicz-Lewandowska D.. Mutacja TP53 u dzieci ze zwiazanym z terapia zespo?em mielodysplastycznym/ostra bialaczka szpikowa po zakonczonym leczeniu miesaka prazkowanokomorkowego (TP53 mutation in children with therapy-related myelodysplastic syndrome/acute myeloid leukemia after rhabdomyosarcoma treatment. P). PALLIATIVE MEDICINE IN PRACTICE.. 2020;14(1):58-67$9$YR$$M$Y$$$20240919$$MD$PL$PL
220915316$22091531$6$F$20220701$20240902$20230314$20240905$EXP$$NVSC2022GB207363$NOVARTIS$$$$A$M$Y$$$20240905$$CN$GB$GB
220917535$22091753$5$F$$20240905$20230314$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-035381$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240910$$MD$US$US
220918409$22091840$9$F$20230203$20240730$20230314$20240805$EXP$$CA-TAKEDA-2021TUS033821$TAKEDA$$35$YR$$F$Y$$$20240805$$MD$CA$CA
220921803$22092180$3$F$20210817$20240729$20230314$20240806$EXP$$US-AMGEN-USASP2023042603$AMGEN$$59$YR$A$M$Y$$$20240806$$CN$US$US
2209253612$22092536$12$F$20230501$20240802$20230314$20240809$EXP$$NVSC2023MX056355$NOVARTIS$$78$YR$$F$Y$58$KG$20240809$$CN$MX$MX
220926462$22092646$2$F$$20240730$20230314$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01962$LUPIN$$$$$$Y$$$20240821$$CN$US$US
220927874$22092787$4$F$20220928$20240723$20230314$20240730$EXP$$US-GSK-US2023035793$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$US$US
220929023$22092902$3$F$$20240730$20230314$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01963$LUPIN$$$$$$Y$$$20240817$$CN$US$US
220929474$22092947$4$F$$20240909$20230314$20240912$EXP$$CA-ROCHE-3303737$ROCHE$$$$A$F$Y$$$20240912$$CN$CA$CA
220930073$22093007$3$F$$20240730$20230314$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01996$LUPIN$$$$$$Y$$$20240820$$CN$US$US
220930183$22093018$3$F$20200101$20240614$20230314$20240904$PER$GB-MLMSERVICE-20230222-4119823-1$GB-STRIDES ARCOLAB LIMITED-2023SP003788$STRIDES$Mohamed M, Athar MW, Mamoojee Y, Brown A, Dowen F, MacFarlane J. Rifabutin-Induced SIADH and Leucopenia in a Renal Transplant Recipient with Genitourinary Tract Tuberculosis: A Case Report and Review of the Literature.. Case Reports in Nephrology and Dialysis.. 2022;12(2):117-23$$$$$Y$$$20240904$$MD$GB$GB
220931654$22093165$4$F$$20240812$20230314$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01971$LUPIN$$$$$$Y$$$20240831$$PH$US$US
220935047$22093504$7$F$20230226$20240708$20230314$20240711$EXP$$BR-TAKEDA-2021TUS062278$TAKEDA$$63$YR$$M$Y$71$KG$20240711$$CN$BR$BR
220935444$22093544$4$F$20200901$20240902$20230314$20240904$EXP$$DE-ROCHE-2722531$ROCHE$$32$YR$A$F$Y$$$20240904$$CN$DE$DE
220936044$22093604$4$F$20220514$20240829$20230314$20240904$EXP$$CA-TAKEDA-2022TUS032700$TAKEDA$$58$YR$$F$Y$$$20240904$$HP$CA$CA
220936184$22093618$4$F$$20240717$20230314$20240723$EXP$$US-TAKEDA-2023TUS010870$TAKEDA$$$$$M$Y$$$20240723$$CN$US$US
220937662$22093766$2$F$$20240812$20230314$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01986$LUPIN$$$$$$Y$$$20240829$$CN$US$US
220938163$22093816$3$F$20230130$20240812$20230314$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01991$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220938473$22093847$3$F$$20240821$20230314$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02002$LUPIN$$$$$$Y$$$20240909$$CN$US$US
220942432$22094243$2$F$$20230303$20230314$20240726$EXP$$NVSC2023US054016$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
220942633$22094263$3$F$$20240718$20230314$20240723$PER$$NVSC2023US052746$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
220943462$22094346$2$F$$20240820$20230314$20240918$PER$$US-SUNOVION-2023SUN000400$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
220944553$22094455$3$F$20230301$20230310$20230314$20240808$PER$$NVSC2023US058278$NOVARTIS$$43$YR$$F$Y$$$20240808$$CN$US$US
220944812$22094481$2$F$20220802$20230508$20230314$20240712$EXP$$NVSC2023US054667$NOVARTIS$$57$YR$$F$Y$$$20240712$$CN$US$US
220945702$22094570$2$F$$20240726$20230314$20240807$EXP$$CA-TEVA-2023-CA-2865161$TEVA$$65$YR$$F$Y$34$KG$20240807$$HP$CA$CA
220947833$22094783$3$F$$20240619$20230314$20240710$EXP$$US-ELI_LILLY_AND_COMPANY-US202303006033$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240710$$CN$US$US
220952874$22095287$4$F$20230301$20240708$20230314$20240711$EXP$$CA-TAKEDA-2023TUS024672$TAKEDA$$53$YR$$M$Y$$$20240711$$CN$CA$CA
220953767$22095376$7$F$20221101$20240920$20230314$20240924$EXP$$US-PFIZER INC-2020044338$PFIZER$$46$YR$$F$Y$$$20240924$$HP$US$US
220953883$22095388$3$F$20200328$20240712$20230314$20240718$EXP$$IN-PFIZER INC-PV202300046592$PFIZER$$66$YR$$M$Y$65.4$KG$20240718$$MD$IN$IN
220954153$22095415$3$F$20240101$20240906$20230314$20240909$EXP$$US-PFIZER INC-PV202300048026$PFIZER$$65$YR$$F$Y$$$20240909$$CN$US$US
220954247$22095424$7$F$$20240815$20230314$20240820$PER$$US-PFIZER INC-PV202300006074$PFIZER$$77$YR$$M$Y$$$20240820$$MD$US$US
220955463$22095546$3$F$20230101$20240814$20230314$20240819$EXP$$US-PFIZER INC-202300105558$PFIZER$$88$YR$$F$Y$$$20240819$$HP$US$US
220956292$22095629$2$F$20210727$20240715$20230314$20240716$EXP$$IN-PFIZER INC-PV202300046587$PFIZER$$79$YR$$M$Y$63.2$KG$20240716$$MD$IN$IN
220957342$22095734$2$F$$20240912$20230314$20240916$PER$$US-PFIZER INC-PV202300046804$PFIZER$$86$YR$$F$Y$$$20240916$$CN$US$US
220957798$22095779$8$F$20230217$20240831$20230314$20240910$EXP$$CA-CELLTRION INC.-2023CA004347$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
220957863$22095786$3$F$20240901$20240910$20230314$20240919$30DAY$$CA-JNJFOC-20230301016$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240919$$HP$CA$CA
220959143$22095914$3$F$20230101$20240821$20230315$20240830$PER$$US-INCYTE CORPORATION-2023IN001651$INCYTE$$$$$$Y$$$20240830$$CN$US$US
220960605$22096060$5$F$$20240808$20230315$20240815$EXP$$US-ABBVIE-4338558$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
220960704$22096070$4$F$20240301$20240828$20230315$20240905$30DAY$$US-GSK-US2023038231$GLAXOSMITHKLINE$$71$YR$$M$Y$$$20240905$$CN$US$US
220961125$22096112$5$F$$20240806$20230315$20240927$PER$$AU-TOLMAR, INC.-23AU038978$TOLMAR$$$$$M$Y$$$20240927$$CN$AU$AU
220961144$22096114$4$F$$20240828$20230315$20240919$PER$$AU-TOLMAR, INC.-23AU039233$TOLMAR$$$$$M$Y$$$20240919$$CN$AU$AU
220961382$22096138$2$F$20171205$20230905$20230315$20240712$EXP$GB-MHRA-ADR 25576193$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-01451$ALKEM$$41$YR$$F$Y$110$KG$20240712$$MD$GB$GB
220962444$22096244$4$F$20230215$20240702$20230315$20240724$PER$$CA-TOLMAR, INC.-23CA038992$TOLMAR$$68$YR$$M$Y$$$20240724$$CN$CA$CA
220962457$22096245$7$F$20231001$20240724$20230315$20240819$PER$$CA-TOLMAR, INC.-23CA038994$TOLMAR$$52$YR$$M$Y$$$20240819$$CN$CA$CA
220962473$22096247$3$F$20230215$20240712$20230315$20240729$PER$$CA-TOLMAR, INC.-23CA039009$TOLMAR$$84$YR$$M$Y$$$20240729$$CN$CA$CA
220962556$22096255$6$F$20221007$20240711$20230315$20240717$EXP$$JP-TAKEDA-2023TJP003318$TAKEDA$$6$YR$$M$Y$16$KG$20240717$$MD$JP$JP
220963372$22096337$2$F$$20240704$20230315$20240711$EXP$$JP-AMGEN-JPNSP2023041573$AMGEN$Sadaga Y.; Watanabe D.; Najima Y. et al.. Ponatinib/blinatumomab combination for relapsed Ph+ acute leukemia as a bridging therapy to allo-SCT. Japanese Society for Transplantation and Cellular Therapy. 2023;272$60$YR$A$M$Y$$$20240711$$HP$JP$JP
220965754$22096575$4$F$$20240724$20230315$20240801$PER$$US-AMGEN-USASP2023045551$AMGEN$$$$A$F$Y$$$20240801$$HP$US$US
220966232$22096623$2$F$20190101$20240823$20230315$20240902$EXP$$BR-EMD Serono-9177312$EMD SERONO INC$$38$YR$A$F$Y$$$20240902$$CN$BR$BR
220966683$22096668$3$F$20230305$20240812$20230315$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01967$LUPIN$$$$$$Y$$$20240831$$CN$US$US
220967803$22096780$3$F$$20240626$20230315$20240702$EXP$$JP-009507513-2205JPN001836J$MERCK$$47$YR$$F$Y$$$20240702$$MD$JP$JP
220967846$22096784$6$F$20230101$20240912$20230315$20240919$EXP$$JP-009507513-2303JPN001087J$MERCK$$76$YR$$M$Y$$$20240919$$MD$JP$JP
220968642$22096864$2$F$$20240730$20230315$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01985$LUPIN$$$$$$Y$$$20240819$$CN$US$US
2209705110$22097051$10$F$$20240708$20230315$20240718$EXP$$ES-AUROBINDO-AUR-APL-2023-011636$AUROBINDO$Duran Barata D, Fedirchyk O, Corral Tuesta C et al. Levofloxacin as a possible cause of myasthenic crisis. Medicina Clinica. 2023;6176:S0025-7753$76$YR$$M$Y$$$20240718$$MD$ES$ES
220970572$22097057$2$F$20230223$20230306$20230315$20240819$EXP$$US-RECORDATI-2023001337$RECORDATI$$$$$$Y$$$20240819$$CN$US$US
220971173$22097117$3$F$20191023$20240725$20230315$20240729$EXP$$GB-ROCHE-2959416$ROCHE$$49$YR$A$M$Y$77.5$KG$20240729$$MD$GB$GB
220971189$22097118$9$F$20230217$20240817$20230315$20240820$EXP$$AR-ROCHE-3305157$ROCHE$$62$YR$A$M$Y$71$KG$20240820$$MD$AR$AR
2209724112$22097241$12$F$20220618$20240827$20230315$20240904$EXP$$CA-CELLTRION INC.-2022CA008852$CELLTRION$$$$$$Y$$$20240904$$MD$CA$CA
220972443$22097244$3$F$20230201$20230424$20230315$20240925$PER$$US-GSK-US2023AMR036818$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
220973042$22097304$2$F$$20240704$20230315$20240710$EXP$$JP-AMGEN-JPNSP2023041577$AMGEN$Sadaga Y.; Watanabe D.; Najima Y. et al.. Ponatinib/blinatumomab combination for relapsed Ph+ acute leukemia as a bridging therapy to allo-SCT. Japanese Society for Transplantation and Cellular Therapy. 2023;272$39$YR$A$M$Y$$$20240710$$HP$JP$JP
220973062$22097306$2$F$$20240821$20230315$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01995$LUPIN$$$$$$Y$$$20240909$$CN$US$US
220974754$22097475$4$F$$20240917$20230315$20240925$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-00761$AMNEAL$$$$$F$Y$15.465$KG$20240925$$CN$US$US
220975933$22097593$3$F$20171228$20240815$20230315$20240820$EXP$$CA-TAKEDA-2017TUS024399$TAKEDA$$59$YR$$F$Y$$$20240820$$CN$CA$CA
220976236$22097623$6$F$20230101$20240814$20230315$20240819$PER$$US-PFIZER INC-PV202300044758$PFIZER$$69$YR$$F$Y$$$20240819$$CN$US$US
220977582$22097758$2$F$$20240704$20230315$20240715$EXP$$CA-PFIZER INC-PV202300046508$PFIZER$Abduelmula, A.. The Use of Janus Kinase Inhibitors for Lichen Planus: An Evidence-Based Review. Journal of Cutaneous Medicine and Surgery. 2023;27(3):271-276$$$$$Y$$$20240715$$HP$CA$CA
220978675$22097867$5$F$20160620$20240724$20230315$20240731$EXP$$BR-GSK-BR2016GSK089178$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$BR$BR
220979498$22097949$8$F$$20240209$20230315$20240807$EXP$$NVSC2022BR296954$NOVARTIS$$$$$F$Y$$$20240807$$CN$BR$BR
220980162$22098016$2$F$$20240730$20230315$20240812$EXP$$US-LUPIN PHARMACEUTICALS INC.-2023-01988$LUPIN$$$$$M$Y$$$20240812$$CN$US$US
220980623$22098062$3$F$$20240730$20230315$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01994$LUPIN$$$$$$Y$$$20240819$$CN$US$US
220981593$22098159$3$F$$20240326$20230315$20240919$PER$$JP-ROCHE-3306776$ROCHE$$4$DEC$A$F$Y$$$20240919$$PH$JP$JP
2209822811$22098228$11$F$20230305$20240917$20230315$20240922$EXP$$BE-ROCHE-3303755$ROCHE$$42$YR$A$F$Y$79.6$KG$20240922$$MD$BE$BE
220982394$22098239$4$F$20201020$20240624$20230315$20240703$EXP$$AU-OTSUKA-2023_005972$OTSUKA$$34$YR$$F$Y$$$20240703$$HP$AU$AU
220985316$22098531$6$F$$20240830$20230315$20240906$EXP$$CA-TAKEDA-2023TUS024994$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
2209854010$22098540$10$F$20230401$20240730$20230315$20240809$EXP$$US-BEH-2023156196$CSL BEHRING$$37$YR$A$F$Y$97.506$KG$20240809$$HP$US$US
220987164$22098716$4$F$20220101$20240711$20230315$20240715$EXP$$JP-ASTELLAS-2022JP005617$ASTELLAS$$$$$F$Y$54$KG$20240715$$CN$JP$JP
220987423$22098742$3$F$$20230605$20230315$20240722$EXP$$AT-ASTELLAS-2023US008243$ASTELLAS$$69$YR$$M$Y$$$20240719$$MD$AT$AT
220989032$22098903$2$F$20230310$20240701$20230315$20240703$EXP$$US-TAKEDA-2023TUS026931$TAKEDA$$12$YR$$M$Y$$$20240703$$MD$US$US
220989152$22098915$2$F$20221101$20240715$20230315$20240722$EXP$$CA-TAKEDA-2023TUS025136$TAKEDA$$71$YR$$M$Y$$$20240722$$CN$CA$CA
220992187$22099218$7$F$20200714$20240905$20230315$20240913$EXP$$CA-TAKEDA-CA202023181$TAKEDA$$61$YR$$M$Y$$$20240913$$HP$CA$CA
220992414$22099241$4$F$$20240806$20230315$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01956$LUPIN$$$$$$Y$$$20240829$$CN$US$US
220992483$22099248$3$F$$20240809$20230315$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01976$LUPIN$$$$$$Y$$$20240828$$CN$US$US
220992555$22099255$5$F$$20240822$20230315$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01993$LUPIN$$$$$$Y$$$20240909$$CN$US$US
220994816$22099481$6$F$$20240705$20230315$20240711$PER$$US-BIOGEN-2023BI01190292$BIOGEN$$$$$M$Y$$$20240711$$CN$US$US
220994852$22099485$2$F$20220421$20240921$20230315$20240925$EXP$$AU-TAKEDA-2022TUS027654$TAKEDA$$74$YR$$F$Y$$$20240925$$MD$AU$AU
220996199$22099619$9$F$20180201$20240805$20230315$20240812$EXP$$DE-MYLANLABS-2023M1025733$MYLAN$$51$YR$$F$Y$$$20240812$$CN$DE$DE
220997837$22099783$7$F$20221101$20240917$20230315$20240920$PER$$US-PFIZER INC-202300112132$PFIZER$$78$YR$$F$Y$52.154$KG$20240920$$CN$US$US
220998795$22099879$5$F$20210907$20240712$20230315$20240722$EXP$$US-JAZZ-2023-US-000628$JAZZ$$62$YR$$M$Y$$$20240722$$CN$US$US
2209997514$22099975$14$F$20230705$20240924$20230315$20240930$EXP$$NVSC2023CA054985$NOVARTIS$$54$YR$$F$Y$$$20240929$$CN$CA$CA
2210005714$22100057$14$F$20230312$20240730$20230315$20240802$EXP$$US-BIOGEN-2023BI01192341$BIOGEN$$53$YR$$F$Y$$$20240802$$MD$US$US
221001254$22100125$4$F$20230308$20240905$20230315$20240911$EXP$$US-BIOMARINAP-US-2023-149032$BIOMARIN$$$$$$Y$$$20240911$$CN$US$US
221002063$22100206$3$F$20230119$20240702$20230315$20240709$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-005848$JAZZ$$62$YR$$M$Y$$$20240709$$CN$US$US
221002637$22100263$7$F$$20240712$20230315$20240725$EXP$$CA-AMGEN-CANNI2019219609$AMGEN$$63$YR$A$F$Y$$$20240724$$MD$CA$CA
221004445$22100444$5$F$20230225$20240919$20230316$20240925$EXP$$US-TAKEDA-2023TUS000279$TAKEDA$$24$YR$$F$Y$55$KG$20240925$$HP$US$US
221006299$22100629$9$F$20131109$20240919$20230316$20240927$EXP$$US-ABBVIE-4341531$ABBVIE$$75$YR$$F$Y$$$20240927$$CN$US$US
221006653$22100665$3$F$20230209$20230310$20230316$20240807$PER$$NVSC2023US057691$NOVARTIS$$77$YR$$M$Y$$$20240807$$CN$US$US
221007156$22100715$6$F$20240506$20240813$20230316$20240820$EXP$$CA-ROCHE-2887348$ROCHE$$17$YR$T$F$Y$$$20240820$$MD$CA$CA
2210072310$22100723$10$F$$20240807$20230316$20240808$EXP$$US-TAKEDA-US201923071$TAKEDA$$$$$F$Y$$$20240808$$MD$US$US
2210085015$22100850$15$F$$20240824$20230316$20240829$EXP$$US-GSK-US2023AMR039017$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$US$US
221008704$22100870$4$F$$20240702$20230316$20240724$PER$$CA-TOLMAR, INC.-23CA039015$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
221010622$22101062$2$F$$20230307$20230316$20240925$PER$$US-GSK-US2023AMR036586$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
221011743$22101174$3$F$20230224$20230410$20230316$20240819$EXP$$US-ORPHANEU-2023001345$RECORDATI$$$$$$Y$$$20240819$$CN$US$US
221012634$22101263$4$F$$20240812$20230316$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01990$LUPIN$$$$$$Y$$$20240831$$CN$US$US
221013343$22101334$3$F$$20240823$20230316$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02000$LUPIN$$$$$$Y$$$20240912$$CN$US$US
221014197$22101419$7$F$20230101$20240822$20230316$20240827$EXP$$CA-PFIZER INC-202300094581$PFIZER$$67$YR$$F$Y$$$20240827$$HP$CA$CA
221014205$22101420$5$F$20230101$20240728$20230316$20240729$EXP$$CA-PFIZER INC-202300104788$PFIZER$$40$YR$$M$Y$$$20240729$$MD$CA$CA
221015818$22101581$8$F$20230609$20240903$20230316$20240905$EXP$$CA-TAKEDA-2023TUS026617$TAKEDA$$71$YR$$F$Y$$$20240905$$CN$CA$CA
2210178212$22101782$12$F$20230101$20240802$20230316$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-038057$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$63.54$KG$20240812$$CN$US$US
221018066$22101806$6$F$20230306$20230414$20230316$20240925$EXP$$US-GSK-US2023AMR039047$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
221019175$22101917$5$F$$20240724$20230316$20240725$PER$$NVSC2023US057573$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
221019212$22101921$2$F$20220108$20240716$20230316$20240725$EXP$$GB-AUROBINDO-AUR-APL-2023-011589$AUROBINDO$$68$YR$$M$Y$$$20240725$$HP$GB$GB
221019254$22101925$4$F$20191101$20240910$20230316$20240912$EXP$$DE-ROCHE-2981743$ROCHE$$40$YR$A$F$Y$$$20240912$$CN$DE$DE
221019264$22101926$4$F$20220201$20240725$20230316$20240731$EXP$$GB-ROCHE-3310164$ROCHE$$42$YR$A$F$Y$$$20240731$$MD$GB$GB
221020808$22102080$8$F$20230301$20240814$20230316$20240822$EXP$$CA-CELLTRION INC.-2023CA005600$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
221022018$22102201$8$F$20220101$20240830$20230316$20240909$EXP$$CA-CELLTRION INC.-2022CA015700$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
221023112$22102311$2$F$$20230308$20230316$20240719$EXP$$NVSC2023US055201$NOVARTIS$$$$$M$Y$$$20240719$$CN$US$US
221023379$22102337$9$F$20210707$20240916$20230316$20240924$EXP$$CA-CELLTRION INC.-2021CA010816$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
221023412$22102341$2$F$$20240911$20230316$20240920$EXP$$BR-CELLTRION INC.-2023BR005265$CELLTRION$$$$$$Y$$$20240920$$CN$BR$BR
221023452$22102345$2$F$20221101$20240913$20230316$20240923$EXP$$BR-CELLTRION INC.-2022BR015416$CELLTRION$$$$$$Y$$$20240923$$CN$BR$BR
221023622$22102362$2$F$$20240910$20230316$20240918$EXP$$BR-CELLTRION INC.-2023BR005259$CELLTRION$$$$$$Y$$$20240918$$CN$BR$BR
221024623$22102462$3$F$$20240625$20230316$20240703$EXP$$FR-CELLTRION INC.-2023FR004954$CELLTRION$Armange L, Lacroix A, Petitgas P, Arvieux C, Piau-Couapel C, Poubeau P, et. al.. The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review.. European Journal of Clinical Microbiology and Infectious Diseases. 2023$$$$$Y$$$20240703$$HP$FR$FR
221024655$22102465$5$F$$20240806$20230316$20240809$EXP$$US-PFIZER INC-PV202300047178$PFIZER$Ahuja, T.. TO PLEX OR NOT TO PLEX FOR AMIODARONE INDUCED THYROTOXICOSIS. Journal of the American College of Cardiology. 2023;81 (8 Suppleme):2604$52$YR$$M$Y$$$20240809$$HP$US$US
221025055$22102505$5$F$20230201$20240626$20230316$20240702$EXP$$JP-009507513-2303JPN001120J$MERCK$$41$YR$$F$Y$$$20240702$$MD$JP$JP
221025516$22102551$6$F$20230214$20240918$20230316$20240926$EXP$$NVSC2023FR058029$NOVARTIS$$75$YR$$F$Y$45$KG$20240926$$MD$FR$FR
221029344$22102934$4$F$20230301$20240904$20230316$20240906$EXP$$US-PFIZER INC-PV202300048966$PFIZER$$82$YR$$F$Y$68.04$KG$20240906$$CN$US$US
221029393$22102939$3$F$20221222$20240710$20230316$20240718$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000056$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
221029443$22102944$3$F$$20240812$20230316$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01954$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221029488$22102948$8$F$$20240822$20230316$20240903$EXP$$CA-OTSUKA-2023_006563$OTSUKA$$$$$M$Y$$$20240903$$HP$CA$CA
2210303710$22103037$10$F$20230606$20240912$20230316$20240921$EXP$$CA-TAKEDA-2023TUS027182$TAKEDA$$56$YR$$F$Y$$$20240921$$CN$CA$CA
221030824$22103082$4$F$$20240912$20230316$20240926$EXP$$BR-CELLTRION INC.-2023BR005392$CELLTRION$$$$$$Y$$$20240926$$CN$BR$BR
221031263$22103126$3$F$20230225$20240809$20230316$20240812$PER$$NVSC2023US057743$NOVARTIS$$42$YR$$F$Y$$$20240812$$CN$US$US
221031345$22103134$5$F$$20240808$20230316$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01999$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221032223$22103222$3$F$$20240821$20230316$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02003$LUPIN$$$$$$Y$$$20240909$$CN$US$US
221032283$22103228$3$F$20210913$20240906$20230316$20240911$EXP$$CA-PFIZER INC-202101211849$PFIZER$$29$YR$$M$Y$84$KG$20240911$$HP$CA$CA
2210328516$22103285$16$F$20230101$20240806$20230316$20240812$EXP$$IN-PFIZER INC-PV202300047943$PFIZER$$64$YR$$M$Y$82$KG$20240812$$CN$IN$IN
221033173$22103317$3$F$$20240821$20230316$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02004$LUPIN$$$$$$Y$$$20240829$$CN$US$US
221034303$22103430$3$F$20230215$20240821$20230316$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02001$LUPIN$$$$$$Y$$$20240909$$CN$US$US
221034713$22103471$3$F$20240601$20240719$20230316$20240723$EXP$$US-TAKEDA-2023TUS026722$TAKEDA$$19$YR$$F$Y$$$20240723$$MD$US$US
221035702$22103570$2$F$20230221$20240716$20230316$20240722$EXP$GR-GREOF-202300190$GR-VERTEX PHARMACEUTICALS-2023-003727$VERTEX$$35$YR$$F$Y$56$KG$20240722$$MD$GR$GR
221036205$22103620$5$F$20181220$20240823$20230316$20240903$EXP$$PHHY2018CA195034$NOVARTIS$$55$YR$$M$Y$$$20240903$$CN$CA$CA
221036693$22103669$3$F$$20240809$20230316$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02052$LUPIN$$$$$$Y$$$20240829$$CN$US$US
221036739$22103673$9$F$20230509$20240918$20230316$20240926$EXP$$BR-TAKEDA-2023TUS027277$TAKEDA$$72$YR$$F$Y$$$20240926$$CN$BR$BR
221037873$22103787$3$F$$20240823$20230316$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01998$LUPIN$$$$$$Y$$$20240902$$CN$US$US
221037983$22103798$3$F$$20240823$20230316$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02006$LUPIN$$$$$$Y$$$20240912$$PH$US$US
221038043$22103804$3$F$$20240823$20230316$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02010$LUPIN$$$$$$Y$$$20240910$$CN$US$US
2210387611$22103876$11$F$$20240918$20230316$20240930$PER$$NVSC2023US058796$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
221041512$22104151$2$F$$20230308$20230316$20240715$EXP$$NVSC2023US057081$NOVARTIS$$$$$M$Y$$$20240715$$CN$US$US
221043558$22104355$8$F$20211201$20240813$20230316$20240816$EXP$$US-PFIZER INC-202300114562$PFIZER$$70$YR$$F$Y$92.971$KG$20240816$$CN$US$US
221043992$22104399$2$F$$20240813$20230316$20240816$PER$$US-TAKEDA-2023TUS027353$TAKEDA$$$$$F$Y$84$KG$20240816$$MD$US$US
221044325$22104432$5$F$$20240809$20230316$20240818$PER$$US-SA-2023SA083429$SANOFI AVENTIS$$20$YR$A$M$Y$75$KG$20240818$$MD$US$US
221044759$22104475$9$F$20220807$20240820$20230316$20240902$EXP$$JP-SAKK-2023SA075610AA$SANOFI AVENTIS$$86$YR$E$M$Y$52.5$KG$20240903$$MD$JP$JP
221046222$22104622$2$F$20230117$20240712$20230316$20240723$EXP$$GB-NOVOPROD-1024570$NOVO NORDISK$$75$YR$$M$Y$86$KG$20240723$$MD$GB$GB
2210465310$22104653$10$F$20230201$20240911$20230316$20240918$EXP$$NVSC2023GB012849$NOVARTIS$$$$A$F$Y$$$20240918$$CN$GB$GB
2210489714$22104897$14$F$20230310$20240904$20230316$20240905$EXP$$NVSC2023US060996$NOVARTIS$$44$YR$$F$Y$$$20240905$$CN$US$US
221049145$22104914$5$F$20230201$20240725$20230316$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-005846$JAZZ$$19$YR$$F$Y$46$KG$20240730$$MD$US$US
221049204$22104920$4$F$20240501$20240708$20230316$20240711$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-006163$JAZZ$$42$YR$$F$Y$$$20240711$$CN$US$US
2210494912$22104949$12$F$20190101$20240806$20230316$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-006142$JAZZ$$$$$M$Y$$$20240813$$CN$US$US
2210496015$22104960$15$F$20200929$20240809$20230316$20240814$EXP$$US-TAKEDA-2023TUS026760$TAKEDA$$25$YR$$M$Y$$$20240814$$CN$US$US
221051774$22105177$4$F$20230312$20240830$20230316$20240905$EXP$$CA-ROCHE-3311432$ROCHE$$42$YR$A$F$Y$$$20240905$$CN$CA$CA
221051907$22105190$7$F$$20240902$20230316$20240916$EXP$$CA-CELLTRION INC.-2023CA005282$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
221052293$22105229$3$F$20230101$20240726$20230317$20240805$PER$$US-SA-2023SA084066$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240804$$MD$US$US
221054193$22105419$3$F$$20240627$20230317$20240702$EXP$$NVSC2020CO095965$NOVARTIS$$$$$F$Y$100$KG$20240702$$CN$CO$CO
221056742$22105674$2$F$$20240812$20230317$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02012$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221056862$22105686$2$F$$20240821$20230317$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02008$LUPIN$$$$$$Y$$$20240904$$CN$US$US
221056973$22105697$3$F$20230306$20240730$20230317$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02021$LUPIN$$$$$$Y$$$20240818$$CN$US$US
221057352$22105735$2$F$20230307$20240821$20230317$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02022$LUPIN$$2$YR$$M$Y$14.51$KG$20240909$$CN$US$US
221057523$22105752$3$F$$20240823$20230317$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02025$LUPIN$$$$$$Y$$$20240912$$PH$US$US
221057712$22105771$2$F$$20240823$20230317$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02026$LUPIN$$$$$$Y$$$20240911$$CN$US$US
221057803$22105780$3$F$20230301$20240802$20230317$20240809$PER$$US-SA-2023SA082487$SANOFI AVENTIS$$62$YR$A$F$Y$81.64$KG$20240809$$MD$US$US
221057944$22105794$4$F$20240801$20240820$20230317$20240911$PER$$US-SA-2023SA082945$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240911$$HP$US$US
221058475$22105847$5$F$20240214$20240809$20230317$20240814$EXP$$JP-TAKEDA-2023TJP003532$TAKEDA$$80$YR$$M$Y$51.8$KG$20240814$$MD$JP$JP
221059843$22105984$3$F$20230301$20240726$20230317$20240806$PER$$US-SA-2023SA081074$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240806$$MD$US$US
221060144$22106014$4$F$$20240705$20230317$20240717$PER$$US-SA-2023SA079964$SANOFI AVENTIS$$$$E$F$Y$$$20240717$$MD$US$US
221060655$22106065$5$F$$20240729$20230317$20240807$PER$$US-SA-2023SA082381$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240807$$MD$US$US
2210609412$22106094$12$F$20230101$20240723$20230317$20240801$EXP$$US-SA-2023SA080386$SANOFI AVENTIS$$26$YR$A$M$Y$68$KG$20240801$$MD$US$US
221061195$22106119$5$F$$20240924$20230317$20240930$EXP$$NVSC2023US061269$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
221061592$22106159$2$F$$20240827$20230317$20240910$PER$$US-SA-2023SA081512$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240910$$MD$US$US
221061795$22106179$5$F$20220525$20240819$20230317$20240827$EXP$$JP-SA-2023SA079797$SANOFI AVENTIS$Tomoda T, Nishimura A, Kamiya T, Inoue K, Katano H, Iida S, et al.. Immune reconstitution and cidofovir administration rescue human adenovirus hepatitis after allogeneic hematopoietic cell transplantation.. Transplant Immunology.. 2024;86:1-8$14$YR$T$M$Y$47.7$KG$20240827$$MD$JP$JP
221062667$22106266$7$F$20221210$20240916$20230317$20240924$EXP$$NL-CELLTRION INC.-2023NL002054$CELLTRION$$$$$$Y$$$20240924$$MD$NL$NL
221063572$22106357$2$F$20230101$20240801$20230317$20240808$PER$$US-SA-2023SA081017$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240808$$MD$US$US
221064323$22106432$3$F$$20240708$20230317$20240716$30DAY$$US-GSK-US2023035944$GLAXOSMITHKLINE$$$$$F$Y$$$20240716$$CN$US$US
221065576$22106557$6$F$20221001$20240716$20230317$20240724$PER$$US-SA-2023SA079616$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240724$$MD$US$US
221065964$22106596$4$F$20230301$20240822$20230317$20240916$EXP$$US-SA-2023SA079455$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240916$$MD$US$US
221066663$22106666$3$F$20240101$20240904$20230317$20240913$PER$$US-SA-2023SA078849$SANOFI AVENTIS$$$$C$F$Y$$$20240913$$MD$US$US
221066788$22106678$8$F$20230601$20240909$20230317$20240919$PER$$US-SA-2023SA079129$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
221067082$22106708$2$F$20240701$20240828$20230317$20240920$PER$$US-SA-2023SA076955$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240920$$MD$US$US
221067193$22106719$3$F$20230101$20240621$20230317$20240705$PER$$US-SA-2023SA076957$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240705$$MD$US$US
221069543$22106954$3$F$20230207$20240625$20230317$20240703$PER$$US-SA-2023SA084741$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240703$$MD$US$US
221070315$22107031$5$F$20231011$20240701$20230317$20240707$PER$$US-SA-2023SA082394$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240707$$MD$US$US
221070663$22107066$3$F$20230301$20240822$20230317$20240917$PER$$US-SA-2023SA082118$SANOFI AVENTIS$$80$YR$E$F$Y$53.5$KG$20240918$$MD$US$US
221070764$22107076$4$F$20221101$20240625$20230317$20240704$PER$$US-SA-2023SA081797$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240704$$CN$US$US
221071883$22107188$3$F$$20240812$20230317$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02029$LUPIN$$$$$$Y$$$20240831$$CN$US$US
221071904$22107190$4$F$20200314$20240815$20230317$20240822$EXP$$US-ABBVIE-4247974$ABBVIE$$64$YR$$F$Y$$$20240822$$CN$US$US
221073692$22107369$2$F$$20240809$20230317$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02048$LUPIN$$$$$$Y$$$20240830$$CN$US$US
221073922$22107392$2$F$$20230314$20230317$20240801$PER$$NVSC2023US060593$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
221075634$22107563$4$F$$20240812$20230317$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02055$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221076874$22107687$4$F$$20240812$20230317$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02056$LUPIN$$$$$$Y$$$20240831$$CN$US$US
221077336$22107733$6$F$20190227$20240917$20230317$20240919$EXP$$CA-TAKEDA-2021TUS078616$TAKEDA$$26$YR$$M$Y$$$20240919$$HP$CA$CA
2210785311$22107853$11$F$20210101$20240905$20230317$20240914$EXP$$CA-CELLTRION INC.-2021CA008135$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
221078614$22107861$4$F$$20240812$20230317$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02060$LUPIN$$$$$$Y$$$20240825$$CN$US$US
2210789412$22107894$12$F$20240301$20240701$20230317$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-037919$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240705$$CN$US$US
221079113$22107911$3$F$$20240911$20230317$20240924$EXP$$BR-CELLTRION INC.-2023BR005267$CELLTRION$$$$$$Y$$$20240924$$CN$BR$BR
221079565$22107956$5$F$20230108$20240726$20230317$20240803$EXP$$CN-TAKEDA-2023TUS027233$TAKEDA$$50$YR$$M$Y$50$KG$20240803$$MD$CN$CN
221079984$22107998$4$F$20230307$20240906$20230317$20240916$30DAY$$US-GSK-US2023037540$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240916$$CN$US$US
221080013$22108001$3$F$$20240717$20230317$20240729$EXP$$CA-APOTEX-2023AP005075$APOTEX$$57$YR$$F$Y$$$20240729$$HP$CA$CA
221080652$22108065$2$F$$20240806$20230317$20240813$PER$$US-SA-2023SA083461$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240814$$MD$US$US
221081942$22108194$2$F$$20230310$20230317$20240919$EXP$$NVSC2023GR058306$NOVARTIS$$$$$$Y$$$20240919$$MD$GR$GR
221082144$22108214$4$F$$20240718$20230317$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-037706$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$CN$CA$CA
221082254$22108225$4$F$$20240812$20230317$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02125$LUPIN$$$$$$Y$$$20240904$$CN$US$US
221083652$22108365$2$F$$20240909$20230317$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02057$LUPIN$$$$$$Y$$$20240925$$CN$US$US
221084136$22108413$6$F$20201026$20240624$20230317$20240704$EXP$$DE-PUMA BIOTECHNOLOGY, INC.-2021DE001401$PUMA$$$$$$Y$$$20240704$$HP$DE$DE
2210851713$22108517$13$F$20221017$20240820$20230317$20240823$EXP$$CA-TAKEDA-2022TUS031901$TAKEDA$$75$YR$$M$Y$$$20240823$$CN$CA$CA
221085453$22108545$3$F$$20240823$20230317$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01992$LUPIN$$$$$$Y$$$20240911$$CN$US$US
221085576$22108557$6$F$20230301$20230615$20230317$20240925$PER$$US-GSK-US2023AMR039845$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240925$$CN$US$US
221086012$22108601$2$F$$20240909$20230317$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02058$LUPIN$$$$$$Y$$$20240925$$CN$US$US
2210866219$22108662$19$F$20200317$20240919$20230317$20240927$EXP$$CA-CELLTRION INC.-2021CA016724$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
221086695$22108669$5$F$20230301$20230403$20230317$20240925$EXP$$US-GSK-US2023AMR038105$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
221089946$22108994$6$F$20231101$20240715$20230317$20240717$EXP$$US-TAKEDA-US202020850$TAKEDA$$76$YR$$F$Y$$$20240717$$HP$US$US
221090075$22109007$5$F$$20240717$20230317$20240723$EXP$$NVSC2023US058486$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
221093233$22109323$3$F$$20230313$20230317$20240827$EXP$$IN-AstraZeneca-2023A061853$ASTRAZENECA$$60$YR$$F$Y$80$KG$20240827$$CN$IN$
221093554$22109355$4$F$20230301$20240909$20230317$20240917$EXP$$DE-SA-2023SA084846$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240917$$HP$DE$DE
221093803$22109380$3$F$$20240812$20230317$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02061$LUPIN$$$$$$Y$$$20240828$$PH$US$US
221094032$22109403$2$F$$20240909$20230317$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02076$LUPIN$$$$$$Y$$$20240925$$CN$US$US
221094455$22109445$5$F$20080101$20240628$20230317$20240705$EXP$$US-JAZZ-2022-US-034000$JAZZ$$$$$F$Y$$$20240705$$CN$US$US
2210948113$22109481$13$F$20231006$20240916$20230317$20240923$EXP$$CA-TAKEDA-2022TUS068637$TAKEDA$$83$YR$$M$Y$$$20240923$$HP$CA$CA
221096033$22109603$3$F$20230124$20240705$20230317$20240711$EXP$$US-INCYTE CORPORATION-2023IN002651$INCYTE$$$$$$Y$$$20240711$$MD$US$US
221096722$22109672$2$F$$20240909$20230317$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02085$LUPIN$$$$$$Y$$$20240923$$PH$US$US
221097363$22109736$3$F$$20240909$20230317$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02086$LUPIN$$$$$$Y$$$20240921$$CN$US$US
221097372$22109737$2$F$20230130$20240904$20230317$20240912$EXP$$BR-CELLTRION INC.-2023BR005369$CELLTRION$$$$$$Y$$$20240912$$CN$BR$BR
2210991010$22109910$10$F$20201218$20240711$20230317$20240716$EXP$$IN-PFIZER INC-PV202200018099$PFIZER$$45$YR$$M$Y$$$20240716$$CN$IN$IN
221099623$22109962$3$F$20230101$20240705$20230317$20240709$EXP$$AR-PFIZER INC-PV202300050973$PFIZER$$73$YR$$F$Y$$$20240709$$CN$AR$AR
221100468$22110046$8$F$20211228$20240816$20230317$20240823$EXP$$NVSC2022GB255963$NOVARTIS$$$$A$F$Y$$$20240823$$MD$GB$GB
221101703$22110170$3$F$$20240905$20230317$20240909$PER$$US-PFIZER INC-202300110420$PFIZER$$62$YR$$F$Y$$$20240909$$MD$US$US
221102702$22110270$2$F$20230127$20240802$20230317$20240812$EXP$FR-AFSSAPS-PV2023000166$FR-TEVA-2023-FR-2866592$TEVA$$10$YR$$F$Y$54$KG$20240812$$MD$FR$FR
221103173$22110317$3$F$$20240829$20230317$20240904$PER$$US-PFIZER INC-PV202300048709$PFIZER$$78$YR$$F$Y$$$20240904$$CN$US$US
221103244$22110324$4$F$$20240722$20230317$20240801$30DAY$$US-GSK-US2023036741$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
221103313$22110331$3$F$$20240903$20230317$20240912$PER$$US-SA-2023SA084705$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240912$$MD$US$US
221103453$22110345$3$F$20220101$20240805$20230317$20240809$EXP$$NVSC2023MX058281$NOVARTIS$$$$$F$Y$72$KG$20240809$$CN$MX$MX
221104232$22110423$2$F$$20240730$20230317$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02102$LUPIN$$$$$$Y$$$20240817$$CN$US$US
221104914$22110491$4$F$$20240812$20230317$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02137$LUPIN$$$$$$Y$$$20240829$$CN$US$US
221106185$22110618$5$F$20230228$20240813$20230317$20240816$EXP$$CA-TAKEDA-2023TUS027551$TAKEDA$$68$YR$$F$Y$$$20240816$$MD$CA$CA
221107046$22110704$6$F$$20240822$20230317$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-039493$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240830$$HP$US$US
221108997$22110899$7$F$20220301$20240912$20230317$20240916$PER$$US-PFIZER INC-PV202300005371$PFIZER$$78$YR$$F$Y$68.95$KG$20240916$$CN$US$US
221110357$22111035$7$F$20221215$20240920$20230317$20240927$EXP$$CA-TAKEDA-2022TUS068191$TAKEDA$$40$YR$$M$Y$$$20240927$$MD$CA$CA
2211106917$22111069$17$F$20230301$20230823$20230317$20240927$EXP$$BG-AKCEA THERAPEUTICS, INC.-2023IS001266$AKCEA THERAPEUTICS$$$$$$Y$$$20240926$$HP$BG$BG
221113682$22111368$2$F$20210101$20240723$20230317$20240726$EXP$$US-009507513-2303USA006068$MERCK$$$$$F$Y$$$20240726$$CN$US$US
2211148411$22111484$11$F$20230205$20240712$20230317$20240717$EXP$$NVSC2023US058443$NOVARTIS$$56$YR$$F$Y$$$20240718$$CN$US$US
221116422$22111642$2$F$$20240716$20230318$20240726$EXP$$GB-AUROBINDO-AUR-APL-2023-011292$AUROBINDO$$68$YR$$M$Y$$$20240726$$HP$GB$GB
221119212$22111921$2$F$20230227$20240906$20230318$20240917$EXP$$US-JNJFOC-20230324379$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240917$$HP$US$US
221119365$22111936$5$F$20230501$20240702$20230318$20240705$EXP$$US-UCBSA-2023011539$UCB$$46$YR$$M$Y$$$20240705$$HP$US$US
221119525$22111952$5$F$20190523$20240625$20230318$20240702$EXP$$NVSC2023DE057832$NOVARTIS$$65$YR$$F$Y$108$KG$20240702$$MD$DE$DE
221120798$22112079$8$F$$20240712$20230318$20240716$EXP$$US-TAKEDA-2023TUS021818$TAKEDA$$$$$M$Y$113$KG$20240716$$HP$US$US
221122753$22112275$3$F$20201101$20240725$20230318$20240726$EXP$$US-UCBSA-2023014129$UCB$$0$YR$$M$Y$1.905$KG$20240726$$HP$US$US
221122773$22112277$3$F$20201101$20240725$20230318$20240726$EXP$$US-UCBSA-2023014127$UCB$$0$YR$$M$Y$2.22$KG$20240726$$HP$US$US
221122962$22112296$2$F$$20240912$20230318$20240920$PER$$US-SA-2023SA085786$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240920$$MD$US$US
221124508$22112450$8$F$20230101$20240709$20230319$20240711$EXP$$CA-UCBSA-2023012748$UCB$$$$$F$Y$$$20240711$$CN$CA$CA
221125806$22112580$6$F$20230101$20240812$20230319$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-225305$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240821$$CN$US$US
221127002$22112700$2$F$20230201$20240722$20230319$20240726$EXP$$US-BIOGEN-2023BI01194190$BIOGEN$$41$YR$$M$Y$$$20240726$$CN$US$US
221128129$22112812$9$F$20220429$20240904$20230320$20240913$EXP$$CA-CELLTRION INC.-2022CA007406$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
221128539$22112853$9$F$$20240715$20230320$20240723$EXP$$US-TAKEDA-2023TUS007175$TAKEDA$$$$$M$Y$$$20240723$$CN$US$US
221129633$22112963$3$F$$20240809$20230320$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02027$LUPIN$$$$$$Y$$$20240830$$CN$US$US
221130192$22113019$2$F$$20240716$20230320$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-039403$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240729$$HP$CA$CA
2211318010$22113180$10$F$20220817$20240822$20230320$20240830$EXP$$CA-CELLTRION INC.-2022CA014041$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
2211321010$22113210$10$F$20221130$20240823$20230320$20240829$EXP$$DE-EXELIXIS-XL18423061914$EXELIXIS$$$$$$Y$$$20240829$$HP$DE$DE
221132126$22113212$6$F$$20231023$20230320$20240911$PER$$NVSC2023US059731$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
221133543$22113354$3$F$$20240812$20230320$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02053$LUPIN$$$$$$Y$$$20240901$$CN$US$US
221133657$22113365$7$F$$20240913$20230320$20240920$EXP$$NVSC2023GB059261$NOVARTIS$$54$YR$$M$Y$$$20240920$$CN$GB$GB
221133795$22113379$5$F$20221229$20240703$20230320$20240710$EXP$$BE-JNJFOC-20230331066$JOHNSON AND JOHNSON$$$$$M$Y$83.3$KG$20240710$$MD$BE$BE
221134203$22113420$3$F$$20230314$20230320$20240813$EXP$$JP-AstraZeneca-2023A063709$ASTRAZENECA$$$$$$Y$$$20240813$$PH$JP$
221135225$22113522$5$F$$20240619$20230320$20240710$PER$$AU-TOLMAR, INC.-23AU039101$TOLMAR$$$$$M$Y$$$20240710$$CN$AU$AU
221136194$22113619$4$F$20220222$20240808$20230320$20240820$EXP$$CA-CELLTRION INC.-2022CA001713$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
221137663$22113766$3$F$$20240725$20230320$20240729$PER$$US-AMGEN-USASP2023048356$AMGEN$$$$A$M$Y$$$20240729$$HP$US$US
221137863$22113786$3$F$$20240909$20230320$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02037$LUPIN$$$$$$Y$$$20240924$$CN$US$US
221138242$22113824$2$F$$20240820$20230320$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02047$LUPIN$$$$$$Y$$$20240906$$CN$US$US
221138543$22113854$3$F$$20240820$20230320$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-01961$LUPIN$$$$$$Y$$$20240830$$CN$US$US
221139172$22113917$2$F$$20230314$20230320$20240731$PER$$NVSC2023US060885$NOVARTIS$$$$$M$Y$$$20240731$$CN$US$US
221139568$22113956$8$F$20220104$20240925$20230320$20240928$EXP$$CH-ABBVIE-22K-151-4228548-00$ABBVIE$$74$YR$$M$Y$85$KG$20240928$$MD$CH$CH
221140163$22114016$3$F$20240101$20240830$20230320$20240911$PER$$US-SA-2023SA086026$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240911$$MD$US$US
221140713$22114071$3$F$$20240909$20230320$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02090$LUPIN$$$$$$Y$$$20240923$$CN$US$US
2211450010$22114500$10$F$20230313$20240625$20230320$20240702$EXP$$CA-GSK-CA2023039005$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$CA$CA
221145262$22114526$2$F$20221201$20240920$20230320$20240926$PER$$US-009507513-2303USA005183$MERCK$$77$YR$$M$Y$$$20240926$$CN$US$US
221146663$22114666$3$F$$20240812$20230320$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02132$LUPIN$$$$$$Y$$$20240831$$CN$US$US
221146682$22114668$2$F$$20240909$20230320$20240921$EXP$$US-AUROBINDO-AUR-APL-2023-011833$AUROBINDO$Anyanwu CO, Sommer LL, Kuzyshyn H, Camacho JM, Eid HM, Heymann WR. Discoid lupus erythematosus following herpes zoster. Cutis. 2018;101(5):370-2.$20$YR$$F$Y$$$20240921$$MD$US$US
221146733$22114673$3$F$20230312$20240705$20230320$20240716$PER$$US-SA-2023SA085558$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240716$$MD$US$US
221148312$22114831$2$F$$20240916$20230320$20240924$EXP$$BR-CELLTRION INC.-2023BR005751$CELLTRION$$$$$$Y$$$20240924$$CN$BR$BR
221148773$22114877$3$F$20230301$20240906$20230320$20240912$PER$$US-BEH-2023156436$CSL BEHRING$$78$YR$E$M$Y$$$20240912$$HP$US$US
221149276$22114927$6$F$20220912$20240808$20230320$20240814$EXP$$IN-PFIZER INC-PV202200064316$PFIZER$$34$YR$$M$Y$74.8$KG$20240814$$CN$IN$IN
221149853$22114985$3$F$$20240823$20230320$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02138$LUPIN$$$$$$Y$$$20240902$$CN$US$US
221150653$22115065$3$F$$20240823$20230320$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02152$LUPIN$$$$$$Y$$$20240910$$CN$US$US
221150663$22115066$3$F$20240901$20240913$20230320$20240923$PER$$US-SA-2023SA087644$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240923$$MD$US$US
221150724$22115072$4$F$20140602$20240703$20230320$20240711$EXP$$US-TAKEDA-US201403124$TAKEDA$$9$YR$$M$Y$46$KG$20240711$$CN$US$US
221152162$22115216$2$F$$20240730$20230320$20240801$PER$$US-PFIZER INC-202300114207$PFIZER$$56$YR$$F$Y$61.23$KG$20240801$$CN$US$US
221153664$22115366$4$F$20230212$20240918$20230320$20240930$PER$$NVSC2023US060030$NOVARTIS$$49$YR$$F$Y$99.773$KG$20240930$$HP$US$US
221153842$22115384$2$F$$20240812$20230320$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02168$LUPIN$$$$$$Y$$$20240831$$CN$US$US
221155562$22115556$2$F$20240101$20240812$20230320$20240821$PER$$US-SA-2023SA087390$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
221156913$22115691$3$F$$20240828$20230320$20240829$EXP$$US-UCBSA-2022072068$UCB$$$$$F$Y$113.38$KG$20240829$$CN$US$US
221157077$22115707$7$F$20230101$20240911$20230320$20240923$EXP$$US-DSJP-DSU-2023-110227$DAIICHI$$$$$F$Y$90.249$KG$20240923$$CN$US$US
221157907$22115790$7$F$20220101$20240719$20230320$20240723$PER$$US-PFIZER INC-202200751480$PFIZER$$81$YR$$M$Y$75.283$KG$20240723$$CN$US$US
221158032$22115803$2$F$20221201$20240809$20230320$20240813$PER$$US-PFIZER INC-202300115936$PFIZER$$56$YR$$F$Y$$$20240813$$HP$US$US
221159693$22115969$3$F$20230101$20240627$20230320$20240701$PER$$US-PFIZER INC-202300118470$PFIZER$$60$YR$$M$Y$$$20240701$$HP$US$US
221159974$22115997$4$F$$20240720$20230320$20240723$PER$$US-PFIZER INC-202300115523$PFIZER$$66$YR$$M$Y$$$20240723$$CN$US$US
221160177$22116017$7$F$$20240715$20230320$20240717$PER$$US-PFIZER INC-PV202300052372$PFIZER$$61$YR$$F$Y$74.8$KG$20240717$$CN$US$US
221161565$22116156$5$F$20230201$20240918$20230320$20240927$EXP$$NVSC2023US063223$NOVARTIS$$25$YR$$M$Y$$$20240927$$CN$US$US
221162682$22116268$2$F$$20240716$20230320$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-037239$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240726$$HP$CA$CA
221164273$22116427$3$F$$20240816$20230320$20240819$EXP$$NVSC2023ZA063112$NOVARTIS$$$$$$Y$$$20240819$$MD$ZA$ZA
221165919$22116591$9$F$20230316$20240826$20230320$20240830$EXP$$US-AMGEN-USASP2023047909$AMGEN$$53$YR$A$F$Y$$$20240830$$HP$US$US
221166293$22116629$3$F$$20240801$20230320$20240808$EXP$NL-LRB-00869528$NL-TAKEDA-2023TUS028898$TAKEDA$$22$YR$$F$Y$60$KG$20240808$$HP$NL$NL
221167007$22116700$7$F$20240808$20240828$20230320$20240902$EXP$$US-TAKEDA-2023TUS026067$TAKEDA$$23$YR$$M$Y$45$KG$20240902$$CN$US$US
221170904$22117090$4$F$$20240702$20230320$20240704$EXP$$US-PFIZER INC-PV202200124784$PFIZER$$73$YR$$M$Y$80.726$KG$20240704$$CN$US$US
2211743813$22117438$13$F$20230201$20240911$20230321$20240918$EXP$$CA-JNJFOC-20201232484$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240918$$CN$CA$CA
221174793$22117479$3$F$$20230315$20230321$20240730$PER$$NVSC2023US062237$NOVARTIS$$$$$M$Y$$$20240730$$CN$US$US
221175572$22117557$2$F$20230101$20240729$20230321$20240806$PER$$US-009507513-2303USA003114$MERCK$$74$YR$$$Y$$$20240806$$CN$US$US
221176356$22117635$6$F$20230301$20230615$20230321$20240925$EXP$$US-GSK-US2023AMR041501$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
221177452$22117745$2$F$$20240827$20230321$20240910$PER$$US-SA-2023SA085214$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$MD$US$US
221181318$22118131$8$F$20230222$20240916$20230321$20240924$EXP$$DE-CELLTRION INC.-2023DE005508$CELLTRION$$$$$$Y$$$20240924$$MD$DE$DE
2211822012$22118220$12$F$20230101$20240821$20230321$20240827$EXP$$JP-009507513-2303JPN001651J$MERCK$$77$YR$$M$Y$$$20240827$$MD$JP$JP
221182236$22118223$6$F$20150101$20240709$20230321$20240711$EXP$$US-UCBSA-2023013612$UCB$$$$$F$Y$$$20240711$$CN$US$US
221182593$22118259$3$F$$20240812$20230321$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02139$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221182652$22118265$2$F$20210701$20240626$20230321$20240705$PER$$US-SA-2023SA089511$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240705$$MD$US$US
221183163$22118316$3$F$$20240823$20230321$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02189$LUPIN$$$$$$Y$$$20240911$$CN$US$US
221185884$22118588$4$F$$20240724$20230321$20240729$EXP$$US-AMGEN-USASP2023047544$AMGEN$$58$YR$A$F$Y$96.599$KG$20240729$$HP$US$US
221185997$22118599$7$F$$20240618$20230321$20240709$EXP$$CA-ROCHE-3306588$ROCHE$$$$A$F$Y$$$20240701$$CN$CA$CA
221188184$22118818$4$F$20221001$20240923$20230321$20240924$EXP$$US-KYOWAKIRIN-2023BKK004104$KYOWA$$$$$$Y$$$20240924$$HP$US$US
221188428$22118842$8$F$20230101$20240711$20230321$20240720$EXP$$CA-CELLTRION INC.-2022CA010553$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
221189672$22118967$2$F$20230220$20230313$20230321$20240712$EXP$$BG-ASTELLAS-2023US008606$ASTELLAS$$77$YR$$M$Y$$$20240712$$MD$BG$BG
221190012$22119001$2$F$20230306$20240701$20230321$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382097$RANBAXY$$$$A$M$Y$$$20240711$$HP$US$US
221190062$22119006$2$F$$20240829$20230321$20240913$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382127$RANBAXY$Sgrulletti M, Cifaldi C, Di Cesare S, Kroegler B, Del Duca E, Ferradini V, et al. Case Report: Crossing a rugged road in a primary immune regulatory disorder. Front Pediatr. 2023;Jan 09; 10:1055091(1-9)$47$YR$$F$Y$$$20240913$$HP$IT$IT
221190092$22119009$2$F$$20240716$20230321$20240718$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382035$RANBAXY$Zhang C, Sun J, Li Z, Liu N, Li C. Acute Visual Impairment in a Patient with Parkinson+apos;s Disease after Successful Bilateral Subthalamic Nucleus Deep Brain Stimulation with Low-Dose Levodopa: A Case Report. Brain Sci. 2023;13(1):103$63$YR$$M$Y$$$20240718$$HP$CN$CN
221190282$22119028$2$F$$20240909$20230321$20240920$EXP$$US-Accord-304201$ACCORD$Anyanwu CO, Sommer LL, Kuzyshyn H, Camacho JM, Eid HM, Heymann WR. Discoid lupus erythematosus following herpes zoster. Cutis. 2018;101(5):370-2$20$YR$A$F$Y$$$20240920$$MD$US$US
221191622$22119162$2$F$$20240712$20230321$20240722$PER$$US-SA-2023SA088962$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240721$$MD$US$US
221192626$22119262$6$F$20221118$20240703$20230321$20240705$EXP$$NVSC2023US060302$NOVARTIS$$54$YR$$F$Y$$$20240705$$CN$US$US
221193434$22119343$4$F$20230420$20240815$20230321$20240822$EXP$$CA-GSK-CA2023AMR041282$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$CA$CA
221197513$22119751$3$F$$20240707$20230321$20240708$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382129$RANBAXY$Liu E, Lv S, Yi P, Feng L, Deng X, Xia H, et al. Central nervous system infection with Seoul Orthohantavirus in a child after hematopoietic stem cell transplantation: a case report. Virol J. 2022;19(1):75 (1-8)$13$YR$$M$Y$$$20240708$$HP$CN$CN
221203303$22120330$3$F$$20240809$20230321$20240813$PER$$US-ROCHE-3237180$ROCHE$$$$$F$Y$$$20240813$$CN$US$US
221205345$22120534$5$F$20240725$20240815$20230321$20240823$EXP$$US-ROCHE-3308164$ROCHE$$57$YR$A$F$Y$527.98$KG$20240823$$CN$US$US
221206033$22120603$3$F$$20240916$20230321$20240924$EXP$$BR-CELLTRION INC.-2023BR005844$CELLTRION$$$$$$Y$$$20240924$$CN$BR$BR
2212080610$22120806$10$F$20210630$20240502$20230321$20240807$EXP$$NVSC2022IN242924$NOVARTIS$$77$YR$$F$Y$39.2$KG$20240807$$CN$IN$IN
221208573$22120857$3$F$$20240807$20230321$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02143$LUPIN$$$$$$Y$$$20240822$$PH$US$US
221209993$22120999$3$F$$20240819$20230321$20240821$EXP$$US-PFIZER INC-202300118862$PFIZER$$60$YR$$F$Y$$$20240821$$HP$US$US
221210134$22121013$4$F$$20240815$20230321$20240821$30DAY$$US-PFIZER INC-202300115090$PFIZER$$11$YR$$M$Y$$$20240821$$CN$US$US
221210213$22121021$3$F$20230315$20240904$20230321$20240915$PER$$US-SA-2023SA089156$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240915$$MD$US$US
221210585$22121058$5$F$20221228$20240819$20230321$20240821$EXP$$CA-PFIZER INC-202201322167$PFIZER$$45$YR$$M$Y$125$KG$20240821$$MD$CA$CA
221210596$22121059$6$F$20230316$20240919$20230321$20240924$EXP$$CA-PFIZER INC-202300058974$PFIZER$$81$YR$$F$Y$74$KG$20240924$$MD$CA$CA
221211008$22121100$8$F$20230301$20240906$20230321$20240911$EXP$$US-PFIZER INC-202300119011$PFIZER$$70$YR$$F$Y$68.027$KG$20240911$$CN$US$US
221212642$22121264$2$F$$20240905$20230321$20240909$EXP$$NZ-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-225976$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240909$$CN$NZ$NZ
221212685$22121268$5$F$$20240716$20230321$20240726$EXP$$JP-ROCHE-3312241$ROCHE$Nakajima N, Yutaka Y, Yuma I, Sayuri T, Hirotaka I, Tsuneyuki T. A case of rhabdomyolysis and acute renal  failure due to atezolizumab plus bevacizumab therapy. [Abstract number: P-0799]. The 33rd Annual Meeting of the Asian Pacific Association for the Study.. 2024;672:$6$DEC$A$M$Y$83$KG$20240726$$MD$JP$JP
2212127510$22121275$10$F$20170324$20240822$20230321$20240827$EXP$$CA-TAKEDA-2017TUS006921$TAKEDA$$61$YR$$F$Y$$$20240827$$HP$CA$CA
221212883$22121288$3$F$20230118$20230511$20230321$20240802$EXP$$BR-SA-2023SA089726$SANOFI AVENTIS$$47$YR$A$M$Y$82$KG$20240802$$CN$BR$BR
221213994$22121399$4$F$$20240719$20230321$20240801$PER$$US-SA-2023SA087849$SANOFI AVENTIS$$$$A$F$Y$$$20240801$$MD$US$US
2212154914$22121549$14$F$20220429$20240913$20230321$20240918$EXP$$US-TAKEDA-2022TUS038542$TAKEDA$$70$YR$$F$Y$95$KG$20240918$$MD$US$US
221216184$22121618$4$F$20230101$20240812$20230321$20240816$EXP$$DE-TAKEDA-2023TUS027562$TAKEDA$$27$YR$$F$Y$70$KG$20240816$$CN$DE$DE
2212162313$22121623$13$F$$20240813$20230321$20240816$EXP$$GB-TAKEDA-2021TUS033199$TAKEDA$$$$$M$Y$$$20240816$$HP$GB$GB
221216273$22121627$3$F$$20240812$20230321$20240816$EXP$$US-TAKEDA-2021TUS079923$TAKEDA$$$$$M$Y$$$20240816$$CN$US$US
221218752$22121875$2$F$$20240910$20230321$20240927$EXP$$CA-JNJFOC-20230338261$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$HP$CA$CA
221219903$22121990$3$F$$20240920$20230321$20240925$EXP$$US-TAKEDA-US201914467$TAKEDA$$$$$F$Y$$$20240925$$HP$US$US
221220273$22122027$3$F$$20240809$20230321$20240820$PER$$US-SA-2023SA089284$SANOFI AVENTIS$$$$T$F$Y$60.3$KG$20240820$$HP$US$US
221221898$22122189$8$F$20221001$20230317$20230321$20240808$EXP$$NVSC2023US064294$NOVARTIS$$63$YR$$M$Y$$$20240808$$CN$US$US
2212238811$22122388$11$F$20230101$20240928$20230321$20240930$EXP$$CA-PFIZER INC-202200939069$PFIZER$$81$YR$$M$Y$$$20240930$$HP$CA$CA
221226175$22122617$5$F$20220901$20240808$20230321$20240813$EXP$$US-INCYTE CORPORATION-2023IN002646$INCYTE$$$$$$Y$$$20240813$$CN$US$US
2212278910$22122789$10$F$20230201$20240725$20230322$20240729$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-222401$BOEHRINGER INGELHEIM$$59$YR$A$F$Y$63.6$KG$20240729$$CN$CA$CA
221229053$22122905$3$F$$20240918$20230322$20240927$EXP$$BR-CELLTRION INC.-2023BR005907$CELLTRION$$$$$$Y$$$20240927$$CN$BR$BR
221229325$22122932$5$F$20221020$20240823$20230322$20240830$EXP$$US-BIOGEN-2023BI01194543$BIOGEN$$61$YR$$F$Y$$$20240830$$CN$US$US
221229553$22122955$3$F$$20240807$20230322$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02117$LUPIN$$$$$$Y$$$20240828$$PH$US$US
221229592$22122959$2$F$$20240802$20230322$20240809$EXP$$GB-CELLTRION INC.-2023GB005941$CELLTRION$$$$$$Y$$$20240809$$PH$GB$GB
221229684$22122968$4$F$$20240823$20230322$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02146$LUPIN$$$$$$Y$$$20240910$$CN$US$US
221229912$22122991$2$F$20230301$20240917$20230322$20240926$EXP$$BR-CELLTRION INC.-2023BR005830$CELLTRION$$$$$$Y$$$20240926$$CN$BR$BR
221230374$22123037$4$F$$20240909$20230322$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02181$LUPIN$$$$$$Y$$$20240924$$CN$US$US
221230402$22123040$2$F$$20240909$20230322$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02209$LUPIN$$$$$$Y$$$20240924$$CN$US$US
221230443$22123044$3$F$$20240909$20230322$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02147$LUPIN$$$$$$Y$$$20240921$$CN$US$US
221230644$22123064$4$F$$20240916$20230322$20240924$EXP$$BR-CELLTRION INC.-2023BR005891$CELLTRION$$$$$$Y$$$20240924$$CN$BR$BR
2212310024$22123100$24$F$20220101$20240906$20230322$20240913$EXP$$CA-CELLTRION INC.-2022CA017088$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
221231442$22123144$2$F$$20240712$20230322$20240718$EXP$$CA-BIOGEN-2023BI01193842$BIOGEN$$64$YR$$F$Y$$$20240718$$CN$CA$CA
221231555$22123155$5$F$20221101$20240902$20230322$20240910$EXP$$JP-BIOGEN-2023BI01193907$BIOGEN$$38$YR$$F$Y$$$20240910$$MD$JP$JP
221232624$22123262$4$F$$20240619$20230322$20240703$EXP$$CA-ROCHE-3312317$ROCHE$$68$YR$E$F$Y$$$20240703$$CN$CA$CA
221233556$22123355$6$F$$20240815$20230322$20240823$EXP$$BR-CELLTRION INC.-2023BR002468$CELLTRION$$$$$$Y$$$20240823$$CN$BR$BR
221235642$22123564$2$F$$20240703$20230322$20240703$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382192$RANBAXY$Etienne S, Vosbeck J, Bernsmeier C, Osthoff M. Prevention of Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: a Case Series and Appraisal of Society Guidelines. J Gen Intern Med. 2023;38(2):490-501$63$YR$$F$Y$$$20240703$$MD$CH$CH
221236432$22123643$2$F$$20230316$20230322$20240712$EXP$$ZA-ASTELLAS-2023US009056$ASTELLAS$$82$YR$$M$Y$$$20240712$$MD$ZA$ZA
221236912$22123691$2$F$$20240809$20230322$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02133$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221236933$22123693$3$F$$20240909$20230322$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02124$LUPIN$$$$$$Y$$$20240924$$CN$US$US
221237684$22123768$4$F$$20240906$20230322$20240910$EXP$$GB-ROCHE-3313723$ROCHE$$44$YR$A$F$Y$$$20240910$$HP$GB$GB
221239052$22123905$2$F$$20230314$20230322$20240925$PER$$US-GSK-US2023AMR040430$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2212394310$22123943$10$F$20240529$20240828$20230322$20240904$EXP$$CA-GSK-CA2023AMR027271$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$HP$CA$CA
2212405812$22124058$12$F$20230114$20240809$20230322$20240812$EXP$$NVSC2023US060860$NOVARTIS$$43$YR$$F$Y$$$20240813$$CN$US$US
221240809$22124080$9$F$20230119$20240725$20230322$20240731$EXP$$GB-MYLANLABS-2023M1007157$MYLAN$$72$YR$$M$Y$$$20240731$$MD$GB$GB
221245615$22124561$5$F$$20240911$20230322$20240913$PER$$US-PFIZER INC-PV202300053421$PFIZER$$75$YR$$F$Y$84.354$KG$20240913$$CN$US$US
2212469211$22124692$11$F$$20240905$20230322$20240910$EXP$$CA-TAKEDA-2021TUS068823$TAKEDA$$$$$M$Y$$$20240910$$HP$CA$CA
221247922$22124792$2$F$20220418$20231122$20230322$20240905$EXP$$PH-OTSUKA-2023_007173$OTSUKA$$44$YR$$F$Y$$$20240905$$CN$PH$PH
2212490810$22124908$10$F$20210101$20240708$20230322$20240715$EXP$$US-VERTEX PHARMACEUTICALS-2023-003850$VERTEX$$19$YR$$F$Y$$$20240715$$CN$US$US
221249317$22124931$7$F$20230313$20240830$20230322$20240903$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-006590$JAZZ$$34$YR$$M$Y$$$20240903$$CN$US$US
221249352$22124935$2$F$$20240716$20230322$20240722$EXP$$BE-MYLANLABS-2023M1029228$MYLAN$$$$$M$Y$$$20240722$$MD$BE$BE
2212504215$22125042$15$F$20220914$20240814$20230322$20240823$EXP$$IN-ROCHE-3272441$ROCHE$$55$YR$A$F$Y$$$20240823$$MD$IN$IN
221250852$22125085$2$F$20220101$20240815$20230322$20240828$PER$$US-SA-2023SA088517$SANOFI AVENTIS$$24$YR$A$M$Y$72.5$KG$20240828$$MD$US$US
2212531217$22125312$17$F$$20240729$20230322$20240801$PER$$US-PFIZER INC-PV202300053314$PFIZER$$68$YR$$F$Y$68.04$KG$20240801$$CN$US$US
221255178$22125517$8$F$$20240910$20230322$20240912$EXP$$CA-JNJFOC-20230106566$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240912$$HP$CA$CA
221257226$22125722$6$F$20191101$20240821$20230322$20240827$EXP$$NVSC2019CA067272$NOVARTIS$$26$YR$$F$Y$$$20240827$$CN$CA$CA
221257316$22125731$6$F$20221116$20240725$20230322$20240807$EXP$FR-ROCHE-3313098$FR-ROCHE-3313098$ROCHE$$72$YR$E$F$Y$59$KG$20240807$$PH$FR$FR
221259004$22125900$4$F$$20240719$20230322$20240722$EXP$$CA-JNJFOC-20230342145$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240722$$HP$CA$CA
221259767$22125976$7$F$20220815$20240715$20230322$20240722$EXP$$CA-TAKEDA-2022TUS058736$TAKEDA$$51$YR$$M$Y$$$20240722$$CN$CA$CA
221266549$22126654$9$F$20240830$20240830$20230322$20240905$EXP$$US-PFIZER INC-PV202300052444$PFIZER$$73$YR$$F$Y$86.18$KG$20240905$$CN$US$US
221267605$22126760$5$F$$20240722$20230322$20240723$EXP$$CA-PFIZER INC-202300121778$PFIZER$$56$YR$$F$Y$$$20240723$$HP$CA$CA
221268756$22126875$6$F$$20240910$20230322$20240912$PER$$US-PFIZER INC-PV202300053690$PFIZER$$82$YR$$F$Y$38.73$KG$20240912$$CN$US$US
221269099$22126909$9$F$20230101$20240726$20230322$20240802$EXP$$FR-JNJFOC-20230334564$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240802$$MD$FR$FR
221269429$22126942$9$F$20220701$20240910$20230322$20240913$EXP$$US-PFIZER INC-PV202300034531$PFIZER$$78$YR$$F$Y$70.31$KG$20240913$$CN$US$US
221275484$22127548$4$F$20230101$20240730$20230323$20240807$PER$$US-SA-2023SA090850$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240807$$MD$US$US
221275532$22127553$2$F$20240401$20240730$20230323$20240813$EXP$$US-CELLTRION INC.-2023US005894$CELLTRION$$$$$$Y$$$20240813$$CN$US$US
221275576$22127557$6$F$20221101$20240906$20230323$20240926$PER$$CA-TOLMAR, INC.-23CA039240$TOLMAR$$85$YR$$M$Y$$$20240926$$CN$CA$CA
221276175$22127617$5$F$$20240701$20230323$20240702$PER$$NVSC2023US060025$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
221276852$22127685$2$F$$20240717$20230323$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382096$RANBAXY$Tiwari S, Grover S. PALIPERIDONE INDUCED CONCURRENT TARDIVE DYSTONIA AND TARDIVE DYSKINESIA IN A YOUNG MALE WITH SCHIZOPHRENIA MANAGED WITH CLOZAPINE: A CASE REPORT. Indian J Psychiatry. 2023;Jan;65(Suppl.1):S73$25$YR$$M$Y$$$20240718$$HP$IN$IN
221277637$22127763$7$F$20220501$20240827$20230323$20240830$EXP$$US-ABBVIE-4697988$ABBVIE$$81$YR$$M$Y$93$KG$20240830$$CN$US$US
221277866$22127786$6$F$$20240917$20230323$20240927$EXP$$BR-CELLTRION INC.-2023BR005928$CELLTRION$$$$$$Y$$$20240927$$CN$BR$BR
221279365$22127936$5$F$20230101$20240812$20230323$20240816$PER$$US-GBT-020943$PFIZER$$67$YR$$F$Y$$$20240816$$CN$US$US
221280212$22128021$2$F$20230315$20240917$20230323$20240926$EXP$$BR-CELLTRION INC.-2023BR006047$CELLTRION$$$$$$Y$$$20240926$$CN$BR$BR
221280646$22128064$6$F$20230202$20240729$20230323$20240731$EXP$$CA-TAKEDA-2022TUS069364$TAKEDA$$77$YR$$F$Y$$$20240731$$CN$CA$CA
2212810611$22128106$11$F$20220101$20240823$20230323$20240827$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-179618$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$$$20240827$$CN$US$US
221282032$22128203$2$F$$20240711$20230323$20240723$EXP$$NL-AUROBINDO-AUR-APL-2023-012333$AUROBINDO$$14$YR$$F$Y$60$KG$20240719$$MD$NL$NL
221285113$22128511$3$F$$20230316$20230323$20240724$PER$$NVSC2023US063003$NOVARTIS$$$$$M$Y$$$20240724$$MD$US$US
221286586$22128658$6$F$20230224$20240828$20230323$20240909$EXP$$US-Accord-304657$ACCORD$$77$YR$E$F$Y$70.7$KG$20240909$$HP$US$US
221286865$22128686$5$F$$20240909$20230323$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02200$LUPIN$$$$$$Y$$$20240925$$CN$US$US
221287707$22128770$7$F$20201204$20240712$20230323$20240725$EXP$$DE-ROCHE-2738966$ROCHE$$58$YR$A$F$Y$$$20240725$$CN$DE$DE
221287912$22128791$2$F$$20240909$20230323$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02199$LUPIN$$$$$$Y$$$20240924$$CN$US$US
221288033$22128803$3$F$$20240823$20230323$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02197$LUPIN$$$$$$Y$$$20240911$$CN$US$US
221288426$22128842$6$F$20230225$20240902$20230323$20240923$PER$$CA-TOLMAR, INC.-23CA039200$TOLMAR$$85$YR$$M$Y$$$20240923$$CN$CA$CA
221288523$22128852$3$F$20230125$20240722$20230323$20240729$EXP$$CA-ABBVIE-4299435$ABBVIE$$88$YR$$F$Y$$$20240729$$CN$CA$CA
221288883$22128888$3$F$$20240909$20230323$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02188$LUPIN$$$$$$Y$$$20240923$$CN$US$US
221289474$22128947$4$F$$20240807$20230323$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02187$LUPIN$$$$$$Y$$$20240828$$PH$US$US
221290516$22129051$6$F$20220501$20240730$20230323$20240802$EXP$$US-ABBVIE-4697891$ABBVIE$$62$YR$$F$Y$70.306$KG$20240802$$CN$US$US
221290932$22129093$2$F$20230318$20230321$20230323$20240808$EXP$$NVSC2023US065997$NOVARTIS$$92$YR$$M$Y$74.83$KG$20240808$$CN$US$US
221291212$22129121$2$F$$20240909$20230323$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02145$LUPIN$$$$$$Y$$$20240920$$CN$US$US
221291445$22129144$5$F$$20240722$20230323$20240725$EXP$$CA-Orion Corporation ORION PHARMA-23_00022721$ORION$$56$YR$A$F$Y$$$20240725$$HP$CA$
221293075$22129307$5$F$20230311$20240826$20230323$20240905$30DAY$$US-GSK-US2023042555$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240905$$CN$US$US
221295232$22129523$2$F$$20240807$20230323$20240820$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202303-000314$UNICHEM$$52$YR$A$M$Y$$$20240820$$HP$US$
221295742$22129574$2$F$$20240902$20230323$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202303010956$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240913$$CN$US$US
2212958512$22129585$12$F$$20240826$20230323$20240902$EXP$$US-TAKEDA-2023TUS027387$TAKEDA$$$$$F$Y$67.574$KG$20240902$$HP$US$US
221296355$22129635$5$F$20220101$20240926$20230323$20240930$EXP$$NVSC2023KW063216$NOVARTIS$$44$YR$$F$Y$$$20240930$$CN$KW$KW
221296397$22129639$7$F$20230201$20240716$20230323$20240722$EXP$$NVSC2023BR062591$NOVARTIS$$75$YR$$F$Y$$$20240722$$CN$BR$BR
221296704$22129670$4$F$20220101$20240918$20230323$20240930$PER$$NVSC2023US063646$NOVARTIS$$9$YR$$F$Y$$$20240930$$CN$US$US
221297593$22129759$3$F$20210620$20240707$20230323$20240718$EXP$$EG-ROCHE-2857591$ROCHE$$48$YR$A$F$Y$120$KG$20240718$$CN$EG$EG
221297864$22129786$4$F$20230201$20240709$20230323$20240715$EXP$$US-ROCHE-3316217$ROCHE$$67$YR$E$M$Y$$$20240715$$MD$US$US
2212983210$22129832$10$F$20220802$20240620$20230323$20240701$EXP$$IE-EXELIXIS-CABO-22054778$EXELIXIS$$49$YR$$M$Y$$$20240630$$HP$IE$IE
221299622$22129962$2$F$20240701$20240808$20230323$20240814$PER$$US-BAYER-2023A028879$BAYER$$40$YR$A$F$Y$$$20240814$$CN$US$US
221299712$22129971$2$F$$20240807$20230323$20240816$EXP$$US-MYLANLABS-2023M1030414$MYLAN$Ahuja T, Nuti O, Kemal C, Kang D, Pashun R, Yuriditsky E, et al. To PLEX or not to PLEX for amiodarone induced thyrotoxicosis. J-Am-Coll-Cardiol 2023;81 (Suppl.)(8):2604.$52$YR$$M$Y$$$20240816$$HP$US$US
2213001112$22130011$12$F$20211201$20240730$20230323$20240807$EXP$$US-GSK-US2021AMR252777$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
221303855$22130385$5$F$$20240816$20230323$20240821$EXP$$CA-TAKEDA-2023TUS029045$TAKEDA$$$$$F$Y$$$20240821$$MD$CA$CA
221304522$22130452$2$F$20221116$20240703$20230323$20240709$EXP$$FR-PFIZER INC-202300120628$PFIZER$$72$YR$$F$Y$59$KG$20240709$$PH$FR$FR
2213048511$22130485$11$F$$20240821$20230323$20240821$EXP$$US-PFIZER INC-PV202300054165$PFIZER$$52$YR$$F$Y$$$20240821$$CN$US$US
221305442$22130544$2$F$$20240916$20230323$20240919$EXP$$CA-Orion Corporation ORION PHARMA-23_00022736$ORION$$52$YR$A$F$Y$$$20240919$$HP$CA$
221306286$22130628$6$F$20230301$20231101$20230323$20240925$EXP$$US-GSK-US2023AMR043763$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
221306299$22130629$9$F$20230301$20240306$20230323$20240925$EXP$$US-GSK-US2023AMR043283$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
221306703$22130670$3$F$$20240909$20230323$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02182$LUPIN$$$$$$Y$$$20240923$$PH$US$US
221307226$22130722$6$F$20230322$20240805$20230323$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-041788$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240806$$CN$US$US
221308504$22130850$4$F$20221201$20240626$20230323$20240703$EXP$$CA-TAKEDA-2022TUS098669$TAKEDA$$34$YR$$F$Y$$$20240703$$MD$CA$CA
221308902$22130890$2$F$$20240916$20230323$20240918$EXP$$CA-PFIZER INC-202300124806$PFIZER$$52$YR$$F$Y$$$20240918$$HP$CA$CA
221308977$22130897$7$F$20230301$20240805$20230323$20240814$PER$$US-SA-2023SA091599$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240814$$MD$US$US
221309633$22130963$3$F$20230101$20240703$20230323$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-039192$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240710$$HP$US$US
221310312$22131031$2$F$20220601$20230320$20230323$20240926$EXP$$US-GSK-US2022AMR066154$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
221310952$22131095$2$F$$20240813$20230323$20240814$PER$$US-PFIZER INC-PV202200133415$PFIZER$$70$YR$$F$Y$$$20240814$$CN$US$US
221310965$22131096$5$F$$20240815$20230323$20240819$EXP$$US-PFIZER INC-PV202300045887$PFIZER$$79$YR$$F$Y$96.599$KG$20240819$$CN$US$US
221311046$22131104$6$F$20230309$20240628$20230323$20240702$EXP$$PR-PFIZER INC-202300122738$PFIZER$$61$YR$$F$Y$$$20240702$$HP$PR$PR
221311514$22131151$4$F$20230101$20240625$20230323$20240703$EXP$NO-NOMAADVRE-PASRAPP-2023-Vqnzdz$NO-TEVA-2023-NO-2867857$TEVA$$51$YR$$M$Y$82$KG$20240703$$CN$NO$NO
221311863$22131186$3$F$20230321$20240917$20230323$20240919$PER$$US-BIOGEN-2023BI01195070$BIOGEN$$28$YR$$F$Y$$$20240919$$CN$US$US
221316712$22131671$2$F$$20240823$20230323$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02202$LUPIN$$$$$$Y$$$20240902$$CN$US$US
2213167810$22131678$10$F$$20240917$20230323$20240919$PER$$US-PFIZER INC-PV202300029859$PFIZER$$70$YR$$M$Y$$$20240919$$MD$US$US
221318023$22131802$3$F$$20240715$20230323$20240717$PER$$US-PFIZER INC-PV202300054914$PFIZER$$60$YR$$F$Y$$$20240717$$HP$US$US
221318065$22131806$5$F$$20240926$20230323$20240930$PER$$US-PFIZER INC-202201050249$PFIZER$$74$YR$$F$Y$$$20240930$$CN$US$US
221318975$22131897$5$F$20230301$20240919$20230323$20240926$EXP$$JP-009507513-2303JPN002445J$MERCK$$78$YR$$F$Y$$$20240926$$MD$JP$JP
221321367$22132136$7$F$20230222$20240904$20230323$20240909$EXP$$JP-FERRING-2023FE01332$FERRING$$$$$$Y$$$20240909$$MD$JP$JP
221324407$22132440$7$F$$20240705$20230323$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-042197$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240712$$CN$US$US
221327702$22132770$2$F$20160217$20240718$20230323$20240724$EXP$$US-TAKEDA-US202013865$TAKEDA$$11$YR$$M$Y$$$20240724$$PH$US$US
221329154$22132915$4$F$20230306$20240715$20230323$20240722$EXP$$US-BIOGEN-2023BI01194663$BIOGEN$$28$YR$$F$Y$$$20240722$$CN$US$US
221329416$22132941$6$F$20220101$20240925$20230323$20240926$EXP$$CH-ABBVIE-4245897$ABBVIE$$79$YR$$F$Y$83$KG$20240926$$MD$CH$CH
221330137$22133013$7$F$20240423$20240717$20230324$20240813$PER$$CA-TOLMAR, INC.-23CA039253$TOLMAR$$79$YR$$M$Y$$$20240813$$CN$CA$CA
221330193$22133019$3$F$20201126$20240918$20230324$20240923$EXP$$DE-TAKEDA-2021TUS059446$TAKEDA$$52$YR$$M$Y$120$KG$20240923$$HP$DE$DE
221331748$22133174$8$F$20230306$20231005$20230324$20240925$PER$$US-GSK-US2023AMR040403$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
2213317710$22133177$10$F$20230301$20240903$20230324$20240910$EXP$$US-GSK-US2023AMR043667$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$HP$US$US
2213328710$22133287$10$F$20220518$20240716$20230324$20240724$EXP$$CA-CELLTRION INC.-2022CA007518$CELLTRION$$$$$$Y$$$20240724$$MD$CA$CA
2213344514$22133445$14$F$20230310$20240213$20230324$20240925$EXP$$US-GSK-US2023AMR041319$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
221334663$22133466$3$F$$20240917$20230324$20240927$EXP$$BR-CELLTRION INC.-2023BR006077$CELLTRION$$$$$$Y$$$20240927$$CN$BR$BR
2213346822$22133468$22$F$20221124$20240821$20230324$20240829$EXP$$US-TAKEDA-2022TUS091589$TAKEDA$$24$YR$$F$Y$$$20240829$$HP$US$US
221336363$22133636$3$F$$20240909$20230324$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02224$LUPIN$$$$$$Y$$$20240921$$PH$US$US
221336852$22133685$2$F$$20240703$20230324$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382245$RANBAXY$Yemul Golhar SR, Trinh MA, Anyanwu AC, Williams E, Chen M. Reversal of Total Artificial Heart Mechanical Valve Thrombosis Using Catheter-Directed Thrombolysis. ASAIOJ. 2023;69(1):E38-E41$57$YR$$M$Y$$$20240703$$HP$US$US
221336903$22133690$3$F$$20240618$20230324$20240703$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382229$RANBAXY$Sharma S, Preeti, Kataria D. Pyridoxine as a useful agent in treating tardive dyskinesia. Indian J Psychiatry. 2023;65(Suppl. 1):S136-S137$59$YR$$F$Y$$$20240703$$HP$IN$IN
221337342$22133734$2$F$20220901$20240826$20230324$20240919$PER$$NL-TOLMAR, INC.-23NL039275$TOLMAR$$67$YR$$M$Y$$$20240919$$CN$NL$NL
221337452$22133745$2$F$$20240717$20230324$20240721$EXP$$IN-ROCHE-3313688$ROCHE$$56$YR$A$F$Y$$$20240721$$MD$IN$IN
221338992$22133899$2$F$$20230316$20230324$20240808$EXP$$NVSC2023US062396$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
221340894$22134089$4$F$20230228$20240911$20230324$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2023-008142$UNITED THERAPEUTICS$$62$YR$$M$Y$80.726$KG$20240920$$$US$US
221341812$22134181$2$F$$20240704$20230324$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02180$LUPIN$$$$$$Y$$$20240728$$CN$US$US
221341992$22134199$2$F$20201208$20240903$20230324$20240910$EXP$$CA-JNJFOC-20201220433$JOHNSON AND JOHNSON$$30$YR$A$F$Y$103$KG$20240910$$HP$CA$CA
221342913$22134291$3$F$$20240909$20230324$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02249$LUPIN$$$$$$Y$$$20240921$$CN$US$US
221343053$22134305$3$F$$20240909$20230324$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02250$LUPIN$$$$$$Y$$$20240923$$CN$US$US
221344833$22134483$3$F$$20240702$20230324$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-039028$BRISTOL MYERS SQUIBB$$40$YR$A$M$Y$$$20240703$$MD$US$US
221345114$22134511$4$F$20201201$20230328$20230324$20240712$EXP$$BG-ASTELLAS-2023US009309$ASTELLAS$$73$YR$$M$Y$$$20240712$$CN$BG$BG
221345712$22134571$2$F$$20240909$20230324$20240916$EXP$$US-SA-2023SA086226$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$MD$US$US
221345723$22134572$3$F$$20240909$20230324$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02225$LUPIN$$$$$$Y$$$20240924$$CN$US$US
221346114$22134611$4$F$$20240909$20230324$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02255$LUPIN$$$$$$Y$$$20240921$$CN$US$US
221346394$22134639$4$F$$20240716$20230324$20240724$EXP$$CA-ROCHE-3316095$ROCHE$$51$YR$A$F$Y$$$20240724$$HP$CA$CA
221346403$22134640$3$F$$20240909$20230324$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02256$LUPIN$$$$$$Y$$$20240923$$CN$US$US
221346842$22134684$2$F$$20240902$20230324$20240904$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382529$RANBAXY$Akeda T, Yamanaka K. Treatment in Patients with Psoriatic Disease and Rheumatoid Arthritis: Seven Case Reports. Clinics Practice. 2023;13(1):177-189$6$DEC$$F$Y$$$20240904$$HP$JP$JP
221347302$22134730$2$F$$20230317$20230324$20240926$EXP$$US-GSK-US2023AMR009417$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
221348689$22134868$9$F$20220601$20240924$20230324$20240930$EXP$$DE-TAKEDA-2023TUS029342$TAKEDA$$55$YR$$M$Y$$$20240930$$HP$DE$DE
221349292$22134929$2$F$$20240620$20230324$20240701$EXP$$CA-APOTEX-2023AP005442$APOTEX$$46$YR$$M$Y$$$20240701$$HP$CA$CA
2213508811$22135088$11$F$20220926$20240906$20230324$20240914$EXP$$JP-UNITED THERAPEUTICS-UNT-2023-004871$UNITED THERAPEUTICS$$5$YR$$M$Y$14.6$KG$20240914$$$JP$JP
221351672$22135167$2$F$$20240702$20230324$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382334$RANBAXY$Ryu YK, Ricker EC, Soderquist CR, Francescone MA, Lipsky AH, Amengual JE. Targeting CD38 with Daratumumab Plus Chemotherapy for Patients with Advanced-Stage Plasmablastoid Large B-Cell Lymphoma. J Clin Med. 2022;11(16):4928; 1-16$28$YR$$F$Y$$$20240703$$HP$US$US
221351712$22135171$2$F$$20240903$20230324$20240918$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382575$RANBAXY$Segui E, Zamora-Martinez C, Barreto TD, Padrosa J, Viladot M, Marco-Hernandez J. Severe Immune-Related Adverse Events: A Case Series of Patients Needing Hospital Admission in a Spanish Oncology Referral Center and Review of the Literature. Diagnostics (Basel). 2022;12(9):2116$79$YR$$M$Y$$$20240918$$HP$ES$ES
221352063$22135206$3$F$20230209$20240716$20230324$20240724$EXP$$BE-JNJFOC-20230354810$JOHNSON AND JOHNSON$$48$YR$A$F$Y$62$KG$20240724$$MD$BE$BE
221355505$22135550$5$F$20230101$20240709$20230324$20240718$PER$$US-SA-2023SA092418$SANOFI AVENTIS$$17$YR$T$F$Y$79.37$KG$20240718$$MD$US$US
221356873$22135687$3$F$20231101$20240627$20230324$20240709$EXP$$US-APOTEX-2023AP005306$APOTEX$$68$YR$E$F$Y$58.5$KG$20240709$$CN$US$US
221357904$22135790$4$F$20230313$20240913$20230324$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2023AMR043119$VIIV$$$$$$Y$$$20240917$$CN$US$US
221358672$22135867$2$F$20220301$20230321$20230324$20240926$EXP$$US-GSK-US2022AMR059600$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
221359272$22135927$2$F$20221001$20240904$20230324$20240923$EXP$$US-THERATECHNOLOGIES INC.-2022-THE-TES-000330$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
221359822$22135982$2$F$20230305$20240718$20230324$20240801$PER$$US-SA-2023SA087794$SANOFI AVENTIS$$37$YR$A$F$Y$77.098$KG$20240801$$MD$US$US
221361212$22136121$2$F$$20240802$20230324$20240807$EXP$$CA-TAKEDA-2019TUS073546$TAKEDA$$$$$F$Y$$$20240807$$HP$CA$CA
221362255$22136225$5$F$20230228$20240903$20230324$20240910$EXP$$JP-AstraZeneca-2023A066606$ASTRAZENECA$$26$YR$$F$Y$$$20240910$$MD$JP$
221362413$22136241$3$F$20220805$20240619$20230324$20240701$EXP$$CA-TAKEDA-2023TUS029619$TAKEDA$$45$YR$$F$Y$$$20240701$$CN$CA$CA
221362782$22136278$2$F$$20240909$20230324$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02269$LUPIN$$$$$$Y$$$20240921$$CN$US$US
221363342$22136334$2$F$$20240909$20230324$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02228$LUPIN$$$$$$Y$$$20240923$$CN$US$US
221363684$22136368$4$F$20220528$20240813$20230324$20240819$EXP$$CA-TAKEDA-2022TUS037464$TAKEDA$$53$YR$$M$Y$$$20240819$$CN$CA$CA
221365394$22136539$4$F$20220726$20230330$20230324$20240725$PER$$DE-PUMA BIOTECHNOLOGY, INC.-2023-PUM-DE000468$PUMA$$$$$$Y$$$20240725$$MD$DE$DE
2213674717$22136747$17$F$20210610$20240923$20230324$20240928$EXP$$CO-TAKEDA-2021TUS035712$TAKEDA$$80$YR$$M$Y$55$KG$20240928$$CN$CO$CO
221368862$22136886$2$F$20230309$20240722$20230324$20240724$PER$$NVSC2023US063659$NOVARTIS$$68$YR$$F$Y$$$20240725$$CN$US$US
221369306$22136930$6$F$$20240819$20230324$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2021-US-011079$JAZZ$$$$$M$Y$$$20240823$$HP$US$US
221369438$22136943$8$F$$20240626$20230324$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-042437$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240718$$CN$US$US
221371403$22137140$3$F$20230316$20240913$20230324$20240919$EXP$$CA-TAKEDA-2023TUS029402$TAKEDA$$18$YR$$M$Y$$$20240919$$MD$CA$CA
221373113$22137311$3$F$$20230321$20230325$20240809$PER$$NVSC2023US067367$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
221373342$22137334$2$F$20221226$20240913$20230325$20240925$EXP$$BE-AUROBINDO-AUR-APL-2023-012660$AUROBINDO$$15$YR$$M$Y$$$20240925$$MD$BE$BE
221373385$22137338$5$F$$20240918$20230325$20240925$PER$$NVSC2023US067388$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
221373933$22137393$3$F$$20240812$20230325$20240823$EXP$$US-AUROBINDO-AUR-APL-2023-012497$AUROBINDO$Ahuja T, Nuti O, Kemal C, Kang D, Pashun R, Yuriditsky E, et al.. TO PLEX OR NOT TO PLEX FOR AMIODARONE INDUCED THYROTOXICOSIS. Journal of the American College of Cardiology. 2023;81(8):2604$52$YR$$M$Y$$$20240823$$PH$US$US
221375116$22137511$6$F$20230323$20240813$20230325$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-042658$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240815$$CN$US$US
221378493$22137849$3$F$20221118$20240724$20230325$20240730$PER$$US-ABBVIE-4702847$ABBVIE$$86$YR$$M$Y$$$20240730$$CN$US$US
221380125$22138012$5$F$$20240829$20230325$20240829$PER$$NVSC2023US066980$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
221381444$22138144$4$F$$20240910$20230325$20240912$EXP$$PHHY2018CO030859$NOVARTIS$$$$$F$Y$62$KG$20240912$$CN$CO$CO
221381598$22138159$8$F$20220101$20240702$20230325$20240708$EXP$$US-GSK-US2023044328$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$HP$US$US
221382502$22138250$2$F$$20240628$20230325$20240701$EXP$$US-TAKEDA-2021TUS079723$TAKEDA$$$$$F$Y$$$20240701$$CN$US$US
221383473$22138347$3$F$20230301$20230315$20230326$20240903$EXP$$IE-JNJFOC-20230339976$JOHNSON AND JOHNSON$$$$$M$Y$81$KG$20240903$$MD$IE$IE
221384225$22138422$5$F$20230311$20240910$20230326$20240917$30DAY$$US-GSK-US2023AMR044286$GLAXOSMITHKLINE$$41$YR$$F$Y$$$20240917$$HP$US$US
221384705$22138470$5$F$20220908$20240911$20230326$20240924$EXP$$US-UCBSA-2023015343$UCB$$13$YR$$F$Y$$$20240924$$CN$US$US
2213848615$22138486$15$F$20230101$20240918$20230326$20240927$EXP$$US-UCBSA-2023003744$UCB$$$$$M$Y$$$20240927$$CN$US$US
221386024$22138602$4$F$$20240911$20230326$20240916$EXP$$NVSC2023BR046822$NOVARTIS$$$$$F$Y$$$20240916$$CN$BR$BR
221388882$22138888$2$F$20220101$20240806$20230327$20240816$EXP$$US-GSK-US2023AMR043653$GLAXOSMITHKLINE$$$$$F$Y$66.667$KG$20240816$$CN$US$US
221389674$22138967$4$F$20221222$20240701$20230327$20240708$EXP$$US-SA-2023SA092811$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240708$$MD$US$US
221390693$22139069$3$F$20230101$20240702$20230327$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001105$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240726$$CN$US$US
221390935$22139093$5$F$$20240617$20230327$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000879$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
221392254$22139225$4$F$20201201$20240716$20230327$20240724$EXP$$BG-TOLMAR, INC.-23BG039588$TOLMAR$$73$YR$$M$Y$$$20240724$$MD$BG$BG
221392693$22139269$3$F$20140529$20240712$20230327$20240717$EXP$$CA-JNJFOC-20230357967$JOHNSON AND JOHNSON$$39$YR$A$F$Y$80$KG$20240717$$HP$CA$CA
221393783$22139378$3$F$$20240821$20230327$20240829$EXP$$BR-CELLTRION INC.-2022BR013500$CELLTRION$$$$$$Y$$$20240829$$CN$BR$BR
221394385$22139438$5$F$20230418$20230601$20230327$20240925$PER$$US-GSK-US2023AMR043446$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240925$$CN$US$US
221395107$22139510$7$F$20221220$20240712$20230327$20240717$EXP$$US-ABBVIE-4703517$ABBVIE$$60$YR$$F$Y$$$20240717$$CN$US$US
221395207$22139520$7$F$$20240819$20230327$20240822$EXP$$CA-BAUSCH-BL-2023-004466$BAUSCH AND LOMB$$33$YR$$F$Y$61$KG$20240822$$HP$CA$CA
221395775$22139577$5$F$$20240712$20230327$20240806$EXP$$JP-BEH-2023156729$CSL BEHRING$$7$DEC$E$F$Y$$$20240806$$MD$JP$JP
221395832$22139583$2$F$20230101$20240724$20230327$20240803$EXP$$CA-ROCHE-3274121$ROCHE$$16$YR$T$F$Y$$$20240803$$CN$CA$CA
221396613$22139661$3$F$$20240905$20230327$20240916$EXP$$US-ROCHE-3165130$ROCHE$$94$YR$E$F$Y$$$20240916$$CN$US$US
221396746$22139674$6$F$20150301$20240717$20230327$20240726$EXP$$CA-ROCHE-1644350$ROCHE$$53$YR$A$F$Y$$$20240726$$CN$CA$CA
221397458$22139745$8$F$20221121$20240925$20230327$20240927$EXP$$CH-ABBVIE-4243131$ABBVIE$$81$YR$$F$Y$49$KG$20240927$$MD$CH$CH
221400085$22140008$5$F$20230322$20230608$20230327$20240924$PER$$NVSC2023US070233$NOVARTIS$$51$YR$$M$Y$82.5$KG$20240924$$CN$US$US
221400127$22140012$7$F$20200220$20240730$20230327$20240806$EXP$$DE-ROCHE-2572788$ROCHE$$51$YR$A$F$Y$$$20240806$$CN$DE$DE
221401005$22140100$5$F$$20230323$20230327$20240730$PER$$NVSC2023US070196$NOVARTIS$$$$$M$Y$$$20240730$$CN$US$US
221402672$22140267$2$F$$20240925$20230327$20240927$EXP$$CA-TAKEDA-2023TUS030894$TAKEDA$$$$$M$Y$$$20240927$$CN$CA$CA
221403553$22140355$3$F$$20240807$20230327$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02295$LUPIN$$$$$$Y$$$20240901$$CN$US$US
221403562$22140356$2$F$$20240808$20230327$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02261$LUPIN$$$$$$Y$$$20240902$$CN$US$US
221403575$22140357$5$F$$20240909$20230327$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02299$LUPIN$$$$$$Y$$$20240921$$CN$US$US
221403792$22140379$2$F$$20240809$20230327$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02213$LUPIN$$$$$$Y$$$20240905$$CN$US$US
221403823$22140382$3$F$$20240807$20230327$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02277$LUPIN$$$$$$Y$$$20240831$$CN$US$US
221403854$22140385$4$F$$20240808$20230327$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02301$LUPIN$$$$$$Y$$$20240904$$CN$US$US
221403863$22140386$3$F$$20240807$20230327$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02335$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221403883$22140388$3$F$$20240809$20230327$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02268$LUPIN$$$$$$Y$$$20240901$$CN$US$US
221403912$22140391$2$F$$20240909$20230327$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02298$LUPIN$$$$$$Y$$$20240920$$CN$US$US
221405022$22140502$2$F$20230201$20240925$20230327$20240930$EXP$$FR-AUROBINDO-AUR-APL-2023-013028$AUROBINDO$$55$YR$$F$Y$75$KG$20240930$$PH$FR$FR
221406234$22140623$4$F$$20240808$20230327$20240813$PER$$NVSC2023US069297$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
2214074310$22140743$10$F$20230101$20240830$20230327$20240904$EXP$$CA-PFIZER INC-202300124824$PFIZER$$22$YR$$M$Y$$$20240904$$MD$CA$CA
221408543$22140854$3$F$$20230424$20230327$20240825$EXP$$US-AstraZeneca-2023A064903$ASTRAZENECA$$$$$M$Y$$$20240825$$CN$US$
221409535$22140953$5$F$20220726$20240622$20230327$20240702$EXP$$JP-ARGENX-2023-ARGX-JP000917$ARGENX BVBA$$$$$$Y$$$20240702$$MD$JP$JP
221410294$22141029$4$F$$20240620$20230327$20240708$EXP$$IN-ROCHE-2899211$ROCHE$$39$YR$A$F$Y$$$20240708$$MD$IN$IN
221410853$22141085$3$F$$20240812$20230327$20240813$EXP$$US-KYOWAKIRIN-2023BKK004436$KYOWA$$$$$$Y$$$20240813$$HP$US$US
221411092$22141109$2$F$$20240702$20230327$20240711$EXP$GB-MLMSERVICE-20221124-3939022-1$GB-MYLANLABS-2023M1031251$MYLAN$Ahmed M, Oyibo ST, Dalvi S, Cowell R. Hydrocortisone-induced symptomatic sinus bradycardia. BMJ-Case-Rep 2022;15:No. 11.$6$DEC$$F$Y$$$20240711$$HP$GB$GB
221411122$22141112$2$F$$20240729$20230327$20240802$EXP$$CA-MYLANLABS-2023M1031498$MYLAN$$$$$M$Y$$$20240802$$HP$CA$CA
221411326$22141132$6$F$20230301$20240730$20230327$20240806$EXP$$US-TAKEDA-2023TUS030325$TAKEDA$$71$YR$$M$Y$$$20240806$$HP$US$US
2214116215$22141162$15$F$20220927$20240731$20230327$20240806$EXP$$CA-PFIZER INC-202201193663$PFIZER$$63$YR$$F$Y$106$KG$20240806$$HP$CA$CA
221412232$22141223$2$F$20230301$20240828$20230327$20240923$PER$$US-SA-2023SA093640$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240923$$CN$US$US
221412673$22141267$3$F$20160720$20240819$20230327$20240822$EXP$$CA-TAKEDA-2016TUS013413$TAKEDA$$24$YR$$F$Y$$$20240822$$MD$CA$CA
221412743$22141274$3$F$$20240705$20230327$20240715$PER$$US-SA-2023SA095240$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240715$$MD$US$US
221413779$22141377$9$F$20230319$20240924$20230327$20240926$30DAY$$CA-PFIZER INC-202300122352$PFIZER$$28$YR$$F$Y$$$20240926$$MD$CA$CA
221413874$22141387$4$F$20230101$20240711$20230327$20240718$EXP$$US-SA-2023SA095967$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240718$$MD$US$US
221413933$22141393$3$F$20210901$20240821$20230327$20240829$EXP$$CN-SA-2023SA091494$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240829$$MD$CN$CN
221414023$22141402$3$F$$20240807$20230327$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02274$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221417315$22141731$5$F$20230101$20240923$20230327$20240926$PER$$US-PFIZER INC-PV202300055031$PFIZER$$65$YR$$F$Y$$$20240926$$MD$US$US
221417343$22141734$3$F$20220601$20240826$20230327$20240828$PER$$US-PFIZER INC-202300127436$PFIZER$$65$YR$$F$Y$$$20240828$$HP$US$US
221417917$22141791$7$F$20230706$20240924$20230327$20240930$EXP$$CA-OTSUKA-2023_007538$OTSUKA$$44$YR$$F$Y$$$20240930$$HP$CA$CA
221418606$22141860$6$F$$20240826$20230327$20240830$EXP$DE-ROCHE-3316504$DE-ROCHE-3316504$ROCHE$$51$YR$A$M$Y$$$20240830$$MD$DE$DE
221418793$22141879$3$F$$20240913$20230327$20240918$EXP$$JP-PFIZER INC-PV202300053124$PFIZER$Kitai, J.. A case of intravascular large B-cell lymphoma occurred in a rheumatoid arthritis patient who has been taking methotrexate orally. The 239th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2023;239th$59$YR$$F$Y$$$20240918$$HP$JP$JP
221419214$22141921$4$F$$20230830$20230327$20240911$EXP$$US-CELLTRION INC.-2023US006364$CELLTRION$$$$$$Y$$$20240911$$PH$US$US
221419672$22141967$2$F$20220127$20230320$20230327$20240925$EXP$$US-GSK-US2022AMR027167$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
2214196911$22141969$11$F$20230404$20240812$20230327$20240820$EXP$$CA-GSK-CA2023AMR043615$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$HP$CA$CA
221420172$22142017$2$F$$20240918$20230327$20240927$EXP$$US-MYLANLABS-2023M1032776$BIOCON$Woolery S,  Bauler L,  Jones P, Azmeh R. Successful desensitization in a patient with adalimumab hypersensitivity.. Clinical Immunology Communications. 2022;2:30-32$$$$$Y$$$20240927$$HP$US$US
221420423$22142042$3$F$20210401$20240821$20230327$20240826$EXP$$CN-PFIZER INC-202300127926$PFIZER$Liu, L.. Case report: Response to endocrine therapy in triple-negative breast cancer metastases with altered hormone receptors. Frontiers in Oncology. 2023;13:10.3389/fonc.2023.1023787$67$YR$$F$Y$$$20240826$$MD$CN$CN
221420674$22142067$4$F$$20240718$20230327$20240723$EXP$$US-ABBVIE-4705156$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
221421595$22142159$5$F$20220508$20240712$20230327$20240717$EXP$$US-TAKEDA-2022TUS081933$TAKEDA$$75$YR$$F$Y$77$KG$20240717$$CN$US$US
221422063$22142206$3$F$$20240723$20230327$20240726$EXP$$CA-PFIZER INC-202300130420$PFIZER$$51$YR$$M$Y$$$20240726$$HP$CA$CA
221422813$22142281$3$F$20230101$20240820$20230327$20240822$EXP$$US-SA-2023SA096238$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240822$$MD$US$US
221423942$22142394$2$F$20230201$20230323$20230327$20240801$PER$$NVSC2023US068546$NOVARTIS$$73$YR$$M$Y$$$20240801$$CN$US$US
221424604$22142460$4$F$$20240820$20230327$20240826$EXP$$AU-ROCHE-3315780$ROCHE$$$$E$M$Y$$$20240826$$MD$AU$AU
221426612$22142661$2$F$20230201$20240726$20230327$20240729$EXP$$US-BAUSCH-BL-2023-004690$BAUSCH AND LOMB$$59$YR$$M$Y$$$20240729$$CN$US$US
221426904$22142690$4$F$$20240909$20230327$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02291$LUPIN$$$$$$Y$$$20240923$$CN$US$US
221427182$22142718$2$F$$20240909$20230327$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02306$LUPIN$$$$$$Y$$$20240924$$CN$US$US
221429696$22142969$6$F$20240601$20240702$20230327$20240709$EXP$$NVSC2023CL067827$NOVARTIS$$65$YR$$F$Y$$$20240709$$CN$CL$CL
221429744$22142974$4$F$$20240716$20230327$20240718$PER$$US-AMGEN-USASP2023051959$AMGEN$$61$YR$A$M$Y$$$20240718$$HP$US$US
221429925$22142992$5$F$20230304$20240813$20230327$20240816$EXP$$US-TAKEDA-2023TUS031268$TAKEDA$$33$YR$$M$Y$$$20240816$$PH$US$US
221429959$22142995$9$F$20221030$20240921$20230327$20240925$EXP$$GB-MYLANLABS-2022M1121076$MYLAN$$76$YR$$F$Y$$$20240925$$CN$GB$GB
221430025$22143002$5$F$$20240828$20230327$20240903$EXP$$NVSC2023BR066872$NOVARTIS$$$$$M$Y$82$KG$20240903$$CN$BR$BR
221431182$22143118$2$F$$20240718$20230327$20240722$EXP$$NVSC2023US065475$NOVARTIS$$$$$M$Y$$$20240722$$CN$US$US
221431467$22143146$7$F$20230308$20240103$20230327$20240826$EXP$$CA-ROCHE-3307403$ROCHE$$31$YR$A$F$Y$$$20240826$$CN$CA$CA
221432336$22143233$6$F$20230404$20240717$20230327$20240720$EXP$$AU-TAKEDA-2023TUS030320$TAKEDA$$63$YR$$F$Y$$$20240720$$CN$AU$AU
221433026$22143302$6$F$20221129$20240813$20230327$20240816$EXP$$DE-TAKEDA-2023TUS030337$TAKEDA$$31$YR$$M$Y$78$KG$20240816$$CN$DE$DE
221433584$22143358$4$F$20230301$20240910$20230327$20240917$PER$$US-SA-2023SA096410$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240918$$CN$US$US
221436913$22143691$3$F$$20240723$20230327$20240726$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-006755$JAZZ$$$$$F$Y$$$20240726$$CN$US$US
221440524$22144052$4$F$20230217$20240814$20230327$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-043426$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240820$$CN$US$US
221442444$22144244$4$F$20221201$20240724$20230328$20240731$EXP$$US-ABBVIE-4701156$ABBVIE$$67$YR$$F$Y$61$KG$20240731$$CN$US$US
221443159$22144315$9$F$20230301$20240910$20230328$20240918$EXP$$CA-JNJFOC-20230358471$JOHNSON AND JOHNSON$$52$YR$A$F$Y$106.69$KG$20240918$$HP$CA$CA
221443476$22144347$6$F$20230301$20240904$20230328$20240926$PER$$CA-TOLMAR, INC.-23CA039287$TOLMAR$$69$YR$$M$Y$$$20240926$$CN$CA$CA
221443526$22144352$6$F$20230301$20240910$20230328$20240930$PER$$CA-TOLMAR, INC.-23CA039325$TOLMAR$$71$YR$$M$Y$$$20240930$$CN$CA$CA
221443546$22144354$6$F$20230303$20240715$20230328$20240723$PER$$CA-TOLMAR, INC.-23CA039332$TOLMAR$$71$YR$$M$Y$$$20240723$$CN$CA$CA
221446683$22144668$3$F$$20240920$20230328$20240930$EXP$$BR-CELLTRION INC.-2023BR006335$CELLTRION$$$$$$Y$$$20240930$$CN$BR$BR
2214471818$22144718$18$F$20221125$20240918$20230328$20240927$EXP$$CA-CELLTRION INC.-2022CA020808$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
221448945$22144894$5$F$$20240830$20230328$20240910$EXP$$CA-AUROBINDO-AUR-APL-2023-013200$AUROBINDO$Claire Avery E, Augustine H, Sade S, Dengler J. Extradigital glomus tumour of the thigh causing 8 years of undiagnosed debilitating pain. BMJ Case Reports. 2022;15(12):1-4$6$DEC$$F$Y$$$20240910$$MD$CA$CA
221450223$22145022$3$F$20230201$20240731$20230328$20240807$EXP$$CA-CELLTRION INC.-2023CA004521$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
221450552$22145055$2$F$$20240909$20230328$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02328$LUPIN$$$$$$Y$$$20240921$$MD$US$US
2214530315$22145303$15$F$20230101$20240911$20230328$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-040736$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240917$$CN$US$US
221453352$22145335$2$F$20230211$20240702$20230328$20240708$EXP$$KR-TAKEDA-2023TUS030310$TAKEDA$$67$YR$$M$Y$76$KG$20240708$$MD$KR$KR
221454775$22145477$5$F$$20240731$20230328$20240806$PER$$US-BIOGEN-2023BI01195543$BIOGEN$$$$$M$Y$$$20240806$$CN$US$US
221457196$22145719$6$F$20230301$20240918$20230328$20240926$EXP$$US-GSK-US2023040157$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
221458962$22145896$2$F$$20240715$20230328$20240729$EXP$$US-CIPLA (EU) LIMITED-2023US00387$CIPLA$$$$$$Y$$$20240730$$MD$US$US
2214593013$22145930$13$F$20230301$20240207$20230328$20240925$EXP$$US-GSK-US2023AMR044251$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
221459314$22145931$4$F$20230301$20230425$20230328$20240925$PER$$US-GSK-US2023AMR045103$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
221459493$22145949$3$F$20230325$20240807$20230328$20240812$EXP$$US-TAKEDA-2023TUS032108$TAKEDA$$52$YR$$F$Y$$$20240812$$MD$US$US
221459586$22145958$6$F$20230101$20240722$20230328$20240722$EXP$$CA-PFIZER INC-202300071843$PFIZER$$21$YR$$F$Y$75$KG$20240722$$HP$CA$CA
221459603$22145960$3$F$$20240726$20230328$20240805$EXP$$CA-APOTEX-2023AP005861$APOTEX$$82$YR$$F$Y$$$20240805$$MD$CA$CA
221460967$22146096$7$F$20230301$20240917$20230328$20240925$30DAY$$US-PFIZER INC-202300127698$PFIZER$$12$YR$$M$Y$$$20240925$$CN$US$US
2214612013$22146120$13$F$20230316$20240916$20230328$20240919$EXP$$DE-ABBVIE-4704600$ABBVIE$$79$YR$$M$Y$72$KG$20240919$$MD$DE$DE
221464682$22146468$2$F$20211106$20240709$20230328$20240715$EXP$$CN-ASTELLAS-2023US009507$ASTELLAS$$43$YR$$M$Y$$$20240715$$HP$CN$CN
221465082$22146508$2$F$$20240711$20230328$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382484$RANBAXY$Vazquez Guillamet LJ, Marx GE, Benjamin W, Pappas P, Lieberman NAP, Bachiashvili K, et al. Relapsing Fever Caused by Borrelia lonestari after Tick Bite in Alabama, USA. Emerging Infect Dis. 2023;Feb;29(2):441-444$75$YR$$M$Y$$$20240712$$HP$US$US
221468044$22146804$4$F$$20240918$20230328$20240930$PER$$NVSC2023US070335$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
221468334$22146833$4$F$20230117$20240812$20230328$20240815$EXP$$DE-TAKEDA-2023TUS029532$TAKEDA$$52$YR$$F$Y$76$KG$20240815$$CN$DE$DE
221469736$22146973$6$F$20230201$20240708$20230328$20240712$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-003703$JAZZ$$35$YR$$F$Y$$$20240712$$MD$US$US
221469774$22146977$4$F$20230105$20240910$20230328$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-025939$JAZZ$$67$YR$$M$Y$$$20240913$$HP$US$US
2214697926$22146979$26$F$20230217$20240802$20230328$20240812$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-004491$JAZZ$$61$YR$$F$Y$$$20240812$$CN$US$US
221470094$22147009$4$F$20230305$20240716$20230328$20240718$PER$$US-PFIZER INC-202300133065$PFIZER$$82$YR$$M$Y$57.596$KG$20240718$$CN$US$US
2214731612$22147316$12$F$20220810$20240726$20230328$20240801$EXP$$US-TAKEDA-2022TUS062397$TAKEDA$$35$YR$$F$Y$63$KG$20240801$$HP$US$US
221473507$22147350$7$F$20230101$20240916$20230328$20240924$PER$$US-DSJP-DSU-2023-111082$DAIICHI$$$$$F$Y$$$20240924$$CN$US$US
221474305$22147430$5$F$20230421$20240917$20230328$20240924$EXP$$CA-TAKEDA-2023TUS030879$TAKEDA$$30$YR$$M$Y$$$20240924$$CN$CA$CA
221474532$22147453$2$F$$20240916$20230328$20240917$EXP$$US-TAKEDA-2023TUS031930$TAKEDA$$$$$F$Y$$$20240917$$CN$US$US
221474549$22147454$9$F$20230222$20240918$20230328$20240928$EXP$$CA-TAKEDA-2021TUS043196$TAKEDA$$84$YR$$F$Y$$$20240928$$MD$CA$CA
221476086$22147608$6$F$$20240807$20230328$20240813$PER$$US-PFIZER INC-PV202300055650$PFIZER$$81$YR$$F$Y$$$20240813$$CN$US$US
2214762016$22147620$16$F$20150113$20240926$20230328$20240930$EXP$$CA-JNJFOC-20230364911$JOHNSON AND JOHNSON$$28$YR$A$F$Y$98$KG$20240930$$CN$CA$CA
221477527$22147752$7$F$20180829$20240621$20230328$20240701$EXP$$US-GILEAD-2023-0621875$GILEAD$$73$YR$E$M$Y$$$20240701$$CN$US$US
2214780324$22147803$24$F$$20240801$20230328$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2023-003638$UNITED THERAPEUTICS$$$$$M$Y$91.156$KG$20240809$$$US$US
2214787316$22147873$16$F$20220101$20240905$20230328$20240911$EXP$$CA-TAKEDA-2022TUS081109$TAKEDA$$$$$F$Y$17$KG$20240911$$CN$CA$CA
221479216$22147921$6$F$20230319$20240704$20230328$20240710$EXP$$CA-TAKEDA-2023TUS024079$TAKEDA$$61$YR$$M$Y$$$20240710$$CN$CA$CA
221480012$22148001$2$F$20220501$20230327$20230328$20240815$PER$$NVSC2023US071686$NOVARTIS$$63$YR$$M$Y$$$20240815$$CN$US$US
2214802418$22148024$18$F$$20240806$20230328$20240812$EXP$$FR-MYLANLABS-2023M1031159$MYLAN$$52$YR$$F$Y$$$20240812$$CN$FR$FR
221483084$22148308$4$F$$20240716$20230328$20240723$PER$$US-SA-2023SA095101$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240723$$MD$US$US
221484904$22148490$4$F$20230101$20240701$20230328$20240710$PER$$US-SA-2023SA096632$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240710$$CN$US$US
2214861416$22148614$16$F$20230101$20240815$20230328$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-006169$JAZZ$$$$$F$Y$$$20240821$$CN$US$US
221486198$22148619$8$F$20230503$20240711$20230328$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-015714$JAZZ$$64$YR$$M$Y$$$20240722$$CN$US$US
221491977$22149197$7$F$20240427$20240814$20230329$20240820$EXP$$CA-JNJFOC-20230355492$JOHNSON AND JOHNSON$$58$YR$A$F$Y$198$KG$20240820$$HP$CA$CA
221492587$22149258$7$F$20230317$20240627$20230329$20240705$EXP$$JP-BIOGEN-2023BI01194448$BIOGEN$$0$YR$$M$Y$4$KG$20240705$$MD$JP$JP
221493433$22149343$3$F$20230301$20230407$20230329$20240926$PER$$US-GSK-US2023AMR044929$GLAXOSMITHKLINE$$45$YR$$F$Y$$$20240926$$CN$US$US
221494287$22149428$7$F$20230301$20240911$20230329$20240919$EXP$$CA-TOLMAR, INC.-23CA039338$TOLMAR$$66$YR$$M$Y$$$20240919$$CN$CA$CA
221497984$22149798$4$F$$20240912$20230329$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02394$LUPIN$$$$$$Y$$$20240927$$PH$US$US
221499374$22149937$4$F$$20240806$20230329$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02326$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221499483$22149948$3$F$$20240806$20230329$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02339$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221499592$22149959$2$F$$20240909$20230329$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02284$LUPIN$$$$$$Y$$$20240923$$CN$US$US
221500352$22150035$2$F$$20240819$20230329$20240826$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382497$RANBAXY$Semchenkova A, Mikhailova E, Komkov A, Gaskova M, Abasov R, Matveev E, et al. Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy. Int J Molecular Sci. 2022;23(7):4019$2$YR$$$Y$$$20240826$$HP$RU$RU
221500482$22150048$2$F$$20240819$20230329$20240826$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382748$RANBAXY$Diago-Munoz D, Martinez-Varea A, Perez-Sancho E, Diago-Almela V. Severe COVID-19 Infection during Pregnancy Requiring ECMO: Case Report and Review of the Literature. J Pers Med. 2023;13(2):263$40$YR$$F$Y$$$20240826$$HP$ES$ES
221500582$22150058$2$F$$20240909$20230329$20240913$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382710$RANBAXY$Alexoudi A, Vlachakis E, Banos S, Oikonomou K, Patrikelis P, Verentzioti A, et al. Combined Invasive Peripheral Nerve Stimulation in the Management of Chronic Post-Intracranial Disorder Headache: A Case Report. Clinics Practice. 2023;13(1):297-304$33$YR$$F$Y$$$20240913$$HP$GR$GR
2215016023$22150160$23$F$20230330$20240822$20230329$20240827$EXP$$CA-TAKEDA-2023TUS024786$TAKEDA$$3$YR$$M$Y$14$KG$20240827$$HP$CA$CA
221501722$22150172$2$F$$20240912$20230329$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02361$LUPIN$$$$$$Y$$$20240927$$CN$US$US
221501973$22150197$3$F$$20240904$20230329$20240925$EXP$$US-ROCHE-3317760$ROCHE$$69$YR$E$F$Y$$$20240925$$CN$US$US
221502353$22150235$3$F$$20240912$20230329$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02396$LUPIN$$$$$$Y$$$20240927$$CN$US$US
221503306$22150330$6$F$$20240808$20230329$20240817$EXP$$FR-AMGEN-FRASP2023050058$AMGEN$Yong K.. Isatuximab plus carfilzomib -dexamethasone versus carfilzomib - dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trial. Lancet Haematology. 2024;1-10$$$$$Y$$$20240817$$HP$FR$FR
2215057043$22150570$43$F$20230323$20240827$20230329$20240829$EXP$$CO-TAKEDA-2023TUS025761$TAKEDA$$39$YR$$F$Y$80$KG$20240829$$CN$CO$CO
221505767$22150576$7$F$20221213$20240807$20230329$20240814$EXP$$CA-CELLTRION INC.-2022CA021436$CELLTRION$$$$$$Y$$$20240814$$HP$CA$CA
221505863$22150586$3$F$$20240912$20230329$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02300$LUPIN$$$$$$Y$$$20240921$$CN$US$US
221507725$22150772$5$F$$20240625$20230329$20240703$EXP$$US-SA-2023SA097657$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240703$$MD$US$US
221508305$22150830$5$F$20230101$20240712$20230329$20240718$PER$$US-SA-2023SA097434$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240718$$MD$US$US
221513203$22151320$3$F$20230216$20240722$20230329$20240801$EXP$$AE-AstraZeneca-2023A070115$ASTRAZENECA$$65$YR$$M$Y$65.8$KG$20240801$$MD$AE$
221513433$22151343$3$F$20230101$20240809$20230329$20240820$PER$$US-SA-2023SA097647$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240820$$CN$US$US
221514874$22151487$4$F$20220901$20240918$20230329$20240930$PER$$NVSC2023US072929$NOVARTIS$$65$YR$$M$Y$$$20240930$$CN$US$US
221515659$22151565$9$F$20221217$20240625$20230329$20240701$EXP$$CA-OTSUKA-2022_053851$OTSUKA$$70$YR$$F$Y$$$20240701$$CN$CA$CA
221515685$22151568$5$F$20180718$20240809$20230329$20240814$EXP$$CA-TAKEDA-2018TUS022772$TAKEDA$$14$YR$$F$Y$$$20240814$$CN$CA$CA
221519863$22151986$3$F$20230308$20240902$20230329$20240909$EXP$$UY-ABBVIE-4708409$ABBVIE$$68$YR$$F$Y$$$20240909$$CN$UY$UY
221520893$22152089$3$F$20230201$20240829$20230329$20240903$PER$$US-BIOGEN-2023BI01182278$BIOGEN$$67$YR$$F$Y$$$20240903$$CN$US$US
2215232812$22152328$12$F$$20240906$20230329$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-042161$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240910$$CN$US$US
221523295$22152329$5$F$20191101$20240819$20230329$20240828$PER$$US-SA-2023SA096230$SANOFI AVENTIS$$90$YR$E$M$Y$65.7$KG$20240828$$MD$US$US
221523862$22152386$2$F$$20240918$20230329$20240930$EXP$$US-UCBSA-2023014020$UCB$$$$$F$Y$106.58$KG$20241001$$HP$US$US
221524724$22152472$4$F$$20240910$20230329$20240911$PER$$NVSC2023US071731$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
221525022$22152502$2$F$$20240807$20230329$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02357$LUPIN$$$$$$Y$$$20240822$$CN$US$US
221525129$22152512$9$F$20230317$20240809$20230329$20240814$EXP$$NVSC2023US070713$NOVARTIS$$49$YR$$F$Y$$$20240814$$CN$US$US
221525442$22152544$2$F$$20240730$20230329$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02383$LUPIN$$$$$$Y$$$20240819$$CN$US$US
221525662$22152566$2$F$$20240909$20230329$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02359$LUPIN$$$$$$Y$$$20240920$$CN$US$US
221526203$22152620$3$F$$20230328$20230329$20240808$PER$$NVSC2023US072814$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
221526279$22152627$9$F$20230519$20240913$20230329$20240920$EXP$$AU-TAKEDA-2023TUS032053$TAKEDA$$43$YR$$F$Y$$$20240920$$CN$AU$AU
221528835$22152883$5$F$20230301$20240918$20230329$20240925$EXP$$CA-TAKEDA-2023TUS030860$TAKEDA$$69$YR$$F$Y$$$20240925$$CN$CA$CA
221529732$22152973$2$F$$20240731$20230329$20240801$EXP$$US-TAKEDA-2022TUS009399$TAKEDA$$$$$F$Y$$$20240801$$CN$US$US
221530192$22153019$2$F$$20240909$20230329$20240913$EXP$PL-EMA-DD-20190819-sahu_k-132941$PL-MYLANLABS-2019M1065931$MYLAN$Komorowska A, Lelonek M.. Cessation of empagliflozin treatment in a hospitalised patient with exacerbated heart failure and reduced ejection fraction.. Folia Cardiologica. 2019;14(2):206-212$56$YR$$M$Y$120$KG$20240913$$HP$PL$PL
2215328012$22153280$12$F$20211101$20240821$20230329$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2021-US-026347$JAZZ$$48$YR$$F$Y$$$20240826$$MD$US$US
221536435$22153643$5$F$20230301$20240724$20230330$20240819$PER$$CA-TOLMAR, INC.-23CA039414$TOLMAR$$58$YR$$M$Y$$$20240819$$CN$CA$CA
221536443$22153644$3$F$$20240731$20230330$20240826$PER$$CA-TOLMAR, INC.-23CA039419$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
221536972$22153697$2$F$$20240909$20230330$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02388$LUPIN$$$$$$Y$$$20240924$$CN$US$US
221538862$22153886$2$F$$20240726$20230330$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02028$LUPIN$$$$$$Y$$$20240813$$CN$US$US
221539622$22153962$2$F$$20240812$20230330$20240820$PER$$US-SA-2023SA098470$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240820$$MD$US$US
221541222$22154122$2$F$$20240913$20230330$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02390$LUPIN$$$$$$Y$$$20240921$$CN$US$US
221542022$22154202$2$F$$20230322$20230330$20240726$EXP$$NVSC2023US068553$NOVARTIS$$$$$M$Y$$$20240726$$CN$US$US
221543482$22154348$2$F$$20240701$20230330$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382471$RANBAXY$$$$A$M$Y$$$20240711$$HP$US$US
221544012$22154401$2$F$20230101$20230323$20230330$20240823$EXP$$US-RECORDATI-2023001833$RECORDATI$$$$$$Y$$$20240823$$CN$US$US
221544872$22154487$2$F$$20240913$20230330$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02360$LUPIN$$$$$$Y$$$20240927$$CN$US$US
2215456811$22154568$11$F$20220101$20240830$20230330$20240830$EXP$$CA-PFIZER INC-202201310308$PFIZER$$82$YR$$F$Y$$$20240830$$MD$CA$CA
221546005$22154600$5$F$$20240807$20230330$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02370$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221546012$22154601$2$F$$20240805$20230330$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02369$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221546812$22154681$2$F$$20230324$20230330$20240925$PER$$US-GSK-US2023AMR015551$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
221551293$22155129$3$F$$20240802$20230330$20240809$EXP$$NVSC2023GB068177$NOVARTIS$$$$A$M$Y$$$20240809$$CN$GB$GB
221551764$22155176$4$F$20210617$20240903$20230330$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-116688$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240911$$MD$JP$JP
221551992$22155199$2$F$20210801$20230328$20230330$20240925$EXP$$US-GSK-US2021AMR174166$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
2215520110$22155201$10$F$20230101$20240821$20230330$20240829$EXP$$CA-CELLTRION INC.-2023CA002559$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
221552053$22155205$3$F$$20240802$20230330$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-045484$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240802$$CN$US$US
221552218$22155221$8$F$20221201$20240918$20230330$20240921$EXP$$NVSC2023US068159$NOVARTIS$$51$YR$$F$Y$$$20240921$$HP$US$US
221556162$22155616$2$F$$20240702$20230330$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381777$RANBAXY$Dewaswala N, Bhopalwala H, Al-Abdouh A, Cao X, Patel R, Arbune A. Anthracycline cardiotoxicity initially presenting as isolated right ventricular failure. J Am Coll Cardiol. 2023;Mar;81 (8):3536$41$YR$$F$Y$$$20240703$$HP$US$US
221556422$22155642$2$F$$20240821$20230330$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382960$RANBAXY$Dhawan D, Sharma D, Chhabra L. PERSISTENT BLOODY DIARRHEA IN A HEART TRANSPLANT PATIENT. J Am Coll Cardiol. 2023;Mar7; 81(SA)(8):3499$57$YR$$M$Y$$$20240826$$HP$US$US
221556472$22155647$2$F$$20240715$20230330$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382997$RANBAXY$Gill K, Castillo A, Hanna P, Moore JP, Hayase J. It takes two (ablations) to make a thing go right, a case of wolff parkinson white in ebstein^s anomaly. J Am Coll Cardiol. 2023;Mar;81(8):2444$33$YR$$M$Y$$$20240718$$HP$US$US
221556532$22155653$2$F$$20240723$20230330$20240729$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383061$RANBAXY$Yukselen Z, Mohamed A, Filiberti AW. Ezetimibe induced severe rhabdomyolysis after longstanding high-intensity statin therapy. J Am Coll Cardiol. 2023;Mar 7;81(SA)(8):3308$64$YR$$F$Y$$$20240729$$HP$US$US
221556542$22155654$2$F$$20240711$20230330$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383058$RANBAXY$Patel J, Meng S. Severe gestational hypertriglyceridemia in a patient with familial hyperchylomicronemia syndrome. J Am Coll Cardiol. 2023;Mar 7;81(SA)(8):3435$36$YR$$F$Y$$$20240712$$HP$US$US
221556692$22155669$2$F$$20240703$20230330$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383217$RANBAXY$Khatri S, Chapagain H, Costabile C, Acharya DN. Early stent thrombosis in essential thrombocythemia after percutaneous coronary intervention: a case report. J Am Coll Cardiol. 2023;Mar;81(8):2736$66$YR$$M$Y$$$20240703$$HP$US$US
221556882$22155688$2$F$$20240702$20230330$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382813$RANBAXY$Vyas H, Jain H, Vandyck-Acquah M. Delayed onset doxorubicin induced cardiomyopathy. J Am Coll Cardiol. 2023;Mar;81(8)SA:3567$72$YR$$F$Y$$$20240703$$HP$US$US
221556912$22155691$2$F$$20240702$20230330$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382766$RANBAXY$Hamza M, Zlotoff DA, Belov D. Double jeopardy: acute cardiomyopathy after doxorubicin and cyclophosphamide administration. J Am Coll Cardiol. 2023;Mar;81(8)SA:3486$77$YR$$F$Y$$$20240703$$HP$US$US
221557462$22155746$2$F$20230301$20240813$20230330$20240820$EXP$$US-SA-2023SA099644$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240820$$MD$US$US
221557773$22155777$3$F$20190501$20240705$20230330$20240723$EXP$$DE-ROCHE-2368044$ROCHE$$52$YR$A$M$Y$$$20240723$$CN$DE$DE
2215580111$22155801$11$F$20230326$20240715$20230330$20240717$EXP$$CA-UCBSA-2023015911$UCB$$72$YR$$F$Y$$$20240717$$CN$CA$CA
221559362$22155936$2$F$$20240717$20230330$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202303015079$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240719$$CN$US$US
2215594510$22155945$10$F$$20240919$20230330$20240925$EXP$$US-PFIZER INC-PV202300054031$PFIZER$$86$YR$$M$Y$81.633$KG$20240925$$MD$US$US
221559724$22155972$4$F$$20240810$20230330$20240813$EXP$$CA-TAKEDA-2022TUS002741$TAKEDA$$$$$M$Y$$$20240813$$HP$CA$CA
221560356$22156035$6$F$20240208$20240813$20230330$20240816$EXP$$CA-TAKEDA-2023TUS032893$TAKEDA$$63$YR$$M$Y$$$20240816$$MD$CA$CA
221560392$22156039$2$F$20230316$20240830$20230330$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202303014218$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240903$$CN$US$US
221562023$22156202$3$F$20230101$20240723$20230330$20240801$PER$$US-SA-2023SA098327$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240801$$MD$US$US
221562832$22156283$2$F$$20240918$20230330$20240930$EXP$$NVSC2023US073817$NOVARTIS$$$$$F$Y$$$20240929$$CN$US$US
221563212$22156321$2$F$20220110$20240621$20230330$20240703$PER$$US-SA-2023SA100517$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240703$$MD$US$US
221563413$22156341$3$F$20240613$20240827$20230330$20240910$PER$$US-SA-2023SA099759$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240910$$MD$US$US
221565553$22156555$3$F$20210308$20240910$20230330$20240924$EXP$$JP-LUNDBECK-DKLU3048474$LUNDBECK$$$$$$Y$$$20240924$$MD$JP$JP
221565582$22156558$2$F$$20240729$20230330$20240805$PER$$US-SA-2023SA100016$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240805$$MD$US$US
221566156$22156615$6$F$$20240911$20230330$20240917$EXP$$US-ABBVIE-4254858$ABBVIE$$$$$F$Y$50$KG$20240917$$CN$US$US
221566897$22156689$7$F$$20240903$20230330$20240911$EXP$$US-AMGEN-USASL2023053205$AMGEN$$61$YR$A$M$Y$82.086$KG$20240911$$MD$US$US
221567173$22156717$3$F$20221001$20240917$20230330$20240927$EXP$$JP-DSJP-DSJ-2023-111890$DAIICHI$$89$YR$$F$Y$44$KG$20240927$$HP$JP$JP
221567609$22156760$9$F$20220101$20240927$20230330$20240927$EXP$$CA-PFIZER INC-202201253461$PFIZER$$62$YR$$M$Y$135$KG$20240927$$MD$CA$CA
221567773$22156777$3$F$$20240920$20230330$20240925$EXP$$IN-PFIZER INC-PV202300057503$PFIZER$$61$YR$$F$Y$$$20240925$$CN$IN$IN
221567904$22156790$4$F$$20240813$20230330$20240816$EXP$$US-PFIZER INC-PV202300056497$PFIZER$$66$YR$$F$Y$$$20240816$$MD$US$US
2215696112$22156961$12$F$$20240708$20230330$20240710$EXP$$US-PFIZER INC-2019375677$PFIZER$$70$YR$$F$Y$54.43$KG$20240710$$MD$US$US
2215696215$22156962$15$F$20180101$20240925$20230330$20240930$EXP$$IL-PFIZER INC-2018084931$PFIZER$$40$YR$$M$Y$$$20240930$$HP$IL$IL
221569723$22156972$3$F$20220308$20240814$20230330$20240819$EXP$$CA-PFIZER INC-202200003483$PFIZER$$23$YR$$F$Y$$$20240819$$HP$CA$CA
221569833$22156983$3$F$$20240823$20230330$20240828$EXP$$ZA-PFIZER INC-PV202300057900$PFIZER$$55$YR$$M$Y$$$20240828$$MD$ZA$ZA
221570545$22157054$5$F$$20240807$20230330$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02400$LUPIN$$$$$$Y$$$20240829$$CN$US$US
221570723$22157072$3$F$$20240913$20230330$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02474$LUPIN$$$$$$Y$$$20240930$$CN$US$US
2215712615$22157126$15$F$20230324$20240924$20230330$20240930$EXP$$CO-TAKEDA-2021TUS053676$TAKEDA$$35$YR$$F$Y$43$KG$20240930$$CN$CO$CO
2215751816$22157518$16$F$20230101$20240913$20230330$20240919$EXP$$CA-PFIZER INC-202300133366$PFIZER$$20$YR$$F$Y$$$20240919$$PH$CA$CA
221576542$22157654$2$F$$20240829$20230330$20240910$PER$$US-SA-2023SA100216$SANOFI AVENTIS$$$$A$F$Y$63.492$KG$20240910$$MD$US$US
221577573$22157757$3$F$20220101$20240812$20230330$20240814$PER$$US-PFIZER INC-PV202300056674$PFIZER$$52$YR$$F$Y$$$20240814$$HP$US$US
221577684$22157768$4$F$20240901$20240911$20230330$20240916$PER$$US-PFIZER INC-PV202300059244$PFIZER$$50$YR$$M$Y$$$20240916$$HP$US$US
221577703$22157770$3$F$20230101$20240916$20230330$20240918$PER$$US-PFIZER INC-PV202300058762$PFIZER$$77$YR$$F$Y$$$20240918$$CN$US$US
221578233$22157823$3$F$20230901$20240807$20230330$20240813$PER$$US-PFIZER INC-202300133667$PFIZER$$61$YR$$F$Y$$$20240813$$HP$US$US
221578825$22157882$5$F$$20240701$20230330$20240703$PER$$US-PFIZER INC-PV202300058307$PFIZER$$51$YR$$F$Y$$$20240703$$CN$US$US
221578962$22157896$2$F$$20240702$20230330$20240704$EXP$$US-PFIZER INC-PV202300057204$PFIZER$$61$YR$$F$Y$$$20240704$$MD$US$US
221579143$22157914$3$F$20230301$20240731$20230330$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-228613$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240801$$HP$US$US
221579987$22157998$7$F$20220914$20240830$20230330$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-043488$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$70$KG$20240913$$MD$JP$JP
221582253$22158225$3$F$20230306$20240722$20230331$20240808$PER$$CA-TOLMAR, INC.-23CA039386$TOLMAR$$85$YR$$M$Y$$$20240808$$CN$CA$CA
221582294$22158229$4$F$20240205$20240912$20230331$20240927$PER$$CA-TOLMAR, INC.-23CA039401$TOLMAR$$84$YR$$M$Y$$$20240927$$CN$CA$CA
2215824615$22158246$15$F$20240201$20240610$20230331$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000954$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240705$$CN$US$US
221582803$22158280$3$F$$20240809$20230331$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001157$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
221583703$22158370$3$F$$20240613$20230331$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000930$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
221583777$22158377$7$F$20230201$20240826$20230331$20240830$EXP$FR-ROCHE-3319387$FR-ROCHE-3319387$ROCHE$$55$YR$A$M$Y$$$20240830$$MD$FR$FR
221588252$22158825$2$F$$20240701$20230331$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382472$RANBAXY$$$$E$F$Y$$$20240711$$MD$US$US
221588759$22158875$9$F$$20240918$20230331$20240926$PER$$NVSC2023US069472$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
221590145$22159014$5$F$20230301$20240719$20230331$20240731$PER$$US-SA-2023SA100775$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240731$$MD$US$US
221591916$22159191$6$F$$20240730$20230331$20240822$PER$$CA-TOLMAR, INC.-23CA039380$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
221592303$22159230$3$F$20230301$20240731$20230331$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02398$LUPIN$$$$$$Y$$$20240818$$CN$US$US
221592624$22159262$4$F$$20240905$20230331$20240910$EXP$$US-TAKEDA-2023TUS032447$TAKEDA$$$$$F$Y$82$KG$20240910$$CN$US$US
221592812$22159281$2$F$20230312$20230328$20230331$20240823$PER$$NVSC2023US073042$NOVARTIS$$65$YR$$F$Y$107.95$KG$20240823$$CN$US$US
221593262$22159326$2$F$$20240806$20230331$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02423$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221594433$22159443$3$F$20230301$20240806$20230331$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02412$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221596353$22159635$3$F$$20240731$20230331$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02435$LUPIN$$$$$$Y$$$20240818$$CN$US$US
221596585$22159658$5$F$20090101$20230724$20230331$20240805$EXP$$NVSC2023US071104$NOVARTIS$$$$$M$Y$$$20240805$$CN$US$US
221596764$22159676$4$F$20221225$20240628$20230331$20240705$EXP$$NVSC2020CA227996$NOVARTIS$$46$YR$$F$Y$$$20240705$$CN$CA$CA
221597252$22159725$2$F$$20230326$20230331$20240715$EXP$$BG-ASTELLAS-2023US010008$ASTELLAS$$65$YR$$M$Y$$$20240715$$MD$BG$BG
221598394$22159839$4$F$20220111$20240627$20230331$20240701$EXP$$JP-ASTELLAS-2022JP001081$ASTELLAS$$67$YR$$M$Y$55.8$KG$20240701$$MD$JP$JP
221598752$22159875$2$F$20210801$20230329$20230331$20240925$EXP$$US-GSK-US2021AMR175094$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
221598922$22159892$2$F$20230301$20240802$20230331$20240807$EXP$$CA-GSK-CA2023043123$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$HP$CA$CA
221600009$22160000$9$F$20230124$20240918$20230331$20240927$PER$$NVSC2023US070341$NOVARTIS$$74$YR$$F$Y$$$20240927$$CN$US$US
221600172$22160017$2$F$20230301$20240822$20230331$20240916$PER$$US-SA-2023SA099114$SANOFI AVENTIS$$37$YR$A$F$Y$81$KG$20240916$$MD$US$US
221600493$22160049$3$F$20230202$20240724$20230331$20240731$PER$$US-SA-2023SA098601$SANOFI AVENTIS$$5$YR$C$M$Y$22.7$KG$20240731$$MD$US$US
221601064$22160106$4$F$20231101$20240626$20230331$20240703$EXP$$CA-GSK-CA2023047812$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CA$CA
221601272$22160127$2$F$20240101$20240821$20230331$20240919$PER$$US-SA-2023SA100232$SANOFI AVENTIS$$$$A$M$Y$$$20240919$$MD$US$US
221601823$22160182$3$F$20230328$20240918$20230331$20240927$PER$$NVSC2023US074487$NOVARTIS$$73$YR$$F$Y$$$20240927$$HP$US$US
221604553$22160455$3$F$20230201$20240820$20230331$20240822$EXP$FR-AFSSAPS-RN2023000299$FR-GSK-FR2023046523$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$MD$FR$FR
221607622$22160762$2$F$$20240829$20230331$20240904$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382893$RANBAXY$van der Made CI, Potjewijd J, Hoogstins A, Willems HPJ, Kwakernaak AJ, de Sevaux RGL, et al. Adult-onset auto inflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS. J Allergy Clin Immunol. 2022;149(1):432-439.e4$66$YR$$M$Y$$$20240904$$MD$NL$NL
221608054$22160805$4$F$$20240905$20230331$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-045512$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240917$$MD$JP$JP
221610717$22161071$7$F$20230201$20240827$20230331$20240830$EXP$FR-AFSSAPS-RN2023000299$FR-009507513-2303FRA009990$MERCK$$55$YR$$M$Y$$$20240830$$MD$FR$FR
221610764$22161076$4$F$$20240806$20230331$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02483$LUPIN$$$$$$Y$$$20240902$$PH$US$US
221610859$22161085$9$F$$20240914$20230331$20240923$EXP$$CA-OTSUKA-2022_031625$OTSUKA$$$$$F$Y$$$20240923$$MD$CA$CA
221611652$22161165$2$F$$20240909$20230331$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02460$LUPIN$$$$$$Y$$$20240921$$CN$US$US
221612535$22161253$5$F$20230301$20240815$20230331$20240819$EXP$$US-INCYTE CORPORATION-2023IN002946$INCYTE$$$$$$Y$$$20240819$$CN$US$US
221612564$22161256$4$F$$20240627$20230331$20240702$EXP$$CN-PFIZER INC-PV202300056149$PFIZER$Wu, X.. Suspected Cefoperazone Sodium and Sulbactam Sodium-induced Drug Hypersensitivity Syndrome: A Case Report. Clinical Medication Journal. 2023;21(2):84-86$73$YR$$M$Y$$$20240702$$HP$CN$CN
221614616$22161461$6$F$20210101$20240715$20230331$20240722$PER$$US-VERTEX PHARMACEUTICALS-2023-004528$VERTEX$$$$$M$Y$58$KG$20240722$$PH$US$US
2216147717$22161477$17$F$20201130$20240902$20230331$20240905$EXP$$IN-PFIZER INC-2020482714$PFIZER$$37$YR$$F$Y$$$20240905$$CN$IN$IN
221614864$22161486$4$F$20230101$20240715$20230331$20240717$EXP$$CA-PFIZER INC-202201401400$PFIZER$$67$YR$$F$Y$$$20240717$$HP$CA$CA
221615102$22161510$2$F$$20240715$20230331$20240717$EXP$$US-PFIZER INC-PV202300052322$PFIZER$$61$YR$$M$Y$$$20240717$$CN$US$US
221615762$22161576$2$F$$20240717$20230331$20240724$EXP$$FR-MYLANLABS-2023M1034453$MYLAN$Duburcq T, Goutay J, Preau S, Mugnier A, Rousse N, Moussa MD, Vincentelli A, Cuny J, Parmentier-Decrucq E, Poissy J.. Venoarterial Extracorporeal Membrane Oxygenation in Severe Drug Intoxication: A Retrospective Comparison of Survivors and Nonsurvivors. ASAIO J.. 2022;1;68(7):907-913.$$$A$$Y$$$20240724$$MD$FR$FR
221616845$22161684$5$F$20220101$20240821$20230331$20240826$EXP$$NVSC2022GB154468$NOVARTIS$$$$A$M$Y$$$20240826$$CN$GB$GB
221617054$22161705$4$F$20180101$20240829$20230331$20240830$EXP$$US-UCBSA-2022068199$UCB$$$$$M$Y$$$20240830$$CN$US$US
2216187912$22161879$12$F$20230218$20240705$20230331$20240710$EXP$$NVSC2023GB041588$NOVARTIS$$$$A$M$Y$$$20240710$$CN$GB$GB
221619333$22161933$3$F$20230327$20240813$20230331$20240826$PER$$US-SA-2023SA099911$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240826$$MD$US$US
221619456$22161945$6$F$$20240723$20230331$20240726$PER$$US-PFIZER INC-PV202300058493$PFIZER$$65$YR$$F$Y$$$20240726$$CN$US$US
221620776$22162077$6$F$$20240716$20230331$20240723$EXP$$US-ABBVIE-4710247$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
221622212$22162221$2$F$$20240812$20230331$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023046642$VIIV$$$$$M$Y$$$20240822$$CN$US$US
221624089$22162408$9$F$$20240708$20230331$20240710$PER$$US-PFIZER INC-PV202300059467$PFIZER$$90$YR$$F$Y$$$20240710$$CN$US$US
221624094$22162409$4$F$$20240814$20230331$20240815$EXP$$US-PFIZER INC-PV202300058274$PFIZER$$66$YR$$F$Y$$$20240815$$CN$US$US
2216242418$22162424$18$F$$20240829$20230331$20240905$EXP$$US-VERTEX PHARMACEUTICALS-2023-004490$VERTEX$$$$$$Y$$$20240905$$CN$US$US
221624986$22162498$6$F$20230301$20240827$20230331$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007188$JAZZ$$32$YR$$M$Y$$$20240830$$HP$US$US
221625245$22162524$5$F$20230323$20240703$20230331$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007046$JAZZ$$23$YR$$M$Y$$$20240708$$CN$US$US
221626625$22162662$5$F$$20240711$20230331$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007036$JAZZ$$$$$M$Y$$$20240717$$HP$US$US
221628243$22162824$3$F$20230305$20240718$20230331$20240805$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000092$Unknown Manufacturer$$$$$$Y$$$20240805$$CN$US$US
221628587$22162858$7$F$20230319$20240827$20230331$20240829$EXP$$CN-TAKEDA-2023TUS033153$TAKEDA$$44$YR$$M$Y$56$KG$20240829$$MD$CN$CN
221629307$22162930$7$F$20200810$20240630$20230331$20240708$EXP$$CA-CELLTRION INC.-2020CA025347$CELLTRION$$$$$$Y$$$20240709$$HP$CA$CA
221629413$22162941$3$F$$20240803$20230401$20240805$EXP$$CA-ROCHE-3321657$ROCHE$$78$YR$E$M$Y$35$KG$20240805$$HP$CA$CA
2216295410$22162954$10$F$$20240808$20230401$20240811$EXP$$NVSC2023US075192$NOVARTIS$$$$$F$Y$$$20240811$$CN$US$US
2216296011$22162960$11$F$20230330$20240726$20230401$20240802$EXP$$NVSC2023US075187$NOVARTIS$$33$YR$$F$Y$$$20240802$$CN$US$US
221629752$22162975$2$F$$20240702$20230401$20240710$EXP$$GR-CELLTRION INC.-2023GR006299$CELLTRION$Zachou M, Pikramenos K, Panoutsakou M, Lalla E, Androutsakos T.. Infliximab (IFX) Biosimilar Induced Drug Induced Liver Injury (DILI): A case Report. Cureus. 2022;14(12)$$$$$Y$$$20240710$$HP$GR$GR
2216301310$22163013$10$F$20180112$20240819$20230401$20240827$EXP$$CA-CELLTRION INC.-2022CA021011$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
221630763$22163076$3$F$$20240821$20230401$20240831$EXP$$PT-AUROBINDO-AUR-APL-2023-013762$AUROBINDO$Serra D, Goncalo M, Mariano A, Figueiredo A.. Pustular psoriasis and drug-induced pustulosis. Giornale Italiano di Dermatologia e Venereologia.. 2011;146(2):155-158$65$YR$$F$Y$$$20240831$$HP$PT$PT
221630993$22163099$3$F$$20240621$20230401$20240704$EXP$$US-ROCHE-3321685$ROCHE$$77$YR$E$M$Y$$$20240704$$CN$US$US
221631735$22163173$5$F$$20240923$20230401$20240927$EXP$$CA-ROCHE-3320437$ROCHE$$61$YR$A$M$Y$$$20240927$$HP$CA$CA
2216323415$22163234$15$F$$20240918$20230401$20240922$EXP$$NVSC2023US073982$NOVARTIS$$$$$F$Y$$$20240922$$CN$US$US
221632764$22163276$4$F$20230313$20240918$20230401$20240930$PER$$NVSC2023US071908$NOVARTIS$$36$YR$$F$Y$47.3$KG$20240930$$CN$US$US
221633002$22163300$2$F$20220223$20230324$20230401$20240812$EXP$$NVSC2023US070725$NOVARTIS$$42$YR$$M$Y$$$20240812$$CN$US$US
221633207$22163320$7$F$20230321$20240904$20230401$20240905$PER$$NVSC2023US071571$NOVARTIS$$60$YR$$M$Y$$$20240905$$CN$US$US
221633466$22163346$6$F$$20240820$20230401$20240823$EXP$$NVSC2023US072242$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
221633607$22163360$7$F$20210522$20240822$20230401$20240829$EXP$$CO-TAKEDA-2020TUS045582$TAKEDA$$18$YR$$F$Y$44$KG$20240829$$CN$CO$CO
221635413$22163541$3$F$$20240722$20230401$20240829$EXP$$US-ROCHE-3321011$ROCHE$$56$YR$A$F$Y$89.35$KG$20240829$$CN$US$US
221637827$22163782$7$F$$20240925$20230401$20240927$EXP$$NVSC2023US072337$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
221638012$22163801$2$F$$20230328$20230401$20240730$PER$$NVSC2023US072890$NOVARTIS$$$$$M$Y$86.18$KG$20240730$$CN$US$US
221638297$22163829$7$F$20180208$20240717$20230401$20240725$EXP$$CN-ROCHE-2215953$ROCHE$$59$YR$A$M$Y$60$KG$20240725$$CN$CN$CN
221640153$22164015$3$F$20230901$20240904$20230402$20240910$EXP$$NVSC2023AE044351$NOVARTIS$$25$YR$$F$Y$$$20240910$$CN$AE$AE
2216402514$22164025$14$F$20221219$20240906$20230402$20240918$EXP$$NVSC2023BR011602$NOVARTIS$$44$YR$$F$Y$$$20240918$$CN$BR$BR
221640337$22164033$7$F$$20240409$20230402$20240807$EXP$$NVSC2023HU030459$NOVARTIS$$$$A$F$Y$$$20240807$$MD$HU$HU
221644215$22164421$5$F$20220131$20240806$20230403$20240812$EXP$FR-SEATTLE GENETICS-2023SGN01847$FR-ROCHE-3319182$ROCHE$$57$YR$A$F$Y$$$20240812$$PH$FR$FR
2216442419$22164424$19$F$20230210$20240830$20230403$20240905$EXP$$AT-ABBVIE-4327910$ABBVIE$$91$YR$$F$Y$61$KG$20240905$$MD$AT$AT
221645985$22164598$5$F$20230116$20240717$20230403$20240718$EXP$$JP-ABBVIE-4713258$ABBVIE$$90$YR$$M$Y$74$KG$20240718$$MD$JP$JP
221646685$22164668$5$F$20221221$20240816$20230403$20240820$EXP$$NVSC2022US303642$NOVARTIS$$6$YR$$F$Y$$$20240820$$HP$US$US
221647762$22164776$2$F$20230131$20240725$20230403$20240726$EXP$$FR-ROCHE-3321031$ROCHE$$57$YR$A$F$Y$$$20240726$$PH$FR$FR
221647894$22164789$4$F$20230301$20240925$20230403$20240927$EXP$$DE-ROCHE-3317054$ROCHE$$52$YR$A$F$Y$54$KG$20240927$$MD$DE$DE
221647953$22164795$3$F$20230101$20240626$20230403$20240702$EXP$$US-ABBVIE-4710918$ABBVIE$$78$YR$$F$Y$$$20240702$$CN$US$US
221649313$22164931$3$F$$20240809$20230403$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02492$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221649334$22164933$4$F$20220523$20240713$20230403$20240726$EXP$$IN-ROCHE-3145262$ROCHE$$71$YR$E$F$Y$63.6$KG$20240726$$MD$IN$IN
221650292$22165029$2$F$$20240805$20230403$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02436$LUPIN$$$$$$Y$$$20240822$$CN$US$US
221650902$22165090$2$F$20220201$20230329$20230403$20240926$PER$$US-GSK-US2023AMR048051$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240926$$CN$US$US
221651197$22165119$7$F$$20240813$20230403$20240819$EXP$$US-TAKEDA-2021TUS041286$TAKEDA$$$$$F$Y$88$KG$20240819$$HP$US$US
2216514310$22165143$10$F$$20240903$20230403$20240910$EXP$$CA-ROCHE-3317828$ROCHE$$62$YR$A$M$Y$$$20240910$$CN$CA$CA
221651992$22165199$2$F$$20230328$20230403$20240711$EXP$$ZA-ASTELLAS-2023US010130$ASTELLAS$$$$$M$Y$$$20240711$$HP$ZA$ZA
221652263$22165226$3$F$$20240925$20230403$20240927$EXP$$IT-TAKEDA-2023TUS033844$TAKEDA$$9$YR$$M$Y$$$20240927$$CN$IT$IT
221652333$22165233$3$F$$20240806$20230403$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02475$LUPIN$$$$$$Y$$$20240829$$CN$US$US
221656355$22165635$5$F$$20240903$20230403$20240911$EXP$$DE-ROCHE-3321681$ROCHE$Kunkele A, Von Stackelberg A, Eggert A, Lang P, Zirngibl F. Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with Xlinked chronic granulomatous disease. Front. Immunol. 2023;14:1-7. doi:10.3389/fimmu.2023.1042650.$14$MON$I$M$Y$$$20240911$$HP$DE$DE
221657092$22165709$2$F$$20240717$20230403$20240801$EXP$$JP-COSETTE-CP2023JP000055$COSETTE PHARMACEUTICALS$$7$DEC$E$F$Y$65$KG$20240801$$MD$JP$JP
221657742$22165774$2$F$$20240701$20230403$20240709$EXP$$FR-AUROBINDO-AUR-APL-2023-014779$AUROBINDO$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al.. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. Journal of Clinical Immunology. 2023;43(3):647-652$33$YR$$M$Y$$$20240709$$HP$FR$FR
221658096$22165809$6$F$20230201$20240816$20230403$20240828$EXP$$FR-AUROBINDO-AUR-APL-2023-014623$AUROBINDO$$55$YR$$M$Y$$$20240828$$MD$FR$FR
221660962$22166096$2$F$20221119$20240702$20230403$20240711$EXP$$NL-PFIZER INC-202300134392$PFIZER$$$$$F$Y$$$20240711$$MD$NL$NL
221661014$22166101$4$F$$20240910$20230403$20240912$EXP$$US-PFIZER INC-PV202300057522$PFIZER$$72$YR$$F$Y$$$20240912$$CN$US$US
2216610212$22166102$12$F$20230201$20240826$20230403$20240903$EXP$FR-AFSSAPS-RN2023000299$FR-PFIZER INC-202300131789$PFIZER$$55$YR$$M$Y$$$20240903$$MD$FR$FR
221661053$22166105$3$F$20220131$20240703$20230403$20240712$EXP$$FR-PFIZER INC-202300131787$PFIZER$$57$YR$$F$Y$$$20240712$$HP$FR$FR
221662632$22166263$2$F$$20240809$20230403$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-046203$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240813$$HP$US$US
221663253$22166325$3$F$20221118$20240822$20230403$20240827$EXP$$US-PFIZER INC-202300135901$PFIZER$$72$YR$$F$Y$$$20240827$$CN$US$US
2216645113$22166451$13$F$$20240829$20230403$20240830$EXP$$NVSC2023US071925$NOVARTIS$$$$$$Y$$$20240830$$CN$US$US
221666664$22166666$4$F$$20240918$20230403$20240924$PER$$NVSC2023US076789$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
221667236$22166723$6$F$20230221$20240701$20230403$20240702$EXP$$NVSC2023CH071110$NOVARTIS$$$$E$F$Y$$$20240702$$MD$CH$CH
221667442$22166744$2$F$20230302$20240729$20230403$20240731$EXP$FR-AFSSAPS-PV2023000299$FR-PFIZER INC-202300138799$PFIZER$$55$YR$$F$Y$48$KG$20240731$$MD$FR$FR
221667886$22166788$6$F$20221118$20240822$20230403$20240827$EXP$$US-PFIZER INC-202300136921$PFIZER$$72$YR$$F$Y$$$20240827$$CN$US$US
221668315$22166831$5$F$$20240824$20230403$20240826$EXP$$US-PFIZER INC-202101720391$PFIZER$$69$YR$$F$Y$83.01$KG$20240826$$CN$US$US
221668993$22166899$3$F$20230330$20240813$20230403$20240814$PER$$NVSC2023US076641$NOVARTIS$$63$YR$$F$Y$53$KG$20240814$$CN$US$US
221669134$22166913$4$F$20180901$20240625$20230403$20240701$EXP$$US-TAKEDA-2022TUS062378$TAKEDA$$27$YR$$F$Y$$$20240701$$HP$US$US
221670064$22167006$4$F$20181026$20240829$20230403$20240906$EXP$$CO-ROCHE-3323336$ROCHE$$47$YR$A$F$Y$63$KG$20240906$$CN$CO$CO
221671303$22167130$3$F$20230318$20240828$20230403$20240830$EXP$$US-PFIZER INC-202300140098$PFIZER$$51$YR$$F$Y$107.94$KG$20240830$$HP$US$US
221672104$22167210$4$F$20230316$20240628$20230403$20240704$EXP$$JP-009507513-2303JPN002370J$MERCK$$80$YR$$M$Y$62$KG$20240704$$MD$JP$JP
221672264$22167226$4$F$$20240809$20230403$20240822$PER$$US-TAKEDA-2023TUS033385$TAKEDA$$$$$M$Y$$$20240822$$CN$US$US
221672625$22167262$5$F$20221201$20240827$20230403$20240830$EXP$$KR-ABBVIE-4713171$ABBVIE$$71$YR$$M$Y$54$KG$20240830$$MD$KR$KR
221673123$22167312$3$F$20230101$20240905$20230403$20240909$PER$$US-PFIZER INC-2020417569$PFIZER$$63$YR$$M$Y$$$20240909$$CN$US$US
221673563$22167356$3$F$20190501$20240725$20230403$20240805$PER$$US-SA-2023SA099099$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240805$$MD$US$US
221673582$22167358$2$F$20230201$20240808$20230403$20240817$PER$$US-SA-2023SA102009$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240817$$MD$US$US
221673959$22167395$9$F$20230101$20240705$20230403$20240716$PER$$US-SA-2023SA102790$SANOFI AVENTIS$$28$YR$A$F$Y$61.2$KG$20240716$$CN$US$US
221674402$22167440$2$F$20230301$20240816$20230403$20240828$PER$$US-SA-2023SA100693$SANOFI AVENTIS$$23$YR$A$F$Y$71.2$KG$20240828$$MD$US$US
221674435$22167443$5$F$$20240812$20230403$20240822$EXP$FR-AFSSAPS-RN2023000299$FR-BAXTER-2023BAX016813$BAXTER$$55$YR$$M$Y$$$20240822$$HP$FR$FR
221674483$22167448$3$F$20230101$20240620$20230403$20240704$PER$$US-SA-2023SA101570$SANOFI AVENTIS$$47$YR$A$F$Y$47.6$KG$20240704$$MD$US$US
2216745311$22167453$11$F$20230101$20240726$20230403$20240802$EXP$$US-SA-2023SA102713$SANOFI AVENTIS$$20$YR$A$M$Y$90.7$KG$20240802$$MD$US$US
221675752$22167575$2$F$$20240709$20230403$20240717$PER$$US-SA-2023SA101745$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240717$$CN$US$US
221676162$22167616$2$F$20230330$20240628$20230403$20240709$PER$$US-SA-2023SA103414$SANOFI AVENTIS$$4$YR$C$M$Y$21.2$KG$20240709$$MD$US$US
2216775916$22167759$16$F$20230319$20240908$20230403$20240916$EXP$$NVSC2023SA074000$NOVARTIS$$2$YR$$M$Y$10.3$KG$20240916$$CN$SA$SA
221678442$22167844$2$F$$20240821$20230403$20240826$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2023-07847$IPSEN$$$$$F$Y$$$20240826$$HP$GB$GB
221680072$22168007$2$F$20230223$20240731$20230403$20240809$EXP$FR-AFSSAPS-PV2023000264$FR-TEVA-2023-FR-2871719$TEVA$$12$YR$$M$Y$56$KG$20240809$$PH$FR$FR
2216814111$22168141$11$F$$20240904$20230403$20240918$EXP$$CA-BAXTER-2023BAX017063$BAXTER$$53$YR$$M$Y$$$20240918$$CN$CA$CA
221682063$22168206$3$F$$20240711$20230403$20240716$EXP$$FR-MYLANLABS-2023M1034191$MYLAN$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al.. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome.. Journal of Clinical Immunology. 2023;43 (3):647-652$4$YR$$F$Y$$$20240716$$HP$FR$FR
221682113$22168211$3$F$$20240627$20230403$20240702$PER$$US-PFIZER INC-PV202300058146$PFIZER$$91$YR$$M$Y$$$20240702$$CN$US$US
221682857$22168285$7$F$$20240821$20230403$20240827$PER$$US-PFIZER INC-PV202300058299$PFIZER$$80$YR$$M$Y$$$20240827$$CN$US$US
221683275$22168327$5$F$20230101$20240627$20230403$20240703$EXP$$JP-009507513-2303JPN003746J$MERCK$$51$YR$$F$Y$$$20240703$$MD$JP$JP
221683313$22168331$3$F$20210914$20240723$20230403$20240729$EXP$$DK-MYLANLABS-2021M1088492$MYLAN$$62$YR$$F$Y$68.9$KG$20240729$$MD$DK$DK
221686278$22168627$8$F$20230201$20240826$20230403$20240830$EXP$FR-AFSSAPS-RN2023000299$FR-MYLANLABS-2023M1033963$MYLAN$$55$YR$$M$Y$$$20240830$$MD$FR$FR
221686442$22168644$2$F$$20240828$20230403$20240903$EXP$$ZA-MYLANLABS-2023M1034216$MYLAN$$$$$M$Y$$$20240903$$MD$ZA$ZA
221686612$22168661$2$F$20240501$20240624$20230403$20240703$PER$$US-SA-2023SA101990$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240703$$MD$US$US
221687437$22168743$7$F$$20240918$20230403$20240924$EXP$$NVSC2023US071657$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
2216878618$22168786$18$F$20230101$20240801$20230403$20240812$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007464$JAZZ$$$$$F$Y$$$20240812$$MD$US$US
2216879710$22168797$10$F$20230630$20240909$20230403$20240913$EXP$$CA-TAKEDA-2023TUS031050$TAKEDA$$60$YR$$M$Y$$$20240913$$HP$CA$CA
221689833$22168983$3$F$20190716$20240724$20230404$20240730$EXP$$JP-ABBVIE-21P-087-4083910-00$ABBVIE$$61$YR$$M$Y$77$KG$20240730$$MD$JP$JP
221691932$22169193$2$F$$20240725$20230404$20240801$EXP$$IN-ROCHE-3321789$ROCHE$$68$YR$E$M$Y$$$20240801$$MD$IN$IN
221692412$22169241$2$F$20230204$20240725$20230404$20240731$EXP$$IN-ROCHE-3280048$ROCHE$$66$YR$E$M$Y$$$20240731$$MD$IN$IN
221694845$22169484$5$F$$20240812$20230404$20240823$EXP$$CA-APOTEX-2023AP005930$APOTEX$$36$YR$$F$Y$$$20240823$$MD$CA$CA
221694852$22169485$2$F$20230201$20240916$20230404$20240920$EXP$$CA-ABBVIE-4713823$ABBVIE$$80$YR$$M$Y$$$20240920$$MD$CA$CA
221696963$22169696$3$F$20230201$20240812$20230404$20240815$EXP$FR-AFSSAPS-RN2023000299$FR-SA-2023SA103199$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240815$$HP$FR$FR
221697239$22169723$9$F$20230729$20240830$20230404$20240909$PER$$US-ROCHE-3319073$ROCHE$$49$YR$A$M$Y$$$20240909$$CN$US$US
221697586$22169758$6$F$20230101$20240801$20230404$20240812$PER$$US-SA-2023SA102642$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240812$$MD$US$US
221699595$22169959$5$F$20220530$20240719$20230404$20240725$EXP$$NVSC2022CA077312$NOVARTIS$$60$YR$$M$Y$$$20240725$$CN$CA$CA
221700362$22170036$2$F$$20240829$20230404$20240908$30DAY$$US-GSK-US2023047367$GLAXOSMITHKLINE$$$$$F$Y$$$20240908$$MD$US$US
221701042$22170104$2$F$$20230331$20230404$20240715$EXP$$GR-ASTELLAS-2023US010523$ASTELLAS$$$$$M$Y$$$20240715$$CN$GR$GR
221701837$22170183$7$F$20230101$20240916$20230404$20240920$EXP$$US-SA-2023SA104638$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240920$$MD$US$US
221702146$22170214$6$F$20230201$20240823$20230404$20240828$EXP$FR-AFSSAPS-RN2023000299$FR-AMGEN-FRASP2023054527$AMGEN$$55$YR$A$M$Y$$$20240828$$MD$FR$FR
221702248$22170224$8$F$20220315$20230814$20230404$20240925$EXP$$NVSC2023AT070792$NOVARTIS$$60$YR$$F$Y$86$KG$20240925$$MD$AT$AT
221702422$22170242$2$F$$20240812$20230404$20240823$PER$$US-JNJFOC-20230379702$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
221702482$22170248$2$F$20210520$20240731$20230404$20240813$EXP$$GB-AUROBINDO-AUR-APL-2022-020823$AUROBINDO$$54$YR$$F$Y$53$KG$20240813$$CN$GB$GB
221703474$22170347$4$F$20230201$20240814$20230404$20240827$EXP$$NL-AUROBINDO-AUR-APL-2023-014438$AUROBINDO$$9$YR$$M$Y$$$20240827$$HP$NL$NL
221705063$22170506$3$F$20230316$20240918$20230404$20240930$PER$$NVSC2023US076926$NOVARTIS$$68$YR$$M$Y$$$20240930$$CN$US$US
221705702$22170570$2$F$$20240826$20230404$20240907$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK080708$GLENMARK$$$$$$Y$$$20240907$$HP$CA$CA
221706642$22170664$2$F$20230101$20240715$20230404$20240724$PER$$US-SA-2023SA103539$SANOFI AVENTIS$$51$YR$A$F$Y$80$KG$20240724$$MD$US$US
221706752$22170675$2$F$20221119$20240724$20230404$20240731$EXP$$NL-ROCHE-3321208$ROCHE$$$$$F$Y$$$20240731$$MD$NL$NL
221707564$22170756$4$F$20230309$20240709$20230404$20240711$EXP$$NVSC2023CA066497$NOVARTIS$$64$YR$$F$Y$57$KG$20240711$$MD$CA$CA
221708623$22170862$3$F$20230317$20240920$20230404$20240927$EXP$$CO-GSK-CO2023AMR047319$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$PH$CO$CO
221709062$22170906$2$F$$20240807$20230404$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02517$LUPIN$$$$$$Y$$$20240901$$CN$US$US
221709853$22170985$3$F$$20240806$20230404$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02527$LUPIN$$$$$$Y$$$20240830$$CN$US$US
221710514$22171051$4$F$20220131$20240711$20230404$20240722$EXP$$FR-AUROBINDO-AUR-APL-2023-014195$AUROBINDO$$57$YR$$F$Y$$$20240722$$PH$FR$FR
221711058$22171105$8$F$20230331$20240705$20230404$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-047291$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$71.67$KG$20240708$$CN$US$US
221711353$22171135$3$F$$20240807$20230404$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02539$LUPIN$$$$$$Y$$$20240829$$PH$US$US
221712234$22171223$4$F$20230316$20240920$20230404$20240928$EXP$$US-GSK-US2023047898$GLAXOSMITHKLINE$$$$$$Y$$$20240928$$MD$US$US
2217145014$22171450$14$F$20200101$20240723$20230404$20240729$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007493$JAZZ$$$$$F$Y$$$20240729$$HP$US$US
221714836$22171483$6$F$20211112$20240815$20230404$20240823$EXP$$CA-JNJFOC-20230367400$JOHNSON AND JOHNSON$$$$A$M$Y$69$KG$20240823$$MD$CA$CA
2217149814$22171498$14$F$20210101$20240911$20230404$20240917$EXP$$US-JAZZ-2022-US-017367$JAZZ$$$$$F$Y$$$20240917$$MD$US$US
221715467$22171546$7$F$$20240925$20230404$20240927$PER$$US-PFIZER INC-PV202300061037$PFIZER$$88$YR$$F$Y$62.585$KG$20240927$$CN$US$US
221715882$22171588$2$F$$20240826$20230404$20240829$PER$$US-PFIZER INC-PV202300060202$PFIZER$$72$YR$$F$Y$$$20240829$$CN$US$US
221720912$22172091$2$F$$20240729$20230404$20240801$EXP$$JP-PFIZER INC-PV202300057434$PFIZER$Nakamura, H.. A case of varices oesophageal where hepatic fibrosis due to methotrexate was considered as its cause. The 132nd Hokkaido Branch Meeting of the Japanese Society of Gastroenterology. 2023;132nd:46$8$DEC$$F$Y$$$20240801$$HP$JP$JP
221721172$22172117$2$F$$20240801$20230404$20240809$EXP$$US-MYLANLABS-2023M1034240$MYLAN$Huang R, Kuniyoshi J, Choi H, Bernas M. Nivolumab associated myocarditis: role of serial biomarkers in management. J-Am-Coll-Cardiol 2023;81 (Suppl.):No. 8.$67$YR$$M$Y$$$20240809$$HP$US$US
221721272$22172127$2$F$20230309$20230329$20230404$20240909$EXP$FR-AFSSAPS-MA2023000999$FR-MYLANLABS-2023M1034301$MYLAN$$70$YR$$F$Y$$$20240909$$MD$FR$FR
221721353$22172135$3$F$$20240807$20230404$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02544$LUPIN$$$$$$Y$$$20240828$$PH$US$US
221721466$22172146$6$F$20220131$20240722$20230404$20240726$EXP$$CA-TAKEDA-2021TUS000507$TAKEDA$$71$YR$$F$Y$$$20240726$$MD$CA$CA
221721573$22172157$3$F$$20240704$20230404$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02545$LUPIN$$$$$$Y$$$20240728$$CN$US$US
221721838$22172183$8$F$$20240729$20230404$20240801$EXP$$US-PFIZER INC-202300058371$PFIZER$$87$YR$$F$Y$$$20240801$$CN$US$US
221723629$22172362$9$F$20230814$20240716$20230404$20240722$EXP$$CA-TAKEDA-2023TUS033441$TAKEDA$$63$YR$$M$Y$$$20240722$$CN$CA$CA
2217248220$22172482$20$F$20220804$20240917$20230404$20240921$EXP$$NVSC2022MX303641$NOVARTIS$$68$YR$$F$Y$56$KG$20240921$$CN$MX$MX
221725642$22172564$2$F$20230217$20240628$20230404$20240702$EXP$FR-AFSSAPS-AM2023000273$FR-MYLANLABS-2023M1033977$MYLAN$$46$YR$$F$Y$73$KG$20240702$$MD$FR$FR
221727363$22172736$3$F$20220801$20240815$20230404$20240821$EXP$$NVSC2023HN074610$NOVARTIS$$52$YR$$F$Y$95.238$KG$20240821$$CN$HN$HN
221727454$22172745$4$F$20210101$20240808$20230404$20240813$PER$$US-PFIZER INC-PV202300060191$PFIZER$$70$YR$$M$Y$129.35$KG$20240813$$MD$US$US
221727828$22172782$8$F$$20240903$20230404$20240910$EXP$$CA-GILEAD-2023-0622790$GILEAD$$82$YR$E$F$Y$$$20240910$$MD$CA$CA
221728193$22172819$3$F$$20240806$20230404$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02550$LUPIN$$$$$$Y$$$20240827$$CN$US$US
2217284221$22172842$21$F$$20240919$20230404$20240927$EXP$$US-VERTEX PHARMACEUTICALS-2023-004815$VERTEX$$25$YR$$M$Y$$$20240927$$CN$US$US
221728623$22172862$3$F$$20240806$20230404$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02564$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221728913$22172891$3$F$$20240625$20230404$20240702$EXP$$FR-MYLANLABS-2023M1033881$MYLAN$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al.. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome.. Journal of Clinical Immunology.. 2023;43(3):647-652$33$YR$$M$Y$$$20240702$$HP$FR$FR
221730325$22173032$5$F$20230502$20240910$20230404$20240916$EXP$$CA-TAKEDA-2023TUS034019$TAKEDA$$44$YR$$F$Y$$$20240916$$CN$CA$CA
221732412$22173241$2$F$$20240723$20230404$20240724$PER$$NVSC2023US077964$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
221735664$22173566$4$F$20220413$20240729$20230404$20240802$EXP$$TW-TAKEDA-2022TUS025763$TAKEDA$$18$YR$$M$Y$$$20240802$$CN$TW$TW
221737029$22173702$9$F$20230101$20240802$20230404$20240806$EXP$$US-KARYOPHARM-2023KPT000995$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240806$$CN$US$US
221737394$22173739$4$F$$20240702$20230404$20240704$EXP$$US-TAKEDA-US201820995$TAKEDA$$$$$F$Y$$$20240704$$HP$US$US
221738322$22173832$2$F$$20240729$20230404$20240808$EXP$$BG-TEVA-2023-BG-2871718$TEVA$Grigorov N, Grigorova B. METFORMIN INTOXICATION - THREE CLINICAL CASES WITH LETHAL OUTCOMES. RECOMMENDATIONS TO THE GENERAL PRACTITIONER. [Bulgarian]. Gen-Med 2023; 25 (1): 45-48.; G N. METFORMIN INTOXICATION - THREE CLINICAL CASES WITH LETHAL OUTCOMES. RECOMMENDATIONS TO THE GENERAL PRACTITIONER. General Medicine 2023; 1: 45-48.; G N.                           -                                    .                                      .               2023; 1: 45-48.; Article Title:  METFORMI...$85$YR$$M$Y$$$20240808$$MD$BG$BG
221738333$22173833$3$F$$20240729$20230404$20240808$EXP$$BG-TEVA-2023-BG-2871655$TEVA$Grigorov N, Grigorova B. METFORMIN INTOXICATION - THREE CLINICAL CASES WITH LETHAL OUTCOMES. RECOMMENDATIONS TO THE GENERAL PRACTITIONER. [Bulgarian]. Gen-Med 2023; 25 (1): 45-48.; G N. METFORMIN INTOXICATION - THREE CLINICAL CASES WITH LETHAL OUTCOMES. RECOMMENDATIONS TO THE GENERAL PRACTITIONER. General Medicine 2023; 1: 45-48.; G N.                           -                                    .                                      .               2023; 1: 45-48.; Article Title:  METFORMI...$70$YR$$F$Y$$$20240808$$MD$BG$BG
221738352$22173835$2$F$$20240729$20230404$20240808$EXP$$BG-TEVA-2023-BG-2871691$TEVA$Grigorov N, Grigorova B. METFORMIN INTOXICATION - THREE CLINICAL CASES WITH LETHAL OUTCOMES. RECOMMENDATIONS TO THE GENERAL PRACTITIONER. [Bulgarian]. Gen-Med 2023; 25 (1): 45-48.; Grigorov N. METFORMIN INTOXICATION - THREE CLINICAL CASES WITH LETHAL OUTCOMES. RECOMMENDATIONS TO THE GENERAL PRACTITIONER. General Medicine 2023; 1: 45-48.; Grigorov N.                           -                                    .                                      .               2023; 1: 45-48.; Article Ti...$53$YR$$F$Y$$$20240808$$MD$BG$BG
221738647$22173864$7$F$$20240718$20230404$20240725$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007392$JAZZ$$$$$F$Y$$$20240725$$MD$US$US
221738697$22173869$7$F$$20240723$20230404$20240725$EXP$$CA-TAKEDA-2022TUS103706$TAKEDA$$$$$F$Y$$$20240725$$CN$CA$CA
221738825$22173882$5$F$20221201$20240829$20230404$20240906$EXP$$US-BIOGEN-2023BI01197274$BIOGEN$$66$YR$$F$Y$$$20240906$$CN$US$US
221743072$22174307$2$F$$20240711$20230405$20240721$EXP$CN-MLMSERVICE-20230317-4167393-1$CN-STRIDES ARCOLAB LIMITED-2023SP004573$STRIDES$Li XL, Luan CY, Fan YJ, Lin XY, Jiang D, Su MX, et al.. A Rare Case of Acute Infectious Purpura Fulminans Caused by Klebsiella Pneumoniae and Human Herpesvirus Type 5.. Journal of Inflammation Research.. 2022;15:4251-60$22$YR$$M$Y$90$KG$20240719$$MD$CN$CN
221743104$22174310$4$F$20230301$20240718$20230405$20240724$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-229618$BOEHRINGER INGELHEIM$Noda N, Katahira K, Hara M, Fukuyama S, Izumi M, Wakamatsu K. A Case of Chronic Hypersensitivity Pneumonitis with Congestive Heart Failure after Initiation of Nintedanib Treatment. The 345th Kyushu Region Meeting of the Japanese Society of Internal Medicine. 2024 May 25;$80$YR$E$F$Y$50$KG$20240724$$MD$JP$JP
221743488$22174348$8$F$20231111$20240912$20230405$20240918$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-01042$AMNEAL$$$$$$Y$$$20240918$$CN$US$US
221743773$22174377$3$F$$20240904$20230405$20240916$EXP$$FR-AUROBINDO-AUR-APL-2023-014791$AUROBINDO$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al.. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. Journal of Clinical Immunology. 2023;43(3):647-652.$30$YR$$M$Y$$$20240916$$MD$FR$FR
221744612$22174461$2$F$20221224$20240701$20230405$20240708$EXP$FR-AFSSAPS-AM2023000272$FR-CHEPLA-2023004324$CHEPLAPHARM$$46$YR$$F$Y$73$KG$20240708$$MD$COUNTRY NOT SPECIFIED$FR
221745602$22174560$2$F$$20230328$20230405$20240823$EXP$$JP-RECORDATI-2023001921$RECORDATI$Nagamine T, Kobayashi S, Ishii Y, Okajima F, Fukuda I et. al. A case of refractory Cushing^s disease treated with osilodrostat followed by a third surgery.$$$$$Y$$$20240823$$MD$JP$JP
221746933$22174693$3$F$$20240806$20230405$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02551$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221747139$22174713$9$F$20230301$20230821$20230405$20240925$PER$$US-GSK-US2023AMR048456$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
221747649$22174764$9$F$20240229$20240726$20230405$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-048084$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240730$$CN$US$US
221747713$22174771$3$F$20230201$20240812$20230405$20240827$EXP$FR-AFSSAPS-RN2023000299$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-090119$ZYDUS PHARM$$$$$$Y$$$20240827$$MD$FR$FR
221748673$22174867$3$F$$20240730$20230405$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02537$LUPIN$$$$$$Y$$$20240819$$CN$US$US
221748825$22174882$5$F$$20240807$20230405$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02538$LUPIN$$$$$$Y$$$20240822$$CN$US$US
221749753$22174975$3$F$$20240807$20230405$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02525$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221752089$22175208$9$F$20230315$20231005$20230405$20240926$EXP$$US-GSK-US2023047915$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
221752154$22175215$4$F$20190101$20230329$20230405$20240806$EXP$$NVSC2023US074371$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
2217531327$22175313$27$F$20220101$20240923$20230405$20240930$EXP$$CA-TAKEDA-2022TUS077552$TAKEDA$$$$$M$Y$$$20240930$$CN$CA$CA
221753204$22175320$4$F$20230306$20240904$20230405$20240911$EXP$$US-GSK-US2023046094$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$US$US
221755034$22175503$4$F$$20240826$20230405$20240905$EXP$$FR-AUROBINDO-AUR-APL-2023-014776$AUROBINDO$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. Journal of Clinical Immunology. 2023;43 (3):647-652$4$YR$$F$Y$$$20240905$$HP$FR$FR
221755082$22175508$2$F$$20240701$20230405$20240708$EXP$$IT-AUROBINDO-AUR-APL-2023-014919$AUROBINDO$$37$YR$$M$Y$$$20240708$$CN$IT$IT
221755143$22175514$3$F$$20240817$20230405$20240821$EXP$$US-SA-2023SA105187$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
221755886$22175588$6$F$20230302$20240708$20230405$20240716$EXP$$CA-ROCHE-3325104$ROCHE$$15$YR$T$F$Y$$$20240716$$CN$CA$CA
221756133$22175613$3$F$20221229$20240625$20230405$20240703$EXP$$FR-AUROBINDO-AUR-APL-2023-014598$AUROBINDO$$46$YR$$F$Y$73$KG$20240703$$MD$FR$FR
221758363$22175836$3$F$20220809$20240903$20230405$20240909$EXP$$NVSJ2023JP005418$NOVARTIS$$58$YR$$M$Y$52$KG$20240909$$MD$JP$JP
221758927$22175892$7$F$20230301$20240801$20230405$20240807$EXP$$US-JAZZ-2022-US-006315$JAZZ$$46$YR$$F$Y$$$20240807$$CN$US$US
221759023$22175902$3$F$$20240820$20230405$20240822$EXP$$CA-ROCHE-2805650$ROCHE$$$$A$M$Y$$$20240822$$CN$CA$CA
221763913$22176391$3$F$$20230403$20230405$20240822$PER$$NVSC2023US079065$NOVARTIS$$$$$M$Y$80.74$KG$20240822$$CN$US$US
221766037$22176603$7$F$20221209$20240917$20230405$20240922$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-205120$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240923$$MD$CA$CA
221766138$22176613$8$F$$20240916$20230405$20240919$PER$$US-PFIZER INC-2020505985$PFIZER$$76$YR$$F$Y$$$20240919$$CN$US$US
221766235$22176623$5$F$$20240904$20230405$20240906$PER$$NVSC2023US077585$NOVARTIS$$$$$M$Y$$$20240906$$CN$US$US
221766262$22176626$2$F$$20230404$20230405$20240813$PER$$NVSC2023US079176$NOVARTIS$$$$$F$Y$$$20240813$$CN$US$US
221767705$22176770$5$F$$20240718$20230405$20240723$EXP$$US-PAREXEL-2021-KAM-US003436$TAKEDA$$$$$M$Y$120$KG$20240723$$CN$US$US
221771246$22177124$6$F$20200117$20240815$20230405$20240820$EXP$$CA-TAKEDA-2019TUS073214$TAKEDA$$65$YR$$F$Y$$$20240820$$CN$CA$CA
221771255$22177125$5$F$$20240813$20230405$20240816$EXP$$US-TAKEDA-2020TUS061228$TAKEDA$$$$$F$Y$$$20240816$$HP$US$US
221772145$22177214$5$F$20231202$20240813$20230405$20240816$EXP$$US-TAKEDA-2023TUS023907$TAKEDA$$64$YR$$F$Y$$$20240816$$HP$US$US
221772513$22177251$3$F$$20230424$20230405$20240911$EXP$$HR-AstraZeneca-2023A079217$ASTRAZENECA$$60$YR$$M$Y$$$20240911$$MD$HR$
221776883$22177688$3$F$$20240807$20230405$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02524$LUPIN$$$$$$Y$$$20240902$$CN$US$US
221778024$22177802$4$F$20220101$20240717$20230405$20240726$EXP$$CA-TAKEDA-2022TUS018528$TAKEDA$$$$$F$Y$$$20240726$$HP$CA$CA
221778443$22177844$3$F$$20240624$20230405$20240702$EXP$$HR-AMGEN-HRVSP2023056002$AMGEN$Krizic M.; Silovski T.; Popovic M. et al.. Real-world efficaccy of dual antiHER2 therapy in first line metastatic HER2-positive breast cancer and the possibility of prediction of long-term response. Cancer Research. 2023;83 (SUPPL_5)$$$$$Y$$$20240702$$HP$HR$HR
221779225$22177922$5$F$20220417$20240924$20230405$20240926$EXP$$US-OTSUKA-2023_008531$OTSUKA$$54$YR$$F$Y$$$20240926$$CN$US$US
221779252$22177925$2$F$$20240728$20230405$20240802$EXP$$IT-AMGEN-ITASP2023056027$AMGEN$Lagana M.; Cosentini D.; Grisanti S. et al.. Bone metastases and skeletal related events in pheochromocytoma and paraganglioma patients: International, retrospective study. ESMO Open. 2023;8 (1):2-3$$$$$Y$$$20240802$$HP$IT$IT
221780825$22178082$5$F$20171001$20240903$20230405$20240906$EXP$$CA-TAKEDA-2017TUS022418$TAKEDA$$69$YR$$M$Y$$$20240906$$MD$CA$CA
221781174$22178117$4$F$20220309$20240710$20230405$20240715$EXP$$CA-TAKEDA-2022TUS013733$TAKEDA$$31$YR$$F$Y$$$20240715$$CN$CA$CA
221783104$22178310$4$F$20200314$20240702$20230405$20240705$EXP$$CA-TAKEDA-CA202017731$TAKEDA$$60$YR$$F$Y$$$20240705$$CN$CA$CA
2217832810$22178328$10$F$$20240823$20230405$20240901$EXP$$US-TAKEDA-2023TUS027797$TAKEDA$$$$$F$Y$108$KG$20240901$$HP$US$US
221783836$22178383$6$F$$20240918$20230405$20240927$EXP$$NVSC2023US075239$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
221784844$22178484$4$F$$20240705$20230405$20240710$PER$$US-PFIZER INC-PV202300062139$PFIZER$$68$YR$$F$Y$78$KG$20240710$$CN$US$US
221785796$22178579$6$F$20230327$20240920$20230405$20240930$EXP$$US-BEH-2023157284$CSL BEHRING$$29$YR$A$F$Y$$$20240930$$HP$US$US
221787172$22178717$2$F$$20230403$20230405$20240813$PER$$NVSC2023US079149$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
221787745$22178774$5$F$20230201$20240820$20230405$20240916$EXP$$FR-Valinor Pharma, LLC-VLR202303-000045$Valinor Pharma$$55$YR$A$M$Y$$$20240916$$MD$FR$
221788295$22178829$5$F$20181201$20240730$20230406$20240807$EXP$$BG-TOLMAR, INC.-23BG039832$TOLMAR$$65$YR$$M$Y$$$20240807$$MD$BG$BG
221789454$22178945$4$F$20220312$20240916$20230406$20240918$EXP$$DE-ROCHE-3325119$ROCHE$$34$YR$A$M$Y$72$KG$20240918$$MD$DE$DE
221792482$22179248$2$F$$20240730$20230406$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02572$LUPIN$$$$$$Y$$$20240817$$CN$US$US
221792784$22179278$4$F$20181001$20240725$20230406$20240801$EXP$$CA-ROCHE-3323545$ROCHE$$20$YR$A$F$Y$$$20240801$$CN$CA$CA
221794722$22179472$2$F$$20240621$20230406$20240701$PER$$US-SA-2023SA071763$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240701$$MD$US$US
221794752$22179475$2$F$$20240806$20230406$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02523$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221795862$22179586$2$F$20230101$20230403$20230406$20240802$PER$$NVSC2023US079034$NOVARTIS$$60$YR$$F$Y$65.77$KG$20240802$$CN$US$US
221796116$22179611$6$F$20230423$20230426$20230406$20240926$EXP$$US-GSK-US2023AMR049203$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
221796232$22179623$2$F$$20240806$20230406$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02573$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221797224$22179722$4$F$20230101$20240806$20230406$20240902$EXP$$US-UCBSA-2023017387$UCB$$$$$F$Y$$$20240902$$CN$US$US
221799412$22179941$2$F$$20240909$20230406$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384020$RANBAXY$Giri AR, Kaur N, Yarrarapu SNS, Rottman Pietrzak KA, Santos C, Lowman PE et al. ^Novel Management of Depression Using Ketamine in the Intensive Care Unit^. J Intensive Care Med. 2022;37(12):1654-1661$63$YR$$F$Y$$$20240913$$HP$US$US
221799432$22179943$2$F$$20240909$20230406$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384022$RANBAXY$Giri AR, Kaur N, Yarrarapu SNS, Rottman Pietrzak KA, Santos C, Lowman PE et al. ^Novel Management of Depression Using Ketamine in the Intensive Care Unit^. J Intensive Care Med. 2022;37(12):1654-1661$61$YR$$M$Y$$$20240913$$HP$US$US
221799462$22179946$2$F$$20240812$20230406$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384023$RANBAXY$Giri AR, Kaur N, Yarrarapu SNS, Rottman Pietrzak KA, Santos C, Lowman PE et al. ^Novel Management of Depression Using Ketamine in the Intensive Care Unit^. J Intensive Care Med. 2022;37(12):1654-1661$20$YR$$F$Y$$$20240826$$HP$US$US
221799864$22179986$4$F$20230316$20240716$20230406$20240724$EXP$$US-BIOGEN-2023BI01194201$BIOGEN$$62$YR$$F$Y$28.148$KG$20240724$$CN$US$US
221800523$22180052$3$F$$20240731$20230406$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02570$LUPIN$$$$$$Y$$$20240820$$HP$US$US
221801112$22180111$2$F$20230301$20230403$20230406$20240925$PER$$US-GSK-US2023AMR049768$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240925$$CN$US$US
221801783$22180178$3$F$$20240816$20230406$20240830$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384024$RANBAXY$Giri AR, Kaur N, Yarrarapu SNS, Rottman Pietrzak KA, Santos C, Lowman PE et al. ^Novel Management of Depression Using Ketamine in the Intensive Care Unit^. J Intensive Care Med. 2022;37(12):1654-1661$56$YR$$F$Y$$$20240830$$HP$US$US
221801812$22180181$2$F$$20240725$20230406$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384026$RANBAXY$Giri AR, Kaur N, Yarrarapu SNS, Rottman Pietrzak KA, Santos C, Lowman PE et al. ^Novel Management of Depression Using Ketamine in the Intensive Care Unit^. J Intensive Care Med. 2022;37(12):1654-1661$76$YR$$F$Y$$$20240727$$HP$US$US
221802082$22180208$2$F$$20240902$20230406$20240904$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-384032$RANBAXY$Rosar F, Bader H, Bartholoma M, Maus S, Burgard C, Linxweiler J, et al. Addition of Standard Enzalutamide Medication Shows Synergistic Effects on Response to [177 Lu]Lu-PSMA-617 Radioligand Therapy in mCRPC Patients with Imminent Treatment Failure-Preliminary Evidence of Pilot Experience. Cancers. 2022;14(11):2691$$$$M$Y$$$20240904$$HP$DE$DE
221802253$22180225$3$F$20230318$20230404$20230406$20240712$EXP$$IT-ASTELLAS-2023US010907$ASTELLAS$$84$YR$$$Y$$$20240712$$MD$IT$IT
221802334$22180233$4$F$$20240701$20230406$20240704$PER$$NVSC2023US076443$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
221802364$22180236$4$F$$20240918$20230406$20240925$PER$$NVSC2023US080023$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
221802595$22180259$5$F$$20240830$20230406$20240904$PER$$US-PFIZER INC-PV202300061933$PFIZER$$73$YR$$F$Y$$$20240904$$CN$US$US
221803016$22180301$6$F$$20240830$20230406$20240904$PER$$US-PFIZER INC-PV202300062675$PFIZER$$84$YR$$F$Y$$$20240904$$CN$US$US
221803952$22180395$2$F$20230322$20240918$20230406$20240926$EXP$$BR-TAKEDA-2023TUS034210$TAKEDA$$61$YR$$M$Y$$$20240926$$CN$BR$BR
221804452$22180445$2$F$$20240716$20230406$20240723$EXP$$DE-MYLANLABS-2023M1035321$MYLAN$$51$YR$$M$Y$$$20240723$$MD$DE$DE
221804967$22180496$7$F$20230101$20240730$20230406$20240731$PER$$US-DSJP-DSU-2023-112656$DAIICHI$$$$$F$Y$$$20240731$$CN$US$US
221806213$22180621$3$F$$20230329$20230406$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381276$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
221806805$22180680$5$F$$20240903$20230406$20240909$EXP$$DE-MYLANLABS-2023M1034828$MYLAN$Scheiermann J, Kunkele A, von Stackelberg A, Eggert A, Lang P, Zirngibl F et al.. Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous disease.. Front Immunol. 2023;14:1042650$14$MON$$M$Y$$$20240909$$MD$DE$DE
221806833$22180683$3$F$20221001$20240711$20230406$20240720$EXP$$DE-AUROBINDO-AUR-APL-2023-015062$AUROBINDO$$$$E$F$Y$$$20240720$$MD$DE$DE
221808164$22180816$4$F$$20240918$20230406$20240925$PER$$NVSC2023US076446$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
221809223$22180922$3$F$$20240730$20230406$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02594$LUPIN$$$$$$Y$$$20240819$$CN$US$US
221812742$22181274$2$F$20221101$20230329$20230406$20240813$EXP$$NVSC2023US078920$NOVARTIS$$33$YR$$F$Y$90.7$KG$20240813$$HP$US$US
2218131414$22181314$14$F$20230403$20240830$20230406$20240905$EXP$$AT-TAKEDA-2023TUS034757$TAKEDA$$8$YR$$M$Y$$$20240905$$CN$AT$AT
221813233$22181323$3$F$$20240808$20230406$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02567$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221813305$22181330$5$F$$20240905$20230406$20240913$EXP$$CA-ROCHE-3323221$ROCHE$$$$A$F$Y$$$20240913$$CN$CA$CA
221813852$22181385$2$F$20220901$20230404$20230406$20240807$EXP$$NVSC2023US079385$NOVARTIS$$32$YR$$M$Y$131.52$KG$20240807$$CN$US$US
221814392$22181439$2$F$$20240917$20230406$20240925$EXP$$FR-AMGEN-FRASP2023056715$AMGEN$Boftosso M.; Sandoval R. L.; Verret B. et al.. HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome. Cancer research. 2023;83 (SUPPL_5)$$$$$Y$$$20240925$$HP$FR$FR
221816702$22181670$2$F$20220615$20240805$20230406$20240808$EXP$$DE-PFIZER INC-202300140500$PFIZER$$72$YR$$M$Y$88.3$KG$20240808$$MD$DE$DE
221816993$22181699$3$F$20220414$20240920$20230406$20240927$EXP$$CA-TAKEDA-2022TUS027828$TAKEDA$$73$YR$$M$Y$$$20240927$$MD$CA$CA
221817892$22181789$2$F$$20240625$20230406$20240701$EXP$$AU-ABBVIE-4715498$ABBVIE$$$$$$Y$$$20240701$$CN$AU$AU
221819613$22181961$3$F$20230101$20240815$20230406$20240827$PER$$US-SA-2023SA106565$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240827$$MD$US$US
221819622$22181962$2$F$20240101$20240910$20230406$20240917$PER$$US-SA-2023SA106211$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240918$$MD$US$US
221819662$22181966$2$F$20230301$20240710$20230406$20240801$PER$$US-SA-2023SA106205$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240719$$MD$US$US
221820535$22182053$5$F$20230101$20240723$20230406$20240801$PER$$US-SA-2023SA107381$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240801$$MD$US$US
221821362$22182136$2$F$20230404$20240730$20230406$20240805$PER$$US-BIOGEN-2023BI01197736$BIOGEN$$41$YR$$F$Y$$$20240805$$CN$US$US
221821525$22182152$5$F$20230321$20240911$20230406$20240916$EXP$$CA-TAKEDA-2023TUS033799$TAKEDA$$62$YR$$M$Y$$$20240916$$MD$CA$CA
221821695$22182169$5$F$20230301$20240702$20230406$20240705$EXP$$CA-TAKEDA-2023TUS034129$TAKEDA$$39$YR$$F$Y$$$20240705$$MD$CA$CA
221823017$22182301$7$F$20230425$20240917$20230406$20240924$EXP$$CA-GSK-CA2023AMR050071$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$CA$CA
221824454$22182445$4$F$$20240828$20230406$20240906$EXP$$US-TEVA-2023-US-2872778$TEVA$Ahuja T,Nuti O,Kemal C,Kang D,Yuriditsky E,Horowitz JM,Pashun R, To PLEX or Not to PLEX for Amiodarone Induced Thyrotoxicosis. US Cardiology Review 18 (Suppl.): 28, Jul 2024.; Ahuja T, Nuti O, Kemal C, Kang D, Pashun R, Yuriditsky E, et al. TO PLEX OR NOT TO PLEX FOR AMIODARONE INDUCED THYROTOXICOSIS. J-Am-Coll-Cardiol 2023; 81 (Suppl.) (8): 2604.; Ahuja T, Nuti O, Kemal C, Kang D, Pashun R, Yuriditsky E, et al. TO PLEX OR NOT TO PLEX FOR AMIODARONE INDUCED THYROTOXICOSIS. J-Am-Coll-Cardiol 2...$52$YR$$M$Y$$$20240906$$HP$US$US
221825804$22182580$4$F$$20240708$20230406$20240709$EXP$$CA-BAUSCH-BL-2023-005142$BAUSCH AND LOMB$$87$YR$$M$Y$$$20240709$$HP$CA$CA
221828284$22182828$4$F$20201224$20240815$20230406$20240822$EXP$$CA-TAKEDA-2019TUS025273$TAKEDA$$54$YR$$F$Y$90$KG$20240822$$HP$CA$CA
221829933$22182993$3$F$$20240710$20230406$20240722$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202304001481$ELI LILLY AND CO$$$$$M$Y$$$20240722$$CN$JP$JP
221834934$22183493$4$F$20230324$20240821$20230406$20240827$PER$$US-PFIZER INC-2017275767$PFIZER$$71$YR$$F$Y$81.2$KG$20240827$$MD$US$US
221835194$22183519$4$F$$20230619$20230406$20240906$PER$$NVSC2023US080211$NOVARTIS$$$$$$Y$$$20240906$$MD$US$US
221835632$22183563$2$F$20230101$20240627$20230406$20240703$EXP$$CZ-MYLANLABS-2023M1035295$MYLAN$$65$YR$$M$Y$$$20240703$$MD$CZ$CZ
221836726$22183672$6$F$20180201$20240628$20230406$20240709$EXP$$CA-TAKEDA-2018TUS005562$TAKEDA$$37$YR$$F$Y$$$20240709$$HP$CA$CA
221837013$22183701$3$F$$20240719$20230406$20240723$PER$$US-PFIZER INC-2021229947$PFIZER$$83$YR$$F$Y$$$20240723$$MD$US$US
221838692$22183869$2$F$20230313$20240827$20230406$20240829$EXP$$US-ABBVIE-4718647$ABBVIE$$82$YR$$M$Y$$$20240829$$CN$US$US
221840263$22184026$3$F$20220422$20240904$20230407$20240917$EXP$$JP-AMGEN-JPNSP2022102989$AMGEN$$34$YR$A$M$Y$$$20240916$$MD$JP$JP
221842032$22184203$2$F$$20240607$20230407$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000877$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
221843512$22184351$2$F$$20240809$20230407$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02602$LUPIN$$$$$$Y$$$20240828$$CN$US$US
221843962$22184396$2$F$$20230331$20230407$20240812$EXP$$NVSC2023US076835$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
221848543$22184854$3$F$20230404$20240916$20230407$20240919$EXP$$US-KYOWAKIRIN-2023BKK005071$KYOWA$$$$$$Y$$$20240919$$HP$US$US
221848855$22184885$5$F$$20240902$20230407$20240917$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-03559$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-03559$ALKEM$Kunkele A, Von Stackelberg A, Eggert A, Lang P, Zirngibl F.. Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with Xlinked chronic granulomatous disease. Front Immunol. 2023;14:1-7$14$MON$$M$Y$$$20240917$$HP$DE$DE
221850555$22185055$5$F$20230101$20240710$20230407$20240714$EXP$$US-AMGEN-USASP2023057415$AMGEN$$38$YR$A$F$Y$$$20240714$$HP$US$US
221850693$22185069$3$F$20230101$20240710$20230407$20240713$EXP$$CA-ABBVIE-4720012$ABBVIE$$$$$F$Y$$$20240713$$CN$CA$CA
221851492$22185149$2$F$$20240807$20230407$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02645$LUPIN$$$$$$Y$$$20240831$$PH$US$US
221851523$22185152$3$F$$20240918$20230407$20240930$PER$$NVSC2023US080690$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
221851863$22185186$3$F$$20230405$20230407$20240813$PER$$NVSC2023US081046$NOVARTIS$$$$$F$Y$58.97$KG$20240813$$CN$US$US
221852163$22185216$3$F$$20240823$20230407$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02656$LUPIN$$$$$$Y$$$20240910$$CN$US$US
221852213$22185221$3$F$$20240823$20230407$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02655$LUPIN$$$$$$Y$$$20240910$$CN$US$US
221854323$22185432$3$F$$20240628$20230407$20240702$PER$$NVSC2023US081163$NOVARTIS$$$$$M$Y$$$20240702$$CN$US$US
221854412$22185441$2$F$20230404$20240805$20230407$20240814$PER$$US-SA-2023SA108660$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240814$$MD$US$US
221855535$22185553$5$F$20220101$20240820$20230407$20240831$EXP$$DE-AUROBINDO-AUR-APL-2023-015377$AUROBINDO$$51$YR$$M$Y$$$20240831$$MD$DE$DE
221856882$22185688$2$F$$20230403$20230407$20240813$EXP$$NVSC2023US077602$NOVARTIS$$$$$F$Y$$$20240813$$CN$US$US
221856984$22185698$4$F$$20230330$20230407$20240712$PER$$US-PFM-2022-05778$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.197$KG$20240712$$HP$US$US
221856993$22185699$3$F$$20230329$20230407$20240711$PER$$CA-PFM-2022-07233$PIERRE FABRE MEDICAMENT$Gendron AA, Marquis A, Mongeon C, Statie A, Bouchard A, Khazaka M. Potassium Supplementation to Prevent Severe Hypokalemia and Paralysis after High-Dose Methylprednisolone for Ophthalmopathy in Uncontrolled Graves Disease: A Case Report. Canadian Journal of Hospital Pharmacy. 2022;75(3):213-3$29$YR$$M$Y$$$20240711$$HP$CA$CA
221859496$22185949$6$F$$20240806$20230407$20240808$PER$$NVSC2023US081088$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
221859854$22185985$4$F$20230225$20240705$20230407$20240715$EXP$IT-MINISAL02-914667$IT-TEVA-2023-IT-2872656$TEVA$$15$YR$$F$Y$59$KG$20240715$$PH$IT$IT
221861602$22186160$2$F$20220101$20240715$20230407$20240718$EXP$$DE-OTSUKA-2023_008503$OTSUKA$$1$DY$$M$Y$2.31$KG$20240718$$MD$DE$DE
221862154$22186215$4$F$$20240809$20230407$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02670$LUPIN$$$$$$Y$$$20240829$$CN$US$US
221862533$22186253$3$F$$20240730$20230407$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02671$LUPIN$$$$$$Y$$$20240821$$PH$US$US
221863373$22186337$3$F$$20240823$20230407$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02681$LUPIN$$$$$$Y$$$20240912$$CN$US$US
221863503$22186350$3$F$$20240906$20230407$20240911$PER$$NVSC2023US080979$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
221865552$22186555$2$F$$20240820$20230407$20240829$EXP$$DE-UCBSA-2023017715$UCB$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:1-28$$$N$$Y$$$20240829$$MD$DE$DE
221866933$22186693$3$F$20230226$20240826$20230407$20240905$EXP$$CA-ORG100014127-2023000351$HRA PHARMA$$65$YR$$M$Y$$$20240905$$CN$CA$CA
221867042$22186704$2$F$$20240717$20230407$20240730$EXP$$US-ALVOGEN-2023089843$ALVOGEN$$$$$F$Y$83$KG$20240730$$MD$US$US
221867525$22186752$5$F$20220101$20240822$20230407$20240829$PER$$US-VERTEX PHARMACEUTICALS-2023-004931$VERTEX$$22$YR$$F$Y$$$20240829$$CN$US$US
221867614$22186761$4$F$$20240820$20230407$20240826$EXP$$DE-UCBSA-2023017727$UCB$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$A$F$Y$$$20240826$$MD$DE$DE
221867723$22186772$3$F$$20240820$20230407$20240826$EXP$$DE-UCBSA-2023017710$UCB$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;1-28$$$N$$Y$$$20240826$$MD$DE$DE
2218709210$22187092$10$F$20230101$20240703$20230407$20240709$PER$$US-PFIZER INC-PV202300060198$PFIZER$$74$YR$$M$Y$109.31$KG$20240709$$CN$US$US
221871214$22187121$4$F$20201217$20240626$20230407$20240702$EXP$$JP-KYOWAKIRIN-2023AKK004997$KYOWA$$$$$$Y$$$20240702$$HP$JP$JP
221872508$22187250$8$F$$20240904$20230407$20240912$EXP$$DE-BAUSCH-BL-2023-005393$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240912$$MD$DE$DE
2218754613$22187546$13$F$20180110$20240913$20230407$20240925$EXP$$JP-ABBVIE-19P-087-2700496-00$ABBVIE$$50$YR$$M$Y$70$KG$20240925$$MD$JP$JP
2218755611$22187556$11$F$20231201$20240719$20230407$20240724$EXP$$NVSC2023US080182$NOVARTIS$$44$YR$$F$Y$$$20240724$$CN$US$US
221876094$22187609$4$F$$20230406$20230407$20240809$PER$$NVSC2023US081398$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
221876296$22187629$6$F$20230101$20240723$20230407$20240727$EXP$$NL-ABBVIE-4322395$ABBVIE$$77$YR$$M$Y$$$20240727$$CN$NL$NL
221877083$22187708$3$F$$20240815$20230408$20240820$PER$$NVSC2023US081407$NOVARTIS$$$$$M$Y$$$20240820$$CN$US$US
221879425$22187942$5$F$20230331$20240917$20230408$20240918$PER$$NVSC2023US081446$NOVARTIS$$31$YR$$$Y$$$20240918$$CN$US$US
221879822$22187982$2$F$20230309$20240705$20230408$20240715$EXP$IT-MINISAL02-915135$IT-TEVA-2023-IT-2873828$TEVA$$13$YR$$M$Y$41$KG$20240715$$PH$IT$IT
221880373$22188037$3$F$$20240827$20230408$20240828$PER$$NVSC2023US081816$NOVARTIS$$$$$F$Y$$$20240829$$HP$US$US
221882017$22188201$7$F$20230118$20240812$20230408$20240817$EXP$$NVSC2023CA013665$NOVARTIS$$78$YR$$F$Y$$$20240817$$MD$CA$CA
221882022$22188202$2$F$$20230403$20230408$20240801$EXP$$NVSC2023US078511$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
221882572$22188257$2$F$$20240909$20230408$20240910$EXP$$DE-UCBSA-2023017706$UCB$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:1-28$4$DY$$$Y$$$20240910$$MD$DE$DE
221883005$22188300$5$F$$20240909$20230408$20240910$EXP$$DE-UCBSA-2023017803$UCB$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$N$$Y$$$20240910$$MD$DE$DE
221883132$22188313$2$F$$20240826$20230408$20240828$EXP$$DE-UCBSA-2023017709$UCB$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;1-28$$$N$$Y$$$20240828$$MD$DE$DE
221883284$22188328$4$F$$20240902$20230408$20240903$EXP$$DE-UCBSA-2023017804$UCB$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-13$3$DY$$F$Y$$$20240903$$MD$DE$DE
221883853$22188385$3$F$20230101$20240823$20230408$20240829$EXP$$CR-AMGEN-CRISL2023033030$AMGEN$$73$YR$E$F$Y$$$20240828$$CN$CR$CR
221883975$22188397$5$F$$20240909$20230408$20240910$EXP$$DE-UCBSA-2023017625$UCB$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;-:1-28$$$A$F$Y$$$20240910$$MD$DE$DE
221884103$22188410$3$F$$20240812$20230408$20240816$EXP$$DE-UCBSA-2023017735$UCB$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;1-28$$$A$F$Y$$$20240816$$MD$DE$DE
221884202$22188420$2$F$$20240826$20230408$20240830$EXP$$DE-UCBSA-2023017713$UCB$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;1-28$$$N$$Y$$$20240830$$MD$DE$DE
221885932$22188593$2$F$$20240801$20230409$20240809$EXP$$US-STRIDES ARCOLAB LIMITED-2023SP004702$STRIDES$Huang R, Kuniyoshi J, Choi H, Bernas M.. NIVOLUMAB ASSOCIATED MYOCARDITIS: ROLE OF SERIAL BIOMARKERS IN MANAGEMENT.. J-Am-Coll-Cardiol. 2023;81 (suppl.) (8):3606$67$YR$$M$Y$$$20240809$$MD$US$US
221886962$22188696$2$F$$20240918$20230409$20240925$EXP$$NVSC2023US077495$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
221889594$22188959$4$F$$20240731$20230409$20240801$PER$$NVSC2023US079581$NOVARTIS$$$$$F$Y$$$20240801$$MD$US$US
221890656$22189065$6$F$20221001$20240718$20230410$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-047242$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$125.19$KG$20240722$$CN$US$US
221892593$22189259$3$F$$20240815$20230410$20240819$EXP$$NVSC2023US077471$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
2218939813$22189398$13$F$20231016$20240920$20230410$20240930$EXP$$CA-CELLTRION INC.-2023CA006909$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
221894052$22189405$2$F$20230404$20240826$20230410$20240910$PER$$US-SA-2023SA108936$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240910$$MD$US$US
2218946515$22189465$15$F$20230101$20240718$20230410$20240726$EXP$$CA-CELLTRION INC.-2022CA005892$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
2218978213$22189782$13$F$20230301$20240905$20230410$20240911$EXP$$US-GSK-US2023AMR049046$GLAXOSMITHKLINE$$39$YR$$F$Y$$$20240911$$MD$US$US
221899064$22189906$4$F$$20240711$20230410$20240718$EXP$$NVSC2023US082148$NOVARTIS$$$$$M$Y$$$20240718$$CN$US$US
221901062$22190106$2$F$20230402$20240729$20230410$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202304002035$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240731$$CN$US$US
221902329$22190232$9$F$20230101$20240912$20230410$20240916$PER$$NVSC2023US082168$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
221902642$22190264$2$F$20230331$20230913$20230410$20240730$PER$$US-SA-2023SA108410$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240730$$MD$US$US
221903687$22190368$7$F$20220101$20240902$20230410$20240910$EXP$$CA-CELLTRION INC.-2022CA010087$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
221904133$22190413$3$F$20230403$20240701$20230410$20240705$EXP$$CA-TAKEDA-2022TUS098340$TAKEDA$$30$YR$$M$Y$$$20240705$$CN$CA$CA
221904522$22190452$2$F$$20240704$20230410$20240705$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-383849$RANBAXY$Yasuda S, Suzuki S, Yanagisawa S, Morita H, Haisa A, Satomura A, et al. HLA typing of patients who developed subacute thyroiditis and Graves? disease after SARS?CoV?2 vaccination: a case report. BMC Endocr Disord. 2023;23(1):54$36$YR$$F$Y$$$20240705$$HP$JP$JP
221905018$22190501$8$F$20221208$20240724$20230410$20240731$EXP$$CA-CELLTRION INC.-2022CA011121$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
2219064012$22190640$12$F$20230414$20240717$20230410$20240724$EXP$$CA-TAKEDA-2023TUS034976$TAKEDA$$79$YR$$M$Y$$$20240724$$MD$CA$CA
221907663$22190766$3$F$$20240723$20230410$20240802$EXP$$AT-BAXTER-2023BAX016251$BAXTER$$$$A$M$Y$$$20240802$$HP$AT$AT
221908005$22190800$5$F$20230101$20240730$20230410$20240731$PER$$US-DSJP-DSU-2023-113093$DAIICHI$$$$$M$Y$$$20240731$$HP$US$US
221908422$22190842$2$F$$20240710$20230410$20240717$EXP$$NVSC2023CO080397$NOVARTIS$$$$$M$Y$65$KG$20240717$$CN$CO$CO
221908463$22190846$3$F$$20240704$20230410$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02686$LUPIN$$$$$$Y$$$20240725$$CN$US$US
221909565$22190956$5$F$20220703$20240807$20230410$20240812$EXP$FR-AFSSAPS-PA20223403$FR-MYLANLABS-2022M1084034$MYLAN$Ingrid Lazaridou, Julien Calvani, Elissa Annabi, H?l?ne Moins-Teisserenc, Van Anh Ta, Jacqueline Rivet, Caroline Ram-Wolff, Ma?lle Dumont, Thibault, Mahevas, Marie-Dominique Vignon-Pennamen, Samia Mou. Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sezary syndrome,. Journal of The european academiy of dermatorogy and vebereology. 2023;1-3.$49$YR$$M$Y$58$KG$20240812$$MD$FR$FR
221909953$22190995$3$F$20230320$20240826$20230410$20240902$EXP$$CA-GSK-CA2023AMR035878$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$CA$CA
221911819$22191181$9$F$20230308$20240722$20230410$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-048249$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240730$$CN$US$US
221912934$22191293$4$F$20240116$20240916$20230410$20240920$EXP$$US-TAKEDA-2023TUS036109$TAKEDA$$39$YR$$M$Y$70.306$KG$20240920$$HP$US$US
221913046$22191304$6$F$20240615$20240716$20230410$20240718$PER$$NVSC2023US081898$NOVARTIS$$29$YR$$F$Y$$$20240718$$CN$US$US
221913673$22191367$3$F$$20240604$20230410$20240710$EXP$$US-ELI_LILLY_AND_COMPANY-US202304001056$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240710$$CN$US$US
221914243$22191424$3$F$20230301$20240710$20230410$20240718$PER$$US-SA-2023SA110219$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240718$$MD$US$US
221915802$22191580$2$F$$20230407$20230410$20240809$PER$$NVSC2023US082504$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
221916086$22191608$6$F$20221101$20240816$20230410$20240826$EXP$$CA-CELLTRION INC.-2022CA012626$CELLTRION$$$$$$Y$$$20240826$$MD$CA$CA
221916463$22191646$3$F$$20240821$20230410$20240829$PER$$NVSC2023US082414$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
221918712$22191871$2$F$20240813$20240813$20230410$20240909$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000106$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
221918765$22191876$5$F$$20240918$20230410$20240927$PER$$NVSC2023US081997$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
221918996$22191899$6$F$20230101$20240729$20230410$20240801$EXP$$US-UCBSA-2023015121$UCB$$$$$F$Y$$$20240801$$CN$US$US
221919434$22191943$4$F$$20240826$20230410$20240827$EXP$$CA-ORGANON-O2304CAN000700$ORGANON$$75$YR$$F$Y$$$20240827$$HP$CA$CA
221920674$22192067$4$F$20150716$20240814$20230410$20240815$PER$$US-GILEAD-2023-0622976$GILEAD$$53$YR$A$M$Y$81.633$KG$20240815$$LW$US$US
221921082$22192108$2$F$$20240819$20230410$20240826$EXP$$JP-PFIZER INC-PV202300064390$PFIZER$$77$YR$$M$Y$$$20240826$$MD$JP$JP
221924065$22192406$5$F$20220601$20240401$20230410$20240722$EXP$FR-AFSSAPS-LL2023000458$FR-SA-2023SA109584$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240722$$MD$FR$FR
221924893$22192489$3$F$$20240812$20230410$20240814$EXP$$NVSC2023CZ082358$NOVARTIS$Zieg J, Bezdicka M, Nemcikova M, Balascakova M, Sukova M, Sterbova K et al.. Schimke immunoosseous dysplasia: an ultra-rare disease. a 20-year case series from the tertiary hospital in the Czech Republic. ITALIAN JOURNAL OF PEDIATRICS. 2023;49(1):1-10$3$YR$$F$Y$9$KG$20240814$$HP$CZ$CZ
221931614$22193161$4$F$$20240724$20230410$20240731$EXP$$CA-APOTEX-2023AP006312$APOTEX$$36$YR$$F$Y$74$KG$20240731$$HP$CA$CA
221932716$22193271$6$F$$20240925$20230410$20240925$EXP$$US-PFIZER INC-PV202200098908$PFIZER$$29$YR$$M$Y$$$20240925$$MD$US$US
221932775$22193277$5$F$$20240724$20230410$20240728$PER$$NVSC2023US082690$NOVARTIS$$$$$M$Y$$$20240728$$CN$US$US
221934534$22193453$4$F$$20240920$20230410$20240925$EXP$$US-TAKEDA-2023TUS033173$TAKEDA$$$$$F$Y$30$KG$20240925$$CN$US$US
221935123$22193512$3$F$$20240913$20230410$20240917$EXP$$US-PFIZER INC-PV202300065274$PFIZER$$78$YR$$F$Y$$$20240917$$CN$US$US
221937614$22193761$4$F$20180101$20240822$20230410$20240827$EXP$$US-GILEAD-2023-0623325$GILEAD$$48$YR$A$F$Y$$$20240826$$LW$US$US
221937659$22193765$9$F$20211222$20240727$20230410$20240805$EXP$$CA-CELLTRION INC.-2022CA002885$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
2219376610$22193766$10$F$20170529$20240918$20230410$20240927$EXP$$CA-CELLTRION INC.-2021CA014014$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
221937906$22193790$6$F$20220101$20240815$20230410$20240823$EXP$$CA-CELLTRION INC.-2022CA005429$CELLTRION$$$$$$Y$$$20240823$$MD$CA$CA
2219379113$22193791$13$F$20210727$20240829$20230410$20240906$EXP$$CA-CELLTRION INC.-2021CA010527$CELLTRION$$$$$$Y$$$20240906$$MD$CA$CA
2219385819$22193858$19$F$20230330$20240919$20230410$20240928$EXP$$CA-CELLTRION INC.-2023CA007127$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
221939016$22193901$6$F$20210805$20240819$20230410$20240822$EXP$$US-TAKEDA-2021TUS052102$TAKEDA$$17$YR$$F$Y$131$KG$20240822$$CN$US$US
221939223$22193922$3$F$$20230425$20230410$20240924$PER$$NVSC2023US082798$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
221940442$22194044$2$F$$20240910$20230411$20240918$PER$$US-SA-2023SA109904$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240918$$MD$US$US
221941215$22194121$5$F$20220601$20240827$20230411$20240830$EXP$$US-ABBVIE-4303587$ABBVIE$$69$YR$$F$Y$96$KG$20240830$$CN$US$US
221943264$22194326$4$F$$20240717$20230411$20240722$EXP$$US-ROCHE-3324756$ROCHE$$49$YR$A$F$Y$106$KG$20240722$$HP$US$US
221944612$22194461$2$F$$20230407$20230411$20240812$PER$$NVSC2023US082990$NOVARTIS$$$$$M$Y$$$20240812$$CN$US$US
221946152$22194615$2$F$$20240726$20230411$20240806$EXP$$FR-ROCHE-3325887$ROCHE$$$$$M$Y$$$20240806$$PH$FR$FR
221946892$22194689$2$F$$20240715$20230411$20240722$EXP$$IN-ROCHE-3328232$ROCHE$$69$YR$E$M$Y$$$20240722$$MD$IN$IN
221947272$22194727$2$F$$20230405$20230411$20240828$PER$$US-SA-2023SA110688$SANOFI AVENTIS$$$$$$Y$$$20240828$$MD$US$US
221947428$22194742$8$F$20230323$20240913$20230411$20240920$EXP$$US-GSK-US2023050779$GLAXOSMITHKLINE$$73$YR$$F$Y$68.6$KG$20240920$$MD$US$US
221951702$22195170$2$F$$20240731$20230411$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02692$LUPIN$$$$$$Y$$$20240820$$CN$US$US
221952122$22195212$2$F$20230101$20240726$20230411$20240805$PER$$US-SA-2023SA110315$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240804$$MD$US$US
2219530115$22195301$15$F$20230101$20240627$20230411$20240705$EXP$$CA-CELLTRION INC.-2023CA002339$CELLTRION$$$$$$Y$$$20240705$$MD$CA$CA
221954456$22195445$6$F$20230101$20240723$20230411$20240731$EXP$$CA-CELLTRION INC.-2023CA006797$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
221955634$22195563$4$F$20230201$20240626$20230411$20240702$EXP$$JP-009507513-2304JPN000720J$MERCK$$6$DEC$$F$Y$$$20240702$$MD$JP$JP
221955822$22195582$2$F$$20240701$20230411$20240708$EXP$$FR-AUROBINDO-AUR-APL-2023-029041$AUROBINDO$Abbara, S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al.. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome.. Journal of Clinical Immunology.. 2023;43(3):647-652$33$YR$$M$Y$$$20240708$$HP$FR$FR
221957693$22195769$3$F$20230402$20240701$20230411$20240708$PER$$US-AMGEN-USASP2023057762$AMGEN$$80$YR$E$M$Y$$$20240708$$CN$US$US
221957872$22195787$2$F$$20240715$20230411$20240717$EXP$$IN-ROCHE-3328159$ROCHE$$65$YR$E$M$Y$$$20240717$$MD$IN$IN
221962085$22196208$5$F$$20240704$20230411$20240711$EXP$$CA-MYLANLABS-2023M1037551$BIOCON$$$$$$Y$$$20240711$$MD$CA$CA
221963695$22196369$5$F$$20240221$20230411$20240809$EXP$$NVSC2023US078444$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
221965443$22196544$3$F$20230329$20240905$20230411$20240914$EXP$$BR-CELLTRION INC.-2022BR019916$CELLTRION$$$$$$Y$$$20240914$$CN$BR$BR
221965475$22196547$5$F$20230225$20240729$20230411$20240801$EXP$$US-TAKEDA-2021TUS054887$TAKEDA$$21$YR$$M$Y$67.574$KG$20240801$$HP$US$US
221966623$22196662$3$F$20210101$20230404$20230411$20240710$EXP$$BR-ASTELLAS-2023US011103$ASTELLAS$$61$YR$$F$Y$$$20240710$$CN$BR$BR
221968272$22196827$2$F$$20230404$20230411$20240814$EXP$$NVSC2023US079538$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
221968765$22196876$5$F$$20240911$20230411$20240919$EXP$$CA-CELLTRION INC.-2023CA007160$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
2219696115$22196961$15$F$20210507$20240806$20230411$20240812$EXP$$MX-TAKEDA-2021TUS030843$TAKEDA$$33$YR$$F$Y$55$KG$20240812$$CN$MX$MX
221969712$22196971$2$F$20230401$20240701$20230411$20240705$PER$$US-BIOGEN-2023BI01198448$BIOGEN$$77$YR$$F$Y$$$20240705$$CN$US$US
221969809$22196980$9$F$20220101$20240704$20230411$20240711$EXP$$CA-PFIZER INC-202200510902$PFIZER$$45$YR$$M$Y$102$KG$20240711$$PH$CA$CA
2219710211$22197102$11$F$20230101$20240717$20230411$20240801$EXP$$US-INSMED, INC.-2023-00845-US$INSMED$$$$$M$Y$$$20240801$$CN$US$US
2219723512$22197235$12$F$20230224$20240714$20230411$20240724$EXP$$CN-GILEAD-2023-0621646$GILEAD$$59$YR$A$F$Y$$$20240724$$MD$CN$CN
221976363$22197636$3$F$20211012$20240909$20230411$20240924$EXP$$CO-BIOMARINAP-CO-2023-149679$BIOMARIN$$$$$$Y$$$20240924$$CN$CO$CO
221977918$22197791$8$F$20230210$20240920$20230411$20240924$EXP$$AU-TAKEDA-2023TUS015937$TAKEDA$$22$YR$$F$Y$$$20240924$$HP$AU$AU
221979522$22197952$2$F$$20220316$20230411$20240930$EXP$$JP-JNJFOC-20220305669$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240930$$MD$JP$JP
221985776$22198577$6$F$20230101$20240628$20230411$20240703$EXP$$US-SA-2023SA110950$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240703$$MD$US$US
221988672$22198867$2$F$20230202$20240714$20230411$20240717$EXP$$BE-BAUSCH-BL-2023-005811$BAUSCH AND LOMB$$$$A$M$Y$65$KG$20240717$$MD$BE$BE
221988852$22198885$2$F$$20240811$20230411$20240813$EXP$$DE-BAUSCH-BL-2023-005855$BAUSCH AND LOMB$$32$YR$$F$Y$75$KG$20240813$$MD$DE$DE
221990094$22199009$4$F$20230301$20240622$20230411$20240701$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2023-08303$IPSEN$$75$YR$E$M$Y$$$20240701$$MD$CA$CA
2219905020$22199050$20$F$20200101$20240715$20230411$20240720$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-019889$JAZZ$$$$$F$Y$$$20240720$$MD$US$US
221990883$22199088$3$F$20220709$20240919$20230411$20240928$EXP$$FR-CELLTRION INC.-2023FR006816$CELLTRION$$$$$$Y$$$20240928$$MD$FR$FR
221991663$22199166$3$F$20230101$20240822$20230411$20240824$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-230864$BOEHRINGER INGELHEIM$$40$YR$A$F$Y$$$20240824$$CN$US$US
221994863$22199486$3$F$$20240911$20230412$20240913$EXP$$CA-ROCHE-3329119$ROCHE$$$$A$F$Y$$$20240913$$HP$CA$CA
221995123$22199512$3$F$$20240726$20230412$20240730$EXP$$JP-SA-2023SA111431$SANOFI AVENTIS$Haruna T, Ogawa A, Saeki T, Higaki T, Okano M.. A case of eosinophilic granulomatosis with polyangiitis following dupilumab treatment for eosinophilic sinusitis.. The 3rd Annual Meeting of the Japan Society of Immunology Allergology and Infect. 2023;UNK:UNK$56$YR$A$F$Y$$$20240731$$MD$JP$JP
221996114$22199611$4$F$20230321$20240815$20230412$20240904$PER$$CA-TOLMAR, INC.-23CA039710$TOLMAR$$82$YR$$M$Y$$$20240904$$HP$CA$CA
221998492$22199849$2$F$20230217$20240702$20230412$20240712$EXP$FR-AFSSAPS-AM2023000273$FR-TEVA-2023-FR-2875352$TEVA$$46$YR$$F$Y$73$KG$20240712$$MD$FR$FR
221998503$22199850$3$F$$20240823$20230412$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02694$LUPIN$$$$$$Y$$$20240911$$CN$US$US
2219988626$22199886$26$F$20230101$20240805$20230412$20240814$EXP$$US-INTERCEPT-PM2023000343$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
221998933$22199893$3$F$$20240823$20230412$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02695$LUPIN$$$$$$Y$$$20240910$$CN$US$US
221999223$22199922$3$F$$20240731$20230412$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02696$LUPIN$$$$$$Y$$$20240818$$PH$US$US
221999353$22199935$3$F$$20240704$20230412$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02703$LUPIN$$$$$$Y$$$20240728$$CN$US$US
222000082$22200008$2$F$$20240812$20230412$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02721$LUPIN$$$$$$Y$$$20240903$$CN$US$US
222000614$22200061$4$F$$20240829$20230412$20240909$EXP$$DE-AUROBINDO-AUR-APL-2023-029339$AUROBINDO$Scheiermann J, Kunkele A, Stackelberg A, Eggert A, Lang P, Bernuth H et.al. Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous disease.. Frontiers in immunology. 2023;14:1-7$14$MON$$M$Y$$$20240909$$MD$DE$DE
222000642$22200064$2$F$$20240704$20230412$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02728$LUPIN$$$$$$Y$$$20240729$$CN$US$US
222000862$22200086$2$F$$20240823$20230412$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02729$LUPIN$$$$$$Y$$$20240911$$CN$US$US
222001076$22200107$6$F$20230404$20240913$20230412$20240924$EXP$$SE-JNJFOC-20230417910$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240924$$HP$SE$SE
2220011814$22200118$14$F$20230801$20240702$20230412$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-049103$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$66.9$KG$20240709$$HP$US$US
2220013913$22200139$13$F$20221101$20240913$20230412$20240923$EXP$$CA-CELLTRION INC.-2022CA019879$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
222002369$22200236$9$F$20230418$20240424$20230412$20240925$EXP$$US-GSK-US2023AMR051808$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
222004094$22200409$4$F$20230404$20240828$20230412$20240905$EXP$$CA-CELLTRION INC.-2022CA022011$CELLTRION$$$$$$Y$$$20240905$$MD$CA$CA
222005032$22200503$2$F$$20240814$20230412$20240826$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383608$RANBAXY$Abhijita B, Chawala N, Deb KS, Chadda R. Dapsone induced psychiatric manifestations - A case report. Indian J Psychiatry. 2023;Jan;65(Suppl1):S150$20$YR$$M$Y$$$20240826$$HP$IN$IN
222005322$22200532$2$F$$20240909$20230412$20240913$EXP$$BO-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-384476$RANBAXY$Siacar Bacarreza SY, Burgoa Vargas J. CHROMAFFIN CELL TUMOR: PHEOCHROMOCYTOMA. Horm Res Paediatr. 2023;96(1):40$12$YR$$M$Y$$$20240913$$HP$BO$BO
222005455$22200545$5$F$$20240913$20230412$20240918$EXP$$NVSC2023ES083617$NOVARTIS$Escalada-Pellitero S, Garcia-Salido A, Clemente-Garulo D, Azorin-Cuadrillero D, De Lama Caro-Paton G, Lopez-Robledillo J. Fatal Pulmonary Veno-Occlusive Disease and Systemic Juvenile Idiopathic Arthritis: Case Report and Literature Review. REUMATOLOGIA CLINICA. 2023;19(1):53-6$6$YR$$F$Y$$$20240919$$HP$ES$ES
222007522$22200752$2$F$$20240723$20230412$20240725$EXP$$US-KYOWAKIRIN-2023BKK005384$KYOWA$$$$$$Y$$$20240725$$HP$US$US
2220075611$22200756$11$F$$20240910$20230412$20240919$EXP$$CA-ROCHE-3329043$ROCHE$$78$YR$E$F$Y$93$KG$20240919$$HP$CA$CA
222008362$22200836$2$F$$20240731$20230412$20240802$PER$$NVSC2023US084190$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
222010025$22201002$5$F$20230401$20240902$20230412$20240911$EXP$$JP-009507513-2304JPN001219J$MERCK$$55$YR$$F$Y$$$20240911$$MD$JP$JP
222010853$22201085$3$F$$20240822$20230412$20240826$EXP$$AR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383971$RANBAXY$Azcoiti ME, Keselman A, Sanguineti N, Crespo C, Krochik G, Costanzo M, et al. POC1A gene defect in two unrelated cases with severe dyslipidemic insulin resistance and SOFT syndrome. Horm Res Paediatr. 2023;96 (Suppl. 2):79/P43$$$C$F$Y$$$20240826$$HP$AR$AR
222010903$22201090$3$F$$20240822$20230412$20240826$EXP$$AR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383972$RANBAXY$Azcoiti ME, Keselman A, Sanguineti N, Crespo C, Krochik G, Costanzo M, et a. POC1A gene defect in two unrelated cases with severe dyslipidemic insulin resistance and SOFT syndrome. Horm Res Paediatr. 2023;96 (Suppl. 2):79/P43$5$YR$$M$Y$$$20240826$$HP$AR$AR
222012927$22201292$7$F$$20240828$20230412$20240904$EXP$$CA-ROCHE-3327757$ROCHE$$64$YR$A$M$Y$$$20240904$$CN$CA$CA
222013104$22201310$4$F$$20240910$20230412$20240915$EXP$$US-TAKEDA-2022TUS088887$TAKEDA$$$$$F$Y$$$20240915$$CN$US$US
222013786$22201378$6$F$20221125$20240715$20230412$20240718$EXP$$CA-TAKEDA-2023TUS036950$TAKEDA$$52$YR$$F$Y$$$20240718$$CN$CA$CA
222014014$22201401$4$F$$20240916$20230412$20240923$EXP$$CA-GSK-CA2023049079$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$PH$CA$CA
222014324$22201432$4$F$20230101$20240704$20230412$20240710$EXP$$CA-TAKEDA-2023TUS036089$TAKEDA$$$$$M$Y$82$KG$20240710$$CN$CA$CA
222014336$22201433$6$F$20240301$20240806$20230412$20240827$PER$$CA-TOLMAR, INC.-23CA039740$TOLMAR$$83$YR$$M$Y$$$20240827$$CN$CA$CA
222017402$22201740$2$F$20230101$20240729$20230412$20240806$PER$$US-SA-2023SA111283$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240806$$MD$US$US
222018662$22201866$2$F$$20240807$20230412$20240809$EXP$$NVSC2023US080322$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
2220189911$22201899$11$F$$20240723$20230412$20240808$EXP$$NVSC2023CO081483$NOVARTIS$$$$$F$Y$63$KG$20240808$$CN$CO$CO
222021132$22202113$2$F$20240903$20240903$20230412$20240906$EXP$$US-TAKEDA-2023TUS037307$TAKEDA$$54$YR$$F$Y$$$20240906$$CN$US$US
222021174$22202117$4$F$20200101$20240711$20230412$20240719$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2023AMR047802$VIIV$$$$$$Y$$$20240719$$MD$CA$CA
222021492$22202149$2$F$$20230403$20230412$20240712$PER$$CA-PFM-2022-00521$PIERRE FABRE MEDICAMENT$$$$E$M$Y$$$20240712$$HP$CA$CA
222021688$22202168$8$F$20220901$20240908$20230412$20240910$PER$$US-PFIZER INC-PV202300066559$PFIZER$$66$YR$$M$Y$$$20240910$$CN$US$US
222022363$22202236$3$F$$20240705$20230412$20240710$PER$$NVSC2023US082170$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
222022968$22202296$8$F$$20240828$20230412$20240830$PER$$US-AMGEN-USASP2023062723$AMGEN$$$$A$F$Y$$$20240830$$HP$US$US
222023676$22202367$6$F$20230101$20240716$20230412$20240718$EXP$$CA-PFIZER INC-PV202300064861$PFIZER$$57$YR$$M$Y$74.5$KG$20240718$$MD$CA$CA
222024256$22202425$6$F$20211214$20240912$20230412$20240916$EXP$$IN-PFIZER INC-202101227191$PFIZER$$70$YR$$M$Y$85.8$KG$20240916$$CN$IN$IN
222024439$22202443$9$F$20220401$20240708$20230412$20240716$EXP$$CA-CELLTRION INC.-2022CA004118$CELLTRION$$$$$$Y$$$20240716$$MD$CA$CA
222027913$22202791$3$F$$20240823$20230412$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02735$LUPIN$$$$$$Y$$$20240913$$CN$US$US
222028462$22202846$2$F$$20230410$20230412$20240816$EXP$$NVSC2023US083640$NOVARTIS$$$$$M$Y$$$20240816$$CN$US$US
222029692$22202969$2$F$20220829$20240627$20230412$20240705$EXP$$CA-TAKEDA-2022TUS061420$TAKEDA$$59$YR$$M$Y$$$20240705$$CN$CA$CA
222031178$22203117$8$F$20230405$20240829$20230412$20240902$EXP$$CA-JNJFOC-20230417229$JOHNSON AND JOHNSON$$62$YR$A$F$Y$65$KG$20240903$$HP$CA$CA
222033422$22203342$2$F$$20240703$20230412$20240711$EXP$$JP-AMGEN-JPNSP2023060063$AMGEN$$$$$$Y$$$20240711$$MD$JP$JP
222036984$22203698$4$F$$20240626$20230412$20240701$EXP$$US-INCYTE CORPORATION-2023IN003470$INCYTE$$$$$$Y$$$20240701$$CN$US$US
222037025$22203702$5$F$$20240828$20230412$20240902$EXP$$US-TAKEDA-US202018571$TAKEDA$$$$$F$Y$$$20240902$$CN$US$US
222037239$22203723$9$F$$20240826$20230412$20240829$EXP$$US-Taiho Oncology Inc-2023-001018$TAIHO ONCOLOGY INC$$67$YR$E$M$Y$$$20240829$$CN$US$US
2220386211$22203862$11$F$20230109$20240901$20230412$20240904$EXP$$FR-BAUSCH-BL-2023-005627$BAUSCH AND LOMB$$75$YR$$F$Y$59$KG$20240904$$HP$FR$FR
222040602$22204060$2$F$$20240715$20230412$20240717$PER$$US-PFIZER INC-PV202300065120$PFIZER$$70$YR$$F$Y$$$20240717$$CN$US$US
222043882$22204388$2$F$20230101$20230410$20230413$20240813$PER$$NVSC2023US083658$NOVARTIS$$49$YR$$$Y$$$20240813$$CN$US$US
222044863$22204486$3$F$20240703$20240711$20230413$20240721$EXP$$BR-CELLTRION INC.-2023BR007418$CELLTRION$$$$$$Y$$$20240722$$CN$BR$BR
222045665$22204566$5$F$20200101$20240711$20230413$20240722$EXP$$CA-JNJFOC-20230425389$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240723$$MD$CA$CA
222046043$22204604$3$F$$20240813$20230413$20240906$PER$$CA-TOLMAR, INC.-23CA039542$TOLMAR$$$$$M$Y$$$20240906$$CN$CA$CA
222049289$22204928$9$F$20230401$20240722$20230413$20240726$EXP$$CA-ROCHE-3330102$ROCHE$$41$YR$A$F$Y$$$20240726$$CN$CA$CA
222049773$22204977$3$F$$20240827$20230413$20240903$EXP$$JP-SA-2023SA111496$SANOFI AVENTIS$Ohno H, Yamamoto M, Fujita Y, Murai Y.. The 54th Annual Meeting of the Congress on Electrolyte Metabolism [Session 2] 2-1: A case of ketoacidosis associated with hypoglycemia in type 2 diabetes mellitus.. Proceedings of the Congress on Electrolyte Metabolism.. 2024;50:20-23$71$YR$E$M$Y$$$20240904$$MD$JP$JP
222050323$22205032$3$F$$20240909$20230413$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02736$LUPIN$$$$$$Y$$$20240921$$CN$US$US
222051873$22205187$3$F$20230301$20240909$20230413$20240919$EXP$$JP-009507513-2304JPN001073J$MERCK$Wanifuchi Y, Fujita T, Asano T, Mori M, Matsumoto N, Isogai A, et al.. SY2-7 Long-term clinical outcome of triple-negative breast cancer treatment and future challenges. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 9$7$DEC$$F$Y$$$20240919$$MD$JP$JP
222051944$22205194$4$F$20220914$20240709$20230413$20240718$EXP$$CA-CELLTRION INC.-2020CA032914$CELLTRION$$$$$$Y$$$20240718$$MD$CA$CA
222053662$22205366$2$F$$20230406$20230413$20240919$EXP$$NVSC2023GB083963$NOVARTIS$$$$$$Y$$$20240919$$MD$GB$GB
2220543612$22205436$12$F$20230405$20240829$20230413$20240906$EXP$$CA-CELLTRION INC.-2023CA007569$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
222055664$22205566$4$F$$20240918$20230413$20240927$PER$$NVSC2023US085124$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
222055766$22205576$6$F$20220201$20240911$20230413$20240922$EXP$$DE-ROCHE-3047219$ROCHE$$50$YR$A$F$Y$83$KG$20240922$$CN$DE$DE
222057154$22205715$4$F$20230302$20240816$20230413$20240827$PER$$US-SA-2023SA112517$SANOFI AVENTIS$$69$YR$E$M$Y$73$KG$20240827$$MD$US$US
222058586$22205858$6$F$20230301$20240812$20230413$20240821$PER$$US-SA-2023SA114645$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240821$$CN$US$US
222059552$22205955$2$F$20230201$20230406$20230413$20240710$EXP$$NL-ASTELLAS-2023US011277$ASTELLAS$$$$$F$Y$$$20240710$$CN$NL$NL
222059582$22205958$2$F$20190701$20230407$20230413$20240716$EXP$$RO-ASTELLAS-2023US011321$ASTELLAS$$71$YR$$M$Y$$$20240716$$MD$RO$RO
2220609513$22206095$13$F$$20240731$20230413$20240813$EXP$$FR-AUROBINDO-AUR-APL-2023-013423$AUROBINDO$$52$YR$$F$Y$$$20240813$$CN$FR$FR
222061332$22206133$2$F$$20240912$20230413$20240925$EXP$$US-SA-2023SA114237$SANOFI AVENTIS$$64$YR$A$M$Y$66.22$KG$20240925$$HP$US$US
2220641213$22206412$13$F$$20240916$20230413$20240925$EXP$$CA-ROCHE-3323777$ROCHE$$$$A$F$Y$$$20240925$$MD$CA$CA
222064202$22206420$2$F$$20240823$20230413$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02788$LUPIN$$$$$$Y$$$20240912$$CN$US$US
222064665$22206466$5$F$20230101$20240730$20230413$20240805$EXP$$US-BIOGEN-2023BI01198984$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
222065394$22206539$4$F$20230406$20240709$20230413$20240712$EXP$$US-UCBSA-2022071972$UCB$$65$YR$$M$Y$$$20240712$$MD$US$US
222065742$22206574$2$F$$20240901$20230413$20240904$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384082$RANBAXY$Li M, Liu L, Ding B, Song X, Xia A, Han Y, et al. Refractory/relapse thrombocytopenia in a patient with Evans^ syndrome successfully treated with zanubrutinib. Br J Haematol. 2022;199(5):e37-e42$15$YR$$F$Y$$$20240904$$HP$CN$CN
222066252$22206625$2$F$20230331$20240918$20230413$20240930$PER$$NVSC2023US085235$NOVARTIS$$65$YR$$F$Y$$$20240930$$HP$US$US
222068213$22206821$3$F$20230301$20240829$20230413$20240923$PER$$US-SA-2023SA114612$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240923$$MD$US$US
222069333$22206933$3$F$20230331$20240918$20230413$20240925$EXP$$NVSC2023US085255$NOVARTIS$$72$YR$$M$Y$103$KG$20240925$$HP$US$US
222070943$22207094$3$F$20230327$20240715$20230413$20240717$EXP$$CA-TAKEDA-2022TUS079415$TAKEDA$$56$YR$$F$Y$$$20240717$$MD$CA$CA
222071233$22207123$3$F$$20240821$20230413$20240830$EXP$$DE-MSNLABS-2023MSNLIT00593$MSN LABORATORIES$Scheiermann J, Kunkele A, Stackelberg A, Eggert A, Lang P, Bernuth H.Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous disease..Front. Immunol.2023;14:1-7$$$$$Y$$$20240830$$MD$DE$DE
222074914$22207491$4$F$$20240719$20230413$20240725$EXP$$US-ELI_LILLY_AND_COMPANY-US202304005907$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240725$$CN$US$US
222075763$22207576$3$F$20230331$20240718$20230413$20240722$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000263$PAREXEL$$$$$$Y$$$20240722$$CN$US$US
222077404$22207740$4$F$20221005$20240830$20230413$20240904$EXP$$US-PFIZER INC-2020423410$PFIZER$$67$YR$$F$Y$$$20240904$$MD$US$US
222077437$22207743$7$F$$20240701$20230413$20240703$EXP$$US-PFIZER INC-202101458440$PFIZER$$64$YR$$M$Y$75.7$KG$20240703$$CN$US$US
222078804$22207880$4$F$20230328$20240903$20230413$20240909$EXP$$CN-TAKEDA-2023TUS037664$TAKEDA$$40$YR$$M$Y$63$KG$20240909$$MD$CN$CN
222079272$22207927$2$F$20230328$20240809$20230413$20240814$EXP$$CO-BIOGEN-2023BI01198856$BIOGEN$$60$YR$$F$Y$51$KG$20240814$$CN$CO$CO
222079303$22207930$3$F$$20240704$20230413$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02792$LUPIN$$$$$$Y$$$20240804$$CN$US$US
222079833$22207983$3$F$20230404$20240704$20230413$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02757$LUPIN$$$$$$Y$$$20240730$$CN$US$US
222080952$22208095$2$F$$20240722$20230413$20240726$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2023-050866$BRISTOL MYERS SQUIBB$Chu Z, Lin H, Zhan Q, Liu T, Wang Y. A retrospective analysis of first-line PD-1 monoclonal antibodies treatment in patients with leptomeningeal metastasis from solid tumors. Journal of Oncology Pharmacy Practice. 2023;29(3):582-9. doi:10.1177/10781552221074622.$$$$$Y$$$20240726$$HP$CN$CN
222081212$22208121$2$F$$20240729$20230413$20240802$PER$$US-SA-2023SA114460$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240802$$MD$US$US
222081593$22208159$3$F$$20240809$20230413$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02804$LUPIN$$$$$$Y$$$20240828$$CN$US$US
222082178$22208217$8$F$20230316$20240904$20230413$20240909$EXP$$US-JNJFOC-20230405319$JOHNSON AND JOHNSON$$66$YR$E$M$Y$83.7$KG$20240909$$MD$US$US
222082623$22208262$3$F$20230307$20240705$20230413$20240715$EXP$IT-MINISAL02-916199$IT-TEVA-2023-IT-2876082$TEVA$$7$YR$$F$Y$25$KG$20240715$$PH$IT$IT
2220830514$22208305$14$F$20240101$20240912$20230413$20240917$EXP$$US-TAKEDA-2023TUS034656$TAKEDA$$57$YR$$F$Y$56$KG$20240917$$HP$US$US
222083582$22208358$2$F$$20240731$20230413$20240807$PER$$US-INCYTE CORPORATION-2023IN003576$INCYTE$$$$$$Y$$$20240807$$CN$US$US
222083652$22208365$2$F$$20240703$20230413$20240708$EXP$$IT-MYLANLABS-2023M1038158$MYLAN$Perriello V, Falini L, Ruggeri, Loredana 1 ; Innocente, Alessandra 1 ; Ballanti S, Costa C, Di Filippo M, Gargaro M, Fallarino F and Falini B. CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma. American Journal of Hematology. 2023;98 (1):212-9$63$YR$$M$Y$$$20240708$$HP$IT$IT
222084322$22208432$2$F$$20240805$20230413$20240806$PER$$US-BIOVITRUM-2022US13548$BIOVITRUM$$76$YR$$F$Y$$$20240806$$CN$US$US
222085249$22208524$9$F$$20240918$20230413$20240925$EXP$$CA-TAKEDA-2023TUS037591$TAKEDA$$$$$F$Y$$$20240925$$CN$CA$CA
222087012$22208701$2$F$20230101$20240723$20230413$20240725$EXP$$US-INCYTE CORPORATION-2023IN002381$INCYTE$$$$$$Y$$$20240725$$HP$US$US
2220896910$22208969$10$F$$20240718$20230413$20240723$PER$$US-PFIZER INC-202200658393$PFIZER$$81$YR$$F$Y$$$20240723$$MD$US$US
222092208$22209220$8$F$20230201$20240913$20230413$20240921$EXP$$FR-CELLTRION INC.-2023FR007257$CELLTRION$$$$$$Y$$$20240921$$MD$FR$FR
222092373$22209237$3$F$20220928$20240722$20230413$20240801$EXP$$RO-JNJFOC-20230429251$JOHNSON AND JOHNSON$$54$YR$A$M$Y$135$KG$20240801$$MD$RO$RO
222092734$22209273$4$F$$20240617$20230413$20240711$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001099$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
222092806$22209280$6$F$20240109$20240917$20230413$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001100$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240927$$CN$US$US
222093879$22209387$9$F$20230711$20240701$20230413$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001154$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240725$$CN$US$US
222094529$22209452$9$F$20230101$20240826$20230414$20240829$EXP$$CO-ABBVIE-4726258$ABBVIE$$$$$M$Y$59$KG$20240829$$CN$CO$CO
222095329$22209532$9$F$20230612$20240627$20230414$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-000364$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240723$$HP$US$US
222095383$22209538$3$F$$20240823$20230414$20240912$PER$$US-SA-2023SA113991$SANOFI AVENTIS$$$$E$M$Y$94.3$KG$20240912$$MD$US$US
222095963$22209596$3$F$20220401$20240701$20230414$20240722$EXP$$DE-ROCHE-3192882$ROCHE$$28$YR$A$F$Y$$$20240722$$CN$DE$DE
2220965312$22209653$12$F$20230101$20240821$20230414$20240829$EXP$$CA-CELLTRION INC.-2023CA003884$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
222097137$22209713$7$F$20220101$20240730$20230414$20240807$EXP$$CA-CELLTRION INC.-2021CA018883$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
222099045$22209904$5$F$20230406$20231219$20230414$20240724$EXP$$CA-CELLTRION INC.-2023CA007639$CELLTRION$$$$$$Y$$$20240724$$HP$CA$CA
222099932$22209993$2$F$$20240709$20230414$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384849$RANBAXY$Miranda M, Gianfreda F, Raffone C, Antonacci D, Pistilli V, Bollero P. The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ). Biomed Res Int. 2021$68$YR$$F$Y$$$20240710$$HP$IT$IT
222102683$22210268$3$F$20230301$20230412$20230414$20240828$PER$$NVSC2023US085678$NOVARTIS$$69$YR$$F$Y$90.72$KG$20240828$$CN$US$US
222103128$22210312$8$F$20230409$20240628$20230414$20240701$EXP$$NVSC2023US084199$NOVARTIS$$63$YR$$F$Y$$$20240701$$CN$US$US
222104982$22210498$2$F$$20240726$20230414$20240805$30DAY$$US-GSK-US2023052568$GLAXOSMITHKLINE$$$$A$F$Y$$$20240805$$CN$US$US
222106493$22210649$3$F$$20240704$20230414$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02822$LUPIN$$$$$$Y$$$20240725$$CN$US$US
222108258$22210825$8$F$20230926$20240628$20230414$20240703$EXP$$CA-TAKEDA-2023TUS037625$TAKEDA$$40$YR$$F$Y$$$20240703$$MD$CA$CA
222110678$22211067$8$F$20221128$20240905$20230414$20240912$EXP$$CA-TAKEDA-2023TUS037711$TAKEDA$$33$YR$$F$Y$56.7$KG$20240912$$MD$CA$CA
222111292$22211129$2$F$20240701$20240827$20230414$20240924$PER$$US-SA-2023SA113052$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$MD$US$US
222112152$22211215$2$F$$20240708$20230414$20240723$EXP$$IT-AUROBINDO-AUR-APL-2023-029776$AUROBINDO$Perriello VM, Falini L, Ruggeri L, Innocente A, Ballanti S, Brunangelo F, et al.. Falini B CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma. American Journal of Hematology. 2023;98 (1):212-9.$63$YR$$M$Y$$$20240719$$HP$IT$IT
222113563$22211356$3$F$20220501$20230417$20230414$20240829$PER$$NVSC2023US085391$NOVARTIS$$76$YR$$F$Y$$$20240829$$CN$US$US
222113743$22211374$3$F$$20240903$20230414$20240905$EXP$$JP-GSK-JP2023034813$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
222118972$22211897$2$F$$20230407$20230414$20240812$EXP$$NVSC2023US083059$NOVARTIS$$$$$M$Y$$$20240812$$CN$US$US
222119086$22211908$6$F$$20240725$20230414$20240801$EXP$$CA-OTSUKA-2022_020968$OTSUKA$$$$$M$Y$$$20240801$$HP$CA$CA
222120933$22212093$3$F$$20240710$20230414$20240723$EXP$JP-MLMSERVICE-20230328-4189767-1$JP-STRIDES ARCOLAB LIMITED-2023SP005203$STRIDES$Furuto Y, Hashimoto H, Namikawa A, Morikawa T, Shibuya Y.. Remission Induction of IgG4-related Membranous Nephropathy with Multitarget Therapy.. Internal medicine. 2023;62(21):3175-3181$67$YR$$M$Y$$$20240723$$MD$JP$JP
222121232$22212123$2$F$$20240829$20230414$20240904$PER$$US-PFIZER INC-202101191913$PFIZER$$72$YR$$F$Y$$$20240904$$CN$US$US
222122644$22212264$4$F$20230101$20240919$20230414$20240924$EXP$$US-ABBVIE-4726035$ABBVIE$$$$$M$Y$99$KG$20240924$$CN$US$US
222123297$22212329$7$F$20220201$20240805$20230414$20240813$EXP$$US-TAKEDA-2022TUS031491$TAKEDA$$5$YR$$M$Y$22$KG$20240813$$CN$US$US
2221261711$22212617$11$F$$20240814$20230414$20240820$EXP$$US-PFIZER INC-PV202300067034$PFIZER$$24$YR$$F$Y$$$20240820$$MD$US$US
222126494$22212649$4$F$20230101$20240723$20230414$20240725$EXP$$US-UCBSA-2023017129$UCB$$$$$F$Y$$$20240725$$HP$US$US
222128352$22212835$2$F$20220717$20240920$20230414$20240930$EXP$$JP-JNJFOC-20230426968$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20241001$$MD$JP$JP
222128503$22212850$3$F$20220520$20240709$20230414$20240712$EXP$$AU-TAKEDA-2022TUS034269$TAKEDA$$77$YR$$F$Y$$$20240712$$CN$AU$AU
222129493$22212949$3$F$20211029$20240731$20230414$20240802$PER$$US-AMGEN-USASP2021216466$AMGEN$$78$YR$E$F$Y$$$20240802$$CN$US$US
222131665$22213166$5$F$20230125$20240911$20230414$20240917$EXP$$CA-TAKEDA-2020TUS019425$TAKEDA$$30$YR$$M$Y$$$20240917$$HP$CA$CA
222136789$22213678$9$F$20220101$20240712$20230414$20240717$EXP$$CA-PFIZER INC-202200547110$PFIZER$$49$YR$$M$Y$$$20240717$$MD$CA$CA
222136837$22213683$7$F$20221004$20240823$20230414$20240828$EXP$$CA-PFIZER INC-202201011051$PFIZER$$45$YR$$F$Y$124$KG$20240828$$MD$CA$CA
222144024$22214402$4$F$20220411$20240730$20230414$20240805$PER$$US-JAZZ PHARMACEUTICALS-2022-US-033717$JAZZ$$40$YR$$F$Y$$$20240804$$MD$US$US
222145483$22214548$3$F$$20240725$20230415$20240806$EXP$$CA-AUROBINDO-AUR-APL-2023-030739$AUROBINDO$Youykheang M, Al Hallaq Z, Menelas K, Biskin RS, Dagenais-Beaule V. Combination of Long- Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders-A Systematic Review of the Literature and Case Series.. J-Clin-Psychopharmacol. 2023;43(1):20-27$32$YR$$F$Y$$$20240806$$HP$CA$CA
222146083$22214608$3$F$20230131$20240725$20230415$20240806$EXP$$FR-AUROBINDO-AUR-APL-2023-029624$AUROBINDO$$57$YR$$F$Y$$$20240806$$PH$FR$FR
2221462316$22214623$16$F$20230326$20240916$20230415$20240924$EXP$$CA-CELLTRION INC.-2023CA002590$CELLTRION$$$$$$Y$$$20240924$$MD$CA$CA
222146685$22214668$5$F$$20240815$20230415$20240827$EXP$$CA-AUROBINDO-AUR-APL-2023-030741$AUROBINDO$Youykheang M, Al Hallaq Z, Menelas K, Biskin RS, Dagenais-Beaule V. Combination of Long- Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders-A Systematic Review of the Literature and Case Series.. J-Clin-Psychopharmacol. 2023;43(1):20-27$67$YR$$F$Y$$$20240827$$HP$CA$CA
222148422$22214842$2$F$$20230413$20230415$20240826$PER$$NVSC2023US086488$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
222148763$22214876$3$F$20220601$20230410$20230415$20240816$EXP$$NVSC2023US083993$NOVARTIS$$47$YR$$M$Y$$$20240816$$CN$US$US
222149386$22214938$6$F$20221214$20240829$20230415$20240829$EXP$$NVSC2023US085484$NOVARTIS$$67$YR$$M$Y$$$20240829$$CN$US$US
222149626$22214962$6$F$20191118$20240819$20230415$20240826$EXP$$CA-TAKEDA-CA202016686$TAKEDA$$32$YR$$F$Y$111$KG$20240826$$CN$CA$CA
222149973$22214997$3$F$$20240628$20230415$20240710$EXP$CA-MHPD-001024969$CA-Accord-307807$ACCORD$$12$MON$I$M$Y$10$KG$20240710$$HP$CA$CA
222150172$22215017$2$F$$20230410$20230415$20240913$EXP$$NVSC2023CN086235$NOVARTIS$$$$$$Y$$$20240913$$HP$CN$CN
222151176$22215117$6$F$20230408$20240808$20230415$20240812$PER$$NVSC2023US086204$NOVARTIS$$52$YR$$M$Y$$$20240812$$HP$US$US
222151403$22215140$3$F$20230401$20240729$20230415$20240807$PER$$US-SA-2023SA116361$SANOFI AVENTIS$$53$YR$A$M$Y$88.9$KG$20240807$$MD$US$US
222153735$22215373$5$F$20230227$20240903$20230416$20240913$EXP$$BE-AUROBINDO-AUR-APL-2023-030278$AUROBINDO$$84$YR$$M$Y$$$20240913$$HP$BE$BE
222157323$22215732$3$F$20130301$20240725$20230416$20240731$EXP$$US-JNJFOC-20230425841$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240801$$LW$US$US
222158112$22215811$2$F$$20230413$20230417$20240813$EXP$$AU-JNJFOC-20230431913$JOHNSON AND JOHNSON$$22$YR$A$M$Y$61$KG$20240813$$HP$AU$AU
222160463$22216046$3$F$$20240902$20230417$20240903$EXP$$DE-UCBSA-2023018247$UCB$Scheiermann J, Kunkele A, Stackelberg A, Eggert A, Lang P, Bernuth H et.al.. Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous disease. Frontiers in Immunology.. 2023;14:1-7$14$MON$$M$Y$$$20240903$$HP$DE$DE
222160494$22216049$4$F$$20240725$20230417$20240813$PER$$CA-TOLMAR, INC.-22CA036804$TOLMAR$$$$$M$Y$$$20240813$$CN$CA$CA
222160664$22216066$4$F$20220101$20240829$20230417$20240906$EXP$$CA-CELLTRION INC.-2022CA005629$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
222161297$22216129$7$F$20230320$20240823$20230417$20240912$PER$$CA-TOLMAR, INC.-23CA039642$TOLMAR$$87$YR$$M$Y$$$20240912$$CN$CA$CA
222161304$22216130$4$F$20230320$20240820$20230417$20240913$PER$$CA-TOLMAR, INC.-23CA039714$TOLMAR$$63$YR$$M$Y$$$20240913$$CN$CA$CA
222161434$22216143$4$F$$20240809$20230417$20240819$EXP$$DE-AUROBINDO-AUR-APL-2023-030314$AUROBINDO$$32$YR$$F$Y$75$KG$20240819$$MD$DE$DE
222162803$22216280$3$F$$20240607$20230417$20240703$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001168$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240703$$CN$US$US
222162962$22216296$2$F$20230331$20240913$20230417$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001357$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240923$$CN$US$US
222163006$22216300$6$F$$20240829$20230417$20240903$EXP$$US-TAKEDA-2021TUS083055$TAKEDA$$$$$F$Y$69$KG$20240903$$MD$US$US
222163169$22216316$9$F$20230101$20240920$20230417$20240930$EXP$$CA-CELLTRION INC.-2023CA005671$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
222163952$22216395$2$F$$20240801$20230417$20240808$EXP$$US-TOLMAR, INC.-23US040073$TOLMAR$$$$$M$Y$74.376$KG$20240808$$MD$US$US
222165134$22216513$4$F$20230301$20240905$20230417$20240911$EXP$$US-ABBVIE-4728683$ABBVIE$$75$YR$$F$Y$68$KG$20240911$$CN$US$US
222165842$22216584$2$F$$20240917$20230417$20240923$EXP$$US-TAKEDA-2023TUS038219$TAKEDA$$$$$F$Y$$$20240923$$MD$US$US
222166125$22216612$5$F$20200601$20240717$20230417$20240729$EXP$$DE-ROCHE-2863946$ROCHE$$51$YR$A$F$Y$$$20240729$$CN$DE$DE
222167992$22216799$2$F$$20240826$20230417$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384622$RANBAXY$Ungar SP, Varkey J, Pierro J, Raetz E, Ratner AJ. Do Not Forget About the Ticks: An Unusual Cause of Fever, GI Distress, and Cytopenias in a Child With ALL. J Pediatr Hematol Oncol. 2022;Jul; 44(5):e901-e904$5$YR$$M$Y$$$20240904$$MD$US$US
222168062$22216806$2$F$$20240829$20230417$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384645$RANBAXY$Gleason L, Joffe D, Bhatti S, Cohen A, Banner L, Correia E et al. Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor. Case Rep Oncol. 2022;15:1088-1094$42$YR$$M$Y$$$20240904$$HP$US$US
222168082$22216808$2$F$$20240814$20230417$20240826$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384693$RANBAXY$Greenway KT, Garel N, Goyette N, Turecki G, Richard-Devantoy S. Adjunctive music improves the tolerability of intravenous ketamine for bipolar depression. Int Clin Psychopharmacol. 2021;36(4):218-220$41$YR$$F$Y$$$20240826$$MD$CA$CA
222168162$22216816$2$F$$20240812$20230417$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384880$RANBAXY$Rimmer S, Ly L, Boh E. Subacute cutaneous lupus erythematosus after mRNA-based SARS-CoV-2 vaccination. JAAD Case Reports. 2023;33:70-2$79$YR$$F$Y$$$20240826$$MD$US$US
222170513$22217051$3$F$20210101$20240712$20230417$20240722$PER$$US-SA-2023SA115501$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240721$$HP$US$US
222170555$22217055$5$F$20230101$20240906$20230417$20240916$PER$$US-SA-2023SA117529$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240916$$MD$US$US
222170572$22217057$2$F$20230401$20240815$20230417$20240828$PER$$US-SA-2023SA117051$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240828$$MD$US$US
222171163$22217116$3$F$$20240925$20230417$20240930$EXP$$NVSC2023GB083759$NOVARTIS$$$$A$M$Y$$$20240930$$CN$GB$GB
222171457$22217145$7$F$20221001$20240807$20230417$20240904$PER$$CA-TOLMAR, INC.-23CA039868$TOLMAR$$54$YR$$M$Y$$$20240904$$CN$CA$CA
222172593$22217259$3$F$20230327$20240712$20230417$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023AMR051785$VIIV$$42$YR$$M$Y$$$20240722$$CN$US$US
222172973$22217297$3$F$20230224$20240723$20230417$20240730$EXP$$FR-AUROBINDO-AUR-APL-2023-029911$AUROBINDO$$62$YR$$M$Y$62.2$KG$20240730$$MD$FR$FR
222173235$22217323$5$F$$20240603$20230417$20240710$PER$$JP-ROCHE-3331384$ROCHE$$44$YR$A$M$Y$96.2$KG$20240628$$MD$JP$JP
222173252$22217325$2$F$$20240925$20230417$20240927$EXP$$US-AUROBINDO-AUR-APL-2023-030672$AUROBINDO$Ingoglia F, Tanfous MB, Ellezam B, Anderson KJ, Pasquali M, Botto LD. MADD-LIKE PATTERN IN PLASMA ACYLCARNITINE PROFILE ASSOCIATED WITH SERTRALINE USE. Molecular Genetics and Metabolism. 2023;138(3):107426$61$YR$$F$Y$$$20240927$$MD$US$US
222174792$22217479$2$F$$20230410$20230417$20240904$EXP$$NVSC2023RU086718$NOVARTIS$$$$$$Y$$$20240905$$MD$RU$RU
2221758410$22217584$10$F$20211204$20240704$20230417$20240715$EXP$$CA-ROCHE-3056890$ROCHE$$60$YR$A$F$Y$$$20240715$$CN$CA$CA
222177203$22217720$3$F$$20240704$20230417$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02831$LUPIN$$$$$$Y$$$20240804$$PH$US$US
222178584$22217858$4$F$20240116$20240917$20230417$20240919$EXP$$NVSC2023US085397$NOVARTIS$$34$YR$$M$Y$133$KG$20240919$$CN$US$US
222179278$22217927$8$F$20230412$20240904$20230417$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-053606$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240904$$CN$US$US
222180685$22218068$5$F$20230201$20240822$20230417$20240829$EXP$$CA-TAKEDA-2020TUS022540$TAKEDA$$75$YR$$F$Y$$$20240829$$MD$CA$CA
222181604$22218160$4$F$$20240910$20230417$20240912$EXP$$CA-ROCHE-3325021$ROCHE$$$$E$F$Y$$$20240912$$CN$CA$CA
222183473$22218347$3$F$$20240807$20230417$20240812$EXP$$JP-PFIZER INC-PV202300065689$PFIZER$Nakamichi, A.. A case of metabolic encephalopathy caused by iatrogenic adrenal insufficiency due to temporary discontinuation of medroxyprogesterone. The 239th Kyushu Regional Meeting of the Japanese Society of Neurology. 2023;239:23$69$YR$$F$Y$$$20240812$$HP$JP$JP
222184164$22218416$4$F$20210802$20240902$20230417$20240905$EXP$$JP-GILEAD-2021-0538296$GILEAD$$60$YR$A$M$Y$$$20240905$$MD$JP$JP
222184442$22218444$2$F$$20240904$20230417$20240913$PER$$US-SA-2023SA117702$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240913$$MD$US$US
2221847311$22218473$11$F$20231014$20240829$20230417$20240905$EXP$$CA-GSK-CA2023AMR055049$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$CA$CA
222186172$22218617$2$F$$20240917$20230417$20240926$PER$$US-SA-2023SA040333$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240926$$MD$US$US
222187223$22218722$3$F$20200117$20240702$20230417$20240704$EXP$$CA-TAKEDA-2020TUS004023$TAKEDA$$70$YR$$F$Y$$$20240704$$CN$CA$CA
222187958$22218795$8$F$$20240921$20230417$20240930$EXP$$CA-OTSUKA-2023_009673$OTSUKA$$$$$M$Y$$$20240930$$HP$CA$CA
222188438$22218843$8$F$20230101$20240913$20230417$20240918$EXP$$US-PFIZER INC-202300155836$PFIZER$$63$YR$$F$Y$54.875$KG$20240918$$HP$US$US
222188843$22218884$3$F$$20240724$20230417$20240726$PER$$US-PFIZER INC-202101738564$PFIZER$$63$YR$$F$Y$$$20240726$$MD$US$US
2221919510$22219195$10$F$20200101$20240816$20230417$20240823$EXP$$CO-TAKEDA-2022TUS103770$TAKEDA$$$$$F$Y$64$KG$20240823$$CN$CO$CO
222192032$22219203$2$F$$20240814$20230417$20240817$PER$$NVSC2023US087278$NOVARTIS$$$$$F$Y$$$20240817$$CN$US$US
222192712$22219271$2$F$20221101$20240711$20230417$20240801$PER$$US-SA-2023SA115585$SANOFI AVENTIS$$8$YR$C$M$Y$43.54$KG$20240719$$MD$US$US
222192853$22219285$3$F$$20240812$20230417$20240816$EXP$$GB-MYLANLABS-2023M1040633$MYLAN$$$$$F$Y$$$20240816$$PH$GB$GB
222195402$22219540$2$F$$20230411$20230417$20240822$EXP$$NVSC2023US084941$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
222196084$22219608$4$F$$20240927$20230417$20240930$EXP$$JP-ABBVIE-4731914$ABBVIE$$$$$F$Y$$$20240930$$HP$JP$JP
222198853$22219885$3$F$$20230411$20230417$20240826$EXP$$NVSC2023US084179$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
222199344$22219934$4$F$20220929$20240809$20230417$20240813$PER$$NVSC2023US087606$NOVARTIS$$62$YR$$F$Y$$$20240813$$CN$US$US
222199456$22219945$6$F$20210826$20240327$20230417$20240807$EXP$$NVSC2023CA005577$NOVARTIS$$$$E$M$Y$73$KG$20240807$$CN$CA$CA
222201184$22220118$4$F$20240701$20240918$20230417$20240925$EXP$$CA-TAKEDA-2021TUS048841$TAKEDA$$27$YR$$M$Y$$$20240925$$CN$CA$CA
222202545$22220254$5$F$20230122$20240723$20230417$20240731$EXP$$JP-EMD Serono-9388428$EMD SERONO INC$$72$YR$E$F$Y$45$KG$20240731$$MD$JP$JP
222204862$22220486$2$F$20220922$20240702$20230417$20240715$EXP$$CZ-INCYTE CORPORATION-2023IN003946$INCYTE$$$$$$Y$$$20240715$$MD$CZ$CZ
222208373$22220837$3$F$$20231010$20230418$20240925$PER$$US-LEO Pharma-351247$LEO PHARM$$82$YR$$M$Y$$$20240925$$PH$US$US
222208419$22220841$9$F$20230328$20240704$20230418$20240712$EXP$$IT-CELLTRION INC.-2023IT007647$CELLTRION$$$$$$Y$$$20240712$$MD$IT$IT
222208554$22220855$4$F$$20240827$20230418$20240906$EXP$$DE-AUROBINDO-AUR-APL-2023-030689$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE, et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. Seizure: European Journal of Epilepsy. 2023;107?113$$$N$F$Y$$$20240906$$MD$DE$DE
222208657$22220865$7$F$20180201$20240729$20230418$20240808$EXP$$DE-AUROBINDO-AUR-APL-2023-009952$AUROBINDO$$51$YR$$F$Y$$$20240809$$CN$DE$DE
222209445$22220944$5$F$20230401$20240722$20230418$20240730$PER$$US-SA-2023SA116870$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240730$$CN$US$US
222209504$22220950$4$F$20220101$20240905$20230418$20240918$EXP$$DE-AUROBINDO-AUR-APL-2023-030673$AUROBINDO$$63$YR$$F$Y$119$KG$20240918$$HP$DE$DE
222209643$22220964$3$F$20220610$20240712$20230418$20240813$PER$$CO-TOLMAR, INC.-22CO035229$TOLMAR$$84$YR$$M$Y$67$KG$20240813$$CN$CO$CO
222209873$22220987$3$F$$20240809$20230418$20240821$EXP$$DE-AUROBINDO-AUR-APL-2023-030693$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;1-28:107-113$$$$$Y$$$20240821$$MD$DE$DE
222210604$22221060$4$F$$20240817$20230418$20240828$EXP$$DE-AUROBINDO-AUR-APL-2023-030809$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$4$DY$$$Y$$$20240828$$MD$DE$DE
222213554$22221355$4$F$20170101$20240710$20230418$20240720$EXP$$US-TEVA-2023-US-2875840$TEVA$$30$YR$$M$Y$$$20240720$$CN$US$US
2222138612$22221386$12$F$20230101$20240704$20230418$20240711$EXP$$CA-CELLTRION INC.-2023CA007925$CELLTRION$$$$$$Y$$$20240711$$CN$CA$CA
222215013$22221501$3$F$$20240730$20230418$20240807$EXP$$AT-TEVA-2023-AT-2877000$TEVA$$$$A$M$Y$$$20240807$$MD$AT$AT
222215513$22221551$3$F$$20240828$20230418$20240906$EXP$$DE-AUROBINDO-AUR-APL-2023-030814$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. European Journal of Epilepsy. 2023;107:1-28, 107-13$3$DY$$F$Y$$$20240906$$MD$DE$DE
222216223$22221622$3$F$$20240806$20230418$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02861$LUPIN$$$$$$Y$$$20240828$$CN$US$US
2222166619$22221666$19$F$20201202$20240814$20230418$20240822$EXP$$CA-CELLTRION INC.-2022CA019281$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
222216682$22221668$2$F$20230314$20240704$20230418$20240711$EXP$$FR-AUROBINDO-AUR-APL-2023-030566$AUROBINDO$$3$YR$$M$Y$12$KG$20240711$$MD$FR$FR
2222171812$22221718$12$F$20240522$20240906$20230418$20240912$EXP$$US-TAKEDA-2022TUS061184$TAKEDA$$6$YR$$M$Y$$$20240912$$MD$US$US
222217634$22221763$4$F$20230216$20240801$20230418$20240808$EXP$$JP-EMD Serono-9396716$EMD SERONO INC$$76$YR$E$F$Y$51$KG$20240808$$HP$JP$JP
222218422$22221842$2$F$$20240828$20230418$20240912$EXP$$CA-BAXTER-2023BAX018141$BAXTER$$56$YR$$F$Y$$$20240912$$CN$CA$CA
222218722$22221872$2$F$20230410$20240729$20230418$20240803$PER$$US-AMGEN-USASP2023062633$AMGEN$$73$YR$E$F$Y$$$20240803$$CN$US$US
222218854$22221885$4$F$20210101$20240714$20230418$20240718$EXP$$CA-BAUSCH-BL-2021-035398$BAUSCH AND LOMB$$37$YR$$F$Y$100$KG$20240718$$CN$CA$CA
222218973$22221897$3$F$20230410$20240917$20230418$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-051695$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240918$$CN$US$US
222219073$22221907$3$F$$20240726$20230418$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02866$LUPIN$$$$$F$Y$54.42$KG$20240817$$CN$US$US
222219833$22221983$3$F$$20240913$20230418$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02867$LUPIN$$$$$$Y$$$20240927$$CN$US$US
222220893$22222089$3$F$$20240918$20230418$20240930$PER$$NVSC2023US088037$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
222221094$22222109$4$F$20220726$20240722$20230418$20240729$EXP$$AU-TAKEDA-2022TUS030081$TAKEDA$$53$YR$$M$Y$$$20240729$$HP$AU$AU
222221305$22222130$5$F$20230708$20240906$20230418$20240910$EXP$$US-TAKEDA-2023TUS038760$TAKEDA$$0$YR$$M$Y$$$20240910$$CN$US$US
222221965$22222196$5$F$20230404$20240812$20230418$20240816$30DAY$$US-PFIZER INC-202300147803$PFIZER$$7$YR$$M$Y$45.4$KG$20240816$$CN$US$US
2222220914$22222209$14$F$20230101$20240801$20230418$20240807$EXP$$GB-ABBVIE-4732295$ABBVIE$$69$YR$$M$Y$$$20240807$$CN$GB$GB
222223256$22222325$6$F$20210101$20240701$20230418$20240709$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-002733$AMGEN$$50$YR$A$F$Y$63.7$KG$20240709$$MD$US$US
222224692$22222469$2$F$$20240819$20230418$20240826$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385097$RANBAXY$Dammacco R, Lisch W, Kivela TT, Terpos E, Kastritis E, Sisto D, et al. The Spectrum of Ocular Manifestations in Patients with Waldenstrom^s Macroglobulinemia. Ocular Immunol Inflamm. 2021;30 (7-8):1659-1668$70$YR$$M$Y$$$20240826$$MD$IT$IT
222224752$22222475$2$F$$20240829$20230418$20240904$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385077$RANBAXY$Teufel LU, van der Made CI, Kluck V, Simons A, Hoischen A, Vernimmen V, et al. Effect of exogenous IL-37 on immune cells from a patient carrying a potential IL37 loss-of-function variant: A case study. Cytokine. 2023;162:156102(1-11)$50$YR$$M$Y$$$20240904$$HP$NL$NL
222224853$22222485$3$F$20220101$20240315$20230418$20240830$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385180$RANBAXY$-. -. -. -;-:-$12$YR$$F$Y$29.4$KG$20240831$$CN$US$US
2222248811$22222488$11$F$20200101$20240822$20230418$20240906$EXP$$CA-SUNPHARMA-2023R1-384108AA$RANBAXY$$$$A$F$Y$$$20240906$$HP$CA$CA
222227108$22222710$8$F$20230101$20240904$20230418$20240911$EXP$$JP-009507513-2302JPN002326J$MERCK$$5$DEC$$F$Y$$$20240911$$MD$JP$JP
222228822$22222882$2$F$$20240726$20230418$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02873$LUPIN$$$$$$Y$$$20240816$$CN$US$US
222229392$22222939$2$F$$20240805$20230418$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02885$LUPIN$$$$$$Y$$$20240822$$PH$US$US
222229773$22222977$3$F$$20231003$20230418$20240720$EXP$$CA-JNJFOC-20230423801$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240719$$HP$CA$CA
2222322112$22223221$12$F$20230411$20240925$20230418$20240930$EXP$$GB-MYLANLABS-2023M1040782$MYLAN$$55$YR$$M$Y$$$20240930$$CN$GB$GB
222234074$22223407$4$F$$20240814$20230418$20240822$PER$$US-PFIZER INC-PV202300050606$PFIZER$$67$YR$$F$Y$$$20240822$$HP$US$US
222234549$22223454$9$F$20230101$20240806$20230418$20240812$EXP$$CA-PFIZER INC-202300049335$PFIZER$$25$YR$$F$Y$81.633$KG$20240812$$MD$CA$CA
222236455$22223645$5$F$20230101$20240620$20230418$20240701$PER$$US-SA-2023SA118225$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240701$$MD$US$US
222236573$22223657$3$F$20230101$20240709$20230418$20240711$EXP$$US-BAUSCH-BL-2023-002980$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240711$$CN$US$US
222236963$22223696$3$F$$20230111$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001776$SUNOVION$$$$$F$Y$81.179$KG$20240728$$CN$US$US
222236982$22223698$2$F$$20221228$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202211-URV-001679$SUNOVION$$71$YR$$M$Y$$$20240728$$CN$US$US
222237024$22223702$4$F$20221201$20230414$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001786$SUNOVION$$83$YR$$F$Y$$$20240728$$CN$US$US
222237762$22223776$2$F$$20221227$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001830$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222237772$22223777$2$F$$20221227$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001834$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222237782$22223778$2$F$$20221228$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001835$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222237792$22223779$2$F$$20221229$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001837$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222237802$22223780$2$F$$20230111$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001832$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222237813$22223781$3$F$20221212$20230124$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001805$SUNOVION$$78$YR$$M$Y$90.703$KG$20240728$$CN$US$US
222237822$22223782$2$F$20221221$20230202$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001824$SUNOVION$$72$YR$$M$Y$97.506$KG$20240728$$CN$US$US
222237833$22223783$3$F$$20230118$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001813$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222237852$22223785$2$F$$20230105$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001822$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222237862$22223786$2$F$$20230103$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000003$SUNOVION$$$$$F$Y$56.689$KG$20240728$$CN$US$US
222237872$22223787$2$F$$20221222$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001827$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222237883$22223788$3$F$$20221230$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001800$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222237892$22223789$2$F$$20221221$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001825$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222237902$22223790$2$F$$20221222$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001826$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222237912$22223791$2$F$$20230126$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001829$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222237922$22223792$2$F$$20221221$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001823$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222237932$22223793$2$F$$20221222$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001828$SUNOVION$$$$$$Y$$$20240728$$CN$US$US
222237953$22223795$3$F$20220810$20230120$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202212-URV-001811$SUNOVION$$79$YR$$M$Y$$$20240728$$CN$US$US
222237992$22223799$2$F$$20230106$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000019$SUNOVION$$$$$F$Y$79.365$KG$20240728$$CN$US$US
222238002$22223800$2$F$20221215$20230106$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000014$SUNOVION$$49$YR$$F$Y$107.03$KG$20240728$$CN$US$US
222238012$22223801$2$F$$20230110$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000028$SUNOVION$$$$$F$Y$43.084$KG$20240728$$CN$US$US
222238022$22223802$2$F$$20230103$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000005$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238032$22223803$2$F$$20230105$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000007$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238042$22223804$2$F$$20230105$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000009$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238052$22223805$2$F$$20230105$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000011$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238062$22223806$2$F$$20230105$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000010$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238072$22223807$2$F$$20230109$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000025$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238082$22223808$2$F$$20230104$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000006$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238092$22223809$2$F$$20230109$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000023$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238102$22223810$2$F$$20230106$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000017$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238112$22223811$2$F$$20230106$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000015$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238122$22223812$2$F$$20230109$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000024$SUNOVION$$45$YR$$F$Y$$$20240728$$CN$US$US
222238132$22223813$2$F$$20230106$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000020$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238142$22223814$2$F$$20230109$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000026$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238152$22223815$2$F$$20230106$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000021$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238162$22223816$2$F$$20230120$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000012$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238172$22223817$2$F$$20230105$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000013$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238182$22223818$2$F$$20230109$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000022$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238352$22223835$2$F$$20230112$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000044$SUNOVION$$5$DEC$$F$Y$$$20240728$$CN$US$US
222238362$22223836$2$F$$20230113$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000049$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238372$22223837$2$F$$20230110$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000029$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238382$22223838$2$F$$20230111$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000035$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238392$22223839$2$F$$20230111$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000033$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238412$22223841$2$F$$20230111$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000040$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238422$22223842$2$F$$20230117$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000056$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238432$22223843$2$F$$20230111$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000037$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238442$22223844$2$F$20230112$20230113$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000047$SUNOVION$$83$YR$$F$Y$75.737$KG$20240728$$CN$US$US
222238462$22223846$2$F$$20230112$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000043$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238472$22223847$2$F$$20230111$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000039$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238482$22223848$2$F$$20230110$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000030$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238492$22223849$2$F$$20230111$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000041$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238502$22223850$2$F$$20230117$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000055$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238512$22223851$2$F$$20230123$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000048$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238522$22223852$2$F$$20230111$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000036$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238532$22223853$2$F$$20230112$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000042$SUNOVION$$98$YR$$M$Y$$$20240728$$CN$US$US
222238542$22223854$2$F$20230101$20230220$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000034$SUNOVION$$91$YR$$F$Y$$$20240728$$CN$US$US
222238552$22223855$2$F$$20230112$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000046$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238562$22223856$2$F$$20230111$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000038$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238632$22223863$2$F$$20230118$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000065$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238662$22223866$2$F$$20230119$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000069$SUNOVION$$$$$F$Y$72.562$KG$20240728$$CN$US$US
222238672$22223867$2$F$20221001$20230120$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000077$SUNOVION$$61$YR$$F$Y$$$20240728$$CN$US$US
222238682$22223868$2$F$$20230118$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000064$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238693$22223869$3$F$$20230118$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000062$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238702$22223870$2$F$$20230119$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000071$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238712$22223871$2$F$$20230118$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000061$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238802$22223880$2$F$$20230118$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000063$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238812$22223881$2$F$$20230117$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000057$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238822$22223882$2$F$20230117$20230119$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000070$SUNOVION$$75$YR$$F$Y$54.422$KG$20240728$$CN$US$US
222238832$22223883$2$F$$20230118$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000067$SUNOVION$$83$YR$$F$Y$$$20240728$$$US$US
222238842$22223884$2$F$$20230120$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000075$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238852$22223885$2$F$$20230210$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000058$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222238862$22223886$2$F$$20230120$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000074$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238873$22223887$3$F$$20230118$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000068$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238883$22223888$3$F$$20230118$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000066$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238893$22223889$3$F$20230116$20230118$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000060$SUNOVION$$78$YR$$F$Y$73.016$KG$20240728$$CN$US$US
222238902$22223890$2$F$$20230123$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000080$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238912$22223891$2$F$$20230117$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000059$SUNOVION$$77$YR$$F$Y$$$20240728$$CN$US$US
222238922$22223892$2$F$$20230120$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000076$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222238992$22223899$2$F$$20230124$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000090$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239002$22223900$2$F$$20230306$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000084$SUNOVION$$$$$$Y$$$20240728$$CN$US$US
222239012$22223901$2$F$$20230125$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000091$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239022$22223902$2$F$$20230306$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000087$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239032$22223903$2$F$$20230122$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000085$SUNOVION$$84$YR$$F$Y$$$20240728$$CN$US$US
222239042$22223904$2$F$$20230127$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000102$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222239052$22223905$2$F$$20230124$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000089$SUNOVION$$$$$$Y$$$20240728$$CN$US$US
222239062$22223906$2$F$$20230123$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000082$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222239072$22223907$2$F$$20230123$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000083$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239082$22223908$2$F$$20230127$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000100$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239092$22223909$2$F$$20230121$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000081$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239102$22223910$2$F$$20230223$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000088$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239112$22223911$2$F$$20230127$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000096$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239122$22223912$2$F$$20230127$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000097$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239132$22223913$2$F$$20230127$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000101$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222239143$22223914$3$F$$20230126$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000095$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239152$22223915$2$F$$20230125$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000092$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239162$22223916$2$F$20230101$20230127$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000094$SUNOVION$$84$YR$$M$Y$$$20240728$$CN$US$US
222239172$22223917$2$F$$20230127$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000099$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239212$22223921$2$F$20230101$20230130$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000108$SUNOVION$$$$$M$Y$$$20240728$$MD$US$US
222239222$22223922$2$F$$20230127$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000105$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239232$22223923$2$F$$20230131$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000114$SUNOVION$$80$YR$$M$Y$$$20240728$$CN$US$US
222239242$22223924$2$F$$20230127$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000103$SUNOVION$$$$$$Y$$$20240728$$CN$US$US
222239252$22223925$2$F$$20230303$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000124$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239262$22223926$2$F$$20230227$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000126$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239272$22223927$2$F$$20230130$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000107$SUNOVION$$$$$F$Y$59.864$KG$20240728$$CN$US$US
222239282$22223928$2$F$$20230131$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000117$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222239292$22223929$2$F$$20230131$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000116$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239302$22223930$2$F$20230101$20230130$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000111$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222239312$22223931$2$F$$20230131$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000112$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222239322$22223932$2$F$$20230201$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000121$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239332$22223933$2$F$$20230201$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000123$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239342$22223934$2$F$$20230202$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000125$SUNOVION$$80$YR$$F$Y$$$20240728$$CN$US$US
222239352$22223935$2$F$$20230131$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000113$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239362$22223936$2$F$$20230130$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000110$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239372$22223937$2$F$$20230130$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000109$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222239382$22223938$2$F$$20230130$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000115$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239392$22223939$2$F$20230129$20230201$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000119$SUNOVION$$81$YR$$F$Y$53.968$KG$20240728$$CN$US$US
222239402$22223940$2$F$$20230128$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202301-URV-000106$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222239482$22223948$2$F$$20230203$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000131$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239492$22223949$2$F$$20230203$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000130$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239512$22223951$2$F$$20230202$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000127$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222239542$22223954$2$F$$20230206$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000165$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222239562$22223956$2$F$$20230203$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000146$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222239692$22223969$2$F$$20230206$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000168$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222240192$22224019$2$F$$20230208$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000200$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222240232$22224023$2$F$$20230207$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000191$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222240452$22224045$2$F$$20230210$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000216$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222240502$22224050$2$F$$20230210$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000219$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222240642$22224064$2$F$$20230215$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000233$SUNOVION$$$$$$Y$$$20240728$$CN$US$US
222240742$22224074$2$F$$20230216$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000242$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222240812$22224081$2$F$$20230215$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000243$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222240822$22224082$2$F$$20230216$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000239$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
2222412712$22224127$12$F$20230401$20240830$20230418$20240905$EXP$$CO-TAKEDA-2023TUS038763$TAKEDA$$4$YR$$F$Y$14$KG$20240905$$CN$CO$CO
222241292$22224129$2$F$$20230221$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000261$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222241442$22224144$2$F$$20230223$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000272$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222241452$22224145$2$F$$20230222$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000271$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222241483$22224148$3$F$$20230322$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000266$SUNOVION$$$$$F$Y$82.086$KG$20240728$$CN$US$US
222241562$22224156$2$F$$20230224$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000285$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222241643$22224164$3$F$$20230324$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000289$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222241672$22224167$2$F$$20230224$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000282$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222241742$22224174$2$F$$20230228$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000299$SUNOVION$$$$$F$Y$68.027$KG$20240728$$CN$US$US
222241852$22224185$2$F$$20230306$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000323$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222241892$22224189$2$F$$20230302$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000316$SUNOVION$$$$$$Y$$$20240728$$CN$US$US
222241902$22224190$2$F$$20230301$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000314$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222241912$22224191$2$F$20230201$20230302$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000315$SUNOVION$$56$YR$$F$Y$$$20240728$$HP$US$US
222241922$22224192$2$F$$20230303$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000320$SUNOVION$$$$$$Y$$$20240728$$CN$US$US
222241942$22224194$2$F$$20230302$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000319$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222241952$22224195$2$F$$20230228$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000307$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222241972$22224197$2$F$$20230228$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202302-URV-000305$SUNOVION$$70$YR$$F$Y$$$20240728$$CN$US$US
222242282$22224228$2$F$20230201$20230310$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000401$SUNOVION$$59$YR$$F$Y$53.968$KG$20240728$$CN$US$US
222242292$22224229$2$F$$20230309$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000398$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222242312$22224231$2$F$$20230307$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000368$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222242432$22224243$2$F$$20230313$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000410$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222242442$22224244$2$F$$20230314$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000422$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222242472$22224247$2$F$$20230313$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000418$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222242502$22224250$2$F$20230301$20230313$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000406$SUNOVION$$70$YR$$M$Y$83.9$KG$20240728$$CN$US$US
222242572$22224257$2$F$$20230313$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000411$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222242662$22224266$2$F$$20230314$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000429$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222242682$22224268$2$F$$20230316$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000439$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222242742$22224274$2$F$$20230314$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000425$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222242812$22224281$2$F$$20230314$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000424$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222243062$22224306$2$F$$20230320$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000453$SUNOVION$$$$$F$Y$$$20240728$$CN$US$US
222243243$22224324$3$F$$20230403$20230418$20240728$PER$$US-UROVANT SCIENCES GMBH-202303-URV-000459$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
222244202$22224420$2$F$$20240801$20230418$20240812$PER$$US-SA-2023SA117133$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240812$$MD$US$US
222244522$22224452$2$F$$20230412$20230418$20240822$EXP$$NVSC2023US086088$NOVARTIS$$$$$M$Y$$$20240822$$CN$US$US
222250984$22225098$4$F$20230101$20240806$20230418$20240812$EXP$$CA-BAUSCH-BL-2021-035835$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240812$$CN$CA$CA
2222520410$22225204$10$F$20230913$20240926$20230418$20240930$EXP$$US-PAREXEL-2021-KAM-US003327$TAKEDA$$84$YR$$M$Y$80$KG$20240930$$HP$US$US
2222533510$22225335$10$F$20230510$20240625$20230418$20240704$EXP$$JP-ABBVIE-4732830$ABBVIE$$57$YR$$M$Y$$$20240704$$CN$JP$JP
222259502$22225950$2$F$20230101$20230414$20230419$20240925$PER$$US-GSK-US2023AMR055915$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
222259525$22225952$5$F$$20240829$20230419$20240909$EXP$$DE-AUROBINDO-AUR-APL-2023-030709$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M,Beyersmann JE et al.. Increasing use of newer antiseizuremedication during pregnancy: An observational study withspecial focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;1-28:107-113$$$N$$Y$$$20240909$$MD$DE$DE
222260004$22226000$4$F$$20240906$20230419$20240916$EXP$$CA-INTERCEPT-PM2023000727$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240916$$MD$CA$CA
222261434$22226143$4$F$$20240807$20230419$20240812$EXP$$IN-PFIZER INC-202101484528$PFIZER$$80$YR$$F$Y$$$20240812$$CN$IN$IN
2222619615$22226196$15$F$20230401$20240708$20230419$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-054503$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240718$$CN$US$US
222262285$22226228$5$F$$20240831$20230419$20240910$EXP$$DE-AUROBINDO-AUR-APL-2023-030818$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. European Journal of Epilepsy. 2023;107:107-113$$$N$F$Y$$$20240910$$MD$DE$DE
222262295$22226229$5$F$$20240829$20230419$20240909$EXP$$DE-AUROBINDO-AUR-APL-2023-031033$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. European Journal of Epilepsy.. 2023;1-28$$$N$$Y$$$20240909$$MD$DE$DE
222262764$22226276$4$F$$20240830$20230419$20240909$EXP$$DE-AUROBINDO-AUR-APL-2023-030688$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. European Journal of Epilepsy.. 2023;107:107?113$$$N$$Y$$$20240909$$MD$DE$DE
222262948$22226294$8$F$20220401$20240805$20230419$20240809$EXP$$DE-ROCHE-3163421$ROCHE$$51$YR$A$F$Y$$$20240809$$CN$DE$DE
222263153$22226315$3$F$$20240729$20230419$20240809$EXP$$JP-ROCHE-3330670$ROCHE$Teketani K, Ikeda S F. A Case of Tumour Lysis Syndrome Which Developed Following Chemotherapy for Hormone Receptor-negative and HER2-positive Advanced Breast Cancer.. The 20th Annual Meeting of Japanese Society of Medical Oncology.. 2023;338.$5$DEC$A$F$Y$$$20240809$$MD$JP$JP
2222645416$22226454$16$F$20230101$20240917$20230419$20240926$EXP$$CA-CELLTRION INC.-2023CA005994$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
222266662$22226666$2$F$20230404$20240918$20230419$20240930$PER$$NVSC2023US089206$NOVARTIS$$65$YR$$F$Y$70.748$KG$20240930$$CN$US$US
222267132$22226713$2$F$20230412$20240910$20230419$20240920$PER$$US-SA-2023SA119476$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240920$$MD$US$US
222267482$22226748$2$F$20230301$20240722$20230419$20240728$EXP$$US-SA-2023SA118820$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240728$$MD$US$US
222268072$22226807$2$F$$20240819$20230419$20240826$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385296$RANBAXY$Cai Y, Zhang J, Yi M, Zhang W, Liu X, Zhang X, et al. Short?term efficacy of decitabine?based therapy in JMML: a retrospective study from a single center in China. Int J Hematol. 2023;117(1):121-127$20$YR$$M$Y$$$20240826$$HP$CN$CN
222269386$22226938$6$F$20190924$20240730$20230419$20240807$EXP$$DE-ROCHE-2423546$ROCHE$$50$YR$A$F$Y$$$20240807$$CN$DE$DE
222270256$22227025$6$F$$20240918$20230419$20240925$EXP$$NVSC2023US089410$NOVARTIS$$$$$F$Y$$$20240925$$MD$US$US
222270394$22227039$4$F$20230311$20240807$20230419$20240814$EXP$$US-UCBSA-2023003671$UCB$$74$YR$$M$Y$$$20240814$$CN$US$US
222271112$22227111$2$F$$20240715$20230419$20240722$PER$$US-SA-2023SA118509$SANOFI AVENTIS$$$$T$M$Y$$$20240721$$MD$US$US
222272872$22227287$2$F$$20240913$20230419$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02913$LUPIN$$$$$$Y$$$20240927$$CN$US$US
222273172$22227317$2$F$$20240722$20230419$20240731$PER$$US-SA-2023SA119932$SANOFI AVENTIS$$$$A$F$Y$102.05$KG$20240731$$MD$US$US
222274563$22227456$3$F$$20240913$20230419$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02914$LUPIN$$$$$$Y$$$20240927$$CN$US$US
222274693$22227469$3$F$20230712$20240828$20230419$20240902$EXP$$CA-TAKEDA-2023TUS039122$TAKEDA$$50$YR$$F$Y$$$20240902$$MD$CA$CA
222276182$22227618$2$F$$20240716$20230419$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385161$RANBAXY$Youykheang M, Hallaq ZA, Menelas K, Biskin RS, Dagenais-Beaule V. Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders-A Systematic Review of the Literature and Case Series. J Clin Psychopharmacol. 2023;Jan/Feb; 43(1):20-27$32$YR$$F$Y$$$20240718$$PH$CA$CA
222276252$22227625$2$F$$20240826$20230419$20240904$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385160$RANBAXY$Youykheang M, Hallaq ZA, Menelas K, Biskin RS, Dagenais-Beaule V. Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders-A Systematic Review of the Literature and Case Series. J Clin Psychopharmacol. 2023;Jan/Feb; 43(1):20-27$49$YR$$M$Y$$$20240904$$PH$CA$CA
222276272$22227627$2$F$$20240819$20230419$20240826$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385294$RANBAXY$Cai Y, Zhang J, Yi M, Zhang W, Liu X, Zhang X, et al. Short?term efficacy of decitabine?based therapy in JMML: a retrospective study from a single center in China. Int J Hematol. 2023;117(1):121-127$15$YR$$M$Y$$$20240826$$HP$CN$CN
222276292$22227629$2$F$$20240715$20230419$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385101$RANBAXY$Braunstein ED, Chugh SS, Makkar RR, Ehdaie A, Shehata M, Wang X. Catheter ablation of typical and atypical atrial flutters in a patient with transcatheter tricuspid valve replacement. HeartRhythm Case Rep. 2023;Feb;9(2):105-108$71$YR$$F$Y$$$20240730$$MD$US$US
222276392$22227639$2$F$20230220$20240708$20230419$20240709$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-384736$RANBAXY$$84$YR$$F$Y$$$20240709$$MD$FR$FR
222276472$22227647$2$F$20230203$20240728$20230419$20240729$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-384904$RANBAXY$$18$YR$$F$Y$48$KG$20240729$$PH$FR$FR
2222766410$22227664$10$F$20230406$20240918$20230419$20240923$30DAY$$US-PFIZER INC-PV202300064936$PFIZER$$13$YR$$M$Y$52.62$KG$20240923$$CN$US$US
222278184$22227818$4$F$20221201$20230517$20230419$20240717$EXP$$HU-ASTELLAS-2023US010488$ASTELLAS$$59$YR$$F$Y$$$20240717$$MD$HU$HU
222278203$22227820$3$F$20230101$20240819$20230419$20240821$PER$$US-AMGEN-USASP2023066723$AMGEN$$33$YR$A$M$Y$$$20240821$$HP$US$US
222280352$22228035$2$F$$20240823$20230419$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02936$LUPIN$$$$$$Y$$$20240911$$CN$US$US
222280762$22228076$2$F$20200206$20240807$20230419$20240808$EXP$$US-SHIRE-US202005161$TAKEDA$$47$YR$$F$Y$$$20240808$$HP$US$US
222281313$22228131$3$F$$20240802$20230419$20240807$EXP$$US-TAKEDA-US202033274$TAKEDA$$$$$F$Y$$$20240807$$HP$US$US
222281583$22228158$3$F$20240714$20240813$20230419$20240816$EXP$$US-TAKEDA-2023TUS033278$TAKEDA$$71$YR$$F$Y$$$20240816$$CN$US$US
222282912$22228291$2$F$$20240827$20230419$20240909$PER$$US-SA-2023SA121456$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240909$$MD$US$US
222283153$22228315$3$F$$20240823$20230419$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02950$LUPIN$$$$$$Y$$$20240913$$CN$US$US
222283393$22228339$3$F$$20240807$20230419$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02951$LUPIN$$$$$$Y$$$20240829$$CN$US$US
222284822$22228482$2$F$$20240705$20230419$20240712$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2020-26382$IPSEN$$85$YR$E$F$Y$$$20240712$$CN$GB$GB
222285304$22228530$4$F$$20240814$20230419$20240819$PER$$US-PFIZER INC-PV202300070319$PFIZER$$67$YR$$F$Y$$$20240819$$CN$US$US
222286496$22228649$6$F$$20240401$20230419$20240909$PER$$US-BEH-2023157520$CSL BEHRING$$65$YR$E$F$Y$$$20240909$$CN$US$US
222286582$22228658$2$F$20230411$20240709$20230419$20240711$EXP$$US-TAKEDA-2023TUS039401$TAKEDA$$9$YR$$M$Y$$$20240711$$PH$US$US
222286753$22228675$3$F$20230201$20240813$20230419$20240823$EXP$FR-AFSSAPS-RN2023000299$FR-TEVA-2023-FR-2878118$TEVA$$55$YR$$M$Y$$$20240823$$MD$FR$FR
222287197$22228719$7$F$$20240709$20230419$20240711$PER$$US-PFIZER INC-PV202300069168$PFIZER$$81$YR$$F$Y$$$20240711$$CN$US$US
222287409$22228740$9$F$20230324$20240903$20230419$20240906$EXP$$US-TAKEDA-2023TUS039175$TAKEDA$$9$YR$$M$Y$$$20240906$$MD$US$US
222288825$22228882$5$F$$20240923$20230419$20240926$EXP$$US-PFIZER INC-PV202300070216$PFIZER$$68$YR$$F$Y$89.81$KG$20240926$$CN$US$US
222288863$22228886$3$F$20230817$20240822$20230419$20240826$EXP$$CA-TAKEDA-2023TUS039330$TAKEDA$$22$YR$$F$Y$$$20240826$$CN$CA$CA
222290753$22229075$3$F$$20240704$20230419$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03003$LUPIN$$$$$$Y$$$20240728$$CN$US$US
222292812$22229281$2$F$$20240702$20230419$20240708$EXP$$CA-PFIZER INC-202300159559$PFIZER$$4$YR$$M$Y$15$KG$20240708$$HP$CA$CA
222296234$22229623$4$F$20230313$20240819$20230419$20240827$EXP$$DE-TAKEDA-2023TUS039363$TAKEDA$$23$YR$$M$Y$57$KG$20240827$$MD$DE$DE
222297594$22229759$4$F$$20240730$20230419$20240813$EXP$$TR-BAYER-2023A051784$BAYER$$24$YR$A$M$Y$63.5$KG$20240813$$CN$TR$TR
222298874$22229887$4$F$20230115$20240826$20230419$20240831$EXP$$US-TAKEDA-2023TUS005093$TAKEDA$$68$YR$$F$Y$104$KG$20240831$$CN$US$US
222300133$22230013$3$F$20190604$20240829$20230419$20240902$EXP$$CA-TAKEDA-2022TUS080216$TAKEDA$$68$YR$$F$Y$$$20240902$$MD$CA$CA
222304716$22230471$6$F$20171219$20240908$20230419$20240916$EXP$$CA-CELLTRION INC.-2018CA017427$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
222305768$22230576$8$F$20210513$20240712$20230420$20240722$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2021-15362$IPSEN$$70$YR$E$M$Y$$$20240722$$MD$JP$JP
222306053$22230605$3$F$20180426$20240607$20230420$20240702$EXP$$JP-ABBVIE-18P-087-2555129-00$ABBVIE$$57$YR$$M$Y$75$KG$20240702$$MD$JP$JP
222306283$22230628$3$F$$20240727$20230420$20240731$EXP$$GB-TAKEDA-2023TUS039473$TAKEDA$$$$$F$Y$$$20240731$$CN$GB$GB
2223065516$22230655$16$F$20221213$20240717$20230420$20240722$EXP$$CH-ABBVIE-4734712$ABBVIE$$72$YR$$M$Y$85$KG$20240722$$MD$CH$CH
222306625$22230662$5$F$20230330$20240822$20230420$20240912$PER$$CA-TOLMAR, INC.-23CA040098$TOLMAR$$62$YR$$M$Y$$$20240912$$CN$CA$CA
222306664$22230666$4$F$$20240626$20230420$20240716$PER$$CA-TOLMAR, INC.-23CA040100$TOLMAR$$$$$M$Y$$$20240715$$CN$CA$CA
222306896$22230689$6$F$20230101$20240708$20230420$20240712$EXP$$CA-JNJFOC-20230411384$JOHNSON AND JOHNSON$$10$YR$C$F$Y$43$KG$20240712$$CN$CA$CA
222307165$22230716$5$F$20240619$20240812$20230420$20240814$EXP$$CA-ROCHE-3331273$ROCHE$$66$YR$E$M$Y$$$20240814$$CN$CA$CA
222307723$22230772$3$F$$20240830$20230420$20240909$EXP$$FR-CELLTRION INC.-2023FR007909$CELLTRION$Breillat P, Mathian A, Rozenberg F, Dutheil A, Barbaud A, Amoura Z et al.. Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?. Lupus. 2023;32(3):453-455$$$$$Y$$$20240909$$HP$FR$FR
222308062$22230806$2$F$$20240823$20230420$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03002$LUPIN$$$$$$Y$$$20240912$$CN$US$US
222308674$22230867$4$F$$20240817$20230420$20240828$EXP$$DE-AUROBINDO-AUR-APL-2023-030796$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$A$F$Y$$$20240828$$MD$DE$DE
2223086814$22230868$14$F$20220101$20240819$20230420$20240827$EXP$$CA-CELLTRION INC.-2022CA016330$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
2223087410$22230874$10$F$20220101$20240711$20230420$20240720$EXP$$CA-CELLTRION INC.-2022CA007254$CELLTRION$$$$$$Y$$$20240720$$CN$CA$CA
222308812$22230881$2$F$$20240628$20230420$20240710$EXP$$IN-ROCHE-3287054$ROCHE$$63$YR$A$M$Y$$$20240710$$MD$IN$IN
222310057$22231005$7$F$20230101$20240827$20230420$20240904$EXP$$CA-CELLTRION INC.-2023CA006199$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
222311024$22231102$4$F$20230405$20230915$20230420$20240925$PER$$US-GSK-US2023AMR056719$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
222312103$22231210$3$F$$20240821$20230420$20240827$PER$$US-PHARMING-PHAUS2023000272$PHARMING GROUP$$$$$$Y$$$20240827$$CN$US$US
222312352$22231235$2$F$20210101$20240906$20230420$20240917$EXP$$US-NOVOPROD-1049827$NOVO NORDISK$$50$YR$$F$Y$$$20240917$$CN$US$US
222312772$22231277$2$F$20050101$20240826$20230420$20240904$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-385083$RANBAXY$$35$YR$$F$Y$$$20240904$$CN$FR$FR
222312862$22231286$2$F$$20240806$20230420$20240812$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385165$RANBAXY$Youykheang M, Hallaq ZA, Menelas K, Biskin RS, Dagenais-Beaule V. Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders-A Systematic Review of the Literature and Case Series. J Clin Psychopharmacol. 2023;Jan/Feb; 43(1):20-27$37$YR$$F$Y$$$20240812$$PH$CA$CA
222312902$22231290$2$F$$20240721$20230420$20240726$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385164$RANBAXY$Youykheang M, Hallaq ZA, Menelas K, Biskin RS, Dagenais-Beaule V. Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders-A Systematic Review of the Literature and Case Series. J Clin Psychopharmacol. 2023;Jan/Feb; 43(1):20-27$37$YR$$F$Y$$$20240727$$PH$CA$CA
222315086$22231508$6$F$$20240822$20230420$20240830$PER$$US-ROCHE-3314998$ROCHE$$35$YR$A$M$Y$77.11$KG$20240830$$CN$US$US
222315487$22231548$7$F$20230401$20240813$20230420$20240816$PER$$US-BIOGEN-2022BI01169288$BIOGEN$$58$YR$$F$Y$$$20240816$$CN$US$US
222315782$22231578$2$F$20230310$20240725$20230420$20240805$EXP$FR-AFSSAPS-PV2023000359$FR-BAXTER-2023BAX018651$BAXTER$$14$YR$$F$Y$54$KG$20240804$$MD$FR$FR
222316586$22231658$6$F$$20240822$20230420$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02957$LUPIN$$$$$$Y$$$20240909$$CN$US$US
222320104$22232010$4$F$$20240717$20230420$20240725$PER$$US-SA-2023SA120630$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240725$$MD$US$US
222320133$22232013$3$F$$20240823$20230420$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02956$LUPIN$$$$$$Y$$$20240910$$CN$US$US
222322462$22232246$2$F$20230101$20240724$20230420$20240802$PER$$US-SA-2023SA120695$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240802$$MD$US$US
222325744$22232574$4$F$$20240704$20230420$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02982$LUPIN$$$$$$Y$$$20240728$$CN$US$US
222337752$22233775$2$F$$20240802$20230420$20240808$PER$$US-VERTEX PHARMACEUTICALS-2023-005387$VERTEX$$$$$F$Y$$$20240808$$CN$US$US
222337815$22233781$5$F$20210101$20240730$20230420$20240802$PER$$US-VERTEX PHARMACEUTICALS-2023-005382$VERTEX$$$$$F$Y$$$20240802$$CN$US$US
222338574$22233857$4$F$20230210$20240711$20230420$20240712$EXP$$US-TAKEDA-2023TUS020295$TAKEDA$$40$YR$$M$Y$$$20240712$$CN$US$US
222338625$22233862$5$F$$20240723$20230420$20240724$EXP$$CA-ORGANON-O2304CAN000184$ORGANON$$65$YR$$F$Y$34$KG$20240724$$HP$CA$CA
222339442$22233944$2$F$20230301$20240826$20230420$20240902$EXP$$US-GSK-US2023054202$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
222339852$22233985$2$F$$20240703$20230420$20240715$PER$$US-ROCHE-3133289$ROCHE$$$$E$M$Y$$$20240716$$CN$US$US
222340693$22234069$3$F$20230718$20240709$20230420$20240716$PER$$US-SA-2023SA120639$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240716$$MD$US$US
222340703$22234070$3$F$20240725$20240808$20230420$20240815$PER$$US-SA-2023SA120823$SANOFI AVENTIS$$52$YR$A$M$Y$81.6$KG$20240815$$MD$US$US
222344069$22234406$9$F$$20240731$20230420$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007591$JAZZ$$$$$M$Y$68.027$KG$20240808$$MD$US$US
222345743$22234574$3$F$20240710$20240715$20230420$20240717$EXP$$CA-UCBSA-2021040340$UCB$$30$YR$$F$Y$$$20240717$$CN$CA$CA
222346209$22234620$9$F$$20240917$20230420$20240924$EXP$$CA-TAKEDA-2022TUS001880$TAKEDA$$$$$F$Y$$$20240924$$CN$CA$CA
222346232$22234623$2$F$$20240723$20230420$20240725$PER$$US-AMGEN-USASP2023067186$AMGEN$$$$A$F$Y$$$20240725$$HP$US$US
222346512$22234651$2$F$20240501$20240821$20230420$20240831$EXP$$US-ABBVIE-22K-163-4366468-00$ABBVIE$$79$YR$$M$Y$$$20240831$$CN$US$US
2223468112$22234681$12$F$$20240715$20230420$20240717$EXP$$US-PFIZER INC-PV202300067294$PFIZER$$84$YR$$F$Y$64.41$KG$20240717$$MD$US$US
222346973$22234697$3$F$$20240722$20230420$20240731$PER$$US-SA-2023SA121119$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240731$$MD$US$US
222347013$22234701$3$F$$20240704$20230420$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02987$LUPIN$$$$$$Y$$$20240728$$CN$US$US
222347408$22234740$8$F$20230411$20240621$20230420$20240701$EXP$$US-SA-2023SA121311$SANOFI AVENTIS$$41$YR$A$M$Y$104.3$KG$20240701$$MD$US$US
222348385$22234838$5$F$20230301$20240730$20230420$20240801$EXP$$US-PFIZER INC-PV202300070947$PFIZER$$51$YR$$F$Y$73.923$KG$20240801$$HP$US$US
222349382$22234938$2$F$$20240902$20230420$20240909$EXP$$DE-MYLANLABS-2023M1041345$MYLAN$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide.. Seizure: European Journal of Epilepsy.. 2023;107:107-13$3$DY$$F$Y$$$20240909$$MD$DE$DE
222349403$22234940$3$F$$20240905$20230420$20240911$EXP$$DE-MYLANLABS-2023M1041289$MYLAN$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide.. Seizure. 2023;107:107-113$3$DY$$$Y$$$20240911$$HP$DE$DE
222352903$22235290$3$F$20230312$20240909$20230420$20240916$EXP$$BR-TAKEDA-2023TUS039998$TAKEDA$$66$YR$$M$Y$68$KG$20240916$$HP$BR$BR
222355054$22235505$4$F$$20240913$20230420$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02887$LUPIN$$$$$$Y$$$20240930$$CN$US$US
2223555512$22235555$12$F$$20240909$20230420$20240924$EXP$$CA-BAXTER-2023BAX018446$BAXTER$$36$YR$$F$Y$$$20240924$$HP$CA$CA
2223557325$22235573$25$F$20221004$20240906$20230420$20240912$EXP$$CO-TAKEDA-2021TUS043064$TAKEDA$$19$YR$$F$Y$46$KG$20240912$$CN$CO$CO
222356082$22235608$2$F$$20240807$20230420$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-02953$LUPIN$$$$$$Y$$$20240828$$CN$US$US
2223565711$22235657$11$F$20230319$20240823$20230420$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-053839$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240826$$CN$US$US
222356982$22235698$2$F$$20240716$20230420$20240718$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385943$RANBAXY$Tomskiy AA, Poddubskaya AA, Gamaleya AA, Zaitsev OS.. Neurosurgical management of Tourette syndrome: A literature review and analysis of a case series treated with deep brain stimulation. Prog Brain Res. 2022;272(1):41-72$26$YR$$M$Y$$$20240718$$HP$RU$RU
222357062$22235706$2$F$$20240729$20230420$20240805$EXP$$DE-MYLANLABS-2023M1041315$MYLAN$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide.. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$N$$Y$$$20240805$$HP$DE$DE
222357082$22235708$2$F$$20240729$20230420$20240805$EXP$$DE-MYLANLABS-2023M1041405$MYLAN$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 2023;107:107-113$4$DY$$$Y$$$20240805$$HP$DE$DE
222357132$22235713$2$F$$20240711$20230420$20240726$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385928$RANBAXY$Nahumi T, Levy I, Schiff E, Attias S, Amromin T, Agbarya A. Acupuncture in the Treatment of Panitumumab Skin Toxicity: A Case Report. Complement Med Res. 2023;30:78-83$58$YR$$M$Y$$$20240726$$HP$IL$IL
222358405$22235840$5$F$$20240824$20230420$20240829$EXP$$US-TAKEDA-2023TUS024285$TAKEDA$$$$$M$Y$$$20240829$$CN$US$US
222359768$22235976$8$F$20230331$20240704$20230420$20240711$EXP$$JP-ROCHE-3332665$ROCHE$$73$YR$E$F$Y$47$KG$20240711$$MD$JP$JP
222360008$22236000$8$F$$20240829$20230420$20240902$EXP$$US-PFIZER INC-202300161168$PFIZER$$73$YR$$F$Y$81.633$KG$20240902$$CN$US$US
2223603514$22236035$14$F$20230417$20240819$20230420$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007763$JAZZ$$29$YR$$F$Y$$$20240826$$HP$US$US
222360464$22236046$4$F$20210101$20240913$20230420$20240917$EXP$$US-PFIZER INC-PV202300070851$PFIZER$$82$YR$$F$Y$$$20240917$$HP$US$US
222366425$22236642$5$F$20240412$20240701$20230420$20240705$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-008898$JAZZ$$18$YR$$M$Y$$$20240705$$HP$US$US
222368472$22236847$2$F$$20240701$20230420$20240710$EXP$$BE-CELLTRION INC.-2023BE007742$CELLTRION$Peeters D, Vereecken M, Denys H, Roels D.. A Case of Corneal Melting in a Patient with HER2-Positive Breast Cancer. Case Reports in Ophthalmology. 2022;13:1036-1041$$$$$Y$$$20240710$$MD$BE$BE
222368652$22236865$2$F$$20240827$20230420$20240905$EXP$$DK-CELLTRION INC.-2022DK022340$CELLTRION$Dahl E, Abed O, Kjeldsen J, Donia M, Svane I, Dige A, et al.. Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis.. Alimentary Pharmacology and Therapeutics. 2022;00:1-13$$$$$Y$$$20240905$$HP$DK$DK
222368936$22236893$6$F$20230501$20240624$20230420$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001216$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240718$$HP$US$US
222372692$22237269$2$F$$20240731$20230421$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001226$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
222373455$22237345$5$F$20230315$20240801$20230421$20240806$EXP$$US-SA-2023SA123406$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240806$$MD$US$US
222373582$22237358$2$F$$20240624$20230421$20240701$EXP$$BE-CELLTRION INC.-2022BE022296$CELLTRION$$$$$$Y$$$20240701$$MD$BE$BE
222373824$22237382$4$F$$20240627$20230421$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2023-011252$UNITED THERAPEUTICS$$$$$F$Y$43.537$KG$20240705$$$US$US
222375683$22237568$3$F$$20240711$20230421$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385151$RANBAXY$Russo AT. Vasopressor-induced ischemia of bilateral feet in a previously healthy 34-year-old female. Foot Ankle Surg (NY). 2022;2(2):100183$34$YR$$F$Y$$$20240712$$HP$US$US
222376032$22237603$2$F$$20240725$20230421$20240806$EXP$$CA-AUROBINDO-AUR-APL-2023-031188$AUROBINDO$$11$YR$$M$Y$$$20240806$$HP$CA$CA
2223764811$22237648$11$F$20230327$20240910$20230421$20240919$EXP$$JP-ROCHE-3333358$ROCHE$$74$YR$E$F$Y$47.6$KG$20240919$$MD$JP$JP
222376703$22237670$3$F$20230407$20230407$20230421$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385398$RANBAXY$$75$YR$E$M$Y$$$20240717$$PH$US$US
222376928$22237692$8$F$20161201$20240918$20230421$20240927$EXP$$CA-CELLTRION INC.-2022CA017558$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
222378132$22237813$2$F$$20240806$20230421$20240815$PER$$US-SA-2023SA121144$SANOFI AVENTIS$$$$C$F$Y$$$20240815$$MD$US$US
222378192$22237819$2$F$20230417$20240903$20230421$20240911$PER$$US-SA-2023SA120777$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240911$$CN$US$US
222379847$22237984$7$F$20230323$20240828$20230421$20240909$EXP$$JP-ROCHE-3334079$ROCHE$Takahashi S, Konsoruboueda T, Ishida M, Yanagisawa S, Hayashi A P-32 A case of age-related macular degeneration with non-infectious endophthalmitis following faricimab administration.. The 39th Annual Meeting of Japanese Society for Ocular Circulation 2023;:107-.$76$YR$E$F$Y$47$KG$20240909$$MD$JP$JP
222380952$22238095$2$F$$20240724$20230421$20240803$EXP$$CA-AUROBINDO-AUR-APL-2023-031254$AUROBINDO$$59$YR$$F$Y$$$20240803$$HP$CA$CA
222383483$22238348$3$F$20190301$20230419$20230421$20240710$EXP$$BG-ASTELLAS-2023US012287$ASTELLAS$$82$YR$$M$Y$$$20240710$$CN$BG$BG
222383583$22238358$3$F$$20240712$20230421$20240722$EXP$$CA-CELLTRION INC.-2023CA008089$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
222385693$22238569$3$F$$20240731$20230421$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03027$LUPIN$$$$$$Y$$$20240820$$CN$US$US
222385932$22238593$2$F$$20240807$20230421$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03054$LUPIN$$$$$$Y$$$20240902$$CN$US$US
222386063$22238606$3$F$$20240807$20230421$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03065$LUPIN$$$$$$Y$$$20240827$$CN$US$US
222386686$22238668$6$F$20240101$20240728$20230421$20240805$EXP$$CA-CELLTRION INC.-2023CA008278$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
222387813$22238781$3$F$20230308$20240904$20230421$20240913$30DAY$$US-GSK-US2023055874$GLAXOSMITHKLINE$$49$YR$$F$Y$53.52$KG$20240913$$CN$US$US
222388832$22238883$2$F$$20240628$20230421$20240711$EXP$$IN-ROCHE-3335083$ROCHE$$37$YR$A$M$Y$$$20240711$$CN$IN$IN
222389339$22238933$9$F$20230523$20240903$20230421$20240906$EXP$$CA-TAKEDA-2023TUS038505$TAKEDA$$65$YR$$M$Y$$$20240906$$CN$CA$CA
222389552$22238955$2$F$$20240819$20230421$20240826$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385417$RANBAXY$Zekic T, Benic MS. Anti-programmed death-1 inhibitor nivolumab-induced immune-related adverse events:hepatitis, renal insufficiency, myositis, vitiligo, and hypothyroidism: a case-based review.[Review]. Rheumatol Int. 2023;43(3):559-565$68$YR$$M$Y$$$20240826$$HP$HR$HR
222389572$22238957$2$F$$20240814$20230421$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384792$RANBAXY$$$$$F$Y$$$20240826$$CN$US$US
222389602$22238960$2$F$$20240702$20230421$20240702$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383884$RANBAXY$Hristovska AM, Uldall-Hansen B, Mehlsen J, Kehlet H, Foss NB. Orthostatic intolerance after intravenous administration of morphine: incidence, haemodynamics and heart rate variability analysis. Anaesthesia. 2023;78(4):526-528$$$$$Y$$$20240702$$HP$DK$DK
222391353$22239135$3$F$$20240517$20230421$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003333$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
222395388$22239538$8$F$$20240913$20230421$20240917$EXP$$IN-PFIZER INC-2019361469$PFIZER$$59$YR$$F$Y$$$20240917$$CN$IN$IN
222397432$22239743$2$F$20230101$20240702$20230421$20240709$PER$$US-SA-2023SA123778$SANOFI AVENTIS$$52$YR$A$F$Y$108.8$KG$20240709$$MD$US$US
222398023$22239802$3$F$20230101$20240801$20230421$20240812$PER$$US-SA-2023SA122913$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
222399162$22239916$2$F$$20240828$20230421$20240923$PER$$US-SA-2023SA122911$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240923$$MD$US$US
222400872$22240087$2$F$$20240814$20230421$20240816$EXP$$US-TAKEDA-2023TUS040268$TAKEDA$$$$$F$Y$$$20240816$$CN$US$US
222407183$22240718$3$F$20220527$20240830$20230421$20240904$EXP$$CA-TAKEDA-2022TUS036333$TAKEDA$$76$YR$$F$Y$$$20240904$$CN$CA$CA
222407622$22240762$2$F$20230412$20240910$20230421$20240918$PER$$US-BRACCO-2023US01800$BRACCO$$47$YR$$M$Y$$$20240918$$HP$US$US
222407782$22240778$2$F$$20240717$20230421$20240722$EXP$$US-TAKEDA-US201927869$TAKEDA$$$$$M$Y$$$20240722$$CN$US$US
222411704$22241170$4$F$$20240820$20230421$20240823$EXP$$NVSC2023US089247$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
222412552$22241255$2$F$$20240628$20230421$20240706$PER$$NVSC2023US086785$NOVARTIS$$$$$F$Y$$$20240706$$CN$US$US
222414373$22241437$3$F$$20240710$20230421$20240713$PER$$NVSC2023US089606$NOVARTIS$$$$$F$Y$$$20240713$$CN$US$US
222415143$22241514$3$F$20230413$20240918$20230421$20240930$PER$$NVSC2023US089258$NOVARTIS$$61$YR$$M$Y$$$20240930$$CN$US$US
222415333$22241533$3$F$20211018$20240308$20230421$20240806$EXP$$NVSC2023CA087480$NOVARTIS$$51$YR$$F$Y$99$KG$20240806$$MD$CA$CA
222416313$22241631$3$F$20220302$20240712$20230421$20240721$EXP$$GR-ROCHE-3334118$ROCHE$$54$YR$A$F$Y$$$20240721$$MD$GR$GR
222417643$22241764$3$F$$20230420$20230421$20240829$PER$$NVSC2023US091363$NOVARTIS$$$$$M$Y$$$20240829$$HP$US$US
222419663$22241966$3$F$20230301$20240806$20230421$20240808$EXP$$NVSC2023MX080609$NOVARTIS$$64$YR$$M$Y$67$KG$20240808$$CN$MX$MX
222419752$22241975$2$F$$20240702$20230421$20240706$EXP$$NVSC2020CO047500$NOVARTIS$$$$$M$Y$73$KG$20240706$$CN$CO$CO
222420192$22242019$2$F$$20230419$20230421$20240826$EXP$$NVSC2023US090960$NOVARTIS$$$$$F$Y$85.714$KG$20240826$$CN$US$US
222420463$22242046$3$F$20230416$20240716$20230421$20240717$PER$$NVSC2023US090877$NOVARTIS$$30$YR$$M$Y$$$20240717$$CN$US$US
222420504$22242050$4$F$20191209$20240912$20230421$20240917$EXP$$NVSC2020FR017909$NOVARTIS$$65$YR$$M$Y$72$KG$20240917$$MD$FR$FR
222420615$22242061$5$F$20160101$20240702$20230421$20240709$EXP$$US-JAZZ-2021-US-018717$JAZZ$$36$YR$$F$Y$$$20240709$$CN$US$US
222421304$22242130$4$F$20220620$20240702$20230421$20240705$EXP$DE-PEI-CADR2022300468$DE-009507513-2207DEU003582$MERCK$$1$YR$$F$Y$7$KG$20240705$$CN$DE$DE
222421418$22242141$8$F$$20240919$20230421$20240926$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-229292$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240926$$CN$US$US
222421606$22242160$6$F$$20240723$20230422$20240815$PER$$US-AMGEN-USASP2023066924$AMGEN$$$$A$F$Y$$$20240815$$HP$US$US
2224220716$22242207$16$F$20230101$20240911$20230422$20240916$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219787$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240916$$CN$US$US
222423497$22242349$7$F$20190716$20240821$20230422$20240902$EXP$DE-EMA-2023322-AUTODUP-1679522402195$DE-Accord-309412$ACCORD$$79$YR$E$F$Y$55$KG$20240902$$HP$DE$DE
222423684$22242368$4$F$$20240827$20230422$20240905$EXP$$CA-AUROBINDO-AUR-APL-2023-031313$AUROBINDO$$54$YR$$F$Y$$$20240905$$HP$CA$CA
222424732$22242473$2$F$20230314$20240711$20230422$20240719$EXP$FR-AFSSAPS-PV2023000353$FR-TEVA-2023-FR-2880279$TEVA$$3$YR$$M$Y$12$KG$20240719$$MD$FR$FR
222427753$22242775$3$F$20230101$20240726$20230424$20240808$PER$$US-SA-2023SA125296$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240808$$MD$US$US
222428527$22242852$7$F$20240415$20240924$20230424$20240930$EXP$$US-TAKEDA-2021TUS061907$TAKEDA$$20$YR$$F$Y$48$KG$20240930$$MD$US$US
222428612$22242861$2$F$20230328$20240904$20230424$20240926$PER$$CA-TOLMAR, INC.-23CA040041$TOLMAR$$99$YR$$M$Y$$$20240926$$CN$CA$CA
222428633$22242863$3$F$20230328$20240813$20230424$20240906$PER$$CA-TOLMAR, INC.-23CA040042$TOLMAR$$86$YR$$M$Y$$$20240906$$CN$CA$CA
222428646$22242864$6$F$20230328$20240816$20230424$20240826$PER$$CA-TOLMAR, INC.-23CA040039$TOLMAR$$75$YR$$M$Y$$$20240826$$CN$CA$CA
222429503$22242950$3$F$$20240716$20230424$20240723$PER$$US-SA-2023SA125765$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
222429583$22242958$3$F$20240101$20240830$20230424$20240925$PER$$US-SA-2023SA125953$SANOFI AVENTIS$$$$A$F$Y$47.17$KG$20240925$$MD$US$US
222431512$22243151$2$F$20230218$20240909$20230424$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-385865$RANBAXY$$52$YR$$M$Y$80$KG$20240913$$PH$FR$FR
222431582$22243158$2$F$$20240814$20230424$20240826$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-386148$RANBAXY$$$$E$M$Y$85$KG$20240826$$MD$NL$NL
222431882$22243188$2$F$$20240711$20230424$20240712$EXP$$LB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-385814$RANBAXY$Abdallah W, Rechdan JB, Lakkis R, Nassar M, Daou L, Kassis NE et al. Fetal supraventricular tachycardia and maternal COVID-19 vaccination: Is there any relationship?. Future Sci OA. 2022;8(7):736-742$34$YR$$F$Y$$$20240712$$HP$LB$LB
222433212$22243321$2$F$$20240724$20230424$20240802$EXP$$CA-AUROBINDO-AUR-APL-2023-031411$AUROBINDO$$66$YR$$F$Y$$$20240802$$HP$CA$CA
222433623$22243362$3$F$20231001$20240723$20230424$20240730$PER$$US-SA-2023SA125443$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240730$$CN$US$US
222435044$22243504$4$F$$20240724$20230424$20240803$EXP$$CA-AUROBINDO-AUR-APL-2023-031226$AUROBINDO$$12$MON$$M$Y$10$KG$20240803$$HP$CA$CA
222435173$22243517$3$F$$20240802$20230424$20240815$EXP$$CA-AUROBINDO-AUR-APL-2023-032196$AUROBINDO$$57$YR$$F$Y$$$20240815$$HP$CA$CA
222435262$22243526$2$F$$20240701$20230424$20240708$EXP$$CA-AUROBINDO-AUR-APL-2023-031933$AUROBINDO$$60$YR$$F$Y$$$20240708$$HP$CA$CA
222435526$22243552$6$F$$20240725$20230424$20240806$EXP$$CA-AUROBINDO-AUR-APL-2023-031185$AUROBINDO$$58$YR$$M$Y$$$20240806$$HP$CA$CA
222435804$22243580$4$F$$20240808$20230424$20240816$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-002407$JAZZ$$$$$M$Y$$$20240816$$MD$US$US
222439043$22243904$3$F$$20240715$20230424$20240720$EXP$$CA-AUROBINDO-AUR-APL-2023-031395$AUROBINDO$$65$YR$$F$Y$34$KG$20240720$$HP$CA$CA
222439302$22243930$2$F$$20240731$20230424$20240802$EXP$$CA-TAKEDA-2023TUS040330$TAKEDA$$$$$F$Y$$$20240802$$MD$CA$CA
222440045$22244004$5$F$$20230810$20230424$20240925$PER$$US-GSK-US2023AMR056715$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
222441243$22244124$3$F$$20240814$20230424$20240904$PER$$CA-TOLMAR, INC.-23CA040210$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
2224436123$22244361$23$F$20230208$20240916$20230424$20240925$EXP$$CA-CELLTRION INC.-2023CA008313$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
222444393$22244439$3$F$20230330$20240622$20230424$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001277$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240716$$CN$US$US
222444663$22244466$3$F$20230901$20230225$20230424$20240801$PER$$NVSC2023US090423$NOVARTIS$$59$YR$$F$Y$$$20240801$$CN$US$US
222446372$22244637$2$F$$20240912$20230424$20240919$EXP$$CA-CELLTRION INC.-2023CA008298$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
222447182$22244718$2$F$20230331$20240826$20230424$20240903$EXP$$IT-CELLTRION INC.-2023IT008189$CELLTRION$$$$$$Y$$$20240903$$MD$IT$IT
222447216$22244721$6$F$$20240813$20230424$20240826$EXP$$CA-AUROBINDO-AUR-APL-2023-032017$AUROBINDO$$62$YR$$F$Y$$$20240826$$HP$CA$CA
222450952$22245095$2$F$20191101$20230418$20230424$20240712$EXP$$BG-ASTELLAS-2023US012277$ASTELLAS$$79$YR$$M$Y$$$20240712$$MD$BG$BG
2224511615$22245116$15$F$20230416$20240319$20230424$20240926$EXP$$US-GSK-US2023AMR057476$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
222451738$22245173$8$F$$20240809$20230424$20240822$EXP$$CA-AUROBINDO-AUR-APL-2022-032038$AUROBINDO$Massey V, Martel V, Nguyen DK, Busque L, Chapdelaine H, Keezer MR. Acute central nervous system graft-versus-host-disease after liver transplantation. Transpl-Immunol. 2022;70:101521$63$YR$$M$Y$$$20240822$$HP$CA$CA
222452723$22245272$3$F$20220101$20240919$20230424$20240925$EXP$$US-TAKEDA-2022TUS008956$TAKEDA$$48$YR$$F$Y$$$20240925$$CN$US$US
222453132$22245313$2$F$$20230418$20230424$20240902$EXP$$NVSC2023US090384$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
222455325$22245532$5$F$$20240710$20230424$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-057221$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240718$$MD$JP$JP
222457353$22245735$3$F$$20240807$20230424$20240821$EXP$$US-LUPIN PHARMACEUTICALS INC.-2023-02992$LUPIN$$$$$$Y$$$20240821$$CN$US$US
222458329$22245832$9$F$20240304$20240912$20230424$20240918$EXP$$US-OTSUKA-2023_010207$OTSUKA$$93$YR$$M$Y$89.72$KG$20240918$$CN$US$US
222462054$22246205$4$F$$20240821$20230424$20240912$PER$$CA-TOLMAR, INC.-23CA040215$TOLMAR$$$$$M$Y$$$20240912$$CN$CA$CA
222462097$22246209$7$F$20230404$20240817$20230424$20240911$PER$$CA-TOLMAR, INC.-23CA040225$TOLMAR$$76$YR$$M$Y$$$20240911$$CN$CA$CA
2224629316$22246293$16$F$20230730$20240813$20230424$20240819$EXP$$US-SA-2023SA126328$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240819$$MD$US$US
2224632824$22246328$24$F$20230116$20240927$20230424$20240927$EXP$$AU-MYLANLABS-2023M1007291$MYLAN$$48$YR$$M$Y$$$20240927$$HP$AU$AU
222463987$22246398$7$F$$20240821$20230424$20240827$EXP$$US-TAKEDA-2023TUS040701$TAKEDA$$$$$F$Y$93$KG$20240827$$CN$US$US
222464513$22246451$3$F$$20240705$20230424$20240710$EXP$$US-TAKEDA-2023TUS041077$TAKEDA$$$$$F$Y$$$20240710$$CN$US$US
222465554$22246555$4$F$20230101$20240919$20230424$20240925$EXP$$US-INCYTE CORPORATION-2023IN002730$INCYTE$$$$$$Y$$$20240925$$CN$US$US
222465793$22246579$3$F$20230326$20240828$20230424$20240830$EXP$$NVSC2023US090994$NOVARTIS$$57$YR$$M$Y$$$20240830$$CN$US$US
222467772$22246777$2$F$20230322$20240802$20230424$20240812$EXP$FR-AFSSAPS-PV2023000336$FR-TEVA-2023-FR-2879477$TEVA$$18$YR$$M$Y$90$KG$20240812$$MD$FR$FR
222468113$22246811$3$F$$20240920$20230424$20240924$PER$$US-PFIZER INC-PV202300035512$PFIZER$$71$YR$$F$Y$$$20240924$$CN$US$US
222469992$22246999$2$F$20230127$20240711$20230424$20240719$EXP$FR-AFSSAPS-PV2023000315$FR-TEVA-2023-FR-2879476$TEVA$$8$YR$$M$Y$22$KG$20240719$$MD$FR$FR
222470313$22247031$3$F$20230330$20240625$20230424$20240702$EXP$$JP-JAZZ PHARMACEUTICALS-2023-JP-009182$JAZZ$$15$YR$$M$Y$59$KG$20240701$$MD$JP$JP
222470885$22247088$5$F$$20240710$20230424$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-057219$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240717$$MD$JP$JP
222470925$22247092$5$F$$20240710$20230424$20240716$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-057855$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240716$$MD$JP$JP
222471149$22247114$9$F$20221229$20240905$20230424$20240910$EXP$$CA-JNJFOC-20230119994$JOHNSON AND JOHNSON$$61$YR$A$F$Y$66$KG$20240910$$HP$CA$CA
222472484$22247248$4$F$20240212$20240726$20230424$20240805$EXP$$BR-CELLTRION INC.-2023BR007722$CELLTRION$$$$$$Y$$$20240805$$CN$BR$BR
222472716$22247271$6$F$$20240911$20230425$20240919$EXP$$CA-CELLTRION INC.-2022CA022346$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
222473148$22247314$8$F$20231101$20240819$20230425$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-029828$JAZZ$$65$YR$$F$Y$$$20240826$$CN$US$US
222474034$22247403$4$F$$20240918$20230425$20240930$PER$$NVSC2023US090779$NOVARTIS$$$$$F$Y$73.8$KG$20240930$$CN$US$US
222474672$22247467$2$F$20230217$20240716$20230425$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-386255$RANBAXY$$58$YR$$M$Y$$$20240718$$MD$FR$FR
222475153$22247515$3$F$20210818$20240828$20230425$20240903$EXP$$GB-ABBVIE-4737937$ABBVIE$$40$YR$$F$Y$$$20240903$$MD$GB$GB
222475233$22247523$3$F$20230101$20240903$20230425$20240909$EXP$$US-ABBVIE-4739435$ABBVIE$$61$YR$$F$Y$$$20240909$$CN$US$US
222475532$22247553$2$F$$20240812$20230425$20240822$EXP$$CA-AUROBINDO-AUR-APL-2022-057217$AUROBINDO$$83$YR$$M$Y$$$20240822$$HP$CA$CA
222475607$22247560$7$F$20230401$20230710$20230425$20240925$PER$$US-GSK-US2023AMR058240$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
222475724$22247572$4$F$$20240802$20230425$20240807$EXP$$US-TAKEDA-2023TUS039901$TAKEDA$$$$$F$Y$$$20240807$$HP$US$US
222476998$22247699$8$F$20220801$20240916$20230425$20240922$EXP$$US-ABBVIE-4737825$ABBVIE$$61$YR$$F$Y$$$20240922$$CN$US$US
222477505$22247750$5$F$20221001$20240812$20230425$20240829$PER$$CA-TOLMAR, INC.-23CA039976$TOLMAR$$83$YR$$M$Y$$$20240829$$CN$CA$CA
222478452$22247845$2$F$20230404$20230418$20230425$20240813$EXP$$NVSC2023AR091226$NOVARTIS$$60$YR$$M$Y$$$20240813$$CN$AR$AR
2224789714$22247897$14$F$$20240816$20230425$20240823$EXP$$US-GSK-US2023AMR058897$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$US$US
222479044$22247904$4$F$$20240816$20230425$20240828$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04206$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$A$F$Y$$$20240828$$MD$DE$DE
222479054$22247905$4$F$$20240816$20230425$20240828$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04211$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$A$F$Y$$$20240828$$HP$DE$DE
222479065$22247906$5$F$$20240812$20230425$20240824$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04201$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$A$F$Y$$$20240825$$MD$DE$DE
222479083$22247908$3$F$$20240812$20230425$20240824$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04239$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$N$$Y$$$20240825$$MD$DE$DE
222479095$22247909$5$F$$20240902$20230425$20240917$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04237$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;V107:P107-113$$$N$$Y$$$20240917$$MD$DE$DE
222479103$22247910$3$F$$20240828$20230425$20240912$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04240$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$3$DY$$F$Y$$$20240912$$MD$DE$DE
222479116$22247911$6$F$$20240911$20230425$20240925$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04236$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:1-28$4$DY$$$Y$$$20240925$$MD$DE$DE
222479124$22247912$4$F$$20240816$20230425$20240828$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04160$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on Lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$A$F$Y$$$20240828$$MD$DE$DE
222479136$22247913$6$F$$20240902$20230425$20240917$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04238$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on Lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$N$$Y$$$20240917$$MD$DE$DE
222479216$22247921$6$F$$20240911$20230425$20240925$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04245$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on Lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$N$$Y$$$20240925$$MD$DE$DE
222479226$22247922$6$F$$20240902$20230425$20240917$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04257$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:1-28$$$N$$Y$$$20240917$$MD$DE$DE
222479233$22247923$3$F$$20240808$20230425$20240822$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04242$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$N$$Y$$$20240822$$MD$DE$DE
222482385$22248238$5$F$20230320$20240709$20230425$20240712$EXP$$NVSC2023BR070046$NOVARTIS$$40$YR$$M$Y$91.4$KG$20240712$$PH$BR$BR
222482582$22248258$2$F$$20240809$20230425$20240821$EXP$$CA-AUROBINDO-AUR-APL-2023-031275$AUROBINDO$$50$YR$$F$Y$$$20240821$$HP$CA$CA
222483202$22248320$2$F$$20240829$20230425$20240909$EXP$$CA-AUROBINDO-AUR-APL-2023-032204$AUROBINDO$$15$YR$$F$Y$$$20240909$$MD$CA$CA
222483554$22248355$4$F$20230419$20230614$20230425$20240925$PER$$US-GSK-US2023AMR058800$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
222485313$22248531$3$F$20230108$20240627$20230425$20240709$EXP$$CA-ROCHE-3336877$ROCHE$$59$YR$A$F$Y$$$20240709$$CN$CA$CA
222485674$22248567$4$F$20230101$20230418$20230425$20240830$EXP$$NVSC2023US090193$NOVARTIS$$59$YR$$M$Y$$$20240830$$CN$US$US
222485795$22248579$5$F$$20240710$20230425$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-057224$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240717$$MD$JP$JP
222486634$22248663$4$F$$20240913$20230425$20240925$30DAY$$CN-JNJFOC-20230418438$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$CN$CN
2224868613$22248686$13$F$20180101$20240918$20230425$20240927$EXP$$CA-CELLTRION INC.-2018CA020488$CELLTRION$$$$$$Y$$$20240927$$CN$CA$CA
222487403$22248740$3$F$$20240815$20230425$20240828$EXP$$CA-AUROBINDO-AUR-APL-2022-030686$AUROBINDO$Okonkwo MC, Moeller A, McCoy K, Tulipan T , Coolen J.. Clinical Conundrum: To Deliver or Not To Deliver a Patient With Pulmonary Edema and Preeclampsia. J-Obstet-Gynaecol-Can. 2021;43(10):1170-1172$29$YR$$F$Y$$$20240828$$HP$CA$CA
222488083$22248808$3$F$$20240909$20230425$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03064$LUPIN$$$$$$Y$$$20240921$$PH$US$US
222490677$22249067$7$F$20230330$20240626$20230425$20240702$EXP$$CA-JNJFOC-20230450837$JOHNSON AND JOHNSON$$40$YR$A$F$Y$110$KG$20240702$$HP$CA$CA
222491588$22249158$8$F$20230329$20240813$20230425$20240826$EXP$$DE-AUROBINDO-AUR-APL-2023-031455$AUROBINDO$$$$A$F$Y$86$KG$20240826$$MD$DE$DE
222492163$22249216$3$F$$20240724$20230425$20240805$EXP$$CA-AUROBINDO-AUR-APL-2023-031900$AUROBINDO$$41$YR$$F$Y$$$20240805$$HP$CA$CA
222492434$22249243$4$F$20230101$20240709$20230425$20240713$PER$$US-SA-2023SA126146$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240713$$CN$US$US
222492772$22249277$2$F$20240101$20240822$20230425$20240906$PER$$US-SA-2023SA127453$SANOFI AVENTIS$$$$C$F$Y$34.921$KG$20240906$$MD$US$US
222494642$22249464$2$F$$20240827$20230425$20240906$EXP$$CA-AUROBINDO-AUR-APL-2023-031187$AUROBINDO$$56$YR$$F$Y$$$20240906$$HP$CA$CA
222494705$22249470$5$F$$20240830$20230425$20240913$EXP$$CA-AUROBINDO-AUR-APL-2023-031208$AUROBINDO$$44$YR$$F$Y$$$20240913$$HP$CA$CA
222495033$22249503$3$F$$20240807$20230425$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03117$LUPIN$$$$$$Y$$$20240822$$CN$US$US
222495692$22249569$2$F$$20240708$20230425$20240722$EXP$CA-MHPD-001028881$CA-Accord-309001$ACCORD$$37$YR$A$F$Y$54$KG$20240719$$HP$CA$CA
222496142$22249614$2$F$$20240914$20230425$20240923$EXP$$BR-TAKEDA-2023TUS039845$TAKEDA$$$$$M$Y$$$20240923$$CN$BR$BR
222497332$22249733$2$F$$20240816$20230425$20240821$PER$$US-PFIZER INC-PV202300073839$PFIZER$$63$YR$$M$Y$$$20240821$$CN$US$US
222498432$22249843$2$F$$20240812$20230425$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-055675$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240819$$CN$US$US
222498563$22249856$3$F$20240101$20240906$20230425$20240916$EXP$$US-ABBVIE-4735004$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
222499573$22249957$3$F$20191211$20240715$20230425$20240718$EXP$ES-MLMSERVICE-20230417-4227991-3$ES-UCBSA-2023021006$UCB$$12$YR$$F$Y$37$KG$20240718$$MD$ES$ES
222499734$22249973$4$F$$20240812$20230425$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03118$LUPIN$$$$$$Y$$$20240829$$$US$US
222499893$22249989$3$F$$20240805$20230425$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03135$LUPIN$$$$$$Y$$$20240828$$PH$US$US
222501255$22250125$5$F$20220601$20240913$20230425$20240917$PER$$US-PFIZER INC-PV202300072331$PFIZER$$69$YR$$F$Y$$$20240917$$CN$US$US
222501343$22250134$3$F$$20240822$20230425$20240826$EXP$$CA-AstraZeneca-2023A094209$ASTRAZENECA$$53$YR$$F$Y$$$20240826$$MD$CA$
222501363$22250136$3$F$20230401$20240708$20230425$20240710$EXP$$US-PFIZER INC-PV202300072295$PFIZER$$66$YR$$F$Y$$$20240710$$HP$US$US
222501815$22250181$5$F$$20240823$20230425$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03143$LUPIN$$$$$$Y$$$20240912$$CN$US$US
222502503$22250250$3$F$$20240807$20230425$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03144$LUPIN$$$$$M$Y$86.18$KG$20240821$$CN$US$US
222502582$22250258$2$F$$20240820$20230425$20240821$EXP$$US-BAXALTA-2016BLT008041AA$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
222502686$22250268$6$F$20220701$20240814$20230425$20240821$EXP$$BR-GSK-BR2015GSK002427$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$BR$BR
222503333$22250333$3$F$$20240805$20230425$20240807$EXP$$US-PFIZER INC-PV202300037959$PFIZER$$74$YR$$F$Y$$$20240807$$CN$US$US
222504212$22250421$2$F$$20240710$20230425$20240715$EXP$$US-PFIZER INC-PV202300072620$PFIZER$Konda, S.. Primary Vitreoretinal Lymphoma Masquerading as Post-Operative Endophthalmitis in a Pregnant Patient with Longstanding Idiopathic Panuveitis. Retinal cases and brief reports. 2023;18 (4):468-472$37$YR$$F$Y$$$20240715$$MD$US$US
222504693$22250469$3$F$$20240812$20230425$20240813$PER$$US-AMGEN-USASP2023070746$AMGEN$$70$YR$E$M$Y$$$20240813$$CN$US$US
222506322$22250632$2$F$20230415$20240917$20230425$20240920$EXP$$US-TAKEDA-2023TUS041242$TAKEDA$$2$YR$$M$Y$$$20240920$$PH$US$US
2225085211$22250852$11$F$20230101$20240718$20230425$20240723$EXP$$US-DSJP-DSU-2023-116174$DAIICHI$$$$$F$Y$84$KG$20240723$$CN$US$US
222511914$22251191$4$F$20230101$20240801$20230425$20240809$PER$$US-SA-2023SA127419$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240809$$MD$US$US
222512833$22251283$3$F$20230215$20240821$20230425$20240904$EXP$$JP-UCBSA-2023011435$UCB$$6$YR$$M$Y$16$KG$20240904$$MD$JP$JP
222513813$22251381$3$F$$20240729$20230425$20240806$EXP$$JP-AstraZeneca-2023A093606$ASTRAZENECA$Sakabe M, Tobino K, Obata Y, Sogabe S, Uchida K, Murakami Y.. Eosinophilic granulomatosis with polyangiitis developed during treatment with benralizmab for severe asthma: A case report and literature review.. Respirology Case Reports 2024;12(7):e01431.$79$YR$$M$Y$$$20240806$$HP$JP$
222518865$22251886$5$F$$20240710$20230425$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-057225$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240717$$MD$JP$JP
222519332$22251933$2$F$$20240726$20230425$20240726$PER$$US-PURDUE PHARMA-USA-2023-0300978$PURDUE$$54$YR$$$Y$$$20240726$$CN$US$US
222519402$22251940$2$F$$20240726$20230425$20240729$PER$$US-PURDUE PHARMA-USA-2023-0300981$PURDUE$$67$YR$$M$Y$$$20240729$$CN$US$US
222520163$22252016$3$F$20050330$20240626$20230425$20240701$EXP$$JP-ABBVIE-4740435$ABBVIE$$35$YR$$M$Y$$$20240701$$HP$JP$JP
222523617$22252361$7$F$20210422$20240816$20230426$20240819$EXP$$JP-ABBVIE-21K-087-4083102-00$ABBVIE$$89$YR$$M$Y$$$20240819$$MD$JP$JP
222523644$22252364$4$F$20171218$20240913$20230426$20240923$EXP$$CA-CELLTRION INC.-2021CA010225$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
222523816$22252381$6$F$20220801$20240904$20230426$20240909$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-020630$JAZZ$$49$YR$$F$Y$$$20240909$$MD$US$US
222524142$22252414$2$F$20230401$20240704$20230426$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03062$LUPIN$$$$$$Y$$$20240728$$CN$US$US
222524813$22252481$3$F$20190301$20240715$20230426$20240723$EXP$$BG-TOLMAR, INC.-23BG040342$TOLMAR$$82$YR$$M$Y$$$20240723$$MD$BG$BG
222525595$22252559$5$F$$20240810$20230426$20240815$PER$$US-ABBVIE-4740742$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
2225256211$22252562$11$F$20220101$20231115$20230426$20240807$EXP$$NVSC2022AR227930$NOVARTIS$$$$$F$Y$$$20240807$$CN$AR$AR
222525762$22252576$2$F$$20240819$20230426$20240830$EXP$$CA-AUROBINDO-AUR-APL-2023-031258$AUROBINDO$$43$YR$$F$Y$68$KG$20240830$$MD$CA$CA
222526894$22252689$4$F$20230205$20240726$20230426$20240731$EXP$$AT-PFIZER INC-202300169019$PFIZER$$73$YR$$M$Y$64$KG$20240731$$HP$AT$AT
222527282$22252728$2$F$20230310$20240913$20230426$20240925$EXP$$DE-CELLTRION INC.-2023DE008308$CELLTRION$$$$$$Y$$$20240925$$MD$DE$DE
222528023$22252802$3$F$$20240829$20230426$20240909$EXP$$CA-AUROBINDO-AUR-APL-2023-031212$AUROBINDO$$59$YR$$F$Y$68$KG$20240909$$HP$CA$CA
222528123$22252812$3$F$$20240708$20230426$20240714$PER$$US-AMGEN-USASP2023071481$AMGEN$$$$A$F$Y$$$20240714$$HP$US$US
222528655$22252865$5$F$$20230607$20230426$20240925$PER$$US-GSK-US2023AMR060581$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$MD$US$US
222529212$22252921$2$F$$20240703$20230426$20240703$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385230$RANBAXY$Gong S, Yang Y, Tan M, Chen J. Effective treatment for massive neonatal catheter-related right atrial thrombosis. Interact Cardiovasc Thorac Surg. 2022;35(1):ivac055$1$MON$$M$Y$2.13$KG$20240703$$HP$CN$CN
222529422$22252942$2$F$$20240829$20230426$20240904$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386269$RANBAXY$Pathmarajah P, Corso R,Salam A, Woolf R, Smith C, Pink A. Neutropenia on dupilumab in patients with atopic dermatitis. Br J Dermatol. 2022;187(Suppl1):83 (P101)$34$YR$$M$Y$$$20240904$$HP$GB$GB
222529502$22252950$2$F$$20240820$20230426$20240826$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386309$RANBAXY$Ruzicka M, Wurm S, Lindner L, Dreyling M, Bergwelt?Baildon MV, Boeck S, et al. Treatment, outcome and re?vaccination of patients with SARS?CoV?2 vaccine?associated immune thrombocytopenia. Infection. 2023;51:231-238$83$YR$$M$Y$$$20240826$$HP$DE$DE
222529773$22252977$3$F$$20240829$20230426$20240903$EXP$$CN-SA-2023SA124119$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240903$$MD$CN$CN
222530075$22253007$5$F$$20230511$20230426$20240926$EXP$$US-GSK-US2023AMR058817$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
222530637$22253063$7$F$20210712$20240807$20230426$20240809$EXP$$CA-TAKEDA-2021TUS046813$TAKEDA$$67$YR$$F$Y$$$20240809$$HP$CA$CA
222531443$22253144$3$F$$20240808$20230426$20240820$EXP$$CA-AUROBINDO-AUR-APL-2023-032100$AUROBINDO$$$$$F$Y$$$20240820$$HP$CA$CA
222531733$22253173$3$F$$20240813$20230426$20240822$EXP$$CA-AUROBINDO-AUR-APL-2023-032177$AUROBINDO$$$$$M$Y$$$20240822$$HP$CA$CA
222534273$22253427$3$F$$20240808$20230426$20240820$EXP$$CA-AUROBINDO-AUR-APL-2023-032090$AUROBINDO$$56$YR$$F$Y$$$20240820$$HP$CA$CA
222534315$22253431$5$F$20230901$20240815$20230426$20240820$EXP$$JP-AMGEN-JPNSP2023067167$AMGEN$$78$YR$E$M$Y$$$20240820$$PH$JP$JP
222534604$22253460$4$F$20230418$20240726$20230426$20240731$EXP$$CN-TAKEDA-2023TUS040617$TAKEDA$$62$YR$$M$Y$60$KG$20240731$$MD$CN$CN
222534974$22253497$4$F$$20240912$20230426$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384222$RANBAXY$Macklin P, Fisher R, Matin R, Ieremia E. Methotrexate-induced cutaneous lymphoproliferative disorders presenting as Epstein-Barr virus-positive mucocutaneous ulcer mimicking high-grade lymphoma. Br J Dermatol. 2022;187 (Suppl. 1):149 (DP11)$66$YR$$F$Y$$$20240927$$HP$GB$GB
222535002$22253500$2$F$$20240703$20230426$20240703$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384271$RANBAXY$Gong S, Yang Y, Tan M, Chen J. Effective treatment for massive neonatal catheter related right atrial thrombosis. Interact CardioVasc Thorac Surg. 2022;35(1):ivac055$$$N$M$Y$3.55$KG$20240703$$HP$CN$CN
222535702$22253570$2$F$20220826$20230424$20230426$20240903$EXP$$NVSC2023US094453$NOVARTIS$$68$YR$$F$Y$$$20240903$$CN$US$US
222535823$22253582$3$F$$20240830$20230426$20240913$EXP$$CA-AUROBINDO-AUR-APL-2023-031195$AUROBINDO$$44$YR$$F$Y$63$KG$20240913$$HP$CA$CA
222536304$22253630$4$F$$20240813$20230426$20240826$EXP$$CA-AUROBINDO-AUR-APL-2023-031266$AUROBINDO$$65$YR$$M$Y$$$20240826$$HP$CA$CA
222536602$22253660$2$F$$20240813$20230426$20240823$EXP$$CA-AUROBINDO-AUR-APL-2023-032400$AUROBINDO$$47$YR$$F$Y$$$20240823$$PH$CA$CA
222536924$22253692$4$F$20220401$20240703$20230426$20240723$EXP$$DE-ROCHE-3337529$ROCHE$$49$YR$A$F$Y$$$20240723$$MD$DE$DE
222536943$22253694$3$F$20230417$20240814$20230426$20240822$EXP$$AU-ROCHE-2677487$ROCHE$$61$YR$A$F$Y$$$20240822$$CN$AU$AU
2225370710$22253707$10$F$$20240708$20230426$20240710$EXP$$CA-ABBVIE-4736287$ABBVIE$$50$YR$$F$Y$68$KG$20240710$$HP$CA$CA
222537104$22253710$4$F$20230401$20240703$20230426$20240723$EXP$$DE-ROCHE-3337515$ROCHE$$35$YR$A$F$Y$$$20240723$$MD$DE$DE
222538464$22253846$4$F$$20240716$20230426$20240812$EXP$$US-GSK-US2023AMR059518$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
222539697$22253969$7$F$20230101$20240624$20230426$20240701$EXP$$US-SA-2023SA127413$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240701$$MD$US$US
222540112$22254011$2$F$$20240725$20230426$20240802$EXP$$CA-GSK-CA2023AMR059876$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$CA$CA
222540425$22254042$5$F$20230401$20240701$20230426$20240708$PER$$US-SA-2023SA129705$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240708$$MD$US$US
222541087$22254108$7$F$$20240717$20230426$20240723$EXP$$CA-ROCHE-3337328$ROCHE$$65$YR$E$F$Y$$$20240723$$CN$CA$CA
222541212$22254121$2$F$$20240805$20230426$20240808$EXP$$CA-AUROBINDO-AUR-APL-2023-032243$AUROBINDO$$72$YR$$F$Y$61$KG$20240808$$HP$CA$CA
222546573$22254657$3$F$20230101$20240805$20230426$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-055620$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240815$$MD$JP$JP
222547613$22254761$3$F$20230414$20231006$20230426$20240911$EXP$$NVSC2023US090332$NOVARTIS$$66$YR$$F$Y$$$20240911$$CN$US$US
222548402$22254840$2$F$$20240806$20230426$20240807$EXP$$US-UCBSA-2023021145$UCB$$$$$M$Y$$$20240807$$CN$US$US
222549192$22254919$2$F$20230224$20240710$20230426$20240725$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-386502$RANBAXY$$55$YR$$M$Y$$$20240725$$MD$IT$IT
222549242$22254924$2$F$20221205$20240705$20230426$20240708$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-386495$RANBAXY$$82$YR$$F$Y$50$KG$20240708$$PH$GB$GB
222550025$22255002$5$F$20230211$20240826$20230426$20240903$EXP$$CH-MYLANLABS-2023M1037033$MYLAN$$$$A$M$Y$$$20240903$$CN$CH$CH
222551605$22255160$5$F$$20240710$20230426$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-057222$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240718$$MD$JP$JP
222553302$22255330$2$F$$20240628$20230426$20240703$EXP$$CA-PFIZER INC-202201117901$PFIZER$$63$YR$$F$Y$$$20240703$$MD$CA$CA
222554635$22255463$5$F$$20240807$20230426$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03166$LUPIN$$$$$$Y$$$20240829$$CN$US$US
222554813$22255481$3$F$$20230503$20230426$20240919$EXP$$NVSC2023GB091672$NOVARTIS$$$$$$Y$$$20240919$$HP$GB$GB
222554975$22255497$5$F$20230101$20231102$20230426$20240805$EXP$$NVSC2023US091287$NOVARTIS$$$$$F$Y$138.8$KG$20240806$$CN$US$US
222555276$22255527$6$F$$20240711$20230426$20240715$EXP$$CA-TAKEDA-2021TUS077281$TAKEDA$$$$$M$Y$$$20240715$$HP$CA$CA
222555507$22255550$7$F$20221201$20240830$20230426$20240905$EXP$$JP-009507513-2301JPN003603J$MERCK$Senda N, Tsuyuki S, Sakamoto A, Henmi S, Tsumura T. P88-7 A case report of steroid?resistant irAE colitis associated with neoadjuvant pembrolizumab in early breast cancer. 2024 the Japanese Society of Medical Oncology Annual Meeting$46$YR$$F$Y$$$20240905$$MD$JP$JP
222556745$22255674$5$F$20221217$20240902$20230426$20240906$EXP$$CN-TAKEDA-2023TUS040587$TAKEDA$$53$YR$$M$Y$58$KG$20240906$$MD$CN$CN
222557712$22255771$2$F$20190901$20230424$20230426$20240927$EXP$$NVSC2023HU094437$NOVARTIS$$$$A$M$Y$150$KG$20240927$$MD$HU$HU
222558352$22255835$2$F$20200807$20240730$20230426$20240807$EXP$$JP-AstraZeneca-2023A051192$ASTRAZENECA$Kishimoto M.. EP-1436 A case of bilateral secondary inflammatory breast cancer with multiple lung and distant lymph node metastases who achieved a long-term disease-free state.. Thge 32nd Annual Meeting of the Japanese Breast Cancer Society 2024;536-.$65$YR$$F$Y$$$20240807$$MD$JP$
2225589814$22255898$14$F$20220609$20240702$20230426$20240716$EXP$$NVSC2022JP303805$NOVARTIS$$9$MON$$M$Y$6.76$KG$20240716$$MD$JP$JP
222561933$22256193$3$F$$20240711$20230426$20240712$PER$$US-PFIZER INC-PV202300072942$PFIZER$$69$YR$$F$Y$$$20240712$$CN$US$US
222563972$22256397$2$F$20230301$20240827$20230426$20240904$EXP$DE-CADRBFARM-2023317512$DE-VERTEX PHARMACEUTICALS-2023-005875$VERTEX$$24$YR$$M$Y$62$KG$20240904$$MD$DE$DE
222564216$22256421$6$F$$20240715$20230426$20240722$EXP$$US-TAKEDA-2023TUS036641$TAKEDA$$$$$F$Y$$$20240722$$HP$US$US
222564983$22256498$3$F$$20240809$20230426$20240816$EXP$$BR-AKCEA THERAPEUTICS, INC.-2023IS001389$AKCEA THERAPEUTICS$$$$$$Y$$$20240815$$MD$BR$BR
222565083$22256508$3$F$$20240809$20230426$20240816$EXP$$BR-AKCEA THERAPEUTICS, INC.-2023IS001390$AKCEA THERAPEUTICS$$$$$$Y$$$20240816$$MD$BR$BR
222565093$22256509$3$F$$20240725$20230426$20240731$EXP$$CA-BAUSCHBL-BL-2018-022082$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240730$$MD$CA$CA
222566937$22256693$7$F$20220101$20240724$20230426$20240729$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-003042$AMGEN$$57$YR$A$F$Y$$$20240729$$MD$US$US
222570794$22257079$4$F$$20230522$20230427$20240926$PER$$US-GSK-US2023AMR057550$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$MD$US$US
222572788$22257278$8$F$20230422$20240709$20230427$20240715$EXP$$CA-ROCHE-3338253$ROCHE$$41$YR$A$M$Y$$$20240715$$MD$CA$CA
222572953$22257295$3$F$20230307$20230424$20230427$20240826$PER$$NVSC2023US093439$NOVARTIS$$80$YR$$M$Y$63.5$KG$20240826$$CN$US$US
2225740311$22257403$11$F$20180211$20240919$20230427$20240925$EXP$$US-ABBVIE-4305901$ABBVIE$$73$YR$$M$Y$$$20240925$$CN$US$US
222574155$22257415$5$F$20221201$20240722$20230427$20240726$EXP$$US-ABBVIE-4742819$ABBVIE$$56$YR$$F$Y$63.502$KG$20240726$$CN$US$US
222574533$22257453$3$F$$20240903$20230427$20240912$EXP$$CA-AUROBINDO-AUR-APL-2023-032191$AUROBINDO$$26$YR$$F$Y$$$20240912$$HP$CA$CA
222578167$22257816$7$F$20230424$20240812$20230427$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-023488$JAZZ$$39$YR$$M$Y$$$20240820$$MD$US$US
222578502$22257850$2$F$$20240813$20230427$20240826$EXP$$CA-AUROBINDO-AUR-APL-2023-032076$AUROBINDO$$57$YR$$F$Y$$$20240826$$HP$CA$CA
222578582$22257858$2$F$$20240913$20230427$20240925$EXP$$CA-AUROBINDO-AUR-APL-2023-032195$AUROBINDO$Massey V, Martel V, Nguyen DK, Busque L, Hapdelaine H, Keezer MR.. Acute central nervous system graft-versus-host-disease after liver transplantation.. Transplant Immunology. 2022;70:1-5$63$YR$$M$Y$$$20240925$$HP$CA$CA
222578643$22257864$3$F$$20240813$20230427$20240827$EXP$$CA-AUROBINDO-AUR-APL-2023-032692$AUROBINDO$$47$YR$$F$Y$$$20240827$$HP$CA$CA
222578946$22257894$6$F$$20240626$20230427$20240704$EXP$$NVSC2023US090637$NOVARTIS$$$$$M$Y$$$20240704$$CN$US$US
222579472$22257947$2$F$20220101$20230420$20230427$20240823$EXP$$NVSC2023US094790$NOVARTIS$$$$$M$Y$63.946$KG$20240824$$CN$US$US
222580392$22258039$2$F$20230414$20240806$20230427$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-059625$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$79.83$KG$20240813$$CN$US$US
222580982$22258098$2$F$$20240703$20230427$20240703$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385657$RANBAXY$Ghosh J, Joy Phillip DS, Ghosh J, Bajpai J, Gulia S, Parmar V, et al. Survival outcomes with 12 weeks of adjuvant or neoadjuvant trastuzumab in breast cancer. Indian J Cancer. 2022;Jul-Sep;59(3):387-393$47$YR$$$Y$$$20240703$$HP$IN$IN
222581102$22258110$2$F$$20240829$20230427$20240904$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386612$RANBAXY$De Brito M, Goldsmith P. Getting to the bottom of things. Br J Dermatol. 2022;187(Suppl1):141-142 (CD18)$39$YR$$F$Y$$$20240904$$HP$GB$GB
222581322$22258132$2$F$$20240826$20230427$20240904$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386574$RANBAXY$Houben R. Reduced frequency of migraine attacks following coronavirus disease 2019: a case report. J Medical Case Rep. 2023;17:62 (1-4)$57$YR$$M$Y$$$20240904$$HP$DE$DE
222581802$22258180$2$F$$20240813$20230427$20240823$EXP$$CA-AUROBINDO-AUR-APL-2023-032084$AUROBINDO$$57$YR$$F$Y$$$20240823$$HP$CA$CA
222582244$22258224$4$F$20221001$20240812$20230427$20240815$PER$$US-AMGEN-USASP2023070756$AMGEN$$64$YR$A$F$Y$$$20240815$$CN$US$US
222582912$22258291$2$F$$20240829$20230427$20240904$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386724$RANBAXY$Farazmand M, Ferguson J, Green R, Goodlad J. An 11-year mystery. Br J Dermatol. 2022;187 (Suppl. 1):149 (Poster ID: DP12)$45$YR$$M$Y$$$20240904$$HP$GB$GB
222582942$22258294$2$F$$20240903$20230427$20240913$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384641$RANBAXY$Furukawa K, Kikui S, Takeshima T, Yamamoto T, Ozaki A. An adult case of neurocutaneous melanosis with acute exacerbation after a long asymptomatic period following excision of a melanocytic nevus. Rinsho Shinkeigaku. 2021;61 (12):844-850$35$YR$$M$Y$$$20240913$$MD$JP$JP
222583703$22258370$3$F$$20240823$20230427$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03192$LUPIN$$$$$$Y$$$20240912$$CN$US$US
222586415$22258641$5$F$20220311$20240913$20230427$20240921$EXP$$IL-ABBVIE-4332896$ABBVIE$$50$YR$$F$Y$64$KG$20240921$$MD$IL$IL
222586754$22258675$4$F$20230418$20240910$20230427$20240918$EXP$$BR-GSK-BR2023AMR058198$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$BR$BR
222587343$22258734$3$F$$20240918$20230427$20240927$PER$$NVSC2023US096027$NOVARTIS$$$$$M$Y$$$20240927$$MD$US$US
222587447$22258744$7$F$20200213$20240910$20230427$20240919$EXP$$DE-ROCHE-2552257$ROCHE$$29$YR$A$F$Y$$$20240919$$CN$DE$DE
222588243$22258824$3$F$$20240912$20230427$20240927$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386770$RANBAXY$Murray G, Wolinska A, Bowe S, Feighery C. Methotrexate-associated cutaneous lymphomatoid granulomatosis. Br J Dermatol. 2022;187 (Suppl. 1):155 (poster ID: DP24)$74$YR$$F$Y$$$20240927$$HP$IE$IE
222588252$22258825$2$F$$20240718$20230427$20240726$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386763$RANBAXY$Doyle C, Blasco MC, Raghallaigh SN. Disseminated cutaneous Nocardia in a patient on dual immunosuppressant therapy. Br J Dermatol. 2022;187 (Suppl. 1):112(poster id: BI19)$60$YR$$M$Y$$$20240727$$HP$IE$IE
222588353$22258835$3$F$$20230505$20230427$20240925$PER$$US-GSK-US2023AMR059972$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
222588703$22258870$3$F$$20240807$20230427$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-060016$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$80.74$KG$20240808$$CN$US$US
222594676$22259467$6$F$20130101$20240821$20230427$20240904$EXP$$DE-35507-2023-03198$LUPIN$Wiemer-Kruel A. Ketogenic diet therapy under special consideration of treatment of the myoclonic-astatic epilepsy. Journal of Epileptology. 2021;34:154-160$3$YR$$M$Y$$$20240904$$MD$DE$DE
222595916$22259591$6$F$20221001$20240906$20230427$20240920$EXP$$ES-009507513-2304ESP009720$MERCK$Oscar JW, Sanchez J, Hernandez S, Martinez C, Perez A, Tsourokdissian CA, et al.. Sclerodermiform case and pulmonary carcinoma: An atypical non-paraneoplastic case. European Journal of Case Reports in Internal Medicine. 2024;Supplement 1:744-5$64$YR$$F$Y$$$20240920$$MD$ES$ES
222597104$22259710$4$F$20210101$20240718$20230427$20240724$EXP$$GB-MYLANLABS-2023M1042465$MYLAN$$$$$F$Y$$$20240724$$CN$GB$GB
222597466$22259746$6$F$20220101$20240708$20230427$20240716$EXP$$NVSC2022GT023080$NOVARTIS$$$$$F$Y$$$20240716$$CN$GT$GT
222599528$22259952$8$F$20210930$20240725$20230427$20240731$EXP$$CA-PFIZER INC-202101301538$PFIZER$$75$YR$$F$Y$71$KG$20240731$$HP$CA$CA
222599595$22259959$5$F$$20240925$20230427$20240930$EXP$$US-PFIZER INC-PV202300074213$PFIZER$$71$YR$$M$Y$$$20240930$$MD$US$US
222600862$22260086$2$F$$20240812$20230427$20240820$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0200466$SUNOVION$$$$$M$Y$$$20240820$$CN$US$US
222600892$22260089$2$F$20221201$20240808$20230427$20240905$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0200629$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
222605142$22260514$2$F$$20240903$20230427$20240919$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0100825$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
222605752$22260575$2$F$$20240821$20230427$20240823$EXP$$CA-MYLANLABS-2023M1044309$MYLAN$$72$YR$$F$Y$61$KG$20240823$$HP$CA$CA
222606525$22260652$5$F$20230418$20240730$20230427$20240806$EXP$$US-VIIV HEALTHCARE LIMITED-US2023AMR057403$VIIV$$$$$$Y$$$20240806$$CN$US$US
222606783$22260678$3$F$20220101$20240710$20230427$20240712$EXP$$US-INCYTE CORPORATION-2023IN004278$INCYTE$$$$$$Y$$$20240712$$CN$US$US
222609839$22260983$9$F$20230102$20240916$20230427$20240919$EXP$$CA-PFIZER INC-202300003970$PFIZER$$43$YR$$F$Y$$$20240919$$PH$CA$CA
222615156$22261515$6$F$20230410$20240710$20230427$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-059546$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240719$$MD$JP$JP
222615832$22261583$2$F$$20230425$20230427$20240823$PER$$NVSC2023US095644$NOVARTIS$$$$$F$Y$54.88$KG$20240823$$CN$US$US
222619244$22261924$4$F$20230418$20240730$20230428$20240807$EXP$$US-JNJFOC-20230462963$JOHNSON AND JOHNSON$$54$YR$A$$Y$$$20240807$$CN$US$US
222619944$22261994$4$F$$20240711$20230428$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-009395$JAZZ$$$$$F$Y$$$20240722$$HP$US$US
222620576$22262057$6$F$$20240903$20230428$20240917$EXP$$CA-BAXTER-2023BAX019691$BAXTER$$35$YR$$F$Y$$$20240917$$HP$CA$CA
222622522$22262252$2$F$20230331$20240618$20230428$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001498$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240712$$CN$US$US
2226230819$22262308$19$F$20230101$20240711$20230428$20240720$EXP$$CA-CELLTRION INC.-2023CA007455$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
222626166$22262616$6$F$20230101$20240709$20230428$20240717$EXP$$CA-CELLTRION INC.-2023CA008885$CELLTRION$$$$$$Y$$$20240717$$CN$CA$CA
2226268610$22262686$10$F$20230316$20240920$20230428$20240930$EXP$$CA-CELLTRION INC.-2023CA005460$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
222627064$22262706$4$F$$20240830$20230428$20240909$30DAY$$CN-JNJFOC-20230430118$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$CN$CN$CN
222630582$22263058$2$F$$20240815$20230428$20240828$EXP$$CA-AUROBINDO-AUR-APL-2023-032821$AUROBINDO$$36$YR$$M$Y$81$KG$20240828$$HP$CA$CA
222630882$22263088$2$F$$20230421$20230428$20240826$EXP$$NVSC2023US093504$NOVARTIS$$$$$$Y$$$20240826$$CN$US$US
222632162$22263216$2$F$20230122$20240730$20230428$20240801$EXP$FR-AFSSAPS-PV2023000385$FR-ORGANON-O2304FRA002239$ORGANON$$17$YR$$F$Y$36$KG$20240801$$MD$FR$FR
2226346110$22263461$10$F$20230901$20240806$20230428$20240811$EXP$$NVSC2023US093304$NOVARTIS$$74$YR$$F$Y$$$20240812$$CN$US$US
222634782$22263478$2$F$$20240720$20230428$20240731$EXP$$CA-AUROBINDO-AUR-APL-2023-032630$AUROBINDO$$34$YR$$F$Y$81$KG$20240731$$HP$CA$CA
2226350419$22263504$19$F$20230313$20240920$20230428$20240927$EXP$$MX-TAKEDA-2023TUS029151$TAKEDA$$27$YR$$M$Y$53.061$KG$20240927$$CN$MX$MX
222635253$22263525$3$F$$20240814$20230428$20240826$EXP$$CA-AUROBINDO-AUR-APL-2023-032727$AUROBINDO$$39$YR$$F$Y$$$20240826$$MD$CA$CA
222638586$22263858$6$F$20230417$20240906$20230428$20240909$30DAY$$CA-PFIZER INC-202300107389$PFIZER$$45$YR$$M$Y$$$20240909$$CN$CA$CA
222638622$22263862$2$F$20220829$20240830$20230428$20240909$EXP$$BR-CELLTRION INC.-2022BR022350$CELLTRION$$$$$$Y$$$20240909$$CN$BR$BR
222639485$22263948$5$F$20180207$20240718$20230428$20240724$EXP$$GB-MYLANLABS-2023M1042055$MYLAN$$81$YR$$F$Y$$$20240724$$HP$GB$GB
222640332$22264033$2$F$$20240703$20230428$20240718$EXP$$JP-MYOVANT SCIENCES GMBH-2023MYSCI0400582$MYOVANT SCIENCES$Sugiyama M. et al.. A case of adenomyosis uteri that was difficult to treat with conservative endocrine therapy - long-term administration of relugolix.. The Journal of the Saitama Medical Society. 2024;58(1):267-270$24$YR$$F$Y$39$KG$20240718$$HP$JP$JP
222640697$22264069$7$F$20210226$20240802$20230428$20240807$EXP$$NVSC2023GB096947$NOVARTIS$$$$$F$Y$64$KG$20240807$$MD$GB$GB
222642002$22264200$2$F$20221201$20240730$20230428$20240806$EXP$$US-ROCHE-3335090$ROCHE$$47$YR$A$F$Y$100.24$KG$20240806$$CN$US$US
222642083$22264208$3$F$$20240723$20230428$20240725$PER$$US-PFIZER INC-202200229519$PFIZER$$77$YR$$F$Y$$$20240725$$MD$US$US
222642405$22264240$5$F$$20240909$20230428$20240912$EXP$$US-TAKEDA-2023TUS042034$TAKEDA$$$$$F$Y$$$20240912$$CN$US$US
222642425$22264242$5$F$20221007$20240820$20230428$20240822$EXP$$CA-TAKEDA-2022TUS033181$TAKEDA$$51$YR$$F$Y$$$20240822$$CN$CA$CA
2226444711$22264447$11$F$$20240905$20230428$20240909$EXP$$NVSC2023US093703$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
222646023$22264602$3$F$20230123$20240715$20230428$20240729$EXP$$DE-ROCHE-3340350$ROCHE$$45$YR$A$F$Y$62$KG$20240729$$MD$DE$DE
222647822$22264782$2$F$$20240910$20230428$20240918$EXP$$CA-ROCHE-3334910$ROCHE$$$$A$F$Y$$$20240918$$MD$CA$CA
222649782$22264978$2$F$20230312$20240802$20230428$20240815$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0300340$SUNOVION$$99$YR$$M$Y$$$20240815$$CN$US$US
222650267$22265026$7$F$20230201$20240110$20230428$20240718$EXP$$US-Taiho Oncology Inc-2023-000602$TAIHO ONCOLOGY INC$$79$YR$E$M$Y$$$20240718$$CN$US$US
222650403$22265040$3$F$20230112$20240909$20230428$20240914$EXP$$KR-TAKEDA-2023TUS042163$TAKEDA$$29$YR$$M$Y$78.9$KG$20240914$$MD$KR$KR
222651703$22265170$3$F$$20240805$20230428$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03243$LUPIN$$$$$$Y$$$20240821$$CN$US$US
222653074$22265307$4$F$20230318$20240916$20230428$20240923$EXP$$US-ABBVIE-4703297$ABBVIE$$79$YR$$F$Y$$$20240923$$CN$US$US
222653224$22265322$4$F$20230306$20240905$20230428$20240910$EXP$$ES-AMGEN-ESPNI2023070572$AMGEN$$72$YR$E$F$Y$97$KG$20240910$$MD$ES$ES
222653847$22265384$7$F$20220606$20240730$20230428$20240802$EXP$$CA-PFIZER INC-202200034193$PFIZER$$67$YR$$M$Y$$$20240802$$MD$CA$CA
222663835$22266383$5$F$20230127$20240718$20230428$20240725$EXP$$JP-009507513-2304JPN003516J$MERCK$$8$DEC$$F$Y$$$20240725$$MD$JP$JP
222666653$22266665$3$F$$20240812$20230428$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03305$LUPIN$$$$$$Y$$$20240829$$CN$US$US
222666842$22266684$2$F$$20240917$20230428$20240926$EXP$$NVSC2023US096178$NOVARTIS$Guevara-Rodriguez N, Flores-Chang M, Chilakala A, Contreras J, Perdomo P, Liliya G. A rare adverse event of atorvastatin inducing leukocytoclastic vasculitis with ANCA-negative (Anti-Neutrophil cytoplasmic antibody) case report and literature review. CLINICAL CASE REPORTS. 2023;11(3):1-5$55$YR$$F$Y$$$20240926$$HP$US$US
222666905$22266690$5$F$20230201$20240803$20230428$20240829$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0200428$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
222668162$22266816$2$F$$20240909$20230428$20240910$EXP$$US-TAKEDA-2023TUS042601$TAKEDA$$$$$F$Y$$$20240910$$CN$US$US
222668635$22266863$5$F$$20240725$20230428$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-061299$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240729$$CN$US$US
222671796$22267179$6$F$$20240805$20230428$20240812$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-060485$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240812$$MD$JP$JP
222672022$22267202$2$F$$20240905$20230428$20240916$EXP$$CA-MYLANLABS-2023M1043169$MYLAN$Elkrief L, Payette O, Foucault J-N, Longpre-Poirier C, Richard M, Desbeaumes Jodoin V, et al.. Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report.. Front-Psychiatry. 2022;13:1-7$43$YR$$M$Y$$$20240916$$HP$CA$CA
222675313$22267531$3$F$$20240815$20230429$20240820$PER$$US-PFIZER INC-PV202200120185$PFIZER$$87$YR$$F$Y$$$20240820$$CN$US$US
222676003$22267600$3$F$$20240812$20230430$20240823$EXP$$CA-AUROBINDO-AUR-APL-2023-032808$AUROBINDO$$44$YR$$F$Y$60$KG$20240823$$HP$CA$CA
222676042$22267604$2$F$$20240819$20230430$20240829$EXP$$CA-AUROBINDO-AUR-APL-2023-032875$AUROBINDO$$$$$$Y$$$20240829$$MD$CA$CA
222676213$22267621$3$F$$20240809$20230430$20240821$EXP$$CA-AUROBINDO-AUR-APL-2023-032091$AUROBINDO$Espino PH, Burneo JG, Moscol G, Gofton T, MacDougall K, Suller Marti A. Long-term outcomes after NORSE: Treatment with vagus nerve stimulation. Epilepsia Open. 2022;7(4)::822-828.$37$YR$$F$Y$$$20240821$$HP$CA$CA
222676223$22267622$3$F$$20240814$20230430$20240827$EXP$$CA-AUROBINDO-AUR-APL-2023-032702$AUROBINDO$$68$YR$$F$Y$48$KG$20240827$$HP$CA$CA
222679363$22267936$3$F$20230419$20230425$20230430$20240904$EXP$$NVSC2023US095459$NOVARTIS$$65$YR$$F$Y$77.11$KG$20240904$$CN$US$US
222679594$22267959$4$F$$20240918$20230430$20240920$PER$$NVSC2023US093906$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
222679923$22267992$3$F$$20240712$20230430$20240716$PER$$NVSC2023US097356$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
222680634$22268063$4$F$20230401$20240918$20230430$20240930$PER$$NVSC2023US095347$NOVARTIS$$51$YR$$F$Y$$$20240930$$CN$US$US
222680876$22268087$6$F$$20240731$20230430$20240801$PER$$NVSC2023US097459$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
222681024$22268102$4$F$$20240917$20230430$20240920$PER$$NVSC2023US095595$NOVARTIS$$$$$M$Y$$$20240921$$CN$US$US
222681156$22268115$6$F$$20240802$20230430$20240806$PER$$NVSC2023US098695$NOVARTIS$$$$$F$Y$70$KG$20240806$$CN$US$US
222682294$22268229$4$F$$20240719$20230430$20240723$PER$$US-PFIZER INC-PV202300074808$PFIZER$$69$YR$$F$Y$$$20240723$$MD$US$US
222682552$22268255$2$F$$20240807$20230430$20240815$PER$$US-SA-2023SA126965$SANOFI AVENTIS$$$$T$M$Y$50$KG$20240815$$MD$US$US
222682652$22268265$2$F$20230101$20240620$20230430$20240702$PER$$US-SA-2023SA128023$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240702$$CN$US$US
222683602$22268360$2$F$$20240913$20230430$20240927$PER$$US-SA-2023SA131113$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240927$$MD$US$US
222683694$22268369$4$F$$20240902$20230430$20240925$PER$$US-SA-2023SA129849$SANOFI AVENTIS$$$$A$M$Y$$$20240925$$MD$US$US
222683972$22268397$2$F$20230101$20240823$20230430$20240917$PER$$US-SA-2023SA130049$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240918$$MD$US$US
222684906$22268490$6$F$20240411$20240705$20230430$20240716$PER$$US-SA-2023SA131948$SANOFI AVENTIS$$63$YR$A$M$Y$91.7$KG$20240716$$CN$US$US
222685712$22268571$2$F$20220613$20240815$20230430$20240828$PER$$US-SA-2023SA131489$SANOFI AVENTIS$$64$YR$A$M$Y$122.4$KG$20240828$$MD$US$US
222687134$22268713$4$F$20220314$20240826$20230501$20240829$EXP$$JP-TAKEDA-2023TJP004110$TAKEDA$$32$YR$$F$Y$36.6$KG$20240829$$MD$JP$JP
222692182$22269218$2$F$20210101$20240829$20230501$20240904$EXP$$BR-ORGANON-O2304BRA002734$ORGANON$$$$$F$Y$90$KG$20240904$$CN$BR$BR
222692385$22269238$5$F$$20240720$20230501$20240726$EXP$$CA-ASTELLAS-2023US012858$ASTELLAS$$63$YR$$M$Y$$$20240726$$CN$CA$CA
222692955$22269295$5$F$20230401$20240725$20230501$20240805$EXP$$US-SA-2023SA131778$SANOFI AVENTIS$$31$YR$A$F$Y$49.8$KG$20240805$$MD$US$US
222693437$22269343$7$F$20221111$20240628$20230501$20240701$EXP$$NVSC2022RU279245$NOVARTIS$$42$YR$$F$Y$60$KG$20240701$$MD$RU$RU
222695804$22269580$4$F$20230322$20240729$20230501$20240802$EXP$$GR-MYLANLABS-2023M1045621$MYLAN$$87$YR$$M$Y$60$KG$20240802$$MD$GR$GR
222696056$22269605$6$F$$20240819$20230501$20240826$EXP$$BR-TAKEDA-2023TUS042649$TAKEDA$$$$$F$Y$40$KG$20240826$$CN$BR$BR
2226985810$22269858$10$F$20230401$20240813$20230501$20240819$30DAY$$US-PFIZER INC-PV202300074888$PFIZER$$14$YR$$M$Y$$$20240819$$CN$US$US
222698802$22269880$2$F$20240101$20240819$20230501$20240829$PER$$US-VERTEX PHARMACEUTICALS-2023-006032$VERTEX$$$$A$$Y$$$20240829$$CN$US$US
222700285$22270028$5$F$20230101$20240819$20230501$20240910$EXP$$US-SA-2023SA133014$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240910$$MD$US$US
222703139$22270313$9$F$20230314$20240618$20230501$20240703$EXP$$JP-AMGEN-JPNNI2023072664$AMGEN$Takenaka Y, Ishida K, Ikoma M, Ueda S, Hosokawa T, Fujiwara H. A case of microscopic polyangiitis with severe liver damage during administration of avacopan. The 68th General Assembly and Scientific Meeting of the Japan College of Rheumatology. 2024 APR;.$79$YR$E$F$Y$40.2$KG$20240702$$MD$JP$JP
222703408$22270340$8$F$20230401$20240816$20230501$20240819$EXP$$CA-TAKEDA-2023TUS042404$TAKEDA$$52$YR$$F$Y$$$20240819$$CN$CA$CA
222703413$22270341$3$F$$20230425$20230501$20240808$EXP$$US-OTSUKA-2023_010956$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
222704153$22270415$3$F$$20230425$20230501$20240808$EXP$$US-OTSUKA-2023_010973$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
222704525$22270452$5$F$20130101$20240822$20230501$20240830$EXP$$DE-ADVANZ PHARMA-202106006750$ADVANZ PHARMA$$$$$$Y$$$20240830$$MD$DE$DE
222705598$22270559$8$F$$20240801$20230501$20240802$PER$$US-PFIZER INC-PV202300076510$PFIZER$$82$YR$$F$Y$$$20240802$$MD$US$US
222705983$22270598$3$F$$20230425$20230501$20240808$EXP$$US-OTSUKA-2023_011007$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
222707667$22270766$7$F$$20240923$20230501$20240924$EXP$$US-PFIZER INC-PV202300075757$PFIZER$$82$YR$$F$Y$64.399$KG$20240924$$CN$US$US
222710078$22271007$8$F$$20240816$20230501$20240822$PER$$US-BIOGEN-2023BI01202279$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
222711489$22271148$9$F$20210727$20240809$20230501$20240819$EXP$$CA-TAKEDA-2023TUS043338$TAKEDA$$55$YR$$F$Y$$$20240819$$CN$CA$CA
222711755$22271175$5$F$20240506$20240715$20230501$20240717$EXP$$CA-TAKEDA-2023TUS042333$TAKEDA$$59$YR$$M$Y$$$20240717$$MD$CA$CA
222712352$22271235$2$F$20210703$20240813$20230501$20240819$EXP$$CA-TAKEDA-2023TUS042302$TAKEDA$$59$YR$$M$Y$$$20240819$$MD$CA$CA
222713062$22271306$2$F$$20240809$20230501$20240820$EXP$$CA-HLS-202300952$HLS THERAPEUTICS$$$$A$M$Y$$$20240820$$HP$CA$CA
222713403$22271340$3$F$20230105$20240917$20230501$20240926$EXP$$CA-TAKEDA-2022TUS042223$TAKEDA$$59$YR$$F$Y$$$20240926$$CN$CA$CA
222714243$22271424$3$F$$20240715$20230501$20240801$EXP$$US-BIOGEN-2023BI01201903$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
222714867$22271486$7$F$$20240702$20230501$20240705$EXP$$US-PFIZER INC-PV202300076689$PFIZER$$85$YR$$F$Y$$$20240705$$CN$US$US
2227178511$22271785$11$F$20230101$20240801$20230502$20240809$EXP$$CA-CELLTRION INC.-2023CA004743$CELLTRION$$$$$$Y$$$20240809$$HP$CA$CA
222721353$22272135$3$F$20230323$20240725$20230502$20240805$EXP$$CA-SAMSUNG BIOEPIS-SB-2023-08619$SAMSUNG BIOEPIS$$32$YR$A$F$Y$$$20240805$$CN$CA$CA
222722782$22272278$2$F$$20240801$20230502$20240802$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-386842$RANBAXY$Weber S, Allgeier J, Denk G, Gerbes AL. Marked Increase of Gamma-Glutamyltransferase as an Indicator of Drug-Induced Liver Injury in Patients without Conventional Diagnostic Criteria of Acute Liver Injury. Visc Med. 2022;38(3):223-228$50$YR$$M$Y$$$20240802$$HP$DE$DE
222722962$22272296$2$F$$20240829$20230502$20240913$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386516$RANBAXY$Megna M, Battista T, Potestio L, Ruggiero A, Ventura V, Fabbrocini G, et al. A case of erythrodermic psoriasis rapidly and successfully treated with Bimekizumab. J Cosmet Dermatol. 2023;22(3):1146-1148$40$YR$$M$Y$$$20240913$$MD$IT$IT
222723302$22272330$2$F$$20240806$20230502$20240812$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-386799$RANBAXY$Chou P-H, Sack AT, Su K-P. Targeting Three Brain Regions (Bilateral SMA, Left and Right DLPFC) Sequentially in One Session Using Combined Repetitive Transcranial Magnetic Stimulation and Intermittent Theta-burst Stimulation in Treatment-refractory Obsessive-compulsive Disorder: A Case Report. Clin Psychopharmacol Neurosci. 2022;20(4):773-776$18$YR$$F$Y$$$20240812$$HP$TW$TW
222724729$22272472$9$F$20210101$20240910$20230502$20240918$EXP$$CA-CELLTRION INC.-2021CA018974$CELLTRION$$$$$$Y$$$20240918$$CN$CA$CA
222724843$22272484$3$F$20230101$20240807$20230502$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03245$LUPIN$$$$$$Y$$$20240829$$CN$US$US
222725946$22272594$6$F$20231108$20240814$20230502$20240816$EXP$$CA-TAKEDA-2023TUS042150$TAKEDA$$25$YR$$M$Y$$$20240816$$MD$CA$CA
222726364$22272636$4$F$$20240809$20230502$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03300$LUPIN$$$$$$Y$$$20240828$$CN$US$US
222726445$22272644$5$F$$20240819$20230502$20240823$EXP$$CA-TAKEDA-2023TUS042668$TAKEDA$$$$$F$Y$$$20240823$$HP$CA$CA
222727252$22272725$2$F$$20240726$20230502$20240730$PER$$NVSC2023US098895$NOVARTIS$$$$$M$Y$$$20240730$$CN$US$US
222727404$22272740$4$F$20230101$20240805$20230502$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03344$LUPIN$$$$$$Y$$$20240904$$CN$US$US
222727763$22272776$3$F$20230101$20240830$20230502$20240912$EXP$$US-CIPLA LTD.-2023US01824$CIPLA$$$$$$Y$$$20240912$$HP$US$US
222727772$22272777$2$F$$20240215$20230502$20240830$PER$$US-CIPLA LTD.-2023US01064$CIPLA$$$$$$Y$$$20240830$$CN$US$US
222727782$22272778$2$F$20230301$20240619$20230502$20240830$PER$$US-CIPLA LTD.-2023US01470$CIPLA$$$$$$Y$$$20240830$$CN$US$US
222728012$22272801$2$F$$20240715$20230502$20240718$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386013$RANBAXY$Xu S-X, Xie X-H, Su  D, Liu Z. Electroconvulsive Therapy in a Young Adult Patient With Bipolar Depression and Dysembryoplastic Neuroepithelial Tumor A Case Report. J ECT. 2023;Mar 01;39(1):61-62.$18$YR$$F$Y$$$20240718$$MD$CN$CN
222728022$22272802$2$F$$20240717$20230502$20240718$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387015$RANBAXY$Weber S, Allgeier J, Denk G, Gerbes AL. Marked Increase of Gamma-Glutamyltransferase as an Indicator of Drug-Induced Liver Injury in Patients without Conventional Diagnostic Criteria of Acute Liver Injury. Visc Med. 2022;38(3):223-228$22$YR$$F$Y$$$20240718$$HP$DE$DE
222729387$22272938$7$F$20230508$20240710$20230502$20240712$EXP$$CA-TAKEDA-2021TUS052340$TAKEDA$$46$YR$$F$Y$$$20240712$$CN$CA$CA
222729476$22272947$6$F$20220713$20240913$20230502$20240923$EXP$$CA-CELLTRION INC.-2022CA007360$CELLTRION$$$$$$Y$$$20240923$$MD$CA$CA
222730102$22273010$2$F$$20230426$20230502$20240717$EXP$$AT-ASTELLAS-2023US013344$ASTELLAS$$50$YR$$M$Y$$$20240717$$CN$AT$AT
222730337$22273033$7$F$20231122$20240715$20230502$20240718$EXP$$US-TAKEDA-US201827889$TAKEDA$$38$YR$$F$Y$62$KG$20240718$$CN$US$US
222730593$22273059$3$F$$20240815$20230502$20240820$EXP$$CA-TAKEDA-2022TUS085896$TAKEDA$$$$$M$Y$$$20240820$$CN$CA$CA
222730649$22273064$9$F$20221122$20240709$20230502$20240712$EXP$$US-TAKEDA-US202003377$TAKEDA$$65$YR$$F$Y$80$KG$20240712$$HP$US$US
222731373$22273137$3$F$20180718$20240814$20230502$20240819$EXP$$AU-AstraZeneca-2023A099394$ASTRAZENECA$$52$YR$$F$Y$$$20240819$$MD$AU$
2227316510$22273165$10$F$20220922$20240715$20230502$20240718$EXP$$CA-TAKEDA-2022TUS095858$TAKEDA$$59$YR$$F$Y$$$20240718$$MD$CA$CA
222732812$22273281$2$F$20211003$20240807$20230502$20240812$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-386522$RANBAXY$$15$YR$$F$Y$80$KG$20240812$$MD$FR$FR
222733022$22273302$2$F$$20240702$20230502$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-386673$RANBAXY$$16$YR$$M$Y$$$20240702$$MD$FR$FR
222733092$22273309$2$F$20230220$20240828$20230502$20240904$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-386728$RANBAXY$$84$YR$$F$Y$92.5$KG$20240904$$MD$FR$FR
222735383$22273538$3$F$$20240827$20230502$20240905$EXP$$CA-AUROBINDO-AUR-APL-2023-033510$AUROBINDO$$52$YR$$F$Y$$$20240905$$HP$CA$CA
222735837$22273583$7$F$20230101$20240826$20230502$20240919$PER$$CA-TOLMAR, INC.-23CA040322$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
222736113$22273611$3$F$$20240919$20230502$20240930$30DAY$$CL-JNJFOC-20230446812$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$PH$CL$CL
222737164$22273716$4$F$$20240722$20230502$20240724$PER$$US-PFIZER INC-PV202300023844$PFIZER$$79$YR$$M$Y$87.982$KG$20240724$$MD$US$US
222739183$22273918$3$F$20230201$20240816$20230502$20240828$EXP$FR-AFSSAPS-RN2023000299$FR-Accord-355677$ACCORD$$55$YR$A$M$Y$$$20240828$$MD$FR$FR
222739805$22273980$5$F$20190903$20231129$20230502$20240926$EXP$$PHHY2019CA215445$NOVARTIS$$52$YR$$F$Y$$$20240926$$MD$CA$CA
222740013$22274001$3$F$20211101$20240625$20230502$20240702$PER$$US-BIOGEN-2021BI01066794$BIOGEN$$63$YR$$F$Y$$$20240702$$CN$US$US
222740292$22274029$2$F$$20240926$20230502$20240930$EXP$$US-PFIZER INC-PV202300078205$PFIZER$$83$YR$$F$Y$$$20240930$$CN$US$US
2227415510$22274155$10$F$$20240918$20230502$20240923$EXP$$CA-PFIZER INC-202201179484$PFIZER$$43$YR$$F$Y$$$20240923$$CN$CA$CA
2227423312$22274233$12$F$20230101$20240806$20230502$20240816$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-23-00199$CATALYST PHARMA$$$$$F$Y$89.615$KG$20240816$$CN$US$US
222742663$22274266$3$F$20220628$20240725$20230502$20240802$EXP$$US-AMNEAL PHARMACEUTICALS-2022-AMRX-02497$AMNEAL$$4$YR$$M$Y$18.594$KG$20240802$$HP$US$US
222743762$22274376$2$F$$20240619$20230502$20240704$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387026$RANBAXY$Moliner-Moron T, Santiago-Cortes R, Ayerza-Casas A, Clavero-Adell M, Jimenez-Montanes L, Palanca-Arias D. Atrial flutter without structural heart disease in pediatrics a retrospective review of cases in the Hospital Infantil Miguel Servet, Zaragoza, Spain. Bol Med Hosp Infant Mex. 2022;79(5):334-339$11$YR$$M$Y$$$20240704$$HP$ES$ES
222743782$22274378$2$F$$20240702$20230502$20240703$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387098$RANBAXY$Affinita MC, Merks JHM, Chisholm JC, Haouy S, Rome A, Rabusin M et al. Rhabdomyosarcoma with unknown primary tumor site: A report from European pediatric Soft tissue sarcoma Study Group (EpSSG). Pediatr Blood Cancer. 2022;69:e29967(1-6)$$$$F$Y$$$20240703$$HP$IT$IT
222745324$22274532$4$F$$20240708$20230502$20240723$EXP$001028218$CA-ASSERTIO THERAPEUTICS, INC.-CA-2023AST000092$ASSERTIO THERAPEUTICS$$44$YR$$F$Y$97$KG$20240723$$HP$CA$CA
222748882$22274888$2$F$20230101$20230718$20230502$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300041$RVL PHARMACEUTICALS$$79$YR$E$F$Y$$$20240815$$$US$US
222750954$22275095$4$F$20231122$20240712$20230502$20240720$EXP$$BR-TAKEDA-2021TUS055101$TAKEDA$$67$YR$$F$Y$72.6$KG$20240720$$CN$BR$BR
222752546$22275254$6$F$20230330$20240830$20230502$20240903$EXP$$JP-ARGENX-2022-ARGX-JP002716$ARGENX BVBA$$$$$$Y$$$20240903$$MD$JP$JP
222753335$22275333$5$F$20230101$20240701$20230502$20240710$EXP$$JP-JAZZ PHARMACEUTICALS-2023-JP-009670$JAZZ$$46$YR$$M$Y$$$20240710$$MD$JP$JP
222755392$22275539$2$F$$20240719$20230502$20240722$PER$$NVSC2023US100141$NOVARTIS$$$$$M$Y$$$20240723$$CN$US$US
222757623$22275762$3$F$20221101$20240808$20230502$20240816$PER$$US-SA-2023SA133471$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240816$$MD$US$US
222757855$22275785$5$F$20230418$20240820$20230502$20240822$EXP$$US-SA-2023SA133036$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240822$$MD$US$US
222758282$22275828$2$F$$20240820$20230502$20240829$PER$$US-SA-2023SA133029$SANOFI AVENTIS$$$$A$M$Y$$$20240829$$CN$US$US
222760897$22276089$7$F$20231012$20240729$20230502$20240809$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000140$THERATECHNOLOGIES$$$$$$Y$$$20240809$$CN$US$US
222761048$22276104$8$F$20230407$20240702$20230502$20240715$EXP$$JP-HORIZON THERAPEUTICS-HZN-2023-003108$AMGEN$$60$YR$A$F$Y$38.7$KG$20240715$$HP$JP$JP
222763112$22276311$2$F$$20240726$20230502$20240806$EXP$$FR-ROCHE-3341966$ROCHE$$$$$F$Y$$$20240806$$MD$FR$FR
222763746$22276374$6$F$$20240829$20230503$20240923$PER$$CA-TOLMAR, INC.-23CA040377$TOLMAR$$$$$M$Y$$$20240923$$CN$CA$CA
222763759$22276375$9$F$20230101$20240826$20230503$20240919$PER$$CA-TOLMAR, INC.-23CA040311$TOLMAR$$66$YR$$M$Y$$$20240919$$CN$CA$CA
222764465$22276446$5$F$20221201$20240727$20230503$20240823$PER$$CA-TOLMAR, INC.-23CA040281$TOLMAR$$70$YR$$M$Y$$$20240823$$CN$CA$CA
222764857$22276485$7$F$20230325$20240702$20230503$20240709$EXP$$NVSC2023IN099164$NOVARTIS$$57$YR$$M$Y$$$20240709$$CN$IN$IN
222765804$22276580$4$F$$20240710$20230503$20240717$EXP$$US-TAKEDA-2022TUS083106$TAKEDA$$$$$F$Y$68$KG$20240717$$CN$US$US
222765925$22276592$5$F$20230401$20230626$20230503$20240925$PER$$US-GSK-US2023AMR062161$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
222766572$22276657$2$F$20221121$20240815$20230503$20240820$EXP$FR-AFSSAPS-PV2023000390$FR-ROCHE-3340619$ROCHE$$61$YR$A$M$Y$$$20240820$$MD$FR$FR
222766982$22276698$2$F$$20240903$20230503$20240912$EXP$$CA-AUROBINDO-AUR-APL-2023-032897$AUROBINDO$$69$YR$$F$Y$$$20240912$$HP$CA$CA
222769103$22276910$3$F$20230401$20240805$20230503$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03299$LUPIN$$$$$$Y$$$20240828$$CN$US$US
2227709018$22277090$18$F$20221220$20240726$20230503$20240802$EXP$$CA-CELLTRION INC.-2023CA000466$CELLTRION$$$$$$Y$$$20240802$$HP$CA$CA
222771002$22277100$2$F$$20240926$20230503$20240930$PER$$US-SA-2023SA135792$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$CN$US$US
222771247$22277124$7$F$20230101$20240907$20230503$20240917$EXP$$CA-CELLTRION INC.-2022CA007984$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
222771542$22277154$2$F$$20240801$20230503$20240806$30DAY$$US-GSK-US2023059634$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$CN$US$US
222774444$22277444$4$F$$20240723$20230503$20240802$EXP$$JP-009507513-2304JPN003839J$MERCK$Nagamori M, Fukuda C, Kaneko Y, Shinohara R, Wakata K, Kawai Y, et al.. EP-0116 A Case of Squamous Cell Carcinoma of the Breast with Rapid Progress. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 206$59$YR$$F$Y$$$20240802$$MD$JP$JP
222774955$22277495$5$F$20230401$20240911$20230503$20240914$EXP$$US-ABBVIE-4749855$ABBVIE$$43$YR$$M$Y$$$20240914$$CN$US$US
222775472$22277547$2$F$20230401$20240809$20230503$20240816$PER$$US-SA-2023SA136060$SANOFI AVENTIS$$5$YR$C$F$Y$24.94$KG$20240816$$MD$US$US
222776707$22277670$7$F$20230131$20240903$20230503$20240904$EXP$$CA-TAKEDA-2023TUS042784$TAKEDA$$46$YR$$F$Y$$$20240904$$MD$CA$CA
222776944$22277694$4$F$$20240708$20230503$20240716$EXP$$CA-CELLTRION INC.-2023CA008924$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
222777028$22277702$8$F$20230101$20240801$20230503$20240813$EXP$$US-INSMED, INC.-2023-01494-US$INSMED$$$$$M$Y$$$20240813$$CN$US$US
222779795$22277979$5$F$$20230531$20230503$20240925$EXP$$US-GSK-US2023AMR060728$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
222779917$22277991$7$F$20230801$20240911$20230503$20240918$EXP$$CA-GSK-CA2023AMR058251$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$CA$CA
222780063$22278006$3$F$$20240909$20230503$20240913$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386694$RANBAXY$Evers S, Buchheister A, Reichelt D, Husstedt IW, Frese A. Botulinum Toxin A Treatment in HIV Infected Patients-A Long-Term Observational Study. J Clin Med. 2022;Apr 14; 11:2197(1-7)$54$YR$$M$Y$$$20240913$$HP$DE$DE
222780072$22278007$2$F$$20240703$20230503$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386810$RANBAXY$Strange K, Cooley A, Monroe K, Shaughnessy E, Wu CL. It^s not the shunt: an atypical cause of fever in an infant with hydrocephalus. Am J Med Sci. 2023;365 (Suppl. 1):S26; abs 46$5$YR$$M$Y$$$20240703$$HP$US$US
222780092$22278009$2$F$$20240830$20230503$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386960$RANBAXY$Bresler SC, Menge TD, Tejasvi T, Carty SA, Hristov AC. Two cases of challenging cutaneous lymphoid infiltrates presenting in the context of COVID-19 vaccination: A reactive lymphomatoid papulosis-like eruption and a bona fide lymphoma. J Cutan Pathol. 2022;1-7$62$YR$$F$Y$$$20240904$$MD$US$US
222780322$22278032$2$F$$20240717$20230503$20240718$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-386511$RANBAXY$Can AT, Hermens DF, Lagopoulos J. A unique case of very low-dose subcutaneous ketamine use: Maintenance option of ketamine for treatment-resistant depression. Clin Case Rep. 2022;10(12):e6675$42$YR$$M$Y$$$20240718$$HP$AU$AU
222780702$22278070$2$F$$20240826$20230503$20240826$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387149$RANBAXY$He W, Zhu Y, Zhang Y, Dong L, Zhou Z, Zhou J. A case report on recurrent alternating Tolosa?Hunt syndrome due to bacterial sphenoid sinusitis: rediscussing the diagnostic terminology and classification. BMC Neurol. 2023;23(1):25$34$YR$$F$Y$$$20240826$$HP$CN$CN
222781266$22278126$6$F$$20240906$20230503$20240911$EXP$$CA-GSK-CA2023062128$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$MD$CA$CA
222782275$22278227$5$F$20230326$20240826$20230503$20240903$EXP$$JP-AstraZeneca-2023A099979$ASTRAZENECA$$73$YR$$F$Y$$$20240903$$MD$JP$
222783864$22278386$4$F$20230401$20230605$20230503$20240925$PER$$US-GSK-US2023AMR061454$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
222786183$22278618$3$F$$20240718$20230503$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-063003$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$68$KG$20240731$$HP$CA$CA
222787692$22278769$2$F$$20240819$20230503$20240821$PER$$US-PFIZER INC-PV202300076315$PFIZER$$70$YR$$F$Y$$$20240821$$MD$US$US
222788883$22278888$3$F$20230419$20240717$20230503$20240723$PER$$US-BIOGEN-2021BI00980362$BIOGEN$$19$YR$$F$Y$$$20240723$$CN$US$US
222788928$22278892$8$F$20220329$20240628$20230503$20240708$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2022-12188$IPSEN$$72$YR$E$F$Y$$$20240708$$MD$JP$JP
222789067$22278906$7$F$20230126$20240912$20230503$20240918$EXP$$US-TAKEDA-2022TUS017303$TAKEDA$$49$YR$$F$Y$$$20240918$$CN$US$US
2227903617$22279036$17$F$$20240916$20230503$20240920$EXP$$CA-AMGEN-CANSP2023075764$AMGEN$$50$YR$A$F$Y$68$KG$20240919$$HP$CA$CA
222790812$22279081$2$F$20210501$20240703$20230503$20240708$PER$$US-PFIZER INC-2021840507$PFIZER$$26$YR$$F$Y$$$20240708$$HP$US$US
222790934$22279093$4$F$20240628$20240716$20230503$20240717$EXP$$US-PFIZER INC-PV202300030592$PFIZER$$62$YR$$M$Y$$$20240717$$HP$US$US
222791002$22279100$2$F$20210101$20240626$20230503$20240701$EXP$$CA-BIOGEN-2023BI01201982$BIOGEN$$$$$F$Y$$$20240630$$HP$CA$CA
222793679$22279367$9$F$20230201$20240815$20230503$20240819$EXP$$US-PFIZER INC-202300173726$PFIZER$$78$YR$$M$Y$135.14$KG$20240819$$CN$US$US
222793883$22279388$3$F$20230401$20240725$20230503$20240729$PER$$US-AMGEN-USASP2023076286$AMGEN$$72$YR$E$M$Y$$$20240729$$CN$US$US
222793922$22279392$2$F$$20240830$20230503$20240904$PER$$US-PFIZER INC-PV202300077404$PFIZER$$68$YR$$F$Y$$$20240904$$CN$US$US
222795456$22279545$6$F$$20240920$20230503$20240926$EXP$$US-TAKEDA-2023TUS041542$TAKEDA$$$$$F$Y$94.082$KG$20240926$$MD$US$US
222795722$22279572$2$F$$20230421$20230503$20240916$EXP$$GB-INCYTE CORPORATION-2023IN004472$INCYTE$$$$$$Y$$$20240916$$MD$GB$GB
222796273$22279627$3$F$20210201$20240815$20230503$20240820$PER$$US-PFIZER INC-202300173922$PFIZER$$78$YR$$M$Y$135.17$KG$20240820$$CN$US$US
2227965910$22279659$10$F$20220817$20240823$20230503$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-029354$JAZZ$$27$YR$$M$Y$57$KG$20240827$$MD$US$US
222796705$22279670$5$F$$20240723$20230503$20240726$PER$$US-PFIZER INC-PV202300043426$PFIZER$$65$YR$$M$Y$$$20240726$$CN$US$US
222797535$22279753$5$F$20230106$20240829$20230503$20240906$EXP$$JP-009507513-2301JPN002328J$MERCK$$70$YR$$M$Y$$$20240906$$MD$JP$JP
222798957$22279895$7$F$$20240809$20230503$20240813$PER$$US-PFIZER INC-PV202200082566$PFIZER$$78$YR$$F$Y$$$20240813$$CN$US$US
222799397$22279939$7$F$20230327$20240626$20230503$20240705$EXP$$US-BAXTER-2023BAX020182$BAXTER$$18$YR$$F$Y$151.1$KG$20240705$$HP$US$US
222800153$22280015$3$F$$20240808$20230503$20240818$30DAY$$US-GSK-US2023GSK060859$GLAXOSMITHKLINE$$$$$F$Y$$$20240818$$MD$US$US
222800516$22280051$6$F$20230425$20240920$20230503$20240925$EXP$$CA-MYLANLABS-2023M1027964$MYLAN$$61$YR$$F$Y$$$20240925$$CN$CA$CA
222800563$22280056$3$F$20130812$20240805$20230503$20240808$EXP$$CA-BIOGEN-2023BI01202202$BIOGEN$$42$YR$$F$Y$$$20240808$$CN$CA$CA
222802052$22280205$2$F$$20240731$20230503$20240805$EXP$$CA-TAKEDA-2023TUS019851$TAKEDA$$$$$M$Y$$$20240805$$CN$CA$CA
222802474$22280247$4$F$20230101$20240814$20230503$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-063068$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240822$$HP$US$US
222805593$22280559$3$F$$20230425$20230503$20240902$PER$$NVSC2023US097224$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
222808574$22280857$4$F$20230421$20240709$20230503$20240718$EXP$$BR-CELLTRION INC.-2023BR009124$CELLTRION$$$$$$Y$$$20240718$$CN$BR$BR
222809625$22280962$5$F$20230401$20240624$20230503$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-063326$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$86.18$KG$20240705$$CN$US$US
222810124$22281012$4$F$20230428$20240919$20230504$20240923$EXP$$CA-ROCHE-3342638$ROCHE$$38$YR$A$F$Y$$$20240923$$CN$CA$CA
222810272$22281027$2$F$$20240820$20230504$20240830$PER$$US-SA-2023SA134705$SANOFI AVENTIS$$64$YR$A$F$Y$79.3$KG$20240830$$MD$US$US
2228111310$22281113$10$F$$20240918$20230504$20240924$EXP$$CA-Orion Corporation ORION PHARMA-22_00020346$ORION$$43$YR$A$F$Y$$$20240924$$HP$CA$
222813303$22281330$3$F$20230101$20240923$20230504$20240925$EXP$$US-GBT-022102$PFIZER$$33$YR$$F$Y$$$20240925$$HP$US$US
222816662$22281666$2$F$20230313$20240717$20230504$20240725$EXP$FR-AFSSAPS-ST2023000524$FR-SA-2023SA137643$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240725$$MD$FR$FR
222817672$22281767$2$F$20230410$20230424$20230504$20240912$EXP$$US-ORGANON-O2304USA002612$ORGANON$$68$YR$$F$Y$$$20240912$$CN$US$US
2228178913$22281789$13$F$20230101$20240920$20230504$20240930$EXP$$CA-CELLTRION INC.-2023CA002111$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
222818597$22281859$7$F$$20230905$20230504$20240801$PER$$NVSC2023US099562$NOVARTIS$$$$$M$Y$87.9$KG$20240801$$CN$US$US
2228191412$22281914$12$F$20221010$20240905$20230504$20240910$EXP$$US-TAKEDA-2021TUS001020$TAKEDA$$53$YR$$F$Y$$$20240910$$MD$US$US
2228197512$22281975$12$F$$20240724$20230504$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-061127$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240731$$CN$US$US
222820124$22282012$4$F$20181221$20240917$20230504$20240925$EXP$$CA-JNJFOC-20230501447$JOHNSON AND JOHNSON$$16$YR$T$M$Y$104$KG$20240925$$HP$CA$CA
222820593$22282059$3$F$$20240809$20230504$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03382$LUPIN$$$$$$Y$$$20240829$$CN$US$US
222821083$22282108$3$F$$20240727$20230504$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03377$LUPIN$$$$$$Y$$$20240821$$CN$US$US
222821202$22282120$2$F$$20240903$20230504$20240913$EXP$$US-GSK-US2023AMR063810$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
222821247$22282124$7$F$20230101$20240717$20230504$20240725$EXP$$CA-CELLTRION INC.-2023CA001095$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
222822072$22282207$2$F$$20240727$20230504$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03395$LUPIN$$$$$$Y$$$20240818$$PH$US$US
222822142$22282214$2$F$20220101$20240827$20230504$20240901$EXP$$CA-TAKEDA-2022TUS064254$TAKEDA$$$$$F$Y$$$20240901$$CN$CA$CA
222822862$22282286$2$F$$20240911$20230504$20240930$EXP$$US-SA-2023SA138059$SANOFI AVENTIS$$$$E$M$Y$77.11$KG$20240930$$MD$US$US
222823914$22282391$4$F$20220930$20240730$20230504$20240802$EXP$$DE-ROCHE-3343248$ROCHE$$56$YR$A$M$Y$$$20240802$$MD$DE$DE
222824015$22282401$5$F$$20240710$20230504$20240714$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-009691$JAZZ$$$$$F$Y$$$20240714$$CN$US$US
222826222$22282622$2$F$$20240722$20230504$20240726$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386819$RANBAXY$Mukhina OA, Fomina DS, Parshin VV, Gushchin VA, Dolzhikova IV, Shchetinin AM, et al. SARS-CoV-2 evolution in a patient with secondary B-cell immunodeficiency: A clinical case. Hum Vaccin Immunother. 2022;18(6):2101334$48$YR$$F$Y$$$20240727$$HP$RU$RU
222827813$22282781$3$F$$20240925$20230504$20240927$EXP$$US-SHIRE-US201847302$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
222827894$22282789$4$F$20240822$20240822$20230504$20240823$EXP$$US-TAKEDA-US202017929$TAKEDA$$57$YR$$F$Y$73$KG$20240823$$CN$US$US
2228280511$22282805$11$F$20230227$20240711$20230504$20240724$EXP$$BE-ASPEN-GLO2023BE002720$ASPEN$$$$$$Y$$$20240719$$HP$BE$BE
222830787$22283078$7$F$20220309$20240923$20230504$20240925$EXP$$IL-ABBVIE-22K-082-4427699-00$ABBVIE$$77$YR$$M$Y$82$KG$20240925$$MD$IL$IL
222833113$22283311$3$F$$20240715$20230504$20240725$EXP$ES-MLMSERVICE-20230417-4227991-3$ES-STRIDES ARCOLAB LIMITED-2023SP006365$STRIDES$Mir-Ihara P, Morales-Cabeza C, Bellon T, Gonzalez-Munoz M, Ramirez E, Gomez-Traseira C. Drug reaction with eosinophilia and systemic symptoms in children. Allergy. European Journal of Allergy and Clinical Immunology. 2023;78(111):684-5.$12$YR$$F$Y$$$20240725$$MD$ES$ES
2228333611$22283336$11$F$20230101$20240710$20230504$20240715$EXP$$CA-PFIZER INC-202300130850$PFIZER$$61$YR$$M$Y$78.6$KG$20240715$$HP$CA$CA
222834024$22283402$4$F$20230401$20240919$20230504$20240924$EXP$$NVSC2023BR098647$NOVARTIS$$52$YR$$F$Y$$$20240924$$MD$BR$BR
222834702$22283470$2$F$$20240823$20230504$20240913$PER$$US-SA-2023SA137542$SANOFI AVENTIS$$$$E$F$Y$$$20240913$$MD$US$US
222836203$22283620$3$F$$20240718$20230504$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-060141$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$68$KG$20240731$$HP$CA$CA
2228380410$22283804$10$F$20220101$20240710$20230504$20240715$EXP$$US-PFIZER INC-PV202300078935$PFIZER$$78$YR$$F$Y$$$20240715$$MD$US$US
222838254$22283825$4$F$$20240809$20230504$20240820$EXP$$US-MYOVANT SCIENCES GMBH-2023MYSCI0300018$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
222838282$22283828$2$F$20220722$20240821$20230504$20240828$EXP$$CA-TAKEDA-2022TUS049788$TAKEDA$$60$YR$$M$Y$$$20240828$$PH$CA$CA
222838334$22283833$4$F$$20240717$20230504$20240726$EXP$$CA-BAXTER-2023BAX020095$BAXTER$$61$YR$$F$Y$70$KG$20240726$$HP$CA$CA
222838355$22283835$5$F$20230427$20240625$20230504$20240701$30DAY$$US-PFIZER INC-202300176639$PFIZER$$14$YR$$M$Y$56.25$KG$20240701$$MD$US$US
222839196$22283919$6$F$20230404$20240702$20230504$20240709$EXP$$BE-VERTEX PHARMACEUTICALS-2023-006297$VERTEX$$35$YR$$F$Y$69$KG$20240709$$MD$BE$BE
222839792$22283979$2$F$20180718$20240816$20230504$20240821$EXP$$AU-ANIPHARMA-2023-AU-000122$ANI$$52$YR$$F$Y$$$20240821$$HP$AU$AU
222839813$22283981$3$F$20220811$20240906$20230504$20240910$EXP$$US-TAKEDA-2022TUS056291$TAKEDA$$18$YR$$M$Y$$$20240910$$PH$US$US
222839912$22283991$2$F$$20240627$20230504$20240701$30DAY$$US-GSK-US2023059918$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
222840604$22284060$4$F$20130101$20240826$20230504$20240828$EXP$DE-EMA-DD-20230420-6644853-072016$DE-TORRENT-00024524$TORRENT$$3$YR$C$M$Y$$$20240828$$MD$DE$DE
222840797$22284079$7$F$20230101$20240707$20230504$20240715$EXP$$JP-009507513-2304JPN002579J$MERCK$Tokitou T, Kikuchi M, Ozawa Y, Naito K, Kaise R, Kaise R, et al.. EP-1087 A case of fulminant type 1 diabetes mellitus during pembrolizumab. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 449$45$YR$$F$Y$$$20240715$$MD$JP$JP
222841173$22284117$3$F$$20240805$20230504$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03416$LUPIN$$$$$$Y$$$20240822$$CN$US$US
222841823$22284182$3$F$$20240712$20230504$20240715$EXP$$US-TAKEDA-2023TUS032746$TAKEDA$$$$$F$Y$$$20240715$$CN$US$US
222847589$22284758$9$F$20180101$20240906$20230504$20240926$EXP$$NVSC2023CA100304$NOVARTIS$$71$YR$$F$Y$69$KG$20240926$$HP$CA$CA
222850055$22285005$5$F$$20240903$20230504$20240913$EXP$$AU-JNJFOC-20230459306$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240913$$HP$AU$AU
222852345$22285234$5$F$20230327$20240917$20230504$20240923$EXP$$JP-009507513-2304JPN003797J$MERCK$$$$E$F$Y$$$20240923$$MD$JP$JP
2228525016$22285250$16$F$$20240916$20230504$20240925$EXP$$CA-PURDUE-USA-2022-0293207$PURDUE$$41$YR$$F$Y$$$20240925$$CN$CA$CA
222852792$22285279$2$F$$20240702$20230504$20240704$EXP$$NVSC2023US100072$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
222853194$22285319$4$F$20240726$20240726$20230504$20240731$EXP$$BR-TAKEDA-2023TUS042582$TAKEDA$$2$YR$$M$Y$9.8$KG$20240731$$MD$BR$BR
2228541414$22285414$14$F$$20240815$20230504$20240820$EXP$$US-PFIZER INC-PV202300066844$PFIZER$$68$YR$$M$Y$117.91$KG$20240820$$CN$US$US
222854216$22285421$6$F$20230101$20240925$20230504$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-061623$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$80.74$KG$20240926$$CN$US$US
2228550413$22285504$13$F$$20240922$20230504$20240923$EXP$$US-PFIZER INC-2018285435$PFIZER$$76$YR$$F$Y$56.7$KG$20240923$$MD$US$US
222856099$22285609$9$F$20230101$20240624$20230504$20240701$PER$$US-PFIZER INC-PV202300014169$PFIZER$$78$YR$$F$Y$$$20240701$$CN$US$US
222857447$22285744$7$F$$20240705$20230504$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-061999$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240710$$CN$US$US
222859872$22285987$2$F$$20240709$20230505$20240723$EXP$$US-AUROBINDO-AUR-APL-2023-032443$AUROBINDO$Matthews BJ, Froehlich A, Goicochea L, Levinson K.. Postmenopausal mixed gestational trophoblastic neoplasia with complete response to immunotherapy-A case report. Gynecologic Oncology Reports. 2023;46:101168$66$YR$$F$Y$$$20240719$$MD$US$US
222860165$22286016$5$F$$20240722$20230505$20240724$PER$$NVSC2023US101052$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
2228603266$22286032$66$F$20230501$20240729$20230505$20240805$EXP$$CN-SA-2023SA138781$SANOFI AVENTIS$$51$YR$A$F$Y$69$KG$20240805$$HP$CN$CN
222860826$22286082$6$F$20230101$20240730$20230505$20240808$PER$$US-SA-2023SA137361$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240808$$MD$US$US
222861775$22286177$5$F$20230301$20240628$20230505$20240705$EXP$$JP-009507513-2304JPN003643J$MERCK$$7$DEC$$M$Y$$$20240705$$MD$JP$JP
222864233$22286423$3$F$20230329$20240711$20230505$20240720$EXP$$CA-JNJFOC-20230315719$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240719$$HP$CA$CA
222867695$22286769$5$F$20191211$20240715$20230505$20240724$EXP$$ES-AUROBINDO-AUR-APL-2023-033122$AUROBINDO$Mir-Ihara P, Morales-Cabeza C, Bellon T, Gonzalez-Munoz M, Ramirez E, Gomez-Traseira C.. Drug reaction with eosinophilia and systemic symptoms in children.. Allergy: European Journal of Allergy and Clinical Immunology. 2023;78(Sup 111):684-685$12$YR$$F$Y$37$KG$20240724$$MD$ES$ES
2228729423$22287294$23$F$20230724$20240517$20230505$20240912$EXP$$NVSC2023CL099873$NOVARTIS$$65$YR$$F$Y$72$KG$20240912$$CN$CL$CL
222873013$22287301$3$F$$20240902$20230505$20240904$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387303$RANBAXY$Bandelier C, Guerne P-A, Genevay S, Finckh A, Gabay C. Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies. Swiss Med Wkly. 2009;139(3-4):41-46$54$YR$$M$Y$$$20240904$$HP$CH$CH
222873062$22287306$2$F$$20240902$20230505$20240904$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387294$RANBAXY$Bandelier C, Guerne P-A, Genevay S, Finckh A, Gabay C. Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies. Swiss Med Wkly. 2009;139(3-4):41-46$56$YR$$F$Y$$$20240904$$HP$CH$CH
222873073$22287307$3$F$$20240828$20230505$20240904$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387296$RANBAXY$Bandelier C, Guerne P-A, Genevay S, Finckh A, Gabay C. Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies. Swiss Med Wkly. 2009;139(3-4):41-46$33$YR$$F$Y$$$20240904$$HP$CH$CH
222873153$22287315$3$F$$20240902$20230505$20240917$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387289$RANBAXY$Bandelier C, Guerne P-A, Genevay S, Finckh A, Gabay C. Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies. Swiss Med Wkly. 2009;139(3-4):41-46$37$YR$$F$Y$$$20240917$$HP$CH$CH
222873163$22287316$3$F$$20240905$20230505$20240913$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387298$RANBAXY$Bandelier C, Guerne P-A, Genevay S, Finckh A, Gabay C. Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies. Swiss Med Wkly. 2009;139(3-4):41-46$30$YR$$M$Y$$$20240913$$HP$CH$CH
222873172$22287317$2$F$$20240820$20230505$20240826$EXP$$AE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387420$RANBAXY$Maufak MM, Khan G, Purushothaman A, Ahamed F, Jallo MK, Rizwan M, et al. Ameliorating effect of erythropoietin in a severe case of COVID-19: case report. Pan Afr Med J. 2022;43(129)$43$YR$$M$Y$$$20240826$$HP$AE$AE
222873192$22287319$2$F$$20240819$20230505$20240826$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387434$RANBAXY$Landwehr-Kenzel S, Muller-Jensen L, Kuehl J-S, Abou-el-Enein M, Hoffmann H, Muench S, et al. Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD. Mol Ther. 2022;Jun; 30(6):2298-2314$8$YR$$M$Y$$$20240826$$MD$DE$DE
222873252$22287325$2$F$$20240811$20230505$20240812$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387454$RANBAXY$Patruno C, Fabbrocini G, Lucia MD, Picone V, Genco L, Napolitano M. Psoriasiform dermatitis induced by dupilumab successfully treated with upadacitinib. Dermatol Ther. 2022;35:e15788(1-2)$58$YR$$F$Y$$$20240812$$HP$IT$IT
222873302$22287330$2$F$$20240909$20230505$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-387019$RANBAXY$$35$YR$$M$Y$184$KG$20240913$$MD$FR$FR
222873342$22287334$2$F$20230227$20240711$20230505$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-386971$RANBAXY$$87$YR$$F$Y$57$KG$20240712$$MD$FR$FR
222874243$22287424$3$F$20230401$20230501$20230505$20240828$PER$$NVSC2023US101408$NOVARTIS$$56$YR$$F$Y$74.83$KG$20240828$$CN$US$US
222875855$22287585$5$F$20230401$20240701$20230505$20240710$PER$$US-SA-2023SA136881$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240710$$MD$US$US
222876396$22287639$6$F$$20240715$20230505$20240819$PER$$AU-TOLMAR, INC.-23AU040338$TOLMAR$$$$$M$Y$$$20240814$$HP$AU$AU
222876662$22287666$2$F$$20240625$20230505$20240704$PER$$US-SA-2023SA138665$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240704$$MD$US$US
222877113$22287711$3$F$20180101$20240704$20230505$20240712$EXP$$DE-CELLTRION INC.-2023DE009431$CELLTRION$Kerle I, Jagerhuber L, Secci R, Pfarr N, Blum P, Roesch R, et al.. Circulating Tumor DNA Profiling of a Diffuse Large B Cell Lymphoma Patient with Secondary Acute Myeloid Leukemia. Cancers. 2022;14 (6):1-10$$$$$Y$$$20240712$$HP$DE$DE
222877502$22287750$2$F$20230425$20230501$20230505$20240829$EXP$$NVSC2023US100076$NOVARTIS$$49$YR$$F$Y$$$20240829$$CN$US$US
222877934$22287793$4$F$$20240812$20230505$20240826$EXP$$CA-AUROBINDO-AUR-APL-2023-033211$AUROBINDO$Lee K, Chan E, Wong T, Erdle S, Roberts H, Latrous M, et al.. Managing DRESS in a pediatric patient with severe tuberculosis using cyclosporin, lymphocyte toxicity assay, and desensitization: Case report. Allergy. European Journal of Allergy and Clinical Immunology.. 2023;78:640$14$YR$$F$Y$$$20240826$$HP$CA$CA
222877952$22287795$2$F$$20240903$20230505$20240930$PER$$US-SA-2023SA137165$SANOFI AVENTIS$$$$A$M$Y$61.36$KG$20240930$$MD$US$US
222878842$22287884$2$F$20230101$20240731$20230505$20240805$PER$$US-SA-2023SA139434$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240805$$MD$US$US
222879933$22287993$3$F$$20240805$20230505$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03392$LUPIN$$$$$$Y$$$20240822$$CN$US$US
222879943$22287994$3$F$$20240726$20230505$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03461$LUPIN$$$$$$Y$$$20240813$$CN$US$US
222880892$22288089$2$F$$20240626$20230505$20240705$PER$$US-SA-2023SA137566$SANOFI AVENTIS$$$$A$F$Y$98.883$KG$20240705$$MD$US$US
222881473$22288147$3$F$20230329$20240708$20230505$20240715$EXP$$NVSC2022MX144933$NOVARTIS$$35$YR$$F$Y$81$KG$20240715$$CN$MX$MX
222882392$22288239$2$F$$20240726$20230505$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03436$LUPIN$$$$$$Y$$$20240822$$CN$US$US
222882416$22288241$6$F$20230502$20240724$20230505$20240801$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-235765$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240801$$HP$US$US
222883054$22288305$4$F$$20240712$20230505$20240718$EXP$$FR-MYLANLABS-2023M1047050$BIOCON$$$$$$Y$$$20240718$$MD$FR$FR
222883063$22288306$3$F$$20240910$20230505$20240924$EXP$$US-MYOVANT SCIENCES GMBH-2023MYSCI0100739$SUNOVION$$$$$M$Y$$$20240924$$CN$US$US
222883674$22288367$4$F$$20230629$20230505$20240930$EXP$$NVSC2023US100240$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
222884994$22288499$4$F$20231212$20240625$20230505$20240701$EXP$$IN-PFIZER INC-PV202300079237$PFIZER$$44$YR$$F$Y$$$20240701$$CN$IN$IN
222885273$22288527$3$F$20230401$20240807$20230505$20240821$PER$$US-SA-2023SA139387$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240821$$MD$US$US
222885709$22288570$9$F$20230425$20240715$20230505$20240723$EXP$$US-BEH-2023158164$CSL BEHRING$$67$YR$E$F$Y$50.794$KG$20240723$$HP$US$US
222886313$22288631$3$F$$20240912$20230505$20240917$PER$$US-PFIZER INC-202200637016$PFIZER$$9$YR$$F$Y$$$20240917$$MD$US$US
222888334$22288833$4$F$20230101$20240912$20230505$20240917$EXP$$CA-PFIZER INC-202300114766$PFIZER$$52$YR$$F$Y$64$KG$20240917$$MD$CA$CA
222889192$22288919$2$F$$20240703$20230505$20240711$EXP$$FR-PFIZER INC-202300174919$PFIZER$$$$$F$Y$$$20240711$$MD$FR$FR
222889397$22288939$7$F$20230130$20240920$20230505$20240930$EXP$$US-UCBSA-2023005785$UCB$$29$YR$$F$Y$$$20240930$$CN$US$US
2228900717$22289007$17$F$20131114$20240911$20230505$20240921$EXP$$CA-ROCHE-3342219$ROCHE$$59$YR$A$F$Y$60$KG$20240921$$HP$CA$CA
222893422$22289342$2$F$20190811$20240806$20230505$20240807$EXP$$FR-TAKEDA-FR201945913$TAKEDA$$65$YR$$M$Y$$$20240807$$HP$FR$FR
222894923$22289492$3$F$$20240903$20230505$20240910$EXP$$CA-TAKEDA-2023TUS043997$TAKEDA$$$$$F$Y$$$20240910$$CN$CA$CA
222899983$22289998$3$F$$20240729$20230505$20240801$EXP$$NVSC2023DE103700$NOVARTIS$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. SEIZURE: EUROPEAN JOURNAL OF EPILEPSY. 2023;107:107-13$$$N$$Y$$$20240801$$HP$DE$DE
2229016511$22290165$11$F$$20240923$20230505$20240925$PER$$US-PFIZER INC-PV202300034703$PFIZER$$71$YR$$F$Y$$$20240925$$CN$US$US
222901843$22290184$3$F$$20240808$20230505$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-064495$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240812$$HP$US$US
222901876$22290187$6$F$20230216$20240905$20230505$20240909$EXP$$NVSC2023CH096050$NOVARTIS$$$$E$F$Y$$$20240909$$MD$CH$CH
222901912$22290191$2$F$$20240913$20230505$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-064227$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240917$$PH$US$US
2229039010$22290390$10$F$20230201$20240703$20230505$20240710$EXP$$US-VERTEX PHARMACEUTICALS-2023-005217$VERTEX$$9$YR$$F$Y$41$KG$20240710$$MD$US$US
2229042610$22290426$10$F$20230425$20240627$20230505$20240701$EXP$$JP-BIOMARINAP-JP-2023-150083$BIOMARIN$$$$$$Y$$$20240701$$CN$JP$JP
222904598$22290459$8$F$20220101$20240918$20230505$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-002148$JAZZ$$$$$F$Y$68.027$KG$20240922$$HP$US$US
222904825$22290482$5$F$$20240919$20230505$20240927$EXP$$US-TAKEDA-2023TUS033627$TAKEDA$$$$$M$Y$$$20240927$$MD$US$US
222907002$22290700$2$F$20230319$20240802$20230505$20240812$EXP$FR-AFSSAPS-PV2023000386$FR-TEVA-2023-FR-2883622$TEVA$$69$YR$$M$Y$68$KG$20240812$$MD$FR$FR
222907092$22290709$2$F$20221001$20240801$20230505$20240809$EXP$$US-ABBVIE-4700970$ABBVIE$$24$YR$$F$Y$55.791$KG$20240809$$CN$US$US
2229073812$22290738$12$F$20200731$20240911$20230505$20240919$EXP$$CA-CELLTRION INC.-2020CA035040$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
222907458$22290745$8$F$$20240826$20230505$20240829$EXP$$NVSC2023US103806$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
222908782$22290878$2$F$$20240705$20230506$20240709$PER$$NVSC2023US103823$NOVARTIS$$$$$M$Y$$$20240709$$CN$US$US
222909002$22290900$2$F$20240704$20240724$20230506$20240805$30DAY$$US-GSK-US2023061559$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240805$$CN$US$US
222909942$22290994$2$F$20191201$20230428$20230506$20240902$EXP$$NVSC2023US099840$NOVARTIS$$60$YR$$M$Y$90.72$KG$20240902$$CN$US$US
2229105714$22291057$14$F$20230101$20240912$20230506$20240921$EXP$$CA-CELLTRION INC.-2023CA009491$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
222911442$22291144$2$F$20210101$20230607$20230506$20240920$EXP$$NVSC2023US103791$NOVARTIS$$$$$M$Y$96.62$KG$20240920$$CN$US$US
222912132$22291213$2$F$$20240903$20230506$20240912$EXP$$CA-AUROBINDO-AUR-APL-2023-034110$AUROBINDO$$35$YR$$M$Y$$$20240912$$HP$CA$CA
222912283$22291228$3$F$$20230428$20230506$20240902$PER$$NVSC2023US101099$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
222912318$22291231$8$F$20230428$20240927$20230506$20240930$EXP$$NVSC2023US099837$NOVARTIS$$48$YR$$M$Y$$$20241001$$CN$US$US
222914435$22291443$5$F$20151120$20240918$20230506$20240920$EXP$$US-GILEAD-2023-0626998$GILEAD$$51$YR$A$M$Y$$$20240920$$LW$US$US
222914442$22291444$2$F$$20240702$20230506$20240725$PER$$US-JNJFOC-20230461723$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240725$$CN$US$US
222917094$22291709$4$F$20230101$20240801$20230507$20240810$PER$$US-SA-2023SA136738$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240810$$CN$US$US
222918323$22291832$3$F$20230101$20240726$20230507$20240731$EXP$$GB-BIOGEN-2022BI01174014$BIOGEN$$61$YR$$M$Y$$$20240731$$CN$GB$GB
222918685$22291868$5$F$$20240803$20230507$20240812$EXP$$CA-ROCHE-3344415$ROCHE$$30$YR$A$F$Y$$$20240812$$HP$CA$CA
222920693$22292069$3$F$$20240621$20230508$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001451$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
222921133$22292113$3$F$$20240807$20230508$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03439$LUPIN$$$$$$Y$$$20240901$$CN$US$US
222921412$22292141$2$F$20230429$20240628$20230508$20240709$EXP$$IN-ROCHE-3345424$ROCHE$$57$YR$A$M$Y$70$KG$20240709$$CN$IN$IN
222921654$22292165$4$F$$20240807$20230508$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03454$LUPIN$$$$$$Y$$$20240902$$CN$US$US
2229217112$22292171$12$F$20210917$20240912$20230508$20240921$EXP$$CA-CELLTRION INC.-2021CA013022$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
222921792$22292179$2$F$20230501$20240731$20230508$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-062676$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240807$$CN$US$US
222922685$22292268$5$F$20230401$20240909$20230508$20240923$EXP$$DE-SA-2023SA140352$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240923$$HP$DE$DE
222922812$22292281$2$F$$20240709$20230508$20240718$EXP$$CA-APOTEX-2023AP007780$APOTEX$$63$YR$$M$Y$$$20240718$$HP$CA$CA
222924784$22292478$4$F$$20230523$20230508$20240925$PER$$US-GSK-US2023AMR064772$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
222926313$22292631$3$F$$20240807$20230508$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03466$LUPIN$$$$$$Y$$$20240828$$CN$US$US
222926404$22292640$4$F$$20240715$20230508$20240718$EXP$$FR-AUROBINDO-AUR-APL-2022-003846$AUROBINDO$Sastre, C, Baillif-couniou v, Fabresse n, Ameline A, Kintz P, Gaulier J,M et all.. Pregabalin misuse: About seven cases of death in the region of Marseille.. Toxicologie Analytique et Clinique.. 2022$43$YR$$M$Y$$$20240718$$HP$FR$FR
2229264827$22292648$27$F$$20240916$20230508$20240923$EXP$$CA-PFIZER INC-202300179895$PFIZER$$50$YR$$F$Y$68$KG$20240923$$HP$CA$CA
222926644$22292664$4$F$$20240716$20230508$20240724$EXP$$US-ROCHE-3342496$ROCHE$$86$YR$E$F$Y$$$20240724$$CN$US$US
222928144$22292814$4$F$20220707$20240706$20230508$20240715$EXP$$CA-BEH-2023158080$CSL BEHRING$$65$YR$E$F$Y$78$KG$20240715$$HP$CA$CA
222929193$22292919$3$F$$20240826$20230508$20240903$EXP$$BR-CELLTRION INC.-2023BR003136$CELLTRION$$$$$$Y$$$20240903$$MD$BR$BR
222929689$22292968$9$F$20230306$20240911$20230508$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-062268$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240917$$CN$US$US
222930192$22293019$2$F$$20240909$20230508$20240911$PER$$US-BIOGEN-2023BI01203717$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
222930974$22293097$4$F$20230401$20240627$20230508$20240704$PER$$US-AMGEN-USASP2023077909$AMGEN$$53$YR$A$M$Y$$$20240704$$HP$US$US
2229317314$22293173$14$F$20230101$20240718$20230508$20240730$EXP$$US-INSMED-2023-01226-USAA$INSMED$$$$$F$Y$$$20240730$$CN$US$US
222932417$22293241$7$F$20210817$20240909$20230508$20240913$EXP$$IT-TAKEDA-2021TUS051901$TAKEDA$$9$YR$$M$Y$$$20240913$$CN$IT$IT
2229331310$22293313$10$F$20230421$20240926$20230508$20240927$EXP$$NVSC2023US102767$NOVARTIS$$41$YR$$F$Y$$$20240927$$CN$US$US
222933445$22293344$5$F$20201119$20240728$20230508$20240801$EXP$$CA-TAKEDA-2020TUS053478$TAKEDA$$67$YR$$M$Y$$$20240801$$MD$CA$CA
222934259$22293425$9$F$$20240814$20230508$20240823$EXP$$CA-ROCHE-3341285$ROCHE$$$$A$M$Y$$$20240823$$CN$CA$CA
222934923$22293492$3$F$20230118$20240715$20230508$20240717$EXP$$US-UCBSA-2023023105$UCB$$34$YR$$M$Y$$$20240717$$CN$US$US
222934973$22293497$3$F$$20240708$20230508$20240710$EXP$$US-ROCHE-3344260$ROCHE$$53$YR$A$F$Y$$$20240710$$CN$US$US
222936384$22293638$4$F$$20240806$20230508$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03465$LUPIN$$$$$$Y$$$20240830$$CN$US$US
222936944$22293694$4$F$$20240917$20230508$20240927$EXP$$US-ROCHE-3342888$ROCHE$$82$YR$E$F$Y$$$20240927$$CN$US$US
222939424$22293942$4$F$$20240701$20230508$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387131$RANBAXY$$$$E$F$Y$$$20240711$$HP$US$US
222939462$22293946$2$F$$20240830$20230508$20240904$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387324$RANBAXY$Ekinci RMK, Ozalp O, Anlas O, Atmis B, Ata A, Balci S. An unusual manifestation in a pediatric patient with MAFB mutation:Sacroiliitis in multicentric carpotarsal osteolysis syndrome. Int J Rheum Dis. 2023;Online aheaad of print$$$C$$Y$$$20240904$$HP$TR$TR
222939534$22293953$4$F$$20240813$20230508$20240826$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-386620$RANBAXY$Gambichler T, Stricker I, Neid M, Tannapfel A, Susok L. Impressive response to four cemiplimab cycles of a sonidegib-resistant giant basosquamous carcinoma of the midface.. J Eur Acad Dermatol Venereol. 2022;36(6):e490-e492$60$YR$$M$Y$$$20240826$$HP$DE$DE
222940095$22294009$5$F$20230810$20240710$20230508$20240712$EXP$$US-PFIZER INC-PV202300050951$PFIZER$$75$YR$$F$Y$$$20240712$$CN$US$US
222944894$22294489$4$F$$20240805$20230508$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03480$LUPIN$$$$$$Y$$$20240829$$CN$US$US
222944948$22294494$8$F$20230401$20240827$20230508$20240903$EXP$$CA-GSK-CA2023064526$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$HP$CA$CA
222947725$22294772$5$F$20231228$20240624$20230508$20240701$EXP$$CA-TAKEDA-2023TUS044086$TAKEDA$$55$YR$$F$Y$$$20240701$$HP$CA$CA
222948016$22294801$6$F$20230101$20240806$20230508$20240808$EXP$$US-ABBVIE-4750129$ABBVIE$$$$$M$Y$68$KG$20240808$$CN$US$US
222948057$22294805$7$F$20230512$20240704$20230508$20240708$EXP$$CA-TAKEDA-2023TUS044462$TAKEDA$$29$YR$$M$Y$$$20240708$$HP$CA$CA
2229485112$22294851$12$F$20210711$20240919$20230508$20240923$EXP$$US-SHIRE-US202004622$TAKEDA$$68$YR$$M$Y$82$KG$20240923$$CN$US$US
222948537$22294853$7$F$$20240726$20230508$20240731$EXP$$US-PFIZER INC-PV202300081965$PFIZER$$47$YR$$F$Y$$$20240731$$CN$US$US
222948755$22294875$5$F$20180419$20240911$20230508$20240919$EXP$$BR-TAKEDA-2018TUS016769$TAKEDA$$33$YR$$M$Y$79$KG$20240919$$CN$BR$BR
222950542$22295054$2$F$20221018$20240813$20230508$20240813$EXP$FR-AFSSAPS-AM2023000360$FR-ORGANON-O2304FRA002559$ORGANON$$71$YR$$F$Y$$$20240813$$MD$FR$FR
222950812$22295081$2$F$$20240925$20230508$20240930$EXP$$NVSC2023US103617$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
222951185$22295118$5$F$20240811$20240815$20230508$20240821$EXP$$CA-TAKEDA-2023TUS032347$TAKEDA$$67$YR$$M$Y$$$20240821$$CN$CA$CA
222952276$22295227$6$F$20230101$20240822$20230508$20240912$PER$$CA-TOLMAR, INC.-23CA040361$TOLMAR$$$$$M$Y$$$20240912$$CN$CA$CA
222953143$22295314$3$F$$20240807$20230508$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03501$LUPIN$$$$$$Y$$$20240822$$CN$US$US
222953764$22295376$4$F$$20240910$20230508$20240912$EXP$$US-PFIZER INC-PV202300080260$PFIZER$$70$YR$$M$Y$$$20240912$$MD$US$US
2229547121$22295471$21$F$20220210$20240923$20230508$20240926$EXP$$US-TAKEDA-2022TUS013473$TAKEDA$$12$YR$$F$Y$$$20240926$$MD$US$US
222955945$22295594$5$F$$20240717$20230508$20240719$EXP$$US-PFIZER INC-PV202300080780$PFIZER$$92$YR$$F$Y$$$20240719$$CN$US$US
222956618$22295661$8$F$20220101$20240702$20230508$20240711$EXP$$US-HORIZON THERAPEUTICS-HZN-2022-000678$AMGEN$$51$YR$A$M$Y$101.13$KG$20240711$$MD$US$US
222957558$22295755$8$F$20220209$20240829$20230508$20240903$EXP$$CA-TAKEDA-2023TUS044998$TAKEDA$$38$YR$$F$Y$$$20240903$$CN$CA$CA
222957892$22295789$2$F$20230314$20240703$20230508$20240711$EXP$IT-MINISAL02-918902$IT-TEVA-2023-IT-2884123$TEVA$$9$YR$$F$Y$27$KG$20240711$$PH$IT$IT
222958425$22295842$5$F$20230825$20240730$20230508$20240806$EXP$$CO-TAKEDA-2023TUS045843$TAKEDA$$38$YR$$M$Y$90$KG$20240806$$CN$CO$CO
222959793$22295979$3$F$20221001$20240816$20230508$20240821$PER$$US-PFIZER INC-PV202300078916$PFIZER$$75$YR$$F$Y$$$20240821$$CN$US$US
222959835$22295983$5$F$$20240802$20230508$20240807$PER$$US-PFIZER INC-PV202300079280$PFIZER$$81$YR$$F$Y$$$20240807$$CN$US$US
222960525$22296052$5$F$$20240916$20230508$20240919$PER$$US-PFIZER INC-PV202300078263$PFIZER$$66$YR$$M$Y$90.703$KG$20240919$$CN$US$US
222960872$22296087$2$F$$20240827$20230508$20240830$PER$$US-PFIZER INC-PV202300054482$PFIZER$$42$YR$$F$Y$$$20240830$$HP$US$US
222960884$22296088$4$F$$20240822$20230508$20240904$PER$$US-PFIZER INC-PV202300080235$PFIZER$$74$YR$$F$Y$$$20240904$$CN$US$US
222961908$22296190$8$F$20240630$20240723$20230508$20240731$EXP$$CA-TAKEDA-2023TUS024250$TAKEDA$$43$YR$$M$Y$$$20240731$$CN$CA$CA
222962184$22296218$4$F$20210201$20240920$20230508$20240926$EXP$$CA-BAUSCH-BL-2021-007832$BAUSCH AND LOMB$$21$YR$$F$Y$$$20240926$$CN$CA$CA
2229623115$22296231$15$F$20230101$20240926$20230508$20240930$EXP$$US-KARYOPHARM-2023KPT001157$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240930$$CN$US$US
222967843$22296784$3$F$$20240924$20230509$20240927$EXP$$CA-AUROBINDO-AUR-APL-2023-034184$AUROBINDO$$44$YR$$F$Y$68$KG$20240927$$HP$CA$CA
222968392$22296839$2$F$20221001$20240711$20230509$20240720$EXP$$FR-AUROBINDO-AUR-APL-2023-034458$AUROBINDO$$$$$F$Y$$$20240720$$MD$FR$FR
222968564$22296856$4$F$$20240723$20230509$20240801$EXP$$CA-TAKEDA-2023TUS045155$TAKEDA$$$$$F$Y$$$20240801$$MD$CA$CA
222969702$22296970$2$F$$20240819$20230509$20240822$EXP$$US-ABBVIE-4755288$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
222969744$22296974$4$F$20240101$20240708$20230509$20240712$EXP$$US-ABBVIE-4754902$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
222971363$22297136$3$F$20240322$20240703$20230509$20240712$EXP$$BR-CELLTRION INC.-2023BR009494$CELLTRION$$$$$$Y$$$20240712$$CN$BR$BR
222971632$22297163$2$F$20230303$20240626$20230509$20240702$EXP$$CA-JNJFOC-20230335708$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240702$$CN$CA$CA
222972094$22297209$4$F$20230428$20240731$20230509$20240807$EXP$$CA-CELLTRION INC.-2022CA006156$CELLTRION$$$$$$Y$$$20240808$$MD$CA$CA
222972646$22297264$6$F$20220101$20240912$20230509$20240921$EXP$$PT-CELLTRION INC.-2023PT009419$CELLTRION$Lopes V, Machado C, and De Sousa Lages A. Autoimmune hypothyroidism and trastuzumab therapy: a rare association. Endocrinology, diabetes + metabolism case reports 2023 Apr 25. 2023;(2):1-4$$$$$Y$$$20240921$$HP$PT$PT
222973844$22297384$4$F$20230328$20240823$20230509$20240828$PER$$NVSC2023US103535$NOVARTIS$$48$YR$$F$Y$$$20240828$$CN$US$US
2229739226$22297392$26$F$20220101$20240917$20230509$20240925$EXP$$CA-JNJFOC-20230408263$JOHNSON AND JOHNSON$$91$YR$E$F$Y$59$KG$20240925$$CN$CA$CA
222974495$22297449$5$F$20230503$20240814$20230509$20240828$EXP$$US-UCBSA-2023023147$UCB$$59$YR$$F$Y$104.32$KG$20240828$$HP$US$US
222974886$22297488$6$F$20230503$20240724$20230509$20240731$PER$$US-BIOGEN-2023BI01201238$BIOGEN$$29$YR$$F$Y$$$20240731$$CN$US$US
222975278$22297527$8$F$20231218$20240815$20230509$20240822$EXP$$CA-TAKEDA-2023TUS045127$TAKEDA$$64$YR$$F$Y$$$20240822$$MD$CA$CA
222975955$22297595$5$F$$20230808$20230509$20240716$PER$$NVSC2023US103264$NOVARTIS$$$$$M$Y$$$20240716$$CN$US$US
222976234$22297623$4$F$20230101$20240920$20230509$20240930$EXP$$CA-CELLTRION INC.-2023CA002117$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
222976534$22297653$4$F$$20240715$20230509$20240716$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-161858$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$$$20240716$$CN$CA$CA
222977092$22297709$2$F$20230101$20240729$20230509$20240806$EXP$$BR-BIOGEN-2023BI01204020$BIOGEN$$$$$F$Y$73$KG$20240806$$CN$BR$BR
222977308$22297730$8$F$$20240916$20230509$20240923$EXP$$US-TAKEDA-2022TUS084472$TAKEDA$$$$$F$Y$67$KG$20240923$$CN$US$US
222980182$22298018$2$F$20180401$20240917$20230509$20240925$EXP$$FR-CELLTRION INC.-2018FR020554$CELLTRION$$$$$$Y$$$20240925$$MD$FR$FR
222981734$22298173$4$F$20230429$20240910$20230509$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-064764$BRISTOL MYERS SQUIBB$$25$YR$A$M$Y$65$KG$20240919$$MD$JP$JP
222982883$22298288$3$F$$20240701$20230509$20240703$PER$$NVSC2023US105825$NOVARTIS$$$$$M$Y$$$20240703$$CN$US$US
222982934$22298293$4$F$20210901$20240401$20230509$20240807$EXP$$NVSC2023EG103441$NOVARTIS$$53$YR$$F$Y$$$20240807$$CN$EG$EG
222983152$22298315$2$F$$20240814$20230509$20240828$EXP$$US-COSETTE-CP2023US000087$COSETTE PHARMACEUTICALS$$59$YR$A$F$Y$131$KG$20240828$$CN$US$US
222984192$22298419$2$F$20230101$20240808$20230509$20240815$PER$$US-ABBVIE-4757107$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
2229849611$22298496$11$F$20210910$20240801$20230509$20240806$EXP$$IN-PFIZER INC-2019132056$PFIZER$$70$YR$$F$Y$$$20240806$$CN$IN$IN
2229856515$22298565$15$F$$20240923$20230509$20240926$EXP$$CA-BAUSCH-BL-2023-006636$BAUSCH AND LOMB$$50$YR$$F$Y$97$KG$20240926$$HP$CA$CA
222985683$22298568$3$F$$20240726$20230509$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03429$LUPIN$$$$$$Y$$$20240816$$CN$US$US
222985723$22298572$3$F$20190101$20240802$20230509$20240809$EXP$$IT-MYLANLABS-2023M1047275$MYLAN$Carpenedo M.. Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists.. Mediterranean Journal of Hematology and Infectious Diseases.. 2023;15(1)$80$YR$$M$Y$$$20240809$$HP$IT$IT
222986874$22298687$4$F$20230502$20240823$20230509$20240828$EXP$$CA-ROCHE-3344419$ROCHE$$44$YR$A$F$Y$$$20240828$$CN$CA$CA
222989113$22298911$3$F$$20230508$20230509$20240906$EXP$$CN-NOVOPROD-1058548$NOVO NORDISK$$59$YR$$M$Y$$$20240906$$CN$CN$CN
222989753$22298975$3$F$$20240731$20230509$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03505$LUPIN$$$$$$Y$$$20240820$$CN$US$US
222990383$22299038$3$F$$20240725$20230509$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03510$LUPIN$$$$$$Y$$$20240816$$CN$US$US
2229905212$22299052$12$F$20230110$20240918$20230509$20240924$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-003359$AMGEN$$62$YR$A$M$Y$104$KG$20240924$$MD$US$US
222990563$22299056$3$F$$20240805$20230509$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03523$LUPIN$$$$$$Y$$$20240822$$CN$US$US
2229907111$22299071$11$F$20181016$20240913$20230509$20240920$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-003379$AMGEN$$61$YR$A$F$Y$56.689$KG$20240919$$HP$US$US
2229910510$22299105$10$F$20190701$20240910$20230509$20240914$EXP$$US-TAKEDA-US201924004$TAKEDA$$44$YR$$F$Y$$$20240914$$CN$US$US
222991276$22299127$6$F$20230208$20240919$20230509$20240923$EXP$$CA-TAKEDA-2022TUS019864$TAKEDA$$33$YR$$M$Y$$$20240923$$HP$CA$CA
222992542$22299254$2$F$$20240916$20230509$20240918$PER$$US-PFIZER INC-PV202300081851$PFIZER$$68$YR$$M$Y$$$20240918$$HP$US$US
222996538$22299653$8$F$20200129$20240916$20230509$20240927$EXP$$CO-ROCHE-3338828$ROCHE$$64$YR$A$F$Y$82$KG$20240927$$CN$CO$CO
222996593$22299659$3$F$$20240612$20230509$20240705$EXP$$CA-ROCHE-3262754$ROCHE$$50$YR$A$F$Y$$$20240705$$HP$CA$CA
222997754$22299775$4$F$$20240712$20230509$20240720$EXP$$IN-TAKEDA-2023TUS045228$TAKEDA$$$$$M$Y$67$KG$20240720$$MD$IN$IN
222999045$22299904$5$F$20240101$20240703$20230509$20240725$EXP$$US-ABBVIE-4711924$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
223000225$22300022$5$F$20230101$20240911$20230509$20240916$EXP$$CA-PFIZER INC-202200643931$PFIZER$$77$YR$$F$Y$$$20240916$$MD$CA$CA
223001966$22300196$6$F$20180101$20240813$20230509$20240815$PER$$US-PFIZER INC-PV202300079637$PFIZER$$70$YR$$M$Y$82.54$KG$20240815$$CN$US$US
223002356$22300235$6$F$20230502$20240911$20230509$20240913$EXP$$NVSC2023US101070$NOVARTIS$$51$YR$$F$Y$$$20240913$$CN$US$US
223003652$22300365$2$F$$20240715$20230509$20240716$EXP$$US-PFIZER INC-PV202300081488$PFIZER$$69$YR$$M$Y$$$20240716$$CN$US$US
223004712$22300471$2$F$20230326$20240918$20230509$20240930$PER$$NVSC2023US103604$NOVARTIS$$63$YR$$F$Y$$$20240930$$CN$US$US
223005954$22300595$4$F$20220901$20240816$20230509$20240820$EXP$$CA-PFIZER INC-202201197518$PFIZER$$76$YR$$F$Y$88.5$KG$20240820$$HP$CA$CA
223005977$22300597$7$F$20230520$20240728$20230509$20240729$EXP$$PE-PFIZER INC-PV202300080755$PFIZER$$12$YR$$M$Y$$$20240729$$CN$PE$PE
223006788$22300678$8$F$20221006$20240621$20230509$20240705$EXP$$JP-AMGEN-2022JPCCXI0420$AMGEN$Koichiro S, Yamaguchi S, Yamazaki M, Kido T, Onose T. . A case of vanishing bile duct syndrome during treatment of microscopic polyangiitis with avacopan.. .. Rheumatology. 2023;JUN 12;1-6. doi$76$YR$E$F$Y$42.5$KG$20240704$$HP$JP$JP
223007007$22300700$7$F$20230801$20240813$20230509$20240820$EXP$$US-SA-2023SA137058$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240820$$MD$US$US
223007113$22300711$3$F$20210617$20240716$20230509$20240724$PER$$US-SA-2023SA137268$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240724$$MD$US$US
223007402$22300740$2$F$$20240726$20230509$20240808$PER$$US-SA-2023SA138037$SANOFI AVENTIS$$31$YR$A$F$Y$56.6$KG$20240808$$MD$US$US
223008863$22300886$3$F$20240721$20240730$20230509$20240808$PER$$US-SA-2023SA139303$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240808$$MD$US$US
223009223$22300922$3$F$$20240715$20230509$20240724$PER$$US-SA-2023SA140764$SANOFI AVENTIS$$$$A$F$Y$105$KG$20240724$$MD$US$US
223009252$22300925$2$F$$20240626$20230509$20240705$PER$$US-SA-2023SA141795$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240705$$MD$US$US
223009442$22300944$2$F$20230430$20240730$20230509$20240807$PER$$US-SA-2023SA139541$SANOFI AVENTIS$$58$YR$A$M$Y$117$KG$20240808$$MD$US$US
223009933$22300993$3$F$20230419$20240807$20230509$20240819$PER$$US-SA-2023SA141262$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240819$$MD$US$US
223010333$22301033$3$F$20230101$20240826$20230509$20240906$PER$$US-SA-2023SA142146$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240906$$MD$US$US
223011043$22301104$3$F$$20240805$20230509$20240813$PER$$US-SA-2023SA139562$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240814$$CN$US$US
2230112115$22301121$15$F$20230101$20240919$20230509$20240924$EXP$$US-SA-2023SA142479$SANOFI AVENTIS$$9$YR$C$F$Y$36.28$KG$20240924$$MD$US$US
223011413$22301141$3$F$$20240909$20230509$20240917$PER$$US-SA-2023SA139889$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240918$$MD$US$US
223012853$22301285$3$F$$20240814$20230509$20240828$PER$$US-SA-2023SA142835$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240828$$MD$US$US
223013055$22301305$5$F$20230501$20240717$20230509$20240726$PER$$US-SA-2023SA141359$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240726$$MD$US$US
2230142112$22301421$12$F$20240219$20240827$20230509$20240829$EXP$$FR-GILEAD-2022-0570896$GILEAD$$$$E$F$Y$54$KG$20240829$$MD$FR$FR
223017227$22301722$7$F$20210405$20240703$20230510$20240710$EXP$$CA-CELLTRION INC.-2021CA009497$CELLTRION$$$$$$Y$$$20240710$$MD$CA$CA
223021187$22302118$7$F$20230101$20240815$20230510$20240822$EXP$$CA-CELLTRION INC.-2023CA009609$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
223022968$22302296$8$F$20210930$20240917$20230510$20240926$EXP$$CA-CELLTRION INC.-2021CA016367$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
223023212$22302321$2$F$20230301$20240722$20230510$20240725$EXP$$US-ABBVIE-4337169$ABBVIE$$78$YR$$F$Y$$$20240725$$CN$US$US
223024715$22302471$5$F$$20240829$20230510$20240830$PER$$NVSC2023US102678$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
223025633$22302563$3$F$$20240805$20230510$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03503$LUPIN$$$$$$Y$$$20240826$$CN$US$US
223027407$22302740$7$F$20230401$20240812$20230510$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-005409$JAZZ$$4$YR$$M$Y$18.4$KG$20240820$$HP$US$US
223028492$22302849$2$F$$20240723$20230510$20240726$EXP$$US-TAKEDA-2022TUS061678$TAKEDA$$$$$F$Y$$$20240726$$HP$US$US
223029732$22302973$2$F$$20240826$20230510$20240829$EXP$$US-TAKEDA-US201912436$TAKEDA$$$$$F$Y$$$20240829$$HP$US$US
223030165$22303016$5$F$$20240701$20230510$20240710$PER$$US-SA-2023SA144657$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240710$$MD$US$US
223030172$22303017$2$F$20230425$20240918$20230510$20240927$PER$$NVSC2023US106330$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
223030694$22303069$4$F$20170922$20240701$20230510$20240716$EXP$$DE-ROCHE-2782850$ROCHE$$61$YR$A$F$Y$$$20240716$$CN$DE$DE
223031043$22303104$3$F$20230401$20240725$20230510$20240801$EXP$$UY-ABBVIE-4759656$ABBVIE$$51$YR$$F$Y$$$20240801$$CN$UY$UY
223031152$22303115$2$F$20230101$20240625$20230510$20240704$PER$$US-SA-2023SA142287$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240704$$MD$US$US
223031163$22303116$3$F$20240903$20240910$20230510$20240924$PER$$US-SA-2023SA143410$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240924$$MD$US$US
223032985$22303298$5$F$$20240815$20230510$20240823$EXP$$CZ-MYLANLABS-2023M1048353$MYLAN$Michaela Novakova. A patient with a severe form of atopic dermatitis treated with abrocitinib - our first experience. PHARMACOTHERAPY. 2023;19(2):195-197$55$YR$$F$Y$99$KG$20240823$$MD$CZ$CZ
223033769$22303376$9$F$20230716$20240808$20230510$20240812$EXP$$NVSC2023PE106113$NOVARTIS$$62$YR$$F$Y$67.6$KG$20240812$$CN$PE$PE
223034152$22303415$2$F$20230424$20230425$20230510$20240729$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-23-00202$Unknown Manufacturer$$$$$M$Y$$$20240729$$CN$US$US
223034652$22303465$2$F$$20230502$20230510$20240919$EXP$$NVSC2023RO103662$NOVARTIS$$$$$$Y$$$20240919$$CN$RO$RO
223035373$22303537$3$F$$20240717$20230510$20240722$PER$$US-PFIZER INC-2020434393$PFIZER$$57$YR$$F$Y$$$20240722$$CN$US$US
223037973$22303797$3$F$$20240826$20230510$20240909$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387267$RANBAXY$Soto-Sierra M, Caro-Magdaleno M, Espejo-Arjona F, Toyos-Saenz FJ. Conjunctival Inflammation and Panuveitis as Manifestations of Ig-G4-Related Disease: A Case Report. Ocul Immunol Inflamm. 2024;6 Apr; 32(5):775-777$75$YR$$F$Y$$$20240909$$MD$ES$ES
223038032$22303803$2$F$$20240830$20230510$20240904$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387723$RANBAXY$Xiao P, Guo T, Yin R. Misdiagnosis of gestational trophoblastic neoplasia as ectopic pregnancy: A 15-year retrospective study. Front Med. 2022;Nov 02; 9:1018573(1-8)$22$YR$$F$Y$$$20240904$$HP$CN$CN
223038082$22303808$2$F$$20240830$20230510$20240904$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387721$RANBAXY$Xiao P, Guo T, Yin R. Misdiagnosis of gestational trophoblastic neoplasia as ectopic pregnancy: A 15-year retrospective study. Front Med. 2022;Nov 02; 9:1018573(1-8)$23$YR$$F$Y$$$20240904$$HP$CN$CN
223038142$22303814$2$F$$20240830$20230510$20240904$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387683$RANBAXY$Xiao P, Guo T, Yin R. Misdiagnosis of gestational trophoblastic neoplasia as ectopic pregnancy: A 15-year retrospective study. Front Med. 2022;Nov 02; 9:1018573(1-8)$40$YR$$F$Y$$$20240904$$HP$CN$CN
223038272$22303827$2$F$$20240827$20230510$20240904$EXP$$SZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387842$RANBAXY$Codoni G, Kirchner T, Engel B, Villamil AM, Efe C, Stattermayer AF, et al. Histological and serological features of acute liver injury after SARS-CoV-2 vaccination. JHEP Rep. 2023;5(1):100605(1-12)$77$YR$$F$Y$$$20240904$$HP$SZ$CH
223038742$22303874$2$F$20230506$20240911$20230510$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202305004514$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240923$$HP$US$US
223038894$22303889$4$F$20200101$20240819$20230510$20240821$EXP$$US-PFIZER INC-202200239087$PFIZER$$81$YR$$M$Y$$$20240821$$CN$US$US
223039383$22303938$3$F$$20240805$20230510$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03453$LUPIN$$$$$$Y$$$20240815$$CN$US$US
223039673$22303967$3$F$20230201$20240816$20230510$20240820$EXP$$US-PFIZER INC-202300185407$PFIZER$$83$YR$$M$Y$74.62$KG$20240820$$CN$US$US
223040272$22304027$2$F$$20240903$20230510$20240909$EXP$$CA-MYLANLABS-2021070131$MYLAN$$80$YR$$M$Y$89$KG$20240909$$CN$CA$CA
223041692$22304169$2$F$$20240830$20230510$20240904$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387724$RANBAXY$Xiao P, Guo T, Yin R. Misdiagnosis of gestational trophoblastic neoplasia as ectopic pregnancy: A 15-year retrospective study. Front Med. 2022;Nov 02; 9:1018573(1-8)$28$YR$$F$Y$$$20240904$$HP$CN$CN
223041722$22304172$2$F$$20240814$20230510$20240826$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387901$RANBAXY$Raffa EH, Srinivasan A, Wall DA, Schechter T, Ali M, Krueger J, et al. Abatacept-based Graft-Versus-Host Disease Prophylaxis in Haplo-identical Hematopoietic Cell Transplant in a High-risk Cohort. J Pediatr Hematol Oncol. 2022;44(7):383-387$12$YR$$M$Y$$$20240826$$MD$CA$CA
223041762$22304176$2$F$$20240816$20230510$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385208$RANBAXY$El Chediak A, Triozzi JL, Schaefer H, Shawar S. Disseminated Nocardiosis in Kidney Transplant Recipients: A Report of 2 Cases. Kidney Med. 2022;Dec; 4(12):100551; 1-5$$$$M$Y$$$20240826$$MD$US$US
223041842$22304184$2$F$$20240814$20230510$20240826$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387902$RANBAXY$Raffa EH, Srinivasan A, Wall DA, Schechter T, Ali M, Krueger J, et al. Abatacept-based Graft-Versus-Host Disease Prophylaxis in Haplo-identical Hematopoietic Cell Transplant in a High-risk Cohort. J Pediatr Hematol Oncol. 2022;Oct;44(7):383-387$24$MON$$M$Y$$$20240826$$MD$CA$CA
223041942$22304194$2$F$$20240826$20230510$20240904$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387919$RANBAXY$Espino PH, Burneo JG, Moscol G, Gofton T, MacDougall K, Marti AS. Long-term outcomes after NORSE: Treatment with vagus nerve stimulation. Epilepsia Open. 2022;7:822-828$33$YR$$M$Y$$$20240904$$HP$CA$CA
223042092$22304209$2$F$$20240803$20230510$20240812$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388150$RANBAXY$Constantinescu AR, Mattoo TK, Smoyer WE, Greenbaum LA, Niu J, Howard N et al. Clinical presentation and management of nephrotic syndrome in the first year of life:A report from the Pediatric Nephrology Research Consortium. Front Pediatr. 2022;Sep 14; 10:98894 1-12$$$I$$Y$$$20240812$$HP$US$US
223042102$22304210$2$F$$20240803$20230510$20240812$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388151$RANBAXY$Constantinescu AR, Mattoo TK, Smoyer WE, Greenbaum LA, Niu J, Howard N et al. Clinical presentation and management of nephrotic syndrome in the first year of life:A report from the Pediatric Nephrology Research Consortium. Front Pediatr. 2022;Sep 14; 10:98894 1-12$$$I$$Y$$$20240812$$HP$US$US
223042202$22304220$2$F$$20240814$20230510$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387946$RANBAXY$Chediak AE, Triozzi JL, Schaefer H, Shawar S. Disseminated Nocardiosis in Kidney Transplant Recipients: A Report of 2 Cases. Kidney Med. 2022;4(12):100551$8$DEC$$F$Y$$$20240826$$MD$US$US
223043192$22304319$2$F$$20240709$20230510$20240717$PER$$US-SA-2023SA144951$SANOFI AVENTIS$$$$A$F$Y$95.25$KG$20240717$$MD$US$US
223043925$22304392$5$F$$20230529$20230510$20240924$EXP$CA-MLMSERVICE-20221018-3866289-1$CA-JUBILANT CADISTA PHARMACEUTICALS-2022CA000675$JUBILANT$Austin E, Maratta C.. Acute thiamine deficiency as a complication of insulin euglycemic therapy for an amlodipine overdose.. Clinical Toxicology. 2022;60(2):124$15$YR$$F$Y$54$KG$20240924$$MD$CA$CA
223045063$22304506$3$F$$20240812$20230510$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03527$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223045924$22304592$4$F$20240623$20240712$20230510$20240716$EXP$$US-PFIZER INC-PV202300077785$PFIZER$$89$YR$$F$Y$$$20240716$$CN$US$US
223046823$22304682$3$F$$20240731$20230510$20240813$EXP$$US-LUPIN PHARMACEUTICALS INC.-2023-03556$LUPIN$$$$$$Y$$$20240813$$CN$US$US
223047884$22304788$4$F$$20240716$20230510$20240718$PER$$US-PFIZER INC-PV202300079432$PFIZER$$82$YR$$F$Y$$$20240718$$CN$US$US
223048103$22304810$3$F$20220701$20240923$20230510$20240930$EXP$$CA-JNJFOC-20220861878$JOHNSON AND JOHNSON$$27$YR$A$F$Y$96$KG$20240930$$HP$CA$CA
223050297$22305029$7$F$$20240905$20230510$20240909$EXP$$US-TAKEDA-2023TUS046073$TAKEDA$$$$$F$Y$$$20240909$$CN$US$US
223050315$22305031$5$F$$20240801$20230510$20240806$EXP$$US-TAKEDA-2022TUS081636$TAKEDA$$$$$M$Y$97.959$KG$20240806$$MD$US$US
223050486$22305048$6$F$$20240730$20230510$20240802$EXP$$CA-TAKEDA-2022TUS018443$TAKEDA$$$$$M$Y$$$20240802$$HP$CA$CA
223053495$22305349$5$F$20230613$20240710$20230510$20240720$EXP$$NVSC2023US105132$NOVARTIS$$76$YR$$M$Y$$$20240720$$CN$US$US
223054306$22305430$6$F$$20240805$20230510$20240806$PER$$NVSC2023US102751$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
223054558$22305455$8$F$$20240816$20230510$20240819$EXP$$US-KYOWAKIRIN-2023BKK006732$KYOWA$$$$$$Y$$$20240819$$HP$US$US
223059452$22305945$2$F$$20230503$20230511$20240919$EXP$$NVSC2023PT064846$NOVARTIS$$$$$$Y$$$20240919$$MD$PT$PT
223061434$22306143$4$F$20230101$20240708$20230511$20240713$EXP$$CA-JNJFOC-20230333873$JOHNSON AND JOHNSON$$58$YR$A$F$Y$61$KG$20240713$$HP$CA$CA
223061515$22306151$5$F$20230203$20240723$20230511$20240725$EXP$$CA-PFIZER INC-202201387254$PFIZER$$79$YR$$F$Y$$$20240725$$MD$CA$CA
223062203$22306220$3$F$20221129$20240701$20230511$20240703$PER$$US-BIOGEN-2022BI01173729$BIOGEN$$65$YR$$F$Y$$$20240703$$CN$US$US
223063984$22306398$4$F$$20240819$20230511$20240826$EXP$$NVSC2023DE103745$NOVARTIS$Hoeltzenbein M, Slim S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. SEIZURE: EUROPEAN JOURNAL OF EPILEPSY. 2023;107:107-13$$$N$$Y$$$20240826$$HP$DE$DE
223065619$22306561$9$F$20240916$20240917$20230511$20240919$EXP$$IN-ROCHE-3333085$ROCHE$$38$YR$A$F$Y$$$20240919$$MD$IN$IN
223066515$22306651$5$F$20230308$20240910$20230511$20240916$EXP$$ES-JNJFOC-20230518749$JOHNSON AND JOHNSON$$73$YR$E$M$Y$76$KG$20240917$$MD$ES$ES
2230665912$22306659$12$F$20210830$20240718$20230511$20240726$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000393$DECIPHERA PHARMACEUTICALS$$61$YR$A$F$Y$$$20240726$$CN$US$US
223067145$22306714$5$F$$20240806$20230511$20240815$EXP$$CA-BAXTER-2023BAX021139$BAXTER$$62$YR$$F$Y$$$20240815$$HP$CA$CA
2230686422$22306864$22$F$$20240829$20230511$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384983$RANBAXY$$$$A$F$Y$63.946$KG$20240913$$CN$US$US
223072892$22307289$2$F$20220513$20240807$20230511$20240809$PER$$US-ROCHE-3104142$ROCHE$$33$YR$A$F$Y$77.11$KG$20240809$$CN$US$US
223073116$22307311$6$F$20221101$20240807$20230511$20240810$EXP$$US-ABBVIE-4759632$ABBVIE$$61$YR$$M$Y$$$20240810$$CN$US$US
223074782$22307478$2$F$$20240731$20230511$20240731$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387754$RANBAXY$Ge Q, Liu, Y, Yang F, Sun G, Guo J, Sun S. Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review. Int J Mol Sci. 2023;24:830$58$YR$$M$Y$$$20240731$$HP$CN$CN
223074902$22307490$2$F$$20240811$20230511$20240812$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387799$RANBAXY$KATO Y, KAWAGUCHI H, IWATAKI S, KIHARA H, OKADA S. Recombinant human soluble thrombomodulin and danaparoid combination anticoagulant therapy for disseminated intravascular coagulation in a child with streptococcal toxic shock syndrome: A case report. Exp Ther Med. 2022;24:714; 1-6$10$YR$$M$Y$$$20240812$$HP$JP$JP
223075032$22307503$2$F$$20240830$20230511$20240904$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388003$RANBAXY$Kimura S, Oshiro Y, Iwasaki H, Kadowaki M, Ogata M, Daa T, et al. Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders. BMC Can. 2022;22(1):1342$31$YR$$M$Y$$$20240904$$HP$JP$JP
223075232$22307523$2$F$$20240704$20230511$20240705$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-387937$RANBAXY$Karahan F, Atay A, Dilek FH, Tavusbay C, Atahan MK. Acute mesenteric thrombosis in a pregnant woman with Factor V Leiden mutation with a history of in vitro fertilization and embryo transfer: case report and literature review. Rev Colomb Obstet Ginecol. 2022;73(4):388-395$37$YR$$F$Y$$$20240705$$HP$TR$TR
223075853$22307585$3$F$20221227$20240806$20230511$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-067004$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$74.93$KG$20240808$$PH$US$US
223077622$22307762$2$F$$20240813$20230511$20240819$PER$$US-BIOGEN-2023BI01204258$BIOGEN$$$$$F$Y$$$20240819$$CN$US$US
223078652$22307865$2$F$20230401$20230501$20230511$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202305001682$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240828$$CN$US$US
223078862$22307886$2$F$$20240918$20230511$20240930$EXP$$NVSC2023US104578$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
223082853$22308285$3$F$$20240729$20230511$20240801$PER$$US-ROCHE-3225006$ROCHE$$30$YR$A$F$Y$$$20240801$$MD$US$US
223083822$22308382$2$F$20230412$20240918$20230511$20240925$PER$$NVSC2023US108322$NOVARTIS$$65$YR$$M$Y$84.3$KG$20240926$$HP$US$US
223088572$22308857$2$F$$20230504$20230511$20240830$EXP$$DE-ABBVIE-4752855$ABBVIE$$$$$F$Y$$$20240830$$MD$DE$DE
223090644$22309064$4$F$$20240724$20230511$20240730$EXP$$US-VERTEX PHARMACEUTICALS-2023-006573$VERTEX$$19$YR$$F$Y$$$20240730$$CN$US$US
223092232$22309223$2$F$$20240829$20230511$20240902$EXP$$CA-PFIZER INC-202300181390$PFIZER$$45$YR$$F$Y$$$20240902$$HP$CA$CA
223092758$22309275$8$F$20230101$20240805$20230511$20240808$EXP$$US-PFIZER INC-PV202300082770$PFIZER$$77$YR$$M$Y$$$20240808$$CN$US$US
223093013$22309301$3$F$20201101$20240816$20230511$20240822$EXP$$US-PFIZER INC-PV202300083794$PFIZER$$54$YR$$F$Y$$$20240822$$MD$US$US
223093373$22309337$3$F$20230116$20240827$20230511$20240828$EXP$$IL-TAKEDA-2023TUS046842$TAKEDA$$$$E$F$Y$$$20240828$$MD$IL$IL
223096763$22309676$3$F$$20240808$20230511$20240812$PER$$NVSC2023US106069$NOVARTIS$$$$$M$Y$$$20240812$$MD$US$US
2230970410$22309704$10$F$20240205$20240708$20230511$20240712$EXP$$NVSC2023CL052917$NOVARTIS$$82$YR$$F$Y$$$20240712$$CN$CL$CL
223098825$22309882$5$F$20190701$20240812$20230511$20240813$EXP$$US-SHIRE-US201909387$TAKEDA$$73$YR$$F$Y$$$20240813$$MD$US$US
223098972$22309897$2$F$20190206$20240826$20230511$20240902$EXP$$CA-TAKEDA-CA201915927$TAKEDA$$24$YR$$M$Y$$$20240902$$HP$CA$CA
223100962$22310096$2$F$20130101$20240829$20230511$20240902$EXP$$US-TAKEDA-US201700132$TAKEDA$$$$$F$Y$$$20240902$$CN$US$US
223101142$22310114$2$F$20221018$20240814$20230511$20240823$EXP$FR-AFSSAPS-AM2023000360$FR-TEVA-2023-FR-2884430$TEVA$$71$YR$$F$Y$$$20240823$$MD$FR$FR
223101853$22310185$3$F$20230323$20240705$20230511$20240715$EXP$IT-MINISAL02-919887$IT-TEVA-2023-IT-2885217$TEVA$$7$YR$$F$Y$25$KG$20240715$$PH$IT$IT
223102012$22310201$2$F$20220131$20240719$20230511$20240729$EXP$$FR-TEVA-2023-FR-2884777$TEVA$$57$YR$$F$Y$$$20240729$$PH$FR$FR
223104842$22310484$2$F$$20240715$20230511$20240723$PER$$US-SA-2023SA144471$SANOFI AVENTIS$$$$T$M$Y$92.9$KG$20240723$$MD$US$US
223105862$22310586$2$F$20221001$20240626$20230511$20240705$PER$$US-SA-2023SA146256$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240705$$MD$US$US
223106432$22310643$2$F$20221211$20240710$20230511$20240717$PER$$US-SA-2023SA145870$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240717$$MD$US$US
223107342$22310734$2$F$20230201$20240702$20230511$20240711$PER$$US-SA-2023SA114848$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240711$$MD$US$US
223107772$22310777$2$F$20230424$20240916$20230511$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202305006473$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240926$$CN$US$US
223108532$22310853$2$F$20230201$20240729$20230511$20240805$EXP$$BR-TAKEDA-2023TUS030987$TAKEDA$$21$YR$$M$Y$$$20240805$$CN$BR$BR
223110245$22311024$5$F$$20240904$20230511$20240906$PER$$US-PFIZER INC-PV202300080971$PFIZER$$66$YR$$F$Y$$$20240906$$HP$US$US
223110894$22311089$4$F$20230101$20240711$20230511$20240715$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-118232$DAIICHI$$$$$F$Y$$$20240715$$CN$US$US
223112107$22311210$7$F$$20240701$20230511$20240703$EXP$$US-PFIZER INC-PV202300080826$PFIZER$$70$YR$$F$Y$$$20240703$$CN$US$US
223114248$22311424$8$F$20230101$20240708$20230511$20240710$EXP$$CA-PFIZER INC-202101190424$PFIZER$$69$YR$$F$Y$$$20240710$$CN$CA$CA
223114263$22311426$3$F$20211201$20240712$20230511$20240716$EXP$$IN-PFIZER INC-202200223560$PFIZER$$46$YR$$M$Y$61.6$KG$20240716$$CN$IN$IN
223114598$22311459$8$F$20230322$20240914$20230511$20240919$EXP$$FR-JNJFOC-20230514129$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240919$$HP$FR$FR
223114963$22311496$3$F$$20240628$20230511$20240702$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003399$PAREXEL$$$$$$Y$$$20240702$$CN$US$US
2231161116$22311611$16$F$20220901$20240813$20230511$20240820$EXP$$CA-CELLTRION INC.-2022CA016089$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
223116549$22311654$9$F$20200304$20240819$20230511$20240823$EXP$$US-ABBVIE-4757704$ABBVIE$$43$YR$$F$Y$68.946$KG$20240823$$MD$US$US
223116945$22311694$5$F$$20240813$20230512$20240816$EXP$$US-PFIZER INC-PV202300056459$PFIZER$$85$YR$$F$Y$$$20240816$$MD$US$US
223117432$22311743$2$F$$20240727$20230512$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-15164$LUPIN$$$$$$Y$$$20240818$$CN$US$US
223118504$22311850$4$F$20220701$20240727$20230512$20240802$EXP$$CA-ABBVIE-4763343$ABBVIE$$64$YR$$M$Y$$$20240802$$HP$CA$CA
223118683$22311868$3$F$20230101$20240919$20230512$20240927$EXP$$FR-AUROBINDO-AUR-APL-2023-035093$AUROBINDO$$52$YR$$F$Y$$$20240927$$MD$FR$FR
223118966$22311896$6$F$$20231010$20230512$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202305005397$ELI LILLY AND CO$$56$YR$A$F$Y$63.039$KG$20240904$$MD$US$US
223119794$22311979$4$F$20220419$20240801$20230512$20240801$EXP$$EG-ROCHE-3099092$ROCHE$$31$YR$A$M$Y$60$KG$20240801$$CN$EG$EG
2231238113$22312381$13$F$20170101$20240820$20230512$20240826$EXP$$US-ABBVIE-4763932$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
223124232$22312423$2$F$$20240725$20230512$20240801$PER$$NVSC2023US104974$NOVARTIS$$$$$M$Y$124.74$KG$20240801$$MD$US$US
223126323$22312632$3$F$$20240731$20230512$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03578$LUPIN$$$$$$Y$$$20240818$$CN$US$US
223128222$22312822$2$F$20230411$20240705$20230512$20240715$EXP$IT-MINISAL02-920772$IT-TEVA-2023-IT-2885014$TEVA$$13$YR$$M$Y$43$KG$20240715$$PH$IT$IT
223128413$22312841$3$F$20230101$20240729$20230512$20240805$PER$$US-SA-2023SA147500$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240804$$MD$US$US
223129252$22312925$2$F$20230301$20240711$20230512$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-388038$RANBAXY$$85$YR$$F$Y$$$20240712$$PH$FR$FR
223129402$22312940$2$F$20230104$20240709$20230512$20240710$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-388052$RANBAXY$$70$YR$$F$Y$108$KG$20240710$$MD$FR$FR
223132005$22313200$5$F$20230824$20240818$20230512$20240913$EXP$$US-BEH-2023158405$CSL BEHRING$$63$YR$A$F$Y$$$20240913$$CN$US$US
223132515$22313251$5$F$20160101$20230908$20230512$20240712$EXP$$CA-MYLANLABS-2023M1041626$MYLAN$$$$$F$Y$49.89$KG$20240712$$CN$CA$CA
223133064$22313306$4$F$$20240726$20230512$20240731$EXP$$US-PFIZER INC-PV202300084867$PFIZER$$69$YR$$F$Y$69.2$KG$20240731$$CN$US$US
223133972$22313397$2$F$$20240625$20230512$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-067417$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240716$$HP$US$US
223136322$22313632$2$F$$20240719$20230512$20240724$PER$$NVSC2023US102726$NOVARTIS$$$$A$F$Y$$$20240724$$CN$US$US
223136389$22313638$9$F$20230301$20240919$20230512$20240927$EXP$$CA-TAKEDA-2023TUS027834$TAKEDA$$68$YR$$M$Y$$$20240927$$HP$CA$CA
223136395$22313639$5$F$20160812$20240708$20230512$20240711$EXP$$CA-TAKEDA-2016TUS022798$TAKEDA$$40$YR$$M$Y$$$20240711$$HP$CA$CA
223137012$22313701$2$F$$20240918$20230512$20240927$EXP$$NVSC2023US109069$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
223137674$22313767$4$F$20220310$20240904$20230512$20240912$EXP$$CA-PFIZER INC-202200156651$PFIZER$$67$YR$$F$Y$73.8$KG$20240911$$MD$CA$CA
223138547$22313854$7$F$20230101$20240826$20230512$20240829$30DAY$$CA-PFIZER INC-202300109612$PFIZER$$34$YR$$F$Y$$$20240829$$MD$CA$CA
223139204$22313920$4$F$$20240924$20230512$20240930$EXP$$CA-ROCHE-3346834$ROCHE$$50$YR$A$F$Y$110$KG$20240930$$MD$CA$CA
2231396310$22313963$10$F$$20240906$20230512$20240910$EXP$$NVSC2023US105695$NOVARTIS$$$$$F$Y$$$20240910$$CN$US$US
223140104$22314010$4$F$20230424$20240904$20230512$20240912$EXP$$US-SA-2023SA147673$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240912$$MD$US$US
223141185$22314118$5$F$$20240618$20230512$20240703$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386521$RANBAXY$Aviles-prieto J, Caro-Magdaleno M, Rodriguez-de-la-Rua-Franch E. Peripheral Ulcerative Keratopathy following Systemic Treatment with Bortezomib: A Case Report. Ocul Immunol Inflamm. 2024;32 (4):470-472$60$YR$$M$Y$$$20240703$$HP$ES$ES
223141484$22314148$4$F$$20240724$20230512$20240726$EXP$$US-PFIZER INC-PV202300083281$PFIZER$$83$YR$$M$Y$117$KG$20240726$$CN$US$US
223141904$22314190$4$F$$20240816$20230512$20240820$EXP$$US-PFIZER INC-PV202300084429$PFIZER$$75$YR$$F$Y$$$20240820$$CN$US$US
223142113$22314211$3$F$$20240814$20230512$20240824$30DAY$$US-GSK-US2023063915$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
223143058$22314305$8$F$20230511$20231114$20230512$20240925$EXP$$US-GSK-US2023AMR065460$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
223143363$22314336$3$F$20230426$20240824$20230512$20240828$EXP$$IT-TAKEDA-2023TUS047464$TAKEDA$$$$E$M$Y$$$20240828$$CN$IT$IT
223143925$22314392$5$F$$20230904$20230512$20240828$EXP$$NVSC2023AU011445$NOVARTIS$$$$$F$Y$$$20240828$$MD$AU$AU
223144864$22314486$4$F$$20240827$20230512$20240830$EXP$$CA-PFIZER INC-202300184955$PFIZER$$50$YR$$M$Y$$$20240830$$HP$CA$CA
223145002$22314500$2$F$$20230508$20230512$20240925$PER$$US-GSK-US2023AMR066887$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
223145055$22314505$5$F$$20240722$20230512$20240729$EXP$$US-GSK-US2023AMR067008$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
223145267$22314526$7$F$$20240610$20230512$20240926$EXP$$US-GSK-US2023AMR067410$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
223146542$22314654$2$F$$20230504$20230512$20240925$PER$$US-GSK-US2023AMR065303$GLAXOSMITHKLINE$$$$$M$Y$$$20240925$$CN$US$US
223146672$22314667$2$F$$20230509$20230512$20240925$PER$$US-GSK-US2023AMR067726$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
223146906$22314690$6$F$$20240703$20230512$20240709$EXP$$NVSC2023US108975$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
2231483514$22314835$14$F$20221202$20240814$20230512$20240820$EXP$$IT-TAKEDA-2022TUS095058$TAKEDA$$$$$F$Y$$$20240820$$HP$IT$IT
223148874$22314887$4$F$20230201$20240718$20230512$20240723$EXP$$US-UCBSA-2023007947$UCB$$12$YR$$F$Y$$$20240723$$CN$US$US
223149794$22314979$4$F$20210506$20240802$20230512$20240807$EXP$$RO-TAKEDA-2023TUS040259$TAKEDA$$23$YR$$F$Y$60$KG$20240807$$HP$RO$RO
2231510211$22315102$11$F$20220916$20240724$20230512$20240726$EXP$$CA-PFIZER INC-202200341962$PFIZER$$58$YR$$F$Y$85$KG$20240726$$HP$CA$CA
223153502$22315350$2$F$$20230511$20230512$20240906$PER$$NVSC2023US109586$NOVARTIS$$$$$M$Y$$$20240906$$CN$US$US
223153655$22315365$5$F$$20240820$20230512$20240822$EXP$$US-PFIZER INC-PV202300083633$PFIZER$$68$YR$$F$Y$$$20240822$$CN$US$US
223154558$22315455$8$F$20220901$20240709$20230512$20240711$PER$$US-PFIZER INC-PV202200052419$PFIZER$$71$YR$$F$Y$66.9$KG$20240711$$CN$US$US
223159572$22315957$2$F$20230302$20240808$20230512$20240813$EXP$FR-AFSSAPS-LY2023000717$FR-ROCHE-3347726$ROCHE$$40$YR$A$F$Y$50$KG$20240813$$MD$FR$FR
223159618$22315961$8$F$20221216$20240905$20230512$20240913$EXP$$DE-ROCHE-3347690$ROCHE$$57$YR$A$F$Y$$$20240913$$MD$DE$DE
2231613310$22316133$10$F$20230417$20240902$20230512$20240905$EXP$$US-BEH-2023158667$CSL BEHRING$$37$YR$A$M$Y$$$20240905$$HP$US$US
223161562$22316156$2$F$$20230509$20230512$20240905$PER$$NVSC2023US107428$NOVARTIS$$$$$M$Y$$$20240905$$CN$US$US
223163852$22316385$2$F$20220925$20230510$20230513$20240906$EXP$$NVSC2023US108309$NOVARTIS$$74$YR$$M$Y$$$20240906$$CN$US$US
223165124$22316512$4$F$$20240821$20230513$20240823$PER$$NVSC2023US110027$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
223165235$22316523$5$F$$20230724$20230513$20240830$PER$$NVSC2023US110033$NOVARTIS$$$$$$Y$$$20240830$$MD$US$US
223165413$22316541$3$F$20221001$20240912$20230513$20240913$PER$$NVSC2023US109992$NOVARTIS$$44$YR$$M$Y$$$20240913$$CN$US$US
223165535$22316553$5$F$20240904$20240918$20230513$20240925$EXP$$NVSC2023US107443$NOVARTIS$$93$YR$$F$Y$$$20240925$$CN$US$US
223166123$22316612$3$F$20231016$20240724$20230513$20240726$EXP$$NVSC2023MX108625$NOVARTIS$$67$YR$$M$Y$$$20240726$$CN$MX$MX
223166564$22316656$4$F$20240304$20240821$20230514$20240830$30DAY$$US-GSK-US2023064940$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240830$$CN$US$US
223166845$22316684$5$F$20220801$20240827$20230513$20240904$EXP$$CA-CELLTRION INC.-2022CA014373$CELLTRION$$$$$$Y$$$20240904$$MD$CA$CA
223167605$22316760$5$F$$20240812$20230513$20240816$EXP$$NVSC2023US108049$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
223172104$22317210$4$F$20230206$20240710$20230515$20240711$EXP$$KR-ABBVIE-4764731$ABBVIE$$57$YR$$M$Y$64$KG$20240711$$MD$KR$KR
223172897$22317289$7$F$$20240913$20230515$20240923$EXP$$GB-CELLTRION INC.-2023GB009867$CELLTRION$$$$$$Y$$$20240923$$MD$GB$GB
223174773$22317477$3$F$$20240625$20230515$20240925$PER$$US-GSK-US2023AMR067696$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$HP$US$US
223174998$22317499$8$F$20220101$20231127$20230515$20240925$PER$$US-GSK-US2023AMR067720$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
223176506$22317650$6$F$20230418$20240820$20230515$20240913$PER$$CA-TOLMAR, INC.-23CA040458$TOLMAR$$75$YR$$M$Y$$$20240913$$CN$CA$CA
223176984$22317698$4$F$$20240802$20230515$20240802$PER$$NVSC2023US108144$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
223177022$22317702$2$F$20230110$20240918$20230515$20240927$PER$$NVSC2023US107109$NOVARTIS$$65$YR$$F$Y$$$20240927$$CN$US$US
223178815$22317881$5$F$20230424$20240730$20230515$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03583$LUPIN$$$$$$Y$$$20240819$$CN$US$US
2231789211$22317892$11$F$20230101$20240906$20230515$20240916$EXP$$CA-CELLTRION INC.-2023CA002538$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
223179002$22317900$2$F$$20240807$20230515$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03585$LUPIN$$$$$$Y$$$20240827$$CN$US$US
223179232$22317923$2$F$$20230511$20230515$20240925$PER$$US-GSK-US2023AMR068749$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
223179543$22317954$3$F$20230422$20240710$20230515$20240729$PER$$CA-TOLMAR, INC.-23CA040530$TOLMAR$$85$YR$$M$Y$$$20240729$$CN$CA$CA
223181669$22318166$9$F$20230501$20240813$20230515$20240820$EXP$$US-SA-2023SA147378$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240820$$MD$US$US
223181694$22318169$4$F$$20240712$20230515$20240717$EXP$$US-SA-2023SA147074$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240717$$MD$US$US
223182303$22318230$3$F$$20240909$20230515$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03590$LUPIN$$$$$$Y$$$20240920$$CN$US$US
223183436$22318343$6$F$20191113$20240919$20230515$20240925$EXP$$CA-TAKEDA-2019TUS065893$TAKEDA$$79$YR$$F$Y$$$20240925$$CN$CA$CA
223184046$22318404$6$F$20230101$20240726$20230515$20240731$EXP$$US-SA-2023SA147641$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240731$$MD$US$US
223184254$22318425$4$F$$20240801$20230515$20240809$30DAY$$CA-JNJFOC-20230413772$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240809$$HP$CA$CA
223184283$22318428$3$F$20230504$20240805$20230515$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03610$LUPIN$$$$$$Y$$$20240820$$CN$US$US
223185043$22318504$3$F$20230201$20240829$20230515$20240912$EXP$FR-AFSSAPS-RN2023000299$FR-Axellia-004729$XELLIA PHARMACEUTICALS$$55$YR$A$M$Y$$$20240912$$MD$FR$FR
223185872$22318587$2$F$20240101$20240911$20230515$20240918$PER$$US-SA-2023SA147501$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240918$$MD$US$US
223185916$22318591$6$F$20230101$20240628$20230515$20240712$PER$$US-SA-2023SA064143$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240712$$MD$US$US
223186506$22318650$6$F$20190308$20240906$20230515$20240911$EXP$$CA-TAKEDA-2023TUS047648$TAKEDA$$32$YR$$M$Y$$$20240911$$MD$CA$CA
223187102$22318710$2$F$20230101$20240709$20230515$20240717$PER$$US-SA-2023SA147760$SANOFI AVENTIS$$97$YR$E$F$Y$$$20240717$$MD$US$US
223187363$22318736$3$F$$20240807$20230515$20240816$PER$$US-SA-2023SA149169$SANOFI AVENTIS$$$$E$F$Y$$$20240816$$MD$US$US
223188164$22318816$4$F$$20240812$20230515$20240817$EXP$$NVSC2023CO108715$NOVARTIS$$$$$F$Y$58$KG$20240817$$CN$CO$CO
223188178$22318817$8$F$20230408$20240807$20230515$20240814$EXP$$NVSC2023PA109947$NOVARTIS$$58$YR$$F$Y$82$KG$20240814$$CN$PA$PA
223189532$22318953$2$F$20190312$20240913$20230515$20240920$EXP$$CA-TAKEDA-2019TUS015931$TAKEDA$$62$YR$$M$Y$$$20240920$$MD$CA$CA
223190906$22319090$6$F$20240628$20240715$20230515$20240725$EXP$$US-VIIV HEALTHCARE LIMITED-US2023065945$VIIV$$52$YR$$M$Y$74.84$KG$20240725$$CN$US$US
223191114$22319111$4$F$20221101$20240924$20230515$20240927$EXP$$CA-PFIZER INC-202300187564$PFIZER$$64$YR$$M$Y$$$20240927$$HP$CA$CA
223192142$22319214$2$F$20230328$20240802$20230515$20240812$EXP$FR-AFSSAPS-PV2023000398$FR-TEVA-2023-FR-2886022$TEVA$$10$YR$$F$Y$35$KG$20240812$$MD$FR$FR
223192453$22319245$3$F$20201101$20240813$20230515$20240910$EXP$FR-AFSSAPS-ST2023000534$FR-TEVA-2023-FR-2886197$TEVA$$76$YR$$F$Y$50$KG$20240902$$MD$FR$FR
223193602$22319360$2$F$$20240809$20230515$20240816$PER$$US-SA-2023SA149371$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240817$$CN$US$US
223194478$22319447$8$F$20200618$20240809$20230515$20240814$EXP$$CA-TAKEDA-2020TUS012651$TAKEDA$$61$YR$$M$Y$$$20240814$$HP$CA$CA
223194923$22319492$3$F$20240501$20240624$20230515$20240703$PER$$US-SA-2023SA147851$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240703$$MD$US$US
223195015$22319501$5$F$$20240926$20230515$20240930$PER$$US-PFIZER INC-PV202300085134$PFIZER$$75$YR$$F$Y$$$20240930$$CN$US$US
223195792$22319579$2$F$$20230503$20230515$20240724$PER$$US-AstraZeneca-2023A111577$ASTRAZENECA$$$$$$Y$$$20240724$$CN$US$
223195843$22319584$3$F$$20240701$20230515$20240708$PER$$US-SA-2023SA149026$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240708$$CN$US$US
223195984$22319598$4$F$20190619$20240815$20230515$20240821$EXP$$CA-TAKEDA-2023TUS043212$TAKEDA$$55$YR$$F$Y$$$20240821$$CN$CA$CA
223196009$22319600$9$F$20230508$20240716$20230515$20240718$EXP$$US-TAKEDA-2023TUS034615$TAKEDA$$6$YR$$M$Y$19$KG$20240718$$HP$US$US
223197236$22319723$6$F$$20240904$20230515$20240911$EXP$$US-GSK-US2023065971$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$HP$US$US
223197512$22319751$2$F$20201201$20240730$20230515$20240802$EXP$$JP-VIATRISJAPAN-2023M1048507AA$MYLAN$$45$YR$$M$Y$92$KG$20240802$$MD$JP$JP
223199073$22319907$3$F$20200101$20240919$20230515$20240925$EXP$$US-VERTEX PHARMACEUTICALS-2023-006879$VERTEX$$$$$$Y$$$20240925$$CN$US$US
223200073$22320007$3$F$20210223$20240815$20230515$20240823$EXP$$DE-ROCHE-2782804$ROCHE$$58$YR$A$F$Y$$$20240823$$CN$DE$DE
223200243$22320024$3$F$20230509$20240827$20230515$20240830$EXP$$CA-TAKEDA-2023TUS026615$TAKEDA$$40$YR$$F$Y$$$20240830$$MD$CA$CA
223200328$22320032$8$F$20230417$20240725$20230515$20240726$EXP$$ES-PFIZER INC-202300186831$PFIZER$$53$YR$$F$Y$60$KG$20240726$$MD$ES$ES
223200643$22320064$3$F$$20240624$20230515$20240701$PER$$US-PFIZER INC-PV202300084322$PFIZER$$68$YR$$F$Y$$$20240701$$CN$US$US
2232029116$22320291$16$F$20230401$20240625$20230515$20240701$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007970$JAZZ$$37$YR$$F$Y$$$20240701$$HP$US$US
223205364$22320536$4$F$$20240726$20230515$20240805$EXP$$CA-MYLANLABS-2022M1038119$BIOCON$$$$$$Y$$$20240805$$CN$CA$CA
223206712$22320671$2$F$20210101$20230512$20230515$20240906$EXP$$NVSC2023US110615$NOVARTIS$$$$$M$Y$71.655$KG$20240906$$CN$US$US
2232091910$22320919$10$F$20181112$20240910$20230515$20240916$EXP$$CA-TAKEDA-2018TUS032716$TAKEDA$$61$YR$$M$Y$$$20240916$$HP$CA$CA
223209415$22320941$5$F$20230427$20240918$20230515$20240930$PER$$NVSC2023US111010$NOVARTIS$$67$YR$$M$Y$$$20240930$$CN$US$US
223210163$22321016$3$F$$20240920$20230515$20240925$PER$$NVSC2023US110686$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
223210343$22321034$3$F$20220801$20240829$20230515$20240904$EXP$$DE-MYLANLABS-2023M1049729$MYLAN$$$$E$M$Y$$$20240904$$MD$DE$DE
2232125810$22321258$10$F$20221121$20240710$20230515$20240712$EXP$$US-PFIZER INC-PV202300085218$PFIZER$$66$YR$$F$Y$84.354$KG$20240712$$PH$US$US
223212622$22321262$2$F$20230101$20240801$20230515$20240809$PER$$US-SA-2023SA148008$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240809$$MD$US$US
223212846$22321284$6$F$20220101$20240625$20230515$20240703$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-003552$AMGEN$$70$YR$E$M$Y$107.7$KG$20240703$$MD$US$US
223213513$22321351$3$F$$20230509$20230515$20240911$PER$$NVSC2023US108379$NOVARTIS$$$$$M$Y$$$20240911$$HP$US$US
223214247$22321424$7$F$$20240819$20230515$20240829$EXP$$CA-CIPHER-2023-CA-000238$CIPHER$$43$YR$A$F$Y$96$KG$20240829$$HP$CA$CA
223214807$22321480$7$F$$20240904$20230515$20240909$EXP$$US-TAKEDA-2022TUS046056$TAKEDA$$$$$F$Y$63$KG$20240909$$CN$US$US
223216997$22321699$7$F$$20240906$20230515$20240912$EXP$$US-BIOGEN-2023BI01205019$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
223218263$22321826$3$F$$20240624$20230516$20240704$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001578$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240704$$CN$US$US
223218382$22321838$2$F$$20240701$20230516$20240708$EXP$$IT-AUROBINDO-AUR-APL-2023-035752$AUROBINDO$$37$YR$$M$Y$$$20240708$$CN$IT$IT
223218494$22321849$4$F$20230315$20240617$20230516$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001557$ACADIA PHARMACEUTICALS$$60$YR$$F$Y$$$20240712$$CN$US$US
223219885$22321988$5$F$20190202$20240919$20230516$20240925$EXP$$US-ABBVIE-4766993$ABBVIE$$66$YR$$F$Y$$$20240925$$CN$US$US
223220342$22322034$2$F$$20240807$20230516$20240817$EXP$$US-GSK-US2023066088$GLAXOSMITHKLINE$$$$$F$Y$$$20240817$$CN$US$US
2232223718$22322237$18$F$20230811$20240612$20230516$20240704$EXP$$US-GSK-US2023AMR068336$GLAXOSMITHKLINE$$45$YR$$F$Y$$$20240704$$CN$US$US
223223469$22322346$9$F$20220729$20240920$20230516$20240930$EXP$$CA-CELLTRION INC.-2022CA006654$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
223228003$22322800$3$F$20180728$20240731$20230516$20240808$EXP$$CO-UCBSA-2023024616$UCB$$60$YR$$F$Y$55$KG$20240808$$CN$CO$CO
223228722$22322872$2$F$20230424$20240719$20230516$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202305005482$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240723$$CN$US$US
223230532$22323053$2$F$20230501$20240903$20230516$20240909$EXP$$US-TAKEDA-2021TUS055623$TAKEDA$$4$YR$$F$Y$$$20240909$$CN$US$US
223230587$22323058$7$F$20180101$20240704$20230516$20240711$EXP$$CA-TAKEDA-2018TUS034386$TAKEDA$$$$$M$Y$$$20240711$$CN$CA$CA
223231932$22323193$2$F$20230417$20240723$20230516$20240802$EXP$FR-AFSSAPS-PV2023000467$FR-TEVA-2023-FR-2887993$TEVA$$14$YR$$F$Y$82$KG$20240802$$MD$FR$FR
223233135$22323313$5$F$20230317$20240712$20230516$20240723$PER$$US-TRAVERE-2023TVT00078$TRAVERE THERAPEUTICS$$55$YR$A$M$Y$$$20240719$$CN$US$US
2232366710$22323667$10$F$20231130$20240819$20230516$20240827$EXP$$CA-GSK-CA2023AMR069340$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$HP$CA$CA
223236742$22323674$2$F$$20240807$20230516$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03589$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223237544$22323754$4$F$20130101$20240829$20230516$20240910$EXP$$DE-Accord-357932$ACCORD$Wiemer-Kruel A. Ketogenic dietary therapy with special consideration of the treatment of myoclonic astatic epilepsy. Epilepsie. Z. Epileptol. 2021;34:154-60. doi:10.1007/s10309-020-00394-w.$3$YR$C$M$Y$$$20240910$$MD$DE$DE
223237983$22323798$3$F$20230501$20230518$20230516$20240925$PER$$US-GSK-US2023AMR068805$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240925$$CN$US$US
223238373$22323837$3$F$20210317$20230720$20230516$20240702$EXP$$NVSC2023US108131$NOVARTIS$$4$YR$$M$Y$$$20240702$$HP$US$US
223238582$22323858$2$F$20230201$20230515$20230516$20240911$PER$$NVSC2023US111798$NOVARTIS$$64$YR$$F$Y$$$20240911$$CN$US$US
223239933$22323993$3$F$20200101$20230615$20230516$20240925$PER$$US-GSK-US2023AMR067704$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2232420011$22324200$11$F$$20240909$20230516$20240912$EXP$$CA-ROCHE-3258733$ROCHE$$$$A$F$Y$$$20240912$$CN$CA$CA
223242014$22324201$4$F$20220120$20240613$20230516$20240709$EXP$$DE-ROCHE-3069123$ROCHE$$37$YR$A$F$Y$$$20240705$$CN$DE$DE
223242186$22324218$6$F$20230301$20240815$20230516$20240824$EXP$$US-UNITED THERAPEUTICS-UNT-2023-008877$UNITED THERAPEUTICS$$32$YR$$F$Y$$$20240824$$$US$US
223243332$22324333$2$F$20230201$20240917$20230516$20240920$PER$$US-PFIZER INC-202300189012$PFIZER$$58$YR$$F$Y$$$20240920$$HP$US$US
223243989$22324398$9$F$20230501$20240910$20230516$20240913$PER$$US-PFIZER INC-PV202300086220$PFIZER$$40$YR$$M$Y$59.87$KG$20240913$$HP$US$US
223244636$22324463$6$F$$20240813$20230516$20240819$PER$$US-PFIZER INC-2020354952$PFIZER$$68$YR$$M$Y$$$20240819$$CN$US$US
223244684$22324468$4$F$$20240627$20230516$20240702$PER$$US-PFIZER INC-202300189082$PFIZER$$65$YR$$F$Y$$$20240702$$HP$US$US
223245267$22324526$7$F$$20240923$20230516$20240928$EXP$$GB-AMGEN-GBRSP2023080922$AMGEN$$$$$F$Y$$$20240927$$MD$GB$GB
223245473$22324547$3$F$$20240807$20230516$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03649$LUPIN$$$$$$Y$$$20240901$$PH$US$US
223246442$22324644$2$F$$20240812$20230516$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388404$RANBAXY$Yates JL, Palat DS, Subik MK, Lee WT, McDonough KA, Conuel E. Pharmacokinetics of convalescent plasma therapy in a COVID-19 patient with X-linked Agammaglobulinemia. Clin Immunol Commun. 2022;2:57-61$39$YR$$M$Y$$$20240826$$HP$US$US
223246522$22324652$2$F$20221101$20240716$20230516$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-388182$RANBAXY$$76$YR$$F$Y$61$KG$20240718$$PH$FR$FR
223246813$22324681$3$F$$20240805$20230516$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03620$LUPIN$$$$$$Y$$$20240828$$CN$US$US
2232478113$22324781$13$F$20230501$20240821$20230516$20240823$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-236536$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$$$20240823$$CN$CA$CA
223248798$22324879$8$F$20230801$20240807$20230516$20240809$EXP$$US-PFIZER INC-PV202300086156$PFIZER$$64$YR$$F$Y$$$20240809$$CN$US$US
223249878$22324987$8$F$20230130$20240705$20230516$20240719$EXP$$US-OTSUKA-2023_012353$OTSUKA$$15$YR$$M$Y$64.3$KG$20240719$$HP$US$US
223250286$22325028$6$F$$20240801$20230516$20240806$PER$$US-PFIZER INC-PV202200116273$PFIZER$$70$YR$$F$Y$53.968$KG$20240806$$HP$US$US
223250768$22325076$8$F$$20240827$20230516$20240830$EXP$$US-PFIZER INC-PV202300086410$PFIZER$$50$YR$$F$Y$58.06$KG$20240830$$CN$US$US
223252492$22325249$2$F$$20240727$20230516$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03650$LUPIN$$$$$$Y$$$20240816$$PH$US$US
2232528313$22325283$13$F$20230101$20240820$20230516$20240827$EXP$$NVSC2023BR009605$NOVARTIS$$61$YR$$F$Y$78$KG$20240827$$CN$BR$BR
223253003$22325300$3$F$20220101$20240725$20230516$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-010439$JAZZ$$$$$M$Y$$$20240730$$CN$US$US
223254762$22325476$2$F$$20240729$20230516$20240731$EXP$$US-PFIZER INC-PV202300085767$PFIZER$$77$YR$$F$Y$$$20240731$$CN$US$US
223255852$22325585$2$F$20230510$20240806$20230516$20240813$PER$$US-BIOMARINAP-US-2023-150386$BIOMARIN$$$$$$Y$$$20240813$$CN$US$US
223255872$22325587$2$F$20230506$20240627$20230516$20240709$EXP$$IN-ROCHE-3349948$ROCHE$$78$YR$E$M$Y$$$20240709$$CN$IN$IN
223257567$22325756$7$F$20190625$20240920$20230516$20240925$EXP$$CA-TAKEDA-2019TUS059262$TAKEDA$$11$YR$$F$Y$$$20240925$$HP$CA$CA
223258242$22325824$2$F$$20230530$20230516$20240917$PER$$NVSC2023US111508$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
223258444$22325844$4$F$$20240917$20230516$20240919$PER$$US-PFIZER INC-PV202300086271$PFIZER$$11$YR$$M$Y$$$20240919$$CN$US$US
223258642$22325864$2$F$$20240718$20230516$20240722$PER$$NVSC2023US112236$NOVARTIS$$$$$M$Y$$$20240722$$CN$US$US
223258977$22325897$7$F$20231201$20240709$20230516$20240716$EXP$$CA-PFIZER INC-2021045067$PFIZER$$57$YR$$F$Y$$$20240716$$MD$CA$CA
223260086$22326008$6$F$$20240924$20230516$20240926$EXP$$US-PFIZER INC-PV202300083772$PFIZER$$65$YR$$F$Y$$$20240926$$MD$US$US
223269914$22326991$4$F$20230515$20240918$20230516$20240927$PER$$NVSC2023US112115$NOVARTIS$$68$YR$$M$Y$130.63$KG$20240927$$CN$US$US
223281444$22328144$4$F$20210101$20240823$20230516$20240831$EXP$$CA-CELLTRION INC.-2021CA012719$CELLTRION$$$$$$Y$$$20240831$$CN$CA$CA
2232826114$22328261$14$F$20220101$20240722$20230517$20240730$EXP$$CA-CELLTRION INC.-2022CA008859$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
223285963$22328596$3$F$20230419$20240613$20230517$20240703$PER$$CA-TOLMAR, INC.-23CA040484$TOLMAR$$75$YR$$M$Y$$$20240703$$CN$CA$CA
223287943$22328794$3$F$20230401$20240724$20230517$20240815$PER$$CO-TOLMAR, INC.-23CO040475$TOLMAR$$85$YR$$M$Y$$$20240814$$CN$CO$CO
223287982$22328798$2$F$20230301$20240910$20230517$20240918$EXP$$GT-TOLMAR, INC.-23GT040596$TOLMAR$$82$YR$$M$Y$$$20240918$$CN$GT$GT
223290373$22329037$3$F$20230202$20240830$20230517$20240910$EXP$$US-NOVOPROD-1063710$NOVO NORDISK$$58$YR$$F$Y$123$KG$20240910$$MD$US$US
223291333$22329133$3$F$20230427$20230507$20230517$20240722$EXP$$GB-NOVOPROD-1061515$NOVO NORDISK$$$$$$Y$$$20240722$$PH$GB$GB
223292604$22329260$4$F$$20240523$20230517$20240701$PER$$US-ROCHE-3317871$ROCHE$$25$YR$A$M$Y$$$20240701$$MD$US$US
223293262$22329326$2$F$20230101$20240730$20230517$20240805$EXP$$JP-009507513-2305JPN000666J$MERCK$$9$DEC$$F$Y$$$20240805$$MD$JP$JP
223294378$22329437$8$F$20190814$20240812$20230517$20240816$EXP$$DE-ROCHE-2389789$ROCHE$$51$YR$A$M$Y$$$20240816$$CN$DE$DE
223294574$22329457$4$F$20230101$20240910$20230517$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2023-012813$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240919$$$US$US
2232946612$22329466$12$F$20230101$20240711$20230517$20240716$PER$$US-UNITED THERAPEUTICS-UNT-2023-004255$UNITED THERAPEUTICS$$$$$F$Y$87.8$KG$20240716$$$US$US
2232947212$22329472$12$F$20221028$20240715$20230517$20240722$EXP$$CH-ROCHE-3349376$ROCHE$$1$YR$I$M$Y$13$KG$20240722$$MD$CH$CH
223306735$22330673$5$F$20230501$20230720$20230517$20240925$PER$$US-GSK-US2023AMR069645$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
2233068610$22330686$10$F$20230401$20240827$20230517$20240829$EXP$$NVSC2023US108873$NOVARTIS$$39$YR$$F$Y$$$20240829$$CN$US$US
223308602$22330860$2$F$$20240626$20230517$20240711$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381213$RANBAXY$Xia W, Chen W, Fang S, Wu J, Zhang J, Yuan H. Case report: Individualized treatment of advanced breast cancer with the use of the patient-derived tumor-like cell cluster model. Front Oncol. 2023;Oct 31; 12:897984(1-8)$56$YR$$F$Y$$$20240711$$HP$CN$CN
2233112013$22331120$13$F$$20240918$20230517$20240930$PER$$NVSC2023US112021$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
223311284$22331128$4$F$$20240807$20230517$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03661$LUPIN$$$$$$Y$$$20240901$$CN$US$US
223311433$22331143$3$F$$20240805$20230517$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03664$LUPIN$$$$$$Y$$$20240818$$CN$US$US
2233135616$22331356$16$F$20230410$20240730$20230517$20240812$EXP$$US-UCBSA-2023019009$UCB$$5$YR$$M$Y$$$20240812$$CN$US$US
223314929$22331492$9$F$$20240912$20230517$20240923$PER$$US-PHARMING-PHAUS2023000374$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
223317896$22331789$6$F$20230417$20240719$20230517$20240722$EXP$$ES-AUROBINDO-AUR-APL-2023-036401$AUROBINDO$$53$YR$$F$Y$60$KG$20240722$$MD$ES$ES
223318387$22331838$7$F$20230501$20240919$20230517$20240930$PER$$US-TRAVERE-2023TVT00100$TRAVERE THERAPEUTICS$$61$YR$A$F$Y$$$20240930$$CN$US$US
2233189110$22331891$10$F$$20240730$20230517$20240801$EXP$$US-PFIZER INC-202300191342$PFIZER$$64$YR$$F$Y$$$20240801$$HP$US$US
223319296$22331929$6$F$20230506$20240912$20230517$20240930$PER$$US-TRAVERE-2023TVT00101$TRAVERE THERAPEUTICS$$57$YR$A$F$Y$65.32$KG$20240930$$CN$US$US
223319372$22331937$2$F$$20240703$20230517$20240709$EXP$$HU-PFIZER INC-202300189507$PFIZER$$35$YR$$F$Y$$$20240709$$MD$HU$HU
223319493$22331949$3$F$$20240905$20230517$20240909$EXP$$US-PFIZER INC-PV202300086228$PFIZER$$51$YR$$F$Y$$$20240909$$MD$US$US
223320173$22332017$3$F$$20240827$20230517$20240903$EXP$$CA-MYLANLABS-2023M1049910$MYLAN$Trollip E, Hawkins K, Kwek I, Dewart K, Qureshi M, Senaratne JM. Bupivacaine and morphine epidural use for refractory neuropathic pain relief in a Guillain-Barre syndrome patient. Clin-Case-Rep 2023;11:No. 4.$3$DEC$$M$Y$$$20240903$$HP$CA$CA
223321546$22332154$6$F$20190101$20240909$20230517$20240921$EXP$$US-UCBSA-2023010690$UCB$$$$$F$Y$165$KG$20240921$$CN$US$US
223321772$22332177$2$F$$20240722$20230517$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-068382$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240729$$MD$JP$JP
223321966$22332196$6$F$$20240625$20230517$20240702$EXP$$US-SA-2023SA152581$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240702$$HP$US$US
223323018$22332301$8$F$20230507$20240918$20230517$20240923$30DAY$$GT-PFIZER INC-PV202200104891$PFIZER$$10$YR$$F$Y$$$20240923$$HP$GT$GT
223323483$22332348$3$F$20171201$20240730$20230517$20240807$EXP$$GB-ROCHE-2117528$ROCHE$$71$YR$E$F$Y$$$20240807$$CN$GB$GB
223324364$22332436$4$F$20221025$20240730$20230517$20240802$EXP$$US-ABBVIE-4769466$ABBVIE$$68$YR$$M$Y$$$20240802$$CN$US$US
223326222$22332622$2$F$20220921$20230516$20230517$20240910$EXP$$NVSC2023US112956$NOVARTIS$$70$YR$$M$Y$$$20240910$$CN$US$US
223326375$22332637$5$F$20230501$20240905$20230517$20240910$EXP$$CA-PFIZER INC-202300192010$PFIZER$$42$YR$$F$Y$$$20240910$$HP$CA$CA
223327504$22332750$4$F$20230101$20240626$20230517$20240702$EXP$$JP-009507513-2305JPN001222J$MERCK$$40$YR$$F$Y$54$KG$20240702$$MD$JP$JP
223327712$22332771$2$F$$20240916$20230517$20240919$PER$$US-PFIZER INC-202300188622$PFIZER$$66$YR$$F$Y$$$20240919$$HP$US$US
223327732$22332773$2$F$20230401$20240805$20230517$20240814$PER$$US-PFIZER INC-PV202300086294$PFIZER$$26$YR$$M$Y$$$20240814$$HP$US$US
223328112$22332811$2$F$$20240821$20230517$20240830$PER$$US-INCYTE CORPORATION-2023IN004874$INCYTE$$$$$$Y$$$20240830$$HP$US$US
2233286712$22332867$12$F$20221013$20240723$20230517$20240729$EXP$$RU-TAKEDA-2022TUS076890$TAKEDA$$5$YR$$M$Y$$$20240729$$HP$RU$RU
223329103$22332910$3$F$20230101$20240722$20230517$20240724$PER$$US-PFIZER INC-PV202300085301$PFIZER$$83$YR$$F$Y$$$20240724$$CN$US$US
2233292911$22332929$11$F$20230519$20240906$20230517$20240911$EXP$$CA-JNJFOC-20230521624$JOHNSON AND JOHNSON$$68$YR$E$F$Y$90$KG$20240911$$HP$CA$CA
223329522$22332952$2$F$20230401$20240626$20230517$20240701$PER$$US-PFIZER INC-202300188987$PFIZER$$83$YR$$F$Y$$$20240701$$HP$US$US
223330595$22333059$5$F$$20230306$20230517$20240722$PER$$NVSC2023US111581$NOVARTIS$$$$$M$Y$$$20240722$$CN$US$US
223330655$22333065$5$F$20230509$20240828$20230517$20240904$EXP$$SK-JNJFOC-20230531275$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240904$$MD$SK$SK
223330825$22333082$5$F$$20240725$20230517$20240730$PER$$US-PFIZER INC-PV202300037981$PFIZER$$71$YR$$F$Y$$$20240730$$CN$US$US
2233316010$22333160$10$F$20220614$20240814$20230517$20240819$EXP$$US-PFIZER INC-US-GBT-013917$PFIZER$$10$YR$$F$Y$49.887$KG$20240819$$HP$US$US
223331948$22333194$8$F$20230314$20240718$20230517$20240723$EXP$$US-PFIZER INC-PV202300086415$PFIZER$$64$YR$$F$Y$44.444$KG$20240723$$CN$US$US
223332662$22333266$2$F$20211229$20240816$20230517$20240822$EXP$$CA-TAKEDA-2020TUS058864$TAKEDA$$23$YR$$F$Y$$$20240822$$CN$CA$CA
223332824$22333282$4$F$20180605$20240920$20230517$20240927$EXP$$CA-TAKEDA-2023TUS048598$TAKEDA$$66$YR$$M$Y$$$20240927$$HP$CA$CA
223333067$22333306$7$F$20230101$20240823$20230517$20240828$PER$$US-TRAVERE-2023TVT00132$TRAVERE THERAPEUTICS$$83$YR$E$M$Y$$$20240828$$CN$US$US
223335783$22333578$3$F$20230516$20240918$20230517$20240930$PER$$NVSC2023US113408$NOVARTIS$$$$$$Y$$$20240930$$HP$US$US
223339574$22333957$4$F$20230501$20240816$20230517$20240822$EXP$$CA-TAKEDA-2023TUS048193$TAKEDA$$67$YR$$F$Y$$$20240822$$CN$CA$CA
223339653$22333965$3$F$20110101$20240723$20230517$20240727$EXP$$CR-BIOGEN-2023BI01205422$BIOGEN$$$$$F$Y$55$KG$20240727$$CN$CR$CR
223340173$22334017$3$F$20220101$20240711$20230517$20240716$EXP$$US-PFIZER INC-US-GBT-019423$PFIZER$$34$YR$$F$Y$$$20240716$$CN$US$US
223341566$22334156$6$F$$20240724$20230517$20240730$PER$$US-PFIZER INC-US-GBT-016971$PFIZER$$31$YR$$F$Y$$$20240730$$CN$US$US
223341934$22334193$4$F$$20240826$20230517$20240829$PER$$US-PFIZER INC-US-GBT-021363$PFIZER$$43$YR$$M$Y$70$KG$20240829$$CN$US$US
223341984$22334198$4$F$20230501$20240822$20230517$20240828$EXP$$US-PFIZER INC-US-GBT-021356$PFIZER$$37$YR$$F$Y$86.18$KG$20240828$$HP$US$US
223342043$22334204$3$F$20210101$20240823$20230517$20240903$EXP$$US-PFIZER INC-US-GBT-21-00997$PFIZER$$27$YR$$F$Y$$$20240903$$CN$US$US
223342182$22334218$2$F$20230517$20240812$20230517$20240812$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-238224$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240813$$CN$US$US
223344523$22334452$3$F$20230122$20230614$20230517$20240912$EXP$$HR-ALXN-A202306426$ALEXION PHARMACEUTICALS$$35$YR$$F$Y$71$KG$20240912$$MD$HR$HR
223348779$22334877$9$F$20171101$20240918$20230518$20240927$EXP$$CA-CELLTRION INC.-2017CA016476$CELLTRION$$$$$$Y$$$20240927$$CN$CA$CA
223353484$22335348$4$F$20230509$20231121$20230518$20240805$PER$$NVSC2023US112857$NOVARTIS$$29$YR$$F$Y$$$20240805$$MD$US$US
223354365$22335436$5$F$$20240701$20230518$20240705$PER$$US-BIOGEN-2020BI00897003$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
223357486$22335748$6$F$20230422$20240903$20230518$20240920$PER$$CA-TOLMAR, INC.-23CA040518$TOLMAR$$76$YR$$M$Y$$$20240919$$CN$CA$CA
2233576212$22335762$12$F$20000916$20240726$20230518$20240802$EXP$DE-EMA-20130920-priyankaevhp-133116397$DE-SA-2023SA152890$SANOFI AVENTIS$$86$YR$E$F$Y$56$KG$20240802$$MD$DE$DE
223358167$22335816$7$F$$20240809$20230518$20240814$EXP$$CA-JNJFOC-20230535826$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240814$$HP$CA$CA
2233609917$22336099$17$F$20200101$20240916$20230518$20240925$EXP$$CA-CELLTRION INC.-2020CA035285$CELLTRION$$$$$$Y$$$20240925$$CN$CA$CA
223363453$22336345$3$F$20201207$20240731$20230518$20240806$EXP$$DE-ROCHE-2811672$ROCHE$$51$YR$A$F$Y$$$20240806$$CN$DE$DE
223363793$22336379$3$F$20230319$20240823$20230518$20240826$EXP$$NVSC2023US113121$NOVARTIS$$59$YR$$M$Y$78.005$KG$20240826$$CN$US$US
2233638811$22336388$11$F$20230125$20240722$20230518$20240726$EXP$$CO-TAKEDA-2023TUS010522$TAKEDA$$10$YR$$F$Y$21.32$KG$20240726$$CN$CO$CO
223364712$22336471$2$F$20230501$20240807$20230518$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03684$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223364853$22336485$3$F$20230201$20240904$20230518$20240906$PER$$US-ROCHE-3171762$ROCHE$$84$YR$E$M$Y$$$20240906$$CN$US$US
223365464$22336546$4$F$20221201$20240307$20230518$20240801$EXP$$NVSC2023DE113412$NOVARTIS$$$$E$M$Y$$$20240801$$CN$DE$DE
223365812$22336581$2$F$$20240627$20230518$20240702$EXP$$CA-JNJFOC-20230537317$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$HP$CA$CA
223369242$22336924$2$F$20180801$20230514$20230518$20240715$EXP$$BG-ASTELLAS-2023US014992$ASTELLAS$$$$$M$Y$$$20240715$$MD$BG$BG
223369422$22336942$2$F$20230224$20230512$20230518$20240715$EXP$$BG-ASTELLAS-2023US014843$ASTELLAS$$76$YR$$M$Y$$$20240715$$MD$BG$BG
223371722$22337172$2$F$$20240913$20230518$20240917$PER$$US-ROCHE-3272237$ROCHE$$$$E$F$Y$$$20240917$$CN$US$US
223374512$22337451$2$F$$20240918$20230518$20240927$EXP$$NVSC2023US113654$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
223374994$22337499$4$F$20220817$20240918$20230518$20240927$PER$$NVSC2023US109108$NOVARTIS$$68$YR$$F$Y$$$20240927$$CN$US$US
223375964$22337596$4$F$$20240910$20230518$20240920$EXP$$BR-Accord-358269$ACCORD$Coradine TLC, Guida LOC, Fraiman P, Santos AJ, Pedroso JL, Barsottini OGP. Post-transplant lymphoproliferative disorder myeloradiculopathy. Practical neurology. 2023;23(5):408-10.$56$YR$A$F$Y$$$20240920$$HP$BR$BR
223380713$22338071$3$F$20230101$20240809$20230518$20240820$PER$$US-SA-2023SA150582$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240820$$MD$US$US
223381465$22338146$5$F$$20240708$20230518$20240711$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-034989$JAZZ$$$$$F$Y$$$20240711$$MD$US$US
223381644$22338164$4$F$$20240806$20230518$20240815$PER$$US-SA-2022SA355622$SANOFI AVENTIS$$52$YR$A$M$Y$42.172$KG$20240815$$MD$US$US
223383172$22338317$2$F$20220801$20240722$20230518$20240727$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-020816$JAZZ$$67$YR$$F$Y$$$20240727$$CN$US$US
223383542$22338354$2$F$$20230517$20230518$20240913$EXP$$NVSC2023US114016$NOVARTIS$$$$$$Y$$$20240913$$CN$US$US
223386686$22338668$6$F$$20240729$20230518$20240806$PER$$US-SA-2023SA151500$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240806$$MD$US$US
223387092$22338709$2$F$$20240722$20230518$20240726$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388508$RANBAXY$Rivalta B, Amodio D, Milito C, Chiriaco M, Di Cesare S, Giancotta C,et al. Case Report: EBV Chronic Infection and Lymphoproliferation in Four APDS Patients: The Challenge ofProper Characterization, Therapy, and Follow-Up. Front Pediat. 2021;9:1-12$19$YR$$M$Y$$$20240727$$HP$IT$IT
223388212$22338821$2$F$$20240707$20230518$20240708$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387611$RANBAXY$Liu Y, Zhao Y, Qi J, Ma X, Qi X, Wu D, et al. Fecal microbiota transplantation combined with ruxolitinib as a salvage treatment for intestinal steroid-refractory acute GVHD. Exp Hem Oncol. 2022;11(1):96$44$YR$$M$Y$$$20240708$$HP$CN$CN
223388552$22338855$2$F$$20240911$20230518$20240913$PER$$US-ROCHE-3259639$ROCHE$$$$E$F$Y$$$20240913$$CN$US$US
223389224$22338922$4$F$20230201$20240708$20230518$20240711$EXP$$DE-ABBVIE-4764585$ABBVIE$$53$YR$$M$Y$106$KG$20240711$$MD$DE$DE
223389272$22338927$2$F$$20240820$20230518$20240826$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387527$RANBAXY$Tizianel I, Sabbadin C, Censi S, Clausi C, Colpo A, Leahu AI, et al. Therapeutic Plasma Exchange for the Treatment of Hyperthyroidism: Approach to the Patient with  thyrotoxicosis or Antithyroid-Drugs Induced Agranulocytosis. J Pers Med. 2023;Mar 13; 13(3):517; 1-11$46$YR$$M$Y$$$20240826$$HP$IT$IT
223389372$22338937$2$F$$20240901$20230518$20240904$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388531$RANBAXY$Kumar A, Reena. A comparison of fetomaternal outcome in PCEA using fentanyl, clonidine and dexmedetomidine as adjuvants with Ropivacaine in painless labor: a prospective, double blinded randomized study. Acta Anaesthesiol Bel. 2023;71(2):75-81$$$$F$Y$$$20240904$$MD$IN$IN
223389472$22338947$2$F$$20240724$20230518$20240808$EXP$$CO-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-389071$RANBAXY$Nieto-Rios JF, Garcia-Prada CA, Aristizabal-Alzate A, Zuluaga-Valencia G, Cadavid-Aljure D, Serna-Higuita LM et al. Nephrotic syndrome as a manifestation of thrombotic microangiopathy due to long long-term use of sunitinib. Nefrologia. 2022;42(6):722-726$74$YR$$M$Y$$$20240808$$HP$CO$CO
223389502$22338950$2$F$$20240803$20230518$20240812$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388851$RANBAXY$Caixeta KEG, de Deus Caixeta Matos W, Ceranto AV, do Amaral e Silva JH, Barbosa KCK. Xanthogranulomatous pyelonephritis in a pediatric patient. Braz J Nephrol. 2022;44(3):452-456$35$MON$$M$Y$$$20240812$$HP$BR$BR
223390793$22339079$3$F$$20240701$20230518$20240705$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-005785$JAZZ$$$$$F$Y$$$20240705$$CN$US$US
223391522$22339152$2$F$20230601$20240719$20230518$20240802$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007193$JAZZ$$49$YR$$F$Y$$$20240802$$CN$US$US
223392497$22339249$7$F$$20240917$20230518$20240927$EXP$$CA-AUROBINDO-AUR-APL-2023-035495$AUROBINDO$Farrell B, Merkley V, Thompson W.. Managing polypharmacy in a 77-year-old woman with multiple prescribers. CMAJ. 2013;185 (14):1240-1245$77$YR$$F$Y$$$20240927$$MD$CA$CA
223393234$22339323$4$F$20220101$20240626$20230518$20240708$EXP$$US-HORIZON THERAPEUTICS-HZN-2022-002935$AMGEN$$76$YR$E$M$Y$60.771$KG$20240707$$MD$US$US
223394326$22339432$6$F$20230201$20240913$20230518$20240919$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-004888$JAZZ$$73$YR$$F$Y$$$20240919$$CN$US$US
223394424$22339442$4$F$20230101$20240729$20230518$20240731$EXP$$US-PFIZER INC-PV202300086940$PFIZER$$35$YR$$F$Y$$$20240731$$LW$US$US
2233947911$22339479$11$F$20221101$20240815$20230518$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-034963$JAZZ$$59$YR$$F$Y$$$20240821$$HP$US$US
223396134$22339613$4$F$$20240821$20230518$20240826$EXP$$AU-TAKEDA-2022TUS003613$TAKEDA$$$$$M$Y$$$20240826$$CN$AU$AU
223397123$22339712$3$F$20230418$20230515$20230518$20240909$PER$$NVSC2023US111836$NOVARTIS$$73$YR$$F$Y$$$20240909$$CN$US$US
223397566$22339756$6$F$$20240909$20230518$20240910$EXP$DE-002147023-NVSC2023DE103700$DE-UCBSA-2023025347$UCB$$$$N$$Y$$$20240910$$HP$DE$DE
223397625$22339762$5$F$$20240820$20230518$20240824$EXP$$MX-TAKEDA-2023TUS022694$TAKEDA$$$$$F$Y$58$KG$20240824$$CN$MX$MX
2233980612$22339806$12$F$20230512$20240916$20230518$20240924$EXP$$NVSC2023US110941$NOVARTIS$$61$YR$$F$Y$$$20240924$$CN$US$US
223398182$22339818$2$F$$20230517$20230518$20240912$PER$$NVSC2023US114236$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
223398853$22339885$3$F$20230119$20240814$20230518$20240820$EXP$$HU-MYLANLABS-2023M1050653$MYLAN$$$$A$F$Y$$$20240820$$MD$HU$HU
223399283$22339928$3$F$$20230517$20230518$20240916$PER$$NVSC2023US114322$NOVARTIS$$$$$M$Y$87.075$KG$20240916$$CN$US$US
223401126$22340112$6$F$20230101$20240716$20230518$20240807$EXP$$JP-009507513-2305JPN001247J$MERCK$Ito E, Hasegawa S, Hoshi M, Endo R, Asahi S. NM-1 Efficacy of Scalp Cooling system (Cell Guard) in prevention of breast cancer chemotherapy-induced alopecia in our hospital. The 21st Tohoku Regional Meeting of Japanese Breast Cancer Society. 28$60$YR$$F$Y$$$20240807$$MD$JP$JP
223401793$22340179$3$F$$20240710$20230518$20240725$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388999$RANBAXY$Rupinski R. Etoricoxib application in the diseases of the motion system-the Warsaw clinical center own experiences. Medycyna Faktow. 2022;15(4):426-31$58$YR$$M$Y$$$20240725$$MD$PL$PL
223402613$22340261$3$F$$20231220$20230518$20240820$EXP$$CA-DSJP-DSJ-2023-119502$DAIICHI$$$$A$F$Y$65$KG$20240820$$MD$CA$CA
2234028615$22340286$15$F$20230101$20240814$20230518$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-008603$JAZZ$$$$$F$Y$$$20240820$$CN$US$US
223404618$22340461$8$F$20231201$20240904$20230518$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-006435$JAZZ$$37$YR$$F$Y$$$20240906$$CN$US$US
223405567$22340556$7$F$20230516$20240827$20230518$20240829$EXP$$AU-TAKEDA-2023TUS048905$TAKEDA$$69$YR$$F$Y$$$20240829$$MD$AU$AU
223406523$22340652$3$F$20230301$20230511$20230518$20240808$EXP$$US-OTSUKA-2023_012664$OTSUKA$$14$YR$$F$Y$$$20240808$$HP$US$US
223407622$22340762$2$F$20220101$20240724$20230518$20240729$PER$$US-PFIZER INC-US-GBT-020817$PFIZER$$41$YR$$F$Y$$$20240729$$CN$US$US
223408272$22340827$2$F$20230221$20240725$20230518$20240801$EXP$FR-AFSSAPS-PV2023000419$FR-Blueprint Medicines Corporation-SP-FR-2023-000781$BLUEPRINT MEDICINES$$65$YR$A$M$Y$66$KG$20240801$$MD$FR$FR
223408625$22340862$5$F$20230701$20240719$20230518$20240723$EXP$$US-PFIZER INC-PV202300086885$PFIZER$$58$YR$$F$Y$$$20240723$$HP$US$US
223408993$22340899$3$F$$20240920$20230518$20240930$EXP$$US-PFIZER INC-US-GBT-021528$PFIZER$$16$YR$$F$Y$$$20240930$$CN$US$US
223409034$22340903$4$F$20240601$20240620$20230518$20240701$PER$$US-PFIZER INC-US-GBT-020893$PFIZER$$6$YR$$M$Y$$$20240701$$CN$US$US
2234100512$22341005$12$F$20230101$20240904$20230518$20240910$EXP$$US-PFIZER INC-US-GBT-021167$PFIZER$$59$YR$$F$Y$62.14$KG$20240909$$HP$US$US
223411742$22341174$2$F$20181018$20240918$20230518$20240923$EXP$$PHHY2018CA180067$NOVARTIS$$25$YR$$M$Y$81.81$KG$20240923$$MD$CA$CA
223414173$22341417$3$F$20231108$20240701$20230518$20240711$EXP$$US-BIOMARINAP-US-2023-150468$BIOMARIN$$$$$$Y$$$20240711$$CN$US$US
223416142$22341614$2$F$$20240706$20230518$20240806$PER$$US-GALDERMA-US2023004818$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
223418936$22341893$6$F$$20240918$20230518$20240925$PER$$NVSC2023US114358$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
223421124$22342112$4$F$20230501$20240808$20230519$20240813$EXP$$US-ABBVIE-4771143$ABBVIE$$76$YR$$F$Y$$$20240813$$CN$US$US
223421205$22342120$5$F$20230324$20230929$20230519$20240809$EXP$$NVSC2023ZA113592$NOVARTIS$$56$YR$$M$Y$$$20240809$$HP$ZA$ZA
223421815$22342181$5$F$20230719$20240918$20230519$20240924$PER$$NVSC2023US113293$NOVARTIS$$46$YR$$M$Y$$$20240924$$HP$US$US
223422792$22342279$2$F$20230510$20240820$20230519$20240823$PER$$US-AMGEN-USASP2023085732$AMGEN$$81$YR$E$F$Y$$$20240822$$CN$US$US
223424177$22342417$7$F$20190501$20240613$20230519$20240702$EXP$$DE-ROCHE-2544348$ROCHE$$33$YR$A$F$Y$$$20240702$$CN$DE$DE
223425012$22342501$2$F$$20240805$20230519$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03690$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223425022$22342502$2$F$$20230515$20230519$20240911$PER$$NVSC2023US112677$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
223425957$22342595$7$F$20190930$20240730$20230519$20240805$EXP$$US-TAKEDA-2023TUS049562$TAKEDA$$17$YR$$M$Y$$$20240805$$CN$US$US
223426573$22342657$3$F$20230626$20230714$20230519$20240925$PER$$US-GSK-US2023AMR070124$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
223426742$22342674$2$F$$20240827$20230519$20240830$EXP$$NVSC2023US110291$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
223429313$22342931$3$F$20220101$20240708$20230519$20240710$EXP$$US-ABBVIE-4769286$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
223431144$22343114$4$F$20220406$20240918$20230519$20240927$EXP$$CA-CELLTRION INC.-2022CA004333$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
223431167$22343116$7$F$20230517$20240715$20230519$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-070306$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240717$$CN$US$US
2234314814$22343148$14$F$20211220$20240813$20230519$20240819$EXP$$CA-TAKEDA-2019TUS043265$TAKEDA$$78$YR$$F$Y$$$20240819$$HP$CA$CA
223431506$22343150$6$F$20221010$20240729$20230519$20240801$EXP$$US-TAKEDA-2022TUS080837$TAKEDA$$49$YR$$F$Y$54$KG$20240801$$HP$US$US
223432346$22343234$6$F$$20240710$20230519$20240718$EXP$$NVSC2023US111153$NOVARTIS$$$$$F$Y$96.62$KG$20240719$$MD$US$US
223432695$22343269$5$F$20240317$20240805$20230519$20240814$PER$$US-SA-2023SA153515$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240814$$MD$US$US
223432943$22343294$3$F$20230501$20240908$20230519$20240924$PER$$US-SA-2023SA151686$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240924$$MD$US$US
223433093$22343309$3$F$$20240807$20230519$20240816$PER$$US-SA-2023SA153822$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240816$$MD$US$US
223434583$22343458$3$F$20220829$20240912$20230519$20240918$EXP$$CA-TAKEDA-2019TUS069107$TAKEDA$$47$YR$$F$Y$$$20240918$$CN$CA$CA
223434592$22343459$2$F$$20240807$20230519$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03735$LUPIN$$$$$$Y$$$20240822$$CN$US$US
223435363$22343536$3$F$$20240909$20230519$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388702$RANBAXY$Anjum F, Ali MM, Jakoby M, Williams V. Abstract #1401109: Quetiapine-induced Hypoglycemia in an Elderly Non-diabetic Patient with Dementia. Endocr Pract. 2023;29 (Suppl.)(5):S9-S10$79$YR$$M$Y$$$20240913$$MD$US$US
223435604$22343560$4$F$20220412$20240903$20230519$20240905$EXP$$JP-ABBVIE-4769880$ABBVIE$$59$YR$$F$Y$57$KG$20240905$$MD$JP$JP
223436672$22343667$2$F$20230130$20240807$20230519$20240812$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-388188$RANBAXY$$92$YR$$F$Y$80$KG$20240812$$MD$FR$FR
223436862$22343686$2$F$$20240801$20230519$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-389132$RANBAXY$$54$YR$$F$Y$$$20240802$$PH$GB$GB
223436942$22343694$2$F$$20240708$20230519$20240709$EXP$$AE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-389216$RANBAXY$AL SHAMSI H, Al Shamsi I, Bashir N.. MANAGEMENT OF ASYMPTOMATIC ANGIOMYOLIPOMA IN PREGNANCY. Kidney Int Rep. 2023;8 (Suppl.)(3)$40$YR$$F$Y$$$20240709$$HP$AE$AE
223437756$22343775$6$F$20230101$20240826$20230519$20240920$PER$$US-SA-2023SA154248$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240920$$MD$US$US
223438594$22343859$4$F$20221227$20240812$20230519$20240815$EXP$$US-UCBSA-2023025133$UCB$$51$YR$$F$Y$$$20240815$$HP$US$US
223438887$22343888$7$F$20230429$20240715$20230519$20240722$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202305008213$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240722$$CN$DE$DE
223441373$22344137$3$F$$20240917$20230519$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-070093$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$82.55$KG$20240918$$CN$US$US
223443259$22344325$9$F$20230101$20240923$20230519$20240927$EXP$$CA-PFIZER INC-202300135734$PFIZER$$40$YR$$F$Y$$$20240927$$HP$CA$CA
223443633$22344363$3$F$$20240903$20230519$20240928$PER$$US-SA-2023SA153623$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240928$$MD$US$US
223444686$22344468$6$F$20200213$20240813$20230519$20240819$EXP$$CA-TAKEDA-2020TUS004984$TAKEDA$$58$YR$$F$Y$$$20240819$$HP$CA$CA
223445363$22344536$3$F$$20240807$20230519$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03752$LUPIN$$$$$$Y$$$20240827$$CN$US$US
223446232$22344623$2$F$20230121$20240811$20230519$20240812$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-389304$RANBAXY$$81$YR$$F$Y$$$20240812$$MD$FR$FR
223447426$22344742$6$F$20230201$20240916$20230519$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-035639$JAZZ$$49$YR$$M$Y$$$20240919$$CN$US$US
2234484415$22344844$15$F$20230101$20240708$20230519$20240717$EXP$$US-UNITED THERAPEUTICS-UNT-2023-013639$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240717$$$US$US
223448755$22344875$5$F$20220321$20240814$20230519$20240820$EXP$$NVSC2023DE113581$NOVARTIS$$$$A$F$Y$78$KG$20240820$$HP$DE$DE
2234494510$22344945$10$F$20210101$20240731$20230519$20240806$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-003625$AMGEN$$73$YR$E$F$Y$123$KG$20240805$$MD$US$US
223449942$22344994$2$F$$20240715$20230519$20240717$EXP$$CA-BAUSCH-BL-2023-007482$BAUSCH AND LOMB$$56$YR$$M$Y$$$20240717$$CN$CA$CA
223450474$22345047$4$F$20171101$20240708$20230519$20240712$EXP$$CA-TAKEDA-2023TUS049983$TAKEDA$$48$YR$$F$Y$$$20240712$$HP$CA$CA
223451884$22345188$4$F$20230301$20240905$20230519$20240909$PER$$US-PFIZER INC-202300193489$PFIZER$$80$YR$$M$Y$$$20240909$$HP$US$US
223452003$22345200$3$F$$20240911$20230519$20240913$PER$$US-PFIZER INC-PV202300086896$PFIZER$$51$YR$$M$Y$$$20240913$$HP$US$US
223452634$22345263$4$F$20230101$20240702$20230519$20240705$EXP$$US-PFIZER INC-202300192315$PFIZER$$65$YR$$F$Y$$$20240705$$HP$US$US
2234527612$22345276$12$F$20231020$20240725$20230519$20240730$PER$$US-PFIZER INC-PV202300086713$PFIZER$$77$YR$$F$Y$70.385$KG$20240730$$MD$US$US
2234536910$22345369$10$F$20221122$20240919$20230519$20240924$EXP$$CA-PFIZER INC-202201287222$PFIZER$$67$YR$$F$Y$98$KG$20240924$$HP$CA$CA
223453826$22345382$6$F$$20240812$20230519$20240812$EXP$NL-LRB-00880148$NL-PFIZER INC-202300192925$PFIZER$$74$YR$$M$Y$$$20240812$$MD$NL$NL
223453987$22345398$7$F$20230101$20240705$20230519$20240710$EXP$$CA-PFIZER INC-202300165369$PFIZER$$41$YR$$F$Y$80$KG$20240710$$HP$CA$CA
223456128$22345612$8$F$$20240919$20230519$20240927$EXP$$US-TAKEDA-2023TUS049640$TAKEDA$$$$$M$Y$210$KG$20240927$$CN$US$US
223457344$22345734$4$F$$20240807$20230519$20240809$EXP$$NVSC2023US113283$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
223459115$22345911$5$F$$20240712$20230519$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-071260$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$117.93$KG$20240718$$CN$US$US
223459478$22345947$8$F$$20240923$20230519$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-036484$JAZZ$$$$$F$Y$$$20240925$$HP$US$US
223459486$22345948$6$F$$20240812$20230519$20240815$EXP$$US-TAKEDA-US201943341$TAKEDA$$$$$F$Y$$$20240815$$CN$US$US
223460515$22346051$5$F$20230110$20240815$20230519$20240820$EXP$$US-TAKEDA-2022TUS077097$TAKEDA$$19$YR$$M$Y$$$20240820$$HP$US$US
223461783$22346178$3$F$$20240729$20230519$20240802$PER$$NVSC2023US114153$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
223461864$22346186$4$F$20240316$20240708$20230519$20240710$EXP$$US-BAUSCH-BL-2023-007575$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240710$$CN$US$US
223462792$22346279$2$F$20230411$20240715$20230519$20240716$EXP$GR-GREOF-202300426$NVSC2023GR111664$NOVARTIS$$44$YR$$M$Y$75$KG$20240716$$MD$GR$GR
223464176$22346417$6$F$20231025$20240827$20230519$20240829$EXP$$NVSC2023US113325$NOVARTIS$$47$YR$$M$Y$$$20240829$$CN$US$US
2234647818$22346478$18$F$20230501$20240912$20230519$20240923$EXP$$US-BEH-2023158859$CSL BEHRING$$30$YR$A$F$Y$$$20240923$$HP$US$US
223466716$22346671$6$F$$20231030$20230520$20240911$EXP$$NVSC2023US111911$NOVARTIS$$$$$M$Y$$$20240911$$CN$US$US
223467122$22346712$2$F$$20230518$20230520$20240912$PER$$NVSC2023US115899$NOVARTIS$$$$$M$Y$$$20240912$$CN$US$US
223469303$22346930$3$F$$20240731$20230520$20240807$EXP$$AU-CELLTRION INC.-2023AU010425$CELLTRION$$$$$$Y$$$20240807$$MD$AU$AU
223471444$22347144$4$F$$20240720$20230520$20240731$EXP$$US-AUROBINDO-AUR-APL-2023-037645$AUROBINDO$Mallaro HL, Rosenthal LJ.. DRESS syndrome: quetiapine associated case report and literature review.. Int Clin Psychopharmacol. 2023$33$YR$$F$Y$$$20240731$$MD$US$US
223471722$22347172$2$F$$20240419$20230520$20240709$EXP$$US-LUOXINA-LUX-2023-US-LIT-00022$LUOXIN AUROVITAS PHARMA(CHENGDU)$MORALES MALAVE.BILATERAL PNEUMOTHORAX, PNEUMOMEDIASTINUM, AND SUBCUTANEOUS EMPHYSEMA.: A CASE OF A RARE SYNCHRONOUS TRIAD IN ASTHMA EXACERBATION$65$YR$A$F$Y$$$20240709$$HP$US$US
223473988$22347398$8$F$20230101$20240910$20230521$20240918$EXP$$CA-CELLTRION INC.-2023CA003772$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
223474324$22347432$4$F$20220929$20240728$20230521$20240802$EXP$$IL-ABBVIE-4701892$ABBVIE$$63$YR$$M$Y$91$KG$20240802$$MD$IL$IL
2234746617$22347466$17$F$20230101$20240730$20230521$20240803$EXP$$CH-ABBVIE-4771009$ABBVIE$$78$YR$$M$Y$93$KG$20240803$$MD$CH$CH
223476523$22347652$3$F$$20240807$20230522$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03753$LUPIN$$$$$$Y$$$20240828$$PH$US$US
223478183$22347818$3$F$$20240909$20230522$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03800$LUPIN$$$$$$Y$$$20240923$$CN$US$US
223478324$22347832$4$F$$20240909$20230522$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03805$LUPIN$$$$$$Y$$$20240923$$CN$US$US
223478545$22347854$5$F$20230501$20240815$20230522$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001724$ACADIA PHARMACEUTICALS$$66$YR$$F$Y$$$20240830$$CN$US$US
223478622$22347862$2$F$20220101$20240625$20230522$20240701$EXP$$US-ABBVIE-4280307$ABBVIE$$72$YR$$M$Y$$$20240701$$CN$US$US
223479404$22347940$4$F$20230505$20240716$20230522$20240725$EXP$$IT-AUROBINDO-AUR-APL-2023-036624$AUROBINDO$$23$YR$$M$Y$$$20240725$$MD$IT$IT
223479803$22347980$3$F$$20240613$20230522$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001619$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
223480592$22348059$2$F$20230501$20240814$20230522$20240828$PER$$US-SA-2023SA154427$SANOFI AVENTIS$$52$YR$A$F$Y$79.3$KG$20240828$$MD$US$US
223482512$22348251$2$F$20221013$20230517$20230522$20240708$EXP$FR-AFSSAPS-LM2023000195$FR-SA-2023SA152832$SANOFI AVENTIS$$72$YR$E$M$Y$105$KG$20240708$$CN$FR$FR
223483824$22348382$4$F$20230714$20240614$20230522$20240703$PER$$CA-TOLMAR, INC.-23CA040505$TOLMAR$$72$YR$$M$Y$$$20240703$$CN$CA$CA
223484433$22348443$3$F$$20240726$20230522$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03784$LUPIN$$$$$$Y$$$20240816$$CN$US$US
223485453$22348545$3$F$20230513$20240903$20230522$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-051693$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240904$$CN$US$US
223486262$22348626$2$F$20050101$20240806$20230522$20240812$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-389031$RANBAXY$$87$YR$$F$Y$55$KG$20240812$$MD$FR$FR
223487589$22348758$9$F$20230506$20240918$20230522$20240925$PER$$NVSC2023US111752$NOVARTIS$$37$YR$$F$Y$61.224$KG$20240925$$CN$US$US
223488862$22348886$2$F$$20240918$20230522$20240927$EXP$$NVSC2023US115663$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
223489203$22348920$3$F$20120101$20240826$20230522$20240904$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387874$RANBAXY$Dal S, Whyte S. Valproate-induced parkinsonism an early warning: case reports and review of literature. J Neurol Neurosurg Psychiatry. 2019;90:E7;035; 12$67$YR$$M$Y$$$20240904$$HP$AU$AU
223489312$22348931$2$F$$20240801$20230522$20240802$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-388813$RANBAXY$Martinez Valenzuela L, Anton P, Tango A, Gomez F, Fulladosa X, De Carvalho A, et al. Avoiding immunogenic drugs is key to preserve renal function in patients receiving immune checkpoint inhibitors: Lessons learned from three illustrative cases. J Onco Nephrol. 2021;5(3):172-177$9$DEC$$M$Y$$$20240802$$HP$ES$ES
223489322$22348932$2$F$$20240828$20230522$20240904$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389187$RANBAXY$Lucchini M, De Fino C, Nociti V, Losavio FA, Mirabella M. Kaposi^s sarcoma in a patient with inflammatory myopathy: immunosuppressive therapy and its management. Ital Soc Myol. -;-:54-55$77$YR$$M$Y$$$20240904$$HP$IT$IT
223489332$22348933$2$F$$20240716$20230522$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389340$RANBAXY$Laxmi R, Grover S. Unmasking of schizophrenia following COVID vaccination. Indian J Psychiatry. 2023;65:385-6$40$YR$$F$Y$$$20240718$$HP$IN$IN
223489342$22348934$2$F$20230214$20240806$20230522$20240812$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-389450$RANBAXY$$20$YR$$F$Y$$$20240812$$CN$FR$FR
223489958$22348995$8$F$$20240711$20230522$20240716$EXP$$US-TAKEDA-2023TUS050126$TAKEDA$$$$$F$Y$80$KG$20240716$$HP$US$US
223490463$22349046$3$F$20210701$20240815$20230522$20240822$EXP$$BR-GSK-BR2021AMR158772$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$BR$BR
2234925011$22349250$11$F$20230606$20240822$20230522$20240826$EXP$$CA-TAKEDA-2023TUS048587$TAKEDA$$84$YR$$F$Y$$$20240826$$HP$CA$CA
223493132$22349313$2$F$$20240705$20230522$20240708$PER$$US-AMGEN-USASP2023086944$AMGEN$$$$A$M$Y$$$20240708$$HP$US$US
223493278$22349327$8$F$$20240408$20230522$20240807$EXP$$NVSC2023GT050013$NOVARTIS$$37$YR$$F$Y$$$20240807$$CN$GT$GT
223493813$22349381$3$F$20190530$20240819$20230522$20240830$EXP$$CA-ROCHE-2330517$ROCHE$$69$YR$E$F$Y$94$KG$20240830$$MD$CA$CA
223494013$22349401$3$F$20210901$20240729$20230522$20240807$EXP$$JP-ABBVIE-22K-087-4297939-00$ABBVIE$$75$YR$$M$Y$68$KG$20240807$$MD$JP$JP
2234941512$22349415$12$F$20220401$20240827$20230522$20240907$EXP$$US-ASTELLAS-2022US021129$ASTELLAS$$83$YR$$M$Y$$$20240907$$CN$US$US
223494217$22349421$7$F$20221121$20240729$20230522$20240809$EXP$$AE-AstraZeneca-2023A007824$ASTRAZENECA$$25$YR$$M$Y$72.2$KG$20240809$$MD$AE$
2234947610$22349476$10$F$20230429$20240712$20230522$20240716$EXP$$CA-TAKEDA-2023TUS043499$TAKEDA$$26$YR$$F$Y$81.6$KG$20240716$$MD$CA$CA
223494823$22349482$3$F$20240129$20240723$20230522$20240802$30DAY$$US-GSK-US2023068672$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240802$$CN$US$US
223496993$22349699$3$F$20230424$20240819$20230522$20240820$EXP$$US-UCBSA-2023025452$UCB$$54$YR$$M$Y$$$20240820$$CN$US$US
223497677$22349767$7$F$20240206$20240828$20230522$20240903$EXP$$CA-TAKEDA-2023TUS049035$TAKEDA$$81$YR$$M$Y$$$20240903$$CN$CA$CA
223497685$22349768$5$F$20230802$20240711$20230522$20240717$EXP$$CA-TAKEDA-2022TUS089256$TAKEDA$$55$YR$$F$Y$$$20240717$$CN$CA$CA
223497755$22349775$5$F$$20240808$20230522$20240812$EXP$$CA-TAKEDA-2018TUS029324$TAKEDA$$$$$F$Y$$$20240812$$CN$CA$CA
223497904$22349790$4$F$20230221$20240701$20230522$20240704$EXP$DE-DCGMA-23200856$NVSC2023DE110605$NOVARTIS$$55$YR$$F$Y$$$20240704$$MD$DE$DE
223498243$22349824$3$F$20211101$20240823$20230522$20240830$EXP$$BR-TAKEDA-2023TUS031275$TAKEDA$$48$YR$$F$Y$$$20240830$$CN$BR$BR
2234990711$22349907$11$F$20230101$20240924$20230522$20240930$EXP$$MX-TAKEDA-2023TUS016468$TAKEDA$$$$$M$Y$64$KG$20240930$$CN$MX$MX
223499423$22349942$3$F$20230302$20240802$20230522$20240808$PER$$US-BIOGEN-2023BI01206275$BIOGEN$$40$YR$$F$Y$$$20240808$$CN$US$US
223499983$22349998$3$F$$20240621$20230522$20240701$PER$$US-SA-2023SA153116$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240701$$MD$US$US
223502052$22350205$2$F$$20240717$20230522$20240726$PER$$US-SA-2023SA155896$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240726$$MD$US$US
223502978$22350297$8$F$20190718$20240916$20230522$20240923$EXP$$CA-TAKEDA-2019TUS044587$TAKEDA$$64$YR$$M$Y$$$20240923$$MD$CA$CA
223503122$22350312$2$F$$20240903$20230522$20240927$PER$$US-SA-2023SA154574$SANOFI AVENTIS$$50$YR$A$F$Y$66.667$KG$20240927$$MD$US$US
223506142$22350614$2$F$$20230531$20230522$20240920$EXP$$NVSC2023US116684$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
223506424$22350642$4$F$20220302$20240924$20230522$20240926$EXP$$CA-TAKEDA-2023TUS050064$TAKEDA$$77$YR$$F$Y$$$20240926$$CN$CA$CA
223506937$22350693$7$F$20230501$20240726$20230522$20240731$PER$$US-PFIZER INC-PV202300088382$PFIZER$$79$YR$$M$Y$$$20240731$$HP$US$US
223508543$22350854$3$F$$20240807$20230522$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03812$LUPIN$$$$$$Y$$$20240901$$CN$US$US
223508603$22350860$3$F$20220101$20240924$20230522$20240927$PER$$US-BIOGEN-2022BI01130837$BIOGEN$$$$$M$Y$$$20240927$$CN$US$US
223508894$22350889$4$F$20180901$20240513$20230522$20240808$EXP$$US-OTSUKA-2023_012533$OTSUKA$$50$YR$$F$Y$111.13$KG$20240808$$CN$US$US
223509066$22350906$6$F$$20240812$20230522$20240814$EXP$$GB-MYLANLABS-2023M1051988$MYLAN$$$$$F$Y$$$20240814$$MD$GB$GB
223509224$22350922$4$F$20230101$20240909$20230522$20240911$PER$$US-PFIZER INC-PV202300087824$PFIZER$$61$YR$$F$Y$$$20240911$$HP$US$US
223509328$22350932$8$F$$20240708$20230522$20240710$EXP$$US-PFIZER INC-PV202300057376$PFIZER$$51$YR$$F$Y$$$20240710$$MD$US$US
223510705$22351070$5$F$$20230718$20230522$20240808$EXP$$US-OTSUKA-2023_012997$OTSUKA$$37$YR$$M$Y$104.78$KG$20240808$$HP$US$US
223510912$22351091$2$F$$20240628$20230522$20240709$EXP$$JP-JNJFOC-20230551309$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240709$$MD$JP$JP
223516384$22351638$4$F$20231016$20240913$20230522$20240927$PER$$CA-TOLMAR, INC.-23CA040715$TOLMAR$$75$YR$$M$Y$$$20240927$$CN$CA$CA
223518168$22351816$8$F$20230711$20240904$20230522$20240906$EXP$$US-INCYTE CORPORATION-2023IN005133$INCYTE$$$$$$Y$$$20240906$$CN$US$US
223518473$22351847$3$F$$20230515$20230522$20240808$EXP$$US-OTSUKA-2023_012866$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
223520202$22352020$2$F$$20240903$20230522$20240904$EXP$$US-TAKEDA-2023TUS050484$TAKEDA$$$$$M$Y$$$20240904$$CN$US$US
223520556$22352055$6$F$$20240827$20230522$20240830$PER$$US-PFIZER INC-PV202300087084$PFIZER$$61$YR$$F$Y$$$20240830$$HP$US$US
223520738$22352073$8$F$20230511$20240807$20230522$20240812$EXP$$US-PFIZER INC-202300194111$PFIZER$$12$YR$$M$Y$32.66$KG$20240812$$CN$US$US
223520925$22352092$5$F$20240301$20240717$20230522$20240722$PER$$US-PFIZER INC-PV202300087809$PFIZER$$66$YR$$F$Y$44.91$KG$20240722$$CN$US$US
223521033$22352103$3$F$20230303$20240710$20230522$20240717$EXP$$CA-TAKEDA-2023TUS049144$TAKEDA$$50$YR$$M$Y$55$KG$20240717$$HP$CA$CA
223521542$22352154$2$F$20230110$20240711$20230522$20240715$EXP$FR-AFSSAPS-PP2023000752$FR-PFIZER INC-202300195302$PFIZER$$40$YR$$F$Y$$$20240715$$MD$FR$FR
223524423$22352442$3$F$$20240909$20230522$20240912$PER$$US-AMGEN-USASP2023085742$AMGEN$$$$$M$Y$$$20240912$$HP$US$US
223525622$22352562$2$F$20230517$20240806$20230522$20240814$PER$$US-SA-2023SA156677$SANOFI AVENTIS$$8$YR$C$F$Y$37$KG$20240814$$MD$US$US
223525928$22352592$8$F$20230401$20240715$20230523$20240724$EXP$$US-BEH-2023158973$CSL BEHRING$$36$YR$A$M$Y$$$20240724$$HP$US$US
223527087$22352708$7$F$20220101$20240813$20230523$20240820$EXP$$CA-CELLTRION INC.-2022CA014069$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
223535853$22353585$3$F$$20240807$20230523$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03774$LUPIN$$$$$$Y$$$20240901$$CN$US$US
2235404911$22354049$11$F$20230801$20240919$20230523$20240926$EXP$$CA-GSK-CA2022AMR195990$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$CA$CA
223540873$22354087$3$F$$20240814$20230523$20240828$PER$$US-SA-2023SA155348$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240828$$MD$US$US
223541264$22354126$4$F$20230501$20240723$20230523$20240805$PER$$US-SA-2023SA155705$SANOFI AVENTIS$$17$YR$T$M$Y$60$KG$20240805$$MD$US$US
223541952$22354195$2$F$20230519$20240710$20230523$20240718$PER$$US-SA-2023SA157199$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240718$$MD$US$US
223542596$22354259$6$F$20240101$20240801$20230523$20240808$PER$$US-SA-2023SA155732$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240808$$MD$US$US
223542982$22354298$2$F$$20230522$20230523$20240916$PER$$NVSC2023US117495$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
223543884$22354388$4$F$20220727$20240821$20230523$20240829$EXP$$US-TAKEDA-2021TUS066197$TAKEDA$$50$YR$$F$Y$73$KG$20240829$$MD$US$US
223544192$22354419$2$F$20220807$20240723$20230523$20240729$EXP$$US-UCBSA-2023025749$UCB$$31$YR$$F$Y$83.9$KG$20240729$$HP$US$US
223546556$22354655$6$F$$20240909$20230523$20240913$30DAY$$US-PFIZER INC-PV202300088658$PFIZER$$14$YR$$M$Y$$$20240913$$MD$US$US
223546845$22354684$5$F$$20240628$20230523$20240703$PER$$US-PFIZER INC-202200962354$PFIZER$$93$YR$$F$Y$79.365$KG$20240703$$CN$US$US
223547124$22354712$4$F$$20240823$20230523$20240916$PER$$US-SA-2023SA158216$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240916$$MD$US$US
223547805$22354780$5$F$$20240627$20230523$20240701$PER$$US-PFIZER INC-PV202300045215$PFIZER$$61$YR$$F$Y$$$20240701$$CN$US$US
223550602$22355060$2$F$20230520$20230522$20230523$20240918$EXP$$NVSC2023US117532$NOVARTIS$$85$YR$$M$Y$$$20240918$$CN$US$US
223552646$22355264$6$F$20230101$20240708$20230523$20240711$EXP$$US-UCBSA-2023026115$UCB$$41$YR$$F$Y$$$20240711$$HP$US$US
223552842$22355284$2$F$$20240808$20230523$20240813$PER$$US-PFIZER INC-PV202300089931$PFIZER$$84$YR$$M$Y$$$20240813$$CN$US$US
223554152$22355415$2$F$$20240730$20230523$20240803$EXP$$US-ABBVIE-5175221$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
223555103$22355510$3$F$20230401$20230517$20230523$20240808$EXP$$US-OTSUKA-2023_013110$OTSUKA$$27$YR$$F$Y$87.54$KG$20240808$$HP$US$US
223555514$22355551$4$F$$20240924$20230523$20240927$PER$$US-PFIZER INC-202300198783$PFIZER$$63$YR$$F$Y$$$20240927$$CN$US$US
223555676$22355567$6$F$20220207$20240905$20230523$20240913$EXP$$CA-TAKEDA-2022TUS013905$TAKEDA$$62$YR$$M$Y$$$20240913$$PH$CA$CA
223556319$22355631$9$F$20230401$20240923$20230523$20240930$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2023CUR001682$CURRAX PHARMACEUTICALS$$70$YR$$F$Y$97.506$KG$20241001$$CN$CA$CA
223557044$22355704$4$F$$20230804$20230523$20240830$PER$$NVSC2023US112004$NOVARTIS$$$$$$Y$$$20240830$$MD$US$US
223557992$22355799$2$F$$20240902$20230523$20240904$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389730$RANBAXY$Toyama D, Matsuno R, Sugishita Y, Kaneko R, Okamoto N, Koganesawa M, et al. Successful Treatment of Pediatric Refractory/Relapsed AML with KIR-Ligand-Mismatched Cord Blood Transplant after FLAG-IDA Reinduction Therapy with or without the GO Regimen. Case Rep Hematol. 2020;2020:1378056 (1-4)$2$YR$$F$Y$$$20240904$$HP$JP$JP
223558043$22355804$3$F$$20240823$20230523$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388655$RANBAXY$Li S, Hong R, Wang X, Yang J. Ovarian epithelioid malignant peripheral nerve sheath tumor with EWSR1-CREM fusion: A case report and literature review. Int J Gynaecol Obstet. 2023;163:521-527$7$YR$$F$Y$$$20240906$$HP$CN$CN
223558192$22355819$2$F$20230101$20240628$20230523$20240702$EXP$$US-PFIZER INC-PV202300088976$PFIZER$$58$YR$$F$Y$$$20240702$$HP$US$US
223559183$22355918$3$F$$20240805$20230523$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03820$LUPIN$$$$$$Y$$$20240827$$CN$US$US
2235596113$22355961$13$F$$20240821$20230523$20240822$EXP$$US-PFIZER INC-PV202300088771$PFIZER$$73$YR$$F$Y$$$20240822$$HP$US$US
223560194$22356019$4$F$20230401$20240902$20230523$20240911$PER$$US-SA-2023SA156920$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240911$$MD$US$US
223560623$22356062$3$F$$20240909$20230523$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03823$LUPIN$$$$$$Y$$$20240920$$CN$US$US
223561075$22356107$5$F$20230418$20240903$20230523$20240910$EXP$$CA-GSK-CA2023AMR071113$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$HP$CA$CA
223562902$22356290$2$F$$20240905$20230523$20240906$EXP$$US-SHIRE-US201920193$TAKEDA$$$$$F$Y$$$20240906$$HP$US$US
223563603$22356360$3$F$20210603$20240803$20230523$20240806$EXP$$JP-BAYER-2023A066296$BAYER$$74$YR$E$M$Y$$$20240806$$MD$JP$JP
223563625$22356362$5$F$20230511$20240919$20230523$20240924$PER$$NVSC2023US113388$NOVARTIS$$51$YR$$F$Y$$$20240924$$CN$US$US
223564453$22356445$3$F$20221111$20230922$20230523$20240909$PER$$NVSC2023US116875$NOVARTIS$$27$YR$$F$Y$$$20240909$$CN$US$US
2235679814$22356798$14$F$20230320$20240902$20230523$20240904$EXP$$BE-BAUSCH-BL-2023-007708$BAUSCH AND LOMB$$65$YR$$F$Y$75.7$KG$20240904$$HP$BE$BE
223569472$22356947$2$F$$20240705$20230523$20240710$PER$$US-BAUSCHBL-2023BNL004330$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240711$$CN$US$US
223573554$22357355$4$F$20230101$20240814$20230524$20240828$PER$$US-SA-2023SA156741$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240828$$MD$US$US
223574333$22357433$3$F$$20240814$20230524$20240817$PER$$NVSC2023US114337$NOVARTIS$$$$$F$Y$$$20240817$$CN$US$US
223575545$22357554$5$F$20230101$20240625$20230524$20240703$EXP$$US-RECORDATI RARE DISEASE INC.-2023003114$RECORDATI$$$$$$Y$$$20240703$$CN$US$US
223578476$22357847$6$F$20230429$20240715$20230524$20240723$EXP$$DE-AUROBINDO-AUR-APL-2023-037415$AUROBINDO$$70$YR$$M$Y$$$20240723$$MD$DE$DE
223578653$22357865$3$F$20230101$20240717$20230524$20240720$EXP$$CO-ABBVIE-5177721$ABBVIE$$$$$F$Y$$$20240720$$CN$CO$CO
223579106$22357910$6$F$20230101$20240618$20230524$20240709$PER$$CA-TOLMAR, INC.-23CA040690$TOLMAR$$$$$M$Y$$$20240709$$CN$CA$CA
223579115$22357911$5$F$20230501$20240723$20230524$20240819$PER$$CA-TOLMAR, INC.-23CA040679$TOLMAR$$76$YR$$M$Y$$$20240814$$CN$CA$CA
223579245$22357924$5$F$20230501$20240626$20230524$20240716$PER$$CA-TOLMAR, INC.-23CA040687$TOLMAR$$74$YR$$M$Y$$$20240715$$CN$CA$CA
223579674$22357967$4$F$20230501$20230809$20230524$20240925$PER$$US-GSK-US2023AMR072753$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240925$$CN$US$US
223580684$22358068$4$F$$20240830$20230524$20240830$PER$$NVSC2023US114567$NOVARTIS$$$$$F$Y$104.32$KG$20240830$$MD$US$US
223582783$22358278$3$F$20220520$20240823$20230524$20240829$EXP$$JP-AMGEN-JPNSP2022118589$AMGEN$Hibino Y.$$$E$M$Y$$$20240829$$MD$JP$JP
223583385$22358338$5$F$20230509$20240722$20230524$20240726$EXP$$US-SA-2023SA158323$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240726$$MD$US$US
2235833912$22358339$12$F$20240725$20240903$20230524$20240909$EXP$$CA-TAKEDA-2023TUS051071$TAKEDA$$29$YR$$F$Y$$$20240909$$CN$CA$CA
223583782$22358378$2$F$$20240909$20230524$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03822$LUPIN$$$$$$Y$$$20240924$$CN$US$US
223583883$22358388$3$F$$20240807$20230524$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03833$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223584263$22358426$3$F$$20240702$20230524$20240716$EXP$$IN-ROCHE-3277821$ROCHE$$45$YR$A$F$Y$$$20240716$$MD$IN$IN
223584323$22358432$3$F$$20240806$20230524$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03858$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223585123$22358512$3$F$$20240903$20230524$20240916$EXP$$US-AUROBINDO-AUR-APL-2023-038191$AUROBINDO$Chumsky J, Kahn P, Carroll WL, Pierce KA, Hillier K. Lupus anti-coagulant hypoprothrombinemia syndrome across different ages: a case report and review of the literature. Clin Rheumatol. 2023;42:2231?2236$8$YR$$F$Y$$$20240916$$HP$US$US
223585393$22358539$3$F$$20240705$20230524$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-072978$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$68$KG$20240716$$HP$CA$CA
223585494$22358549$4$F$20221209$20240910$20230524$20240917$EXP$$JP-AstraZeneca-2023A116542$ASTRAZENECA$Yamazaki N, et al.. 152 Two cases in which olaparib was successfully resumed after suspension due to drug-induced interstitial pneumonia during the treatment.. Modern Trends in Obstetrics + Gynecology 2024;73((S)):S69-.$27064$DY$$F$Y$$$20240917$$MD$JP$
223588766$22358876$6$F$$20240903$20230524$20240907$EXP$$CA-ASTELLAS-2022US037236$ASTELLAS$$38$YR$A$F$Y$$$20240907$$HP$CA$CA
223590973$22359097$3$F$20221201$20240724$20230524$20240807$EXP$$US-UCBSA-2023000912$UCB$$61$YR$$M$Y$$$20240807$$HP$US$US
223591422$22359142$2$F$20221101$20240816$20230524$20240828$EXP$$FR-AUROBINDO-AUR-APL-2023-037396$AUROBINDO$$64$YR$$M$Y$93$KG$20240828$$MD$FR$FR
223592732$22359273$2$F$$20230522$20230524$20240925$PER$$US-GSK-US2023AMR072680$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2235933411$22359334$11$F$20230625$20240912$20230524$20240921$EXP$$AU-TAKEDA-2023TUS051169$TAKEDA$$76$YR$$F$Y$$$20240921$$HP$AU$AU
223593383$22359338$3$F$20230501$20240918$20230524$20240930$PER$$NVSC2023US116829$NOVARTIS$$67$YR$$F$Y$$$20240930$$CN$US$US
223593393$22359339$3$F$$20240814$20230524$20240817$PER$$NVSC2023US115769$NOVARTIS$$$$$F$Y$$$20240817$$MD$US$US
223594554$22359455$4$F$$20240815$20230524$20240828$EXP$$CA-AUROBINDO-AUR-APL-2023-036598$AUROBINDO$Trollip E, Hawkins K, Kwek I, Dewart K, Qureshi M, Senaratne JM.. Bupivacaine and morphine epidural use for refractory neuropathic pain relief in a Guillain-Barre syndrome patient.. Clinical Case Reports. 2023;11(4):1-6$3$DEC$$M$Y$$$20240828$$HP$CA$CA
223594757$22359475$7$F$20210914$20240625$20230524$20240703$EXP$$DK-CELLTRION INC.-2021DK019433$CELLTRION$$$$$$Y$$$20240703$$MD$DK$DK
223599263$22359926$3$F$20230501$20240725$20230524$20240805$PER$$US-SA-2023SA158971$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240805$$MD$US$US
223599803$22359980$3$F$$20240716$20230524$20240724$PER$$US-SA-2023SA159611$SANOFI AVENTIS$$$$A$M$Y$83.91$KG$20240724$$MD$US$US
223600125$22360012$5$F$$20240828$20230524$20240920$PER$$US-SA-2023SA158252$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240920$$MD$US$US
223600213$22360021$3$F$$20230517$20230524$20240808$EXP$$US-OTSUKA-2023_013142$OTSUKA$$$$$M$Y$68.04$KG$20240808$$CN$US$US
223601164$22360116$4$F$$20240830$20230524$20240904$30DAY$$PA-PFIZER INC-PV202300090037$PFIZER$$11$YR$$M$Y$$$20240904$$HP$PA$PA
223602503$22360250$3$F$20230101$20240831$20230524$20240924$PER$$US-SA-2023SA156957$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240924$$MD$US$US
223603782$22360378$2$F$$20240712$20230524$20240716$EXP$$CN-PFIZER INC-PV202300089654$PFIZER$Wang, S.. One case of delayed hypersensitivity caused by methylprednisolone sodium succinate. Central South Pharmacy. 2023;21(3):837-838$48$YR$$F$Y$60$KG$20240716$$PH$CN$CN
223604062$22360406$2$F$20200201$20240625$20230524$20240703$EXP$$RO-AMGEN-ROUSP2023084181$AMGEN$$49$YR$A$M$Y$$$20240703$$MD$RO$RO
223604374$22360437$4$F$$20230530$20230524$20240711$EXP$$IT-ASTELLAS-2023US015773$ASTELLAS$$$$$M$Y$$$20240711$$MD$IT$IT
223605838$22360583$8$F$$20240724$20230524$20240729$EXP$$US-PFIZER INC-PV202300091490$PFIZER$$72$YR$$F$Y$94.331$KG$20240729$$HP$US$US
223606624$22360662$4$F$20230501$20240805$20230524$20240819$EXP$$US-LUPIN PHARMACEUTICALS INC.-2023-03862$LUPIN$$$$$$Y$$$20240819$$CN$US$US
223607685$22360768$5$F$20230801$20240816$20230524$20240823$EXP$$NVSC2023US114152$NOVARTIS$$63$YR$$F$Y$$$20240823$$CN$US$US
223607733$22360773$3$F$20230101$20240813$20230524$20240821$EXP$$CA-CELLTRION INC.-2023CA002476$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
223610612$22361061$2$F$20200201$20240625$20230524$20240703$EXP$$RO-AMGEN-ROUSP2023085196$AMGEN$$61$YR$A$M$Y$$$20240703$$MD$RO$RO
223611042$22361104$2$F$$20240709$20230524$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389528$RANBAXY$Slater KN, Valk B, Kartono F. A case of generalized granuloma annulare treated with upadacitinib. JAAD Case Rep. 2023;34:12-14$57$YR$$F$Y$$$20240710$$MD$US$US
223611052$22361105$2$F$$20240826$20230524$20240904$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389800$RANBAXY$Vakrinou A, Murphy E, Sisodiya SM, Vivekananda U, Balestrini S. Risk factors and outcome of hyperammonaemia in people with epilepsy. J Neurol. 2022;269:6395-6405$$$A$$Y$$$20240904$$HP$GB$GB
223611185$22361118$5$F$$20240903$20230524$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388980$RANBAXY$$$$$F$Y$117.91$KG$20240918$$MD$US$US
223611283$22361128$3$F$$20240826$20230524$20240904$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389769$RANBAXY$Vakrinou A, Murphy E, Sisodiya SM, Vivekananda U, Balestrini S. Risk factors and outcome of hyperammonaemia in people with epilepsy. J Neurol. 2022;269:6395-6405$$$A$$Y$$$20240904$$HP$GB$GB
223611496$22361149$6$F$$20240924$20230524$20240930$PER$$US-PFIZER INC-US-GBT-021115$PFIZER$$44$YR$$M$Y$$$20240930$$CN$US$US
223611693$22361169$3$F$20230101$20240802$20230524$20240808$PER$$US-ABBVIE-5176048$ABBVIE$$61$YR$$F$Y$$$20240808$$CN$US$US
223611706$22361170$6$F$20220912$20240717$20230524$20240719$EXP$$US-TAKEDA-2022TUS065388$TAKEDA$$51$YR$$F$Y$$$20240719$$HP$US$US
223612592$22361259$2$F$$20240805$20230524$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03891$LUPIN$$$$$$Y$$$20240828$$CN$US$US
2236130411$22361304$11$F$$20240819$20230524$20240822$EXP$$CA-AMGEN-CANSP2023086709$AMGEN$$44$YR$A$F$Y$97$KG$20240822$$HP$CA$CA
223613775$22361377$5$F$20230101$20240711$20230524$20240715$EXP$$US-PFIZER INC-202300197170$PFIZER$$41$YR$$M$Y$$$20240715$$CN$US$US
2236139412$22361394$12$F$$20240830$20230524$20240905$EXP$$US-TAKEDA-2022TUS015556$TAKEDA$$$$$M$Y$$$20240905$$HP$US$US
223615032$22361503$2$F$$20240826$20230524$20240902$EXP$$IT-UCBSA-2023026098$UCB$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series. Journal of Clinical Medicine. 2023;12(1):129$29$YR$$M$Y$$$20240902$$HP$IT$IT
223615296$22361529$6$F$20231101$20240807$20230524$20240816$PER$$US-SA-2023SA061565$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240816$$HP$US$US
223615575$22361557$5$F$$20230522$20230524$20240916$PER$$NVSC2023US118780$NOVARTIS$$$$$M$Y$$$20240916$$HP$US$US
223615912$22361591$2$F$20230201$20240813$20230524$20240814$EXP$$US-UCBSA-2023026010$UCB$$47$YR$$F$Y$$$20240814$$CN$US$US
223616024$22361602$4$F$$20240805$20230524$20240809$EXP$$CA-PFIZER INC-202300195871$PFIZER$$62$YR$$F$Y$$$20240809$$CN$CA$CA
223616634$22361663$4$F$$20240909$20230524$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03843$LUPIN$$$$$$Y$$$20240923$$CN$US$US
223616714$22361671$4$F$$20240819$20230524$20240822$EXP$$NVSC2021CA315419$NOVARTIS$$77$YR$$F$Y$$$20240822$$HP$CA$CA
223617063$22361706$3$F$20230403$20240701$20230524$20240709$EXP$$TR-JNJFOC-20230418796$JOHNSON AND JOHNSON$$70$YR$E$F$Y$82.4$KG$20240709$$MD$TR$TR
223617634$22361763$4$F$20150324$20240725$20230524$20240802$EXP$$FR-UCBSA-2023026287$UCB$$44$YR$$F$Y$$$20240802$$LW$FR$FR
223617652$22361765$2$F$$20240723$20230524$20240801$PER$$US-SA-2023SA158097$SANOFI AVENTIS$$$$A$F$Y$$$20240801$$MD$US$US
223620393$22362039$3$F$$20240827$20230524$20240830$EXP$$US-PFIZER INC-202300197242$PFIZER$$74$YR$$M$Y$60.33$KG$20240830$$CN$US$US
2236207719$22362077$19$F$20220101$20240813$20230524$20240816$EXP$$CA-PFIZER INC-202200750420$PFIZER$$47$YR$$F$Y$50$KG$20240816$$CN$CA$CA
223621272$22362127$2$F$20230425$20240723$20230524$20240729$EXP$$FR-MYLANLABS-2023M1052797$MYLAN$$$$A$M$Y$78$KG$20240729$$MD$FR$FR
223621672$22362167$2$F$20220414$20240807$20230524$20240812$EXP$$CA-TAKEDA-2022TUS025944$TAKEDA$$63$YR$$M$Y$$$20240812$$HP$CA$CA
223621725$22362172$5$F$20221216$20240902$20230524$20240905$EXP$$NVSC2023DE113680$NOVARTIS$$57$YR$$F$Y$$$20240905$$MD$DE$DE
223623312$22362331$2$F$$20240630$20230524$20240702$EXP$$CA-PFIZER INC-202300198798$PFIZER$$9$YR$$M$Y$30$KG$20240702$$PH$CA$CA
223623562$22362356$2$F$$20240701$20230524$20240702$EXP$$CA-PFIZER INC-202300198794$PFIZER$$7$MON$$M$Y$7$KG$20240702$$PH$CA$CA
223625084$22362508$4$F$$20240717$20230524$20240723$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-010995$JAZZ$$$$$F$Y$$$20240723$$CN$US$US
223625937$22362593$7$F$20220101$20240722$20230524$20240730$EXP$$US-HORIZON THERAPEUTICS-HZN-2022-006160$AMGEN$$65$YR$E$M$Y$94.331$KG$20240730$$LW$US$US
223627416$22362741$6$F$$20240829$20230524$20240830$PER$$NVSC2023US116861$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
223627993$22362799$3$F$$20230524$20230524$20240909$EXP$$NVSC2023IE118201$NOVARTIS$$$$$$Y$$$20240909$$PH$IE$IE
223628223$22362822$3$F$$20240709$20230524$20240710$EXP$$US-TAKEDA-2022TUS043181$TAKEDA$$$$$M$Y$35.743$KG$20240710$$CN$US$US
223628442$22362844$2$F$$20240725$20230524$20240731$EXP$$US-TAKEDA-US202007706$TAKEDA$$$$$M$Y$$$20240731$$MD$US$US
223634322$22363432$2$F$20230501$20240815$20230525$20240829$PER$$US-SA-2023SA158796$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240829$$MD$US$US
223634865$22363486$5$F$20230505$20240723$20230525$20240819$PER$$CA-TOLMAR, INC.-23CA040773$TOLMAR$$75$YR$$M$Y$$$20240814$$CN$CA$CA
223636004$22363600$4$F$20230101$20240811$20230525$20240819$EXP$$CA-CELLTRION INC.-2023CA007540$CELLTRION$$$$$$Y$$$20240819$$HP$CA$CA
223637165$22363716$5$F$20240828$20240905$20230525$20240910$EXP$$US-TAKEDA-2021TUS073604$TAKEDA$$70$YR$$F$Y$142$KG$20240910$$HP$US$US
223640565$22364056$5$F$$20240906$20230525$20240911$EXP$$NVSC2023ZA115276$NOVARTIS$$63$YR$$M$Y$$$20240911$$CN$ZA$ZA
223643643$22364364$3$F$20220901$20240823$20230525$20240905$EXP$$US-UCBSA-2023000754$UCB$$36$YR$$F$Y$$$20240905$$HP$US$US
223645118$22364511$8$F$20230501$20240815$20230525$20240816$EXP$$US-TAKEDA-2023TUS045606$TAKEDA$$63$YR$$M$Y$$$20240816$$CN$US$US
223645712$22364571$2$F$20040101$20240725$20230525$20240731$EXP$$US-EMD Serono-8157637$EMD SERONO INC$$49$YR$A$F$Y$$$20240731$$CN$US$US
223646292$22364629$2$F$$20240901$20230525$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390045$RANBAXY$Iskandar S, Martins MS, Hudson A, Hirsch JG, Jahr JS. Does Dexmedetomidine Improve or Worsen Restless Leg Syndrome under Sedation: A Case Report and Extensive Review. Case Rep Crit Care. 2022;Sep 5;2022:2447461(1-5)$71$YR$$M$Y$$$20240904$$HP$US$US
223646322$22364632$2$F$$20240903$20230525$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389599$RANBAXY$Guenin SH, Khattri S, Lebwohl MG. Spesolimab use in treatment of pyoderma gangrenosum. JAAD Case Rep. 2023;Apr; 34:18-22$39$YR$$F$Y$$$20240913$$HP$US$US
223646665$22364666$5$F$20220413$20240904$20230525$20240914$EXP$$CA-ROCHE-3077574$ROCHE$$45$YR$A$F$Y$$$20240914$$HP$CA$CA
223646786$22364678$6$F$20230101$20240801$20230525$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-071891$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240805$$CN$US$US
223646937$22364693$7$F$20230420$20240810$20230525$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-070949$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240815$$CN$US$US
223647065$22364706$5$F$$20240805$20230525$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-239803$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240813$$CN$US$US
223649535$22364953$5$F$$20240822$20230525$20240823$PER$$NVSC2023US116031$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
223650272$22365027$2$F$20230309$20230516$20230525$20240925$PER$$US-GSK-US2023AMR070241$GLAXOSMITHKLINE$$39$YR$$F$Y$$$20240925$$CN$US$US
223653252$22365325$2$F$20240730$20240812$20230525$20240824$EXP$$US-UCBSA-2023008036$UCB$$80$YR$$M$Y$$$20240824$$HP$US$US
223653568$22365356$8$F$20230222$20240905$20230525$20240910$EXP$$DE-JNJFOC-20230414614$JOHNSON AND JOHNSON$$76$YR$E$M$Y$94.6$KG$20240910$$MD$DE$DE
223655692$22365569$2$F$20230415$20240827$20230525$20240830$EXP$$PHHY2018CO201729$NOVARTIS$$59$YR$$F$Y$77$KG$20240830$$CN$CO$CO
223655742$22365574$2$F$20230101$20240621$20230525$20240702$PER$$US-SA-2023SA159421$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240702$$MD$US$US
223655782$22365578$2$F$20230101$20240913$20230525$20240925$PER$$US-SA-2023SA160162$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240925$$MD$US$US
223656053$22365605$3$F$20240701$20240716$20230525$20240723$PER$$US-SA-2023SA160497$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
223656202$22365620$2$F$20230101$20240621$20230525$20240705$PER$$US-SA-2023SA159603$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240705$$CN$US$US
223656995$22365699$5$F$$20240722$20230525$20240725$EXP$$US-TAKEDA-2023TUS032578$TAKEDA$$$$$M$Y$70$KG$20240725$$HP$US$US
223657613$22365761$3$F$$20240909$20230525$20240920$EXP$$CA-GLENMARK PHARMACEUTICALS-2022GMK074313$GLENMARK$$$$$$Y$$$20240920$$HP$CA$CA
223658015$22365801$5$F$20230101$20240730$20230525$20240809$EXP$$JP-RECORDATI-2023002979$RECORDATI$Nakagawa Y, Sakasegawa N, Yoshikawa G, Shibayama M, Soga A, Yamaguchi Y et al. A case of Cushing disease patient who became pregnant while taking Osilodrostat and underwent  delivery with Pasireotide and Metyrapone$$$$$Y$$$20240809$$MD$JP$JP
223661052$22366105$2$F$$20240807$20230525$20240815$EXP$$JP-CHEPLA-2022007587$CHEPLAPHARM$$$$$F$Y$$$20240814$$CN$COUNTRY NOT SPECIFIED$JP
2236622810$22366228$10$F$20210830$20240918$20230525$20240926$EXP$$US-TAKEDA-US202007144$TAKEDA$$11$YR$$M$Y$53.968$KG$20240926$$HP$US$US
223662342$22366234$2$F$20230301$20230519$20230525$20240912$EXP$$NVSC2023US116961$NOVARTIS$$67$YR$$M$Y$83$KG$20240912$$CN$US$US
223662722$22366272$2$F$20151216$20240822$20230525$20240826$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385461$RANBAXY$Yu Y, Yao Y, Zhou J, Zhou H. Mucormycosis occurred during tigecycline treatment for infections caused by extensively resistant gram negative bacilli infection: report of two cases. [Chinese].. Chinese J Clin Infect Dis. 2020;13(6):446-449$34$YR$$M$Y$$$20240826$$HP$CN$CN
223663782$22366378$2$F$20240201$20240704$20230525$20240711$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023069967$VIIV$$32$YR$$M$Y$$$20240711$$MD$US$US
2236647611$22366476$11$F$$20240924$20230525$20240927$EXP$$US-PFIZER INC-PV202300075354$PFIZER$$61$YR$$F$Y$$$20240927$$MD$US$US
223665254$22366525$4$F$20220729$20240903$20230525$20240912$EXP$$IT-CELLTRION INC.-2022IT017537$CELLTRION$$$$$$Y$$$20240912$$MD$IT$IT
223665963$22366596$3$F$$20240701$20230525$20240705$PER$$NVSC2023US116616$NOVARTIS$$$$$M$Y$$$20240705$$CN$US$US
223666052$22366605$2$F$$20240821$20230525$20240902$EXP$$ES-Accord-359002$ACCORD$Margarit-Soler A, Deya-Martinez A, Canizales J, Vlagea A, Garcia-Garcia A, Marsal J, et al. Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders. Frontiers in Immunology. 2022;13:1-10.$21$YR$A$M$Y$$$20240902$$HP$ES$ES
223666365$22366636$5$F$20220401$20240905$20230525$20240910$PER$$US-BIOGEN-2022BI01113430$BIOGEN$$54$YR$$F$Y$$$20240910$$CN$US$US
223668242$22366824$2$F$20230516$20240807$20230525$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03869$LUPIN$$$$$$Y$$$20240822$$CN$US$US
223669482$22366948$2$F$20230514$20240710$20230525$20240715$EXP$$CO-BIOGEN-2023BI01207104$BIOGEN$$27$YR$$F$Y$47$KG$20240715$$CN$CO$CO
223669836$22366983$6$F$20230201$20240625$20230525$20240715$PER$$CA-TOLMAR, INC.-23CA040635$TOLMAR$$60$YR$$M$Y$$$20240715$$CN$CA$CA
223669856$22366985$6$F$20230101$20240626$20230525$20240716$PER$$CA-TOLMAR, INC.-23CA040508$TOLMAR$$61$YR$$M$Y$$$20240715$$CN$CA$CA
223670102$22367010$2$F$20230416$20240822$20230525$20240828$EXP$ES-AEMPS-1367906$ES-MYLANLABS-2023M1052783$MYLAN$$79$YR$$M$Y$$$20240828$$MD$ES$ES
223670772$22367077$2$F$$20240711$20230525$20240718$PER$$US-BIOGEN-2023BI01207098$BIOGEN$$$$$M$Y$$$20240718$$CN$US$US
223670844$22367084$4$F$$20240807$20230525$20240813$EXP$$CA-GSK-CA2023071712$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CA$CA
223670868$22367086$8$F$20230511$20240625$20230525$20240701$EXP$$GR-EXELIXIS-XL18423063984$EXELIXIS$$$$$$Y$$$20240701$$MD$GR$GR
223671492$22367149$2$F$20240101$20240807$20230525$20240820$PER$$US-SA-2023SA160634$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240820$$MD$US$US
223671622$22367162$2$F$20230101$20240816$20230525$20240820$PER$$US-PFIZER INC-202300198775$PFIZER$$60$YR$$F$Y$$$20240820$$HP$US$US
223673555$22367355$5$F$20220101$20240705$20230525$20240710$EXP$$CA-UCBSA-2023022031$UCB$$$$$F$Y$$$20240710$$CN$CA$CA
223673856$22367385$6$F$20240514$20240625$20230525$20240705$EXP$$CA-ROCHE-3130169$ROCHE$$40$YR$A$F$Y$$$20240705$$CN$CA$CA
223673872$22367387$2$F$20230501$20240722$20230525$20240731$PER$$US-SA-2023SA159678$SANOFI AVENTIS$$51$YR$A$F$Y$58.5$KG$20240731$$MD$US$US
223676138$22367613$8$F$$20240815$20230525$20240821$EXP$$US-TAKEDA-2023TUS051344$TAKEDA$$$$$M$Y$91$KG$20240821$$CN$US$US
223676272$22367627$2$F$20230308$20240829$20230525$20240906$EXP$$TR-EMD Serono-9339921$EMD SERONO INC$$30$YR$A$F$Y$$$20240906$$MD$TR$TR
223676353$22367635$3$F$20230501$20230531$20230525$20240925$PER$$US-GSK-US2023AMR073821$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$MD$US$US
223676555$22367655$5$F$$20240910$20230525$20240912$PER$$US-PFIZER INC-PV202300091634$PFIZER$$72$YR$$F$Y$$$20240912$$MD$US$US
223677223$22367722$3$F$$20240805$20230525$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03861$LUPIN$$$$$$Y$$$20240822$$CN$US$US
223677544$22367754$4$F$$20240805$20230525$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03879$LUPIN$$$$$$Y$$$20240821$$CN$US$US
223678603$22367860$3$F$$20240730$20230525$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03882$LUPIN$$$$$$Y$$$20240819$$CN$US$US
223678714$22367871$4$F$20240701$20240827$20230525$20240901$EXP$$BR-TAKEDA-2023TUS034097$TAKEDA$$45$YR$$M$Y$72$KG$20240901$$CN$BR$BR
223679576$22367957$6$F$20230423$20240906$20230525$20240912$EXP$$JP-AstraZeneca-2023A119334$ASTRAZENECA$$80$YR$$F$Y$53$KG$20240912$$MD$JP$
223679743$22367974$3$F$$20240805$20230525$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03898$LUPIN$$$$$$Y$$$20240822$$CN$US$US
223680483$22368048$3$F$$20240805$20230525$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03894$LUPIN$$$$$$Y$$$20240821$$CN$US$US
223683057$22368305$7$F$20230101$20240805$20230525$20240807$EXP$$US-PFIZER INC-PV202300092337$PFIZER$$55$YR$$F$Y$$$20240807$$HP$US$US
223684136$22368413$6$F$20200101$20240726$20230525$20240802$EXP$$IN-PFIZER INC-2020113411$PFIZER$$56$YR$$M$Y$71.4$KG$20240802$$CN$IN$IN
223684384$22368438$4$F$20230301$20240723$20230525$20240730$EXP$$FR-TAKEDA-2023TUS050337$TAKEDA$$61$YR$$M$Y$59$KG$20240730$$CN$FR$FR
223684842$22368484$2$F$$20240807$20230525$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03885$LUPIN$$$$$$Y$$$20240829$$CN$US$US
223685124$22368512$4$F$$20240807$20230525$20240809$EXP$$US-TAKEDA-2023TUS040218$TAKEDA$$$$$M$Y$47.3$KG$20240809$$MD$US$US
223685243$22368524$3$F$$20240805$20230525$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03900$LUPIN$$$$$$Y$$$20240821$$CN$US$US
223685345$22368534$5$F$20230101$20240807$20230525$20240809$EXP$$US-PFIZER INC-PV202300090813$PFIZER$$86$YR$$F$Y$$$20240809$$CN$US$US
223685402$22368540$2$F$$20240731$20230525$20240802$EXP$$US-PFIZER INC-PV202300090880$PFIZER$$82$YR$$F$Y$$$20240802$$CN$US$US
223685552$22368555$2$F$$20240805$20230525$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03901$LUPIN$$$$$$Y$$$20240821$$CN$US$US
2236865912$22368659$12$F$20230301$20240916$20230525$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-072775$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240923$$CN$US$US
223687823$22368782$3$F$$20240705$20230525$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-072404$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$68$KG$20240716$$HP$CA$CA
223690146$22369014$6$F$20230129$20240715$20230525$20240718$EXP$$FR-BAUSCH-BL-2023-007605$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240718$$HP$FR$FR
223690493$22369049$3$F$20220101$20240820$20230525$20240823$PER$$US-AMGEN-USASP2023086550$AMGEN$$73$YR$E$M$Y$$$20240823$$HP$US$US
2236908112$22369081$12$F$20230101$20240912$20230525$20240921$EXP$$CA-CELLTRION INC.-2023CA006743$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
223690832$22369083$2$F$$20230524$20230525$20240920$EXP$$NVSC2023CA119588$NOVARTIS$$$$$$Y$$$20240920$$MD$CA$CA
223691752$22369175$2$F$$20240911$20230525$20240918$PER$$US-SA-2023SA159479$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240918$$MD$US$US
2236918213$22369182$13$F$20230501$20240702$20230525$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-001785$ACADIA PHARMACEUTICALS$$16$YR$$M$Y$$$20240726$$CN$US$US
223693603$22369360$3$F$20230401$20240709$20230526$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001668$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240731$$HP$US$US
223694333$22369433$3$F$$20240827$20230526$20240906$PER$$US-SA-2023SA161076$SANOFI AVENTIS$$$$C$F$Y$15.7$KG$20240906$$MD$US$US
223695183$22369518$3$F$20230101$20240723$20230526$20240801$PER$$US-SA-2023SA160732$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240801$$MD$US$US
223699063$22369906$3$F$$20240711$20230526$20240715$EXP$$US-BIOGEN-2023BI01207400$BIOGEN$$$$$M$Y$$$20240715$$CN$US$US
223699162$22369916$2$F$$20240726$20230526$20240807$EXP$$US-LUPIN PHARMACEUTICALS INC.-2023-03926$LUPIN$$$$$$Y$$$20240807$$CN$US$US
2237026818$22370268$18$F$20220101$20240812$20230526$20240816$EXP$$CA-JNJFOC-20230558048$JOHNSON AND JOHNSON$$56$YR$A$F$Y$88$KG$20240816$$CN$CA$CA
223702697$22370269$7$F$20210101$20240617$20230526$20240729$EXP$$JP-009507513-2305JPN002306J$MERCK$Yamazato M, Nakamura H, Yamakawa N, Nakagawa Y, Ueda N, Yagyuu T, et al.. P-086 A Case of Maxillary Gingival Squamous Cell Carcinoma in which IrAE encephalitis Developed after the First Dose of Pembrolizumab. The 48th Annual Meeting of Japan Society for Head and Neck Cancer. 2024;50(2):221$84$YR$$F$Y$$$20240729$$MD$JP$JP
223703244$22370324$4$F$$20240711$20230526$20240720$EXP$$CA-CELLTRION INC.-2023CA003473$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
223703603$22370360$3$F$20230101$20240723$20230526$20240801$PER$$US-SA-2023SA160473$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240801$$MD$US$US
223703732$22370373$2$F$$20240802$20230526$20240812$PER$$US-SA-2023SA161241$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240812$$MD$US$US
223704234$22370423$4$F$20230623$20240829$20230526$20240902$EXP$$CA-TAKEDA-2022TUS088793$TAKEDA$$42$YR$$F$Y$$$20240902$$CN$CA$CA
2237049515$22370495$15$F$$20240917$20230526$20240923$EXP$$PT-AMGEN-PRTSP2023088854$AMGEN$$$$E$$Y$$$20240923$$MD$PT$PT
223707986$22370798$6$F$20220328$20240815$20230526$20240827$EXP$FR-SEATTLE GENETICS-2023SGN04789$FR-ROCHE-3354844$ROCHE$$50$YR$A$F$Y$$$20240827$$HP$FR$FR
223708073$22370807$3$F$$20240902$20230526$20240904$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390240$RANBAXY$Lin J, Ye A. Acute kidney injury due to venous pumping of overdose methotrexate in an ectopic pregnancy patient. ADRJ. 2020;Nov;22(11):640-641$36$YR$$F$Y$$$20240904$$HP$CN$CN
223708112$22370811$2$F$20230505$20240701$20230526$20240702$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389004$RANBAXY$$67$YR$E$M$Y$98$KG$20240702$$PH$BR$BR
223708644$22370864$4$F$$20240703$20230526$20240704$EXP$$US-PFIZER INC-PV202300049124$PFIZER$Harris, E.. Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease. Pediatric Blood and Cancer. 2023;70(5):10.1002/pbc.30254$$$A$$Y$$$20240704$$HP$US$US
223708694$22370869$4$F$$20240627$20230526$20240702$EXP$$US-TAKEDA-2023TUS051754$TAKEDA$$$$$F$Y$56.689$KG$20240702$$CN$US$US
223708795$22370879$5$F$20230411$20240923$20230526$20240926$EXP$$AU-TAKEDA-2023TUS038493$TAKEDA$$33$YR$$M$Y$$$20240926$$CN$AU$AU
223710384$22371038$4$F$20230522$20240806$20230526$20240813$PER$$US-SA-2023SA161537$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240814$$MD$US$US
2237111010$22371110$10$F$$20240808$20230526$20240813$EXP$$NVSC2023US120727$NOVARTIS$$$$$F$Y$$$20240813$$CN$US$US
223711352$22371135$2$F$$20240805$20230526$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03928$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223712134$22371213$4$F$$20240828$20230526$20240924$PER$$US-SA-2023SA161819$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240924$$MD$US$US
223712532$22371253$2$F$$20240711$20230526$20240801$PER$$US-SA-2023SA162139$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240719$$MD$US$US
223712607$22371260$7$F$20230101$20240828$20230526$20240829$EXP$$US-UCBSA-2023026488$UCB$$$$$M$Y$$$20240829$$CN$US$US
2237129411$22371294$11$F$20211219$20240726$20230526$20240801$EXP$$BR-GSK-BR2017GSK152546$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$BR$BR
223714159$22371415$9$F$20230504$20240625$20230526$20240702$EXP$$CA-MYLANLABS-2023M1054904$MYLAN$$78$YR$$F$Y$35.83$KG$20240702$$MD$CA$CA
223714238$22371423$8$F$$20240716$20230526$20240718$PER$$NVSC2023US118356$NOVARTIS$$$$$M$Y$$$20240718$$CN$US$US
223714634$22371463$4$F$20211001$20240820$20230526$20240902$PER$$US-SA-2022SA060869$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240902$$MD$US$US
223714736$22371473$6$F$20210615$20240626$20230526$20240711$EXP$$EG-ROCHE-3353284$ROCHE$$53$YR$A$F$Y$75$KG$20240711$$CN$EG$EG
223715414$22371541$4$F$20230512$20240802$20230526$20240809$EXP$$NVSC2022CO239292$NOVARTIS$$73$YR$$F$Y$67$KG$20240809$$CN$CO$CO
223715614$22371561$4$F$20221205$20240723$20230526$20240729$EXP$$CA-TAKEDA-2022TUS042455$TAKEDA$$68$YR$$F$Y$$$20240729$$HP$CA$CA
223715622$22371562$2$F$20230501$20240829$20230526$20240903$EXP$$CA-JNJFOC-20230433267$JOHNSON AND JOHNSON$$14$YR$T$F$Y$60$KG$20240903$$HP$CA$CA
223717223$22371722$3$F$20240501$20240814$20230526$20240815$EXP$$GB-ROCHE-3356830$ROCHE$$28$YR$A$F$Y$$$20240815$$HP$GB$GB
223717292$22371729$2$F$$20240920$20230526$20240930$PER$$US-GSK-US2023AMR070134$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
223717478$22371747$8$F$20231121$20240909$20230526$20240927$EXP$$US-SA-2023SA161376$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240927$$MD$US$US
223717745$22371774$5$F$$20240910$20230526$20240912$EXP$$US-TAKEDA-2023TUS052074$TAKEDA$$$$$F$Y$86$KG$20240912$$HP$US$US
223721264$22372126$4$F$$20240807$20230526$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03913$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223721793$22372179$3$F$20231210$20240724$20230526$20240725$EXP$$US-UCBSA-2023026507$UCB$$60$YR$$M$Y$$$20240725$$HP$US$US
223723063$22372306$3$F$$20240703$20230526$20240703$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390237$RANBAXY$Shen Y, Su H. Aspirin-induced liver injury in a pediatric patient with Kawasaki disease. [Chinese].. Advers Drug React J. 2020;22(11):648-649$28$YR$$M$Y$$$20240703$$HP$CN$CN
223723122$22372312$2$F$$20240703$20230526$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389379$RANBAXY$Santucci A. Allergy to Brassicaceae, possible outcome of pollen cross reactivity?. Eur J Allergy Clin Immunol. 492-493/001504$47$YR$$F$Y$$$20240710$$HP$IT$IT
223723132$22372313$2$F$20201230$20240822$20230526$20240826$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390534$RANBAXY$Buenestado-serrano S, Recio R, Sola Campoy PJ, Catalan P, Folgueira MD, Villa J, et al. First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant. Enferm Infecc Microbiol Clin. 2022;40:546-549$33$YR$$M$Y$$$20240826$$HP$ES$ES
223723192$22372319$2$F$$20240708$20230526$20240709$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-389818$RANBAXY$Matsumoto T, Sakurai Y, Fujiki T, Kusakabe Y, Nakayama E, Tanaka A, et al. Allergy to Omalizumab: Lessons from a Reaction to the Coronavirus 2019 Vaccine. Intern Med. 2023;62(8):1219-1222$18$YR$$F$Y$$$20240709$$HP$JP$JP
223724492$22372449$2$F$20221101$20240917$20230526$20240926$PER$$US-SA-2023SA162616$SANOFI AVENTIS$$38$YR$A$F$Y$66.213$KG$20240926$$MD$US$US
223724902$22372490$2$F$$20240725$20230526$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03943$LUPIN$$$$$$Y$$$20240817$$CN$US$US
223725023$22372502$3$F$20221122$20240814$20230526$20240830$EXP$$FR-PFIZER INC-FR-GBT-019127$PFIZER$$33$YR$$F$Y$48$KG$20240830$$PH$FR$FR
223725282$22372528$2$F$$20240703$20230526$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-390442$RANBAXY$$23$YR$$F$Y$56$KG$20240703$$CN$GB$GB
223725572$22372557$2$F$$20240722$20230526$20240726$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-390802$RANBAXY$$83$YR$$F$Y$$$20240727$$PH$ES$ES
223725782$22372578$2$F$20220104$20240715$20230526$20240715$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-390451$RANBAXY$$59$YR$$F$Y$80$KG$20240715$$CN$GB$GB
223725862$22372586$2$F$$20240828$20230526$20240904$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390435$RANBAXY$Gallo G, Mastorino L, Barila D, Cattel F, Panzone M, Quaglino P, et al. Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasis. Dermatol Ther. 2022;35:e15917; 1-4$36$YR$$M$Y$$$20240904$$HP$IT$IT
223726012$22372601$2$F$$20240703$20230526$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390739$RANBAXY$Bencze JM, Crotteau JA, Urbina TM, Schulz EV. Bilious Emesis and Failure to Pass Meconium in the Nursery: A Case Study. Neonatal netw. 2023;Jan/Feb; 42(1):31-36$41$YR$$F$Y$$$20240710$$MD$US$US
223726454$22372645$4$F$20211119$20240704$20230526$20240710$EXP$$US-PFIZER INC-US-GBT-017603$PFIZER$$58$YR$$F$Y$77.1$KG$20240710$$MD$US$US
223727313$22372731$3$F$$20240729$20230526$20240802$PER$$NVSC2023US117228$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
223727576$22372757$6$F$20230101$20240819$20230526$20240827$PER$$US-AMGEN-USASP2023089091$AMGEN$$65$YR$E$M$Y$$$20240827$$HP$US$US
223728512$22372851$2$F$20220328$20240703$20230526$20240710$EXP$$FR-PFIZER INC-202300198322$PFIZER$$50$YR$$F$Y$$$20240710$$HP$FR$FR
223728773$22372877$3$F$$20240801$20230526$20240807$EXP$$CA-TAKEDA-2020TUS023638$TAKEDA$$$$$M$Y$$$20240807$$CN$CA$CA
223728984$22372898$4$F$20230320$20240702$20230526$20240709$EXP$$BR-TAKEDA-2023TUS022665$TAKEDA$$48$YR$$F$Y$63$KG$20240709$$CN$BR$BR
223733863$22373386$3$F$$20240805$20230526$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03916$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223734104$22373410$4$F$$20240925$20230526$20240927$EXP$$US-PFIZER INC-PV202300092473$PFIZER$$76$YR$$F$Y$75.7$KG$20240927$$CN$US$US
223734922$22373492$2$F$$20240820$20230526$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389759$RANBAXY$Ahmed W, Pahwa D, Jalal A, Takalloo A, Ganta V, Zenebe A, et al. Endocrinopathies in Rubinstein Taybi Syndrome (RTS). Endocrine Practice. 2023;29:1407524; S43$47$YR$$M$Y$120.18$KG$20240826$$MD$US$US
223735482$22373548$2$F$$20240731$20230526$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03942$LUPIN$$$$$$Y$$$20240820$$PH$US$US
223735986$22373598$6$F$$20240919$20230526$20240920$EXP$$US-TAKEDA-2023TUS018728$TAKEDA$$$$$F$Y$$$20240920$$CN$US$US
223736184$22373618$4$F$20220101$20240925$20230526$20240930$EXP$$CA-PFIZER INC-202200120764$MYLAN$$$$$M$Y$28.12$KG$20240930$$HP$CA$CA
223737064$22373706$4$F$20220801$20240813$20230526$20240819$PER$$US-PFIZER INC-US-GBT-016791$PFIZER$$19$YR$$F$Y$$$20240819$$CN$US$US
223737373$22373737$3$F$$20240805$20230526$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03917$LUPIN$$$$$$Y$$$20240822$$CN$US$US
223740922$22374092$2$F$20230518$20240625$20230526$20240702$EXP$$TW-TAKEDA-2023TUS051341$TAKEDA$$51$YR$$F$Y$$$20240702$$CN$TW$TW
223741287$22374128$7$F$20230101$20240815$20230526$20240821$EXP$$CA-TAKEDA-2023TUS016727$TAKEDA$$$$$F$Y$$$20240821$$CN$CA$CA
2237453826$22374538$26$F$$20240819$20230526$20240826$EXP$$CA-PFIZER INC-202300201014$PFIZER$$44$YR$$F$Y$97$KG$20240826$$HP$CA$CA
223747454$22374745$4$F$20231201$20240913$20230526$20240920$PER$$NVSC2023US121067$NOVARTIS$$32$YR$$F$Y$$$20240920$$CN$US$US
223747742$22374774$2$F$$20240725$20230526$20240729$PER$$NVSC2023US120631$NOVARTIS$$$$$F$Y$$$20240729$$CN$US$US
223748202$22374820$2$F$20230505$20240716$20230527$20240726$EXP$$IT-AUROBINDO-AUR-APL-2023-038403$AUROBINDO$$23$YR$$M$Y$$$20240726$$MD$IT$IT
223748744$22374874$4$F$20230101$20240723$20230527$20240730$EXP$$US-AMGEN-USASP2023089730$AMGEN$$53$YR$A$F$Y$$$20240730$$HP$US$US
223749603$22374960$3$F$$20240828$20230527$20240906$EXP$$CA-CELLTRION INC.-2023CA010728$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
223751055$22375105$5$F$20200101$20240329$20230527$20240806$EXP$$NVSC2023US120325$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
2237511718$22375117$18$F$20230101$20240820$20230527$20240828$EXP$$CA-CELLTRION INC.-2023CA009633$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
223751534$22375153$4$F$20220210$20240813$20230527$20240814$EXP$$US-UCBSA-2023026311$UCB$$51$YR$$F$Y$$$20240814$$HP$US$US
223755144$22375514$4$F$20230516$20240913$20230527$20240917$PER$$NVSC2023US121456$NOVARTIS$$50$YR$$F$Y$$$20240917$$CN$US$US
223755232$22375523$2$F$$20240828$20230527$20240904$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390431$RANBAXY$Gallo G, Mastorino L, Barila D, et al.. Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasis. Dermatol Ther. 2022;35(12):e15917$23$YR$$F$Y$$$20240904$$HP$IT$IT
223755402$22375540$2$F$$20240821$20230527$20240826$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390818$RANBAXY$Thompson E, Arbuckle J. Presentation, Evaluation and Management of Uterine Fibroids in Two Adolescents. J Pediatr Adolesc Gynecol. 2023;36(2):189 (28)$17$YR$$F$Y$$$20240826$$HP$GB$GB
223755502$22375550$2$F$$20240828$20230527$20240904$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390434$RANBAXY$Gallo G, Mastorino L, Barila D, Cattel F, Panzone M, Quaglino P, et al. Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasis. Dermatol Ther. 2022;35(12):e15917$55$YR$$F$Y$$$20240904$$HP$IT$IT
223755582$22375558$2$F$$20240717$20230527$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389370$RANBAXY$Martinez-Arcediano A, Audicana-Berasategui MT, Velasco-Azagra M, Villarreal-Balza De Vallejo MO, Gutierrez-Niso M, De La Viuda-Camino E, et al. Allergy to alpha-gal, compounding factors and the risk of anaphylaxis in 4 European pediatric and adolescent patients. Allergy. 2023;78(Suppl111):176-177 (001594)$$$C$M$Y$$$20240718$$HP$ES$ES
223756092$22375609$2$F$$20240820$20230527$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389226$RANBAXY$Rizk M, Sherpa C, Singh V, Zahedpour S, Gabriely I, Ellangovan R, et al. Abstract #1411962:Methimazole Induced Agranulocytosis: A Treatment Dilemma. Endocr Pract. 2023;29(Suppl.)(5):S117-S118/1411962$21$YR$$F$Y$$$20240826$$MD$US$US
223762117$22376211$7$F$20230501$20240916$20230527$20240919$PER$$NVSC2023US121943$NOVARTIS$$12$YR$$F$Y$$$20240919$$CN$US$US
223764572$22376457$2$F$$20240913$20230528$20240923$EXP$$FR-AUROBINDO-AUR-APL-2023-037762$AUROBINDO$Bihan, K, Lipszyc L, Lemaitrec F, Dautriche A, F?drizzi S, Atzenhoffer M. Nirmatrelvir/ritonavir (Paxlovid): French pharmacovigilance survey 2022. Therapies. 2023$85$YR$$F$Y$$$20240923$$HP$FR$FR
223766746$22376674$6$F$$20240717$20230528$20240723$EXP$$CA-AMGEN-CANNI2023089582$AMGEN$$18$YR$A$M$Y$$$20240723$$HP$CA$CA
223768843$22376884$3$F$20230401$20240725$20230529$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-072233$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240729$$CN$US$US
223770202$22377020$2$F$$20240812$20230529$20240821$PER$$US-SA-2023SA162451$SANOFI AVENTIS$$$$E$M$Y$$$20240821$$MD$US$US
223770318$22377031$8$F$$20240709$20230529$20240715$EXP$$CA-ROCHE-2670875$ROCHE$$$$A$F$Y$$$20240715$$CN$CA$CA
223776482$22377648$2$F$20230501$20230524$20230529$20240925$PER$$US-GSK-US2023AMR075010$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240925$$CN$US$US
223776894$22377689$4$F$20230509$20240905$20230529$20240915$EXP$$SK-AUROBINDO-AUR-APL-2023-038226$AUROBINDO$$78$YR$$F$Y$$$20240915$$MD$SK$SK
223777885$22377788$5$F$$20240627$20230529$20240704$EXP$$CA-TAKEDA-2023TUS007056$TAKEDA$$$$$M$Y$$$20240704$$PH$CA$CA
223778942$22377894$2$F$$20230517$20230529$20240925$EXP$HU-EMA-DD-20180905-dprabhakar9p-101548$HU-JUBILANT CADISTA PHARMACEUTICALS-2023HU000427$JUBILANT$Ban A, Pinter E, Kun J.. Proper oral health can protect from developing gingival hyperplasia induced by calcium channel blockers.. Orv Hetil. 2018;159(29):1183-1187$55$YR$$M$Y$$$20240925$$MD$HU$HU
223779667$22377966$7$F$$20231004$20230529$20240925$PER$$US-GSK-US2023AMR070447$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$HP$US$US
223780342$22378034$2$F$$20230524$20230529$20240822$EXP$$ES-KYOWAKIRIN-2023BKK007737$KYOWA$$$$$$Y$$$20240822$$HP$ES$ES
223780657$22378065$7$F$20210701$20240709$20230529$20240723$EXP$$DE-AUROBINDO-AUR-APL-2023-037612$AUROBINDO$$62$YR$$F$Y$96$KG$20240719$$MD$DE$DE
223781333$22378133$3$F$20230101$20240716$20230529$20240724$PER$$US-SA-2023SA162753$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240724$$MD$US$US
223781793$22378179$3$F$20230101$20240717$20230529$20240726$EXP$$JP-009507513-2305JPN002650J$MERCK$$$$$F$Y$$$20240726$$MD$JP$JP
223782072$22378207$2$F$20240827$20240918$20230529$20240926$PER$$US-GSK-US2023071756$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240926$$HP$US$US
223789532$22378953$2$F$$20230526$20230529$20240915$PER$$NVSC2023US122606$NOVARTIS$$$$$F$Y$$$20240915$$CN$US$US
223790132$22379013$2$F$20221101$20230525$20230529$20240712$EXP$$BG-ASTELLAS-2023US016293$ASTELLAS$$78$YR$$M$Y$$$20240712$$MD$BG$BG
223790723$22379072$3$F$$20240920$20230529$20240923$EXP$$ZA-ROCHE-3354323$ROCHE$$$$A$F$Y$$$20240923$$MD$ZA$ZA
223791932$22379193$2$F$$20240823$20230529$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390856$RANBAXY$Lee J, Pham B, Karanjawala ZE, Adesina O. Postpartum fevers, a rare presentation of secondary hemophagocytic lymphohistiocytosis. Clin Case Rep. 2023;11(3):e7070; 1-6$20$YR$$F$Y$$$20240826$$HP$US$US
223791982$22379198$2$F$$20240813$20230529$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-391415$RANBAXY$THE USE OF RITUXIMAB IN CHILDREN WITH JUVENILE DERMATOMYOSITIS AND ANTI-MDA5 ANTIBODIES$$$C$$Y$$$20240826$$HP$US$US
223791992$22379199$2$F$$20240812$20230529$20240826$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-391000$RANBAXY$Deiana CM, Marras A, Messina MR, Costanzo G, Del Giacco S, Firinu D. Efficacy of anakinra treatment in autoinflammatory syndrome: a case report. Allergy. 2023;78 (Suppl. 111):520 (000737)$72$YR$$M$Y$$$20240826$$HP$IT$IT
223792012$22379201$2$F$20230216$20240801$20230529$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-390409$RANBAXY$$84$YR$$M$Y$51.6$KG$20240802$$PH$FR$FR
223792052$22379205$2$F$$20240909$20230529$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389566$RANBAXY$Ataallah B, Orlander P. Moyamoya Syndrome in a Patient with Thyroid Storm; Role of Plasmapheresis?. Endocr Pract. 2023;29 (Suppl.)(5):1395609; S95$28$YR$$F$Y$$$20240913$$MD$US$US
223792122$22379212$2$F$20230301$20240618$20230529$20240703$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-390413$RANBAXY$$72$YR$$F$Y$$$20240703$$PH$FR$FR
223792162$22379216$2$F$20230209$20240801$20230529$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-390769$RANBAXY$$48$YR$$M$Y$$$20240802$$MD$FR$FR
223792222$22379222$2$F$20221026$20240722$20230529$20240726$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-391751$RANBAXY$$75$YR$$F$Y$$$20240727$$PH$ES$ES
223792904$22379290$4$F$20240501$20240726$20230529$20240805$EXP$$CA-TOLMAR, INC.-23CA040784$TOLMAR$$70$YR$$M$Y$$$20240805$$CN$CA$CA
223792926$22379292$6$F$20210728$20240828$20230529$20240904$EXP$$US-GSK-US2023AMR074159$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$US$US
223793486$22379348$6$F$$20240703$20230529$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-074629$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240715$$CN$US$US
223793663$22379366$3$F$$20240624$20230529$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-074637$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240701$$MD$JP$JP
2237938910$22379389$10$F$20230331$20240725$20230529$20240730$EXP$$CA-TAKEDA-2023TUS051766$TAKEDA$$71$YR$$F$Y$$$20240730$$HP$CA$CA
223797054$22379705$4$F$20230509$20240928$20230529$20240930$EXP$$IT-TAKEDA-2023TUS052326$TAKEDA$$66$YR$$F$Y$43$KG$20240930$$HP$IT$IT
223797332$22379733$2$F$20230501$20240716$20230529$20240722$EXP$$MX-TAKEDA-2023TUS051967$TAKEDA$$77$YR$$F$Y$49$KG$20240722$$MD$MX$MX
223797483$22379748$3$F$$20240805$20230529$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04021$LUPIN$$$$$$Y$$$20240818$$CN$US$US
223797573$22379757$3$F$$20240725$20230529$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04022$LUPIN$$$$$$Y$$$20240816$$CN$US$US
223797613$22379761$3$F$$20240805$20230529$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-03988$LUPIN$$$$$$Y$$$20240818$$CN$US$US
223797793$22379779$3$F$$20240725$20230529$20240809$EXP$$US-LUPIN PHARMACEUTICALS INC.-2023-03989$LUPIN$$$$$$Y$$$20240809$$CN$US$US
223799652$22379965$2$F$$20240904$20230529$20240909$EXP$$CA-TAKEDA-2023TUS052353$TAKEDA$$$$$M$Y$$$20240909$$CN$CA$CA
223801784$22380178$4$F$$20240717$20230529$20240722$EXP$$US-PFIZER INC-PV202300095129$PFIZER$$75$YR$$M$Y$70.748$KG$20240722$$CN$US$US
223802264$22380226$4$F$20230501$20240703$20230529$20240711$EXP$$JP-JAZZ PHARMACEUTICALS-2023-JP-011515$JAZZ$$32$YR$$M$Y$72.8$KG$20240711$$MD$JP$JP
2238029810$22380298$10$F$20230101$20240924$20230529$20240927$EXP$$CA-PFIZER INC-202300202412$PFIZER$$59$YR$$F$Y$78.998$KG$20240927$$HP$CA$CA
223803342$22380334$2$F$20200201$20240704$20230529$20240709$EXP$$RO-BRISTOL-MYERS SQUIBB COMPANY-2023-075242$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240709$$MD$RO$RO
223803362$22380336$2$F$$20230525$20230529$20240913$EXP$$NVSC2023US121234$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
223803392$22380339$2$F$20220623$20230525$20230529$20240916$EXP$$NVSC2023US120903$NOVARTIS$$38$YR$$F$Y$$$20240916$$CN$US$US
223805713$22380571$3$F$20230101$20240717$20230529$20240801$PER$$US-SA-2023SA163701$SANOFI AVENTIS$$50$YR$A$F$Y$106.5$KG$20240801$$MD$US$US
223805842$22380584$2$F$20221201$20240806$20230529$20240814$EXP$$FR-AstraZeneca-2023A117614$ASTRAZENECA$$60$YR$$M$Y$$$20240814$$MD$FR$
223808134$22380813$4$F$$20240625$20230530$20240715$PER$$CA-TOLMAR, INC.-23CA040798$TOLMAR$$$$$M$Y$$$20240715$$CN$CA$CA
2238097312$22380973$12$F$20230101$20240822$20230530$20240830$EXP$$CA-CELLTRION INC.-2023CA010939$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
2238099113$22380991$13$F$20230505$20240620$20230530$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-001790$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240712$$CN$US$US
223810323$22381032$3$F$20230518$20240730$20230530$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04043$LUPIN$$$$$$Y$$$20240821$$CN$US$US
223811082$22381108$2$F$$20240820$20230530$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-391258$RANBAXY$Staropoli PC, Iyer P, Gregori G, Rosenfeld PJ, Flynn Jr HW. Identification of macular neovascularization in central serous chorioretinopathy using swept-source OCT angiography. Am J Ophthalmol Case Rep. 2023;30:101843 (1-5)$63$YR$$M$Y$$$20240826$$HP$US$US
223811142$22381114$2$F$$20240902$20230530$20240904$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-391233$RANBAXY$Yamamoto M, Kase M, Sano H, Kamijima R, Sano S. Persistent varicella zoster virus infection following mRNA COVID-19 vaccination was associated with the presence of encoded spike protein in the lesion. J Cutan Immunol Allergy. 2023;6(1):18-23$64$YR$$M$Y$$$20240904$$MD$JP$JP
223811182$22381118$2$F$$20240820$20230530$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-391260$RANBAXY$Staropoli PC, Iyer P, Gregori G, Rosenfeld PJ, Flynn HW. Identification of macular neovascularization in central serous chorioretinopathy using swept-source OCT angiography. Am J Ophthalmol Case Rep. 2023;30:no pagination$67$YR$$M$Y$$$20240826$$HP$US$US
223814082$22381408$2$F$$20230516$20230530$20240924$EXP$HU-EMA-DD-20180604-pagraharip-095819$HU-JUBILANT CADISTA PHARMACEUTICALS-2023HU000411$JUBILANT$Szabo A. Easier Solution, More Effective Cooperation, Better Results In The Treatment Of Hypertension With Fix Combination. Haziorvos Tovabbkepzo Szemle. 2018;23:158-160$69$YR$$F$Y$$$20240924$$MD$HU$HU
2238151717$22381517$17$F$20230225$20240723$20230530$20240730$EXP$$BE-EXELIXIS-XL18423061634$EXELIXIS$$$$$$Y$$$20240729$$MD$BE$BE
223815513$22381551$3$F$$20240814$20230530$20240827$EXP$$DE-AUROBINDO-AUR-APL-2023-038076$AUROBINDO$Hoffmann J, Schliesser G, Neubauer A... Abatacept as salvage therapy for life-threatening refractory autoimmune hemolytic anemia: a case report... Hematology.. 2023;28(1):1-5$54$YR$$F$Y$$$20240827$$MD$DE$DE
223816032$22381603$2$F$$20240619$20230530$20240717$EXP$$CA-ORGANON-O2305CAN002534$ORGANON$Unknown. Unknown. Unknown$15$YR$$F$Y$54$KG$20240717$$HP$CA$CA
223816416$22381641$6$F$$20240911$20230530$20240920$EXP$$ES-CELLTRION INC.-2023ES010884$CELLTRION$$$$$$Y$$$20240920$$MD$ES$ES
2238179810$22381798$10$F$20110101$20240722$20230530$20240726$EXP$$FR-BIOGEN-2023BI01207730$BIOGEN$$16$YR$$F$Y$67$KG$20240726$$LW$FR$FR
223818359$22381835$9$F$20230101$20240916$20230530$20240922$EXP$$US-ABBVIE-4749955$ABBVIE$$$$$M$Y$$$20240922$$CN$US$US
223819385$22381938$5$F$20220101$20240724$20230530$20240802$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2023-070892$REGENERON$$62$YR$$F$Y$$$20240802$$HP$CO$CO
223823113$22382311$3$F$$20240625$20230530$20240703$EXP$$NVSC2023CA122504$NOVARTIS$$77$YR$$F$Y$$$20240703$$CN$CA$CA
223824415$22382441$5$F$20230101$20240625$20230530$20240708$EXP$$US-MYLANLABS-2023M1055646$MYLAN$$50$YR$$M$Y$$$20240708$$CN$US$US
223824744$22382474$4$F$$20240821$20230530$20240828$EXP$$CA-GSK-CA2023AMR021892$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$PH$CA$CA
223825614$22382561$4$F$20230101$20240722$20230530$20240729$PER$$US-SA-2023SA164152$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240729$$MD$US$US
2238266311$22382663$11$F$20230428$20240904$20230530$20240911$EXP$$CA-GSK-CA2023064307$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$HP$CA$CA
223828602$22382860$2$F$20180101$20230517$20230530$20240925$EXP$HU-EGIS-HUN-2019-0039$HU-JUBILANT CADISTA PHARMACEUTICALS-2023HU000423$JUBILANT$$84$YR$$F$Y$$$20240925$$MD$HU$HU
223828613$22382861$3$F$$20230523$20230530$20240925$EXP$HU-EGIS-HUN-2019-0098$HU-JUBILANT CADISTA PHARMACEUTICALS-2023HU000429$JUBILANT$V?gh J, ?brah?m G, K?lm?n J, Z?llei M, Forster T. A hyponatraemia klinikai jelentos?ge.. Orvosi Hetilap. 2019;160(8):314-319$85$YR$$F$Y$$$20240925$$MD$HU$HU
223828682$22382868$2$F$$20230516$20230530$20240924$EXP$HU-KRKA-HU2022K14939LIT$HU-JUBILANT PHARMA LTD-2023HU000418$JUBILANT$Papp E. Therapeutic benefits related to the use of rilmenidine in everyday practice. METABOLISM. 2020;20(4):184-5$49$YR$$F$Y$$$20240924$$MD$HU$HU
223830107$22383010$7$F$$20240829$20230530$20240903$EXP$$US-PFIZER INC-US-GBT-021966$PFIZER$$30$YR$$M$Y$68.9$KG$20240903$$CN$US$US
223830414$22383041$4$F$20210101$20240808$20230530$20240812$EXP$$US-KYOWAKIRIN-2023BKK007790$KYOWA$$$$$$Y$$$20240812$$HP$US$US
223832682$22383268$2$F$$20240730$20230530$20240805$EXP$$CA-PFIZER INC-202300060517$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
223835313$22383531$3$F$$20230519$20230530$20240806$EXP$$US-TORRENT-00012689$TORRENT$$60$YR$A$M$Y$$$20240806$$HP$US$US
223835374$22383537$4$F$$20240705$20230530$20240715$EXP$$DE-INCYTE CORPORATION-2023IN005263$INCYTE$Kloehn J, Kruchen A, Schutze K, Wustrau K, Schrum J, Muller I.. Immune ablation and stem cell rescue in two pediatric patients with progressive severe chronic graft-versus-host disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022;23:15403$$$$$Y$$$20240715$$HP$DE$DE
223836862$22383686$2$F$$20240704$20230530$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388379$RANBAXY$Malhotra A, Pathak MA, Dalia T, Vidic A. Endomyocardial biopsy-proven hydroxychloroquine-induced cardiomyopathy in a patient with rheumatoid arthritis. BMJ Case Rep. 2023;16(4):no pagination/e252327$7$DEC$$F$Y$$$20240705$$HP$US$US
223836912$22383691$2$F$$20240814$20230530$20240826$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388607$RANBAXY$Verga S, Evans R, Underwood H, Nandavaram S. Alternaria in Lung Transplant: An Unusual Pathogen. J Heart Lung Transplant. 2023;42 (Suppl.)(4):S305/688$67$YR$$M$Y$$$20240826$$HP$US$US
223837092$22383709$2$F$20200101$20240721$20230530$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-391403$RANBAXY$Holzbauer SM, Schrodt CA, Prabhu RM, Asch-Kendrick RJ, Ireland M, Klumb C, et al. Fatal Human Rabies Infection with Suspected Host-mediated Failure of Post-Exposure Prophylaxis Following a Recognized Zoonotic Exposure-Minnesota, 2021. Clin Infect Dis. 2023;1-16$84$YR$$M$Y$$$20240727$$HP$US$US
223837102$22383710$2$F$$20240728$20230530$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-391622$RANBAXY$George B, Guglin M. Heart Failure With Severely Reduced Ejection Fraction Following Covid-19 Vaccine: A Case Series. J Card Fail. 2023;Apr;29(4):707-708 (392)$22$YR$$M$Y$$$20240809$$HP$US$US
223837322$22383732$2$F$$20240905$20230530$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392037$RANBAXY$Rojulpote C, Patil S, Vidula MK, Kotloff R, Prenner S, Bravo PE. Persistent FDG Uptake at Apical Aneurysm in a Patient With Cardiac Sarcoidosis. JACC: CASE REPORTS. 2023;MAR;15:101763$71$YR$$M$Y$$$20240913$$MD$US$US
223837412$22383741$2$F$$20240723$20230530$20240726$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-391879$RANBAXY$Grabanska-Martynska K, Korzeniowska K. Adverse effects of clonidine ? a case report and a review of the literature. Geriatria. 2023;17(1):27-31$84$YR$$F$Y$$$20240727$$HP$PL$PL
223841654$22384165$4$F$20240101$20240802$20230530$20240805$PER$$US-PFIZER INC-PV202300095138$PFIZER$$77$YR$$F$Y$$$20240805$$CN$US$US
223841923$22384192$3$F$20230516$20240219$20230530$20240906$PER$$US-FARMAPROD-202305-1498$DOMPE FARMACEUTICI$$75$YR$E$M$Y$83.91$KG$20240903$$CN$US$
223843443$22384344$3$F$$20240909$20230530$20240916$EXP$$DE-AKCEA THERAPEUTICS, INC.-2023IS001157$AKCEA THERAPEUTICS$$$$$$Y$$$20240912$$HP$DE$DE
223847694$22384769$4$F$20230101$20240924$20230530$20240927$PER$$US-PFIZER INC-202300199079$PFIZER$$75$YR$$F$Y$$$20240927$$HP$US$US
223847773$22384777$3$F$$20230524$20230530$20240925$EXP$$US-TAKEDA-2022TUS014442$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
223847906$22384790$6$F$$20240916$20230530$20240918$EXP$$CA-TAKEDA-2020TUS041838$TAKEDA$$$$$F$Y$$$20240918$$MD$CA$CA
223848569$22384856$9$F$20230518$20240902$20230530$20240909$EXP$$DE-TAKEDA-2023TUS050812$TAKEDA$$69$YR$$M$Y$$$20240909$$MD$DE$DE
223848979$22384897$9$F$20220228$20240912$20230530$20240919$EXP$$CA-TAKEDA-2022TUS008657$TAKEDA$$59$YR$$F$Y$$$20240919$$HP$CA$CA
223849762$22384976$2$F$$20240725$20230530$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04104$LUPIN$$$$$$Y$$$20240817$$CN$US$US
223850432$22385043$2$F$$20240807$20230530$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04125$LUPIN$$$$$$Y$$$20240831$$CN$US$US
223850652$22385065$2$F$$20240805$20230530$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04137$LUPIN$$$$$$Y$$$20240830$$CN$US$US
223850755$22385075$5$F$$20240725$20230530$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-011181$JAZZ$$$$$F$Y$$$20240730$$MD$US$US
223851132$22385113$2$F$20230301$20240823$20230530$20240823$EXP$FR-AFSSAPS-MP2023000707$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-240605$BOEHRINGER INGELHEIM$$85$YR$E$F$Y$$$20240823$$MD$FR$FR
223851456$22385145$6$F$20230705$20240719$20230530$20240723$EXP$$US-PFIZER INC-PV202200132439$PFIZER$$77$YR$$F$Y$62.6$KG$20240723$$CN$US$US
223851712$22385171$2$F$$20240710$20230530$20240718$EXP$$CA-TAKEDA-2023TUS051770$TAKEDA$$$$$M$Y$$$20240718$$CN$CA$CA
223852256$22385225$6$F$20230101$20240822$20230530$20240828$EXP$$US-PFIZER INC-202300171301$PFIZER$$45$YR$$F$Y$$$20240828$$HP$US$US
223853312$22385331$2$F$$20240812$20230530$20240814$PER$$US-PFIZER INC-PV202300093868$PFIZER$$72$YR$$M$Y$$$20240814$$CN$US$US
2238535710$22385357$10$F$20220101$20240905$20230530$20240909$EXP$$KR-JNJFOC-20220617860$JOHNSON AND JOHNSON$$4$YR$C$F$Y$$$20240910$$CN$KR$KR
223853612$22385361$2$F$$20240814$20230530$20240819$EXP$$CN-PFIZER INC-202300202629$PFIZER$Yin, W.. A case of septic shock due to delayed diagnosis of Cryptosporidium infection after liver transplantation. BMC Infectious Diseases. 2023;23(1):260$55$YR$$M$Y$$$20240819$$MD$CN$CN
223855496$22385549$6$F$$20240814$20230530$20240819$PER$$US-PFIZER INC-PV202300094087$PFIZER$$14$YR$$F$Y$$$20240819$$CN$US$US
223855879$22385587$9$F$20230324$20240910$20230530$20240917$EXP$$JP-AstraZeneca-2023A076414$ASTRAZENECA$$2$YR$$M$Y$$$20240917$$MD$JP$
223857015$22385701$5$F$20230525$20240819$20230530$20240822$EXP$$CA-TAKEDA-2023TUS052727$TAKEDA$$42$YR$$F$Y$$$20240822$$HP$CA$CA
223857167$22385716$7$F$$20240822$20230530$20240826$EXP$$NVSC2023US122728$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
223858692$22385869$2$F$$20240816$20230530$20240820$PER$$US-PFIZER INC-PV202300093172$PFIZER$$54$YR$$M$Y$$$20240820$$CN$US$US
223862395$22386239$5$F$20230101$20240911$20230530$20240918$EXP$$JP-009507513-2305JPN003010J$MERCK$$73$YR$$F$Y$$$20240918$$MD$JP$JP
223862514$22386251$4$F$20230517$20240918$20230530$20240925$PER$$NVSC2023US122118$NOVARTIS$$43$YR$$F$Y$$$20240925$$CN$US$US
223863314$22386331$4$F$20200901$20240913$20230530$20240918$EXP$$US-ABBVIE-5181280$ABBVIE$$58$YR$$F$Y$52$KG$20240918$$CN$US$US
223864552$22386455$2$F$$20230518$20230531$20240906$EXP$$CN-NOVOPROD-1066857$NOVO NORDISK$$61$YR$$F$Y$51.5$KG$20240906$$CN$CN$CN
223864992$22386499$2$F$$20240724$20230531$20240819$PER$$CA-TOLMAR, INC.-23CA040775$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
223865392$22386539$2$F$$20240911$20230531$20240920$EXP$$BR-CELLTRION INC.-2023BR005320$CELLTRION$$$$$$Y$$$20240920$$CN$BR$BR
223865403$22386540$3$F$20230421$20230523$20230531$20240809$EXP$$NVSC2023CN121566$NOVARTIS$$38$YR$$F$Y$55$KG$20240809$$HP$CN$CN
223866232$22386623$2$F$$20240918$20230531$20240930$PER$$NVSC2023US123890$NOVARTIS$$$$$M$Y$$$20240930$$HP$US$US
223866282$22386628$2$F$$20240729$20230531$20240802$PER$$US-AMGEN-USASP2023091245$AMGEN$Patel V.. Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis^. Dermatology and Therapy. 2024;14 (7):1891-1899$$$$$Y$$$20240802$$HP$US$US
223867546$22386754$6$F$20231201$20240711$20230531$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-076367$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240718$$CN$US$US
223868072$22386807$2$F$$20230517$20230531$20240925$EXP$HU-MYLANLABS-2022M1128361$HU-JUBILANT PHARMA LTD-2023HU000415$JUBILANT$Nagy V. Amikor a. When the hypertonia centrum can help. Hypertonia and Nephrology. 2022;34-35$77$YR$$F$Y$$$20240925$$MD$HU$HU
223869184$22386918$4$F$20230501$20230622$20230531$20240925$PER$$US-GSK-US2023AMR076184$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240925$$CN$US$US
223872022$22387202$2$F$20240620$20240621$20230531$20240701$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000469$DECIPHERA PHARMACEUTICALS$$74$YR$E$F$Y$92.2$KG$20240701$$CN$US$US
223873077$22387307$7$F$20220701$20240805$20230531$20240809$EXP$$DE-ROCHE-3249315$ROCHE$$60$YR$A$F$Y$$$20240809$$MD$DE$DE
223873342$22387334$2$F$20220328$20240627$20230531$20240702$EXP$$CA-TAKEDA-2022TUS022360$TAKEDA$$73$YR$$F$Y$$$20240702$$CN$CA$CA
223874464$22387446$4$F$20190919$20240827$20230531$20240906$EXP$$CA-ROCHE-2425094$ROCHE$$59$YR$A$F$Y$$$20240906$$CN$CA$CA
223874722$22387472$2$F$20180101$20240826$20230531$20240831$EXP$$BR-TAKEDA-2023TUS052235$TAKEDA$$$$$F$Y$$$20240831$$CN$BR$BR
223875382$22387538$2$F$20200901$20240627$20230531$20240712$EXP$$DE-ROCHE-2739662$ROCHE$$33$YR$A$F$Y$$$20240712$$MD$DE$DE
223875884$22387588$4$F$20210423$20240724$20230531$20240729$EXP$$CA-TAKEDA-2021TUS027001$TAKEDA$$49$YR$$M$Y$$$20240729$$MD$CA$CA
223876365$22387636$5$F$20220919$20240725$20230531$20240730$EXP$$NVSJ2023JP008418$NOVARTIS$$42$YR$$M$Y$70.9$KG$20240730$$MD$JP$JP
223876584$22387658$4$F$$20240920$20230531$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-076576$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240927$$MD$JP$JP
223876856$22387685$6$F$20230125$20240801$20230531$20240813$EXP$$CO-TAKEDA-2022TUS102519$TAKEDA$$47$YR$$F$Y$72$KG$20240813$$CN$CO$CO
223880282$22388028$2$F$$20240820$20230531$20240824$EXP$$CN-ROCHE-3353079$ROCHE$Tie X, Zhang Z, Zhou R, Li Y, Xu J and Yin W. A case of septic shock due to delayed diagnosis of Cryptosporidium infection after liver transplantation.DOI:10.1186/s12879-023-08252-6. BMC Infectious Diseases 2023;23.1:1-8.$55$YR$A$M$Y$$$20240824$$MD$CN$CN
223880713$22388071$3$F$20220207$20240819$20230531$20240827$EXP$$CA-CELLTRION INC.-2022CA005530$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
223881633$22388163$3$F$$20240709$20230531$20240718$PER$$US-SA-2023SA166143$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240718$$MD$US$US
2238820712$22388207$12$F$20220101$20240809$20230531$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-076715$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240814$$CN$US$US
223882662$22388266$2$F$$20240730$20230531$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04057$LUPIN$$$$$$Y$$$20240819$$PH$US$US
223883082$22388308$2$F$20230523$20230525$20230531$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202305015448$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240828$$CN$US$US
223883353$22388335$3$F$$20240805$20230531$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04114$LUPIN$$$$$$Y$$$20240822$$CN$US$US
223883485$22388348$5$F$20230101$20240724$20230531$20240821$PER$$US-AMGEN-USASP2023093060$AMGEN$$77$YR$E$F$Y$$$20240821$$PH$US$US
223883732$22388373$2$F$$20230525$20230531$20240913$PER$$NVSC2023US120885$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
223883805$22388380$5$F$20221221$20240816$20230531$20240822$EXP$IT-MINISAL02-926225$IT-VIIV HEALTHCARE LIMITED-IT2023075044$VIIV$$$$$$Y$$$20240822$$PH$IT$IT
2238838710$22388387$10$F$20231101$20240904$20230531$20240911$EXP$$CA-GSK-CA2023AMR060585$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$HP$CA$CA
223883992$22388399$2$F$$20230526$20230531$20240820$EXP$$US-JNJFOC-20230564564$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
223884086$22388408$6$F$20230425$20230922$20230531$20240711$PER$$JP-PFM-2023-03109$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.71$KG$20240711$$PH$JP$JP
223884267$22388426$7$F$20190723$20240723$20230531$20240726$EXP$$CA-TAKEDA-2019TUS050904$TAKEDA$$6$YR$$F$Y$49$KG$20240726$$MD$CA$CA
223885212$22388521$2$F$$20230517$20230531$20240925$EXP$HU-EGIS-HUN-2022-0930$HU-JUBILANT CADISTA PHARMACEUTICALS-2023HU000428$JUBILANT$Farkas H.. Meglep? k?resetek ? az ACE-g?tl?k ?lc?j?ban. AMEGA. 2022;(4):21-24$59$YR$$M$Y$$$20240925$$MD$HU$HU
223885692$22388569$2$F$$20230517$20230531$20240925$EXP$HU-ALVOGEN-2020-ALVOGEN-107614$HU-JUBILANT CADISTA PHARMACEUTICALS-2023HU000430$JUBILANT$Illes E.. Many lessons from the cases of fewer patients with multiple hypertension through the eyes of a neurologist.. Journal of Hungarian Family Physicians. 2019;5:13-14$75$YR$$F$Y$$$20240925$$MD$HU$HU
223887094$22388709$4$F$20230101$20240812$20230531$20240827$PER$$US-SA-2023SA165622$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240827$$CN$US$US
223888272$22388827$2$F$20221026$20240826$20230531$20240829$EXP$$JP-OTSUKA-2023_014148$OTSUKA$$94$YR$$M$Y$46.7$KG$20240829$$MD$JP$JP
223888572$22388857$2$F$20220826$20240826$20230531$20240828$EXP$$JP-OTSUKA-2023_014152$OTSUKA$$80$YR$$M$Y$44$KG$20240828$$MD$JP$JP
2238889611$22388896$11$F$20220629$20240910$20230531$20240916$EXP$$US-TAKEDA-2022TUS041288$TAKEDA$$24$YR$$F$Y$57$KG$20240916$$HP$US$US
223891068$22389106$8$F$20230801$20240903$20230531$20240905$EXP$$US-PFIZER INC-2019292030$PFIZER$$51$YR$$F$Y$$$20240905$$HP$US$US
223891085$22389108$5$F$20220630$20240823$20230531$20240829$EXP$$PL-PFIZER INC-202300203238$PFIZER$$67$YR$$F$Y$55$KG$20240829$$MD$PL$PL
223891492$22389149$2$F$$20240703$20230531$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-392158$RANBAXY$$$$$F$Y$$$20240703$$PH$GB$GB
223891522$22389152$2$F$$20240902$20230531$20240904$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392137$RANBAXY$Han J, Liu L, Meng L, Guo H, Zhang J, Han Z-Q, et al. Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies. Front Oncol. 2021;11759805$$$A$$Y$$$20240904$$HP$CN$CN
223891543$22389154$3$F$$20240902$20230531$20240904$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388412$RANBAXY$Hattori S, Kano Y, Ichikawa H, Muneoka Y, Ishikawa T, Ishikawa H, et al. A Case of Granulocyte Colony Stimulating Factor-Associated Aortitis during Neoadjuvant Chemotherapy for Esophageal Cancer. Jpn J Cancer Chemother. 2022;Dec; 49(13):1817-1819$71$YR$$M$Y$58$KG$20240904$$HP$JP$JP
223891692$22389169$2$F$$20240718$20230531$20240729$EXP$$CM-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-390869$RANBAXY$Mambap AT, Bechem E, Kan KM, Laah SN, Sunjoh F, Ashuntantang GE. Case report: 11 years on hemodialysis with a 4-year-old baby girl: A success story. Front Med. 2023;9:no pagination$29$YR$$F$Y$$$20240729$$HP$CM$CM
223892032$22389203$2$F$$20240709$20230531$20240710$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392135$RANBAXY$Miyauchi T, Kobayashi S, Yamamoto H., Fujimaru T, Taki F, Nagahama M et al. Simultaneous Serious Infection of Trichosporon asahii and Multi Drug Resistant Pseudomonas aeruginosa in Kidney Transplant Patient. J Am Soc Nephrol. 2016;27:1016A(PUB490)$83$YR$$M$Y$$$20240710$$HP$JP$JP
223892287$22389228$7$F$20230120$20240819$20230531$20240823$EXP$$CA-TAKEDA-2022TUS059961$TAKEDA$$56$YR$$F$Y$$$20240823$$PH$CA$CA
223892688$22389268$8$F$20221101$20240903$20230531$20240906$EXP$$US-PFIZER INC-US-GBT-020385$PFIZER$$9$YR$$F$Y$22.8$KG$20240906$$CN$US$US
223893543$22389354$3$F$$20230525$20230531$20240808$EXP$$US-OTSUKA-2023_013919$OTSUKA$Patel S, Gautam M, Sivananthan M.. Letter to the Editor: Protracted Neutropenia After Treatment With Non-Clozapine Antipsychotic Medications. J Clin Psychopharmacol. 2022;42(6):596-597$28$YR$$F$Y$$$20240808$$HP$US$US
223893654$22389365$4$F$$20230531$20230531$20240808$EXP$$US-OTSUKA-2023_013960$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
223893803$22389380$3$F$$20230525$20230531$20240808$EXP$$US-OTSUKA-2023_013987$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
223895323$22389532$3$F$$20240812$20230531$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04107$LUPIN$$$$$$Y$$$20240901$$CN$US$US
2238954112$22389541$12$F$20230523$20240812$20230531$20240816$EXP$$NVSC2023US120858$NOVARTIS$$56$YR$$F$Y$$$20240816$$CN$US$US
223895573$22389557$3$F$$20240909$20230531$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04156$LUPIN$$$$$$Y$$$20240923$$CN$US$US
223895923$22389592$3$F$$20240730$20230531$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04113$LUPIN$$$$$$Y$$$20240819$$CN$US$US
223896252$22389625$2$F$$20240806$20230531$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04160$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223896452$22389645$2$F$$20240730$20230531$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04161$LUPIN$$$$$$Y$$$20240821$$PH$US$US
223896884$22389688$4$F$$20230626$20230531$20240824$EXP$$US-TAKEDA-2023TUS053296$TAKEDA$$$$$F$Y$$$20240824$$CN$US$US
223896922$22389692$2$F$20230501$20240923$20230531$20240926$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2022-22839$IPSEN$$60$YR$A$M$Y$$$20240926$$HP$GB$GB
223896936$22389693$6$F$20230501$20240227$20230531$20240812$EXP$$NVSC2022PA037539$NOVARTIS$$72$YR$$M$Y$$$20240812$$CN$PA$PA
223897122$22389712$2$F$$20240809$20230531$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04164$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223897263$22389726$3$F$$20240806$20230531$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04169$LUPIN$$$$$$Y$$$20240829$$HP$US$US
223897462$22389746$2$F$$20240909$20230531$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04202$LUPIN$$$$$$Y$$$20240921$$CN$US$US
223897472$22389747$2$F$20230522$20240806$20230531$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04184$LUPIN$$$$$$Y$$$20240902$$HP$US$US
223897793$22389779$3$F$20230420$20240917$20230531$20240923$EXP$$BG-MYLANLABS-2023M1056566$MYLAN$$68$YR$$F$Y$96.8$KG$20240923$$HP$BG$BG
223898093$22389809$3$F$$20240806$20230531$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04194$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223898162$22389816$2$F$$20240730$20230531$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04203$LUPIN$$$$$$Y$$$20240819$$CN$US$US
223899618$22389961$8$F$$20240815$20230531$20240820$EXP$$CA-TAKEDA-2023TUS043368$TAKEDA$$$$$M$Y$$$20240820$$HP$CA$CA
223901263$22390126$3$F$20220101$20240918$20230531$20240920$PER$$US-PFIZER INC-PV202300094136$PFIZER$$20$YR$$M$Y$68$KG$20240920$$CN$US$US
223901324$22390132$4$F$20230701$20240918$20230531$20240920$PER$$US-PFIZER INC-PV202300094338$PFIZER$$83$YR$$F$Y$$$20240920$$CN$US$US
223901483$22390148$3$F$$20240830$20230531$20240903$EXP$$US-PFIZER INC-202300205424$PFIZER$Ali, S.. Testosterone Supplement-Induced Pancreatitis. American Journal of Gastroenterology. 2022;117 (10S):S1289$51$YR$$M$Y$$$20240903$$MD$US$US
223901805$22390180$5$F$$20240917$20230531$20240919$EXP$$US-PFIZER INC-202101866515$PFIZER$$61$YR$$F$Y$$$20240919$$CN$US$US
223902016$22390201$6$F$$20240920$20230531$20240920$PER$$US-PFIZER INC-PV202300094415$PFIZER$$72$YR$$F$Y$63.049$KG$20240920$$CN$US$US
223902046$22390204$6$F$$20240819$20230531$20240829$EXP$$CA-ORGANON-O2212CAN000978$ORGANON$$60$YR$$M$Y$$$20240829$$HP$CA$CA
223902575$22390257$5$F$$20240722$20230531$20240724$PER$$US-PFIZER INC-PV202300094696$PFIZER$$81$YR$$F$Y$$$20240724$$CN$US$US
223902865$22390286$5$F$20230101$20240611$20230531$20240903$PER$$US-KARYOPHARM-2023KPT001281$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
223903282$22390328$2$F$$20240805$20230531$20240806$PER$$US-PFIZER INC-PV202300096504$PFIZER$$64$YR$$F$Y$$$20240806$$CN$US$US
223904743$22390474$3$F$20140731$20240628$20230531$20240701$EXP$$ZA-PFIZER INC-202300207618$PFIZER$$50$YR$$F$Y$$$20240701$$MD$ZA$ZA
223905849$22390584$9$F$20211129$20240826$20230531$20240903$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-004009$AMGEN$$77$YR$E$F$Y$$$20240903$$MD$US$US
223906517$22390651$7$F$20230401$20240912$20230531$20240920$EXP$$CA-VER-202300201$VERITY PHARMACEUTICALS$$75$YR$E$M$Y$$$20240920$$CN$CA$CA
223907005$22390700$5$F$20220529$20240830$20230531$20240903$EXP$$NVSJ2023JP008483$NOVARTIS$$49$YR$$M$Y$53$KG$20240904$$MD$JP$JP
223907062$22390706$2$F$20230512$20240703$20230531$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-075292$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$72.12$KG$20240709$$CN$US$US
2239079814$22390798$14$F$20230101$20240906$20230531$20240916$EXP$$CA-CELLTRION INC.-2023CA011243$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
223908034$22390803$4$F$20220101$20240820$20230531$20240822$EXP$$US-ABBVIE-5185576$ABBVIE$$$$$M$Y$102.05$KG$20240822$$CN$US$US
223908315$22390831$5$F$20221201$20240813$20230531$20240820$EXP$$GB-ABBVIE-4268536$ABBVIE$$33$YR$$F$Y$$$20240820$$HP$GB$GB
223908625$22390862$5$F$20220815$20240916$20230601$20240924$EXP$$US-SA-2023SA165335$SANOFI AVENTIS$$20$YR$A$M$Y$63.5$KG$20240924$$MD$US$US
223909312$22390931$2$F$20230416$20240823$20230601$20240902$EXP$ES-AEMPS-1367906$ES-TEVA-2023-ES-2892158$TEVA$$79$YR$$M$Y$$$20240902$$MD$ES$ES
223909434$22390943$4$F$20231013$20240828$20230601$20240905$EXP$$IN-ROCHE-3256774$ROCHE$$61$YR$A$F$Y$$$20240905$$MD$IN$IN
223910132$22391013$2$F$20231107$20240508$20230601$20240819$EXP$$CA-CELLTRION INC.-2023CA010988$CELLTRION$$$$$$Y$$$20240819$$MD$CA$CA
223910493$22391049$3$F$20230522$20240806$20230601$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04110$LUPIN$$$$$$Y$$$20240827$$CN$US$US
223910633$22391063$3$F$20220901$20240711$20230601$20240716$EXP$$US-ABBVIE-5186092$ABBVIE$$26$YR$$M$Y$$$20240716$$CN$US$US
223910672$22391067$2$F$20230527$20240718$20230601$20240724$EXP$$US-ABBVIE-5186161$ABBVIE$$26$YR$$F$Y$$$20240724$$CN$US$US
223912852$22391285$2$F$20230401$20240806$20230601$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-075042$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$90.99$KG$20240812$$CN$US$US
223913446$22391344$6$F$20230530$20240906$20230601$20240920$EXP$$NL-ABBVIE-5186260$ABBVIE$$$$E$M$Y$$$20240920$$CN$NL$NL
223913712$22391371$2$F$$20240118$20230601$20240830$EXP$$NVSC2023TR121997$NOVARTIS$$$$$F$Y$52$KG$20240830$$MD$TR$TR
2239142310$22391423$10$F$20230521$20240325$20230601$20240925$EXP$$US-GSK-US2023AMR076512$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
223914342$22391434$2$F$$20240806$20230601$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04186$LUPIN$$$$$$Y$$$20240821$$CN$US$US
223915346$22391534$6$F$20230524$20240905$20230601$20240907$EXP$$NVSC2023CA122109$NOVARTIS$$56$YR$$M$Y$133.5$KG$20240908$$CN$CA$CA
223918762$22391876$2$F$$20240704$20230601$20240710$EXP$$JP-AMGEN-JPNSP2023091233$AMGEN$$$$$$Y$$$20240710$$MD$JP$JP
223919025$22391902$5$F$$20240918$20230601$20240925$PER$$NVSC2023US122114$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
223919413$22391941$3$F$20200408$20240802$20230601$20240816$EXP$$JP-ROCHE-2711816$ROCHE$Chiba K, Sato R, Sakuishi K, Shimura S, Hinata S, Ujino M and Okabayashi K. Hematologic malignancy cases with COVID-19 pneumonia refractory to standard antiviral therapy in our hospital. [abstract number: PP777].. The 64th Annual Meeting of the Japanese Respiratory Society.. 2024;$66$YR$E$M$Y$91$KG$20240816$$MD$JP$JP
223920833$22392083$3$F$$20240916$20230601$20240919$EXP$$CA-TAKEDA-2023TUS053215$TAKEDA$$$$$F$Y$$$20240919$$MD$CA$CA
2239211413$22392114$13$F$20220704$20240903$20230601$20240912$EXP$$DE-ROCHE-3136814$ROCHE$$53$YR$A$F$Y$$$20240912$$CN$DE$DE
223923474$22392347$4$F$20220419$20240828$20230601$20240830$EXP$$PL-ROCHE-3108211$ROCHE$$57$YR$A$F$Y$66$KG$20240830$$MD$PL$PL
223924845$22392484$5$F$20230522$20240724$20230601$20240802$PER$$US-SA-2023SA165383$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240802$$MD$US$US
223925134$22392513$4$F$20230526$20240809$20230601$20240820$PER$$US-SA-2023SA164237$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240820$$CN$US$US
223927003$22392700$3$F$$20240628$20230601$20240704$EXP$$BR-TAKEDA-2023TUS033994$TAKEDA$$$$$F$Y$$$20240704$$CN$BR$BR
223928672$22392867$2$F$$20240812$20230601$20240827$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392192$RANBAXY$Ouellette S, Frias G, Shah R, Alamgir M, Wassef C. Dermal Hypersensitivity Reaction to Semaglutide: two case reports. J Drugs Dermatol. 2023;Apr; 22(4):413-415/JO04022$75$YR$$F$Y$$$20240827$$HP$US$US
223929142$22392914$2$F$20221202$20230528$20230601$20240712$EXP$$BG-ASTELLAS-2023US016391$ASTELLAS$$65$YR$$M$Y$$$20240712$$MD$BG$BG
223929704$22392970$4$F$20230520$20240806$20230601$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04190$LUPIN$$$$$$Y$$$20240830$$CN$US$US
223929752$22392975$2$F$$20240719$20230601$20240729$EXP$$FR-TEVA-2023-FR-2891697$TEVA$$$$$F$Y$$$20240729$$MD$FR$FR
223929803$22392980$3$F$20230221$20240703$20230601$20240711$EXP$$DE-TEVA-2023-DE-2891512$TEVA$$55$YR$$F$Y$$$20240711$$MD$DE$DE
223931439$22393143$9$F$20230516$20240909$20230601$20240916$EXP$$US-GSK-US2023072938$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$US$US
223932696$22393269$6$F$20200401$20240912$20230601$20240916$EXP$AT-ROCHE-3358395$AT-ROCHE-3358395$ROCHE$$51$YR$A$M$Y$73$KG$20240916$$HP$AT$AT
2239336317$22393363$17$F$20230101$20240703$20230601$20240709$PER$$US-PFIZER INC-PV202300094389$PFIZER$$73$YR$$F$Y$$$20240709$$CN$US$US
223934133$22393413$3$F$$20230526$20230601$20240808$EXP$$US-OTSUKA-2023_014098$OTSUKA$$57$YR$$F$Y$$$20240808$$CN$US$US
2239350710$22393507$10$F$20230101$20240705$20230601$20240709$30DAY$$US-PFIZER INC-PV202300096519$PFIZER$$15$YR$$M$Y$$$20240709$$HP$US$US
223935767$22393576$7$F$20221221$20240816$20230601$20240823$EXP$IT-MINISAL02-926225$IT-JNJFOC-20230567669$JOHNSON AND JOHNSON$$51$YR$A$M$Y$127$KG$20240823$$PH$IT$IT
223936052$22393605$2$F$$20240626$20230601$20240708$PER$$US-SA-2023SA166975$SANOFI AVENTIS$$21$YR$A$F$Y$76.6$KG$20240708$$MD$US$US
223936492$22393649$2$F$$20240826$20230601$20240830$EXP$$US-PFIZER INC-PV202300096089$PFIZER$$67$YR$$F$Y$$$20240830$$CN$US$US
223937542$22393754$2$F$$20240705$20230601$20240709$EXP$$IT-PFIZER INC-202300205113$PFIZER$$$$$F$Y$$$20240709$$MD$IT$IT
223937685$22393768$5$F$20230605$20240822$20230601$20240826$EXP$$CA-TAKEDA-2023TUS052755$TAKEDA$$64$YR$$M$Y$$$20240826$$CN$CA$CA
2239383814$22393838$14$F$20230524$20240807$20230601$20240813$EXP$$CA-TAKEDA-2023TUS053313$TAKEDA$$73$YR$$M$Y$$$20240813$$HP$CA$CA
223938742$22393874$2$F$20230301$20240823$20230601$20240828$EXP$FR-AFSSAPS-MP2023000707$FR-PFIZER INC-202300206470$PFIZER$$85$YR$$F$Y$$$20240828$$MD$FR$FR
223938783$22393878$3$F$$20240911$20230601$20240912$EXP$$US-PFIZER INC-PV202300096549$PFIZER$$81$YR$$F$Y$$$20240912$$CN$US$US
223938953$22393895$3$F$20230530$20240723$20230601$20240802$PER$$US-SA-2023SA167518$SANOFI AVENTIS$$93$YR$E$M$Y$$$20240802$$MD$US$US
223940226$22394022$6$F$20220601$20240913$20230601$20240918$EXP$$US-ABBVIE-5187094$ABBVIE$$65$YR$$M$Y$108.86$KG$20240918$$CN$US$US
223940762$22394076$2$F$$20240730$20230601$20240805$EXP$$BR-TAKEDA-2023TUS054055$TAKEDA$$$$$F$Y$$$20240805$$CN$BR$BR
223940888$22394088$8$F$20230831$20240911$20230601$20240919$EXP$$CA-TAKEDA-2023TUS053631$TAKEDA$$18$YR$$M$Y$$$20240919$$MD$CA$CA
223942343$22394234$3$F$20240601$20240701$20230601$20240705$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-011430$JAZZ$$62$YR$$F$Y$$$20240705$$CN$US$US
223943956$22394395$6$F$$20240809$20230601$20240829$PER$$US-VERTEX PHARMACEUTICALS-2023-007799$VERTEX$$$$$$Y$$$20240829$$CN$DE$DE
223944008$22394400$8$F$20230531$20240724$20230601$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-077437$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240725$$CN$US$US
223944226$22394422$6$F$20230101$20240813$20230601$20240820$PER$$US-SA-2023SA165867$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240820$$MD$US$US
223945913$22394591$3$F$$20240805$20230601$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04134$LUPIN$$$$$$Y$$$20240828$$CN$US$US
223946202$22394620$2$F$20230528$20240925$20230601$20240927$EXP$$US-TAKEDA-2023TUS053959$TAKEDA$$20$YR$$F$Y$$$20240927$$HP$US$US
223947222$22394722$2$F$$20240806$20230601$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04172$LUPIN$$$$$$Y$$$20240829$$CN$US$US
223947252$22394725$2$F$20240301$20240628$20230601$20240708$30DAY$$US-GSK-US2023076700$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240708$$CN$US$US
2239478612$22394786$12$F$$20240923$20230601$20240925$PER$$US-PFIZER INC-202300135789$PFIZER$$87$YR$$F$Y$$$20240925$$CN$US$US
223948463$22394846$3$F$$20240627$20230601$20240701$PER$$US-PFIZER INC-PV202300097630$PFIZER$$63$YR$$M$Y$$$20240701$$HP$US$US
223948564$22394856$4$F$20230213$20240822$20230601$20240828$EXP$$US-PFIZER INC-PV202300096431$PFIZER$$64$YR$$F$Y$$$20240828$$HP$US$US
223949495$22394949$5$F$20221214$20240712$20230601$20240716$EXP$$CA-PFIZER INC-202201270027$PFIZER$$68$YR$$F$Y$53$KG$20240716$$MD$CA$CA
223950424$22395042$4$F$20230501$20240912$20230601$20240916$PER$$US-PFIZER INC-PV202300096601$PFIZER$$50$YR$$F$Y$$$20240916$$HP$US$US
223951452$22395145$2$F$$20240827$20230601$20240903$EXP$$CA-FreseniusKabi-FK202307151$FRESENIUS KABI$$16$YR$T$F$Y$49$KG$20240903$$PH$CA$CA
223952242$22395224$2$F$20170101$20240715$20230601$20240717$EXP$$ZA-PFIZER INC-PV202300095482$PFIZER$$67$YR$$F$Y$52$KG$20240717$$MD$ZA$ZA
223953522$22395352$2$F$$20240709$20230601$20240715$EXP$$GR-PFIZER INC-202300205211$PFIZER$$$$$F$Y$$$20240715$$MD$GR$GR
223953872$22395387$2$F$$20240628$20230601$20240702$EXP$$CA-TAKEDA-2023TUS053852$TAKEDA$O^Brien TM. Acute eosinophilic pneumonia-like syndrome post-initiation of vortioxetine. Drug and Therapeutics Bulletin. 2024;e254254$4$DEC$$M$Y$$$20240702$$$COUNTRY NOT SPECIFIED$CA
2239559011$22395590$11$F$$20240709$20230601$20240718$EXP$$US-Taiho Oncology Inc-2023-004275$TAIHO ONCOLOGY INC$$$$A$M$Y$$$20240718$$CN$US$US
223962285$22396228$5$F$20230101$20240628$20230601$20240704$EXP$$JP-009507513-2305JPN003405J$MERCK$$7$DEC$$M$Y$$$20240704$$MD$JP$JP
223968274$22396827$4$F$$20240819$20230601$20240826$EXP$$JP-009507513-2304JPN002171J$MERCK$$5$DEC$$F$Y$$$20240826$$MD$JP$JP
223968336$22396833$6$F$20230501$20240617$20230601$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-001757$ACADIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240712$$CN$US$US
223968507$22396850$7$F$20240124$20240815$20230601$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-077351$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240826$$CN$US$US
223970712$22397071$2$F$20220101$20240820$20230602$20240826$EXP$$US-ABBVIE-5187501$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
2239714316$22397143$16$F$20230511$20240722$20230602$20240725$EXP$$CO-Ipsen Biopharmaceuticals, Inc.-2023-12985$IPSEN$$73$YR$E$F$Y$54$KG$20240725$$CN$CO$CO
223972172$22397217$2$F$20221101$20240822$20230602$20240831$EXP$FR-AFSSAPS-NY2023000625$FR-TEVA-2023-FR-2892739$TEVA$$64$YR$$M$Y$93$KG$20240831$$MD$FR$FR
223972194$22397219$4$F$$20240816$20230602$20240826$EXP$NL-LRB-00880148$NL-TEVA-2023-NL-2892520$TEVA$$74$YR$$M$Y$$$20240826$$MD$NL$NL
223972804$22397280$4$F$20210816$20240712$20230602$20240722$EXP$$CA-CELLTRION INC.-2021CA012699$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
223973017$22397301$7$F$$20240911$20230602$20240919$EXP$$IN-ROCHE-3283338$ROCHE$$73$YR$E$M$Y$$$20240919$$MD$IN$IN
223973055$22397305$5$F$20230101$20240822$20230602$20240828$EXP$$CA-JNJFOC-20230559555$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240828$$PH$CA$CA
223975006$22397500$6$F$20230831$20240613$20230602$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001815$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240708$$CN$US$US
223977072$22397707$2$F$20240601$20240822$20230602$20240917$PER$$US-SA-2023SA167230$SANOFI AVENTIS$$10$YR$C$F$Y$25.58$KG$20240918$$MD$US$US
223981282$22398128$2$F$$20240725$20230602$20240726$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392574$RANBAXY$Radhakrishnan VS, Modak K, Bhave SJ, Kumar J, Roychowdhury M, Ghosh M, et al. Inotuzumab Ozogamicin Monotherapy as an Outpatient Salvage Treatment in Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia: Compassionate Access. Indian J Med Pediatr Oncol. 2021;42(2):199-203$23$YR$$M$Y$$$20240727$$MD$IN$IN
223982302$22398230$2$F$20220328$20240709$20230602$20240718$PER$$US-APOTEX-2023AP008533$APOTEX$Kabir KF, Gaddapati H, Singla V. A Rare Case of Leflunomide-Induced Colitis: Clinical, Endoscopic and Microscopic Findings. American Journal of Gastroenterology. 2022;117(S2)(10):S1362$79$YR$$F$Y$$$20240718$$MD$US$US
2239840521$22398405$21$F$20230101$20240920$20230602$20240930$EXP$$CA-CELLTRION INC.-2023CA009458$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
223984612$22398461$2$F$$20240910$20230602$20240910$EXP$$PT-ROCHE-3359586$ROCHE$$67$YR$E$F$Y$$$20240910$$MD$PT$PT
223986112$22398611$2$F$20230505$20240703$20230602$20240716$PER$$US-SA-2023SA168347$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240716$$MD$US$US
223986995$22398699$5$F$20240101$20240827$20230602$20240903$EXP$$CA-GSK-CA2023076636$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$HP$CA$CA
223987065$22398706$5$F$20230101$20240813$20230602$20240827$PER$$US-SA-2023SA168190$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240827$$MD$US$US
223987434$22398743$4$F$20230601$20240522$20230602$20240918$EXP$$DE-LEO Pharma-352536$LEO PHARM$$66$YR$$F$Y$60$KG$20240918$$MD$DE$DE
223987953$22398795$3$F$$20240925$20230602$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-076464$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240927$$CN$US$US
223988003$22398800$3$F$20230512$20240703$20230602$20240802$PER$$CA-TOLMAR, INC.-23CA040900$TOLMAR$$67$YR$$M$Y$$$20240802$$CN$CA$CA
223989624$22398962$4$F$$20240909$20230602$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04175$LUPIN$$$$$$Y$$$20240925$$CN$US$US
223990794$22399079$4$F$20220122$20240822$20230602$20240823$EXP$$JP-ABBVIE-5188987$ABBVIE$$64$YR$$M$Y$70$KG$20240823$$MD$JP$JP
223991363$22399136$3$F$$20240807$20230602$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04179$LUPIN$$$$$$Y$$$20240829$$CN$US$US
223991493$22399149$3$F$$20240813$20230602$20240816$EXP$$US-TAKEDA-2023TUS033064$TAKEDA$$$$$M$Y$53.52$KG$20240816$$CN$US$US
223991512$22399151$2$F$$20240807$20230602$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04178$LUPIN$$$$$$Y$$$20240901$$CN$US$US
223993014$22399301$4$F$20230516$20240821$20230602$20240824$PER$$US-AMGEN-USASP2023095046$AMGEN$$75$YR$E$F$Y$$$20240824$$CN$US$US
223993247$22399324$7$F$20231110$20240725$20230602$20240731$EXP$$CA-TAKEDA-2023TUS013433$TAKEDA$$60$YR$$M$Y$$$20240731$$CN$CA$CA
223993672$22399367$2$F$$20240725$20230602$20240726$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-391837$RANBAXY$Dembowska-Baginska B, Rutynowska O, Stypinska M, Maldyk J, Kalicinski P. Plasmoblastic lymphoma (PBL) following liver transplantation. Report on 2 pediatric patients. Leuk Res. 2022;121(Suppl.):S52-S53$2$YR$$M$Y$$$20240727$$HP$PL$PL
223993853$22399385$3$F$20230504$20230615$20230602$20240711$EXP$$CZ-ASTELLAS-2023US016549$ASTELLAS$$43$YR$$F$Y$$$20240711$$HP$CZ$CZ
223994863$22399486$3$F$20211201$20240913$20230602$20240927$EXP$$FR-SERVIER-S23005685$SERVIER$$$$$$Y$$$20240927$$MD$FR$FR
223995563$22399556$3$F$$20240909$20230602$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04253$LUPIN$$$$$$Y$$$20240923$$CN$US$US
2239955911$22399559$11$F$20230526$20240911$20230602$20240924$EXP$$US-MYOVANT SCIENCES GMBH-2023MYSCI0500810$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
223996144$22399614$4$F$20190501$20240806$20230602$20240812$EXP$$FR-PFIZER INC-202300205260$PFIZER$$44$YR$$F$Y$$$20240812$$LW$FR$FR
223996586$22399658$6$F$$20240904$20230602$20240909$EXP$$US-TAKEDA-2023TUS016721$TAKEDA$$$$$F$Y$76$KG$20240909$$CN$US$US
223996819$22399681$9$F$20231121$20240821$20230602$20240828$EXP$$IN-PFIZER INC-PV202300095694$PFIZER$$33$YR$$M$Y$$$20240828$$CN$IN$IN
223997722$22399772$2$F$$20240926$20230602$20240930$EXP$$US-PFIZER INC-PV202300096698$PFIZER$$64$YR$$F$Y$$$20240930$$CN$US$US
223998023$22399802$3$F$$20240827$20230602$20240830$EXP$$US-PFIZER INC-PV202300096477$PFIZER$$70$YR$$F$Y$$$20240830$$HP$US$US
223998903$22399890$3$F$$20240909$20230602$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04248$LUPIN$$$$$$Y$$$20240924$$CN$US$US
223999749$22399974$9$F$20230101$20240712$20230602$20240722$EXP$$US-TEVA-2023-US-2892166$TEVA$$70$YR$$M$Y$$$20240722$$CN$US$US
224000832$22400083$2$F$20230527$20230530$20230602$20240926$PER$$US-ABBVIE-5188723$ABBVIE$$71$YR$$M$Y$$$20240926$$CN$US$US
224000994$22400099$4$F$$20240805$20230602$20240811$EXP$$US-SA-2023SA169221$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240811$$MD$US$US
224001254$22400125$4$F$$20240809$20230602$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04250$LUPIN$$$$$$Y$$$20240830$$CN$US$US
224001384$22400138$4$F$20230501$20240903$20230602$20240905$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-011680$JAZZ$$27$YR$$M$Y$$$20240905$$MD$US$US
224002853$22400285$3$F$$20240726$20230602$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04272$LUPIN$$$$$$Y$$$20240817$$CN$US$US
224003084$22400308$4$F$$20240906$20230602$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202306000523$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240912$$CN$US$US
224003453$22400345$3$F$20230417$20240621$20230602$20240701$EXP$$DE-PUMA BIOTECHNOLOGY, INC.-2023-PUM-DE000875$PUMA$$$$$$Y$$$20240701$$HP$DE$DE
2240038115$22400381$15$F$20230401$20240630$20230602$20240704$EXP$$US-GSK-US2023AMR074703$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$MD$US$US
224008017$22400801$7$F$20230601$20240723$20230602$20240726$PER$$US-PFIZER INC-PV202300097632$PFIZER$$11$YR$$F$Y$$$20240726$$CN$US$US
2240080212$22400802$12$F$20240108$20240723$20230602$20240726$PER$$US-PFIZER INC-PV202300097437$PFIZER$$79$YR$$F$Y$58.05$KG$20240726$$CN$US$US
224008153$22400815$3$F$$20240729$20230602$20240801$EXP$$US-PFIZER INC-202300207141$PFIZER$$81$YR$$M$Y$89.36$KG$20240801$$CN$US$US
224008282$22400828$2$F$$20240806$20230602$20240809$EXP$$US-PFIZER INC-PV202300089616$PFIZER$$85$YR$$M$Y$$$20240809$$CN$US$US
225164312$22516431$2$F$20230401$20240730$20230602$20240802$EXP$$GR-ROCHE-3359178$ROCHE$$49$YR$A$F$Y$$$20240802$$MD$GR$GR
225164398$22516439$8$F$20201222$20240627$20230602$20240705$EXP$$CA-CELLTRION INC.-2022CA021449$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
225165053$22516505$3$F$$20240724$20230603$20240806$EXP$$CA-AUROBINDO-AUR-APL-2023-039139$AUROBINDO$$64$YR$$M$Y$121$KG$20240806$$HP$CA$CA
225165183$22516518$3$F$$20240725$20230603$20240806$EXP$$CA-AUROBINDO-AUR-APL-2023-039155$AUROBINDO$$70$YR$$F$Y$$$20240806$$MD$CA$CA
225168074$22516807$4$F$20230501$20240821$20230603$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2023-015427$UNITED THERAPEUTICS$$87$YR$$M$Y$95.238$KG$20240828$$$US$US
225168703$22516870$3$F$$20240724$20230603$20240805$EXP$$CA-AUROBINDO-AUR-APL-2023-039116$AUROBINDO$$62$YR$$F$Y$$$20240805$$HP$CA$CA
225171538$22517153$8$F$$20240715$20230603$20240723$EXP$$ES-AUROBINDO-AUR-APL-2023-039393$AUROBINDO$C. Espinos Ramirez, A. Artigas Soler, P. Gil Esteller, N. Garcia Medina, J. Tangarife Benjumea y M. Martinez Garcia. Refractory hypotension secondary to chronic treatment with high doses of quetiapine.. Rev Esp Anestesiol Reanim (Engl Ed).. 2023;S2341-1929(23)0:00089-6$71$YR$$M$Y$$$20240719$$MD$ES$ES
225172982$22517298$2$F$20230101$20240826$20230603$20240905$PER$$US-AstraZeneca-2023A126802$ASTRAZENECA$$66$YR$$F$Y$$$20240905$$CN$US$
225174002$22517400$2$F$$20240912$20230603$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387757$RANBAXY$Kuribayashi A, Kawashima S, Kayamori K, Sakamoto J, Tomisato H, Watanabe H, et al. Magnetic resonance imaging of methotrexate-related lymphoproliferative disorder with a chief complaint of oral symptoms. Oral Radiol. 2023;39(2):235-241$53$YR$$F$Y$$$20240927$$HP$JP$JP
225174012$22517401$2$F$$20240912$20230603$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387756$RANBAXY$Kuribayashi A, Kawashima S, Kayamori K, Sakamoto J, Tomisato H, Watanabe H, et al. Magnetic resonance imaging of methotrexate-related lymphoproliferative disorder with a chief complaint of oral symptoms. Oral Radiol. 2023;39(2):235-241$65$YR$$F$Y$$$20240927$$HP$JP$JP
225174033$22517403$3$F$$20240703$20230603$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-392661$RANBAXY$$$$$M$Y$$$20240703$$PH$GB$GB
225174133$22517413$3$F$$20240710$20230603$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392333$RANBAXY$Sindu D, Tokman S, Mcanally K, Walia R, Mohamed H, Abdelrazek H, et al. Thoracic Capnocytophaga Infection in a Lung Transplant Recipient. J Heart Lung Transplant. 2023;Apr; 42(4S):S303(684)$72$YR$$M$Y$$$20240711$$HP$US$US
225175283$22517528$3$F$$20240903$20230604$20240913$EXP$$IT-AUROBINDO-AUR-APL-2023-039754$AUROBINDO$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox?Gastaut Syndrome: A Case Series. Journal of Clinical Medicine. 2023;12(1):129$29$YR$$M$Y$$$20240913$$HP$IT$IT
225176405$22517640$5$F$20230222$20240911$20230604$20240923$EXP$$DE-AUROBINDO-AUR-APL-2023-039557$AUROBINDO$$76$YR$$M$Y$94.6$KG$20240923$$MD$DE$DE
225176783$22517678$3$F$20171218$20240906$20230604$20240910$EXP$$CA-TAKEDA-2018TUS012813$TAKEDA$$64$YR$$F$Y$$$20240910$$CN$CA$CA
225176796$22517679$6$F$20211230$20240924$20230604$20240930$EXP$$US-TAKEDA-US202029047$TAKEDA$$73$YR$$F$Y$46$KG$20240930$$HP$US$US
225179744$22517974$4$F$20240101$20240806$20230605$20240827$PER$$AU-TOLMAR, INC.-23AU040821$TOLMAR$$$$$M$Y$$$20240827$$CN$AU$AU
225179762$22517976$2$F$20230927$20240807$20230605$20240815$PER$$CA-TOLMAR, INC.-23CA040913$TOLMAR$$70$YR$$M$Y$$$20240815$$CN$CA$CA
225180172$22518017$2$F$$20240729$20230605$20240808$EXP$$CA-AUROBINDO-AUR-APL-2023-039547$AUROBINDO$Greenway K, Garel N, Goyette N, Turecki G, Richard-Devantoy S.. Adjunctive music improves the tolerability of intravenous ketamine for bipolar depression. International Clinical Psychopharmacology. 2021;36(4):218-220$41$YR$$F$Y$$$20240808$$HP$CA$CA
2251808018$22518080$18$F$20230101$20240822$20230605$20240906$EXP$$JP-AMGEN-JPNSP2023094730$AMGEN$Shirai T, Shirota S, Mori K, Inoue J, Sato H, Ishii T. Comment on: A case of vanishing bile duct syndrome during treatment of microscopic polyangiitis with avacopan. Rheumatology. 2023;1-7.$70$YR$E$F$Y$36$KG$20240905$$MD$JP$JP
225183324$22518332$4$F$$20240803$20230605$20240809$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000484$DECIPHERA PHARMACEUTICALS$$80$YR$E$M$Y$$$20240809$$CN$US$US
225183667$22518366$7$F$20230502$20240704$20230605$20240715$EXP$$CA-ROCHE-3358810$ROCHE$$31$YR$A$F$Y$$$20240715$$CN$CA$CA
225184705$22518470$5$F$$20231128$20230605$20240925$PER$$US-GSK-US2023AMR077900$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
225185629$22518562$9$F$20230531$20240911$20230605$20240912$PER$$US-AMGEN-USASP2023095564$AMGEN$$62$YR$A$M$Y$96.599$KG$20240912$$MD$US$US
225186902$22518690$2$F$20230601$20240814$20230605$20240824$30DAY$$US-GSK-US2023077680$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240824$$MD$US$US
225187392$22518739$2$F$$20240812$20230605$20240816$PER$$US-JNJFOC-20230567666$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$US$US
225188068$22518806$8$F$20230524$20240923$20230605$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-078305$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240925$$CN$US$US
2251881718$22518817$18$F$20230101$20240916$20230605$20240924$EXP$$CA-CELLTRION INC.-2023CA007214$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
2251884214$22518842$14$F$20230101$20240827$20230605$20240904$EXP$$CA-CELLTRION INC.-2023CA011466$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
225189754$22518975$4$F$20230101$20240717$20230605$20240723$EXP$$CA-JNJFOC-20230343403$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240723$$HP$CA$CA
225189813$22518981$3$F$20230401$20240829$20230605$20240904$EXP$$GR-AMGEN-GRCSP2023094128$AMGEN$$49$YR$A$F$Y$$$20240904$$MD$GR$GR
225191883$22519188$3$F$20230122$20240827$20230605$20240829$EXP$$US-ROCHE-3359710$ROCHE$$50$YR$A$M$Y$$$20240829$$CN$US$US
225193647$22519364$7$F$20240201$20240918$20230605$20240925$EXP$$CA-GSK-CA2023077189$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$CA$CA
225196283$22519628$3$F$20230401$20240805$20230605$20240814$PER$$US-SA-2023SA170247$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240814$$MD$US$US
225196952$22519695$2$F$$20240702$20230605$20240712$PER$$US-SA-2023SA170359$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240712$$CN$US$US
225198372$22519837$2$F$$20240628$20230605$20240709$PER$$US-SA-2023SA170118$SANOFI AVENTIS$$51$YR$A$M$Y$77.111$KG$20240709$$MD$US$US
225201003$22520100$3$F$$20240806$20230605$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04245$LUPIN$$$$$$Y$$$20240827$$CN$US$US
225201622$22520162$2$F$20200116$20240916$20230605$20240925$EXP$$US-MYLANLABS-2023M1057534$MYLAN$$86$YR$$F$Y$67.58$KG$20240925$$LW$US$US
225202163$22520216$3$F$$20240809$20230605$20240813$EXP$$CA-TAKEDA-2022TUS057095$TAKEDA$$$$$F$Y$$$20240813$$CN$CA$CA
225202932$22520293$2$F$$20240730$20230605$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04252$LUPIN$$$$$$Y$$$20240820$$CN$US$US
225204226$22520422$6$F$20210330$20240731$20230605$20240806$EXP$$JP-ABBVIE-5189339$ABBVIE$$79$YR$$M$Y$40.4$KG$20240806$$MD$JP$JP
225207233$22520723$3$F$20230904$20240717$20230605$20240722$EXP$$US-PFIZER INC-PV202300098247$PFIZER$$89$YR$$M$Y$68.9$KG$20240722$$CN$US$US
2252077517$22520775$17$F$$20240913$20230605$20240920$EXP$$PT-ELI_LILLY_AND_COMPANY-PT202305017221$ELI LILLY AND CO$$$$E$$Y$$$20240920$$MD$PT$PT
225207883$22520788$3$F$$20240726$20230605$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04299$LUPIN$$$$$$Y$$$20240816$$CN$US$US
225208202$22520820$2$F$$20240726$20230605$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04300$LUPIN$$$$$$Y$$$20240816$$CN$US$US
225208767$22520876$7$F$20230406$20240725$20230605$20240731$EXP$$CA-TAKEDA-2022TUS090980$TAKEDA$$34$YR$$F$Y$$$20240731$$MD$CA$CA
225209329$22520932$9$F$20220907$20240912$20230605$20240916$EXP$$CO-TAKEDA-2021TUS001346$TAKEDA$$66$YR$$F$Y$52$KG$20240916$$PH$CO$CO
225210443$22521044$3$F$20230601$20240717$20230605$20240723$EXP$$BR-TAKEDA-2023TUS055217$TAKEDA$$58$YR$$F$Y$$$20240723$$CN$BR$BR
225211748$22521174$8$F$$20240808$20230605$20240814$EXP$$US-TAKEDA-2023TUS055151$TAKEDA$$$$$F$Y$54$KG$20240814$$CN$US$US
225212615$22521261$5$F$20230519$20240916$20230605$20240917$EXP$$US-TAKEDA-2023TUS055059$TAKEDA$$31$YR$$M$Y$$$20240917$$CN$US$US
225213015$22521301$5$F$20230801$20240815$20230605$20240821$EXP$$US-PFIZER INC-PV202300048481$PFIZER$$71$YR$$F$Y$$$20240821$$HP$US$US
225213479$22521347$9$F$20231008$20240708$20230605$20240712$EXP$$US-TAKEDA-2023TUS045497$TAKEDA$$78$YR$$M$Y$90$KG$20240712$$HP$US$US
225214455$22521445$5$F$$20240909$20230605$20240912$PER$$US-PFIZER INC-202300209106$PFIZER$$68$YR$$F$Y$45.36$KG$20240912$$CN$US$US
225215074$22521507$4$F$$20240730$20230605$20240802$PER$$US-PFIZER INC-US-GBT-013642$PFIZER$$16$YR$$F$Y$49.8$KG$20240802$$CN$US$US
225216177$22521617$7$F$$20240802$20230605$20240807$PER$$US-PFIZER INC-PV202300012537$PFIZER$$78$YR$$F$Y$$$20240807$$HP$US$US
225217958$22521795$8$F$$20240419$20230605$20240812$EXP$$NVSC2023US125446$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
225218204$22521820$4$F$$20240916$20230605$20240918$PER$$NVSC2023US122385$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
225218543$22521854$3$F$$20240807$20230605$20240809$PER$$NVSC2023US125652$NOVARTIS$$$$$M$Y$$$20240809$$HP$US$US
2252186423$22521864$23$F$20221005$20240806$20230605$20240828$EXP$$NVSC2022TW255189$NOVARTIS$$30$YR$$F$Y$87$KG$20240828$$MD$TW$TW
225219094$22521909$4$F$$20240927$20230605$20240930$EXP$$NVSC2023CA125767$NOVARTIS$$3$YR$$F$Y$64$KG$20240930$$CN$CA$CA
225219733$22521973$3$F$20230522$20240823$20230605$20240826$PER$$NVSC2023US124850$NOVARTIS$$65$YR$$F$Y$$$20240826$$CN$US$US
225219972$22521997$2$F$$20230601$20230605$20240920$PER$$NVSC2023US126331$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
225221973$22522197$3$F$$20240629$20230605$20240708$EXP$$NVSC2023AU124520$NOVARTIS$Morton A. Low haptoglobin and a positive direct antiglobulin test without haemolysis in pregnancy. OBSTETRIC MEDICINE. 2022;15(4):280-2$29$YR$$F$Y$$$20240708$$HP$AU$AU
225221992$22522199$2$F$$20240629$20230605$20240702$EXP$$NVSC2023AU124522$NOVARTIS$Morton A. Low haptoglobin and a positive direct antiglobulin test without haemolysis in pregnancy. OBSTETRIC MEDICINE. 2022;15 (4):280-2$$$N$$Y$$$20240702$$HP$AU$AU
225222126$22522212$6$F$20240601$20240719$20230605$20240809$EXP$$NVSC2021DO228530$NOVARTIS$$49$YR$$F$Y$$$20240809$$CN$DO$DO
225222503$22522250$3$F$$20240918$20230605$20240930$PER$$NVSC2023US126670$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
225223316$22522331$6$F$20150501$20231005$20230605$20240912$EXP$$NVSC2023US123528$NOVARTIS$$45$YR$$F$Y$$$20240912$$CN$US$US
225223737$22522373$7$F$20230501$20240305$20230605$20240807$EXP$$NVSC2023US124685$NOVARTIS$$76$YR$$F$Y$$$20240807$$CN$US$US
225224536$22522453$6$F$20230522$20240816$20230605$20240821$EXP$$NVSC2023US127070$NOVARTIS$$74$YR$$F$Y$$$20240821$$CN$US$US
225224612$22522461$2$F$$20240814$20230605$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2023-000903$BLUEPRINT MEDICINES$$$$A$$Y$$$20240823$$MD$CN$CN
225224673$22522467$3$F$20170901$20240806$20230605$20240812$EXP$$NVSC2023CA123850$NOVARTIS$$54$YR$$F$Y$$$20240812$$MD$CA$CA
225225882$22522588$2$F$$20230531$20230605$20240904$EXP$$NVSC2023CN126728$NOVARTIS$$$$$$Y$$$20240904$$MD$CN$CN
225226846$22522684$6$F$$20240820$20230605$20240822$EXP$$NVSC2023US124647$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
225227376$22522737$6$F$20230101$20240909$20230605$20240915$EXP$$US-ABBVIE-5276186$ABBVIE$$$$$F$Y$54.431$KG$20240915$$CN$US$US
225229235$22522923$5$F$20230608$20240906$20230606$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-076581$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240913$$CN$US$US
225230353$22523035$3$F$20230809$20240913$20230606$20240919$EXP$$US-ABBVIE-5276264$ABBVIE$$72$YR$$F$Y$$$20240919$$CN$US$US
225233902$22523390$2$F$$20240628$20230606$20240702$EXP$$JP-TAKEDA-2023TJP007074$TAKEDA$$80$YR$$M$Y$$$20240702$$MD$JP$JP
225234213$22523421$3$F$20230414$20240920$20230606$20240923$EXP$$BE-ROCHE-3361560$ROCHE$$32$YR$A$F$Y$60.5$KG$20240923$$MD$BE$BE
225236503$22523650$3$F$20230605$20240729$20230606$20240801$PER$$US-AMGEN-USASP2023096871$AMGEN$$74$YR$E$F$Y$$$20240801$$CN$US$US
225237532$22523753$2$F$20230528$20240723$20230606$20240802$30DAY$$US-GSK-US2023076630$GLAXOSMITHKLINE$$66$YR$$M$Y$$$20240802$$HP$US$US
225241145$22524114$5$F$20230524$20230718$20230606$20240925$PER$$US-GSK-US2023AMR077524$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240925$$CN$US$US
225241353$22524135$3$F$$20240709$20230606$20240712$EXP$$GB-AMGEN-GBRSL2023095958$AMGEN$$70$YR$E$F$Y$$$20240712$$CN$GB$GB
225241914$22524191$4$F$20220107$20240916$20230606$20240928$EXP$$DE-TAKEDA-2022TUS013175$TAKEDA$$56$YR$$F$Y$$$20240928$$CN$DE$DE
2252419411$22524194$11$F$$20240715$20230606$20240719$EXP$$US-TAKEDA-2023TUS044302$TAKEDA$$$$$F$Y$$$20240719$$MD$US$US
225242034$22524203$4$F$$20240920$20230606$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-077190$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$MD$JP$JP
225242693$22524269$3$F$$20240719$20230606$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-079204$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$51.26$KG$20240722$$CN$US$US
225242793$22524279$3$F$$20240802$20230606$20240816$EXP$$CA-AUROBINDO-AUR-APL-2023-040393$AUROBINDO$$89$YR$$M$Y$$$20240816$$PH$CA$CA
225242932$22524293$2$F$$20240730$20230606$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04340$LUPIN$$$$$$Y$$$20240818$$PH$US$US
225243084$22524308$4$F$$20240709$20230606$20240718$EXP$$US-INSMED, INC.-2023-01957-US$INSMED$$$$$F$Y$$$20240718$$CN$US$US
225243487$22524348$7$F$20171116$20240920$20230606$20240927$EXP$$CO-TAKEDA-2018TUS012049$TAKEDA$$55$YR$$F$Y$88$KG$20240927$$HP$CO$CO
225244203$22524420$3$F$20230710$20240801$20230606$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-079243$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240806$$CN$US$US
225244433$22524443$3$F$20240401$20240711$20230606$20240723$EXP$$US-EMD Serono-9373352$EMD SERONO INC$$65$YR$E$M$Y$$$20240719$$CN$US$US
225244752$22524475$2$F$20230501$20240731$20230606$20240808$EXP$$US-AMGEN-USASL2023094123$AMGEN$$59$YR$A$M$Y$$$20240808$$CN$US$US
225245283$22524528$3$F$$20240909$20230606$20240912$EXP$$US-TAKEDA-2021TUS033655$TAKEDA$$$$$F$Y$$$20240912$$HP$US$US
225246318$22524631$8$F$20190806$20240829$20230606$20240903$EXP$$CA-TAKEDA-2023TUS054914$TAKEDA$$50$YR$$F$Y$$$20240903$$MD$CA$CA
225246523$22524652$3$F$20230531$20240805$20230606$20240809$EXP$$CA-GSK-CA2023077660$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$CA$CA
225247505$22524750$5$F$$20240730$20230606$20240808$PER$$US-SA-2023SA169915$SANOFI AVENTIS$$$$A$F$Y$$$20240808$$MD$US$US
225248143$22524814$3$F$20230501$20240827$20230606$20240920$PER$$US-SA-2023SA169928$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240920$$MD$US$US
225248432$22524843$2$F$20230101$20240727$20230606$20240805$PER$$US-SA-2023SA170838$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240805$$MD$US$US
2252489010$22524890$10$F$20220509$20240705$20230606$20240724$EXP$$CA-CELLTRION INC.-2022CA005888$CELLTRION$$$$$$Y$$$20240724$$MD$CA$CA
225249822$22524982$2$F$$20240918$20230606$20240923$PER$$US-SA-2023SA171163$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240923$$MD$US$US
225250458$22525045$8$F$20240101$20240717$20230606$20240723$PER$$US-AMGEN-USASP2023095858$AMGEN$$67$YR$E$F$Y$$$20240723$$HP$US$US
225251935$22525193$5$F$20220719$20240717$20230606$20240724$EXP$$RO-ASTELLAS-2023US005146$ASTELLAS$$63$YR$$M$Y$$$20240724$$CN$RO$RO
225252525$22525252$5$F$$20240916$20230606$20240925$EXP$$US-ASTELLAS-2023US016772$ASTELLAS$$71$YR$E$M$Y$116.57$KG$20240925$$CN$US$US
225253612$22525361$2$F$$20240703$20230606$20240715$PER$$US-SA-2023SA171356$SANOFI AVENTIS$$54$YR$A$M$Y$137.89$KG$20240715$$MD$US$US
225253635$22525363$5$F$$20240722$20230606$20240724$PER$$US-PFIZER INC-PV202300039359$PFIZER$$73$YR$$F$Y$$$20240724$$CN$US$US
225254342$22525434$2$F$$20240811$20230606$20240812$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-392111$RANBAXY$Murciano M, Laterza C, Attolini E, Storelli S, Dipietro G, Rubino A, et al. Procedural analgesia with nitrous oxide at home for epidermolysis bullosa: A case report. Medicine. 2022;101(1):e28474$28$YR$$M$Y$$$20240812$$MD$IT$IT
225254402$22525440$2$F$$20240708$20230606$20240709$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-392432$RANBAXY$Ogawa K, Akimoto T, Hara M, Fujishiro M, Uei H, Nakajima H. Two Patients with Spontaneous Spinal Epidural Hematoma Carrying a Good Prognosis without Surgical Operations. Neurol Int. 2023;15(1):362-370$87$YR$$F$Y$$$20240709$$HP$JP$JP
2252560210$22525602$10$F$20230101$20240822$20230606$20240824$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-122377$DAIICHI$$$$$F$Y$$$20240824$$CN$US$US
225256909$22525690$9$F$20231204$20240829$20230606$20240902$EXP$$US-TAKEDA-US202020432$TAKEDA$$81$YR$$F$Y$$$20240902$$HP$US$US
225260113$22526011$3$F$$20240730$20230606$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04336$LUPIN$$$$$$Y$$$20240819$$CN$US$US
225260125$22526012$5$F$$20240829$20230606$20240904$PER$$US-PFIZER INC-PV202300097566$PFIZER$$70$YR$$F$Y$67.574$KG$20240904$$HP$US$US
225262517$22526251$7$F$20230101$20240818$20230606$20240823$EXP$$CA-GSK-CA2023077587$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$CA$CA
225263103$22526310$3$F$$20240905$20230606$20240912$PER$$US-VERTEX PHARMACEUTICALS-2023-006814$VERTEX$$$$$$Y$$$20240912$$CN$US$US
225265832$22526583$2$F$20230531$20240905$20230606$20240930$PER$$US-SA-2022SA402276$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240930$$MD$US$US
225266766$22526676$6$F$$20240829$20230606$20240902$PER$$NVSC2023US127772$NOVARTIS$$$$$F$Y$$$20240902$$HP$US$US
225267552$22526755$2$F$20220602$20240702$20230606$20240705$EXP$$JP-PFIZER INC-PV202300098656$PFIZER$$66$YR$$M$Y$104.4$KG$20240705$$MD$JP$JP
225268369$22526836$9$F$20230520$20240913$20230606$20240916$EXP$$NVSC2023US126645$NOVARTIS$$46$YR$$F$Y$$$20240916$$CN$US$US
225269039$22526903$9$F$$20240905$20230606$20240911$PER$$US-PFIZER INC-PV202300098168$PFIZER$$68$YR$$M$Y$$$20240911$$CN$US$US
225269282$22526928$2$F$20230221$20240904$20230606$20240910$EXP$$PL-ROCHE-3361562$ROCHE$$40$YR$A$M$Y$80$KG$20240910$$MD$PL$PL
225273793$22527379$3$F$$20240822$20230606$20240827$PER$$US-PFIZER INC-PV202300098314$PFIZER$$43$YR$$F$Y$$$20240827$$CN$US$US
225273803$22527380$3$F$$20240627$20230606$20240701$PER$$US-PFIZER INC-PV202300098335$PFIZER$$64$YR$$F$Y$$$20240701$$CN$US$US
225273962$22527396$2$F$20200201$20240706$20230606$20240711$EXP$$RO-BAUSCH-BL-2023-008347$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240711$$MD$RO$RO
225274074$22527407$4$F$$20240627$20230606$20240701$PER$$US-PFIZER INC-PV202300098337$PFIZER$$83$YR$$F$Y$$$20240701$$CN$US$US
2252761712$22527617$12$F$20220101$20240904$20230606$20240912$EXP$$NVSC2022CA136344$NOVARTIS$$66$YR$$F$Y$$$20240912$$CN$CA$CA
225276763$22527676$3$F$$20240804$20230606$20240819$EXP$$NVSC2023EG120130$NOVARTIS$$$$$M$Y$$$20240819$$CN$EG$EG
225277338$22527733$8$F$20230101$20240902$20230606$20240912$EXP$$NVSC2023CO015046$NOVARTIS$$$$$F$Y$82$KG$20240912$$CN$CO$CO
225277493$22527749$3$F$$20230607$20230606$20240909$PER$$NVSC2023US128749$NOVARTIS$$$$$$Y$$$20240909$$MD$US$US
225277608$22527760$8$F$$20240819$20230606$20240820$PER$$NVSC2023US126587$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
225280112$22528011$2$F$20230513$20240822$20230606$20240829$EXP$$BR-CELLTRION INC.-2023BR011422$CELLTRION$$$$$$Y$$$20240829$$CN$BR$BR
225280842$22528084$2$F$$20240731$20230607$20240813$EXP$$US-CIPLA LTD.-2023US02941$CIPLA$Brenner A, Kern C, Lee E, Flomenhoft D,. Sevelamer Induced Ischemic Ulcerative Colitis. The American College of Gastroenterology. 2022;S2187$$$$$Y$$$20240813$$MD$US$US
225281063$22528106$3$F$20220101$20240916$20230607$20240920$EXP$$CO-ABBVIE-5277850$ABBVIE$$$$$M$Y$83$KG$20240920$$CN$CO$CO
225281664$22528166$4$F$$20240904$20230607$20240913$PER$$US-SA-2023SA172975$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$MD$US$US
225282532$22528253$2$F$$20240918$20230607$20240925$PER$$NVSC2023US129613$NOVARTIS$$$$$$Y$$$20240925$$HP$US$US
225287004$22528700$4$F$20230316$20240905$20230607$20240914$EXP$$DE-ROCHE-2766746$ROCHE$$44$YR$A$F$Y$$$20240914$$CN$DE$DE
225287023$22528702$3$F$$20240821$20230607$20240826$EXP$$CA-ROCHE-3286512$ROCHE$$38$YR$A$F$Y$$$20240826$$HP$CA$CA
225287692$22528769$2$F$20230530$20230602$20230607$20240925$PER$$US-GSK-US2023AMR079319$GLAXOSMITHKLINE$$54$YR$$M$Y$$$20240925$$CN$US$US
225289006$22528900$6$F$$20240812$20230607$20240815$EXP$$US-AMGEN-USASP2023096996$AMGEN$$$$$M$Y$$$20240815$$HP$US$US
225289222$22528922$2$F$20210501$20230530$20230607$20240925$PER$$US-GSK-US2023AMR076864$GLAXOSMITHKLINE$$48$YR$$F$Y$$$20240925$$CN$US$US
225289917$22528991$7$F$20211101$20240806$20230607$20240808$EXP$$NVSC2022GB099966$NOVARTIS$$58$YR$$F$Y$76.3$KG$20240809$$CN$GB$GB
225289983$22528998$3$F$$20240719$20230607$20240725$PER$$US-BIOGEN-2023BI01208983$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
225291173$22529117$3$F$20230528$20230606$20230607$20240923$EXP$$NVSC2023US129604$NOVARTIS$$84$YR$$M$Y$$$20240923$$CN$US$US
225291752$22529175$2$F$$20230601$20230607$20240711$EXP$$HK-ASTELLAS-2023US016888$ASTELLAS$$4$DEC$$F$Y$$$20240711$$MD$HK$HK
225292276$22529227$6$F$$20240715$20230607$20240718$EXP$$NVSC2023GB126338$NOVARTIS$$$$A$M$Y$$$20240719$$CN$GB$GB
225293004$22529300$4$F$20240601$20240708$20230607$20240718$EXP$$CO-ROCHE-3362926$ROCHE$$16$YR$T$F$Y$65$KG$20240718$$CN$CO$CO
225293019$22529301$9$F$20230928$20240722$20230607$20240730$EXP$$CA-TAKEDA-2023TUS055205$TAKEDA$$51$YR$$M$Y$$$20240730$$MD$CA$CA
225293173$22529317$3$F$20230519$20240731$20230607$20240805$30DAY$$US-GSK-US2023077263$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240805$$CN$US$US
225295983$22529598$3$F$$20240918$20230607$20240930$EXP$$NVSC2023US126144$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
225296445$22529644$5$F$20230325$20240705$20230607$20240708$EXP$$CN-TAKEDA-2023TUS055632$TAKEDA$$29$YR$$F$Y$67$KG$20240708$$MD$CN$CN
225296623$22529662$3$F$$20240806$20230607$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04351$LUPIN$$$$$$Y$$$20240828$$CN$US$US
225297043$22529704$3$F$$20240730$20230607$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04344$LUPIN$$$$$$Y$$$20240821$$PH$US$US
2252983113$22529831$13$F$20230402$20240703$20230607$20240710$EXP$$CA-GSK-CA2023AMR076638$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$CA$CA
225300263$22530026$3$F$$20230719$20230607$20240919$EXP$$US-SA-2023SA173385$SANOFI AVENTIS$$$$A$$Y$$$20240919$$CN$US$US
225300353$22530035$3$F$20230519$20240809$20230607$20240828$30DAY$$US-GSK-US2023077708$GLAXOSMITHKLINE$$38$YR$$F$Y$$$20240828$$CN$US$US
225304386$22530438$6$F$$20240830$20230607$20240904$PER$$US-PFIZER INC-PV202300099722$PFIZER$$79$YR$$F$Y$$$20240904$$CN$US$US
2253045346$22530453$46$F$20230324$20240821$20230607$20240923$EXP$$CN-SA-2023SA105631$SANOFI AVENTIS$$68$YR$E$F$Y$66.5$KG$20240923$$CN$CN$CN
225305943$22530594$3$F$20221206$20240719$20230607$20240730$EXP$$DE-ROCHE-3363806$ROCHE$$73$YR$E$F$Y$69$KG$20240730$$MD$DE$DE
225306883$22530688$3$F$20240101$20240820$20230607$20240917$PER$$US-SA-2023SA170630$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240918$$MD$US$US
225308272$22530827$2$F$$20240814$20230607$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2023-000911$BLUEPRINT MEDICINES$$$$A$$Y$$$20240823$$MD$CN$CN
225308372$22530837$2$F$$20240709$20230607$20240710$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390955$RANBAXY$Tomita S, Fujii R, Imai Y, Nishiyama N, Tanaka M, Uchitani K, et al. A Case of Thrombocytopenia Following Minocycline Administration. Yakugaku Zasshi. 2023;143(5):477-479$80$YR$$F$Y$$$20240710$$HP$JP$JP
225308413$22530841$3$F$$20240828$20230607$20240904$EXP$$EG-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392844$RANBAXY$Samir A, Abdel-Gawad MS, Elabd AM, Abed WM, Mahmoud A, Gaweesh TY, et al. Early CT and MRI signs of invasive fungal sinusitis complicating COVID-19 infection: case report. Egypt J Otolaryngol. 2022;38(1):17$71$YR$$M$Y$$$20240904$$HP$EG$EG
225308482$22530848$2$F$$20240717$20230607$20240726$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392827$RANBAXY$Huiwei X, Haiwen W, Yingqing X, Haiying Y, Yan Z. Acute liver injury due to Gukang capsules, Jieguqili pills, and ibuprofen and codeine phosphate tablets. ADRJ. 2020;May; 22(5):323-25$66$YR$$F$Y$$$20240727$$HP$CN$CN
225308562$22530856$2$F$$20240806$20230607$20240812$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392981$RANBAXY$Bolat H, Derin H, Unsel-Bolat G. Phenotypic and Brain Imaging Findings Associated With a 10p Proximal Deletion Including the WAC Gene: Case Report and Literature Review. Cogn Behav Neurol. 2022;Sep;35(3):221-226$9$YR$$M$Y$22$KG$20240812$$MD$TR$TR
225308792$22530879$2$F$$20240903$20230607$20240904$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392873$RANBAXY$Yoshioka H, Okuda T, Nakao T, Fujita M, Takahashi JC. Experience With Tirabrutinib in the Treatment of Primary Central Nervous System Lymphoma that Is Difficult to Treat With Standard Treatment. Anticancer Res. 2022;42(8):4173-4178$76$YR$$F$Y$$$20240904$$HP$JP$JP
225308802$22530880$2$F$$20240903$20230607$20240913$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392822$RANBAXY$Matsuya M, Komatsu S, Iida T, Hashimoto Y, Honma M, Ishida-Yamamoto A. Visceral disseminated varicella zoster virus infection in a patient with rheumatoid arthritis treated with immunosuppressive therapy including a Janus kinase inhibitor. J Dermatol. 2023;50(3):e92-e93$68$YR$$F$Y$$$20240913$$HP$JP$JP
225308852$22530885$2$F$$20240903$20230607$20240904$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392872$RANBAXY$Yoshioka H, Okuda T, Nakao T, Fujita M, Takahashi JC. Experience With Tirabrutinib in the Treatment of Primary Central Nervous System Lymphoma that Is Difficult to Treat With Standard Treatment. Anticancer Res. 2022;42(8):4173-4178$77$YR$$F$Y$$$20240904$$HP$JP$JP
225309262$22530926$2$F$20230501$20240820$20230607$20240914$PER$$US-SA-2023SA172887$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240914$$MD$US$US
225309652$22530965$2$F$20230211$20240811$20230607$20240812$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-393003$RANBAXY$$73$YR$$M$Y$75$KG$20240812$$PH$FR$FR
225311062$22531106$2$F$20230501$20240830$20230607$20240905$EXP$$US-PFIZER INC-202300213316$PFIZER$$48$YR$$F$Y$$$20240905$$CN$US$US
225311095$22531109$5$F$20230301$20240822$20230607$20240827$EXP$$US-PFIZER INC-PV202300100185$PFIZER$$69$YR$$F$Y$$$20240827$$HP$US$US
225312162$22531216$2$F$$20240904$20230607$20240913$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393209$RANBAXY$Singh GK, Sapra D, Bahuguna A, Das P. Methotrexate toxicity in psoriasis-A multicentric retrospective study. Dermatol Ther. 2022;35(10):e15765(1-9)$29$YR$$M$Y$$$20240913$$HP$IN$IN
225312572$22531257$2$F$$20240909$20230607$20240913$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-393227$RANBAXY$Enokizono K, Nagase S, Oka S, Miyazaki Y, Wakamiya A, Shimamoto K, et al. A COMBINATION OF LOW-DOSE QUINIDINE AND VERAPAMIL FOR MULTIFOCAL ECTOPIC PURKINJE-RELATED PREMATURE CONTRACTIONS IN A CASE WITH SCN5A MUTATION. Heart-Rhythm. 2023;20(Suppl.)(5):S694$32$YR$$M$Y$$$20240913$$HP$JP$JP
225313114$22531311$4$F$20230719$20240625$20230607$20240702$EXP$$CA-TAKEDA-2023TUS055865$TAKEDA$$62$YR$$M$Y$$$20240702$$MD$CA$CA
225314085$22531408$5$F$$20240916$20230607$20240918$EXP$$US-PFIZER INC-PV202300094104$PFIZER$$44$YR$$F$Y$$$20240918$$CN$US$US
225315153$22531515$3$F$20221019$20240814$20230607$20240823$PER$$CN-Blueprint Medicines Corporation-LT-CN-2023-000905$BLUEPRINT MEDICINES$$$$$$Y$$$20240823$$MD$CN$CN
225316062$22531606$2$F$20221204$20240814$20230607$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2023-000906$BLUEPRINT MEDICINES$$$$A$$Y$$$20240823$$MD$CN$CN
225316093$22531609$3$F$$20240918$20230607$20240925$PER$$NVSC2023US130194$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
225316734$22531673$4$F$20230528$20240703$20230607$20240708$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-002580$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240708$$MD$JP$JP
225319832$22531983$2$F$$20240814$20230607$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2023-000913$BLUEPRINT MEDICINES$$$$A$$Y$$$20240824$$MD$CN$CN
225320042$22532004$2$F$$20240627$20230607$20240702$EXP$$NVSC2023US126563$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
225320444$22532044$4$F$20231130$20240920$20230607$20240926$PER$$US-PFIZER INC-202300209272$PFIZER$$47$YR$$M$Y$63.5$KG$20240926$$CN$US$US
2253206411$22532064$11$F$20220406$20240920$20230607$20240927$EXP$$US-TAKEDA-2021TUS080664$TAKEDA$$57$YR$$F$Y$67$KG$20240927$$HP$US$US
225320652$22532065$2$F$$20240814$20230607$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2023-000907$BLUEPRINT MEDICINES$$$$$$Y$$$20240823$$MD$CN$CN
225321074$22532107$4$F$20230222$20240917$20230607$20240920$EXP$$DE-MYLANLABS-2023M1059322$MYLAN$$76$YR$$M$Y$94.6$KG$20240920$$MD$DE$DE
225321422$22532142$2$F$20221104$20240814$20230607$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2023-000904$BLUEPRINT MEDICINES$$$$$$Y$$$20240823$$MD$CN$CN
225322114$22532211$4$F$20230117$20240730$20230607$20240805$EXP$$JP-009507513-2301JPN002255J$MERCK$$6$DEC$$F$Y$$$20240805$$MD$JP$JP
225323324$22532332$4$F$20230522$20240902$20230607$20240906$EXP$$NVSC2023AE109055$NOVARTIS$$40$YR$$F$Y$$$20240906$$CN$AE$AE
225323393$22532339$3$F$$20191202$20230607$20240731$EXP$$CA-Covis Pharma GmbH-2021COV22172$COVIS PHARMA$$53$YR$A$M$Y$$$20240731$$$COUNTRY NOT SPECIFIED$CA
225323899$22532389$9$F$20230101$20240725$20230607$20240730$PER$$US-DSJP-DSU-2023-122378$DAIICHI$$$$$F$Y$$$20240730$$CN$US$US
225325395$22532539$5$F$20200401$20240722$20230607$20240725$EXP$$AT-BAUSCH-BL-2023-008675$BAUSCH AND LOMB$$51$YR$$M$Y$73$KG$20240725$$MD$AT$AT
225326182$22532618$2$F$$20240827$20230607$20240903$EXP$$NVSC2019US053745$NOVARTIS$Rajpurkar M, Lafferty J, Wakeling E, Ravindranath Y, Savasan S. Acquired Pure Red Cell Aplasia and Acquired Amegakaryocytic Thrombocytopenia Associated with Clonal Expansion of T-Cell Large Granular Lymphocytes in a Patient with Lipopolysaccharide-responsive Beige-like Anchor (LRBA) Protein Deficiency. JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY. 2019;41:e542-5$16$YR$$M$Y$$$20240903$$HP$US$US
225331322$22533132$2$F$$20240814$20230607$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2023-000910$BLUEPRINT MEDICINES$$$$A$$Y$$$20240823$$MD$CN$CN
225331762$22533176$2$F$$20240814$20230607$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2023-000914$BLUEPRINT MEDICINES$$$$A$$Y$$$20240824$$MD$CN$CN
225331902$22533190$2$F$$20240814$20230607$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2023-000912$BLUEPRINT MEDICINES$$$$A$$Y$$$20240824$$MD$CN$CN
225333044$22533304$4$F$$20240702$20230607$20240710$EXP$$CA-CELLTRION INC.-2023CA002241$CELLTRION$$$$$$Y$$$20240710$$CN$CA$CA
225334437$22533443$7$F$20230601$20231005$20230608$20240925$PER$$US-GSK-US2023AMR079309$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240925$$CN$US$US
225334568$22533456$8$F$20230501$20240319$20230608$20240926$EXP$$US-GSK-US2023AMR079326$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
225334864$22533486$4$F$20240501$20240718$20230608$20240730$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023AMR077339$VIIV$$41$YR$$M$Y$105.2$KG$20240730$$MD$US$US
225338042$22533804$2$F$$20240809$20230608$20240821$EXP$$CA-AUROBINDO-AUR-APL-2023-040329$AUROBINDO$Eberhard, R.. Response to Hydrocortisone in an Extremely Preterm Neonate With LateOnset Sepsis, Meningoencephalitis, and Drug-Resistant Seizures.. Clinical EEG and neuroscience.. 2022$$$$F$Y$$$20240821$$HP$CA$CA
225338613$22533861$3$F$20201211$20240828$20230608$20240904$EXP$$PK-AMGEN-PAKSP2021020683$AMGEN$$29$YR$A$F$Y$$$20240904$$CN$PK$PK
2253388910$22533889$10$F$20220601$20240806$20230608$20240808$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-215383$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240808$$CN$US$US
225339127$22533912$7$F$20220101$20240916$20230608$20240924$EXP$$CA-CELLTRION INC.-2022CA014167$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
225339174$22533917$4$F$$20240809$20230608$20240820$EXP$$CA-AUROBINDO-AUR-APL-2023-040342$AUROBINDO$$63$YR$$M$Y$$$20240820$$HP$CA$CA
2253397319$22533973$19$F$20220318$20240730$20230608$20240807$EXP$$CA-CELLTRION INC.-2022CA005237$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
225339928$22533992$8$F$20211022$20240703$20230608$20240706$EXP$$CA-TAKEDA-2021TUS076472$TAKEDA$$21$YR$$F$Y$$$20240706$$HP$CA$CA
225341713$22534171$3$F$$20240624$20230608$20240701$PER$$US-BIOGEN-2023BI01209615$BIOGEN$$$$$F$Y$$$20240701$$CN$US$US
225342732$22534273$2$F$20230517$20240715$20230608$20240717$EXP$$FR-EXELIXIS-CABO-23064601$EXELIXIS$$65$YR$$M$Y$98$KG$20240717$$MD$FR$FR
225342867$22534286$7$F$20230101$20240923$20230608$20240927$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-035883$JAZZ$$$$$M$Y$$$20240927$$CN$US$US
225342922$22534292$2$F$$20240905$20230608$20240914$30DAY$$US-GSK-US2023AMR077895$GLAXOSMITHKLINE$$$$$F$Y$$$20240914$$CN$US$US
225343912$22534391$2$F$$20240705$20230608$20240710$EXP$$BR-AMGEN-BRASL2023096470$AMGEN$$18$YR$A$F$Y$$$20240710$$PH$BR$BR
225344054$22534405$4$F$20230501$20240624$20230608$20240701$EXP$$JP-009507513-2306JPN000443J$MERCK$$55$YR$$F$Y$$$20240701$$MD$JP$JP
225345055$22534505$5$F$20230521$20240830$20230608$20240904$EXP$$NVSC2023US127369$NOVARTIS$$52$YR$$F$Y$$$20240904$$CN$US$US
225345768$22534576$8$F$20240701$20240828$20230608$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-012141$JAZZ$$57$YR$$M$Y$118$KG$20240830$$HP$US$US
225346193$22534619$3$F$20230527$20240723$20230608$20240726$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000443$PAREXEL$$$$$$Y$$$20240726$$MD$US$US
225346274$22534627$4$F$20221201$20230601$20230608$20240920$EXP$$NVSC2023US127549$NOVARTIS$$70$YR$$F$Y$$$20240920$$CN$US$US
2253465811$22534658$11$F$20210903$20240724$20230608$20240725$EXP$$US-TAKEDA-2021TUS057135$TAKEDA$$79$YR$$M$Y$85$KG$20240725$$CN$US$US
2253481228$22534812$28$F$20200708$20240911$20230608$20240916$EXP$$AU-MYLANLABS-2023M1059730$MYLAN$$69$YR$$M$Y$$$20240916$$MD$AU$AU
225349314$22534931$4$F$$20240730$20230608$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04325$LUPIN$$$$$$Y$$$20240819$$CN$US$US
225350459$22535045$9$F$20230508$20240812$20230608$20240819$PER$$NVSC2023US127904$NOVARTIS$$30$YR$$F$Y$$$20240819$$CN$US$US
225351423$22535142$3$F$20220606$20240806$20230608$20240809$EXP$$GB-ROCHE-3112996$ROCHE$$28$YR$A$F$Y$$$20240809$$HP$GB$GB
225352034$22535203$4$F$$20240805$20230608$20240809$EXP$$BR-TAKEDA-BR201922808$TAKEDA$$$$$M$Y$36$KG$20240809$$MD$BR$BR
225352069$22535206$9$F$20230101$20240816$20230608$20240822$EXP$$US-ABBVIE-4295122$ABBVIE$$$$$F$Y$124$KG$20240822$$CN$US$US
225353042$22535304$2$F$$20240724$20230608$20240729$EXP$$CA-MYLANLABS-2023M1058038$MYLAN$$$$$M$Y$$$20240729$$CN$CA$CA
225353725$22535372$5$F$20210101$20240627$20230608$20240702$EXP$$CA-TAKEDA-2021TUS053320$TAKEDA$$$$$F$Y$$$20240702$$CN$CA$CA
225354565$22535456$5$F$$20240919$20230608$20240924$EXP$$AU-TAKEDA-2021TUS018288$TAKEDA$$$$$F$Y$$$20240924$$CN$AU$AU
225354694$22535469$4$F$$20240702$20230608$20240709$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681$BOEHRINGER INGELHEIM$$42$YR$A$M$Y$$$20240709$$HP$CA$CA
225355224$22535522$4$F$20220328$20240801$20230608$20240810$EXP$$US-TEVA-2023-US-2893764$TEVA$Kabir KF,Gaddipati H,Singla V. Leflunomide-induced colitis with clinical, endoscopic + microscopic findings: a case report. AME Medical Journal 9: no pagination, No. 0, Sep 2024; Kabir KF, Gaddapati H, Singla V. A Rare Case of Leflunomide-Induced Colitis: Clinical, Endoscopic and Microscopic Findings. Am-J-Gastroenterol 2022; 117 (Suppl.) (10): S1362.; Kabir KF, Gaddapati H, Singla V. A Rare Case of Leflunomide-Induced Colitis: Clinical, Endoscopic and Microscopic Findings. Am-J-Gastroenterol...$79$YR$$F$Y$$$20240810$$MD$US$US
2253557810$22535578$10$F$$20240917$20230608$20240919$EXP$$US-PFIZER INC-PV202300014950$PFIZER$$68$YR$$F$Y$$$20240919$$CN$US$US
2253560911$22535609$11$F$20230424$20240906$20230608$20240913$EXP$$CA-GSK-CA2023048442$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$CA$CA
225356184$22535618$4$F$20230501$20240814$20230608$20240820$EXP$$BR-TAKEDA-2023TUS055956$TAKEDA$$70$YR$$M$Y$$$20240820$$CN$BR$BR
225356732$22535673$2$F$$20240625$20230608$20240704$PER$$US-SA-2023SA170284$SANOFI AVENTIS$$$$A$F$Y$97$KG$20240704$$MD$US$US
225356852$22535685$2$F$20230501$20240621$20230608$20240705$PER$$US-SA-2023SA173513$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240705$$MD$US$US
225356963$22535696$3$F$20230101$20240816$20230608$20240828$PER$$US-SA-2023SA172963$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240828$$MD$US$US
225357363$22535736$3$F$$20240812$20230608$20240821$PER$$US-SA-2023SA173227$SANOFI AVENTIS$$$$E$F$Y$$$20240821$$MD$US$US
225357435$22535743$5$F$20220929$20240626$20230608$20240708$PER$$US-SA-2023SA173272$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240708$$MD$US$US
225357462$22535746$2$F$$20240702$20230608$20240709$PER$$US-SA-2023SA172270$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240709$$MD$US$US
225358233$22535823$3$F$$20240628$20230608$20240709$PER$$US-SA-2023SA174468$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240709$$MD$US$US
225360892$22536089$2$F$$20240804$20230608$20240813$PER$$US-SA-2023SA173719$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240814$$MD$US$US
225361202$22536120$2$F$$20240828$20230608$20240911$PER$$US-SA-2023SA175369$SANOFI AVENTIS$$51$YR$A$F$Y$129$KG$20240911$$MD$US$US
225361253$22536125$3$F$20230601$20240715$20230608$20240724$PER$$US-SA-2023SA175112$SANOFI AVENTIS$$$$E$M$Y$$$20240724$$MD$US$US
225361525$22536152$5$F$20230401$20240717$20230608$20240724$EXP$$US-GSK-US2023079232$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$US$US
225362722$22536272$2$F$20220221$20240709$20230608$20240715$EXP$RO-AMGEN-ROUSP2023085196$RO-MYLANLABS-2023M1059448$MYLAN$$61$YR$$M$Y$$$20240715$$MD$RO$RO
225365123$22536512$3$F$$20240719$20230608$20240722$EXP$FR-AFSSAPS-NT2023000585$FR-JNJFOC-20230611640$JOHNSON AND JOHNSON$$57$YR$A$F$Y$60$KG$20240722$$MD$FR$FR
225366232$22536623$2$F$$20240814$20230608$20240826$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393159$RANBAXY$Andraus W, Pinheiro RS, Fortunato AC, Galvao FHF, Arantes Junior RM, Waisberg DR, et al. First Successful Isolated Intestinal Transplant in a Brazilian Series. Clinics. 2021;76:e3016$44$YR$$M$Y$$$20240826$$HP$BR$KH
225366542$22536654$2$F$$20240703$20230608$20240703$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393469$RANBAXY$Suzaki K, Kobayashi M, Kosugi N. Non-operative Management of Spontaneous Gastropleural Fistula Caused by Primary Gastric Diffuse Large B-cell Lymphoma. Intern Med Advance Publication. 2023;No pagination$79$YR$$M$Y$$$20240703$$HP$JP$JP
225366622$22536662$2$F$$20240721$20230608$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393425$RANBAXY$Ali RB, Rao A, Boyle S, Goldman JM. Treatment of Malignancy-Associated Hypercalcemia with Low Calcium Hemodialysis Yields Several Benefits for Cancer Patient. J Am Soc Nephrol. 2015;26:366A(FR-PO042)$56$YR$$M$Y$$$20240727$$HP$US$US
225367042$22536704$2$F$$20240816$20230608$20240826$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392886$RANBAXY$Wydra A, Cylke-Falkowska K, Czajka-Oraniec I, Kolasinska-Cwikla A, Cwikla J, Zgliczynski W, et al. Severe ectopic Cushing syndrome in a transgender man with a metastatic gastrinoma and an adrenal tumor-A case report and review of the literature. Front Endocrinol. 2023;14:1135016$$$$$Y$$$20240826$$HP$PL$PL
225367132$22536713$2$F$$20240708$20230608$20240709$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393411$RANBAXY$Zhang Y, Zhu R, Yu Z, Hou S, Niu J. Patent foramen ovale-associated stroke repeatedly misdiagnosed as cerebral small vessel disease A case report. Medicine. 2023;102(11):e32996$60$YR$$M$Y$$$20240709$$MD$CN$CN
225367152$22536715$2$F$$20240625$20230608$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393049$RANBAXY$Saro?Nunez L, Traina TA, Cadoo KA, Gilewski T, Glezerman I. Hypomagnesemia After Treatment with Pertuzumab. J Am Soc Nephrol. 2015;26:(PUB412)$58$YR$$F$Y$$$20240710$$HP$US$US
225367163$22536716$3$F$$20240704$20230608$20240705$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393483$RANBAXY$Cho SC, Lee JE, Han KE. Retinal toxicity developed after use of hydroxychloroquine for 5.5 months without any risk factors detected at baseline screening. Doc Ophthalmol. 2023;146 (Suppl. 1):S33-S34 (P1-2)$59$YR$$F$Y$48$KG$20240705$$HP$KR$KR
225368732$22536873$2$F$$20240814$20230608$20240906$PER$$US-INCYTE CORPORATION-2023IN004998$INCYTE$$$$$$Y$$$20240906$$CN$US$US
225368944$22536894$4$F$$20240730$20230608$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04357$LUPIN$$$$$$Y$$$20240819$$CN$US$US
225369023$22536902$3$F$$20240905$20230608$20240909$PER$$US-PFIZER INC-202300211883$PFIZER$$53$YR$$F$Y$$$20240909$$HP$US$US
225369084$22536908$4$F$$20240906$20230608$20240911$EXP$$IT-MYLANLABS-2023M1060118$MYLAN$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox?Gastaut Syndrome: A Case Series.. Journal of Clinical Medicine.. 2023;12(1):129$29$YR$$M$Y$$$20240911$$HP$IT$IT
225369142$22536914$2$F$$20240823$20230608$20240828$PER$$US-PFIZER INC-PV202300100094$PFIZER$$74$YR$$F$Y$$$20240828$$CN$US$US
225369383$22536938$3$F$$20240629$20230608$20240703$EXP$$US-PFIZER INC-PV202300102002$PFIZER$$76$YR$$F$Y$$$20240703$$CN$US$US
225370513$22537051$3$F$$20240909$20230608$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04393$LUPIN$$$$$$Y$$$20240923$$PH$US$US
2253716815$22537168$15$F$20230101$20240723$20230608$20240724$EXP$$ES-PFIZER INC-202300213546$PFIZER$$64$YR$$M$Y$70$KG$20240724$$MD$ES$ES
225371783$22537178$3$F$20230428$20240705$20230608$20240715$EXP$IT-MINISAL02-924861$IT-TEVA-2023-IT-2893437$TEVA$$15$YR$$F$Y$50$KG$20240715$$PH$IT$IT
225372282$22537228$2$F$20240209$20240703$20230608$20240709$EXP$$BR-TAKEDA-2022TUS102930$TAKEDA$$42$YR$$F$Y$$$20240709$$CN$BR$BR
225375985$22537598$5$F$20230101$20240808$20230608$20240812$PER$$US-PFIZER INC-PV202300100264$PFIZER$$66$YR$$M$Y$74.84$KG$20240812$$CN$US$US
225377065$22537706$5$F$$20240726$20230608$20240730$PER$$US-PFIZER INC-202300214305$PFIZER$$18$YR$$M$Y$64$KG$20240730$$MD$US$US
225377244$22537724$4$F$$20240918$20230608$20240930$PER$$NVSC2023US131127$NOVARTIS$$79$YR$$M$Y$$$20240930$$HP$US$US
2253783515$22537835$15$F$20210414$20240911$20230608$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210504497$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$51.25$KG$20240923$$MD$US$US
225379014$22537901$4$F$20230316$20240826$20230608$20240828$EXP$$NVSC2023KR129442$NOVARTIS$$$$A$M$Y$$$20240828$$MD$KR$KR
225381856$22538185$6$F$20240615$20240614$20230608$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001844$ACADIA PHARMACEUTICALS$$58$YR$$F$Y$$$20240709$$CN$US$US
2253819211$22538192$11$F$20230503$20240617$20230608$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-001889$ACADIA PHARMACEUTICALS$$9$YR$$F$Y$$$20240712$$CN$US$US
2253819512$22538195$12$F$20230505$20240620$20230608$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-001888$ACADIA PHARMACEUTICALS$$19$YR$$F$Y$$$20240712$$HP$US$US
225382935$22538293$5$F$20230513$20240626$20230609$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-001849$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240719$$CN$US$US
225383622$22538362$2$F$$20240725$20230609$20240802$PER$$US-SA-2023SA175079$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240802$$CN$US$US
225385662$22538566$2$F$$20240821$20230609$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001915$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
225386056$22538605$6$F$20180621$20240711$20230609$20240719$EXP$$JP-ABBVIE-5282782$ABBVIE$$65$YR$$M$Y$57.5$KG$20240719$$MD$JP$JP
225387723$22538772$3$F$20230515$20240911$20230609$20240917$EXP$$US-ABBVIE-5281743$ABBVIE$$35$YR$$F$Y$88$KG$20240917$$MD$US$US
225388304$22538830$4$F$$20240806$20230609$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04356$LUPIN$$$$$$Y$$$20240828$$CN$US$US
2253883311$22538833$11$F$20230101$20240731$20230609$20240808$EXP$$US-ABBVIE-5281371$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
225388473$22538847$3$F$20230101$20240816$20230609$20240822$EXP$$US-ABBVIE-5283041$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
225388892$22538889$2$F$20220710$20240806$20230609$20240810$EXP$$ES-ROCHE-3362766$ROCHE$$64$YR$A$$Y$$$20240810$$MD$ES$ES
225389292$22538929$2$F$$20230602$20230609$20240701$PER$$US-ABBVIE-5279795$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
225390075$22539007$5$F$$20240828$20230609$20240829$EXP$$NVSC2023US126445$NOVARTIS$$$$$F$Y$96.62$KG$20240829$$HP$US$US
225390613$22539061$3$F$20221029$20240923$20230609$20240926$EXP$$CN-CHEPLA-2023003528$CHEPLAPHARM$$73$YR$$M$Y$80$KG$20240926$$MD$COUNTRY NOT SPECIFIED$CN
225391405$22539140$5$F$20230519$20240723$20230609$20240726$EXP$$JP-ABBVIE-5282613$ABBVIE$$70$YR$$F$Y$55$KG$20240726$$MD$JP$JP
225393597$22539359$7$F$$20240711$20230609$20240717$EXP$$US-TAKEDA-2023TUS002190$TAKEDA$$$$$F$Y$$$20240717$$CN$US$US
225393622$22539362$2$F$$20240705$20230609$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-23-00059$IMMUNOGEN$$$$$$Y$$$20240829$$HP$US$US
225393903$22539390$3$F$20230325$20240716$20230609$20240724$PER$$US-AMGEN-USASP2023099180$AMGEN$$62$YR$A$M$Y$$$20240724$$PH$US$US
225393933$22539393$3$F$$20240909$20230609$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04432$LUPIN$$$$$$Y$$$20240920$$PH$US$US
225394052$22539405$2$F$20230530$20230602$20230609$20240924$EXP$$NVSC2023US127632$NOVARTIS$$59$YR$$F$Y$81.19$KG$20240924$$CN$US$US
225394222$22539422$2$F$$20240904$20230609$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202306004483$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240909$$CN$US$US
225395293$22539529$3$F$20220325$20240823$20230609$20240902$EXP$$DE-AUROBINDO-AUR-APL-2023-040601$AUROBINDO$$$$A$F$Y$95$KG$20240902$$MD$DE$DE
225396729$22539672$9$F$20231026$20240813$20230609$20240815$EXP$$CA-TAKEDA-2020TUS026487$TAKEDA$$90$YR$$M$Y$$$20240815$$CN$CA$CA
2253969313$22539693$13$F$20230101$20240812$20230609$20240819$EXP$$NVSC2023CL024300$NOVARTIS$$39$YR$$F$Y$$$20240819$$CN$CL$CL
225397412$22539741$2$F$$20240819$20230609$20240823$EXP$$CA-CHEPLA-2023006697$CHEPLAPHARM$Garneau B, Desharnais B, Beauchamp-Dore A,  Lavallee C, Mireault P, Lajeunesse A. Challenges Related to Three Cases of Fatal Intoxication to Multiple Novel Synthetic Opioids. Journal of Analytical Toxicology, 2020;7;44(1):86-91. DOI: 10.1093/jat/bkz018.$30$YR$$M$Y$84$KG$20240822$$HP$COUNTRY NOT SPECIFIED$CA
2254014311$22540143$11$F$$20240910$20230609$20240920$EXP$$CA-OTSUKA-2022_050112$OTSUKA$$$$$M$Y$$$20240920$$MD$CA$CA
225403202$22540320$2$F$$20240808$20230609$20240815$PER$$US-SA-2023SA174867$SANOFI AVENTIS$$$$A$F$Y$$$20240815$$MD$US$US
225404102$22540410$2$F$$20240814$20230609$20240828$PER$$US-SA-2023SA176239$SANOFI AVENTIS$$$$T$M$Y$32.3$KG$20240828$$MD$US$US
225405232$22540523$2$F$$20240703$20230609$20240711$EXP$$JP-AMGEN-JPNSP2023098065$AMGEN$Numata H. The Japanese Journal of Dermatology  Number 5. Japanese Dermatological Association. 2023;133:1391$66$YR$E$M$Y$$$20240711$$MD$JP$JP
225405926$22540592$6$F$20220301$20231107$20230609$20240926$EXP$$US-GSK-US2022048350$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
225407234$22540723$4$F$$20240724$20230609$20240729$PER$$US-PFIZER INC-US-GBT-018564$PFIZER$$15$YR$$F$Y$$$20240729$$CN$US$US
225407792$22540779$2$F$20211001$20240703$20230609$20240703$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-393574$RANBAXY$$$$A$$Y$$$20240703$$MD$ES$ES
225407814$22540781$4$F$$20240820$20230609$20240904$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-393186$RANBAXY$$83$YR$$M$Y$$$20240904$$CN$GB$GB
225408357$22540835$7$F$20230708$20240722$20230609$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-081455$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240723$$CN$US$US
225409622$22540962$2$F$$20240917$20230609$20240920$PER$$US-PFIZER INC-202101619781$PFIZER$$44$YR$$F$Y$$$20240920$$CN$US$US
225409765$22540976$5$F$$20240827$20230609$20240829$EXP$$US-PFIZER INC-PV202300100028$PFIZER$$74$YR$$F$Y$88.435$KG$20240829$$CN$US$US
225410355$22541035$5$F$20240125$20240708$20230609$20240712$EXP$$CA-PFIZER INC-202201304065$PFIZER$$54$YR$$F$Y$59$KG$20240712$$MD$CA$CA
225411822$22541182$2$F$$20240703$20230609$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-393571$RANBAXY$$76$YR$$M$Y$$$20240703$$HP$GB$GB
225411832$22541183$2$F$$20240813$20230609$20240826$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-393376$RANBAXY$Colombo E, Gurizzan C, Ottini A, Caspani F, Bergamini C, Locati LD, et al. The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports. Front Oncol. 2023;13:no pagination$76$YR$$M$Y$$$20240826$$HP$IT$IT
225411982$22541198$2$F$$20240908$20230609$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-393589$RANBAXY$$60$YR$$F$Y$87$KG$20240913$$MD$GB$GB
225412552$22541255$2$F$$20240902$20230609$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393558$RANBAXY$Taylor H, Sanders S, Ramani PK. A case report of pediatric sarcoidosis presenting as superior vena cava syndrome. J Investig Med. 2021;69:940/P30$16$YR$$F$Y$$$20240904$$HP$US$US
225412712$22541271$2$F$$20240904$20230609$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393754$RANBAXY$Langer S. When Treatment Teams Feel Helpless: An Inpatient Perspective. Wiley. 2023;S1:45-46(23.1)$23$YR$$F$Y$$$20240913$$HP$US$US
225413252$22541325$2$F$20221208$20240827$20230609$20240903$EXP$$US-ABBVIE-5280436$ABBVIE$$66$YR$$F$Y$$$20240903$$CN$US$US
2254164210$22541642$10$F$20240808$20240916$20230609$20240919$EXP$$US-TAKEDA-2023TUS056847$TAKEDA$$81$YR$$F$Y$52$KG$20240919$$HP$US$US
225416706$22541670$6$F$20230415$20240624$20230609$20240703$EXP$$JP-AstraZeneca-2023A101418$ASTRAZENECA$$14$YR$$F$Y$47$KG$20240703$$MD$JP$
225417622$22541762$2$F$20220801$20240716$20230609$20240718$EXP$FR-AFSSAPS-ST2023000670$FR-009507513-2306FRA001774$MERCK$$59$YR$$F$Y$50$KG$20240718$$MD$FR$FR
225417872$22541787$2$F$$20240625$20230609$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202306001745$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240705$$CN$US$US
2254190312$22541903$12$F$20220524$20240823$20230609$20240830$EXP$$US-Blueprint Medicines Corporation-SP-US-2023-000936$BLUEPRINT MEDICINES$$58$YR$A$F$Y$$$20240830$$HP$US$US
225419193$22541919$3$F$20240101$20240710$20230609$20240717$EXP$$US-BEH-2023159579$CSL BEHRING$$7$DEC$E$F$Y$$$20240717$$HP$US$US
225419434$22541943$4$F$$20240918$20230609$20240925$PER$$NVSC2023US132179$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
2254195219$22541952$19$F$20220822$20240919$20230609$20240924$EXP$$IN-PFIZER INC-PV202300019259$PFIZER$$71$YR$$F$Y$64.6$KG$20240924$$CN$IN$IN
225420725$22542072$5$F$$20240806$20230609$20240808$EXP$$FR-JNJFOC-20230603451$JOHNSON AND JOHNSON$$2$YR$C$F$Y$$$20240808$$HP$FR$FR
225421444$22542144$4$F$$20240919$20230609$20240926$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-222933$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240926$$CN$CA$CA
225850384$22585038$4$F$20150324$20240808$20230609$20240814$EXP$$FR-MYLANLABS-2023M1060202$MYLAN$$$$$F$Y$$$20240814$$LW$FR$FR
225851793$22585179$3$F$$20230606$20230609$20240918$PER$$NVSC2023US130375$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
225851897$22585189$7$F$20230707$20240902$20230609$20240910$EXP$$NVSC2023PT124031$NOVARTIS$$36$YR$$M$Y$$$20240910$$HP$PT$PT
225852902$22585290$2$F$$20230606$20230610$20240919$PER$$NVSC2023US130249$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
225853913$22585391$3$F$$20240809$20230610$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04423$LUPIN$$$$$$Y$$$20240829$$CN$US$US
2258540414$22585404$14$F$20230607$20240820$20230610$20240822$EXP$$NVSC2023US132532$NOVARTIS$$60$YR$$F$Y$$$20240822$$CN$US$US
225854307$22585430$7$F$20230101$20240730$20230610$20240807$EXP$$CA-CELLTRION INC.-2022CA019663$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
225855093$22585509$3$F$$20240906$20230610$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202306004563$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240910$$CN$US$US
225855712$22585571$2$F$20221220$20240711$20230610$20240722$EXP$$CA-CELLTRION INC.-2022CA022382$CELLTRION$$$$$$Y$$$20240722$$MD$CA$CA
225855839$22585583$9$F$20240601$20240723$20230610$20240724$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-216804$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240724$$CN$US$US
225855972$22585597$2$F$20230525$20240826$20230610$20240902$PER$$NVSC2023US132810$NOVARTIS$$76$YR$$M$Y$$$20240902$$CN$US$US
225856897$22585689$7$F$20230222$20240724$20230610$20240726$EXP$$US-UCBSA-2023011759$UCB$$61$YR$$F$Y$83.9$KG$20240726$$CN$US$US
225859307$22585930$7$F$20221017$20240717$20230610$20240726$EXP$$CA-TAKEDA-2023TUS056515$TAKEDA$$73$YR$$M$Y$87$KG$20240726$$HP$CA$CA
225860552$22586055$2$F$$20240803$20230610$20240812$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394034$RANBAXY$Dunphy L, Ford J. Arteriovenous malformation of the small intestine presenting with a transfusion-dependent in pregnancy. BMJ Case Rep. 2023;16:e251653;1-5$$$$F$Y$$$20240812$$HP$GB$GB
225860752$22586075$2$F$$20240904$20230610$20240919$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394030$RANBAXY$Abel M, Nazon C, Spiegel-Bouhadid A, Salmon A, Fornecker L, Nicolae A et al. PRE-TRANSPLANT TREATMENT OF HEPATISPLENIC T-CELL LYMPHOMA (GAMMA-DELATA): A PEDIATRIC CASE REPORT. Leuk Res. 2022;121S:S38-S74$11$YR$$M$Y$$$20240919$$HP$FR$FR
225860822$22586082$2$F$$20240704$20230610$20240718$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393976$RANBAXY$Boussaid S, Majdouba MB, Rekik S, Jemmali S, Zouaoui K, Rahmouni S et al. Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus. F1000Research. 2022;11:922(1-9)$56$YR$$M$Y$$$20240718$$HP$TN$TN
225860862$22586086$2$F$$20240626$20230610$20240711$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394050$RANBAXY$Fischer S, Gotze TO, Omlin A, Baird RD, Dawson KM, Zitt C, et al. A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2?Positive Breast Cancer After Prior Trastuzumab and Pertuzumab. Case Report. 2022;1-8$37$YR$$F$Y$$$20240711$$MD$CH$CH
225861402$22586140$2$F$$20240826$20230610$20240904$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393966$RANBAXY$Kostik MM, Raupov RK, Suspitsin EN, Isupova EA, Gaidar EV, Gabrusskaya TV et al. The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience. Front Pediatr. 2022;10:820586(1-9)$8$YR$$F$Y$$$20240904$$HP$RU$RU
225861582$22586158$2$F$$20240826$20230610$20240904$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393914$RANBAXY$Mangano GD, Antona V, Cali E, Fontana A, Salpietro V, Houlden H, et al. A complex epileptic and dysmorphic phenotype associated with a novel frameshift KDM5B variant and deletion of SCN gene cluster. Seizure. 2022;97:20-22$25$YR$$M$Y$$$20240904$$HP$IT$IT
225861692$22586169$2$F$$20240902$20230610$20240904$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393906$RANBAXY$Fardeau C, Alafaleq M, Ferchaud M-A, Hie M, Besnard C, Meynier S, et al. Casitas B-lineage lymphoma Gene Mutation Ocular Phenotype. Int J Molecular Sci. 2022;23(14:7868$13$YR$$F$Y$$$20240904$$HP$FR$FR
225861762$22586176$2$F$$20240711$20230610$20240712$EXP$$KP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394079$RANBAXY$Nham E, Song E, Hyun H, Seong H, Yoon JG, Noh JY et al. Concurrent Subacute Thyroiditis and Graves? Disease After COVID-19: A Case Report. J Korean Med Sci. 2023;May 8;38(18):e134$27$YR$$F$Y$$$20240712$$HP$KP$KP
225863042$22586304$2$F$20221101$20240822$20230611$20240904$EXP$FR-AFSSAPS-NY2023000625$FR-Accord-361730$ACCORD$$64$YR$A$M$Y$93$KG$20240903$$MD$FR$FR
225869923$22586992$3$F$20230504$20240905$20230612$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-081501$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240916$$HP$US$US
225870204$22587020$4$F$$20240708$20230612$20240718$EXP$ES-MLMSERVICE-20230523-4301264-1$ES-JUBILANT CADISTA PHARMACEUTICALS-2023ES000499$JUBILANT$Fedirchyk-Tymchuk O, Corral-Tuesta C, Duran-Barata D, Torras de Caralt E, Ortega-Garcia P, Cabanes-Martinez L.. N?206 - Myasthenic crisis triggered by levofloxacin: A case report.,Levofloxacin as a possible cause of myasthenic. Clinical Neurophysiology. 2023;150:e138$76$YR$$M$Y$$$20240718$$MD$ES$ES
225870532$22587053$2$F$$20240718$20230612$20240725$EXP$$NVSC2023CO131791$NOVARTIS$$$$$F$Y$$$20240725$$CN$CO$CO
225870902$22587090$2$F$20230101$20240913$20230612$20240923$PER$$US-SA-2023SA177484$SANOFI AVENTIS$$$$A$M$Y$$$20240923$$MD$US$US
225871007$22587100$7$F$20240515$20240709$20230612$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001948$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240731$$CN$US$US
225872227$22587222$7$F$20230516$20240626$20230612$20240705$EXP$$JP-UNITED THERAPEUTICS-UNT-2023-014703$UNITED THERAPEUTICS$$5$YR$$F$Y$14$KG$20240705$$MD$JP$JP
225874193$22587419$3$F$$20240730$20230612$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04431$LUPIN$$$$$$Y$$$20240818$$CN$US$US
225874363$22587436$3$F$$20240806$20230612$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04447$LUPIN$$$$$$Y$$$20240829$$CN$US$US
225874924$22587492$4$F$20230522$20240619$20230612$20240710$PER$$CA-TOLMAR, INC.-23CA041049$TOLMAR$$70$YR$$M$Y$$$20240710$$CN$CA$CA
225875162$22587516$2$F$20230602$20240723$20230612$20240726$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000449$PAREXEL$$$$$$Y$$$20240726$$CN$US$US
225875544$22587554$4$F$$20240730$20230612$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04453$LUPIN$$$$$$Y$$$20240819$$CN$US$US
225876053$22587605$3$F$$20240809$20230612$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04448$LUPIN$$$$$$Y$$$20240901$$CN$US$US
225876294$22587629$4$F$$20240712$20230612$20240722$EXP$$JP-009507513-2306JPN000776J$MERCK$$$$$F$Y$$$20240719$$MD$JP$JP
225876672$22587667$2$F$20200910$20240702$20230612$20240708$EXP$$DE-AUROBINDO-AUR-APL-2023-040780$AUROBINDO$$$$E$F$Y$$$20240708$$MD$DE$DE
225876792$22587679$2$F$$20240731$20230612$20240814$EXP$$US-AUROBINDO-AUR-APL-2023-040574$AUROBINDO$Cardenas J, Borasino S, Timpa J, Hawkins J, McBride M, Rushton W, et al.. Central ECMO Cannulation for Severe Amlodipine Intoxication.. ASAIO Journal.. 2023;69 (S1):50$12$YR$$F$Y$63$KG$20240814$$MD$US$US
225877264$22587726$4$F$$20240924$20230612$20240927$EXP$$ES-AUROBINDO-AUR-APL-2023-010313$AUROBINDO$Chamoun B, Sanchez P, Torres I, Gabaldo A, Perello M, Sellar J. e.tal. Tocilizumab in the treatment of active chronic humoral rejection resistant to standard therapy. Transplant International. 2021;34 (SUP: 1):291$73$YR$$F$Y$$$20240927$$MD$ES$ES
225878395$22587839$5$F$20200901$20240708$20230612$20240722$EXP$$DE-ROCHE-2811899$ROCHE$$60$YR$A$F$Y$$$20240719$$CN$DE$DE
225881673$22588167$3$F$20230606$20240816$20230612$20240822$EXP$$CA-TAKEDA-2023TUS056343$TAKEDA$$27$YR$$F$Y$$$20240822$$CN$CA$CA
225882385$22588238$5$F$20230608$20240826$20230612$20240828$EXP$$US-TAKEDA-2023TUS057011$TAKEDA$$26$YR$$M$Y$$$20240828$$PH$US$US
225882754$22588275$4$F$$20240819$20230612$20240823$EXP$$CZ-ROCHE-3364560$ROCHE$Ptackova H, Poupetova H, Vlaskova H, Honzik T and Jesina P Late diagnosis of mucopolysaccharidosis type I in a girl with hand contractures.. Ces-slov Pediat [Czech-Slovak Paediatrics] 2023;78 (3):155-60.$4$YR$C$F$Y$32.8$KG$20240823$$HP$CZ$CZ
225882886$22588288$6$F$$20240726$20230612$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-082086$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$81.19$KG$20240730$$CN$US$US
225883775$22588377$5$F$20221223$20240716$20230612$20240726$EXP$$IT-AUROBINDO-AUR-APL-2023-041026$AUROBINDO$$88$YR$$F$Y$$$20240726$$MD$IT$IT
225884282$22588428$2$F$$20230607$20230612$20240919$EXP$$NVSC2023US131696$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
225885862$22588586$2$F$20230103$20240718$20230612$20240726$EXP$$CA-ROCHE-3366667$ROCHE$$50$YR$A$F$Y$$$20240726$$CN$CA$CA
225886262$22588626$2$F$$20240904$20230612$20240911$EXP$$CA-MYLANLABS-2023M1060288$MYLAN$$$$$F$Y$$$20240911$$MD$CA$CA
225886287$22588628$7$F$20230101$20240723$20230612$20240731$EXP$$CA-ROCHE-3342115$ROCHE$$51$YR$A$F$Y$$$20240731$$MD$CA$CA
225886344$22588634$4$F$20190724$20240730$20230612$20240801$EXP$$CA-CHEPLA-2023006831$CHEPLAPHARM$$71$YR$E$F$Y$$$20240801$$HP$COUNTRY NOT SPECIFIED$CA
225887644$22588764$4$F$20221201$20240715$20230612$20240722$EXP$$FR-AUROBINDO-AUR-APL-2023-041302$AUROBINDO$Hoebeke C, Dollinger A, Chouk M, Verhoeven F, Prati C,Wendling D. La polyarthrite rhumato?de : un cas ? se creuserles m?ningesRheumatoid arthritis: a case to rack your brains. La Lettre du Rhumatologue. 2023;492:44-47$68$YR$$F$Y$$$20240722$$MD$FR$FR
225888564$22588856$4$F$20230603$20240702$20230612$20240712$EXP$$CA-CELLTRION INC.-2023CA011728$CELLTRION$$$$$$Y$$$20240712$$CN$CA$CA
225889034$22588903$4$F$$20240909$20230612$20240919$EXP$$US-LUPIN PHARMACEUTICALS INC.-2023-04420$LUPIN$$$$$$Y$$$20240919$$CN$US$US
225890103$22589010$3$F$$20240628$20230612$20240704$PER$$US-BIOGEN-2020BI00871403$BIOGEN$$$$$M$Y$$$20240704$$CN$US$US
225890934$22589093$4$F$$20240722$20230612$20240731$EXP$$US-TEVA-2023-US-2896006$TEVA$Bharwad A, Wuthnow C, Mahdi M,Rowe K. UNRESOLVED CHRONIC DIARRHEA: A CASE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-INDUCED MESENTERIC ANGIOEDEMA. European Journal of Case Reports in Internal Medicine 10: No. 8, 23 Nov 2023.; Wuthnow C, Bharwad A, Rowe K. Often Reported, Rarely Considered: A Case of ACEI-Induced Mesenteric Angioedema. Am-J-Gastroenterol 2022; 117 (Suppl.) (10): S2179.; Wuthnow C, Bharwad A, Rowe K. Often Reported, Rarely Considered: A Case of ACEI-Induced Mesenteric Angioede...$49$YR$$M$Y$$$20240731$$MD$US$US
225892492$22589249$2$F$$20240913$20230612$20240918$PER$$US-AMGEN-USASP2023098564$AMGEN$$$$$F$Y$$$20240917$$HP$US$US
225892702$22589270$2$F$$20240703$20230612$20240703$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-393821$RANBAXY$$$$A$M$Y$$$20240703$$HP$FR$FR
225892752$22589275$2$F$20230515$20240703$20230612$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-393791$RANBAXY$$52$YR$$F$Y$128$KG$20240703$$MD$GB$GB
225892822$22589282$2$F$20230310$20240717$20230612$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-393873$RANBAXY$$23$YR$$F$Y$55$KG$20240718$$MD$FR$FR
2258931111$22589311$11$F$20230501$20240823$20230612$20240902$EXP$$BR-GSK-BR2019AMR166017$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$BR$BR
225893154$22589315$4$F$20230601$20240726$20230612$20240801$EXP$$CA-GSK-CA2023078364$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$HP$CA$CA
225895297$22589529$7$F$20230418$20240702$20230612$20240703$EXP$ES-AEMPS-1373638$ES-009507513-2306ESP002863$MERCK$Fernandez Martinez V, Garcia-Avello Fernandez-Cueto A, Valencia Soto CM, Barbadillo Villanueva S, Ochagavia Sufrategui M, Rioja Carrera M, et al.. Pembrolizumab-induced agranulocytosis. Journal of Oncology Pharmacy Practice. 2024;30(4):767-71$68$YR$$M$Y$51$KG$20240703$$HP$ES$ES
225897737$22589773$7$F$20230529$20240724$20230612$20240730$EXP$$IT-TAKEDA-2023TUS056331$TAKEDA$$$$$M$Y$$$20240730$$CN$IT$IT
225898002$22589800$2$F$$20240809$20230612$20240819$30DAY$$US-GSK-US2023078380$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
225898504$22589850$4$F$$20240723$20230612$20240801$PER$$US-SA-2023SA176024$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240801$$MD$US$US
225898552$22589855$2$F$$20240919$20230612$20240930$PER$$US-SA-2023SA177280$SANOFI AVENTIS$$5$YR$C$M$Y$18.1$KG$20240930$$CN$US$US
225898882$22589888$2$F$$20240708$20230612$20240716$PER$$US-SA-2023SA176047$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240716$$MD$US$US
225900114$22590011$4$F$20230401$20240709$20230612$20240716$PER$$US-SA-2023SA176729$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240716$$MD$US$US
225900173$22590017$3$F$20230509$20240822$20230612$20240830$EXP$$KR-JNJFOC-20230601936$JOHNSON AND JOHNSON$$80$YR$E$F$Y$54$KG$20240830$$MD$KR$KR
225901495$22590149$5$F$$20240713$20230612$20240720$EXP$$IN-TAKEDA-2022TUS031519$TAKEDA$$$$$M$Y$$$20240720$$CN$IN$IN
225903504$22590350$4$F$20211117$20240704$20230612$20240708$EXP$$CA-TAKEDA-2021TUS077342$TAKEDA$$83$YR$$M$Y$$$20240708$$MD$CA$CA
2259051512$22590515$12$F$20230327$20240815$20230612$20240823$EXP$$CN-GILEAD-2023-0632105$GILEAD$$71$YR$E$F$Y$$$20240823$$MD$CN$CN
225905412$22590541$2$F$20230501$20240816$20230612$20240819$EXP$$JP-AstraZeneca-2023A134216$ASTRAZENECA$$70$YR$$M$Y$$$20240819$$MD$JP$
2259062411$22590624$11$F$20210915$20240923$20230612$20240930$EXP$$CO-TAKEDA-2021TUS056487$TAKEDA$$68$YR$$F$Y$63$KG$20240929$$CN$CO$CO
225906849$22590684$9$F$$20240921$20230612$20240927$EXP$$CA-ROCHE-3362482$ROCHE$$43$YR$A$F$Y$68$KG$20240927$$HP$CA$CA
225906935$22590693$5$F$20230615$20240805$20230612$20240807$PER$$US-PFIZER INC-PV202300101032$PFIZER$$70$YR$$M$Y$80.74$KG$20240807$$CN$US$US
225907022$22590702$2$F$20180816$20240831$20230612$20240906$EXP$$CA-TAKEDA-2023TUS057272$TAKEDA$$43$YR$$M$Y$$$20240906$$CN$CA$CA
225910813$22591081$3$F$$20240904$20230612$20240911$EXP$$US-GSK-US2023080445$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$US$US
225911797$22591179$7$F$$20240715$20230612$20240717$PER$$US-PFIZER INC-PV202300102571$PFIZER$$72$YR$$F$Y$$$20240717$$CN$US$US
225914093$22591409$3$F$20230601$20240715$20230612$20240724$EXP$$US-BIOMARINAP-US-2023-150908$BIOMARIN$$$$$$Y$$$20240724$$CN$US$US
225915286$22591528$6$F$20230601$20240702$20230612$20240703$PER$$US-BAUSCHBL-2023BNL004830$BAUSCH AND LOMB$$63$YR$$F$Y$50.848$KG$20240704$$CN$US$US
225919746$22591974$6$F$20211220$20240725$20230612$20240727$EXP$$US-ABBVIE-4345049$ABBVIE$$64$YR$$F$Y$77$KG$20240727$$MD$US$US
225920967$22592096$7$F$20220708$20240805$20230612$20240806$EXP$$NVSC2022JP299781$NOVARTIS$$76$YR$$M$Y$61$KG$20240807$$MD$JP$JP
225923052$22592305$2$F$20220131$20240715$20230613$20240722$PER$$US-BIOGEN-2022BI01093581$BIOGEN$$75$YR$$F$Y$$$20240722$$CN$US$US
225923426$22592342$6$F$20240129$20240613$20230613$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001966$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240708$$CN$US$US
225923743$22592374$3$F$$20240815$20230613$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001958$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
225923955$22592395$5$F$20221215$20240813$20230613$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001961$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240906$$HP$US$US
225925252$22592525$2$F$20230201$20240828$20230613$20240919$PER$$AU-TOLMAR, INC.-23AU041094$TOLMAR$$67$YR$$M$Y$$$20240919$$CN$AU$AU
2259263613$22592636$13$F$20221116$20240919$20230613$20240928$EXP$$CA-CELLTRION INC.-2022CA019775$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
225926564$22592656$4$F$20180701$20240311$20230613$20240916$EXP$$NVSC2023FR133092$NOVARTIS$$$$A$F$Y$65.6$KG$20240916$$LW$FR$FR
2259269910$22592699$10$F$20190506$20240912$20230613$20240921$EXP$$CA-CELLTRION INC.-2019CA021528$CELLTRION$$$$$$Y$$$20240921$$CN$CA$CA
225927174$22592717$4$F$$20240910$20230613$20240913$EXP$$JP-BEH-2023159507$CSL BEHRING$$11$YR$C$M$Y$$$20240913$$MD$JP$JP
2259274610$22592746$10$F$20240201$20240617$20230613$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-001962$ACADIA PHARMACEUTICALS$$26$YR$$F$Y$$$20240712$$CN$US$US
225927614$22592761$4$F$20120101$20240718$20230613$20240723$EXP$$US-BAUSCH-BL-2023-008826$BAUSCH AND LOMB$$55$YR$$M$Y$$$20240723$$CN$US$US
225927677$22592767$7$F$20210101$20240821$20230613$20240903$EXP$$US-ROCHE-3361244$ROCHE$$73$YR$E$M$Y$72.57$KG$20240903$$CN$US$US
225928264$22592826$4$F$$20240703$20230613$20240705$EXP$$NVSC2023US131097$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
225928789$22592878$9$F$20240101$20240802$20230613$20240806$PER$$US-JAZZ PHARMACEUTICALS-2022-US-028425$JAZZ$$47$YR$$F$Y$$$20240806$$HP$US$US
225928832$22592883$2$F$$20230608$20230613$20240904$PER$$NVSC2023US134024$NOVARTIS$$$$$$Y$$$20240904$$CN$US$US
225928924$22592892$4$F$$20240918$20230613$20240930$PER$$NVSC2023US131391$NOVARTIS$$$$$F$Y$$$20240929$$MD$US$US
225930207$22593020$7$F$20230501$20240702$20230613$20240708$PER$$US-BIOGEN-2023BI01207197$BIOGEN$$21$YR$$F$Y$61.744$KG$20240708$$CN$US$US
225930634$22593063$4$F$$20240827$20230613$20240830$PER$$NVSC2023US134278$NOVARTIS$$$$$M$Y$$$20240831$$CN$US$US
225932126$22593212$6$F$20190806$20240726$20230613$20240820$EXP$$CO-UCBSA-2023029435$UCB$$67$YR$$F$Y$48$KG$20240820$$CN$CO$CO
225932183$22593218$3$F$$20240726$20230613$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04445$LUPIN$$$$$$Y$$$20240817$$CN$US$US
225932373$22593237$3$F$$20240730$20230613$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04460$LUPIN$$$$$$Y$$$20240818$$PH$US$US
225933182$22593318$2$F$$20240727$20230613$20240805$PER$$US-SA-2023SA177376$SANOFI AVENTIS$$$$E$F$Y$$$20240805$$MD$US$US
2259334811$22593348$11$F$20231211$20240819$20230613$20240829$PER$$US-SA-2023SA178758$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240829$$MD$US$US
225934912$22593491$2$F$20220401$20230609$20230613$20240926$EXP$$NVSC2023US134077$NOVARTIS$$59$YR$$M$Y$72.57$KG$20240926$$CN$US$US
225936673$22593667$3$F$$20240820$20230613$20240827$PER$$US-SA-2023SA155199$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$HP$US$US
225937098$22593709$8$F$20230605$20240220$20230613$20240926$EXP$$US-GSK-US2023AMR082135$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
225937152$22593715$2$F$20211019$20230607$20230613$20240926$EXP$$US-GSK-US2021AMR227221$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
225937236$22593723$6$F$20240201$20240627$20230613$20240703$EXP$$US-GSK-US2021AMR221394$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$US$US
225937384$22593738$4$F$20220211$20230803$20230613$20240926$EXP$$US-GSK-US2021AMR237327$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
225938562$22593856$2$F$20230524$20240628$20230613$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-082232$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$64.41$KG$20240703$$HP$US$US
225938636$22593863$6$F$$20240717$20230613$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-082541$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240724$$CN$US$US
225938674$22593867$4$F$20220801$20240918$20230613$20240925$PER$$NVSC2023US134655$NOVARTIS$$70$YR$$M$Y$85.729$KG$20240925$$CN$US$US
225939324$22593932$4$F$$20240809$20230613$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-081963$BRISTOL MYERS SQUIBB$Ichiki N, et al. A case of multiple palmoplantar subepidermal blistering disease after use of immune checkpoint inhibitor. The Japanese Journal of Dermatology. 2023;133(5):1355.$71$YR$E$M$Y$$$20240816$$MD$JP$JP
225940015$22594001$5$F$$20240828$20230613$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-080609$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240903$$MD$JP$JP
225940633$22594063$3$F$20230101$20240709$20230613$20240715$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2023-081243$BRISTOL MYERS SQUIBB$$$$$M$Y$76$KG$20240715$$HP$DE$DE
225941132$22594113$2$F$$20240826$20230613$20240827$EXP$$US-TAKEDA-US201848494$TAKEDA$$$$$F$Y$$$20240827$$MD$US$US
2259412511$22594125$11$F$20230607$20240808$20230613$20240814$EXP$$CA-GSK-CA2023AMR080350$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$HP$CA$CA
225942032$22594203$2$F$$20240729$20230613$20240731$PER$$NVSC2023US134874$NOVARTIS$$$$$F$Y$$$20240731$$CN$US$US
225942343$22594234$3$F$$20240730$20230613$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04476$LUPIN$$$$$$Y$$$20240820$$CN$US$US
225942533$22594253$3$F$$20230612$20230613$20240927$PER$$NVSC2023US134846$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
225942582$22594258$2$F$$20240730$20230613$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04510$LUPIN$$$$$$Y$$$20240818$$CN$US$US
225942943$22594294$3$F$20190101$20240822$20230613$20240823$EXP$FR-JNJFOC-20230563661$FR-UCBSA-2023029524$UCB$$52$YR$$F$Y$$$20240823$$MD$FR$FR
225943403$22594340$3$F$$20240726$20230613$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04490$LUPIN$$$$$$Y$$$20240817$$CN$US$US
225944746$22594474$6$F$20230109$20240829$20230613$20240903$EXP$$DE-TAKEDA-2023TUS032983$TAKEDA$$24$YR$$F$Y$90$KG$20240903$$MD$DE$DE
225945046$22594504$6$F$$20240918$20230613$20240930$PER$$NVSC2023US133937$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
225945243$22594524$3$F$$20240731$20230613$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04506$LUPIN$$$$$$Y$$$20240820$$CN$US$US
225945906$22594590$6$F$20230606$20240730$20230613$20240802$EXP$$GB-MYLANLABS-2023M1061519$MYLAN$$36$YR$$M$Y$$$20240802$$CN$GB$GB
2259465714$22594657$14$F$20220616$20240911$20230613$20240916$EXP$$NVSC2022CH169584$NOVARTIS$$52$YR$$F$Y$55.8$KG$20240916$$MD$CH$CH
225947044$22594704$4$F$20221103$20240701$20230613$20240709$PER$$AT-PUMA BIOTECHNOLOGY, LTD.-2023-PUM-AT000931$PUMA$$$$$$Y$$$20240709$$HP$AT$AT
225947113$22594711$3$F$$20240730$20230613$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04513$LUPIN$$$$$$Y$$$20240818$$CN$US$US
225947552$22594755$2$F$$20240730$20230613$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04516$LUPIN$$$$$$Y$$$20240819$$CN$US$US
225947753$22594775$3$F$$20240730$20230613$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04515$LUPIN$$$$$$Y$$$20240820$$CN$US$US
225947838$22594783$8$F$$20240923$20230613$20240925$PER$$US-PFIZER INC-PV202300094125$PFIZER$$70$YR$$F$Y$$$20240925$$CN$US$US
225948584$22594858$4$F$$20240730$20230613$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04528$LUPIN$$$$$$Y$$$20240819$$CN$US$US
225948674$22594867$4$F$20211030$20240809$20230613$20240815$EXP$$CA-TAKEDA-2021TUS068246$TAKEDA$$77$YR$$M$Y$$$20240815$$HP$CA$CA
225948714$22594871$4$F$20220101$20240627$20230613$20240701$PER$$US-PFIZER INC-PV202300102188$PFIZER$$67$YR$$F$Y$$$20240701$$HP$US$US
225949935$22594993$5$F$$20230313$20230613$20240806$PER$$NVSC2023US135056$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
225950223$22595022$3$F$$20240911$20230613$20240920$EXP$$FR-CELLTRION INC.-2023FR011775$CELLTRION$Delbet J, Hogan J, Parmentier C, Ulinski T and Dossier C. Successful global anti-B-cell strategy with daratumumab in a patient with post-transplant nephrotic syndrome recurrence unresponsive to immunoadsorption and obinutuzumab. Pediatric transplantation. 2023;E14544$$$$$Y$$$20240920$$HP$FR$FR
225951003$22595100$3$F$20230525$20240913$20230613$20240927$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392885$RANBAXY$$83$YR$$F$Y$53.3$KG$20240927$$PH$BR$BR
225951382$22595138$2$F$20130101$20240717$20230613$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-393880$RANBAXY$$$$$F$Y$$$20240718$$MD$FR$FR
225951512$22595151$2$F$$20240909$20230613$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394290$RANBAXY$Qiongwen Z, Ying H. Bipolar disorder cured by vitamin D supplementation in a 15-year-old boy: A case report. Bipolar Disord. 2022;24(3):334-336$15$YR$$M$Y$$$20240913$$HP$CN$CN
225951672$22595167$2$F$$20240822$20230613$20240828$PER$$US-PFIZER INC-PV202300103149$PFIZER$$33$YR$$M$Y$$$20240828$$CN$US$US
225952133$22595213$3$F$$20240703$20230613$20240712$PER$$US-SA-2023SA178186$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240712$$MD$US$US
225953143$22595314$3$F$$20240713$20230613$20240723$EXP$$NVSC2023KR133591$NOVARTIS$Ryoo YW, Yun JM, Kim HW, Kim S. Early-onset generalized pustular psoriasis of pregnancy following hydroxychloroquine use. ANNALS OF DERMATOLOGY. 2023;35(1):S43-7$$$N$$Y$$$20240723$$HP$KR$KR
225953858$22595385$8$F$20230101$20240625$20230613$20240704$PER$$US-SA-2023SA178431$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240704$$MD$US$US
225954744$22595474$4$F$$20240805$20230613$20240809$EXP$$US-PFIZER INC-PV202200119172$PFIZER$$86$YR$$F$Y$$$20240809$$CN$US$US
225955872$22595587$2$F$$20240805$20230613$20240807$EXP$$NVSC2023US131410$NOVARTIS$$$$$M$Y$$$20240807$$CN$US$US
2259578010$22595780$10$F$20230822$20240711$20230613$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-012437$JAZZ$$30$YR$$F$Y$$$20240722$$CN$US$US
225958102$22595810$2$F$$20240716$20230613$20240718$PER$$US-PFIZER INC-PV202300103230$PFIZER$$71$YR$$M$Y$$$20240718$$CN$US$US
225958184$22595818$4$F$$20240802$20230613$20240806$PER$$US-PFIZER INC-PV202300102995$PFIZER$$54$YR$$F$Y$84.46$KG$20240806$$PH$US$US
225958293$22595829$3$F$$20240918$20230613$20240920$PER$$US-PFIZER INC-PV202300104491$PFIZER$$78$YR$$F$Y$$$20240920$$MD$US$US
225962952$22596295$2$F$20230520$20240723$20230613$20240819$PER$$GT-TOLMAR, INC.-23GT041075$TOLMAR$$74$YR$$M$Y$$$20240814$$CN$GT$GT
225963195$22596319$5$F$$20240726$20230613$20240730$PER$$US-PFIZER INC-202300220456$PFIZER$$79$YR$$F$Y$$$20240730$$CN$US$US
225963313$22596331$3$F$$20240627$20230613$20240701$PER$$US-PFIZER INC-PV202300104034$PFIZER$$51$YR$$M$Y$87.4$KG$20240701$$MD$US$US
225963324$22596332$4$F$$20240722$20230613$20240723$30DAY$$JP-PFIZER INC-PV202300101149$PFIZER$$13$YR$$M$Y$$$20240723$$CN$JP$JP
225964793$22596479$3$F$$20240709$20230613$20240713$EXP$$PL-SA-2022SA514969$SANOFI AVENTIS$Niedzwiedz M, Zebrowska A, Lesiak A, Narbutt J, Skibinska M.. Enoxaparin-induced eruptive angiokeratomas.. Pol Arch Intern Med.. 2023;133(5):1-2$78$YR$E$M$Y$$$20240713$$MD$PL$PL
225965182$22596518$2$F$$20240906$20230613$20240910$PER$$NVSC2023US133427$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
225965372$22596537$2$F$$20240816$20230613$20240822$EXP$$CA-TAKEDA-2023TUS057712$TAKEDA$$$$$M$Y$$$20240822$$CN$CA$CA
225966105$22596610$5$F$20230316$20240702$20230613$20240705$EXP$$CA-TAKEDA-2023TUS043516$TAKEDA$$61$YR$$M$Y$$$20240705$$HP$CA$CA
225966154$22596615$4$F$$20240717$20230613$20240722$PER$$US-PFIZER INC-202300182046$PFIZER$$59$YR$$F$Y$$$20240722$$MD$US$US
225966388$22596638$8$F$20200601$20240822$20230613$20240829$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202306004282$ELI LILLY AND CO$$80$YR$E$M$Y$69$KG$20240829$$CN$CA$DE
2259701216$22597012$16$F$20200228$20240918$20230613$20240928$EXP$$CA-CELLTRION INC.-2020CA019892$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
225970183$22597018$3$F$20230601$20240724$20230613$20240729$EXP$$US-ABBVIE-5287131$ABBVIE$$55$YR$$F$Y$$$20240729$$CN$US$US
225970582$22597058$2$F$20220909$20240912$20230613$20240917$EXP$$JP-JNJFOC-20230559652$JOHNSON AND JOHNSON$Nagai K, Suzuki M, Oku Y, Yamamoto J, Nobuchi T, Nakai S, et al.. P-66 A Case of Oral Care Intervention for Oral Hemorrhage Probably Caused by Xarelto. The 20th Annual Meeting of the Japanese Society of Oral Care. 2023;231$86$YR$E$F$Y$$$20240917$$HP$JP$JP
225970712$22597071$2$F$20230501$20240719$20230613$20240729$EXP$$US-ABBVIE-5288071$ABBVIE$$64$YR$$F$Y$$$20240729$$CN$US$US
2259709511$22597095$11$F$20221124$20240918$20230613$20240924$EXP$$US-TAKEDA-2022TUS017370$TAKEDA$$68$YR$$F$Y$73$KG$20240924$$HP$US$US
225971562$22597156$2$F$20150101$20240712$20230614$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202306007579$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240716$$CN$US$US
225971832$22597183$2$F$$20240827$20230614$20240828$EXP$$CA-TAKEDA-CA202022489$TAKEDA$$$$$F$Y$$$20240828$$CN$CA$CA
225974733$22597473$3$F$$20240620$20230614$20240710$PER$$CA-TOLMAR, INC.-23CA041131$TOLMAR$$$$$M$Y$$$20240710$$CN$CA$CA
225975328$22597532$8$F$20230101$20240708$20230614$20240712$EXP$$US-ABBVIE-4342960$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
225976156$22597615$6$F$20230524$20240806$20230614$20240827$PER$$CA-TOLMAR, INC.-23CA041070$TOLMAR$$84$YR$$M$Y$$$20240827$$CN$CA$CA
225976382$22597638$2$F$20220101$20240813$20230614$20240815$EXP$$ES-ROCHE-3366872$ROCHE$$40$YR$A$M$Y$$$20240815$$MD$ES$ES
225976422$22597642$2$F$$20240730$20230614$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04517$LUPIN$$$$$$Y$$$20240820$$CN$US$US
225976792$22597679$2$F$$20240703$20230614$20240712$EXP$$CA-CELLTRION INC.-2023CA008645$CELLTRION$$$$$$Y$$$20240712$$HP$CA$CA
225976854$22597685$4$F$$20240722$20230614$20240725$EXP$$SK-TAKEDA-2023TUS057494$TAKEDA$$$$E$F$Y$$$20240725$$CN$SK$SK
225976993$22597699$3$F$$20240814$20230614$20240827$EXP$US-MLMSERVICE-20230525-4305439-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-06340$ALKEM$King R, Sekar P, Patel H, Naveed M, Aqtash S, Adroja S, Jacob D, Riaz T. CNS toxoplasmosis, a rare presentation in a patient with Myasthenia Gravis. IDCases. 2023;32:e01780$78$YR$$M$Y$$$20240827$$MD$US$US
225977004$22597700$4$F$20230101$20240710$20230614$20240712$PER$$US-AMGEN-USASP2023101699$AMGEN$$51$YR$A$M$Y$$$20240712$$HP$US$US
225977012$22597701$2$F$20230608$20240724$20230614$20240802$30DAY$$US-GSK-US2023080918$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240802$$CN$US$US
225977032$22597703$2$F$$20240815$20230614$20240827$EXP$$CA-AUROBINDO-AUR-APL-2023-041588$AUROBINDO$$35$YR$$F$Y$56$KG$20240827$$MD$CA$CA
225979144$22597914$4$F$20230201$20240816$20230614$20240827$PER$$US-SA-2023SA180296$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240827$$MD$US$US
225979294$22597929$4$F$20230101$20240829$20230614$20240910$EXP$$US-SA-2023SA178333$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240910$$MD$US$US
225979518$22597951$8$F$20230101$20240627$20230614$20240703$EXP$$US-UCBSA-2023023723$UCB$$$$$M$Y$78$KG$20240703$$CN$US$US
225980734$22598073$4$F$20230505$20240613$20230614$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001999$ACADIA PHARMACEUTICALS$$62$YR$$M$Y$$$20240708$$CN$US$US
225983162$22598316$2$F$20080101$20240809$20230614$20240821$EXP$$US-COLLEGIUM PHARMACEUTICAL, INC.-20230500453$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240821$$CN$US$US
225984263$22598426$3$F$$20240910$20230614$20240918$EXP$$CA-CELLTRION INC.-2022CA019764$CELLTRION$$$$$$Y$$$20240918$$CN$CA$CA
225986523$22598652$3$F$20230501$20240730$20230614$20240807$EXP$$NL-BIOGEN-2023BI01210584$BIOGEN$$65$YR$$F$Y$$$20240807$$HP$NL$NL
225987114$22598711$4$F$20221201$20240715$20230614$20240722$EXP$$FR-AUROBINDO-AUR-APL-2023-041526$AUROBINDO$C. Hoebeke, A. Dollinger, M. Chouk, F. Verhoeven, C. Prati, D. Wendling et al... rheumatologist in Rheumatoid arthritis: a case to rack your brains.. Rheumatologist letter. 2023;44-46$68$YR$$F$Y$$$20240722$$MD$FR$FR
225987414$22598741$4$F$20230101$20240829$20230614$20240906$EXP$$US-ABBVIE-5289118$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
225987613$22598761$3$F$$20240722$20230614$20240731$30DAY$$US-GSK-US2023079189$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$CN$US$US
225989202$22598920$2$F$20220601$20230608$20230614$20240922$EXP$$NVSC2023US132387$NOVARTIS$$61$YR$$F$Y$108.86$KG$20240922$$CN$US$US
225989285$22598928$5$F$$20240719$20230614$20240729$EXP$$US-GSK-US2023082258$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
225990063$22599006$3$F$$20240904$20230614$20240917$EXP$$US-SA-2023SA177821$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240917$$CN$US$US
225990643$22599064$3$F$$20240912$20230614$20240923$PER$$US-GSK-US2023AMR081818$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
225996435$22599643$5$F$20221012$20240710$20230614$20240710$EXP$$CA-PFIZER INC-202201117768$PFIZER$$45$YR$$M$Y$$$20240710$$MD$CA$CA
225998304$22599830$4$F$20230101$20240819$20230614$20240828$PER$$US-SA-2023SA179129$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240828$$MD$US$US
225998864$22599886$4$F$$20240627$20230614$20240708$PER$$US-SA-2023SA016797$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240708$$MD$US$US
225998963$22599896$3$F$20230501$20240816$20230614$20240830$PER$$US-SA-2023SA180761$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240830$$MD$US$US
225999284$22599928$4$F$20230517$20240710$20230614$20240715$EXP$$ES-PFIZER INC-202300217301$PFIZER$$69$YR$$M$Y$$$20240715$$MD$ES$ES
225999965$22599996$5$F$20221017$20240703$20230614$20240705$EXP$$US-OTSUKA-2023_015411$OTSUKA$$20$YR$$M$Y$70.31$KG$20240705$$CN$US$US
226000129$22600012$9$F$20230101$20240711$20230614$20240718$PER$$US-SA-2023SA181142$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240718$$MD$US$US
226000626$22600062$6$F$20230601$20240821$20230614$20240905$PER$$US-SA-2023SA181084$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240905$$MD$US$US
226000862$22600086$2$F$20230101$20240722$20230614$20240731$PER$$US-SA-2023SA181147$SANOFI AVENTIS$$11$YR$C$F$Y$34$KG$20240731$$MD$US$US
226001733$22600173$3$F$20230101$20240714$20230614$20240801$EXP$$US-SA-2023SA181751$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240719$$MD$US$US
226002453$22600245$3$F$$20230609$20230614$20240808$EXP$$US-OTSUKA-2023_015655$OTSUKA$$$$$M$Y$68.04$KG$20240808$$HP$US$US
226003617$22600361$7$F$20230101$20240910$20230614$20240918$EXP$$JP-009507513-2305JPN001254J$MERCK$$68$YR$$M$Y$$$20240918$$MD$JP$JP
226004382$22600438$2$F$20230601$20240918$20230614$20240930$PER$$NVSC2023US135845$NOVARTIS$$73$YR$$F$Y$$$20240929$$CN$US$US
2260044510$22600445$10$F$20221223$20240723$20230614$20240725$EXP$$US-TAKEDA-2022TUS103873$TAKEDA$$42$YR$$F$Y$$$20240725$$MD$US$US
226004897$22600489$7$F$$20240805$20230614$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-083505$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240807$$CN$US$US
226005652$22600565$2$F$$20240808$20230614$20240812$PER$$US-PFIZER INC-2021245234$PFIZER$$59$YR$$F$Y$$$20240812$$CN$US$US
226005662$22600566$2$F$$20240702$20230614$20240703$PER$$US-PFIZER INC-202300217075$PFIZER$$65$YR$$F$Y$$$20240703$$CN$US$US
226005866$22600586$6$F$20230101$20240718$20230614$20240723$EXP$$US-ABBVIE-5288438$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
226005913$22600591$3$F$20240101$20240905$20230614$20240913$PER$$US-SA-2023SA181469$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240913$$MD$US$US
226006292$22600629$2$F$$20240730$20230614$20240801$PER$$US-PFIZER INC-202300218117$PFIZER$$$$$F$Y$$$20240801$$CN$US$US
226006506$22600650$6$F$20230101$20240809$20230614$20240816$EXP$$JP-009507513-2305JPN002241J$MERCK$$73$YR$$F$Y$54$KG$20240816$$MD$JP$JP
226006737$22600673$7$F$20230609$20240730$20230614$20240802$EXP$$AU-TAKEDA-2022TUS094366$TAKEDA$$57$YR$$F$Y$$$20240802$$CN$AU$AU
226007004$22600700$4$F$20230104$20240725$20230614$20240730$EXP$$US-TAKEDA-2023TUS057431$TAKEDA$$32$YR$$M$Y$149$KG$20240730$$HP$US$US
226007802$22600780$2$F$$20240909$20230614$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394331$RANBAXY$Krishnan N, Baltus T, Chan A. A GRAVE SITUATION: HYPERTHYROIDISM IN PREGNANCY. J Paediatr Child Health. 2023;59 (supp 1):89-90$24$YR$$F$Y$$$20240913$$HP$AU$AU
226007852$22600785$2$F$$20240826$20230614$20240904$EXP$$SG-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392952$RANBAXY$Tan Y-J, Sim CY, Narasimhalu K, Lim KS. New-onset refractory status epilepticus after first dose of tozinameran. Neurol Asia. 2022;Sept; 27(3):771-776$18$YR$$M$Y$$$20240904$$HP$SG$SG
226008002$22600800$2$F$$20240626$20230614$20240711$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394469$RANBAXY$Wu MJ, Chen YC, Cui XL, Yang Q, Xue QL. Tislelizumab for squamous lung cancer combined with basal cell carcinoma of the skin. Medicine. 2023;102(19):e33788$74$YR$$M$Y$$$20240711$$HP$CN$CN
226008142$22600814$2$F$$20240702$20230614$20240702$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394447$RANBAXY$Nagamine T. Beware of serotonin syndrome during the COVID-19 pandemic. Aust N Z J Psychiatry. 2022;56(7):862-85$74$YR$$M$Y$$$20240702$$HP$JP$JP
226008162$22600816$2$F$$20240709$20230614$20240710$EXP$$RS-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392841$RANBAXY$Sakic B, Gres A, Gajic Z. Mirtazapine-Induced Hyponatremia In A Patient With Systemic Mastocytosis And Generalized Anxiety Disorder. Psychiatr Danub. 2023;35(1):126-127$34$YR$$F$Y$$$20240710$$MD$RS$RS
226008205$22600820$5$F$20230402$20240827$20230614$20240909$EXP$$AU-ABBVIE-5290305$ABBVIE$$56$YR$$F$Y$66$KG$20240909$$MD$AU$AU
2260082119$22600821$19$F$20090101$20240909$20230614$20240919$EXP$GB-MHRA-ADR 27803572$GB-JUBILANT PHARMA LTD-2023GB000528$JUBILANT$$37$YR$$M$Y$$$20240919$$CN$GB$GB
226008472$22600847$2$F$$20240703$20230614$20240703$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394609$RANBAXY$Sadowska B, Gawinowska M, Sztormowska M, Chelminska. Hypersensitivity of azo dyes in urticaria patients based on a single-blind, placebo-controlled oral challenge. Adv Dermatol Allergol. 2022;5:877-879$53$YR$$M$Y$$$20240703$$MD$PL$PL
226008665$22600866$5$F$$20240715$20230614$20240717$EXP$$US-PFIZER INC-PV202300102824$PFIZER$$79$YR$$F$Y$$$20240717$$CN$US$US
226009183$22600918$3$F$20230501$20240627$20230614$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202306002411$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240709$$CN$US$US
226010224$22601022$4$F$20221006$20240701$20230614$20240702$PER$$US-PFIZER INC-202300217522$PFIZER$$31$YR$$F$Y$135$KG$20240702$$CN$US$US
226015142$22601514$2$F$$20240808$20230614$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-083905$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240813$$HP$US$US
226015959$22601595$9$F$20230503$20240901$20230614$20240905$EXP$$JP-AMGEN-JPNSP2023100401$AMGEN$$73$YR$E$F$Y$36$KG$20240905$$MD$JP$JP
226016274$22601627$4$F$20220314$20240828$20230614$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-080834$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240904$$MD$JP$JP
226016783$22601678$3$F$$20240918$20230614$20240930$EXP$$NVSC2023US135201$NOVARTIS$$$$$F$Y$$$20240930$$HP$US$US
226017812$22601781$2$F$20230609$20230609$20230614$20240924$PER$$US-ABBVIE-5287828$ABBVIE$$60$YR$$F$Y$$$20240924$$CN$US$US
226018682$22601868$2$F$$20230612$20230614$20240904$PER$$NVSC2023US136156$NOVARTIS$$$$$$Y$$$20240904$$MD$US$US
226018762$22601876$2$F$20230513$20230515$20230614$20240715$PER$$US-MYLANLABS-2023M1051605$BIOCON$$48$YR$$F$Y$$$20240715$$PH$US$US
226019173$22601917$3$F$20230403$20240709$20230614$20240724$EXP$$CN-G1 THERAPEUTICS-2023G1CN0000099$G1 THERAPEUTICS$$$$$$Y$$$20240724$$MD$CN$CN
226021733$22602173$3$F$20230505$20240821$20230614$20240829$EXP$$BR-TAKEDA-2023TUS051391$TAKEDA$$67$YR$$F$Y$$$20240829$$CN$BR$BR
226022019$22602201$9$F$20230605$20240715$20230614$20240723$EXP$$CO-TAKEDA-2023TUS058199$TAKEDA$$18$YR$$M$Y$54$KG$20240723$$CN$CO$CO
226022084$22602208$4$F$20240709$20240709$20230614$20240712$EXP$$CA-TAKEDA-2023TUS034130$TAKEDA$$80$YR$$M$Y$$$20240712$$CN$CA$CA
226022284$22602228$4$F$$20240716$20230614$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-243992$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240717$$CN$US$US
2260223240$22602232$40$F$20230423$20240903$20230614$20240909$EXP$$MX-TAKEDA-2023TUS054944$TAKEDA$$46$YR$$F$Y$$$20240909$$HP$MX$MX
226022996$22602299$6$F$20230307$20240825$20230614$20240827$EXP$$NL-BAUSCH-BL-2023-009036$BAUSCH AND LOMB$$81$YR$$M$Y$74.4$KG$20240827$$HP$NL$NL
226023276$22602327$6$F$20240601$20240912$20230614$20240918$EXP$$US-INCYTE CORPORATION-2023IN005996$INCYTE$$$$$$Y$$$20240918$$CN$US$US
2260238713$22602387$13$F$20200101$20240822$20230614$20240829$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-004418$AMGEN$$61$YR$A$F$Y$$$20240828$$MD$US$US
226024419$22602441$9$F$20230101$20240807$20230614$20240823$EXP$$US-BEH-2023159710$CSL BEHRING$$35$YR$A$M$Y$$$20240823$$CN$US$US
226025102$22602510$2$F$20210501$20240910$20230614$20240917$EXP$$US-ABBVIE-5289342$ABBVIE$$46$YR$$F$Y$$$20240917$$CN$US$US
226025293$22602529$3$F$$20240801$20230614$20240809$EXP$$AT-ABBVIE-5288787$ABBVIE$$$$$$Y$$$20240809$$HP$AT$AT
226025765$22602576$5$F$20230315$20240626$20230614$20240704$EXP$$NVSJ2023JP009342$NOVARTIS$$65$YR$$F$Y$$$20240704$$MD$JP$JP
226026642$22602664$2$F$$20240705$20230615$20240716$EXP$$CA-CELLTRION INC.-2023CA011976$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
226027813$22602781$3$F$20240501$20240716$20230615$20240724$PER$$US-SA-2023SA181900$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240724$$MD$US$US
226027929$22602792$9$F$20230101$20240906$20230615$20240916$EXP$$CA-CELLTRION INC.-2022CA012259$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
226029762$22602976$2$F$20230607$20230608$20230615$20240925$PER$$US-GSK-US2023AMR081965$GLAXOSMITHKLINE$$72$YR$$M$Y$$$20240925$$CN$US$US
226029793$22602979$3$F$20230615$20230619$20230615$20240925$PER$$US-GSK-US2023AMR082615$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
226030023$22603002$3$F$$20230621$20230615$20240925$PER$$US-GSK-US2023AMR079924$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
226030916$22603091$6$F$$20240824$20230615$20240828$EXP$$NVSC2023CO135300$NOVARTIS$$$$$F$Y$63$KG$20240828$$CN$CO$CO
226030984$22603098$4$F$$20240701$20230615$20240711$30DAY$$US-NOVOPROD-1076074$NOVO NORDISK$$$$E$F$Y$$$20240711$$CN$US$US
226031434$22603143$4$F$$20240726$20230615$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04541$LUPIN$$$$$$Y$$$20240816$$CN$US$US
226031592$22603159$2$F$20230501$20240802$20230615$20240812$EXP$$US-ORPHANEU-2023003493$RECORDATI$$$$$$Y$$$20240812$$CN$US$US
226031665$22603166$5$F$$20240808$20230615$20240814$EXP$$US-TAKEDA-2023TUS056787$TAKEDA$$$$$F$Y$92$KG$20240814$$CN$US$US
226031833$22603183$3$F$20220516$20240802$20230615$20240809$EXP$$CA-CELLTRION INC.-2022CA007172$CELLTRION$$$$$$Y$$$20240809$$HP$CA$CA
226032773$22603277$3$F$$20240809$20230615$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04564$LUPIN$$$$$$Y$$$20240829$$CN$US$US
2260334316$22603343$16$F$20191224$20240816$20230615$20240822$EXP$$AT-ROCHE-3368603$ROCHE$$32$YR$A$F$Y$62$KG$20240822$$MD$AT$AT
226033513$22603351$3$F$$20240809$20230615$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04523$LUPIN$$$$$$Y$$$20240901$$CN$US$US
226034085$22603408$5$F$20230609$20230707$20230615$20240925$EXP$$US-GSK-US2023AMR083294$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
226034515$22603451$5$F$20240626$20240720$20230615$20240728$PER$$US-BEH-2023159787$CSL BEHRING$$57$YR$A$F$Y$$$20240728$$CN$US$US
226035214$22603521$4$F$$20240801$20230615$20240808$EXP$$BR-CELLTRION INC.-2023BR000324$CELLTRION$$$$$$Y$$$20240808$$CN$BR$BR
226037672$22603767$2$F$$20240703$20230615$20240704$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-244024$BOEHRINGER INGELHEIM$$$$$$Y$$$20240704$$MD$US$US
2260377915$22603779$15$F$20230101$20240920$20230615$20240930$EXP$$CA-CELLTRION INC.-2023CA009798$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
226038304$22603830$4$F$20230301$20240907$20230615$20240912$EXP$$CA-JNJFOC-20230414915$JOHNSON AND JOHNSON$$26$YR$A$F$Y$109$KG$20240912$$HP$CA$CA
226039323$22603932$3$F$20230530$20240709$20230615$20240716$EXP$$NVSC2023PE091375$NOVARTIS$$45$YR$$F$Y$$$20240716$$CN$PE$PE
226040136$22604013$6$F$20240716$20240716$20230615$20240813$PER$$CA-TOLMAR, INC.-23CA041098$TOLMAR$$57$YR$$M$Y$$$20240813$$CN$CA$CA
226040273$22604027$3$F$$20240918$20230615$20240930$PER$$NVSC2023US136261$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
2260407810$22604078$10$F$20221114$20240830$20230615$20240902$EXP$$NVSC2023RU012016$NOVARTIS$$48$YR$$F$Y$83$KG$20240902$$MD$RU$RU
226042574$22604257$4$F$$20240819$20230615$20240827$EXP$$IL-TAKEDA-2023TUS058262$TAKEDA$$$$$F$Y$$$20240827$$CN$IL$IL
226043014$22604301$4$F$20230803$20240802$20230615$20240808$EXP$$CA-TAKEDA-2019TUS053784$TAKEDA$$74$YR$$F$Y$$$20240808$$CN$CA$CA
226043183$22604318$3$F$20240813$20240919$20230615$20240926$EXP$$CA-GSK-CA2023AMR069261$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$CA$CA
226043423$22604342$3$F$$20240909$20230615$20240920$EXP$GR-STERISCIENCE B.V.-2023-ST-001464$GR-STERISCIENCE B.V.-2023-ST-001464$Steriscience PTE$Kaiafa G, Daios S, Bountola S, Perifanis V, Matiakis A, Savopoulos C.. cthyma gangrenosum as the primary manifestation of acute myeloid leukemia in a previously healthy patient.. Pol-Arch-Med-Wewn. 2022;132(11)$50$YR$$F$Y$$$20240920$$MD$GR$GR
226043508$22604350$8$F$$20240916$20230615$20240920$EXP$$CA-GSK-CA2023AMR081437$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$MD$CA$CA
2260440314$22604403$14$F$20120901$20240827$20230615$20240906$EXP$$CA-ROCHE-3365192$ROCHE$$65$YR$E$F$Y$58$KG$20240906$$HP$CA$CA
226046632$22604663$2$F$$20240729$20230615$20240806$PER$$US-SA-2023SA181818$SANOFI AVENTIS$$$$E$M$Y$$$20240806$$MD$US$US
226048612$22604861$2$F$$20240823$20230615$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-080043$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240827$$CN$US$US
226050309$22605030$9$F$20230101$20240905$20230615$20240910$EXP$$CA-PFIZER INC-202300144556$PFIZER$$50$YR$$F$Y$$$20240910$$MD$CA$CA
226050658$22605065$8$F$20230101$20240920$20230615$20240927$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-244012$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240927$$CN$US$US
226051154$22605115$4$F$20230101$20240626$20230615$20240704$EXP$$JP-009507513-2302JPN003198J$MERCK$$43$YR$$F$Y$$$20240704$$MD$JP$JP
226051354$22605135$4$F$20230101$20240827$20230615$20240903$EXP$$JP-009507513-2306JPN001420J$MERCK$$7$DEC$$$Y$$$20240903$$MD$JP$JP
226051642$22605164$2$F$$20240626$20230615$20240702$EXP$$JP-009507513-2306JPN001573J$MERCK$$60$YR$$F$Y$$$20240702$$MD$JP$JP
226051754$22605175$4$F$20230201$20240626$20230615$20240702$EXP$$JP-009507513-2302JPN000274J$MERCK$$54$YR$$F$Y$$$20240702$$MD$JP$JP
226052637$22605263$7$F$20230609$20240819$20230615$20240821$EXP$$CA-PFIZER INC-202300219537$PFIZER$$72$YR$$F$Y$70$KG$20240821$$HP$CA$CA
226053536$22605353$6$F$20230220$20240904$20230615$20240911$EXP$$CA-ROCHE-3365848$ROCHE$$57$YR$A$F$Y$$$20240911$$CN$CA$CA
226054202$22605420$2$F$$20240919$20230615$20240925$EXP$$PT-MYLANLABS-2023M1062337$MYLAN$$62$YR$$M$Y$$$20240925$$MD$PT$PT
226055834$22605583$4$F$20220901$20230804$20230615$20240808$EXP$$US-OTSUKA-2023_015459$OTSUKA$$56$YR$$F$Y$56.7$KG$20240808$$CN$US$US
226056766$22605676$6$F$20221111$20240710$20230615$20240716$EXP$$ES-PFIZER INC-202300217300$PFIZER$$65$YR$$M$Y$$$20240716$$MD$ES$ES
226057606$22605760$6$F$20210101$20240712$20230615$20240718$EXP$$US-PFIZER INC-US-GBT-21-00981$PFIZER$$43$YR$$F$Y$$$20240718$$CN$US$US
226058212$22605821$2$F$20230316$20240801$20230615$20240802$EXP$$CN-PFIZER INC-PV202300103408$PFIZER$$57$YR$$F$Y$80$KG$20240802$$HP$CN$CN
226058792$22605879$2$F$$20240819$20230615$20240824$EXP$$NVSC2023IN136693$NOVARTIS$Kaur P, Munikoty V, Chandramohan V. Carbamazepine-triggered hemophagocytic lymphohistiocytosis: A case report and review of literature. PEDIATRIC NEUROLOGY. 2023;144:69-71$4$YR$$F$Y$$$20240824$$HP$IN$IN
226059292$22605929$2$F$20230101$20240828$20230615$20240909$PER$$US-SA-2023SA182374$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240909$$MD$US$US
226060462$22606046$2$F$$20240715$20230615$20240722$PER$$US-BIOGEN-2023BI01210421$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
226061233$22606123$3$F$20230426$20240705$20230615$20240711$EXP$$CN-TAKEDA-2023TUS058228$TAKEDA$$68$YR$$M$Y$$$20240711$$MD$CN$CN
226061252$22606125$2$F$$20240705$20230615$20240716$PER$$US-SA-2023SA182289$SANOFI AVENTIS$$$$C$F$Y$$$20240716$$MD$US$US
2260629722$22606297$22$F$20230508$20240701$20230615$20240724$EXP$$CH-SA-2023SA147633$SANOFI AVENTIS$$46$YR$A$M$Y$100.1$KG$20240724$$HP$CH$CH
226065472$22606547$2$F$$20240722$20230615$20240729$EXP$$US-JAZZ-2022-US-033751$JAZZ$$$$$F$Y$$$20240728$$HP$US$US
226065913$22606591$3$F$$20240705$20230615$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-083771$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240717$$HP$CA$CA
226066473$22606647$3$F$20230607$20240923$20230615$20240925$EXP$$US-TAKEDA-2023TUS057743$TAKEDA$$7$YR$$M$Y$$$20240925$$PH$US$US
226066575$22606657$5$F$20240109$20240819$20230615$20240826$EXP$$BR-TAKEDA-2023TUS058751$TAKEDA$$46$YR$$F$Y$$$20240826$$CN$BR$BR
226066652$22606665$2$F$$20240625$20230615$20240704$PER$$US-SA-2023SA182248$SANOFI AVENTIS$$$$A$M$Y$$$20240704$$MD$US$US
226067975$22606797$5$F$20230101$20240731$20230615$20240731$EXP$$CA-PFIZER INC-202300194281$PFIZER$$56$YR$$M$Y$$$20240731$$PH$CA$CA
226068668$22606866$8$F$20230101$20240815$20230615$20240820$PER$$US-PFIZER INC-PV202300086634$PFIZER$$73$YR$$F$Y$$$20240820$$HP$US$US
226069914$22606991$4$F$20230501$20240730$20230615$20240807$EXP$$JP-009507513-2306JPN001056J$MERCK$$5$DEC$$F$Y$$$20240807$$MD$JP$JP
226070842$22607084$2$F$$20230614$20230615$20240926$PER$$NVSC2023US137261$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
226071522$22607152$2$F$$20240710$20230615$20240717$PER$$US-SA-2023SA182372$SANOFI AVENTIS$$$$E$F$Y$$$20240717$$MD$US$US
226071706$22607170$6$F$20230118$20240819$20230615$20240821$EXP$$NVSJ2023JP007189$NOVARTIS$$43$YR$$F$Y$42$KG$20240822$$MD$JP$JP
226072282$22607228$2$F$20230101$20240731$20230615$20240807$EXP$$US-ABBVIE-5290300$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
226072767$22607276$7$F$20230522$20240614$20230615$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002023$ACADIA PHARMACEUTICALS$$17$YR$$F$Y$53$KG$20240709$$CN$US$US
226073214$22607321$4$F$20230605$20240905$20230615$20240912$EXP$$US-ABBVIE-5289183$ABBVIE$$62$YR$$F$Y$$$20240912$$CN$US$US
226073536$22607353$6$F$$20240904$20230616$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002048$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
226074923$22607492$3$F$20231125$20240619$20230616$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002025$ACADIA PHARMACEUTICALS$$54$YR$$M$Y$$$20240712$$CN$US$US
226075849$22607584$9$F$20230501$20240624$20230616$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-001972$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240718$$CN$US$US
2260759613$22607596$13$F$20230101$20240626$20230616$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002002$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
226076082$22607608$2$F$20230515$20240625$20230616$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002052$ACADIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240719$$CN$US$US
226076955$22607695$5$F$20230913$20240815$20230616$20240904$PER$$CA-TOLMAR, INC.-23CA041154$TOLMAR$$75$YR$$M$Y$$$20240904$$CN$CA$CA
226076983$22607698$3$F$20221001$20240715$20230616$20240819$PER$$CO-TOLMAR, INC.-23CO041117$TOLMAR$$67$YR$$M$Y$72$KG$20240814$$CN$CO$CO
226077033$22607703$3$F$20230501$20240628$20230616$20240705$EXP$$US-ABBVIE-22K-163-4532969-00$ABBVIE$$79$YR$$F$Y$$$20240705$$CN$US$US
226077292$22607729$2$F$$20240806$20230616$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-084790$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240809$$CN$US$US
226077492$22607749$2$F$20230101$20240814$20230616$20240819$PER$$US-AMGEN-USASP2023104219$AMGEN$$73$YR$E$M$Y$$$20240819$$CN$US$US
226078483$22607848$3$F$20210429$20240712$20230616$20240726$EXP$$DE-ROCHE-2838411$ROCHE$$33$YR$A$F$Y$$$20240726$$CN$DE$DE
226078892$22607889$2$F$20230613$20240910$20230616$20240918$PER$$US-AMGEN-USASP2023103618$AMGEN$$64$YR$A$F$Y$$$20240918$$CN$US$US
226079062$22607906$2$F$$20240705$20230616$20240716$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02029$HIKMA$$82$YR$$M$Y$74$KG$20240716$$HP$CA$CA
226079932$22607993$2$F$$20240705$20230616$20240715$PER$$US-SA-2023SA183769$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240715$$CN$US$US
226079952$22607995$2$F$$20240828$20230616$20240910$PER$$US-SA-2023SA182914$SANOFI AVENTIS$$$$A$M$Y$$$20240910$$MD$US$US
226080322$22608032$2$F$$20240813$20230616$20240826$PER$$US-SA-2023SA181676$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
226080562$22608056$2$F$$20240806$20230616$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04562$LUPIN$$$$$$Y$$$20240830$$CN$US$US
226080958$22608095$8$F$20230101$20240629$20230616$20240712$EXP$$CA-ROCHE-3332883$ROCHE$$57$YR$A$F$Y$50$KG$20240712$$CN$CA$CA
2260812814$22608128$14$F$20230329$20240822$20230616$20240905$EXP$$US-UCBSA-2023015672$UCB$$9$YR$$M$Y$$$20240905$$CN$US$US
226081302$22608130$2$F$20230515$20240809$20230616$20240822$EXP$$US-UCBSA-2023025030$UCB$$9$YR$$F$Y$$$20240822$$CN$US$US
226085923$22608592$3$F$$20240809$20230616$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04629$LUPIN$$$$$$Y$$$20240830$$CN$US$US
226088875$22608887$5$F$20230101$20240725$20230616$20240805$PER$$US-SA-2023SA183659$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240805$$HP$US$US
226092003$22609200$3$F$$20240725$20230616$20240802$PER$$US-SA-2023SA184320$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240802$$MD$US$US
226092472$22609247$2$F$$20240827$20230616$20240902$EXP$$CA-TAKEDA-2023TUS058402$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
226092904$22609290$4$F$20211231$20240514$20230616$20240813$EXP$$NVSC2023IN136614$NOVARTIS$$58$YR$$F$Y$$$20240813$$CN$IN$IN
226096386$22609638$6$F$20230331$20240902$20230616$20240906$EXP$$NL-OTSUKA-2023_015693$OTSUKA$$9$YR$$M$Y$$$20240906$$MD$NL$NL
226098092$22609809$2$F$$20240701$20230616$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394004$RANBAXY$$$$A$M$Y$$$20240711$$MD$US$US
226098432$22609843$2$F$20230530$20240819$20230616$20240903$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-394315$RANBAXY$$36$YR$$F$Y$91$KG$20240903$$MD$GB$GB
226098452$22609845$2$F$$20240711$20230616$20240712$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-394375$RANBAXY$Ono R, Watanabe M, Ueda H, Iwahana T, Kato H, Kubota Y, et al. Stent-Graft Placement for Radiation-Induced Abdominal Aortic Stenosis after Renal Autotransplantation. Int Heart J. 2023;64(2):306-309$27$YR$$F$Y$25$KG$20240712$$MD$JP$JP
226098492$22609849$2$F$20230501$20240618$20230616$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-394344$RANBAXY$$76$YR$$M$Y$$$20240703$$HP$GB$GB
226098542$22609854$2$F$$20240703$20230616$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-394295$RANBAXY$$$$$M$Y$$$20240703$$PH$GB$GB
226098552$22609855$2$F$$20240716$20230616$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-394367$RANBAXY$Sanchini C, Papia C, Cutaia C, Poloni TE, Cesari M. A. Case of Reversible Dementia? Dementia vs Delirium in Lyme Disease. Ann Geriatr Med Res. 2023;27(1):80-82$75$YR$$M$Y$$$20240718$$MD$IT$IT
226098562$22609856$2$F$$20240704$20230616$20240705$EXP$GB-MHRA-TPP2822637C9504499YC1685378846314$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-394296$RANBAXY$$86$YR$$F$Y$$$20240705$$MD$GB$GB
226098602$22609860$2$F$$20240708$20230616$20240709$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-394238$RANBAXY$Liang L, Park KH, Lee J-H, Park J-W. Causes and Diagnostic Usefulness of Tryptase Measurements for Anaphylaxis in a Korean Tertiary Care General Hospital. Yonsei Med J. 2022;63(12):1099-1105$$$$$Y$$$20240709$$HP$KR$KR
226098902$22609890$2$F$$20240717$20230616$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394986$RANBAXY$Lei D, Heasley V, Dailey S, Foster T. Groin Pain in a Dancer After Landing a Jump Split. Clin J Sports Med. 2023;33(3):e72$13$YR$$F$Y$$$20240718$$MD$US$US
226099057$22609905$7$F$20230529$20240722$20230616$20240808$PER$$CA-TOLMAR, INC.-23CA041170$TOLMAR$$61$YR$$M$Y$$$20240808$$CN$CA$CA
2260991912$22609919$12$F$20230405$20240702$20230616$20240708$EXP$$FR-EXELIXIS-XL18423064922$EXELIXIS$$$$$$Y$$$20240708$$MD$FR$FR
226099303$22609930$3$F$20190306$20240814$20230616$20240828$EXP$$FR-SERVIER-S21009797$SERVIER$$$$$$Y$$$20240828$$MD$FR$FR
226101422$22610142$2$F$20230601$20240808$20230616$20240814$EXP$$US-SA-2023SA183740$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240814$$MD$US$US
226101665$22610166$5$F$20230204$20240816$20230616$20240821$EXP$$US-PFIZER INC-US-GBT-021529$PFIZER$$51$YR$$F$Y$48.53$KG$20240820$$CN$US$US
226102092$22610209$2$F$20230601$20240820$20230616$20240829$PER$$US-SA-2023SA072649$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240829$$HP$US$US
226102182$22610218$2$F$20220208$20240808$20230616$20240816$EXP$$GB-TAKEDA-2022TUS009614$TAKEDA$$75$YR$$M$Y$$$20240816$$CN$GB$GB
226104772$22610477$2$F$20230601$20240809$20230616$20240816$PER$$US-VERTEX PHARMACEUTICALS-2023-008611$VERTEX$$18$MON$$M$Y$$$20240816$$CN$US$US
226109292$22610929$2$F$$20240902$20230616$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389928$RANBAXY$Shah M, Calderon J, Shirali AC. The Crystal Clear Answer to Methotrexate Toxicity?. J Am Soc Nephrol. 2016;27:376A (FR-PO044)$72$YR$$M$Y$$$20240913$$HP$US$US
226109492$22610949$2$F$$20240710$20230616$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394686$RANBAXY$Gadapa SP, Pitukweerakul S, Pilla SV,. Lupus Flare Presenting as Acute Pericarditis in a Patient with Stage V CKD on Hemodialysis Secondary to Lupus Nephritis. J Am Soc Nephrol. 2016;27:FR-PO033$41$YR$$F$Y$$$20240711$$HP$US$US
226109572$22610957$2$F$$20240717$20230616$20240718$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394622$RANBAXY$Mboma O, Wirth S, Aydin M. The Risk of Nonsteroidal Anti-Inflammatory Drugs in Pediatric Medicine: Listen Carefully to Children with Pain. Children. 2021;8:1048$17$YR$$M$Y$98$KG$20240718$$HP$DE$DE
226109582$22610958$2$F$$20240717$20230616$20240718$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394645$RANBAXY$Mboma O, Wirth S, Aydin M.. The Risk of Nonsteroidal Anti-Inflammatory Drugs in Pediatric Medicine: Listen Carefully to Children with Pain. Children. 2021;8(11):1048(1-10)$16$YR$$F$Y$112$KG$20240718$$HP$DE$DE
226109716$22610971$6$F$20230501$20240819$20230616$20240826$EXP$$JP-009507513-2306JPN001555J$MERCK$$8$DEC$$M$Y$$$20240826$$MD$JP$JP
2261135112$22611351$12$F$20230101$20240829$20230616$20240903$EXP$$CA-PFIZER INC-202300166752$PFIZER$$84$YR$$F$Y$$$20240903$$HP$CA$CA
226113613$22611361$3$F$20230522$20240502$20230616$20240718$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000208$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
226114307$22611430$7$F$20221109$20240731$20230616$20240813$EXP$$US-Rhythm Pharmaceuticals, Inc.-2022RHM000156$RHYTHM PHARMACEUTICALS$$36$YR$A$F$Y$$$20240809$$CN$US$US
226118265$22611826$5$F$20230524$20240913$20230616$20240923$EXP$$JP-009507513-2306JPN001423J$MERCK$Kawamata A, Kobayashi M, Yoshiyama T. EP-1158 A case of irAE due to pembrolizumab which was impossible to save life. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 467$48$YR$$F$Y$$$20240923$$MD$JP$JP
226119344$22611934$4$F$20230610$20240815$20230617$20240828$PER$$US-SA-2023SA183788$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240828$$MD$US$US
226121933$22612193$3$F$20230419$20230615$20230617$20240926$EXP$$NVSC2023US138602$NOVARTIS$$61$YR$$M$Y$154$KG$20240926$$CN$US$US
226122792$22612279$2$F$$20240701$20230617$20240715$EXP$$US-MSNLABS-2023MSNLIT00995$MSN LABORATORIES$Bharwad A, Wuthnow C, Mahdi M, Rowe K.Unresolved chronic diarrhea: A case of angiotensin-converting enzyme inhibitor-induced mesenteric angioedema.European Journal of Case Reports in Internal Medicine.2023;10 (8)$$$$$Y$$$20240715$$MD$US$US
226123474$22612347$4$F$$20240821$20230617$20240824$EXP$$NVSC2023US136289$NOVARTIS$$$$$F$Y$$$20240824$$CN$US$US
226123812$22612381$2$F$20240301$20240708$20230617$20240709$EXP$DE-BFARM-23004542$NVSC2023DE137051$NOVARTIS$$61$YR$$M$Y$72$KG$20240709$$CN$DE$DE
226124282$22612428$2$F$$20240724$20230617$20240806$EXP$$CA-AUROBINDO-AUR-APL-2023-041932$AUROBINDO$Kobylianskii J, Austin E, Kumachev A, Wu PE.. Surdose de  medicaments presumee chez une femme de 53 ans (Suspected drug overdose in 53-yearold woman). CMAJ. 2022;194:16$53$YR$$F$Y$$$20240806$$MD$CA$CA
226124312$22612431$2$F$$20240724$20230617$20240727$PER$$US-AMGEN-USASP2023103738$AMGEN$$$$A$F$Y$$$20240726$$HP$US$US
226127343$22612734$3$F$$20240712$20230617$20240717$30DAY$$US-GSK-US2023081398$GLAXOSMITHKLINE$$$$$M$Y$$$20240717$$HP$US$US
226127732$22612773$2$F$$20240728$20230617$20240729$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393324$RANBAXY$Reiche WS,Abodunrin F,Rangray R, Velagapudi M. Doxycycline-Induced Pancreatitis: An Uncommon Complication of a Common Drug. Am J Gastroenterol. 2022;117 (Sup2;10:S1219$$$$$Y$$$20240729$$MD$US$US
226127742$22612774$2$F$$20240711$20230617$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395086$RANBAXY$Reiche WS, Abodunrin F, Rangray R, Velagapudi M. Doxycycline-Induced Pancreatitis: An Uncommon Complication of a Common Drug. Am J Gastroenterol. 2022;Oct;117;sp2;10:S1219;S1721$60$YR$$F$Y$$$20240712$$MD$US$US
226127852$22612785$2$F$$20240709$20230617$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395243$RANBAXY$Malone JC, Zamora EA, Reeves I, Loghin A, Merwat SK. A Classic Cutaneous Manifestation of Newly Diagnosed Ulcerative Colitis. Am J Gastroenterol. 2022;Oct; 117(S):S1824/S2787$36$YR$$M$Y$$$20240710$$MD$US$US
226127962$22612796$2$F$$20240725$20230617$20240726$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394293$RANBAXY$Ulutas Z, Ermis H, Ermis N, Berber I, Hidayet S.. Bone Marrow Transplantation as a Rare Cause of Pulmonary Arterial Hypertension. Turk Kardiyol Dern Ars. 2023;51(2):151-154$22$YR$$F$Y$$$20240727$$HP$TR$TR
226128092$22612809$2$F$$20240709$20230617$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394679$RANBAXY$Mohammad S, Amendola M, Banc-Husu A, Chapin C, Cheng K, Chu C, et al. WORLDWIDE OUTBREAK OF ACUTE HEPATITIS IN CHILDREN: INTERIM RESULTS FROM THE SEVERE HEPATITIS IN PEDIATRIC PATIENTS (SHIPP) INTERNATIONAL REGISTRY. Hepatology. 2023;Nov 7;77(5):E116-E117$$$C$$Y$$$20240710$$HP$US$US
226128152$22612815$2$F$$20240703$20230617$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395212$RANBAXY$Jarbath M, Rouan G. Vibrio Species Infection Followed by New Onset Lymphocytic Colitis: Cause or Coincidence. Am J Gastroenterol. 2022;117(Suppl2)(10):S1463(Abs ID:S2157)$68$YR$$M$Y$$$20240718$$MD$US$US
226131408$22613140$8$F$20230101$20240916$20230618$20240925$EXP$$CA-CELLTRION INC.-2023CA002834$CELLTRION$$$$$$Y$$$20240925$$MD$CA$CA
226132045$22613204$5$F$$20240626$20230618$20240703$EXP$$JP-009507513-2306JPN001637J$MERCK$$54$YR$$F$Y$$$20240703$$MD$JP$JP
2261328411$22613284$11$F$20230101$20240913$20230619$20240918$EXP$$CA-PFIZER INC-202300104840$PFIZER$$74$YR$$M$Y$$$20240918$$CN$CA$CA
226133908$22613390$8$F$20230607$20231102$20230619$20240926$EXP$$US-GSK-US2023AMR084110$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
226134625$22613462$5$F$20230511$20240117$20230619$20240923$PER$$AT-ROCHE-3368665$ROCHE$$35$YR$A$F$Y$62$KG$20240923$$MD$AT$AT
226135332$22613533$2$F$$20240815$20230619$20240828$EXP$$CA-AUROBINDO-AUR-APL-2023-041935$AUROBINDO$$62$YR$$M$Y$$$20240828$$HP$CA$CA
226135424$22613542$4$F$20230616$20240813$20230619$20240814$PER$$US-AMGEN-USASP2023105647$AMGEN$$77$YR$E$M$Y$$$20240814$$CN$US$US
226136137$22613613$7$F$$20240905$20230619$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002066$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
226137745$22613774$5$F$20220101$20240814$20230619$20240821$EXP$$CA-CELLTRION INC.-2022CA009716$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
226143582$22614358$2$F$20230306$20240806$20230619$20240809$EXP$$DE-ROCHE-3368335$ROCHE$$6$YR$C$F$Y$23$KG$20240809$$MD$DE$DE
2261438310$22614383$10$F$20230101$20240906$20230619$20240912$EXP$$CA-TAKEDA-2023TUS058735$TAKEDA$$$$$F$Y$$$20240912$$HP$CA$CA
226144513$22614451$3$F$$20240802$20230619$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-01917$HIKMA$$53$YR$$F$Y$$$20240813$$HP$CA$CA
226145353$22614535$3$F$$20240918$20230619$20240927$PER$$NVSC2023US139116$NOVARTIS$$$$$$Y$$$20240927$$CN$US$US
2261455824$22614558$24$F$20230101$20240904$20230619$20240910$EXP$$US-CIPLA (EU) LIMITED-2023US03226$CIPLA$$$$$$Y$$$20240910$$CN$US$US
226145932$22614593$2$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-02010$PIERRE FABRE MEDICAMENT$$34$YR$$F$Y$$$20240710$$MD$CA$CA
226145952$22614595$2$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-02007$PIERRE FABRE MEDICAMENT$$71$YR$$F$Y$$$20240710$$MD$CA$CA
226145962$22614596$2$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-02014$PIERRE FABRE MEDICAMENT$$61$YR$$M$Y$$$20240710$$MD$CA$CA
226145972$22614597$2$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-02012$PIERRE FABRE MEDICAMENT$$43$YR$$F$Y$$$20240710$$MD$CA$CA
226145982$22614598$2$F$$20220621$20230619$20240710$PER$$CA-PFM-2020-15202$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240710$$MD$CA$CA
226145992$22614599$2$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-01996$PIERRE FABRE MEDICAMENT$$51$YR$$F$Y$$$20240710$$MD$CA$CA
226146002$22614600$2$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-02004$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240710$$MD$CA$CA
226146012$22614601$2$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-02001$PIERRE FABRE MEDICAMENT$$24$YR$$F$Y$$$20240710$$MD$CA$CA
226146022$22614602$2$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-03674$PIERRE FABRE MEDICAMENT$$44$YR$$F$Y$$$20240710$$MD$CA$CA
226146032$22614603$2$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-03668$PIERRE FABRE MEDICAMENT$$74$YR$$M$Y$$$20240710$$CN$CA$CA
226146053$22614605$3$F$$20220930$20230619$20240710$PER$$CA-PFM-2021-04502$PIERRE FABRE MEDICAMENT$$23$YR$$F$Y$$$20240710$$MD$CA$CA
226146073$22614607$3$F$$20220930$20230619$20240710$PER$$CA-PFM-2021-05159$PIERRE FABRE MEDICAMENT$$45$YR$$F$Y$$$20240710$$MD$CA$CA
226146093$22614609$3$F$20200101$20220930$20230619$20240710$PER$$CA-PFM-2019-08319$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240710$$MD$CA$CA
226146133$22614613$3$F$$20221003$20230619$20240710$PER$$CA-PFM-2019-14514$PIERRE FABRE MEDICAMENT$$27$YR$$F$Y$$$20240710$$MD$CA$CA
226146153$22614615$3$F$$20221205$20230619$20240710$PER$$CA-PFM-2021-02364$PIERRE FABRE MEDICAMENT$$33$YR$$F$Y$$$20240710$$MD$CA$CA
226146173$22614617$3$F$$20220930$20230619$20240710$PER$$CA-PFM-2021-05422$PIERRE FABRE MEDICAMENT$$34$YR$$F$Y$$$20240710$$MD$CA$CA
226146263$22614626$3$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-02016$PIERRE FABRE MEDICAMENT$$63$YR$$F$Y$61$KG$20240710$$MD$CA$CA
226146273$22614627$3$F$20200601$20221024$20230619$20240710$PER$$CA-PFM-2021-04351$PIERRE FABRE MEDICAMENT$$60$YR$$F$Y$$$20240710$$MD$CA$CA
226146293$22614629$3$F$$20221024$20230619$20240710$PER$$CA-PFM-2019-12378$PIERRE FABRE MEDICAMENT$$47$YR$$F$Y$$$20240710$$MD$CA$CA
226146533$22614653$3$F$$20220810$20230619$20240712$PER$$CA-PFM-2022-02384$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240712$$MD$CA$CA
226146543$22614654$3$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-02000$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$HP$CA$CA
226146622$22614662$2$F$$20220914$20230619$20240712$PER$$CA-PFM-2021-10321$PIERRE FABRE MEDICAMENT$$46$YR$$F$Y$$$20240712$$MD$CA$CA
226146652$22614665$2$F$$20220930$20230619$20240710$PER$$CA-PFM-2021-05423$PIERRE FABRE MEDICAMENT$$45$YR$$F$Y$$$20240710$$MD$CA$CA
226146752$22614675$2$F$$20221003$20230619$20240712$PER$$CA-PFM-2021-11489$PIERRE FABRE MEDICAMENT$$29$YR$$M$Y$$$20240712$$MD$CA$CA
226146763$22614676$3$F$$20240809$20230619$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04648$LUPIN$$$$$$Y$$$20240829$$CN$US$US
226146772$22614677$2$F$$20220914$20230619$20240712$PER$$CA-PFM-2021-12152$PIERRE FABRE MEDICAMENT$$50$YR$$F$Y$$$20240712$$MD$CA$CA
226146782$22614678$2$F$20200901$20220928$20230619$20240715$PER$$CA-PFM-2021-06573$PIERRE FABRE MEDICAMENT$$42$YR$$F$Y$$$20240715$$MD$CA$CA
226146832$22614683$2$F$20230524$20240704$20230619$20240705$EXP$GB-MHRA-TPP22917314C625644YC1685462006635$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-394770$RANBAXY$$83$YR$$M$Y$72$KG$20240705$$MD$GB$GB
226146842$22614684$2$F$$20240908$20230619$20240913$EXP$$CO-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-394742$RANBAXY$Rangel Jaimes GW, Ortega Agon KA, Cediel Carrillo XJ. Intrathecal neurolysis for the management of refractory pain in a patient with terminal oncological disease: case report. Pain Management. 2022;12(5):569-577$47$YR$$F$Y$$$20240913$$HP$CO$CO
226146993$22614699$3$F$20200424$20221223$20230619$20240710$PER$$JP-PFM-2020-13103$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$4.7$KG$20240710$$MD$JP$JP
226147003$22614700$3$F$20190710$20230403$20230619$20240712$PER$$CA-PFM-2022-00520$PIERRE FABRE MEDICAMENT$$55$YR$$F$Y$$$20240712$$MD$CA$CA
226147013$22614701$3$F$$20230403$20230619$20240712$PER$$CA-PFM-2022-02383$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240712$$MD$CA$CA
226147053$22614705$3$F$20210401$20230403$20230619$20240712$PER$$CA-PFM-2022-02385$PIERRE FABRE MEDICAMENT$$40$YR$$F$Y$$$20240712$$MD$CA$CA
226147077$22614707$7$F$$20240628$20230619$20240703$EXP$$US-TAKEDA-2023TUS051883$TAKEDA$$$$$F$Y$72$KG$20240703$$CN$US$US
226147093$22614709$3$F$20210115$20221027$20230619$20240712$PER$$ES-PFM-2021-11298$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6$KG$20240712$$MD$ES$ES
226147163$22614716$3$F$$20230403$20230619$20240712$PER$$CA-PFM-2022-00519$PIERRE FABRE MEDICAMENT$$53$YR$$F$Y$$$20240712$$MD$CA$CA
226147252$22614725$2$F$$20240708$20230619$20240712$EXP$$NVSC2023FR138264$NOVARTIS$Gendarme S, Pastre J, Billaud EM, Gibault L, Guillemain R, Oudard S et al.. Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patients. THERAPIE. 2023;78:267-78$$$$$Y$$$20240712$$HP$FR$FR
226147262$22614726$2$F$20220203$20220503$20230619$20240712$PER$$BE-PFM-2022-02789$PIERRE FABRE MEDICAMENT$$15$WK$$F$Y$6.5$KG$20240712$$MD$BE$BE
226147312$22614731$2$F$20220222$20230914$20230619$20240712$PER$$JP-PFM-2022-02447$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$8.92$KG$20240712$$MD$JP$JP
226147322$22614732$2$F$20220316$20220930$20230619$20240712$PER$$JP-PFM-2022-02704$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$4.22$KG$20240712$$MD$JP$JP
226147362$22614736$2$F$20210101$20230227$20230619$20240712$PER$FR-AFSSAPS-DJ20220192$FR-PFM-2022-01240$PIERRE FABRE MEDICAMENT$$61$YR$$F$Y$67$KG$20240712$$MD$FR$FR
226147382$22614738$2$F$$20220428$20230619$20240712$PER$$JP-PFM-2022-02970$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$PH$JP$JP
226147392$22614739$2$F$20220309$20220608$20230619$20240712$PER$$JP-PFM-2022-03704$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$8$KG$20240712$$MD$JP$JP
226147402$22614740$2$F$20220216$20220517$20230619$20240712$PER$$JP-PFM-2022-03628$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$4$KG$20240712$$MD$JP$JP
226147422$22614742$2$F$$20220425$20230619$20240712$PER$$US-PFM-2022-03894$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240712$$PH$US$US
226147432$22614743$2$F$20211119$20220426$20230619$20240712$PER$FR-AFSSAPS-PA20222648$FR-PFM-2022-03882$PIERRE FABRE MEDICAMENT$$24$YR$$F$Y$88$KG$20240712$$CN$FR$FR
226147442$22614744$2$F$$20220425$20230619$20240712$PER$$US-PFM-2022-03796$PIERRE FABRE MEDICAMENT$$$$$M$Y$4$KG$20240712$$HP$US$US
226147452$22614745$2$F$$20220426$20230619$20240712$PER$$US-PFM-2022-03897$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
226147462$22614746$2$F$$20220426$20230619$20240712$PER$$US-PFM-2022-03896$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
226147472$22614747$2$F$$20220427$20230619$20240712$PER$$US-PFM-2022-03977$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.42$KG$20240712$$HP$US$US
226147482$22614748$2$F$$20220427$20230619$20240712$PER$$US-PFM-2022-03975$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.7$KG$20240712$$HP$US$US
226147492$22614749$2$F$20220103$20220426$20230619$20240712$PER$FR-AFSSAPS-AM20221097$FR-PFM-2022-03883$PIERRE FABRE MEDICAMENT$$57$YR$$F$Y$$$20240712$$CN$FR$FR
226147502$22614750$2$F$$20220427$20230619$20240712$PER$$US-PFM-2022-03976$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.617$KG$20240712$$HP$US$US
226147512$22614751$2$F$$20220429$20230619$20240712$PER$$US-PFM-2022-04056$PIERRE FABRE MEDICAMENT$$$$$F$Y$2.721$KG$20240712$$HP$US$US
226147522$22614752$2$F$$20220502$20230619$20240712$PER$$US-PFM-2022-04107$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.442$KG$20240712$$HP$US$US
226147532$22614753$2$F$$20220428$20230619$20240712$PER$$US-PFM-2022-04034$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.646$KG$20240712$$HP$US$US
226147542$22614754$2$F$$20220428$20230619$20240712$PER$$US-PFM-2022-04035$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.617$KG$20240712$$HP$US$US
226147552$22614755$2$F$$20220502$20230619$20240712$PER$$US-PFM-2022-04135$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
226147562$22614756$2$F$$20220503$20230619$20240712$PER$$US-PFM-2022-04137$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.896$KG$20240712$$HP$US$US
226147572$22614757$2$F$$20220729$20230619$20240712$PER$$US-PFM-2022-04136$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240712$$HP$US$US
226147582$22614758$2$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-02015$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240710$$HP$CA$CA
226147592$22614759$2$F$20180320$20220527$20230619$20240712$PER$$JP-PFM-2022-00439$PIERRE FABRE MEDICAMENT$Sugimoto A, Aoki R, Toyohara E, Ogawa R. Infantile Hemangiomas Cleared by Combined Therapy with Pulsed Dye Laser and Propranolol. American Society for Dermatologic Surgery. 2021;47(8):1052-57$4$MON$$F$Y$$$20240712$$MD$JP$JP
226147602$22614760$2$F$$20220914$20230619$20240710$PER$$CA-PFM-2020-02097$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$HP$CA$CA
226147612$22614761$2$F$20171007$20220527$20230619$20240712$PER$$JP-PFM-2022-00437$PIERRE FABRE MEDICAMENT$Sugimoto A, Aoki R,Toyohara E,Ogawa R. Infantile hemangiomas cleared by combined therapy with pulsed dye laser and propranolol. Dermatologic surgery : official publication for American Society for Dermatologi. 2021;47(8):1052-057$2$YR$$F$Y$13$KG$20240712$$MD$JP$JP
226147622$22614762$2$F$$20221031$20230619$20240712$PER$$TR-PFM-2022-01492$PIERRE FABRE MEDICAMENT$Boyraz RK, Sahan E, Kirpinar I. A case report with a mini-review of the literature on the overeating and weight gain due to propranolol. Medicina Academica Mostariensia. 2021;9(2):330-2$34$YR$$F$Y$$$20240712$$MD$TR$TR
226147632$22614763$2$F$$20221031$20230619$20240712$PER$$TR-PFM-2022-02212$PIERRE FABRE MEDICAMENT$Leventoglu E, Buyukkaragoz B, Kenan BU, Sari S, Bakkaloglu SA. Macroscopic hematuria in a child with portal hypertension: Questions. Pediatric nephrology. 2020;36:4033-5$8$YR$$M$Y$$$20240712$$HP$TR$TR
226147642$22614764$2$F$$20221201$20230619$20240715$PER$$JP-PFM-2021-09655$PIERRE FABRE MEDICAMENT$Lee R. Study on 93 cases of infantile haemangioma treated with oral propranolol. The 45th Annual Meeting of the Japanese Society of Pediatric Dermatology. 2021;140$$$I$$Y$$$20240715$$HP$JP$JP
226147652$22614765$2$F$$20221121$20230619$20240710$PER$$SI-PFM-2020-02409$PIERRE FABRE MEDICAMENT$Delic M.. Inpatient management of GHB/GBL withdrawal. Psychiatria Danubina. 2019;31:354-356$30$YR$$M$Y$$$20240710$$HP$SI$SI
226147662$22614766$2$F$20211011$20230306$20230619$20240712$PER$$JP-PFM-2021-10765$PIERRE FABRE MEDICAMENT$Noguchi M. A case of propranolol discontinuation due to bradycardia after induction of oral propranolol for infantile haemangioma. Journal of Japan Society of Plastic and Reconstructive Surgery. 2023;43(1):43$3$MON$$M$Y$$$20240712$$MD$JP$JP
226147672$22614767$2$F$$20220509$20230619$20240712$PER$$DE-PFM-2022-03964$PIERRE FABRE MEDICAMENT$Muller MKR, Christ M, Naumann M, Bayas A et al. Prolonged-release fampridine for the treatment of myoclonus after cervical myelitis: a case report. Therapeutic Advances in Neurological Disorders. 2022;15:1-5$32$YR$$F$Y$$$20240712$$HP$DE$DE
2261505912$22615059$12$F$20230901$20240828$20230619$20240904$EXP$$CA-GSK-CA2023AMR084350$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$HP$CA$CA
226152422$22615242$2$F$$20230614$20230619$20240925$EXP$$NVSC2023US137327$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
226153473$22615347$3$F$$20240831$20230619$20240909$PER$$US-SA-2023SA184556$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240909$$MD$US$US
226153792$22615379$2$F$20240601$20240830$20230619$20240913$PER$$US-SA-2023SA184314$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240913$$MD$US$US
226153882$22615388$2$F$$20240703$20230619$20240712$PER$$US-SA-2023SA083952$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240712$$MD$US$US
226155123$22615512$3$F$$20240708$20230619$20240711$EXP$$CA-TAKEDA-2023TUS053244$TAKEDA$$$$$F$Y$$$20240711$$CN$CA$CA
226155979$22615597$9$F$20230220$20240924$20230619$20240928$EXP$$JP-009507513-2305JPN000890J$MERCK$$72$YR$$F$Y$$$20240928$$MD$JP$JP
226156262$22615626$2$F$20230101$20240625$20230619$20240704$PER$$US-SA-2023SA185407$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240704$$MD$US$US
226157083$22615708$3$F$$20240802$20230619$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202306009111$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240814$$CN$US$US
226157342$22615734$2$F$20230112$20240701$20230619$20240706$EXP$$ES-AMGEN-ESPNI2023103823$AMGEN$$55$YR$A$M$Y$90$KG$20240705$$MD$ES$ES
226158004$22615800$4$F$$20240902$20230619$20240912$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032$HIKMA$$61$YR$$F$Y$$$20240912$$HP$CA$CA
226162265$22616226$5$F$20220929$20240919$20230619$20240927$EXP$$CA-TAKEDA-2023TUS045650$TAKEDA$$53$YR$$F$Y$$$20240927$$HP$CA$CA
226162946$22616294$6$F$$20240705$20230619$20240719$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02106$HIKMA$$46$YR$$M$Y$$$20240719$$HP$CA$CA
226163086$22616308$6$F$20230101$20240808$20230619$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-084681$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240812$$CN$US$US
226163358$22616335$8$F$20230611$20240814$20230619$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-085628$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240821$$CN$US$US
226163729$22616372$9$F$20210518$20240802$20230619$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-086183$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240812$$CN$US$US
226163894$22616389$4$F$20230110$20240628$20230619$20240703$EXP$$JP-ARGENX-2023-ARGX-JP000102$ARGENX BVBA$$$$$$Y$$$20240703$$MD$JP$JP
226165904$22616590$4$F$$20240816$20230619$20240826$EXP$$GB-TAKEDA-2022TUS034193$TAKEDA$$$$$M$Y$$$20240826$$CN$GB$GB
226167543$22616754$3$F$20230516$20240215$20230619$20240918$EXP$FR-AFSSAPS-AM2023000535$FR-BAUSCH-BL-2023-009400$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240918$$MD$FR$FR
2261690215$22616902$15$F$$20240913$20230619$20240915$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-085713$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240916$$MD$US$US
226169516$22616951$6$F$$20240729$20230619$20240731$EXP$$AU-JNJFOC-20230634620$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240731$$HP$AU$AU
226169662$22616966$2$F$$20240729$20230619$20240807$PER$$US-SA-2023SA185109$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$MD$US$US
226169895$22616989$5$F$20230616$20240923$20230620$20240925$EXP$$US-TAKEDA-2023TUS059869$TAKEDA$$30$YR$$M$Y$$$20240925$$CN$US$US
226170814$22617081$4$F$20230101$20240717$20230620$20240720$EXP$$CO-ABBVIE-5294644$ABBVIE$$$$$M$Y$60$KG$20240720$$CN$CO$CO
226170825$22617082$5$F$20220601$20240808$20230620$20240821$EXP$$PL-AUROBINDO-AUR-APL-2023-042184$AUROBINDO$Obtulowicz A, Pizun A, Radzimowska-Dudek J, Obtulowicz B, Wojas-Pelc A.. Podostry sk?rny tocze? rumieniowaty indukowany lekami wst?pnie diagnozowany jako rumie? obr?czkowaty od?rodkowy (Drug-induced subacute cutaneous lupus erythematosus initially diagnosed as erythema annular centrifugal). PRZEGL?D DERMATOLOGICZNY (DERMATOLOGICAL REVIEW). 2023;110(3):299-300$89$YR$$F$Y$$$20240821$$MD$PL$PL
226170884$22617088$4$F$$20240705$20230620$20240717$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02110$HIKMA$$50$YR$$M$Y$$$20240717$$CN$CA$CA
2261711521$22617115$21$F$20230524$20240830$20230620$20240903$EXP$$AT-ABBVIE-5293088$ABBVIE$$67$YR$$M$Y$75$KG$20240903$$MD$AT$AT
226172084$22617208$4$F$20220314$20240711$20230620$20240722$EXP$$US-ABBVIE-5295273$ABBVIE$$64$YR$$M$Y$84$KG$20240719$$MD$US$US
226172275$22617227$5$F$20230101$20240906$20230620$20240916$EXP$$CA-CELLTRION INC.-2023CA010870$CELLTRION$$$$$$Y$$$20240916$$CN$CA$CA
226174062$22617406$2$F$$20220504$20230620$20240712$PER$$US-PFM-2022-04205$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240712$$HP$US$US
226174072$22617407$2$F$$20220503$20230620$20240712$PER$$US-PFM-2022-04138$PIERRE FABRE MEDICAMENT$$$$$F$Y$15$KG$20240712$$HP$US$US
226174082$22617408$2$F$$20220503$20230620$20240712$PER$$US-PFM-2022-04139$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.887$KG$20240712$$HP$US$US
226174092$22617409$2$F$$20220506$20230620$20240712$PER$$US-PFM-2022-04284$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.245$KG$20240712$$HP$US$US
226174102$22617410$2$F$20220211$20220509$20230620$20240712$PER$HR-HALMED-300054564$HR-PFM-2022-04293$PIERRE FABRE MEDICAMENT$$10$WK$$F$Y$6$KG$20240712$$CN$HR$HR
226174112$22617411$2$F$$20220509$20230620$20240712$PER$$US-PFM-2022-04374$PIERRE FABRE MEDICAMENT$$$$$M$Y$17.9$KG$20240712$$HP$US$US
226174122$22617412$2$F$$20220505$20230620$20240712$PER$$US-PFM-2022-04251$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
226174132$22617413$2$F$$20220509$20230620$20240712$PER$$US-PFM-2022-04373$PIERRE FABRE MEDICAMENT$$$$$F$Y$22.676$KG$20240712$$HP$US$US
226174142$22617414$2$F$$20220510$20230620$20240712$PER$$US-PFM-2022-04410$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.4$KG$20240712$$HP$US$US
226174162$22617416$2$F$$20240201$20230620$20240712$PER$$US-PFM-2022-04414$PIERRE FABRE MEDICAMENT$$$$$F$Y$15.1$KG$20240712$$HP$US$US
226174172$22617417$2$F$20220414$20220509$20230620$20240712$PER$RO-NMA-2022-SP44745$RO-PFM-2022-04303$PIERRE FABRE MEDICAMENT$$30$YR$$F$Y$45$KG$20240712$$CN$RO$RO
226174182$22617418$2$F$$20220510$20230620$20240712$PER$$US-PFM-2022-04411$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240712$$HP$US$US
226174192$22617419$2$F$$20220915$20230620$20240712$PER$$US-PFM-2022-04140$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
226174202$22617420$2$F$$20221110$20230620$20240712$PER$$US-PFM-2022-04413$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240712$$HP$US$US
226174212$22617421$2$F$$20220729$20230620$20240712$PER$$US-PFM-2022-04358$PIERRE FABRE MEDICAMENT$$$$$F$Y$14$KG$20240712$$HP$US$US
226174222$22617422$2$F$20200112$20220525$20230620$20240712$PER$ES-AEMPS-1174877$ES-PFM-2022-04669$PIERRE FABRE MEDICAMENT$$13$MON$$F$Y$3.7$KG$20240712$$PH$ES$ES
226174232$22617423$2$F$$20230322$20230620$20240712$PER$$US-PFM-2022-04357$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.297$KG$20240712$$HP$US$US
226174242$22617424$2$F$$20240708$20230620$20240716$PER$$US-PFM-2022-04356$PIERRE FABRE MEDICAMENT$$$$$F$Y$14.1$KG$20240716$$HP$US$US
226174252$22617425$2$F$20221001$20221214$20230620$20240712$PER$$US-PFM-2022-04460$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.529$KG$20240712$$HP$US$US
226174262$22617426$2$F$$20230203$20230620$20240712$PER$$US-PFM-2022-04412$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.7$KG$20240712$$HP$US$US
226174282$22617428$2$F$$20220512$20230620$20240712$PER$$US-PFM-2022-04573$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.431$KG$20240712$$HP$US$US
226174292$22617429$2$F$$20220517$20230620$20240712$PER$$US-PFM-2022-04548$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
226174302$22617430$2$F$$20220517$20230620$20240712$PER$$US-PFM-2022-04547$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240712$$HP$US$US
226174322$22617432$2$F$$20220512$20230620$20240712$PER$$MX-PFM-2022-04597$PIERRE FABRE MEDICAMENT$$2$YR$$M$Y$$$20240712$$CN$MX$MX
226174332$22617433$2$F$$20231005$20230620$20240712$PER$$US-PFM-2022-04546$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.596$KG$20240712$$HP$US$US
226174342$22617434$2$F$$20220518$20230620$20240712$PER$$US-PFM-2022-04549$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.129$KG$20240712$$HP$US$US
226174352$22617435$2$F$$20220518$20230620$20240712$PER$$US-PFM-2022-04550$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.039$KG$20240712$$HP$US$US
226174362$22617436$2$F$$20220519$20230620$20240712$PER$$US-PFM-2022-04551$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.442$KG$20240712$$HP$US$US
226174372$22617437$2$F$$20220520$20230620$20240712$PER$$US-PFM-2022-04554$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
226174382$22617438$2$F$$20220519$20230620$20240712$PER$$US-PFM-2022-04552$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.37$KG$20240712$$HP$US$US
226174392$22617439$2$F$$20220520$20230620$20240712$PER$$US-PFM-2022-04555$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.7$KG$20240712$$HP$US$US
226174402$22617440$2$F$$20220520$20230620$20240712$PER$$US-PFM-2022-04556$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.803$KG$20240712$$HP$US$US
226174412$22617441$2$F$$20220520$20230620$20240712$PER$$US-PFM-2022-04553$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.397$KG$20240712$$HP$US$US
226174422$22617442$2$F$$20220520$20230620$20240712$PER$$US-PFM-2022-04557$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.118$KG$20240712$$HP$US$US
226174432$22617443$2$F$$20220523$20230620$20240712$PER$$US-PFM-2022-04591$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.431$KG$20240712$$HP$US$US
226174442$22617444$2$F$$20220523$20230620$20240712$PER$$US-PFM-2022-04595$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.129$KG$20240712$$HP$US$US
226174452$22617445$2$F$$20220524$20230620$20240712$PER$$US-PFM-2022-04630$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
226174462$22617446$2$F$$20221027$20230620$20240712$PER$$US-PFM-2022-04574$PIERRE FABRE MEDICAMENT$$$$$F$Y$46.893$KG$20240712$$HP$US$US
226174472$22617447$2$F$$20220524$20230620$20240712$PER$$US-PFM-2022-04629$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.1$KG$20240712$$HP$US$US
226174482$22617448$2$F$$20221115$20230620$20240712$PER$$US-PFM-2022-04592$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.57$KG$20240712$$HP$US$US
226174502$22617450$2$F$$20220525$20230620$20240712$PER$$US-PFM-2022-04667$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.256$KG$20240712$$HP$US$US
226174512$22617451$2$F$$20220526$20230620$20240712$PER$$US-PFM-2022-04684$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
226174532$22617453$2$F$$20220527$20230620$20240712$PER$$US-PFM-2022-04708$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240712$$HP$US$US
226174542$22617454$2$F$$20220527$20230620$20240712$PER$$US-PFM-2022-04709$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240712$$HP$US$US
226174552$22617455$2$F$20220405$20220527$20230620$20240712$PER$$FR-PFM-2022-04786$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240712$$CN$FR$FR
226174562$22617456$2$F$$20220527$20230620$20240712$PER$$US-PFM-2022-04710$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240712$$HP$US$US
226174572$22617457$2$F$$20220524$20230620$20240712$PER$$US-PFM-2022-04631$PIERRE FABRE MEDICAMENT$$$$$M$Y$13$KG$20240712$$HP$US$US
226174592$22617459$2$F$$20220527$20230620$20240712$PER$$US-PFM-2022-04711$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240712$$HP$US$US
226174602$22617460$2$F$$20220601$20230620$20240712$PER$$US-PFM-2022-04805$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240712$$HP$US$US
226174612$22617461$2$F$$20220602$20230620$20240712$PER$$FR-PFM-2022-04867$PIERRE FABRE MEDICAMENT$$$$$$Y$8$KG$20240712$$MD$FR$FR
226174622$22617462$2$F$$20220601$20230620$20240712$PER$$US-PFM-2022-04803$PIERRE FABRE MEDICAMENT$$$$$F$Y$3$KG$20240712$$HP$US$US
226174632$22617463$2$F$20200101$20220531$20230620$20240712$PER$$DE-PFM-2022-04777$PIERRE FABRE MEDICAMENT$$32$YR$$F$Y$$$20240712$$HP$DE$DE
226174642$22617464$2$F$$20220602$20230620$20240712$PER$$US-PFM-2022-04879$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.7$KG$20240712$$HP$US$US
226174652$22617465$2$F$$20220602$20230620$20240712$PER$$US-PFM-2022-04877$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240712$$HP$US$US
226174662$22617466$2$F$$20220603$20230620$20240712$PER$$US-PFM-2022-04892$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.37$KG$20240712$$HP$US$US
226174672$22617467$2$F$$20220602$20230620$20240712$PER$$US-PFM-2022-04876$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240712$$HP$US$US
226174682$22617468$2$F$20220506$20220616$20230620$20240712$PER$$JP-PFM-2022-04888$PIERRE FABRE MEDICAMENT$$1$YR$$M$Y$$$20240712$$MD$JP$JP
226174702$22617470$2$F$$20220601$20230620$20240712$PER$$US-PFM-2022-04802$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.4$KG$20240712$$HP$US$US
226174712$22617471$2$F$$20220815$20230620$20240712$PER$$US-PFM-2022-04804$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
226174722$22617472$2$F$$20221110$20230620$20240712$PER$$US-PFM-2022-04801$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.43$KG$20240712$$HP$US$US
226174743$22617474$3$F$$20240719$20230620$20240729$30DAY$$US-GSK-US2023082391$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
226174752$22617475$2$F$$20220603$20230620$20240712$PER$$US-PFM-2022-04893$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.4$KG$20240712$$HP$US$US
226174762$22617476$2$F$$20220607$20230620$20240712$PER$$US-PFM-2022-04925$PIERRE FABRE MEDICAMENT$$$$$M$Y$5$KG$20240712$$HP$US$US
226174772$22617477$2$F$$20220609$20230620$20240712$PER$$US-PFM-2022-04974$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
226174782$22617478$2$F$$20220531$20230620$20240712$PER$$JP-PFM-2022-04915$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$PH$JP$JP
226174792$22617479$2$F$$20220609$20230620$20240712$PER$$US-PFM-2022-04976$PIERRE FABRE MEDICAMENT$$$$$M$Y$13$KG$20240712$$HP$US$US
226174802$22617480$2$F$$20220613$20230620$20240712$PER$$US-PFM-2022-05024$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240712$$HP$US$US
226174812$22617481$2$F$$20220927$20230620$20240712$PER$$JP-PFM-2022-04935$PIERRE FABRE MEDICAMENT$$4$MON$$M$Y$$$20240712$$PH$JP$JP
226174822$22617482$2$F$$20220830$20230620$20240712$PER$$JP-PFM-2022-05073$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240712$$PH$JP$JP
226174842$22617484$2$F$$20221007$20230620$20240712$PER$$US-PFM-2022-05025$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.99$KG$20240712$$HP$US$US
226174862$22617486$2$F$$20221110$20230620$20240712$PER$$US-PFM-2022-04975$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.6$KG$20240712$$HP$US$US
226174882$22617488$2$F$$20220502$20230620$20240712$PER$$TR-PFM-2022-04149$PIERRE FABRE MEDICAMENT$Kayas L, Camtosun E, Akinci A, Bircan R. TSHRV656F Activating Variant of the Thyroid Stimulating Hormone Receptor Gene in Neonatal Onset Hyperthyroidism: A Case Review. J Clin Res Pediatr Endocrinol. 2022;14(1):114-18$7$DY$$F$Y$4$KG$20240712$$HP$TR$TR
226174892$22617489$2$F$$20220502$20230620$20240712$PER$$ES-PFM-2022-04180$PIERRE FABRE MEDICAMENT$Mata MA, Jimenez AB, Lopez FM, de la Camara Morano C. Thyroid Hormone Resistance: Multicentrical Case Series Study. Horm Metab Res. 2022;54:67-75$11$YR$$F$Y$$$20240712$$HP$ES$ES
226174902$22617490$2$F$$20220502$20230620$20240712$PER$$ES-PFM-2022-04181$PIERRE FABRE MEDICAMENT$Mata MA, Jimenez AB, Lopez FM, de la Camara Morano C. Thyroid Hormone Resistance: Multicentrical Case Series Study. Horm Metab Res. 2022;54:67-75$42$YR$$M$Y$$$20240712$$HP$ES$ES
226174912$22617491$2$F$$20220506$20230620$20240712$PER$$RU-PFM-2022-04270$PIERRE FABRE MEDICAMENT$Khachatryan LA, Shcherbakov AP, Chikvina II, Nikolaeva DM. New approaches for solving the old problem. Haematology/oncology and immunopathology issues in paediatrics. 2022;21 (1):122-35$3$MON$$$Y$$$20240712$$HP$RU$RU
226174922$22617492$2$F$$20220509$20230620$20240712$PER$$TR-PFM-2022-04417$PIERRE FABRE MEDICAMENT$Sulu A, Karacan M, and Ergul Y. A very rare cause of sudden cardiac arrest in children: triadin knockout syndrome. Cardiology in the Young. 2022;1-3$7$YR$$M$Y$$$20240712$$HP$TR$TR
226174932$22617493$2$F$$20220509$20230620$20240712$PER$$TR-PFM-2022-04423$PIERRE FABRE MEDICAMENT$Tumgor G, Yavuz S, Uskudar O, Ozkan U. Treatment With Balloon Angioplasty of Chronic Portal Vein Thrombosis. ACG CASE REPORTS JOURNAL. 2022;9:1-4$15$MON$$$Y$5$KG$20240712$$HP$TR$TR
226174942$22617494$2$F$$20220506$20230620$20240712$PER$$RU-PFM-2022-04271$PIERRE FABRE MEDICAMENT$Khachatryan L, Shcherbakov A, Chikvina I, Nikolaeva D. New approaches for solving the old problem. Haematology/oncology and immunopathology issues in paediatrics. 2022;21:122-135$3$MON$$F$Y$$$20240712$$HP$RU$RU
226174952$22617495$2$F$$20220502$20230620$20240712$PER$$ES-PFM-2022-04178$PIERRE FABRE MEDICAMENT$Mata MAS, Jimenez ABA, Lopez FM, Morano CDLC. Thyroid Hormone Resistance: Multicentrical Case Series Study. Horm Metab Res. 2022;54:67-75$22$DY$$F$Y$$$20240712$$HP$ES$ES
226174962$22617496$2$F$$20220509$20230620$20240712$PER$$TR-PFM-2022-04419$PIERRE FABRE MEDICAMENT$Sulu A, Karacan M, Ergul Y. A very rare cause of sudden cardiac arrest in children: triadin knockout syndrome. Cardiology in the Young. 2022;1-3$4$YR$$M$Y$$$20240712$$HP$TR$TR
226174992$22617499$2$F$$20220509$20230620$20240712$PER$$CH-PFM-2022-04427$PIERRE FABRE MEDICAMENT$Bally JF, Kern DS, Fearon C, Camargos S, Barbosa ER, Ozelius LJ et al. DYT-TUBB4A (DYT4 Dystonia): Clinical anthology of 11 cases and review. Movement disorder. 2022;1-17$34$YR$$M$Y$$$20240712$$HP$CH$CH
226175002$22617500$2$F$$20220509$20230620$20240712$PER$$TR-PFM-2022-04425$PIERRE FABRE MEDICAMENT$Yakarisik M, Akkoz C, Ayvaz M, Dulger A. A new risk factor for hepatic encephalopathy: Ingestion of mad honey. Journal of emergency medicine case reports. 2021;12(3):71-3$66$YR$$M$Y$$$20240712$$HP$TR$TR
226175012$22617501$2$F$$20220509$20230620$20240712$PER$$TR-PFM-2022-04432$PIERRE FABRE MEDICAMENT$Bostan H, Ucan B, Kizilgul M, Calapkulu M, Hepsen S, Gul U et al. Relapsed and newly diagnosed Graves^ disease due to immunization against COVID-19: A case series and review of the literature. Journal of Autoimmunity. 2022;128:102809$44$YR$$F$Y$$$20240712$$HP$TR$TR
226175022$22617502$2$F$$20220615$20230620$20240712$PER$$FR-PFM-2022-05076$PIERRE FABRE MEDICAMENT$Matteo Pozzi MD, Buzzi R, Hayek A, Portran P, Schweize R, Fellahi JL et al. Veno-arterial extracorporeal membrane oxygenation for drug intoxications: A single center, 14-year experience. Cardiac Surgery. 2022;37:1512-1519$$$$$Y$$$20240712$$HP$FR$FR
226175032$22617503$2$F$$20220509$20230620$20240712$PER$$TR-PFM-2022-04433$PIERRE FABRE MEDICAMENT$Bostan H, Ucan B, Kizilgul M, Calapkulu M, Hepsen S, Gul U et al. Relapsed and newly diagnosed Graves^ disease due to immunization against COVID-19: A case series and review of the literature. Journal of Autoimmunity. 2022;128:102809$49$YR$$M$Y$$$20240712$$HP$TR$TR
226175042$22617504$2$F$$20220509$20230620$20240712$PER$$TR-PFM-2022-04434$PIERRE FABRE MEDICAMENT$Bostan H, Ucan B, Kizilgul M, Calapkulu M, Hepsen S, Gul U et al. Relapsed and newly diagnosed Graves^ disease due to immunization against COVID-19: A case series and review of the literature. Journal of Autoimmunity. 2022;128:102809$31$YR$$F$Y$$$20240712$$HP$TR$TR
226175062$22617506$2$F$$20220509$20230620$20240712$PER$$TR-PFM-2022-04436$PIERRE FABRE MEDICAMENT$Bostan H, Ucan B, Kizilgul M, Calapkulu M, Hepsen S, Gul U et al. Relapsed and newly diagnosed Graves^ disease due to immunization against COVID-19: A case series and review of the literature. Journal of Autoimmunity. 2022;128:1-6$51$YR$$F$Y$$$20240712$$HP$TR$TR
226175072$22617507$2$F$$20220509$20230620$20240712$PER$$TR-PFM-2022-04435$PIERRE FABRE MEDICAMENT$Bostan H, Ucan B, Kizilgul M, Calapkulu M, Hepsen S, Gul U et al. Relapsed and newly diagnosed Graves^ disease due to immunization against COVID-19: A case series and review of the literature. Journal of Autoimmunity. 2022;128:1-6$53$YR$$F$Y$$$20240712$$HP$TR$TR
226175092$22617509$2$F$$20220509$20230620$20240712$PER$$TR-PFM-2022-04437$PIERRE FABRE MEDICAMENT$Bostan H, Ucan B, Kizilgul M, Calapkulu M, Hepsen S, Gul U et al. Relapsed and newly diagnosed Graves^ disease due to immunization against COVID-19: A case series and review of the literature. Journal of Autoimmunity. 2022;128:1-6$47$YR$$F$Y$$$20240712$$HP$TR$TR
226175102$22617510$2$F$$20220509$20230620$20240712$PER$$TR-PFM-2022-04438$PIERRE FABRE MEDICAMENT$Bostan H, Ucan B, Kizilgul M, Calapkulu M, Hepsen S, Gul U et al. Relapsed and newly diagnosed Graves^ disease due to immunization against COVID-19: A case series and review of the literature. Journal of Autoimmunity. 2022;128:102809$46$YR$$M$Y$$$20240712$$HP$TR$TR
226175152$22617515$2$F$$20220519$20230620$20240712$PER$$ES-PFM-2022-04521$PIERRE FABRE MEDICAMENT$Rios-Leon R, Rodriguez-Gandia MA, Palomera-Rico A, Foruny-Olcina JR, Nunez-Gomez L, Albillos-Martinez A. Gastric arteriovenous malformation as a cause of recurrent gastrointestinal bleeding in a cirrhotic patient. Gastroenterologia y Hepatologia. 2022;45:24-6$43$YR$$M$Y$$$20240712$$HP$ES$ES
226175162$22617516$2$F$$20220512$20230620$20240712$PER$$RO-PFM-2022-04502$PIERRE FABRE MEDICAMENT$Cioanca LG, Grama A, Petrescu L, Cainap S, Mateescu RB, Benta G et al. Acute liver failure associated with recent SARS-CoV-2 infection in a pediatric patient - case report. Pediatru ro. 2022;65(1):42-5$5$YR$$M$Y$$$20240712$$HP$RO$RO
226175172$22617517$2$F$$20220530$20230620$20240712$PER$$GR-PFM-2022-04858$PIERRE FABRE MEDICAMENT$Gkoufa A, Angelousi A, Neonaki A, Athanasouli F, Cholongitas E. Severe symptomatic hypocalcemia associated With Denosumab administration in a patient with decompensated cirrhosis and renal dysfunction. Ann Pharmacotherapy. 2022;56(7):853-55$41$YR$$M$Y$$$20240712$$HP$GR$GR
226175182$22617518$2$F$$20220601$20230620$20240712$PER$$HR-PFM-2022-04874$PIERRE FABRE MEDICAMENT$Radovic K, Vuletic V. Deep brain stimulation and essential tremor in an elderly patient with brain atrophy: a case report. Medicina fluminensis. 2022;58(2):177-82$72$YR$$M$Y$$$20240712$$HP$HR$HR
226175192$22617519$2$F$$20220530$20230620$20240712$PER$$CA-PFM-2022-04856$PIERRE FABRE MEDICAMENT$Lun R, Moores M, Mestre T, Breiner A. Thyrotoxicosis resulting in unilateral upper limb chorea and ballismus. Can J Neurol Sci. 2022;49(3):431-2$67$YR$$M$Y$$$20240712$$HP$CA$CA
226175202$22617520$2$F$$20220607$20230620$20240712$PER$$BE-PFM-2022-04939$PIERRE FABRE MEDICAMENT$Carbonez K, Kefer J, Sluysmans T, Moniotte S. Treatment of a severe distal thoracic and abdominal coarctation with cutting balloon and stent implantation in an infant: From fetal diagnosis to adolescence. Health Science Reports. 2022;5:e625$12$YR$$M$Y$$$20240712$$HP$BE$BE
226175212$22617521$2$F$$20220610$20230620$20240712$PER$$JP-PFM-2022-05006$PIERRE FABRE MEDICAMENT$Ichiro Kobayashi, Masaki Shimomuraa, Masahiro Uekib, Shunichiro Takezakib, Yuka Okuraa, Mitsuru Nawate et al. Development of Graves^ disease during drug-free remission of juvenile dermatomyositis. Modern Rheumatology Case Reports. 2022;6(1):55-8$6$YR$$M$Y$$$20240712$$CN$JP$JP
226175222$22617522$2$F$$20220610$20230620$20240712$PER$$JP-PFM-2022-05003$PIERRE FABRE MEDICAMENT$Nogami N, Constantine S, Sai S. Neurological and gastrointestinal symptoms as an initial presentation of pediatric thyroid storm: report of three cases. J Pediatr Endocrinol Metab. 2022;34(9):1197-1200$14$YR$$M$Y$$$20240712$$HP$JP$JP
226175232$22617523$2$F$$20220516$20230620$20240712$PER$$TR-PFM-2022-04522$PIERRE FABRE MEDICAMENT$Gulhan B, Unsal Y, Baltu D, Ertas NBC, Ozdemir G, Utine E et al. Apparent mineralocorticoid excess: A diagnosis beyond classical causes of severe hypertension in a child. Blood Pressure Monitoring. 2022;27(3):208-11$4$YR$$F$Y$$$20240712$$HP$TR$TR
226175242$22617524$2$F$$20220613$20230620$20240712$PER$$DE-PFM-2022-05075$PIERRE FABRE MEDICAMENT$Menden B, Gutschalk A, Wunderlich G, Haack TB. Expanded Genetic Spectrum and Variable Disease Onset in AOPEP-Associated Dystonia. Movement Disorders. 2022;37(5):1113-5$38$YR$$M$Y$$$20240712$$HP$DE$DE
226175252$22617525$2$F$$20220516$20230620$20240712$PER$$NL-PFM-2022-04517$PIERRE FABRE MEDICAMENT$Swinnen B, Bot M, Goes K, Beudel M, Schuurman R. Directional stimulation improves stimulation-induced dysgeusia in DBS for essential tremor. Brain Stimulation. 2022;15:680-82$71$YR$$F$Y$$$20240712$$HP$NL$NL
226175662$22617566$2$F$$20220614$20230620$20240712$PER$$US-PFM-2022-05180$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
226175672$22617567$2$F$$20220609$20230620$20240712$PER$$JP-PFM-2022-05139$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$PH$JP$JP
226175682$22617568$2$F$$20220613$20230620$20240712$PER$$US-PFM-2022-05169$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
226175692$22617569$2$F$$20220615$20230620$20240712$PER$$US-PFM-2022-05113$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240712$$HP$US$US
226175702$22617570$2$F$$20220614$20230620$20240712$PER$$US-PFM-2022-05171$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.442$KG$20240712$$HP$US$US
226175722$22617572$2$F$$20220621$20230620$20240712$PER$$US-PFM-2022-05263$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.896$KG$20240712$$HP$US$US
226175733$22617573$3$F$$20220621$20230620$20240712$PER$$JP-PFM-2022-05341$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$MD$JP$JP
226175742$22617574$2$F$$20220615$20230620$20240712$PER$$US-PFM-2022-05170$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.719$KG$20240712$$HP$US$US
226175752$22617575$2$F$$20220621$20230620$20240712$PER$$FR-PFM-2022-05275$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240712$$MD$FR$FR
226175763$22617576$3$F$$20220624$20230620$20240712$PER$$US-PFM-2022-05359$PIERRE FABRE MEDICAMENT$$$$$F$Y$16$KG$20240712$$HP$US$US
226175772$22617577$2$F$$20220623$20230620$20240712$PER$$US-PFM-2022-05296$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.44$KG$20240712$$HP$US$US
226175783$22617578$3$F$$20220627$20230620$20240712$PER$$US-PFM-2022-05360$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
226175793$22617579$3$F$$20220627$20230620$20240712$PER$$US-PFM-2022-05361$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
226175802$22617580$2$F$$20220817$20230620$20240712$PER$$US-PFM-2022-05112$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
226175812$22617581$2$F$$20220812$20230620$20240712$PER$$US-PFM-2022-05212$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
226175822$22617582$2$F$$20220919$20230620$20240712$PER$$US-PFM-2022-05232$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.8$KG$20240712$$HP$US$US
226175832$22617583$2$F$$20230627$20230620$20240712$PER$$US-PFM-2022-05231$PIERRE FABRE MEDICAMENT$$$$$F$Y$15.896$KG$20240712$$HP$US$US
226175843$22617584$3$F$$20220624$20230620$20240712$PER$$US-PFM-2022-05328$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.2$KG$20240712$$HP$US$US
226175863$22617586$3$F$20220617$20220627$20230620$20240712$PER$$US-PFM-2022-05362$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$8$KG$20240712$$HP$US$US
226175873$22617587$3$F$20220623$20220629$20230620$20240712$PER$$US-PFM-2022-05452$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7$KG$20240712$$PH$US$US
226175883$22617588$3$F$$20220628$20230620$20240712$PER$$US-PFM-2022-05408$PIERRE FABRE MEDICAMENT$$$$$M$Y$11$KG$20240712$$HP$US$US
226175893$22617589$3$F$$20220629$20230620$20240712$PER$$US-PFM-2022-05438$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240712$$HP$US$US
226175903$22617590$3$F$$20220630$20230620$20240712$PER$$US-PFM-2022-05455$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.6$KG$20240712$$HP$US$US
226175913$22617591$3$F$$20220630$20230620$20240712$PER$$US-PFM-2022-05454$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240712$$HP$US$US
226175923$22617592$3$F$$20220706$20230620$20240712$PER$$US-PFM-2022-05439$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
226175943$22617594$3$F$$20220630$20230620$20240712$PER$NL-LRB-00817987$NL-PFM-2022-05451$PIERRE FABRE MEDICAMENT$$$$N$F$Y$3$KG$20240712$$MD$NL$NL
226175953$22617595$3$F$$20220928$20230620$20240712$PER$$US-PFM-2022-05409$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$HP$US$US
226175963$22617596$3$F$20220525$20220721$20230620$20240712$PER$$JP-PFM-2022-05430$PIERRE FABRE MEDICAMENT$$2$MON$$M$Y$5$KG$20240712$$MD$JP$JP
226175972$22617597$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05153$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240712$$HP$CA$CA
226175983$22617598$3$F$$20220701$20230620$20240712$PER$$US-PFM-2022-05473$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.3$KG$20240712$$HP$US$US
226175993$22617599$3$F$$20220706$20230620$20240712$PER$$US-PFM-2022-05578$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240712$$HP$US$US
226176003$22617600$3$F$20220613$20220705$20230620$20240712$PER$$JP-PFM-2022-05497$PIERRE FABRE MEDICAMENT$$19$DY$$M$Y$3$KG$20240712$$PH$JP$JP
226176013$22617601$3$F$$20220706$20230620$20240712$PER$$US-PFM-2022-05579$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
226176023$22617602$3$F$$20220718$20230620$20240712$PER$$US-PFM-2022-05530$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240712$$HP$US$US
226176033$22617603$3$F$$20220719$20230620$20240712$PER$$JP-PFM-2022-05553$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$$$20240712$$PH$JP$JP
226176043$22617604$3$F$20220620$20220725$20230620$20240712$PER$$JP-PFM-2022-05516$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240712$$PH$JP$JP
226176053$22617605$3$F$$20220711$20230620$20240712$PER$$HR-PFM-2022-05468$PIERRE FABRE MEDICAMENT$$40$YR$$F$Y$$$20240712$$MD$HR$HR
226176063$22617606$3$F$$20220804$20230620$20240712$PER$$US-PFM-2022-05474$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
226176132$22617613$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05145$PIERRE FABRE MEDICAMENT$$49$YR$$F$Y$$$20240712$$MD$CA$CA
226176142$22617614$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05178$PIERRE FABRE MEDICAMENT$$30$YR$$F$Y$$$20240712$$MD$CA$CA
226176152$22617615$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05152$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240712$$MD$CA$CA
226176162$22617616$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05177$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240712$$MD$CA$CA
226176182$22617618$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05154$PIERRE FABRE MEDICAMENT$$57$YR$$F$Y$$$20240712$$MD$CA$CA
226176192$22617619$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05135$PIERRE FABRE MEDICAMENT$$19$YR$$F$Y$$$20240712$$MD$CA$CA
226176202$22617620$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05179$PIERRE FABRE MEDICAMENT$$36$YR$$F$Y$$$20240712$$MD$CA$CA
226176222$22617622$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05144$PIERRE FABRE MEDICAMENT$$58$YR$$F$Y$$$20240712$$MD$CA$CA
226176232$22617623$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05146$PIERRE FABRE MEDICAMENT$$63$YR$$F$Y$$$20240712$$MD$CA$CA
226176272$22617627$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05147$PIERRE FABRE MEDICAMENT$$51$YR$$F$Y$$$20240712$$MD$CA$CA
226176292$22617629$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05148$PIERRE FABRE MEDICAMENT$$32$YR$$F$Y$$$20240712$$MD$CA$CA
226176302$22617630$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05151$PIERRE FABRE MEDICAMENT$$24$YR$$F$Y$$$20240712$$MD$CA$CA
226176312$22617631$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05149$PIERRE FABRE MEDICAMENT$$50$YR$$F$Y$$$20240712$$MD$CA$CA
226176322$22617632$2$F$$20220616$20230620$20240712$PER$$ES-PFM-2022-05197$PIERRE FABRE MEDICAMENT$Borrella Gras AJ, Gomez Rubio M, Olazaran Narvaez I, Castellanos Gonzalez M. Hepatosplenic schistosomiasis: a rare cause of chronic liver disease with portal hypertension diagnosed by abdominal ultrasound. Rev Esp Enferm Dig. 2022;114(1):47-8$22$YR$$M$Y$$$20240712$$HP$ES$ES
226176333$22617633$3$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05327$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:1-8$$$N$$Y$$$20240712$$HP$KR$KR
226176342$22617634$2$F$$20220620$20230620$20240712$PER$$FR-PFM-2022-05264$PIERRE FABRE MEDICAMENT$Chastanet S, Maruani A, Laure B, Herbreteau D, Joly A. Effect of Beta-blockers on Extracranial Arteriovenous Malformations. Acta Derm Venereol. 2022;102:1-3$56$YR$$M$Y$$$20240712$$HP$FR$FR
226176352$22617635$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05326$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:1-8$$$N$$Y$$$20240712$$HP$KR$KR
226176362$22617636$2$F$$20220620$20230620$20240712$PER$$FR-PFM-2022-05267$PIERRE FABRE MEDICAMENT$Chastanet S, Maruani A, Laure B, Herbreteau D, Joly A. Effect of Beta-blockers on Extracranial Arteriovenous Malformations. Acta Derm Venereol. 2022;102:1-3$41$YR$$M$Y$$$20240712$$HP$FR$FR
226176372$22617637$2$F$$20220620$20230620$20240712$PER$$FR-PFM-2022-05265$PIERRE FABRE MEDICAMENT$Chastanet S, Maruani A, Laure B, Herbreteau D, Joly A. Effect of Beta-blockers on Extracranial Arteriovenous Malformations. Acta Derm Venereol. 2022;102:1-3$55$YR$$M$Y$$$20240712$$HP$FR$FR
226176382$22617638$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05316$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:1-8$$$$$Y$$$20240712$$HP$KR$KR
226176392$22617639$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05314$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:1-8$$$N$$Y$$$20240712$$HP$KR$KR
226176402$22617640$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05315$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:1-8$$$N$$Y$$$20240712$$HP$KR$KR
226176412$22617641$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05317$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:1-8$$$N$$Y$$$20240712$$HP$KR$KR
226176422$22617642$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05318$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:3279$$$N$$Y$$$20240712$$HP$KR$KR
226176432$22617643$2$F$$20220613$20230620$20240712$PER$$CA-PFM-2022-05150$PIERRE FABRE MEDICAMENT$$45$YR$$F$Y$$$20240712$$MD$CA$CA
226176442$22617644$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05313$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:1-8$$$N$$Y$$$20240712$$HP$KR$KR
226176452$22617645$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05319$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:3279$$$N$$Y$$$20240712$$HP$KR$KR
226176462$22617646$2$F$$20220620$20230620$20240712$PER$$FR-PFM-2022-05269$PIERRE FABRE MEDICAMENT$Chastanet S, Maruani A, Laure B, Herbreteau D, Joly A. Effect of Beta-blockers on Extracranial Arteriovenous Malformations. Acta Derm Venereol. 2022;102:1-3$40$YR$$F$Y$$$20240712$$HP$FR$FR
226176472$22617647$2$F$$20220620$20230620$20240712$PER$$FR-PFM-2022-05268$PIERRE FABRE MEDICAMENT$Chastanet S, Maruani A, Laure B, Herbreteau D, Joly A. Effect of Beta-blockers on Extracranial Arteriovenous Malformations. Acta Derm Venereol. 2022;102:1-3$67$YR$$F$Y$$$20240712$$HP$FR$FR
226176482$22617648$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05283$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates May requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:1-8$$$$$Y$$$20240712$$HP$KR$KR
226176513$22617651$3$F$$20220630$20230620$20240712$PER$$ES-PFM-2022-05486$PIERRE FABRE MEDICAMENT$Selvi-Sabater P, Carvajal-Sanchez MA, Carrera-Hueso FJ. Two possible cases of erenumab-induced xerostomia. J Clin Pharm Ther. 2022;47:824-5$60$YR$$F$Y$$$20240712$$HP$ES$ES
226176522$22617652$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05321$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:1-8$$$N$$Y$$$20240712$$HP$KR$KR
226176532$22617653$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05320$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:3279$$$$$Y$$$20240712$$HP$KR$KR
226176542$22617654$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05322$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:1-8$$$N$$Y$$$20240712$$HP$KR$KR
226176552$22617655$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05323$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:1-8$$$N$$Y$$$20240712$$HP$KR$KR
226176562$22617656$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05324$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:3279$$$N$$Y$$$20240712$$HP$KR$KR
226176572$22617657$2$F$$20220620$20230620$20240712$PER$$KR-PFM-2022-05325$PIERRE FABRE MEDICAMENT$Lim YT, Kim YH, Kwon JE. Effective control of supraventricular tachycardia in neonates may requires combination pharmacologic therapy. Journal of clinical medicine. 2022;11:1-8$$$N$$Y$$$20240712$$HP$KR$KR
226176583$22617658$3$F$$20220623$20230620$20240712$PER$$IT-PFM-2022-05343$PIERRE FABRE MEDICAMENT$Galosi S, Edani BH, Martinelli S, Hansikova H, Eklund EA, Caputi C, et al. De novo DHDDS variants cause a neurodevelopmental and neurodegenerative disorder with myoclonus. Brain. 2022;145(1):208-23$44$YR$$M$Y$$$20240712$$HP$IT$IT
226176593$22617659$3$F$$20220704$20230620$20240712$PER$$CH-PFM-2022-05563$PIERRE FABRE MEDICAMENT$Luchsinger I, Schwieger-Briel A, Theiler M, Rast A.C, Waelchli R, Weibel L. Large congenital pyogenic granuloma: report of two cases and review of the literature. Pediatric dermatology. 2022;39(1):70$3$MON$$F$Y$$$20240712$$HP$CH$CH
226176613$22617661$3$F$20220701$20220704$20230620$20240712$PER$$JP-PFM-2022-05656$PIERRE FABRE MEDICAMENT$$4$MON$$M$Y$6$KG$20240712$$PH$JP$JP
226176622$22617662$2$F$$20220621$20230620$20240712$PER$$CA-PFM-2022-05290$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240712$$MD$CA$CA
226176643$22617664$3$F$$20220704$20230620$20240712$PER$$ES-PFM-2022-05562$PIERRE FABRE MEDICAMENT$Carpena GJ, Cabanes JCP, Quiles H, Garcia VS, Paco AB, Guerola PT et al. Two new cases of tardive expansion congenital hemangiomas: The importance of long-term clinical follow-up. Pediatric dermatology. 2022;39(1):69-70$9$MON$$M$Y$$$20240712$$HP$ES$ES
226176653$22617665$3$F$$20220704$20230620$20240712$PER$$ES-PFM-2022-05556$PIERRE FABRE MEDICAMENT$Macia-Rivas L, Velasco-Roces L,  Fernandez-Laguna C L, Alvarez-Asteinza C, Maray M, Lastras SF et al. Galcanezumab In Prophylaxis Of Refractory High-Frequency Episodic Migraine In Clinical Practice. Eur J Hosp Pharm. 2022;29 (Suppl 1):A1-218$$$$$Y$$$20240712$$HP$ES$ES
226176663$22617666$3$F$$20220704$20230620$20240712$PER$$TR-PFM-2022-05558$PIERRE FABRE MEDICAMENT$Yuksekgonul A U, Azak E, Akalin A, Ertugrul I, Kilic E, Utine G E et al. Efficacy of flecainide in bidirectional ventricular tachycardia and  tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome. European Journal of Medical Genetics. 2022;65:104499$14$YR$$F$Y$$$20240712$$HP$TR$TR
226176673$22617667$3$F$$20220704$20230620$20240712$PER$$ES-PFM-2022-05571$PIERRE FABRE MEDICAMENT$Briceno Casado MDP, Gil-Sierra MD, De La Calle-Riaguas B , Julia Luna FJ, Piqueras-Romero C. Use of monoclonal antibodies against the calcitonin gene-related peptide pathway in chronic migraine in clinical practice. Eur J Hosp Pharm. 2022;29 (Suppl 1):A1-218$$$$$Y$$$20240712$$HP$ES$ES
226176683$22617668$3$F$$20220704$20230620$20240712$PER$$DE-PFM-2022-05557$PIERRE FABRE MEDICAMENT$Violano M, Poller W, Abraham MR, Huemer M, Scheinman M, Landmesser U et al. Deadly emotional argument: Sudden cardiac death in catecholaminergic polymorphic ventricular  tachycardia (CPVT). IJC Heart + Vasculature. 2022;41:1-4$41$YR$$F$Y$$$20240712$$HP$DE$DE
226176693$22617669$3$F$20220707$20220707$20230620$20240712$PER$$GR-PFM-2022-05621$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$6$KG$20240712$$CN$GR$GR
226176703$22617670$3$F$$20220707$20230620$20240712$PER$$US-PFM-2022-05620$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.977$KG$20240712$$HP$US$US
226176713$22617671$3$F$20220711$20220711$20230620$20240712$PER$$US-PFM-2022-05680$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240712$$PH$US$US
226176723$22617672$3$F$$20220711$20230620$20240712$PER$$US-PFM-2022-05668$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
226176763$22617676$3$F$$20220712$20230620$20240712$PER$$US-PFM-2022-05686$PIERRE FABRE MEDICAMENT$$$$$M$Y$10$KG$20240712$$HP$US$US
226176783$22617678$3$F$$20220712$20230620$20240712$PER$$US-PFM-2022-05683$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
226176793$22617679$3$F$$20220713$20230620$20240712$PER$$US-PFM-2022-05715$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
226176803$22617680$3$F$$20220711$20230620$20240712$PER$$JP-PFM-2022-05671$PIERRE FABRE MEDICAMENT$Kitagawa D, Ominami M, Taira K, Tanoue K, Higashimori A, Maruyama H et al. Lustrous White Erosions Surrounded by an Erythematous Mucosa: A Novel Endoscopic Finding of Gastric Lesions in Patients with Wilson Disease. Internal Medicine. 2022;61:1835-41$20$YR$$M$Y$$$20240712$$HP$JP$JP
226176813$22617681$3$F$$20220713$20230620$20240712$PER$$US-PFM-2022-05714$PIERRE FABRE MEDICAMENT$$$$$F$Y$13$KG$20240712$$HP$US$US
226176823$22617682$3$F$$20220714$20230620$20240712$PER$$US-PFM-2022-05752$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240712$$HP$US$US
226176833$22617683$3$F$$20220714$20230620$20240712$PER$$US-PFM-2022-05734$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240712$$HP$US$US
226176843$22617684$3$F$$20220715$20230620$20240712$PER$$US-PFM-2022-05770$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
226176853$22617685$3$F$$20220718$20230620$20240712$PER$$US-PFM-2022-05815$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.4$KG$20240712$$HP$US$US
226176873$22617687$3$F$$20220718$20230620$20240712$PER$$US-PFM-2022-05924$PIERRE FABRE MEDICAMENT$Gatts JE, Rush MC, Check JF, Samelak DM, McLean TW. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age. Pediatric Dermatology. 2022;39(3):389-93$$$I$M$Y$$$20240712$$HP$US$US
226176883$22617688$3$F$$20220718$20230620$20240712$PER$$US-PFM-2022-05900$PIERRE FABRE MEDICAMENT$Gatts JE, Rush MC, Check JF, Samelak DM, McLean TW. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age. Pediatric Dermatology. 2022;39(3):389-93$$$I$$Y$$$20240712$$HP$US$US
226176892$22617689$2$F$$20221024$20230620$20240712$PER$$CA-PFM-2022-05289$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240712$$MD$CA$CA
226176903$22617690$3$F$$20220719$20230620$20240712$PER$$FR-PFM-2022-05885$PIERRE FABRE MEDICAMENT$Boccara O.. Actualit?s th?rapeutiques dans les anomalies vasculaires de l^enfant. Th?rapeutiques en Dermato- V?n?rologie. 2022;311:33-36$$$I$$Y$$$20240712$$HP$FR$FR
226176913$22617691$3$F$$20220718$20230620$20240712$PER$$US-PFM-2022-05925$PIERRE FABRE MEDICAMENT$Gatts JE, Rush MC, Check JF, Samelak DM, McLean TW. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age. Pediatric Dermatology. 2022;39(3):389-93$$$$F$Y$$$20240712$$HP$US$US
226176923$22617692$3$F$$20220718$20230620$20240712$PER$$IT-PFM-2022-05899$PIERRE FABRE MEDICAMENT$Tassi A, Capodicasa V, Driul D, Driul L. 134 A particular case of craniopharyngioma.. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2022;273:e56$18$YR$$F$Y$$$20240712$$HP$IT$IT
226176933$22617693$3$F$$20220718$20230620$20240712$PER$$SE-PFM-2022-05876$PIERRE FABRE MEDICAMENT$Stenberg R, Brummer R J, Noren T. Faecal transplantation in a two-year-old child with  therapy-resistant Clostridiodes difficileinfection. Acta Paediatrica, International Journal of Paediatrics. 2022;111(8):1628-9$2$DY$$F$Y$$$20240712$$HP$SE$SE
226176943$22617694$3$F$$20220720$20230620$20240712$PER$$US-PFM-2022-05844$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
226176953$22617695$3$F$$20220718$20230620$20240712$PER$$JP-PFM-2022-05898$PIERRE FABRE MEDICAMENT$Takahagi S, Okamoto M, Ishii K, Tanaka A, Mizuno H, Harada N et al. Clinical and histological characterization of transient dermal pain triggered by sweating stimuli. Allergology International. 2022;71(3):362-72$$$$$Y$$$20240712$$HP$JP$JP
226176963$22617696$3$F$$20220722$20230620$20240712$PER$$US-PFM-2022-05872$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
226176973$22617697$3$F$$20220727$20230620$20240712$PER$$US-PFM-2022-05951$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$PH$US$US
226176983$22617698$3$F$$20220721$20230620$20240712$PER$$US-PFM-2022-05852$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240712$$HP$US$US
226176993$22617699$3$F$$20220725$20230620$20240712$PER$$US-PFM-2022-05902$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240712$$HP$US$US
226177003$22617700$3$F$$20220728$20230620$20240712$PER$$US-PFM-2022-05952$PIERRE FABRE MEDICAMENT$$$$$F$Y$4$KG$20240712$$HP$US$US
226177013$22617701$3$F$$20220728$20230620$20240712$PER$$US-PFM-2022-05955$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240712$$HP$US$US
226177023$22617702$3$F$$20220728$20230620$20240712$PER$$US-PFM-2022-05954$PIERRE FABRE MEDICAMENT$$$$$F$Y$12$KG$20240712$$HP$US$US
226177033$22617703$3$F$$20220728$20230620$20240712$PER$$US-PFM-2022-05953$PIERRE FABRE MEDICAMENT$$$$$M$Y$10$KG$20240712$$HP$US$US
226177043$22617704$3$F$$20230406$20230620$20240712$PER$$US-PFM-2022-05873$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.288$KG$20240712$$HP$US$US
226177053$22617705$3$F$$20220801$20230620$20240712$PER$$US-PFM-2022-05923$PIERRE FABRE MEDICAMENT$Gatts JE, Rush MC, Check JF, Samelak DM, McLean TW. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age. Pediatric Dermatology. 2022;39(3):389-93$$$I$F$Y$$$20240712$$HP$US$US
226177063$22617706$3$F$$20230522$20230620$20240712$PER$$US-PFM-2022-05850$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.22$KG$20240712$$MD$US$US
226177093$22617709$3$F$$20220725$20230620$20240712$PER$$JP-PFM-2022-05996$PIERRE FABRE MEDICAMENT$Mori H, Sumitomo N, Tsutsui K, Nabeshima T. A novel mechanism of sudden infant death syndrome during atrioventricular reentrant tachycardia: a case report. European Heart Journal - Case Reports. 2022;6(6):1-4$3$MON$$M$Y$8$KG$20240712$$HP$JP$JP
226177103$22617710$3$F$20220515$20220515$20230620$20240712$PER$$DE-PFM-2022-06011$PIERRE FABRE MEDICAMENT$$15$MON$$F$Y$10$KG$20240712$$HP$DE$DE
226177113$22617711$3$F$$20220725$20230620$20240712$PER$$TR-PFM-2022-06019$PIERRE FABRE MEDICAMENT$Marasli H, Acipayam C, Gullu UU, Dincer S, Dalgic EF, Karakucuk SN et al. Evaluation of cases with infantile hemangioma requiring treatment. Folia Medica (Plovdiv). 2022;64(1):67-74$$$I$$Y$$$20240712$$HP$TR$TR
226177123$22617712$3$F$$20220729$20230620$20240712$PER$$KR-PFM-2022-05987$PIERRE FABRE MEDICAMENT$$$$N$$Y$$$20240712$$CN$KR$KR
226177133$22617713$3$F$$20220725$20230620$20240712$PER$$ES-PFM-2022-05997$PIERRE FABRE MEDICAMENT$Ballesteros RV, Alvarez ZG, Blanco CO. Interpretation of giant negative T waves: on the verge of iatrogeny. European Heart Journal - Case Reports. 2022;6(6):1-2$70$YR$$M$Y$$$20240712$$HP$ES$ES
226177153$22617715$3$F$$20220801$20230620$20240712$PER$$TR-PFM-2022-06050$PIERRE FABRE MEDICAMENT$Gunay C, Edem P, Hiz-Kurul AS, Yasar E, Yis U. Recurrent painful ophthalmoplegic neuropathy: a report of  two new pediatric cases. The Turkish Journal of Pediatrics. 2022;64:592-8$7$YR$$F$Y$$$20240712$$HP$TR$TR
226177163$22617716$3$F$20220722$20220801$20230620$20240712$PER$$US-PFM-2022-06045$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$4.943$KG$20240712$$PH$US$US
226177173$22617717$3$F$$20220725$20230620$20240712$PER$$DE-PFM-2022-06002$PIERRE FABRE MEDICAMENT$Nikolaus M, Kuhne F, Tietze A, Thumfart J, Kempf C, Gratopp A et al. Modified zipper method a promising treatment option in severe pediatric immune-mediated neurologic disorders. Journal of Child Neurology. 2022;37(6):505-16$12$YR$$F$Y$$$20240712$$HP$DE$DE
226177183$22617718$3$F$$20220803$20230620$20240712$PER$$US-PFM-2022-06072$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240712$$HP$US$US
226177193$22617719$3$F$20220101$20220802$20230620$20240712$PER$$FR-PFM-2022-06052$PIERRE FABRE MEDICAMENT$$$$$F$Y$12$KG$20240712$$PH$FR$FR
226177203$22617720$3$F$$20220803$20230620$20240712$PER$$US-PFM-2022-06071$PIERRE FABRE MEDICAMENT$$$$$M$Y$4$KG$20240712$$HP$US$US
226177213$22617721$3$F$$20220801$20230620$20240712$PER$$TR-PFM-2022-06049$PIERRE FABRE MEDICAMENT$Gunay C, Edem P, Hiz-Kurul AS, Yasar E, Yis U. Recurrent painful ophthalmoplegic neuropathy: a report of  two new pediatric cases. The Turkish Journal of Pediatrics. 2022;64:592-8$4$YR$$F$Y$$$20240712$$HP$TR$TR
226177223$22617722$3$F$$20220802$20230620$20240712$PER$$US-PFM-2022-06003$PIERRE FABRE MEDICAMENT$Espay AJ, Ries S, Maloney T, Vannest J, Neefus E, Dwivedi AK et al. Clinical and neural responses to cognitive behavioral therapy for functional tremor. Neurology. 2019;93:e1787-98$38$YR$$F$Y$$$20240712$$HP$US$US
226177233$22617723$3$F$$20220803$20230620$20240712$PER$$US-PFM-2022-06068$PIERRE FABRE MEDICAMENT$Hackett G, Lin TK, Imundo JR. Use of ivabradine in a critically ill pediatric patient with recalcitrant ectopic atrial tachycardia and complex congenital heart disease. HeartRhythm Case Reports. 2022;8(6):415-9$$$N$F$Y$$$20240712$$MD$US$US
226177242$22617724$2$F$$20220803$20230620$20240711$PER$$CA-PFM-2022-06150$PIERRE FABRE MEDICAMENT$$49$YR$$F$Y$$$20240711$$MD$CA$CA
226177263$22617726$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06127$PIERRE FABRE MEDICAMENT$$44$YR$$F$Y$$$20240712$$MD$CA$CA
226177273$22617727$3$F$$20220811$20230620$20240712$PER$$US-PFM-2022-06046$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240712$$HP$US$US
226177283$22617728$3$F$$20221007$20230620$20240712$PER$$US-PFM-2022-06044$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.088$KG$20240712$$HP$US$US
226177302$22617730$2$F$$20220803$20230620$20240711$PER$$CA-PFM-2022-06152$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240711$$MD$CA$CA
226177312$22617731$2$F$$20220803$20230620$20240711$PER$$CA-PFM-2022-06151$PIERRE FABRE MEDICAMENT$$31$YR$$F$Y$$$20240711$$MD$CA$CA
226177383$22617738$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06136$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240712$$MD$CA$CA
226177393$22617739$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06135$PIERRE FABRE MEDICAMENT$$59$YR$$F$Y$$$20240712$$MD$CA$CA
226177402$22617740$2$F$$20220808$20230620$20240711$PER$$US-PFM-2022-06171$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.798$KG$20240711$$HP$US$US
226177412$22617741$2$F$$20220808$20230620$20240711$PER$$US-PFM-2022-06173$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.751$KG$20240711$$HP$US$US
226177422$22617742$2$F$$20220803$20230620$20240711$PER$$CA-PFM-2022-06149$PIERRE FABRE MEDICAMENT$$35$YR$$M$Y$$$20240711$$MD$CA$CA
226177433$22617743$3$F$$20220819$20230620$20240712$PER$$US-PFM-2022-06073$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240712$$HP$US$US
226177443$22617744$3$F$$20220825$20230620$20240712$PER$$US-PFM-2022-06097$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240712$$HP$US$US
226177452$22617745$2$F$$20220809$20230620$20240711$PER$$JP-PFM-2022-06185$PIERRE FABRE MEDICAMENT$Numazawa M, Tomari K, Igaki J, Koki M, Kina Y, Matsuoka T. Advantages of monitoring rT3 and dividing LT3 dose in the treatment of consumptive hypothyroidism associated with infantile hepatic hemangioma. Journal of Pediatric Endocrinology and Metabolism. 2022;1-4$23$DY$$M$Y$$$20240711$$HP$JP$JP
226177463$22617746$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06139$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240712$$MD$CA$CA
226177472$22617747$2$F$$20220805$20230620$20240711$PER$$US-PFM-2022-06170$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240711$$HP$US$US
226177493$22617749$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06146$PIERRE FABRE MEDICAMENT$$44$YR$$F$Y$$$20240712$$MD$CA$CA
226177503$22617750$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06138$PIERRE FABRE MEDICAMENT$$29$YR$$F$Y$$$20240712$$MD$CA$CA
226177513$22617751$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06132$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240712$$MD$CA$CA
226177523$22617752$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06137$PIERRE FABRE MEDICAMENT$$48$YR$$F$Y$$$20240712$$MD$CA$CA
226177533$22617753$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06134$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240712$$MD$CA$CA
226177553$22617755$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06130$PIERRE FABRE MEDICAMENT$$48$YR$$F$Y$$$20240712$$MD$CA$CA
226177563$22617756$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06147$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240712$$MD$CA$CA
226177573$22617757$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06129$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240712$$MD$CA$CA
226177603$22617760$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06131$PIERRE FABRE MEDICAMENT$$48$YR$$F$Y$$$20240712$$MD$CA$CA
226177612$22617761$2$F$$20220808$20230620$20240711$PER$$JP-PFM-2022-06279$PIERRE FABRE MEDICAMENT$Umebayashi K et al. Two cases of PHACE syndrome at our hospital. The 65th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery. 2022;315$29$DY$$F$Y$$$20240711$$HP$JP$JP
226177622$22617762$2$F$$20220808$20230620$20240711$PER$$TR-PFM-2022-06249$PIERRE FABRE MEDICAMENT$Salt I, Aslan IK, Bicer CIO Gozke E. Reversal of Oral Vitamin K Antagonists Using Prothrombin Complex Concentration Prior to IV tPA Administration. Neurology India. 2022;70(3):1238-239$63$YR$$M$Y$$$20240711$$HP$TR$TR
226177632$22617763$2$F$$20220808$20230620$20240711$PER$$ES-PFM-2022-06216$PIERRE FABRE MEDICAMENT$Gomez GL, Sanchez de Peurta CDM, Hidalgo RL, Lopez MV, Valderrama EB, Pascual AC et al. Tremor and frontal epilepsy secondary to gain-of-function mutation in SCN8A: a case report. European Journal of Neurology. 2022;29 (Suppl. 1):690-837$14$YR$$F$Y$$$20240711$$HP$ES$ES
226177642$22617764$2$F$$20220808$20230620$20240711$PER$$JP-PFM-2022-06241$PIERRE FABRE MEDICAMENT$$9$YR$$$Y$$$20240711$$PH$JP$JP
226177652$22617765$2$F$$20220808$20230620$20240711$PER$$RO-PFM-2022-06219$PIERRE FABRE MEDICAMENT$Dobra IM, Rosu P, Ilie IR, Blesneag AV, Muresanu DF. Hypokalemic periodic paralysis due to Basedow-Graves disease. Romania Journal of Neurology. 2018;17$25$YR$$M$Y$$$20240711$$HP$RO$RO
226177662$22617766$2$F$$20220809$20230620$20240711$PER$$US-PFM-2022-06196$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240711$$HP$US$US
226177672$22617767$2$F$$20220808$20230620$20240711$PER$$TR-PFM-2022-06247$PIERRE FABRE MEDICAMENT$Salt I, Aslan IK, Bicer CIO, Gozke E. Reversal of Oral Vitamin K Antagonists Using Prothrombin Complex Concentration Prior to IV tPA Administration. Neurology India. 2022;70(3):1238-9$69$YR$$F$Y$$$20240711$$HP$TR$TR
226177682$22617768$2$F$$20220808$20230620$20240711$PER$$DE-PFM-2022-06202$PIERRE FABRE MEDICAMENT$Ropke EF, Chwoika M, Treber T, Meyer J, Paasch C. Infectious hematogenous lumbar spondylodiscitis caused by Actinotignum  schaalii in a 74-year-old man: A case report. International Journal of Surgery Case Reports. 2022;97:1-5$74$YR$$M$Y$$$20240711$$HP$DE$DE
226177693$22617769$3$F$$20220803$20230620$20240712$PER$$CA-PFM-2022-06128$PIERRE FABRE MEDICAMENT$$49$YR$$F$Y$$$20240712$$MD$CA$CA
226177702$22617770$2$F$$20220810$20230620$20240711$PER$$US-PFM-2022-06222$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240711$$HP$US$US
226177712$22617771$2$F$$20220811$20230620$20240711$PER$$US-PFM-2022-06233$PIERRE FABRE MEDICAMENT$$$$$F$Y$3$KG$20240711$$HP$US$US
226177722$22617772$2$F$$20220810$20230620$20240711$PER$$US-PFM-2022-06223$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240711$$HP$US$US
226177732$22617773$2$F$$20220810$20230620$20240711$PER$$JP-PFM-2022-06225$PIERRE FABRE MEDICAMENT$Nakashima R, Takase S, Kai K, Sakamoto K, Tsutsui H. Mexiletine effectively prevented refractory Torsades de Pointes and ventricular fibrillation in a patient with congenital type 2 long QT syndrome. J Cardiovasc Electrophysiol. 2022;33:1592-595$28$YR$$F$Y$55$KG$20240711$$HP$JP$JP
226177742$22617774$2$F$$20220810$20230620$20240711$PER$$CA-PFM-2022-06246$PIERRE FABRE MEDICAMENT$$60$YR$$M$Y$$$20240711$$MD$CA$CA
226177752$22617775$2$F$$20220810$20230620$20240711$PER$$CA-PFM-2022-06243$PIERRE FABRE MEDICAMENT$$33$YR$$F$Y$$$20240711$$MD$CA$CA
226177762$22617776$2$F$20220722$20221123$20230620$20240711$PER$$US-PFM-2022-06197$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$4$KG$20240711$$HP$US$US
226177772$22617777$2$F$$20220907$20230620$20240711$PER$$US-PFM-2022-06221$PIERRE FABRE MEDICAMENT$$$$$F$Y$13$KG$20240711$$HP$US$US
226177782$22617778$2$F$$20220811$20230620$20240711$PER$$SI-PFM-2022-06227$PIERRE FABRE MEDICAMENT$Kuralt H, Fidler A, Blatnik A, Novakovic S, Plavc G. Bilateral parotid glands aplasia: a case report and literature review. Oral Radiology. 2022;38:423-29$64$YR$$F$Y$$$20240711$$HP$SI$SI
226177792$22617779$2$F$$20220812$20230620$20240711$PER$$US-PFM-2022-06258$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240711$$HP$US$US
226177802$22617780$2$F$$20220811$20230620$20240711$PER$$US-PFM-2022-06232$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240711$$HP$US$US
226177812$22617781$2$F$$20220815$20230620$20240711$PER$$US-PFM-2022-06276$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240711$$HP$US$US
226177822$22617782$2$F$$20220812$20230620$20240711$PER$$US-PFM-2022-06257$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240711$$HP$US$US
226177832$22617783$2$F$$20220816$20230620$20240711$PER$$IT-PFM-2022-06375$PIERRE FABRE MEDICAMENT$Pensabene M, Di Pace MR, Baldanza F, Grasso F, Patti M, Sergio M et al. Quality of life improving after propranolol treatment in patients with Infantile Hemangiomas. Italian Journal of Pediatrics. 2022;48(1):1-6$$$I$$Y$$$20240711$$HP$IT$IT
226177842$22617784$2$F$$20220816$20230620$20240711$PER$$ES-PFM-2022-06370$PIERRE FABRE MEDICAMENT$Fadrique-Fuentes A, Martinez-Rafael B, Poves-Alvarez R, Gomez-Pesquera E. Anesthesia outside the operating room in a patient with mitochondrial disease. Case Reports in Anesthesiology. 2020;1-3$21$YR$$F$Y$$$20240711$$HP$ES$ES
226177852$22617785$2$F$$20220816$20230620$20240711$PER$$IT-PFM-2022-06374$PIERRE FABRE MEDICAMENT$Pensabene M, Pace M, Baldanza F, Grasso F, Patti M, Sergio M et al. Quality of life improving after propranolol treatment in patients with Infantile Hemangiomas. Italian Journal of Pediatrics. 2022;48:1-6$$$I$$Y$$$20240711$$HP$IT$IT
226177882$22617788$2$F$$20220816$20230620$20240711$PER$$GB-PFM-2022-06365$PIERRE FABRE MEDICAMENT$Pang S, D Ambrosio S, Battaglia G, Jimenez-Jimenez D, Perulli M, Silvennoinen K et al. The impact of Transcranial Magnetic Stimulation (TMS) on seizure course in people with and without epilepsy. Clinical Neurophysiology Practice. 2022;7:174-82$23$YR$$M$Y$$$20240711$$HP$GB$GB
226177902$22617790$2$F$$20220817$20230620$20240711$PER$$US-PFM-2022-06304$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240711$$HP$US$US
226177912$22617791$2$F$$20220816$20230620$20240711$PER$$IT-PFM-2022-06373$PIERRE FABRE MEDICAMENT$Pensabene M, Pace MRD, Baldanza F, Grasso F, Patti M, Sergio M et al. Quality of life improving after propranolol treatment in patients with Infantile Hemangiomas. Italian Journal of Pediatrics. 2022;48(140):1-6$$$I$$Y$$$20240711$$HP$IT$IT
226177922$22617792$2$F$$20220810$20230620$20240711$PER$$CA-PFM-2022-06244$PIERRE FABRE MEDICAMENT$$25$YR$$F$Y$$$20240711$$MD$CA$CA
2261779314$22617793$14$F$20230101$20240826$20230620$20240903$EXP$$CA-CELLTRION INC.-2023CA010765$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
226177942$22617794$2$F$$20220816$20230620$20240711$PER$$IT-PFM-2022-06376$PIERRE FABRE MEDICAMENT$Pensabene M, Pace MRD, Baldanza F, Grasso F, Patti M, Sergio M et al. Quality of life improving after propranolol treatment in patients with Infantile Hemangiomas. Italian Journal of Pediatrics. 2022;48(140):1-6$$$I$$Y$$$20240711$$HP$IT$IT
226177952$22617795$2$F$$20220816$20230620$20240711$PER$$GB-PFM-2022-06364$PIERRE FABRE MEDICAMENT$Pang S, D Ambrosio S, Battaglia G, Jimenez-Jimenez D, Perulli M, Silvennoinen K et al. The impact of Transcranial Magnetic Stimulation (TMS) on seizure course in people with and without epilepsy. Clinical Neurophysiology Practice. 2022;7:174-82$47$YR$$F$Y$$$20240711$$HP$GB$GB
226177962$22617796$2$F$$20220816$20230620$20240711$PER$$GB-PFM-2022-06363$PIERRE FABRE MEDICAMENT$Pang S, D^Ambrosio S, Battaglia G, Jimenez-Jimenez D, Perulli M, Silvennoinen K et al. The impact of Transcranial Magnetic Stimulation (TMS) on seizure course in people with and without epilepsy. Clinical Neurophysiology Practice. 2022;7:174-82$23$YR$$F$Y$$$20240711$$HP$GB$GB
226177972$22617797$2$F$$20230721$20230620$20240711$PER$$US-PFM-2022-06408$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.896$KG$20240711$$HP$US$US
226177982$22617798$2$F$20220601$20220822$20230620$20240711$PER$$US-PFM-2022-06394$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6$KG$20240711$$PH$US$US
226177992$22617799$2$F$$20220822$20230620$20240711$PER$$US-PFM-2022-06395$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240711$$HP$US$US
226178002$22617800$2$F$$20220823$20230620$20240711$PER$$US-PFM-2022-06410$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240711$$HP$US$US
226178012$22617801$2$F$$20220829$20230620$20240711$PER$$US-PFM-2022-06409$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.163$KG$20240711$$HP$US$US
226178022$22617802$2$F$$20220824$20230620$20240711$PER$$US-PFM-2022-06433$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240711$$HP$US$US
226178032$22617803$2$F$$20220823$20230620$20240711$PER$$US-PFM-2022-06411$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240711$$HP$US$US
226178042$22617804$2$F$$20230206$20230620$20240711$PER$$JP-PFM-2022-06398$PIERRE FABRE MEDICAMENT$$3$MON$$$Y$$$20240711$$MD$JP$JP
226178062$22617806$2$F$$20231117$20230620$20240711$PER$$US-PFM-2022-06349$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.907$KG$20240711$$HP$US$US
226178378$22617837$8$F$20230522$20240808$20230620$20240816$EXP$$CA-CELLTRION INC.-2023CA011457$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
226178692$22617869$2$F$$20220824$20230620$20240711$PER$$US-PFM-2022-06443$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240711$$HP$US$US
226178712$22617871$2$F$$20220825$20230620$20240711$PER$$US-PFM-2022-06451$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240711$$HP$US$US
226178722$22617872$2$F$20220601$20220808$20230620$20240711$PER$$DE-PFM-2022-06686$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$7.8$KG$20240711$$PH$DE$DE
226178732$22617873$2$F$$20220824$20230620$20240711$PER$$US-PFM-2022-06445$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240711$$HP$US$US
226178742$22617874$2$F$$20220826$20230620$20240711$PER$$US-PFM-2022-06467$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240711$$HP$US$US
226178752$22617875$2$F$$20240408$20230620$20240711$PER$$US-PFM-2022-06452$PIERRE FABRE MEDICAMENT$$$$$F$Y$14.8$KG$20240711$$HP$US$US
226178762$22617876$2$F$$20220824$20230620$20240711$PER$$US-PFM-2022-06447$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240711$$HP$US$US
226178772$22617877$2$F$$20220824$20230620$20240711$PER$$JP-PFM-2022-06496$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$PH$JP$JP
226178782$22617878$2$F$$20220827$20230620$20240711$PER$$JP-PFM-2022-06573$PIERRE FABRE MEDICAMENT$Okune M. Ten cases of infantile haemangiomas treated with propranolol at our department. The 86th Annual Meeting of the Eastern Division of JDA. 2022;140$$$I$$Y$$$20240711$$HP$JP$JP
226178792$22617879$2$F$$20220826$20230620$20240711$PER$$RO-PFM-2022-06503$PIERRE FABRE MEDICAMENT$Macovei ML, Azis U. A case report of a patient with severe thyroid eye disease. Romanian Journal of Ophthalmology. 2022;66(2):153-7$52$YR$$M$Y$$$20240711$$HP$RO$RO
226178802$22617880$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06626$PIERRE FABRE MEDICAMENT$$30$YR$$F$Y$$$20240711$$MD$CA$CA
226178812$22617881$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06627$PIERRE FABRE MEDICAMENT$$50$YR$$F$Y$$$20240711$$MD$CA$CA
226178822$22617882$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06628$PIERRE FABRE MEDICAMENT$$36$YR$$M$Y$$$20240711$$MD$CA$CA
226178832$22617883$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06629$PIERRE FABRE MEDICAMENT$$31$YR$$F$Y$$$20240711$$MD$CA$CA
226178852$22617885$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06631$PIERRE FABRE MEDICAMENT$$51$YR$$F$Y$$$20240711$$MD$CA$CA
226178862$22617886$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06633$PIERRE FABRE MEDICAMENT$$32$YR$$F$Y$$$20240711$$MD$CA$CA
226178872$22617887$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06630$PIERRE FABRE MEDICAMENT$$34$YR$$F$Y$$$20240711$$MD$CA$CA
226178882$22617888$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06634$PIERRE FABRE MEDICAMENT$$42$YR$$F$Y$$$20240711$$MD$CA$CA
226178892$22617889$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06632$PIERRE FABRE MEDICAMENT$$40$YR$$F$Y$$$20240711$$MD$CA$CA
226178902$22617890$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06625$PIERRE FABRE MEDICAMENT$$36$YR$$F$Y$$$20240711$$MD$CA$CA
226178982$22617898$2$F$$20220829$20230620$20240711$PER$$US-PFM-2022-06513$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240711$$HP$US$US
226178992$22617899$2$F$$20220829$20230620$20240711$PER$$US-PFM-2022-06504$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240711$$HP$US$US
226179002$22617900$2$F$$20220830$20230620$20240711$PER$$US-PFM-2022-06536$PIERRE FABRE MEDICAMENT$$$$$M$Y$2$KG$20240711$$HP$US$US
226179012$22617901$2$F$$20220829$20230620$20240711$PER$$CA-PFM-2022-06577$PIERRE FABRE MEDICAMENT$Harding M, Deyell R, Hansen T. Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?. Cancer Reports. 2022;5:1-5$$$I$$Y$$$20240711$$HP$CA$CA
226179022$22617902$2$F$$20220829$20230620$20240711$PER$$CA-PFM-2022-06578$PIERRE FABRE MEDICAMENT$Harding M,  Deyell R, Hansen T. Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?. Cancer Reports. 2022;5:1-5$$$$$Y$$$20240711$$HP$CA$CA
226179032$22617903$2$F$$20220830$20230620$20240711$PER$$US-PFM-2022-06535$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240711$$HP$US$US
226179042$22617904$2$F$$20220831$20230620$20240711$PER$$US-PFM-2022-06563$PIERRE FABRE MEDICAMENT$$$$$F$Y$16$KG$20240711$$HP$US$US
226179052$22617905$2$F$$20220831$20230620$20240711$PER$$US-PFM-2022-06564$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240711$$HP$US$US
226179062$22617906$2$F$$20220901$20230620$20240711$PER$$US-PFM-2022-06598$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240711$$HP$US$US
226179072$22617907$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06653$PIERRE FABRE MEDICAMENT$$44$YR$$M$Y$$$20240711$$MD$CA$CA
226179082$22617908$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06656$PIERRE FABRE MEDICAMENT$$37$YR$$M$Y$$$20240711$$MD$CA$CA
226179092$22617909$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06655$PIERRE FABRE MEDICAMENT$$55$YR$$F$Y$$$20240711$$MD$CA$CA
226179102$22617910$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06658$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240711$$MD$CA$CA
226179112$22617911$2$F$$20220906$20230620$20240711$PER$$US-PFM-2022-06718$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240711$$HP$US$US
226179122$22617912$2$F$$20220902$20230620$20240711$PER$$US-PFM-2022-06641$PIERRE FABRE MEDICAMENT$$$$$M$Y$9$KG$20240711$$HP$US$US
226179132$22617913$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06652$PIERRE FABRE MEDICAMENT$$26$YR$$F$Y$$$20240711$$MD$CA$CA
226179142$22617914$2$F$$20220905$20230620$20240711$PER$$IT-PFM-2022-06708$PIERRE FABRE MEDICAMENT$Cetta I, Messina R, Colombo B, Filippi M. Myocardial infarction in a patient with migraine and triptan overuse treated with anti-CGRP receptor monoclonal antibody: a case report. Journal of Neurology. 2022;269:5170-2$55$YR$$M$Y$110$KG$20240711$$HP$IT$IT
226179162$22617916$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06637$PIERRE FABRE MEDICAMENT$$34$YR$$F$Y$$$20240711$$MD$CA$CA
226179172$22617917$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06635$PIERRE FABRE MEDICAMENT$$50$YR$$F$Y$$$20240711$$MD$CA$CA
226179182$22617918$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06651$PIERRE FABRE MEDICAMENT$$18$YR$$F$Y$$$20240711$$MD$CA$CA
226179192$22617919$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06636$PIERRE FABRE MEDICAMENT$$30$YR$$F$Y$$$20240711$$MD$CA$CA
226179202$22617920$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06657$PIERRE FABRE MEDICAMENT$$36$YR$$F$Y$$$20240711$$MD$CA$CA
226179222$22617922$2$F$$20220907$20230620$20240711$PER$$US-PFM-2022-06744$PIERRE FABRE MEDICAMENT$$$$$F$Y$11$KG$20240711$$HP$US$US
226179232$22617923$2$F$20220901$20220908$20230620$20240711$PER$$US-PFM-2022-06720$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$4.5$KG$20240711$$HP$US$US
226179242$22617924$2$F$$20220906$20230620$20240711$PER$$US-PFM-2022-06723$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240711$$HP$US$US
226179252$22617925$2$F$$20220909$20230620$20240711$PER$$US-PFM-2022-06829$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.93$KG$20240711$$HP$US$US
226179262$22617926$2$F$$20220901$20230620$20240711$PER$$CA-PFM-2022-06654$PIERRE FABRE MEDICAMENT$$53$YR$$F$Y$$$20240711$$MD$CA$CA
226179282$22617928$2$F$$20220905$20230620$20240711$PER$$KR-PFM-2022-06709$PIERRE FABRE MEDICAMENT$Ryou JH, Han DH, Lee Reeree, Kim SM. Aripiprazole Improved Post-Streptococcal Dyskinesia by  Modulating Dopaminergic Activity: A Case Report. Clinical Psychopharmacology and Neuroscience. 2022;20(3):581-3$32$YR$$M$Y$$$20240711$$HP$KR$KR
226179292$22617929$2$F$$20220909$20230620$20240711$PER$$US-PFM-2022-06831$PIERRE FABRE MEDICAMENT$$$$$F$Y$3$KG$20240711$$HP$US$US
226179302$22617930$2$F$$20220915$20230620$20240711$PER$$US-PFM-2022-06450$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.4$KG$20240711$$HP$US$US
226179322$22617932$2$F$$20220907$20230620$20240711$PER$$KR-PFM-2022-06757$PIERRE FABRE MEDICAMENT$Yun JA, Lee CH. Written Exposure Therapy for Korean Adolescents With PTSD: Four Case Studies. Clinical Case Studies. 2022;21(4):291-307$18$YR$$M$Y$$$20240711$$HP$KR$KR
226179332$22617933$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07063$PIERRE FABRE MEDICAMENT$$40$YR$$F$Y$$$20240711$$MD$CA$CA
226179342$22617934$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07064$PIERRE FABRE MEDICAMENT$$46$YR$$F$Y$$$20240711$$MD$CA$CA
226179352$22617935$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07065$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240711$$MD$CA$CA
226179362$22617936$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07066$PIERRE FABRE MEDICAMENT$$34$YR$$F$Y$$$20240711$$MD$CA$CA
226179372$22617937$2$F$$20230322$20230620$20240711$PER$$US-PFM-2022-06644$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.161$KG$20240711$$HP$US$US
226179382$22617938$2$F$$20230329$20230620$20240711$PER$$US-PFM-2022-06444$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.837$KG$20240711$$HP$US$US
226179392$22617939$2$F$$20230418$20230620$20240711$PER$$US-PFM-2022-06512$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.596$KG$20240711$$HP$US$US
226179412$22617941$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07068$PIERRE FABRE MEDICAMENT$$46$YR$$F$Y$$$20240711$$MD$CA$CA
226179432$22617943$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07067$PIERRE FABRE MEDICAMENT$$64$YR$$F$Y$$$20240711$$MD$CA$CA
226179512$22617951$2$F$$20220912$20230620$20240711$PER$$US-PFM-2022-06836$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240711$$HP$US$US
226179532$22617953$2$F$$20220913$20230620$20240711$PER$$US-PFM-2022-06867$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.07$KG$20240711$$HP$US$US
226179542$22617954$2$F$$20220909$20230620$20240711$PER$$US-PFM-2022-06830$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240711$$HP$US$US
226179552$22617955$2$F$$20220912$20230620$20240711$PER$$US-PFM-2022-06835$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.64$KG$20240711$$HP$US$US
226179562$22617956$2$F$20220822$20220914$20230620$20240711$PER$$US-PFM-2022-06893$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
226179582$22617958$2$F$20220815$20220914$20230620$20240711$PER$$US-PFM-2022-06907$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$HP$US$US
226179592$22617959$2$F$$20220914$20230620$20240711$PER$$TR-PFM-2022-06909$PIERRE FABRE MEDICAMENT$Kurtulmus N, Kayikci K. Subacute Thyroiditis Following SARS-CoV-2 Vaccines: Six Cases Report and Review of the Literature. Horm Metab Res. 2022;24:556-61$35$YR$$F$Y$$$20240711$$HP$TR$TR
226179622$22617962$2$F$$20220914$20230620$20240711$PER$$TR-PFM-2022-06908$PIERRE FABRE MEDICAMENT$Kurtulmus N, Kayikci K. Subacute Thyroiditis Following SARS-CoV-2 Vaccines: Six Cases Report and Review of the Literature. Horm Metab Res. 2022;54:556-61$47$YR$$M$Y$$$20240711$$HP$TR$TR
226179632$22617963$2$F$$20220914$20230620$20240711$PER$$TR-PFM-2022-06913$PIERRE FABRE MEDICAMENT$Kurtulmus N, Kayikci K. Subacute Thyroiditis Following SARS-CoV-2 Vaccines: Six Cases Report and Review of the Literature. Horm Metab Res. 2022;54:556-61$45$YR$$M$Y$$$20240711$$HP$TR$TR
226179642$22617964$2$F$20220801$20220916$20230620$20240711$PER$$US-PFM-2022-06954$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
226179652$22617965$2$F$20220910$20220915$20230620$20240711$PER$$US-PFM-2022-06957$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$10.4$KG$20240711$$PH$US$US
226179672$22617967$2$F$$20220915$20230620$20240711$PER$$US-PFM-2022-06958$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240711$$HP$US$US
226179682$22617968$2$F$$20220914$20230620$20240711$PER$$TR-PFM-2022-06910$PIERRE FABRE MEDICAMENT$Kurtulmus N, Kayikci K. Subacute Thyroiditis Following SARS-CoV-2 Vaccines: Six Cases  Report and Review of the Literature. Horm Metab Res. 2022;54:556-61$50$YR$$M$Y$$$20240711$$HP$TR$TR
226179692$22617969$2$F$$20220916$20230620$20240711$PER$$US-PFM-2022-06952$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.3$KG$20240711$$HP$US$US
226179702$22617970$2$F$$20220917$20230620$20240711$PER$$JP-PFM-2022-07045$PIERRE FABRE MEDICAMENT$Ariizumi T. A study of pediatric macrovascular lesions with disseminated intravascular coagulopathy. The 18th Annual Meeting of Japanese Society for the Study of Vascular Anomalies. 2022;02-4$$$I$$Y$$$20240711$$HP$JP$JP
226179712$22617971$2$F$$20220917$20230620$20240711$PER$$JP-PFM-2022-07044$PIERRE FABRE MEDICAMENT$Ariizumi T. A study of pediatric macrovascular lesions with disseminated intravascular coagulopathy. The 18th Annual Meeting of Japanese Society for the Study of Vascular Anomalies. 2022;02-4$$$I$$Y$$$20240711$$HP$JP$JP
226179722$22617972$2$F$$20220917$20230620$20240711$PER$$JP-PFM-2022-07046$PIERRE FABRE MEDICAMENT$Ariizumi T et al. A study of pediatric macrovascular lesions with disseminated intravascular coagulopathy. The 18th Annual Meeting of Japanese Society for the Study of Vascular Anomalies. 2022;02-4$$$I$$Y$$$20240711$$HP$JP$JP
226179732$22617973$2$F$$20220919$20230620$20240711$PER$$US-PFM-2022-06973$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.658$KG$20240711$$HP$US$US
226179742$22617974$2$F$$20220919$20230620$20240711$PER$$US-PFM-2022-06974$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.29$KG$20240711$$HP$US$US
226179762$22617976$2$F$$20220914$20230620$20240711$PER$$TR-PFM-2022-06912$PIERRE FABRE MEDICAMENT$Kurtulmus N, Kayikci K. Subacute Thyroiditis Following SARS-CoV-2 Vaccines: Six Cases Report and Review of the Literature. Horm Metab Res. 2022;54:556-61$35$YR$$F$Y$$$20240711$$HP$TR$TR
226179832$22617983$2$F$$20220919$20230620$20240711$PER$$GR-PFM-2022-07037$PIERRE FABRE MEDICAMENT$Antoniadi K, Kelaidi C, Tzotzola V, Ampatzidou M, Karanasios E, Drakopoulou M et al. P1700 Early Appearance Of Cardiotoxicity In Children With Hematological Malignancies (HM). HemaSphere. 2022;6(S3):2981-2$$$$$Y$$$20240711$$HP$GR$GR
226179842$22617984$2$F$20220901$20220920$20230620$20240711$PER$$US-PFM-2022-06990$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
226179852$22617985$2$F$$20220921$20230620$20240711$PER$$US-PFM-2022-07022$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.31$KG$20240711$$HP$US$US
226179862$22617986$2$F$$20220919$20230620$20240711$PER$$KR-PFM-2022-07034$PIERRE FABRE MEDICAMENT$Park J, Kim S, Lee J, An JY. A case of transient POTS following COVID-19 vaccine. Acta Neurologica Belgica. 2022;122:1081-83$40$YR$$M$Y$$$20240711$$HP$KR$KR
226179872$22617987$2$F$$20220921$20230620$20240711$PER$$US-PFM-2022-07023$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.49$KG$20240711$$HP$US$US
226179882$22617988$2$F$20220907$20220927$20230620$20240711$PER$$JP-PFM-2022-06863$PIERRE FABRE MEDICAMENT$$2$MON$$$Y$$$20240711$$PH$JP$JP
226179892$22617989$2$F$$20220923$20230620$20240711$PER$$US-PFM-2022-06956$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.721$KG$20240711$$HP$US$US
226179902$22617990$2$F$$20221011$20230620$20240711$PER$$US-PFM-2022-06866$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.138$KG$20240711$$HP$US$US
226179912$22617991$2$F$$20221014$20230620$20240711$PER$$JP-PFM-2022-07032$PIERRE FABRE MEDICAMENT$Tanaka H et al. Safety and efficacy of oral propranolol therapy for infantile haemangioma. The 18th Annual Meeting of Japanese Society for the Study of Vascular Anomalies. 2022;03-3$8$MON$$M$Y$$$20240711$$HP$JP$JP
226179922$22617992$2$F$$20221017$20230620$20240711$PER$$IL-PFM-2022-07047$PIERRE FABRE MEDICAMENT$$6$MON$$F$Y$7.1$KG$20240711$$CN$IL$IL
226179932$22617993$2$F$$20221129$20230620$20240711$PER$$JP-PFM-2022-06575$PIERRE FABRE MEDICAMENT$Okune M. Ten cases of infantile haemangiomas treated with propranolol at our department. The 86th Annual Meeting of the Eastern Division of JDA. 2022;140$$$I$$Y$$$20240711$$HP$JP$JP
226179942$22617994$2$F$20220901$20221123$20230620$20240711$PER$$DZ-PFM-2022-06828$PIERRE FABRE MEDICAMENT$$7$MON$$F$Y$$$20240711$$MD$DZ$DZ
226179952$22617995$2$F$$20221129$20230620$20240711$PER$$JP-PFM-2022-06574$PIERRE FABRE MEDICAMENT$Okune M. Ten cases of infantile haemangiomas treated with propranolol at our department. The 86th Annual Meeting of the Eastern Division of JDA. 2022;140$$$I$$Y$$$20240711$$HP$JP$JP
226179972$22617997$2$F$$20230320$20230620$20240711$PER$$US-PFM-2022-06719$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.467$KG$20240711$$HP$US$US
226179982$22617998$2$F$20220502$20220923$20230620$20240711$PER$FR-AFSSAPS-AN20222034$FR-PFM-2022-07004$PIERRE FABRE MEDICAMENT$$71$YR$$F$Y$65$KG$20240711$$PH$FR$FR
226179992$22617999$2$F$$20230123$20230620$20240711$PER$$US-PFM-2022-06743$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.048$KG$20240711$$HP$US$US
226180002$22618000$2$F$$20230317$20230620$20240711$PER$$US-PFM-2022-06894$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.698$KG$20240711$$HP$US$US
226180012$22618001$2$F$$20230721$20230620$20240711$PER$$US-PFM-2022-06722$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.707$KG$20240711$$HP$US$US
226180022$22618002$2$F$$20230403$20230620$20240711$PER$$US-PFM-2022-06991$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.916$KG$20240711$$HP$US$US
226180302$22618030$2$F$20220901$20220926$20230620$20240711$PER$$US-PFM-2022-07136$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
226180312$22618031$2$F$$20220923$20230620$20240711$PER$$US-PFM-2022-07085$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.19$KG$20240711$$HP$US$US
226180322$22618032$2$F$20220901$20220923$20230620$20240711$PER$$US-PFM-2022-07134$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
226180332$22618033$2$F$$20221115$20230620$20240711$PER$$US-PFM-2022-07202$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.901$KG$20240711$$HP$US$US
226180342$22618034$2$F$$20221215$20230620$20240711$PER$$US-PFM-2022-07084$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.342$KG$20240711$$HP$US$US
226180352$22618035$2$F$$20230407$20230620$20240711$PER$$US-PFM-2022-07135$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.948$KG$20240711$$HP$US$US
226180362$22618036$2$F$20210920$20220926$20230620$20240711$PER$SI-JAZMP-NCPHV-2022SI8995_8995$SI-PFM-2022-07140$PIERRE FABRE MEDICAMENT$$66$YR$$M$Y$$$20240711$$PH$SI$SI
226180382$22618038$2$F$$20221004$20230620$20240711$PER$$US-PFM-2022-07325$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.317$KG$20240711$$HP$US$US
226180392$22618039$2$F$20221005$20221005$20230620$20240711$PER$$US-PFM-2022-07356$PIERRE FABRE MEDICAMENT$$2$YR$$M$Y$12.5$KG$20240711$$HP$US$US
226180402$22618040$2$F$$20220929$20230620$20240711$PER$$IT-PFM-2022-07256$PIERRE FABRE MEDICAMENT$$2$YR$$F$Y$12$KG$20240711$$HP$IT$IT
226180412$22618041$2$F$$20220930$20230620$20240711$PER$$US-PFM-2022-07214$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.62$KG$20240711$$HP$US$US
226180422$22618042$2$F$$20221006$20230620$20240711$PER$$US-PFM-2022-07397$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.617$KG$20240711$$HP$US$US
226180432$22618043$2$F$$20221006$20230620$20240711$PER$$US-PFM-2022-07357$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.63$KG$20240711$$HP$US$US
226180442$22618044$2$F$$20221006$20230620$20240711$PER$$US-PFM-2022-07396$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.32$KG$20240711$$HP$US$US
226180452$22618045$2$F$$20221010$20230620$20240711$PER$$US-PFM-2022-07433$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.68$KG$20240711$$HP$US$US
226180462$22618046$2$F$$20221007$20230620$20240711$PER$$US-PFM-2022-07399$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.49$KG$20240711$$HP$US$US
226180482$22618048$2$F$$20221021$20230620$20240711$PER$$US-PFM-2022-07398$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$HP$US$US
226180492$22618049$2$F$$20221010$20230620$20240711$PER$$US-PFM-2022-07434$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.29$KG$20240711$$HP$US$US
226180502$22618050$2$F$$20221010$20230620$20240711$PER$$US-PFM-2022-07255$PIERRE FABRE MEDICAMENT$$$$$F$Y$9$KG$20240711$$HP$US$US
226180512$22618051$2$F$$20221031$20230620$20240711$PER$$US-PFM-2022-07355$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.256$KG$20240711$$HP$US$US
226180522$22618052$2$F$$20221011$20230620$20240711$PER$$US-PFM-2022-07454$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.633$KG$20240711$$HP$US$US
226180552$22618055$2$F$$20221010$20230620$20240711$PER$$US-PFM-2022-07435$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.887$KG$20240711$$HP$US$US
226180562$22618056$2$F$$20240125$20230620$20240711$PER$$US-PFM-2022-07445$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.5$KG$20240711$$HP$US$US
226180572$22618057$2$F$$20221011$20230620$20240711$PER$$US-PFM-2022-07451$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.531$KG$20240711$$HP$US$US
226180582$22618058$2$F$$20221011$20230620$20240711$PER$$US-PFM-2022-07450$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.399$KG$20240711$$HP$US$US
226180592$22618059$2$F$$20221013$20230620$20240711$PER$$US-PFM-2022-07527$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.029$KG$20240711$$HP$US$US
226180602$22618060$2$F$$20230425$20230620$20240711$PER$$US-PFM-2022-07449$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.8$KG$20240711$$HP$US$US
226180682$22618068$2$F$$20221017$20230620$20240711$PER$$US-PFM-2022-07572$PIERRE FABRE MEDICAMENT$$$$$F$Y$12$KG$20240711$$CN$US$US
226180692$22618069$2$F$$20221013$20230620$20240711$PER$$US-PFM-2022-07528$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.601$KG$20240711$$HP$US$US
226180702$22618070$2$F$$20230814$20230620$20240711$PER$$US-PFM-2022-07530$PIERRE FABRE MEDICAMENT$$$$$M$Y$12.998$KG$20240711$$HP$US$US
226180712$22618071$2$F$$20221013$20230620$20240711$PER$$US-PFM-2022-07529$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.803$KG$20240711$$HP$US$US
226180722$22618072$2$F$$20221013$20230620$20240711$PER$$US-PFM-2022-07546$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.2$KG$20240711$$HP$US$US
226180732$22618073$2$F$$20221013$20230620$20240711$PER$$US-PFM-2022-07547$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.098$KG$20240711$$HP$US$US
226180752$22618075$2$F$20220901$20221017$20230620$20240711$PER$$US-PFM-2022-07573$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.79$KG$20240711$$PH$US$US
226180762$22618076$2$F$$20221017$20230620$20240711$PER$$US-PFM-2022-07574$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.587$KG$20240711$$HP$US$US
226180772$22618077$2$F$$20221017$20230620$20240711$PER$$US-PFM-2022-07575$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.701$KG$20240711$$CN$US$US
226180782$22618078$2$F$$20230208$20230620$20240711$PER$$US-PFM-2022-07576$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.07$KG$20240711$$HP$US$US
226180832$22618083$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07069$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240711$$MD$CA$CA
226180852$22618085$2$F$$20221014$20230620$20240711$PER$$US-PFM-2022-07577$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.739$KG$20240711$$HP$US$US
226180862$22618086$2$F$$20221014$20230620$20240711$PER$$US-PFM-2022-07579$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.293$KG$20240711$$HP$US$US
226180872$22618087$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07070$PIERRE FABRE MEDICAMENT$$49$YR$$F$Y$$$20240711$$MD$CA$CA
226180882$22618088$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07072$PIERRE FABRE MEDICAMENT$$62$YR$$F$Y$$$20240711$$MD$CA$CA
226180892$22618089$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07073$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240711$$MD$CA$CA
226180902$22618090$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07071$PIERRE FABRE MEDICAMENT$$36$YR$$M$Y$$$20240711$$MD$CA$CA
226180912$22618091$2$F$20220926$20221015$20230620$20240711$PER$$US-PFM-2022-07578$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$5.8$KG$20240711$$PH$US$US
226180922$22618092$2$F$$20221017$20230620$20240711$PER$$US-PFM-2022-07642$PIERRE FABRE MEDICAMENT$$$$$$Y$8.549$KG$20240711$$CN$US$US
226180932$22618093$2$F$$20221018$20230620$20240711$PER$$KR-PFM-2022-07644$PIERRE FABRE MEDICAMENT$$24$MON$$$Y$$$20240711$$CN$KR$KR
226180952$22618095$2$F$$20221018$20230620$20240711$PER$$US-PFM-2022-07645$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.782$KG$20240711$$CN$US$US
226181002$22618100$2$F$$20221017$20230620$20240711$PER$$US-PFM-2022-07646$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.594$KG$20240711$$CN$US$US
226181042$22618104$2$F$$20221019$20230620$20240711$PER$$US-PFM-2022-07699$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.8$KG$20240711$$HP$US$US
226181052$22618105$2$F$$20221019$20230620$20240711$PER$$US-PFM-2022-07700$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.499$KG$20240711$$CN$US$US
226181112$22618111$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07078$PIERRE FABRE MEDICAMENT$$31$YR$$F$Y$$$20240711$$MD$CA$CA
226181122$22618112$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07077$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240711$$MD$CA$CA
226181132$22618113$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07076$PIERRE FABRE MEDICAMENT$$51$YR$$F$Y$$$20240711$$MD$CA$CA
226181142$22618114$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07074$PIERRE FABRE MEDICAMENT$$49$YR$$F$Y$$$20240711$$MD$CA$CA
226181152$22618115$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07075$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226181212$22618121$2$F$$20220928$20230620$20240711$PER$$CA-PFM-2022-07226$PIERRE FABRE MEDICAMENT$$47$YR$$M$Y$$$20240711$$MD$CA$CA
226181222$22618122$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07083$PIERRE FABRE MEDICAMENT$$$$A$M$Y$$$20240711$$MD$CA$CA
226181232$22618123$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07080$PIERRE FABRE MEDICAMENT$$27$YR$$F$Y$$$20240711$$MD$CA$CA
226181242$22618124$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07081$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240711$$MD$CA$CA
226181252$22618125$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07082$PIERRE FABRE MEDICAMENT$$16$YR$$F$Y$$$20240711$$MD$CA$CA
226181272$22618127$2$F$$20220922$20230620$20240711$PER$$CA-PFM-2022-07079$PIERRE FABRE MEDICAMENT$$27$YR$$F$Y$104$KG$20240711$$MD$CA$CA
226181282$22618128$2$F$$20220928$20230620$20240711$PER$$CA-PFM-2022-07223$PIERRE FABRE MEDICAMENT$$46$YR$$M$Y$$$20240711$$MD$CA$CA
226181292$22618129$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07314$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226181302$22618130$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07313$PIERRE FABRE MEDICAMENT$$51$YR$$F$Y$$$20240711$$MD$CA$CA
226181312$22618131$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07312$PIERRE FABRE MEDICAMENT$$44$YR$$F$Y$$$20240711$$MD$CA$CA
226181322$22618132$2$F$$20220928$20230620$20240711$PER$$CA-PFM-2022-07224$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240711$$MD$CA$CA
226181332$22618133$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07316$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240711$$MD$CA$CA
226181342$22618134$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07317$PIERRE FABRE MEDICAMENT$$49$YR$$F$Y$$$20240711$$MD$CA$CA
226181352$22618135$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07315$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226181362$22618136$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07318$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240711$$MD$CA$CA
226181372$22618137$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07310$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226181382$22618138$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07346$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226181412$22618141$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07311$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226181422$22618142$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07347$PIERRE FABRE MEDICAMENT$$33$YR$$F$Y$$$20240711$$MD$CA$CA
226181432$22618143$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07319$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226181492$22618149$2$F$$20221005$20230620$20240711$PER$$US-PFM-2022-07373$PIERRE FABRE MEDICAMENT$Kokorelis C, Bodurtha J, Guthrie K, Rowe PC. Successful Treatment of Refractory Orthostatic Intolerance (OI) With Droxidopa. Clinical Pediatrics. 2022;61(9):593-5$2$DEC$$F$Y$$$20240711$$MD$US$US
226181502$22618150$2$F$$20240402$20230620$20240711$PER$$ES-PFM-2022-07182$PIERRE FABRE MEDICAMENT$Bravo AL, Cid AO, Olaondo AM, Cuadrado ML. Nummular headache responsive to anti-calcitonin gene-related peptide monoclonal antibodies in a patient with migraine. Headache. 2022;62(8):1063-66$34$YR$$M$Y$$$20240711$$HP$ES$ES
226181512$22618151$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07348$PIERRE FABRE MEDICAMENT$$60$YR$$F$Y$$$20240711$$MD$CA$CA
226181542$22618154$2$F$$20221003$20230620$20240711$PER$$CA-PFM-2022-07349$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226181552$22618155$2$F$$20221010$20230620$20240711$PER$$KR-PFM-2022-07467$PIERRE FABRE MEDICAMENT$Kim YM, Lee Y, Choi Y, Choi IH, Heo SH, Choi JM, Do HS et al. Clinical and genetic analyses of patients with lateralized overgrowth. BMC Medical Genomics. 2022;15(206):1-11$4$MON$$M$Y$$$20240711$$HP$KR$KR
226181562$22618156$2$F$$20221010$20230620$20240711$PER$$KR-PFM-2022-07466$PIERRE FABRE MEDICAMENT$Kim YM, Lee Y, Choi Y, Choi IH, Heo SH, Choi JM, Do HS et al. Clinical and genetic analyses of patients with lateralized overgrowth. BMC Medical Genomics. 2022;15(206):1-11$4$MON$$F$Y$$$20240711$$HP$KR$KR
226181572$22618157$2$F$$20221010$20230620$20240711$PER$$KR-PFM-2022-07468$PIERRE FABRE MEDICAMENT$Kim YM, Lee Y, Choi Y, Choi HI, Heo SH, Choi JM et al. Clinical and genetic analyses of patients with lateralized overgrowth. BMC Medical Genomics. 2022;15(206):1-11$7$YR$$M$Y$$$20240711$$HP$KR$KR
226181582$22618158$2$F$$20221010$20230620$20240711$PER$$KR-PFM-2022-07464$PIERRE FABRE MEDICAMENT$Kim YM, Lee Y, Choi Y, Choi HI, Heo SH, Choi JM et al. Clinical and genetic analyses of patients with lateralized overgrowth. BMC Medical Genomics. 2022;15(206):1-11$39$YR$$F$Y$$$20240711$$HP$KR$KR
226181592$22618159$2$F$$20221010$20230620$20240711$PER$$KR-PFM-2022-07465$PIERRE FABRE MEDICAMENT$Kim YM, Lee Y, Choi Y, Choi IH, Heo SH, Choi JM, Do HS et al. Clinical and genetic analyses of patients with lateralized overgrowth. BMC Medical Genomics. 2022;15(206):1-11$53$YR$$F$Y$$$20240711$$HP$KR$KR
226181602$22618160$2$F$$20221010$20230620$20240711$PER$$DE-PFM-2022-07473$PIERRE FABRE MEDICAMENT$Walter A, Calite E, Muller A, Kalff JC, Meyer C, Geipel A et al. Prenatal diagnosis and management of a giant intrahepatic  arteriovenous malformation-Sonographic findings,  clinical implications, and treatment. Clin Case Rep. 2022;10:1-8$$$N$M$Y$3.33$KG$20240711$$HP$DE$DE
226181612$22618161$2$F$$20221010$20230620$20240711$PER$$KR-PFM-2022-07461$PIERRE FABRE MEDICAMENT$Kim YM, Lee Y, Choi Y, Choi IH, Heo SH, Choi JM, Do HS et.al. Clinical and genetic analyses of patients with lateralized overgrowth. BMC Medical Genomics. 2022;15(206):1-12$7$YR$$M$Y$$$20240711$$HP$KR$KR
226181622$22618162$2$F$$20221010$20230620$20240711$PER$$KR-PFM-2022-07463$PIERRE FABRE MEDICAMENT$Kim YM, Lee Y, Choi Y, Choi IH, Heo SH, Choi JM, Do HS et al. Clinical and genetic analyses of patients with lateralized overgrowth. BMC Medical Genomics. 2022;15(206):1-12$7$YR$$M$Y$$$20240711$$HP$KR$KR
226181632$22618163$2$F$$20221010$20230620$20240711$PER$$KR-PFM-2022-07469$PIERRE FABRE MEDICAMENT$Kim YM, Lee Y, Choi Y, Choi IH, Heo SH, Choi JM, Do HS et al. Clinical and genetic analyses of patients with lateralized overgrowth. BMC Medical Genomics. 2022;15(206):1-11$2$YR$$F$Y$$$20240711$$HP$KR$KR
226181642$22618164$2$F$$20221010$20230620$20240711$PER$$KR-PFM-2022-07470$PIERRE FABRE MEDICAMENT$Kim YM, Lee Y, Choi Y, Choi HI, Heo SH, Choi JM et al. Clinical and genetic analyses of patients with lateralized overgrowth. BMC Medical Genomics. 2022;15(206):1-11$3$YR$$M$Y$$$20240711$$HP$KR$KR
226181652$22618165$2$F$$20221010$20230620$20240711$PER$$KR-PFM-2022-07471$PIERRE FABRE MEDICAMENT$Kim YM, Lee Y, Choi Y, Choi IH, Heo SH, Choi JM, Do HS et al. Clinical and genetic analyses of patients with lateralized overgrowth. BMC Medical Genomics. 2022;15(206):1-11$17$YR$$M$Y$$$20240711$$HP$KR$KR
226181662$22618166$2$F$$20221010$20230620$20240711$PER$$KR-PFM-2022-07472$PIERRE FABRE MEDICAMENT$Kim YM, Lee Y, Choi Y, Choi HI, Heo SH, Choi JM et al. Clinical and genetic analyses of patients with lateralized overgrowth. BMC Medical Genomics. 2022;15(206):1-11$47$YR$$M$Y$$$20240711$$HP$KR$KR
226181672$22618167$2$F$$20221010$20230620$20240711$PER$$KR-PFM-2022-07476$PIERRE FABRE MEDICAMENT$Kim YM, Lee Y, Choi Y, Choi IH, Heo SH, Choi JM, Do HS et al. Clinical and genetic analyses of patients with lateralized overgrowth. BMC Medical Genomics. 2022;15(206):1-11$43$YR$$M$Y$$$20240711$$HP$KR$KR
226181682$22618168$2$F$$20221017$20230620$20240711$PER$$FI-PFM-2022-07657$PIERRE FABRE MEDICAMENT$Helenius K, Parkkola R, Arola A, Peltola V, Haanpaa M. Detailed prenatal and postnatal MRI findings and clinical analysis of RAF1  in Noonan syndrome. European Journal of Medical Genetics. 2022;65:1-5$3$DY$$F$Y$$$20240711$$HP$FI$FI
226181692$22618169$2$F$$20221017$20230620$20240711$PER$$DE-PFM-2022-07661$PIERRE FABRE MEDICAMENT$Voges I. Editorial: A case reports in pediatric cardiology: 2021. Frontiers in cardiovascular medicine. 2022;9:1-2$$$N$$Y$$$20240711$$HP$DE$DE
226181752$22618175$2$F$$20221017$20230620$20240711$PER$$TR-PFM-2022-07694$PIERRE FABRE MEDICAMENT$Goknar N, Kelesoglu E, Kasap N, Uckardes D, Candan C. A case of chronic kidney disease with pulmonary hypertension, hyperuricemia, immunodeficiency and other extrarenal findings: Answers. Pediatric Nephrology. 2022;37:2617-19$$$$F$Y$$$20240711$$HP$TR$TR
226181772$22618177$2$F$$20221017$20230620$20240711$PER$$ES-PFM-2022-07685$PIERRE FABRE MEDICAMENT$Dolader P, Alegria I, Oloron PM, Fernandez-Doblas J, Gran F, Roses-Noguer F et al. Case report: Removal of a subcutaneous implantable cardiac defibrillator in a pediatric patient with hypertrophic cardiomyopathy after a septal myectomy. Insights on current indications of type of ICD in children with hypertrophic cardiomyopathy and left ventricular tract obstruction. Frontiers in Pediatrics. 2022;1-7$14$YR$$M$Y$$$20240711$$HP$ES$ES
226182022$22618202$2$F$$20230306$20230620$20240711$PER$$HR-PFM-2022-07515$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$MD$HR$HR
226182902$22618290$2$F$$20221019$20230620$20240711$PER$$US-PFM-2022-07716$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.619$KG$20240711$$CN$US$US
226182912$22618291$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07742$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226182922$22618292$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07740$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240711$$MD$CA$CA
226182932$22618293$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07738$PIERRE FABRE MEDICAMENT$$65$YR$$F$Y$$$20240711$$MD$CA$CA
226182942$22618294$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07739$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226182952$22618295$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07737$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226182962$22618296$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07736$PIERRE FABRE MEDICAMENT$$42$YR$$F$Y$$$20240711$$MD$CA$CA
226182972$22618297$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07741$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226182982$22618298$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07728$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226182992$22618299$2$F$$20221019$20230620$20240711$PER$$US-PFM-2022-07715$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.803$KG$20240711$$CN$US$US
226183002$22618300$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07744$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226183012$22618301$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07743$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226183022$22618302$2$F$$20221019$20230620$20240711$PER$$US-PFM-2022-07712$PIERRE FABRE MEDICAMENT$$$$$M$Y$3.841$KG$20240711$$HP$US$US
226183032$22618303$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07729$PIERRE FABRE MEDICAMENT$$$$A$M$Y$$$20240711$$MD$CA$CA
226183042$22618304$2$F$$20221020$20230620$20240711$PER$$US-PFM-2022-07776$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.197$KG$20240711$$CN$US$US
226183052$22618305$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07745$PIERRE FABRE MEDICAMENT$$42$YR$$F$Y$$$20240711$$MD$CA$CA
226183062$22618306$2$F$$20221020$20230620$20240711$PER$$US-PFM-2022-07771$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.399$KG$20240711$$CN$US$US
226183072$22618307$2$F$$20221019$20230620$20240711$PER$$US-PFM-2022-07713$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.88$KG$20240711$$HP$US$US
226183082$22618308$2$F$$20221021$20230620$20240711$PER$$US-PFM-2022-07773$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.889$KG$20240711$$CN$US$US
226183092$22618309$2$F$$20221019$20230620$20240711$PER$$CA-PFM-2022-07735$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226183102$22618310$2$F$$20230403$20230620$20240711$PER$$CA-PFM-2022-07857$PIERRE FABRE MEDICAMENT$$44$YR$$F$Y$$$20240711$$MD$CA$CA
226183112$22618311$2$F$$20230404$20230620$20240711$PER$$CA-PFM-2022-07860$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240711$$MD$CA$CA
226183122$22618312$2$F$$20230403$20230620$20240711$PER$$CA-PFM-2022-07858$PIERRE FABRE MEDICAMENT$$29$YR$$M$Y$$$20240711$$MD$CA$CA
226183132$22618313$2$F$$20221024$20230620$20240711$PER$$CA-PFM-2022-07856$PIERRE FABRE MEDICAMENT$$$$A$M$Y$$$20240711$$MD$CA$CA
226183142$22618314$2$F$$20230404$20230620$20240711$PER$$CA-PFM-2022-07861$PIERRE FABRE MEDICAMENT$$48$YR$$F$Y$$$20240711$$MD$CA$CA
226183152$22618315$2$F$$20221024$20230620$20240711$PER$$CA-PFM-2022-07855$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240711$$MD$CA$CA
226183162$22618316$2$F$$20230404$20230620$20240711$PER$$CA-PFM-2022-07859$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226183172$22618317$2$F$$20221021$20230620$20240711$PER$$US-PFM-2022-07796$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.435$KG$20240711$$CN$US$US
226183192$22618319$2$F$20220101$20221021$20230620$20240711$PER$FR-AFSSAPS-PA20224149$FR-PFM-2022-07754$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240711$$MD$FR$FR
226183202$22618320$2$F$$20221024$20230620$20240711$PER$$US-PFM-2022-07812$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.898$KG$20240711$$CN$US$US
226183212$22618321$2$F$$20221021$20230620$20240711$PER$$US-PFM-2022-07775$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.796$KG$20240711$$HP$US$US
226183222$22618322$2$F$$20221024$20230620$20240711$PER$$KR-PFM-2022-07803$PIERRE FABRE MEDICAMENT$Lee G, Ban JE. Embarrassed Radiofrequency Catheter Ablation of  Supraventricular Tachycardia in Pectus Excavatum. The Ewha medical Journal. 2022;45(3):e6:1-5$16$YR$$M$Y$$$20240711$$HP$KR$KR
226183232$22618323$2$F$$20221024$20230620$20240711$PER$$US-PFM-2022-07815$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.71$KG$20240711$$HP$US$US
226183242$22618324$2$F$$20221024$20230620$20240711$PER$$DE-PFM-2022-07851$PIERRE FABRE MEDICAMENT$Walther A, Haberle B, Kuppers J, Lurz E, Schmid I, Schmidt H et al. Severe consumptive hypothyroidism in hepatic hemangioendothelioma: A rare complication of a common clinical condition. Journal of Pediatric Endocrinology and Metabolism. 2022;1-4$5$WK$$M$Y$$$20240711$$HP$DE$DE
226183262$22618326$2$F$$20221025$20230620$20240711$PER$$US-PFM-2022-07919$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240711$$CN$US$US
226183272$22618327$2$F$$20221026$20230620$20240711$PER$$US-PFM-2022-07868$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.098$KG$20240711$$CN$US$US
226183282$22618328$2$F$$20221025$20230620$20240711$PER$$US-PFM-2022-07814$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.499$KG$20240711$$HP$US$US
226183292$22618329$2$F$$20230404$20230620$20240711$PER$$CA-PFM-2022-07862$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226183302$22618330$2$F$$20230404$20230620$20240711$PER$$CA-PFM-2022-07863$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226183312$22618331$2$F$$20221104$20230620$20240711$PER$$US-PFM-2022-07714$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.8$KG$20240711$$CN$US$US
226183332$22618333$2$F$$20230112$20230620$20240711$PER$$US-PFM-2022-07813$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.542$KG$20240711$$CN$US$US
226183342$22618334$2$F$$20221026$20230620$20240711$PER$$US-PFM-2022-07869$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.215$KG$20240711$$CN$US$US
226183352$22618335$2$F$$20230404$20230620$20240711$PER$$CA-PFM-2022-07864$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226183362$22618336$2$F$20220730$20221115$20230620$20240711$PER$IT-MINISAL02-893921$IT-PFM-2022-08266$PIERRE FABRE MEDICAMENT$$58$YR$$M$Y$$$20240711$$MD$IT$IT
226183372$22618337$2$F$$20230222$20230620$20240711$PER$$US-PFM-2022-07769$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.185$KG$20240711$$CN$US$US
226183382$22618338$2$F$$20230303$20230620$20240711$PER$$US-PFM-2022-07795$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.39$KG$20240711$$HP$US$US
226183392$22618339$2$F$$20230506$20230620$20240711$PER$$US-PFM-2022-07772$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.578$KG$20240711$$CN$US$US
226183402$22618340$2$F$20221024$20240515$20230620$20240711$PER$$US-PFM-2022-07794$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$11.3$KG$20240711$$HP$US$US
226183412$22618341$2$F$20220105$20221031$20230620$20240711$PER$$DE-PFM-2022-07957$PIERRE FABRE MEDICAMENT$$3$YR$$F$Y$17$KG$20240711$$MD$DE$DE
226183422$22618342$2$F$$20221027$20230620$20240711$PER$$US-PFM-2022-07921$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240711$$CN$US$US
226183432$22618343$2$F$$20221026$20230620$20240711$PER$$US-PFM-2022-07920$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.107$KG$20240711$$CN$US$US
226183442$22618344$2$F$$20221031$20230620$20240711$PER$$JP-PFM-2022-08083$PIERRE FABRE MEDICAMENT$Yamaguchi Y. A case of infantile asthma during propranolol treatment. Allergy. 2022;71:872$8$MON$$M$Y$$$20240711$$HP$JP$JP
226183452$22618345$2$F$$20221027$20230620$20240711$PER$$US-PFM-2022-07946$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240711$$CN$US$US
226183462$22618346$2$F$$20230404$20230620$20240711$PER$$CA-PFM-2022-07866$PIERRE FABRE MEDICAMENT$$60$YR$$F$Y$$$20240711$$HP$CA$CA
226183472$22618347$2$F$$20221031$20230620$20240711$PER$$TR-PFM-2022-08019$PIERRE FABRE MEDICAMENT$Leventoglu E, Fidan K, Buyukkaragoz B, Serdaroglu E, Atalay T, Yazol M et al. Neurofibromatosis Type 1 and Systemic Vasculopathies. Pediatric Nephrology. 2022;37:2948$4$YR$$M$Y$$$20240711$$HP$TR$TR
226183482$22618348$2$F$$20221101$20230620$20240711$PER$$US-PFM-2022-07995$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.26$KG$20240711$$CN$US$US
226183492$22618349$2$F$$20221101$20230620$20240711$PER$$US-PFM-2022-07994$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.21$KG$20240711$$CN$US$US
226183502$22618350$2$F$$20221031$20230620$20240711$PER$$JP-PFM-2022-08021$PIERRE FABRE MEDICAMENT$Shimamura A, Miyata K, Hamada H, Mitsuishi T. Coexistence of infantile hemangioma and capillary malformation on the abdomen of a Japanese boy. The Journal of Demonology. 2022;49:e303-e304$6$MON$$M$Y$$$20240711$$HP$JP$JP
226183512$22618351$2$F$$20221102$20230620$20240711$PER$$US-PFM-2022-08052$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.32$KG$20240711$$HP$US$US
226183532$22618353$2$F$$20221107$20230620$20240711$PER$$US-PFM-2022-08134$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.52$KG$20240711$$CN$US$US
226183562$22618356$2$F$$20221104$20230620$20240711$PER$$US-PFM-2022-08098$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.98$KG$20240711$$CN$US$US
226183572$22618357$2$F$$20221102$20230620$20240711$PER$$US-PFM-2022-08053$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.617$KG$20240711$$CN$US$US
226183582$22618358$2$F$$20221108$20230620$20240711$PER$$US-PFM-2022-08133$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.717$KG$20240711$$CN$US$US
226183592$22618359$2$F$$20240318$20230620$20240711$PER$$US-PFM-2022-07992$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.18$KG$20240711$$CN$US$US
226183602$22618360$2$F$$20230314$20230620$20240711$PER$$US-PFM-2022-08099$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.288$KG$20240711$$CN$US$US
226183612$22618361$2$F$$20221107$20230620$20240711$PER$$US-PFM-2022-08079$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.65$KG$20240711$$CN$US$US
226183632$22618363$2$F$$20230418$20230620$20240711$PER$$US-PFM-2022-07993$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.2$KG$20240711$$CN$US$US
226183672$22618367$2$F$$20221109$20230620$20240711$PER$$US-PFM-2022-08146$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.9$KG$20240711$$CN$US$US
226183682$22618368$2$F$20221001$20221109$20230620$20240711$PER$$US-PFM-2022-08143$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
226183692$22618369$2$F$$20221109$20230620$20240711$PER$$US-PFM-2022-08145$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.297$KG$20240711$$HP$US$US
226183702$22618370$2$F$$20221109$20230620$20240711$PER$$US-PFM-2022-08147$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.907$KG$20240711$$HP$US$US
226183712$22618371$2$F$$20221109$20230620$20240711$PER$$US-PFM-2022-08144$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.791$KG$20240711$$HP$US$US
226183722$22618372$2$F$$20240126$20230620$20240711$PER$$US-PFM-2022-08170$PIERRE FABRE MEDICAMENT$$$$$F$Y$14.5$KG$20240711$$CN$US$US
226183732$22618373$2$F$$20221110$20230620$20240711$PER$$US-PFM-2022-08172$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.596$KG$20240711$$CN$US$US
226183742$22618374$2$F$$20221110$20230620$20240711$PER$$US-PFM-2022-08171$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.91$KG$20240711$$CN$US$US
226183752$22618375$2$F$$20230705$20230620$20240711$PER$$US-PFM-2022-08142$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.45$KG$20240711$$CN$US$US
226183762$22618376$2$F$$20221111$20230620$20240711$PER$$US-PFM-2022-08242$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.079$KG$20240711$$CN$US$US
226183772$22618377$2$F$$20230824$20230620$20240711$PER$$US-PFM-2022-08239$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.12$KG$20240711$$HP$US$US
226183782$22618378$2$F$$20221108$20230620$20240711$PER$$RU-PFM-2022-08124$PIERRE FABRE MEDICAMENT$Khachatryan LA, Kletskaya IS, Shcherbakov AP. Multifocal lymphangioendotheliomatosis with thrombocytopenia/dermal visceral angiomatosis with thrombocytopenia. Pediatric Hematology/Oncology and Immunopathology. 2022;21(3):90-9$$$C$$Y$$$20240711$$HP$RU$RU
226183792$22618379$2$F$$20221115$20230620$20240711$PER$$US-PFM-2022-08291$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.426$KG$20240711$$HP$US$US
226183802$22618380$2$F$20221001$20221116$20230620$20240711$PER$$US-PFM-2022-08293$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
226183812$22618381$2$F$$20221116$20230620$20240711$PER$$US-PFM-2022-08292$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240711$$CN$US$US
226183822$22618382$2$F$20220801$20221116$20230620$20240711$PER$$US-PFM-2022-08331$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.71$KG$20240711$$PH$US$US
226183832$22618383$2$F$20220807$20221116$20230620$20240711$PER$$US-PFM-2022-08338$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$7.256$KG$20240711$$PH$US$US
226183842$22618384$2$F$$20221116$20230620$20240711$PER$$US-PFM-2022-08336$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.288$KG$20240711$$CN$US$US
226183852$22618385$2$F$$20221104$20230620$20240711$PER$$TR-PFM-2022-08055$PIERRE FABRE MEDICAMENT$Selcuk N S, Ertugrul I, Karagoz T. Giant diverticulum of coronary sinus with multiple accessory pathways treated with catheter ablation. Cardiology in the Young. 2022;32:658-61$5$YR$$M$Y$14$KG$20240711$$HP$TR$TR
226183862$22618386$2$F$$20221114$20230620$20240711$PER$$IT-PFM-2022-08280$PIERRE FABRE MEDICAMENT$Cannarella R, Musmeci M, Garofalo V, Timpanaro TA, Leone G, Caruso M et al. Resistance to Thyroid Hormones: A Case-Series Study. International journal of molecular sciences. 2022;23:1-9$$$$M$Y$$$20240711$$HP$IT$IT
226183872$22618387$2$F$20220121$20221114$20230620$20240711$PER$BE-FAMHP-DHH-N2022-115330$BE-PFM-2022-08217$PIERRE FABRE MEDICAMENT$$55$YR$$M$Y$80$KG$20240711$$MD$BE$BE
226183882$22618388$2$F$$20221114$20230620$20240711$PER$$IT-PFM-2022-08279$PIERRE FABRE MEDICAMENT$Pellitteri G, Pez S, Nilo A, Surcinelli A, Gigli GL, Lettieri C et al. Erenumab Impact on Sleep Assessed With Questionnaires and Home-Polysomnography in Patients With Migraine: The ERESON Study. Frontiers in neurology. 2022;13:1-13$$$$$Y$$$20240711$$HP$IT$IT
226183892$22618389$2$F$$20221116$20230620$20240711$PER$$US-PFM-2022-08329$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.968$KG$20240711$$CN$US$US
226183902$22618390$2$F$$20221117$20230620$20240711$PER$$US-PFM-2022-08327$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.939$KG$20240711$$HP$US$US
226183912$22618391$2$F$$20221117$20230620$20240711$PER$$US-PFM-2022-08323$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.719$KG$20240711$$HP$US$US
226183942$22618394$2$F$$20221117$20230620$20240711$PER$$TR-PFM-2022-08097$PIERRE FABRE MEDICAMENT$Kulluoglu EP, Luleyap D, Cicek A, Anil AB, Konca C, Berksoy E et al. A case of severe poisoning due to oral hydrofluoric acid ingestion that could survive with timely effective treatments. Dr. Behcet Uz Children^s Hospital. 2022;12(3):233-38$13$MON$$M$Y$$$20240711$$HP$TR$TR
226183972$22618397$2$F$$20221117$20230620$20240711$PER$$US-PFM-2022-08319$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.399$KG$20240711$$CN$US$US
226183982$22618398$2$F$$20221117$20230620$20240711$PER$$US-PFM-2022-08318$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.93$KG$20240711$$HP$US$US
226184032$22618403$2$F$$20221118$20230620$20240711$PER$$TR-PFM-2022-08326$PIERRE FABRE MEDICAMENT$Eris D, Pac FA. Asymptomatic cardiac tumour with premature ventricular contraction in an athlete: case report. Cardiology in the Young. 2022;32:644-7$10$YR$$M$Y$$$20240711$$HP$TR$TR
226184042$22618404$2$F$$20221118$20230620$20240711$PER$$CA-PFM-2022-08324$PIERRE FABRE MEDICAMENT$Fung WKW, Fasano A. ^Stretched Slinky^ Sign Another Clue to Functional Tremor. Neurology: Clinical Practice. 2022;12(5):e121-3$58$YR$$M$Y$$$20240711$$HP$CA$CA
226184052$22618405$2$F$20220923$20221118$20230620$20240711$PER$FR-AFSSAPS-TO20223377$FR-PFM-2022-08333$PIERRE FABRE MEDICAMENT$$89$YR$$M$Y$70$KG$20240711$$PH$FR$FR
226184503$22618450$3$F$20230601$20240725$20230620$20240803$PER$$US-SA-2023SA185576$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240803$$MD$US$US
226184812$22618481$2$F$20221119$20221119$20230620$20240711$PER$$US-PFM-2022-08384$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$4.707$KG$20240711$$CN$US$US
226184822$22618482$2$F$$20221114$20230620$20240711$PER$$JP-PFM-2022-08372$PIERRE FABRE MEDICAMENT$Miho N et al. A case of propranolol discontinuation due to bradycardia after induction of oral propranolol for infantile haemangioma. The 117th Kyushu and Okinawa Regional Meeting of the japan society of plastic an. 2022$$$I$$Y$$$20240711$$HP$JP$JP
226184832$22618483$2$F$$20221121$20230620$20240711$PER$$GB-PFM-2022-08434$PIERRE FABRE MEDICAMENT$Medved S,  Ostojic Z, Jurin H, Medved V. Broken heart after ECT. Published online by Cambridge University Press. 2019;56S:S322-553$$$$M$Y$$$20240711$$HP$GB$HR
226184842$22618484$2$F$$20221121$20230620$20240711$PER$$US-PFM-2022-08387$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.782$KG$20240711$$HP$US$US
226184852$22618485$2$F$$20221122$20230620$20240711$PER$$US-PFM-2022-08432$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.898$KG$20240711$$CN$US$US
226184862$22618486$2$F$$20221121$20230620$20240711$PER$$US-PFM-2022-08385$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.556$KG$20240711$$CN$US$US
226184872$22618487$2$F$$20221122$20230620$20240711$PER$$US-PFM-2022-08429$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.918$KG$20240711$$CN$US$US
226184882$22618488$2$F$$20221122$20230620$20240711$PER$$FR-PFM-2022-08402$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$CN$FR$FR
226184892$22618489$2$F$20221012$20221122$20230620$20240711$PER$FR-AFSSAPS-NT20222820$FR-PFM-2022-08380$PIERRE FABRE MEDICAMENT$$68$YR$$F$Y$60$KG$20240711$$MD$FR$FR
226184912$22618491$2$F$$20221205$20230620$20240711$PER$$CA-PFM-2022-08715$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226184932$22618493$2$F$$20221205$20230620$20240711$PER$$CA-PFM-2022-08714$PIERRE FABRE MEDICAMENT$$30$YR$$F$Y$$$20240711$$MD$CA$CA
226184942$22618494$2$F$$20221122$20230620$20240711$PER$$US-PFM-2022-08428$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.499$KG$20240711$$CN$US$US
226184952$22618495$2$F$$20230403$20230620$20240711$PER$$CA-PFM-2022-08710$PIERRE FABRE MEDICAMENT$$81$YR$$F$Y$$$20240711$$MD$CA$CA
226184982$22618498$2$F$$20221205$20230620$20240711$PER$$CA-PFM-2022-08713$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240711$$MD$CA$CA
226185002$22618500$2$F$$20221123$20230620$20240711$PER$$US-PFM-2022-08386$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.2$KG$20240711$$CN$US$US
226185012$22618501$2$F$20211020$20230403$20230620$20240711$PER$$CA-PFM-2022-08711$PIERRE FABRE MEDICAMENT$$50$YR$$F$Y$$$20240711$$MD$CA$CA
226185022$22618502$2$F$$20230502$20230620$20240711$PER$$JP-PFM-2022-08394$PIERRE FABRE MEDICAMENT$$4$MON$$F$Y$$$20240711$$MD$JP$JP
226185032$22618503$2$F$$20230720$20230620$20240711$PER$$US-PFM-2022-08430$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.349$KG$20240711$$CN$US$US
226185042$22618504$2$F$$20230906$20230620$20240711$PER$$US-PFM-2022-08427$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.737$KG$20240711$$CN$US$US
226185052$22618505$2$F$$20221205$20230620$20240711$PER$$CA-PFM-2022-08716$PIERRE FABRE MEDICAMENT$$34$YR$$F$Y$$$20240711$$MD$CA$CA
226185062$22618506$2$F$$20221125$20230620$20240711$PER$NL-LRB-00851178$NL-PFM-2022-08469$PIERRE FABRE MEDICAMENT$$$$A$F$Y$95$KG$20240711$$CN$NL$NL
226185072$22618507$2$F$$20221123$20230620$20240711$PER$$US-PFM-2022-08477$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.787$KG$20240711$$CN$US$US
226185082$22618508$2$F$$20221128$20230620$20240711$PER$$US-PFM-2022-08570$PIERRE FABRE MEDICAMENT$$$$$M$Y$17.397$KG$20240711$$HP$US$US
226185092$22618509$2$F$$20221128$20230620$20240711$PER$$US-PFM-2022-08497$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.009$KG$20240711$$CN$US$US
226185102$22618510$2$F$$20221129$20230620$20240711$PER$$US-PFM-2022-08564$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.896$KG$20240711$$CN$US$US
226185112$22618511$2$F$$20221129$20230620$20240711$PER$$US-PFM-2022-08563$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.068$KG$20240711$$HP$US$US
226185122$22618512$2$F$$20221129$20230620$20240711$PER$$US-PFM-2022-08561$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.338$KG$20240711$$HP$US$US
226185142$22618514$2$F$$20221129$20230620$20240711$PER$$US-PFM-2022-08562$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.07$KG$20240711$$CN$US$US
226185152$22618515$2$F$$20221129$20230620$20240711$PER$$US-PFM-2022-08567$PIERRE FABRE MEDICAMENT$$$$$M$Y$3.678$KG$20240711$$HP$US$US
226185162$22618516$2$F$$20221130$20230620$20240711$PER$$US-PFM-2022-08613$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.803$KG$20240711$$CN$US$US
226185182$22618518$2$F$20221101$20221129$20230620$20240711$PER$$US-PFM-2022-08559$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6.803$KG$20240711$$PH$US$US
226185192$22618519$2$F$20221102$20221201$20230620$20240711$PER$FR-AFSSAPS-RS20222217$FR-PFM-2022-08614$PIERRE FABRE MEDICAMENT$$4$MON$$F$Y$6.2$KG$20240711$$MD$FR$FR
226185202$22618520$2$F$$20221130$20230620$20240711$PER$$US-PFM-2022-08615$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240711$$CN$US$US
226185212$22618521$2$F$20221110$20221129$20230620$20240711$PER$ES-AEMPS-1296104$ES-PFM-2022-08516$PIERRE FABRE MEDICAMENT$$27$YR$$M$Y$$$20240711$$MD$ES$ES
226185222$22618522$2$F$$20221222$20230620$20240711$PER$$US-PFM-2022-08431$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.125$KG$20240711$$CN$US$US
226185232$22618523$2$F$$20221228$20230620$20240711$PER$$US-PFM-2022-08565$PIERRE FABRE MEDICAMENT$$$$$F$Y$19.197$KG$20240711$$CN$US$US
226185242$22618524$2$F$$20230103$20230620$20240711$PER$$US-PFM-2022-08616$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.698$KG$20240711$$CN$US$US
226185252$22618525$2$F$$20221219$20230620$20240711$PER$$US-PFM-2022-08566$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.163$KG$20240711$$CN$US$US
226185282$22618528$2$F$$20230825$20230620$20240711$PER$$US-PFM-2022-08433$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.696$KG$20240711$$CN$US$US
226185292$22618529$2$F$$20230124$20230620$20240711$PER$$US-PFM-2022-08569$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.499$KG$20240711$$CN$US$US
226185332$22618533$2$F$$20221201$20230620$20240711$PER$$US-PFM-2022-08624$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.297$KG$20240711$$CN$US$US
226185352$22618535$2$F$$20221201$20230620$20240711$PER$$US-PFM-2022-08619$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.311$KG$20240711$$HP$US$US
226185362$22618536$2$F$$20230110$20230620$20240711$PER$$US-PFM-2022-08617$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.37$KG$20240711$$CN$US$US
226185412$22618541$2$F$$20221202$20230620$20240711$PER$$JP-PFM-2022-08750$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240711$$MD$JP$JP
226185442$22618544$2$F$$20221128$20230620$20240711$PER$$JP-PFM-2022-08662$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$MD$JP$JP
226185452$22618545$2$F$$20230828$20230620$20240711$PER$$US-PFM-2022-08625$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.49$KG$20240711$$CN$US$US
226185462$22618546$2$F$$20221202$20230620$20240711$PER$$US-PFM-2022-08626$PIERRE FABRE MEDICAMENT$$$$$M$Y$10$KG$20240711$$CN$US$US
226185472$22618547$2$F$$20221202$20230620$20240711$PER$$JP-PFM-2022-08694$PIERRE FABRE MEDICAMENT$$8$MON$$$Y$$$20240711$$PH$JP$JP
226185482$22618548$2$F$$20221202$20230620$20240711$PER$$US-PFM-2022-08693$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.617$KG$20240711$$CN$US$US
226185492$22618549$2$F$$20221205$20230620$20240711$PER$$US-PFM-2022-08698$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.299$KG$20240711$$CN$US$US
226185502$22618550$2$F$$20221202$20230620$20240711$PER$$US-PFM-2022-08692$PIERRE FABRE MEDICAMENT$$$$$F$Y$2.259$KG$20240711$$HP$US$US
226185512$22618551$2$F$$20221205$20230620$20240711$PER$$US-PFM-2022-08724$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.497$KG$20240711$$CN$US$US
226185522$22618552$2$F$$20221205$20230620$20240711$PER$$US-PFM-2022-08722$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.789$KG$20240711$$HP$US$US
226185532$22618553$2$F$$20221214$20230620$20240711$PER$$US-PFM-2022-08628$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.109$KG$20240711$$CN$US$US
226185542$22618554$2$F$$20221205$20230620$20240711$PER$$US-PFM-2022-08699$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.152$KG$20240711$$CN$US$US
226185552$22618555$2$F$$20230313$20230620$20240711$PER$$US-PFM-2022-08729$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.06$KG$20240711$$CN$US$US
226185562$22618556$2$F$20221125$20221221$20230620$20240711$PER$$US-PFM-2022-08696$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240711$$MD$US$JP
226185572$22618557$2$F$$20230405$20230620$20240711$PER$$US-PFM-2022-08695$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.299$KG$20240711$$CN$US$US
226185582$22618558$2$F$$20230315$20230620$20240711$PER$$US-PFM-2022-08726$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.65$KG$20240711$$CN$US$US
226185592$22618559$2$F$$20230421$20230620$20240711$PER$$US-PFM-2022-08627$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.17$KG$20240711$$CN$US$US
226185632$22618563$2$F$$20221123$20230620$20240711$PER$$RU-PFM-2022-08449$PIERRE FABRE MEDICAMENT$Kotlukova NP, Belysheva TS, Valiev TT, Konstantinova NK, Telezhnikova ND, Lavrova TR. Interdisciplinary approach to the treatment of infant hemangioma. Pediatric. 2021;100(3):174-82$2$YR$$$Y$$$20240711$$HP$RU$RU
226185642$22618564$2$F$$20221128$20230620$20240711$PER$$TR-PFM-2022-08498$PIERRE FABRE MEDICAMENT$Ozcan F, Altuntas M, Kati C. Clinical toxicology of propranolol and metoprolol overdose in adults. Journal of Experimental and Clinical Medicine. 2022;39(4):1241-45$$$A$$Y$$$20240711$$HP$TR$TR
226185652$22618565$2$F$$20221129$20230620$20240711$PER$$RU-PFM-2022-08520$PIERRE FABRE MEDICAMENT$Kotlukova NP, Belysheva TS, Valiev T, Konstantinova NK, Telezhnikov ND, Lavrova TR. Interdisciplinary approach to the treatment of infant hemangiomas. Pediatrics. 2021;100(3):174-82$$$I$$Y$$$20240711$$HP$RU$RU
226185662$22618566$2$F$$20221205$20230620$20240711$PER$$US-PFM-2022-08745$PIERRE FABRE MEDICAMENT$Roberts MT, Robbins NM. Autonomic nervous system abnormalities in patients with post-acute COVID syndrome (long-haul COVID). Clin Auton Res. 2022;32:367-68$$$$$Y$$$20240711$$HP$US$US
226185672$22618567$2$F$$20221205$20230620$20240711$PER$$US-PFM-2022-08705$PIERRE FABRE MEDICAMENT$Zamil DH, Fernandez JK, Brown DN, Kralik SF, Herd JT. Intracranial hemangioma-associated cranial nerve VII palsy treated with propranolol in an infant with possible PHACE syndrome. Pediatric Dermatology. 2022;39:950-51$2$WK$$F$Y$$$20240711$$HP$US$US
226185682$22618568$2$F$$20221205$20230620$20240711$PER$$US-PFM-2022-08744$PIERRE FABRE MEDICAMENT$Reinhart JP, Kumar AB, Casanegra AI, Rooke T, Sartori-Valinotti JC, Tollefson M et al. BASCULE syndrome: the Mayo Clinic experience of a recently described clinical entity. Clin Auton Res. 2022;32:360-61$$$$$Y$$$20240711$$HP$US$US
226185692$22618569$2$F$$20221205$20230620$20240711$PER$$US-PFM-2022-08743$PIERRE FABRE MEDICAMENT$Roberts MT, Robbins NM. Isolating autonomic dyspnea: expanding the clinical spectrum of anti-MAG neuropathy. Clin Auton Res. 2022;32:343$61$YR$$M$Y$$$20240711$$HP$US$US
226185702$22618570$2$F$$20221206$20230620$20240711$PER$$US-PFM-2022-08819$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.34$KG$20240711$$CN$US$US
226185712$22618571$2$F$$20221205$20230620$20240711$PER$$RO-PFM-2022-08741$PIERRE FABRE MEDICAMENT$Gabor-Miklosi D, Cerghit-Paler A, Sus I, Ghiragosian-Rusu S, Fagarasan A, Toganel R et al. Atypical Atrial Tachycardia in a  Newborn - a Case Report. Journal of Interdisciplinary Medicine. 2022;7(3):69-73$$$N$$Y$$$20240711$$HP$RO$RO
226185722$22618572$2$F$$20221206$20230620$20240711$PER$$US-PFM-2022-08820$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.778$KG$20240711$$CN$US$US
226185732$22618573$2$F$$20221208$20230620$20240711$PER$$US-PFM-2022-08822$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.127$KG$20240711$$CN$US$US
226185742$22618574$2$F$$20221208$20230620$20240711$PER$$US-PFM-2022-08821$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.651$KG$20240711$$HP$US$US
226185752$22618575$2$F$$20221208$20230620$20240711$PER$$US-PFM-2022-08848$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.889$KG$20240711$$CN$US$US
226185762$22618576$2$F$20221208$20221209$20230620$20240711$PER$$GR-PFM-2022-08846$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240711$$CN$GR$GR
226185772$22618577$2$F$$20221213$20230620$20240711$PER$$US-PFM-2022-08914$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.998$KG$20240711$$CN$US$US
226185782$22618578$2$F$$20221209$20230620$20240711$PER$$US-PFM-2022-08847$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.896$KG$20240711$$CN$US$US
226185792$22618579$2$F$20221117$20221212$20230620$20240711$PER$$FR-PFM-2022-08867$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6$KG$20240711$$MD$FR$FR
226185802$22618580$2$F$$20221201$20230620$20240711$PER$$JP-PFM-2022-08749$PIERRE FABRE MEDICAMENT$Ogawa T. Oral propranolol treatment in infantile hemangioma - Cooperation between dermatology and pediatrics$1$MON$$F$Y$$$20240711$$HP$JP$JP
226185812$22618581$2$F$$20221207$20230620$20240711$PER$$TR-PFM-2022-08746$PIERRE FABRE MEDICAMENT$Pehlivanoglu C, Genc HM, Kalin S. A rare cause of arterial hypertension in a child with developmental delay: Answers. Pediatric Nephrology. 2022;37:333-36$$$C$$Y$$$20240711$$HP$TR$TR
226185822$22618582$2$F$$20221205$20230620$20240711$PER$$GR-PFM-2022-08775$PIERRE FABRE MEDICAMENT$Sampatakakis SN, Lymperopoulos L, Mavridis T, Karagiorgis G, Papadopoulos C, Deligianni CI et al. Visual snow: A systematic review and a case series. Cephalalgia. 2022;42(13):1409-19$$$$$Y$$$20240711$$HP$GR$GR
226185832$22618583$2$F$$20221205$20230620$20240711$PER$$TR-PFM-2022-08748$PIERRE FABRE MEDICAMENT$Koksal M, Kocak G, Ozturk Y, Tufan AE. A Case of Emetophobia Responding to Mirtazapine  and Propranolol Treatment. Journal of Neurogastroenterology and Motility. 2022;28(4):709-10$14$YR$$F$Y$$$20240711$$HP$TR$TR
226185842$22618584$2$F$$20221221$20230620$20240711$PER$$JP-PFM-2022-08755$PIERRE FABRE MEDICAMENT$Ogawa T. Oral propranolol treatment in infantile hemangioma - Cooperation between dermatology and pediatrics$$$I$$Y$$$20240711$$HP$JP$JP
226185852$22618585$2$F$$20221207$20230620$20240711$PER$$IT-PFM-2022-08747$PIERRE FABRE MEDICAMENT$Primiano G, Rollo E, Romozzi M, Calabresi P, Servidei S, Vollono C. Preventive migraine treatment in mitochondrial diseases: a case report of erenumab efcacy and literature review. Neurological Sciences. 2022;43:6955-9$37$YR$$F$Y$$$20240711$$HP$IT$IT
226185872$22618587$2$F$$20221208$20230620$20240711$PER$$TR-PFM-2022-08798$PIERRE FABRE MEDICAMENT$Yilmazer MM, Vuran G, Mese T, Guven B, Zihni C, Gerceker E et al. Endovascular treatment of aortic coarctation with a novel BeGraft aortic stent in children and young adults: a single-centre experience with short-term follow-up results.. Cardiology in the Young. 2022;32(3):451-8$21$YR$$F$Y$46$KG$20240711$$HP$TR$TR
226185882$22618588$2$F$$20221208$20230620$20240711$PER$$TR-PFM-2022-08800$PIERRE FABRE MEDICAMENT$Yilmazer M, Vuran G, Mese T, Guven B, Zihni C, Gerceker E et al. Endovascular treatment of aortic coarctation with a novel BeGraft aortic stent in children and young adults: a single-centre experience with short-term follow-up results.. Cardiology in the Young. 2022;32(3):451-58$14$YR$$F$Y$$$20240711$$HP$TR$TR
226185902$22618590$2$F$$20221208$20230620$20240711$PER$$TR-PFM-2022-08796$PIERRE FABRE MEDICAMENT$Yilmazer MM, Vuran G, Mese T, Guven B, Zihni C, Ger?eker E et al. Endovascular treatment of aortic coarctation with a novel BeGraft aortic stent in children and young adults: a single-centre experience with short-term follow-up results. Cardiology in the Young. 2022;32(3):451-58$16$YR$$M$Y$75$KG$20240711$$HP$TR$TR
226185912$22618591$2$F$$20221208$20230620$20240711$PER$$TR-PFM-2022-08792$PIERRE FABRE MEDICAMENT$Yilmazer MM, Vuran G, Mese T, Guven B, Zihni C, Ger?eker E et al. Endovascular treatment of aortic coarctation with a novel BeGraft aortic stent in children and young adults: a single-centre experience with short-term follow-up results. Cardiology in the Young. 2022;32(3):451-58$13$YR$$M$Y$78$KG$20240711$$HP$TR$TR
226185922$22618592$2$F$$20221208$20230620$20240711$PER$$TR-PFM-2022-08797$PIERRE FABRE MEDICAMENT$Yilmazer MM, Vuran G, Mese T, Guven B, Zihni C, Ger?eker E et al. Endovascular treatment of aortic coarctation with a novel BeGraft aortic stent in children and young adults: a single-centre experience with short-term follow-up results. Cardiology in the Young. 2022;32(3):451-58$18$YR$$M$Y$63$KG$20240711$$HP$TR$TR
226185932$22618593$2$F$$20221208$20230620$20240711$PER$$TR-PFM-2022-08799$PIERRE FABRE MEDICAMENT$Yllmazer M, Vuran G, Mese T, Guven B, Zihni C, Gerceker E et al. Endovascular treatment of aortic coarctation with a novel BeGraft aortic stent in children and young adults: a single-centre experience with short-term follow-up results. Cardiology in the Young. 2022;32(3):451-58$21$YR$$F$Y$62$KG$20240711$$HP$TR$TR
226185942$22618594$2$F$$20221208$20230620$20240711$PER$$TR-PFM-2022-08801$PIERRE FABRE MEDICAMENT$Yllmazer M, Vuran G, Mese T, Guven B, Zihni C, Gerceker E et al. Endovascular treatment of aortic coarctation with a novel BeGraft aortic stent in children and young adults: a single-centre experience with short-term follow-up results.. Cardiology in the Young. 2022;32(3):451-4$13$YR$$M$Y$65$KG$20240711$$HP$TR$TR
226185952$22618595$2$F$$20221208$20230620$20240711$PER$$TR-PFM-2022-08802$PIERRE FABRE MEDICAMENT$Yllmazer MM, Vuran G, Mese T, Guven B, Zihni C, Gerceker E et al. Endovascular treatment of aortic coarctation with a novel BeGraft aortic stent in children and young adults: a single-centre experience with short-term follow-up results. Cardiology in the Young. 2022;32(3):451-4$17$YR$$M$Y$80$KG$20240711$$HP$TR$TR
226185962$22618596$2$F$$20221208$20230620$20240711$PER$$TR-PFM-2022-08804$PIERRE FABRE MEDICAMENT$Yilmazer MM, Vuran G, Mese T, Guven B, Zihni C, Gerceker E et al. Endovascular treatment of aortic coarctation with a novel BeGraft aortic stent in children and young adults: a single-centre experience with short-term follow-up results. Cardiology in the Young. 2022;32(3):451-58$14$YR$$M$Y$65$KG$20240711$$HP$TR$TR
226185972$22618597$2$F$$20221212$20230620$20240711$PER$$JP-PFM-2022-08888$PIERRE FABRE MEDICAMENT$Ohashi N, Nishikawa H, Yoshida S, Imai Y, Yoshii K, Nagata Y, et.al. Focal atrial tachycardia originating from the pulmonary vein with onset later than 3 years of age might have a better prognosis, possibly converting in adolescence. Journal of Electrocardiology. 2022;71:74-8$4$YR$$F$Y$$$20240711$$HP$JP$JP
226185982$22618598$2$F$$20221208$20230620$20240711$PER$$TR-PFM-2022-08805$PIERRE FABRE MEDICAMENT$Yilmazer MM, Vuran G, Mese T, Guven B, Zihni C, Gerceker E et al. Endovascular treatment of aortic coarctation with a novel BeGraft aortic stent in children and young adults: a single-centre experience with short-term follow-up results. Cardiology in the Young. 2022;32(3):451-58$14$YR$$F$Y$60$KG$20240711$$HP$TR$TR
226185992$22618599$2$F$$20221208$20230620$20240711$PER$$TR-PFM-2022-08803$PIERRE FABRE MEDICAMENT$Yilmazer MM, Vuran G, Mese T, Guven B, Zihni C, Gerceker E et al. Endovascular treatment of aortic coarctation with a novel BeGraft aortic stent in children and young adults: a single-centre experience with short-term follow-up results. Cardiology in the Young. 2022;32(3):451-58$14$YR$$M$Y$103$KG$20240711$$HP$TR$TR
226186012$22618601$2$F$$20221212$20230620$20240711$PER$$FI-PFM-2022-08865$PIERRE FABRE MEDICAMENT$Pironetti R, Keskinen P. Pienen tyton toistuvat hypoglykemiat. Duodecim. 2022;138(23):2089-90$3$YR$$F$Y$$$20240711$$MD$FI$FI
226186022$22618602$2$F$$20221212$20230620$20240711$PER$$JP-PFM-2022-08887$PIERRE FABRE MEDICAMENT$Ohashi N, Nishikawa H, Yoshida S, Imai Y, Yoshii K, Nagata Y, et.al. Focal atrial tachycardia originating from the pulmonary vein with onset later than 3 years of age might have a better prognosis, possibly converting in adolescence. Journal of Electrocardiology. 2022;71:74-8$8$YR$$M$Y$$$20240711$$HP$JP$JP
226186032$22618603$2$F$$20221212$20230620$20240711$PER$$JP-PFM-2022-08886$PIERRE FABRE MEDICAMENT$Ohashi N, Nishikawa H, Yoshida S, Imai Y, Yoshii K, Nagata Y, et al. Focal atrial tachycardia originating from the pulmonary vein with onset later than 3 years of age might have a better prognosis, possibly converting in adolescence. Journal of Electrocardiology. 2022;71:74-8$6$YR$$F$Y$$$20240711$$HP$JP$JP
226186042$22618604$2$F$$20221212$20230620$20240711$PER$$JP-PFM-2022-08889$PIERRE FABRE MEDICAMENT$Ohashi N, Nishikawa H, Yoshida S, Imai Y, Yoshii K, Nagata Y, et al. Focal atrial tachycardia originating from the pulmonary vein with onset later than 3 years of age might have a better prognosis, possibly converting in adolescence. Journal of Electrocardiology. 2022;71:74-8$5$YR$$F$Y$$$20240711$$HP$JP$JP
226186302$22618630$2$F$$20221213$20230620$20240711$PER$$US-PFM-2022-08915$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.719$KG$20240711$$CN$US$US
226186312$22618631$2$F$$20221214$20230620$20240711$PER$$US-PFM-2022-08917$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.478$KG$20240711$$CN$US$US
226186322$22618632$2$F$$20221212$20230620$20240711$PER$$US-PFM-2022-08919$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.376$KG$20240711$$CN$US$US
226186332$22618633$2$F$$20221212$20230620$20240711$PER$$US-PFM-2022-08920$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.54$KG$20240711$$HP$US$US
226186342$22618634$2$F$$20221216$20230620$20240711$PER$$US-PFM-2022-09002$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.2$KG$20240711$$CN$US$US
226186352$22618635$2$F$$20221215$20230620$20240711$PER$$US-PFM-2022-08936$PIERRE FABRE MEDICAMENT$$$$$M$Y$21.488$KG$20240711$$CN$US$US
226186362$22618636$2$F$$20221216$20230620$20240711$PER$$US-PFM-2022-09005$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.088$KG$20240711$$CN$US$US
226186382$22618638$2$F$$20221216$20230620$20240711$PER$$US-PFM-2022-09006$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.798$KG$20240711$$CN$US$US
226186392$22618639$2$F$20221213$20230102$20230620$20240711$PER$$SK-PFM-2022-09011$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$$$20240711$$MD$SK$SK
226186402$22618640$2$F$$20230104$20230620$20240711$PER$$US-PFM-2022-09004$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.71$KG$20240711$$CN$US$US
226186412$22618641$2$F$$20221216$20230620$20240711$PER$$US-PFM-2022-09003$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.859$KG$20240711$$HP$US$US
226186422$22618642$2$F$$20221219$20230620$20240711$PER$$US-PFM-2022-09008$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.667$KG$20240711$$CN$US$US
226186432$22618643$2$F$$20230111$20230620$20240711$PER$$CA-PFM-2023-00234$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240711$$MD$CA$CA
226186442$22618644$2$F$$20230111$20230620$20240711$PER$$CA-PFM-2023-00235$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226186452$22618645$2$F$$20230111$20230620$20240711$PER$$CA-PFM-2023-00236$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226186462$22618646$2$F$$20230119$20230620$20240711$PER$$US-PFM-2022-08935$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.499$KG$20240711$$HP$US$US
226186472$22618647$2$F$$20230621$20230620$20240711$PER$$US-PFM-2022-08916$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.617$KG$20240711$$HP$US$US
226186482$22618648$2$F$$20230109$20230620$20240711$PER$$CA-PFM-2023-00178$PIERRE FABRE MEDICAMENT$$46$YR$$F$Y$$$20240711$$MD$CA$CA
226186492$22618649$2$F$$20230328$20230620$20240711$PER$$US-PFM-2022-09060$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.198$KG$20240711$$CN$US$US
226186502$22618650$2$F$$20221221$20230620$20240711$PER$$US-PFM-2022-09061$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.091$KG$20240711$$CN$US$US
226186512$22618651$2$F$20220101$20230602$20230620$20240711$PER$$CA-PFM-2023-00177$PIERRE FABRE MEDICAMENT$$65$YR$$M$Y$$$20240711$$MD$CA$CA
226186522$22618652$2$F$$20221212$20230620$20240711$PER$$JP-PFM-2022-08971$PIERRE FABRE MEDICAMENT$Yoshino K et al. A case of propranolol discontinuation due to bradycardia after induction of oral propranolol for infantile haemangioma. The 76th Annual Meeting of Japanese Society of National Medical Services. 2022$5$MON$$M$Y$$$20240711$$HP$JP$JP
226186532$22618653$2$F$$20221216$20230620$20240711$PER$$TR-PFM-2022-09050$PIERRE FABRE MEDICAMENT$Anik A. Beta-blocker rebound phenomenon in an adolescent with graves^ disease. J Clin Res Pediatr Endocrinol. 2022;14(4):490-1$17$YR$$F$Y$$$20240711$$MD$TR$TR
226186542$22618654$2$F$$20221219$20230620$20240711$PER$$IT-PFM-2022-09035$PIERRE FABRE MEDICAMENT$Tuli G, Munarin J, Tessaris D, Quaglino F, Sanctis Ld. Papillary thyroid microcarcinoma in a boy with Graves^ disease: a case report  and review of the literature. Pediatr Endocrinol Diabetes Metab. 2022;28(1):88-90$16$YR$$M$Y$49$KG$20240711$$HP$IT$IT
226186552$22618655$2$F$20221220$20221222$20230620$20240711$PER$$US-PFM-2022-09062$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$8.01$KG$20240711$$HP$US$US
226186562$22618656$2$F$$20221222$20230620$20240711$PER$$US-PFM-2022-09063$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.27$KG$20240711$$CN$US$US
226186582$22618658$2$F$$20221226$20230620$20240711$PER$$CA-PFM-2022-09208$PIERRE FABRE MEDICAMENT$Stephenson A, Punjwani Z, Eszlinger M, Sawicka B, Bossowski A, Paschke R. Report of a family with three generations of undiagnosed familial nonautoimmune hyperthyroidism. Endocrinology, diabetes, and metabolism. 2021;1-6$$$$F$Y$$$20240711$$HP$CA$CA
226186612$22618661$2$F$$20221226$20230620$20240711$PER$$JP-PFM-2022-09210$PIERRE FABRE MEDICAMENT$Hoshina Y, Iijima H, Kubota M, Murakami T, Nagai A. Case of atrial septal defect closure relieving refractory migraine. Clin Case Rep. 2022;10:e06484:1-3$14$YR$$F$Y$$$20240711$$HP$JP$JP
226186622$22618662$2$F$$20221227$20230620$20240711$PER$NL-LRB-00858721$NL-PFM-2022-09172$PIERRE FABRE MEDICAMENT$$$$I$F$Y$$$20240711$$MD$NL$NL
226186632$22618663$2$F$$20221226$20230620$20240711$PER$$CA-PFM-2022-09207$PIERRE FABRE MEDICAMENT$Stephenson A, Punjwani Z, Eszlinger M, Sawicka B, Bossowski A, Paschke R. Report of a family with three generations of undiagnosed familial nonautoimmune hyperthyroidism. Endocrinology, diabetes, and metabolism. 2021;1-6$6$YR$$M$Y$$$20240711$$HP$CA$CA
226186642$22618664$2$F$$20221227$20230620$20240711$PER$$US-PFM-2022-09166$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.698$KG$20240711$$CN$US$US
226186652$22618665$2$F$$20221227$20230620$20240711$PER$$US-PFM-2022-09232$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.07$KG$20240711$$CN$US$US
226186662$22618666$2$F$20221224$20221227$20230620$20240711$PER$$US-PFM-2022-09168$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$4.535$KG$20240711$$HP$US$US
226186672$22618667$2$F$$20221226$20230620$20240711$PER$$IT-PFM-2022-09201$PIERRE FABRE MEDICAMENT$Benetton C, Pace D, Corti F, Cimador M, Gamba P, Midrio P. Propranolol and infantile hemangiomas: Outcome from a tricentric study. Journal of Plastic, Reconstructive and Aesthetic Surgery. 2023;76:57-9$$$I$$Y$$$20240711$$HP$IT$IT
226186682$22618668$2$F$$20221226$20230620$20240711$PER$$CA-PFM-2022-09206$PIERRE FABRE MEDICAMENT$Stephenson A, Punjwani Z, Eszlinger M, Sawicka B, Bossowski A, Paschke R. Report of a family with three generations of  undiagnosed familial nonautoimmune hyperthyroidism. Endocrinology, diabetes and metabolism. 2021;1-6$3$YR$$M$Y$$$20240711$$HP$CA$CA
226186692$22618669$2$F$$20221228$20230620$20240711$PER$$US-PFM-2023-00007$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.839$KG$20240711$$CN$US$US
226186702$22618670$2$F$$20221229$20230620$20240711$PER$$US-PFM-2023-00009$PIERRE FABRE MEDICAMENT$$$$$M$Y$3.351$KG$20240711$$HP$US$US
226186712$22618671$2$F$$20221229$20230620$20240711$PER$$US-PFM-2023-00010$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.156$KG$20240711$$HP$US$US
226186722$22618672$2$F$$20221229$20230620$20240711$PER$$US-PFM-2023-00008$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.524$KG$20240711$$CN$US$US
226186732$22618673$2$F$20210601$20221229$20230620$20240711$PER$FR-AFSSAPS-BX20215456$FR-PFM-2022-09222$PIERRE FABRE MEDICAMENT$$42$YR$$F$Y$76$KG$20240711$$CN$FR$FR
226186802$22618680$2$F$$20221230$20230620$20240711$PER$$US-PFM-2023-00021$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.438$KG$20240711$$HP$US$US
226186812$22618681$2$F$20221113$20221229$20230620$20240711$PER$FR-AFSSAPS-LL20223642$FR-PFM-2022-09219$PIERRE FABRE MEDICAMENT$$23$YR$$F$Y$108.5$KG$20240711$$PH$FR$FR
226186822$22618682$2$F$$20221230$20230620$20240711$PER$$US-PFM-2023-00073$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.719$KG$20240711$$HP$US$US
226186832$22618683$2$F$20221229$20221229$20230620$20240711$PER$$US-PFM-2023-00012$PIERRE FABRE MEDICAMENT$$8$MON$$M$Y$8$KG$20240711$$HP$US$US
226186842$22618684$2$F$$20221230$20230620$20240711$PER$$US-PFM-2023-00020$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.671$KG$20240711$$CN$US$US
226186852$22618685$2$F$20221123$20230102$20230620$20240711$PER$ES-AEMPS-1313347$ES-PFM-2023-00045$PIERRE FABRE MEDICAMENT$$50$YR$$F$Y$$$20240711$$MD$ES$ES
226186862$22618686$2$F$$20221230$20230620$20240711$PER$$US-PFM-2023-00018$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.029$KG$20240711$$CN$US$US
226186872$22618687$2$F$20221114$20221230$20230620$20240711$PER$FR-AFSSAPS-MP20223517$FR-PFM-2022-09251$PIERRE FABRE MEDICAMENT$$38$YR$$M$Y$95$KG$20240711$$CN$FR$FR
226186882$22618688$2$F$$20230102$20230620$20240711$PER$$IT-PFM-2023-00064$PIERRE FABRE MEDICAMENT$Tereshko Y, Belgrado E, Lettieri C, Passon N, Damante G, Gigli GL et al. Dystonic tremor and blepharospasm in a patient with deletion of 18q. Clinical neurology and neurosurgery. 2022;224:1-3$40$YR$$M$Y$$$20240711$$HP$IT$IT
226186892$22618689$2$F$$20230103$20230620$20240711$PER$$US-PFM-2023-00081$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.44$KG$20240711$$CN$US$US
226186922$22618692$2$F$$20230105$20230620$20240711$PER$$US-PFM-2023-00155$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.946$KG$20240711$$CN$US$US
226186932$22618693$2$F$$20230807$20230620$20240711$PER$$US-PFM-2023-00130$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.297$KG$20240711$$CN$US$US
226186952$22618695$2$F$20221211$20230109$20230620$20240711$PER$$US-PFM-2023-00189$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$8.11$KG$20240711$$PH$US$US
226186962$22618696$2$F$$20230928$20230620$20240711$PER$$US-PFM-2023-00191$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.442$KG$20240711$$CN$US$US
226186972$22618697$2$F$$20230106$20230620$20240711$PER$$US-PFM-2023-00158$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.497$KG$20240711$$CN$US$US
226186982$22618698$2$F$$20230109$20230620$20240711$PER$$IT-PFM-2023-00259$PIERRE FABRE MEDICAMENT$Pompanin S, Scaravilli T, Quatrale R. PRIMARY FAMILIAL BRAIN CALCIFICATION DUE TO A NOVEL MUTATION IN SLC20A2 GENE: A CASE REPORT. Neurological Sciences. 2022;43(Suppl 1):s260-61$69$YR$$M$Y$$$20240711$$HP$IT$IT
226186992$22618699$2$F$$20230105$20230620$20240711$PER$$US-PFM-2023-00154$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.651$KG$20240711$$HP$US$US
226187002$22618700$2$F$$20230106$20230620$20240711$PER$$US-PFM-2023-00157$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.039$KG$20240711$$CN$US$US
226187012$22618701$2$F$20221226$20230109$20230620$20240711$PER$$US-PFM-2023-00190$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
226187022$22618702$2$F$$20231010$20230620$20240711$PER$$US-PFM-2023-00244$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.9$KG$20240711$$CN$US$US
226187042$22618704$2$F$20220101$20230216$20230620$20240711$PER$$FR-PFM-2023-00187$PIERRE FABRE MEDICAMENT$$10$MON$$F$Y$$$20240711$$MD$FR$FR
226187052$22618705$2$F$$20231215$20230620$20240711$PER$$US-PFM-2023-00156$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.34$KG$20240711$$CN$US$US
226187062$22618706$2$F$$20230111$20230620$20240711$PER$$US-PFM-2023-00257$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.56$KG$20240711$$HP$US$US
226187082$22618708$2$F$$20230111$20230620$20240711$PER$$CA-PFM-2023-00237$PIERRE FABRE MEDICAMENT$$44$YR$$F$Y$$$20240711$$MD$CA$CA
226187092$22618709$2$F$$20230109$20230620$20240711$PER$$IT-PFM-2023-00260$PIERRE FABRE MEDICAMENT$Curto L, Della Vecchia A, Ferrari E, Siciliano G, Baldacci F, Gori S. Galcanezumab in unremitting subtype of hemicrania continua: a case report. Neurological Sciences. Conference: 52nd Annual Conference of the Italian Society. 2022;43(Suppl 1):S38$28$YR$$F$Y$$$20240711$$HP$IT$IT
226187102$22618710$2$F$$20230131$20230620$20240711$PER$$US-PFM-2023-00129$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.896$KG$20240711$$CN$US$US
226187112$22618711$2$F$$20230111$20230620$20240711$PER$$US-PFM-2023-00256$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.998$KG$20240711$$CN$US$US
226187122$22618712$2$F$$20230112$20230620$20240711$PER$$US-PFM-2023-00287$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.497$KG$20240711$$CN$US$US
226187132$22618713$2$F$$20230110$20230620$20240711$PER$$DE-PFM-2023-00182$PIERRE FABRE MEDICAMENT$$77$YR$$M$Y$$$20240711$$CN$DE$DE
226187142$22618714$2$F$20220616$20230316$20230620$20240711$PER$$JP-PFM-2023-00188$PIERRE FABRE MEDICAMENT$$3$MON$$M$Y$5.5$KG$20240711$$MD$JP$JP
226187152$22618715$2$F$$20230323$20230620$20240711$PER$$US-PFM-2023-00019$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.499$KG$20240711$$CN$US$US
226187162$22618716$2$F$$20230224$20230620$20240711$PER$$JP-PFM-2022-09138$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$MD$JP$JP
226187182$22618718$2$F$20210112$20240718$20230620$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-086386$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$84.69$KG$20240722$$HP$US$US
226187192$22618719$2$F$$20230112$20230620$20240711$PER$$US-PFM-2023-00288$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.549$KG$20240711$$CN$US$US
226187202$22618720$2$F$$20230112$20230620$20240711$PER$$US-PFM-2023-00289$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.898$KG$20240711$$CN$US$US
226187242$22618724$2$F$$20230113$20230620$20240711$PER$$SE-PFM-2023-00294$PIERRE FABRE MEDICAMENT$Hultin M, Sundberg E. Spontaneous Conversions of Supraventricular  Tachycardia to Sinus Rhythm in Children After  Premedication With Intranasal Dexmedetomidine:  A Case Report. A + A PRACTICE. 2018;11:219-20$1$YR$$F$Y$12.3$KG$20240711$$HP$SE$SE
226187252$22618725$2$F$$20230113$20230620$20240711$PER$$TR-PFM-2023-00366$PIERRE FABRE MEDICAMENT$Halime B, Nagehan H, Nursun O, Birce S , Ismail G , Didem A at al. Evaluation of Clinical Findings in Children with Chylothorax:  A Descriptive Study. Turk Arch Pediatr. 2023;58(1):28-33$1$YR$$M$Y$$$20240711$$HP$TR$TR
226187262$22618726$2$F$$20230112$20230620$20240711$PER$$TR-PFM-2023-00258$PIERRE FABRE MEDICAMENT$Ustun I, Tanik Pak A, Sengul Y. Are more nerve injections in the same session more effective in migraine treatment?  3-month follow-up results. Ideggyogy Sz. 2022;75(11-12):419-24$$$A$$Y$$$20240711$$HP$TR$TR
226187272$22618727$2$F$$20230116$20230620$20240711$PER$$CA-PFM-2023-00377$PIERRE FABRE MEDICAMENT$Penslar J, Udupa S. Ivabradine in the Management of Pediatric Arrhythmias. Canadian Journal of Cardiology. 2023;39:11-13$$$I$F$Y$$$20240711$$HP$CA$CA
226187282$22618728$2$F$$20230113$20230620$20240711$PER$$SE-PFM-2023-00297$PIERRE FABRE MEDICAMENT$Hultin M, Sundberg E. Spontaneous Conversions of Supraventricular Tachycardia to Sinus Rhythm in Children After Premedication With Intranasal Dexmedetomidine: A Case Report. A and A PRACTICE. 2018;11(8):219-20$3$YR$$M$Y$16$KG$20240711$$HP$SE$SE
226187292$22618729$2$F$$20230116$20230620$20240711$PER$$CZ-PFM-2023-00375$PIERRE FABRE MEDICAMENT$Mazankova D, Mazanek P,  Maskova V, Tinka P, Kyr M. Overall survival and event free survival in patients with high-risk neuroblastoma after targeted therapy. Int J Clin Pharm. 2022;44:1546$$$$$Y$$$20240711$$HP$CZ$CZ
226187302$22618730$2$F$$20230116$20230620$20240711$PER$$JP-PFM-2023-00419$PIERRE FABRE MEDICAMENT$Furuya R, Sakakibara H. O-33 PHACE syndrome: Treatment with propranolol for giant facial hemangiomas with cerebrovascular abnormalities. JTS Abstracts. 2022;62(6):A22$2$MON$$F$Y$$$20240711$$HP$JP$JP
226187312$22618731$2$F$$20230119$20230620$20240711$PER$$US-PFM-2023-00427$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.698$KG$20240711$$CN$US$US
226187322$22618732$2$F$20221201$20240206$20230620$20240711$PER$$US-PFM-2023-00426$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.63$KG$20240711$$PH$US$US
226187332$22618733$2$F$$20230120$20230620$20240711$PER$$US-PFM-2023-00463$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.247$KG$20240711$$CN$US$US
226187342$22618734$2$F$$20230120$20230620$20240711$PER$$US-PFM-2023-00464$PIERRE FABRE MEDICAMENT$$$$$M$Y$18.499$KG$20240711$$HP$US$US
226187352$22618735$2$F$$20230116$20230620$20240711$PER$$CZ-PFM-2023-00374$PIERRE FABRE MEDICAMENT$Mazankova D, Mazanek P,  Maskova V, Tinka P, Kyr M. Overall survival and event free survival in patients with high-risk neuroblastoma after targeted therapy. Int J Clin Pharm. 2022;44:1546$$$$$Y$$$20240711$$HP$CZ$CZ
226187362$22618736$2$F$$20230120$20230620$20240711$PER$$US-PFM-2023-00462$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.197$KG$20240711$$CN$US$US
226187372$22618737$2$F$20221201$20230120$20230620$20240711$PER$$RU-PFM-2023-00437$PIERRE FABRE MEDICAMENT$$2$MON$$F$Y$$$20240711$$MD$RU$RU
226187382$22618738$2$F$$20230120$20230620$20240711$PER$$US-PFM-2023-00461$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.417$KG$20240711$$CN$US$US
226187392$22618739$2$F$20221201$20230120$20230620$20240711$PER$$RU-PFM-2023-00436$PIERRE FABRE MEDICAMENT$$3$MON$$M$Y$$$20240711$$MD$RU$RU
226187412$22618741$2$F$$20230120$20230620$20240711$PER$$JP-PFM-2023-00467$PIERRE FABRE MEDICAMENT$Murakami M, Akashi N, Isobe R, Shimomura M, Hanai Y, Mitsuma M. A case of infantile hemangioma of an extremely low-birth-weight infant successfully treated with propranolol. The nishinihon journal of dermatology. 2022;84:415-7$5$WK$$$Y$4.03$KG$20240711$$HP$JP$JP
226187422$22618742$2$F$$20230118$20230620$20240711$PER$$IT-PFM-2023-00372$PIERRE FABRE MEDICAMENT$Pozzilli V, Marano M, Magliozzi A, Mallio CA, Marruzzo D, Barbieri FR et al. Deep brain stimulation of the dentato-rubro-thalamic tract in a case of Holmes tremor: a constrained spherical deconvolution (CSD)-guided procedure. Neurological Sciences. 2023;44(1):411-5$51$YR$$F$Y$$$20240711$$HP$IT$IT
226187432$22618743$2$F$$20230123$20230620$20240711$PER$$BG-PFM-2023-00523$PIERRE FABRE MEDICAMENT$Yankov I, Shentova-Eneva R, Mumdzhiev H, Petleshkova P, Krasteva M, Chatalbashev D et al. Extrahepatic Portal Vein Thrombosis  in Childhood: Risk Factors, Clinical  Manifestations, and Management. Med Princ Pract. 2022;31:524-31$$$$$Y$$$20240711$$HP$BG$BG
226187462$22618746$2$F$$20230126$20230620$20240711$PER$$US-PFM-2023-00588$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.397$KG$20240711$$HP$US$US
226187472$22618747$2$F$20230126$20230126$20230620$20240711$PER$$US-PFM-2023-00589$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$7.71$KG$20240711$$PH$US$US
226187482$22618748$2$F$$20230125$20230620$20240711$PER$$US-PFM-2023-00548$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.401$KG$20240711$$CN$US$US
226187492$22618749$2$F$$20230214$20230620$20240711$PER$$JP-PFM-2023-00336$PIERRE FABRE MEDICAMENT$Koizumi A. Three cases of neonatal hepatic haemangioma associated with placental villous haemangioma. Journal of Japan Society for Neonatal Health and Development. 2022;34(3):546$7$DY$$F$Y$$$20240711$$HP$JP$JP
226187502$22618750$2$F$$20230123$20230620$20240711$PER$$TR-PFM-2023-00520$PIERRE FABRE MEDICAMENT$Kaymakci ES, Kendirlioglu BK, Kucukgoncu S. Parkinsonism Symptoms After Exposure to Low-Dose Aripiprazole. Journal of Clinical Psychopharmacology. 2023;43 (1):69-70$54$YR$$F$Y$$$20240711$$HP$TR$TR
226187532$22618753$2$F$$20230126$20230620$20240711$PER$$US-PFM-2023-00590$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.138$KG$20240711$$HP$US$US
226187562$22618756$2$F$$20230427$20230620$20240711$PER$$TR-PFM-2023-00342$PIERRE FABRE MEDICAMENT$Selma C, Derya O, Servet G, Sonay O, Fatma Y, Arzu E et al. Orbital alveolar soft part sarcoma misdiagnosed as Hemangioma in an infant. Turkish Archives of Pediatrics. 2023;58(1):107-08$15$MON$$M$Y$$$20240711$$HP$TR$TR
226188396$22618839$6$F$20210823$20240911$20230620$20240919$EXP$$CA-CELLTRION INC.-2021CA016002$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
226189752$22618975$2$F$20240501$20240611$20230620$20240808$PER$$US-JNJFOC-20230639480$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240808$$CN$US$US
226190026$22619002$6$F$20230614$20240812$20230620$20240817$EXP$$US-SA-2023SA168400$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240817$$MD$US$US
226190234$22619023$4$F$20221223$20240716$20230620$20240726$EXP$$IT-AUROBINDO-AUR-APL-2023-042403$AUROBINDO$$88$YR$$F$Y$$$20240726$$MD$IT$IT
226190422$22619042$2$F$20221228$20230124$20230620$20240711$PER$$JP-PFM-2023-00638$PIERRE FABRE MEDICAMENT$$4$MON$$F$Y$$$20240711$$MD$JP$JP
226190432$22619043$2$F$20230128$20230130$20230620$20240711$PER$$DE-PFM-2023-00643$PIERRE FABRE MEDICAMENT$$20$WK$$F$Y$5$KG$20240711$$CN$DE$DE
226190442$22619044$2$F$$20230130$20230620$20240711$PER$$RO-PFM-2023-00723$PIERRE FABRE MEDICAMENT$Fagarasan A, Gozar L, Ghiragosian SER, Murariu M, Pop M, Crauciuc A et al. Severe early onset manifestations of generalized arterial calcification of infancy (mimicking severe coarctation of the aorta) with ABCC6 gene variant-Case report and literature review. Front. Cardiovasc. Med. 2022;9:1-10$18$MON$$M$Y$$$20240711$$HP$RO$RO
226190462$22619046$2$F$$20230126$20230620$20240711$PER$$US-PFM-2023-00591$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.9$KG$20240711$$CN$US$US
226190472$22619047$2$F$$20230130$20230620$20240711$PER$$NL-PFM-2023-00705$PIERRE FABRE MEDICAMENT$van der Linde A, van Baelen A, van Bergen C. Avascular necrosis of the hip as a rare complication  of growth hormone therapy. Horm Res Paediatr. 2022;95(suppl 2):1-616$12$YR$$F$Y$$$20240711$$HP$NL$NL
226190492$22619049$2$F$$20230130$20230620$20240711$PER$$ES-PFM-2023-00691$PIERRE FABRE MEDICAMENT$Juan-Carpena G, Palazon-cabanes JC, Tallon-guerola Paloma, Jamie MND, Betlloch-mas I. A Case Series of 18 Congenital Haemangiomas: Clinical, Histological  and Ultrasound Features, and their Relationship with Complications and Atypical Behaviour. Acta Derm Venereol. 2023;103:1-7$$$$M$Y$$$20240711$$HP$ES$ES
226190502$22619050$2$F$$20230131$20230620$20240711$PER$$US-PFM-2023-00672$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.619$KG$20240711$$HP$US$US
226190512$22619051$2$F$$20230130$20230620$20240711$PER$$US-PFM-2023-00671$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.787$KG$20240711$$CN$US$US
226190522$22619052$2$F$$20230130$20230620$20240711$PER$$NL-PFM-2023-00722$PIERRE FABRE MEDICAMENT$Koopmann TT, Jamshidi Y, Naghibi-Sistani M, Klift HMvd, Birjandi H, Al-Hassnan Z et al. Biallelic loss of LDB3 leads to a lethal pediatric dilated cardiomyopathy. European Journal of Human Genetics. 2023;31(97):97-104$5$WK$$M$Y$$$20240711$$HP$NL$NL
226190532$22619053$2$F$$20230201$20230620$20240711$PER$$US-PFM-2023-00703$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.306$KG$20240711$$HP$US$US
226190542$22619054$2$F$$20230203$20230620$20240711$PER$$US-PFM-2023-00731$PIERRE FABRE MEDICAMENT$$$$$M$Y$3.088$KG$20240711$$HP$US$US
226190552$22619055$2$F$$20230203$20230620$20240711$PER$$JP-PFM-2023-00919$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240711$$MD$JP$JP
226190562$22619056$2$F$$20230201$20230620$20240711$PER$$US-PFM-2023-00701$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240711$$HP$US$US
226190582$22619058$2$F$$20230203$20230620$20240711$PER$$US-PFM-2023-00730$PIERRE FABRE MEDICAMENT$$$$$F$Y$1.719$KG$20240711$$HP$US$US
226190592$22619059$2$F$$20230203$20230620$20240711$PER$$US-PFM-2023-00729$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.088$KG$20240711$$CN$US$US
226190602$22619060$2$F$$20230203$20230620$20240711$PER$$US-PFM-2023-00728$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.118$KG$20240711$$CN$US$US
226190622$22619062$2$F$$20230203$20230620$20240711$PER$$US-PFM-2023-00762$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.197$KG$20240711$$CN$US$US
226190632$22619063$2$F$$20230201$20230620$20240711$PER$$US-PFM-2023-00707$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.678$KG$20240711$$HP$US$US
2261906613$22619066$13$F$20230627$20240919$20230620$20240925$EXP$$CO-TAKEDA-2023TUS024671$TAKEDA$$54$YR$$F$Y$63$KG$20240925$$CN$CO$CO
226190672$22619067$2$F$20230113$20230204$20230620$20240711$PER$$US-PFM-2023-00840$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6.5$KG$20240711$$PH$US$US
226190682$22619068$2$F$$20230206$20230620$20240711$PER$$TR-PFM-2023-00824$PIERRE FABRE MEDICAMENT$Yalcin A, Ceylan M, Cakir M, Ceylan O, Yilmaz A. Deep brain stimulation for the abernethy malformation related tremor. Clinical Neurology and Neurosurgery. 2023;224:1-2$42$YR$$M$Y$$$20240711$$HP$TR$TR
226190692$22619069$2$F$$20230206$20230620$20240711$PER$$US-PFM-2023-00841$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.776$KG$20240711$$CN$US$US
226190702$22619070$2$F$$20230206$20230620$20240711$PER$$US-PFM-2023-00843$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.515$KG$20240711$$HP$US$US
226190723$22619072$3$F$$20230720$20230620$20240711$PER$$CA-PFM-2023-00808$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226190732$22619073$2$F$$20230720$20230620$20240711$PER$$CA-PFM-2023-00807$PIERRE FABRE MEDICAMENT$$49$YR$$F$Y$$$20240711$$MD$CA$CA
226190772$22619077$2$F$$20230720$20230620$20240711$PER$$CA-PFM-2023-00811$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226190782$22619078$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00815$PIERRE FABRE MEDICAMENT$$34$YR$$F$Y$$$20240711$$MD$CA$CA
226190832$22619083$2$F$20220901$20230720$20230620$20240711$PER$$CA-PFM-2023-00812$PIERRE FABRE MEDICAMENT$$34$YR$$F$Y$113.05$KG$20240711$$MD$CA$CA
226190852$22619085$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00817$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226190882$22619088$2$F$$20230206$20230620$20240711$PER$$JP-PFM-2023-00939$PIERRE FABRE MEDICAMENT$$5$MON$$M$Y$$$20240711$$PH$JP$JP
226190892$22619089$2$F$$20230206$20230620$20240711$PER$$IT-PFM-2023-00822$PIERRE FABRE MEDICAMENT$Patrizioa A, Vivab T, Ferraric M S, Eliad G, Ragusad F, Paparod R S, et al. Graves^ disease induced by IFN-?1a therapy: A case report, review of literature and new insights into the pathogenesis. Autoimmunity Reviews. 2023;22:1-3$60$YR$$F$Y$$$20240711$$HP$IT$IT
226190902$22619090$2$F$$20230206$20230620$20240711$PER$$IT-PFM-2023-00821$PIERRE FABRE MEDICAMENT$Lioncino M, Fusco A, Monda E, Colonna D, Sibilio M, Caiazza M, et al. Severe Lymphatic Disorder and Multifocal Atrial Tachycardia Treated with Trametinib in a Patient with Noonan Syndrome and SOS1 Mutation. Genes. 2022;13:1-7$34$WK$$M$Y$$$20240711$$HP$IT$IT
226190912$22619091$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00816$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226190922$22619092$2$F$$20230207$20230620$20240711$PER$$US-PFM-2023-00842$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.798$KG$20240711$$CN$US$US
226190932$22619093$2$F$$20230206$20230620$20240711$PER$$PT-PFM-2023-00823$PIERRE FABRE MEDICAMENT$Abreu JB, Cordeiro CR, Amorim AI,  Catanho TG, Gama KD. Combined neuraxial-general anesthesia in opsoclonus-myoclonus syndrome: A case report. Saudi Journal of Anesthesia. 2023;17:94-6$5$YR$$F$Y$27$KG$20240711$$HP$PT$PT
226190942$22619094$2$F$$20230208$20230620$20240711$PER$$US-PFM-2023-00732$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.719$KG$20240711$$HP$US$US
226190962$22619096$2$F$$20230206$20230620$20240711$PER$$TR-PFM-2023-00820$PIERRE FABRE MEDICAMENT$Gezer E, Canturk Z, ?etinarslan B, Selek A, Sozen M, Vural C, et.al. CUSHING^S SYNDROME DUE TO PRIMARY BILATERAL MACRONODULAR ADRENAL HYPERPLASIA AND METACHRONOUS PHEOCHROMOCYTOMA. Acta Endocrinologica. 2022;18(3):361-67$43$YR$$F$Y$$$20240711$$HP$TR$TR
226190982$22619098$2$F$$20230720$20230620$20240711$PER$$CA-PFM-2023-00810$PIERRE FABRE MEDICAMENT$$57$YR$$F$Y$$$20240711$$MD$CA$CA
226191052$22619105$2$F$$20230208$20230620$20240711$PER$$US-PFM-2023-00874$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.921$KG$20240711$$HP$US$US
226191062$22619106$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00814$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240711$$CN$CA$CA
226191072$22619107$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00830$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226191082$22619108$2$F$20230101$20230209$20230620$20240711$PER$$US-PFM-2023-00871$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
226191092$22619109$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00831$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226191112$22619111$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00869$PIERRE FABRE MEDICAMENT$$76$YR$$M$Y$$$20240711$$MD$CA$CA
226191122$22619112$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00870$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240711$$MD$CA$CA
226191132$22619113$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00825$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226191142$22619114$2$F$$20230209$20230620$20240711$PER$$US-PFM-2023-00872$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.617$KG$20240711$$CN$US$US
226191152$22619115$2$F$$20231017$20230620$20240711$PER$$US-PFM-2023-00873$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.49$KG$20240711$$CN$US$US
226191162$22619116$2$F$$20230210$20230620$20240711$PER$$US-PFM-2023-00941$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.71$KG$20240711$$CN$US$US
226191182$22619118$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00828$PIERRE FABRE MEDICAMENT$$49$YR$$M$Y$$$20240711$$MD$CA$CA
226191192$22619119$2$F$$20230213$20230620$20240711$PER$$IT-PFM-2023-01011$PIERRE FABRE MEDICAMENT$Trimboli M, Troisi L. Refractory trichodynia treated using onabotulinumtoxin-A. Pain Medicine. 2021;22(3):759-60$25$YR$$F$Y$$$20240711$$HP$IT$IT
226191222$22619122$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00819$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226191252$22619125$2$F$$20230213$20230620$20240711$PER$$US-PFM-2023-00944$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.499$KG$20240711$$CN$US$US
226191262$22619126$2$F$$20230213$20230620$20240711$PER$$US-PFM-2023-00976$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.488$KG$20240711$$HP$US$US
226191272$22619127$2$F$$20230213$20230620$20240711$PER$$TR-PFM-2023-01008$PIERRE FABRE MEDICAMENT$Gultekin M, Ulutabanca H. One year follow up vim thalamic deep brain stimulation in patient with severe tremor in l-2- hydroxyglutaric aciduria. Stereotact Funct Neurosurgy. 2022;100(1):262$47$YR$$M$Y$$$20240711$$HP$TR$TR
226191292$22619129$2$F$$20230213$20230620$20240711$PER$$US-PFM-2023-00943$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.469$KG$20240711$$CN$US$US
226191302$22619130$2$F$$20230215$20230620$20240711$PER$$US-PFM-2023-01026$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.599$KG$20240711$$HP$US$US
226191312$22619131$2$F$$20230216$20230620$20240711$PER$$US-PFM-2023-01054$PIERRE FABRE MEDICAMENT$$$$$M$Y$3.147$KG$20240711$$HP$US$US
226191322$22619132$2$F$$20230220$20230620$20240711$PER$$US-PFM-2023-01112$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.968$KG$20240711$$CN$US$US
226191332$22619133$2$F$20230207$20230306$20230620$20240711$PER$$JP-PFM-2023-00973$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240711$$MD$JP$JP
226191342$22619134$2$F$$20240401$20230620$20240711$PER$$US-PFM-2023-00942$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.39$KG$20240711$$CN$US$US
226191352$22619135$2$F$$20230214$20230620$20240711$PER$$US-PFM-2023-01025$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.111$KG$20240711$$CN$US$US
226191362$22619136$2$F$$20230808$20230620$20240711$PER$$US-PFM-2023-01028$PIERRE FABRE MEDICAMENT$$$$$M$Y$12.998$KG$20240711$$CN$US$US
226191372$22619137$2$F$$20230215$20230620$20240711$PER$$US-PFM-2023-01027$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.091$KG$20240711$$HP$US$US
226191382$22619138$2$F$$20230216$20230620$20240711$PER$$US-PFM-2023-01056$PIERRE FABRE MEDICAMENT$$$$$F$Y$16.399$KG$20240711$$HP$US$US
226191392$22619139$2$F$20230210$20230328$20230620$20240711$PER$IT-MINISAL02-910038$IT-PFM-2023-01103$PIERRE FABRE MEDICAMENT$$42$YR$$F$Y$61$KG$20240711$$MD$IT$IT
226191402$22619140$2$F$$20230216$20230620$20240711$PER$$US-PFM-2023-01057$PIERRE FABRE MEDICAMENT$$$$$M$Y$17.995$KG$20240711$$HP$US$US
226191412$22619141$2$F$$20230216$20230620$20240711$PER$$US-PFM-2023-01055$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.941$KG$20240711$$HP$US$US
226191422$22619142$2$F$$20230216$20230620$20240711$PER$$US-PFM-2023-01053$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.891$KG$20240711$$HP$US$US
226191432$22619143$2$F$20230125$20230220$20230620$20240711$PER$$US-PFM-2023-01111$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$4.6$KG$20240711$$PH$US$US
226191442$22619144$2$F$$20230308$20230620$20240711$PER$$JP-PFM-2023-00637$PIERRE FABRE MEDICAMENT$$1$MON$$$Y$$$20240711$$PH$JP$JP
226191452$22619145$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00826$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240711$$MD$CA$CA
226191462$22619146$2$F$$20230217$20230620$20240711$PER$$US-PFM-2023-01058$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.297$KG$20240711$$CN$US$US
226191472$22619147$2$F$20220922$20230221$20230620$20240711$PER$ES-AEMPS-1334261$ES-PFM-2023-01101$PIERRE FABRE MEDICAMENT$$75$YR$$F$Y$$$20240711$$PH$ES$ES
226191482$22619148$2$F$$20230330$20230620$20240711$PER$$US-PFM-2023-00702$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.579$KG$20240711$$HP$US$US
226191492$22619149$2$F$$20240624$20230620$20240711$PER$$US-PFM-2023-00610$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.32$KG$20240711$$CN$US$US
226191502$22619150$2$F$20221124$20230803$20230620$20240711$PER$$JP-PFM-2023-00918$PIERRE FABRE MEDICAMENT$$2$MON$$F$Y$$$20240711$$MD$JP$JP
226191542$22619154$2$F$20221014$20230213$20230620$20240711$PER$FR-AFSSAPS-LL2023000171$FR-PFM-2023-00995$PIERRE FABRE MEDICAMENT$$61$YR$$F$Y$62$KG$20240711$$MD$FR$FR
226191612$22619161$2$F$$20230220$20230620$20240711$PER$$US-PFM-2023-01113$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.061$KG$20240711$$CN$US$US
226191622$22619162$2$F$$20230222$20230620$20240711$PER$$US-PFM-2023-01178$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240711$$CN$US$US
226191632$22619163$2$F$$20230208$20230620$20240711$PER$$CA-PFM-2023-00829$PIERRE FABRE MEDICAMENT$$43$YR$$F$Y$$$20240711$$MD$CA$CA
226191652$22619165$2$F$$20230217$20230620$20240711$PER$$JP-PFM-2023-01233$PIERRE FABRE MEDICAMENT$$$$$$Y$6.065$KG$20240711$$CN$JP$JP
226191662$22619166$2$F$20230125$20230221$20230620$20240711$PER$$US-PFM-2023-01144$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$MD$US$US
226191672$22619167$2$F$$20230227$20230620$20240711$PER$$US-PFM-2023-01245$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.837$KG$20240711$$HP$US$US
226191682$22619168$2$F$20221015$20230224$20230620$20240711$PER$FR-AFSSAPS-AN2023000187$FR-PFM-2023-01226$PIERRE FABRE MEDICAMENT$$91$YR$$M$Y$$$20240711$$PH$FR$FR
226191692$22619169$2$F$$20230228$20230620$20240711$PER$$US-PFM-2023-01278$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.22$KG$20240711$$CN$US$US
226191702$22619170$2$F$$20230228$20230620$20240711$PER$$US-PFM-2023-01279$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.009$KG$20240711$$HP$US$US
226191712$22619171$2$F$$20240131$20230620$20240711$PER$$US-PFM-2023-01294$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.84$KG$20240711$$CN$US$US
226191742$22619174$2$F$$20230222$20230620$20240711$PER$$US-PFM-2023-01222$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.85$KG$20240711$$HP$US$US
226191752$22619175$2$F$$20231012$20230620$20240711$PER$$US-PFM-2023-01205$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.5$KG$20240711$$HP$US$US
226191762$22619176$2$F$$20230810$20230620$20240711$PER$$US-PFM-2023-01244$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.601$KG$20240711$$CN$US$US
226191772$22619177$2$F$$20230227$20230620$20240711$PER$$US-PFM-2023-01276$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.367$KG$20240711$$HP$US$US
226191782$22619178$2$F$$20230420$20230620$20240711$PER$$US-PFM-2023-01179$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.927$KG$20240711$$HP$US$US
2261917912$22619179$12$F$$20240913$20230620$20240920$EXP$$US-GSK-US2023083752$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$US$US
226191812$22619181$2$F$$20230227$20230620$20240711$PER$$CH-PFM-2023-01293$PIERRE FABRE MEDICAMENT$Chwolka M, Goadsby PJ, Gantenbein AR. Comorbidity or combination - more evidence for cluster-migraine?. Cephalalgia. 2023;43(1):1-6$51$YR$$M$Y$$$20240711$$HP$CH$CH
226191822$22619182$2$F$$20230228$20230620$20240711$PER$$US-PFM-2023-01277$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.617$KG$20240711$$CN$US$US
226191832$22619183$2$F$20230217$20230411$20230620$20240711$PER$$JP-PFM-2023-01248$PIERRE FABRE MEDICAMENT$$2$MON$$F$Y$$$20240711$$MD$JP$JP
226191842$22619184$2$F$20230220$20231228$20230620$20240711$PER$$US-PFM-2023-01243$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$9.578$KG$20240711$$CN$US$US
226191872$22619187$2$F$20230202$20230420$20230620$20240711$PER$$US-PFM-2023-01177$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
226191922$22619192$2$F$$20230228$20230620$20240711$PER$$HR-PFM-2023-01189$PIERRE FABRE MEDICAMENT$$42$YR$$M$Y$$$20240711$$MD$HR$HR
226191992$22619199$2$F$$20230220$20230620$20240711$PER$$DE-PFM-2023-01135$PIERRE FABRE MEDICAMENT$Grobe-Einsler M, Kaut O. Remarkable improvement of primary orthostatic tremor using perampanel. Grobe-Einsler and Kaut Neurological Research and Practice. 2020;2:3:1-3$53$YR$$F$Y$$$20240711$$HP$DE$DE
2261920216$22619202$16$F$20230101$20240731$20230620$20240807$EXP$$CA-CELLTRION INC.-2023CA011735$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
226192092$22619209$2$F$$20230215$20230620$20240711$PER$$TR-PFM-2023-01036$PIERRE FABRE MEDICAMENT$Taskaldiran I, Altay F, Bozcus Y, Iyidir O, Nar A, Tutuncu L. A case report of concurrent graves^ disease and subacute thyroiditis following SARS-CoV-2 vaccination: An autoimmune/inflammatory syndrome (ASIA). Endocrine, Metabolic + Immune Disorders-Drug Targets. 2023;23(2):242-6$31$YR$$F$Y$$$20240711$$HP$TR$TR
226192484$22619248$4$F$20210624$20240621$20230620$20240701$EXP$$CA-TAKEDA-2023TUS060039$TAKEDA$$32$YR$$F$Y$$$20240701$$CN$CA$CA
226192892$22619289$2$F$$20230301$20230620$20240711$PER$$US-PFM-2023-01321$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.07$KG$20240711$$CN$US$US
226192922$22619292$2$F$$20240117$20230620$20240711$PER$$US-PFM-2023-01322$PIERRE FABRE MEDICAMENT$$$$$F$Y$15.397$KG$20240711$$HP$US$US
226192932$22619293$2$F$$20240209$20230620$20240711$PER$$US-PFM-2023-01295$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.89$KG$20240711$$HP$US$US
226192942$22619294$2$F$$20230301$20230620$20240711$PER$$US-PFM-2023-01297$PIERRE FABRE MEDICAMENT$$$$$M$Y$12.077$KG$20240711$$HP$US$US
226192952$22619295$2$F$$20230407$20230620$20240711$PER$$US-PFM-2023-01298$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.537$KG$20240711$$CN$US$US
226192962$22619296$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01431$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226192972$22619297$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01430$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226192982$22619298$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01432$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226192992$22619299$2$F$$20230403$20230620$20240711$PER$$US-PFM-2023-01301$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.701$KG$20240711$$CN$US$US
226193002$22619300$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01435$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226193012$22619301$2$F$$20230922$20230620$20240711$PER$$US-PFM-2023-01323$PIERRE FABRE MEDICAMENT$$$$$F$Y$12$KG$20240711$$HP$US$US
226193022$22619302$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01438$PIERRE FABRE MEDICAMENT$$$$A$M$Y$$$20240711$$MD$CA$CA
226193032$22619303$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01433$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240711$$MD$CA$CA
226193042$22619304$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01436$PIERRE FABRE MEDICAMENT$$48$YR$$F$Y$$$20240711$$MD$CA$CA
226193052$22619305$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01429$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226193062$22619306$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01427$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226193072$22619307$2$F$20230302$20240305$20230620$20240711$PER$$US-PFM-2023-01296$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$7.38$KG$20240711$$HP$US$US
226193082$22619308$2$F$20230207$20230307$20230620$20240711$PER$ES-AEMPS-1339289$ES-PFM-2023-01405$PIERRE FABRE MEDICAMENT$$27$YR$$M$Y$$$20240711$$MD$ES$ES
226193092$22619309$2$F$20220429$20230306$20230620$20240711$PER$FR-AFSSAPS-NY2023000327$FR-PFM-2023-01417$PIERRE FABRE MEDICAMENT$$20$YR$$F$Y$73$KG$20240711$$MD$FR$FR
226193102$22619310$2$F$$20230302$20230620$20240711$PER$$US-PFM-2023-01350$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.95$KG$20240711$$HP$US$US
226193122$22619312$2$F$20230301$20230313$20230620$20240711$PER$$US-PFM-2023-01543$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$4.535$KG$20240711$$PH$US$US
226193142$22619314$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01437$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240711$$MD$CA$CA
226193162$22619316$2$F$$20230308$20230620$20240711$PER$$US-PFM-2023-01457$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.837$KG$20240711$$CN$US$US
226193172$22619317$2$F$$20230308$20230620$20240711$PER$$US-PFM-2023-01458$PIERRE FABRE MEDICAMENT$$$$$M$Y$12.599$KG$20240711$$CN$US$US
226193182$22619318$2$F$$20230308$20230620$20240711$PER$$US-PFM-2023-01459$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.68$KG$20240711$$CN$US$US
226193192$22619319$2$F$$20230310$20230620$20240711$PER$$US-PFM-2023-01522$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.639$KG$20240711$$CN$US$US
226193202$22619320$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01428$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226193212$22619321$2$F$$20230303$20230620$20240711$PER$$US-PFM-2023-01378$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.658$KG$20240711$$CN$US$US
226193222$22619322$2$F$$20230310$20230620$20240711$PER$$US-PFM-2023-01524$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.982$KG$20240711$$CN$US$US
226193232$22619323$2$F$20230311$20230312$20230620$20240711$PER$$HR-PFM-2023-01525$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$5$KG$20240711$$CN$HR$HR
226193242$22619324$2$F$$20230328$20230620$20240711$PER$$US-PFM-2023-01463$PIERRE FABRE MEDICAMENT$$$$$M$Y$12.245$KG$20240711$$CN$US$US
226193252$22619325$2$F$$20230313$20230620$20240711$PER$$US-PFM-2023-01545$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.639$KG$20240711$$HP$US$US
226193262$22619326$2$F$20220901$20230313$20230620$20240711$PER$FR-AFSSAPS-GR2023000270$FR-PFM-2023-01509$PIERRE FABRE MEDICAMENT$$84$YR$$F$Y$$$20240711$$MD$FR$FR
226193272$22619327$2$F$$20230405$20230620$20240711$PER$$US-PFM-2023-01523$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.177$KG$20240711$$CN$US$US
226193282$22619328$2$F$$20230427$20230620$20240711$PER$$US-PFM-2023-01349$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.29$KG$20240711$$CN$US$US
226193292$22619329$2$F$$20230418$20230620$20240711$PER$$US-PFM-2023-01544$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240711$$CN$US$US
226193302$22619330$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01434$PIERRE FABRE MEDICAMENT$$54$YR$$F$Y$$$20240711$$MD$CA$CA
226193312$22619331$2$F$$20230503$20230620$20240711$PER$$US-PFM-2023-01461$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.259$KG$20240711$$CN$US$US
226193322$22619332$2$F$$20230516$20230620$20240711$PER$$ES-PFM-2023-01344$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.7$KG$20240711$$MD$ES$ES
226193372$22619337$2$F$$20230308$20230620$20240711$PER$$CA-PFM-2023-01439$PIERRE FABRE MEDICAMENT$$59$YR$$F$Y$$$20240711$$MD$CA$CA
226193432$22619343$2$F$$20230314$20230620$20240711$PER$$US-PFM-2023-01585$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.263$KG$20240711$$HP$US$US
226193442$22619344$2$F$$20230313$20230620$20240711$PER$$US-PFM-2023-01546$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240711$$HP$US$US
226193452$22619345$2$F$$20230313$20230620$20240711$PER$$US-PFM-2023-01547$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.546$KG$20240711$$HP$US$US
226193472$22619347$2$F$$20230314$20230620$20240711$PER$$US-PFM-2023-01582$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.211$KG$20240711$$CN$US$US
226193482$22619348$2$F$$20230314$20230620$20240711$PER$$US-PFM-2023-01584$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.798$KG$20240711$$HP$US$US
226193492$22619349$2$F$$20230314$20230620$20240711$PER$$US-PFM-2023-01583$PIERRE FABRE MEDICAMENT$$$$$F$Y$14.798$KG$20240711$$CN$US$US
226193502$22619350$2$F$20230118$20230316$20230620$20240711$PER$HR-HALMED-300059460$HR-PFM-2023-01599$PIERRE FABRE MEDICAMENT$$87$YR$$F$Y$$$20240711$$PH$HR$HR
226193512$22619351$2$F$$20230315$20230620$20240711$PER$$US-PFM-2023-01677$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.891$KG$20240711$$CN$US$US
226193522$22619352$2$F$$20230919$20230620$20240711$PER$$US-PFM-2023-01678$PIERRE FABRE MEDICAMENT$$$$$F$Y$12$KG$20240711$$CN$US$US
226193532$22619353$2$F$$20230511$20230620$20240711$PER$$US-PFM-2023-01581$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.086$KG$20240711$$CN$US$US
226193582$22619358$2$F$$20230227$20230620$20240711$PER$$KR-PFM-2023-01300$PIERRE FABRE MEDICAMENT$Yuk CD, Ahn JH, Oh JK, Chang IB, Song JH, Kim JH. Deep brain stimulation of the ventralis intermedius nucleus of the thalamus and posterior subthalamic area for Holmes^ tremor secondary to brainstem hemorrhage: A case report. Journal of Clinical Neuroscience. 2019;60:160-4$55$YR$$M$Y$$$20240711$$HP$KR$KR
226193592$22619359$2$F$$20230227$20230620$20240711$PER$$CA-PFM-2023-01304$PIERRE FABRE MEDICAMENT$Alwithenani R, Andrade DM, Zhang L, Gomez-Hernandez KE. Myopathic dysphagia caused by thyrotoxicosis: a case report and review of the literature. Endocrinology, diabetes + Metabolism. 2022;1-4$77$YR$$M$Y$$$20240711$$HP$CA$CA
226193602$22619360$2$F$$20230306$20230620$20240711$PER$$KR-PFM-2023-01404$PIERRE FABRE MEDICAMENT$Kim HE, Yang J, Park JE, Baek JC, Jo HC. Thyroid storm in a pregnant woman with COVID-19 infection: A case report and review of literatures. World J Clin Cases. 2023;11(4):888-95$42$YR$$F$Y$$$20240711$$HP$KR$KR
226193612$22619361$2$F$$20230227$20230620$20240711$PER$$FI-PFM-2023-01299$PIERRE FABRE MEDICAMENT$Hahl-H?kkinen L, Rask SM, Solismaa A, Ruuhonen S, Leinonen E. Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports. Journal of Psychopharmacology. 2023;37(2):229-33$39$YR$$F$Y$$$20240711$$HP$FI$FI
226193622$22619362$2$F$$20230308$20230620$20240711$PER$$IT-PFM-2023-01309$PIERRE FABRE MEDICAMENT$Silvestro M, Orologio I, Trojsi F, Tessitore A, Tedeschi G, Russo A. Effectiveness and safety of CGRP monoclonal antibodies in migraine related  to mitochondrial diseases in patients with NARP and PEO syndromes. Clinical Neurology and Neurosurgery. 2023;226:1-3$57$YR$$F$Y$$$20240711$$HP$IT$IT
226193632$22619363$2$F$$20230308$20230620$20240711$PER$$IT-PFM-2023-01308$PIERRE FABRE MEDICAMENT$Silvestro M, Orologio I, Trojsi F, Tessitore A, Tedeschi G, Russo A. Effectiveness and safety of CGRP monoclonal antibodies in migraine related  to mitochondrial diseases in patients with NARP and PEO syndromes. Clinical Neurology and Neurosurgery. 2023;226:1-3$62$YR$$F$Y$$$20240711$$HP$IT$IT
226193642$22619364$2$F$$20230308$20230620$20240711$PER$$IT-PFM-2023-01449$PIERRE FABRE MEDICAMENT$Famularo G, Baldelli R. Graves disease, COVID-19 and vaccination. Minerva Endocrinology. 2022;47(4):476-77$29$YR$$F$Y$$$20240711$$HP$IT$IT
226193662$22619366$2$F$$20230313$20230620$20240711$PER$$JP-PFM-2023-01707$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$PH$JP$JP
226193722$22619372$2$F$$20230313$20230620$20240711$PER$$IT-PFM-2023-01571$PIERRE FABRE MEDICAMENT$Torrente A, Alonge P, Stefano VD, Baschi R, Ornello R, Correnti E et al. New-onset headache following COVID-19: An Italian multicentre case series. Journal of the Neurological Sciences. 2023;446:120591:1-5$$$$F$Y$$$20240711$$HP$IT$IT
226193742$22619374$2$F$$20230313$20230620$20240711$PER$$GR-PFM-2023-01574$PIERRE FABRE MEDICAMENT$Alexoudi A, Vlachakis E, Banos S, Oikonomou K, Patrikelis P, Verentzioti A et al. Combined Invasive Peripheral Nerve Stimulation in the Management of Chronic Post-Intracranial Disorder Headache: A Case Report. Clin. Pract.. 2023;13:297-304$33$YR$$F$Y$$$20240711$$HP$GR$GR
226193762$22619376$2$F$$20230313$20230620$20240711$PER$$CH-PFM-2023-01553$PIERRE FABRE MEDICAMENT$Bally JF, Zhang M, Dwosh E, Sato C, Rutka J, Lang AE et al. Genomic study of a large family with complex neurological phenotype including hearing loss, imbalance and action tremor. Neurobiology of Aging. 2022;113:137-42$68$YR$$$Y$$$20240711$$HP$CH$CH
226193772$22619377$2$F$$20230316$20230620$20240711$PER$$US-PFM-2023-01679$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.22$KG$20240711$$CN$US$US
226193782$22619378$2$F$$20230317$20230620$20240711$PER$$US-PFM-2023-01706$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.297$KG$20240711$$CN$US$US
226193792$22619379$2$F$$20230319$20230620$20240711$PER$$US-PFM-2023-01735$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.342$KG$20240711$$CN$US$US
226193802$22619380$2$F$$20230320$20230620$20240711$PER$$JP-PFM-2023-01882$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240711$$PH$JP$JP
226193812$22619381$2$F$$20230320$20230620$20240711$PER$$US-PFM-2023-01736$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.15$KG$20240711$$HP$US$US
226193822$22619382$2$F$$20230320$20230620$20240711$PER$$US-PFM-2023-01737$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.442$KG$20240711$$HP$US$US
226193832$22619383$2$F$$20230317$20230620$20240711$PER$$HR-PFM-2023-01715$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$HR$HR
226193842$22619384$2$F$$20230320$20230620$20240711$PER$$US-PFM-2023-01738$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.719$KG$20240711$$HP$US$US
226193852$22619385$2$F$$20230320$20230620$20240711$PER$$IT-PFM-2023-01755$PIERRE FABRE MEDICAMENT$Sarubbi B, Farina G, Colonna D, Correra A, Romeo E, Ciriello GD et al. Subcutaneous finger cardioverter-defibrillator in low weight paediatric patients: a case series. Monaldi Arch Chest Dis. 2023;93(2203)$3$YR$$M$Y$16$KG$20240711$$HP$IT$IT
226193872$22619387$2$F$$20230320$20230620$20240711$PER$$IT-PFM-2023-01754$PIERRE FABRE MEDICAMENT$Sarubbi B, Farina G, Colonna D, Correra A, Romeo E, Ciriello GD et al. Subcutaneous finger cardioverter-defibrillator in low weight paediatric patients: a case series. Monaldi Arch Chest Dis. 2022;93(2203)$3$YR$$M$Y$17.5$KG$20240711$$HP$IT$IT
226193882$22619388$2$F$$20230320$20230620$20240711$PER$$IT-PFM-2023-01753$PIERRE FABRE MEDICAMENT$Sarubbi B, Farina G, Colonna D, Correra A, Romeo E, Ciriello G et al. Subcutaneous finger cardioverter-defibrillator in low weight paediatric patients: a case series. Monaldi Arch Chest Dis. 2023;93$3$YR$$F$Y$14.58$KG$20240711$$HP$IT$IT
226193892$22619389$2$F$$20230807$20230620$20240711$PER$$US-PFM-2023-01773$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.256$KG$20240711$$CN$US$US
226193902$22619390$2$F$$20230320$20230620$20240711$PER$$PT-PFM-2023-01746$PIERRE FABRE MEDICAMENT$Amador F, Mendonca F, Costa CD, Canha M, Neves JS, Pinto R et al. Total thyroidectomy in a patient awaiting heart transplant  with amiodarone-induced thyrotoxicosis: A case report. Clin Case Rep. 2022;11(2):1-8$53$YR$$M$Y$$$20240711$$HP$PT$PT
226193912$22619391$2$F$$20230321$20230620$20240711$PER$$US-PFM-2023-01830$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.07$KG$20240711$$HP$US$US
226193922$22619392$2$F$$20230815$20230620$20240711$PER$$US-PFM-2023-01821$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.209$KG$20240711$$CN$US$US
226193932$22619393$2$F$$20230321$20230620$20240711$PER$$US-PFM-2023-01772$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.497$KG$20240711$$HP$US$US
226193943$22619394$3$F$$20230713$20230620$20240711$PER$$US-PFM-2023-01774$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240711$$HP$US$US
226193952$22619395$2$F$20230201$20230321$20230620$20240711$PER$$US-PFM-2023-01804$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$5.87$KG$20240711$$PH$US$US
226193962$22619396$2$F$$20230321$20230620$20240711$PER$$US-PFM-2023-01819$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.12$KG$20240711$$CN$US$US
226193982$22619398$2$F$$20230322$20230620$20240711$PER$$US-PFM-2023-01802$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.297$KG$20240711$$CN$US$US
226193992$22619399$2$F$20230301$20230321$20230620$20240711$PER$$US-PFM-2023-01771$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$8.299$KG$20240711$$HP$US$US
226194002$22619400$2$F$$20230321$20230620$20240711$PER$$US-PFM-2023-01820$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.259$KG$20240711$$CN$US$US
226194012$22619401$2$F$$20230322$20230620$20240711$PER$$TR-PFM-2023-01795$PIERRE FABRE MEDICAMENT$Tonyali A, Karacetin G, Yesilkaya C, Arik FNT, Ocakoglu BK. Appearance of extrapyramidal symptoms in adolescent psychiatry patients during COVID-19 infection. J Med Virol. 2023;95:e28556:1-11$13$YR$$M$Y$$$20240711$$HP$TR$TR
226194022$22619402$2$F$$20230322$20230620$20240711$PER$$JP-PFM-2023-01930$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$PH$JP$JP
226194032$22619403$2$F$$20230831$20230620$20240711$PER$$US-PFM-2023-01838$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.265$KG$20240711$$HP$US$US
226194042$22619404$2$F$$20230322$20230620$20240711$PER$$US-PFM-2023-01841$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.245$KG$20240711$$HP$US$US
226194052$22619405$2$F$$20230324$20230620$20240711$PER$$US-PFM-2023-01897$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.998$KG$20240711$$CN$US$US
226194062$22619406$2$F$$20230323$20230620$20240711$PER$$US-PFM-2023-01837$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.209$KG$20240711$$CN$US$US
226194082$22619408$2$F$$20230323$20230620$20240711$PER$$US-PFM-2023-01840$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.798$KG$20240711$$CN$US$US
226194092$22619409$2$F$$20230323$20230620$20240711$PER$$US-PFM-2023-01839$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.218$KG$20240711$$HP$US$US
226194102$22619410$2$F$$20230324$20230620$20240711$PER$$TR-PFM-2023-01896$PIERRE FABRE MEDICAMENT$G Emrah, U Hacer, K Fevzi, B Edin, G Anar, B Burak et al. Retrospective Evaluation of Patients Who  Underwent Bronchoscopy in a Tertiary Pediatric Intensive Care Unit. Pediatric Emergency and Intensive Care  Medicine Journal of Pediatric Emergency. 2023;10:26-33$$$$$Y$$$20240711$$MD$TR$TR
226194112$22619411$2$F$$20230324$20230620$20240711$PER$$US-PFM-2023-01925$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.188$KG$20240711$$HP$US$US
226194122$22619412$2$F$$20240226$20230620$20240711$PER$$US-PFM-2023-01926$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.16$KG$20240711$$CN$US$US
226194132$22619413$2$F$$20230831$20230620$20240711$PER$$US-PFM-2023-01928$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.4$KG$20240711$$CN$US$US
226194142$22619414$2$F$$20230328$20230620$20240711$PER$$US-PFM-2023-01929$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.059$KG$20240711$$CN$US$US
226194152$22619415$2$F$$20230406$20230620$20240711$PER$$JP-PFM-2023-01881$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$$$20240711$$PH$JP$JP
226194162$22619416$2$F$$20231010$20230620$20240711$PER$$US-PFM-2023-01927$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.5$KG$20240711$$CN$US$US
226194172$22619417$2$F$$20230517$20230620$20240711$PER$$US-PFM-2023-01836$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.839$KG$20240711$$CN$US$US
226194642$22619464$2$F$20230327$20230607$20230620$20240711$PER$$JP-PFM-2023-01483$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$PH$JP$JP
226194934$22619493$4$F$20230101$20240913$20230620$20240921$EXP$$CA-CELLTRION INC.-2023CA009480$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
226196603$22619660$3$F$20230315$20240705$20230620$20240717$PER$$US-SA-2023SA186021$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240717$$MD$US$US
226196846$22619684$6$F$20231005$20240828$20230620$20240830$EXP$$CA-TAKEDA-2023TUS058637$TAKEDA$$48$YR$$F$Y$$$20240830$$CN$CA$CA
226197093$22619709$3$F$20230118$20240919$20230620$20240930$EXP$$BR-TAKEDA-2023TUS008630$TAKEDA$$65$YR$$M$Y$$$20240929$$CN$BR$BR
226197184$22619718$4$F$20240812$20240812$20230620$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-086320$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240816$$CN$US$US
226197225$22619722$5$F$$20240617$20230620$20240701$EXP$CA-SA-SAC20230616001488$CA-SA-2023SA185858$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240701$$CN$CA$CA
226197292$22619729$2$F$20230614$20240705$20230620$20240716$PER$$US-SA-2023SA186910$SANOFI AVENTIS$$1$YR$I$M$Y$13$KG$20240716$$MD$US$US
226197486$22619748$6$F$$20240621$20230620$20240716$EXP$$US-GSK-US2023083733$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$US$US
226197732$22619773$2$F$20240101$20240724$20230620$20240731$PER$$US-SA-2023SA186399$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240801$$MD$US$US
226198037$22619803$7$F$20230630$20240709$20230620$20240712$EXP$$US-GSK-US2023083875$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$HP$US$US
226198042$22619804$2$F$$20230615$20230620$20240925$PER$$US-GSK-US2023AMR085429$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
226199284$22619928$4$F$$20240625$20230620$20240701$EXP$$BR-TAKEDA-2023TUS058756$TAKEDA$$$$$F$Y$$$20240701$$CN$BR$BR
226200242$22620024$2$F$$20230329$20230620$20240711$PER$$CA-PFM-2023-01978$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240711$$MD$CA$CA
226200252$22620025$2$F$$20230329$20230620$20240711$PER$$CA-PFM-2023-01975$PIERRE FABRE MEDICAMENT$$20$YR$$F$Y$$$20240711$$MD$CA$CA
226200262$22620026$2$F$$20230329$20230620$20240711$PER$$CA-PFM-2023-01976$PIERRE FABRE MEDICAMENT$$42$YR$$F$Y$$$20240711$$MD$CA$CA
226200272$22620027$2$F$$20230329$20230620$20240711$PER$$CA-PFM-2023-01977$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240711$$MD$CA$CA
226200282$22620028$2$F$$20230329$20230620$20240711$PER$$CA-PFM-2023-01982$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226200292$22620029$2$F$$20230329$20230620$20240711$PER$$CA-PFM-2023-01979$PIERRE FABRE MEDICAMENT$$$$A$M$Y$$$20240711$$MD$CA$CA
226200302$22620030$2$F$$20230329$20230620$20240711$PER$$CA-PFM-2023-01983$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226200312$22620031$2$F$20221124$20230413$20230620$20240711$PER$IT-MINISAL02-918647$IT-PFM-2023-02261$PIERRE FABRE MEDICAMENT$$69$YR$$F$Y$$$20240711$$MD$IT$IT
226200342$22620034$2$F$$20230329$20230620$20240711$PER$$CA-PFM-2023-01980$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226200352$22620035$2$F$$20230329$20230620$20240711$PER$$CA-PFM-2023-01981$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226200412$22620041$2$F$$20230418$20230620$20240711$PER$$CA-PFM-2023-02344$PIERRE FABRE MEDICAMENT$$17$YR$$F$Y$$$20240711$$MD$CA$CA
226200422$22620042$2$F$$20230418$20230620$20240711$PER$$CA-PFM-2023-02341$PIERRE FABRE MEDICAMENT$$65$YR$$M$Y$$$20240711$$MD$CA$CA
226200432$22620043$2$F$$20230418$20230620$20240711$PER$$CA-PFM-2023-02343$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226200442$22620044$2$F$$20230418$20230620$20240711$PER$$CA-PFM-2023-02342$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
226200452$22620045$2$F$$20230418$20230620$20240711$PER$$CA-PFM-2023-02345$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240711$$MD$CA$CA
226200472$22620047$2$F$$20230418$20230620$20240711$PER$$CA-PFM-2023-02347$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240711$$MD$CA$CA
226200482$22620048$2$F$$20230418$20230620$20240711$PER$$CA-PFM-2023-02346$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240711$$MD$CA$CA
226200492$22620049$2$F$$20230418$20230620$20240711$PER$$CA-PFM-2023-02348$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240711$$MD$CA$CA
226200502$22620050$2$F$$20230418$20230620$20240711$PER$$CA-PFM-2023-02349$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226200512$22620051$2$F$$20230418$20230620$20240711$PER$$CA-PFM-2023-02350$PIERRE FABRE MEDICAMENT$$49$YR$$M$Y$$$20240711$$MD$CA$CA
226200522$22620052$2$F$$20230327$20230620$20240711$PER$$JP-PFM-2023-02027$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$CN$JP$JP
226200532$22620053$2$F$$20230331$20230620$20240711$PER$$US-PFM-2023-02006$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.218$KG$20240711$$CN$US$US
226200542$22620054$2$F$$20230330$20230620$20240711$PER$$US-PFM-2023-02004$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.098$KG$20240711$$CN$US$US
226200552$22620055$2$F$$20230404$20230620$20240711$PER$$US-PFM-2023-02108$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.009$KG$20240711$$CN$US$US
226200562$22620056$2$F$20230201$20230331$20230620$20240711$PER$FR-AFSSAPS-AN2023000463$FR-PFM-2023-02032$PIERRE FABRE MEDICAMENT$$45$YR$$M$Y$86$KG$20240711$$MD$FR$FR
226200572$22620057$2$F$$20230404$20230620$20240711$PER$$US-PFM-2023-02075$PIERRE FABRE MEDICAMENT$$$$$M$Y$22.694$KG$20240711$$CN$US$US
226200582$22620058$2$F$$20230404$20230620$20240711$PER$$US-PFM-2023-02074$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.048$KG$20240711$$CN$US$US
226200592$22620059$2$F$$20230405$20230620$20240711$PER$$US-PFM-2023-02109$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.98$KG$20240711$$CN$US$US
226200602$22620060$2$F$$20230405$20230620$20240711$PER$$US-PFM-2023-02110$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.778$KG$20240711$$CN$US$US
226200612$22620061$2$F$$20230406$20230620$20240711$PER$$US-PFM-2023-02128$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.218$KG$20240711$$HP$US$US
226200622$22620062$2$F$$20230418$20230620$20240711$PER$$CA-PFM-2023-02360$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
226200632$22620063$2$F$$20230502$20230620$20240711$PER$$US-PFM-2023-02107$PIERRE FABRE MEDICAMENT$$$$$F$Y$77.098$KG$20240711$$HP$US$US
226200642$22620064$2$F$$20230418$20230620$20240711$PER$$CA-PFM-2023-02361$PIERRE FABRE MEDICAMENT$$23$YR$$F$Y$$$20240711$$MD$CA$CA
226200652$22620065$2$F$$20230517$20230620$20240711$PER$$US-PFM-2023-02005$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.42$KG$20240711$$CN$US$US
226200662$22620066$2$F$$20230502$20230620$20240711$PER$$US-PFM-2023-01968$PIERRE FABRE MEDICAMENT$$$$$M$Y$14.698$KG$20240711$$HP$US$US
226200672$22620067$2$F$$20230407$20230620$20240711$PER$$US-PFM-2023-02149$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.567$KG$20240711$$CN$US$US
226200682$22620068$2$F$$20230406$20230620$20240711$PER$$US-PFM-2023-02129$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.041$KG$20240711$$HP$US$US
226200692$22620069$2$F$$20230406$20230620$20240711$PER$$US-PFM-2023-02148$PIERRE FABRE MEDICAMENT$$$$$F$Y$16.825$KG$20240711$$CN$US$US
226200702$22620070$2$F$$20230406$20230620$20240711$PER$$US-PFM-2023-02131$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.488$KG$20240711$$CN$US$US
226200713$22620071$3$F$$20230628$20230620$20240711$PER$$US-PFM-2023-02130$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.469$KG$20240711$$CN$US$US
226200782$22620078$2$F$$20231002$20230620$20240711$PER$$US-PFM-2023-02248$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.75$KG$20240711$$CN$US$US
226200802$22620080$2$F$$20230407$20230620$20240711$PER$$US-PFM-2023-02168$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.698$KG$20240711$$CN$US$US
226200842$22620084$2$F$$20230407$20230620$20240711$PER$$US-PFM-2023-02170$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.891$KG$20240711$$CN$US$US
226200852$22620085$2$F$$20230817$20230620$20240711$PER$$US-PFM-2023-02171$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.898$KG$20240711$$HP$US$US
226200882$22620088$2$F$$20230411$20230620$20240711$PER$$US-PFM-2023-02199$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.701$KG$20240711$$HP$US$US
226200892$22620089$2$F$$20230412$20230620$20240711$PER$$US-PFM-2023-02246$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.821$KG$20240711$$CN$US$US
226200912$22620091$2$F$$20230411$20230620$20240711$PER$$US-PFM-2023-02201$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.943$KG$20240711$$CN$US$US
226200942$22620094$2$F$$20230411$20230620$20240711$PER$$US-PFM-2023-02202$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.256$KG$20240711$$CN$US$US
226200962$22620096$2$F$$20230413$20230620$20240711$PER$$US-PFM-2023-02249$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.61$KG$20240711$$CN$US$US
226200982$22620098$2$F$$20230414$20230620$20240711$PER$$US-PFM-2023-02303$PIERRE FABRE MEDICAMENT$$$$$M$Y$13.551$KG$20240711$$HP$US$US
226201002$22620100$2$F$$20230414$20230620$20240711$PER$$US-PFM-2023-02305$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.83$KG$20240711$$CN$US$US
226201032$22620103$2$F$$20230413$20230620$20240711$PER$$US-PFM-2023-02250$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.197$KG$20240711$$CN$US$US
226201062$22620106$2$F$$20230414$20230620$20240711$PER$$US-PFM-2023-02304$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.499$KG$20240711$$CN$US$US
226201072$22620107$2$F$$20230417$20230620$20240711$PER$$US-PFM-2023-02336$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.957$KG$20240711$$HP$US$US
226201092$22620109$2$F$$20230417$20230620$20240711$PER$$US-PFM-2023-02337$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.528$KG$20240711$$CN$US$US
226201112$22620111$2$F$$20230417$20230620$20240711$PER$$US-PFM-2023-02338$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.338$KG$20240711$$HP$US$US
226201132$22620113$2$F$$20230501$20230620$20240711$PER$$US-PFM-2023-02169$PIERRE FABRE MEDICAMENT$$$$$F$Y$17.238$KG$20240711$$CN$US$US
226201152$22620115$2$F$$20230809$20230620$20240711$PER$$US-PFM-2023-02395$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.696$KG$20240711$$CN$US$US
226201162$22620116$2$F$$20230518$20230620$20240711$PER$$US-PFM-2023-02200$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.56$KG$20240711$$CN$US$US
226201172$22620117$2$F$20230406$20230513$20230620$20240711$PER$$JP-PFM-2023-02262$PIERRE FABRE MEDICAMENT$$4$MON$$$Y$$$20240711$$MD$JP$JP
226201262$22620126$2$F$$20230418$20230620$20240711$PER$$US-PFM-2023-02398$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.995$KG$20240711$$CN$US$US
226201272$22620127$2$F$$20230419$20230620$20240711$PER$$US-PFM-2023-02263$PIERRE FABRE MEDICAMENT$Parker N, Flowers R, Vickery K, Stolf A, Bugnitz C. Assessing the risk of hypoglycemia secondary to propranolol therapy for the treatment of supraventricular tachycardia in infants. Pediatric Cardiology. 2023;44:836-44$$$I$$Y$$$20240711$$HP$US$US
226201292$22620129$2$F$$20230403$20230620$20240711$PER$$JP-PFM-2023-02054$PIERRE FABRE MEDICAMENT$Le K, Ishizuka K, Sakai T, Motohashi I, Asai S, Okuse C. Subacute thyroiditis developing within 2 days of vaccination against COVID-19 with BNT162b2 mRNA. European Journal of Case Reports in Internal Medicine. 2023;10(1):1-3$32$YR$$F$Y$$$20240711$$HP$JP$JP
226201302$22620130$2$F$$20231120$20230620$20240711$PER$$US-PFM-2023-02397$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.739$KG$20240711$$CN$US$US
226201322$22620132$2$F$20230414$20230419$20230620$20240711$PER$$US-PFM-2023-02409$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
226201342$22620134$2$F$$20230419$20230620$20240711$PER$$US-PFM-2023-02408$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.397$KG$20240711$$CN$US$US
226201362$22620136$2$F$$20230419$20230620$20240711$PER$$US-PFM-2023-02265$PIERRE FABRE MEDICAMENT$Parker N, Flowers R, Vickery K, Stolf A, Bugnitz C. Assessing the risk of hypoglycemia secondary to propranolol therapy for the treatment of supraventricular tachycardia in infants. Pediatric Cardiology. 2023;44:836-44$$$I$$Y$$$20240711$$HP$US$US
226201372$22620137$2$F$$20230419$20230620$20240711$PER$$US-PFM-2023-02267$PIERRE FABRE MEDICAMENT$Parker N, Flowers R, Vickery K, Stolf A, Bugnitz C. Assessing the risk of hypoglycemia secondary to propranolol therapy for the treatment of supraventricular tachycardia in infants. Pediatric Cardiology. 2023;44:836-44$$$I$$Y$$$20240711$$HP$US$US
226201382$22620138$2$F$$20230419$20230620$20240711$PER$$US-PFM-2023-02268$PIERRE FABRE MEDICAMENT$Parker N, Flowers R, Vickery K, Stolf A, Bugnitz C. Assessing the risk of hypoglycemia secondary to propranolol therapy for the treatment of supraventricular tachycardia in infants. Pediatric Cardiology. 2023;44:836-44$$$I$$Y$$$20240711$$HP$US$US
226201392$22620139$2$F$$20230419$20230620$20240711$PER$$US-PFM-2023-02266$PIERRE FABRE MEDICAMENT$Parker N, Flowers R, Vickery K, Stolf A, Bugnitz C. Assessing the risk of hypoglycemia secondary to propranolol therapy for the treatment of supraventricular tachycardia in infants. Pediatric Cardiology. 2023;44:836-44$$$I$$Y$$$20240711$$HP$US$US
226201402$22620140$2$F$$20230419$20230620$20240711$PER$$US-PFM-2023-02269$PIERRE FABRE MEDICAMENT$Parker N, Flowers R, Vickery K, Stolf A, Bugnitz C. Assessing the risk of hypoglycemia secondary to propranolol therapy for the treatment of supraventricular tachycardia in infants. Pediatric Cardiology. 2023;44:836-44$$$I$$Y$$$20240711$$HP$US$US
226201412$22620141$2$F$$20230419$20230620$20240711$PER$$US-PFM-2023-02271$PIERRE FABRE MEDICAMENT$Parker N, Flowers R, Vickery K, Stolf A, Bugnitz C. Assessing the risk of hypoglycemia secondary to propranolol therapy for the treatment of supraventricular tachycardia in infants. Pediatric Cardiology. 2023;44:836-44$$$I$$Y$$$20240711$$HP$US$US
226201422$22620142$2$F$$20230419$20230620$20240711$PER$$US-PFM-2023-02270$PIERRE FABRE MEDICAMENT$Parker N, Flowers R, Vickery K, Stolf A, Bugnitz C. Assessing the risk of hypoglycemia secondary to propranolol therapy for the treatment of supraventricular tachycardia in infants. Pediatric Cardiology. 2023;44:836-44$$$I$$Y$$$20240711$$HP$US$US
226201432$22620143$2$F$$20230420$20230620$20240711$PER$$US-PFM-2023-02519$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.669$KG$20240711$$CN$US$US
226201442$22620144$2$F$$20230419$20230620$20240711$PER$$US-PFM-2023-02272$PIERRE FABRE MEDICAMENT$Parker N, Flowers R, Vickery K, Stolf A, Bugnitz C. Assessing the risk of hypoglycemia secondary to propranolol therapy for the treatment of supraventricular tachycardia in infants. Pediatric Cardiology. 2023;44:836-44$$$I$F$Y$$$20240711$$HP$US$US
226201452$22620145$2$F$$20230421$20230620$20240711$PER$$US-PFM-2023-02505$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.51$KG$20240711$$CN$US$US
226201462$22620146$2$F$$20230710$20230620$20240711$PER$$US-PFM-2023-02503$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.478$KG$20240711$$CN$US$US
226201472$22620147$2$F$$20230512$20230620$20240711$PER$$JP-PFM-2023-02493$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$PH$JP$JP
226201482$22620148$2$F$$20230526$20230620$20240711$PER$$US-PFM-2023-02396$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.778$KG$20240711$$CN$US$US
226201492$22620149$2$F$$20230815$20230620$20240711$PER$$US-PFM-2023-02502$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.524$KG$20240711$$CN$US$US
226201522$22620152$2$F$$20230405$20230620$20240711$PER$$JP-PFM-2023-02088$PIERRE FABRE MEDICAMENT$Kuwabara Y, Ozeki M, Hira K, Fujisaki H, Ohnishi H. A case of sirolimus treatment of kaposiform hemangioendothelioma in the neck. Pediatrics International. 2022;64:1-3$2$MON$$M$Y$$$20240711$$HP$JP$JP
226201532$22620153$2$F$$20230410$20230620$20240711$PER$$CA-PFM-2023-02212$PIERRE FABRE MEDICAMENT$Paff M, Boutet A, Neudorfer C, Elias GJB, Germann J, Loh A et al. Magnetic resonance-guided focused ultrasound thalamotomy to treat essential tremor in nonagenarians. Stereotactic and functional neurosurgery. 2020;98(3):182-86$93$YR$$F$Y$$$20240711$$HP$CA$CA
226201542$22620154$2$F$$20230405$20230620$20240711$PER$$JP-PFM-2023-02087$PIERRE FABRE MEDICAMENT$Ichikawa Y, Sato T, Ichihashi Y, Ishii T, Hasegawa T. Destructive thyroiditis without autoantibodies in an infant. Pediatrics International. 2022;64(e14709):1-3$$$I$F$Y$$$20240711$$HP$JP$JP
226201552$22620155$2$F$$20230405$20230620$20240711$PER$$JP-PFM-2023-02089$PIERRE FABRE MEDICAMENT$Sasai H, Goto H, Kawashiri M, Kuwahara T. Long QT as a first sign for propionic acidemia in a 10-year-old girl. Pediatrics International. 2022;64(e14752):1-3$10$YR$$F$Y$$$20240711$$HP$JP$JP
226201562$22620156$2$F$$20230410$20230620$20240711$PER$$JP-PFM-2023-02225$PIERRE FABRE MEDICAMENT$Kubota K, Inai K, Shimada E, Shinohara T. ?/?- and ?-blocker exposure in pregnancy and the risk of neonatal hypoglycemia and small for gestational age. Circulation Journal. 2023;87:569-77$$$$F$Y$$$20240711$$MD$JP$JP
226201572$22620157$2$F$$20230410$20230620$20240711$PER$$BE-PFM-2023-02230$PIERRE FABRE MEDICAMENT$Schnebert B, Montjoye L, Baeck M. A rare case of adrenergic urticaria in a child. J Eur Acad Dermatol Venereol. 2023;37:226-8$9$YR$$M$Y$$$20240711$$HP$BE$BE
226201582$22620158$2$F$$20230410$20230620$20240711$PER$$KR-PFM-2023-02220$PIERRE FABRE MEDICAMENT$Choi S, Yu J, Hwang H, Kim H. Orolingual Tremor on Smiling. Annals of child neurology. 2020;28(1):37-8$16$YR$$M$Y$$$20240711$$MD$KR$KR
226201592$22620159$2$F$$20230512$20230620$20240711$PER$$JP-PFM-2023-02156$PIERRE FABRE MEDICAMENT$Nakasute K. New dermatology seminarium treatment of haemangioma, vascular malformation, and varicose veins of lower extremities from experts 1 Operational techniques of oral propranolol therapy for infantile haemangioma in which aggressive therapeutic intervention is desirable. The Journal of Japanese Dermatology Association. 2023;133(2):195-203$$$I$F$Y$$$20240711$$HP$JP$JP
226201602$22620160$2$F$$20230512$20230620$20240711$PER$$JP-PFM-2023-02160$PIERRE FABRE MEDICAMENT$Nakasute K. New dermatology seminarium treatment of haemangioma, vascular malformation, and varicose veins of lower extremities from experts 1 Operational techniques of oral propranolol therapy for infantile haemangioma in which aggressive therapeutic intervention is desirable. The Journal of Japanese Dermatology Association. 2023;133(2):195-203$$$I$F$Y$$$20240711$$HP$JP$JP
226201612$22620161$2$F$$20230512$20230620$20240711$PER$$JP-PFM-2023-02158$PIERRE FABRE MEDICAMENT$Nakasute K. New dermatology seminarium treatment of haemangioma, vascular malformation, and varicose veins of lower extremities from experts 1 Operational techniques of oral propranolol therapy for infantile haemangioma in which aggressive therapeutic intervention is desirable. The Journal of Japanese Dermatology Association. 2023;133(2):195-203$$$I$F$Y$$$20240711$$HP$JP$JP
226201652$22620165$2$F$$20230407$20230620$20240711$PER$$JP-PFM-2023-02243$PIERRE FABRE MEDICAMENT$Kuwabara K. Long-term follow-up of infantile hemangioma cases treated with oral propranolol. The 66th Annual Meeting of the Japan Society. 2023;195$$$I$$Y$$$20240711$$HP$JP$JP
226201662$22620166$2$F$$20230410$20230620$20240711$PER$$JP-PFM-2023-02238$PIERRE FABRE MEDICAMENT$Kubota K, Inai K, Shimada E, Shinohara T. ?/?- and ?-blocker exposure in pregnancy and the risk of neonatal hypoglycemia and small for gestational age. Circulation Journal. 2023;87:569-77$$$$F$Y$$$20240711$$MD$JP$JP
226201672$22620167$2$F$$20230410$20230620$20240711$PER$$JP-PFM-2023-02237$PIERRE FABRE MEDICAMENT$Kubota K, Inai K, Shimada E, Shinohara T. ?/?- and ?-blocker exposure in pregnancy and the risk of neonatal hypoglycemia and small for gestational age. Circulation Journal. 2023;87:569-77$$$$F$Y$$$20240711$$MD$JP$JP
226201682$22620168$2$F$20180101$20230413$20230620$20240711$PER$$TR-PFM-2023-02278$PIERRE FABRE MEDICAMENT$Unler M, Tamdemir SE, Ertek IE, Arikan Z. Clozapine-Induced Obsessive-Compulsive Symptoms and Augmentation with Clonazepam: Risks and Rationales. Turkish Journal of Psychiatry. 2023;34(1):60-4$36$YR$$M$Y$$$20240711$$MD$TR$TR
226201692$22620169$2$F$$20230417$20230620$20240711$PER$$DE-PFM-2023-02376$PIERRE FABRE MEDICAMENT$M Telishevska, S Lengauer, M Schwendt, I Deisenhofer, G Hessling. Radiofrequency ablation of an unusual focal atrial tachycardia. Thorac Cardiovasc Surgery. 2023;71:73-106$$$$F$Y$$$20240711$$HP$DE$DE
226201702$22620170$2$F$$20230419$20230620$20240711$PER$$ES-PFM-2023-02233$PIERRE FABRE MEDICAMENT$Pesque D, Pujol R, Arnau A. Reply to ^A rare case of adrenergic urticaria in a child^ by Schnebert  et al. J Eur Acad Dermatol Venereol. 2023;37:229-30$16$YR$$M$Y$$$20240711$$HP$ES$ES
226201712$22620171$2$F$$20230624$20230620$20240711$PER$$BE-PFM-2023-02401$PIERRE FABRE MEDICAMENT$Boogers A, Bogaert TV, Peeters J, Kilic U, Sunaert S, Vandenberghe W et al. Aligning dentato-rubro-thalamic tract and subthalamic nucleus targets in a patient with comorbid essential tremor and parkinson^s disease: case report. Stereotact Funct Neurosurg. 2022;100(5-6):340-45$70$YR$$M$Y$$$20240711$$HP$BE$BE
226202132$22620213$2$F$$20230612$20230620$20240711$PER$$US-PFM-2023-02247$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.689$KG$20240711$$CN$US$US
226202784$22620278$4$F$$20240902$20230620$20240912$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02082$HIKMA$$$$$F$Y$$$20240912$$HP$CA$CA
226204192$22620419$2$F$$20240726$20230620$20240806$PER$$US-SA-2023SA186823$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
226205272$22620527$2$F$$20230613$20230620$20240912$EXP$$US-MYLANLABS-2023M1063691$MYLAN$$82$YR$$M$Y$74.83$KG$20240912$$CN$US$US
226205445$22620544$5$F$$20240912$20230620$20240916$PER$$US-PFIZER INC-PV202300105252$PFIZER$$44$YR$$F$Y$$$20240916$$CN$US$US
226205812$22620581$2$F$20220221$20240917$20230620$20240921$EXP$$FR-ABBVIE-22K-056-4420078-00$ABBVIE$$59$YR$$M$Y$99$KG$20240921$$MD$FR$FR
226205824$22620582$4$F$$20240626$20230620$20240703$EXP$$CA-OTSUKA-2023_015809$OTSUKA$$21$YR$$M$Y$$$20240703$$MD$CA$CA
226205962$22620596$2$F$20240101$20240628$20230620$20240712$PER$$US-SA-2023SA185556$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240712$$MD$US$US
226206014$22620601$4$F$$20240806$20230620$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04715$LUPIN$$$$$$Y$$$20240828$$CN$US$US
226206062$22620606$2$F$20230101$20240715$20230620$20240723$EXP$$DE-FreseniusKabi-FK202308467$FRESENIUS KABI$$$$$M$Y$$$20240723$$HP$DE$DE
2262062718$22620627$18$F$20230201$20240923$20230620$20240926$EXP$$US-PFIZER INC-PV202300106154$PFIZER$$76$YR$$F$Y$86.18$KG$20240926$$HP$US$US
226206463$22620646$3$F$$20240806$20230620$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04716$LUPIN$$$$$$Y$$$20240827$$CN$US$US
226207632$22620763$2$F$20230418$20240624$20230620$20240701$EXP$$US-MYLANLABS-2023M1063472$MYLAN$$26$YR$$F$Y$$$20240701$$MD$US$US
226209329$22620932$9$F$20230201$20240907$20230620$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-012943$JAZZ$$62$YR$$F$Y$$$20240912$$CN$US$US
226210414$22621041$4$F$20220912$20240923$20230620$20240927$EXP$$US-TAKEDA-US201900012$TAKEDA$$68$YR$$F$Y$$$20240927$$MD$US$US
2262105011$22621050$11$F$$20240902$20230620$20240912$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02031$HIKMA$$65$YR$$M$Y$96$KG$20240912$$HP$CA$CA
226210623$22621062$3$F$20230401$20240822$20230620$20240829$PER$$US-PFIZER INC-202300222552$PFIZER$$51$YR$$F$Y$$$20240829$$HP$US$US
226211232$22621123$2$F$$20240905$20230620$20240913$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395331$RANBAXY$Tekin ZE, Gulleroglu NB, Celikel E, Ayd?n F, Kurt T, Tekgoz N, et al. Chronic non-bacterial osteomyelitis in children: Outcomes, quality of life. Pediatr Int. 2022;64:e15351(1-9)$12$YR$$M$Y$$$20240913$$HP$TR$TR
226211322$22621132$2$F$$20240722$20230620$20240726$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395491$RANBAXY$Clarissa A, Fauze M, Adriano F, Maristela A. Covid-19 Infection in a Patient with Crohn?s Disease Under Treatment with Ustekinumab - Case Report. Am J Gastroenterol. 2020;115(Suppl):S5(Abs ID: P019)$44$YR$$$Y$$$20240727$$HP$BR$BR
226211562$22621156$2$F$$20240701$20230620$20240702$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395325$RANBAXY$Tekin ZE, Gulleroglu NB, Celikel E, Ayd?n F, Kurt T, Tekgoz N, et al. Chronic non-bacterial osteomyelitis in children: Outcomes, quality of life. Pediatr Int. 2022;64:e15351(1-9)$17$YR$$F$Y$$$20240702$$HP$TR$TR
226211612$22621161$2$F$$20240905$20230620$20240913$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395340$RANBAXY$Ekici Tekin Z, Gulleroglu NB, Celikel E, Aydin F, Kurt T, Tekgoz N, et al. Chronic non-bacterial osteomyelitis in children: Outcomes, quality of life. Pediatr Int. 2022;64:e15351$15$YR$$F$Y$$$20240913$$HP$TR$TR
226211902$22621190$2$F$20230501$20240717$20230620$20240718$PER$$US-PFIZER INC-202300223570$PFIZER$$62$YR$$F$Y$$$20240718$$HP$US$US
226212384$22621238$4$F$$20240711$20230620$20240716$EXP$$CA-PFIZER INC-202200044553$PFIZER$$42$YR$$F$Y$$$20240716$$MD$CA$CA
226213288$22621328$8$F$20230221$20240805$20230620$20240809$EXP$$IN-PFIZER INC-PV202300036678$PFIZER$$64$YR$$M$Y$73.2$KG$20240809$$CN$IN$IN
226213713$22621371$3$F$20230510$20240808$20230620$20240823$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2023-14760$IPSEN$$51$YR$A$F$Y$$$20240823$$CN$GB$GB
226214046$22621404$6$F$20160101$20240725$20230620$20240730$EXP$$AU-PFIZER INC-202300225185$PFIZER$Lilburn, P.. A hole lot of trouble: Severe bilateral anastomotic dehiscence following bilateral single sequential lung transplant. Respirology Case Reports. 2023;11(6):e01164$22$YR$$F$Y$$$20240730$$MD$AU$AU
226214584$22621458$4$F$$20230711$20230620$20240926$EXP$$US-GSK-US2023AMR082136$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
226216427$22621642$7$F$$20240829$20230620$20240904$PER$$US-PFIZER INC-US-GBT-018735$PFIZER$$47$YR$$M$Y$73$KG$20240904$$CN$US$US
226217313$22621731$3$F$$20240808$20230620$20240812$EXP$$US-GSK-US2023083143$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$MD$US$US
226218064$22621806$4$F$20220615$20240621$20230620$20240709$EXP$$CA-ROCHE-3122807$ROCHE$$40$YR$A$F$Y$$$20240705$$CN$CA$CA
2262195912$22621959$12$F$20230401$20240708$20230620$20240711$PER$$US-ALXN-A202308001$ALEXION PHARMACEUTICALS$$24$YR$$F$Y$$$20240711$$MD$US$US
226220794$22622079$4$F$20230509$20240809$20230620$20240816$EXP$$CN-TAKEDA-2023TUS059317$TAKEDA$$33$YR$$M$Y$65$KG$20240816$$MD$CN$CN
226220815$22622081$5$F$$20240822$20230620$20240827$EXP$$US-PFIZER INC-PV202300107108$PFIZER$$90$YR$$F$Y$$$20240827$$CN$US$US
226222233$22622223$3$F$20230101$20240904$20230620$20240913$PER$$US-SA-2023SA185438$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240914$$MD$US$US
226222903$22622290$3$F$20230101$20240906$20230620$20240911$EXP$$US-BIOGEN-2023BI01211035$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
226223913$22622391$3$F$$20240717$20230620$20240724$EXP$$US-ABBVIE-5297388$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
226225344$22622534$4$F$20221111$20221114$20230621$20240722$PER$$US-ASTELLAS-2022US040616$ASTELLAS$$82$YR$$M$Y$$$20240722$$MD$US$US
226225423$22622542$3$F$$20230504$20230621$20240722$PER$$US-ASTELLAS-2023US014169$ASTELLAS$$87$YR$$F$Y$$$20240722$$HP$US$US
226225433$22622543$3$F$$20230403$20230621$20240722$PER$$US-ASTELLAS-2023US010980$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226225483$22622548$3$F$$20230301$20230621$20240722$PER$$US-ASTELLAS-2023US007461$ASTELLAS$$8$YR$$M$Y$$$20240722$$MD$US$US
226225892$22622589$2$F$20230101$20240722$20230621$20240731$EXP$$US-ROCHE-3366551$ROCHE$$55$YR$A$F$Y$70.31$KG$20240731$$CN$US$US
226227754$22622775$4$F$20230427$20240906$20230621$20240911$EXP$$CA-JNJFOC-20230464806$JOHNSON AND JOHNSON$$14$YR$T$M$Y$59$KG$20240911$$HP$CA$CA
226229684$22622968$4$F$20240506$20240730$20230621$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-086930$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240731$$CN$US$US
226231293$22623129$3$F$$20240618$20230621$20240701$EXP$$CA-INTERCEPT-PM2023000951$INTERCEPT PHARMACEUTICALS$$79$YR$$F$Y$$$20240701$$CN$CA$CA
226232472$22623247$2$F$$20240830$20230621$20240907$EXP$$CA-CELLTRION INC.-2022CA001076$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
226232495$22623249$5$F$20230616$20240619$20230621$20240709$EXP$$CA-ROCHE-3371537$ROCHE$$27$YR$A$F$Y$$$20240703$$CN$CA$CA
226233252$22623325$2$F$20230501$20240819$20230621$20240822$EXP$$CA-ABBVIE-5298015$ABBVIE$$70$YR$$F$Y$$$20240822$$CN$CA$CA
226234025$22623402$5$F$20230101$20240829$20230621$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-087284$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$54.43$KG$20240903$$CN$US$US
226234106$22623410$6$F$20221201$20240920$20230621$20240927$EXP$$US-TAKEDA-2023TUS037171$TAKEDA$$73$YR$$F$Y$78$KG$20240927$$CN$US$US
226236592$22623659$2$F$20230101$20240904$20230621$20240925$PER$$US-SA-2023SA187674$SANOFI AVENTIS$$91$YR$E$F$Y$77.1$KG$20240925$$MD$US$US
226236813$22623681$3$F$20230101$20240719$20230621$20240726$PER$$US-SA-2023SA188448$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240726$$CN$US$US
226236822$22623682$2$F$20230410$20240625$20230621$20240704$PER$$US-SA-2023SA186904$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240704$$MD$US$US
226237244$22623724$4$F$$20240718$20230621$20240728$PER$$US-SA-2023SA188576$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240728$$MD$US$US
226238584$22623858$4$F$20230201$20240712$20230621$20240723$EXP$$CA-ROCHE-3364363$ROCHE$$71$YR$E$F$Y$$$20240723$$CN$CA$CA
226240674$22624067$4$F$20230614$20240903$20230621$20240910$EXP$$US-GSK-US2023083899$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
226241566$22624156$6$F$$20240808$20230621$20240814$EXP$$FR-MYLANLABS-2023M1063553$MYLAN$Delbet J-D, Hogan J, Parmentier C, Ulinski T and Dossier C. Successful global anti-B-cell strategy with daratumumab in a patient with post-transplant nephrotic syndrome recurrence unresponsive to immunoadsorption and obinutuzumab.. Pediatr-Transplant. 2023;27 (5):E14544$2$YR$$F$Y$$$20240814$$HP$FR$FR
226241634$22624163$4$F$$20240911$20230621$20240916$30DAY$$US-PFIZER INC-202300225218$PFIZER$$14$YR$$M$Y$$$20240916$$CN$US$US
226243905$22624390$5$F$20230612$20240702$20230621$20240705$EXP$$US-TAKEDA-2023TUS060461$TAKEDA$$35$YR$$F$Y$68$KG$20240705$$CN$US$US
226244952$22624495$2$F$$20240809$20230621$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04752$LUPIN$$$$$$Y$$$20240828$$CN$US$US
226245423$22624542$3$F$$20240806$20230621$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04756$LUPIN$$$$$$Y$$$20240828$$CN$US$US
226246286$22624628$6$F$20231219$20240722$20230621$20240726$EXP$$CA-TAKEDA-2023TUS043864$TAKEDA$$73$YR$$M$Y$$$20240726$$CN$CA$CA
2262464911$22624649$11$F$20220712$20240903$20230621$20240906$EXP$$GB-MYLANLABS-2022M1078399$MYLAN$$63$YR$$M$Y$$$20240906$$MD$GB$GB
226247215$22624721$5$F$$20240917$20230621$20240920$EXP$$CA-PFIZER INC-2020243389$PFIZER$$50$YR$$F$Y$$$20240920$$HP$CA$CA
226247303$22624730$3$F$$20240731$20230621$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04754$LUPIN$$$$$$Y$$$20240818$$CN$US$US
226248838$22624883$8$F$$20240829$20230621$20240904$EXP$$KR-PFIZER INC-PV202300106338$PFIZER$$66$YR$$F$Y$$$20240904$$CN$KR$KR
226249018$22624901$8$F$20230201$20240724$20230621$20240729$EXP$$IN-PFIZER INC-PV202300105367$PFIZER$$72$YR$$F$Y$$$20240729$$CN$IN$IN
226249034$22624903$4$F$20210923$20240704$20230621$20240708$EXP$$CA-PFIZER INC-202101265372$PFIZER$$62$YR$$F$Y$50.8$KG$20240708$$HP$CA$CA
226250152$22625015$2$F$$20230614$20230621$20240703$EXP$$FR-JNJFOC-20230638251$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240703$$MD$FR$FR
226250759$22625075$9$F$20230225$20240725$20230621$20240729$EXP$$IN-PFIZER INC-PV202300108059$PFIZER$$54$YR$$F$Y$64$KG$20240729$$CN$IN$IN
226251234$22625123$4$F$20221115$20240815$20230621$20240821$PER$$US-PFIZER INC-PV202300107046$PFIZER$$52$YR$$F$Y$$$20240821$$CN$US$US
226251533$22625153$3$F$20230501$20240703$20230621$20240718$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000187$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
226251543$22625154$3$F$20221006$20240807$20230621$20240909$EXP$$US-THERATECHNOLOGIES INC.-2022-THE-TES-000313$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
226251713$22625171$3$F$$20240820$20230621$20240826$PER$$US-PFIZER INC-202300208504$PFIZER$$46$YR$$F$Y$56.25$KG$20240826$$CN$US$US
226252067$22625206$7$F$$20240916$20230621$20240919$EXP$$CA-BAYER-2023A083437$BAYER$$43$YR$A$F$Y$68$KG$20240919$$HP$CA$CA
226253478$22625347$8$F$20220101$20240904$20230621$20240906$PER$$US-PFIZER INC-PV202300107088$PFIZER$$56$YR$$M$Y$81.633$KG$20240906$$CN$US$US
226253492$22625349$2$F$20230314$20240804$20230621$20240812$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-394728$RANBAXY$$77$YR$$M$Y$$$20240812$$MD$ES$ES
2262535512$22625355$12$F$20230501$20240705$20230621$20240709$EXP$$US-PFIZER INC-202300222886$PFIZER$$72$YR$$M$Y$$$20240709$$CN$US$US
226253583$22625358$3$F$20220511$20240620$20230621$20240702$EXP$$FR-TAKEDA-2023TUS060048$TAKEDA$$33$YR$$F$Y$41$KG$20240702$$CN$FR$FR
226253772$22625377$2$F$20220106$20240806$20230621$20240812$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-394910$RANBAXY$$14$YR$$F$Y$65$KG$20240812$$PH$FR$FR
226254072$22625407$2$F$$20240619$20230621$20240704$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395496$RANBAXY$Bhatt H, Regan W, Rosenthal E, Bellsham-Revell H. Flecainide toxicity: ECG changes associated with supratherapeutic levels in milk-fed infants. BMJ Case Rep. 2023;16(2):e252823$$$I$M$Y$$$20240704$$HP$GB$GB
226254192$22625419$2$F$$20240716$20230621$20240731$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395604$RANBAXY$Yu Y, Ding X, Guo F, Ze K, Sun X, Li X. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors and baricitinib: A case report and literature review. Front Med. 2023;10:1132574$15$YR$$M$Y$$$20240731$$HP$CN$CN
226254362$22625436$2$F$$20240715$20230621$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395766$RANBAXY$Alamon-Reig F, Serra-Garcia L, Bosch-Amate X, Riquelme-Mc Loughlin C, Mascaro Jr JM. Dupilumab in Hailey-Hailey disease: a case series. JEADV. 2022;36:e776-e779$25$YR$$F$Y$$$20240718$$HP$ES$ES
226254392$22625439$2$F$$20240828$20230621$20240904$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395756$RANBAXY$Eriksson V, Eriksson E, Sherif A. Thromboembolic events during neoadjuvant chemotherapy in muscle invasive bladder cancer ? any correlation to the central venous access? A clinical practice article [version 1; peer review: 1 approved with reservations]. F1000Res. 2022;11(40):1-7$71$YR$$M$Y$$$20240904$$HP$SE$SE
226254612$22625461$2$F$$20240715$20230621$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395762$RANBAXY$Alamon-Reig F, Serra-Garcia L, Bosch-Amate X, Riquelme-Mc Loughlin C, Mascaro Jr JM. Dupilumab in Hailey-Hailey disease: a case series. JEADV. 2022;36:e776-e779$56$YR$$F$Y$$$20240718$$HP$ES$ES
226255112$22625511$2$F$$20240716$20230621$20240718$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395334$RANBAXY$Ding J, Yang L, Zhang Y, Meng Z, Ren J, Zhang S et al. Usefulness of Therapeutic Drug Monitoring and Pharmacogenetics for a Patient Treated with Olanzapine, Buspirone, and Fluvoxamine: A Case Study. Ther Drug Monit. 2023$50$YR$$M$Y$$$20240718$$MD$CN$CN
226255362$22625536$2$F$$20240905$20230621$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395571$RANBAXY$Yang J, Li J, Shi L. Successful remission with tofacitinib in a patient with refractory bullous systemic lupus erythematosus. Rheumatology. 2022;61:e341-e343$33$YR$$F$Y$$$20240913$$HP$CN$CN
226255442$22625544$2$F$$20240905$20230621$20240913$EXP$$EG-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395877$RANBAXY$Zoheir MGT, Almohsen AM, Amer MAEM, Abdel-Hameed AKS. Intralesional full-concentration (25 mg/ml) methotrexate in the treatment of plantar warts: A pilot study. Dermatol Ther. 2022;35:e15815$$$A$$Y$$$20240913$$HP$EG$EG
226255743$22625574$3$F$20230101$20240918$20230621$20240920$EXP$$US-PFIZER INC-PV202300066150$PFIZER$$80$YR$$F$Y$75.75$KG$20240920$$CN$US$US
2262568912$22625689$12$F$$20240920$20230621$20240926$EXP$$US-TAKEDA-2021TUS053993$TAKEDA$$$$$F$Y$115$KG$20240926$$HP$US$US
226257824$22625782$4$F$20230801$20240813$20230621$20240821$PER$$US-SA-2023SA187859$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240821$$MD$US$US
226258305$22625830$5$F$$20240617$20230621$20240705$EXP$$CA-ABBVIE-5299251$ABBVIE$$42$YR$$M$Y$$$20240705$$CN$CA$CA
2262588218$22625882$18$F$20230601$20240815$20230621$20240819$EXP$$CA-HLS-202301551$HLS THERAPEUTICS$$71$YR$E$M$Y$$$20240819$$PH$CA$CA
226259103$22625910$3$F$20030101$20240704$20230621$20240708$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202306012228$ELI LILLY AND CO$$65$YR$E$M$Y$70$KG$20240708$$CN$CN$CN
226259925$22625992$5$F$20230101$20240805$20230621$20240813$EXP$$US-ABBVIE-5298387$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
226260993$22626099$3$F$20230314$20240913$20230621$20240917$EXP$$US-TAKEDA-2023TUS027404$TAKEDA$$29$YR$$M$Y$$$20240917$$PH$US$US
226262117$22626211$7$F$20220520$20240711$20230621$20240725$EXP$$CA-SAMSUNG BIOEPIS-SB-2022-12771$SAMSUNG BIOEPIS$$75$YR$E$F$Y$80$KG$20240725$$HP$CA$CA
226262842$22626284$2$F$$20240905$20230621$20240917$PER$$US-Calliditas-2023CAL00770$CALLIDITAS THERAPEUTICS$$11$YR$C$F$Y$$$20240917$$CN$US$US
226263187$22626318$7$F$20221205$20240722$20230621$20240723$EXP$$ES-ROCHE-3373347$ROCHE$$49$YR$A$M$Y$$$20240723$$MD$ES$ES
226264333$22626433$3$F$$20240830$20230621$20240906$EXP$$PL-REGENERON PHARMACEUTICALS, INC.-2023-079851$REGENERON$Zukowska P, Ciepiela K, Kudrymska A, Kie?bowski K, Becht R.. Successful Treatment of Cutaneous Squamous Cell Cancer with Cemiplimab-A Report of Two Cases Demonstrating the Management of Pseudoprogression and Adverse Events.. J Clin Med. 2024;13(14):4236$80$YR$$F$Y$$$20240906$$MD$PL$PL
226264723$22626472$3$F$$20240706$20230621$20240716$PER$$US-SA-2023SA187704$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240716$$CN$US$US
226264747$22626474$7$F$20230601$20240829$20230621$20240909$PER$$US-INCYTE CORPORATION-2023IN006310$INCYTE$$$$$$Y$$$20240909$$CN$US$US
226265032$22626503$2$F$$20240719$20230621$20240731$PER$$US-SA-2023SA188821$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240731$$MD$US$US
226267022$22626702$2$F$20230101$20240905$20230622$20240913$EXP$$CA-CELLTRION INC.-2023CA008722$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
226268123$22626812$3$F$$20230710$20230622$20240710$PER$$PT-ROCHE-3370750$ROCHE$Costa R, Silva J, Pinto R, Fernandes R, Gaspar C, Bordalo J  and Pereira D De novo heart failure: one heart, two culprits. (Abstract number 452). 29th National Conference of Internal medicine ;:462-.$40$YR$A$F$Y$$$20240628$$HP$PT$PT
226268335$22626833$5$F$20210516$20240714$20230622$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000543$DECIPHERA PHARMACEUTICALS$$66$YR$A$M$Y$$$20240731$$CN$US$US
226272167$22627216$7$F$20230613$20230713$20230622$20240925$EXP$$US-GSK-US2023AMR085352$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
226272185$22627218$5$F$20230401$20240803$20230622$20240813$EXP$$US-HETERO-HET2023US01598$HETERO$$67$YR$$F$Y$$$20240813$$CN$US$US
226273794$22627379$4$F$$20240731$20230622$20240806$EXP$$US-ABBVIE-5298632$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
226274306$22627430$6$F$$20240910$20230622$20240916$PER$$US-PHARMING-PHAUS2023000446$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
226274874$22627487$4$F$20220726$20240909$20230622$20240920$EXP$$DE-AUROBINDO-AUR-APL-2023-009842$AUROBINDO$$$$E$F$Y$103$KG$20240920$$MD$DE$DE
226275605$22627560$5$F$20230601$20230816$20230622$20240925$PER$$US-GSK-US2023AMR086757$GLAXOSMITHKLINE$$82$YR$$F$Y$63$KG$20240925$$CN$US$US
226275833$22627583$3$F$20230417$20240905$20230622$20240910$EXP$$IT-ABBVIE-5299271$ABBVIE$$70$YR$$F$Y$52$KG$20240910$$HP$IT$IT
226276796$22627679$6$F$$20240703$20230622$20240705$EXP$$US-UCBSA-2023030835$UCB$$$$$M$Y$117.91$KG$20240705$$HP$US$US
226277255$22627725$5$F$20220101$20240607$20230622$20240709$EXP$IT-UCBSA-2023028465$IT-ROCHE-3373582$ROCHE$Bernardi S, Zorat F, Calabro V, Faustini F, Fabris B. A case of cerebral salt wasting syndrome in a patient with central diabetes insipidus and status epilepticus.. Journal of Endocrinological Investigation.. 2023;46 (6):1275-7. doi:10.1007/s40618-023-02053-z.$27$YR$A$F$Y$144$KG$20240703$$HP$IT$IT
226277334$22627733$4$F$20230620$20240920$20230622$20240930$PER$$US-GSK-US2023086050$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240930$$HP$US$US
2262773413$22627734$13$F$20230710$20240415$20230622$20240925$PER$$US-GSK-US2023AMR086475$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
226277716$22627771$6$F$20180720$20240905$20230622$20240911$EXP$$CA-TAKEDA-2019TUS019408$TAKEDA$$69$YR$$M$Y$$$20240911$$CN$CA$CA
226278165$22627816$5$F$20230619$20240718$20230622$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-013194$JAZZ$$41$YR$$F$Y$$$20240724$$CN$US$US
226278293$22627829$3$F$20220225$20240918$20230622$20240926$EXP$$CA-TAKEDA-2022TUS015863$TAKEDA$$26$YR$$F$Y$$$20240926$$MD$CA$CA
226278685$22627868$5$F$20220310$20240708$20230622$20240722$PER$$US-Ipsen Biopharmaceuticals, Inc.-2023-14255$IPSEN$$90$YR$E$F$Y$86$KG$20240719$$CN$US$US
2262794210$22627942$10$F$20230405$20240816$20230622$20240821$EXP$$CA-TAKEDA-2023TUS060559$TAKEDA$$74$YR$$F$Y$$$20240821$$CN$CA$CA
226280092$22628009$2$F$$20240828$20230622$20240907$EXP$$CA-AUROBINDO-AUR-APL-2023-042638$AUROBINDO$$35$YR$$F$Y$$$20240907$$HP$CA$CA
226280762$22628076$2$F$$20240923$20230622$20240930$EXP$$CA-BIOGEN-2023BI01211782$BIOGEN$$$$$F$Y$$$20240930$$MD$CA$CA
226281513$22628151$3$F$$20231106$20230622$20240930$EXP$$AU-JNJFOC-20230639236$JOHNSON AND JOHNSON$$56$YR$A$F$Y$45$KG$20241001$$CN$AU$AU
226282475$22628247$5$F$$20240108$20230622$20240926$EXP$$US-GSK-US2023AMR086460$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
226284177$22628417$7$F$$20240905$20230622$20240909$EXP$$CA-TAKEDA-2022TUS103834$TAKEDA$$$$$F$Y$$$20240909$$MD$CA$CA
226285759$22628575$9$F$20230101$20240806$20230622$20240813$EXP$$US-SA-2023SA189417$SANOFI AVENTIS$$73$YR$E$F$Y$45$KG$20240813$$MD$US$US
226285794$22628579$4$F$20230501$20240801$20230622$20240807$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-003698$AURINIA PHARMACEUTICALS$$26$YR$$F$Y$48.073$KG$20240807$$CN$US$US
226286435$22628643$5$F$$20240722$20230622$20240725$EXP$$CA-PFIZER INC-202300225233$PFIZER$Sandal, S.. Sequelae of Cryptococcal-Immune Reconstitution Inflammatory Syndrome in a Kidney Transplant Recipient: A Case Report.. Journal of Kidney Health and Disease. 2023;10:1-6$58$YR$$M$Y$$$20240725$$MD$CA$CA
226287092$22628709$2$F$$20240722$20230622$20240731$PER$$US-SA-2023SA187917$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240731$$MD$US$US
226287134$22628713$4$F$20230401$20240711$20230622$20240719$EXP$$JP-AstraZeneca-2023A139412$ASTRAZENECA$$35$YR$$F$Y$50$KG$20240719$$MD$JP$
226288454$22628845$4$F$20211014$20240830$20230622$20240903$EXP$$US-TAKEDA-2022TUS031880$TAKEDA$$47$YR$$F$Y$74$KG$20240903$$CN$US$US
226289432$22628943$2$F$$20240830$20230622$20240910$EXP$$US-SA-2023SA190498$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240910$$MD$US$US
226289502$22628950$2$F$$20240704$20230622$20240716$EXP$$GB-Orion Corporation ORION PHARMA-23_00024262$ORION$Koksa K, Acres R. Disseminated Mucormycosis in a patient on long term immunosuppression: Severe fungal infections as multi-system disorders. J-Intens-Care-Soc. 2023;24 (1 SUPPL):43-4.$5$DEC$A$F$Y$$$20240716$$MD$GB$
226290554$22629055$4$F$20230201$20240827$20230622$20240917$PER$$CA-TOLMAR, INC.-23CA041309$TOLMAR$$75$YR$$M$Y$$$20240917$$CN$CA$CA
226292733$22629273$3$F$$20230613$20230622$20240808$EXP$$US-OTSUKA-2023_016004$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
226293666$22629366$6$F$20210506$20240812$20230622$20240815$EXP$$IT-TAKEDA-2021TUS030155$TAKEDA$$5$YR$$M$Y$$$20240815$$MD$IT$IT
226295046$22629504$6$F$20210212$20240707$20230622$20240710$EXP$$IN-PFIZER INC-2021464592$PFIZER$$75$YR$$F$Y$$$20240710$$CN$IN$IN
226295422$22629542$2$F$$20230613$20230622$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202306010798$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
226295634$22629563$4$F$$20240806$20230622$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04787$LUPIN$$$$$$Y$$$20240828$$CN$US$US
226296253$22629625$3$F$20220818$20240725$20230622$20240731$EXP$$DE-ROCHE-3167443$ROCHE$$32$YR$A$F$Y$$$20240731$$CN$DE$DE
226297772$22629777$2$F$$20240912$20230622$20240927$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395269$RANBAXY$Bar-Ilan E, Ollech A, Baum S, Barzilai A, Greenberger S.. Adolescent with concomitant atopic dermatitis and alopecia areata successfully treated with upadacitinib-Case report and review of the literature. Pediatr Dermatol. 2023;40(Suppl. 2)74:P162$14$YR$$M$Y$$$20240927$$HP$IL$IL
226297803$22629780$3$F$$20240912$20230622$20240927$EXP$$HK-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395793$RANBAXY$Chow T-K. Hepatic Superscan in Methotrexate-Associated Lymphoproliferative Disorder. Clin Nucl Med. 2023;48(6):534-535$60$YR$$M$Y$$$20240927$$HP$HK$HK
226297812$22629781$2$F$$20240702$20230622$20240717$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-395450$RANBAXY$Gireada B, Chirita V, Chirita R, Dobrin I. Young-onset dementia. New insights and a case report. Bulletin of Integrative Psychiatry/Buletin de Psihiatrie Integrativa. 2023;2:121-127$55$YR$$M$Y$$$20240717$$MD$RO$RO
226298062$22629806$2$F$$20240703$20230622$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388264$RANBAXY$$$$E$M$Y$$$20240703$$CN$US$US
226298082$22629808$2$F$$20240905$20230622$20240909$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396106$RANBAXY$Mazereeuw-hautier J, Denos C, Severino-Freire M. Cardio-facio-cutanoeus syndrome: Major skin improvement with Dupilumab. Pediatr Dermatol. 2023;40(suppl 2):38(Abs P069)$$$$F$Y$$$20240909$$HP$FR$ES
226298242$22629824$2$F$$20240716$20230622$20240731$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395595$RANBAXY$Topkarci Z, Erdogan B, Ozler EN. What^s happening on the follicular unit of adolescents after the COVID-19 pandemic: Severe acne is a growing problem of nowadays. Pediatr Dermatol. 2023;40 (Suppl. 2):56(P114)$$$T$M$Y$$$20240731$$HP$TR$TR
226298253$22629825$3$F$$20240718$20230622$20240726$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396064$RANBAXY$Miura K, Takahashi H, Nakagawa M, Hamada T, Uchino Y, Iizuka K, et al. Ideal dose intensity of R-CHOP in diffuse large Bcell lymphoma. Expert Rev Anticancer Ther. 2022;22(6):583-595$56$YR$$F$Y$$$20240727$$HP$JP$JP
226302286$22630228$6$F$20230101$20240730$20230622$20240802$PER$$US-AMGEN-USASP2023107615$AMGEN$$34$YR$A$F$Y$$$20240802$$HP$US$US
226302732$22630273$2$F$$20240726$20230622$20240731$EXP$$CA-TAKEDA-2022TUS059606$TAKEDA$$$$$F$Y$$$20240731$$CN$CA$CA
226304553$22630455$3$F$20240318$20240827$20230622$20240828$EXP$$US-TAKEDA-2023TUS060673$TAKEDA$$41$YR$$M$Y$$$20240828$$HP$US$US
226305626$22630562$6$F$20230101$20240802$20230622$20240807$EXP$$CA-BAUSCH-BL-2023-009529$BAUSCH AND LOMB$$20$YR$$F$Y$$$20240807$$CN$CA$CA
226305774$22630577$4$F$$20240627$20230622$20240702$PER$$US-PFIZER INC-PV202300106623$PFIZER$$58$YR$$F$Y$$$20240702$$MD$US$US
226307432$22630743$2$F$$20230606$20230622$20240703$PER$$US-GALDERMA-US2023008942$GALDERMA$$$$$$Y$$$20240703$$CN$US$US
2263086025$22630860$25$F$20240101$20240920$20230622$20240930$EXP$$US-TAKEDA-2023TUS058339$TAKEDA$$84$YR$$F$Y$50$KG$20240930$$HP$US$US
226309007$22630900$7$F$20220101$20240823$20230622$20240828$EXP$$PL-009507513-2306POL010093$MERCK$$$$E$M$Y$$$20240828$$MD$PL$PL
226310548$22631054$8$F$20230523$20240703$20230622$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002110$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240712$$CN$US$US
226310563$22631056$3$F$$20240820$20230622$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002137$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
226311458$22631145$8$F$$20240611$20230623$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002157$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
226313412$22631341$2$F$20230619$20230619$20230623$20240905$PER$$NVSC2023US140961$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
226313745$22631374$5$F$20230517$20240806$20230623$20240816$EXP$$NVSC2023GB138942$NOVARTIS$$76$YR$$M$Y$90$KG$20240816$$MD$GB$GB
226315359$22631535$9$F$20230614$20240920$20230623$20240924$EXP$$NVSC2023US137803$NOVARTIS$$66$YR$$F$Y$$$20240924$$CN$US$US
226315675$22631567$5$F$20230601$20240820$20230623$20240823$EXP$$US-ABBVIE-5300389$ABBVIE$$76$YR$$F$Y$$$20240823$$CN$US$US
226317275$22631727$5$F$$20240712$20230623$20240716$PER$$NVSC2023US141532$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
226317319$22631731$9$F$20231201$20240816$20230623$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-088033$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240826$$CN$US$US
226317608$22631760$8$F$20230615$20240821$20230623$20240828$EXP$$NVSC2023US139625$NOVARTIS$$51$YR$$F$Y$$$20240828$$CN$US$US
226317872$22631787$2$F$$20240718$20230623$20240725$EXP$$NVSC2023IN139457$NOVARTIS$R C, Malik PS, Sahoo RK, Sharawat S, Singh M, Garg V et al.. Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution. ANNALS OF HEMATOLOGY. 2023;1-10$22$YR$$F$Y$$$20240725$$HP$IN$IN
226318352$22631835$2$F$$20230616$20230623$20240925$EXP$$NVSC2023US139432$NOVARTIS$$86$YR$$F$Y$$$20240925$$CN$US$US
226319232$22631923$2$F$$20240806$20230623$20240812$EXP$$NVSC2023GB139991$NOVARTIS$$$$$M$Y$$$20240812$$HP$GB$GB
226321102$22632110$2$F$$20240918$20230623$20240930$EXP$$NVSC2023US142858$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
226322454$22632245$4$F$20230509$20240730$20230623$20240808$30DAY$$US-GSK-US2023084518$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240808$$CN$US$US
226323354$22632335$4$F$20230101$20240722$20230623$20240726$EXP$$US-SA-2023SA187568$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240726$$CN$US$US
226324424$22632442$4$F$$20240429$20230623$20240814$EXP$$NVSC2023CA140675$NOVARTIS$$44$YR$$F$Y$$$20240814$$MD$CA$CA
226324444$22632444$4$F$$20230807$20230623$20240925$PER$$NVSC2023US142148$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
226325083$22632508$3$F$20230604$20240709$20230623$20240715$EXP$$NVSJ2023JP009919$NOVARTIS$$82$YR$$F$Y$$$20240716$$MD$JP$JP
226325493$22632549$3$F$20230614$20230627$20230623$20240925$PER$$US-GSK-US2023AMR086478$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
226325815$22632581$5$F$20220101$20240726$20230623$20240805$EXP$$AU-CELLTRION INC.-2023AU012709$CELLTRION$$$$$$Y$$$20240805$$MD$AU$AU
226328493$22632849$3$F$$20240820$20230623$20240904$EXP$$ES-Accord-363092$ACCORD$Rabadan-Marquez P, Bautista-Vidal C, Espana-Navarro R. Kidney transplant with Scedosporium apiospermun infection: case report and literature review. Revista Mexicana de Urologia. 2022;82(4).$53$YR$A$F$Y$$$20240903$$MD$ES$ES
2263332413$22633324$13$F$20230101$20240919$20230623$20240924$EXP$$CA-PFIZER INC-202300168765$PFIZER$$72$YR$$F$Y$$$20240924$$HP$CA$CA
2263351810$22633518$10$F$20230501$20240723$20230623$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-086974$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240724$$CN$US$US
226336195$22633619$5$F$$20240828$20230623$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-022450$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240904$$MD$JP$JP
226336912$22633691$2$F$20230301$20240705$20230623$20240715$EXP$$DE-AUROBINDO-AUR-APL-2023-043125$AUROBINDO$$61$YR$$M$Y$72$KG$20240715$$MD$DE$DE
226337137$22633713$7$F$20231024$20240830$20230623$20240909$EXP$$CA-TAKEDA-2023TUS061526$TAKEDA$$59$YR$$F$Y$$$20240909$$CN$CA$CA
226338493$22633849$3$F$$20240820$20230623$20240830$30DAY$$US-GSK-US2023083180$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$MD$US$US
226339374$22633937$4$F$20210727$20240715$20230623$20240718$EXP$$CA-TAKEDA-2023TUS061028$TAKEDA$$73$YR$$F$Y$$$20240718$$CN$CA$CA
226339635$22633963$5$F$20240216$20240816$20230623$20240831$EXP$$CA-SAMSUNG BIOEPIS-SB-2023-16555$SAMSUNG BIOEPIS$$64$YR$A$M$Y$$$20240831$$CN$CA$CA
226340772$22634077$2$F$$20240830$20230623$20240909$30DAY$$US-GSK-US2023AMR084580$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$CN$US$US
226341338$22634133$8$F$$20240731$20230623$20240805$PER$$US-PFIZER INC-PV202300107149$PFIZER$$62$YR$$F$Y$82.086$KG$20240805$$CN$US$US
226341432$22634143$2$F$$20240820$20230623$20240822$PER$$US-PFIZER INC-PV202300106836$PFIZER$$67$YR$$F$Y$$$20240822$$CN$US$US
226341454$22634145$4$F$20230101$20240705$20230623$20240709$PER$$US-PFIZER INC-202300224463$PFIZER$$17$YR$$F$Y$45.36$KG$20240709$$CN$US$US
226341464$22634146$4$F$20230401$20240806$20230623$20240807$PER$$US-PFIZER INC-PV202300057746$PFIZER$$68$YR$$F$Y$$$20240807$$CN$US$US
226342613$22634261$3$F$$20240919$20230623$20240926$EXP$$FR-JNJFOC-20230648432$JOHNSON AND JOHNSON$$57$YR$A$M$Y$78$KG$20240926$$PH$FR$FR
226343394$22634339$4$F$20230101$20240830$20230623$20240904$PER$$US-PFIZER INC-2021248987$PFIZER$$66$YR$$F$Y$$$20240904$$CN$US$US
226343408$22634340$8$F$20220101$20240816$20230623$20240821$PER$$US-PFIZER INC-PV202300049763$PFIZER$$89$YR$$F$Y$$$20240821$$MD$US$US
226343993$22634399$3$F$$20240715$20230623$20240722$EXP$$US-ROCHE-3371839$ROCHE$$81$YR$E$F$Y$$$20240719$$CN$US$US
2263440715$22634407$15$F$20230101$20240915$20230623$20240916$EXP$$CA-PFIZER INC-202300159728$PFIZER$$54$YR$$F$Y$$$20240916$$MD$CA$CA
226345055$22634505$5$F$20230612$20240717$20230623$20240718$30DAY$$DE-PFIZER INC-PV202300105550$PFIZER$$$$$F$Y$$$20240718$$PH$DE$DE
226345104$22634510$4$F$20230531$20240822$20230623$20240917$PER$$CA-TOLMAR, INC.-23CA041241$TOLMAR$$90$YR$$M$Y$$$20240917$$CN$CA$CA
226345155$22634515$5$F$20230602$20240819$20230623$20240912$PER$$CA-TOLMAR, INC.-23CA041260$TOLMAR$$77$YR$$M$Y$$$20240912$$CN$CA$CA
226345196$22634519$6$F$20230601$20240827$20230623$20240917$PER$$CA-TOLMAR, INC.-23CA041262$TOLMAR$$79$YR$$M$Y$$$20240917$$CN$CA$CA
226345252$22634525$2$F$20230619$20240709$20230623$20240711$EXP$$US-UCBSA-2023031487$UCB$$32$YR$$F$Y$$$20240711$$CN$US$US
226345672$22634567$2$F$20230401$20240710$20230623$20240711$EXP$$NVSC2023EG139163$NOVARTIS$$43$YR$$F$Y$$$20240711$$CN$EG$EG
226347026$22634702$6$F$20230524$20240705$20230623$20240716$EXP$$ES-TEVA-2023-ES-2898952$TEVA$$60$YR$$F$Y$59.1$KG$20240716$$HP$ES$ES
226348755$22634875$5$F$20211001$20240628$20230623$20240707$PER$$US-SA-2023SA190938$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240708$$MD$US$US
226348922$22634892$2$F$$20240730$20230623$20240807$PER$$US-SA-2023SA191616$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240807$$MD$US$US
226349614$22634961$4$F$20230601$20240720$20230623$20240731$PER$$US-SA-2023SA191772$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240731$$MD$US$US
226349652$22634965$2$F$20240911$20240913$20230623$20240927$PER$$US-SA-2023SA190578$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240927$$CN$US$US
226351032$22635103$2$F$20230525$20240813$20230623$20240826$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-393633$RANBAXY$-. -. -. -;-:-$18$YR$$F$Y$52.4$KG$20240826$$MD$DE$DE
226351262$22635126$2$F$20221001$20240704$20230623$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-395365$RANBAXY$$42$YR$$F$Y$$$20240705$$PH$FR$FR
226351312$22635131$2$F$$20240704$20230623$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-395403$RANBAXY$$51$YR$$F$Y$$$20240705$$PH$FR$FR
226351602$22635160$2$F$20230315$20240728$20230623$20240729$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-395970$RANBAXY$$28$YR$$M$Y$43$KG$20240729$$MD$FR$FR
226351822$22635182$2$F$$20240704$20230623$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396147$RANBAXY$Blaise M, Cardot-Leccia N, Seitz-Polski B, Picard-Gauci A, Bertold C, Passeron T, et al. Tocilizumab for Corticosteroid-Refractory Immune Checkpoint Inhibitor-Induced Generalized Morphea. JAMA Dermatol. 2023;Jan;159(1):112-114$78$YR$$F$Y$$$20240705$$HP$FR$FR
226351952$22635195$2$F$$20240913$20230623$20240927$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396214$RANBAXY$Qu FJ, Wu S, Kong Y. Oral fruquintinib combined with tegafur-gimeracil-oteracil potassium for advanced colorectal cancer to obtain longer progression-free survival: A case report. World J Gastrointest Oncol. 2023;May 15; 15(5):902-910$58$YR$$M$Y$$$20240927$$HP$CN$CN
226352022$22635202$2$F$$20240806$20230623$20240812$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396078$RANBAXY$Rolfes M, Waubant E, Francisco C. Acute onset visual and auditory hallucinations: An unusual case of pediatric-onset multiple sclerosis. Neuroimmunol Rep. 2021;1:1-3$9$YR$$M$Y$$$20240812$$HP$US$US
226353084$22635308$4$F$$20240806$20230623$20240809$EXP$$US-PFIZER INC-202300226600$PFIZER$$65$YR$$M$Y$$$20240809$$HP$US$US
226354214$22635421$4$F$$20240729$20230623$20240801$EXP$$CA-PFIZER INC-202300227671$PFIZER$$52$YR$$F$Y$$$20240801$$HP$CA$CA
226355432$22635543$2$F$20230525$20240715$20230623$20240722$EXP$$DE-MYLANLABS-2023M1064584$BIOCON$$$$$$Y$$$20240722$$MD$DE$DE
226355522$22635552$2$F$20220501$20240914$20230623$20240923$EXP$$GB-ROCHE-3371592$ROCHE$$39$YR$A$F$Y$$$20240923$$MD$GB$GB
226356524$22635652$4$F$20230329$20240717$20230623$20240723$EXP$$JP-ARGENX-2023-ARGX-JP002023$ARGENX BVBA$$$$$$Y$$$20240723$$MD$JP$JP
2263569910$22635699$10$F$20220101$20240625$20230623$20240701$EXP$$CO-AMGEN-COLSL2022109484$AMGEN$$49$YR$A$M$Y$85$KG$20240701$$CN$CO$CO
226363013$22636301$3$F$$20240819$20230623$20240821$PER$$NVSC2023US144036$NOVARTIS$$$$$M$Y$100$KG$20240821$$CN$US$US
226365005$22636500$5$F$$20240911$20230623$20240916$PER$$US-PFIZER INC-202300227136$PFIZER$$86$YR$$F$Y$70.31$KG$20240916$$CN$US$US
226365246$22636524$6$F$20230601$20240626$20230623$20240701$PER$$US-PFIZER INC-202300228519$PFIZER$$66$YR$$F$Y$$$20240701$$HP$US$US
226365485$22636548$5$F$$20240903$20230623$20240905$PER$$US-PFIZER INC-2019510002$PFIZER$$93$YR$$F$Y$68.027$KG$20240905$$CN$US$US
226365617$22636561$7$F$20230101$20240814$20230623$20240816$EXP$$US-PFIZER INC-202300110874$PFIZER$$80$YR$$F$Y$91.63$KG$20240816$$CN$US$US
2263662514$22636625$14$F$20161205$20240904$20230623$20240916$EXP$$NVSC2016CA016546$NOVARTIS$$58$YR$$F$Y$$$20240916$$HP$CA$CA
2263666319$22636663$19$F$20230601$20240918$20230623$20240924$EXP$$US-BEH-2023160238$CSL BEHRING$$45$YR$A$F$Y$72.562$KG$20240924$$HP$US$US
226367992$22636799$2$F$20230531$20240722$20230626$20240808$PER$$CO-TOLMAR, INC.-23CO041317$TOLMAR$$8$YR$$F$Y$34$KG$20240808$$CN$CO$CO
226370412$22637041$2$F$20230101$20240831$20230626$20240905$PER$$US-AMGEN-USASP2023108272$AMGEN$$66$YR$E$M$Y$$$20240905$$HP$US$US
226371553$22637155$3$F$$20240726$20230626$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04895$LUPIN$$$$$$Y$$$20240816$$CN$US$US
226373493$22637349$3$F$$20240726$20230626$20240726$EXP$$US-BAYER-2023A088304$BAYER$$$$$F$Y$$$20240726$$HP$US$US
2263736811$22637368$11$F$20230601$20240301$20230626$20240926$EXP$$US-GSK-US2023AMR087069$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
226373982$22637398$2$F$$20230620$20230626$20240715$EXP$$BE-ASTELLAS-2023US016995$ASTELLAS$$$$$F$Y$$$20240715$$MD$BE$BE
226374792$22637479$2$F$20230617$20230622$20230626$20240930$EXP$$NVSC2023US144294$NOVARTIS$$65$YR$$F$Y$$$20240930$$CN$US$US
226374813$22637481$3$F$20230616$20240822$20230626$20240829$EXP$$IL-ROCHE-3372997$ROCHE$$40$YR$A$F$Y$$$20240829$$CN$IL$IL
226374942$22637494$2$F$$20240726$20230626$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04868$LUPIN$$$$$$Y$$$20240816$$CN$US$US
2263750810$22637508$10$F$20240521$20240910$20230626$20240917$EXP$$CA-GSK-CA2023AMR073872$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
226375307$22637530$7$F$20240314$20240828$20230626$20240902$EXP$$CA-TAKEDA-2023TUS061847$TAKEDA$$22$YR$$M$Y$$$20240902$$MD$CA$CA
226376173$22637617$3$F$$20240806$20230626$20240807$PER$$NVSC2023US144694$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
226379003$22637900$3$F$$20240717$20230626$20240722$EXP$$NVSC2023US140868$NOVARTIS$$$$$$Y$$$20240722$$MD$US$US
2263792210$22637922$10$F$20220420$20240917$20230626$20240926$EXP$$CA-CELLTRION INC.-2022CA004031$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
226379338$22637933$8$F$$20240918$20230626$20240930$EXP$$NVSC2023US144819$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
2263803213$22638032$13$F$20231001$20240905$20230626$20240912$EXP$$US-TAKEDA-2023TUS045435$TAKEDA$$61$YR$$F$Y$53$KG$20240912$$HP$US$US
226380463$22638046$3$F$$20240708$20230626$20240716$PER$$US-SA-2023SA192586$SANOFI AVENTIS$$$$A$F$Y$55$KG$20240716$$CN$US$US
2263808613$22638086$13$F$20130101$20240422$20230626$20240712$EXP$$NVSC2023DE139619$NOVARTIS$$26$YR$$F$Y$47$KG$20240712$$MD$DE$DE
226381463$22638146$3$F$20230501$20240827$20230626$20240912$PER$$US-SA-2023SA193095$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240912$$MD$US$US
226381722$22638172$2$F$$20240801$20230626$20240802$EXP$$US-PFIZER INC-202300229483$PFIZER$$57$YR$$F$Y$$$20240802$$HP$US$US
226382223$22638222$3$F$20230401$20240627$20230626$20240702$EXP$$NVSC2023CA142313$NOVARTIS$$69$YR$$F$Y$$$20240702$$CN$CA$CA
2263823210$22638232$10$F$20231217$20240830$20230626$20240906$EXP$$NVSC2023CL096070$NOVARTIS$$67$YR$$F$Y$$$20240906$$CN$CL$CL
226382476$22638247$6$F$$20231101$20230626$20240913$EXP$$NVSC2023US142973$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
2263832812$22638328$12$F$$20240912$20230626$20240919$EXP$$NVSC2023US143981$NOVARTIS$$68$YR$$F$Y$$$20240919$$CN$US$US
226384022$22638402$2$F$$20240703$20230626$20240712$PER$$US-SA-2023SA189546$SANOFI AVENTIS$$65$YR$E$F$Y$54.4$KG$20240712$$MD$US$US
226384176$22638417$6$F$20230101$20240809$20230626$20240816$PER$$US-SA-2023SA193123$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240816$$CN$US$US
226385124$22638512$4$F$20220520$20240808$20230626$20240813$EXP$$JP-ABBVIE-5301826$ABBVIE$$48$YR$$F$Y$65$KG$20240813$$MD$JP$JP
226385813$22638581$3$F$$20240730$20230626$20240822$PER$$CA-TOLMAR, INC.-23CA041339$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
226385856$22638585$6$F$20221201$20240615$20230626$20240712$PER$$CA-TOLMAR, INC.-23CA041343$TOLMAR$$70$YR$$M$Y$$$20240712$$CN$CA$CA
226386665$22638666$5$F$20211005$20240905$20230626$20240911$EXP$$JP-009507513-2306JPN002866J$MERCK$Sakamoto K, Sakanushi A, Nakaishi M, Okubo K. P-131 Two cases in which hypopituitarism developed during treatment with Pembrolizumab. Japanese Journal of Head and Neck Cancer The 47th Annual Meeting of Japan Societ. 2023;49(2):230$7$DEC$$M$Y$$$20240911$$MD$JP$JP
226387622$22638762$2$F$$20230816$20230626$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK081973$GLENMARK$$$$$$Y$$$20240805$$CN$US$US
226388383$22638838$3$F$20230413$20240705$20230626$20240715$EXP$IT-MINISAL02-929077$IT-TEVA-2023-IT-2899505$TEVA$$7$YR$$F$Y$25$KG$20240715$$PH$IT$IT
226389822$22638982$2$F$$20240718$20230626$20240722$PER$$US-AMGEN-USASP2023108471$AMGEN$$$$$F$Y$$$20240722$$HP$US$US
226389943$22638994$3$F$$20240827$20230626$20240909$PER$$US-SA-2023SA192082$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240909$$MD$US$US
226390465$22639046$5$F$20230501$20240918$20230626$20240926$EXP$$US-BEH-2023160134$CSL BEHRING$$58$YR$A$M$Y$$$20240926$$HP$US$US
2263906318$22639063$18$F$20230616$20240729$20230626$20240806$EXP$$CA-CELLTRION INC.-2023CA009656$CELLTRION$$$$$$Y$$$20240806$$MD$CA$CA
2263907117$22639071$17$F$20230101$20240905$20230626$20240913$EXP$$CA-CELLTRION INC.-2023CA010042$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
226391663$22639166$3$F$$20240827$20230626$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2023085618$VIIV$$$$$M$Y$$$20240917$$HP$US$US
226392215$22639221$5$F$20230508$20240917$20230626$20240925$EXP$$JP-009507513-2306JPN002914J$MERCK$Hirata M, Akamatsu K, Katayama Y, Kato S, Kurita T. EP-0497 Perioperative pembrolizumab administration in triple negative breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 302$57$YR$$F$Y$$$20240925$$MD$JP$JP
226392483$22639248$3$F$20240601$20240725$20230626$20240730$PER$$NVSC2023US142950$NOVARTIS$$43$YR$$F$Y$$$20240730$$CN$US$US
226392967$22639296$7$F$20230101$20240925$20230626$20240926$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2023-088727$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$54.43$KG$20240926$$CN$PR$PR
226392998$22639299$8$F$$20240925$20230626$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-089044$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$56.7$KG$20240926$$CN$US$US
226394113$22639411$3$F$$20240903$20230626$20240905$PER$$US-AMGEN-USASP2023108495$AMGEN$$$$E$F$Y$$$20240905$$HP$US$US
2263943914$22639439$14$F$20171222$20240919$20230626$20240930$EXP$$JP-ABBVIE-5302641$ABBVIE$$60$YR$$M$Y$71.9$KG$20240930$$MD$JP$JP
226395692$22639569$2$F$20240704$20240808$20230626$20240813$EXP$$ZA-ROCHE-3372544$ROCHE$$71$YR$E$F$Y$$$20240813$$MD$ZA$ZA
226395714$22639571$4$F$20190101$20240920$20230626$20240925$EXP$$NVSC2022DE153344$NOVARTIS$$66$YR$$F$Y$93$KG$20240926$$MD$DE$DE
226395887$22639588$7$F$$20240222$20230626$20240813$EXP$$NVSC2023GB143793$NOVARTIS$$61$YR$$F$Y$$$20240813$$CN$GB$GB
226396236$22639623$6$F$20220101$20240913$20230626$20240925$EXP$$PL-AUROBINDO-AUR-APL-2023-043654$AUROBINDO$Kurek M.Kurek I, Zaorska J, Fiszer U, Milewska M M.. Weaning from high-dose opioids (fentanyl and oxycodone). two case reports. BOL.. 2023;24(1):37-43$32$YR$$F$Y$$$20240925$$MD$PL$PL
226396442$22639644$2$F$20240101$20240708$20230626$20240712$EXP$$US-SA-2023SA192261$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240712$$CN$US$US
226398064$22639806$4$F$20150101$20240716$20230626$20240718$EXP$$CH-PFIZER INC-PV202300109960$PFIZER$$42$YR$$F$Y$$$20240718$$PH$CH$CH
226399163$22639916$3$F$20230620$20240702$20230626$20240710$PER$$US-SA-2023SA166918$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240710$$MD$US$US
226400086$22640008$6$F$20230301$20240703$20230626$20240710$EXP$$CA-CELLTRION INC.-2023CA005211$CELLTRION$$$$$$Y$$$20240710$$CN$CA$CA
2264004314$22640043$14$F$20230101$20240816$20230626$20240826$EXP$$CA-CELLTRION INC.-2023CA006091$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
2264004418$22640044$18$F$20230517$20240624$20230626$20240702$EXP$$CA-CELLTRION INC.-2023CA007136$CELLTRION$$$$$$Y$$$20240702$$MD$CA$CA
226400734$22640073$4$F$20230616$20230620$20230626$20240926$EXP$$NVSC2023US141677$NOVARTIS$$69$YR$$M$Y$$$20240926$$CN$US$US
226400774$22640077$4$F$$20230622$20230626$20240927$EXP$$NVSC2023US143995$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
226401844$22640184$4$F$20230101$20240918$20230626$20240930$PER$$NVSC2023US142628$NOVARTIS$$47$YR$$F$Y$$$20240929$$HP$US$US
2264021611$22640216$11$F$20191224$20240826$20230626$20240827$EXP$$NVSC2023AT139298$NOVARTIS$$32$YR$$F$Y$62$KG$20240827$$MD$AT$AT
2264022112$22640221$12$F$20230101$20240710$20230626$20240722$EXP$$CA-CELLTRION INC.-2023CA012739$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
226402682$22640268$2$F$$20240813$20230626$20240824$EXP$$CA-Accord-362945$ACCORD$Lasry D, Cantarovich M, Sandal S. Sequelae of Cryptococcal-Immune Reconstitution Inflammatory Syndrome in a Kidney Transplant Recipient: A Case Report. Canadian Journal of Kidney Health and Disease. 2023;10:20543581231172399$58$YR$A$M$Y$$$20240824$$MD$CA$CA
226404435$22640443$5$F$$20240830$20230626$20240830$EXP$$NVSC2023US144719$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
2264072812$22640728$12$F$20230919$20240722$20230626$20240730$EXP$$CA-CELLTRION INC.-2023CA012725$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
226409262$22640926$2$F$$20240908$20230626$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-395642$RANBAXY$$86$YR$$$Y$$$20240913$$PH$GB$GB
226409962$22640996$2$F$$20240722$20230626$20240724$EXP$$CA-TAKEDA-2021TUS070198$TAKEDA$$$$$F$Y$$$20240724$$CN$CA$CA
226411066$22641106$6$F$$20240828$20230626$20240903$EXP$$PT-MYLANLABS-2023M1067010$MYLAN$Lopes D, Simoes F, Andrade J, Sousa R, Iglesias F, Goncalves I, Angela C, Matos R, Ferreira P, Santos G, Marques S, Apolinario I, Cruz A and Carvalho A.. Disseminated mycobacteriosis caused by Mycobacterium celatum: A case of persistence in diagnosis.. 29th National conference of internal medicine. 2023;819$60$YR$$F$Y$$$20240903$$HP$PT$PT
226411342$22641134$2$F$20230301$20240710$20230626$20240716$EXP$DE-BFARM-23004542$DE-MYLANLABS-2023M1066051$MYLAN$$61$YR$$M$Y$72$KG$20240716$$CN$DE$DE
226411474$22641147$4$F$$20240915$20230626$20240916$EXP$$US-PFIZER INC-PV202300110343$PFIZER$$56$YR$$M$Y$$$20240916$$CN$US$US
2264121411$22641214$11$F$20220815$20240910$20230626$20240913$EXP$$GB-MYLANLABS-2022M1087395$MYLAN$$63$YR$$M$Y$$$20240913$$MD$GB$GB
226412504$22641250$4$F$20230101$20240705$20230626$20240715$PER$$US-SA-2023SA187796$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240715$$MD$US$US
226412572$22641257$2$F$$20240826$20230626$20240909$PER$$US-SA-2023SA191804$SANOFI AVENTIS$$$$A$F$Y$$$20240909$$MD$US$US
226412742$22641274$2$F$20230601$20240815$20230626$20240827$PER$$US-SA-2023SA193428$SANOFI AVENTIS$$55$YR$A$F$Y$75$KG$20240827$$MD$US$US
226414537$22641453$7$F$20230703$20240911$20230626$20240919$EXP$$US-OTSUKA-2023_013688$OTSUKA$$84$YR$$F$Y$76.66$KG$20240919$$CN$US$US
226415879$22641587$9$F$20230101$20240905$20230626$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-089509$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$68.04$KG$20240916$$CN$US$US
226415897$22641589$7$F$20240901$20240919$20230626$20240920$PER$$US-BIOGEN-2023BI01212555$BIOGEN$$77$YR$$F$Y$$$20240920$$CN$US$US
226416345$22641634$5$F$20180101$20240827$20230626$20240902$EXP$$IN-PFIZER INC-2018504443$PFIZER$$54$YR$$F$Y$$$20240902$$CN$IN$IN
226416574$22641657$4$F$20230608$20240917$20230626$20240925$EXP$$CA-TAKEDA-2019TUS043748$TAKEDA$$35$YR$$M$Y$$$20240925$$CN$CA$CA
226417483$22641748$3$F$$20240723$20230626$20240726$EXP$$CA-PFIZER INC-202300228458$PFIZER$$32$YR$$F$Y$$$20240726$$HP$CA$CA
226417533$22641753$3$F$$20240725$20230626$20240731$EXP$$CA-PFIZER INC-202300228693$PFIZER$$66$YR$$F$Y$$$20240731$$HP$CA$CA
226417893$22641789$3$F$20230520$20240711$20230626$20240723$EXP$FR-AFSSAPS-AM2023000506$FR-TEVA-2023-FR-2899776$TEVA$$73$YR$$M$Y$100$KG$20240723$$MD$FR$FR
226418124$22641812$4$F$$20240813$20230626$20240815$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-125655$DAIICHI$$$$$M$Y$$$20240815$$MD$US$US
226419285$22641928$5$F$20230601$20240730$20230626$20240806$PER$$US-PFIZER INC-PV202300107138$PFIZER$$17$YR$$M$Y$64.8$KG$20240806$$MD$US$US
226419294$22641929$4$F$$20240904$20230626$20240905$PER$$US-PFIZER INC-PV202300110432$PFIZER$$34$YR$$M$Y$$$20240905$$CN$US$US
226420352$22642035$2$F$$20240730$20230626$20240808$EXP$$JP-AMGEN-JPNSP2023109394$AMGEN$Komeda Y, Kaya D, Ota K, Matsuo Y, Tamada Y, Ozaki K, et al.. A case of Fournier^s gangrene during administration of lenvatinib for advanced hepatocellular carcinoma. The 28th Japan Association of Systemic Therapy for HCC. 2023;165$66$YR$E$M$Y$$$20240808$$MD$JP$JP
226421314$22642131$4$F$$20240923$20230626$20240930$EXP$$US-ABBVIE-5303699$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
226421594$22642159$4$F$20230515$20240711$20230626$20240716$EXP$$US-ABBVIE-4769334$ABBVIE$$87$YR$$M$Y$$$20240716$$CN$US$US
226421972$22642197$2$F$20230130$20240725$20230626$20240729$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-003729$AURINIA PHARMACEUTICALS$$22$YR$$F$Y$$$20240729$$HP$US$US
226422723$22642272$3$F$20230101$20240807$20230626$20240809$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2023-118731$DAIICHI$Takahashi R, Tou U. EP-0622 Experience with Trastuzumab-Deruxtecan in HER2-low recurrent breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;333$47$YR$$F$Y$51.9$KG$20240809$$MD$JP$JP
226423007$22642300$7$F$$20240715$20230626$20240719$EXP$$US-Taiho Oncology Inc-2023-004264$TAIHO ONCOLOGY INC$$62$YR$A$M$Y$$$20240719$$CN$US$US
2264233014$22642330$14$F$20201101$20240801$20230626$20240809$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-004759$AMGEN$$52$YR$A$M$Y$$$20240809$$MD$US$US
226423706$22642370$6$F$$20240711$20230626$20240720$EXP$$FR-CELLTRION INC.-2023FR012626$CELLTRION$$$$$$Y$$$20240720$$PH$FR$FR
226424553$22642455$3$F$20230609$20240827$20230626$20240901$EXP$$KR-ABBVIE-5302995$ABBVIE$$46$YR$$M$Y$84$KG$20240901$$MD$KR$KR
226424722$22642472$2$F$$20240711$20230626$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-089958$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240712$$CN$US$US
226425296$22642529$6$F$$20240909$20230627$20240917$EXP$$CA-CELLTRION INC.-2022CA019793$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
226425413$22642541$3$F$$20240927$20230627$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-088286$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240930$$CN$US$US
226425813$22642581$3$F$20221015$20240719$20230627$20240722$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-246290$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$72.5$KG$20240722$$MD$JP$JP
226428636$22642863$6$F$$20240806$20230627$20240817$EXP$$US-Accord-296195$ACCORD$$$$A$F$Y$70$KG$20240817$$HP$US$US
226431293$22643129$3$F$$20240702$20230627$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-089524$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$53.98$KG$20240704$$CN$US$US
226432058$22643205$8$F$20230623$20240904$20230627$20240906$EXP$$NVSC2023US144836$NOVARTIS$$47$YR$$F$Y$$$20240906$$CN$US$US
226432244$22643224$4$F$$20230622$20230627$20240830$PER$$NVSC2023US145733$NOVARTIS$$$$$F$Y$$$20240830$$HP$US$US
226432497$22643249$7$F$20230101$20240919$20230627$20240926$EXP$$US-RECORDATI-2023004166$RECORDATI$$$$$$Y$$$20240926$$CN$US$US
226433013$22643301$3$F$20220818$20240822$20230627$20240829$EXP$$JP-ABBVIE-5304746$ABBVIE$$73$YR$$M$Y$58.1$KG$20240829$$MD$JP$JP
226434184$22643418$4$F$$20240821$20230627$20240827$EXP$$CA-ROCHE-3375662$ROCHE$$88$YR$E$F$Y$$$20240827$$HP$CA$CA
226434633$22643463$3$F$20200912$20240821$20230627$20240824$EXP$$US-TAKEDA-US202002673$TAKEDA$$49$YR$$F$Y$$$20240824$$HP$US$US
2264348610$22643486$10$F$20230614$20240719$20230627$20240724$EXP$$US-GSK-US2023AMR087237$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$US$US
226435742$22643574$2$F$$20240621$20230627$20240702$PER$$US-SA-2023SA194287$SANOFI AVENTIS$$13$YR$T$F$Y$58.05$KG$20240702$$MD$US$US
226435812$22643581$2$F$20230401$20240621$20230627$20240702$PER$$US-SA-2023SA192977$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240702$$HP$US$US
226435923$22643592$3$F$20240701$20240713$20230627$20240722$PER$$US-SA-2023SA193907$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240722$$MD$US$US
226436064$22643606$4$F$20240717$20240719$20230627$20240801$PER$$US-SA-2023SA193310$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240801$$MD$US$US
226436413$22643641$3$F$$20240726$20230627$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04915$LUPIN$$$$$$Y$$$20240817$$CN$US$US
226438355$22643835$5$F$$20240823$20230627$20240902$EXP$$BR-ROCHE-3373022$ROCHE$$22$YR$A$M$Y$$$20240902$$MD$BR$BR
226439022$22643902$2$F$$20230629$20230627$20240701$PER$$US-APOTEX-2023AP008486$APOTEX$$$$$F$Y$$$20240701$$CN$US$US
226439523$22643952$3$F$20230124$20240806$20230627$20240809$EXP$$NVSC2023GB144925$NOVARTIS$$71$YR$$M$Y$$$20240809$$MD$GB$GB
226439532$22643953$2$F$20231206$20240628$20230627$20240704$EXP$$NVSC2023CA144180$NOVARTIS$$$$E$F$Y$$$20240704$$HP$CA$CA
226441917$22644191$7$F$20190501$20240813$20230627$20240820$EXP$$PHHY2019CO201398$NOVARTIS$$66$YR$$M$Y$86$KG$20240820$$CN$CO$CO
226442498$22644249$8$F$20230715$20231101$20230627$20240925$EXP$$US-GSK-US2023AMR087048$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
226443412$22644341$2$F$20230501$20230829$20230627$20240701$PER$$US-APOTEX-2023AP008343$APOTEX$$$$$F$Y$$$20240701$$PH$US$US
226444412$22644441$2$F$20220101$20240725$20230627$20240731$PER$$NVSC2023US144755$NOVARTIS$$$$$F$Y$$$20240731$$HP$US$US
226444505$22644450$5$F$20230601$20240820$20230627$20240824$EXP$$JP-AMGEN-JPNSP2023108795$AMGEN$$91$YR$E$M$Y$43$KG$20240824$$MD$JP$JP
226444565$22644456$5$F$20230601$20240807$20230627$20240813$EXP$$CA-GSK-CA2023AMR086908$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CA$CA
226447974$22644797$4$F$$20240925$20230627$20240927$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-125683$DAIICHI$$$$$M$Y$$$20240928$$CN$US$US
226448584$22644858$4$F$$20240328$20230627$20240910$EXP$$CA-BEH-2023160231$CSL BEHRING$$43$YR$A$F$Y$96$KG$20240910$$HP$CA$CA
2264490110$22644901$10$F$$20240731$20230627$20240807$EXP$$NVSC2023US146031$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
226451065$22645106$5$F$20210101$20240808$20230627$20240809$EXP$$US-PFIZER INC-PV202300111125$PFIZER$$67$YR$$M$Y$$$20240809$$CN$US$US
226451134$22645113$4$F$20231123$20240814$20230627$20240819$EXP$$US-TAKEDA-US201916748$TAKEDA$$72$YR$$M$Y$$$20240819$$HP$US$US
226451296$22645129$6$F$20230101$20240709$20230627$20240716$EXP$$US-SA-2023SA194928$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240716$$MD$US$US
226452692$22645269$2$F$20220501$20240801$20230627$20240809$PER$$US-SA-2023SA195162$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240809$$CN$US$US
226453203$22645320$3$F$$20231009$20230627$20240806$PER$$NVSC2023US142088$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
226453586$22645358$6$F$20230101$20240828$20230627$20240923$PER$$US-SA-2023SA195073$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240923$$MD$US$US
226453605$22645360$5$F$20240501$20240814$20230627$20240828$PER$$US-SA-2023SA195847$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240828$$MD$US$US
226454842$22645484$2$F$$20240619$20230627$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396275$RANBAXY$Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J Drug Alcohol Res. 2022;11(2):236162$60$YR$$M$Y$$$20240704$$HP$US$US
2264554710$22645547$10$F$20220601$20240731$20230627$20240801$EXP$$DE-TAKEDA-2023TUS061204$TAKEDA$$77$YR$$F$Y$84$KG$20240801$$MD$DE$DE
226456023$22645602$3$F$20230101$20240830$20230627$20240904$EXP$$CA-PFIZER INC-PV202200114709$PFIZER$$33$YR$$M$Y$$$20240904$$CN$CA$CA
226457392$22645739$2$F$$20240708$20230627$20240716$EXP$$NVSC2023AR145387$NOVARTIS$Leonardi N, Gilligan G, Piemonte E, Panico R. Therapeutic alternatives of medication-related osteonecrosis of the jaw (MRONJ): reports of two clinical cases and review of the literature. JOURNAL OF THE FACULTY OF MEDICAL SCIENCES OF CORDOBA. 2022;79(4):379-82$72$YR$$F$Y$$$20240716$$HP$AR$AR
226457985$22645798$5$F$$20240710$20230627$20240712$EXP$$US-PFIZER INC-PV202300112679$PFIZER$$75$YR$$F$Y$50.34$KG$20240712$$CN$US$US
226460603$22646060$3$F$20230601$20240802$20230627$20240813$EXP$$US-ROCHE-3377275$ROCHE$$31$YR$A$F$Y$73.03$KG$20240813$$CN$US$US
226461982$22646198$2$F$20230619$20240715$20230627$20240725$EXP$$CA-SAMSUNG BIOEPIS-SB-2023-16825$SAMSUNG BIOEPIS$$32$YR$A$M$Y$$$20240725$$HP$CA$CA
226462035$22646203$5$F$20230928$20240725$20230627$20240731$EXP$$CO-TAKEDA-2023TUS058359$TAKEDA$$27$YR$$F$Y$56$KG$20240731$$CN$CO$CO
226464382$22646438$2$F$20230101$20240715$20230627$20240723$PER$$US-SA-2023SA194069$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240723$$MD$US$US
226464968$22646496$8$F$20240717$20240716$20230627$20240723$EXP$$US-TAKEDA-2023TUS043171$TAKEDA$$40$YR$$M$Y$94.3$KG$20240723$$MD$US$US
226465532$22646553$2$F$20230127$20240808$20230627$20240814$EXP$FR-AFSSAPS-AM2023000560$FR-ELI_LILLY_AND_COMPANY-FR202306015204$ELI LILLY AND CO$$69$YR$E$F$Y$73$KG$20240814$$CN$FR$FR
226465874$22646587$4$F$20200304$20240802$20230627$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-090106$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240805$$CN$US$US
226466074$22646607$4$F$$20240821$20230627$20240829$PER$$US-VERTEX PHARMACEUTICALS-2023-009340$VERTEX$$$$C$M$Y$$$20240829$$CN$US$US
226466593$22646659$3$F$$20240906$20230627$20240912$EXP$$US-GILEAD-2023-0634221$GILEAD$$62$YR$A$M$Y$$$20240912$$HP$US$US
226466903$22646690$3$F$$20240906$20230627$20240912$EXP$$US-GILEAD-2023-0634236$GILEAD$$62$YR$A$F$Y$$$20240912$$HP$US$US
226466953$22646695$3$F$20221030$20240813$20230627$20240819$EXP$DE-CADRBFARM-2023319808$DE-MYLANLABS-2023M1066456$MYLAN$$34$YR$$F$Y$53$KG$20240819$$CN$DE$DE
226467267$22646726$7$F$20240101$20240729$20230627$20240801$EXP$$US-PFIZER INC-PV202300111352$PFIZER$$78$YR$$F$Y$$$20240801$$CN$US$US
2264678317$22646783$17$F$$20240718$20230627$20240724$EXP$$CA-SAKK-2023SA177830AA$SANOFI AVENTIS$$80$YR$E$M$Y$69$KG$20240724$$MD$CA$CA
226467852$22646785$2$F$$20240906$20230627$20240911$EXP$$US-GILEAD-2023-0634302$GILEAD$$64$YR$A$M$Y$$$20240911$$HP$US$US
226467983$22646798$3$F$$20240906$20230627$20240912$EXP$$US-GILEAD-2023-0634304$GILEAD$$68$YR$E$M$Y$$$20240912$$HP$US$US
226470646$22647064$6$F$$20240903$20230627$20240909$EXP$$NVSC2023GB143911$NOVARTIS$$$$A$M$Y$$$20240909$$CN$GB$GB
226471273$22647127$3$F$$20240906$20230627$20240911$EXP$$US-GILEAD-2020-0467027$GILEAD$$52$YR$A$M$Y$$$20240911$$HP$US$US
226471752$22647175$2$F$$20240607$20230627$20240801$PER$$US-LUNDBECK-DKLU3062262$LUNDBECK$$$$$$Y$$$20240801$$PH$US$US
226471878$22647187$8$F$20230101$20240829$20230627$20240906$EXP$$JP-AstraZeneca-2023A131060$ASTRAZENECA$Yoshida K. A study of two cases in which bone marrow  aspiration was performed due to suspected  hemophagocytic syndrome after treatment with  immune checkpoint inhibitor combination therapy  for advanced hepatocellular carcinoma.. Acta Hepatologica Japonica 2024; 65(S1): A294-. (not from Embase);Same as the above 2024;65:$74$YR$$F$Y$48$KG$20240906$$MD$JP$
226473245$22647324$5$F$20220301$20240903$20230627$20240905$EXP$$JP-TAKEDA-2023TJP008291$TAKEDA$$33$YR$$M$Y$50.9$KG$20240905$$MD$JP$JP
226473255$22647325$5$F$20220509$20240903$20230627$20240905$EXP$$JP-TAKEDA-2023TJP008289$TAKEDA$$4$YR$$F$Y$11.7$KG$20240905$$MD$JP$JP
226473765$22647376$5$F$20230601$20230718$20230627$20240926$EXP$$US-GSK-US2023AMR087658$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
226474364$22647436$4$F$20220125$20240905$20230628$20240909$EXP$$JP-TAKEDA-2023TJP007044$TAKEDA$$6$YR$$M$Y$20.2$KG$20240909$$MD$JP$JP
226474592$22647459$2$F$20230623$20230623$20230628$20240926$EXP$$US-ABBVIE-5305392$ABBVIE$$67$YR$$M$Y$$$20240926$$CN$US$US
226474964$22647496$4$F$20210706$20240723$20230628$20240729$EXP$$JP-JNJFOC-20230659738$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240729$$MD$JP$JP
226475013$22647501$3$F$20221201$20240920$20230628$20240930$EXP$$CA-CELLTRION INC.-2022CA017216$CELLTRION$$$$$$Y$$$20240930$$CN$CA$CA
226476286$22647628$6$F$20230101$20240827$20230628$20240903$EXP$$US-ABBVIE-5305590$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
226476812$22647681$2$F$$20240815$20230628$20240828$PER$$US-SA-2023SA192049$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
226477918$22647791$8$F$20230524$20240813$20230628$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-087867$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$42.9$KG$20240821$$MD$JP$JP
226478472$22647847$2$F$20221001$20240916$20230628$20240924$EXP$$CA-CELLTRION INC.-2022CA016624$CELLTRION$$$$$$Y$$$20240924$$CN$CA$CA
2264786212$22647862$12$F$20220701$20240826$20230628$20240909$EXP$$US-SA-2023SA194908$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240909$$MD$US$US
226478703$22647870$3$F$$20240731$20230628$20240808$EXP$$CA-CELLTRION INC.-2023CA002917$CELLTRION$$$$$$Y$$$20240808$$CN$CA$CA
226479103$22647910$3$F$20230607$20240728$20230628$20240806$EXP$$NVSC2023IN146061$NOVARTIS$$33$YR$$F$Y$$$20240806$$CN$IN$IN
226479983$22647998$3$F$20230120$20240709$20230628$20240720$EXP$$BG-CELLTRION INC.-2023BG012856$CELLTRION$$$$$$Y$$$20240720$$MD$BG$BG
226480502$22648050$2$F$20220701$20230911$20230628$20240715$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00209$PRINSTON PHARMACEUTICAL$$69$YR$$F$Y$$$20240703$$CN$US$US
226483579$22648357$9$F$20230402$20240729$20230628$20240805$EXP$$US-BIOGEN-2023BI01212145$BIOGEN$$63$YR$$M$Y$$$20240805$$CN$US$US
226483908$22648390$8$F$20230601$20231211$20230628$20240925$PER$$US-GSK-US2023AMR080571$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240925$$MD$US$US
226484692$22648469$2$F$$20240918$20230628$20240927$PER$$NVSC2023US146817$NOVARTIS$$70$YR$$F$Y$$$20240927$$HP$US$US
226484712$22648471$2$F$$20240731$20230628$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-04930$LUPIN$$$$$$Y$$$20240820$$CN$US$US
226484767$22648476$7$F$$20240705$20230628$20240709$EXP$$NVSC2023US147076$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
226485013$22648501$3$F$$20240722$20230628$20240730$PER$$US-SA-2023SA195727$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240730$$MD$US$US
226486257$22648625$7$F$20230502$20240830$20230628$20240904$EXP$$CA-JNJFOC-20230658048$JOHNSON AND JOHNSON$$54$YR$A$F$Y$122$KG$20240904$$HP$CA$CA
226486766$22648676$6$F$20220101$20240830$20230628$20240912$EXP$$CA-CELLTRION INC.-2022CA011876$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
226487042$22648704$2$F$$20240816$20230628$20240823$EXP$$AT-ROCHE-3373454$ROCHE$$$$$$Y$$$20240823$$HP$AT$AT
226487067$22648706$7$F$$20231206$20230628$20240925$PER$$US-GSK-US2023AMR088287$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2264870810$22648708$10$F$20230101$20240909$20230628$20240917$EXP$$CA-CELLTRION INC.-2023CA000207$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
226487684$22648768$4$F$$20240827$20230628$20240902$EXP$$TH-TAKEDA-2023TUS062914$TAKEDA$$43$YR$$F$Y$$$20240902$$CN$TH$TH
226488396$22648839$6$F$$20240805$20230628$20240813$EXP$$US-TAKEDA-2023TUS060889$TAKEDA$$$$$F$Y$$$20240813$$MD$US$US
226488409$22648840$9$F$20230519$20240814$20230628$20240820$EXP$$CA-TAKEDA-2023TUS002370$TAKEDA$$56$YR$$M$Y$$$20240820$$HP$CA$CA
226488787$22648878$7$F$20230106$20240923$20230628$20240930$EXP$$CA-TAKEDA-2023TUS042245$TAKEDA$$36$YR$$F$Y$$$20240930$$CN$CA$CA
226489652$22648965$2$F$$20230624$20230628$20240717$EXP$$AT-ASTELLAS-2023US019238$ASTELLAS$$62$YR$$M$Y$$$20240717$$CN$AT$AT
226490674$22649067$4$F$20230101$20240702$20230628$20240711$PER$$US-SA-2023SA194289$SANOFI AVENTIS$$29$YR$A$F$Y$104$KG$20240711$$MD$US$US
226491154$22649115$4$F$20220425$20240710$20230628$20240715$EXP$$NVSC2023DE146398$NOVARTIS$$$$A$F$Y$72$KG$20240715$$HP$DE$DE
226491582$22649158$2$F$20230621$20240625$20230628$20240701$EXP$$NVSC2023AE146049$NOVARTIS$$68$YR$$F$Y$$$20240701$$MD$AE$AE
226491702$22649170$2$F$$20240719$20230628$20240723$EXP$$JP-BAYER-2023A085981$BAYER$$92$YR$E$M$Y$$$20240723$$MD$JP$JP
226491722$22649172$2$F$$20240719$20230628$20240723$EXP$$JP-BAYER-2023A085980$BAYER$$89$YR$E$M$Y$$$20240723$$MD$JP$JP
226492652$22649265$2$F$$20240719$20230628$20240723$EXP$$JP-BAYER-2023A085983$BAYER$$74$YR$E$M$Y$$$20240723$$MD$JP$JP
226492662$22649266$2$F$$20240722$20230628$20240729$EXP$$NVSC2023AT145418$NOVARTIS$Haninger-Vacariu N, Aigner C, Gaggl M, Kain R, Prohaszka Z, Bohmig GA et al.. Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy. CLINICAL KIDNEY JOURNAL. 2021;14(4):1255-60$$$A$F$Y$$$20240729$$HP$AT$AT
226492713$22649271$3$F$$20230623$20230628$20240720$EXP$$NVSC2023AR145386$NOVARTIS$Leonardi N, Gilligan G, Piemonte E, Panico R. Therapeutic alternatives of medication-related osteonecrosis of the jaw (MRONJ): reports of two clinical cases and review of the literature. JOURNAL OF THE FACULTY OF MEDICAL SCIENCES OF CORDOBA. 2022;79(4):379-82$68$YR$$F$Y$$$20240719$$HP$AR$AR
226493432$22649343$2$F$$20240719$20230628$20240723$EXP$$JP-BAYER-2023A085984$BAYER$$83$YR$E$M$Y$$$20240723$$MD$JP$JP
226493452$22649345$2$F$$20240719$20230628$20240722$EXP$$JP-BAYER-2023A085985$BAYER$$90$YR$E$M$Y$$$20240722$$MD$JP$JP
226494402$22649440$2$F$20170601$20240904$20230628$20240913$PER$$US-SA-2023SA197137$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240913$$MD$US$US
226496682$22649668$2$F$20210315$20230622$20230628$20240912$EXP$$IL-SA-2022SA493934$SANOFI AVENTIS$$$$$M$Y$$$20240912$$HP$IL$IL
226498072$22649807$2$F$$20240909$20230628$20240916$EXP$$CA-APOTEX-2023AP009421$APOTEX$$43$YR$$F$Y$68$KG$20240916$$HP$CA$CA
226498297$22649829$7$F$20230724$20240715$20230628$20240722$EXP$$CA-TAKEDA-2023TUS062856$TAKEDA$$30$YR$$F$Y$$$20240722$$HP$CA$CA
226500562$22650056$2$F$$20240705$20230628$20240716$PER$$US-SA-2023SA197407$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240716$$MD$US$US
226500737$22650073$7$F$$20240917$20230628$20240925$EXP$$CA-TAKEDA-2023TUS061072$TAKEDA$$$$$M$Y$$$20240925$$CN$CA$CA
226500896$22650089$6$F$20220801$20240627$20230628$20240704$EXP$$CA-GSK-CA2023088542$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$CA$CA
226501484$22650148$4$F$$20240702$20230628$20240708$EXP$$KR-MYLANLABS-2023M1064922$MYLAN$$$$$M$Y$$$20240708$$CN$KR$KR
2265023320$22650233$20$F$20221101$20240807$20230628$20240808$EXP$$NVSC2023JP070433$NOVARTIS$$72$YR$$M$Y$55.1$KG$20240809$$HP$JP$JP
226503176$22650317$6$F$20230331$20240730$20230628$20240731$EXP$$NL-ORGANON-O2306NLD002827$ORGANON$$9$YR$$M$Y$$$20240731$$MD$NL$NL
226503248$22650324$8$F$20230101$20240918$20230628$20240923$EXP$$DE-TAKEDA-2023TUS062966$TAKEDA$$55$YR$$M$Y$$$20240923$$HP$DE$DE
226507362$22650736$2$F$$20240703$20230628$20240703$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396780$RANBAXY$Gui L, Cao J, Ji D, Zhang H, Fan Q, Zhu J, et al. Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma. Chin J Cancer Res.. 2021;33(5):616-626$$$A$$Y$$$20240703$$HP$CN$CN
226507453$22650745$3$F$$20240822$20230628$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396391$RANBAXY$Arbouche N, Raul JS, Kintz P. Evidence of exposure to flecainide in a newborn by keratinous matrices testing and interpretation of the findings. Drug Test Anal. 2024;16:162-167$9$MON$$F$Y$$$20240906$$HP$FR$FR
226507462$22650746$2$F$$20240704$20230628$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396690$RANBAXY$Delgado-Fernandez M, Garcia-Gemar GM, Fuentes-Lopez A, Munoz-Perez MI, Oyonarte-Gomez S, Ruiz-Garcia I, et al. Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency ? Three consecutive cases and review of the literature. Enferm Infecc Microbiol Clin. 2022;40(9):507-516$62$YR$$M$Y$$$20240718$$HP$ES$ES
226507632$22650763$2$F$$20240704$20230628$20240705$EXP$$NP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-396614$RANBAXY$Neupane S, Pudasaini P, Dhakal B, Awal S, Thapa S, Subedi B. Protein S Deficiency with Recurrent Deep Vein Thrombosis and Post Thrombotic Syndrome: A Case Report. JNMA. 2022;60(254):892-894$40$YR$$M$Y$$$20240705$$HP$NP$NP
226507973$22650797$3$F$$20240826$20230628$20240904$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396920$RANBAXY$OPREA-LEBEDENCO M, BERBEC N, STANCA O, TURBATU A, MARIN S, DOBREA C, et al. Classic Hodgkin Lymphoma- mixed cellularity -case report and review of literature. Ro J Med Pract. 2023;18(1):28-30$26$YR$$M$Y$$$20240904$$HP$RO$RO
226510692$22651069$2$F$$20240722$20230628$20240729$EXP$$NVSC2023AT145424$NOVARTIS$Haninger-Vacariu N, Aigner C, Gaggl M, Kain R, Prohaszka Z, Bohmig GA et al.. Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy. CLINICAL KIDNEY JOURNAL. 2021;14(4):1255-60$38$YR$$F$Y$$$20240729$$HP$AT$AT
226510792$22651079$2$F$$20240722$20230628$20240729$EXP$$NVSC2023AT145423$NOVARTIS$Haninger-Vacariu N, Aigner C, Gaggl M, Kain R, Prohaszka Z, Bohmig GA et al.. Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy. CLINICAL KIDNEY JOURNAL. 2021;14(4):1255-60$$$N$M$Y$3.41$KG$20240729$$HP$AT$AT
226510802$22651080$2$F$$20240722$20230628$20240729$EXP$$NVSC2023AT145425$NOVARTIS$Haninger-Vacariu N, Aigner C, Gaggl M, Kain R, Prohaszka Z, Bohmig GA et al.. Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy. CLINICAL KIDNEY JOURNAL. 2021;14(4):1255-60$$$A$F$Y$$$20240729$$HP$AT$AT
226512723$22651272$3$F$$20240906$20230628$20240911$EXP$$US-GILEAD-2022-0587616$GILEAD$$73$YR$E$M$Y$$$20240911$$MD$US$US
226513433$22651343$3$F$$20240906$20230628$20240911$EXP$$US-GILEAD-2022-0590095$GILEAD$$74$YR$E$F$Y$$$20240911$$HP$US$US
226513472$22651347$2$F$$20240815$20230628$20240822$EXP$$BR-GSK-BR2022AMR008163$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$BR$BR
2265134810$22651348$10$F$20230517$20240701$20230628$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-091097$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$78.93$KG$20240702$$CN$US$US
226518313$22651831$3$F$$20240905$20230628$20240912$EXP$$NVSC2023NO145254$NOVARTIS$Sommerfelta H, Sandvik LF, Bachmann IM, Brekke RL, Svendsen HL, Guttormsen AB et al.. Toxic epidermal necrolysis after immune checkpoint inhibition, case report, and review of the literature. ACTA ONCOLOGICA. 2022;61(10):1295-9$34$YR$$M$Y$$$20240912$$HP$NO$NO
226518993$22651899$3$F$$20240906$20230628$20240912$EXP$$US-GILEAD-2022-0603211$GILEAD$$60$YR$A$M$Y$$$20240912$$MD$US$US
226519193$22651919$3$F$$20240906$20230628$20240912$EXP$$US-GILEAD-2023-0618098$GILEAD$$68$YR$E$M$Y$$$20240912$$MD$US$US
226519973$22651997$3$F$$20240715$20230628$20240730$EXP$$GB-TEVA-2023-GB-2901265$TEVA$Koksa K, Acres R, Studley M, Briggs J. Disseminated Mucormycosis in a patient on long term immunosuppression_ Severe fungal infections as multi-system disorders. J Intensive Care Soc. 2023;24(1)_ 43-4. doi_10.1177_17511437231156066.; Koksa K, Acres R, Studley M, Briggs J. Disseminated Mucormycosis in a patient on long term immunosuppression: Severe fungal infections as multi-system disorders. J-Intens-Care-Soc 2023;24 (Suppl.)(1):43-44 abstr. 4736.$$$A$F$Y$$$20240730$$HP$GB$GB
226520232$22652023$2$F$20240101$20240717$20230628$20240723$EXP$$US-BAUSCH-BL-2023-009811$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240723$$HP$US$US
226520514$22652051$4$F$$20240906$20230628$20240912$EXP$$US-GILEAD-2023-0634303$GILEAD$$65$YR$E$M$Y$$$20240912$$HP$US$US
226521133$22652113$3$F$$20240906$20230628$20240911$EXP$$US-GILEAD-2021-0517013$GILEAD$$56$YR$A$M$Y$$$20240911$$HP$US$US
226521693$22652169$3$F$20220715$20240906$20230628$20240912$EXP$$US-GILEAD-2022-0589824$GILEAD$$55$YR$A$F$Y$$$20240912$$HP$US$US
226523052$22652305$2$F$20230603$20240730$20230628$20240802$EXP$$US-ABBVIE-5308206$ABBVIE$$54$YR$$F$Y$$$20240802$$CN$US$US
226523114$22652311$4$F$20230425$20240716$20230628$20240723$EXP$$NVSJ2023JP007810$NOVARTIS$Onagawa S, Yanagida K, Miura M. A case of retinal vasculitis and delayed scleritis after intravitreal injection of brolucizumab. The 40 Annual Meeting of the Japanese Society of Ocular Circulation. 2024;P-7$68$YR$$M$Y$60$KG$20240724$$MD$JP$JP
226523466$22652346$6$F$20200708$20240825$20230628$20240902$EXP$$CA-CELLTRION INC.-2020CA024304$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
226523982$22652398$2$F$20210101$20240729$20230628$20240807$EXP$$US-ASTELLAS-2023US009013$ASTELLAS$$77$YR$$M$Y$$$20240807$$CN$US$US
226524614$22652461$4$F$$20240812$20230629$20240813$PER$$NVSC2023US145251$NOVARTIS$$$$$F$Y$$$20240813$$CN$US$US
226524662$22652466$2$F$$20240725$20230629$20240727$EXP$$US-TAKEDA-US202008116$TAKEDA$$$$$F$Y$$$20240727$$CN$US$US
226524792$22652479$2$F$$20240819$20230629$20240828$PER$$US-SA-2023SA197249$SANOFI AVENTIS$$$$C$F$Y$27.66$KG$20240828$$MD$US$US
226525775$22652577$5$F$20210801$20240726$20230629$20240807$EXP$$DE-AUROBINDO-AUR-APL-2023-044042$AUROBINDO$$$$A$F$Y$$$20240807$$MD$DE$DE
226527635$22652763$5$F$20221227$20240626$20230629$20240704$EXP$$CA-CELLTRION INC.-2023CA001395$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
226527992$22652799$2$F$20230623$20230626$20230629$20240925$PER$$US-GSK-US2023AMR089156$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
226528599$22652859$9$F$20220101$20240626$20230629$20240704$EXP$$CA-CELLTRION INC.-2022CA019005$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
226530044$22653004$4$F$20160101$20240726$20230629$20240809$EXP$AU-MLMSERVICE-20230609-4338617-1$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-06869$ALKEM$White C, Stuart A, Plit M, Malouf M, Lilburn P.. A hole lot of trouble: Severe bilateral anastomotic dehiscence following bilateral single sequential lung transplant. Respirology Case Reports. 2023;11(6):e01164$22$YR$$F$Y$$$20240809$$MD$AU$AU
226530213$22653021$3$F$20230101$20240710$20230629$20240720$EXP$$CA-CELLTRION INC.-2022CA001487$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
226530366$22653036$6$F$20230513$20240722$20230629$20240729$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-009891$JAZZ$$27$YR$$F$Y$$$20240729$$MD$US$US
226531342$22653134$2$F$20230101$20240724$20230629$20240727$EXP$$US-ABBVIE-5307662$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
226531528$22653152$8$F$20230101$20240815$20230629$20240820$EXP$$US-UCBSA-2023002726$UCB$$$$$M$Y$$$20240820$$CN$US$US
226532002$22653200$2$F$$20240912$20230629$20240919$EXP$$US-EMD Serono-9396040$EMD SERONO INC$$$$E$F$Y$$$20240919$$CN$US$US
226532042$22653204$2$F$20230622$20240918$20230629$20240927$EXP$$NVSC2023US147679$NOVARTIS$$72$YR$$M$Y$$$20240927$$CN$US$US
226532755$22653275$5$F$$20240920$20230629$20240928$EXP$$CA-AUROBINDO-AUR-APL-2023-033501$AUROBINDO$$66$YR$$M$Y$70$KG$20240928$$HP$CA$CA
226533945$22653394$5$F$20220831$20240905$20230629$20240910$EXP$$JP-009507513-2306JPN002867J$MERCK$Sakamoto K, Sakanushi A, Nakaishi M, Okuhoto K. P-131 Two cases in which hypopituitarism developed during treatment with Pembrolizumab. Japanese Journal of Head and Neck Cancer The 47th Annual Meeting of Japan Societ. 2023;49(2):230$8$DEC$$M$Y$$$20240910$$MD$JP$JP
2265345917$22653459$17$F$20230605$20240708$20230629$20240723$EXP$$US-AKCEA THERAPEUTICS, INC.-2023IS001599$AKCEA THERAPEUTICS$$$$$$Y$$$20240723$$MD$US$US
226536353$22653635$3$F$20230209$20240625$20230629$20240701$EXP$$NVSC2023MY127081$NOVARTIS$$65$YR$$F$Y$$$20240702$$MD$MY$MY
226537082$22653708$2$F$$20240722$20230629$20240729$EXP$$NVSC2023AT145427$NOVARTIS$Haninger-Vacariu N, Aigner C, Gaggl M, Kain R, Prohaszka Z, Bohmig GA et al.. Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy. CLINICAL KIDNEY JOURNAL. 2021;14(4):1255-60$$$N$F$Y$0.888$KG$20240729$$HP$AT$AT
226537802$22653780$2$F$20230424$20240716$20230629$20240722$EXP$$CA-TAKEDA-2023TUS043707$TAKEDA$$77$YR$$M$Y$$$20240722$$CN$CA$CA
226537866$22653786$6$F$$20240820$20230629$20240825$EXP$$IT-ROCHE-3375698$ROCHE$Valenti C, Moretti G C. Teamwork is successful (1): Favoureable re-challenge of double ANTI-HER2 Treatment in severe myocardial dysfunction in patient with Advanced breast cancer and occult type II diabetes. (Abstract number: P280). European Heart Journal. 2023-May;25 (SUP: D):D149-50. doi:10.1093/eurheartjsupp/suad.$55$YR$A$F$Y$$$20240825$$HP$IT$IT
226538503$22653850$3$F$$20240628$20230629$20240702$PER$$NVSC2023US147899$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
226539224$22653922$4$F$$20240626$20230629$20240701$EXP$$US-SA-2023SA195004$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240701$$MD$US$US
226540477$22654047$7$F$20191112$20240820$20230629$20240828$EXP$$CA-CELLTRION INC.-2019CA025445$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
226540658$22654065$8$F$20230331$20240814$20230629$20240827$EXP$$NL-AUROBINDO-AUR-APL-2023-043971$AUROBINDO$$9$YR$$M$Y$$$20240827$$MD$NL$NL
226541142$22654114$2$F$20230624$20240801$20230629$20240810$PER$$US-SA-2023SA197177$SANOFI AVENTIS$$52$YR$A$F$Y$78.93$KG$20240810$$MD$US$US
226541432$22654143$2$F$20211101$20240817$20230629$20240823$EXP$$US-ABBVIE-5300104$ABBVIE$$64$YR$$F$Y$$$20240823$$CN$US$US
2265414910$22654149$10$F$20230410$20240816$20230629$20240821$EXP$$IN-TAKEDA-2022TUS061375$TAKEDA$$11$YR$$M$Y$$$20240821$$HP$IN$IN
226542864$22654286$4$F$20230620$20240705$20230629$20240715$PER$$US-TAKEDA-2023TUS063467$TAKEDA$$66$YR$$F$Y$131.06$KG$20240715$$MD$US$US
226543132$22654313$2$F$20230601$20240625$20230629$20240704$PER$$US-SA-2023SA198015$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240704$$MD$US$US
226543362$22654336$2$F$$20240726$20230629$20240801$EXP$$US-BIOGEN-2023BI01213221$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
226543684$22654368$4$F$20230628$20240911$20230629$20240913$PER$$NVSC2023US147978$NOVARTIS$$52$YR$$M$Y$$$20240913$$CN$US$US
226545132$22654513$2$F$$20240829$20230629$20240902$30DAY$$US-ABBVIE-5308044$ABBVIE$$$$$$Y$$$20240902$$HP$US$US
226546023$22654602$3$F$20190211$20240709$20230629$20240715$EXP$$CA-TAKEDA-2019TUS010599$TAKEDA$$31$YR$$M$Y$$$20240715$$CN$CA$CA
226548654$22654865$4$F$20230616$20240731$20230629$20240807$30DAY$$US-GSK-US2023085537$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240807$$CN$US$US
226549654$22654965$4$F$20230601$20240723$20230629$20240730$EXP$$JP-JAZZ PHARMACEUTICALS-2023-JP-013889$JAZZ$$60$YR$$F$Y$68$KG$20240730$$MD$JP$JP
226550998$22655099$8$F$20231101$20240918$20230629$20240924$EXP$$US-TAKEDA-US202027088$TAKEDA$$64$YR$$F$Y$82$KG$20240924$$CN$US$US
226551423$22655142$3$F$$20240715$20230629$20240730$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396923$RANBAXY$Koksa K, Acres R, Studley M, Briggs J. Disseminated Mucormycosis in a patient on long term immunosuppression: Severe fungal infections as multi-system disorders. J Intens Care Soc. 2023;24 (Suppl.1):43$5$YR$$F$Y$$$20240730$$HP$GB$GB
226551572$22655157$2$F$$20240819$20230629$20240826$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396873$RANBAXY$Shivaram S, Nagappa M, Varghese N, Seshagiri DV, Duble S, Siddappa SA, et al. Rituximab in Myasthenia Gravis? Experience from a Low? and Middle?Income Country (LMIC) Setting. Neurol India. 2022;70:1931-41$27$YR$$F$Y$$$20240826$$HP$IN$IN
226551582$22655158$2$F$$20240819$20230629$20240826$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396878$RANBAXY$Shivaram S, Nagappa M, Varghese N, Seshagiri DV, Duble S, Siddappa SA, et al. Rituximab in Myasthenia Gravis? Experience from a Low? and Middle?Income Country (LMIC) Setting. Neurol India. 2022;70:1931-41$47$YR$$F$Y$$$20240826$$HP$IN$IN
226551592$22655159$2$F$$20240828$20230629$20240904$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396879$RANBAXY$Shivaram S, Nagappa M, Varghese N, Seshagiri DV, Duble S, Siddappa SA, et al. Rituximab in Myasthenia Gravis? Experience from a Low? and Middle?Income Country (LMIC) Setting. Neurol India. 2022;70:1931-41$59$YR$$M$Y$$$20240904$$HP$IN$IN
226551602$22655160$2$F$$20240707$20230629$20240708$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396880$RANBAXY$Shivaram S, Nagappa M, Varghese N, Seshagiri DV, Duble S, Siddappa SA, et al. Rituximab in Myasthenia Gravis? Experience from a Low? and Middle?Income Country (LMIC) Setting. Neurol India. 2022;70:1931-41$32$YR$$F$Y$$$20240708$$HP$IN$IN
226551612$22655161$2$F$$20240708$20230629$20240709$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396881$RANBAXY$Shivaram S, Nagappa M, Varghese N, Seshagiri DV, Duble S, Siddappa SA, et al. Rituximab in Myasthenia Gravis-Experience from a Low-and Middle-Income Country (LMIC) Setting. Neurol India. 2022;70:1931-41$27$YR$$M$Y$$$20240709$$HP$IN$IN
226551762$22655176$2$F$$20240722$20230629$20240729$EXP$$NVSC2023AT148287$NOVARTIS$Haninger-Vacariu N, Aigner C, Gaggl M, Kain R, Prohaszka Z, Bohmig GA et al.. Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy. CLINICAL KIDNEY JOURNAL. 2021;14(4):1255-60$$$N$M$Y$4$KG$20240729$$HP$AT$AT
226552403$22655240$3$F$$20240817$20230629$20240821$EXP$$NVSC2023CA115212$NOVARTIS$$61$YR$$M$Y$$$20240821$$CN$CA$CA
226553132$22655313$2$F$$20230626$20230629$20240927$EXP$$NVSC2023US146361$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
226554903$22655490$3$F$20230622$20240909$20230629$20240911$PER$$US-PFIZER INC-PV202300110538$PFIZER$$63$YR$$F$Y$$$20240911$$CN$US$US
226555634$22655563$4$F$$20240821$20230629$20240829$PER$$US-VERTEX PHARMACEUTICALS-2023-005372$VERTEX$$$$C$F$Y$$$20240829$$CN$US$US
226556448$22655644$8$F$20231106$20240803$20230629$20240808$EXP$$IN-PFIZER INC-PV202300009637$PFIZER$$66$YR$$F$Y$71.7$KG$20240808$$CN$IN$IN
226557453$22655745$3$F$20230601$20240806$20230629$20240808$PER$$US-PFIZER INC-202300232668$PFIZER$$49$YR$$F$Y$$$20240808$$HP$US$US
226558394$22655839$4$F$20240615$20240730$20230629$20240806$EXP$$CA-GSK-CA2023087367$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$HP$CA$CA
226558949$22655894$9$F$$20240911$20230629$20240913$EXP$$US-PFIZER INC-PV202300113367$PFIZER$$84$YR$$F$Y$$$20240913$$CN$US$US
2265599915$22655999$15$F$20230801$20240801$20230629$20240806$PER$$US-PFIZER INC-202300224886$PFIZER$$61$YR$$F$Y$68.04$KG$20240806$$MD$US$US
226561364$22656136$4$F$20230301$20240918$20230629$20240930$PER$$NVSC2023US148738$NOVARTIS$$49$YR$$F$Y$$$20240930$$CN$US$US
226561984$22656198$4$F$20231201$20240710$20230629$20240910$PER$$US-LUNDBECK-DKLU3062677$LUNDBECK$$$$$$Y$$$20240910$$MD$US$US
226562375$22656237$5$F$20230101$20240726$20230629$20240807$PER$$US-SA-2023SA196486$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240807$$MD$US$US
2265624513$22656245$13$F$20240304$20240812$20230629$20240814$EXP$$CA-GILEAD-2023-0634617$GILEAD$$61$YR$A$F$Y$$$20240814$$PH$CA$CA
226562928$22656292$8$F$20230614$20240801$20230629$20240807$EXP$$JP-009507513-2306JPN002951J$MERCK$$63$YR$$F$Y$$$20240807$$MD$JP$JP
226565002$22656500$2$F$20240511$20240705$20230629$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002522$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240729$$CN$US$US
226565538$22656553$8$F$20230625$20240807$20230630$20240809$EXP$$GB-ABBVIE-5309299$ABBVIE$$73$YR$$F$Y$60$KG$20240809$$MD$GB$GB
226566044$22656604$4$F$$20240626$20230630$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002286$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
226566438$22656643$8$F$20230601$20240808$20230630$20240818$EXP$$US-JAZZ PHARMACEUTICALS-2021-US-021894$JAZZ$$32$YR$$F$Y$$$20240818$$HP$US$US
226566485$22656648$5$F$20230706$20230815$20230630$20240925$PER$$US-GSK-US2023AMR088795$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
226566699$22656669$9$F$20230606$20240607$20230630$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002232$ACADIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240701$$CN$US$US
226566775$22656677$5$F$20230604$20240611$20230630$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002265$ACADIA PHARMACEUTICALS$$22$YR$$F$Y$$$20240705$$CN$US$US
226566787$22656678$7$F$$20240621$20230630$20240717$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002254$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
2265693315$22656933$15$F$20230801$20240926$20230630$20240930$EXP$$NVSC2023US148878$NOVARTIS$$53$YR$$F$Y$$$20240930$$CN$US$US
226569704$22656970$4$F$20221021$20240906$20230630$20240915$EXP$$AT-AUROBINDO-AUR-APL-2023-044650$AUROBINDO$$78$YR$$F$Y$$$20240915$$MD$AT$AT
226571226$22657122$6$F$$20240812$20230630$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202306018150$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240814$$HP$US$US
226571606$22657160$6$F$20220101$20240826$20230630$20240912$EXP$$CA-CELLTRION INC.-2022CA007600$CELLTRION$$$$$$Y$$$20240912$$MD$CA$CA
226571802$22657180$2$F$$20240708$20230630$20240716$PER$$US-SA-2023SA196082$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240716$$MD$US$US
226572353$22657235$3$F$20220524$20240822$20230630$20240830$EXP$$CA-CELLTRION INC.-2022CA007932$CELLTRION$$$$$$Y$$$20240830$$MD$CA$CA
2265761912$22657619$12$F$20230822$20240711$20230630$20240716$EXP$$CA-BIOGEN-2021BI01069345$BIOGEN$$36$YR$$M$Y$$$20240716$$CN$CA$CA
226576892$22657689$2$F$$20240812$20230630$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05215$LUPIN$$$$$$Y$$$20240829$$CN$US$US
226578124$22657812$4$F$20230626$20240918$20230630$20240930$PER$$NVSC2023US148771$NOVARTIS$$59$YR$$F$Y$94.3$KG$20240930$$CN$US$US
226579272$22657927$2$F$20230101$20240809$20230630$20240815$EXP$$US-ABBVIE-4745279$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
226579302$22657930$2$F$$20240903$20230630$20240905$PER$$US-AMGEN-USASP2023111793$AMGEN$$49$YR$A$F$Y$$$20240904$$HP$US$US
2265795014$22657950$14$F$20210101$20240912$20230630$20240921$EXP$$CA-CELLTRION INC.-2021CA008988$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
226579934$22657993$4$F$$20240730$20230630$20240730$EXP$$FR-JNJFOC-20230662289$JOHNSON AND JOHNSON$$54$YR$A$F$Y$95$KG$20240731$$MD$FR$FR
226580853$22658085$3$F$20230712$20240822$20230630$20240828$EXP$$CA-TAKEDA-2023TUS057978$TAKEDA$$34$YR$$F$Y$$$20240828$$MD$CA$CA
226580932$22658093$2$F$20230612$20240827$20230630$20240829$EXP$$US-TAKEDA-2023TUS063983$TAKEDA$$72$YR$$F$Y$$$20240829$$MD$US$US
226581313$22658131$3$F$$20240805$20230630$20240809$EXP$$NVSC2023GB079383$NOVARTIS$$$$A$F$Y$$$20240809$$PH$GB$GB
226582442$22658244$2$F$$20240708$20230630$20240717$PER$$US-SA-2023SA197924$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240717$$MD$US$US
226583042$22658304$2$F$20230525$20240814$20230630$20240822$EXP$$BR-CELLTRION INC.-2023BR012364$CELLTRION$$$$$$Y$$$20240822$$CN$BR$BR
2265832010$22658320$10$F$$20240422$20230630$20240711$EXP$$DE-GLAXOSMITHKLINE-DECH2023031049$Haleon PLC$$26$YR$$F$Y$47$KG$20240711$$MD$DE$DE
226583674$22658367$4$F$$20240708$20230630$20240710$PER$$US-PFIZER INC-PV202200009253$PFIZER$$80$YR$$F$Y$$$20240710$$MD$US$US
226584342$22658434$2$F$20230407$20240719$20230630$20240722$EXP$FR-AFSSAPS-BR2023000581$FR-ROCHE-3376637$ROCHE$$26$YR$A$M$Y$73$KG$20240722$$MD$FR$FR
2265865213$22658652$13$F$20230101$20240904$20230630$20240913$EXP$$US-INSMED-2023-01233-USAA$INSMED$$$$$$Y$$$20240913$$HP$US$US
226588932$22658893$2$F$20230514$20240710$20230630$20240712$EXP$FR-AFSSAPS-AM2023000587$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-091580$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$61$KG$20240712$$MD$FR$FR
226592472$22659247$2$F$20200601$20240715$20230630$20240722$EXP$$NVSC2023BR148648$NOVARTIS$$44$YR$$F$Y$$$20240722$$CN$BR$BR
226592542$22659254$2$F$20230101$20240730$20230630$20240828$PER$$US-009507513-2306USA001249$MERCK$$$$$F$Y$$$20240828$$HP$US$US
226594369$22659436$9$F$20220101$20240419$20230630$20240808$EXP$$NVSC2022PA297027$NOVARTIS$$$$$F$Y$$$20240808$$CN$PA$PA
226594932$22659493$2$F$20211201$20240827$20230630$20240830$EXP$$CH-PFIZER INC-202300231564$PFIZER$Cathomas, M.. Herpes simplex virus colitis mimicking acute severe ulcerative colitis: a case report and review of the literature. Journal of Surgical Case Reports. 2023;2023 (4):1-3$60$YR$$F$Y$71$KG$20240830$$MD$CH$CH
226595553$22659555$3$F$$20240718$20230630$20240724$PER$$US-BIOGEN-2023BI01213592$BIOGEN$$$$$F$Y$$$20240724$$CN$US$US
226596023$22659602$3$F$$20240821$20230630$20240828$EXP$$CN-PFIZER INC-202300233491$PFIZER$Deng, L.. Co-existing squamous cell carcinoma and chronic myelomonocytic leukemia with ASXL1 and EZH2 gene mutations: A case report. World Journal of Clinical Cases. 2023;11(15):3643-3650$63$YR$$M$Y$$$20240828$$MD$CN$CN
226596636$22659663$6$F$20230301$20240626$20230630$20240709$EXP$$FR-ACRAF SpA-2023-030996$SK LIFE SCIENCE$$$$$$Y$$$20240709$$MD$FR$FR
226597143$22659714$3$F$20230515$20240723$20230630$20240730$EXP$$NVSC2023BR114625$NOVARTIS$$58$YR$$F$Y$93$KG$20240730$$CN$BR$BR
226600045$22660004$5$F$20230101$20240805$20230630$20240808$PER$$US-PFIZER INC-202300235164$PFIZER$$64$YR$$F$Y$74.84$KG$20240808$$CN$US$US
226601914$22660191$4$F$20220520$20240816$20230630$20240830$EXP$$US-UCBSA-2023033275$UCB$$49$YR$$F$Y$58.957$KG$20240830$$HP$US$US
226602133$22660213$3$F$20230410$20240722$20230630$20240725$EXP$$JP-ARGENX-2023-ARGX-JP002156$ARGENX BVBA$$$$$$Y$$$20240725$$MD$JP$JP
226602732$22660273$2$F$$20230606$20230630$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-002628$ENDO$$$$$F$Y$$$20240712$$CN$US$US
226602844$22660284$4$F$20221105$20240708$20230630$20240711$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-034862$JAZZ$$64$YR$$F$Y$104.32$KG$20240711$$CN$US$US
226603776$22660377$6$F$20230612$20240910$20230630$20240913$EXP$$IT-TAKEDA-2021TUS023064$TAKEDA$$40$YR$$M$Y$$$20240913$$CN$IT$IT
226605746$22660574$6$F$$20240710$20230630$20240722$PER$$US-VERTEX PHARMACEUTICALS-2023-005422$VERTEX$$$$A$$Y$77$KG$20240722$$CN$US$US
226607453$22660745$3$F$20220720$20240723$20230630$20240729$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-024460$JAZZ$$52$YR$$F$Y$$$20240728$$CN$US$US
226608452$22660845$2$F$$20240808$20230630$20240812$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-396605$RANBAXY$$$$$$Y$$$20240812$$PH$GB$GB
226608542$22660854$2$F$20230605$20240705$20230630$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-396544$RANBAXY$$79$YR$$M$Y$$$20240719$$MD$GB$GB
226608892$22660889$2$F$$20240828$20230630$20240904$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397069$RANBAXY$De Somer L, Bader-Meunier B, Breton S, Brachi S, Wouters C, Zulian F. Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis. Pediatr Rheumatol. 2023;21(1):7(1-8)$$$C$M$Y$$$20240904$$MD$BE$BE
226608912$22660891$2$F$$20240828$20230630$20240904$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397067$RANBAXY$De Somer L, Bader-Meunier B, Breton S, Brachi S, Wouters C, Zulian F. Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis. Pediatr Rheumatol. 2023;21(1):7(1-8)$$$C$F$Y$$$20240904$$HP$BE$BE
226608922$22660892$2$F$$20240828$20230630$20240904$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397066$RANBAXY$De Somer L, Bader-Meunier B, Breton S, Brachi S, Wouters C, Zulian F. Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis. Pediatr Rheumatol. 2023;21(1):7(1-8)$$$C$F$Y$$$20240904$$HP$BE$BE
226609112$22660911$2$F$$20240708$20230630$20240709$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-396194$RANBAXY$Choi K-Y. Valproate Adjuvant Cognitive Behavioral Therapy in PaDisorder Patients With Comorbid  Bipolar Disorder: Case Series and Review of the Literature. Psychiatry Invest. 2022;19(8):614-625$5$DEC$$$Y$$$20240709$$HP$KR$KR
226609392$22660939$2$F$$20240619$20230630$20240704$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396653$RANBAXY$Moureau G, Zarrouk E, Hoton D, Saint-Marcoux F, Boland L, Haufroid V, et al. Flecainide?induced pneumonitis: a case report. J Med Case Rep. 2022;16(1):404$61$YR$$F$Y$68$KG$20240704$$HP$BE$BE
226609462$22660946$2$F$20030101$20240717$20230630$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-396985$RANBAXY$$48$YR$$M$Y$60$KG$20240718$$MD$FR$FR
226609492$22660949$2$F$$20240828$20230630$20240904$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397063$RANBAXY$De Somer L, Bader-Meunier B, Breton S, Brachi S, Wouters C, Zulian F. Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis. Pediatr Rheumatol. 2023;21(1):7(1-8)$$$$M$Y$$$20240904$$HP$BE$BE
226609502$22660950$2$F$$20240828$20230630$20240904$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397064$RANBAXY$De Somer L, Bader-Meunier B, Breton S, Brachi S, Wouters C, Zulian F. Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis. Pediatr Rheumatol. 2023;21(1):7(1-8)$$$C$F$Y$$$20240904$$HP$BE$BE
226609512$22660951$2$F$$20240828$20230630$20240904$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397065$RANBAXY$De Somer L, Bader-Meunier B, Breton S, Brachi S, Wouters C, Zulian F. Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis. Pediatr Rheumatol. 2023;21(1):7(1-8)$$$C$F$Y$$$20240904$$HP$BE$BE
226609522$22660952$2$F$$20240813$20230630$20240826$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397158$RANBAXY$Mouri M, Imamura M, Suzuki S, Kawasaki T, Ishizaki Y, Sakurai K, et al. Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines. Allergology International. 2022;71(4):512-519$51$YR$$F$Y$$$20240826$$HP$JP$JP
226609532$22660953$2$F$$20240725$20230630$20240726$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396936$RANBAXY$Gulmez SevimD, Sener H, Evereklioglu C. Bilateral Acute Iris Transillumination and Elevated Intraocular Pressure After COVID-19 Infection. J Glaucoma. 2023;Jun; 32(6):e56-e59$43$YR$$M$Y$$$20240727$$MD$TR$TR
226609572$22660957$2$F$$20240902$20230630$20240904$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396908$RANBAXY$Zhang Y, Li Y, Zhuang Z, Wang W, Wei C, Zhao D, et al. Preliminary Evaluation of Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid  Distribution of Zanubrutinib: A 13-Case Series. Frontiers in Oncology. 11:1-10$53$YR$$F$Y$$$20240904$$HP$CN$CN
226610032$22661003$2$F$$20240828$20230630$20240904$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397061$RANBAXY$De Somer L, Bader-Meunier B, Breton S, Brachi S, Wouters C, Zulian F. Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis. Pediatr Rheumatol. 2023;21(1):7(1-8)$$$$F$Y$$$20240904$$HP$BE$BE
226610042$22661004$2$F$$20240828$20230630$20240904$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397062$RANBAXY$De Somer L, Bader-Meunier B, Breton S, Brachi S, Wouters C, Zulian F. Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis. Pediatr Rheumatol. 2023;21(1):7(1-8)$$$$M$Y$$$20240904$$HP$BE$BE
226613999$22661399$9$F$$20240808$20230630$20240813$PER$$US-BIOGEN-2019BI00810191$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
226614374$22661437$4$F$$20240826$20230630$20240828$EXP$$US-GW PHARMA-2022-US-035715$JAZZ$$$$$M$Y$40$KG$20240828$$MD$US$US
226615954$22661595$4$F$20190520$20240802$20230630$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-092282$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240812$$CN$US$US
226616952$22661695$2$F$20230608$20240708$20230630$20240710$EXP$FR-AFSSAPS-PC2023000560$FR-PFIZER INC-202300232167$PFIZER$$35$YR$$F$Y$$$20240710$$MD$FR$FR
226618116$22661811$6$F$20230101$20240805$20230630$20240808$EXP$$JP-JNJFOC-20230537200$JOHNSON AND JOHNSON$$75$YR$E$M$Y$56$KG$20240808$$HP$JP$JP
226618142$22661814$2$F$$20240822$20230630$20240828$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202306016137$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240828$$CN$NL$CN
226618199$22661819$9$F$$20240308$20230630$20240701$EXP$$US-AKCEA THERAPEUTICS, INC.-2023IS001729$AKCEA THERAPEUTICS$$$$$$Y$$$20240701$$MD$US$US
226618314$22661831$4$F$20230101$20240905$20230630$20240914$EXP$$US-ROCHE-3377408$ROCHE$$66$YR$E$F$Y$40.37$KG$20240914$$CN$US$US
226618493$22661849$3$F$20230610$20240724$20230630$20240801$EXP$$CO-TAKEDA-2023TUS063992$TAKEDA$$27$YR$$M$Y$$$20240801$$CN$CO$CO
226620018$22662001$8$F$20230619$20240702$20230630$20240711$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-014093$JAZZ$$74$YR$$M$Y$85.3$KG$20240711$$MD$US$US
226620983$22662098$3$F$$20240708$20230701$20240715$EXP$$PT-AUROBINDO-AUR-APL-2023-041288$AUROBINDO$Oliveira T, Nabais I, Pereira LM, Seuqeira C, Magalh?es RT, Relvas R et al.. A case of acyclovir-induced neurotoxicity.. Congresses of the Portuguese Society of Internal Medicine: 29th National Congres. 2023;29(Sup 1 ):257-258.$51$YR$$F$Y$$$20240715$$HP$PT$PT
226621823$22662182$3$F$$20240806$20230701$20240819$EXP$$US-CIPLA LTD.-2023US03521$CIPLA$Miklin D, Marecki G, Weintraub SF, Kuvin JT.. Bodybuilders cardiomyopathy a unique case of hormone induced heart failure. Journal of the American College of Cardiology. 2023;81(8):2973$$$$$Y$$$20240819$$MD$US$US
226622683$22662268$3$F$20200913$20240706$20230701$20240717$EXP$$DE-AUROBINDO-AUR-APL-2023-044317$AUROBINDO$$$$A$F$Y$63$KG$20240717$$MD$DE$DE
226625676$22662567$6$F$20221218$20240628$20230701$20240709$EXP$$DE-BAXTER-2023BAX025246$BAXTER$$72$YR$$M$Y$65$KG$20240709$$HP$DE$DE
226628405$22662840$5$F$20220701$20240906$20230702$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-091308$BRISTOL MYERS SQUIBB$Hamaguchi M, et al. A case of bullous pemphigoid during nivolumab administration. Skin Research. 2023;22(1):73.$67$YR$E$M$Y$66$KG$20240913$$MD$JP$JP
226628464$22662846$4$F$20230307$20240711$20230702$20240715$EXP$FR-AFSSAPS-AN2023000854$FR-ABBVIE-5311393$ABBVIE$$45$YR$$M$Y$93.6$KG$20240715$$PH$FR$FR
226631063$22663106$3$F$$20240807$20230703$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05048$LUPIN$$$$$$Y$$$20240822$$CN$US$US
226631128$22663112$8$F$20221228$20240807$20230703$20240809$EXP$$GB-ABBVIE-5309241$ABBVIE$$72$YR$$F$Y$59$KG$20240809$$MD$GB$GB
226631727$22663172$7$F$20230608$20240813$20230703$20240821$PER$$CA-TOLMAR, INC.-23CA041447$TOLMAR$$68$YR$$M$Y$$$20240821$$CN$CA$CA
226633992$22663399$2$F$$20230626$20230703$20240711$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-01737$HIKMA$$$$$$Y$$$20240710$$HP$US$US
226634052$22663405$2$F$20230101$20240627$20230703$20240703$PER$$US-BIOGEN-2023BI01207815$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
2266344811$22663448$11$F$20230101$20240816$20230703$20240826$EXP$$CA-CELLTRION INC.-2023CA011802$CELLTRION$$$$$$Y$$$20240826$$MD$CA$CA
226635613$22663561$3$F$20220322$20240823$20230703$20240904$EXP$$BR-NOVOPROD-1082491$NOVO NORDISK$$741$MON$$M$Y$67$KG$20240904$$CN$BR$BR
226636066$22663606$6$F$20230519$20240611$20230703$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002296$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$13$KG$20240705$$CN$US$US
226637282$22663728$2$F$20240824$20240826$20230703$20240902$EXP$$US-TAKEDA-2023TUS062897$TAKEDA$$71$YR$$F$Y$$$20240902$$CN$US$US
226637646$22663764$6$F$20230525$20240813$20230703$20240815$EXP$FR-AFSSAPS-PO2023000643$FR-ABBVIE-5311352$ABBVIE$$59$YR$$F$Y$$$20240815$$MD$FR$FR
226637672$22663767$2$F$20230602$20240719$20230703$20240723$EXP$FR-AFSSAPS-BX2023001078$FR-ROCHE-3380020$ROCHE$$36$YR$A$F$Y$42$KG$20240723$$PH$FR$FR
226637923$22663792$3$F$20230401$20240916$20230703$20240919$EXP$$CA-ABBVIE-5297465$ABBVIE$$73$YR$$M$Y$$$20240919$$CN$CA$CA
226638194$22663819$4$F$20210201$20240626$20230703$20240704$EXP$$DE-AUROBINDO-AUR-APL-2023-044902$AUROBINDO$$$$E$F$Y$52.5$KG$20240704$$MD$DE$DE
226638624$22663862$4$F$20211104$20240708$20230703$20240717$EXP$$CA-CELLTRION INC.-2021CA006990$CELLTRION$$$$$$Y$$$20240717$$HP$CA$CA
226638655$22663865$5$F$20230524$20240917$20230703$20240923$EXP$$JP-ASTELLAS-2023JP007719$ASTELLAS$$78$YR$E$F$Y$53$KG$20240923$$MD$JP$JP
226638703$22663870$3$F$20170516$20240704$20230703$20240710$EXP$$BR-TAKEDA-2017TUS011508$TAKEDA$$62$YR$$M$Y$$$20240710$$CN$BR$BR
226639416$22663941$6$F$$20240701$20230703$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-092362$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$62.6$KG$20240702$$CN$US$US
226641105$22664110$5$F$20220630$20240711$20230703$20240714$EXP$$US-TAKEDA-US202029625$TAKEDA$$73$YR$$M$Y$$$20240714$$CN$US$US
2266412415$22664124$15$F$20230621$20240829$20230703$20240904$EXP$$CA-TAKEDA-2023TUS044265$TAKEDA$$67$YR$$F$Y$$$20240904$$CN$CA$CA
226642914$22664291$4$F$$20240703$20230703$20240705$EXP$$CA-TAKEDA-2022TUS103113$TAKEDA$$$$$M$Y$$$20240705$$CN$CA$CA
226643255$22664325$5$F$$20240909$20230703$20240911$PER$$US-PFIZER INC-PV202300084494$PFIZER$$72$YR$$F$Y$76.644$KG$20240911$$MD$US$US
2266433010$22664330$10$F$$20240828$20230703$20240904$PER$$US-PFIZER INC-PV202300114610$PFIZER$$85$YR$$F$Y$59$KG$20240904$$CN$US$US
226643384$22664338$4$F$$20240708$20230703$20240710$PER$$US-PFIZER INC-PV202300112661$PFIZER$$79$YR$$F$Y$63.492$KG$20240710$$CN$US$US
226644452$22664445$2$F$$20240816$20230703$20240820$PER$$US-PFIZER INC-PV202300115710$PFIZER$$62$YR$$M$Y$$$20240820$$CN$US$US
226646479$22664647$9$F$20230601$20240626$20230703$20240703$PER$$US-BIOGEN-2023BI01212621$BIOGEN$$69$YR$$F$Y$$$20240703$$CN$US$US
226646933$22664693$3$F$20230101$20240904$20230703$20240912$PER$$US-009507513-2306USA008394$MERCK$$$$$F$Y$72.109$KG$20240912$$HP$US$US
226646995$22664699$5$F$20230620$20240711$20230703$20240717$PER$$US-ABBVIE-5312308$ABBVIE$$$$$F$Y$$$20240717$$HP$US$US
226647183$22664718$3$F$$20240909$20230703$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05128$LUPIN$$$$$$Y$$$20240923$$CN$US$US
226647363$22664736$3$F$$20240704$20230703$20240705$EXP$$CA-PFIZER INC-202300234782$PFIZER$$53$YR$$F$Y$$$20240705$$HP$CA$CA
2266493612$22664936$12$F$20230101$20240919$20230703$20240930$EXP$$US-INSMED, INC.-2023-02363-US$INSMED$$$$$M$Y$$$20240930$$CN$US$US
226651062$22665106$2$F$$20240729$20230703$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394499$RANBAXY$Mikheev AT, Adawi M, Mirza A, Bechtel A.. Prolonged fever and inflammation in a young child in the midst of the pandemic-it^s not always MIS-C. Am j med sci. 2023;365(S1):S390(710)$10$YR$$M$Y$$$20240813$$HP$US$US
226651262$22665126$2$F$$20240905$20230703$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381922$RANBAXY$Harada Y, Wang S-H, Juel VC. Clinical Reasoning: A 36-Year-Old Man With Asymmetric Muscle Weakness. Neurology. 2022;Dec;99(23):1057-1061$36$YR$$M$Y$$$20240913$$MD$US$US
226651612$22665161$2$F$$20240702$20230703$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395709$RANBAXY$Charara R, ShapiroKrew AP. The Role of Lithium in the Management of Altered Mental Status in Phelan-McDermid Syndrome: A Case Report. J Acad Consult Liaison Psychiatry. 2022;63(Suppl.2):S161(98)$18$YR$$M$Y$$$20240717$$HP$US$US
226651762$22665176$2$F$$20240618$20230703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381331$RANBAXY$Morataya C, Nugent K. A case of recurrent neuroleptic malignant syndrome. Am J Med Sci. 2023;365 (Suppl. 1):S258-S259(479)$36$YR$$M$Y$$$20240703$$HP$US$US
226652562$22665256$2$F$$20240901$20230703$20240904$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381662$RANBAXY$Piazera FZ, Paiva CRC, Araujo LL, Andrade IRA, Souza MVF, Saba E, et al. CASE REPSEPTIC ARTHRITIS CYTOMEGALOVIRUS (CMV) INFECTION AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION. Hematol Transfus Cell Ther. 2022;44 (Suppl. 2):S327-S328$41$YR$$M$Y$$$20240904$$HP$BR$BR
226652572$22665257$2$F$$20240716$20230703$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381953$RANBAXY$Hutchison SM, Brain U, Grunau RE, Kuzeljevic B, Irvine M, Masse LC, et al. Associations between maternal depressive symptoms and selective serotonin reuptake inhibitor antidepressant treatment on internalising and anxiety behaviours in children: 12-year longitudinal study. BJPsych Open. 2023;9(2):e26, 1-9$$$$F$Y$$$20240718$$HP$CA$CA
226652692$22665269$2$F$$20240709$20230703$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381916$RANBAXY$Vial B, Lieb M, Pysick H, Hettinger P, Rusy L, Hoben G. Challenges and Potential in Targeted Muscle Reinnervation in Pediatric Amputees. Pediatrics. 2022;149(1):e2021051010(1-6)$7$YR$$M$Y$$$20240710$$MD$US$US
226653272$22665327$2$F$$20240816$20230703$20240826$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-388740$RANBAXY$Kikuchi Y, Odashima Y, Yoshikawa K, Oda T, Tanaka F, Oikawa H, et al.. Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema. BMC Nephrol. 2022;23(1):348$55$YR$$F$Y$$$20240826$$HP$JP$JP
226653402$22665340$2$F$$20240723$20230703$20240807$EXP$$PR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-381293$RANBAXY$Ortiz Velez I, Gener E, Quiles-Cruz C, Roman-Velez N, Rodriguez KP, Rosado-Jimenez M, et al. The Challenge of multi-organism lung infection with human immunodeficiency virus. Am J Med Sci. 2023;365 (Suppl. 1):S160-S161$57$YR$$M$Y$$$20240807$$HP$PR$PR
226654312$22665431$2$F$$20240814$20230703$20240819$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381348$RANBAXY$Yehia R, Weidow N, Maertens PA,Tengsupakul  S. Successful treatment of parechovirus meningoencephalitis and myocarditis in two neonates. Am J Med Sci. 2023;365 (Suppl1:S225-S226 (423)$10$DY$$F$Y$$$20240819$$HP$US$US
226654382$22665438$2$F$$20240913$20230703$20240927$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381598$RANBAXY$$$$E$M$Y$75$KG$20240927$$PH$BR$BR
226654842$22665484$2$F$20230223$20240910$20230703$20240925$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-384219$RANBAXY$$57$YR$$F$Y$$$20240925$$CN$GB$GB
226656233$22665623$3$F$20230619$20240921$20230703$20240927$EXP$$CO-GSK-CO2023AMR089625$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$PH$CO$CO
226656996$22665699$6$F$20231101$20240911$20230703$20240916$EXP$$US-ABBVIE-5312220$ABBVIE$$76$YR$$M$Y$$$20240916$$CN$US$US
226657254$22665725$4$F$$20240814$20230703$20240819$EXP$$US-PFIZER INC-PV202300114549$PFIZER$$70$YR$$F$Y$$$20240819$$HP$US$US
226657725$22665772$5$F$$20240819$20230703$20240826$EXP$$US-OTSUKA-2023_017212$OTSUKA$$$$$M$Y$$$20240826$$CN$US$US
226658535$22665853$5$F$20230630$20240925$20230703$20240930$PER$$US-BIOGEN-2023BI01213801$BIOGEN$$68$YR$$F$Y$$$20240930$$CN$US$US
226658544$22665854$4$F$20240401$20240829$20230703$20240902$EXP$$US-UCBSA-2023033424$UCB$$37$YR$$M$Y$$$20240902$$CN$US$US
226658653$22665865$3$F$20230522$20240828$20230703$20240906$EXP$$NL-GSK-NL2023EME089547$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$NL$NL
226659064$22665906$4$F$20230619$20240708$20230703$20240708$EXP$PT-INFARMED-E202306-858$PT-PFIZER INC-202300235316$PFIZER$$64$YR$$F$Y$$$20240708$$PH$PT$PT
226660875$22666087$5$F$20230101$20240909$20230703$20240916$PER$$US-SA-2023SA196483$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240916$$MD$US$US
226661512$22666151$2$F$20230601$20240712$20230703$20240722$PER$$US-SA-2023SA200338$SANOFI AVENTIS$$19$YR$A$F$Y$58.05$KG$20240722$$MD$US$US
226663473$22666347$3$F$20230101$20240820$20230703$20240829$EXP$$JP-AstraZeneca-2023A150584$ASTRAZENECA$$75$YR$$F$Y$42$KG$20240829$$MD$JP$
226665202$22666520$2$F$20230509$20240705$20230703$20240715$EXP$IT-MINISAL02-928798$IT-TEVA-2023-IT-2901604$TEVA$$17$YR$$F$Y$43$KG$20240715$$PH$IT$IT
2266662815$22666628$15$F$20230118$20240711$20230703$20240720$EXP$$CA-GILEAD-2023-0626590$GILEAD$$70$YR$E$F$Y$$$20240719$$MD$CA$CA
226667273$22666727$3$F$20220801$20240916$20230703$20240920$EXP$$FR-PFIZER INC-FR-GBT-015968$PFIZER$$15$YR$$F$Y$$$20240920$$MD$FR$FR
226667357$22666735$7$F$20230622$20240903$20230703$20240905$EXP$$CA-ROCHE-3380623$ROCHE$$56$YR$A$F$Y$$$20240905$$CN$CA$CA
226669422$22666942$2$F$$20240620$20230704$20240703$EXP$$JP-AMGEN-JPNSP2023113941$AMGEN$Narushima M. A case of HER2 positive breast cancer with successful long-term survival after multimodal therapy for repeated postoperative recurrence in consideration of adverse events. The 31st Annual Meeting of the Japanese Breast Cancer Society. 2023;429$60$YR$A$F$Y$$$20240703$$MD$JP$JP
226669925$22666992$5$F$20230606$20240618$20230704$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002322$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240712$$CN$US$US
226670113$22667011$3$F$20230615$20240814$20230704$20240827$EXP$$NL-AUROBINDO-AUR-APL-2023-045152$AUROBINDO$$69$YR$$M$Y$98.7$KG$20240827$$MD$NL$NL
226670425$22667042$5$F$20230616$20240905$20230704$20240926$PER$$CA-TOLMAR, INC.-23CA041538$TOLMAR$$81$YR$$M$Y$$$20240926$$CN$CA$CA
226671546$22667154$6$F$20230331$20240913$20230704$20240921$EXP$$CA-CELLTRION INC.-2023CA008870$CELLTRION$$$$$$Y$$$20240921$$CN$CA$CA
226672172$22667217$2$F$$20240806$20230704$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05154$LUPIN$$$$$$Y$$$20240828$$CN$US$US
226675123$22667512$3$F$$20240821$20230704$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-091603$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240828$$MD$JP$JP
226675193$22667519$3$F$20230629$20240711$20230704$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-092790$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240712$$CN$US$US
226675994$22667599$4$F$$20240710$20230704$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-092928$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240715$$CN$US$US
226677608$22667760$8$F$20230623$20240628$20230704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-092964$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240704$$CN$US$US
226681259$22668125$9$F$20220204$20240830$20230704$20240904$EXP$$CA-TAKEDA-2023TUS001123$TAKEDA$$21$YR$$F$Y$$$20240904$$CN$CA$CA
226681327$22668132$7$F$20230801$20240808$20230704$20240904$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000562$DECIPHERA PHARMACEUTICALS$$44$YR$A$M$Y$$$20240904$$MD$US$US
226681524$22668152$4$F$20230105$20240613$20230704$20240701$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000563$DECIPHERA PHARMACEUTICALS$$57$YR$A$M$Y$$$20240701$$MD$US$US
226682446$22668244$6$F$20231201$20240708$20230704$20240716$EXP$$CA-TAKEDA-CA202020716$TAKEDA$$26$YR$$F$Y$85$KG$20240716$$MD$CA$CA
226684303$22668430$3$F$$20240712$20230704$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202306019613$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240730$$CN$US$US
226685825$22668582$5$F$20230403$20240812$20230704$20240816$EXP$$CO-TAKEDA-2023TUS035376$TAKEDA$$43$YR$$F$Y$59$KG$20240816$$CN$CO$CO
226686095$22668609$5$F$20230101$20240626$20230704$20240705$EXP$$US-ABBVIE-5310037$ABBVIE$$$$$M$Y$122$KG$20240705$$CN$US$US
226686146$22668614$6$F$20220528$20240702$20230704$20240705$EXP$$JP-AstraZeneca-2023A151837$ASTRAZENECA$Horibe R, et al.. [CASE REPORT] De novo Hepatitis B Virus Reactivation during Treatment with an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Patient with Advanced Lung Cancer. Internal medicine 2024;63(12):1797-1800.$71$YR$$F$Y$46$KG$20240705$$MD$JP$
2266868310$22668683$10$F$20200101$20240715$20230704$20240725$EXP$$CA-TAKEDA-CA202005318$TAKEDA$$50$YR$$F$Y$41$KG$20240725$$HP$CA$CA
226686845$22668684$5$F$$20240903$20230704$20240909$EXP$$CA-TAKEDA-2023TUS054251$TAKEDA$$$$$M$Y$$$20240909$$HP$CA$CA
226687683$22668768$3$F$20230613$20240729$20230704$20240731$EXP$$AR-ABBVIE-5312008$ABBVIE$$48$YR$$F$Y$$$20240731$$CN$AR$AR
226688034$22668803$4$F$$20240916$20230704$20240918$EXP$$ZA-TAKEDA-2023TUS059851$TAKEDA$$$$$M$Y$$$20240918$$CN$ZA$ZA
226689353$22668935$3$F$$20240816$20230704$20240822$EXP$$AT-MYLANLABS-2023M1069585$MYLAN$$$$$$Y$$$20240822$$HP$AT$AT
226689465$22668946$5$F$20220726$20240814$20230704$20240819$EXP$$US-PFIZER INC-PV202300115393$PFIZER$$90$YR$$M$Y$$$20240819$$CN$US$US
226689774$22668977$4$F$20230101$20240718$20230704$20240726$PER$$US-SA-2023SA202297$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240726$$MD$US$US
226691234$22669123$4$F$20210101$20240807$20230704$20240814$PER$$US-SA-2023SA202230$SANOFI AVENTIS$$$$C$F$Y$$$20240814$$MD$US$US
226691952$22669195$2$F$20230625$20240725$20230704$20240806$PER$$US-SA-2023SA203041$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240806$$MD$US$US
226692642$22669264$2$F$20230703$20240701$20230704$20240703$EXP$$US-TAKEDA-2023TUS065246$TAKEDA$$56$YR$$M$Y$$$20240703$$MD$US$US
226693087$22669308$7$F$20230610$20240912$20230704$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-092417$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$69.4$KG$20240916$$CN$US$US
226693286$22669328$6$F$20230420$20240628$20230704$20240703$EXP$$IN-PFIZER INC-PV202300113761$PFIZER$$54$YR$$F$Y$58.9$KG$20240703$$CN$IN$IN
226693994$22669399$4$F$20211213$20240705$20230704$20240712$EXP$IT-MINISAL02-849712$IT-PFIZER INC-202300234731$PFIZER$Dubbini, M.. Apoptotic colitis secondary to brentuximab vedotin: an immune mediated adverse event responsive to steroid treatment. Leukemia + Lymphoma. 2023;1-3$49$YR$$M$Y$$$20240712$$HP$IT$IT
226694142$22669414$2$F$$20240828$20230704$20240904$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397248$RANBAXY$Acar T, Sahin AC, Semiz I, Gulac B. Cesarean scar pregnancy: role of serial transabdominal ultrasonography in the diagnosis and treatment response following dilation and curettage. Med Ultrason. 2016;18(1):135-136$31$YR$$F$Y$$$20240904$$HP$TR$TR
226694402$22669440$2$F$20140101$20240731$20230704$20240802$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397532$RANBAXY$Gronich N, Maman D, Stein N, Saliba W. Culprit Medications and Risk Factors Associated with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case-Control Study. Am J Clin Derm. 2022;23(2):257-266$83$YR$$F$Y$$$20240802$$MD$IL$IL
226696132$22669613$2$F$20180928$20240818$20230704$20240902$EXP$$AT-SAMSUNG BIOEPIS-SB-2023-17225$SAMSUNG BIOEPIS$$78$YR$E$F$Y$58$KG$20240902$$MD$AT$AT
226696534$22669653$4$F$$20240805$20230704$20240807$PER$$US-PFIZER INC-PV202300113769$PFIZER$$69$YR$$M$Y$$$20240807$$CN$US$US
226696814$22669681$4$F$20230525$20240828$20230704$20240829$EXP$FR-AFSSAPS-PO2023000643$FR-BAUSCH-BL-2023-010094$BAUSCH AND LOMB$$59$YR$$F$Y$$$20240829$$MD$FR$FR
226696884$22669688$4$F$20230301$20240830$20230704$20240905$EXP$$JP-009507513-2306JPN004343J$MERCK$$66$YR$$M$Y$$$20240905$$MD$JP$JP
226696892$22669689$2$F$$20240904$20230704$20240909$PER$$US-PFIZER INC-202300235191$PFIZER$$63$YR$$F$Y$$$20240909$$HP$US$US
226696993$22669699$3$F$20230101$20240627$20230704$20240702$EXP$$US-UCBSA-2023033525$UCB$$$$$F$Y$$$20240702$$HP$US$US
2266973111$22669731$11$F$20230101$20240807$20230704$20240815$EXP$$CA-TAKEDA-2023TUS063179$TAKEDA$$$$$M$Y$$$20240815$$MD$CA$CA
226698715$22669871$5$F$20210101$20240826$20230704$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-014173$JAZZ$$$$$F$Y$$$20240828$$CN$US$US
226699393$22669939$3$F$20230101$20240801$20230704$20240806$EXP$$US-ABBVIE-5312278$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
226699596$22669959$6$F$20230627$20240829$20230704$20240904$EXP$$US-ABBVIE-5313198$ABBVIE$$38$YR$$M$Y$$$20240904$$CN$US$US
226699964$22669996$4$F$$20240722$20230704$20240726$EXP$$ZA-TAKEDA-2023TUS030951$TAKEDA$$$$$F$Y$$$20240726$$MD$ZA$ZA
226700135$22670013$5$F$20221212$20240906$20230704$20240911$EXP$$CA-PFIZER INC-202201372573$PFIZER$$64$YR$$F$Y$$$20240911$$HP$CA$CA
226700243$22670024$3$F$$20240724$20230704$20240729$EXP$$US-PFIZER INC-202300235095$PFIZER$$21$YR$$M$Y$61.23$KG$20240729$$CN$US$US
226701062$22670106$2$F$$20240628$20230704$20240706$PER$$US-SA-2023SA200880$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240706$$CN$US$US
2267020910$22670209$10$F$20210223$20240628$20230704$20240706$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202306018737$ELI LILLY AND CO$$$$A$F$Y$60$KG$20240706$$MD$DE$DE
2267029315$22670293$15$F$20210730$20240906$20230705$20240916$EXP$$CA-CELLTRION INC.-2021CA012561$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
226703237$22670323$7$F$$20240717$20230705$20240724$EXP$$CA-TAKEDA-2023TUS064889$TAKEDA$$$$$F$Y$$$20240724$$CN$CA$CA
226704252$22670425$2$F$20230619$20230627$20230705$20240925$PER$$US-GSK-US2023AMR089460$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240925$$CN$US$US
226705114$22670511$4$F$20200721$20240828$20230705$20240906$EXP$$US-JNJFOC-20230659124$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240906$$LW$US$US
2267053712$22670537$12$F$20230619$20240916$20230705$20240920$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-246829$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240920$$CN$US$US
226706412$22670641$2$F$$20230629$20230705$20240925$PER$$US-GSK-US2023AMR090709$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
226707402$22670740$2$F$$20230627$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003289$SAREPTA THERAPEUTICS$$$$$M$Y$36.281$KG$20240702$$CN$US$US
226707452$22670745$2$F$20230519$20230703$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003514$SAREPTA THERAPEUTICS$$15$YR$$M$Y$40.4$KG$20240702$$HP$US$US
226707522$22670752$2$F$20230614$20230703$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003510$SAREPTA THERAPEUTICS$$25$YR$$M$Y$127.89$KG$20240702$$HP$US$US
226707542$22670754$2$F$20230101$20240918$20230705$20240923$EXP$$US-SA-2023SA203082$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240923$$MD$US$US
226707572$22670757$2$F$20230607$20231106$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003463$SAREPTA THERAPEUTICS$$11$YR$$M$Y$74$KG$20240702$$HP$US$US
226707622$22670762$2$F$20230620$20230628$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003520$SAREPTA THERAPEUTICS$$12$YR$$M$Y$$$20240702$$HP$US$US
226707762$22670776$2$F$20230403$20230728$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003294$SAREPTA THERAPEUTICS$$11$YR$$M$Y$55.3$KG$20240702$$CN$US$US
226707942$22670794$2$F$20230602$20231003$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003450$SAREPTA THERAPEUTICS$$11$YR$$M$Y$60.771$KG$20240702$$HP$US$US
226707972$22670797$2$F$20230614$20230719$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003528$SAREPTA THERAPEUTICS$$9$YR$$M$Y$18.6$KG$20240702$$HP$US$US
226707992$22670799$2$F$20230518$20230719$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003419$SAREPTA THERAPEUTICS$$23$YR$$M$Y$63.492$KG$20240702$$HP$US$US
226708112$22670811$2$F$20230511$20231002$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003363$SAREPTA THERAPEUTICS$$20$YR$$M$Y$$$20240702$$HP$US$US
226708142$22670814$2$F$20230608$20230626$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003469$SAREPTA THERAPEUTICS$$18$YR$$M$Y$28.99$KG$20240702$$HP$US$US
226708152$22670815$2$F$$20230803$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003318$SAREPTA THERAPEUTICS$$$$$M$Y$109.1$KG$20240702$$HP$US$US
226708182$22670818$2$F$20230502$20230913$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003347$SAREPTA THERAPEUTICS$$11$YR$$M$Y$39.4$KG$20240702$$CN$US$US
226708202$22670820$2$F$20230601$20230718$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003443$SAREPTA THERAPEUTICS$$11$YR$$M$Y$47.619$KG$20240702$$HP$US$US
226708212$22670821$2$F$20230617$20230912$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003513$SAREPTA THERAPEUTICS$$26$YR$$M$Y$$$20240702$$HP$US$US
226708242$22670824$2$F$20230518$20230720$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003415$SAREPTA THERAPEUTICS$$11$YR$$M$Y$44.943$KG$20240702$$HP$US$US
226708312$22670831$2$F$20230615$20230630$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003516$SAREPTA THERAPEUTICS$$22$YR$$M$Y$43.084$KG$20240702$$HP$US$US
226708332$22670833$2$F$20230531$20231221$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003502$SAREPTA THERAPEUTICS$$15$YR$$M$Y$63.49$KG$20240702$$HP$US$US
226708342$22670834$2$F$20230425$20230720$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003325$SAREPTA THERAPEUTICS$$12$YR$$F$Y$37.2$KG$20240702$$HP$US$US
226708372$22670837$2$F$20230523$20230809$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003509$SAREPTA THERAPEUTICS$$13$YR$$M$Y$58.7$KG$20240702$$HP$US$US
226708542$22670854$2$F$20230301$20230922$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003121$SAREPTA THERAPEUTICS$$26$YR$$M$Y$60.771$KG$20240702$$HP$US$US
226708885$22670888$5$F$$20240628$20230705$20240703$EXP$$CA-TAKEDA-2023TUS060881$TAKEDA$$$$$F$Y$$$20240703$$CN$CA$CA
226709852$22670985$2$F$20230106$20240108$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-002995$SAREPTA THERAPEUTICS$$18$YR$$M$Y$$$20240702$$HP$US$US
226709952$22670995$2$F$20220901$20230803$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2022-002886$SAREPTA THERAPEUTICS$$24$YR$$M$Y$43.54$KG$20240702$$HP$US$US
226710742$22671074$2$F$$20240105$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2022-002707$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$CN$US$US
226710802$22671080$2$F$20221109$20230801$20230705$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2022-002676$SAREPTA THERAPEUTICS$$12$YR$$M$Y$$$20240702$$HP$US$US
226713243$22671324$3$F$20230620$20240716$20230705$20240726$30DAY$$US-GSK-US2023089185$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240726$$CN$US$US
226714175$22671417$5$F$$20240815$20230705$20240820$EXP$$CA-JNJFOC-20230668671$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240821$$HP$CA$CA
226714473$22671447$3$F$20231213$20240905$20230705$20240911$EXP$$CA-TAKEDA-2023TUS063809$TAKEDA$$82$YR$$M$Y$$$20240911$$CN$CA$CA
226714725$22671472$5$F$$20240822$20230705$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-094243$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$75.75$KG$20240824$$CN$US$US
226715002$22671500$2$F$$20240817$20230705$20240826$EXP$$US-AMGEN-USASP2023112175$AMGEN$Moore C.A.. Incidence of Acute Cellular Rejection After Granulocyte Colony- Stimulating Factor in Lung Transplant Recipients. Journal of Pharmacy Practice. 2023;0(0):1-8$$$$$Y$$$20240826$$HP$US$US
226716055$22671605$5$F$20230611$20230801$20230705$20240723$EXP$$AE-AstraZeneca-2023A150706$ASTRAZENECA$$49$YR$$M$Y$90.8$KG$20240723$$MD$AE$
226717303$22671730$3$F$$20240829$20230705$20240904$EXP$$BR-TAKEDA-2023TUS065001$TAKEDA$$$$$F$Y$67$KG$20240904$$CN$BR$BR
226718234$22671823$4$F$20220607$20230828$20230705$20240925$EXP$$US-GSK-US2021AMR251835$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
226718375$22671837$5$F$20230319$20240830$20230705$20240909$EXP$$CN-TAKEDA-2022TUS098609$TAKEDA$$49$YR$$M$Y$68$KG$20240909$$MD$CN$CN
226718432$22671843$2$F$$20240819$20230705$20240821$PER$$NVSC2023US044638$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
226719222$22671922$2$F$$20240730$20230705$20240807$EXP$$JP-AMGEN-JPNCT2023114372$AMGEN$Ichinokawa K, Takeno N, Kubota T, Kushibiki T, Takano H, Doumen H, et al.. EP-0736 12 cases of metastatic breast cancer treated with trastuzumab deruxtecan (Second Report). The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;361$$$$$Y$$$20240806$$MD$JP$JP
226720143$22672014$3$F$20230515$20240730$20230705$20240805$EXP$FR-AFSSAPS-PV2023000562$FR-EMD Serono-2023457825$EMD SERONO INC$$11$YR$C$M$Y$44$KG$20240805$$MD$FR$FR
226723065$22672306$5$F$$20240911$20230705$20240919$EXP$$JP-GSK-JP2023JPN090217$GLAXOSMITHKLINE$Wada Y. Towards future actual treatment of SLE. SLE Advanced Meeting. 2024$$$$$Y$$$20240919$$MD$JP$JP
226724783$22672478$3$F$$20240812$20230705$20240816$EXP$$PL-MYLANLABS-2022M1113318$MYLAN$Liszka K, Resztak M, Zalewska P, Kalwak K.. Therapeutic drug monitoring of posaconazole for effective prophylaxis of invasive fungal infections in pediatric patients. pilot study. Acta Haematologica Polonica.. 2021;52(6):578-83$4$YR$$$Y$18$KG$20240816$$HP$PL$PL
226725334$22672533$4$F$20221001$20240819$20230705$20240826$EXP$$US-VERTEX PHARMACEUTICALS-2022-016067$VERTEX$$32$YR$$M$Y$81$KG$20240826$$MD$US$US
226725363$22672536$3$F$$20240809$20230705$20240814$PER$$US-VERTEX PHARMACEUTICALS-2023-009622$VERTEX$$$$$F$Y$$$20240814$$CN$US$US
226725952$22672595$2$F$$20240903$20230705$20240905$EXP$$NVSC2023US148928$NOVARTIS$$$$$M$Y$$$20240905$$CN$US$US
226726363$22672636$3$F$20210301$20230913$20230705$20240714$EXP$$NL-SA-2023SA203996$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240715$$CN$NL$NL
226726882$22672688$2$F$20230601$20240621$20230705$20240705$PER$$US-SA-2023SA201519$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240705$$MD$US$US
226727442$22672744$2$F$$20240708$20230705$20240716$PER$$US-SA-2023SA201122$SANOFI AVENTIS$$4$YR$C$M$Y$15$KG$20240716$$MD$US$US
226727723$22672772$3$F$20230525$20240816$20230705$20240820$EXP$FR-AFSSAPS-PO2023000643$FR-PFIZER INC-202300238921$PFIZER$$59$YR$$F$Y$$$20240820$$MD$FR$FR
226735013$22673501$3$F$20230530$20240831$20230705$20240905$EXP$$JP-009507513-2306JPN004159J$MERCK$$65$YR$$F$Y$49$KG$20240905$$MD$JP$JP
226735236$22673523$6$F$20230525$20240924$20230705$20240927$EXP$$US-PFIZER INC-202300236353$PFIZER$$40$YR$$M$Y$79$KG$20240927$$CN$US$US
226735832$22673583$2$F$20240709$20240710$20230705$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-014184$JAZZ$$11$YR$$M$Y$$$20240716$$CN$US$US
226736032$22673603$2$F$$20240702$20230705$20240705$EXP$$GB-PFIZER INC-202300239187$PFIZER$$$$$F$Y$$$20240705$$PH$GB$GB
226736042$22673604$2$F$$20240703$20230705$20240705$EXP$$GB-PFIZER INC-202300237651$PFIZER$$$$$$Y$$$20240705$$PH$GB$GB
226736104$22673610$4$F$$20240816$20230705$20240824$EXP$$CA-TAKEDA-2023TUS039682$TAKEDA$$$$$F$Y$135$KG$20240824$$CN$CA$CA
226736117$22673611$7$F$$20240917$20230705$20240919$EXP$GB-TAKEDA-2022TUS008130$GB-MYLANLABS-2023M1069500$MYLAN$$74$YR$$M$Y$$$20240919$$CN$GB$GB
226736738$22673673$8$F$20231024$20240813$20230705$20240819$EXP$$CA-TAKEDA-2023TUS047710$TAKEDA$$41$YR$$F$Y$$$20240819$$MD$CA$CA
2267377210$22673772$10$F$20230101$20240917$20230705$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-093853$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240918$$CN$US$US
2267380512$22673805$12$F$20230101$20240808$20230705$20240819$PER$$US-XERIS PHARMACEUTICALS-2023XER01959$XERIS PHARMACEUTICALS$$$$$F$Y$129.25$KG$20240816$$CN$US$US
226739422$22673942$2$F$$20240727$20230705$20240805$EXP$$US-EMD Serono-2023458447$EMD SERONO INC$$$$A$F$Y$$$20240805$$CN$US$US
226739635$22673963$5$F$20210801$20240808$20230705$20240814$EXP$$DE-MYLANLABS-2023M1069666$MYLAN$$$$A$F$Y$$$20240814$$HP$DE$DE
226741107$22674110$7$F$20231201$20240721$20230705$20240725$EXP$$CA-JNJFOC-20230706504$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240725$$HP$CA$CA
226742118$22674211$8$F$20230331$20240917$20230705$20240923$EXP$$NL-MYLANLABS-2023M1069138$MYLAN$$9$YR$$M$Y$$$20240923$$MD$NL$NL
226743423$22674342$3$F$$20240820$20230705$20240829$PER$$US-INCYTE CORPORATION-2023IN006712$INCYTE$$$$$$Y$$$20240829$$CN$US$US
226745334$22674533$4$F$$20240819$20230705$20240821$PER$$US-PFIZER INC-PV202300114146$PFIZER$$84$YR$$M$Y$68$KG$20240821$$CN$US$US
226745555$22674555$5$F$20240401$20240924$20230705$20240925$EXP$$US-PFIZER INC-202300236180$PFIZER$$61$YR$$F$Y$$$20240925$$HP$US$US
2267457612$22674576$12$F$20220601$20240910$20230705$20240912$PER$$US-PFIZER INC-PV202200126377$PFIZER$$74$YR$$F$Y$$$20240912$$CN$US$US
226746472$22674647$2$F$20220205$20240701$20230705$20240703$EXP$$US-INCYTE CORPORATION-2023IN006891$INCYTE$$$$$$Y$$$20240703$$CN$US$US
226748018$22674801$8$F$20230623$20231027$20230705$20240925$PER$$US-GSK-US2023AMR089365$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240925$$CN$US$US
2267491216$22674912$16$F$20230101$20240723$20230706$20240724$EXP$$AT-ABBVIE-5289628$ABBVIE$$68$YR$$F$Y$82$KG$20240724$$MD$AT$AT
226750923$22675092$3$F$20230616$20240829$20230706$20240923$PER$$CA-TOLMAR, INC.-23CA041511$TOLMAR$$75$YR$$M$Y$$$20240923$$CN$CA$CA
226752072$22675207$2$F$20210818$20240709$20230706$20240715$EXP$$CA-JNJFOC-20210762046$JOHNSON AND JOHNSON$$14$YR$T$F$Y$81$KG$20240715$$HP$CA$CA
226752462$22675246$2$F$$20240802$20230706$20240809$EXP$$IL-ROCHE-3377536$ROCHE$Berger T, Shochat T, Aumann S, Nachmias B, Goldschmidt N, Horesh N, Hare R, Aviv A, Shmert E, Abadi U, Shimony S, Raanani P, Gafter-Gvili A and Gurion R. Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study. Doi:10.1007/s00277-023-05306-2. Annals of hematology 2023 Jun 19;:-.$$$$$Y$$$20240809$$HP$IL$IL
226753812$22675381$2$F$$20240729$20230706$20240802$EXP$$NVSC2023US149941$NOVARTIS$$$$$M$Y$$$20240802$$CN$US$US
226754603$22675460$3$F$$20240904$20230706$20240911$EXP$$NVSC2023GB149934$NOVARTIS$$$$A$F$Y$$$20240911$$CN$GB$GB
226755066$22675506$6$F$20230101$20240906$20230706$20240916$EXP$$CA-CELLTRION INC.-2023CA013535$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
226755764$22675576$4$F$20230101$20240725$20230706$20240731$EXP$$CA-ABBVIE-5316113$ABBVIE$$$$$F$Y$$$20240731$$CN$CA$CA
226756406$22675640$6$F$20220318$20240604$20230706$20240730$EXP$$US-NOVOPROD-1085650$NOVO NORDISK$$69$YR$$F$Y$$$20240730$$HP$US$US
226756925$22675692$5$F$$20240906$20230706$20240911$EXP$$CA-TAKEDA-2023TUS012336$TAKEDA$$$$$F$Y$$$20240911$$CN$CA$CA
226756978$22675697$8$F$20230625$20240801$20230706$20240805$EXP$$CA-TAKEDA-2023TUS065631$TAKEDA$$68$YR$$M$Y$$$20240805$$HP$CA$CA
226757319$22675731$9$F$20230627$20240708$20230706$20240713$EXP$$US-JNJFOC-20230703725$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240713$$MD$US$US
226757358$22675735$8$F$20230101$20240723$20230706$20240726$EXP$$US-BAUSCH-BL-2023-006201$BAUSCH AND LOMB$$45$YR$$F$Y$$$20240726$$CN$US$US
226758793$22675879$3$F$20220716$20240626$20230706$20240702$EXP$$BR-TAKEDA-2023TUS065355$TAKEDA$$29$YR$$F$Y$$$20240702$$CN$BR$BR
226758846$22675884$6$F$20230617$20240828$20230706$20240902$EXP$$CA-TAKEDA-2023TUS065067$TAKEDA$$41$YR$$M$Y$$$20240902$$CN$CA$CA
226758852$22675885$2$F$20230501$20240918$20230706$20240925$EXP$$CA-TAKEDA-2023TUS065619$TAKEDA$$32$YR$$M$Y$$$20240925$$MD$CA$CA
226759662$22675966$2$F$$20240801$20230706$20240808$30DAY$$US-GSK-US2023089053$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
226759983$22675998$3$F$$20240910$20230706$20240913$EXP$$FR-ASTELLAS-2023US019824$ASTELLAS$$77$YR$E$M$Y$$$20240913$$MD$FR$FR
226761563$22676156$3$F$$20240918$20230706$20240927$EXP$$GR-CELLTRION INC.-2023GR013361$CELLTRION$$$$$$Y$$$20240927$$MD$GR$GR
226763105$22676310$5$F$$20240827$20230706$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-094875$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$107.5$KG$20240829$$CN$US$US
2267643410$22676434$10$F$$20240909$20230706$20240916$EXP$$CA-GSK-CA2023AMR076581$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$CA$CA
2267646121$22676461$21$F$20230616$20240916$20230706$20240924$EXP$$CA-TAKEDA-2023TUS008807$TAKEDA$$72$YR$$M$Y$$$20240924$$HP$CA$CA
226768293$22676829$3$F$20230601$20240918$20230706$20240930$PER$$NVSC2023US150824$NOVARTIS$$72$YR$$M$Y$$$20240930$$CN$US$US
226769524$22676952$4$F$20220607$20240802$20230706$20240812$EXP$$CN-ROCHE-1669940$ROCHE$$65$YR$E$M$Y$63$KG$20240812$$MD$CN$CN
2267697331$22676973$31$F$20230611$20240711$20230706$20240717$EXP$$NVSC2023RU150394$NOVARTIS$$1$YR$$M$Y$12.1$KG$20240717$$CN$RU$RU
226769895$22676989$5$F$$20240630$20230706$20240709$EXP$$CA-OTSUKA-2023_015060$OTSUKA$$$$$F$Y$$$20240709$$HP$CA$CA
226770642$22677064$2$F$20230613$20240801$20230706$20240805$EXP$$CN-PFIZER INC-PV202300115923$PFIZER$$71$YR$$M$Y$$$20240805$$HP$CN$CN
226773864$22677386$4$F$20230429$20240624$20230706$20240704$EXP$$JP-ARGENX-2023-ARGX-JP002169$ARGENX BVBA$$$$$$Y$$$20240704$$MD$JP$JP
226774093$22677409$3$F$$20240628$20230706$20240703$EXP$$US-PFIZER INC-202300238320$PFIZER$$6$YR$$F$Y$17.234$KG$20240703$$CN$US$US
226774364$22677436$4$F$$20240802$20230706$20240807$EXP$$CA-TAKEDA-2023TUS005283$TAKEDA$$$$$F$Y$$$20240807$$CN$CA$CA
226775297$22677529$7$F$20220824$20240810$20230706$20240813$EXP$$AU-TAKEDA-2022TUS056461$TAKEDA$$65$YR$$M$Y$$$20240813$$CN$AU$AU
226775302$22677530$2$F$$20230627$20230706$20240820$EXP$$CA-AstraZeneca-2023A109106$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$CA$
226775992$22677599$2$F$20230703$20240702$20230706$20240704$EXP$$US-TAKEDA-2023TUS066199$TAKEDA$$42$YR$$M$Y$$$20240704$$PH$US$US
226776106$22677610$6$F$20230627$20240919$20230706$20240923$PER$$NVSC2023US150420$NOVARTIS$$56$YR$$F$Y$$$20240923$$CN$US$US
226776144$22677614$4$F$$20230705$20230706$20240802$EXP$$US-TAKEDA-2023TUS065959$TAKEDA$Sinha Ray A, Ghosh M, Dehal NK, Landeen C. Colchicine- ^a safe anti-inflammatory drug^- but, how safe it is?. American Journal of Respiratory and Critical Care Medicine. 2023;207(1)$35$YR$$F$Y$$$20240802$$HP$US$US
226776158$22677615$8$F$$20240918$20230706$20240926$PER$$NVSC2023US150436$NOVARTIS$$$$$F$Y$75.737$KG$20240926$$HP$US$US
226777886$22677788$6$F$20230601$20240915$20230706$20240918$30DAY$$DO-PFIZER INC-PV202300113327$PFIZER$$11$YR$$$Y$$$20240918$$CN$DO$DO
226778709$22677870$9$F$20230101$20240719$20230706$20240726$EXP$$US-SA-2023SA202753$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240726$$MD$US$US
226778732$22677873$2$F$$20240819$20230706$20240828$PER$$US-SA-2023SA203744$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
226778746$22677874$6$F$20240701$20240815$20230706$20240829$PER$$US-SA-2023SA203592$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240829$$MD$US$US
226778852$22677885$2$F$20230101$20240621$20230706$20240702$PER$$US-SA-2023SA204278$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240702$$MD$US$US
226779484$22677948$4$F$20230101$20240828$20230706$20240925$PER$$US-SA-2023SA205282$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240925$$MD$US$US
226780043$22678004$3$F$20230501$20240828$20230706$20240910$PER$$US-SA-2023SA205256$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240910$$MD$US$US
226780287$22678028$7$F$20230101$20240903$20230706$20240912$PER$$US-SA-2023SA206042$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240912$$MD$US$US
226780564$22678056$4$F$20230101$20240627$20230706$20240710$PER$$US-SA-2023SA205351$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240710$$MD$US$US
226780604$22678060$4$F$20230101$20240909$20230706$20240923$PER$$US-SA-2023SA206292$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240923$$HP$US$US
226781353$22678135$3$F$$20230706$20230706$20240819$EXP$$AU-AstraZeneca-2023A151042$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$AU$
226781559$22678155$9$F$20230406$20240716$20230706$20240717$EXP$$US-JNJFOC-20230708631$JOHNSON AND JOHNSON$$64$YR$A$M$Y$99.34$KG$20240718$$MD$US$US
226782086$22678208$6$F$20240810$20240814$20230706$20240819$PER$$US-PFIZER INC-US-GBT-021537$PFIZER$$13$YR$$M$Y$$$20240819$$CN$US$US
226782964$22678296$4$F$20230705$20240705$20230706$20240709$PER$$US-AMGEN-USASP2023117498$AMGEN$$83$YR$E$M$Y$$$20240709$$CN$US$US
226783173$22678317$3$F$20221001$20240918$20230706$20240923$PER$$NVSC2023US151511$NOVARTIS$$71$YR$$F$Y$$$20240923$$CN$US$US
226783357$22678335$7$F$20230601$20240716$20230706$20240723$PER$$US-SA-2023SA204125$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240723$$MD$US$US
226783652$22678365$2$F$20190101$20230628$20230706$20240909$EXP$FR-AFSSAPS-ST2023000806$FR-MYLANLABS-2023M1071062$MYLAN$$30$YR$$F$Y$$$20240909$$MD$FR$FR
2267852811$22678528$11$F$$20240910$20230706$20240912$EXP$$US-PFIZER INC-202300237586$PFIZER$$73$YR$$F$Y$65.77$KG$20240912$$CN$US$US
226785756$22678575$6$F$20230410$20240809$20230706$20240814$PER$$US-PFIZER INC-202300237454$PFIZER$$52$YR$$F$Y$$$20240814$$CN$US$US
226786116$22678611$6$F$$20240909$20230706$20240912$PER$$US-PFIZER INC-202300239619$PFIZER$$50$YR$$M$Y$$$20240912$$CN$US$US
226786672$22678667$2$F$20230101$20240808$20230706$20240813$PER$$US-PFIZER INC-PV202300116996$PFIZER$$77$YR$$F$Y$$$20240813$$CN$US$US
226787733$22678773$3$F$20230629$20240814$20230706$20240819$EXP$$IN-PFIZER INC-PV202200052331$PFIZER$$54$YR$$F$Y$$$20240819$$CN$IN$IN
226787883$22678788$3$F$20220101$20240819$20230706$20240827$EXP$$PL-BAUSCH-BL-2023-009853$BAUSCH AND LOMB$$$$E$M$Y$$$20240827$$MD$PL$PL
226788177$22678817$7$F$20230617$20240913$20230706$20240924$EXP$$US-BEH-2023160780$CSL BEHRING$$40$YR$A$F$Y$$$20240924$$HP$US$US
226788694$22678869$4$F$$20240827$20230706$20240905$PER$$US-ROCHE-3318679$ROCHE$$62$YR$A$F$Y$$$20240905$$HP$US$US
226789565$22678956$5$F$20230317$20240812$20230706$20240822$EXP$$US-ROCHE-3328496$ROCHE$$83$YR$E$M$Y$76.2$KG$20240822$$CN$US$US
226790764$22679076$4$F$20240101$20240617$20230706$20240708$EXP$$US-ROCHE-3169354$ROCHE$$80$YR$E$M$Y$93.44$KG$20240708$$CN$US$US
226790972$22679097$2$F$$20240308$20230706$20240710$PER$$US-ROCHE-3321690$ROCHE$$$$T$M$Y$$$20240628$$CN$US$US
226791473$22679147$3$F$20230212$20240902$20230706$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-094800$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$84.3$KG$20240912$$MD$JP$JP
226792045$22679204$5$F$20190101$20240712$20230706$20240718$EXP$$JP-ABBVIE-19S-087-2699772-00$ABBVIE$$62$YR$$M$Y$61$KG$20240718$$MD$JP$JP
226792584$22679258$4$F$$20240702$20230706$20240709$EXP$$AU-CELLTRION INC.-2023AU013603$CELLTRION$$$$$$Y$$$20240709$$MD$AU$AU
226792942$22679294$2$F$$20240629$20230707$20240702$PER$$US-TAKEDA-2023TUS066187$TAKEDA$$$$$$Y$$$20240702$$CN$US$US
2267932410$22679324$10$F$20231205$20240618$20230707$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002346$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$37$KG$20240712$$CN$US$US
226793312$22679331$2$F$20240503$20240716$20230707$20240717$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-247132$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$$$20240718$$CN$US$US
2267937310$22679373$10$F$20230101$20240828$20230707$20240905$EXP$$CA-CELLTRION INC.-2023CA010959$CELLTRION$$$$$$Y$$$20240905$$PH$CA$CA
226799614$22679961$4$F$20230401$20240805$20230707$20240815$EXP$$BR-BAYER-2023A057692$BAYER$$41$YR$A$F$Y$$$20240815$$CN$BR$BR
226800525$22680052$5$F$20240524$20240806$20230707$20240812$EXP$$CA-TAKEDA-2023TUS066221$TAKEDA$$56$YR$$F$Y$$$20240812$$CN$CA$CA
226800673$22680067$3$F$20230101$20230626$20230707$20240829$EXP$$AU-MYLANLABS-2023M1069002$MYLAN$$$$$M$Y$$$20240829$$CN$AU$AU
2268007111$22680071$11$F$$20240909$20230707$20240911$EXP$$US-PFIZER INC-PV202200120476$PFIZER$$26$YR$$M$Y$$$20240911$$HP$US$US
226803274$22680327$4$F$20230601$20240925$20230707$20240930$EXP$$CA-PFIZER INC-202300229617$PFIZER$$17$YR$$M$Y$56$KG$20240930$$MD$CA$CA
226804087$22680408$7$F$20230628$20240925$20230707$20240930$EXP$$US-TAKEDA-2021TUS076999$TAKEDA$$56$YR$$F$Y$67$KG$20240930$$HP$US$US
226804243$22680424$3$F$20230307$20240822$20230707$20240828$EXP$$BR-TAKEDA-2023TUS045423$TAKEDA$$45$YR$$F$Y$$$20240828$$CN$BR$BR
226804617$22680461$7$F$20230601$20240618$20230707$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002374$ACADIA PHARMACEUTICALS$$66$YR$$F$Y$$$20240712$$CN$US$US
226805713$22680571$3$F$20230601$20240930$20230707$20240930$EXP$GR-GREOF-202300581$GR-ABBVIE-5318576$ABBVIE$$46$YR$$F$Y$80$KG$20240930$$MD$GR$GR
226805753$22680575$3$F$$20240617$20230707$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002395$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
2268060912$22680609$12$F$20230628$20240702$20230707$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002397$ACADIA PHARMACEUTICALS$$19$YR$$F$Y$$$20240725$$CN$US$US
2268061612$22680616$12$F$20230101$20240621$20230707$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002407$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
226806437$22680643$7$F$20230626$20240628$20230707$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002643$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240723$$CN$US$US
226806732$22680673$2$F$$20230626$20230707$20240715$PER$$US-MYLANLABS-2023M1051171$BIOCON$$$$$F$Y$88.8$KG$20240715$$$US$US
226807185$22680718$5$F$20240902$20240902$20230707$20240912$EXP$$AE-TAKEDA-2023TUS066536$TAKEDA$$$$$$Y$$$20240912$$CN$AE$AE
226807256$22680725$6$F$20230701$20240731$20230707$20240809$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02293$AMNEAL$$2$YR$$F$Y$13.56$KG$20240809$$HP$US$US
226808255$22680825$5$F$20190101$20240905$20230707$20240919$EXP$$NL-AUROBINDO-AUR-APL-2023-046013$AUROBINDO$Chang Yue Chui, Dirk Jan A R Moes, Stijn L W Koolen, Jesse J Swen, Hans Gelderblom. Pharmacokinetic Profile of Irinotecan in Patients with Chronic Kidney Disease: Two Cases and Literature Review. British journal of clinical pharmacology.. 2023;89:2920?2925.$72$YR$$M$Y$$$20240919$$PH$NL$NL
226808325$22680832$5$F$$20240827$20230707$20240905$EXP$$IT-AUROBINDO-AUR-APL-2023-046480$AUROBINDO$Valenti C, Moretti G, Copelli S, Cicilia R, Manca F, Cioni E, Gasparini E, Pinto C, Navazio A and Tarantini L.. Teamwork is successful (1): Favoureable re-challenge of double ANTI-HER2 Treatment in severe myocardial dysfunction in patient with Advanced breast cancer and occult type II diabetes.. European Heart Journal, Supplement. 2023;25 (SUP: D):D149-150.$55$YR$$F$Y$$$20240905$$HP$IT$IT
226808603$22680860$3$F$$20240725$20230707$20240807$EXP$$CA-AUROBINDO-AUR-APL-2022-046482$AUROBINDO$Singh D, Sit S, Singh N. Diagnostic and therapeutic dilemma of cervical adenitis in an adult. BMJ Case Reports. 2022;15:e247303$3$DEC$$F$Y$$$20240807$$HP$CA$CA
226812694$22681269$4$F$$20240715$20230707$20240723$PER$$US-SA-2023SA207599$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240723$$CN$US$US
226813426$22681342$6$F$20240116$20240828$20230707$20240902$EXP$$CA-TAKEDA-2023TUS066129$TAKEDA$$30$YR$$M$Y$$$20240902$$CN$CA$CA
226814872$22681487$2$F$$20240628$20230707$20240712$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397590$RANBAXY$Mahajan V. VIJAYA-The one who fights to win. Cancer Res Stat Treat. 2023;6(1):65-67$$$$F$Y$$$20240712$$HP$IN$IN
226815782$22681578$2$F$$20240803$20230707$20240812$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-398270$RANBAXY$Hasegawa M, Fujimaru T, Heath Y, Taki F, Futatsuyama M, Nagahama M, et al. Renal Replacement Therapy for Severe Hyponatremia (PNa 99mEq/L),Using 5% Dextrose Solution Infusion Method. J Am Soc Nephrol. 2015;26:374A (FR-PO077)$46$YR$$F$Y$$$20240812$$HP$JP$JP
226816905$22681690$5$F$$20240917$20230707$20240930$EXP$$US-TRAVERE-2023TVT00271$TRAVERE THERAPEUTICS$$32$YR$A$M$Y$$$20240930$$CN$US$US
2268183713$22681837$13$F$20230608$20240813$20230707$20240816$EXP$$NZ-MYLANLABS-2023M1062184$MYLAN$$46$YR$$M$Y$$$20240816$$CN$NZ$NZ
226818784$22681878$4$F$$20240917$20230707$20240925$PER$$US-VERTEX PHARMACEUTICALS-2023-009574$VERTEX$$$$$F$Y$$$20240925$$CN$US$US
226819304$22681930$4$F$$20240820$20230707$20240822$EXP$$US-PFIZER INC-PV202300118229$PFIZER$$88$YR$$F$Y$$$20240822$$CN$US$US
226820285$22682028$5$F$20230703$20240918$20230707$20240926$EXP$$US-UCBSA-2023034318$UCB$$15$YR$$F$Y$$$20240926$$CN$US$US
2268205012$22682050$12$F$20230822$20240918$20230707$20240925$EXP$$CA-TAKEDA-2023TUS032503$TAKEDA$$24$YR$$M$Y$$$20240925$$HP$CA$CA
226822583$22682258$3$F$$20240821$20230707$20240829$EXP$$CA-ASTELLAS-2023EU001988$ASTELLAS$Jiang S, Xiong W, Shahidi N. A case of colonic malakoplakia presenting as a large cecal mass : not every polyp has to look like a nail. Journal of the Canadian Association of Gastroenterology 2023;6(Supplement 1):71-2.$80$YR$E$M$Y$$$20240829$$HP$CA$CA
226823345$22682334$5$F$20220812$20240826$20230707$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-095893$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240828$$MD$JP$JP
226824042$22682404$2$F$20210430$20240918$20230707$20240920$EXP$$NVSC2023DE152226$NOVARTIS$$$$E$F$Y$65$KG$20240920$$MD$DE$DE
226825913$22682591$3$F$20230101$20240703$20230707$20240708$EXP$$CA-PFIZER INC-PV202300118683$PFIZER$$82$YR$$F$Y$$$20240708$$CN$CA$CA
226827784$22682778$4$F$$20240717$20230707$20240724$EXP$$CA-VERTEX PHARMACEUTICALS-2023-001076$VERTEX$$$$$M$Y$$$20240724$$MD$CA$CA
226828315$22682831$5$F$20230617$20240807$20230707$20240813$EXP$$BR-AMGEN-BRASP2023108503$AMGEN$$41$YR$A$F$Y$$$20240813$$PH$BR$BR
226828614$22682861$4$F$20230401$20240717$20230707$20240722$EXP$$US-TAKEDA-2023TUS066845$TAKEDA$$26$YR$$M$Y$$$20240722$$CN$US$US
226830155$22683015$5$F$$20240829$20230707$20240904$PER$$US-PFIZER INC-PV202300030008$PFIZER$$78$YR$$F$Y$70.7$KG$20240904$$CN$US$US
2268305412$22683054$12$F$20220101$20240813$20230707$20240819$PER$$US-PFIZER INC-PV202300069537$PFIZER$$54$YR$$F$Y$83.91$KG$20240819$$CN$US$US
226830785$22683078$5$F$20240701$20240709$20230707$20240711$EXP$$US-PFIZER INC-PV202300116987$PFIZER$$80$YR$$F$Y$$$20240711$$CN$US$US
226831525$22683152$5$F$$20240708$20230707$20240715$EXP$$NVSC2023US152537$NOVARTIS$$$$$M$Y$$$20240715$$HP$US$US
226832809$22683280$9$F$20221218$20240627$20230707$20240704$EXP$$DE-BAUSCH-BL-2023-010259$BAUSCH AND LOMB$$72$YR$$M$Y$65$KG$20240704$$MD$DE$DE
226833335$22683333$5$F$$20240729$20230707$20240806$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-014482$JAZZ$$$$$F$Y$$$20240806$$CN$US$US
226835992$22683599$2$F$$20240828$20230708$20240829$PER$$NVSC2023US152841$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
226836522$22683652$2$F$$20230216$20230708$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK079292$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
226836612$22683661$2$F$$20230328$20230708$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK080674$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
226836652$22683665$2$F$$20230413$20230708$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK081143$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
226836662$22683666$2$F$$20230413$20230708$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK081144$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
226836682$22683668$2$F$$20230821$20230708$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK081890$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
226836702$22683670$2$F$$20230523$20230708$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK082198$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
226836836$22683683$6$F$$20240917$20230708$20240925$EXP$$GB-TEVA-2023-GB-2903580$TEVA$$74$YR$$M$Y$$$20240925$$CN$GB$GB
226837263$22683726$3$F$20230122$20240801$20230708$20240802$EXP$$US-TAKEDA-2023TUS066931$TAKEDA$$39$YR$$M$Y$$$20240802$$HP$US$US
226837697$22683769$7$F$20230630$20240912$20230708$20240917$EXP$$NVSC2023US150424$NOVARTIS$$41$YR$$F$Y$$$20240917$$CN$US$US
226837703$22683770$3$F$$20240806$20230708$20240813$EXP$$NVSC2023GB116550$NOVARTIS$$$$$M$Y$$$20240813$$CN$GB$GB
226837924$22683792$4$F$20231201$20240710$20230708$20240713$EXP$$NVSC2023GB151732$NOVARTIS$$$$$M$Y$$$20240713$$CN$GB$GB
226838273$22683827$3$F$$20240918$20230708$20240930$PER$$NVSC2023US152627$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
226839242$22683924$2$F$$20240923$20230708$20240925$EXP$$NVSC2023EG150770$NOVARTIS$$$$$F$Y$$$20240925$$CN$EG$EG
226840102$22684010$2$F$20201228$20240814$20230708$20240817$EXP$$NVSC2021IN173990$NOVARTIS$$83$YR$$M$Y$$$20240817$$CN$IN$IN
226840162$22684016$2$F$$20240801$20230708$20240802$EXP$$NVSC2023NO149556$NOVARTIS$Varland S, Bronstad KM, Skinner SJ, Arnesen T. A nonsense variant in the N-terminal acetyltransferase NAA30 may be associated with global developmental delay and tracheal cleft. AMERICAN JOURNAL OF MEDICAL GENETICS, PART A. 2023;1-9$$$N$M$Y$$$20240802$$HP$NO$NO
226840323$22684032$3$F$$20240709$20230709$20240718$EXP$$PL-AUROBINDO-AUR-APL-2023-030576$AUROBINDO$Dudek D. Aripiprazole in clinical practice. MEDYCYNA FAKTOW. 2022;(2):242-247$38$YR$$M$Y$$$20240718$$MD$PL$PL
226840719$22684071$9$F$20221123$20240912$20230709$20240920$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-35020$IPSEN$$60$YR$A$F$Y$$$20240920$$CN$CA$CA
226841202$22684120$2$F$$20240909$20230709$20240921$EXP$$US-LUPIN PHARMACEUTICALS INC.-2023-05338$LUPIN$$$$$$Y$$$20240921$$CN$US$US
226841462$22684146$2$F$20240101$20240722$20230709$20240730$PER$$US-SA-2023SA206690$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240730$$MD$US$US
226842315$22684231$5$F$20230101$20240905$20230709$20240913$PER$$US-VERTEX PHARMACEUTICALS-2023-009635$VERTEX$$$$$$Y$$$20240913$$CN$US$US
226842492$22684249$2$F$20240601$20240827$20230709$20240830$EXP$$US-ABBVIE-5318459$ABBVIE$$57$YR$$M$Y$$$20240830$$CN$US$US
226844204$22684420$4$F$20230101$20240806$20230710$20240812$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-240266$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240812$$CN$US$US
226844564$22684456$4$F$$20240624$20230710$20240702$EXP$$NVSC2022CO263883$NOVARTIS$$$$$M$Y$85$KG$20240702$$CN$CO$CO
226844969$22684496$9$F$20230101$20240627$20230710$20240708$PER$$US-BEH-2023160635$CSL BEHRING$$20$YR$A$M$Y$86.7$KG$20240708$$CN$US$US
226845165$22684516$5$F$20230502$20240722$20230710$20240802$EXP$$US-Accord-365767$ACCORD$$71$YR$E$M$Y$81.4$KG$20240802$$HP$US$US
226846022$22684602$2$F$20230517$20230625$20230710$20240808$PER$$US-EPICPHARMA-US-2023EPCSPO01175$EPIC PHARM$$65$YR$E$F$Y$68$KG$20240808$$CN$US$US
226846102$22684610$2$F$$20230626$20230710$20240808$EXP$$CN-PURACAP-CN-2023EPCLIT01149$PURACAP$Dan Sun.Stomach ulcer caused by mistakenly oral medication of 14,400 mg ibuprofen: A case report.Medicine.19-MAY-2023;102:1-3$35$YR$A$F$Y$$$20240808$$HP$CN$CN
226848182$22684818$2$F$20230601$20240705$20230710$20240716$PER$$US-SA-2023SA207378$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240716$$MD$US$US
226848846$22684884$6$F$20230706$20240823$20230710$20240827$EXP$$NVSC2023US152286$NOVARTIS$$35$YR$$F$Y$$$20240827$$CN$US$US
226850042$22685004$2$F$20230629$20240909$20230710$20240919$EXP$$US-GSK-US2023090054$GLAXOSMITHKLINE$$73$YR$$M$Y$$$20240919$$HP$US$US
226850397$22685039$7$F$20230702$20240725$20230710$20240729$EXP$$DE-TAKEDA-2023TUS066778$TAKEDA$$12$YR$$F$Y$$$20240729$$HP$DE$DE
226850508$22685050$8$F$$20240920$20230710$20240930$EXP$$PT-CELLTRION INC.-2023PT013582$CELLTRION$Simao RD, Cordeiro AI, Parente FJ, Valente PM, Neves C, Farela NJ et al. Case Report: Patient with deficiency of ADA2 presenting leukocytoclastic vasculitis and pericarditis during infliximab treatment. Frontiers in Pediatrics. 2023;11:1200401$$$$$Y$$$20240930$$HP$PT$PT
226851047$22685104$7$F$20230701$20231114$20230710$20240925$PER$$US-GSK-US2023AMR092988$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
226851102$22685110$2$F$$20230531$20230710$20240717$PER$$US-GRUNENTHAL-2022-108417$AVERITAS$$82$YR$$M$Y$$$20240710$$CN$US$US
226852775$22685277$5$F$20230619$20240902$20230710$20240923$PER$$CA-TOLMAR, INC.-23CA041590$TOLMAR$$78$YR$$M$Y$$$20240923$$CN$CA$CA
226853313$22685331$3$F$$20240703$20230710$20240705$EXP$$GR-ABBVIE-5319354$ABBVIE$$67$YR$$F$Y$$$20240705$$MD$GR$GR
226854156$22685415$6$F$$20240916$20230710$20240924$EXP$$IT-CELLTRION INC.-2023IT013371$CELLTRION$Valenti C, Moretti G, Copelli S, Cicilia R, Manca F, Cioni E, et al.. Teamwork is successful (1): Favoureable re-challenge of double ANTI-HER2 Treatment in severe myocardial dysfunction in patient with Advanced breast cancer and occult type II diabetes.. European Heart Journal, Supplement. 2023;25 (SUP: D:D149-50$$$$$Y$$$20240924$$HP$IT$IT
226855172$22685517$2$F$20221212$20240715$20230710$20240722$EXP$FR-AFSSAPS-ST2023000870$FR-BAXTER-2023BAX025473$BAXTER$$32$YR$$F$Y$86$KG$20240722$$MD$FR$FR
226855293$22685529$3$F$20230101$20240711$20230710$20240717$EXP$$US-ABBVIE-5319500$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
226855622$22685562$2$F$20180101$20230629$20230710$20240716$EXP$$US-NOVOPROD-1087408$NOVO NORDISK$$$$$$Y$$$20240716$$CN$US$US
2268562011$22685620$11$F$20221226$20240821$20230710$20240826$EXP$$CO-Ipsen Biopharmaceuticals, Inc.-2023-15839$IPSEN$$72$YR$E$M$Y$65$KG$20240826$$CN$CO$CO
226856265$22685626$5$F$20230617$20240903$20230710$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-092778$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240913$$MD$JP$JP
226856337$22685633$7$F$20221122$20240823$20230710$20240902$EXP$$JP-ASTELLAS-2023JP002184$ASTELLAS$Yanagida K, Kawai T, Seito T, Matsumoto K, Kaneko T, Nakagawa T. Myelodysplastic syndrome occurring after enfortumab vedotin treatment for metastatic urothelial carcinoma. IJU Case Reports 2024;7(4):316-9.$73$YR$E$M$Y$63$KG$20240902$$MD$JP$JP
226856883$22685688$3$F$20221221$20240912$20230710$20240923$EXP$$CA-TAKEDA-2022TUS018442$TAKEDA$$43$YR$$F$Y$$$20240923$$MD$CA$CA
2268575011$22685750$11$F$20231016$20240613$20230710$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002420$ACADIA PHARMACEUTICALS$$13$YR$$F$Y$$$20240708$$CN$US$US
226858602$22685860$2$F$$20230530$20230710$20240717$PER$$US-GRUNENTHAL-2023-102570$AVERITAS$$$$E$F$Y$$$20240710$$HP$US$US
226858752$22685875$2$F$$20230516$20230710$20240717$PER$$US-GRUNENTHAL-2023-111337$AVERITAS$$70$YR$$M$Y$$$20240710$$CN$US$US
226860314$22686031$4$F$$20240917$20230710$20240930$EXP$$CN-JNJFOC-20230712223$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240930$$HP$CN$CN
226860889$22686088$9$F$20220505$20240907$20230710$20240917$EXP$$CA-CELLTRION INC.-2022CA007652$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
226861123$22686112$3$F$$20240624$20230710$20240702$EXP$$NVSC2023GB152848$NOVARTIS$$$$$M$Y$$$20240702$$PH$GB$GB
226861335$22686133$5$F$20231001$20240805$20230710$20240806$EXP$$US-TAKEDA-US201904502$TAKEDA$$9$YR$$M$Y$$$20240806$$CN$US$US
226864183$22686418$3$F$$20240509$20230710$20240716$PER$$US-JAZZ PHARMACEUTICALS-2023-US-012983$JAZZ$$$$$F$Y$$$20240716$$HP$US$US
2268657413$22686574$13$F$20230706$20240216$20230710$20240923$EXP$$NVSC2023US152888$NOVARTIS$$61$YR$$F$Y$$$20240923$$CN$US$US
226865752$22686575$2$F$$20240705$20230710$20240715$EXP$$CA-GSK-CA2023092274$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$HP$CA$CA
226868242$22686824$2$F$20230307$20240625$20230710$20240702$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-00830$AMNEAL$$90$YR$$F$Y$$$20240702$$CN$US$US
226870202$22687020$2$F$$20240812$20230710$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05300$LUPIN$$$$$$Y$$$20240831$$CN$US$US
226871274$22687127$4$F$20180101$20240724$20230710$20240728$EXP$$US-ABBVIE-5318470$ABBVIE$$$$$M$Y$$$20240728$$CN$US$US
226871497$22687149$7$F$20230617$20231030$20230710$20240711$EXP$$JP-AstraZeneca-2023A156083$ASTRAZENECA$$81$YR$$M$Y$54$KG$20240711$$MD$JP$
226872353$22687235$3$F$20230520$20240806$20230710$20240819$EXP$$US-MYOVANT SCIENCES GMBH-2023MYSCI0700016$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
226873522$22687352$2$F$$20240626$20230710$20240705$PER$$US-SA-2023SA208249$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
226873892$22687389$2$F$20100101$20240924$20230710$20240930$EXP$$FR-PFIZER INC-202300239469$PFIZER$$40$YR$$F$Y$$$20240930$$CN$FR$FR
226874022$22687402$2$F$20230101$20240628$20230710$20240709$PER$$US-SA-2023SA207633$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240709$$MD$US$US
226874163$22687416$3$F$$20240718$20230710$20240801$PER$$US-SA-2023SA165024$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240801$$MD$US$US
226874423$22687442$3$F$$20240705$20230710$20240713$PER$$US-SA-2023SA207716$SANOFI AVENTIS$$8$YR$C$M$Y$50$KG$20240713$$MD$US$US
226874886$22687488$6$F$$20240905$20230710$20240910$EXP$$NVSC2023US152378$NOVARTIS$$$$$F$Y$$$20240910$$CN$US$US
226874963$22687496$3$F$$20240705$20230710$20240710$PER$$US-BIOGEN-2020BI00950102$BIOGEN$$$$$M$Y$$$20240710$$CN$US$US
226876027$22687602$7$F$$20240901$20230710$20240903$30DAY$$US-PFIZER INC-PV202300115068$PFIZER$$10$YR$$F$Y$$$20240903$$MD$US$US
226877202$22687720$2$F$20230331$20240626$20230710$20240704$PER$$US-INCYTE CORPORATION-2023IN005710$INCYTE$$$$$$Y$$$20240704$$CN$US$US
226878124$22687812$4$F$$20240710$20230710$20240722$EXP$$NVSC2023US152781$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
226878332$22687833$2$F$$20240812$20230710$20240813$PER$$US-PFIZER INC-PV202300116874$PFIZER$$46$YR$$F$Y$$$20240813$$HP$US$US
226880085$22688008$5$F$$20240723$20230710$20240724$EXP$$US-TAKEDA-US202009684$TAKEDA$$$$$F$Y$$$20240724$$MD$US$US
226883076$22688307$6$F$20230325$20240816$20230710$20240823$EXP$$ES-ABBVIE-4711743$ABBVIE$$83$YR$$F$Y$62$KG$20240823$$MD$ES$ES
226884216$22688421$6$F$20230707$20240807$20230710$20240810$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2023-096794$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$88.45$KG$20240810$$CN$PR$PR
226885743$22688574$3$F$20240711$20240730$20230710$20240731$EXP$$US-KYOWAKIRIN-2023BKK010374$KYOWA$$$$$$Y$$$20240731$$PH$US$US
226886117$22688611$7$F$$20240808$20230710$20240814$EXP$$CA-TAKEDA-2023TUS043651$TAKEDA$$$$$M$Y$$$20240814$$MD$CA$CA
226886153$22688615$3$F$$20240723$20230710$20240726$PER$$NVSC2023US153505$NOVARTIS$$$$$M$Y$$$20240726$$HP$US$US
226886493$22688649$3$F$$20240813$20230710$20240820$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202307002232$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240820$$CN$GB$GB
226888972$22688897$2$F$20221001$20230812$20230710$20240711$PER$$US-KRAMERLABS-2023-US-008606$KRAMER LABORATORIES$$88$YR$$M$Y$$$20240711$$CN$US$US
226891574$22689157$4$F$20220201$20240707$20230710$20240710$EXP$$JP-TAKEDA-2023TJP009000$TAKEDA$$38$YR$$F$Y$52.4$KG$20240710$$CN$JP$JP
226891934$22689193$4$F$$20240911$20230711$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-096862$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240912$$MD$US$US
226892472$22689247$2$F$$20240911$20230711$20240917$EXP$$JP-AMGEN-JPNSP2023116820$AMGEN$$$$$F$Y$$$20240917$$PH$JP$JP
2268926317$22689263$17$F$20230324$20240719$20230711$20240724$EXP$$US-TAKEDA-2022TUS081726$TAKEDA$$62$YR$$M$Y$51$KG$20240724$$HP$US$US
226892654$22689265$4$F$20230301$20240905$20230711$20240926$PER$$CA-TOLMAR, INC.-23CA041566$TOLMAR$$77$YR$$M$Y$$$20240926$$CN$CA$CA
226893022$22689302$2$F$20220901$20240318$20230711$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00253$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240705$$CN$US$US
226893583$22689358$3$F$$20240626$20230711$20240703$PER$$US-BIOGEN-2023BI01214935$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
226894382$22689438$2$F$$20240715$20230711$20240722$EXP$$FR-AUROBINDO-AUR-APL-2022-046906$AUROBINDO$Sastre C, Baillif-Couniou V, Fabresse N, Ameline A, Kintz P, Gaulier J-M, et al.. Pregabalin misuse: About seven cases of death in the region of Marseille.. Toxic Analyt Clinique.. 2022;34 (3):151-158$43$YR$$M$Y$$$20240722$$HP$FR$FR
226895465$22689546$5$F$20230201$20240723$20230711$20240801$EXP$$DE-ROCHE-3385183$ROCHE$$65$YR$E$F$Y$62$KG$20240801$$MD$DE$DE
226895562$22689556$2$F$$20220720$20230711$20240930$EXP$$CA-BAUSCHBL-BL-2022-018534$BAUSCH AND LOMB$$61$YR$$F$Y$70$KG$20240930$$CN$CA$CA
226895662$22689566$2$F$20230222$20230630$20230711$20240906$EXP$CN-NMPA-5101821043965202300224$CN-NOVOPROD-1086765$NOVO NORDISK$$52$YR$$M$Y$65$KG$20240906$$HP$CN$CN
226896002$22689600$2$F$20230204$20230706$20230711$20240802$EXP$$DE-ROCHE-3384384$ROCHE$$27$YR$A$F$Y$59$KG$20240802$$MD$DE$DE
2268968912$22689689$12$F$20230601$20240507$20230711$20240925$EXP$$US-GSK-US2023AMR093018$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
2268971210$22689712$10$F$20230628$20240821$20230711$20240826$EXP$$TR-JNJFOC-20230716348$JOHNSON AND JOHNSON$$64$YR$A$M$Y$65$KG$20240826$$MD$TR$TR
226897194$22689719$4$F$20230320$20240731$20230711$20240813$EXP$$CA-INTERCEPT-PM2023000664$INTERCEPT PHARMACEUTICALS$$46$YR$$F$Y$$$20240813$$CN$CA$CA
226898492$22689849$2$F$$20230818$20230711$20240711$PER$$US-STRIDES ARCOLAB LIMITED-2023SP001331$STRIDES$Adams MR, Pijut KD, Uttal-Veroff KC, Davis GA.. Acute Portal and Superior Mesenteric Vein Thrombosis with Topical Testosterone Therapy: An Adverse Drug Event Case Report.. J Pharm Pract. 2022;8971900211073286$55$YR$$M$Y$$$20240711$$PH$US$US
226900814$22690081$4$F$20230615$20240911$20230711$20240914$EXP$$US-ABBVIE-5320235$ABBVIE$$72$YR$$F$Y$$$20240914$$CN$US$US
2269010914$22690109$14$F$20230101$20240917$20230711$20240927$EXP$$US-INSMED, INC.-2023-01105-US$INSMED$$$$$$Y$$$20240927$$CN$US$US
226901343$22690134$3$F$$20240903$20230711$20240906$EXP$$US-AMGEN-USASP2023118496$AMGEN$Budhu G.; Cauff B.. THE EXPANDING ROLE OF ELTROMBOPAG IN CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA POST-SPLENECTOMY. Pediatric Blood + Cancer. 2023;70:S139-S140$3$YR$C$M$Y$$$20240906$$HP$US$US
226902554$22690255$4$F$20230502$20240725$20230711$20240729$EXP$$DE-TAKEDA-2023TUS066767$TAKEDA$$12$YR$$F$Y$$$20240729$$HP$DE$DE
226903335$22690333$5$F$20240222$20240725$20230711$20240802$EXP$$BR-CELLTRION INC.-2023BR009509$CELLTRION$$$$$$Y$$$20240802$$CN$BR$BR
226904013$22690401$3$F$20190529$20240719$20230711$20240731$PER$$US-SA-2023SA208830$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240731$$MD$US$US
226904313$22690431$3$F$20210201$20240701$20230711$20240708$EXP$$DE-MYLANLABS-2023M1070544$MYLAN$$$$E$F$Y$52.5$KG$20240708$$HP$DE$DE
2269043311$22690433$11$F$$20240624$20230711$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002447$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
226904423$22690442$3$F$20230101$20240716$20230711$20240724$PER$$US-SA-2023SA209942$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240724$$MD$US$US
226904952$22690495$2$F$20230705$20240904$20230711$20240913$PER$$US-SA-2023SA209232$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240913$$MD$US$US
226905194$22690519$4$F$20230525$20240826$20230711$20240904$EXP$$FR-AUROBINDO-AUR-APL-2023-046375$AUROBINDO$$59$YR$$F$Y$$$20240904$$MD$FR$FR
226905394$22690539$4$F$20230502$20240725$20230711$20240730$EXP$$DE-TAKEDA-2023TUS066809$TAKEDA$$12$YR$$F$Y$$$20240730$$HP$DE$DE
226905483$22690548$3$F$20230401$20240708$20230711$20240716$EXP$$US-SA-2023SA207579$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240716$$CN$US$US
226906193$22690619$3$F$20170501$20240710$20230711$20240718$EXP$$JP-SA-2023SA206564$SANOFI AVENTIS$Sugimoto S et al.. A Case of Descending Colon Cancer with Distant Metastasis Obtaining Long-Term CR Overcoming Multiple Severe Side Effects of Chemotherapy. Japanese Journal of Cancer and Chemotherapy. 2023;50:144$69$YR$E$M$Y$$$20240718$$MD$JP$JP
226907022$22690702$2$F$20091210$20240715$20230711$20240724$EXP$$FR-AUROBINDO-AUR-APL-2023-045964$AUROBINDO$$42$YR$$F$Y$$$20240724$$LW$FR$FR
226907885$22690788$5$F$20220901$20240701$20230711$20240709$EXP$$JP-ASTELLAS-2023JP007952$ASTELLAS$Sawada K, Kawaji T, Yamana K, Matsuhashi K, Hara Y, Kuriyama N, et al.. Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory distress syndrome: a case report. Journal of Cardiothoracic Surgery. 2024;19(1):358$41$YR$$F$Y$44$KG$20240709$$MD$JP$JP
226910334$22691033$4$F$20230501$20240710$20230711$20240712$EXP$$NVSC2023US153344$NOVARTIS$$73$YR$$F$Y$$$20240712$$CN$US$US
226910867$22691086$7$F$20210817$20240814$20230711$20240823$EXP$$CA-ROCHE-2895863$ROCHE$$43$YR$A$F$Y$$$20240823$$CN$CA$CA
226914163$22691416$3$F$$20240814$20230711$20240821$EXP$$PL-AUROBINDO-AUR-APL-2022-011355$AUROBINDO$Liszka K, Resztak M, Zalewska P, Kalwak K.. Therapeutic drug monitoring of posaconazole for effective prophylaxis of invasive fungal infections in pediatric patients: A pilot study. Acta Haematologica Polonica. 2021;52(6):578-83$1$YR$$$Y$8.8$KG$20240821$$HP$PL$PL
226914423$22691442$3$F$$20240726$20230711$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05352$LUPIN$$$$$$Y$$$20240816$$CN$US$US
226914769$22691476$9$F$20231208$20240711$20230711$20240715$EXP$$CA-GSK-CA2023AMR078397$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$HP$CA$CA
226914787$22691478$7$F$$20240625$20230711$20240702$EXP$$CA-GSK-CA2023092283$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$CA$CA
226915102$22691510$2$F$20240708$20240715$20230711$20240717$EXP$$CA-PFIZER INC-202300241682$PFIZER$$88$YR$$M$Y$$$20240717$$MD$CA$CA
226916062$22691606$2$F$$20240625$20230711$20240704$PER$$US-SA-2023SA208706$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240704$$MD$US$US
226918572$22691857$2$F$20230612$20240731$20230711$20240802$EXP$$CN-PFIZER INC-PV202300119795$PFIZER$$48$YR$$F$Y$50$KG$20240802$$HP$CN$CN
226918893$22691889$3$F$$20240802$20230711$20240806$PER$$NVSC2023US153920$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
226919423$22691942$3$F$$20240704$20230711$20240705$EXP$$NVSC2023CA153655$NOVARTIS$$$$A$F$Y$$$20240705$$MD$CA$CA
226920515$22692051$5$F$$20240709$20230711$20240710$PER$$US-PFIZER INC-PV202300119995$PFIZER$$74$YR$$F$Y$$$20240710$$CN$US$US
226921282$22692128$2$F$20240601$20240628$20230711$20240702$PER$$US-PFIZER INC-PV202300118371$PFIZER$$70$YR$$F$Y$$$20240702$$CN$US$US
2269214210$22692142$10$F$20230906$20240919$20230711$20240926$EXP$$US-TAKEDA-2023TUS067068$TAKEDA$$62$YR$$F$Y$46$KG$20240926$$CN$US$US
226921988$22692198$8$F$20240101$20240830$20230711$20240904$EXP$$US-PFIZER INC-202300243636$PFIZER$$48$YR$$F$Y$55.79$KG$20240904$$CN$US$US
226922642$22692264$2$F$20230301$20230620$20230711$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00345$UPSHER-SMITH$$$$$M$Y$$$20240719$$CN$US$US
226922872$22692287$2$F$20220101$20230725$20230711$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00165$UPSHER-SMITH$$$$$M$Y$95.238$KG$20240719$$CN$US$US
226923097$22692309$7$F$$20240830$20230711$20240905$PER$$US-PFIZER INC-PV202300120301$PFIZER$$77$YR$$F$Y$$$20240905$$MD$US$US
226923342$22692334$2$F$$20240909$20230711$20240917$PER$$US-SA-2023SA208738$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240918$$MD$US$US
2269239212$22692392$12$F$20230701$20240912$20230711$20240917$30DAY$$US-PFIZER INC-PV202300118704$PFIZER$$13$YR$$M$Y$38.56$KG$20240917$$CN$US$US
226924983$22692498$3$F$$20240726$20230711$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05355$LUPIN$$$$$$Y$$$20240816$$CN$US$US
226925053$22692505$3$F$$20240726$20230711$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05356$LUPIN$$$$$$Y$$$20240817$$CN$US$US
226925344$22692534$4$F$20230628$20240806$20230711$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05357$LUPIN$$$$$$Y$$$20240920$$CN$US$US
226925467$22692546$7$F$20230621$20240814$20230711$20240814$30DAY$$US-PFIZER INC-202300238241$PFIZER$$12$YR$$M$Y$29.48$KG$20240814$$CN$US$US
226925962$22692596$2$F$$20220906$20230711$20240722$PER$$US-ASTELLAS-2022US032033$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226925972$22692597$2$F$$20220708$20230711$20240722$PER$$US-ASTELLAS-2022US024793$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226925992$22692599$2$F$20220913$20221213$20230711$20240722$PER$$US-ASTELLAS-2022US033447$ASTELLAS$$84$YR$$F$Y$$$20240722$$MD$US$US
226926004$22692600$4$F$20220801$20220920$20230711$20240722$PER$$US-ASTELLAS-2022US028624$ASTELLAS$$66$YR$$F$Y$$$20240722$$CN$US$US
226926022$22692602$2$F$$20220930$20230711$20240722$PER$$US-ASTELLAS-2022US035197$ASTELLAS$$50$YR$$F$Y$$$20240722$$CN$US$US
226926032$22692603$2$F$$20220817$20230711$20240722$PER$$US-ASTELLAS-2022US029687$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926042$22692604$2$F$20220301$20220810$20230711$20240722$PER$$US-ASTELLAS-2022US024851$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
226926222$22692622$2$F$$20220706$20230711$20240722$PER$$US-ASTELLAS-2022US024688$ASTELLAS$$38$YR$$F$Y$$$20240722$$CN$US$US
226926232$22692623$2$F$20220601$20220808$20230711$20240722$PER$$US-ASTELLAS-2022US028406$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
226926242$22692624$2$F$20220101$20221017$20230711$20240722$PER$$US-ASTELLAS-2022US027970$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926252$22692625$2$F$$20220715$20230711$20240722$PER$$US-ASTELLAS-2022US025695$ASTELLAS$$61$YR$$F$Y$$$20240722$$CN$US$US
226926262$22692626$2$F$$20220822$20230711$20240722$PER$$US-ASTELLAS-2022US030256$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926272$22692627$2$F$$20220912$20230711$20240722$PER$$US-ASTELLAS-2022US032751$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926282$22692628$2$F$20220709$20220808$20230711$20240722$PER$$US-ASTELLAS-2022US025164$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
226926292$22692629$2$F$20220920$20220920$20230711$20240722$PER$$US-ASTELLAS-2022US034023$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226926302$22692630$2$F$20220918$20220929$20230711$20240722$PER$$US-ASTELLAS-2022US035040$ASTELLAS$$34$YR$$F$Y$$$20240722$$CN$US$US
226926312$22692631$2$F$$20220913$20230711$20240722$PER$$US-ASTELLAS-2022US033107$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
226926322$22692632$2$F$$20220826$20230711$20240722$PER$$US-ASTELLAS-2022US030975$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
226926332$22692633$2$F$$20220817$20230711$20240722$PER$$US-ASTELLAS-2022US029694$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226926342$22692634$2$F$$20220920$20230711$20240722$PER$$US-ASTELLAS-2022US033825$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926352$22692635$2$F$$20221108$20230711$20240722$PER$$US-ASTELLAS-2022US035602$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226926362$22692636$2$F$20220701$20221110$20230711$20240722$PER$$US-ASTELLAS-2022US032722$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
226926382$22692638$2$F$20220701$20220722$20230711$20240722$PER$$US-ASTELLAS-2022US026592$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226926392$22692639$2$F$20220914$20220915$20230711$20240722$PER$$US-ASTELLAS-2022US033293$ASTELLAS$$78$YR$$M$Y$$$20240722$$CN$US$US
226926402$22692640$2$F$20210101$20220830$20230711$20240722$PER$$US-ASTELLAS-2022US031214$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226926412$22692641$2$F$20220901$20220930$20230711$20240722$PER$$US-ASTELLAS-2022US035198$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226926422$22692642$2$F$20220901$20220902$20230711$20240722$PER$$US-ASTELLAS-2022US031872$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
226926432$22692643$2$F$$20220815$20230711$20240722$PER$$US-ASTELLAS-2022US029261$ASTELLAS$$$$$F$Y$64.41$KG$20240722$$CN$US$US
226926442$22692644$2$F$20220721$20220812$20230711$20240722$PER$$US-ASTELLAS-2022US026825$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
226926452$22692645$2$F$$20220818$20230711$20240722$PER$$US-ASTELLAS-2022US029783$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926462$22692646$2$F$$20220908$20230711$20240722$PER$$US-ASTELLAS-2022US032483$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926472$22692647$2$F$$20221209$20230711$20240722$PER$$US-ASTELLAS-2022US035365$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226926482$22692648$2$F$$20220809$20230711$20240722$PER$$US-ASTELLAS-2022US028553$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
226926492$22692649$2$F$$20220908$20230711$20240722$PER$$US-ASTELLAS-2022US032556$ASTELLAS$$7$DEC$$F$Y$$$20240722$$CN$US$US
226926502$22692650$2$F$20220911$20220912$20230711$20240722$PER$$US-ASTELLAS-2022US032713$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
226926512$22692651$2$F$20220715$20220718$20230711$20240722$PER$$US-ASTELLAS-2022US025836$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226926524$22692652$4$F$$20220908$20230711$20240722$PER$$US-ASTELLAS-2022US032477$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
226926532$22692653$2$F$$20220707$20230711$20240722$PER$$US-ASTELLAS-2022US024957$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926542$22692654$2$F$$20220728$20230711$20240722$PER$$US-ASTELLAS-2022US027347$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
226926552$22692655$2$F$$20220921$20230711$20240722$PER$$US-ASTELLAS-2022US033994$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226926562$22692656$2$F$$20220907$20230711$20240722$PER$$US-ASTELLAS-2022US025436$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926572$22692657$2$F$$20220802$20230711$20240722$PER$$US-ASTELLAS-2022US027800$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
226926582$22692658$2$F$$20220822$20230711$20240722$PER$$US-ASTELLAS-2022US030195$ASTELLAS$$9$DEC$$F$Y$$$20240722$$HP$US$US
226926592$22692659$2$F$20220801$20220810$20230711$20240722$PER$$US-ASTELLAS-2022US028736$ASTELLAS$$37$YR$$F$Y$$$20240722$$CN$US$US
226926602$22692660$2$F$20210101$20220815$20230711$20240722$PER$$US-ASTELLAS-2022US027663$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226926612$22692661$2$F$$20220921$20230711$20240722$PER$$US-ASTELLAS-2022US033914$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
226926622$22692662$2$F$$20220921$20230711$20240722$PER$$US-ASTELLAS-2022US033918$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226926632$22692663$2$F$20220909$20220909$20230711$20240722$PER$$US-ASTELLAS-2022US032732$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226926642$22692664$2$F$$20221003$20230711$20240722$PER$$US-ASTELLAS-2022US035295$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226926654$22692665$4$F$$20220926$20230711$20240722$PER$$US-ASTELLAS-2022US034470$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226926662$22692666$2$F$$20220921$20230711$20240722$PER$$US-ASTELLAS-2022US034035$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926672$22692667$2$F$20220101$20220921$20230711$20240722$PER$$US-ASTELLAS-2022US032988$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
226926682$22692668$2$F$$20220908$20230711$20240722$PER$$US-ASTELLAS-2022US032715$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926692$22692669$2$F$$20221004$20230711$20240722$PER$$US-ASTELLAS-2022US035530$ASTELLAS$$49$YR$$M$Y$$$20240722$$PH$US$US
226926702$22692670$2$F$$20221212$20230711$20240722$PER$$US-ASTELLAS-2022US034494$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926712$22692671$2$F$$20220701$20230711$20240722$PER$$US-ASTELLAS-2022US024066$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226926722$22692672$2$F$20220728$20220804$20230711$20240722$PER$$US-ASTELLAS-2022US028262$ASTELLAS$$92$YR$$M$Y$$$20240722$$CN$US$US
226926742$22692674$2$F$20210101$20220725$20230711$20240722$PER$$US-ASTELLAS-2022US026945$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926752$22692675$2$F$20220816$20220817$20230711$20240722$PER$$US-ASTELLAS-2022US029726$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226926762$22692676$2$F$$20220803$20230711$20240722$PER$$US-ASTELLAS-2022US027994$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
226926772$22692677$2$F$$20220701$20230711$20240722$PER$$US-ASTELLAS-2022US023974$ASTELLAS$$87$YR$$M$Y$$$20240722$$CN$US$US
226926782$22692678$2$F$$20220902$20230711$20240722$PER$$US-ASTELLAS-2022US031871$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926792$22692679$2$F$$20220806$20230711$20240722$PER$$US-ASTELLAS-2022US024476$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926802$22692680$2$F$$20220823$20230711$20240722$PER$$US-ASTELLAS-2022US030055$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926812$22692681$2$F$20220901$20220914$20230711$20240722$PER$$US-ASTELLAS-2022US033118$ASTELLAS$$72$YR$$M$Y$$$20240722$$CN$US$US
226926822$22692682$2$F$$20220823$20230711$20240722$PER$$US-ASTELLAS-2022US031634$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926832$22692683$2$F$$20220926$20230711$20240722$PER$$US-ASTELLAS-2022US034677$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
226926842$22692684$2$F$$20220922$20230711$20240722$PER$$US-ASTELLAS-2022US034177$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926852$22692685$2$F$$20220907$20230711$20240722$PER$$US-ASTELLAS-2022US032197$ASTELLAS$$88$YR$$M$Y$$$20240722$$MD$US$US
226926862$22692686$2$F$$20220802$20230711$20240722$PER$$US-ASTELLAS-2022US025679$ASTELLAS$$84$YR$$M$Y$$$20240722$$CN$US$US
226926872$22692687$2$F$$20221013$20230711$20240722$PER$$US-ASTELLAS-2022US034012$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226926882$22692688$2$F$$20220808$20230711$20240722$PER$$US-ASTELLAS-2022US028394$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926892$22692689$2$F$$20220824$20230711$20240722$PER$$US-ASTELLAS-2022US030574$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
226926902$22692690$2$F$20220901$20220912$20230711$20240722$PER$$US-ASTELLAS-2022US032874$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
226926912$22692691$2$F$$20220802$20230711$20240722$PER$$US-ASTELLAS-2022US027782$ASTELLAS$$6$DEC$$F$Y$$$20240722$$CN$US$US
226926924$22692692$4$F$20220101$20220926$20230711$20240722$PER$$US-ASTELLAS-2022US031241$ASTELLAS$$89$YR$$F$Y$$$20240722$$CN$US$US
226926934$22692693$4$F$20220801$20221011$20230711$20240722$PER$$US-ASTELLAS-2022US031656$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
226926942$22692694$2$F$$20220923$20230711$20240722$PER$$US-ASTELLAS-2022US034319$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
226926952$22692695$2$F$20220727$20220728$20230711$20240722$PER$$US-ASTELLAS-2022US027481$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226926962$22692696$2$F$$20220919$20230711$20240722$PER$$US-ASTELLAS-2022US016368$ASTELLAS$$65$YR$$F$Y$$$20240722$$CN$US$US
226926972$22692697$2$F$$20220816$20230711$20240722$PER$$US-ASTELLAS-2022US029472$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226926992$22692699$2$F$20220126$20221019$20230711$20240722$PER$$US-ASTELLAS-2022US033290$ASTELLAS$$72$YR$$F$Y$$$20240722$$MD$US$US
226927002$22692700$2$F$20220801$20220802$20230711$20240722$PER$$US-ASTELLAS-2022US027976$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226927012$22692701$2$F$$20220822$20230711$20240722$PER$$US-ASTELLAS-2022US030212$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
226927022$22692702$2$F$20220826$20221012$20230711$20240722$PER$$US-ASTELLAS-2022US030946$ASTELLAS$$79$YR$$F$Y$$$20240722$$MD$US$US
226927032$22692703$2$F$$20220920$20230711$20240722$PER$$US-ASTELLAS-2022US034045$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
226927042$22692704$2$F$20150211$20231113$20230711$20240722$PER$$US-ASTELLAS-2022US027633$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226927052$22692705$2$F$20220601$20221017$20230711$20240722$PER$$US-ASTELLAS-2022US029293$ASTELLAS$$66$YR$$F$Y$$$20240722$$CN$US$US
226927062$22692706$2$F$20220701$20220801$20230711$20240722$PER$$US-ASTELLAS-2022US027635$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
226927072$22692707$2$F$$20220920$20230711$20240722$PER$$US-ASTELLAS-2022US034051$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
226927082$22692708$2$F$20220101$20220707$20230711$20240722$PER$$US-ASTELLAS-2022US024666$ASTELLAS$$69$YR$$M$Y$$$20240722$$CN$US$US
226927124$22692712$4$F$$20220726$20230711$20240722$PER$$US-ASTELLAS-2022US026958$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927132$22692713$2$F$20220601$20221214$20230711$20240722$PER$$US-ASTELLAS-2022US026776$ASTELLAS$$79$YR$$F$Y$$$20240722$$MD$US$US
226927142$22692714$2$F$$20220728$20230711$20240722$PER$$US-ASTELLAS-2022US027216$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927152$22692715$2$F$$20220810$20230711$20240722$PER$$US-ASTELLAS-2022US028701$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
226927162$22692716$2$F$$20220921$20230711$20240722$PER$$US-ASTELLAS-2022US034164$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226927172$22692717$2$F$$20220930$20230711$20240722$PER$$US-ASTELLAS-2022US035279$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927182$22692718$2$F$$20220801$20230711$20240722$PER$$US-ASTELLAS-2022US027672$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927192$22692719$2$F$20220823$20220825$20230711$20240722$PER$$US-ASTELLAS-2022US030788$ASTELLAS$$93$YR$$M$Y$$$20240722$$CN$US$US
226927202$22692720$2$F$$20220913$20230711$20240722$PER$$US-ASTELLAS-2022US032934$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226927212$22692721$2$F$$20221101$20230711$20240722$PER$$US-ASTELLAS-2022US035572$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
226927222$22692722$2$F$$20220812$20230711$20240722$PER$$US-ASTELLAS-2022US027217$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
226927232$22692723$2$F$20220701$20220719$20230711$20240722$PER$$US-ASTELLAS-2022US026056$ASTELLAS$$78$YR$$M$Y$$$20240722$$CN$US$US
226927242$22692724$2$F$$20220928$20230711$20240722$PER$$US-ASTELLAS-2022US034839$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927252$22692725$2$F$$20220802$20230711$20240722$PER$$US-ASTELLAS-2022US027821$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
226927274$22692727$4$F$20220101$20220921$20230711$20240722$PER$$US-ASTELLAS-2022US034192$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
226927282$22692728$2$F$$20220812$20230711$20240722$PER$$US-ASTELLAS-2022US029067$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
226927292$22692729$2$F$$20220822$20230711$20240722$PER$$US-ASTELLAS-2022US030235$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
226927302$22692730$2$F$$20221003$20230711$20240722$PER$$US-ASTELLAS-2022US032982$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
226927312$22692731$2$F$$20220902$20230711$20240722$PER$$US-ASTELLAS-2022US031865$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226927322$22692732$2$F$$20220726$20230711$20240722$PER$$US-ASTELLAS-2022US026960$ASTELLAS$$$$A$M$Y$$$20240722$$HP$US$US
226927332$22692733$2$F$$20220711$20230711$20240722$PER$$US-ASTELLAS-2022US024922$ASTELLAS$$$$$M$Y$$$20240722$$PH$US$US
226927342$22692734$2$F$$20220816$20230711$20240722$PER$$US-ASTELLAS-2022US029414$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927352$22692735$2$F$$20220728$20230711$20240722$PER$$US-ASTELLAS-2022US027537$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226927362$22692736$2$F$$20220906$20230711$20240722$PER$$US-ASTELLAS-2022US028393$ASTELLAS$$$$$F$Y$105.2$KG$20240722$$CN$US$US
226927372$22692737$2$F$20220801$20220808$20230711$20240722$PER$$US-ASTELLAS-2022US028414$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
226927382$22692738$2$F$$20220808$20230711$20240722$PER$$US-ASTELLAS-2022US028390$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927392$22692739$2$F$20220101$20220930$20230711$20240722$PER$$US-ASTELLAS-2022US035233$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226927402$22692740$2$F$$20220907$20230711$20240722$PER$$US-ASTELLAS-2022US032470$ASTELLAS$$91$YR$$F$Y$$$20240722$$CN$US$US
226927412$22692741$2$F$$20220718$20230711$20240722$PER$$US-ASTELLAS-2022US025842$ASTELLAS$$88$YR$$M$Y$$$20240722$$CN$US$US
226927422$22692742$2$F$$20220816$20230711$20240722$PER$$US-ASTELLAS-2022US029528$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927432$22692743$2$F$20190220$20220801$20230711$20240722$PER$$US-ASTELLAS-2022US025482$ASTELLAS$$8$DEC$$M$Y$$$20240722$$HP$US$US
226927444$22692744$4$F$20220101$20220810$20230711$20240722$PER$$US-ASTELLAS PHARMA EUROPE B.V.-2022US028917$ASTELLAS$$67$YR$$M$Y$$$20240722$$CN$US$US
226927452$22692745$2$F$$20220823$20230711$20240722$PER$$US-ASTELLAS-2022US030533$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
226927462$22692746$2$F$$20220715$20230711$20240722$PER$$US-ASTELLAS-2022US025698$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927472$22692747$2$F$$20220801$20230711$20240722$PER$$US-ASTELLAS-2022US027629$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
226927482$22692748$2$F$$20220923$20230711$20240722$PER$$US-ASTELLAS-2022US034513$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226927492$22692749$2$F$$20220812$20230711$20240722$PER$$US-ASTELLAS-2022US029083$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927502$22692750$2$F$$20220829$20230711$20240722$PER$$US-ASTELLAS-2022US031041$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
226927512$22692751$2$F$$20220721$20230711$20240722$PER$$US-ASTELLAS-2022US026964$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927522$22692752$2$F$$20220818$20230711$20240722$PER$$US-ASTELLAS-2022US029843$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226927532$22692753$2$F$$20220719$20230711$20240722$PER$$US-ASTELLAS-2022US026192$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226927542$22692754$2$F$$20220719$20230711$20240722$PER$$US-ASTELLAS-2022US026195$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
226927552$22692755$2$F$$20220818$20230711$20240722$PER$$US-ASTELLAS-2022US029836$ASTELLAS$$51$YR$$M$Y$$$20240722$$CN$US$US
226927562$22692756$2$F$20220906$20220930$20230711$20240722$PER$$US-ASTELLAS-2022US034316$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
226927572$22692757$2$F$$20220705$20230711$20240722$PER$$US-ASTELLAS PHARMA EUROPE B.V.-2022US024269$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
226927584$22692758$4$F$$20220920$20230711$20240722$PER$$US-ASTELLAS-2022US033826$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927592$22692759$2$F$$20220811$20230711$20240722$PER$$US-ASTELLAS-2022US028861$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226927602$22692760$2$F$20220809$20220824$20230711$20240722$PER$$US-ASTELLAS-2022US028756$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927612$22692761$2$F$$20220714$20230711$20240722$PER$$US-ASTELLAS PHARMA EUROPE B.V.-2022US025489$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226927622$22692762$2$F$20220819$20220822$20230711$20240722$PER$$US-ASTELLAS-2022US030230$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
226927632$22692763$2$F$$20220706$20230711$20240722$PER$$US-ASTELLAS-2022US024411$ASTELLAS$$8$DEC$$F$Y$$$20240722$$CN$US$US
226927692$22692769$2$F$$20220725$20230711$20240722$PER$$US-ASTELLAS-2022US026792$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226927702$22692770$2$F$$20220907$20230711$20240722$PER$$US-ASTELLAS-2022US032447$ASTELLAS$$73$YR$$M$Y$$$20240722$$CN$US$US
226927712$22692771$2$F$$20220825$20230711$20240722$PER$$US-ASTELLAS-2022US031045$ASTELLAS$$$$E$$Y$$$20240722$$CN$US$US
226927722$22692772$2$F$$20220926$20230711$20240722$PER$$US-ASTELLAS-2022US030780$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226927732$22692773$2$F$$20220718$20230711$20240722$PER$$US-ASTELLAS-2022US025832$ASTELLAS$$88$YR$$M$Y$$$20240722$$CN$US$US
226927742$22692774$2$F$20220701$20220908$20230711$20240722$PER$$US-ASTELLAS-2022US031272$ASTELLAS$$65$YR$$F$Y$$$20240722$$CN$US$US
226927752$22692775$2$F$20220601$20220719$20230711$20240722$PER$$US-ASTELLAS-2022US024307$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
226927762$22692776$2$F$$20220831$20230711$20240722$PER$$US-ASTELLAS-2022US031468$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226927774$22692777$4$F$$20220726$20230711$20240722$PER$$US-ASTELLAS-2022US026949$ASTELLAS$$87$YR$$F$Y$$$20240722$$CN$US$US
226927782$22692778$2$F$20220101$20220930$20230711$20240722$PER$$US-ASTELLAS-2022US035416$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927792$22692779$2$F$20220701$20220729$20230711$20240722$PER$$US-ASTELLAS-2022US027495$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226927802$22692780$2$F$$20220929$20230711$20240722$PER$$US-ASTELLAS-2022US035030$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927812$22692781$2$F$$20220809$20230711$20240722$PER$$US-ASTELLAS-2022US028620$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
226927822$22692782$2$F$$20220720$20230711$20240722$PER$$US-ASTELLAS-2022US026227$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
226927832$22692783$2$F$$20220812$20230711$20240722$PER$$US-ASTELLAS-2022US029054$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226927852$22692785$2$F$20220501$20220930$20230711$20240722$PER$$US-ASTELLAS-2022US035226$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927862$22692786$2$F$$20220707$20230711$20240722$PER$$US-ASTELLAS-2022US024841$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226927872$22692787$2$F$20140101$20221012$20230711$20240722$PER$$US-ASTELLAS-2022US034580$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226927882$22692788$2$F$$20220828$20230711$20240722$PER$$US-ASTELLAS-2022US030872$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
226927892$22692789$2$F$$20220826$20230711$20240722$PER$$US-ASTELLAS-2022US030943$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927902$22692790$2$F$20220701$20220718$20230711$20240722$PER$$US-ASTELLAS-2022US025828$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
226927912$22692791$2$F$20220706$20220708$20230711$20240722$PER$$US-ASTELLAS-2022US024847$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
226927922$22692792$2$F$$20220929$20230711$20240722$PER$$US-ASTELLAS-2022US035085$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927932$22692793$2$F$$20220922$20230711$20240722$PER$$US-ASTELLAS-2022US034189$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226927942$22692794$2$F$20220825$20220825$20230711$20240722$PER$$US-ASTELLAS-2022US030939$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
226927952$22692795$2$F$20220101$20220714$20230711$20240722$PER$$US-ASTELLAS-2022US024518$ASTELLAS$$72$YR$$M$Y$$$20240722$$CN$US$US
226927962$22692796$2$F$20220701$20220712$20230711$20240722$PER$$US-ASTELLAS-2022US025115$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
226927972$22692797$2$F$20220725$20220725$20230711$20240722$PER$$US-ASTELLAS-2022US026803$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927982$22692798$2$F$$20220719$20230711$20240722$PER$$US-ASTELLAS-2022US026042$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226927992$22692799$2$F$$20220920$20230711$20240722$PER$$US-ASTELLAS-2022US032724$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226928002$22692800$2$F$$20220809$20230711$20240722$PER$$US-ASTELLAS-2022US028617$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928012$22692801$2$F$20220708$20220708$20230711$20240722$PER$$US-ASTELLAS-2022US024821$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
226928032$22692803$2$F$$20220714$20230711$20240722$PER$$US-ASTELLAS-2022US024073$ASTELLAS$$84$YR$$M$Y$$$20240722$$CN$US$US
226928042$22692804$2$F$20220101$20220930$20230711$20240722$PER$$US-ASTELLAS-2022US027222$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928052$22692805$2$F$20180823$20220902$20230711$20240722$PER$$US-ASTELLAS-2022US025483$ASTELLAS$$70$YR$$M$Y$$$20240722$$CN$US$US
226928062$22692806$2$F$$20220912$20230711$20240722$PER$$US-ASTELLAS-2022US032901$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226928072$22692807$2$F$$20230614$20230711$20240722$PER$$US-ASTELLAS-2023US018221$ASTELLAS$$63$YR$$F$Y$$$20240722$$CN$US$US
226928082$22692808$2$F$$20221007$20230711$20240722$PER$$US-ASTELLAS-2022US036084$ASTELLAS$$69$YR$$F$Y$$$20240722$$CN$US$US
226928092$22692809$2$F$$20221209$20230711$20240722$PER$$US-ASTELLAS-2022US044162$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
226928102$22692810$2$F$$20220713$20230711$20240722$PER$$US-ASTELLAS-2022US025442$ASTELLAS$$9$DEC$$M$Y$$$20240722$$CN$US$US
226928112$22692811$2$F$$20220711$20230711$20240722$PER$$US-ASTELLAS-2022US025127$ASTELLAS$$$$A$F$Y$$$20240722$$HP$US$US
226928122$22692812$2$F$$20220706$20230711$20240722$PER$$US-ASTELLAS-2022US024449$ASTELLAS$$46$YR$$F$Y$$$20240722$$CN$US$US
226928132$22692813$2$F$$20220912$20230711$20240722$PER$$US-ASTELLAS-2022US032899$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226928142$22692814$2$F$$20230127$20230711$20240722$PER$$US-ASTELLAS-2023US003422$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226928152$22692815$2$F$$20230130$20230711$20240722$PER$$US-ASTELLAS-2023US003653$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928232$22692823$2$F$20230510$20230628$20230711$20240722$PER$$US-ASTELLAS-2023US014681$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
226928242$22692824$2$F$$20221118$20230711$20240722$PER$$US-ASTELLAS-2022US039681$ASTELLAS$$61$YR$$F$Y$$$20240722$$CN$US$US
226928252$22692825$2$F$20230314$20230315$20230711$20240722$PER$$US-ASTELLAS-2023US009120$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226928262$22692826$2$F$20221201$20230104$20230711$20240722$PER$$US-ASTELLAS-2023US000611$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
226928272$22692827$2$F$$20230302$20230711$20240722$PER$$US-ASTELLAS-2023US007630$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928282$22692828$2$F$$20230313$20230711$20240722$PER$$US-ASTELLAS-2023US008701$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928292$22692829$2$F$$20230406$20230711$20240722$PER$$US-ASTELLAS-2023US011310$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928302$22692830$2$F$20230601$20230623$20230711$20240722$PER$$US-ASTELLAS-2023US018470$ASTELLAS$$9$DEC$$F$Y$$$20240722$$CN$US$US
226928312$22692831$2$F$$20230426$20230711$20240722$PER$$US-ASTELLAS-2023US013226$ASTELLAS$$$$$F$Y$$$20240722$$HP$US$US
226928324$22692832$4$F$$20230626$20230711$20240722$PER$$US-ASTELLAS-2023US019394$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226928332$22692833$2$F$20230401$20230616$20230711$20240722$PER$$US-ASTELLAS-2023US018601$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
226928342$22692834$2$F$$20230501$20230711$20240722$PER$$US-ASTELLAS-2023US013669$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226928354$22692835$4$F$20220101$20230103$20230711$20240722$PER$$US-ASTELLAS-2023US000452$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928362$22692836$2$F$$20230503$20230711$20240722$PER$$US-ASTELLAS-2023US013992$ASTELLAS$$70$YR$$M$Y$$$20240722$$CN$US$US
226928372$22692837$2$F$$20221020$20230711$20240722$PER$$US-ASTELLAS-2022US037781$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928384$22692838$4$F$$20230509$20230711$20240722$PER$$US-ASTELLAS-2023US014458$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928392$22692839$2$F$20230421$20230525$20230711$20240722$PER$$US-ASTELLAS-2023US013347$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
226928402$22692840$2$F$20230601$20230606$20230711$20240722$PER$$US-ASTELLAS-2023US017403$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
226928412$22692841$2$F$$20230509$20230711$20240722$PER$$US-ASTELLAS-2023US014601$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226928422$22692842$2$F$20230508$20230511$20230711$20240722$PER$$US-ASTELLAS-2023US014921$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928432$22692843$2$F$$20230523$20230711$20240722$PER$$US-ASTELLAS-2023US016016$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928442$22692844$2$F$$20230427$20230711$20240722$PER$$US-ASTELLAS-2023US013384$ASTELLAS$$8$DEC$$F$Y$$$20240722$$CN$US$US
226928452$22692845$2$F$$20230612$20230711$20240722$PER$$US-ASTELLAS-2023US018054$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226928462$22692846$2$F$$20230127$20230711$20240722$PER$$US-ASTELLAS-2023US001535$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
226928472$22692847$2$F$20230301$20230426$20230711$20240722$PER$$US-ASTELLAS-2023US013232$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928482$22692848$2$F$20230227$20230327$20230711$20240722$PER$$US-ASTELLAS-2023US010167$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928492$22692849$2$F$$20230412$20230711$20240722$PER$$US-ASTELLAS-2023US012497$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226928502$22692850$2$F$20230412$20230412$20230711$20240722$PER$$US-ASTELLAS-2023US011871$ASTELLAS$$58$YR$$F$Y$$$20240722$$CN$US$US
226928512$22692851$2$F$20230101$20230118$20230711$20240722$PER$$US-ASTELLAS-2023US002236$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226928524$22692852$4$F$20221201$20230525$20230711$20240722$PER$$US-ASTELLAS-2023US001698$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226928532$22692853$2$F$$20230126$20230711$20240722$PER$$US-ASTELLAS-2023US003301$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226928542$22692854$2$F$20230203$20230206$20230711$20240722$PER$$US-ASTELLAS-2023US004611$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226928554$22692855$4$F$$20230329$20230711$20240722$PER$$US-ASTELLAS-2023US010458$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
226928562$22692856$2$F$$20230303$20230711$20240722$PER$$US-ASTELLAS-2023US007572$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
226928572$22692857$2$F$$20230523$20230711$20240722$PER$$US-ASTELLAS-2023US013011$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226928584$22692858$4$F$20230103$20230221$20230711$20240722$PER$$US-ASTELLAS-2023US003638$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226928592$22692859$2$F$20221005$20221020$20230711$20240722$PER$$US-ASTELLAS-2022US035720$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928602$22692860$2$F$$20230329$20230711$20240722$PER$$US-ASTELLAS-2023US010479$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928612$22692861$2$F$$20230109$20230711$20240722$PER$$US-ASTELLAS-2023US000773$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
226928622$22692862$2$F$20220101$20230501$20230711$20240722$PER$$US-ASTELLAS-2023US013668$ASTELLAS$$60$YR$$M$Y$$$20240722$$CN$US$US
226928652$22692865$2$F$$20221109$20230711$20240722$PER$$US-ASTELLAS-2022US040291$ASTELLAS$$$$$$Y$$$20240722$$CN$US$US
226928682$22692868$2$F$20230413$20230628$20230711$20240722$PER$$US-ASTELLAS-2023US012482$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
226928712$22692871$2$F$$20230113$20230711$20240722$PER$$US-ASTELLAS-2023US001739$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
226928722$22692872$2$F$$20230222$20230711$20240722$PER$$US-ASTELLAS-2023US006569$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
226928732$22692873$2$F$$20221129$20230711$20240722$PER$$US-ASTELLAS-2022US042669$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
226928742$22692874$2$F$20230201$20230223$20230711$20240722$PER$$US-ASTELLAS-2023US006778$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226928754$22692875$4$F$$20221216$20230711$20240722$PER$$US-ASTELLAS-2022US044962$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226928762$22692876$2$F$20220101$20230310$20230711$20240722$PER$$US-ASTELLAS-2023US008684$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
226928772$22692877$2$F$$20230320$20230711$20240722$PER$$US-ASTELLAS-2023US009362$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
226928782$22692878$2$F$$20221020$20230711$20240722$PER$$US-ASTELLAS-2022US037942$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928792$22692879$2$F$$20230116$20230711$20240722$PER$$US-ASTELLAS-2023US001838$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
226928802$22692880$2$F$20221115$20221207$20230711$20240722$PER$$US-ASTELLAS-2022US042553$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226928812$22692881$2$F$20220101$20221027$20230711$20240722$PER$$US-ASTELLAS-2022US038867$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
226928822$22692882$2$F$$20230607$20230711$20240722$PER$$US-ASTELLAS-2023US017530$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928832$22692883$2$F$$20230330$20230711$20240722$PER$$US-ASTELLAS-2023US010602$ASTELLAS$$79$YR$$M$Y$$$20240722$$CN$US$US
226928842$22692884$2$F$$20221219$20230711$20240722$PER$$US-ASTELLAS-2022US045148$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226928852$22692885$2$F$$20230420$20230711$20240722$PER$$US-ASTELLAS-2023US012801$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
226928862$22692886$2$F$$20230307$20230711$20240722$PER$$US-ASTELLAS-2023US007999$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928872$22692887$2$F$$20230426$20230711$20240722$PER$$US-ASTELLAS-2023US013219$ASTELLAS$$$$$F$Y$$$20240722$$HP$US$US
226928882$22692888$2$F$$20230221$20230711$20240722$PER$$US-ASTELLAS-2023US006563$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928892$22692889$2$F$$20230411$20230711$20240722$PER$$US-ASTELLAS-2023US011841$ASTELLAS$$87$YR$$M$Y$$$20240722$$CN$US$US
226928902$22692890$2$F$20230311$20230313$20230711$20240722$PER$$US-ASTELLAS-2023US008542$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
226928914$22692891$4$F$20230401$20230425$20230711$20240722$PER$$US-ASTELLAS-2023US012498$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
226928922$22692892$2$F$$20230220$20230711$20240722$PER$$US-ASTELLAS-2022US044804$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
226928932$22692893$2$F$20230401$20230428$20230711$20240722$PER$$US-ASTELLAS-2023US012316$ASTELLAS$$65$YR$$M$Y$$$20240722$$CN$US$US
226928942$22692894$2$F$20230227$20230227$20230711$20240722$PER$$US-ASTELLAS-2023US007123$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226928952$22692895$2$F$$20230222$20230711$20240722$PER$$US-ASTELLAS-2023US006573$ASTELLAS$$60$YR$$M$Y$$$20240722$$CN$US$US
226928962$22692896$2$F$20221201$20221202$20230711$20240722$PER$$US-ASTELLAS-2022US043215$ASTELLAS$$61$YR$$M$Y$$$20240722$$HP$US$US
226928972$22692897$2$F$20221022$20221024$20230711$20240722$PER$$US-ASTELLAS-2022US038220$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226928982$22692898$2$F$$20230116$20230711$20240722$PER$$US-ASTELLAS-2023US001845$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
226928992$22692899$2$F$$20230404$20230711$20240722$PER$$US-ASTELLAS-2023US006891$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
226929002$22692900$2$F$20230401$20230407$20230711$20240722$PER$$US-ASTELLAS-2023US011441$ASTELLAS$$79$YR$$M$Y$$$20240722$$CN$US$US
226929012$22692901$2$F$20230426$20230426$20230711$20240722$PER$$US-ASTELLAS-2023US013350$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
226929022$22692902$2$F$20230101$20230125$20230711$20240722$PER$$US-ASTELLAS-2023US003103$ASTELLAS$$73$YR$$M$Y$$$20240722$$CN$US$US
226929032$22692903$2$F$20230301$20230313$20230711$20240722$PER$$US-ASTELLAS-2023US008713$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
226929042$22692904$2$F$$20230331$20230711$20240722$PER$$US-ASTELLAS-2023US008604$ASTELLAS$$40$YR$$M$Y$$$20240722$$CN$US$US
226929052$22692905$2$F$20230101$20230123$20230711$20240722$PER$$US-ASTELLAS-2023US002789$ASTELLAS$$65$YR$$M$Y$$$20240722$$CN$US$US
226929062$22692906$2$F$20230201$20230418$20230711$20240722$PER$$US-ASTELLAS-2023US012376$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
226929074$22692907$4$F$$20230331$20230711$20240722$PER$$US-ASTELLAS-2023US010723$ASTELLAS$$34$YR$$F$Y$$$20240722$$CN$US$US
226929082$22692908$2$F$$20221102$20230711$20240722$PER$$US-ASTELLAS-2022US039451$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226929094$22692909$4$F$$20230131$20230711$20240722$PER$$US-ASTELLAS-2023US001707$ASTELLAS$$8$DEC$$M$Y$$$20240722$$CN$US$US
226929102$22692910$2$F$$20221205$20230711$20240722$PER$$US-ASTELLAS-2022US043461$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
226929112$22692911$2$F$20221004$20221018$20230711$20240722$PER$$US-ASTELLAS-2022US035716$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929122$22692912$2$F$$20221121$20230711$20240722$PER$$US-ASTELLAS-2022US041728$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
226929132$22692913$2$F$$20221018$20230711$20240722$PER$$US-ASTELLAS-2022US037555$ASTELLAS$$$$$M$Y$$$20240722$$MD$US$US
226929142$22692914$2$F$$20221019$20230711$20240722$PER$$US-ASTELLAS-2022US037719$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929152$22692915$2$F$20221220$20221221$20230711$20240722$PER$$US-ASTELLAS-2022US045431$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
226929172$22692917$2$F$20221201$20221223$20230711$20240722$PER$$US-ASTELLAS-2022US044006$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
226929182$22692918$2$F$$20221020$20230711$20240722$PER$$US-ASTELLAS-2022US037939$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
226929192$22692919$2$F$$20230627$20230711$20240722$PER$$US-ASTELLAS-2023US018476$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226929202$22692920$2$F$$20230407$20230711$20240722$PER$$US-ASTELLAS-2023US010184$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929222$22692922$2$F$$20230315$20230711$20240722$PER$$US-ASTELLAS-2023US009034$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929232$22692923$2$F$20221001$20221025$20230711$20240722$PER$$US-ASTELLAS-2022US038414$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226929242$22692924$2$F$20230501$20230518$20230711$20240722$PER$$US-ASTELLAS-2023US015588$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
226929252$22692925$2$F$$20230610$20230711$20240722$PER$$US-ASTELLAS-2023US019028$ASTELLAS$$92$YR$$M$Y$$$20240722$$CN$US$US
226929262$22692926$2$F$20230301$20230313$20230711$20240722$PER$$US-ASTELLAS-2023US008708$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226929272$22692927$2$F$20220101$20230302$20230711$20240722$PER$$US-ASTELLAS-2023US007629$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929282$22692928$2$F$$20230118$20230711$20240722$PER$$US-ASTELLAS-2023US002170$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226929302$22692930$2$F$$20221021$20230711$20240722$PER$$US-ASTELLAS-2022US037991$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
226929312$22692931$2$F$20221117$20221117$20230711$20240722$PER$$US-ASTELLAS-2022US041452$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
226929324$22692932$4$F$20230501$20230602$20230711$20240722$PER$$US-ASTELLAS-2023US017090$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
226929344$22692934$4$F$$20221014$20230711$20240722$PER$$US-ASTELLAS-2022US037010$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929352$22692935$2$F$$20230116$20230711$20240722$PER$$US-ASTELLAS-2023US001839$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
226929362$22692936$2$F$$20221215$20230711$20240722$PER$$US-ASTELLAS-2022US044801$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226929372$22692937$2$F$$20230619$20230711$20240722$PER$$US-ASTELLAS-2023US018770$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
226929382$22692938$2$F$$20230515$20230711$20240722$PER$$US-ASTELLAS-2023US015097$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226929392$22692939$2$F$$20221026$20230711$20240722$PER$$US-ASTELLAS-2022US038765$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226929402$22692940$2$F$$20230322$20230711$20240722$PER$$US-ASTELLAS-2023US007858$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
226929414$22692941$4$F$20230501$20230619$20230711$20240722$PER$$US-ASTELLAS-2023US018972$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226929424$22692942$4$F$$20230323$20230711$20240722$PER$$US-ASTELLAS-2023US009845$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929434$22692943$4$F$$20230410$20230711$20240722$PER$$US-ASTELLAS-2023US011565$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
226929442$22692944$2$F$20220901$20221021$20230711$20240722$PER$$US-ASTELLAS-2022US036843$ASTELLAS$$95$YR$$M$Y$$$20240722$$CN$US$US
226929452$22692945$2$F$$20230602$20230711$20240722$PER$$US-ASTELLAS-2023US017148$ASTELLAS$$57$YR$$F$Y$$$20240722$$CN$US$US
226929464$22692946$4$F$20220701$20230502$20230711$20240722$PER$$US-ASTELLAS-2023US010178$ASTELLAS$$92$YR$$F$Y$$$20240722$$MD$US$US
226929472$22692947$2$F$$20230119$20230711$20240722$PER$$US-ASTELLAS-2023US002356$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929484$22692948$4$F$$20230317$20230711$20240722$PER$$US-ASTELLAS-2023US009260$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929494$22692949$4$F$$20230118$20230711$20240722$PER$$US-ASTELLAS-2023US002174$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
226929502$22692950$2$F$$20230106$20230711$20240722$PER$$US-ASTELLAS-2023US000912$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
226929512$22692951$2$F$20230301$20230315$20230711$20240722$PER$$US-ASTELLAS-2023US009119$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226929522$22692952$2$F$$20230105$20230711$20240722$PER$$US-ASTELLAS-2023US000738$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929534$22692953$4$F$$20230815$20230711$20240722$PER$$US-ASTELLAS-2022US035705$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226929542$22692954$2$F$$20240105$20230711$20240722$PER$$US-ASTELLAS-2023US001101$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226929552$22692955$2$F$$20230516$20230711$20240722$PER$$US-ASTELLAS-2023US015338$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226929562$22692956$2$F$20230501$20230524$20230711$20240722$PER$$US-ASTELLAS-2023US016183$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
226929582$22692958$2$F$$20230406$20230711$20240722$PER$$US-ASTELLAS-2023US011344$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226929592$22692959$2$F$$20221212$20230711$20240722$PER$$US-ASTELLAS-2022US044642$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929612$22692961$2$F$$20221018$20230711$20240722$PER$$US-ASTELLAS-2022US037453$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226929622$22692962$2$F$$20230327$20230711$20240722$PER$$US-ASTELLAS-2023US010191$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929642$22692964$2$F$$20230509$20230711$20240722$PER$$US-ASTELLAS-2023US014606$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226929652$22692965$2$F$20221013$20221013$20230711$20240722$PER$$US-ASTELLAS-2022US036830$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
226929662$22692966$2$F$$20230327$20230711$20240722$PER$$US-ASTELLAS-2023US010175$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226929672$22692967$2$F$$20230301$20230711$20240722$PER$$US-ASTELLAS-2023US007506$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929682$22692968$2$F$$20230518$20230711$20240722$PER$$US-ASTELLAS-2023US015488$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226929694$22692969$4$F$$20230509$20230711$20240722$PER$$US-ASTELLAS-2023US014596$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
226929702$22692970$2$F$$20240521$20230711$20240722$PER$$US-ASTELLAS-2023US009125$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
226929712$22692971$2$F$20230101$20230619$20230711$20240722$PER$$US-ASTELLAS-2023US015342$ASTELLAS$$78$YR$$M$Y$$$20240722$$CN$US$US
226929722$22692972$2$F$$20230614$20230711$20240722$PER$$US-ASTELLAS-2023US015343$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
226929732$22692973$2$F$$20230622$20230711$20240722$PER$$US-ASTELLAS-2023US019400$ASTELLAS$$95$YR$$M$Y$$$20240722$$CN$US$US
226929742$22692974$2$F$$20230501$20230711$20240722$PER$$US-ASTELLAS-2023US013670$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226929752$22692975$2$F$20230124$20230125$20230711$20240722$PER$$US-ASTELLAS-2023US003098$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929764$22692976$4$F$$20230301$20230711$20240722$PER$$US-ASTELLAS-2023US007426$ASTELLAS$$57$YR$$M$Y$$$20240722$$CN$US$US
226929782$22692978$2$F$20230303$20230317$20230711$20240722$PER$$US-ASTELLAS-2023US007763$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
226929792$22692979$2$F$$20230104$20230711$20240722$PER$$US-ASTELLAS-2023US000605$ASTELLAS$$69$YR$$M$Y$$$20240722$$CN$US$US
226929802$22692980$2$F$$20230222$20230711$20240722$PER$$US-ASTELLAS-2023US006550$ASTELLAS$$65$YR$$F$Y$$$20240722$$CN$US$US
226929812$22692981$2$F$$20230623$20230711$20240722$PER$$US-ASTELLAS-2023US019314$ASTELLAS$$98$YR$$M$Y$$$20240722$$CN$US$US
226929822$22692982$2$F$20230511$20230511$20230711$20240722$PER$$US-ASTELLAS-2023US015027$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929832$22692983$2$F$$20221201$20230711$20240722$PER$$US-ASTELLAS-2022US042089$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
226929842$22692984$2$F$$20230127$20230711$20240722$PER$$US-ASTELLAS-2023US003281$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226929852$22692985$2$F$20221101$20221118$20230711$20240722$PER$$US-ASTELLAS-2022US041643$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
226929862$22692986$2$F$$20221216$20230711$20240722$PER$$US-ASTELLAS-2022US044986$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
226929872$22692987$2$F$$20221215$20230711$20240722$PER$$US-ASTELLAS-2022US044797$ASTELLAS$$60$YR$$F$Y$$$20240722$$CN$US$US
226929882$22692988$2$F$20221101$20221128$20230711$20240722$PER$$US-ASTELLAS-2022US042524$ASTELLAS$$55$YR$$M$Y$$$20240722$$CN$US$US
226929892$22692989$2$F$20230301$20230407$20230711$20240722$PER$$US-ASTELLAS-2023US004250$ASTELLAS$$43$YR$$F$Y$$$20240722$$CN$US$US
226929902$22692990$2$F$$20230329$20230711$20240722$PER$$US-ASTELLAS-2023US010468$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226929922$22692992$2$F$20221222$20221223$20230711$20240722$PER$$US-ASTELLAS-2022US046016$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
226929932$22692993$2$F$20230301$20230403$20230711$20240722$PER$$US-ASTELLAS-2023US010991$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226929942$22692994$2$F$20220101$20221020$20230711$20240722$PER$$US-ASTELLAS-2022US037937$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226929952$22692995$2$F$$20230403$20230711$20240722$PER$$US-ASTELLAS-2023US010977$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
226929962$22692996$2$F$$20230120$20230711$20240722$PER$$US-ASTELLAS-2023US002535$ASTELLAS$$68$YR$$F$Y$116.21$KG$20240722$$HP$US$US
226929972$22692997$2$F$$20230425$20230711$20240722$PER$$US-ASTELLAS-2023US013106$ASTELLAS$$60$YR$$M$Y$$$20240722$$CN$US$US
226929982$22692998$2$F$$20230131$20230711$20240722$PER$$US-ASTELLAS-2023US003814$ASTELLAS$$95$YR$$M$Y$$$20240722$$HP$US$US
226929992$22692999$2$F$$20230103$20230711$20240722$PER$$US-ASTELLAS-2023US000437$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
226930004$22693000$4$F$$20221021$20230711$20240722$PER$$US-ASTELLAS-2022US037988$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930022$22693002$2$F$20230201$20230223$20230711$20240722$PER$$US-ASTELLAS-2023US006775$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930032$22693003$2$F$$20221102$20230711$20240722$PER$$US-ASTELLAS-2022US039547$ASTELLAS$$76$YR$$M$Y$136.08$KG$20240722$$CN$US$US
226930052$22693005$2$F$$20230313$20230711$20240722$PER$$US-ASTELLAS-2023US007143$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930062$22693006$2$F$$20230525$20230711$20240722$PER$$US-ASTELLAS-2023US016264$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
226930072$22693007$2$F$$20230104$20230711$20240722$PER$$US-ASTELLAS-2023US000585$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930092$22693009$2$F$$20221121$20230711$20240722$PER$$US-ASTELLAS-2022US041742$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930104$22693010$4$F$$20230220$20230711$20240722$PER$$US-ASTELLAS-2023US002243$ASTELLAS$$74$YR$$M$Y$$$20240722$$PH$US$US
226930112$22693011$2$F$$20221020$20230711$20240722$PER$$US-ASTELLAS-2022US037782$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
226930122$22693012$2$F$20221208$20221208$20230711$20240722$PER$$US-ASTELLAS-2022US043993$ASTELLAS$$89$YR$$M$Y$$$20240722$$CN$US$US
226930132$22693013$2$F$$20230613$20230711$20240722$PER$$US-ASTELLAS-2023US016863$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226930142$22693014$2$F$20230101$20230116$20230711$20240722$PER$$US-ASTELLAS-2023US001834$ASTELLAS$$69$YR$$F$Y$$$20240722$$CN$US$US
226930172$22693017$2$F$$20230217$20230711$20240722$PER$$US-ASTELLAS-2023US006132$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930184$22693018$4$F$$20221206$20230711$20240722$PER$$US-ASTELLAS-2022US043817$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226930192$22693019$2$F$$20230321$20230711$20240722$PER$$US-ASTELLAS-2023US009561$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226930204$22693020$4$F$$20230213$20230711$20240722$PER$$US-ASTELLAS-2023US002878$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226930212$22693021$2$F$$20230612$20230711$20240722$PER$$US-ASTELLAS-2023US017866$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930222$22693022$2$F$$20230213$20230711$20240722$PER$$US-ASTELLAS-2023US005237$ASTELLAS$$6$DEC$$F$Y$$$20240722$$CN$US$US
226930232$22693023$2$F$20230524$20230524$20230711$20240722$PER$$US-ASTELLAS-2023US014580$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
226930242$22693024$2$F$20220101$20221221$20230711$20240722$PER$$US-ASTELLAS-2022US040400$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
226930252$22693025$2$F$20221201$20221206$20230711$20240722$PER$$US-ASTELLAS-2022US043606$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
226930262$22693026$2$F$$20221123$20230711$20240722$PER$$US-ASTELLAS-2022US042102$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
226930272$22693027$2$F$$20230323$20230711$20240722$PER$$US-ASTELLAS-2023US009747$ASTELLAS$$$$$M$Y$$$20240722$$HP$US$US
226930292$22693029$2$F$$20230413$20230711$20240722$PER$$US-ASTELLAS-2023US012493$ASTELLAS$$68$YR$$M$Y$$$20240722$$CN$US$US
226930302$22693030$2$F$$20230118$20230711$20240722$PER$$US-ASTELLAS-2023US002238$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
226930312$22693031$2$F$$20230519$20230711$20240722$PER$$US-ASTELLAS-2023US015855$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930322$22693032$2$F$20230501$20230508$20230711$20240722$PER$$US-ASTELLAS-2023US014327$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930332$22693033$2$F$$20221117$20230711$20240722$PER$$US-ASTELLAS-2022US041389$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930342$22693034$2$F$20221207$20221212$20230711$20240722$PER$$US-ASTELLAS-2022US044296$ASTELLAS$$79$YR$$M$Y$$$20240722$$CN$US$US
226930352$22693035$2$F$$20230612$20230711$20240722$PER$$US-ASTELLAS-2023US018147$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
226930362$22693036$2$F$$20230214$20230711$20240722$PER$$US-ASTELLAS-2023US005360$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930372$22693037$2$F$$20221207$20230711$20240722$PER$$US-ASTELLAS-2022US043819$ASTELLAS$$93$YR$$F$Y$$$20240722$$CN$US$US
226930382$22693038$2$F$$20230224$20230711$20240722$PER$$US-ASTELLAS-2023US006895$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226930392$22693039$2$F$$20221220$20230711$20240722$PER$$US-ASTELLAS-2022US045233$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930402$22693040$2$F$$20230718$20230711$20240722$PER$$US-ASTELLAS-2023US004714$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226930412$22693041$2$F$20230415$20230428$20230711$20240722$PER$$US-ASTELLAS-2023US012304$ASTELLAS$$96$YR$$F$Y$$$20240722$$CN$US$US
226930422$22693042$2$F$20230313$20230314$20230711$20240722$PER$$US-ASTELLAS-2023US009032$ASTELLAS$$97$YR$$M$Y$$$20240722$$CN$US$US
226930432$22693043$2$F$20221201$20221212$20230711$20240722$PER$$US-ASTELLAS-2022US044290$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930442$22693044$2$F$$20230323$20230711$20240722$PER$$US-ASTELLAS-2023US009859$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226930452$22693045$2$F$$20230306$20230711$20240722$PER$$US-ASTELLAS-2023US007857$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
226930462$22693046$2$F$$20230417$20230711$20240722$PER$$US-ASTELLAS-2023US012319$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930472$22693047$2$F$20230112$20230112$20230711$20240722$PER$$US-ASTELLAS-2023US001526$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
226930482$22693048$2$F$$20230127$20230711$20240722$PER$$US-ASTELLAS-2023US003420$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226930494$22693049$4$F$$20221216$20230711$20240722$PER$$US-ASTELLAS-2022US044965$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930502$22693050$2$F$$20230602$20230711$20240722$PER$$US-ASTELLAS-2023US012149$ASTELLAS$$91$YR$$F$Y$$$20240722$$CN$US$US
226930512$22693051$2$F$$20221104$20230711$20240722$PER$$US-ASTELLAS-2022US039837$ASTELLAS$$$$$F$Y$$$20240722$$HP$US$US
226930522$22693052$2$F$20230301$20230321$20230711$20240722$PER$$US-ASTELLAS-2023US009425$ASTELLAS$$67$YR$$M$Y$$$20240722$$CN$US$US
226930532$22693053$2$F$$20230111$20230711$20240722$PER$$US-ASTELLAS-2023US001473$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226930542$22693054$2$F$$20230517$20230711$20240722$PER$$US-ASTELLAS-2023US015466$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226930552$22693055$2$F$20230206$20230207$20230711$20240722$PER$$US-ASTELLAS-2023US004715$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
226930562$22693056$2$F$20221105$20221108$20230711$20240722$PER$$US-ASTELLAS-2022US040270$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226930572$22693057$2$F$$20230322$20230711$20240722$PER$$US-ASTELLAS-2023US009587$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
226930582$22693058$2$F$20221101$20221213$20230711$20240722$PER$$US-ASTELLAS-2022US044437$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
226930602$22693060$2$F$$20230109$20230711$20240722$PER$$US-ASTELLAS-2023US000951$ASTELLAS$$60$YR$$M$Y$$$20240722$$HP$US$US
226930612$22693061$2$F$$20230302$20230711$20240722$PER$$US-ASTELLAS-2023US007443$ASTELLAS$$$$$F$Y$61.224$KG$20240722$$CN$US$US
226930622$22693062$2$F$20221101$20221129$20230711$20240722$PER$$US-ASTELLAS-2022US041103$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
226930632$22693063$2$F$$20230119$20230711$20240722$PER$$US-ASTELLAS-2023US002298$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226930642$22693064$2$F$$20221221$20230711$20240722$PER$$US-ASTELLAS-2022US045350$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
226930652$22693065$2$F$20230201$20230317$20230711$20240722$PER$$US-ASTELLAS-2023US005222$ASTELLAS$$60$YR$$M$Y$$$20240722$$CN$US$US
226930662$22693066$2$F$20221101$20221121$20230711$20240722$PER$$US-ASTELLAS-2022US041794$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226930672$22693067$2$F$$20221121$20230711$20240722$PER$$US-ASTELLAS-2022US041747$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226930682$22693068$2$F$$20221116$20230711$20240722$PER$$US-ASTELLAS-2022US039652$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226930692$22693069$2$F$$20221114$20230711$20240722$PER$$US-ASTELLAS-2022US040860$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226930702$22693070$2$F$$20221018$20230711$20240722$PER$$US-ASTELLAS-2022US037554$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
226930712$22693071$2$F$$20230217$20230711$20240722$PER$$US-ASTELLAS-2023US006104$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930722$22693072$2$F$$20230124$20230711$20240722$PER$$US-ASTELLAS-2023US002885$ASTELLAS$$88$YR$$M$Y$$$20240722$$CN$US$US
226930734$22693073$4$F$20230301$20230421$20230711$20240722$PER$$US-ASTELLAS-2023US011597$ASTELLAS$$59$YR$$F$Y$$$20240722$$CN$US$US
226930744$22693074$4$F$$20230330$20230711$20240722$PER$$US-ASTELLAS-2023US010029$ASTELLAS$$93$YR$$M$Y$$$20240722$$CN$US$US
226930752$22693075$2$F$$20230217$20230711$20240722$PER$$US-ASTELLAS-2023US006111$ASTELLAS$$87$YR$$M$Y$$$20240722$$CN$US$US
226930764$22693076$4$F$20221201$20230103$20230711$20240722$PER$$US-ASTELLAS-2022US044440$ASTELLAS$$90$YR$$M$Y$$$20240722$$CN$US$US
226930772$22693077$2$F$20221101$20221130$20230711$20240722$PER$$US-ASTELLAS-2022US041454$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
226930782$22693078$2$F$$20221109$20230711$20240722$PER$$US-ASTELLAS-2022US040583$ASTELLAS$$82$YR$$M$Y$$$20240722$$MD$US$US
226930792$22693079$2$F$20230501$20230601$20230711$20240722$PER$$US-ASTELLAS-2023US017000$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930802$22693080$2$F$$20230301$20230711$20240722$PER$$US-ASTELLAS-2023US007788$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930812$22693081$2$F$$20230601$20230711$20240722$PER$$US-ASTELLAS-2023US016971$ASTELLAS$$92$YR$$F$Y$$$20240722$$CN$US$US
226930822$22693082$2$F$$20230328$20230711$20240722$PER$$US-ASTELLAS-2023US010346$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930832$22693083$2$F$$20221111$20230711$20240722$PER$$US-ASTELLAS-2022US040669$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930842$22693084$2$F$$20230612$20230711$20240722$PER$$US-ASTELLAS-2023US017860$ASTELLAS$$4$DEC$$F$Y$$$20240722$$CN$US$US
226930852$22693085$2$F$20221206$20230104$20230711$20240722$PER$$US-ASTELLAS-2022US043820$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
226930862$22693086$2$F$$20230610$20230711$20240722$PER$$US-ASTELLAS-2023US018138$ASTELLAS$$$$$$Y$$$20240722$$CN$US$US
226930872$22693087$2$F$$20230427$20230711$20240722$PER$$US-ASTELLAS-2023US013390$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930882$22693088$2$F$20230101$20230418$20230711$20240722$PER$$US-ASTELLAS-2023US012538$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
226930892$22693089$2$F$$20230418$20230711$20240722$PER$$US-ASTELLAS-2023US012487$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930902$22693090$2$F$$20230419$20230711$20240722$PER$$US-ASTELLAS-2023US012800$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930912$22693091$2$F$$20230601$20230711$20240722$PER$$US-ASTELLAS-2023US016997$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930922$22693092$2$F$$20230605$20230711$20240722$PER$$US-ASTELLAS-2023US017292$ASTELLAS$$92$YR$$F$Y$$$20240722$$CN$US$US
226930932$22693093$2$F$$20230602$20230711$20240722$PER$$US-ASTELLAS-2023US017137$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226930942$22693094$2$F$$20230620$20230711$20240722$PER$$US-ASTELLAS-2023US018867$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226930962$22693096$2$F$$20230512$20230711$20240722$PER$$US-ASTELLAS-2023US015032$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930982$22693098$2$F$$20230407$20230711$20240722$PER$$US-ASTELLAS-2023US011434$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226930992$22693099$2$F$20200101$20230511$20230711$20240722$PER$$US-ASTELLAS-2023US014919$ASTELLAS$$67$YR$$F$Y$$$20240722$$PH$US$US
226931002$22693100$2$F$$20230526$20230711$20240722$PER$$US-ASTELLAS-2023US014917$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
226931012$22693101$2$F$20230101$20230131$20230711$20240722$PER$$US-ASTELLAS-2023US004015$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226931022$22693102$2$F$20230205$20230206$20230711$20240722$PER$$US-ASTELLAS-2023US004492$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226931032$22693103$2$F$$20221121$20230711$20240722$PER$$US-ASTELLAS-2022US041739$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931042$22693104$2$F$$20230222$20230711$20240722$PER$$US-ASTELLAS-2023US006533$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
226931052$22693105$2$F$$20230515$20230711$20240722$PER$$US-ASTELLAS-2023US013996$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226931062$22693106$2$F$20230130$20230131$20230711$20240722$PER$$US-ASTELLAS-2023US003827$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
226931072$22693107$2$F$$20221116$20230711$20240722$PER$$US-ASTELLAS-2022US041309$ASTELLAS$$88$YR$$M$Y$$$20240722$$CN$US$US
226931082$22693108$2$F$$20230206$20230711$20240722$PER$$US-ASTELLAS-2023US004512$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
226931092$22693109$2$F$20230101$20230216$20230711$20240722$PER$$US-ASTELLAS-2023US005874$ASTELLAS$$88$YR$$M$Y$$$20240722$$CN$US$US
226931102$22693110$2$F$$20221117$20230711$20240722$PER$$US-ASTELLAS-2022US041393$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
226931112$22693111$2$F$$20230222$20230711$20240722$PER$$US-ASTELLAS-2023US006490$ASTELLAS$$3$DEC$$F$Y$$$20240722$$CN$US$US
226931122$22693112$2$F$$20230211$20230711$20240722$PER$$US-ASTELLAS-2023US005095$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226931132$22693113$2$F$$20230413$20230711$20240722$PER$$US-ASTELLAS-2023US011874$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931142$22693114$2$F$$20230310$20230711$20240722$PER$$US-ASTELLAS-2023US009131$ASTELLAS$$97$YR$$M$Y$$$20240722$$CN$US$US
226931152$22693115$2$F$20220901$20230309$20230711$20240722$PER$$US-ASTELLAS-2023US008309$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
226931162$22693116$2$F$$20221207$20230711$20240722$PER$$US-ASTELLAS-2022US043920$ASTELLAS$$6$DEC$$F$Y$$$20240722$$CN$US$US
226931182$22693118$2$F$$20230214$20230711$20240722$PER$$US-ASTELLAS-2023US005539$ASTELLAS$$89$YR$$M$Y$$$20240722$$CN$US$US
226931192$22693119$2$F$$20230524$20230711$20240722$PER$$US-ASTELLAS-2023US016241$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931202$22693120$2$F$$20230711$20230711$20240722$PER$$US-ASTELLAS-2023US019476$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931212$22693121$2$F$$20230327$20230711$20240722$PER$$US-ASTELLAS-2023US010322$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931222$22693122$2$F$20230122$20230123$20230711$20240722$PER$$US-ASTELLAS-2023US002771$ASTELLAS$$95$YR$$M$Y$$$20240722$$CN$US$US
226931232$22693123$2$F$20230601$20230619$20230711$20240722$PER$$US-ASTELLAS-2023US018701$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
226931242$22693124$2$F$$20230225$20230711$20240722$PER$$US-ASTELLAS-2023US005398$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
226931252$22693125$2$F$20230101$20230623$20230711$20240722$PER$$US-ASTELLAS-2023US019299$ASTELLAS$$91$YR$$M$Y$$$20240722$$CN$US$US
226931262$22693126$2$F$20230101$20230207$20230711$20240722$PER$$US-ASTELLAS-2023US004710$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226931272$22693127$2$F$20221101$20230207$20230711$20240722$PER$$US-ASTELLAS-2023US004721$ASTELLAS$$49$YR$$F$Y$$$20240722$$CN$US$US
226931282$22693128$2$F$$20230421$20230711$20240722$PER$$US-ASTELLAS-2023US010465$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
226931292$22693129$2$F$$20230626$20230711$20240722$PER$$US-ASTELLAS-2023US019624$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226931302$22693130$2$F$$20230227$20230711$20240722$PER$$US-ASTELLAS-2023US007107$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226931342$22693134$2$F$$20221118$20230711$20240722$PER$$US-ASTELLAS-2022US041630$ASTELLAS$$62$YR$$M$Y$$$20240722$$CN$US$US
226931352$22693135$2$F$$20221103$20230711$20240722$PER$$US-ASTELLAS-2022US039727$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931372$22693137$2$F$$20221202$20230711$20240722$PER$$US-ASTELLAS-2022US041935$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226931382$22693138$2$F$20221018$20221019$20230711$20240722$PER$$US-ASTELLAS-2022US037725$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
226931392$22693139$2$F$$20230322$20230711$20240722$PER$$US-ASTELLAS-2023US009509$ASTELLAS$$9$DEC$$F$Y$$$20240722$$CN$US$US
226931402$22693140$2$F$20221101$20221206$20230711$20240722$PER$$US-ASTELLAS-2022US043659$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226931412$22693141$2$F$20220101$20221011$20230711$20240722$PER$$US-ASTELLAS-2022US036335$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226931422$22693142$2$F$$20230207$20230711$20240722$PER$$US-ASTELLAS-2023US004609$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226931432$22693143$2$F$20230528$20230531$20230711$20240722$PER$$US-ASTELLAS-2023US016849$ASTELLAS$$65$YR$$F$Y$$$20240722$$CN$US$US
226931442$22693144$2$F$20221001$20221013$20230711$20240722$PER$$US-ASTELLAS-2022US036817$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226931452$22693145$2$F$20230201$20230217$20230711$20240722$PER$$US-ASTELLAS-2023US006113$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
226931472$22693147$2$F$$20230210$20230711$20240722$PER$$US-ASTELLAS-2023US005219$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931482$22693148$2$F$$20221101$20230711$20240722$PER$$US-ASTELLAS-2022US039387$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
226931492$22693149$2$F$$20221012$20230711$20240722$PER$$US-ASTELLAS-2022US036596$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
226931502$22693150$2$F$$20230209$20230711$20240722$PER$$US-ASTELLAS-2023US004879$ASTELLAS$$61$YR$$$Y$$$20240722$$CN$US$US
226931512$22693151$2$F$$20221104$20230711$20240722$PER$$US-ASTELLAS-2022US039981$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226931522$22693152$2$F$20230113$20230331$20230711$20240722$PER$$US-ASTELLAS-2023US010787$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
226931532$22693153$2$F$$20221103$20230711$20240722$PER$$US-ASTELLAS-2022US039713$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226931542$22693154$2$F$$20230314$20230711$20240722$PER$$US-ASTELLAS-2023US005925$ASTELLAS$$92$YR$$M$Y$$$20240722$$CN$US$US
226931552$22693155$2$F$20221101$20221123$20230711$20240722$PER$$US-ASTELLAS-2022US042106$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226931562$22693156$2$F$20221001$20221216$20230711$20240722$PER$$US-ASTELLAS-2022US036814$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
226931572$22693157$2$F$$20230131$20230711$20240722$PER$$US-ASTELLAS-2023US003835$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226931582$22693158$2$F$20221101$20221206$20230711$20240722$PER$$US-ASTELLAS-2022US043647$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931592$22693159$2$F$20221210$20221212$20230711$20240722$PER$$US-ASTELLAS-2022US044280$ASTELLAS$$88$YR$$M$Y$$$20240722$$CN$US$US
226931602$22693160$2$F$20210601$20221117$20230711$20240722$PER$$US-ASTELLAS-2022US041333$ASTELLAS$$81$YR$$F$Y$$$20240722$$HP$US$US
226931612$22693161$2$F$20230401$20230619$20230711$20240722$PER$$US-ASTELLAS-2023US016303$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226931622$22693162$2$F$20230315$20230404$20230711$20240722$PER$$US-ASTELLAS-2023US010466$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
226931702$22693170$2$F$$20230210$20230711$20240722$PER$$US-ASTELLAS-2023US005226$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931712$22693171$2$F$$20230120$20230711$20240722$PER$$US-ASTELLAS-2023US002628$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931722$22693172$2$F$$20230216$20230711$20240722$PER$$US-ASTELLAS-2023US005876$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
226931732$22693173$2$F$$20230727$20230711$20240722$PER$$US-ASTELLAS-2022US037035$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
226931742$22693174$2$F$$20230602$20230711$20240722$PER$$US-ASTELLAS-2023US017048$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931752$22693175$2$F$$20221213$20230711$20240722$PER$$US-ASTELLAS-2022US043231$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931762$22693176$2$F$$20230203$20230711$20240722$PER$$US-ASTELLAS-2023US004367$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226931772$22693177$2$F$$20230329$20230711$20240722$PER$$US-ASTELLAS-2023US010405$ASTELLAS$$8$DEC$$F$Y$$$20240722$$CN$US$US
226931782$22693178$2$F$20230101$20230110$20230711$20240722$PER$$US-ASTELLAS-2023US001207$ASTELLAS$$69$YR$$M$Y$$$20240722$$CN$US$US
226931792$22693179$2$F$20230524$20230728$20230711$20240722$PER$$US-ASTELLAS-2023US019986$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226931802$22693180$2$F$$20230515$20230711$20240722$PER$$US-ASTELLAS-2023US015202$ASTELLAS$$69$YR$$F$Y$$$20240722$$CN$US$US
226931812$22693181$2$F$20221219$20221219$20230711$20240722$PER$$US-ASTELLAS-2022US045120$ASTELLAS$$91$YR$$F$Y$$$20240722$$CN$US$US
226931822$22693182$2$F$$20221215$20230711$20240722$PER$$US-ASTELLAS-2022US044807$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
226931832$22693183$2$F$$20230221$20230711$20240722$PER$$US-ASTELLAS-2023US006302$ASTELLAS$$66$YR$$M$Y$$$20240722$$CN$US$US
226931852$22693185$2$F$20230501$20230531$20230711$20240722$PER$$US-ASTELLAS-2023US016835$ASTELLAS$$78$YR$$M$Y$$$20240722$$CN$US$US
226931862$22693186$2$F$$20221013$20230711$20240722$PER$$US-ASTELLAS-2022US037020$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
226931872$22693187$2$F$20221201$20221219$20230711$20240722$PER$$US-ASTELLAS-2022US045153$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226931902$22693190$2$F$$20221206$20230711$20240722$PER$$US-ASTELLAS-2022US043562$ASTELLAS$$7$DEC$$F$Y$$$20240722$$CN$US$US
226931912$22693191$2$F$$20230131$20230711$20240722$PER$$US-ASTELLAS-2023US003824$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
226931922$22693192$2$F$$20221129$20230711$20240722$PER$$US-ASTELLAS-2022US042772$ASTELLAS$$59$YR$$F$Y$$$20240722$$CN$US$US
226931932$22693193$2$F$$20230223$20230711$20240722$PER$$US-ASTELLAS-2023US006788$ASTELLAS$$73$YR$$M$Y$$$20240722$$CN$US$US
226931942$22693194$2$F$20221001$20221010$20230711$20240722$PER$$US-ASTELLAS-2022US036116$ASTELLAS$$87$YR$$M$Y$$$20240722$$CN$US$US
226931952$22693195$2$F$$20221010$20230711$20240722$PER$$US-ASTELLAS-2022US036267$ASTELLAS$$65$YR$$M$Y$$$20240722$$CN$US$US
226931962$22693196$2$F$$20230208$20230711$20240722$PER$$US-ASTELLAS-2023US003365$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226931972$22693197$2$F$$20221202$20230711$20240722$PER$$US-ASTELLAS-2022US043265$ASTELLAS$$9$DEC$$F$Y$$$20240722$$CN$US$US
226932042$22693204$2$F$20230330$20230508$20230711$20240722$PER$$US-ASTELLAS-2023US014317$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226932052$22693205$2$F$20230601$20230628$20230711$20240722$PER$$US-ASTELLAS-2023US019739$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
226932062$22693206$2$F$$20230330$20230711$20240722$PER$$US-ASTELLAS-2023US010621$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226932072$22693207$2$F$20220809$20230707$20230711$20240722$PER$$US-ASTELLAS-2023US019969$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
226932082$22693208$2$F$$20230109$20230711$20240722$PER$$US-ASTELLAS-2023US001096$ASTELLAS$$96$YR$$F$Y$$$20240722$$CN$US$US
226932092$22693209$2$F$$20230405$20230711$20240722$PER$$US-ASTELLAS-2023US011175$ASTELLAS$$64$YR$$F$Y$$$20240722$$CN$US$US
226932102$22693210$2$F$$20230629$20230711$20240722$PER$$US-ASTELLAS-2023US019914$ASTELLAS$$$$$$Y$$$20240722$$CN$US$US
226932112$22693211$2$F$20230117$20230118$20230711$20240722$PER$$US-ASTELLAS-2023US002179$ASTELLAS$$56$YR$$M$Y$$$20240722$$CN$US$US
226932122$22693212$2$F$$20230628$20230711$20240722$PER$$US-ASTELLAS-2023US019749$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932132$22693213$2$F$$20230607$20230711$20240722$PER$$US-ASTELLAS-2023US017531$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932142$22693214$2$F$20230601$20230629$20230711$20240722$PER$$US-ASTELLAS-2023US019846$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226932152$22693215$2$F$20220901$20221006$20230711$20240722$PER$$US-ASTELLAS-2022US035891$ASTELLAS$$87$YR$$M$Y$$$20240722$$CN$US$US
226932162$22693216$2$F$20230301$20230627$20230711$20240722$PER$$US-ASTELLAS-2023US019627$ASTELLAS$$45$YR$$F$Y$$$20240722$$CN$US$US
226932182$22693218$2$F$$20230502$20230711$20240722$PER$$US-ASTELLAS-2023US013885$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
226932194$22693219$4$F$$20230605$20230711$20240722$PER$$US-ASTELLAS-2023US017302$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
226932202$22693220$2$F$20230601$20230628$20230711$20240722$PER$$US-ASTELLAS-2023US019863$ASTELLAS$$93$YR$$F$Y$$$20240722$$CN$US$US
226932212$22693221$2$F$$20221215$20230711$20240722$PER$$US-ASTELLAS-2022US044769$ASTELLAS$$$$$F$Y$$$20240722$$HP$US$US
226932224$22693222$4$F$$20230306$20230711$20240722$PER$$US-ASTELLAS-2023US007866$ASTELLAS$$68$YR$$F$Y$$$20240722$$CN$US$US
226932232$22693223$2$F$$20221108$20230711$20240722$PER$$US-ASTELLAS-2022US040283$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932242$22693224$2$F$$20221129$20230711$20240722$PER$$US-ASTELLAS-2022US042691$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
226932252$22693225$2$F$$20221129$20230711$20240722$PER$$US-ASTELLAS-2022US042906$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226932262$22693226$2$F$$20221219$20230711$20240722$PER$$US-ASTELLAS-2022US045086$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226932272$22693227$2$F$$20230525$20230711$20240722$PER$$US-ASTELLAS-2023US016425$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
226932282$22693228$2$F$$20230508$20230711$20240722$PER$$US-ASTELLAS-2023US014407$ASTELLAS$$$$$F$Y$$$20240722$$MD$US$US
226932292$22693229$2$F$$20221012$20230711$20240722$PER$$US-ASTELLAS-2022US036816$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
226932302$22693230$2$F$$20230307$20230711$20240722$PER$$US-ASTELLAS-2023US007997$ASTELLAS$$73$YR$$M$Y$$$20240722$$CN$US$US
226932312$22693231$2$F$20230416$20230428$20230711$20240722$PER$$US-ASTELLAS-2023US012311$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
226932332$22693233$2$F$$20230623$20230711$20240722$PER$$US-ASTELLAS-2023US019306$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932342$22693234$2$F$$20230530$20230711$20240722$PER$$US-ASTELLAS-2023US016738$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
226932354$22693235$4$F$20220801$20221013$20230711$20240722$PER$$US-ASTELLAS-2022US036852$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
226932372$22693237$2$F$20221101$20221128$20230711$20240722$PER$$US-ASTELLAS-2022US042535$ASTELLAS$$97$YR$$F$Y$$$20240722$$CN$US$US
226932382$22693238$2$F$$20230227$20230711$20240722$PER$$US-ASTELLAS-2023US007152$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
226932392$22693239$2$F$$20230327$20230711$20240722$PER$$US-ASTELLAS-2023US010199$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226932402$22693240$2$F$$20230224$20230711$20240722$PER$$US-ASTELLAS-2023US006892$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932412$22693241$2$F$$20221108$20230711$20240722$PER$$US-ASTELLAS-2022US040215$ASTELLAS$$92$YR$$M$Y$$$20240722$$CN$US$US
226932422$22693242$2$F$$20221207$20230711$20240722$PER$$US-ASTELLAS-2022US043724$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
226932432$22693243$2$F$$20230417$20230711$20240722$PER$$US-ASTELLAS-2023US010349$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
226932502$22693250$2$F$$20221026$20230711$20240722$PER$$US-ASTELLAS-2022US038628$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226932522$22693252$2$F$$20230515$20230711$20240722$PER$$US-ASTELLAS-2023US015212$ASTELLAS$$80$YR$$F$Y$$$20240722$$HP$US$US
226932532$22693253$2$F$20221201$20230109$20230711$20240722$PER$$US-ASTELLAS-2022US043594$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226932542$22693254$2$F$$20221111$20230711$20240722$PER$$US-ASTELLAS-2022US036617$ASTELLAS$$69$YR$$F$Y$$$20240722$$CN$US$US
226932552$22693255$2$F$$20230331$20230711$20240722$PER$$US-ASTELLAS-2023US010780$ASTELLAS$$97$YR$$M$Y$$$20240722$$CN$US$US
226932562$22693256$2$F$$20230522$20230711$20240722$PER$$US-ASTELLAS-2023US015861$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932574$22693257$4$F$$20230330$20230711$20240722$PER$$US-ASTELLAS-2023US010615$ASTELLAS$$89$YR$$F$Y$$$20240722$$CN$US$US
226932612$22693261$2$F$$20221020$20230711$20240722$PER$$US-ASTELLAS-2022US037940$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932652$22693265$2$F$$20230303$20230711$20240722$PER$$US-ASTELLAS-2023US007821$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226932662$22693266$2$F$$20230306$20230711$20240722$PER$$US-ASTELLAS-2023US007880$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
226932672$22693267$2$F$$20230117$20230711$20240722$PER$$US-ASTELLAS-2023US001855$ASTELLAS$$$$$F$Y$$$20240722$$HP$US$US
226932682$22693268$2$F$$20221101$20230711$20240722$PER$$US-ASTELLAS-2022US039566$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
226932692$22693269$2$F$$20230207$20230711$20240722$PER$$US-ASTELLAS-2023US004565$ASTELLAS$$$$$F$Y$$$20240722$$MD$US$US
226932702$22693270$2$F$$20221201$20230711$20240722$PER$$US-ASTELLAS-2022US043230$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226932712$22693271$2$F$$20221007$20230711$20240722$PER$$US-ASTELLAS-2022US036068$ASTELLAS$$87$YR$$F$Y$$$20240722$$CN$US$US
226932722$22693272$2$F$$20221202$20230711$20240722$PER$$US-ASTELLAS-2022US043233$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932732$22693273$2$F$20230101$20230118$20230711$20240722$PER$$US-ASTELLAS-2023US002037$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
226932762$22693276$2$F$$20230417$20230711$20240722$PER$$US-ASTELLAS-2023US011112$ASTELLAS$$30$MON$$F$Y$$$20240722$$CN$US$US
226932782$22693278$2$F$20220901$20221121$20230711$20240722$PER$$US-ASTELLAS-2022US036083$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226932792$22693279$2$F$$20221010$20230711$20240722$PER$$US-ASTELLAS-2022US036484$ASTELLAS$$94$YR$$F$Y$$$20240722$$CN$US$US
226932802$22693280$2$F$20230616$20230616$20230711$20240722$PER$$US-ASTELLAS-2023US018585$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
226932812$22693281$2$F$20230401$20230619$20230711$20240722$PER$$US-ASTELLAS-2023US018690$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
226932822$22693282$2$F$20220101$20221011$20230711$20240722$PER$$US-ASTELLAS-2022US036500$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932832$22693283$2$F$$20221206$20230711$20240722$PER$$US-ASTELLAS-2022US043762$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932842$22693284$2$F$$20230404$20230711$20240722$PER$$US-ASTELLAS-2023US011088$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932852$22693285$2$F$$20221109$20230711$20240722$PER$$US-ASTELLAS-2022US040407$ASTELLAS$$65$YR$$F$Y$$$20240722$$CN$US$US
226932882$22693288$2$F$$20230104$20230711$20240722$PER$$US-ASTELLAS-2023US000560$ASTELLAS$$90$YR$$M$Y$$$20240722$$CN$US$US
226932892$22693289$2$F$20230201$20230203$20230711$20240722$PER$$US-ASTELLAS-2023US004347$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
226932902$22693290$2$F$$20230511$20230711$20240722$PER$$US-ASTELLAS-2023US014814$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
226932912$22693291$2$F$20211101$20221021$20230711$20240722$PER$$US-ASTELLAS-2022US035838$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
226932922$22693292$2$F$$20230608$20230711$20240722$PER$$US-ASTELLAS-2023US017729$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226932932$22693293$2$F$20230101$20230201$20230711$20240722$PER$$US-ASTELLAS-2023US004007$ASTELLAS$$87$YR$$M$Y$$$20240722$$CN$US$US
226932942$22693294$2$F$$20230112$20230711$20240722$PER$$US-ASTELLAS-2023US001522$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
226932952$22693295$2$F$20230508$20230508$20230711$20240722$PER$$US-ASTELLAS-2023US014523$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
226932962$22693296$2$F$$20230522$20230711$20240722$PER$$US-ASTELLAS-2023US014592$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932982$22693298$2$F$20230522$20230605$20230711$20240722$PER$$US-ASTELLAS-2023US017304$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226932992$22693299$2$F$20230401$20230414$20230711$20240722$PER$$US-ASTELLAS-2023US012189$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226933032$22693303$2$F$$20221123$20230711$20240722$PER$$US-ASTELLAS-2022US040922$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226933042$22693304$2$F$20221101$20221109$20230711$20240722$PER$$US-ASTELLAS-2022US040412$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226933052$22693305$2$F$$20230612$20230711$20240722$PER$$US-ASTELLAS-2023US018160$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226933062$22693306$2$F$$20221201$20230711$20240722$PER$$US-ASTELLAS-2022US043018$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
226933072$22693307$2$F$$20230501$20230711$20240722$PER$$US-ASTELLAS-2023US013671$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226933082$22693308$2$F$20230401$20230501$20230711$20240722$PER$$US-ASTELLAS-2023US013651$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226933092$22693309$2$F$20230301$20230304$20230711$20240722$PER$$US-ASTELLAS-2023US007773$ASTELLAS$$89$YR$$F$Y$$$20240722$$CN$US$US
226933102$22693310$2$F$20230401$20230421$20230711$20240722$PER$$US-ASTELLAS-2023US012924$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
226933112$22693311$2$F$$20230510$20230711$20240722$PER$$US-ASTELLAS-2023US014731$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
226933132$22693313$2$F$$20230320$20230711$20240722$PER$$US-ASTELLAS-2023US009429$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226933142$22693314$2$F$20220901$20230309$20230711$20240722$PER$$US-ASTELLAS-2023US008311$ASTELLAS$$7$DEC$$F$Y$$$20240722$$CN$US$US
226933152$22693315$2$F$20230501$20230623$20230711$20240722$PER$$US-ASTELLAS-2023US019322$ASTELLAS$$65$YR$$M$Y$$$20240722$$CN$US$US
226933162$22693316$2$F$$20221110$20230711$20240722$PER$$US-ASTELLAS-2022US040566$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
226933182$22693318$2$F$20221001$20221110$20230711$20240722$PER$$US-ASTELLAS-2022US040574$ASTELLAS$$7$DEC$$F$Y$$$20240722$$CN$US$US
226933192$22693319$2$F$$20221114$20230711$20240722$PER$$US-ASTELLAS-2022US039717$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226933202$22693320$2$F$20230216$20230220$20230711$20240722$PER$$US-ASTELLAS-2023US006195$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226933212$22693321$2$F$$20221129$20230711$20240722$PER$$US-ASTELLAS-2022US042708$ASTELLAS$$95$YR$$F$Y$$$20240722$$CN$US$US
226933272$22693327$2$F$20221204$20221205$20230711$20240722$PER$$US-ASTELLAS-2022US043465$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
226933282$22693328$2$F$$20230518$20230711$20240722$PER$$US-ASTELLAS-2023US015582$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226933292$22693329$2$F$20220101$20230508$20230711$20240722$PER$$US-ASTELLAS-2023US014320$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226933302$22693330$2$F$20230501$20230512$20230711$20240722$PER$$US-ASTELLAS-2023US015039$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226933312$22693331$2$F$$20230331$20230711$20240722$PER$$US-ASTELLAS-2023US010716$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226933322$22693332$2$F$20221205$20221205$20230711$20240722$PER$$US-ASTELLAS-2022US043470$ASTELLAS$$67$YR$$F$Y$$$20240722$$CN$US$US
226933332$22693333$2$F$$20230131$20230711$20240722$PER$$US-ASTELLAS-2023US001505$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226933342$22693334$2$F$$20230531$20230711$20240722$PER$$US-ASTELLAS-2023US016837$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226933352$22693335$2$F$$20240404$20230711$20240722$PER$$US-ASTELLAS-2023US008683$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
226933362$22693336$2$F$20221201$20230119$20230711$20240722$PER$$US-ASTELLAS-2023US000643$ASTELLAS$$68$YR$$F$Y$$$20240722$$CN$US$US
226933372$22693337$2$F$20230112$20230329$20230711$20240722$PER$$US-ASTELLAS-2023US001519$ASTELLAS$$62$YR$$F$Y$$$20240722$$CN$US$US
226933382$22693338$2$F$$20230314$20230711$20240722$PER$$US-ASTELLAS-2023US006578$ASTELLAS$$$$$F$Y$$$20240722$$PH$US$US
226933392$22693339$2$F$$20221201$20230711$20240722$PER$$US-ASTELLAS-2022US043057$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
226933402$22693340$2$F$$20221011$20230711$20240722$PER$$US-ASTELLAS-2022US036477$ASTELLAS$$66$YR$$F$Y$$$20240722$$CN$US$US
226933412$22693341$2$F$20230201$20230303$20230711$20240722$PER$$US-ASTELLAS-2023US007772$ASTELLAS$$72$YR$$M$Y$$$20240722$$CN$US$US
226933432$22693343$2$F$$20230615$20230711$20240722$PER$$US-ASTELLAS-2023US018435$ASTELLAS$$90$YR$$M$Y$$$20240722$$CN$US$US
226933442$22693344$2$F$$20230105$20230711$20240722$PER$$US-ASTELLAS-2023US000736$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
226933452$22693345$2$F$$20230530$20230711$20240722$PER$$US-ASTELLAS-2023US016734$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226933462$22693346$2$F$$20230626$20230711$20240722$PER$$US-ASTELLAS-2023US019439$ASTELLAS$$59$YR$$F$Y$$$20240722$$CN$US$US
226933472$22693347$2$F$$20230622$20230711$20240722$PER$$US-ASTELLAS-2023US019139$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
226933482$22693348$2$F$20230228$20230415$20230711$20240722$PER$$US-ASTELLAS-2023US007626$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
226933492$22693349$2$F$20220101$20230605$20230711$20240722$PER$$US-ASTELLAS-2023US017296$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
226933502$22693350$2$F$$20230103$20230711$20240722$PER$$US-ASTELLAS-2023US000459$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
226933512$22693351$2$F$$20230405$20230711$20240722$PER$$US-ASTELLAS-2023US011097$ASTELLAS$$89$YR$$F$Y$$$20240722$$CN$US$US
226933522$22693352$2$F$$20230629$20230711$20240722$PER$$US-ASTELLAS-2023US020036$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
226933532$22693353$2$F$$20230106$20230711$20240722$PER$$US-ASTELLAS-2023US000919$ASTELLAS$$87$YR$$M$Y$$$20240722$$CN$US$US
226934198$22693419$8$F$20230403$20240813$20230711$20240819$EXP$$US-TAKEDA-2023TUS011122$TAKEDA$$84$YR$$F$Y$77$KG$20240819$$HP$US$US
226934262$22693426$2$F$$20240626$20230711$20240711$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-398552$RANBAXY$Mann E, Paterson S, Burns R. Delivery challenges of Bethlem myopathy, a rare congenital muscular dystrophy. Int J Obstet Anesth. 2023;54(S1):52(P91)$30$YR$$F$Y$$$20240711$$HP$GB$GB
226934273$22693427$3$F$20220701$20230710$20230711$20240830$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-398548$RANBAXY$Fort-Casamartina E, Munoz-Sanchez C, Rigo-Bonnin RF, Del VC, Gonzalo-Diego N, Otero-Torres S, et al. First reported double drug-drug interaction in a cancer renal patient under everolimus treatment: therapeutic drug monitoring and review of literature. Eur J Med Res. 2023;28(1):202;1-6$72$YR$$F$Y$$$20240831$$HP$ES$ES
226934328$22693432$8$F$$20240711$20230711$20240717$30DAY$$US-PFIZER INC-PV202300118114$PFIZER$$5$YR$$F$Y$16.33$KG$20240717$$MD$US$US
226935292$22693529$2$F$$20240701$20230711$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-375770$RANBAXY$$$$E$F$Y$$$20240711$$MD$US$US
226935675$22693567$5$F$$20240821$20230711$20240827$EXP$$IT-MYLANLABS-2023M1072402$MYLAN$Di Chiara C, Mengato D, De Pieri M, Longo G, Benetti E, Venturini F, Giaquinto C and Dona D.. Early Use of Sotrovimab in Children: A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2. Children. 2022;9(4):1-6$11$YR$$M$Y$36$KG$20240827$$HP$IT$IT
226935992$22693599$2$F$$20240726$20230711$20240730$EXP$$US-INCYTE CORPORATION-2023IN007005$INCYTE$$$$$$Y$$$20240730$$CN$US$US
2269372411$22693724$11$F$20230101$20240912$20230711$20240918$EXP$$GB-ABBVIE-5299829$ABBVIE$$63$YR$$M$Y$$$20240918$$CN$GB$GB
226937832$22693783$2$F$20230626$20240703$20230711$20240718$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000260$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
226938483$22693848$3$F$20230601$20230822$20230711$20240809$EXP$$US-AstraZeneca-2023A157025$ASTRAZENECA$$907$MON$$F$Y$$$20240809$$CN$US$
226939115$22693911$5$F$$20240708$20230711$20240709$EXP$$CA-BAUSCH-BL-2023-010537$BAUSCH AND LOMB$$39$YR$$F$Y$$$20240709$$CN$CA$CA
226940426$22694042$6$F$20220101$20240827$20230711$20240830$EXP$$CA-BAUSCH-BL-2022-011694$BAUSCH AND LOMB$$97$YR$$F$Y$$$20240830$$CN$CA$CA
2269420914$22694209$14$F$20230405$20240714$20230711$20240724$EXP$$CN-GILEAD-2023-0635936$GILEAD$$59$YR$A$F$Y$$$20240724$$MD$CN$CN
226942885$22694288$5$F$$20240712$20230711$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-097529$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240719$$HP$US$US
226944308$22694430$8$F$20230101$20240718$20230712$20240726$EXP$$CA-CELLTRION INC.-2022CA021861$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
226944697$22694469$7$F$20201203$20240812$20230712$20240820$EXP$$CA-CELLTRION INC.-2022CA004303$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
226944892$22694489$2$F$$20240726$20230712$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05364$LUPIN$$$$$$Y$$$20240817$$CN$US$US
226945034$22694503$4$F$$20240726$20230712$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05398$LUPIN$$$$$$Y$$$20240817$$CN$US$US
226945484$22694548$4$F$20230101$20240912$20230712$20240926$PER$$US-SA-2023SA210258$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240926$$MD$US$US
226945774$22694577$4$F$$20240627$20230712$20240702$PER$$NVSC2023US152711$NOVARTIS$$$$$M$Y$$$20240702$$MD$US$US
226947333$22694733$3$F$20230625$20240726$20230712$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05403$LUPIN$$$$$$Y$$$20240817$$CN$US$US
226947652$22694765$2$F$20230701$20240918$20230712$20240925$PER$$NVSC2023US153846$NOVARTIS$$62$YR$$F$Y$82$KG$20240925$$PH$US$US
226947842$22694784$2$F$20230627$20240705$20230712$20240715$EXP$$PT-AUROBINDO-AUR-APL-2023-046326$AUROBINDO$$59$YR$$F$Y$45$KG$20240715$$MD$PT$PT
226948174$22694817$4$F$$20240729$20230712$20240730$PER$$NVSC2023US154208$NOVARTIS$$$$$M$Y$$$20240730$$CN$US$US
226949984$22694998$4$F$$20240806$20230712$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05407$LUPIN$$$$$$Y$$$20240828$$PH$US$US
226950232$22695023$2$F$$20240726$20230712$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05408$LUPIN$$$$$$Y$$$20240817$$CN$US$US
226950326$22695032$6$F$20230424$20240703$20230712$20240704$EXP$$NVSJ2023JP010761$NOVARTIS$$$$A$M$Y$63.7$KG$20240705$$MD$JP$JP
226950523$22695052$3$F$$20240806$20230712$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05410$LUPIN$$$$$$Y$$$20240827$$CN$US$US
226951042$22695104$2$F$20240701$20240828$20230712$20240904$EXP$$US-ABBVIE-5322487$ABBVIE$$82$YR$$M$Y$$$20240904$$CN$US$US
226951303$22695130$3$F$$20240806$20230712$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05459$LUPIN$$$$$$Y$$$20240828$$CN$US$US
226952044$22695204$4$F$20230315$20240723$20230712$20240726$EXP$$GB-ROCHE-3385898$ROCHE$$43$YR$A$F$Y$$$20240726$$HP$GB$GB
226952434$22695243$4$F$$20240806$20230712$20240809$EXP$$PL-AUROBINDO-AUR-APL-2022-037809$AUROBINDO$Liszka K, Resztak M, Zalewska P, Kalwak K.. Therapeutic drug monitoring of posaconazole for effective prophylaxis of invasive fungal infections in pediatric patients: A pilot study. Acta Haematologica Polonica.. 2021;52(6):578-83$4$YR$$$Y$18$KG$20240809$$MD$PL$PL
226952583$22695258$3$F$20230710$20240730$20230712$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-097710$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240730$$CN$US$US
226953003$22695300$3$F$$20240806$20230712$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05478$LUPIN$$$$$$Y$$$20240828$$CN$US$US
226953378$22695337$8$F$$20240711$20230712$20240716$EXP$$CA-ROCHE-3386385$ROCHE$$$$A$F$Y$$$20240716$$CN$CA$CA
226953775$22695377$5$F$$20240906$20230712$20240911$EXP$$US-TAKEDA-2023TUS067267$TAKEDA$$$$$M$Y$$$20240911$$CN$US$US
226953843$22695384$3$F$$20240918$20230712$20240923$EXP$$CA-TAKEDA-2023TUS067109$TAKEDA$$$$$M$Y$$$20240923$$MD$CA$CA
226954693$22695469$3$F$$20240726$20230712$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05461$LUPIN$$$$$$Y$$$20240817$$CN$US$US
226955062$22695506$2$F$20230401$20240626$20230712$20240704$EXP$$FR-AUROBINDO-AUR-APL-2023-046417$AUROBINDO$$56$YR$$F$Y$80$KG$20240704$$MD$FR$FR
226955492$22695549$2$F$$20240717$20230712$20240720$EXP$$NVSC2023US153818$NOVARTIS$$$$$M$Y$$$20240719$$CN$US$US
226957263$22695726$3$F$$20240806$20230712$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05354$LUPIN$$$$$$Y$$$20240830$$CN$US$US
2269580610$22695806$10$F$$20240802$20230712$20240805$EXP$$CA-ROCHE-3386795$ROCHE$$$$A$F$Y$$$20240805$$CN$CA$CA
226958812$22695881$2$F$$20240725$20230712$20240729$EXP$$US-TAKEDA-US202023378$TAKEDA$$$$$F$Y$$$20240729$$HP$US$US
226960552$22696055$2$F$20230710$20240815$20230712$20240822$EXP$$AR-GSK-AR2023AMR094489$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$AR$AR
226961653$22696165$3$F$$20240812$20230712$20240815$EXP$$US-PFIZER INC-202101340054$PFIZER$Stark, J.. Clinical impact of administering soda with the hepatitis C treatment sofosbuvir-velpatasvir and a proton-pump inhibitor: A case report.. JACCP Journal of the American College of Clinical Pharmacy.. 2021;4(9):1250$64$YR$$M$Y$$$20240815$$PH$US$US
226962613$22696261$3$F$20230505$20230711$20230712$20240805$EXP$$NVSC2023US154381$NOVARTIS$$22$YR$$F$Y$$$20240805$$CN$US$US
226963942$22696394$2$F$$20240730$20230712$20240801$EXP$$GB-MYLANLABS-2023M1073566$MYLAN$$$$$M$Y$$$20240801$$PH$GB$GB
226964293$22696429$3$F$$20240819$20230712$20240826$EXP$$CA-GSK-CA2023AMR092853$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$CA$CA
226964914$22696491$4$F$20230718$20240919$20230712$20240927$EXP$$CA-TAKEDA-2023TUS068064$TAKEDA$$59$YR$$M$Y$$$20240927$$HP$CA$CA
226965527$22696552$7$F$$20240919$20230712$20240928$EXP$$PL-CELLTRION INC.-2023PL013741$CELLTRION$Swoboda R, Gajda K, Lamch R, Giebel S.. Burkitt-like lymphoma with 11q aberration mimicking appendicitis in a young man: a diagnostic and therapeutic challenge. Hematology in clinical practice. 2022;13(2):75-79$$$$$Y$$$20240928$$MD$PL$PL
226966993$22696699$3$F$20230610$20240829$20230712$20240918$EXP$$US-SA-2023SA210550$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240918$$MD$US$US
226967494$22696749$4$F$20230731$20240718$20230712$20240727$PER$$US-SA-2023SA211003$SANOFI AVENTIS$$8$YR$C$M$Y$27.6$KG$20240727$$MD$US$US
226967652$22696765$2$F$20230601$20240628$20230712$20240708$PER$$US-SA-2023SA210890$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240708$$MD$US$US
226967804$22696780$4$F$$20240705$20230712$20240710$PER$$US-SA-2023SA211476$SANOFI AVENTIS$$67$YR$E$M$Y$81.6$KG$20240710$$MD$US$US
226967813$22696781$3$F$20240701$20240726$20230712$20240805$PER$$US-SA-2023SA210858$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240805$$MD$US$US
226967962$22696796$2$F$20220825$20240807$20230712$20240815$PER$$US-SA-2023SA210785$SANOFI AVENTIS$$55$YR$A$M$Y$83$KG$20240815$$MD$US$US
226969914$22696991$4$F$20230101$20240806$20230712$20240813$PER$$US-SA-2023SA210354$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240814$$MD$US$US
226970262$22697026$2$F$20220601$20240804$20230712$20240812$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-398432$RANBAXY$$52$YR$$F$Y$75$KG$20240812$$CN$FR$FR
226972363$22697236$3$F$20230703$20240730$20230712$20240802$EXP$$JP-AstraZeneca-2023A156932$ASTRAZENECA$Suzuki M, et al.. 54 A case of a patient who died 6 hours after the start of andexanet alfa administration including pathological autopsy findings.. The 697th Kanto Regional Meeting of the  Japanese Society of Internal Medicine 2024;$74$YR$$M$Y$$$20240802$$MD$JP$
226973376$22697337$6$F$$20240805$20230712$20240808$EXP$$US-PFIZER INC-PV202300121094$PFIZER$$80$YR$$F$Y$$$20240808$$CN$US$US
226973522$22697352$2$F$$20230629$20230712$20240909$EXP$$NL-INCYTE CORPORATION-2023IN006983$INCYTE$$$$$$Y$$$20240909$$MD$NL$NL
226973772$22697377$2$F$$20230629$20230712$20240909$EXP$$NL-INCYTE CORPORATION-2023IN007007$INCYTE$$$$$$Y$$$20240909$$MD$NL$NL
226973794$22697379$4$F$20230101$20240719$20230712$20240730$PER$$US-SA-2023SA209307$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240730$$MD$US$US
2269741511$22697415$11$F$20150101$20240821$20230712$20240823$EXP$$US-PFIZER INC-PV202300120315$PFIZER$$72$YR$$F$Y$75.283$KG$20240823$$CN$US$US
226974482$22697448$2$F$$20240705$20230712$20240710$EXP$$NVSC2023GB154466$NOVARTIS$$$$A$F$Y$$$20240710$$CN$GB$GB
226978252$22697825$2$F$$20240801$20230712$20240810$PER$$US-SA-2023SA211368$SANOFI AVENTIS$$$$A$M$Y$$$20240810$$MD$US$US
226978714$22697871$4$F$20190524$20240712$20230712$20240720$EXP$$MX-TAKEDA-MX201917443$TAKEDA$$4$YR$$M$Y$16$KG$20240720$$CN$MX$MX
226978783$22697878$3$F$$20240820$20230712$20240822$PER$$NVSC2023US154932$NOVARTIS$$$$$$Y$$$20240822$$CN$US$US
226979183$22697918$3$F$$20240918$20230712$20240930$PER$$NVSC2023US154037$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
226980182$22698018$2$F$$20240813$20230712$20240815$PER$$US-PFIZER INC-PV202300117652$PFIZER$$69$YR$$F$Y$91.247$KG$20240815$$MD$US$US
226980215$22698021$5$F$$20240806$20230712$20240808$PER$$US-PFIZER INC-PV202300076299$PFIZER$$24$YR$$M$Y$$$20240808$$HP$US$US
226980322$22698032$2$F$20230202$20240906$20230712$20240911$EXP$$US-TAKEDA-2023TUS014502$TAKEDA$$49$YR$$M$Y$91$KG$20240911$$CN$US$US
226980514$22698051$4$F$$20240722$20230712$20240724$PER$$US-PFIZER INC-PV202300119048$PFIZER$$53$YR$$F$Y$$$20240724$$CN$US$US
226982032$22698203$2$F$$20240819$20230712$20240822$PER$$US-PFIZER INC-PV202200035832$PFIZER$$86$YR$$M$Y$$$20240822$$CN$US$US
226982144$22698214$4$F$20230401$20240715$20230712$20240717$PER$$US-PFIZER INC-202300246452$PFIZER$$41$YR$$F$Y$$$20240717$$CN$US$US
226982238$22698223$8$F$20230629$20240702$20230712$20240705$EXP$$NL-ABBVIE-5323251$ABBVIE$$80$YR$$M$Y$93$KG$20240705$$CN$NL$NL
226984195$22698419$5$F$20230101$20240716$20230712$20240806$EXP$$JP-009507513-2303JPN004224J$MERCK$Sawada M, Masuda S, Taniguchi R, Ochi Y, Kurose Y, Kanno K, et al.. OS-120 A case of a patient with advanced adenocarcinoma of the cervix who experienced refractory irAE colitis resistant to anti-TNF alpha antibody and could not be saved. Japanese Journal of Gynecological Oncology / The 66th Annual Meeting of Japan So. 2024;42(3):287$74$YR$$F$Y$$$20240806$$MD$JP$JP
226984993$22698499$3$F$$20240806$20230712$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-098304$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240807$$HP$US$US
226985372$22698537$2$F$20230626$20240625$20230712$20240704$PER$$US-SA-2023SA211608$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240704$$MD$US$US
226985583$22698558$3$F$$20240916$20230712$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-098301$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240917$$HP$US$US
226985976$22698597$6$F$20230101$20240703$20230712$20240708$EXP$$CA-ABBVIE-5323589$ABBVIE$$$$$M$Y$$$20240708$$HP$CA$CA
226987642$22698764$2$F$20230101$20240805$20230713$20240807$PER$$US-AMGEN-USASP2023115699$AMGEN$$$$A$M$Y$$$20240807$$HP$US$US
226988792$22698879$2$F$$20230728$20230713$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083198$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
2269889110$22698891$10$F$20230901$20240807$20230713$20240812$EXP$$US-TAKEDA-US201915675$TAKEDA$$64$YR$$F$Y$54$KG$20240812$$CN$US$US
2269900610$22699006$10$F$20230101$20240712$20230713$20240717$EXP$$GB-UCBSA-2023034821$UCB$$$$$F$Y$$$20240717$$CN$GB$GB
226991732$22699173$2$F$20230711$20240821$20230713$20240826$PER$$US-AMGEN-USASP2023121666$AMGEN$$75$YR$E$F$Y$$$20240826$$CN$US$US
226992718$22699271$8$F$20220123$20231023$20230713$20240710$PER$$AU-ROCHE-3130223$ROCHE$$37$YR$A$F$Y$69.25$KG$20240628$$MD$AU$AU
226992783$22699278$3$F$20220908$20240712$20230713$20240721$EXP$FR-AFSSAPS-LL2023001072$NVSC2023FR154368$NOVARTIS$$31$YR$$M$Y$$$20240720$$MD$FR$FR
2269929713$22699297$13$F$$20240812$20230713$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-098099$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240816$$CN$US$US
226993755$22699375$5$F$20230612$20240119$20230713$20240926$PER$$US-GSK-US2023AMR093574$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240926$$CN$US$US
226994234$22699423$4$F$$20240715$20230713$20240722$PER$$US-BIOGEN-2023BI01215502$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
2269943115$22699431$15$F$20230101$20240916$20230713$20240924$EXP$$CA-CELLTRION INC.-2023CA004920$CELLTRION$$$$$$Y$$$20240924$$MD$CA$CA
226994427$22699442$7$F$20230731$20230919$20230713$20240925$EXP$$US-GSK-US2023AMR095163$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
226997662$22699766$2$F$20230601$20240719$20230713$20240729$30DAY$$US-GSK-US2023091093$GLAXOSMITHKLINE$$65$YR$$M$Y$$$20240729$$HP$US$US
226997743$22699774$3$F$$20240822$20230713$20240828$EXP$$CA-ROCHE-3386391$ROCHE$$61$YR$A$M$Y$$$20240828$$HP$CA$CA
227002483$22700248$3$F$20220901$20240918$20230713$20240919$EXP$$NVSC2023EG154299$NOVARTIS$$44$YR$$F$Y$$$20240919$$CN$EG$EG
227002762$22700276$2$F$20230702$20240909$20230713$20240913$EXP$$TW-TAKEDA-2023TUS067628$TAKEDA$$27$YR$$F$Y$$$20240913$$CN$TW$TW
227003263$22700326$3$F$20230306$20240703$20230713$20240708$PER$$US-BAYER-2023A094966$BAYER$$33$YR$A$F$Y$$$20240708$$HP$US$US
227003402$22700340$2$F$20230525$20240816$20230713$20240826$EXP$FR-AFSSAPS-PO2023000643$FR-BAXTER-2023BAX025579$BAXTER$$59$YR$$F$Y$$$20240826$$MD$FR$FR
227003768$22700376$8$F$$20240814$20230713$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000639$DECIPHERA PHARMACEUTICALS$$77$YR$E$F$Y$52.154$KG$20240905$$HP$US$US
227003956$22700395$6$F$$20240722$20230713$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000640$DECIPHERA PHARMACEUTICALS$$65$YR$A$F$Y$$$20240731$$CN$US$US
227005332$22700533$2$F$20230101$20240717$20230713$20240726$PER$$US-SA-2023SA212815$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240726$$MD$US$US
227006253$22700625$3$F$20230101$20240703$20230713$20240712$PER$$US-SA-2023SA212660$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240712$$MD$US$US
227006753$22700675$3$F$$20240905$20230713$20240914$PER$$US-SA-2023SA212686$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240914$$MD$US$US
227006812$22700681$2$F$$20240828$20230713$20240910$PER$$US-SA-2023SA213111$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240910$$MD$US$US
227007063$22700706$3$F$$20240822$20230713$20240905$PER$$US-SA-2023SA213070$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240905$$MD$US$US
227007086$22700708$6$F$$20240817$20230713$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-235793$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240821$$CN$US$US
2270076213$22700762$13$F$20230508$20240619$20230713$20240704$EXP$$DE-ROCHE-3383711$ROCHE$$62$YR$A$M$Y$$$20240704$$MD$DE$DE
227008802$22700880$2$F$20230710$20240729$20230713$20240807$PER$$US-SA-2023SA213247$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240807$$MD$US$US
227008853$22700885$3$F$$20240916$20230713$20240923$EXP$$US-SA-2023SA211988$SANOFI AVENTIS$$$$A$F$Y$102.51$KG$20240923$$MD$US$US
227009142$22700914$2$F$20230518$20240725$20230713$20240731$EXP$$NVSC2023NL155059$NOVARTIS$$72$YR$$F$Y$$$20240731$$HP$NL$NL
227010852$22701085$2$F$$20240829$20230713$20240830$EXP$$NVSC2023US155339$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
227012414$22701241$4$F$20230601$20240731$20230713$20240813$EXP$$US-UCBSA-2023035490$UCB$$53$YR$$F$Y$$$20240813$$HP$US$US
227013254$22701325$4$F$20230623$20240819$20230713$20240828$PER$$US-SA-2023SA212271$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240828$$MD$US$US
227013635$22701363$5$F$$20240725$20230713$20240729$EXP$$US-TAKEDA-US202000395$TAKEDA$$$$$F$Y$$$20240729$$HP$US$US
227013835$22701383$5$F$20230718$20240814$20230713$20240815$EXP$$CA-TAKEDA-2023TUS068391$TAKEDA$$42$YR$$M$Y$$$20240815$$CN$CA$CA
227016968$22701696$8$F$20230712$20240911$20230713$20240919$EXP$$CA-TAKEDA-2023TUS067572$TAKEDA$$46$YR$$F$Y$$$20240919$$HP$CA$CA
227020807$22702080$7$F$20230101$20240713$20230713$20240718$EXP$$US-SA-2023SA209279$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240718$$MD$US$US
227024432$22702443$2$F$$20240718$20230713$20240724$EXP$$CA-BIOGEN-2023BI01215536$BIOGEN$$$$$F$Y$$$20240724$$PH$CA$CA
227024492$22702449$2$F$20230617$20240703$20230713$20240705$EXP$$BG-BAUSCH-BL-2023-010378$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240705$$MD$BG$BG
227024652$22702465$2$F$$20240826$20230713$20240902$EXP$$NO-ROCHE-3386138$ROCHE$Sommerfelt H, Sandvik LF, Bachmann IM, Brekke RL, Svendsen HL, Guttormsen AB. Toxic epidermal necrolysis after immune checkpoint inhibition, case report, and review of the literature. https://doi.org/10.1080/0284186X.2022.2119099.. Acta Oncologica 2022;61(10):1295-1299.$34$YR$A$M$Y$$$20240902$$HP$NO$NO
227025384$22702538$4$F$20230101$20240917$20230713$20240920$PER$$US-PFIZER INC-PV202300120751$PFIZER$$47$YR$$F$Y$$$20240920$$HP$US$US
227026283$22702628$3$F$20230112$20240717$20230713$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-097958$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$70.6$KG$20240722$$PH$JP$JP
227026825$22702682$5$F$20230329$20240816$20230713$20240820$PER$$US-PFIZER INC-2021651373$PFIZER$$69$YR$$F$Y$79.365$KG$20240820$$MD$US$US
2270282711$22702827$11$F$20230101$20240918$20230713$20240924$EXP$$CA-PFIZER INC-202300176491$PFIZER$$22$YR$$F$Y$$$20240924$$MD$CA$CA
227028362$22702836$2$F$20230701$20240723$20230713$20240801$PER$$US-SA-2023SA212672$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240801$$MD$US$US
227030132$22703013$2$F$$20240805$20230713$20240807$PER$$US-PFIZER INC-US-GBT-017847$PFIZER$$13$YR$$F$Y$$$20240807$$CN$US$US
227031102$22703110$2$F$20221221$20230310$20230713$20240723$PER$$US-NOVOPROD-1015898$NOVO NORDISK$$52$YR$$F$Y$$$20240723$$MD$US$US
227031602$22703160$2$F$20230101$20230531$20230713$20240723$PER$$US-NOVOPROD-1048754$NOVO NORDISK$$74$YR$$M$Y$$$20240723$$CN$US$US
227032302$22703230$2$F$20230101$20230515$20230713$20240723$PER$$US-NOVOPROD-1066889$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
227033323$22703332$3$F$20190101$20240806$20230713$20240807$EXP$$CA-PFIZER INC-2019050703$PFIZER$$60$YR$$F$Y$$$20240807$$PH$CA$CA
227033392$22703339$2$F$$20240923$20230713$20240925$PER$$NVSC2023US155842$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
227034176$22703417$6$F$20230821$20240819$20230713$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-014929$JAZZ$$55$YR$$F$Y$$$20240822$$HP$US$US
227034809$22703480$9$F$20230528$20240718$20230713$20240812$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002505$ACADIA PHARMACEUTICALS$$2$YR$$M$Y$$$20240812$$CN$US$US
227034879$22703487$9$F$20230613$20240610$20230713$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002517$ACADIA PHARMACEUTICALS$$19$YR$$F$Y$$$20240705$$CN$US$US
227035157$22703515$7$F$20220101$20240724$20230713$20240728$EXP$$JP-TAKEDA-2023TJP007192$TAKEDA$$13$YR$$F$Y$31$KG$20240728$$HP$JP$JP
2270373610$22703736$10$F$20230601$20240617$20230714$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002504$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240712$$CN$US$US
227037622$22703762$2$F$20230614$20240629$20230714$20240704$PER$$US-HETERO-HET2023US01950$HETERO$$14$YR$$M$Y$49$KG$20240704$$CN$US$US
227039914$22703991$4$F$$20240716$20230714$20240726$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2023-098863$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240726$$MD$GB$GB
227041043$22704104$3$F$20230101$20240813$20230714$20240821$PER$$US-SA-2023SA212779$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240821$$MD$US$US
227041354$22704135$4$F$20210512$20240709$20230714$20240712$EXP$$CA-TAKEDA-2023TUS068805$TAKEDA$$34$YR$$F$Y$$$20240712$$HP$CA$CA
227041394$22704139$4$F$$20230822$20230714$20240925$PER$$US-GSK-US2023AMR094772$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
227041894$22704189$4$F$$20240724$20230714$20240806$EXP$$FR-AUROBINDO-AUR-APL-2023-046446$AUROBINDO$AINS (ibuprofene/ketoprofene facteur aggravant d^infection bacterienne severe concernant la DCI ketoprofen [NSAIDs (nonsteroidal anti-inflammatory drugs) (ibuprofen/ketoprofen): aggravating factor in severe bacterial infection].. BULLETIN D^INFORMATION TRIMESTRIEL (QUARTERLY NEWSLETTER).. 2023;45$16$YR$$M$Y$$$20240806$$MD$FR$FR
227042237$22704223$7$F$20231130$20240719$20230714$20240724$EXP$$CA-JNJFOC-20230521563$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240724$$CN$CA$CA
2270424410$22704244$10$F$20230701$20240830$20230714$20240902$EXP$$NVSC2023US154780$NOVARTIS$$56$YR$$F$Y$$$20240902$$HP$US$US
227043122$22704312$2$F$$20240821$20230714$20240830$EXP$$CO-SA-2023SA212782$SANOFI AVENTIS$Alfonso JG, Reyes S, Rodriguez D, Salej V, Otero J, Toro J.. Osmotic Demyelinating Syndrome Secondary to Breast Cancer Chemotherapy: a Case Report.. Neurology.. 2023;100(17)Suppl 2:unk$71$YR$E$F$Y$$$20240830$$HP$CO$CO
227043402$22704340$2$F$20230401$20240701$20230714$20240713$EXP$FR-AFSSAPS-AM2023000592$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-095445$ZYDUS PHARM$$$$$$Y$$$20240713$$MD$FR$FR
227045592$22704559$2$F$20230619$20240716$20230714$20240726$EXP$$IT-AUROBINDO-AUR-APL-2023-046769$AUROBINDO$$88$YR$$F$Y$$$20240726$$MD$IT$IT
227047163$22704716$3$F$20230701$20240627$20230714$20240703$EXP$$JP-009507513-2307JPN000858J$MERCK$$9$DEC$$$Y$$$20240703$$PH$JP$JP
227048115$22704811$5$F$$20240830$20230714$20240830$PER$$NVSC2023US156037$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
227049202$22704920$2$F$20200101$20240909$20230714$20240923$EXP$$US-SA-2023SA213299$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240923$$HP$US$US
227049463$22704946$3$F$$20240726$20230714$20240730$EXP$$NVSC2023GB155124$NOVARTIS$$$$E$M$Y$$$20240730$$CN$GB$GB
227049753$22704975$3$F$$20240625$20230714$20240703$EXP$$US-AUROBINDO-AUR-APL-2023-046618$AUROBINDO$Pagliuca S, Wagner C, Pietruszka BL, Jindal S. Thiazide Induced Hyponatremia Presenting as a Fall in an Older Adult. Journal of the American Geriatrics Society. 2023;71 Supplement 1:S199$10$DEC$$M$Y$87$KG$20240703$$MD$US$US
227051004$22705100$4$F$20190114$20240704$20230714$20240710$EXP$$CA-TAKEDA-2023TUS063457$TAKEDA$$42$YR$$F$Y$$$20240710$$CN$CA$CA
227051013$22705101$3$F$20230323$20240719$20230714$20240729$EXP$$BR-TAKEDA-BR202030483$TAKEDA$$47$YR$$F$Y$71$KG$20240729$$MD$BR$BR
227051738$22705173$8$F$20230101$20240805$20230714$20240813$PER$$US-SA-2023SA211382$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240814$$MD$US$US
227051842$22705184$2$F$20230626$20240622$20230714$20240701$PER$$US-SA-2023SA213334$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240701$$MD$US$US
227051924$22705192$4$F$20230101$20240716$20230714$20240722$PER$$US-SA-2023SA212964$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240721$$MD$US$US
227052156$22705215$6$F$20240120$20240717$20230714$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-099479$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240722$$HP$US$US
227053104$22705310$4$F$20230630$20240705$20230714$20240712$EXP$$US-SA-2023SA213677$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240712$$MD$US$US
227053123$22705312$3$F$$20240627$20230714$20240708$PER$$US-SA-2023SA214396$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240708$$CN$US$US
227053375$22705337$5$F$20230713$20240906$20230714$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-099032$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240910$$CN$US$US
227053462$22705346$2$F$$20240807$20230714$20240814$EXP$$GB-ROCHE-3387254$ROCHE$$41$YR$A$M$Y$$$20240814$$CN$GB$GB
227054002$22705400$2$F$$20240715$20230714$20240718$EXP$$CA-MYLANLABS-2023M1074356$MYLAN$$69$YR$$M$Y$$$20240718$$CN$CA$CA
2270544615$22705446$15$F$20230705$20240918$20230714$20240928$EXP$$CA-CELLTRION INC.-2023CA014013$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
227056564$22705656$4$F$$20230706$20230714$20240730$EXP$$US-CHATTEMPRD-2023OHG000009$CHATTEM$$$$$$Y$$$20240730$$LW$US$US
227056622$22705662$2$F$20230101$20240911$20230714$20240925$EXP$$US-ENDO PHARMACEUTICALS INC-2023-004093$ENDO$$$$$F$Y$$$20240925$$CN$US$US
227057552$22705755$2$F$$20240803$20230714$20240806$EXP$$US-TAKEDA-US201730474$TAKEDA$$$$$F$Y$$$20240806$$HP$US$US
227058182$22705818$2$F$20230307$20240711$20230714$20240715$EXP$FR-AFSSAPS-AN2023000908$FR-ABBVIE-5325917$ABBVIE$$45$YR$$M$Y$93$KG$20240715$$HP$FR$FR
227058723$22705872$3$F$20230307$20240904$20230714$20240911$EXP$$BE-Blueprint Medicines Corporation-SO-BE-2023-001082$BLUEPRINT MEDICINES$$60$YR$A$M$Y$$$20240911$$MD$BE$FR
227059443$22705944$3$F$$20240625$20230714$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-097947$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240702$$MD$JP$JP
227060657$22706065$7$F$20230425$20240711$20230714$20240717$EXP$$FR-PFIZER INC-202300188272$PFIZER$$$$E$M$Y$69$KG$20240717$$MD$FR$FR
2270607720$22706077$20$F$20230101$20240921$20230714$20240925$EXP$$US-PFIZER INC-PV202300116774$PFIZER$$63$YR$$M$Y$$$20240925$$CN$US$US
227061806$22706180$6$F$20231009$20240627$20230714$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-099353$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240701$$CN$US$US
227062213$22706221$3$F$20210910$20240731$20230714$20240805$EXP$$US-PFIZER INC-US-GBT-020868$PFIZER$$29$YR$$M$Y$$$20240805$$CN$US$US
227062524$22706252$4$F$20221016$20240723$20230714$20240729$EXP$$US-TAKEDA-2023TUS068654$TAKEDA$$8$YR$$M$Y$28$KG$20240729$$CN$US$US
227063512$22706351$2$F$20230401$20240711$20230714$20240716$EXP$FR-AFSSAPS-LY2023000879$FR-PFIZER INC-202300247959$PFIZER$$65$YR$$M$Y$70$KG$20240716$$PH$FR$FR
227063666$22706366$6$F$20200528$20240711$20230714$20240715$EXP$$CA-TAKEDA-2023TUS066961$TAKEDA$$82$YR$$F$Y$$$20240715$$CN$CA$CA
227064013$22706401$3$F$20230201$20240703$20230714$20240705$EXP$$NVSC2023US155680$NOVARTIS$$62$YR$$M$Y$122.47$KG$20240705$$CN$US$US
227064623$22706462$3$F$$20230710$20230714$20240808$EXP$$US-OTSUKA-2023_018555$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
227065452$22706545$2$F$$20240909$20230714$20240911$PER$$US-PFIZER INC-PV202300121085$PFIZER$$75$YR$$F$Y$$$20240911$$MD$US$US
227066842$22706684$2$F$20230711$20230711$20230714$20240926$PER$$US-ABBVIE-5325878$ABBVIE$$42$YR$$F$Y$$$20240926$$CN$US$US
227067327$22706732$7$F$20211124$20240807$20230714$20240812$EXP$$AU-TAKEDA-2021TUS075364$TAKEDA$$65$YR$$M$Y$$$20240812$$CN$AU$AU
227067476$22706747$6$F$20230712$20240815$20230714$20240823$EXP$$US-TAKEDA-2023TUS068407$TAKEDA$$21$YR$$F$Y$47$KG$20240823$$HP$US$US
227069603$22706960$3$F$20230420$20240723$20230714$20240801$EXP$FR-AFSSAPS-PV2023000649$FR-ABBVIE-5327640$ABBVIE$$$$$F$Y$$$20240801$$MD$FR$FR
227070323$22707032$3$F$20200101$20240923$20230714$20240925$EXP$$US-PFIZER INC-PV202300121077$PFIZER$$65$YR$$F$Y$$$20240925$$HP$US$US
227070953$22707095$3$F$20191201$20240812$20230714$20240815$EXP$$CA-TAKEDA-2018TUS007178$TAKEDA$$51$YR$$M$Y$$$20240815$$CN$CA$CA
227071123$22707112$3$F$$20240925$20230714$20240927$EXP$$NVSC2023US155934$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
227071446$22707144$6$F$20230801$20240909$20230714$20240912$PER$$US-AMGEN-USASP2023121221$AMGEN$$55$YR$A$F$Y$$$20240912$$HP$US$US
227073142$22707314$2$F$$20240619$20230714$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399129$RANBAXY$Salvarani N, Peretto G, Silvia C, Villatore A,Thairi C, Santoni A, et al. Functional Characterisation of the Rare SCN5A p.E1225K Variant, Segregating in a Brugada Syndrome Familial Case, in Human Cardiomyocytes from Pluripotent Stem Cells. Int J Molecular Sci. 2023;24(11):No pagination (9548)$24$YR$$M$Y$$$20240704$$HP$IT$IT
227073154$22707315$4$F$$20240712$20230714$20240717$PER$$NVSC2023US156197$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
227075014$22707501$4$F$20230613$20240822$20230714$20240823$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-096787$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240823$$HP$JP$JP
227076972$22707697$2$F$20230101$20240805$20230714$20240809$EXP$$US-ABBVIE-5326644$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
227078024$22707802$4$F$20230601$20240131$20230714$20240914$PER$$US-ABBVIE-5321619$ABBVIE$$73$YR$$F$Y$104.32$KG$20240914$$CN$US$US
227078474$22707847$4$F$$20240910$20230714$20240913$EXP$$US-TAKEDA-2023TUS064856$TAKEDA$$$$$M$Y$70$KG$20240913$$CN$US$US
227078504$22707850$4$F$20240725$20240828$20230714$20240904$EXP$$US-TAKEDA-2023TUS069052$TAKEDA$$42$YR$$F$Y$88$KG$20240904$$CN$US$US
227081883$22708188$3$F$20230705$20240626$20230715$20240703$30DAY$$US-GSK-US2023092741$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240703$$HP$US$US
227084406$22708440$6$F$$20240723$20230715$20240729$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-030953$JAZZ$$$$$F$Y$$$20240729$$CN$US$US
2270855411$22708554$11$F$$20240923$20230715$20240926$EXP$$NVSC2023US156930$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
227089484$22708948$4$F$20230619$20240905$20230716$20240909$PER$$US-ABBVIE-5327131$ABBVIE$$74$YR$$F$Y$73.481$KG$20240909$$CN$US$US
227090412$22709041$2$F$$20240828$20230717$20240904$EXP$$US-JNJFOC-20230722324$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240904$$HP$US$US
227090552$22709055$2$F$$20240827$20230717$20240829$EXP$$NVSC2023US156858$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
227091626$22709162$6$F$20230101$20240909$20230717$20240916$EXP$$JP-009507513-2307JPN001089J$MERCK$Wanifuchi Y, Fujita T, Asano T, Mori M, Matsumoto N, Isogai A, et al. SY2-7 Long-term clinical outcome of triple-negative breast cancer treatment and future challenges. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 9$66$YR$$F$Y$$$20240916$$MD$JP$JP
227091653$22709165$3$F$$20240731$20230717$20240807$EXP$$US-ROCHE-3387849$ROCHE$$69$YR$E$F$Y$73.94$KG$20240807$$CN$US$US
227093575$22709357$5$F$20230101$20240802$20230717$20240812$PER$$US-SA-2023SA212302$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240812$$MD$US$US
227094279$22709427$9$F$20200224$20240711$20230717$20240720$EXP$$CA-CELLTRION INC.-2022CA015235$CELLTRION$$$$$$Y$$$20240720$$CN$CA$CA
227095273$22709527$3$F$$20240826$20230717$20240830$EXP$$CA-ROCHE-3387576$ROCHE$$47$YR$A$F$Y$210$KG$20240830$$HP$CA$CA
227095632$22709563$2$F$$20240912$20230717$20240917$EXP$$US-ROCHE-2743716$ROCHE$$62$YR$A$F$Y$$$20240917$$HP$US$US
2270963013$22709630$13$F$20220101$20240626$20230717$20240701$EXP$$PT-ABBVIE-4729416$ABBVIE$$$$E$M$Y$$$20240701$$CN$PT$PT
227096412$22709641$2$F$20230208$20240625$20230717$20240701$EXP$$DE-ABBVIE-5328698$ABBVIE$$63$YR$$M$Y$114$KG$20240701$$MD$DE$DE
227096926$22709692$6$F$20230101$20240810$20230717$20240819$PER$$US-SA-2023SA212427$SANOFI AVENTIS$$16$YR$T$F$Y$139$KG$20240819$$MD$US$US
227097865$22709786$5$F$$20240830$20230717$20240901$PER$$NVSC2023US155184$NOVARTIS$$$$$M$Y$72.57$KG$20240902$$MD$US$US
227098232$22709823$2$F$$20240622$20230717$20240701$PER$$US-SA-2023SA216042$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$MD$US$US
227098517$22709851$7$F$$20240826$20230717$20240831$EXP$$CA-ABBVIE-4340902$ABBVIE$$65$YR$$F$Y$69$KG$20240831$$HP$CA$CA
227098926$22709892$6$F$$20231211$20230717$20240926$PER$$US-GSK-US2023AMR096691$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$MD$US$US
227098984$22709898$4$F$20230602$20240627$20230717$20240701$EXP$$DE-009507513-2306DEU011827$MERCK$$52$YR$$M$Y$70$KG$20240701$$MD$DE$DE
227099474$22709947$4$F$20230101$20240723$20230717$20240801$PER$$US-SA-2023SA213976$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240801$$MD$US$US
227099689$22709968$9$F$$20240626$20230717$20240702$EXP$$NVSC2023US156771$NOVARTIS$$$$$F$Y$$$20240702$$HP$US$US
227101303$22710130$3$F$20240701$20240716$20230717$20240724$PER$$US-SA-2023SA215411$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240724$$MD$US$US
227101439$22710143$9$F$20230601$20240829$20230717$20240907$EXP$$US-GSK-US2023AMR096436$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240907$$CN$US$US
227103203$22710320$3$F$$20240919$20230717$20240925$EXP$$CA-ROCHE-3388391$ROCHE$$33$YR$A$F$Y$$$20240925$$HP$CA$CA
227107293$22710729$3$F$20220201$20230821$20230717$20240926$EXP$$US-GSK-US2022AMR042730$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
227108752$22710875$2$F$$20230727$20230717$20240813$PER$$US-GALDERMA-US2023008969$GALDERMA$$$$$$Y$$$20240813$$CN$US$US
227109523$22710952$3$F$$20240821$20230717$20240826$EXP$$CO-PFIZER INC-202300250592$PFIZER$Reyes, S.. Osmotic Demyelinating Syndrome Secondary to Breast Cancer Chemotherapy: a Case Report. Neurology. 2023;100 (17) Suppl2:10.1212/WNL.0000000000203142$71$YR$$F$Y$$$20240826$$MD$CO$CO
227110512$22711051$2$F$$20230726$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006838$VANDA PHARMACEUTICALS$$$$$F$Y$51.701$KG$20240723$$CN$US$US
227110862$22711086$2$F$$20231016$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006666$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
227110912$22711091$2$F$$20240108$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006743$VANDA PHARMACEUTICALS$$$$$M$Y$108.84$KG$20240723$$CN$US$US
2271110111$22711101$11$F$20231201$20240919$20230717$20240926$EXP$$CA-GSK-CA2023AMR095389$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$CA$CA
227111042$22711104$2$F$20230709$20240801$20230717$20240808$EXP$$CA-GSK-CA2023AMR095299$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$CA$CA
227111472$22711147$2$F$$20231003$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006640$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
227111562$22711156$2$F$20170101$20240308$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006826$VANDA PHARMACEUTICALS$$$$$M$Y$92.971$KG$20240723$$CN$US$US
227111582$22711158$2$F$$20230721$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006661$VANDA PHARMACEUTICALS$$$$$F$Y$104.31$KG$20240723$$CN$US$US
227111622$22711162$2$F$20230430$20230731$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006730$VANDA PHARMACEUTICALS$$61$YR$$F$Y$$$20240723$$CN$US$US
227111722$22711172$2$F$$20231101$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006699$VANDA PHARMACEUTICALS$$$$$M$Y$29.116$KG$20240723$$CN$US$US
227111792$22711179$2$F$$20230927$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006799$VANDA PHARMACEUTICALS$$$$$F$Y$73.469$KG$20240723$$CN$US$US
227111892$22711189$2$F$$20231201$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006803$VANDA PHARMACEUTICALS$$$$$F$Y$88.435$KG$20240723$$CN$US$US
227111922$22711192$2$F$$20231121$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006739$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
227112192$22711219$2$F$$20230804$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006819$VANDA PHARMACEUTICALS$$$$$F$Y$52.063$KG$20240723$$CN$US$US
227112272$22711227$2$F$20230901$20230915$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006830$VANDA PHARMACEUTICALS$$30$YR$$M$Y$96.599$KG$20240723$$CN$US$US
227112313$22711231$3$F$$20240923$20230717$20240927$EXP$$CA-ROCHE-3387761$ROCHE$$66$YR$E$F$Y$$$20240927$$HP$CA$CA
227112342$22711234$2$F$$20230918$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006754$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
227112352$22711235$2$F$$20230817$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006762$VANDA PHARMACEUTICALS$$$$$M$Y$117.91$KG$20240723$$CN$US$US
227112392$22711239$2$F$$20230927$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006727$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
227112412$22711241$2$F$20230502$20240611$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006734$VANDA PHARMACEUTICALS$$52$YR$$F$Y$74.376$KG$20240723$$CN$US$US
227112622$22711262$2$F$20220101$20231011$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006759$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
227112812$22711281$2$F$$20230824$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006786$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
227112882$22711288$2$F$$20230925$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006783$VANDA PHARMACEUTICALS$$$$$F$Y$112.49$KG$20240723$$CN$US$US
227113042$22711304$2$F$$20231212$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006646$VANDA PHARMACEUTICALS$$$$$M$Y$98.866$KG$20240723$$CN$US$US
227113102$22711310$2$F$$20240624$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006820$VANDA PHARMACEUTICALS$$$$$F$Y$48.526$KG$20240723$$CN$US$US
227113332$22711333$2$F$$20230901$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006686$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
227113412$22711341$2$F$20220101$20230901$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006724$VANDA PHARMACEUTICALS$$$$$F$Y$166.44$KG$20240723$$CN$US$US
227113539$22711353$9$F$20230228$20240708$20230717$20240712$EXP$$DE-TAKEDA-2023TUS068626$TAKEDA$$30$YR$$M$Y$100$KG$20240712$$CN$DE$DE
227113612$22711361$2$F$$20240530$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006813$VANDA PHARMACEUTICALS$$$$$M$Y$92.517$KG$20240723$$CN$US$US
227114282$22711428$2$F$$20231114$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006616$VANDA PHARMACEUTICALS$$$$$F$Y$76.689$KG$20240723$$CN$US$US
227114332$22711433$2$F$$20231012$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006483$VANDA PHARMACEUTICALS$$$$$M$Y$57.596$KG$20240723$$CN$US$US
227114342$22711434$2$F$20230316$20240604$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006605$VANDA PHARMACEUTICALS$$40$YR$$M$Y$82.54$KG$20240723$$CN$US$US
227114362$22711436$2$F$$20230726$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006547$VANDA PHARMACEUTICALS$$$$$F$Y$88.435$KG$20240723$$CN$US$US
227114852$22711485$2$F$$20230807$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006619$VANDA PHARMACEUTICALS$$$$$M$Y$83.9$KG$20240723$$CN$US$US
227114882$22711488$2$F$$20230711$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006497$VANDA PHARMACEUTICALS$$$$$F$Y$131.52$KG$20240723$$CN$US$US
227114932$22711493$2$F$$20240117$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006620$VANDA PHARMACEUTICALS$$$$$M$Y$78.277$KG$20240723$$CN$US$US
227114962$22711496$2$F$20230216$20240701$20230717$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-380701$RANBAXY$$39$YR$A$F$Y$$$20240711$$MD$US$US
227114992$22711499$2$F$20230101$20240311$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006581$VANDA PHARMACEUTICALS$$40$YR$$F$Y$63.492$KG$20240723$$CN$US$US
227115752$22711575$2$F$$20231226$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006539$VANDA PHARMACEUTICALS$$$$$M$Y$104.31$KG$20240723$$CN$US$US
227115792$22711579$2$F$$20230717$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006540$VANDA PHARMACEUTICALS$$$$$M$Y$104.31$KG$20240723$$CN$US$US
227115952$22711595$2$F$$20231115$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006542$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
227116502$22711650$2$F$20221225$20240826$20230717$20240830$EXP$$CO-TAKEDA-2023TUS001946$TAKEDA$$61$YR$$F$Y$61$KG$20240830$$CN$CO$CO
227116582$22711658$2$F$$20230719$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006604$VANDA PHARMACEUTICALS$$$$$M$Y$77.551$KG$20240723$$CN$US$US
227117382$22711738$2$F$$20240701$20230717$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394821$RANBAXY$Kazi SE, Mohammed JMM, Schenck CH. Sleepwalking, sleep-related eating disorder and sleep-related smoking successfully treated with topiramate: a case report. Sleep Sci.. 2022;15(3):370-73$45$YR$$$Y$$$20240711$$HP$US$US
227117462$22711746$2$F$$20240829$20230717$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394615$RANBAXY$Holbrook NR, Klontz EH, Adams GC, Schnittman SR, Issa NC, Bond SA, et al. Babesia microti Variant with Multiple Resistance Mutations Detected in an Immunocompromised Patient Receiving Atovaquone Prophylaxis. Open Forum Infect Dis. 2023;Feb:1-4$$$$M$Y$$$20240904$$HP$US$US
227117692$22711769$2$F$$20231023$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006447$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
227117722$22711772$2$F$$20240709$20230717$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394981$RANBAXY$Chen DL, Beran MC, Duncan M, Young JA, Napolitano JT, MacDonald J. Achilles Tendon Injuries Requiring Surgical Treatment in the Pediatric and Adolescent Population: A Case Series. Curr Sports Med Rep. 2022;Dec; 21 (12):431-435$16$YR$$F$Y$$$20240710$$MD$US$US
227117933$22711793$3$F$$20240703$20230717$20240708$EXP$$US-PFIZER INC-PV202300090755$PFIZER$$77$YR$$M$Y$$$20240708$$HP$US$US
227118232$22711823$2$F$20221222$20240306$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2022TASUS006384$VANDA PHARMACEUTICALS$$67$YR$$M$Y$103.86$KG$20240723$$CN$US$US
227118352$22711835$2$F$20230101$20230706$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2022TASUS006377$VANDA PHARMACEUTICALS$$45$YR$$F$Y$$$20240723$$CN$US$US
227120102$22712010$2$F$$20230831$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2022TASUS006241$VANDA PHARMACEUTICALS$$$$$M$Y$80.726$KG$20240723$$CN$US$US
227122352$22712235$2$F$$20231130$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2022TASUS006124$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
227122534$22712253$4$F$$20240910$20230717$20240916$EXP$$DE-PFIZER INC-PV202300123427$PFIZER$$77$YR$$M$Y$100$KG$20240916$$MD$DE$DE
227123332$22712333$2$F$$20240821$20230717$20240826$EXP$$CA-TAKEDA-2023TUS068167$TAKEDA$$$$$F$Y$$$20240826$$CN$CA$CA
227124222$22712422$2$F$$20230731$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2022TASUS006030$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
227124569$22712456$9$F$20230901$20240909$20230717$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-013040$JAZZ$$63$YR$$F$Y$$$20240912$$MD$US$US
227125068$22712506$8$F$20230809$20240821$20230717$20240827$EXP$$CA-TAKEDA-2023TUS069061$TAKEDA$$51$YR$$F$Y$$$20240827$$CN$CA$CA
227125502$22712550$2$F$20220501$20231221$20230717$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2022TASUS005979$VANDA PHARMACEUTICALS$$59$YR$$F$Y$$$20240723$$CN$US$US
227126562$22712656$2$F$$20230809$20230717$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00606$TARO$$$$$$Y$$$20240718$$CN$US$US
227128102$22712810$2$F$$20240716$20230717$20240721$EXP$$US-PFIZER INC-PV202300124317$PFIZER$$81$YR$$M$Y$$$20240721$$CN$US$US
227128524$22712852$4$F$20230101$20240821$20230717$20240823$PER$$US-PFIZER INC-PV202300123274$PFIZER$$47$YR$$F$Y$$$20240823$$HP$US$US
227128554$22712855$4$F$20221129$20240703$20230717$20240708$PER$$US-PFIZER INC-PV202300117095$PFIZER$$85$YR$$F$Y$$$20240708$$MD$US$US
227128867$22712886$7$F$$20240830$20230717$20240903$EXP$$US-PFIZER INC-PV202300121777$PFIZER$$71$YR$$F$Y$$$20240903$$HP$US$US
227130815$22713081$5$F$20180620$20240729$20230717$20240731$EXP$$CA-TAKEDA-2018TUS020369$TAKEDA$$66$YR$$M$Y$$$20240731$$CN$CA$CA
227131618$22713161$8$F$20210322$20240812$20230717$20240814$EXP$$US-TAKEDA-2020TUS045610$TAKEDA$$56$YR$$F$Y$$$20240814$$HP$US$US
227133027$22713302$7$F$$20240709$20230717$20240711$EXP$$CA-TAKEDA-2022TUS033412$TAKEDA$$$$$M$Y$$$20240711$$CN$CA$CA
227133492$22713349$2$F$$20230822$20230717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-378423$RANBAXY$$$$E$F$Y$$$20240717$$CN$US$US
227133502$22713350$2$F$20230101$20230809$20230717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381745$RANBAXY$$70$YR$E$M$Y$$$20240717$$CN$US$US
227133652$22713365$2$F$20230320$20230622$20230717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383285$RANBAXY$$66$YR$E$M$Y$$$20240717$$CN$US$US
227133956$22713395$6$F$20230601$20240821$20230717$20240916$PER$$US-SA-2023SA214825$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
227134832$22713483$2$F$$20240628$20230717$20240702$EXP$$US-BAUSCH-BL-2023-010905$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240702$$CN$US$US
227135243$22713524$3$F$20230522$20240916$20230717$20240918$EXP$$NL-ORGANON-O2307NLD001813$ORGANON$$9$YR$$M$Y$$$20240918$$MD$NL$NL
227135312$22713531$2$F$$20230322$20230717$20240715$PER$$US-NOVOPROD-1048860$NOVO NORDISK$$$$A$M$Y$$$20240716$$HP$US$US
227136653$22713665$3$F$$20240902$20230717$20240909$EXP$$CA-MYLANLABS-2023M1075301$BIOCON$$$$$$Y$$$20240909$$CN$CA$CA
227138669$22713866$9$F$20230801$20240823$20230717$20240923$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000273$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
227138986$22713898$6$F$20220801$20240724$20230717$20240730$EXP$$CN-TAKEDA-2023TUS022638$TAKEDA$$62$YR$$F$Y$60$KG$20240730$$HP$CN$CN
227139498$22713949$8$F$20230630$20240919$20230717$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-100284$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$77.56$KG$20240923$$CN$US$US
2271416712$22714167$12$F$20230101$20240918$20230718$20240927$EXP$$CA-CELLTRION INC.-2023CA014177$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
227142248$22714224$8$F$20230609$20240628$20230718$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002587$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240723$$CN$US$US
227142309$22714230$9$F$20240601$20240626$20230718$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002588$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240719$$CN$US$US
227142369$22714236$9$F$20230603$20240621$20230718$20240717$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002590$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240717$$CN$US$US
227142495$22714249$5$F$20210816$20240718$20230718$20240726$EXP$$CA-CELLTRION INC.-2020CA021838$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
227142694$22714269$4$F$$20240815$20230718$20240828$EXP$$CA-AUROBINDO-AUR-APL-2023-046799$AUROBINDO$Picard M, Filion CA, Auclair MH, Noujaim J, de Guerk? L, Dionne JL, et al.. Cytokine profiling, pretreatment with anakinra, and tolerance development in platinum-induced mixed hypersensitivity reactions.. American College annals of Allergy, Asthma + Immunology. 2023;1?12$68$YR$$M$Y$$$20240828$$MD$CA$CA
2271431111$22714311$11$F$20230607$20240627$20230718$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002573$ACADIA PHARMACEUTICALS$$14$YR$$F$Y$$$20240708$$CN$US$US
227144862$22714486$2$F$20230101$20240624$20230718$20240702$EXP$$ZA-AMGEN-ZAFSP2023123726$AMGEN$$59$YR$A$F$Y$53$KG$20240701$$MD$ZA$ZA
227144885$22714488$5$F$20230101$20240715$20230718$20240722$EXP$$US-ABBVIE-5329103$ABBVIE$$$$$M$Y$$$20240719$$CN$US$US
2271456111$22714561$11$F$20230101$20240913$20230718$20240921$EXP$$CA-CELLTRION INC.-2023CA014244$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
227146147$22714614$7$F$$20240909$20230718$20240919$EXP$$CA-THEA-2022000475$Thea Pharma$$75$YR$$F$Y$70$KG$20240919$$HP$CA$CA
227147073$22714707$3$F$20230606$20240821$20230718$20240829$EXP$$US-NOVOPROD-1091538$NOVO NORDISK$$$$$F$Y$$$20240829$$CN$US$US
227147673$22714767$3$F$20230620$20240905$20230718$20240911$EXP$$US-ABBVIE-5330299$ABBVIE$$61$YR$$F$Y$$$20240911$$CN$US$US
227147813$22714781$3$F$20230101$20240826$20230718$20240904$EXP$$CA-ROCHE-3388089$ROCHE$$67$YR$E$F$Y$$$20240904$$CN$CA$CA
227148263$22714826$3$F$$20240926$20230718$20240930$EXP$$ES-AUROBINDO-AUR-APL-2023-047828$AUROBINDO$Escribano R, Lacambra M, As?n A, Foguet-Boreu Q.. Generalized Clonic Jerks After Administration of Etomidate Before ECT. A Case Report. Journal of ECT.. 2023;39(2):121-123$65$YR$$F$Y$$$20240930$$MD$ES$ES
227148973$22714897$3$F$20090101$20240904$20230718$20240916$EXP$$IE-AUROBINDO-AUR-APL-2023-047408$AUROBINDO$Medisch Contact. 2009;64 (27):1191$50$YR$$M$Y$60$KG$20240916$$MD$US$IE
227149472$22714947$2$F$20220220$20231009$20230718$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2022-07712$ALKEM$$34$YR$$M$Y$$$20240723$$MD$FR$FR
227149492$22714949$2$F$20220923$20231009$20230718$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2022-15352$ALKEM$$54$YR$$F$Y$$$20240723$$MD$FR$FR
227149562$22714956$2$F$20230109$20240419$20230718$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2022-15424$ALKEM$$40$YR$$M$Y$$$20240723$$MD$FR$FR
227149632$22714963$2$F$$20240125$20230718$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2022-15472$ALKEM$$$$E$F$Y$$$20240723$$MD$FR$FR
227149682$22714968$2$F$20220202$20240122$20230718$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2022-05992$ALKEM$$51$YR$$F$Y$$$20240723$$MD$FR$FR
227149862$22714986$2$F$20220101$20240103$20230718$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2022-15339$ALKEM$$58$YR$$F$Y$$$20240723$$MD$FR$FR
227150182$22715018$2$F$20220101$20231030$20230718$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2022-09271$ALKEM$$84$YR$$F$Y$$$20240723$$MD$FR$FR
227150322$22715032$2$F$$20240705$20230718$20240723$EXP$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2022-15341$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2022-15341$ALKEM$$$$$F$Y$$$20240723$$MD$FR$FR
227150874$22715087$4$F$20230101$20240725$20230718$20240726$EXP$$US-UCBSA-2023022261$UCB$$$$$M$Y$$$20240726$$CN$US$US
227150886$22715088$6$F$20230701$20240710$20230718$20240719$EXP$$CA-CELLTRION INC.-2023CA009563$CELLTRION$$$$$$Y$$$20240719$$MD$CA$CA
227151643$22715164$3$F$20230619$20240716$20230718$20240726$EXP$$IT-AUROBINDO-AUR-APL-2023-047862$AUROBINDO$$88$YR$$F$Y$$$20240726$$MD$IT$IT
227154013$22715401$3$F$$20240921$20230718$20240930$EXP$$BR-TAKEDA-2022TUS068017$TAKEDA$$$$$M$Y$$$20240930$$MD$BR$BR
2271540812$22715408$12$F$20230718$20240730$20230718$20240806$EXP$$CO-TAKEDA-2023TUS070156$TAKEDA$$29$YR$$F$Y$54$KG$20240806$$CN$CO$CO
227155182$22715518$2$F$20211019$20240820$20230718$20240826$EXP$$CA-TAKEDA-2020TUS054597$TAKEDA$$66$YR$$F$Y$$$20240826$$CN$CA$CA
227157323$22715732$3$F$20240903$20240903$20230718$20240923$EXP$$US-SA-2023SA217965$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240923$$CN$US$US
227157438$22715743$8$F$$20240919$20230718$20240928$EXP$$AT-CELLTRION INC.-2023AT014053$CELLTRION$Feige J, Klausner F, Pfaff J, Trinka E, Pikija S, Safdarian M. Stroke-like presentation of acute toxic leukoencephalopathy due to capecitabine treatment with extensive intramyelinic edema. Chronic Diseases and Translational Medicine. 2023;1-5$$$$$Y$$$20240928$$MD$AT$AT
2271574912$22715749$12$F$20230711$20240918$20230718$20240920$EXP$$DE-TAKEDA-2023TUS069351$TAKEDA$$7$YR$$M$Y$$$20240920$$CN$DE$DE
227157512$22715751$2$F$20150101$20240904$20230718$20240909$EXP$$CA-TAKEDA-2015TUS017139$TAKEDA$$$$$F$Y$$$20240909$$CN$CA$CA
227157566$22715756$6$F$20230724$20240912$20230718$20240918$EXP$$AU-TAKEDA-2023TUS070351$TAKEDA$$33$YR$$M$Y$$$20240918$$CN$AU$AU
227158084$22715808$4$F$$20240813$20230718$20240827$EXP$$CA-AUROBINDO-AUR-APL-2023-046805$AUROBINDO$Picard M, Filion CA, Auclair MH, Noujaim J, de Guerk? L, Dionne JL, et al. Cytokine profiling, pretreatment with anakinra, and tolerance development in platinum-induced mixed hypersensitivity reactions. Annals of allergy, asthma+ immunology : official publication of the American Col. 2023;1-12$62$YR$$M$Y$$$20240827$$MD$CA$CA
227158116$22715811$6$F$$20240709$20230718$20240718$EXP$$US-GSK-US2023094531$GLAXOSMITHKLINE$$$$$F$Y$93$KG$20240718$$CN$US$US
227158363$22715836$3$F$20230629$20240708$20230718$20240919$EXP$$US-Accord-367815$ACCORD$$64$YR$A$M$Y$$$20240919$$HP$US$US
227158522$22715852$2$F$$20240711$20230718$20240717$EXP$$US-KAMADA LIMITED-2019US005822$TAKEDA$$$$$F$Y$$$20240717$$MD$US$US
227158893$22715889$3$F$$20240821$20230718$20240829$EXP$$CA-APOTEX-2023AP010346$APOTEX$$$$$$Y$$$20240829$$HP$CA$CA
227161892$22716189$2$F$$20230823$20230718$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2022-AMRX-03041$AMNEAL$$$$$F$Y$$$20240715$$CN$US$US
227162232$22716223$2$F$20230504$20230614$20230718$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-01613$AMNEAL$$$$$F$Y$$$20240715$$CN$US$US
227162292$22716229$2$F$$20230608$20230718$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-01569$AMNEAL$$$$$$Y$$$20240715$$CN$US$US
227162382$22716238$2$F$$20230706$20230718$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-01875$AMNEAL$$$$$F$Y$$$20240715$$CN$US$US
227162392$22716239$2$F$$20230614$20230718$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-01657$AMNEAL$$$$$F$Y$$$20240715$$CN$US$US
227163003$22716300$3$F$20230705$20240709$20230718$20240720$EXP$$US-Accord-367813$ACCORD$$75$YR$E$F$Y$$$20240720$$HP$US$US
227163517$22716351$7$F$20231031$20240704$20230718$20240710$EXP$$CA-TAKEDA-2023TUS069095$TAKEDA$$37$YR$$F$Y$$$20240710$$CN$CA$CA
227167883$22716788$3$F$20230112$20240917$20230718$20240924$EXP$$CA-TAKEDA-2022TUS013673$TAKEDA$$55$YR$$F$Y$$$20240924$$CN$CA$CA
227169623$22716962$3$F$20230705$20240708$20230718$20240715$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2023095308$VIIV$$$$$$Y$$$20240715$$PH$CA$CA
227169633$22716963$3$F$20230708$20240816$20230718$20240826$30DAY$$US-GSK-US2023093938$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240826$$CN$US$US
2271698016$22716980$16$F$$20240924$20230718$20240926$EXP$$US-TAKEDA-2023TUS026828$TAKEDA$$$$$F$Y$$$20240926$$MD$US$US
227170326$22717032$6$F$20160323$20240708$20230718$20240710$PER$$US-PFIZER INC-2016121748$PFIZER$$38$YR$$F$Y$70.31$KG$20240710$$HP$US$US
227170834$22717083$4$F$20240419$20240822$20230718$20240827$EXP$$US-PFIZER INC-202300250035$PFIZER$$16$YR$$M$Y$57.9$KG$20240827$$CN$US$US
227171962$22717196$2$F$$20240918$20230718$20240925$EXP$$NVSC2023US158362$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
227172074$22717207$4$F$$20240625$20230718$20240701$PER$$US-PFIZER INC-PV202300124084$PFIZER$$54$YR$$F$Y$$$20240701$$PH$US$US
227172284$22717228$4$F$$20240904$20230718$20240919$EXP$$CA-BAXTER-2023BAX026268$BAXTER$$26$YR$$F$Y$$$20240919$$MD$CA$CA
227173609$22717360$9$F$20220504$20240731$20230718$20240806$EXP$$CA-TAKEDA-2022TUS017502$TAKEDA$$77$YR$$F$Y$$$20240806$$CN$CA$CA
227175003$22717500$3$F$$20240829$20230718$20240829$PER$$NVSC2023US158605$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
227176802$22717680$2$F$20230630$20240628$20230718$20240712$EXP$GB-MHRA-TPP22856288C8356469YC1688130374949$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-399151$RANBAXY$$90$YR$$F$Y$45$KG$20240712$$MD$GB$GB
227178834$22717883$4$F$$20240705$20230718$20240712$PER$$US-VERTEX PHARMACEUTICALS-2023-010299$VERTEX$$$$$F$Y$$$20240712$$MD$US$US
227179193$22717919$3$F$$20240808$20230718$20240809$EXP$$NVSC2022PL092997$NOVARTIS$Liszka K, Resztak M, Zalewska P, Kalwak K. Therapeutic drug monitoring of posaconazole for effective prophylaxis of invasive fungal infections in pediatric patients: A pilot study. ACTA HAEMATOLOGICA POLONICA. 2021;52(6):578-83$4$YR$$$Y$18$KG$20240809$$HP$PL$PL
227179752$22717975$2$F$$20230406$20230718$20240728$PER$$US-UROVANT SCIENCES GMBH-202209-URV-001302$SUNOVION$$$$$M$Y$$$20240728$$CN$US$US
227179863$22717986$3$F$$20240717$20230718$20240723$EXP$$CA-TAKEDA-2023TUS068590$TAKEDA$$$$$F$Y$$$20240723$$CN$CA$CA
227180848$22718084$8$F$20221228$20240720$20230718$20240724$EXP$$AR-MYLANLABS-2023M1000441$MYLAN$$27$YR$$F$Y$$$20240724$$HP$AR$AR
227182685$22718268$5$F$20230615$20240828$20230718$20240902$EXP$$US-TAKEDA-2023TUS059921$TAKEDA$$42$YR$$F$Y$106$KG$20240902$$CN$US$US
227183474$22718347$4$F$20230101$20240726$20230718$20240805$PER$$US-SA-2023SA216059$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240805$$MD$US$US
227183744$22718374$4$F$20230705$20240925$20230718$20240930$PER$$US-SA-2023SA216902$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240930$$HP$US$US
227184217$22718421$7$F$20230101$20240917$20230718$20240919$EXP$$US-SA-2023SA216294$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240919$$MD$US$US
227184754$22718475$4$F$20230101$20240820$20230718$20240826$PER$$US-SA-2023SA217179$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240826$$MD$US$US
227185082$22718508$2$F$20230706$20240709$20230718$20240717$PER$$US-SA-2023SA216446$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240717$$MD$US$US
227185232$22718523$2$F$20230630$20240828$20230718$20240910$PER$$US-SA-2023SA212149$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240910$$MD$US$US
227186154$22718615$4$F$20230101$20240809$20230718$20240820$PER$$US-SA-2023SA218136$SANOFI AVENTIS$$2$YR$C$M$Y$15.422$KG$20240820$$MD$US$US
227186482$22718648$2$F$$20240822$20230718$20240903$PER$$US-SA-2023SA217494$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240903$$MD$US$US
227186652$22718665$2$F$$20240712$20230718$20240723$PER$$US-SA-2023SA216776$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240723$$MD$US$US
227189802$22718980$2$F$20230709$20240815$20230718$20240826$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2023-000442$SK LIFE SCIENCE$$$$$$Y$$$20240826$$CN$US$US
227189842$22718984$2$F$20220201$20240711$20230718$20240716$PER$$US-INCYTE CORPORATION-2023IN007215$INCYTE$$$$$$Y$$$20240716$$CN$US$US
227190356$22719035$6$F$20220717$20240719$20230718$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202307004087$ELI LILLY AND CO$$90$YR$E$$Y$$$20240802$$CN$US$US
227192352$22719235$2$F$$20240822$20230718$20240828$PER$$US-UROVANT SCIENCES GMBH-202305-URV-000881$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
227194913$22719491$3$F$20230602$20240624$20230718$20240701$EXP$$DE-FreseniusKabi-FK202309058$FRESENIUS KABI$$52$YR$A$M$Y$70$KG$20240701$$MD$DE$DE
227195672$22719567$2$F$20230401$20230428$20230718$20240728$PER$$US-UROVANT SCIENCES GMBH-202111-URV-000680$SUNOVION$$84$YR$$M$Y$$$20240728$$CN$US$US
227196742$22719674$2$F$20230614$20240725$20230718$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-101113$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$97.52$KG$20240726$$HP$US$US
2272000418$22720004$18$F$20230101$20240908$20230718$20240916$EXP$$CA-CELLTRION INC.-2022CA005586$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
227200162$22720016$2$F$$20230705$20230718$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000082$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
227200472$22720047$2$F$20230501$20240103$20230718$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000098$EVOKE PHARMA$$$$$$Y$$$20240724$$CN$US$US
227200596$22720059$6$F$20210720$20240916$20230718$20240924$EXP$$CA-CELLTRION INC.-2021CA012281$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
227201547$22720154$7$F$$20240829$20230718$20240903$EXP$$NVSJ2023JP011113$NOVARTIS$$49$YR$$F$Y$53$KG$20240903$$MD$JP$JP
227201856$22720185$6$F$$20240709$20230718$20240710$EXP$$TW-JNJFOC-20230725124$JOHNSON AND JOHNSON$$40$YR$A$M$Y$110$KG$20240711$$CN$TW$TW
2272026714$22720267$14$F$20220101$20240808$20230719$20240815$EXP$$CA-CELLTRION INC.-2022CA014982$CELLTRION$$$$$$Y$$$20240815$$MD$CA$CA
227203212$22720321$2$F$20180522$20240820$20230719$20240826$EXP$$JP-GILEAD-2019-0435066$GILEAD$$35$YR$A$M$Y$$$20240826$$MD$JP$JP
227203936$22720393$6$F$20231201$20240822$20230719$20240827$EXP$$US-ABBVIE-5331660$ABBVIE$$69$YR$$F$Y$$$20240827$$CN$US$US
227204333$22720433$3$F$$20240813$20230719$20240820$EXP$GR-SEATTLE GENETICS-2023SGN07031$GR-ROCHE-3389423$ROCHE$$$$$F$Y$$$20240820$$MD$GR$GR
227204505$22720450$5$F$20230101$20240807$20230719$20240816$PER$$US-SA-2023SA196430$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240816$$MD$US$US
227204816$22720481$6$F$20230701$20240118$20230719$20240925$PER$$US-GSK-US2023AMR097730$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240925$$CN$US$US
227206183$22720618$3$F$$20240909$20230719$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05703$LUPIN$$$$$$Y$$$20240925$$CN$US$US
227206322$22720632$2$F$$20240628$20230719$20240701$PER$$NVSC2023US154626$NOVARTIS$$49$YR$$F$Y$$$20240701$$CN$US$US
227206602$22720660$2$F$$20240719$20230719$20240729$PER$$US-SA-2023SA218640$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240729$$MD$US$US
227206813$22720681$3$F$$20240726$20230719$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05731$LUPIN$$$$$$Y$$$20240818$$CN$US$US
227207942$22720794$2$F$20230501$20230725$20230719$20240806$PER$$US-APOTEX-2023AP008595$APOTEX$$$$$F$Y$$$20240806$$CN$US$US
227208986$22720898$6$F$20200123$20240729$20230719$20240803$EXP$$JP-ABBVIE-5293419$ABBVIE$$65$YR$$M$Y$67$KG$20240803$$MD$JP$JP
227209762$22720976$2$F$$20221205$20230719$20240723$PER$$US-OTSUKA-2022_053973$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227209772$22720977$2$F$$20220922$20230719$20240723$EXP$$US-OTSUKA-2022_046228$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227209783$22720978$3$F$$20220921$20230719$20240723$PER$$US-OTSUKA-2022_046112$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227209802$22720980$2$F$$20221107$20230719$20240723$PER$$US-OTSUKA-2022_051229$OTSUKA$$59$YR$$F$Y$$$20240723$$CN$US$US
227209812$22720981$2$F$$20220921$20230719$20240723$PER$$US-OTSUKA-2022_046129$OTSUKA$$6$DEC$$M$Y$$$20240723$$HP$US$US
227209822$22720982$2$F$$20220725$20230719$20240723$PER$$US-OTSUKA-2022_038288$OTSUKA$$8$DEC$$F$Y$$$20240723$$HP$US$US
227209832$22720983$2$F$$20221207$20230719$20240723$PER$$US-OTSUKA-2022_054363$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227209842$22720984$2$F$$20221206$20230719$20240723$PER$$US-OTSUKA-2022_054225$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227209852$22720985$2$F$20220901$20220922$20230719$20240723$PER$$US-OTSUKA-2022_046227$OTSUKA$$6$DEC$$M$Y$$$20240723$$HP$US$US
227209862$22720986$2$F$$20220929$20230719$20240723$EXP$$US-OTSUKA-2022_047046$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227209872$22720987$2$F$$20220929$20230719$20240723$PER$$US-OTSUKA-2022_047049$OTSUKA$$12$YR$$F$Y$$$20240723$$CN$US$US
227209882$22720988$2$F$20221101$20221206$20230719$20240723$PER$$US-OTSUKA-2022_054261$OTSUKA$$68$YR$$M$Y$99.34$KG$20240723$$CN$US$US
227209892$22720989$2$F$$20220922$20230719$20240723$EXP$$US-OTSUKA-2022_046274$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227209902$22720990$2$F$20221101$20221104$20230719$20240723$PER$$US-OTSUKA-2022_051185$OTSUKA$$19$YR$$F$Y$$$20240723$$HP$US$US
227209912$22720991$2$F$$20221206$20230719$20240723$PER$$US-OTSUKA-2022_054222$OTSUKA$$$$$M$Y$114.31$KG$20240723$$CN$US$US
227209922$22720992$2$F$$20221205$20230719$20240723$PER$$US-OTSUKA-2022_054263$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227209932$22720993$2$F$$20221103$20230719$20240723$PER$$US-OTSUKA-2022_050919$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227209942$22720994$2$F$$20221205$20230719$20240723$PER$$US-OTSUKA-2022_054099$OTSUKA$$30$YR$$F$Y$$$20240723$$HP$US$US
227209952$22720995$2$F$$20220725$20230719$20240723$PER$$US-OTSUKA-2022_038284$OTSUKA$$5$DEC$$F$Y$$$20240723$$HP$US$US
227209962$22720996$2$F$$20221207$20230719$20240723$EXP$$US-OTSUKA-2022_054364$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227209972$22720997$2$F$$20221107$20230719$20240723$PER$$US-OTSUKA-2022_051199$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227209982$22720998$2$F$$20221202$20230719$20240723$PER$$US-OTSUKA-2022_053782$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227209992$22720999$2$F$$20220921$20230719$20240723$PER$$US-OTSUKA-2022_046139$OTSUKA$$5$DEC$$F$Y$$$20240723$$HP$US$US
227210002$22721000$2$F$20221103$20221104$20230719$20240723$PER$$US-OTSUKA-2022_051111$OTSUKA$$79$YR$$F$Y$$$20240723$$CN$US$US
227210012$22721001$2$F$$20221103$20230719$20240723$PER$$US-OTSUKA-2022_050918$OTSUKA$$$$$F$Y$72.57$KG$20240723$$CN$US$US
227210022$22721002$2$F$$20221019$20230719$20240723$PER$$US-OTSUKA-2022_048135$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227210032$22721003$2$F$$20220930$20230719$20240723$PER$$US-OTSUKA-2022_047135$OTSUKA$$4$DEC$$F$Y$$$20240723$$HP$US$US
227210042$22721004$2$F$$20220921$20230719$20240723$EXP$$US-OTSUKA-2022_046144$OTSUKA$$4$DEC$$F$Y$$$20240723$$MD$US$US
227210052$22721005$2$F$20220301$20221207$20230719$20240723$PER$$US-OTSUKA-2022_054347$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227210062$22721006$2$F$$20220726$20230719$20240723$PER$$US-OTSUKA-2022_038583$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227210072$22721007$2$F$$20221005$20230719$20240723$PER$$US-OTSUKA-2022_046289$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227210082$22721008$2$F$$20220928$20230719$20240723$EXP$$US-OTSUKA-2022_047008$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227210092$22721009$2$F$$20221126$20230719$20240723$PER$$US-OTSUKA-2022_046943$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227210102$22721010$2$F$$20221202$20230719$20240723$PER$$US-OTSUKA-2022_053796$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227210112$22721011$2$F$$20221101$20230719$20240723$PER$$US-OTSUKA-2022_050710$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227210133$22721013$3$F$$20220927$20230719$20240723$PER$$US-OTSUKA-2022_038525$OTSUKA$$55$YR$$F$Y$$$20240723$$MD$US$US
227210172$22721017$2$F$$20220728$20230719$20240723$PER$$US-OTSUKA-2022_038997$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227210182$22721018$2$F$$20220727$20230719$20240723$PER$$US-OTSUKA-2022_038765$OTSUKA$$50$YR$$F$Y$$$20240723$$HP$US$US
227210192$22721019$2$F$$20220804$20230719$20240723$PER$$US-OTSUKA-2022_039800$OTSUKA$$19$YR$$M$Y$90.72$KG$20240723$$HP$US$US
227210202$22721020$2$F$$20220729$20230719$20240723$PER$$US-OTSUKA-2022_039057$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227210212$22721021$2$F$$20220802$20230719$20240723$PER$$US-OTSUKA-2022_039451$OTSUKA$$35$YR$$F$Y$97.52$KG$20240723$$HP$US$US
227210222$22721022$2$F$$20220803$20230719$20240723$PER$$US-OTSUKA-2022_039681$OTSUKA$$80$YR$$M$Y$$$20240723$$HP$US$US
227210232$22721023$2$F$$20220728$20230719$20240723$PER$$US-OTSUKA-2022_038946$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227210242$22721024$2$F$$20220802$20230719$20240723$PER$$US-OTSUKA-2022_039515$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227210252$22721025$2$F$$20220727$20230719$20240723$PER$$US-OTSUKA-2022_038721$OTSUKA$$32$YR$$F$Y$65.77$KG$20240723$$HP$US$US
227210262$22721026$2$F$$20220729$20230719$20240723$PER$$US-OTSUKA-2022_039088$OTSUKA$$$$$M$Y$104.33$KG$20240723$$CN$US$US
227210272$22721027$2$F$20220616$20220802$20230719$20240723$PER$$US-OTSUKA-2022_039520$OTSUKA$$60$YR$$M$Y$$$20240723$$CN$US$US
227210282$22721028$2$F$$20220802$20230719$20240723$PER$$US-OTSUKA-2022_039504$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227210292$22721029$2$F$$20220727$20230719$20240723$PER$$US-OTSUKA-2022_038696$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227210302$22721030$2$F$$20220804$20230719$20240723$PER$$US-OTSUKA-2022_039817$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227210312$22721031$2$F$$20220728$20230719$20240723$PER$$US-OTSUKA-2022_038998$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227210322$22721032$2$F$20220101$20220727$20230719$20240723$PER$$US-OTSUKA-2022_038743$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227210332$22721033$2$F$20220101$20220802$20230719$20240723$PER$$US-OTSUKA-2022_039453$OTSUKA$$49$YR$$F$Y$$$20240723$$HP$US$US
227210342$22721034$2$F$20220310$20220802$20230719$20240723$EXP$$US-OTSUKA-2022_039452$OTSUKA$$42$YR$$F$Y$96.16$KG$20240723$$HP$US$US
227210352$22721035$2$F$$20220729$20230719$20240723$PER$$US-OTSUKA-2022_039040$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227210362$22721036$2$F$$20220907$20230719$20240723$PER$$US-OTSUKA-2022_044535$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227210372$22721037$2$F$$20220928$20230719$20240723$PER$$US-OTSUKA-2022_046898$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227210382$22721038$2$F$$20220906$20230719$20240723$PER$$US-OTSUKA-2022_041933$OTSUKA$$$$$F$Y$58.97$KG$20240723$$CN$US$US
227210392$22721039$2$F$$20221006$20230719$20240723$PER$$US-OTSUKA-2022_047872$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227210402$22721040$2$F$$20220901$20230719$20240723$PER$$US-OTSUKA-2022_043595$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
227210412$22721041$2$F$$20221024$20230719$20240723$PER$$US-OTSUKA-2022_049732$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
227210423$22721042$3$F$$20220907$20230719$20240723$PER$$US-OTSUKA-2022_044433$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227210432$22721043$2$F$20220801$20221021$20230719$20240723$PER$$US-OTSUKA-2022_049568$OTSUKA$$34$YR$$M$Y$99.79$KG$20240723$$CN$US$US
227210442$22721044$2$F$$20220908$20230719$20240723$PER$$US-OTSUKA-2022_044572$OTSUKA$$18$YR$$F$Y$$$20240723$$HP$US$US
227210452$22721045$2$F$$20220906$20230719$20240723$PER$$US-OTSUKA-2022_044345$OTSUKA$$$$$F$Y$61.23$KG$20240723$$CN$US$US
227210462$22721046$2$F$20220401$20220920$20230719$20240723$PER$$US-OTSUKA-2022_039284$OTSUKA$$43$YR$$F$Y$$$20240723$$HP$US$US
227210472$22721047$2$F$$20220922$20230719$20240723$EXP$$US-OTSUKA-2022_046309$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227210482$22721048$2$F$$20221018$20230719$20240723$PER$$US-OTSUKA-2022_049147$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
227210492$22721049$2$F$$20220823$20230719$20240723$PER$$US-OTSUKA-2022_053620$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227210503$22721050$3$F$$20220923$20230719$20240723$PER$$US-OTSUKA-2022_046461$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227210512$22721051$2$F$$20221020$20230719$20240723$PER$$US-OTSUKA-2022_049367$OTSUKA$$5$DEC$$F$Y$$$20240723$$HP$US$US
227210522$22721052$2$F$$20220924$20230719$20240723$EXP$$US-OTSUKA-2022_046501$OTSUKA$$$$$F$Y$49.9$KG$20240723$$CN$US$US
227210532$22721053$2$F$$20221003$20230719$20240723$PER$$US-OTSUKA-2022_047374$OTSUKA$$$$$M$Y$149.69$KG$20240723$$CN$US$US
227210542$22721054$2$F$$20220928$20230719$20240723$PER$$US-OTSUKA-2022_046906$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227210552$22721055$2$F$$20221020$20230719$20240723$EXP$$US-OTSUKA-2022_049358$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227210562$22721056$2$F$$20221011$20230719$20240723$PER$$US-OTSUKA-2022_048344$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227210573$22721057$3$F$$20220902$20230719$20240723$PER$$US-OTSUKA-2022_043812$OTSUKA$$30$YR$$F$Y$$$20240723$$HP$US$US
227210582$22721058$2$F$$20221020$20230719$20240723$PER$$US-OTSUKA-2022_049393$OTSUKA$$4$DEC$$F$Y$$$20240723$$MD$US$US
227210592$22721059$2$F$$20221003$20230719$20240723$PER$$US-OTSUKA-2022_047574$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227210602$22721060$2$F$$20221006$20230719$20240723$EXP$$US-OTSUKA-2022_047890$OTSUKA$$$$A$F$Y$$$20240723$$MD$US$US
227210612$22721061$2$F$20220101$20220906$20230719$20240723$PER$$US-OTSUKA-2022_044280$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227210622$22721062$2$F$$20220902$20230719$20240723$PER$$US-OTSUKA-2022_043840$OTSUKA$$$$$$Y$$$20240723$$PH$US$US
227210632$22721063$2$F$$20221012$20230719$20240723$PER$$US-OTSUKA-2022_048568$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227210642$22721064$2$F$$20220923$20230719$20240723$PER$$US-OTSUKA-2022_046464$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227210652$22721065$2$F$$20220926$20230719$20240723$PER$$US-OTSUKA-2022_046570$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227210662$22721066$2$F$$20220928$20230719$20240723$PER$$US-OTSUKA-2022_046928$OTSUKA$$52$YR$$M$Y$$$20240723$$HP$US$US
227210672$22721067$2$F$$20221010$20230719$20240723$PER$$US-OTSUKA-2022_048247$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227210682$22721068$2$F$$20221010$20230719$20240723$PER$$US-OTSUKA-2022_048252$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227210692$22721069$2$F$$20221108$20230719$20240723$PER$$US-OTSUKA-2022_051372$OTSUKA$$43$YR$$M$Y$$$20240723$$MD$US$US
227210702$22721070$2$F$$20221011$20230719$20240723$PER$$US-OTSUKA-2022_048375$OTSUKA$$4$DEC$$F$Y$$$20240723$$HP$US$US
227210712$22721071$2$F$$20221006$20230719$20240723$PER$$US-OTSUKA-2022_048004$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227210722$22721072$2$F$$20221020$20230719$20240723$PER$$US-OTSUKA-2022_049352$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227210732$22721073$2$F$20220601$20221005$20230719$20240723$PER$$US-OTSUKA-2022_047656$OTSUKA$$65$YR$$M$Y$86.18$KG$20240723$$CN$US$US
227210742$22721074$2$F$$20220923$20230719$20240723$PER$$US-OTSUKA-2022_046466$OTSUKA$$23$YR$$F$Y$$$20240723$$HP$US$US
227210752$22721075$2$F$$20220831$20230719$20240723$PER$$US-OTSUKA-2022_043432$OTSUKA$$$$$F$Y$72.57$KG$20240723$$HP$US$US
227210762$22721076$2$F$$20220928$20230719$20240723$PER$$US-OTSUKA-2022_046934$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227210772$22721077$2$F$$20220902$20230719$20240723$PER$$US-OTSUKA-2022_043711$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227210782$22721078$2$F$$20221012$20230719$20240723$PER$$US-OTSUKA-2022_048483$OTSUKA$$$$$F$Y$54.43$KG$20240723$$CN$US$US
227210792$22721079$2$F$$20220930$20230719$20240723$PER$$US-OTSUKA-2022_047233$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227210802$22721080$2$F$$20220831$20230719$20240723$PER$$US-OTSUKA-2022_043473$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
227210812$22721081$2$F$$20221107$20230719$20240723$PER$$US-OTSUKA-2022_051249$OTSUKA$$59$YR$$M$Y$$$20240723$$HP$US$US
227210822$22721082$2$F$$20221011$20230719$20240723$PER$$US-OTSUKA-2022_048478$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227210832$22721083$2$F$$20220927$20230719$20240723$PER$$US-OTSUKA-2022_046701$OTSUKA$$$$A$M$Y$$$20240723$$HP$US$US
227210842$22721084$2$F$20221001$20221021$20230719$20240723$PER$$US-OTSUKA-2022_049566$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227210852$22721085$2$F$$20221011$20230719$20240723$PER$$US-OTSUKA-2022_048413$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227210862$22721086$2$F$$20220901$20230719$20240723$PER$$US-OTSUKA-2022_043671$OTSUKA$$$$A$M$Y$$$20240723$$HP$US$US
227210872$22721087$2$F$$20220923$20230719$20240723$PER$$US-OTSUKA-2022_046440$OTSUKA$$$$$F$Y$86.18$KG$20240723$$CN$US$US
227210882$22721088$2$F$$20221006$20230719$20240723$PER$$US-OTSUKA-2022_047852$OTSUKA$$71$YR$$F$Y$$$20240723$$HP$US$US
227210892$22721089$2$F$$20221010$20230719$20240723$PER$$US-OTSUKA-2022_048139$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227210902$22721090$2$F$20221001$20221109$20230719$20240723$EXP$$US-OTSUKA-2022_051455$OTSUKA$$51$YR$$F$Y$97.07$KG$20240723$$CN$US$US
227210912$22721091$2$F$$20221006$20230719$20240723$PER$$US-OTSUKA-2022_047880$OTSUKA$$7$DEC$$F$Y$$$20240723$$HP$US$US
227210922$22721092$2$F$20220101$20220920$20230719$20240723$PER$$US-OTSUKA-2022_038768$OTSUKA$$56$YR$$M$Y$72.57$KG$20240723$$HP$US$US
227210933$22721093$3$F$$20221103$20230719$20240723$PER$$US-OTSUKA-2022_043665$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227210942$22721094$2$F$20220301$20220927$20230719$20240723$PER$$US-OTSUKA-2022_046709$OTSUKA$$29$YR$$F$Y$$$20240723$$HP$US$US
227210952$22721095$2$F$$20221006$20230719$20240723$PER$$US-OTSUKA-2022_047800$OTSUKA$$66$YR$$F$Y$54.43$KG$20240723$$HP$US$US
227210962$22721096$2$F$20221004$20221012$20230719$20240723$PER$$US-OTSUKA-2022_048544$OTSUKA$$44$YR$$F$Y$83.01$KG$20240723$$CN$US$US
227210972$22721097$2$F$$20221017$20230719$20240723$PER$$US-OTSUKA-2022_049000$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227210982$22721098$2$F$$20221007$20230719$20240723$PER$$US-OTSUKA-2022_047938$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227210992$22721099$2$F$$20221019$20230719$20240723$PER$$US-OTSUKA-2022_049220$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211012$22721101$2$F$20180501$20220930$20230719$20240723$PER$$US-OTSUKA-2022_047175$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227211032$22721103$2$F$$20221110$20230719$20240723$PER$$US-OTSUKA-2022_051647$OTSUKA$$5$DEC$$F$Y$$$20240723$$HP$US$US
227211042$22721104$2$F$$20221110$20230719$20240723$PER$$US-OTSUKA-2022_051644$OTSUKA$$7$DEC$$F$Y$$$20240723$$HP$US$US
227211052$22721105$2$F$$20221110$20230719$20240723$PER$$US-OTSUKA-2022_051629$OTSUKA$$59$YR$$F$Y$$$20240723$$HP$US$US
227211062$22721106$2$F$$20221110$20230719$20240723$EXP$$US-OTSUKA-2022_051578$OTSUKA$$34$YR$$F$Y$$$20240723$$HP$US$US
227211073$22721107$3$F$$20221110$20230719$20240723$PER$$US-OTSUKA-2022_051634$OTSUKA$$47$YR$$F$Y$$$20240723$$HP$US$US
227211082$22721108$2$F$$20221109$20230719$20240723$PER$$US-OTSUKA-2022_051483$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211092$22721109$2$F$$20221110$20230719$20240723$PER$$US-OTSUKA-2022_051638$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227211102$22721110$2$F$$20220823$20230719$20240723$PER$$US-OTSUKA-2022_042115$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211112$22721111$2$F$$20220912$20230719$20240723$EXP$$US-OTSUKA-2022_044902$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211122$22721112$2$F$20220809$20220809$20230719$20240723$PER$$US-OTSUKA-2022_040397$OTSUKA$$71$YR$$F$Y$54.88$KG$20240723$$CN$US$US
227211133$22721113$3$F$$20220915$20230719$20240723$PER$$US-OTSUKA-2022_045509$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227211142$22721114$2$F$20221109$20221110$20230719$20240723$PER$$US-OTSUKA-2022_051674$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211152$22721115$2$F$$20220915$20230719$20240723$PER$$US-OTSUKA-2022_045462$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211162$22721116$2$F$$20220919$20230719$20240723$PER$$US-OTSUKA-2022_045756$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227211172$22721117$2$F$$20220817$20230719$20240723$PER$$US-OTSUKA-2022_041457$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227211182$22721118$2$F$$20220913$20230719$20240723$EXP$$US-OTSUKA-2022_045073$OTSUKA$$4$DEC$$F$Y$$$20240723$$MD$US$US
227211193$22721119$3$F$$20220823$20230719$20240723$EXP$$US-OTSUKA-2022_042232$OTSUKA$$78$YR$$F$Y$$$20240723$$HP$US$US
227211202$22721120$2$F$$20220818$20230719$20240723$EXP$$US-OTSUKA-2022_041679$OTSUKA$$72$YR$$M$Y$$$20240723$$HP$US$US
227211212$22721121$2$F$$20220824$20230719$20240723$PER$$US-OTSUKA-2022_053619$OTSUKA$$32$YR$$F$Y$$$20240723$$HP$US$US
227211222$22721122$2$F$$20220920$20230719$20240723$PER$$US-OTSUKA-2022_045965$OTSUKA$$52$YR$$M$Y$$$20240723$$HP$US$US
227211232$22721123$2$F$20220603$20220914$20230719$20240723$EXP$$US-OTSUKA-2022_045298$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211242$22721124$2$F$20220915$20220915$20230719$20240723$PER$$US-OTSUKA-2022_045592$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227211252$22721125$2$F$$20220805$20230719$20240723$PER$$US-OTSUKA-2022_039992$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211262$22721126$2$F$$20220822$20230719$20240723$PER$$US-OTSUKA-2022_042008$OTSUKA$$$$$M$Y$127.01$KG$20240723$$CN$US$US
227211273$22721127$3$F$$20220824$20230719$20240723$PER$$US-OTSUKA-2022_042416$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211282$22721128$2$F$$20220818$20230719$20240723$PER$$US-OTSUKA-2022_041690$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
227211292$22721129$2$F$$20220920$20230719$20240723$PER$$US-OTSUKA-2022_045934$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
227211302$22721130$2$F$$20220919$20230719$20240723$PER$$US-OTSUKA-2022_045803$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211312$22721131$2$F$$20220921$20230719$20240723$EXP$$US-OTSUKA-2022_046077$OTSUKA$$7$DEC$$M$Y$$$20240723$$HP$US$US
227211323$22721132$3$F$20220501$20220921$20230719$20240723$PER$$US-OTSUKA-2022_046108$OTSUKA$$58$YR$$F$Y$90.72$KG$20240723$$CN$US$US
227211332$22721133$2$F$20220101$20220826$20230719$20240723$PER$$US-OTSUKA-2022_041472$OTSUKA$$$$$F$Y$65.77$KG$20240723$$CN$US$US
227211342$22721134$2$F$$20220819$20230719$20240723$PER$$US-OTSUKA-2022_053617$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
227211352$22721135$2$F$$20220919$20230719$20240723$EXP$$US-OTSUKA-2022_045804$OTSUKA$$40$YR$$F$Y$$$20240723$$HP$US$US
227211362$22721136$2$F$$20220816$20230719$20240723$EXP$$US-OTSUKA-2022_041289$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211372$22721137$2$F$$20220812$20230719$20240723$PER$$US-OTSUKA-2022_040921$OTSUKA$$52$YR$$F$Y$$$20240723$$HP$US$US
227211382$22721138$2$F$$20220918$20230719$20240723$PER$$US-OTSUKA-2022_045680$OTSUKA$$4$DEC$$M$Y$$$20240723$$HP$US$US
227211392$22721139$2$F$$20220818$20230719$20240723$PER$$US-OTSUKA-2022_042446$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
227211402$22721140$2$F$$20220909$20230719$20240723$PER$$US-OTSUKA-2022_044807$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211412$22721141$2$F$$20220811$20230719$20240723$PER$$US-OTSUKA-2022_040695$OTSUKA$$$$$M$Y$104.33$KG$20240723$$CN$US$US
227211422$22721142$2$F$$20220822$20230719$20240723$EXP$$US-OTSUKA-2022_041964$OTSUKA$$37$YR$$M$Y$$$20240723$$HP$US$US
227211432$22721143$2$F$$20220823$20230719$20240723$PER$$US-OTSUKA-2022_042234$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211442$22721144$2$F$$20220817$20230719$20240723$PER$$US-OTSUKA-2022_041576$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227211452$22721145$2$F$$20220811$20230719$20240723$PER$$US-OTSUKA-2022_040775$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227211462$22721146$2$F$$20220825$20230719$20240723$PER$$US-OTSUKA-2022_042489$OTSUKA$$35$YR$$F$Y$$$20240723$$HP$US$US
227211472$22721147$2$F$$20220919$20230719$20240723$PER$$US-OTSUKA-2022_045731$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211482$22721148$2$F$$20220819$20230719$20240723$PER$$US-OTSUKA-2022_041774$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211492$22721149$2$F$$20220824$20230719$20240723$PER$$US-OTSUKA-2022_042377$OTSUKA$$6$DEC$$F$Y$$$20240723$$MD$US$US
227211502$22721150$2$F$$20220915$20230719$20240723$PER$$US-OTSUKA-2022_045455$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227211512$22721151$2$F$$20220819$20230719$20240723$EXP$$US-OTSUKA-2022_041803$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211522$22721152$2$F$$20220919$20230719$20240723$PER$$US-OTSUKA-2022_045742$OTSUKA$$$$$M$Y$74.84$KG$20240723$$CN$US$US
227211533$22721153$3$F$$20220805$20230719$20240723$PER$$US-OTSUKA-2022_039933$OTSUKA$$$$$F$Y$90.72$KG$20240723$$CN$US$US
227211542$22721154$2$F$$20220908$20230719$20240723$PER$$US-OTSUKA-2022_044574$OTSUKA$$$$$F$Y$88.9$KG$20240723$$HP$US$US
227211553$22721155$3$F$$20220915$20230719$20240723$PER$$US-OTSUKA-2022_045424$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211562$22721156$2$F$$20220804$20230719$20240723$PER$$US-OTSUKA-2022_053585$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227211572$22721157$2$F$$20220816$20230719$20240723$PER$$US-OTSUKA-2022_041362$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227211582$22721158$2$F$$20220824$20230719$20240723$EXP$$US-OTSUKA-2022_042445$OTSUKA$$3$DEC$$F$Y$$$20240723$$HP$US$US
227211593$22721159$3$F$$20221003$20230719$20240723$PER$$US-OTSUKA-2022_045718$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211602$22721160$2$F$$20220822$20230719$20240723$EXP$$US-OTSUKA-2022_041971$OTSUKA$$50$YR$$M$Y$$$20240723$$HP$US$US
227211612$22721161$2$F$$20220915$20230719$20240723$EXP$$US-OTSUKA-2022_045514$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227211622$22721162$2$F$20220101$20220808$20230719$20240723$PER$$US-OTSUKA-2022_040168$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211632$22721163$2$F$$20220920$20230719$20240723$PER$$US-OTSUKA-2022_045964$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211662$22721166$2$F$20220101$20220812$20230719$20240723$PER$$US-OTSUKA-2022_040929$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211672$22721167$2$F$$20221026$20230719$20240723$PER$$US-OTSUKA-2022_050059$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227211682$22721168$2$F$$20221207$20230719$20240723$PER$$US-OTSUKA-2022_054421$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227211692$22721169$2$F$$20221207$20230719$20240723$EXP$$US-OTSUKA-2022_054365$OTSUKA$$3$DEC$$M$Y$$$20240723$$HP$US$US
227211702$22721170$2$F$$20221115$20230719$20240723$EXP$$US-OTSUKA-2022_052111$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227211712$22721171$2$F$$20221027$20230719$20240723$EXP$$US-OTSUKA-2022_050248$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211722$22721172$2$F$$20221117$20230719$20240723$PER$$US-OTSUKA-2022_052354$OTSUKA$$$$$M$Y$86.18$KG$20240723$$HP$US$US
227211732$22721173$2$F$$20221201$20230719$20240723$PER$$US-OTSUKA-2022_053753$OTSUKA$$38$YR$$M$Y$18.14$KG$20240723$$HP$US$US
227211742$22721174$2$F$$20221115$20230719$20240723$PER$$US-OTSUKA-2022_052185$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211752$22721175$2$F$$20221214$20230719$20240723$PER$$US-OTSUKA-2022_054973$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227211763$22721176$3$F$$20221014$20230719$20240723$PER$$US-OTSUKA-2022_040945$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211772$22721177$2$F$20221104$20221115$20230719$20240723$PER$$US-OTSUKA-2022_052100$OTSUKA$$51$YR$$F$Y$77.11$KG$20240723$$CN$US$US
227211782$22721178$2$F$$20221212$20230719$20240723$PER$$US-OTSUKA-2022_054896$OTSUKA$$34$YR$$F$Y$$$20240723$$HP$US$US
227211792$22721179$2$F$$20221220$20230719$20240723$PER$$US-OTSUKA-2022_049519$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227211802$22721180$2$F$$20221208$20230719$20240723$PER$$US-OTSUKA-2022_054487$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211812$22721181$2$F$$20221101$20230719$20240723$PER$$US-OTSUKA-2022_050677$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211822$22721182$2$F$$20221115$20230719$20240723$PER$$US-OTSUKA-2022_052182$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211832$22721183$2$F$$20221115$20230719$20240723$PER$$US-OTSUKA-2022_052137$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211842$22721184$2$F$$20221115$20230719$20240723$PER$$US-OTSUKA-2022_052119$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211852$22721185$2$F$$20221027$20230719$20240723$EXP$$US-OTSUKA-2022_050247$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227211863$22721186$3$F$$20221114$20230719$20240723$PER$$US-OTSUKA-2022_051946$OTSUKA$$14$YR$$F$Y$55.79$KG$20240723$$MD$US$US
227211872$22721187$2$F$$20221026$20230719$20240723$PER$$US-OTSUKA-2022_050026$OTSUKA$$$$$M$Y$88.45$KG$20240723$$CN$US$US
227211882$22721188$2$F$20221001$20221220$20230719$20240723$PER$$US-OTSUKA-2022_049613$OTSUKA$$68$YR$$F$Y$$$20240723$$CN$US$US
227211892$22721189$2$F$20221101$20221117$20230719$20240723$PER$$US-OTSUKA-2022_052390$OTSUKA$$42$YR$$M$Y$122.02$KG$20240723$$HP$US$US
227211902$22721190$2$F$$20221024$20230719$20240723$PER$$US-OTSUKA-2022_049713$OTSUKA$$$$$M$Y$72.57$KG$20240723$$CN$US$US
227211912$22721191$2$F$$20221121$20230719$20240723$PER$$US-OTSUKA-2022_052711$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227211922$22721192$2$F$$20221213$20230719$20240723$PER$$US-OTSUKA-2022_054960$OTSUKA$$4$DEC$$M$Y$$$20240723$$HP$US$US
227211932$22721193$2$F$$20221019$20230719$20240723$PER$$US-OTSUKA-2022_049661$OTSUKA$$44$YR$$M$Y$$$20240723$$MD$US$US
227211942$22721194$2$F$$20221122$20230719$20240723$PER$$US-OTSUKA-2022_052843$OTSUKA$$$$$F$Y$63.5$KG$20240723$$CN$US$US
227211952$22721195$2$F$$20221111$20230719$20240723$PER$$US-OTSUKA-2022_051759$OTSUKA$$$$$F$Y$49.9$KG$20240723$$CN$US$US
227211962$22721196$2$F$$20221110$20230719$20240723$PER$$US-OTSUKA-2022_049993$OTSUKA$$3$DEC$$F$Y$$$20240723$$HP$US$US
227211972$22721197$2$F$20220101$20221214$20230719$20240723$PER$$US-OTSUKA-2022_055027$OTSUKA$$$$A$F$Y$$$20240723$$MD$US$US
227211982$22721198$2$F$$20221128$20230719$20240723$PER$$US-OTSUKA-2022_052954$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227211993$22721199$3$F$$20221129$20230719$20240723$PER$$US-OTSUKA-2022_053459$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227212002$22721200$2$F$$20221026$20230719$20240723$PER$$US-OTSUKA-2022_049994$OTSUKA$$67$YR$$F$Y$$$20240723$$HP$US$US
227212012$22721201$2$F$$20221209$20230719$20240723$PER$$US-OTSUKA-2022_054614$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212022$22721202$2$F$20220913$20221119$20230719$20240723$EXP$$US-OTSUKA-2022_045737$OTSUKA$$58$YR$$F$Y$96.15$KG$20240723$$HP$US$US
227212032$22721203$2$F$$20221121$20230719$20240723$PER$$US-OTSUKA-2022_052687$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227212042$22721204$2$F$$20221024$20230719$20240723$PER$$US-OTSUKA-2022_049766$OTSUKA$$$$$F$Y$81.65$KG$20240723$$CN$US$US
227212052$22721205$2$F$$20221114$20230719$20240723$EXP$$US-OTSUKA-2022_051927$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212062$22721206$2$F$$20221121$20230719$20240723$PER$$US-OTSUKA-2022_052695$OTSUKA$$30$YR$$F$Y$$$20240723$$HP$US$US
227212072$22721207$2$F$20221117$20221121$20230719$20240723$PER$$US-OTSUKA-2022_052676$OTSUKA$$35$YR$$M$Y$$$20240723$$HP$US$US
227212082$22721208$2$F$$20221115$20230719$20240723$PER$$US-OTSUKA-2022_052123$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227212092$22721209$2$F$$20221025$20230719$20240723$PER$$US-OTSUKA-2022_049937$OTSUKA$$$$A$M$Y$$$20240723$$HP$US$US
227212102$22721210$2$F$$20221130$20230719$20240723$EXP$$US-OTSUKA-2022_051487$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227212112$22721211$2$F$$20221209$20230719$20240723$PER$$US-OTSUKA-2022_054582$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227212122$22721212$2$F$$20221208$20230719$20240723$PER$$US-OTSUKA-2022_054496$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227212132$22721213$2$F$$20221114$20230719$20240723$PER$$US-OTSUKA-2022_051892$OTSUKA$$$$$M$Y$81.65$KG$20240723$$HP$US$US
227212142$22721214$2$F$$20221110$20230719$20240723$PER$$US-OTSUKA-2022_051630$OTSUKA$$34$YR$$F$Y$$$20240723$$MD$US$US
227212152$22721215$2$F$$20221216$20230719$20240723$PER$$US-OTSUKA-2022_055280$OTSUKA$$32$YR$$M$Y$$$20240723$$HP$US$US
227212162$22721216$2$F$$20221115$20230719$20240723$PER$$US-OTSUKA-2022_052127$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227212172$22721217$2$F$$20221122$20230719$20240723$PER$$US-OTSUKA-2022_052851$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227212182$22721218$2$F$20221010$20221216$20230719$20240723$PER$$US-OTSUKA-2022_055297$OTSUKA$$46$YR$$F$Y$86.82$KG$20240723$$HP$US$US
227212192$22721219$2$F$$20221122$20230719$20240723$PER$$US-OTSUKA-2022_052846$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212202$22721220$2$F$$20221025$20230719$20240723$PER$$US-OTSUKA-2022_049878$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
227212212$22721221$2$F$$20221114$20230719$20240723$PER$$US-OTSUKA-2022_052026$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212222$22721222$2$F$20220101$20221212$20230719$20240723$PER$$US-OTSUKA-2022_051868$OTSUKA$$$$$M$Y$106.59$KG$20240723$$CN$US$US
227212232$22721223$2$F$$20221024$20230719$20240723$PER$$US-OTSUKA-2022_049724$OTSUKA$$50$YR$$F$Y$$$20240723$$MD$US$US
227212242$22721224$2$F$$20221118$20230719$20240723$EXP$$US-OTSUKA-2022_052504$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227212252$22721225$2$F$$20221021$20230719$20240723$PER$$US-OTSUKA-2022_049614$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227212262$22721226$2$F$$20221214$20230719$20240723$PER$$US-OTSUKA-2022_055071$OTSUKA$$76$YR$$F$Y$$$20240723$$HP$US$US
227212272$22721227$2$F$$20221114$20230719$20240723$PER$$US-OTSUKA-2022_051925$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227212282$22721228$2$F$20221001$20221026$20230719$20240723$EXP$$US-OTSUKA-2022_050044$OTSUKA$$34$YR$$M$Y$$$20240723$$HP$US$US
227212292$22721229$2$F$$20221129$20230719$20240723$PER$$US-OTSUKA-2022_053455$OTSUKA$$$$$F$Y$106.59$KG$20240723$$CN$US$US
227212302$22721230$2$F$$20221212$20230719$20240723$PER$$US-OTSUKA-2022_054786$OTSUKA$$$$$F$Y$81.65$KG$20240723$$CN$US$US
227212312$22721231$2$F$20221101$20221130$20230719$20240723$EXP$$US-OTSUKA-2022_053560$OTSUKA$$60$YR$$F$Y$$$20240723$$HP$US$US
227212322$22721232$2$F$$20221219$20230719$20240723$EXP$$US-OTSUKA-2022_055529$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227212332$22721233$2$F$$20221110$20230719$20240723$PER$$US-OTSUKA-2022_051625$OTSUKA$$45$YR$$F$Y$$$20240723$$MD$US$US
227212343$22721234$3$F$20221101$20221212$20230719$20240723$PER$$US-OTSUKA-2022_054707$OTSUKA$$63$YR$$F$Y$$$20240723$$CN$US$US
227212352$22721235$2$F$$20221121$20230719$20240723$PER$$US-OTSUKA-2022_052801$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227212362$22721236$2$F$20220701$20221108$20230719$20240723$PER$$US-OTSUKA-2022_044826$OTSUKA$$64$YR$$F$Y$99.79$KG$20240723$$CN$US$US
227212372$22721237$2$F$$20221101$20230719$20240723$PER$$US-OTSUKA-2022_050673$OTSUKA$$$$A$M$Y$$$20240723$$HP$US$US
227212382$22721238$2$F$20221101$20221118$20230719$20240723$PER$$US-OTSUKA-2022_052547$OTSUKA$$52$YR$$F$Y$74.84$KG$20240723$$CN$US$US
227212392$22721239$2$F$$20221220$20230719$20240723$PER$$US-OTSUKA-2022_055606$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227212402$22721240$2$F$$20230120$20230719$20240723$PER$$US-OTSUKA-2023_001933$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227212412$22721241$2$F$$20230109$20230719$20240723$EXP$$US-OTSUKA-2023_000711$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227212422$22721242$2$F$$20230126$20230719$20240723$PER$$US-OTSUKA-2023_002524$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227212432$22721243$2$F$$20230118$20230719$20240723$PER$$US-OTSUKA-2023_001586$OTSUKA$$$$$F$Y$60.33$KG$20240723$$CN$US$US
227212442$22721244$2$F$$20230117$20230719$20240723$PER$$US-OTSUKA-2023_001491$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227212452$22721245$2$F$$20230125$20230719$20240723$EXP$$US-OTSUKA-2023_002345$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227212462$22721246$2$F$$20230111$20230719$20240723$PER$$US-OTSUKA-2023_000959$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212472$22721247$2$F$$20230104$20230719$20240723$PER$$US-OTSUKA-2023_000256$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227212482$22721248$2$F$20221231$20221231$20230719$20240723$PER$$US-OTSUKA-2023_000023$OTSUKA$$35$YR$$M$Y$$$20240723$$CN$US$US
227212492$22721249$2$F$$20230120$20230719$20240723$PER$$US-OTSUKA-2023_001918$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212502$22721250$2$F$$20221220$20230719$20240723$PER$$ES-OTSUKA-2022_055648$OTSUKA$$$$$M$Y$$$20240723$$MD$ES$US
227212512$22721251$2$F$$20230118$20230719$20240723$PER$$US-OTSUKA-2023_001606$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212522$22721252$2$F$$20230104$20230719$20240723$PER$$US-OTSUKA-2023_000304$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227212532$22721253$2$F$$20221223$20230719$20240723$PER$$US-OTSUKA-2022_050154$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227212543$22721254$3$F$$20230123$20230719$20240723$PER$$US-OTSUKA-2023_002076$OTSUKA$$$$$F$Y$74.84$KG$20240723$$CN$US$US
227212552$22721255$2$F$$20230112$20230719$20240723$PER$$US-OTSUKA-2023_001098$OTSUKA$$$$$F$Y$$$20240723$$PH$US$US
227212562$22721256$2$F$$20230125$20230719$20240723$PER$$US-OTSUKA-2023_002341$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212572$22721257$2$F$$20230119$20230719$20240723$PER$$US-OTSUKA-2023_001691$OTSUKA$$$$$F$Y$53.07$KG$20240723$$CN$US$US
227212582$22721258$2$F$$20230123$20230719$20240723$PER$$US-OTSUKA-2023_002141$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227212592$22721259$2$F$$20230126$20230719$20240723$PER$$US-OTSUKA-2023_002455$OTSUKA$$5$DEC$$M$Y$$$20240723$$MD$US$US
227212602$22721260$2$F$$20230110$20230719$20240723$PER$$US-OTSUKA-2023_000878$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227212612$22721261$2$F$$20230119$20230719$20240723$PER$$US-OTSUKA-2023_001849$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227212622$22721262$2$F$$20230111$20230719$20240723$PER$$US-OTSUKA-2023_000956$OTSUKA$$$$$$Y$108.86$KG$20240723$$MD$US$US
227212632$22721263$2$F$$20230125$20230719$20240723$PER$$US-OTSUKA-2023_002332$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227212642$22721264$2$F$$20230123$20230719$20240723$PER$$US-OTSUKA-2023_002071$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212652$22721265$2$F$$20230125$20230719$20240723$PER$$US-OTSUKA-2023_002347$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227212662$22721266$2$F$$20230110$20230719$20240723$PER$$US-OTSUKA-2023_000824$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212672$22721267$2$F$20221230$20230110$20230719$20240723$PER$$US-OTSUKA-2023_000861$OTSUKA$$53$YR$$F$Y$42.64$KG$20240723$$CN$US$US
227212682$22721268$2$F$$20230104$20230719$20240723$PER$$US-OTSUKA-2023_000258$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227212692$22721269$2$F$$20230125$20230719$20240723$PER$$US-OTSUKA-2023_002328$OTSUKA$$46$YR$$F$Y$$$20240723$$HP$US$US
227212702$22721270$2$F$$20230104$20230719$20240723$EXP$$US-OTSUKA-2023_000484$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227212712$22721271$2$F$20221020$20221220$20230719$20240723$EXP$$US-OTSUKA-2022_049377$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227212722$22721272$2$F$$20230110$20230719$20240723$EXP$$US-OTSUKA-2023_000823$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212732$22721273$2$F$$20230119$20230719$20240723$EXP$$US-OTSUKA-2023_001755$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227212742$22721274$2$F$$20230120$20230719$20240723$PER$$US-OTSUKA-2023_001928$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227212752$22721275$2$F$$20221228$20230719$20240723$PER$$US-OTSUKA-2022_056348$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227212763$22721276$3$F$$20230105$20230719$20240723$PER$$US-OTSUKA-2022_049570$OTSUKA$$$$$F$Y$101.15$KG$20240723$$MD$US$US
227212772$22721277$2$F$20220101$20230124$20230719$20240723$PER$$US-OTSUKA-2023_002349$OTSUKA$$55$YR$$F$Y$104.33$KG$20240723$$CN$US$US
227212782$22721278$2$F$$20230119$20230719$20240723$EXP$$US-OTSUKA-2023_001690$OTSUKA$$69$YR$$F$Y$$$20240723$$MD$US$US
227212792$22721279$2$F$$20230119$20230719$20240723$PER$$US-OTSUKA-2023_001788$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212802$22721280$2$F$$20230118$20230719$20240723$PER$$US-OTSUKA-2023_001593$OTSUKA$$30$YR$$F$Y$$$20240723$$HP$US$US
227212812$22721281$2$F$$20230111$20230719$20240723$PER$$US-OTSUKA-2023_000957$OTSUKA$$35$YR$$F$Y$$$20240723$$HP$US$US
227212822$22721282$2$F$$20230103$20230719$20240723$PER$$US-OTSUKA-2023_000194$OTSUKA$$$$$F$Y$81.65$KG$20240723$$HP$US$US
227212832$22721283$2$F$$20230126$20230719$20240723$PER$$US-OTSUKA-2023_002711$OTSUKA$$20$YR$$F$Y$$$20240723$$MD$US$US
227212842$22721284$2$F$$20230125$20230719$20240723$PER$$US-OTSUKA-2023_002327$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227212852$22721285$2$F$$20230123$20230719$20240723$PER$$US-OTSUKA-2023_002052$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212862$22721286$2$F$$20221229$20230719$20240723$PER$$US-OTSUKA-2022_056438$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227212872$22721287$2$F$$20230119$20230719$20240723$PER$$US-OTSUKA-2023_001808$OTSUKA$$41$YR$$M$Y$$$20240723$$MD$US$US
227212882$22721288$2$F$$20230110$20230719$20240723$PER$$US-OTSUKA-2023_000829$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
227212892$22721289$2$F$$20230109$20230719$20240723$PER$$US-OTSUKA-2023_000656$OTSUKA$$$$T$$Y$$$20240723$$MD$US$US
227212902$22721290$2$F$$20230126$20230719$20240723$PER$$US-OTSUKA-2023_002483$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227213052$22721305$2$F$20221101$20221222$20230719$20240723$PER$$US-OTSUKA-2022_055941$OTSUKA$$61$YR$$F$Y$$$20240723$$CN$US$US
227213082$22721308$2$F$$20230321$20230719$20240723$PER$$US-OTSUKA-2023_007534$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227213092$22721309$2$F$$20230327$20230719$20240723$PER$$US-OTSUKA-2023_007991$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227213112$22721311$2$F$20230127$20230127$20230719$20240723$PER$$US-OTSUKA-2023_002595$OTSUKA$$54$YR$$F$Y$95.25$KG$20240723$$CN$US$US
227213122$22721312$2$F$$20230207$20230719$20240723$EXP$$US-OTSUKA-2023_003748$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227213132$22721313$2$F$20221222$20230202$20230719$20240723$PER$$US-OTSUKA-2023_000559$OTSUKA$$75$YR$$F$Y$92.1$KG$20240723$$HP$US$US
227213142$22721314$2$F$$20230509$20230719$20240723$PER$$US-OTSUKA-2023_012186$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213153$22721315$3$F$$20230208$20230719$20240723$PER$$US-OTSUKA-2022_054467$OTSUKA$$$$A$F$Y$$$20240723$$CN$US$US
227213162$22721316$2$F$$20230509$20230719$20240723$PER$$US-OTSUKA-2023_012384$OTSUKA$$$$A$F$Y$$$20240723$$MD$US$US
227213172$22721317$2$F$$20230509$20230719$20240723$EXP$$US-OTSUKA-2023_012172$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213183$22721318$3$F$20230112$20230317$20230719$20240723$PER$$US-OTSUKA-2023_001123$OTSUKA$$65$YR$$F$Y$$$20240723$$MD$US$US
227213192$22721319$2$F$$20230320$20230719$20240723$PER$$US-OTSUKA-2023_007371$OTSUKA$$$$$M$Y$99.79$KG$20240723$$CN$US$US
227213202$22721320$2$F$$20230307$20230719$20240723$PER$$US-OTSUKA-2023_000555$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227213212$22721321$2$F$$20230208$20230719$20240723$PER$$US-OTSUKA-2023_003726$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227213222$22721322$2$F$$20230212$20230719$20240723$PER$$US-OTSUKA-2022_055304$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227213232$22721323$2$F$$20230322$20230719$20240723$PER$$US-OTSUKA-2023_007667$OTSUKA$$$$$M$Y$88.45$KG$20240723$$CN$US$US
227213242$22721324$2$F$$20230212$20230719$20240723$PER$$US-OTSUKA-2022_055091$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213252$22721325$2$F$$20230324$20230719$20240723$EXP$$US-OTSUKA-2023_007830$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213263$22721326$3$F$$20230127$20230719$20240723$PER$$US-OTSUKA-2023_002594$OTSUKA$$34$YR$$F$Y$$$20240723$$MD$US$US
227213272$22721327$2$F$$20230508$20230719$20240723$PER$$US-OTSUKA-2023_012032$OTSUKA$$$$$F$Y$$$20240723$$PH$US$US
227213282$22721328$2$F$20230322$20230322$20230719$20240723$PER$$US-OTSUKA-2023_007577$OTSUKA$$43$YR$$F$Y$99.79$KG$20240723$$CN$US$US
227213292$22721329$2$F$$20230511$20230719$20240723$PER$$US-OTSUKA-2023_012687$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227213302$22721330$2$F$$20230126$20230719$20240723$EXP$$US-OTSUKA-2023_002468$OTSUKA$$7$DEC$$M$Y$$$20240723$$MD$US$US
227213312$22721331$2$F$$20230201$20230719$20240723$PER$$US-OTSUKA-2023_003019$OTSUKA$$20$YR$$M$Y$$$20240723$$HP$US$US
227213322$22721332$2$F$$20230207$20230719$20240723$PER$$US-OTSUKA-2023_003670$OTSUKA$$$$$F$Y$88.45$KG$20240723$$CN$US$US
227213332$22721333$2$F$20210602$20230214$20230719$20240723$EXP$$US-OTSUKA-2023_003030$OTSUKA$$33$YR$$F$Y$97.96$KG$20240723$$HP$US$US
227213342$22721334$2$F$20230312$20230407$20230719$20240723$EXP$$US-OTSUKA-2023_007535$OTSUKA$$80$YR$$F$Y$$$20240723$$HP$US$US
227213352$22721335$2$F$$20230201$20230719$20240723$PER$$US-OTSUKA-2023_003028$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213362$22721336$2$F$$20230403$20230719$20240723$PER$$US-OTSUKA-2023_003192$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227213372$22721337$2$F$20210602$20230214$20230719$20240723$PER$$US-OTSUKA-2023_003024$OTSUKA$$33$YR$$F$Y$97.96$KG$20240723$$HP$US$US
227213382$22721338$2$F$$20230512$20230719$20240723$PER$$US-OTSUKA-2023_000040$OTSUKA$$$$$$Y$$$20240723$$PH$US$US
227213392$22721339$2$F$20230122$20230207$20230719$20240723$PER$$US-OTSUKA-2023_002050$OTSUKA$$58$YR$$F$Y$78.02$KG$20240723$$CN$US$US
227213402$22721340$2$F$$20230323$20230719$20240723$PER$$US-OTSUKA-2023_007712$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213412$22721341$2$F$$20230323$20230719$20240723$PER$$US-OTSUKA-2023_007842$OTSUKA$$$$A$M$Y$$$20240723$$CN$US$US
227213422$22721342$2$F$20200823$20230403$20230719$20240723$PER$$US-OTSUKA-2023_006970$OTSUKA$$47$YR$$M$Y$$$20240723$$HP$US$US
227213432$22721343$2$F$$20230323$20230719$20240723$PER$$US-OTSUKA-2023_007851$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227213442$22721344$2$F$$20230322$20230719$20240723$PER$$US-OTSUKA-2023_007595$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213452$22721345$2$F$$20230322$20230719$20240723$PER$$US-OTSUKA-2023_007603$OTSUKA$$3$DEC$$M$Y$$$20240723$$MD$US$US
227213462$22721346$2$F$20220601$20230127$20230719$20240723$PER$$US-OTSUKA-2023_002598$OTSUKA$$76$YR$$M$Y$$$20240723$$HP$US$US
227213473$22721347$3$F$$20230327$20230719$20240723$PER$$US-OTSUKA-2023_007995$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227213482$22721348$2$F$$20230329$20230719$20240723$PER$$US-OTSUKA-2023_002419$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213492$22721349$2$F$20220519$20230207$20230719$20240723$PER$$US-OTSUKA-2023_003635$OTSUKA$$20$YR$$F$Y$$$20240723$$HP$US$US
227213502$22721350$2$F$$20230315$20230719$20240723$PER$$US-OTSUKA-2023_007104$OTSUKA$$38$YR$$M$Y$$$20240723$$HP$US$US
227213512$22721351$2$F$$20230509$20230719$20240723$PER$$US-OTSUKA-2023_012165$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213522$22721352$2$F$$20230208$20230719$20240723$PER$$US-OTSUKA-2023_003711$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213532$22721353$2$F$$20230207$20230719$20240723$PER$$US-OTSUKA-2023_003627$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227213542$22721354$2$F$$20230509$20230719$20240723$PER$$US-OTSUKA-2023_012236$OTSUKA$$18$YR$$M$Y$$$20240723$$MD$US$US
227213552$22721355$2$F$$20230321$20230719$20240723$PER$$US-OTSUKA-2023_007526$OTSUKA$$$$$F$Y$80.29$KG$20240723$$CN$US$US
227213562$22721356$2$F$$20230508$20230719$20240723$PER$$US-OTSUKA-2023_012064$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227213572$22721357$2$F$$20230203$20230719$20240723$PER$$US-OTSUKA-2023_003278$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227213582$22721358$2$F$$20230509$20230719$20240723$EXP$$US-OTSUKA-2023_012272$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213592$22721359$2$F$20221104$20230512$20230719$20240723$PER$$US-OTSUKA-2022_051528$OTSUKA$$32$YR$$M$Y$106.59$KG$20240723$$CN$US$US
227213602$22721360$2$F$$20230207$20230719$20240723$PER$$US-OTSUKA-2023_003581$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227213612$22721361$2$F$$20230322$20230719$20240723$PER$$US-OTSUKA-2023_007663$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213622$22721362$2$F$20220927$20230131$20230719$20240723$PER$$US-OTSUKA-2023_002739$OTSUKA$$74$YR$$F$Y$$$20240723$$MD$US$US
227213632$22721363$2$F$$20230208$20230719$20240723$PER$$US-OTSUKA-2023_003849$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
227213642$22721364$2$F$$20230321$20230719$20240723$PER$$US-OTSUKA-2023_007508$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227213652$22721365$2$F$$20230321$20230719$20240723$PER$$US-OTSUKA-2023_007495$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227213662$22721366$2$F$$20230511$20230719$20240723$PER$$US-OTSUKA-2023_012434$OTSUKA$$36$YR$$F$Y$$$20240723$$HP$US$US
227213673$22721367$3$F$$20230207$20230719$20240723$PER$$US-OTSUKA-2023_003631$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213682$22721368$2$F$$20230509$20230719$20240723$PER$$US-OTSUKA-2023_012210$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227213692$22721369$2$F$$20230508$20230719$20240723$PER$$US-OTSUKA-2023_012039$OTSUKA$$$$$F$Y$58.97$KG$20240723$$CN$US$US
227213702$22721370$2$F$$20230317$20230719$20240723$PER$$US-OTSUKA-2023_007210$OTSUKA$$$$$F$Y$54.43$KG$20240723$$CN$US$US
227213712$22721371$2$F$$20230320$20230719$20240723$PER$$US-OTSUKA-2023_007370$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227213722$22721372$2$F$$20230510$20230719$20240723$PER$$US-OTSUKA-2023_012514$OTSUKA$$$$A$M$Y$$$20240723$$HP$US$US
227213732$22721373$2$F$$20230208$20230719$20240723$PER$$US-OTSUKA-2023_003833$OTSUKA$$9$DEC$$F$Y$$$20240723$$HP$US$US
227213742$22721374$2$F$$20230127$20230719$20240723$PER$$US-OTSUKA-2023_002597$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227213752$22721375$2$F$$20230207$20230719$20240723$PER$$US-OTSUKA-2023_003655$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227213762$22721376$2$F$$20230208$20230719$20240723$PER$$US-OTSUKA-2023_003728$OTSUKA$$5$DEC$$F$Y$$$20240723$$MD$US$US
227213772$22721377$2$F$20210602$20230214$20230719$20240723$PER$$US-OTSUKA-2023_002981$OTSUKA$$33$YR$$F$Y$$$20240723$$HP$US$US
227213792$22721379$2$F$$20230620$20230719$20240723$PER$$US-OTSUKA-2023_016623$OTSUKA$$70$YR$$M$Y$$$20240723$$CN$US$US
227213802$22721380$2$F$20230610$20230616$20230719$20240723$PER$$US-OTSUKA-2023_016345$OTSUKA$$45$YR$$F$Y$$$20240723$$MD$US$US
227213812$22721381$2$F$20230428$20230616$20230719$20240723$EXP$$US-OTSUKA-2023_013409$OTSUKA$$61$YR$$M$Y$106.59$KG$20240723$$CN$US$US
227213822$22721382$2$F$$20230623$20230719$20240723$PER$$US-OTSUKA-2023_016920$OTSUKA$$4$DEC$$F$Y$$$20240723$$HP$US$US
227213832$22721383$2$F$$20230614$20230719$20240723$EXP$$US-OTSUKA-2023_016103$OTSUKA$$5$DEC$$F$Y$$$20240723$$MD$US$US
227213842$22721384$2$F$$20230620$20230719$20240723$PER$$US-OTSUKA-2023_016574$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213862$22721386$2$F$20221129$20230719$20230719$20240723$EXP$$US-OTSUKA-2023_016690$OTSUKA$$63$YR$$F$Y$87.53$KG$20240723$$HP$US$US
227213872$22721387$2$F$20230401$20230531$20230719$20240723$EXP$$US-OTSUKA-2023_012360$OTSUKA$$67$YR$$F$Y$$$20240723$$MD$US$US
227213882$22721388$2$F$$20230622$20230719$20240723$PER$$US-OTSUKA-2023_016926$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227213892$22721389$2$F$$20230709$20230719$20240723$PER$$US-OTSUKA-2023_012168$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227213902$22721390$2$F$$20230620$20230719$20240723$PER$$US-OTSUKA-2023_016588$OTSUKA$$35$YR$$M$Y$$$20240723$$MD$US$US
227213912$22721391$2$F$$20230621$20230719$20240723$PER$$US-OTSUKA-2023_016646$OTSUKA$$60$YR$$M$Y$83.91$KG$20240723$$HP$US$US
227213922$22721392$2$F$$20230619$20230719$20240723$PER$$US-OTSUKA-2023_016476$OTSUKA$$$$$F$Y$125.64$KG$20240723$$CN$US$US
227213932$22721393$2$F$20230324$20230616$20230719$20240723$PER$$US-OTSUKA-2023_008010$OTSUKA$$16$YR$$M$Y$90.72$KG$20240723$$CN$US$US
227213942$22721394$2$F$20230301$20230515$20230719$20240723$EXP$$US-OTSUKA-2023_012839$OTSUKA$$46$YR$$F$Y$68.95$KG$20240723$$CN$US$US
227213952$22721395$2$F$$20230621$20230719$20240723$PER$$US-OTSUKA-2023_016672$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213962$22721396$2$F$$20230623$20230719$20240723$PER$$US-OTSUKA-2023_016924$OTSUKA$$55$YR$$M$Y$$$20240723$$HP$US$US
227213973$22721397$3$F$$20230622$20230719$20240723$PER$$US-OTSUKA-2023_016845$OTSUKA$$26$YR$$F$Y$$$20240723$$HP$US$US
227213982$22721398$2$F$$20230615$20230719$20240723$EXP$$US-OTSUKA-2023_016201$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227213992$22721399$2$F$$20230815$20230719$20240723$PER$$US-OTSUKA-2023_016159$OTSUKA$$24$YR$$M$Y$$$20240723$$HP$US$US
227214002$22721400$2$F$20210901$20230524$20230719$20240723$PER$$US-OTSUKA-2022_039482$OTSUKA$$34$YR$$M$Y$97.52$KG$20240723$$CN$US$US
227214012$22721401$2$F$$20230623$20230719$20240723$PER$$US-OTSUKA-2023_016993$OTSUKA$$9$DEC$$F$Y$$$20240723$$HP$US$US
227214022$22721402$2$F$20230504$20230712$20230719$20240723$EXP$$US-OTSUKA-2023_013501$OTSUKA$$42$YR$$F$Y$96.15$KG$20240723$$HP$US$US
227214032$22721403$2$F$$20230622$20230719$20240723$PER$$US-OTSUKA-2023_016814$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227214042$22721404$2$F$$20230630$20230719$20240723$PER$$US-OTSUKA-2022_053687$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227214062$22721406$2$F$$20230621$20230719$20240723$PER$$US-OTSUKA-2023_010406$OTSUKA$$19$YR$$F$Y$$$20240723$$HP$US$US
227214092$22721409$2$F$$20220830$20230719$20240723$EXP$$US-OTSUKA-2022_043208$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227214102$22721410$2$F$$20230329$20230719$20240723$PER$$US-OTSUKA-2023_008337$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227214112$22721411$2$F$$20230327$20230719$20240723$PER$$US-OTSUKA-2023_008062$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227214122$22721412$2$F$$20230418$20230719$20240723$PER$$US-OTSUKA-2023_010404$OTSUKA$$42$YR$$F$Y$$$20240723$$HP$US$US
227214132$22721413$2$F$20220728$20230104$20230719$20240723$EXP$$US-OTSUKA-2022_043384$OTSUKA$$58$YR$$F$Y$96.6$KG$20240723$$HP$US$US
227214142$22721414$2$F$$20230330$20230719$20240723$EXP$$US-OTSUKA-2023_008371$OTSUKA$$60$YR$$F$Y$$$20240723$$MD$US$US
227214152$22721415$2$F$$20230328$20230719$20240723$PER$$US-OTSUKA-2023_008151$OTSUKA$$$$$M$Y$136.08$KG$20240723$$CN$US$US
227214162$22721416$2$F$$20230328$20230719$20240723$PER$$US-OTSUKA-2023_008287$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227214172$22721417$2$F$$20230328$20230719$20240723$EXP$$US-OTSUKA-2023_008212$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227214182$22721418$2$F$$20230419$20230719$20240723$PER$$US-OTSUKA-2023_010316$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227214192$22721419$2$F$$20220825$20230719$20240723$EXP$$US-OTSUKA-2022_042581$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227214202$22721420$2$F$$20230402$20230719$20240723$PER$$US-OTSUKA-2023_008600$OTSUKA$$7$DEC$$F$Y$$$20240723$$HP$US$US
227214212$22721421$2$F$$20220829$20230719$20240723$PER$$US-OTSUKA-2022_042914$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227214222$22721422$2$F$$20230419$20230719$20240723$PER$$US-OTSUKA-2023_010345$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227214233$22721423$3$F$$20230420$20230719$20240723$PER$$US-OTSUKA-2023_011521$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227214242$22721424$2$F$$20230418$20230719$20240723$PER$$US-OTSUKA-2023_010276$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227214252$22721425$2$F$$20230413$20230719$20240723$PER$$US-OTSUKA-2023_009942$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227214262$22721426$2$F$$20230417$20230719$20240723$PER$$US-OTSUKA-2023_010169$OTSUKA$$5$DEC$$F$Y$$$20240723$$MD$US$US
227214272$22721427$2$F$$20230406$20230719$20240723$PER$$US-OTSUKA-2023_009081$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227214282$22721428$2$F$$20230426$20230719$20240723$PER$$US-OTSUKA-2023_011015$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227214292$22721429$2$F$20220821$20230330$20230719$20240723$PER$$US-OTSUKA-2023_008436$OTSUKA$$31$YR$$F$Y$88$KG$20240723$$CN$US$US
227214302$22721430$2$F$20220601$20220826$20230719$20240723$PER$$US-OTSUKA-2022_042726$OTSUKA$$32$YR$$F$Y$66.68$KG$20240723$$CN$US$US
227214312$22721431$2$F$$20230407$20230719$20240723$PER$$US-OTSUKA-2023_009219$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227214322$22721432$2$F$$20230425$20230719$20240723$EXP$$US-OTSUKA-2023_010937$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227214332$22721433$2$F$$20230411$20230719$20240723$PER$$US-OTSUKA-2023_009524$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227214342$22721434$2$F$20230129$20230210$20230719$20240723$PER$$US-OTSUKA-2023_003966$OTSUKA$$80$YR$$M$Y$98.43$KG$20240723$$CN$US$US
227214352$22721435$2$F$$20230405$20230719$20240723$PER$$US-OTSUKA-2023_009006$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227214362$22721436$2$F$$20230405$20230719$20240723$PER$$US-OTSUKA-2023_009026$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227214372$22721437$2$F$$20230331$20230719$20240723$PER$$US-OTSUKA-2023_008579$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227214382$22721438$2$F$$20230420$20230719$20240723$EXP$$US-OTSUKA-2023_010470$OTSUKA$$64$YR$$M$Y$$$20240723$$HP$US$US
227214392$22721439$2$F$$20230331$20230719$20240723$PER$$US-OTSUKA-2023_008575$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227214402$22721440$2$F$$20220830$20230719$20240723$PER$$US-OTSUKA-2022_043275$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227214412$22721441$2$F$$20230406$20230719$20240723$PER$$US-OTSUKA-2023_009082$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227214422$22721442$2$F$$20230329$20230719$20240723$PER$$US-OTSUKA-2023_008473$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
227214432$22721443$2$F$$20230331$20230719$20240723$PER$$US-OTSUKA-2023_008584$OTSUKA$$$$$F$Y$54.43$KG$20240723$$CN$US$US
227214442$22721444$2$F$20221001$20230330$20230719$20240723$PER$$US-OTSUKA-2023_008420$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
227214452$22721445$2$F$$20230403$20230719$20240723$PER$$US-OTSUKA-2023_008744$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227214462$22721446$2$F$$20230327$20230719$20240723$PER$$US-OTSUKA-2023_008059$OTSUKA$$$$$F$Y$79.38$KG$20240723$$CN$US$US
227214472$22721447$2$F$$20230411$20230719$20240723$PER$$US-OTSUKA-2023_009491$OTSUKA$$$$$M$Y$102.06$KG$20240723$$CN$US$US
227214483$22721448$3$F$$20230424$20230719$20240723$PER$$US-OTSUKA-2023_011897$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227214492$22721449$2$F$$20220825$20230719$20240723$PER$$US-OTSUKA-2022_042607$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227214502$22721450$2$F$$20230328$20230719$20240723$PER$$US-OTSUKA-2023_008169$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227214512$22721451$2$F$$20230414$20230719$20240723$PER$$US-OTSUKA-2023_009947$OTSUKA$$$$$F$Y$68.04$KG$20240723$$CN$US$US
227214522$22721452$2$F$$20230405$20230719$20240723$PER$$US-OTSUKA-2023_009007$OTSUKA$$$$$F$Y$$$20240723$$PH$US$US
227214532$22721453$2$F$20230411$20230419$20230719$20240723$PER$$US-OTSUKA-2023_010405$OTSUKA$$18$YR$$F$Y$$$20240723$$HP$US$US
227214542$22721454$2$F$$20220830$20230719$20240723$PER$$US-OTSUKA-2022_043279$OTSUKA$$71$YR$$M$Y$$$20240723$$HP$US$US
227214552$22721455$2$F$$20230405$20230719$20240723$PER$$US-OTSUKA-2023_009043$OTSUKA$$70$YR$$F$Y$$$20240723$$MD$US$US
227214562$22721456$2$F$$20230403$20230719$20240723$PER$$US-OTSUKA-2023_008752$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
227214572$22721457$2$F$$20230330$20230719$20240723$PER$$US-OTSUKA-2023_008377$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227214582$22721458$2$F$$20230330$20230719$20240723$PER$$US-OTSUKA-2023_008434$OTSUKA$$$$$M$Y$33.11$KG$20240723$$CN$US$US
227214593$22721459$3$F$$20220913$20230719$20240723$EXP$$US-OTSUKA-2022_042579$OTSUKA$$$$$M$Y$74.56$KG$20240723$$HP$US$US
227214602$22721460$2$F$$20230331$20230719$20240723$PER$$US-OTSUKA-2023_008563$OTSUKA$$81$YR$$F$Y$$$20240723$$MD$US$US
227214612$22721461$2$F$$20230425$20230719$20240723$PER$$US-OTSUKA-2023_010954$OTSUKA$$26$YR$$F$Y$$$20240723$$MD$US$US
227214622$22721462$2$F$$20230329$20230719$20240723$PER$$US-OTSUKA-2023_008331$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227214632$22721463$2$F$$20230420$20230719$20240723$PER$$US-OTSUKA-2023_010531$OTSUKA$$27$YR$$M$Y$$$20240723$$MD$US$US
227214642$22721464$2$F$$20220928$20230719$20240723$PER$$US-OTSUKA-2022_043271$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227214652$22721465$2$F$$20220826$20230719$20240723$PER$$US-OTSUKA-2022_042748$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227214662$22721466$2$F$$20230422$20230719$20240723$EXP$$US-OTSUKA-2023_010689$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227214672$22721467$2$F$$20230327$20230719$20240723$PER$$US-OTSUKA-2023_008056$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227214692$22721469$2$F$$20230404$20230719$20240723$PER$$US-OTSUKA-2023_008911$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227214702$22721470$2$F$$20220829$20230719$20240723$PER$$US-OTSUKA-2022_042891$OTSUKA$$7$DEC$$F$Y$$$20240723$$MD$US$US
227214712$22721471$2$F$$20230419$20230719$20240723$PER$$US-OTSUKA-2023_010314$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227214742$22721474$2$F$$20230621$20230719$20240723$PER$$US-OTSUKA-2023_016686$OTSUKA$$74$YR$$F$Y$68.04$KG$20240723$$HP$US$US
227214752$22721475$2$F$20230411$20230503$20230719$20240723$PER$$US-OTSUKA-2023_010456$OTSUKA$$21$YR$$F$Y$44.04$KG$20240723$$HP$US$US
227214762$22721476$2$F$20230529$20230531$20230719$20240723$PER$$US-OTSUKA-2023_014622$OTSUKA$$47$YR$$F$Y$$$20240723$$CN$US$US
227214772$22721477$2$F$$20230502$20230719$20240723$PER$$US-OTSUKA-2023_011600$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227214782$22721478$2$F$$20230627$20230719$20240723$EXP$$US-OTSUKA-2023_017321$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227214792$22721479$2$F$$20230614$20230719$20240723$PER$$US-OTSUKA-2023_016087$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227214802$22721480$2$F$$20230517$20230719$20240723$PER$$US-OTSUKA-2023_013130$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227214812$22721481$2$F$$20230612$20230719$20240723$PER$$US-OTSUKA-2023_015790$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227214822$22721482$2$F$$20230428$20230719$20240723$PER$$US-OTSUKA-2023_011330$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227214832$22721483$2$F$$20230501$20230719$20240723$EXP$$US-OTSUKA-2023_011519$OTSUKA$$42$YR$$F$Y$$$20240723$$MD$US$US
227214842$22721484$2$F$$20230427$20230719$20240723$PER$$US-OTSUKA-2023_011152$OTSUKA$$80$YR$$M$Y$$$20240723$$HP$US$US
227214852$22721485$2$F$20230504$20230627$20230719$20240723$PER$$US-OTSUKA-2023_011784$OTSUKA$$$$$M$Y$$$20240723$$PH$US$US
227214862$22721486$2$F$$20230427$20230719$20240723$PER$$US-OTSUKA-2023_011295$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227214872$22721487$2$F$20220101$20230626$20230719$20240723$PER$$US-OTSUKA-2023_017066$OTSUKA$$$$$F$Y$61.23$KG$20240723$$CN$US$US
227214882$22721488$2$F$$20230605$20230719$20240723$EXP$$CA-OTSUKA-2023_015095$OTSUKA$$27$YR$$F$Y$$$20240723$$HP$CA$US
227214892$22721489$2$F$$20230516$20230719$20240723$PER$$US-OTSUKA-2023_013021$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227214902$22721490$2$F$$20230426$20230719$20240723$PER$$US-OTSUKA-2023_011069$OTSUKA$$$$$F$Y$52.16$KG$20240723$$CN$US$US
227214912$22721491$2$F$$20230426$20230719$20240723$PER$$US-OTSUKA-2023_011034$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227214922$22721492$2$F$$20230519$20230719$20240723$PER$$US-OTSUKA-2023_013382$OTSUKA$$40$YR$$F$Y$$$20240723$$HP$US$US
227214932$22721493$2$F$$20230518$20230719$20240723$PER$$US-OTSUKA-2023_013294$OTSUKA$$52$YR$$F$Y$$$20240723$$MD$US$US
227214944$22721494$4$F$$20230807$20230719$20240808$PER$$US-OTSUKA-2023_014960$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
227214952$22721495$2$F$$20230505$20230719$20240723$PER$$US-OTSUKA-2023_011906$OTSUKA$$$$$F$Y$117.93$KG$20240723$$CN$US$US
227214962$22721496$2$F$$20230522$20230719$20240723$PER$$US-OTSUKA-2023_013723$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227214972$22721497$2$F$$20230523$20230719$20240723$PER$$US-OTSUKA-2023_013714$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227214982$22721498$2$F$$20230523$20230719$20240723$PER$$US-OTSUKA-2023_013815$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227214992$22721499$2$F$$20230621$20230719$20240723$PER$$US-OTSUKA-2023_016639$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227215002$22721500$2$F$$20230522$20230719$20240723$EXP$$US-OTSUKA-2023_008187$OTSUKA$$$$$F$Y$61.22$KG$20240723$$HP$US$US
227215012$22721501$2$F$$20230613$20230719$20240723$EXP$$US-OTSUKA-2023_016039$OTSUKA$$70$YR$$M$Y$$$20240723$$MD$US$US
227215022$22721502$2$F$$20230522$20230719$20240723$PER$$US-OTSUKA-2023_013724$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227215032$22721503$2$F$$20230622$20230719$20240723$PER$$US-OTSUKA-2023_016839$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227215042$22721504$2$F$$20230519$20230719$20240723$PER$$US-OTSUKA-2023_013369$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
227215052$22721505$2$F$$20230503$20230719$20240723$PER$$US-OTSUKA-2023_011687$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227215062$22721506$2$F$$20230601$20230719$20240723$PER$$US-OTSUKA-2023_014914$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227215072$22721507$2$F$$20230428$20230719$20240723$PER$$US-OTSUKA-2023_011386$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215082$22721508$2$F$$20230522$20230719$20240723$PER$$US-OTSUKA-2023_013518$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227215092$22721509$2$F$$20230516$20230719$20240723$PER$$US-OTSUKA-2023_013024$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227215112$22721511$2$F$$20230628$20230719$20240723$PER$$US-OTSUKA-2023_017366$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
227215122$22721512$2$F$$20230522$20230719$20240723$PER$$US-OTSUKA-2023_013689$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227215132$22721513$2$F$$20230516$20230719$20240723$EXP$$US-OTSUKA-2023_013023$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227215142$22721514$2$F$$20230607$20230719$20240723$PER$$US-OTSUKA-2023_015435$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227215152$22721515$2$F$$20230601$20230719$20240723$PER$$US-OTSUKA-2023_014818$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
227215162$22721516$2$F$$20230622$20230719$20240723$PER$$US-OTSUKA-2023_017181$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227215172$22721517$2$F$$20230626$20230719$20240723$EXP$$US-OTSUKA-2023_017057$OTSUKA$$3$DEC$$F$Y$$$20240723$$MD$US$US
227215182$22721518$2$F$$20230503$20230719$20240723$EXP$$US-OTSUKA-2023_011708$OTSUKA$$64$YR$$F$Y$$$20240723$$MD$US$US
227215192$22721519$2$F$$20230504$20230719$20240723$PER$$US-OTSUKA-2023_011788$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215202$22721520$2$F$$20230608$20230719$20240723$PER$$US-OTSUKA-2023_015506$OTSUKA$$34$YR$$F$Y$$$20240723$$MD$US$US
227215212$22721521$2$F$$20230503$20230719$20240723$PER$$US-OTSUKA-2023_011685$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227215222$22721522$2$F$$20230606$20230719$20240723$PER$$US-OTSUKA-2023_015306$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227215232$22721523$2$F$$20230515$20230719$20240723$PER$$US-OTSUKA-2023_012879$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
227215242$22721524$2$F$20230401$20230531$20230719$20240723$PER$$US-OTSUKA-2023_014580$OTSUKA$$54$YR$$F$Y$92$KG$20240723$$PH$US$US
227215252$22721525$2$F$$20230426$20230719$20240723$PER$$US-OTSUKA-2023_011768$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215262$22721526$2$F$$20230605$20230719$20240723$PER$$US-OTSUKA-2023_015316$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227215272$22721527$2$F$$20230504$20230719$20240723$PER$$US-OTSUKA-2023_011804$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227215282$22721528$2$F$$20230427$20230719$20240723$PER$$US-OTSUKA-2023_011288$OTSUKA$$29$YR$$F$Y$$$20240723$$MD$US$US
227215292$22721529$2$F$$20230428$20230719$20240723$EXP$$US-OTSUKA-2023_011315$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227215302$22721530$2$F$$20230427$20230719$20240723$PER$$US-OTSUKA-2023_011151$OTSUKA$$36$YR$$F$Y$$$20240723$$HP$US$US
227215312$22721531$2$F$$20230519$20230719$20240723$PER$$US-OTSUKA-2023_013408$OTSUKA$$37$YR$$M$Y$$$20240723$$HP$US$US
227215322$22721532$2$F$$20230503$20230719$20240723$PER$$US-OTSUKA-2023_011699$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215332$22721533$2$F$$20230426$20230719$20240723$PER$$US-OTSUKA-2023_011043$OTSUKA$$33$YR$$F$Y$$$20240723$$HP$US$US
227215342$22721534$2$F$$20230621$20230719$20240723$PER$$US-OTSUKA-2023_016723$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227215352$22721535$2$F$$20230515$20230719$20240723$PER$$US-OTSUKA-2023_012889$OTSUKA$$$$$M$Y$77.56$KG$20240723$$CN$US$US
227215362$22721536$2$F$$20230518$20230719$20240723$PER$$US-OTSUKA-2023_013295$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215372$22721537$2$F$20230603$20230605$20230719$20240723$PER$$US-OTSUKA-2023_015016$OTSUKA$$33$YR$$M$Y$81.65$KG$20240723$$CN$US$US
227215382$22721538$2$F$$20230503$20230719$20240723$PER$$US-OTSUKA-2023_011697$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227215392$22721539$2$F$20230301$20230426$20230719$20240723$PER$$US-OTSUKA-2023_011065$OTSUKA$$27$YR$$F$Y$$$20240723$$HP$US$US
227215402$22721540$2$F$$20230516$20230719$20240723$PER$$US-OTSUKA-2023_013012$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227215412$22721541$2$F$$20230427$20230719$20240723$PER$$US-OTSUKA-2023_011149$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227215422$22721542$2$F$$20230526$20230719$20240723$PER$$US-OTSUKA-2023_014117$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227215434$22721543$4$F$20220101$20230814$20230719$20240808$EXP$$US-OTSUKA-2023_017300$OTSUKA$$30$YR$$F$Y$126.98$KG$20240808$$HP$US$US
227215442$22721544$2$F$$20230427$20230719$20240723$PER$$US-OTSUKA-2023_011350$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227215452$22721545$2$F$$20230426$20230719$20240723$PER$$US-OTSUKA-2023_011037$OTSUKA$$22$YR$$F$Y$$$20240723$$MD$US$US
227215462$22721546$2$F$$20230522$20230719$20240723$PER$$US-OTSUKA-2023_013601$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215472$22721547$2$F$$20230505$20230719$20240723$PER$$US-OTSUKA-2023_011860$OTSUKA$$$$$F$Y$77.11$KG$20240723$$CN$US$US
227215482$22721548$2$F$$20230601$20230719$20240723$PER$$US-OTSUKA-2023_014707$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227215492$22721549$2$F$$20230601$20230719$20240723$PER$$US-OTSUKA-2023_014866$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227215502$22721550$2$F$$20230622$20230719$20240723$PER$$US-OTSUKA-2023_017182$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227215512$22721551$2$F$$20230530$20230719$20240723$PER$$US-OTSUKA-2023_014424$OTSUKA$$$$A$$Y$$$20240723$$CN$US$US
227215522$22721552$2$F$20230401$20230504$20230719$20240723$PER$$US-OTSUKA-2023_011783$OTSUKA$$64$YR$$M$Y$90.72$KG$20240723$$CN$US$US
227215532$22721553$2$F$$20230428$20230719$20240723$PER$$US-OTSUKA-2023_011332$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227215542$22721554$2$F$$20230531$20230719$20240723$PER$$US-OTSUKA-2023_014547$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215552$22721555$2$F$$20230515$20230719$20240723$PER$$US-OTSUKA-2023_012859$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227215562$22721556$2$F$20230520$20230601$20230719$20240723$PER$$US-OTSUKA-2023_014691$OTSUKA$$67$YR$$M$Y$74.84$KG$20240723$$CN$US$US
227215572$22721557$2$F$$20230524$20230719$20240723$PER$$US-OTSUKA-2023_013543$OTSUKA$$$$A$M$Y$$$20240723$$HP$US$US
227215582$22721558$2$F$$20230531$20230719$20240723$PER$$US-OTSUKA-2023_014586$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215592$22721559$2$F$$20230522$20230719$20240723$PER$$US-OTSUKA-2023_013722$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227215602$22721560$2$F$$20230522$20230719$20240723$PER$$US-OTSUKA-2023_013600$OTSUKA$$$$$M$Y$77.11$KG$20240723$$CN$US$US
227215612$22721561$2$F$20230330$20230426$20230719$20240723$EXP$$US-OTSUKA-2023_008909$OTSUKA$$33$YR$$F$Y$$$20240723$$HP$US$US
227215622$22721562$2$F$$20230612$20230719$20240723$PER$$US-OTSUKA-2023_016012$OTSUKA$$$$E$$Y$$$20240723$$HP$US$US
227215632$22721563$2$F$20230501$20230530$20230719$20240723$PER$$US-OTSUKA-2023_014386$OTSUKA$$68$YR$$F$Y$69.85$KG$20240723$$CN$US$US
227215642$22721564$2$F$$20240829$20230719$20240829$PER$$NVSC2023US157725$NOVARTIS$$$$$M$Y$90.72$KG$20240829$$HP$US$US
227215652$22721565$2$F$20160101$20230628$20230719$20240723$PER$$US-OTSUKA-2023_017332$OTSUKA$$63$YR$$F$Y$$$20240723$$HP$US$US
227215662$22721566$2$F$$20230707$20230719$20240723$PER$$US-OTSUKA-2023_018318$OTSUKA$$6$DEC$$F$Y$$$20240723$$CN$US$US
227215672$22721567$2$F$$20230629$20230719$20240723$PER$$US-OTSUKA-2023_017590$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227215682$22721568$2$F$$20230706$20230719$20240723$PER$$US-OTSUKA-2023_018185$OTSUKA$$4$DEC$$M$Y$$$20240723$$MD$US$US
227215692$22721569$2$F$20230606$20230828$20230719$20240723$PER$$US-OTSUKA-2023_015415$OTSUKA$$61$YR$$F$Y$$$20240723$$CN$US$US
227215702$22721570$2$F$$20230628$20230719$20240723$PER$$US-OTSUKA-2023_017384$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227215712$22721571$2$F$$20230702$20230719$20240723$PER$$US-OTSUKA-2023_011810$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227215732$22721573$2$F$$20230706$20230719$20240723$PER$$US-OTSUKA-2023_018183$OTSUKA$$4$DEC$$F$Y$$$20240723$$MD$US$US
227215742$22721574$2$F$$20230709$20230719$20240723$PER$$US-OTSUKA-2023_010363$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227215753$22721575$3$F$20230501$20230629$20230719$20240723$EXP$$US-OTSUKA-2023_017614$OTSUKA$$50$YR$$$Y$$$20240723$$HP$US$US
227215762$22721576$2$F$$20230630$20230719$20240723$PER$$US-OTSUKA-2023_017603$OTSUKA$$$$$F$Y$53.07$KG$20240723$$CN$US$US
227215812$22721581$2$F$$20230412$20230719$20240723$PER$$US-OTSUKA-2023_009675$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215822$22721582$2$F$$20230210$20230719$20240723$PER$$US-OTSUKA-2023_004002$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215832$22721583$2$F$$20230217$20230719$20240723$PER$$US-OTSUKA-2023_004625$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215842$22721584$2$F$20220117$20230512$20230719$20240723$PER$$US-OTSUKA-2023_004001$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227215852$22721585$2$F$$20230214$20230719$20240723$EXP$$US-OTSUKA-2023_004289$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227215862$22721586$2$F$20221101$20230216$20230719$20240723$PER$$US-OTSUKA-2023_004669$OTSUKA$$20$YR$$M$Y$$$20240723$$MD$US$US
227215872$22721587$2$F$$20230412$20230719$20240723$PER$$US-OTSUKA-2023_009658$OTSUKA$$4$DEC$$F$Y$$$20240723$$MD$US$US
227215882$22721588$2$F$20220101$20220721$20230719$20240723$EXP$$US-OTSUKA-2022_037847$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215892$22721589$2$F$$20220712$20230719$20240723$EXP$$US-OTSUKA-2022_036333$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227215902$22721590$2$F$$20230220$20230719$20240723$PER$$US-OTSUKA-2023_004844$OTSUKA$$18$YR$$F$Y$$$20240723$$HP$US$US
227215912$22721591$2$F$$20230414$20230719$20240723$PER$$US-OTSUKA-2023_009876$OTSUKA$$$$A$F$Y$$$20240723$$MD$US$US
227215922$22721592$2$F$$20230213$20230719$20240723$PER$$US-OTSUKA-2023_004082$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215932$22721593$2$F$$20230411$20230719$20240723$PER$$US-OTSUKA-2023_009538$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227215942$22721594$2$F$$20230414$20230719$20240723$PER$$US-OTSUKA-2023_009880$OTSUKA$$$$$F$Y$90.72$KG$20240723$$CN$US$US
227215952$22721595$2$F$$20230412$20230719$20240723$PER$$US-OTSUKA-2023_009703$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215962$22721596$2$F$$20230217$20230719$20240723$PER$$US-OTSUKA-2023_004598$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227215972$22721597$2$F$$20220712$20230719$20240723$PER$$US-OTSUKA-2022_036340$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227215982$22721598$2$F$$20220712$20230719$20240723$PER$$US-OTSUKA-2022_036334$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227215993$22721599$3$F$$20230215$20230719$20240723$PER$$US-OTSUKA-2023_004389$OTSUKA$$40$YR$$M$Y$$$20240723$$HP$US$US
227216002$22721600$2$F$$20230216$20230719$20240723$EXP$$US-OTSUKA-2023_004488$OTSUKA$$18$YR$$F$Y$$$20240723$$MD$US$US
227216012$22721601$2$F$20230201$20230412$20230719$20240723$EXP$$US-OTSUKA-2023_009680$OTSUKA$$31$YR$$F$Y$$$20240723$$MD$US$US
227216022$22721602$2$F$$20220712$20230719$20240723$PER$$US-OTSUKA-2022_036441$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227216032$22721603$2$F$$20230213$20230719$20240723$EXP$$US-OTSUKA-2023_004111$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227216042$22721604$2$F$$20230719$20230719$20240723$EXP$$US-OTSUKA-2023_018074$OTSUKA$$77$YR$$F$Y$$$20240723$$HP$US$US
227216052$22721605$2$F$$20230412$20230719$20240723$PER$$US-OTSUKA-2023_009656$OTSUKA$$3$DEC$$M$Y$$$20240723$$CN$US$US
227216072$22721607$2$F$$20230427$20230719$20240723$EXP$$US-OTSUKA-2023_011305$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227216082$22721608$2$F$$20230412$20230719$20240723$PER$$US-OTSUKA-2023_009607$OTSUKA$$60$YR$$F$Y$$$20240723$$HP$US$US
227216092$22721609$2$F$$20230411$20230719$20240723$EXP$$US-OTSUKA-2023_009539$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227216102$22721610$2$F$$20230213$20230719$20240723$PER$$US-OTSUKA-2023_004103$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227216112$22721611$2$F$$20220713$20230719$20240723$PER$$US-OTSUKA-2022_036899$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227216122$22721612$2$F$$20220711$20230719$20240723$PER$$US-OTSUKA-2022_036178$OTSUKA$$22$YR$$F$Y$$$20240723$$MD$US$US
227216132$22721613$2$F$$20230214$20230719$20240723$PER$$US-OTSUKA-2023_004292$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227216142$22721614$2$F$$20230214$20230719$20240723$PER$$US-OTSUKA-2023_004330$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
227216152$22721615$2$F$$20220711$20230719$20240723$PER$$US-OTSUKA-2022_036148$OTSUKA$$6$DEC$$M$Y$$$20240723$$HP$US$US
227216162$22721616$2$F$$20220712$20230719$20240723$PER$$US-OTSUKA-2022_036330$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227216172$22721617$2$F$$20230424$20230719$20240723$PER$$US-OTSUKA-2023_004487$OTSUKA$$64$YR$$F$Y$$$20240723$$CN$US$US
227216182$22721618$2$F$$20230214$20230719$20240723$PER$$US-OTSUKA-2023_004315$OTSUKA$$25$YR$$F$Y$$$20240723$$HP$US$US
227216192$22721619$2$F$$20230214$20230719$20240723$EXP$$US-OTSUKA-2023_004290$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227216202$22721620$2$F$$20230214$20230719$20240723$PER$$US-OTSUKA-2023_004249$OTSUKA$$5$DEC$$M$Y$$$20240723$$HP$US$US
227216212$22721621$2$F$$20230706$20230719$20240723$PER$$US-OTSUKA-2023_018276$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227216242$22721624$2$F$$20230222$20230719$20240723$EXP$$US-OTSUKA-2023_005036$OTSUKA$$7$DEC$$F$Y$$$20240723$$MD$US$US
227216252$22721625$2$F$$20220718$20230719$20240723$PER$$US-OTSUKA-2022_037135$OTSUKA$$52$YR$$F$Y$$$20240723$$MD$US$US
227216262$22721626$2$F$20220612$20220914$20230719$20240723$PER$$US-OTSUKA-2022_037458$OTSUKA$$64$YR$$F$Y$$$20240723$$CN$US$US
227216272$22721627$2$F$$20230223$20230719$20240723$EXP$$US-OTSUKA-2023_005116$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227216282$22721628$2$F$$20220721$20230719$20240723$PER$$US-OTSUKA-2022_037762$OTSUKA$$$$$F$Y$79.38$KG$20240723$$CN$US$US
227216292$22721629$2$F$$20230223$20230719$20240723$EXP$$US-OTSUKA-2023_005115$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227216302$22721630$2$F$$20220718$20230719$20240723$PER$$US-OTSUKA-2022_037170$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227216312$22721631$2$F$$20230221$20230719$20240723$EXP$$US-OTSUKA-2023_004957$OTSUKA$$53$YR$$F$Y$$$20240723$$MD$US$US
227216322$22721632$2$F$$20230222$20230719$20240723$PER$$US-OTSUKA-2023_005046$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227216332$22721633$2$F$$20220719$20230719$20240723$PER$$US-OTSUKA-2022_037364$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227216342$22721634$2$F$$20220719$20230719$20240723$PER$$US-OTSUKA-2022_037460$OTSUKA$$3$DEC$$F$Y$$$20240723$$HP$US$US
227216352$22721635$2$F$$20230224$20230719$20240723$PER$$US-OTSUKA-2023_005243$OTSUKA$$50$YR$$F$Y$$$20240723$$MD$US$US
227216362$22721636$2$F$20230217$20230217$20230719$20240723$PER$$US-OTSUKA-2023_004670$OTSUKA$$59$YR$$F$Y$61.23$KG$20240723$$CN$US$US
227216372$22721637$2$F$$20230222$20230719$20240723$PER$$US-OTSUKA-2023_005044$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227216382$22721638$2$F$$20230224$20230719$20240723$EXP$$US-OTSUKA-2023_005240$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227216392$22721639$2$F$$20230222$20230719$20240723$PER$$US-OTSUKA-2023_005061$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227216402$22721640$2$F$$20220718$20230719$20240723$PER$$US-OTSUKA-2022_037174$OTSUKA$$$$$F$Y$58.97$KG$20240723$$CN$US$US
227216412$22721641$2$F$$20220720$20230719$20240723$PER$$US-OTSUKA-2022_037602$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227216422$22721642$2$F$$20230221$20230719$20240723$PER$$US-OTSUKA-2023_004919$OTSUKA$$5$DEC$$F$Y$$$20240723$$HP$US$US
227216432$22721643$2$F$20221201$20230224$20230719$20240723$PER$$US-OTSUKA-2023_005265$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227216442$22721644$2$F$$20230221$20230719$20240723$PER$$US-OTSUKA-2023_004922$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227216452$22721645$2$F$$20230222$20230719$20240723$PER$$US-OTSUKA-2023_005037$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227216462$22721646$2$F$$20220721$20230719$20240723$PER$$US-OTSUKA-2022_037763$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227216472$22721647$2$F$$20230224$20230719$20240723$PER$$US-OTSUKA-2023_005261$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227216482$22721648$2$F$$20220910$20230719$20240723$PER$$US-OTSUKA-2022_036444$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227216492$22721649$2$F$$20220714$20230719$20240723$PER$$US-OTSUKA-2022_036685$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227216502$22721650$2$F$$20220715$20230719$20240723$PER$$US-OTSUKA-2022_037177$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
227216532$22721653$2$F$$20230223$20230719$20240723$EXP$$US-OTSUKA-2023_005147$OTSUKA$$62$YR$$F$Y$$$20240723$$HP$US$US
227216562$22721656$2$F$$20220725$20230719$20240723$PER$$US-OTSUKA-2022_038268$OTSUKA$$4$DEC$$F$Y$$$20240723$$HP$US$US
227216572$22721657$2$F$$20220721$20230719$20240723$PER$$US-OTSUKA-2022_037769$OTSUKA$$46$YR$$F$Y$$$20240723$$MD$US$US
227216583$22721658$3$F$20220725$20220725$20230719$20240723$PER$$US-OTSUKA-2022_038258$OTSUKA$$60$YR$$F$Y$$$20240723$$CN$US$US
227216592$22721659$2$F$$20220721$20230719$20240723$PER$$US-OTSUKA-2022_037846$OTSUKA$$$$A$F$Y$$$20240723$$MD$US$US
227216602$22721660$2$F$$20220721$20230719$20240723$PER$$US-OTSUKA-2022_037845$OTSUKA$$5$DEC$$F$Y$$$20240723$$HP$US$US
227216612$22721661$2$F$$20220722$20230719$20240723$PER$$US-OTSUKA-2022_037995$OTSUKA$$$$$F$Y$77.11$KG$20240723$$CN$US$US
227216622$22721662$2$F$20220701$20220721$20230719$20240723$PER$$US-OTSUKA-2022_037803$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227216632$22721663$2$F$$20220721$20230719$20240723$PER$$US-OTSUKA-2022_037848$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227216642$22721664$2$F$$20220721$20230719$20240723$PER$$US-OTSUKA-2022_037815$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227216652$22721665$2$F$20230201$20230224$20230719$20240723$EXP$$US-OTSUKA-2023_005266$OTSUKA$$34$YR$$M$Y$$$20240723$$HP$US$US
227216662$22721666$2$F$$20230301$20230719$20240723$PER$$US-OTSUKA-2023_005636$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227216672$22721667$2$F$$20230302$20230719$20240723$PER$$US-OTSUKA-2023_005717$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227216682$22721668$2$F$$20230302$20230719$20240723$PER$$US-OTSUKA-2023_005738$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227216692$22721669$2$F$$20230308$20230719$20240723$PER$$US-OTSUKA-2023_006359$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227216702$22721670$2$F$20220501$20230503$20230719$20240723$EXP$$US-OTSUKA-2023_005718$OTSUKA$$18$YR$$F$Y$$$20240723$$MD$US$US
227216712$22721671$2$F$$20230307$20230719$20240723$PER$$US-OTSUKA-2023_006164$OTSUKA$$4$DEC$$F$Y$$$20240723$$HP$US$US
227216722$22721672$2$F$$20230308$20230719$20240723$PER$$US-OTSUKA-2023_006355$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227216732$22721673$2$F$$20230308$20230719$20240723$PER$$US-OTSUKA-2023_006267$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227216742$22721674$2$F$$20221031$20230719$20240723$PER$$US-OTSUKA-2022_050464$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227216752$22721675$2$F$$20230308$20230719$20240723$PER$$US-OTSUKA-2023_006290$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227216762$22721676$2$F$$20230307$20230719$20240723$PER$$US-OTSUKA-2023_006188$OTSUKA$$63$YR$$F$Y$$$20240723$$HP$US$US
227216772$22721677$2$F$20230201$20230302$20230719$20240723$PER$$US-OTSUKA-2023_005737$OTSUKA$$34$YR$$F$Y$$$20240723$$HP$US$US
227216782$22721678$2$F$$20230306$20230719$20240723$PER$$US-OTSUKA-2023_005992$OTSUKA$$$$$M$Y$68.04$KG$20240723$$CN$US$US
227216792$22721679$2$F$$20230308$20230719$20240723$PER$$US-OTSUKA-2023_006341$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227216802$22721680$2$F$$20230228$20230719$20240723$PER$$US-OTSUKA-2023_005511$OTSUKA$$44$YR$$F$Y$$$20240723$$HP$US$US
227216812$22721681$2$F$20220101$20230328$20230719$20240723$PER$$US-OTSUKA-2023_006062$OTSUKA$$$$$F$Y$113.4$KG$20240723$$CN$US$US
227216822$22721682$2$F$20230224$20230227$20230719$20240723$EXP$$US-OTSUKA-2023_005372$OTSUKA$$30$YR$$F$Y$95.25$KG$20240723$$CN$US$US
227216832$22721683$2$F$$20230308$20230719$20240723$PER$$US-OTSUKA-2023_006293$OTSUKA$$$$$F$Y$104.33$KG$20240723$$CN$US$US
227216842$22721684$2$F$$20230501$20230719$20240723$PER$$US-OTSUKA-2023_005502$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227216852$22721685$2$F$$20230505$20230719$20240723$PER$$US-OTSUKA-2023_006026$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227216862$22721686$2$F$$20230307$20230719$20240723$PER$$US-OTSUKA-2023_006166$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227216872$22721687$2$F$$20230501$20230719$20240723$PER$$US-OTSUKA-2023_005380$OTSUKA$$$$$$Y$$$20240723$$PH$US$US
227216882$22721688$2$F$$20230228$20230719$20240723$PER$$US-OTSUKA-2023_005519$OTSUKA$$68$YR$$F$Y$$$20240723$$HP$US$US
227216892$22721689$2$F$$20230308$20230719$20240723$PER$$US-OTSUKA-2023_006361$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227216902$22721690$2$F$$20230303$20230719$20240723$PER$$US-OTSUKA-2023_005922$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227216912$22721691$2$F$$20230308$20230719$20240723$PER$$US-OTSUKA-2023_006351$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227216922$22721692$2$F$$20230320$20230719$20240723$EXP$$US-OTSUKA-2023_006030$OTSUKA$$$$$F$Y$65.77$KG$20240723$$CN$US$US
227216932$22721693$2$F$$20230308$20230719$20240723$PER$$US-OTSUKA-2023_006287$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
227216942$22721694$2$F$$20230307$20230719$20240723$PER$$US-OTSUKA-2023_006186$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227216952$22721695$2$F$20220601$20230227$20230719$20240723$PER$$US-OTSUKA-2023_005367$OTSUKA$$29$YR$$M$Y$92.99$KG$20240723$$CN$US$US
227216962$22721696$2$F$$20230306$20230719$20240723$PER$$US-OTSUKA-2023_006043$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
227216972$22721697$2$F$$20230308$20230719$20240723$PER$$US-OTSUKA-2023_006352$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
227216982$22721698$2$F$$20230228$20230719$20240723$PER$$US-OTSUKA-2023_005616$OTSUKA$$$$A$M$Y$$$20240723$$MD$US$US
227216992$22721699$2$F$$20230301$20230719$20240723$PER$$US-OTSUKA-2023_005624$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227217102$22721710$2$F$$20230309$20230719$20240723$PER$$US-OTSUKA-2023_006392$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
227217112$22721711$2$F$$20230315$20230719$20240723$PER$$US-OTSUKA-2023_006933$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
227217122$22721712$2$F$$20230310$20230719$20240723$PER$$US-OTSUKA-2023_006539$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
227217132$22721713$2$F$20221201$20230315$20230719$20240723$PER$$US-OTSUKA-2023_006946$OTSUKA$$64$YR$$F$Y$88.45$KG$20240723$$CN$US$US
227217142$22721714$2$F$$20230309$20230719$20240723$EXP$$US-OTSUKA-2023_006429$OTSUKA$$29$YR$$F$Y$$$20240723$$MD$US$US
227217152$22721715$2$F$$20230310$20230719$20240723$PER$$US-OTSUKA-2023_006542$OTSUKA$$7$DEC$$F$Y$$$20240723$$MD$US$US
227217162$22721716$2$F$$20230314$20230719$20240723$PER$$US-OTSUKA-2023_006821$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
227217172$22721717$2$F$$20230310$20230719$20240723$PER$$US-OTSUKA-2023_006540$OTSUKA$$28$YR$$F$Y$$$20240723$$HP$US$US
227217182$22721718$2$F$$20230314$20230719$20240723$PER$$US-OTSUKA-2023_006960$OTSUKA$$7$DEC$$F$Y$$$20240723$$HP$US$US
227219673$22721967$3$F$$20240812$20230719$20240823$EXP$$CA-APOTEX-2023AP010354$APOTEX$$36$YR$$F$Y$$$20240823$$HP$CA$CA
227220595$22722059$5$F$$20240827$20230719$20240830$EXP$$CA-SANDOZ INC.-SDZ2022CA000009$SANDOZ$$64$YR$$F$Y$89$KG$20240830$$HP$CA$CA
227221346$22722134$6$F$20240306$20240801$20230719$20240814$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000624$DECIPHERA PHARMACEUTICALS$$85$YR$E$F$Y$$$20240814$$CN$US$US
227222813$22722281$3$F$$20240719$20230719$20240731$PER$$US-SA-2023SA215698$SANOFI AVENTIS$$$$A$M$Y$$$20240731$$MD$US$US
227223542$22722354$2$F$20200901$20240806$20230719$20240813$PER$$US-SA-2023SA219263$SANOFI AVENTIS$$$$A$M$Y$$$20240813$$MD$US$US
227223752$22722375$2$F$$20240719$20230719$20240730$PER$$US-SA-2023SA219345$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240730$$MD$US$US
227224156$22722415$6$F$$20240830$20230719$20240905$PER$$US-TAKEDA-2023TUS070699$TAKEDA$$$$$F$Y$$$20240905$$PH$US$US
227224352$22722435$2$F$$20240809$20230719$20240816$EXP$$CA-TAKEDA-2023TUS070423$TAKEDA$$$$$M$Y$$$20240816$$CN$CA$CA
227224455$22722445$5$F$20230623$20240911$20230719$20240927$PER$$CA-TOLMAR, INC.-23CA041688$TOLMAR$$74$YR$$M$Y$$$20240927$$CN$CA$CA
227224512$22722451$2$F$20230622$20240808$20230719$20240904$PER$$CA-TOLMAR, INC.-23CA041648$TOLMAR$$66$YR$$M$Y$$$20240904$$CN$CA$CA
227224543$22722454$3$F$20230615$20240722$20230719$20240807$PER$$CO-TOLMAR, INC.-23CO041627$TOLMAR$$69$YR$$M$Y$95$KG$20240806$$CN$CO$CO
227225222$22722522$2$F$20230713$20240808$20230719$20240820$PER$$US-SA-2023SA217210$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240820$$CN$US$US
227225932$22722593$2$F$20230101$20240806$20230719$20240816$PER$$US-SA-2023SA219820$SANOFI AVENTIS$$64$YR$A$F$Y$131.54$KG$20240816$$MD$US$US
227226023$22722602$3$F$$20240624$20230719$20240703$EXP$GB-MHRA-ADR 28029341$GB-Accord-367506$ACCORD$$$$$M$Y$$$20240703$$PH$GB$
227226282$22722628$2$F$$20240808$20230719$20240815$PER$$US-SA-2023SA219707$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240815$$MD$US$US
227226447$22722644$7$F$20231005$20240703$20230719$20240705$EXP$$CA-TAKEDA-2023TUS067503$TAKEDA$$47$YR$$F$Y$$$20240705$$CN$CA$CA
227226644$22722664$4$F$20230701$20240802$20230719$20240813$PER$$US-SA-2023SA216784$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240814$$MD$US$US
227227263$22722726$3$F$20230101$20240820$20230719$20240917$PER$$US-SA-2023SA218456$SANOFI AVENTIS$$24$YR$A$F$Y$65.91$KG$20240918$$MD$US$US
227229372$22722937$2$F$20221001$20230711$20230719$20240813$EXP$$US-AstraZeneca-2023A160159$ASTRAZENECA$$937$MON$$F$Y$$$20240813$$CN$US$
227230464$22723046$4$F$20230617$20240802$20230719$20240812$EXP$$CO-Ipsen Biopharmaceuticals, Inc.-2023-17514$IPSEN$$31$YR$A$M$Y$85$KG$20240812$$CN$CO$CO
227230833$22723083$3$F$$20240909$20230719$20240920$EXP$$US-LUPIN PHARMACEUTICALS INC.-2023-05796$LUPIN$$$$$$Y$$$20240920$$CN$US$US
2272316411$22723164$11$F$20230101$20240724$20230719$20240801$EXP$$CA-GSK-CA2023AMR070593$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$MD$CA$CA
2272336621$22723366$21$F$20230101$20240919$20230719$20240928$EXP$$CA-CELLTRION INC.-2023CA011129$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
227235362$22723536$2$F$$20240918$20230719$20240925$EXP$$NVSC2023US157353$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
227236682$22723668$2$F$20220901$20230504$20230719$20240715$PER$$US-PERRIGO-22US014239$PERRIGO$$56$YR$$M$Y$77.098$KG$20240715$$CN$US$US
227238325$22723832$5$F$20221216$20240806$20230719$20240812$EXP$$CN-TAKEDA-2023TUS024206$TAKEDA$$68$YR$$F$Y$50$KG$20240812$$MD$CN$CN
227238513$22723851$3$F$$20240717$20230719$20240726$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202307006928$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240726$$CN$JP$JP
227239104$22723910$4$F$20220301$20240917$20230719$20240920$EXP$$US-TAKEDA-2021TUS081748$TAKEDA$$44$YR$$M$Y$118$KG$20240920$$MD$US$US
227240804$22724080$4$F$20230101$20240819$20230719$20240826$EXP$NO-NOMAADVRE-PASRAPP-2023-V5r85w$NO-OTSUKA-2023_019023$OTSUKA$$33$YR$$M$Y$82$KG$20240826$$CN$NO$NO
227242174$22724217$4$F$$20240718$20230719$20240725$PER$$US-ALXN-A202309203$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
227242376$22724237$6$F$20230101$20240909$20230719$20240917$EXP$$JP-009507513-2307JPN001090J$MERCK$Wanifuchi Y, Fujita T, Asano T, Mori M, Matsumoto N, Isogai A, et al. SY2-7 Long-term clinical outcome of triple-negative breast cancer treatment and future challenges. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 9$39$YR$$F$Y$$$20240917$$MD$JP$JP
227243233$22724323$3$F$20170804$20240610$20230719$20240702$EXP$$ES-ABBVIE-5332300$ABBVIE$$49$YR$$F$Y$$$20240702$$MD$ES$ES
227244272$22724427$2$F$$20240828$20230719$20240902$PER$$US-SA-2023SA219939$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240902$$MD$US$US
227246142$22724614$2$F$20211213$20240627$20230719$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-399281$RANBAXY$$14$YR$$M$Y$80$KG$20240712$$MD$FR$FR
227247196$22724719$6$F$20200101$20240731$20230719$20240807$EXP$$US-ABBVIE-5332396$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
227249082$22724908$2$F$$20230404$20230719$20240723$PER$$US-OTSUKA-2023_008890$OTSUKA$$30$YR$$$Y$$$20240723$$HP$US$US
227250783$22725078$3$F$$20240827$20230719$20240831$EXP$$US-ABBVIE-5328433$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
227251824$22725182$4$F$$20240807$20230719$20240810$EXP$$US-TAKEDA-2023TUS070026$TAKEDA$$$$$F$Y$$$20240810$$CN$US$US
227257243$22725724$3$F$20220101$20240830$20230719$20240906$EXP$$JP-009507513-2301JPN004114J$MERCK$$65$YR$$M$Y$$$20240906$$MD$JP$JP
227257714$22725771$4$F$20230601$20240719$20230719$20240724$EXP$$US-BEH-2023161129$CSL BEHRING$$41$YR$A$M$Y$$$20240724$$CN$US$US
227257872$22725787$2$F$$20240826$20230719$20240911$PER$$US-INCYTE CORPORATION-2023IN006922$INCYTE$$$$$$Y$$$20240911$$CN$US$US
227258666$22725866$6$F$20230101$20240904$20230719$20240912$PER$$US-SA-2023SA215323$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240912$$MD$US$US
227258683$22725868$3$F$20230101$20240710$20230719$20240722$EXP$$JP-SUNOVION-2023SMP011677$SUNOVION$$$$$$Y$$$20240722$$CN$JP$JP
227258742$22725874$2$F$$20240710$20230719$20240718$PER$$US-SA-2023SA216061$SANOFI AVENTIS$$92$YR$E$F$Y$$$20240718$$MD$US$US
227259012$22725901$2$F$20221020$20240912$20230719$20240919$EXP$$US-ABBVIE-4337038$ABBVIE$$58$YR$$F$Y$$$20240919$$CN$US$US
227260268$22726026$8$F$20230701$20231016$20230720$20240926$EXP$$US-GSK-US2023AMR098292$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
227261173$22726117$3$F$20230714$20230727$20230720$20240704$PER$$US-BAUSCHBL-2023BNL006029$BAUSCH AND LOMB$$$$$F$Y$$$20240705$$CN$US$US
227261839$22726183$9$F$$20240703$20230720$20240712$EXP$$CA-CELLTRION INC.-2023CA001012$CELLTRION$$$$$$Y$$$20240712$$HP$CA$CA
227262403$22726240$3$F$20221101$20231101$20230720$20240925$PER$$US-GSK-US2023AMR095555$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240925$$CN$US$US
227263012$22726301$2$F$$20240820$20230720$20240902$EXP$$US-AUROBINDO-AUR-APL-2023-047426$AUROBINDO$Fling C, Granados L, Coruh B. An Ophtha-MALA-gic Anomaly: Metformin Associated Lactic Acidosis Causing Transient Blindness. American Journal of Respiratory and Critical Care Medicine. 2023;207(1):A3498$62$YR$$M$Y$$$20240902$$MD$US$US
227263092$22726309$2$F$$20240909$20230720$20240918$EXP$$GB-CELLTRION INC.-2023GB014232$CELLTRION$$$$$$Y$$$20240918$$CN$GB$GB
227265002$22726500$2$F$$20230727$20230720$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK081027$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
227265982$22726598$2$F$20230629$20240906$20230720$20240924$PER$$CA-TOLMAR, INC.-23CA041764$TOLMAR$$83$YR$$M$Y$$$20240924$$CN$CA$CA
227266335$22726633$5$F$$20240628$20230720$20240706$EXP$$NL-AUROBINDO-AUR-APL-2023-047465$AUROBINDO$$$$E$F$Y$$$20240706$$CN$NL$NL
227266522$22726652$2$F$20230401$20240611$20230720$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023096150$VIIV$$63$YR$$M$Y$$$20240808$$PH$US$US
227266794$22726679$4$F$$20240726$20230720$20240802$EXP$$JP-009507513-1309JPN005866$MERCK$Sano T, et al... A case of a patient in whom recurrence of ifosfamide encephalopathy was prevented by discontinuing concomitant use of aprepitant for monotherapy with ifosfamide. the 11th Annual Meeting of Japanese Society of Medical Oncology. 2013$72$YR$$M$Y$$$20240802$$PH$JP$JP
227267617$22726761$7$F$20090101$20240904$20230720$20240909$EXP$GB-SANDOZ-SDZ2023GB003000$GB-SANDOZ-SDZ2023GB003000$SANDOZ$$37$YR$$M$Y$$$20240909$$CN$GB$GB
227268313$22726831$3$F$$20240812$20230720$20240814$EXP$$CA-ROCHE-2825737$ROCHE$$$$A$F$Y$$$20240814$$CN$CA$CA
227271506$22727150$6$F$$20240809$20230720$20240812$EXP$$US-TAKEDA-2023TUS070218$TAKEDA$$$$$M$Y$106$KG$20240812$$HP$US$US
227272372$22727237$2$F$20230701$20230716$20230720$20240724$EXP$$NVSC2023IT158924$NOVARTIS$$$$$F$Y$$$20240724$$MD$IT$IT
227273895$22727389$5$F$20180417$20240717$20230720$20240722$EXP$$US-GILEAD-2023-0637075$GILEAD$$48$YR$A$M$Y$$$20240719$$LW$US$US
227274016$22727401$6$F$20230714$20240731$20230720$20240807$EXP$$JP-ASTELLAS-2023JP008522$ASTELLAS$$82$YR$$M$Y$$$20240807$$MD$JP$JP
227275684$22727568$4$F$$20240911$20230720$20240918$EXP$$MX-AMGEN-MEXNI2023126732$AMGEN$$46$YR$A$F$Y$59.5$KG$20240918$$CN$MX$MX
227277386$22727738$6$F$20230220$20240906$20230720$20240912$EXP$$JP-AstraZeneca-2023A060144$ASTRAZENECA$Hida T, et al.. G-10 A case of plexiform neurofibroma in which multiple adverse reactions occurred after selumetinib administration.. The 15th Annual Meeting of the Japanese Society of Recklinghausen Disease 2024;31-.$16$YR$$M$Y$70$KG$20240912$$MD$JP$
227277532$22727753$2$F$20220718$20240731$20230720$20240807$EXP$$NVSC2023GB052459$NOVARTIS$$$$E$M$Y$$$20240807$$HP$GB$GB
227278072$22727807$2$F$$20240725$20230720$20240729$EXP$$CA-ROCHE-3265620$ROCHE$$$$A$F$Y$$$20240729$$CN$CA$CA
227278703$22727870$3$F$$20240909$20230720$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05760$LUPIN$$$$$$Y$$$20240924$$CN$US$US
227279274$22727927$4$F$$20240909$20230720$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05764$LUPIN$$$$$$Y$$$20240921$$CN$US$US
227279567$22727956$7$F$20230411$20240729$20230720$20240803$EXP$JP-MMM-1FAVEPW0$JP-ABBVIE-5334396$ABBVIE$$79$YR$$M$Y$44.5$KG$20240803$$MD$JP$JP
227279984$22727998$4$F$20230301$20240920$20230720$20240927$EXP$$NVSC2023PT159562$NOVARTIS$$41$YR$$M$Y$$$20240927$$CN$PT$PT
227280114$22728011$4$F$$20240715$20230720$20240724$EXP$$BR-TAKEDA-2023TUS070511$TAKEDA$$$$$F$Y$42$KG$20240724$$CN$BR$BR
227280422$22728042$2$F$20171102$20240910$20230720$20240919$EXP$$IT-CELLTRION INC.-2023IT014149$CELLTRION$$$$$$Y$$$20240919$$MD$IT$IT
227280725$22728072$5$F$20230701$20240802$20230720$20240812$PER$$US-SA-2023SA216284$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240812$$MD$US$US
227281983$22728198$3$F$20230601$20240826$20230720$20240905$PER$$US-SA-2023SA163145$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240905$$MD$US$US
227285833$22728583$3$F$$20240722$20230720$20240731$EXP$$US-GSK-US2023096296$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$HP$US$US
227286093$22728609$3$F$20220525$20240214$20230720$20240711$EXP$$CA-SAMSUNG BIOEPIS-SB-2022-01711$SAMSUNG BIOEPIS$$48$YR$A$F$Y$73$KG$20240711$$CN$CA$CA
2272864810$22728648$10$F$20230701$20240802$20230720$20240812$EXP$$US-GSK-US2023AMR095528$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240812$$CN$US$US
227286792$22728679$2$F$$20240718$20230720$20240727$PER$$US-SA-2023SA218509$SANOFI AVENTIS$$$$E$M$Y$96.1$KG$20240727$$MD$US$US
227287736$22728773$6$F$20230718$20240723$20230720$20240726$EXP$$NVSC2023US160091$NOVARTIS$$62$YR$$F$Y$$$20240726$$HP$US$US
227290413$22729041$3$F$20230715$20240823$20230720$20240904$PER$$US-INCYTE CORPORATION-2023IN007350$INCYTE$$$$$$Y$$$20240904$$CN$US$US
227291604$22729160$4$F$$20240628$20230720$20240704$EXP$$BR-TAKEDA-2023TUS070934$TAKEDA$$$$$F$Y$70$KG$20240704$$CN$BR$BR
227292093$22729209$3$F$$20240909$20230720$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05802$LUPIN$$$$$$Y$$$20240924$$CN$US$US
227292332$22729233$2$F$20230101$20240826$20230720$20240828$EXP$$NVSC2023US159667$NOVARTIS$$48$YR$$M$Y$$$20240828$$CN$US$US
227292362$22729236$2$F$$20240701$20230720$20240703$PER$$US-PFIZER INC-202300033761$PFIZER$$83$YR$$F$Y$64.41$KG$20240703$$CN$US$US
2272940418$22729404$18$F$20230101$20240820$20230720$20240828$30DAY$$CA-PFIZER INC-202300249291$PFIZER$$20$YR$$F$Y$$$20240828$$MD$CA$CA
227294922$22729492$2$F$20230101$20240820$20230720$20240822$EXP$$CA-PFIZER INC-202300252648$PFIZER$$29$YR$$M$Y$$$20240822$$MD$CA$CA
2272961811$22729618$11$F$20230701$20240919$20230720$20240927$EXP$$AU-TAKEDA-2023TUS071132$TAKEDA$$81$YR$$M$Y$$$20240927$$CN$AU$AU
227296556$22729655$6$F$20230101$20240812$20230720$20240816$EXP$$CA-AMGEN-CANSL2023112470$AMGEN$$64$YR$A$F$Y$$$20240816$$MD$CA$CA
227296719$22729671$9$F$20240806$20240812$20230720$20240813$EXP$$US-PFIZER INC-PV202300124996$PFIZER$$82$YR$$F$Y$$$20240813$$CN$US$US
227297482$22729748$2$F$20230211$20231012$20230720$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00058$MEDEXUS PHARMA$$42$YR$$F$Y$$$20240826$$CN$US$US
227297562$22729756$2$F$20230809$20230810$20230720$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00177$MEDEXUS PHARMA$$85$YR$$F$Y$$$20240826$$CN$US$US
227297612$22729761$2$F$$20230802$20230720$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00154$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
227297632$22729763$2$F$20230819$20230821$20230720$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00178$MEDEXUS PHARMA$$70$YR$$M$Y$88.435$KG$20240826$$CN$US$US
227297662$22729766$2$F$20230101$20230808$20230720$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00202$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
227297782$22729778$2$F$20230401$20230824$20230720$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00168$MEDEXUS PHARMA$$54$YR$$F$Y$$$20240826$$CN$US$US
227297885$22729788$5$F$20230309$20240723$20230720$20240725$EXP$$CA-TAKEDA-2023TUS070320$TAKEDA$$58$YR$$F$Y$$$20240725$$CN$CA$CA
227298062$22729806$2$F$20230713$20240709$20230720$20240711$EXP$$US-PFIZER INC-202300251428$PFIZER$$54$YR$$F$Y$$$20240711$$HP$US$US
227299322$22729932$2$F$$20240627$20230720$20240712$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399695$RANBAXY$Nebhinani N. Oculogyric Crisis In Patients With Schizophrenia. Indian J Psychiatry. 2017;Jan;59(Suppl 2):S234-S235$25$YR$$M$Y$$$20240712$$MD$IN$IN
227302392$22730239$2$F$$20240717$20230720$20240724$EXP$$GR-AMGEN-GRCSP2023124392$AMGEN$$$$$F$Y$$$20240724$$MD$GR$GR
227305022$22730502$2$F$$20240625$20230720$20240702$PER$$US-JNJFOC-20230731944$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$HP$US$US
227305414$22730541$4$F$20230706$20240717$20230720$20240724$EXP$$CO-GSK-CO2023AMR099580$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$PH$CO$CO
227305562$22730556$2$F$$20230828$20230720$20240716$PER$$US-EVOFEM BIOSCIENCES, INC.-2023-EVO-US000034$PAREXEL$$$$$$Y$$$20240617$$HP$US$US
227305593$22730559$3$F$20210101$20240702$20230720$20240711$EXP$$FR-TEVA-2023-FR-2907357$TEVA$$30$YR$$M$Y$$$20240711$$CN$FR$FR
227305959$22730595$9$F$20210101$20240805$20230720$20240813$EXP$$BR-AKCEA THERAPEUTICS, INC.-2023IS001911$AKCEA THERAPEUTICS$$$$$$Y$$$20240809$$MD$BR$BR
227306393$22730639$3$F$$20240703$20230720$20240705$EXP$$US-PFIZER INC-202300251624$PFIZER$$69$YR$$F$Y$61.23$KG$20240705$$CN$US$US
227307176$22730717$6$F$20230613$20240917$20230720$20240926$EXP$$CA-JNJFOC-20230618483$JOHNSON AND JOHNSON$$76$YR$E$F$Y$49$KG$20240926$$HP$CA$CA
227307392$22730739$2$F$20230606$20240731$20230720$20240808$PER$$US-SA-2023SA220907$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240808$$MD$US$US
227307812$22730781$2$F$20230401$20240703$20230720$20240713$EXP$FR-AFSSAPS-AM2023000592$FR-TEVA-2023-FR-2907974$TEVA$$56$YR$$F$Y$80$KG$20240713$$MD$FR$FR
227308756$22730875$6$F$$20240705$20230720$20240719$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-23-01914$HIKMA$$65$YR$$F$Y$69$KG$20240719$$HP$CA$CA
227310012$22731001$2$F$20221212$20240719$20230720$20240729$EXP$FR-AFSSAPS-ST2023000870$FR-TEVA-2023-FR-2907326$TEVA$$32$YR$$F$Y$86$KG$20240729$$MD$FR$FR
227311922$22731192$2$F$$20230403$20230720$20240716$PER$$US-NOVOPROD-1051568$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
227312452$22731245$2$F$20230401$20231227$20230720$20240715$PER$$US-PERRIGO-23US005347$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
227314333$22731433$3$F$$20230703$20230720$20240716$PER$$US-NOVOPROD-1053981$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
227315002$22731500$2$F$$20230519$20230720$20240716$PER$$US-NOVOPROD-1072108$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
227315102$22731510$2$F$20230515$20230522$20230720$20240716$PER$$US-NOVOPROD-1072414$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
227315552$22731555$2$F$20230101$20230522$20230720$20240716$PER$$US-NOVOPROD-1073008$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
227315594$22731559$4$F$$20240812$20230720$20240814$PER$$NVSC2023US160532$NOVARTIS$$$$$M$Y$87.528$KG$20240814$$MD$US$US
227315762$22731576$2$F$20230119$20230215$20230720$20240716$PER$$US-NOVOPROD-1026232$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
227315772$22731577$2$F$20230116$20240123$20230720$20240716$PER$$US-NOVOPROD-1026439$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
227316534$22731653$4$F$$20230519$20230720$20240716$PER$$US-NOVOPROD-1025785$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
227316662$22731666$2$F$20230410$20240503$20230720$20240716$PER$$US-NOVOPROD-1073100$NOVO NORDISK$$55$YR$$$Y$$$20240717$$CN$US$US
227316752$22731675$2$F$20230101$20231027$20230720$20240716$PER$$US-NOVOPROD-1073171$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
227317812$22731781$2$F$$20240405$20230720$20240716$PER$$US-NOVOPROD-1073720$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
227317822$22731782$2$F$20230424$20230523$20230720$20240716$PER$$US-NOVOPROD-1073740$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
227318013$22731801$3$F$$20230527$20230720$20240716$PER$$US-NOVOPROD-1074307$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
227318042$22731804$2$F$20230501$20230526$20230720$20240716$PER$$US-NOVOPROD-1074379$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
227318052$22731805$2$F$$20230525$20230720$20240716$PER$$US-NOVOPROD-1074412$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
227318082$22731808$2$F$20230528$20230530$20230720$20240716$PER$$US-NOVOPROD-1074415$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
227318363$22731836$3$F$20230525$20231130$20230720$20240716$PER$$US-NOVOPROD-1074431$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
227319474$22731947$4$F$20221201$20230125$20230720$20240716$PER$$US-NOVOPROD-1030599$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
227320053$22732005$3$F$$20230623$20230720$20240716$PER$$US-NOVOPROD-1054847$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
227320172$22732017$2$F$20230510$20230607$20230720$20240716$PER$$US-NOVOPROD-1076338$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
227320213$22732021$3$F$20230510$20230621$20230720$20240716$PER$$US-NOVOPROD-1076260$NOVO NORDISK$$78$YR$$M$Y$$$20240717$$MD$US$US
227320222$22732022$2$F$$20230526$20230720$20240716$PER$$US-NOVOPROD-1081207$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
227320233$22732023$3$F$20230401$20230612$20230720$20240716$PER$$US-NOVOPROD-1078144$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
227320392$22732039$2$F$$20230531$20230720$20240716$PER$$US-NOVOPROD-1085544$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
227321402$22732140$2$F$$20230210$20230720$20240716$PER$$US-NOVOPROD-1033274$NOVO NORDISK$$$$$F$Y$139.23$KG$20240717$$CN$US$US
227322012$22732201$2$F$20230101$20230523$20230720$20240716$PER$$US-NOVOPROD-1056574$NOVO NORDISK$$72$YR$$F$Y$124$KG$20240717$$HP$US$US
227322292$22732229$2$F$20230405$20230814$20230720$20240716$PER$$US-NOVOPROD-1057344$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
227322883$22732288$3$F$$20240911$20230720$20240912$PER$$NVSC2023US160742$NOVARTIS$$$$$M$Y$$$20240912$$CN$US$US
227323122$22732312$2$F$20220101$20230308$20230720$20240716$PER$$US-NOVOPROD-1034740$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$HP$US$US
227324232$22732423$2$F$$20230421$20230720$20240716$PER$$US-NOVOPROD-1060620$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
227324512$22732451$2$F$$20240501$20230720$20240716$PER$$US-NOVOPROD-1049928$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
227328792$22732879$2$F$$20240212$20230720$20240716$PER$$US-NOVOPROD-1041013$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
227329822$22732982$2$F$20230301$20230420$20230720$20240716$PER$$US-NOVOPROD-1043849$NOVO NORDISK$$72$YR$$M$Y$$$20240717$$CN$US$US
227330025$22733002$5$F$20230206$20230710$20230720$20240716$PER$$US-NOVOPROD-1062435$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
227330252$22733025$2$F$20230311$20240222$20230720$20240716$PER$$US-NOVOPROD-1041980$NOVO NORDISK$$$$$M$Y$91.8$KG$20240717$$MD$US$US
227331472$22733147$2$F$20230309$20230316$20230720$20240716$PER$$US-NOVOPROD-1044389$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
227333633$22733363$3$F$20230428$20230703$20230720$20240716$PER$$US-NOVOPROD-1067016$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
227333864$22733386$4$F$20221201$20230217$20230720$20240716$PER$$US-NOVOPROD-1020444$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
227333962$22733396$2$F$20220101$20230310$20230720$20240716$PER$$US-NOVOPROD-1021097$NOVO NORDISK$$59$YR$$$Y$$$20240717$$CN$US$US
227334232$22733423$2$F$20221001$20230111$20230720$20240716$PER$$US-NOVOPROD-1022200$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
227335222$22733522$2$F$$20230222$20230720$20240716$PER$$US-NOVOPROD-1068973$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
227335292$22733529$2$F$20230425$20230616$20230720$20240716$PER$$US-NOVOPROD-1068834$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
227335466$22733546$6$F$20230610$20240626$20230720$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002419$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240719$$CN$US$US
227335592$22733559$2$F$20230504$20230510$20230720$20240716$PER$$US-NOVOPROD-1069273$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
227335864$22733586$4$F$20220101$20240312$20230720$20240919$EXP$$DE-TEVA-2022-DE-2066344$TEVA$$$$N$M$Y$$$20240919$$MD$DE$DE
227336295$22733629$5$F$20211007$20240731$20230720$20240807$EXP$$AR-JNJFOC-20230726988$JOHNSON AND JOHNSON$$46$YR$A$F$Y$60$KG$20240807$$CN$AR$AR
227336763$22733676$3$F$$20240823$20230720$20240826$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-250820$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240826$$MD$US$US
227337192$22733719$2$F$$20240624$20230720$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002691$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
2273373314$22733733$14$F$20230609$20240613$20230720$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002650$ACADIA PHARMACEUTICALS$$11$YR$$F$Y$$$20240708$$CN$US$US
227337554$22733755$4$F$$20240628$20230720$20240702$EXP$$US-TAKEDA-2023TUS069161$TAKEDA$$$$$F$Y$$$20240702$$CN$US$US
2273377710$22733777$10$F$20231001$20240627$20230721$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002640$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240723$$CN$US$US
2273379112$22733791$12$F$20230601$20240705$20230721$20240728$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002647$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
227338652$22733865$2$F$20230401$20240611$20230721$20240807$PER$$US-JNJFOC-20230739190$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240807$$HP$US$US
227338842$22733884$2$F$$20240718$20230721$20240726$EXP$$BR-CELLTRION INC.-2023BR000721$CELLTRION$$$$$$Y$$$20240726$$HP$BR$BR
227339652$22733965$2$F$20230710$20240729$20230721$20240805$EXP$$US-EMD Serono-2023462414$EMD SERONO INC$$61$YR$A$F$Y$$$20240805$$CN$US$US
227339765$22733976$5$F$20240527$20240613$20230721$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002669$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240708$$CN$US$US
227339773$22733977$3$F$$20240730$20230721$20240814$EXP$$US-AUROBINDO-AUR-APL-2023-047671$AUROBINDO$Riestra I, Porquera c Em. Fibrocystic Sarcoidosis:Should Patients Be on Prophylaxis for Opportunistic Infections?. American Journal of Respiratory and Critical Care Medicine. 2023;207(1):A3251$53$YR$$M$Y$$$20240814$$MD$US$US
2273398610$22733986$10$F$20230616$20240709$20230721$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002672$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240731$$CN$US$US
227342485$22734248$5$F$20230701$20231213$20230721$20240720$EXP$$NVSJ2023JP011465$NOVARTIS$$54$YR$$M$Y$$$20240719$$MD$JP$JP
227343072$22734307$2$F$$20240809$20230721$20240813$EXP$$NVSC2023US160359$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
227343238$22734323$8$F$20200205$20240815$20230721$20240822$EXP$$CA-CELLTRION INC.-2020CA019351$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
227343244$22734324$4$F$$20240719$20230721$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202307011235$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240820$$CN$US$US
227343563$22734356$3$F$20230701$20240623$20230721$20240702$PER$$US-SA-2023SA219813$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240702$$MD$US$US
227343792$22734379$2$F$$20240806$20230721$20240816$PER$$US-SA-2023SA221195$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$MD$US$US
227346064$22734606$4$F$$20240729$20230721$20240731$EXP$$IN-ROCHE-3390358$ROCHE$$49$YR$A$F$Y$$$20240731$$MD$IN$IN
227346865$22734686$5$F$20230101$20240724$20230721$20240801$EXP$$CA-SANDOZ INC.-SDZ2023CA003537$SANDOZ$$64$YR$$M$Y$$$20240801$$MD$CA$CA
2273476011$22734760$11$F$20230101$20240719$20230721$20240731$EXP$$US-BEH-2023161193$CSL BEHRING$$32$YR$A$F$Y$$$20240731$$CN$US$US
227347885$22734788$5$F$20231024$20240819$20230721$20240821$EXP$$AU-TAKEDA-2023TUS070484$TAKEDA$$76$YR$$F$Y$$$20240821$$HP$AU$AU
227348362$22734836$2$F$20221018$20231218$20230721$20240819$PER$$US-ENDO PHARMACEUTICALS INC-2023-001928$ENDO$$33$YR$$F$Y$$$20240819$$MD$US$US
227349252$22734925$2$F$$20240724$20230721$20240803$EXP$$CA-AUROBINDO-AUR-APL-2022-046485$AUROBINDO$ansky D, Kline G, Mahajan A, Koro K, Pasieka JL, Champagne P.. Ectopic Cushing^s syndrome from an ACTH-producing pheochromocytoma with a non-functioning pituitary adenoma. Endocrinology Diabetes and Metabolism Case Reports. 2022;2022 (1)$43$YR$$F$Y$$$20240803$$HP$CA$CA
227351023$22735102$3$F$20230718$20240813$20230721$20240819$EXP$$CA-TAKEDA-2023TUS070862$TAKEDA$$76$YR$$F$Y$$$20240819$$CN$CA$CA
227351083$22735108$3$F$$20240812$20230721$20240815$EXP$$US-TAKEDA-2023TUS070803$TAKEDA$$$$$F$Y$$$20240815$$CN$US$US
227351554$22735155$4$F$20230718$20240827$20230721$20240909$EXP$$JP-ASTELLAS-2023JP008595$ASTELLAS$$85$YR$E$M$Y$$$20240909$$MD$JP$JP
227352963$22735296$3$F$20240101$20240713$20230721$20240716$PER$$US-AMGEN-USASP2023125287$AMGEN$$$$A$M$Y$$$20240715$$HP$US$US
227353152$22735315$2$F$20220417$20240807$20230721$20240813$EXP$$DE-TAKEDA-2022TUS029346$TAKEDA$$60$YR$$F$Y$61$KG$20240813$$HP$DE$DE
227353379$22735337$9$F$20230614$20240711$20230721$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-013155$JAZZ$$35$YR$$F$Y$$$20240717$$HP$US$US
227354083$22735408$3$F$$20240826$20230721$20240910$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-04235$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$3$DY$$$Y$$$20240910$$MD$DE$DE
227354724$22735472$4$F$20230101$20240711$20230721$20240716$EXP$$CA-JNJFOC-20230252883$JOHNSON AND JOHNSON$$71$YR$E$M$Y$113$KG$20240716$$HP$CA$CA
227357332$22735733$2$F$20230601$20240718$20230721$20240801$EXP$$US-ENDO PHARMACEUTICALS INC-2023-004224$ENDO$$$$$F$Y$$$20240801$$CN$US$US
227358263$22735826$3$F$20230906$20240629$20230721$20240708$PER$$US-SA-2023SA220228$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240708$$MD$US$US
227359222$22735922$2$F$20230402$20230615$20230721$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-01819$AMNEAL$$46$YR$$F$Y$90$KG$20240720$$HP$US$US
227359232$22735923$2$F$$20230609$20230721$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-01852$AMNEAL$$$$$F$Y$$$20240720$$PH$US$US
227359983$22735998$3$F$$20240805$20230721$20240808$EXP$$BE-TAKEDA-2023TUS067121$TAKEDA$$73$YR$$M$Y$$$20240808$$HP$BE$BE
227360036$22736003$6$F$20230625$20240902$20230721$20240906$EXP$$IL-AMGEN-ISRSL2023052038$AMGEN$$86$YR$E$F$Y$$$20240906$$CN$IL$IL
227360056$22736005$6$F$20230710$20240815$20230721$20240827$EXP$$US-Accord-368346$ACCORD$$39$YR$A$M$Y$$$20240827$$HP$US$US
227360164$22736016$4$F$20230706$20240820$20230721$20240831$EXP$$US-Accord-368638$ACCORD$$69$YR$E$M$Y$$$20240831$$HP$US$US
2273606419$22736064$19$F$20230418$20240709$20230721$20240715$EXP$$DE-AMGEN-DEUNI2023119741$AMGEN$$55$YR$A$M$Y$88.9$KG$20240715$$HP$DE$DE
227361635$22736163$5$F$20230706$20240712$20230721$20240722$EXP$$JP-009507513-2307JPN001739J$MERCK$$43$YR$$F$Y$$$20240722$$MD$JP$JP
227361923$22736192$3$F$$20231006$20230721$20240809$EXP$$NVSC2023TH124163$NOVARTIS$$$$$F$Y$$$20240809$$CN$TH$TH
227362383$22736238$3$F$20230629$20240719$20230721$20240726$EXP$$US-SA-2023SA220460$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240726$$MD$US$US
2273637612$22736376$12$F$20240101$20240725$20230721$20240806$EXP$$US-INSMED, INC.-2023-02695-US$INSMED$$$$$M$Y$$$20240806$$CN$US$US
227363972$22736397$2$F$20230717$20230720$20230721$20240701$PER$$US-ABBVIE-5335977$ABBVIE$$87$YR$$F$Y$$$20240701$$CN$US$US
227364136$22736413$6$F$$20240628$20230721$20240705$EXP$$CA-OTSUKA-2023_018771$OTSUKA$$29$YR$$M$Y$$$20240705$$HP$CA$CA
227364235$22736423$5$F$20230101$20240813$20230721$20240821$PER$$US-SA-2023SA222071$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240821$$MD$US$US
227364246$22736424$6$F$20230101$20240717$20230721$20240726$PER$$US-SA-2023SA219144$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240726$$MD$US$US
227364297$22736429$7$F$$20240815$20230721$20240826$EXP$$BE-PFIZER INC-PV202300124067$PFIZER$Baczewska, N.. Immune checkpoint inhibitor refractory colitis leading to total colectomy in a melanoma patient.. Acta gastro-enterologica Belgica. 2023;86(2):371-373$73$YR$$M$Y$$$20240826$$HP$BE$BE
227364795$22736479$5$F$$20240710$20230721$20240722$EXP$CA-MHPD-E2B_001037118$CA-Accord-367853$ACCORD$$19$YR$A$M$Y$98$KG$20240719$$HP$CA$CA
227366102$22736610$2$F$20230701$20240725$20230721$20240803$PER$$US-SA-2023SA216029$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240803$$MD$US$US
227367115$22736711$5$F$20231010$20240702$20230721$20240705$EXP$$CA-TAKEDA-2023TUS070401$TAKEDA$$23$YR$$F$Y$$$20240705$$MD$CA$CA
227367733$22736773$3$F$$20240909$20230721$20240910$EXP$$US-PURDUE PHARMA-USA-2023-0303606$PURDUE$$$$$M$Y$$$20240910$$CN$US$US
227367932$22736793$2$F$20230317$20240918$20230721$20240930$EXP$$NVSC2023US159510$NOVARTIS$$46$YR$$M$Y$138$KG$20240930$$HP$US$US
227368314$22736831$4$F$$20240918$20230721$20240926$EXP$$NVSC2023US160470$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
227368393$22736839$3$F$$20240729$20230721$20240807$EXP$$IT-ARGENX-2023-ARGX-IT002341$ARGENX BVBA$Carpenedo, M.. Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists.. Mediterranean Journal of Hematology and Infectious Diseases. 2023;15 (1)$$$$$Y$$$20240807$$HP$IT$IT
227368673$22736867$3$F$20221215$20240729$20230721$20240805$EXP$FR-AFSSAPS-NY2023000947$FR-009507513-2307FRA007711$MERCK$$71$YR$$F$Y$64.8$KG$20240805$$MD$FR$FR
227368819$22736881$9$F$20230925$20240708$20230721$20240711$EXP$$US-TAKEDA-2023TUS069006$TAKEDA$$78$YR$$F$Y$67$KG$20240711$$HP$US$US
227368927$22736892$7$F$20220101$20240919$20230721$20240927$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-015490$JAZZ$$$$$M$Y$$$20240927$$CN$US$US
227368992$22736899$2$F$$20240906$20230721$20240920$EXP$IT-PFIZER INC-2017328890$IT-SERVIER-S17010466$SERVIER$Minetto P., Bisso N., Guolo F., Clavio M., Coviello E., Guardo D. et al.. Patient and therapy-related factors affecting the toxicity of pegylated-asparaginase for the treatment of adult acute lymphoblastic leukemia. Blood.. 2017;130 (Suppl 1):1297$$$$$Y$$$20240920$$HP$IT$IT
227370782$22737078$2$F$$20240812$20230721$20240817$PER$$US-SA-2023SA221072$SANOFI AVENTIS$$$$A$F$Y$$$20240817$$MD$US$US
227371223$22737122$3$F$$20240909$20230721$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-05807$LUPIN$$$$$$Y$$$20240921$$CN$US$US
227371713$22737171$3$F$$20240729$20230721$20240731$EXP$$IT-BAUSCH-BL-2023-011167$BAUSCH AND LOMB$$71$YR$$M$Y$70$KG$20240731$$MD$IT$IT
227372553$22737255$3$F$$20240909$20230721$20240919$EXP$$CA-APOTEX-2023AP010457$APOTEX$$40$YR$$M$Y$$$20240919$$HP$CA$CA
227373802$22737380$2$F$20230518$20240712$20230721$20240717$EXP$$US-FreseniusKabi-FK202310728$FRESENIUS KABI$$82$YR$E$M$Y$$$20240717$$MD$US$US
227375272$22737527$2$F$20151001$20240904$20230721$20240912$EXP$$US-JNJFOC-20230735677$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240912$$CN$US$US
227376012$22737601$2$F$$20240730$20230721$20240807$PER$$US-SA-2023SA221290$SANOFI AVENTIS$$$$A$F$Y$$$20240808$$HP$US$US
227377493$22737749$3$F$$20240816$20230721$20240820$PER$$NVSC2023US161591$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
227378343$22737834$3$F$20210101$20240801$20230721$20240806$EXP$$CA-PFIZER INC-202101729657$PFIZER$$59$YR$$F$Y$75$KG$20240806$$CN$CA$CA
227378752$22737875$2$F$$20240718$20230721$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400734$RANBAXY$Habibi M, Abd- Elsayed A. Temporary Peripheral Nerve Stimulators for Treatment of Common Peroneal Neuralgia. Neuromodulation. 2023;26:S215(ID: 213222)$90$YR$$M$Y$$$20240727$$MD$US$US
2273821210$22738212$10$F$$20240903$20230721$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-102397$BRISTOL MYERS SQUIBB$Takekawa T, Hara H, Maruta K, Ishii H, Ueda R, Okuno S. A case of diabetes mellitus diagnosed at the onset of diabetic ketoacidosis after immune checkpoint inhibitor administration. The 240th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2023;39.$73$YR$E$M$Y$$$20240913$$MD$JP$JP
227382313$22738231$3$F$20230701$20240729$20230721$20240807$PER$$US-SA-2023SA221222$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240807$$MD$US$US
227382444$22738244$4$F$20230713$20240923$20230721$20240924$EXP$$US-PFIZER INC-PV202300126137$PFIZER$$60$YR$$F$Y$72.109$KG$20240924$$MD$US$US
227382684$22738268$4$F$20221005$20240714$20230721$20240716$EXP$$DE-BAUSCH-BL-2023-010939$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240716$$HP$DE$DE
227383495$22738349$5$F$$20240718$20230721$20240722$PER$$US-PFIZER INC-PV202300125760$PFIZER$$85$YR$$F$Y$$$20240722$$MD$US$US
227383897$22738389$7$F$$20240910$20230721$20240911$PER$$US-PFIZER INC-PV202300124788$PFIZER$$79$YR$$F$Y$$$20240911$$CN$US$US
227383909$22738390$9$F$$20240912$20230721$20240918$PER$$US-PFIZER INC-PV202300124158$PFIZER$$72$YR$$F$Y$$$20240918$$CN$US$US
2273842521$22738425$21$F$20230101$20240905$20230721$20240909$EXP$$US-PFIZER INC-PV202300123517$PFIZER$$79$YR$$F$Y$$$20240909$$CN$US$US
2273848010$22738480$10$F$20230605$20240628$20230721$20240709$EXP$$US-BEH-2023161235$CSL BEHRING$$26$YR$A$F$Y$$$20240709$$CN$US$US
227384986$22738498$6$F$$20240816$20230721$20240816$PER$$US-PFIZER INC-PV202200132809$PFIZER$$88$YR$$F$Y$$$20240816$$HP$US$US
227386054$22738605$4$F$$20230518$20230721$20240721$PER$$US-NOVOPROD-1063878$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
227386123$22738612$3$F$20230314$20240215$20230721$20240721$PER$$US-NOVOPROD-1065364$NOVO NORDISK$$46$YR$$M$Y$$$20240721$$CN$US$US
227387462$22738746$2$F$20230422$20230510$20230721$20240721$PER$$US-NOVOPROD-1068414$NOVO NORDISK$$44$YR$$F$Y$$$20240721$$HP$US$US
227387816$22738781$6$F$$20230622$20230721$20240721$PER$$US-NOVOPROD-1071653$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
227387902$22738790$2$F$20230530$20230526$20230721$20240721$PER$$US-NOVOPROD-1073288$NOVO NORDISK$$49$YR$$F$Y$$$20240721$$CN$US$US
227388062$22738806$2$F$$20230531$20230721$20240721$PER$$US-NOVOPROD-1075550$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
227388182$22738818$2$F$20230519$20230601$20230721$20240721$PER$$US-NOVOPROD-1076043$NOVO NORDISK$$45$YR$$F$Y$$$20240721$$CN$US$US
227388192$22738819$2$F$20230512$20230524$20230721$20240721$PER$$US-NOVOPROD-1075676$NOVO NORDISK$$31$YR$$F$Y$$$20240721$$CN$US$US
227388562$22738856$2$F$20230309$20240311$20230721$20240721$PER$$US-NOVOPROD-1042063$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
227389022$22738902$2$F$20230131$20230706$20230721$20240721$PER$$US-NOVOPROD-1035464$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
227389163$22738916$3$F$20230401$20230614$20230721$20240721$PER$$US-NOVOPROD-1076581$NOVO NORDISK$$58$YR$$M$Y$$$20240721$$CN$US$US
227389554$22738955$4$F$20230522$20240805$20230721$20240814$EXP$$NL-TEVA-2023-NL-2909302$TEVA$$9$YR$$M$Y$$$20240814$$MD$NL$NL
227390744$22739074$4$F$$20230601$20230721$20240721$PER$$US-NOVOPROD-1060475$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
227390902$22739090$2$F$20230402$20230423$20230721$20240721$PER$$US-NOVOPROD-1061327$NOVO NORDISK$$48$YR$$F$Y$$$20240721$$CN$US$US
227391133$22739113$3$F$$20240920$20230721$20240923$PER$$NVSC2023US160484$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
227391462$22739146$2$F$$20240918$20230722$20240925$PER$$NVSC2023US161263$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
227391713$22739171$3$F$$20240829$20230722$20240829$PER$$NVSC2023US161660$NOVARTIS$$$$$F$Y$$$20240829$$HP$US$US
2273923112$22739231$12$F$20220617$20240913$20230722$20240921$EXP$$CA-CELLTRION INC.-2022CA008923$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
2273931014$22739310$14$F$20230717$20240906$20230722$20240913$EXP$$NVSC2023US161409$NOVARTIS$$35$YR$$F$Y$$$20240913$$CN$US$US
227393295$22739329$5$F$$20240723$20230722$20240725$PER$$NVSC2023US161846$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
2273933515$22739335$15$F$20190626$20240918$20230722$20240927$EXP$$CA-CELLTRION INC.-2021CA010439$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
227393522$22739352$2$F$20230706$20240725$20230722$20240726$EXP$FR-AFSSAPS-PV2023000678$NVSC2023FR159140$NOVARTIS$$9$YR$$M$Y$31$KG$20240726$$PH$FR$FR
227393913$22739391$3$F$$20240830$20230722$20240830$PER$$NVSC2023US160676$NOVARTIS$$$$$M$Y$77.11$KG$20240830$$MD$US$US
227394713$22739471$3$F$20200929$20240814$20230722$20240827$PER$$US-SA-2023SA222715$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240827$$MD$US$US
227394836$22739483$6$F$$20240911$20230722$20240926$EXP$$CA-002147023-NVSC2023CA027846$Haleon PLC$$81$YR$$F$Y$38$KG$20240926$$HP$CA$CA
227395822$22739582$2$F$20220210$20240808$20230722$20240820$EXP$$NL-AUROBINDO-AUR-APL-2023-047912$AUROBINDO$$69$YR$$M$Y$98$KG$20240820$$MD$NL$NL
227396612$22739661$2$F$20230101$20240715$20230722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2023-047815$AUROBINDO$$45$YR$$F$Y$$$20240722$$PH$FR$FR
227398802$22739880$2$F$20220211$20240808$20230723$20240820$EXP$$NL-AUROBINDO-AUR-APL-2023-048208$AUROBINDO$$69$YR$$M$Y$98$KG$20240820$$MD$NL$NL
227402833$22740283$3$F$20230627$20240918$20230723$20240919$PER$$US-AMGEN-USASP2023127398$AMGEN$$73$YR$E$M$Y$$$20240919$$HP$US$US
227403692$22740369$2$F$$20240807$20230724$20240815$PER$$US-SA-2023SA219817$SANOFI AVENTIS$$$$A$M$Y$$$20240815$$MD$US$US
227404015$22740401$5$F$$20240919$20230724$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-103224$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240923$$HP$US$US
227405168$22740516$8$F$$20240917$20230724$20240920$EXP$$JP-TAKEDA-2023TJP003714$TAKEDA$$$$$M$Y$$$20240920$$CN$JP$JP
227405173$22740517$3$F$20210101$20240720$20230724$20240730$EXP$$FR-AUROBINDO-AUR-APL-2023-048684$AUROBINDO$Samah AS, Ruth T, Roua K, Louis VR.. Ustekinumab-induced autoimmune hepatitis: a case report.. Pan African Medical Journal. 2023;44(44)$53$YR$$M$Y$$$20240730$$HP$FR$FR
227405463$22740546$3$F$$20240705$20230724$20240709$PER$$NVSC2023US160197$NOVARTIS$$$$$F$Y$$$20240709$$HP$US$US
227405992$22740599$2$F$20230427$20240905$20230724$20240909$PER$$US-ABBVIE-5337931$ABBVIE$$58$YR$$F$Y$78$KG$20240909$$MD$US$US
227406012$22740601$2$F$$20230728$20230724$20240717$PER$$US-AUROBINDO-AUR-APL-2023-043069$AUROBINDO$$$$$M$Y$$$20240717$$CN$US$US
227410564$22741056$4$F$$20240702$20230724$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-103251$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240703$$CN$US$US
227411632$22741163$2$F$$20240805$20230724$20240808$EXP$$US-ABBVIE-5335642$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
227414623$22741462$3$F$20230601$20240725$20230724$20240731$EXP$$CA-BAUSCH-BL-2023-011163$BAUSCH AND LOMB$$68$YR$$F$Y$$$20240731$$CN$CA$CA
227414684$22741468$4$F$$20230822$20230724$20240926$EXP$$US-GSK-US2023AMR097636$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
227414776$22741477$6$F$20230718$20240730$20230724$20240805$EXP$$CO-TAKEDA-2023TUS071694$TAKEDA$$33$YR$$M$Y$78$KG$20240805$$CN$CO$CO
227415065$22741506$5$F$20220917$20240823$20230724$20240828$EXP$$NVSC2023US157721$NOVARTIS$$34$YR$$F$Y$$$20240828$$CN$US$US
227416008$22741600$8$F$20230701$20240730$20230724$20240806$EXP$$NVSC2023PT160157$NOVARTIS$$30$YR$$F$Y$$$20240806$$CN$PT$PT
227416374$22741637$4$F$$20240918$20230724$20240930$EXP$$US-AUROBINDO-AUR-APL-2023-047881$AUROBINDO$Wang C, Freyer D. A DE NOVO GERMLINE RUNX-1 VARIANT PRECEDING DEVELOPMENT OF T-ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatric Blood and Cancer. 2023;70(Suppl 3):10.1002/pbc.30390$12$YR$$F$Y$$$20240930$$MD$US$US
227416882$22741688$2$F$$20240809$20230724$20240819$EXP$$AU-MYLANLABS-2023M1077637$MYLAN$Backhouse B, Scully T, Rajakariar K, Jin D, Chandrasekhar J, Freeman M. Coronary Artery Vasospasm in Patients With Eosinophilia. J A C C: case reports. 2023;19:1-7$53$YR$$M$Y$$$20240819$$MD$AU$AU
227417165$22741716$5$F$20220404$20240709$20230724$20240715$EXP$$JP-009507513-2307JPN002596J$MERCK$$57$YR$$M$Y$$$20240715$$MD$JP$JP
227417843$22741784$3$F$$20240719$20230724$20240724$EXP$$NVSC2023TW159426$NOVARTIS$Hung Y, Huang Y, Wu J. Drug-Induced Subcutaneous Sweet Syndrome. MAYO CLINIC PROCEEDINGS. 2023;98 (4):631-2$6$DEC$$M$Y$$$20240724$$HP$TW$TW
227418006$22741800$6$F$$20240813$20230724$20240821$PER$$US-BIOGEN-2023BI01217287$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
2274196112$22741961$12$F$20190101$20240801$20230724$20240807$EXP$$US-BIOGEN-2023BI01217308$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
227422822$22742282$2$F$$20240701$20230724$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-380819$RANBAXY$$$$A$M$Y$$$20240711$$MD$US$US
227422962$22742296$2$F$$20240701$20230724$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383320$RANBAXY$$$$A$F$Y$$$20240711$$HP$US$US
227423432$22742343$2$F$20230101$20240731$20230724$20240806$PER$$US-SA-2023SA224074$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240806$$CN$US$US
227423506$22742350$6$F$20230101$20240816$20230724$20240828$PER$$US-SA-2023SA220151$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240828$$MD$US$US
227423994$22742399$4$F$20230101$20240731$20230724$20240808$PER$$US-SA-2023SA220078$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240808$$MD$US$US
227424184$22742418$4$F$20230101$20240816$20230724$20240830$PER$$US-SA-2023SA224438$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240830$$MD$US$US
227424403$22742440$3$F$20230101$20240626$20230724$20240705$PER$$US-SA-2023SA224399$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240705$$MD$US$US
227424475$22742447$5$F$20240101$20240917$20230724$20240919$EXP$$US-SA-2023SA224383$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240919$$MD$US$US
227425313$22742531$3$F$20230703$20240625$20230724$20240704$PER$$US-SA-2023SA223431$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240704$$MD$US$US
227425468$22742546$8$F$20230101$20240819$20230724$20240827$EXP$$US-SA-2023SA222918$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240827$$MD$US$US
227425633$22742563$3$F$20230701$20240819$20230724$20240829$PER$$US-SA-2023SA224313$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240829$$MD$US$US
227425762$22742576$2$F$$20230720$20230724$20240826$PER$$US-BIOGEN-2023BI01217423$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
227426195$22742619$5$F$$20240729$20230724$20240807$EXP$$CA-ALCON LABORATORIES-ALC2023CA000447$ALCON$$53$YR$$F$Y$$$20240807$$HP$CA$CA
227427415$22742741$5$F$$20240917$20230724$20240920$30DAY$$US-PFIZER INC-PV202300124537$PFIZER$$9$YR$$F$Y$$$20240920$$MD$US$US
227427473$22742747$3$F$20230701$20240921$20230724$20240930$EXP$$US-BEH-2023161203$CSL BEHRING$$29$YR$A$M$Y$$$20240930$$HP$US$US
227428544$22742854$4$F$$20240401$20230724$20240808$EXP$$NVSC2023CA117175$NOVARTIS$$79$YR$$F$Y$$$20240808$$MD$CA$CA
2274286425$22742864$25$F$20230606$20240923$20230724$20240930$EXP$$IE-MYLANLABS-2023M1076794$MYLAN$$49$YR$$M$Y$$$20240930$$CN$IE$IE
227431303$22743130$3$F$20230716$20240718$20230724$20240726$PER$$US-SA-2023SA222191$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240726$$MD$US$US
227431615$22743161$5$F$20230605$20240906$20230724$20240913$EXP$$CA-TAKEDA-2023TUS055931$TAKEDA$$53$YR$$F$Y$$$20240913$$CN$CA$CA
227432298$22743229$8$F$20230101$20240827$20230724$20240903$EXP$$CA-OTSUKA-2023_019283$OTSUKA$$$$$M$Y$$$20240903$$HP$CA$CA
227434273$22743427$3$F$20221229$20240809$20230724$20240821$PER$$US-SA-2023SA220311$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240821$$CN$US$US
227435428$22743542$8$F$20230101$20240917$20230724$20240926$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-130230$DAIICHI$$$$$F$Y$$$20240926$$CN$US$US
2274361010$22743610$10$F$20221016$20240918$20230724$20240925$EXP$$US-TAKEDA-2022TUS078580$TAKEDA$$12$YR$$F$Y$54$KG$20240925$$MD$US$US
227436575$22743657$5$F$20230101$20240808$20230724$20240812$EXP$$CA-BIOMARINAP-CA-2023-151555$BIOMARIN$$$$$$Y$$$20240812$$CN$CA$CA
227437632$22743763$2$F$20230309$20230719$20230724$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300170$RVL PHARMACEUTICALS$$43$YR$A$F$Y$$$20240815$$HP$US$US
227437822$22743782$2$F$20230701$20230714$20230724$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300189$RVL PHARMACEUTICALS$$81$YR$E$M$Y$$$20240815$$$US$US
227439986$22743998$6$F$20200626$20240925$20230724$20240927$EXP$$US-TAKEDA-US202020989$TAKEDA$$73$YR$$F$Y$$$20240927$$HP$US$US
227440053$22744005$3$F$$20240822$20230724$20240828$PER$$US-VERTEX PHARMACEUTICALS-2023-010666$VERTEX$$$$$$Y$$$20240828$$CN$US$US
2274402520$22744025$20$F$20230601$20240815$20230724$20240820$EXP$$US-TAKEDA-2023TUS057924$TAKEDA$$68$YR$$F$Y$$$20240820$$HP$US$US
227440953$22744095$3$F$20230101$20240806$20230724$20240815$PER$$US-SA-2023SA224404$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240815$$MD$US$US
227442803$22744280$3$F$$20240702$20230724$20240710$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-003880$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240710$$HP$US$US
227444102$22744410$2$F$20230719$20240724$20230724$20240729$EXP$$CA-LUNDBECK-DKLU3065156$LUNDBECK$$$$$$Y$$$20240729$$CN$CA$CA
227449329$22744932$9$F$$20240723$20230725$20240725$EXP$$CA-TAKEDA-2023TUS072287$TAKEDA$$$$$M$Y$$$20240725$$CN$CA$CA
2274494711$22744947$11$F$20220823$20240821$20230725$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2022-019475$UNITED THERAPEUTICS$$56$YR$$F$Y$67.12$KG$20240831$$$US$US
227450552$22745055$2$F$$20240904$20230725$20240913$EXP$$IT-AUROBINDO-AUR-APL-2023-047915$AUROBINDO$Chiera M, Draghetti S, De Ronchi D, Scaramelli AR, Fabbri C, Serrettia A, et al.. Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation.. InternationalClinical Psychopharmacology. 2023;38(4):269-72$73$YR$$F$Y$$$20240913$$MD$IT$IT
227450582$22745058$2$F$20230801$20240801$20230725$20240806$EXP$$CA-ABBVIE-5332288$ABBVIE$$69$YR$$F$Y$$$20240806$$CN$CA$CA
227450752$22745075$2$F$20230531$20230828$20230725$20240805$EXP$$ZA-BIOVITRUM-2023-ZA-013150$BIOVITRUM$$222$DY$$F$Y$3.8$KG$20240805$$CN$ZA$ZA
227452169$22745216$9$F$20230701$20240213$20230725$20240926$EXP$$US-GSK-US2023AMR100992$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
227454264$22745426$4$F$20210318$20240911$20230725$20240916$EXP$$DE-ROCHE-2857724$ROCHE$$42$YR$A$F$Y$$$20240916$$CN$DE$DE
227455813$22745581$3$F$$20240918$20230725$20240926$PER$$NVSC2023US163155$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
227456132$22745613$2$F$$20240826$20230725$20240827$EXP$$CA-SANDOZ INC.-SDZ2023CA004778$SANDOZ$$$$$M$Y$$$20240827$$CN$CA$CA
2274590613$22745906$13$F$20230221$20240729$20230725$20240801$EXP$$SA-ROCHE-3294437$ROCHE$$3$YR$C$F$Y$12$KG$20240801$$CN$SA$SA
227460372$22746037$2$F$20230316$20240719$20230725$20240724$EXP$$GB-ROCHE-3392931$ROCHE$$44$YR$A$M$Y$$$20240724$$HP$GB$GB
227461027$22746102$7$F$20210101$20240805$20230725$20240816$EXP$$GB-AUROBINDO-AUR-APL-2023-012002$AUROBINDO$$42$YR$$M$Y$90$KG$20240816$$CN$GB$GB
227461903$22746190$3$F$20210702$20240729$20230725$20240801$EXP$$US-TAKEDA-2021TUS042292$TAKEDA$$62$YR$$M$Y$74$KG$20240801$$CN$US$US
227462573$22746257$3$F$20230607$20240813$20230725$20240820$EXP$$AR-GSK-AR2023AMR100129$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$AR$AR
227463424$22746342$4$F$20230514$20240723$20230725$20240801$PER$$US-SA-2023SA224340$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240801$$HP$US$US
227463542$22746354$2$F$20230101$20240826$20230725$20240918$PER$$US-SA-2023SA224200$SANOFI AVENTIS$$6$YR$C$F$Y$20.8$KG$20240918$$MD$US$US
227465655$22746565$5$F$20240823$20240826$20230725$20240902$EXP$$CA-GSK-CA2023AMR099954$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$CA$CA
227465674$22746567$4$F$20230718$20240626$20230725$20240702$EXP$$IN-GSK-IN2023APC099294$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$IN$IN
227465687$22746568$7$F$20230714$20240724$20230725$20240801$EXP$$CA-GSK-CA2023AMR101169$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$HP$CA$CA
227465817$22746581$7$F$20240514$20240823$20230725$20240829$EXP$$NVSC2022CL264463$NOVARTIS$$31$YR$$F$Y$$$20240829$$CN$CL$CL
227467812$22746781$2$F$20230701$20240716$20230725$20240731$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399656$RANBAXY$$46$YR$$F$Y$74$KG$20240731$$CN$BR$BR
227469072$22746907$2$F$$20240821$20230725$20240905$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400966$RANBAXY$Baraban E, Ding C C-K, White M, Vohra P, Simko J, Boyle K et al. Prostate Cancer in Male-to-Female Transgender Individuals: Histopathologic Findings and Association With Gender-affirming Hormonal Therapy. Am J Surg Pathol. 2022;46(12):1650-1658$65$YR$$$Y$$$20240905$$MD$US$US
227469464$22746946$4$F$$20240823$20230725$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-104274$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$72.57$KG$20240826$$CN$US$US
227470463$22747046$3$F$20230708$20240719$20230725$20240725$EXP$$US-ABBVIE-5339240$ABBVIE$$60$YR$$F$Y$$$20240725$$CN$US$US
227470547$22747054$7$F$20230704$20240807$20230725$20240812$EXP$$US-SA-2023SA224808$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240812$$MD$US$US
227471122$22747112$2$F$20230401$20240716$20230725$20240726$EXP$$EG-ELI_LILLY_AND_COMPANY-EG202307011019$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240726$$CN$EG$EG
227472365$22747236$5$F$20230501$20240626$20230725$20240702$EXP$$JP-009507513-2307JPN002859J$MERCK$$6$DEC$$F$Y$$$20240702$$MD$JP$JP
227473032$22747303$2$F$20230101$20240823$20230725$20240911$PER$$US-SA-2023SA225652$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240911$$MD$US$US
227474336$22747433$6$F$20231201$20240730$20230725$20240803$EXP$$CL-JNJFOC-20230564615$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240803$$CN$CL$CL
227474642$22747464$2$F$20230317$20240809$20230725$20240905$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0300532$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
2274746712$22747467$12$F$$20240919$20230725$20240927$PER$$US-VERTEX PHARMACEUTICALS-2023-010847$VERTEX$$$$$F$Y$$$20240927$$CN$US$US
227475613$22747561$3$F$20190222$20240816$20230725$20240822$EXP$$CA-TAKEDA-2019TUS012019$TAKEDA$$29$YR$$F$Y$$$20240822$$CN$CA$CA
227478215$22747821$5$F$$20240906$20230725$20240912$EXP$$US-GILEAD-2023-0637195$GILEAD$$68$YR$E$M$Y$$$20240912$$HP$US$US
227478542$22747854$2$F$20230701$20240826$20230725$20240829$EXP$$US-PFIZER INC-PV202300127069$PFIZER$$35$YR$$F$Y$$$20240829$$HP$US$US
227481235$22748123$5$F$20230101$20240802$20230725$20240807$EXP$$US-ABBVIE-5339601$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
227481682$22748168$2$F$$20240816$20230725$20240830$EXP$$US-UCBSA-2023037366$UCB$$$$$M$Y$$$20240830$$HP$US$US
227482569$22748256$9$F$20230101$20240705$20230725$20240712$EXP$$US-BAYER-2023A098172$BAYER$$73$YR$E$M$Y$$$20240712$$CN$US$US
227482635$22748263$5$F$20240630$20240703$20230725$20240704$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2023-104576$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$107.05$KG$20240704$$CN$PR$PR
227482656$22748265$6$F$$20240910$20230725$20240925$EXP$$CA-002147023-NVSC2021CA012042$Haleon PLC$$75$YR$$F$Y$70$KG$20240925$$HP$CA$CA
227483582$22748358$2$F$20120101$20240619$20230725$20240704$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000288$Unknown Manufacturer$$$$$$Y$$$20240702$$LW$US$US
227483615$22748361$5$F$20230701$20240716$20230725$20240722$EXP$$CA-UCBSA-2023037242$UCB$$41$YR$$M$Y$$$20240719$$CN$CA$CA
227484664$22748466$4$F$20230616$20240809$20230725$20240815$EXP$$FR-PFIZER INC-PV202300125261$PFIZER$$30$YR$$M$Y$80$KG$20240815$$MD$FR$FR
227484975$22748497$5$F$$20240823$20230725$20240829$EXP$$ZA-TAKEDA-2022TUS034947$TAKEDA$$$$$F$Y$$$20240829$$CN$ZA$ZA
227485164$22748516$4$F$20230711$20240716$20230725$20240722$EXP$$CO-UCBSA-2023037501$UCB$$33$YR$$F$Y$55$KG$20240722$$CN$CO$CO
2274852210$22748522$10$F$20230101$20240726$20230725$20240805$PER$$US-SA-2023SA205280$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240804$$MD$US$US
227486382$22748638$2$F$$20240714$20230725$20240722$EXP$$IT-AstraZeneca-2023A166662$ASTRAZENECA$Rossi S., Costa R., di Federico A., Lobianco F., D^Angelo R., Asioli G.M., De Giglio A., Sperandi F., Guarino M., Rinaldi R., Ardizzoni A., Cenacchi G., Gelsomino F.. Histopathological Evidence for a Non- Inflammatory Mechanism in Osimertinib-Induced Myopathy: A Case Report. Journal of Thoracic Oncology 2024;$71$YR$$F$Y$$$20240722$$MD$IT$
227487292$22748729$2$F$20240201$20240508$20230725$20240723$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0300721$MYOVANT SCIENCES$$45$YR$$F$Y$$$20240723$$CN$US$US
227488217$22748821$7$F$20230724$20240703$20230725$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-103928$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240710$$CN$US$US
227488713$22748871$3$F$$20240718$20230725$20240722$EXP$$US-PFIZER INC-PV202300126715$PFIZER$$55$YR$$F$Y$$$20240722$$HP$US$US
227488903$22748890$3$F$$20240812$20230725$20240814$PER$$US-PFIZER INC-PV202300126403$PFIZER$$60$YR$$F$Y$$$20240814$$HP$US$US
227489024$22748902$4$F$$20240816$20230725$20240820$PER$$US-PFIZER INC-202300254626$PFIZER$$76$YR$$F$Y$$$20240820$$CN$US$US
227489418$22748941$8$F$$20240830$20230725$20240830$EXP$$NVSC2023US163565$NOVARTIS$$$$$F$Y$98.18$KG$20240830$$MD$US$US
2274898710$22748987$10$F$20230803$20240816$20230725$20240822$EXP$$CA-TAKEDA-2023TUS071683$TAKEDA$$28$YR$$F$Y$$$20240822$$HP$CA$CA
2274914014$22749140$14$F$$20240716$20230725$20240718$EXP$$DE-ABBVIE-5286126$ABBVIE$$$$A$F$Y$$$20240718$$MD$DE$DE
227491835$22749183$5$F$20210101$20240710$20230725$20240712$PER$$US-PFIZER INC-202300252630$PFIZER$$36$YR$$F$Y$95.71$KG$20240712$$CN$US$US
227492604$22749260$4$F$$20240711$20230725$20240716$PER$$US-PFIZER INC-PV202300125105$PFIZER$$74$YR$$F$Y$$$20240716$$CN$US$US
227492764$22749276$4$F$$20240807$20230725$20240812$PER$$US-PFIZER INC-PV202300125712$PFIZER$$68$YR$$F$Y$$$20240812$$HP$US$US
227492852$22749285$2$F$20210510$20240628$20230725$20240703$EXP$$US-AVEO ONCOLOGY-2021-AVEO-US003412$PAREXEL$$$$$$Y$$$20240703$$HP$US$US
227493094$22749309$4$F$$20240815$20230725$20240819$EXP$$US-TAKEDA-2023TUS071730$TAKEDA$$$$$F$Y$84$KG$20240819$$MD$US$US
227496164$22749616$4$F$20230101$20240619$20230726$20240710$PER$$CA-TOLMAR, INC.-23CA041860$TOLMAR$$$$$M$Y$$$20240710$$CN$CA$CA
227497363$22749736$3$F$$20240717$20230726$20240725$PER$$US-SA-2023SA226944$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240725$$MD$US$US
227498566$22749856$6$F$$20240919$20230726$20240926$EXP$$US-GSK-US2023AMR100567$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
2274995214$22749952$14$F$20230101$20240627$20230726$20240702$EXP$$US-UNITED THERAPEUTICS-UNT-2023-020086$UNITED THERAPEUTICS$$$$$M$Y$82.086$KG$20240702$$$US$US
227499872$22749987$2$F$$20240827$20230726$20240905$EXP$$GB-INTERCEPT-PM2023001341$INTERCEPT PHARMACEUTICALS$$75$YR$$F$Y$$$20240905$$CN$GB$GB
227499924$22749992$4$F$20190916$20240806$20230726$20240815$EXP$$CA-INTERCEPT-PM2020002086$INTERCEPT PHARMACEUTICALS$$59$YR$$F$Y$$$20240815$$MD$CA$CA
227501883$22750188$3$F$20230701$20231003$20230726$20240925$PER$$US-GSK-US2023AMR100755$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$HP$US$US
227501934$22750193$4$F$20230101$20240801$20230726$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2023-006161$UNITED THERAPEUTICS$$$$$F$Y$65.306$KG$20240809$$$US$US
227502043$22750204$3$F$20230718$20240903$20230726$20240905$EXP$$IL-ROCHE-3393855$ROCHE$$54$YR$A$F$Y$$$20240905$$CN$IL$IL
2275022911$22750229$11$F$20230101$20240628$20230726$20240706$EXP$$CA-CELLTRION INC.-2023CA011961$CELLTRION$$$$$$Y$$$20240706$$MD$CA$CA
227502833$22750283$3$F$20230715$20240827$20230726$20240831$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-251552$BOEHRINGER INGELHEIM$$86$YR$E$F$Y$$$20240831$$CN$US$US
227503765$22750376$5$F$20230214$20240906$20230726$20240910$EXP$$NVSC2023MX048810$NOVARTIS$$22$YR$$F$Y$100$KG$20240910$$CN$MX$MX
2275043811$22750438$11$F$20221011$20240806$20230726$20240807$EXP$$NVSJ2023JP011550$NOVARTIS$$53$YR$$F$Y$52.1$KG$20240808$$MD$JP$JP
227504515$22750451$5$F$20230703$20240822$20230726$20240829$EXP$$PK-AMGEN-PAKSP2023129725$AMGEN$$61$YR$A$M$Y$$$20240828$$CN$PK$PK
227506643$22750664$3$F$$20240924$20230726$20240928$EXP$$CA-ROCHE-3393086$ROCHE$$78$YR$E$M$Y$$$20240928$$HP$CA$CA
227506987$22750698$7$F$20230701$20240820$20230726$20240826$EXP$$CA-TAKEDA-2023TUS061147$TAKEDA$$74$YR$$F$Y$$$20240826$$CN$CA$CA
227507122$22750712$2$F$$20240808$20230726$20240820$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023099508$VIIV$$$$$M$Y$$$20240820$$HP$US$US
227508172$22750817$2$F$$20240918$20230726$20240926$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-63402$HIKMA$Wang C, Freyer D.. Wang C, Freyer D. A DE NOVO GERMLINE RUNX-1 VARIANT PRECEDING DEVELOPMENT OF T-ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatric Blood and Cancer. 2023;70(Suppl 3)$12$YR$$F$Y$$$20240926$$MD$US$US
227509456$22750945$6$F$20220608$20240920$20230726$20240926$EXP$$US-TAKEDA-US202032084$TAKEDA$$58$YR$$F$Y$90$KG$20240926$$CN$US$US
2275105313$22751053$13$F$20230329$20240829$20230726$20240906$EXP$$CA-CELLTRION INC.-2023CA006491$CELLTRION$$$$$$Y$$$20240906$$CN$CA$CA
227511662$22751166$2$F$20230607$20240702$20230726$20240711$PER$$US-SA-2023SA225061$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240711$$MD$US$US
227512842$22751284$2$F$20230717$20240722$20230726$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-102816$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$PH$JP$JP
227513927$22751392$7$F$20230814$20240709$20230726$20240717$EXP$$CA-TAKEDA-2023TUS072603$TAKEDA$$67$YR$$F$Y$$$20240717$$HP$CA$CA
227514457$22751445$7$F$$20240905$20230726$20240912$EXP$$IE-ROCHE-3389459$ROCHE$$$$$M$Y$$$20240912$$CN$IE$IE
227515232$22751523$2$F$$20230612$20230726$20240715$PER$$US-MYLANLABS-2023M1063049$BIOCON$$$$$F$Y$$$20240715$$PH$US$US
227516273$22751627$3$F$$20240815$20230726$20240829$EXP$$CA-ASTELLAS-2023US021972$ASTELLAS$$63$YR$A$M$Y$$$20240826$$MD$CA$CA
227516404$22751640$4$F$20220710$20240903$20230726$20240915$EXP$$CA-UCBSA-2022041034$UCB$$57$YR$$F$Y$$$20240915$$CN$CA$CA
227516464$22751646$4$F$$20240718$20230726$20240718$30DAY$$US-PFIZER INC-PV202300126795$PFIZER$$28$YR$$F$Y$$$20240718$$PH$US$US
227518336$22751833$6$F$$20240726$20230726$20240801$EXP$$CA-ABBVIE-5341104$ABBVIE$$$$$F$Y$$$20240801$$HP$CA$CA
227518366$22751836$6$F$20230101$20240722$20230726$20240725$EXP$$US-ABBVIE-5341530$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
227519122$22751912$2$F$$20240816$20230726$20240821$EXP$$CA-ROCHE-3391718$ROCHE$$60$YR$A$F$Y$$$20240821$$CN$CA$CA
227519463$22751946$3$F$20230621$20240705$20230726$20240709$EXP$$US-UCBSA-2023024550$UCB$$42$YR$$F$Y$108.84$KG$20240709$$HP$US$US
227519548$22751954$8$F$20230101$20240627$20230726$20240706$PER$$US-SA-2023SA225467$SANOFI AVENTIS$$16$YR$T$M$Y$77.11$KG$20240706$$MD$US$US
227521089$22752108$9$F$20230526$20240919$20230726$20240926$EXP$$FR-EXELIXIS-XL18423065837$EXELIXIS$$$$$$Y$$$20240926$$MD$FR$FR
227521364$22752136$4$F$20190801$20240722$20230726$20240725$EXP$$CA-TAKEDA-2019TUS052094$TAKEDA$$71$YR$$F$Y$$$20240725$$HP$CA$CA
227523059$22752305$9$F$20221117$20240924$20230726$20240930$EXP$$CA-PFIZER INC-202201206626$PFIZER$$71$YR$$F$Y$69.15$KG$20240930$$MD$CA$CA
227523132$22752313$2$F$20230701$20240802$20230726$20240806$EXP$$US-PFIZER INC-202300256218$PFIZER$$71$YR$$M$Y$110.22$KG$20240806$$CN$US$US
227524064$22752406$4$F$$20240826$20230726$20240909$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399631$RANBAXY$Chakar B, Salter M, Roberts DM. Accidental minoxidil overdose with hypotension effectively managed with noradrenaline, rather than dopamine. Clin Toxicol (Phila). 2023;61(2):107/ 225$36$YR$$M$Y$$$20240909$$HP$AU$AU
227525164$22752516$4$F$20230701$20240808$20230726$20240811$PER$$NVSC2023US164282$NOVARTIS$$61$YR$$F$Y$$$20240811$$CN$US$US
227525973$22752597$3$F$20230501$20240715$20230726$20240718$EXP$$US-UCBSA-2023037682$UCB$$39$YR$$F$Y$$$20240718$$HP$US$US
227526628$22752662$8$F$20230701$20240718$20230726$20240726$EXP$$US-TAKEDA-2023TUS066263$TAKEDA$$75$YR$$F$Y$81$KG$20240726$$HP$US$US
227527122$22752712$2$F$20221201$20240808$20230726$20240813$EXP$$US-ROCHE-3391163$ROCHE$$53$YR$A$F$Y$81.65$KG$20240813$$CN$US$US
227527622$22752762$2$F$$20240715$20230726$20240722$EXP$$GR-MYLANLABS-2023M1078790$BIOCON$$$$$$Y$$$20240719$$MD$GR$GR
2275282813$22752828$13$F$20000916$20240725$20230726$20240730$EXP$$DE-PFIZER INC-202300257619$PFIZER$$86$YR$$F$Y$56$KG$20240730$$MD$DE$DE
227531324$22753132$4$F$20230726$20240903$20230726$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-105219$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240905$$CN$US$US
227531832$22753183$2$F$$20240729$20230726$20240904$PER$$US-LUNDBECK-DKLU3064796$LUNDBECK$$$$$$Y$$$20240904$$CN$US$US
227532794$22753279$4$F$$20240709$20230726$20240711$EXP$$US-PFIZER INC-202300257056$PFIZER$$42$YR$$F$Y$50.35$KG$20240711$$CN$US$US
227532804$22753280$4$F$$20240819$20230726$20240822$PER$$US-PFIZER INC-PV202300125618$PFIZER$$76$YR$$F$Y$$$20240822$$HP$US$US
227532952$22753295$2$F$$20240826$20230726$20240829$PER$$US-PFIZER INC-PV202300126362$PFIZER$$66$YR$$F$Y$$$20240829$$HP$US$US
227533526$22753352$6$F$20230910$20231107$20230726$20240909$PER$$NVSC2023US164312$NOVARTIS$$42$YR$$M$Y$$$20240909$$CN$US$US
227533643$22753364$3$F$20231201$20240625$20230726$20240701$PER$$US-PFIZER INC-PV202300125465$PFIZER$$65$YR$$F$Y$$$20240701$$CN$US$US
227534003$22753400$3$F$$20240917$20230726$20240923$PER$$US-PFIZER INC-202300254937$PFIZER$$17$YR$$F$Y$$$20240923$$HP$US$US
227534334$22753433$4$F$20220101$20240820$20230726$20240826$PER$$US-PFIZER INC-PV202300128750$PFIZER$$87$YR$$M$Y$76.19$KG$20240826$$MD$US$US
227534402$22753440$2$F$$20240711$20230726$20240715$PER$$NVSC2023US164225$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
227534627$22753462$7$F$20200101$20240827$20230726$20240830$EXP$$US-PFIZER INC-US-GBT-020846$PFIZER$$61$YR$$M$Y$$$20240830$$CN$US$US
227537302$22753730$2$F$$20240812$20230726$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-104846$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$91.72$KG$20240821$$CN$US$US
227537662$22753766$2$F$$20240909$20230726$20240917$PER$$US-SA-2023SA227404$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
227541573$22754157$3$F$$20240830$20230727$20240830$PER$$NVSC2023US164277$NOVARTIS$$$$$F$Y$$$20240830$$MD$US$US
227543192$22754319$2$F$20191001$20240830$20230727$20240910$EXP$$US-NOVOPROD-1094687$NOVO NORDISK$$$$$$Y$$$20240910$$CN$US$US
227543202$22754320$2$F$20220209$20240909$20230727$20240920$EXP$$US-NOVOPROD-1093121$NOVO NORDISK$$64$YR$$M$Y$$$20240920$$CN$US$US
227543499$22754349$9$F$$20240711$20230727$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202307007402$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240715$$CN$US$US
227543712$22754371$2$F$20230622$20240703$20230727$20240711$EXP$IT-MINISAL02-933596$IT-TEVA-2023-IT-2910485$TEVA$$9$YR$$F$Y$27$KG$20240711$$PH$IT$IT
227544313$22754431$3$F$20230701$20240709$20230727$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2023-021001$UNITED THERAPEUTICS$$75$YR$$F$Y$70.295$KG$20240717$$$US$US
227544782$22754478$2$F$20201112$20240711$20230727$20240720$EXP$$CA-CELLTRION INC.-2020CA031859$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
227546619$22754661$9$F$20230101$20240907$20230727$20240916$EXP$$CA-CELLTRION INC.-2023CA010937$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
227546789$22754678$9$F$20210329$20240906$20230727$20240916$EXP$$CA-CELLTRION INC.-2021CA004914$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
227546922$22754692$2$F$$20240808$20230727$20240821$PER$$US-JNJFOC-20230756277$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$HP$US$US
227546993$22754699$3$F$20230302$20240807$20230727$20240814$EXP$$CA-CELLTRION INC.-2023CA004956$CELLTRION$$$$$$Y$$$20240814$$CN$CA$CA
227547812$22754781$2$F$$20240705$20230727$20240710$PER$$US-AMGEN-USASP2023128817$AMGEN$$$$A$F$Y$$$20240710$$HP$US$US
227548106$22754810$6$F$20230101$20240918$20230727$20240927$EXP$$CA-CELLTRION INC.-2023CA014953$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
227548313$22754831$3$F$$20240708$20230727$20240710$30DAY$$US-ABBVIE-5338501$ABBVIE$$$$$$Y$$$20240710$$HP$US$US
227548735$22754873$5$F$20230601$20240702$20230727$20240708$EXP$$US-TAKEDA-2023TUS072810$TAKEDA$$42$YR$$M$Y$$$20240708$$CN$US$US
227548892$22754889$2$F$$20230818$20230727$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGNX-23-00368$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$9.705$KG$20240905$$CN$US$US
227548952$22754895$2$F$$20230630$20230727$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-00703$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$10.5$KG$20240905$$CN$US$US
227549002$22754900$2$F$$20230801$20230727$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-00697$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$24.9$KG$20240905$$MD$US$US
227550852$22755085$2$F$20230214$20240701$20230727$20240713$EXP$FR-AFSSAPS-AM2023000635$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-096120$ZYDUS PHARM$$$$$$Y$$$20240713$$MD$FR$FR
227550973$22755097$3$F$$20240830$20230727$20240830$PER$$NVSC2023US164654$NOVARTIS$$$$$M$Y$92.4$KG$20240830$$CN$US$US
227551235$22755123$5$F$20230101$20240806$20230727$20240812$EXP$$JP-009507513-2307JPN002869J$MERCK$$77$YR$$M$Y$60$KG$20240812$$MD$JP$JP
227551346$22755134$6$F$20230101$20240816$20230727$20240827$EXP$$DE-INSMED, INC.-2023-02775-DE$INSMED$$70$YR$$M$Y$$$20240827$$MD$DE$DE
227551485$22755148$5$F$20230701$20231005$20230727$20240926$PER$$US-GSK-US2023AMR102191$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240926$$CN$US$US
227553664$22755366$4$F$20230718$20240822$20230727$20240903$EXP$$US-Accord-369383$ACCORD$$59$YR$A$M$Y$$$20240903$$HP$US$US
227553945$22755394$5$F$20210101$20240815$20230727$20240827$EXP$$BE-Accord-368959$ACCORD$Baczewska N, Philippart M, Siplet J, Baurain JF, Stainier L, Laterre E, et.al. Immune checkpoint inhibitor refractory colitis leading to total colectomy in a melanoma patient. Acta Gastroenterol Belg. 2023 Apr-Jun;86(2):371-373.$73$YR$E$M$Y$$$20240827$$MD$BE$BE
227556088$22755608$8$F$20220417$20240911$20230727$20240919$EXP$$US-CELLTRION INC.-2023US014781$CELLTRION$$$$$$Y$$$20240919$$CN$US$US
227556743$22755674$3$F$20180101$20240828$20230727$20240830$PER$$NVSC2023US165131$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
227557522$22755752$2$F$$20240725$20230727$20240802$PER$$NVSC2023US165277$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
227558284$22755828$4$F$$20240904$20230727$20240916$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2023-103205$BRISTOL MYERS SQUIBB$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A, et al. B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. report of three cases and review of the literature. Leukemia and Lymphoma. 2023 Jul 17;64(10):1701-5. doi:10.1080/10428194.2023.2234527.$69$YR$E$F$Y$$$20240916$$HP$ES$ES
227558783$22755878$3$F$$20240727$20230727$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-06064$LUPIN$$$$$$Y$$$20240821$$CN$US$US
227559314$22755931$4$F$$20240709$20230727$20240717$PER$$US-VERTEX PHARMACEUTICALS-2023-010576$VERTEX$$34$YR$$$Y$$$20240717$$CN$US$US
227560612$22756061$2$F$20221201$20240724$20230727$20240725$EXP$FR-AFSSAPS-PB2023000913$FR-ROCHE-3393041$ROCHE$$41$YR$A$M$Y$$$20240725$$PH$FR$FR
227561422$22756142$2$F$$20240724$20230727$20240801$PER$$US-SA-2023SA226761$SANOFI AVENTIS$$$$C$M$Y$22.676$KG$20240801$$MD$US$US
227561555$22756155$5$F$20230517$20240903$20230727$20240910$EXP$FR-AFSSAPS-PV2023000673$NVSC2023FR163636$NOVARTIS$$17$YR$$F$Y$57$KG$20240910$$MD$FR$FR
227561573$22756157$3$F$20220211$20240818$20230727$20240827$EXP$$NVSC2023IN164373$NOVARTIS$$75$YR$$F$Y$$$20240827$$CN$IN$IN
227562302$22756230$2$F$$20240906$20230727$20240916$PER$$US-SA-2023SA227848$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240916$$MD$US$US
227562642$22756264$2$F$20230101$20240827$20230727$20240909$PER$$US-SA-2023SA229018$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240909$$MD$US$US
227562935$22756293$5$F$20220101$20240906$20230727$20240916$EXP$$CA-TAKEDA-2020TUS031605$TAKEDA$$$$$F$Y$$$20240916$$PH$CA$CA
227563256$22756325$6$F$$20240701$20230727$20240704$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2023-104804$BRISTOL MYERS SQUIBB$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A, et al. B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. report of three cases and review of the literature. Leukemia and Lymphoma. 2023 Jul 17;64(10):1701-5.doi:10.1080/10428194.2023.2234527.$67$YR$E$M$Y$$$20240704$$HP$ES$ES
227564434$22756443$4$F$20230518$20240814$20230727$20240821$EXP$$DE-TAKEDA-2023TUS046567$TAKEDA$$32$YR$$F$Y$60$KG$20240821$$MD$DE$DE
227564803$22756480$3$F$$20240715$20230727$20240717$PER$$NVSC2023US164034$NOVARTIS$$$$$$Y$$$20240717$$CN$US$US
227565342$22756534$2$F$20220401$20240711$20230727$20240718$EXP$$US-SA-2023SA228546$SANOFI AVENTIS$$44$YR$A$M$Y$140$KG$20240718$$MD$US$US
227565882$22756588$2$F$$20240801$20230727$20240802$EXP$$CA-PURDUE-USA-2023-0303735$PURDUE$$47$YR$$F$Y$$$20240802$$HP$CA$CA
227566493$22756649$3$F$$20230725$20230727$20240911$PER$$NVSC2023US164723$NOVARTIS$$$$$$Y$$$20240911$$MD$US$US
227569719$22756971$9$F$20230719$20240815$20230727$20240819$EXP$$CA-TAKEDA-2023TUS073075$TAKEDA$$45$YR$$F$Y$$$20240819$$HP$CA$CA
2275709215$22757092$15$F$$20240910$20230727$20240913$EXP$$US-PFIZER INC-2020045877$PFIZER$$76$YR$$F$Y$67.13$KG$20240913$$MD$US$US
227572875$22757287$5$F$$20240812$20230727$20240816$EXP$$CA-TAKEDA-2023TUS073112$TAKEDA$$$$$F$Y$$$20240816$$CN$CA$CA
227573143$22757314$3$F$$20240821$20230727$20240828$EXP$$BR-TAKEDA-2023TUS052708$TAKEDA$$$$$M$Y$$$20240828$$CN$BR$BR
227573354$22757335$4$F$20190101$20240722$20230727$20240726$PER$$US-PFIZER INC-202300255892$PFIZER$$71$YR$$F$Y$64.41$KG$20240726$$CN$US$US
227574792$22757479$2$F$$20240805$20230727$20240807$EXP$$NVSC2023US165137$NOVARTIS$$$$$M$Y$$$20240807$$CN$US$US
227574993$22757499$3$F$20001001$20240802$20230727$20240808$EXP$$US-ABBVIE-5341306$ABBVIE$$49$YR$$F$Y$103.41$KG$20240808$$CN$US$US
2275764114$22757641$14$F$20230101$20240802$20230727$20240809$EXP$$JP-009507513-2307JPN003086J$MERCK$Uchiyama N, Miyamoto T, Takeuchi H, Ando H, Kobara H, Ida K, et al.. P-9-3 Two cases of acute aortic dissection after treatment with VEGF-inhibitors. Acta Obstetrica et Gynaecologica Japonica The 76th Annual Congress of the Japan. 2024;76(S):S408$$$$F$Y$66$KG$20240809$$MD$JP$JP
227577752$22757775$2$F$20230726$20240918$20230727$20240927$PER$$NVSC2023US165483$NOVARTIS$$87$YR$$F$Y$$$20240927$$CN$US$US
227580002$22758000$2$F$$20240722$20230727$20240726$EXP$$IT-VERTEX PHARMACEUTICALS-2023-010800$VERTEX$Terlizzi V, Timpano S, Salvi M, Tosco A, Castaldo A, Fevola C, et al.. Hyperbilirubinemia and Gilbert^s syndrome in cystic fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor. J Cyst Fibros. 2023$27$YR$$M$Y$$$20240726$$MD$IT$IT
227580032$22758003$2$F$$20240722$20230727$20240726$EXP$$IT-VERTEX PHARMACEUTICALS-2023-010797$VERTEX$Terlizzi V, Timpano S, Salvi M, Tosco A, Castaldo A, Fevola C, et al.. Hyperbilirubinemia and Gilbert^s syndrome in cystic fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor. J Cyst Fibros. 2023$16$YR$$M$Y$$$20240726$$MD$IT$IT
227580153$22758015$3$F$20230601$20240628$20230727$20240705$EXP$$JP-009507513-2307JPN002843J$MERCK$$8$DEC$$M$Y$$$20240705$$MD$JP$JP
227580262$22758026$2$F$$20240718$20230727$20240722$EXP$GB-MHRA-MIDB-3862d22b-77ef-41f7-8aa6-eb1928a825de$GB-MYLANLABS-2023M1078543$MYLAN$$88$YR$$$Y$$$20240722$$PH$GB$GB
227582413$22758241$3$F$20220101$20240711$20230727$20240716$EXP$$NVSC2022CA208501$NOVARTIS$$32$YR$$M$Y$$$20240716$$CN$CA$CA
227583534$22758353$4$F$$20240808$20230727$20240813$EXP$$US-ABBVIE-5344380$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
2275844311$22758443$11$F$$20240614$20230727$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002732$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
227584488$22758448$8$F$20230731$20240625$20230727$20240719$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002738$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240719$$CN$US$US
227584496$22758449$6$F$20230614$20240613$20230727$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002737$ACADIA PHARMACEUTICALS$$16$YR$$F$Y$$$20240708$$CN$US$US
227584566$22758456$6$F$20230601$20240613$20230728$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002752$ACADIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240708$$CN$US$US
2275846311$22758463$11$F$20230701$20240711$20230728$20240802$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002767$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240802$$CN$US$US
2275847210$22758472$10$F$20230615$20240822$20230728$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002797$ACADIA PHARMACEUTICALS$$22$YR$$F$Y$$$20240913$$CN$US$US
227585075$22758507$5$F$$20240916$20230728$20240923$EXP$$PT-ABBVIE-4769806$ABBVIE$$$$E$$Y$$$20240923$$MD$PT$PT
227585782$22758578$2$F$$20240823$20230728$20240830$EXP$$US-ABBVIE-5183488$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
227586042$22758604$2$F$$20240712$20230728$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-060324$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240722$$MD$JP$JP
227586409$22758640$9$F$20230526$20240814$20230728$20240821$EXP$$CA-TAKEDA-2023TUS053796$TAKEDA$$64$YR$$M$Y$$$20240821$$CN$CA$CA
227586432$22758643$2$F$$20240705$20230728$20240707$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-252094$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240707$$CN$US$US
227588542$22758854$2$F$20230214$20240626$20230728$20240704$EXP$$FR-AUROBINDO-AUR-APL-2023-048539$AUROBINDO$$73$YR$$F$Y$$$20240704$$MD$FR$FR
227588783$22758878$3$F$$20240722$20230728$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-105952$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240724$$CN$US$US
227590526$22759052$6$F$20230309$20240924$20230728$20240930$EXP$$DE-ABBVIE-5344291$ABBVIE$$72$YR$$M$Y$75$KG$20240930$$MD$DE$DE
227590583$22759058$3$F$$20240624$20230728$20240702$EXP$$CA-CELLTRION INC.-2023CA014916$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
227591995$22759199$5$F$20240401$20240731$20230728$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-106202$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240801$$CN$US$US
227592002$22759200$2$F$20190701$20240723$20230728$20240729$EXP$$US-SA-2023SA229204$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240729$$MD$US$US
227592133$22759213$3$F$20230721$20240829$20230728$20240903$EXP$$CA-JNJFOC-20230742954$JOHNSON AND JOHNSON$$10$YR$C$M$Y$39.6$KG$20240903$$HP$CA$CA
227592163$22759216$3$F$20221230$20240813$20230728$20240814$EXP$$US-UCBSA-2023032243$UCB$$41$YR$$F$Y$$$20240814$$HP$US$US
227592388$22759238$8$F$20220621$20240826$20230728$20240829$EXP$$JP-TAKEDA-2023TJP003295AA$TAKEDA$$42$YR$$F$Y$53$KG$20240829$$CN$JP$JP
227592945$22759294$5$F$20230308$20240730$20230728$20240808$EXP$$JP-ROCHE-3394981$ROCHE$$59$YR$A$F$Y$46.7$KG$20240808$$MD$JP$JP
227593624$22759362$4$F$$20240717$20230728$20240719$EXP$$JP-ABBVIE-5343631$ABBVIE$$66$YR$$M$Y$$$20240719$$PH$JP$JP
227596426$22759642$6$F$20230701$20240727$20230728$20240806$EXP$$JP-UNITED THERAPEUTICS-UNT-2023-021143$UNITED THERAPEUTICS$$74$YR$$M$Y$$$20240806$$$JP$JP
227596534$22759653$4$F$20220101$20240909$20230728$20240912$EXP$$US-ABBVIE-5343595$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
227596804$22759680$4$F$$20240704$20230728$20240710$EXP$$AU-CELLTRION INC.-2023AU014984$CELLTRION$$$$$$Y$$$20240710$$MD$AU$AU
227596965$22759696$5$F$20221101$20240815$20230728$20240822$EXP$$DE-ROCHE-3349404$ROCHE$$34$YR$A$F$Y$$$20240822$$CN$DE$DE
227598143$22759814$3$F$$20240216$20230728$20240926$EXP$$US-GSK-US2021AMR095860$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
227598353$22759835$3$F$20230620$20240912$20230728$20240919$EXP$$JP-AMGEN-JPNSP2023128914$AMGEN$$72$YR$E$M$Y$$$20240919$$MD$JP$JP
227599702$22759970$2$F$$20240722$20230728$20240729$EXP$$TN-AMGEN-TUNSP2023131927$AMGEN$Mahjoubi Y.; Kaabi W.; Lakhoua G. et al.. Tubulointerstitial nephritis induced by adalimumab. Fundamental and Clinical Pharmacology. 2023;37 (SUPP_1):200$59$YR$A$M$Y$$$20240729$$HP$TN$TN
227600094$22760009$4$F$20230712$20240828$20230728$20240906$30DAY$$US-GSK-US2023098692$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240906$$CN$US$US
227600563$22760056$3$F$$20240906$20230728$20240917$EXP$$NO-STRIDES ARCOLAB LIMITED-2023SP012173$STRIDES$Sommerfelt H, Sandvik LF, Bachmann IM, Brekke RL, Svendsen HL, Guttormsen AB. Toxic epidermal necrolysis after immune checkpoint inhibition, case report, and review of the literature. Acta Oncologica. 2022;61(10):1295-1299$34$YR$$M$Y$$$20240917$$HP$NO$NO
227600792$22760079$2$F$20230127$20240816$20230728$20240828$EXP$FR-AFSSAPS-AM2023000560$FR-Accord-369329$ACCORD$$69$YR$E$F$Y$73$KG$20240828$$MD$FR$FR
227600864$22760086$4$F$20210101$20240719$20230728$20240724$PER$$US-PFIZER INC-PV202300128458$PFIZER$$76$YR$$F$Y$$$20240724$$HP$US$US
227601025$22760102$5$F$$20240801$20230728$20240805$PER$$US-PFIZER INC-PV202300130060$PFIZER$$77$YR$$F$Y$83.9$KG$20240805$$CN$US$US
227601119$22760111$9$F$20230101$20240703$20230728$20240704$PER$$US-PFIZER INC-202200254917$PFIZER$$83$YR$$F$Y$$$20240704$$CN$US$US
227601476$22760147$6$F$20220101$20240801$20230728$20240805$EXP$$US-PFIZER INC-PV202300130146$PFIZER$$54$YR$$F$Y$$$20240805$$HP$US$US
227602733$22760273$3$F$$20240822$20230728$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-06023$LUPIN$$$$$$Y$$$20240909$$CN$US$US
227603175$22760317$5$F$$20240626$20230728$20240701$PER$$US-PFIZER INC-202300261100$PFIZER$$77$YR$$F$Y$$$20240701$$CN$US$US
227603282$22760328$2$F$$20240725$20230728$20240730$PER$$US-PFIZER INC-PV202300129304$PFIZER$$51$YR$$F$Y$$$20240730$$CN$US$US
227603336$22760333$6$F$20230722$20240820$20230728$20240827$EXP$$CA-CELLTRION INC.-2023CA015023$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
227603794$22760379$4$F$$20240725$20230728$20240730$EXP$$US-JAZZ-2022-US-033780$JAZZ$$$$$F$Y$$$20240730$$PH$US$US
227604503$22760450$3$F$20021001$20240702$20230728$20240708$EXP$$GB-MYLANLABS-2023M1078418$MYLAN$$38$YR$$M$Y$$$20240708$$MD$GB$GB
227605773$22760577$3$F$20230928$20240718$20230728$20240722$EXP$$CA-TAKEDA-2023TUS072354$TAKEDA$$75$YR$$M$Y$$$20240722$$CN$CA$CA
227606114$22760611$4$F$20220927$20240808$20230728$20240815$EXP$$CA-CELLTRION INC.-2022CA016423$CELLTRION$$$$$$Y$$$20240815$$CN$CA$CA
227606682$22760668$2$F$$20240625$20230728$20240701$EXP$$CA-MYLANLABS-2023M1078107$MYLAN$$54$YR$$F$Y$$$20240701$$HP$CA$CA
227607623$22760762$3$F$20221001$20240709$20230728$20240716$PER$$US-SA-2023SA227681$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240716$$MD$US$US
2276077310$22760773$10$F$20230101$20240808$20230728$20240816$PER$$US-SA-2023SA230077$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240816$$MD$US$US
227607832$22760783$2$F$$20240719$20230728$20240730$PER$$US-SA-2023SA229758$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240730$$MD$US$US
227608112$22760811$2$F$20230721$20240903$20230728$20240913$PER$$US-SA-2023SA229701$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240913$$MD$US$US
227608175$22760817$5$F$20230704$20240814$20230728$20240819$EXP$$US-SA-2023SA227507$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240819$$MD$US$US
227608693$22760869$3$F$20230101$20240826$20230728$20240910$PER$$US-SA-2023SA228895$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240910$$MD$US$US
227608783$22760878$3$F$20230101$20240624$20230728$20240701$PER$$US-SA-2023SA227235$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240701$$MD$US$US
227609952$22760995$2$F$$20240920$20230728$20240924$EXP$$CN-PFIZER INC-PV202300127103$PFIZER$Xie, Z.. Early first line combination of Tofacitinib for severe anti-melanoma differentiation associated gene-5 positive dermatomyositis with rapidly progressive interstitial lung disease:a case report and literature review. Chinese Journal of Clinical Pathologist. 2023;15(1):97-102$49$YR$$M$Y$72$KG$20240924$$HP$CN$CN
2276130321$22761303$21$F$20090101$20240909$20230728$20240912$EXP$$GB-MYLANLABS-2023M1078797$MYLAN$$37$YR$$M$Y$$$20240912$$CN$GB$GB
227613043$22761304$3$F$$20240805$20230728$20240828$PER$$US-PHARMING-PHAUS2023000535$PHARMING GROUP$$$$$$Y$$$20240808$$CN$US$US
2276141615$22761416$15$F$20230101$20240925$20230728$20240927$PER$$US-PFIZER INC-202300195635$PFIZER$$70$YR$$F$Y$58.97$KG$20240927$$CN$US$US
227614288$22761428$8$F$20220301$20240822$20230728$20240828$PER$$US-PFIZER INC-PV202300129750$PFIZER$$63$YR$$F$Y$56.6$KG$20240828$$MD$US$US
227615197$22761519$7$F$20230701$20240809$20230728$20240814$EXP$$US-SA-2023SA229757$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240814$$MD$US$US
227615624$22761562$4$F$20240602$20240701$20230728$20240702$EXP$$US-PFIZER INC-PV202300127056$PFIZER$$78$YR$$F$Y$$$20240702$$HP$US$US
227615926$22761592$6$F$20240202$20240711$20230728$20240715$EXP$$US-ARGENX-2023-ARGX-US001399$ARGENX BVBA$$$$$$Y$$$20240715$$CN$US$US
227616105$22761610$5$F$20240101$20240903$20230728$20240905$PER$$US-PFIZER INC-PV202300128427$PFIZER$$61$YR$$F$Y$$$20240905$$HP$US$US
227616144$22761614$4$F$$20240722$20230728$20240730$PER$$US-PFIZER INC-PV202300130382$PFIZER$$75$YR$$F$Y$$$20240730$$CN$US$US
227616214$22761621$4$F$$20240628$20230728$20240703$PER$$US-PFIZER INC-PV202300129087$PFIZER$$66$YR$$F$Y$$$20240703$$HP$US$US
227616222$22761622$2$F$$20240625$20230728$20240701$PER$$US-PFIZER INC-PV202300129060$PFIZER$$80$YR$$F$Y$$$20240701$$CN$US$US
227621572$22762157$2$F$20220926$20240625$20230728$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-383158$RANBAXY$$86$YR$$M$Y$$$20240710$$MD$IT$IT
227622182$22762218$2$F$$20240802$20230728$20240816$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401215$RANBAXY$Tiv H, Vandelaer A, Delanaye P, Forte F, Bouquegneau A. Diagnostic trap: Lithium neurotoxicity with normal lithemia. Nephrol ther. 2022;18(7):650-654$53$YR$$F$Y$$$20240816$$HP$BE$BE
227622586$22762258$6$F$20080101$20240624$20230728$20240702$EXP$$CO-LUNDBECK-DKLU3065411$LUNDBECK$$$$$$Y$$$20240702$$HP$FR$CO
227624912$22762491$2$F$20230214$20240701$20230728$20240708$EXP$FR-AFSSAPS-AM2023000635$FR-MYLANLABS-2023M1079474$MYLAN$$73$YR$$F$Y$$$20240708$$MD$FR$FR
227625113$22762511$3$F$20230712$20240909$20230728$20240911$PER$$US-PFIZER INC-202300262156$PFIZER$$28$YR$$F$Y$$$20240911$$HP$US$US
227625175$22762517$5$F$20200101$20240807$20230728$20240812$PER$$US-PFIZER INC-PV202200082201$PFIZER$$25$YR$$F$Y$$$20240812$$HP$US$US
227625463$22762546$3$F$$20240826$20230728$20240827$PER$$US-PFIZER INC-PV202300130292$PFIZER$$87$YR$$M$Y$$$20240827$$CN$US$US
227625493$22762549$3$F$$20240703$20230728$20240708$EXP$$US-PFIZER INC-US-GBT-021957$PFIZER$$34$YR$$F$Y$62.6$KG$20240708$$CN$US$US
227626205$22762620$5$F$20220701$20240813$20230728$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202307016133$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240816$$CN$US$US
227626925$22762692$5$F$20230522$20240722$20230728$20240729$EXP$$DE-ABBVIE-5345705$ABBVIE$$60$YR$$F$Y$$$20240729$$CN$DE$DE
227627017$22762701$7$F$20230314$20240813$20230728$20240821$EXP$$HU-PFIZER INC-202300144869$PFIZER$$49$YR$$F$Y$$$20240820$$HP$HU$HU
227627236$22762723$6$F$20221101$20240919$20230728$20240930$EXP$$CA-INTERCEPT-PM2023000503$INTERCEPT PHARMACEUTICALS$$65$YR$$F$Y$$$20240930$$PH$CA$CA
227627684$22762768$4$F$20230514$20240826$20230728$20240904$EXP$$JP-JAZZ PHARMACEUTICALS-2023-JP-016151$JAZZ$$53$YR$$F$Y$61.3$KG$20240903$$MD$JP$JP
227629232$22762923$2$F$$20230726$20230728$20240904$PER$$NVSC2023US166054$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
227631183$22763118$3$F$20230712$20240805$20230729$20240816$EXP$$US-Accord-369445$ACCORD$$54$YR$A$F$Y$$$20240816$$MD$US$US
227631203$22763120$3$F$$20240815$20230729$20240827$EXP$$PT-Accord-369554$ACCORD$Lopes DF, Simoes FO, Andrade J, Sousa RM, Iglesias F, Goncalves I. Mycobacteriosis disseminated by Mycobacterium celatum: A case of diagnostic persistence. 29TH NATIONAL CONGRESS OF INTERNAL MEDICINE. 2023;819$60$YR$A$F$Y$$$20240827$$HP$PT$PT
227632142$22763214$2$F$20230620$20240705$20230729$20240715$EXP$IT-MINISAL02-934682$IT-TEVA-2023-IT-2911150$TEVA$$12$YR$$M$Y$52$KG$20240715$$PH$IT$IT
227632436$22763243$6$F$20230101$20240404$20230729$20240808$EXP$$NVSC2023CR139843$NOVARTIS$$75$YR$$F$Y$$$20240808$$CN$CR$CR
227633723$22763372$3$F$$20240821$20230730$20240826$PER$$NVSC2023US165792$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
227634793$22763479$3$F$$20240727$20230730$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-06111$LUPIN$$$$$$Y$$$20240817$$CN$US$US
227635393$22763539$3$F$$20240829$20230730$20240904$PER$$NVSC2023US165915$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
227635435$22763543$5$F$20211213$20240725$20230730$20240801$EXP$$NVSC2021AR296625$NOVARTIS$$67$YR$$F$Y$$$20240802$$CN$AR$AR
227635912$22763591$2$F$$20230728$20230730$20240829$EXP$$NVSC2023US164445$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
227636123$22763612$3$F$20230509$20240712$20230730$20240720$EXP$FR-AFSSAPS-RE2023000520$NVSC2023FR127953$NOVARTIS$$87$YR$$F$Y$75$KG$20240719$$MD$FR$FR
227637842$22763784$2$F$$20240726$20230730$20240807$PER$$US-SA-2023SA228195$SANOFI AVENTIS$$10$YR$C$F$Y$25.4$KG$20240807$$MD$US$US
227639853$22763985$3$F$20230720$20240718$20230730$20240721$EXP$$JP-TAKEDA-2023TJP009984$TAKEDA$$14$YR$$M$Y$$$20240721$$MD$JP$JP
2276412811$22764128$11$F$20240601$20240729$20230731$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-106077$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240806$$HP$US$US
227642406$22764240$6$F$20230401$20240722$20230731$20240731$PER$$US-SA-2023SA230619$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240731$$MD$US$US
227643224$22764322$4$F$20230224$20240720$20230731$20240729$EXP$$DE-AUROBINDO-AUR-APL-2023-049103$AUROBINDO$$36$YR$$M$Y$89$KG$20240729$$MD$DE$DE
227643543$22764354$3$F$20230101$20240701$20230731$20240709$PER$$US-SA-2023SA228816$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240709$$MD$US$US
227644035$22764403$5$F$20240101$20240612$20230731$20240703$PER$$CA-TOLMAR, INC.-23CA041829$TOLMAR$$$$$M$Y$$$20240703$$CN$CA$CA
227644086$22764408$6$F$$20240828$20230731$20240923$PER$$CA-TOLMAR, INC.-23CA041844$TOLMAR$$$$$M$Y$$$20240923$$CN$CA$CA
227645406$22764540$6$F$$20240624$20230731$20240702$EXP$$CA-APOTEX-2023AP011052$APOTEX$$50$YR$$F$Y$$$20240702$$HP$CA$CA
227645765$22764576$5$F$20230908$20240903$20230731$20240910$EXP$$CA-TAKEDA-2023TUS073133$TAKEDA$$68$YR$$M$Y$$$20240910$$CN$CA$CA
227646482$22764648$2$F$20230526$20230725$20230731$20240913$EXP$$US-BIOGEN-2023BI01208421$BIOGEN$$54$YR$$F$Y$$$20240913$$CN$US$US
227646529$22764652$9$F$20230701$20240625$20230731$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002796$ACADIA PHARMACEUTICALS$$41$YR$$F$Y$$$20240719$$CN$US$US
2276465313$22764653$13$F$20230705$20240620$20230731$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002802$ACADIA PHARMACEUTICALS$$22$YR$$F$Y$$$20240712$$CN$US$US
227646598$22764659$8$F$20230710$20240722$20230731$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002824$ACADIA PHARMACEUTICALS$$14$YR$$F$Y$$$20240814$$CN$US$US
2276466012$22764660$12$F$20230501$20240620$20230731$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002804$ACADIA PHARMACEUTICALS$$13$YR$$F$Y$$$20240712$$CN$US$US
227646624$22764662$4$F$20240601$20240613$20230731$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003093$ACADIA PHARMACEUTICALS$$88$YR$$F$Y$$$20240708$$CN$US$US
227647063$22764706$3$F$20220101$20240708$20230731$20240711$EXP$$CO-JNJFOC-20230760017$JOHNSON AND JOHNSON$$61$YR$A$F$Y$90$KG$20240711$$HP$CO$CO
227647408$22764740$8$F$20230723$20240304$20230731$20240925$PER$$US-GSK-US2023AMR101596$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240925$$CN$US$US
2276485242$22764852$42$F$20230725$20240917$20230731$20240925$EXP$$CA-TAKEDA-2023TUS027915$TAKEDA$$5$YR$$M$Y$23.12$KG$20240925$$CN$CA$CA
227648922$22764892$2$F$$20240624$20230731$20240702$EXP$$FR-TOLMAR, INC.-23FR042146$TOLMAR$$78$YR$$M$Y$92$KG$20240702$$MD$FR$FR
227650073$22765007$3$F$$20240412$20230731$20240813$EXP$$CA-TEVA-2023-CA-2903693$TEVA$$50$YR$$F$Y$$$20240813$$HP$CA$CA
2276503310$22765033$10$F$20220101$20240626$20230731$20240703$EXP$$JP-AMGEN-JPNSP2022102945$AMGEN$$$$A$M$Y$$$20240703$$PH$JP$JP
227650493$22765049$3$F$$20230725$20230731$20240710$PER$$US-ROCHE-3394833$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
227653172$22765317$2$F$20230613$20240125$20230731$20240830$PER$$US-CIPLA LTD.-2023US03422$CIPLA$$$$$$Y$$$20240830$$HP$US$US
227653192$22765319$2$F$20230101$20240125$20230731$20240830$PER$$US-CIPLA LTD.-2023US03248$CIPLA$$$$$$Y$$$20240830$$CN$US$US
227653376$22765337$6$F$20240416$20240913$20230731$20240923$EXP$$CA-TAKEDA-2023TUS073671$TAKEDA$$53$YR$$F$Y$$$20240923$$HP$CA$CA
227655573$22765557$3$F$20240611$20240827$20230731$20240906$30DAY$$US-GSK-US2023100607$GLAXOSMITHKLINE$$24$YR$$F$Y$$$20240906$$CN$US$US
227655983$22765598$3$F$20221123$20240805$20230731$20240806$EXP$$JP-TAKEDA-2022TJP078710$TAKEDA$$47$YR$$F$Y$$$20240806$$MD$JP$JP
227656509$22765650$9$F$20230510$20240801$20230731$20240806$EXP$$CA-TAKEDA-2023TUS061752$TAKEDA$$9$YR$$F$Y$$$20240806$$MD$CA$CA
227656522$22765652$2$F$20230601$20230802$20230731$20240716$PER$$US-APOTEX-2023AP010134$APOTEX$$$$$F$Y$$$20240716$$CN$US$US
227659777$22765977$7$F$20230428$20240905$20230731$20240909$EXP$$JP-GILEAD-2023-0628230$GILEAD$$60$YR$A$M$Y$49$KG$20240909$$MD$JP$JP
227660444$22766044$4$F$20230717$20240829$20230731$20240910$EXP$$US-Accord-369361$ACCORD$$30$YR$A$F$Y$$$20240910$$MD$US$US
227661752$22766175$2$F$$20240808$20230731$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202307016093$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240829$$CN$US$US
227662358$22766235$8$F$20230513$20240904$20230731$20240909$EXP$$IN-PFIZER INC-PV202300086906$PFIZER$$54$YR$$F$Y$98.3$KG$20240909$$CN$IN$IN
227663003$22766300$3$F$19980101$20240628$20230731$20240711$EXP$NL-LRB-00896459$NL-PFIZER INC-202300257851$PFIZER$$46$YR$$F$Y$93$KG$20240711$$MD$NL$NL
227663214$22766321$4$F$$20240806$20230731$20240812$EXP$$BE-MYLANLABS-2023M1079350$MYLAN$Verhe M, Somer TD, Defoort B, Vanderstraeten E, Monsaert E, Bouderez V, et al. The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report. Case Rep Oncol. 2023;16:453?460$73$YR$$M$Y$$$20240812$$HP$BE$BE
227664462$22766446$2$F$$20240719$20230731$20240724$EXP$$US-ABBVIE-5338202$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
227664862$22766486$2$F$20230531$20230814$20230731$20240813$PER$$US-ENDO PHARMACEUTICALS INC-2023-002610$ENDO$$$$$$Y$$$20240813$$PH$US$US
227664872$22766487$2$F$20230531$20230814$20230731$20240813$PER$$US-ENDO PHARMACEUTICALS INC-2023-002600$ENDO$$$$$$Y$$$20240813$$PH$US$US
227664892$22766489$2$F$20230606$20240906$20230731$20240916$EXP$$BR-TAKEDA-2023TUS049913$TAKEDA$$38$YR$$M$Y$$$20240916$$CN$BR$BR
227665264$22766526$4$F$$20240626$20230731$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202307015868$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240708$$CN$US$US
227665822$22766582$2$F$$20240712$20230731$20240722$30DAY$$US-GSK-US2023AMR103138$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$HP$US$US
227666445$22766644$5$F$$20240802$20230731$20240809$EXP$$US-PHARMAAND-2023PHR00084$pharmaAND$$$$$F$Y$$$20240809$$CN$US$US
227668226$22766822$6$F$20200101$20240826$20230731$20240828$EXP$$US-JAZZ-2021-US-023489$JAZZ$$41$YR$$F$Y$$$20240828$$MD$US$US
227668293$22766829$3$F$20230420$20230720$20230731$20240730$EXP$FR-AFSSAPS-PV2023000649$FR-009507513-2307FRA010441$MERCK$$$$$F$Y$$$20240730$$MD$FR$FR
227668517$22766851$7$F$20230101$20240711$20230731$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-011830$JAZZ$$$$$M$Y$$$20240722$$HP$US$US
2276687611$22766876$11$F$20230101$20240718$20230731$20240723$EXP$$CA-PFIZER INC-202300210400$PFIZER$$40$YR$$F$Y$59$KG$20240723$$MD$CA$CA
2276692110$22766921$10$F$$20240918$20230731$20240923$EXP$$IN-PFIZER INC-PV202200118097$PFIZER$$46$YR$$F$Y$$$20240923$$CN$IN$IN
227669632$22766963$2$F$20230622$20240725$20230731$20240726$EXP$PT-INFARMED-J202307-541$PT-PFIZER INC-202300260692$PFIZER$$68$YR$$F$Y$$$20240726$$PH$PT$PT
2276703311$22767033$11$F$20230914$20240725$20230731$20240730$EXP$$US-PFIZER INC-PV202300130259$PFIZER$$76$YR$$F$Y$48.073$KG$20240730$$CN$US$US
2276705813$22767058$13$F$20231014$20240907$20230731$20240911$EXP$$IN-PFIZER INC-2021355950$PFIZER$$59$YR$$F$Y$$$20240911$$CN$IN$IN
227670936$22767093$6$F$20220101$20240625$20230731$20240701$EXP$$US-PFIZER INC-PV202200063118$PFIZER$$78$YR$$M$Y$77.11$KG$20240701$$CN$US$US
227670943$22767094$3$F$$20240715$20230731$20240717$EXP$$US-PFIZER INC-PV202300131739$PFIZER$$65$YR$$F$Y$70.295$KG$20240717$$CN$US$US
227672084$22767208$4$F$$20240807$20230731$20240813$PER$$US-JAZZ PHARMACEUTICALS-2023-US-008646$JAZZ$$$$$F$Y$$$20240812$$MD$US$US
227672675$22767267$5$F$20220101$20240826$20230731$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-011346$JAZZ$$54$YR$$F$Y$$$20240830$$CN$US$US
227673774$22767377$4$F$20230101$20240717$20230731$20240723$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-011194$JAZZ$$$$$F$Y$$$20240723$$CN$US$US
227673992$22767399$2$F$20220901$20240916$20230731$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-010450$JAZZ$$52$YR$$F$Y$$$20240919$$HP$US$US
227674628$22767462$8$F$20230726$20240824$20230731$20240828$EXP$$GR-ABBVIE-5346352$ABBVIE$$77$YR$$F$Y$$$20240828$$CN$GR$GR
2276757610$22767576$10$F$20230130$20240701$20230731$20240705$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-003191$JAZZ$$28$YR$$F$Y$$$20240705$$HP$US$US
2276769016$22767690$16$F$20140927$20240801$20230731$20240816$EXP$$AU-TASMAN PHARMA, INC.-2023TSM00135$TASMAN PHARMA$$27$YR$$M$Y$78$KG$20240816$$HP$AU$AU
227680165$22768016$5$F$20230101$20240730$20230731$20240808$PER$$US-SA-2023SA228508$SANOFI AVENTIS$$10$MON$I$M$Y$$$20240808$$MD$US$US
227680185$22768018$5$F$$20240719$20230731$20240731$PER$$US-SA-2023SA228270$SANOFI AVENTIS$$13$DY$N$F$Y$$$20240731$$MD$US$US
227680204$22768020$4$F$20230101$20240823$20230731$20240906$PER$$US-SA-2023SA226945$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240906$$MD$US$US
227680232$22768023$2$F$20230101$20240726$20230731$20240805$PER$$US-SA-2023SA226776$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240805$$MD$US$US
227680392$22768039$2$F$20230101$20240815$20230731$20240829$PER$$US-SA-2023SA227870$SANOFI AVENTIS$$49$YR$A$F$Y$68$KG$20240829$$MD$US$US
227682254$22768225$4$F$20220901$20240628$20230731$20240712$PER$$US-SA-2023SA227652$SANOFI AVENTIS$$20$YR$A$F$Y$61.2$KG$20240712$$MD$US$US
227682313$22768231$3$F$20230723$20240807$20230731$20240816$PER$$US-SA-2023SA229309$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240816$$MD$US$US
227682402$22768240$2$F$20230101$20240813$20230731$20240821$PER$$US-SA-2023SA229407$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240821$$MD$US$US
227682572$22768257$2$F$$20240620$20230731$20240702$PER$$US-SA-2023SA231537$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240702$$MD$US$US
227682654$22768265$4$F$20230701$20240624$20230731$20240701$PER$$US-SA-2023SA228110$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240701$$MD$US$US
227682962$22768296$2$F$20230101$20240726$20230731$20240806$PER$$US-SA-2023SA228609$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240806$$MD$US$US
227683052$22768305$2$F$20230701$20240816$20230731$20240829$PER$$US-SA-2023SA229742$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240829$$MD$US$US
227683114$22768311$4$F$20230501$20240720$20230731$20240729$PER$$US-SA-2023SA229479$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240729$$MD$US$US
227683714$22768371$4$F$20230101$20240731$20230731$20240809$PER$$US-SA-2023SA227886$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240809$$MD$US$US
227684935$22768493$5$F$20230701$20240729$20230731$20240801$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-010338$JAZZ$$39$YR$$F$Y$$$20240801$$MD$US$US
227684957$22768495$7$F$20230329$20240902$20230731$20240908$EXP$$AU-TAKEDA-2023TUS034005$TAKEDA$$40$YR$$M$Y$$$20240908$$CN$AU$AU
227685184$22768518$4$F$20160108$20240730$20230731$20240802$EXP$$CA-TAKEDA-2015TUS017444$TAKEDA$$43$YR$$M$Y$$$20240802$$HP$CA$CA
227685773$22768577$3$F$20230501$20240827$20230731$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-105207$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240906$$CN$US$US
227686264$22768626$4$F$20230101$20240830$20230731$20240904$PER$$US-BIOGEN-2023BI01218826$BIOGEN$$$$$F$Y$$$20240904$$CN$US$US
227686553$22768655$3$F$$20240806$20230731$20240809$EXP$$US-PFIZER INC-US-GBT-013700$PFIZER$$53$YR$$M$Y$90.72$KG$20240809$$CN$US$US
2276875913$22768759$13$F$$20240719$20230731$20240723$PER$$US-PFIZER INC-PV202300130810$PFIZER$$81$YR$$F$Y$$$20240723$$CN$US$US
2276879310$22768793$10$F$$20240905$20230731$20240909$PER$$US-PFIZER INC-PV202300127279$PFIZER$$79$YR$$M$Y$81.633$KG$20240909$$CN$US$US
227688762$22768876$2$F$20230701$20240711$20230731$20240718$PER$$US-BAYER-2023A105246$BAYER$$$$$F$Y$$$20240718$$CN$US$US
227688842$22768884$2$F$20230707$20240912$20230731$20240913$EXP$FR-AFSSAPS-CF2023000357$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-107035$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$44$KG$20240913$$MD$FR$FR
227689109$22768910$9$F$20240104$20240719$20230731$20240729$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2023-18381$IPSEN$$76$YR$E$F$Y$68.6$KG$20240729$$HP$CA$CA
227689303$22768930$3$F$$20240627$20230731$20240701$PER$$US-PFIZER INC-US-GBT-020937$PFIZER$$43$YR$$F$Y$$$20240701$$HP$US$US
227689702$22768970$2$F$20231101$20240725$20230731$20240730$PER$$US-PFIZER INC-US-GBT-016583$PFIZER$$43$YR$$F$Y$$$20240730$$CN$US$US
227689758$22768975$8$F$20230623$20240923$20230731$20240926$PER$$US-PFIZER INC-PV202300129514$PFIZER$$32$YR$$F$Y$$$20240926$$HP$US$US
227690932$22769093$2$F$$20240808$20230731$20240813$PER$$US-PFIZER INC-202300260282$PFIZER$$54$YR$$F$Y$$$20240813$$CN$US$US
227692224$22769222$4$F$20230710$20240802$20230731$20240812$EXP$$JP-JNJFOC-20230766021$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240812$$MD$JP$JP
227692633$22769263$3$F$$20240924$20230731$20240930$EXP$$US-BIOGEN-2023BI01218699$BIOGEN$$$$$F$Y$$$20240929$$CN$US$US
2276928611$22769286$11$F$20180101$20240716$20230731$20240718$EXP$$US-PFIZER INC-US-GBT-020654$PFIZER$$62$YR$$M$Y$63.5$KG$20240718$$CN$US$US
227693232$22769323$2$F$$20240716$20230731$20240718$PER$$NVSC2023US167510$NOVARTIS$$$$$M$Y$$$20240718$$CN$US$US
227693913$22769391$3$F$20220725$20240726$20230731$20240730$EXP$$NVSJ2023JP011740$NOVARTIS$$45$YR$$F$Y$63$KG$20240731$$MD$JP$JP
227695312$22769531$2$F$20230101$20240703$20230801$20240712$PER$$US-SA-2023SA231149$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240712$$MD$US$US
2276970011$22769700$11$F$20230101$20240909$20230801$20240917$EXP$$CA-CELLTRION INC.-2021CA007651$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
227697217$22769721$7$F$20240110$20240628$20230801$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002850$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240708$$CN$US$US
227697494$22769749$4$F$20231012$20240905$20230801$20240914$EXP$$CA-TAKEDA-2023TUS055070$TAKEDA$$37$YR$$F$Y$61$KG$20240914$$CN$CA$CA
227698385$22769838$5$F$20230101$20240731$20230801$20240809$PER$$US-SA-2023SA231614$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240809$$MD$US$US
227698534$22769853$4$F$20230201$20240725$20230801$20240801$PER$$US-SA-2023SA232885$SANOFI AVENTIS$$55$YR$A$M$Y$95.25$KG$20240801$$MD$US$US
227698672$22769867$2$F$$20240905$20230801$20240930$PER$$US-SA-2023SA231886$SANOFI AVENTIS$$49$YR$A$M$Y$81.6$KG$20240930$$MD$US$US
227698765$22769876$5$F$20230701$20240823$20230801$20240906$PER$$US-SA-2023SA231201$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240906$$MD$US$US
227698776$22769877$6$F$20230707$20240626$20230801$20240701$EXP$$ZA-SANDOZ INC.-SDZ2023ZA006387$SANDOZ$$14$YR$$F$Y$22$KG$20240701$$MD$ZA$ZA
227699562$22769956$2$F$$20230815$20230801$20240802$PER$$US-HIKMA PHARMACEUTICALS-US-H14001-23-01433$HIKMA$$$$$M$Y$$$20240802$$CN$US$US
227700802$22770080$2$F$20230701$20240819$20230801$20240826$PER$$US-SA-2023SA227212$SANOFI AVENTIS$$60$YR$A$F$Y$97.88$KG$20240826$$MD$US$US
227701003$22770100$3$F$$20240819$20230801$20240828$PER$$US-SA-2023SA229405$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240828$$HP$US$US
227701062$22770106$2$F$20220727$20240713$20230801$20240724$PER$$US-SA-2023SA228213$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240724$$MD$US$US
227701762$22770176$2$F$$20240624$20230801$20240705$PER$$US-CHATTEMPRD-2020SA308035$CHATTEM$$$$$M$Y$$$20240705$$CN$US$US
227705074$22770507$4$F$20230824$20240702$20230801$20240710$EXP$$CA-JNJFOC-20230705583$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240710$$CN$CA$CA
227705182$22770518$2$F$20190626$20240625$20230801$20240702$EXP$$JP-GILEAD-2020-0475375$GILEAD$$26$YR$A$M$Y$$$20240702$$MD$JP$JP
227705352$22770535$2$F$20230728$20240805$20230801$20240813$PER$$US-SA-2023SA233340$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240814$$MD$US$US
227706152$22770615$2$F$20230717$20240717$20230801$20240726$EXP$$BR-CELLTRION INC.-2023BR015179$CELLTRION$$$$$$Y$$$20240726$$CN$BR$BR
227708892$22770889$2$F$$20240806$20230801$20240813$PER$$US-SA-2023SA232613$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240814$$MD$US$US
227711912$22771191$2$F$20230101$20240319$20230801$20240715$PER$$US-CIPLA LTD.-2023US03055$CIPLA$$$$$$Y$$$20240715$$CN$US$US
227714044$22771404$4$F$20220920$20240722$20230801$20240726$EXP$$ZA-TAKEDA-2022TUS068574$TAKEDA$$41$YR$$F$Y$$$20240726$$MD$ZA$ZA
227715575$22771557$5$F$20000101$20230915$20230801$20240904$EXP$DE-MYLANLABS-2023M1066032$DE-TORRENT-00024995$TORRENT$$74$YR$E$F$Y$85$KG$20240904$$MD$DE$DE
227715757$22771575$7$F$20230101$20240830$20230801$20240918$EXP$$US-SA-2023SA182154$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240918$$CN$US$US
227716103$22771610$3$F$$20240716$20230801$20240730$EXP$$JP-009507513-2307JPN012445$MERCK$Hamada H, et al.. A case of oversedation suggestive of interaction with aprepitant during Oxycodone administration. The 57th Annual Meeting of the Japan Society of Pain Clinicians. 2023;355$8$DEC$$M$Y$$$20240730$$MD$JP$JP
227717228$22771722$8$F$20220101$20240819$20230801$20240827$EXP$$CA-CELLTRION INC.-2022CA014090$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
227717362$22771736$2$F$20230701$20240809$20230801$20240817$PER$$US-SA-2023SA233511$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240817$$MD$US$US
227717484$22771748$4$F$20230830$20240724$20230801$20240730$EXP$$CA-BAYER-2023A105978$BAYER$$46$YR$A$F$Y$$$20240730$$MD$CA$CA
227718403$22771840$3$F$20220901$20240823$20230801$20240828$EXP$$US-PFIZER INC-PV202300131773$PFIZER$$56$YR$$F$Y$$$20240828$$HP$US$US
227719283$22771928$3$F$$20240927$20230801$20240927$30DAY$$JP-PFIZER INC-PV202300127682$PFIZER$$9$YR$$F$Y$$$20240927$$CN$JP$JP
227719956$22771995$6$F$20230101$20240802$20230801$20240805$PER$$US-PFIZER INC-PV202300130987$PFIZER$$36$YR$$F$Y$$$20240805$$HP$US$US
227721535$22772153$5$F$$20240910$20230801$20240912$PER$$NVSC2023US166448$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
227722084$22772208$4$F$$20240829$20230801$20240829$PER$$NVSC2023US167242$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
227722282$22772228$2$F$$20240830$20230801$20240902$EXP$$NVSC2023US167024$NOVARTIS$$$$$M$Y$191$KG$20240902$$HP$US$US
227722887$22772288$7$F$$20240724$20230801$20240727$EXP$$NVSC2023HR166943$NOVARTIS$$$$A$F$Y$$$20240727$$HP$HR$HR
227723076$22772307$6$F$20221124$20240827$20230801$20240829$EXP$$NVSJ2023JP006963$NOVARTIS$$$$A$M$Y$65.6$KG$20240830$$MD$JP$JP
227724146$22772414$6$F$$20240705$20230801$20240709$EXP$$US-INCYTE CORPORATION-2023IN007670$INCYTE$$$$$$Y$$$20240709$$CN$US$US
227725955$22772595$5$F$20220218$20240712$20230801$20240717$EXP$$US-PFIZER INC-PV202300093732$PFIZER$$84$YR$$F$Y$$$20240717$$HP$US$US
227725995$22772599$5$F$$20240820$20230801$20240826$PER$$US-PFIZER INC-2016246616$PFIZER$$22$YR$$M$Y$53.52$KG$20240826$$HP$US$US
227726342$22772634$2$F$20221102$20240909$20230801$20240910$EXP$$US-UCBSA-2022070271$UCB$$35$YR$$M$Y$$$20240910$$CN$US$US
227727165$22772716$5$F$20210101$20240627$20230801$20240703$EXP$$US-ABBVIE-5347889$ABBVIE$$71$YR$$M$Y$77$KG$20240703$$CN$US$US
227727582$22772758$2$F$20230728$20240918$20230801$20240925$EXP$$NVSC2023US167984$NOVARTIS$$94$YR$$F$Y$$$20240925$$CN$US$US
227728795$22772879$5$F$20230725$20240919$20230801$20240924$EXP$$CA-PFIZER INC-202300138130$PFIZER$$43$YR$$M$Y$94$KG$20240924$$MD$CA$CA
227729884$22772988$4$F$20240901$20240918$20230801$20240920$EXP$$US-PFIZER INC-202300263161$PFIZER$$42$YR$$M$Y$$$20240920$$CN$US$US
227730684$22773068$4$F$20230507$20240627$20230801$20240701$EXP$$CA-TAKEDA-2019TUS068607$TAKEDA$$69$YR$$F$Y$$$20240701$$CN$CA$CA
227730695$22773069$5$F$$20240716$20230801$20240723$EXP$$CA-TAKEDA-2020TUS019355$TAKEDA$$$$$M$Y$$$20240723$$MD$CA$CA
227730794$22773079$4$F$$20240722$20230801$20240729$PER$$US-SA-2023SA231667$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$MD$US$US
227733492$22773349$2$F$$20230725$20230801$20240904$PER$$US-009507513-2307USA012166$MERCK$Jones A.A, Schloemer N.J, Wirostko W.J. Successful Treatment of Von Hippel-Lindau (VHL) Disease-Associated Retinal Capillary Hemangioblastoma (RCH) with Belzutifan in a Pediatric Patient. Retinal cases + brief reports. 2023;656-59$18$YR$$M$Y$$$20240904$$MD$US$US
2277344010$22773440$10$F$20230720$20240901$20230801$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-106708$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240906$$HP$US$US
2277344113$22773441$13$F$20230412$20240705$20230801$20240709$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-053508$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$88$KG$20240709$$HP$CA$CA
227734528$22773452$8$F$20231023$20240731$20230801$20240805$EXP$$US-DAIICHI SANKYO, INC.-DSU-2023-131374$DAIICHI$$59$YR$$F$Y$$$20240805$$CN$US$US
227734884$22773488$4$F$$20240625$20230801$20240703$PER$$US-PFIZER INC-PV202300131044$PFIZER$$56$YR$$F$Y$$$20240703$$CN$US$US
227735795$22773579$5$F$20230702$20240903$20230801$20240911$EXP$$JP-009507513-2307JPN004023J$MERCK$$7$DEC$$M$Y$$$20240911$$PH$JP$JP
227736082$22773608$2$F$20230701$20240916$20230801$20240918$EXP$$US-PFIZER INC-PV202300093528$PFIZER$$65$YR$$M$Y$$$20240918$$HP$US$US
2277360916$22773609$16$F$20231001$20240702$20230801$20240708$PER$$US-PFIZER INC-PV202300086200$PFIZER$$14$YR$$M$Y$50$KG$20240708$$CN$US$US
2277361110$22773611$10$F$20230101$20240821$20230801$20240827$EXP$$US-PFIZER INC-PV202300100293$PFIZER$$64$YR$$F$Y$63.492$KG$20240827$$CN$US$US
227736297$22773629$7$F$$20240718$20230801$20240722$PER$$NVSC2023US168361$NOVARTIS$$$$$F$Y$$$20240722$$HP$US$US
227736325$22773632$5$F$20230711$20240814$20230801$20240819$EXP$$US-BEH-2023161531$CSL BEHRING$$36$YR$A$M$Y$$$20240819$$MD$US$US
227736523$22773652$3$F$20230101$20240903$20230801$20240918$PER$$US-SA-2023SA230306$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240918$$CN$US$US
227737163$22773716$3$F$$20240716$20230801$20240718$PER$$US-PFIZER INC-202300213637$PFIZER$$84$YR$$M$Y$89.81$KG$20240718$$CN$US$US
2277372414$22773724$14$F$20090101$20240916$20230801$20240930$EXP$$GB-TEVA-2023-GB-2911749$TEVA$$37$YR$$M$Y$$$20240930$$HP$GB$GB
227737962$22773796$2$F$$20240703$20230801$20240705$EXP$$US-KAMADA LIMITED-2021US001484$TAKEDA$$$$$M$Y$89$KG$20240705$$CN$US$US
227738796$22773879$6$F$20230717$20240706$20230801$20240709$EXP$$MX-PFIZER INC-PV202300131325$PFIZER$$2$YR$$M$Y$$$20240709$$CN$MX$MX
227739212$22773921$2$F$$20240912$20230801$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-016184$JAZZ$$$$$F$Y$63.5$KG$20240918$$CN$US$US
227739457$22773945$7$F$$20240807$20230801$20240816$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000307$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
2277401212$22774012$12$F$20230630$20240920$20230801$20240930$EXP$$GB-TEVA-2023-GB-2911746$TEVA$$48$YR$$F$Y$49.8$KG$20240930$$MD$GB$GB
227741122$22774112$2$F$$20240703$20230801$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-252873$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240703$$CN$US$US
227742286$22774228$6$F$20220824$20240730$20230801$20240801$EXP$$JP-ABBVIE-5349492$ABBVIE$$58$YR$$M$Y$56$KG$20240801$$MD$JP$JP
227742783$22774278$3$F$$20240829$20230801$20240830$PER$$NVSC2023US168389$NOVARTIS$$$$$M$Y$88.45$KG$20240830$$HP$US$US
227743062$22774306$2$F$20230724$20240722$20230801$20240724$EXP$$JP-TAKEDA-2023TJP010147$TAKEDA$$32$YR$$F$Y$$$20240724$$MD$JP$JP
227744197$22774419$7$F$20220101$20240724$20230802$20240729$EXP$$JP-TAKEDA-2021TJP043185$TAKEDA$$$$$F$Y$65.2$KG$20240729$$CN$JP$JP
227744662$22774466$2$F$20230101$20240725$20230802$20240813$PER$$BR-TOLMAR, INC.-23BR041997$TOLMAR$$8$YR$$F$Y$$$20240813$$CN$BR$BR
227746899$22774689$9$F$20230701$20240109$20230802$20240926$EXP$$US-GSK-US2023AMR103945$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
227746932$22774693$2$F$20211223$20240403$20230802$20240923$PER$$PT-ROCHE-3252397$ROCHE$$76$YR$E$F$Y$$$20240923$$HP$PT$PT
227747592$22774759$2$F$20230709$20230916$20230802$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083712$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
227747625$22774762$5$F$$20240719$20230802$20240724$EXP$$US-TAKEDA-2023TUS074160$TAKEDA$$$$$M$Y$$$20240724$$CN$US$US
227747795$22774779$5$F$20230101$20240814$20230802$20240821$PER$$US-SA-2023SA234131$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240821$$CN$US$US
227747812$22774781$2$F$20230612$20231109$20230802$20240830$PER$$US-CIPLA LTD.-2023US03535$CIPLA$$$$$$Y$$$20240830$$HP$US$US
227747842$22774784$2$F$$20231006$20230802$20240830$PER$$US-CIPLA LTD.-2023US03350$CIPLA$$$$$$Y$$$20240830$$CN$US$US
2277478514$22774785$14$F$$20240905$20230802$20240919$EXP$$US-CIPLA LTD.-2023US04019$CIPLA$$$$$$Y$$$20240920$$CN$US$US
227747882$22774788$2$F$20230101$20231009$20230802$20240830$EXP$$US-CIPLA LTD.-2023US03940$CIPLA$$$$$$Y$$$20240830$$CN$US$US
227747984$22774798$4$F$$20240724$20230802$20240726$EXP$$US-TAKEDA-2023TUS074945$TAKEDA$$$$$F$Y$102$KG$20240726$$CN$US$US
227748662$22774866$2$F$$20240704$20230802$20240712$EXP$$CA-CELLTRION INC.-2023CA015091$CELLTRION$$$$$$Y$$$20240712$$CN$CA$CA
227748813$22774881$3$F$20230414$20240920$20230802$20240920$EXP$$JP-JNJFOC-20230800584$JOHNSON AND JOHNSON$$63$YR$A$M$Y$67$KG$20240920$$MD$JP$JP
227749867$22774986$7$F$$20240815$20230802$20240827$EXP$$CA-AUROBINDO-AUR-APL-2023-049558$AUROBINDO$Rodin I, Evans A. Case of Clozapine-Associated Negative Myoclonus. Journal of clinical psychopharmacology. 2023;43(4):386-7$74$YR$$F$Y$$$20240827$$MD$CA$CA
227751225$22775122$5$F$20220620$20240904$20230802$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-104876$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240912$$MD$JP$JP
227751572$22775157$2$F$$20240731$20230802$20240809$PER$$US-SA-2023SA234137$SANOFI AVENTIS$$$$A$M$Y$86.8$KG$20240809$$MD$US$US
227752622$22775262$2$F$$20240812$20230802$20240814$EXP$$NVSC2023US168150$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
227753433$22775343$3$F$20230628$20240919$20230802$20240928$EXP$$ES-CELLTRION INC.-2023ES015029$CELLTRION$$$$$$Y$$$20240928$$MD$ES$ES
227754023$22775402$3$F$$20230807$20230802$20240710$PER$$IN-ROCHE-3396574$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$IN$IN
227754619$22775461$9$F$20230601$20240913$20230802$20240923$EXP$$AU-ROCHE-3394615$ROCHE$$85$YR$E$F$Y$$$20240923$$MD$AU$AU
227754742$22775474$2$F$$20240808$20230802$20240813$EXP$$FR-002147023-NVSC2023FR148282$Haleon PLC$NSAIDs (ibuprofen/ketoprofen) factor aggravating severe bacterial infection. Bulletin d^information trimestriel (Quarterly newsletter). 2023;45; AINS (ibuprofene/ketoprofene facteur aggravant d^infection bacterienne severe concernant la DCI ketoprofen [NSAIDs (nonsteroidal anti-inflammatory drugs) (ibuprofen/ketoprofen): aggravating factor in severe bacterial infection]. BULLETIN D^INFORMATION TRIMESTRIEL (QUARTERLY NEWSLETTER). 2023;45$16$YR$$M$Y$$$20240813$$HP$FR$FR
227754783$22775478$3$F$$20240906$20230802$20240909$PER$$NVSC2023US168702$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
227755246$22775524$6$F$$20240829$20230802$20240910$EXP$$CA-AUROBINDO-AUR-APL-2023-049553$AUROBINDO$Balgobin S, Lemaire M, Noone D, Christoph L.. A case of topiramate-associated hypokalemia in a with as yet undiagnosed Gitelman syndrome. Pediatric Nephrology. 2023;38(7):2413$16$MON$$M$Y$$$20240910$$MD$CA$CA
227755262$22775526$2$F$20230101$20240724$20230802$20240801$EXP$$BR-CELLTRION INC.-2023BR015291$CELLTRION$$$$$$Y$$$20240801$$CN$BR$BR
227756193$22775619$3$F$20230224$20240720$20230802$20240730$EXP$$DE-AUROBINDO-AUR-APL-2023-049839$AUROBINDO$$36$YR$$M$Y$89$KG$20240730$$MD$DE$DE
227756323$22775632$3$F$20230724$20240717$20230802$20240724$EXP$$NVSC2023CO167826$NOVARTIS$$58$YR$$F$Y$65$KG$20240724$$CN$CO$CO
227756549$22775654$9$F$20230810$20240404$20230802$20240925$EXP$$US-GSK-US2023AMR101597$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
227756783$22775678$3$F$20230623$20240724$20230802$20240731$PER$$US-009507513-2307USA012501$MERCK$$73$YR$$M$Y$$$20240731$$CN$US$US
2277568920$22775689$20$F$20230101$20240906$20230802$20240917$EXP$$US-UCBSA-2023036282$UCB$$$$$M$Y$55$KG$20240917$$PH$US$US
227757277$22775727$7$F$20230727$20240920$20230802$20240927$EXP$$CA-TAKEDA-2023TUS074388$TAKEDA$$64$YR$$F$Y$$$20240927$$CN$CA$CA
227757714$22775771$4$F$$20240816$20230802$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202308000215$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240828$$CN$US$US
227758902$22775890$2$F$20210506$20240723$20230802$20240726$EXP$$CA-TAKEDA-2023TUS074387$TAKEDA$$82$YR$$M$Y$$$20240726$$CN$CA$CA
227759493$22775949$3$F$$20240703$20230802$20240705$PER$$NVSC2023US168976$NOVARTIS$$$$$M$Y$$$20240706$$CN$US$US
227759977$22775997$7$F$20230814$20240903$20230802$20240913$EXP$$DE-JNJFOC-20230765944$JOHNSON AND JOHNSON$$82$YR$E$F$Y$52$KG$20240913$$HP$DE$DE
227761024$22776102$4$F$20230101$20240805$20230802$20240813$PER$$US-SA-2023SA233348$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240814$$MD$US$US
227761287$22776128$7$F$$20240912$20230802$20240919$EXP$$CA-TAKEDA-2023TUS074355$TAKEDA$$$$$M$Y$$$20240919$$CN$CA$CA
227761312$22776131$2$F$20240101$20240816$20230802$20240829$PER$$US-SA-2023SA233978$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240829$$MD$US$US
227761625$22776162$5$F$20230101$20240626$20230802$20240705$PER$$US-SA-2023SA234274$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240705$$MD$US$US
227761844$22776184$4$F$20230720$20240820$20230802$20240829$PER$$US-SA-2023SA234449$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240829$$MD$US$US
227762756$22776275$6$F$$20240918$20230802$20240930$EXP$$NVSC2023US168852$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
227763072$22776307$2$F$20220105$20230722$20230802$20240903$EXP$GB-MHRA-EYC 00270984$GB-TORRENT-00027215$TORRENT$$32$YR$A$F$Y$53$KG$20240903$$CN$GB$GB
227763422$22776342$2$F$20220601$20240716$20230802$20240726$EXP$$PL-Accord-370557$ACCORD$Kozlowska A, Obtulowicz A, Pizun A, Radzimowska-Dudek J, Staron A, Dyduch G, et al. Drug-induced subacute cutaneous lupus erythematosus initially diagnosed as erythema annulare centrifugum. Przeglad Dermatologiczny. 2024;11(1):52-8.$89$YR$E$F$Y$$$20240726$$HP$PL$PL
227764692$22776469$2$F$20240101$20240705$20230802$20240717$PER$$US-SA-2023SA234421$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240717$$MD$US$US
227765554$22776555$4$F$20230214$20240702$20230802$20240707$EXP$$JP-ARGENX-2023-ARGX-JP002517$ARGENX BVBA$$$$$$Y$$$20240707$$MD$JP$JP
227765772$22776577$2$F$$20240730$20230802$20240805$PER$$US-BAYER-2023A097684$BAYER$$72$YR$E$F$Y$$$20240805$$MD$US$US
227766148$22776614$8$F$20230324$20240724$20230802$20240729$EXP$$CO-TAKEDA-2023TUS033660$TAKEDA$$4$YR$$M$Y$12$KG$20240729$$HP$CO$CO
227767232$22776723$2$F$$20240710$20230802$20240722$EXP$$CA-APOTEX-2023AP011019$APOTEX$$56$YR$$F$Y$$$20240722$$MD$CA$CA
227767384$22776738$4$F$20230109$20240816$20230802$20240820$EXP$$DE-ROCHE-3266991$ROCHE$$51$YR$A$F$Y$76$KG$20240820$$MD$DE$DE
227767992$22776799$2$F$$20240703$20230802$20240710$EXP$$ES-TAKEDA-2023TUS074898$TAKEDA$$67$YR$$M$Y$$$20240710$$HP$ES$ES
227768403$22776840$3$F$$20240911$20230802$20240916$PER$$US-TAKEDA-2023TUS074092$TAKEDA$$$$$F$Y$95$KG$20240916$$MD$US$US
227771533$22777153$3$F$$20240719$20230802$20240725$EXP$$NVSC2023US167368$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
227772653$22777265$3$F$$20240909$20230802$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-06369$LUPIN$$$$$$Y$$$20240925$$CN$US$US
227773313$22777331$3$F$20230703$20240821$20230802$20240823$EXP$$US-UCBSA-2023038418$UCB$$48$YR$$F$Y$$$20240823$$MD$US$US
227773414$22777341$4$F$20210729$20240805$20230802$20240808$EXP$$US-PAREXEL-2021-KAM-US003511$TAKEDA$$64$YR$$F$Y$$$20240808$$CN$US$US
227775112$22777511$2$F$$20240726$20230802$20240801$EXP$$NVSC2023CA167341$NOVARTIS$$76$YR$$F$Y$$$20240801$$CN$CA$CA
227776016$22777601$6$F$$20240705$20230802$20240711$EXP$$CA-JNJFOC-20230737313$JOHNSON AND JOHNSON$$19$MON$I$M$Y$$$20240711$$HP$CA$CA
227777382$22777738$2$F$$20240708$20230802$20240723$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-401083$RANBAXY$Rojas-Tula DG, Vargas-Hidalgo T. Sarcoidosis and pancreatic cancer. A case presentation. Journal of Respiratory Diseases. 2023;26(2):23-26$55$YR$$F$Y$$$20240723$$HP$ES$ES
227777952$22777795$2$F$20220201$20240807$20230802$20240822$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-402224$RANBAXY$Milos Holanek. Achieving complete remission with trastuzumab deruxtecan in a female patient with HER2-positive metastatic breast cancer. -. -;-:-$42$YR$$F$Y$$$20240822$$MD$CZ$CZ
227783033$22778303$3$F$20230701$20240815$20230802$20240820$EXP$$CO-JNJFOC-20230759619$JOHNSON AND JOHNSON$$52$YR$A$F$Y$85$KG$20240820$$HP$CO$CO
227783648$22778364$8$F$20230714$20240916$20230802$20240923$EXP$$AU-TAKEDA-2023TUS074922$TAKEDA$$61$YR$$F$Y$$$20240923$$CN$AU$AU
227784563$22778456$3$F$20230623$20240812$20230802$20240814$EXP$$US-BAUSCH-BL-2023-011753$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240814$$HP$US$US
227784734$22778473$4$F$20230101$20240702$20230802$20240704$EXP$$US-UCBSA-2023019036$UCB$$$$$M$Y$$$20240704$$CN$US$US
227785352$22778535$2$F$$20240710$20230802$20240718$PER$$NVSC2023US168347$NOVARTIS$$$$$F$Y$79.365$KG$20240718$$MD$US$US
227785573$22778557$3$F$20190314$20240801$20230802$20240802$PER$$US-BIOGEN-2020BI00844283$BIOGEN$$59$YR$$F$Y$$$20240802$$CN$US$US
227785979$22778597$9$F$20231207$20240918$20230802$20240923$EXP$$US-TAKEDA-2022TUS074921$TAKEDA$$70$YR$$F$Y$$$20240923$$HP$US$US
227787116$22778711$6$F$20230101$20240802$20230802$20240807$EXP$$CA-UCBSA-2023013469$UCB$$$$$F$Y$$$20240807$$CN$CA$CA
227787294$22778729$4$F$$20240731$20230802$20240808$PER$$US-SA-2023SA234179$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240808$$MD$US$US
227788863$22778886$3$F$20230728$20240721$20230802$20240722$EXP$$CA-PFIZER INC-202300264902$PFIZER$$26$YR$$F$Y$42$KG$20240722$$HP$CA$CA
227789724$22778972$4$F$$20240625$20230802$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-104816$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240702$$MD$JP$JP
227789757$22778975$7$F$20230720$20240624$20230802$20240701$EXP$$MX-TAKEDA-2023TUS074720$TAKEDA$$35$YR$$F$Y$76$KG$20240701$$MD$MX$MX
227792466$22779246$6$F$20230616$20240719$20230802$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-108385$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$46.8$KG$20240723$$MD$JP$JP
227795634$22779563$4$F$20230819$20240817$20230802$20240830$EXP$$US-BEH-2023161746$CSL BEHRING$$83$YR$E$M$Y$$$20240830$$CN$US$US
227795818$22779581$8$F$20230722$20240830$20230802$20240903$EXP$$US-BEH-2023161689$CSL BEHRING$$23$YR$A$M$Y$$$20240903$$CN$US$US
227796218$22779621$8$F$20230721$20240909$20230802$20240916$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-253086$BOEHRINGER INGELHEIM$$57$YR$A$F$Y$115$KG$20240916$$PH$DE$DE
227797488$22779748$8$F$20230622$20240911$20230803$20240917$EXP$$FR-ABBVIE-5351081$ABBVIE$$39$YR$$M$Y$85$KG$20240917$$MD$FR$FR
227797557$22779755$7$F$20221101$20240725$20230803$20240731$EXP$$JP-ABBVIE-4206182$ABBVIE$$65$YR$$M$Y$$$20240731$$CN$JP$JP
227798836$22779883$6$F$20220101$20240822$20230803$20240830$EXP$$CA-CELLTRION INC.-2022CA004323$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
227799124$22779912$4$F$$20230817$20230803$20240925$PER$$US-GSK-US2023AMR103938$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2277992612$22779926$12$F$20220107$20240702$20230803$20240717$EXP$$DE-ROCHE-3096753$ROCHE$$38$YR$A$F$Y$61$KG$20240717$$MD$DE$DE
227799553$22779955$3$F$$20240612$20230803$20240703$PER$$CA-TOLMAR, INC.-23CA041945$TOLMAR$$$$$M$Y$$$20240703$$CN$CA$CA
227799596$22779959$6$F$20230401$20240823$20230803$20240917$PER$$CA-TOLMAR, INC.-23CA041935$TOLMAR$$67$YR$$M$Y$$$20240917$$CN$CA$CA
227800892$22780089$2$F$20230404$20240905$20230803$20240910$EXP$$CA-TAKEDA-2023TUS035533$TAKEDA$$17$YR$$M$Y$$$20240910$$CN$CA$CA
227801642$22780164$2$F$$20240705$20230803$20240710$EXP$$CA-TAKEDA-CA202032415$TAKEDA$$$$$M$Y$63$KG$20240710$$CN$CA$CA
2278018611$22780186$11$F$20201014$20240916$20230803$20240923$EXP$$CA-JNJFOC-20220202552$JOHNSON AND JOHNSON$$59$YR$A$F$Y$68.2$KG$20240924$$HP$CA$CA
227802242$22780224$2$F$20230715$20240828$20230803$20240917$EXP$$US-SA-2023SA235198$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240917$$MD$US$US
2278035313$22780353$13$F$20211022$20240911$20230803$20240919$EXP$$CA-CELLTRION INC.-2021CA017685$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
227803992$22780399$2$F$$20240924$20230803$20240930$EXP$$CA-ROCHE-3397030$ROCHE$$52$YR$A$F$Y$$$20240930$$HP$CA$CA
227805714$22780571$4$F$20240701$20240819$20230803$20240822$EXP$$CA-JNJFOC-20230800713$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240822$$HP$CA$CA
227805844$22780584$4$F$$20240912$20230803$20240920$EXP$$CA-CELLTRION INC.-2021CA019450$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
227805874$22780587$4$F$$20231211$20230803$20240925$PER$$US-GSK-US2023AMR102755$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
227806492$22780649$2$F$$20240506$20230803$20240809$PER$$US-SA-2023SA231710$SANOFI AVENTIS$$$$T$F$Y$90$KG$20240809$$MD$US$US
227807482$22780748$2$F$20140101$20240715$20230803$20240724$EXP$$DE-AUROBINDO-AUR-APL-2023-050163$AUROBINDO$Schonharting W, Roehnisch T, Manoochehri M, Christoph J, Sieger M, Nogueira M et al.. Improved Survival of a HER2-Positive Metastatic Breast Cancer Patient Following a Personalized Peptide Immunization.. Vaccines. 2023;11 (6):1-9$40$YR$$F$Y$$$20240724$$HP$DE$DE
227810143$22781014$3$F$$20240821$20230803$20240823$EXP$$CA-Orion Corporation ORION PHARMA-23_00024939$ORION$$70$YR$E$F$Y$$$20240823$$HP$CA$
227810364$22781036$4$F$$20240814$20230803$20240822$EXP$$AU-CELLTRION INC.-2023AU015393$CELLTRION$$$$$$Y$$$20240822$$MD$AU$AU
227811023$22781102$3$F$20240630$20240705$20230803$20240715$30DAY$$US-GSK-US2023104720$GLAXOSMITHKLINE$$79$YR$$F$Y$$$20240715$$HP$US$US
2278114320$22781143$20$F$20230101$20240918$20230803$20240928$EXP$$CA-CELLTRION INC.-2023CA014085$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
227813292$22781329$2$F$$20240108$20230803$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-108559$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240729$$CN$CA$CA
227814912$22781491$2$F$20230726$20240718$20230803$20240724$PER$$US-SA-2023SA236974$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240724$$MD$US$US
227815072$22781507$2$F$$20240910$20230803$20240917$PER$$US-SA-2023SA235353$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240918$$MD$US$US
227815889$22781588$9$F$20090101$20240805$20230803$20240813$EXP$GB-SANDOZ-SDZ2023GB003000$GB-TORRENT-00032542$TORRENT$$37$YR$A$M$Y$$$20240813$$HP$GB$GB
227816045$22781604$5$F$20230730$20240923$20230803$20240930$EXP$$US-SA-2023SA235891$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240930$$MD$US$US
227816816$22781681$6$F$$20240904$20230803$20240909$EXP$$CA-PFIZER INC-202300264840$PFIZER$$75$YR$$F$Y$47$KG$20240909$$HP$CA$CA
227816923$22781692$3$F$$20240821$20230803$20240822$EXP$$CA-PFIZER INC-202300263028$PFIZER$$70$YR$$F$Y$$$20240822$$HP$CA$CA
227817145$22781714$5$F$20240611$20240826$20230803$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2023-007635$UNITED THERAPEUTICS$$55$YR$$F$Y$76.19$KG$20240903$$$US$US
227818516$22781851$6$F$$20240911$20230803$20240918$PER$$US-PFIZER INC-2020334481$PFIZER$$3$YR$$M$Y$$$20240918$$MD$US$US
227818772$22781877$2$F$20221201$20231215$20230803$20240803$PER$$US-AUROBINDO-AUR-APL-2022-057789$AUROBINDO$$61$YR$$F$Y$79.4$KG$20240803$$CN$US$US
227818832$22781883$2$F$$20240625$20230803$20240701$EXP$$US-TAKEDA-US202025442$TAKEDA$$$$$F$Y$95$KG$20240701$$HP$US$US
227819747$22781974$7$F$$20240830$20230803$20240906$EXP$$NVSC2021GB241749$NOVARTIS$$63$YR$$M$Y$$$20240906$$CN$GB$GB
227820734$22782073$4$F$$20240716$20230803$20240725$EXP$$GB-EXELIXIS-CABO-23065460$EXELIXIS$$48$YR$$F$Y$$$20240725$$HP$GB$GB
227821524$22782152$4$F$20240101$20240801$20230803$20240805$EXP$$US-BAUSCH-BL-2023-011765$BAUSCH AND LOMB$$37$YR$$M$Y$$$20240805$$MD$US$US
227823453$22782345$3$F$20240601$20240904$20230803$20240906$EXP$$IN-PFIZER INC-PV202300133330$PFIZER$$58$YR$$F$Y$$$20240906$$CN$IN$IN
227823529$22782352$9$F$20230725$20240904$20230803$20240909$EXP$$IN-PFIZER INC-PV202300133302$PFIZER$$59$YR$$M$Y$$$20240909$$CN$IN$IN
227823735$22782373$5$F$20230718$20240705$20230803$20240709$EXP$$AU-TAKEDA-2019TUS021330$TAKEDA$$66$YR$$M$Y$$$20240709$$MD$AU$AU
227829102$22782910$2$F$$20230801$20230803$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202308001658$ELI LILLY AND CO$$$$$F$Y$$$20240903$$CN$US$US
227829383$22782938$3$F$$20240725$20230803$20240726$EXP$$US-INCYTE CORPORATION-2023IN007701$INCYTE$$$$$$Y$$$20240726$$CN$US$US
227829553$22782955$3$F$$20240701$20230803$20240703$PER$$US-PFIZER INC-PV202300132737$PFIZER$$65$YR$$F$Y$$$20240703$$MD$US$US
227831198$22783119$8$F$$20240903$20230803$20240906$PER$$US-PFIZER INC-PV202300132705$PFIZER$$75$YR$$F$Y$61.68$KG$20240906$$CN$US$US
227835273$22783527$3$F$20221001$20240916$20230803$20240918$PER$$US-PFIZER INC-US-GBT-019405$PFIZER$$9$YR$$M$Y$$$20240918$$CN$US$US
227836364$22783636$4$F$$20240819$20230803$20240830$EXP$$CA-GILEAD-2023-0638508$GILEAD$$81$YR$E$F$Y$$$20240830$$CN$CA$CA
227837925$22783792$5$F$20200703$20240719$20230803$20240801$PER$$US-Ipsen Biopharmaceuticals, Inc.-2023-13333$IPSEN$$49$YR$A$M$Y$120.65$KG$20240801$$PH$US$US
227839096$22783909$6$F$20221115$20240627$20230803$20240702$EXP$$US-PFIZER INC-202300266654$PFIZER$$72$YR$$M$Y$80.74$KG$20240702$$CN$US$US
227839793$22783979$3$F$20221201$20240822$20230803$20240827$EXP$$US-PFIZER INC-PV202300134279$PFIZER$$64$YR$$F$Y$$$20240827$$HP$US$US
227839862$22783986$2$F$20230711$20240712$20230803$20240722$EXP$$JP-MALLINCKRODT-MNK202303491$MALLINCKRODT$$69$YR$E$F$Y$68$KG$20240722$$MD$JP$JP
227840164$22784016$4$F$20230801$20240823$20230803$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-107513$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240903$$CN$US$US
227842217$22784221$7$F$20230618$20240729$20230803$20240802$PER$$US-VERTEX PHARMACEUTICALS-2023-011317$VERTEX$$5$YR$$F$Y$$$20240802$$HP$US$US
227842253$22784225$3$F$$20240709$20230803$20240715$PER$$US-VERTEX PHARMACEUTICALS-2023-011405$VERTEX$$$$$$Y$$$20240715$$CN$US$US
227842263$22784226$3$F$20230101$20240715$20230803$20240722$PER$$US-VERTEX PHARMACEUTICALS-2023-010241$VERTEX$$$$$F$Y$$$20240722$$CN$US$US
227842383$22784238$3$F$20230501$20240826$20230803$20240828$EXP$$US-BEH-2023161789$CSL BEHRING$$14$YR$T$M$Y$$$20240828$$CN$US$US
227842757$22784275$7$F$20230101$20240721$20230803$20240722$EXP$$CA-PFIZER INC-202300249260$PFIZER$$58$YR$$M$Y$81$KG$20240722$$MD$CA$CA
227843153$22784315$3$F$$20240702$20230803$20240712$PER$$US-SA-2023SA234186$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240712$$MD$US$US
227843585$22784358$5$F$20230529$20240820$20230803$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-108257$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240826$$MD$JP$JP
227845282$22784528$2$F$20230101$20240717$20230804$20240719$EXP$$AR-ABBVIE-5352497$ABBVIE$$60$YR$$F$Y$$$20240719$$CN$AR$AR
227845474$22784547$4$F$20240920$20240923$20230804$20240930$PER$$US-SA-2023SA236915$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240930$$MD$US$US
227845576$22784557$6$F$$20240701$20230804$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002862$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
227845843$22784584$3$F$$20240715$20230804$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003193$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
227846047$22784604$7$F$20230701$20231220$20230804$20240925$PER$$US-GSK-US2023AMR103830$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
227846423$22784642$3$F$20180508$20240813$20230804$20240815$EXP$$DE-ROCHE-2135928$ROCHE$$23$YR$A$F$Y$$$20240815$$CN$DE$DE
227850763$22785076$3$F$$20240701$20230804$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202308002038$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240704$$CN$US$US
227851032$22785103$2$F$$20230811$20230804$20240808$PER$$US-OTSUKA-2023_000251$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
227851592$22785159$2$F$$20240701$20230804$20240808$PER$$US-OTSUKA-2022_055277$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
227852042$22785204$2$F$$20230224$20230804$20240808$PER$$US-OTSUKA-2023_005213$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
227852572$22785257$2$F$$20230904$20230804$20240808$PER$$US-OTSUKA-2023_009502$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
227853222$22785322$2$F$20230510$20230718$20230804$20240808$PER$$US-OTSUKA-2023_013255$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
227853542$22785354$2$F$20230424$20230717$20230804$20240808$PER$$US-OTSUKA-2023_010790$OTSUKA$$77$YR$$F$Y$$$20240808$$PH$US$US
227853942$22785394$2$F$$20220801$20230804$20240808$PER$$US-OTSUKA-2022_038511$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
227854122$22785412$2$F$$20221108$20230804$20240808$PER$$US-OTSUKA-2022_051373$OTSUKA$$$$$M$Y$$$20240808$$MD$US$US
227854852$22785485$2$F$$20230727$20230804$20240808$PER$$US-OTSUKA-2023_014025$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
227854942$22785494$2$F$20230523$20230725$20230804$20240808$PER$$US-OTSUKA-2023_013694$OTSUKA$$69$YR$$F$Y$$$20240808$$HP$US$US
227854952$22785495$2$F$20230612$20230809$20230804$20240808$PER$$US-OTSUKA-2023_016028$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
227855252$22785525$2$F$$20230726$20230804$20240808$PER$$US-OTSUKA-2023_013788$OTSUKA$$$$$M$Y$$$20240808$$PH$US$US
227855382$22785538$2$F$20230216$20230720$20230804$20240808$PER$$US-OTSUKA-2023_013500$OTSUKA$$46$YR$$M$Y$85.37$KG$20240808$$HP$US$US
227855402$22785540$2$F$20230601$20230803$20230804$20240808$PER$$US-OTSUKA-2023_014690$OTSUKA$$46$YR$$$Y$$$20240808$$PH$US$US
227855552$22785555$2$F$20230702$20230905$20230804$20240808$PER$$US-OTSUKA-2023_018511$OTSUKA$$30$YR$$M$Y$117.93$KG$20240808$$CN$US$US
227855722$22785572$2$F$$20230905$20230804$20240808$PER$$US-OTSUKA-2023_019136$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
227855842$22785584$2$F$$20230817$20230804$20240808$PER$$US-OTSUKA-2023_016189$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
227855862$22785586$2$F$20230714$20230905$20230804$20240808$PER$$US-OTSUKA-2023_019107$OTSUKA$$36$YR$$M$Y$102.49$KG$20240808$$HP$US$US
227855892$22785589$2$F$$20230905$20230804$20240808$PER$$US-OTSUKA-2023_019134$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
227855922$22785592$2$F$20230505$20230815$20230804$20240808$PER$$US-OTSUKA-2023_016664$OTSUKA$$65$YR$$F$Y$65.77$KG$20240808$$CN$US$US
227856032$22785603$2$F$$20230905$20230804$20240808$PER$$US-OTSUKA-2023_018375$OTSUKA$$$$$F$Y$61.23$KG$20240808$$CN$US$US
227856082$22785608$2$F$$20230809$20230804$20240808$EXP$$US-OTSUKA-2023_015545$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
227857014$22785701$4$F$$20240819$20230804$20240902$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-109120$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$97$KG$20240902$$HP$CA$CA
227857902$22785790$2$F$$20230905$20230804$20240808$PER$$US-OTSUKA-2023_018077$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
227858022$22785802$2$F$$20230905$20230804$20240808$PER$$US-OTSUKA-2023_018836$OTSUKA$$$$$M$Y$$$20240808$$MD$US$US
227858202$22785820$2$F$20230627$20230830$20230804$20240808$PER$$US-OTSUKA-2023_017311$OTSUKA$$26$YR$$M$Y$138.78$KG$20240808$$HP$US$US
227858252$22785825$2$F$$20230712$20230804$20240723$PER$$US-OTSUKA-2023_018962$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
227858482$22785848$2$F$$20231225$20230804$20240808$PER$$US-OTSUKA-2023_000078$OTSUKA$Hong S, Smithedajkul P,Kim J, Groesbeck EA, Linzie H. (157) A Case of Psychosis Precipitated by Ingestion of Herbal Tea Made with Hawaiian Baby Woodrose (Argyreia Nervosa). Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63 (S2):S189$18$YR$$M$Y$$$20240808$$HP$US$US
227858492$22785849$2$F$$20231225$20230804$20240808$PER$$US-OTSUKA-2023_000062$OTSUKA$Syed A, Datta V. Treatment of post-ictal psychosis in medically refractory epilepsy complicated by takotsubo cardiomyopathy and myocardial infarction: a case report and literature review. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S162$43$YR$$M$Y$$$20240808$$HP$US$US
227858572$22785857$2$F$$20231225$20230804$20240808$PER$$US-OTSUKA-2023_000059$OTSUKA$Nayagan J, Oh J, Sanzone K, Lopez G, Pradhan B, Milano AM et.al.. COVID-19 and Pediatric Catatonia. J Acad Consult Liaison Psychiatry. 2022;63:S128-S129$15$YR$$F$Y$$$20240808$$HP$US$US
227858682$22785868$2$F$$20231225$20230804$20240808$EXP$$US-OTSUKA-2022_056192$OTSUKA$Ying P, Deutch AB, Sidelnik SA, Abroms M, Caravella RA. (4) Creation of a Mobile-based Application to Assess Risk of Psychiatric Medications in the Setting of Prolonged QTc Interval. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S114$$$$$Y$$$20240808$$HP$US$US
227858692$22785869$2$F$$20231225$20230804$20240808$PER$$US-OTSUKA-2023_000172$OTSUKA$Nayagan J, Oh J, Sanzone K, Lopez G, Pradhan B, Milano AM et.al.. (33) COVID-19 and Pediatric Catatonia. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S128-S129$16$YR$$F$Y$$$20240808$$HP$US$US
227859182$22785918$2$F$20150101$20230720$20230804$20240802$EXP$$US-Accord-272013$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
227859222$22785922$2$F$20200730$20231110$20230804$20240802$PER$$US-Accord-274095$ACCORD$$49$YR$A$F$Y$$$20240802$$LW$US$US
227859232$22785923$2$F$20160101$20230724$20230804$20240802$PER$$US-Accord-275500$ACCORD$$55$YR$A$F$Y$$$20240802$$LW$US$US
227859242$22785924$2$F$20140101$20230721$20230804$20240802$EXP$$US-Accord-275496$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
227859272$22785927$2$F$20180101$20230721$20230804$20240802$EXP$$US-Accord-275503$ACCORD$$57$YR$A$F$Y$$$20240802$$LW$US$US
227859702$22785970$2$F$$20230719$20230804$20240802$EXP$$US-Accord-298747$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
227859752$22785975$2$F$20200101$20230721$20230804$20240802$EXP$$US-Accord-304590$ACCORD$$41$YR$A$F$Y$$$20240802$$LW$US$US
227859802$22785980$2$F$20110101$20230816$20230804$20240802$PER$$US-Accord-356544$ACCORD$$52$YR$A$F$Y$85.73$KG$20240802$$LW$US$US
227860178$22786017$8$F$20230803$20240701$20230804$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-109402$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240703$$CN$US$US
227861482$22786148$2$F$20230315$20240912$20230804$20240919$EXP$$JP-AMGEN-JPNSP2023052186$AMGEN$$62$YR$A$M$Y$$$20240919$$MD$JP$JP
227861592$22786159$2$F$20210101$20230721$20230804$20240802$PER$$US-Accord-277030$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
227861622$22786162$2$F$20161001$20230609$20230804$20240802$EXP$$US-Accord-278161$ACCORD$$58$YR$A$F$Y$130$KG$20240802$$LW$US$US
227861702$22786170$2$F$20210518$20230719$20230804$20240802$EXP$$US-Accord-284337$ACCORD$$44$YR$$F$Y$$$20240802$$LW$US$US
227861712$22786171$2$F$20210101$20230724$20230804$20240802$EXP$$US-Accord-284339$ACCORD$$53$YR$$F$Y$$$20240802$$LW$US$US
227861762$22786176$2$F$20200918$20230719$20230804$20240802$EXP$$US-Accord-287320$ACCORD$$59$YR$$M$Y$$$20240802$$LW$US$US
227862233$22786223$3$F$$20240726$20230804$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-06378$LUPIN$$$$$$Y$$$20240826$$CN$US$US
227862906$22786290$6$F$20230101$20240918$20230804$20240926$EXP$$CA-UCBSA-2023022523$UCB$$$$$F$Y$$$20240926$$CN$CA$CA
227864489$22786448$9$F$20210222$20240916$20230804$20240924$EXP$$CA-CELLTRION INC.-2021CA003352$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
227864683$22786468$3$F$$20240823$20230804$20240830$EXP$$GB-CELLTRION INC.-2023GB015369$CELLTRION$$$$$$Y$$$20240830$$HP$GB$GB
227866147$22786614$7$F$20200914$20240904$20230804$20240915$EXP$$US-AUROBINDO-AUR-APL-2023-051132$AUROBINDO$$$$E$M$Y$64$KG$20240915$$MD$US$US
2278666516$22786665$16$F$20230101$20240920$20230804$20240930$EXP$$CA-CELLTRION INC.-2023CA004932$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
227867072$22786707$2$F$$20231219$20230804$20240802$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2023-00472$ALKEM$Tourian L, Margolese HC.. Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine. J Clin Psychopharmacol. 2011;31:665-667$41$YR$$F$Y$$$20240802$$HP$CA$CA
227869393$22786939$3$F$$20240715$20230804$20240723$EXP$$US-ORG100014127-2023000824$HRA PHARMA$$64$YR$$M$Y$$$20240723$$CN$US$US
227869529$22786952$9$F$20220420$20240808$20230804$20240815$EXP$$CA-CELLTRION INC.-2020CA031081$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
227869655$22786965$5$F$20230612$20240716$20230804$20240718$EXP$$JP-ASTELLAS-2023JP008975$ASTELLAS$$72$YR$$M$Y$58$KG$20240718$$PH$JP$JP
227869883$22786988$3$F$20190101$20240812$20230804$20240816$EXP$$US-ABBVIE-5354207$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
227870138$22787013$8$F$20230727$20240830$20230804$20240909$EXP$$CA-CELLTRION INC.-2023CA015414$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
227871202$22787120$2$F$$20230717$20230804$20240724$PER$$US-AstraZeneca-2023A176956$ASTRAZENECA$$71$YR$$F$Y$$$20240724$$CN$US$
227871299$22787129$9$F$20230617$20240903$20230804$20240906$EXP$$FR-EXELIXIS-XL18423065516$EXELIXIS$$$$$$Y$$$20240906$$MD$FR$FR
227872026$22787202$6$F$20220901$20240911$20230804$20240919$EXP$$NVSC2023BR168582$NOVARTIS$$67$YR$$F$Y$64$KG$20240919$$CN$BR$BR
227872088$22787208$8$F$20230711$20240411$20230804$20240813$EXP$$NVSC2023BR159988$NOVARTIS$$66$YR$$F$Y$$$20240813$$CN$BR$BR
227873053$22787305$3$F$$20230828$20230804$20240711$PER$$US-PFM-2023-03180$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.299$KG$20240711$$HP$US$US
227873267$22787326$7$F$20210101$20240721$20230804$20240729$EXP$$AU-CELLTRION INC.-2020AU025096$CELLTRION$$$$$$Y$$$20240729$$MD$AU$AU
227874016$22787401$6$F$20230620$20240809$20230804$20240817$EXP$$CA-CELLTRION INC.-2023CA012509$CELLTRION$$$$$$Y$$$20240817$$MD$CA$CA
2278765818$22787658$18$F$20230228$20240924$20230804$20240925$EXP$$US-TAKEDA-2023TUS022815$TAKEDA$$30$YR$$F$Y$50.34$KG$20240925$$HP$US$US
2278767315$22787673$15$F$20090101$20240909$20230804$20240921$EXP$GB-MACLEODS PHARMA EU LTD-MAC2023042720$GB-MACLEODS PHARMA EU LTD-MAC2023042720$MACLEODS$$$$$$Y$$$20240921$$CN$GB$GB
2278769112$22787691$12$F$20230714$20240728$20230804$20240731$EXP$$US-PFIZER INC-202300265788$PFIZER$$74$YR$$F$Y$53.52$KG$20240731$$MD$US$US
227877006$22787700$6$F$20230627$20240201$20230804$20240807$EXP$$NVSC2023US170702$NOVARTIS$$71$YR$$F$Y$$$20240807$$CN$US$US
227877304$22787730$4$F$20230701$20240718$20230804$20240801$EXP$$US-UCBSA-2023039199$UCB$$70$YR$$F$Y$$$20240801$$HP$US$US
227877956$22787795$6$F$20230802$20240806$20230804$20240808$PER$$NVSC2023US170211$NOVARTIS$$57$YR$$F$Y$131.54$KG$20240808$$CN$US$US
227878452$22787845$2$F$$20240829$20230804$20240830$PER$$NVSC2023US169164$NOVARTIS$$$$$F$Y$68.04$KG$20240830$$HP$US$US
227878684$22787868$4$F$$20240830$20230804$20240830$PER$$NVSC2023US169602$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
227879202$22787920$2$F$$20230725$20230804$20240926$EXP$$US-GSK-US2023AMR102401$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
227879684$22787968$4$F$20210609$20240708$20230804$20240722$EXP$$US-GLENMARK PHARMACEUTICALS-2023GMK083921$GLENMARK$Acharya I, Weisman DS, Smith LW, Arend LJ.. Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis. BMJ case reports. 2023;16:7:e254736$$$$$Y$$$20240722$$HP$US$US
227880432$22788043$2$F$20190801$20231030$20230804$20240826$EXP$$US-PHARMAAND-2023PHR00023$pharmaAND$$61$YR$$F$Y$78.005$KG$20240826$$CN$US$US
227881984$22788198$4$F$20230721$20240919$20230804$20240924$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02612$AMNEAL$$73$YR$$F$Y$48.526$KG$20240924$$CN$US$US
227882865$22788286$5$F$20230101$20240712$20230804$20240723$PER$$US-SA-2023SA236957$SANOFI AVENTIS$$52$YR$A$F$Y$210$KG$20240723$$MD$US$US
227884548$22788454$8$F$20240704$20240827$20230804$20240831$EXP$$BR-TAKEDA-2023TUS033480$TAKEDA$$53$YR$$M$Y$52$KG$20240831$$CN$BR$BR
227884962$22788496$2$F$$20240813$20230804$20240826$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402337$RANBAXY$$$$$$Y$$$20240826$$MD$IN$IN
227884972$22788497$2$F$$20240813$20230804$20240826$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402338$RANBAXY$$$$$$Y$$$20240826$$MD$IN$IN
227885002$22788500$2$F$$20240813$20230804$20240826$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402336$RANBAXY$$$$$$Y$$$20240826$$MD$IN$IN
227885112$22788511$2$F$$20240618$20230804$20240703$EXP$GB-MHRA-MIDB-ee72c03e-798b-4bdf-89a4-89438182441e$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-402164$RANBAXY$$$$$M$Y$$$20240703$$PH$GB$GB
227885642$22788564$2$F$$20240904$20230804$20240919$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402705$RANBAXY$Kim SY, Kim YE, Kim KW, Byun SH. A Case of Status Epilepticus Caused by Intravenous Tramadol. Ann Child Neurol. 2023;31(3):222-225$15$YR$$F$Y$47$KG$20240919$$MD$KR$KR
227886536$22788653$6$F$20230101$20240816$20230804$20240829$PER$$US-SA-2023SA237326$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240829$$MD$US$US
227887143$22788714$3$F$20230701$20240918$20230804$20240923$EXP$$US-PFIZER INC-PV202300133812$PFIZER$$34$YR$$M$Y$$$20240923$$CN$US$US
2278874613$22788746$13$F$20220101$20240814$20230804$20240819$EXP$$CA-PFIZER INC-PV202200078541$PFIZER$$58$YR$$M$Y$82.8$KG$20240819$$MD$CA$CA
227887572$22788757$2$F$$20240805$20230804$20240814$EXP$$JP-ROCHE-3399797$ROCHE$Hara R, Wakuta A, Shiota S, Kariyama K, Nouso K. Two Cases of hepatocellular carcinoma with intratumoral hemorrhage after atezolizumab and bevacizumab administration.. The 59th Annual Meeting of Liver Cancer Study Group of Japan.. 2023;226.$8$DEC$E$F$Y$$$20240814$$MD$JP$JP
227888242$22788824$2$F$$20240816$20230804$20240830$PER$$US-SA-2023SA235722$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240830$$MD$US$US
227889082$22788908$2$F$20230214$20240703$20230804$20240711$EXP$FR-AFSSAPS-AM2023000635$FR-TEVA-2023-FR-2912060$TEVA$$73$YR$$F$Y$$$20240711$$MD$FR$FR
227892202$22789220$2$F$$20240912$20230804$20240919$EXP$$CA-TAKEDA-2023TUS075258$TAKEDA$$$$$F$Y$$$20240919$$MD$CA$CA
227893692$22789369$2$F$$20240807$20230804$20240809$EXP$$ID-PFIZER INC-PV202300135222$PFIZER$$$$$$Y$$$20240809$$MD$ID$ID
227893824$22789382$4$F$$20240821$20230804$20240826$EXP$$CA-PFIZER INC-202201242584$PFIZER$$59$YR$$F$Y$$$20240826$$MD$CA$CA
227894202$22789420$2$F$20230101$20240808$20230804$20240821$EXP$$US-CIPLA LTD.-2023US04324$CIPLA$$$$$$Y$$$20240821$$CN$US$US
227894408$22789440$8$F$20230101$20240709$20230804$20240713$EXP$$CA-ABBVIE-5354010$ABBVIE$$$$$F$Y$$$20240713$$CN$CA$CA
227895395$22789539$5$F$20230706$20240701$20230804$20240705$EXP$$US-SHIRE-US201900361$TAKEDA$$84$YR$$F$Y$$$20240705$$CN$US$US
227895556$22789555$6$F$20200126$20240918$20230804$20240925$EXP$$US-SHIRE-US202004122$TAKEDA$$68$YR$$F$Y$$$20240925$$CN$US$US
227896366$22789636$6$F$$20240816$20230804$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-015099$JAZZ$$$$$F$Y$$$20240822$$MD$US$US
227896697$22789669$7$F$$20240730$20230804$20240801$EXP$$US-PFIZER INC-PV202300133513$PFIZER$$78$YR$$F$Y$77.098$KG$20240801$$CN$US$US
227897343$22789734$3$F$$20240906$20230804$20240909$EXP$$US-PFIZER INC-PV202300134984$PFIZER$$64$YR$$F$Y$$$20240909$$CN$US$US
227897923$22789792$3$F$$20240812$20230804$20240816$PER$$US-PFIZER INC-PV202300133018$PFIZER$$72$YR$$F$Y$$$20240816$$CN$US$US
227897982$22789798$2$F$$20240910$20230804$20240912$EXP$$US-PFIZER INC-202300267155$PFIZER$$89$YR$$F$Y$$$20240912$$CN$US$US
227898586$22789858$6$F$20230701$20240716$20230804$20240722$EXP$$NVSC2023CR168717$NOVARTIS$$66$YR$$F$Y$$$20240722$$CN$CR$CR
227898753$22789875$3$F$20221001$20240830$20230804$20240904$PER$$NVSC2023US171097$NOVARTIS$$$$A$F$Y$$$20240904$$CN$US$US
227900019$22790001$9$F$20230701$20240917$20230804$20240919$EXP$$CA-TAKEDA-2023TUS075432$TAKEDA$$14$YR$$M$Y$$$20240919$$HP$CA$CA
227900364$22790036$4$F$20200403$20240717$20230804$20240722$PER$$US-GILEAD-2023-0639012$GILEAD$$50$YR$A$M$Y$$$20240719$$LW$US$US
2279034414$22790344$14$F$20090101$20240814$20230805$20240827$EXP$$GB-AUROBINDO-AUR-APL-2023-050853$AUROBINDO$$37$YR$$M$Y$$$20240827$$HP$GB$GB
227904344$22790434$4$F$20230525$20240822$20230805$20240903$EXP$FR-AFSSAPS-PO2023000643$FR-Accord-371105$ACCORD$$59$YR$A$F$Y$$$20240903$$MD$FR$FR
227904545$22790454$5$F$20230502$20240731$20230805$20240802$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-132234$DAIICHI$$63$YR$$M$Y$$$20240802$$HP$US$US
227904913$22790491$3$F$20230108$20240829$20230805$20240830$PER$$NVSC2023US170531$NOVARTIS$$48$YR$$M$Y$102.27$KG$20240830$$MD$US$US
2279050412$22790504$12$F$20230101$20240710$20230805$20240713$EXP$$US-UNITED THERAPEUTICS-UNT-2023-021234$UNITED THERAPEUTICS$$$$$F$Y$53.061$KG$20240713$$$US$US
227905873$22790587$3$F$20240807$20240808$20230805$20240813$PER$$NVSC2023US170703$NOVARTIS$$$$$F$Y$$$20240813$$HP$US$US
227905923$22790592$3$F$20230101$20240620$20230805$20240702$PER$$US-SA-2023SA237892$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240702$$MD$US$US
227911953$22791195$3$F$20230201$20240924$20230806$20240927$EXP$$US-ABBVIE-5355206$ABBVIE$$66$YR$$F$Y$77$KG$20240927$$CN$US$US
227912357$22791235$7$F$20230728$20240701$20230807$20240704$EXP$$US-TAKEDA-2023TUS067824$TAKEDA$$42$YR$$F$Y$98$KG$20240704$$HP$US$US
227915335$22791533$5$F$$20240806$20230807$20240903$PER$$NVSC2023US171491$NOVARTIS$$$$$$Y$$$20240903$$MD$US$US
227915543$22791554$3$F$20230601$20240915$20230807$20240926$EXP$$JP-NOVOPROD-1087531$NOVO NORDISK$$76$YR$$M$Y$46.8$KG$20240926$$MD$JP$JP
227915624$22791562$4$F$$20240904$20230807$20240912$PER$$US-SA-2023SA238794$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$MD$US$US
2279160214$22791602$14$F$20230723$20240607$20230807$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003118$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240701$$CN$US$US
227917438$22791743$8$F$20230601$20240717$20230807$20240723$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-235013$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240719$$CN$CA$CA
227918484$22791848$4$F$20230628$20240621$20230807$20240717$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002932$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240717$$CN$US$US
2279185312$22791853$12$F$20230501$20240628$20230807$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002953$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240708$$CN$US$US
227918583$22791858$3$F$$20240610$20230807$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-002952$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
227919304$22791930$4$F$$20240723$20230807$20240801$EXP$$HU-BRISTOL-MYERS SQUIBB COMPANY-2023-108816$BRISTOL MYERS SQUIBB$Gabriella M, Peter B, Arpad I, Robert S. Differential diagnosis of hemorrhagic colitis in patient with Ph+ acute lymphoblastic leukemia, after several years of dasatinib treatment. Can TKI be discontinued in Ph+ ALL?. Hematology-Transfusology. 2023;49.$58$YR$A$F$Y$$$20240801$$HP$HU$HU
227919645$22791964$5$F$20210609$20240813$20230807$20240816$EXP$$NVSC2022CA151741$NOVARTIS$$66$YR$$F$Y$$$20240817$$MD$CA$CA
227919703$22791970$3$F$20221201$20240801$20230807$20240806$PER$$NVSC2023US170719$NOVARTIS$$48$YR$$M$Y$$$20240806$$CN$US$US
227919872$22791987$2$F$$20240808$20230807$20240813$EXP$$US-ABBVIE-5355617$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
227920145$22792014$5$F$20180301$20240911$20230807$20240917$EXP$$CZ-AUROBINDO-AUR-APL-2023-050890$AUROBINDO$Homolov? Richtrov? N, Fremanezumab v. klinick? praxi.. Remedia. 2023;33(3):224-228$30$YR$$F$Y$$$20240917$$MD$CZ$CZ
227920295$22792029$5$F$20230712$20240717$20230807$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002955$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240809$$CN$US$US
227920314$22792031$4$F$$20240612$20230807$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002956$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240707$$CN$US$US
227921036$22792103$6$F$20200616$20240904$20230807$20240916$EXP$$DE-AUROBINDO-AUR-APL-2020-035559$AUROBINDO$$$$E$F$Y$$$20240916$$MD$DE$DE
227921427$22792142$7$F$20230101$20240819$20230807$20240829$EXP$$US-INSMED, INC.-2023-00924-US$INSMED$$$$$F$Y$$$20240829$$CN$US$US
227922492$22792249$2$F$$20240823$20230807$20240902$PER$$US-Nobelpharma America, LLC-NPA-2023-01506$NOBELPHARMA$$$$$F$Y$$$20240902$$HP$US$US
227924299$22792429$9$F$$20240813$20230807$20240816$EXP$$GB-TAKEDA-2023TUS057886$TAKEDA$$$$$F$Y$$$20240816$$CN$GB$GB
227924834$22792483$4$F$20230101$20240709$20230807$20240711$EXP$$US-UCBSA-2023039064$UCB$$$$$F$Y$48.073$KG$20240711$$MD$US$US
227925483$22792548$3$F$$20240727$20230807$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-06445$LUPIN$$$$$$Y$$$20240818$$CN$US$US
227926016$22792601$6$F$20230701$20240912$20230807$20240916$EXP$$JP-009507513-2307JPN004329J$MERCK$$81$YR$$F$Y$$$20240916$$MD$JP$JP
227927999$22792799$9$F$20230731$20240828$20230807$20240901$EXP$$US-TAKEDA-2021TUS070502$TAKEDA$$37$YR$$M$Y$72.109$KG$20240901$$HP$US$US
227929292$22792929$2$F$20230803$20240701$20230807$20240702$PER$$NVSC2023US171691$NOVARTIS$$34$YR$$F$Y$$$20240702$$CN$US$US
227930493$22793049$3$F$$20240910$20230807$20240913$EXP$$NVSC2023GB170695$NOVARTIS$$$$$F$Y$$$20240913$$HP$GB$GB
227930634$22793063$4$F$20220701$20240124$20230807$20240809$EXP$$NVSC2022PA245155$NOVARTIS$$55$YR$$F$Y$$$20240809$$CN$PA$PA
227930792$22793079$2$F$$20230802$20230807$20240920$EXP$$NVSC2023DE170923$NOVARTIS$$$$$$Y$$$20240920$$MD$DE$DE
227931493$22793149$3$F$20230727$20240801$20230807$20240810$PER$$US-SA-2023SA238457$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240810$$MD$US$US
227931852$22793185$2$F$20210705$20240625$20230807$20240701$EXP$$DE-ABBVIE-5355586$ABBVIE$$74$YR$$F$Y$85$KG$20240701$$MD$DE$DE
227931884$22793188$4$F$$20240805$20230807$20240813$PER$$US-SA-2023SA238912$SANOFI AVENTIS$$$$E$F$Y$84.73$KG$20240814$$MD$US$US
227934015$22793401$5$F$$20240703$20230807$20240709$EXP$$US-PFIZER INC-PV202300134641$PFIZER$$87$YR$$M$Y$$$20240709$$CN$US$US
227934493$22793449$3$F$20220601$20240826$20230807$20240830$PER$$US-PFIZER INC-PV202300112529$PFIZER$$64$YR$$F$Y$108.84$KG$20240830$$CN$US$US
227935076$22793507$6$F$20221218$20240627$20230807$20240701$EXP$$DE-BAUSCHBL-2023BNL006602$BAUSCH AND LOMB$$72$YR$$M$Y$65$KG$20240701$$HP$DE$DE
227935384$22793538$4$F$$20240923$20230807$20240927$PER$$NVSC2023US172019$NOVARTIS$$$$$$Y$$$20240927$$CN$US$US
227936722$22793672$2$F$20080101$20240723$20230807$20240730$EXP$$CA-PFIZER INC-2018518605$MYLAN$$44$YR$$F$Y$63$KG$20240730$$MD$CA$CA
227939034$22793903$4$F$20230427$20240912$20230807$20240923$EXP$$CO-EXELIXIS-CABO-23066390$EXELIXIS$$88$YR$$F$Y$65$KG$20240923$$CN$CO$CO
227939757$22793975$7$F$20230802$20240724$20230807$20240731$PER$$US-BIOGEN-2023BI01189280$BIOGEN$$58$YR$$F$Y$$$20240731$$CN$US$US
227939797$22793979$7$F$20230103$20240806$20230807$20240812$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2023-110403$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$97.3$KG$20240812$$MD$DE$DE
227940106$22794010$6$F$20230329$20240918$20230807$20240930$EXP$$NVSC2023US171762$NOVARTIS$$57$YR$$F$Y$$$20240930$$CN$US$US
227940126$22794012$6$F$20230824$20240725$20230807$20240729$EXP$$CA-TAKEDA-2020TUS022052$TAKEDA$$58$YR$$M$Y$$$20240729$$CN$CA$CA
227940627$22794062$7$F$20230724$20240924$20230807$20240927$PER$$US-PFIZER INC-202300247120$PFIZER$$73$YR$$M$Y$90.72$KG$20240927$$CN$US$US
227941444$22794144$4$F$20230101$20240709$20230807$20240717$PER$$US-SA-2023SA238932$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240717$$MD$US$US
227942273$22794227$3$F$$20240711$20230807$20240724$EXP$GR-GREOF-202300672$GR-ELI_LILLY_AND_COMPANY-GR202307018225$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240723$$CN$GR$GR
227942627$22794262$7$F$20230722$20240626$20230807$20240703$EXP$$CO-AMGEN-COLSL2023135463$AMGEN$$78$YR$E$F$Y$61$KG$20240703$$MD$CO$CO
227942702$22794270$2$F$20230301$20240903$20230807$20240905$EXP$$US-PFIZER INC-US-GBT-020424$PFIZER$$13$YR$$M$Y$$$20240905$$CN$US$US
227943583$22794358$3$F$$20240717$20230807$20240722$EXP$$US-MYLANLABS-2023M1082425$MYLAN$$$$$F$Y$113.4$KG$20240722$$CN$US$US
227943925$22794392$5$F$20230101$20240731$20230807$20240805$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-003696$AMGEN$$26$YR$A$F$Y$$$20240805$$MD$US$US
227944052$22794405$2$F$$20240729$20230807$20240731$EXP$$FR-DSJP-DSE-2023-132235$DAIICHI$$66$YR$$F$Y$68$KG$20240731$$MD$FR$FR
227944202$22794420$2$F$20230201$20240814$20230807$20240819$EXP$$CA-OTSUKA-2023_020502$OTSUKA$$41$YR$$M$Y$$$20240819$$CN$CA$CA
227944532$22794453$2$F$$20240702$20230807$20240711$PER$$US-SA-2023SA237394$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240711$$MD$US$US
227944896$22794489$6$F$20230101$20240717$20230807$20240724$EXP$$CA-TAKEDA-2023TUS063725$TAKEDA$$$$$F$Y$$$20240724$$CN$CA$CA
227946162$22794616$2$F$$20240828$20230807$20240903$EXP$$CA-TAKEDA-2021TUS010357$TAKEDA$$$$$F$Y$$$20240903$$MD$CA$CA
227949323$22794932$3$F$20230101$20240701$20230807$20240703$PER$$US-PFIZER INC-PV202300134804$PFIZER$$64$YR$$F$Y$$$20240703$$HP$US$US
227949359$22794935$9$F$20230101$20240917$20230807$20240919$PER$$US-PFIZER INC-202300267836$PFIZER$$81$YR$$F$Y$45.351$KG$20240919$$CN$US$US
227953222$22795322$2$F$$20240904$20230807$20240911$EXP$$US-VERTEX PHARMACEUTICALS-2023-011738$VERTEX$Baroud E, Chaudhary N, Georgiopoulos AM.. Management of neuropsychiatric symptoms in adults treated with elexacaftor/tezacaftor/ivacaftor. Pediatr Pulmonol. 2023$28$YR$$F$Y$$$20240911$$MD$US$US
227953232$22795323$2$F$$20240904$20230807$20240909$EXP$$US-VERTEX PHARMACEUTICALS-2023-011740$VERTEX$Baroud E, Chaudhary N, Georgiopoulos AM.. Management of neuropsychiatric symptoms in adults treated with elexacaftor/tezacaftor/ivacaftor. Pediatr Pulmonol. 2023;58:1920-30$19$YR$$M$Y$$$20240909$$MD$US$US
227954542$22795454$2$F$$20240819$20230807$20240830$EXP$$SE-Nova Laboratories Limited-2144548$NOVA LABORATORIES$$7$YR$$M$Y$$$20240830$$$SE$SE
227955442$22795544$2$F$20221218$20240822$20230807$20240903$EXP$$US-ELI_LILLY_AND_COMPANY-US202301007624$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240903$$CN$US$US
227956632$22795663$2$F$$20240904$20230807$20240910$EXP$$US-VERTEX PHARMACEUTICALS-2023-011742$VERTEX$Baroud E, Chaudhary N, Georgiopoulos AM.. Management of neuropsychiatric symptoms in adults treated with elexacaftor/tezacaftor/ivacaftor. Pediatr Pulmonol. 2023$62$YR$$F$Y$$$20240910$$MD$US$US
227957903$22795790$3$F$$20240904$20230807$20240910$EXP$$US-VERTEX PHARMACEUTICALS-2023-011745$VERTEX$Baroud E, Chaudhary N, Georgiopoulos AM.. Management of neuropsychiatric symptoms in adults treated with elexacaftor/tezacaftor/ivacaftor. Pediatr Pulmonol. 2023$$$$$Y$$$20240910$$MD$US$US
227958782$22795878$2$F$20230214$20240628$20230807$20240703$EXP$FR-AFSSAPS-AM2023000635$FR-JNJFOC-20230815817$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240703$$MD$FR$FR
227959392$22795939$2$F$$20240703$20230807$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-109578$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240704$$CN$US$US
227960044$22796004$4$F$$20240730$20230807$20240805$PER$$NVSC2023US172330$NOVARTIS$$$$$M$Y$$$20240804$$CN$US$US
227962153$22796215$3$F$$20240905$20230808$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002986$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
227962188$22796218$8$F$20231001$20240909$20230808$20240916$EXP$$US-TAKEDA-2023TUS076849$TAKEDA$$65$YR$$F$Y$36$KG$20240916$$CN$US$US
2279628312$22796283$12$F$20230728$20240903$20230808$20240910$EXP$$US-GSK-US2023AMR105139$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240910$$CN$US$US
227963042$22796304$2$F$20230701$20230731$20230808$20240925$PER$$US-GSK-US2023AMR104827$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
227963393$22796339$3$F$20230720$20240708$20230808$20240716$PER$$CA-TOLMAR, INC.-23CA042078$TOLMAR$$74$YR$$M$Y$$$20240716$$CN$CA$CA
227964183$22796418$3$F$$20240830$20230808$20240830$PER$$NVSC2023US171915$NOVARTIS$$$$$F$Y$$$20240830$$MD$US$US
227966324$22796632$4$F$$20230929$20230808$20240925$PER$$US-GSK-US2023AMR105770$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
227967056$22796705$6$F$20230101$20240916$20230808$20240920$EXP$$NVSC2023US172442$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
227967836$22796783$6$F$20230701$20240718$20230808$20240728$PER$$US-SA-2023SA239428$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240728$$MD$US$US
227967902$22796790$2$F$$20240717$20230808$20240725$PER$$US-SA-2023SA238919$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240725$$MD$US$US
227968936$22796893$6$F$20240612$20240816$20230808$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-003357$JAZZ$$37$YR$$F$Y$$$20240822$$HP$US$US
2279694714$22796947$14$F$20230802$20240627$20230808$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003014$ACADIA PHARMACEUTICALS$$23$YR$$F$Y$$$20240708$$CN$US$US
227970293$22797029$3$F$20180301$20240712$20230808$20240725$PER$$US-SA-2023SA239181$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240725$$MD$US$US
227970462$22797046$2$F$20230701$20240701$20230808$20240710$PER$$US-SA-2023SA239801$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240710$$MD$US$US
227970672$22797067$2$F$20230101$20240916$20230808$20240919$EXP$$US-SA-2023SA240357$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240919$$MD$US$US
227971093$22797109$3$F$20210115$20240729$20230808$20240806$EXP$$NVSC2021IN023024$NOVARTIS$$49$YR$$F$Y$$$20240806$$CN$IN$IN
227972132$22797213$2$F$20170610$20240723$20230808$20240801$EXP$$ES-AUROBINDO-AUR-APL-2019-095585$AUROBINDO$$82$YR$$F$Y$$$20240801$$MD$ES$ES
227973032$22797303$2$F$20230307$20240819$20230808$20240827$EXP$$JP-ROCHE-3400889$ROCHE$Masuoka M, Miyoshi S S. 5 A case of ROS1 fusion gene mutation positive lung adenocarcinoma in which cardiac failure acute developed during administration of entrectinib. The 199th Kanto Branch Scientific Meeting of the Japan Lung Cancer Society. 2024;24.$65$YR$E$M$Y$57.4$KG$20240827$$MD$JP$JP
227973293$22797329$3$F$20221101$20240715$20230808$20240723$EXP$$US-SA-2023SA239987$SANOFI AVENTIS$$8$YR$C$M$Y$45.177$KG$20240723$$MD$US$US
227974042$22797404$2$F$20200101$20240906$20230808$20240916$PER$$US-SA-2023SA240467$SANOFI AVENTIS$$11$YR$C$F$Y$54$KG$20240916$$MD$US$US
2279744611$22797446$11$F$20210101$20240729$20230808$20240802$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-013522$JAZZ$$$$$F$Y$$$20240802$$MD$US$US
227975132$22797513$2$F$20230701$20240715$20230808$20240723$PER$$US-SA-2023SA240411$SANOFI AVENTIS$$63$YR$A$M$Y$78$KG$20240723$$MD$US$US
227977242$22797724$2$F$20230105$20230706$20230808$20240806$EXP$$US-AMNEAL-2022-AMRX-02196$AMNEAL$$34$YR$$M$Y$67$KG$20240806$$MD$US$US
227978472$22797847$2$F$$20231013$20230808$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2022-AMRX-04086$AMNEAL$$$$$F$Y$$$20240806$$MD$US$US
227978522$22797852$2$F$20230501$20240809$20230808$20240810$EXP$$US-TAKEDA-2023TUS077282$TAKEDA$$61$YR$$M$Y$$$20240810$$MD$US$US
227979252$22797925$2$F$20240507$20240520$20230808$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-01382$AMNEAL$$53$YR$$M$Y$$$20240806$$MD$US$US
227979382$22797938$2$F$$20230731$20230808$20240925$PER$$US-GSK-US2023AMR104883$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
227979492$22797949$2$F$$20230704$20230808$20240806$EXP$$US-AMNEAL-2023-AMRX-01867$AMNEAL$$$$$$Y$$$20240806$$MD$US$US
227979512$22797951$2$F$20230501$20230713$20230808$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-01954$AMNEAL$$69$YR$$F$Y$63.492$KG$20240806$$CN$US$US
227979883$22797988$3$F$20230729$20240708$20230808$20240718$PER$$US-SA-2023SA240327$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240718$$HP$US$US
227980607$22798060$7$F$20230720$20240723$20230808$20240725$EXP$$CN-CHEPLA-2023009664$CHEPLAPHARM$$66$YR$$M$Y$70.199$KG$20240725$$MD$COUNTRY NOT SPECIFIED$CN
227980863$22798086$3$F$$20240814$20230808$20240827$PER$$US-SA-2023SA239569$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240828$$MD$US$US
227984063$22798406$3$F$$20240830$20230808$20240903$PER$$NVSC2023US172367$NOVARTIS$$$$$F$Y$$$20240903$$MD$US$US
227984812$22798481$2$F$20230717$20240826$20230808$20240919$PER$$CO-TOLMAR, INC.-23CO042083$TOLMAR$$79$YR$$M$Y$73$KG$20240919$$CN$CO$CO
2279861711$22798617$11$F$$20240812$20230808$20240816$EXP$$US-TAKEDA-2022TUS088624$TAKEDA$$$$$F$Y$106$KG$20240816$$CN$US$US
227986338$22798633$8$F$$20240910$20230808$20240920$EXP$$PK-AMGEN-PAKSP2023137246$AMGEN$$73$YR$E$F$Y$$$20240920$$CN$PK$PK
227986504$22798650$4$F$20220801$20240716$20230808$20240720$EXP$$US-ARGENX-2022-ARGX-US001908$ARGENX BVBA$$$$$$Y$$$20240720$$CN$US$US
227987144$22798714$4$F$$20240829$20230808$20240903$EXP$$CA-TAKEDA-2022TUS030783$TAKEDA$$$$$M$Y$$$20240903$$HP$CA$CA
227988058$22798805$8$F$20230701$20240924$20230808$20240925$30DAY$$JP-PFIZER INC-202300263421$PFIZER$$$$T$M$Y$40.6$KG$20240925$$MD$JP$JP
2279918812$22799188$12$F$20231013$20240819$20230808$20240821$EXP$$US-PFIZER INC-PV202300136851$PFIZER$$76$YR$$F$Y$55.329$KG$20240821$$CN$US$US
2279930311$22799303$11$F$$20240718$20230808$20240723$PER$$US-PFIZER INC-PV202300128370$PFIZER$$53$YR$$F$Y$$$20240723$$MD$US$US
227993318$22799331$8$F$20240101$20240921$20230808$20240925$EXP$$IN-PFIZER INC-PV202300136201$PFIZER$$61$YR$$M$Y$$$20240925$$CN$IN$IN
227993739$22799373$9$F$$20240916$20230808$20240919$EXP$$US-PFIZER INC-PV202300135988$PFIZER$$59$YR$$F$Y$$$20240919$$CN$US$US
227994365$22799436$5$F$$20240730$20230808$20240805$PER$$US-PFIZER INC-PV202300113369$PFIZER$$77$YR$$F$Y$113.38$KG$20240805$$CN$US$US
227994403$22799440$3$F$$20240910$20230808$20240912$EXP$$US-PFIZER INC-PV202300136141$PFIZER$$64$YR$$F$Y$$$20240912$$CN$US$US
227995466$22799546$6$F$20230101$20240710$20230808$20240716$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2023-097732$REGENERON$$$$$F$Y$$$20240716$$CN$US$US
227996764$22799676$4$F$20220802$20240807$20230808$20240809$EXP$$CA-UCBSA-2022038944$UCB$$72$YR$$F$Y$$$20240809$$CN$CA$CA
227999312$22799931$2$F$20230417$20240628$20230808$20240702$EXP$$NVSC2023CA172008$NOVARTIS$$65$YR$$M$Y$$$20240702$$CN$CA$CA
227999412$22799941$2$F$$20240829$20230808$20240830$EXP$$NVSC2023US170609$NOVARTIS$$$$$$Y$92.99$KG$20240830$$HP$US$US
2280007816$22800078$16$F$20230101$20240911$20230808$20240913$PER$$US-BIOGEN-2023BI01220085$BIOGEN$$$$$F$Y$$$20240913$$CN$US$US
228000872$22800087$2$F$$20240920$20230808$20240926$EXP$$US-TAKEDA-2023TUS075131$TAKEDA$$$$$M$Y$$$20240926$$HP$US$US
228002106$22800210$6$F$20200909$20240725$20230808$20240731$EXP$$NVSC2023US168084$NOVARTIS$$3$MON$$F$Y$7.055$KG$20240801$$MD$US$US
228002384$22800238$4$F$20230101$20240718$20230808$20240723$EXP$$JP-AstraZeneca-2023A147528$ASTRAZENECA$$56$YR$$M$Y$83$KG$20240723$$MD$JP$
228004374$22800437$4$F$20230622$20240830$20230808$20240905$EXP$$NVSC2023KR172412$NOVARTIS$$61$YR$$F$Y$50.5$KG$20240905$$MD$KR$KR
228005883$22800588$3$F$20230220$20240711$20230808$20240715$EXP$$US-PFIZER INC-US-GBT-020474$PFIZER$$16$YR$$M$Y$$$20240715$$CN$US$US
228006455$22800645$5$F$$20240907$20230808$20240916$EXP$$US-BAUSCHBL-2023BNL006672$BAUSCH AND LOMB$$$$$M$Y$$$20240916$$CN$US$US
228006874$22800687$4$F$20230703$20240816$20230808$20240820$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-253838$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$70$KG$20240820$$MD$DE$DE
228007635$22800763$5$F$20230127$20240917$20230808$20240925$EXP$$CA-HLS-202301898$HLS THERAPEUTICS$$50$YR$A$F$Y$$$20240925$$CN$CA$CA
228008103$22800810$3$F$20210924$20240625$20230808$20240709$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2018JPN132443$VIIV$$$$$$Y$$$20240709$$MD$JP$JP
228008593$22800859$3$F$$20240628$20230808$20240705$EXP$$JP-009507513-2308JPN000247J$MERCK$$$$$F$Y$$$20240705$$MD$JP$JP
228008653$22800865$3$F$20221001$20240910$20230808$20240917$EXP$$US-GSK-US2023104674$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$US$US
228008872$22800887$2$F$20200706$20240918$20230808$20240927$EXP$$JP-JAZZ PHARMACEUTICALS-2023-JP-016841$JAZZ$$62$YR$$M$Y$66$KG$20240927$$MD$JP$JP
228008929$22800892$9$F$$20240704$20230808$20240712$EXP$$CA-GILEAD-2023-0636270$GILEAD$$67$YR$E$F$Y$$$20240712$$CN$CA$CA
228009316$22800931$6$F$20230730$20231020$20230808$20240925$PER$$US-GSK-US2023AMR106132$GLAXOSMITHKLINE$$37$YR$$F$Y$$$20240925$$CN$US$US
228010803$22801080$3$F$$20240808$20230808$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-111578$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240809$$HP$US$US
228011103$22801110$3$F$$20240717$20230808$20240725$EXP$$BR-CELLTRION INC.-2023BR015591$CELLTRION$$$$$$Y$$$20240725$$CN$BR$BR
228011694$22801169$4$F$20240130$20240828$20230809$20240902$EXP$$US-ABBVIE-5358193$ABBVIE$$80$YR$$M$Y$$$20240902$$CN$US$US
228013988$22801398$8$F$20230701$20240823$20230809$20240909$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000713$DECIPHERA PHARMACEUTICALS$$76$YR$E$M$Y$$$20240909$$CN$US$US
228015032$22801503$2$F$20230501$20230721$20230809$20240807$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00307$PRINSTON PHARMACEUTICAL$$71$YR$$M$Y$54.422$KG$20240730$$CN$US$US
228015895$22801589$5$F$20230717$20240916$20230809$20240919$EXP$$US-AMGEN-USASP2023139054$AMGEN$$69$YR$E$F$Y$55.782$KG$20240919$$HP$US$US
228016695$22801669$5$F$$20230807$20230809$20240801$PER$$NVSC2023US173231$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
228017452$22801745$2$F$20201228$20240704$20230809$20240709$EXP$$CA-TAKEDA-2020TUS051122$TAKEDA$$64$YR$$M$Y$$$20240709$$CN$CA$CA
228018883$22801888$3$F$20230701$20240904$20230809$20240916$PER$$US-SA-2023SA240474$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240916$$MD$US$US
228019105$22801910$5$F$20230101$20240820$20230809$20240902$EXP$$US-SA-2023SA239831$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240902$$MD$US$US
228019352$22801935$2$F$$20240806$20230809$20240813$EXP$$US-SA-2023SA241709$SANOFI AVENTIS$$$$A$F$Y$$$20240813$$MD$US$US
228020672$22802067$2$F$$20240802$20230809$20240808$EXP$$JP-ALXN-A202309978AA$ALEXION PHARMACEUTICALS$$44$YR$$F$Y$$$20240808$$PH$JP$JP
228020912$22802091$2$F$$20240723$20230809$20240801$EXP$$CA-AUROBINDO-AUR-APL-2023-051864$AUROBINDO$$$$$$Y$$$20240801$$HP$CA$CA
228023823$22802382$3$F$$20240905$20230809$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-06510$LUPIN$$$$$$Y$$$20240920$$CN$US$US
228024137$22802413$7$F$$20240708$20230809$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-111198$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240710$$CN$US$US
228024284$22802428$4$F$20230619$20231019$20230809$20240926$EXP$$US-GSK-US2023AMR076444$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
228025209$22802520$9$F$20230821$20240705$20230809$20240925$EXP$$US-GSK-US2023AMR106414$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
228025652$22802565$2$F$$20240919$20230809$20240930$PER$$US-SA-2023SA239010$SANOFI AVENTIS$$10$YR$C$F$Y$$$20241001$$MD$US$US
228025695$22802569$5$F$20180101$20240912$20230809$20240919$PER$$US-009507513-2308USA002291$MERCK$$$$$M$Y$$$20240919$$CN$US$US
228025712$22802571$2$F$20240601$20240721$20230809$20240731$PER$$US-SA-2023SA242589$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240731$$MD$US$US
228026228$22802622$8$F$$20240904$20230809$20240917$EXP$$ES-AUROBINDO-AUR-APL-2023-051733$AUROBINDO$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A, et al. B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature. Leukemia + Lymphoma. 2023;1-5$69$YR$$F$Y$$$20240917$$MD$ES$ES
228026952$22802695$2$F$20220501$20240708$20230809$20240717$EXP$CN-MLMSERVICE-20230725-4435035-1$CN-STRIDES ARCOLAB LIMITED-2023SP012756$STRIDES$Lu H, Yuan J, Wu Z, Wang L, Wu S, Chen Q, et al. Distribution of drug-resistant genes in alveolar lavage fluid from patients with psittacosis and traceability analysis of causative organisms. Frontiers in Microbiology. 2023;14:1182604$73$YR$$M$Y$$$20240717$$MD$CN$CN
228027092$22802709$2$F$$20240726$20230809$20240805$EXP$$US-STRIDES ARCOLAB LIMITED-2023SP012717$STRIDES$Rafeq R, Salzman M.. Use of Concentrated Insulin in the Management of Calcium Channel Blocker Overdose: A Case Report.. J Pharm Pract.. 2023;36 (6):1519-1522$73$YR$$F$Y$69.9$KG$20240805$$PH$US$US
2280287013$22802870$13$F$20230801$20240823$20230809$20240903$EXP$$JP-ASTELLAS-2023JP004050$ASTELLAS$$7$DEC$E$M$Y$$$20240903$$PH$JP$JP
228029076$22802907$6$F$$20240722$20230809$20240729$EXP$$CA-JNJFOC-20230816745$JOHNSON AND JOHNSON$$19$YR$A$M$Y$98$KG$20240729$$HP$CA$CA
228029722$22802972$2$F$20230728$20240816$20230809$20240828$EXP$$US-Accord-371566$ACCORD$$75$YR$E$F$Y$$$20240828$$HP$US$US
228029896$22802989$6$F$20230101$20240830$20230809$20240911$PER$$US-SA-2023SA241898$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240911$$MD$US$US
228030043$22803004$3$F$20230101$20240828$20230809$20240927$PER$$US-009507513-2307USA005893$MERCK$$$$$M$Y$$$20240927$$CN$US$US
2280310714$22803107$14$F$20231121$20240809$20230809$20240816$EXP$$US-GSK-US2023AMR106549$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240816$$CN$US$US
228031552$22803155$2$F$$20231109$20230809$20240730$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389008$RANBAXY$$$$E$F$Y$$$20240730$$CN$US$US
228033504$22803350$4$F$$20240722$20230809$20240725$PER$$NVSC2023US173645$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
228033946$22803394$6$F$$20240913$20230809$20240918$30DAY$$US-PFIZER INC-PV202300136427$PFIZER$$79$YR$$M$Y$$$20240918$$CN$US$US
228034315$22803431$5$F$$20240916$20230809$20240924$EXP$$CA-BAYER-2023A108686$BAYER$$50$YR$A$F$Y$$$20240924$$HP$CA$CA
228034683$22803468$3$F$20230726$20240723$20230809$20240729$EXP$$JP-ABBVIE-5355139$ABBVIE$$53$YR$$F$Y$44$KG$20240729$$MD$JP$JP
228035962$22803596$2$F$$20230721$20230809$20240722$PER$$US-BAYER-2023A104089$BAYER$$$$$F$Y$$$20240722$$CN$US$US
228036022$22803602$2$F$20230106$20240715$20230809$20240722$EXP$$US-MYLANLABS-2023M1002667$MYLAN$$52$YR$$F$Y$72.57$KG$20240722$$CN$US$US
228036642$22803664$2$F$$20240918$20230809$20240927$PER$$NVSC2023US173845$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
228037353$22803735$3$F$$20240822$20230809$20240829$EXP$$US-TAKEDA-2023TUS077100$TAKEDA$$$$$F$Y$44$KG$20240829$$MD$US$US
228037524$22803752$4$F$20230101$20240828$20230809$20240902$EXP$$CA-TAKEDA-2023TUS077067$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
228037775$22803777$5$F$20230801$20240921$20230809$20240926$EXP$$DE-TAKEDA-2023TUS077446$TAKEDA$$71$YR$$F$Y$$$20240926$$HP$DE$DE
228037943$22803794$3$F$20230714$20240726$20230809$20240731$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202307011822$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240731$$CN$JP$JP
228038316$22803831$6$F$20230713$20240815$20230809$20240820$EXP$$US-TAKEDA-2023TUS070439$TAKEDA$$72$YR$$F$Y$71$KG$20240820$$CN$US$US
228042113$22804211$3$F$$20240620$20230809$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403137$RANBAXY$Khan S, Babu K, Sidhu, Niemi M. Caffeine intoxication treated with hemodialysis. Semin Dial. 2023;36:414-418$23$YR$$M$Y$$$20240705$$HP$US$US
228042962$22804296$2$F$$20240618$20230809$20240703$EXP$$SK-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400905$RANBAXY$Feketeova E, Dragasek J, Klobucnikova K, Durdik P, Carnakovic S, Slavkovska M, et al. Psychotic Episode and Schizophrenia in Slovakian Narcolepsy Database. Brain Sci. 2023;13(1):43$13$YR$$M$Y$$$20240703$$HP$SK$SK
228043043$22804304$3$F$$20240701$20230809$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-380789$RANBAXY$$$$A$F$Y$$$20240711$$HP$US$US
228043133$22804313$3$F$$20240701$20230809$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-380721$RANBAXY$$$$A$M$Y$$$20240711$$HP$US$US
228044585$22804458$5$F$20230101$20240913$20230809$20240926$EXP$$JP-AMGEN-2023JPCCXI0930$AMGEN$Nagashima H, Tamura M, Noguchi K, Matsui K. A case of microscopic polyangiitis suspected to be persistent hepatic function disorder due to avacopan. The 244th Kinki Regional Association of the Japanese Society ofInternal Medicine. 2024 JUN 29;$54$YR$A$F$Y$55$KG$20240926$$MD$JP$JP
228045192$22804519$2$F$20230214$20240805$20230809$20240809$EXP$FR-AFSSAPS-AM2023000635$FR-ABBVIE-5358717$ABBVIE$$73$YR$$F$Y$$$20240809$$MD$FR$FR
228048422$22804842$2$F$20230101$20240814$20230809$20240828$PER$$US-SA-2023SA242802$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240828$$HP$US$US
228048644$22804864$4$F$$20240801$20230809$20240806$EXP$$JP-009507513-2308JPN000008J$MERCK$$8$DEC$$M$Y$$$20240806$$MD$JP$JP
228049292$22804929$2$F$20230401$20240920$20230809$20240925$EXP$$CA-PFIZER INC-202300270883$PFIZER$$38$YR$$F$Y$$$20240925$$HP$CA$CA
228049445$22804944$5$F$20230101$20240809$20230809$20240814$EXP$$US-PFIZER INC-PV202300136656$PFIZER$$58$YR$$F$Y$$$20240814$$CN$US$US
228052144$22805214$4$F$$20240724$20230809$20240729$EXP$$US-TAKEDA-2023TUS022590$TAKEDA$$$$$F$Y$$$20240729$$MD$US$US
228052213$22805221$3$F$20221112$20240807$20230809$20240816$EXP$$SI-TAKEDA-2023TUS077515$TAKEDA$$$$$M$Y$78$KG$20240816$$CN$SI$SI
228052662$22805266$2$F$20240812$20240814$20230809$20240820$EXP$$HN-MYLANLABS-2023M1083243$MYLAN$$79$YR$$M$Y$$$20240820$$CN$HN$HN
228052742$22805274$2$F$$20240919$20230809$20240926$EXP$$US-MYLANLABS-2023M1083486$MYLAN$Ademi B, Rothwell WB. STATIN-INDUCED NECROTIZING MYOPATHY. J-Gen-Intern-Med 2023;38 (Suppl. 2):S598.$47$YR$$M$Y$$$20240926$$HP$US$US
228053544$22805354$4$F$20240617$20240805$20230809$20240806$EXP$$US-TAKEDA-2018TUS028422$TAKEDA$$50$YR$$M$Y$$$20240806$$HP$US$US
228055732$22805573$2$F$20201130$20240918$20230809$20240927$EXP$$JP-JAZZ PHARMACEUTICALS-2023-JP-016833$JAZZ$$35$YR$$M$Y$45$KG$20240927$$MD$JP$JP
228055866$22805586$6$F$20230101$20240710$20230809$20240716$EXP$$US-PFIZER INC-PV202300107264$PFIZER$$67$YR$$M$Y$$$20240716$$CN$US$US
228056813$22805681$3$F$20230801$20240801$20230809$20240805$PER$$US-PFIZER INC-PV202300136677$PFIZER$$63$YR$$F$Y$$$20240805$$HP$US$US
228059003$22805900$3$F$20230101$20240726$20230809$20240805$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2023-03725$IPSEN$$25$YR$A$M$Y$$$20240805$$CN$US$US
228060003$22806000$3$F$20230101$20240918$20230809$20240927$PER$$US-SA-2023SA239932$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240927$$MD$US$US
228061182$22806118$2$F$$20240801$20230809$20240815$EXP$$US-BIOCODEX2-2023001114$BIOCODEX$$$$$M$Y$44.9$KG$20240814$$CN$US$US
228061213$22806121$3$F$20240123$20240611$20230809$20240710$PER$$US-009507513-2308USA002035$MERCK$$46$YR$$M$Y$$$20240710$$HP$US$US
228061283$22806128$3$F$$20240724$20230809$20240808$EXP$$CA-HLS-202301921$HLS THERAPEUTICS$$35$YR$A$M$Y$$$20240808$$MD$CA$CA
228061627$22806162$7$F$20220101$20240903$20230809$20240911$EXP$$JP-009507513-2209JPN001519J$MERCK$Nakamura N, Usui H, Hanyu Y, Otsuka S, Katayama E, Okuya R, et al.. P-110 A Case of Advanced Corpus Uteri Carcinoma Successfully Treated with Lenvatinib/Pembrolizumab Combination Therapy and Surgery Became Feasible. Japanese Journal of Gynecological Oncology/The 65th Annual Meeting of Japan Soci. 2023;41(3):334$51$YR$$F$Y$$$20240911$$MD$JP$JP
228062392$22806239$2$F$20240814$20240814$20230809$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-112267$BRISTOL MYERS SQUIBB$$101$YR$E$F$Y$$$20240819$$CN$US$US
228063182$22806318$2$F$$20240806$20230809$20240815$PER$$US-SA-2023SA240330$SANOFI AVENTIS$$65$YR$E$F$Y$84.82$KG$20240815$$MD$US$US
228063253$22806325$3$F$20230101$20240705$20230809$20240713$EXP$$CA-CELLTRION INC.-2023CA015691$CELLTRION$$$$$$Y$$$20240713$$CN$CA$CA
228064432$22806443$2$F$20240701$20240814$20230810$20240828$PER$$US-SA-2023SA242524$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240828$$MD$US$US
228064975$22806497$5$F$20230101$20240716$20230810$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2023-022331$UNITED THERAPEUTICS$$$$$M$Y$64.853$KG$20240726$$$US$US
228065752$22806575$2$F$$20240624$20230810$20240701$EXP$$US-AUROBINDO-AUR-APL-2023-051250$AUROBINDO$Saad Khan, Kavita Babu, Rohan Sidhu, Matthew Niemi.. Caffeine intoxication treated with hemodialysis.. Semin Dial. 2023;36414-418$23$YR$$M$Y$$$20240701$$HP$US$US
228065923$22806592$3$F$$20240814$20230810$20240820$EXP$$CA-TAKEDA-2023TUS066141$TAKEDA$$$$$M$Y$$$20240820$$CN$CA$CA
228066026$22806602$6$F$20230906$20231113$20230810$20240926$EXP$$US-GSK-US2023AMR105828$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
228067442$22806744$2$F$$20240802$20230810$20240808$EXP$$US-ABBVIE-5361022$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
2280695510$22806955$10$F$20230101$20240125$20230810$20240926$EXP$$US-GSK-US2023AMR106621$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
228069653$22806965$3$F$20230710$20240701$20230810$20240709$EXP$$BE-CELLTRION INC.-2023BE015734$CELLTRION$$$$$$Y$$$20240709$$MD$BE$BE
228070272$22807027$2$F$$20240722$20230810$20240729$EXP$$US-ROCHE-3401988$ROCHE$$$$E$M$Y$$$20240729$$CN$US$US
2280706610$22807066$10$F$20230502$20240628$20230810$20240702$EXP$$US-TAKEDA-2023TUS075839$TAKEDA$$48$YR$$F$Y$133$KG$20240702$$HP$US$US
228071198$22807119$8$F$20230101$20240909$20230810$20240916$EXP$$CA-TAKEDA-2023TUS071727$TAKEDA$$$$$F$Y$$$20240916$$CN$CA$CA
228071339$22807133$9$F$$20240629$20230810$20240708$EXP$$ES-AUROBINDO-AUR-APL-2023-051749$AUROBINDO$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A, et al.. B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. report of three cases and review of the literature. Leukemia and Lymphoma.. Leukemia + Lymphoma. 2023;13:1-5$67$YR$$M$Y$$$20240708$$MD$ES$ES
228071345$22807134$5$F$20230504$20240729$20230810$20240803$EXP$$DE-ABBVIE-5360923$ABBVIE$$72$YR$$F$Y$87$KG$20240803$$HP$DE$DE
228073158$22807315$8$F$20230101$20240910$20230810$20240923$EXP$$CA-UCBSA-2023039985$UCB$$$$$F$Y$$$20240923$$CN$CA$CA
228073742$22807374$2$F$$20240714$20230810$20240718$EXP$$US-JNJFOC-20230806716$JOHNSON AND JOHNSON$$$$A$$Y$$$20240718$$MD$US$DK
228074057$22807405$7$F$20230731$20240829$20230810$20240830$EXP$$NVSC2023US174287$NOVARTIS$$58$YR$$F$Y$122.4$KG$20240830$$CN$US$US
228075502$22807550$2$F$$20240710$20230810$20240718$EXP$$NVSC2023US171124$NOVARTIS$$$$$M$Y$$$20240718$$MD$US$US
228076347$22807634$7$F$20230617$20240812$20230810$20240826$EXP$$GR-UCBSA-2023036046$UCB$$16$YR$$M$Y$95$KG$20240826$$MD$GR$GR
228077552$22807755$2$F$$20230806$20230810$20240710$EXP$$AU-ASTELLAS-2023US023652$ASTELLAS$$$$$F$Y$$$20240710$$MD$AU$AU
228077652$22807765$2$F$$20240801$20230810$20240809$EXP$$CA-002147023-NVSC2022CA303639$Haleon PLC$$40$YR$$F$Y$$$20240809$$HP$CA$CA
228077682$22807768$2$F$$20230806$20230810$20240710$EXP$$AU-ASTELLAS-2023US023650$ASTELLAS$$$$$$Y$$$20240710$$CN$AU$AU
228079332$22807933$2$F$20240829$20240829$20230810$20240919$PER$$US-SA-2023SA241843$SANOFI AVENTIS$$61$YR$A$M$Y$115.65$KG$20240919$$MD$US$US
228079463$22807946$3$F$$20240723$20230810$20240801$PER$$US-SA-2023SA242039$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240801$$MD$US$US
228079712$22807971$2$F$$20240709$20230810$20240716$PER$$US-SA-2023SA243684$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240716$$MD$US$US
228080077$22808007$7$F$20230101$20240918$20230810$20240930$PER$$US-SA-2023SA242624$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240930$$MD$US$US
228080552$22808055$2$F$$20240726$20230810$20240807$PER$$US-SA-2023SA242576$SANOFI AVENTIS$$21$YR$A$F$Y$72.562$KG$20240807$$MD$US$US
228080584$22808058$4$F$20230101$20240719$20230810$20240730$PER$$US-SA-2023SA241121$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240730$$MD$US$US
228080782$22808078$2$F$$20240814$20230810$20240826$EXP$$IT-AUROBINDO-AUR-APL-2023-049413$AUROBINDO$Minghetti S, Vannini M, Casula L, Asprea M, Gori S, Calvani AM, et al. Epidemiological and Psychopharmacological Study about Off-Label Treatment in Child and Adolescent Psychiatric Emergencies: A Tertiary/Single Center Experience. Pediatr-Emerg-Care. 2022;38(11):E1660-E1663$12$YR$$M$Y$$$20240826$$MD$IT$IT
228081602$22808160$2$F$$20240701$20230810$20240705$EXP$$AU-009507513-2308AUS003437$MERCK$$$$E$M$Y$$$20240705$$MD$AU$AU
228082344$22808234$4$F$20190703$20240823$20230810$20240902$EXP$$DE-ROCHE-2393355$ROCHE$$53$YR$A$F$Y$$$20240902$$CN$DE$DE
228085042$22808504$2$F$$20230809$20230810$20240702$EXP$$US-SA-2023SA238986$SANOFI AVENTIS$Alamgir M, Sikandar D, Badal S.. A case of acute toxicity of calcium channel blocker (ccb) caused by overdose.. Journal of General Internal Medicine.. 2023;38(Suppl 2):S368-9$54$YR$A$F$Y$$$20240702$$HP$US$US
228085613$22808561$3$F$$20240708$20230810$20240716$EXP$$JP-SA-2023SA240492$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240716$$HP$JP$JP
228086759$22808675$9$F$$20240925$20230810$20240928$EXP$$CA-JNJFOC-20230816742$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240928$$HP$CA$CA
228086852$22808685$2$F$20240101$20240517$20230810$20240710$PER$$US-LUNDBECK-DKLU3065382$LUNDBECK$$$$$$Y$$$20240711$$CN$US$US
228087276$22808727$6$F$$20240913$20230810$20240923$EXP$$CA-CELLTRION INC.-2022CA018181$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
228087982$22808798$2$F$$20240703$20230810$20240709$EXP$$FR-PFIZER INC-202300270661$PFIZER$$36$YR$$F$Y$$$20240709$$MD$FR$FR
228088063$22808806$3$F$$20240806$20230810$20240808$EXP$FR-AFSSAPS-PV2023000738$FR-PFIZER INC-202300268582$PFIZER$$20$WK$$M$Y$0.456$KG$20240808$$MD$FR$FR
228088525$22808852$5$F$$20240828$20230810$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-112710$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240829$$CN$US$US
228088934$22808893$4$F$20220101$20240816$20230810$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202308004481$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240820$$CN$US$US
228090684$22809068$4$F$20230101$20240813$20230810$20240821$PER$$US-SA-2023SA244738$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240821$$MD$US$US
228091412$22809141$2$F$20230210$20240627$20230810$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-403135$RANBAXY$$$$$F$Y$$$20240712$$PH$GB$GB
228091903$22809190$3$F$$20240807$20230810$20240822$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402249$RANBAXY$Kapkanova N, Elliott C, Lucas D. Lithium nephropathy: Unique sonographic appearance and application of new on cart tools. Sonogr. 2020;Feb 12; 7(1):33-35$65$YR$$F$Y$$$20240822$$HP$AU$AU
228094222$22809422$2$F$$20240925$20230810$20240926$EXP$$US-SANDOZ INC.-SDZ2023US002322$SANDOZ$$$$$$Y$$$20240926$$CN$US$US
228094512$22809451$2$F$$20240628$20230810$20240701$EXP$$US-SANDOZ INC.-SDZ2023US000676$SANDOZ$$$$$$Y$$$20240701$$CN$US$US
228095223$22809522$3$F$$20240628$20230810$20240704$EXP$$US-SANDOZ INC.-SDZ2023US000589$SANDOZ$$$$$$Y$$$20240704$$CN$US$US
228095972$22809597$2$F$$20240924$20230810$20240925$EXP$$PR-SANDOZ INC.-SDZ2023PR000618$SANDOZ$$$$$$Y$$$20240925$$CN$PR$PR
228095982$22809598$2$F$$20240924$20230810$20240927$EXP$$US-SANDOZ INC.-SDZ2023US000552$SANDOZ$$$$$$Y$$$20240927$$CN$US$US
228096082$22809608$2$F$20230626$20240924$20230810$20240925$EXP$$US-SANDOZ INC.-SDZ2023US000578$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
228096102$22809610$2$F$$20240924$20230810$20240926$EXP$$US-SANDOZ INC.-SDZ2023US001098$SANDOZ$$$$$$Y$$$20240926$$CN$US$US
228096232$22809623$2$F$20230626$20240924$20230810$20240924$EXP$$US-SANDOZ INC.-SDZ2023US000280$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
228097372$22809737$2$F$$20240628$20230810$20240701$EXP$$US-SANDOZ INC.-SDZ2023US004082$SANDOZ$$$$$$Y$$$20240701$$CN$US$US
228102713$22810271$3$F$$20240925$20230810$20240926$PER$$US-PFIZER INC-PV202300137566$PFIZER$$69$YR$$M$Y$63.492$KG$20240926$$CN$US$US
228102925$22810292$5$F$$20240714$20230810$20240715$PER$$US-PFIZER INC-202300271996$PFIZER$$46$YR$$F$Y$81.65$KG$20240715$$CN$US$US
228102955$22810295$5$F$20230101$20240829$20230810$20240904$PER$$US-PFIZER INC-PV202300116421$PFIZER$$26$YR$$M$Y$$$20240904$$HP$US$US
228103272$22810327$2$F$20240101$20240906$20230810$20240909$PER$$US-PFIZER INC-PV202300137216$PFIZER$$66$YR$$M$Y$$$20240909$$CN$US$US
228103557$22810355$7$F$$20240712$20230810$20240717$PER$$US-PFIZER INC-PV202300108748$PFIZER$$62$YR$$F$Y$$$20240717$$CN$US$US
228103785$22810378$5$F$20110811$20240715$20230810$20240722$PER$$US-BIOGEN-2020BI00909756$BIOGEN$$34$YR$$F$Y$$$20240722$$CN$US$US
228103863$22810386$3$F$20230615$20240703$20230810$20240709$EXP$$CO-TAKEDA-2023TUS078192$TAKEDA$$33$YR$$F$Y$65$KG$20240709$$HP$CO$CO
228105152$22810515$2$F$$20240704$20230810$20240710$EXP$FR-AFSSAPS-TS2023000933$FR-MYLANLABS-2023M1083156$MYLAN$$57$YR$$F$Y$80$KG$20240710$$MD$FR$FR
228106826$22810682$6$F$$20240909$20230810$20240911$EXP$$US-TAKEDA-US201924456$TAKEDA$$$$$F$Y$$$20240911$$HP$US$US
228107163$22810716$3$F$$20240911$20230810$20240916$PER$$US-AMGEN-USASP2023140304$AMGEN$$58$YR$A$F$Y$$$20240916$$HP$US$US
228107345$22810734$5$F$20221025$20240905$20230810$20240910$EXP$$CA-PFIZER INC-202201261696$PFIZER$$39$YR$$M$Y$$$20240910$$HP$CA$CA
228107387$22810738$7$F$20230101$20240820$20230810$20240823$EXP$$CA-PFIZER INC-202300222608$PFIZER$$60$YR$$F$Y$79.819$KG$20240823$$HP$CA$CA
228107532$22810753$2$F$$20240705$20230810$20240712$EXP$$DE-MYLANLABS-2023M1083084$MYLAN$Schonharting W, Roehnisch T, Manoochehri M, Christoph J, Sieger M, Nogueira M, Martos-Contreras M and Kunz M. Improved Survival of a HER2-Positive Metastatic Breast Cancer Patient Following a Personalized Peptide Immunization. Vaccines-(Basel). 2023;11 (6):1-9$40$YR$$F$Y$$$20240712$$HP$DE$DE
228107756$22810775$6$F$$20240830$20230810$20240906$EXP$$CA-TAKEDA-2023TUS078077$TAKEDA$$$$$M$Y$$$20240906$$HP$CA$CA
228108507$22810850$7$F$20230101$20240722$20230810$20240805$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000311$Unknown Manufacturer$$$$$$Y$$$20240805$$CN$US$US
228109262$22810926$2$F$$20240821$20230810$20240823$EXP$PT-INFARMED-F202307-763$PT-MYLANLABS-2023M1083473$MYLAN$$30$YR$$F$Y$$$20240823$$CN$PT$PT
228109474$22810947$4$F$$20240724$20230810$20240725$PER$$NVSC2023US174743$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
228109865$22810986$5$F$20230731$20240920$20230810$20240926$EXP$$US-BIOGEN-2023BI01220779$BIOGEN$$46$YR$$F$Y$$$20240926$$CN$US$US
228111354$22811135$4$F$$20240812$20230810$20240813$EXP$$CA-BAUSCH-BL-2023-012099$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240813$$CN$CA$CA
228113755$22811375$5$F$20240101$20240909$20230810$20240911$PER$$US-PFIZER INC-PV202300097653$PFIZER$$81$YR$$F$Y$$$20240911$$CN$US$US
228113903$22811390$3$F$$20240812$20230810$20240820$EXP$$US-BAUSCHBL-2023BNL006689$BAUSCH AND LOMB$$$$$F$Y$$$20240820$$CN$US$US
228114068$22811406$8$F$20230101$20240906$20230810$20240909$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-133100$DAIICHI$$$$$F$Y$$$20240909$$MD$US$US
228115193$22811519$3$F$20221201$20240821$20230810$20240827$PER$$US-ALXN-A202310156$ALEXION PHARMACEUTICALS$$26$YR$$F$Y$$$20240827$$CN$US$US
228115713$22811571$3$F$$20240730$20230810$20240806$30DAY$$US-GSK-US2023105206$GLAXOSMITHKLINE$$$$$M$Y$$$20240806$$CN$US$US
228115973$22811597$3$F$$20240903$20230810$20240906$EXP$$US-TAKEDA-2023TUS055247$TAKEDA$$$$$M$Y$$$20240906$$CN$US$US
228116328$22811632$8$F$20230101$20240829$20230810$20240907$EXP$$CA-CELLTRION INC.-2023CA015884$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
228116593$22811659$3$F$20230101$20240705$20230810$20240711$EXP$$NL-ABBVIE-4281704$ABBVIE$$71$YR$$M$Y$$$20240711$$CN$NL$NL
228117387$22811738$7$F$20230713$20240725$20230810$20240813$EXP$$CA-ABBVIE-5360443$ABBVIE$$23$YR$$M$Y$$$20240813$$MD$CA$CA
228118133$22811813$3$F$20230717$20240619$20230811$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003011$ACADIA PHARMACEUTICALS$$13$YR$$F$Y$$$20240712$$CN$US$US
228118143$22811814$3$F$$20240611$20230811$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003053$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
228118205$22811820$5$F$20230701$20240613$20230811$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003058$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240708$$CN$US$US
228118246$22811824$6$F$$20240617$20230811$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003024$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
2281183811$22811838$11$F$20230515$20240801$20230811$20240805$EXP$$CA-ROCHE-3372281$ROCHE$$58$YR$A$M$Y$$$20240805$$CN$CA$CA
228118763$22811876$3$F$20230101$20240827$20230811$20240909$EXP$$CA-JNJFOC-20230823095$JOHNSON AND JOHNSON$$17$YR$T$F$Y$64$KG$20240909$$HP$CA$CA
2281190410$22811904$10$F$20230101$20240704$20230811$20240712$EXP$$CA-CELLTRION INC.-2023CA011121$CELLTRION$$$$$$Y$$$20240712$$MD$CA$CA
228119092$22811909$2$F$$20240729$20230811$20240807$PER$$US-SA-2023SA242835$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240807$$MD$US$US
228119272$22811927$2$F$$20230721$20230811$20240808$PER$$US-OTSUKA-2023_019704$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
228119282$22811928$2$F$20230718$20230726$20230811$20240808$PER$$US-OTSUKA-2023_020075$OTSUKA$$4$DEC$$M$Y$$$20240808$$MD$US$US
228119345$22811934$5$F$20240415$20240718$20230811$20240725$PER$$US-BIOGEN-2023BI01220079$BIOGEN$$24$YR$$F$Y$$$20240725$$CN$US$US
228119933$22811993$3$F$$20240708$20230811$20240718$EXP$$IT-AUROBINDO-AUR-APL-2023-051704$AUROBINDO$Lagana AS, Marin L, Ambrosini G, Nuzzi L, Buzzaccarini G, Esposito F, et al.. Intrahepatic cholestasis of pregnancy after ovarian hyperstimulation syndrome with wild-type ABCB4 gene: a peculiar case and literature review.. BMC Women^s Health.. 2023;23:316$$$N$$Y$2.5$KG$20240718$$HP$IT$IT
228120848$22812084$8$F$20211201$20240918$20230811$20240924$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2021-12596$IPSEN$$77$YR$E$M$Y$$$20240924$$MD$CA$CA
228120965$22812096$5$F$20230702$20240701$20230811$20240716$EXP$$JP-AMGEN-JPNSP2023127803$AMGEN$P1-1 Case report of patients treated with chemotherapy for breast cancer with the use of a scalp cooling device - Future challenges obtained from the patients -. The 7th Gunma Pharmaceutical Meeting. 40$49$YR$A$F$Y$$$20240716$$MD$JP$JP
228121754$22812175$4$F$20230801$20240912$20230811$20240920$EXP$$US-ABBVIE-5361510$ABBVIE$$60$YR$$M$Y$$$20240920$$CN$US$US
228122443$22812244$3$F$$20240711$20230811$20240720$EXP$$CA-CELLTRION INC.-2023CA015856$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
228122975$22812297$5$F$$20240911$20230811$20240912$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-223466$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240912$$CN$CA$CA
228124333$22812433$3$F$$20240815$20230811$20240828$PER$$US-SA-2023SA243682$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240828$$CN$US$US
228125565$22812556$5$F$20230101$20240822$20230811$20240926$PER$$US-SA-2023SA241947$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240926$$MD$US$US
228127243$22812724$3$F$$20240708$20230811$20240720$EXP$JP-MACLEODS PHARMACEUTICALS US LTD-MAC2023042842$JP-MACLEODS PHARMACEUTICALS US LTD-MAC2023042842$MACLEODS$$$$$$Y$$$20240720$$MD$JP$JP
228127819$22812781$9$F$20230412$20240913$20230811$20240924$EXP$$US-UCBSA-2023023574$UCB$$4$YR$$M$Y$$$20240924$$CN$US$US
228128218$22812821$8$F$20230712$20240902$20230811$20240913$EXP$$GB-LEO Pharma-361585$LEO PHARM$$36$YR$$F$Y$$$20240913$$MD$GB$GB
228128524$22812852$4$F$20230805$20240818$20230811$20240827$PER$$US-SA-2023SA244488$SANOFI AVENTIS$$23$YR$A$F$Y$53.5$KG$20240827$$MD$US$US
2281288910$22812889$10$F$20230801$20240917$20230811$20240925$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000718$DECIPHERA PHARMACEUTICALS$$67$YR$A$M$Y$$$20240925$$CN$US$US
228129365$22812936$5$F$$20240916$20230811$20240925$EXP$$CA-CELLTRION INC.-2020CA035299$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
228129454$22812945$4$F$20230801$20240805$20230811$20240813$PER$$US-SA-2023SA244168$SANOFI AVENTIS$$3$YR$C$F$Y$14$KG$20240814$$MD$US$US
228129727$22812972$7$F$20230801$20240229$20230811$20240925$PER$$US-GSK-US2023AMR108402$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
228130052$22813005$2$F$$20240830$20230811$20240902$EXP$$NVSC2023AU175105$NOVARTIS$$$$$F$Y$$$20240902$$HP$AU$AU
228132622$22813262$2$F$$20231114$20230811$20240710$PER$$US-ROCHE-3238001$ROCHE$$$$$M$Y$$$20240628$$PH$US$US
228133032$22813303$2$F$20230701$20240724$20230811$20240730$EXP$$NVSC2023EG175118$NOVARTIS$$38$YR$$M$Y$$$20240730$$CN$EG$EG
228133574$22813357$4$F$20230703$20240904$20230811$20240914$30DAY$$US-GSK-US2023104602$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240914$$MD$US$US
228133642$22813364$2$F$20230617$20230803$20230811$20240710$PER$$US-ROCHE-3371755$ROCHE$$44$YR$A$F$Y$52.16$KG$20240628$$CN$US$US
228133903$22813390$3$F$$20230830$20230811$20240710$PER$$US-ROCHE-3139929$ROCHE$$71$YR$E$F$Y$66.68$KG$20240628$$CN$US$US
228133922$22813392$2$F$$20230718$20230811$20240710$PER$$US-ROCHE-3378453$ROCHE$$58$YR$A$M$Y$$$20240628$$CN$US$US
2281344311$22813443$11$F$$20240820$20230811$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-113039$BRISTOL MYERS SQUIBB$Shiratori T, Nakamura K, Chiyubachi K, Tanaka Y, Ishidoya M, Sakamoto H, et al. A case of septic shock attributed to influenza A infection during maintenance therapy with nivolumab and ipilimumab. The 62nd Tohoku Branch Meeting of the Japan Lung Cancer Society. 2023;20$65$YR$E$M$Y$$$20240826$$MD$JP$JP
228134525$22813452$5$F$$20240827$20230811$20240907$EXP$$US-ASTELLAS-2023US024006$ASTELLAS$$81$YR$E$M$Y$$$20240907$$CN$US$US
228134544$22813454$4$F$20230801$20230908$20230811$20240925$PER$$US-GSK-US2023AMR108421$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
228135883$22813588$3$F$20230801$20240814$20230811$20240821$EXP$$PR-ABBVIE-5363323$ABBVIE$$47$YR$$F$Y$79$KG$20240821$$CN$PR$PR
228136292$22813629$2$F$$20231010$20230811$20240710$PER$$US-ROCHE-3332584$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
228137545$22813754$5$F$20230101$20240710$20230811$20240715$PER$$US-SA-2023SA240462$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240715$$MD$US$US
228138673$22813867$3$F$20230710$20240210$20230811$20240710$PER$$US-ROCHE-3386975$ROCHE$$14$DY$N$F$Y$$$20240701$$CN$US$US
228139072$22813907$2$F$$20230914$20230811$20240710$PER$$US-ROCHE-3374733$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
228139804$22813980$4$F$20230717$20240508$20230811$20240710$PER$$US-ROCHE-3394700$ROCHE$$39$YR$A$M$Y$86.18$KG$20240701$$CN$US$US
228140133$22814013$3$F$$20240715$20230811$20240724$EXP$$BR-TAKEDA-2023TUS022700$TAKEDA$$$$$F$Y$$$20240724$$CN$BR$BR
228141263$22814126$3$F$$20240628$20230811$20240703$EXP$$US-TAKEDA-2022TUS000608$TAKEDA$$$$$M$Y$62.132$KG$20240703$$HP$US$US
2281436412$22814364$12$F$20230101$20240910$20230811$20240912$EXP$$US-DAIICHI SANKYO, INC.-DSU-2023-133217$DAIICHI$$$$$F$Y$$$20240913$$CN$US$US
228143653$22814365$3$F$20190711$20240805$20230811$20240814$EXP$$FR-NORDICGR-052896$NORDIC PHARMA$$$$A$F$Y$$$20240814$$LW$FR$FR
228143883$22814388$3$F$20230101$20240729$20230811$20240807$PER$$US-SA-2023SA246143$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240807$$MD$US$US
228144392$22814439$2$F$20230701$20240828$20230811$20240910$PER$$US-SA-2023SA245011$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240910$$HP$US$US
228145174$22814517$4$F$20230719$20240617$20230811$20240709$PER$$CA-TOLMAR, INC.-23CA042096$TOLMAR$$71$YR$$M$Y$$$20240709$$CN$CA$CA
228145214$22814521$4$F$20240911$20240911$20230811$20240927$PER$$CA-TOLMAR, INC.-23CA042109$TOLMAR$$81$YR$$M$Y$$$20240927$$CN$CA$CA
228145617$22814561$7$F$20211207$20240821$20230811$20240825$EXP$$NVSC2021AU285605$NOVARTIS$$46$YR$$F$Y$$$20240826$$CN$AU$AU
228145943$22814594$3$F$$20240918$20230811$20240926$EXP$$CA-APOTEX-2023AP011613$APOTEX$$62$YR$$F$Y$107$KG$20240926$$HP$CA$CA
228147703$22814770$3$F$20221201$20240628$20230811$20240709$EXP$$CA-ROCHE-2947477$ROCHE$$28$YR$A$F$Y$$$20240709$$CN$CA$CA
228148034$22814803$4$F$20230804$20240802$20230811$20240807$EXP$$JP-AstraZeneca-2023A180398$ASTRAZENECA$$73$YR$$F$Y$$$20240807$$MD$JP$
228151686$22815168$6$F$20230101$20240801$20230811$20240805$EXP$$US-PFIZER INC-PV202300138047$PFIZER$$54$YR$$F$Y$$$20240805$$HP$US$US
228151843$22815184$3$F$$20240702$20230811$20240703$PER$$US-PFIZER INC-PV202300137184$PFIZER$$78$YR$$F$Y$79$KG$20240703$$CN$US$US
228152882$22815288$2$F$$20240812$20230811$20240816$PER$$US-PFIZER INC-202300273935$PFIZER$$8$YR$$M$Y$$$20240816$$CN$US$US
228154042$22815404$2$F$20230101$20240916$20230811$20240918$PER$$US-PFIZER INC-2020017577$PFIZER$$73$YR$$F$Y$$$20240918$$CN$US$US
228154522$22815452$2$F$$20240628$20230811$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-403176$RANBAXY$$71$YR$$M$Y$84$KG$20240712$$HP$GB$GB
228155302$22815530$2$F$$20240806$20230811$20240821$EXP$$KP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404071$RANBAXY$Park H, Heo J, Kim MJ, Lee JH, Kim MS, Jin DK, et al. The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy. Epilepsia. 2022;63:3148-3155$11$YR$$F$Y$$$20240821$$HP$KR$KR
228155392$22815539$2$F$$20240802$20230811$20240816$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404063$RANBAXY$Park H, Heo J, Kim M-J, Lee J-H, Kim M-S, Jin D-K, et al. The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy. Epilepsia. 2022;63:3148-3155$15$YR$$F$Y$$$20240816$$HP$KR$KR
228155432$22815543$2$F$$20240806$20230811$20240821$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404073$RANBAXY$Park H, Heo J, Kim MJ, Lee JH, Kim MS, Jin DK, et al. The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy. Epilepsia. 2022;63:3148?3155$6$YR$$F$Y$$$20240821$$HP$KR$KR
228155442$22815544$2$F$$20240806$20230811$20240821$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404072$RANBAXY$Park H, Heo J, Kim MJ, Lee JH, Kim MS, Jin DK, et al. The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy. Epilepsia. 2022;63:3148?3155$8$YR$$F$Y$$$20240821$$HP$KR$KR
228155782$22815578$2$F$$20240704$20230811$20240718$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381553$RANBAXY$Santos M, Leal I, Morais Sarmento T, Mano SS, Jose P, Vaz-Pereira S. Bull?s Eye Maculopathy in Near-Infrared Reflectance as An Early Sign of Hydroxychloroquine Toxicity. Diagnostics (Basel). 2023;13(3):445(1-9)$60$YR$$F$Y$$$20240718$$HP$PT$PT
228155904$22815590$4$F$20230101$20240802$20230811$20240812$PER$$US-SA-2023SA244933$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240812$$MD$US$US
228156723$22815672$3$F$$20240709$20230811$20240712$EXP$$IT-TAKEDA-2023TUS078589$TAKEDA$Sorrenti B, Laurini C, Bosco L, Strano CM, Scarlato M, Gastaldi M, et al. Overcoming therapeutic challenges: successful management of a supposedly triple seronegative, refractory generalized myasthenia gravis patient with efgartigimod. European Journal Of Neurology. 2024;31(7)$28$YR$$F$Y$$$20240712$$HP$IT$IT
228156763$22815676$3$F$$20240703$20230811$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-027999$JAZZ$$$$$M$Y$$$20240708$$MD$US$US
228158118$22815811$8$F$$20240802$20230811$20240802$EXP$$US-PFIZER INC-PV202300137169$PFIZER$$46$YR$$F$Y$82$KG$20240802$$CN$US$US
228158205$22815820$5$F$20230101$20240806$20230811$20240813$EXP$$NVSC2023BR165142$NOVARTIS$$$$$F$Y$$$20240813$$CN$BR$BR
228158284$22815828$4$F$$20240702$20230811$20240708$EXP$$US-KYOWAKIRIN-2023BKK012591$KYOWA$$$$$$Y$$$20240708$$HP$US$US
228159092$22815909$2$F$20230810$20240618$20230811$20240704$EXP$$IN-ROCHE-3404303$ROCHE$$68$YR$E$M$Y$$$20240704$$CN$IN$IN
228159232$22815923$2$F$20230801$20240704$20230811$20240709$EXP$$CA-ABBVIE-5361964$ABBVIE$$57$YR$$F$Y$$$20240709$$CN$CA$CA
228160646$22816064$6$F$20240301$20240716$20230811$20240717$EXP$$CA-TAKEDA-2023TUS059974$TAKEDA$$33$YR$$F$Y$$$20240717$$MD$CA$CA
228161382$22816138$2$F$20230717$20240627$20230811$20240705$EXP$$BR-TAKEDA-2023TUS075003$TAKEDA$$36$YR$$F$Y$$$20240705$$CN$BR$BR
228162527$22816252$7$F$20200416$20240815$20230811$20240819$EXP$$US-TAKEDA-2023TUS078875$TAKEDA$$70$YR$$M$Y$$$20240819$$HP$US$US
228163212$22816321$2$F$$20240822$20230811$20240830$EXP$PT-INFARMED-F202307-763$PT-TEVA-2023-PT-2914199$TEVA$$30$YR$$F$Y$$$20240830$$CN$PT$PT
228163246$22816324$6$F$20230805$20240702$20230811$20240704$EXP$$AU-ABBVIE-5360394$ABBVIE$$49$YR$$F$Y$55$KG$20240704$$MD$AU$AU
228163442$22816344$2$F$$20240807$20230811$20240815$EXP$$FR-AMGEN-FRASP2023138736$AMGEN$$20$WK$I$M$Y$0.456$KG$20240815$$MD$FR$FR
228163665$22816366$5$F$$20240724$20230811$20240730$PER$$US-BAYER-2023A107781$BAYER$$76$YR$E$M$Y$$$20240730$$CN$US$US
228163683$22816368$3$F$20240401$20240801$20230811$20240807$EXP$$NVSC2023MX135651$NOVARTIS$$41$YR$$F$Y$91$KG$20240807$$CN$MX$MX
228164046$22816404$6$F$20080101$20240909$20230811$20240911$EXP$$CA-BAUSCH-BL-2023-012100$BAUSCH AND LOMB$Cvijovic K, Boon H, Jaeger W, Vohra S. Polypharmacy, multiple natural health products and hepatotoxicity. Canadian Medical Association Journal. 2011 OCT 04;183(14):E1085-E1089. doi:10.1503 /cmaj.091948$53$YR$$F$Y$$$20240911$$HP$CA$CA
228164443$22816444$3$F$$20240911$20230811$20240919$EXP$$US-AMGEN-USASP2023139817$AMGEN$$72$YR$E$F$Y$157.48$KG$20240919$$MD$US$US
228164516$22816451$6$F$20221026$20240723$20230811$20240723$EXP$$IN-PFIZER INC-PV202200093493$PFIZER$$59$YR$$F$Y$$$20240723$$CN$IN$IN
228165699$22816569$9$F$20230728$20240802$20230811$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-109054$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240808$$CN$US$US
228166092$22816609$2$F$$20240701$20230811$20240702$PER$$NVSC2023US175746$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
228168053$22816805$3$F$$20240807$20230812$20240813$EXP$$FR-AMGEN-FRASP2023141904$AMGEN$$36$YR$A$F$Y$$$20240813$$MD$FR$FR
228169157$22816915$7$F$$20240705$20230812$20240711$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017049$JAZZ$$$$$F$Y$$$20240711$$CN$US$US
228169265$22816926$5$F$20230801$20240628$20230812$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-012553$JAZZ$$24$YR$$F$Y$$$20240704$$MD$US$US
228169364$22816936$4$F$$20240628$20230812$20240706$EXP$$CA-CELLTRION INC.-2023CA015898$CELLTRION$$$$$$Y$$$20240706$$HP$CA$CA
228169783$22816978$3$F$$20240812$20230812$20240817$PER$$NVSC2023US175565$NOVARTIS$$$$$F$Y$$$20240817$$CN$US$US
2281697912$22816979$12$F$20220101$20240910$20230812$20240918$EXP$$CA-CELLTRION INC.-2022CA005799$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
228169943$22816994$3$F$$20240818$20230812$20240819$PER$$NVSC2023US176150$NOVARTIS$$$$$M$Y$$$20240819$$CN$US$US
228170585$22817058$5$F$$20240715$20230812$20240730$EXP$FR-EMA-DD-20210705-Bisht_p-153512$FR-TEVA-2023-FR-2916357$TEVA$$55$YR$$M$Y$70$KG$20240730$$MD$FR$FR
228171303$22817130$3$F$20190101$20240805$20230812$20240813$EXP$NL-LRB-00893851$NL-TEVA-2023-NL-2914877$TEVA$$24$YR$$F$Y$75$KG$20240813$$CN$NL$NL
228173062$22817306$2$F$$20240124$20230812$20240913$EXP$$DE-TEVA-2023-DE-2915484$TEVA$$60$YR$$M$Y$$$20240913$$MD$DE$DE
228173212$22817321$2$F$20230731$20240805$20230812$20240814$30DAY$$US-GSK-US2023105672$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240814$$CN$US$US
228173324$22817332$4$F$20240401$20240715$20230812$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202308007013$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240813$$CN$US$US
228173726$22817372$6$F$20230619$20240909$20230812$20240913$EXP$$US-SA-2023SA245695$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240913$$MD$US$US
228174795$22817479$5$F$20141101$20240911$20230813$20240919$EXP$$CZ-AUROBINDO-AUR-APL-2023-052135$AUROBINDO$Homolova Richtrova N. Fremanezumab in  clinical practice. REMEDY. REMEDY. 2023;33(3):224, 226-228$30$YR$$F$Y$$$20240919$$MD$CZ$CZ
228176163$22817616$3$F$20230723$20240725$20230813$20240730$30DAY$$CA-JNJFOC-20230752647$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240730$$HP$CA$CA
228176512$22817651$2$F$$20240813$20230813$20240826$PER$$US-SA-2023SA244697$SANOFI AVENTIS$$$$E$F$Y$$$20240826$$MD$US$US
228178205$22817820$5$F$20230204$20240819$20230813$20240823$EXP$$AU-ABBVIE-5327988$ABBVIE$$37$YR$$M$Y$123$KG$20240823$$MD$AU$AU
2281816910$22818169$10$F$$20240924$20230814$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-112110$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240927$$MD$US$US
228182663$22818266$3$F$20230804$20240629$20230814$20240704$EXP$$US-EMD Serono-2023467211$EMD SERONO INC$$53$YR$A$F$Y$$$20240704$$CN$US$US
228183772$22818377$2$F$20230401$20230714$20230814$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00324$PRINSTON PHARMACEUTICAL$$76$YR$$F$Y$43.991$KG$20240730$$CN$US$US
2281847210$22818472$10$F$20230715$20240625$20230814$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003009$ACADIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240719$$CN$US$US
228185976$22818597$6$F$20230803$20240710$20230814$20240718$EXP$$CA-ROCHE-3402886$ROCHE$$47$YR$A$F$Y$$$20240718$$HP$CA$CA
228186243$22818624$3$F$$20240710$20230814$20240717$PER$$NVSC2023US176434$NOVARTIS$$$$$M$Y$77.1$KG$20240717$$MD$US$US
228186652$22818665$2$F$$20240624$20230814$20240703$30DAY$$US-GSK-US2023107911$GLAXOSMITHKLINE$$$$$M$Y$$$20240703$$CN$US$US
228186823$22818682$3$F$20230501$20240826$20230814$20240827$PER$$NVSC2023US176428$NOVARTIS$$59$YR$$M$Y$$$20240827$$CN$US$US
228187062$22818706$2$F$$20240917$20230814$20240927$EXP$$CA-APOTEX-2023AP011723$APOTEX$$52$YR$$F$Y$98$KG$20240927$$HP$CA$CA
228188052$22818805$2$F$$20240917$20230814$20240921$EXP$$US-ABBVIE-5360209$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
228188605$22818860$5$F$$20240711$20230814$20240712$EXP$$CA-TAKEDA-2023TUS078717$TAKEDA$$$$$M$Y$$$20240712$$MD$CA$CA
228188706$22818870$6$F$$20240821$20230814$20240824$EXP$$NVSC2023CO175525$NOVARTIS$$$$$F$Y$55$KG$20240824$$CN$CO$CO
228189514$22818951$4$F$20230413$20240702$20230814$20240715$EXP$$AT-ROCHE-3403730$ROCHE$$75$YR$E$F$Y$50$KG$20240715$$MD$AT$AT
228189832$22818983$2$F$20230624$20240625$20230814$20240710$EXP$$BR-GSK-BR2023AMR105051$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$BR$BR
228190643$22819064$3$F$$20240803$20230814$20240805$EXP$$CA-ROCHE-3403113$ROCHE$$43$YR$A$F$Y$$$20240805$$HP$CA$CA
228191202$22819120$2$F$$20240701$20230814$20240702$PER$$NVSC2023US176787$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
228192952$22819295$2$F$$20240723$20230814$20240725$EXP$$CA-MYLANLABS-2023M1082764$MYLAN$$56$YR$$M$Y$$$20240725$$HP$CA$CA
228193264$22819326$4$F$20200922$20240913$20230814$20240920$EXP$$CO-TAKEDA-CO202031273$TAKEDA$$57$YR$$M$Y$74$KG$20240920$$CN$CO$CO
228194055$22819405$5$F$20230101$20240730$20230814$20240805$EXP$$NVSC2023CR172213$NOVARTIS$$$$$F$Y$$$20240805$$CN$CR$CR
228195182$22819518$2$F$20221101$20240903$20230814$20240910$EXP$$CA-SA-2023SA247356$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240910$$HP$CA$CA
228197105$22819710$5$F$20230101$20240820$20230814$20240830$PER$$US-SA-2023SA243612$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240830$$MD$US$US
228197344$22819734$4$F$20230101$20240822$20230814$20240904$PER$$US-SA-2023SA245371$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240904$$MD$US$US
228197452$22819745$2$F$$20240627$20230814$20240708$PER$$US-SA-2023SA245478$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240708$$MD$US$US
228197467$22819746$7$F$20230101$20240709$20230814$20240717$PER$$US-SA-2023SA243926$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240717$$MD$US$US
228197583$22819758$3$F$20230101$20240823$20230814$20240906$PER$$US-SA-2023SA246032$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240906$$MD$US$US
228198104$22819810$4$F$20230101$20240719$20230814$20240730$PER$$US-SA-2023SA244114$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240730$$MD$US$US
228198153$22819815$3$F$$20240701$20230814$20240710$PER$$US-SA-2023SA246585$SANOFI AVENTIS$$10$YR$C$F$Y$41$KG$20240710$$MD$US$US
228198229$22819822$9$F$20230101$20240829$20230814$20240909$EXP$$US-SA-2023SA244886$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240909$$MD$US$US
228198593$22819859$3$F$20230101$20240809$20230814$20240826$PER$$US-SA-2023SA245018$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240826$$MD$US$US
228200384$22820038$4$F$20220401$20230903$20230814$20240712$EXP$$DE-ASTELLAS-2023US024323$ASTELLAS$$66$YR$$F$Y$$$20240712$$PH$DE$DE
2282009110$22820091$10$F$20230808$20240716$20230814$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-100020$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$66.68$KG$20240719$$CN$US$US
228202679$22820267$9$F$20230724$20240815$20230814$20240822$EXP$$NVSC2023US176920$NOVARTIS$$28$YR$$M$Y$$$20240822$$CN$US$US
228203556$22820355$6$F$$20240718$20230814$20240718$30DAY$$CA-PFIZER INC-202300269178$PFIZER$$$$$F$Y$$$20240718$$PH$CA$CA
228205186$22820518$6$F$20180622$20240812$20230814$20240815$EXP$$CA-TAKEDA-2023TUS073441$TAKEDA$$62$YR$$F$Y$$$20240815$$CN$CA$CA
228205723$22820572$3$F$20220629$20240820$20230814$20240827$EXP$$US-ABBVIE-4757398$ABBVIE$$66$YR$$F$Y$66.678$KG$20240827$$CN$US$US
228206005$22820600$5$F$$20240919$20230814$20240923$PER$$US-BIOGEN-2020BI00900011$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
228206282$22820628$2$F$$20240709$20230814$20240717$EXP$$US-MYLANLABS-2023M1084590$MYLAN$Menon A, Enunwa C, James K. Rare Delayed Ifosfamide Encephalopathy: A Case Report Of Chemotherapeutic Neurotoxicity In Presumed Ewing Sarcoma. J-Gen-Intern-Med 2023;38 (Suppl. 2):S520-S521.$25$YR$$F$Y$$$20240717$$HP$US$US
228206489$22820648$9$F$20230101$20240810$20230814$20240815$EXP$$IN-PFIZER INC-PV202300120302$PFIZER$$65$YR$$F$Y$$$20240815$$CN$IN$IN
228208262$22820826$2$F$20230727$20240711$20230814$20240717$PER$$US-TAKEDA-2023TUS078802$TAKEDA$$61$YR$$M$Y$91$KG$20240717$$CN$US$US
2282095613$22820956$13$F$$20240627$20230814$20240702$PER$$US-PFIZER INC-PV202300109886$PFIZER$$70$YR$$M$Y$81.65$KG$20240702$$CN$US$US
228209792$22820979$2$F$20221001$20230801$20230814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006068$AEGERION$$69$YR$$F$Y$$$20240814$$CN$US$US
228209832$22820983$2$F$$20230927$20230814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006151$AEGERION$$$$$F$Y$58.957$KG$20240814$$CN$US$US
228210072$22821007$2$F$$20240110$20230814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006296$AEGERION$$$$$M$Y$127.26$KG$20240814$$HP$US$US
228210103$22821010$3$F$$20240708$20230814$20240711$PER$$US-PFIZER INC-PV202300138746$PFIZER$$49$YR$$M$Y$$$20240711$$CN$US$US
228210262$22821026$2$F$$20231005$20230814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006518$AEGERION$$$$$F$Y$26.213$KG$20240814$$CN$US$US
228210322$22821032$2$F$20230726$20230802$20230814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006612$AEGERION$$87$YR$$F$Y$$$20240814$$CN$US$US
228210342$22821034$2$F$$20231121$20230814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006523$AEGERION$$$$$F$Y$68.027$KG$20240814$$CN$US$US
228210402$22821040$2$F$$20231012$20230814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006516$AEGERION$$$$$F$Y$93.878$KG$20240814$$CN$US$US
228210495$22821049$5$F$$20240906$20230814$20240910$EXP$$US-PFIZER INC-202300274664$PFIZER$$13$YR$$F$Y$$$20240910$$CN$US$US
228211423$22821142$3$F$20230801$20240723$20230814$20240725$EXP$$US-PFIZER INC-PV202300139539$PFIZER$$76$YR$$F$Y$$$20240725$$CN$US$US
228212335$22821233$5$F$20230804$20240903$20230814$20240911$EXP$$JP-AstraZeneca-2023A179297$ASTRAZENECA$$70$YR$$M$Y$74$KG$20240911$$MD$JP$
228212532$22821253$2$F$20240101$20240807$20230814$20240812$PER$$US-BIOGEN-2023BI01220588$BIOGEN$$$$$M$Y$$$20240812$$CN$US$US
2282141718$22821417$18$F$20230804$20240911$20230814$20240919$EXP$$CA-TAKEDA-2023TUS077684$TAKEDA$$26$YR$$M$Y$$$20240919$$CN$CA$CA
228215155$22821515$5$F$20230804$20240823$20230814$20240828$EXP$$US-TAKEDA-2023TUS071289$TAKEDA$$65$YR$$F$Y$$$20240828$$CN$US$US
228216123$22821612$3$F$$20240829$20230814$20240829$PER$$NVSC2023US177026$NOVARTIS$$$$$M$Y$$$20240830$$HP$US$US
228216779$22821677$9$F$20230804$20240814$20230814$20240826$EXP$$US-UCBSA-2023040148$UCB$$44$YR$$F$Y$70.8$KG$20240826$$PH$US$US
228217143$22821714$3$F$20230710$20240708$20230814$20240712$EXP$BE-GRINDPROD-2023003071$BE-ROCHE-3402993$ROCHE$$82$YR$E$F$Y$59.6$KG$20240713$$MD$BE$BE
2282174541$22821745$41$F$20230101$20240909$20230814$20240912$EXP$$CA-PFIZER INC-202300200922$PFIZER$$38$YR$$M$Y$74$KG$20240912$$MD$CA$CA
228217812$22821781$2$F$$20240909$20230814$20240913$EXP$$CA-BAUSCH-BL-2023-012115$BAUSCH AND LOMB$$$$$F$Y$$$20240913$$HP$CA$CA
228218504$22821850$4$F$$20240624$20230814$20240702$EXP$$DE-OTSUKA-2023_021259$OTSUKA$$$$$M$Y$$$20240702$$CN$DE$DE
228218904$22821890$4$F$20210101$20240710$20230814$20240716$EXP$$BE-MYLANLABS-2023M1084611$MYLAN$Baczewska N, Philippart M, Siplet J, Baurain JF, Stainier L, Laterre E, et al. Immune checkpoint inhibitor refractory colitis leading to total colectomy in a melanoma patient. Acta Gastroenterol Belg. 2023;86(2):371-373$73$YR$$M$Y$$$20240716$$MD$BE$BE
228221253$22822125$3$F$$20240819$20230814$20240913$PER$$US-INCYTE CORPORATION-2023IN007066$INCYTE$$$$$$Y$$$20240913$$MD$US$US
228221386$22822138$6$F$20230803$20240920$20230814$20240927$EXP$$JP-TAKEDA-2023TUS079064$TAKEDA$$32$YR$$M$Y$$$20240927$$MD$JP$JP
228223322$22822332$2$F$$20240830$20230814$20240905$EXP$$US-BIOGEN-2023BI01220784$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
228223852$22822385$2$F$$20240809$20230815$20240815$EXP$FR-AFSSAPS-PV2023000738$FR-CHEPLA-2023010010$CHEPLAPHARM$$$$$M$Y$0.4564$KG$20240815$$MD$COUNTRY NOT SPECIFIED$FR
228223872$22822387$2$F$$20240809$20230815$20240815$EXP$FR-AFSSAPS-PV2023000738$FR-CHEPLA-2023010084$CHEPLAPHARM$$36$YR$$F$Y$$$20240815$$MD$COUNTRY NOT SPECIFIED$FR
228225183$22822518$3$F$$20240910$20230815$20240918$EXP$$BR-CELLTRION INC.-2023BR003539$CELLTRION$$$$$$Y$$$20240918$$CN$BR$BR
228225593$22822559$3$F$$20230912$20230815$20240904$EXP$$JP-AMGEN-JPNSP2023143337$AMGEN$$82$YR$E$$Y$$$20240904$$PH$JP$JP
2282261012$22822610$12$F$20230329$20240911$20230815$20240914$EXP$$SA-ROCHE-3327045$ROCHE$$2$YR$C$M$Y$14.15$KG$20240914$$CN$SA$SA
228226395$22822639$5$F$20210101$20240709$20230815$20240717$PER$$US-SA-2023SA243065$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240717$$MD$US$US
228226793$22822679$3$F$$20240830$20230815$20240902$PER$$NVSC2023US177479$NOVARTIS$$$$$F$Y$$$20240902$$MD$US$US
228228453$22822845$3$F$20161129$20240729$20230815$20240801$EXP$$PHHY2016CA165978$NOVARTIS$$50$YR$$F$Y$$$20240801$$CN$CA$CA
228229877$22822987$7$F$$20240815$20230815$20240821$EXP$$NVSC2023US177473$NOVARTIS$$$$$M$Y$$$20240821$$CN$US$US
2282300612$22823006$12$F$20230513$20240807$20230815$20240809$EXP$$US-TAKEDA-2023TUS042336$TAKEDA$$71$YR$$M$Y$$$20240809$$CN$US$US
228230544$22823054$4$F$20230101$20240809$20230815$20240817$PER$$US-SA-2023SA246151$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240817$$MD$US$US
228231523$22823152$3$F$$20240705$20230815$20240712$EXP$$CA-SUNOVION-2023SUN000991$SUNOVION$$$$$$Y$$$20240712$$HP$CA$CA
228234024$22823402$4$F$$20240904$20230815$20240905$PER$$NVSC2023US177581$NOVARTIS$$$$$$Y$$$20240905$$CN$US$US
228234532$22823453$2$F$20160709$20240722$20230815$20240729$EXP$$ZA-AMGEN-ZAFSP2018092095$AMGEN$$31$YR$A$F$Y$79.2$KG$20240728$$MD$ZA$ZA
2282358110$22823581$10$F$20240101$20240802$20230815$20240808$EXP$$IN-PFIZER INC-PV202300139423$PFIZER$$27$YR$$M$Y$$$20240808$$CN$IN$IN
228235842$22823584$2$F$$20240801$20230815$20240805$EXP$$EG-PFIZER INC-PV202300138193$PFIZER$$37$YR$$F$Y$$$20240805$$PH$EG$EG
228237872$22823787$2$F$20230611$20240828$20230815$20240830$PER$$PR-PFIZER INC-202300275529$PFIZER$$71$YR$$F$Y$$$20240830$$HP$PR$PR
228238323$22823832$3$F$20220601$20240723$20230815$20240807$EXP$$CA-HLS-202301948$HLS THERAPEUTICS$$61$YR$A$F$Y$46$KG$20240807$$PH$CA$CA
228239034$22823903$4$F$$20240829$20230815$20240903$EXP$$JP-009507513-2308JPN001344J$MERCK$$58$YR$$F$Y$$$20240903$$MD$JP$JP
228241018$22824101$8$F$20230725$20240829$20230815$20240902$EXP$$CA-TAKEDA-2023TUS073407$TAKEDA$$46$YR$$M$Y$$$20240902$$CN$CA$CA
228241572$22824157$2$F$$20240814$20230815$20240826$EXP$$US-BIOMARINAP-US-2023-152077$BIOMARIN$$$$$$Y$$$20240826$$CN$US$US
228241882$22824188$2$F$$20240723$20230815$20240801$PER$$US-SA-2023SA247680$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240801$$MD$US$US
228242267$22824226$7$F$20230813$20240905$20230815$20240909$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-009187$JAZZ$$63$YR$$M$Y$$$20240909$$CN$US$US
228242532$22824253$2$F$20230801$20240904$20230815$20240910$EXP$$CA-TAKEDA-2023TUS078583$TAKEDA$$91$YR$$F$Y$$$20240910$$MD$CA$CA
228244064$22824406$4$F$$20240816$20230815$20240821$EXP$$US-TAKEDA-2022TUS028528$TAKEDA$$$$$F$Y$70$KG$20240821$$CN$US$US
228244404$22824440$4$F$20230101$20240821$20230815$20240827$EXP$$US-PFIZER INC-PV202300139910$PFIZER$$39$YR$$M$Y$$$20240827$$HP$US$US
228244474$22824447$4$F$20230727$20240822$20230815$20240830$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-006115$AMGEN$$57$YR$A$F$Y$$$20240829$$MD$US$US
228244564$22824456$4$F$20230101$20240626$20230815$20240705$PER$$US-SA-2023SA246001$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240705$$MD$US$US
228244798$22824479$8$F$20231025$20240806$20230815$20240812$EXP$$CA-TAKEDA-2023TUS078142$TAKEDA$$70$YR$$F$Y$$$20240812$$CN$CA$CA
228245116$22824511$6$F$$20240809$20230815$20240814$EXP$$CA-TAKEDA-2022TUS077050$TAKEDA$$$$$M$Y$$$20240814$$HP$CA$CA
228246296$22824629$6$F$$20240819$20230815$20240829$EXP$$CA-CIPHER-2023-CA-000355$CIPHER$$44$YR$A$F$Y$$$20240829$$HP$CA$CA
228246762$22824676$2$F$$20240712$20230815$20240812$PER$$US-ANIPHARMA-2023-US-022593$ANI$$$$$F$Y$$$20240812$$HP$US$US
228247802$22824780$2$F$$20240711$20230815$20240720$EXP$$CA-CELLTRION INC.-2023CA016064$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
228247892$22824789$2$F$20010101$20240802$20230815$20240808$EXP$$US-ABBVIE-5359749$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
228249007$22824900$7$F$20230101$20240829$20230815$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-113792$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240902$$CN$US$US
228249842$22824984$2$F$20210101$20240702$20230816$20240705$EXP$$US-ABBVIE-5366076$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
228250025$22825002$5$F$20230809$20240709$20230816$20240718$EXP$$CA-CELLTRION INC.-2023CA016163$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
228250195$22825019$5$F$$20240712$20230816$20240717$EXP$$US-TAKEDA-2023TUS069358$TAKEDA$$$$$F$Y$$$20240717$$HP$US$US
228250782$22825078$2$F$$20240809$20230816$20240817$PER$$US-SA-2023SA247049$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240817$$MD$US$US
228251873$22825187$3$F$$20240830$20230816$20240831$PER$$NVSC2023US177736$NOVARTIS$$$$$F$Y$$$20240831$$CN$US$US
228251916$22825191$6$F$20230807$20240715$20230816$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-114148$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240722$$CN$US$US
228252165$22825216$5$F$$20240911$20230816$20240918$EXP$$TH-TAKEDA-2023TUS079262$TAKEDA$$38$YR$$F$Y$$$20240918$$CN$TH$TH
228252252$22825225$2$F$20230217$20240903$20230816$20240906$EXP$$CA-SA-2023SA246834$SANOFI AVENTIS$$87$YR$E$M$Y$72$KG$20240906$$HP$CA$CA
228253282$22825328$2$F$$20240827$20230816$20240909$EXP$$US-AUROBINDO-AUR-APL-2023-051999$AUROBINDO$Mansour MK, King JD, Chen ST, Fishman JA, Nazarian RM.. Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes.. New England Journal of Medicine. 2023;388(10):926-37$70$YR$$M$Y$$$20240909$$MD$US$US
228253843$22825384$3$F$$20240718$20230816$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017265$JAZZ$$$$$M$Y$$$20240724$$CN$US$US
228253893$22825389$3$F$20230807$20240830$20230816$20240927$PER$$US-SA-2023SA244978$SANOFI AVENTIS$$11$YR$C$M$Y$44.31$KG$20240927$$MD$US$US
228254393$22825439$3$F$20240715$20240717$20230816$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202308007881$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240723$$CN$US$US
228254662$22825466$2$F$$20240822$20230816$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-06594$LUPIN$$$$$$Y$$$20240909$$PH$US$US
228254894$22825489$4$F$20240618$20240715$20230816$20240717$EXP$$US-ROCHE-3404441$ROCHE$$41$YR$A$F$Y$73.5$KG$20240717$$CN$US$US
228255713$22825571$3$F$20230727$20240727$20230816$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-06707$LUPIN$$$$$$Y$$$20240817$$CN$US$US
2282566812$22825668$12$F$20230719$20240920$20230816$20240930$EXP$$ES-AUROBINDO-AUR-APL-2023-052985$AUROBINDO$$55$YR$$F$Y$$$20240930$$HP$ES$ES
228260499$22826049$9$F$20230801$20240711$20230816$20240925$PER$$US-GSK-US2023AMR108453$GLAXOSMITHKLINE$$70$YR$$F$Y$55.782$KG$20240925$$CN$US$US
228261232$22826123$2$F$$20240627$20230816$20240710$EXP$$GB-ROCHE-3404534$ROCHE$$12$MON$I$M$Y$$$20240710$$HP$GB$GB
228261942$22826194$2$F$20230504$20240905$20230816$20240910$EXP$$AU-TAKEDA-2023TUS049821$TAKEDA$$59$YR$$F$Y$$$20240910$$CN$AU$AU
228262463$22826246$3$F$20230101$20240808$20230816$20240814$EXP$$JP-AMGEN-JPNSP2023141499$AMGEN$$$$E$F$Y$$$20240813$$MD$JP$JP
2282629216$22826292$16$F$20221221$20240904$20230816$20240912$EXP$$CA-CELLTRION INC.-2023CA000771$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
228263132$22826313$2$F$20230101$20240705$20230816$20240712$EXP$$US-SA-2023SA248493$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240712$$MD$US$US
228263635$22826363$5$F$20240517$20240809$20230816$20240813$EXP$$CA-TAKEDA-2023TUS079536$TAKEDA$$72$YR$$M$Y$$$20240813$$CN$CA$CA
228264346$22826434$6$F$20230817$20240723$20230816$20240725$EXP$$AU-TAKEDA-2023TUS079134$TAKEDA$$81$YR$$M$Y$$$20240725$$CN$AU$AU
228264782$22826478$2$F$20240101$20240910$20230816$20240918$EXP$$US-ROCHE-3405702$ROCHE$$43$YR$A$F$Y$70.31$KG$20240918$$MD$US$US
228266352$22826635$2$F$20230101$20240715$20230816$20240722$EXP$$FR-AUROBINDO-AUR-APL-2023-052122$AUROBINDO$$45$YR$$F$Y$$$20240722$$PH$FR$FR
2282693412$22826934$12$F$$20240924$20230816$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-114479$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240926$$CN$US$US
228269632$22826963$2$F$$20240625$20230816$20240702$EXP$$MY-ROCHE-3406112$ROCHE$$66$YR$E$$Y$$$20240702$$MD$MY$MY
228270473$22827047$3$F$20230601$20231026$20230816$20240909$PER$$NVSC2023US177841$NOVARTIS$$51$YR$$M$Y$$$20240909$$CN$US$US
228271096$22827109$6$F$20230725$20240730$20230816$20240810$EXP$$JP-ABBVIE-5368253$ABBVIE$Natsuyama R, et al. Share of a case which developed contact dermatitis due to buccal administration of asenapine maleate (SYCREST). The program/abstract (Web) of the 75th Kyushu Association of Neuropsychiatry/The 68th Kyushu Association of Neuropsychiatry. 2023; (Shin A-44).; Natsuyama R, et al. Share of a case which developed contact dermatitis due to buccal administration of asenapine maleate?(SYCREST). The program/abstract (Web) of the 75th Kyushu Association of Neuropsychiatry/The 68th Ky...$30$YR$$F$Y$$$20240810$$MD$JP$JP
228271108$22827110$8$F$20230811$20240719$20230816$20240726$EXP$$US-GSK-US2023107447$GLAXOSMITHKLINE$$52$YR$$F$Y$29.615$KG$20240726$$MD$US$US
228271694$22827169$4$F$$20240826$20230816$20240829$EXP$$NVSC2023US177847$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
228274677$22827467$7$F$$20240308$20230816$20240806$EXP$$NVSC2023US178423$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
228275872$22827587$2$F$20230101$20240720$20230816$20240730$EXP$$US-ORG100014127-2023000893$HRA PHARMA$$42$YR$$F$Y$$$20240730$$CN$US$US
228276783$22827678$3$F$$20230907$20230816$20240822$EXP$$US-AstraZeneca-2023A180859$ASTRAZENECA$$$$$F$Y$$$20240822$$MD$US$
228277142$22827714$2$F$$20240814$20230816$20240828$PER$$US-SA-2023SA248869$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240828$$MD$US$US
228277735$22827773$5$F$20240401$20240819$20230816$20240821$PER$$US-PFIZER INC-PV202300017430$PFIZER$$81$YR$$F$Y$71.7$KG$20240821$$MD$US$US
228277913$22827791$3$F$20240803$20240805$20230816$20240819$PER$$US-SA-2023SA247023$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240819$$HP$US$US
228278274$22827827$4$F$20230509$20240805$20230816$20240814$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2023PTK00376$PARATEK PHARMACEUTICALS$$57$YR$$F$Y$44$KG$20240814$$MD$US$US
228278464$22827846$4$F$20210501$20240822$20230816$20240826$EXP$$US-UCBSA-2022057766$UCB$$51$YR$$F$Y$$$20240826$$CN$US$US
228278626$22827862$6$F$20240101$20240928$20230816$20240930$EXP$$CA-PFIZER INC-202300058279$PFIZER$$37$YR$$M$Y$86$KG$20240930$$MD$CA$CA
228278783$22827878$3$F$$20240710$20230816$20240712$EXP$$US-PFIZER INC-202200528140$PFIZER$$66$YR$$F$Y$$$20240712$$HP$US$US
2282789516$22827895$16$F$20231018$20240711$20230816$20240716$EXP$$US-PFIZER INC-PV202300140005$PFIZER$$78$YR$$F$Y$$$20240716$$CN$US$US
228279058$22827905$8$F$20230101$20240816$20230816$20240821$EXP$$CA-PFIZER INC-202300215207$PFIZER$$33$YR$$F$Y$85$KG$20240821$$MD$CA$CA
2282795810$22827958$10$F$20240122$20240429$20230816$20240812$EXP$$NVSC2023CO177408$NOVARTIS$$74$YR$$F$Y$49$KG$20240812$$CN$CO$CO
228279969$22827996$9$F$20240101$20240926$20230816$20240930$PER$$US-PFIZER INC-PV202200087346$PFIZER$$85$YR$$F$Y$$$20240930$$CN$US$US
228280253$22828025$3$F$$20240912$20230816$20240913$PER$$US-PFIZER INC-PV202300141059$PFIZER$$62$YR$$F$Y$$$20240913$$CN$US$US
228281343$22828134$3$F$20230301$20240726$20230816$20240730$PER$$US-PFIZER INC-PV202300139760$PFIZER$$64$YR$$F$Y$$$20240730$$HP$US$US
228282292$22828229$2$F$$20240904$20230816$20240916$EXP$$CA-UCBSA-2023030549$UCB$$$$$F$Y$$$20240916$$CN$CA$CA
228282644$22828264$4$F$20230101$20240806$20230816$20240808$EXP$$CA-UCBSA-2023031852$UCB$$$$$F$Y$$$20240808$$CN$CA$CA
228283702$22828370$2$F$$20240819$20230816$20240821$EXP$$US-TAKEDA-2023TUS079794$TAKEDA$$$$$F$Y$$$20240821$$HP$US$US
228284252$22828425$2$F$$20240704$20230816$20240718$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381587$RANBAXY$Santos M, Leal I, Morais Sarmento T, Mano SS, Jose P, Vaz-Pereira S. Bull?s Eye Maculopathy in Near-Infrared Reflectance as An Early Sign of Hydroxychloroquine Toxicity. Diagnostics (Basel). 2023;13(3):445(1-9)$59$YR$$F$Y$$$20240718$$HP$PT$PT
228284393$22828439$3$F$$20240706$20230816$20240708$30DAY$$US-PFIZER INC-202300272945$PFIZER$$$$$F$Y$$$20240708$$CN$US$US
228284512$22828451$2$F$$20240906$20230816$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-364187$RANBAXY$$$$$M$Y$$$20240920$$CN$US$US
228284592$22828459$2$F$$20240625$20230816$20240710$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404634$RANBAXY$Chen Y, Nagaoka S, Katayose T, Sekine N. Safety and effectiveness of ramucirumab and docetaxel: a single-arm, prospective, multicenter, non-interventional, observational, post-marketing safety study of NSCLC in Japan. Expert Opin Drug Saf. 2022;21(5):691-698$62$YR$$$Y$$$20240710$$HP$JP$JP
228284735$22828473$5$F$20030101$20230604$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003223$ENDO$$4$DEC$$M$Y$$$20240712$$CN$US$US
2282848111$22828481$11$F$20080101$20240227$20230816$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-003222$ENDO$$$$$M$Y$$$20240917$$CN$US$US
228285555$22828555$5$F$20230803$20240906$20230816$20240911$EXP$$CO-TAKEDA-2023TUS079340$TAKEDA$$33$YR$$F$Y$71$KG$20240911$$CN$CO$CO
228285795$22828579$5$F$20230101$20240709$20230816$20240712$EXP$$CA-ABBVIE-5367945$ABBVIE$$$$$M$Y$$$20240712$$HP$CA$CA
228285944$22828594$4$F$$20230602$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003140$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228285965$22828596$5$F$20000101$20230603$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003150$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228285985$22828598$5$F$$20230606$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003166$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228285995$22828599$5$F$$20230606$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003161$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228286006$22828600$6$F$$20230607$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003165$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228286015$22828601$5$F$$20230604$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003152$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228286047$22828604$7$F$$20230606$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003158$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228286365$22828636$5$F$$20230606$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003325$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228286386$22828638$6$F$$20230606$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003318$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228286615$22828661$5$F$$20230606$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003341$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228286624$22828662$4$F$$20230607$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003347$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228286647$22828664$7$F$$20230606$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003342$ENDO$$$$$$Y$$$20240712$$CN$US$US
228286725$22828672$5$F$$20230606$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003289$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228287453$22828745$3$F$$20240802$20230816$20240808$PER$$US-ABBVIE-5365791$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
228287732$22828773$2$F$$20240828$20230816$20240912$PER$$US-INCYTE CORPORATION-2023IN008113$INCYTE$$$$$$Y$$$20240912$$CN$US$US
228287895$22828789$5$F$$20230604$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003189$ENDO$$$$$$Y$$$20240712$$CN$US$US
228287927$22828792$7$F$$20230606$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003192$ENDO$$$$$$Y$$$20240712$$CN$US$US
228287936$22828793$6$F$$20230603$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003178$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228287945$22828794$5$F$$20230604$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003184$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228288004$22828800$4$F$$20230606$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003171$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228288066$22828806$6$F$$20230604$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003190$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228288268$22828826$8$F$20230804$20240814$20230816$20240827$EXP$$US-JNJFOC-20230832034$JOHNSON AND JOHNSON$$44$YR$A$F$Y$70.8$KG$20240827$$PH$US$US
228288365$22828836$5$F$$20230607$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003389$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228289003$22828900$3$F$$20240918$20230816$20240920$EXP$$US-TAKEDA-2022TUS078349$TAKEDA$$$$$F$Y$$$20240920$$CN$US$US
228289123$22828912$3$F$$20230607$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003199$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228289204$22828920$4$F$$20230604$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003216$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228290222$22829022$2$F$$20240207$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003860$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
228290323$22829032$3$F$$20230607$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003459$ENDO$$$$$$Y$$$20240712$$CN$US$US
228290357$22829035$7$F$20060101$20230607$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003446$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228290463$22829046$3$F$20240122$20240522$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003894$AURINIA PHARMACEUTICALS$$64$YR$$M$Y$$$20240731$$CN$US$US
228291023$22829102$3$F$20230712$20240201$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003852$AURINIA PHARMACEUTICALS$$60$YR$$F$Y$$$20240731$$CN$US$US
228291343$22829134$3$F$20230807$20240212$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003799$AURINIA PHARMACEUTICALS$$32$YR$$F$Y$70.295$KG$20240731$$CN$US$US
228291448$22829144$8$F$20230418$20240919$20230816$20240926$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-003460$AURINIA PHARMACEUTICALS$$58$YR$$F$Y$$$20240926$$HP$US$US
228291612$22829161$2$F$20221223$20240627$20230816$20240710$PER$$US-MYLANLABS-2023M1083054$MYLAN$$71$YR$$M$Y$80.7$KG$20240710$$CN$US$US
228291792$22829179$2$F$20230222$20240708$20230816$20240716$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-003686$AURINIA PHARMACEUTICALS$$30$YR$$M$Y$$$20240716$$HP$US$US
228292733$22829273$3$F$$20240904$20230816$20240910$EXP$$US-TAKEDA-2023TUS079305$TAKEDA$$$$$M$Y$$$20240910$$CN$US$US
228292744$22829274$4$F$20220101$20240822$20230816$20240827$EXP$$CA-PFIZER INC-202201374457$PFIZER$$30$YR$$F$Y$136$KG$20240827$$MD$CA$CA
228292752$22829275$2$F$$20230814$20230816$20240906$EXP$$PL-BAUSCH-BL-2023-012424$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240906$$MD$PL$PL
228293022$22829302$2$F$$20240305$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003055$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
228293237$22829323$7$F$$20240213$20230816$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-002485$ENDO$$$$$M$Y$$$20240917$$CN$US$US
228293392$22829339$2$F$20240301$20240610$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003076$AURINIA PHARMACEUTICALS$$29$YR$$F$Y$$$20240731$$CN$US$US
228294734$22829473$4$F$20230101$20240716$20230816$20240723$EXP$$US-ABBVIE-5366618$ABBVIE$$$$$F$Y$71$KG$20240723$$CN$US$US
228295033$22829503$3$F$20230617$20240322$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003728$AURINIA PHARMACEUTICALS$$31$YR$$F$Y$$$20240731$$CN$US$US
228295293$22829529$3$F$$20230602$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003083$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228295305$22829530$5$F$$20230606$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003084$ENDO$$$$$$Y$$$20240712$$CN$US$US
228295366$22829536$6$F$$20230607$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003105$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228295416$22829541$6$F$$20230602$20230816$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003090$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228295663$22829566$3$F$$20240411$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003693$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
228296742$22829674$2$F$20230201$20240222$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003022$AURINIA PHARMACEUTICALS$$54$YR$$F$Y$$$20240731$$CN$US$US
228296816$22829681$6$F$20230801$20240910$20230816$20240916$EXP$$JP-ABBVIE-5368567$ABBVIE$$78$YR$$F$Y$44$KG$20240916$$MD$JP$JP
228296972$22829697$2$F$$20240508$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003231$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
228297923$22829792$3$F$20230401$20240304$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003464$AURINIA PHARMACEUTICALS$$59$YR$$F$Y$$$20240731$$CN$US$US
228297952$22829795$2$F$$20240516$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003329$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
228297983$22829798$3$F$20230501$20240212$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003500$AURINIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240731$$CN$US$US
228298323$22829832$3$F$20230626$20240306$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003416$AURINIA PHARMACEUTICALS$$21$YR$$M$Y$$$20240731$$CN$US$US
228298612$22829861$2$F$$20240814$20230816$20240817$PER$$NVSC2023US178454$NOVARTIS$$$$$M$Y$$$20240817$$CN$US$US
228299173$22829917$3$F$$20240607$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003233$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
228299243$22829924$3$F$$20240718$20230816$20240725$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-003206$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$HP$US$US
228299753$22829975$3$F$$20240717$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003517$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
228299762$22829976$2$F$$20240125$20230816$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-003654$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
228300112$22830011$2$F$20220209$20240207$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003374$AURINIA PHARMACEUTICALS$$31$YR$$F$Y$63.265$KG$20240731$$CN$US$US
228300359$22830035$9$F$20230101$20240912$20230816$20240919$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-003622$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
228300383$22830038$3$F$20230221$20240228$20230816$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003066$AURINIA PHARMACEUTICALS$$65$YR$$F$Y$68$KG$20240731$$CN$US$US
228300743$22830074$3$F$$20240816$20230816$20240819$PER$$NVSC2023US178357$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
228304772$22830477$2$F$$20240625$20230817$20240702$EXP$$MY-ROCHE-3406120$ROCHE$$59$YR$A$$Y$$$20240702$$MD$MY$MY
2283048813$22830488$13$F$20230729$20240627$20230817$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003353$ACADIA PHARMACEUTICALS$$31$YR$$F$Y$$$20240708$$CN$US$US
228305593$22830559$3$F$$20240705$20230817$20240709$EXP$$CA-ABBVIE-5369123$ABBVIE$$$$$M$Y$$$20240709$$CN$CA$CA
228305883$22830588$3$F$$20240731$20230817$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-06724$LUPIN$$$$$$Y$$$20240827$$CN$US$US
228306763$22830676$3$F$20230727$20240718$20230817$20240813$PER$$CA-TOLMAR, INC.-23CA042282$TOLMAR$$65$YR$$M$Y$$$20240813$$CN$CA$CA
228306774$22830677$4$F$20230728$20240624$20230817$20240717$PER$$CA-TOLMAR, INC.-23CA042292$TOLMAR$$67$YR$$M$Y$$$20240717$$CN$CA$CA
228307117$22830711$7$F$$20240815$20230817$20240827$EXP$$CA-AUROBINDO-AUR-APL-2023-052626$AUROBINDO$Awara MA, Downing LM, Elnenaei MO.. Psychiatric sequelae of thromboangiitis obliterans: a case report and review of the literature. Review. J-Med-Case-Rep. 2023;17(1):40$29$YR$$M$Y$$$20240827$$HP$CA$CA
228307223$22830722$3$F$20230101$20240905$20230817$20240913$EXP$$US-LEO Pharma-360453$LEO PHARM$$43$YR$$F$Y$$$20240913$$PH$US$US
228307312$22830731$2$F$20230801$20240829$20230817$20240911$PER$$US-SA-2023SA249855$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240911$$HP$US$US
2283074915$22830749$15$F$20230417$20240919$20230817$20240924$EXP$$GB-SA-2023SA130222$SANOFI AVENTIS$$65$YR$E$M$Y$86.4$KG$20240924$$HP$GB$GB
2283075413$22830754$13$F$20221021$20240920$20230817$20240930$EXP$$CA-CELLTRION INC.-2022CA004504$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
228307563$22830756$3$F$20230101$20240812$20230817$20240814$EXP$$US-ABBVIE-5366578$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
228308092$22830809$2$F$$20240627$20230817$20240716$PER$$CA-TOLMAR, INC.-23CA042348$TOLMAR$$$$$M$Y$$$20240715$$CN$CA$CA
228308124$22830812$4$F$20230725$20240624$20230817$20240717$PER$$CA-TOLMAR, INC.-23CA042223$TOLMAR$$69$YR$$M$Y$$$20240717$$CN$CA$CA
228308492$22830849$2$F$$20240904$20230817$20240912$EXP$$PT-CELLTRION INC.-2023PT016172$CELLTRION$Damas J, Vida A, Marques J, Caeiro F, Aires I, Dias J, et.al. Adenovirus Infection in a Kidney-Pancreatic Transplant Recipient: Case Report. InTransplantation proceedings. 2023;1-3$$$$$Y$$$20240912$$HP$PT$PT
228309917$22830991$7$F$20220309$20240819$20230817$20240903$EXP$$US-UCBSA-2023040793$UCB$$6$YR$$M$Y$22$KG$20240903$$MD$US$US
228310414$22831041$4$F$$20240801$20230817$20240814$EXP$$CA-AUROBINDO-AUR-APL-2023-052623$AUROBINDO$$59$YR$$F$Y$$$20240814$$HP$CA$CA
228310803$22831080$3$F$20230501$20230713$20230817$20240813$PER$$US-SPECGX-T202301490$SPECGX$$56$YR$$M$Y$120$KG$20240813$$CN$US$US
228311453$22831145$3$F$$20240724$20230817$20240805$EXP$$CA-AUROBINDO-AUR-APL-2023-052581$AUROBINDO$$51$YR$$M$Y$$$20240805$$HP$CA$CA
228311895$22831189$5$F$20230410$20240820$20230817$20240822$EXP$$JP-ABBVIE-5369229$ABBVIE$$73$YR$$F$Y$47$KG$20240822$$MD$JP$JP
228311973$22831197$3$F$$20240918$20230817$20240926$EXP$$NVSC2023US178424$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
228312426$22831242$6$F$$20240819$20230817$20240827$EXP$$NVSC2023CZ124570$NOVARTIS$Ptackova H, Poupetova H, Vlaskova H, Honzik T, Jesina P. Pozdni diagnoza mukopolysacharidozy I. typu u divky s kontrakturami rukou [Late diagnosis of mucopolysaccharidosis type I in a girl with hand contractures]. CESKO-SLOVENSKA PEDIATRIE. 2023;78(3):155-60$4$YR$$F$Y$32.8$KG$20240827$$HP$CZ$CZ
228312732$22831273$2$F$$20240923$20230817$20240930$EXP$$CA-TAKEDA-2017TUS020400$TAKEDA$$$$$F$Y$$$20240930$$CN$CA$CA
228312805$22831280$5$F$20230501$20240712$20230817$20240715$EXP$$NVSC2023US178393$NOVARTIS$$51$YR$$M$Y$$$20240715$$CN$US$US
228313184$22831318$4$F$20230716$20240821$20230817$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-113538$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240830$$HP$US$US
228313833$22831383$3$F$$20240904$20230817$20240909$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-115398$BRISTOL MYERS SQUIBB$Schwarz C, Morel A, Rondeau E, Marie M, Dahan K, Luque Y. Hepatitis B reactivation in kidney transplant recipients treated with belatacept. Kidney International Reports. 2021;6(4):S335. doi:10.1016/j.ekir.2021 03.800.$25$YR$A$$Y$$$20240909$$HP$FR$FR
2283139614$22831396$14$F$20240621$20240917$20230817$20240924$EXP$$CA-TAKEDA-2023TUS079759$TAKEDA$$65$YR$$F$Y$$$20240924$$CN$CA$CA
228314044$22831404$4$F$20230726$20240705$20230817$20240712$EXP$$CO-TAKEDA-2023TUS075093$TAKEDA$$50$YR$$M$Y$55$KG$20240712$$CN$CO$CO
228314163$22831416$3$F$$20240906$20230817$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000698$DECIPHERA PHARMACEUTICALS$$71$YR$E$M$Y$$$20240927$$CN$US$US
228314193$22831419$3$F$20180219$20240710$20230817$20240712$EXP$$PHHY2018CA029076$NOVARTIS$$60$YR$$M$Y$$$20240712$$CN$CA$CA
228314442$22831444$2$F$$20240812$20230817$20240819$EXP$$CA-TAKEDA-2023TUS043372$TAKEDA$$71$YR$$F$Y$93$KG$20240819$$HP$CA$CA
2283145424$22831454$24$F$20220101$20240910$20230817$20240921$EXP$$CA-UCBSA-2022068557$UCB$$$$$F$Y$$$20240921$$CN$CA$CA
228315972$22831597$2$F$20160101$20240925$20230817$20240930$EXP$$JP-ASTELLAS-2023JP005374$ASTELLAS$Miyoshi Y, Kise T, Yokokawa N, Tsuchida N, Maeda A, Kirino Y, et al.. A case of VEXAS syndrome complicated with EBV associated T/NK lymphoproliferative disease successfully treated with etoposide and CHOP therapy. The 67th Annual General Assembly and Scientific Meeting of the Japan College of 2023:734.$6$DEC$A$M$Y$$$20240930$$MD$JP$JP
228316372$22831637$2$F$$20240724$20230817$20240802$EXP$$CA-AUROBINDO-AUR-APL-2023-052605$AUROBINDO$$86$YR$$M$Y$$$20240802$$HP$CA$CA
228317997$22831799$7$F$20230801$20231121$20230817$20240925$PER$$US-GSK-US2023AMR110998$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240925$$CN$US$US
228318213$22831821$3$F$$20240904$20230817$20240910$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-115403$BRISTOL MYERS SQUIBB$Schwarz C, Morel A, Rondeau E, Marie M, Dahan K, Luque Y. Hepatitis B reactivation in kidney transplant recipients treated with belatacept. Kidney International Reports. 2021;6(4):S335. doi:10.1016/j.ekir.2021 03.800.$77$YR$E$$Y$$$20240910$$HP$FR$FR
228320605$22832060$5$F$$20240719$20230817$20240730$PER$$US-SA-2023SA247949$SANOFI AVENTIS$$$$T$F$Y$$$20240730$$MD$US$US
228320793$22832079$3$F$20230801$20240712$20230817$20240722$PER$$US-SA-2023SA249018$SANOFI AVENTIS$$31$YR$A$M$Y$90.7$KG$20240720$$MD$US$US
228325944$22832594$4$F$20230816$20240919$20230817$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-023275$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240920$$MD$US$US
228326744$22832674$4$F$$20240829$20230817$20240831$PER$$NVSC2023US174910$NOVARTIS$$$$$F$Y$79.365$KG$20240831$$HP$US$US
228327282$22832728$2$F$$20230807$20230817$20240708$EXP$$CA-TEVA-2023-CA-2916943$TEVA$$80$YR$$F$Y$$$20240708$$CN$CA$CA
228327904$22832790$4$F$$20240717$20230817$20240723$EXP$$US-ARGENX-2023-ARGX-US002181$ARGENX BVBA$$$$$$Y$$$20240723$$CN$US$US
2283298712$22832987$12$F$20230816$20240821$20230817$20240829$EXP$$CA-ROCHE-3406618$ROCHE$$43$YR$A$F$Y$$$20240829$$CN$CA$CA
228331314$22833131$4$F$$20240924$20230817$20240926$EXP$$US-TAKEDA-US201925999$TAKEDA$$$$$M$Y$$$20240926$$HP$US$US
228333726$22833372$6$F$20230101$20240627$20230817$20240705$EXP$$JP-009507513-2308JPN001122J$MERCK$$8$DEC$$M$Y$$$20240705$$MD$JP$JP
228334912$22833491$2$F$20230101$20240911$20230817$20240916$PER$$US-AMGEN-USASL2023144546$AMGEN$$62$YR$A$M$Y$$$20240916$$HP$US$US
228336872$22833687$2$F$20230330$20240628$20230817$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-403675$RANBAXY$$77$YR$$F$Y$58$KG$20240712$$HP$FR$FR
228338024$22833802$4$F$$20240809$20230817$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404485$RANBAXY$Henkind RE, Christensen E, Scherbak Y, King CJ. PROLONGED SUPRATHERAPEUTIC LEVETIRACETAM IN AN ADULT WITH DEVELOPMENTAL DELAY. J Gen Intern Med. 2023;38 (Suppl.2):S517/3876742$63$YR$$M$Y$$$20240823$$HP$US$US
228338182$22833818$2$F$$20240722$20230817$20240726$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404593$RANBAXY$Wu L, Kong Q, Huang H, Xu S, Qu W, Zhang P, et al. Effect of PCSK9 inhibition in combination with statin therapy on intracranial atherosclerotic stenosis: A high-resolution MRI study. Front Aging Neurosci. 2023;15:1127534 (1-10)$34$YR$$F$Y$$$20240727$$HP$CN$CN
228338313$22833831$3$F$$20240913$20230817$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404597$RANBAXY$Meili Z, Fineman J. Trading blindness for dyspnea, a case of medication induced metabolic acidosis or how I learned to love the ABG. J Gen Intern Med. 2023;38(S2):S601$44$YR$$F$Y$$$20240927$$HP$US$US
228338559$22833855$9$F$$20240802$20230817$20240807$EXP$$NVSC2023US179356$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
228339523$22833952$3$F$20200101$20240910$20230817$20240918$EXP$$CA-OTSUKA-2023_021602$OTSUKA$$43$YR$$M$Y$$$20240918$$MD$CA$CA
228340033$22834003$3$F$$20240912$20230817$20240919$EXP$$NVSC2023CN176772$NOVARTIS$Wang Q, Ye X, Zheng W, Jin T, Zhou Y, Hu X et al.. NLRC4 gain-of-function variant is identified in a patient with systemic lupus erythematosus. CLINICAL IMMUNOLOGY. 2023;255:1-5$$$N$M$Y$2.62$KG$20240919$$HP$CN$CN
228340266$22834026$6$F$$20240917$20230817$20240921$EXP$$CA-ABBVIE-5370183$ABBVIE$$58$YR$$F$Y$$$20240921$$HP$CA$CA
228340345$22834034$5$F$20230718$20240913$20230817$20240920$EXP$$JP-009507513-2308JPN001513J$MERCK$Aihara T. P-046 A case of irAE meningoencephalitis developed after administration of lenvatinib + pembrolizumab for recurrent corpus uteri carcinoma. The 66th Annual Meeting of Japan Society of Gynecologic Oncology. 2024;42(3):77$59$YR$$F$Y$40$KG$20240920$$MD$JP$JP
228340484$22834048$4$F$$20240708$20230817$20240708$EXP$$US-PFIZER INC-PV202300140457$PFIZER$$64$YR$$F$Y$$$20240708$$CN$US$US
228340727$22834072$7$F$20240318$20240815$20230817$20240821$EXP$$US-PFIZER INC-202300276647$PFIZER$$54$YR$$F$Y$$$20240820$$HP$US$US
228341732$22834173$2$F$$20240805$20230817$20240808$PER$$US-PFIZER INC-US-GBT-018259$PFIZER$$33$YR$$F$Y$$$20240808$$CN$US$US
228342876$22834287$6$F$$20240902$20230817$20240912$EXP$E2B_06390563, 2023SA071578$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-64203$HIKMA$$44$YR$$F$Y$$$20240912$$HP$CA$CA
228344044$22834404$4$F$20230601$20240726$20230817$20240926$EXP$$US-GSK-US2023AMR103683$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
228344202$22834420$2$F$$20240909$20230817$20240917$EXP$$CA-BAUSCHBL-2023BNL006962$BAUSCH AND LOMB$$$$$F$Y$$$20240917$$HP$CA$CA
228344325$22834432$5$F$20231101$20240911$20230817$20240918$EXP$$US-BAUSCHBL-2023BNL006871$BAUSCH AND LOMB$$86$YR$$F$Y$$$20240918$$CN$US$US
228345525$22834552$5$F$$20240812$20230817$20240821$EXP$$CA-BAUSCHBL-BL-2020-025875$BAUSCH AND LOMB$$61$YR$$F$Y$$$20240821$$CN$CA$CA
228349594$22834959$4$F$20230620$20240821$20230818$20240830$EXP$$GB-ROCHE-3391895$ROCHE$$61$YR$A$F$Y$$$20240830$$CN$GB$GB
228349982$22834998$2$F$$20240909$20230818$20240917$PER$$US-SA-2023SA249619$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240918$$MD$US$US
2283503312$22835033$12$F$20230701$20240620$20230818$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003110$ACADIA PHARMACEUTICALS$$15$YR$$M$Y$$$20240712$$CN$US$US
228350775$22835077$5$F$$20240815$20230818$20240828$EXP$$CA-AUROBINDO-AUR-APL-2023-007216$AUROBINDO$Lafreniere S, Blier P.. Medical assistance in living after failure of ECT and ketamine. J-Psychiatry-Neurosci. 2022;47(5):323- 324$33$YR$$M$Y$$$20240828$$MD$CA$CA
2283507811$22835078$11$F$20230723$20240625$20230818$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003166$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240708$$CN$US$US
228350942$22835094$2$F$$20240724$20230818$20240803$EXP$$CA-AUROBINDO-AUR-APL-2023-052619$AUROBINDO$$57$YR$$F$Y$$$20240803$$HP$CA$CA
228351092$22835109$2$F$$20240726$20230818$20240807$EXP$$CA-AUROBINDO-AUR-APL-2023-052773$AUROBINDO$$47$YR$$F$Y$$$20240807$$CN$CA$CA
228351764$22835176$4$F$$20240729$20230818$20240807$EXP$FR-002147023-NVSC2023FR148282$FR-STRIDES ARCOLAB LIMITED-2023SP013034$STRIDES$AINS (ibuprofene/ketoprofene facteur aggravant d^infection bacterienne severe concernant la DCI ketoprofen [NSAIDs (nonsteroidal anti-inflammatory drugs) (ibuprofen/ketoprofen): aggravating factor in severe bacterial infection].. BULLETIN D^INFORMATION TRIMESTRIEL (QUARTERLY NEWSLETTER). 2023;45$16$YR$$M$Y$$$20240807$$MD$FR$FR
228352033$22835203$3$F$20021001$20240704$20230818$20240709$EXP$GB-MYLANLABS-2023M1078418$GB-STRIDES ARCOLAB LIMITED-2023SP013136$STRIDES$$38$YR$$M$Y$$$20240709$$MD$GB$GB
228355984$22835598$4$F$20230809$20240923$20230818$20240924$EXP$$US-TAKEDA-2023TUS072455$TAKEDA$$50$YR$$M$Y$$$20240924$$HP$US$US
228358044$22835804$4$F$$20240826$20230818$20240829$EXP$$US-BAUSCH-BL-2023-012462$BAUSCH AND LOMB$$54$YR$$M$Y$$$20240829$$CN$US$US
228358923$22835892$3$F$$20240715$20230818$20240717$PER$$NVSC2023US180070$NOVARTIS$$$$$M$Y$$$20240717$$CN$US$US
228363583$22836358$3$F$20230809$20240911$20230818$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2023-023267$UNITED THERAPEUTICS$$63$YR$$M$Y$77.098$KG$20240921$$$US$US
228365236$22836523$6$F$20230728$20240913$20230818$20240927$PER$$CA-TOLMAR, INC.-23CA042295$TOLMAR$$71$YR$$M$Y$$$20240927$$CN$CA$CA
228365323$22836532$3$F$20230101$20240627$20230818$20240716$PER$$CA-TOLMAR, INC.-23CA042325$TOLMAR$$$$$M$Y$$$20240715$$CN$CA$CA
228365353$22836535$3$F$20230728$20240805$20230818$20240826$PER$$CO-TOLMAR, INC.-23CO042286$TOLMAR$$7$YR$$F$Y$20$KG$20240826$$CN$CO$CO
228366562$22836656$2$F$$20240729$20230818$20240808$EXP$$CA-AUROBINDO-AUR-APL-2023-052758$AUROBINDO$$60$YR$$M$Y$$$20240808$$CN$CA$CA
228367776$22836777$6$F$20230804$20240812$20230818$20240813$EXP$$SE-JNJFOC-20230827419$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240813$$MD$SE$SE
228367888$22836788$8$F$20230728$20240627$20230818$20240703$EXP$$AR-GSK-AR2023AMR106198$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$HP$AR$AR
228368406$22836840$6$F$20230808$20240903$20230818$20240924$EXP$$US-SA-2023SA251072$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240924$$MD$US$US
228368432$22836843$2$F$$20230814$20230818$20240803$EXP$$NVSC2023MX178755$NOVARTIS$$$$$F$Y$$$20240803$$CN$MX$MX
228368986$22836898$6$F$20030101$20240702$20230818$20240713$EXP$$GB-ABBVIE-5362417$ABBVIE$$38$YR$$M$Y$$$20240713$$MD$GB$GB
228369633$22836963$3$F$20230801$20230828$20230818$20240925$PER$$US-GSK-US2023AMR111731$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
228370503$22837050$3$F$20021001$20240702$20230818$20240710$EXP$$GB-AUROBINDO-AUR-APL-2023-052666$AUROBINDO$$38$YR$$M$Y$$$20240710$$MD$GB$GB
228370746$22837074$6$F$20230220$20240626$20230818$20240704$EXP$$CN-TAKEDA-2023TUS079393$TAKEDA$$65$YR$$M$Y$65$KG$20240704$$MD$CN$CN
228374394$22837439$4$F$20190101$20240715$20230818$20240722$EXP$$FR-AUROBINDO-AUR-APL-2023-052978$AUROBINDO$Langlume L, Eiden C, Roy S, Taruffi F, Gambier J, Donnadieu-Rigole H, et al.. Management of Pregabalin Use Disorder: A Case Series.. J-Psychoactive-Drugs. 2023;54(4):386-391$26$YR$$F$Y$$$20240722$$HP$FR$FR
228375414$22837541$4$F$$20240923$20230818$20240930$EXP$$CA-JNJFOC-20230829405$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$HP$CA$CA
228376508$22837650$8$F$20210605$20240905$20230818$20240911$EXP$$DE-AMERICAN REGENT INC-2023001907$AMERICAN REGENT$$80$YR$$M$Y$69$KG$20240911$$HP$DE$DE
228377282$22837728$2$F$$20240826$20230818$20240904$30DAY$$US-GSK-US2023107459$GLAXOSMITHKLINE$$$$$M$Y$$$20240904$$CN$US$US
228377293$22837729$3$F$20230809$20240805$20230818$20240807$30DAY$$US-GSK-US2023108433$GLAXOSMITHKLINE$$83$YR$$F$Y$$$20240807$$MD$US$US
228378562$22837856$2$F$20190601$20230808$20230818$20240903$EXP$GB-MHRA-EYC 00208423$GB-TORRENT-00022030$TORRENT$$2$YR$C$F$Y$19$KG$20240903$$PH$GB$GB
228378952$22837895$2$F$20230101$20240816$20230818$20240822$EXP$$US-ABBVIE-5370694$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
228379085$22837908$5$F$$20240918$20230818$20240927$EXP$$CA-TAKEDA-2023TUS062739$TAKEDA$$$$$M$Y$$$20240927$$CN$CA$CA
228379693$22837969$3$F$$20240923$20230818$20240927$PER$$US-TAKEDA-2023TUS079409$TAKEDA$$$$$$Y$$$20240927$$CN$US$US
228379948$22837994$8$F$20230101$20240917$20230818$20240927$EXP$$US-INSMED, INC.-2023-00389-US$INSMED$$$$$F$Y$$$20240927$$CN$US$US
228381053$22838105$3$F$20230712$20240819$20230818$20240829$EXP$$US-VIIV HEALTHCARE LIMITED-US2023108003$VIIV$$34$YR$$M$Y$$$20240829$$CN$US$US
228382516$22838251$6$F$20230813$20240719$20230818$20240731$EXP$$JP-ROCHE-3406759$ROCHE$$68$YR$E$M$Y$77.5$KG$20240731$$MD$JP$JP
228382983$22838298$3$F$$20240705$20230818$20240716$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-64271$HIKMA$$36$YR$$F$Y$$$20240716$$HP$CA$CA
2283838210$22838382$10$F$20231009$20240719$20230818$20240724$EXP$$NVSC2023US178105$NOVARTIS$$51$YR$$F$Y$$$20240724$$CN$US$US
228383948$22838394$8$F$$20240705$20230818$20240720$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-23-64311$HIKMA$$36$YR$$F$Y$$$20240720$$PH$CA$CA
228387762$22838776$2$F$20230101$20230804$20230818$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404377$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
228388062$22838806$2$F$20221220$20240625$20230818$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-404155$RANBAXY$$86$YR$$F$Y$$$20240710$$MD$GB$GB
228388272$22838827$2$F$$20240704$20230818$20240718$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381588$RANBAXY$Santos M, Leal I, Morais Sarmento T, Mano SS, Jose P, Vaz-Pereira S. Bull?s Eye Maculopathy in Near-Infrared Reflectance as An Early Sign of Hydroxychloroquine Toxicity. Diagnostics (Basel). 2023;13(3):445(1-9)$40$YR$$F$Y$$$20240718$$HP$PT$PT
228388303$22838830$3$F$$20240822$20230818$20240906$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386603$RANBAXY$Okamoto K, Takeda A, Hatsuta H, Sano T, Takao M, Ohsawa M et al. An autopsy case of progressive multifocal leukoencephalopathy with massive iron deposition in juxtacortical lesions. Neuropathology. 2023;Feb 27; 43:396-402$71$YR$$F$Y$$$20240906$$HP$JP$JP
228390102$22839010$2$F$$20240819$20230818$20240821$EXP$$US-INCYTE CORPORATION-2023IN008541$INCYTE$$$$$$Y$$$20240821$$CN$US$US
228390682$22839068$2$F$$20240912$20230818$20240916$EXP$$EG-TAKEDA-2023TUS080678$TAKEDA$$$$$F$Y$$$20240916$$CN$EG$EG
228390713$22839071$3$F$$20240729$20230818$20240731$EXP$$CA-TAKEDA-2019TUS064346$TAKEDA$$$$$F$Y$$$20240731$$CN$CA$CA
228392795$22839279$5$F$$20240708$20230818$20240710$30DAY$$US-GSK-US2023108588$GLAXOSMITHKLINE$$$$$M$Y$$$20240710$$CN$US$US
228393383$22839338$3$F$20220721$20240918$20230818$20240923$EXP$$US-PFIZER INC-PV202300139115$PFIZER$$75$YR$$F$Y$110.38$KG$20240923$$CN$US$US
228393475$22839347$5$F$20240311$20240806$20230818$20240809$EXP$$US-PFIZER INC-PV202300141787$PFIZER$$78$YR$$F$Y$$$20240809$$CN$US$US
228393715$22839371$5$F$$20240627$20230818$20240701$PER$$US-PFIZER INC-PV202300140438$PFIZER$$84$YR$$F$Y$$$20240701$$CN$US$US
228393994$22839399$4$F$20230801$20240709$20230818$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-116414$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240710$$PH$US$US
228394337$22839433$7$F$20220113$20240814$20230818$20240820$EXP$$CO-TAKEDA-CO202004952$TAKEDA$$60$YR$$F$Y$73$KG$20240820$$CN$CO$CO
228394564$22839456$4$F$20230101$20240726$20230818$20240802$EXP$$JP-AstraZeneca-2023A172318$ASTRAZENECA$$62$YR$$M$Y$47$KG$20240802$$MD$JP$
228395377$22839537$7$F$20240710$20240710$20230818$20240712$EXP$$US-TAKEDA-2023TUS066729$TAKEDA$$73$YR$$M$Y$$$20240712$$CN$US$US
228396512$22839651$2$F$$20230814$20230818$20240718$EXP$$US-Taiho Oncology Inc-2023-006309$TAIHO ONCOLOGY INC$$46$YR$A$F$Y$$$20240718$$CN$US$US
228396959$22839695$9$F$$20240923$20230818$20240925$EXP$$US-TAKEDA-2023TUS043325$TAKEDA$$$$$M$Y$$$20240925$$MD$US$US
228397502$22839750$2$F$20210101$20240827$20230818$20240829$EXP$$PR-BEH-2023162339$CSL BEHRING$$29$YR$A$F$Y$50.35$KG$20240829$$CN$PR$PR
228398103$22839810$3$F$20230801$20240731$20230818$20240805$PER$$US-PFIZER INC-202300277996$PFIZER$$59$YR$$F$Y$$$20240805$$HP$US$US
228398563$22839856$3$F$$20240821$20230818$20240826$EXP$$US-PFIZER INC-PV202300141470$PFIZER$$44$YR$$F$Y$$$20240826$$CN$US$US
228401837$22840183$7$F$20210601$20240912$20230819$20240920$EXP$$CA-CELLTRION INC.-2021CA010441$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
2284036411$22840364$11$F$20230701$20240821$20230819$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017484$JAZZ$$49$YR$$M$Y$59.9$KG$20240823$$MD$US$US
228404286$22840428$6$F$$20240826$20230819$20240910$EXP$$CA-TAKEDA-2023TUS049751$TAKEDA$$$$$F$Y$$$20240910$$CN$CA$CA
228404326$22840432$6$F$20230811$20240802$20230819$20240808$EXP$$CA-CELLTRION INC.-2023CA016107$CELLTRION$$$$$$Y$$$20240808$$CN$CA$CA
228405285$22840528$5$F$20230101$20240730$20230819$20240812$EXP$$US-UCBSA-2023041309$UCB$$$$$F$Y$$$20240812$$CN$US$US
228405656$22840565$6$F$20230101$20240821$20230819$20240904$PER$$US-SA-2023SA222934$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240904$$MD$US$US
228406522$22840652$2$F$20230322$20240717$20230819$20240727$EXP$CH-SM-2023-15603$CH-Accord-374381$ACCORD$$59$YR$A$F$Y$$$20240727$$MD$CH$CH
228408324$22840832$4$F$20230814$20240927$20230819$20240928$PER$$US-AMGEN-USASP2023146455$AMGEN$$67$YR$E$F$Y$$$20240928$$MD$US$US
228409299$22840929$9$F$20230101$20240820$20230819$20240830$EXP$$JP-UNITED THERAPEUTICS-UNT-2023-020918$UNITED THERAPEUTICS$$71$YR$$M$Y$75.6$KG$20240830$$$JP$JP
228410392$22841039$2$F$$20240913$20230820$20240917$PER$$NVSC2023US180895$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
228411892$22841189$2$F$20230801$20240703$20230820$20240712$EXP$$US-VIIV HEALTHCARE LIMITED-US2023AMR108899$VIIV$$43$YR$$M$Y$$$20240712$$CN$US$US
228412632$22841263$2$F$$20240823$20230820$20240909$PER$$US-SA-2023SA154743$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240909$$MD$US$US
228412785$22841278$5$F$20230814$20240918$20230820$20240926$EXP$$CA-JNJFOC-20230836605$JOHNSON AND JOHNSON$$60$YR$A$F$Y$92$KG$20240926$$CN$CA$CA
228413702$22841370$2$F$$20230919$20230820$20240923$EXP$$BG-ABBVIE-5373387$ABBVIE$$$$E$F$Y$$$20240923$$CN$BG$BG
228414173$22841417$3$F$$20240709$20230820$20240712$EXP$$US-ABBVIE-5371720$ABBVIE$$$$$F$Y$88$KG$20240712$$CN$US$US
228414263$22841426$3$F$20240802$20240802$20230820$20240806$EXP$$NVSC2023CA115411$NOVARTIS$$43$YR$$F$Y$$$20240806$$CN$CA$CA
228414832$22841483$2$F$20230101$20240731$20230821$20240811$EXP$$DE-AUROBINDO-AUR-APL-2023-053337$AUROBINDO$$$$A$F$Y$$$20240812$$CN$DE$DE
228414842$22841484$2$F$20230101$20240923$20230821$20240927$EXP$$CA-ABBVIE-5368128$ABBVIE$$$$$F$Y$$$20240927$$CN$CA$CA
228414974$22841497$4$F$20221101$20240919$20230821$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-116681$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240924$$MD$JP$JP
228414992$22841499$2$F$$20240708$20230821$20240717$EXP$$JP-Encube-000450$ENCUBE ETHICALS$Suda T. Response to Before Diagnosing Metronidazole Encephalopathy, Rule out Its Differential Diagnoses. Intern Med. 2024 Jul 1;63(13):1969-1970. doi: 10.2169/internalmedicine.2903-23. Epub 2023 Nov 13. PMID: 37952944.$62$YR$A$F$Y$$$20240716$$MD$JP$
228415273$22841527$3$F$20220509$20240826$20230821$20240903$EXP$$CA-CELLTRION INC.-2022CA008995$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
228415527$22841552$7$F$20230617$20240912$20230821$20240920$EXP$$CA-JNJFOC-20230635370$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240920$$CN$CA$CA
228415722$22841572$2$F$$20240821$20230821$20240826$EXP$$US-ABBVIE-5371568$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
228415784$22841578$4$F$20240801$20240904$20230821$20240913$PER$$US-SA-2023SA249056$SANOFI AVENTIS$$64$YR$A$F$Y$120$KG$20240913$$MD$US$US
228416242$22841624$2$F$20230322$20240717$20230821$20240725$EXP$CH-SM-2023-15603$CH-009507513-2308CHE005575$MERCK$$59$YR$$F$Y$$$20240725$$MD$CH$CH
228416965$22841696$5$F$20220327$20240802$20230821$20240806$EXP$$US-TAKEDA-2022TUS021788$TAKEDA$$30$YR$$F$Y$$$20240806$$MD$US$US
228417813$22841781$3$F$20230101$20240710$20230821$20240718$PER$$US-SA-2023SA251608$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240718$$MD$US$US
2284181410$22841814$10$F$20230101$20240702$20230821$20240709$EXP$$CA-CELLTRION INC.-2023CA012560$CELLTRION$$$$$$Y$$$20240709$$MD$CA$CA
228419414$22841941$4$F$20230101$20240904$20230821$20240913$PER$$US-SA-2023SA249708$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240913$$MD$US$US
228419482$22841948$2$F$$20240827$20230821$20240827$PER$$NVSC2023US181083$NOVARTIS$$$$$F$Y$$$20240827$$MD$US$US
228420935$22842093$5$F$20221231$20240729$20230821$20240806$EXP$$CA-CELLTRION INC.-2023CA000196$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
2284211213$22842112$13$F$20230901$20240911$20230821$20240919$EXP$$CA-TAKEDA-2021TUS050115$TAKEDA$$28$YR$$F$Y$$$20240919$$HP$CA$CA
228421674$22842167$4$F$$20240809$20230821$20240820$EXP$$FR-ROCHE-3405313$ROCHE$$36$YR$A$F$Y$$$20240820$$MD$FR$FR
228422052$22842205$2$F$20230101$20240904$20230821$20240905$EXP$$US-ABBVIE-5338979$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
228422084$22842208$4$F$20180101$20240823$20230821$20240830$EXP$$US-ABBVIE-5179391$ABBVIE$$$$$M$Y$61.234$KG$20240830$$CN$US$US
228422292$22842229$2$F$$20240717$20230821$20240731$EXP$$CA-GSK-CA2023AMR110331$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$CA$CA
228423508$22842350$8$F$$20240625$20230821$20240703$EXP$$IT-CELLTRION INC.-2023IT016405$CELLTRION$Zingarella S, Marinelli GP, Bolzonell S, Piacentini G, Saccomani MD, Banzato C.. A CASE OF DOUBLE DELAYED HYPERSENSITIVITY REACTION TO TNF ALPHA INHIBITORS.. Journal of Pediatric Gastroenterology and Nutrition. 2023;76 (Suppl 1):648$$$$$Y$$$20240703$$HP$IT$IT
228424012$22842401$2$F$20240731$20240724$20230821$20240802$30DAY$$US-GSK-US2023110342$GLAXOSMITHKLINE$$$$A$F$Y$$$20240802$$CN$US$US
228424872$22842487$2$F$$20240903$20230821$20240909$EXP$$IN-JNJFOC-20230842893$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$HP$IN$IN
228425412$22842541$2$F$$20240717$20230821$20240723$EXP$$CA-TAKEDA-2023TUS080223$TAKEDA$$$$$F$Y$$$20240723$$MD$CA$CA
228425482$22842548$2$F$$20240807$20230821$20240812$EXP$$US-TAKEDA-2023TUS080588$TAKEDA$$$$$M$Y$164.8$KG$20240812$$HP$US$US
228426032$22842603$2$F$$20240807$20230821$20240811$PER$$NVSC2023US179358$NOVARTIS$$$$$F$Y$$$20240811$$MD$US$US
228426542$22842654$2$F$$20240831$20230821$20240910$EXP$$GB-ROCHE-3407325$ROCHE$$$$A$F$Y$$$20240910$$CN$GB$GB
2284277014$22842770$14$F$20230710$20240726$20230821$20240803$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2023-18110$IPSEN$$72$YR$E$M$Y$$$20240803$$MD$CA$CA
228428483$22842848$3$F$20230815$20240729$20230821$20240802$PER$$US-AMGEN-USASP2023147444$AMGEN$$70$YR$E$F$Y$$$20240802$$CN$US$US
228432814$22843281$4$F$20230101$20240918$20230821$20240925$EXP$$CA-JNJFOC-20230841278$JOHNSON AND JOHNSON$$5$YR$C$F$Y$$$20240925$$HP$CA$CA
228432965$22843296$5$F$$20240712$20230821$20240718$EXP$$SE-MYLANLABS-2023M1080351$MYLAN$$77$YR$$F$Y$$$20240718$$CN$SE$SE
228433763$22843376$3$F$20230812$20230830$20230821$20240709$EXP$$NL-ASTELLAS-2023US024948$ASTELLAS$$66$YR$$F$Y$$$20240709$$CN$NL$NL
228435377$22843537$7$F$20200508$20240912$20230821$20240916$EXP$$CA-TAKEDA-2023TUS034855$TAKEDA$$69$YR$$M$Y$$$20240916$$CN$CA$CA
228436788$22843678$8$F$$20240905$20230821$20240912$EXP$$IE-ABBVIE-5374184$ABBVIE$$$$$M$Y$$$20240912$$HP$IE$IE
228437635$22843763$5$F$20230101$20240904$20230821$20240905$30DAY$$US-UCBSA-2023040767$UCB$$$$$F$Y$$$20240905$$CN$US$US
228437652$22843765$2$F$20230720$20230803$20230821$20240726$PER$$US-BAYER-2023A109966$BAYER$$21$YR$A$F$Y$$$20240726$$HP$US$US
228438024$22843802$4$F$$20240812$20230821$20240819$EXP$$FR-ROCHE-3405264$ROCHE$$$$$M$Y$0.4564$KG$20240819$$MD$FR$FR
228442173$22844217$3$F$$20240822$20230821$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-06846$LUPIN$$$$$$Y$$$20240909$$CN$US$US
228442533$22844253$3$F$$20240611$20230821$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003192$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240707$$CN$US$US
228442784$22844278$4$F$$20240919$20230821$20240924$EXP$$NVSC2022CA228650$NOVARTIS$$64$YR$$F$Y$$$20240924$$CN$CA$CA
228442852$22844285$2$F$$20230809$20230821$20240716$EXP$$US-NOVOPROD-1102987$NOVO NORDISK$$$$$F$Y$$$20240716$$CN$US$US
228443272$22844327$2$F$$20240816$20230821$20240819$PER$$NVSC2023US181536$NOVARTIS$$$$$F$Y$83.91$KG$20240819$$MD$US$US
228443607$22844360$7$F$20230806$20240808$20230821$20240812$EXP$$ES-TAKEDA-2023TUS081262$TAKEDA$$42$YR$$F$Y$$$20240812$$HP$ES$ES
228444636$22844463$6$F$$20240816$20230821$20240820$EXP$$CA-TAKEDA-2023TUS081078$TAKEDA$$$$$F$Y$$$20240820$$CN$CA$CA
228445922$22844592$2$F$20230517$20240909$20230821$20240919$EXP$FR-AFSSAPS-PV2023000673$FR-TEVA-2023-FR-2918488$TEVA$$17$YR$$F$Y$57$KG$20240919$$MD$FR$FR
228445952$22844595$2$F$$20240712$20230821$20240717$EXP$$CA-UCBSA-2022063339$UCB$$$$$F$Y$$$20240717$$CN$CA$CA
228446012$22844601$2$F$20230726$20240829$20230821$20240918$PER$$US-SA-2023SA250190$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240918$$CN$US$US
228446422$22844642$2$F$20200601$20240715$20230821$20240723$PER$$US-SA-2023SA252592$SANOFI AVENTIS$$47$YR$A$F$Y$98$KG$20240723$$MD$US$US
228446493$22844649$3$F$20230801$20240708$20230821$20240716$PER$$US-SA-2023SA251342$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240716$$MD$US$US
228446624$22844662$4$F$20230101$20240711$20230821$20240801$PER$$US-SA-2023SA251714$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240719$$MD$US$US
228446733$22844673$3$F$20230727$20240702$20230821$20240711$PER$$US-SA-2023SA252921$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240711$$MD$US$US
228447252$22844725$2$F$20230101$20240730$20230821$20240807$PER$$US-SA-2023SA251824$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240807$$CN$US$US
228447393$22844739$3$F$$20240628$20230821$20240712$PER$$US-SA-2023SA251246$SANOFI AVENTIS$$$$A$M$Y$$$20240712$$MD$US$US
228448292$22844829$2$F$$20240308$20230821$20240819$PER$$US-ANIPHARMA-2023-US-011614$ANI$$52$YR$$F$Y$$$20240819$$CN$US$US
228448495$22844849$5$F$20230101$20240822$20230821$20240905$PER$$US-SA-2023SA252067$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240905$$MD$US$US
228448772$22844877$2$F$20230414$20240802$20230821$20240812$EXP$FR-AFSSAPS-PV2023000730$FR-TEVA-2023-FR-2918258$TEVA$$48$YR$$F$Y$$$20240812$$MD$FR$FR
228451384$22845138$4$F$$20240815$20230821$20240819$EXP$$US-PFIZER INC-202300277045$PFIZER$Boyd, F.. A Case of Fatal Clostridium perfringens Sepsis with Massive Hemolysis in the Setting of a Coincidental Platelet Transfusion. Laboratory Medicine. 2023;54(4):E108-E110$62$YR$$F$Y$$$20240819$$MD$US$US
228451666$22845166$6$F$20200519$20240625$20230821$20240702$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-006267$AMGEN$$70$YR$E$F$Y$63.2$KG$20240701$$MD$US$US
228452555$22845255$5$F$$20240819$20230821$20240821$PER$$US-PFIZER INC-PV202300141416$PFIZER$$75$YR$$F$Y$$$20240821$$HP$US$US
228452752$22845275$2$F$$20240702$20230821$20240715$EXP$$IT-MYLANLABS-2023M1086562$MYLAN$Marin L, Ambrosini G, Nuzzi L, Buzzaccarini G, Esposito F, Capobianco G et al.. Intrahepatic cholestasis of pregnancy after ovarian hyperstimulation syndrome with wild-type ABCB4 gene: a peculiar case and literature review.. BMC Women^s Health.. 2023;23:316$34$YR$$F$Y$$$20240715$$HP$IT$IT
228453465$22845346$5$F$20230501$20240716$20230821$20240723$EXP$$CO-GSK-CO2023AMR111456$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$CO$CO
228453892$22845389$2$F$$20240828$20230821$20240830$PER$$NVSC2023US181463$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
228454153$22845415$3$F$20190101$20240831$20230821$20240904$EXP$$US-KYOWAKIRIN-2023BKK013035$KYOWA$$$$$$Y$$$20240904$$HP$US$US
228454697$22845469$7$F$20230101$20240627$20230821$20240701$EXP$$PR-PFIZER INC-202300278977$PFIZER$$54$YR$$F$Y$$$20240701$$HP$PR$PR
228454736$22845473$6$F$20240301$20240703$20230821$20240708$PER$$US-PFIZER INC-PV202300142320$PFIZER$$70$YR$$M$Y$63.5$KG$20240708$$CN$US$US
228455174$22845517$4$F$$20240919$20230821$20240924$PER$$US-PFIZER INC-PV202300113857$PFIZER$$65$YR$$M$Y$$$20240924$$MD$US$US
228455728$22845572$8$F$$20240806$20230821$20240812$EXP$$US-TAKEDA-2023TUS079610$TAKEDA$$$$$F$Y$$$20240812$$CN$US$US
228455924$22845592$4$F$20230110$20240723$20230821$20240729$EXP$$US-TAKEDA-2023TUS037952$TAKEDA$$49$YR$$F$Y$75$KG$20240729$$HP$US$US
228457196$22845719$6$F$20220401$20240808$20230821$20240813$EXP$$US-ABBVIE-4272005$ABBVIE$$63$YR$$F$Y$$$20240813$$CN$US$US
228457294$22845729$4$F$20230701$20240724$20230821$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00014$AVADEL CNS PHARMA$$42$YR$$F$Y$78.912$KG$20240822$$CN$US$US
228457313$22845731$3$F$20230701$20240717$20230821$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00022$AVADEL CNS PHARMA$$41$YR$$F$Y$81.633$KG$20240822$$CN$US$US
228457465$22845746$5$F$20230101$20240714$20230821$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00019$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
228460475$22846047$5$F$20220101$20240625$20230821$20240704$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-006269$AMGEN$$62$YR$A$F$Y$$$20240704$$MD$US$US
228461228$22846122$8$F$20230811$20240905$20230821$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-115824$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$62.14$KG$20240909$$CN$US$US
228466502$22846650$2$F$$20240624$20230822$20240702$EXP$$CA-CELLTRION INC.-2023CA016341$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
228468452$22846845$2$F$$20230920$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202207-000131$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
2284686112$22846861$12$F$20220128$20240623$20230822$20240701$EXP$$CA-CELLTRION INC.-2021CA018464$CELLTRION$$$$$$Y$$$20240701$$MD$CA$CA
2284688926$22846889$26$F$20230101$20240710$20230822$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2023-023348$UNITED THERAPEUTICS$$$$$F$Y$45.351$KG$20240719$$$US$US
228469266$22846926$6$F$$20240716$20230822$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-117256$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$70.31$KG$20240718$$CN$US$US
228470609$22847060$9$F$20240101$20240611$20230822$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003209$ACADIA PHARMACEUTICALS$$22$YR$$F$Y$$$20240705$$CN$US$US
228470722$22847072$2$F$$20240919$20230822$20240923$EXP$$CA-ROCHE-3406283$ROCHE$$53$YR$A$F$Y$$$20240923$$HP$CA$CA
228470742$22847074$2$F$$20240816$20230822$20240822$EXP$$FR-EMD Serono-9291064$EMD SERONO INC$$$$$F$Y$$$20240822$$CN$FR$FR
228471272$22847127$2$F$$20240703$20230822$20240725$PER$$CA-TOLMAR, INC.-23CA042335$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
228472123$22847212$3$F$20230731$20240627$20230822$20240716$PER$$CA-TOLMAR, INC.-23CA042328$TOLMAR$$77$YR$$M$Y$$$20240715$$CN$CA$CA
228472132$22847213$2$F$20230731$20240705$20230822$20240725$PER$$CA-TOLMAR, INC.-23CA042323$TOLMAR$$90$YR$$M$Y$$$20240724$$CN$CA$CA
228473585$22847358$5$F$20230830$20240819$20230822$20240823$EXP$$US-TAKEDA-2023TUS076056$TAKEDA$$64$YR$$F$Y$$$20240823$$CN$US$US
228474132$22847413$2$F$$20240708$20230822$20240723$EXP$$GB-NORDICGR-202002597$NORDIC PHARMA$$$$E$F$Y$$$20240722$$CN$GB$GB
228474332$22847433$2$F$20240820$20240820$20230822$20240827$EXP$$US-VIIV HEALTHCARE LIMITED-US2023AMR110452$VIIV$$$$$$Y$$$20240827$$CN$PR$US
228474616$22847461$6$F$$20240902$20230822$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-116193$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240910$$MD$JP$JP
2284782911$22847829$11$F$20240101$20240913$20230822$20240924$EXP$$US-INSMED, INC.-2023-03095-US$INSMED$$$$$$Y$$$20240924$$CN$US$US
228478684$22847868$4$F$$20240715$20230822$20240720$EXP$$US-TAKEDA-2023TUS079611$TAKEDA$$$$$F$Y$$$20240720$$HP$US$US
228478932$22847893$2$F$$20240902$20230822$20240909$EXP$$CN-MSNLABS-2023MSNLIT01408$MSN LABORATORIES$$$$$$Y$$$20240909$$HP$CN$CN
228479256$22847925$6$F$20220705$20240705$20230822$20240710$PER$$US-AMGEN-USASP2023145318$AMGEN$$43$YR$A$F$Y$$$20240710$$CN$US$US
228479542$22847954$2$F$20210801$20240912$20230822$20240917$EXP$$NVSC2022GB073567$NOVARTIS$$$$A$M$Y$$$20240918$$CN$GB$GB
228480632$22848063$2$F$$20240715$20230822$20240717$EXP$$US-TAKEDA-US202018420$TAKEDA$$$$$F$Y$$$20240717$$CN$US$US
228481192$22848119$2$F$$20240904$20230822$20240910$EXP$$GB-ROCHE-3406946$ROCHE$Uchida L, Loechel C, Nodale M, Bond S and Jayne D Long-term surveillance study of Rituximab (Mabthera)-treated patients with Granulomatosis with polyangiitis (GPA) or Microscopic polyangiitis (MPA): rituximab Surveillance study in vasculitis (RIVAS) (Abstract number: POS0223). DOI: 10.1136/annrheumd. Scientific Abstracts ;:339-.$$$$$Y$$$20240910$$HP$GB$GB
228481877$22848187$7$F$$20240905$20230822$20240912$EXP$$DE-ROCHE-3332160$ROCHE$$$$$$Y$$$20240912$$CN$DE$DE
228482209$22848220$9$F$$20240902$20230822$20240909$EXP$$CA-MYLANLABS-2023M1076400$BIOCON$$$$$$Y$$$20240909$$MD$CA$CA
228482433$22848243$3$F$20230615$20240913$20230822$20240917$PER$$NVSC2023US182412$NOVARTIS$$62$YR$$F$Y$$$20240917$$CN$US$US
228482769$22848276$9$F$20230501$20240806$20230822$20240813$EXP$$NVSC2023BR128427$NOVARTIS$$40$YR$$F$Y$60$KG$20240813$$CN$BR$BR
228483122$22848312$2$F$$20240708$20230822$20240717$EXP$JP-MLMSERVICE-20230807-4469245-1$JP-STRIDES ARCOLAB LIMITED-2023SP013285$STRIDES$Mizutani N, Goda K, Kenzaka T. A Case of Milk-Alkali Syndrome Caused by Diuretic-Induced Alkalosis and Polypharmacy. Medicina (Kaunas, Lithuania).. 2023;59(7)$85$YR$$F$Y$$$20240717$$MD$JP$JP
228483252$22848325$2$F$$20231121$20230822$20240814$EXP$$US-SPECGX-T202301487$SPECGX$$$$$$Y$$$20240814$$MD$US$US
228483582$22848358$2$F$$20231004$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202209-000235$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
228483863$22848386$3$F$$20240917$20230822$20240927$EXP$$AU-BEH-2023162144$CSL BEHRING$$$$A$F$Y$$$20240927$$CN$AU$AU
228484703$22848470$3$F$20221001$20240726$20230822$20240730$EXP$$CA-ROCHE-3277458$ROCHE$$56$YR$A$F$Y$$$20240730$$MD$CA$CA
228485869$22848586$9$F$20230801$20240126$20230822$20240926$EXP$$US-GSK-US2023AMR111769$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
228486082$22848608$2$F$20130101$20240923$20230822$20240924$EXP$$US-BAYER-2023A114297$BAYER$$33$YR$A$F$Y$$$20240924$$CN$US$US
228488322$22848832$2$F$$20240716$20230822$20240727$EXP$$US-Accord-374075$ACCORD$$62$YR$A$M$Y$$$20240726$$MD$US$US
228489912$22848991$2$F$$20240729$20230822$20240807$PER$$US-SA-2023SA252211$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240807$$MD$US$US
228490562$22849056$2$F$20190101$20240731$20230822$20240808$PER$$US-SA-2023SA252659$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240808$$MD$US$US
228491416$22849141$6$F$20230101$20240715$20230822$20240724$EXP$$US-UNITED THERAPEUTICS-UNT-2023-016922$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240724$$$US$US
228491789$22849178$9$F$$20240917$20230822$20240920$30DAY$$BR-PFIZER INC-202300270891$PFIZER$$44$YR$$F$Y$63$KG$20240920$$CN$BR$BR
228492513$22849251$3$F$$20240618$20230822$20240703$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403245$RANBAXY$Tsujii S. A case of septic shock in which high temperature persisted and the complication of neuroleptic malignant syndrome was suggested from the clinical course. The 7th Meeting of Kansai Branch of Japanese Society of Intensive Care Medicine. 2023;51$6$DEC$$M$Y$$$20240703$$MD$JP$JP
228493388$22849338$8$F$20221016$20240717$20230822$20240723$EXP$$CA-TAKEDA-2022TUS084460$TAKEDA$$62$YR$$F$Y$$$20240723$$MD$CA$CA
228493484$22849348$4$F$20240509$20240628$20230822$20240703$EXP$$CA-TAKEDA-2021TUS083018$TAKEDA$$72$YR$$M$Y$$$20240703$$CN$CA$CA
228494513$22849451$3$F$$20240718$20230822$20240725$EXP$$CA-APOTEX-2023AP012188$APOTEX$$57$YR$$M$Y$$$20240725$$HP$CA$CA
228494643$22849464$3$F$$20240717$20230822$20240723$EXP$$IT-MYLANLABS-2023M1086132$MYLAN$Marin L, Ambrosini G, Nuzzi L, Buzzaccarini G, Esposito F, Capobianco G et al.. Intrahepatic cholestasis of pregnancy after ovarian hyperstimulation syndrome with wild-type ABCB4 gene: a peculiar case and literature review. BMC Women^s Health. 2023;23(1):316$$$$$Y$2.5$KG$20240723$$HP$IT$IT
2284946611$22849466$11$F$$20240823$20230822$20240829$EXP$$ES-MYLANLABS-2023M1086148$MYLAN$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A, Ar?valo CE, Montan? C, Ribes-Amor?s J, Zamora L, Granada I, Gamundi E, Arnan M, Sureda A. B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. report of three cases and review of the literature.. Leukemia and Lymphoma. 2023;64(10):1701-1705$68$YR$$F$Y$$$20240829$$HP$ES$ES
228495509$22849550$9$F$20230628$20240614$20230822$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003207$ACADIA PHARMACEUTICALS$$9$YR$$F$Y$$$20240709$$CN$US$US
228496212$22849621$2$F$$20240806$20230822$20240814$EXP$HU-EMA-2023809-AUTODUP-1691608089540$HU-BAXTER-2023BAX028736$BAXTER$$58$YR$$F$Y$$$20240814$$HP$HU$HU
228496307$22849630$7$F$20230818$20240924$20230822$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-116985$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$65.77$KG$20240925$$CN$US$US
228496772$22849677$2$F$20230628$20230911$20230822$20240829$PER$$US-BSC-2023000033$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$HP$US$US
228496822$22849682$2$F$20230628$20230911$20230822$20240829$PER$$US-BSC-2023000032$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$HP$US$US
228496852$22849685$2$F$20230728$20231018$20230822$20240829$PER$$US-BSC-2023000038$BOSTON SCIENTIFIC$$$$E$F$Y$$$20240829$$HP$US$US
228497395$22849739$5$F$20230101$20240916$20230822$20240921$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-134074$DAIICHI$$$$$F$Y$$$20240921$$CN$US$US
228498752$22849875$2$F$20220101$20230905$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202210-000258$EMMAUS LIFE SCIENCES$$11$YR$C$F$Y$61.235$KG$20240823$$CN$US$
228499552$22849955$2$F$$20230814$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202301-000022$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
228500042$22850004$2$F$$20240402$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202303-000070$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
228500142$22850014$2$F$$20230830$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202304-000094$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
228500492$22850049$2$F$20230101$20240116$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202306-000132$EMMAUS LIFE SCIENCES$$9$YR$C$F$Y$$$20240823$$CN$US$
228500532$22850053$2$F$20230616$20230912$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202306-000138$EMMAUS LIFE SCIENCES$$44$YR$A$M$Y$$$20240823$$CN$US$
228500552$22850055$2$F$20230624$20230913$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202306-000142$EMMAUS LIFE SCIENCES$$32$YR$A$M$Y$$$20240823$$CN$US$
228500562$22850056$2$F$$20230913$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202306-000143$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
228500932$22850093$2$F$$20240801$20230822$20240805$PER$$US-PFIZER INC-PV202200081707$PFIZER$$31$YR$$F$Y$$$20240805$$HP$US$US
228500945$22850094$5$F$$20240722$20230822$20240724$PER$$US-PFIZER INC-PV202300142477$PFIZER$$73$YR$$F$Y$$$20240724$$HP$US$US
228501412$22850141$2$F$20230501$20230810$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202208-000144$EMMAUS LIFE SCIENCES$$34$YR$A$M$Y$$$20240823$$CN$US$
228501422$22850142$2$F$$20230817$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202210-000239$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
228501472$22850147$2$F$20230225$20230929$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202303-000065$EMMAUS LIFE SCIENCES$$22$YR$A$F$Y$$$20240823$$CN$US$
228501502$22850150$2$F$$20230811$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202306-000130$EMMAUS LIFE SCIENCES$$$$$F$Y$63.412$KG$20240823$$CN$US$
228501512$22850151$2$F$$20230818$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202305-000107$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
228501532$22850153$2$F$20230619$20230810$20230822$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000145$EMMAUS LIFE SCIENCES$$27$YR$A$F$Y$54.885$KG$20240823$$CN$US$
2285019412$22850194$12$F$$20240704$20230822$20240709$EXP$$ES-MYLANLABS-2023M1085992$MYLAN$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A, C. E. Arevalo, C. Montane, J. Ribes-Amoros, L. Zamora, I. Granada, E. Gamundi, M. Arnan + A. Sureda. B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. report of three cases and review of the literature. Leukemia and Lymphoma. 2023;64(10):1701-5$67$YR$$M$Y$$$20240709$$HP$ES$ES
2285019611$22850196$11$F$$20240909$20230822$20240911$EXP$$ES-MYLANLABS-2023M1085929$MYLAN$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A, Arevalo C, Montane C, Ribes-Amoros J, Zamora L, Granada I, Gamundi E, Arnan M, Sureda A. B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature. Leukemia and Lymphoma. 2023;64(10):1701-1705$69$YR$$F$Y$$$20240911$$HP$ES$ES
228502153$22850215$3$F$$20240820$20230822$20240822$EXP$$US-ROCHE-3408088$ROCHE$$59$YR$A$M$Y$95.7$KG$20240822$$CN$US$US
228502553$22850255$3$F$$20230705$20230822$20240723$EXP$$NVSC2023CA154681$NOVARTIS$$$$$$Y$$$20240723$$MD$CA$CA
228502592$22850259$2$F$20240820$20240820$20230822$20240828$EXP$$US-JNJFOC-20230847543$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240828$$CN$PR$US
228503193$22850319$3$F$20230503$20240828$20230822$20240904$PER$$US-PFIZER INC-US-GBT-022208$PFIZER$$59$YR$$F$Y$$$20240904$$CN$US$US
228503513$22850351$3$F$$20240822$20230822$20240830$EXP$$CA-TAKEDA-2022TUS005882$TAKEDA$$$$$M$Y$$$20240830$$CN$CA$CA
228503723$22850372$3$F$20230810$20240807$20230822$20240814$EXP$$BR-Ipsen Biopharmaceuticals, Inc.-2023-19534$IPSEN$$44$YR$A$M$Y$88$KG$20240814$$CN$BR$BR
228504113$22850411$3$F$20230805$20240829$20230822$20240903$EXP$$BR-BAYER-2023A114605$BAYER$$26$YR$A$F$Y$$$20240903$$CN$BR$BR
228504253$22850425$3$F$20230712$20240829$20230822$20240830$EXP$$NVSC2023US181096$NOVARTIS$$57$YR$$M$Y$$$20240830$$CN$US$US
228504526$22850452$6$F$$20240731$20230822$20240805$EXP$$US-TAKEDA-2023TUS077512$TAKEDA$$$$$F$Y$$$20240805$$MD$US$US
228504873$22850487$3$F$20230701$20240913$20230822$20240920$PER$$US-SA-2023SA253954$SANOFI AVENTIS$$12$YR$T$M$Y$43.084$KG$20240920$$MD$US$US
228507912$22850791$2$F$$20230820$20230822$20240926$EXP$$NVSC2023CA182181$NOVARTIS$$32$YR$$F$Y$$$20240926$$PH$CA$CA
228508054$22850805$4$F$20230101$20240823$20230822$20240827$EXP$$US-PFIZER INC-PV202300074886$PFIZER$$83$YR$$F$Y$70.295$KG$20240827$$CN$US$US
228508623$22850862$3$F$$20240803$20230822$20240812$EXP$$HU-MYLANLABS-2023M1087283$MYLAN$Gabriella Mezei, P?ter Bat?r, ?rp?d Ill?s, R?bert Sz?sz. Differential Diagnosis of Hemorrhagic Colitis in Patient with Ph+ Acute Lymphoblastic Leukemia, after Several Years of Dasatinib Treatment. Can TKI be discontinued in Ph+ ALL?$58$YR$$F$Y$$$20240812$$MD$HU$HU
228508934$22850893$4$F$$20230821$20230822$20240710$PER$$NVSC2023US182941$NOVARTIS$$$$$M$Y$$$20240710$$CN$US$US
228508956$22850895$6$F$20220314$20240628$20230822$20240703$EXP$$JP-009507513-2304JPN001210J$MERCK$Shiomi M, Nakamura S, Tomai E, Hara R, Fujiyoshi E, Terada M, et al.. p-43-8 Experience with Lenvatinib/Pembrolizumab Therapy for Corpus Uteri Carcinoma at Our Hospital. Acta Obstetrica et Gynaecologica Japonica, The 76th Annual Congress of the Japan. 2024;76(S):S548$65$YR$$F$Y$$$20240703$$MD$JP$JP
228510033$22851003$3$F$20211103$20240619$20230822$20240809$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202308009504$ELI LILLY AND CO$$25$YR$A$M$Y$59.9$KG$20240809$$CN$GB$GB
228510192$22851019$2$F$20230512$20240813$20230822$20240816$PER$$US-JNJFOC-20230805048$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240816$$CN$US$US
228510266$22851026$6$F$20211226$20240902$20230822$20240910$EXP$$JP-GSK-JP2023JPN112183$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$JP$JP
228510364$22851036$4$F$20220620$20240628$20230822$20240705$EXP$$CO-009507513-2207COL005318$MERCK$$60$YR$$M$Y$90$KG$20240705$$CN$CO$CO
228510974$22851097$4$F$$20240910$20230822$20240926$EXP$$CA-TAKEDA-2023TUS081780$TAKEDA$$43$YR$$M$Y$$$20240926$$HP$CA$CA
228511084$22851108$4$F$20211201$20240111$20230822$20240926$EXP$$US-GSK-US2021097868$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
228511415$22851141$5$F$20191114$20240709$20230822$20240712$EXP$$JP-ABBVIE-4742574$ABBVIE$$72$YR$$M$Y$$$20240712$$MD$JP$JP
228511832$22851183$2$F$$20240828$20230822$20240902$PER$$NVSC2023US182985$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
228511873$22851187$3$F$20220401$20240110$20230822$20240926$EXP$$US-GSK-US2022AMR065608$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
228512375$22851237$5$F$20230101$20240711$20230822$20240715$PER$$US-PFIZER INC-202300276833$PFIZER$$54$YR$$F$Y$90.72$KG$20240715$$CN$US$US
228512412$22851241$2$F$20230701$20240913$20230822$20240918$PER$$US-PFIZER INC-PV202300143360$PFIZER$$57$YR$$M$Y$$$20240918$$HP$US$US
228513814$22851381$4$F$$20240801$20230822$20240810$EXP$$US-TEVA-2023-US-2918554$TEVA$Menon A,Enunwa CA,Read WL,James KP Rare Delayed Ifosfamide Encephalopathy: A Case Report of Chemotherapeutic Neurotoxicity. Case Reports in Oncology 17: 202-207, No. 1, 06 Feb 2024.; Menon A, Enunwa C, James K. RARE + DELAYED IFOSFAMIDE ENCEPHALOPATHY: A CASE REPORT OF CHEMOTHERAPEUTIC NEUROTOXICITY IN PRESUMED EWING SARCOMA. J-Gen-Intern-Med 2023; 38 (Suppl.) S520-S521.?Menon A,Enunwa CA,Read WL,James KP Rare Delayed Ifosfamide Encephalopathy: A Case Report of Chemotherapeutic Neurotoxicity....$25$YR$$F$Y$$$20240810$$HP$US$US
228514532$22851453$2$F$$20240924$20230822$20240930$EXP$$CA-TAKEDA-2023TUS081592$TAKEDA$$$$$F$Y$$$20240930$$CN$CA$CA
228514993$22851499$3$F$$20240717$20230822$20240725$PER$$US-SA-2023SA253595$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240725$$MD$US$US
228515324$22851532$4$F$$20240904$20230822$20240913$PER$$US-SA-2023SA254458$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240913$$HP$US$US
228515953$22851595$3$F$20230816$20240824$20230822$20240829$PER$$US-AMGEN-USASP2023145187$AMGEN$$35$YR$A$F$Y$72.6$KG$20240829$$PH$US$US
228516943$22851694$3$F$20230804$20240722$20230823$20240725$PER$$US-BIOGEN-2023BI01222228$BIOGEN$$56$YR$$F$Y$$$20240725$$CN$US$US
228517003$22851700$3$F$20230818$20240923$20230823$20240924$PER$$US-AMGEN-USASP2023148203$AMGEN$$76$YR$E$F$Y$$$20240923$$MD$US$US
228519942$22851994$2$F$$20240710$20230823$20240720$PER$$NVSC2023US183094$NOVARTIS$$$$$F$Y$98.18$KG$20240719$$MD$US$US
228521742$22852174$2$F$20230806$20240730$20230823$20240808$PER$$US-SA-2023SA254100$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240809$$MD$US$US
228521777$22852177$7$F$$20240702$20230823$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-117377$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240708$$CN$US$US
228522284$22852228$4$F$20230101$20240724$20230823$20240802$PER$$US-SA-2023SA251550$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240802$$MD$US$US
228523844$22852384$4$F$20220501$20240625$20230823$20240702$EXP$$NVSC2023DE180661$NOVARTIS$$70$YR$$M$Y$71$KG$20240702$$MD$DE$DE
228524172$22852417$2$F$$20240708$20230823$20240718$EXP$JP-MLMSERVICE-20230807-4469245-1$JP-JUBILANT CADISTA PHARMACEUTICALS-2023JP000943$JUBILANT$Mizutani N, Goda K, Kenzaka T. A Case of Milk-Alkali Syndrome Caused by Diuretic-Induced Alkalosis and Polypharmacy. Medicina (Kaunas, Lithuania).. 2023;59(7)$85$YR$$F$Y$$$20240718$$MD$JP$JP
228524404$22852440$4$F$$20240904$20230823$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202308013266$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240908$$CN$US$US
228525932$22852593$2$F$$20240904$20230823$20240905$EXP$$US-TAKEDA-2023TUS081218$TAKEDA$$$$$M$Y$$$20240905$$CN$US$US
228526214$22852621$4$F$20230805$20240624$20230823$20240702$EXP$$CO-AMGEN-COLSL2023144907$AMGEN$$88$YR$E$F$Y$48$KG$20240702$$CN$CO$CO
228526597$22852659$7$F$20230724$20240228$20230823$20240925$PER$$US-GSK-US2023AMR111741$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240925$$CN$US$US
228527345$22852734$5$F$$20240713$20230823$20240723$30DAY$$US-GSK-US2023AMR113575$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$CN$US$US
228528132$22852813$2$F$20230724$20240808$20230823$20240813$PER$$US-BIOGEN-2023BI01222194$BIOGEN$$43$YR$$F$Y$$$20240813$$CN$US$US
228529944$22852994$4$F$20230815$20240702$20230823$20240710$EXP$$US-UNITED THERAPEUTICS-UNT-2023-023357$UNITED THERAPEUTICS$$44$YR$$F$Y$47.619$KG$20240710$$$US$US
228533378$22853337$8$F$20231026$20240918$20230823$20240926$EXP$$NVSC2023US182677$NOVARTIS$$59$YR$$F$Y$$$20240926$$CN$US$US
228535693$22853569$3$F$20230813$20240708$20230823$20240716$PER$$US-SA-2023SA253840$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240716$$MD$US$US
228535762$22853576$2$F$20230809$20240716$20230823$20240723$PER$$US-ABBVIE-5377924$ABBVIE$$65$YR$$M$Y$123$KG$20240723$$MD$US$US
228536012$22853601$2$F$$20240828$20230823$20240910$PER$$US-SA-2023SA252950$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240910$$MD$US$US
228536472$22853647$2$F$20230817$20240711$20230823$20240718$PER$$US-SA-2023SA256987$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240718$$MD$US$US
228536653$22853665$3$F$$20240905$20230823$20240905$PER$$US-PFIZER INC-2019301783$PFIZER$$11$YR$$M$Y$37$KG$20240905$$HP$US$US
228536853$22853685$3$F$$20240722$20230823$20240730$PER$$US-SA-2023SA255603$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240730$$HP$US$US
228536915$22853691$5$F$20230101$20240714$20230823$20240722$PER$$US-SA-2023SA253440$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240722$$MD$US$US
228537443$22853744$3$F$20190101$20240715$20230823$20240722$EXP$$FR-AUROBINDO-AUR-APL-2022-002345$AUROBINDO$Langlume LLanglume L, Eiden C, Roy S, Taruffi F, Gambier J, Donnadieu-Rigole H, et al.. Management of Pregabalin Use Disorder: A Case Series. Journal of Psychoactive Drugs. 2021$26$YR$$F$Y$$$20240722$$HP$FR$FR
228537543$22853754$3$F$20230714$20240715$20230823$20240801$PER$$US-SA-2023SA257636$SANOFI AVENTIS$$78$YR$E$M$Y$69.3$KG$20240719$$MD$US$US
228540154$22854015$4$F$$20230913$20230823$20240801$PER$$NVSC2023US183488$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
228540192$22854019$2$F$20230613$20230809$20230823$20240729$PER$$US-BAYER-2023A112798$BAYER$$27$YR$A$F$Y$$$20240729$$MD$US$US
228541482$22854148$2$F$$20240729$20230823$20240801$EXP$$CA-PFIZER INC-PV202300142469$PFIZER$$45$YR$$F$Y$80.4$KG$20240801$$MD$CA$CA
228541924$22854192$4$F$$20240802$20230823$20240808$EXP$$US-TAKEDA-2023TUS081598$TAKEDA$$$$$F$Y$$$20240808$$CN$US$US
228542384$22854238$4$F$20230701$20240710$20230823$20240717$EXP$$US-SA-2023SA249919$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240717$$MD$US$US
228542605$22854260$5$F$$20240717$20230823$20240722$EXP$$CA-ROCHE-2771725$ROCHE$$$$A$F$Y$$$20240722$$MD$CA$CA
228542793$22854279$3$F$20230701$20240919$20230823$20240926$EXP$$BR-PFIZER INC-PV202300118729$PFIZER$$61$YR$$M$Y$65$KG$20240926$$MD$BR$BR
228543736$22854373$6$F$20230815$20240710$20230823$20240718$EXP$$US-BEH-2023162375$CSL BEHRING$$78$YR$E$F$Y$$$20240718$$HP$US$US
228544172$22854417$2$F$$20240627$20230823$20240910$EXP$$US-SANDOZ INC.-SDZ2023US008119$SANDOZ$$$$$F$Y$$$20240910$$CN$US$US
228544192$22854419$2$F$20230726$20240625$20230823$20240910$EXP$$US-SANDOZ INC.-SDZ2023US010319$SANDOZ$$81$YR$$F$Y$$$20240910$$CN$US$US
228544333$22854433$3$F$$20240829$20230823$20240830$EXP$$US-SANDOZ INC.-SDZ2023US006704$SANDOZ$$$$$F$Y$$$20240830$$CN$US$US
228544542$22854454$2$F$20230717$20240906$20230823$20240910$EXP$$CN-PFIZER INC-PV202300142824$PFIZER$$$$E$M$Y$$$20240910$$CN$CN$CN
228544563$22854456$3$F$20240307$20240904$20230823$20240905$EXP$$US-PFIZER INC-PV202300142858$PFIZER$$71$YR$$F$Y$$$20240905$$CN$US$US
228545533$22854553$3$F$20220725$20240711$20230823$20240716$EXP$$US-PFIZER INC-PV202300095283$PFIZER$$35$YR$$M$Y$42.18$KG$20240716$$CN$US$US
228545582$22854558$2$F$20230301$20240809$20230823$20240816$EXP$$IN-PFIZER INC-202300282262$PFIZER$$30$YR$$M$Y$$$20240816$$CN$IN$IN
228545605$22854560$5$F$20230101$20240923$20230823$20240927$EXP$$CA-PFIZER INC-202101287792$PFIZER$$55$YR$$F$Y$$$20240927$$MD$CA$CA
228550062$22855006$2$F$20230701$20240703$20230823$20240714$PER$$US-SA-2023SA254062$SANOFI AVENTIS$$26$YR$A$F$Y$72.5$KG$20240714$$MD$US$US
228550233$22855023$3$F$20200819$20240917$20230823$20240926$EXP$$GB-TAKEDA-2021TUS006758$TAKEDA$$53$YR$$M$Y$$$20240926$$HP$GB$GB
228552422$22855242$2$F$$20240725$20230823$20240726$PER$$NVSC2023US183234$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
228553032$22855303$2$F$20220101$20231107$20230823$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-000844$ENDO$$$$$F$Y$83.91$KG$20240830$$CN$US$US
228554615$22855461$5$F$20230705$20240816$20230823$20240822$EXP$$PT-BIOGEN-2023BI01217358$BIOGEN$$41$YR$$F$Y$55$KG$20240822$$MD$PT$PT
228555072$22855507$2$F$20221101$20240709$20230823$20240711$EXP$$US-ABBVIE-5374262$ABBVIE$$76$YR$$F$Y$$$20240711$$CN$US$US
228556295$22855629$5$F$20231221$20240221$20230823$20240813$EXP$$NVSC2023BR181123$NOVARTIS$$51$YR$$F$Y$$$20240813$$CN$BR$BR
228559886$22855988$6$F$20230801$20240710$20230823$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405210$RANBAXY$$87$YR$E$F$Y$$$20240725$$CN$US$US
228560235$22856023$5$F$20230101$20240805$20230823$20240814$PER$$US-SA-2023SA251921$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240814$$MD$US$US
228563283$22856328$3$F$20220719$20240821$20230823$20240824$EXP$$US-TAKEDA-2021TUS080828$TAKEDA$$85$YR$$F$Y$67$KG$20240824$$CN$US$US
228563492$22856349$2$F$$20230817$20230823$20240718$EXP$$US-Taiho Oncology Inc-2023-006803$TAIHO ONCOLOGY INC$$69$YR$E$M$Y$$$20240718$$CN$US$US
228563862$22856386$2$F$20191101$20240828$20230823$20240829$EXP$$KR-MYLANLABS-2023M1088134$MYLAN$$$$$M$Y$$$20240829$$CN$KR$KR
228563973$22856397$3$F$$20240904$20230823$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-117819$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240910$$HP$US$US
228564504$22856450$4$F$20230506$20240919$20230823$20240919$EXP$$NVSC2023FR180676$NOVARTIS$$77$YR$$M$Y$78$KG$20240919$$MD$FR$FR
228565052$22856505$2$F$20230801$20240815$20230823$20240819$EXP$$US-PFIZER INC-PV202300143040$PFIZER$$56$YR$$F$Y$$$20240819$$HP$US$US
228565825$22856582$5$F$20220501$20240730$20230823$20240801$EXP$$US-PFIZER INC-US-GBT-017841$PFIZER$$51$YR$$F$Y$61.23$KG$20240801$$CN$US$US
228566834$22856683$4$F$20180907$20240729$20230823$20240803$EXP$$JP-ABBVIE-19P-087-2920298-00$ABBVIE$$62$YR$$M$Y$70.9$KG$20240803$$MD$JP$JP
228567593$22856759$3$F$$20240531$20230823$20240723$PER$$US-Stemline Therapeutics, Inc.-2023ST001630$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
228570703$22857070$3$F$20240514$20240601$20230823$20240724$PER$$US-Stemline Therapeutics, Inc.-2023ST002006$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
228576086$22857608$6$F$20240201$20240708$20230823$20240710$PER$$US-PFIZER INC-PV202300120242$PFIZER$$57$YR$$M$Y$$$20240710$$HP$US$US
228576194$22857619$4$F$$20240724$20230823$20240730$EXP$$US-PFIZER INC-202300280214$PFIZER$$80$YR$$F$Y$$$20240730$$CN$US$US
228576508$22857650$8$F$20230701$20240909$20230823$20240911$PER$$US-PFIZER INC-PV202200120682$PFIZER$$74$YR$$F$Y$76.7$KG$20240911$$MD$US$US
228577093$22857709$3$F$20210901$20240812$20230823$20240826$EXP$$US-HLS-202300848$HLS THERAPEUTICS$$56$YR$A$M$Y$$$20240826$$MD$US$US
228577285$22857728$5$F$20230522$20240729$20230823$20240816$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000195$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
2285778618$22857786$18$F$20230801$20240823$20230823$20240904$EXP$$US-BEH-2023162510$CSL BEHRING$$55$YR$A$M$Y$$$20240904$$HP$US$US
228579702$22857970$2$F$20230816$20240819$20230823$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-118783$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240827$$HP$US$US
228579882$22857988$2$F$20080401$20240916$20230824$20240921$EXP$$US-ABBVIE-4711888$ABBVIE$$59$YR$$F$Y$73.935$KG$20240921$$CN$US$US
228580903$22858090$3$F$20230801$20240701$20230824$20240722$PER$$CA-TOLMAR, INC.-23CA042366$TOLMAR$$66$YR$$M$Y$$$20240722$$CN$CA$CA
228581085$22858108$5$F$20230801$20240918$20230824$20240925$PER$$US-SA-2023SA252119$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240925$$MD$US$US
228581102$22858110$2$F$$20240625$20230824$20240704$PER$$US-SA-2023SA255481$SANOFI AVENTIS$$$$E$F$Y$97.06$KG$20240704$$MD$US$US
228581384$22858138$4$F$20230101$20240806$20230824$20240816$PER$$US-SA-2023SA253359$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240816$$MD$US$US
228581642$22858164$2$F$20230801$20240805$20230824$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017744$JAZZ$$35$YR$$M$Y$74.2$KG$20240813$$CN$US$US
228582152$22858215$2$F$20210101$20240904$20230824$20240916$EXP$$CA-INTERCEPT-PM2021000101$INTERCEPT PHARMACEUTICALS$$75$YR$$F$Y$$$20240916$$CN$CA$CA
228583222$22858322$2$F$20230527$20240813$20230824$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-118664$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240814$$CN$US$US
228584392$22858439$2$F$20230314$20240903$20230824$20240913$EXP$$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2023-016233$VALIDUS$$$$$$Y$$$20240913$$HP$CA$CA
228584402$22858440$2$F$$20240709$20230824$20240710$EXP$$CA-SANDOZ INC.-SDZ2023CA017643$SANDOZ$$$$$M$Y$$$20240710$$MD$CA$CA
228584933$22858493$3$F$20230822$20240626$20230824$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-119099$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240701$$CN$US$US
228585782$22858578$2$F$20230731$20231019$20230824$20240829$PER$$US-BSC-2023000039$BOSTON SCIENTIFIC$$40$YR$A$F$Y$$$20240829$$HP$US$US
228585792$22858579$2$F$20230724$20230823$20230824$20240829$PER$$US-BSC-2023000036$BOSTON SCIENTIFIC$$52$YR$A$F$Y$$$20240829$$CN$US$US
228585812$22858581$2$F$$20240602$20230824$20240829$PER$$US-BSC-2023000027$BOSTON SCIENTIFIC$$88$YR$$F$Y$$$20240829$$CN$US$US
228585842$22858584$2$F$$20230830$20230824$20240829$PER$$US-BSC-2023000040$BOSTON SCIENTIFIC$$74$YR$E$F$Y$$$20240829$$MD$US$US
228585912$22858591$2$F$20211013$20230821$20230824$20240829$PER$$US-BSC-2023000029$BOSTON SCIENTIFIC$$54$YR$$F$Y$$$20240829$$CN$US$US
228586717$22858671$7$F$20230101$20240911$20230824$20240918$PER$$US-SA-2023SA254169$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240918$$MD$US$US
228586944$22858694$4$F$20230101$20240802$20230824$20240813$PER$$US-SA-2023SA256160$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240814$$MD$US$US
228587795$22858779$5$F$$20240820$20230824$20240827$PER$$US-BIOGEN-2023BI01222301$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
228588896$22858889$6$F$20230620$20240716$20230824$20240723$EXP$$NVSC2023FR168372$NOVARTIS$$73$YR$$F$Y$85$KG$20240723$$MD$FR$FR
228591324$22859132$4$F$20230828$20240829$20230824$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-118953$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240906$$CN$US$US
228592739$22859273$9$F$20230720$20240311$20230824$20240724$EXP$$FR-SA-2023SA255269$SANOFI AVENTIS$$74$YR$E$M$Y$77$KG$20240724$$HP$FR$FR
228593866$22859386$6$F$20230101$20240715$20230824$20240724$PER$$US-SA-2023SA254744$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240724$$MD$US$US
228593959$22859395$9$F$$20240910$20230824$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-119158$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240912$$CN$US$US
228594262$22859426$2$F$20230806$20240913$20230824$20240919$PER$$US-SA-2023SA257053$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240919$$MD$US$US
228594532$22859453$2$F$$20240805$20230824$20240813$PER$$US-SA-2023SA257007$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240814$$MD$US$US
228594542$22859454$2$F$20230101$20240820$20230824$20240910$PER$$US-SA-2023SA257091$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240910$$MD$US$US
228594682$22859468$2$F$20230101$20230818$20230824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2023ARB000259$ARBOR$$$$$F$Y$$$20240802$$CN$US$US
228595852$22859585$2$F$20230301$20240708$20230824$20240710$EXP$$NVSC2023CA182969$NOVARTIS$$74$YR$$M$Y$$$20240710$$MD$CA$CA
228596522$22859652$2$F$20230718$20240816$20230824$20240822$EXP$$US-SA-2023SA256516$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240822$$MD$US$US
228597452$22859745$2$F$$20240719$20230824$20240723$PER$$NVSC2023US183618$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
228599182$22859918$2$F$$20230915$20230824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2023ARB003055$ARBOR$$$$$F$Y$$$20240802$$CN$US$US
2285991910$22859919$10$F$20230101$20240923$20230824$20240926$PER$$US-BIOGEN-2023BI01222478$BIOGEN$$$$$M$Y$$$20240926$$CN$US$US
228599572$22859957$2$F$20230901$20240701$20230824$20240703$EXP$$US-TAKEDA-2023TUS082125$TAKEDA$$48$YR$$M$Y$$$20240703$$PH$US$US
228600615$22860061$5$F$20201205$20240801$20230824$20240807$EXP$$CA-JNJFOC-20201213403$JOHNSON AND JOHNSON$$10$YR$C$M$Y$31$KG$20240807$$HP$CA$CA
228601565$22860156$5$F$20230816$20240710$20230824$20240718$PER$$US-SA-2023SA253861$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240718$$MD$US$US
228601957$22860195$7$F$$20240827$20230824$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07024$LUPIN$$$$$$Y$$$20240916$$PH$US$US
228602517$22860251$7$F$$20240813$20230824$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-119201$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240822$$CN$US$US
228603363$22860336$3$F$$20240719$20230824$20240723$EXP$$JP-OTSUKA-2023_022287$OTSUKA$$54$YR$$F$Y$86$KG$20240723$$MD$JP$JP
2286043910$22860439$10$F$20230101$20240920$20230824$20240924$EXP$$US-PFIZER INC-PV202300144287$PFIZER$$80$YR$$F$Y$74.84$KG$20240924$$HP$US$US
228606204$22860620$4$F$20230101$20240729$20230824$20240807$PER$$US-SA-2023SA257288$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240807$$MD$US$US
2286065013$22860650$13$F$$20240819$20230824$20240902$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-118555$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$96$KG$20240902$$HP$CA$CA
228606526$22860652$6$F$20220101$20240903$20230824$20240905$PER$$US-PFIZER INC-PV202300143110$PFIZER$$79$YR$$F$Y$99.32$KG$20240905$$CN$US$US
228606604$22860660$4$F$$20240911$20230824$20240912$PER$$US-PFIZER INC-PV202300143394$PFIZER$$70$YR$$F$Y$$$20240912$$CN$US$US
228608112$22860811$2$F$$20240718$20230824$20240722$EXP$GB-MHRA-ADR 28126537$GB-MYLANLABS-2023M1088053$MYLAN$$88$YR$$$Y$$$20240722$$PH$GB$GB
228609115$22860911$5$F$20140309$20240905$20230824$20240910$PER$$US-GILEAD-2023-0641248$GILEAD$$31$YR$A$M$Y$$$20240910$$LW$US$US
2286112124$22861121$24$F$20230805$20240807$20230824$20240814$EXP$$NVSC2023RU180976$NOVARTIS$$0$YR$$F$Y$7.7$KG$20240814$$CN$RU$RU
228611904$22861190$4$F$$20240820$20230824$20240829$PER$$US-SA-2023SA254572$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240829$$MD$US$US
228613466$22861346$6$F$$20240827$20230824$20240830$PER$$US-PFIZER INC-202300281628$PFIZER$$29$YR$$F$Y$$$20240830$$CN$US$US
228613563$22861356$3$F$$20240626$20230824$20240701$PER$$US-PFIZER INC-202300281658$PFIZER$$48$YR$$F$Y$$$20240701$$CN$US$US
228613635$22861363$5$F$$20240919$20230824$20240923$PER$$US-PFIZER INC-PV202300143948$PFIZER$$82$YR$$F$Y$108.86$KG$20240923$$MD$US$US
228613679$22861367$9$F$20230101$20240923$20230824$20240926$PER$$US-PFIZER INC-PV202300144672$PFIZER$$58$YR$$F$Y$$$20240926$$CN$US$US
228613682$22861368$2$F$20230901$20240719$20230824$20240723$EXP$$US-PFIZER INC-202300280549$PFIZER$$33$YR$$F$Y$$$20240723$$CN$US$US
228613745$22861374$5$F$20230701$20240903$20230824$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-117455$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240904$$CN$US$US
228614572$22861457$2$F$20220101$20240207$20230824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB001682$ARBOR$$$$$M$Y$$$20240802$$CN$US$US
228615202$22861520$2$F$20220101$20231019$20230824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB002036$ARBOR$$$$$F$Y$$$20240802$$CN$US$US
228615742$22861574$2$F$20220919$20240313$20230824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB002145$ARBOR$$8$YR$$F$Y$$$20240802$$HP$US$US
228615892$22861589$2$F$20220101$20230915$20230824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB002231$ARBOR$$$$$F$Y$$$20240802$$HP$US$US
228615942$22861594$2$F$20220726$20230830$20230824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB002217$ARBOR$$10$YR$$F$Y$$$20240802$$PH$US$US
228615952$22861595$2$F$20220101$20240130$20230824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB002280$ARBOR$$$$$F$Y$$$20240802$$CN$US$US
228615974$22861597$4$F$$20240711$20230824$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-117201$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240715$$CN$US$US
228616332$22861633$2$F$20220101$20230727$20230824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB002837$ARBOR$$$$$F$Y$$$20240802$$CN$US$US
228617142$22861714$2$F$20230101$20230703$20230824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2023ARB003984$ARBOR$$$$$F$Y$$$20240802$$CN$US$US
228617152$22861715$2$F$20230620$20230807$20230824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2023ARB004352$ARBOR$$7$YR$$F$Y$$$20240802$$CN$US$US
228617382$22861738$2$F$20230101$20230718$20230824$20240802$PER$$US-ARBOR PHARMACEUTICALS, LLC-US-2023ARB004227$ARBOR$$$$$M$Y$$$20240802$$CN$US$US
228618532$22861853$2$F$$20230817$20230824$20240711$PER$$DE-PFM-2023-04196$PIERRE FABRE MEDICAMENT$Wilke PI, Biermann D, Grafmann M, Kozlik-Feldmann R, Papingi D, Sachweh JS et al. Siblings with Gorlin-Goltz syndrome associated with cardiac tumors: a case report and review of literature. Orphanet Journal of Rare Diseases. 2023;18(1):178$13$MON$$F$Y$10.3$KG$20240711$$MD$DE$DE
228618542$22861854$2$F$20221230$20240705$20230824$20240710$EXP$$DE-ABBVIE-5378205$ABBVIE$$33$YR$$M$Y$59$KG$20240710$$MD$DE$DE
228619012$22861901$2$F$$20230818$20230824$20240722$PER$$US-BAYER-2023A117597$BAYER$$$$A$F$Y$$$20240722$$MD$US$US
228621518$22862151$8$F$20230101$20240629$20230824$20240709$PER$$US-SA-2023SA254004$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240709$$MD$US$US
228621962$22862196$2$F$$20240910$20230824$20240913$PER$$US-BIOGEN-2022BI01131028$BIOGEN$$$$$M$Y$$$20240913$$CN$US$US
228622663$22862266$3$F$20220501$20240627$20230824$20240701$EXP$$US-PFIZER INC-US-GBT-018923$PFIZER$$13$YR$$M$Y$$$20240701$$CN$US$US
228623054$22862305$4$F$20230401$20240829$20230824$20240829$PER$$NVSC2023US184646$NOVARTIS$$49$YR$$F$Y$$$20240829$$CN$US$US
2286240311$22862403$11$F$$20240809$20230824$20240813$PER$$US-VERTEX PHARMACEUTICALS-2023-012500$VERTEX$$$$$F$Y$$$20240813$$CN$US$US
228624957$22862495$7$F$$20240912$20230824$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-117863$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240917$$HP$US$US
2286310513$22863105$13$F$20230416$20240904$20230824$20240911$EXP$$CA-GSK-CA2023AMR060743$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$HP$CA$CA
228631183$22863118$3$F$20231204$20240719$20230824$20240726$EXP$$US-GSK-US2023111988$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
228631323$22863132$3$F$20220425$20240813$20230824$20240819$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2018JPN152795$VIIV$$$$$$Y$$$20240819$$MD$JP$JP
228631514$22863151$4$F$20230718$20240624$20230824$20240701$EXP$$JP-009507513-2308JPN002377J$MERCK$$54$YR$$F$Y$$$20240701$$MD$JP$JP
228631652$22863165$2$F$20230601$20240813$20230824$20240826$PER$$US-SA-2023SA255270$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240826$$MD$US$US
228632803$22863280$3$F$20230701$20240820$20230824$20240829$PER$$US-SA-2023SA256861$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240829$$MD$US$US
228633134$22863313$4$F$20230101$20240916$20230824$20240922$PER$$US-SA-2023SA220085$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240922$$MD$US$US
228633462$22863346$2$F$20221019$20240903$20230824$20240910$EXP$$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2023-016234$VALIDUS$$$$$$Y$$$20240910$$PH$CA$CA
228634215$22863421$5$F$$20240607$20230824$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003269$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
228634744$22863474$4$F$$20240725$20230825$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017830$JAZZ$$$$$F$Y$$$20240730$$CN$US$US
228634909$22863490$9$F$20230101$20240813$20230825$20240821$EXP$$CA-CELLTRION INC.-2022CA021082$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
228635048$22863504$8$F$20240101$20240620$20230825$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003260$ACADIA PHARMACEUTICALS$$11$YR$$M$Y$$$20240712$$CN$US$US
228635222$22863522$2$F$$20240823$20230825$20240902$EXP$$CA-GALDERMA-CA2023012416$GALDERMA$$$$$$Y$$$20240902$$HP$CA$CA
228635238$22863523$8$F$20230820$20240701$20230825$20240710$PER$$US-SA-2023SA257503$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240710$$MD$US$US
2286356014$22863560$14$F$20230802$20240626$20230825$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003381$ACADIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240719$$CN$US$US
228637678$22863767$8$F$20231003$20240704$20230825$20240712$EXP$$CA-TAKEDA-2023TUS082373$TAKEDA$$51$YR$$M$Y$$$20240712$$CN$CA$CA
228637686$22863768$6$F$20230208$20240815$20230825$20240820$EXP$$CA-TAKEDA-2023TUS032724$TAKEDA$$13$YR$$M$Y$$$20240820$$CN$CA$CA
228637755$22863775$5$F$20230720$20240912$20230825$20240920$EXP$$CA-TAKEDA-2023TUS082535$TAKEDA$$45$YR$$F$Y$$$20240920$$CN$CA$CA
228638212$22863821$2$F$20170101$20240708$20230825$20240712$EXP$$NVSC2023US167731$NOVARTIS$$53$YR$$M$Y$87$KG$20240712$$HP$US$US
228638732$22863873$2$F$20230101$20240812$20230825$20240816$PER$$US-SA-2023SA258435$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240816$$MD$US$US
228638932$22863893$2$F$$20231212$20230825$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2022SP014820$STRIDES$Wiener BG, Smith CT, Patel S, Hoffman RS.. Insulin concentrations following termination of high-dose insulin euglycemic therapy.. Clin-Toxicol-(Phila). 2023;61:697-701$50$YR$$F$Y$$$20240826$$HP$US$US
2286397310$22863973$10$F$$20240614$20230825$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003282$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
228639779$22863977$9$F$$20240627$20230825$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003284$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
228641235$22864123$5$F$20230101$20240812$20230825$20240819$PER$$US-SA-2023SA259091$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240819$$MD$US$US
228641392$22864139$2$F$20230101$20240812$20230825$20240815$EXP$$US-ABBVIE-5380742$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
228641523$22864152$3$F$$20240826$20230825$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-119599$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240828$$CN$US$US
228641573$22864157$3$F$20230212$20240816$20230825$20240823$EXP$$US-BIOGEN-2023BI01204874$BIOGEN$$59$YR$$F$Y$$$20240823$$CN$US$US
228642172$22864217$2$F$20230807$20240626$20230825$20240702$EXP$$DE-ABBVIE-5381112$ABBVIE$$36$YR$$F$Y$63$KG$20240702$$MD$DE$DE
228643542$22864354$2$F$$20240731$20230825$20240807$EXP$$PT-TAKEDA-2023TUS078133$TAKEDA$Cabreira V, Ferreira D, Melo C, Rebelo J, Fonseca J, Sousa R, et al. Child neurology: anti-hu encephalitis in an adolescent with a mediastinal seminoma. Neurology. 2023;101:e1640-5$15$YR$$M$Y$$$20240807$$HP$PT$PT
228643966$22864396$6$F$20230805$20240912$20230825$20240921$EXP$$CN-ABBVIE-5380899$ABBVIE$$68$YR$$M$Y$78$KG$20240921$$MD$CN$CN
228645202$22864520$2$F$20230801$20240809$20230825$20240815$EXP$$US-ABBVIE-5381074$ABBVIE$$72$YR$$M$Y$$$20240815$$CN$US$US
2286454013$22864540$13$F$20230701$20240726$20230825$20240803$EXP$$CA-CELLTRION INC.-2023CA010958$CELLTRION$$$$$$Y$$$20240803$$MD$CA$CA
228646425$22864642$5$F$$20240715$20230825$20240719$EXP$$CA-GSK-CA2023AMR112545$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$MD$CA$CA
228646772$22864677$2$F$20230706$20240624$20230825$20240702$EXP$$JP-JAZZ PHARMACEUTICALS-2023-JP-017915$JAZZ$$31$YR$$F$Y$41.4$KG$20240702$$HP$JP$JP
228647057$22864705$7$F$$20240709$20230825$20240716$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2020186809$VIIV$$$$$$Y$$$20240716$$MD$CA$CA
228647137$22864713$7$F$20230101$20240705$20230825$20240709$EXP$$CA-JNJFOC-20230806885$JOHNSON AND JOHNSON$$12$YR$T$F$Y$61$KG$20240709$$HP$CA$CA
228647185$22864718$5$F$$20240626$20230825$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-119551$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$63.96$KG$20240701$$CN$US$US
2286477810$22864778$10$F$20230820$20240916$20230825$20240920$EXP$$US-TAKEDA-2023TUS071081$TAKEDA$$60$YR$$F$Y$$$20240920$$CN$US$US
228648082$22864808$2$F$$20240627$20230825$20240708$PER$$US-SA-2023SA254979$SANOFI AVENTIS$$$$E$M$Y$$$20240708$$MD$US$US
228649463$22864946$3$F$20230823$20240820$20230825$20240827$PER$$US-SA-2023SA259675$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240827$$MD$US$US
228651353$22865135$3$F$$20240809$20230825$20240812$EXP$$NVSC2023DE182112$NOVARTIS$Bergner CG, Schafer L, Vucinic V, Schetschorke B, Lier J, Scherlach C. Case report: Treatment of advanced CSF1-receptor associated leukoencephalopathy with hematopoietic stem cell transplant. FRONTIERS IN NEUROLOGY. 2023;14$42$YR$$M$Y$$$20240812$$HP$DE$DE
228653234$22865323$4$F$$20240814$20230825$20240904$PER$$AU-TOLMAR, INC.-23AU042412$TOLMAR$$$$$M$Y$$$20240904$$HP$AU$AU
228654627$22865462$7$F$20200423$20240820$20230825$20240823$EXP$$CA-TAKEDA-2021TUS079223$TAKEDA$$20$YR$$F$Y$100$KG$20240823$$CN$CA$CA
228656583$22865658$3$F$$20240904$20230825$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-118893$BRISTOL MYERS SQUIBB$Purt B, Nugent A, Wu P, Paulus YM. Subtenon triamcinolone-induced iatrogenic cushing^s syndrome with use of anti-HIV medications. Investigative Ophthalmology and Visual Science. 2023 Jun;64(8):4745.$82$YR$E$M$Y$$$20240917$$HP$US$US
228656774$22865677$4$F$$20240808$20230825$20240813$EXP$$NVSC2023US185241$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
228657344$22865734$4$F$$20240829$20230825$20240909$EXP$$CA-AUROBINDO-AUR-APL-2023-054748$AUROBINDO$Thulasirajah S, Wang X, Sell E, Davila J, Dyment DA, Kernohan KD.. A De Novo Missense Variant in TUBG2 in a Child with Global Developmental Delay, Microcephaly, Refractory Epilepsy and Perisylvian Polymicrogyria.. Genes-(Basel). 14:No. 1$3$YR$$M$Y$$$20240909$$HP$CA$CA
2286578914$22865789$14$F$20230701$20240610$20230825$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003255$ACADIA PHARMACEUTICALS$$34$YR$$F$Y$$$20240705$$CN$US$US
228659213$22865921$3$F$$20240916$20230825$20240920$EXP$$US-SA-2023SA258579$SANOFI AVENTIS$$$$E$M$Y$$$20240920$$MD$US$US
228659222$22865922$2$F$20220901$20240903$20230825$20240913$EXP$$CA-ASTELLAS-2023US025305$ASTELLAS$$60$YR$A$F$Y$64$KG$20240913$$HP$CA$CA
228659506$22865950$6$F$20231101$20240906$20230825$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-120001$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240913$$CN$US$US
228660418$22866041$8$F$20231002$20240822$20230825$20240828$EXP$$CO-TAKEDA-2023TUS061544$TAKEDA$$59$YR$$M$Y$84$KG$20240828$$CN$CO$CO
228660552$22866055$2$F$$20240819$20230825$20240819$PER$$NVSC2023US185287$NOVARTIS$$$$$M$Y$181.41$KG$20240819$$HP$US$US
228662682$22866268$2$F$$20240903$20230825$20240913$EXP$$CA-ASTELLAS-2023US025395$ASTELLAS$$2$YR$C$M$Y$$$20240913$$HP$CA$CA
228663723$22866372$3$F$$20240912$20230825$20240917$PER$$NVSC2023US179448$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
228665732$22866573$2$F$20230718$20240802$20230825$20240805$EXP$$US-ROCHE-3405977$ROCHE$$44$YR$A$F$Y$$$20240805$$CN$US$US
228668752$22866875$2$F$20230709$20240705$20230825$20240715$EXP$IT-MINISAL02-939155$IT-TEVA-2023-IT-2919746$TEVA$$2$YR$$F$Y$11$KG$20240715$$PH$IT$IT
228671044$22867104$4$F$20230801$20240822$20230825$20240906$PER$$US-SA-2023SA254830$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240906$$MD$US$US
228671346$22867134$6$F$$20240905$20230825$20240910$EXP$$US-ROCHE-3410682$ROCHE$$50$YR$A$F$Y$$$20240910$$CN$US$US
228671412$22867141$2$F$$20240820$20230825$20240829$30DAY$$US-GSK-US2023AMR111608$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
228672223$22867222$3$F$$20240829$20230825$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07075$LUPIN$$$$$$Y$$$20240911$$CN$US$US
228673243$22867324$3$F$20220828$20240830$20230825$20240905$EXP$$US-PFIZER INC-202300281723$PFIZER$$57$YR$$F$Y$61.23$KG$20240905$$CN$US$US
228673972$22867397$2$F$$20240822$20230825$20240827$EXP$$NL-MYLANLABS-2023M1088231$MYLAN$$$$A$F$Y$$$20240827$$CN$NL$NL
228679242$22867924$2$F$20230301$20240717$20230825$20240723$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-003322$JAZZ$$69$YR$$F$Y$$$20240723$$CN$US$US
228679303$22867930$3$F$20171012$20240827$20230825$20240830$PER$$US-BIOGEN-2023BI01222797$BIOGEN$$14$YR$$M$Y$$$20240830$$CN$US$US
228679574$22867957$4$F$$20240829$20230825$20240906$EXP$$CA-MYLANLABS-2023M1089041$BIOCON$$$$$$Y$$$20240906$$CN$CA$CA
228680662$22868066$2$F$$20240711$20230825$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-120186$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$97$KG$20240722$$MD$CA$CA
228681603$22868160$3$F$$20240701$20230825$20240703$EXP$$NVSC2023DE184833$NOVARTIS$$28$YR$$M$Y$$$20240703$$MD$DE$DE
228681877$22868187$7$F$20230101$20240919$20230825$20240927$EXP$$NL-ABBVIE-5380855$ABBVIE$$$$E$F$Y$$$20240927$$CN$NL$NL
228682544$22868254$4$F$20230101$20240712$20230825$20240722$PER$$US-CYCLE PHARMACEUTICALS LTD-2023-CYC-000059$Unknown Manufacturer$$$$$$Y$$$20240722$$CN$US$US
228684072$22868407$2$F$$20240701$20230825$20240709$EXP$$AR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405925$RANBAXY$Gerde  M, Ibarra E, Mac Kenzie R, Fernandez Suarez C, Heer C, Alvarez R et al. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Thromb Res. 2021;206:104-110$$$A$F$Y$$$20240709$$HP$AR$AR
228685016$22868501$6$F$$20240923$20230825$20240926$EXP$$CA-PFIZER INC-202300205665$PFIZER$$53$YR$$M$Y$$$20240926$$HP$CA$CA
228685423$22868542$3$F$20230701$20240726$20230825$20240730$PER$$US-INCYTE CORPORATION-2023IN008778$INCYTE$$$$$$Y$$$20240730$$CN$US$US
228685446$22868544$6$F$$20240625$20230825$20240703$EXP$$CA-MYLANLABS-2023M1088047$MYLAN$$$$$F$Y$$$20240703$$HP$CA$CA
228687322$22868732$2$F$$20240717$20230825$20240718$PER$$US-PFIZER INC-202300214220$PFIZER$$84$YR$$F$Y$$$20240718$$CN$US$US
228688945$22868894$5$F$$20240829$20230825$20240904$PER$$US-PFIZER INC-PV202300145040$PFIZER$$78$YR$$M$Y$$$20240904$$CN$US$US
228689075$22868907$5$F$20230801$20240905$20230825$20240909$PER$$US-PFIZER INC-202300284578$PFIZER$$79$YR$$M$Y$97.506$KG$20240909$$CN$US$US
228689084$22868908$4$F$20230816$20240805$20230825$20240808$PER$$US-PFIZER INC-202300284488$PFIZER$$12$YR$$M$Y$43.54$KG$20240808$$CN$US$US
228689113$22868911$3$F$20230818$20240826$20230825$20240829$PER$$US-PFIZER INC-202300283712$PFIZER$$76$YR$$F$Y$76.2$KG$20240829$$CN$US$US
228689334$22868933$4$F$$20240924$20230825$20240926$PER$$US-PFIZER INC-202300260810$PFIZER$$18$YR$$F$Y$$$20240926$$CN$US$US
228690923$22869092$3$F$$20240708$20230825$20240710$PER$$NVSC2023US185524$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
228691622$22869162$2$F$20230814$20230815$20230826$20240801$EXP$$US-GLENMARK PHARMACEUTICALS-2023GMK084349$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
228692466$22869246$6$F$$20240705$20230826$20240708$PER$$NVSC2023US185081$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
228695493$22869549$3$F$$20240812$20230826$20240823$EXP$$CA-AUROBINDO-AUR-APL-2023-054787$AUROBINDO$$32$YR$$F$Y$$$20240823$$HP$CA$CA
228696183$22869618$3$F$$20240827$20230826$20240903$EXP$$CA-AUROBINDO-AUR-APL-2023-006289$AUROBINDO$Sharma V.. Treatment of Depression in a Patient With Intractable Hyperemesis Gravidarum. Prim-Care-Comp-CNS-Disorders. 2021;23(6):20cr02905$26$YR$$F$Y$$$20240903$$MD$CA$CA
228696733$22869673$3$F$20230801$20240729$20230828$20240807$PER$$US-SA-2023SA256904$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240807$$MD$US$US
228696833$22869683$3$F$$20240715$20230826$20240725$EXP$$US-AUROBINDO-AUR-APL-2023-054246$AUROBINDO$Herzberg SD, Bosso AM, Sangal NR, Bosso JV.. Eosinophilic Granulomatosis with Polyangiitis Presenting as Aspirin Exacerbated Respiratory Disease. Annals of allergy, asthma + immunology : official publication of the American Co. 2023;1-2$$$A$F$Y$$$20240725$$MD$US$US
2286981813$22869818$13$F$20230101$20240903$20230826$20240911$EXP$$US-UNITED THERAPEUTICS-UNT-2023-024038$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240911$$$US$US
228698282$22869828$2$F$$20240828$20230826$20240829$EXP$$NVSC2023US185909$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
228698853$22869885$3$F$20230721$20240705$20230826$20240715$EXP$IT-MINISAL02-939160$IT-TEVA-2023-IT-2920343$TEVA$$18$YR$$F$Y$43$KG$20240715$$PH$IT$IT
228699312$22869931$2$F$20230430$20240829$20230828$20240902$EXP$$SG-AstraZeneca-2023A193840$ASTRAZENECA$$23656$DY$$$Y$$$20240902$$CN$SG$
228699342$22869934$2$F$20230823$20240730$20230828$20240808$PER$$US-SA-2023SA260994$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240809$$MD$US$US
228699472$22869947$2$F$20230801$20240821$20230826$20240905$PER$$US-SA-2023SA259262$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240905$$MD$US$US
228699806$22869980$6$F$$20240819$20230826$20240826$EXP$$US-TAKEDA-2022TUS041805$TAKEDA$$$$$F$Y$83$KG$20240826$$HP$US$US
228700664$22870066$4$F$$20240815$20230827$20240827$PER$$US-SA-2023SA259450$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
228700853$22870085$3$F$$20240815$20230827$20240829$EXP$$US-AUROBINDO-AUR-APL-2023-054253$AUROBINDO$Boyd FA, O^Leary MF, Benson K, Baluch A. A Case of Fatal Clostridium perfringens Sepsis with Massive Hemolysis in the Setting of a Coincidental Platelet Transfusion. Lab Medicine. 2023;54(4):E108-10$62$YR$$F$Y$$$20240829$$MD$US$US
228701062$22870106$2$F$$20240904$20230827$20240915$EXP$$CA-AUROBINDO-AUR-APL-2023-055060$AUROBINDO$Awara MA, Downing LM, Elnenaei MO.. Psychiatric  sequelae of thromboangiitis obliterans: a case report  and review of the literature. [Review]. J-Med-Case-Rep. 2023;17(1):40$29$YR$$F$Y$$$20240915$$HP$CA$CA
228701422$22870142$2$F$20220901$20240807$20230827$20240816$PER$$US-SA-2023SA257993$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240816$$MD$US$US
228701902$22870190$2$F$$20240815$20230827$20240828$EXP$$CA-AUROBINDO-AUR-APL-2023-055139$AUROBINDO$$31$YR$$M$Y$$$20240828$$MD$CA$CA
228702075$22870207$5$F$20230101$20240913$20230828$20240923$PER$$US-SA-2023SA258425$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240923$$MD$US$US
228703283$22870328$3$F$20230101$20240918$20230827$20240927$PER$$US-SA-2023SA255158$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240927$$MD$US$US
228704892$22870489$2$F$$20240812$20230827$20240820$EXP$$GB-AMGEN-GBRNI2023141723$AMGEN$$$$A$F$Y$$$20240819$$CN$GB$GB
228707072$22870707$2$F$$20240701$20230828$20240708$PER$$US-SA-2023SA258407$SANOFI AVENTIS$$$$E$M$Y$88$KG$20240708$$MD$US$US
228707705$22870770$5$F$20230801$20240102$20230828$20240925$EXP$$US-GSK-US2023AMR115131$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
228711428$22871142$8$F$20230810$20240911$20230828$20240917$EXP$$US-TAKEDA-2023TUS000282$TAKEDA$$70$YR$$F$Y$62.1$KG$20240917$$HP$US$US
228712702$22871270$2$F$$20240710$20230828$20240717$PER$$NVSC2023US186260$NOVARTIS$$$$$F$Y$61$KG$20240717$$HP$US$US
228713253$22871325$3$F$$20240809$20230828$20240814$EXP$$DE-SANDOZ INC.-SDZ2023DE018816$SANDOZ$$42$YR$$M$Y$$$20240814$$HP$DE$DE
228715165$22871516$5$F$20230804$20240820$20230828$20240823$EXP$$BR-JNJFOC-20230857215$JOHNSON AND JOHNSON$$77$YR$E$F$Y$89$KG$20240823$$CN$BR$BR
228715264$22871526$4$F$20190424$20240904$20230828$20240906$EXP$$CA-TAKEDA-2019TUS023192$TAKEDA$$26$YR$$M$Y$$$20240906$$MD$CA$CA
228716883$22871688$3$F$$20240726$20230828$20240808$EXP$$PT-AUROBINDO-AUR-APL-2023-054881$AUROBINDO$Cabreira V, Ferreira D, Melo C, Rebelo J, Fonseca J, Sousa R, et al.. Child Neurology: Anti-Hu Encephalitis in an Adolescent With a Mediastinal Seminoma.. Neurology. 2023;101:e1640-e1645$15$YR$$M$Y$$$20240808$$MD$PT$PT
228717463$22871746$3$F$20230818$20240919$20230828$20240923$EXP$$US-ABBVIE-5383417$ABBVIE$$67$YR$$F$Y$90$KG$20240923$$CN$US$US
228720893$22872089$3$F$$20240904$20230828$20240909$EXP$$CA-TAKEDA-2022TUS049242$TAKEDA$$$$$M$Y$$$20240909$$CN$CA$CA
228721003$22872100$3$F$$20240705$20230828$20240717$EXP$$CA-Accord-369211$ACCORD$Balgobin S, Lemaire M, Noone D, Christoph L. A case of topiramate-associated hypokalemia in a with as yet undiagnosed Gitelman syndrome. Pediatric Nephrology. 2023;38(7):2413. DOI: 10.1007/s00467-022-05865-y.$19$MON$I$M$Y$$$20240717$$MD$CA$CA
228721344$22872134$4$F$20221104$20240702$20230828$20240704$EXP$$JP-TAKEDA-2023TJP011031$TAKEDA$$35$YR$$F$Y$54$KG$20240704$$MD$JP$JP
228721588$22872158$8$F$20230817$20240617$20230828$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003303$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240712$$CN$US$US
228721732$22872173$2$F$$20240904$20230828$20240911$EXP$$US-ROCHE-3411896$ROCHE$$$$E$F$Y$$$20240911$$CN$US$US
228721793$22872179$3$F$$20240802$20230828$20240812$EXP$$CA-BAXTER-2023BAX029095$BAXTER$$59$YR$$F$Y$$$20240812$$HP$CA$CA
228721814$22872181$4$F$$20240802$20230828$20240813$EXP$$CA-BAXTER-2023BAX029098$BAXTER$$53$YR$$F$Y$$$20240813$$HP$CA$CA
228721834$22872183$4$F$$20240802$20230828$20240812$EXP$$CA-BAXTER-2023BAX029096$BAXTER$$62$YR$$F$Y$$$20240812$$HP$CA$CA
228722832$22872283$2$F$$20240731$20230828$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07113$LUPIN$$$$$$Y$$$20240820$$CN$US$US
228723853$22872385$3$F$$20240913$20230828$20240916$PER$$US-PFIZER INC-2019396894$PFIZER$$71$YR$$F$Y$$$20240916$$CN$US$US
228724065$22872406$5$F$20170601$20240923$20230828$20240930$EXP$$CA-ROCHE-1806090$ROCHE$$40$YR$A$F$Y$88$KG$20240930$$MD$CA$CA
228724395$22872439$5$F$$20240715$20230828$20240717$PER$$US-PFIZER INC-PV202300145599$PFIZER$$82$YR$$F$Y$$$20240717$$CN$US$US
228724446$22872444$6$F$20230101$20240705$20230828$20240712$PER$$US-PFIZER INC-202300285483$PFIZER$$50$YR$$F$Y$$$20240712$$CN$US$US
228725672$22872567$2$F$20230501$20240801$20230828$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000785$DECIPHERA PHARMACEUTICALS$$84$YR$E$F$Y$$$20240806$$CN$US$US
228727835$22872783$5$F$$20240917$20230828$20240919$EXP$$CA-PURDUE-USA-2023-0304340$PURDUE$$75$YR$$F$Y$$$20240919$$CN$CA$CA
228728584$22872858$4$F$$20240727$20230828$20240729$PER$$US-PFIZER INC-202300269718$PFIZER$$16$YR$$M$Y$$$20240729$$CN$US$US
2287293214$22872932$14$F$20230101$20240904$20230828$20240916$EXP$$US-UCBSA-2023022612$UCB$$$$$F$Y$55$KG$20240916$$CN$US$US
2287296011$22872960$11$F$20230101$20240905$20230828$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2023-020934$UNITED THERAPEUTICS$$$$$F$Y$$$20240913$$$US$US
228730373$22873037$3$F$20230701$20240916$20230828$20240921$EXP$$US-ABBVIE-5383374$ABBVIE$$58$YR$$M$Y$90.718$KG$20240921$$CN$US$US
228731264$22873126$4$F$20230804$20240726$20230828$20240731$EXP$$JP-009507513-2308JPN000946J$MERCK$$64$YR$$M$Y$$$20240731$$MD$JP$JP
228731574$22873157$4$F$20240101$20240715$20230828$20240717$EXP$$US-UCBSA-2023042078$UCB$$$$$F$Y$141.04$KG$20240717$$HP$US$US
228733866$22873386$6$F$20230822$20240723$20230828$20240726$EXP$$GB-MYLANLABS-2023M1089072$MYLAN$$53$YR$$M$Y$$$20240726$$CN$GB$GB
228734062$22873406$2$F$$20240802$20230828$20240808$EXP$$CA-UCBSA-2023001206$UCB$$$$$F$Y$$$20240808$$CN$CA$CA
228734163$22873416$3$F$20230811$20240917$20230828$20240923$PER$$US-VIIV HEALTHCARE LIMITED-US2023112686$VIIV$$61$YR$$F$Y$$$20240923$$MD$US$US
228734305$22873430$5$F$20230801$20240821$20230828$20240905$PER$$US-SA-2023SA254838$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240905$$MD$US$US
228734645$22873464$5$F$20231101$20240808$20230828$20240820$EXP$$US-SA-2023SA258398$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240820$$MD$US$US
228735912$22873591$2$F$20230101$20240820$20230828$20240827$EXP$$US-ABBVIE-5184158$ABBVIE$$$$$F$Y$71.213$KG$20240827$$MD$US$US
228738452$22873845$2$F$20230421$20240717$20230828$20240723$EXP$$US-TAKEDA-2023TUS007786$TAKEDA$$39$YR$$M$Y$$$20240723$$CN$US$US
228738513$22873851$3$F$20230101$20240701$20230828$20240705$EXP$$JP-JAZZ PHARMACEUTICALS-2023-JP-018120$JAZZ$$52$YR$$M$Y$49.2$KG$20240705$$MD$JP$JP
228741205$22874120$5$F$$20240904$20230828$20240911$EXP$$IE-TAKEDA-2023TUS082977$TAKEDA$$$$$F$Y$$$20240911$$CN$IE$IE
228741515$22874151$5$F$20140901$20240617$20230828$20240710$EXP$$US-TEVA-2023-US-2921717$TEVA$$48$YR$$F$Y$$$20240710$$CN$US$US
228744223$22874422$3$F$20240812$20240903$20230828$20240906$EXP$$CO-LUNDBECK-DKLU3066875$LUNDBECK$$$$$$Y$$$20240906$$CN$CO$CO
228745702$22874570$2$F$$20240822$20230828$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-117736$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240829$$MD$JP$JP
228746793$22874679$3$F$20220405$20240912$20230828$20240924$EXP$$CA-INTERCEPT-PM2022000511$INTERCEPT PHARMACEUTICALS$$77$YR$$F$Y$$$20240924$$CN$CA$CA
228753832$22875383$2$F$20230701$20240914$20230829$20240923$PER$$US-SA-2023SA260744$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240923$$MD$US$US
228753953$22875395$3$F$$20240710$20230829$20240723$EXP$JP-STRIDES ARCOLAB LIMITED-2023SP013390$JP-STRIDES ARCOLAB LIMITED-2023SP013390$STRIDES$Tanaka Y, Yamamoto M, Nozu K, Hara S. An 8-month-old boy with infantile nephrotic syndrome caused by semaphorin 3B-associated membranous nephropathy. CEN Case Reports. 2023;12(3):281-286.$8$MON$$M$Y$$$20240723$$MD$JP$JP
228754212$22875421$2$F$$20240819$20230829$20240827$EXP$$ES-STRIDES ARCOLAB LIMITED-2023SP013519$STRIDES$Soto-Sierra M, Caro-Magdaleno M, Espejo-Arjona F, Toyos-Saenz FJ, Rodriguez-Calvo-de-Mora M, Rodriguez-de-la-Rua E. Conjunctival Inflammation and Panuveitis as Manifestations of Ig-G4-Related Disease: A Case Report. Ocul Immunol Inflamm. 2023;32 (5):1-3$75$YR$$F$Y$$$20240827$$HP$ES$ES
228754514$22875451$4$F$20231221$20240730$20230829$20240822$PER$$AU-TOLMAR, INC.-23AU042484$TOLMAR$$85$YR$$M$Y$$$20240822$$CN$AU$AU
228754687$22875468$7$F$20230801$20240221$20230829$20240925$PER$$US-GSK-US2023AMR115893$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240925$$CN$US$US
228755502$22875550$2$F$$20240801$20230829$20240810$EXP$$BR-CELLTRION INC.-2023BR001093$CELLTRION$$$$$$Y$$$20240810$$CN$BR$BR
228755562$22875556$2$F$20230315$20240905$20230829$20240910$EXP$$JP-AstraZeneca-2023A194532$ASTRAZENECA$Hiraoka R, et al.. 119 A case of lung cancer in which aplastic anemia developed during the use of osimertinib and was successfully treated with ciclosporin.. The Joint Meeting of the 132nd Kinki Branch Meeting of the Japanese Society for Tuberculosis and Nontuberculous Mycobasteriosis 2024;82:$72$YR$$M$Y$69$KG$20240910$$MD$JP$
228756152$22875615$2$F$$20240710$20230829$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390595$RANBAXY$Gandhi D, Oluwole OO, Caudell A, Salazar MN, Mohan P. Fatal Disseminated Adenovirus Infection in Renal Transplant Recipient. J AM Soc Nephrol. 2016;27:1023A; PUB519$61$YR$$F$Y$$$20240711$$HP$US$US
228756302$22875630$2$F$$20240710$20230829$20240711$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393772$RANBAXY$nada Y, Hattori S, Fujita Y, Amagai T.. A Cancer-Pain Analgesia as Prolonging Strategy of Surviving Time after Failure of Adjuvant Chemotherapy in Patient with Progressive Bone-Metastatic Hepatocellular Carcinoma. Case Rep Gastroenterol. 2022;16(2):394-399$$$$$Y$$$20240711$$HP$JP$JP
228756322$22875632$2$F$$20240705$20230829$20240708$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393810$RANBAXY$Fan L, Ma L. A rare case report: vaginal paraganglioma. Am J Transl Res. 2022;14(12):8773-8781$39$YR$$F$Y$$$20240708$$HP$CN$CN
228756642$22875664$2$F$20230824$20240918$20230829$20240923$PER$$US-AMGEN-USASP2023152114$AMGEN$$86$YR$E$F$Y$$$20240923$$HP$US$US
228756974$22875697$4$F$20230612$20240722$20230829$20240730$PER$$CA-TOLMAR, INC.-23CA042789$TOLMAR$$73$YR$$M$Y$$$20240730$$CN$CA$CA
228757733$22875773$3$F$20230821$20240710$20230829$20240717$PER$$US-SA-2023SA258174$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240717$$MD$US$US
228757822$22875782$2$F$20230601$20240625$20230829$20240704$PER$$US-SA-2023SA261305$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240704$$CN$US$US
228758188$22875818$8$F$20230208$20240822$20230829$20240829$EXP$$CA-TAKEDA-2023TUS015895$TAKEDA$$6$YR$$M$Y$$$20240829$$MD$CA$CA
228758762$22875876$2$F$$20240626$20230829$20240703$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-018035$JAZZ$$$$$F$Y$$$20240703$$HP$US$US
228758843$22875884$3$F$20230811$20240917$20230829$20240926$PER$$US-JNJFOC-20230863977$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240926$$MD$US$US
228759453$22875945$3$F$$20240904$20230829$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003354$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
228759567$22875956$7$F$20240601$20240607$20230829$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003365$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240701$$CN$US$US
228760693$22876069$3$F$$20240731$20230829$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07120$LUPIN$$$$$$Y$$$20240818$$CN$US$US
228761044$22876104$4$F$20230801$20240708$20230829$20240716$EXP$$JP-009507513-2308JPN003320J$MERCK$$5$DEC$$M$Y$$$20240716$$PH$JP$JP
228761794$22876179$4$F$20230501$20240722$20230829$20240730$EXP$$CA-CELLTRION INC.-2023CA012285$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
228762312$22876231$2$F$$20240812$20230829$20240819$EXP$$GB-GSK-GB2023EME115917$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$CN$GB$GB
228762322$22876232$2$F$$20240812$20230829$20240819$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2023EME115917$VIIV$$$$$$Y$$$20240819$$CN$GB$GB
2287625210$22876252$10$F$20230730$20240614$20230829$20240710$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003432$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$30$KG$20240710$$CN$US$US
228762538$22876253$8$F$$20240619$20230829$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003385$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
228762558$22876255$8$F$$20240624$20230829$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003348$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
2287625914$22876259$14$F$20230820$20240830$20230829$20240906$EXP$$JP-009507513-2308JPN002751J$MERCK$$51$YR$$F$Y$$$20240906$$MD$JP$JP
228762749$22876274$9$F$20190904$20240815$20230829$20240823$EXP$$CA-CELLTRION INC.-2021CA016359$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
228763354$22876335$4$F$$20230607$20230829$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003214$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228763633$22876363$3$F$20230724$20240828$20230829$20240904$EXP$$BR-GSK-BR2023AMR112802$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$BR$BR
228764625$22876462$5$F$$20230604$20230829$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003224$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228764832$22876483$2$F$20230701$20240823$20230829$20240828$EXP$$CA-Orion Corporation ORION PHARMA-23_00025364$ORION$$62$YR$A$M$Y$$$20240828$$MD$CA$
228765285$22876528$5$F$20230101$20240916$20230829$20240923$EXP$$US-ASTELLAS-2023US023749$ASTELLAS$$82$YR$E$M$Y$$$20240923$$CN$US$US
228765682$22876568$2$F$20230401$20230824$20230829$20240830$EXP$$SG-AstraZeneca-2023A194375$ASTRAZENECA$$82$YR$$$Y$$$20240830$$CN$SG$
228766684$22876668$4$F$20240101$20240915$20230829$20240919$EXP$$US-ABBVIE-5348675$ABBVIE$$$$$M$Y$72$KG$20240919$$CN$US$US
228767464$22876746$4$F$20230815$20240710$20230829$20240712$PER$$US-PFIZER INC-PV202300140385$PFIZER$$81$YR$$F$Y$82.54$KG$20240712$$CN$US$US
228767595$22876759$5$F$20160101$20240919$20230829$20240920$PER$$US-PFIZER INC-PV202300144846$PFIZER$$56$YR$$M$Y$$$20240920$$MD$US$US
228767664$22876766$4$F$$20240906$20230829$20240910$PER$$US-PFIZER INC-PV202300145496$PFIZER$$70$YR$$F$Y$102.06$KG$20240910$$MD$US$US
228767842$22876784$2$F$$20240626$20230829$20240702$PER$$US-PFIZER INC-PV202300144820$PFIZER$$52$YR$$F$Y$$$20240702$$MD$US$US
228768422$22876842$2$F$$20230704$20230829$20240806$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-358106$RANBAXY$$$$E$M$Y$$$20240806$$CN$US$US
228768512$22876851$2$F$$20230713$20230829$20240806$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-376816$RANBAXY$$$$E$M$Y$$$20240806$$HP$US$US
228768522$22876852$2$F$$20231107$20230829$20240806$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-380490$RANBAXY$$$$E$F$Y$$$20240806$$CN$US$US
228768582$22876858$2$F$20230101$20240118$20230829$20240806$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381720$RANBAXY$$74$YR$E$F$Y$$$20240806$$HP$US$US
228768782$22876878$2$F$$20230721$20230829$20240806$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-398383$RANBAXY$$$$E$M$Y$$$20240806$$HP$US$US
228769063$22876906$3$F$$20240828$20230829$20240905$EXP$$CA-APOTEX-2023AP012560$APOTEX$$78$YR$$F$Y$$$20240905$$HP$CA$CA
228769763$22876976$3$F$20240311$20240709$20230829$20240730$PER$$CA-TOLMAR, INC.-23CA042462$TOLMAR$$73$YR$$M$Y$$$20240730$$CN$CA$CA
228769833$22876983$3$F$20230712$20230914$20230829$20240717$EXP$$CA-ASTELLAS-2023US024255$ASTELLAS$$75$YR$$M$Y$$$20240717$$CN$CA$CA
228771182$22877118$2$F$20230815$20240806$20230829$20240816$PER$$US-SA-2023SA254753$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240816$$MD$US$US
228771623$22877162$3$F$$20240727$20230829$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07135$LUPIN$$$$$$Y$$$20240816$$CN$US$US
228771933$22877193$3$F$20240601$20240802$20230829$20240813$PER$$US-SA-2023SA259839$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240814$$MD$US$US
228772105$22877210$5$F$$20240627$20230829$20240708$PER$$US-SA-2023SA258348$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240708$$MD$US$US
228772392$22877239$2$F$$20240411$20230829$20240701$PER$$US-SA-2023SA259041$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240701$$MD$US$US
228772645$22877264$5$F$20230101$20240830$20230829$20240910$PER$$US-SA-2023SA257984$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240910$$MD$US$US
228772774$22877277$4$F$$20230607$20230829$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-004633$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228773572$22877357$2$F$20230802$20240911$20230829$20240918$PER$$US-SA-2023SA262265$SANOFI AVENTIS$$24$YR$A$F$Y$54.4$KG$20240918$$MD$US$US
228774224$22877422$4$F$$20240514$20230829$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-003345$ENDO$$$$A$M$Y$$$20240917$$CN$US$US
228774244$22877424$4$F$20120101$20230607$20230829$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003356$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228774494$22877449$4$F$20230101$20240626$20230829$20240705$PER$$US-SA-2023SA262014$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240705$$MD$US$US
228774853$22877485$3$F$$20230603$20230829$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003088$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228775264$22877526$4$F$20230728$20240624$20230829$20240706$PER$$US-SA-2023SA259800$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240706$$MD$US$US
228776004$22877600$4$F$20230101$20240826$20230829$20240903$EXP$$JP-009507513-2308JPN002752J$MERCK$$70$YR$$M$Y$$$20240903$$MD$JP$JP
228776985$22877698$5$F$$20230607$20230829$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003440$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228776996$22877699$6$F$20070601$20240220$20230829$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-003429$ENDO$$$$$M$Y$$$20240917$$CN$US$US
228777014$22877701$4$F$$20230607$20230829$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003426$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228778132$22877813$2$F$20190916$20240822$20230829$20240824$EXP$$US-TAKEDA-US201930618$TAKEDA$$40$YR$$F$Y$$$20240824$$MD$US$US
228778243$22877824$3$F$$20231219$20230829$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-003113$ENDO$$$$$M$Y$$$20240917$$CN$US$US
228778494$22877849$4$F$$20230603$20230829$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003123$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228778503$22877850$3$F$$20230607$20230829$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003145$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228778513$22877851$3$F$20050101$20230606$20230829$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003159$ENDO$$$$$M$Y$$$20240712$$CN$US$US
228778523$22877852$3$F$$20230606$20230829$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003160$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228778564$22877856$4$F$20210101$20230606$20230829$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003126$ENDO$$$$$F$Y$$$20240712$$CN$US$US
228778945$22877894$5$F$20230512$20240712$20230829$20240722$EXP$$JP-009507513-2308JPN003318J$MERCK$$8$DEC$$F$Y$$$20240722$$MD$JP$JP
228779062$22877906$2$F$20210601$20240705$20230829$20240712$EXP$$US-SA-2023SA261483$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240712$$MD$US$US
228779883$22877988$3$F$20230807$20240703$20230829$20240709$EXP$$US-TAKEDA-2023TUS083480$TAKEDA$$4$YR$$M$Y$$$20240709$$PH$US$US
228780752$22878075$2$F$$20240617$20230829$20240711$EXP$$CA-002147023-NVSC2022CA209785$Haleon PLC$$62$YR$$F$Y$$$20240710$$HP$CA$CA
228784015$22878401$5$F$20230101$20240912$20230829$20240920$EXP$$US-SA-2023SA262393$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240920$$MD$US$US
228785503$22878550$3$F$20211124$20240709$20230829$20240715$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-119273$BRISTOL MYERS SQUIBB$Sawada A, et al. A case vogt-koyanagi-harada disease-like uveitis caused by nivolumab administration. The 39th Annual Meeting of Japanese Society for Ocular Circulation. 2023;111.$9$DEC$E$F$Y$$$20240715$$MD$JP$JP
228786162$22878616$2$F$$20240729$20230829$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-121614$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240730$$CN$US$US
228788592$22878859$2$F$20230701$20230824$20230829$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202308015304$ELI LILLY AND CO$$$$A$F$Y$$$20240828$$CN$US$US
228788813$22878881$3$F$$20240731$20230829$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07143$LUPIN$$$$$$Y$$$20240820$$CN$US$US
228789853$22878985$3$F$$20240829$20230829$20240903$EXP$$JP-PFIZER INC-PV202300145516$PFIZER$Takiguchi, N.. A case of fulminant amoebic colitis during systemic chemotherapy for gastric cancer. Clinical Journal of Gastroenterology. 2023;16(5):689-92$65$YR$$M$Y$$$20240903$$HP$JP$JP
228790554$22879055$4$F$$20240701$20230829$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-121619$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240703$$CN$US$US
228791935$22879193$5$F$20230101$20240829$20230829$20240903$PER$$CA-PFIZER INC-202300275921$PFIZER$$54$YR$$M$Y$70.748$KG$20240903$$MD$CA$CA
228792494$22879249$4$F$$20231108$20230829$20240909$PER$$NVSC2023US185121$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
228792643$22879264$3$F$20230726$20240806$20230829$20240809$EXP$$JP-BAYER-2023A119664$BAYER$$31$YR$A$M$Y$58.1$KG$20240809$$MD$JP$JP
228792852$22879285$2$F$$20240910$20230829$20240913$EXP$$NVSC2023MX186822$NOVARTIS$$$$$F$Y$35$KG$20240913$$CN$MX$MX
228793243$22879324$3$F$20220101$20240829$20230829$20240903$PER$$US-BIOGEN-2023BI01223246$BIOGEN$$$$$F$Y$$$20240903$$CN$US$US
228793257$22879325$7$F$20240101$20240814$20230829$20240821$EXP$$CA-ROCHE-3412133$ROCHE$$60$YR$A$F$Y$$$20240821$$CN$CA$CA
228793386$22879338$6$F$$20240705$20230829$20240709$EXP$$NVSC2023US185048$NOVARTIS$$$$$F$Y$$$20240709$$HP$US$US
228794342$22879434$2$F$20240401$20240902$20230829$20240909$EXP$$US-ABBVIE-5385939$ABBVIE$$66$YR$$M$Y$$$20240909$$CN$US$US
228795624$22879562$4$F$$20240805$20230829$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-119913$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240812$$CN$US$US
2288020212$22880202$12$F$20211101$20240709$20230829$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-011531$JAZZ$$31$YR$$F$Y$$$20240717$$CN$US$US
228803792$22880379$2$F$$20240916$20230829$20240917$PER$$NVSC2023US187610$NOVARTIS$$$$$M$Y$$$20240917$$CN$US$US
228804114$22880411$4$F$20080101$20240731$20230829$20240806$EXP$$IL-ELI_LILLY_AND_COMPANY-IL202308014703$ELI LILLY AND CO$$71$YR$E$F$Y$90$KG$20240806$$CN$IL$IL
228805234$22880523$4$F$20230101$20240718$20230829$20240726$PER$$US-SA-2023SA258687$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240726$$MD$US$US
228806672$22880667$2$F$20240101$20240711$20230829$20240721$EXP$$US-ABBVIE-5315433$ABBVIE$$$$$F$Y$$$20240719$$MD$US$US
228807287$22880728$7$F$20230601$20240802$20230830$20240808$EXP$$CN-ABBVIE-5386579$ABBVIE$$16$YR$$M$Y$49$KG$20240808$$MD$CN$CN
228807757$22880775$7$F$20230817$20240802$20230830$20240806$EXP$$NVSC2023US187523$NOVARTIS$$41$YR$$F$Y$$$20240806$$CN$US$US
228808297$22880829$7$F$20230816$20240913$20230830$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-121875$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240916$$CN$US$US
228809123$22880912$3$F$$20240731$20230830$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07129$LUPIN$$$$$$Y$$$20240818$$CN$US$US
228809653$22880965$3$F$$20240731$20230830$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07150$LUPIN$$$$$$Y$$$20240820$$CN$US$US
228809923$22880992$3$F$$20240731$20230830$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07114$LUPIN$$$$$$Y$$$20240820$$CN$US$US
228810583$22881058$3$F$$20240731$20230830$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07166$LUPIN$$$$$$Y$$$20240820$$CN$US$US
228810899$22881089$9$F$20230601$20240903$20230830$20240905$EXP$$CA-ROCHE-3411724$ROCHE$$48$YR$A$F$Y$$$20240905$$MD$CA$CA
2288109011$22881090$11$F$20230401$20240731$20230830$20240802$EXP$$DE-ROCHE-3410933$ROCHE$$51$YR$A$F$Y$$$20240802$$MD$DE$DE
228811645$22881164$5$F$$20240828$20230830$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-119618$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240904$$MD$JP$JP
228811653$22881165$3$F$$20240830$20230830$20240902$PER$$NVSC2023US187332$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
228812292$22881229$2$F$$20240730$20230830$20240806$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-256929$BOEHRINGER INGELHEIM$STRINGER F, COOKE R, MACLSAAC RJ, TENG J. Lipid management in patients with type 2 diabetes and effects of gender-affirming therapy. St Vincent^s Hospital.$58$YR$A$F$Y$$$20240806$$HP$AU$AU
228812702$22881270$2$F$20230716$20230731$20230830$20240826$PER$$US-CIPLA LTD.-2023US04156$CIPLA$$$$$$Y$$$20240826$$CN$US$US
228813162$22881316$2$F$$20240712$20230830$20240722$PER$$US-SA-2023SA258555$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240721$$MD$US$US
228813262$22881326$2$F$20230821$20240823$20230830$20240905$PER$$US-SA-2023SA261415$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240905$$MD$US$US
228815784$22881578$4$F$20230314$20240924$20230830$20240926$EXP$$DE-ROCHE-3334522$ROCHE$$46$YR$A$F$Y$$$20240926$$CN$DE$DE
228816092$22881609$2$F$20230621$20230822$20230830$20240826$PER$$US-CIPLA LTD.-2023US03566$CIPLA$$$$$$Y$$$20240826$$CN$US$US
2288161012$22881610$12$F$20200912$20240722$20230830$20240730$EXP$$CA-CELLTRION INC.-2020CA028007$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
228816157$22881615$7$F$20230914$20240905$20230830$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-122183$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$75.75$KG$20240911$$CN$US$US
228817163$22881716$3$F$$20240826$20230830$20240902$EXP$$CA-ROCHE-3411704$ROCHE$$56$YR$A$F$Y$$$20240902$$HP$CA$CA
228817703$22881770$3$F$$20240816$20230830$20240816$PER$$NVSC2023US187870$NOVARTIS$$$$$M$Y$97.52$KG$20240816$$MD$US$US
228818648$22881864$8$F$20221130$20240710$20230830$20240716$EXP$$NVSC2022AR284492$NOVARTIS$$66$YR$$M$Y$$$20240716$$CN$AR$AR
228818923$22881892$3$F$$20240712$20230830$20240722$EXP$$FR-AUROBINDO-AUR-APL-2023-055269$AUROBINDO$Michel V, Mahlaoui N, Bougnoux ME, Garcia-Hermoso D, Lanternier F, Levy R. Prolonged Remission of Azole-Resistant Lung Aspergillosis with Olorofim, in an Adolescent with X-Linked Chronic Granulomatous Disease. Journal of Clinical Immunology. 2023;43(6):1170-1172$14$YR$$M$Y$$$20240722$$HP$FR$FR
228819222$22881922$2$F$20230101$20240820$20230830$20240830$PER$$US-SA-2023SA261683$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240830$$MD$US$US
228819514$22881951$4$F$20230801$20240702$20230830$20240718$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000335$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
228819709$22881970$9$F$20230101$20240731$20230830$20240805$EXP$$CA-SA-2023SA258151$SANOFI AVENTIS$$6$MON$I$F$Y$10$KG$20240805$$HP$CA$US
228819933$22881993$3$F$20230101$20240806$20230830$20240812$PER$$US-SA-2023SA261404$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240812$$MD$US$US
228821572$22882157$2$F$$20240808$20230830$20240809$EXP$$US-PFIZER INC-PV202300101757$PFIZER$$69$YR$$F$Y$$$20240809$$CN$US$US
228821772$22882177$2$F$$20240729$20230830$20240731$PER$$US-PFIZER INC-PV202300094943$PFIZER$$28$YR$$F$Y$$$20240731$$CN$US$US
228824552$22882455$2$F$20230512$20230825$20230830$20240830$EXP$$SG-AstraZeneca-2023A195596$ASTRAZENECA$$85$YR$$M$Y$$$20240830$$CN$SG$
2288250212$22882502$12$F$20230801$20240830$20230830$20240906$EXP$$US-GSK-US2023AMR114336$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240906$$CN$US$US
228825616$22882561$6$F$20240501$20240808$20230830$20240810$EXP$$NVSC2023US187744$NOVARTIS$$60$YR$$F$Y$$$20240810$$CN$US$US
228836462$22883646$2$F$20230101$20240902$20230830$20240916$EXP$$US-RIGEL PHARMACEUTICALS, INC.-2023OLU000040$RIGEL PHARMACEUTICALS$Kuykendall A., Arp C., Al Ali N., Sallman D., Padron E., Chan O., Xie Z., Walker A., Lancet J., Komrokji R.. MPN-525 Olutasidenib Demonstrates Promising Tolerability and Efficacy in IDH1-Mutated Accelerated/Blast Phase Myeloproliferative Neoplasms. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S437. doi:10.1016/S21252-2650(24)01442-3$$$$M$Y$$$20240916$$CN$US$US
228836484$22883648$4$F$$20240822$20230830$20240902$EXP$$CA-APOTEX-2023AP012618$APOTEX$$65$YR$$F$Y$$$20240902$$HP$CA$CA
228837622$22883762$2$F$20230820$20240805$20230830$20240809$EXP$$US-SA-2023SA262646$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240809$$CN$US$US
228839264$22883926$4$F$20220920$20240731$20230830$20240812$EXP$$AT-Accord-374907$ACCORD$Preiss M, Rabl U, Popper V, Watzal V, Treiber M, Ivkic D et al. Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine. Frontiers in Psychiatry. 2023;14:1204009.$34$YR$A$M$Y$$$20240812$$HP$AT$AT
228841383$22884138$3$F$20221201$20240808$20230830$20240814$EXP$$DE-MYLANLABS-2023M1090108$MYLAN$$$$E$M$Y$$$20240814$$CN$DE$DE
228841572$22884157$2$F$$20240730$20230830$20240801$EXP$$CA-ROCHE-3413525$ROCHE$$$$A$F$Y$$$20240801$$CN$CA$CA
228841723$22884172$3$F$20220717$20240628$20230830$20240701$EXP$$JP-DSJP-DSJ-2023-122704$DAIICHI$$90$YR$$M$Y$63.5$KG$20240702$$MD$JP$JP
228842185$22884218$5$F$20230703$20240307$20230830$20240813$EXP$$NVSC2023BR151238$NOVARTIS$$56$YR$$F$Y$$$20240813$$CN$BR$BR
2288422511$22884225$11$F$20230101$20240905$20230830$20240911$EXP$$NVSC2023BR153617$NOVARTIS$$$$$F$Y$$$20240911$$CN$BR$BR
228843232$22884323$2$F$20230801$20240724$20230830$20240725$EXP$$US-BAUSCH-BL-2023-012985$BAUSCH AND LOMB$$81$YR$$F$Y$$$20240725$$CN$US$US
228844104$22884410$4$F$$20240923$20230830$20240925$EXP$$CA-SANDOZ INC.-NVSC2022CA189759$SANDOZ$$$$$F$Y$$$20240925$$CN$CA$CA
228844523$22884452$3$F$20230809$20240624$20230830$20240703$PER$$US-SA-2023SA256192$SANOFI AVENTIS$$16$YR$T$F$Y$58.9$KG$20240703$$MD$US$US
2288449919$22884499$19$F$20230822$20240913$20230830$20240918$EXP$$CO-TAKEDA-2023TUS083893$TAKEDA$$0$YR$$M$Y$$$20240918$$CN$CO$CO
228845444$22884544$4$F$20230816$20240731$20230830$20240801$EXP$$US-PFIZER INC-PV202300146884$PFIZER$$75$YR$$F$Y$$$20240801$$CN$US$US
228845984$22884598$4$F$20230405$20240906$20230830$20240913$EXP$$DE-SANDOZ INC.-SDZ2023DE013888$SANDOZ$$$$E$F$Y$58.5$KG$20240913$$HP$DE$DE
228846504$22884650$4$F$$20240830$20230830$20240906$EXP$$US-SANDOZ INC.-NVSC2022US152298$SANDOZ$$$$$F$Y$87.075$KG$20240906$$CN$US$US
228849805$22884980$5$F$20230816$20240711$20230830$20240719$EXP$$JP-009507513-2308JPN003493J$MERCK$Tsuda M, Kinouchi S, Fukumori T, Tomita M, Horiguchi H. 4 An Autopsy Case of Pericarditis Developed and Death during Pembrolizumab + Axitinib Treatment for Metastatic Renal Cell Carcinoma. The 113rd Shikoku Branch Meeting of the Japanese Urological Association. 22$60$YR$$M$Y$70$KG$20240719$$MD$JP$JP
228852533$22885253$3$F$$20240923$20230831$20240925$EXP$$US-TAKEDA-US202028165$TAKEDA$$$$$F$Y$$$20240925$$HP$US$US
2288529011$22885290$11$F$20200218$20240910$20230831$20240919$EXP$$CA-CELLTRION INC.-2020CA018688$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
228852914$22885291$4$F$20240101$20240625$20230831$20240711$EXP$$US-ABBVIE-5388174$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
228853874$22885387$4$F$20230809$20240712$20230831$20240729$PER$$CA-TOLMAR, INC.-23CA042546$TOLMAR$$81$YR$$M$Y$$$20240729$$CN$CA$CA
228854854$22885485$4$F$$20240919$20230831$20240920$EXP$$DE-SANDOZ INC.-NVSC2021DE315868$SANDOZ$$80$YR$$M$Y$69$KG$20240920$$HP$DE$DE
228854953$22885495$3$F$20190101$20240725$20230831$20240802$EXP$$CO-TOLMAR, INC.-23CO042347$TOLMAR$$$$$M$Y$$$20240802$$CN$CO$CO
228861405$22886140$5$F$20211103$20240821$20230831$20240827$EXP$$CA-SANDOZ INC.-NVSC2022CA187129$SANDOZ$$78$YR$$F$Y$$$20240827$$CN$CA$CA
228861804$22886180$4$F$20240715$20240715$20230831$20240720$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-018198$JAZZ$$17$YR$$M$Y$29$KG$20240719$$HP$US$US
228861875$22886187$5$F$20230101$20240911$20230831$20240919$EXP$$AU-CELLTRION INC.-2023AU017076$CELLTRION$$$$$$Y$$$20240919$$MD$AU$AU
228862992$22886299$2$F$$20240830$20230831$20240903$EXP$$JP-009507513-2308JPN003571J$MERCK$Kono S, Hashimoto Y, Ohmatsu K, Kawanishi M, Kuribayashi S, Karasawa K, et al.. CASE REPORT-RADIOTHERAPY A long-term survival case of bladder cancer with distant metastases:abscopal effect of brain metastases after stereotactic radiotherapy with immune checkpoint blockade therapy to lung metastases. International Cancer Conference Journal. 2023;12(3):205-9$58$YR$$F$Y$$$20240903$$MD$JP$JP
228863143$22886314$3$F$$20240731$20230831$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07186$LUPIN$$$$$$Y$$$20240820$$CN$US$US
228863153$22886315$3$F$20230801$20240806$20230831$20240809$EXP$$US-ABBVIE-5388313$ABBVIE$$53$YR$$M$Y$$$20240809$$CN$US$US
228863486$22886348$6$F$20240201$20240828$20230831$20240904$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-018272$JAZZ$$2$YR$$F$Y$$$20240904$$HP$US$US
228863513$22886351$3$F$$20240817$20230831$20240824$EXP$$CA-TAKEDA-2023TUS042572$TAKEDA$$$$$F$Y$65.8$KG$20240824$$CN$CA$CA
228864183$22886418$3$F$$20240909$20230831$20240918$30DAY$$US-GSK-US2023113487$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
228864193$22886419$3$F$$20240731$20230831$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07197$LUPIN$$$$$$Y$$$20240818$$CN$US$US
228864754$22886475$4$F$$20240827$20230831$20240913$EXP$$US-SA-2023SA264440$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240913$$CN$US$US
228864995$22886499$5$F$$20240809$20230831$20240814$EXP$$TH-SANDOZ INC.-NVSC2022TH187521$SANDOZ$$$$$F$Y$$$20240814$$CN$TH$TH
228865654$22886565$4$F$20230812$20240718$20230831$20240729$EXP$$JP-ROCHE-3412899$ROCHE$Inoe , Sugamo K, Aruga T, Umeda S, Yamanaka H, Nakajima T. A case of serious irAE which occurred due to administration of atezolizumab as adjuvant therapy after surgery for lung cancer [Abstract number O9-6]. The 41st Annual Meeting of the Japanese Association for Chest Surgery. 2024;$74$YR$E$M$Y$48.75$KG$20240729$$MD$JP$JP
228866893$22886689$3$F$20230802$20240809$20230831$20240815$EXP$$US-BIOGEN-2023BI01223579$BIOGEN$$7$YR$$M$Y$38.5$KG$20240815$$MD$US$US
228867324$22886732$4$F$20230824$20240707$20230831$20240713$EXP$$AU-CELLTRION INC.-2023AU017073$CELLTRION$$$$$$Y$$$20240713$$MD$AU$AU
228868433$22886843$3$F$20220118$20240907$20230831$20240910$EXP$$EG-ROCHE-3017141$ROCHE$$33$YR$A$F$Y$40$KG$20240910$$CN$EG$EG
228868963$22886896$3$F$20200601$20240919$20230831$20240920$EXP$$DE-SANDOZ INC.-NVSC2021DE238788$SANDOZ$$80$YR$$M$Y$69$KG$20240920$$HP$DE$DE
228869446$22886944$6$F$20230816$20240923$20230831$20240925$EXP$$NVSC2023BR185029$NOVARTIS$$46$YR$$F$Y$80$KG$20240925$$CN$BR$BR
2288697311$22886973$11$F$20230101$20240909$20230831$20240921$EXP$$US-UCBSA-2023025189$UCB$$$$$F$Y$35.4$KG$20240921$$CN$US$US
228870023$22887002$3$F$20230101$20240816$20230831$20240830$PER$$US-SA-2023SA263751$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240830$$MD$US$US
228870172$22887017$2$F$20240101$20240916$20230831$20240930$PER$$US-SA-2023SA260734$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240930$$MD$US$US
228877474$22887747$4$F$20191001$20240916$20230831$20240925$EXP$$DE-ROCHE-2716836$ROCHE$$46$YR$A$F$Y$$$20240925$$CN$DE$DE
228877657$22887765$7$F$$20240722$20230831$20240802$EXP$$US-TAKEDA-2023TUS084022$TAKEDA$$$$$M$Y$$$20240802$$CN$US$US
228878134$22887813$4$F$$20240919$20230831$20240930$PER$$US-Ipsen Biopharmaceuticals, Inc.-2023-20620$IPSEN$$56$YR$A$M$Y$92$KG$20240930$$CN$US$US
228878144$22887814$4$F$$20240620$20230831$20240703$PER$$US-Ipsen Biopharmaceuticals, Inc.-2023-14566$IPSEN$$64$YR$A$M$Y$73.02$KG$20240703$$HP$US$US
228878237$22887823$7$F$20221120$20240903$20230831$20240911$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2023-14501$IPSEN$$87$YR$E$F$Y$68$KG$20240911$$CN$US$US
228878292$22887829$2$F$$20230828$20230831$20240710$PER$$RU-ROCHE-3413420$ROCHE$$$$A$M$Y$$$20240628$$MD$RU$RU
228878773$22887877$3$F$$20240720$20230831$20240725$PER$$US-Ipsen Biopharmaceuticals, Inc.-2023-20623$IPSEN$$63$YR$A$F$Y$128$KG$20240725$$MD$US$US
228881103$22888110$3$F$$20240712$20230831$20240720$EXP$$CA-ALCON LABORATORIES-ALC2020CA008441$ALCON$$36$YR$$F$Y$$$20240720$$HP$CA$CA
228881615$22888161$5$F$20230101$20240827$20230831$20240904$EXP$$CA-CELLTRION INC.-2023CA004025$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
228882012$22888201$2$F$20220101$20240905$20230831$20240912$EXP$$US-VERTEX PHARMACEUTICALS-2023-012834$VERTEX$$29$YR$$$Y$$$20240912$$CN$US$US
228882582$22888258$2$F$$20240830$20230831$20240830$PER$$NVSC2023US186340$NOVARTIS$$$$$$Y$$$20240830$$CN$US$US
228882634$22888263$4$F$20230101$20240709$20230831$20240715$EXP$$JP-009507513-2308JPN003722J$MERCK$$6$DEC$$F$Y$$$20240715$$MD$JP$JP
228883163$22888316$3$F$$20240829$20230831$20240902$EXP$$CA-PFIZER INC-202300285456$PFIZER$$60$YR$$M$Y$$$20240902$$HP$CA$CA
228883515$22888351$5$F$$20240823$20230831$20240829$EXP$$US-PFIZER INC-202300287229$PFIZER$$15$YR$$M$Y$$$20240829$$MD$US$US
228883852$22888385$2$F$20230101$20240829$20230831$20240909$PER$$US-SA-2023SA264711$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240909$$MD$US$US
228884224$22888422$4$F$$20240208$20230831$20240710$PER$$US-ROCHE-3411904$ROCHE$$2$YR$C$F$Y$12.9$KG$20240701$$CN$US$US
228884732$22888473$2$F$20220906$20240716$20230831$20240722$EXP$$CA-SANDOZ INC.-NVSC2022CA203089$SANDOZ$$45$YR$$F$Y$67.12$KG$20240722$$CN$CA$CA
228884822$22888482$2$F$20230701$20240822$20230831$20240827$EXP$$CA-PFIZER INC-202300284368$PFIZER$$62$YR$$M$Y$$$20240827$$MD$CA$CA
228884945$22888494$5$F$$20240916$20230831$20240920$EXP$$NVSC2023PT186560$NOVARTIS$$$$E$$Y$$$20240921$$HP$PT$PT
228884977$22888497$7$F$20230820$20240915$20230831$20240920$EXP$$IL-PFIZER INC-PV202300142969$PFIZER$$11$YR$$F$Y$$$20240920$$HP$IL$IL
228886782$22888678$2$F$20220101$20240805$20230831$20240813$PER$$US-SA-2023SA264556$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240814$$MD$US$US
228888082$22888808$2$F$$20230824$20230831$20240701$EXP$$FR-ROCHE-3411332$ROCHE$Souidi S, Loap P,  Laki F, Amessis M, Fourquet, A, Kirova, Y. Long-term efficacy and tolerance of a technique for postmastectomy electron beam radiation therapy of the unreconstructed chest wall and lymph node areas for nonmetastatic breast cancers. DOI:10.1016/j.canrad.2023.04.003. Cancer/Radiotherapie 2023;27 (5):362-9.$$$$$Y$$$20240701$$HP$FR$FR
228888904$22888890$4$F$$20240716$20230831$20240722$EXP$$HU-MYLANLABS-2023M1090371$MYLAN$Gausz FD, Pap R, Benak A, Miklos M, Horvath Z et al.. Invisible (ECG) trace: Cardiac, neurological or iatrogenic syncope?. Cardiologia Hungarica. 2023;53 (6):614-618$44$YR$$F$Y$$$20240722$$MD$HU$HU
228888995$22888899$5$F$20230828$20240715$20230831$20240717$PER$$NVSC2023US189160$NOVARTIS$$14$YR$$F$Y$$$20240717$$HP$US$US
228889815$22888981$5$F$20230801$20240806$20230831$20240811$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-122604$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240812$$MD$JP$JP
228890502$22889050$2$F$20230804$20240823$20230831$20240828$EXP$$US-ABBVIE-5388408$ABBVIE$$54$YR$$F$Y$$$20240828$$CN$US$US
228891075$22889107$5$F$20170704$20240802$20230831$20240807$EXP$$CA-TAKEDA-2023TUS084429$TAKEDA$$44$YR$$M$Y$$$20240807$$CN$CA$CA
228893522$22889352$2$F$$20240712$20230831$20240722$PER$$US-SA-2023SA261564$SANOFI AVENTIS$$13$YR$T$M$Y$61.2$KG$20240721$$MD$US$US
228894294$22889429$4$F$20230101$20240910$20230831$20240913$EXP$$CA-PFIZER INC-202300286854$PFIZER$$46$YR$$M$Y$$$20240913$$HP$CA$CA
228894434$22889443$4$F$20220523$20240827$20230831$20240828$EXP$$DE-SANDOZ INC.-SDZ2023DE020817$SANDOZ$$$$$F$Y$$$20240828$$HP$DE$DE
228897353$22889735$3$F$20220701$20240916$20230831$20240919$PER$$US-BIOGEN-2022BI01141563$BIOGEN$$59$YR$$F$Y$$$20240919$$CN$US$US
228898415$22889841$5$F$20230717$20240730$20230831$20240805$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-015270$JAZZ$$11$YR$$M$Y$$$20240804$$HP$US$US
228898542$22889854$2$F$$20240819$20230831$20240828$EXP$$ES-MYLANLABS-2023M1090368$MYLAN$Bellido-Cuellar S, Perez de la Fuente R, Lezana-Rosales JM, Sanchez-Calvin MT, Saiz-Diaz RA, Gonzalez de la Aleja J. Epilepsy and Autism spectrum disorder caused by a pathogenic variant in TNRC6B. Seizure: European Journal of Epilepsy. 2023;110:117-118$28$YR$$F$Y$$$20240828$$HP$ES$ES
228899094$22889909$4$F$20180803$20240821$20230831$20240827$EXP$$US-PFIZER INC-202300289105$PFIZER$$59$YR$$F$Y$$$20240827$$HP$US$US
228900304$22890030$4$F$$20240905$20230831$20240911$PER$$NVSC2023US188450$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
228900344$22890034$4$F$20230101$20240704$20230831$20240709$EXP$$NVSC2023CA100512$NOVARTIS$$43$YR$$M$Y$$$20240710$$CN$CA$CA
228900885$22890088$5$F$$20240906$20230831$20240910$EXP$$DE-PFIZER INC-202300285150$PFIZER$$$$$$Y$$$20240910$$CN$DE$DE
228901305$22890130$5$F$$20240828$20230831$20240905$PER$$US-Ipsen Biopharmaceuticals, Inc.-2023-14490$IPSEN$$34$YR$A$M$Y$85$KG$20240905$$CN$US$US
228901334$22890133$4$F$20190901$20240808$20230831$20240905$EXP$$CO-Ipsen Biopharmaceuticals, Inc.-2023-20052$IPSEN$$63$YR$A$F$Y$69$KG$20240905$$CN$CO$CO
228901453$22890145$3$F$$20240701$20230831$20240704$EXP$$CA-BAUSCH-BL-2023-013108$BAUSCH AND LOMB$$50$YR$$F$Y$133$KG$20240704$$HP$CA$CA
228902002$22890200$2$F$20230301$20230825$20230831$20240718$EXP$$US-Taiho Oncology Inc-2023-004420$TAIHO ONCOLOGY INC$$52$YR$A$F$Y$94.8$KG$20240718$$CN$US$US
228903287$22890328$7$F$20210101$20240821$20230831$20240827$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-006567$AMGEN$$59$YR$A$F$Y$72.599$KG$20240827$$MD$US$US
228903652$22890365$2$F$20230617$20240628$20230831$20240702$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-121873$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$83$KG$20240702$$MD$FR$FR
228904075$22890407$5$F$20230818$20240619$20230831$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003382$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240712$$CN$US$US
228905585$22890558$5$F$20231207$20240614$20230831$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003435$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240709$$CN$US$US
228905594$22890559$4$F$20230901$20240626$20230831$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003378$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240719$$CN$US$US
2289062311$22890623$11$F$20230101$20240802$20230901$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2023-022173$UNITED THERAPEUTICS$$$$$M$Y$77.098$KG$20240810$$$US$US
228906399$22890639$9$F$20230720$20240613$20230901$20240711$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003344$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240711$$CN$US$US
228906466$22890646$6$F$20230901$20240624$20230901$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003346$ACADIA PHARMACEUTICALS$$9$YR$$F$Y$$$20240718$$CN$US$US
228913474$22891347$4$F$$20240717$20230901$20240722$EXP$$CA-SANDOZ INC.-NVSC2022CA081115$SANDOZ$$$$$F$Y$$$20240722$$HP$CA$CA
228913582$22891358$2$F$$20240710$20230901$20240717$EXP$$US-SANDOZ INC.-NVSC2023US099480$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
228913637$22891363$7$F$20220311$20240716$20230901$20240722$EXP$$JP-TAKEDA-2023TJP005147$TAKEDA$$15$YR$$M$Y$31.4$KG$20240722$$CN$JP$JP
228913913$22891391$3$F$20230601$20240624$20230901$20240703$PER$$US-SA-2023SA262001$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240703$$MD$US$US
228915273$22891527$3$F$$20240731$20230901$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07222$LUPIN$$$$$$Y$$$20240820$$CN$US$US
228915872$22891587$2$F$$20240805$20230901$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07226$LUPIN$$$$$$Y$$$20240902$$CN$US$US
228916173$22891617$3$F$$20240822$20230901$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07228$LUPIN$$$$$$Y$$$20240909$$CN$US$US
228916512$22891651$2$F$20230824$20240722$20230901$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202308018117$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240724$$CN$US$US
228916868$22891686$8$F$20230803$20240827$20230901$20240906$EXP$$CA-SANDOZ INC.-NVSC2021CA213152$SANDOZ$$49$YR$$F$Y$$$20240906$$MD$CA$CA
228916953$22891695$3$F$20230101$20240829$20230901$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2023-019667$UNITED THERAPEUTICS$$$$$F$Y$82.54$KG$20240906$$$US$US
2289184812$22891848$12$F$20230101$20240918$20230901$20240927$EXP$$CA-CELLTRION INC.-2023CA007535$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
228919035$22891903$5$F$20230101$20240909$20230901$20240911$EXP$$US-TAKEDA-2023TUS037569$TAKEDA$$70$YR$$F$Y$$$20240911$$CN$US$US
228919052$22891905$2$F$20201021$20240729$20230901$20240801$EXP$$CA-SANDOZ INC.-NVSC2020CA286977$SANDOZ$$67$YR$$F$Y$$$20240801$$CN$CA$CA
228920582$22892058$2$F$20230813$20230830$20230901$20240906$EXP$IT-MINISAL02-942009$NVSC2023IT188009$NOVARTIS$$38$YR$$M$Y$$$20240906$$MD$IT$IT
228920876$22892087$6$F$20230907$20240912$20230901$20240920$EXP$$CA-TAKEDA-2023TUS014145$TAKEDA$$77$YR$$M$Y$$$20240920$$HP$CA$CA
2289217215$22892172$15$F$20230812$20240708$20230901$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003774$ACADIA PHARMACEUTICALS$$19$YR$$F$Y$$$20240716$$CN$US$US
228921766$22892176$6$F$20230911$20240909$20230901$20240917$EXP$$CA-TAKEDA-2023TUS058752$TAKEDA$$60$YR$$F$Y$$$20240917$$CN$CA$CA
228922472$22892247$2$F$$20240731$20230901$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07236$LUPIN$$$$$$Y$$$20240827$$CN$US$US
228922783$22892278$3$F$$20240701$20230901$20240708$EXP$$JP-GSK-JP2023JPN117486$GLAXOSMITHKLINE$Morimoto M, Sato S, Sawaki K, Otsuka S, Rikumaru M, Inagaki N. 1) A case of herpes zoster with suspected drug-induced renal impairment and encephalopathy due to valaciclovir. The 49th Oita Association for Acute Medicine. 21$$$$$Y$$$20240708$$HP$JP$JP
228923633$22892363$3$F$20230801$20240830$20230901$20240911$PER$$US-SA-2023SA261586$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240911$$MD$US$US
228924803$22892480$3$F$$20240819$20230901$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-123736$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240822$$HP$US$US
228925664$22892566$4$F$20140901$20240809$20230901$20240812$PER$$US-GILEAD-2023-0641875$GILEAD$$55$YR$A$M$Y$74.83$KG$20240812$$LW$US$US
228926425$22892642$5$F$$20231211$20230901$20240926$EXP$$US-GSK-US2023AMR118148$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
228926727$22892672$7$F$20230101$20240626$20230901$20240708$EXP$$DE-TAKEDA-2023TUS084844$TAKEDA$$8$DEC$$$Y$$$20240708$$HP$DE$DE
228932562$22893256$2$F$20230808$20240628$20230901$20240708$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-004300$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$FR$FR
228937112$22893711$2$F$$20230825$20230901$20240830$EXP$$SG-AstraZeneca-2023A195764$ASTRAZENECA$$66$YR$$M$Y$$$20240830$$HP$SG$
228939033$22893903$3$F$20230723$20240625$20230901$20240701$EXP$$CA-ABBVIE-5391092$ABBVIE$$74$YR$$$Y$$$20240701$$MD$CA$CA
228939102$22893910$2$F$$20240816$20230901$20240820$EXP$$CA-SANDOZ INC.-SDZ2023CA019951$SANDOZ$$$$$F$Y$$$20240820$$MD$CA$CA
228940322$22894032$2$F$20230401$20240124$20230901$20240830$PER$$US-PERRIGO-23US005004$PERRIGO$$$$$M$Y$$$20240830$$CN$US$US
228941172$22894117$2$F$$20240821$20230901$20240902$PER$$US-SA-2023SA259124$SANOFI AVENTIS$$$$E$F$Y$$$20240902$$MD$US$US
228941813$22894181$3$F$20210101$20240912$20230901$20240917$EXP$$CA-BAUSCH-BL-2021-012681$BAUSCH AND LOMB$$67$YR$$F$Y$113.5$KG$20240917$$CN$CA$CA
228942344$22894234$4$F$20240601$20240823$20230901$20240916$PER$$US-SA-2023SA260797$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240916$$MD$US$US
228943623$22894362$3$F$$20240731$20230901$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07231$LUPIN$$$$$$Y$$$20240820$$CN$US$US
228950222$22895022$2$F$$20240827$20230901$20240829$EXP$$CA-PFIZER INC-202300288242$PFIZER$$67$YR$$F$Y$$$20240829$$HP$CA$CA
228950372$22895037$2$F$$20240906$20230901$20240910$EXP$$NVSC2023US188386$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
228951095$22895109$5$F$20230101$20240715$20230901$20240729$EXP$$US-UCBSA-2023040050$UCB$$$$$F$Y$$$20240729$$CN$US$US
228951413$22895141$3$F$20220101$20240821$20230901$20240823$EXP$$NVSC2022CA199830$NOVARTIS$$78$YR$$F$Y$$$20240823$$MD$CA$CA
228951562$22895156$2$F$20230718$20240619$20230901$20240704$EXP$FR-AFSSAPS-AM2023000708$FR-TEVA-2023-FR-2921520$TEVA$$69$YR$$M$Y$66$KG$20240704$$PH$FR$FR
228952752$22895275$2$F$$20230807$20230901$20240711$PER$$ES-PFM-2023-04520$PIERRE FABRE MEDICAMENT$Kuzior A, Rios-Gomez C, Ojeda-Santana B, Leon-Durango RJd, Hernandez-Lazaro A, Arnas-Leon C et al. Post hoc ergo propter hoc? Not everything that happens after covid-19 is long covid. Or, the many masquerades of pheochromocytoma. Journal of Hypertension. 2023;41(Suppl 3):e191-2$57$YR$$F$Y$$$20240711$$HP$ES$ES
228953733$22895373$3$F$20230817$20240824$20230901$20240904$EXP$$HU-INCYTE CORPORATION-2023IN008919$INCYTE$$$$$$Y$$$20240904$$MD$HU$HU
228953753$22895375$3$F$$20240824$20230901$20240904$EXP$$HU-INCYTE CORPORATION-2023IN008917$INCYTE$$$$$$Y$$$20240904$$MD$HU$HU
228955242$22895524$2$F$$20240912$20230901$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406525$RANBAXY$Ueda Y, Tanaka T, Asakura S, Yano T. A case of classic Hodgkin lymphoma arising after remission of methotrexate-associated follicular lymphoma. J Clin Exp Hematop. 2023;-:1-4$66$YR$$M$Y$$$20240927$$HP$JP$JP
228955302$22895530$2$F$$20240628$20230901$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-405945$RANBAXY$$$$$$Y$$$20240712$$PH$GB$GB
228956312$22895631$2$F$$20240719$20230901$20240724$EXP$$DE-SANDOZ INC.-NVSC2023DE117187$SANDOZ$$$$E$F$Y$$$20240724$$HP$DE$DE
228957065$22895706$5$F$20230724$20240810$20230901$20240814$EXP$FR-AFSSAPS-AM2023000746$FR-BAUSCH-BL-2023-013210$BAUSCH AND LOMB$$78$YR$$M$Y$80$KG$20240814$$MD$FR$FR
228958443$22895844$3$F$$20240827$20230901$20240830$PER$$US-PFIZER INC-PV202300148563$PFIZER$$68$YR$$F$Y$$$20240830$$MD$US$US
228958762$22895876$2$F$$20240708$20230901$20240710$PER$$US-PFIZER INC-PV202300147230$PFIZER$$72$YR$$F$Y$$$20240710$$CN$US$US
228960452$22896045$2$F$$20230826$20230901$20240902$EXP$$NVSC2023US187221$NOVARTIS$Fatima R, Sidiki S, Sim JM, Altorok N. Secukinumab induced bullous pemphigoid in a patient with psoriatic arthritis. AMERICAN JOURNAL OF THERAPEUTICS. 2023;0:1-2$62$YR$$M$Y$$$20240902$$HP$US$US
228960763$22896076$3$F$$20240701$20230901$20240704$EXP$$CA-BAUSCH-BL-2023-013223$BAUSCH AND LOMB$$41$YR$$F$Y$133$KG$20240704$$HP$CA$CA
228962062$22896206$2$F$20190701$20240627$20230901$20240701$PER$$US-PFIZER INC-PV202300147163$PFIZER$$53$YR$$F$Y$$$20240701$$LW$US$US
228962232$22896223$2$F$$20240917$20230901$20240919$PER$$US-AMGEN-USASP2023152235$AMGEN$$$$$F$Y$$$20240919$$MD$US$US
228962387$22896238$7$F$20230227$20240926$20230901$20240930$PER$$US-PFIZER INC-PV202300148792$PFIZER$$57$YR$$F$Y$109.04$KG$20240930$$MD$US$US
228963726$22896372$6$F$$20240719$20230901$20240723$EXP$$US-PFIZER INC-202300287254$PFIZER$$40$YR$$M$Y$$$20240723$$CN$US$US
228963892$22896389$2$F$$20240718$20230901$20240719$EXP$$US-PFIZER INC-PV202300148613$PFIZER$$74$YR$$F$Y$$$20240719$$CN$US$US
228964252$22896425$2$F$$20240910$20230901$20240920$EXP$$CA-SANDOZ INC.-NVSC2022CA291950$SANDOZ$$59$YR$$M$Y$$$20240920$$HP$CA$CA
228964663$22896466$3$F$20230801$20240802$20230901$20240807$EXP$$US-PFIZER INC-PV202300148890$PFIZER$$66$YR$$M$Y$$$20240807$$CN$US$US
228965164$22896516$4$F$$20240910$20230901$20240917$EXP$$US-TAKEDA-2023TUS084707$TAKEDA$$$$$F$Y$$$20240917$$CN$US$US
228965282$22896528$2$F$$20240701$20230901$20240705$EXP$$AU-009507513-2308AUS010718$MERCK$Tam PCK, Daniel S, Lim J, Beligaswatte A. Pristinamycin-induced sideroblastic anaemia. J Antimicrob Chemother. 2023;78:2104?6$84$YR$$F$Y$$$20240705$$HP$AU$AU
228967863$22896786$3$F$20220101$20240702$20230901$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-018473$JAZZ$$$$$M$Y$$$20240708$$HP$US$US
228968783$22896878$3$F$$20240917$20230902$20240919$PER$$NVSC2023US190236$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
228968892$22896889$2$F$$20240422$20230902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2022GMK076417$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
228969026$22896902$6$F$20230811$20240703$20230902$20240711$EXP$$CA-CELLTRION INC.-2023CA016259$CELLTRION$$$$$$Y$$$20240711$$CN$CA$CA
228969462$22896946$2$F$20151101$20221202$20230902$20240920$EXP$$GB-SANDOZ INC.-NVSC2019GB105927$SANDOZ$$59$YR$$M$Y$62$KG$20240920$$MD$GB$GB
2289698514$22896985$14$F$20230101$20240713$20230902$20240722$EXP$$CA-CELLTRION INC.-2023CA010542$CELLTRION$$$$$$Y$$$20240722$$PH$CA$CA
228969929$22896992$9$F$20230810$20240915$20230902$20240918$EXP$$NVSC2022CA251372$NOVARTIS$$70$YR$$M$Y$$$20240918$$CN$CA$CA
228969972$22896997$2$F$$20240710$20230902$20240715$EXP$$US-SANDOZ INC.-SDZ2023US021808$SANDOZ$$$$$M$Y$$$20240715$$MD$US$US
228973692$22897369$2$F$20230101$20240829$20230902$20240913$PER$$US-SA-2023SA262161$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240913$$MD$US$US
228973815$22897381$5$F$20230101$20240712$20230902$20240718$EXP$$NVSC2023US187916$NOVARTIS$$15$YR$$M$Y$$$20240718$$CN$US$US
228974042$22897404$2$F$$20240828$20230902$20240909$EXP$$SE-Accord-376047$ACCORD$Krstic A, Rezayee F, Saft L, Hammarsjo A, Svenberg P, Barbany G.. Case Report: Whole genome sequencing identifies CCDC88C as a novel JAK2 fusion partner in pediatric T-cell acutelymphoblastic leukemia.. Front Pediatr. 2023;10:1082986:doi:10.3389/fped.2022.1082986$7$YR$C$M$Y$$$20240909$$HP$SE$SE
228975162$22897516$2$F$$20240830$20230902$20240913$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406425$RANBAXY$Hirakawa T, Tanimoto T, Hattori Y, Katsura R, Miyake S, Fujita S et al. Pseudomesotheliomatous Carcinoma of the Lung with Morphological Characteristics of Signet Ring Cell Carcinoma: An Autopsy Case Report. Intern Med. 2023;Aug 16:Online ahead of print$50$YR$$F$Y$$$20240913$$HP$JP$JP
228976456$22897645$6$F$20230101$20240829$20230902$20240912$PER$$US-SA-2023SA263337$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240912$$MD$US$US
228977463$22897746$3$F$$20240702$20230902$20240704$EXP$$CA-SANDOZ INC.-NVSC2022CA001388$SANDOZ$$$$$F$Y$$$20240704$$CN$CA$CA
228977592$22897759$2$F$20220701$20240801$20230902$20240816$EXP$$DE-SANDOZ INC.-SDZ2023DE021915$SANDOZ$$58$YR$$M$Y$$$20240816$$HP$DE$DE
228977912$22897791$2$F$$20240710$20230903$20240715$EXP$$US-SANDOZ INC.-SDZ2023US022022$SANDOZ$$$$$F$Y$$$20240715$$CN$US$US
228978187$22897818$7$F$20220601$20240821$20230903$20240829$EXP$$GB-SANDOZ INC.-NVSC2020GB022293$SANDOZ$$62$YR$$M$Y$$$20240829$$CN$GB$GB
228978203$22897820$3$F$$20240731$20230903$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07250$LUPIN$$$$$$Y$$$20240820$$CN$US$US
228978783$22897878$3$F$$20240731$20230903$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07282$LUPIN$$$$$$Y$$$20240818$$CN$US$US
228980043$22898004$3$F$$20240731$20230903$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07270$LUPIN$$$$$$Y$$$20240820$$CN$US$US
228981052$22898105$2$F$$20240710$20230903$20240722$EXP$$CA-APOTEX-2023AP012742$APOTEX$$51$YR$$F$Y$99$KG$20240722$$HP$CA$CA
228981062$22898106$2$F$20230821$20240822$20230903$20240905$PER$$US-SA-2023SA262975$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240905$$MD$US$US
228981373$22898137$3$F$$20240723$20230903$20240801$PER$$US-SA-2023SA265604$SANOFI AVENTIS$$4$YR$C$F$Y$19$KG$20240801$$HP$US$US
228981503$22898150$3$F$20240101$20240827$20230903$20240905$PER$$US-SA-2023SA265653$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240905$$MD$US$US
228982342$22898234$2$F$20230815$20240718$20230903$20240723$EXP$$US-ABBVIE-5390988$ABBVIE$$78$YR$$M$Y$$$20240723$$CN$US$US
228982653$22898265$3$F$20190704$20240716$20230903$20240724$EXP$$JP-ABBVIE-21P-087-3870943-00$ABBVIE$$66$YR$$M$Y$67$KG$20240724$$MD$JP$JP
228983335$22898333$5$F$$20240910$20230903$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-123969$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240912$$MD$US$US
228983388$22898338$8$F$20230331$20240417$20230903$20240725$EXP$$JP-SA-2023SA104311$SANOFI AVENTIS$$80$YR$E$M$Y$51$KG$20240726$$MD$JP$JP
228984452$22898445$2$F$$20240706$20230904$20240709$30DAY$$US-SANDOZ INC.-SDZ2023US022056$SANDOZ$$$$$$Y$$$20240709$$CN$US$US
228985768$22898576$8$F$20211101$20240813$20230904$20240820$EXP$$CA-CELLTRION INC.-2021CA015773$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
228986543$22898654$3$F$$20240731$20230904$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07296$LUPIN$$$$$$Y$$$20240827$$CN$US$US
228987725$22898772$5$F$20230101$20240827$20230904$20240909$PER$$US-SA-2023SA261727$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240909$$MD$US$US
228992672$22899267$2$F$$20240719$20230904$20240729$PER$$US-SA-2023SA265000$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240729$$MD$US$US
228992807$22899280$7$F$$20240621$20230904$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-123671$BRISTOL MYERS SQUIBB$Koizumi K, Kishikawa M, Ueno H, Nabeshima S, Etou E, Yoshimura T. A case of successful early therapy intervention for fulminant type 1 diabetes mellitus after use of nivolumab and ipilimumab. The 342nd Kyushu Regional Meeting of the Japanese Society of Internal Medicine. 2023;72.$63$YR$A$M$Y$$$20240702$$MD$JP$JP
228992814$22899281$4$F$20230811$20240716$20230904$20240805$PER$$CA-TOLMAR, INC.-23CA042588$TOLMAR$$76$YR$$M$Y$$$20240805$$CN$CA$CA
228993736$22899373$6$F$$20231031$20230904$20240926$EXP$$US-GSK-US2023AMR118396$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
228994174$22899417$4$F$20230101$20240629$20230904$20240708$PER$$US-SA-2023SA261472$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240708$$CN$US$US
2289945416$22899454$16$F$20240801$20240819$20230904$20240825$EXP$$IE-ABBVIE-5392617$ABBVIE$$$$E$M$Y$$$20240825$$CN$IE$IE
228994625$22899462$5$F$20160505$20240913$20230904$20240920$EXP$$CA-SANDOZ INC.-PHHY2017CA152629$SANDOZ$$27$YR$$F$Y$$$20240920$$CN$CA$CA
228994838$22899483$8$F$20231030$20240904$20230904$20240911$EXP$$US-GSK-US2023116239$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$HP$US$US
228995062$22899506$2$F$20230309$20240627$20230904$20240704$EXP$$CO-GSK-CO2023AMR115876$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$CO$CO
228995862$22899586$2$F$20230816$20240719$20230904$20240726$EXP$$AR-GSK-AR2023AMR115468$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$AR$AR
229002179$22900217$9$F$20230824$20240627$20230904$20240701$EXP$$NVSC2023US188993$NOVARTIS$$27$YR$$F$Y$104.2$KG$20240701$$CN$US$US
229002302$22900230$2$F$20240718$20240718$20230904$20240730$EXP$$AE-ROCHE-3268991$ROCHE$$40$YR$A$M$Y$$$20240730$$CN$AE$AE
229002543$22900254$3$F$20221206$20240724$20230904$20240729$EXP$$US-UCBSA-2023042924$UCB$$33$YR$$F$Y$78.607$KG$20240729$$HP$US$US
229002683$22900268$3$F$20230810$20240624$20230904$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003442$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240718$$CN$US$US
229002753$22900275$3$F$20120720$20240826$20230904$20240827$EXP$$DE-SANDOZ INC.-PHHY2013DE156345$SANDOZ$$28$YR$$M$Y$$$20240827$$MD$DE$DE
229003382$22900338$2$F$$20240806$20230904$20240812$EXP$$US-TAKEDA-2022TUS093693$TAKEDA$$$$$F$Y$$$20240812$$MD$US$US
229003864$22900386$4$F$$20240712$20230904$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-124055$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240715$$CN$US$US
229006507$22900650$7$F$20230601$20240807$20230904$20240814$EXP$$NVSC2023US190876$NOVARTIS$$71$YR$$M$Y$55.8$KG$20240815$$CN$US$US
229007062$22900706$2$F$20230825$20240624$20230904$20240703$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023116308$VIIV$$29$YR$$M$Y$$$20240703$$PH$US$US
229007204$22900720$4$F$20230826$20240911$20230904$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-123080$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240918$$CN$US$US
229007536$22900753$6$F$20240715$20240911$20230904$20240913$EXP$$CA-JAZZ-2022-CA-012206$JAZZ$$45$YR$$F$Y$$$20240913$$CN$CA$CA
229007834$22900783$4$F$20230301$20240911$20230904$20240925$EXP$$PT-SUNOVION-2023SUN001051$SUNOVION$$$$$$Y$$$20240925$$MD$KR$KR
229008224$22900822$4$F$$20240812$20230904$20240815$EXP$$CA-TAKEDA-2023TUS006632$TAKEDA$$$$$M$Y$$$20240815$$HP$CA$CA
229008525$22900852$5$F$20230401$20240819$20230904$20240827$EXP$$NVSC2023MX105456$NOVARTIS$$44$YR$$F$Y$64$KG$20240828$$CN$MX$MX
229008799$22900879$9$F$20240318$20240814$20230904$20240820$EXP$$CA-TAKEDA-2023TUS085404$TAKEDA$$70$YR$$M$Y$$$20240820$$MD$CA$CA
229009463$22900946$3$F$20230512$20240914$20230904$20240923$EXP$$FR-TAKEDA-2023TUS084902$TAKEDA$$54$YR$$M$Y$68$KG$20240923$$HP$FR$FR
229009484$22900948$4$F$20220323$20240628$20230904$20240703$EXP$$JP-ASTELLAS-2022JP005783$ASTELLAS$$79$YR$$M$Y$54$KG$20240703$$CN$JP$JP
229009492$22900949$2$F$20240615$20240830$20230904$20240905$EXP$$CA-Orion Corporation ORION PHARMA-23_00025455$ORION$$42$YR$A$M$Y$68.03$KG$20240905$$MD$CA$
229009622$22900962$2$F$20220401$20240912$20230904$20240913$EXP$FR-AFSSAPS-AN2023001084$FR-BIOVITRUM-2023-FR-014426$BIOVITRUM$$52$YR$$M$Y$72$KG$20240913$$PH$FR$FR
229009683$22900968$3$F$$20240813$20230904$20240819$PER$$NVSC2023US191070$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
229010153$22901015$3$F$20220101$20240821$20230904$20240822$EXP$$CA-SANDOZ INC.-NVSC2022CA199830$SANDOZ$$$$$F$Y$$$20240822$$MD$CA$CA
229010643$22901064$3$F$20240122$20240828$20230904$20240903$PER$$US-TAKEDA-2023TUS085285$TAKEDA$$43$YR$$M$Y$$$20240903$$HP$US$US
229010663$22901066$3$F$20230811$20230901$20230904$20240820$EXP$$IT-ABBVIE-5392308$ABBVIE$$75$YR$$F$Y$$$20240820$$MD$IT$IT
229011043$22901104$3$F$20230101$20240701$20230904$20240702$EXP$$US-UCBSA-2023029019$UCB$$$$$F$Y$$$20240702$$CN$US$US
229011555$22901155$5$F$$20240812$20230904$20240819$EXP$$CA-APOTEX-2023AP012729$APOTEX$$82$YR$$F$Y$$$20240819$$CN$CA$CA
229011593$22901159$3$F$$20240624$20230904$20240703$EXP$CA-MHPD-E2B_06422572$CA-Accord-375923$ACCORD$$61$YR$A$$Y$$$20240703$$HP$CA$CA
229011652$22901165$2$F$$20240812$20230904$20240820$EXP$FR-AFSSAPS-PV2023000738$FR-Accord-377168$ACCORD$$20$WK$I$M$Y$0.4564$KG$20240820$$MD$FR$FR
229011752$22901175$2$F$20230821$20240829$20230904$20240910$EXP$$US-Accord-376419$ACCORD$$23$YR$A$M$Y$$$20240910$$HP$US$US
229012357$22901235$7$F$20240226$20240907$20230904$20240911$EXP$$US-TAKEDA-2023TUS060615$TAKEDA$$54$YR$$F$Y$63.5$KG$20240911$$CN$US$US
229012372$22901237$2$F$20230501$20240813$20230904$20240816$EXP$$CA-TAKEDA-2023TUS063284$TAKEDA$$40$YR$$F$Y$$$20240816$$MD$CA$CA
229012704$22901270$4$F$20121108$20240801$20230904$20240816$EXP$$DE-SANDOZ INC.-PHHY2013DE156331$SANDOZ$$47$YR$$M$Y$$$20240816$$MD$DE$DE
229012713$22901271$3$F$$20240909$20230904$20240925$PER$$US-AMGEN-USASP2023154718$AMGEN$$74$YR$E$F$Y$$$20240925$$CN$US$US
2290135514$22901355$14$F$20221128$20240826$20230904$20240903$EXP$$CA-CELLTRION INC.-2022CA017636$CELLTRION$$$$$$Y$$$20240903$$MD$CA$CA
229014165$22901416$5$F$$20240724$20230904$20240730$EXP$$DE-ABBVIE-5390322$ABBVIE$$28$YR$$M$Y$$$20240730$$MD$DE$DE
229014373$22901437$3$F$$20240624$20230904$20240703$EXP$$KR-REGENERON PHARMACEUTICALS, INC.-2023-107655$REGENERON$MD. Min Chul Kim ; MD. Jae Hui Kim.. Efficacy of Injection Interval Shortening in Neovascular Age-related Macular Degeneration with Limited Response to Bimonthly Aflibercept.. Journal of the Korean Ophthalmological Society. 2023;64 (8):700-708$65$YR$$$Y$$$20240703$$MD$KR$KR
229015793$22901579$3$F$$20240925$20230904$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202308016658$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240930$$LW$US$US
229015982$22901598$2$F$$20240909$20230904$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07322$LUPIN$$$$$$Y$$$20240921$$CN$US$US
229016483$22901648$3$F$20230709$20240909$20230904$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07333$LUPIN$$$$$$Y$$$20240920$$PH$US$US
229018224$22901822$4$F$$20240917$20230904$20240925$EXP$$CA-ROCHE-3410147$ROCHE$$54$YR$A$F$Y$108$KG$20240925$$HP$CA$CA
229019474$22901947$4$F$20230101$20240808$20230904$20240819$PER$$US-SA-2023SA266599$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240819$$MD$US$US
229019742$22901974$2$F$20230829$20240715$20230904$20240723$PER$$US-SA-2023SA266371$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240723$$MD$US$US
229020513$22902051$3$F$20210830$20240921$20230904$20240927$EXP$$US-SA-2021SA303053$SANOFI AVENTIS$$67$YR$E$F$Y$105.8$KG$20240927$$HP$US$US
229021434$22902143$4$F$20230430$20240912$20230904$20240917$EXP$$DE-ROCHE-3415922$ROCHE$$33$YR$A$F$Y$99$KG$20240917$$MD$DE$DE
229021572$22902157$2$F$$20240618$20230904$20240702$EXP$001029011$CA-ICU MEDICAL, INC.-ICU2023CA00014$ICU MEDICAL$$$$$$Y$$$20240702$$HP$COUNTRY NOT SPECIFIED$CA
229021582$22902158$2$F$$20240618$20230904$20240702$EXP$E2B_06258426$CA-ICU MEDICAL, INC.-ICU2023CA00015$ICU MEDICAL$$$$$$Y$$$20240702$$MD$CA$CA
229022086$22902208$6$F$20230201$20240819$20230904$20240828$EXP$$JP-009507513-2303JPN001213J$MERCK$$72$YR$$M$Y$$$20240828$$MD$JP$JP
229022386$22902238$6$F$20230821$20240806$20230904$20240812$EXP$$CA-TAKEDA-2023TUS054961$TAKEDA$$72$YR$$F$Y$$$20240812$$CN$CA$CA
229022934$22902293$4$F$20201012$20240708$20230904$20240710$EXP$$US-UCBSA-2022064259$UCB$$2$YR$$M$Y$21.315$KG$20240710$$CN$US$US
229023558$22902355$8$F$20230101$20240812$20230904$20240813$EXP$$US-UCBSA-2023042956$UCB$$$$$F$Y$81.633$KG$20240813$$CN$US$US
229023692$22902369$2$F$20230831$20240626$20230904$20240704$PER$$US-ABBVIE-5393349$ABBVIE$$42$YR$$F$Y$$$20240704$$CN$US$US
229026008$22902600$8$F$$20240715$20230904$20240717$EXP$$US-TAKEDA-2023TUS080918$TAKEDA$$$$$F$Y$48$KG$20240717$$HP$US$US
229026663$22902666$3$F$$20240705$20230904$20240708$EXP$$DE-BAUSCH-BL-2023-013281$BAUSCH AND LOMB$$$$$M$Y$$$20240708$$CN$DE$DE
229026843$22902684$3$F$20230201$20240712$20230904$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-002929$JAZZ$$34$YR$$M$Y$$$20240722$$HP$US$US
229027093$22902709$3$F$20230101$20240802$20230904$20240808$PER$$US-ABBVIE-5392347$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
229028472$22902847$2$F$$20240710$20230904$20240715$EXP$$US-SANDOZ INC.-SDZ2023US022554$SANDOZ$$$$$F$Y$$$20240715$$MD$US$US
229028542$22902854$2$F$$20230831$20230904$20240920$EXP$$US-SANDOZ INC.-SDZ2023US015508$SANDOZ$Trail, Allison, Rogers, Jane, Ajani, Jaffer. Can You Establish the Cause ofThis Patient?s Shortness of Breath?. 2023;version-1$56$YR$$M$Y$$$20240920$$HP$US$US
229028662$22902866$2$F$$20240716$20230904$20240722$EXP$$US-SANDOZ INC.-NVSC2022US209032$SANDOZ$$$$$M$Y$23.946$KG$20240722$$CN$US$US
229029624$22902962$4$F$$20240830$20230904$20240902$EXP$$CA-009507513-2308CAN011307$MERCK$$71$YR$$F$Y$$$20240902$$HP$CA$CA
229030038$22903003$8$F$20180101$20240906$20230904$20240924$EXP$$CA-SANDOZ INC.-NVSC2023CA100304$SANDOZ$$71$YR$$F$Y$69$KG$20240924$$HP$CA$CA
229030454$22903045$4$F$20230101$20240624$20230904$20240702$EXP$$CA-CELLTRION INC.-2023CA011747$CELLTRION$$$$$$Y$$$20240702$$MD$CA$CA
229034882$22903488$2$F$$20240802$20230905$20240806$EXP$$US-ABBVIE-5391762$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
229038772$22903877$2$F$$20240710$20230905$20240717$PER$$NVSC2023US191601$NOVARTIS$$$$$F$Y$$$20240717$$MD$US$US
229038794$22903879$4$F$20230814$20240715$20230905$20240805$PER$$CA-TOLMAR, INC.-23CA042638$TOLMAR$$69$YR$$M$Y$$$20240802$$CN$CA$CA
229038835$22903883$5$F$20240205$20240722$20230905$20240808$PER$$CA-TOLMAR, INC.-23CA042658$TOLMAR$$76$YR$$M$Y$$$20240808$$CN$CA$CA
229038872$22903887$2$F$20230810$20240715$20230905$20240805$PER$$CO-TOLMAR, INC.-23CO042613$TOLMAR$$8$YR$$F$Y$30$KG$20240805$$CN$CO$CO
229039145$22903914$5$F$20230801$20240829$20230905$20240908$EXP$$US-GSK-US2023119148$GLAXOSMITHKLINE$$45$YR$$F$Y$$$20240908$$CN$US$US
229039572$22903957$2$F$20220920$20240731$20230905$20240916$EXP$AT-MACLEODS PHARMACEUTICALS US LTD-MAC2023043224$AT-MACLEODS PHARMACEUTICALS US LTD-MAC2023043224$MACLEODS$Preiss M, Rabl U, Popper V, Watzal V, Treiber M, Ivkic D et al..Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine.Frontiers in Psychiatry.2023;14:1204009.$$$$$Y$$$20240916$$MD$AT$AT
229039964$22903996$4$F$20230314$20240712$20230905$20240719$EXP$$JP-ABBVIE-5340424$ABBVIE$$73$YR$$M$Y$54$KG$20240719$$MD$JP$JP
229040223$22904022$3$F$20230801$20240731$20230905$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07254$LUPIN$$$$$$Y$$$20240820$$CN$US$US
229040263$22904026$3$F$20230101$20240909$20230905$20240916$EXP$$TW-AMGEN-TWNSP2023154257$AMGEN$$63$YR$A$F$Y$$$20240916$$HP$TW$TW
229040373$22904037$3$F$20240601$20240807$20230905$20240812$EXP$$BR-TAKEDA-2023TUS084909$TAKEDA$$72$YR$$M$Y$$$20240812$$CN$BR$BR
229040773$22904077$3$F$$20240716$20230905$20240828$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-259071$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240828$$CN$GB$GB
229041752$22904175$2$F$$20240819$20230905$20240902$EXP$$US-UCBSA-2023035461$UCB$$$$$F$Y$$$20240902$$HP$US$US
229042302$22904230$2$F$20220831$20240913$20230905$20240919$EXP$$US-ABBVIE-5392082$ABBVIE$$78$YR$$M$Y$$$20240919$$CN$US$US
229046933$22904693$3$F$$20240821$20230905$20240917$PER$$US-SA-2023SA263451$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
229048662$22904866$2$F$20230301$20240717$20230905$20240724$PER$$US-SA-2023SA267067$SANOFI AVENTIS$$8$YR$C$F$Y$31.5$KG$20240725$$MD$US$US
229048772$22904877$2$F$$20240826$20230905$20240910$PER$$US-SA-2023SA266503$SANOFI AVENTIS$$43$YR$A$F$Y$73.9$KG$20240910$$MD$US$US
229049253$22904925$3$F$20230101$20240827$20230905$20240904$PER$$US-SA-2023SA265386$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240904$$MD$US$US
229049784$22904978$4$F$$20240809$20230905$20240816$EXP$$CA-GSK-CA2023AMR119402$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$HP$CA$CA
229050233$22905023$3$F$$20240715$20230905$20240724$EXP$$NL-AUROBINDO-AUR-APL-2023-056210$AUROBINDO$Achten NB, Been JV, Schoenmakers S, Vermont CL, Verdijk RM, Reiss IKM etl... Fatal early-onset sepsis caused by intrauterine transmission of serogroup y meningococcus. THE PEDIATRIC INFECTIOUS DISEASES JOURNAL. 2022;41:e517-e519$$$N$M$Y$1.59$KG$20240724$$HP$NL$NL
229050505$22905050$5$F$20221017$20240729$20230905$20240801$EXP$$JP-ABBVIE-5394500$ABBVIE$$54$YR$$F$Y$56$KG$20240801$$MD$JP$JP
229050529$22905052$9$F$$20240719$20230905$20240724$EXP$$NVSC2023AU190263$NOVARTIS$$$$$F$Y$$$20240724$$MD$AU$AU
229050849$22905084$9$F$$20240627$20230905$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003468$ACADIA PHARMACEUTICALS$$$$$F$Y$30$KG$20240723$$CN$US$US
229050909$22905090$9$F$20230811$20240617$20230905$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003479$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240712$$CN$US$US
229050928$22905092$8$F$20230811$20240613$20230905$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003473$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240708$$CN$US$US
229051483$22905148$3$F$$20240923$20230905$20240926$EXP$$CA-ROCHE-3412384$ROCHE$$48$YR$A$F$Y$68$KG$20240926$$HP$CA$CA
229051532$22905153$2$F$20230101$20240628$20230905$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003476$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
229052313$22905231$3$F$20230101$20240821$20230905$20240828$EXP$$US-ABBVIE-5391632$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
229052542$22905254$2$F$$20230612$20230905$20240723$EXP$$CA-SANDOZ INC.-NVSC2023CA007242$SANDOZ$$44$YR$$F$Y$68$KG$20240723$$MD$CA$CA
229052972$22905297$2$F$$20240816$20230905$20240816$PER$$NVSC2023US191878$NOVARTIS$$$$$M$Y$$$20240816$$CN$US$US
229053354$22905335$4$F$$20240508$20230905$20240814$EXP$$PA-SANDOZ INC.-SDZ2023PA011752$SANDOZ$$$$$F$Y$$$20240814$$CN$PA$PA
229053416$22905341$6$F$20230227$20240726$20230905$20240730$EXP$$US-TAKEDA-2023TUS026958$TAKEDA$$49$YR$$F$Y$47.62$KG$20240730$$CN$US$US
229053802$22905380$2$F$20230817$20240718$20230905$20240726$PER$$US-SA-2023SA266671$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240726$$MD$US$US
229054072$22905407$2$F$20230405$20240628$20230905$20240706$EXP$$FR-AUROBINDO-AUR-APL-2023-056121$AUROBINDO$$68$YR$$M$Y$79.5$KG$20240706$$MD$FR$FR
229054294$22905429$4$F$20221001$20231016$20230905$20240917$EXP$$JP-LEO Pharma-362223$LEO PHARM$$73$YR$$M$Y$$$20240917$$MD$JP$JP
229057024$22905702$4$F$20231117$20240709$20230905$20240712$EXP$$US-UCBSA-2023043078$UCB$$74$YR$$M$Y$$$20240712$$HP$US$US
229058262$22905826$2$F$$20240828$20230905$20240829$PER$$NVSC2023US191908$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
229058825$22905882$5$F$$20240726$20230905$20240805$EXP$$CA-MYLANLABS-2023M1087422$BIOCON$$$$$$Y$$$20240805$$CN$CA$CA
229058912$22905891$2$F$$20240816$20230905$20240823$EXP$$BR-TAKEDA-2022TUS099988$TAKEDA$$$$$F$Y$$$20240823$$CN$BR$BR
229058975$22905897$5$F$20230101$20240830$20230905$20240911$EXP$$US-UCBSA-2023043182$UCB$$$$$F$Y$$$20240911$$HP$US$US
229059313$22905931$3$F$20230101$20240627$20230905$20240706$PER$$US-SA-2023SA264758$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240706$$MD$US$US
229059717$22905971$7$F$20230101$20240904$20230905$20240913$EXP$$US-UCBSA-2023040046$UCB$$$$$F$Y$$$20240913$$CN$US$US
229059842$22905984$2$F$20230520$20230831$20230905$20240903$EXP$$SG-AstraZeneca-2023A198916$ASTRAZENECA$$29202$DY$$$Y$$$20240903$$CN$SG$
229062362$22906236$2$F$20230101$20240830$20230905$20240830$PER$$NVSC2023US191904$NOVARTIS$$$$$F$Y$$$20240830$$MD$US$US
229062702$22906270$2$F$$20240704$20230905$20240710$EXP$$AU-TAKEDA-2023TUS086113$TAKEDA$$$$$F$Y$$$20240710$$CN$AU$AU
2290632011$22906320$11$F$20240402$20240826$20230905$20240904$EXP$$US-INSMED, INC.-2023-03271-US$INSMED$$21$YR$$M$Y$$$20240904$$CN$US$US
229063443$22906344$3$F$20230101$20240703$20230905$20240710$PER$$US-SA-2023SA219999$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240710$$MD$US$US
2290639710$22906397$10$F$20230421$20240702$20230905$20240708$EXP$$GB-MYLANLABS-2023M1092248$MYLAN$$26$YR$$M$Y$$$20240708$$MD$GB$GB
229064184$22906418$4$F$$20240712$20230905$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-124570$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240716$$HP$US$US
229065344$22906534$4$F$$20240826$20230905$20240829$EXP$$US-SANDOZ INC.-SDZ2023US022928$SANDOZ$$$$$M$Y$$$20240829$$CN$US$US
229066726$22906672$6$F$20210901$20240827$20230905$20240910$EXP$$CA-UCBSA-2022057732$UCB$$43$YR$$F$Y$$$20240910$$PH$CA$CA
229067344$22906734$4$F$20220702$20240806$20230905$20240809$EXP$$BE-EXELIXIS-XL18422054740$EXELIXIS$$$$$$Y$$$20240809$$MD$BE$BE
229069132$22906913$2$F$20240411$20240827$20230905$20240830$EXP$$US-PFIZER INC-PV202300149509$PFIZER$$69$YR$$M$Y$$$20240830$$CN$US$US
229069402$22906940$2$F$20230401$20240812$20230905$20240812$PER$$NVSC2023US192078$NOVARTIS$$68$YR$$F$Y$$$20240813$$CN$US$US
229071167$22907116$7$F$20230701$20240701$20230905$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-124828$BRISTOL MYERS SQUIBB$Ohara S. Current status and device with preoperative treatment using nivolumab at our hospital. The 41st Annual Meeting of the Japanese Association for Chest Surgery. 2024;O1-3.$85$YR$E$M$Y$$$20240705$$MD$JP$JP
229071567$22907156$7$F$20230817$20240718$20230905$20240719$30DAY$$US-PFIZER INC-202300280323$PFIZER$$15$YR$$F$Y$56.25$KG$20240719$$PH$US$US
229072422$22907242$2$F$$20240819$20230905$20240821$PER$$NVSC2023US191508$NOVARTIS$$$$$M$Y$$$20240821$$CN$US$US
229073213$22907321$3$F$20230208$20240829$20230905$20240902$EXP$$DE-BAUSCH-BL-2023-013268$BAUSCH AND LOMB$$81$YR$$F$Y$63$KG$20240902$$MD$DE$DE
229073224$22907322$4$F$20230101$20240817$20230905$20240820$EXP$$DE-BAUSCH-BL-2023-013305$BAUSCH AND LOMB$$8$DEC$$M$Y$90$KG$20240820$$MD$DE$DE
229073348$22907334$8$F$20220101$20240813$20230905$20240819$EXP$$IN-PFIZER INC-PV202200016823$PFIZER$$34$YR$$M$Y$$$20240819$$CN$IN$IN
229073372$22907337$2$F$$20240830$20230905$20240904$EXP$$CA-PFIZER INC-202300290149$PFIZER$$42$YR$$M$Y$68.03$KG$20240904$$MD$CA$CA
229074602$22907460$2$F$$20240531$20230905$20240829$PER$$US-AMERICAN REGENT INC-2023000615$AMERICAN REGENT$$$$$F$Y$48.163$KG$20240829$$MD$US$US
229075195$22907519$5$F$20230411$20240711$20230905$20240723$EXP$$CA-PFIZER INC-202300154170$PFIZER$$64$YR$$M$Y$$$20240723$$HP$CA$CA
229075385$22907538$5$F$20220928$20240919$20230905$20240926$EXP$$CA-PFIZER INC-202200531999$PFIZER$$33$YR$$F$Y$90$KG$20240926$$CN$CA$CA
229075447$22907544$7$F$20221228$20240907$20230905$20240910$EXP$$IN-PFIZER INC-PV202300000643$PFIZER$$60$YR$$F$Y$$$20240910$$CN$IN$IN
229075513$22907551$3$F$20230101$20240808$20230905$20240812$EXP$$CA-PFIZER INC-202300047282$PFIZER$$61$YR$$F$Y$70$KG$20240812$$HP$CA$CA
229076775$22907677$5$F$20230823$20240705$20230905$20240711$EXP$$BR-TAKEDA-BR201941621$TAKEDA$$27$YR$$M$Y$$$20240711$$CN$BR$BR
2290774110$22907741$10$F$20230101$20240626$20230905$20240701$EXP$$CA-PFIZER INC-202300153766$PFIZER$$68$YR$$F$Y$89$KG$20240701$$HP$CA$CA
229077493$22907749$3$F$20210909$20240923$20230905$20240927$EXP$$CA-PFIZER INC-202101458032$PFIZER$$54$YR$$M$Y$$$20240927$$MD$CA$CA
229077626$22907762$6$F$20230801$20240905$20230905$20240910$EXP$$CA-PFIZER INC-202300266746$PFIZER$$35$YR$$F$Y$$$20240910$$MD$CA$CA
229080722$22908072$2$F$$20240820$20230905$20240829$EXP$$CA-GILEAD-2023-0641954$GILEAD$$41$YR$A$F$Y$$$20240829$$HP$CA$CA
229081265$22908126$5$F$$20240826$20230905$20240906$EXP$$US-SA-2023SA266534$SANOFI AVENTIS$$$$E$F$Y$$$20240906$$MD$US$US
229082214$22908221$4$F$$20240925$20230905$20240927$PER$$US-PFIZER INC-202300289855$PFIZER$$$$$F$Y$109.04$KG$20240927$$MD$US$US
229082313$22908231$3$F$20230901$20240710$20230905$20240712$EXP$$US-PFIZER INC-PV202300147284$PFIZER$$73$YR$$F$Y$86.168$KG$20240712$$CN$US$US
229083186$22908318$6$F$20230823$20240828$20230905$20240906$EXP$$PL-Covis Pharma GmbH-2023COV01586$COVIS PHARMA$$79$YR$E$F$Y$52.9$KG$20240906$$MD$PL$PL
229083283$22908328$3$F$20230820$20240730$20230905$20240731$PER$$US-PFIZER INC-202300290727$PFIZER$$66$YR$$F$Y$$$20240731$$HP$US$US
229083322$22908332$2$F$$20240916$20230905$20240919$PER$$US-PFIZER INC-PV202300100112$PFIZER$$68$YR$$F$Y$$$20240919$$MD$US$US
229084594$22908459$4$F$20230101$20240816$20230905$20240821$PER$$US-PFIZER INC-PV202300149582$PFIZER$$58$YR$$F$Y$95.25$KG$20240821$$HP$US$US
229084724$22908472$4$F$$20240905$20230905$20240909$PER$$US-PFIZER INC-PV202300097625$PFIZER$$69$YR$$F$Y$$$20240909$$CN$US$US
229084872$22908487$2$F$20230501$20240829$20230905$20240904$PER$$US-PFIZER INC-202300290393$PFIZER$$35$YR$$F$Y$$$20240904$$HP$US$US
229085485$22908548$5$F$20230830$20240725$20230905$20240731$EXP$$NVSC2023DE060395$NOVARTIS$$40$YR$$F$Y$$$20240731$$MD$DE$DE
229085859$22908585$9$F$20230614$20240429$20230905$20240816$EXP$$CL-SANDOZ INC.-NVSC2022CL102048$SANDOZ$$67$YR$$F$Y$$$20240816$$CN$CL$CL
229086313$22908631$3$F$20200101$20240312$20230905$20240809$EXP$$PA-SANDOZ INC.-NVSC2022PA264116$SANDOZ$$$$$F$Y$86.168$KG$20240809$$CN$PA$PA
229087783$22908778$3$F$20230101$20240829$20230905$20240904$EXP$$JP-009507513-2308JPN004208J$MERCK$$$$$F$Y$$$20240904$$MD$JP$JP
229088152$22908815$2$F$$20240624$20230905$20240701$EXP$$CA-GSK-CA2023AMR120034$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$CA$CA
229088888$22908888$8$F$$20240718$20230905$20240723$EXP$$US-SANDOZ INC.-NVSC2021US151026$SANDOZ$$$$$M$Y$97.052$KG$20240723$$CN$US$US
229089255$22908925$5$F$20230101$20240802$20230905$20240807$EXP$$US-ABBVIE-5389912$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
229089877$22908987$7$F$20230801$20240826$20230905$20240903$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2023-20850$IPSEN$$53$YR$A$M$Y$$$20240903$$MD$CA$CA
229090024$22909002$4$F$$20240715$20230905$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-125473$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240717$$CN$US$US
229090039$22909003$9$F$20230501$20240624$20230905$20240702$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-259387$BOEHRINGER INGELHEIM$$48$YR$A$F$Y$$$20240702$$CN$JP$JP
229091403$22909140$3$F$$20240916$20230906$20240926$EXP$$BR-CELLTRION INC.-2023BR005933$CELLTRION$$$$$$Y$$$20240926$$CN$BR$BR
229094332$22909433$2$F$$20240831$20230906$20240923$PER$$US-SA-2023SA268977$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240923$$MD$US$US
229094343$22909434$3$F$20230801$20240816$20230906$20240827$PER$$US-SA-2023SA264984$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240827$$HP$US$US
229097484$22909748$4$F$20230831$20240920$20230906$20240930$EXP$$US-UCBSA-2023043731$UCB$$69$YR$$F$Y$122.45$KG$20240930$$HP$US$US
229097538$22909753$8$F$$20240827$20230906$20240904$PER$$US-ROCHE-3416518$ROCHE$$$$C$M$Y$$$20240904$$CN$US$US
2290978717$22909787$17$F$20230101$20240718$20230906$20240726$EXP$$CA-CELLTRION INC.-2023CA017286$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
229097982$22909798$2$F$$20240702$20230906$20240705$EXP$$US-SANDOZ INC.-NVSC2023US096053$SANDOZ$$$$$F$Y$113.38$KG$20240705$$CN$US$US
229098292$22909829$2$F$20230815$20240717$20230906$20240813$PER$$CA-TOLMAR, INC.-23CA042645$TOLMAR$$66$YR$$M$Y$$$20240813$$CN$CA$CA
229098514$22909851$4$F$$20240820$20230906$20240827$PER$$NVSC2023US192197$NOVARTIS$$$$$M$Y$$$20240827$$CN$US$US
229099512$22909951$2$F$$20240818$20230906$20240819$PER$$NVSC2023US192329$NOVARTIS$$$$$M$Y$86.18$KG$20240819$$CN$US$US
229100153$22910015$3$F$$20240731$20230906$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07384$LUPIN$$$$$$Y$$$20240820$$CN$US$US
229100613$22910061$3$F$20230824$20240806$20230906$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07413$LUPIN$$$$$$Y$$$20240827$$CN$US$US
229102194$22910219$4$F$20240101$20240905$20230906$20240914$PER$$US-SA-2023SA269029$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240914$$MD$US$US
2291025515$22910255$15$F$20230101$20240913$20230906$20240926$EXP$$US-UCBSA-2023043702$UCB$$$$$M$Y$$$20240926$$CN$US$US
2291029711$22910297$11$F$20220801$20240626$20230906$20240926$EXP$$US-GSK-US2023AMR119252$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
229104004$22910400$4$F$20240401$20240919$20230906$20240924$EXP$$US-SANDOZ INC.-NVSC2022US284338$SANDOZ$$76$YR$$F$Y$92.517$KG$20240924$$CN$US$US
229104413$22910441$3$F$$20240821$20230906$20240904$PER$$US-SA-2023SA266496$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240904$$MD$US$US
229104524$22910452$4$F$20230101$20240801$20230906$20240808$PER$$US-SA-2023SA269912$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240808$$MD$US$US
229104933$22910493$3$F$$20240909$20230906$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07414$LUPIN$$$$$$Y$$$20240924$$HP$US$US
229105614$22910561$4$F$20230619$20240627$20230906$20240705$EXP$$US-PHARMAESSENTIA CORPORATION-US-2023-PEC-001631$PHARMAESSENTIA$$$$$F$Y$$$20240705$$CN$US$US
229105782$22910578$2$F$20230101$20240821$20230906$20240912$PER$$US-SA-2023SA267507$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240912$$MD$US$US
229105982$22910598$2$F$20230825$20240703$20230906$20240712$PER$$US-SA-2023SA267187$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240712$$MD$US$US
229106224$22910622$4$F$20201228$20240627$20230906$20240703$PER$$US-BIOGEN-2021BI00965330$BIOGEN$$60$YR$$F$Y$$$20240703$$HP$US$US
229106742$22910674$2$F$$20240911$20230906$20240923$EXP$$CA-APOTEX-2023AP012927$APOTEX$$55$YR$$F$Y$74$KG$20240923$$MD$CA$CA
229107312$22910731$2$F$20230731$20240620$20230906$20240703$EXP$$IN-ROCHE-3417008$ROCHE$$66$YR$E$M$Y$$$20240703$$CN$IN$IN
229107743$22910774$3$F$$20240910$20230906$20240917$PER$$NVSC2023US190790$NOVARTIS$$$$$M$Y$$$20240917$$CN$US$US
229107962$22910796$2$F$$20240715$20230906$20240722$PER$$US-SA-2023SA266235$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240721$$MD$US$US
229110712$22911071$2$F$20211006$20240717$20230906$20240801$EXP$$FR-SERVIER-S23010230$SERVIER$$$$$$Y$$$20240801$$MD$FR$FR
229112082$22911208$2$F$20220721$20240711$20230906$20240717$EXP$$US-AMERICAN REGENT INC-2023001518$AMERICAN REGENT$$76$YR$$M$Y$$$20240717$$LW$US$US
229112612$22911261$2$F$20230221$20230831$20230906$20240710$EXP$$FR-ASTELLAS-2023US010126$ASTELLAS$$71$YR$$M$Y$$$20240710$$CN$FR$FR
229113505$22911350$5$F$$20240813$20230906$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-125747$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$62.14$KG$20240814$$CN$US$US
229113735$22911373$5$F$20230101$20240709$20230906$20240717$PER$$US-SA-2023SA269691$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240717$$MD$US$US
229113802$22911380$2$F$$20240722$20230906$20240729$EXP$$CN-AMGEN-CHNSP2023152771$AMGEN$Lan D.; Liu X.; Xie Y. et al.. Hypercalcemia in Children Following a Discontinuation of Denosumab Therapy: A Case Report and Literature Review. Clinical Pediatrics. 2023;1-5$8$YR$C$M$Y$$$20240729$$MD$CN$CN
229113922$22911392$2$F$$20240912$20230906$20240923$PER$$US-SA-2023SA270284$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$MD$US$US
229113942$22911394$2$F$$20240718$20230906$20240726$PER$$US-SA-2023SA267160$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240726$$MD$US$US
229115364$22911536$4$F$20230101$20240911$20230906$20240919$EXP$$NVSC2023PT192069$NOVARTIS$$62$YR$$F$Y$$$20240919$$CN$PT$PT
229115634$22911563$4$F$$20240827$20230906$20240830$PER$$NVSC2023US192255$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
229115712$22911571$2$F$20230819$20240729$20230906$20240808$EXP$$US-Accord-376961$ACCORD$$36$YR$A$M$Y$$$20240808$$MD$US$US
229117862$22911786$2$F$20230101$20240805$20230906$20240814$PER$$US-SA-2023SA270317$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240814$$CN$US$US
229118664$22911866$4$F$20240221$20240729$20230906$20240801$PER$$US-PFIZER INC-PV202300150259$PFIZER$$62$YR$$F$Y$$$20240801$$HP$US$US
229118866$22911886$6$F$20230801$20240819$20230906$20240822$PER$$US-PFIZER INC-PV202300150061$PFIZER$$41$YR$$F$Y$65.306$KG$20240822$$HP$US$US
229118893$22911889$3$F$20230322$20240808$20230906$20240812$PER$$US-PFIZER INC-PV202200099849$PFIZER$$43$YR$$M$Y$82.54$KG$20240812$$HP$US$US
229118904$22911890$4$F$$20240923$20230906$20240925$EXP$$CA-PFIZER INC-202300288155$PFIZER$$55$YR$$F$Y$$$20240925$$HP$CA$CA
229119195$22911919$5$F$$20240815$20230906$20240820$EXP$$US-PFIZER INC-202300291199$PFIZER$$6$YR$$M$Y$$$20240820$$CN$US$US
229119442$22911944$2$F$$20240826$20230906$20240828$EXP$$US-TAKEDA-2023TUS041689$TAKEDA$$$$$F$Y$$$20240828$$CN$US$US
229119583$22911958$3$F$20220901$20240920$20230906$20240925$EXP$$IT-TAKEDA-2022TUS098389$TAKEDA$$53$YR$$M$Y$78$KG$20240925$$HP$IT$IT
229120133$22912013$3$F$$20240904$20230906$20240906$PER$$US-PFIZER INC-PV202300133942$PFIZER$$86$YR$$F$Y$$$20240906$$CN$US$US
229120685$22912068$5$F$20240608$20240715$20230906$20240717$EXP$$US-PFIZER INC-PV202300150400$PFIZER$$85$YR$$M$Y$73.5$KG$20240717$$CN$US$US
229120723$22912072$3$F$20230915$20240806$20230906$20240809$EXP$$US-PFIZER INC-202101130022$PFIZER$$55$YR$$F$Y$$$20240809$$MD$US$US
229120742$22912074$2$F$$20240716$20230906$20240717$PER$$US-PFIZER INC-202300293429$PFIZER$$63$YR$$F$Y$$$20240717$$CN$US$US
229120813$22912081$3$F$$20240828$20230906$20240830$EXP$$CA-SANDOZ INC.-NVSC2023CA052410$SANDOZ$$$$$F$Y$99$KG$20240830$$HP$CA$CA
229120866$22912086$6$F$20220901$20240726$20230906$20240805$EXP$$JP-ARGENX-2023-ARGX-JP000045$ARGENX BVBA$$$$$$Y$$$20240805$$MD$JP$JP
229121113$22912111$3$F$$20240816$20230906$20240829$PER$$US-SA-2023SA269065$SANOFI AVENTIS$$$$C$F$Y$$$20240829$$MD$US$US
229121565$22912156$5$F$20220101$20240626$20230906$20240701$EXP$$CA-UCBSA-2022038331$UCB$$$$$M$Y$$$20240701$$CN$CA$CA
229121635$22912163$5$F$20230901$20240702$20230906$20240704$EXP$$CA-TAKEDA-2023TUS086422$TAKEDA$$49$YR$$F$Y$$$20240704$$CN$CA$CA
229121787$22912178$7$F$20230801$20240527$20230906$20240813$EXP$$NVSC2023BR192565$NOVARTIS$$71$YR$$F$Y$$$20240813$$CN$BR$BR
229124002$22912400$2$F$20230101$20240828$20230906$20240902$PER$$NVSC2023US192779$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
229124592$22912459$2$F$$20240802$20230906$20240807$EXP$$CA-PFIZER INC-202300292502$PFIZER$$65$YR$$M$Y$$$20240807$$CN$CA$CA
229125982$22912598$2$F$$20240812$20230906$20240814$EXP$$US-TAKEDA-2016BLT004336$TAKEDA$$$$$F$Y$$$20240814$$HP$US$US
229126943$22912694$3$F$20230811$20240810$20230906$20240815$EXP$$IN-PFIZER INC-2021685580$PFIZER$$62$YR$$F$Y$$$20240815$$CN$IN$IN
229127523$22912752$3$F$20230604$20240719$20230906$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02022$AMNEAL$$$$$F$Y$$$20240904$$CN$US$US
229127793$22912779$3$F$20230901$20240701$20230906$20240703$EXP$$PK-PFIZER INC-PV202300150071$PFIZER$$43$YR$$F$Y$$$20240703$$CN$PK$PK
229128472$22912847$2$F$20230901$20240715$20230906$20240722$EXP$$AU-009507513-2309AUS000978$MERCK$$80$YR$$M$Y$$$20240719$$MD$AU$AU
229128662$22912866$2$F$20210101$20240822$20230906$20240903$PER$$US-SA-2023SA265293$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240903$$MD$US$US
229129922$22912992$2$F$20230824$20240805$20230906$20240816$EXP$$US-Accord-376800$ACCORD$$33$YR$A$M$Y$$$20240816$$HP$US$US
229130122$22913012$2$F$20230812$20230814$20230906$20240903$EXP$$GB-JNJFOC-20230859691$JOHNSON AND JOHNSON$$$$$M$Y$68$KG$20240903$$HP$GB$GB
2291305615$22913056$15$F$20230225$20240912$20230906$20240916$EXP$$SA-ROCHE-3300624$ROCHE$$8$YR$C$M$Y$20.95$KG$20240916$$CN$SA$SA
229130742$22913074$2$F$$20230629$20230906$20240830$PER$$NVSC2023US187705$NOVARTIS$$$$$M$Y$69.853$KG$20240830$$HP$US$US
229132844$22913284$4$F$20230320$20240914$20230906$20240924$EXP$$DE-TAKEDA-2023TUS086563$TAKEDA$$61$YR$$M$Y$$$20240924$$HP$DE$DE
229133167$22913316$7$F$20100528$20240801$20230906$20240809$EXP$$CA-CHIESI-2023CHF04571$CHIESI$$19$YR$$F$Y$52.8$KG$20240809$$PH$CA$CA
229134092$22913409$2$F$20220429$20230831$20230906$20240926$EXP$$US-GSK-US2022AMR072396$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
229134162$22913416$2$F$$20240710$20230906$20240715$30DAY$$US-SANDOZ INC.-SDZ2023US023804$SANDOZ$$$$$$Y$53.97$KG$20240715$$HP$US$US
229134372$22913437$2$F$$20240625$20230906$20240710$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407228$RANBAXY$Reiter N, Andersen CU, Thomsen KL, Wamberg CA, Petersen TS, Dalhoff K. Risk of prolonged sedation with the use of chlordiazepoxide in alcohol withdrawal treatment. Wolters Kluwer. 2023;Jun; 340:1319-1322$61$YR$$F$Y$$$20240710$$HP$DK$DK
229134672$22913467$2$F$$20230831$20230906$20240718$EXP$$US-Taiho Oncology Inc-2023-007348$TAIHO ONCOLOGY INC$$75$YR$E$M$Y$$$20240718$$CN$US$US
229136098$22913609$8$F$20230601$20240805$20230906$20240809$EXP$$US-TAKEDA-2023TUS077635$TAKEDA$$68$YR$$F$Y$72$KG$20240809$$MD$US$US
229136412$22913641$2$F$$20240701$20230906$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202309002066$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240712$$HP$US$US
229136594$22913659$4$F$20220601$20240808$20230906$20240904$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0500479$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
229136796$22913679$6$F$$20240809$20230906$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-126120$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240812$$HP$US$US
229138843$22913884$3$F$$20240919$20230906$20240930$PER$$US-SA-2023SA270552$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240930$$MD$US$US
2291402711$22914027$11$F$$20240822$20230906$20240828$EXP$$US-INCYTE CORPORATION-2023IN007968$INCYTE$$$$$$Y$$$20240828$$HP$US$US
229144275$22914427$5$F$$20240911$20230906$20240918$EXP$$US-BIOGEN-2023BI01224490$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
229144633$22914463$3$F$20220101$20240702$20230907$20240712$PER$$US-SA-2023SA267508$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240712$$MD$US$US
229144648$22914464$8$F$20230101$20240710$20230907$20240719$PER$$US-SA-2023SA268086$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240719$$MD$US$US
229144733$22914473$3$F$$20240828$20230907$20240904$EXP$$US-GSK-US2023AMR118975$GLAXOSMITHKLINE$$$$$M$Y$$$20240904$$CN$US$US
229145615$22914561$5$F$$20240719$20230907$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-126212$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$78.47$KG$20240723$$CN$US$US
229145666$22914566$6$F$20230124$20240726$20230907$20240731$EXP$$JP-009507513-2309JPN000029J$MERCK$$85$YR$$M$Y$$$20240731$$MD$JP$JP
229145762$22914576$2$F$20230208$20240806$20230907$20240814$EXP$$CA-CELLTRION INC.-2022CA010693$CELLTRION$$$$$$Y$$$20240814$$MD$CA$CA
229145952$22914595$2$F$20230828$20230830$20230907$20240925$PER$$US-GSK-US2023AMR118788$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
229145974$22914597$4$F$20230801$20231009$20230907$20240925$PER$$US-GSK-US2023AMR118927$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
229146192$22914619$2$F$20230401$20240709$20230907$20240717$EXP$FR-AFSSAPS-NT2023000939$FR-TEVA-2023-FR-2922942$TEVA$$66$YR$$F$Y$105$KG$20240717$$PH$FR$FR
229146292$22914629$2$F$$20240807$20230907$20240816$EXP$$CA-TEVA-2023-CA-2922909$TEVA$$32$YR$$M$Y$$$20240816$$HP$CA$CA
229147479$22914747$9$F$$20240827$20230907$20240904$EXP$$CA-CELLTRION INC.-2023CA017470$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
229148108$22914810$8$F$$20240910$20230907$20240912$EXP$$US-TAKEDA-2023TUS086497$TAKEDA$$$$$F$Y$$$20240912$$CN$US$US
229149093$22914909$3$F$20230101$20240826$20230907$20240909$PER$$US-SA-2023SA267666$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240909$$MD$US$US
229149142$22914914$2$F$20230101$20240820$20230907$20240827$PER$$NVSC2023US193298$NOVARTIS$$$$$M$Y$$$20240827$$CN$US$US
229150354$22915035$4$F$20230101$20240830$20230907$20240909$EXP$$CA-CELLTRION INC.-2023CA015149$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
229150694$22915069$4$F$20230416$20240902$20230907$20240911$EXP$$RO-CELLTRION INC.-2023RO017359$CELLTRION$$$$$$Y$$$20240911$$MD$RO$RO
229152415$22915241$5$F$$20240709$20230907$20240712$EXP$$CA-TAKEDA-2023TUS083854$TAKEDA$$$$$F$Y$$$20240712$$CN$CA$CA
2291531223$22915312$23$F$20230805$20240910$20230907$20240913$EXP$$AT-ABBVIE-5396172$ABBVIE$$$$E$F$Y$64$KG$20240913$$MD$AT$AT
2291534217$22915342$17$F$20230101$20240905$20230907$20240914$EXP$$CA-CELLTRION INC.-2023CA010219$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
229153764$22915376$4$F$20220101$20240701$20230907$20240708$EXP$$US-AMGEN-USASP2023154770$AMGEN$$75$YR$E$F$Y$43.991$KG$20240708$$CN$US$US
229154499$22915449$9$F$20230101$20240918$20230907$20240927$EXP$$CA-CELLTRION INC.-2023CA006227$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
229154512$22915451$2$F$$20240823$20230907$20240828$EXP$$NVSC2023US192948$NOVARTIS$$$$$M$Y$$$20240828$$CN$US$US
229154652$22915465$2$F$$20240625$20230907$20240702$EXP$$CA-APOTEX-2023AP012923$APOTEX$$50$YR$$F$Y$$$20240702$$HP$CA$CA
2291547510$22915475$10$F$20230101$20240820$20230907$20240828$EXP$$CA-CELLTRION INC.-2023CA010009$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
229154804$22915480$4$F$$20240814$20230907$20240814$PER$$NVSC2023US193329$NOVARTIS$$$$$M$Y$$$20240814$$HP$US$US
229155523$22915552$3$F$20230101$20240821$20230907$20240822$PER$$NVSC2023US193463$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
2291556524$22915565$24$F$20230729$20240705$20230907$20240710$EXP$$NVSC2023RU178251$NOVARTIS$$1$YR$$M$Y$9.6$KG$20240710$$CN$RU$RU
229155882$22915588$2$F$$20240624$20230907$20240701$EXP$$CA-GSK-CA2023AMR120063$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$HP$CA$CA
229157115$22915711$5$F$$20240829$20230907$20240906$EXP$$CA-MYLANLABS-2023M1069961$BIOCON$$$$$$Y$$$20240906$$CN$CA$CA
229157454$22915745$4$F$20200310$20240918$20230907$20240923$EXP$$US-AMGEN-USASP2023155743$AMGEN$$82$YR$E$F$Y$$$20240923$$MD$US$US
229157512$22915751$2$F$$20230813$20230907$20240823$PER$$US-CHATTEMPRD-2023OHG004330$CHATTEM$$$$E$F$Y$$$20240823$$CN$US$US
229158374$22915837$4$F$20240401$20240611$20230907$20240730$PER$$US-TRAVERE-2023TVT00355$TRAVERE THERAPEUTICS$$40$YR$A$M$Y$$$20240730$$CN$US$US
229158994$22915899$4$F$$20240614$20230907$20240730$PER$$US-TRAVERE-2023TVT00378$TRAVERE THERAPEUTICS$$68$YR$E$M$Y$$$20240730$$CN$US$US
229159082$22915908$2$F$20230101$20240724$20230907$20240730$EXP$$CA-PFIZER INC-202300097175$PFIZER$$64$YR$$F$Y$$$20240730$$CN$CA$CA
229159405$22915940$5$F$20230730$20240620$20230907$20240701$EXP$$US-TRAVERE-2023TVT00384$TRAVERE THERAPEUTICS$$68$YR$E$M$Y$$$20240701$$CN$US$US
229159612$22915961$2$F$$20240702$20230907$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023117366$VIIV$$$$$F$Y$$$20240705$$MD$US$US
229160352$22916035$2$F$20230101$20240619$20230907$20240701$PER$$US-SA-2023SA269788$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240701$$MD$US$US
229161687$22916168$7$F$20230228$20240807$20230907$20240809$EXP$$GB-ROCHE-3411680$ROCHE$$56$YR$A$F$Y$111$KG$20240809$$MD$GB$GB
229162553$22916255$3$F$$20240905$20230907$20240918$PER$PT-ALM-HQ-PT-2023-1691$PT-LEO Pharma-361529$LEO PHARM$Raimundo DB. Psoriatic Arthritis in Pregnancy: Misfortune or Opportunity. Not provided.$41$YR$$F$Y$$$20240912$$HP$PT$PT
2291626912$22916269$12$F$$20240812$20230907$20240814$EXP$$NVSC2023US192841$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
229163362$22916336$2$F$$20240625$20230907$20240704$PER$$US-SA-2023SA271126$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240704$$MD$US$US
229163604$22916360$4$F$20230801$20240819$20230907$20240829$EXP$$FR-EXELIXIS-CABO-23067737$EXELIXIS$$74$YR$$F$Y$77$KG$20240829$$HP$FR$FR
229164647$22916464$7$F$20230101$20240418$20230907$20240808$EXP$$NVSC2023CR190824$NOVARTIS$$$$$F$Y$$$20240808$$CN$CR$CR
229164928$22916492$8$F$20230602$20240826$20230907$20240830$EXP$$IN-PFIZER INC-PV202300082320$PFIZER$$68$YR$$F$Y$$$20240830$$CN$IN$IN
229166002$22916600$2$F$20230522$20240711$20230907$20240716$EXP$$IN-AMERICAN REGENT INC-2023001290$AMERICAN REGENT$$49$YR$$F$Y$61.6$KG$20240716$$HP$IN$IN
2291660910$22916609$10$F$20200522$20240829$20230907$20240904$EXP$$US-PFIZER INC-202101870992$PFIZER$$80$YR$$F$Y$$$20240904$$CN$US$US
229166442$22916644$2$F$$20240814$20230907$20240816$PER$$US-TAKEDA-2023TUS086924$TAKEDA$$$$$M$Y$$$20240816$$MD$US$US
229166664$22916666$4$F$20240621$20240911$20230907$20240913$EXP$$US-PFIZER INC-PV202300151661$PFIZER$$86$YR$$F$Y$$$20240913$$CN$US$US
229168098$22916809$8$F$20230101$20240627$20230907$20240703$EXP$$US-ABBVIE-5359283$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
229169563$22916956$3$F$20230101$20240708$20230907$20240710$PER$$US-PFIZER INC-PV202300151042$PFIZER$$66$YR$$M$Y$$$20240710$$CN$US$US
229169658$22916965$8$F$$20240926$20230907$20240930$PER$$US-PFIZER INC-PV202300071826$PFIZER$$80$YR$$F$Y$$$20240930$$CN$US$US
229170568$22917056$8$F$20230508$20240919$20230907$20240924$EXP$$IN-PFIZER INC-PV202200017165$PFIZER$$63$YR$$M$Y$$$20240924$$CN$IN$IN
2291727817$22917278$17$F$20230801$20240912$20230907$20240916$EXP$$US-BEH-2023162950$CSL BEHRING$$28$YR$A$F$Y$$$20240916$$HP$US$US
229173025$22917302$5$F$$20240603$20230907$20240710$PER$$US-TRAVERE-2023TVT00341$TRAVERE THERAPEUTICS$$73$YR$E$F$Y$$$20240710$$CN$US$US
229173109$22917310$9$F$$20240808$20230907$20240813$EXP$$US-TRAVERE-2023TVT00356$TRAVERE THERAPEUTICS$$$$$M$Y$79.83$KG$20240813$$CN$US$US
229173323$22917332$3$F$$20240724$20230907$20240819$PER$$US-MYLANLABS-2023M1091309$BIOCON$$$$$$Y$$$20240819$$CN$US$US
229174384$22917438$4$F$20200318$20230914$20230907$20240707$EXP$$MX-SANDOZ INC.-SDZ2023MX023480$SANDOZ$$49$YR$$M$Y$69$KG$20240707$$CN$MX$MX
229174833$22917483$3$F$$20240626$20230907$20240702$PER$$US-BAYER-2023A119031$BAYER$$42$YR$A$F$Y$$$20240702$$HP$US$US
229175702$22917570$2$F$20220101$20240919$20230907$20240925$EXP$$US-ABBVIE-5397170$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
229175842$22917584$2$F$20230901$20240906$20230907$20240923$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000355$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
229175853$22917585$3$F$20230601$20240710$20230907$20240722$EXP$$JP-009507513-2309JPN000004J$MERCK$$66$YR$$F$Y$$$20240719$$MD$JP$JP
229176364$22917636$4$F$$20240808$20230907$20240822$EXP$$JP-009507513-2303JPN002949J$MERCK$Nomaki M, Kawabe R, Yamada S, Takatsuka M, Ota H, Tsukahara Y, et al.. [1 A case of fulminant type 1 diabetes mellitus developed during chemotherapy for squamous cell carcinoma of the lung]. The 60th Annual Meeting of Saitama Medical Association. 21$69$YR$$M$Y$$$20240822$$MD$JP$JP
229177002$22917700$2$F$$20240801$20230907$20240807$EXP$$IT-AMGEN-ITASP2023153912$AMGEN$Lania A.G.; Antonini S.; Pedersini R. et al.. Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors. Journal of Endocrinological Investigation. 2023;1-10$$$$F$Y$$$20240807$$HP$IT$IT
229177076$22917707$6$F$$20240822$20230907$20240917$PER$$US-TRAVERE-2023TVT00215$TRAVERE THERAPEUTICS$$63$YR$A$M$Y$$$20240917$$CN$US$US
229177365$22917736$5$F$20221104$20240826$20230907$20240904$EXP$$JP-PFIZER INC-PV202300071817$PFIZER$$2$MON$$F$Y$$$20240904$$MD$JP$JP
229178185$22917818$5$F$20200318$20230914$20230907$20240711$EXP$$MX-SANDOZ INC.-SDZ2023MX023507$SANDOZ$$49$YR$$M$Y$69$KG$20240711$$CN$MX$MX
229179556$22917955$6$F$20230724$20240903$20230907$20240905$PER$$US-TRAVERE-2023TVT00365$TRAVERE THERAPEUTICS$$43$YR$A$F$Y$$$20240905$$CN$US$US
229181182$22918118$2$F$20230818$20240628$20230907$20240712$EXP$GB-MHRA-TPP35887875C9323961YC1692357744756$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-406799$RANBAXY$$80$YR$$F$Y$76$KG$20240712$$PH$GB$GB
229181282$22918128$2$F$$20240705$20230907$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407467$RANBAXY$Garg AK, Wang J, Martinez AC, Alonzo B, Yi J, Kashani AH. Characterization of outer retinal changes in patients with long-term hydroxychloroquine use with visible light optical coherence tomography (vis-OCT). Invest Ophthalmol Vis Sci. 2023;64(8):3381$53$YR$$$Y$$$20240719$$HP$US$US
229181312$22918131$2$F$$20240705$20230907$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407473$RANBAXY$Garg AK, Wang J, Martinez AC, Alonzo B, Yi J, Kashani AH. Characterization of outer retinal changes in patients with long-term hydroxychloroquine use with visible light optical coherence tomography (vis-OCT). Invest Ophthalmol Vis Sci. 2023;64(8):3381$31$YR$$$Y$$$20240719$$HP$US$US
229182325$22918232$5$F$$20240719$20230907$20240725$PER$$US-TRAVERE-2023TVT00242$TRAVERE THERAPEUTICS$$55$YR$A$M$Y$$$20240725$$CN$US$US
229182747$22918274$7$F$$20240801$20230907$20240808$PER$$US-TRAVERE-2023TVT00398$TRAVERE THERAPEUTICS$$52$YR$A$F$Y$$$20240808$$CN$US$US
229182842$22918284$2$F$20230801$20240718$20230907$20240723$PER$$US-ABBVIE-5397073$ABBVIE$$22$YR$$M$Y$$$20240723$$CN$US$US
229182976$22918297$6$F$20170101$20240911$20230907$20240914$EXP$$US-TAKEDA-US201706856$TAKEDA$$$$$F$Y$83.44$KG$20240914$$CN$US$US
229183072$22918307$2$F$$20240815$20230907$20240909$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000343$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
229184122$22918412$2$F$20230701$20240827$20230907$20240904$EXP$$JP-AstraZeneca-2023A158540$ASTRAZENECA$$$$T$M$Y$43$KG$20240904$$MD$JP$
229185045$22918504$5$F$20230401$20240905$20230907$20240927$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0400545$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
229185292$22918529$2$F$20240610$20240827$20230907$20240828$EXP$$US-KYOWAKIRIN-2023KK013362$KYOWA$$$$$$Y$$$20240828$$PH$US$US
229185629$22918562$9$F$$20240910$20230907$20240916$PER$$US-PFIZER INC-PV202300066722$PFIZER$$18$YR$$M$Y$68.027$KG$20240916$$CN$US$US
229186232$22918623$2$F$$20240830$20230907$20240904$EXP$$US-KYOWAKIRIN-2023KK013851$KYOWA$$$$$$Y$$$20240904$$HP$US$US
229186742$22918674$2$F$$20240812$20230907$20240812$PER$$NVSC2023US193984$NOVARTIS$$$$$M$Y$$$20240813$$MD$US$US
229187012$22918701$2$F$20230101$20240626$20230907$20240701$EXP$$BR-BIOGEN-2023BI01224853$BIOGEN$$$$$M$Y$60$KG$20240701$$CN$BR$BR
229187723$22918772$3$F$20240923$20240923$20230907$20240926$EXP$$CA-TAKEDA-2023TUS086902$TAKEDA$$23$YR$$F$Y$$$20240926$$CN$CA$CA
229188355$22918835$5$F$$20240715$20230907$20240802$EXP$$CA-SANDOZ INC.-NVSC2020CA262667$SANDOZ$$43$YR$$F$Y$68$KG$20240802$$CN$CA$CA
229190062$22919006$2$F$20230823$20240722$20230907$20240731$PER$$US-SA-2023SA268033$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240731$$MD$US$US
229190172$22919017$2$F$$20230904$20230907$20240820$EXP$$QA-BAUSCHBL-2023BNL007972$BAUSCH AND LOMB$Habib M, Abdelghani M, Elyas A, Ashour A, Altermanini M, Imran S, Arabi A. Acute thrombotic occlusion involving three coronary arteries. A unique association with COVID-19 pneumonia. Clinical Case Reports. 2023;11:E7803:1-5. doi:10.1002/ccr3.7803$47$YR$$M$Y$$$20240820$$HP$QA$QA
229190184$22919018$4$F$20230801$20240903$20230907$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003509$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240926$$CN$US$US
229190258$22919025$8$F$20230805$20240916$20230907$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003545$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240930$$CN$US$US
229190307$22919030$7$F$20230829$20240813$20230907$20240814$EXP$$JP-TAKEDA-2023TJP011689$TAKEDA$$78$YR$$M$Y$54$KG$20240814$$HP$JP$JP
229190405$22919040$5$F$$20240802$20230907$20240808$EXP$$JP-TAKEDA-2023TJP011770$TAKEDA$$74$YR$$M$Y$56$KG$20240808$$HP$JP$JP
229191122$22919112$2$F$$20240702$20230907$20240707$PER$$US-JNJFOC-20230913902$JOHNSON AND JOHNSON$$$$$F$Y$$$20240707$$MD$US$US
229193664$22919366$4$F$20230817$20240716$20230908$20240805$PER$$CA-TOLMAR, INC.-23CA042744$TOLMAR$$65$YR$$M$Y$$$20240805$$CN$CA$CA
229193694$22919369$4$F$20230817$20240717$20230908$20240813$PER$$CA-TOLMAR, INC.-23CA042751$TOLMAR$$76$YR$$M$Y$$$20240813$$CN$CA$CA
229193723$22919372$3$F$20230818$20240720$20230908$20240808$PER$$CA-TOLMAR, INC.-23CA042764$TOLMAR$$79$YR$$M$Y$$$20240808$$CN$CA$CA
229193832$22919383$2$F$$20240730$20230908$20240807$EXP$$IT-STRIDES ARCOLAB LIMITED-2023SP014097$STRIDES$Conversano E, Debiec H, Colucci M, Emma F, Ronco P, Vivarelli M.. A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance. Pediatric Nephrology.. 2023;38(Suppl.2):S123-S124 Su-3MP 147.$2$YR$$M$Y$$$20240807$$HP$IT$IT
229194385$22919438$5$F$20230805$20240618$20230908$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003495$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240712$$CN$US$US
229194468$22919446$8$F$20231201$20240618$20230908$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003499$ACADIA PHARMACEUTICALS$$3$YR$$M$Y$$$20240712$$CN$US$US
229194533$22919453$3$F$20140710$20240924$20230908$20240930$EXP$$CA-SANDOZ INC.-SDZ2023CA024319$SANDOZ$$69$YR$$F$Y$$$20240930$$CN$CA$CA
229195342$22919534$2$F$$20240807$20230908$20240812$EXP$$CA-TAKEDA-2023TUS087294$TAKEDA$$$$$F$Y$37$KG$20240812$$CN$CA$CA
229195434$22919543$4$F$$20240703$20230908$20240712$EXP$$US-NOVOPROD-1108966$NOVO NORDISK$$$$$M$Y$$$20240712$$CN$US$US
229197712$22919771$2$F$20240801$20240826$20230908$20240913$PER$$US-SA-2023SA272470$SANOFI AVENTIS$$64$YR$A$M$Y$94$KG$20240913$$MD$US$US
229197752$22919775$2$F$$20240813$20230908$20240821$PER$$US-SA-2023SA268954$SANOFI AVENTIS$$46$YR$A$F$Y$143.7$KG$20240821$$MD$US$US
229200953$22920095$3$F$20230201$20240821$20230908$20240827$PER$$NVSC2023US194097$NOVARTIS$$65$YR$$M$Y$$$20240827$$CN$US$US
229203452$22920345$2$F$$20240709$20230908$20240709$EXP$$CN-TAKEDA-2023TUS086587$TAKEDA$Li X, Shao Q, Shen J, Ren S, Li L, Lu H, et. al. Association between the initial dose urate-lowering drugs and gout flares in adult males with gout. Rheumatology (Oxford, England). 2023;63(6):1599-1606$$$A$M$Y$$$20240709$$MD$CN$CN
229205802$22920580$2$F$20230823$20240827$20230908$20240905$PER$$US-SA-2023SA270285$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240905$$MD$US$US
229206004$22920600$4$F$$20240730$20230908$20240801$EXP$$GB-SANDOZ INC.-NVSC2023GB072235$SANDOZ$$$$C$F$Y$$$20240801$$HP$GB$GB
229206762$22920676$2$F$$20240827$20230908$20240827$PER$$NVSC2023US194040$NOVARTIS$$$$$M$Y$113.38$KG$20240827$$MD$US$US
2292068910$22920689$10$F$20240801$20240923$20230908$20240925$EXP$$US-SANDOZ INC.-NVSC2022US060358$SANDOZ$$48$YR$$F$Y$54.422$KG$20240925$$CN$US$US
2292074713$22920747$13$F$20230201$20240705$20230908$20240713$EXP$$CA-CELLTRION INC.-2022CA021801$CELLTRION$$$$$$Y$$$20240713$$MD$CA$CA
229207542$22920754$2$F$$20240710$20230908$20240716$PER$$NVSC2023US194059$NOVARTIS$$$$$$Y$$$20240716$$MD$US$US
229208482$22920848$2$F$$20230810$20230908$20240906$PER$$US-FARMAPROD-202304-1178$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
229208496$22920849$6$F$20230801$20240715$20230908$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023AMR118823$VIIV$$66$YR$$M$Y$$$20240725$$CN$PR$US
229208942$22920894$2$F$$20240807$20230908$20240808$EXP$$IN-SANDOZ INC.-SDZ2023IN024823$SANDOZ$Sreenivasan A , Lekshmipriya KS , Vijayan M , Pai PG.. Atorvastatin induced liver injury: A Case Series. Research J. Pharm. and Tech.. 2022;15(8):3507-3510$41$YR$$M$Y$$$20240808$$HP$IN$IN
229209606$22920960$6$F$20230101$20240828$20230908$20240905$EXP$$CA-CELLTRION INC.-2023CA016918$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
229209942$22920994$2$F$$20230920$20230908$20240922$PER$$US-CIPLA LTD.-2022US06380$CIPLA$$$$$$Y$$$20240922$$CN$US$US
229210522$22921052$2$F$$20240214$20230908$20240906$PER$$US-FARMAPROD-202305-1275$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229210832$22921083$2$F$20230503$20230830$20230908$20240906$PER$$US-FARMAPROD-202305-1306$DOMPE FARMACEUTICI$$50$YR$A$F$Y$$$20240903$$CN$US$
229211162$22921116$2$F$20230829$20230829$20230908$20240906$PER$$US-FARMAPROD-202305-1303$DOMPE FARMACEUTICI$$86$YR$E$M$Y$$$20240903$$CN$US$
229211313$22921131$3$F$20230911$20230912$20230908$20240926$PER$$US-GSK-US2023AMR120061$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240926$$CN$US$US
229211862$22921186$2$F$$20240813$20230908$20240826$EXP$$CA-APOTEX-2023AP013209$APOTEX$$64$YR$$F$Y$$$20240826$$CN$CA$CA
229212475$22921247$5$F$20220101$20240805$20230908$20240812$EXP$$ES-ABBVIE-5396211$ABBVIE$$$$$F$Y$54$KG$20240812$$CN$ES$ES
229212622$22921262$2$F$$20230714$20230908$20240906$PER$$US-FARMAPROD-202305-1393$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240903$$CN$US$
229212762$22921276$2$F$$20230822$20230908$20240906$PER$$US-FARMAPROD-202305-1390$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
229212812$22921281$2$F$$20230807$20230908$20240906$PER$$US-FARMAPROD-202305-1428$DOMPE FARMACEUTICI$$$$E$M$Y$68.04$KG$20240903$$CN$US$
229212922$22921292$2$F$$20230714$20230908$20240906$PER$$US-FARMAPROD-202305-1409$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229212942$22921294$2$F$20240103$20240115$20230908$20240906$PER$$US-FARMAPROD-202305-1402$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240903$$CN$US$
229212962$22921296$2$F$$20230719$20230908$20240906$PER$$US-FARMAPROD-202305-1446$DOMPE FARMACEUTICI$$$$E$F$Y$85.28$KG$20240903$$CN$US$
229213032$22921303$2$F$20230514$20230831$20230908$20240906$PER$$US-FARMAPROD-202305-1431$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240903$$MD$US$
229213232$22921323$2$F$$20230707$20230908$20240906$PER$$US-FARMAPROD-202305-1492$DOMPE FARMACEUTICI$$$$E$F$Y$47.36$KG$20240903$$MD$US$
229213482$22921348$2$F$$20230712$20230908$20240906$PER$$US-FARMAPROD-202305-1602$DOMPE FARMACEUTICI$$$$E$F$Y$81.65$KG$20240903$$MD$US$
229213502$22921350$2$F$20230701$20230721$20230908$20240906$PER$$US-FARMAPROD-202305-1597$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240903$$CN$US$
229213592$22921359$2$F$20230501$20230710$20230908$20240906$PER$$US-FARMAPROD-202305-1546$DOMPE FARMACEUTICI$$53$YR$A$F$Y$$$20240903$$MD$US$
229213652$22921365$2$F$$20230726$20230908$20240906$PER$$US-FARMAPROD-202306-1650$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229213812$22921381$2$F$20230603$20230720$20230908$20240906$PER$$US-FARMAPROD-202306-1649$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240903$$CN$US$
229213832$22921383$2$F$20230526$20230718$20230908$20240906$PER$$US-FARMAPROD-202306-1646$DOMPE FARMACEUTICI$$83$YR$E$F$Y$$$20240903$$CN$US$
229213852$22921385$2$F$$20230714$20230908$20240906$PER$$US-FARMAPROD-202306-1632$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$MD$US$
229213872$22921387$2$F$$20230817$20230908$20240906$PER$$US-FARMAPROD-202306-1697$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229213882$22921388$2$F$$20230724$20230908$20240906$PER$$US-FARMAPROD-202306-1674$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
229213892$22921389$2$F$$20230727$20230908$20240906$PER$$US-FARMAPROD-202306-1664$DOMPE FARMACEUTICI$$$$E$F$Y$61.6$KG$20240903$$CN$US$
229213902$22921390$2$F$20230602$20230710$20230908$20240906$EXP$$US-FARMAPROD-202306-1655$DOMPE FARMACEUTICI$$53$YR$A$F$Y$59.42$KG$20240903$$CN$US$
229213912$22921391$2$F$$20230710$20230908$20240906$PER$$US-FARMAPROD-202306-1675$DOMPE FARMACEUTICI$$$$E$F$Y$47.17$KG$20240903$$CN$US$
229213922$22921392$2$F$20230505$20230729$20230908$20240906$PER$$US-FARMAPROD-202306-1676$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240903$$MD$US$
229213952$22921395$2$F$20230701$20230717$20230908$20240906$PER$$US-FARMAPROD-202306-1692$DOMPE FARMACEUTICI$$86$YR$E$F$Y$$$20240903$$CN$US$
229213962$22921396$2$F$$20230710$20230908$20240906$PER$$US-FARMAPROD-202305-1562$DOMPE FARMACEUTICI$$$$E$M$Y$104.33$KG$20240903$$CN$US$
229213982$22921398$2$F$$20230714$20230908$20240906$PER$$US-FARMAPROD-202306-1666$DOMPE FARMACEUTICI$$$$E$F$Y$57.15$KG$20240903$$MD$US$
229213992$22921399$2$F$$20230706$20230908$20240906$PER$$US-FARMAPROD-202306-1687$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229214012$22921401$2$F$$20230808$20230908$20240906$PER$$US-FARMAPROD-202306-1696$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
229214042$22921404$2$F$$20230731$20230908$20240906$PER$$US-FARMAPROD-202306-1679$DOMPE FARMACEUTICI$$47$YR$A$F$Y$72.57$KG$20240903$$MD$US$
229214072$22921407$2$F$20230610$20231205$20230908$20240906$PER$$US-FARMAPROD-202306-1742$DOMPE FARMACEUTICI$$34$YR$A$F$Y$$$20240903$$CN$US$
229214092$22921409$2$F$20230601$20230718$20230908$20240906$PER$$US-FARMAPROD-202306-1717$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240903$$MD$US$
229214132$22921413$2$F$$20231004$20230908$20240906$PER$$US-FARMAPROD-202306-1715$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$MD$US$
229214152$22921415$2$F$20230601$20231010$20230908$20240906$PER$$US-FARMAPROD-202306-1749$DOMPE FARMACEUTICI$$79$YR$E$F$Y$$$20240903$$CN$US$
229214202$22921420$2$F$$20230717$20230908$20240906$PER$$US-FARMAPROD-202306-1793$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
229214222$22921422$2$F$20230605$20230723$20230908$20240906$PER$$US-FARMAPROD-202306-1767$DOMPE FARMACEUTICI$$72$YR$E$F$Y$68.49$KG$20240903$$CN$US$
229214232$22921423$2$F$$20230712$20230908$20240906$PER$$US-FARMAPROD-202306-1773$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
229214252$22921425$2$F$$20230707$20230908$20240906$PER$$US-FARMAPROD-202306-1810$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229214262$22921426$2$F$20230614$20230710$20230908$20240906$PER$$US-FARMAPROD-202306-1784$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240903$$CN$US$
229214322$22921432$2$F$$20230714$20230908$20240906$PER$$US-FARMAPROD-202306-1823$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229214342$22921434$2$F$20230601$20230706$20230908$20240906$PER$$US-FARMAPROD-202306-1806$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240903$$CN$US$
229214402$22921440$2$F$$20230711$20230908$20240906$PER$$US-FARMAPROD-202306-1847$DOMPE FARMACEUTICI$$$$E$M$Y$128.05$KG$20240903$$CN$US$
229214412$22921441$2$F$$20230713$20230908$20240906$PER$$US-FARMAPROD-202306-1836$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229214422$22921442$2$F$20230601$20231113$20230908$20240906$PER$$US-FARMAPROD-202306-1841$DOMPE FARMACEUTICI$$89$YR$E$F$Y$58.97$KG$20240903$$CN$US$
229214432$22921443$2$F$20230613$20240417$20230908$20240906$PER$$US-FARMAPROD-202306-1815$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240903$$CN$US$
229214462$22921446$2$F$20230621$20230724$20230908$20240906$PER$$US-FARMAPROD-202306-1874$DOMPE FARMACEUTICI$$64$YR$A$F$Y$$$20240903$$CN$US$
229214472$22921447$2$F$$20230706$20230908$20240906$PER$$US-FARMAPROD-202306-1805$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229214482$22921448$2$F$20230620$20230706$20230908$20240906$PER$$US-FARMAPROD-202306-1883$DOMPE FARMACEUTICI$$83$YR$E$F$Y$$$20240903$$CN$US$
229214512$22921451$2$F$20230609$20230731$20230908$20240906$PER$$US-FARMAPROD-202306-1812$DOMPE FARMACEUTICI$$79$YR$E$F$Y$70.31$KG$20240903$$CN$US$
229214522$22921452$2$F$20230601$20230719$20230908$20240906$PER$$US-FARMAPROD-202306-1867$DOMPE FARMACEUTICI$$90$YR$E$M$Y$$$20240903$$CN$US$
229214542$22921454$2$F$20230601$20231020$20230908$20240906$PER$$US-FARMAPROD-202306-1901$DOMPE FARMACEUTICI$$69$YR$E$M$Y$94.35$KG$20240903$$CN$US$
229214572$22921457$2$F$20230615$20230719$20230908$20240906$PER$$US-FARMAPROD-202306-1813$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240903$$CN$US$
229214602$22921460$2$F$20230601$20240123$20230908$20240906$PER$$US-FARMAPROD-202306-1795$DOMPE FARMACEUTICI$$65$YR$E$M$Y$$$20240903$$CN$US$
229214612$22921461$2$F$20230605$20230725$20230908$20240906$PER$$US-FARMAPROD-202306-1924$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240903$$CN$US$
229214623$22921462$3$F$20230616$20240703$20230908$20240906$EXP$$US-FARMAPROD-202306-1886$DOMPE FARMACEUTICI$$73$YR$E$F$Y$55.57$KG$20240903$$CN$US$US
229214632$22921463$2$F$20230601$20240312$20230908$20240906$PER$$US-FARMAPROD-202306-1899$DOMPE FARMACEUTICI$$89$YR$E$F$Y$53.98$KG$20240903$$CN$US$
229214642$22921464$2$F$20230715$20230810$20230908$20240906$PER$$US-FARMAPROD-202306-1928$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240903$$CN$US$
229214652$22921465$2$F$20230622$20230706$20230908$20240906$PER$$US-FARMAPROD-202306-1910$DOMPE FARMACEUTICI$$79$YR$E$F$Y$88$KG$20240903$$CN$US$
229214662$22921466$2$F$$20230713$20230908$20240906$PER$$US-FARMAPROD-202306-1902$DOMPE FARMACEUTICI$$$$E$F$Y$69.85$KG$20240903$$CN$US$
229214672$22921467$2$F$20230620$20230712$20230908$20240906$PER$$US-FARMAPROD-202306-1912$DOMPE FARMACEUTICI$$78$YR$E$F$Y$59.6$KG$20240903$$CN$US$
229214682$22921468$2$F$$20230720$20230908$20240906$PER$$US-FARMAPROD-202306-1931$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
229214692$22921469$2$F$$20230804$20230908$20240906$PER$$US-FARMAPROD-202306-1959$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229214712$22921471$2$F$20230620$20230728$20230908$20240906$PER$$US-FARMAPROD-202306-1927$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240903$$CN$US$
229214732$22921473$2$F$$20230714$20230908$20240906$PER$$US-FARMAPROD-202306-1862$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229214742$22921474$2$F$20230629$20230719$20230908$20240906$PER$$US-FARMAPROD-202307-1968$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240904$$CN$US$
229214752$22921475$2$F$20230628$20230731$20230908$20240906$PER$$US-FARMAPROD-202306-1941$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
229214762$22921476$2$F$20230628$20230718$20230908$20240906$PER$$US-FARMAPROD-202306-1957$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$CN$US$
229214772$22921477$2$F$20230601$20230719$20230908$20240906$PER$$US-FARMAPROD-202306-1880$DOMPE FARMACEUTICI$$70$YR$E$M$Y$90.26$KG$20240903$$CN$US$
229214782$22921478$2$F$$20231116$20230908$20240906$PER$$US-FARMAPROD-202306-1926$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
229214792$22921479$2$F$$20230801$20230908$20240906$PER$$US-FARMAPROD-202307-1979$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229214802$22921480$2$F$$20230727$20230908$20240906$PER$$US-FARMAPROD-202306-1933$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229214832$22921483$2$F$20230624$20230727$20230908$20240906$PER$$US-FARMAPROD-202306-1918$DOMPE FARMACEUTICI$$56$YR$A$F$Y$54.3$KG$20240903$$CN$US$
229214842$22921484$2$F$20230626$20230717$20230908$20240906$PER$$US-FARMAPROD-202306-1932$DOMPE FARMACEUTICI$$74$YR$E$F$Y$52.16$KG$20240904$$CN$US$
229214852$22921485$2$F$20230627$20230717$20230908$20240906$PER$$US-FARMAPROD-202307-1969$DOMPE FARMACEUTICI$$69$YR$E$F$Y$84.37$KG$20240904$$CN$US$
229214862$22921486$2$F$20230703$20230814$20230908$20240906$PER$$US-FARMAPROD-202307-2013$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240903$$CN$US$
229214872$22921487$2$F$20230704$20230724$20230908$20240906$PER$$US-FARMAPROD-202307-2014$DOMPE FARMACEUTICI$$62$YR$A$M$Y$81.19$KG$20240903$$CN$US$
229214892$22921489$2$F$20230601$20230810$20230908$20240906$PER$$US-FARMAPROD-202306-1951$DOMPE FARMACEUTICI$$53$YR$A$M$Y$80.92$KG$20240904$$CN$US$
229214904$22921490$4$F$$20231027$20230908$20240906$PER$$US-FARMAPROD-202307-2006$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$MD$US$
229214922$22921492$2$F$20230822$20230822$20230908$20240906$PER$$US-FARMAPROD-202307-1996$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240904$$CN$US$
229214942$22921494$2$F$$20230725$20230908$20240906$PER$$US-FARMAPROD-202306-1920$DOMPE FARMACEUTICI$$$$$F$Y$$$20240903$$CN$US$
229214952$22921495$2$F$20230601$20230824$20230908$20240906$PER$$US-FARMAPROD-202306-1915$DOMPE FARMACEUTICI$$92$YR$E$F$Y$50.3$KG$20240903$$CN$US$
229214982$22921498$2$F$20230525$20230824$20230908$20240906$PER$$US-FARMAPROD-202305-1585$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240903$$CN$US$
229214992$22921499$2$F$$20230726$20230908$20240906$PER$$US-FARMAPROD-202306-1935$DOMPE FARMACEUTICI$$$$E$F$Y$70.31$KG$20240904$$CN$US$
229215032$22921503$2$F$$20231127$20230908$20240906$PER$$US-FARMAPROD-202306-1610$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229215082$22921508$2$F$$20230719$20230908$20240906$PER$$US-FARMAPROD-202307-2016$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229215212$22921521$2$F$20230627$20230807$20230908$20240906$PER$$US-FARMAPROD-202306-1961$DOMPE FARMACEUTICI$$56$YR$A$M$Y$$$20240904$$CN$US$
229215412$22921541$2$F$20230625$20230802$20230908$20240906$PER$$US-FARMAPROD-202306-1919$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240903$$CN$US$
229215472$22921547$2$F$$20230808$20230908$20240906$PER$$US-FARMAPROD-202306-1945$DOMPE FARMACEUTICI$$$$E$M$Y$87.82$KG$20240904$$CN$US$
229216284$22921628$4$F$$20240812$20230908$20240814$PER$$NVSC2023US194374$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
229217112$22921711$2$F$$20240326$20230908$20240902$PER$$US-ASTELLAS-2023US025801$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
229217122$22921712$2$F$$20240109$20230908$20240902$PER$$US-ASTELLAS-2023US025596$ASTELLAS$$$$E$M$Y$84.3$KG$20240830$$MD$US$US
229217349$22921734$9$F$20240201$20240923$20230908$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-127229$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240924$$HP$US$US
229217982$22921798$2$F$$20240308$20230908$20240902$PER$$US-ASTELLAS-2022US041846$ASTELLAS$$59$YR$A$M$Y$$$20240830$$CN$US$US
229218552$22921855$2$F$$20231024$20230908$20240902$PER$$US-ASTELLAS-2022US027840$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
229218593$22921859$3$F$20230825$20230829$20230908$20240903$EXP$$US-JNJFOC-20230868036$JOHNSON AND JOHNSON$$79$YR$E$F$Y$75$KG$20240903$$MD$US$US
229218822$22921882$2$F$$20231013$20230908$20240902$PER$$US-ASTELLAS-2023US014076$ASTELLAS$$65$YR$E$M$Y$$$20240830$$CN$US$US
229220042$22922004$2$F$20230718$20230818$20230908$20240923$PER$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-23-00418$Unknown Manufacturer$$73$YR$$F$Y$$$20240904$$HP$US$US
229220567$22922056$7$F$20230101$20240724$20230908$20240729$EXP$$NVSC2023CA135482$NOVARTIS$$36$YR$$F$Y$$$20240729$$CN$CA$CA
229220597$22922059$7$F$20230822$20240716$20230908$20240722$EXP$$JP-ASTELLAS-2023JP010071$ASTELLAS$$51$YR$$M$Y$$$20240719$$MD$JP$JP
229220982$22922098$2$F$$20240522$20230908$20240906$PER$$US-FARMAPROD-202301-0039$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
229221152$22922115$2$F$20240304$20240304$20230908$20240906$PER$$US-FARMAPROD-202301-0068$DOMPE FARMACEUTICI$$30$YR$A$F$Y$$$20240904$$CN$US$
229221192$22922119$2$F$$20240403$20230908$20240906$PER$$US-FARMAPROD-202301-0074$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229221252$22922125$2$F$20240202$20240206$20230908$20240906$PER$$US-FARMAPROD-202301-0054$DOMPE FARMACEUTICI$$79$YR$E$F$Y$$$20240904$$CN$US$
229221702$22922170$2$F$$20231127$20230908$20240906$PER$$US-FARMAPROD-202301-0096$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229221722$22922172$2$F$20230111$20230928$20230908$20240906$PER$$US-FARMAPROD-202301-0112$DOMPE FARMACEUTICI$$54$YR$A$M$Y$$$20240904$$CN$US$
229221772$22922177$2$F$$20240429$20230908$20240906$PER$$US-FARMAPROD-202301-0123$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229222132$22922213$2$F$20230902$20240714$20230908$20240722$PER$$US-SA-2023SA272000$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240722$$MD$US$US
229222562$22922256$2$F$$20240119$20230908$20240906$PER$$US-FARMAPROD-202301-0234$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229222862$22922286$2$F$$20230710$20230908$20240906$PER$$US-FARMAPROD-202302-0283$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229223122$22922312$2$F$$20231113$20230908$20240906$PER$$US-FARMAPROD-202302-0276$DOMPE FARMACEUTICI$$$$E$F$Y$29.94$KG$20240904$$CN$US$
229223722$22922372$2$F$20230210$20231006$20230908$20240906$PER$$US-FARMAPROD-202302-0389$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$
229223992$22922399$2$F$$20230711$20230908$20240906$PER$$US-FARMAPROD-202302-0431$DOMPE FARMACEUTICI$$$$C$M$Y$$$20240904$$CN$US$
229224022$22922402$2$F$20230201$20230719$20230908$20240906$PER$$US-FARMAPROD-202302-0462$DOMPE FARMACEUTICI$$41$YR$A$F$Y$72.76$KG$20240904$$CN$US$
229224122$22922412$2$F$20230217$20230828$20230908$20240906$PER$$US-FARMAPROD-202302-0453$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$CN$US$
229224372$22922437$2$F$20231118$20231117$20230908$20240906$PER$$US-FARMAPROD-202302-0474$DOMPE FARMACEUTICI$$72$YR$E$M$Y$$$20240904$$CN$US$
229224492$22922449$2$F$$20230925$20230908$20240906$PER$$US-FARMAPROD-202302-0486$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229224972$22922497$2$F$20230701$20240401$20230908$20240906$PER$$US-FARMAPROD-202302-0540$DOMPE FARMACEUTICI$$67$YR$E$F$Y$84.82$KG$20240904$$CN$US$
229225092$22922509$2$F$20230308$20240626$20230908$20240906$PER$$US-FARMAPROD-202302-0546$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$US
229225484$22922548$4$F$$20240112$20230908$20240906$PER$$US-FARMAPROD-202303-0613$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
229225796$22922579$6$F$20220515$20240827$20230908$20240902$EXP$$CA-TAKEDA-2022TUS033595$TAKEDA$$34$YR$$F$Y$$$20240902$$CN$CA$CA
229225872$22922587$2$F$$20231023$20230908$20240906$PER$$US-FARMAPROD-202303-0646$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229226052$22922605$2$F$20230308$20231120$20230908$20240906$PER$$US-FARMAPROD-202303-0680$DOMPE FARMACEUTICI$$55$YR$A$F$Y$57.88$KG$20240904$$CN$US$
229226262$22922626$2$F$$20240131$20230908$20240906$PER$$US-FARMAPROD-202303-0719$DOMPE FARMACEUTICI$$$$A$F$Y$79.38$KG$20240904$$CN$US$
229226372$22922637$2$F$$20230718$20230908$20240906$PER$$US-FARMAPROD-202303-0694$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$HP$US$
229226612$22922661$2$F$$20230919$20230908$20240906$PER$$US-FARMAPROD-202303-0722$DOMPE FARMACEUTICI$$$$E$F$Y$43.54$KG$20240904$$CN$US$
229226922$22922692$2$F$20220414$20240702$20230908$20240705$EXP$$GB-SA-2023SA271867$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240705$$MD$GB$GB
229227334$22922733$4$F$$20240907$20230908$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202309004026$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240910$$CN$US$US
229228502$22922850$2$F$$20240822$20230908$20240822$PER$$NVSC2023US181507$NOVARTIS$$$$$M$Y$$$20240822$$MD$US$US
229230045$22923004$5$F$$20240905$20230908$20240917$EXP$$NVSJ2023JP013454$NOVARTIS$Fukui R, Onishi M, Sasaki Y, Shishido M, Asano W, Sato Y, et al. Solar Keratosis and Spinocellular Carcinoma During Continued Immunosuppressant Therapy after Renal Transplantation. Program and Abstracts for the 39th Annual Meeting of the Japanese Skin Cancer So. 2023;220$68$YR$$M$Y$$$20240917$$HP$JP$JP
229230124$22923012$4$F$20230905$20240702$20230908$20240717$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000816$DECIPHERA PHARMACEUTICALS$$67$YR$A$F$Y$$$20240717$$CN$US$US
2292303311$22923033$11$F$20231101$20240715$20230908$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-123894$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240716$$CN$US$US
229231252$22923125$2$F$$20240807$20230908$20240813$EXP$$CA-TAKEDA-2023TUS087373$TAKEDA$$$$$M$Y$$$20240813$$MD$CA$CA
2292314011$22923140$11$F$20230101$20240909$20230908$20240911$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-137155$DAIICHI$$$$$F$Y$$$20240911$$HP$US$US
229231554$22923155$4$F$$20240918$20230908$20240927$EXP$US-MACLEODS PHARMACEUTICALS US LTD-MAC2023043269$US-MACLEODS PHARMACEUTICALS US LTD-MAC2023043269$MACLEODS$Purt B, Nugent A, Wu PS, Paulus YM.Sub-Tenon Triamcinolone and Anti-HIV MedicationInduced Cushing Syndrome.JAMA Ophthalmology.2024$$$$$Y$$$20240927$$MD$US$US
229231893$22923189$3$F$20231003$20231011$20230908$20240926$EXP$$US-GSK-US2023AMR121089$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
229232013$22923201$3$F$20230301$20240807$20230908$20240813$EXP$$BR-TAKEDA-2023TUS087083$TAKEDA$$40$YR$$F$Y$$$20240813$$CN$BR$BR
229232073$22923207$3$F$20211117$20240703$20230908$20240711$EXP$$CA-ROCHE-2959817$ROCHE$$40$YR$A$F$Y$$$20240711$$CN$CA$CA
229232214$22923221$4$F$$20240712$20230908$20240717$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-259622$BOEHRINGER INGELHEIM$$$$N$F$Y$$$20240717$$HP$CA$CA
229232482$22923248$2$F$$20240809$20230908$20240809$PER$$NVSC2023US194690$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
229233174$22923317$4$F$20240130$20240716$20230908$20240723$EXP$$US-BEH-2023162758$CSL BEHRING$$74$YR$E$F$Y$27.22$KG$20240723$$CN$US$US
229234162$22923416$2$F$20220720$20240904$20230908$20240918$EXP$$US-ASTELLAS-2022US032484$ASTELLAS$$60$YR$A$M$Y$$$20240918$$CN$US$US
229234752$22923475$2$F$$20240613$20230908$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003801$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
2292356913$22923569$13$F$$20240809$20230908$20240816$EXP$$NVSC2023US194371$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
229236692$22923669$2$F$$20240716$20230908$20240719$EXP$$JP-009507513-2309JPN000427$MERCK$Sato F, et al.. A case of DKA at an early stage after initiation of anamorelin hydrochloride in a patient with type 2 diabetes mellitus. The 60th Kanto-Koshinetsu Regional Meeting of the Japan Diabetes Society. 2023;35$68$YR$$F$Y$$$20240719$$MD$JP$JP
229236793$22923679$3$F$$20240626$20230908$20240701$EXP$$US-SA-2023SA270808$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$MD$US$US
229237362$22923736$2$F$20240301$20240402$20230908$20240906$PER$$US-FARMAPROD-202209-1916$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240904$$CN$US$
229237652$22923765$2$F$20220922$20231031$20230908$20240906$PER$$US-FARMAPROD-202209-1866$DOMPE FARMACEUTICI$$36$YR$A$F$Y$$$20240904$$CN$US$
229237742$22923774$2$F$$20231213$20230908$20240906$PER$$US-FARMAPROD-202209-1833$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229238742$22923874$2$F$20221125$20230823$20230908$20240906$PER$$US-FARMAPROD-202211-2321$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240904$$CN$US$
229239112$22923911$2$F$$20240412$20230908$20240906$PER$$US-FARMAPROD-202212-2521$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
229239952$22923995$2$F$20231102$20231102$20230908$20240906$PER$$US-FARMAPROD-202210-1959$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$
229240372$22924037$2$F$$20240610$20230908$20240906$PER$$US-FARMAPROD-202212-2545$DOMPE FARMACEUTICI$$$$E$F$Y$61.23$KG$20240904$$CN$US$US
229240402$22924040$2$F$$20240329$20230908$20240906$PER$$US-FARMAPROD-202212-2542$DOMPE FARMACEUTICI$$$$A$F$Y$47.4$KG$20240904$$CN$US$
229240582$22924058$2$F$20240401$20240507$20230908$20240906$PER$$US-FARMAPROD-202211-2416$DOMPE FARMACEUTICI$$79$YR$E$F$Y$$$20240904$$CN$US$
229242782$22924278$2$F$$20230905$20230908$20240906$PER$$US-FARMAPROD-202210-2089$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
229242943$22924294$3$F$20240518$20240718$20230908$20240724$EXP$$NVSC2023US193862$NOVARTIS$$57$YR$$M$Y$$$20240725$$CN$US$US
229243262$22924326$2$F$$20230817$20230908$20240710$PER$$ID-ROCHE-3408801$ROCHE$$$$$F$Y$$$20240628$$MD$ID$ID
229243284$22924328$4$F$20230628$20240801$20230908$20240808$EXP$$US-MYLANLABS-2023M1095975$MYLAN$$$$$F$Y$2.43$KG$20240808$$HP$US$US
229243719$22924371$9$F$20230101$20240918$20230908$20240926$EXP$$CA-JNJFOC-20230751962$JOHNSON AND JOHNSON$$67$YR$E$M$Y$80$KG$20240926$$HP$CA$CA
229244922$22924492$2$F$$20240625$20230908$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-407122$RANBAXY$$67$YR$$F$Y$$$20240710$$PH$GB$GB
2292454712$22924547$12$F$20230214$20240711$20230908$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407731$RANBAXY$$68$YR$E$M$Y$87.1$KG$20240726$$MD$US$US
229246713$22924671$3$F$$20240716$20230908$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-127531$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240719$$HP$US$US
229248085$22924808$5$F$$20240830$20230908$20240902$EXP$$CA-SANDOZ INC.-NVSC2023CA088708$SANDOZ$$44$YR$$F$Y$97$KG$20240902$$HP$CA$CA
229248202$22924820$2$F$20230801$20240919$20230908$20240925$EXP$$US-INCYTE CORPORATION-2023IN009220$INCYTE$$$$$$Y$$$20240925$$CN$US$US
229248952$22924895$2$F$$20240816$20230908$20240828$PER$$US-INCYTE CORPORATION-2023IN008599$INCYTE$$$$$$Y$$$20240828$$CN$US$US
229249505$22924950$5$F$20221222$20240917$20230908$20240919$EXP$$US-PFIZER INC-US-GBT-018994$PFIZER$$41$YR$$M$Y$70.31$KG$20240919$$CN$US$US
229249635$22924963$5$F$20230920$20240731$20230908$20240806$EXP$$CA-PFIZER INC-2021894741$PFIZER$$77$YR$$F$Y$$$20240806$$MD$CA$CA
229249763$22924976$3$F$20110101$20230929$20230908$20240914$EXP$$IE-TEVA-2023-IE-2924332$TEVA$Finnegan P, Ahmad K, Sadlier M, Lynch M. A retrospective review of the management of patients following a malignancy diagnosis on biologic therapies for the treatment of dermatological disorders. JAAD Case Reports. 2023;39:81-7.; Finnegan P, Ahmad K, Sadlier M, Lynch M. A retrospective review of the management of patients following a malignancy diagnosis on biologic therapies for the treatment of dermatological disorders. JAAD Case Reports. 2023 Sep 01;39:81-87.$55$YR$$F$Y$$$20240914$$HP$IE$IE
229249784$22924978$4$F$20240716$20240716$20230908$20240723$PER$$US-SA-2023SA270149$SANOFI AVENTIS$$66$YR$E$F$Y$95$KG$20240723$$MD$US$US
229249797$22924979$7$F$20230101$20240801$20230908$20240809$PER$$US-SA-2023SA269897$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240809$$MD$US$US
229249863$22924986$3$F$20220101$20240819$20230908$20240821$EXP$$CA-PFIZER INC-202201209766$PFIZER$$80$YR$$F$Y$$$20240821$$CN$CA$CA
229250943$22925094$3$F$$20240701$20230908$20240702$30DAY$$US-SANDOZ INC.-SDZ2023US025179$SANDOZ$$$$$M$Y$$$20240702$$CN$US$US
229251012$22925101$2$F$20221125$20240628$20230908$20240704$EXP$$US-BIOGEN-2023BI01219579$BIOGEN$$71$YR$$F$Y$$$20240704$$CN$US$US
229253933$22925393$3$F$$20230901$20230908$20240816$EXP$$US-AstraZeneca-2023A200664$ASTRAZENECA$$$$$$Y$$$20240816$$CN$US$
229254938$22925493$8$F$20231025$20240806$20230908$20240813$EXP$$CA-TAKEDA-2023TUS087087$TAKEDA$$50$YR$$F$Y$$$20240813$$HP$CA$CA
229255192$22925519$2$F$$20240909$20230908$20240912$PER$$PR-PFIZER INC-202300294310$PFIZER$$58$YR$$F$Y$$$20240912$$CN$PR$PR
229256178$22925617$8$F$20230321$20230908$20230908$20240802$EXP$$NVSC2023KR193468$NOVARTIS$$51$YR$$M$Y$59$KG$20240802$$HP$KR$KR
229256462$22925646$2$F$$20240710$20230908$20240716$PER$$NVSC2023US194878$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
229256652$22925665$2$F$$20240806$20230908$20240811$EXP$$NVSC2023US194704$NOVARTIS$$$$$F$Y$$$20240811$$CN$US$US
229257346$22925734$6$F$20130101$20240711$20230908$20240718$EXP$$US-JAZZ-2022-US-037397$JAZZ$$42$YR$$F$Y$$$20240718$$HP$US$US
229258742$22925874$2$F$20230807$20230901$20230908$20240907$PER$$US-ZENPEP LLC-2023AIMT00792$AIMMUNE$$$$$$Y$$$20240907$$HP$COUNTRY NOT SPECIFIED$US
229258842$22925884$2$F$$20240229$20230908$20240907$PER$$US-ZENPEP LLC-2023AIMT00203$AIMMUNE$$$$$$Y$$$20240907$$MD$US$US
229259182$22925918$2$F$20220101$20230920$20230908$20240908$PER$$US-ZENPEP LLC-2023AIMT00092$AIMMUNE$$$$$$Y$$$20240908$$HP$US$US
2292591910$22925919$10$F$$20240819$20230908$20240823$EXP$$CA-GSK-CA2023GSK122929$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$CA$CA
229259212$22925921$2$F$$20230906$20230908$20240718$EXP$$US-Taiho Oncology Inc-2023-004854$TAIHO ONCOLOGY INC$$51$YR$A$M$Y$$$20240718$$CN$US$US
229259427$22925942$7$F$20230828$20240719$20230908$20240726$EXP$$US-BEH-2023162929$CSL BEHRING$$30$YR$A$F$Y$78.912$KG$20240726$$MD$US$US
229259812$22925981$2$F$20220211$20231101$20230908$20240702$EXP$$CA-CELLTRION INC.-2021CA018434$CELLTRION$$$$$$Y$$$20240702$$MD$CA$CA
229260012$22926001$2$F$$20240710$20230909$20240717$PER$$NVSC2023US195050$NOVARTIS$$$$$M$Y$$$20240717$$MD$US$US
229260172$22926017$2$F$20230601$20240922$20230909$20240926$EXP$$NVSC2023EG193089$NOVARTIS$$69$YR$$M$Y$$$20240926$$CN$EG$EG
229261325$22926132$5$F$$20240918$20230909$20240926$EXP$$NVSC2023US192401$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
229262142$22926214$2$F$$20240625$20230909$20240703$EXP$$US-AUROBINDO-AUR-APL-2023-056642$AUROBINDO$Karczewski D, B?cker H, Andronic O, Bedi A, Adelhoefer S, M?llner M, et al.. Serratia marcescens prosthetic joint infection: two case reports and a review of the literature. Journal of Medical Case Reports.. 2023;17(1):294$72$YR$$F$Y$$$20240703$$MD$US$US
229262154$22926215$4$F$$20240829$20230909$20240829$PER$$NVSC2023US191268$NOVARTIS$$$$$M$Y$$$20240830$$HP$US$US
229262325$22926232$5$F$20200207$20240916$20230909$20240924$EXP$$CA-CELLTRION INC.-2019CA027978$CELLTRION$$$$$$Y$$$20240924$$MD$CA$CA
229263403$22926340$3$F$20230101$20240919$20230909$20240925$EXP$$JP-AMGEN-JPNSP2023157491$AMGEN$$$$$M$Y$$$20240925$$PH$JP$JP
229265467$22926546$7$F$20230726$20240821$20230909$20240828$EXP$$US-TRAVERE-2023TVT00399$TRAVERE THERAPEUTICS$$58$YR$A$F$Y$$$20240828$$CN$US$US
229265566$22926556$6$F$20220204$20240925$20230909$20240930$EXP$$CA-SANDOZ INC.-NVSC2023CA054831$SANDOZ$$74$YR$$F$Y$$$20240930$$MD$CA$CA
2292658119$22926581$19$F$20220601$20240911$20230909$20240913$EXP$$CA-SANDOZ INC.-NVSC2022CA109965$SANDOZ$$83$YR$$F$Y$$$20240913$$MD$CA$CA
229265892$22926589$2$F$$20230907$20230909$20240924$PER$$NVSC2023US194772$NOVARTIS$$$$$M$Y$$$20240924$$CN$US$US
229267162$22926716$2$F$$20240826$20230910$20240909$PER$$US-SA-2023SA267798$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240909$$MD$US$US
229267605$22926760$5$F$$20240919$20230910$20240924$EXP$$CA-SANDOZ INC.-SDZ2023CA025771$SANDOZ$$$$$F$Y$$$20240924$$CN$CA$CA
229267794$22926779$4$F$$20240126$20230910$20240912$EXP$$NVSC2023TH194925$NOVARTIS$$$$$F$Y$$$20240912$$CN$TH$TH
229268163$22926816$3$F$20230817$20240731$20230910$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-125582$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240801$$HP$US$US
229269202$22926920$2$F$$20240704$20230911$20240715$EXP$$CA-ROCHE-3418118$ROCHE$$31$YR$A$F$Y$$$20240715$$MD$CA$CA
229270358$22927035$8$F$20221220$20240916$20230911$20240925$EXP$$CA-CELLTRION INC.-2022CA021930$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
229270922$22927092$2$F$$20230920$20230911$20240921$PER$$US-CIPLA LTD.-2022US06668$CIPLA$$$$$$Y$$$20240921$$CN$US$US
229271222$22927122$2$F$20230522$20240716$20230911$20240805$PER$$CA-TOLMAR, INC.-23CA042775$TOLMAR$$87$YR$$M$Y$$$20240805$$CN$CA$CA
229271313$22927131$3$F$$20240723$20230911$20240819$PER$$CA-TOLMAR, INC.-23CA042909$TOLMAR$$$$$M$Y$$$20240814$$CN$CA$CA
229271382$22927138$2$F$20221101$20230920$20230911$20240921$PER$$US-CIPLA LTD.-2023US00447$CIPLA$$$$$$Y$$$20240921$$CN$US$US
229271462$22927146$2$F$20200101$20240603$20230911$20240921$PER$$US-CIPLA LTD.-2023US01771$CIPLA$$$$$$Y$$$20240921$$CN$US$US
229272042$22927204$2$F$20230101$20230920$20230911$20240921$PER$$US-CIPLA LTD.-2023US04106$CIPLA$$$$$$Y$$$20240921$$CN$US$US
229272072$22927207$2$F$20230301$20231214$20230911$20240923$PER$$US-CIPLA LTD.-2023US02515$CIPLA$$$$$$Y$$$20240923$$CN$US$US
229272293$22927229$3$F$20230101$20240725$20230911$20240730$EXP$$US-ABBVIE-5398914$ABBVIE$$84$YR$$F$Y$$$20240730$$CN$US$US
2292734311$22927343$11$F$$20240722$20230911$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-127389$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240724$$CN$US$US
229273747$22927374$7$F$$20240708$20230911$20240710$EXP$$CA-SANDOZ INC.-NVSC2019CA104654$SANDOZ$$60$YR$$F$Y$61$KG$20240710$$MD$CA$CA
229274423$22927442$3$F$20230208$20240827$20230911$20240906$EXP$$DE-AUROBINDO-AUR-APL-2023-056943$AUROBINDO$$81$YR$$F$Y$63$KG$20240906$$MD$DE$DE
229274793$22927479$3$F$20220126$20240816$20230911$20240826$EXP$$CA-CELLTRION INC.-2022CA003988$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
229275354$22927535$4$F$20230801$20240822$20230911$20240906$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-23-00515$CATALYST PHARMA$$62$YR$$M$Y$104.31$KG$20240906$$CN$US$US
229275674$22927567$4$F$20231215$20240920$20230911$20240925$EXP$$CA-TAKEDA-2023TUS064113$TAKEDA$$64$YR$$F$Y$$$20240925$$CN$CA$CA
229276052$22927605$2$F$$20231123$20230911$20240910$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-02184$ALKEM$$46$YR$$M$Y$58$KG$20240910$$HP$DE$DE
229276922$22927692$2$F$$20231212$20230911$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2023SP007760$STRIDES$Modi P, Qiu L, Fallah T, Courtwright A, Halpern C.. Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Treatment of Severe Essential Tremor in a Lung Transplant Recipient.. J-Heart-Lung-Transplant.. 2023$65$YR$$F$Y$$$20240905$$HP$US$US
2292772812$22927728$12$F$20230529$20240918$20230911$20240924$EXP$$US-TAKEDA-US202028873$TAKEDA$$31$YR$$F$Y$108$KG$20240924$$HP$US$US
229277532$22927753$2$F$20221028$20230920$20230911$20240922$PER$$US-CIPLA LTD.-2022US06523$CIPLA$$$$$$Y$$$20240922$$CN$US$US
229277752$22927775$2$F$20230701$20231004$20230911$20240925$PER$$US-CIPLA LTD.-2023US04205$CIPLA$$$$$$Y$$$20240925$$CN$US$US
229277822$22927782$2$F$20230601$20230810$20230911$20240922$PER$$US-CIPLA LTD.-2023US03615$CIPLA$$$$$$Y$$$20240922$$CN$US$US
229277982$22927798$2$F$20230101$20230920$20230911$20240922$EXP$$US-CIPLA LTD.-2023US04009$CIPLA$$$$$$Y$$$20240922$$CN$US$US
229278134$22927813$4$F$20230801$20240823$20230911$20240902$EXP$$FR-ROCHE-3418166$ROCHE$$53$YR$A$F$Y$$$20240902$$HP$FR$FR
229278164$22927816$4$F$20230824$20240802$20230911$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-122066$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240805$$HP$US$US
229278362$22927836$2$F$$20240909$20230911$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07529$LUPIN$$$$$$Y$$$20240921$$CN$US$US
229279928$22927992$8$F$20230930$20240613$20230911$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003590$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240708$$CN$US$US
229280315$22928031$5$F$20230828$20240607$20230911$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003580$ACADIA PHARMACEUTICALS$$5$YR$$F$Y$$$20240701$$CN$US$US
229280542$22928054$2$F$20230829$20240827$20230911$20240911$PER$$US-SA-2023SA272244$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240911$$MD$US$US
229280613$22928061$3$F$20230101$20240819$20230911$20240829$PER$$US-SA-2023SA269415$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240829$$MD$US$US
229281442$22928144$2$F$20180601$20240722$20230911$20240730$PER$$US-SA-2023SA271097$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240731$$MD$US$US
229281723$22928172$3$F$$20240703$20230911$20240711$EXP$$DE-AUROBINDO-AUR-APL-2023-057031$AUROBINDO$$$$$M$Y$$$20240711$$CN$DE$DE
229284342$22928434$2$F$20230101$20240724$20230911$20240802$PER$$US-SA-2023SA269527$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240802$$MD$US$US
229284364$22928436$4$F$20230720$20240917$20230911$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-107403$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$55.9$KG$20240924$$MD$JP$JP
229285812$22928581$2$F$$20240711$20230911$20240722$PER$$US-SA-2023SA274352$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240721$$MD$US$US
229286295$22928629$5$F$20230101$20240821$20230911$20240830$EXP$$US-INSMED, INC.-2023-03037-US$INSMED$$$$$F$Y$$$20240830$$CN$US$US
229286325$22928632$5$F$20231208$20240812$20230911$20240820$EXP$$CO-SANDOZ INC.-NVSC2021CO081990$SANDOZ$$62$YR$$M$Y$97$KG$20240820$$CN$CO$CO
229287954$22928795$4$F$20230513$20240919$20230911$20240926$PER$$ZA-REGENERON PHARMACEUTICALS, INC.-2023-110975$REGENERON$$$$$F$Y$$$20240926$$CN$ZA$ZA
2292889910$22928899$10$F$20220802$20240701$20230911$20240703$EXP$$US-SANDOZ INC.-NVSC2022US151233$SANDOZ$$64$YR$$F$Y$58.05$KG$20240703$$CN$US$US
229289422$22928942$2$F$20221230$20231221$20230911$20240829$EXP$$US-MYLANLABS-2023M1001931$MYLAN$$67$YR$$F$Y$69.3$KG$20240829$$HP$US$US
229289993$22928999$3$F$$20240805$20230911$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07566$LUPIN$$$$$$Y$$$20240820$$PH$US$US
2292900910$22929009$10$F$20230826$20240723$20230911$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-127244$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$57.5$KG$20240731$$MD$JP$JP
229290135$22929013$5$F$$20240717$20230911$20240723$EXP$$CA-SANDOZ INC.-NVSC2022CA104631$SANDOZ$$$$$F$Y$$$20240723$$CN$CA$CA
229290372$22929037$2$F$$20240828$20230911$20240909$EXP$$US-Accord-377744$ACCORD$$$$$F$Y$$$20240909$$PH$US$US
229292692$22929269$2$F$$20240913$20230911$20240923$EXP$$PT-Atnahs Limited-ATNAHS20221011000$Atnahs Healthcare$Neves, N., et all, Hipereosinofilia - um desafio diagn stico e terapeutico (PA N.  0426); COMUNICACOES ORAIS | CASOS CLiNICOS. Medicina Interna - Congressos Nacionais. 28CNMI. 2022-10.$77$YR$E$M$Y$$$20240923$$MD$PT$PT
229294405$22929440$5$F$20220504$20240731$20230911$20240807$EXP$$US-ABBVIE-4287928$ABBVIE$$71$YR$$F$Y$$$20240807$$CN$US$US
229295384$22929538$4$F$$20240709$20230911$20240712$EXP$$CA-GILEAD-2023-0642689$GILEAD$$62$YR$A$F$Y$$$20240712$$CN$CA$CA
229296472$22929647$2$F$$20240923$20230911$20240924$PER$$NVSC2023US195884$NOVARTIS$$$$$M$Y$$$20240924$$CN$US$US
229297204$22929720$4$F$20231212$20240918$20230911$20240923$EXP$$CA-TAKEDA-2023TUS087407$TAKEDA$$26$YR$$F$Y$$$20240923$$CN$CA$CA
229297835$22929783$5$F$20230601$20240717$20230911$20240722$PER$$US-PFIZER INC-PV202300104317$PFIZER$$66$YR$$F$Y$89.342$KG$20240722$$CN$US$US
229297959$22929795$9$F$20230101$20240829$20230911$20240904$PER$$US-PFIZER INC-202300291059$PFIZER$$66$YR$$M$Y$78.47$KG$20240904$$CN$US$US
229297967$22929796$7$F$$20240730$20230911$20240802$PER$$US-PFIZER INC-PV202300151837$PFIZER$$79$YR$$F$Y$$$20240802$$CN$US$US
229298325$22929832$5$F$20230829$20240918$20230911$20240924$EXP$$DE-TAKEDA-2023TUS085921$TAKEDA$$27$YR$$M$Y$$$20240924$$CN$DE$DE
229298534$22929853$4$F$20230812$20240712$20230911$20240722$EXP$$IT-CELLTRION INC.-2023IT017645$CELLTRION$$$$$$Y$$$20240722$$MD$IT$IT
229298583$22929858$3$F$$20240708$20230911$20240709$PER$$US-PFIZER INC-PV202300151400$PFIZER$$76$YR$$F$Y$$$20240709$$CN$US$US
229298726$22929872$6$F$$20240805$20230911$20240808$PER$$US-PFIZER INC-PV202300151790$PFIZER$$73$YR$$F$Y$$$20240808$$CN$US$US
229298906$22929890$6$F$20220101$20240917$20230911$20240919$EXP$$US-ROCHE-3197525$ROCHE$$58$YR$A$F$Y$63.5$KG$20240919$$CN$US$US
229299883$22929988$3$F$$20240923$20230911$20240926$PER$$US-PFIZER INC-PV202300091602$PFIZER$$83$YR$$M$Y$$$20240926$$CN$US$US
229300224$22930022$4$F$$20240830$20230911$20240904$EXP$$US-PFIZER INC-202300295450$PFIZER$$71$YR$$F$Y$88.45$KG$20240904$$CN$US$US
229300892$22930089$2$F$$20240806$20230911$20240807$PER$$NVSC2023US195820$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
229302694$22930269$4$F$$20240719$20230911$20240723$PER$$NVSC2023US195874$NOVARTIS$$$$$$Y$35$KG$20240723$$CN$US$US
2293028110$22930281$10$F$20230908$20240625$20230911$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-128017$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240704$$CN$US$US
229302858$22930285$8$F$$20240909$20230911$20240913$30DAY$$US-PFIZER INC-202300287740$PFIZER$$13$YR$$M$Y$$$20240913$$MD$US$US
229303062$22930306$2$F$20220328$20240826$20230911$20240828$EXP$$CA-SANDOZ INC.-NVSC2022CA077914$SANDOZ$$30$YR$$M$Y$$$20240828$$CN$CA$CA
229303585$22930358$5$F$20240301$20240712$20230911$20240719$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-001551$AMGEN$$54$YR$A$F$Y$$$20240719$$MD$US$US
229304512$22930451$2$F$$20240828$20230911$20240903$EXP$$FR-MYLANLABS-2023M1093446$MYLAN$$$$$F$Y$$$20240903$$CN$FR$FR
229304654$22930465$4$F$20230101$20240919$20230911$20240923$PER$$US-PFIZER INC-202300295532$PFIZER$$49$YR$$M$Y$80.5$KG$20240923$$CN$US$US
229304705$22930470$5$F$20230101$20240823$20230911$20240828$PER$$US-PFIZER INC-202300296343$PFIZER$$38$YR$$F$Y$83.46$KG$20240828$$CN$US$US
229305552$22930555$2$F$20230701$20240813$20230911$20240819$EXP$$HN-MYLANLABS-2023M1096242$MYLAN$$67$YR$$M$Y$$$20240819$$CN$HN$HN
229306444$22930644$4$F$20201001$20240911$20230911$20240919$PER$$US-SA-2023SA273320$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240919$$MD$US$US
229306652$22930665$2$F$$20240920$20230911$20240928$EXP$$CA-TAKEDA-2023TUS087275$TAKEDA$$3$DEC$$M$Y$$$20240928$$HP$CA$CA
229306904$22930690$4$F$$20240716$20230911$20240722$PER$$US-BIOGEN-2023BI01224942$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
229309053$22930905$3$F$$20240824$20230911$20240827$PER$$NVSC2023US196206$NOVARTIS$$$$$F$Y$$$20240827$$MD$US$US
229309202$22930920$2$F$$20240709$20230911$20240711$PER$$US-AMGEN-USASP2023157866$AMGEN$$48$YR$A$F$Y$$$20240711$$HP$US$US
229309278$22930927$8$F$$20240716$20230911$20240731$EXP$$CA-SANDOZ INC.-SDZ2023CA025157$SANDOZ$$40$YR$$F$Y$96$KG$20240731$$HP$CA$CA
229309622$22930962$2$F$$20240819$20230911$20240823$EXP$$CA-TAKEDA-2023TUS087421$TAKEDA$$$$$F$Y$$$20240823$$MD$CA$CA
229309648$22930964$8$F$20230827$20240712$20230911$20240718$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2023-123536$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$73$KG$20240718$$MD$IL$IL
2293099811$22930998$11$F$20231011$20240912$20230911$20240920$EXP$$CA-TAKEDA-2023TUS087413$TAKEDA$$53$YR$$F$Y$$$20240920$$CN$CA$CA
229310442$22931044$2$F$20240101$20240709$20230911$20240717$PER$$US-SA-2023SA273968$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240717$$MD$US$US
229311154$22931115$4$F$20190901$20240905$20230911$20240913$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202010010225$ELI LILLY AND CO$$54$YR$A$F$Y$54$KG$20240913$$MD$JP$JP
229311404$22931140$4$F$20200821$20240722$20230911$20240726$EXP$$CA-TAKEDA-2023TUS087705$TAKEDA$$56$YR$$M$Y$$$20240726$$HP$CA$CA
229311742$22931174$2$F$20230101$20240731$20230911$20240802$EXP$$CA-UCBSA-2022066351$UCB$$$$$F$Y$$$20240802$$CN$CA$CA
229311994$22931199$4$F$20220307$20240916$20230911$20240928$EXP$$IL-ABBVIE-4145165$ABBVIE$$74$YR$$F$Y$64$KG$20240928$$MD$IL$IL
229312006$22931200$6$F$20230622$20240624$20230911$20240701$EXP$$CA-TAKEDA-2023TUS064256$TAKEDA$$64$YR$$M$Y$75$KG$20240701$$CN$CA$CA
229312226$22931222$6$F$20230101$20240702$20230911$20240704$EXP$$CA-PFIZER INC-202300295292$PFIZER$$62$YR$$M$Y$$$20240704$$CN$CA$CA
229312674$22931267$4$F$20230323$20240917$20230911$20240923$EXP$$CA-PFIZER INC-PV202300032278$PFIZER$$56$YR$$F$Y$64$KG$20240923$$CN$CA$CA
229316478$22931647$8$F$$20240726$20230911$20240731$EXP$$US-VERTEX PHARMACEUTICALS-2023-013309$VERTEX$$$$A$$Y$$$20240731$$CN$US$US
229317063$22931706$3$F$20230101$20240731$20230911$20240808$PER$$US-SA-2023SA216752$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240808$$MD$US$US
2293171110$22931711$10$F$20230801$20240626$20230911$20240708$EXP$$US-BEH-2023162979$CSL BEHRING$$49$YR$A$F$Y$$$20240708$$HP$US$US
229317572$22931757$2$F$20230801$20230829$20230911$20240906$PER$$US-FARMAPROD-202308-2406$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240903$$CN$US$
229317913$22931791$3$F$$20240902$20230911$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-127852$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$56.8$KG$20240909$$MD$JP$JP
229317954$22931795$4$F$$20240911$20230911$20240913$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-259763$BOEHRINGER INGELHEIM$$35$YR$A$F$Y$$$20240913$$CN$CA$CA
229322158$22932215$8$F$20230301$20240802$20230912$20240807$EXP$$US-ABBVIE-5399598$ABBVIE$$70$YR$$F$Y$106.14$KG$20240807$$CN$US$US
229322713$22932271$3$F$20210101$20240912$20230912$20240923$PER$$US-SA-2023SA271527$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240923$$MD$US$US
229322903$22932290$3$F$20230101$20240814$20230912$20240904$PER$$CA-TOLMAR, INC.-23CA042824$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
229323842$22932384$2$F$20230101$20240715$20230912$20240723$EXP$$US-ABBVIE-5400767$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
229324504$22932450$4$F$20230805$20240702$20230912$20240711$EXP$$JP-009507513-2309JPN001062J$MERCK$$60$YR$$M$Y$$$20240711$$MD$JP$JP
229324828$22932482$8$F$20240402$20240811$20230912$20240820$EXP$$US-SANDOZ INC.-SDZ2023US021606$SANDOZ$$50$YR$$F$Y$65.76$KG$20240820$$CN$US$US
2293251210$22932512$10$F$20230101$20240819$20230912$20240828$PER$$US-SA-2023SA272988$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240828$$MD$US$US
229325242$22932524$2$F$$20240717$20230912$20240722$EXP$$US-UCBSA-2022031246$UCB$$$$$M$Y$$$20240722$$CN$US$US
2293259012$22932590$12$F$20230901$20240625$20230912$20240719$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003514$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240719$$CN$US$US
229325944$22932594$4$F$20230101$20240801$20230912$20240811$EXP$$DE-ABBVIE-5396769$ABBVIE$Abu Rached N, Gambichler T, Ocker L, Schultheis B, Susok L, Schmidt W, et al. Upadacitinib treatment associated with varicella zoster infection complicated by haemophagocytic lymphohistiocytosis in a patient with severe hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2024;38(2):e139-e141.$$$$M$Y$$$20240811$$MD$DE$DE
229325994$22932599$4$F$20200111$20240705$20230912$20240709$EXP$$AU-SANDOZ INC.-NVSC2020AU007771$SANDOZ$$74$YR$$F$Y$74.2$KG$20240709$$MD$AU$AU
229326322$22932632$2$F$20230810$20240725$20230912$20240819$PER$$CA-TOLMAR, INC.-23CA042785$TOLMAR$$74$YR$$M$Y$$$20240819$$CN$CA$CA
229326733$22932673$3$F$20230902$20240807$20230912$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202309005394$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240816$$CN$US$US
229326873$22932687$3$F$$20240829$20230912$20240906$30DAY$$IL-JNJFOC-20230909542$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$IL$IL
229327125$22932712$5$F$20230101$20240708$20230912$20240717$PER$$US-SA-2023SA275520$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240717$$MD$US$US
229327162$22932716$2$F$20230817$20230907$20230912$20240925$PER$$US-GSK-US2023AMR123970$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
2293272111$22932721$11$F$$20240822$20230912$20240829$EXP$$US-GSK-US2023AMR122084$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
229327553$22932755$3$F$20230613$20240705$20230912$20240714$EXP$$AU-SA-2023SA271446$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240714$$MD$AU$AU
229328123$22932812$3$F$$20240902$20230912$20240906$PER$$US-PHARMING-PHAUS2023000659$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
229329204$22932920$4$F$20231001$20231110$20230912$20240925$PER$$US-GSK-US2023AMR120033$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
229329326$22932932$6$F$20230801$20240715$20230912$20240726$PER$$US-JNJFOC-20230916131$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240726$$CN$US$US
229330132$22933013$2$F$20230818$20240911$20230912$20240921$EXP$$FR-AUROBINDO-AUR-APL-2023-057114$AUROBINDO$$39$YR$$F$Y$$$20240921$$PH$FR$FR
229330352$22933035$2$F$20230801$20240628$20230912$20240710$PER$$US-SA-2023SA273453$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240709$$MD$US$US
229330843$22933084$3$F$20180701$20240923$20230912$20240926$EXP$$FR-BIOGEN-2023BI01225255$BIOGEN$$$$A$F$Y$65.6$KG$20240926$$LW$FR$US
229331614$22933161$4$F$20230101$20240903$20230912$20240915$EXP$$US-UCBSA-2023021804$UCB$$$$$F$Y$70.295$KG$20240915$$HP$US$US
229332864$22933286$4$F$$20230605$20230912$20240903$EXP$$FI-JNJFOC-20230618750$JOHNSON AND JOHNSON$$$$E$F$Y$109$KG$20240903$$MD$FI$FI
229333673$22933367$3$F$$20240822$20230912$20240905$EXP$$PT-SA-2023SA271515$SANOFI AVENTIS$$$$E$$Y$$$20240905$$CN$NL$PT
229334073$22933407$3$F$20230901$20240719$20230912$20240723$EXP$$US-009507513-2309USA001602$MERCK$$76$YR$$M$Y$75$KG$20240723$$PH$US$US
229334744$22933474$4$F$$20240722$20230912$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202309005832$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240725$$CN$US$US
229334865$22933486$5$F$$20240813$20230912$20240819$EXP$$NVSC2023US195248$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
229335864$22933586$4$F$20231101$20240912$20230912$20240922$EXP$$US-UCBSA-2023044576$UCB$$44$YR$$M$Y$$$20240922$$HP$US$US
229336092$22933609$2$F$20230527$20240830$20230912$20240903$EXP$PT-INFARMED-R202309-19$PT-JNJFOC-20230920813$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240903$$MD$PT$PT
229336112$22933611$2$F$$20230731$20230912$20240710$PER$$SE-ROCHE-3398045$ROCHE$$72$YR$E$M$Y$$$20240628$$MD$SE$SE
229336924$22933692$4$F$20230807$20240726$20230912$20240730$EXP$$GB-MYLANLABS-2023M1083960$MYLAN$$61$YR$$M$Y$$$20240730$$MD$GB$GB
229338342$22933834$2$F$$20230731$20230912$20240906$PER$$US-FARMAPROD-202303-0820$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229338372$22933837$2$F$20230413$20240409$20230912$20240906$PER$$US-FARMAPROD-202303-0831$DOMPE FARMACEUTICI$$72$YR$E$F$Y$93.44$KG$20240904$$CN$US$
229338452$22933845$2$F$$20230905$20230912$20240906$PER$$US-FARMAPROD-202303-0837$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
229339032$22933903$2$F$20230328$20230713$20230912$20240906$PER$$US-FARMAPROD-202304-0884$DOMPE FARMACEUTICI$$88$YR$E$M$Y$$$20240903$$CN$US$
229339042$22933904$2$F$20230301$20230806$20230912$20240906$EXP$$US-FARMAPROD-202304-0931$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240903$$CN$US$
229339112$22933911$2$F$$20240129$20230912$20240906$PER$$US-FARMAPROD-202304-0975$DOMPE FARMACEUTICI$$$$E$M$Y$86.18$KG$20240903$$CN$US$
229339142$22933914$2$F$20230405$20230717$20230912$20240906$PER$$US-FARMAPROD-202304-0941$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240903$$CN$US$
229339202$22933920$2$F$$20240401$20230912$20240906$PER$$US-FARMAPROD-202304-0928$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
229339412$22933941$2$F$$20231212$20230912$20240906$PER$$US-FARMAPROD-202304-0957$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
229339472$22933947$2$F$$20240528$20230912$20240906$PER$$US-FARMAPROD-202304-1008$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$US
229339872$22933987$2$F$$20230908$20230912$20240906$PER$$US-FARMAPROD-202304-1032$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
229340322$22934032$2$F$20230901$20240104$20230912$20240906$PER$$US-FARMAPROD-202304-1160$DOMPE FARMACEUTICI$$58$YR$A$M$Y$$$20240903$$CN$US$
229340372$22934037$2$F$20230412$20240301$20230912$20240906$PER$$US-FARMAPROD-202304-1030$DOMPE FARMACEUTICI$$78$YR$E$F$Y$54.43$KG$20240903$$CN$US$
2293404612$22934046$12$F$20230101$20240812$20230912$20240820$EXP$$CA-CELLTRION INC.-2023CA009183$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
229340813$22934081$3$F$$20240925$20230912$20240927$EXP$$CA-SANDOZ INC.-SDZ2023CA026392$SANDOZ$$$$$M$Y$$$20240927$$CN$CA$CA
229341703$22934170$3$F$20230101$20240827$20230912$20240923$PER$$US-SA-2023SA273134$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240923$$MD$US$US
229342142$22934214$2$F$$20240624$20230912$20240702$PER$$US-SA-2023SA274237$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240702$$CN$US$US
229342704$22934270$4$F$20230724$20240814$20230912$20240819$EXP$FR-AFSSAPS-AM2023000746$FR-BAYER-2023A124667$BAYER$$78$YR$E$M$Y$80$KG$20240819$$MD$FR$FR
229343025$22934302$5$F$20230101$20240430$20230912$20240814$EXP$$NVSC2023PE191631$NOVARTIS$$$$$F$Y$$$20240814$$CN$PE$PE
229343673$22934367$3$F$$20240808$20230912$20240814$EXP$$CA-TAKEDA-2023TUS072553$TAKEDA$$$$$F$Y$75$KG$20240814$$HP$CA$CA
229343792$22934379$2$F$20230101$20240708$20230912$20240717$PER$$US-SA-2023SA272371$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240717$$MD$US$US
229343874$22934387$4$F$20230901$20240409$20230912$20240814$EXP$$NVSC2023BR195156$NOVARTIS$$77$YR$$F$Y$$$20240814$$CN$BR$BR
229344632$22934463$2$F$$20231129$20230912$20240906$PER$$US-FARMAPROD-202207-1392$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
229344752$22934475$2$F$20220717$20231121$20230912$20240906$PER$$US-FARMAPROD-202207-1340$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$
229345822$22934582$2$F$20220803$20230808$20230912$20240906$PER$$US-FARMAPROD-202208-1519$DOMPE FARMACEUTICI$$74$YR$E$F$Y$87.09$KG$20240904$$CN$US$
229346282$22934628$2$F$20220806$20240209$20230912$20240906$PER$$US-FARMAPROD-202208-1524$DOMPE FARMACEUTICI$$72$YR$E$M$Y$83.46$KG$20240904$$CN$US$
229346362$22934636$2$F$20220818$20230829$20230912$20240906$PER$$US-FARMAPROD-202208-1617$DOMPE FARMACEUTICI$$49$YR$A$M$Y$$$20240904$$CN$US$
229346382$22934638$2$F$20220801$20231107$20230912$20240906$PER$$US-FARMAPROD-202208-1627$DOMPE FARMACEUTICI$$59$YR$A$F$Y$$$20240904$$CN$US$
229347622$22934762$2$F$20220801$20231124$20230912$20240906$PER$$US-FARMAPROD-202209-1692$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240904$$CN$US$
229347652$22934765$2$F$$20240216$20230912$20240906$PER$$US-FARMAPROD-202209-1785$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
229348382$22934838$2$F$20220201$20231212$20230912$20240906$PER$$US-FARMAPROD-202209-1808$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240904$$CN$US$
229348533$22934853$3$F$$20240912$20230912$20240916$EXP$$US-TAKEDA-US201924432$TAKEDA$$$$$F$Y$$$20240916$$MD$US$US
229348772$22934877$2$F$20230101$20240620$20230912$20240702$PER$$US-SA-2023SA246453$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240702$$MD$US$US
229348992$22934899$2$F$20230101$20240711$20230912$20240722$PER$$US-SA-2023SA272751$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240722$$MD$US$US
229350363$22935036$3$F$$20240903$20230912$20240906$EXP$$CA-009507513-2309CAN003660$MERCK$$45$YR$$F$Y$97$KG$20240906$$HP$CA$CA
229350583$22935058$3$F$20230101$20240806$20230912$20240815$PER$$US-SA-2023SA273405$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240815$$MD$US$US
229351052$22935105$2$F$20230801$20240828$20230912$20240925$PER$$US-SA-2023SA273977$SANOFI AVENTIS$$26$YR$A$F$Y$47.627$KG$20240925$$MD$US$US
229354028$22935402$8$F$20211007$20240807$20230912$20240812$EXP$$CA-TAKEDA-2020TUS024088$TAKEDA$$40$YR$$M$Y$$$20240812$$CN$CA$CA
229354522$22935452$2$F$$20240620$20230912$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407844$RANBAXY$Tobert KE, Bos JM, Moir C, Polites SF, Ackerman MJ. Bilateral cardiac sympathetic denervation in patients with congenital long QT syndrome. Heart Rhythm. 2023;20(7):1033-1038$$$$M$Y$$$20240705$$HP$US$US
229354542$22935454$2$F$$20240911$20230912$20240926$EXP$$AT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407884$RANBAXY$Preiss M, Rabl U, Popper V, Watzal V, Treiber M, Ivkic D, et al. Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine. Front Psychiatry. 2023;14:1204009$34$YR$$M$Y$$$20240926$$HP$AT$AT
229355447$22935544$7$F$20230101$20240919$20230912$20240919$EXP$$CA-PFIZER INC-202201206358$PFIZER$$45$YR$$M$Y$$$20240919$$HP$CA$CA
229355695$22935569$5$F$20230901$20240628$20230912$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017386$JAZZ$$63$YR$$F$Y$$$20240704$$CN$US$US
229355892$22935589$2$F$$20240625$20230912$20240705$EXP$$US-Accord-377421$ACCORD$Leung JG, Allen ND, Markota M. A case series of clozapine titrations affected by inflammatory processes. Schizophr Res. 2023 Aug 24:S0920-9964(23)00275-X.$38$YR$A$F$Y$$$20240705$$PH$US$US
229355912$22935591$2$F$$20240625$20230912$20240705$EXP$$US-Accord-377418$ACCORD$Leung JG, Allen ND, Markota M. A case series of clozapine titrations affected by inflammatory processes. Schizophrenia Research. 2024;268:94-7. DOI:10.1016/j.schres.2023.08.007.$69$YR$E$M$Y$$$20240705$$PH$US$US
229356354$22935635$4$F$$20240925$20230912$20240930$EXP$$US-TAKEDA-2023TUS088242$TAKEDA$$$$$M$Y$$$20240930$$CN$US$US
229356364$22935636$4$F$20211015$20240626$20230912$20240703$EXP$$JP-009507513-2303JPN000218J$MERCK$$65$YR$$M$Y$67$KG$20240703$$MD$JP$JP
229356794$22935679$4$F$$20240824$20230912$20240826$30DAY$$CO-PFIZER INC-202300283386$PFIZER$$10$YR$$M$Y$$$20240826$$CN$CO$CO
229359303$22935930$3$F$20191011$20240719$20230912$20240725$EXP$$CA-TAKEDA-2023TUS087043$TAKEDA$$41$YR$$F$Y$$$20240725$$CN$CA$CA
229359842$22935984$2$F$$20240801$20230912$20240810$PER$$US-SA-2023SA277019$SANOFI AVENTIS$$$$E$F$Y$$$20240810$$MD$US$US
229360264$22936026$4$F$20210901$20240910$20230912$20240925$EXP$$JP-ABBVIE-5401417$ABBVIE$$58$YR$$M$Y$83$KG$20240925$$MD$JP$JP
229360323$22936032$3$F$$20240905$20230912$20240910$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-018941$JAZZ$$$$$F$Y$33.3$KG$20240910$$HP$US$US
229361214$22936121$4$F$20200616$20240902$20230912$20240913$EXP$DE-EMA-2023801-AUTODUP-1690922933823$DE-Accord-377655$ACCORD$$$$E$F$Y$$$20240913$$MD$DE$DE
229361525$22936152$5$F$20240701$20240812$20230912$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202309005056$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240823$$MD$US$US
229362062$22936206$2$F$$20240710$20230912$20240712$EXP$$US-SANDOZ INC.-SDZ2023US026642$SANDOZ$$$$$M$Y$86.18$KG$20240712$$HP$US$US
229362613$22936261$3$F$$20240724$20230912$20240725$EXP$$CA-SANDOZ INC.-SDZ2023CA026395$SANDOZ$$$$$F$Y$$$20240725$$MD$CA$CA
229364212$22936421$2$F$20230123$20230905$20230912$20240822$PER$$US-AstraZeneca-2023A205223$ASTRAZENECA$$49$YR$$F$Y$$$20240822$$CN$US$
229364542$22936454$2$F$20230801$20240912$20230912$20240918$EXP$$US-INCYTE CORPORATION-2023IN009342$INCYTE$$$$$$Y$$$20240918$$CN$US$US
229366922$22936692$2$F$$20240711$20230912$20240716$PER$$US-INCYTE CORPORATION-2023IN009289$INCYTE$$$$$$Y$$$20240716$$CN$US$US
229368262$22936826$2$F$20230803$20240701$20230912$20240705$EXP$$GB-SANDOZ INC.-SDZ2023GB026798$SANDOZ$$17$YR$$M$Y$$$20240705$$PH$GB$GB
229368543$22936854$3$F$20230801$20240829$20230912$20240910$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202309002806$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240910$$CN$JP$JP
229368693$22936869$3$F$$20240801$20230912$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-260830$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240802$$CN$US$US
229369072$22936907$2$F$$20240904$20230912$20240905$PER$$NVSC2023US197170$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
229369403$22936940$3$F$20220411$20240810$20230912$20240815$EXP$$NVSJ2022JP006091$NOVARTIS$$$$A$F$Y$$$20240816$$CN$JP$JP
229369904$22936990$4$F$$20230906$20230912$20240823$EXP$$CA-BIOGEN-2023BI01225230$BIOGEN$$$$$F$Y$$$20240823$$CN$CA$CA
229370642$22937064$2$F$20230414$20240916$20230912$20240924$EXP$$CA-CELLTRION INC.-2023CA008170$CELLTRION$$$$$$Y$$$20240924$$CN$CA$CA
229372202$22937220$2$F$$20240708$20230913$20240716$EXP$$CA-AstraZeneca-2023A206641$ASTRAZENECA$$47$YR$$F$Y$$$20240716$$MD$CA$
229373762$22937376$2$F$20230701$20240830$20230913$20240901$PER$$NVSC2023US197452$NOVARTIS$$54$YR$$M$Y$91.36$KG$20240901$$CN$US$US
229374732$22937473$2$F$20220101$20240723$20230913$20240731$EXP$HK-MLMSERVICE-20230831-4521386-1$HK-STRIDES ARCOLAB LIMITED-2023SP014200$STRIDES$Xing F, Xia Y, Lu Q, Lo SKF, Lau SKP, Woo PCY. Rapid diagnosis of fatal Nocardia kroppenstedtii bacteremic pneumonia and empyema thoracis by next-generation sequencing: a case report. Frontiers in Medicine. 2023;10:1226126$71$YR$$F$Y$$$20240731$$MD$CN$CN
229375223$22937522$3$F$$20240828$20230913$20240828$EXP$$NVSC2023US197551$NOVARTIS$$$$$M$Y$86.18$KG$20240828$$HP$US$US
229376198$22937619$8$F$$20240828$20230913$20240905$EXP$$IT-CELLTRION INC.-2023IT017653$CELLTRION$Maceroni, M, Minnella, A.. Resolution of Macular Edema secondary to rituximab after intravitreal dexamethasone: A case report and a review of the literature.. European journal of ophthalmology. 2023;1-4$$$$$Y$$$20240905$$HP$IT$IT
229376512$22937651$2$F$$20240826$20230913$20240827$PER$$NVSC2023US197430$NOVARTIS$$$$$F$Y$$$20240827$$MD$US$US
229376653$22937665$3$F$20230408$20240702$20230913$20240707$EXP$$US-ABBVIE-5403550$ABBVIE$$74$YR$$F$Y$$$20240707$$CN$US$US
229377634$22937763$4$F$20230101$20240725$20230913$20240806$PER$$US-SA-2023SA275583$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240806$$MD$US$US
229377807$22937780$7$F$20240601$20240829$20230913$20240904$EXP$$US-SANDOZ INC.-SDZ2023US002895$SANDOZ$$84$YR$$F$Y$43.991$KG$20240904$$CN$US$US
229378718$22937871$8$F$20230101$20240919$20230913$20240924$EXP$$CA-JNJFOC-20230738427$JOHNSON AND JOHNSON$$29$YR$A$F$Y$59$KG$20240924$$HP$CA$CA
229379624$22937962$4$F$20230910$20240628$20230913$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019009$JAZZ$$47$YR$$M$Y$$$20240704$$PH$US$US
229380352$22938035$2$F$$20240920$20230913$20240930$EXP$$BR-CELLTRION INC.-2023BR006336$CELLTRION$$$$$$Y$$$20240930$$CN$BR$BR
229380908$22938090$8$F$20230901$20240807$20230913$20240812$EXP$$US-ABBVIE-5289879$ABBVIE$$57$YR$$M$Y$$$20240812$$CN$US$US
229381035$22938103$5$F$20230101$20240815$20230913$20240820$EXP$$US-ABBVIE-5402726$ABBVIE$$$$$F$Y$92$KG$20240820$$CN$US$US
229381124$22938112$4$F$20240601$20240723$20230913$20240730$EXP$$CO-ROCHE-3265760$ROCHE$$63$YR$A$F$Y$74$KG$20240730$$CN$CO$CO
229382632$22938263$2$F$20230826$20240725$20230913$20240729$EXP$FR-AFSSAPS-PV2023000874$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-128967$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$58.3$KG$20240730$$MD$FR$FR
229383145$22938314$5$F$20230101$20240816$20230913$20240828$EXP$$DE-AUROBINDO-AUR-APL-2023-057166$AUROBINDO$$8$DEC$$$Y$90$KG$20240828$$MD$DE$DE
229383334$22938333$4$F$$20240814$20230913$20240816$PER$$NVSC2023US197559$NOVARTIS$$$$$M$Y$81.65$KG$20240816$$HP$US$US
229383513$22938351$3$F$20230127$20240710$20230913$20240718$EXP$$CA-TAKEDA-2023TUS049157$TAKEDA$$24$YR$$F$Y$54$KG$20240718$$MD$CA$CA
229384696$22938469$6$F$$20240807$20230913$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-128176$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$100.7$KG$20240812$$CN$US$US
229385614$22938561$4$F$$20240723$20230913$20240725$PER$$NVSC2023US197461$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
229385819$22938581$9$F$20230404$20240729$20230913$20240801$EXP$$US-TAKEDA-2023TUS035960$TAKEDA$$70$YR$$F$Y$57$KG$20240801$$HP$US$US
229386258$22938625$8$F$$20240725$20230913$20240801$EXP$$CA-GSK-CA2023AMR123818$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$MD$CA$CA
229386643$22938664$3$F$20230808$20240709$20230913$20240711$PER$$NVSC2023US198036$NOVARTIS$$39$YR$$M$Y$$$20240711$$CN$US$US
229387523$22938752$3$F$20240708$20240911$20230913$20240917$EXP$$GB-SANDOZ INC.-SDZ2023GB013016$SANDOZ$$60$YR$$F$Y$$$20240917$$CN$GB$GB
229388853$22938885$3$F$$20230907$20230913$20240924$PER$$NVSC2023US197021$NOVARTIS$$$$$M$Y$$$20240924$$CN$US$US
229391349$22939134$9$F$20240417$20240923$20230913$20240926$EXP$$US-TAKEDA-US201843829$TAKEDA$$71$YR$$M$Y$72$KG$20240926$$HP$US$US
229392692$22939269$2$F$$20240726$20230913$20240801$PER$$US-VERTEX PHARMACEUTICALS-2023-013454$VERTEX$$$$$$Y$$$20240801$$CN$US$US
229393636$22939363$6$F$20180516$20240717$20230913$20240828$EXP$$BR-TAKEDA-2018TUS021193$TAKEDA$$54$YR$$M$Y$$$20240828$$CN$BR$BR
2293943513$22939435$13$F$20230101$20240809$20230913$20240814$EXP$$CA-PFIZER INC-202300295281$PFIZER$$45$YR$$M$Y$105.9$KG$20240814$$HP$CA$CA
229394438$22939443$8$F$20190901$20240807$20230913$20240808$EXP$$US-ALXN-A202311791$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240808$$CN$US$US
229394933$22939493$3$F$20230726$20240703$20230913$20240709$EXP$$CA-TAKEDA-2023TUS087538$TAKEDA$$38$YR$$F$Y$$$20240709$$HP$CA$CA
229395325$22939532$5$F$20230101$20240905$20230913$20240925$EXP$$US-SA-2023SA276806$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240925$$MD$US$US
229395342$22939534$2$F$$20240826$20230913$20240828$PER$$US-AMGEN-USASP2023162421$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
229395455$22939545$5$F$20230101$20240831$20230913$20240910$EXP$$US-SA-2023SA278119$SANOFI AVENTIS$$61$YR$A$F$Y$65.3$KG$20240910$$MD$US$US
229396502$22939650$2$F$$20240708$20230913$20240717$PER$$US-SA-2023SA277155$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240717$$MD$US$US
229396773$22939677$3$F$20230901$20240715$20230913$20240723$PER$$US-SA-2023SA278353$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240723$$MD$US$US
229397903$22939790$3$F$$20240729$20230913$20240802$PER$$NVSC2023US198083$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
229398486$22939848$6$F$20230101$20240814$20230913$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-129031$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240822$$CN$US$US
229399984$22939998$4$F$20220901$20240817$20230913$20240821$EXP$$FR-TAKEDA-2022TUS069212$TAKEDA$$8$YR$$F$Y$14$KG$20240821$$HP$FR$FR
229400462$22940046$2$F$$20230823$20230913$20240823$PER$$US-MYLANLABS-2023M1090476$MYLAN$$$$$F$Y$95.25$KG$20240823$$CN$US$US
229400824$22940082$4$F$$20240822$20230913$20240906$EXP$$PT-VALIDUS PHARMACEUTICALS LLC-PT-VDP-2023-016302$VALIDUS$$$$$$Y$$$20240906$$HP$PT$PT
229402206$22940220$6$F$20220317$20240902$20230913$20240905$EXP$$CO-TAKEDA-2022TUS022498$TAKEDA$$76$YR$$M$Y$56$KG$20240905$$CN$CO$CO
229402402$22940240$2$F$20200515$20240626$20230913$20240705$PER$$US-SA-2023SA276756$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240705$$MD$US$US
229403162$22940316$2$F$$20240819$20230913$20240909$PER$$US-INCYTE CORPORATION-2023IN008789$INCYTE$$$$$$Y$$$20240909$$CN$US$US
229403302$22940330$2$F$$20240911$20230913$20240926$PER$$US-SA-2023SA275889$SANOFI AVENTIS$$$$A$F$Y$72.73$KG$20240926$$MD$US$US
229403452$22940345$2$F$20230101$20240709$20230913$20240716$PER$$US-SA-2023SA275954$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240716$$MD$US$US
229404533$22940453$3$F$20230815$20240816$20230913$20240826$PER$$US-INCYTE CORPORATION-2023IN008834$INCYTE$$$$$$Y$$$20240826$$CN$US$US
229406604$22940660$4$F$$20240916$20230913$20240923$EXP$$CA-GSK-CA2023AMR122663$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$HP$CA$CA
229406883$22940688$3$F$$20240903$20230913$20240910$EXP$$CA-ORGANON-O2309CAN001658$ORGANON$$45$YR$$F$Y$97$KG$20240910$$HP$CA$CA
229408852$22940885$2$F$$20240815$20230913$20240819$PER$$NVSC2023US195848$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
229410435$22941043$5$F$20220608$20240827$20230913$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-129873$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$95.25$KG$20240830$$CN$US$US
229411247$22941124$7$F$20190901$20240827$20230913$20240902$EXP$$AT-SANDOZ INC.-NVSC2019AT011540$SANDOZ$$$$A$F$Y$67$KG$20240902$$MD$AT$AT
2294119318$22941193$18$F$20230101$20240920$20230913$20240924$EXP$$CA-HLS-202302152$HLS THERAPEUTICS$$67$YR$E$M$Y$$$20240924$$PH$CA$CA
229413219$22941321$9$F$20230907$20240830$20230913$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-128288$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240906$$CN$US$US
229414062$22941406$2$F$$20230726$20230914$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-01794$AMNEAL$$$$$$Y$$$20240909$$CN$US$US
229415373$22941537$3$F$20230101$20240813$20230914$20240821$PER$$US-SA-2023SA275563$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240821$$MD$US$US
229415814$22941581$4$F$20230824$20240722$20230914$20240808$PER$$CA-TOLMAR, INC.-23CA042905$TOLMAR$$79$YR$$M$Y$$$20240808$$CN$CA$CA
229415862$22941586$2$F$20240723$20240723$20230914$20240819$PER$$CA-TOLMAR, INC.-23CA042933$TOLMAR$$73$YR$$M$Y$$$20240814$$CN$CA$CA
229415873$22941587$3$F$$20240725$20230914$20240819$PER$$CA-TOLMAR, INC.-23CA042946$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
229415884$22941588$4$F$20231214$20240722$20230914$20240808$PER$$CA-TOLMAR, INC.-23CA042945$TOLMAR$$80$YR$$M$Y$$$20240808$$CN$CA$CA
229415913$22941591$3$F$$20240728$20230914$20240820$PER$$CA-TOLMAR, INC.-23CA042922$TOLMAR$$$$$M$Y$$$20240820$$CN$CA$CA
229416162$22941616$2$F$$20240819$20230914$20240819$PER$$NVSC2023US198450$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
229416592$22941659$2$F$20230101$20240805$20230914$20240813$PER$$US-SA-2023SA274322$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240814$$MD$US$US
229416913$22941691$3$F$20230101$20240725$20230914$20240802$EXP$$CA-CELLTRION INC.-2023CA014707$CELLTRION$$$$$$Y$$$20240802$$HP$CA$CA
229416968$22941696$8$F$20230101$20240711$20230914$20240718$PER$$US-SA-2023SA276026$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240719$$MD$US$US
229417432$22941743$2$F$$20240910$20230914$20240920$EXP$$CA-SANDOZ INC.-NVSC2021CA113974$SANDOZ$$50$YR$$M$Y$$$20240920$$CN$CA$CA
2294174622$22941746$22$F$20230816$20240909$20230914$20240916$EXP$$US-TAKEDA-2023TUS086739$TAKEDA$$24$YR$$F$Y$90$KG$20240916$$HP$US$US
229417905$22941790$5$F$20230901$20240812$20230914$20240816$EXP$$US-KYOWAKIRIN-2023KK014265$KYOWA$$$$$$Y$$$20240816$$HP$US$US
229418102$22941810$2$F$20230101$20240823$20230914$20240826$PER$$NVSC2023US198434$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
229418262$22941826$2$F$20230101$20240628$20230914$20240703$EXP$$JP-009507513-2309JPN001536J$MERCK$$8$DEC$$$Y$$$20240703$$MD$JP$JP
2294185810$22941858$10$F$20230301$20240912$20230914$20240919$EXP$$FR-EXELIXIS-XL18423063378$EXELIXIS$$$$$$Y$$$20240919$$MD$FR$FR
229419117$22941911$7$F$20230908$20240807$20230914$20240813$EXP$$CA-ABBVIE-5405097$ABBVIE$$23$YR$$M$Y$$$20240813$$MD$CA$CA
229419472$22941947$2$F$20230724$20240812$20230914$20240823$EXP$FR-AFSSAPS-AM2023000746$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-097807$ZYDUS PHARM$$$$$$Y$$$20240823$$MD$FR$FR
2294196310$22941963$10$F$20231031$20240904$20230914$20240910$EXP$$CA-TAKEDA-2023TUS075013$TAKEDA$$2$YR$$F$Y$9.97$KG$20240910$$CN$CA$CA
229419692$22941969$2$F$$20240625$20230914$20240701$EXP$$NVSC2023AR189835$NOVARTIS$$$$$F$Y$$$20240701$$CN$AR$AR
229420992$22942099$2$F$$20240701$20230914$20240705$EXP$GB-MHRA-MED-202308261215089510-NJVSR$GB-SANDOZ INC.-SDZ2023GB027628$SANDOZ$$$$$M$Y$$$20240705$$CN$GB$GB
229421077$22942107$7$F$20230905$20240802$20230914$20240812$EXP$$US-GSK-US2023122468$GLAXOSMITHKLINE$$68$YR$$F$Y$55.3$KG$20240812$$CN$US$US
229421362$22942136$2$F$20230612$20240819$20230914$20240822$EXP$$FI-ROCHE-3375880$ROCHE$$19$YR$A$M$Y$85$KG$20240822$$MD$FI$FI
229422638$22942263$8$F$$20240905$20230914$20240912$EXP$$CA-ROCHE-3418753$ROCHE$$50$YR$A$F$Y$68$KG$20240912$$HP$CA$CA
229423552$22942355$2$F$20230904$20240830$20230914$20240904$EXP$$CN-CHEPLA-2023011278$CHEPLAPHARM$$69$YR$$M$Y$55.9$KG$20240904$$MD$COUNTRY NOT SPECIFIED$CN
229423606$22942360$6$F$20230730$20240830$20230914$20240909$EXP$$JP-ROCHE-3421098$ROCHE$$84$YR$E$M$Y$47.9$KG$20240909$$MD$JP$JP
229424325$22942432$5$F$20230826$20240719$20230914$20240725$EXP$$JP-GSK-JP2023124180$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$JP$JP
229424562$22942456$2$F$$20240903$20230914$20240905$EXP$$CA-ROCHE-3422288$ROCHE$$$$A$F$Y$$$20240905$$CN$CA$CA
229424665$22942466$5$F$20230101$20240626$20230914$20240701$PER$$US-AMGEN-USASP2023163208$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
229424892$22942489$2$F$$20240820$20230914$20240820$PER$$NVSC2023US197682$NOVARTIS$$$$$M$Y$$$20240820$$MD$US$US
229427118$22942711$8$F$20230101$20240814$20230914$20240822$EXP$$US-INSMED, INC.-2023-03408-US$INSMED$$$$$M$Y$$$20240822$$CN$US$US
229427658$22942765$8$F$20230501$20240709$20230914$20240712$EXP$$NVSC2023CA138697$NOVARTIS$$55$YR$$M$Y$$$20240712$$CN$CA$CA
229428258$22942825$8$F$20240917$20240912$20230914$20240920$EXP$$CA-TAKEDA-2023TUS086405$TAKEDA$$65$YR$$F$Y$$$20240920$$HP$CA$CA
229428463$22942846$3$F$20240501$20240821$20230914$20240829$EXP$$US-BIOGEN-2023BI01225206$BIOGEN$$49$YR$$F$Y$$$20240829$$CN$US$US
229428483$22942848$3$F$$20240723$20230914$20240730$PER$$US-PHARMING-PHAUS2023000663$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
229429505$22942950$5$F$20240501$20240808$20230914$20240816$EXP$$CO-SANDOZ INC.-NVSC2022CO144701$SANDOZ$$70$YR$$F$Y$74$KG$20240816$$CN$CO$CO
229431652$22943165$2$F$20230617$20240703$20230914$20240709$EXP$$FR-MYLANLABS-2023M1096965$MYLAN$$54$YR$$F$Y$83$KG$20240709$$MD$FR$FR
229433023$22943302$3$F$$20240627$20230914$20240819$PER$$US-MYLANLABS-2023M1096436$BIOCON$$$$$$Y$$$20240819$$CN$US$US
229433322$22943332$2$F$$20240723$20230914$20240726$EXP$$NVSC2023EG187265$NOVARTIS$$$$$M$Y$2$KG$20240726$$CN$EG$EG
229434088$22943408$8$F$20230101$20240904$20230914$20240909$EXP$$IN-PFIZER INC-PV202300119398$PFIZER$$54$YR$$F$Y$$$20240909$$CN$IN$IN
229434334$22943433$4$F$20210304$20240924$20230914$20240930$EXP$$IN-PFIZER INC-2020222306$PFIZER$$65$YR$$F$Y$68$KG$20240930$$CN$IN$IN
229434562$22943456$2$F$20221201$20240827$20230914$20240827$EXP$$NVSC2023US198376$NOVARTIS$$59$YR$$M$Y$$$20240827$$CN$US$US
2294348514$22943485$14$F$20230501$20240823$20230914$20240828$EXP$$DE-EXELIXIS-XL18423064873$EXELIXIS$$$$$$Y$$$20240828$$MD$DE$DE
229435113$22943511$3$F$$20240727$20230914$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07732$LUPIN$$$$$$Y$$$20240816$$CN$US$US
2294354610$22943546$10$F$20200104$20240919$20230914$20240924$EXP$$US-PAREXEL-2021-KAM-US003428$TAKEDA$$77$YR$$F$Y$81$KG$20240924$$HP$US$US
229435543$22943554$3$F$$20240727$20230914$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07743$LUPIN$$$$$$Y$$$20240818$$CN$US$US
229435804$22943580$4$F$$20240723$20230914$20240726$EXP$$NVSC2023AU042131$NOVARTIS$$$$$F$Y$$$20240726$$HP$AU$AU
229438396$22943839$6$F$20230101$20240918$20230914$20240926$EXP$$CA-PFIZER INC-202300133294$PFIZER$$83$YR$$F$Y$57$KG$20240926$$MD$CA$CA
229439693$22943969$3$F$20230912$20240906$20230914$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-130065$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$$$20240910$$HP$US$US
229441142$22944114$2$F$$20240621$20230914$20240701$EXP$$NVSC2023US198751$NOVARTIS$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. ALLERGY, ASTHMA AND CLINICAL IMMUNOLOGY. 2023;19(1):78$39$YR$$M$Y$$$20240701$$HP$US$US
229441173$22944117$3$F$20220506$20240827$20230914$20240830$EXP$$NVSC2023US198454$NOVARTIS$$43$YR$$F$Y$$$20240830$$CN$US$US
229441227$22944122$7$F$20230101$20240815$20230914$20240819$EXP$$CA-PFIZER INC-202300265944$PFIZER$$63$YR$$M$Y$$$20240819$$HP$CA$CA
229442163$22944216$3$F$20240701$20240717$20230914$20240726$PER$$US-SA-2023SA279202$SANOFI AVENTIS$$$$A$F$Y$113$KG$20240726$$MD$US$US
229442682$22944268$2$F$20240101$20240715$20230914$20240724$PER$$US-SA-2022SA496696$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240724$$CN$US$US
229443303$22944330$3$F$20230101$20240925$20230914$20240930$PER$$US-SA-2023SA228341$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240930$$MD$US$US
229443574$22944357$4$F$$20240807$20230914$20240822$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408023$RANBAXY$$$$E$M$Y$$$20240822$$CN$US$US
229444052$22944405$2$F$$20240902$20230914$20240917$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408044$RANBAXY$Gomez-Aguilar F, Martinez-Sanchez L, Arias-Constanti V, Munoz-Santanach D, Sarquella-Brugada G. QT prolongation and Torsade de Pointes in a 13-year-old transgender adolescent in treatment with bicalutamide and tacrolimus. Clin Toxicol. 2023;61 (1):81 (170)$13$YR$$F$Y$$$20240917$$HP$ES$ES
229445843$22944584$3$F$$20240913$20230914$20240925$EXP$$PL-AUROBINDO-AUR-APL-2023-051244$AUROBINDO$Frankiewicz Z, Splocharski G, Mosakowska M, Rymarz A, Niemczyk S. CEWKOWO-?R?DMI??SZOWE ZAPALENIE NEREK ? SERIA PRZYPADK?W Z JEDNEGO O?RODKA(Tubulointerstitial nephritis - a case report series from one center). MILITARY DOCTOR (LEKARZ WOJSKOWY). 2023;101(2):142-147$20$YR$$F$Y$$$20240925$$HP$PL$PL
229446403$22944640$3$F$20230801$20240820$20230914$20240822$EXP$$FR-AMGEN-FRANI2023159076$AMGEN$$53$YR$A$F$Y$$$20240822$$HP$FR$FR
229446706$22944670$6$F$20230830$20240917$20230914$20240925$PER$$US-SA-2023SA275851$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240925$$MD$US$US
229446885$22944688$5$F$20230101$20240730$20230914$20240809$EXP$$US-SA-2023SA275175$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240809$$MD$US$US
229447738$22944773$8$F$$20240726$20230914$20240801$EXP$$NVSC2023US198814$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
229449242$22944924$2$F$20230309$20240829$20230914$20240830$EXP$$NVSC2023US198462$NOVARTIS$$80$YR$$F$Y$44.4$KG$20240830$$CN$US$US
229449482$22944948$2$F$$20240702$20230914$20240704$EXP$$CA-TAKEDA-2023TUS017898$TAKEDA$$$$$F$Y$$$20240704$$CN$CA$CA
229449704$22944970$4$F$$20240729$20230914$20240731$PER$$US-PFIZER INC-202300295597$PFIZER$$85$YR$$F$Y$66.68$KG$20240731$$CN$US$US
229449806$22944980$6$F$$20240910$20230914$20240913$PER$$US-PFIZER INC-PV202300098924$PFIZER$$77$YR$$F$Y$77.098$KG$20240913$$CN$US$US
229449933$22944993$3$F$$20240730$20230914$20240802$PER$$US-PFIZER INC-PV202300154069$PFIZER$$67$YR$$F$Y$$$20240802$$CN$US$US
229449954$22944995$4$F$$20240827$20230914$20240830$PER$$US-PFIZER INC-PV202300154083$PFIZER$$65$YR$$M$Y$74.84$KG$20240830$$CN$US$US
229450035$22945003$5$F$20240901$20240919$20230914$20240923$PER$$US-PFIZER INC-PV202300154926$PFIZER$$50$YR$$F$Y$$$20240923$$CN$US$US
229450205$22945020$5$F$20230101$20240903$20230914$20240911$EXP$$CA-TAKEDA-2023TUS033832$TAKEDA$$$$$M$Y$118$KG$20240911$$CN$CA$CA
229451022$22945102$2$F$20230101$20240709$20230914$20240711$PER$$US-PFIZER INC-PV202300154077$PFIZER$$80$YR$$F$Y$$$20240711$$CN$US$US
229453703$22945370$3$F$$20240702$20230914$20240705$EXP$$GB-SANDOZ INC.-SDZ2023GB012716$SANDOZ$$38$YR$$M$Y$$$20240705$$MD$GB$GB
229455837$22945583$7$F$20201223$20240831$20230914$20240906$EXP$$MX-TAKEDA-2021TUS000362$TAKEDA$$3$YR$$M$Y$23$KG$20240906$$CN$MX$MX
229455953$22945595$3$F$20210519$20240724$20230914$20240730$EXP$$CA-SANDOZ INC.-NVSC2021CA120972$SANDOZ$$79$YR$$M$Y$$$20240730$$CN$CA$CA
229456113$22945611$3$F$$20240627$20230914$20240701$EXP$$CA-TAKEDA-2023TUS088016$TAKEDA$$$$$F$Y$$$20240701$$CN$CA$CA
229456227$22945622$7$F$20220101$20240904$20230914$20240911$EXP$$CO-BIOGEN-2023BI01195992$BIOGEN$$$$$M$Y$21$KG$20240911$$CN$CO$CO
229456499$22945649$9$F$20221201$20240906$20230914$20240912$EXP$$GT-SANDOZ INC.-NVSC2022GT298503$SANDOZ$$57$YR$$F$Y$$$20240912$$CN$GT$GT
2294579910$22945799$10$F$20230614$20240827$20230914$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-128929$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$62.9$KG$20240904$$PH$JP$JP
229458984$22945898$4$F$20220801$20240917$20230914$20240920$EXP$$JP-TAKEDA-2022TJP069270$TAKEDA$$62$YR$$M$Y$60.7$KG$20240920$$MD$JP$JP
229459186$22945918$6$F$20230817$20240620$20230915$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003654$ACADIA PHARMACEUTICALS$$33$YR$$F$Y$$$20240712$$CN$US$US
229460044$22946004$4$F$$20240902$20230915$20240923$PER$$AU-TOLMAR, INC.-23AU042970$TOLMAR$$$$$M$Y$$$20240923$$CN$AU$AU
229460202$22946020$2$F$$20240702$20230915$20240703$EXP$$NVSC2023GB195849$NOVARTIS$$75$YR$$M$Y$$$20240703$$CN$GB$GB
229462052$22946205$2$F$20230801$20230905$20230915$20240925$PER$$US-GSK-US2023AMR121165$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
229462476$22946247$6$F$$20231128$20230915$20240926$EXP$$US-GSK-US2023AMR122618$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
229462624$22946262$4$F$$20240906$20230915$20240910$EXP$$CA-ROCHE-3422089$ROCHE$$14$YR$T$M$Y$50$KG$20240910$$HP$CA$CA
229462834$22946283$4$F$$20230918$20230915$20240925$EXP$$US-GSK-US2023AMR122662$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
229464742$22946474$2$F$$20240610$20230915$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003626$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
229464845$22946484$5$F$20230904$20240226$20230915$20240923$EXP$$NVSC2023US198609$NOVARTIS$$67$YR$$F$Y$$$20240923$$CN$US$US
229466173$22946617$3$F$20240901$20240904$20230915$20240909$EXP$$US-BEH-2023163126$CSL BEHRING$$63$YR$A$F$Y$$$20240909$$HP$US$US
229466417$22946641$7$F$$20240820$20230915$20240822$EXP$$CA-ROCHE-3408026$ROCHE$$$$A$F$Y$$$20240822$$MD$CA$CA
229466533$22946653$3$F$20230724$20240814$20230915$20240823$EXP$FR-AFSSAPS-AM2023000746$FR-TEVA-2023-FR-2925455$TEVA$$78$YR$$M$Y$80$KG$20240823$$MD$FR$FR
229466603$22946660$3$F$$20240824$20230915$20240826$PER$$NVSC2023US199599$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
229467113$22946711$3$F$20230829$20240703$20230915$20240711$30DAY$$US-GSK-US2023121484$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240711$$CN$US$US
229467128$22946712$8$F$20000916$20240924$20230915$20240926$EXP$$DE-SANDOZ INC.-NVSC2018DE014390$SANDOZ$$86$YR$$F$Y$56$KG$20240926$$CN$DE$DE
229467149$22946714$9$F$20230101$20240705$20230915$20240713$EXP$$CA-CELLTRION INC.-2023CA003484$CELLTRION$$$$$$Y$$$20240713$$HP$CA$CA
229467794$22946779$4$F$$20240625$20230915$20240709$EXP$$NVSC2023MY199163$NOVARTIS$$$$$M$Y$$$20240709$$CN$MY$MY
229468164$22946816$4$F$20230825$20240729$20230915$20240821$PER$$CA-TOLMAR, INC.-23CA042953$TOLMAR$$71$YR$$M$Y$$$20240821$$CN$CA$CA
2294686510$22946865$10$F$$20240806$20230915$20240813$EXP$$US-GSK-US2023123636$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
2294688712$22946887$12$F$20230801$20240717$20230915$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003616$ACADIA PHARMACEUTICALS$$37$YR$$F$Y$59$KG$20240809$$CN$US$US
229469427$22946942$7$F$20240723$20240724$20230915$20240729$EXP$$CA-TAKEDA-2023TUS088966$TAKEDA$$73$YR$$F$Y$$$20240729$$CN$CA$CA
229470202$22947020$2$F$20220812$20240723$20230915$20240730$EXP$$US-CHATTEMPRD-2023OHG006528$CHATTEM$$61$YR$E$M$Y$72.57$KG$20240730$$LW$US$US
229470352$22947035$2$F$20190522$20240626$20230915$20240707$EXP$$PL-SANDOZ INC.-NVSC2021PL058600$SANDOZ$$46$YR$$M$Y$$$20240707$$MD$PL$PL
229470462$22947046$2$F$$20240731$20230915$20240813$EXP$$CA-AUROBINDO-AUR-APL-2023-057785$AUROBINDO$Croitoru DO, Seigel K, Nathanielsz N, Elsawi R, Silverberg MS, Piguet V, et al.. Treatment of severe hidradenitis Suppurativa and Fistulizing Crohn^s disease with Guselkumab.. Journal European Academy of Dermatology and Venereology. 2022;36(7):e563-e565$43$YR$$M$Y$$$20240813$$HP$CA$CA
229474282$22947428$2$F$$20230905$20230915$20240927$PER$$US-LEO Pharma-362719$LEO PHARM$$52$YR$$F$Y$$$20240927$$PH$US$US
229474373$22947437$3$F$20230101$20240221$20230915$20240710$PER$$US-ROCHE-3349938$ROCHE$$52$YR$A$M$Y$$$20240628$$CN$US$US
229474612$22947461$2$F$$20230905$20230915$20240927$PER$$US-LEO Pharma-362525$LEO PHARM$$56$YR$$M$Y$$$20240927$$MD$US$US
229476495$22947649$5$F$20240401$20240806$20230915$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-131269$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240807$$HP$US$US
2294775410$22947754$10$F$20230101$20240827$20230915$20240910$EXP$$CA-UCBSA-2023044889$UCB$$$$$M$Y$$$20240910$$CN$CA$CA
229477552$22947755$2$F$20230301$20240729$20230915$20240806$EXP$$US-GSK-US2023123228$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240806$$CN$US$US
229477564$22947756$4$F$$20240709$20230915$20240711$PER$$NVSC2023US199621$NOVARTIS$$$$$F$Y$$$20240711$$CN$US$US
229477592$22947759$2$F$$20240829$20230915$20240829$PER$$NVSC2023US198081$NOVARTIS$$$$$M$Y$$$20240830$$MD$US$US
229480178$22948017$8$F$20230101$20240619$20230915$20240807$EXP$$NVSC2023BR197902$NOVARTIS$$$$$F$Y$$$20240807$$CN$BR$BR
229480962$22948096$2$F$20230101$20240725$20230915$20240805$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2023-113214$REGENERON$$65$YR$$M$Y$$$20240805$$HP$CO$CO
229482922$22948292$2$F$20230807$20230908$20230915$20240726$EXP$$CN-ROCHE-3419672$ROCHE$$65$YR$E$M$Y$80$KG$20240726$$HP$CN$CN
2294833216$22948332$16$F$20230101$20240917$20230915$20240926$EXP$$CA-CELLTRION INC.-2023CA017977$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
229484304$22948430$4$F$20230101$20240815$20230915$20240822$PER$$US-BIOGEN-2023BI01226132$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
229484513$22948451$3$F$20221001$20240625$20230915$20240702$EXP$$NVSC2023DE196284$NOVARTIS$$$$A$F$Y$98$KG$20240702$$MD$DE$DE
229484702$22948470$2$F$20221103$20240729$20230915$20240731$EXP$$GB-SANDOZ INC.-SDZ2023GB028388$SANDOZ$$1$HR$$F$Y$$$20240731$$HP$GB$GB
229485352$22948535$2$F$$20240718$20230915$20240723$EXP$$NVSC2023US198133$NOVARTIS$$$$$M$Y$$$20240724$$CN$US$US
229485664$22948566$4$F$20230914$20240816$20230915$20240820$PER$$NVSC2023US199662$NOVARTIS$$46$YR$$M$Y$$$20240820$$CN$US$US
229486152$22948615$2$F$20230101$20240628$20230915$20240712$PER$$US-SA-2023SA275231$SANOFI AVENTIS$$16$YR$T$M$Y$58.01$KG$20240712$$MD$US$US
229486543$22948654$3$F$20220101$20240806$20230915$20240816$PER$$US-SA-2023SA275859$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240816$$MD$US$US
229486753$22948675$3$F$20230101$20240903$20230915$20240912$PER$$US-SA-2023SA276731$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240912$$MD$US$US
229487092$22948709$2$F$$20240729$20230915$20240807$PER$$US-SA-2023SA281708$SANOFI AVENTIS$$$$E$F$Y$57.606$KG$20240807$$MD$US$US
229487463$22948746$3$F$$20240904$20230915$20240913$PER$$US-SA-2023SA279917$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240913$$MD$US$US
229487804$22948780$4$F$20230101$20240710$20230915$20240717$PER$$US-SA-2023SA281230$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240717$$MD$US$US
229488192$22948819$2$F$$20230908$20230915$20240829$PER$$US-MYLANLABS-2023M1097482$BIOCON$$$$$F$Y$$$20240829$$$US$US
229488593$22948859$3$F$20230815$20240628$20230915$20240708$EXP$$DE-AUROBINDO-AUR-APL-2023-057899$AUROBINDO$$67$YR$$F$Y$70$KG$20240708$$MD$DE$DE
229490317$22949031$7$F$20200625$20240807$20230915$20240810$EXP$$CA-TAKEDA-2023TUS040363$TAKEDA$$75$YR$$F$Y$$$20240810$$MD$CA$CA
229490325$22949032$5$F$20211027$20240815$20230915$20240821$EXP$$CA-TAKEDA-2021TUS068356$TAKEDA$$47$YR$$M$Y$$$20240821$$CN$CA$CA
229490332$22949033$2$F$$20240830$20230915$20240909$PER$$US-SA-2023SA280384$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240909$$PH$US$US
229490542$22949054$2$F$$20240805$20230915$20240807$EXP$$US-KYOWAKIRIN-2023KK014340$KYOWA$$$$$$Y$$$20240807$$HP$US$US
229491052$22949105$2$F$$20230908$20230915$20240930$PER$$US-LEO Pharma-362774$LEO PHARM$$70$YR$$M$Y$$$20240930$$PH$US$US
2294915414$22949154$14$F$20210729$20240923$20230915$20240927$EXP$$CO-TAKEDA-2021TUS001128$TAKEDA$$17$YR$$F$Y$58$KG$20240927$$CN$CO$CO
229494472$22949447$2$F$20230908$20240916$20230915$20240917$PER$$NVSC2023US200036$NOVARTIS$$44$YR$$F$Y$$$20240917$$CN$US$US
229494682$22949468$2$F$20230301$20240429$20230915$20240723$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0700079$MYOVANT SCIENCES$$40$YR$$F$Y$$$20240723$$CN$US$US
229494832$22949483$2$F$20230601$20240729$20230915$20240826$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0600830$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
229495346$22949534$6$F$20230101$20240819$20230915$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-131065$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$64.86$KG$20240823$$CN$US$US
229495816$22949581$6$F$20220601$20240314$20230915$20240812$EXP$$GT-SANDOZ INC.-NVSC2022GT262901$SANDOZ$$42$YR$$F$Y$$$20240812$$CN$GT$GT
229495905$22949590$5$F$$20240701$20230915$20240709$PER$$US-PFIZER INC-PV202300102191$PFIZER$$27$YR$$M$Y$$$20240709$$MD$US$US
229498394$22949839$4$F$20230402$20240903$20230915$20240904$EXP$$JP-ABBVIE-5409961$ABBVIE$$77$YR$$F$Y$$$20240904$$MD$JP$JP
229498524$22949852$4$F$20230101$20240708$20230915$20240715$EXP$$NVSC2023FR174718$NOVARTIS$$64$YR$$M$Y$108$KG$20240715$$CN$FR$FR
229500423$22950042$3$F$20240101$20240919$20230915$20240924$PER$$US-PFIZER INC-PV202300155848$PFIZER$$66$YR$$M$Y$$$20240924$$HP$US$US
229500453$22950045$3$F$20220101$20240724$20230915$20240726$PER$$US-PFIZER INC-US-GBT-018887$PFIZER$$26$YR$$F$Y$$$20240726$$CN$US$US
229501302$22950130$2$F$$20240814$20230915$20240816$EXP$$IT-ROCHE-3422433$ROCHE$Lania A, Antonini S, Pedersini R, et al. Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.. Journal of Endocrinological Investigation.. 2023;1-10. doi:10.1007/s40618-023-02174-5.$$$$F$Y$$$20240816$$HP$IT$IT
229501373$22950137$3$F$20201201$20230912$20230915$20240815$EXP$$FR-AstraZeneca-2023A210219$ASTRAZENECA$$54$YR$$F$Y$$$20240815$$MD$FR$
229501673$22950167$3$F$20230825$20240628$20230915$20240705$EXP$$US-TAKEDA-2023TUS083800$TAKEDA$$68$YR$$M$Y$81.6$KG$20240705$$CN$US$US
229502953$22950295$3$F$$20240812$20230915$20240815$EXP$$US-PFIZER INC-PV202300154309$PFIZER$$69$YR$$M$Y$$$20240815$$CN$US$US
229503084$22950308$4$F$19970101$20240717$20230915$20240718$EXP$$US-PFIZER INC-PV202300155560$PFIZER$$52$YR$$F$Y$54.422$KG$20240718$$CN$US$US
229503504$22950350$4$F$20220101$20240816$20230915$20240823$EXP$$US-LUNDBECK-DKLU3067639$LUNDBECK$J. James,C. Watson,M. Burns. Chronic Doxepin Toxicity Masquerading as Epilepsy in a 10-Year-Old Boy. Journal of Medical Toxicology. 2023;UNK:UNK-UNK$$$$$Y$$$20240823$$HP$US$US
229505252$22950525$2$F$$20230809$20230915$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00553$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
229505977$22950597$7$F$$20240916$20230915$20240927$EXP$$CA-CIPHER-2023-CA-000419$CIPHER$$65$YR$E$F$Y$34$KG$20240927$$HP$CA$CA
229506073$22950607$3$F$$20240801$20230915$20240826$30DAY$$US-GSK-US2023122389$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
229506403$22950640$3$F$20230101$20240906$20230916$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2023-026019$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240914$$$US$US
229506892$22950689$2$F$20230101$20240904$20230916$20240926$PER$$US-SA-2023SA277949$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240926$$MD$US$US
2295072112$22950721$12$F$20230101$20240812$20230916$20240820$EXP$$CA-CELLTRION INC.-2023CA018046$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
229507833$22950783$3$F$20230810$20240814$20230916$20240828$PER$$US-SA-2023SA281803$SANOFI AVENTIS$$2$YR$C$F$Y$17.69$KG$20240828$$MD$US$US
229508002$22950800$2$F$20230801$20240620$20230916$20240702$PER$$US-SA-2023SA277600$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240702$$MD$US$US
229508024$22950802$4$F$$20240812$20230916$20240821$PER$$US-SA-2023SA282225$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240821$$MD$US$US
229508752$22950875$2$F$20230101$20240814$20230916$20240828$PER$$US-SA-2023SA281889$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240828$$MD$US$US
229509442$22950944$2$F$$20240829$20230916$20240910$EXP$$JP-Accord-377615$ACCORD$Takiguchi N, Hata T, Saito T, Sekido Y, Hamabe A, Ogino T, et al. A case of fulminant amoebic colitis during systemic chemotherapy for gastric cancer. Clinical Journal of Gastroenterology. 2023;16(5):689-92$65$YR$E$M$Y$$$20240910$$MD$JP$JP
229510582$22951058$2$F$$20240710$20230916$20240717$30DAY$$US-SANDOZ INC.-SDZ2023US029035$SANDOZ$$$$$M$Y$$$20240717$$MD$US$US
229511523$22951152$3$F$20180201$20240708$20230916$20240710$EXP$$CA-SANDOZ INC.-PHHY2017CA127737$SANDOZ$$65$YR$$F$Y$$$20240710$$CN$CA$CA
229512343$22951234$3$F$$20240809$20230917$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07801$LUPIN$$$$$$Y$$$20240829$$CN$US$US
229512514$22951251$4$F$$20240915$20230917$20240920$EXP$$ES-VELOXIS PHARMACEUTICALS, INC.-2020-VEL-00479$VELOXIS PHARMACEUTICALS$Cases-Corona C, Shabaka A, Gonzalez-Lopez A, Martin-Segarra O, Moreno de la Higuera MA, Lucena R et al.. Fulminant emphysematous pyelonephritis by candida glabrata in a kidney allograft.. Nephron. 2020;144(6):304-9$56$YR$$F$Y$$$20240920$$MD$ES$ES
229513912$22951391$2$F$$20240917$20230917$20240925$EXP$$CA-CELLTRION INC.-2023CA015341$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
229513943$22951394$3$F$20230815$20240729$20230917$20240730$EXP$$CA-ROCHE-3278353$ROCHE$$29$YR$A$F$Y$$$20240730$$CN$CA$CA
229514977$22951497$7$F$20230101$20240722$20230918$20240727$EXP$$US-ABBVIE-5406248$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
229515017$22951501$7$F$20230801$20240810$20230918$20240812$EXP$$DE-TAKEDA-2023TUS087851$TAKEDA$$51$YR$$F$Y$$$20240812$$HP$DE$DE
229515173$22951517$3$F$20220101$20240730$20230918$20240822$PER$$CA-TOLMAR, INC.-23CA042994$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
229516813$22951681$3$F$$20230816$20230918$20240710$PER$$US-ROCHE-3405678$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
2295168311$22951683$11$F$20090101$20240919$20230918$20240924$EXP$$BR-TAKEDA-BR201817426$TAKEDA$$$$$M$Y$67$KG$20240924$$CN$BR$BR
229517112$22951711$2$F$$20230905$20230918$20240927$PER$$US-LEO Pharma-362763$LEO PHARM$$50$YR$$M$Y$$$20240927$$MD$US$US
229517848$22951784$8$F$20170101$20240625$20230918$20240703$EXP$$CA-SANDOZ INC.-PHHY2017CA188494$SANDOZ$$45$YR$$F$Y$$$20240703$$CN$CA$CA
229519354$22951935$4$F$20220101$20240826$20230918$20240905$EXP$$JP-009507513-2309JPN001899J$MERCK$$8$DEC$$M$Y$$$20240905$$MD$JP$JP
229519403$22951940$3$F$$20240802$20230918$20240808$PER$$US-BIOVITRUM-2023-US-014869$BIOVITRUM$$56$YR$$F$Y$$$20240808$$CN$US$US
229519623$22951962$3$F$$20240718$20230918$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019229$JAZZ$$$$$M$Y$$$20240724$$CN$US$US
229520072$22952007$2$F$20230826$20240718$20230918$20240722$EXP$$JP-ABBVIE-5380751$ABBVIE$$85$YR$$F$Y$$$20240722$$MD$JP$JP
229521763$22952176$3$F$20230909$20240917$20230918$20240919$EXP$$US-TAKEDA-2023TUS088701$TAKEDA$$0$YR$$M$Y$$$20240919$$CN$US$US
229522213$22952221$3$F$20230101$20240730$20230918$20240807$PER$$CA-TOLMAR, INC.-23CA043046$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
229522282$22952228$2$F$20230401$20240801$20230918$20240826$PER$$CO-TOLMAR, INC.-23CO042678$TOLMAR$$78$YR$$M$Y$65$KG$20240826$$CN$CO$CO
229522443$22952244$3$F$$20240807$20230918$20240812$EXP$$US-TAKEDA-US201829310$TAKEDA$$$$$F$Y$$$20240812$$HP$US$US
229523219$22952321$9$F$20230101$20240717$20230918$20240722$EXP$$US-UCBSA-2023045362$UCB$$$$$M$Y$23.8$KG$20240722$$CN$US$US
229523479$22952347$9$F$20230101$20240904$20230918$20240910$EXP$$CA-JNJFOC-20230764036$JOHNSON AND JOHNSON$$37$YR$A$F$Y$71$KG$20240910$$HP$CA$CA
229524243$22952424$3$F$20230101$20240625$20230918$20240704$PER$$US-SA-2023SA277357$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240704$$MD$US$US
229524946$22952494$6$F$20231002$20240805$20230918$20240814$PER$$US-SA-2023SA280438$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240814$$CN$US$US
2295264910$22952649$10$F$20220615$20240909$20230918$20240917$EXP$$CA-CELLTRION INC.-2022CA010285$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
229527013$22952701$3$F$$20240829$20230918$20240901$PER$$NVSC2023US199772$NOVARTIS$$$$$F$Y$$$20240901$$CN$US$US
229527822$22952782$2$F$$20240808$20230918$20240902$PER$$NVSC2023US199614$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
229528263$22952826$3$F$20201218$20240819$20230918$20240827$EXP$$CA-CELLTRION INC.-2020CA034838$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
229528314$22952831$4$F$20230801$20240814$20230918$20240818$PER$$NVSC2023US199657$NOVARTIS$$29$YR$$M$Y$$$20240818$$CN$US$US
229528632$22952863$2$F$$20240826$20230918$20240909$PER$$US-SA-2023SA278431$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240909$$MD$US$US
229529454$22952945$4$F$20230101$20240801$20230918$20240810$PER$$US-SA-2023SA279071$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240810$$MD$US$US
229530853$22953085$3$F$20230726$20240626$20230918$20240708$EXP$IT-MINISAL02-938232$IT-Accord-378939$ACCORD$Costantini I, Mantelli G, Carollo M, Losso L, Morando E, Bacchion M, et al. Not only Van Gogh: a case of BRASH syndrome with concomitant digoxin toxicity. J Med Case Rep. 2024 Jun 9;18(1):273. doi: 10.1186/s13256-024-04600-5.$66$YR$E$F$Y$80$KG$20240708$$MD$IT$IT
229531984$22953198$4$F$20230724$20240814$20230918$20240820$EXP$FR-AFSSAPS-AM2023000746$FR-MYLANLABS-2023M1097212$MYLAN$$78$YR$$M$Y$80$KG$20240820$$MD$FR$FR
2295320520$22953205$20$F$20230623$20240809$20230918$20240815$EXP$$DE-SA-2023SA203785$SANOFI AVENTIS$$67$YR$E$M$Y$84.1$KG$20240815$$HP$DE$DE
229532183$22953218$3$F$$20240823$20230918$20240902$EXP$$US-TAKEDA-2023TUS089915$TAKEDA$$$$$F$Y$$$20240902$$MD$US$US
229532772$22953277$2$F$$20240702$20230918$20240703$PER$$NVSC2023US199966$NOVARTIS$$$$$M$Y$$$20240703$$CN$US$US
229532963$22953296$3$F$20230913$20240829$20230918$20240830$PER$$US-AMGEN-USASP2023164482$AMGEN$$37$YR$A$M$Y$$$20240830$$CN$US$US
229533502$22953350$2$F$$20240819$20230918$20240821$EXP$$US-KYOWAKIRIN-2023KK014411$KYOWA$$$$$$Y$$$20240821$$HP$US$US
229534053$22953405$3$F$20230208$20240830$20230918$20240903$EXP$$DE-MYLANLABS-2023M1097603$MYLAN$$81$YR$$F$Y$63$KG$20240903$$MD$DE$DE
229535364$22953536$4$F$20230501$20240723$20230918$20240729$EXP$$US-TAKEDA-2023TUS061073$TAKEDA$$63$YR$$M$Y$92.06$KG$20240729$$HP$US$US
229536342$22953634$2$F$$20240825$20230918$20240826$PER$$NVSC2023US201261$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
229538907$22953890$7$F$20230811$20240926$20230918$20240930$EXP$$FR-PFIZER INC-PV202300153568$PFIZER$$62$YR$$M$Y$97$KG$20240930$$MD$FR$FR
229539123$22953912$3$F$$20240710$20230918$20240715$EXP$$US-SANDOZ INC.-SDZ2023US004966$SANDOZ$$$$$M$Y$$$20240715$$MD$US$US
229539243$22953924$3$F$$20240828$20230918$20240902$EXP$$CA-PFIZER INC-202300299893$PFIZER$$58$YR$$F$Y$$$20240902$$HP$CA$CA
229539254$22953925$4$F$$20240809$20230918$20240813$EXP$$US-PFIZER INC-202300300125$PFIZER$$75$YR$$M$Y$$$20240813$$HP$US$US
229540942$22954094$2$F$$20240827$20230918$20240829$EXP$$TR-ABBVIE-5408474$ABBVIE$$$$$M$Y$52$KG$20240829$$CN$TR$TR
229541104$22954110$4$F$$20240813$20230918$20240816$PER$$US-BIOGEN-2023BI01226093$BIOGEN$$$$$M$Y$$$20240816$$CN$US$US
229542582$22954258$2$F$$20240903$20230918$20240912$EXP$$CA-ROCHE-2879226$ROCHE$$$$A$F$Y$$$20240912$$MD$CA$CA
229542846$22954284$6$F$20230701$20240703$20230918$20240708$PER$$US-PFIZER INC-PV202300156450$PFIZER$$49$YR$$F$Y$$$20240708$$HP$US$US
229542856$22954285$6$F$$20240802$20230918$20240805$PER$$US-PFIZER INC-PV202300156151$PFIZER$$60$YR$$F$Y$$$20240805$$HP$US$US
229543702$22954370$2$F$$20240807$20230918$20240820$EXP$$HU-Accord-378859$ACCORD$Gabriella Mezei, Peter Batar, Arpad Illes, Robert Szasz. Differential Diagnosis of Hemorrhagic Colitis in Patient with Ph Acute Lymphoblastic Leukemia, after Several Years of Dasatinib Treatment. Can TKI be discontinued in Ph ALL$58$YR$A$F$Y$$$20240820$$MD$HU$HU
229544743$22954474$3$F$20240501$20240822$20230918$20240903$EXP$$US-SA-2023SA179070$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240903$$MD$US$US
229545052$22954505$2$F$$20240815$20230918$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-132000$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$55$KG$20240822$$HP$US$US
229546022$22954602$2$F$20230514$20240626$20230918$20240703$EXP$$CN-GSK-CN2023GSK127213$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CN$CN
229547724$22954772$4$F$20230904$20240910$20230918$20240917$EXP$$US-TAKEDA-2023TUS088621$TAKEDA$$58$YR$$F$Y$92$KG$20240917$$CN$US$US
229547977$22954797$7$F$20230814$20240926$20230918$20240930$EXP$$DE-MYLANLABS-2023M1098464$MYLAN$$6$YR$$M$Y$$$20240930$$MD$DE$DE
229548034$22954803$4$F$20230324$20240131$20230918$20240806$EXP$$NVSC2023AR200653$NOVARTIS$$64$YR$$M$Y$$$20240806$$CN$AR$AR
229550655$22955065$5$F$20230913$20240709$20230918$20240716$EXP$$CA-ROCHE-3423734$ROCHE$$32$YR$A$F$Y$$$20240716$$CN$CA$CA
229551256$22955125$6$F$20240601$20240828$20230918$20240902$EXP$$US-PFIZER INC-202300300711$PFIZER$$63$YR$$F$Y$$$20240902$$HP$US$US
229551735$22955173$5$F$20230817$20240711$20230918$20240725$PER$$US-Calliditas-2023CAL01181$CALLIDITAS THERAPEUTICS$$46$YR$A$F$Y$$$20240725$$CN$US$US
229552096$22955209$6$F$$20240801$20230918$20240805$EXP$$US-PFIZER INC-PV202300155591$PFIZER$$59$YR$$M$Y$$$20240805$$HP$US$US
229552418$22955241$8$F$20230101$20240923$20230918$20240930$EXP$$CA-TAKEDA-CA202009930$TAKEDA$$$$$M$Y$42.3$KG$20240930$$CN$CA$CA
229552625$22955262$5$F$20230201$20240716$20230918$20240722$EXP$$DE-MYLANLABS-2023M1097711$MYLAN$$27$YR$$F$Y$$$20240722$$CN$DE$DE
229552674$22955267$4$F$20230801$20240903$20230918$20240910$EXP$$BR-GSK-BR2023AMR122438$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$BR$BR
229553962$22955396$2$F$$20240823$20230918$20240828$EXP$$US-GSK-US2023GSK128022$GLAXOSMITHKLINE$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al. 2022 Annual report of the national poison data system (NPDS) from america?s poison Centers: 40th annual report. Clinical toxicology. 2023;61(10):717-939$$$$$Y$$$20240828$$HP$US$US
229554292$22955429$2$F$20230615$20240926$20230918$20240930$EXP$NL-LRB-00904555$NL-SANDOZ INC.-SDZ2023NL029223$SANDOZ$$$$N$F$Y$4.6$KG$20240930$$MD$NL$NL
229555102$22955510$2$F$$20230910$20230918$20240711$PER$$TR-PFM-2023-05016$PIERRE FABRE MEDICAMENT$Lim IV, Yurttas NO, Ayer M, Poturoglu S, Kinaci E, Ozden I. Entecavir-induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide. Clin Case Rep. 2023;11:e7741:1-6$39$YR$$F$Y$$$20240711$$HP$TR$TR
229555137$22955513$7$F$20230101$20240822$20230918$20240827$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-137758$DAIICHI$$$$$F$Y$$$20240827$$CN$US$US
229555233$22955523$3$F$$20240822$20230918$20240822$PER$$NVSC2023US200811$NOVARTIS$$$$$M$Y$$$20240822$$CN$US$US
229555462$22955546$2$F$$20240814$20230918$20240814$PER$$NVSC2023US200924$NOVARTIS$$$$$F$Y$$$20240814$$MD$US$US
229555492$22955549$2$F$$20240710$20230918$20240719$PER$$NVSC2023US201127$NOVARTIS$$$$$M$Y$$$20240720$$MD$US$US
229556022$22955602$2$F$$20240828$20230918$20240831$PER$$NVSC2023US201086$NOVARTIS$$$$$M$Y$117.93$KG$20240831$$HP$US$US
229556327$22955632$7$F$$20240919$20230918$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-130338$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$$$20240926$$CN$US$US
229556446$22955644$6$F$$20240722$20230918$20240725$EXP$$NVSJ2023JP013683$NOVARTIS$$39$YR$$M$Y$74$KG$20240726$$MD$JP$JP
229556526$22955652$6$F$20221223$20240917$20230918$20240918$EXP$$NVSJ2023JP010330$NOVARTIS$$53$YR$$F$Y$37.6$KG$20240919$$MD$JP$JP
229557863$22955786$3$F$$20240808$20230919$20240902$PER$$NVSC2023US200978$NOVARTIS$$42$YR$$F$Y$$$20240902$$HP$US$US
229558356$22955835$6$F$20200130$20240724$20230919$20240731$EXP$$CO-SANDOZ INC.-NVSC2020CO178285$SANDOZ$$54$YR$$F$Y$54$KG$20240731$$HP$CO$CO
229560923$22956092$3$F$$20240828$20230919$20240831$PER$$NVSC2023US201690$NOVARTIS$$$$$F$Y$$$20240831$$MD$US$US
229561035$22956103$5$F$20230722$20240806$20230919$20240813$EXP$$CA-CELLTRION INC.-2023CA015173$CELLTRION$$$$$$Y$$$20240813$$HP$CA$CA
229561433$22956143$3$F$$20240905$20230919$20240909$PER$$NVSC2023US198530$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
229561755$22956175$5$F$20220706$20240705$20230919$20240709$EXP$$US-UCBSA-2023045151$UCB$$65$YR$$F$Y$$$20240709$$HP$US$US
229561962$22956196$2$F$$20240827$20230919$20240830$PER$$NVSC2023US199837$NOVARTIS$$$$$F$Y$$$20240830$$PH$US$US
229562294$22956229$4$F$$20240809$20230919$20240812$EXP$$GR-SANDOZ INC.-SDZ2023GR029447$SANDOZ$$$$E$M$Y$$$20240812$$PH$GR$GR
229562727$22956272$7$F$20240301$20240709$20230919$20240711$EXP$$NVSJ2023JP013715$NOVARTIS$$$$T$M$Y$$$20240712$$MD$JP$JP
229563772$22956377$2$F$20190531$20240202$20230919$20240912$PER$$US-ALVOGEN-2021084129$ALVOGEN$$67$YR$$F$Y$$$20240912$$MD$US$US
229563913$22956391$3$F$20230821$20240821$20230919$20240828$EXP$$KR-CELLTRION INC.-2023KR017004$CELLTRION$$$$$$Y$$$20240828$$HP$KR$KR
229563965$22956396$5$F$$20240730$20230919$20240731$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-261983$BOEHRINGER INGELHEIM$Sakai W, Tanimoto M, Kanazawa T. Two cases of drug-induced intestinal cystic emphysematosis with intraperitoneal free gas that was relieved by conservative treatment. 2513.$64$YR$A$F$Y$$$20240731$$MD$JP$JP
229564192$22956419$2$F$$20230913$20230919$20240801$EXP$$NVSC2023US199972$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
229564533$22956453$3$F$20230901$20230925$20230919$20240925$PER$$US-GSK-US2023AMR125589$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
229564735$22956473$5$F$20230901$20240821$20230919$20240828$PER$$US-BIOGEN-2023BI01226300$BIOGEN$$15$YR$$M$Y$$$20240828$$MD$US$US
229564893$22956489$3$F$$20240624$20230919$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003703$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
229565392$22956539$2$F$$20240408$20230919$20240912$PER$$US-ALVOGEN-2021085331$ALVOGEN$$68$YR$$F$Y$$$20240912$$MD$US$US
229565435$22956543$5$F$$20240910$20230919$20240920$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2023AST000468$ASSERTIO THERAPEUTICS$$43$YR$$F$Y$97$KG$20240920$$HP$CA$CA
229565554$22956555$4$F$20190701$20240730$20230919$20240802$EXP$$PHHY2019CA163873$NOVARTIS$$47$YR$$F$Y$$$20240802$$CN$CA$CA
229565652$22956565$2$F$$20231107$20230919$20240912$PER$$US-ALVOGEN-2023091911$ALVOGEN$$66$YR$$M$Y$100.4$KG$20240912$$MD$US$US
229567819$22956781$9$F$20230101$20240702$20230919$20240709$EXP$$CA-CELLTRION INC.-2023CA005131$CELLTRION$$$$$$Y$$$20240709$$HP$CA$CA
229569963$22956996$3$F$$20240916$20230919$20240919$EXP$$GB-SANDOZ INC.-SDZ2023GB029867$SANDOZ$$$$$F$Y$$$20240919$$CN$GB$GB
229570022$22957002$2$F$20230901$20240829$20230919$20240902$PER$$US-AMGEN-USASP2023164842$AMGEN$$66$YR$E$F$Y$$$20240901$$CN$US$US
229570424$22957042$4$F$$20231020$20230919$20240926$EXP$$US-GSK-US2023AMR127387$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
229571048$22957104$8$F$$20240705$20230919$20240717$EXP$$DE-CLINUVEL INC-2146126$CLINUVEL$$67$YR$$F$Y$80$KG$20240717$$MD$DE$DE
229573953$22957395$3$F$$20240904$20230919$20240916$EXP$$US-MYOVANT SCIENCES GMBH-2023MYSCI0900356$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
229573963$22957396$3$F$$20240830$20230919$20240830$PER$$NVSC2023US198784$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
229574423$22957442$3$F$$20240625$20230919$20240702$EXP$$CA-SANDOZ INC.-NVSC2020CA069822$SANDOZ$$77$YR$$M$Y$$$20240702$$MD$CA$CA
229574974$22957497$4$F$$20240917$20230919$20240923$EXP$$NVSC2023MX200880$NOVARTIS$$$$$M$Y$$$20240923$$CN$MX$MX
229575276$22957527$6$F$$20240918$20230919$20240925$EXP$$NVSC2023US199967$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
229576564$22957656$4$F$$20240820$20230919$20240822$PER$$NVSC2023US196771$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
2295773410$22957734$10$F$20240209$20240711$20230919$20240715$EXP$$CA-UCBSA-2022039471$UCB$$96$YR$$F$Y$$$20240715$$CN$CA$CA
229578725$22957872$5$F$$20240823$20230919$20240828$PER$$US-PFIZER INC-PV202300156201$PFIZER$$56$YR$$F$Y$71.655$KG$20240828$$CN$US$US
229580452$22958045$2$F$$20230913$20230919$20240927$PER$$US-LEO Pharma-362834$LEO PHARM$$56$YR$$F$Y$$$20240927$$HP$US$US
229580794$22958079$4$F$20230818$20240729$20230919$20240801$EXP$$JP-PFIZER INC-PV202300156208$PFIZER$$80$YR$$M$Y$$$20240801$$MD$JP$JP
229581272$22958127$2$F$20230903$20240830$20230919$20240912$PER$$US-SA-2023SA279936$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240912$$MD$US$US
229581377$22958137$7$F$20230101$20240722$20230919$20240731$PER$$US-SA-2023SA277912$SANOFI AVENTIS$$16$YR$T$M$Y$68.03$KG$20240731$$MD$US$US
229581395$22958139$5$F$20230905$20240923$20230919$20240930$EXP$$US-SA-2023SA281316$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240930$$MD$US$US
229581425$22958142$5$F$20230101$20240312$20230919$20240813$PER$$US-SA-2023SA281517$SANOFI AVENTIS$$79$YR$E$F$Y$72.1$KG$20240814$$MD$US$US
229581683$22958168$3$F$20230801$20240909$20230919$20240918$PER$$US-SA-2023SA280410$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240918$$MD$US$US
229581895$22958189$5$F$20230901$20240703$20230919$20240712$PER$$US-SA-2023SA277845$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240712$$MD$US$US
229581982$22958198$2$F$20230101$20240731$20230919$20240808$PER$$US-SA-2023SA280282$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240808$$MD$US$US
229583032$22958303$2$F$20230801$20240717$20230919$20240724$PER$$US-SA-2023SA258472$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240724$$MD$US$US
229583622$22958362$2$F$20230818$20240711$20230919$20240715$EXP$FR-AFSSAPS-SE2023000765$FR-PFIZER INC-202300300568$PFIZER$$28$YR$$M$Y$97$KG$20240715$$MD$FR$FR
229583873$22958387$3$F$20230913$20240913$20230919$20240919$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019430$JAZZ$$16$YR$$F$Y$40.8$KG$20240919$$CN$US$US
229585448$22958544$8$F$20230429$20240822$20230919$20240829$EXP$$JP-LUNDBECK-DKLU3067847$LUNDBECK$$$$$$Y$$$20240829$$MD$JP$JP
229585973$22958597$3$F$20220101$20240920$20230919$20240930$EXP$$CA-AMGEN-CANSL2022205803$AMGEN$$46$YR$A$M$Y$$$20240930$$MD$CA$CA
229586005$22958600$5$F$20240725$20240725$20230919$20240731$EXP$$CA-TAKEDA-2023TUS090662$TAKEDA$$40$YR$$F$Y$$$20240731$$CN$CA$CA
229587142$22958714$2$F$$20240625$20230919$20240710$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408574$RANBAXY$Palasik M. Apalutamide treatment of locally advanced prostate cancer. OncoReview. 2023;13(1):31-32$85$YR$$M$Y$$$20240710$$MD$PL$PL
229588952$22958895$2$F$$20230906$20230919$20240710$PER$$US-ROCHE-3418028$ROCHE$$31$YR$A$M$Y$$$20240628$$CN$US$US
229589212$22958921$2$F$20230801$20240625$20230919$20240701$EXP$$JP-009507513-2308JPN000934J$MERCK$$66$YR$$F$Y$$$20240701$$MD$JP$JP
229590002$22959000$2$F$20230101$20240710$20230919$20240723$PER$$US-SA-2023SA279081$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240723$$MD$US$US
229590112$22959011$2$F$$20240827$20230919$20240905$PER$$US-BIOMARINAP-US-2023-152739$BIOMARIN$$$$$$Y$$$20240905$$CN$US$US
229590886$22959088$6$F$20221001$20240909$20230919$20240911$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-199759$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240911$$CN$CA$CA
229591233$22959123$3$F$$20240910$20230919$20240919$EXP$$CA-CELLTRION INC.-2023CA018136$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
229591502$22959150$2$F$20190101$20240806$20230920$20240808$EXP$$PR-ABBVIE-5410784$ABBVIE$$$$$F$Y$64.41$KG$20240808$$CN$PR$PR
229592793$22959279$3$F$20230522$20240710$20230920$20240716$EXP$$IT-ABBVIE-5408044$ABBVIE$$59$YR$$M$Y$$$20240716$$MD$IT$IT
229595323$22959532$3$F$$20240909$20230920$20240917$PER$$US-ROCHE-3424597$ROCHE$Pacholec M, Sami F, Newell K and Atrouni W Fatal disseminated Mycobacterium haemophilum infection involving the central nervous system in a renal transplant recipient. DOi: 10.1016/j.jctube.2020.100197. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2020;21:1-7.$65$YR$E$M$Y$$$20240917$$HP$US$US
229595693$22959569$3$F$$20240627$20230920$20240703$EXP$$GB-TAKEDA-2023TUS070518$TAKEDA$$$$$F$Y$$$20240703$$CN$GB$GB
229596892$22959689$2$F$20130701$20240711$20230920$20240718$PER$$US-BIOGEN-2020BI00908604$BIOGEN$$53$YR$$F$Y$$$20240718$$CN$US$US
229597312$22959731$2$F$20220107$20240624$20230920$20240701$EXP$$KR-REGENERON PHARMACEUTICALS, INC.-2023-114922$REGENERON$$$$$M$Y$$$20240701$$MD$KR$KR
229597552$22959755$2$F$20190207$20240826$20230920$20240902$EXP$$IT-CELLTRION INC.-2019IT020954$CELLTRION$$$$$$Y$$$20240902$$MD$IT$IT
229598042$22959804$2$F$$20240802$20230920$20240806$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-262228$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240806$$CN$US$US
229599132$22959913$2$F$$20240813$20230920$20240904$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000823$DECIPHERA PHARMACEUTICALS$$71$YR$E$F$Y$$$20240904$$CN$US$US
229599472$22959947$2$F$20230101$20240726$20230920$20240819$PER$$CA-TOLMAR, INC.-23CA043037$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
229599514$22959951$4$F$20240729$20240729$20230920$20240821$PER$$CA-TOLMAR, INC.-23CA043043$TOLMAR$$82$YR$$M$Y$$$20240821$$CN$CA$CA
229599562$22959956$2$F$$20240829$20230920$20240903$EXP$$CA-CELLTRION INC.-2023CA015245$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
229600192$22960019$2$F$$20230901$20230920$20240930$PER$$US-LEO Pharma-362739$LEO PHARM$$$$$M$Y$$$20240930$$MD$US$US
229600372$22960037$2$F$$20230925$20230920$20240912$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02424$AMNEAL$$$$$M$Y$$$20240912$$CN$US$US
229600942$22960094$2$F$20230101$20231008$20230920$20240912$EXP$$PT-009507513-2309PRT005775$MERCK$$67$YR$$M$Y$$$20240912$$MD$PT$PT
229600993$22960099$3$F$$20240826$20230920$20240904$EXP$$JP-009507513-2309JPN001897J$MERCK$$7$DEC$$M$Y$$$20240904$$MD$JP$JP
2296017517$22960175$17$F$20230101$20240916$20230920$20240925$EXP$$CA-CELLTRION INC.-2023CA015351$CELLTRION$$$$$$Y$$$20240925$$MD$CA$CA
229601973$22960197$3$F$$20240705$20230920$20240719$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-65141$HIKMA$$85$YR$$M$Y$$$20240719$$HP$CA$CA
229602895$22960289$5$F$20230908$20231019$20230920$20240925$PER$$US-GSK-US2023AMR126415$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240925$$CN$US$US
229603123$22960312$3$F$20230701$20240715$20230920$20240717$EXP$$US-TAKEDA-2023TUS090514$TAKEDA$$15$YR$$M$Y$$$20240717$$CN$US$US
229604442$22960444$2$F$20221215$20240808$20230920$20240808$EXP$$GB-JNJFOC-20230934505$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240808$$CN$GB$GB
229605134$22960513$4$F$$20240704$20230920$20240705$EXP$$NVSC2023US200815$NOVARTIS$$$$$M$Y$$$20240705$$CN$US$US
229606183$22960618$3$F$$20240718$20230920$20240724$EXP$$CA-TAKEDA-2023TUS089514$TAKEDA$$$$$F$Y$$$20240724$$CN$CA$CA
229606522$22960652$2$F$20230527$20231009$20230920$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003420$SAREPTA THERAPEUTICS$$22$YR$$M$Y$65$KG$20240917$$HP$US$US
229606702$22960670$2$F$$20240131$20230920$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003493$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240917$$CN$US$US
229606942$22960694$2$F$20230811$20231104$20230920$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003718$SAREPTA THERAPEUTICS$$16$YR$$M$Y$102.04$KG$20240917$$HP$US$US
229607038$22960703$8$F$20230706$20240717$20230920$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-235676$BOEHRINGER INGELHEIM$$59$YR$A$M$Y$88.95$KG$20240719$$CN$US$US
229607162$22960716$2$F$20230829$20230926$20230920$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003753$SAREPTA THERAPEUTICS$$14$YR$$M$Y$$$20240917$$HP$US$US
229607172$22960717$2$F$20230710$20230920$20230920$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003758$SAREPTA THERAPEUTICS$$2$YR$$M$Y$11.338$KG$20240917$$HP$US$US
229607323$22960732$3$F$$20240826$20230920$20240919$PER$$AU-TOLMAR, INC.-23AU043066$TOLMAR$$$$$M$Y$$$20240919$$HP$AU$AU
229608592$22960859$2$F$20230913$20240715$20230920$20240719$PER$$US-AMGEN-USASP2023164638$AMGEN$$76$YR$E$M$Y$$$20240718$$HP$US$US
229608832$22960883$2$F$20230111$20240804$20230920$20240814$EXP$$JP-EMD Serono-2023455657$EMD SERONO INC$$86$YR$E$M$Y$69$KG$20240814$$MD$JP$JP
229608963$22960896$3$F$$20240731$20230920$20240812$EXP$CA-MHPD-E2B_06435793$CA-Accord-378680$ACCORD$$$$A$M$Y$$$20240812$$HP$CA$CA
229609184$22960918$4$F$20220101$20240920$20230920$20240927$EXP$$US-BEH-2023163274$CSL BEHRING$$$$E$F$Y$$$20240927$$HP$US$US
229609276$22960927$6$F$$20240902$20230920$20240916$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-65182$HIKMA$$53$YR$$F$Y$$$20240916$$HP$CA$CA
229610302$22961030$2$F$20230918$20240731$20230920$20240803$PER$$US-AMGEN-USASP2023166397$AMGEN$$80$YR$E$F$Y$$$20240803$$CN$US$US
229611278$22961127$8$F$20230914$20240815$20230920$20240820$EXP$$NVSC2023US200967$NOVARTIS$$74$YR$$F$Y$$$20240820$$CN$US$US
229611923$22961192$3$F$$20240802$20230920$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-65164$HIKMA$$44$YR$$M$Y$$$20240813$$HP$CA$CA
229612492$22961249$2$F$$20240913$20230920$20240923$PER$$US-SA-2023SA281209$SANOFI AVENTIS$$$$C$F$Y$$$20240923$$MD$US$US
229612923$22961292$3$F$20230801$20240620$20230920$20240702$PER$$US-SA-2023SA282122$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240702$$MD$US$US
229613112$22961311$2$F$$20240813$20230920$20240826$PER$$US-SA-2023SA281223$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240826$$CN$US$US
229613353$22961335$3$F$$20240809$20230920$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07720$LUPIN$$$$$$Y$$$20240829$$CN$US$US
229614202$22961420$2$F$20230901$20240917$20230920$20240919$EXP$$IT-ABBVIE-5412331$ABBVIE$$75$YR$$F$Y$$$20240919$$HP$IT$IT
229614443$22961444$3$F$20230910$20240718$20230920$20240723$EXP$$CA-JNJFOC-20230932845$JOHNSON AND JOHNSON$$16$YR$T$M$Y$38$KG$20240723$$HP$CA$CA
229614805$22961480$5$F$20230101$20240820$20230920$20240909$EXP$$US-SA-2023SA285310$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240909$$MD$US$US
229614833$22961483$3$F$20240903$20240903$20230920$20240925$PER$$US-SA-2023SA285547$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240925$$HP$US$US
229615072$22961507$2$F$20201201$20240726$20230920$20240730$EXP$$FR-MYLANLABS-2023M1099792$MYLAN$$54$YR$$F$Y$$$20240730$$CN$FR$FR
229615662$22961566$2$F$20230317$20240621$20230920$20240702$EXP$$US-SA-2023SA109103$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240702$$MD$US$US
229616233$22961623$3$F$$20240727$20230920$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07857$LUPIN$$$$$$Y$$$20240818$$PH$US$US
229616785$22961678$5$F$20240326$20240821$20230920$20240823$EXP$$CA-TAKEDA-2023TUS090259$TAKEDA$$26$YR$$M$Y$$$20240823$$CN$CA$CA
229617062$22961706$2$F$$20240918$20230920$20240926$PER$$NVSC2023US203074$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
229617334$22961733$4$F$$20240915$20230920$20240919$EXP$$CA-SANDOZ INC.-NVSC2022CA225497$SANDOZ$$$$$M$Y$$$20240919$$CN$CA$CA
229617382$22961738$2$F$$20240924$20230920$20240926$EXP$$BR-PFIZER INC-PV202300157970$PFIZER$Lopes, L.. Toxicity and outcome of adults with acute myeloid leukemia receiving consolidation with high-dose cytarabine. Hematology, Transfusion and Cell Therapy. 2023;1-5$$$$$Y$$$20240926$$HP$BR$BR
229617432$22961743$2$F$$20240924$20230920$20240926$EXP$$BR-PFIZER INC-202300304702$PFIZER$Lopes, L.. Toxicity and outcome of adults with acute myeloid leukemia receiving consolidation with high-dose cytarabine. Hematology, Transfusion and Cell Therapy. 2023;1-5$$$A$$Y$$$20240926$$HP$BR$BR
229617725$22961772$5$F$$20240626$20230920$20240702$EXP$$US-TAKEDA-2022TUS084127$TAKEDA$$$$$M$Y$84$KG$20240702$$HP$US$US
229619514$22961951$4$F$$20240917$20230920$20240919$EXP$$US-TAKEDA-2023TUS054277$TAKEDA$$$$$F$Y$$$20240919$$CN$US$US
229620463$22962046$3$F$$20231020$20230920$20240902$EXP$$CN-TEVA-2023-CN-2928431$TEVA$Xiuqiu L, Min O, Yang L, Junjie L, Xiaohua W. Adalimumab-induced edema of extremities in a psoriatic patient: a case report. J Diagn Ther Dermato-venerol. 2023;30(4):349-351.; Xiuqiu L, Min O, Yang L, Junjie L, Xiaohua W. Adalimumab-induced edema of extremities in a psoriatic patient: a case report. J Diagn Ther Dermato-venerol. 2023;30(4):349-351.; Wang X. Adalimumab-induced edema of extremities in a psoriatic patient: a case report.. Diagn Ther Dermato-venerol 2023-08; 30(4): 349-351.; Xiuq...$60$YR$$M$Y$$$20240902$$HP$CN$CN
229621212$22962121$2$F$$20240710$20230920$20240715$EXP$$CA-TAKEDA-2023TUS090683$TAKEDA$$$$$M$Y$$$20240715$$CN$CA$CA
229621873$22962187$3$F$$20240902$20230920$20240911$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-65267$HIKMA$$50$YR$$F$Y$64$KG$20240911$$HP$CA$CA
229621925$22962192$5$F$20220401$20240724$20230920$20240729$EXP$$US-TAKEDA-2023TUS090878$TAKEDA$$53$YR$$M$Y$98$KG$20240729$$HP$US$US
229622232$22962223$2$F$20230101$20230801$20230920$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US000720$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
2296232914$22962329$14$F$20201119$20240918$20230920$20240920$EXP$$CO-TAKEDA-CO202010921$TAKEDA$$31$YR$$F$Y$60$KG$20240920$$CN$CO$CO
2296233118$22962331$18$F$20230714$20240821$20230920$20240827$EXP$$GB-MYLANLABS-2023M1098664$MYLAN$$34$YR$$F$Y$$$20240827$$HP$GB$GB
229624143$22962414$3$F$$20240708$20230920$20240712$EXP$$DE-MYLANLABS-2023M1097784$MYLAN$$$$$M$Y$$$20240712$$CN$DE$DE
229625454$22962545$4$F$$20240801$20230920$20240802$EXP$$TH-TAKEDA-2023TUS090785$TAKEDA$$38$YR$$F$Y$$$20240802$$CN$TH$TH
229625622$22962562$2$F$20240701$20240725$20230920$20240730$EXP$$US-PFIZER INC-202300301063$PFIZER$$75$YR$$F$Y$$$20240730$$HP$US$US
229625647$22962564$7$F$$20240827$20230920$20240829$EXP$$US-PFIZER INC-PV202300156880$PFIZER$$86$YR$$M$Y$$$20240829$$CN$US$US
229625808$22962580$8$F$20230313$20240917$20230920$20240927$EXP$$CA-ROCHE-3310049$ROCHE$$37$YR$A$F$Y$143$KG$20240927$$HP$CA$CA
229625887$22962588$7$F$$20240902$20230920$20240912$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-23-65163$HIKMA$$$$$$Y$$$20240912$$HP$CA$CA
229626503$22962650$3$F$20230701$20240718$20230920$20240722$EXP$$CA-PFIZER INC-202200835583$PFIZER$$70$YR$$F$Y$$$20240722$$HP$CA$CA
229626553$22962655$3$F$20221101$20240822$20230920$20240828$EXP$$IN-PFIZER INC-PV202300095419$PFIZER$$60$YR$$M$Y$$$20240828$$CN$IN$IN
2296271113$22962711$13$F$20230426$20240825$20230920$20240828$EXP$$DE-BAUSCH-BL-2023-010109$BAUSCH AND LOMB$$83$YR$$F$Y$74$KG$20240828$$HP$DE$DE
229627642$22962764$2$F$20221121$20240725$20230920$20240726$EXP$FR-AFSSAPS-AN2023001198$FR-PFIZER INC-202300301673$PFIZER$$64$YR$$M$Y$$$20240726$$MD$FR$FR
229628282$22962828$2$F$20240101$20240710$20230920$20240717$PER$$US-SA-2023SA285780$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240717$$MD$US$US
229628394$22962839$4$F$20230801$20240916$20230920$20240918$EXP$$US-TAKEDA-2023TUS090547$TAKEDA$$61$YR$$M$Y$$$20240918$$CN$US$US
2296297533$22962975$33$F$20230901$20240725$20230920$20240730$EXP$$CA-PFIZER INC-PV202300141155$PFIZER$$75$YR$$M$Y$74.2$KG$20240730$$MD$CA$CA
229629923$22962992$3$F$20240615$20240719$20230920$20240724$EXP$$US-BEH-2023163368$CSL BEHRING$$19$YR$A$M$Y$$$20240724$$CN$US$US
229631805$22963180$5$F$20191201$20240816$20230920$20240827$EXP$$CO-SANDOZ INC.-NVSC2020CO001090$SANDOZ$$41$YR$$F$Y$117$KG$20240827$$CN$CO$CO
229631936$22963193$6$F$20190130$20240813$20230920$20240823$EXP$$DE-SANDOZ INC.-PHHY2019DE121451$SANDOZ$$68$YR$$F$Y$88.8$KG$20240823$$MD$DE$DE
229632556$22963255$6$F$$20231028$20230920$20240705$EXP$$US-AKCEA THERAPEUTICS, INC.-2023IS001706$AKCEA THERAPEUTICS$$$$$$Y$$$20240704$$HP$US$US
229632895$22963289$5$F$20200801$20240805$20230920$20240809$EXP$$US-SA-2023SA281103$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240809$$MD$US$US
229633152$22963315$2$F$$20240716$20230920$20240725$PER$$US-SA-2023SA281771$SANOFI AVENTIS$$66$YR$E$F$Y$88.45$KG$20240725$$MD$US$US
229633405$22963340$5$F$$20240703$20230920$20240709$EXP$$US-TAKEDA-2023TUS090162$TAKEDA$$$$$M$Y$$$20240709$$CN$US$US
229635209$22963520$9$F$20230329$20240812$20230920$20240816$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-213943$BOEHRINGER INGELHEIM$$84$YR$E$M$Y$78$KG$20240816$$CN$US$US
229635624$22963562$4$F$20231001$20240828$20230920$20240902$EXP$$US-ABBVIE-5413807$ABBVIE$$94$YR$$M$Y$$$20240902$$CN$US$US
2296357211$22963572$11$F$20230101$20240627$20230920$20240706$EXP$$CA-CELLTRION INC.-2023CA017738$CELLTRION$$$$$$Y$$$20240706$$CN$CA$CA
229635807$22963580$7$F$$20240619$20230921$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004026$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
229636914$22963691$4$F$20230101$20240731$20230921$20240826$PER$$CA-TOLMAR, INC.-23CA043109$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
229638432$22963843$2$F$20230907$20240903$20230921$20240905$EXP$$US-ABBVIE-5415018$ABBVIE$$76$YR$$M$Y$$$20240905$$CN$US$US
229639664$22963966$4$F$20230722$20240812$20230921$20240816$EXP$$CO-AMGEN-COLSL2023165232$AMGEN$$21$YR$A$F$Y$$$20240816$$CN$CO$CO
229640173$22964017$3$F$$20240805$20230921$20240807$PER$$NVSC2023US201926$NOVARTIS$$$$$M$Y$$$20240807$$CN$US$US
229640292$22964029$2$F$$20240715$20230921$20240720$EXP$$NVSC2023CA202333$NOVARTIS$$25$YR$$F$Y$$$20240719$$CN$CA$CA
2296407118$22964071$18$F$20230911$20240612$20230921$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003666$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$42$KG$20240705$$CN$US$US
229641943$22964194$3$F$20230919$20231204$20230921$20240905$PER$$NVSC2023US203405$NOVARTIS$$$$$$Y$$$20240905$$MD$US$US
229642012$22964201$2$F$20230830$20240820$20230921$20240826$EXP$$US-BEH-2023163265$CSL BEHRING$$34$YR$A$F$Y$$$20240826$$HP$US$US
229642796$22964279$6$F$20230922$20231027$20230921$20240926$EXP$$US-GSK-US2023AMR126438$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
229644463$22964446$3$F$$20240626$20230921$20240702$EXP$$PL-GILEAD-2023-0644063$GILEAD$$37$YR$A$M$Y$$$20240702$$MD$PL$PL
229644983$22964498$3$F$$20240709$20230921$20240710$EXP$$CA-SANDOZ INC.-NVSC2022CA054705$SANDOZ$$62$YR$$M$Y$$$20240710$$CN$CA$CA
2296452910$22964529$10$F$20231101$20240917$20230921$20240925$EXP$$US-GSK-US2023126692$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
229645344$22964534$4$F$20230705$20240711$20230921$20240718$EXP$$CA-JNJFOC-20230936934$JOHNSON AND JOHNSON$$49$YR$A$F$Y$115$KG$20240718$$HP$CA$CA
229645942$22964594$2$F$$20240826$20230921$20240902$EXP$$CA-GSK-CA2023AMR129144$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$HP$CA$CA
229648222$22964822$2$F$$20230920$20230921$20240801$EXP$$NVSC2023PH203128$NOVARTIS$$$$$M$Y$$$20240801$$CN$PH$PH
229648307$22964830$7$F$$20240118$20230921$20240926$EXP$$US-GSK-US2023AMR127084$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
229648463$22964846$3$F$20230807$20240701$20230921$20240710$EXP$$GB-SANDOZ INC.-SDZ2023GB030317$SANDOZ$$$$$F$Y$$$20240710$$MD$GB$GB
229648584$22964858$4$F$20240301$20240723$20230921$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007870$JAZZ$$40$YR$$M$Y$$$20240730$$MD$US$US
229648693$22964869$3$F$$20240624$20230921$20240703$EXP$$ES-SA-2023SA284334$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240704$$HP$ES$ES
229648786$22964878$6$F$$20240909$20230921$20240913$30DAY$$US-PFIZER INC-202300290364$PFIZER$$5$YR$$M$Y$20.7$KG$20240913$$HP$US$US
229650332$22965033$2$F$20230719$20240701$20230921$20240705$EXP$$GB-SANDOZ INC.-SDZ2023GB030713$SANDOZ$$35$YR$$F$Y$$$20240705$$PH$GB$GB
229652026$22965202$6$F$20240715$20240724$20230921$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-132761$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240801$$CN$US$US
229652476$22965247$6$F$20230801$20240724$20230921$20240731$EXP$$CO-GSK-CO2023AMR127405$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$CO$CO
229652724$22965272$4$F$$20240827$20230921$20240906$EXP$$US-BAUSCH-BL-2023-013933$BAUSCH AND LOMB$Kirschner R, Smith K. Pediatric bupropion fatality despite removal of intact pills and pharmacobezoar. Clinical toxicology. 2023;61 (SUPPLEMENT 2):171-172. doi:10.1080/15563650.2023.2233835$3$YR$$F$Y$$$20240906$$MD$US$US
229655163$22965516$3$F$20230808$20240907$20230921$20240914$EXP$$CA-JNJFOC-20230931475$JOHNSON AND JOHNSON$$96$YR$E$F$Y$54.48$KG$20240914$$HP$CA$CA
229656643$22965664$3$F$20231205$20240814$20230921$20240820$EXP$$BR-TAKEDA-2023TUS038138$TAKEDA$$37$YR$$F$Y$$$20240820$$CN$BR$BR
229656728$22965672$8$F$20230101$20240701$20230921$20240711$EXP$$US-INSMED-2023-01628-USAA$INSMED$$$$$F$Y$$$20240711$$HP$US$US
229657622$22965762$2$F$$20240705$20230921$20240711$EXP$$US-MYLANLABS-2023M1099664$MYLAN$Konda SM, Deaner JD, Proia AD, Jaffe GJ. Primary Vitreoretinal Lymphoma Masquerading as Post-Operative Endophthalmitis in a Pregnant Patient with Longstanding Idiopathic Panuveitis. Retin-Cases-Brief-Rep 2023.$37$YR$$F$Y$$$20240711$$MD$US$US
229658298$22965829$8$F$20230216$20240918$20230921$20240923$EXP$$CA-SANDOZ INC.-NVSC2023CA038950$SANDOZ$$45$YR$$F$Y$$$20240923$$CN$CA$CA
229658373$22965837$3$F$20230815$20240703$20230921$20240708$EXP$$DE-MYLANLABS-2023M1099322$MYLAN$$67$YR$$F$Y$70$KG$20240708$$MD$DE$DE
229658474$22965847$4$F$20230101$20240822$20230921$20240826$EXP$$TR-PFIZER INC-PV202300067801$PFIZER$$60$YR$$F$Y$$$20240826$$MD$TR$TR
229658503$22965850$3$F$20230806$20240704$20230921$20240709$EXP$$BE-PFIZER INC-202300301537$PFIZER$$69$YR$$F$Y$70.8$KG$20240709$$MD$BE$BE
229660915$22966091$5$F$$20240923$20230921$20240925$EXP$$CA-PFIZER INC-202300271869$PFIZER$$77$YR$$M$Y$$$20240925$$HP$CA$CA
229661063$22966106$3$F$$20240731$20230921$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-07937$LUPIN$$$$$$Y$$$20240818$$CN$US$US
229661104$22966110$4$F$20230101$20240821$20230921$20240828$EXP$$US-VERTEX PHARMACEUTICALS-2023-013980$VERTEX$$$$$M$Y$$$20240828$$CN$US$US
229661332$22966133$2$F$$20240819$20230921$20240821$PER$$NVSC2023US202778$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
229661662$22966166$2$F$20230822$20240711$20230921$20240726$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00090$AVADEL CNS PHARMA$$67$YR$$F$Y$$$20240726$$CN$US$US
229662637$22966263$7$F$20240325$20240626$20230921$20240703$EXP$$CA-TAKEDA-2023TUS090312$TAKEDA$$73$YR$$F$Y$$$20240703$$CN$CA$CA
229663183$22966318$3$F$20240201$20240822$20230921$20240830$EXP$$US-ABBVIE-5413806$ABBVIE$$78$YR$$M$Y$$$20240829$$CN$US$US
229664042$22966404$2$F$$20240715$20230921$20240722$EXP$$NVSC2023CL082852$NOVARTIS$$68$YR$$M$Y$$$20240722$$CN$CL$CL
229664222$22966422$2$F$20230824$20240731$20230921$20240806$EXP$$DE-PFIZER INC-202300303064$PFIZER$$69$YR$$M$Y$77$KG$20240806$$MD$DE$DE
229664624$22966462$4$F$20230101$20240627$20230921$20240708$PER$$US-SA-2023SA281159$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240708$$MD$US$US
229665262$22966526$2$F$$20240720$20230921$20240729$PER$$US-SA-2023SA179159$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240729$$MD$US$US
229665412$22966541$2$F$$20240828$20230921$20240910$PER$$US-SA-2023SA188633$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240910$$MD$US$US
229666684$22966668$4$F$20230302$20240905$20230921$20240910$EXP$$CA-SA-2023SA283239$SANOFI AVENTIS$$44$YR$A$F$Y$84$KG$20240910$$HP$CA$CA
229666994$22966699$4$F$$20240923$20230921$20240926$EXP$$IN-PFIZER INC-PV202300075880$PFIZER$$56$YR$$F$Y$$$20240926$$CN$IN$IN
229667024$22966702$4$F$20230201$20240807$20230921$20240812$EXP$$JP-PFIZER INC-PV202300156145$PFIZER$$77$YR$$M$Y$59.2$KG$20240812$$PH$JP$JP
229667454$22966745$4$F$20230501$20240830$20230921$20240904$PER$$US-PFIZER INC-PV202300157457$PFIZER$$76$YR$$F$Y$$$20240904$$CN$US$US
229668364$22966836$4$F$20230101$20240808$20230921$20240813$PER$$US-PFIZER INC-PV202300157450$PFIZER$$54$YR$$F$Y$$$20240813$$HP$US$US
229669773$22966977$3$F$$20240726$20230921$20240801$EXP$$CA-SANDOZ INC.-NVSC2020CA282677$SANDOZ$$63$YR$$F$Y$$$20240801$$HP$CA$CA
229670567$22967056$7$F$20240118$20240627$20230921$20240703$EXP$$JP-UCBSA-2023046352$UCB$$8$YR$$F$Y$18.3$KG$20240703$$MD$JP$JP
229672298$22967229$8$F$20190117$20240917$20230921$20240919$EXP$$CA-TAKEDA-2023TUS089286$TAKEDA$$49$YR$$M$Y$$$20240919$$CN$CA$CA
229673088$22967308$8$F$20230901$20240924$20230921$20240927$PER$$US-PFIZER INC-PV202300157361$PFIZER$$72$YR$$F$Y$82.993$KG$20240927$$CN$US$US
229673163$22967316$3$F$$20240711$20230921$20240715$PER$$US-PFIZER INC-PV202300074177$PFIZER$$83$YR$$F$Y$$$20240715$$CN$US$US
229673545$22967354$5$F$$20240819$20230921$20240821$PER$$US-PFIZER INC-PV202300157578$PFIZER$$71$YR$$F$Y$$$20240821$$CN$US$US
229673563$22967356$3$F$20230501$20240925$20230921$20240927$EXP$$US-PFIZER INC-202300300951$PFIZER$$69$YR$$F$Y$68.95$KG$20240927$$CN$US$US
229673703$22967370$3$F$$20240621$20230921$20240701$PER$$US-PFIZER INC-PV202300152957$PFIZER$$79$YR$$F$Y$$$20240701$$MD$US$US
229674223$22967422$3$F$$20240912$20230921$20240916$EXP$$US-PFIZER INC-202300301091$PFIZER$$79$YR$$F$Y$$$20240916$$CN$US$US
229674273$22967427$3$F$$20240805$20230921$20240807$PER$$US-PFIZER INC-PV202300104083$PFIZER$$81$YR$$F$Y$$$20240807$$MD$US$US
229675553$22967555$3$F$20221101$20240806$20230921$20240816$EXP$$US-JNJFOC-20230934032$JOHNSON AND JOHNSON$$0$YR$$M$Y$2.43$KG$20240816$$HP$US$US
229675842$22967584$2$F$$20240729$20230921$20240807$PER$$US-SA-2023SA281448$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240807$$MD$US$US
229677924$22967792$4$F$$20240911$20230921$20240918$EXP$$US-TAKEDA-2023TUS041213$TAKEDA$$$$$F$Y$$$20240918$$CN$US$US
229678695$22967869$5$F$20230803$20240827$20230921$20240903$EXP$$NVSC2021CA213152$NOVARTIS$$47$YR$$F$Y$$$20240903$$MD$CA$CA
229678767$22967876$7$F$20231013$20240918$20230921$20240923$EXP$$US-OTSUKA-2023_022423$OTSUKA$$87$YR$$F$Y$$$20240923$$CN$US$US
229678893$22967889$3$F$20230712$20240626$20230921$20240701$EXP$$DE-BAUSCH-BL-2023-013981$BAUSCH AND LOMB$$72$YR$$F$Y$70$KG$20240701$$HP$DE$DE
229678913$22967891$3$F$20230525$20240829$20230921$20240904$EXP$$NVSC2023IN125492$NOVARTIS$$27$YR$$M$Y$$$20240904$$CN$IN$IN
229681193$22968119$3$F$$20240628$20230921$20240705$EXP$$CO-GSK-CO2023AMR127435$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$CO$CO
229681463$22968146$3$F$20230827$20230922$20230921$20240814$EXP$$CN-VIIV HEALTHCARE LIMITED-CN2023APC127057$VIIV$$$$$$Y$$$20240814$$CN$CN$CN
229683514$22968351$4$F$$20240903$20230921$20240909$EXP$$JP-009507513-2309JPN002774J$MERCK$$56$YR$$F$Y$$$20240909$$MD$JP$JP
229683615$22968361$5$F$20230410$20240927$20230921$20240927$EXP$$CA-PFIZER INC-202300099962$PFIZER$$18$YR$$F$Y$$$20240927$$MD$CA$CA
229685454$22968545$4$F$20230515$20240627$20230921$20240706$EXP$$US-ROCHE-3421026$ROCHE$$65$YR$E$F$Y$118.84$KG$20240706$$CN$US$US
229685746$22968574$6$F$20230827$20240617$20230921$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003732$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240712$$CN$US$US
229685944$22968594$4$F$$20240613$20230921$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003769$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
229686219$22968621$9$F$20240201$20240620$20230921$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003807$ACADIA PHARMACEUTICALS$$13$YR$$F$Y$$$20240712$$CN$US$US
229688806$22968880$6$F$$20240829$20230922$20240906$EXP$$IN-ROCHE-3424434$ROCHE$$62$YR$A$F$Y$$$20240906$$MD$IN$IN
229689064$22968906$4$F$20220414$20240702$20230922$20240703$EXP$$GB-ABBVIE-5417482$ABBVIE$$78$YR$$F$Y$$$20240703$$MD$GB$GB
229689182$22968918$2$F$20230801$20240628$20230922$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003775$ACADIA PHARMACEUTICALS$$9$YR$$F$Y$$$20240723$$CN$US$US
229689212$22968921$2$F$$20240618$20230922$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003780$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
229689222$22968922$2$F$$20240917$20230922$20240925$EXP$$CA-CELLTRION INC.-2023CA018332$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
229689298$22968929$8$F$20240601$20240627$20230922$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003783$ACADIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240723$$CN$US$US
2296902215$22969022$15$F$20230905$20240912$20230922$20240917$EXP$$US-TAKEDA-2023TUS091663$TAKEDA$$48$YR$$M$Y$$$20240917$$MD$US$US
229690924$22969092$4$F$$20240807$20230922$20240904$PER$$CA-TOLMAR, INC.-23CA043129$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
229690943$22969094$3$F$20230817$20240722$20230922$20240808$PER$$CA-TOLMAR, INC.-23CA042732$TOLMAR$$63$YR$$M$Y$$$20240808$$CN$CA$CA
229690966$22969096$6$F$20230801$20240805$20230922$20240827$PER$$CA-TOLMAR, INC.-23CA043147$TOLMAR$$80$YR$$M$Y$$$20240827$$CN$CA$CA
229691536$22969153$6$F$$20240816$20230922$20240821$EXP$$CA-JNJFOC-20230947988$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240821$$HP$CA$CA
229691576$22969157$6$F$20230913$20240923$20230922$20240927$EXP$$US-TAKEDA-2022TUS057645$TAKEDA$$9$YR$$M$Y$43$KG$20240927$$CN$US$US
229693973$22969397$3$F$20230905$20231122$20230922$20240905$EXP$$NVSC2023US202127$NOVARTIS$$36$YR$$F$Y$64$KG$20240905$$CN$US$US
229695544$22969554$4$F$20230919$20240718$20230922$20240729$PER$$US-AMGEN-USASP2023168384$AMGEN$$78$YR$E$F$Y$$$20240729$$CN$US$US
229696019$22969601$9$F$20230816$20240913$20230922$20240923$EXP$$CA-CELLTRION INC.-2023CA016615$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
229696394$22969639$4$F$20230918$20240918$20230922$20240925$EXP$$FR-TAKEDA-2023TUS091577$TAKEDA$$28$YR$$M$Y$$$20240925$$HP$FR$FR
229696433$22969643$3$F$$20231222$20230922$20240719$EXP$$US-TEVA-2023-US-2928278$TEVA$$$$$M$Y$113$KG$20240719$$MD$US$US
229696494$22969649$4$F$$20240830$20230922$20240830$PER$$NVSC2023US200160$NOVARTIS$$$$$$Y$$$20240830$$MD$US$US
229696668$22969666$8$F$20230403$20240809$20230922$20240815$EXP$$NVSC2023US202507$NOVARTIS$$22$YR$$F$Y$$$20240815$$CN$US$US
229697513$22969751$3$F$20230921$20240913$20230922$20240918$PER$$US-AMGEN-USASP2023168583$AMGEN$$69$YR$E$F$Y$$$20240918$$CN$US$US
229697684$22969768$4$F$$20240715$20230922$20240722$EXP$$CA-SANDOZ INC.-SDZ2023CA032303$SANDOZ$$25$YR$$F$Y$$$20240722$$CN$CA$CA
229698444$22969844$4$F$20200101$20240724$20230922$20240730$EXP$$US-ABBVIE-5412709$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
229700844$22970084$4$F$20230906$20240819$20230922$20240822$EXP$$US-TAKEDA-2023TUS087620$TAKEDA$$57$YR$$M$Y$94$KG$20240822$$CN$US$US
229701012$22970101$2$F$$20240726$20230922$20240802$PER$$US-ABBVIE-5413035$ABBVIE$$$$$$Y$$$20240802$$HP$US$US
229701354$22970135$4$F$20230515$20240827$20230922$20240829$EXP$$CA-TAKEDA-2023TUS048424$TAKEDA$$54$YR$$F$Y$$$20240829$$HP$CA$CA
229701703$22970170$3$F$20230916$20240924$20230922$20240927$EXP$$PL-ROCHE-3426030$ROCHE$$45$YR$A$F$Y$$$20240927$$MD$PL$PL
229702656$22970265$6$F$20230912$20240920$20230922$20240925$PER$$US-VIIV HEALTHCARE LIMITED-US2023AMR127875$VIIV$$39$YR$$F$Y$$$20240925$$CN$US$US
229702742$22970274$2$F$$20240905$20230922$20240911$EXP$$BR-JNJFOC-20230948449$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240912$$MD$BR$BR
229702944$22970294$4$F$$20240829$20230922$20240903$EXP$$US-TAKEDA-2023TUS049158$TAKEDA$$$$$F$Y$59$KG$20240903$$CN$US$US
229703826$22970382$6$F$20230401$20240920$20230922$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-131066$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$107.23$KG$20240926$$PH$US$US
229705704$22970570$4$F$$20240827$20230922$20240902$EXP$$CA-TAKEDA-2023TUS075057$TAKEDA$$$$$M$Y$$$20240902$$CN$CA$CA
229705852$22970585$2$F$$20240710$20230922$20240722$PER$$NVSC2023US200271$NOVARTIS$$$$$F$Y$$$20240722$$MD$US$US
229706345$22970634$5$F$$20240919$20230922$20240925$EXP$$US-TAKEDA-2023TUS091408$TAKEDA$$$$$F$Y$55$KG$20240925$$CN$US$US
229707292$22970729$2$F$20180620$20240827$20230922$20240830$EXP$$CA-TAKEDA-2022TUS047989$TAKEDA$$46$YR$$F$Y$$$20240830$$MD$CA$CA
229708463$22970846$3$F$$20240703$20230922$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202309012011$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240712$$CN$US$US
229708503$22970850$3$F$$20240627$20230922$20240701$EXP$$CA-TAKEDA-2023TUS091720$TAKEDA$$$$$F$Y$$$20240701$$CN$CA$CA
229708642$22970864$2$F$20220601$20240822$20230922$20240826$PER$$NVSC2023US204371$NOVARTIS$$66$YR$$F$Y$$$20240826$$CN$US$US
229708903$22970890$3$F$$20240708$20230922$20240712$EXP$$DE-TAKEDA-2023TUS091118$TAKEDA$$51$YR$$M$Y$$$20240712$$CN$DE$DE
229709069$22970906$9$F$20231206$20240912$20230922$20240919$EXP$$CA-TAKEDA-2022TUS059594$TAKEDA$$66$YR$$M$Y$$$20240919$$CN$CA$CA
229711214$22971121$4$F$$20240715$20230922$20240724$EXP$$CA-GSK-CA2023AMR128482$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$CA$CA
229711253$22971125$3$F$$20240821$20230922$20240825$PER$$NVSC2023US200257$NOVARTIS$$$$$M$Y$$$20240825$$HP$US$US
2297112716$22971127$16$F$$20240909$20230922$20240913$EXP$$CA-GSK-CA2023AMR128415$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$CA$CA
2297169210$22971692$10$F$20230101$20240820$20230922$20240827$30DAY$$CA-PFIZER INC-PV202300141135$PFIZER$$71$YR$$M$Y$$$20240827$$HP$CA$CA
229717172$22971717$2$F$$20230912$20230922$20240801$PER$$NVSC2023US204564$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
229717692$22971769$2$F$20190601$20240826$20230922$20240910$PER$$US-SA-2023SA283503$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240910$$MD$US$US
229717824$22971782$4$F$20230912$20240829$20230922$20240910$EXP$$US-SA-2023SA278220$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240910$$MD$US$US
229717872$22971787$2$F$$20240727$20230922$20240805$PER$$US-SA-2023SA282238$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240805$$MD$US$US
229719193$22971919$3$F$$20240822$20230922$20240902$PER$$US-SA-2023SA287640$SANOFI AVENTIS$$$$A$F$Y$$$20240902$$MD$US$US
2297195710$22971957$10$F$20220521$20240917$20230922$20240925$EXP$$CA-TAKEDA-2021TUS083285$TAKEDA$$36$YR$$F$Y$$$20240925$$CN$CA$CA
229720304$22972030$4$F$$20240827$20230922$20240829$EXP$$CA-PFIZER INC-202300305667$PFIZER$$77$YR$$F$Y$$$20240829$$HP$CA$CA
229720736$22972073$6$F$$20240820$20230922$20240827$EXP$$CA-PFIZER INC-202300305905$PFIZER$$68$YR$$M$Y$$$20240827$$HP$CA$CA
229721166$22972116$6$F$20231001$20240624$20230922$20240702$EXP$$CA-TAKEDA-2023TUS091591$TAKEDA$$47$YR$$M$Y$$$20240702$$HP$CA$CA
229722152$22972215$2$F$20230506$20240924$20230922$20240926$EXP$$FR-MYLANLABS-2023M1099474$MYLAN$$77$YR$$M$Y$78$KG$20240926$$MD$FR$FR
2297241710$22972417$10$F$20240101$20240826$20230922$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-134765$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240828$$HP$US$US
229724512$22972451$2$F$$20240706$20230922$20240720$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393187$RANBAXY$Singh GK, Sapra D, Bahuguna A, Das P. Methotrexate toxicity in psoriasis-A multicentric retrospective study. Dermatol Ther. 2022;35(10):e15765$54$YR$$M$Y$$$20240719$$HP$IN$IN
229724832$22972483$2$F$20210823$20240910$20230922$20240919$EXP$$CA-SAMSUNG BIOEPIS-SB-2021-20670$SAMSUNG BIOEPIS$$13$YR$T$F$Y$35.5$KG$20240919$$HP$CA$CA
229725923$22972592$3$F$20181130$20240704$20230922$20240708$EXP$$CA-TAKEDA-2023TUS088340$TAKEDA$$48$YR$$M$Y$$$20240708$$HP$CA$CA
229726623$22972662$3$F$20220901$20240808$20230922$20240812$EXP$$CA-PFIZER INC-202201246046$PFIZER$$74$YR$$M$Y$$$20240812$$CN$CA$CA
229726704$22972670$4$F$$20240913$20230922$20240917$EXP$$US-GSK-US2023AMR126191$GLAXOSMITHKLINE$$$$$F$Y$$$20240917$$CN$US$US
229726723$22972672$3$F$$20231023$20230922$20240925$PER$$US-GSK-US2023AMR128591$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
229726772$22972677$2$F$$20240730$20230922$20240802$EXP$$CA-TAKEDA-2023TUS092113$TAKEDA$$$$$M$Y$$$20240802$$CN$CA$CA
229727022$22972702$2$F$20230127$20240717$20230922$20240722$EXP$$JP-ABBVIE-5414969$ABBVIE$$70$YR$$F$Y$45$KG$20240722$$MD$JP$JP
229727064$22972706$4$F$20230806$20240717$20230922$20240724$EXP$$BE-AMGEN INC.-BELNI2023164600$AMGEN$$69$YR$E$F$Y$70.8$KG$20240724$$MD$BE$BE
229727286$22972728$6$F$20240628$20240911$20230922$20240913$EXP$$NVSC2023US202662$NOVARTIS$$77$YR$$M$Y$$$20240913$$CN$US$US
2297285216$22972852$16$F$20230719$20240923$20230922$20240930$EXP$$ES-JNJFOC-20230932891$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240930$$CN$ES$ES
229728962$22972896$2$F$$20240814$20230922$20240816$PER$$NVSC2023US204343$NOVARTIS$$$$$M$Y$$$20240816$$MD$US$US
229729956$22972995$6$F$20210101$20240822$20230922$20240828$EXP$$AR-JNJFOC-20221153310$JOHNSON AND JOHNSON$$74$YR$E$F$Y$45$KG$20240828$$CN$AR$AR
229730833$22973083$3$F$$20240627$20230922$20240708$EXP$$US-ABBVIE-5400282$ABBVIE$$$$$M$Y$$$20240708$$MD$US$US
229731674$22973167$4$F$20230422$20240827$20230922$20240906$EXP$$ES-ABBVIE-5415840$ABBVIE$$78$YR$$M$Y$$$20240906$$MD$ES$ES
229732392$22973239$2$F$$20240723$20230922$20240725$30DAY$$US-SANDOZ INC.-SDZ2023US030100$SANDOZ$$$$$F$Y$$$20240725$$CN$US$US
229732642$22973264$2$F$$20240823$20230922$20240826$PER$$NVSC2023US204360$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
229732832$22973283$2$F$$20240806$20230922$20240812$EXP$$RU-SANDOZ INC.-SDZ2023RU032310$SANDOZ$Fedyukova YG, Zyuzgin IS, Volchenkov SA, Novik SN. Use of post-transplant cyclophosphamide in allogeneic hematopoietic stem cell transplantation after total body irradiation in children with acute lymphoblastic leukemia. Experience of one Center. PEDIATRIC HEMATOLOGY/ONCOLOGY AND IMMUNOPATHOLOGY. 2023;22(2):126$$$$$Y$$$20240812$$HP$RU$RU
229732843$22973284$3$F$$20240728$20230922$20240730$EXP$$GB-SANDOZ INC.-NVSC2021GB053016$SANDOZ$$$$$F$Y$$$20240730$$CN$GB$GB
229735654$22973565$4$F$$20240916$20230922$20240927$EXP$$CA-SANDOZ INC.-NVSC2021CA211434$SANDOZ$$59$YR$$F$Y$68$KG$20240927$$CN$CA$CA
229736309$22973630$9$F$$20240710$20230922$20240715$EXP$$US-PFIZER INC-PV202300128153$PFIZER$$79$YR$$F$Y$$$20240715$$CN$US$US
229736352$22973635$2$F$20220626$20240709$20230922$20240712$EXP$$RU-PFIZER INC-PV202300125769$PFIZER$$57$YR$$F$Y$$$20240712$$MD$RU$RU
229738724$22973872$4$F$20200712$20240827$20230922$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-134988$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$48.4$KG$20240830$$MD$JP$JP
229738804$22973880$4$F$$20240906$20230922$20240912$EXP$$CA-JNJFOC-20230944594$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240912$$CN$CA$CA
229739033$22973903$3$F$$20240813$20230922$20240814$EXP$GR-SEATTLE GENETICS-2023SGN10111$GR-ROCHE-3426509$ROCHE$$33$YR$A$F$Y$$$20240814$$MD$GR$GR
229739334$22973933$4$F$$20240813$20230922$20240821$EXP$GR-SEATTLE GENETICS-2023SGN10213$GR-ROCHE-3426654$ROCHE$$$$$F$Y$$$20240821$$MD$GR$GR
229739612$22973961$2$F$20220101$20240821$20230922$20240828$EXP$$US-ABBVIE-5413918$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
229740074$22974007$4$F$$20240820$20230922$20240820$PER$$NVSC2023US204421$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
229741224$22974122$4$F$20230423$20240716$20230923$20240726$EXP$$JP-ROCHE-3376870$ROCHE$Ogawa K, Kobayashi M, Ito S, and Takano D. W2-4 Cases of three patients with the onset of myocardial infarction, sudden death, and cardiac failure after intravitreal injection of anti- VEGF drug. Diabetic Complications / The 38th Annual Meeting of the Japan Society of Diabeti 2023;37(S-1):136-.$51$YR$A$M$Y$74.2$KG$20240726$$MD$JP$JP
229741815$22974181$5$F$$20240827$20230923$20240829$EXP$$NVSC2023US202052$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
229742172$22974217$2$F$20230101$20240703$20230923$20240711$EXP$$CA-CELLTRION INC.-2023CA012843$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
229742362$22974236$2$F$$20240814$20230923$20240814$PER$$NVSC2023US206053$NOVARTIS$$$$$M$Y$$$20240814$$MD$US$US
229743455$22974345$5$F$$20240829$20230923$20240927$EXP$$NVSC2023CO205837$NOVARTIS$$$$$F$Y$70$KG$20240927$$CN$CO$CO
229743487$22974348$7$F$20240101$20240918$20230923$20240927$EXP$$CA-CELLTRION INC.-2023CA018414$CELLTRION$$$$$$Y$$$20240927$$CN$CA$CA
229743562$22974356$2$F$$20240909$20230923$20240911$EXP$$NVSC2023US204319$NOVARTIS$$$$$M$Y$$$20240911$$CN$US$US
229744345$22974434$5$F$20230101$20240918$20230923$20240927$EXP$$CA-CELLTRION INC.-2023CA016721$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
229744763$22974476$3$F$$20240624$20230923$20240702$EXP$$CA-TAKEDA-2020TUS049359$TAKEDA$$$$$M$Y$$$20240702$$CN$CA$CA
229744987$22974498$7$F$20210514$20240711$20230923$20240717$EXP$$CO-TAKEDA-2021TUS032236$TAKEDA$$30$YR$$F$Y$50$KG$20240717$$CN$CO$CO
229745352$22974535$2$F$$20240903$20230923$20240911$EXP$$FR-TAKEDA-2023TUS091536$TAKEDA$$$$N$M$Y$2.67$KG$20240911$$HP$FR$FR
229745395$22974539$5$F$20230901$20240715$20230923$20240718$EXP$$CA-TAKEDA-2023TUS070906$TAKEDA$$48$YR$$M$Y$79.365$KG$20240718$$MD$CA$CA
229746424$22974642$4$F$20230615$20240819$20230923$20240821$EXP$$NL-SANDOZ INC.-SDZ2023NL032547$SANDOZ$$69$YR$$M$Y$98.7$KG$20240821$$MD$NL$NL
229746813$22974681$3$F$20220601$20231201$20230923$20240918$PER$$US-Accord-362043$ACCORD$$61$YR$A$M$Y$108.84$KG$20240918$$CN$US$US
229746982$22974698$2$F$$20240710$20230923$20240716$PER$$NVSC2023US205908$NOVARTIS$$$$$M$Y$$$20240716$$MD$US$US
229747033$22974703$3$F$20230101$20240701$20230923$20240702$EXP$$DE-SANDOZ INC.-SDZ2023DE032520$SANDOZ$$70$YR$$F$Y$$$20240702$$MD$DE$DE
229747843$22974784$3$F$$20231116$20230923$20240909$PER$$NVSC2023US205132$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
229748024$22974802$4$F$20230831$20240723$20230923$20240729$EXP$$AU-TAKEDA-2023TUS086099$TAKEDA$$46$YR$$F$Y$$$20240729$$CN$AU$AU
229748653$22974865$3$F$$20240814$20230923$20240821$EXP$$CA-TAKEDA-2023TUS091272$TAKEDA$$$$$M$Y$$$20240821$$CN$CA$CA
229748854$22974885$4$F$$20240910$20230923$20240916$EXP$$BR-TAKEDA-2023TUS092291$TAKEDA$$$$$M$Y$$$20240916$$CN$BR$BR
229748903$22974890$3$F$$20240812$20230923$20240816$EXP$$GB-TAKEDA-2023TUS091648$TAKEDA$$$$$F$Y$$$20240816$$CN$GB$GB
229748912$22974891$2$F$$20230918$20230923$20240926$EXP$$US-ABBVIE-5417001$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
229748944$22974894$4$F$20230801$20240725$20230923$20240731$EXP$$BG-TAKEDA-2023TUS058856$TAKEDA$$33$YR$$M$Y$$$20240731$$CN$BG$BG
229749452$22974945$2$F$$20240817$20230923$20240829$EXP$$CZ-Accord-379960$ACCORD$Michaela Novakova. A patient with a severe form of atopic dermatitis treated?with abrocitinib - our first experience. PHARMACOTHERAPY. 2023,19(2):195-?197$55$YR$A$F$Y$99$KG$20240829$$MD$CZ$CZ
2297495611$22974956$11$F$20180101$20240913$20230923$20240918$EXP$$US-TAKEDA-2020TUS013896$TAKEDA$$$$$M$Y$82$KG$20240918$$MD$US$US
229749633$22974963$3$F$$20240913$20230923$20240916$EXP$$CA-SANDOZ INC.-SDZ2023CA032049$SANDOZ$$3$DEC$$M$Y$$$20240916$$MD$CA$CA
229749884$22974988$4$F$20230603$20240705$20230923$20240715$EXP$$US-TAKEDA-2023TUS061046$TAKEDA$$74$YR$$F$Y$66$KG$20240715$$CN$US$US
229752802$22975280$2$F$$20240815$20230924$20240820$EXP$$GB-SANDOZ INC.-NVSC2021GB247430$SANDOZ$$$$$F$Y$$$20240820$$CN$GB$GB
229754532$22975453$2$F$$20240903$20230924$20240909$EXP$$JP-009507513-2309JPN002770J$MERCK$$$$$F$Y$$$20240909$$MD$JP$JP
2297549012$22975490$12$F$20230101$20240819$20230924$20240827$EXP$$ES-ABBVIE-5329204$ABBVIE$$$$$M$Y$$$20240827$$CN$ES$ES
229755404$22975540$4$F$20221227$20240508$20230925$20240710$PER$$CA-ROCHE-3284445$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$CA$CA
229755643$22975564$3$F$20230914$20240909$20230925$20240917$EXP$$NVSC2023CA205887$NOVARTIS$$74$YR$$M$Y$$$20240917$$CN$CA$CA
2297559316$22975593$16$F$20230101$20240917$20230925$20240926$EXP$$CA-CELLTRION INC.-2023CA015198$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
229756117$22975611$7$F$$20240730$20230925$20240805$EXP$$US-TAKEDA-2023TUS092451$TAKEDA$$$$$M$Y$100$KG$20240805$$CN$US$US
229756723$22975672$3$F$$20240624$20230925$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003733$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
229756977$22975697$7$F$$20240613$20230925$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003770$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
229757243$22975724$3$F$20230918$20240718$20230925$20240725$PER$$NVSC2023US202162$NOVARTIS$$33$YR$$F$Y$$$20240725$$CN$US$US
229758385$22975838$5$F$$20240926$20230925$20240927$PER$$NVSC2023US206758$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
229760113$22976011$3$F$$20240718$20230925$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-135376$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240719$$HP$US$US
229760125$22976012$5$F$20230101$20240820$20230925$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-134959$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240822$$PH$JP$JP
229760725$22976072$5$F$$20240703$20230925$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-135388$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240704$$CN$US$US
229762087$22976208$7$F$$20240916$20230925$20240918$EXP$$US-TAKEDA-2023TUS089052$TAKEDA$$$$$F$Y$117$KG$20240918$$HP$US$US
229762123$22976212$3$F$$20230912$20230925$20240801$PER$$NVSC2023US206666$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
2297624212$22976242$12$F$20230101$20240912$20230925$20240921$EXP$$CA-CELLTRION INC.-2023CA014450$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
229762584$22976258$4$F$20230101$20240716$20230925$20240724$EXP$$CA-CELLTRION INC.-2023CA015753$CELLTRION$$$$$$Y$$$20240724$$HP$CA$CA
229762842$22976284$2$F$20230101$20240920$20230925$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-033301$JAZZ$$$$$F$Y$$$20240923$$CN$US$US
2297631112$22976311$12$F$$20240812$20230925$20240816$EXP$$CA-SANDOZ INC.-NVSC2021CA152437$SANDOZ$$36$YR$$F$Y$$$20240816$$PH$CA$CA
229763912$22976391$2$F$20230907$20240905$20230925$20240924$PER$$CA-TOLMAR, INC.-23CA043194$TOLMAR$$53$YR$$M$Y$$$20240924$$CN$CA$CA
229763944$22976394$4$F$20230101$20240627$20230925$20240702$PER$$CA-TOLMAR, INC.-23CA043205$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
229764647$22976464$7$F$20231031$20240917$20230925$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019754$JAZZ$$64$YR$$F$Y$$$20240923$$CN$US$US
229764713$22976471$3$F$20230806$20240809$20230925$20240820$EXP$BE-SEATTLE GENETICS-2023SGN10072$BE-ROCHE-3424004$ROCHE$$69$YR$E$F$Y$70.8$KG$20240820$$MD$BE$BE
229765367$22976536$7$F$20100101$20240911$20230925$20240917$EXP$$US-ABBVIE-5418953$ABBVIE$$$$$M$Y$74$KG$20240917$$CN$US$US
229765854$22976585$4$F$20230101$20240731$20230925$20240807$EXP$$CA-CELLTRION INC.-2022CA018900$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
229766683$22976668$3$F$$20240918$20230925$20240923$EXP$$CA-SANDOZ INC.-NVSC2020CA102759$SANDOZ$$53$YR$$M$Y$$$20240923$$CN$CA$CA
229766697$22976669$7$F$$20240822$20230925$20240823$EXP$$CA-SANDOZ INC.-NVSC2021CA119696$SANDOZ$$80$YR$$M$Y$89$KG$20240823$$CN$CA$CA
229766735$22976673$5$F$20220101$20240709$20230925$20240715$EXP$$IT-MYLANLABS-2023M1025263$MYLAN$Stefano P, Matteo C, Sabrina P. Thrombocytopenia induced by panitumumab in a patient with colorectal cancer. Pharmadvances. 2023;5$49$YR$$F$Y$$$20240715$$HP$IT$IT
229767872$22976787$2$F$20230908$20231128$20230925$20240702$EXP$$US-TEVA-2023-US-2928198$TEVA$$71$YR$$F$Y$58.97$KG$20240702$$CN$US$US
2297680613$22976806$13$F$20230901$20240830$20230925$20240913$EXP$$CA-UCBSA-2023027853$UCB$$75$YR$$F$Y$$$20240913$$CN$CA$CA
229769067$22976906$7$F$20210101$20240912$20230925$20240924$PER$$US-SA-2023SA285788$SANOFI AVENTIS$$62$YR$A$F$Y$107$KG$20240924$$MD$US$US
229769502$22976950$2$F$$20240624$20230925$20240701$PER$$US-SA-2023SA290020$SANOFI AVENTIS$$63$YR$A$F$Y$105$KG$20240701$$MD$US$US
229769753$22976975$3$F$20230101$20240813$20230925$20240826$PER$$US-SA-2023SA289682$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240826$$CN$US$US
229769772$22976977$2$F$20230906$20240827$20230925$20240923$PER$$US-SA-2023SA287884$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240923$$MD$US$US
229769993$22976999$3$F$20190414$20240919$20230925$20240924$EXP$$CA-SHIRE-CA201909881AA$TAKEDA$$72$YR$$M$Y$$$20240924$$CN$CA$CA
229770138$22977013$8$F$$20240104$20230925$20240902$EXP$$NVSC2023US199707$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
229770234$22977023$4$F$20200101$20240712$20230925$20240720$EXP$$BR-TAKEDA-2021TUS007263$TAKEDA$$$$$F$Y$$$20240720$$CN$BR$BR
2297704912$22977049$12$F$20230101$20240830$20230925$20240909$EXP$$CA-CELLTRION INC.-2023CA018440$CELLTRION$$$$$$Y$$$20240909$$MD$CA$CA
229771533$22977153$3$F$$20230720$20230925$20240816$EXP$$MX-BAYER-2023A134557$BAYER$$65$YR$E$F$Y$$$20240816$$MD$MX$MX
229771913$22977191$3$F$$20240821$20230925$20240827$EXP$$US-SANDOZ INC.-NVSC2022US158369$SANDOZ$$$$$F$Y$84.807$KG$20240827$$CN$US$US
229771922$22977192$2$F$$20230713$20230925$20240710$PER$$IN-ROCHE-3388181$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$IN$IN
229772098$22977209$8$F$$20240819$20230925$20240822$30DAY$$US-PFIZER INC-PV202300150080$PFIZER$$9$YR$$M$Y$$$20240822$$CN$US$US
229772363$22977236$3$F$$20240830$20230925$20240830$PER$$NVSC2023US202733$NOVARTIS$$$$$M$Y$$$20240830$$HP$US$US
229772722$22977272$2$F$$20240709$20230925$20240711$EXP$$MX-PFIZER INC-202300307414$PFIZER$Teco-Cortes, J.. Disseminated mucormycosis in a child with acute lymphoblastic leukemia: autopsy findings.. Boletin Medico del Hospital Infantil de Mexico. 2023;80(Supplement 1:1-6$8$YR$$M$Y$$$20240711$$MD$MX$MX
229772903$22977290$3$F$$20240626$20230925$20240701$EXP$$FR-TAKEDA-2023TUS091761$TAKEDA$$$$E$F$Y$$$20240701$$CN$FR$FR
229773466$22977346$6$F$20230101$20240822$20230925$20240905$PER$$US-SA-2023SA285514$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240905$$MD$US$US
229773902$22977390$2$F$$20240627$20230925$20240701$EXP$$US-TAKEDA-2023TUS088204$TAKEDA$$$$$F$Y$42.63$KG$20240701$$HP$US$US
229774033$22977403$3$F$$20240801$20230925$20240806$PER$$US-LEO Pharma-363043$LEO PHARM$$58$YR$$F$Y$$$20240806$$CN$US$US
229774253$22977425$3$F$20240601$20240820$20230925$20240830$30DAY$$US-GSK-US2023AMR128096$GLAXOSMITHKLINE$$33$YR$$F$Y$56.7$KG$20240830$$CN$US$US
229774459$22977445$9$F$$20240919$20230925$20240923$PER$$US-PFIZER INC-202300299881$PFIZER$$83$YR$$M$Y$88.45$KG$20240923$$CN$US$US
229774566$22977456$6$F$20230501$20240829$20230925$20240904$PER$$US-PFIZER INC-PV202300093176$PFIZER$$44$YR$$M$Y$95.25$KG$20240904$$CN$US$US
229775473$22977547$3$F$20190129$20240625$20230925$20240701$EXP$$NVSC2023DE206100$NOVARTIS$$$$A$F$Y$50$KG$20240702$$MD$DE$DE
229775695$22977569$5$F$20230531$20240820$20230925$20240822$EXP$$US-INCYTE CORPORATION-2023IN009779$INCYTE$$$$$$Y$$$20240822$$CN$US$US
229775824$22977582$4$F$20230901$20240619$20230925$20240703$EXP$$CA-ROCHE-3427645$ROCHE$$65$YR$E$M$Y$$$20240703$$CN$CA$CA
229779192$22977919$2$F$$20240812$20230925$20240814$PER$$US-TAKEDA-2023TUS091774$TAKEDA$$$$$F$Y$$$20240814$$PH$US$US
229780962$22978096$2$F$20230901$20240717$20230925$20240723$EXP$$US-PFIZER INC-202300300127$PFIZER$$7$YR$$F$Y$$$20240723$$CN$US$US
229782932$22978293$2$F$20221215$20240808$20230925$20240817$EXP$$GB-TEVA-2023-GB-2928093$TEVA$$38$YR$$F$Y$$$20240817$$CN$GB$GB
229784402$22978440$2$F$20221101$20240829$20230925$20240904$EXP$$CA-SANDOZ INC.-NVSC2022CA191230$SANDOZ$$76$YR$$F$Y$$$20240904$$CN$CA$CA
229786006$22978600$6$F$20230101$20240626$20230925$20240701$EXP$$CA-PFIZER INC-202300305750$PFIZER$$34$YR$$F$Y$$$20240701$$MD$CA$CA
2297893612$22978936$12$F$20230601$20240826$20230925$20240830$EXP$$US-TAKEDA-2023TUS074301$TAKEDA$$59$YR$$F$Y$52$KG$20240830$$CN$US$US
229790113$22979011$3$F$$20240624$20230925$20240705$EXP$$US-HBP-2023US029125$HELSINN HEALTHCARE$$$$$F$Y$$$20240705$$CN$US$US
229791744$22979174$4$F$20231201$20240625$20230925$20240705$EXP$$US-BEH-2023163563$CSL BEHRING$$75$YR$E$F$Y$$$20240705$$HP$US$US
229792125$22979212$5$F$20181204$20240828$20230925$20240830$EXP$$CA-TAKEDA-2022TUS041819$TAKEDA$$21$YR$$F$Y$$$20240830$$MD$CA$CA
229793436$22979343$6$F$20230728$20240802$20230925$20240806$EXP$$NVSC2023US202454$NOVARTIS$$65$YR$$M$Y$$$20240806$$CN$US$US
2297936318$22979363$18$F$20230701$20240708$20230925$20240718$EXP$$US-UNITED THERAPEUTICS-UNT-2023-019224$UNITED THERAPEUTICS$$41$YR$$F$Y$118.82$KG$20240718$$$US$US
229794423$22979442$3$F$20240301$20240813$20230925$20240819$PER$$US-PFIZER INC-202300303843$PFIZER$$38$YR$$F$Y$$$20240819$$HP$US$US
229794485$22979448$5$F$$20240830$20230925$20240904$EXP$$US-PFIZER INC-PV202300158000$PFIZER$Kornblau, I.. Testosterone-Induced Central Serous Chorioretinopathy Mimicking a Choroidal Mass. Retinal cases and brief reports. 2023;10.1097/ICB.0000000000001482$63$YR$$M$Y$$$20240904$$MD$US$US
229794512$22979451$2$F$$20240723$20230925$20240724$EXP$$US-PFIZER INC-PV202300158626$PFIZER$Schmeissing, S.. DOUBLE TROUBLE: INFANT INTRAVENTRICULAR HEMORRHAGE AND DEMISE AFTER MATERNAL BRODIFACOUM POISONING. Clinical Toxicology. 2011;49(6):614$$$I$F$Y$$$20240724$$HP$US$US
229795453$22979545$3$F$$20240819$20230925$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-134818$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240827$$CN$US$US
229795548$22979554$8$F$$20240813$20230925$20240816$PER$$US-PFIZER INC-PV202300144568$PFIZER$$74$YR$$F$Y$97.506$KG$20240816$$CN$US$US
229795563$22979556$3$F$20210101$20240729$20230925$20240802$PER$$US-PFIZER INC-202300305813$PFIZER$$69$YR$$M$Y$95.238$KG$20240802$$HP$US$US
229795675$22979567$5$F$20240115$20240627$20230925$20240701$PER$$US-PFIZER INC-PV202300158386$PFIZER$$60$YR$$M$Y$$$20240701$$HP$US$US
229795912$22979591$2$F$$20240807$20230925$20240809$PER$$US-PFIZER INC-PV202300157675$PFIZER$$76$YR$$M$Y$$$20240809$$CN$US$US
229797244$22979724$4$F$20230901$20240724$20230925$20240730$PER$$US-BIOGEN-2023BI01227437$BIOGEN$$30$YR$$F$Y$$$20240730$$CN$US$US
229797894$22979789$4$F$$20240903$20230925$20240905$PER$$US-PFIZER INC-PV202300106981$PFIZER$$72$YR$$F$Y$72.57$KG$20240905$$HP$US$US
229797944$22979794$4$F$$20240821$20230925$20240827$PER$$US-PFIZER INC-PV202300014056$PFIZER$$37$YR$$F$Y$$$20240827$$MD$US$US
229798029$22979802$9$F$20230101$20240712$20230925$20240717$PER$$US-PFIZER INC-202300306665$PFIZER$$24$YR$$F$Y$63.5$KG$20240717$$CN$US$US
229798222$22979822$2$F$20240707$20240918$20230925$20240925$EXP$$CA-TAKEDA-2023TUS090176$TAKEDA$$88$YR$$M$Y$63$KG$20240925$$CN$CA$CA
229798492$22979849$2$F$$20230918$20230925$20240813$EXP$$US-GILEAD-2023-0644571$GILEAD$$68$YR$E$M$Y$$$20240813$$CN$US$US
229798663$22979866$3$F$$20240708$20230925$20240711$PER$$US-PFIZER INC-202300309037$PFIZER$$63$YR$$F$Y$$$20240711$$CN$US$US
229799218$22979921$8$F$20190910$20240803$20230925$20240806$PER$$US-BIOVITRUM-2022US06593$BIOVITRUM$$55$YR$$F$Y$$$20240806$$CN$US$US
229799414$22979941$4$F$20230101$20240624$20230925$20240703$PER$$US-SA-2023SA285934$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240703$$MD$US$US
229802264$22980226$4$F$20211101$20240829$20230925$20240904$EXP$$CA-PFIZER INC-202101706110$PFIZER$$9$YR$$F$Y$27.6$KG$20240904$$CN$CA$CA
229802952$22980295$2$F$$20240903$20230925$20240909$EXP$$JP-009507513-2309JPN002769J$MERCK$$$$$F$Y$$$20240909$$MD$JP$JP
229803242$22980324$2$F$20230817$20240705$20230925$20240715$PER$$US-SA-2023SA284232$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240715$$MD$US$US
229803374$22980337$4$F$$20231130$20230925$20240805$EXP$$NVSC2023US206227$NOVARTIS$$$$$M$Y$$$20240803$$CN$US$US
229804246$22980424$6$F$20230802$20240812$20230925$20240819$EXP$$CA-TAKEDA-2023TUS078339$TAKEDA$$65$YR$$M$Y$$$20240819$$CN$CA$CA
229805192$22980519$2$F$20210301$20240807$20230925$20240813$EXP$$IN-PFIZER INC-2021395803$PFIZER$$55$YR$$F$Y$$$20240813$$CN$IN$IN
229806142$22980614$2$F$$20240823$20230925$20240827$EXP$$NVSC2023US207333$NOVARTIS$$$$$M$Y$$$20240827$$CN$US$US
229807752$22980775$2$F$20220910$20230831$20230925$20240927$PER$$US-VIVUS LLC-2023V1000083$VIVUS$$64$YR$A$F$Y$70.37$KG$20240912$$CN$US$US
229811112$22981111$2$F$$20230801$20230925$20240927$PER$$US-VIVUS LLC-2023V1000573$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
229811592$22981159$2$F$$20230823$20230925$20240927$PER$$US-VIVUS LLC-2023V1000645$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
2298133610$22981336$10$F$20230719$20240924$20230925$20240930$EXP$$ES-MYLANLABS-2023M1100572$MYLAN$$55$YR$$F$Y$$$20240930$$CN$ES$ES
229813783$22981378$3$F$$20240919$20230925$20240927$EXP$$JP-009507513-2309JPN002926J$MERCK$$56$YR$$F$Y$$$20240927$$MD$JP$JP
229813892$22981389$2$F$$20240722$20230925$20240725$EXP$$JP-DSJP-DSJ-2023-139075$DAIICHI$Fukuda Y, Yoshinaga K, Kondo S, Otsuka Y. A case of successful haemostasis by using andexanet alfa after surgical thrombectomy for pulmonary thromboembolism. Cardiovascular Anesthesia/The 28th Annual Meeting of JSCVA. 2023;27:233$69$YR$$M$Y$$$20240725$$MD$JP$JP
229814953$22981495$3$F$20230101$20240821$20230925$20240827$EXP$$US-PFIZER INC-202300307863$PFIZER$$63$YR$$F$Y$$$20240827$$HP$US$US
229815665$22981566$5$F$20230101$20240816$20230925$20240820$EXP$$CA-PFIZER INC-202300306720$PFIZER$$89$YR$$M$Y$66$KG$20240820$$HP$CA$CA
229816345$22981634$5$F$20230101$20240920$20230925$20240927$EXP$$CA-KARYOPHARM-2023KPT001274$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240927$$HP$CA$CA
229818183$22981818$3$F$20230907$20240830$20230925$20240905$EXP$$US-ABBVIE-5422055$ABBVIE$$67$YR$$M$Y$$$20240905$$CN$US$US
229818407$22981840$7$F$20240208$20240910$20230925$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-136048$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240917$$HP$US$US
229819793$22981979$3$F$20240601$20240806$20230926$20240816$PER$$US-SA-2023SA284395$SANOFI AVENTIS$$58$YR$A$F$Y$66.6$KG$20240816$$MD$US$US
229819802$22981980$2$F$$20240822$20230926$20240920$PER$$US-SA-2023SA286247$SANOFI AVENTIS$$$$T$F$Y$$$20240920$$MD$US$US
229820025$22982002$5$F$20230228$20240913$20230926$20240926$EXP$$JP-AMGEN-JPNNI2023168730$AMGEN$$66$YR$E$F$Y$45.1$KG$20240926$$MD$JP$JP
2298219611$22982196$11$F$20190101$20240710$20230926$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017037$JAZZ$$20$YR$$F$Y$$$20240716$$CN$US$US
229822465$22982246$5$F$20211110$20240722$20230926$20240731$30DAY$$DK-NOVOPROD-1116337$NOVO NORDISK$$70$YR$$M$Y$81$KG$20240731$$CN$DK$TR
229822974$22982297$4$F$$20240823$20230926$20240911$PER$$CA-TOLMAR, INC.-23CA043189$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
229823014$22982301$4$F$20230906$20240806$20230926$20240827$PER$$CA-TOLMAR, INC.-23CA043175$TOLMAR$$73$YR$$M$Y$$$20240827$$CN$CA$CA
229823082$22982308$2$F$$20240809$20230926$20240904$PER$$CA-TOLMAR, INC.-23CA043170$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
229823203$22982320$3$F$20230101$20240628$20230926$20240712$PER$$US-SA-2023SA286350$SANOFI AVENTIS$$74$YR$E$F$Y$83.6$KG$20240712$$MD$US$US
229823337$22982333$7$F$20230830$20240620$20230926$20240715$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003867$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240715$$CN$US$US
229823447$22982344$7$F$20231001$20240627$20230926$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003868$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240723$$CN$US$US
229823565$22982356$5$F$20230901$20231222$20230926$20240925$PER$$US-GSK-US2023AMR130615$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
229823667$22982366$7$F$20231201$20240628$20230926$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003869$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240723$$CN$US$US
229824177$22982417$7$F$20231201$20240607$20230926$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003873$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240701$$CN$US$US
229824493$22982449$3$F$20230801$20240807$20230926$20240816$PER$$US-SA-2023SA286857$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240816$$MD$US$US
229825853$22982585$3$F$$20230921$20230926$20240731$PER$$NVSC2023US205485$NOVARTIS$$$$$F$Y$$$20240731$$CN$US$US
229826152$22982615$2$F$20230719$20240702$20230926$20240703$EXP$$GB-SANDOZ INC.-SDZ2023GB033299$SANDOZ$$35$YR$$F$Y$$$20240703$$PH$GB$GB
229826162$22982616$2$F$20210101$20240918$20230926$20240921$EXP$$US-ABBVIE-5420082$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
229826288$22982628$8$F$$20240820$20230926$20240827$EXP$$BR-TAKEDA-2023TUS092694$TAKEDA$$$$$F$Y$59$KG$20240827$$MD$BR$BR
229826684$22982668$4$F$20230830$20240625$20230926$20240701$EXP$$MY-SANDOZ INC.-SDZ2023MY033174$SANDOZ$$$$$F$Y$$$20240701$$PH$MY$MY
229826782$22982678$2$F$$20240830$20230926$20240913$EXP$$US-ENDO PHARMACEUTICALS INC-2023-002756$ENDO$$$$$M$Y$$$20240913$$CN$US$US
229827552$22982755$2$F$$20240621$20230926$20240702$PER$$US-SA-2022SA014001$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240702$$MD$US$US
229834212$22983421$2$F$$20240715$20230926$20240723$EXP$$US-AUROBINDO-AUR-APL-2023-058905$AUROBINDO$Young KZ, Guan LL, Friedman BJ, Rambhatla PV. Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil.. International Journal of Women^s Dermatology. 2022;8(3):A47$47$YR$$F$Y$$$20240723$$MD$US$US
229834853$22983485$3$F$20230801$20240906$20230926$20240919$EXP$$IT-AUROBINDO-AUR-APL-2023-057227$AUROBINDO$$64$YR$$F$Y$71$KG$20240919$$MD$IT$IT
229835702$22983570$2$F$$20230925$20230926$20240921$PER$$US-AUROBINDO-AUR-APL-2023-052258$AUROBINDO$$58$YR$$F$Y$57.6$KG$20240921$$CN$US$US
229836002$22983600$2$F$20230708$20230913$20230926$20240921$PER$$US-AUROBINDO-AUR-APL-2023-049852$AUROBINDO$$65$YR$$F$Y$59$KG$20240921$$CN$US$US
2298370411$22983704$11$F$20220701$20240904$20230926$20240912$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-28348$IPSEN$$67$YR$E$F$Y$$$20240912$$HP$CA$CA
229837262$22983726$2$F$$20230911$20230926$20240826$EXP$$SE-BRAEBURN-SE-BRA-23-000008$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$SE$SE
229837484$22983748$4$F$20230707$20240716$20230926$20240725$EXP$$CA-CELLTRION INC.-2023CA014234$CELLTRION$$$$$$Y$$$20240725$$CN$CA$CA
229837494$22983749$4$F$20240801$20240912$20230926$20240919$EXP$$BR-TAKEDA-2023TUS073544$TAKEDA$$39$YR$$F$Y$$$20240919$$CN$BR$BR
229838893$22983889$3$F$20240801$20240911$20230926$20240926$PER$$US-SA-2023SA286568$SANOFI AVENTIS$$15$YR$T$M$Y$85.72$KG$20240926$$MD$US$US
229840263$22984026$3$F$$20240708$20230926$20240717$EXP$$CA-APOTEX-2023AP013816$APOTEX$$50$YR$$F$Y$110$KG$20240717$$MD$CA$CA
229842552$22984255$2$F$$20240711$20230926$20240715$EXP$$US-SANDOZ INC.-SDZ2023US016269$SANDOZ$$$$$F$Y$$$20240715$$CN$US$US
229843163$22984316$3$F$20230416$20240726$20230926$20240730$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-263281$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$88.2$KG$20240730$$MD$JP$JP
229844072$22984407$2$F$$20240910$20230926$20240920$EXP$$CA-APOTEX-2023AP013774$APOTEX$$78$YR$$F$Y$93$KG$20240920$$HP$CA$CA
229844323$22984432$3$F$20240918$20240919$20230926$20240927$EXP$$CA-TAKEDA-2023TUS092103$TAKEDA$$28$YR$$F$Y$$$20240927$$CN$CA$CA
229844493$22984449$3$F$20230901$20240826$20230926$20240914$PER$$US-SA-2023SA288472$SANOFI AVENTIS$$73$YR$E$M$Y$93.4$KG$20240914$$MD$US$US
229845775$22984577$5$F$20181001$20240827$20230926$20240828$EXP$$CA-SANDOZ INC.-PHHY2018CA147655$SANDOZ$$34$YR$$F$Y$$$20240828$$CN$CA$CA
229845893$22984589$3$F$20230911$20240924$20230926$20240927$EXP$$CA-TAKEDA-2023TUS066513$TAKEDA$$56$YR$$M$Y$$$20240927$$CN$CA$CA
229846712$22984671$2$F$20230812$20240716$20230926$20240726$EXP$$IT-AUROBINDO-AUR-APL-2023-059278$AUROBINDO$$24$YR$$M$Y$$$20240726$$MD$IT$IT
229847406$22984740$6$F$20240506$20240603$20230926$20240917$30DAY$$US-GSK-US2023AMR131407$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240917$$CN$US$US
229847523$22984752$3$F$$20240718$20230926$20240723$EXP$$CA-Orion Corporation ORION PHARMA-23_00025754$ORION$$54$YR$A$M$Y$$$20240723$$HP$CA$
229848432$22984843$2$F$$20240622$20230926$20240701$PER$$US-SA-2023SA287528$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240701$$MD$US$US
229848743$22984874$3$F$20180625$20240806$20230926$20240812$EXP$$CA-SANDOZ INC.-PHHY2018CA035329$SANDOZ$$30$YR$$F$Y$70$KG$20240812$$CN$CA$CA
229851284$22985128$4$F$$20240719$20230926$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-136377$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$81.65$KG$20240722$$CN$US$US
229851588$22985158$8$F$20230101$20240730$20230926$20240812$EXP$$US-UCBSA-2023046377$UCB$$$$$M$Y$70.8$KG$20240812$$MD$US$US
229851784$22985178$4$F$20211201$20240903$20230926$20240906$EXP$$CA-TAKEDA-CA201921847$TAKEDA$$64$YR$$M$Y$84$KG$20240906$$CN$CA$CA
229851953$22985195$3$F$$20240729$20230926$20240731$EXP$$CA-SANDOZ INC.-NVSC2023CA147037$SANDOZ$$$$$M$Y$$$20240731$$CN$CA$CA
229852574$22985257$4$F$20230106$20240920$20230926$20240925$EXP$$US-TAKEDA-2023TUS002168$TAKEDA$$58$YR$$M$Y$$$20240925$$MD$US$US
229852643$22985264$3$F$20230923$20240806$20230926$20240807$EXP$$US-TAKEDA-2023TUS092920$TAKEDA$$31$YR$$M$Y$$$20240807$$PH$US$US
229858672$22985867$2$F$$20240625$20230926$20240703$EXP$$US-AstraZeneca-2023A213395$ASTRAZENECA$$$$$$Y$$$20240703$$CN$US$
229858969$22985896$9$F$20230801$20240917$20230926$20240923$EXP$$NVSC2023AR205163$NOVARTIS$$35$YR$$F$Y$$$20240923$$CN$AR$AR
229860658$22986065$8$F$$20240918$20230926$20240923$EXP$$NVSC2023US207276$NOVARTIS$$$$$M$Y$$$20240923$$CN$US$US
229861012$22986101$2$F$$20240808$20230926$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-135563$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$83.01$KG$20240812$$CN$US$US
229861244$22986124$4$F$$20240829$20230926$20240829$PER$$NVSC2023US203624$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
229862914$22986291$4$F$20240508$20240816$20230926$20240819$PER$$NVSC2023US206629$NOVARTIS$$36$YR$$F$Y$$$20240819$$CN$US$US
229866727$22986672$7$F$$20240826$20230926$20240829$PER$$US-PFIZER INC-PV202300161080$PFIZER$$80$YR$$F$Y$$$20240829$$CN$US$US
229867633$22986763$3$F$$20240918$20230926$20240923$PER$$US-PFIZER INC-PV202300160461$PFIZER$$41$YR$$F$Y$$$20240923$$HP$US$US
229867822$22986782$2$F$$20240829$20230926$20240904$EXP$$US-PFIZER INC-PV202300160386$PFIZER$$$$$F$Y$$$20240904$$CN$US$US
229868903$22986890$3$F$$20240829$20230926$20240909$EXP$$PT-CHATTEMPRD-2023OHG007924$CHATTEM$$$$E$$Y$$$20240909$$HP$PT$PT
229869002$22986900$2$F$$20240725$20230926$20240809$PER$$US-IMPEL PHARMACEUTICALS INC-2023-SPO-TR-0287$IMPEL NEUROPHARMA$$$$$$Y$$$20240809$$CN$US$US
229870002$22987000$2$F$$20240808$20230926$20240813$EXP$$NVSC2023TH203214$NOVARTIS$$$$$F$Y$$$20240813$$CN$TH$TH
229870363$22987036$3$F$$20240906$20230926$20240913$EXP$$GB-ABBVIE-5420119$ABBVIE$$$$E$M$Y$$$20240913$$CN$GB$GB
229870855$22987085$5$F$20230101$20240904$20230926$20240912$EXP$$US-SA-2023SA291255$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240912$$MD$US$US
229871262$22987126$2$F$20201201$20230922$20230926$20240812$EXP$$FR-OTSUKA-2023_025156$OTSUKA$$53$YR$$F$Y$$$20240812$$CN$FR$FR
229872172$22987217$2$F$$20230921$20230926$20240909$PER$$NVSC2023US206192$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
229872872$22987287$2$F$20230803$20240712$20230926$20240718$EXP$$BE-MYLANLABS-2023M1101338$BIOCON$$$$$$Y$$$20240718$$MD$BE$BE
229873712$22987371$2$F$20230920$20240809$20230926$20240814$EXP$$US-TAKEDA-2023TUS092568$TAKEDA$$68$YR$$F$Y$$$20240814$$CN$US$US
229874822$22987482$2$F$20190601$20240826$20230926$20240910$EXP$$US-BIOMARINAP-US-2023-152936$BIOMARIN$$$$$$Y$$$20240910$$MD$US$US
229874912$22987491$2$F$20200101$20240821$20230926$20240826$EXP$$CA-SANDOZ INC.-PHHY2018CA173575$SANDOZ$$$$$M$Y$$$20240826$$CN$CA$CA
229875014$22987501$4$F$$20240828$20230926$20240830$EXP$$CA-SANDOZ INC.-NVSC2022CA221440$SANDOZ$$57$YR$$F$Y$$$20240830$$CN$CA$CA
229876316$22987631$6$F$$20240827$20230926$20240830$EXP$$JP-PFIZER INC-202300305997$PFIZER$Kubota, A.. Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody. Journal of NeuroVirology. 2023;10.1007/s13365-023-01171-x$59$YR$$F$Y$52.3$KG$20240830$$MD$JP$JP
229876874$22987687$4$F$20230801$20240723$20230926$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-136663$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240725$$HP$US$US
229877235$22987723$5$F$20230619$20240808$20230926$20240813$EXP$$US-TAKEDA-2023TUS037477$TAKEDA$$72$YR$$F$Y$62$KG$20240813$$MD$US$US
229877515$22987751$5$F$20230901$20240806$20230926$20240812$EXP$$GB-VERTEX PHARMACEUTICALS-2023-014208$VERTEX$$$$A$F$Y$$$20240812$$CN$GB$GB
229877786$22987778$6$F$20230101$20240919$20230926$20240924$EXP$$CA-TAKEDA-2023TUS044126$TAKEDA$$$$$F$Y$$$20240924$$CN$CA$CA
229878113$22987811$3$F$$20240717$20230926$20240723$EXP$$US-ABBVIE-5420103$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
229879123$22987912$3$F$20220120$20240711$20230926$20240718$EXP$$DE-AUROBINDO-AUR-APL-2023-050444$AUROBINDO$$37$YR$$F$Y$$$20240718$$CN$DE$DE
229880044$22988004$4$F$$20240830$20230926$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-136381$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240903$$CN$US$US
229881732$22988173$2$F$$20240628$20230926$20240708$PER$$US-SA-2023SA286108$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240708$$MD$US$US
229882703$22988270$3$F$20230823$20240816$20230926$20240821$EXP$$US-ABBVIE-5421895$ABBVIE$$61$YR$$M$Y$$$20240821$$CN$US$US
229882716$22988271$6$F$$20240715$20230926$20240718$PER$$US-DSJP-DSU-2023-128312$DAIICHI$$$$$F$Y$$$20240718$$CN$US$US
229882905$22988290$5$F$20230901$20240716$20230926$20240718$EXP$$AT-DSJP-DSE-2023-139543$DAIICHI$$61$YR$$F$Y$$$20240718$$MD$AT$AT
229883278$22988327$8$F$$20240720$20230926$20240805$EXP$$CA-ASTELLAS-2023US028555$ASTELLAS$$43$YR$$F$Y$$$20240805$$CN$CA$CA
229883425$22988342$5$F$$20240828$20230926$20240830$EXP$$NVSC2023US203671$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
229883625$22988362$5$F$20230901$20240722$20230926$20240725$EXP$$ES-PFIZER INC-202300306230$PFIZER$$47$YR$$M$Y$76.1$KG$20240725$$MD$ES$ES
229884128$22988412$8$F$20230915$20240629$20230926$20240702$EXP$$MX-TAKEDA-2023TUS092442$TAKEDA$$46$YR$$F$Y$$$20240702$$CN$MX$MX
229885032$22988503$2$F$$20240709$20230926$20240712$EXP$$MX-BAUSCH-BL-2023-014111$BAUSCH AND LOMB$Teco-Cortes J, Arrecillas-Zamora M. Mucormicosis diseminada en un paciente pedi?trico con leucemia linfobl?stica  aguda: hallazgos de la autopsia. Boletin Medico del Hospital Infantil de Mexico. 2022 JUL 12;80(SUPL 1):1-6. doi:10.24875/BMHIM.22000050$9$YR$$M$Y$$$20240712$$HP$MX$MX
229885464$22988546$4$F$20160101$20240805$20230926$20240806$EXP$AT-SA-2022SA138652$AT-SANDOZ INC.-SDZ2023AT033218$SANDOZ$$54$YR$$M$Y$$$20240806$$MD$AT$AT
229886073$22988607$3$F$20230816$20240913$20230926$20240916$EXP$FR-AFSSAPS-LY2023001507$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-136454$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240917$$PH$FR$FR
229886788$22988678$8$F$20230922$20240807$20230926$20240813$EXP$$CA-TAKEDA-2023TUS056292$TAKEDA$$49$YR$$F$Y$$$20240813$$CN$CA$CA
229886892$22988689$2$F$$20230731$20230926$20240716$EXP$$US-NOVOPROD-1103479$NOVO NORDISK$$$$$M$Y$$$20240716$$CN$US$US
229887723$22988772$3$F$20230912$20240709$20230926$20240715$EXP$$US-ABBVIE-5420280$ABBVIE$$46$YR$$F$Y$70.306$KG$20240715$$CN$US$US
229888014$22988801$4$F$20230101$20240619$20230926$20240703$EXP$$JP-AMGEN-JPNSP2023170663$AMGEN$$87$YR$E$F$Y$$$20240702$$MD$JP$JP
229888422$22988842$2$F$$20240717$20230926$20240726$EXP$$US-AUROBINDO-AUR-APL-2023-059055$AUROBINDO$Bradshaw S, Oertling E, Rezigh A.. Synchronous visceral Kaposi sarcoma and extracavitary primary effusion lymphoma in a patient with AIDS.. BMJ Case Reports.. 2022;15(3):e245306.$3$DEC$$M$Y$$$20240726$$MD$US$US
229889744$22988974$4$F$$20240923$20230927$20240930$EXP$$CA-SANDOZ INC.-NVSC2023CA088007$SANDOZ$$50$YR$$F$Y$68$KG$20240930$$HP$CA$CA
229890182$22989018$2$F$$20240812$20230927$20240821$PER$$US-SA-2023SA288793$SANOFI AVENTIS$$54$YR$A$M$Y$105.2$KG$20240821$$MD$US$US
2298902012$22989020$12$F$20200101$20240918$20230927$20240927$EXP$$CA-CELLTRION INC.-2020CA020997$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
2298902714$22989027$14$F$20230601$20240718$20230927$20240723$EXP$$PT-ABBVIE-5311885$ABBVIE$$73$YR$$F$Y$$$20240723$$CN$PT$PT
229890573$22989057$3$F$$20240812$20230927$20240829$PER$$CA-TOLMAR, INC.-23CA043265$TOLMAR$$$$$M$Y$$$20240829$$CN$CA$CA
229890592$22989059$2$F$$20240809$20230927$20240904$PER$$CA-TOLMAR, INC.-23CA043268$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
229890603$22989060$3$F$20230911$20240913$20230927$20240927$PER$$CA-TOLMAR, INC.-23CA043279$TOLMAR$$65$YR$$M$Y$$$20240927$$CN$CA$CA
229890633$22989063$3$F$$20240807$20230927$20240904$PER$$CA-TOLMAR, INC.-23CA043302$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
229890644$22989064$4$F$20230911$20240809$20230927$20240830$PER$$CA-TOLMAR, INC.-23CA043319$TOLMAR$$83$YR$$M$Y$$$20240830$$CN$CA$CA
229890654$22989065$4$F$20230911$20240809$20230927$20240830$PER$$CA-TOLMAR, INC.-23CA043318$TOLMAR$$79$YR$$M$Y$$$20240830$$CN$CA$CA
229890684$22989068$4$F$20230911$20240809$20230927$20240830$PER$$CA-TOLMAR, INC.-23CA043320$TOLMAR$$72$YR$$M$Y$$$20240830$$CN$CA$CA
229890882$22989088$2$F$$20240816$20230927$20240829$PER$$US-SA-2023SA290357$SANOFI AVENTIS$$58$YR$A$F$Y$96$KG$20240829$$MD$US$US
229891792$22989179$2$F$20230914$20230919$20230927$20240710$EXP$$NVSC2023RU205269$NOVARTIS$$18$YR$$F$Y$$$20240710$$HP$RU$RU
229892097$22989209$7$F$20230918$20231107$20230927$20240926$EXP$$US-GSK-US2023AMR130659$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
229892692$22989269$2$F$$20240718$20230927$20240723$EXP$$GR-AMGEN-GRCSP2023167506$AMGEN$$$$$F$Y$$$20240723$$MD$GR$GR
2298932110$22989321$10$F$$20240710$20230927$20240712$EXP$$CA-SANDOZ INC.-NVSC2021CA225003$SANDOZ$$65$YR$$M$Y$$$20240712$$CN$CA$CA
229893772$22989377$2$F$$20240717$20230927$20240723$EXP$$GR-AMGEN-GRCSP2023167492$AMGEN$$$$$F$Y$$$20240723$$MD$GR$GR
229894143$22989414$3$F$20210902$20240715$20230927$20240722$EXP$$FR-AUROBINDO-AUR-APL-2021-028671$AUROBINDO$Laurent R, Gauthier V, Varvat C, Goudard D, Delavenne X, Moreau A et al.. Drug monitoring for diagnosis of pharmacobezoar: A case report.. Fundamental and Clinical Pharmacology. 2021;35(1):195$51$YR$$F$Y$38$KG$20240722$$MD$FR$FR
229894642$22989464$2$F$$20240925$20230927$20240926$PER$$NVSC2023US207331$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
229894913$22989491$3$F$$20240718$20230927$20240723$EXP$$US-TAKEDA-US202033378$TAKEDA$$$$$F$Y$$$20240723$$HP$US$US
2298952211$22989522$11$F$20210707$20240913$20230927$20240923$EXP$$CA-CELLTRION INC.-2021CA010732$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
2298966318$22989663$18$F$20230101$20240918$20230927$20240926$EXP$$CA-JNJFOC-20230719511$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240926$$HP$CA$CA
229897874$22989787$4$F$20230920$20240814$20230927$20240822$EXP$$IL-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-003592$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240822$$MD$IL$IL
229898005$22989800$5$F$$20240920$20230927$20240927$EXP$$CA-TAKEDA-2023TUS093192$TAKEDA$$$$$M$Y$$$20240927$$CN$CA$CA
229898034$22989803$4$F$$20240719$20230927$20240726$EXP$$NVSC2023DE207577$NOVARTIS$$64$YR$$F$Y$$$20240726$$CN$DE$DE
2298987010$22989870$10$F$20230917$20240918$20230927$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-014759$JAZZ$$63$YR$$M$Y$$$20240922$$CN$US$US
229898725$22989872$5$F$20230101$20240823$20230927$20240902$EXP$$JP-009507513-2309JPN003142J$MERCK$$50$YR$$F$Y$59$KG$20240902$$MD$JP$JP
229899332$22989933$2$F$20221201$20240723$20230927$20240724$EXP$FR-AFSSAPS-PV2023000756$FR-ROCHE-3427253$ROCHE$$16$YR$T$M$Y$73$KG$20240724$$MD$FR$FR
229899874$22989987$4$F$20230912$20240806$20230927$20240815$PER$$US-SA-2023SA288035$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240815$$MD$US$US
229899913$22989991$3$F$20240801$20240821$20230927$20240917$PER$$US-SA-2023SA289303$SANOFI AVENTIS$$48$YR$A$M$Y$92.98$KG$20240918$$MD$US$US
229899986$22989998$6$F$20231019$20240710$20230927$20240711$EXP$$JP-GSK-JP2023JPN131190$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$JP$JP
229900082$22990008$2$F$20230101$20240726$20230927$20240806$PER$$US-SA-2023SA288160$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240806$$MD$US$US
229900563$22990056$3$F$$20240626$20230927$20240705$PER$$US-SA-2023SA288118$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240705$$MD$US$US
229900593$22990059$3$F$20230101$20240729$20230927$20240807$PER$$US-SA-2023SA288820$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240807$$MD$US$US
229905323$22990532$3$F$$20240701$20230927$20240703$PER$$NVSC2023US208708$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
229913353$22991335$3$F$20230829$20240830$20230927$20240912$PER$$US-SA-2023SA292486$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240912$$MD$US$US
229913868$22991386$8$F$20230101$20240710$20230927$20240712$EXP$$US-UCBSA-2023028436$UCB$$$$$M$Y$$$20240712$$CN$US$US
229915383$22991538$3$F$20230118$20240812$20230927$20240814$EXP$$CA-SANDOZ INC.-NVSC2023CA013665$SANDOZ$$78$YR$$F$Y$$$20240814$$MD$CA$CA
229918233$22991823$3$F$$20240820$20230927$20240821$EXP$$CA-SANDOZ INC.-SDZ2023CA033827$SANDOZ$$64$YR$$M$Y$85$KG$20240821$$CN$CA$CA
229918432$22991843$2$F$20240101$20240828$20230927$20240920$PER$$US-SA-2023SA292401$SANOFI AVENTIS$$56$YR$A$F$Y$58.957$KG$20240920$$MD$US$US
229921652$22992165$2$F$20240101$20240712$20230927$20240722$PER$$US-SA-2023SA292949$SANOFI AVENTIS$$63$YR$A$F$Y$67.58$KG$20240721$$MD$US$US
229927415$22992741$5$F$$20240827$20230927$20240829$EXP$$NVSC2023US207207$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
229927633$22992763$3$F$20230101$20240715$20230927$20240719$EXP$$PT-009507513-2309PRT008097$MERCK$$31$YR$$F$Y$$$20240719$$MD$PT$PT
229933002$22993300$2$F$$20240807$20230927$20240809$PER$$US-PFIZER INC-PV202300161066$PFIZER$$$$$F$Y$$$20240809$$CN$US$US
229934962$22993496$2$F$20230301$20240726$20230927$20240731$EXP$$CA-ABBVIE-5422284$ABBVIE$$64$YR$$F$Y$63.6$KG$20240731$$MD$CA$CA
229935256$22993525$6$F$20230407$20240708$20230927$20240712$EXP$$JP-AstraZeneca-2023A216188$ASTRAZENECA$Fukuoka H.. [O8-04] A case of multiple artery obstructions including bilateral renal artery obstructions after administration of Andexanet alfa.. The 27th Congress of Japanese Society for Emergency Medicine. 2024;0-0.$74$YR$$M$Y$$$20240712$$MD$JP$
229936263$22993626$3$F$$20240830$20230927$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-137076$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240902$$CN$US$US
229937285$22993728$5$F$$20240813$20230927$20240817$EXP$$CA-SANDOZ INC.-NVSC2022CA226042$SANDOZ$$48$YR$$F$Y$$$20240817$$CN$CA$CA
229937832$22993783$2$F$$20240725$20230927$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-136927$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240731$$MD$US$US
2299389110$22993891$10$F$20230907$20240827$20230927$20240830$EXP$$DE-EXELIXIS-XL18423068125$EXELIXIS$$$$$$Y$$$20240830$$MD$DE$DE
229939033$22993903$3$F$$20231002$20230927$20240718$EXP$$US-Taiho Oncology Inc-2023-008065$TAIHO ONCOLOGY INC$$$$A$M$Y$88.45$KG$20240718$$CN$US$US
229939203$22993920$3$F$$20240812$20230927$20240814$EXP$$CA-SANDOZ INC.-SDZ2023CA034157$SANDOZ$$45$YR$$M$Y$$$20240814$$MD$CA$CA
229939444$22993944$4$F$20230101$20240815$20230927$20240829$PER$$US-SA-2023SA287791$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240829$$MD$US$US
229941468$22994146$8$F$$20240827$20230927$20240829$EXP$$CA-TAKEDA-2022TUS083262$TAKEDA$$$$$M$Y$$$20240829$$HP$CA$CA
229941582$22994158$2$F$20230918$20240711$20230927$20240722$PER$$US-SA-2023SA292681$SANOFI AVENTIS$$16$YR$T$M$Y$81.6$KG$20240721$$MD$US$US
229942179$22994217$9$F$$20240808$20230927$20240812$PER$$NVSC2023US208545$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
229942425$22994242$5$F$20231012$20240710$20230927$20240715$EXP$$CA-TAKEDA-2023TUS093442$TAKEDA$$41$YR$$M$Y$$$20240715$$CN$CA$CA
229945545$22994554$5$F$20230605$20240718$20230927$20240724$EXP$$JP-009507513-2309JPN003149J$MERCK$$80$YR$$M$Y$$$20240724$$MD$JP$JP
2299464017$22994640$17$F$20171020$20240918$20230927$20240926$EXP$$US-TAKEDA-US201938672$TAKEDA$$52$YR$$F$Y$$$20240926$$HP$US$US
229950434$22995043$4$F$20240701$20240716$20230927$20240725$EXP$$US-ABBVIE-5421882$ABBVIE$$79$YR$$M$Y$$$20240725$$CN$US$US
229954294$22995429$4$F$$20240717$20230927$20240726$EXP$$CA-TAKEDA-2023TUS093447$TAKEDA$$$$$F$Y$$$20240726$$CN$CA$CA
229954552$22995455$2$F$$20240815$20230927$20240824$EXP$$CA-AstraZeneca-2021A597927$ASTRAZENECA$$75$YR$$F$Y$$$20240823$$MD$CA$
229955976$22995597$6$F$20230920$20240919$20230927$20240924$EXP$$GB-MYLANLABS-2023M1101032$MYLAN$$47$YR$$F$Y$$$20240924$$CN$GB$GB
229956133$22995613$3$F$20240523$20240705$20230927$20240712$EXP$$AR-GSK-AR2023AMR118648$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$AR$AR
2299570618$22995706$18$F$20230801$20240920$20230927$20240927$EXP$$NVSC2023BR189127$NOVARTIS$$55$YR$$F$Y$$$20240927$$CN$BR$BR
229957613$22995761$3$F$$20240722$20230927$20240726$EXP$$CA-GSK-CA2023AMR132036$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$HP$CA$CA
229958715$22995871$5$F$20230822$20240703$20230927$20240711$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019909$JAZZ$$28$YR$$F$Y$$$20240711$$HP$US$US
229962152$22996215$2$F$20230601$20240828$20230927$20240904$EXP$$US-ABBVIE-5425214$ABBVIE$$73$YR$$F$Y$$$20240904$$CN$US$US
229962453$22996245$3$F$$20240823$20230927$20240826$EXP$$US-ABBVIE-5419620$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
2299629211$22996292$11$F$20231001$20240820$20230927$20240828$EXP$$US-MALLINCKRODT-MNK202304540$MALLINCKRODT$$67$YR$$F$Y$$$20240828$$CN$US$US
229964535$22996453$5$F$$20240827$20230928$20240828$EXP$$IT-SANDOZ INC.-SDZ2023IT033343$SANDOZ$$11$YR$$M$Y$36$KG$20240828$$HP$IT$IT
229965933$22996593$3$F$20230101$20240811$20230928$20240903$PER$$CA-TOLMAR, INC.-23CA043305$TOLMAR$$$$$M$Y$$$20240903$$CN$CA$CA
229966209$22996620$9$F$20230101$20240918$20230928$20240927$EXP$$CA-CELLTRION INC.-2023CA018669$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
229967093$22996709$3$F$$20240717$20230928$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-135501$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240719$$CN$US$US
229967486$22996748$6$F$20230525$20240904$20230928$20240905$EXP$FR-AFSSAPS-PO2023000643$FR-SANDOZ INC.-SDZ2023FR004861$SANDOZ$$59$YR$$F$Y$$$20240905$$MD$FR$FR
229971902$22997190$2$F$$20230925$20230928$20240927$PER$$US-LEO Pharma-363200$LEO PHARM$$$$$F$Y$$$20240927$$HP$US$US
229975472$22997547$2$F$$20240803$20230928$20240810$EXP$$CA-ROCHE-3428929$ROCHE$$85$YR$E$F$Y$$$20240810$$HP$CA$CA
229979959$22997995$9$F$20230830$20240708$20230928$20240716$EXP$$DE-GALDERMA-DE2023013882$GALDERMA$$$$$$Y$$$20240716$$HP$DE$DE
229980303$22998030$3$F$20230724$20240813$20230928$20240822$EXP$FR-AFSSAPS-AM2023000746$FR-EMD Serono-2023476664$EMD SERONO INC$$78$YR$E$M$Y$80$KG$20240822$$MD$FR$FR
229980408$22998040$8$F$$20240923$20230928$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-137153$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240925$$CN$US$US
229980492$22998049$2$F$20230101$20240820$20230928$20240822$EXP$$US-ABBVIE-5423103$ABBVIE$$$$$F$Y$$$20240822$$MD$US$US
229980736$22998073$6$F$$20231129$20230928$20240926$EXP$$US-GSK-US2023AMR129278$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
229981132$22998113$2$F$$20240705$20230928$20240709$PER$$NVSC2023US208845$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
229981433$22998143$3$F$20230101$20240724$20230928$20240731$EXP$$US-ABBVIE-22K-163-4455850-00$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
229982422$22998242$2$F$20230101$20240917$20230928$20240919$EXP$$US-SA-2023SA294197$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240919$$MD$US$US
229984677$22998467$7$F$20230420$20240704$20230928$20240711$EXP$$BR-SANDOZ INC.-NVSC2023BR006369$SANDOZ$$68$YR$$F$Y$$$20240711$$CN$BR$BR
229984815$22998481$5$F$$20240910$20230928$20240920$EXP$$US-HBP-2023US029762$HELSINN HEALTHCARE$$$$$F$Y$$$20240920$$CN$US$US
229985063$22998506$3$F$20230801$20240809$20230928$20240816$EXP$$CA-CELLTRION INC.-2022CA006600$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
229987622$22998762$2$F$$20240722$20230928$20240724$EXP$$CA-Orion Corporation ORION PHARMA-23_00025792$ORION$$40$YR$A$$Y$119$KG$20240724$$MD$CA$
229990757$22999075$7$F$$20240723$20230928$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-137710$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240731$$HP$US$US
229997853$22999785$3$F$$20240913$20230928$20240917$EXP$$CA-SANDOZ INC.-SDZ2023CA034251$SANDOZ$$3$DEC$$M$Y$$$20240917$$HP$CA$CA
229999544$22999954$4$F$$20240826$20230928$20240827$PER$$NVSC2023US209750$NOVARTIS$$$$$M$Y$$$20240827$$CN$US$US
2300001011$23000010$11$F$20230302$20240723$20230928$20240730$EXP$$BR-GSK-BR2023AMR034408$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$BR$BR
230001912$23000191$2$F$$20240628$20230928$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202309014719$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240702$$CN$US$US
230003863$23000386$3$F$20230605$20240531$20230928$20240916$PER$$US-KVK-TECH, INC-20230600096$KVK-TECH$$$$$F$Y$$$20240916$$CN$US$US
230003872$23000387$2$F$20230601$20240606$20230928$20240916$PER$$US-KVK-TECH, INC-20230600100$KVK-TECH$$$$$$Y$$$20240916$$PH$US$US
230003952$23000395$2$F$20230101$20240606$20230928$20240916$PER$$US-KVK-TECH, INC-20230300045$KVK-TECH$$$$$M$Y$$$20240916$$CN$US$US
230005094$23000509$4$F$20230220$20240629$20230928$20240705$EXP$$JP-AstraZeneca-2023A052563$ASTRAZENECA$$16$YR$$F$Y$$$20240705$$MD$JP$
230005203$23000520$3$F$$20240820$20230928$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-137672$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240830$$CN$US$US
230005653$23000565$3$F$20230101$20240715$20230928$20240718$EXP$$US-SA-2023SA292930$SANOFI AVENTIS$$60$YR$A$F$Y$90.7$KG$20240718$$MD$US$US
230008924$23000892$4$F$$20240819$20230928$20240823$EXP$$CA-SANDOZ INC.-NVSC2023CA007230$SANDOZ$$49$YR$$F$Y$96$KG$20240823$$HP$CA$CA
230009853$23000985$3$F$$20240812$20230928$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08150$LUPIN$$$$$$Y$$$20240901$$PH$US$US
230010932$23001093$2$F$$20240624$20230928$20240701$EXP$$CA-GSK-CA2023AMR130469$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$CA$CA
230016993$23001699$3$F$20230904$20240723$20230928$20240801$PER$$US-AMGEN-USASP2023171761$AMGEN$$51$YR$A$F$Y$$$20240801$$HP$US$US
230018022$23001802$2$F$20220501$20240816$20230928$20240826$PER$$US-INCYTE CORPORATION-2023IN009160$INCYTE$$$$$$Y$$$20240826$$CN$US$US
230018052$23001805$2$F$20230412$20240719$20230928$20240726$EXP$$IT-SA-2023SA149154$SANOFI AVENTIS$$56$YR$A$F$Y$48$KG$20240726$$MD$IT$IT
230018242$23001824$2$F$$20230925$20230928$20240930$PER$$US-LEO Pharma-363194$LEO PHARM$$$$$F$Y$$$20240930$$CN$US$US
230019418$23001941$8$F$$20240709$20230928$20240718$EXP$$CA-SANDOZ INC.-NVSC2023CA092320$SANDOZ$$58$YR$$F$Y$$$20240718$$HP$CA$CA
2300194612$23001946$12$F$20230101$20240702$20230928$20240710$EXP$$JP-BIOGEN-2023BI01226241$BIOGEN$$$$$F$Y$$$20240710$$MD$JP$JP
230021704$23002170$4$F$$20240710$20230928$20240718$PER$$US-SA-2023SA289330$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240718$$MD$US$US
230022113$23002211$3$F$20230901$20240625$20230928$20240704$PER$$US-SA-2023SA289296$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240704$$MD$US$US
230022622$23002262$2$F$20230911$20240722$20230928$20240731$PER$$US-SA-2023SA137533$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240731$$MD$US$US
230022682$23002268$2$F$20230101$20240813$20230928$20240820$PER$$US-SA-2023SA293925$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240820$$MD$US$US
230023023$23002302$3$F$20210801$20240820$20230928$20240827$PER$$US-SA-2023SA294498$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240827$$MD$US$US
230023335$23002333$5$F$20230101$20240703$20230928$20240712$PER$$US-SA-2023SA293932$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240712$$HP$US$US
230023342$23002334$2$F$$20240805$20230928$20240814$PER$$US-SA-2023SA294464$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240814$$MD$US$US
230024282$23002428$2$F$$20240708$20230928$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-136985$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240711$$CN$US$US
230024532$23002453$2$F$$20240705$20230928$20240710$EXP$$NVSC2023IE204093$NOVARTIS$$48$YR$$M$Y$$$20240710$$CN$IE$IE
230024622$23002462$2$F$20230622$20240902$20230928$20240911$EXP$$US-AstraZeneca-2023A217702$ASTRAZENECA$$86$YR$$M$Y$60.5$KG$20240911$$HP$US$
230025693$23002569$3$F$$20240813$20230928$20240816$PER$$US-PFIZER INC-202300311159$PFIZER$$47$YR$$F$Y$$$20240816$$HP$US$US
230027332$23002733$2$F$$20240902$20230928$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-137695$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$36.3$KG$20240910$$MD$JP$JP
230027852$23002785$2$F$$20240819$20230928$20240823$EXP$$US-MYLANLABS-2023M1100858$MYLAN$$$$$M$Y$68.04$KG$20240823$$HP$US$US
230028722$23002872$2$F$20211105$20240627$20230928$20240701$EXP$FR-AFSSAPS-PC20222316$FR-PFIZER INC-202201264939$PFIZER$$81$YR$$M$Y$$$20240701$$MD$FR$FR
230029532$23002953$2$F$$20240918$20230928$20240923$PER$$US-JAZZ PHARMACEUTICALS-2023-US-020113$JAZZ$$$$$F$Y$$$20240923$$CN$US$US
2300316711$23003167$11$F$20230101$20240826$20230928$20240829$PER$$US-BIOGEN-2023BI01227991$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
230033074$23003307$4$F$20231001$20240808$20230928$20240816$EXP$$GB-SANDOZ INC.-SDZ2023GB034374$SANDOZ$$4$YR$$F$Y$$$20240816$$CN$GB$GB
230035274$23003527$4$F$20230901$20240903$20230928$20240923$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000371$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
230040444$23004044$4$F$$20240628$20230928$20240704$EXP$$CA-SANDOZ INC.-SDZ2023CA026221$SANDOZ$$$$$F$Y$93.64$KG$20240704$$CN$CA$CA
230040649$23004064$9$F$$20240708$20230928$20240709$EXP$$CA-SANDOZ INC.-NVSC2023CA091867$SANDOZ$$$$$F$Y$68$KG$20240709$$HP$CA$CA
230041243$23004124$3$F$$20240708$20230928$20240709$EXP$$CA-SANDOZ INC.-NVSC2022CA225823$SANDOZ$$56$YR$$M$Y$$$20240709$$HP$CA$CA
230041462$23004146$2$F$$20230926$20230928$20240802$EXP$$BE-SANDOZ INC.-SDZ2023BE034768$SANDOZ$Semeu, PK, Taghavi, M, Geers, C, Mouthon, L, Gutierrez, LB and Stordeur, P. Scleroderma renal crisis triggered byibuprofen: Insights on complement-directedtherapy. Journal of Scleroderma and Related Disorders. 2023;8(3):NP6-NP8$59$YR$$M$Y$$$20240802$$HP$BE$BE
230042294$23004229$4$F$20200914$20240722$20230928$20240726$EXP$$JP-BAUSCH-BL-2021-014867$BAUSCH AND LOMB$$66$YR$$M$Y$65.7$KG$20240726$$$COUNTRY NOT SPECIFIED$JP
230042519$23004251$9$F$20230101$20240716$20230928$20240719$EXP$$CA-PFIZER INC-202300281574$PFIZER$$74$YR$$F$Y$$$20240719$$MD$CA$CA
230042995$23004299$5$F$$20240827$20230928$20240902$EXP$$CA-SANDOZ INC.-SDZ2023CA034810$SANDOZ$$65$YR$$F$Y$$$20240902$$MD$CA$CA
230043602$23004360$2$F$$20240916$20230928$20240918$EXP$$CA-SANDOZ INC.-NVSC2020CA153004$SANDOZ$$56$YR$$F$Y$$$20240918$$CN$CA$CA
230044382$23004438$2$F$20230801$20240730$20230928$20240805$EXP$$CR-BIOGEN-2023BI01228234$BIOGEN$$42$YR$$F$Y$50$KG$20240805$$CN$CR$CR
230045284$23004528$4$F$20230521$20240628$20230928$20240704$EXP$$JP-009507513-2309JPN003493J$MERCK$$57$YR$$F$Y$$$20240704$$MD$JP$JP
230045352$23004535$2$F$20230501$20240826$20230928$20240830$EXP$$BR-BIOGEN-2023BI01227607$BIOGEN$$39$YR$$F$Y$$$20240830$$CN$BR$BR
230045777$23004577$7$F$20230826$20240612$20230928$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003881$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240705$$CN$US$US
230045859$23004585$9$F$20230907$20240726$20230928$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003880$ACADIA PHARMACEUTICALS$$16$YR$$F$Y$$$20240820$$CN$US$US
230046198$23004619$8$F$20240601$20240618$20230928$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003922$ACADIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240712$$CN$US$US
230046206$23004620$6$F$$20240617$20230928$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003906$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
230046299$23004629$9$F$20231101$20240628$20230928$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003932$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240723$$CN$US$US
230046344$23004634$4$F$20230703$20240814$20230928$20240823$EXP$$CN-009507513-2309CHN008843$MERCK$$72$YR$$M$Y$80$KG$20240823$$MD$CN$CN
230046362$23004636$2$F$20230810$20240722$20230928$20240806$EXP$$GR-JNJFOC-20230966944$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240806$$MD$GR$GR
230047103$23004710$3$F$20230101$20240722$20230929$20240728$EXP$$NVSC2022CO194685$NOVARTIS$$$$$F$Y$22$KG$20240728$$CN$CO$CO
230047368$23004736$8$F$20231001$20240614$20230929$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-TRF-003253$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240709$$CN$US$US
230047638$23004763$8$F$20230904$20240628$20230929$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003907$ACADIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240723$$CN$US$US
230047793$23004779$3$F$20230101$20240621$20230929$20240701$PER$$US-SA-2023SA294618$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240701$$CN$US$US
230053933$23005393$3$F$20230622$20240626$20230929$20240704$EXP$$US-UNITED THERAPEUTICS-UNT-2023-018580$UNITED THERAPEUTICS$$35$YR$$F$Y$66.667$KG$20240704$$$US$US
230061225$23006122$5$F$$20240829$20230929$20240902$EXP$$CA-ROCHE-3020505$ROCHE$$$$A$F$Y$$$20240902$$CN$CA$CA
230061696$23006169$6$F$20230831$20240710$20230929$20240715$EXP$$GB-ABBVIE-5426898$ABBVIE$$28$YR$$F$Y$$$20240715$$MD$GB$GB
230061873$23006187$3$F$20230707$20240712$20230929$20240722$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2023-109518$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$91$KG$20240723$$HP$DE$DE
230064023$23006402$3$F$$20240822$20230929$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08157$LUPIN$$$$$$Y$$$20240909$$CN$US$US
230067082$23006708$2$F$$20230927$20230929$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-137620$BRISTOL MYERS SQUIBB$$23$YR$A$M$Y$$$20240708$$HP$US$US
230070952$23007095$2$F$$20230818$20230929$20240911$PER$$US-ALVOGEN-2023091541$ALVOGEN$$$$$F$Y$$$20240911$$CN$US$US
230074367$23007436$7$F$20230901$20231214$20230929$20240925$PER$$US-GSK-US2023AMR131224$GLAXOSMITHKLINE$$56$YR$$F$Y$70.1$KG$20240925$$MD$US$US
230076352$23007635$2$F$20211231$20240702$20230929$20240705$EXP$$DE-SANDOZ INC.-NVSC2022DE000519$SANDOZ$$67$YR$$M$Y$62.6$KG$20240705$$MD$DE$DE
230076474$23007647$4$F$$20240808$20230929$20240821$EXP$$CA-AUROBINDO-AUR-APL-2023-060493$AUROBINDO$Riggan M, Lum L, Bernadette-Cote E, Thurgur L. Severe flecainide toxicity treated with sodium bicarbonate, intravenous lipid emulsion and lidocaine infusion. Clinical Toxicology. 2023;61(Suppl 2):102$53$YR$$F$Y$$$20240821$$MD$CA$CA
230076765$23007676$5$F$$20231214$20230929$20240926$EXP$$US-GSK-US2023AMR131229$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
230076936$23007693$6$F$20200501$20240910$20230929$20240914$EXP$$PL-ROCHE-3429477$ROCHE$Dabrowska M. A patient with colorectal cancer with the BRAF V600E mutation treated with encorafenib in combination with cetuximab. Onkologia w praktyce klinicznej -edukacja. 2023;9 (SUP:C):C25-.$58$YR$A$M$Y$$$20240914$$HP$PL$PL
230077204$23007720$4$F$20230901$20231019$20230929$20240925$PER$$US-GSK-US2023AMR131541$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240925$$CN$US$US
230078672$23007867$2$F$$20240715$20230929$20240716$EXP$$CA-ORGANON-O2309CAN002937$ORGANON$Unknown. Unknown. Unknown$$$$F$Y$$$20240716$$HP$CA$CA
230078922$23007892$2$F$$20240821$20230929$20240822$PER$$NVSC2023US206720$NOVARTIS$$$$$M$Y$$$20240822$$CN$US$US
230079002$23007900$2$F$$20240715$20230929$20240722$EXP$$FR-MYLANLABS-2023M1103316$MYLAN$$59$YR$$F$Y$$$20240722$$MD$FR$FR
230080369$23008036$9$F$20230905$20240725$20230929$20240729$EXP$$US-UCBSA-2023047375$UCB$$4$YR$$F$Y$$$20240729$$CN$US$US
230080967$23008096$7$F$20230722$20240716$20230929$20240724$EXP$$US-ABBVIE-5428218$ABBVIE$$57$YR$$F$Y$$$20240724$$CN$US$US
230083325$23008332$5$F$$20240821$20230929$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-138032$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$90.71$KG$20240903$$CN$US$US
230084812$23008481$2$F$20191208$20240708$20230929$20240722$EXP$$FR-NORDICGR-053502$NORDIC PHARMA$$22$YR$$F$Y$$$20240722$$MD$FR$FR
230085984$23008598$4$F$$20240821$20230929$20240826$EXP$$CA-SANDOZ INC.-NVSC2022CA214707$SANDOZ$$76$YR$$F$Y$$$20240826$$HP$CA$CA
230092423$23009242$3$F$20230317$20240919$20230929$20240923$EXP$$GB-ROCHE-3313542$ROCHE$$43$YR$A$M$Y$$$20240923$$HP$GB$GB
230096554$23009655$4$F$20221207$20240807$20230929$20240808$EXP$$US-UCBSA-2023003676$UCB$$34$YR$$F$Y$$$20240808$$CN$US$US
230097883$23009788$3$F$20230501$20240925$20230929$20240930$EXP$$PL-VERTEX PHARMACEUTICALS-2023-014331$VERTEX$$$$$$Y$$$20240930$$CN$PL$PL
230098553$23009855$3$F$20140415$20240718$20230929$20240722$PER$$US-GILEAD-2023-0645831$GILEAD$$46$YR$A$M$Y$$$20240722$$LW$US$US
2300988911$23009889$11$F$20230901$20240913$20230929$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-138457$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240920$$CN$US$US
2301009610$23010096$10$F$20230101$20240724$20230929$20240801$EXP$$US-SA-2023SA295393$SANOFI AVENTIS$$7$MON$I$M$Y$$$20240801$$MD$US$US
230102522$23010252$2$F$20230101$20240828$20230929$20240926$PER$$US-SA-2023SA191556$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240926$$MD$US$US
230102552$23010255$2$F$20230101$20240808$20230929$20240817$PER$$US-SA-2023SA294768$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240817$$MD$US$US
230102732$23010273$2$F$$20240701$20230929$20240710$PER$$US-SA-2023SA294859$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240710$$MD$US$US
230102982$23010298$2$F$$20240828$20230929$20240909$EXP$$US-MYOVANT SCIENCES GMBH-2023MYSCI0900783$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
230103932$23010393$2$F$$20240822$20230929$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08214$LUPIN$$$$$$Y$$$20240909$$CN$US$US
230104263$23010426$3$F$20230901$20231013$20230929$20240812$EXP$$TW-AstraZeneca-2023A216665$ASTRAZENECA$$55$YR$$M$Y$$$20240812$$CN$TW$
230104472$23010447$2$F$20190618$20230901$20230929$20240927$PER$$US-Indivior Limited-INDV-139462-2023$RECKITT BENCKISER$$60$YR$$M$Y$$$20240927$$HP$US$US
230104524$23010452$4$F$$20240706$20230929$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08215$LUPIN$$$$$$Y$$$20240728$$PH$US$US
230106373$23010637$3$F$20160919$20240719$20230929$20240729$EXP$$CA-SANDOZ INC.-PHHY2016CA132023$SANDOZ$$68$YR$$F$Y$$$20240729$$HP$CA$CA
230107152$23010715$2$F$20230101$20240628$20230929$20240705$PER$$US-SA-2023SA296018$SANOFI AVENTIS$$14$YR$T$M$Y$71.6$KG$20240705$$MD$US$US
230107523$23010752$3$F$$20231006$20230929$20240718$EXP$$US-Taiho Oncology Inc-2023-008154$TAIHO ONCOLOGY INC$$$$A$F$Y$$$20240718$$CN$US$US
230107622$23010762$2$F$20230101$20230815$20230929$20240927$PER$$US-Indivior Limited-INDV-139952-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
230108292$23010829$2$F$20230101$20240814$20230929$20240819$PER$$US-PFIZER INC-PV202300147957$PFIZER$$65$YR$$M$Y$$$20240819$$HP$US$US
230108322$23010832$2$F$$20240807$20230929$20240813$EXP$$US-PFIZER INC-202300312052$PFIZER$$60$YR$$M$Y$$$20240813$$HP$US$US
230108843$23010884$3$F$$20240905$20230929$20240910$PER$$US-PFIZER INC-202300312097$PFIZER$$55$YR$$F$Y$$$20240910$$HP$US$US
230109094$23010909$4$F$20230101$20240814$20230929$20240820$EXP$$US-PFIZER INC-202300312010$PFIZER$$59$YR$$M$Y$$$20240820$$CN$US$US
230110114$23011011$4$F$$20240821$20230929$20240827$EXP$$US-AGIOS-2309US03484$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
230111153$23011115$3$F$20210101$20240726$20230929$20240801$EXP$$US-VERTEX PHARMACEUTICALS-2021-006435$VERTEX$$$$$M$Y$70$KG$20240801$$MD$US$US
230111762$23011176$2$F$$20240905$20230929$20240920$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409059$RANBAXY$$$$$F$Y$$$20240920$$MD$IN$IN
230112715$23011271$5$F$$20240715$20230929$20240722$EXP$$NVSC2022CA304408$NOVARTIS$$43$YR$$F$Y$97$KG$20240722$$HP$CA$CA
230113222$23011322$2$F$$20240625$20230929$20240701$EXP$$CA-SANDOZ INC.-SDZ2023CA035367$SANDOZ$$$$$F$Y$95$KG$20240701$$CN$CA$CA
230113244$23011324$4$F$$20240624$20230929$20240702$EXP$$CO-SANDOZ INC.-NVSC2022CO142736$SANDOZ$$$$$F$Y$60$KG$20240702$$CN$CO$CO
2301133111$23011331$11$F$20220601$20240806$20230929$20240808$EXP$$DE-ROCHE-3430723$ROCHE$$40$YR$A$F$Y$72$KG$20240808$$MD$DE$DE
230114504$23011450$4$F$20230424$20240823$20230929$20240902$EXP$$CA-ROCHE-3347183$ROCHE$$45$YR$A$F$Y$$$20240902$$CN$CA$CA
230114883$23011488$3$F$$20240827$20230929$20240902$EXP$$CA-SANDOZ INC.-NVSC2022CA263637$SANDOZ$$27$YR$$F$Y$120$KG$20240902$$HP$CA$CA
230115886$23011588$6$F$$20240715$20230929$20240724$EXP$$NVSC2022CA304409$NOVARTIS$$43$YR$$F$Y$97$KG$20240724$$HP$CA$CA
2301167411$23011674$11$F$$20240706$20230929$20240708$PER$$US-PFIZER INC-202300311051$PFIZER$$66$YR$$M$Y$102.06$KG$20240708$$MD$US$US
230118667$23011866$7$F$20230925$20240916$20230929$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-020172$JAZZ$$69$YR$$F$Y$$$20240919$$CN$US$US
230120143$23012014$3$F$$20240802$20230929$20240815$EXP$$CA-AMGEN-CANSP2023159905$AMGEN$$40$YR$A$F$Y$96$KG$20240815$$HP$CA$CA
230121335$23012133$5$F$20230901$20240429$20230930$20240925$PER$$US-GSK-US2023AMR131375$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
230122395$23012239$5$F$20220614$20240902$20230930$20240902$EXP$$JP-ABBVIE-5429304$ABBVIE$$95$YR$$F$Y$52$KG$20240902$$MD$JP$JP
230122604$23012260$4$F$$20240815$20230930$20240827$EXP$$CA-AUROBINDO-AUR-APL-2023-060466$AUROBINDO$Youykheang M, Al Hallaq Z, Menelas K, Biskin RS, Dagenais-Beaule V. Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders-A Systematic Review of the Literature and Case Series. J-Clin-Psychopharmacol. 2023;43(1):E163-6$$$$F$Y$$$20240827$$PH$CA$CA
230122712$23012271$2$F$$20230922$20230930$20240911$PER$$NVSC2023US209839$NOVARTIS$$$$$M$Y$$$20240911$$MD$US$US
230123342$23012334$2$F$20210121$20240710$20230930$20240717$EXP$$US-SA-2023SA297388$SANOFI AVENTIS$$70$YR$E$M$Y$86.183$KG$20240717$$MD$US$US
230123902$23012390$2$F$20230901$20240715$20230930$20240723$PER$$US-SA-2023SA240841$SANOFI AVENTIS$$3$YR$C$F$Y$12$KG$20240723$$MD$US$US
230124078$23012407$8$F$20230201$20240923$20230930$20240927$EXP$$ES-JNJFOC-20230946066$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240927$$CN$ES$ES
230124525$23012452$5$F$20230101$20240620$20230930$20240702$PER$$US-SA-2023SA295759$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240702$$CN$US$US
230125233$23012523$3$F$20230101$20240816$20230930$20240830$PER$$US-SA-2023SA293280$SANOFI AVENTIS$$59$YR$A$M$Y$86.18$KG$20240830$$MD$US$US
230125454$23012545$4$F$20230801$20240722$20230930$20240805$EXP$$US-UCBSA-2023047139$UCB$$46$YR$$F$Y$$$20240805$$HP$US$US
230125595$23012559$5$F$20230830$20240626$20230930$20240702$EXP$$DE-JNJFOC-20230957043$JOHNSON AND JOHNSON$$91$YR$E$M$Y$94$KG$20240702$$HP$DE$DE
230126112$23012611$2$F$$20240722$20230930$20240730$PER$$US-SA-2023SA292810$SANOFI AVENTIS$$5$YR$C$M$Y$19.05$KG$20240730$$MD$US$US
230126155$23012615$5$F$20230101$20240828$20230930$20240905$EXP$$CA-CELLTRION INC.-2023CA008233$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
230127192$23012719$2$F$$20240716$20230930$20240723$PER$$US-SA-2023SA292277$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240723$$MD$US$US
230127503$23012750$3$F$20230901$20240715$20230930$20240723$PER$$US-SA-2023SA296172$SANOFI AVENTIS$$72$YR$E$M$Y$80.7$KG$20240723$$MD$US$US
230128303$23012830$3$F$20200704$20240619$20230930$20240704$EXP$$DE-TEVA-2023-DE-2930159$TEVA$$38$YR$$F$Y$$$20240704$$MD$DE$DE
230128453$23012845$3$F$20230101$20240911$20230930$20240917$PER$$US-SA-2023SA291814$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240918$$MD$US$US
230128502$23012850$2$F$20230801$20240702$20230930$20240711$PER$$US-SA-2023SA292138$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240711$$MD$US$US
230128704$23012870$4$F$20230101$20240912$20230930$20240920$PER$$US-SA-2023SA291994$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240921$$MD$US$US
230129012$23012901$2$F$20230830$20240703$20230930$20240711$EXP$FR-AFSSAPS-AM2023000806$FR-TEVA-2023-FR-2930477$TEVA$$87$YR$$M$Y$78$KG$20240711$$PH$FR$FR
230129532$23012953$2$F$20230101$20230922$20230930$20240703$EXP$$NVSC2023MX195333$NOVARTIS$$$$$M$Y$68$KG$20240703$$CN$MX$MX
230130362$23013036$2$F$$20240820$20230930$20240830$PER$$US-SA-2023SA292609$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240830$$MD$US$US
230130422$23013042$2$F$$20240715$20230930$20240718$EXP$$DE-ABBVIE-5425088$ABBVIE$$51$YR$$M$Y$$$20240718$$CN$DE$DE
230130612$23013061$2$F$$20240703$20230930$20240716$EXP$$CA-SA-2023SA295287$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240716$$HP$CA$CA
230130952$23013095$2$F$$20240627$20230930$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-410237$RANBAXY$$17$YR$$M$Y$$$20240712$$MD$FR$FR
230131382$23013138$2$F$20230921$20230921$20230930$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409946$RANBAXY$$19$YR$A$$Y$$$20240702$$HP$US$US
230131456$23013145$6$F$20240109$20240628$20230930$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410024$RANBAXY$$46$YR$A$F$Y$$$20240712$$CN$CA$CA
230133346$23013334$6$F$20230924$20240822$20230930$20240829$EXP$$CA-ROCHE-3428558$ROCHE$$42$YR$A$F$Y$$$20240829$$CN$CA$CA
230133392$23013339$2$F$$20240625$20230930$20240703$EXP$$CA-SANDOZ INC.-NVSC2020CA096583$SANDOZ$$66$YR$$F$Y$$$20240703$$CN$CA$CA
230133435$23013343$5$F$$20240917$20230930$20240919$EXP$$CA-SANDOZ INC.-SDZ2023CA003570$SANDOZ$$62$YR$$F$Y$107$KG$20240919$$HP$CA$CA
230134102$23013410$2$F$20240911$20240919$20231001$20240923$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-139819$DAIICHI$$45$YR$$M$Y$$$20240923$$CN$US$US
230134372$23013437$2$F$20230101$20240730$20231001$20240807$PER$$US-SA-2023SA294891$SANOFI AVENTIS$$2$YR$C$F$Y$30.9$KG$20240807$$MD$US$US
230135242$23013524$2$F$20230101$20240822$20231001$20240916$PER$$US-SA-2023SA293089$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240916$$MD$US$US
230135284$23013528$4$F$20230801$20240905$20231001$20240915$PER$$US-SA-2023SA293127$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240915$$MD$US$US
230135743$23013574$3$F$$20240730$20231001$20240807$PER$$US-SA-2023SA296215$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240807$$MD$US$US
230136432$23013643$2$F$20230725$20240906$20231001$20240917$PER$$US-SA-2023SA293733$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240918$$MD$US$US
230139064$23013906$4$F$20230817$20240806$20231001$20240807$EXP$$NVSJ2023JP014156$NOVARTIS$$37$YR$$F$Y$60$KG$20240808$$MD$JP$JP
230139652$23013965$2$F$20230101$20240701$20231001$20240710$PER$$US-SA-2023SA296090$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240710$$CN$US$US
230140283$23014028$3$F$20220101$20240719$20231002$20240725$EXP$$CA-BEH-2023163662$CSL BEHRING$$83$YR$E$F$Y$76$KG$20240725$$HP$CA$CA
230140953$23014095$3$F$20211201$20230927$20231002$20240805$EXP$$FR-JAZZ PHARMACEUTICALS-2023-FR-020180$JAZZ$$$$$$Y$$$20240805$$HP$FR$FR
230141112$23014111$2$F$$20240918$20231002$20240928$EXP$CA-HEALTH CANADA-06450183$CA-ABBVIE-5426860$ABBVIE$$40$YR$$F$Y$$$20240928$$CN$CA$CA
230141673$23014167$3$F$20240101$20240814$20231002$20240904$PER$$CA-TOLMAR, INC.-23CA043373$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
230142558$23014255$8$F$20210101$20240802$20231002$20240812$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-23-00119$CATALYST PHARMA$$$$$M$Y$$$20240812$$CN$US$US
230145017$23014501$7$F$20160902$20240819$20231002$20240823$EXP$$CA-TAKEDA-2023TUS093768$TAKEDA$$72$YR$$F$Y$$$20240823$$CN$CA$CA
230145453$23014545$3$F$20230901$20230925$20231002$20240801$PER$$NVSC2023US211577$NOVARTIS$$72$YR$$M$Y$90.703$KG$20240801$$CN$US$US
230145667$23014566$7$F$$20240730$20231002$20240806$EXP$$JP-009507513-2309JPN002694J$MERCK$$60$YR$$F$Y$$$20240806$$MD$JP$JP
230147438$23014743$8$F$20230922$20240708$20231002$20240711$EXP$$US-PHARMING-PHAUS2023000718$PHARMING GROUP$$$$$$Y$$$20240711$$CN$US$US
230147622$23014762$2$F$20230901$20240801$20231002$20240814$EXP$$US-UCBSA-2023042342$UCB$$61$YR$$F$Y$$$20240814$$CN$US$US
230148766$23014876$6$F$20220225$20240730$20231002$20240731$EXP$$AU-TAKEDA-2022TUS016961$TAKEDA$$82$YR$$F$Y$$$20240731$$HP$AU$AU
230149035$23014903$5$F$20230101$20240708$20231002$20240716$EXP$$CA-BAYER-2023A132839$BAYER$$28$YR$A$F$Y$$$20240716$$HP$CA$CA
230149228$23014922$8$F$$20240620$20231002$20240702$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202308009695$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240702$$CN$ES$ES
230152174$23015217$4$F$$20240913$20231002$20240916$EXP$$US-PFIZER INC-202300312221$PFIZER$Lesley, N.. Digital necrosis following combined liquid nitrogen and candida antigen therapy for digital warts.. JAAD Case Reports. 2023;39:142-4$42$YR$$M$Y$125$KG$20240916$$MD$US$US
230152362$23015236$2$F$20200101$20230925$20231002$20240802$EXP$$NVSC2023HN210966$NOVARTIS$$$$$M$Y$$$20240802$$PH$HN$HN
230154936$23015493$6$F$20230801$20240820$20231002$20240823$EXP$$US-TAKEDA-2023TUS094049$TAKEDA$$71$YR$$F$Y$$$20240823$$CN$US$US
230155062$23015506$2$F$20230103$20240723$20231002$20240802$EXP$ES-AEMPS-1426150$ES-BAXTER-2023BAX031924$BAXTER$$30$YR$$M$Y$$$20240802$$MD$ES$ES
230157685$23015768$5$F$20230907$20240913$20231002$20240919$30DAY$$US-PFIZER INC-202300298442$PFIZER$$8$YR$$M$Y$$$20240919$$CN$US$US
230157805$23015780$5$F$$20240829$20231002$20240903$EXP$$CA-TAKEDA-2022TUS086962$TAKEDA$$$$$M$Y$$$20240903$$CN$CA$CA
230157819$23015781$9$F$$20240712$20231002$20240722$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000859$DECIPHERA PHARMACEUTICALS$$63$YR$A$M$Y$$$20240722$$CN$US$US
230158143$23015814$3$F$20230606$20240625$20231002$20240701$EXP$$NVSC2023DE211895$NOVARTIS$$$$A$F$Y$51$KG$20240701$$MD$DE$DE
2301586811$23015868$11$F$20230101$20240905$20231002$20240909$EXP$$KR-PFIZER INC-PV202300146011$PFIZER$$52$YR$$F$Y$$$20240909$$CN$KR$KR
230159075$23015907$5$F$20230707$20240822$20231002$20240904$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2023FOS001022$RIGEL PHARMACEUTICALS$$71$YR$$F$Y$54$KG$20240904$$MD$JP$JP
230159094$23015909$4$F$20230922$20240730$20231002$20240805$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000874$DECIPHERA PHARMACEUTICALS$$68$YR$A$M$Y$$$20240805$$HP$US$US
230160123$23016012$3$F$20230701$20240905$20231002$20240919$EXP$$CO-ASTELLAS-2023US025341$ASTELLAS$$81$YR$E$M$Y$70$KG$20240919$$CN$CO$CO
2301605616$23016056$16$F$20230101$20240911$20231002$20240917$EXP$$CA-PFIZER INC-202300070439$PFIZER$$54$YR$$F$Y$$$20240917$$HP$CA$CA
230160794$23016079$4$F$$20240705$20231002$20240712$EXP$$JP-009507513-2309JPN003588J$MERCK$$68$YR$$M$Y$$$20240712$$MD$JP$JP
230160932$23016093$2$F$$20240710$20231002$20240712$EXP$$JP-GSK-JP2023JPN133273$GLAXOSMITHKLINE$Maeda Y, Eguchi G, Kanai Y. A married couple with HIV infection who experienced cerebrovascular disorder after their children were born. Progress in Medicine. 2023;43:729-732$$$$$Y$$$20240712$$MD$JP$JP
230161002$23016100$2$F$$20240710$20231002$20240712$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2023JPN133273$VIIV$Maeda Y, Eguchi G, Kanai Y. A married couple with HIV infection who experienced cerebrovascular disorder after their children were born. Progress in Medicine. 2023;43:729-732$$$$$Y$$$20240712$$MD$JP$JP
230161473$23016147$3$F$20230812$20240711$20231002$20240715$EXP$$JP-009507513-2309JPN003846J$MERCK$$58$YR$$M$Y$$$20240715$$MD$JP$JP
230163615$23016361$5$F$$20240812$20231002$20240820$EXP$$CA-SANDOZ INC.-NVSC2020CA360604$SANDOZ$$72$YR$$M$Y$79.55$KG$20240820$$MD$CA$CA
230164233$23016423$3$F$20230901$20240916$20231002$20240923$PER$$US-SA-2023SA296223$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240923$$MD$US$US
2301643615$23016436$15$F$20230530$20240919$20231002$20240930$EXP$$CN-BAXTER-2023BAX026474$BAXTER$$49$YR$$F$Y$45$KG$20240930$$MD$CN$CN
230174482$23017448$2$F$20230101$20240829$20231003$20240911$PER$$US-SA-2023SA296791$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240911$$MD$US$US
230174853$23017485$3$F$20230801$20240815$20231003$20240827$PER$$US-SA-2023SA294885$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240827$$MD$US$US
230175235$23017523$5$F$20221218$20240625$20231003$20240705$EXP$DE-EMA-DD-20230824-6644991-112458$DE-Accord-381174$ACCORD$$73$YR$E$M$Y$65$KG$20240705$$MD$DE$DE
230175434$23017543$4$F$$20240703$20231003$20240709$EXP$$AT-009507513-2309AUT010354$MERCK$$34$YR$$F$Y$$$20240709$$MD$AT$AT
230175612$23017561$2$F$20230323$20240805$20231003$20240810$EXP$$US-ABBVIE-4743207$ABBVIE$$60$YR$$F$Y$$$20240810$$CN$US$US
230175725$23017572$5$F$20221227$20240827$20231003$20240903$PER$$US-Vifor (International) Inc.-VIT-2023-07243$VIFOR$$16$YR$$F$Y$48.3$KG$20240903$$MD$US$US
230176955$23017695$5$F$$20240904$20231003$20240911$EXP$$NVSC2023US208068$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
230177003$23017700$3$F$20221217$20240626$20231003$20240707$EXP$$JP-BEH-2023163659$CSL BEHRING$$29$YR$A$M$Y$$$20240707$$MD$JP$JP
230177577$23017757$7$F$20240201$20240613$20231003$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003909$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240708$$CN$US$US
230179253$23017925$3$F$$20240909$20231003$20240927$PER$$CA-TOLMAR, INC.-23CA043130$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
230179315$23017931$5$F$20230913$20240814$20231003$20240904$PER$$CA-TOLMAR, INC.-23CA043356$TOLMAR$$61$YR$$M$Y$$$20240904$$CN$CA$CA
230180442$23018044$2$F$20230901$20240705$20231003$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08362$LUPIN$$$$$$Y$$$20240731$$CN$US$US
230181106$23018110$6$F$20230901$20240620$20231003$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004254$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240712$$CN$US$US
230181335$23018133$5$F$20230918$20240625$20231003$20240702$EXP$$CN-ABBVIE-5429287$ABBVIE$$25$YR$$F$Y$60$KG$20240702$$MD$CN$CN
230181443$23018144$3$F$20221118$20240815$20231003$20240821$EXP$$JP-009507513-2212JPN000190J$MERCK$$48$YR$$F$Y$$$20240821$$PH$JP$JP
230188052$23018805$2$F$20221020$20230926$20231003$20240924$EXP$$NVSC2022AU242676$NOVARTIS$$58$YR$$F$Y$$$20240924$$HP$AU$AU
230193183$23019318$3$F$$20240626$20231003$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003934$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
230193205$23019320$5$F$$20240909$20231003$20240912$EXP$$CA-SANDOZ INC.-NVSC2020CA255124$SANDOZ$$$$$F$Y$$$20240912$$HP$CA$CA
230194102$23019410$2$F$$20240821$20231003$20240823$EXP$$IT-ROCHE-3425994$ROCHE$$3$MON$I$M$Y$$$20240823$$MD$IT$IT
230194283$23019428$3$F$$20240620$20231003$20240701$EXP$$CA-TAKEDA-2022TUS037270$TAKEDA$$$$$M$Y$$$20240701$$CN$CA$CA
230194685$23019468$5$F$$20240712$20231003$20240718$EXP$$CA-Novartis Pharma AG-NVSC2022CA110346$SANDOZ$$53$YR$$M$Y$$$20240718$$CN$CA$CA
230195105$23019510$5$F$20210106$20240918$20231003$20240924$EXP$$CA-SANDOZ INC.-PHHY2019CA038618$SANDOZ$$31$YR$$F$Y$$$20240924$$CN$CA$CA
230195786$23019578$6$F$20230911$20240830$20231003$20240904$EXP$$US-TAKEDA-2023TUS085261$TAKEDA$$63$YR$$F$Y$$$20240904$$CN$US$US
230198257$23019825$7$F$20190614$20240918$20231003$20240927$EXP$$CA-CELLTRION INC.-2021CA019251$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
230198862$23019886$2$F$$20240812$20231003$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08349$LUPIN$$$$$$Y$$$20240828$$CN$US$US
230199565$23019956$5$F$20170507$20240703$20231003$20240717$EXP$$FR-TAKEDA-2023TUS094861$TAKEDA$$39$YR$$M$Y$$$20240717$$MD$FR$FR
230200663$23020066$3$F$20230914$20240827$20231003$20240902$EXP$$CA-TAKEDA-2023TUS094411$TAKEDA$$69$YR$$M$Y$$$20240902$$HP$CA$CA
230201724$23020172$4$F$20210101$20240920$20231003$20240928$EXP$$CA-TAKEDA-2020TUS031713$TAKEDA$$38$YR$$F$Y$$$20240928$$MD$CA$CA
230202132$23020213$2$F$20130921$20230906$20231003$20240927$PER$$US-CHIESI-2023CHF03009$CHIESI$$34$YR$$F$Y$47.62$KG$20240927$$CN$US$US
230202632$23020263$2$F$20230825$20240624$20231003$20240704$EXP$$IN-ROCHE-3388178$ROCHE$$50$YR$A$M$Y$$$20240704$$MD$IN$IN
230202978$23020297$8$F$20230926$20240702$20231003$20240709$EXP$$CA-CELLTRION INC.-2023CA000543$CELLTRION$$$$$$Y$$$20240709$$MD$CA$CA
230202993$23020299$3$F$20230901$20240717$20231003$20240723$EXP$$AT-AMGEN-AUTSP2023172176$AMGEN$$61$YR$A$F$Y$$$20240723$$MD$AT$AT
230205282$23020528$2$F$20230929$20240710$20231003$20240712$PER$$US-AMGEN-USASP2023174853$AMGEN$$61$YR$A$F$Y$$$20240711$$CN$US$US
230205788$23020578$8$F$$20240725$20231003$20240727$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-140199$DAIICHI$$$$$F$Y$$$20240727$$CN$US$US
230206502$23020650$2$F$20230602$20240918$20231003$20240926$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004306$AURINIA PHARMACEUTICALS$$36$YR$$F$Y$$$20240926$$HP$US$US
230211002$23021100$2$F$20220324$20230922$20231003$20240731$EXP$GB-MHRA-TPP1363119C7317935YC1648121192311$GB-TORRENT-00027780$TORRENT$$21$YR$A$M$Y$85$KG$20240730$$MD$GB$GB
2302116214$23021162$14$F$20230925$20240925$20231003$20240930$EXP$$US-Taiho Oncology Inc-2023-007725$TAIHO ONCOLOGY INC$$70$YR$E$F$Y$46.81$KG$20240930$$CN$US$US
230211707$23021170$7$F$$20240919$20231003$20240925$EXP$$US-VERTEX PHARMACEUTICALS-2023-014488$VERTEX$$$$A$F$Y$$$20240925$$CN$US$US
230212042$23021204$2$F$20230816$20240919$20231003$20240923$EXP$FR-AFSSAPS-LY2023001507$FR-MYLANLABS-2023M1103527$MYLAN$$69$YR$$M$Y$$$20240923$$PH$FR$FR
230213022$23021302$2$F$$20240814$20231003$20240816$EXP$$AU-ROCHE-3426906$ROCHE$$$$$F$Y$$$20240816$$MD$AU$AU
230214726$23021472$6$F$20230921$20240731$20231003$20240802$PER$$US-PFIZER INC-202300310757$PFIZER$$80$YR$$F$Y$68.04$KG$20240802$$CN$US$US
230215383$23021538$3$F$20230901$20240829$20231003$20240912$PER$$US-SA-2023SA297786$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240912$$MD$US$US
230216864$23021686$4$F$20230525$20240711$20231003$20240712$EXP$$ES-PFIZER INC-202300307352$PFIZER$$65$YR$$F$Y$64.5$KG$20240712$$HP$ES$ES
230216934$23021693$4$F$$20240704$20231003$20240709$EXP$$IN-PFIZER INC-PV202300159958$PFIZER$$35$YR$$M$Y$$$20240709$$CN$IN$IN
230218223$23021822$3$F$$20240903$20231003$20240905$EXP$$TN-PFIZER INC-PV202300160580$PFIZER$$40$YR$$M$Y$$$20240905$$MD$TN$TN
230219062$23021906$2$F$20230204$20240628$20231003$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-410323$RANBAXY$$69$YR$$F$Y$65$KG$20240712$$PH$FR$FR
230220715$23022071$5$F$20230911$20240819$20231003$20240821$EXP$$JP-DSJP-DSJ-2023-139135$DAIICHI$Imai A, Miyamoto K, Matsui C, Koyama H. EP-0629 Efficacy and Safety of Trastuzumab Deruxtecan Including Late Line. The 32nd Annual Meeting of the Japan Breast Cancer Society. 2024;335$54$YR$$F$Y$47.2$KG$20240821$$MD$JP$JP
230220974$23022097$4$F$20230912$20240723$20231003$20240726$EXP$$US-AVEO ONCOLOGY-2023-AVEO-US000714$PAREXEL$$$$$$Y$$$20240726$$HP$US$US
230221022$23022102$2$F$$20240827$20231003$20240904$EXP$$JP-DSJP-DSJ-2023-139883$DAIICHI$Nakamura K, Yoshimoto N, Nakamichi R, Torimitsu T, Adachi K, Hashiguchi A, et al.. A case with difficulty in differentiation between anticoagulant-related nephropathy and IgA nephropathy. The Japanese Journal of Nephrology/The 53rd Eastern Regional Meeting of the JSN. 2023;65 (6-E):659$75$YR$$M$Y$$$20240904$$MD$JP$JP
230221373$23022137$3$F$$20240716$20231003$20240720$EXP$$CA-JNJFOC-20231003171$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240719$$CN$CA$CA
230222043$23022204$3$F$20231210$20240705$20231003$20240712$EXP$$CA-ROCHE-3432524$ROCHE$$55$YR$A$F$Y$$$20240712$$CN$CA$CA
230223794$23022379$4$F$20230816$20240923$20231003$20240930$EXP$$DE-PFIZER INC-202300311691$PFIZER$$51$YR$$M$Y$$$20240930$$HP$DE$DE
230232704$23023270$4$F$$20240923$20231003$20240927$EXP$$CA-SANDOZ INC.-NVSC2023CA059073$SANDOZ$$$$$F$Y$$$20240927$$CN$CA$CA
230233446$23023344$6$F$20191224$20240725$20231003$20240729$EXP$$CA-SANDOZ INC.-NVSC2019CA084251$SANDOZ$$72$YR$$F$Y$$$20240729$$CN$CA$CA
230234913$23023491$3$F$$20240904$20231003$20240908$EXP$$CA-SANDOZ INC.-SDZ2023CA033925$SANDOZ$$26$YR$$F$Y$$$20240908$$MD$CA$CA
230235068$23023506$8$F$$20240715$20231003$20240723$EXP$$CA-SANDOZ INC.-NVSC2022CA145572$SANDOZ$$65$YR$$F$Y$34$KG$20240723$$HP$CA$CA
230235855$23023585$5$F$$20240730$20231003$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-139563$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$100.7$KG$20240802$$CN$US$US
230236086$23023608$6$F$20230117$20240909$20231003$20240926$EXP$$JP-009507513-2309JPN003290J$MERCK$Mochizuki S, Sudo T, Sato K, Fukase M, Iizawa H. PS-146-7 Study of MSI-High Colorectal Cancer in Our Department. The 124th Annual Congress of Japan Surgical Society. 2011$69$YR$$M$Y$$$20240926$$MD$JP$JP
230236215$23023621$5$F$20230901$20240820$20231003$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-139164$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240821$$CN$US$US
230236292$23023629$2$F$$20240821$20231003$20240822$PER$$US-PFIZER INC-PV202300146894$PFIZER$$66$YR$$F$Y$$$20240822$$CN$US$US
230236314$23023631$4$F$20200101$20240917$20231003$20240919$EXP$$US-PFIZER INC-PV202300137568$PFIZER$$80$YR$$F$Y$52.154$KG$20240919$$CN$US$US
230236533$23023653$3$F$20230101$20240709$20231003$20240718$EXP$$JP-009507513-2307JPN001315J$MERCK$$65$YR$$F$Y$$$20240718$$MD$JP$JP
230238084$23023808$4$F$20231101$20240710$20231003$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-137968$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240711$$CN$US$US
230239303$23023930$3$F$20160609$20240807$20231003$20240813$EXP$$CA-SANDOZ INC.-PHHY2016CA082637$SANDOZ$$62$YR$$F$Y$$$20240813$$MD$CA$CA
230239542$23023954$2$F$$20240716$20231003$20240723$EXP$$US-BIOGEN-2023BI01228848$BIOGEN$$$$$F$Y$$$20240723$$HP$US$US
230240472$23024047$2$F$20230625$20240730$20231003$20240805$EXP$$NL-BIOGEN-2023BI01228792$BIOGEN$$34$YR$$M$Y$$$20240804$$HP$NL$NL
230241162$23024116$2$F$20230601$20240702$20231004$20240707$EXP$$NVSJ2023JP014308$NOVARTIS$$36$YR$$F$Y$$$20240708$$MD$JP$JP
230241633$23024163$3$F$$20240830$20231004$20240911$EXP$$CA-AUROBINDO-AUR-APL-2023-061067$AUROBINDO$$42$YR$$F$Y$$$20240911$$HP$CA$CA
2302416710$23024167$10$F$20180101$20240729$20231004$20240802$EXP$$ES-AUROBINDO-AUR-APL-2023-059834$AUROBINDO$Alvarez, R., Lopez M, Arregui M, Crisostomo AR, Calles A,  ?lvarez A.. Prolonged survival of a patient with desmoplastic small round cell tumor.. Cancer and Chemotherapy Reviews.. 2022;17 (3):41-46$34$YR$$M$Y$$$20240802$$MD$ES$ES
230242282$23024228$2$F$$20240829$20231004$20240907$EXP$$CA-AUROBINDO-AUR-APL-2023-060833$AUROBINDO$$$$$M$Y$$$20240907$$HP$CA$CA
230242772$23024277$2$F$$20240821$20231004$20240903$EXP$$CA-AUROBINDO-AUR-APL-2023-060745$AUROBINDO$$62$YR$$F$Y$$$20240903$$CN$CA$CA
230242922$23024292$2$F$19930101$20240904$20231004$20240916$EXP$$FR-AUROBINDO-AUR-APL-2018-034743$AUROBINDO$Chalayer E, Tavernier-Tardy E, Clavreul G, Bay JO, Cornillon J.. Carcinomatosis lymphangitis and pleurisy after allo-SCT in two patients with secondary leukemia after breast cancer. Bone Marrow Transplant.. 2012;47 (1):155-6$39$YR$$F$Y$$$20240916$$HP$FR$FR
230243107$23024310$7$F$20230830$20240708$20231004$20240718$EXP$$DE-AUROBINDO-AUR-APL-2023-060302$AUROBINDO$$91$YR$$M$Y$94$KG$20240718$$HP$DE$DE
230243732$23024373$2$F$$20240904$20231004$20240916$EXP$$CA-AUROBINDO-AUR-APL-2023-060981$AUROBINDO$$47$YR$$M$Y$$$20240916$$CN$CA$CA
230244032$23024403$2$F$$20231019$20231004$20240926$PER$$US-AUROBINDO-AUR-APL-2023-054217$AUROBINDO$$55$YR$$F$Y$$$20240926$$CN$US$US
230244212$23024421$2$F$$20240821$20231004$20240831$EXP$$CA-AUROBINDO-AUR-APL-2023-060769$AUROBINDO$Unknown.Unknown.Unknown$53$YR$$F$Y$$$20240831$$HP$CA$CA
230244603$23024460$3$F$$20240808$20231004$20240819$PER$$US-SA-2023SA295401$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240819$$CN$US$US
230244652$23024465$2$F$$20240621$20231004$20240705$PER$$US-SA-2023SA296154$SANOFI AVENTIS$$$$A$M$Y$113$KG$20240705$$MD$US$US
230244682$23024468$2$F$20230616$20230906$20231004$20240927$PER$$US-CHIESI-2023CHF03830$CHIESI$$82$YR$$F$Y$75.7$KG$20240927$$CN$US$US
230244913$23024491$3$F$$20240717$20231004$20240729$EXP$$DE-AUROBINDO-AUR-APL-2023-061077$AUROBINDO$$64$YR$$F$Y$$$20240729$$CN$DE$DE
230246815$23024681$5$F$$20240918$20231004$20240925$EXP$$AR-GSK-AR2023AMR131859$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$AR$AR
230257003$23025700$3$F$20230816$20240919$20231004$20240927$EXP$FR-AFSSAPS-LY2023001507$FR-EMD Serono-2023478177$EMD SERONO INC$$69$YR$E$M$Y$$$20240927$$PH$FR$FR
230257319$23025731$9$F$20230101$20240822$20231004$20240905$EXP$$US-SA-2023SA300097$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240905$$MD$US$US
230259297$23025929$7$F$$20240617$20231004$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003938$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
230259413$23025941$3$F$$20231107$20231004$20240925$PER$$US-GSK-US2023AMR133356$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
230259534$23025953$4$F$20230801$20240802$20231004$20240816$EXP$$US-UCBSA-2023047648$UCB$$33$YR$$F$Y$$$20240816$$HP$US$US
230261265$23026126$5$F$$20240918$20231004$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-140001$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240919$$CN$US$US
230261457$23026145$7$F$$20240703$20231004$20240710$EXP$$US-VIIV HEALTHCARE LIMITED-US2023AMR133412$VIIV$$$$$$Y$$$20240710$$CN$US$US
230261632$23026163$2$F$20230801$20240702$20231004$20240705$EXP$$US-UCBSA-2023047644$UCB$$47$YR$$F$Y$$$20240705$$HP$US$US
230261654$23026165$4$F$20240630$20240703$20231004$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-140175$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240704$$HP$US$US
230262332$23026233$2$F$$20240703$20231004$20240706$EXP$$NVSC2023CA212635$NOVARTIS$$52$YR$$F$Y$$$20240706$$CN$CA$CA
230262504$23026250$4$F$20230917$20240823$20231004$20240911$PER$$CA-TOLMAR, INC.-23CA043419$TOLMAR$$80$YR$$M$Y$$$20240911$$CN$CA$CA
230263376$23026337$6$F$$20240719$20231004$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-139870$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240726$$CN$US$US
230263434$23026343$4$F$20230101$20240730$20231004$20240805$EXP$$JP-009507513-2304JPN003639J$MERCK$$62$YR$$F$Y$$$20240805$$MD$JP$JP
230264004$23026400$4$F$20230916$20240726$20231004$20240802$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2023-139872$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$69.85$KG$20240802$$CN$PR$PR
230264578$23026457$8$F$$20240730$20231004$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-139301$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240806$$CN$US$US
230265872$23026587$2$F$20230109$20240826$20231004$20240906$EXP$CH-SM-2023-10377$CH-ROCHE-3428420$ROCHE$Batsry L, Batsry L, Yinon Y. The vanishing twin: Diagnosis and implications.. Best Pract Res Clin Obstet Gynaecol. 2022;84:66-75.$35$YR$A$F$Y$72$KG$20240906$$PH$CH$CH
230265954$23026595$4$F$20230515$20240910$20231004$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-139696$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240919$$MD$JP$JP
230266422$23026642$2$F$$20240724$20231004$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202310001095$ELI LILLY AND CO$$57$YR$A$$Y$$$20240725$$CN$US$US
230267903$23026790$3$F$20230101$20240916$20231004$20240925$PER$$US-SA-2023SA294283$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240925$$MD$US$US
230268044$23026804$4$F$20231121$20240621$20231004$20240709$EXP$$IN-ROCHE-3386919$ROCHE$$68$YR$E$M$Y$64$KG$20240701$$MD$IN$IN
230268834$23026883$4$F$20220809$20240819$20231004$20240822$EXP$$US-TAKEDA-2022TUS054871$TAKEDA$$58$YR$$F$Y$$$20240822$$CN$US$US
230269427$23026942$7$F$20230924$20240429$20231004$20240912$EXP$$NVSC2023BR198208$NOVARTIS$$45$YR$$F$Y$$$20240912$$CN$BR$BR
230269823$23026982$3$F$20230922$20240723$20231004$20240801$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202309014579$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240801$$CN$JP$JP
230271552$23027155$2$F$20220901$20240718$20231004$20240724$EXP$$CA-PFIZER INC-202201197512$PFIZER$$24$YR$$F$Y$$$20240724$$HP$CA$CA
2302718014$23027180$14$F$20211016$20240903$20231004$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-028631$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$44.65$KG$20240906$$MD$JP$JP
230272134$23027213$4$F$20220426$20240823$20231004$20240830$EXP$$JP-ABBVIE-5431462$ABBVIE$$61$YR$$M$Y$50.9$KG$20240830$$MD$JP$JP
230272588$23027258$8$F$20230101$20240909$20231004$20240917$EXP$$US-SA-2023SA299821$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240917$$MD$US$US
2302726212$23027262$12$F$20230101$20240705$20231004$20240715$EXP$$US-UCBSA-2023048018$UCB$$$$$F$Y$103$KG$20240715$$CN$US$US
230273324$23027332$4$F$20231001$20240827$20231004$20240829$PER$$US-AMGEN-USASP2023175541$AMGEN$$67$YR$E$F$Y$$$20240829$$CN$US$US
230273404$23027340$4$F$20231030$20240704$20231004$20240708$EXP$$CA-TAKEDA-2021TUS044164$TAKEDA$$74$YR$$M$Y$$$20240708$$HP$CA$CA
230274395$23027439$5$F$$20240913$20231004$20240916$EXP$$US-PFIZER INC-202300314626$PFIZER$Malhotra, R.. Acute Local Anesthetic Systemic Toxicity From Hypogastric Nerve Block for Chronic Pelvic Pain. Neuromodulation. 2023;26(4 Suppl):S239$25$YR$$F$Y$$$20240916$$MD$US$US
230274413$23027441$3$F$$20240822$20231004$20240829$EXP$$CA-Orion Corporation ORION PHARMA-23_00025868$ORION$$71$YR$E$F$Y$$$20240829$$HP$CA$
230274482$23027448$2$F$$20240909$20231004$20240912$EXP$$ES-MYLANLABS-2023M1103743$MYLAN$Rico-nieto, A.. Lumbar arthrodesis infection by multi-resistant Klebsiella pneumoniae, successfully treated with implant retention and ceftazidime/avibactam.. Spanish Journal of Orthopedic Surgery and Traumatology.. 2018;62 (6):471-473$29$YR$$F$Y$$$20240912$$HP$ES$ES
230274676$23027467$6$F$$20240726$20231004$20240801$30DAY$$US-PFIZER INC-202300297577$PFIZER$$70$YR$$F$Y$62.14$KG$20240801$$MD$US$US
230274686$23027468$6$F$$20240913$20231004$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-139990$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240916$$HP$US$US
230275873$23027587$3$F$20230901$20240819$20231004$20240828$EXP$$CA-OTSUKA-2023_004343$OTSUKA$$53$YR$$M$Y$$$20240828$$HP$CA$CA
230276024$23027602$4$F$20230924$20231019$20231004$20240718$EXP$$CA-ASTELLAS-2023US029404$ASTELLAS$$69$YR$$F$Y$$$20240718$$CN$CA$CA
230277802$23027780$2$F$20230101$20240524$20231004$20240715$PER$$US-TG THERAPEUTICS INC.-TGT002836$TG THERAPEUTICS$$$$$F$Y$129.71$KG$20240715$$CN$US$US
230278947$23027894$7$F$20231001$20240731$20231004$20240802$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2023-139965$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$49.44$KG$20240802$$CN$PR$PR
230279232$23027923$2$F$$20240722$20231004$20240723$EXP$$CA-PFIZER INC-202300309509$PFIZER$$40$YR$$$Y$119$KG$20240723$$MD$CA$CA
230279663$23027966$3$F$20230913$20240703$20231004$20240712$PER$$US-SA-2023SA297069$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240712$$MD$US$US
230279792$23027979$2$F$$20240717$20231004$20240725$EXP$$GE-AstraZeneca-2023A222577$ASTRAZENECA$$51$YR$$M$Y$$$20240725$$MD$DE$
230279854$23027985$4$F$$20240916$20231004$20240920$EXP$$GB-SANDOZ INC.-NVSC2021GB281803$SANDOZ$$$$A$F$Y$$$20240920$$CN$GB$GB
230280114$23028011$4$F$20211220$20240821$20231004$20240829$EXP$$CA-SANDOZ INC.-NVSC2021CA294244$SANDOZ$$44$YR$$M$Y$$$20240829$$CN$CA$CA
230280567$23028056$7$F$20230619$20240729$20231004$20240801$EXP$$US-TAKEDA-2023TUS069480$TAKEDA$$44$YR$$F$Y$101$KG$20240801$$CN$US$US
2302832513$23028325$13$F$20230921$20240620$20231004$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202310001701$ELI LILLY AND CO$$63$YR$A$F$Y$80.726$KG$20240702$$CN$US$US
230285806$23028580$6$F$20230601$20240919$20231004$20240924$PER$$US-PFIZER INC-PV202300162734$PFIZER$$67$YR$$F$Y$$$20240924$$HP$US$US
230285826$23028582$6$F$20231002$20240827$20231004$20240902$EXP$$US-PFIZER INC-202300316002$PFIZER$$71$YR$$F$Y$$$20240902$$PH$US$US
230287415$23028741$5$F$20230808$20240820$20231004$20240827$EXP$$NVSC2023GB178075$NOVARTIS$$37$YR$$F$Y$$$20240827$$CN$GB$GB
230287553$23028755$3$F$$20240718$20231004$20240802$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410895$RANBAXY$Yao J-M. A Case of Adult Acute B-Cell Lymphoblastic Leukemia with Hypercalcemia and Osteolytic Bone Lesions. Clin Lab. 2023;69(7):1534-1536$53$YR$$M$Y$$$20240802$$HP$CN$CN
230287712$23028771$2$F$$20240829$20231004$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409791$RANBAXY$Vantyghem M-C. Iatrogenic endocrine complications of lithium therapy. Ann Endocrinol (Paris). 2023;May;84(3):391-397$$$$F$Y$$$20240913$$HP$FR$FR
230287783$23028778$3$F$20230901$20240716$20231004$20240731$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409888$RANBAXY$$45$YR$A$F$Y$110$KG$20240731$$CN$BR$BR
230288243$23028824$3$F$20201118$20231010$20231004$20240827$EXP$$NVSC2021RU085263$NOVARTIS$$$$$M$Y$78$KG$20240827$$MD$RU$RU
230288822$23028882$2$F$20230906$20240912$20231004$20240923$EXP$$US-ROCHE-3424740$ROCHE$$43$YR$A$F$Y$$$20240923$$CN$US$US
230289113$23028911$3$F$20200101$20240911$20231004$20240918$EXP$$BR-TAKEDA-BR202022850$TAKEDA$$4$YR$$M$Y$18.3$KG$20240918$$CN$BR$BR
230289402$23028940$2$F$$20240816$20231004$20240819$EXP$$US-BAUSCH-BL-2023-014697$BAUSCH AND LOMB$$74$YR$$F$Y$$$20240819$$CN$US$US
230292415$23029241$5$F$$20240712$20231004$20240717$EXP$$CA-SANDOZ INC.-SDZ2023CA035098$SANDOZ$$71$YR$$F$Y$$$20240717$$HP$CA$CA
230292633$23029263$3$F$20230831$20240723$20231004$20240726$EXP$$KR-OTSUKA-2023_023249$OTSUKA$$50$YR$$M$Y$$$20240726$$MD$KR$KR
230294493$23029449$3$F$20230801$20240702$20231004$20240705$EXP$$US-PFIZER INC-PV202300163836$PFIZER$$68$YR$$F$Y$83.447$KG$20240705$$CN$US$US
230295064$23029506$4$F$$20240922$20231004$20240926$PER$$US-009507513-2309USA009723$MERCK$$$$$F$Y$40.816$KG$20240926$$CN$US$US
230295313$23029531$3$F$$20240708$20231004$20240709$EXP$$CA-SANDOZ INC.-NVSC2023CA011039$SANDOZ$$49$YR$$F$Y$91$KG$20240709$$HP$CA$CA
230295614$23029561$4$F$20230912$20240802$20231004$20240809$EXP$$JP-009507513-2309JPN004038J$MERCK$$61$YR$$F$Y$$$20240809$$MD$JP$JP
230295706$23029570$6$F$20230601$20240729$20231004$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-037189$JAZZ$$17$YR$$F$Y$$$20240807$$CN$US$US
230296254$23029625$4$F$20230620$20240711$20231004$20240719$EXP$IT-MINISAL02-945700$IT-GILEAD-2023-0646185$GILEAD$Soravia A, Simeon V, Menchini F, DiRienzo G, DiBin F, Olivieri J et al.. Case Report: CAR-T cell therapy-induced Acute Macular Neuroretinopathy. European Sociery of Blood and Marrow Transplanation. unk;unk:1$64$YR$A$F$Y$51$KG$20240719$$MD$IT$IT
230297082$23029708$2$F$20220101$20240722$20231004$20240726$EXP$$CA-SANDOZ INC.-NVSC2022CA143733$SANDOZ$$$$$F$Y$$$20240726$$CN$CA$CA
230298015$23029801$5$F$$20240625$20231004$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-138232$BRISTOL MYERS SQUIBB$Yoshida S, Satou K, Yajima T, Jinguu D, Ubukata S, Watanabei H. A case of cytokine release syndrome (CRS) during chemotherapy for malignant pleural mesothelioma.The 230th Tohoku Regional Meeting of the Japanese Society of Internal Medicine.2023;52.$84$YR$E$M$Y$$$20240703$$MD$JP$JP
230299336$23029933$6$F$$20240911$20231005$20240925$EXP$$CA-SANDOZ INC.-NVSC2020CA259010$SANDOZ$$48$YR$$F$Y$68$KG$20240925$$HP$CA$CA
230299712$23029971$2$F$$20240822$20231005$20240911$PER$$CA-TOLMAR, INC.-23CA043508$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
230300755$23030075$5$F$20230918$20240821$20231005$20240911$PER$$CA-TOLMAR, INC.-23CA043403$TOLMAR$$73$YR$$M$Y$$$20240911$$CN$CA$CA
230300784$23030078$4$F$20230101$20240819$20231005$20240909$PER$$CA-TOLMAR, INC.-23CA043412$TOLMAR$$$$$M$Y$$$20240909$$CN$CA$CA
230301833$23030183$3$F$20230718$20240815$20231005$20240819$EXP$$US-ABBVIE-5433820$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
230302092$23030209$2$F$20230816$20240913$20231005$20240924$EXP$FR-AFSSAPS-LY2023001507$FR-NOVOPROD-1120469$NOVO NORDISK$$69$YR$$M$Y$$$20240924$$PH$FR$FR
230302263$23030226$3$F$20230401$20240625$20231005$20240708$EXP$$US-NOVOPROD-1123314$NOVO NORDISK$$45$YR$$M$Y$$$20240708$$CN$US$US
230302424$23030242$4$F$20230101$20240826$20231005$20240909$PER$$US-SA-2023SA299396$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240909$$MD$US$US
2303032410$23030324$10$F$20230101$20240822$20231005$20240824$EXP$$DE-TAKEDA-2023TUS094677$TAKEDA$$74$YR$$M$Y$$$20240824$$HP$DE$DE
230303924$23030392$4$F$20230901$20231013$20231005$20240926$PER$$US-GSK-US2023AMR133303$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240926$$CN$US$US
230304703$23030470$3$F$20220112$20240826$20231005$20240902$EXP$$US-TAKEDA-2022TUS003098$TAKEDA$$44$YR$$F$Y$92$KG$20240902$$CN$US$US
230304853$23030485$3$F$20230901$20240903$20231005$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-140903$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240904$$HP$US$US
230304923$23030492$3$F$20230925$20240828$20231005$20240909$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003830$SAREPTA THERAPEUTICS$$19$YR$$M$Y$88.44$KG$20240909$$HP$US$US
230305133$23030513$3$F$$20240722$20231005$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-140627$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240723$$HP$US$US
230305674$23030567$4$F$20240105$20240906$20231005$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-140507$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240910$$CN$US$US
230306452$23030645$2$F$20220724$20240701$20231005$20240703$EXP$$FR-GILEAD-2022-0584043$GILEAD$$$$E$F$Y$80$KG$20240703$$MD$FR$FR
230306742$23030674$2$F$$20240724$20231005$20240731$PER$$US-SA-2023SA299701$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240801$$MD$US$US
230306915$23030691$5$F$$20240914$20231005$20240926$PER$$US-Ipsen Biopharmaceuticals, Inc.-2023-22949$IPSEN$$$$$F$Y$91.17$KG$20240926$$MD$US$US
230307232$23030723$2$F$20221001$20240702$20231005$20240708$EXP$FR-AFSSAPS-TS2023001201$FR-SA-2023SA301120$SANOFI AVENTIS$$83$YR$E$F$Y$76$KG$20240708$$MD$FR$FR
230307524$23030752$4$F$20230807$20240905$20231005$20240913$EXP$$JP-009507513-2308JPN002286J$MERCK$Takahara Y, Katsurada N, Tsukamoto S, Kurata K, Hazama D, Yamamoto M, et al.. 127 An autopsy case of non-small cell lung cancer with suspected thrombocytopenia and lung disorder due to pembrolizumab. Joint meeting of the 132nd Kinki Branch Meeting of the Japanese Society for Tube. 84$79$YR$$M$Y$$$20240913$$MD$JP$JP
230307852$23030785$2$F$$20240717$20231005$20240717$EXP$$DE-JNJFOC-20231001820$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240718$$CN$DE$DE
230308262$23030826$2$F$$20240917$20231005$20240920$EXP$$US-SANDOZ INC.-SDZ2023US037016$SANDOZ$$$$$F$Y$$$20240920$$HP$US$US
2303085810$23030858$10$F$20230801$20240612$20231005$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004045$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240705$$CN$US$US
230308682$23030868$2$F$20230101$20240701$20231005$20240706$EXP$$US-ABBVIE-5433977$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
230308845$23030884$5$F$20240305$20240704$20231005$20240710$EXP$$CA-TAKEDA-2023TUS094525$TAKEDA$$63$YR$$M$Y$$$20240710$$MD$CA$CA
230309263$23030926$3$F$20230101$20240716$20231005$20240724$PER$$US-SA-2023SA300283$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240724$$MD$US$US
230315343$23031534$3$F$$20240801$20231005$20240805$EXP$$CA-SANDOZ INC.-NVSC2022CA064682$SANDOZ$$$$$M$Y$95.238$KG$20240805$$CN$CA$CA
230315873$23031587$3$F$$20240822$20231005$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08424$LUPIN$$$$$$Y$$$20240909$$CN$US$US
230316076$23031607$6$F$$20240229$20231005$20240925$PER$$US-GSK-US2023AMR132889$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
230316256$23031625$6$F$20240528$20240728$20231005$20240731$EXP$$CA-SANDOZ INC.-SDZ2023CA036716$SANDOZ$$67$YR$$F$Y$$$20240731$$CN$CA$CA
230316523$23031652$3$F$20220901$20240918$20231005$20240920$EXP$$CA-SANDOZ INC.-NVSC2022CA190087$SANDOZ$$73$YR$$F$Y$$$20240920$$CN$CA$CA
230317492$23031749$2$F$$20240923$20231005$20240924$PER$$NVSC2023US213329$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
2303177711$23031777$11$F$$20240725$20231005$20240802$EXP$$CA-CHATTEMPRD-2018SA339770$CHATTEM$$58$YR$A$F$Y$$$20240802$$HP$CA$CA
230318355$23031835$5$F$20230101$20240806$20231005$20240812$EXP$$US-ABBVIE-5426770$ABBVIE$$$$$M$Y$76$KG$20240812$$CN$US$US
230318632$23031863$2$F$$20240711$20231005$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08448$LUPIN$$$$$$Y$$$20240809$$CN$US$US
230319058$23031905$8$F$20230101$20240808$20231005$20240814$EXP$$US-SA-2023SA271791$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240814$$MD$US$US
2303200218$23032002$18$F$20220811$20240825$20231005$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-140382$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$63$KG$20240902$$MD$JP$JP
2303201911$23032019$11$F$20200817$20240923$20231005$20240926$EXP$$US-SANDOZ INC.-NVSC2020US047767$SANDOZ$$22$YR$$F$Y$81.633$KG$20240926$$PH$US$US
230320272$23032027$2$F$20240101$20240824$20231005$20240919$EXP$$US-SA-2023SA301893$SANOFI AVENTIS$$77$YR$E$M$Y$88.64$KG$20240919$$MD$US$US
230320864$23032086$4$F$$20240709$20231005$20240711$PER$$NVSC2023US214267$NOVARTIS$$$$$M$Y$$$20240711$$CN$US$US
230321703$23032170$3$F$$20240727$20231005$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08481$LUPIN$$$$$$Y$$$20240818$$CN$US$US
230322145$23032214$5$F$$20240731$20231005$20240807$EXP$$CA-SANDOZ INC.-NVSC2022CA048912$SANDOZ$$$$$M$Y$$$20240807$$CN$CA$CA
230322563$23032256$3$F$20231027$20240802$20231005$20240807$EXP$$CA-TAKEDA-2023TUS095749$TAKEDA$$62$YR$$M$Y$$$20240807$$CN$CA$CA
230323602$23032360$2$F$$20240812$20231005$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08485$LUPIN$$$$$$Y$$$20240903$$CN$US$US
230324374$23032437$4$F$$20240718$20231005$20240722$EXP$$US-PFIZER INC-202300157840$PFIZER$$74$YR$$M$Y$92.336$KG$20240722$$CN$US$US
230324684$23032468$4$F$20230901$20240904$20231005$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2023-028058$UNITED THERAPEUTICS$$80$YR$$F$Y$$$20240913$$$US$US
230325169$23032516$9$F$20230101$20240813$20231005$20240820$EXP$$US-SA-2023SA302446$SANOFI AVENTIS$$1$YR$I$M$Y$14.51$KG$20240820$$MD$US$US
230325852$23032585$2$F$20230103$20240710$20231005$20240712$EXP$ES-AEMPS-1426150$ES-PFIZER INC-202300308874$PFIZER$$30$YR$$M$Y$$$20240712$$MD$ES$ES
230325985$23032598$5$F$20220812$20240801$20231005$20240806$EXP$$CA-PFIZER INC-202200731225$PFIZER$$61$YR$$F$Y$$$20240806$$MD$CA$CA
230326082$23032608$2$F$$20240805$20231005$20240806$EXP$$CA-PFIZER INC-202300310750$PFIZER$$2$YR$$F$Y$$$20240806$$HP$CA$CA
230326686$23032668$6$F$$20240510$20231005$20240802$EXP$$SK-ROCHE-3430000$ROCHE$$59$YR$A$M$Y$$$20240802$$MD$SK$SK
230327273$23032727$3$F$$20240719$20231005$20240723$PER$$NVSC2023US213511$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
2303289810$23032898$10$F$20230927$20240910$20231005$20240916$EXP$$CO-TAKEDA-2023TUS094836$TAKEDA$$11$YR$$M$Y$32$KG$20240916$$CN$CO$CO
230330355$23033035$5$F$20231011$20240712$20231005$20240716$EXP$$CA-TAKEDA-2019TUS043822$TAKEDA$$61$YR$$F$Y$$$20240716$$CN$CA$CA
230330615$23033061$5$F$$20240903$20231005$20240906$EXP$$CA-TAKEDA-2023TUS067595$TAKEDA$$$$$M$Y$$$20240906$$CN$CA$CA
230331323$23033132$3$F$$20240820$20231005$20240822$EXP$$CA-PFIZER INC-2021040392$PFIZER$$63$YR$$M$Y$$$20240822$$HP$CA$CA
230332336$23033233$6$F$20230101$20240624$20231005$20240703$PER$$US-SA-2023SA301779$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240703$$MD$US$US
230332365$23033236$5$F$20230509$20240726$20231005$20240730$EXP$$ES-MYLANLABS-2023M1074290$MYLAN$$64$YR$$M$Y$64$KG$20240730$$MD$ES$ES
230332827$23033282$7$F$20201015$20240730$20231005$20240801$EXP$$BR-ROCHE-2599367$ROCHE$$52$YR$A$F$Y$70$KG$20240801$$MD$BR$BR
230333892$23033389$2$F$20230901$20240709$20231005$20240711$EXP$$AT-PFIZER INC-202300310295$PFIZER$$61$YR$$F$Y$$$20240711$$MD$AT$AT
230333953$23033395$3$F$$20240702$20231005$20240704$EXP$$CA-PFIZER INC-202300311688$PFIZER$$78$YR$$F$Y$$$20240704$$HP$CA$CA
230337207$23033720$7$F$20240206$20240325$20231005$20240718$EXP$$US-Taiho Oncology Inc-2023-007483$TAIHO ONCOLOGY INC$$65$YR$A$F$Y$$$20240718$$CN$US$US
230337595$23033759$5$F$20230630$20240903$20231005$20240910$EXP$$JP-009507513-2307JPN001551J$MERCK$$8$DEC$$M$Y$$$20240910$$MD$JP$JP
230337624$23033762$4$F$20211201$20240726$20231005$20240802$EXP$$CA-VERTEX PHARMACEUTICALS-2022-006672$VERTEX$$28$YR$$F$Y$62$KG$20240802$$MD$CA$CA
230338285$23033828$5$F$$20240923$20231005$20240925$EXP$$CA-SANDOZ INC.-NVSC2022CA265992$SANDOZ$$$$$F$Y$$$20240925$$CN$CA$CA
230338822$23033882$2$F$$20240808$20231005$20240815$PER$$US-SA-2023SA197305$SANOFI AVENTIS$$$$A$F$Y$$$20240815$$MD$US$US
230338875$23033887$5$F$$20231110$20231005$20240718$EXP$$US-Taiho Oncology Inc-2023-008371$TAIHO ONCOLOGY INC$$57$YR$A$M$Y$59.42$KG$20240718$$CN$US$US
230339103$23033910$3$F$20231005$20240816$20231005$20240821$EXP$$CA-TAKEDA-2018TUS024703$TAKEDA$$51$YR$$F$Y$$$20240821$$CN$CA$CA
230340047$23034004$7$F$20200113$20240731$20231005$20240802$EXP$$DE-SANDOZ INC.-NVSC2020DE079272$SANDOZ$$$$E$F$Y$80.6$KG$20240802$$MD$DE$DE
230340062$23034006$2$F$20230821$20231002$20231005$20240704$EXP$$US-JNJFOC-20231001232$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
230341062$23034106$2$F$20210611$20240706$20231005$20240711$EXP$$CA-TAKEDA-2023TUS093078$TAKEDA$$21$YR$$F$Y$111$KG$20240711$$CN$CA$CA
230341162$23034116$2$F$20230623$20240902$20231005$20240910$EXP$$JP-AstraZeneca-2023A222173$ASTRAZENECA$Machida R, et al.. P-050 Survey on the use of Olaparib and onset of adverse reactions in ovarian cancer patients at our hospital.. Journal of Japanese Society of Pharmaceutical Oncology 2024;36:275-.$69$YR$$F$Y$$$20240910$$MD$JP$
230343418$23034341$8$F$$20240903$20231005$20240905$EXP$$US-TAKEDA-2023TUS085060$TAKEDA$$$$$M$Y$89$KG$20240905$$CN$US$US
230343617$23034361$7$F$20240326$20240814$20231005$20240821$EXP$$MX-TAKEDA-2023TUS095669$TAKEDA$$20$YR$$M$Y$$$20240821$$CN$MX$MX
230343842$23034384$2$F$$20240903$20231005$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411021$RANBAXY$Savarino J, Mokszycki R, Tubbs R, Wightman R. Refractory hypoglycemia due to sulfonylurea contamination of illicit opioid medication. Clin Toxicol. 2023;61 (Suppl. 2):171/351$67$YR$$M$Y$$$20240918$$HP$US$US
230344103$23034410$3$F$$20240820$20231005$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410588$RANBAXY$Gennaro VL, Maclin J, Weiser P, Stoll ML, Smitherman EA. Juvenile Idiopathic Arthritis With Associated Inflammatory Bowel Disease and CARD8 Mutation. Pediatrics. 2023;152(4):e2022058964(1-4)$7$YR$$F$Y$$$20240904$$HP$US$US
230344322$23034432$2$F$$20240830$20231005$20240913$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-410670$RANBAXY$$61$YR$$M$Y$72$KG$20240913$$CN$DE$DE
230345665$23034566$5$F$20230901$20240820$20231005$20240828$EXP$$US-BIOMARINAP-US-2023-153045$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
230346164$23034616$4$F$20240629$20240703$20231005$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-141529$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240704$$CN$US$US
230346673$23034667$3$F$20231003$20240702$20231005$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-141352$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$105.5$KG$20240711$$PH$US$US
230347104$23034710$4$F$$20240916$20231005$20240923$EXP$$CA-GSK-CA2023AMR134057$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$HP$CA$CA
230347375$23034737$5$F$20230801$20240807$20231005$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017379$JAZZ$$35$YR$$F$Y$$$20240813$$CN$US$US
230347492$23034749$2$F$$20240722$20231005$20240729$EXP$$IT-VERTEX PHARMACEUTICALS-2023-014739$VERTEX$Manciulli T, Bresci S, Mencarini J, Avarello A, Taccetti G, Terlizzi V.. Prevalence of adverse events in cystic fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor: experience of the regional referral center in Tuscany, Italy. Pediatr Pulmonol. 2023$31$YR$$$Y$$$20240729$$MD$IT$IT
230347673$23034767$3$F$20230919$20240918$20231005$20240924$EXP$$US-BIOGEN-2023BI01229421$BIOGEN$$58$YR$$F$Y$$$20240924$$CN$US$US
230348688$23034868$8$F$20190101$20240716$20231005$20240718$EXP$$US-PFIZER INC-PV202300164183$PFIZER$$61$YR$$F$Y$72.109$KG$20240718$$CN$US$US
230348793$23034879$3$F$$20240715$20231005$20240717$PER$$US-PFIZER INC-PV202300114717$PFIZER$$81$YR$$F$Y$$$20240717$$CN$US$US
230349882$23034988$2$F$$20240802$20231005$20240808$EXP$$US-ABBVIE-5434659$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
230350646$23035064$6$F$20230601$20240909$20231005$20240923$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000306$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
230350973$23035097$3$F$20230929$20240820$20231005$20240822$PER$$US-AMGEN-USASP2023176829$AMGEN$$67$YR$E$F$Y$$$20240822$$CN$US$US
230351522$23035152$2$F$20230901$20240624$20231005$20240703$PER$$US-SA-2023SA298136$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240703$$MD$US$US
230352055$23035205$5$F$20230926$20240719$20231005$20240726$EXP$$US-SA-2023SA302055$SANOFI AVENTIS$$40$YR$A$F$Y$95$KG$20240726$$MD$US$US
230353134$23035313$4$F$20240418$20240614$20231005$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004051$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240709$$CN$US$US
230353479$23035347$9$F$20230911$20240621$20231005$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004014$ACADIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240716$$CN$US$US
230353705$23035370$5$F$$20240729$20231005$20240805$EXP$$CA-JNJFOC-20230967291$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240805$$MD$CA$CA
230353823$23035382$3$F$$20240711$20231005$20240802$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004070$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
230353853$23035385$3$F$20220724$20240802$20231005$20240806$EXP$$JP-TAKEDA-2023TJP012827$TAKEDA$$84$YR$$F$Y$$$20240806$$MD$JP$JP
230353883$23035388$3$F$$20240620$20231005$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004050$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
230353997$23035399$7$F$20230101$20240620$20231005$20240715$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004053$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
230354194$23035419$4$F$20240601$20240625$20231006$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004061$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240719$$CN$US$US
230354268$23035426$8$F$$20240612$20231006$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004069$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
230354373$23035437$3$F$20230926$20240708$20231006$20240712$EXP$$BR-ABBVIE-5437572$ABBVIE$$37$YR$$F$Y$88$KG$20240712$$CN$BR$BR
230354998$23035499$8$F$20230906$20240627$20231006$20240708$EXP$JP-MMM-B9FUCM5S$JP-ABBVIE-5436751$ABBVIE$$71$YR$$M$Y$60$KG$20240708$$MD$JP$JP
230355303$23035530$3$F$20240624$20240709$20231006$20240715$EXP$$BR-TAKEDA-2023TUS096030$TAKEDA$$31$YR$$M$Y$$$20240715$$CN$BR$BR
230355756$23035575$6$F$20240101$20240819$20231006$20240822$EXP$$US-SA-2023SA303385$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240822$$MD$US$US
230356373$23035637$3$F$20230808$20240909$20231006$20240927$PER$$CA-TOLMAR, INC.-23CA043489$TOLMAR$$91$YR$$M$Y$$$20240927$$CN$CA$CA
230356414$23035641$4$F$20230920$20240821$20231006$20240911$PER$$CA-TOLMAR, INC.-23CA043506$TOLMAR$$70$YR$$M$Y$$$20240911$$CN$CA$CA
230356894$23035689$4$F$$20240904$20231006$20240910$EXP$$JP-009507513-2310JPN000017J$MERCK$$67$YR$$M$Y$$$20240910$$MD$JP$JP
230357385$23035738$5$F$20230701$20240729$20231006$20240805$PER$$US-BEH-2023163605$CSL BEHRING$$59$YR$A$M$Y$$$20240805$$CN$US$US
230358642$23035864$2$F$20221202$20240702$20231006$20240704$EXP$$NVSJ2023JP014428$NOVARTIS$$78$YR$$M$Y$53.7$KG$20240705$$MD$JP$JP
2303599512$23035995$12$F$20230801$20240904$20231006$20240909$EXP$$NVSC2023AE211564$NOVARTIS$$$$$M$Y$$$20240909$$CN$AE$AE
230360242$23036024$2$F$20230901$20240801$20231006$20240812$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-23-00561$CATALYST PHARMA$$67$YR$$M$Y$$$20240812$$CN$US$US
230360344$23036034$4$F$$20240902$20231006$20240913$EXP$CA-MHPD-E2B 06472900$CA-Accord-381420$ACCORD$$25$YR$A$F$Y$$$20240913$$HP$CA$CA
230361653$23036165$3$F$$20231003$20231006$20240724$EXP$SK-CELLTRION HEALTHCARE HUNGARY KFT-2023SK018407$SK-ROCHE-3432085$ROCHE$Reporter known to company, Majernik S. Recidivujuci priebeh COVID-19 u pacientov s liecbou anti CD20 monoklonalnymi protilatkami - kazuistiky. LEKARSKE LISTY, PRILOHA ZN. 2023;14:18-19.$42$YR$A$F$Y$$$20240724$$MD$SK$SK
230363129$23036312$9$F$20240523$20240802$20231006$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004016$ACADIA PHARMACEUTICALS$$29$YR$$F$Y$$$20240827$$CN$US$US
230363513$23036351$3$F$20231002$20240906$20231006$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-141951$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240910$$PH$US$US
2303645713$23036457$13$F$20230101$20240910$20231006$20240917$EXP$$CA-CELLTRION INC.-2023CA019073$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
230364603$23036460$3$F$$20240626$20231006$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-141079$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240701$$HP$US$US
230364628$23036462$8$F$20230921$20240818$20231006$20240822$EXP$$CA-TAKEDA-2023TUS094921$TAKEDA$$57$YR$$F$Y$$$20240822$$MD$CA$CA
230366428$23036642$8$F$20240103$20240920$20231006$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-140707$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240925$$CN$US$US
230366557$23036655$7$F$20200203$20240828$20231006$20240903$EXP$$CA-TAKEDA-2023TUS076022$TAKEDA$$43$YR$$F$Y$$$20240903$$MD$CA$CA
230366797$23036679$7$F$20230901$20240920$20231006$20240925$EXP$$NVSC2023RO206283$NOVARTIS$$69$YR$$F$Y$$$20240925$$CN$RO$RO
230368542$23036854$2$F$20201101$20240801$20231006$20240816$EXP$$DE-SANDOZ INC.-NVSC2021DE101726$SANDOZ$$30$YR$$F$Y$69$KG$20240816$$MD$DE$DE
2303688512$23036885$12$F$20220801$20240823$20231006$20240828$EXP$$NVSC2023BR168490$NOVARTIS$$55$YR$$F$Y$52$KG$20240828$$CN$BR$BR
230370209$23037020$9$F$20230924$20240917$20231006$20240919$EXP$$NVSC2023US213993$NOVARTIS$$48$YR$$F$Y$$$20240919$$CN$US$US
230370492$23037049$2$F$20230808$20240918$20231006$20240930$PER$$NVSC2023US215218$NOVARTIS$$52$YR$$M$Y$$$20240930$$CN$US$US
2303705511$23037055$11$F$20231201$20240815$20231006$20240821$EXP$$US-GSK-US2023AMR136063$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
230370866$23037086$6$F$20230101$20240816$20231006$20240821$EXP$$DE-ROCHE-3434574$ROCHE$$34$YR$A$F$Y$$$20240821$$CN$DE$DE
230370903$23037090$3$F$20220101$20231012$20231006$20240709$EXP$$FR-ASTELLAS-2023US029408$ASTELLAS$$74$YR$$M$Y$$$20240709$$PH$FR$FR
230371683$23037168$3$F$20230727$20240410$20231006$20240704$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-09591$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-09591$ALKEM$$46$YR$$M$Y$134$KG$20240704$$HP$DE$DE
2303722912$23037229$12$F$20210422$20240918$20231006$20240923$EXP$$CH-SANDOZ INC.-NVSC2021CH201825$SANDOZ$$79$YR$$F$Y$70.9$KG$20240923$$MD$CH$CH
230373284$23037328$4$F$20231101$20240816$20231006$20240823$EXP$$CO-GSK-CO2023AMR133686$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$CO$CO
230374672$23037467$2$F$20230901$20240717$20231006$20240723$EXP$$BR-TAKEDA-2023TUS061975$TAKEDA$$84$YR$$M$Y$$$20240723$$CN$BR$BR
230375673$23037567$3$F$20230801$20240812$20231006$20240821$PER$$US-SA-2023SA299985$SANOFI AVENTIS$$72$YR$A$M$Y$65.306$KG$20240821$$MD$US$US
230375705$23037570$5$F$20240301$20240624$20231006$20240703$PER$$US-SA-2023SA301408$SANOFI AVENTIS$$51$YR$A$M$Y$89.81$KG$20240703$$MD$US$US
230376182$23037618$2$F$$20240812$20231006$20240820$PER$$US-SA-2023SA299431$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240820$$MD$US$US
230376703$23037670$3$F$20220204$20240725$20231006$20240806$EXP$$FR-Accord-382360$ACCORD$Arnould B, Miranda S, Mignon F, Camus V. G-CSF-induced TIPIC syndrome and large vessel vasculitis: A case report. Clin Case Rep. 2023 Sep 14;11(9):e7918$73$YR$E$F$Y$$$20240806$$HP$FR$FR
230377732$23037773$2$F$20230101$20240903$20231006$20240924$PER$$US-SA-2023SA301537$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240924$$MD$US$US
230377843$23037784$3$F$20240101$20240807$20231006$20240816$PER$$US-SA-2023SA301829$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240816$$MD$US$US
230377872$23037787$2$F$$20240612$20231006$20240718$PER$$US-SA-2023SA303303$SANOFI AVENTIS$$$$E$M$Y$$$20240719$$CN$US$US
230377954$23037795$4$F$20240718$20240920$20231006$20240925$EXP$$NVSC2023US213786$NOVARTIS$$53$YR$$F$Y$$$20240925$$CN$US$US
230378052$23037805$2$F$20211121$20240707$20231006$20240714$PER$$US-SA-2023SA301696$SANOFI AVENTIS$$71$YR$E$M$Y$73.016$KG$20240715$$MD$US$US
230381704$23038170$4$F$20230714$20240912$20231006$20240916$EXP$$CA-SANDOZ INC.-SDZ2023CA002928$SANDOZ$$75$YR$$F$Y$45$KG$20240916$$CN$CA$CA
230381802$23038180$2$F$20221012$20240820$20231006$20240828$EXP$$KR-VIVUS LLC-2022V1000528$VIVUS$$42$YR$A$F$Y$$$20240822$$$COUNTRY NOT SPECIFIED$KR
230382053$23038205$3$F$$20240711$20231006$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-140916$BRISTOL MYERS SQUIBB$Nakamura H, Shionoya A, Arihara Y, Hayasaka N, Kubo T, Usami M, et al. Pemphigus vulgaris as an immune-related adverse event in recurrent metastatic esophageal squamous cell carcinoma treated with ipilimumab plus nivolumab: a case report and literature review. Frontiers in Immunology. 2023 Sep 11;14:1-5.doi:10.3389/fimmu.2023.1259071.$73$YR$E$M$Y$$$20240719$$MD$JP$JP
230382152$23038215$2$F$$20240925$20231006$20240927$EXP$$CA-SANDOZ INC.-SDZ2023CA037587$SANDOZ$$28$YR$$F$Y$$$20240927$$CN$CA$CA
230383874$23038387$4$F$$20240710$20231006$20240715$EXP$$CA-SANDOZ INC.-NVSC2023CA086217$SANDOZ$$$$$F$Y$$$20240715$$MD$CA$CA
230384535$23038453$5$F$$20240126$20231006$20240925$PER$$US-GSK-US2023AMR133895$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
230384562$23038456$2$F$$20230927$20231006$20240925$PER$$US-GSK-US2023AMR135210$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
230385783$23038578$3$F$20230101$20240724$20231006$20240730$EXP$$US-KYOWAKIRIN-2023KK015671$KYOWA$$$$$$Y$$$20240730$$CN$US$US
230386192$23038619$2$F$$20240717$20231006$20240720$PER$$NVSC2023US215833$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
230386584$23038658$4$F$20180101$20240820$20231006$20240827$EXP$$CA-SANDOZ INC.-NVSC2022CA089948$SANDOZ$$71$YR$$F$Y$69$KG$20240827$$CN$CA$CA
230386893$23038689$3$F$20231001$20240719$20231006$20240808$PER$$US-009507513-2310USA000958$MERCK$$62$YR$$F$Y$$$20240808$$CN$US$US
230389823$23038982$3$F$20220625$20240902$20231006$20240904$EXP$$DE-SANDOZ INC.-NVSC2023DE096973$SANDOZ$$$$A$M$Y$$$20240904$$MD$DE$DE
230392859$23039285$9$F$20231006$20240802$20231006$20240812$EXP$$CA-TAKEDA-2023TUS083299$TAKEDA$$80$YR$$F$Y$$$20240812$$CN$CA$CA
230393458$23039345$8$F$$20240830$20231006$20240906$EXP$$CA-TAKEDA-2023TUS086419$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
230393715$23039371$5$F$20190101$20240828$20231006$20240829$EXP$$US-BAUSCH-BL-2023-014875$BAUSCH AND LOMB$$60$YR$$F$Y$$$20240829$$CN$US$US
230394232$23039423$2$F$$20231003$20231006$20240917$EXP$$JP-LEO Pharma-363396$LEO PHARM$$47$YR$$F$Y$$$20240917$$PH$JP$JP
230394654$23039465$4$F$20230101$20240924$20231006$20240927$EXP$$CA-PFIZER INC-202300253696$PFIZER$$86$YR$$F$Y$45.351$KG$20240927$$HP$CA$CA
2303948910$23039489$10$F$20230405$20240827$20231006$20240903$EXP$$US-OTSUKA-2023_009110$OTSUKA$$30$YR$$M$Y$$$20240903$$MD$US$US
230394978$23039497$8$F$$20240830$20231006$20240909$EXP$$US-GSK-US2023AMR135561$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
230396702$23039670$2$F$$20240821$20231006$20240905$EXP$$SG-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409795$RANBAXY$Teo BHK, Au EongJTW, Au EongKG. Steroid-induced glaucoma: an avoidable cause of irreversible blindness. BMJ Case Rep. 2023;16(9):no pagination/e254709$8$DEC$$M$Y$$$20240905$$HP$SG$SG
230396962$23039696$2$F$20230521$20240828$20231006$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-411185$RANBAXY$$84$YR$$F$Y$$$20240912$$MD$IT$IT
230398222$23039822$2$F$20240808$20240822$20231006$20240826$EXP$$GB-SANDOZ INC.-SDZ2023GB037044$SANDOZ$$$$E$F$Y$$$20240826$$CN$GB$GB
230398885$23039888$5$F$20230401$20240322$20231006$20240807$EXP$$NVSC2023CR214473$NOVARTIS$$76$YR$$F$Y$$$20240807$$CN$CR$CR
230400174$23040017$4$F$20230101$20240711$20231006$20240722$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000389$Unknown Manufacturer$$$$$$Y$$$20240722$$CN$US$US
230400306$23040030$6$F$20230801$20240906$20231006$20240909$EXP$$JP-JNJFOC-20230933065$JOHNSON AND JOHNSON$$75$YR$E$M$Y$56.8$KG$20240910$$MD$JP$JP
230402432$23040243$2$F$20230401$20240711$20231006$20240715$EXP$$CA-PFIZER INC-202300157674$PFIZER$$58$YR$$F$Y$$$20240715$$HP$CA$CA
230403155$23040315$5$F$20221101$20240912$20231006$20240913$EXP$$US-PFIZER INC-PV202300165722$PFIZER$$79$YR$$F$Y$$$20240913$$HP$US$US
230403817$23040381$7$F$20230101$20240828$20231006$20240830$EXP$$CA-PFIZER INC-202300311859$PFIZER$$67$YR$$F$Y$$$20240830$$HP$CA$CA
230404013$23040401$3$F$20230309$20240709$20231006$20240710$EXP$$CA-SANDOZ INC.-NVSC2023CA066497$SANDOZ$$64$YR$$F$Y$57$KG$20240710$$MD$CA$CA
230404152$23040415$2$F$20221101$20240718$20231006$20240731$EXP$$NVSC2023ZA055778$NOVARTIS$$26$YR$$F$Y$$$20240731$$HP$ZA$ZA
230405582$23040558$2$F$$20240611$20231006$20240813$EXP$$NVSC2023CL132738$NOVARTIS$$66$YR$$F$Y$$$20240813$$CN$CL$CL
230405777$23040577$7$F$$20240710$20231006$20240717$EXP$$US-SA-2023SA301786$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240717$$CN$US$US
230406152$23040615$2$F$20230101$20240813$20231006$20240823$EXP$$HR-TEVA-2023-HR-2931247$TEVA$$63$YR$$M$Y$$$20240823$$MD$HR$HR
230406292$23040629$2$F$$20240701$20231006$20240708$EXP$$RU-ROCHE-3432435$ROCHE$$$$E$F$Y$48$KG$20240708$$MD$RU$RU
230406758$23040675$8$F$20200908$20240813$20231006$20240821$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2020-19100$IPSEN$$68$YR$E$M$Y$107$KG$20240821$$CN$CA$CA
230407542$23040754$2$F$$20240722$20231006$20240729$EXP$$IT-VERTEX PHARMACEUTICALS-2023-014772$VERTEX$Manciulli T, Bresci S, Mencarini J, Avarello A, Taccetti G, Terlizzi V.. Prevalence of adverse events in cystic fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor: experience of the regional referral center in Tuscany, Italy. Pediatr Pulmonol. 2023$26$YR$$F$Y$$$20240729$$MD$IT$IT
230407733$23040773$3$F$20230926$20240826$20231006$20240902$EXP$$AR-GSK-AR2023AMR133767$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$AR$AR
230407762$23040776$2$F$20230101$20240823$20231006$20240830$EXP$$CO-GSK-CO2023AMR135729$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$CO$CO
230409142$23040914$2$F$$20240820$20231006$20240828$EXP$$FR-SA-2023SA301783$SANOFI AVENTIS$Na?m G, Malissin I, M?garbane B.. Cerebral microbleeds in the poisoned patient: An observationalmagnetic resonance imaging study.. Basic Clin Pharmacol Toxicol. 2023;133(3):770-777$72$YR$E$F$Y$$$20240828$$HP$FR$FR
230410355$23041035$5$F$20231004$20240920$20231006$20240923$EXP$$NVSC2023US216045$NOVARTIS$$50$YR$$F$Y$$$20240923$$CN$US$US
230410873$23041087$3$F$20230911$20240624$20231007$20240702$EXP$$FR-AUROBINDO-AUR-APL-2023-061898$AUROBINDO$$65$YR$$M$Y$67$KG$20240702$$MD$FR$FR
230412887$23041288$7$F$20231109$20240913$20231007$20240917$EXP$$NVSC2023US216290$NOVARTIS$$60$YR$$M$Y$131.51$KG$20240917$$CN$US$US
230413802$23041380$2$F$20221101$20240718$20231007$20240729$EXP$$PT-AUROBINDO-AUR-APL-2023-061903$AUROBINDO$$65$YR$$M$Y$87$KG$20240729$$MD$PT$PT
230413983$23041398$3$F$20230709$20240812$20231007$20240821$PER$$US-SA-2023SA301622$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240821$$MD$US$US
2304144411$23041444$11$F$20230101$20240808$20231007$20240816$EXP$$CA-CELLTRION INC.-2023CA011063$CELLTRION$$$$$$Y$$$20240816$$PH$CA$CA
230414705$23041470$5$F$20210728$20240627$20231007$20240702$EXP$$CO-TAKEDA-2021TUS048415$TAKEDA$$32$YR$$F$Y$70$KG$20240702$$MD$CO$CO
230415442$23041544$2$F$$20240701$20231007$20240708$EXP$$US-AUROBINDO-AUR-APL-2017-35899$AUROBINDO$Munjal S, Smolin YV.. Ciprofloxacin associated exacerbation of anxiety in an elderly patient: A review of anxiogenic potential of fluoroquinolones. Journal of Clinical Psychopharmacology. 2017;37:370-2$85$YR$$F$Y$$$20240708$$MD$US$US
230415653$23041565$3$F$20230101$20240906$20231007$20240916$EXP$$CA-CELLTRION INC.-2023CA019135$CELLTRION$$$$$$Y$$$20240916$$CN$CA$CA
230416584$23041658$4$F$20231201$20240809$20231007$20240814$EXP$$CA-TAKEDA-2022TUS081732$TAKEDA$$26$YR$$F$Y$$$20240814$$CN$CA$CA
230418243$23041824$3$F$20231004$20240905$20231007$20240909$EXP$$US-TAKEDA-2023TUS096196$TAKEDA$$23$YR$$M$Y$$$20240909$$PH$US$US
230419068$23041906$8$F$20240301$20240705$20231007$20240709$EXP$$CA-UCBSA-2022041793$UCB$$44$YR$$F$Y$$$20240709$$MD$CA$CA
230419342$23041934$2$F$20231004$20231004$20231007$20240910$PER$$NVSC2023US216711$NOVARTIS$$44$YR$$F$Y$$$20240910$$CN$US$US
230420202$23042020$2$F$20220604$20240714$20231008$20240722$EXP$$DE-SANDOZ INC.-NVSC2023DE080747$SANDOZ$$$$A$F$Y$92$KG$20240722$$MD$DE$DE
230420993$23042099$3$F$20230926$20240822$20231008$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08487$LUPIN$$$$$$Y$$$20240910$$CN$US$US
230423332$23042333$2$F$20091001$20240625$20231008$20240704$EXP$$PL-STRIDES ARCOLAB LIMITED-2023SP015202$STRIDES$Razik M, Rozwadowska P, Koclega A, Helbig G.. Double Malignancy and Double Transplant-A Bumpy Road to Success. Medicina-Kaunas. 2023;59 (7):1209$2$DEC$$F$Y$$$20240704$$HP$PL$PL
230425344$23042534$4$F$$20240815$20231008$20240820$EXP$$US-SANDOZ INC.-NVSC2023US091545$SANDOZ$$$$$F$Y$78.925$KG$20240820$$CN$US$US
230425362$23042536$2$F$20230601$20240722$20231009$20240730$PER$$US-SA-2023SA302456$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240730$$MD$US$US
230425523$23042552$3$F$20230922$20240726$20231009$20240801$EXP$$AR-GSK-AR2023AMR135714$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$AR$AR
230425553$23042555$3$F$$20240718$20231009$20240725$EXP$$US-BIOGEN-2023BI01229847$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
230425703$23042570$3$F$20210101$20240711$20231009$20240718$PER$$US-SA-2023SA299125$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240718$$MD$US$US
230426414$23042641$4$F$$20231115$20231009$20240810$EXP$$JP-ABBVIE-5440402$ABBVIE$$80$YR$$M$Y$$$20240810$$MD$JP$JP
230426743$23042674$3$F$20230913$20240829$20231009$20240923$PER$$US-SA-2023SA289084$SANOFI AVENTIS$$11$YR$C$F$Y$63.084$KG$20240923$$MD$US$US
2304275916$23042759$16$F$20230824$20240613$20231009$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004047$ACADIA PHARMACEUTICALS$$26$YR$$F$Y$$$20240708$$CN$US$US
230427642$23042764$2$F$$20240624$20231009$20240703$PER$$US-SA-2023SA298512$SANOFI AVENTIS$$$$A$M$Y$$$20240703$$MD$US$US
230427732$23042773$2$F$20230901$20240821$20231009$20240909$PER$$US-SA-2023SA299180$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240909$$MD$US$US
230432013$23043201$3$F$$20240812$20231009$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08508$LUPIN$$$$$$Y$$$20240901$$CN$US$US
230432065$23043206$5$F$20191101$20240918$20231009$20240923$EXP$$US-AMGEN-USASP2023178262$AMGEN$$63$YR$A$M$Y$98.6$KG$20240923$$MD$US$US
230432504$23043250$4$F$20240701$20240806$20231009$20240816$PER$$US-SA-2023SA301837$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240816$$CN$US$US
230434394$23043439$4$F$20230927$20240819$20231009$20240829$PER$$US-SA-2023SA301238$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240829$$MD$US$US
230434564$23043456$4$F$20210310$20240731$20231009$20240814$EXP$$JP-ROCHE-3131304$ROCHE$Okamoto T, Yamakawa T, Kurihara S, Saika R, Yamamoto T, Rin Y Pj-058-2 Study on neuromyelitis optica spectrum disorder accompanied by severe complication during administration of satralizumab. The 65th Annual Meeting of the Japanese Society of Neurology / The 19th Asian Oc. 2024;:487-.$69$YR$E$F$Y$46$KG$20240814$$MD$JP$JP
230434982$23043498$2$F$$20240828$20231009$20240914$PER$$US-SA-2023SA303821$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240914$$MD$US$US
230435532$23043553$2$F$20240828$20240830$20231009$20240923$PER$$US-SA-2023SA303806$SANOFI AVENTIS$$60$YR$A$F$Y$86.36$KG$20240923$$MD$US$US
2304357011$23043570$11$F$20230901$20240808$20231009$20240818$EXP$$US-GSK-US2023AMR136000$GLAXOSMITHKLINE$$57$YR$$F$Y$46$KG$20240818$$MD$US$US
230435954$23043595$4$F$20231010$20240628$20231009$20240705$EXP$$CA-SANDOZ INC.-SDZ2023CA038907$SANDOZ$$$$E$F$Y$$$20240705$$CN$CA$CA
230436223$23043622$3$F$20230101$20240813$20231009$20240826$PER$$US-SA-2023SA301342$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240826$$MD$US$US
230436264$23043626$4$F$$20240806$20231009$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202310002635$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240809$$MD$US$US
230436383$23043638$3$F$20230828$20240909$20231009$20240921$EXP$$US-UCBSA-2023048101$UCB$$64$YR$$M$Y$81.64$KG$20240921$$CN$US$US
230436672$23043667$2$F$20221130$20240813$20231009$20240818$EXP$$JP-JNJFOC-20231013518$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240819$$MD$JP$JP
230436713$23043671$3$F$20220601$20240916$20231009$20240918$EXP$$US-TAKEDA-US202013837$TAKEDA$$67$YR$$F$Y$$$20240918$$HP$US$US
230437487$23043748$7$F$20240501$20240724$20231009$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-140673$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240726$$CN$US$US
230437523$23043752$3$F$20230607$20240627$20231009$20240702$EXP$$US-CIPLA (EU) LIMITED-2023US05853$CIPLA$$$$$$Y$$$20240702$$LW$US$US
230437597$23043759$7$F$20230101$20240813$20231009$20240823$EXP$$US-INSMED, INC.-2023-00319-US$INSMED$$$$$F$Y$$$20240823$$HP$US$US
230437902$23043790$2$F$20230101$20240812$20231009$20240817$PER$$US-SA-2023SA302564$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240817$$CN$US$US
230437917$23043791$7$F$20231206$20240826$20231009$20240902$EXP$$CA-TAKEDA-2023TUS095824$TAKEDA$$58$YR$$M$Y$$$20240902$$HP$CA$CA
230437929$23043792$9$F$20230316$20240717$20231009$20240730$EXP$$CA-ROCHE-3432271$ROCHE$$23$YR$A$F$Y$$$20240730$$CN$CA$CA
230438415$23043841$5$F$$20240729$20231009$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-020529$JAZZ$$$$$M$Y$$$20240806$$MD$US$US
230438429$23043842$9$F$$20240812$20231009$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004140$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
230439482$23043948$2$F$20220416$20240702$20231009$20240705$EXP$$ES-ABBVIE-5438796$ABBVIE$$57$YR$$M$Y$$$20240705$$MD$ES$ES
230439894$23043989$4$F$20230929$20240628$20231009$20240704$EXP$$CA-JNJFOC-20231010486$JOHNSON AND JOHNSON$$53$YR$A$F$Y$109$KG$20240704$$HP$CA$CA
230440682$23044068$2$F$20230101$20240813$20231009$20240820$PER$$US-SA-2023SA303828$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240820$$MD$US$US
230440962$23044096$2$F$$20240904$20231009$20240906$EXP$$CA-SANDOZ INC.-SDZ2023CA039232$SANDOZ$$37$YR$$M$Y$$$20240906$$CN$CA$CA
230441152$23044115$2$F$$20240806$20231009$20240813$PER$$US-SA-2023SA301639$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240814$$MD$US$US
230441462$23044146$2$F$$20240717$20231009$20240726$EXP$$CA-APOTEX-2023AP014520$APOTEX$$77$YR$$F$Y$$$20240726$$HP$CA$CA
230442302$23044230$2$F$$20240419$20231009$20240709$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03100$AMNEAL$$$$$M$Y$$$20240709$$CN$US$US
230442964$23044296$4$F$20230929$20240920$20231009$20240927$PER$$US-GSK-US2023AMR135307$GLAXOSMITHKLINE$$72$YR$$M$Y$$$20240927$$CN$US$US
230443063$23044306$3$F$20230901$20240903$20231009$20240912$PER$$US-SA-2023SA301287$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240912$$MD$US$US
230443545$23044354$5$F$$20240802$20231009$20240808$PER$$US-ABBVIE-5438740$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
230444104$23044410$4$F$20230101$20240916$20231009$20240924$EXP$$NL-ABBVIE-5380696$ABBVIE$$76$YR$$M$Y$$$20240924$$CN$NL$NL
230444813$23044481$3$F$20230101$20240826$20231009$20240912$PER$$US-SA-2023SA304032$SANOFI AVENTIS$$53$YR$A$M$Y$104.3$KG$20240912$$MD$US$US
230446373$23044637$3$F$$20240626$20231009$20240703$EXP$$CA-SANDOZ INC.-NVSC2022CA181018$SANDOZ$$$$$F$Y$$$20240703$$CN$CA$CA
230446665$23044666$5$F$20211022$20240718$20231009$20240725$EXP$$CA-TAKEDA-2023TUS033690$TAKEDA$$61$YR$$F$Y$$$20240725$$MD$CA$CA
230447082$23044708$2$F$20230904$20240911$20231009$20240916$PER$$US-SA-2023SA305699$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240916$$MD$US$US
230447424$23044742$4$F$$20240821$20231009$20240829$EXP$$CA-APOTEX-2023AP014638$APOTEX$$78$YR$$F$Y$$$20240829$$HP$CA$CA
230447613$23044761$3$F$20230101$20240828$20231009$20240910$PER$$US-SA-2023SA301182$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240910$$MD$US$US
230448219$23044821$9$F$$20240904$20231009$20240906$PER$$US-PFIZER INC-PV202300142056$PFIZER$$71$YR$$M$Y$$$20240906$$CN$US$US
230448273$23044827$3$F$$20240729$20231009$20240731$PER$$US-PFIZER INC-PV202300166396$PFIZER$$78$YR$$M$Y$$$20240731$$CN$US$US
230448284$23044828$4$F$$20240828$20231009$20240904$PER$$US-PFIZER INC-PV202300154129$PFIZER$$64$YR$$F$Y$117.93$KG$20240904$$CN$US$US
230448293$23044829$3$F$$20240829$20231009$20240904$PER$$US-PFIZER INC-202300318620$PFIZER$$64$YR$$F$Y$$$20240904$$HP$US$US
230448585$23044858$5$F$20151101$20240703$20231009$20240708$PER$$US-PFIZER INC-PV202300166368$PFIZER$$72$YR$$F$Y$90.72$KG$20240708$$CN$US$US
230449085$23044908$5$F$20230612$20240924$20231009$20240930$EXP$$AU-TAKEDA-2023TUS058422$TAKEDA$$65$YR$$F$Y$$$20240930$$CN$AU$AU
230453163$23045316$3$F$$20240822$20231009$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08526$LUPIN$$$$$$Y$$$20240905$$PH$US$US
230453356$23045335$6$F$20181211$20240806$20231009$20240812$EXP$$CA-TAKEDA-2023TUS075585$TAKEDA$$75$YR$$F$Y$$$20240812$$CN$CA$CA
230453703$23045370$3$F$20230724$20240711$20231009$20240719$EXP$$US-ABBVIE-5434077$ABBVIE$$67$YR$$F$Y$63.049$KG$20240719$$MD$US$US
230453812$23045381$2$F$20230801$20240621$20231009$20240701$EXP$$BR-EMD Serono-2023478488$EMD SERONO INC$$35$YR$A$F$Y$$$20240701$$CN$BR$BR
230456122$23045612$2$F$20230101$20230928$20231009$20240809$EXP$$US-ORPHANEU-2023005596$RECORDATI$$$$$$Y$$$20240809$$HP$US$US
230456326$23045632$6$F$20230101$20240807$20231009$20240814$EXP$$US-ABBVIE-5439917$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
230456339$23045633$9$F$$20240903$20231009$20240905$PER$$US-BIOVITRUM-2023-US-015319$BIOVITRUM$$41$YR$$M$Y$$$20240905$$CN$US$US
230457853$23045785$3$F$$20240809$20231009$20240812$PER$$NVSC2023US217539$NOVARTIS$$$$$F$Y$$$20240812$$HP$US$US
230458184$23045818$4$F$20230101$20240718$20231009$20240730$EXP$$AU-TASMAN PHARMA, INC.-2023TSM00159$TASMAN PHARMA$$$$$M$Y$$$20240730$$HP$AU$AU
230460177$23046017$7$F$$20240919$20231009$20240925$EXP$$CA-ALCON LABORATORIES-ALC2022CA003214$ALCON$$$$$$Y$$$20240925$$HP$CA$DE
230460712$23046071$2$F$20230101$20240910$20231009$20240923$EXP$$CA-SA-2023SA266847$SANOFI AVENTIS$$2$YR$C$F$Y$13.1$KG$20240923$$CN$CA$CA
230461982$23046198$2$F$$20231116$20231009$20240829$EXP$$PH-OTSUKA-2023_026206$OTSUKA$$$$$M$Y$$$20240829$$MD$PH$PH
230462202$23046220$2$F$20170804$20240708$20231009$20240722$EXP$$ES-NORDICGR-053634$NORDIC PHARMA$$49$YR$$F$Y$$$20240719$$MD$ES$ES
230462492$23046249$2$F$20210101$20240801$20231009$20240805$EXP$$US-TAKEDA-2016BLT005316$TAKEDA$$58$YR$$F$Y$$$20240805$$CN$US$US
230462583$23046258$3$F$20220309$20240716$20231009$20240718$EXP$$ES-SANDOZ INC.-NVSC2022ES182566$SANDOZ$$55$YR$$M$Y$74.8$KG$20240718$$MD$ES$ES
230462973$23046297$3$F$20230925$20240715$20231009$20240722$EXP$$MX-TAKEDA-2023TUS096313$TAKEDA$$50$YR$$F$Y$53$KG$20240722$$MD$MX$MX
230463982$23046398$2$F$$20240830$20231009$20240904$EXP$$IN-PFIZER INC-2021666253$PFIZER$$58$YR$$M$Y$$$20240904$$CN$IN$IN
230464075$23046407$5$F$20230928$20240806$20231009$20240809$EXP$$CA-PFIZER INC-202300187610$PFIZER$$51$YR$$F$Y$$$20240809$$MD$CA$CA
230464105$23046410$5$F$20230101$20240906$20231009$20240911$EXP$$CA-PFIZER INC-202300316161$PFIZER$$74$YR$$F$Y$$$20240911$$HP$CA$CA
230464258$23046425$8$F$20220101$20240911$20231009$20240913$EXP$$US-PFIZER INC-PV202300163574$PFIZER$$74$YR$$F$Y$66.667$KG$20240913$$CN$US$US
230464363$23046436$3$F$20180608$20240712$20231009$20240716$EXP$FR-AFSSAPS-NY2023001347$FR-PFIZER INC-202300312310$PFIZER$$70$YR$$F$Y$$$20240716$$MD$FR$FR
230464553$23046455$3$F$20200101$20240716$20231009$20240718$EXP$$US-PFIZER INC-202300313186$PFIZER$$74$YR$$F$Y$60.33$KG$20240718$$CN$US$US
230464643$23046464$3$F$20230101$20240711$20231009$20240716$EXP$$CA-JNJFOC-20230641423$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240716$$CN$CA$CA
230464932$23046493$2$F$$20240625$20231009$20240710$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410351$RANBAXY$Vasan AS, Chowdhary GS, Pandey I, Garg Y, Soneji D. Docetaxel-induced lung injury. Med J Armed Forces India. 2023;-:no pagination$60$YR$$F$Y$$$20240710$$HP$IN$IN
230465656$23046565$6$F$20230101$20240716$20231009$20240724$EXP$$US-SA-2023SA304305$SANOFI AVENTIS$$50$YR$A$F$Y$72.1$KG$20240724$$MD$US$US
230467002$23046700$2$F$20230917$20240827$20231009$20240913$PER$$US-SA-2023SA303973$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240913$$MD$US$US
230468053$23046805$3$F$$20240822$20231009$20240828$EXP$$CA-PFIZER INC-202300312948$PFIZER$$71$YR$$F$Y$$$20240828$$HP$CA$CA
2304689311$23046893$11$F$20221219$20240906$20231009$20240920$EXP$$BR-SANDOZ INC.-NVSC2023BR011602$SANDOZ$$44$YR$$F$Y$$$20240920$$CN$BR$BR
230469003$23046900$3$F$20230101$20240829$20231009$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-141989$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240904$$HP$US$US
230471222$23047122$2$F$20231005$20240827$20231009$20240829$EXP$$US-GILEAD-2023-0646784$GILEAD$$38$YR$A$F$Y$$$20240829$$PH$US$US
230471873$23047187$3$F$$20240904$20231009$20240905$EXP$$CA-SANDOZ INC.-NVSC2023CA039479$SANDOZ$$$$$F$Y$$$20240905$$CN$CA$CA
230472304$23047230$4$F$20230601$20240711$20231009$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-141061$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$68$KG$20240716$$PH$US$US
230473332$23047333$2$F$20230101$20240923$20231010$20240926$EXP$$CA-ABBVIE-5441750$ABBVIE$$$$$M$Y$$$20240926$$CN$CA$CA
230475045$23047504$5$F$20231107$20240625$20231010$20240701$EXP$$CA-TAKEDA-2023TUS022112$TAKEDA$$55$YR$$F$Y$$$20240701$$CN$CA$CA
230475632$23047563$2$F$$20240802$20231010$20240805$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2023-US-001721$IPCA$Maxwell Green, Laura Williams, Drew Kuraitis, et.al.. Utility of laboratory monitoring for dermatology patients prescribed hydroxychloroquine. J Am Acad Dermatol. 2023;AB246$$$$$Y$$$20240805$$HP$US$US
230475913$23047591$3$F$$20240806$20231010$20240813$EXP$$US-TAKEDA-2023TUS096559$TAKEDA$$$$$M$Y$13.605$KG$20240813$$HP$US$US
230476684$23047668$4$F$$20240923$20231010$20240927$EXP$$CA-TAKEDA-2023TUS096914$TAKEDA$$$$$F$Y$$$20240927$$CN$CA$CA
230476762$23047676$2$F$$20240724$20231010$20240730$EXP$$NL-IPCA LABORATORIES LIMITED-IPC-2023-NL-001694$IPCA$Choon SE, Elewski BE, Fujita H et al.. Diversity in the clinical presentation of generalized pustular psoriasis (GPP): A series of case vignettes from around the world. Experimental Dermatology. 2023;32(8):1284-1295$$$$$Y$$$20240730$$MD$NL$NL
230477884$23047788$4$F$20230624$20240809$20231010$20240816$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-254999$BOEHRINGER INGELHEIM$$87$YR$E$F$Y$$$20240816$$CN$US$US
230478023$23047802$3$F$$20240923$20231010$20240927$PER$$US-PHARMING-PHAUS2023000744$PHARMING GROUP$$$$$$Y$$$20240927$$CN$US$US
230478552$23047855$2$F$$20240805$20231010$20240808$EXP$$NVSC2023AE215495$NOVARTIS$$$$N$F$Y$1.5$KG$20240808$$CN$AE$AE
230479324$23047932$4$F$20230918$20240703$20231010$20240711$EXP$$US-BEH-2023164117$CSL BEHRING$$42$YR$A$M$Y$$$20240711$$HP$US$US
230480138$23048013$8$F$20230905$20240909$20231010$20240916$EXP$$BR-GSK-BR2023AMR135682$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$BR$BR
230480914$23048091$4$F$20230101$20240626$20231010$20240702$EXP$$JP-009507513-2310JPN000330J$MERCK$$$$$F$Y$39$KG$20240702$$MD$JP$JP
2304824315$23048243$15$F$20230901$20240627$20231010$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004393$ACADIA PHARMACEUTICALS$$16$YR$$F$Y$$$20240705$$CN$US$US
230482515$23048251$5$F$20220101$20240910$20231010$20240912$EXP$$CA-SANDOZ INC.-NVSC2020CA350110$SANDOZ$$70$YR$$M$Y$$$20240912$$MD$CA$CA
230482654$23048265$4$F$20230901$20240912$20231010$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000906$DECIPHERA PHARMACEUTICALS$$68$YR$A$M$Y$100$KG$20240927$$CN$US$US
230483163$23048316$3$F$20240701$20240914$20231010$20240919$PER$$US-AMGEN-USASP2023179973$AMGEN$$58$YR$A$F$Y$$$20240919$$HP$US$US
230483718$23048371$8$F$20231012$20240626$20231010$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004092$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240719$$CN$US$US
230484624$23048462$4$F$$20240611$20231010$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004188$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240707$$CN$US$US
230485708$23048570$8$F$20230901$20240919$20231010$20240924$EXP$$DE-TAKEDA-2023TUS096242$TAKEDA$$$$A$M$Y$80$KG$20240924$$HP$DE$DE
230486772$23048677$2$F$20220901$20240918$20231010$20240920$EXP$$US-TAKEDA-2023TUS006963$TAKEDA$$61$YR$$F$Y$$$20240920$$MD$US$US
230487216$23048721$6$F$$20240830$20231010$20240905$EXP$$NVSC2023BR188843$NOVARTIS$$$$$F$Y$$$20240905$$CN$BR$BR
230487572$23048757$2$F$20230106$20240718$20231010$20240724$EXP$$CH-SANDOZ INC.-NVSC2023CH016463$SANDOZ$$$$A$F$Y$$$20240724$$MD$CH$CH
230487889$23048788$9$F$$20240827$20231010$20240904$EXP$$US-TAKEDA-2023TUS096162$TAKEDA$$$$$F$Y$66$KG$20240904$$CN$US$US
230488657$23048865$7$F$20230605$20240722$20231010$20240725$EXP$$AR-MYLANLABS-2023M1066015$MYLAN$$46$YR$$M$Y$$$20240725$$CN$AR$AR
230489259$23048925$9$F$20230101$20240918$20231010$20240924$PER$$US-BIOGEN-2023BI01224504$BIOGEN$$$$$F$Y$$$20240924$$CN$US$US
230489922$23048992$2$F$20230920$20240730$20231010$20240801$EXP$$US-KYOWAKIRIN-2023KK015841$KYOWA$$$$$$Y$$$20240801$$HP$US$US
230490118$23049011$8$F$20231221$20240730$20231010$20240805$EXP$$CA-TAKEDA-2023TUS094166$TAKEDA$$37$YR$$F$Y$$$20240805$$CN$CA$CA
230491273$23049127$3$F$$20240925$20231010$20240925$EXP$$VN-SANDOZ INC.-SDZ2023VN040077$SANDOZ$Quan TVH, Huong NTT, Tan PH. Results of CHOPE regimen in peripheral t-cell lymphoma at Vietnam national cancer hospital. VIETNAM MEDICAL JOURNAL. 2023;530(1B):5-9$$$$$Y$$$20240925$$HP$VN$VN
230491582$23049158$2$F$20230501$20240918$20231010$20240930$EXP$CA-HEALTH CANADA-001052286$CA-ABBVIE-5438082$ABBVIE$$65$YR$$F$Y$$$20240930$$PH$CA$CA
230493514$23049351$4$F$$20240606$20231010$20240801$PER$$US-LUNDBECK-DKLU3067814$LUNDBECK$$$$$$Y$$$20240801$$CN$US$US
230493833$23049383$3$F$20230929$20240628$20231010$20240702$PER$$US-AMGEN-USASP2023180160$AMGEN$$67$YR$E$M$Y$$$20240702$$CN$US$US
230494295$23049429$5$F$$20240819$20231010$20240824$EXP$$NVSC2023US218445$NOVARTIS$$$$$M$Y$$$20240824$$CN$US$US
230494395$23049439$5$F$$20240905$20231010$20240909$30DAY$$US-PFIZER INC-202300302449$PFIZER$$11$YR$$M$Y$$$20240909$$CN$US$US
230495214$23049521$4$F$20230101$20240711$20231010$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-142901$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$167.83$KG$20240716$$CN$US$US
230496143$23049614$3$F$20230101$20240801$20231010$20240809$EXP$$US-MYLANLABS-2023M1106707$MYLAN$$1$YR$$M$Y$7.71$KG$20240809$$PH$US$US
230497163$23049716$3$F$$20240828$20231010$20240905$EXP$$CA-CELLTRION INC.-2023CA019382$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
230497992$23049799$2$F$$20240716$20231010$20240718$PER$$NVSC2023US218006$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
230500967$23050096$7$F$$20240925$20231010$20240925$PER$$US-PFIZER INC-202300321062$PFIZER$$71$YR$$M$Y$$$20240925$$CN$US$US
230501473$23050147$3$F$20231005$20231106$20231010$20240918$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2023-122447$REGENERON$$$$$F$Y$$$20240918$$PH$US$US
230502267$23050226$7$F$$20240704$20231010$20240711$EXP$$NVSC2023ES218087$NOVARTIS$Alvarez R, Lopez GM, Arregui M, Alvarez A, Gonzalez Crisostomo AR, Calles A et al.. Prolonged survival of a patient with desmoplastic small round cell tumor. CANCER AND CHEMOTHERAPY REVIEWS. 2022;17(3):41-6$34$YR$$M$Y$$$20240711$$HP$ES$ES
230503593$23050359$3$F$20200601$20240724$20231010$20240729$EXP$$US-ABBVIE-5380626$ABBVIE$$73$YR$$F$Y$103$KG$20240729$$CN$US$US
230503813$23050381$3$F$$20240628$20231010$20240703$PER$$US-PFIZER INC-PV202300167997$PFIZER$$66$YR$$F$Y$$$20240703$$HP$US$US
230504356$23050435$6$F$20240301$20240827$20231010$20240829$EXP$$US-PFIZER INC-PV202300165685$PFIZER$$76$YR$$F$Y$$$20240829$$HP$US$US
230504393$23050439$3$F$$20240806$20231010$20240812$PER$$US-PFIZER INC-202300321102$PFIZER$$61$YR$$M$Y$$$20240812$$HP$US$US
230504412$23050441$2$F$$20240826$20231010$20240828$PER$$US-PFIZER INC-PV202300082894$PFIZER$$68$YR$$F$Y$$$20240828$$CN$US$US
230504433$23050443$3$F$$20240626$20231010$20240701$PER$$US-PFIZER INC-202300321002$PFIZER$$65$YR$$F$Y$71.67$KG$20240701$$CN$US$US
230504563$23050456$3$F$20220101$20240723$20231010$20240726$PER$$US-PFIZER INC-202300321164$PFIZER$$64$YR$$F$Y$$$20240726$$HP$US$US
230506242$23050624$2$F$$20240618$20231010$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-411834$RANBAXY$$61$YR$$M$Y$$$20240703$$PH$GB$GB
230506284$23050628$4$F$20230926$20240822$20231010$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410624$RANBAXY$$87$YR$E$M$Y$50$KG$20240906$$MD$CN$CN
230507009$23050700$9$F$$20240723$20231010$20240726$EXP$$US-SANDOZ INC.-NVSC2022US064553$SANDOZ$$$$$F$Y$70.385$KG$20240726$$CN$US$US
230508082$23050808$2$F$$20231024$20231010$20240830$PER$$NVSC2023US214244$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
230509103$23050910$3$F$20230801$20240628$20231010$20240704$PER$$US-SA-2023SA305276$SANOFI AVENTIS$$85$YR$E$F$Y$79$KG$20240705$$MD$US$US
230509599$23050959$9$F$20240101$20240621$20231010$20240701$PER$$US-SA-2023SA303968$SANOFI AVENTIS$$$$A$M$Y$$$20240701$$MD$US$US
230509983$23050998$3$F$20230101$20240621$20231010$20240705$PER$$US-SA-2023SA303753$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240705$$MD$US$US
230510712$23051071$2$F$20230801$20240702$20231010$20240711$PER$$US-SA-2023SA305805$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240711$$MD$US$US
230511702$23051170$2$F$$20240816$20231010$20240828$PER$$US-SA-2023SA306886$SANOFI AVENTIS$$11$YR$C$M$Y$39$KG$20240828$$MD$US$US
230511917$23051191$7$F$20230101$20240816$20231010$20240821$PER$$US-SA-2023SA305005$SANOFI AVENTIS$$59$YR$A$M$Y$60.2$KG$20240821$$MD$US$US
230513222$23051322$2$F$$20230920$20231010$20240718$PER$$US-Taiho Oncology Inc-2023-008014$TAIHO ONCOLOGY INC$$$$E$F$Y$$$20240718$$CN$US$US
2305146820$23051468$20$F$20240613$20240906$20231010$20240909$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-141651$DAIICHI$$$$$F$Y$$$20240909$$CN$US$US
230515053$23051505$3$F$20230101$20240730$20231010$20240802$EXP$$JP-ABBVIE-5443625$ABBVIE$$79$YR$$F$Y$$$20240802$$MD$JP$JP
230519785$23051978$5$F$20230101$20240726$20231010$20240801$EXP$$US-ABBVIE-5438596$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
230519935$23051993$5$F$20240904$20240910$20231010$20240918$PER$$US-BEH-2023164055$CSL BEHRING$$25$YR$A$F$Y$71.655$KG$20240918$$MD$US$US
230520575$23052057$5$F$$20240627$20231010$20240701$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-265966$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240701$$CN$US$US
230521192$23052119$2$F$$20240605$20231010$20240805$PER$$US-JNJFOC-20230969957$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240805$$CN$US$US
230521813$23052181$3$F$20220117$20240816$20231010$20240826$EXP$$ZA-CELLTRION INC.-2022ZA000492$CELLTRION$$$$$$Y$$$20240826$$CN$ZA$ZA
230522813$23052281$3$F$20230901$20240719$20231010$20240724$PER$$US-AMGEN-USASP2023177316$AMGEN$$75$YR$E$F$Y$$$20240724$$HP$US$US
230524144$23052414$4$F$20231001$20231018$20231011$20240925$PER$$US-GSK-US2023AMR137219$GLAXOSMITHKLINE$$39$YR$$F$Y$$$20240925$$CN$US$US
230524877$23052487$7$F$20200101$20240909$20231011$20240917$EXP$$CA-CELLTRION INC.-2020CA024423$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
230525564$23052556$4$F$$20240622$20231011$20240701$EXP$$GB-AMGEN-GBRSP2023179756$AMGEN$$83$YR$E$F$Y$$$20240701$$CN$GB$GB
230525583$23052558$3$F$20230801$20240828$20231011$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023AMR137241$VIIV$$29$YR$$M$Y$$$20240905$$CN$US$US
230526332$23052633$2$F$20230101$20240913$20231011$20240923$PER$$US-SA-2023SA307669$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240923$$MD$US$US
230526585$23052658$5$F$$20240610$20231011$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004090$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
230527344$23052734$4$F$20230101$20240708$20231011$20240716$PER$$US-SA-2023SA306499$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
230528016$23052801$6$F$20230601$20240718$20231011$20240725$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007525$JAZZ$$53$YR$$F$Y$$$20240724$$CN$US$US
230528342$23052834$2$F$20200818$20240918$20231011$20240925$EXP$$CA-TAKEDA-2023TUS082787$TAKEDA$$65$YR$$M$Y$$$20240925$$CN$CA$CA
230528432$23052843$2$F$$20240903$20231011$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-122180$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240911$$MD$JP$JP
230528462$23052846$2$F$$20231002$20231011$20240925$PER$$US-GSK-US2023AMR135973$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
230529269$23052926$9$F$20220801$20240827$20231011$20240905$EXP$$CA-ROCHE-3433293$ROCHE$$52$YR$A$F$Y$$$20240905$$MD$CA$CA
230530034$23053003$4$F$20230101$20240909$20231011$20240919$EXP$$US-UCBSA-2023048742$UCB$$$$$M$Y$99.32$KG$20240919$$HP$US$US
230530355$23053035$5$F$20230929$20240806$20231011$20240809$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-020652$JAZZ$$17$YR$$M$Y$$$20240809$$HP$US$US
230530564$23053056$4$F$$20231120$20231011$20240801$PER$$NVSC2023US216300$NOVARTIS$$65$YR$$M$Y$$$20240801$$CN$US$US
230530574$23053057$4$F$$20240703$20231011$20240712$30DAY$$US-JNJFOC-20230965939$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$CN$US$US
230531852$23053185$2$F$20231002$20231002$20231011$20240927$PER$$NVSC2023US215337$NOVARTIS$$75$YR$$F$Y$$$20240927$$CN$US$US
230531869$23053186$9$F$20210316$20240708$20231011$20240716$EXP$$CA-CELLTRION INC.-2020CA028485$CELLTRION$$$$$$Y$$$20240716$$MD$CA$CA
230532083$23053208$3$F$20230101$20240903$20231011$20240918$PER$$US-SA-2023SA308498$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240918$$CN$US$US
230532405$23053240$5$F$20230101$20240911$20231011$20240930$PER$$US-SA-2023SA308864$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240930$$MD$US$US
2305325011$23053250$11$F$20240101$20240829$20231011$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-143822$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240902$$CN$US$US
230533417$23053341$7$F$20230101$20240810$20231011$20240815$EXP$$US-ABBVIE-5444533$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
230533456$23053345$6$F$$20240910$20231011$20240918$EXP$$CA-TAKEDA-2023TUS096820$TAKEDA$$$$$F$Y$$$20240918$$MD$CA$CA
230533603$23053360$3$F$$20240729$20231011$20240802$EXP$$NVSC2023US215421$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
230534039$23053403$9$F$20230101$20240903$20231011$20240911$EXP$$DE-INSMED, INC.-2023-01150-DE$INSMED$$$$$$Y$$$20240911$$MD$DE$DE
2305346813$23053468$13$F$20231002$20240628$20231011$20240709$EXP$$US-BEH-2023164175$CSL BEHRING$$60$YR$A$F$Y$$$20240709$$HP$US$US
230535974$23053597$4$F$20231205$20240909$20231011$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-144095$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240912$$CN$US$US
230536212$23053621$2$F$20230228$20240625$20231011$20240703$EXP$$NVSC2023DE217566$NOVARTIS$$77$YR$$M$Y$95$KG$20240703$$MD$DE$DE
2305363611$23053636$11$F$20230701$20240913$20231011$20240920$EXP$$US-TAKEDA-2023TUS097207$TAKEDA$$44$YR$$M$Y$87.7$KG$20240920$$CN$US$US
230536444$23053644$4$F$20231001$20240628$20231011$20240704$EXP$$JP-009507513-2310JPN000877J$MERCK$$58$YR$$M$Y$$$20240704$$MD$JP$JP
230537555$23053755$5$F$20220101$20240720$20231011$20240731$EXP$$FR-AUROBINDO-AUR-APL-2023-062597$AUROBINDO$B?rang?re Arnould, S?bastien Miranda, Fran?ois Mignon, Vincent Camus.. G-CSF-induced TIPIC syndrome and large vessel vasculitis: A case report.. Clinical Case Reports.. 2023;11:1-5$73$YR$$F$Y$$$20240731$$HP$FR$FR
230539102$23053910$2$F$20230818$20240620$20231011$20240702$EXP$AT-EMA-2023906-AUTODUP-1694027798372$AT-Accord-383073$ACCORD$$28$YR$A$M$Y$$$20240701$$MD$AT$AT
230539814$23053981$4$F$20230920$20231009$20231011$20240715$EXP$$IL-ASTELLAS-2023US029879$ASTELLAS$$75$YR$$$Y$$$20240715$$MD$IL$IL
230540325$23054032$5$F$20230714$20240723$20231011$20240730$EXP$$BE-EXELIXIS-XL18423069084$EXELIXIS$$$$$$Y$$$20240729$$MD$BE$BE
230541612$23054161$2$F$20230811$20240813$20231011$20240814$EXP$FR-AFSSAPS-PO2023000997$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-144059$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$50$KG$20240814$$PH$FR$FR
230541982$23054198$2$F$20230101$20240701$20231011$20240709$PER$$US-SA-2023SA304368$SANOFI AVENTIS$$71$YR$E$F$Y$123.8$KG$20240709$$MD$US$US
230542073$23054207$3$F$$20240828$20231011$20240923$PER$$US-SA-2023SA304871$SANOFI AVENTIS$$38$YR$A$F$Y$65$KG$20240923$$MD$US$US
230542393$23054239$3$F$20230101$20240702$20231011$20240711$PER$$US-SA-2023SA305295$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240711$$MD$US$US
230542893$23054289$3$F$20240501$20240709$20231011$20240715$EXP$$US-SA-2023SA002208$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240715$$CN$US$US
230543112$23054311$2$F$20230101$20240709$20231011$20240718$PER$$US-SA-2023SA304317$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240718$$MD$US$US
230543213$23054321$3$F$20210503$20240904$20231011$20240930$PER$$US-SA-2023SA307191$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240930$$PH$US$US
230543422$23054342$2$F$20240101$20240823$20231011$20240918$PER$$US-SA-2023SA308015$SANOFI AVENTIS$$54$YR$A$F$Y$41.723$KG$20240918$$MD$US$US
230543754$23054375$4$F$$20240904$20231011$20240913$EXP$$CA-CELLTRION INC.-2023CA019257$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
230544384$23054438$4$F$20230101$20240813$20231011$20240819$EXP$$CL-JNJFOC-20231008404$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240819$$MD$CL$CL
230546448$23054644$8$F$20231005$20240905$20231011$20240911$EXP$$CA-TAKEDA-2023TUS038612$TAKEDA$$72$YR$$F$Y$$$20240911$$MD$CA$CA
230546522$23054652$2$F$20161205$20240718$20231011$20240723$EXP$$CA-TAKEDA-2023TUS096915$TAKEDA$$61$YR$$M$Y$$$20240723$$MD$CA$CA
230546643$23054664$3$F$$20240923$20231011$20240925$PER$$NVSC2023US218787$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
230548706$23054870$6$F$20230101$20240717$20231011$20240725$PER$$US-SA-2023SA303737$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240725$$MD$US$US
230548742$23054874$2$F$$20240903$20231011$20240909$EXP$$US-BEH-2023164125$CSL BEHRING$$$$A$M$Y$$$20240909$$MD$US$US
230550112$23055011$2$F$20231006$20240916$20231011$20240918$PER$$US-AMGEN-USASP2023179509$AMGEN$$81$YR$E$F$Y$$$20240918$$CN$US$US
230550409$23055040$9$F$20230917$20240923$20231011$20240927$EXP$$US-INCYTE CORPORATION-2023IN010280$INCYTE$$$$$$Y$$$20240927$$MD$US$US
230550512$23055051$2$F$$20230703$20231011$20240912$PER$$NVSC2023US219356$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
230550653$23055065$3$F$$20240816$20231011$20240906$PER$$US-INCYTE CORPORATION-2023IN009538$INCYTE$$$$$$Y$$$20240906$$CN$US$US
230550744$23055074$4$F$20230101$20240703$20231011$20240709$EXP$$NL-ABBVIE-4309853$ABBVIE$$$$$M$Y$$$20240709$$CN$NL$NL
230550797$23055079$7$F$20230901$20240717$20231011$20240725$EXP$$CA-UCBSA-2023029613$UCB$$27$YR$$F$Y$$$20240725$$CN$CA$CA
230551626$23055162$6$F$20230206$20240819$20231011$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-142289$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$61$KG$20240829$$PH$JP$JP
230552563$23055256$3$F$20220815$20240716$20231011$20240718$EXP$$DE-SANDOZ INC.-NVSC2023DE098017$SANDOZ$$$$A$M$Y$$$20240718$$MD$DE$DE
230552722$23055272$2$F$20240101$20240715$20231011$20240723$PER$$US-SA-2023SA302158$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240723$$MD$US$US
230553064$23055306$4$F$20231005$20240715$20231011$20240719$EXP$$NL-ABBVIE-5445151$ABBVIE$$$$A$M$Y$$$20240719$$CN$NL$NL
230553802$23055380$2$F$$20240703$20231011$20240710$EXP$$US-OTSUKA-2023_026066$OTSUKA$$$$$F$Y$$$20240710$$CN$US$US
230553883$23055388$3$F$20190415$20240723$20231011$20240726$EXP$$CA-TAKEDA-2019TUS021808$TAKEDA$$51$YR$$F$Y$$$20240726$$MD$CA$CA
230554542$23055454$2$F$20221219$20240703$20231011$20240712$EXP$$JP-JNJFOC-20230101402$JOHNSON AND JOHNSON$$36$YR$A$M$Y$118.8$KG$20240712$$PH$JP$JP
230554846$23055484$6$F$20230829$20240625$20231011$20240703$EXP$$CA-OTSUKA-2023_026277$OTSUKA$$74$YR$$M$Y$$$20240703$$MD$CA$CA
230555652$23055565$2$F$$20240816$20231011$20240828$PER$$US-INCYTE CORPORATION-2023IN009672$INCYTE$$$$$$Y$$$20240828$$CN$US$US
230556553$23055655$3$F$20230101$20240904$20231011$20240909$EXP$$US-BAUSCH-BL-2023-014926$BAUSCH AND LOMB$$36$YR$$F$Y$$$20240909$$CN$US$US
230557242$23055724$2$F$20230202$20240618$20231011$20240703$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-411639$RANBAXY$$49$YR$$M$Y$$$20240703$$MD$FR$FR
230557272$23055727$2$F$20230101$20240617$20231011$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-411908$RANBAXY$$50$YR$$F$Y$$$20240702$$PH$FR$FR
230557873$23055787$3$F$$20231030$20231011$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411896$RANBAXY$$$$T$$Y$$$20240702$$MD$US$US
230558235$23055823$5$F$20230905$20240704$20231011$20240709$EXP$$AE-AstraZeneca-2023A227262$ASTRAZENECA$$72$YR$$F$Y$109$KG$20240709$$MD$AE$
230558647$23055864$7$F$$20240724$20231011$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-144483$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$112.04$KG$20240812$$CN$US$US
230559163$23055916$3$F$20230101$20240828$20231011$20240905$PER$$US-JNJFOC-20231024018$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240905$$CN$US$US
230560082$23056008$2$F$$20240816$20231011$20240826$PER$$US-INCYTE CORPORATION-2023IN009841$INCYTE$$$$$$Y$$$20240826$$CN$US$US
230560532$23056053$2$F$$20240806$20231011$20240808$EXP$$US-SANDOZ INC.-SDZ2023US040926$SANDOZ$$$$$F$Y$$$20240808$$CN$US$US
230561575$23056157$5$F$20230101$20240829$20231011$20240904$EXP$$HR-MYLANLABS-2023M1105584$MYLAN$$63$YR$$M$Y$$$20240904$$MD$HR$HR
230561653$23056165$3$F$$20240628$20231011$20240702$30DAY$$US-SANDOZ INC.-SDZ2023US010866$SANDOZ$$$$$F$Y$$$20240702$$CN$US$US
230562133$23056213$3$F$20230801$20240722$20231011$20240723$PER$$US-Eisai-EC-2023-146753$EISAI$$61$YR$A$F$Y$$$20240723$$CN$US$US
230562253$23056225$3$F$20230911$20240627$20231011$20240703$EXP$FR-AFSSAPS-TS2023001217$FR-MYLANLABS-2023M1105519$MYLAN$$65$YR$$M$Y$67$KG$20240703$$MD$FR$FR
230562973$23056297$3$F$$20240709$20231011$20240718$PER$$US-SA-2023SA303910$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240718$$MD$US$US
230564603$23056460$3$F$$20240705$20231011$20240711$EXP$$DE-TAKEDA-2020TUS051281$TAKEDA$$$$$F$Y$$$20240711$$HP$DE$DE
230565215$23056521$5$F$20230101$20240815$20231011$20240828$PER$$US-SA-2023SA308105$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240828$$MD$US$US
230566954$23056695$4$F$20240523$20240710$20231012$20240717$EXP$$US-ABBVIE-5440864$ABBVIE$$79$YR$$F$Y$97.068$KG$20240717$$CN$US$US
230567174$23056717$4$F$20230701$20240916$20231012$20240921$EXP$$US-ABBVIE-5444448$ABBVIE$$62$YR$$F$Y$$$20240921$$CN$US$US
230567356$23056735$6$F$20230921$20240917$20231012$20240925$EXP$$JP-EMD Serono-2023479845$EMD SERONO INC$$63$YR$A$M$Y$57$KG$20240925$$MD$JP$JP
230567398$23056739$8$F$$20240920$20231012$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-144600$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240927$$MD$JP$JP
230567975$23056797$5$F$20240102$20240920$20231012$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-145157$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240923$$CN$US$US
230569532$23056953$2$F$20200907$20240625$20231012$20240701$EXP$$DE-ABBVIE-5445579$ABBVIE$$28$YR$$F$Y$54$KG$20240701$$MD$DE$DE
230569582$23056958$2$F$20230914$20240624$20231012$20240704$EXP$$NL-DENTSPLY-2023SCDP000339$DENTSPLY$$94$YR$$F$Y$$$20240704$$MD$NL$NL
230570646$23057064$6$F$20240101$20240826$20231012$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-020134$JAZZ$$$$$F$Y$$$20240828$$CN$US$US
230571682$23057168$2$F$20230801$20240903$20231012$20240925$PER$$US-SA-2023SA306993$SANOFI AVENTIS$$53$YR$A$F$Y$76.65$KG$20240925$$MD$US$US
230572073$23057207$3$F$$20231222$20231012$20240905$PER$$NVSC2023US219702$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
230572123$23057212$3$F$20220101$20240912$20231012$20240915$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-011950$JAZZ$$$$$F$Y$$$20240915$$MD$US$US
230572712$23057271$2$F$20230101$20240911$20231012$20240918$EXP$$US-AMGEN-USASP2023177637$AMGEN$$61$YR$A$F$Y$$$20240918$$CN$US$US
230572953$23057295$3$F$20220501$20240828$20231012$20240904$EXP$$DE-ABBVIE-5442017$ABBVIE$$$$A$F$Y$$$20240904$$CN$DE$DE
230573104$23057310$4$F$20230101$20240802$20231012$20240808$PER$$US-AMGEN-USASP2023180219$AMGEN$$66$YR$E$M$Y$$$20240807$$HP$US$US
230573723$23057372$3$F$$20231002$20231012$20240715$EXP$$US-NOVOPROD-1124461$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
230574292$23057429$2$F$20221001$20240715$20231012$20240726$PER$$US-009507513-2309USA007858$MERCK$$58$YR$$M$Y$$$20240726$$CN$US$US
230574405$23057440$5$F$20230908$20240909$20231012$20240916$EXP$$US-GSK-US2023135700$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$US$US
230574563$23057456$3$F$20230801$20240730$20231012$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-020742$JAZZ$$21$YR$$M$Y$$$20240808$$CN$US$US
230575112$23057511$2$F$20220201$20240826$20231012$20240916$PER$$US-SA-2023SA306824$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240916$$MD$US$US
230575723$23057572$3$F$20240701$20240709$20231012$20240717$EXP$$CA-JNJFOC-20230954175$JOHNSON AND JOHNSON$$46$YR$A$F$Y$116$KG$20240717$$HP$CA$CA
230576132$23057613$2$F$20221216$20240808$20231012$20240814$EXP$$JP-009507513-2310JPN001288J$MERCK$$74$YR$$M$Y$$$20240814$$MD$JP$JP
230576324$23057632$4$F$20221101$20240827$20231012$20240903$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007271$JAZZ$$49$YR$$F$Y$$$20240903$$HP$US$US
230576338$23057633$8$F$$20240823$20231012$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-144585$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240830$$MD$JP$JP
230578597$23057859$7$F$20240513$20240620$20231012$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004460$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240712$$CN$US$US
230578687$23057868$7$F$20240701$20240821$20231012$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-143980$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$57.61$KG$20240822$$HP$US$US
230579062$23057906$2$F$20230901$20240621$20231012$20240702$PER$$US-SA-2023SA305460$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240702$$MD$US$US
230579182$23057918$2$F$$20240812$20231012$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08687$LUPIN$$$$$$Y$$$20240831$$CN$US$US
230579244$23057924$4$F$20230815$20240823$20231012$20240911$PER$$CA-TOLMAR, INC.-23CA043572$TOLMAR$$86$YR$$M$Y$$$20240911$$CN$CA$CA
230579544$23057954$4$F$$20240902$20231012$20240906$EXP$$FR-SANDOZ INC.-PHHY2012FR136303$SANDOZ$$56$YR$$M$Y$$$20240906$$HP$FR$FR
230579843$23057984$3$F$20221001$20240805$20231012$20240808$EXP$$NVSC2022AE259983$NOVARTIS$$31$YR$$F$Y$$$20240808$$CN$AE$AE
230579927$23057992$7$F$20230822$20240912$20231012$20240920$EXP$$AU-TAKEDA-2023TUS098083$TAKEDA$$66$YR$$F$Y$38$KG$20240920$$CN$AU$AU
230579962$23057996$2$F$$20240822$20231012$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202310005826$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240826$$CN$US$US
230580544$23058054$4$F$20230929$20240709$20231012$20240715$EXP$$CA-JNJFOC-20230803915$JOHNSON AND JOHNSON$$75$YR$E$M$Y$76$KG$20240715$$CN$CA$CA
230581763$23058176$3$F$$20240711$20231012$20240718$30DAY$$US-GSK-US2023135009$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
230582197$23058219$7$F$$20240809$20231012$20240817$PER$$US-SA-2023SA308455$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240817$$PH$US$US
230583554$23058355$4$F$20230101$20240909$20231012$20240911$PER$$US-PFIZER INC-PV202300167798$PFIZER$$53$YR$$M$Y$$$20240911$$HP$US$US
230585243$23058524$3$F$$20240828$20231012$20240903$EXP$$US-INCYTE CORPORATION-2023IN010580$INCYTE$$$$$$Y$$$20240903$$CN$US$US
230585392$23058539$2$F$$20240830$20231012$20240904$EXP$$NVSC2023US219303$NOVARTIS$$$$$M$Y$$$20240904$$CN$US$US
230585942$23058594$2$F$20231003$20240708$20231012$20240716$PER$$US-SA-2023SA305812$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240716$$MD$US$US
230586657$23058665$7$F$20231002$20240822$20231012$20240831$EXP$$US-GSK-US2023AMR137228$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240831$$CN$US$US
230586982$23058698$2$F$$20240703$20231012$20240709$EXP$$US-MYLANLABS-2023M1106557$MYLAN$Chajkowski A, Rodriguez CA, Qaiser S, Yosry N, Adelizzi A. CLOSTRIDIUM DIFFICILE BACTEREMIA: GOING BEYOND THE GUT. Chest 2023;164(4):A2548-A2549 (plus poster).$71$YR$$M$Y$$$20240709$$HP$US$US
230587134$23058713$4$F$20221201$20240919$20231012$20240925$EXP$$NVSC2022CR298911$NOVARTIS$$44$YR$$F$Y$$$20240925$$CN$CR$CR
230587264$23058726$4$F$$20240905$20231012$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-144864$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240906$$CN$US$US
230587873$23058787$3$F$20231003$20240911$20231012$20240913$PER$$US-PFIZER INC-202300320754$PFIZER$$72$YR$$F$Y$54.422$KG$20240913$$CN$US$US
230589072$23058907$2$F$20231008$20240819$20231012$20240822$PER$$US-PFIZER INC-PV202300168051$PFIZER$$62$YR$$F$Y$$$20240822$$HP$US$US
230589265$23058926$5$F$$20240903$20231012$20240905$PER$$US-PFIZER INC-PV202300025982$PFIZER$$70$YR$$F$Y$$$20240905$$CN$US$US
230589857$23058985$7$F$20190213$20240822$20231012$20240828$PER$$US-PFIZER INC-2020467585$PFIZER$$80$YR$$M$Y$$$20240828$$CN$US$US
230589965$23058996$5$F$$20240730$20231012$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-144996$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240731$$HP$US$US
230590576$23059057$6$F$20230907$20240729$20231012$20240805$EXP$$US-GSK-US2023AMR136240$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$US$US
2305912912$23059129$12$F$20220601$20240812$20231012$20240814$EXP$$NVSC2023DE214160$NOVARTIS$$40$YR$$F$Y$72$KG$20240814$$MD$DE$DE
230591763$23059176$3$F$$20240723$20231012$20240725$PER$$US-PFIZER INC-PV202300168097$PFIZER$$67$YR$$F$Y$$$20240725$$CN$US$US
230591882$23059188$2$F$$20240923$20231012$20240924$PER$$US-PFIZER INC-PV202300164743$PFIZER$$62$YR$$F$Y$$$20240924$$CN$US$US
230592652$23059265$2$F$$20240814$20231012$20240819$EXP$$CA-MYLANLABS-2023M1107260$MYLAN$$$$$M$Y$$$20240819$$HP$CA$CA
230592895$23059289$5$F$20230501$20240913$20231012$20240919$EXP$$JP-TAKEDA-2023TUS097691$TAKEDA$$78$YR$$F$Y$42.1$KG$20240919$$MD$JP$JP
230592994$23059299$4$F$20230101$20240906$20231012$20240910$PER$$US-BIOGEN-2023BI01198641$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
230593204$23059320$4$F$$20240725$20231012$20240802$EXP$$AT-EXELIXIS-CABO-23069182$EXELIXIS$$$$$M$Y$$$20240802$$MD$AT$AT
230593744$23059374$4$F$20230801$20240727$20231012$20240801$PER$$US-SA-2023SA307640$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240801$$MD$US$US
230594072$23059407$2$F$$20240820$20231012$20240827$EXP$$PT-MYLANLABS-2023M1106792$MYLAN$Vaz Rodrigues L, Roriz D, Salgado-Seixas F, Marinho S, Ferreira PR. A nephrogenic mechanism underlies dexmedetomidine-induced polyuria. A case report. Rev Esp Anestesiol Reanim (Engl Ed). 2024;71(4):332-338$38$YR$$M$Y$98$KG$20240827$$HP$PT$PT
230594792$23059479$2$F$$20231006$20231012$20240925$PER$$US-GSK-US2023AMR139326$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
230595026$23059502$6$F$$20240903$20231012$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-145228$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240904$$CN$US$US
230597174$23059717$4$F$$20240702$20231012$20240711$EXP$$US-TAKEDA-2023TUS097956$TAKEDA$$$$$M$Y$$$20240711$$CN$US$US
230597193$23059719$3$F$$20240823$20231012$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-020716$JAZZ$$$$$M$Y$$$20240828$$CN$US$US
230599213$23059921$3$F$$20240905$20231012$20240909$EXP$$NVSC2023US220351$NOVARTIS$$$$$F$Y$$$20240909$$MD$US$US
230600445$23060044$5$F$$20240823$20231012$20240827$EXP$$NVSC2023US219083$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
230601473$23060147$3$F$$20240628$20231012$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-143242$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240705$$HP$US$US
230602305$23060230$5$F$$20240805$20231012$20240808$EXP$$US-TAKEDA-2022TUS034969$TAKEDA$$$$$F$Y$$$20240808$$CN$US$US
230603059$23060305$9$F$$20240823$20231012$20240830$EXP$$NVSC2023US218361$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
230604863$23060486$3$F$20230828$20240711$20231012$20240718$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-027176$JAZZ$$49$YR$$F$Y$$$20240718$$CN$US$US
230606573$23060657$3$F$20221101$20240711$20231012$20240717$EXP$$PT-PFIZER INC-202300315557$PFIZER$$65$YR$$M$Y$87$KG$20240717$$MD$PT$PT
230606844$23060684$4$F$$20240910$20231012$20240912$EXP$$CH-PFIZER INC-PV202300155833$PFIZER$$$$A$F$Y$55$KG$20240912$$CN$CH$CH
230606962$23060696$2$F$$20240903$20231012$20240912$EXP$FR-EMA-20150318-AUTODUP-410940$FR-ROCHE-3434514$ROCHE$Robert T, Leterrier M, Cassagnau E, Pape P, Danner-Boucher I. Phaeohyphomycosis due to Alternaria infectoria: A single-center experience with utility of PCR for diagnosis and species identification.. Medical Mycology. 2012;50:594-600.$56$YR$A$M$Y$$$20240912$$HP$FR$FR
230607164$23060716$4$F$$20240701$20231012$20240710$EXP$$US-TEVA-2023-US-2933026$TEVA$Gooley B, Wilkinson J. Amifampridine overdose leading to refractory status epilepticus. Clin-Toxicol-(Phila) 2023;61 (Suppl. 2):95 abstr. 196.; Gooley B, Wilkinson J. Amifampridine overdose leading to refractory status epilepticus. Clin-Toxicol-(Phila) 2023; 61 (Suppl.) 95.; Gooley B, Wilkinson J. Amifampridine overdose leading to refractory status epilepticus. Clin-Toxicol-(Phila) 2023;61 (Suppl. 2):95 abstr. 196.$67$YR$$M$Y$$$20240710$$HP$US$US
230607464$23060746$4$F$$20240821$20231012$20240822$EXP$$CA-SANDOZ INC.-SDZ2023CA017050$SANDOZ$$$$$F$Y$$$20240822$$CN$CA$CA
230607504$23060750$4$F$$20240709$20231012$20240711$EXP$$CA-SANDOZ INC.-SDZ2023CA040829$SANDOZ$$70$YR$$F$Y$97$KG$20240711$$CN$CA$CA
230608082$23060808$2$F$20130301$20240801$20231012$20240816$EXP$$DE-SANDOZ INC.-PHHY2019DE104459$SANDOZ$$58$YR$$F$Y$102$KG$20240816$$MD$DE$DE
230608845$23060884$5$F$$20240828$20231012$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-143908$BRISTOL MYERS SQUIBB$Manabe O, Jinnouchi H, Aikawa T, Shirai K, Oyama-Manabe N. Ischaemia in the right ventricle and left ventricle, and rheumatoid myalgia incidentally found in a lung cancer patient treated with immune checkpoint inhibitors: a case report with 18F-fluorodeoxyglucose-positron emission tomography/computed tomography imaging. European Heart Journal Cardiovascular Imaging. 2024 Jan 01;25(1):e58. doi:10.1093/ehjci/jead244.$$$E$F$Y$$$20240905$$MD$JP$JP
230609267$23060926$7$F$20230101$20240913$20231012$20240921$EXP$$CA-CELLTRION INC.-2023CA012279$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
230609435$23060943$5$F$$20240904$20231012$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004177$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
230609519$23060951$9$F$20230917$20240823$20231012$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004216$ACADIA PHARMACEUTICALS$$17$YR$$F$Y$$$20240916$$CN$US$US
230609912$23060991$2$F$$20240827$20231013$20240906$EXP$JP-MLMSERVICE-20230925-4563746-1$JP-STRIDES ARCOLAB LIMITED-2023SP015228$STRIDES$Ariga M, Hagita J, Soda M, Oida Y, Teramachi H, Kitaichi K.. Daily dose of metformin caused acute kidney injury with lactic acidosis: a case report.. Journal of Medical Case Reports. 2023;17(1):393$60$YR$$M$Y$69.3$KG$20240906$$PH$JP$JP
230610385$23061038$5$F$20231221$20240315$20231013$20240925$PER$$US-GSK-US2023AMR137915$GLAXOSMITHKLINE$$79$YR$$F$Y$$$20240925$$CN$US$US
230610515$23061051$5$F$20231001$20231121$20231013$20240925$PER$$US-GSK-US2023AMR139745$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
230610576$23061057$6$F$20230915$20240612$20231013$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004243$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240705$$CN$US$US
230610984$23061098$4$F$20240101$20240909$20231013$20240912$EXP$$NVSC2023GB062918$NOVARTIS$$$$$M$Y$$$20240912$$CN$GB$GB
230611145$23061114$5$F$20230901$20240825$20231013$20240913$PER$$CA-TOLMAR, INC.-23CA043624$TOLMAR$$71$YR$$M$Y$102.04$KG$20240913$$CN$CA$CA
230611214$23061121$4$F$20230926$20240829$20231013$20240923$PER$$CA-TOLMAR, INC.-23CA043646$TOLMAR$$62$YR$$M$Y$$$20240923$$CN$CA$CA
230611676$23061167$6$F$$20240730$20231013$20240806$EXP$$AR-GSK-AR2023AMR138397$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$AR$AR
230611862$23061186$2$F$20230811$20240813$20231013$20240819$EXP$FR-AFSSAPS-PO2023000997$FR-ABBVIE-5442348$ABBVIE$$76$YR$$F$Y$50$KG$20240819$$PH$FR$FR
230612112$23061211$2$F$20230916$20240913$20231013$20240927$PER$$CO-TOLMAR, INC.-23CO043653$TOLMAR$$8$YR$$F$Y$$$20240927$$CN$CO$CO
230612132$23061213$2$F$$20240822$20231013$20240911$PER$$CA-TOLMAR, INC.-23CA043587$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
230613753$23061375$3$F$20230919$20240729$20231013$20240801$EXP$$DE-JNJFOC-20231023954$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240801$$HP$DE$DE
230614815$23061481$5$F$$20240817$20231013$20240829$EXP$$FR-AUROBINDO-AUR-APL-2023-062887$AUROBINDO$Naim G, Malissin I, Megarbane B. Cerebral microbleeds in the poisoned patient - an observational magnetic resonance imaging study.. Basic Clin Pharmacol Toxicol. 2023;133:770-777.$72$YR$$F$Y$$$20240829$$MD$FR$FR
2306155412$23061554$12$F$20230926$20240711$20231013$20240802$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004049$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240802$$CN$US$US
230616533$23061653$3$F$20210201$20240801$20231013$20240810$PER$$US-SA-2023SA307943$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240810$$MD$US$US
230616546$23061654$6$F$20230101$20240705$20231013$20240712$EXP$$US-SA-2023SA309704$SANOFI AVENTIS$$82$YR$E$M$Y$87.528$KG$20240712$$MD$US$US
230616593$23061659$3$F$20230101$20240903$20231013$20240910$EXP$$CA-GSK-CA2023AMR098040$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$HP$CA$CA
230617082$23061708$2$F$20220501$20240710$20231013$20240715$EXP$$JP-009507513-2307JPN003514J$MERCK$Yanagisawa S, Ihara D, Kamihara H, Takahashi H, Onari Y. KT-32 A case of Sarcoidosis-like reaction during administration of pembrolizumab for recurrent bladder cancer and renal pelvis cancer. The 68th Chugoku-Shikoku Regional Meeting of the Japanese Respiratory Society. 79$73$YR$$M$Y$$$20240715$$MD$JP$JP
230617615$23061761$5$F$$20240628$20231013$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-145936$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$85.28$KG$20240701$$CN$US$US
230618056$23061805$6$F$20231001$20240628$20231013$20240703$EXP$$CO-JNJFOC-20231026066$JOHNSON AND JOHNSON$$58$YR$A$F$Y$61$KG$20240703$$HP$CO$CO
230620072$23062007$2$F$$20240826$20231013$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08755$LUPIN$$$$$$Y$$$20240910$$CN$US$US
230620364$23062036$4$F$20200301$20240701$20231013$20240702$EXP$$US-TAKEDA-2023TUS098478$TAKEDA$$53$YR$$M$Y$$$20240702$$CN$US$US
230620452$23062045$2$F$$20240626$20231013$20240704$EXP$$CA-CELLTRION INC.-2023CA019318$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
230621102$23062110$2$F$20210101$20240919$20231013$20240930$PER$$US-SA-2023SA311662$SANOFI AVENTIS$$$$A$M$Y$102$KG$20240930$$MD$US$US
230624078$23062407$8$F$20231016$20240711$20231013$20240718$EXP$$US-BEH-2023164052$CSL BEHRING$$24$YR$A$F$Y$$$20240718$$HP$US$US
230624355$23062435$5$F$$20240628$20231013$20240701$PER$$US-PFIZER INC-PV202300165536$PFIZER$$68$YR$$F$Y$73.48$KG$20240701$$HP$US$US
230624967$23062496$7$F$20220827$20240822$20231013$20240829$EXP$$NVSC2022GB201634$NOVARTIS$$53$YR$$M$Y$$$20240829$$CN$GB$GB
230625146$23062514$6$F$$20240724$20231013$20240729$EXP$$US-TAKEDA-2023TUS098198$TAKEDA$$$$$M$Y$93$KG$20240729$$CN$US$US
230626247$23062624$7$F$20210123$20240722$20231013$20240730$EXP$$CA-ROCHE-2757182$ROCHE$$56$YR$A$F$Y$48.3$KG$20240730$$CN$CA$CA
230626372$23062637$2$F$$20240703$20231013$20240716$EXP$$US-STERISCIENCE B.V.-2023-ST-002020$Steriscience PTE$Chajkowski A, Rodriguez CA, Qaiser S, Yosry N, Adelizzi A. CLOSTRIDIUM DIFFICILE BACTEREMIA: GOING BEYOND THE GUT.. Chest. 2023;164 (Suppl.)(4):A2548-A2549$71$YR$$M$Y$$$20240716$$HP$US$US
230626704$23062670$4$F$20240301$20240910$20231013$20240913$EXP$$NVSC2023US220122$NOVARTIS$$42$YR$$F$Y$$$20240913$$CN$US$US
230627103$23062710$3$F$$20240726$20231013$20240807$EXP$$RO-ROCHE-3434534$ROCHE$$67$YR$E$M$Y$85$KG$20240807$$MD$RO$RO
230627283$23062728$3$F$$20240626$20231013$20240711$PER$$US-PHARMING-PHAUS2023000758$PHARMING GROUP$$$$$$Y$$$20240711$$CN$US$US
230627544$23062754$4$F$20240812$20240826$20231013$20240904$EXP$$US-SA-2023SA309881$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240904$$CN$US$US
230627644$23062764$4$F$$20240809$20231013$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-144479$BRISTOL MYERS SQUIBB$$75$YR$E$$Y$$$20240815$$MD$JP$JP
230627762$23062776$2$F$20230101$20240814$20231013$20240827$PER$$US-SA-2023SA306241$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240828$$MD$US$US
2306278415$23062784$15$F$20231101$20240912$20231013$20240920$EXP$$US-TAKEDA-2023TUS097874$TAKEDA$$46$YR$$F$Y$$$20240920$$MD$US$US
230627954$23062795$4$F$20230101$20240712$20231013$20240724$EXP$$US-INSMED-2023-02071-USAA$INSMED$$$$$M$Y$$$20240724$$CN$US$US
230628157$23062815$7$F$20230903$20240815$20231013$20240816$EXP$$ES-TAKEDA-2023TUS098436$TAKEDA$$4$YR$$M$Y$$$20240816$$HP$ES$ES
230630355$23063035$5$F$20230901$20240716$20231013$20240723$EXP$$NVSC2023FR217888$NOVARTIS$$$$A$F$Y$45$KG$20240723$$MD$FR$FR
230630632$23063063$2$F$$20240723$20231013$20240803$EXP$CA-MHPD-001056363$CA-Accord-383202$ACCORD$$54$YR$A$M$Y$$$20240802$$MD$CA$CA
230632694$23063269$4$F$$20240903$20231013$20240905$EXP$$CA-SANDOZ INC.-NVSC2021CA178134$SANDOZ$$58$YR$$F$Y$$$20240905$$HP$CA$CA
230633063$23063306$3$F$$20240803$20231013$20240807$EXP$$US-ABBVIE-5441576$ABBVIE$$$$$M$Y$71$KG$20240807$$CN$US$US
230633773$23063377$3$F$$20240710$20231013$20240717$EXP$$US-GSK-US2023136341$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$US$US
230634073$23063407$3$F$20140101$20240916$20231013$20240920$EXP$$US-OTSUKA-2023_026221$OTSUKA$$23$YR$$F$Y$80$KG$20240920$$HP$US$US
230634336$23063433$6$F$20230821$20240918$20231013$20240924$EXP$$AU-TAKEDA-2023TUS097570$TAKEDA$$33$YR$$M$Y$$$20240924$$CN$AU$AU
230634692$23063469$2$F$$20231003$20231013$20240711$PER$$US-PFM-2023-04657$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.599$KG$20240711$$CN$US$US
230638438$23063843$8$F$$20240725$20231013$20240802$EXP$$CA-APOTEX-2023AP015150$APOTEX$$62$YR$$M$Y$$$20240802$$HP$CA$CA
230640093$23064009$3$F$$20240731$20231013$20240806$EXP$$CA-OTSUKA-2023_026699$OTSUKA$$$$$M$Y$$$20240806$$HP$CA$CA
230640102$23064010$2$F$$20240827$20231013$20240904$EXP$$JP-AstraZeneca-2023A218888$ASTRAZENECA$$71$YR$$F$Y$$$20240904$$MD$JP$
230641584$23064158$4$F$20240705$20240910$20231013$20240913$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266508$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240913$$CN$US$US
230641754$23064175$4$F$$20240624$20231013$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-145498$BRISTOL MYERS SQUIBB$Moku R, Ariga S, Oohara Y, Honma R, Noguti T, Taguti J et al. A case of repeated remission and aggravation of skin metastasis and enterocolitis during nivolumab + ipilimumab therapy in a patient with malignant melanoma. The 295th Hokkaido Regional Meeting of the Japanese Society of Internal Medicine. 2022;41.$70$YR$E$M$Y$67$KG$20240701$$MD$JP$JP
230642182$23064218$2$F$20230930$20240829$20231013$20240904$EXP$$SG-AstraZeneca-2023A231851$ASTRAZENECA$$29511$DY$$$Y$$$20240904$$CN$SG$
230642293$23064229$3$F$20090519$20240704$20231013$20240709$EXP$$DE-MYLANLABS-2023M1107067$MYLAN$$78$YR$$M$Y$64$KG$20240709$$MD$DE$DE
230642854$23064285$4$F$20230708$20240711$20231013$20240717$EXP$$JP-ARGENX-2023-ARGX-JP003490$ARGENX BVBA$$$$$$Y$$$20240717$$PH$JP$JP
230644919$23064491$9$F$20230828$20240716$20231013$20240720$EXP$$CA-TAKEDA-2023TUS097710$TAKEDA$$43$YR$$F$Y$$$20240720$$CN$CA$CA
2306449816$23064498$16$F$20230606$20240625$20231013$20240729$EXP$$US-ROCHE-3391878$ROCHE$$36$YR$A$F$Y$113.85$KG$20240729$$CN$US$US
230645962$23064596$2$F$20221001$20240723$20231013$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-010937$JAZZ$$55$YR$$F$Y$$$20240730$$CN$US$US
230646072$23064607$2$F$$20240618$20231013$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-412048$RANBAXY$$$$$M$Y$$$20240703$$PH$GB$GB
230646262$23064626$2$F$20230609$20240627$20231013$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-412316$RANBAXY$$29$YR$$F$Y$86$KG$20240712$$MD$FR$FR
230646732$23064673$2$F$$20240807$20231013$20240822$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-412226$RANBAXY$Genzor S, Prasko J, Mizera J, Kufa J, Zurkova M, Jakubec P, et al. Sex transition from female to male as a risk factor for sleep-disordered breathing. Sleep Med. 2023;102:180-185$33$YR$$M$Y$$$20240822$$HP$CZ$CZ
230647014$23064701$4$F$20231001$20240802$20231013$20240811$EXP$$CA-JNJFOC-20231026850$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240812$$CN$CA$CA
230649212$23064921$2$F$20230101$20240910$20231013$20240916$EXP$$US-PFIZER INC-202300318462$PFIZER$$57$YR$$F$Y$58.06$KG$20240916$$HP$US$US
230649294$23064929$4$F$$20240822$20231013$20240828$PER$$US-PFIZER INC-2020218209$PFIZER$$58$YR$$F$Y$88.45$KG$20240828$$CN$US$US
230649664$23064966$4$F$20231002$20231025$20231013$20240729$EXP$$NVSC2023FR216405$NOVARTIS$$$$E$M$Y$59$KG$20240729$$MD$MC$FR
230649879$23064987$9$F$20230921$20240723$20231013$20240801$EXP$$NVSC2023GB207336$NOVARTIS$$56$YR$$F$Y$$$20240801$$CN$GB$GB
230650898$23065089$8$F$20240501$20240909$20231013$20240912$PER$$US-PFIZER INC-202300319801$PFIZER$$35$YR$$F$Y$106.14$KG$20240912$$HP$US$US
230651803$23065180$3$F$$20240716$20231013$20240722$EXP$$US-BAUSCH-BL-2023-015147$BAUSCH AND LOMB$Paige A, Mirza N, Rayad M, Miller R. Metformin-induced lactic acidosis complicated by acute liver failure. Chest. 2023 OCT;164(4)SUPPLEMENT:1875A. doi:10.1016/j.chest.2023.07.1294$63$YR$$F$Y$$$20240722$$HP$US$US
230652153$23065215$3$F$$20240819$20231013$20240829$EXP$$CA-CIPHER-2023-CA-000443$CIPHER$$65$YR$E$F$Y$34$KG$20240829$$HP$CA$CA
230652734$23065273$4$F$20230929$20240903$20231013$20240912$EXP$$JP-Eisai-EC-2023-150261$EISAI$Arata Kobayashi et al.. A case of hemophagocytic syndrome caused by immune checkpoint inhibitor therapy for recurrent uterine cancer. Japanese Journal of Gynecological Oncology The 66th Annual Meeting of the Japanese Society of Gynecologic Oncology. 2024; 42(3): 367-367.$60$YR$A$F$Y$$$20240913$$MD$JP$JP
230653387$23065338$7$F$20230601$20240729$20231013$20240805$EXP$$JP-009507513-2310JPN000869J$MERCK$$68$YR$$M$Y$$$20240805$$MD$JP$JP
230653588$23065358$8$F$20230101$20240712$20231013$20240717$EXP$$US-PFIZER INC-202300322368$PFIZER$$13$YR$$M$Y$31.75$KG$20240717$$CN$US$US
230653687$23065368$7$F$20230920$20240813$20231013$20240815$PER$$US-PFIZER INC-PV202300168045$PFIZER$$81$YR$$F$Y$54.875$KG$20240815$$CN$US$US
230653844$23065384$4$F$$20240710$20231013$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-018985$JAZZ$$$$$F$Y$$$20240717$$HP$US$US
230655623$23065562$3$F$20221201$20240816$20231013$20240829$PER$$US-SA-2023SA306270$SANOFI AVENTIS$$66$YR$E$M$Y$81.179$KG$20240829$$MD$US$US
230655763$23065576$3$F$20201117$20240906$20231013$20240920$EXP$$CA-CELLTRION INC.-2023CA014673$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
230655843$23065584$3$F$20220701$20240710$20231013$20240713$EXP$IT-ROCHE-3439198$IT-ROCHE-3439198$ROCHE$Longo B, Venuti F, Gaviraghi A, Lupia T, Ranzani F, Pepe A, Ponzetta L, Vita D, Allice T, Gregorc V, Frascione P, De Rosa F, Calcagno A and Bonora S Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series. DOI: 10.3390/antibiotics12091460.. Antibiotics 2023 Sep 19;12 (9):1-12.$81$YR$E$$Y$$$20240713$$HP$IT$IT
230655966$23065596$6$F$20231001$20240917$20231014$20240926$EXP$$CA-CELLTRION INC.-2023CA019923$CELLTRION$$$$$$Y$$$20240926$$PH$CA$CA
230656402$23065640$2$F$20230101$20240814$20231014$20240823$EXP$$CA-CELLTRION INC.-2023CA018827$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
230656522$23065652$2$F$20230701$20240811$20231014$20240817$PER$$US-SA-2023SA211343$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240817$$MD$US$US
230657644$23065764$4$F$20230101$20240826$20231014$20240904$EXP$$HR-AUROBINDO-AUR-APL-2023-063041$AUROBINDO$$63$YR$$M$Y$$$20240904$$MD$HR$HR
230657756$23065775$6$F$20230101$20240814$20231014$20240828$PER$$US-SA-2023SA309113$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240828$$MD$US$US
2306579018$23065790$18$F$20231109$20240906$20231014$20240912$EXP$$NVSC2023AU185013$NOVARTIS$$47$YR$$F$Y$$$20240912$$HP$AU$AU
230658425$23065842$5$F$20230101$20240829$20231014$20240920$PER$$US-SA-2023SA307557$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240920$$MD$US$US
230659283$23065928$3$F$20231003$20240712$20231014$20240718$EXP$$US-GSK-US2023137022$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$US$US
230659442$23065944$2$F$20230811$20240813$20231014$20240822$EXP$$FR-AUROBINDO-AUR-APL-2023-063149$AUROBINDO$$76$YR$$F$Y$50$KG$20240822$$PH$FR$FR
230659522$23065952$2$F$$20240723$20231014$20240729$EXP$$JP-AMGEN-JPNSP2023181220$AMGEN$Abematsu T.; Nishikawa T.; Kasabata H. et al.. Blinatumomab maintenance therapy following bone marrow transplantation for an early relapsed pediatric B-cell precursor acute lymphoblastic leukemia. Japanese Journal of Pediatric Hematology/Oncology. 2023;60 (4):311$5$YR$C$M$Y$$$20240729$$HP$JP$JP
230659632$23065963$2$F$$20240823$20231014$20240827$PER$$NVSC2023US220276$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
230659723$23065972$3$F$$20240725$20231014$20240730$PER$$NVSC2023US220280$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
230660063$23066006$3$F$20231001$20240718$20231014$20240725$PER$$US-SA-2023SA312609$SANOFI AVENTIS$$90$YR$E$F$Y$$$20240725$$MD$US$US
230660752$23066075$2$F$$20240819$20231014$20240903$EXP$$CA-CIPHER-2023-CA-000444$CIPHER$$43$YR$A$F$Y$97$KG$20240903$$HP$CA$CA
230661646$23066164$6$F$$20240702$20231014$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202310006663$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240705$$MD$US$US
230664293$23066429$3$F$20190501$20240826$20231015$20240918$PER$$US-SA-2023SA307987$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240918$$MD$US$US
230664303$23066430$3$F$$20240919$20231015$20240926$PER$$US-SA-2023SA308061$SANOFI AVENTIS$$60$YR$A$F$Y$64.86$KG$20240926$$MD$US$US
230664587$23066458$7$F$$20240827$20231015$20240903$EXP$$NVSC2023AR221535$NOVARTIS$$$$$F$Y$$$20240903$$CN$AR$AR
230665352$23066535$2$F$20230101$20240722$20231015$20240731$PER$$US-SA-2023SA307880$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240731$$MD$US$US
230665452$23066545$2$F$20231001$20240910$20231015$20240911$EXP$$US-TAKEDA-2023TUS098879$TAKEDA$$91$YR$$F$Y$$$20240911$$CN$US$US
230665903$23066590$3$F$20230911$20240809$20231015$20240813$EXP$$US-ABBVIE-5447203$ABBVIE$$74$YR$$F$Y$$$20240813$$CN$US$US
230666194$23066619$4$F$20211130$20240820$20231016$20240821$EXP$$DE-SANDOZ INC.-NVSC2022DE239855$SANDOZ$$$$E$F$Y$$$20240821$$MD$DE$DE
230666742$23066674$2$F$20230724$20240812$20231016$20240814$EXP$FR-AFSSAPS-AM2023000746$FR-SANDOZ INC.-SDZ2023FR042293$SANDOZ$$78$YR$$M$Y$80$KG$20240814$$MD$FR$FR
230668143$23066814$3$F$20231001$20240702$20231016$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-146426$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$MD$JP$JP
230669085$23066908$5$F$20230929$20240903$20231016$20240909$EXP$$NVSC2023US219342$NOVARTIS$$36$YR$$F$Y$$$20240909$$CN$US$US
230669774$23066977$4$F$20231001$20240731$20231016$20240807$EXP$$JP-009507513-2310JPN001363J$MERCK$$86$YR$$F$Y$$$20240807$$MD$JP$JP
230670022$23067002$2$F$20200430$20231012$20231016$20240923$EXP$$DE-SANDOZ INC.-NVSC2020DE118691$SANDOZ$$49$YR$$F$Y$74.1$KG$20240923$$MD$DE$DE
230671326$23067132$6$F$20230902$20240717$20231016$20240723$EXP$$BG-TAKEDA-2023TUS087969$TAKEDA$$10$YR$$M$Y$$$20240723$$CN$BG$BG
230671388$23067138$8$F$20230920$20240913$20231016$20240923$EXP$$IT-JNJFOC-20231036097$JOHNSON AND JOHNSON$$68$YR$E$F$Y$59$KG$20240923$$MD$IT$IT
230672644$23067264$4$F$20230101$20240725$20231016$20240731$EXP$$US-ABBVIE-5449898$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
2306732911$23067329$11$F$20230922$20240802$20231016$20240808$EXP$$US-GSK-US2023AMR138286$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
230673338$23067333$8$F$20220223$20240415$20231016$20240926$EXP$$US-GSK-US2022AMR034742$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
230674027$23067402$7$F$20231101$20240618$20231016$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004341$ACADIA PHARMACEUTICALS$$11$YR$$F$Y$$$20240712$$CN$US$US
230674115$23067411$5$F$20230101$20240916$20231016$20240924$EXP$$CA-CELLTRION INC.-2023CA008874$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
230676025$23067602$5$F$$20240808$20231016$20240821$EXP$$PL-AUROBINDO-AUR-APL-2023-063183$AUROBINDO$Le?niak K., Behrendt H., Bieda A., Niemczyk S. Severe skeletal damage suggesting neoplastic disease as a picture of tenofovir-induced Fanconi syndrome in chronic hepatitis B. Pol-Arch-inter-Medc. 2023;16571:1897-9483$55$YR$$M$Y$$$20240821$$MD$PL$PL
230676913$23067691$3$F$$20240828$20231016$20240830$EXP$$CA-TAKEDA-2021TUS011522$TAKEDA$$$$$F$Y$$$20240830$$CN$CA$CA
230678484$23067848$4$F$20220101$20240905$20231016$20240912$EXP$$NVSC2023MX221022$NOVARTIS$$$$$F$Y$76$KG$20240912$$CN$MX$MX
230678744$23067874$4$F$20161019$20240918$20231016$20240925$EXP$$CA-TAKEDA-2018TUS032961$TAKEDA$$16$YR$$M$Y$$$20240925$$MD$CA$CA
230678809$23067880$9$F$20231020$20240917$20231016$20240924$EXP$$CA-TAKEDA-2023TUS070265$TAKEDA$$33$YR$$F$Y$$$20240924$$HP$CA$CA
230679272$23067927$2$F$20230915$20240701$20231016$20240711$EXP$IT-MINISAL02-947964$IT-BAXTER-2023BAX032958$BAXTER$$7$YR$$M$Y$32$KG$20240711$$PH$IT$IT
2306802912$23068029$12$F$$20240808$20231016$20240814$EXP$$CA-ROCHE-3334576$ROCHE$$54$YR$A$F$Y$$$20240814$$CN$CA$CA
230680847$23068084$7$F$20231008$20240725$20231016$20240729$EXP$$CA-UCBSA-2022053748$UCB$$35$YR$$F$Y$$$20240729$$CN$CA$CA
230680954$23068095$4$F$20171130$20240729$20231016$20240730$EXP$$CA-SANDOZ INC.-PHHY2017CA179377$SANDOZ$$31$YR$$F$Y$$$20240730$$CN$CA$CA
230682314$23068231$4$F$$20240923$20231016$20240930$EXP$$CA-TAKEDA-2023TUS097504$TAKEDA$$$$$M$Y$$$20240930$$HP$CA$CA
230682623$23068262$3$F$20230101$20240705$20231016$20240715$EXP$$DE-TEVA-2023-DE-2934528$TEVA$$70$YR$$F$Y$$$20240715$$MD$DE$DE
230682674$23068267$4$F$$20240711$20231016$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-145927$BRISTOL MYERS SQUIBB$Shimizu Y, et al. A case of complete response to prednisolone for immune-related cystitis after nivolumab administration. The 88th Annual Meeting of Eastern Section of Japanese Urological Association. 2023;274.$81$YR$E$M$Y$$$20240717$$MD$JP$JP
230683482$23068348$2$F$$20240904$20231016$20240913$30DAY$$US-GSK-US2023140559$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
230685382$23068538$2$F$$20240703$20231016$20240712$EXP$$US-STRIDES ARCOLAB LIMITED-2023SP015503$STRIDES$Chajkowski A, Rodriguez CA, Qaiser S, Yosry N, Adelizzi A.. CLOSTRIDIUM DIFFICILE BACTEREMIA: GOING BEYOND THE GUT.. Chest. 2023;164(suppl 4):A2548-A2549 (plus poster)$71$YR$$M$Y$$$20240712$$HP$US$US
230685784$23068578$4$F$20230921$20240730$20231016$20240808$PER$$US-SA-2023SA306376$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240808$$MD$US$US
230685892$23068589$2$F$$20240822$20231016$20240904$PER$$US-SA-2023SA308773$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240904$$MD$US$US
230686767$23068676$7$F$20230101$20240708$20231016$20240716$PER$$US-SA-2023SA312218$SANOFI AVENTIS$$58$YR$A$F$Y$102$KG$20240716$$MD$US$US
230687163$23068716$3$F$20240801$20240904$20231016$20240930$PER$$US-SA-2023SA310286$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240930$$MD$US$US
230687634$23068763$4$F$20231006$20240918$20231016$20240920$EXP$$GB-MYLANLABS-2023M1107317$MYLAN$$53$YR$$M$Y$$$20240920$$PH$GB$GB
230687653$23068765$3$F$20220204$20240717$20231016$20240722$EXP$$FR-MYLANLABS-2023M1105971$MYLAN$Berangere Arnould, Sebastien Miranda, Francois Mignon, Vincent Camus. G-CSF-induced TIPIC syndrome and large vessel vasculitis. Clin Case Rep. 2023;11(9):1-5$73$YR$$F$Y$$$20240722$$HP$FR$FR
230688176$23068817$6$F$20230101$20240819$20231016$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-146701$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240828$$CN$US$US
2306883410$23068834$10$F$20240301$20240705$20231016$20240711$EXP$$CA-TAKEDA-2023TUS098180$TAKEDA$$36$YR$$M$Y$$$20240711$$HP$CA$CA
230688572$23068857$2$F$$20230818$20231016$20240715$EXP$$HK-ASTELLAS-2023US030713$ASTELLAS$$50$YR$$F$Y$$$20240715$$CN$HK$HK
230689265$23068926$5$F$20231001$20240730$20231016$20240805$EXP$$FR-VERTEX PHARMACEUTICALS-2023-015371$VERTEX$$31$YR$$F$Y$$$20240805$$MD$FR$FR
230689505$23068950$5$F$20240905$20240905$20231016$20240914$EXP$$CA-TAKEDA-2023TUS079352$TAKEDA$$71$YR$$M$Y$$$20240914$$CN$CA$CA
230689989$23068998$9$F$20231001$20240730$20231016$20240816$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000404$THERATECHNOLOGIES$$$$$$Y$$$20240816$$CN$US$US
230689996$23068999$6$F$20231004$20240710$20231016$20240718$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000399$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
230690497$23069049$7$F$20231007$20240810$20231016$20240815$EXP$$IT-TAKEDA-2022TUS068677$TAKEDA$$48$YR$$M$Y$$$20240815$$CN$IT$IT
2306910816$23069108$16$F$20231214$20240802$20231016$20240802$EXP$$CA-PFIZER INC-PV202300163097$PFIZER$$73$YR$$M$Y$75$KG$20240802$$MD$CA$CA
230692912$23069291$2$F$$20240924$20231016$20240926$EXP$$GB-BAYER-2023A141643$BAYER$$$$$F$Y$$$20240926$$MD$GB$GB
2306931411$23069314$11$F$20221201$20240919$20231016$20240923$EXP$$IN-PFIZER INC-PV202300166461$PFIZER$$75$YR$$F$Y$57$KG$20240923$$CN$IN$IN
2306933415$23069334$15$F$20230101$20240823$20231016$20240827$EXP$$CA-PFIZER INC-202300306808$PFIZER$$80$YR$$F$Y$68$KG$20240827$$MD$CA$CA
230693786$23069378$6$F$$20240626$20231016$20240701$EXP$$CA-SANDOZ INC.-NVSC2022CA209785$SANDOZ$$62$YR$$F$Y$$$20240701$$HP$CA$CA
230694133$23069413$3$F$$20240705$20231016$20240708$EXP$$US-PFIZER INC-PV202300166235$PFIZER$$65$YR$$F$Y$$$20240708$$CN$US$US
230694364$23069436$4$F$20230908$20240718$20231016$20240721$EXP$$NVSC2023US221998$NOVARTIS$$56$YR$$F$Y$$$20240721$$CN$US$US
230694925$23069492$5$F$20170101$20240909$20231016$20240925$EXP$$BR-SANDOZ INC.-NVSC2022BR027975$SANDOZ$$$$$M$Y$$$20240925$$CN$BR$BR
230695312$23069531$2$F$20200101$20240909$20231016$20240911$EXP$$US-TAKEDA-2023TUS093894$TAKEDA$$$$$M$Y$$$20240911$$CN$US$US
230695613$23069561$3$F$$20240703$20231016$20240710$EXP$$US-MYLANLABS-2023M1091798$MYLAN$$$$$F$Y$133.3$KG$20240710$$CN$US$US
230696904$23069690$4$F$$20240708$20231016$20240709$EXP$$CA-SANDOZ INC.-NVSC2021CA074900$SANDOZ$$54$YR$$F$Y$$$20240709$$CN$CA$CA
230696973$23069697$3$F$20210101$20240624$20231016$20240703$PER$$US-SA-2023SA309307$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
230698892$23069889$2$F$20190301$20240718$20231016$20240730$PER$$US-SA-2023SA308364$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240730$$MD$US$US
230699163$23069916$3$F$20231201$20240716$20231016$20240722$PER$$US-PFIZER INC-PV202300166583$PFIZER$$44$YR$$F$Y$$$20240722$$HP$US$US
230699353$23069935$3$F$20230827$20240916$20231016$20240926$PER$$US-ALKERMES INC.-ALK-2023-004028$ALKERMES$$23$YR$$F$Y$80$KG$20240926$$HP$US$US
230699515$23069951$5$F$20230301$20240802$20231016$20240808$EXP$$IN-PFIZER INC-PV202300167288$PFIZER$$72$YR$$F$Y$52.8$KG$20240808$$CN$IN$IN
230699824$23069982$4$F$20231011$20240702$20231016$20240710$PER$$US-ALKERMES INC.-ALK-2023-004084$ALKERMES$$57$YR$$F$Y$62.585$KG$20240710$$MD$US$US
230700053$23070005$3$F$20230101$20240730$20231016$20240805$EXP$$CA-PFIZER INC-202300318341$PFIZER$$34$YR$$F$Y$$$20240805$$MD$CA$CA
230700784$23070078$4$F$$20240909$20231016$20240911$EXP$$US-PFIZER INC-PV202300168055$PFIZER$$63$YR$$M$Y$$$20240911$$CN$US$US
230700995$23070099$5$F$$20240920$20231016$20240920$PER$$US-PFIZER INC-202300320576$PFIZER$$72$YR$$F$Y$60.78$KG$20240920$$CN$US$US
230701023$23070102$3$F$$20240628$20231016$20240702$EXP$$AT-PFIZER INC-202300320034$PFIZER$$34$YR$$F$Y$$$20240702$$MD$AT$AT
230701752$23070175$2$F$20230101$20240710$20231016$20240715$EXP$$CA-PFIZER INC-202300311887$PFIZER$$52$YR$$M$Y$48$KG$20240715$$MD$CA$CA
230702925$23070292$5$F$20220101$20240919$20231016$20240925$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-223465$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$70.7$KG$20240925$$CN$US$US
230703124$23070312$4$F$20230101$20240627$20231016$20240701$EXP$$US-KYOWAKIRIN-2023KK016187$KYOWA$$$$$$Y$$$20240701$$HP$US$US
2307041719$23070417$19$F$20240320$20240916$20231016$20240920$EXP$$IN-PFIZER INC-PV202300165926$PFIZER$$50$YR$$F$Y$$$20240920$$CN$IN$IN
230704595$23070459$5$F$$20240805$20231016$20240812$EXP$$CA-OTSUKA-2022_047661$OTSUKA$$$$$F$Y$$$20240812$$HP$CA$CA
230705382$23070538$2$F$20230911$20240705$20231016$20240712$EXP$IT-MINISAL02-947770$IT-PFIZER INC-202300321571$PFIZER$$51$YR$$F$Y$$$20240712$$MD$IT$IT
230707433$23070743$3$F$$20240731$20231016$20240812$EXP$$DE-BAUSCH-BL-2023-015350$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240812$$CN$DE$DE
2307089410$23070894$10$F$$20240909$20231016$20240912$EXP$$CA-BAUSCH-BL-2023-015108$BAUSCH AND LOMB$$78$YR$$F$Y$93$KG$20240912$$CN$CA$CA
230709317$23070931$7$F$20230901$20240903$20231016$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-146890$BRISTOL MYERS SQUIBB$$23$YR$A$F$Y$$$20240904$$HP$US$US
230709603$23070960$3$F$20240518$20240715$20231016$20240718$EXP$$US-PFIZER INC-PV202300169381$PFIZER$$71$YR$$F$Y$$$20240718$$CN$US$US
230710484$23071048$4$F$$20240918$20231016$20240920$PER$$US-PFIZER INC-PV202300168927$PFIZER$$75$YR$$F$Y$$$20240920$$CN$US$US
230711387$23071138$7$F$20231218$20240828$20231016$20240902$EXP$$US-TAKEDA-2022TUS081935$TAKEDA$$39$YR$$M$Y$69$KG$20240902$$HP$US$US
230711503$23071150$3$F$$20240626$20231016$20240701$EXP$$JP-009507513-2310JPN001661J$MERCK$$80$YR$$M$Y$$$20240701$$MD$JP$JP
230711932$23071193$2$F$$20231015$20231016$20240930$EXP$$GB-JNJFOC-20231035918$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240930$$HP$GB$GB
230711959$23071195$9$F$20230101$20240730$20231016$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-145825$BRISTOL MYERS SQUIBB$Yamashige Y, et al. A case of TIF-1 gamma antibody-positive dermatomyositis after nivolumab administration for advanced oesophago-gastric junction carcinoma. The 689th Kanto Regional Meeting of the Japanese Society of Internal Medicine. 2023;97.$65$YR$E$M$Y$$$20240805$$MD$JP$JP
230712306$23071230$6$F$20240201$20240709$20231016$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-146220$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240712$$MD$JP$JP
230712603$23071260$3$F$20221013$20240625$20231016$20240701$EXP$$DE-ABBVIE-5451239$ABBVIE$$59$YR$$M$Y$88$KG$20240701$$MD$DE$DE
2307129011$23071290$11$F$20230101$20240819$20231016$20240827$EXP$$CA-CELLTRION INC.-2023CA000307$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
230713083$23071308$3$F$$20240918$20231016$20240920$EXP$$CA-SANDOZ INC.-SDZ2023CA041809$SANDOZ$$$$A$F$Y$$$20240920$$HP$CA$CA
230716964$23071696$4$F$$20240702$20231017$20240711$PER$$US-SA-2023SA314291$SANOFI AVENTIS$$84$YR$E$F$Y$72$KG$20240711$$MD$US$US
230718522$23071852$2$F$20230101$20240809$20231017$20240820$PER$$US-SA-2023SA312676$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240820$$CN$US$US
230718904$23071890$4$F$20210101$20240828$20231017$20240923$PER$$CA-TOLMAR, INC.-23CA043710$TOLMAR$$$$$M$Y$$$20240923$$CN$CA$CA
230718913$23071891$3$F$20240501$20240625$20231017$20240715$PER$$AU-TOLMAR, INC.-23AU043433$TOLMAR$$82$YR$$M$Y$$$20240715$$HP$AU$AU
230718985$23071898$5$F$20231222$20240905$20231017$20240924$PER$$CA-TOLMAR, INC.-23CA043742$TOLMAR$$71$YR$$M$Y$$$20240924$$CN$CA$CA
230723035$23072303$5$F$20231001$20231227$20231017$20240925$PER$$US-GSK-US2023AMR140828$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
230723072$23072307$2$F$20230901$20240830$20231017$20240909$EXP$$JP-009507513-2309JPN003826J$MERCK$$10$DEC$$F$Y$$$20240909$$MD$JP$JP
230723523$23072352$3$F$20231007$20240917$20231017$20240924$EXP$$CA-TAKEDA-2023TUS098630$TAKEDA$$39$YR$$M$Y$$$20240924$$CN$CA$CA
230723956$23072395$6$F$$20240826$20231017$20240830$EXP$$CA-CELLTRION INC.-2023CA019619$CELLTRION$$$$$$Y$$$20240831$$HP$CA$CA
230724403$23072440$3$F$$20240725$20231017$20240805$EXP$AT-KOREA IPSEN Pharma-2023-23161$AT-BRISTOL-MYERS SQUIBB COMPANY-2023-146558$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240805$$MD$AT$AT
230724433$23072443$3$F$20220601$20240904$20231017$20240909$EXP$$CA-TAKEDA-2021TUS009489$TAKEDA$$71$YR$$M$Y$$$20240909$$CN$CA$CA
230725352$23072535$2$F$$20240812$20231017$20240816$EXP$$MY-IPCA LABORATORIES LIMITED-IPC-2023-MY-001800$IPCA$Sarah Yi Xin Khoo, Siti Nuriah Rafiah Ibrahim and KN Kamarudin. Rectus sheath hematoma post-caesarean section in patient receiving anticoagulant: A case report. Med J Malaysia. 2023;78(1):51$$$$$Y$$$20240816$$HP$MY$MY
230725472$23072547$2$F$$20240705$20231017$20240708$EXP$$PL-SANDOZ INC.-SDZ2023PL024767$SANDOZ$Tomasik J, Drozd-Sokolowska J, Kacprzyk P, Tomaszewska A, Machowicz R, Urbanowska E, et al.. Tisagenlecleucel CAR-T for relapsed/refractorydiffuse large B-cell lymphoma;one therapy, two clinical presentations:urgent need to design adverse event predictors. Acta Haematologica Polonica. 2023;54:100-103$38$YR$$F$Y$$$20240708$$HP$PL$PL
230727105$23072710$5$F$20231114$20240725$20231017$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-020991$JAZZ$$21$YR$$F$Y$$$20240730$$HP$US$US
230727206$23072720$6$F$20151221$20240820$20231017$20240827$EXP$$CA-SANDOZ INC.-PHHY2015CA169582$SANDOZ$$59$YR$$F$Y$$$20240827$$CN$CA$CA
2307275410$23072754$10$F$20240101$20240613$20231017$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004315$ACADIA PHARMACEUTICALS$$5$YR$$F$Y$$$20240708$$CN$US$US
230727573$23072757$3$F$$20240906$20231017$20240909$EXP$$FR-ROCHE-3438276$ROCHE$$59$YR$A$F$Y$$$20240909$$HP$FR$FR
230728056$23072805$6$F$20240101$20240621$20231017$20240717$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004320$ACADIA PHARMACEUTICALS$$5$YR$$F$Y$$$20240717$$CN$US$US
230728973$23072897$3$F$20220901$20240812$20231017$20240824$EXP$CO-ALKEM LABORATORIES LIMITED-CO-ALKEM-2023-12369$CO-ALKEM LABORATORIES LIMITED-CO-ALKEM-2023-12369$ALKEM$Hoyos-Llanos DM, Cortes-Mejia NA, Rico-Bolivar DL, Giraldo-Posada P, Perez-Rengifo FA, Vera-Torres A.. Cytomegalovirus-related Guillain-Barre syndrome in an adult liver transplant recipient: a case report. Infectio. 2023;27 (3):187-191$67$YR$$M$Y$$$20240825$$MD$CO$CO
230729164$23072916$4$F$$20240822$20231017$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08896$LUPIN$$$$$$Y$$$20240909$$CN$US$US
230729492$23072949$2$F$20230811$20240815$20231017$20240819$EXP$FR-AFSSAPS-PO2023000997$FR-SERVIER-S23011626$SERVIER$$$$$$Y$$$20240819$$PH$FR$FR
230729866$23072986$6$F$20230714$20240812$20231017$20240820$EXP$$CA-TAKEDA-2023TUS079644$TAKEDA$$44$YR$$M$Y$$$20240820$$MD$CA$CA
230729942$23072994$2$F$$20240724$20231017$20240730$EXP$$CA-TAKEDA-2023TUS098223$TAKEDA$$$$$M$Y$$$20240730$$MD$CA$CA
230730922$23073092$2$F$$20240913$20231017$20240926$EXP$$US-AUROBINDO-AUR-APL-2023-063378$AUROBINDO$Toker M, Kirkpatrick C, Srivastava P, Amin B, Wu B. Cutaneous presentation of Candida krusei fungemia refractory to amphotericin B. Pediatr-Blood-Cancer. 2023;70:9$23$YR$$F$Y$$$20240926$$MD$US$US
230730996$23073099$6$F$$20240912$20231017$20240916$EXP$$CA-SANDOZ INC.-NVSC2021CA012042$SANDOZ$$75$YR$$F$Y$70$KG$20240916$$HP$CA$CA
230731102$23073110$2$F$$20240826$20231017$20240904$EXP$$ZA-ROCHE-2998867$ROCHE$$31$YR$A$F$Y$$$20240904$$CN$ZA$ZA
230731413$23073141$3$F$$20240920$20231017$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-146980$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240926$$MD$JP$JP
230732463$23073246$3$F$$20240920$20231017$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-146985$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240930$$MD$JP$JP
230733602$23073360$2$F$20230101$20240807$20231017$20240814$EXP$$US-SA-2023SA315573$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240814$$CN$US$US
230733722$23073372$2$F$20230901$20240926$20231017$20240926$EXP$$BR-SANDOZ INC.-SDZ2023BR042547$SANDOZ$$71$YR$$F$Y$$$20240926$$CN$BR$BR
230733887$23073388$7$F$20160101$20240715$20231017$20240717$EXP$$CA-SANDOZ INC.-PHHY2016CA168430$SANDOZ$$56$YR$$F$Y$$$20240717$$MD$CA$CA
230734895$23073489$5$F$20211118$20240812$20231017$20240819$EXP$$CA-CELLTRION INC.-2023CA008851$CELLTRION$$$$$$Y$$$20240819$$HP$CA$CA
230735603$23073560$3$F$$20240911$20231017$20240917$EXP$$CA-TAKEDA-2023TUS001709$TAKEDA$$$$$F$Y$$$20240917$$CN$CA$CA
2307361817$23073618$17$F$20230101$20240913$20231017$20240919$EXP$$US-ABBVIE-5366281$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
230738512$23073851$2$F$$20240705$20231017$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-147753$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240708$$CN$US$US
230739342$23073934$2$F$$20240910$20231017$20240918$EXP$$NVSC2023AT222754$NOVARTIS$$$$A$M$Y$$$20240918$$MD$AT$AT
230740283$23074028$3$F$20230901$20240919$20231017$20240924$30DAY$$JP-PFIZER INC-202300314848$PFIZER$$$$$$Y$$$20240924$$MD$JP$JP
230740503$23074050$3$F$$20240702$20231017$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-147344$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240703$$CN$US$US
230740713$23074071$3$F$20230901$20240919$20231017$20240924$30DAY$$JP-PFIZER INC-202300313122$PFIZER$$$$$$Y$$$20240924$$MD$JP$JP
230740763$23074076$3$F$20230901$20240919$20231017$20240924$30DAY$$JP-PFIZER INC-202300314851$PFIZER$$$$$$Y$$$20240924$$MD$JP$JP
230740823$23074082$3$F$20230901$20240919$20231017$20240924$30DAY$$JP-PFIZER INC-PV202300160158$PFIZER$$$$$$Y$$$20240924$$MD$JP$JP
230740853$23074085$3$F$20230901$20240919$20231017$20240924$30DAY$$JP-PFIZER INC-202300314850$PFIZER$$$$$$Y$$$20240924$$MD$JP$JP
230740873$23074087$3$F$20230901$20240919$20231017$20240924$30DAY$$JP-PFIZER INC-202300314849$PFIZER$$$$$$Y$$$20240924$$MD$JP$JP
230742044$23074204$4$F$20200107$20240925$20231017$20240927$EXP$$DE-ROCHE-2521787$ROCHE$$25$YR$A$F$Y$$$20240927$$CN$DE$DE
230742175$23074217$5$F$20230101$20240711$20231017$20240715$EXP$$US-UCBSA-2023045851$UCB$$$$$F$Y$$$20240715$$CN$US$US
230742623$23074262$3$F$20230101$20240829$20231017$20240912$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00225$AVADEL CNS PHARMA$$$$$F$Y$126.98$KG$20240912$$CN$US$US
230744227$23074422$7$F$$20240809$20231017$20240813$EXP$$CA-ROCHE-3438103$ROCHE$$$$A$F$Y$$$20240813$$MD$CA$CA
230745735$23074573$5$F$20230901$20240730$20231017$20240808$EXP$$KR-Accord-384927$ACCORD$$69$YR$E$M$Y$62.8$KG$20240808$$HP$KR$KR
230746773$23074677$3$F$20230102$20240709$20231017$20240712$EXP$FR-AFSSAPS-RE2023000925$FR-KYOWAKIRIN-2023KK016243$KYOWA$$$$$$Y$$$20240712$$MD$FR$FR
230747536$23074753$6$F$$20240902$20231017$20240910$EXP$$JP-AstraZeneca-2023A199104$ASTRAZENECA$Saeki I.. Combination immunotherapy for hepatocellular carcinoma - CTLA-4 blockade and VEGF blockade - Treatment strategies for unresectable hepatocellular carcinoma: from a basic perspective.. The 30th Japan Association of Systemic Therapy for HCC, Sponsored session No. 2. 2024;0-0.$$$A$$Y$$$20240910$$MD$JP$
230747673$23074767$3$F$$20240912$20231017$20240916$EXP$$NVSC2019CA046057$NOVARTIS$$20$YR$$M$Y$$$20240916$$MD$CA$CA
230749263$23074926$3$F$20231009$20240712$20231017$20240722$PER$$US-AstraZeneca-2023A231846$ASTRAZENECA$$48$YR$$$Y$79.4$KG$20240722$$HP$US$
230749493$23074949$3$F$20231012$20240730$20231017$20240801$EXP$$US-PFIZER INC-PV202300168502$PFIZER$$53$YR$$F$Y$$$20240801$$HP$US$US
230750134$23075013$4$F$$20240926$20231017$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-148004$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240927$$HP$US$US
230750823$23075082$3$F$$20240709$20231017$20240715$EXP$$JP-AMGEN-JPNSP2023182812$AMGEN$Makino R.; Yokomichi M.; Uchimura S. et al.. Bridging to cord blood transplantation with blinatumomab for primary induction failure DS-ALL. Japanese Journal of Pediatric Hematology/Oncology. 2023;60 (4):376$8$YR$C$M$Y$$$20240715$$MD$JP$JP
230751354$23075135$4$F$20230101$20240911$20231017$20240911$EXP$$CA-PFIZER INC-202300181439$PFIZER$$78$YR$$F$Y$$$20240911$$HP$CA$CA
230753182$23075318$2$F$$20240819$20231017$20240829$PER$$US-SA-2023SA211786$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240829$$MD$US$US
230754112$23075411$2$F$$20240711$20231017$20240722$PER$$US-SA-2023SA315227$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240721$$MD$US$US
230754222$23075422$2$F$$20240625$20231017$20240704$PER$$US-SA-2023SA246639$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240704$$MD$US$US
230755313$23075531$3$F$$20240905$20231017$20240912$EXP$$FR-AMGEN-FRANI2023182486$AMGEN$$59$YR$A$F$Y$$$20240912$$HP$FR$FR
230756284$23075628$4$F$20231009$20240731$20231017$20240806$EXP$$NL-ABBVIE-5445405$ABBVIE$$$$E$F$Y$$$20240806$$CN$NL$NL
230756884$23075688$4$F$20230901$20240801$20231017$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-147693$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240802$$HP$US$US
230758142$23075814$2$F$20230106$20240823$20231017$20240829$EXP$$CA-TAKEDA-2023TUS098661$TAKEDA$$36$YR$$F$Y$$$20240829$$MD$CA$CA
230758693$23075869$3$F$$20240618$20231017$20240703$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413017$RANBAXY$Kara H, Ozcelik OD. A case of tardive dyskinesia induced by olanzapine use. Psychiatr Clin Psychopharmacolog. 2019;29 (Suppl. 1):168/0246$64$YR$$M$Y$$$20240703$$HP$TR$TR
230761784$23076178$4$F$20230101$20240628$20231017$20240710$PER$$US-SA-2023SA311960$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240710$$MD$US$US
230762613$23076261$3$F$20230801$20240906$20231017$20240918$PER$$US-SA-2023SA314495$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240918$$MD$US$US
230763132$23076313$2$F$20190301$20240718$20231017$20240802$PER$$US-BIOMARINAP-US-2023-153354$BIOMARIN$$$$$$Y$$$20240802$$CN$US$US
230764134$23076413$4$F$20230718$20240903$20231017$20240906$EXP$$JP-Eisai-EC-2023-146464$EISAI$Aihara T. A case of irAE meningoencephalitis after administration of lenvatinib + pembrolizumab for recurrent uterine cancer. Japanese Journal of Gynecological Oncology.2024; 42(3): -46.$59$YR$A$F$Y$40$KG$20240906$$MD$JP$JP
230764692$23076469$2$F$20230914$20240704$20231017$20240709$PER$$US-PFIZER INC-PV202300168959$PFIZER$$58$YR$$F$Y$$$20240709$$CN$US$US
230764862$23076486$2$F$$20240829$20231017$20240904$PER$$US-PFIZER INC-PV202300169225$PFIZER$$20$YR$$M$Y$$$20240904$$HP$US$US
230765228$23076522$8$F$20231007$20240815$20231017$20240821$EXP$$US-Blueprint Medicines Corporation-SP-US-2023-001613$BLUEPRINT MEDICINES$$77$YR$E$F$Y$$$20240822$$CN$US$US
230765277$23076527$7$F$20220301$20240805$20231017$20240813$EXP$$US-UNITED THERAPEUTICS-UNT-2023-027409$UNITED THERAPEUTICS$$62$YR$$F$Y$58.957$KG$20240813$$$US$US
230765284$23076528$4$F$20231016$20240813$20231017$20240814$PER$$US-AMGEN-USASP2023184609$AMGEN$$67$YR$E$F$Y$$$20240814$$CN$US$US
230765294$23076529$4$F$20230908$20240919$20231017$20240927$EXP$$US-BEH-2023164426$CSL BEHRING$$32$YR$A$F$Y$$$20240927$$MD$US$US
230765833$23076583$3$F$20210501$20240819$20231017$20240820$EXP$$CA-SANDOZ INC.-NVSC2023CA090389$SANDOZ$$65$YR$$F$Y$$$20240820$$MD$CA$CA
230766183$23076618$3$F$20230801$20240912$20231017$20240919$PER$$JP-Eisai-EC-2023-150844$EISAI$$77$YR$E$M$Y$$$20240919$$MD$JP$JP
230766973$23076697$3$F$20220301$20240805$20231017$20240807$EXP$$JP-SA-2023SA315125$SANOFI AVENTIS$$49$YR$A$M$Y$53$KG$20240808$$MD$JP$JP
230767455$23076745$5$F$20230919$20240924$20231017$20240927$EXP$$DE-SANDOZ INC.-SDZ2023DE043295$SANDOZ$$$$E$F$Y$$$20240927$$MD$DE$DE
230767846$23076784$6$F$20220428$20240902$20231017$20240904$EXP$$DE-JNJFOC-20231036407$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240904$$CN$DE$DE
230768315$23076831$5$F$$20240918$20231018$20240920$EXP$$NVSC2023US222064$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
230768373$23076837$3$F$20230101$20240903$20231018$20240906$EXP$$US-ABBVIE-5451912$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
230769177$23076917$7$F$20191224$20240813$20231018$20240819$EXP$$AT-SANDOZ INC.-NVSC2023AT139298$SANDOZ$$35$YR$$F$Y$62$KG$20240819$$MD$AT$AT
230770198$23077019$8$F$20240303$20240816$20231018$20240826$EXP$$US-GSK-US2023AMR138848$GLAXOSMITHKLINE$$86$YR$$F$Y$$$20240826$$CN$US$US
230770262$23077026$2$F$$20240813$20231018$20240820$EXP$$CO-AMGEN-COLSL2023182766$AMGEN$$65$YR$E$M$Y$$$20240820$$CN$CO$CO
230770838$23077083$8$F$20221222$20240830$20231018$20240909$EXP$$CA-CELLTRION INC.-2022CA022047$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
230770957$23077095$7$F$$20240819$20231018$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-146832$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240827$$CN$US$US
230771763$23077176$3$F$$20240815$20231018$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-148082$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240821$$HP$US$US
230771907$23077190$7$F$20230901$20240826$20231018$20240904$EXP$$US-GSK-US2023AMR142309$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240904$$CN$US$US
230772576$23077257$6$F$20230601$20240820$20231018$20240826$EXP$$CA-JNJFOC-20230726546$JOHNSON AND JOHNSON$$36$YR$A$F$Y$72$KG$20240826$$HP$CA$CA
230773503$23077350$3$F$$20240913$20231018$20240920$PER$$US-SA-2023SA316096$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
230774057$23077405$7$F$20230712$20240815$20231018$20240822$EXP$$CA-CELLTRION INC.-2023CA014395$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
230775006$23077500$6$F$20230824$20240823$20231018$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-008106$JAZZ$$50$YR$$F$Y$$$20240826$$HP$US$US
230775332$23077533$2$F$$20240729$20231018$20240805$PER$$US-SA-2023SA224787$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240805$$MD$US$US
2307759719$23077597$19$F$20230101$20240722$20231018$20240731$EXP$$US-UNITED THERAPEUTICS-UNT-2023-026878$UNITED THERAPEUTICS$$$$$M$Y$76.19$KG$20240731$$$US$US
230776937$23077693$7$F$20230901$20240626$20231018$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004283$ACADIA PHARMACEUTICALS$$67$YR$$F$Y$$$20240719$$CN$US$US
230777003$23077700$3$F$20231016$20240628$20231018$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-147575$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240701$$HP$US$US
230777325$23077732$5$F$$20240702$20231018$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-147914$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240704$$CN$US$US
230777464$23077746$4$F$20230901$20240710$20231018$20240717$PER$$US-SA-2023SA314106$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240717$$MD$US$US
230777782$23077778$2$F$20220110$20240812$20231018$20240814$EXP$$GR-SANDOZ INC.-SDZ2023GR043269$SANDOZ$$79$YR$$M$Y$$$20240814$$HP$GR$GR
230778075$23077807$5$F$$20240829$20231018$20240923$PER$$CA-TOLMAR, INC.-23CA043772$TOLMAR$$$$$M$Y$$$20240923$$CN$CA$CA
230778835$23077883$5$F$20230801$20240830$20231018$20240904$EXP$$NVSC2023AT223007$NOVARTIS$$49$YR$$M$Y$$$20240904$$MD$AT$AT
230778893$23077889$3$F$20230509$20240828$20231018$20240905$EXP$$SK-TAKEDA-2023TUS049229$TAKEDA$$78$YR$$F$Y$$$20240905$$MD$SK$SK
230779272$23077927$2$F$$20240802$20231018$20240807$EXP$$US-AMGEN-USASP2023183672$AMGEN$$$$$M$Y$$$20240807$$HP$US$US
230782112$23078211$2$F$20230919$20240712$20231018$20240717$PER$$NVSC2023US220540$NOVARTIS$$31$YR$$F$Y$$$20240717$$CN$US$US
230783016$23078301$6$F$20230227$20240902$20231018$20240904$EXP$$BE-SANDOZ INC.-SDZ2023BE040899$SANDOZ$$85$YR$$M$Y$$$20240904$$MD$BE$BE
230784383$23078438$3$F$$20240729$20231018$20240731$EXP$$JP-VIATRISJAPAN-2023M1105135AA$MYLAN$$60$YR$$M$Y$$$20240731$$MD$JP$JP
230784595$23078459$5$F$20230901$20240904$20231018$20240914$EXP$$US-UCBSA-2023049683$UCB$$25$YR$$F$Y$93.3$KG$20240914$$HP$US$US
230785003$23078500$3$F$$20240711$20231018$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-012599$JAZZ$$$$$F$Y$$$20240716$$CN$US$US
230785394$23078539$4$F$20231008$20240908$20231018$20240910$EXP$$CA-ROCHE-3440761$ROCHE$$51$YR$A$F$Y$$$20240910$$CN$CA$CA
230785503$23078550$3$F$$20240905$20231018$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-148208$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240906$$CN$US$US
230786392$23078639$2$F$20231005$20240808$20231018$20240812$EXP$$NVSC2023US220384$NOVARTIS$$44$YR$$M$Y$$$20240812$$HP$US$US
230787106$23078710$6$F$20240604$20240624$20231018$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004295$ACADIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240718$$CN$US$US
230787253$23078725$3$F$20210924$20240709$20231018$20240711$EXP$$AT-PFIZER INC-202101346716$PFIZER$$40$YR$$F$Y$$$20240711$$MD$AT$AT
230787937$23078793$7$F$$20240917$20231018$20240921$EXP$$CA-ABBVIE-5446597$ABBVIE$$36$YR$$F$Y$$$20240921$$HP$CA$CA
230788042$23078804$2$F$20231009$20240918$20231018$20240925$EXP$$CO-GSK-CO2023AMR141138$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$CO$CO
230789103$23078910$3$F$$20240920$20231018$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-147756$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240927$$MD$JP$JP
230789264$23078926$4$F$$20240905$20231018$20240916$EXP$$US-ASTELLAS-2023US030956$ASTELLAS$$$$E$M$Y$$$20240916$$HP$US$US
230789774$23078977$4$F$20230923$20240709$20231018$20240712$EXP$$CN-PFIZER INC-PV202300167291$PFIZER$$49$YR$$F$Y$60$KG$20240712$$MD$CN$CN
230790482$23079048$2$F$20230901$20240820$20231018$20240826$PER$$US-BIOGEN-2023BI01227920$BIOGEN$$56$YR$$F$Y$$$20240826$$CN$US$US
230790622$23079062$2$F$$20231004$20231018$20240909$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2023-016982$VALIDUS$Janga C, Naeem I, Mehreen R, Abideen FZU, Memon R, Crocetti J. Methylene blue magic in beta blocker overdose. Chest. 2023;164(4):A2843$$$$$Y$$$20240909$$HP$US$US
230790703$23079070$3$F$20240801$20240816$20231018$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-148655$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240822$$PH$US$US
230792032$23079203$2$F$20230101$20240730$20231018$20240802$EXP$$CA-PFIZER INC-PV202300169751$PFIZER$$81$YR$$F$Y$66.3$KG$20240802$$MD$CA$CA
230792504$23079250$4$F$20231011$20240729$20231018$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-148409$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240806$$HP$US$US
230792666$23079266$6$F$20190801$20240829$20231018$20240905$EXP$$CO-SANDOZ INC.-NVSC2019CO070097$SANDOZ$$57$YR$$F$Y$60$KG$20240905$$CN$CO$CO
230793587$23079358$7$F$20220428$20240718$20231018$20240723$EXP$$CA-PFIZER INC-202100934592$PFIZER$$54$YR$$M$Y$117$KG$20240723$$MD$CA$CA
230794624$23079462$4$F$20231009$20240627$20231018$20240702$EXP$$US-SA-2023SA316338$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240702$$MD$US$US
230794972$23079497$2$F$$20231011$20231018$20240715$PER$$US-MYLANLABS-2023M1108290$BIOCON$$$$$$Y$$$20240715$$CN$US$US
230796174$23079617$4$F$$20240821$20231018$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-145995$BRISTOL MYERS SQUIBB$$58$YR$A$$Y$$$20240828$$MD$JP$JP
230796287$23079628$7$F$20230101$20240804$20231018$20240805$EXP$$CA-PFIZER INC-202300163468$PFIZER$$43$YR$$F$Y$$$20240805$$MD$CA$CA
230796303$23079630$3$F$20220101$20240917$20231018$20240919$EXP$$PR-PFIZER INC-202300331112$PFIZER$$77$YR$$F$Y$$$20240919$$HP$PR$PR
230796583$23079658$3$F$20221001$20240626$20231018$20240701$EXP$$JP-009507513-2310JPN001660J$MERCK$$60$YR$$M$Y$$$20240701$$MD$JP$JP
230796727$23079672$7$F$20220601$20240731$20231018$20240806$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-021098$JAZZ$$54$YR$$F$Y$$$20240806$$CN$US$US
230798668$23079866$8$F$$20240701$20231018$20240708$EXP$$US-MYLANLABS-2023M1109213$MYLAN$$$$$M$Y$$$20240708$$CN$US$US
230798983$23079898$3$F$$20240509$20231018$20240809$EXP$$CO-SANDOZ INC.-NVSC2020CO009814$SANDOZ$$$$$F$Y$$$20240809$$CN$CO$CO
230799013$23079901$3$F$$20240909$20231018$20240913$EXP$$CA-SANDOZ INC.-NVSC2021CA282246$SANDOZ$$$$$M$Y$$$20240913$$CN$CA$CA
230799482$23079948$2$F$20230929$20240705$20231018$20240716$PER$$US-SA-2023SA310801$SANOFI AVENTIS$$19$YR$A$F$Y$63.5$KG$20240716$$MD$US$US
230799683$23079968$3$F$20230601$20240801$20231018$20240810$PER$$US-SA-2023SA314502$SANOFI AVENTIS$$61$YR$A$F$Y$65.7$KG$20240810$$MD$US$US
230800092$23080009$2$F$20231006$20240727$20231018$20240805$PER$$US-SA-2023SA312813$SANOFI AVENTIS$$39$YR$A$F$Y$70.3$KG$20240805$$MD$US$US
230800564$23080056$4$F$20230101$20240710$20231018$20240718$PER$$US-SA-2023SA314029$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240718$$MD$US$US
230800745$23080074$5$F$$20240805$20231018$20240813$PER$$US-SA-2023SA315382$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240814$$HP$US$US
230801634$23080163$4$F$20190130$20240828$20231018$20240906$EXP$$DE-LABORATORIOS LICONSA S.A.-1905DE03350$INSUD PHARMA$$68$YR$$F$Y$88.8$KG$20240906$$MD$DE$DE
230802715$23080271$5$F$20230613$20240812$20231018$20240814$EXP$$PR-PFIZER INC-202300253917$PFIZER$$54$YR$$F$Y$63$KG$20240814$$HP$PR$PR
230802953$23080295$3$F$$20240910$20231018$20240911$EXP$$NVSC2023CA222744$NOVARTIS$$58$YR$$M$Y$$$20240911$$HP$CA$CA
230804389$23080438$9$F$20230425$20240807$20231018$20240809$EXP$$US-PFIZER INC-PV202200122810$PFIZER$$72$YR$$F$Y$58.957$KG$20240809$$MD$US$US
230805082$23080508$2$F$$20240903$20231018$20240930$PER$$US-SA-2023SA317751$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
230805365$23080536$5$F$$20240709$20231018$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-146721$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240711$$CN$US$US
230805384$23080538$4$F$$20240819$20231018$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-148639$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240826$$CN$US$US
230805893$23080589$3$F$$20240808$20231018$20240812$PER$$US-PFIZER INC-PV202300170038$PFIZER$$75$YR$$F$Y$$$20240812$$CN$US$US
230805923$23080592$3$F$20231201$20240909$20231018$20240911$EXP$$US-PFIZER INC-PV202300170678$PFIZER$$57$YR$$M$Y$$$20240911$$CN$US$US
230806234$23080623$4$F$$20240819$20231018$20240822$EXP$$US-PFIZER INC-PV202300170683$PFIZER$$77$YR$$F$Y$$$20240822$$CN$US$US
230806323$23080632$3$F$$20240626$20231018$20240701$PER$$US-PFIZER INC-PV202300170741$PFIZER$$64$YR$$F$Y$$$20240701$$CN$US$US
230806889$23080688$9$F$20221103$20240919$20231018$20240924$EXP$$DE-ROCHE-3438611$ROCHE$$57$YR$A$F$Y$96$KG$20240924$$MD$DE$DE
2308076614$23080766$14$F$20060101$20240821$20231018$20240823$EXP$$US-ORGANON-O2310USA002174$ORGANON$$$$$F$Y$$$20240823$$MD$US$US
230807744$23080774$4$F$20201201$20240718$20231018$20240724$EXP$$US-TAKEDA-US202017336$TAKEDA$$31$YR$$M$Y$$$20240724$$MD$US$US
2308084011$23080840$11$F$20231001$20240822$20231018$20240828$EXP$$US-TAKEDA-2023TUS097321$TAKEDA$$67$YR$$F$Y$$$20240828$$CN$US$US
230808643$23080864$3$F$20220411$20240708$20231018$20240715$EXP$$JP-009507513-2310JPN000593J$MERCK$$76$YR$$M$Y$$$20240715$$MD$JP$JP
230808708$23080870$8$F$20210817$20240910$20231018$20240924$EXP$$BR-TAKEDA-2023TUS005793$TAKEDA$$5$YR$$F$Y$24$KG$20240924$$MD$BR$BR
230808854$23080885$4$F$20210101$20240808$20231018$20240814$EXP$$US-ABBVIE-5456055$ABBVIE$$$$$F$Y$93$KG$20240814$$CN$US$US
230810082$23081008$2$F$20180110$20240708$20231018$20240711$EXP$$PL-ELI_LILLY_AND_COMPANY-PL201802004653$ELI LILLY AND CO$$24$YR$A$F$Y$70$KG$20240710$$CN$PL$PL
230812945$23081294$5$F$20240703$20240806$20231018$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-148436$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240809$$HP$US$US
230812963$23081296$3$F$$20240919$20231018$20240925$EXP$$US-SANDOZ INC.-NVSC2022US041275$SANDOZ$$$$$F$Y$50.794$KG$20240925$$CN$US$US
2308132513$23081325$13$F$20200110$20240911$20231018$20240919$EXP$$CA-CELLTRION INC.-2020CA024319$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
230813272$23081327$2$F$$20240925$20231018$20240926$EXP$$VN-SANDOZ INC.-SDZ2023VN043527$SANDOZ$Quan TVH, Huong NTT, Tan PH. Ket qua dieu tri phac do chope tren benh nhan u lympho khong hodgkin te bao t ngoai vi tai benh vien k [Results of CHOPE regimen in peripheral T-cell lymphoma patients at Vietnam national cancer hospital]. VIETNAM MEDICAL JOURNAL. 2023;530(1B):5-9$$$$$Y$$$20240926$$HP$VN$VN
230813632$23081363$2$F$$20240909$20231018$20240913$EXP$$CA-ABBVIE-5455578$ABBVIE$$$$$F$Y$$$20240913$$CN$CA$CA
230813822$23081382$2$F$20230201$20240912$20231018$20240919$EXP$$JP-Eisai-EC-2023-135773$EISAI$Kubota H. Kubota Hiroki. 10 cases to be considered from 2023 onwards.. Len/Pem Treatment Results (2023 and after). 2023;$76$YR$E$M$Y$$$20240919$$MD$JP$JP
230813952$23081395$2$F$$20240701$20231018$20240705$EXP$$GB-SANDOZ INC.-SDZ2023GB028434$SANDOZ$$$$$F$Y$$$20240705$$PH$GB$GB
230815303$23081530$3$F$$20240727$20231019$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-08966$LUPIN$$$$$$Y$$$20240816$$CN$US$US
230815667$23081566$7$F$20230801$20240807$20231019$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004302$ACADIA PHARMACEUTICALS$$22$YR$$F$Y$$$20240829$$CN$US$US
230816313$23081631$3$F$20220216$20240812$20231019$20240816$EXP$$CO-TAKEDA-CO202010839$TAKEDA$$36$YR$$M$Y$73$KG$20240816$$CN$CO$CO
2308168311$23081683$11$F$20230808$20240917$20231019$20240926$EXP$$CA-CELLTRION INC.-2023CA016130$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
230817772$23081777$2$F$$20240710$20231019$20240715$EXP$$US-SANDOZ INC.-SDZ2023US016165$SANDOZ$$78$YR$$F$Y$$$20240715$$CN$US$US
230818369$23081836$9$F$$20240826$20231019$20240829$EXP$$CO-SANDOZ INC.-PHHY2018CO192009$SANDOZ$$$$$M$Y$70$KG$20240829$$CN$CO$CO
230818743$23081874$3$F$20230926$20240726$20231019$20240806$PER$$US-SA-2023SA313528$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240806$$MD$US$US
230818904$23081890$4$F$20230101$20240828$20231019$20240923$PER$$US-SA-2023SA316671$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240923$$MD$US$US
230819223$23081922$3$F$20230101$20240822$20231019$20240903$EXP$$US-UCBSA-2023028262$UCB$$$$$F$Y$$$20240903$$HP$US$US
230820093$23082009$3$F$$20240920$20231019$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-147763$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240930$$MD$JP$JP
230820252$23082025$2$F$$20240809$20231019$20240815$PER$$US-SA-2023SA317666$SANOFI AVENTIS$$12$YR$T$F$Y$34.4$KG$20240815$$MD$US$US
230820263$23082026$3$F$$20240828$20231019$20240923$PER$$US-SA-2023SA316830$SANOFI AVENTIS$$$$E$F$Y$58.51$KG$20240923$$MD$US$US
230820863$23082086$3$F$20230921$20240912$20231019$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-148792$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$56.25$KG$20240916$$CN$US$US
230821267$23082126$7$F$20230930$20240612$20231019$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004314$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240705$$CN$US$US
230821289$23082128$9$F$20240129$20240621$20231019$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004311$ACADIA PHARMACEUTICALS$$4$YR$$M$Y$$$20240716$$CN$US$US
2308212911$23082129$11$F$20231001$20240627$20231019$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004312$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240723$$CN$US$US
230821985$23082198$5$F$$20240809$20231019$20240813$PER$$NVSC2023US221449$NOVARTIS$$$$$F$Y$$$20240813$$HP$US$US
230823192$23082319$2$F$20230301$20240626$20231019$20240704$EXP$$HU-CELLTRION INC.-2023HU019439$CELLTRION$Gyetko Z, Vegh, E, Rakoczi, E, Szucs, G. Immunodeficiency in a patient with seropositive rheumatoid arthritis. Submitted abstracts of presentations and posters of the 2023 Annual Meeting of t. 2023;64(3 B):169-170$$$$$Y$$$20240704$$HP$HU$HU
230824232$23082423$2$F$20200228$20240820$20231019$20240824$EXP$$US-TAKEDA-US202011844$TAKEDA$$32$YR$$F$Y$$$20240824$$HP$US$US
230824433$23082443$3$F$20210703$20240822$20231019$20240825$EXP$$DE-ROCHE-3441558$ROCHE$$59$YR$A$M$Y$83$KG$20240825$$MD$DE$DE
230825237$23082523$7$F$20230101$20240723$20231019$20240729$EXP$$US-UCBSA-2023049840$UCB$$$$$M$Y$$$20240729$$CN$US$US
230825582$23082558$2$F$20221111$20240816$20231019$20240822$EXP$$CA-TAKEDA-2022TUS086432$TAKEDA$$83$YR$$M$Y$$$20240822$$PH$CA$CA
2308257810$23082578$10$F$$20240920$20231019$20240930$EXP$$CA-TAKEDA-2023TUS099317$TAKEDA$$$$$M$Y$$$20240930$$MD$CA$CA
230827822$23082782$2$F$$20240822$20231019$20240905$EXP$$JP-AMGEN-JPNSP2023184347$AMGEN$Mutou Y, Okamoto T, Mitsui H, Shimada S, Kawamura T. A case of Pott^s puffy tumor suspected to be related to lenvatinib. 87th Annual Meeting of Eastern Division of Japanese Dermatological Association. 2023;149$71$YR$E$F$Y$$$20240905$$MD$JP$JP
230828672$23082867$2$F$20230901$20240722$20231019$20240731$EXP$$AT-TEVA-2023-AT-2935088$TEVA$$61$YR$$F$Y$$$20240731$$MD$AT$AT
230829402$23082940$2$F$20230702$20240625$20231019$20240701$EXP$$NVSC2023DE223927$NOVARTIS$$$$E$M$Y$97$KG$20240701$$MD$DE$DE
230829615$23082961$5$F$20231003$20240903$20231019$20240920$PER$$CA-TOLMAR, INC.-23CA043810$TOLMAR$$81$YR$$M$Y$$$20240919$$CN$CA$CA
230829952$23082995$2$F$20220623$20240409$20231019$20240826$EXP$$DE-JNJFOC-20230861786$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240826$$MD$DE$DE
230830453$23083045$3$F$20230501$20240723$20231019$20240725$EXP$$CA-TAKEDA-2023TUS101218$TAKEDA$$54$YR$$F$Y$$$20240725$$MD$CA$CA
230831363$23083136$3$F$$20240712$20231019$20240717$EXP$$US-TAKEDA-2023TUS100255$TAKEDA$$$$$F$Y$$$20240717$$CN$US$US
230832237$23083223$7$F$20230101$20240807$20231019$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2023-028439$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240817$$$US$US
230832752$23083275$2$F$20240801$20240822$20231019$20240917$PER$$US-SA-2023SA314564$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240918$$CN$US$US
230834362$23083436$2$F$$20240208$20231019$20240806$EXP$ES-AMGEN-ESPSP2023182950$ES-AMGEN-ESPSP2023182950$SANDOZ$$$$$$Y$$$20240806$$HP$ES$ES
230835523$23083552$3$F$$20240829$20231019$20240904$EXP$$US-PFIZER INC-PV202300167723$PFIZER$Nepal, N. WHEN WORKOUT GOES WRONG: SPONTANEOUS CORONARY ARTERY DISSECTION IN A BODYBUILDER ON ANABOLIC STEROIDS. Chest. 2023;164(4 Suppl):551A$34$YR$$M$Y$$$20240904$$HP$US$US
230835663$23083566$3$F$$20240722$20231019$20240725$EXP$$CA-TAKEDA-2023TUS099274$TAKEDA$$$$$M$Y$$$20240725$$MD$CA$CA
230836293$23083629$3$F$20231010$20240828$20231019$20240904$EXP$$CO-GSK-CO2023AMR141577$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$CO$CO
230836306$23083630$6$F$20231223$20240726$20231019$20240802$EXP$$CO-GSK-CO2023AMR141587$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$CO$CO
230837069$23083706$9$F$$20240916$20231019$20240923$EXP$$US-TAKEDA-2022TUS009208$TAKEDA$$$$$F$Y$44$KG$20240923$$MD$US$US
230838023$23083802$3$F$$20231013$20231019$20240926$PER$$US-LEO Pharma-364056$LEO PHARM$$54$YR$$F$Y$$$20240926$$PH$US$US
2308381419$23083814$19$F$20230101$20240828$20231019$20240903$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-001597$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240903$$MD$JP$JP
230839974$23083997$4$F$$20240730$20231019$20240802$PER$$US-PFIZER INC-202300331450$PFIZER$$71$YR$$F$Y$90.703$KG$20240802$$CN$US$US
230840012$23084001$2$F$$20240917$20231019$20240919$PER$$US-PFIZER INC-PV202300172461$PFIZER$$72$YR$$M$Y$$$20240919$$HP$US$US
230841935$23084193$5$F$20231001$20240806$20231019$20240813$EXP$$US-GSK-US2023AMR143745$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
230842793$23084279$3$F$20140101$20240828$20231019$20240902$EXP$$CA-SANDOZ INC.-PHHY2014CA116710$SANDOZ$$67$YR$$F$Y$77$KG$20240902$$CN$CA$CA
230843183$23084318$3$F$$20240909$20231019$20240916$EXP$$CA-APOTEX-2023AP015180$APOTEX$$$$$F$Y$$$20240916$$HP$CA$CA
230843535$23084353$5$F$$20240716$20231019$20240722$PER$$US-AMGEN-USASP2023186529$AMGEN$$$$$F$Y$$$20240722$$HP$US$US
230844316$23084431$6$F$20230820$20240621$20231019$20240701$EXP$$US-TAKEDA-2023TUS083121$TAKEDA$$70$YR$$F$Y$$$20240701$$MD$US$US
230845144$23084514$4$F$20230808$20240809$20231019$20240819$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2023-109437$REGENERON$$48$YR$$F$Y$$$20240819$$PH$CA$CA
230845844$23084584$4$F$$20240829$20231019$20240910$EXP$$US-SA-2023SA319438$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240910$$MD$US$US
230845873$23084587$3$F$$20240913$20231019$20240916$EXP$$CA-SANDOZ INC.-NVSC2022CA283466$SANDOZ$$34$YR$$F$Y$81$KG$20240916$$HP$CA$CA
230845954$23084595$4$F$$20240918$20231019$20240920$EXP$$CA-ASTELLAS-2023US030922$ASTELLAS$$58$YR$A$M$Y$$$20240920$$HP$CA$CA
230846002$23084600$2$F$20240801$20240816$20231019$20240829$PER$$US-SA-2023SA312549$SANOFI AVENTIS$$74$YR$E$M$Y$239.9$KG$20240829$$MD$US$US
2308462511$23084625$11$F$$20240909$20231019$20240913$EXP$$CA-OTSUKA-2022_053858$OTSUKA$$$$$M$Y$$$20240913$$MD$CA$CA
230846319$23084631$9$F$20240318$20240827$20231019$20240902$EXP$$US-SANDOZ INC.-NVSC2022US170245$SANDOZ$$32$YR$$F$Y$93.424$KG$20240902$$CN$US$US
230847326$23084732$6$F$20230101$20240820$20231019$20240827$EXP$$JP-DSJP-DSJ-2023-142660$DAIICHI$Sekine S, Tachibana A, Oono K, Hamaguchi Y. A case of recurrent breast cancer recovered from multiple organ failure due to side effects of antibody-drug conjugates (EP-1172). The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024$55$YR$$F$Y$51.2$KG$20240827$$PH$JP$JP
230847423$23084742$3$F$20230101$20240827$20231019$20240904$EXP$$BR-AstraZeneca-2023A233968$ASTRAZENECA$$40$YR$$F$Y$55$KG$20240904$$CN$BR$
230847592$23084759$2$F$20230414$20240628$20231019$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-412883$RANBAXY$$73$YR$$F$Y$42$KG$20240712$$PH$FR$FR
230847862$23084786$2$F$$20240711$20231019$20240717$EXP$$FR-PFIZER INC-202300321915$PFIZER$Valyraki, N. Human pegivirus identified in severe myelitis and optic neuritis in immunocompromised patients: A pathogenic role for a forgotten virus?. Rev-Neurol-Paris. 2023;179(4):361-367$46$YR$$F$Y$$$20240717$$HP$FR$FR
230847922$23084792$2$F$20230101$20240719$20231019$20240723$EXP$$US-PFIZER INC-PV202300172081$PFIZER$$61$YR$$F$Y$$$20240723$$CN$US$US
230848046$23084804$6$F$20230701$20240826$20231019$20240829$EXP$$US-PFIZER INC-PV202300171755$PFIZER$$73$YR$$M$Y$104$KG$20240829$$CN$US$US
230848443$23084844$3$F$$20240701$20231019$20240716$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-281171$RANBAXY$Valerio M, Vasquez V, Alvarez-Uria A, Zatarain-Nicolas E, Pavone P, Martinez-Jimenez MDC et al. Disseminated Lomentosporiosis in a Heart Transplant Recipient: CaseReport and Review of the Literature. Transpl Infect Dis. 2021;00:e13574; 1-7$25$YR$$M$Y$$$20240716$$HP$ES$ES
230849422$23084942$2$F$20210520$20240722$20231019$20240724$EXP$$US-SANDOZ INC.-NVSC2021US184167$SANDOZ$$2$YR$$F$Y$19.955$KG$20240724$$HP$US$US
230851173$23085117$3$F$$20240731$20231019$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-148946$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240801$$HP$US$US
230851604$23085160$4$F$$20240809$20231019$20240812$EXP$$US-TAKEDA-2023TUS101313$TAKEDA$$$$$F$Y$$$20240812$$MD$US$US
230852054$23085205$4$F$$20240924$20231019$20240927$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-142874$DAIICHI$$$$$F$Y$$$20240928$$CN$US$US
230853874$23085387$4$F$20230915$20240917$20231019$20240919$EXP$$US-PFIZER INC-202300332757$PFIZER$$78$YR$$M$Y$115.21$KG$20240919$$CN$US$US
230853924$23085392$4$F$$20240809$20231019$20240814$EXP$$US-PFIZER INC-202300332316$PFIZER$$84$YR$$M$Y$81.65$KG$20240814$$CN$US$US
230853934$23085393$4$F$$20240712$20231019$20240716$EXP$$US-PFIZER INC-202300332420$PFIZER$$64$YR$$F$Y$$$20240716$$CN$US$US
230856163$23085616$3$F$20240501$20240905$20231019$20240909$EXP$$US-PFIZER INC-PV202300170811$PFIZER$$73$YR$$F$Y$$$20240909$$CN$US$US
230856174$23085617$4$F$20231008$20240924$20231019$20240926$PER$$US-PFIZER INC-202300331003$PFIZER$$47$YR$$F$Y$56.25$KG$20240926$$CN$US$US
230856274$23085627$4$F$20231213$20240916$20231019$20240918$PER$$US-PFIZER INC-PV202300170795$PFIZER$$66$YR$$F$Y$$$20240918$$HP$US$US
230856393$23085639$3$F$20210901$20240923$20231019$20240927$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-018364$JAZZ$$22$YR$$M$Y$$$20240927$$MD$US$US
230856483$23085648$3$F$$20240724$20231019$20240725$EXP$$CA-SANDOZ INC.-NVSC2023CA031212$SANDOZ$$50$YR$$F$Y$110$KG$20240725$$MD$CA$CA
230856576$23085657$6$F$$20240806$20231019$20240809$PER$$US-PFIZER INC-PV202300170503$PFIZER$$57$YR$$F$Y$$$20240809$$HP$US$US
230856675$23085667$5$F$20220720$20240917$20231019$20240920$PER$$US-PFIZER INC-PV202300171247$PFIZER$$68$YR$$F$Y$$$20240920$$CN$US$US
230857152$23085715$2$F$$20240808$20231019$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-008877$JAZZ$$$$$F$Y$$$20240821$$CN$US$US
230857302$23085730$2$F$$20240801$20231019$20240814$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017264$JAZZ$$$$$F$Y$$$20240814$$HP$US$US
230859553$23085955$3$F$20230814$20240819$20231019$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-018086$JAZZ$$51$YR$$F$Y$$$20240821$$MD$US$US
230860024$23086002$4$F$20220101$20240827$20231019$20240829$EXP$$US-PFIZER INC-PV202300172351$PFIZER$$70$YR$$F$Y$$$20240829$$HP$US$US
230860496$23086049$6$F$20231101$20240923$20231019$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-014711$JAZZ$$35$YR$$F$Y$$$20240926$$HP$US$US
230861316$23086131$6$F$20220101$20240816$20231019$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-016669$JAZZ$$$$$F$Y$$$20240822$$MD$US$US
230863185$23086318$5$F$$20240627$20231019$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-146997$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240705$$MD$JP$JP
230863474$23086347$4$F$20240617$20240711$20231019$20240717$EXP$$GB-SANDOZ INC.-SDZ2023GB043597$SANDOZ$$86$YR$$F$Y$$$20240717$$CN$GB$GB
230863623$23086362$3$F$20230713$20240923$20231019$20240925$EXP$$US-SANDOZ INC.-SDZ2023US006923$SANDOZ$$60$YR$$F$Y$72.109$KG$20240925$$MD$US$US
230864814$23086481$4$F$$20240926$20231019$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-147506$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$90.72$KG$20240927$$CN$US$US
230865134$23086513$4$F$20230101$20240822$20231019$20240906$PER$$US-SA-2023SA319359$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240906$$MD$US$US
230867736$23086773$6$F$$20240625$20231020$20240719$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004375$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
230868462$23086846$2$F$$20240914$20231020$20240917$EXP$$US-SANDOZ INC.-SDZ2023US043453$SANDOZ$$$$$M$Y$$$20240917$$CN$US$US
230868592$23086859$2$F$$20240716$20231020$20240726$EXP$$US-AUROBINDO-AUR-APL-2023-063795$AUROBINDO$Paige AMY, Mirza N, Rayad M, Miller RA.. Metformin-induced lactic acidosis complicated by acute liver failure. Chest. 2023;164(4):A1875$63$YR$$F$Y$$$20240726$$MD$US$US
230869433$23086943$3$F$$20240904$20231020$20240905$PER$$US-AMGEN-USASP2023185842$AMGEN$$26$YR$A$F$Y$$$20240905$$HP$US$US
230869723$23086972$3$F$20230801$20240820$20231020$20240913$PER$$CA-TOLMAR, INC.-23CA043529$TOLMAR$$68$YR$$M$Y$$$20240913$$CN$CA$CA
230869934$23086993$4$F$20200815$20240616$20231020$20240704$EXP$$US-ROCHE-3115360$ROCHE$$61$YR$A$M$Y$83.91$KG$20240704$$CN$US$US
230870353$23087035$3$F$20210101$20240910$20231020$20240930$PER$$CA-TOLMAR, INC.-23CA043782$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
230870372$23087037$2$F$20231003$20240621$20231020$20240710$PER$$CA-TOLMAR, INC.-23CA043803$TOLMAR$$81$YR$$M$Y$$$20240710$$CN$CA$CA
230871094$23087109$4$F$$20240919$20231020$20240927$EXP$$US-TAKEDA-2022TUS087652$TAKEDA$$$$$M$Y$93$KG$20240927$$HP$US$US
230871843$23087184$3$F$20210701$20240812$20231020$20240823$EXP$$CA-AUROBINDO-AUR-APL-2023-063600$AUROBINDO$Pang SA, Elkrief A, Capella MP, Miller WH. Two Cases of Durable and Deep Responses to Immune Checkpoint Inhibition-Refractory Metastatic Melanoma after Addition of Camu Camu Prebiotic. Current Oncology. 2023;30(9):7852-7859$71$YR$$F$Y$$$20240823$$MD$CA$CA
2308735914$23087359$14$F$20230413$20240918$20231020$20240926$EXP$$IT-TAKEDA-2023TUS006649$TAKEDA$$70$YR$$M$Y$$$20240926$$CN$IT$IT
230873783$23087378$3$F$20220701$20240627$20231020$20240704$EXP$$US-HETERO-HET2023US02953$HETERO$$56$YR$$F$Y$68$KG$20240704$$CN$US$US
230874382$23087438$2$F$20231004$20240910$20231020$20240930$PER$$CA-TOLMAR, INC.-23CA043835$TOLMAR$$80$YR$$M$Y$$$20240930$$CN$CA$CA
230874515$23087451$5$F$$20240903$20231020$20240920$PER$$CA-TOLMAR, INC.-23CA043865$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
230875369$23087536$9$F$20230101$20240801$20231020$20240807$EXP$$CA-CELLTRION INC.-2023CA006392$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
230876152$23087615$2$F$$20240812$20231020$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004378$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
230876793$23087679$3$F$20230101$20240809$20231020$20240820$PER$$US-SA-2023SA177540$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240820$$MD$US$US
230879514$23087951$4$F$20230101$20240709$20231020$20240715$EXP$$CA-JNJFOC-20231011497$JOHNSON AND JOHNSON$$10$YR$C$F$Y$32$KG$20240715$$HP$CA$CA
230880364$23088036$4$F$$20240903$20231020$20240906$PER$$US-PHARMING-PHAUS2023000775$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
230882974$23088297$4$F$20240801$20240904$20231020$20240911$EXP$$CO-GSK-CO2023AMR129435$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$CO$CO
230883024$23088302$4$F$20230101$20240702$20231020$20240809$EXP$$NVSC2023KR167529$NOVARTIS$$$$A$F$Y$$$20240809$$HP$KR$KR
2308835111$23088351$11$F$20230801$20240731$20231020$20240805$EXP$$JP-GSK-JP2023JPN142197$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$MD$JP$JP
230884054$23088405$4$F$20230924$20240801$20231020$20240807$EXP$$AU-EXELIXIS-CABO-23069362$EXELIXIS$$47$YR$$F$Y$68$KG$20240807$$MD$AU$AU
230884292$23088429$2$F$20200114$20221202$20231020$20240920$EXP$$GB-SANDOZ INC.-NVSC2022GB303465$SANDOZ$$59$YR$$M$Y$62$KG$20240920$$MD$GB$GB
230884414$23088441$4$F$20231012$20240710$20231020$20240823$EXP$$MX-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-267993$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$$$20240823$$CN$MX$MX
230886015$23088601$5$F$20230401$20240902$20231020$20240910$EXP$$NVSC2023MX223510$NOVARTIS$$42$YR$$F$Y$69$KG$20240910$$CN$MX$MX
230886995$23088699$5$F$$20240917$20231020$20240923$EXP$$CA-SANDOZ INC.-SDZ2023CA043794$SANDOZ$$54$YR$$F$Y$$$20240923$$CN$CA$CA
230887075$23088707$5$F$$20240812$20231020$20240828$30DAY$$US-GSK-US2023139779$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$CN$US$US
230887118$23088711$8$F$20220731$20240624$20231020$20240926$EXP$$US-GSK-US2021AMR232744$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
230888622$23088862$2$F$20200101$20240709$20231020$20240717$EXP$$LV-STRIDES ARCOLAB LIMITED-2023SP015841$STRIDES$Vrublevska J.. Case report: Successful administration of cariprazine in a young, severely ill patient with recurrent relapses of schizophrenia and persistent negative symptoms. Front. Psychiatry. 2023;14:1-8.$22$YR$$M$Y$$$20240717$$HP$LV$LV
230888783$23088878$3$F$20230929$20240729$20231020$20240808$EXP$$US-VIIV HEALTHCARE LIMITED-US2023139805$VIIV$$34$YR$$M$Y$195$KG$20240808$$MD$US$US
230889005$23088900$5$F$$20240627$20231020$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004374$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
230889642$23088964$2$F$$20240621$20231020$20240702$EXP$$CA-APOTEX-2023AP015541$APOTEX$$$$$M$Y$$$20240702$$MD$CA$CA
230889715$23088971$5$F$20230801$20240704$20231020$20240709$EXP$$JP-PFIZER INC-202300333933$PFIZER$$65$YR$$M$Y$$$20240709$$CN$JP$JP
230889738$23088973$8$F$20230101$20240715$20231020$20240718$EXP$$CA-PFIZER INC-202300332408$PFIZER$$91$YR$$F$Y$$$20240718$$CN$CA$CA
230889984$23088998$4$F$20230101$20240717$20231020$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-021354$JAZZ$$$$$F$Y$$$20240722$$CN$US$US
230890833$23089083$3$F$$20231106$20231020$20240905$EXP$$NVSC2023CA109909$NOVARTIS$$$$E$M$Y$$$20240905$$HP$CA$CA
230891602$23089160$2$F$$20240709$20231020$20240730$PER$$US-INCYTE CORPORATION-2023IN009543$INCYTE$$$$$$Y$$$20240730$$HP$US$US
230892228$23089222$8$F$20230922$20240621$20231020$20240709$EXP$$JP-ROCHE-3423194$ROCHE$$93$YR$E$M$Y$46$KG$20240705$$MD$JP$JP
230892532$23089253$2$F$$20240625$20231020$20240701$EXP$$NVSC2023JP224794$NOVARTIS$Nishimoto M, Takakuwa T, Kuno M, Makuuchi Y, Okamura H, Nakashima Y et al.. Recapitulated late-onset inflammatory toxicities and progressive dysautonomia with persistence of central memory CD4+ chimeric antigen receptor T cells in a case of transformed follicular lymphoma: Case report. ACTA HAEMATOLOGICA. 2023;146(4):341-5$69$YR$$M$Y$$$20240701$$HP$JP$JP
230893502$23089350$2$F$20230909$20240731$20231020$20240809$EXP$GR-GREOF-202300896$GR-009507513-2310GRC007767$MERCK$$71$YR$$M$Y$60$KG$20240809$$MD$GR$GR
230893642$23089364$2$F$$20231016$20231020$20240729$EXP$$IE-Ipsen Biopharmaceuticals, Inc.-2023-23981$IPSEN$$$$$M$Y$$$20240729$$PH$IE$IE
230894652$23089465$2$F$20230901$20240702$20231020$20240712$PER$$US-SA-2023SA321222$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
230894702$23089470$2$F$20230101$20240724$20231020$20240801$PER$$US-SA-2023SA314472$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240801$$MD$US$US
230895123$23089512$3$F$$20240906$20231020$20240915$PER$$US-SA-2023SA320987$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240915$$MD$US$US
230895503$23089550$3$F$20230101$20240816$20231020$20240830$EXP$$US-SMITH AND NEPHEW, INC-2023SMT00075$SMITH AND NEPHEW$$$$$F$Y$$$20240830$$CN$US$US
230895823$23089582$3$F$20240821$20240828$20231020$20240909$PER$$US-SA-2023SA319229$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240909$$MD$US$US
230897042$23089704$2$F$20230101$20240917$20231020$20240920$EXP$$JP-ROCHE-3408481$ROCHE$$$$A$M$Y$$$20240921$$MD$JP$JP
230897532$23089753$2$F$20230801$20240708$20231020$20240710$EXP$$CA-TAKEDA-2023TUS099767$TAKEDA$$49$YR$$M$Y$$$20240710$$CN$CA$CA
230898775$23089877$5$F$20220803$20240731$20231020$20240805$EXP$$CO-TAKEDA-2022TUS055650$TAKEDA$$50$YR$$F$Y$50$KG$20240805$$CN$CO$CO
230899403$23089940$3$F$20231001$20240909$20231020$20240911$PER$$US-PFIZER INC-PV202300172352$PFIZER$$46$YR$$F$Y$$$20240911$$HP$US$US
230899722$23089972$2$F$$20240703$20231020$20240704$PER$$US-PFIZER INC-PV202300173809$PFIZER$$82$YR$$F$Y$$$20240704$$CN$US$US
230900189$23090018$9$F$$20240911$20231020$20240923$EXP$$CA-APOTEX-2023AP015360$APOTEX$$80$YR$$M$Y$69$KG$20240923$$HP$CA$CA
230900543$23090054$3$F$20220307$20240726$20231020$20240801$EXP$$CA-TAKEDA-2022TUS015596$TAKEDA$$36$YR$$F$Y$122$KG$20240801$$CN$CA$CA
230901012$23090101$2$F$$20240905$20231020$20240918$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2023-001261$SK LIFE SCIENCE$$$$$$Y$$$20240918$$HP$US$US
230901642$23090164$2$F$20231008$20240702$20231020$20240711$PER$$US-SA-2023SA315209$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240711$$MD$US$US
230902545$23090254$5$F$20231001$20240627$20231020$20240703$EXP$$JP-009507513-2310JPN001735J$MERCK$$$$$F$Y$$$20240703$$MD$JP$JP
230902557$23090255$7$F$20231001$20240807$20231020$20240807$30DAY$$CA-PFIZER INC-202300307854$PFIZER$$33$YR$$M$Y$$$20240807$$HP$CA$CA
230903282$23090328$2$F$$20240731$20231020$20240801$EXP$$NVSC2023CZ225675$NOVARTIS$Blazkova K, Samal V, Richter, Paldus V, Mecl J. Lecba oboustrannych objemnych angiomyolipomu ledviny everolimem [Treatment of bilateral bulky angiomyolipomas of the kidney with everolimus]. CESKA UROLOGIE. 2023;27 Supplement A:47$37$YR$$F$Y$$$20240801$$HP$CZ$CZ
230903364$23090336$4$F$$20240129$20231020$20240926$PER$$US-GSK-US2023AMR143491$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
230903593$23090359$3$F$$20240823$20231020$20240828$EXP$$US-PFIZER INC-202300327816$PFIZER$Husna, A.. COINCIDENCE OR CORRELATION: A DIAGNOSTIC CONUNDRUM-A PATIENT WITH EOSINOPHILIC PNEUMONIA, HYPERSENSITIVITY PNEUMONITIS, AND ADENOCARCINOMA OF THE LUNG. Chest. 2023;164(4):A4804$75$YR$$F$Y$$$20240828$$MD$US$US
230904794$23090479$4$F$$20240730$20231020$20240802$EXP$$US-PFIZER INC-PV202300171451$PFIZER$$68$YR$$F$Y$108.86$KG$20240802$$CN$US$US
230904887$23090488$7$F$20230101$20240823$20231020$20240828$PER$$US-PFIZER INC-PV202300172417$PFIZER$$61$YR$$F$Y$$$20240828$$CN$US$US
230905455$23090545$5$F$$20240903$20231020$20240911$EXP$$CA-JNJFOC-20231044507$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240911$$HP$CA$CA
230906473$23090647$3$F$$20240723$20231020$20240725$EXP$$US-TAKEDA-2023TUS102032$TAKEDA$$$$$F$Y$$$20240725$$CN$US$US
230906802$23090680$2$F$$20240626$20231020$20240711$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413914$RANBAXY$Sohda M, Yokobori T, Kimura A, Kosaka T, Yoshida K, Hakamada K, et al. Efficacy of chemotherapy for comorbid cancer in patients with simultaneous double cancers: a multicenter study. Surg Today. 2023;53(1):98-108$$$$$Y$$$20240711$$HP$JP$JP
230906982$23090698$2$F$$20230925$20231020$20240912$PER$$US-INCYTE CORPORATION-2023IN010014$INCYTE$$$$$$Y$$$20240912$$CN$US$US
230907775$23090777$5$F$$20240731$20231020$20240801$EXP$$CA-SANDOZ INC.-SDZ2023CA043701$SANDOZ$$53$YR$$F$Y$$$20240801$$HP$CA$CA
230907962$23090796$2$F$$20240906$20231020$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-412811$RANBAXY$Yousaf H, Sharma A, Khan A, Elamin M, Ranjha S, Katib H. Acquired QT interval prolongation and torsades de pointes with trimethoprim-sulfamethoxazole use in an HIV-infected patient. Chest. 2023;Oct; 164(4S):A651-A652$61$YR$$M$Y$$$20240920$$HP$US$US
230907986$23090798$6$F$20231005$20240822$20231020$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413307$RANBAXY$$76$YR$E$M$Y$63.5$KG$20240906$$MD$CN$CN
230908317$23090831$7$F$20240101$20240809$20231020$20240814$EXP$$US-PFIZER INC-202300334437$PFIZER$$53$YR$$F$Y$57.143$KG$20240814$$CN$US$US
230908723$23090872$3$F$20220101$20240715$20231020$20240722$EXP$$BR-BIOGEN-2023BI01231645$BIOGEN$$$$$F$Y$$$20240722$$CN$BR$BR
230909594$23090959$4$F$20231001$20240708$20231020$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-149265$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240711$$CN$US$US
230909892$23090989$2$F$$20231004$20231020$20240906$PER$$US-LEO Pharma-364005$LEO PHARM$$$$$F$Y$$$20240906$$CN$US$US
230910303$23091030$3$F$20230928$20240709$20231020$20240716$EXP$$CR-BIOGEN-2023BI01231649$BIOGEN$$32$YR$$F$Y$66$KG$20240716$$CN$CR$CR
230910388$23091038$8$F$$20240725$20231020$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-149379$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240729$$CN$US$US
230911313$23091131$3$F$20231016$20240920$20231020$20240925$EXP$$CA-PFIZER INC-202300332547$PFIZER$$42$YR$$F$Y$$$20240925$$HP$CA$CA
230911775$23091177$5$F$$20240731$20231020$20240802$EXP$$CA-SANDOZ INC.-SDZ2023CA043781$SANDOZ$$53$YR$$F$Y$$$20240802$$HP$CA$CA
230912602$23091260$2$F$$20240916$20231020$20240919$EXP$$CA-PFIZER INC-202300331168$PFIZER$$65$YR$$F$Y$$$20240919$$HP$CA$CA
230912613$23091261$3$F$$20240722$20231020$20240723$EXP$$CA-PFIZER INC-202300331254$PFIZER$$66$YR$$M$Y$$$20240723$$CN$CA$CA
230912784$23091278$4$F$20230124$20240709$20231020$20240716$EXP$$ES-PFIZER INC-202300332859$PFIZER$$72$YR$$M$Y$78.7$KG$20240716$$MD$ES$ES
230912796$23091279$6$F$$20240816$20231020$20240820$EXP$$CA-PFIZER INC-202300333425$PFIZER$$58$YR$$F$Y$120$KG$20240820$$HP$CA$CA
230914375$23091437$5$F$$20240904$20231020$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-148534$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240906$$HP$US$US
230915122$23091512$2$F$$20240710$20231020$20240715$EXP$$US-PFIZER INC-202300327825$PFIZER$Morales, D.. A CASE OF INTRA-ARTERIAL VERAPAMIL AS SALVAGE THERAPY FOR POST-INFECTIOUS CEREBRAL VASCULITIS. Chest. 2023;164(4):A2374-A2375$54$YR$$F$Y$$$20240715$$MD$US$US
230916824$23091682$4$F$20230925$20240916$20231020$20240918$EXP$$NVSC2023US224628$NOVARTIS$$64$YR$$F$Y$$$20240918$$CN$US$US
230916978$23091697$8$F$20231002$20240725$20231020$20240731$EXP$$JP-009507513-2310JPN002269J$MERCK$Kuroyanagi M, Sakado M, Mizuno K, Hiromura K, Suzuki M, Fukuhara N, et al.. OS-210 A case of uterine carcinosarcoma with severe irAe-related encephalitis during lenvatinib and pembrolizumab therapy. The 66th Annual Meeting of Japan Society of Gynecologic Oncology. 2024;42(3):310$73$YR$$F$Y$$$20240731$$MD$JP$JP
230917034$23091703$4$F$20230101$20240809$20231020$20240825$EXP$$JP-009507513-2308JPN000241J$MERCK$Nemoto N, Ikami A, Kitada K, Makino M, Okado R, Yamamoto A, et al.. Resident-4 A Case of Myocarditis Caused by Pembrolizumab. The 163rd Tokai Regional Meeting of the Japanese Circulation Society. 44$$$$M$Y$33$KG$20240824$$MD$JP$JP
230917612$23091761$2$F$$20240921$20231020$20240930$PER$$US-SA-2023SA317620$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240930$$MD$US$US
230919192$23091919$2$F$20231001$20240725$20231021$20240805$PER$$US-SA-2023SA318638$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240805$$MD$US$US
230919245$23091924$5$F$20230101$20240715$20231021$20240723$PER$$US-SA-2023SA319558$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240723$$MD$US$US
230920132$23092013$2$F$$20240716$20231021$20240730$EXP$$US-GLENMARK PHARMACEUTICALS-2023GMK085712$GLENMARK$Paige A, Mirza N, Rayad M, Miller RA.. Metformin-induced lactic acidosis complicated by acute liver failure.. Chest.. 2023;164 (4):A1875,$$$$$Y$$$20240730$$MD$US$US
230920392$23092039$2$F$$20240812$20231021$20240826$EXP$$ES-EPICPHARMA-ES-2023EPCLIT01496$EPIC PHARM$$54$YR$A$F$Y$$$20240826$$HP$ES$ES
2309205910$23092059$10$F$20230605$20240709$20231021$20240718$EXP$$GB-CELLTRION INC.-2023GB020108$CELLTRION$$$$$$Y$$$20240718$$MD$GB$GB
230921383$23092138$3$F$20220101$20240731$20231021$20240809$PER$$US-SA-2023SA317240$SANOFI AVENTIS$$14$YR$T$M$Y$7.7$KG$20240809$$MD$US$US
230921403$23092140$3$F$20240501$20240706$20231021$20240715$PER$$US-SA-2023SA323110$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240715$$MD$US$US
230923496$23092349$6$F$20230921$20240820$20231021$20240902$PER$$US-SA-2023SA318017$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240902$$MD$US$US
230924914$23092491$4$F$$20240727$20231021$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-09107$LUPIN$$$$$$Y$$$20240816$$CN$US$US
230925102$23092510$2$F$20230101$20240827$20231021$20240910$PER$$US-SA-2023SA289537$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240910$$MD$US$US
230927172$23092717$2$F$$20240729$20231021$20240806$PER$$US-SA-2023SA322832$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240806$$MD$US$US
230929332$23092933$2$F$20211001$20240725$20231021$20240806$PER$$US-SA-2023SA316893$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240806$$CN$US$US
230929494$23092949$4$F$20230101$20240912$20231021$20240930$EXP$$US-SA-2023SA322525$SANOFI AVENTIS$$83$YR$E$M$Y$70.3$KG$20240930$$MD$US$US
230931182$23093118$2$F$20230101$20240816$20231022$20240828$PER$$US-SA-2023SA323788$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240828$$MD$US$US
230932062$23093206$2$F$$20240712$20231022$20240717$EXP$$FR-SANDOZ INC.-SDZ2023FR044199$SANDOZ$$62$YR$$M$Y$$$20240717$$PH$FR$FR
230932507$23093250$7$F$$20240706$20231022$20240715$EXP$$NVSC2023PL222768$NOVARTIS$Sokolowska A, Iwanski M, Dabrowski P. A patient with overlap syndrome: systemic lupus erythematosus, dermatomyositis, and sjogren?s syndrome-a rare overlapping diseases case report. EUROPEAN JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. 2023;21(3):659-62$27$YR$$M$Y$88.7$KG$20240715$$HP$PL$PL
230932877$23093287$7$F$20230101$20240708$20231022$20240716$PER$$US-SA-2023SA323532$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240716$$CN$US$US
230933215$23093321$5$F$20220524$20240805$20231022$20240806$EXP$$JP-TAKEDA-2023TJP013278$TAKEDA$$21$YR$$F$Y$$$20240806$$HP$JP$JP
230933722$23093372$2$F$20230727$20240730$20231022$20240801$EXP$GR-GREOF-202300934$GR-JNJFOC-20231052903$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240801$$MD$GR$GR
230937166$23093716$6$F$20230913$20240924$20231023$20240926$EXP$$JP-TAKEDA-2023TJP013381$TAKEDA$$75$YR$$M$Y$52$KG$20240926$$MD$JP$JP
230937583$23093758$3$F$$20231106$20231023$20240906$EXP$$CA-SANDOZ INC.-NVSC2023CA109909$SANDOZ$$$$E$M$Y$$$20240906$$HP$CA$CA
230937855$23093785$5$F$20210101$20240819$20231023$20240903$EXP$$GR-ABBVIE-5456359$ABBVIE$$$$$M$Y$60$KG$20240903$$HP$GR$GR
230938522$23093852$2$F$$20240716$20231023$20240723$EXP$$CA-TAKEDA-2023TUS101200$TAKEDA$$$$$F$Y$$$20240723$$CN$CA$CA
230938534$23093853$4$F$$20240812$20231023$20240823$EXP$$CA-APOTEX-2023AP015313$APOTEX$$65$YR$$M$Y$$$20240823$$MD$CA$CA
230938903$23093890$3$F$$20231120$20231023$20240729$EXP$$CA-SANDOZ INC.-NVSC2021CA302395$SANDOZ$$44$YR$$F$Y$68$KG$20240729$$CN$CA$CA
230939098$23093909$8$F$20220101$20240726$20231023$20240730$EXP$$CA-AMGEN-CANSL2022181620$AMGEN$$42$YR$A$F$Y$$$20240730$$HP$CA$CA
230939315$23093931$5$F$20230615$20240808$20231023$20240813$EXP$$ES-ORGANON-O2310ESP002508$ORGANON$$$$$F$Y$$$20240813$$MD$ES$ES
230939382$23093938$2$F$20210401$20240717$20231023$20240725$EXP$$FR-EMD Serono-9371913$EMD SERONO INC$$76$YR$E$F$Y$$$20240725$$CN$FR$FR
230940142$23094014$2$F$$20240619$20231023$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004376$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
230940453$23094045$3$F$20230101$20240807$20231023$20240814$EXP$$US-ABBVIE-5371865$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
230940872$23094087$2$F$$20240917$20231023$20240924$EXP$$CA-TAKEDA-2023TUS045027$TAKEDA$$$$$F$Y$$$20240924$$CN$CA$CA
230941987$23094198$7$F$20190607$20240718$20231023$20240724$EXP$$US-SHIRE-US201918704AA$TAKEDA$$28$YR$$M$Y$$$20240724$$PH$US$US
230942133$23094213$3$F$$20240716$20231023$20240726$EXP$US-MACLEODS PHARMACEUTICALS US LTD-MAC2023043921$US-MACLEODS PHARMACEUTICALS US LTD-MAC2023043921$MACLEODS$$$$$$Y$$$20240726$$MD$US$US
230942615$23094261$5$F$$20240816$20231023$20240820$EXP$$CA-SANDOZ INC.-NVSC2020CA057529$SANDOZ$$72$YR$$M$Y$$$20240820$$HP$CA$CA
230942703$23094270$3$F$20230101$20240723$20231023$20240807$EXP$$US-INSMED, INC.-2023-03927-US$INSMED$$$$$M$Y$$$20240807$$CN$US$US
230943683$23094368$3$F$20200330$20240813$20231023$20240819$EXP$$CA-JNJFOC-20211014862$JOHNSON AND JOHNSON$$25$YR$A$F$Y$62.2$KG$20240820$$HP$CA$CA
230943863$23094386$3$F$$20240819$20231023$20240823$EXP$$CA-TAKEDA-2023TUS101155$TAKEDA$$$$$F$Y$$$20240823$$CN$CA$CA
230944464$23094446$4$F$$20240709$20231023$20240711$30DAY$$US-GSK-US2023AMR144160$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
2309447010$23094470$10$F$$20240812$20231023$20240816$EXP$$CA-SANDOZ INC.-NVSC2022CA093891$SANDOZ$$80$YR$$M$Y$68.998$KG$20240816$$HP$CA$CA
230945308$23094530$8$F$20231016$20240827$20231023$20240918$EXP$$US-SA-2023SA324075$SANOFI AVENTIS$$49$YR$A$M$Y$66.667$KG$20240918$$MD$US$US
230945706$23094570$6$F$20240125$20240812$20231023$20240818$EXP$$NVSC2023US224578$NOVARTIS$$70$YR$$F$Y$$$20240818$$CN$US$US
230946798$23094679$8$F$$20240724$20231023$20240731$EXP$$NVSC2023CL138214$NOVARTIS$$59$YR$$F$Y$$$20240731$$CN$CL$CL
230946893$23094689$3$F$$20240814$20231023$20240819$EXP$$IE-MYLANLABS-2023M1110588$MYLAN$$$$$M$Y$$$20240819$$MD$IE$IE
230947434$23094743$4$F$20230818$20240705$20231023$20240715$EXP$IT-MINISAL02-947505$IT-TEVA-2023-IT-2937416$TEVA$$18$YR$$F$Y$43$KG$20240715$$PH$IT$IT
230949283$23094928$3$F$20221018$20240829$20231023$20240905$EXP$$US-ABBVIE-5460092$ABBVIE$$56$YR$$F$Y$$$20240905$$CN$US$US
230949503$23094950$3$F$20220901$20240907$20231023$20240909$EXP$$CO-ROCHE-3444304$ROCHE$$39$YR$A$F$Y$50.5$KG$20240910$$MD$CO$CO
230955582$23095558$2$F$20230901$20240703$20231023$20240705$EXP$$US-UCBSA-2023050316$UCB$$34$YR$$F$Y$$$20240705$$HP$US$US
230962007$23096200$7$F$20230419$20240710$20231023$20240713$EXP$$NVSC2023CA090965$NOVARTIS$$51$YR$$M$Y$79$KG$20240713$$HP$CA$CA
230963397$23096339$7$F$20231004$20240829$20231023$20240907$EXP$$CA-CELLTRION INC.-2023CA020426$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
230963678$23096367$8$F$$20240923$20231023$20240926$EXP$$GB-TAKEDA-2023TUS099923$TAKEDA$$$$$F$Y$$$20240926$$CN$GB$GB
2309649012$23096490$12$F$20230601$20240919$20231023$20240924$EXP$$US-PFIZER INC-202300334467$PFIZER$$80$YR$$F$Y$67.12$KG$20240924$$CN$US$US
230965514$23096551$4$F$20231001$20240730$20231023$20240805$EXP$$JP-009507513-2310JPN002355J$MERCK$$8$DEC$$F$Y$$$20240805$$PH$JP$JP
230966583$23096658$3$F$$20240717$20231023$20240725$PER$$US-SA-2023SA324529$SANOFI AVENTIS$$71$YR$E$F$Y$93$KG$20240725$$MD$US$US
2309669110$23096691$10$F$20230101$20240801$20231023$20240806$EXP$$CA-PFIZER INC-202300283583$PFIZER$$58$YR$$M$Y$103.6$KG$20240806$$HP$CA$CA
230966973$23096697$3$F$20210709$20240913$20231023$20240919$EXP$$CA-PFIZER INC-2021892843$PFIZER$$52$YR$$M$Y$$$20240919$$HP$CA$CA
230967124$23096712$4$F$$20240627$20231023$20240701$EXP$$US-PFIZER INC-PV202300173808$PFIZER$$54$YR$$F$Y$61.678$KG$20240701$$CN$US$US
230967195$23096719$5$F$20230301$20240912$20231023$20240917$EXP$$IN-PFIZER INC-PV202300143259$PFIZER$$30$YR$$M$Y$$$20240917$$CN$IN$IN
230967215$23096721$5$F$20230801$20240819$20231023$20240822$EXP$$US-PFIZER INC-202300280386$PFIZER$$49$YR$$F$Y$$$20240822$$CN$US$US
2309683410$23096834$10$F$20231115$20240823$20231023$20240827$EXP$$US-PFIZER INC-PV202300173159$PFIZER$$64$YR$$F$Y$$$20240827$$HP$US$US
230969044$23096904$4$F$20231016$20240812$20231023$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-148563$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240816$$CN$US$US
230970863$23097086$3$F$20230101$20240625$20231023$20240702$EXP$$US-ABBVIE-4345176$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
230970898$23097089$8$F$20231122$20240913$20231023$20240920$EXP$$US-GSK-US2023AMR144694$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240920$$CN$US$US
230970954$23097095$4$F$$20240724$20231023$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-149293$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240726$$CN$US$US
230971394$23097139$4$F$20190130$20240902$20231023$20240912$EXP$$DE-TEVA-2023-DE-2937090$TEVA$$68$YR$$F$Y$88.8$KG$20240912$$MD$DE$DE
230971912$23097191$2$F$$20240911$20231023$20240926$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413745$RANBAXY$Youssef D, Richards S, Sheppard C, Hornberger L, Pietrosanu M, Bates A. Preteen with Prenatal Agenesis of the Ductus Venosus Presenting with a Portosystemic Shunt and Severe Delayed-Onset Pulmonary Arterial Hypertension: A Rare Case Report. J Heart Lung Transplant. 2023;42(Suppl)(4):S490; 1142$10$YR$$F$Y$$$20240926$$HP$CA$CA
230972033$23097203$3$F$20230116$20240624$20231023$20240708$EXP$$DE-NORDICGR-053814$NORDIC PHARMA$$$$A$M$Y$$$20240705$$MD$DE$DE
230974115$23097411$5$F$$20240910$20231023$20240916$EXP$$CA-TAKEDA-2023TUS101784$TAKEDA$$$$$M$Y$$$20240916$$CN$CA$CA
230974492$23097449$2$F$20230927$20240718$20231023$20240723$EXP$$CA-TAKEDA-2023TUS099362$TAKEDA$$43$YR$$F$Y$$$20240723$$CN$CA$CA
230975132$23097513$2$F$20230506$20240625$20231023$20240701$EXP$$DE-ABBVIE-5460071$ABBVIE$$49$YR$$M$Y$140$KG$20240701$$MD$DE$DE
230976062$23097606$2$F$20220701$20240821$20231023$20240824$EXP$$US-ABBVIE-22K-163-4471866-00$ABBVIE$$61$YR$$F$Y$$$20240824$$CN$US$US
230976225$23097622$5$F$20230724$20240628$20231023$20240701$EXP$$FR-ASTELLAS-2023US029714$ASTELLAS$$72$YR$$M$Y$$$20240701$$HP$FR$FR
230976316$23097631$6$F$20231212$20240911$20231023$20240919$EXP$$CA-TAKEDA-2023TUS080642$TAKEDA$$74$YR$$F$Y$$$20240919$$HP$CA$CA
230980023$23098002$3$F$20231002$20240801$20231023$20240809$EXP$$JP-ROCHE-3443163$ROCHE$$8$DEC$E$M$Y$68$KG$20240810$$MD$JP$JP
230980142$23098014$2$F$20230425$20240730$20231023$20240731$EXP$$NO-TAKEDA-2023TUS102504$TAKEDA$$52$YR$$F$Y$$$20240731$$HP$NO$NO
230981029$23098102$9$F$20210101$20240919$20231023$20240926$PER$$US-VERTEX PHARMACEUTICALS-2023-015801$VERTEX$$$$$$Y$$$20240926$$CN$US$US
230982114$23098211$4$F$20230822$20240710$20231023$20240716$EXP$$IT-BAUSCH-BL-2023-015817$BAUSCH AND LOMB$$56$YR$$M$Y$$$20240716$$HP$IT$IT
230982333$23098233$3$F$$20240717$20231023$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-150629$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$66.68$KG$20240718$$CN$US$US
230983248$23098324$8$F$20210504$20240917$20231023$20240920$EXP$$IN-PFIZER INC-2021739353$PFIZER$$50$YR$$F$Y$64.8$KG$20240920$$CN$IN$IN
230984172$23098417$2$F$$20231018$20231023$20240801$PER$$NVSC2023US226192$NOVARTIS$$$$$M$Y$$$20240801$$MD$US$US
230984495$23098449$5$F$20240725$20240802$20231023$20240806$EXP$$US-PFIZER INC-PV202300174541$PFIZER$$81$YR$$F$Y$$$20240806$$CN$US$US
230984872$23098487$2$F$$20240814$20231023$20240820$EXP$$CA-SANDOZ INC.-NVSC2022CA243040$SANDOZ$$$$$M$Y$$$20240820$$CN$CA$CA
230984985$23098498$5$F$$20240723$20231023$20240726$EXP$$NVSC2023US227388$NOVARTIS$$$$$M$Y$$$20240726$$CN$US$US
230986122$23098612$2$F$$20240703$20231023$20240827$PER$$US-BAUSCHBL-2023BNL010107$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240827$$MD$US$US
230986213$23098621$3$F$20221212$20240725$20231023$20240730$EXP$$JP-Eisai-EC-2023-134902$EISAI$$48$YR$A$F$Y$65$KG$20240730$$MD$JP$JP
230987093$23098709$3$F$$20240615$20231024$20240710$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004410$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
230987462$23098746$2$F$$20240827$20231024$20240904$EXP$$CA-CELLTRION INC.-2023CA020146$CELLTRION$$$$$$Y$$$20240904$$CN$CA$CA
230988472$23098847$2$F$20190523$20240625$20231024$20240703$EXP$$DE-ABBVIE-5458128$ABBVIE$$36$YR$$F$Y$69$KG$20240703$$MD$DE$DE
230988932$23098893$2$F$20230401$20240618$20231024$20240701$EXP$$CA-ROCHE-3331872$ROCHE$$24$YR$A$F$Y$$$20240701$$CN$CA$CA
230991152$23099115$2$F$20230630$20240718$20231024$20240723$EXP$$US-PAREXEL-2021-KAM-US003551$TAKEDA$$60$YR$$F$Y$47$KG$20240723$$HP$US$US
230991382$23099138$2$F$20230926$20240626$20231024$20240704$EXP$$DE-AUROBINDO-AUR-APL-2023-064449$AUROBINDO$$85$YR$$F$Y$61$KG$20240704$$MD$DE$DE
230991883$23099188$3$F$20231027$20240708$20231024$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-150995$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$69.85$KG$20240710$$CN$US$US
230991894$23099189$4$F$20230917$20240821$20231024$20240902$EXP$$FR-AUROBINDO-AUR-APL-2023-064437$AUROBINDO$$81$YR$$M$Y$52$KG$20240902$$MD$FR$FR
230991946$23099194$6$F$20220101$20240816$20231024$20240906$PER$$US-INCYTE CORPORATION-2023IN010101$INCYTE$$$$$$Y$$$20240906$$MD$US$US
230991973$23099197$3$F$$20240909$20231024$20240912$PER$$US-BIOGEN-2023BI01232342$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
230992377$23099237$7$F$20230901$20240913$20231024$20240923$EXP$$CA-CELLTRION INC.-2023CA020467$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
230992905$23099290$5$F$20231017$20240624$20231024$20240701$EXP$$NVSC2023US226811$NOVARTIS$$37$YR$$F$Y$$$20240701$$CN$US$US
230993042$23099304$2$F$$20240919$20231024$20240924$EXP$$US-SA-2023SA323753$SANOFI AVENTIS$$$$E$F$Y$$$20240924$$MD$US$US
230993303$23099330$3$F$20210301$20240816$20231024$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-021555$JAZZ$$43$YR$$F$Y$$$20240821$$CN$US$US
230993432$23099343$2$F$20210401$20240717$20231024$20240728$EXP$$FR-Merck Healthcare KGaA-9371913$MERCK KGAA$$76$YR$E$F$Y$$$20240725$$CN$FR$FR
230993994$23099399$4$F$20230101$20240628$20231024$20240708$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2023-18238$IPSEN$$50$YR$A$F$Y$$$20240708$$HP$CA$CA
230994816$23099481$6$F$20210726$20240829$20231024$20240903$EXP$$CA-TAKEDA-2021TUS047617$TAKEDA$$87$YR$$M$Y$$$20240903$$HP$CA$CA
230995393$23099539$3$F$20230101$20240821$20231024$20240905$PER$$US-SA-2023SA319345$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240905$$MD$US$US
230996273$23099627$3$F$$20240722$20231024$20240725$EXP$$CA-Orion Corporation ORION PHARMA-23_00026142$ORION$$66$YR$E$M$Y$$$20240725$$CN$CA$
230997634$23099763$4$F$20230915$20240628$20231024$20240718$EXP$$JP-AstraZeneca-2023A239032$ASTRAZENECA$$73$YR$$F$Y$68$KG$20240718$$MD$JP$
230999167$23099916$7$F$$20240816$20231024$20240823$EXP$$AR-GSK-AR2023AMR133265$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$AR$AR
230999386$23099938$6$F$$20240827$20231024$20240904$EXP$$CA-CELLTRION INC.-2023CA020139$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
230999693$23099969$3$F$$20240727$20231024$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-09252$LUPIN$$$$$$Y$$$20240816$$CN$US$US
230999803$23099980$3$F$20231016$20240712$20231024$20240715$PER$$US-PFIZER INC-202300335200$PFIZER$$61$YR$$F$Y$$$20240715$$HP$US$US
231000706$23100070$6$F$20220613$20240910$20231024$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-149773$BRISTOL MYERS SQUIBB$Takagi K, et al. A case of suspected drug-induced optic neuropathy associated with nivolumab. The 77th Annual Congress of Japan Clinical Ophthalmology. 2023;171.$51$YR$A$F$Y$$$20240918$$MD$JP$JP
2310015110$23100151$10$F$20230713$20240911$20231024$20240925$EXP$$US-INSMED-2023-02714-USAA$INSMED$$77$YR$$M$Y$$$20240925$$CN$US$US
231001716$23100171$6$F$20231012$20240808$20231024$20240809$EXP$$CA-ROCHE-3443128$ROCHE$$31$YR$A$F$Y$$$20240809$$HP$CA$CA
231005393$23100539$3$F$20231021$20240628$20231024$20240702$PER$$US-AMGEN-USASP2023189222$AMGEN$$52$YR$A$M$Y$$$20240702$$HP$US$US
231005783$23100578$3$F$20220428$20240916$20231024$20240919$EXP$$CA-PFIZER INC-202200425782$PFIZER$$63$YR$$M$Y$$$20240919$$MD$CA$CA
231006135$23100613$5$F$20230101$20240626$20231024$20240705$EXP$$JP-009507513-2310JPN002727J$MERCK$$8$DEC$$F$Y$$$20240705$$MD$JP$JP
231006572$23100657$2$F$20230920$20240801$20231024$20240802$EXP$$CN-PFIZER INC-PV202300173592$PFIZER$$18$YR$$M$Y$70$KG$20240802$$HP$CN$CN
231007493$23100749$3$F$20231019$20240722$20231024$20240912$EXP$$NVSC2023US226696$NOVARTIS$$39$YR$$F$Y$$$20240912$$CN$US$US
231009003$23100900$3$F$20230101$20240802$20231024$20240813$EXP$$JP-NOVOPROD-1126650$NOVO NORDISK$E.Kumagai et.al... A patient with type II diabetes who developed severe reflux oesophagitis, dehydration, and ketosis induced by 0.25 mg of semaglutide. The 61st Japan Diabetes Society Kanto Koshinetsu Regional Association. 2024;O-105$41$YR$$M$Y$$$20240813$$MD$JP$JP
231009258$23100925$8$F$20230831$20240701$20231024$20240711$EXP$$CN-GILEAD-2023-0648627$GILEAD$$61$YR$A$M$Y$$$20240711$$MD$CN$CN
231009266$23100926$6$F$20231019$20240717$20231024$20240722$EXP$$JP-Eisai-EC-2023-151167$EISAI$$43$YR$A$F$Y$$$20240719$$MD$JP$JP
231011742$23101174$2$F$$20240626$20231024$20240705$PER$$US-SA-2023SA323187$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240705$$MD$US$US
231011772$23101177$2$F$$20231021$20231024$20240906$EXP$$FR-BAUSCH-BL-2023-015826$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240906$$MD$FR$FR
231011812$23101181$2$F$$20231022$20231024$20240918$EXP$$ES-BAUSCH-BL-2023-015851$BAUSCH AND LOMB$$$$E$$Y$$$20240918$$MD$ES$ES
231012652$23101265$2$F$$20240703$20231024$20240711$EXP$$BE-PFIZER INC-202300333920$PFIZER$$58$YR$$F$Y$$$20240711$$MD$BE$BE
231012702$23101270$2$F$$20240703$20231024$20240711$EXP$$BE-PFIZER INC-202300333946$PFIZER$$54$YR$$F$Y$$$20240711$$MD$BE$BE
231013272$23101327$2$F$20230815$20240911$20231024$20240918$PER$$CN-Eisai-EC-2023-150937$EISAI$$53$YR$A$M$Y$$$20240918$$MD$CN$CN
231014092$23101409$2$F$$20240625$20231024$20240704$PER$$US-SA-2023SA322829$SANOFI AVENTIS$$3$YR$C$F$Y$13.108$KG$20240704$$MD$US$US
231014254$23101425$4$F$$20240720$20231024$20240725$EXP$$GB-BIOGEN-2023BI01230626$BIOGEN$$$$A$F$Y$$$20240725$$CN$GB$GB
2310144511$23101445$11$F$20230101$20240829$20231024$20240907$EXP$$CA-CELLTRION INC.-2023CA015014$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
231014514$23101451$4$F$20230925$20240827$20231024$20240903$EXP$$JP-009507513-2310JPN002691J$MERCK$$60$YR$$M$Y$$$20240903$$MD$JP$JP
231015513$23101551$3$F$20240801$20240802$20231025$20240810$EXP$$CA-CELLTRION INC.-2023CA020566$CELLTRION$$$$$$Y$$$20240810$$HP$CA$CA
231015595$23101559$5$F$20240705$20240903$20231025$20240913$EXP$$BR-CELLTRION INC.-2023BR020549$CELLTRION$$$$$$Y$$$20240913$$CN$BR$BR
231015863$23101586$3$F$20191101$20240625$20231025$20240702$EXP$$US-ABBVIE-5383114$ABBVIE$$61$YR$$M$Y$90$KG$20240702$$CN$US$US
231015937$23101593$7$F$$20240917$20231025$20240923$EXP$$CA-ABBVIE-5453806$ABBVIE$$$$A$F$Y$$$20240923$$HP$CA$CA
231016692$23101669$2$F$20231005$20240820$20231025$20240822$EXP$$US-ABBVIE-5458897$ABBVIE$$64$YR$$M$Y$$$20240822$$CN$US$US
2310171420$23101714$20$F$20230101$20240722$20231025$20240727$EXP$$US-UNITED THERAPEUTICS-UNT-2023-029777$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240727$$$US$US
231017285$23101728$5$F$$20240906$20231025$20240924$PER$$CA-TOLMAR, INC.-23CA043939$TOLMAR$$$$$M$Y$$$20240924$$CN$CA$CA
231019029$23101902$9$F$$20240905$20231025$20240916$EXP$$US-INSMED, INC.-2023-02914-US$INSMED$$$$$M$Y$$$20240916$$CN$US$US
231019056$23101905$6$F$$20240620$20231025$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004390$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
231020369$23102036$9$F$20230101$20240729$20231025$20240802$EXP$$CA-JNJFOC-20230901979$JOHNSON AND JOHNSON$$53$YR$A$F$Y$48$KG$20240802$$PH$CA$CA
231021042$23102104$2$F$20230101$20240724$20231025$20240801$EXP$$CA-CELLTRION INC.-2023CA020611$CELLTRION$$$$$$Y$$$20240801$$CN$CA$CA
231021183$23102118$3$F$20231004$20240701$20231025$20240708$EXP$$JP-NXDC-2023GLE00053$NX DEVELOPMENT CORPORATION$Yoshizawa S, Yoshida J, Yoshihara A, Nemoto C, Inoue S. Caution:Patient-specific preoperative preparations combined with procedure-specific 5-aminolevulinic acid may lead to critical events. Fukushima J Med Sci. 2024 Jun 26.$83$YR$E$M$Y$60$KG$20240708$$MD$JP$JP
231021323$23102132$3$F$20230901$20240805$20231025$20240814$PER$$US-SA-2023SA319507$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240814$$MD$US$US
231021772$23102177$2$F$20230901$20240815$20231025$20240827$PER$$US-SA-2023SA320461$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240827$$MD$US$US
231022446$23102244$6$F$20231024$20240917$20231025$20240925$EXP$$CA-TAKEDA-2023TUS081628$TAKEDA$$56$YR$$F$Y$$$20240925$$HP$CA$CA
231023084$23102308$4$F$20220101$20240722$20231025$20240725$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-190163$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240725$$CN$US$US
231023299$23102329$9$F$20240214$20240918$20231025$20240926$EXP$$CA-UCBSA-2022059105$UCB$$69$YR$$F$Y$$$20240926$$CN$CA$CA
231024574$23102457$4$F$19940401$20240709$20231025$20240718$EXP$$FR-SA-96007123$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240718$$MD$DE$DE
231025852$23102585$2$F$$20240819$20231025$20240821$EXP$$ES-SANDOZ INC.-NVSC2023ES128801$SANDOZ$$53$YR$$F$Y$$$20240821$$MD$ES$ES
2310259310$23102593$10$F$20231205$20240918$20231025$20240925$EXP$$CA-TAKEDA-2023TUS035656$TAKEDA$$64$YR$$F$Y$$$20240925$$HP$CA$CA
231026736$23102673$6$F$20230801$20240903$20231025$20240911$PER$$CA-TOLMAR, INC.-23CA043909$TOLMAR$$78$YR$$M$Y$$$20240911$$CN$CA$CA
231026955$23102695$5$F$20230924$20240705$20231025$20240709$EXP$$US-UCBSA-2023050662$UCB$$26$YR$$F$Y$$$20240709$$HP$US$US
231027924$23102792$4$F$20231201$20240826$20231025$20240829$EXP$$US-TAKEDA-2023TUS071786$TAKEDA$$39$YR$$F$Y$55$KG$20240829$$HP$US$US
231028835$23102883$5$F$$20240607$20231025$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004403$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
231029073$23102907$3$F$20230101$20240814$20231025$20240819$EXP$$FR-ORGANON-O2310FRA002838$ORGANON$$$$$F$Y$$$20240819$$CN$FR$FR
231029303$23102930$3$F$20231008$20240727$20231025$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-09232$LUPIN$$$$$$Y$$$20240817$$CN$US$US
231029923$23102992$3$F$20230503$20240819$20231025$20240829$EXP$$JP-ASTELLAS-2023JP011760$ASTELLAS$$47$YR$A$F$Y$$$20240828$$MD$JP$JP
231032324$23103232$4$F$20230101$20240703$20231025$20240709$30DAY$$JP-PFIZER INC-PV202300168758$PFIZER$$10$YR$$M$Y$$$20240709$$MD$JP$JP
231032469$23103246$9$F$20230901$20240903$20231025$20240904$30DAY$$CO-PFIZER INC-PV202300164835$PFIZER$$13$YR$$M$Y$$$20240904$$HP$CO$CO
231032662$23103266$2$F$$20240703$20231025$20240715$EXP$DE-MACLEODS PHARMACEUTICALS US LTD-MAC2023043945$DE-MACLEODS PHARMACEUTICALS US LTD-MAC2023043945$MACLEODS$$$$$$Y$$$20240715$$CN$DE$DE
231034424$23103442$4$F$$20240904$20231025$20240911$PER$$US-TAKEDA-2023TUS102811$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
231034572$23103457$2$F$$20240723$20231025$20240801$PER$$US-SA-2023SA327362$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240801$$CN$US$US
231034917$23103491$7$F$20231017$20240923$20231025$20240930$EXP$$NVSC2023US226106$NOVARTIS$$50$YR$$F$Y$$$20240930$$CN$US$US
231036043$23103604$3$F$20230717$20240712$20231025$20240715$EXP$ES-CELLTRION HEALTHCARE HUNGARY KFT-2023ES019680$ES-ROCHE-3442737$ROCHE$$70$YR$E$M$Y$$$20240715$$MD$ES$ES
231038126$23103812$6$F$20240201$20240819$20231025$20240823$EXP$$US-TAKEDA-2023TUS027520$TAKEDA$$50$YR$$F$Y$109$KG$20240823$$MD$US$US
231038284$23103828$4$F$$20240721$20231025$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-09268$LUPIN$$$$$$Y$$$20240822$$CN$US$US
2310394114$23103941$14$F$20221005$20240816$20231025$20240903$EXP$$US-UCBSA-2022062230$UCB$$13$YR$$F$Y$44.1$KG$20240903$$CN$US$US
231039885$23103988$5$F$20230831$20240911$20231025$20240921$EXP$$JP-ABBVIE-5463633$ABBVIE$$66$YR$$M$Y$$$20240921$$MD$JP$JP
231044165$23104416$5$F$20231001$20240903$20231025$20240912$PER$$US-SA-2023SA320693$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240912$$MD$US$US
231044992$23104499$2$F$$20240903$20231025$20240904$EXP$$FR-SANDOZ INC.-SDZ2023FR044560$SANDOZ$$40$YR$$F$Y$$$20240904$$HP$FR$FR
231045954$23104595$4$F$$20240828$20231025$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03672$AMNEAL$$$$$F$Y$$$20240905$$CN$US$US
231049018$23104901$8$F$20240306$20240907$20231025$20240910$EXP$$NVSC2023EG225707$NOVARTIS$$37$YR$$M$Y$67$KG$20240910$$CN$EG$EG
2310491814$23104918$14$F$20220101$20240802$20231025$20240812$EXP$$NVSC2023MX145847$NOVARTIS$$$$$F$Y$79$KG$20240812$$CN$MX$MX
231051292$23105129$2$F$$20240628$20231025$20240703$PER$$JP-Eisai-EC-2023-150701$EISAI$$74$YR$E$F$Y$$$20240703$$MD$JP$JP
231052349$23105234$9$F$20231006$20240829$20231025$20240903$EXP$$US-TAKEDA-2023TUS026126$TAKEDA$$81$YR$$F$Y$66$KG$20240903$$HP$US$US
231052722$23105272$2$F$$20240919$20231025$20240927$EXP$$JP-ROCHE-3444892$ROCHE$$7$DEC$E$F$Y$$$20240927$$MD$JP$JP
231052835$23105283$5$F$20230901$20240805$20231025$20240814$PER$$JP-Eisai-EC-2023-148604$EISAI$$$$E$F$Y$$$20240814$$MD$JP$JP
231053356$23105335$6$F$$20240710$20231025$20240710$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-143311$DAIICHI$$$$$F$Y$$$20240710$$CN$US$US
231056424$23105642$4$F$20190101$20240820$20231025$20240822$EXP$$US-PFIZER INC-PV202300174833$PFIZER$$65$YR$$F$Y$$$20240822$$HP$US$US
231058084$23105808$4$F$20230101$20240904$20231025$20240908$EXP$$US-ABBVIE-5464290$ABBVIE$$$$$M$Y$$$20240908$$CN$US$US
231058842$23105884$2$F$19940401$20240709$20231025$20240716$EXP$DE-EMA-DD-20231012-225467-082753$DE-MYLANLABS-2023M1110846$MYLAN$Not reported. Rifampicin-induced acute adrenal insufficiency during renal tuberculosis. Clinical facts. 1996;916-918$52$YR$$M$Y$$$20240716$$MD$DE$DE
231059073$23105907$3$F$20230208$20240708$20231025$20240712$PER$$JP-Eisai-EC-2023-149795$EISAI$$67$YR$E$F$Y$51$KG$20240712$$MD$JP$JP
2310620314$23106203$14$F$20230101$20240920$20231025$20240927$EXP$$CA-KARYOPHARM-2023KPT001594$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240927$$CN$CA$CA
2310629012$23106290$12$F$20230918$20240826$20231025$20240905$EXP$$CN-VER-202300001$VERITY PHARMACEUTICALS$$72$YR$E$M$Y$51$KG$20240905$$HP$CN$CN
231063152$23106315$2$F$20231022$20240710$20231025$20240712$PER$$US-AMGEN-USASP2023189018$AMGEN$$65$YR$E$F$Y$$$20240712$$CN$US$US
231063752$23106375$2$F$20170101$20240910$20231025$20240916$EXP$$CA-SANDOZ INC.-PHHY2017CA010851$SANDOZ$$76$YR$$M$Y$$$20240916$$CN$CA$CA
231064473$23106447$3$F$20230919$20240807$20231025$20240812$EXP$$ES-ABBVIE-5453348$ABBVIE$$20$YR$$F$Y$60$KG$20240812$$MD$ES$ES
231064624$23106462$4$F$20231001$20240725$20231025$20240730$EXP$$CA-ABBVIE-5464925$ABBVIE$$74$YR$$F$Y$$$20240730$$MD$CA$CA
231064877$23106487$7$F$20220608$20240722$20231025$20240724$EXP$$NVSJ2023JP015326$NOVARTIS$$73$YR$$M$Y$46.6$KG$20240724$$CN$JP$JP
231065422$23106542$2$F$20230101$20240620$20231026$20240702$PER$$US-SA-2023SA323533$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240702$$MD$US$US
231066125$23106612$5$F$20230901$20240617$20231026$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004431$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240712$$CN$US$US
231067484$23106748$4$F$20230101$20240925$20231026$20240930$PER$$CA-TOLMAR, INC.-23CA043973$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
231067504$23106750$4$F$20240130$20240910$20231026$20240930$PER$$CA-TOLMAR, INC.-23CA043982$TOLMAR$$81$YR$$M$Y$$$20240930$$CN$CA$CA
231067514$23106751$4$F$$20240909$20231026$20240927$PER$$CA-TOLMAR, INC.-23CA043975$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
231067664$23106766$4$F$20230101$20240703$20231026$20240711$EXP$$JP-Eisai-EC-2023-150864$EISAI$Kuroyanagi M. A case of uterine carcinosarcoma with severe irAe-associated encephalitis during lenvatinib and pembrolizumab therapy. Society of Gynecological Oncology.$73$YR$E$F$Y$$$20240711$$MD$JP$JP
231067803$23106780$3$F$$20240805$20231026$20240816$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK085863$GLENMARK$$$$$$Y$$$20240816$$HP$CA$CA
231069374$23106937$4$F$$20240920$20231026$20240925$EXP$$US-SA-2023SA327946$SANOFI AVENTIS$$$$E$F$Y$$$20240925$$MD$US$US
231069799$23106979$9$F$20231016$20240903$20231026$20240911$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000976$DECIPHERA PHARMACEUTICALS$$71$YR$E$M$Y$$$20240911$$CN$US$US
231070382$23107038$2$F$$20240904$20231026$20240911$EXP$$US-CIPLA LTD.-2023US06525$CIPLA$Nepal N, Okam N, Ahmed-Khan M, Vargas J.. When workout goes wrong: Spontaneous coronary artery dissection in a bodybuilder on anabolic steroids. Chest. 2023;164 (4) Suppl:A551$$$$$Y$$$20240911$$HP$US$US
231070543$23107054$3$F$20240408$20240620$20231026$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003568$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240712$$CN$US$US
231070603$23107060$3$F$20231018$20240725$20231026$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004450$ACADIA PHARMACEUTICALS$$61$YR$$F$Y$42.63$KG$20240816$$CN$US$US
231071844$23107184$4$F$20231001$20240625$20231026$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003811$ACADIA PHARMACEUTICALS$$13$YR$$F$Y$$$20240719$$CN$US$US
231071872$23107187$2$F$$20240815$20231026$20240822$EXP$$GR-AMGEN-GRCSP2023188649$AMGEN$$$$$F$Y$$$20240822$$MD$GR$GR
231071919$23107191$9$F$20230301$20240909$20231026$20240919$EXP$$DE-ROCHE-3445332$ROCHE$$49$YR$A$F$Y$107$KG$20240919$$MD$DE$DE
231073054$23107305$4$F$$20240715$20231026$20240720$EXP$$NVSC2023US228283$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
231074025$23107402$5$F$20230915$20240802$20231026$20240808$EXP$$BR-CELLTRION INC.-2023BR020643$CELLTRION$$$$$$Y$$$20240808$$CN$BR$BR
231074233$23107423$3$F$$20240722$20231026$20240731$EXP$$US-NOVOPROD-1117523$NOVO NORDISK$$$$A$M$Y$$$20240731$$CN$US$US
231074622$23107462$2$F$$20240705$20231026$20240712$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-151035$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240712$$HP$CA$CA
231075486$23107548$6$F$$20240807$20231026$20240813$EXP$JP-MMM-I1M08YL2$JP-GSK-JP2023146002$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$MD$JP$JP
231075783$23107578$3$F$$20240909$20231026$20240921$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK085823$GLENMARK$$$$$$Y$$$20240921$$CN$CA$CA
2310760610$23107606$10$F$$20240808$20231026$20240816$EXP$$NVSC2023US225072$NOVARTIS$$$$$M$Y$$$20240816$$CN$US$US
231076144$23107614$4$F$20231215$20240918$20231026$20240928$EXP$$CA-CELLTRION INC.-2023CA020703$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
231076203$23107620$3$F$$20240925$20231026$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-152173$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240926$$CN$US$US
231077227$23107722$7$F$20220101$20240910$20231026$20240918$EXP$$CA-CELLTRION INC.-2023CA004940$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
231077475$23107747$5$F$20231001$20240717$20231026$20240723$PER$$US-BIOGEN-2023BI01232440$BIOGEN$$62$YR$$M$Y$$$20240723$$CN$US$US
231077944$23107794$4$F$20210919$20240624$20231026$20240702$EXP$$JP-009507513-2308JPN004496J$MERCK$$72$YR$$M$Y$$$20240702$$MD$JP$JP
231080013$23108001$3$F$20231005$20231110$20231026$20240710$EXP$$GB-ROCHE-3441411$ROCHE$$59$YR$A$F$Y$$$20240710$$MD$GB$GB
231080333$23108033$3$F$$20240812$20231026$20240920$EXP$$US-BEH-2023164460$CSL BEHRING$$$$E$M$Y$$$20240920$$HP$US$US
231080356$23108035$6$F$20230918$20240829$20231026$20240902$EXP$$CN-CHEPLA-2023012854$CHEPLAPHARM$$68$YR$$M$Y$63$KG$20240902$$MD$COUNTRY NOT SPECIFIED$CN
231080864$23108086$4$F$$20240806$20231026$20240814$EXP$$CA-TEVA-2023-CA-2937768$TEVA$$30$YR$$M$Y$$$20240814$$MD$CA$CA
231081125$23108112$5$F$20231023$20240718$20231026$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-152352$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240719$$CN$US$US
231081263$23108126$3$F$20170501$20240801$20231026$20240809$EXP$$CA-TAKEDA-2017TUS010135$TAKEDA$$70$YR$$F$Y$$$20240809$$CN$CA$CA
231082603$23108260$3$F$20230818$20240628$20231026$20240705$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2023-130350$REGENERON$$$$$M$Y$$$20240705$$CN$CO$CO
231084062$23108406$2$F$$20240621$20231026$20240722$PER$$US-INCYTE CORPORATION-2023IN009748$INCYTE$$$$$$Y$$$20240719$$CN$US$US
231086423$23108642$3$F$$20240227$20231026$20240806$EXP$$NVSC2023ZA164314$NOVARTIS$$69$YR$$F$Y$$$20240806$$HP$ZA$ZA
231086723$23108672$3$F$$20240627$20231026$20240704$PER$$US-BIOGEN-2023BI01222083$BIOGEN$$$$$F$Y$$$20240704$$CN$US$US
231087074$23108707$4$F$20231010$20240627$20231026$20240706$EXP$$CO-TAKEDA-2023TUS098678$TAKEDA$$34$YR$$M$Y$49$KG$20240706$$CN$CO$CO
231087712$23108771$2$F$$20240723$20231026$20240801$PER$$US-SA-2023SA323071$SANOFI AVENTIS$$$$E$M$Y$$$20240801$$MD$US$US
231087893$23108789$3$F$$20240820$20231026$20240830$PER$$US-SA-2023SA322508$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240830$$MD$US$US
231087943$23108794$3$F$20230101$20240710$20231026$20240718$PER$$US-SA-2023SA324224$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240718$$MD$US$US
231088973$23108897$3$F$20230101$20240720$20231026$20240729$PER$$US-SA-2023SA328121$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240729$$MD$US$US
231090304$23109030$4$F$20230616$20240708$20231026$20240709$EXP$$CA-UCBSA-2023050986$UCB$$32$YR$$F$Y$$$20240709$$MD$CA$CA
231090366$23109036$6$F$20231020$20240811$20231026$20240814$EXP$$US-TAKEDA-2023TUS096822$TAKEDA$$38$YR$$M$Y$$$20240814$$MD$US$US
231090372$23109037$2$F$$20240823$20231026$20240910$PER$$US-SA-2023SA327928$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$MD$US$US
231091202$23109120$2$F$20200101$20240703$20231026$20240705$EXP$$US-PFIZER INC-PV202200050142$PFIZER$$67$YR$$M$Y$$$20240705$$HP$US$US
231093586$23109358$6$F$$20240111$20231026$20240911$EXP$$NVSC2023US226958$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
231094092$23109409$2$F$20231024$20231024$20231026$20240813$PER$$NVSC2023US229385$NOVARTIS$$27$YR$$F$Y$$$20240813$$CN$US$US
231094986$23109498$6$F$$20231019$20231026$20240816$EXP$$NVSC2023US226466$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
231096494$23109649$4$F$20230822$20240710$20231026$20240712$EXP$$IT-BAUSCHBL-2023BNL010439$BAUSCH AND LOMB$$56$YR$$M$Y$$$20240712$$HP$IT$IT
2310972813$23109728$13$F$$20240909$20231026$20240926$EXP$$CA-GSK-CA2021268668$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$CA$CA
231098144$23109814$4$F$20231013$20240805$20231026$20240810$EXP$$AU-TAKEDA-2022TUS090001$TAKEDA$$61$YR$$M$Y$$$20240810$$CN$AU$AU
231098602$23109860$2$F$$20240627$20231026$20240708$PER$$US-SA-2023SA322505$SANOFI AVENTIS$$$$E$M$Y$$$20240708$$MD$US$US
231099232$23109923$2$F$$20240806$20231026$20240813$EXP$$BR-TAKEDA-2023TUS046416$TAKEDA$$$$$M$Y$$$20240813$$CN$BR$BR
2311021313$23110213$13$F$$20240919$20231026$20240927$EXP$$CA-OTSUKA-2023_008159$OTSUKA$$$$$M$Y$$$20240927$$MD$CA$CA
231103124$23110312$4$F$20231016$20240802$20231026$20240812$PER$$US-SA-2023SA322803$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240812$$MD$US$US
231103163$23110316$3$F$$20240813$20231026$20240821$PER$$US-SA-2023SA323672$SANOFI AVENTIS$$$$A$M$Y$90.703$KG$20240821$$MD$US$US
231103295$23110329$5$F$20240501$20240625$20231026$20240701$EXP$$US-INCYTE CORPORATION-2023IN010823$INCYTE$$$$$$Y$$$20240701$$CN$US$US
231104314$23110431$4$F$$20240801$20231026$20240810$EXP$$US-TEVA-2023-US-2937914$TEVA$Chajkowski A, Rodriguez CA Clostridium Difficile Bacteremia: Going Beyond the Gut. American Journal of Respiratory and Critical Care Medicine 209: , No. 0, May 2024.; Chajkowski A, Rodriguez CA, Qaiser S, Yosry N, Adelizzi A. CLOSTRIDIUM DIFFICILE BACTEREMIA: GOING BEYOND THE GUT. Chest 2023; 164 (Suppl.) (4): A2548-A2549.; Chajkowski A, Rodriguez CA, Qaiser S, Yosry N, Adelizzi A. CLOSTRIDIUM DIFFICILE BACTEREMIA: GOING BEYOND THE GUT. Chest 2023;164(4):A2548-A2549 (plus poster).$71$YR$$M$Y$$$20240810$$HP$US$US
231105756$23110575$6$F$20231001$20240711$20231026$20240722$PER$$US-SA-2023SA323094$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240722$$MD$US$US
231106092$23110609$2$F$$20240912$20231026$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-414408$RANBAXY$Tanaka K, Yujiro K, Kawahata T, Yuichi M, Okubo T, Sato T, et al. BASELINE MODIFIED TOTAL SHARP SCORE MAY BE A PREDICTOR FOR FLARE AND SUCCESSIVE JOINT DAMAGE IN TAPERING OF METHOTREXATE. Ann Rheum Dis. 2023;82(suppl 1):1427-1428(AB0469)$$$E$$Y$$$20240927$$HP$JP$JP
231106372$23110637$2$F$$20240912$20231026$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-414370$RANBAXY$Macklin PS, Fisher R, Stonard C, Matin RN, Ieremia E. Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer - A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature. Am J Dermatopathol. 2023;45(8):519-528$85$YR$$M$Y$$$20240927$$HP$GB$GB
231106692$23110669$2$F$$20240806$20231026$20240821$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392840$RANBAXY$Hu X, Jing M, Wang Y, Liu Y, Hua Y. Functional analysis of a novel de novo SCN2A variant in a patient with seizures refractory to oxcarbazepine. Front Mol Neurosci. 2023;16:1159649(01-04)$$$N$F$Y$$$20240821$$HP$CN$CN
231107292$23110729$2$F$$20240704$20231026$20240718$EXP$$CO-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-414423$RANBAXY$Cajamarca-Baron J, Sanmiguel Reyes C, Bedoya E, Lamos A, Rivadeneira Chamorro S, Guevara D, et al. Intravenous Immunoglobulin In Pregnant Women With Severe Active Lupus: A Case Series. Ann Rheum Dis. 2023;82(Suppl. 1):1473$25$YR$$F$Y$$$20240718$$HP$CO$CO
231107833$23110783$3$F$$20240816$20231026$20240826$PER$$US-INCYTE CORPORATION-2023IN010296$INCYTE$$$$$$Y$$$20240826$$CN$US$US
231113285$23111328$5$F$20230101$20240812$20231026$20240823$EXP$$US-UCBSA-2023028043$UCB$$$$$F$Y$66.22$KG$20240823$$CN$US$US
231114467$23111446$7$F$20230819$20240812$20231026$20240816$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-245109$BOEHRINGER INGELHEIM$$57$YR$A$F$Y$$$20240816$$CN$US$US
231114872$23111487$2$F$$20240806$20231026$20240809$EXP$$AU-AstraZeneca-2023A240187$ASTRAZENECA$$20383$DY$$M$Y$$$20240809$$MD$AU$
231115042$23111504$2$F$20180701$20240815$20231026$20240822$EXP$$CO-TAKEDA-2018TUS024732$TAKEDA$$44$YR$$M$Y$66$KG$20240822$$MD$CO$CO
231115752$23111575$2$F$20230101$20240730$20231026$20240801$EXP$$JP-DSJP-DSJ-2023-143761$DAIICHI$$34$YR$$M$Y$63.5$KG$20240801$$MD$JP$JP
231115974$23111597$4$F$20231001$20231114$20231026$20240925$PER$$US-GSK-US2023AMR146267$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240925$$CN$US$US
231116272$23111627$2$F$$20240828$20231026$20240909$PER$$US-SA-2023SA325009$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240909$$CN$US$US
2311163610$23111636$10$F$20220120$20240923$20231026$20240930$EXP$$NVSC2020CO371021$NOVARTIS$$50$YR$$F$Y$53$KG$20240930$$CN$CO$CO
231116552$23111655$2$F$20230926$20240701$20231026$20240708$EXP$$DE-MYLANLABS-2023M1111726$MYLAN$$85$YR$$F$Y$61$KG$20240708$$MD$DE$DE
231118922$23111892$2$F$$20240910$20231026$20240917$EXP$$PH-OTSUKA-2023_027454$OTSUKA$$$$$F$Y$$$20240917$$CN$PH$PH
231118933$23111893$3$F$$20240801$20231026$20240810$EXP$$CA-TEVA-2023-CA-2938379$TEVA$$26$YR$$F$Y$$$20240810$$HP$CA$CA
231119264$23111926$4$F$$20240819$20231026$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-152166$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$72.57$KG$20240826$$CN$US$US
231119312$23111931$2$F$20190401$20240827$20231026$20240904$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2023-152217$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$54$KG$20240904$$HP$KR$KR
231119426$23111942$6$F$20230101$20240919$20231026$20240923$EXP$$US-PFIZER INC-202300347225$PFIZER$$68$YR$$F$Y$$$20240923$$HP$US$US
2311204412$23112044$12$F$20230210$20240910$20231026$20240917$EXP$$NVSC2023US229900$NOVARTIS$$58$YR$$F$Y$53$KG$20240918$$MD$US$US
231120734$23112073$4$F$20230901$20240717$20231026$20240723$EXP$$JP-009507513-2309JPN002745J$MERCK$$7$DEC$$M$Y$$$20240723$$MD$JP$JP
231120742$23112074$2$F$$20240828$20231026$20240830$EXP$$US-INDIVIOR EUROPE LIMITED-INDV-141454-2023$RECKITT BENCKISER$$$$$$Y$$$20240830$$MD$US$US
231120775$23112077$5$F$$20240912$20231026$20240918$EXP$$JP-009507513-2310JPN002842J$MERCK$$61$YR$$F$Y$$$20240918$$MD$JP$JP
231120794$23112079$4$F$20231013$20240701$20231026$20240711$EXP$$US-BIOMARINAP-US-2023-153561$BIOMARIN$$$$$$Y$$$20240711$$CN$US$US
2311212410$23112124$10$F$20230601$20240715$20231026$20240724$PER$$US-Blueprint Medicines Corporation-SP-US-2023-001684$BLUEPRINT MEDICINES$$35$YR$A$F$Y$$$20240724$$CN$US$US
231121826$23112182$6$F$20231012$20240920$20231026$20240925$EXP$$US-BIOGEN-2023BI01232577$BIOGEN$$64$YR$$M$Y$$$20240925$$CN$US$US
231122309$23112230$9$F$$20240806$20231026$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-117215$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240808$$CN$US$US
231122393$23112239$3$F$20221101$20240725$20231026$20240725$EXP$$AU-ROCHE-3108556$ROCHE$$44$YR$A$F$Y$$$20240725$$CN$AU$AU
231122904$23112290$4$F$$20240820$20231026$20240820$EXP$$GR-ROCHE-3445069$ROCHE$$$$$F$Y$$$20240820$$MD$GR$GR
231124198$23112419$8$F$20220101$20240802$20231027$20240813$EXP$$JP-ABBVIE-5466560$ABBVIE$Inamine I. IBRUTINIB for Pediatric and AYA Chronic GVHD: A Review of Experienced Cases. Proceedings of the 46th JSTCT Annual Meeting (JSTCT2024) Japanese Society for Transplantation and Cellular Therapy. 2024;243.$$$$M$Y$58$KG$20240813$$MD$JP$JP
231124224$23112422$4$F$$20240905$20231027$20240924$PER$$CA-TOLMAR, INC.-23CA043872$TOLMAR$$$$$M$Y$$$20240924$$CN$CA$CA
231124253$23112425$3$F$20231004$20240614$20231027$20240703$PER$$CA-TOLMAR, INC.-23CA043877$TOLMAR$$84$YR$$M$Y$$$20240703$$CN$CA$CA
231125763$23112576$3$F$$20240409$20231027$20240808$EXP$$HU-SANDOZ INC.-NVSC2023HU030459$SANDOZ$$$$A$F$Y$$$20240808$$MD$HU$HU
231126039$23112603$9$F$20231004$20240802$20231027$20240808$EXP$$DE-SANDOZ INC.-SDZ2023DE046592$SANDOZ$$$$A$F$Y$68$KG$20240808$$HP$DE$DE
231126472$23112647$2$F$20231017$20240626$20231027$20240713$PER$$US-ABBVIE-5468515$ABBVIE$$31$YR$$F$Y$$$20240713$$CN$US$US
231126544$23112654$4$F$20231006$20240906$20231027$20240924$PER$$CA-TOLMAR, INC.-23CA043933$TOLMAR$$60$YR$$M$Y$$$20240924$$CN$CA$CA
231126555$23112655$5$F$20231228$20240904$20231027$20240924$PER$$CA-TOLMAR, INC.-23CA043938$TOLMAR$$73$YR$$M$Y$$$20240924$$CN$CA$CA
231126563$23112656$3$F$20231006$20240903$20231027$20240920$PER$$CA-TOLMAR, INC.-23CA043936$TOLMAR$$62$YR$$M$Y$$$20240919$$CN$CA$CA
231126574$23112657$4$F$$20240907$20231027$20240924$PER$$CA-TOLMAR, INC.-23CA043934$TOLMAR$$$$$M$Y$$$20240924$$CN$CA$CA
231126593$23112659$3$F$20230901$20240904$20231027$20240924$PER$$CA-TOLMAR, INC.-23CA044237$TOLMAR$$83$YR$$M$Y$$$20240924$$CN$CA$CA
231126986$23112698$6$F$20230906$20240918$20231027$20240927$EXP$$CA-CELLTRION INC.-2023CA014720$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
231127032$23112703$2$F$20240911$20240919$20231027$20240926$EXP$$CO-GSK-CO2023AMR145560$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CO$CO
231127252$23112725$2$F$$20231024$20231027$20240925$PER$$US-GSK-US2023AMR147542$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
231129273$23112927$3$F$$20240916$20231027$20240927$PER$$US-SA-2023SA239096$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240927$$MD$US$US
231129794$23112979$4$F$$20240905$20231027$20240911$EXP$FR-EMA-20150408-AUTODUP-436097$FR-ROCHE-3441768$ROCHE$Khanafer N, Neuraz A, Benet T, Cour M, Persat F, Labussiere H et al. Acute graft-versus-host disease, invasive aspergillosis and Clostridium difficile colitis after peripheral blood stem cell transplantation: A complex network of causalities and a challenge for prevention. Anaerobe. 2015;33:98-100.$58$YR$A$M$Y$$$20240911$$HP$FR$FR
231130842$23113084$2$F$20190928$20240916$20231027$20240924$EXP$$CO-SANDOZ INC.-NVSC2019CO012896$SANDOZ$$70$YR$$F$Y$60$KG$20240924$$CN$CO$CO
231131535$23113153$5$F$20230901$20240914$20231027$20240923$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-263900$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$74.8$KG$20240923$$CN$US$US
231131583$23113158$3$F$$20240628$20231027$20240705$EXP$$NL-AMGEN-NLDSL2023188105$AMGEN$$79$YR$E$M$Y$$$20240705$$MD$NL$NL
231132332$23113233$2$F$$20240912$20231027$20240923$PER$$US-GSK-US2023143898$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
2311336524$23113365$24$F$20230101$20240805$20231027$20240810$EXP$$JP-JNJFOC-20231065510$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240810$$HP$JP$JP
231133809$23113380$9$F$20230901$20240726$20231027$20240819$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004461$ACADIA PHARMACEUTICALS$$13$YR$$F$Y$$$20240819$$CN$US$US
231133902$23113390$2$F$20230701$20230725$20231027$20240710$PER$$CN-ROCHE-3395988$ROCHE$$32$YR$A$M$Y$80$KG$20240628$$CN$CN$CN
231134004$23113400$4$F$20231113$20240731$20231027$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004469$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240823$$CN$US$US
231134029$23113402$9$F$20230504$20240920$20231027$20240930$EXP$$CA-CELLTRION INC.-2023CA009809$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
231135174$23113517$4$F$20230918$20240709$20231027$20240712$EXP$$IL-TAKEDA-2023TUS091046$TAKEDA$$43$YR$$F$Y$84$KG$20240712$$MD$IL$IL
231135365$23113536$5$F$20231014$20240903$20231027$20240910$EXP$$US-GSK-US2023144295$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
231135394$23113539$4$F$20230101$20240822$20231027$20240824$PER$$US-AMGEN-USASP2023188745$AMGEN$$55$YR$A$M$Y$$$20240824$$HP$US$US
231135505$23113550$5$F$20231027$20240906$20231027$20240912$EXP$$JP-ABBVIE-5283608$ABBVIE$$62$YR$$F$Y$$$20240912$$CN$JP$JP
231136702$23113670$2$F$$20240708$20231027$20240709$EXP$$CA-SANDOZ INC.-NVSC2023CA100202$SANDOZ$$$$$M$Y$$$20240709$$HP$CA$CA
231137596$23113759$6$F$20230101$20240821$20231027$20240822$EXP$$US-UCBSA-2023051103$UCB$$$$$F$Y$$$20240822$$CN$US$US
2311379411$23113794$11$F$$20240925$20231027$20240927$EXP$$CA-ROCHE-3374376$ROCHE$$47$YR$A$F$Y$$$20240927$$HP$CA$CA
231138256$23113825$6$F$20230902$20240914$20231027$20240920$EXP$$CO-TAKEDA-2023TUS061486$TAKEDA$$46$YR$$F$Y$56$KG$20240920$$CN$CO$CO
231138415$23113841$5$F$$20240827$20231027$20240903$EXP$$US-GSK-US2023146761$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
231142899$23114289$9$F$20230413$20240821$20231027$20240826$EXP$$BE-AUROBINDO-AUR-APL-2023-064810$AUROBINDO$$85$YR$$M$Y$$$20240827$$MD$BE$BE
231142913$23114291$3$F$20210301$20240912$20231027$20240913$EXP$$DE-SANDOZ INC.-SDZ2023DE044364$SANDOZ$$27$YR$$F$Y$$$20240913$$HP$DE$DE
231143524$23114352$4$F$$20240722$20231027$20240725$EXP$$US-BIOGEN-2023BI01228761$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
231144273$23114427$3$F$$20240629$20231027$20240703$EXP$$JP-009507513-2310JPN003587J$MERCK$$92$YR$$M$Y$$$20240703$$MD$JP$JP
2311446813$23114468$13$F$20230101$20240703$20231027$20240710$EXP$$CA-PFIZER INC-202300260205$PFIZER$$32$YR$$F$Y$$$20240710$$HP$CA$CA
231145842$23114584$2$F$$20240814$20231027$20240828$PER$$US-SA-2023SA327039$SANOFI AVENTIS$$6$YR$C$F$Y$24$KG$20240828$$MD$US$US
231146352$23114635$2$F$20230101$20240712$20231027$20240723$PER$$US-SA-2023SA330028$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240723$$MD$US$US
231146392$23114639$2$F$20231011$20240816$20231027$20240829$PER$$US-SA-2023SA329562$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240829$$MD$US$US
231146962$23114696$2$F$$20240708$20231027$20240722$EXP$DE-CHIESI-2023CHF04633$DE-TORRENT-00025588$TORRENT$$31$YR$A$F$Y$82$KG$20240719$$MD$DE$DE
231147926$23114792$6$F$20231019$20240626$20231027$20240703$PER$$US-BIOGEN-2023BI01232328$BIOGEN$$67$YR$$F$Y$$$20240703$$CN$US$US
231148373$23114837$3$F$20240101$20240625$20231027$20240705$EXP$$JP-009507513-2310JPN002889J$MERCK$$70$YR$$M$Y$$$20240705$$MD$JP$JP
231149972$23114997$2$F$20240701$20240729$20231027$20240807$PER$$US-SA-2023SA323115$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240807$$MD$US$US
231149995$23114999$5$F$20230101$20240829$20231027$20240923$PER$$US-SA-2023SA329932$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240923$$CN$US$US
231151045$23115104$5$F$20230101$20240730$20231027$20240806$PER$$US-BIOGEN-2023BI01232068$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
231151753$23115175$3$F$20230717$20240705$20231027$20240715$EXP$IT-MINISAL02-947956$IT-TEVA-2023-IT-2938456$TEVA$$7$YR$$F$Y$$$20240715$$PH$IT$IT
231152892$23115289$2$F$20230101$20240722$20231027$20240729$EXP$$IT-UCBSA-2023051358$UCB$$$$E$M$Y$$$20240729$$CN$IT$IT
231153137$23115313$7$F$20230101$20240716$20231027$20240722$EXP$$CA-PFIZER INC-202300337442$PFIZER$$30$YR$$M$Y$$$20240722$$HP$CA$CA
231154122$23115412$2$F$20170101$20240821$20231027$20240830$EXP$$CA-SANDOZ INC.-PHHY2017CA014133$SANDOZ$$$$$F$Y$105$KG$20240830$$MD$CA$CA
231159692$23115969$2$F$20230101$20240819$20231027$20240828$PER$$US-SA-2023SA323866$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240828$$MD$US$US
231161043$23116104$3$F$$20240723$20231027$20240725$EXP$$US-PFIZER INC-202300348265$PFIZER$$82$YR$$M$Y$$$20240725$$PH$US$US
231162414$23116241$4$F$20160701$20240805$20231027$20240807$EXP$FR-AFSSAPS-RN20161244$FR-SANDOZ INC.-PHHY2018FR120334$SANDOZ$$76$YR$$F$Y$$$20240807$$MD$FR$FR
231162672$23116267$2$F$20230401$20240628$20231027$20240703$EXP$$CR-PFIZER INC-PV202300163518$PFIZER$$49$YR$$F$Y$$$20240703$$HP$CR$CR
231162883$23116288$3$F$20230803$20240802$20231027$20240816$EXP$$LT-VER-202300001$VERITY PHARMACEUTICALS$$77$YR$E$M$Y$79$KG$20240816$$HP$LT$LT
2311631113$23116311$13$F$20231001$20240722$20231027$20240725$EXP$$US-PFIZER INC-202300347216$PFIZER$$39$YR$$M$Y$$$20240725$$CN$US$US
2311632715$23116327$15$F$20231001$20240903$20231027$20240905$EXP$$US-PFIZER INC-202300348027$PFIZER$$70$YR$$F$Y$104.31$KG$20240905$$CN$US$US
231163286$23116328$6$F$20231016$20240918$20231027$20240925$EXP$$US-SA-2023SA324991$SANOFI AVENTIS$$59$YR$A$M$Y$114$KG$20240925$$MD$US$US
231163404$23116340$4$F$20240101$20240920$20231027$20240925$EXP$$US-PFIZER INC-202300347198$PFIZER$$48$YR$$F$Y$$$20240925$$CN$US$US
231164449$23116444$9$F$20230101$20240724$20231027$20240726$EXP$$CA-PFIZER INC-202300276652$PFIZER$$28$YR$$M$Y$78$KG$20240726$$MD$CA$CA
231164732$23116473$2$F$20230101$20240817$20231027$20240829$PER$$US-SA-2023SA329907$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240829$$MD$US$US
231164914$23116491$4$F$20230905$20240715$20231027$20240724$PER$$US-SA-2023SA325484$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240724$$MD$US$US
231164923$23116492$3$F$20230101$20240712$20231027$20240716$PER$$US-AMGEN-USASP2023191484$AMGEN$$66$YR$E$F$Y$$$20240715$$HP$US$US
231165727$23116572$7$F$$20240826$20231027$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-150974$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240902$$CN$US$US
231165804$23116580$4$F$20231024$20240703$20231027$20240704$EXP$$BR-TAKEDA-2023TUS104024$TAKEDA$$25$YR$$M$Y$$$20240704$$MD$BR$BR
2311661312$23116613$12$F$20230325$20240723$20231027$20240731$EXP$$JP-ARGENX-2023-ARGX-JP003603$ARGENX BVBA$$$$$$Y$$$20240731$$CN$JP$JP
231167503$23116750$3$F$$20240914$20231027$20240918$EXP$$NVSC2022GB202563$NOVARTIS$$$$A$F$Y$$$20240918$$CN$GB$GB
231167814$23116781$4$F$20230622$20240703$20231027$20240711$PER$$JP-Eisai-EC-2023-144400$EISAI$$55$YR$A$M$Y$$$20240711$$MD$JP$JP
231167873$23116787$3$F$20230101$20240827$20231027$20240904$EXP$$CA-TAKEDA-2023TUS043341$TAKEDA$$$$$F$Y$79.7$KG$20240904$$CN$CA$CA
231168099$23116809$9$F$20231018$20240904$20231027$20240906$EXP$$CA-TAKEDA-2023TUS102674$TAKEDA$$70$YR$$F$Y$$$20240906$$CN$CA$CA
231168522$23116852$2$F$$20240913$20231027$20240927$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-414627$RANBAXY$Sureshkumar K, Srinivasan K, Lingeshwaran GP, Durairaj M, Thiruvengadam G, Mary Martin Daniel PJ, et al. Toxicity profile, adverse drug reactions and drug-drug interactions among geriatric cancer patients under metronomic chemotherapy in a South Indian tertiary care hospital. J Oncol Pharm Pract. 2023;29(4):778-784$$$E$$Y$$$20240927$$HP$IN$IN
231169624$23116962$4$F$$20240715$20231027$20240722$EXP$$CA-SANDOZ INC.-NVSC2022CA213187$SANDOZ$$60$YR$$F$Y$$$20240722$$HP$CA$CA
231169854$23116985$4$F$20230914$20240813$20231027$20240828$EXP$$NL-VER-202300081$VERITY PHARMACEUTICALS$$75$YR$E$M$Y$75$KG$20240828$$HP$NL$NL
231169934$23116993$4$F$20240601$20240705$20231027$20240715$EXP$$BR-TAKEDA-2023TUS103010$TAKEDA$$52$YR$$M$Y$81$KG$20240715$$CN$BR$BR
231169962$23116996$2$F$$20231023$20231027$20240828$EXP$$US-ABBVIE-5469922$ABBVIE$Nepal N, Okam N, Ahmed-Khan M, Vargas J, Okam N. When workout goes wrong: spontaneous coronary artery dissection in a bodybuilder on anabolic steroids. CHEST. 2023:551A.$34$YR$$M$Y$$$20240828$$HP$US$US
231170532$23117053$2$F$20231019$20231019$20231027$20240715$PER$$US-MYLANLABS-2023M1111316$BIOCON$$17$YR$$F$Y$$$20240715$$$US$US
231171515$23117151$5$F$20231020$20240430$20231027$20240816$PER$$US-MYLANLABS-2023M1112006$BIOCON$$64$YR$$M$Y$72.56$KG$20240816$$PH$US$US
231172385$23117238$5$F$$20240722$20231027$20240725$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-021588$JAZZ$$$$$F$Y$$$20240725$$HP$US$US
231172412$23117241$2$F$$20240816$20231027$20240826$PER$$US-INCYTE CORPORATION-2023IN010560$INCYTE$$$$$$Y$$$20240826$$CN$US$US
231172603$23117260$3$F$$20240805$20231027$20240821$PER$$US-INCYTE CORPORATION-2023IN010812$INCYTE$$$$$$Y$$$20240822$$CN$US$US
231172823$23117282$3$F$$20240816$20231027$20240906$PER$$US-INCYTE CORPORATION-2023IN010968$INCYTE$$$$$$Y$$$20240906$$CN$US$US
231174512$23117451$2$F$20230501$20240624$20231027$20240703$PER$$JP-Eisai-EC-2023-150953$EISAI$$$$E$F$Y$$$20240703$$MD$JP$JP
231176083$23117608$3$F$$20240830$20231027$20240902$EXP$$IT-SANDOZ INC.-SDZ2023IT047057$SANDOZ$$55$YR$$F$Y$$$20240902$$HP$IT$IT
231178545$23117854$5$F$$20240910$20231027$20240913$PER$$US-PFIZER INC-PV202200022971$PFIZER$$74$YR$$F$Y$$$20240913$$HP$US$US
231179825$23117982$5$F$$20240625$20231027$20240701$PER$$US-PFIZER INC-202300270002$PFIZER$$81$YR$$F$Y$48.99$KG$20240701$$CN$US$US
231181455$23118145$5$F$20180101$20240720$20231027$20240729$EXP$$CL-BIOMARINAP-CL-2023-153204$BIOMARIN$$$$$$Y$$$20240729$$CN$CL$CL
231183022$23118302$2$F$20110101$20231020$20231028$20240827$EXP$$JP-ABBVIE-5462166$ABBVIE$Furuto Y, Kawamura M, Namikawa A, Takahashi H, Shibuya Y. Successful management of visceral disseminated varicella zoster virus infection during treatment of membranous nephropathy: a case report. BMC Infect Dis. 2019;19(1):2-7.$36$YR$$F$Y$66$KG$20240827$$MD$JP$JP
2311842311$23118423$11$F$$20240827$20231028$20240904$EXP$$CA-CELLTRION INC.-2023CA020663$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
231184373$23118437$3$F$20230723$20240904$20231028$20240912$EXP$$CA-CELLTRION INC.-2023CA015293$CELLTRION$$$$$$Y$$$20240912$$CN$CA$CA
231185033$23118503$3$F$20210201$20240904$20231028$20240908$EXP$$CA-SANDOZ INC.-NVSC2023CA063757$SANDOZ$$67$YR$$F$Y$$$20240908$$MD$CA$CA
231185236$23118523$6$F$$20240715$20231028$20240720$EXP$$CA-SANDOZ INC.-NVSC2023CA052105$SANDOZ$$15$YR$$F$Y$54$KG$20240720$$HP$CA$CA
231185383$23118538$3$F$20230101$20240917$20231028$20240924$EXP$$US-ABBVIE-5345828$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
231186613$23118661$3$F$$20231025$20231028$20240814$PER$$NVSC2023US231283$NOVARTIS$$$$$$Y$$$20240814$$MD$US$US
231186752$23118675$2$F$$20240909$20231028$20240919$30DAY$$US-GSK-US2023144313$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
231188374$23118837$4$F$$20240628$20231028$20240705$EXP$AU-MLMSERVICE-20231010-4597531-1$AU-STRIDES ARCOLAB LIMITED-2023SP015954$STRIDES$McMullen L, Khoo L, Anderson L, Strasser S, Gracey DM.. BK viraemia as a cause of anaemia in after ABO-incompatible liver transplant: a case report.. BMC Infectious Diseases.. 2023;23(1):609$59$YR$$M$Y$$$20240705$$MD$AU$AU
231189043$23118904$3$F$$20240920$20231028$20240930$EXP$$US-TAKEDA-2023TUS104524$TAKEDA$$$$$F$Y$$$20240930$$MD$US$US
231189204$23118920$4$F$20230503$20240809$20231028$20240813$EXP$$US-TAKEDA-2023TUS068105$TAKEDA$$32$YR$$M$Y$$$20240813$$PH$US$US
231189314$23118931$4$F$$20240827$20231028$20240904$EXP$$CA-CELLTRION INC.-2023CA020678$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
231191514$23119151$4$F$20190117$20240729$20231028$20240802$EXP$$ES-SANDOZ INC.-SDZ2023ES046875$SANDOZ$$79$YR$$F$Y$$$20240802$$HP$ES$ES
231191723$23119172$3$F$$20240819$20231028$20240820$EXP$$IT-SANDOZ INC.-SDZ2023IT047314$SANDOZ$$55$YR$$F$Y$$$20240820$$HP$IT$IT
231192767$23119276$7$F$20200101$20240919$20231028$20240920$EXP$$DE-SANDOZ INC.-NVSC2021DE022616$SANDOZ$$80$YR$$M$Y$69$KG$20240920$$HP$DE$DE
231194197$23119419$7$F$20231013$20240815$20231028$20240823$EXP$$CA-TAKEDA-2022TUS034422$TAKEDA$$84$YR$$F$Y$$$20240823$$HP$CA$CA
231194224$23119422$4$F$$20240919$20231028$20240920$EXP$$CA-SANDOZ INC.-NVSC2023CA120197$SANDOZ$$80$YR$$M$Y$69$KG$20240920$$HP$CA$CA
231194239$23119423$9$F$20200601$20240902$20231028$20240905$EXP$DE-002147023-NVSC2021DE318041$DE-SANDOZ INC.-SDZ2023DE047678$SANDOZ$$80$YR$$M$Y$69$KG$20240905$$HP$DE$DE
231194333$23119433$3$F$20231020$20240806$20231028$20240828$EXP$$TW-SANDOZ INC.-SDZ2023TW047598$SANDOZ$$37$YR$$F$Y$47.7$KG$20240828$$MD$TW$TW
231216616$23121661$6$F$$20240709$20231029$20240712$EXP$$CA-SANDOZ INC.-NVSC2021CA315425$SANDOZ$$58$YR$$F$Y$$$20240712$$HP$CA$CA
231216663$23121666$3$F$$20240911$20231029$20240916$EXP$$JP-TAKEDA-2023TJP011303$TAKEDA$$2$YR$$F$Y$$$20240916$$PH$JP$JP
231216692$23121669$2$F$20230801$20240917$20231029$20240928$PER$$US-009507513-2310USA009449$MERCK$$75$YR$$F$Y$$$20240928$$CN$US$US
2312171211$23121712$11$F$20230101$20240709$20231029$20240715$EXP$$NL-ABBVIE-5468312$ABBVIE$$$$A$F$Y$$$20240715$$CN$NL$NL
231217192$23121719$2$F$$20240808$20231029$20240813$EXP$$US-ABBVIE-5445894$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
231217983$23121798$3$F$20221221$20240627$20231030$20240702$EXP$$US-ABBVIE-5469069$ABBVIE$$57$YR$$F$Y$63$KG$20240702$$CN$US$US
231218163$23121816$3$F$20220701$20240717$20231030$20240720$EXP$$US-ABBVIE-5463649$ABBVIE$$58$YR$$F$Y$$$20240720$$CN$US$US
231218787$23121878$7$F$20210313$20240716$20231030$20240724$EXP$$CO-TAKEDA-2020TUS059167$TAKEDA$$45$YR$$M$Y$71$KG$20240724$$HP$CO$CO
231219214$23121921$4$F$20230101$20240822$20231030$20240827$EXP$$CA-JNJFOC-20230671914$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240827$$HP$CA$CA
231219252$23121925$2$F$$20240802$20231030$20240812$PER$$US-SA-2023SA331452$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
231221363$23122136$3$F$20240317$20240812$20231030$20240815$EXP$$CA-TAKEDA-2023TUS058641$TAKEDA$$85$YR$$F$Y$$$20240815$$CN$CA$CA
231221457$23122145$7$F$20240725$20240917$20231030$20240924$EXP$$CA-TAKEDA-2023TUS088322$TAKEDA$$73$YR$$M$Y$$$20240924$$MD$CA$CA
231222493$23122249$3$F$$20240702$20231030$20240711$PER$$US-SA-2023SA331381$SANOFI AVENTIS$$$$E$F$Y$$$20240711$$MD$US$US
231223632$23122363$2$F$20240803$20240807$20231030$20240809$PER$$NVSC2023US229515$NOVARTIS$$37$YR$$F$Y$$$20240809$$CN$US$US
231223716$23122371$6$F$20230101$20240822$20231030$20240830$EXP$$CA-CELLTRION INC.-2023CA020891$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
231223723$23122372$3$F$20231001$20240729$20231030$20240802$PER$$US-SA-2023SA303417$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240802$$MD$US$US
231223892$23122389$2$F$20230511$20240806$20231030$20240808$EXP$$NVSJ2023JP013370$NOVARTIS$$3$YR$$M$Y$$$20240808$$MD$JP$JP
2312244010$23122440$10$F$20230101$20240718$20231030$20240723$EXP$$US-SA-2023SA331269$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240723$$MD$US$US
231224622$23122462$2$F$$20240718$20231030$20240729$EXP$$CA-APOTEX-2023AP016047$APOTEX$$$$A$F$Y$$$20240729$$PH$CA$CA
231224632$23122463$2$F$20220314$20240815$20231030$20240820$EXP$$CA-ROCHE-3053401$ROCHE$$42$YR$A$F$Y$$$20240820$$CN$CA$CA
231224872$23122487$2$F$$20240628$20231030$20240705$PER$$NVSC2023US229558$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
231225015$23122501$5$F$20220101$20240715$20231030$20240723$EXP$$CA-CELLTRION INC.-2022CA015663$CELLTRION$$$$$$Y$$$20240723$$CN$CA$CA
231225035$23122503$5$F$$20240725$20231030$20240801$EXP$$SI-ROCHE-3442888$ROCHE$$41$YR$A$F$Y$$$20240801$$HP$SI$SI
2312253215$23122532$15$F$20230101$20240924$20231030$20240927$PER$$US-BIOGEN-2023BI01233001$BIOGEN$$$$$F$Y$$$20240927$$CN$US$US
231227513$23122751$3$F$$20230804$20231030$20240701$PER$$US-UCBSA-2023039643$UCB$$39$YR$$F$Y$$$20240701$$CN$US$US
231227593$23122759$3$F$$20230703$20231030$20240701$PER$$US-UCBSA-2023034133$UCB$Ali W., Ahmad T., Ali A., Ahmad K.. Status Epilepticus in Myxedema Coma, A Rare Entity. American Journal of Respiratory and Critical Care Medicine. 2023;207(1):-$70$YR$$F$Y$$$20240701$$HP$US$US
231227928$23122792$8$F$20231018$20240620$20231030$20240709$EXP$$CA-ROCHE-3445742$ROCHE$$13$YR$T$F$Y$$$20240702$$CN$CA$CA
231228795$23122879$5$F$20231017$20240923$20231030$20240930$EXP$$AU-TAKEDA-2023TUS060663$TAKEDA$$56$YR$$M$Y$$$20240930$$CN$AU$AU
231228872$23122887$2$F$20240810$20240824$20231030$20240830$EXP$$CO-GSK-CO2023AMR147824$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$CO$CO
2312303814$23123038$14$F$20231201$20240910$20231030$20240917$EXP$$US-TAKEDA-2023TUS091625$TAKEDA$$75$YR$$M$Y$74$KG$20240917$$CN$US$US
231231442$23123144$2$F$20230101$20240822$20231030$20240827$EXP$$CA-JNJFOC-20231062559$JOHNSON AND JOHNSON$$38$YR$A$M$Y$111$KG$20240827$$HP$CA$CA
231232922$23123292$2$F$$20240912$20231030$20240924$EXP$$CA-APOTEX-2023AP015957$APOTEX$$44$YR$$F$Y$$$20240924$$HP$CA$CA
231233213$23123321$3$F$20231023$20240718$20231030$20240727$EXP$$CA-CELLTRION INC.-2023CA021032$CELLTRION$$$$$$Y$$$20240727$$HP$CA$CA
231233704$23123370$4$F$20230911$20240729$20231030$20240812$EXP$$JP-AMGEN-JPNSP2023191480$AMGEN$$81$YR$E$M$Y$70.1$KG$20240812$$MD$JP$JP
231234174$23123417$4$F$$20240711$20231030$20240719$30DAY$$US-GSK-US2023AMR147752$GLAXOSMITHKLINE$$$$$F$Y$59$KG$20240719$$HP$US$US
231234506$23123450$6$F$20230101$20240812$20231030$20240822$EXP$$US-JNJFOC-20231050227$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240822$$CN$US$US
231235042$23123504$2$F$$20240620$20231030$20240716$PER$$CA-TOLMAR, INC.-23CA043931$TOLMAR$$$$$M$Y$$$20240716$$CN$CA$CA
231235173$23123517$3$F$20230906$20240730$20231030$20240822$PER$$NL-TOLMAR, INC.-23NL043884$TOLMAR$$79$YR$$M$Y$$$20240822$$CN$NL$NL
231235258$23123525$8$F$20230901$20240922$20231030$20240924$EXP$$NVSC2023SA229824$NOVARTIS$$31$YR$$M$Y$$$20240924$$CN$SA$SA
231235804$23123580$4$F$20141217$20240923$20231030$20240926$EXP$$CA-ROCHE-1510943$ROCHE$$58$YR$A$F$Y$65$KG$20240926$$HP$CA$CA
231237272$23123727$2$F$$20240727$20231030$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-09311$LUPIN$$$$$$Y$$$20240818$$CN$US$US
231237476$23123747$6$F$20200201$20240918$20231030$20240925$PER$$NVSC2023US229727$NOVARTIS$$92$YR$$F$Y$$$20240925$$CN$US$US
231237932$23123793$2$F$20231002$20231026$20231030$20240919$EXP$FR-AFSSAPS-PP2023001440$FR-BAUSCH-BL-2023-016116$BAUSCH AND LOMB$$65$YR$$F$Y$50$KG$20240919$$MD$FR$FR
231238508$23123850$8$F$20230710$20240925$20231030$20240927$EXP$$AU-MYLANLABS-2023M1074997$MYLAN$$19$YR$$M$Y$$$20240927$$HP$AU$AU
231238652$23123865$2$F$20220401$20231023$20231030$20240827$EXP$$US-009507513-2310USA010223$MERCK$$$$$F$Y$$$20240827$$CN$US$US
231238983$23123898$3$F$$20240315$20231030$20240808$EXP$$NVSC2023BR219059$NOVARTIS$$$$$F$Y$$$20240808$$CN$BR$BR
231243152$23124315$2$F$$20240719$20231030$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-152625$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240725$$PH$JP$JP
231243163$23124316$3$F$20220801$20240629$20231030$20240703$EXP$$JP-009507513-2310JPN002726J$MERCK$$83$YR$$F$Y$$$20240703$$MD$JP$JP
231243173$23124317$3$F$20230101$20240629$20231030$20240703$EXP$$JP-009507513-2310JPN003586J$MERCK$$50$YR$$F$Y$$$20240703$$MD$JP$JP
231243404$23124340$4$F$20231001$20231226$20231030$20240925$PER$$US-GSK-US2023AMR146187$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
231243973$23124397$3$F$$20231026$20231030$20240731$PER$$NVSC2023US232265$NOVARTIS$$$$$M$Y$$$20240731$$CN$US$US
231244654$23124465$4$F$20230920$20240917$20231030$20240925$PER$$CN-Eisai-EC-2023-151215$EISAI$$55$YR$A$F$Y$$$20240925$$MD$CN$CN
2312447511$23124475$11$F$20130101$20240904$20231030$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-154078$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240911$$CN$US$US
231248763$23124876$3$F$20211130$20240828$20231030$20240903$EXP$$DE-MYLANLABS-2023M1113250$MYLAN$$$$E$F$Y$$$20240903$$MD$DE$DE
231249622$23124962$2$F$20231001$20240629$20231030$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202310016272$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240703$$CN$US$US
231249943$23124994$3$F$20230501$20240628$20231030$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-153909$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$63.2$KG$20240705$$MD$JP$JP
231250543$23125054$3$F$$20240629$20231030$20240704$EXP$$JP-009507513-2310JPN002722J$MERCK$$97$YR$$M$Y$$$20240704$$MD$JP$JP
231250665$23125066$5$F$20230930$20240729$20231030$20240801$EXP$$JP-DSJP-DSJ-2023-144290AA$DAIICHI$$67$YR$$F$Y$50$KG$20240801$$MD$JP$JP
231251275$23125127$5$F$20231013$20240816$20231030$20240820$EXP$$NVSC2023US232221$NOVARTIS$$$$N$F$Y$$$20240820$$MD$US$US
231251483$23125148$3$F$20230601$20240629$20231030$20240705$EXP$$JP-009507513-2310JPN002728J$MERCK$$71$YR$$M$Y$$$20240705$$MD$JP$JP
231252012$23125201$2$F$$20240617$20231030$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-415011$RANBAXY$$51$YR$$F$Y$$$20240702$$PH$FR$FR
231252082$23125208$2$F$20231006$20240805$20231030$20240816$PER$$JP-IGSA-BIG0026235$GRIFOLS$$70$YR$$M$Y$48$KG$20240816$$MD$JP$JP
231252912$23125291$2$F$$20231019$20231030$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415443$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
231253923$23125392$3$F$20230101$20240629$20231030$20240703$EXP$$JP-009507513-2310JPN003589J$MERCK$$93$YR$$F$Y$$$20240703$$MD$JP$JP
231254212$23125421$2$F$20231020$20240731$20231030$20240809$PER$$US-ABBVIE-5469255$ABBVIE$$54$YR$$F$Y$$$20240809$$CN$US$US
231255042$23125504$2$F$20231007$20240728$20231030$20240806$PER$$US-SA-2023SA327313$SANOFI AVENTIS$$53$YR$A$F$Y$71.655$KG$20240806$$MD$US$US
231255103$23125510$3$F$20230101$20240808$20231030$20240817$PER$$US-SA-2023SA326531$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240817$$MD$US$US
231255754$23125575$4$F$20230101$20240628$20231030$20240703$PER$$US-SA-2023SA330327$SANOFI AVENTIS$$62$YR$A$M$Y$105.7$KG$20240703$$MD$US$US
231255882$23125588$2$F$20230101$20240621$20231030$20240703$PER$$US-SA-2023SA326665$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240703$$MD$US$US
231256022$23125602$2$F$20230101$20231025$20231030$20240702$PER$$US-SA-2023SA328685$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240702$$MD$US$US
231256102$23125610$2$F$20240101$20240815$20231030$20240828$PER$$US-SA-2023SA327175$SANOFI AVENTIS$$$$A$M$Y$80.7$KG$20240828$$MD$US$US
231256202$23125620$2$F$20230101$20240801$20231030$20240812$PER$$US-SA-2023SA328000$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240812$$MD$US$US
231256533$23125653$3$F$20230101$20240708$20231030$20240712$PER$$US-SA-2023SA326770$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240712$$MD$US$US
231257252$23125725$2$F$20220501$20240721$20231030$20240730$PER$$US-SA-2023SA330250$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240730$$MD$US$US
231257703$23125770$3$F$20230901$20240707$20231030$20240714$PER$$US-SA-2023SA331413$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240714$$MD$US$US
231257752$23125775$2$F$$20240710$20231030$20240718$PER$$US-SA-2023SA330383$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240718$$MD$US$US
231262354$23126235$4$F$$20240629$20231030$20240705$EXP$$JP-009507513-2310JPN003637J$MERCK$$98$YR$$F$Y$$$20240705$$MD$JP$JP
231264247$23126424$7$F$20170726$20240919$20231030$20240926$EXP$$CA-TAKEDA-2022TUS066593$TAKEDA$$41$YR$$F$Y$$$20240926$$HP$CA$CA
231264332$23126433$2$F$20171101$20231025$20231030$20240918$EXP$$SE-BAUSCH-BL-2017-036176$BAUSCH AND LOMB$$32$YR$$F$Y$$$20240918$$MD$SE$SE
231264842$23126484$2$F$$20240924$20231030$20240927$EXP$$JP-PFIZER INC-202300350225$PFIZER$$$$$$Y$$$20240927$$MD$JP$JP
2312651110$23126511$10$F$20220101$20240919$20231030$20240924$EXP$$CA-PFIZER INC-202200615499$PFIZER$$32$YR$$F$Y$72.8$KG$20240924$$MD$CA$CA
231265959$23126595$9$F$$20240620$20231030$20240710$EXP$$CA-JNJFOC-20231070933$JOHNSON AND JOHNSON$$44$YR$A$F$Y$70$KG$20240710$$MD$CA$CA
231266332$23126633$2$F$$20240710$20231030$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-269913$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240710$$CN$US$US
231266493$23126649$3$F$$20240629$20231030$20240703$EXP$$JP-009507513-2310JPN003638J$MERCK$$94$YR$$M$Y$$$20240703$$MD$JP$JP
231266503$23126650$3$F$$20240629$20231030$20240708$EXP$$JP-009507513-2310JPN003641J$MERCK$$77$YR$$F$Y$$$20240708$$MD$JP$JP
231266773$23126677$3$F$$20240629$20231030$20240708$EXP$$JP-009507513-2310JPN003633J$MERCK$$53$YR$$F$Y$$$20240708$$MD$JP$JP
231266843$23126684$3$F$$20240629$20231030$20240704$EXP$$JP-009507513-2310JPN003642J$MERCK$$89$YR$$F$Y$$$20240704$$MD$JP$JP
231267204$23126720$4$F$20240101$20240905$20231030$20240909$PER$$US-PFIZER INC-202300347687$PFIZER$$69$YR$$F$Y$$$20240909$$HP$US$US
231267384$23126738$4$F$20211101$20240808$20231030$20240823$EXP$$US-TEVA-2023-US-2941520$TEVA$$59$YR$$M$Y$102.06$KG$20240822$$LW$US$US
231267932$23126793$2$F$$20240705$20231030$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-001458$JAZZ$$$$$F$Y$$$20240710$$CN$US$US
231268053$23126805$3$F$20240717$20240717$20231030$20240801$PER$$US-SA-2023SA331465$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240801$$MD$US$US
231268186$23126818$6$F$20230101$20240710$20231030$20240718$EXP$$JP-009507513-2308JPN002937J$MERCK$$55$YR$$M$Y$$$20240718$$MD$JP$JP
231268588$23126858$8$F$$20240912$20231030$20240918$EXP$$US-SANDOZ INC.-NVSC2021US233693$SANDOZ$$$$$F$Y$53.968$KG$20240918$$CN$US$US
231268663$23126866$3$F$$20240827$20231030$20240903$EXP$$GB-SANDOZ INC.-SDZ2023GB047908$SANDOZ$$$$$M$Y$$$20240903$$CN$GB$GB
231269252$23126925$2$F$$20240830$20231030$20240911$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202309007373$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240911$$CN$BR$BR
231269383$23126938$3$F$20230101$20240826$20231030$20240829$EXP$$HR-SANDOZ INC.-SDZ2023HR048132$SANDOZ$$63$YR$$M$Y$$$20240829$$MD$HR$HR
231269748$23126974$8$F$$20240916$20231030$20240919$EXP$$DE-SANDOZ INC.-NVSC2023DE009044$SANDOZ$$61$YR$$F$Y$$$20240919$$MD$DE$DE
231269765$23126976$5$F$$20240910$20231030$20240925$EXP$$CA-SANDOZ INC.-SDZ2023CA002777$SANDOZ$$67$YR$$F$Y$34$KG$20240925$$HP$CA$CA
2312699411$23126994$11$F$20230714$20240723$20231030$20240725$EXP$$GB-SANDOZ INC.-SDZ2023GB035670$SANDOZ$$34$YR$$F$Y$$$20240725$$MD$GB$GB
231270528$23127052$8$F$20230101$20240829$20231030$20240906$EXP$$NL-ABBVIE-5470818$ABBVIE$$79$YR$$M$Y$$$20240906$$CN$NL$NL
231271444$23127144$4$F$20231025$20240813$20231030$20240821$PER$$US-SA-2023SA330407$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240821$$MD$US$US
231271853$23127185$3$F$20231017$20240710$20231030$20240718$PER$$US-SA-2023SA331388$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240718$$MD$US$US
231271984$23127198$4$F$$20240911$20231030$20240927$PER$$CA-TOLMAR, INC.-23CA044005$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
231272054$23127205$4$F$20231012$20240911$20231030$20240927$PER$$CA-TOLMAR, INC.-23CA044017$TOLMAR$$84$YR$$M$Y$$$20240927$$CN$CA$CA
231272092$23127209$2$F$20231012$20240628$20231030$20240716$PER$$CA-TOLMAR, INC.-23CA044034$TOLMAR$$68$YR$$M$Y$$$20240715$$CN$CA$CA
231274063$23127406$3$F$$20240913$20231031$20240919$EXP$$CA-SHIRE-CA201941881AA$TAKEDA$$$$$M$Y$$$20240919$$CN$CA$CA
231274436$23127443$6$F$$20240822$20231031$20240828$EXP$$US-TAKEDA-2021TUS049922$TAKEDA$$$$$F$Y$78$KG$20240828$$HP$US$US
231275793$23127579$3$F$$20240830$20231031$20240910$EXP$CA-HEALTH CANADA-001055161$CA-ABBVIE-5462552$ABBVIE$$65$YR$$M$Y$$$20240910$$MD$CA$CA
231276212$23127621$2$F$$20230406$20231031$20240820$EXP$$NVSC2023US229263$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
231277184$23127718$4$F$$20240918$20231031$20240926$PER$$NVSC2023US232363$NOVARTIS$$$$$F$Y$$$20240926$$MD$US$US
231277464$23127746$4$F$$20240709$20231031$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-152603$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240717$$CN$US$US
231277472$23127747$2$F$$20240806$20231031$20240808$EXP$$CA-TAKEDA-2023TUS103762$TAKEDA$$$$$F$Y$$$20240808$$CN$CA$CA
231278924$23127892$4$F$20240126$20240902$20231031$20240923$PER$$CA-TOLMAR, INC.-23CA043988$TOLMAR$$61$YR$$M$Y$$$20240923$$CN$CA$CA
2312796611$23127966$11$F$20230924$20240712$20231031$20240722$EXP$$ES-ROCHE-3447606$ROCHE$$71$YR$E$F$Y$70$KG$20240719$$MD$ES$ES
231279703$23127970$3$F$20231213$20240715$20231031$20240722$EXP$$CO-TAKEDA-2023TUS104000$TAKEDA$$60$YR$$F$Y$44$KG$20240722$$CN$CO$CO
231279722$23127972$2$F$$20240826$20231031$20240830$EXP$$CA-ROCHE-3447739$ROCHE$$66$YR$E$M$Y$$$20240830$$HP$CA$CA
2312805117$23128051$17$F$20210210$20240920$20231031$20240927$EXP$$CO-TAKEDA-2020TUS050346$TAKEDA$$65$YR$$F$Y$59$KG$20240927$$CN$CO$CO
231281613$23128161$3$F$20220407$20240913$20231031$20240921$EXP$$CA-CELLTRION INC.-2022CA022263$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
231281943$23128194$3$F$$20240712$20231031$20240719$EXP$$ES-GSK-ES2023EME148822$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$MD$ES$ES
231281994$23128199$4$F$20231020$20240729$20231031$20240806$EXP$$US-ABBVIE-5470222$ABBVIE$$64$YR$$F$Y$$$20240806$$CN$US$US
231282353$23128235$3$F$$20240821$20231031$20240902$EXP$$CA-AUROBINDO-AUR-APL-2023-065940$AUROBINDO$Yeung DF, Toma M, Davis MK, Ignaszewski A. Ranolazine for Refractory Angina in a Heart Transplant Recipient With Cardiac Allograft Vasculopathy. American Journal of Transplantation. 2017;17(5):1427-1428$32$YR$$M$Y$$$20240902$$HP$CA$CA
231282552$23128255$2$F$$20231023$20231031$20240917$PER$$US-LEO Pharma-364550$LEO PHARM$$59$YR$$F$Y$$$20240917$$CN$US$US
231283722$23128372$2$F$20230101$20240926$20231031$20240930$PER$$US-BIOGEN-2023BI01232106$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
231284408$23128440$8$F$20200101$20240826$20231031$20240831$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-008278$AMGEN$$68$YR$E$F$Y$$$20240830$$MD$US$US
231285666$23128566$6$F$$20240816$20231031$20240919$EXP$AU-MLMSERVICE-20231010-4597531-1$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-12739$ALKEM$McMullen L, Khoo L, Anderson L, Strasser S, Gracey DM.. BK viraemia as a cause of anaemia in after ABO-incompatible liver transplant: a case report. BMC Infectious Diseases. 2023;23(1):609$59$YR$$M$Y$$$20240918$$MD$AU$AU
231285883$23128588$3$F$$20231025$20231031$20240910$PER$$NVSC2023US229873$NOVARTIS$$$$$F$Y$$$20240910$$CN$US$US
231286454$23128645$4$F$20230101$20240703$20231031$20240709$EXP$$JP-BAUSCH-BL-2023-015993$BAUSCH AND LOMB$$89$YR$$M$Y$$$20240709$$PH$JP$JP
231287963$23128796$3$F$20230101$20240802$20231031$20240806$EXP$$KR-ORGANON-O2310KOR001031$ORGANON$$29$YR$$F$Y$$$20240806$$HP$KR$KR
2312895710$23128957$10$F$20231014$20240906$20231031$20240913$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000963$DECIPHERA PHARMACEUTICALS$$61$YR$A$M$Y$$$20240913$$HP$US$US
231289953$23128995$3$F$$20240822$20231031$20240826$PER$$NVSC2023US232724$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
231290433$23129043$3$F$$20240212$20231031$20240710$PER$$US-ROCHE-3446158$ROCHE$$$$$$Y$$$20240628$$CN$US$US
231290732$23129073$2$F$$20240624$20231031$20240701$EXP$$US-SA-2023SA332942$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240701$$MD$US$US
231290802$23129080$2$F$$20240722$20231031$20240729$PER$$US-INCYTE CORPORATION-2023IN011009$INCYTE$$$$$$Y$$$20240729$$CN$US$US
231291802$23129180$2$F$20230528$20240806$20231031$20240814$EXP$$US-GSK-US2023AMR149698$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$HP$US$US
231292043$23129204$3$F$$20240708$20231031$20240710$EXP$$CA-UCBSA-2023051624$UCB$$$$$F$Y$$$20240710$$CN$CA$CA
2312923810$23129238$10$F$20230921$20240830$20231031$20240902$EXP$$NVSC2023US232951$NOVARTIS$$53$YR$$F$Y$$$20240902$$CN$US$US
231293015$23129301$5$F$20230901$20240905$20231031$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-151995$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$57.15$KG$20240909$$CN$US$US
231293652$23129365$2$F$20210501$20240826$20231031$20240830$EXP$$IT-ROCHE-3446143$ROCHE$Pennese E, Salutari P, Carriero L, Restuccia F, De Filippis A, De Luca G, Giancola R, Guardalupi F, Corradi G, Fabi B, Baldoni S and Di Ianni M. Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis. Doi: 10.3389/fimmu.2023.1272798. Frontiers in Immunology 2023;14:1-5.$55$YR$A$F$Y$$$20240830$$HP$IT$IT
231297052$23129705$2$F$20230818$20240729$20231031$20240730$EXP$GR-GREOF-202300985$GR-ABBVIE-5469300$ABBVIE$$81$YR$$F$Y$70$KG$20240730$$MD$GR$GR
231298136$23129813$6$F$20240515$20240723$20231031$20240731$EXP$$JP-ARGENX-2023-ARGX-JP003675$ARGENX BVBA$$$$$$Y$$$20240731$$CN$JP$JP
231299002$23129900$2$F$20240101$20240627$20231031$20240702$EXP$$US-PFIZER INC-202300349849$PFIZER$$84$YR$$M$Y$62.132$KG$20240702$$PH$US$US
231299263$23129926$3$F$20230928$20240820$20231031$20240823$EXP$$CO-TAKEDA-2023TUS095254$TAKEDA$$22$YR$$F$Y$52$KG$20240823$$CN$CO$CO
231299306$23129930$6$F$20231025$20240909$20231031$20240913$EXP$$US-OTSUKA-2023_028094$OTSUKA$$$$$F$Y$$$20240913$$CN$US$US
231299613$23129961$3$F$20230821$20240729$20231031$20240731$EXP$FR-AFSSAPS-SE2023000892$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-152331$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$58$KG$20240731$$MD$FR$FR
231299742$23129974$2$F$$20231026$20231031$20240816$PER$$US-MYLANLABS-2023M1114167$MYLAN$$$$$F$Y$22.67$KG$20240816$$PH$US$US
231301475$23130147$5$F$20230301$20240917$20231031$20240926$EXP$$JP-009507513-2310JPN003650J$MERCK$Hirata M, Akamatsu K, Sekiya K, Kato S, Katayama Y, Kurita T. P57-7 Investigation for Perioperative pembrolizumab administration for Triple negative breast cancer. The 61st Annual Meeting of Japan Society of Clinical Oncology. 2023;1339$52$YR$$F$Y$$$20240926$$MD$JP$JP
231302212$23130221$2$F$$20240820$20231031$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-154690$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$85.28$KG$20240822$$CN$US$US
231302249$23130224$9$F$$20240819$20231031$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-155151$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240820$$CN$US$US
231302392$23130239$2$F$20221207$20240821$20231031$20240825$EXP$$AT-ABBVIE-5473995$ABBVIE$$$$E$F$Y$58$KG$20240825$$MD$AT$AT
231304263$23130426$3$F$20201222$20240906$20231031$20240918$EXP$$DE-AUROBINDO-AUR-APL-2023-065529$AUROBINDO$$$$E$F$Y$$$20240918$$MD$DE$DE
231304703$23130470$3$F$$20240718$20231031$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415127$RANBAXY$Fatahzadeh M, Suster D. A dramatic case of oral epitheliolysis. Quintess Int. 2023;54:580-586$73$YR$$F$Y$$$20240802$$HP$US$US
231304832$23130483$2$F$20230317$20240628$20231031$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-415718$RANBAXY$$74$YR$$M$Y$118$KG$20240712$$PH$GB$GB
231305742$23130574$2$F$$20240625$20231031$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-415533$RANBAXY$$$$$$Y$$$20240710$$PH$GB$GB
231306042$23130604$2$F$$20240917$20231031$20240919$PER$$US-PFIZER INC-202300348025$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
231307552$23130755$2$F$$20240723$20231031$20240726$EXP$$US-TAKEDA-2023TUS105331$TAKEDA$$$$$F$Y$$$20240726$$CN$US$US
231309413$23130941$3$F$$20240629$20231031$20240703$EXP$$JP-009507513-2310JPN003574J$MERCK$$94$YR$$F$Y$$$20240703$$MD$JP$JP
231309874$23130987$4$F$$20240812$20231031$20240814$EXP$$US-SA-2023SA330414$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240815$$CN$US$US
231309963$23130996$3$F$$20240914$20231031$20240927$EXP$$JP-JNJFOC-20231064077$JOHNSON AND JOHNSON$$69$YR$E$M$Y$77$KG$20240927$$MD$JP$JP
231310174$23131017$4$F$20240101$20240829$20231031$20240919$PER$$US-SA-2023SA328338$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240919$$MD$US$US
231310222$23131022$2$F$20230101$20240828$20231031$20240910$PER$$US-SA-2023SA327446$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240910$$MD$US$US
231311902$23131190$2$F$$20240909$20231031$20240926$PER$$US-SA-2023SA334641$SANOFI AVENTIS$$62$YR$A$F$Y$70$KG$20240926$$MD$US$US
231311973$23131197$3$F$20231010$20240812$20231031$20240821$PER$$US-SA-2023SA333381$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240821$$MD$US$US
231312242$23131224$2$F$20231012$20240812$20231031$20240826$PER$$US-SA-2023SA335113$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240826$$MD$US$US
231312658$23131265$8$F$20231220$20240719$20231031$20240725$EXP$$US-SA-2023SA331744$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240725$$MD$US$US
231314263$23131426$3$F$$20240923$20231031$20240927$PER$$US-PHARMING-PHAUS2023000797$PHARMING GROUP$$$$$$Y$$$20240927$$CN$US$US
231314462$23131446$2$F$20230401$20240624$20231031$20240709$EXP$$CH-OPKO PHARMACEUTICALS, LLC.-2023OPK00058$OPKO HEALTH$$73$YR$$M$Y$66.6$KG$20240709$$CN$CH$DE
231315093$23131509$3$F$20230101$20240910$20231031$20240912$EXP$$US-DSJP-DSU-2023-138748$DAIICHI$$$$$F$Y$66.213$KG$20240912$$MD$US$US
231315922$23131592$2$F$20120531$20231026$20231031$20240823$EXP$$US-ORGANON-O2310USA003727$ORGANON$$28$YR$$M$Y$$$20240823$$HP$US$US
231316062$23131606$2$F$20220921$20240626$20231031$20240701$EXP$$JP-009507513-2303JPN000221J$MERCK$$75$YR$$M$Y$50$KG$20240701$$MD$JP$JP
231317135$23131713$5$F$20231001$20240827$20231031$20240831$EXP$$US-ABBVIE-5470433$ABBVIE$$44$YR$$F$Y$$$20240831$$CN$US$US
231317462$23131746$2$F$$20240710$20231031$20240715$30DAY$$US-SANDOZ INC.-SDZ2023US015721$SANDOZ$$$$$F$Y$$$20240715$$MD$US$US
231317682$23131768$2$F$20230501$20240718$20231031$20240723$EXP$$US-ABBVIE-5475371$ABBVIE$$68$YR$$F$Y$$$20240723$$CN$US$US
231319153$23131915$3$F$$20240726$20231101$20240808$EXP$$ES-ABBVIE-5475764$ABBVIE$Pomares H, Arribas I, Quinones T, Hernandez JV, Amoros JR, Artigal CM, et al. Long-term outcomes after venetoclax-hypomethylating agent combination therapy discontinuation, in patients with acute myeloid leukemia. Experience of a single center. Blood. 2023;142(Supplement 1):4225-4226.$80$YR$$F$Y$$$20240731$$MD$ES$ES
231319423$23131942$3$F$20230930$20240812$20231101$20240816$PER$$NVSC2023US232042$NOVARTIS$$69$YR$$M$Y$$$20240816$$CN$US$US
231319527$23131952$7$F$20230101$20240905$20231101$20240912$EXP$$US-ABBVIE-5473463$ABBVIE$$$$$M$Y$82.1$KG$20240912$$CN$US$US
231320445$23132044$5$F$20230101$20240911$20231101$20240917$EXP$$US-ABBVIE-5474546$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
231321093$23132109$3$F$$20240727$20231101$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-09480$LUPIN$$$$$$Y$$$20240816$$CN$US$US
231322106$23132210$6$F$20231019$20240702$20231101$20240707$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-155320$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$30$KG$20240708$$MD$JP$JP
231324076$23132407$6$F$20231001$20231226$20231101$20240926$EXP$$US-GSK-US2023AMR147508$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
231324572$23132457$2$F$20240101$20240816$20231101$20240829$PER$$US-SA-2023SA331369$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240829$$MD$US$US
231324743$23132474$3$F$$20240726$20231101$20240731$EXP$$ES-ABBVIE-5475776$ABBVIE$Pomares H, Arribas I, Quinones T, Hernandez JV, Amoros JR, Artigal CM, et al. Long-term outcomes after venetoclax-hypomethylating agent combination therapy discontinuation, in patients with acute myeloid leukemia. Experience of a single center. Blood. 2023;142(Supplement 1):4225-4226.$79$YR$$M$Y$$$20240731$$MD$ES$ES
231325693$23132569$3$F$20231029$20240724$20231101$20240729$PER$$US-AMGEN-USASP2023194746$AMGEN$$59$YR$A$M$Y$$$20240729$$CN$US$US
231326653$23132665$3$F$20231001$20240625$20231101$20240702$EXP$$US-GSK-US2023AMR147498$GLAXOSMITHKLINE$$65$YR$$F$Y$61.995$KG$20240702$$CN$US$US
231326947$23132694$7$F$20220101$20240831$20231101$20240910$EXP$$FR-AUROBINDO-AUR-APL-2023-065756$AUROBINDO$Bendjilali-Sabiani JJ, Larquey M, Lamy A, Pouget AM, Boyer JC, Reboul P.. A free- alcohol drink not so inoffensive: case report.. Toxic-Analyt-Clinique (Suppl.). 2023;35 (Suppl.)(3):S94$68$YR$$M$Y$$$20240910$$MD$FR$FR
231327176$23132717$6$F$20100722$20240731$20231101$20240814$EXP$$FR-AUROBINDO-AUR-APL-2019-045420$AUROBINDO$Javelot M, Sergheraert J, Agbo-Godeau S, Levy-Weil F, Laurence S, Goudot P, et al. Rituximab as a trigger factor of medication-related osteonecrosis of the jaw. A case report. Journal of stomatology, oral and maxillofacial surgery. 2019;10:1-15$69$YR$$F$Y$63$KG$20240814$$MD$FR$FR
231327862$23132786$2$F$20231031$20240726$20231101$20240731$PER$$US-AMGEN-USASP2023194796$AMGEN$$72$YR$E$F$Y$$$20240730$$CN$US$US
231327912$23132791$2$F$$20240916$20231101$20240918$EXP$$CA-SANDOZ INC.-SDZ2023CA048892$SANDOZ$$55$YR$$F$Y$74$KG$20240918$$HP$CA$CA
231327924$23132792$4$F$20230429$20240716$20231101$20240722$EXP$$DE-SANDOZ INC.-SDZ2023DE048665$SANDOZ$$70$YR$$M$Y$$$20240722$$MD$DE$DE
231329449$23132944$9$F$20230101$20240708$20231101$20240711$PER$$US-BIOGEN-2023BI01187762$BIOGEN$$69$YR$$F$Y$$$20240711$$CN$US$US
231330672$23133067$2$F$20220405$20240715$20231101$20240721$EXP$$HR-ROCHE-3445838$ROCHE$$77$YR$E$M$Y$$$20240721$$MD$HR$HR
231330752$23133075$2$F$20230928$20240720$20231101$20240730$EXP$$DE-AUROBINDO-AUR-APL-2023-065656$AUROBINDO$$50$YR$$F$Y$$$20240730$$MD$DE$DE
231330792$23133079$2$F$$20240624$20231101$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-153812$BRISTOL MYERS SQUIBB$Tokuhira M, Kimura Y, Tabayashi T, Watanabe N, Tsuchiya S, Takaku T, et al. Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects. International Journal of Hematology. doi: 10.1007/s12185-023-03606-x. 2023; 118(2): 210-20.$$$E$$Y$$$20240704$$MD$JP$JP
231330802$23133080$2$F$20221201$20240807$20231101$20240809$EXP$FR-AFSSAPS-ST2023001402$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-155015$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$65.5$KG$20240809$$MD$FR$FR
231331126$23133112$6$F$$20240705$20231101$20240711$PER$$US-Blueprint Medicines Corporation-SP-US-2023-001698$BLUEPRINT MEDICINES$$$$$F$Y$$$20240711$$CN$US$US
231331589$23133158$9$F$20210610$20240731$20231101$20240806$EXP$$DE-SANDOZ INC.-NVSC2021DE265342$SANDOZ$$$$E$F$Y$$$20240806$$HP$DE$DE
231332177$23133217$7$F$20240416$20240731$20231101$20240806$EXP$$CA-TAKEDA-2023TUS047222$TAKEDA$$74$YR$$F$Y$$$20240806$$MD$CA$CA
231332625$23133262$5$F$20231012$20240919$20231101$20240925$EXP$$US-TAKEDA-2023TUS103935$TAKEDA$$46$YR$$M$Y$100$KG$20240925$$CN$US$US
231333253$23133325$3$F$$20240710$20231101$20240715$EXP$$GB-MYLANLABS-2023M1114288$MYLAN$$$$$F$Y$$$20240715$$PH$GB$GB
231333733$23133373$3$F$$20240712$20231101$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-155754$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240718$$CN$US$US
231335403$23133540$3$F$$20240709$20231101$20240712$PER$$US-BIOGEN-2020BI00900268$BIOGEN$$$$$F$Y$$$20240712$$CN$US$US
2313359810$23133598$10$F$$20240823$20231101$20240828$EXP$$CA-TAKEDA-2023TUS103558$TAKEDA$$$$$M$Y$$$20240828$$CN$CA$CA
231336852$23133685$2$F$$20240807$20231101$20240808$PER$$NVSC2023US232197$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
231337133$23133713$3$F$20231001$20240912$20231101$20240924$EXP$$CA-APOTEX-2023AP016050$APOTEX$$37$YR$A$M$Y$$$20240924$$CN$CA$CA
231337172$23133717$2$F$$20240916$20231101$20240927$EXP$$CA-CIPHER-2023-CA-000495$CIPHER$$44$YR$A$F$Y$$$20240927$$HP$CA$CA
231338914$23133891$4$F$$20240801$20231101$20240802$EXP$$ZA-GILEAD-2023-0649305$GILEAD$$$$I$M$Y$2.75$KG$20240802$$MD$ZA$ZA
231339192$23133919$2$F$20230301$20240202$20231101$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK080107$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
231340432$23134043$2$F$20230101$20240909$20231101$20240923$EXP$$AU-TASMAN PHARMA, INC.-2023TSM00158$TASMAN PHARMA$$$$$M$Y$$$20240923$$HP$AU$AU
231341102$23134110$2$F$20231012$20231027$20231101$20240830$EXP$$NVSC2023GR231014$NOVARTIS$$55$YR$$M$Y$$$20240830$$PH$GR$GR
231341672$23134167$2$F$$20240913$20231101$20240918$EXP$FR-AFSSAPS-AVNT2023000847$FR-MYLANLABS-2023M1114327$MYLAN$$41$YR$$M$Y$$$20240918$$MD$FR$FR
231342923$23134292$3$F$20230828$20240820$20231101$20240827$EXP$$JP-AstraZeneca-2023A243751$ASTRAZENECA$$84$YR$$M$Y$46$KG$20240827$$MD$JP$
231343015$23134301$5$F$20231001$20240905$20231101$20240918$EXP$$DE-UCBSA-2023049296$UCB$$40$YR$$F$Y$66$KG$20240918$$HP$DE$DE
2313432311$23134323$11$F$$20240925$20231101$20240925$EXP$$NVSC2023US232215$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
231344474$23134447$4$F$20230505$20240717$20231101$20240723$EXP$$IN-PFIZER INC-PV202300082009$PFIZER$$28$YR$$M$Y$79.3$KG$20240723$$CN$IN$IN
231344616$23134461$6$F$20230917$20240919$20231101$20240927$EXP$$JP-009507513-2310JPN003178J$MERCK$$62$YR$$M$Y$$$20240927$$MD$JP$JP
231345102$23134510$2$F$$20240917$20231101$20240924$PER$$US-SA-2023SA270795$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240924$$MD$US$US
231345363$23134536$3$F$20240701$20240726$20231101$20240807$PER$$US-SA-2023SA331951$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240807$$MD$US$US
231345694$23134569$4$F$$20240711$20231101$20240718$EXP$$US-SA-2023SA333800$SANOFI AVENTIS$$33$YR$A$F$Y$90.71$KG$20240718$$MD$US$US
231346352$23134635$2$F$$20240712$20231101$20240722$PER$$US-SA-2023SA335395$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240721$$CN$US$US
231347252$23134725$2$F$20230101$20240822$20231101$20240917$PER$$US-SA-2023SA332439$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$MD$US$US
231347432$23134743$2$F$$20240711$20231101$20240801$PER$$US-SA-2023SA333808$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240719$$MD$US$US
231348163$23134816$3$F$20231001$20240912$20231101$20240923$PER$$US-SA-2023SA333874$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240923$$MD$US$US
231348413$23134841$3$F$$20240917$20231101$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-155385$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$53.98$KG$20240924$$HP$US$US
231348686$23134868$6$F$20230201$20240705$20231101$20240716$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2023-001310$SK LIFE SCIENCE$$$$$$Y$$$20240716$$CN$US$US
231348813$23134881$3$F$$20240913$20231101$20240920$EXP$$CA-TAKEDA-2023TUS086592$TAKEDA$$$$$F$Y$$$20240920$$MD$CA$CA
231350333$23135033$3$F$20230101$20240826$20231101$20240910$PER$$US-SA-2023SA331435$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240910$$MD$US$US
231350526$23135052$6$F$20231018$20240815$20231101$20240823$EXP$$CA-ROCHE-3445641$ROCHE$$51$YR$A$F$Y$$$20240823$$CN$CA$CA
231350684$23135068$4$F$20231020$20240828$20231101$20240902$EXP$$US-TAKEDA-2023TUS104070$TAKEDA$$68$YR$$M$Y$$$20240902$$CN$US$US
231350716$23135071$6$F$20240301$20240819$20231101$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-155248$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240822$$CN$US$US
231351149$23135114$9$F$20230501$20240806$20231101$20240815$EXP$$NVSC2023BR233955$NOVARTIS$$40$YR$$F$Y$60$KG$20240816$$CN$BR$BR
231351404$23135140$4$F$20230929$20240819$20231101$20240829$PER$$US-SA-2023SA334229$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240829$$MD$US$US
231351934$23135193$4$F$20230101$20240806$20231101$20240816$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202310013793$ELI LILLY AND CO$$45$YR$A$M$Y$55$KG$20240816$$CN$JP$JP
231352433$23135243$3$F$20231001$20240723$20231101$20240801$EXP$$CA-TAKEDA-2023TUS037558$TAKEDA$$58$YR$$M$Y$$$20240801$$HP$CA$CA
231353152$23135315$2$F$$20240828$20231101$20240905$EXP$$US-INCYTE CORPORATION-2023IN010930$INCYTE$Boyd FA, O^Leary MF, Benson K, Baluch A. A Case of Fatal Clostridium perfringens Sepsis with Massive Hemolysis in the Setting of a Coincidental Platelet Transfusion. LABORATORY MEDICINE. 2023;54(4):e108-e110$$$$$Y$$$20240905$$HP$US$US
231353233$23135323$3$F$$20240726$20231101$20240807$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202310017085$ELI LILLY AND CO$Ippolito E.,Pantano F.,Silipigni S.,Alaimo R.,Infante J.,Onorati E.,Talocco C.,Greco C.,Fiore M.,Donato M.,Tonini G.,DAngelillo R.M.,Ramella S.CONCURRENT USE OF ABEMACICLIB AND RADIOTHERAPY IN METASTATIC BREAST CANCER PATIENTS: A SINGLE CENTRE EXPERIENCE...Chemotherapy. 2024;:.DOI:10.1159/000538847$$$$$Y$$$20240807$$CN$COUNTRY NOT SPECIFIED$IT
231353243$23135324$3$F$$20240726$20231101$20240807$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202310017094$ELI LILLY AND CO$Ippolito E.,Pantano F.,Silipigni S.,Alaimo R.,Infante J.,Onorati E.,Talocco C.,Greco C.,Fiore M.,Donato M.,Tonini G.,D Angelillo R.M.,Ramella S..CONCURRENT USE OF ABEMACICLIB AND RADIOTHERAPY IN METASTATIC BREAST CANCER PATIENTS: A SINGLE CENTRE EXPERIENCE...Chemotherapy. 2024;:.DOI:10.1159/000538847$$$$$Y$$$20240807$$CN$COUNTRY NOT SPECIFIED$IT
231353863$23135386$3$F$20231017$20240815$20231101$20240816$PER$$US-GILEAD-2023-0649424$GILEAD$$66$YR$E$M$Y$83.2$KG$20240816$$HP$US$US
231354304$23135430$4$F$20240201$20240712$20231101$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-154870$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240716$$CN$US$US
231356203$23135620$3$F$20230501$20240626$20231101$20240703$EXP$$JP-Eisai-EC-2023-145042$EISAI$$$$A$F$Y$$$20240703$$MD$JP$JP
231356515$23135651$5$F$20230901$20240710$20231101$20240718$PER$$JP-Eisai-EC-2023-151388$EISAI$$55$YR$A$M$Y$$$20240718$$MD$JP$JP
231357074$23135707$4$F$20240301$20240717$20231101$20240729$EXP$$US-ROCHE-3450273$ROCHE$$86$YR$E$F$Y$$$20240729$$CN$US$US
231357252$23135725$2$F$20240101$20240910$20231101$20240918$PER$$US-SA-2023SA333968$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240918$$MD$US$US
231357482$23135748$2$F$$20240808$20231101$20240826$PER$$US-SA-2023SA334096$SANOFI AVENTIS$$$$C$F$Y$$$20240826$$MD$US$US
231359994$23135999$4$F$20240123$20240617$20231102$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004564$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240712$$CN$US$US
231361322$23136132$2$F$$20240624$20231102$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-153811$BRISTOL MYERS SQUIBB$Tokuhira M, Kimura Y, Ando M, Takaku T, Iriyama N, Hatta Y et al.  Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects. International Journal of Hematology. doi: 10.1007/s12185-023-03606-x. 2023; 118(2): 210-20.$$$E$$Y$$$20240701$$MD$JP$JP
231361475$23136147$5$F$20230801$20240219$20231102$20240806$EXP$$NVSC2023AE169997$NOVARTIS$$41$YR$$F$Y$$$20240806$$CN$AE$AE
231363283$23136328$3$F$20230101$20240906$20231102$20240916$PER$$CA-TOLMAR, INC.-23CA044299$TOLMAR$$$$$M$Y$$$20240916$$MD$CA$CA
231364172$23136417$2$F$20230101$20240716$20231102$20240722$EXP$$US-ABBVIE-5475111$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
231366688$23136668$8$F$$20240611$20231102$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004592$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
231366717$23136671$7$F$$20240716$20231102$20240723$EXP$$BR-JNJFOC-20230917588$JOHNSON AND JOHNSON$$15$YR$T$M$Y$56$KG$20240722$$CN$BR$BR
231366723$23136672$3$F$20230309$20240625$20231102$20240702$EXP$$DE-ABBVIE-5468952$ABBVIE$$60$YR$$F$Y$72$KG$20240702$$MD$DE$DE
231368274$23136827$4$F$20240701$20240719$20231102$20240728$PER$$US-SA-2023SA328590$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240728$$MD$US$US
231369588$23136958$8$F$20230101$20240821$20231102$20240829$EXP$$JP-009507513-2310JPN004142J$MERCK$$$$$M$Y$51$KG$20240829$$MD$JP$JP
231370212$23137021$2$F$$20231025$20231102$20240813$EXP$$CI-BRISTOL-MYERS SQUIBB COMPANY-2023-153242$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240813$$MD$CI$CI
231372262$23137226$2$F$$20240624$20231102$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-155955$BRISTOL MYERS SQUIBB$Tokuhira M, Kimura Y,Tabayashi T,  Watanabe N, Tsuchiya S, Takaku T, et al. Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects. International Journal of Hematology. doi: 10.1007/s12185-023-03606-x.  2023; 118(2): 210-20.$$$E$$Y$$$20240702$$MD$JP$JP
231372752$23137275$2$F$20210503$20240725$20231102$20240801$EXP$$US-VIIV HEALTHCARE LIMITED-US2023AMR149113$VIIV$$$$$$Y$$$20240801$$CN$US$US
231376704$23137670$4$F$20231030$20240827$20231102$20240830$EXP$$NVSC2023US234512$NOVARTIS$$28$YR$$F$Y$$$20240830$$CN$US$US
231378983$23137898$3$F$20240308$20240712$20231102$20240722$30DAY$$US-GSK-US2023149416$GLAXOSMITHKLINE$$65$YR$$M$Y$74.84$KG$20240722$$CN$US$US
231379663$23137966$3$F$$20240705$20231102$20240709$PER$$NVSC2023US234494$NOVARTIS$$$$$M$Y$$$20240709$$CN$US$US
231380582$23138058$2$F$$20240729$20231102$20240730$EXP$$JP-VIATRISJAPAN-2023M1108468AA$MYLAN$$24$YR$$F$Y$$$20240730$$MD$JP$JP
231381633$23138163$3$F$20170301$20240731$20231102$20240806$EXP$$NVSJ2023JP015498$NOVARTIS$Takano C, Fukumoto H, Iwasaki T, Watanabe C and Takano M.. Metastatic breast cancer of the mandibular after separating necrotic bone of MRONJ. Abstracts for The 4 Joint Academic Meetings of The 43rd Annual Meeting of the Ja. 2023;P14-3$83$YR$$F$Y$$$20240806$$HP$JP$JP
231382384$23138238$4$F$20231013$20240709$20231102$20240713$EXP$$CA-TAKEDA-2023TUS074781$TAKEDA$$74$YR$$F$Y$$$20240713$$CN$CA$CA
231382603$23138260$3$F$20230426$20240830$20231102$20240905$EXP$$JP-009507513-2310JPN003971J$MERCK$$82$YR$$M$Y$54.2$KG$20240905$$MD$JP$JP
2313840610$23138406$10$F$20231023$20240923$20231102$20240930$EXP$$CO-TAKEDA-2023TUS105762$TAKEDA$$8$YR$$M$Y$32.6$KG$20240930$$HP$CO$CO
231384963$23138496$3$F$20230101$20240629$20231102$20240703$EXP$$JP-009507513-2310JPN003643J$MERCK$$91$YR$$F$Y$$$20240703$$MD$JP$JP
231385113$23138511$3$F$$20240822$20231102$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-09588$LUPIN$$$$$$Y$$$20240904$$CN$US$US
231385254$23138525$4$F$20231001$20240724$20231102$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-155987$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240729$$MD$JP$JP
2313853210$23138532$10$F$20230101$20240920$20231102$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-154484$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240924$$CN$US$US
231385824$23138582$4$F$20230117$20240826$20231102$20240902$EXP$$JP-ORPHANEU-2023007533$RECORDATI$$$$$$Y$$$20240902$$MD$JP$JP
2313882511$23138825$11$F$20210817$20240724$20231102$20240729$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-28499$IPSEN$$67$YR$E$F$Y$$$20240729$$HP$CA$CA
231388686$23138868$6$F$$20240920$20231102$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-154999$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240926$$MD$JP$JP
2313887411$23138874$11$F$20230511$20240705$20231102$20240715$EXP$$CA-OTSUKA-2023_012743$OTSUKA$$54$YR$$F$Y$$$20240715$$MD$CA$CA
231389822$23138982$2$F$20230101$20240711$20231102$20240712$PER$$US-AMGEN-USASP2023195845$AMGEN$$52$YR$A$F$Y$$$20240712$$HP$US$US
231389915$23138991$5$F$20231001$20240807$20231102$20240812$PER$$US-PFIZER INC-202300350049$PFIZER$$25$YR$$F$Y$83.91$KG$20240812$$CN$US$US
231390172$23139017$2$F$$20240805$20231102$20240809$EXP$$US-PFIZER INC-PV202300178303$PFIZER$$56$YR$$F$Y$$$20240809$$MD$US$US
231391814$23139181$4$F$20210101$20240916$20231102$20240919$PER$$US-PFIZER INC-PV202300178343$PFIZER$$79$YR$$F$Y$61.235$KG$20240919$$CN$US$US
231393715$23139371$5$F$20230101$20240820$20231102$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-156741$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240828$$CN$US$US
231393745$23139374$5$F$20230301$20240820$20231102$20240823$EXP$$BR-JNJFOC-20231066136$JOHNSON AND JOHNSON$$64$YR$A$F$Y$68$KG$20240823$$CN$BR$BR
231394018$23139401$8$F$20230915$20240821$20231102$20240905$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-415876$RANBAXY$$85$YR$$M$Y$$$20240905$$MD$BE$BE
231394043$23139404$3$F$$20240701$20231102$20240716$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-415867$RANBAXY$Mori K, Hirose T, Matsumura T, Yoshimura T. Follow-up of Clinical Symptoms and Blood Concentration in Donepezil Overdose. Prim Care Comp CNS Disorders. 2023;25(5):no pagination$77$YR$$F$Y$$$20240716$$HP$JP$JP
231394472$23139447$2$F$20230214$20240823$20231102$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-415898$RANBAXY$$73$YR$$F$Y$$$20240906$$MD$FR$FR
231396653$23139665$3$F$$20240829$20231102$20240904$EXP$$US-TAKEDA-2023TUS052040$TAKEDA$$$$$F$Y$53$KG$20240904$$HP$US$US
231399133$23139913$3$F$20230922$20240822$20231102$20240827$EXP$$JP-SANDOZ INC.-SDZ2023JP049610$SANDOZ$$83$YR$$F$Y$$$20240827$$CN$JP$JP
231399658$23139965$8$F$20231014$20240822$20231102$20240830$EXP$$US-TAKEDA-2023TUS069917$TAKEDA$$74$YR$$F$Y$60$KG$20240830$$HP$US$US
231400242$23140024$2$F$$20240716$20231102$20240718$PER$$US-PFIZER INC-202300347824$PFIZER$$$$$$Y$$$20240718$$CN$US$US
231400544$23140054$4$F$20220601$20240718$20231102$20240722$EXP$$US-PFIZER INC-PV202300029794$PFIZER$$78$YR$$M$Y$82.01$KG$20240722$$CN$US$US
231400603$23140060$3$F$$20240820$20231102$20240822$PER$$US-PFIZER INC-202300313758$PFIZER$$56$YR$$F$Y$68.027$KG$20240822$$CN$US$US
231400766$23140076$6$F$$20240807$20231102$20240814$PER$$US-PFIZER INC-PV202300176985$PFIZER$$72$YR$$F$Y$$$20240814$$CN$US$US
231400845$23140084$5$F$20230101$20240826$20231102$20240829$EXP$$US-PFIZER INC-PV202300176374$PFIZER$$48$YR$$F$Y$$$20240829$$HP$US$US
231401514$23140151$4$F$20230901$20240716$20231102$20240725$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-022085$JAZZ$$50$YR$$F$Y$$$20240725$$CN$US$US
231402643$23140264$3$F$20240315$20240719$20231102$20240724$EXP$$US-LUNDBECK-DKLU3067930$LUNDBECK$$$$$$Y$$$20240724$$CN$US$US
231403443$23140344$3$F$20201030$20240904$20231102$20240906$EXP$$DE-SANDOZ INC.-NVSC2022DE243757$SANDOZ$$$$A$F$Y$$$20240906$$MD$DE$DE
231403574$23140357$4$F$20210201$20240812$20231102$20240819$EXP$$CO-SANDOZ INC.-PHHY2019CO192918$SANDOZ$$91$YR$$F$Y$70$KG$20240819$$CN$CO$CO
231404195$23140419$5$F$20230901$20240718$20231102$20240725$EXP$$NL-ABBVIE-5477310$ABBVIE$$79$YR$$M$Y$$$20240725$$CN$NL$NL
231404288$23140428$8$F$20230101$20240821$20231102$20240827$EXP$$JP-009507513-2310JPN004139J$MERCK$$$$$M$Y$66$KG$20240827$$MD$JP$JP
231404874$23140487$4$F$20231020$20240626$20231102$20240702$PER$$US-BIOGEN-2023BI01232979$BIOGEN$$74$YR$$M$Y$$$20240702$$CN$US$US
231406882$23140688$2$F$20220101$20231027$20231103$20240925$EXP$$US-GSK-US2022AMR030425$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
231406955$23140695$5$F$20230926$20240725$20231103$20240730$EXP$$US-ABBVIE-5476990$ABBVIE$$56$YR$$M$Y$$$20240730$$CN$US$US
231407542$23140754$2$F$$20240823$20231103$20240830$EXP$$MX-EMD Serono-2023483981$EMD SERONO INC$$$$C$F$Y$$$20240830$$CN$MX$MX
231407573$23140757$3$F$20231028$20240826$20231103$20240830$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2023-156200$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240830$$CN$PR$PR
231407995$23140799$5$F$$20240916$20231103$20240920$EXP$$US-TAKEDA-2021TUS063522$TAKEDA$$$$$M$Y$15$KG$20240920$$HP$US$US
231409216$23140921$6$F$20201019$20240916$20231103$20240920$EXP$$US-TAKEDA-US202030130$TAKEDA$$25$YR$$F$Y$68.48$KG$20240920$$HP$US$US
231409276$23140927$6$F$$20240806$20231103$20240807$PER$$US-ALXN-A202314038$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
231409962$23140996$2$F$20230101$20240802$20231103$20240809$EXP$$US-ABBVIE-5468458$ABBVIE$$$$$M$Y$96.615$KG$20240809$$MD$US$US
2314104414$23141044$14$F$20230101$20240814$20231103$20240822$EXP$$CA-CELLTRION INC.-2023CA014105$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
231410502$23141050$2$F$$20240821$20231103$20240825$EXP$$NVSC2023US233013$NOVARTIS$$$$$M$Y$$$20240825$$HP$US$US
231410967$23141096$7$F$$20240614$20231103$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004622$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
231411756$23141175$6$F$20240101$20240731$20231103$20240805$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-022173$JAZZ$$$$$F$Y$$$20240805$$HP$US$US
231411905$23141190$5$F$20231001$20240919$20231103$20240925$EXP$$JP-009507513-2310JPN003790J$MERCK$$3$DEC$$F$Y$$$20240925$$MD$JP$JP
231412454$23141245$4$F$20240504$20240629$20231103$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004646$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240723$$CN$US$US
2314125212$23141252$12$F$20230101$20240820$20231103$20240827$EXP$$CA-CELLTRION INC.-2022CA021972$CELLTRION$$$$$$Y$$$20240827$$MD$CA$CA
231412558$23141255$8$F$20220901$20240916$20231103$20240924$EXP$$CA-CELLTRION INC.-2022CA016692$CELLTRION$$$$$$Y$$$20240924$$CN$CA$CA
231412566$23141256$6$F$20230710$20240711$20231103$20240718$PER$$US-ALXN-A202309086$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240718$$CN$US$US
231413664$23141366$4$F$$20231103$20231103$20240708$EXP$$US-LEO Pharma-364574$LEO PHARM$$71$YR$$F$Y$$$20240708$$HP$US$US
2314138512$23141385$12$F$20191202$20240905$20231103$20240914$EXP$$CA-ROCHE-2495574$ROCHE$$65$YR$E$F$Y$66$KG$20240914$$CN$CA$CA
2314138827$23141388$27$F$20230101$20240710$20231103$20240715$EXP$$CA-PFIZER INC-PV202300129702$PFIZER$$53$YR$$M$Y$72.5$KG$20240715$$MD$CA$CA
231415122$23141512$2$F$$20230921$20231103$20240808$PER$$US-OTSUKA-2023_025016$OTSUKA$$4$DEC$$F$Y$$$20240808$$HP$US$US
231415142$23141514$2$F$20230927$20230927$20231103$20240808$PER$$US-OTSUKA-2023_025525$OTSUKA$$41$YR$$F$Y$86.18$KG$20240808$$HP$US$US
231415152$23141515$2$F$$20230727$20231103$20240808$PER$$US-OTSUKA-2023_020330$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
231415172$23141517$2$F$$20231018$20231103$20240808$PER$$US-OTSUKA-2023_027323$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
231415222$23141522$2$F$$20230731$20231103$20240808$PER$$US-OTSUKA-2023_020544$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
231415262$23141526$2$F$$20231004$20231103$20240808$PER$$US-OTSUKA-2023_026057$OTSUKA$$$$A$M$Y$$$20240808$$HP$US$US
231415282$23141528$2$F$$20231013$20231103$20240808$EXP$$US-OTSUKA-2023_026930$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
231415302$23141530$2$F$$20230925$20231103$20240808$PER$$US-OTSUKA-2023_025257$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
231415322$23141532$2$F$$20230918$20231103$20240808$PER$$US-OTSUKA-2023_024698$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
231415332$23141533$2$F$20230701$20231121$20231103$20240808$PER$$US-OTSUKA-2023_024895$OTSUKA$$39$YR$$F$Y$49.89$KG$20240808$$HP$US$US
231415352$23141535$2$F$20230923$20231010$20231103$20240808$PER$$US-OTSUKA-2023_026577$OTSUKA$$45$YR$$M$Y$$$20240808$$HP$US$US
231416852$23141685$2$F$$20231023$20231103$20240827$EXP$$CN-ABBVIE-5478419$ABBVIE$Xing L, Wang H, Liu D, He Q, Li Z. Immunochemotherapy combined with novel agents for Richter syndrome: report of 3 cases. Holist Integ Oncol. 2023;2(1):1-5.$68$YR$$F$Y$$$20240827$$HP$CN$CN
231416983$23141698$3$F$$20240801$20231103$20240806$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-022192$JAZZ$$$$$F$Y$$$20240806$$CN$US$US
231417332$23141733$2$F$20231020$20240801$20231103$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004926$ACADIA PHARMACEUTICALS$$88$YR$$M$Y$$$20240827$$CN$US$US
231417428$23141742$8$F$20231114$20240821$20231103$20240826$EXP$$CA-TAKEDA-2023TUS102604$TAKEDA$$71$YR$$M$Y$$$20240826$$CN$CA$CA
231417824$23141782$4$F$20230701$20240805$20231103$20240904$EXP$$MX-GILEAD-2023-0649387$GILEAD$$17$YR$T$M$Y$$$20240904$$MD$MX$MX
231417892$23141789$2$F$$20240818$20231103$20240912$EXP$$US-HETERO-HET2023US03081$HETERO$Anis TR, Meher J. Allopurinol-Induced Stevens?Johnson Syndrome. Clinical Pharmacology: Advances and Applications. 2023;15:99-105$95$YR$$F$Y$$$20240827$$PH$US$US
231417964$23141796$4$F$20230331$20240902$20231103$20240910$EXP$$RO-CELLTRION INC.-2023RO021057$CELLTRION$$$$$$Y$$$20240910$$MD$RO$RO
231418792$23141879$2$F$$20240829$20231103$20240830$PER$$NVSC2023US233472$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
231418817$23141881$7$F$20231001$20240906$20231103$20240916$EXP$$CA-CELLTRION INC.-2023CA021245$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
231421422$23142142$2$F$20230801$20240821$20231103$20240917$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0800970$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
231422072$23142207$2$F$$20240909$20231103$20240923$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0900038$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
231422827$23142282$7$F$20231024$20240705$20231103$20240713$EXP$$CA-CELLTRION INC.-2023CA021241$CELLTRION$$$$$$Y$$$20240713$$HP$CA$CA
231423904$23142390$4$F$20230111$20240625$20231103$20240702$EXP$$NVSC2023DE232554$NOVARTIS$$$$$M$Y$103$KG$20240702$$MD$DE$DE
231424162$23142416$2$F$$20240913$20231103$20240920$EXP$$US-TAKEDA-2021TUS071069$TAKEDA$$$$$M$Y$$$20240920$$CN$US$US
231424765$23142476$5$F$$20240627$20231103$20240703$EXP$$US-ASTELLAS-2023EU003993$ASTELLAS$$$$$M$Y$$$20240703$$CN$US$US
231427588$23142758$8$F$20230214$20240821$20231103$20240828$EXP$$JP-Eisai-EC-2023-151659$EISAI$Yamauchi A. Atsushi Yamauchi: 0-4.$77$YR$E$M$Y$51$KG$20240828$$MD$JP$JP
231428062$23142806$2$F$$20240823$20231103$20240827$EXP$$US-TAKEDA-2016BLT001191$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
231428903$23142890$3$F$$20240715$20231103$20240718$EXP$$NVSC2023CA233954$NOVARTIS$$43$YR$$F$Y$68$KG$20240718$$HP$CA$CA
231429142$23142914$2$F$$20240726$20231103$20240805$EXP$$US-VIIV HEALTHCARE LIMITED-US2023147277$VIIV$$$$$M$Y$$$20240805$$HP$US$US
231430633$23143063$3$F$$20240910$20231103$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202311000366$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240916$$CN$US$US
231430863$23143086$3$F$$20240909$20231103$20240916$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0900404$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
231431152$23143115$2$F$20230913$20230915$20231103$20240930$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0900524$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
231431683$23143168$3$F$$20240815$20231103$20240911$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0900626$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
231431982$23143198$2$F$20211207$20240816$20231103$20240822$EXP$$DE-LABORATORIOS LICONSA S.A.-2112DE03806$INSUD PHARMA$$$$E$F$Y$88$KG$20240822$$HP$DE$DE
231433744$23143374$4$F$20231026$20240801$20231103$20240809$EXP$$JP-009507513-2310JPN004157J$MERCK$Takeuchi H. P-150 Two cases of fulminant type 1 diabetes mellitus developed during combination therapy with pembrolizumab. The 66th Annual Meeting of Japan Society of Gynecologic Oncology. 2024;42(3):83$61$YR$$F$Y$48$KG$20240809$$MD$JP$JP
231433876$23143387$6$F$$20240708$20231103$20240710$EXP$$US-TAKEDA-2023TUS042820$TAKEDA$$$$$M$Y$$$20240710$$CN$US$US
231434622$23143462$2$F$$20240813$20231103$20240910$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0700849$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
231435222$23143522$2$F$20230907$20240911$20231103$20240923$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR006736$AEGERION$$0$YR$$M$Y$3.175$KG$20240923$$MD$US$US
231435265$23143526$5$F$$20240822$20231103$20240905$EXP$$US-MYOVANT SCIENCES GMBH-2023MYSCI0800541$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
231435585$23143558$5$F$20210218$20240708$20231103$20240724$EXP$$DE-ROCHE-3131067$ROCHE$$48$YR$A$F$Y$56.8$KG$20240724$$CN$DE$DE
231438652$23143865$2$F$20230601$20240730$20231103$20240823$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0700605$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
231441874$23144187$4$F$20240601$20240710$20231103$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-154125$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240717$$CN$US$US
231442025$23144202$5$F$20231025$20240830$20231103$20240911$EXP$$DE-SAMSUNG BIOEPIS-SB-2023-29102$SAMSUNG BIOEPIS$$58$YR$A$M$Y$56$KG$20240911$$MD$DE$DE
231442594$23144259$4$F$20230101$20240723$20231103$20240730$EXP$$NVSC2023FR226434$NOVARTIS$$$$A$F$Y$70$KG$20240730$$MD$FR$FR
231443323$23144332$3$F$20231025$20231025$20231103$20240701$PER$$US-UCBSA-2023051648$UCB$$24$YR$$F$Y$$$20240701$$CN$US$US
231443587$23144358$7$F$$20240802$20231103$20240806$EXP$$US-PFIZER INC-PV202300177672$PFIZER$$65$YR$$F$Y$$$20240806$$HP$US$US
231443702$23144370$2$F$20231010$20240911$20231103$20240926$PER$$US-PFIZER INC-202300349048$PFIZER$$68$YR$$F$Y$48.99$KG$20240926$$CN$US$US
231444205$23144420$5$F$20230417$20240830$20231103$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-156535$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$59$KG$20240906$$MD$JP$JP
231445703$23144570$3$F$20230820$20240629$20231103$20240703$EXP$$JP-009507513-2310JPN003630J$MERCK$$34$YR$$F$Y$$$20240703$$MD$JP$JP
231445722$23144572$2$F$20230801$20240822$20231103$20240827$EXP$$DE-MYLANLABS-2023M1114904$MYLAN$$64$YR$$F$Y$$$20240827$$MD$DE$DE
231446166$23144616$6$F$20240101$20240703$20231103$20240709$PER$$US-PFIZER INC-PV202300180493$PFIZER$$52$YR$$F$Y$$$20240709$$CN$US$US
231447473$23144747$3$F$$20240813$20231103$20240909$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1000123$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
231447753$23144775$3$F$$20240701$20231103$20240702$PER$$US-PFIZER INC-PV202300178484$PFIZER$$67$YR$$F$Y$$$20240702$$CN$US$US
231447823$23144782$3$F$$20240723$20231103$20240726$PER$$US-PFIZER INC-PV202300178405$PFIZER$$55$YR$$F$Y$$$20240726$$CN$US$US
231447863$23144786$3$F$20231026$20240821$20231103$20240826$EXP$$US-PFIZER INC-PV202300178525$PFIZER$$64$YR$$F$Y$$$20240826$$HP$US$US
231447932$23144793$2$F$$20240725$20231103$20240729$PER$$US-PFIZER INC-202300341619$PFIZER$$54$YR$$F$Y$$$20240729$$MD$US$US
231449225$23144922$5$F$20240201$20240610$20231103$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004669$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240705$$CN$US$US
231449983$23144998$3$F$$20240813$20231103$20240820$EXP$$US-ALXN-A202312743$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$HP$US$US
231451113$23145111$3$F$20231024$20240829$20231103$20240904$EXP$$CA-PFIZER INC-202300353165$PFIZER$$66$YR$$F$Y$134$KG$20240904$$HP$CA$CA
231451174$23145117$4$F$20240711$20240711$20231103$20240715$EXP$$JP-PFIZER INC-PV202300178279$PFIZER$$72$YR$$F$Y$$$20240715$$MD$JP$JP
231451255$23145125$5$F$20230606$20240805$20231103$20240811$EXP$FR-AFSSAPS-TS2023001354$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-155280$BRISTOL MYERS SQUIBB$$20$YR$A$F$Y$$$20240812$$MD$FR$FR
231451373$23145137$3$F$$20240124$20231103$20240808$EXP$$PA-SANDOZ INC.-NVSC2022PA202326$SANDOZ$$$$$F$Y$$$20240808$$CN$PA$PA
231452995$23145299$5$F$$20240806$20231103$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-053905$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240808$$HP$US$US
231453744$23145374$4$F$20231001$20240723$20231103$20240725$PER$$US-PFIZER INC-PV202300178963$PFIZER$$43$YR$$M$Y$$$20240725$$HP$US$US
231454247$23145424$7$F$20231121$20240712$20231103$20240716$EXP$$CA-TAKEDA-2023TUS105333$TAKEDA$$28$YR$$F$Y$$$20240716$$CN$CA$CA
231454562$23145456$2$F$20231101$20240722$20231103$20240724$PER$$US-AMGEN-USASP2023197065$AMGEN$$76$YR$E$M$Y$$$20240724$$CN$US$US
231454612$23145461$2$F$20230901$20240723$20231103$20240726$EXP$$JP-AstraZeneca-2023A249804$ASTRAZENECA$Seki N.. A step towards the future in stage IV NSCLC treatment: A treatment approach using Imfinzi (durvalumab) + Imjudo (tremelimumab) + chemotherapy learned from post-marketing clinical use cases. Luncheon seminar 23 in the 64th Annual Meeting of the Japan Lung Cancer Society. 2023: 0-. (not from Embase) 2023;$70$YR$$M$Y$51$KG$20240726$$MD$JP$
2314551815$23145518$15$F$20231018$20240827$20231103$20240919$EXP$$AU-TAKEDA-2023TUS102735$TAKEDA$$74$YR$$F$Y$$$20240919$$HP$AU$AU
231455278$23145527$8$F$20230425$20240913$20231103$20240917$EXP$$US-TAKEDA-2023TUS042984$TAKEDA$$15$YR$$F$Y$89$KG$20240917$$HP$US$US
231456028$23145602$8$F$20210101$20240719$20231103$20240727$EXP$$US-JAZZ PHARMACEUTICALS-2021-US-016797$JAZZ$$$$$F$Y$$$20240727$$HP$US$US
231458892$23145889$2$F$$20240912$20231104$20240923$EXP$$FR-AUROBINDO-AUR-APL-2023-066435$AUROBINDO$Perge K, Pons L, Protsenko N, Collin-Chavagnac D.. A Novel Leptin Receptor LEPR Variant in a Toddler With Early-Onset Fatal Obesity.. Pediatrics. 2023;152 (1):1-6$11$MON$$M$Y$$$20240923$$MD$FR$FR
231459523$23145952$3$F$20171024$20240702$20231104$20240709$EXP$$FR-AUROBINDO-AUR-APL-2018-056409$AUROBINDO$Galinat H, Hoffmann C, Amiral J, Rezig S, Kerspern H, Jantzem H et al. A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome.. European Journal of Haematology.. 2019$92$YR$$F$Y$79$KG$20240709$$HP$FR$FR
231459658$23145965$8$F$20230101$20240808$20231104$20240816$EXP$$CA-CELLTRION INC.-2023CA008350$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
231460213$23146021$3$F$$20240823$20231104$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-09556$LUPIN$$$$$$Y$$$20240910$$CN$US$US
231460314$23146031$4$F$20231020$20240712$20231104$20240720$EXP$$JP-UNITED THERAPEUTICS-UNT-2023-031595$UNITED THERAPEUTICS$$74$YR$$F$Y$$$20240720$$$JP$JP
231460604$23146060$4$F$$20240726$20231104$20240801$PER$$NVSC2023US234687$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
231461515$23146151$5$F$$20240313$20231104$20240806$EXP$$NVSC2023US234974$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
2314615915$23146159$15$F$20231001$20240827$20231104$20240904$EXP$$CA-CELLTRION INC.-2023CA021261$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
231461718$23146171$8$F$20230101$20240722$20231104$20240730$EXP$$CA-CELLTRION INC.-2023CA021321$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
231461765$23146176$5$F$$20240731$20231104$20240809$EXP$$JP-ROCHE-3450380$ROCHE$$6$YR$C$M$Y$10.5$KG$20240809$$PH$JP$JP
231461953$23146195$3$F$20230301$20240710$20231104$20240712$EXP$$NVSC2023US235095$NOVARTIS$$56$YR$$M$Y$$$20240712$$CN$US$US
231462243$23146224$3$F$20210501$20240822$20231104$20240902$EXP$$FR-AUROBINDO-AUR-APL-2023-066556$AUROBINDO$$71$YR$$M$Y$$$20240902$$MD$FR$FR
231462822$23146282$2$F$$20240809$20231104$20240812$PER$$NVSC2023US235614$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
231465612$23146561$2$F$20230821$20240807$20231105$20240815$EXP$$JP-ROCHE-3428976$ROCHE$$78$YR$E$M$Y$59$KG$20240815$$PH$JP$JP
231466522$23146652$2$F$20230101$20240628$20231105$20240705$EXP$$JP-009507513-2310JPN004005J$MERCK$$8$DEC$$F$Y$$$20240705$$MD$JP$JP
231466822$23146682$2$F$$20240829$20231105$20240903$EXP$$NVSC2023US234954$NOVARTIS$$$$$F$Y$$$20240903$$CN$US$US
231466859$23146685$9$F$20231001$20240812$20231105$20240816$EXP$$NVSC2023ZA233604$NOVARTIS$$77$YR$$M$Y$$$20240816$$HP$ZA$ZA
231466924$23146692$4$F$20230801$20240806$20231105$20240811$PER$$NVSC2023US234217$NOVARTIS$$82$YR$$F$Y$$$20240811$$CN$US$US
231467242$23146724$2$F$20201001$20240625$20231105$20240701$EXP$$MY-JNJFOC-20231110034$JOHNSON AND JOHNSON$Diaz A.B.; Chow J.; Hoo F.K.; Koh K.W.; Lee G.C.K.; Teo W.S.; Venketasubramanian N.; Wang C.-C.; Mehta R.. Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region. Drugs in Context (2023) 12 (1-15). 2023;12:1-15$70$YR$E$F$Y$46.1$KG$20240701$$HP$MY$MY
231468473$23146847$3$F$20160413$20240920$20231105$20240925$EXP$$US-TAKEDA-US201604834$TAKEDA$$69$YR$$F$Y$$$20240925$$CN$US$US
231469314$23146931$4$F$$20240813$20231106$20240816$EXP$$US-TAKEDA-US202013058$TAKEDA$$$$$M$Y$107$KG$20240816$$MD$US$US
231469954$23146995$4$F$20240701$20240911$20231106$20240927$PER$$CA-TOLMAR, INC.-23CA043806$TOLMAR$$74$YR$$M$Y$$$20240927$$CN$CA$CA
231470696$23147069$6$F$20231023$20240710$20231106$20240718$EXP$$CA-CELLTRION INC.-2023CA015716$CELLTRION$$$$$$Y$$$20240718$$MD$CA$CA
2314721915$23147219$15$F$20230101$20240903$20231106$20240906$EXP$$CA-JNJFOC-20231101347$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240906$$HP$CA$CA
231472288$23147228$8$F$20231026$20240823$20231106$20240902$EXP$$CA-CELLTRION INC.-2023CA021274$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
231472436$23147243$6$F$$20240924$20231106$20240930$EXP$$US-SANDOZ INC.-SDZ2023US034273$SANDOZ$$$$$F$Y$56.689$KG$20240930$$CN$US$US
231472967$23147296$7$F$20230501$20240718$20231106$20240725$EXP$$US-GSK-US2021019648$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$US$US
231473165$23147316$5$F$20231029$20240730$20231106$20240802$PER$$US-AMGEN-USASP2023195081$AMGEN$$64$YR$A$F$Y$$$20240801$$MD$US$US
231473964$23147396$4$F$20230601$20240719$20231106$20240802$EXP$$US-UCBSA-2023035240$UCB$$63$YR$$F$Y$$$20240802$$HP$US$US
231474312$23147431$2$F$20230528$20240805$20231106$20240814$EXP$$US-JNJFOC-20231073939$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$HP$US$US
231475427$23147542$7$F$$20240318$20231106$20240926$EXP$$US-GSK-US2023AMR152597$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
231475863$23147586$3$F$20220301$20240909$20231106$20240917$EXP$$JP-GSK-JP2023JPN150498$GLAXOSMITHKLINE$Ishizuka T, Ochima M, Suzuki T, Masuda T, Minemura N, Suzuki A. A case of systemic lupus erythematosus with mycobacterium tuberculosis complex lung infection during therapy with belimumab and hydroxychloroquine. Proceedings of Kanto Rheumatology Conference. 56:29-33$$$$$Y$$$20240917$$MD$JP$JP
231475893$23147589$3$F$20231014$20240924$20231106$20240926$EXP$$CA-ROCHE-3452475$ROCHE$$27$YR$A$F$Y$$$20240926$$CN$CA$CA
2314761810$23147618$10$F$20230514$20240729$20231106$20240805$EXP$$CA-TAKEDA-2023TUS048416$TAKEDA$$26$YR$$F$Y$$$20240805$$CN$CA$CA
231476605$23147660$5$F$20220913$20240923$20231106$20240925$EXP$$DE-ROCHE-3206080$ROCHE$$39$YR$A$M$Y$$$20240925$$CN$DE$DE
231477524$23147752$4$F$$20240814$20231106$20240825$EXP$$CA-JNJFOC-20231064721$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240825$$HP$CA$CA
231477602$23147760$2$F$20220331$20231030$20231106$20240926$EXP$$US-GSK-US2022AMR061953$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
231477907$23147790$7$F$20230601$20240923$20231106$20240926$EXP$$IE-JNJFOC-20230813988$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240926$$HP$IE$IE
231478222$23147822$2$F$$20240429$20231106$20240717$EXP$$NVSC2023ZA234927$NOVARTIS$$48$YR$$M$Y$$$20240717$$CN$ZA$ZA
231478993$23147899$3$F$$20240801$20231106$20240805$PER$$NVSC2023US235881$NOVARTIS$$$$$M$Y$$$20240805$$CN$US$US
231479593$23147959$3$F$$20240715$20231106$20240720$EXP$$CA-SANDOZ INC.-SDZ2023CA050515$SANDOZ$$43$YR$$F$Y$68$KG$20240720$$HP$CA$CA
231481042$23148104$2$F$20230101$20240621$20231106$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-155555$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$59.1$KG$20240701$$MD$JP$JP
231481283$23148128$3$F$20231024$20240830$20231106$20240906$EXP$$CA-Orion Corporation ORION PHARMA-23_00026361$ORION$$66$YR$E$F$Y$134$KG$20240906$$HP$CA$
231481866$23148186$6$F$20231022$20240911$20231106$20240914$EXP$$GR-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-271003$BOEHRINGER INGELHEIM$$63$YR$A$F$Y$72$KG$20240914$$MD$GR$GR
231481924$23148192$4$F$20231017$20240722$20231106$20240729$EXP$$CA-TAKEDA-2023TUS101779$TAKEDA$$28$YR$$M$Y$$$20240729$$HP$CA$CA
231482372$23148237$2$F$20231027$20240815$20231106$20240822$EXP$$CA-TAKEDA-2023TUS105058$TAKEDA$$32$YR$$F$Y$$$20240822$$CN$CA$CA
231483404$23148340$4$F$20230901$20240729$20231106$20240807$PER$$US-Eisai-EC-2023-149728$EISAI$$68$YR$E$M$Y$62.27$KG$20240807$$CN$US$US
231485753$23148575$3$F$$20240726$20231106$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-158195$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240807$$MD$JP$JP
231485882$23148588$2$F$20170407$20240820$20231106$20240823$EXP$$US-TAKEDA-US201708800$TAKEDA$$75$YR$$F$Y$58$KG$20240823$$MD$US$US
231486074$23148607$4$F$$20240816$20231106$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-09692$LUPIN$$$$$$Y$$$20240903$$CN$US$US
231486182$23148618$2$F$20230811$20230919$20231106$20240710$PER$$CN-ROCHE-3283720$ROCHE$$39$YR$A$F$Y$55$KG$20240628$$CN$CN$CN
231486252$23148625$2$F$20221130$20240710$20231106$20240712$EXP$$JP-Eisai-EC-2022-129633$EISAI$$72$YR$E$M$Y$56$KG$20240712$$MD$JP$JP
231486805$23148680$5$F$20230501$20240821$20231106$20240826$EXP$$US-LUNDBECK-DKLU3068484$LUNDBECK$$$$$$Y$$$20240826$$CN$US$US
231486964$23148696$4$F$20231028$20240725$20231106$20240731$EXP$$NVSC2023CO236065$NOVARTIS$$61$YR$$M$Y$85$KG$20240731$$CN$CO$CO
231487053$23148705$3$F$20230815$20240716$20231106$20240723$EXP$$CA-TAKEDA-2023TUS080865$TAKEDA$$61$YR$$F$Y$51$KG$20240723$$CN$CA$CA
231487542$23148754$2$F$$20240802$20231106$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-158160$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240805$$CN$US$US
231487614$23148761$4$F$20231226$20240729$20231106$20240806$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004527$AURINIA PHARMACEUTICALS$$57$YR$$F$Y$$$20240806$$CN$US$US
2314891911$23148919$11$F$$20240718$20231106$20240718$30DAY$$US-PFIZER INC-PV202300170868$PFIZER$$11$YR$$M$Y$$$20240718$$PH$US$US
231489283$23148928$3$F$20220921$20240703$20231106$20240705$EXP$$JP-BAYER-2023A153481$BAYER$$8$DEC$E$M$Y$$$20240705$$MD$JP$JP
231489643$23148964$3$F$$20240726$20231106$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-156342$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240802$$MD$JP$JP
231491958$23149195$8$F$20230823$20240823$20231106$20240828$EXP$$NVSC2023CL214882$NOVARTIS$$55$YR$$F$Y$$$20240828$$CN$CL$CL
231492213$23149221$3$F$20230924$20240706$20231106$20240709$EXP$$US-SANDOZ INC.-SDZ2023US050925$SANDOZ$$41$YR$$F$Y$$$20240709$$CN$US$US
231493235$23149323$5$F$20211122$20240820$20231106$20240828$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2021-30919$IPSEN$$72$YR$E$F$Y$$$20240828$$CN$CA$CA
231494142$23149414$2$F$$20240809$20231106$20240823$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-416629$RANBAXY$Singh R, Athwani VK, Malviya LM, Lazarus M, Sachdeva K, Madoriya K, et al. Neonatal Rhino- Orbito-Cerebral Mucormycosis. Perinatology. 2023;24(2)(3)(S2):S92-S96$$$N$F$Y$2$KG$20240823$$HP$IN$IN
231494257$23149425$7$F$20230823$20240821$20231106$20240905$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-416140$RANBAXY$$69$YR$E$M$Y$61$KG$20240905$$MD$CN$CN
2314947810$23149478$10$F$20230824$20240625$20231106$20240701$EXP$$ES-MYLANLABS-2023M1115855$MYLAN$$71$YR$$F$Y$70$KG$20240701$$MD$ES$ES
231496024$23149602$4$F$20230901$20240228$20231106$20240710$PER$$VN-ROCHE-3448967$ROCHE$$$$A$F$Y$$$20240628$$MD$VN$VN
231496484$23149648$4$F$20230101$20240913$20231106$20240923$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2023FOS001148$RIGEL PHARMACEUTICALS$$75$YR$$F$Y$41$KG$20240924$$CN$JP$JP
231497436$23149743$6$F$$20240705$20231106$20240808$EXP$$CA-SANDOZ INC.-NVSC2020CA224094$SANDOZ$$44$YR$$F$Y$96$KG$20240808$$HP$CA$CA
231498604$23149860$4$F$$20231127$20231106$20240905$EXP$$NVSC2023US234299$NOVARTIS$$$$$M$Y$$$20240905$$CN$US$US
231499019$23149901$9$F$20240308$20240910$20231106$20240913$EXP$$US-SANDOZ INC.-NVSC2022US281463$SANDOZ$$64$YR$$F$Y$$$20240913$$HP$US$US
2314997311$23149973$11$F$$20240812$20231106$20240816$PER$$US-PFIZER INC-PV202300092528$PFIZER$$81$YR$$M$Y$$$20240816$$CN$US$US
231499942$23149994$2$F$$20240715$20231106$20240717$EXP$$US-PFIZER INC-2020425906$PFIZER$$70$YR$$M$Y$$$20240717$$CN$US$US
231499954$23149995$4$F$$20240722$20231106$20240724$PER$$US-PFIZER INC-PV202300181164$PFIZER$$49$YR$$F$Y$$$20240724$$HP$US$US
231500213$23150021$3$F$$20240903$20231106$20240905$PER$$US-PFIZER INC-PV202300179354$PFIZER$$67$YR$$F$Y$$$20240905$$CN$US$US
231501148$23150114$8$F$20230328$20240914$20231106$20240925$EXP$$FR-JNJFOC-20231025427$JOHNSON AND JOHNSON$$77$YR$E$M$Y$64$KG$20240925$$MD$FR$FR
2315013612$23150136$12$F$20230705$20240918$20231106$20240923$EXP$$US-TAKEDA-2023TUS070553$TAKEDA$$65$YR$$F$Y$$$20240923$$MD$US$US
231502452$23150245$2$F$20231001$20240716$20231106$20240717$EXP$$CA-SANDOZ INC.-SDZ2023CA051047$SANDOZ$$59$YR$$F$Y$$$20240717$$HP$CA$CA
231504052$23150405$2$F$$20231026$20231106$20240827$EXP$$US-ABBVIE-5476807$ABBVIE$Kaufman J. Venetoclax/Carfilzomib/Dexamethasone Triplet Shows Early Efficacy in t(l 1; 14)+ R/R Myelomac, 2023, 1-3.$$$$$Y$$$20240827$$HP$US$US
231504352$23150435$2$F$20230101$20240628$20231106$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-157395$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$97.52$KG$20240702$$CN$US$US
231504362$23150436$2$F$$20231103$20231106$20240923$EXP$$US-ABBVIE-5480151$ABBVIE$$$$$F$Y$$$20240923$$HP$US$US
231504832$23150483$2$F$$20240719$20231106$20240729$EXP$$BR-TAKEDA-2023TUS105780$TAKEDA$$$$$M$Y$$$20240729$$CN$BR$BR
231505843$23150584$3$F$20240601$20240701$20231106$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-022032$JAZZ$$40$YR$$F$Y$$$20240704$$CN$US$US
2315058811$23150588$11$F$20230807$20240726$20231106$20240806$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-009228$JAZZ$$57$YR$$F$Y$$$20240806$$HP$US$US
231508203$23150820$3$F$20190901$20240625$20231106$20240702$EXP$$NVSC2023DE232452$NOVARTIS$$56$YR$$F$Y$88$KG$20240702$$MD$DE$DE
231509565$23150956$5$F$20230101$20240910$20231106$20240912$EXP$$JP-Eisai-EC-2023-151896$EISAI$$70$YR$E$F$Y$40$KG$20240912$$MD$JP$JP
231509887$23150988$7$F$20230828$20240827$20231106$20240904$EXP$$DE-ABBVIE-5480096$ABBVIE$$65$YR$$M$Y$$$20240904$$HP$DE$DE
231511202$23151120$2$F$20231025$20240911$20231106$20240913$EXP$$US-ABBVIE-5478480$ABBVIE$$26$YR$$F$Y$$$20240913$$CN$US$US
231511556$23151155$6$F$20230812$20240919$20231106$20240926$EXP$$US-BIOGEN-2023BI01234168$BIOGEN$$79$YR$$F$Y$$$20240926$$CN$US$US
231512123$23151212$3$F$20231030$20240828$20231106$20240902$EXP$$RU-JNJFOC-20231105362$JOHNSON AND JOHNSON$$$$A$M$Y$52$KG$20240902$$HP$RU$RU
231513294$23151329$4$F$20230601$20240911$20231107$20240927$PER$$CA-TOLMAR, INC.-23CA044139$TOLMAR$$55$YR$$M$Y$$$20240927$$CN$CA$CA
231513342$23151334$2$F$20231018$20240614$20231107$20240703$PER$$CA-TOLMAR, INC.-23CA044174$TOLMAR$$94$YR$$M$Y$$$20240703$$CN$CA$CA
231514192$23151419$2$F$20230929$20240904$20231107$20240910$EXP$$US-TAKEDA-2023TUS095342$TAKEDA$$3$YR$$F$Y$16.7$KG$20240910$$CN$US$US
231515562$23151556$2$F$$20240720$20231107$20240730$30DAY$$US-GSK-US2023AMR152604$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$CN$US$US
231516022$23151602$2$F$$20240906$20231107$20240909$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-021987$JAZZ$$$$$F$Y$$$20240909$$CN$US$US
231517824$23151782$4$F$$20240726$20231107$20240730$EXP$$JP-009507513-2310JPN004480J$MERCK$Saijo A, Komiyama C, Matsuyama S, Yamaguchi Y, Miura Y, Suyama K, et al.. P9-2 Intervention for pericardial syndromes due to metastases to pericardium of malignant tumour - Comparing investigation on a case where carcinomatous pericarditis became severe cardiac failure during treatment of relapse after surgery for triple negative breast cancer and other cases of carcinomatous pericarditis -. The 6th Annual Meeting of the Japanese Onco-Cardiology Society. 127$6$DEC$$F$Y$$$20240730$$MD$JP$JP
231517864$23151786$4$F$$20240806$20231107$20240809$PER$$US-BIOGEN-2023BI01224679$BIOGEN$$$$$F$Y$$$20240809$$CN$US$US
231518182$23151818$2$F$$20240815$20231107$20240823$EXP$$CA-BAXTER-2023BAX034678$BAXTER$$50$YR$$F$Y$64$KG$20240823$$HP$CA$CA
231518473$23151847$3$F$20230701$20240919$20231107$20240926$EXP$$US-TAKEDA-2023TUS000837$TAKEDA$$69$YR$$M$Y$$$20240926$$HP$US$US
231518818$23151881$8$F$$20240822$20231107$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004691$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
231519013$23151901$3$F$20231031$20240716$20231107$20240719$EXP$$CO-ABBVIE-5484173$ABBVIE$$72$YR$$F$Y$65$KG$20240719$$CN$CO$CO
231519053$23151905$3$F$$20240726$20231107$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-156336$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240802$$MD$JP$JP
231519742$23151974$2$F$20210501$20240827$20231107$20240828$EXP$FR-AFSSAPS-AN20211823$FR-ORGANON-O2311FRA000138$ORGANON$$71$YR$$M$Y$$$20240828$$MD$FR$FR
231520985$23152098$5$F$20230905$20240918$20231107$20240927$EXP$$NVSC2023US233701$NOVARTIS$$57$YR$$M$Y$119$KG$20240927$$CN$US$US
2315215018$23152150$18$F$20230101$20240924$20231107$20240927$EXP$$JP-TAKEDA-2023TJP012923$TAKEDA$$$$$F$Y$$$20240927$$CN$JP$JP
231522013$23152201$3$F$$20240625$20231107$20240702$EXP$$JP-009507513-2310JPN004579J$MERCK$$7$DEC$$F$Y$$$20240702$$MD$JP$JP
231522153$23152215$3$F$$20240909$20231107$20240917$EXP$$JP-AMGEN-JPNSP2023195071$AMGEN$Nomura H. Clinical Outcome of Romosozumab for Fresh Osteoporotic Vertebral Fracture. Journal of Spine Research (e-journal). 2023;14 (9):1225-1233$$$E$M$Y$$$20240917$$MD$JP$JP
231522614$23152261$4$F$$20240807$20231107$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-157561$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$87.54$KG$20240808$$CN$US$US
231522862$23152286$2$F$$20240719$20231107$20240726$EXP$$BE-GSK-BE2023EME152474$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$BE$BE
231523827$23152382$7$F$20230920$20240607$20231107$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004679$ACADIA PHARMACEUTICALS$$16$YR$$F$Y$$$20240701$$CN$US$US
231524895$23152489$5$F$20230101$20240628$20231107$20240705$EXP$$US-UCBSA-2023034466$UCB$$$$$M$Y$$$20240705$$CN$US$US
231525217$23152521$7$F$20230907$20240708$20231107$20240715$EXP$$JP-009507513-2309JPN002900J$MERCK$$67$YR$$F$Y$$$20240715$$MD$JP$JP
231525492$23152549$2$F$$20231030$20231107$20240925$EXP$$US-GSK-US2023AMR151825$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
231525712$23152571$2$F$$20240801$20231107$20240806$EXP$$CA-TAKEDA-2023TUS106073$TAKEDA$$$$$M$Y$$$20240806$$MD$CA$CA
231525915$23152591$5$F$20230101$20240730$20231107$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2023-021833$UNITED THERAPEUTICS$$$$$F$Y$126.98$KG$20240807$$$US$US
231525993$23152599$3$F$20240205$20240801$20231107$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004733$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240827$$CN$US$US
231526137$23152613$7$F$20231001$20240909$20231107$20240921$EXP$$US-UCBSA-2023052308$UCB$$73$YR$$F$Y$$$20240921$$CN$US$US
231527693$23152769$3$F$$20240718$20231107$20240723$EXP$$CA-TAKEDA-2023TUS106531$TAKEDA$$$$$F$Y$$$20240723$$CN$CA$CA
231527734$23152773$4$F$20231001$20231211$20231107$20240926$PER$$US-GSK-US2023AMR147517$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240926$$CN$US$US
231528392$23152839$2$F$20230923$20240622$20231107$20240702$EXP$FR-AFSSAPS-PC2023000877$FR-Accord-387937$ACCORD$$66$YR$E$M$Y$67$KG$20240702$$MD$FR$FR
2315286312$23152863$12$F$20230623$20240809$20231107$20240813$EXP$$DE-AMGEN-DEUNI2023122628$AMGEN$$67$YR$E$M$Y$84.1$KG$20240813$$HP$DE$DE
231529984$23152998$4$F$20210315$20240925$20231107$20240930$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2021-07231$IPSEN$$70$YR$E$M$Y$$$20240930$$HP$CA$CA
231532034$23153203$4$F$$20240717$20231107$20240725$EXP$$US-TAKEDA-2023TUS105204$TAKEDA$$$$$F$Y$$$20240725$$MD$US$US
231533323$23153332$3$F$$20240904$20231107$20240906$EXP$$CA-SANDOZ INC.-NVSC2022CA239774$SANDOZ$$$$$F$Y$$$20240906$$CN$CA$CA
231533705$23153370$5$F$$20240711$20231107$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405723$RANBAXY$$$$$F$Y$108.84$KG$20240725$$CN$US$US
231533773$23153377$3$F$$20240709$20231107$20240728$30DAY$$CN-JNJFOC-20231074011$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$CN$CN
231533823$23153382$3$F$20231025$20240912$20231107$20240924$EXP$$US-BEH-2023164986$CSL BEHRING$$12$YR$T$M$Y$$$20240924$$HP$US$US
231534123$23153412$3$F$$20240801$20231107$20240806$EXP$$NVSC2020GB273223$NOVARTIS$$$$A$F$Y$$$20240806$$CN$GB$GB
231534474$23153447$4$F$20230401$20231102$20231107$20240711$PER$$US-PFM-2023-02646$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$5.519$KG$20240711$$CN$US$US
231534532$23153453$2$F$$20240905$20231107$20240906$EXP$$NVSJ2023JP015945$NOVARTIS$$46$YR$$M$Y$$$20240906$$MD$JP$JP
231535044$23153504$4$F$20230908$20240923$20231107$20240926$EXP$$CA-PFIZER INC-202101814653$PFIZER$$61$YR$$M$Y$$$20240926$$HP$CA$CA
231535323$23153532$3$F$20221018$20240828$20231107$20240903$EXP$$KR-009507513-2311KOR001755$MERCK$$43$YR$$M$Y$75$KG$20240903$$MD$KR$KR
231535424$23153542$4$F$20231101$20240819$20231107$20240827$PER$$US-BAUSCHBL-2023BNL011189$BAUSCH AND LOMB$$75$YR$$M$Y$106.14$KG$20240828$$CN$US$US
231535472$23153547$2$F$$20240701$20231107$20240708$EXP$$US-AMGEN-USASP2023195793$AMGEN$Bekaii-saab T. Ahn D.; Yuan C. et al.. Sequential treatment with regorafenib (REG) and trifluridine/tipiracil (TAS) +/- bevacizumab (Bev) in refractory metastatic colorectal cancer (mCRC) in community clinical practice in the USA. Annals of Oncology. 2023;34:S442$$$$$Y$$$20240708$$HP$US$US
231535635$23153563$5$F$$20240221$20231107$20240809$EXP$$NVSC2023US234989$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
231535683$23153568$3$F$20190101$20240828$20231107$20240903$EXP$BE-FAMHP-DHH-N2023-121052$BE-BAYER-2023A154970$BAYER$$49$YR$A$F$Y$$$20240903$$CN$BE$BE
231536993$23153699$3$F$$20231103$20231107$20240730$PER$$NVSC2023US237500$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
231538384$23153838$4$F$$20240829$20231107$20240903$EXP$$CA-PFIZER INC-202300350644$PFIZER$$77$YR$$F$Y$$$20240903$$HP$CA$CA
231538985$23153898$5$F$20231101$20240716$20231107$20240719$PER$$US-AMGEN-USASP2023197797$AMGEN$$39$YR$A$M$Y$$$20240719$$CN$US$US
231539056$23153905$6$F$20171023$20240712$20231107$20240716$EXP$$CA-TAKEDA-2017TUS020160$TAKEDA$$46$YR$$M$Y$$$20240716$$HP$CA$CA
231541137$23154113$7$F$20231101$20240312$20231107$20240925$PER$$US-GSK-US2023AMR153275$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
231541712$23154171$2$F$20230923$20240902$20231107$20240906$EXP$IT-MINISAL02-951368$IT-FreseniusKabi-FK202317694$FRESENIUS KABI$$32$YR$A$F$Y$80$KG$20240906$$MD$IT$IT
231546343$23154634$3$F$20230101$20240725$20231107$20240730$PER$$US-PFIZER INC-PV202300180715$PFIZER$$77$YR$$F$Y$$$20240730$$HP$US$US
231546813$23154681$3$F$$20240903$20231107$20240906$EXP$$US-SA-2023SA339020$SANOFI AVENTIS$Chan J, Hicks R, Habib M.. Panhypopituitarism as a cause of Pancytopenia in a Male Adolescent with Thrombophilia.. Hormone Research in Paediatrics. 2023;96(Suppl 3):237-8$17$YR$T$M$Y$$$20240906$$MD$US$US
231547055$23154705$5$F$$20240906$20231107$20240910$PER$$US-PFIZER INC-PV202300180154$PFIZER$$59$YR$$F$Y$$$20240910$$HP$US$US
231547763$23154776$3$F$20230101$20240812$20231107$20240819$PER$$US-ABBVIE-5474277$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
231549465$23154946$5$F$20171106$20240711$20231107$20240719$EXP$$US-SHIRE-US201729808$TAKEDA$$31$YR$$M$Y$49$KG$20240719$$MD$US$US
231550743$23155074$3$F$20171120$20240919$20231107$20240925$EXP$$CA-TAKEDA-2018TUS014551$TAKEDA$$25$YR$$M$Y$$$20240925$$CN$CA$CA
231551377$23155137$7$F$$20240815$20231107$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-022337$JAZZ$$$$$M$Y$$$20240821$$MD$US$US
231552114$23155211$4$F$$20240717$20231107$20240726$PER$$US-SA-2023SA336358$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240726$$CN$US$US
231552352$23155235$2$F$$20240916$20231107$20240924$PER$$US-SA-2023SA336840$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240924$$MD$US$US
231552442$23155244$2$F$20240825$20240827$20231107$20240919$PER$$US-SA-2023SA338560$SANOFI AVENTIS$$13$YR$T$M$Y$44.9$KG$20240919$$MD$US$US
231552514$23155251$4$F$20231018$20240710$20231107$20240718$PER$$US-SA-2023SA336882$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240718$$MD$US$US
231552523$23155252$3$F$20230101$20240731$20231107$20240809$PER$$US-SA-2023SA335383$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240809$$MD$US$US
231552642$23155264$2$F$$20240702$20231107$20240709$PER$$US-SA-2023SA335725$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240709$$MD$US$US
231552822$23155282$2$F$$20240812$20231107$20240821$PER$$US-SA-2023SA333440$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240821$$MD$US$US
231552972$23155297$2$F$$20240808$20231107$20240817$PER$$US-SA-2023SA234684$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240817$$MD$US$US
231553023$23155302$3$F$20230101$20240903$20231107$20240912$PER$$US-SA-2023SA335958$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240912$$MD$US$US
231553112$23155311$2$F$20230901$20240715$20231107$20240724$PER$$US-SA-2023SA296908$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240724$$MD$US$US
231553842$23155384$2$F$20230701$20240723$20231107$20240730$PER$$US-SA-2023SA338559$SANOFI AVENTIS$$26$YR$A$M$Y$235$KG$20240731$$MD$US$US
231553879$23155387$9$F$20230101$20240903$20231107$20240912$PER$$US-SA-2023SA336398$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240912$$MD$US$US
231553962$23155396$2$F$20230101$20240820$20231107$20240829$PER$$US-SA-2023SA335834$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240829$$MD$US$US
231554162$23155416$2$F$20230101$20240706$20231107$20240717$PER$$US-SA-2023SA333476$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240717$$MD$US$US
231555043$23155504$3$F$20240101$20240712$20231107$20240723$PER$$US-SA-2023SA337560$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240723$$MD$US$US
231555373$23155537$3$F$20240201$20240726$20231107$20240807$PER$$US-SA-2023SA337218$SANOFI AVENTIS$$2$YR$C$F$Y$13.6$KG$20240807$$MD$US$US
231556473$23155647$3$F$$20240710$20231107$20240718$PER$$US-SA-2023SA335257$SANOFI AVENTIS$$58$YR$A$F$Y$78$KG$20240718$$MD$US$US
231556983$23155698$3$F$20230207$20240829$20231107$20240919$PER$$US-SA-2023SA338274$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240919$$MD$US$US
231558152$23155815$2$F$20201001$20240628$20231107$20240704$PER$$US-SA-2023SA337053$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240704$$MD$US$US
231558282$23155828$2$F$20231101$20240725$20231107$20240806$PER$$US-SA-2023SA338590$SANOFI AVENTIS$$71$YR$E$F$Y$52.16$KG$20240806$$MD$US$US
231558625$23155862$5$F$20240101$20240820$20231107$20240823$EXP$$US-DSJP-DSU-2023-144769$DAIICHI$$$$$F$Y$$$20240823$$CN$US$US
231559393$23155939$3$F$20240704$20240724$20231107$20240802$PER$$US-SA-2023SA339743$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240802$$MD$US$US
231559633$23155963$3$F$20231001$20240816$20231107$20240822$EXP$$US-BIOGEN-2023BI01234652$BIOGEN$$54$YR$$F$Y$$$20240822$$HP$US$US
231561106$23156110$6$F$$20240729$20231107$20240805$EXP$$CA-Eisai-EC-2023-146893$EISAI$$51$YR$A$F$Y$$$20240805$$HP$CA$CA
231565906$23156590$6$F$20221201$20240729$20231107$20240801$EXP$$US-ABBVIE-5483939$ABBVIE$$67$YR$$M$Y$93.893$KG$20240801$$CN$US$US
231566772$23156677$2$F$$20231030$20231107$20240918$PER$$US-LEO Pharma-364705$LEO PHARM$$88$YR$$F$Y$$$20240918$$PH$US$US
231567773$23156777$3$F$$20240611$20231108$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004989$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
231567974$23156797$4$F$$20240617$20231108$20240703$30DAY$$CN-JNJFOC-20231070162$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$CN$CN
231568146$23156814$6$F$$20240619$20231108$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004988$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
231569523$23156952$3$F$$20240909$20231108$20240916$EXP$$JP-AMGEN-JPNSP2023194949$AMGEN$Nomura:H.. Comparative analysis of dropout rate of the patients with osteoporosis associated with fresh vertebral fractures followed by romosozumab or oral bisphosphonates treatment. The Journal of Japan Osteoporosis Society. 2024;10 (1):69-79$$$$F$Y$$$20240916$$MD$JP$JP
231570165$23157016$5$F$20050101$20240912$20231108$20240916$EXP$$US-GILEAD-2023-0650227$GILEAD$$$$A$F$Y$$$20240916$$LW$US$US
231571506$23157150$6$F$$20240906$20231108$20240922$EXP$$NL-ABBVIE-5485818$ABBVIE$$$$E$F$Y$$$20240922$$CN$NL$NL
231573393$23157339$3$F$20230916$20240718$20231108$20240722$EXP$$DE-TAKEDA-2023TUS107261$TAKEDA$$69$YR$$M$Y$$$20240722$$HP$DE$DE
231573783$23157378$3$F$20161225$20240709$20231108$20240724$EXP$$US-ENDO PHARMACEUTICALS INC-2023-004411$ENDO$$$$A$M$Y$76.19$KG$20240724$$CN$US$US
231573804$23157380$4$F$20091101$20240912$20231108$20240916$EXP$$US-GILEAD-2023-0650232$GILEAD$$40$YR$A$M$Y$$$20240916$$LW$US$US
231573926$23157392$6$F$20211022$20240911$20231108$20240916$EXP$$CA-TAKEDA-2023TUS106563$TAKEDA$$57$YR$$M$Y$$$20240916$$CN$CA$CA
231574072$23157407$2$F$20210501$20240827$20231108$20240905$EXP$FR-AFSSAPS-AN20211823$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-099847$ZYDUS PHARM$$$$$$Y$$$20240905$$MD$FR$FR
231574285$23157428$5$F$20230316$20240904$20231108$20240906$EXP$$FR-TAKEDA-2023TUS056496$TAKEDA$$4$YR$$M$Y$$$20240906$$HP$FR$FR
231574613$23157461$3$F$$20240405$20231108$20240925$PER$$US-GSK-US2023AMR153166$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
231575803$23157580$3$F$20231101$20231222$20231108$20240926$EXP$$US-GSK-US2023AMR152655$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
231576103$23157610$3$F$$20240711$20231108$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-159348$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$55.4$KG$20240717$$CN$US$US
231576316$23157631$6$F$20231001$20231129$20231108$20240926$EXP$$US-GSK-US2023AMR151463$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
231576577$23157657$7$F$20230823$20240823$20231108$20240829$EXP$$CL-SANDOZ INC.-SDZ2023CL042995$SANDOZ$$55$YR$$F$Y$$$20240829$$CN$CL$CL
231577677$23157767$7$F$20230101$20240801$20231108$20240805$EXP$$CA-UCBSA-2023052906$UCB$$$$$M$Y$$$20240805$$CN$CA$CA
231577692$23157769$2$F$20220227$20240624$20231108$20240717$PER$$CO-TOLMAR, INC.-23CO044262$TOLMAR$$83$YR$$M$Y$$$20240717$$CN$CO$CO
231577862$23157786$2$F$$20240820$20231108$20240822$PER$$NVSC2023US238304$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
231578003$23157800$3$F$$20240206$20231108$20240809$EXP$$NVSC2023US238168$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
231578322$23157832$2$F$$20231102$20231108$20240805$EXP$$NVSC2023US236218$NOVARTIS$$$$$M$Y$$$20240803$$CN$US$US
231578943$23157894$3$F$20240101$20240726$20231108$20240731$EXP$$US-ABBVIE-5484774$ABBVIE$$71$YR$$M$Y$$$20240731$$CN$US$US
231579037$23157903$7$F$20230101$20240723$20231108$20240731$EXP$$CA-CELLTRION INC.-2023CA021508$CELLTRION$$$$$$Y$$$20240731$$CN$CA$CA
2315795213$23157952$13$F$20230321$20240830$20231108$20240909$EXP$$CA-CELLTRION INC.-2023CA006475$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
231579714$23157971$4$F$$20240624$20231108$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-158418$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$MD$JP$JP
231580193$23158019$3$F$20230901$20240726$20231108$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-158308$BRISTOL MYERS SQUIBB$Seki N. A step towards the future in stage IV NSCLC treatment: a treatment approach using Imfinzi (durvalumab) + Imjudo (tremelimumab) + chemotherapy learned from post-marketing clinical use cases. Luncheon Seminar 23 in the 64th Annual Meeting of the Japan Lung Cancer Society. 2023;$70$YR$E$M$Y$51$KG$20240730$$MD$JP$JP
2315817611$23158176$11$F$20240201$20240809$20231108$20240814$EXP$$CA-ROCHE-2715114$ROCHE$$49$YR$A$F$Y$$$20240814$$CN$CA$CA
231582203$23158220$3$F$$20240820$20231108$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-158791$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$71.67$KG$20240829$$CN$US$US
231583047$23158304$7$F$20230101$20240910$20231108$20240917$EXP$$JP-009507513-2310JPN004710J$MERCK$$70$YR$$F$Y$$$20240917$$MD$JP$JP
231585073$23158507$3$F$$20240912$20231108$20240913$EXP$$CA-SANDOZ INC.-NVSC2022CA246738$SANDOZ$$52$YR$$M$Y$$$20240913$$CN$CA$CA
231585413$23158541$3$F$20140306$20240628$20231108$20240701$PER$$US-GILEAD-2023-0650321$GILEAD$$51$YR$A$M$Y$$$20240701$$LW$US$US
231587494$23158749$4$F$$20231103$20231108$20240801$PER$$NVSC2023US238290$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
231589378$23158937$8$F$$20240830$20231108$20240904$EXP$$CA-Eisai-EC-2023-152101$EISAI$$65$YR$E$F$Y$$$20240904$$HP$CA$CA
231589622$23158962$2$F$$20240726$20231108$20240726$EXP$$US-BAYER-2023A156615$BAYER$$28$YR$A$F$Y$$$20240726$$MD$US$US
231590612$23159061$2$F$20230605$20240918$20231108$20240924$EXP$$CO-UCBSA-2023053236$UCB$$39$YR$$F$Y$68$KG$20240924$$CN$CO$CO
231590852$23159085$2$F$$20240911$20231108$20240925$EXP$$US-INSMED, INC.-2023-04258-US$INSMED$$$$$M$Y$$$20240925$$HP$US$US
231591507$23159150$7$F$20231018$20240919$20231108$20240923$30DAY$$US-PFIZER INC-202300340242$PFIZER$$11$YR$$F$Y$31.3$KG$20240923$$CN$US$US
231593242$23159324$2$F$$20240722$20231108$20240724$EXP$$CA-SANDOZ INC.-SDZ2023CA051268$SANDOZ$$40$YR$$$Y$119$KG$20240724$$MD$CA$CA
231593433$23159343$3$F$$20240726$20231108$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-156339$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240806$$MD$JP$JP
231594792$23159479$2$F$20230301$20240823$20231108$20240829$EXP$$NVSC2023RU237517$NOVARTIS$$8$YR$$M$Y$28.4$KG$20240829$$HP$RU$RU
231595294$23159529$4$F$20230101$20240626$20231108$20240701$PER$$US-PFIZER INC-202300354477$PFIZER$$65$YR$$F$Y$$$20240701$$MD$US$US
231595317$23159531$7$F$20240101$20240823$20231108$20240827$PER$$US-PFIZER INC-PV202300181050$PFIZER$$77$YR$$F$Y$$$20240827$$HP$US$US
231595383$23159538$3$F$$20240924$20231108$20240925$EXP$$CA-SANDOZ INC.-NVSC2023CA035437$SANDOZ$$42$YR$$F$Y$$$20240925$$MD$CA$CA
231595653$23159565$3$F$20131017$20240628$20231108$20240701$EXP$$US-GILEAD-2023-0650317$GILEAD$$55$YR$A$M$Y$$$20240701$$LW$US$US
231595673$23159567$3$F$20201229$20240730$20231108$20240802$EXP$$CA-TAKEDA-2023TUS105854$TAKEDA$$72$YR$$F$Y$$$20240802$$MD$CA$CA
231595733$23159573$3$F$20190901$20240701$20231108$20240703$EXP$$US-GILEAD-2023-0650334$GILEAD$$51$YR$A$F$Y$$$20240703$$LW$US$US
231596154$23159615$4$F$$20240921$20231108$20240924$EXP$$GB-SANDOZ INC.-SDZ2023GB051458$SANDOZ$$$$$F$Y$$$20240924$$CN$GB$GB
231596433$23159643$3$F$$20240917$20231108$20240919$EXP$$US-PFIZER INC-202300352434$PFIZER$$55$YR$$F$Y$63.5$KG$20240919$$CN$US$US
231596542$23159654$2$F$$20240914$20231108$20240917$EXP$$US-SANDOZ INC.-SDZ2023US051588$SANDOZ$$$$$F$Y$$$20240917$$CN$US$US
231596944$23159694$4$F$20230801$20240412$20231108$20240925$EXP$$US-GSK-US2023AMR154298$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
231597044$23159704$4$F$20161201$20240913$20231108$20240917$EXP$$US-GILEAD-2023-0650338$GILEAD$$44$YR$A$F$Y$$$20240917$$LW$US$US
231597243$23159724$3$F$$20240624$20231108$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-158085$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$MD$JP$JP
231597922$23159792$2$F$$20240828$20231108$20240910$EXP$$US-MYLANLABS-2023M1118033$MYLAN$Xing H, Babajanyan H, Bohnenblust E, Kuo A. Cerebral Venous Sinus Thrombosis Following Lumbar Epidural Steroid Injection. J-Neurosurg-Anesthesiol 2023;35(4):e24 abstr. SNACC 28.$33$YR$$M$Y$$$20240910$$HP$US$US
231598365$23159836$5$F$20070107$20240913$20231108$20240917$PER$$US-GILEAD-2023-0650358$GILEAD$$50$YR$A$M$Y$$$20240917$$LW$US$US
231598973$23159897$3$F$20230101$20240708$20231108$20240712$PER$$US-VERTEX PHARMACEUTICALS-2023-016519$VERTEX$$$$$$Y$$$20240712$$CN$US$US
231599247$23159924$7$F$$20240917$20231108$20240927$EXP$$CA-TEVA-2023-CA-2944276$TEVA$$65$YR$$M$Y$$$20240927$$HP$CA$CA
231601294$23160129$4$F$20220101$20231206$20231108$20240802$EXP$$CZ-MYLANLABS-2023M1115293$MYLAN$MUDr. Masopust J, MUDr. Kopecek M, MUDr. Lucie Kalisova,  MUDr. Hyza M, MUDr. Risler M, MUDr. Skrabalova T, et,al.. Differences between brexpiprazole and aripiprazole in clinical practice. Case series. PSYCHIATRIE PRO PRAXI. 2023;24 (3):182-190$18$YR$$F$Y$$$20240802$$MD$CZ$CZ
231601474$23160147$4$F$20090101$20240627$20231108$20240701$EXP$$US-GILEAD-2023-0650213$GILEAD$$$$A$M$Y$$$20240701$$LW$US$US
231601974$23160197$4$F$20190101$20240906$20231108$20240930$EXP$$US-SA-2023SA341445$SANOFI AVENTIS$$44$YR$A$F$Y$104.3$KG$20240930$$MD$US$US
231602074$23160207$4$F$$20240903$20231108$20240911$EXP$$NVSC2023AU233879$NOVARTIS$Shivasabesan G, Logan B, Brennan X, Lau C, Vaze A, Bennett M et al.. Disseminated aspergillus lentulus infection in a heart transplant recipient: A case report. CLINICAL INFECTIOUS DISEASES. 2022;75(7):1235-8$72$YR$$F$Y$$$20240911$$HP$AU$AU
231602564$23160256$4$F$20230206$20240627$20231108$20240701$EXP$$NVSC2023GB030015$NOVARTIS$$$$$F$Y$$$20240701$$CN$GB$GB
231603694$23160369$4$F$$20240918$20231108$20240930$EXP$$NVSC2023US237741$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
231604243$23160424$3$F$$20240822$20231108$20240823$EXP$$CA-PURDUE-USA-2023-0305762$PURDUE$$27$YR$$M$Y$$$20240823$$CN$CA$CA
231604833$23160483$3$F$20221025$20240918$20231108$20240925$PER$$JP-Eisai-EC-2022-127034$EISAI$$57$YR$A$F$Y$78$KG$20240925$$MD$JP$JP
231606024$23160602$4$F$20160328$20240723$20231108$20240731$EXP$$JP-ALXN-A201602606AA$ALEXION PHARMACEUTICALS$$5$YR$$M$Y$$$20240731$$MD$JP$JP
231606084$23160608$4$F$$20240730$20231108$20240807$PER$$US-ALXN-A202312836AA$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
231606345$23160634$5$F$$20240805$20231108$20240813$PER$$US-ALXN-A202308106$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$MD$US$US
231606964$23160696$4$F$20240403$20240801$20231108$20240810$PER$$US-SA-2023SA336386$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240810$$MD$US$US
231607173$23160717$3$F$20240101$20240806$20231108$20240813$PER$$US-SA-2023SA335285$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240814$$MD$US$US
231607242$23160724$2$F$20240101$20240711$20231108$20240723$PER$$US-SA-2023SA338631$SANOFI AVENTIS$$$$C$F$Y$16$KG$20240723$$MD$US$US
231608144$23160814$4$F$20230101$20240703$20231108$20240712$PER$$US-SA-2023SA336088$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240712$$MD$US$US
231608234$23160823$4$F$20240101$20240807$20231108$20240813$PER$$US-SA-2023SA335137$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240813$$MD$US$US
231608402$23160840$2$F$20230101$20240904$20231108$20240930$PER$$US-SA-2023SA337621$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
231608573$23160857$3$F$20230101$20240815$20231108$20240829$PER$$US-SA-2023SA335423$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240829$$MD$US$US
231608706$23160870$6$F$20231022$20240712$20231108$20240722$EXP$$US-SA-2023SA338694$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240722$$MD$US$US
231609442$23160944$2$F$20231026$20240806$20231108$20240813$PER$$US-SA-2023SA342092$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240814$$MD$US$US
231609933$23160993$3$F$20230101$20240730$20231108$20240808$PER$$US-SA-2023SA342119$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240808$$MD$US$US
231609962$23160996$2$F$20230101$20240712$20231108$20240801$PER$$US-SA-2023SA342212$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240719$$MD$US$US
231610062$23161006$2$F$20230101$20240802$20231108$20240812$PER$$US-SA-2023SA340547$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240812$$MD$US$US
231610282$23161028$2$F$$20240826$20231108$20240917$PER$$US-SA-2023SA339319$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
231610622$23161062$2$F$20231024$20240722$20231108$20240730$PER$$US-SA-2023SA342164$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240730$$MD$US$US
231610742$23161074$2$F$$20240701$20231108$20240710$PER$$US-SA-2023SA341071$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240710$$MD$US$US
231611833$23161183$3$F$20231003$20240311$20231108$20240923$EXP$$PT-SUNOVION-2023SUN001224$SUNOVION$$$$$$Y$$$20240923$$MD$KR$KR
231612315$23161231$5$F$20231201$20240711$20231108$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-160022$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240719$$CN$US$US
231613414$23161341$4$F$20230901$20240726$20231108$20240801$EXP$$CO-SANDOZ INC.-NVSC2019CO013487$SANDOZ$$86$YR$$F$Y$52$KG$20240801$$CN$CO$CO
231615005$23161500$5$F$$20240715$20231108$20240720$EXP$$CA-JNJFOC-20210128581$JOHNSON AND JOHNSON$$13$YR$T$F$Y$50.3$KG$20240719$$HP$CA$CA
231616284$23161628$4$F$20230101$20240827$20231108$20240829$EXP$$NVSJ2023JP016000$NOVARTIS$$63$YR$$M$Y$$$20240830$$MD$JP$JP
231616947$23161694$7$F$20230818$20240904$20231108$20240909$EXP$$DE-AMGEN-DEUNI2023166409$AMGEN$$60$YR$A$F$Y$50.4$KG$20240909$$MD$DE$DE
231617032$23161703$2$F$20231025$20240806$20231108$20240813$PER$$US-SA-2023SA342483$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240814$$MD$US$US
231617843$23161784$3$F$$20240802$20231108$20240812$PER$$US-SA-2023SA340592$SANOFI AVENTIS$$$$A$M$Y$90.2$KG$20240812$$MD$US$US
231617993$23161799$3$F$20210713$20240807$20231108$20240815$EXP$$PK-AMGEN-PAKSP2021211350$AMGEN$$30$YR$A$M$Y$111$KG$20240815$$CN$PK$PK
231618612$23161861$2$F$20230505$20240704$20231108$20240710$EXP$$AU-SA-2023SA149567$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240710$$MD$AU$AU
231620783$23162078$3$F$$20240911$20231109$20240927$PER$$CA-TOLMAR, INC.-23CA043967$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
231621093$23162109$3$F$$20240815$20231109$20240821$EXP$$CA-TAKEDA-2023TUS107242$TAKEDA$$$$$F$Y$$$20240821$$CN$CA$CA
231622842$23162284$2$F$20240801$20240913$20231109$20240924$PER$$US-SA-2023SA339898$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240924$$MD$US$US
231623232$23162323$2$F$$20231027$20231109$20240801$EXP$$CA-SA-2023SA339693$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240801$$HP$CA$CA
231623846$23162384$6$F$20231009$20240614$20231109$20240703$30DAY$$FR-JNJFOC-20231034080$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240703$$PH$FR$FR
231625283$23162528$3$F$20230812$20240703$20231109$20240706$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-271851$BOEHRINGER INGELHEIM$$89$YR$E$M$Y$74$KG$20240706$$MD$FR$FR
231625629$23162562$9$F$$20240703$20231109$20240708$EXP$$CA-TAKEDA-2023TUS041567$TAKEDA$$$$$M$Y$$$20240708$$CN$CA$CA
231625717$23162571$7$F$20230818$20240831$20231109$20240911$EXP$$DE-AUROBINDO-AUR-APL-2023-059285$AUROBINDO$$60$YR$$F$Y$50.4$KG$20240911$$MD$DE$DE
231626035$23162603$5$F$20231113$20240305$20231109$20240926$EXP$$US-GSK-US2023AMR153836$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
231626772$23162677$2$F$20230916$20240701$20231109$20240712$PER$$DE-IGSA-BIG0026383$GRIFOLS$$69$YR$$M$Y$$$20240712$$MD$DE$DE
231627825$23162782$5$F$$20240903$20231109$20240918$EXP$$US-CHATTEMPRD-2023OHG014386$CHATTEM$Chan J, Hicks R, Habib M. Panhypopituitarism as a cause of Pancytopenia in a Male Adolescent with Thrombophilia. Hormone Research in Paediatrics. 2023;96 (Supplement 3): 237-8. DOI:  10.1159/000531602.$17$YR$T$M$Y$$$20240918$$MD$US$US
231627832$23162783$2$F$$20240708$20231109$20240723$EXP$$DE-SAMSUNG BIOEPIS-SB-2023-29198$SAMSUNG BIOEPIS$Schade S, Koenig U, Mekolli A, Gaedcke J, Neesse A, Reinecke J et al.. Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and Trastuzumab. REPORTS IN GASTROENTEROLOGY. 2022;16:80-8$30$YR$A$M$Y$67$KG$20240723$$MD$DE$DE
231627944$23162794$4$F$20230412$20240712$20231109$20240715$EXP$$US-TAKEDA-US201941651$TAKEDA$$15$YR$$M$Y$23.58$KG$20240715$$CN$US$US
231627984$23162798$4$F$20230526$20240816$20231109$20240828$EXP$$FR-AUROBINDO-AUR-APL-2023-066907$AUROBINDO$$20$YR$$F$Y$$$20240828$$MD$FR$FR
231628189$23162818$9$F$20231101$20240911$20231109$20240924$EXP$$NL-ABBVIE-5488202$ABBVIE$$75$YR$$M$Y$$$20240924$$CN$NL$NL
231629412$23162941$2$F$20230909$20240729$20231109$20240729$EXP$FR-AFSSAPS-PV2023000993$NVSC2023FR229041$NOVARTIS$$65$YR$$F$Y$54$KG$20240729$$MD$FR$FR
231629472$23162947$2$F$$20240902$20231109$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-160619$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240911$$HP$US$US
231629483$23162948$3$F$$20240624$20231109$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004738$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
231630153$23163015$3$F$20231105$20240918$20231109$20240919$EXP$$CA-ROCHE-3454882$ROCHE$$52$YR$A$M$Y$$$20240919$$CN$CA$CA
231630373$23163037$3$F$20230806$20240710$20231109$20240712$EXP$$US-UCBSA-2023040794$UCB$$10$YR$$F$Y$$$20240712$$CN$US$US
2316323813$23163238$13$F$$20240919$20231109$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-160167$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240927$$CN$US$US
231633092$23163309$2$F$$20240918$20231109$20240920$EXP$$US-GILEAD-2023-0650191$GILEAD$$$$$F$Y$$$20240920$$MD$US$US
231634944$23163494$4$F$20231024$20240703$20231109$20240725$PER$$CA-TOLMAR, INC.-23CA044267$TOLMAR$$65$YR$$M$Y$$$20240724$$CN$CA$CA
231635372$23163537$2$F$$20240819$20231109$20240827$EXP$$JP-ROCHE-3452683$ROCHE$Tanigawa T, Goto I, Suguura S, Sato Y and Iwata M A case of a patient with breast cancer in which the onset of cardiac failure was predictable by regular assessment of GLS (Abstract number: P6-6). The 6th Annual Meeting of the Japanese Onco-Cardiology Society 2023;:118-.$6$DEC$A$F$Y$45$KG$20240827$$MD$JP$JP
231635555$23163555$5$F$20231016$20240910$20231109$20240921$EXP$$KR-Accord-389459$ACCORD$$82$YR$E$F$Y$43$KG$20240921$$HP$KR$KR
231635724$23163572$4$F$$20240723$20231109$20240801$EXP$CA-MHPD-E2B_06539829$CA-Accord-388583$ACCORD$$60$YR$A$F$Y$$$20240801$$HP$CA$CA
231635743$23163574$3$F$$20240613$20231109$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004517$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
231637002$23163700$2$F$20190101$20240917$20231109$20240925$EXP$$CA-TAKEDA-2019TUS044572$TAKEDA$$$$$M$Y$$$20240925$$CN$CA$CA
231641783$23164178$3$F$20190130$20240830$20231109$20240911$EXP$DE-EMA-20231013-AUTODUP-1697234383291$DE-Accord-388756$ACCORD$$68$YR$E$F$Y$88.8$KG$20240911$$MD$DE$DE
231643013$23164301$3$F$20231019$20240906$20231109$20240913$EXP$$US-SA-2023SA222692$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240913$$MD$US$US
231643802$23164380$2$F$20220101$20240906$20231109$20240918$EXP$$US-INSMED, INC.-2022-03174-US$INSMED$$$$$F$Y$$$20240918$$CN$US$US
231644263$23164426$3$F$$20240829$20231109$20240910$EXP$$US-INSMED, INC.-2023-03065-US$INSMED$$$$$M$Y$$$20240910$$CN$US$US
231645694$23164569$4$F$20231001$20240102$20231109$20240925$PER$$US-GSK-US2023AMR150657$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
231645972$23164597$2$F$20230717$20231030$20231109$20240828$EXP$DE-CADRBFARM-2023323400$DE-TORRENT-00025652$TORRENT$$28$YR$A$F$Y$85$KG$20240828$$CN$DE$DE
231646333$23164633$3$F$20230620$20240806$20231109$20240809$EXP$$IT-ROCHE-3373042$ROCHE$$63$YR$A$M$Y$60$KG$20240809$$MD$IT$IT
231648585$23164858$5$F$20231030$20240916$20231109$20240925$EXP$$US-GSK-US2023150261$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
231651792$23165179$2$F$$20240713$20231109$20240717$EXP$$CN-PFIZER INC-PV202300178687$PFIZER$Wang, B.. Double Whammy: Crizotinib-Associated Necrotizing Scleritis. Ophthalmology. 2023;10.1016/j.ophtha.2023.09.021$62$YR$$F$Y$$$20240717$$MD$CN$CN
231653655$23165365$5$F$20230101$20240905$20231109$20240917$EXP$$NL-ABBVIE-5487676$ABBVIE$$84$YR$$F$Y$$$20240917$$CN$NL$NL
231654135$23165413$5$F$20230110$20240912$20231109$20240924$EXP$$JP-Eisai-EC-2023-146837$EISAI$$55$YR$A$F$Y$54$KG$20240924$$MD$JP$JP
231654265$23165426$5$F$$20240729$20231109$20240806$PER$$US-ALXN-A202310023$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
231654472$23165447$2$F$20210501$20240827$20231109$20240830$EXP$FR-AFSSAPS-AN20211823$FR-MYLANLABS-2023M1118269$MYLAN$$71$YR$$M$Y$$$20240830$$MD$FR$FR
231656433$23165643$3$F$20230101$20240605$20231109$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00293$AVADEL CNS PHARMA$$$$$F$Y$55.782$KG$20240822$$CN$US$US
231656612$23165661$2$F$20231101$20240808$20231109$20240809$PER$$US-AMGEN-USASP2023197764$AMGEN$$50$YR$A$M$Y$$$20240809$$CN$US$US
231656664$23165666$4$F$$20240625$20231109$20240709$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK086262$GLENMARK$$$$$$Y$$$20240709$$HP$CA$CA
231657332$23165733$2$F$$20240806$20231109$20240807$EXP$$US-TAKEDA-2023TUS106728$TAKEDA$$$$$F$Y$$$20240807$$MD$US$US
231664093$23166409$3$F$20231005$20240819$20231109$20240904$PER$$US-GLAXOSMITHKLINE-USCH2023053169$Haleon PLC$$69$YR$$F$Y$$$20240904$$CN$US$US
231664983$23166498$3$F$20230808$20240905$20231109$20240911$EXP$$US-OTSUKA-2023_023293$OTSUKA$$$$$F$Y$$$20240911$$CN$US$US
231665345$23166534$5$F$20230101$20240902$20231109$20240912$EXP$$JP-009507513-2308JPN001500J$MERCK$$$$$F$Y$42$KG$20240912$$MD$JP$JP
231665522$23166552$2$F$$20240627$20231109$20240701$EXP$$CA-PFIZER INC-202300354075$PFIZER$$62$YR$$F$Y$$$20240701$$HP$CA$CA
231665562$23166556$2$F$$20240806$20231109$20240809$EXP$$CA-PFIZER INC-202300356461$PFIZER$$$$$$Y$$$20240809$$PH$CA$CA
231665963$23166596$3$F$$20240819$20231109$20240821$EXP$$US-PFIZER INC-PV202300182949$PFIZER$$70$YR$$F$Y$109.7$KG$20240821$$CN$US$US
231665992$23166599$2$F$$20240807$20231109$20240809$EXP$$CA-PFIZER INC-202300354208$PFIZER$$50$YR$$M$Y$$$20240809$$HP$CA$CA
231666095$23166609$5$F$20230201$20240904$20231109$20240913$PER$$JP-Eisai-EC-2023-134544$EISAI$$$$A$F$Y$$$20240913$$MD$JP$JP
231666405$23166640$5$F$20191001$20240919$20231109$20240923$EXP$$CA-SANDOZ INC.-NVSC2019CA023085$SANDOZ$$51$YR$$F$Y$$$20240923$$CN$CA$CA
231666666$23166666$6$F$20231102$20240702$20231109$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-022270$JAZZ$$25$YR$$F$Y$$$20240708$$MD$US$US
231666852$23166685$2$F$20230101$20240813$20231109$20240814$EXP$$US-BAUSCH-BL-2023-016735$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240814$$CN$US$US
231667152$23166715$2$F$20230807$20240805$20231109$20240808$EXP$$NVSC2023GB183070$NOVARTIS$$35$YR$$F$Y$$$20240808$$CN$GB$GB
231668112$23166811$2$F$$20240927$20231109$20240927$EXP$$US-SANDOZ INC.-SDZ2023US004419$SANDOZ$$53$YR$$M$Y$180$KG$20240927$$MD$US$US
231668232$23166823$2$F$$20240710$20231109$20240715$EXP$$US-SANDOZ INC.-SDZ2023US018726$SANDOZ$$$$$F$Y$$$20240715$$CN$US$US
231668402$23166840$2$F$20230101$20240925$20231109$20240926$EXP$$US-SANDOZ INC.-SDZ2023US019672$SANDOZ$$$$$F$Y$$$20240926$$MD$US$US
231668505$23166850$5$F$20231025$20240916$20231109$20240919$EXP$$DE-FreseniusKabi-FK202317947$FRESENIUS KABI$$58$YR$A$M$Y$56$KG$20240919$$MD$DE$DE
231668513$23166851$3$F$20231026$20240710$20231109$20240715$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-005890$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240715$$HP$US$US
231668932$23166893$2$F$20220801$20240816$20231109$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-417307$RANBAXY$$47$YR$$F$Y$$$20240830$$MD$FR$FR
231670545$23167054$5$F$20230701$20240814$20231109$20240816$EXP$$JP-ARGENX-2023-ARGX-JP002493$ARGENX BVBA$$$$$$Y$$$20240816$$MD$JP$JP
231670742$23167074$2$F$20240419$20240621$20231109$20240701$30DAY$$US-GSK-US2023151157$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240701$$CN$US$US
231670753$23167075$3$F$20231023$20240801$20231109$20240802$EXP$$DE-ROCHE-3451987$ROCHE$$67$YR$E$M$Y$$$20240802$$CN$DE$DE
231671225$23167122$5$F$20240110$20240923$20231109$20240927$EXP$$US-TAKEDA-2023TUS092930$TAKEDA$$79$YR$$M$Y$91$KG$20240927$$CN$US$US
231671422$23167142$2$F$20220928$20240719$20231109$20240726$EXP$$ME-TAKEDA-2023TUS109144$TAKEDA$$35$YR$$M$Y$82$KG$20240726$$CN$ME$ME
231672062$23167206$2$F$20240101$20240711$20231109$20240718$EXP$$US-SA-2023SA347581$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
231672272$23167227$2$F$20240806$20240806$20231109$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202311004673$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240816$$CN$US$US
231672356$23167235$6$F$$20240903$20231109$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-160493$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240910$$CN$US$US
231672793$23167279$3$F$$20240805$20231109$20240809$EXP$$IT-MYLANLABS-2018M1038948$MYLAN$Schierz I.A.M., Giuffre M., Piro E., Placa S.L., Corsello G.. A case of cardiomyopathy due to premature ductus arteriosus closure: The flip side of paracetamol.. Pediatrics.. 2018;141 (2):1-3$38$WK$$F$Y$$$20240809$$MD$IT$IT
231673364$23167336$4$F$20240319$20240816$20231109$20240821$EXP$$US-ABBVIE-5484478$ABBVIE$$73$YR$$M$Y$$$20240821$$CN$US$US
231674172$23167417$2$F$$20240809$20231109$20240817$PER$$US-SA-2023SA335827$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240817$$MD$US$US
231674432$23167443$2$F$$20240910$20231109$20240917$PER$$US-SA-2023SA338792$SANOFI AVENTIS$$16$YR$T$F$Y$57.8$KG$20240918$$HP$US$US
231674492$23167449$2$F$20230101$20240905$20231109$20240916$PER$$US-SA-2023SA338456$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240916$$MD$US$US
231675023$23167502$3$F$$20240806$20231109$20240813$PER$$US-SA-2023SA340415$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240814$$CN$US$US
231675512$23167551$2$F$20230101$20240726$20231109$20240802$PER$$US-SA-2023SA342041$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240802$$MD$US$US
231675562$23167556$2$F$20230101$20240627$20231109$20240708$PER$$US-SA-2023SA339654$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240708$$MD$US$US
231675952$23167595$2$F$20231027$20240705$20231109$20240716$PER$$US-SA-2023SA339812$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240716$$MD$US$US
231676013$23167601$3$F$$20240807$20231109$20240816$PER$$US-SA-2023SA340453$SANOFI AVENTIS$$42$YR$A$M$Y$65.76$KG$20240816$$MD$US$US
231676063$23167606$3$F$20230101$20240806$20231109$20240813$PER$$US-SA-2023SA342444$SANOFI AVENTIS$$62$YR$A$F$Y$49.44$KG$20240814$$MD$US$US
231676594$23167659$4$F$20230801$20240918$20231109$20240926$PER$$US-SA-2023SA343990$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240926$$MD$US$US
231677202$23167720$2$F$20230101$20240717$20231109$20240723$PER$$US-SA-2023SA343257$SANOFI AVENTIS$$19$YR$A$$Y$$$20240723$$CN$US$US
231677253$23167725$3$F$$20240702$20231109$20240711$PER$$US-SA-2023SA343255$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240711$$MD$US$US
231677625$23167762$5$F$20231023$20240918$20231109$20240927$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2023-157373$BRISTOL MYERS SQUIBB$Maurizi N, Antiochos P, Muller O, Wuerzner G, Monney P. Accelerated hypertension following mavacamten introduction in severe obstructive hypertrophic cardiomyopathy with hypertension: a case report. European Heart Journal - Case Reports. 2024 Aug 26;8(9):1-5. doi:10.1093/ehjcr/ytae450.$55$YR$A$M$Y$$$20240927$$MD$CH$CH
231678822$23167882$2$F$$20240624$20231109$20240701$PER$$US-VERTEX PHARMACEUTICALS-2023-016710$VERTEX$$$$$F$Y$$$20240701$$CN$US$US
231680124$23168012$4$F$20230101$20240805$20231109$20240812$EXP$$AU-009507513-2311AUS002037$MERCK$$68$YR$$F$Y$$$20240812$$MD$AU$AU
231680142$23168014$2$F$20230224$20240812$20231109$20240816$EXP$$AR-BIOGEN-2023BI01193843$BIOGEN$$35$YR$$F$Y$$$20240816$$CN$AR$AR
231680303$23168030$3$F$20230101$20240821$20231109$20240911$EXP$$NL-ABBVIE-5316378$ABBVIE$$$$E$M$Y$$$20240911$$HP$NL$NL
231680543$23168054$3$F$20161220$20240812$20231109$20240814$EXP$$CA-SANDOZ INC.-PHHY2016CA178692$SANDOZ$$63$YR$$M$Y$$$20240814$$CN$CA$CA
231680843$23168084$3$F$20231002$20240827$20231109$20240902$EXP$$DE-SANDOZ INC.-SDZ2023DE052527$SANDOZ$$$$A$F$Y$54$KG$20240902$$HP$DE$DE
231681634$23168163$4$F$$20240729$20231109$20240802$EXP$$US-ABBVIE-5489225$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
231681722$23168172$2$F$$20240909$20231109$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004782$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
231682398$23168239$8$F$20230913$20240916$20231109$20240919$EXP$$US-SANDOZ INC.-SDZ2023US052453$SANDOZ$$63$YR$$F$Y$$$20240919$$CN$US$US
231682972$23168297$2$F$20230926$20240828$20231109$20240903$EXP$$US-ALXN-202311GLO000043US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$HP$US$US
231683346$23168334$6$F$$20240614$20231110$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004776$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
231688592$23168859$2$F$$20240820$20231110$20240913$PER$$CA-TOLMAR, INC.-23CA044147$TOLMAR$$$$$M$Y$$$20240913$$CN$CA$CA
231691149$23169114$9$F$20230425$20240826$20231110$20240904$EXP$$IT-SA-2023SA340550$SANOFI AVENTIS$$73$YR$E$M$Y$75$KG$20240904$$HP$IT$IT
231691362$23169136$2$F$$20240704$20231110$20240712$EXP$$CA-CELLTRION INC.-2023CA021445$CELLTRION$$$$$$Y$$$20240712$$HP$CA$CA
2316914712$23169147$12$F$20231028$20240630$20231110$20240708$EXP$$US-Blueprint Medicines Corporation-SP-US-2023-001757$BLUEPRINT MEDICINES$$73$YR$E$F$Y$$$20240708$$CN$US$US
231692155$23169215$5$F$20231026$20240607$20231110$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003816$ACADIA PHARMACEUTICALS$$26$YR$$F$Y$$$20240701$$CN$US$US
231692998$23169299$8$F$20240601$20240801$20231110$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-011216$JAZZ$$33$YR$$F$Y$$$20240806$$CN$US$US
231693027$23169302$7$F$20200102$20240917$20231110$20240926$EXP$$US-SHIRE-US202000038$TAKEDA$$40$YR$$F$Y$122$KG$20240926$$CN$US$US
231693244$23169324$4$F$20231107$20240919$20231110$20240920$EXP$$NVSC2023US239304$NOVARTIS$$52$YR$$F$Y$$$20240920$$CN$US$US
231693464$23169346$4$F$20231105$20240724$20231110$20240731$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-022675$JAZZ$$41$YR$$F$Y$$$20240731$$MD$US$US
231693505$23169350$5$F$20230301$20240710$20231110$20240721$30DAY$$US-GSK-US2023151092$GLAXOSMITHKLINE$$31$YR$$F$Y$$$20240721$$CN$US$US
231693633$23169363$3$F$20230401$20240807$20231110$20240812$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2023-161181$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$82.55$KG$20240812$$CN$PR$PR
231693764$23169376$4$F$$20240618$20231110$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004767$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
231695153$23169515$3$F$$20240624$20231110$20240701$EXP$$CO-GSK-CO2023AMR147787$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$HP$CO$CO
231695212$23169521$2$F$20160101$20240706$20231110$20240717$EXP$$FR-AUROBINDO-AUR-APL-2023-067180$AUROBINDO$$50$YR$$F$Y$96$KG$20240717$$HP$FR$FR
231697316$23169731$6$F$20230101$20240716$20231110$20240724$EXP$$CA-JNJFOC-20230746455$JOHNSON AND JOHNSON$$35$YR$A$F$Y$95$KG$20240724$$HP$CA$CA
231697462$23169746$2$F$$20240629$20231110$20240711$EXP$CA-MHPD-E2B_06546894$CA-Accord-388802$ACCORD$$54$YR$A$F$Y$68$KG$20240711$$HP$CA$CA
231697765$23169776$5$F$20231024$20240905$20231110$20240906$EXP$$US-TAKEDA-2023TUS109420$TAKEDA$$36$YR$$F$Y$86$KG$20240906$$CN$US$US
231698093$23169809$3$F$$20240819$20231110$20240822$EXP$$US-TAKEDA-2023TUS049194$TAKEDA$$$$$F$Y$57$KG$20240822$$CN$US$US
231698384$23169838$4$F$20201030$20240909$20231110$20240919$EXP$$DE-AUROBINDO-AUR-APL-2023-067409$AUROBINDO$$$$A$F$Y$$$20240919$$MD$DE$DE
231698913$23169891$3$F$20231003$20240705$20231110$20240715$EXP$IT-MINISAL02-949961$IT-TEVA-2023-IT-2942636$TEVA$$14$YR$$F$Y$67$KG$20240715$$PH$IT$IT
231699714$23169971$4$F$20231115$20240906$20231110$20240913$EXP$$AU-TAKEDA-2023TUS109184$TAKEDA$$83$YR$$F$Y$$$20240913$$HP$AU$AU
231700943$23170094$3$F$$20240827$20231110$20240902$EXP$$CA-TAKEDA-2023TUS084561$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
231701272$23170127$2$F$20230101$20240625$20231110$20240701$EXP$$DE-UCBSA-2023053597$UCB$$$$$$Y$$$20240701$$MD$DE$DE
231701615$23170161$5$F$20231110$20240819$20231110$20240828$EXP$$US-ROCHE-3455250$ROCHE$$88$YR$E$F$Y$150$KG$20240828$$CN$US$US
231702853$23170285$3$F$$20240711$20231110$20240716$EXP$$US-TAKEDA-2023TUS109254$TAKEDA$$$$$M$Y$$$20240716$$CN$US$US
231703772$23170377$2$F$$20230914$20231110$20240913$EXP$$US-SANDOZ INC.-SDZ2023US034517$SANDOZ$$$$$F$Y$$$20240913$$CN$US$US
231704882$23170488$2$F$20220420$20240917$20231110$20240925$EXP$$GB-Hikma Pharmaceuticals-GB-H14001-22-57747$HIKMA$$58$YR$$M$Y$$$20240925$$PH$GB$GB
231705043$23170504$3$F$20231029$20240708$20231110$20240715$EXP$$US-TAKEDA-2023TUS108494$TAKEDA$$39$YR$$M$Y$$$20240715$$CN$US$US
231705092$23170509$2$F$$20240624$20231110$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-160027$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240701$$PH$JP$JP
231705253$23170525$3$F$20230101$20240808$20231110$20240821$EXP$$US-UCBSA-2023052963$UCB$$$$$F$Y$151.02$KG$20240821$$HP$US$US
231705624$23170562$4$F$20240208$20240726$20231110$20240731$EXP$$CA-TAKEDA-2023TUS108047$TAKEDA$$61$YR$$M$Y$$$20240731$$MD$CA$CA
2317063916$23170639$16$F$20230101$20240701$20231110$20240710$EXP$$US-UNITED THERAPEUTICS-UNT-2023-031082$UNITED THERAPEUTICS$$$$$F$Y$67.574$KG$20240710$$$US$US
231706593$23170659$3$F$$20240118$20231110$20240925$PER$$US-GSK-US2023AMR152614$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
231707335$23170733$5$F$20240103$20240731$20231110$20240805$EXP$$CA-TAKEDA-2023TUS107905$TAKEDA$$31$YR$$F$Y$$$20240805$$HP$CA$CA
231707782$23170778$2$F$$20240819$20231110$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-161462$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240821$$CN$US$US
231709002$23170900$2$F$20230726$20240915$20231110$20240917$PER$$CN-Eisai-EC-2023-152445$EISAI$$70$YR$E$F$Y$57$KG$20240917$$MD$CN$CN
2317096310$23170963$10$F$20230811$20240911$20231110$20240916$EXP$$IT-BIOGEN-2023BI01224752$BIOGEN$$65$YR$$F$Y$65$KG$20240916$$MD$IT$IT
231710462$23171046$2$F$$20240802$20231110$20240806$EXP$$US-TAKEDA-2023TUS108512$TAKEDA$$$$$F$Y$$$20240806$$CN$US$US
231712124$23171212$4$F$20211130$20240902$20231110$20240912$EXP$$DE-TEVA-2023-DE-2942465$TEVA$$$$E$F$Y$$$20240912$$MD$DE$DE
231712273$23171227$3$F$$20240919$20231110$20240925$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03896$AMNEAL$$$$$F$Y$$$20240925$$CN$US$US
231712502$23171250$2$F$20231024$20240725$20231110$20240802$EXP$$CA-TEVA-2023-CA-2943200$TEVA$$41$YR$$M$Y$$$20240802$$HP$CA$CA
231712583$23171258$3$F$$20240801$20231110$20240806$EXP$$US-TAKEDA-US202016594$TAKEDA$$$$$F$Y$$$20240806$$HP$US$US
231712662$23171266$2$F$$20240725$20231110$20240730$EXP$$CA-SANDOZ INC.-NVSC2022CA143711$SANDOZ$$$$$F$Y$$$20240730$$CN$CA$CA
231713954$23171395$4$F$20231001$20240909$20231110$20240917$PER$$US-SA-2023SA345043$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240918$$MD$US$US
231714482$23171448$2$F$$20240813$20231110$20240820$PER$$US-SA-2023SA347274$SANOFI AVENTIS$$$$E$M$Y$$$20240820$$MD$US$US
231714852$23171485$2$F$20230101$20240917$20231110$20240923$PER$$US-SA-2023SA348815$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240923$$MD$US$US
231715973$23171597$3$F$20231105$20240717$20231110$20240722$PER$$US-AMGEN-USASP2023201190$AMGEN$$46$YR$A$F$Y$$$20240722$$CN$US$US
231716278$23171627$8$F$20231201$20240916$20231110$20240920$EXP$$US-TAKEDA-2023TUS108500$TAKEDA$$68$YR$$F$Y$82$KG$20240920$$MD$US$US
231716654$23171665$4$F$20230605$20240726$20231110$20240731$EXP$$CA-TAKEDA-2023TUS055881$TAKEDA$$61$YR$$M$Y$$$20240731$$HP$CA$CA
231718152$23171815$2$F$$20240822$20231110$20240826$EXP$$CA-SANDOZ INC.-NVSC2022CA224184$SANDOZ$$41$YR$$F$Y$$$20240826$$CN$CA$CA
231718946$23171894$6$F$$20240710$20231110$20240722$PER$$US-VERTEX PHARMACEUTICALS-2023-005982$VERTEX$$$$A$$Y$$$20240722$$CN$US$US
231719068$23171906$8$F$20231018$20240923$20231110$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2023-030484$UNITED THERAPEUTICS$$63$YR$$F$Y$79.365$KG$20240927$$$US$US
231719795$23171979$5$F$20230526$20240822$20231110$20240830$EXP$FR-AFSSAPS-TS2023001354$FR-MYLANLABS-2023M1119447$MYLAN$$20$YR$$F$Y$$$20240830$$MD$FR$FR
231721042$23172104$2$F$20180401$20240903$20231110$20240905$EXP$$IT-SANDOZ INC.-PHHY2018IT171301$SANDOZ$$60$YR$$M$Y$$$20240905$$MD$IT$IT
231721674$23172167$4$F$20230907$20240903$20231110$20240913$PER$$JP-Eisai-EC-2023-149729$EISAI$$$$E$M$Y$$$20240913$$MD$JP$JP
231722082$23172208$2$F$$20240729$20231110$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-416998$RANBAXY$Negro G, Boccellino A, Napolano A, Micaglio E, Calovic Z, Anastasia L, et al. Arrhythmogenic substrate elimination for safe testosterone therapy in symptomatic Brugada syndrome patients. Europace. 2023;25(9):1-4$26$YR$$M$Y$$$20240813$$HP$IT$IT
231722112$23172211$2$F$$20240729$20231110$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417001$RANBAXY$Negro G, Boccellino A, Napolano A, Micaglio E, Calovic Z, Anastasia L, et al. Arrhythmogenic substrate elimination for safe testosterone therapy in symptomatic Brugada syndrome patients. Europace. 2023;25(9):1-4$21$YR$$M$Y$$$20240813$$HP$IT$IT
231722462$23172246$2$F$$20240701$20231110$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417562$RANBAXY$$$$E$M$Y$$$20240712$$CN$US$US
231723423$23172342$3$F$$20240701$20231110$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417560$RANBAXY$$$$A$M$Y$$$20240712$$HP$US$US
231723614$23172361$4$F$20231030$20240705$20231110$20240712$EXP$$FR-009507513-2311FRA002408$MERCK$$71$YR$$F$Y$72$KG$20240712$$PH$FR$FR
231723714$23172371$4$F$20231026$20240701$20231110$20240709$EXP$$JP-ROCHE-3452707$ROCHE$$3$YR$C$M$Y$12.1$KG$20240709$$MD$JP$JP
231724325$23172432$5$F$20240801$20240821$20231110$20240828$EXP$$CA-GSK-CA2023151551$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$CA$CA
231725086$23172508$6$F$20230912$20240821$20231110$20240826$EXP$$CA-TAKEDA-2023TUS093492$TAKEDA$$41$YR$$F$Y$$$20240826$$MD$CA$CA
231726694$23172669$4$F$$20240722$20231110$20240724$EXP$$CA-SANDOZ INC.-NVSC2023CA035858$SANDOZ$$26$YR$$F$Y$47$KG$20240724$$HP$CA$CA
231726726$23172672$6$F$$20240813$20231110$20240819$EXP$$US-TAKEDA-2023TUS108726$TAKEDA$$$$$M$Y$$$20240819$$CN$US$US
231727209$23172720$9$F$20230621$20240701$20231110$20240711$EXP$$CN-GILEAD-2023-0639601$GILEAD$$70$YR$E$F$Y$$$20240711$$MD$CN$CN
231727903$23172790$3$F$20230101$20240811$20231110$20240812$EXP$$CA-PFIZER INC-202300038305$PFIZER$$33$YR$$F$Y$$$20240812$$MD$CA$CA
2317279910$23172799$10$F$20230612$20240906$20231110$20240913$EXP$$NVSC2023US240224$NOVARTIS$$73$YR$$F$Y$$$20240913$$CN$US$US
231728622$23172862$2$F$$20240816$20231110$20240823$PER$$US-INCYTE CORPORATION-2023IN011369$INCYTE$$$$$$Y$$$20240823$$CN$US$US
231728672$23172867$2$F$$20240816$20231110$20240823$PER$$US-INCYTE CORPORATION-2023IN011229$INCYTE$$$$$$Y$$$20240823$$CN$US$US
2317291410$23172914$10$F$20231102$20240709$20231110$20240717$EXP$$US-DAIICHI SANKYO, INC.-DSU-2023-145460$DAIICHI$$22$YR$$M$Y$88.4$KG$20240717$$MD$US$US
231729649$23172964$9$F$$20240911$20231110$20240912$EXP$$CA-SANDOZ INC.-NVSC2023CA096330$SANDOZ$$44$YR$$F$Y$97$KG$20240912$$MD$CA$CA
231730032$23173003$2$F$$20231027$20231110$20240730$EXP$$US-Jiangsu Hengrui Medicine Co., Ltd.-2148091$JIANGSU HENGRUI MEDICINE$Literature title: Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma.?Literature publication journal: JAMA Oncology, 2023, E1-E6.?Literature authors: Gulam A. Manji, Shing Lee, Armando Del Portillo, Michael May, Sarah Sta Ana, Emily Alouani, Naomi Sender, Tiffany Negri, Katarzyna Gautier, Liner Ge, Weijia Fan, Mengyu Xie, Amrita Sethi, Beth Schrope, Aik Choon Tan, Haeseong Park, Paul E. Oberstein, Manish A. Shah, Alexander G. Raufi.$90$YR$$$Y$$$20240730$$MD$US$US
231730303$23173030$3$F$20230101$20240821$20231110$20240912$PER$$US-SA-2023SA347370$SANOFI AVENTIS$$26$YR$A$F$Y$83.914$KG$20240912$$MD$US$US
231730992$23173099$2$F$20230101$20240903$20231111$20240930$PER$$US-SA-2023SA344916$SANOFI AVENTIS$$7$YR$C$M$Y$27.27$KG$20240930$$MD$US$US
231731372$23173137$2$F$$20240123$20231111$20240724$EXP$$US-TEVA-2023-US-2872865$TEVA$$18$YR$$M$Y$$$20240724$$CN$US$US
2317318610$23173186$10$F$20220801$20240816$20231111$20240826$EXP$$CA-CELLTRION INC.-2022CA013922$CELLTRION$$$$$$Y$$$20240826$$MD$CA$CA
2317322210$23173222$10$F$20230101$20240909$20231111$20240917$EXP$$CA-CELLTRION INC.-2023CA016305$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
231733022$23173302$2$F$$20231108$20231111$20240910$PER$$NVSC2023US240113$NOVARTIS$$$$$F$Y$$$20240910$$CN$US$US
231734192$23173419$2$F$20230101$20240715$20231111$20240723$PER$$US-SA-2023SA348579$SANOFI AVENTIS$$$$A$M$Y$$$20240723$$MD$US$US
231734802$23173480$2$F$20231101$20240706$20231111$20240715$PER$$US-SA-2023SA349375$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240715$$CN$US$US
2317351110$23173511$10$F$20190108$20240710$20231111$20240715$EXP$DE-PEI-202200124449$DE-TAKEDA-2023TUS108442$TAKEDA$$10$YR$$F$Y$56$KG$20240715$$CN$DE$DE
231735472$23173547$2$F$20230101$20240711$20231111$20240722$PER$$US-SA-2023SA348776$SANOFI AVENTIS$$38$YR$A$F$Y$77.11$KG$20240721$$MD$US$US
231735714$23173571$4$F$20231120$20240808$20231111$20240813$EXP$$US-SA-2023SA345142$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240813$$MD$US$US
231736075$23173607$5$F$20230830$20240703$20231111$20240708$EXP$$CA-TAKEDA-2023TUS109686$TAKEDA$$70$YR$$F$Y$94.4$KG$20240708$$CN$CA$CA
231736123$23173612$3$F$20231107$20240923$20231111$20240930$EXP$$DE-SA-2023SA349277$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240930$$CN$DE$DE
231736296$23173629$6$F$20230101$20240723$20231111$20240729$PER$$US-SA-2023SA348440$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240729$$CN$US$US
231736362$23173636$2$F$20231110$20240816$20231111$20240820$PER$$US-AMGEN-USASP2023202099$AMGEN$$73$YR$E$F$Y$$$20240819$$CN$US$US
231736382$23173638$2$F$$20240823$20231111$20240830$EXP$TR-MLMSERVICE-20231024-4622290-1$TR-STRIDES ARCOLAB LIMITED-2023SP016565$STRIDES$Cebisli E, Ulgen-Tekerek N, Dursun O, Koker A, Kisaoglu A, Artan R, et al. Intestinal Mucormycosis in a Child With Maple Syrup Urine Disease After Orthotopic Liver Transplant. Experimental and Clinical Transplantation. 2023;21(4):375-379$3$YR$$F$Y$10$KG$20240830$$MD$TR$TR
231736404$23173640$4$F$20231101$20240625$20231111$20240704$PER$$US-SA-2023SA348284$SANOFI AVENTIS$$10$MON$I$M$Y$$$20240704$$MD$US$US
231736614$23173661$4$F$$20240903$20231111$20240911$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK086248$GLENMARK$$$$$$Y$$$20240911$$MD$CA$CA
231736666$23173666$6$F$20220819$20240925$20231111$20240930$EXP$$JP-SANDOZ INC.-SDZ2023JP052624$SANDOZ$$51$YR$$F$Y$119.1$KG$20240930$$MD$JP$JP
231736686$23173668$6$F$20100722$20240802$20231111$20240808$EXP$$FR-SANDOZ INC.-PHHY2019FR205615$SANDOZ$$69$YR$$F$Y$63$KG$20240808$$MD$FR$FR
231736727$23173672$7$F$20201208$20240819$20231111$20240821$EXP$$US-SANDOZ INC.-NVSC2020US329734$SANDOZ$$26$YR$$F$Y$77$KG$20240821$$CN$US$US
231737259$23173725$9$F$20230915$20240714$20231111$20240724$EXP$$CN-GILEAD-2023-0650708$GILEAD$$50$YR$A$M$Y$$$20240724$$MD$CN$CN
231737334$23173733$4$F$20230917$20240815$20231111$20240823$EXP$$CN-GILEAD-2023-0650824$GILEAD$$26$YR$A$F$Y$$$20240823$$MD$CN$CN
231737883$23173788$3$F$$20240906$20231111$20240912$EXP$$US-GILEAD-2023-0650571$GILEAD$$84$YR$E$M$Y$$$20240912$$HP$US$US
231738039$23173803$9$F$20231114$20240710$20231111$20240715$EXP$$CA-TAKEDA-2023TUS106714$TAKEDA$$23$YR$$M$Y$$$20240715$$HP$CA$CA
231738402$23173840$2$F$$20240726$20231111$20240730$PER$$NVSC2023US240667$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
231738593$23173859$3$F$$20240913$20231111$20240920$PER$$US-SA-2023SA349419$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240920$$MD$US$US
231738676$23173867$6$F$20220803$20240826$20231111$20240830$EXP$$JP-AMGEN-JPNSP2023199944$AMGEN$$78$YR$E$M$Y$58$KG$20240830$$MD$JP$JP
231739384$23173938$4$F$$20240906$20231111$20240912$EXP$$US-GILEAD-2023-0650672$GILEAD$$75$YR$E$M$Y$$$20240912$$HP$US$US
231749542$23174954$2$F$20231003$20240722$20231112$20240731$EXP$GR-GREOF-202300950$GR-TEVA-2023-GR-2943115$TEVA$$7$YR$$F$Y$29$KG$20240731$$MD$GR$GR
231749797$23174979$7$F$20240301$20240722$20231112$20240731$EXP$$CO-SANDOZ INC.-NVSC2022CO050358$SANDOZ$$65$YR$$F$Y$76$KG$20240731$$CN$CO$CO
231750733$23175073$3$F$$20240703$20231112$20240708$EXP$$GB-BIOGEN-2023BI01234871$BIOGEN$$$$A$M$Y$$$20240708$$CN$GB$GB
231751662$23175166$2$F$20231001$20240724$20231112$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-160186$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240731$$CN$US$US
231751714$23175171$4$F$20210717$20240716$20231112$20240725$EXP$$BE-AUROBINDO-AUR-APL-2023-067419$AUROBINDO$$73$YR$$F$Y$79.1$KG$20240725$$MD$BE$BE
231752394$23175239$4$F$20200513$20240731$20231113$20240809$EXP$$IT-ROCHE-2610172$ROCHE$$70$YR$E$F$Y$$$20240809$$MD$IT$IT
231753035$23175303$5$F$$20240904$20231113$20240904$EXP$$US-ALXN-202310USA000324US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
231754026$23175402$6$F$20221007$20240909$20231113$20240917$EXP$$CA-CELLTRION INC.-2023CA021757$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
231754085$23175408$5$F$20231001$20240830$20231113$20240905$30DAY$$AR-JNJFOC-20231059657$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240906$$CN$AR$AR
231754426$23175442$6$F$$20240731$20231113$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-160959$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240805$$CN$US$US
231754593$23175459$3$F$$20240812$20231113$20240821$PER$$US-JNJFOC-20231053193$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240821$$CN$US$US
231754692$23175469$2$F$20230126$20240813$20231113$20240821$EXP$$BR-CELLTRION INC.-2023BR002448$CELLTRION$$$$$$Y$$$20240821$$CN$BR$BR
231755233$23175523$3$F$20231109$20240814$20231113$20240821$PER$$US-AMGEN-USASP2023202572$AMGEN$$71$YR$E$M$Y$$$20240821$$CN$US$US
231755517$23175551$7$F$20230919$20240701$20231113$20240724$EXP$$FR-SA-2023SA317625$SANOFI AVENTIS$$74$YR$E$M$Y$63$KG$20240724$$HP$FR$FR
2317557712$23175577$12$F$20230214$20240910$20231113$20240918$EXP$$CA-CELLTRION INC.-2023CA019826$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
231757399$23175739$9$F$20230101$20240919$20231113$20240927$EXP$$US-UCBSA-2023026314$UCB$$$$$F$Y$$$20240927$$CN$US$US
231758188$23175818$8$F$20230927$20240625$20231113$20240719$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004413$ACADIA PHARMACEUTICALS$$44$YR$$F$Y$$$20240719$$CN$US$US
231758717$23175871$7$F$20220101$20240628$20231113$20240703$EXP$$US-UCBSA-2022052488$UCB$$$$$M$Y$$$20240703$$CN$US$US
231758737$23175873$7$F$20230722$20240909$20231113$20240912$EXP$$US-ALXN-A202307801$ALEXION PHARMACEUTICALS$$77$YR$$F$Y$62.132$KG$20240912$$HP$US$US
231758993$23175899$3$F$20230101$20240719$20231113$20240724$EXP$$US-SA-2023SA350719$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240724$$MD$US$US
2317592511$23175925$11$F$20230510$20240628$20231113$20240701$EXP$$NVSC2023US241558$NOVARTIS$$55$YR$$F$Y$$$20240701$$CN$US$US
231760783$23176078$3$F$20220606$20240711$20231113$20240717$EXP$$JP-GILEAD-2023-0638658$GILEAD$$58$YR$A$M$Y$$$20240717$$MD$JP$JP
231761074$23176107$4$F$$20240717$20231113$20240720$EXP$$CA-TAKEDA-2023TUS109634$TAKEDA$$$$$F$Y$$$20240720$$CN$CA$CA
231761094$23176109$4$F$$20240716$20231113$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-161871$BRISTOL MYERS SQUIBB$Fukuda Y, Obuchi Y, Umeda Y, Araki J, Yamazaki M, Okamasa H, et al. Experiences of immune checkpoint inhibitor-related cardiovascular adverse events at our hospital. The 6th Annual Meeting of the Japanese Onco-Cardiology Society. 2023;112.$$$$$Y$$$20240724$$MD$JP$JP
231761152$23176115$2$F$$20240726$20231113$20240730$PER$$NVSC2023US241546$NOVARTIS$$$$$F$Y$$$20240730$$MD$US$US
231761207$23176120$7$F$20230101$20240702$20231113$20240705$EXP$$US-UCBSA-2023003746$UCB$$$$$M$Y$61.23$KG$20240705$$CN$US$US
231763633$23176363$3$F$$20240905$20231113$20240916$EXP$$US-ASTELLAS-2023EU004238$ASTELLAS$$$$E$M$Y$$$20240916$$CN$US$US
231763893$23176389$3$F$20221228$20240710$20231113$20240717$EXP$$JP-009507513-2311JPN000734J$MERCK$$79$YR$$M$Y$$$20240717$$MD$JP$JP
231766585$23176658$5$F$20240714$20240715$20231113$20240717$EXP$$CA-TAKEDA-CA201847051$TAKEDA$$10$YR$$F$Y$10$KG$20240717$$HP$CA$CA
231766754$23176675$4$F$$20240909$20231113$20240912$EXP$$CA-PFIZER INC-202201261047$PFIZER$$46$YR$$F$Y$92$KG$20240912$$CN$CA$CA
231768077$23176807$7$F$20150526$20240702$20231113$20240708$EXP$$CA-SANDOZ INC.-PHHY2015CA077176$SANDOZ$$72$YR$$M$Y$$$20240708$$CN$CA$CA
231769842$23176984$2$F$$20240828$20231113$20240902$EXP$$CA-SANDOZ INC.-NVSC2023CA135870$SANDOZ$$63$YR$$M$Y$96$KG$20240902$$HP$CA$CA
231769983$23176998$3$F$$20240723$20231113$20240726$EXP$$US-CHATTEMPRD-2023OHG013582$CHATTEM$$73$YR$E$M$Y$$$20240726$$LW$US$US
231771037$23177103$7$F$20231025$20240912$20231113$20240926$PER$$US-SA-2023SA338175$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240926$$MD$US$US
231771086$23177108$6$F$20231027$20240624$20231113$20240703$PER$$US-SA-2023SA339643$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240703$$MD$US$US
231771173$23177117$3$F$20220101$20240812$20231113$20240815$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2023-162373$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240816$$MD$BR$BR
231771344$23177134$4$F$20240401$20240620$20231113$20240701$PER$$US-SA-2023SA345189$SANOFI AVENTIS$$5$YR$C$F$Y$34.014$KG$20240701$$MD$US$US
231771754$23177175$4$F$20230101$20240919$20231113$20240930$PER$$US-SA-2023SA345012$SANOFI AVENTIS$$70$YR$E$F$Y$$$20241001$$MD$US$US
231771782$23177178$2$F$20230101$20240708$20231113$20240716$PER$$US-SA-2023SA343332$SANOFI AVENTIS$$13$YR$T$F$Y$47$KG$20240716$$MD$US$US
231771913$23177191$3$F$20230101$20240628$20231113$20240711$PER$$US-SA-2023SA291108$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240711$$MD$US$US
231772132$23177213$2$F$20230101$20240710$20231113$20240722$PER$$US-SA-2023SA347112$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240721$$MD$US$US
231772235$23177223$5$F$20230101$20240807$20231113$20240815$PER$$US-SA-2023SA348706$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240815$$MD$US$US
231772863$23177286$3$F$$20240720$20231113$20240729$PER$$US-SA-2023SA350154$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
231772932$23177293$2$F$20230101$20240812$20231113$20240817$PER$$US-SA-2023SA347339$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240817$$MD$US$US
231773922$23177392$2$F$$20240904$20231113$20240909$EXP$$US-MYLANLABS-2023M1120330$MYLAN$$$$$F$Y$$$20240909$$PH$US$US
2317745613$23177456$13$F$20231020$20240910$20231113$20240920$EXP$$DE-SANDOZ INC.-SDZ2023DE053466$SANDOZ$$$$A$F$Y$60$KG$20240920$$MD$DE$DE
231775064$23177506$4$F$$20240621$20231113$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-162403$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240701$$MD$JP$JP
231775692$23177569$2$F$$20240710$20231113$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-161074$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$HP$JP$JP
231775778$23177577$8$F$20231001$20240715$20231113$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004806$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240809$$CN$US$US
231779673$23177967$3$F$20231106$20240715$20231113$20240718$EXP$$CA-TAKEDA-2023TUS107804$TAKEDA$$61$YR$$F$Y$$$20240718$$HP$CA$CA
231780762$23178076$2$F$20210413$20240621$20231113$20240705$EXP$FR-EMA-DD-20230725-7180171-112632$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-417548$RANBAXY$$72$YR$$M$Y$74$KG$20240705$$MD$FR$FR
231781322$23178132$2$F$$20240925$20231113$20240925$EXP$$US-SANDOZ INC.-SDZ2023US005829$SANDOZ$$$$$M$Y$$$20240925$$CN$US$US
231781915$23178191$5$F$20220502$20240908$20231113$20240916$EXP$$CA-OTSUKA-2022_050652$OTSUKA$$38$YR$$F$Y$$$20240916$$MD$CA$CA
231783273$23178327$3$F$20210728$20240729$20231113$20240731$EXP$$US-TAKEDA-US201905550$TAKEDA$$57$YR$$F$Y$$$20240731$$HP$US$US
231783284$23178328$4$F$20230101$20240904$20231113$20240913$EXP$$US-TEVA-2023-US-2936821$TEVA$$42$YR$$F$Y$$$20240913$$CN$US$US
231784204$23178420$4$F$20200201$20240807$20231113$20240821$EXP$$BR-TAKEDA-BR202017266$TAKEDA$$21$YR$$F$Y$92$KG$20240821$$CN$BR$BR
231785334$23178533$4$F$20230924$20240429$20231113$20240913$EXP$$BR-SANDOZ INC.-SDZ2023BR029616$SANDOZ$$45$YR$$F$Y$$$20240913$$CN$BR$BR
231787808$23178780$8$F$20230701$20240801$20231113$20240807$EXP$$CA-BAUSCH-BL-2023-016774$BAUSCH AND LOMB$$71$YR$$F$Y$59.02$KG$20240807$$CN$CA$CA
231787892$23178789$2$F$20231005$20240722$20231113$20240730$EXP$GR-GREOF-202300951$GR-TEVA-2023-GR-2944020$TEVA$$13$YR$$F$Y$48$KG$20240730$$MD$GR$GR
231787914$23178791$4$F$20191217$20240826$20231113$20240904$EXP$$DE-TEVA-2023-DE-2943487$TEVA$$$$E$F$Y$91$KG$20240904$$CN$DE$DE
231788604$23178860$4$F$20230101$20240812$20231113$20240815$EXP$$CA-PFIZER INC-PV202300181768$PFIZER$$73$YR$$F$Y$89$KG$20240815$$CN$CA$CA
231789178$23178917$8$F$20230101$20240913$20231113$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-022712$JAZZ$$$$$M$Y$$$20240917$$CN$US$US
231789365$23178936$5$F$20230630$20240828$20231113$20240903$EXP$$IN-PFIZER INC-PV202200112274$PFIZER$$56$YR$$F$Y$57.8$KG$20240903$$CN$IN$IN
231789846$23178984$6$F$20230201$20240729$20231113$20240731$EXP$$US-PFIZER INC-202300361505$PFIZER$$84$YR$$F$Y$68.027$KG$20240731$$CN$US$US
231789872$23178987$2$F$$20240904$20231113$20240910$EXP$$CA-PFIZER INC-202300359048$PFIZER$$52$YR$$M$Y$$$20240909$$CN$CA$CA
231790072$23179007$2$F$$20240903$20231113$20240905$EXP$$CA-PFIZER INC-202300359033$PFIZER$$$$$$Y$$$20240905$$MD$CA$CA
231790146$23179014$6$F$$20240829$20231113$20240902$EXP$$US-PFIZER INC-202300362088$PFIZER$$71$YR$$M$Y$$$20240902$$CN$US$US
231790412$23179041$2$F$$20240816$20231113$20240821$EXP$$US-PFIZER INC-202300359948$PFIZER$$51$YR$$F$Y$$$20240821$$CN$US$US
231790685$23179068$5$F$20230101$20240730$20231113$20240805$EXP$$CA-PFIZER INC-202300357924$PFIZER$$13$YR$$F$Y$$$20240805$$HP$CA$CA
231790803$23179080$3$F$$20240906$20231113$20240912$EXP$$US-GILEAD-2023-0650671$GILEAD$$63$YR$A$F$Y$$$20240912$$HP$US$US
231791252$23179125$2$F$$20240717$20231113$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202311007544$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240718$$CN$US$US
231791454$23179145$4$F$20231105$20240729$20231113$20240805$PER$$US-SA-2023SA350338$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240805$$MD$US$US
231791468$23179146$8$F$20230101$20240820$20231113$20240822$EXP$$CA-PFIZER INC-202300318698$PFIZER$$47$YR$$F$Y$68$KG$20240822$$CN$CA$CA
231791973$23179197$3$F$20240101$20240719$20231113$20240723$PER$$US-PFIZER INC-PV202300180829$PFIZER$$61$YR$$F$Y$$$20240723$$CN$US$US
231792142$23179214$2$F$$20240802$20231113$20240807$PER$$US-PFIZER INC-PV202300181411$PFIZER$$69$YR$$M$Y$$$20240807$$HP$US$US
231792384$23179238$4$F$20240101$20240729$20231113$20240802$EXP$$US-PFIZER INC-202300355990$PFIZER$$38$YR$$F$Y$$$20240802$$CN$US$US
231792575$23179257$5$F$20220701$20240725$20231113$20240730$EXP$$US-PFIZER INC-202300352603$PFIZER$$13$YR$$M$Y$42.1$KG$20240730$$CN$US$US
2317927410$23179274$10$F$20231001$20240925$20231113$20240930$EXP$$US-PFIZER INC-202300355456$PFIZER$$56$YR$$F$Y$$$20240930$$CN$US$US
231794798$23179479$8$F$20231101$20240705$20231113$20240715$EXP$$AU-BEH-2023165054$CSL BEHRING$$5$YR$C$F$Y$21$KG$20240715$$MD$AU$AU
231794873$23179487$3$F$20230101$20240820$20231113$20240902$PER$$US-SA-2023SA346994$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240902$$MD$US$US
231795075$23179507$5$F$$20240731$20231114$20240805$EXP$$US-ABBVIE-4286554$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
231795402$23179540$2$F$$20240803$20231114$20240816$EXP$$ES-AUROBINDO-AUR-APL-2023-067840$AUROBINDO$Pomares H, Arribas I, Quinones T, Hernandez JV, Amoros JR, Artigal CM, et al.. Long-term outcomes after venetoclaxhypomethylating agent combination therapy discontinuation, in patients with acute myeloid leukemia. Experience of a single center.. Blood. 2023;142(Suppl 1):4225?4226$79$YR$$M$Y$$$20240816$$MD$ES$ES
231795687$23179568$7$F$20231109$20240613$20231114$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004801$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240708$$CN$US$US
231796872$23179687$2$F$$20240703$20231114$20240712$PER$$US-SA-2023SA344134$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240712$$MD$US$US
231797994$23179799$4$F$20231001$20240710$20231114$20240713$PER$$US-ALXN-202311USA000424US$ALEXION PHARMACEUTICALS$$39$YR$$F$Y$$$20240713$$MD$US$US
231798032$23179803$2$F$$20240628$20231114$20240706$EXP$$ES-CELLTRION INC.-2023ES021699$CELLTRION$$$$$$Y$$$20240706$$MD$ES$ES
231800463$23180046$3$F$$20240823$20231114$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-161943$BRISTOL MYERS SQUIBB$Kobayashi R, et al. A case of nivolumab-induced fulminant type 1 diabetes mellitus leading to diabetic ketoacidosis complicated by non-occlusive mesenteric ischaemia. The 153rd Shinetsu Regional Meeting of the Japanese Society of Internal Medicine. 2023;2.$73$YR$E$M$Y$48.9$KG$20240829$$MD$JP$JP
231800489$23180048$9$F$$20240813$20231114$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004822$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
231801963$23180196$3$F$20231111$20240731$20231114$20240805$PER$$US-AMGEN-USASP2023203075$AMGEN$$80$YR$E$M$Y$$$20240804$$CN$US$US
2318022311$23180223$11$F$20231109$20240711$20231114$20240718$EXP$$AU-TAKEDA-2023TUS109744$TAKEDA$$48$YR$$M$Y$68$KG$20240718$$CN$AU$AU
231803794$23180379$4$F$$20240704$20231114$20240708$PER$$US-ALXN-202311USA000070US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
231804669$23180466$9$F$$20240823$20231114$20240828$PER$$US-ALXN-202311USA000457US$ALEXION PHARMACEUTICALS$$$$$F$Y$48.073$KG$20240828$$HP$US$US
231805374$23180537$4$F$20230101$20240918$20231114$20240927$EXP$$CA-CELLTRION INC.-2023CA021870$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
231805562$23180556$2$F$20230601$20240830$20231114$20240903$PER$$US-ALXN-A202307040$ALEXION PHARMACEUTICALS$$9$YR$$M$Y$$$20240903$$HP$US$US
231805844$23180584$4$F$20221214$20240712$20231114$20240720$EXP$$NVSC2022GB296440$NOVARTIS$$41$YR$$F$Y$$$20240720$$CN$GB$GB
231806062$23180606$2$F$$20240718$20231114$20240722$PER$$US-ABBVIE-5492421$ABBVIE$$75$YR$$M$Y$$$20240722$$CN$US$US
231806095$23180609$5$F$$20240126$20231114$20240830$PER$$NVSC2023US240815$NOVARTIS$$37$YR$$F$Y$52$KG$20240830$$MD$US$US
231806113$23180611$3$F$20231101$20240627$20231114$20240705$EXP$$US-VIIV HEALTHCARE LIMITED-US2023154337$VIIV$$65$YR$$M$Y$99.79$KG$20240705$$CN$US$US
231806194$23180619$4$F$20220805$20240802$20231114$20240805$EXP$$LV-TAKEDA-2023TUS108906$TAKEDA$$69$YR$$F$Y$$$20240805$$HP$LV$LV
231806523$23180652$3$F$20231101$20240910$20231114$20240920$EXP$$CO-GSK-CO2023AMR153825$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$CO$CO
231806942$23180694$2$F$20230101$20231107$20231114$20240801$PER$$NVSC2023US238973$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
231807274$23180727$4$F$20231001$20240710$20231114$20240724$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66728$HIKMA$$74$YR$$M$Y$86$KG$20240724$$HP$US$US
231807534$23180753$4$F$20231019$20240725$20231114$20240808$EXP$$DE-UCBSA-2023053935$UCB$$38$YR$$F$Y$63$KG$20240808$$MD$DE$DE
231807982$23180798$2$F$$20240904$20231114$20240909$EXP$$CA-TAKEDA-2021TUS054459$TAKEDA$$$$$M$Y$$$20240909$$CN$CA$CA
2318082810$23180828$10$F$20230101$20240717$20231114$20240827$EXP$$CA-CELLTRION INC.-2023CA021855$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
2318087711$23180877$11$F$$20240912$20231114$20240919$EXP$$CA-TAKEDA-2023TUS108826$TAKEDA$$$$$F$Y$$$20240919$$CN$CA$CA
231809524$23180952$4$F$$20240731$20231114$20240805$30DAY$$GB-PFIZER INC-PV202300178547$PFIZER$$$$A$F$Y$$$20240805$$CN$GB$GB
231809706$23180970$6$F$20231031$20240805$20231114$20240812$EXP$$BR-GSK-BR2023AMR013368$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$BR$BR
231809793$23180979$3$F$20231013$20240731$20231114$20240810$EXP$$US-TEVA-2023-US-2946217$TEVA$$12$YR$$F$Y$39.4$KG$20240810$$HP$US$US
231810183$23181018$3$F$20230901$20240729$20231114$20240803$PER$$US-BEH-2023165241$CSL BEHRING$$72$YR$E$M$Y$$$20240803$$CN$US$US
231810569$23181056$9$F$20231003$20240626$20231114$20240703$EXP$$AU-TAKEDA-2023TUS065639$TAKEDA$$63$YR$$F$Y$$$20240703$$HP$AU$AU
231811032$23181103$2$F$20231023$20231102$20231114$20240711$PER$$US-PFM-2023-06127$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$CN$US$US
231812465$23181246$5$F$$20240828$20231114$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-163410$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240909$$MD$JP$JP
231814422$23181442$2$F$20220101$20240717$20231114$20240729$EXP$$CA-INTERCEPT-PM2022001337$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$CA$CA
231815293$23181529$3$F$$20240823$20231114$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-161752$BRISTOL MYERS SQUIBB$Furuya A, et al. A case of immune-related adverse reaction fulminant type 1 diabetes mellitus presenting with inappetence and feeling of weakness of lower extremities. The 60th Kinki Regional Meeting of the Japan Diabetes Society. 2023;O36-5.$7$DEC$E$M$Y$$$20240829$$MD$JP$JP
231817604$23181760$4$F$$20240822$20231114$20240827$EXP$$US-OTSUKA-2023_029318$OTSUKA$$$$$M$Y$68.5$KG$20240827$$CN$US$US
231818272$23181827$2$F$20230825$20240709$20231114$20240711$EXP$$US-ALXN-A202312976$ALEXION PHARMACEUTICALS$$57$YR$$M$Y$$$20240711$$MD$US$US
231818336$23181833$6$F$20231201$20240828$20231114$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-160403$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240829$$CN$US$US
231819082$23181908$2$F$$20240820$20231114$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-160076$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240829$$CN$US$US
231820445$23182044$5$F$20230101$20240910$20231114$20240916$EXP$$CA-MYLANLABS-2023M1121731$MYLAN$$$$$M$Y$$$20240916$$HP$CA$CA
231820742$23182074$2$F$$20240814$20231114$20240814$PER$$US-PURDUE PHARMA-USA-2023-0302144$PURDUE$$$$$$Y$$$20240814$$CN$US$US
231822204$23182220$4$F$$20231221$20231114$20240925$PER$$US-GSK-US2023AMR153824$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
231822615$23182261$5$F$20231101$20231214$20231114$20240925$PER$$US-GSK-US2023AMR154610$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240925$$HP$US$US
231823312$23182331$2$F$20230112$20240805$20231114$20240808$EXP$$ES-ABBVIE-4718302$ABBVIE$$72$YR$$M$Y$71$KG$20240808$$MD$ES$ES
231823452$23182345$2$F$$20240731$20231114$20240803$PER$$US-AMGEN-USASP2023202895$AMGEN$$$$$F$Y$$$20240803$$CN$US$US
2318246011$23182460$11$F$$20240807$20231114$20240809$EXP$$US-TAKEDA-2023TUS022355$TAKEDA$$$$$F$Y$68$KG$20240809$$HP$US$US
231826573$23182657$3$F$20230801$20240819$20231114$20240822$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-003825$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240822$$CN$US$US
231826973$23182697$3$F$20240101$20240709$20231114$20240712$EXP$$US-PFIZER INC-202300360756$PFIZER$$58$YR$$M$Y$$$20240712$$HP$US$US
231827306$23182730$6$F$20240125$20240902$20231114$20240904$EXP$$IN-PFIZER INC-PV202300072123$PFIZER$$63$YR$$F$Y$$$20240904$$CN$IN$IN
231828424$23182842$4$F$20231030$20240725$20231114$20240805$PER$$US-SA-2023SA345318$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240804$$MD$US$US
231828693$23182869$3$F$20230101$20240906$20231114$20240917$PER$$US-SA-2023SA345372$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240918$$MD$US$US
231829143$23182914$3$F$20230101$20240905$20231114$20240930$PER$$US-SA-2023SA345062$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240930$$MD$US$US
231829175$23182917$5$F$20230822$20240911$20231114$20240920$PER$$US-SA-2023SA348721$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240920$$MD$US$US
231829183$23182918$3$F$20230101$20240809$20231114$20240817$PER$$US-SA-2023SA346972$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240817$$MD$US$US
231829314$23182931$4$F$20230101$20240815$20231114$20240829$PER$$US-SA-2023SA345088$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240829$$MD$US$US
231829346$23182934$6$F$20230101$20240731$20231114$20240808$PER$$US-SA-2023SA345185$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240808$$MD$US$US
231830343$23183034$3$F$20241101$20240903$20231114$20240930$PER$$US-SA-2023SA344643$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240930$$PH$US$US
231830582$23183058$2$F$$20240815$20231114$20240828$PER$$US-SA-2023SA344214$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240828$$MD$US$US
231831762$23183176$2$F$20230101$20240809$20231114$20240817$PER$$US-SA-2023SA348600$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240817$$MD$US$US
231832222$23183222$2$F$20230901$20240829$20231114$20240910$PER$$US-SA-2023SA350724$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240910$$MD$US$US
231832972$23183297$2$F$$20231106$20231114$20240813$PER$$US-ABBVIE-5492829$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
231833162$23183316$2$F$20220401$20240624$20231114$20240708$EXP$$DE-NORDICGR-2023000084$NORDIC PHARMA$$43$YR$$M$Y$$$20240705$$MD$DE$DE
231833613$23183361$3$F$20220925$20231108$20231114$20240720$EXP$$NVSC2023TR239454$NOVARTIS$Kapagan T, Bulut N, Demirer S, Erdem GU. Ribociclib-induced visual hallucination in a patient with metastatic breast cancer. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2023;29 (6):1529-32$72$YR$$F$Y$$$20240719$$HP$TR$TR
231833726$23183372$6$F$20230101$20240917$20231114$20240920$EXP$$CA-PFIZER INC-202300256112$PFIZER$$73$YR$$M$Y$$$20240920$$HP$CA$CA
231833735$23183373$5$F$20230101$20240705$20231114$20240709$EXP$$CA-PFIZER INC-202300135934$PFIZER$$68$YR$$M$Y$$$20240709$$MD$CA$CA
231834532$23183453$2$F$$20231107$20231114$20240903$EXP$$BR-JNJFOC-20231121771$JOHNSON AND JOHNSON$$$$$M$Y$71$KG$20240903$$MD$BR$BR
231835462$23183546$2$F$$20240808$20231114$20240812$PER$$US-PFIZER INC-202300356246$PFIZER$$61$YR$$M$Y$$$20240812$$MD$US$US
231836132$23183613$2$F$$20240806$20231114$20240808$PER$$US-PFIZER INC-PV202300139553$PFIZER$$67$YR$$M$Y$$$20240808$$CN$US$US
231836244$23183624$4$F$$20240917$20231114$20240919$EXP$$US-PFIZER INC-PV202300181382$PFIZER$$76$YR$$F$Y$$$20240919$$CN$US$US
231836263$23183626$3$F$$20240626$20231114$20240701$PER$$US-PFIZER INC-202300355585$PFIZER$$12$YR$$F$Y$$$20240701$$MD$US$US
231838295$23183829$5$F$20221023$20240628$20231114$20240704$EXP$$AU-SANDOZ INC.-NVSC2022AU296737$SANDOZ$$52$YR$$M$Y$94.6$KG$20240704$$MD$AU$AU
231838592$23183859$2$F$20230901$20240926$20231114$20240927$EXP$$BR-SANDOZ INC.-SDZ2023BR053369$SANDOZ$$71$YR$$F$Y$$$20240927$$CN$BR$BR
231838615$23183861$5$F$20171101$20240709$20231114$20240711$EXP$$CA-SANDOZ INC.-PHHY2017CA165643$SANDOZ$$50$YR$$F$Y$74$KG$20240711$$CN$CA$CA
2318386322$23183863$22$F$20230101$20240830$20231114$20240909$EXP$$CA-CELLTRION INC.-2023CA021365$CELLTRION$$$$$$Y$$$20240909$$PH$CA$CA
231840782$23184078$2$F$$20240701$20231115$20240708$EXP$$US-SA-2023SA353072$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240708$$MD$US$US
2318412510$23184125$10$F$20240116$20240823$20231115$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-161958$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240902$$CN$US$US
231841423$23184142$3$F$20231017$20240618$20231115$20240709$PER$$US-TOLMAR, INC.-23US044334$TOLMAR$$$$$M$Y$$$20240709$$HP$US$US
231841634$23184163$4$F$20220101$20240920$20231115$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-162502$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240924$$HP$US$US
231841672$23184167$2$F$$20240820$20231115$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202311007947$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240827$$CN$US$US
231842206$23184220$6$F$20211104$20240813$20231115$20240820$EXP$$CA-CELLTRION INC.-2021CA019156$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
231842999$23184299$9$F$20231030$20240812$20231115$20240819$EXP$$CO-GSK-CO2023AMR151677$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$CN$CO$CO
231843342$23184334$2$F$20231011$20240729$20231115$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004846$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240821$$CN$US$US
231843795$23184379$5$F$20231101$20240624$20231115$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004830$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240718$$CN$US$US
231844543$23184454$3$F$20231201$20240820$20231115$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-003412$JAZZ$$35$YR$$F$Y$$$20240823$$HP$US$US
2318446510$23184465$10$F$20230606$20240924$20231115$20240926$EXP$$AU-ABBVIE-5492491$ABBVIE$$37$YR$$M$Y$120$KG$20240926$$MD$AU$AU
231845034$23184503$4$F$20230101$20240806$20231115$20240814$EXP$$CA-CELLTRION INC.-2023CA014301$CELLTRION$$$$$$Y$$$20240814$$HP$CA$CA
231845076$23184507$6$F$$20240708$20231115$20240711$EXP$$US-TAKEDA-2023TUS103133$TAKEDA$$$$$F$Y$$$20240711$$HP$US$US
231845242$23184524$2$F$$20240715$20231115$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202311007691$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240723$$HP$US$US
231846164$23184616$4$F$20190507$20240709$20231115$20240717$EXP$$JP-AMGEN-JPNCT2020201052$AMGEN$$77$YR$E$M$Y$$$20240717$$MD$JP$JP
231846465$23184646$5$F$20230710$20240801$20231115$20240806$EXP$$US-UCBSA-2023035456$UCB$$65$YR$$M$Y$95.692$KG$20240806$$CN$US$US
231848343$23184834$3$F$20230807$20240708$20231115$20240711$EXP$$US-BIOGEN-2023BI01235355$BIOGEN$$53$YR$$F$Y$$$20240711$$CN$US$US
231848373$23184837$3$F$20230512$20240828$20231115$20240909$EXP$$US-UCBSA-2023025022$UCB$$5$YR$$F$Y$$$20240909$$CN$US$US
231848477$23184847$7$F$20230101$20240815$20231115$20240823$EXP$$US-ABBVIE-5489756$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
231848642$23184864$2$F$$20240708$20231115$20240718$EXP$$BE-AUROBINDO-AUR-APL-2023-060082$AUROBINDO$Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A et al.. PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triplenegative breast cancer.. Cold Spring Harbor Molecular Case Studies. 2023;9 (2):1-16$30$YR$$F$Y$$$20240718$$HP$BE$BE
231849758$23184975$8$F$20230101$20240712$20231115$20240718$EXP$$NL-ABBVIE-5458007$ABBVIE$$81$YR$$F$Y$$$20240718$$HP$NL$NL
231849892$23184989$2$F$20221117$20240904$20231115$20240912$EXP$$GR-TAKEDA-2023TUS098086$TAKEDA$$74$YR$$M$Y$$$20240912$$CN$GR$GR
231850372$23185037$2$F$$20240808$20231115$20240816$EXP$$JP-STRIDES ARCOLAB LIMITED-2023SP016938$STRIDES$Okamoto K, Takeda A, Hatsuta H, Sano T, Takao M, Ohsawa M, et al. An autopsy case of progressive multifocal leukoencephalopathy with massive iron deposition in juxtacortical lesions.. Neuropathology. 2023;43(5):396-402$71$YR$$F$Y$$$20240816$$HP$JP$JP
231850562$23185056$2$F$20230930$20240628$20231115$20240710$EXP$$CA-ROCHE-3457962$ROCHE$$61$YR$A$F$Y$$$20240710$$CN$CA$CA
231851375$23185137$5$F$20231101$20240704$20231115$20240715$EXP$$JP-TAKEDA-2023TUS110355$TAKEDA$$3$YR$$M$Y$18$KG$20240715$$MD$JP$JP
231851416$23185141$6$F$20231022$20240816$20231115$20240822$EXP$$US-TAKEDA-2022TUS043959$TAKEDA$$6$YR$$F$Y$19$KG$20240822$$HP$US$US
2318514213$23185142$13$F$20231017$20240705$20231115$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004889$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240712$$CN$US$US
231852625$23185262$5$F$20230801$20240822$20231115$20240829$EXP$$US-KYOWAKIRIN-2023KK017973$KYOWA$$$$$$Y$$$20240829$$PH$US$US
231852632$23185263$2$F$20180112$20240903$20231115$20240909$EXP$$GB-ALXN-A202306270$ALEXION PHARMACEUTICALS$$1$YR$$F$Y$$$20240909$$MD$GB$GB
2318537310$23185373$10$F$$20240710$20231115$20240715$EXP$$CA-TAKEDA-2023TUS080111$TAKEDA$$$$$F$Y$$$20240715$$HP$CA$CA
231854706$23185470$6$F$$20240716$20231115$20240724$EXP$$NVSC2023GB134316$NOVARTIS$$$$A$F$Y$$$20240724$$CN$GB$GB
231854978$23185497$8$F$$20240801$20231115$20240802$EXP$$NVSC2023US240432$NOVARTIS$$52$YR$$F$Y$$$20240802$$MD$US$US
231856534$23185653$4$F$$20240916$20231115$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-163302$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240917$$CN$US$US
231856812$23185681$2$F$20231101$20240627$20231115$20240702$PER$$US-AMGEN-USASP2023203603$AMGEN$$56$YR$A$F$Y$$$20240701$$HP$US$US
231857282$23185728$2$F$20231019$20231101$20231115$20240709$EXP$$US-ALXN-202311GLO000002US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240709$$MD$US$US
231858375$23185837$5$F$20230720$20240730$20231115$20240801$EXP$$FR-AMGEN-FRANI2023151325$AMGEN$$74$YR$E$M$Y$77$KG$20240801$$HP$FR$FR
231859764$23185976$4$F$$20240903$20231115$20240913$EXP$$CA-MYLANLABS-2023M1121210$BIOCON$$$$$$Y$$$20240913$$CN$CA$CA
231860244$23186024$4$F$20230101$20240710$20231115$20240724$EXP$$US-UCBSA-2023037503$UCB$$$$$F$Y$$$20240724$$MD$US$US
231861015$23186101$5$F$20231108$20240816$20231115$20240821$EXP$$CO-TAKEDA-2023TUS110447$TAKEDA$$66$YR$$M$Y$74.5$KG$20240821$$CN$CO$CO
231862163$23186216$3$F$20231105$20240826$20231115$20240827$EXP$$US-GILEAD-2023-0651185$GILEAD$$10$YR$C$F$Y$$$20240827$$CN$US$US
231862244$23186224$4$F$20230501$20240809$20231115$20240812$EXP$$US-SANDOZ INC.-NVSC2023US005798$SANDOZ$$40$YR$$M$Y$124.72$KG$20240812$$CN$US$US
231862522$23186252$2$F$$20240622$20231115$20240703$EXP$$JP-ARGENX-2023-ARGX-JP000920$ARGENX BVBA$$$$$$Y$$$20240703$$MD$JP$JP
231862613$23186261$3$F$$20240906$20231115$20240912$PER$$US-AGIOS-2311US03537$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
231863714$23186371$4$F$20231225$20240705$20231115$20240714$PER$$US-SA-2023SA340211$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240714$$MD$US$US
231864913$23186491$3$F$20231009$20240917$20231115$20240925$PER$$US-SA-2023SA348558$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240925$$MD$US$US
231865062$23186506$2$F$20210701$20240715$20231115$20240724$PER$$US-SA-2023SA347608$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240724$$MD$US$US
231865113$23186511$3$F$$20240815$20231115$20240828$PER$$US-SA-2023SA348464$SANOFI AVENTIS$$75$YR$E$F$Y$99.79$KG$20240828$$MD$US$US
231865422$23186542$2$F$20230101$20240828$20231115$20240924$PER$$US-SA-2023SA348697$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240924$$MD$US$US
231866123$23186612$3$F$20230101$20240621$20231115$20240701$PER$$US-SA-2023SA348395$SANOFI AVENTIS$$$$C$F$Y$$$20240701$$MD$US$US
231866564$23186656$4$F$20230101$20240801$20231115$20240809$PER$$US-SA-2023SA353671$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240809$$MD$US$US
231866892$23186689$2$F$20230101$20240806$20231115$20240812$PER$$US-SA-2023SA353351$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240812$$MD$US$US
231866903$23186690$3$F$20230101$20240801$20231115$20240813$PER$$US-SA-2023SA351713$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240814$$CN$US$US
231866913$23186691$3$F$20230101$20240705$20231115$20240716$PER$$US-SA-2023SA353816$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240716$$MD$US$US
231867323$23186732$3$F$20230101$20240820$20231115$20240916$PER$$US-SA-2023SA350874$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240916$$CN$US$US
231867372$23186737$2$F$20240101$20240627$20231115$20240708$PER$$US-SA-2023SA353343$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240708$$MD$US$US
231867542$23186754$2$F$$20240725$20231115$20240802$PER$$US-SA-2023SA352868$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240802$$HP$US$US
231867613$23186761$3$F$20240301$20240725$20231115$20240805$PER$$US-SA-2023SA354239$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240805$$MD$US$US
231868002$23186800$2$F$20210401$20240826$20231115$20240903$EXP$$NO-MYLANLABS-2023M1120837$MYLAN$$$$$M$Y$$$20240903$$CN$NO$NO
231871942$23187194$2$F$20231101$20240627$20231115$20240703$PER$$US-SA-2023SA353908$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240704$$MD$US$US
231872659$23187265$9$F$$20240725$20231115$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-164167$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240801$$CN$US$US
231873033$23187303$3$F$$20240802$20231115$20240806$PER$$NVSC2023US243328$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
231874283$23187428$3$F$20230101$20240721$20231115$20240730$PER$$US-SA-2023SA351762$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240730$$MD$US$US
231875068$23187506$8$F$20240301$20240829$20231115$20240904$EXP$$NVSC2023MX220905$NOVARTIS$$59$YR$$F$Y$66$KG$20240904$$CN$MX$MX
231877123$23187712$3$F$$20240610$20231115$20240722$PER$$US-TRAVERE-2023TVT00586$TRAVERE THERAPEUTICS$$46$YR$A$M$Y$$$20240722$$CN$US$US
231877149$23187714$9$F$20231001$20240910$20231115$20240923$EXP$$US-TRAVERE-2023TVT00587$TRAVERE THERAPEUTICS$$67$YR$E$M$Y$$$20240923$$CN$US$US
231878033$23187803$3$F$20230619$20230619$20231115$20240716$PER$$US-NOVOPROD-1085905$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
231878114$23187811$4$F$20230515$20230608$20231115$20240715$EXP$$US-NOVOPROD-1082553$NOVO NORDISK$$54$YR$$M$Y$$$20240715$$CN$US$US
231878496$23187849$6$F$20231002$20240801$20231115$20240822$PER$$US-TRAVERE-2023TVT00596$TRAVERE THERAPEUTICS$$52$YR$A$M$Y$$$20240822$$CN$US$US
231879515$23187951$5$F$20231022$20240718$20231115$20240730$EXP$$KR-JAZZ PHARMACEUTICALS-2023-KR-022322$JAZZ$$80$YR$$M$Y$50.3$KG$20240730$$MD$KR$KR
231879652$23187965$2$F$20221109$20240625$20231115$20240703$EXP$$TW-ALXN-A202307141$ALEXION PHARMACEUTICALS$$59$YR$$F$Y$72$KG$20240703$$MD$TW$TW
231879675$23187967$5$F$20231001$20240815$20231115$20240819$EXP$$US-PFIZER INC-PV202300183699$PFIZER$$71$YR$$M$Y$113.4$KG$20240819$$CN$US$US
231879893$23187989$3$F$$20240802$20231115$20240807$PER$$US-PFIZER INC-202300359947$PFIZER$$4$YR$$M$Y$$$20240807$$CN$US$US
231880603$23188060$3$F$$20240705$20231115$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-163165$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$89.36$KG$20240709$$HP$US$US
231881027$23188102$7$F$$20240730$20231115$20240805$PER$$US-PFIZER INC-PV202300182040$PFIZER$$76$YR$$F$Y$$$20240805$$CN$US$US
231881294$23188129$4$F$20231028$20240701$20231115$20240703$PER$$US-PFIZER INC-202300356938$PFIZER$$7$YR$$F$Y$27.67$KG$20240703$$CN$US$US
231881492$23188149$2$F$$20240819$20231115$20240822$PER$$US-PFIZER INC-2021070589$PFIZER$$81$YR$$M$Y$89.99$KG$20240822$$HP$US$US
231881548$23188154$8$F$$20240826$20231115$20240829$EXP$$US-PFIZER INC-PV202300182339$PFIZER$$79$YR$$F$Y$89.27$KG$20240829$$CN$US$US
231881717$23188171$7$F$20230917$20240829$20231115$20240904$EXP$$US-PFIZER INC-PV202300182220$PFIZER$$77$YR$$F$Y$79.365$KG$20240904$$CN$US$US
231882274$23188227$4$F$$20240806$20231115$20240812$PER$$US-PFIZER INC-PV202300183589$PFIZER$$71$YR$$F$Y$$$20240812$$HP$US$US
231882594$23188259$4$F$20230101$20240702$20231115$20240704$PER$$US-PFIZER INC-PV202300182980$PFIZER$$56$YR$$F$Y$74.83$KG$20240704$$CN$US$US
231882866$23188286$6$F$$20240924$20231115$20240926$EXP$$US-PFIZER INC-PV202300183877$PFIZER$$67$YR$$F$Y$$$20240926$$CN$US$US
231883934$23188393$4$F$$20240823$20231115$20240829$EXP$$US-PFIZER INC-PV202300158200$PFIZER$$72$YR$$F$Y$$$20240829$$CN$US$US
231884012$23188401$2$F$$20240801$20231115$20240805$EXP$$CA-Covis Pharma GmbH-2023COV01804$COVIS PHARMA$$39$YR$A$M$Y$$$20240805$$MD$CA$CA
231884032$23188403$2$F$$20240905$20231115$20240910$EXP$$CA-Covis Pharma GmbH-2023COV01808$COVIS PHARMA$$63$YR$A$F$Y$$$20240910$$CN$CA$CA
231884882$23188488$2$F$$20240716$20231115$20240718$PER$$US-PFIZER INC-202300366327$PFIZER$$75$YR$$F$Y$$$20240718$$CN$US$US
231884965$23188496$5$F$$20240919$20231115$20240923$EXP$$US-PFIZER INC-202300366151$PFIZER$$77$YR$$F$Y$$$20240923$$HP$US$US
231884973$23188497$3$F$20231001$20240905$20231115$20240913$EXP$$JP-Eisai-EC-2023-152493$EISAI$Sumiyoshi A. Kumamoto Hospital Pharmaceutical Association..$72$YR$E$F$Y$$$20240913$$PH$JP$JP
231888214$23188821$4$F$20230101$20240806$20231115$20240812$PER$$US-PFIZER INC-202300352374$PFIZER$$58$YR$$M$Y$$$20240812$$CN$US$US
231888296$23188829$6$F$$20240829$20231115$20240904$PER$$US-PFIZER INC-2021263958$PFIZER$$68$YR$$F$Y$$$20240904$$CN$US$US
231888582$23188858$2$F$$20231106$20231115$20240814$EXP$$CA-SANDOZ INC.-SDZ2023CA053539$SANDOZ$$44$YR$$F$Y$63$KG$20240814$$HP$CA$CA
231888684$23188868$4$F$20231001$20240720$20231115$20240729$PER$$US-SA-2023SA350465$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240729$$MD$US$US
231889284$23188928$4$F$20230101$20240913$20231115$20240924$EXP$$AU-NOVOPROD-1138585$NOVO NORDISK$$56$YR$$F$Y$$$20240924$$HP$AU$AU
231890512$23189051$2$F$$20240716$20231115$20240725$PER$$US-SA-2023SA345032$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240725$$MD$US$US
231890846$23189084$6$F$20230322$20240628$20231115$20240709$EXP$$JP-ROCHE-3394442$ROCHE$$75$YR$E$F$Y$40.2$KG$20240709$$MD$JP$JP
231892672$23189267$2$F$$20240715$20231115$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023153470$VIIV$$$$$M$Y$$$20240724$$HP$US$US
231893683$23189368$3$F$$20240820$20231116$20240827$EXP$$JP-009507513-2311JPN001387J$MERCK$$8$DEC$$M$Y$$$20240827$$MD$JP$JP
231894062$23189406$2$F$20231113$20240719$20231116$20240725$PER$$US-AMGEN-USASP2023204322$AMGEN$$49$YR$A$M$Y$$$20240725$$CN$US$US
231895152$23189515$2$F$$20240827$20231116$20240903$PER$$US-ALXN-A202312901$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$HP$US$US
231895612$23189561$2$F$20231111$20240813$20231116$20240817$PER$$US-AMGEN-USASP2023203534$AMGEN$$70$YR$E$F$Y$$$20240816$$CN$US$US
231895623$23189562$3$F$$20240816$20231116$20240822$EXP$$US-TAKEDA-US202019581$TAKEDA$$$$$F$Y$88.889$KG$20240822$$CN$US$US
231896383$23189638$3$F$$20240828$20231116$20240910$PER$$US-SA-2023SA350729$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240910$$MD$US$US
231896574$23189657$4$F$$20240823$20231116$20240904$EXP$$US-SA-2023SA354441$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240904$$MD$US$US
231897256$23189725$6$F$$20240726$20231116$20240731$EXP$$CA-ROCHE-3458416$ROCHE$$$$A$M$Y$$$20240731$$CN$CA$CA
231897712$23189771$2$F$$20240923$20231116$20240930$EXP$$US-EMD Serono-2023487434$EMD SERONO INC$$59$YR$A$M$Y$$$20240930$$HP$US$US
231898326$23189832$6$F$20240201$20240628$20231116$20240705$PER$$US-BIOGEN-2023BI01235825$BIOGEN$$67$YR$$F$Y$$$20240705$$CN$US$US
231898385$23189838$5$F$20230101$20240809$20231116$20240814$EXP$$US-SA-2023SA355148$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240814$$CN$US$US
231898942$23189894$2$F$20230917$20240815$20231116$20240820$PER$$US-AMGEN-USASP2023204395$AMGEN$$79$YR$E$F$Y$$$20240820$$CN$US$US
2318994213$23189942$13$F$20221001$20240822$20231116$20240827$EXP$$CA-JNJFOC-20221044190$JOHNSON AND JOHNSON$$52$YR$A$F$Y$113$KG$20240827$$HP$CA$CA
231899632$23189963$2$F$$20240715$20231116$20240724$PER$$US-JNJFOC-20231143475$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$HP$US$US
231900145$23190014$5$F$$20240903$20231116$20240909$EXP$$CA-JNJFOC-20231128755$JOHNSON AND JOHNSON$$69$YR$E$F$Y$31.1$KG$20240909$$PH$CA$CA
231901143$23190114$3$F$20231101$20240718$20231116$20240726$PER$$US-BIOGEN-2023BI01227959$BIOGEN$$60$YR$$F$Y$$$20240726$$CN$US$US
231901862$23190186$2$F$20230126$20240905$20231116$20240912$EXP$$PA-SANDOZ INC.-NVSC2023PA013748$SANDOZ$$32$YR$$F$Y$$$20240912$$CN$PA$PA
231902112$23190211$2$F$$20240621$20231116$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-160763$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240701$$PH$JP$JP
231902252$23190225$2$F$20230528$20240808$20231116$20240809$EXP$$FR-SANDOZ INC.-SDZ2023FR054236$SANDOZ$$20$YR$$F$Y$60$KG$20240809$$MD$FR$FR
231902337$23190233$7$F$20230911$20240716$20231116$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004289$ACADIA PHARMACEUTICALS$$16$YR$$F$Y$$$20240809$$CN$US$US
231902788$23190278$8$F$20230101$20240828$20231116$20240906$EXP$$US-INSMED-2023-03923-USAA$INSMED$$$$$F$Y$$$20240906$$CN$US$US
231903062$23190306$2$F$20230101$20240904$20231116$20240912$EXP$$CA-ABBVIE-5495072$ABBVIE$$$$$M$Y$$$20240912$$CN$CA$CA
231904167$23190416$7$F$20230101$20240712$20231116$20240717$EXP$$US-ABBVIE-5492637$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
231904749$23190474$9$F$20180430$20240626$20231116$20240708$EXP$$CA-ROCHE-2118216$ROCHE$$60$YR$A$M$Y$$$20240708$$CN$CA$CA
231904924$23190492$4$F$20230101$20240705$20231116$20240708$EXP$$US-UCBSA-2023047570$UCB$$$$$F$Y$180$KG$20240708$$CN$US$US
231905594$23190559$4$F$$20240823$20231116$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-163333$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240904$$CN$US$US
231905662$23190566$2$F$$20240812$20231116$20240819$EXP$$CA-BAUSCH-BL-2023-016677$BAUSCH AND LOMB$Baxter C, Martin E, Marwa B, Pacaud D, Cummings E. Very severe hypertriglyceridemia complicating pediatric acute lymphoblastic leukemia treatment: a call for management guidelines. Journal of Pediatric Endocrinology and Metabolism. 2023 JUL 06;36(10):978-982. doi:10.1515/jpem-2023-0122$11$YR$$F$Y$$$20240819$$HP$CA$CA
231905713$23190571$3$F$20240629$20240706$20231116$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-023070$JAZZ$$32$YR$$M$Y$$$20240710$$MD$US$US
231906182$23190618$2$F$$20240816$20231116$20240820$EXP$$NVSC2023US240813$NOVARTIS$$$$$M$Y$$$20240820$$CN$US$US
231906308$23190630$8$F$$20240619$20231116$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004882$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$HP$US$US
231907234$23190723$4$F$20160807$20240814$20231116$20240821$EXP$$CA-TAKEDA-2016TUS015239$TAKEDA$$48$YR$$F$Y$$$20240821$$MD$CA$CA
231907302$23190730$2$F$$20240618$20231116$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004850$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
231907326$23190732$6$F$$20240903$20231116$20240905$EXP$$CA-ROCHE-3458796$ROCHE$$$$A$F$Y$$$20240905$$CN$CA$CA
231908373$23190837$3$F$$20240801$20231116$20240813$EXP$CA-MHPD-001052537$CA-Accord-389919$ACCORD$$10$YR$C$F$Y$27$KG$20240813$$PH$CA$CA
231908802$23190880$2$F$$20240805$20231116$20240809$PER$$NVSC2023US243899$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
231909463$23190946$3$F$20230501$20240709$20231116$20240717$PER$$CA-TOLMAR, INC.-23CA044370$TOLMAR$$57$YR$$M$Y$$$20240717$$CN$CA$CA
231909615$23190961$5$F$$20240709$20231116$20240712$30DAY$$US-PFIZER INC-PV202300182159$PFIZER$$12$YR$$M$Y$$$20240712$$CN$US$US
231909725$23190972$5$F$20230101$20240725$20231116$20240725$30DAY$$US-PFIZER INC-202300358289$PFIZER$$14$YR$$F$Y$88.5$KG$20240725$$HP$US$US
231909928$23190992$8$F$20231101$20240617$20231116$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004855$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240712$$CN$US$US
231910564$23191056$4$F$20220101$20240702$20231116$20240704$EXP$$US-SANDOZ INC.-NVSC2021US284776$SANDOZ$$$$$F$Y$66.213$KG$20240704$$CN$US$US
231910639$23191063$9$F$20231010$20240709$20231116$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004856$ACADIA PHARMACEUTICALS$$20$YR$$F$Y$42.3$KG$20240731$$CN$US$US
231910832$23191083$2$F$20230728$20240701$20231116$20240704$EXP$FR-AFSSAPS-AM2023000963$FR-EMD Serono-2023487572$EMD SERONO INC$$72$YR$E$M$Y$90$KG$20240704$$HP$FR$FR
231911727$23191172$7$F$20231101$20240719$20231116$20240813$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004847$ACADIA PHARMACEUTICALS$$30$YR$$F$Y$$$20240813$$CN$US$US
231912104$23191210$4$F$20230101$20240917$20231116$20240927$EXP$$NL-ABBVIE-5495828$ABBVIE$$$$E$M$Y$$$20240927$$CN$NL$NL
231912203$23191220$3$F$20230620$20240915$20231116$20240927$EXP$$JP-PFM-2023-03744$PIERRE FABRE MEDICAMENT$$$$I$F$Y$6.265$KG$20240927$$MD$JP$JP
231912776$23191277$6$F$20231029$20240627$20231116$20240703$EXP$$ES-UCBSA-2023054512$UCB$$44$YR$$M$Y$74$KG$20240703$$MD$ES$ES
231912822$23191282$2$F$$20240816$20231116$20240820$EXP$$ZA-SANDOZ INC.-NVSC2023ZA137076$SANDOZ$$$$$F$Y$$$20240820$$CN$ZA$ZA
231913212$23191321$2$F$20230912$20240712$20231116$20240726$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-418246$RANBAXY$$72$YR$$M$Y$$$20240726$$HP$DE$DE
231913412$23191341$2$F$20230408$20240627$20231116$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-418170$RANBAXY$$42$YR$$M$Y$$$20240712$$MD$FR$FR
231913944$23191394$4$F$20190101$20240708$20231116$20240715$EXP$$JP-009507513-2311JPN000745J$MERCK$$8$DEC$$M$Y$$$20240715$$MD$JP$JP
231915556$23191555$6$F$$20240926$20231116$20240927$EXP$$NVSC2023US243243$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
231916165$23191616$5$F$20230812$20240726$20231116$20240802$PER$$US-ALXN-A202309566$ALEXION PHARMACEUTICALS$$47$YR$$F$Y$$$20240802$$CN$US$US
231916612$23191661$2$F$20220301$20240625$20231116$20240702$EXP$$NVSC2023DE240937$NOVARTIS$$69$YR$$M$Y$100$KG$20240702$$MD$DE$DE
231916652$23191665$2$F$20220825$20240625$20231116$20240702$EXP$$NVSC2022DE281139$NOVARTIS$$$$A$M$Y$105$KG$20240702$$MD$DE$DE
231916762$23191676$2$F$$20240802$20231116$20240808$EXP$$JP-009507513-2311JPN000999J$MERCK$$40$YR$$F$Y$$$20240808$$MD$JP$JP
231916917$23191691$7$F$20231017$20240306$20231116$20240814$EXP$$NVSC2023CO155088$NOVARTIS$$70$YR$$F$Y$56$KG$20240814$$CN$CO$CO
231916954$23191695$4$F$$20240910$20231116$20240913$EXP$$NVSC2023GB078703$NOVARTIS$$$$$F$Y$$$20240913$$CN$GB$GB
231917113$23191711$3$F$20200101$20240712$20231116$20240720$EXP$$NVSC2023US239483$NOVARTIS$$65$YR$$F$Y$90.7$KG$20240719$$HP$US$US
231917505$23191750$5$F$$20240904$20231116$20240930$PER$$US-TRAVERE-2023TVT00633$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
2319177511$23191775$11$F$$20240919$20231116$20240920$EXP$$GB-SANDOZ INC.-SDZ2023GB054276$SANDOZ$$$$$F$Y$$$20240920$$CN$GB$GB
231918596$23191859$6$F$20230201$20240426$20231116$20240809$EXP$$NVSC2021AR233757$NOVARTIS$$62$YR$$F$Y$$$20240809$$CN$AR$AR
231919708$23191970$8$F$$20240620$20231116$20240701$EXP$$CA-TAKEDA-2023TUS081497$TAKEDA$$$$$F$Y$$$20240701$$MD$CA$CA
231919892$23191989$2$F$$20240715$20231116$20240717$EXP$$NVSC2023GB242273$NOVARTIS$$$$A$F$Y$$$20240717$$CN$GB$GB
231920355$23192035$5$F$20230101$20240508$20231116$20240904$EXP$$NVSC2023BR243203$NOVARTIS$$$$$F$Y$64$KG$20240904$$CN$BR$BR
231920874$23192087$4$F$20231026$20240830$20231116$20240917$PER$$US-TRAVERE-2023TVT00667$TRAVERE THERAPEUTICS$$52$YR$A$F$Y$69.72$KG$20240917$$CN$US$US
231921368$23192136$8$F$20240601$20240819$20231116$20240917$PER$$US-TRAVERE-2023TVT00674$TRAVERE THERAPEUTICS$$69$YR$E$F$Y$$$20240917$$CN$US$US
231921876$23192187$6$F$20231001$20240917$20231116$20240927$EXP$$US-TRAVERE-2023TVT00651$TRAVERE THERAPEUTICS$$39$YR$A$F$Y$66$KG$20240927$$CN$US$US
231923262$23192326$2$F$$20240918$20231116$20240926$EXP$$NVSC2023US241746$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
231923442$23192344$2$F$20230101$20240628$20231116$20240703$EXP$$US-ABBVIE-5493232$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
231924644$23192464$4$F$20230701$20240918$20231116$20240919$EXP$$US-INCYTE CORPORATION-2023IN011941$INCYTE$$$$$$Y$$$20240919$$MD$US$US
231924752$23192475$2$F$$20240802$20231116$20240807$EXP$$JP-009507513-2311JPN001004J$MERCK$$48$YR$$F$Y$$$20240807$$MD$JP$JP
231924962$23192496$2$F$$20240916$20231116$20240919$EXP$$CA-BIOGEN-2023BI01234846$BIOGEN$$$$$M$Y$$$20240919$$HP$CA$CA
231925272$23192527$2$F$$20240612$20231116$20240730$PER$$US-TRAVERE-2023TVT00684$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240730$$CN$US$US
231925465$23192546$5$F$20240301$20240907$20231116$20240913$EXP$$JP-009507513-2311JPN001572J$MERCK$$57$YR$$F$Y$$$20240913$$MD$JP$JP
231926152$23192615$2$F$20231001$20240813$20231116$20240826$PER$$US-SA-2023SA345117$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240826$$MD$US$US
231926434$23192643$4$F$20230101$20240626$20231116$20240705$PER$$US-SA-2023SA350610$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240705$$MD$US$US
231926447$23192644$7$F$20230101$20240820$20231116$20240910$PER$$US-SA-2023SA353454$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240910$$MD$US$US
231926453$23192645$3$F$20240101$20240916$20231116$20240923$PER$$US-SA-2023SA349905$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240923$$MD$US$US
231926473$23192647$3$F$20230101$20240711$20231116$20240801$PER$$US-SA-2023SA349892$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240719$$MD$US$US
231926883$23192688$3$F$20231016$20240918$20231116$20240927$PER$$US-SA-2023SA318129$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240927$$MD$US$US
231927013$23192701$3$F$20230101$20240708$20231116$20240717$PER$$US-SA-2023SA351589$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240717$$MD$US$US
231927594$23192759$4$F$$20240830$20231116$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-165512$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240903$$CN$US$US
231927913$23192791$3$F$$20240801$20231116$20240806$EXP$$US-TAKEDA-2023TUS111123$TAKEDA$$$$$F$Y$$$20240806$$CN$US$US
231927925$23192792$5$F$20231114$20240814$20231116$20240816$EXP$$CA-TAKEDA-2019TUS048973$TAKEDA$$73$YR$$F$Y$$$20240816$$CN$CA$CA
231928103$23192810$3$F$$20240828$20231116$20240911$PER$$US-SA-2023SA350149$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240911$$MD$US$US
231928363$23192836$3$F$20231001$20240620$20231116$20240701$PER$$US-SA-2023SA349573$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240701$$MD$US$US
231929344$23192934$4$F$20231001$20240612$20231116$20240730$PER$$US-TRAVERE-2023TVT00699$TRAVERE THERAPEUTICS$$66$YR$E$M$Y$$$20240730$$CN$US$US
231929357$23192935$7$F$20231018$20240715$20231116$20240815$PER$$US-TRAVERE-2023TVT00649$TRAVERE THERAPEUTICS$$59$YR$A$M$Y$101.2$KG$20240815$$CN$US$US
231929453$23192945$3$F$20200101$20240708$20231116$20240723$EXP$$DE-NORDICGR-054199$NORDIC PHARMA$$77$YR$$F$Y$$$20240723$$MD$DE$DE
2319301411$23193014$11$F$20220901$20240625$20231116$20240705$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR006756$AEGERION$$47$YR$$F$Y$$$20240705$$MD$US$US
231930326$23193032$6$F$20210729$20240905$20231116$20240910$EXP$$CH-ABBVIE-21K-151-4091372-00$ABBVIE$$70$YR$$F$Y$63$KG$20240910$$MD$CH$CH
231930693$23193069$3$F$$20240906$20231116$20240912$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2023-163710$BRISTOL MYERS SQUIBB$Ricchiuto A, Antenora F, Valzano I, Montanaro V, Giorgio A, Manco A, et al. Diffuse alveolar hemorrhage associated with apixaban therapy. Respiration. 2023 Sep 01;102(8):704. doi:10.1159/000531211.$58$YR$A$M$Y$$$20240912$$HP$IT$IT
231931115$23193111$5$F$20231122$20240715$20231116$20240717$EXP$$CA-TAKEDA-2023TUS109874$TAKEDA$$61$YR$$M$Y$$$20240717$$MD$CA$CA
231931135$23193113$5$F$20231106$20240708$20231116$20240712$EXP$$CA-TAKEDA-2023TUS109179$TAKEDA$$58$YR$$M$Y$$$20240712$$HP$CA$CA
231931193$23193119$3$F$20230101$20240720$20231116$20240729$PER$$US-SA-2023SA353770$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240729$$MD$US$US
231931222$23193122$2$F$20231114$20240819$20231116$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202311008746$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240823$$CN$US$US
231931504$23193150$4$F$20240510$20240917$20231116$20240924$EXP$$PA-INCYTE CORPORATION-2023IN011802$INCYTE$$$$$$Y$$$20240924$$CN$PA$PA
231931833$23193183$3$F$$20240725$20231116$20240815$PER$$US-TRAVERE-2023TVT00730$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$HP$US$US
231932473$23193247$3$F$$20240828$20231116$20240905$PER$$US-BIOMARINAP-US-2023-153756$BIOMARIN$$$$$$Y$$$20240905$$CN$US$US
231932742$23193274$2$F$$20240812$20231116$20240813$EXP$$US-TAKEDA-2023TUS110933$TAKEDA$$$$$F$Y$$$20240813$$CN$US$US
231934483$23193448$3$F$20231109$20240626$20231116$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-162400$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240702$$MD$JP$JP
231934704$23193470$4$F$$20240130$20231116$20240718$EXP$$US-Taiho Oncology Inc-2023-009634$TAIHO ONCOLOGY INC$$$$A$F$Y$$$20240718$$CN$US$US
231935062$23193506$2$F$$20240812$20231116$20240814$PER$$US-VERTEX PHARMACEUTICALS-2023-017003$VERTEX$$$$$$Y$$$20240814$$CN$US$US
231936874$23193687$4$F$$20240704$20231116$20240705$EXP$$KW-ALXN-202311MES000936KW$ALEXION PHARMACEUTICALS$$$$C$M$Y$19$KG$20240705$$MD$KW$KW
231937144$23193714$4$F$$20240624$20231116$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-162575$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240702$$MD$JP$JP
231937153$23193715$3$F$20231113$20240731$20231116$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-165361$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$73$KG$20240802$$CN$US$US
231938633$23193863$3$F$20231022$20231114$20231116$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004832$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$34$KG$20240828$$CN$US$US
231939292$23193929$2$F$$20240920$20231117$20240925$EXP$$NVSC2023US240943$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
231939614$23193961$4$F$20231103$20240720$20231117$20240808$PER$$CA-TOLMAR, INC.-23CA044557$TOLMAR$$68$YR$$M$Y$$$20240808$$CN$CA$CA
231939643$23193964$3$F$20231103$20240910$20231117$20240930$PER$$CA-TOLMAR, INC.-23CA044559$TOLMAR$$70$YR$$M$Y$$$20240930$$CN$CA$CA
231939663$23193966$3$F$$20240613$20231117$20240703$PER$$CA-TOLMAR, INC.-23CA044560$TOLMAR$$$$$M$Y$$$20240703$$CN$CA$CA
231942422$23194242$2$F$$20231107$20231117$20240925$PER$$US-GSK-US2023AMR156397$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
231942443$23194244$3$F$20231120$20240723$20231117$20240725$EXP$$CA-TAKEDA-2023TUS109828$TAKEDA$$39$YR$$F$Y$$$20240725$$CN$CA$CA
231943294$23194329$4$F$20240801$20240904$20231117$20240912$EXP$$US-SA-2023SA355198$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240912$$MD$US$US
231943788$23194378$8$F$20231001$20240607$20231117$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004881$ACADIA PHARMACEUTICALS$$11$YR$$F$Y$$$20240701$$CN$US$US
231943889$23194388$9$F$20231001$20240715$20231117$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004870$ACADIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240809$$CN$US$US
231943956$23194395$6$F$20230101$20240801$20231117$20240814$EXP$$US-UCBSA-2023053842$UCB$$$$$M$Y$38$KG$20240814$$CN$US$US
231944405$23194440$5$F$20230501$20240912$20231117$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-023061$JAZZ$$62$YR$$F$Y$$$20240918$$CN$US$US
231944792$23194479$2$F$20231031$20240620$20231117$20240716$PER$$CA-TOLMAR, INC.-23CA044443$TOLMAR$$66$YR$$M$Y$$$20240716$$CN$CA$CA
231945196$23194519$6$F$$20240723$20231117$20240731$EXP$$GB-JNJFOC-20231131462$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240731$$CN$GB$GB
231945802$23194580$2$F$20200101$20240829$20231117$20240905$EXP$$BR-GSK-BR2023AMR156424$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$BR$BR
231946253$23194625$3$F$20230901$20240723$20231117$20240730$EXP$$JP-ALXN-202311JPN000139JP$ALEXION PHARMACEUTICALS$$$$A$M$Y$70$KG$20240730$$MD$JP$JP
231946263$23194626$3$F$20240208$20240814$20231117$20240819$EXP$$CA-TAKEDA-2023TUS110525$TAKEDA$$31$YR$$M$Y$$$20240819$$CN$CA$CA
231946883$23194688$3$F$20220101$20240712$20231117$20240717$EXP$$PR-JNJFOC-20231128364$JOHNSON AND JOHNSON$$78$YR$E$M$Y$73.48$KG$20240717$$CN$PR$PR
231946892$23194689$2$F$20231016$20240723$20231117$20240725$EXP$$US-ABBVIE-5496304$ABBVIE$$61$YR$$F$Y$$$20240725$$CN$US$US
231947313$23194731$3$F$$20240909$20231117$20240913$EXP$$CA-ROCHE-3457455$ROCHE$$69$YR$E$F$Y$$$20240913$$HP$CA$CA
231948703$23194870$3$F$20230101$20240815$20231117$20240820$EXP$$US-ABBVIE-5496232$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
231948859$23194885$9$F$20240701$20240821$20231117$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-023133$JAZZ$$57$YR$$M$Y$95$KG$20240826$$HP$US$US
231949663$23194966$3$F$20220310$20240807$20231117$20240809$EXP$$GB-ROCHE-3457788$ROCHE$$48$YR$A$F$Y$76.2$KG$20240809$$MD$GB$GB
231949752$23194975$2$F$20231105$20240715$20231117$20240718$PER$$US-AMGEN-USASP2023203839$AMGEN$$66$YR$E$F$Y$$$20240718$$CN$US$US
231950043$23195004$3$F$$20240727$20231117$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-10120$LUPIN$$$$$$Y$$$20240816$$PH$US$US
231950252$23195025$2$F$20201119$20240731$20231117$20240802$EXP$$DE-ROCHE-2725507$ROCHE$$39$YR$A$F$Y$$$20240802$$CN$DE$DE
231950488$23195048$8$F$20231001$20240624$20231117$20240702$EXP$$CA-CELLTRION INC.-2023CA022044$CELLTRION$$$$$$Y$$$20240702$$CN$CA$CA
231950854$23195085$4$F$20230926$20240902$20231117$20240909$EXP$$BE-JNJFOC-20231131213$JOHNSON AND JOHNSON$$56$YR$A$F$Y$103$KG$20240909$$MD$BE$BE
231950953$23195095$3$F$$20240705$20231117$20240717$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-23-66782$HIKMA$$30$YR$$M$Y$84$KG$20240717$$MD$CA$CA
231951343$23195134$3$F$$20231129$20231117$20240701$PER$$US-UCBSA-2023053481$UCB$$$$$F$Y$$$20240701$$CN$US$US
231951735$23195173$5$F$20230101$20240822$20231117$20240826$EXP$$US-ROCHE-3451589$ROCHE$$70$YR$E$F$Y$55.79$KG$20240826$$MD$US$US
231954142$23195414$2$F$20130101$20240718$20231117$20240727$EXP$$DE-TEVA-2023-DE-2944649$TEVA$$62$YR$$M$Y$119$KG$20240727$$CN$DE$DE
231954363$23195436$3$F$$20240814$20231117$20240821$EXP$$CA-SANDOZ INC.-NVSC2020CA113431$SANDOZ$$71$YR$$F$Y$69$KG$20240821$$HP$CA$CA
231954922$23195492$2$F$20230101$20240621$20231117$20240702$PER$$US-SA-2023SA356390$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240702$$MD$US$US
231955914$23195591$4$F$20200915$20240820$20231117$20240826$EXP$$CA-TAKEDA-2020TUS039078$TAKEDA$$72$YR$$F$Y$$$20240826$$CN$CA$CA
231956563$23195656$3$F$20231030$20240904$20231117$20240909$PER$$US-ALXN-202311USA000932US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240909$$HP$US$US
231957812$23195781$2$F$20221009$20240715$20231117$20240724$EXP$$CN-CHEPLA-2023014438$CHEPLAPHARM$Xin L, Xiaobo H, Guowei W. A case report of the treatment options for a patient with treatment-resistant schizophrenia. Chinese Journal of Psychiatry. 2023;56(5):378-381.doi:10.3760/cma.j.cn113661-20221229-00355.$19$YR$$F$Y$47$KG$20240724$$HP$COUNTRY NOT SPECIFIED$CN
231957983$23195798$3$F$$20240919$20231117$20240920$EXP$$CA-MYLANLABS-2023M1118316$MYLAN$$56$YR$$M$Y$$$20240920$$HP$CA$CA
231958097$23195809$7$F$20221123$20240830$20231117$20240909$EXP$$CA-CELLTRION INC.-2022CA020737$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
231958266$23195826$6$F$20230101$20240722$20231117$20240729$EXP$$US-SA-2023SA357919$SANOFI AVENTIS$$60$YR$A$F$Y$58.9$KG$20240729$$MD$US$US
231959762$23195976$2$F$20230815$20231026$20231117$20240923$PER$$MX-ROCHE-3449193$ROCHE$$54$YR$A$F$Y$78$KG$20240923$$CN$MX$MX
231959784$23195978$4$F$20231106$20240806$20231117$20240807$EXP$$CA-JNJFOC-20231116883$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240807$$CN$CA$CA
231959882$23195988$2$F$$20240730$20231117$20240802$EXP$$CA-Orion Corporation ORION PHARMA-23_00023056$ORION$$33$YR$A$F$Y$$$20240802$$MD$CA$
2319599814$23195998$14$F$20210106$20240909$20231117$20240914$EXP$$CA-SANDOZ INC.-NVSC2020CA249757$SANDOZ$$77$YR$$F$Y$$$20240914$$CN$CA$CA
231959994$23195999$4$F$20231101$20240918$20231117$20240923$EXP$$JP-009507513-2311JPN001056J$MERCK$$7$DEC$$F$Y$$$20240923$$MD$JP$JP
231960083$23196008$3$F$20200101$20240717$20231117$20240723$EXP$$CA-SANDOZ INC.-NVSC2021CA082382$SANDOZ$$$$$F$Y$$$20240723$$CN$CA$CA
231960942$23196094$2$F$$20240626$20231117$20240701$EXP$$NVSC2023US241888$NOVARTIS$$$$$M$Y$$$20240701$$CN$US$US
231961352$23196135$2$F$$20240913$20231117$20240923$EXP$$CA-MYLANLABS-2023M1119685$BIOCON$$$$$$Y$$$20240923$$HP$CA$CA
231961663$23196166$3$F$$20240820$20231117$20240830$PER$$US-SA-2023SA351610$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240830$$MD$US$US
231961932$23196193$2$F$20230101$20240731$20231117$20240809$PER$$US-SA-2023SA353322$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240809$$MD$US$US
231962535$23196253$5$F$20230101$20240722$20231117$20240730$PER$$US-SA-2023SA356901$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240730$$MD$US$US
231962554$23196255$4$F$20231001$20240801$20231117$20240806$EXP$$US-UCBSA-2023054518$UCB$$71$YR$$F$Y$76.65$KG$20240806$$HP$US$US
231963242$23196324$2$F$20230801$20231107$20231117$20240704$EXP$DE-EMBRYOTOX-202307174$DE-TORRENT-00025709$TORRENT$$1$DY$N$F$Y$3$KG$20240704$$MD$DE$DE
231963387$23196338$7$F$20240227$20240828$20231117$20240903$EXP$$CA-TAKEDA-2023TUS109674$TAKEDA$$23$YR$$M$Y$$$20240903$$CN$CA$CA
231963722$23196372$2$F$20230101$20240626$20231117$20240705$PER$$US-SA-2023SA357145$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240705$$MD$US$US
231964855$23196485$5$F$20220101$20240913$20231117$20240918$EXP$$CA-TAKEDA-2022TUS029982$TAKEDA$$$$$F$Y$50$KG$20240918$$CN$CA$CA
231965692$23196569$2$F$20230801$20240819$20231117$20240821$EXP$$DE-NORDICGR-054382$NORDIC PHARMA$$64$YR$$F$Y$$$20240821$$MD$DE$DE
231965952$23196595$2$F$20231108$20240827$20231117$20240829$EXP$$US-PFIZER INC-PV202300145954$PFIZER$$72$YR$$M$Y$$$20240829$$MD$US$US
231966193$23196619$3$F$20210813$20240821$20231117$20240827$EXP$$CA-TAKEDA-2022TUS038494$TAKEDA$$32$YR$$M$Y$$$20240827$$MD$CA$CA
231967652$23196765$2$F$20230101$20240725$20231117$20240802$EXP$$JP-AstraZeneca-2023A255422$ASTRAZENECA$$78$YR$$M$Y$$$20240802$$MD$JP$
231967932$23196793$2$F$$20240805$20231117$20240812$EXP$$AU-009507513-2311AUS005325$MERCK$Nilajgi S, Kasmeridis N, Ganessan K. A Case Of Immune Check Point Inhibitor - Induced Hypophysitis. J Endocr Soc. 2021;5(Supplement 1):A560$70$YR$$F$Y$$$20240812$$MD$AU$AU
231968062$23196806$2$F$$20240828$20231117$20240918$PER$$US-SA-2023SA350522$SANOFI AVENTIS$$56$YR$A$F$Y$67.5$KG$20240918$$MD$US$US
231968185$23196818$5$F$$20240903$20231117$20240905$EXP$$US-PFIZER INC-PV202300186816$PFIZER$$84$YR$$F$Y$80.272$KG$20240905$$MD$US$US
231968566$23196856$6$F$$20240906$20231117$20240909$EXP$$US-PFIZER INC-PV202300033115$PFIZER$$73$YR$$F$Y$$$20240909$$CN$US$US
231968662$23196866$2$F$$20240805$20231117$20240809$EXP$$CA-PFIZER INC-202300361716$PFIZER$$65$YR$$F$Y$$$20240809$$MD$CA$CA
231969922$23196992$2$F$$20240905$20231117$20240911$EXP$$ES-MYLANLABS-2023M1121682$MYLAN$Quintero V, Bueno-Sanchez D, Mozo-Del-Castillo Y, Urtasun-Erburu A, Sisinni L, Lopez-Duarte M et al.. Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow Failure. Transplantation and Cellular Therapy. 2023;29(10):621.e1-6$11$YR$$F$Y$$$20240911$$HP$ES$ES
2319703110$23197031$10$F$20220104$20240920$20231117$20240926$EXP$$IN-PFIZER INC-2021176193$PFIZER$$67$YR$$F$Y$75.3$KG$20240926$$CN$IN$IN
231970392$23197039$2$F$20231005$20240806$20231117$20240808$EXP$$US-PFIZER INC-202300366201$PFIZER$$61$YR$$F$Y$$$20240808$$HP$US$US
231971225$23197122$5$F$20231026$20240730$20231117$20240807$EXP$$JP-AstraZeneca-2023A256786$ASTRAZENECA$Yokotani T, et al.. EP-1146 Three cases of coughing attacks, flushed face, and respiratory discomfort during administration of fulvestrant.. The 32nd Annual Meeting of the Japanese Breast Cancer Society 2024;464-.$81$YR$$F$Y$46$KG$20240807$$MD$JP$
231972255$23197225$5$F$20231007$20240725$20231117$20240801$EXP$$NVSC2023GT241870$NOVARTIS$$38$YR$$M$Y$$$20240801$$CN$GT$GT
231972269$23197226$9$F$20230626$20240627$20231117$20240702$EXP$$CA-OTSUKA-2023_017442$OTSUKA$$82$YR$$F$Y$$$20240702$$MD$CA$CA
231973473$23197347$3$F$20240404$20240412$20231117$20240925$PER$$US-GSK-US2023AMR156104$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
231973703$23197370$3$F$20220401$20240812$20231117$20240827$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-418089$RANBAXY$Faxen L, Edvinsson M. Persistent SARS-CoV-2 infection in patients with B-cell deficiency: a case series of successful antiviral treatment of four patients. Upsala J Med Sci. 2023;128:e9807$76$YR$$M$Y$$$20240827$$HP$SE$SE
231974327$23197432$7$F$20231001$20240723$20231117$20240730$EXP$$JP-ARGENX-2023-ARGX-JP003633$ARGENX BVBA$$$$$$Y$$$20240730$$CN$JP$JP
231974425$23197442$5$F$20230401$20240709$20231117$20240715$EXP$$FR-ASTELLAS-2023US012178$ASTELLAS$$67$YR$$M$Y$$$20240715$$PH$FR$FR
231976002$23197600$2$F$$20240906$20231117$20240909$EXP$$NO-SANDOZ INC.-SDZ2023NO054705$SANDOZ$$34$YR$$M$Y$$$20240909$$HP$NO$NO
231976493$23197649$3$F$$20240705$20231117$20240716$PER$$US-SA-2023SA350914$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240716$$CN$US$US
231977094$23197709$4$F$20230227$20240906$20231117$20240916$EXP$BE-EMA-DD-20231027-7207890-132527$BE-TEVA-2023-BE-2945692$TEVA$$85$YR$$M$Y$$$20240916$$MD$BE$BE
231978359$23197835$9$F$20230119$20240822$20231117$20240828$EXP$$BE-JNJFOC-20230739812$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$80$KG$20240828$$MD$BE$BE
231979603$23197960$3$F$$20240709$20231117$20240716$EXP$$CA-GSK-CA2019AMR234244$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$MD$CA$CA
231980152$23198015$2$F$$20240731$20231117$20240809$PER$$US-SA-2023SA352398$SANOFI AVENTIS$$$$C$M$Y$39.9$KG$20240809$$MD$US$US
231980512$23198051$2$F$$20240802$20231117$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-65031$HIKMA$$$$$$Y$$$20240813$$MD$CA$CA
231981095$23198109$5$F$$20240820$20231117$20240820$PER$$US-ALXN-A202305581AA$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
231981123$23198112$3$F$$20240823$20231117$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-166369$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$66.32$KG$20240902$$CN$US$US
231981412$23198141$2$F$20230101$20240726$20231117$20240802$PER$$US-SA-2023SA352121$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240802$$MD$US$US
231981912$23198191$2$F$20230901$20240806$20231117$20240816$PER$$US-SA-2023SA351768$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240816$$MD$US$US
231982358$23198235$8$F$20231001$20240701$20231117$20240703$EXP$$IN-PFIZER INC-PV202300170697$PFIZER$$57$YR$$M$Y$$$20240703$$CN$IN$IN
231982666$23198266$6$F$20231101$20240819$20231117$20240821$EXP$$US-PFIZER INC-PV202300186003$PFIZER$$62$YR$$F$Y$$$20240821$$HP$US$US
2319833715$23198337$15$F$20230418$20240701$20231117$20240704$EXP$$DE-SA-2023SA167832$SANOFI AVENTIS$$56$YR$A$$Y$88.9$KG$20240704$$HP$DE$DE
231983597$23198359$7$F$$20240624$20231117$20240731$PER$$US-TRAVERE-2023TVT00459$TRAVERE THERAPEUTICS$$68$YR$E$M$Y$$$20240731$$CN$US$US
231983655$23198365$5$F$20230701$20240815$20231117$20240827$PER$$US-TRAVERE-2023TVT00462$TRAVERE THERAPEUTICS$$64$YR$A$M$Y$117.48$KG$20240827$$CN$US$US
231983864$23198386$4$F$20231020$20240702$20231117$20240712$EXP$$US-VIIV HEALTHCARE LIMITED-US2023145843$VIIV$$76$YR$$M$Y$$$20240712$$CN$US$US
231984392$23198439$2$F$20230101$20240726$20231117$20240802$EXP$$CA-PFIZER INC-202300355974$PFIZER$$34$YR$$F$Y$$$20240802$$MD$CA$CA
231984416$23198441$6$F$20160401$20240712$20231117$20240716$EXP$$IN-PFIZER INC-202200380041$PFIZER$$62$YR$$M$Y$$$20240716$$CN$IN$IN
231984944$23198494$4$F$20230101$20240824$20231117$20240827$EXP$$CA-PFIZER INC-202300370189$PFIZER$$84$YR$$M$Y$$$20240827$$HP$CA$CA
231985942$23198594$2$F$20231003$20240822$20231117$20240901$30DAY$$US-GSK-US2023154910$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240901$$CN$US$US
231986022$23198602$2$F$20230814$20240909$20231117$20240930$PER$$US-TRAVERE-2023TVT00452$TRAVERE THERAPEUTICS$$57$YR$A$M$Y$$$20240930$$CN$US$US
231986087$23198608$7$F$$20240909$20231117$20240917$PER$$US-TRAVERE-2023TVT00461$TRAVERE THERAPEUTICS$$37$YR$A$F$Y$118.39$KG$20240917$$CN$US$US
231986125$23198612$5$F$$20240828$20231117$20240917$PER$$US-TRAVERE-2023TVT00465$TRAVERE THERAPEUTICS$$36$YR$A$F$Y$5.64$KG$20240917$$CN$US$US
231986172$23198617$2$F$$20240823$20231117$20240828$EXP$$US-PFIZER INC-202300362252$PFIZER$Chan, J.. Panhypopituitarism as a cause of Pancytopenia in a Male Adolescent with Thrombophilia.. Hormone Research in Paediatrics.. 2023;96(Supple 3):237-8$17$YR$$M$Y$$$20240828$$MD$US$US
231986566$23198656$6$F$20220913$20240902$20231117$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-124516$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$43.2$KG$20240911$$MD$JP$JP
231987696$23198769$6$F$20231101$20240827$20231117$20240902$EXP$$US-PFIZER INC-PV202300187476$PFIZER$$75$YR$$F$Y$$$20240902$$CN$US$US
231988724$23198872$4$F$$20240826$20231117$20240830$PER$$US-PFIZER INC-202300369729$PFIZER$$19$YR$$F$Y$$$20240830$$CN$US$US
231988766$23198876$6$F$$20240814$20231117$20240820$PER$$US-PFIZER INC-PV202300162208$PFIZER$$65$YR$$F$Y$90.72$KG$20240820$$CN$US$US
231990113$23199011$3$F$$20240502$20231117$20240724$PER$$US-Stemline Therapeutics, Inc.-2023ST003357$STEMLINE THERAPEUTICS$$52$YR$A$F$Y$$$20240718$$CN$US$US
231991392$23199139$2$F$20230822$20240611$20231117$20240723$PER$$US-Stemline Therapeutics, Inc.-2023ST003011$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$65.83$KG$20240718$$PH$US$US
231994174$23199417$4$F$20230801$20240520$20231117$20240724$PER$$US-Stemline Therapeutics, Inc.-2023ST002577$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
231998073$23199807$3$F$$20240606$20231117$20240724$PER$$US-Stemline Therapeutics, Inc.-2023ST002503$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
231998163$23199816$3$F$$20240905$20231117$20240909$PER$$US-PFIZER INC-PV202300186078$PFIZER$$74$YR$$F$Y$79.365$KG$20240909$$CN$US$US
231998383$23199838$3$F$$20240910$20231117$20240912$PER$$US-PFIZER INC-PV202300186789$PFIZER$$71$YR$$F$Y$$$20240912$$CN$US$US
231998406$23199840$6$F$20231101$20240828$20231117$20240904$PER$$US-PFIZER INC-PV202300142108$PFIZER$$27$YR$$F$Y$$$20240904$$CN$US$US
231998533$23199853$3$F$20231101$20240801$20231117$20240805$PER$$US-PFIZER INC-202300356227$PFIZER$$57$YR$$M$Y$$$20240805$$MD$US$US
231999153$23199915$3$F$20220101$20240829$20231117$20240905$EXP$$JP-009507513-2311JPN000765J$MERCK$$60$YR$$M$Y$$$20240905$$MD$JP$JP
2320000211$23200002$11$F$20220614$20240806$20231117$20240814$EXP$$CA-CELLTRION INC.-2023CA021958$CELLTRION$$$$$$Y$$$20240814$$HP$CA$CA
232000262$23200026$2$F$20160917$20240701$20231117$20240708$EXP$$ES-AUROBINDO-AUR-APL-2018-048286$AUROBINDO$$52$YR$$F$Y$$$20240708$$MD$ES$ES
232000743$23200074$3$F$20230101$20240827$20231117$20240902$EXP$$US-ABBVIE-5408289$ABBVIE$$$$$F$Y$97$KG$20240902$$CN$US$US
232000805$23200080$5$F$20230101$20240909$20231117$20240916$EXP$$CA-CELLTRION INC.-2023CA021959$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
232000873$23200087$3$F$$20240802$20231117$20240815$EXP$$US-AUROBINDO-AUR-APL-2023-068103$AUROBINDO$Guntaka S, Barron C, Baer T, Cohen L, Regelmann M. Dexamethasone swish and spit, a cause of iatrogenic adrenal insufficiency. Hormone Research in Paediatrics. 2023;96:13-4$14$YR$$M$Y$$$20240815$$MD$US$US
232001864$23200186$4$F$$20240710$20231118$20240815$PER$$US-TRAVERE-2023TVT00668$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$CN$US$US
232002002$23200200$2$F$$20240805$20231118$20240817$EXP$$NL-AUROBINDO-AUR-APL-2023-068639$AUROBINDO$Fijen L, Petersen RS, Cohn DM. Facial swelling due to angioedema Mostly mast-cell mediated, but not always. CLINICAL LESSON. 2023;167:D7610$60$YR$$M$Y$$$20240817$$HP$NL$NL
232002172$23200217$2$F$20230101$20240903$20231118$20240912$PER$$US-SA-2023SA350711$SANOFI AVENTIS$$13$YR$T$M$Y$69.85$KG$20240912$$MD$US$US
232002743$23200274$3$F$20230620$20231120$20231118$20240718$EXP$$NVSC2023US245841$NOVARTIS$$68$YR$$F$Y$80.56$KG$20240718$$HP$US$US
232008493$23200849$3$F$$20240715$20231118$20240723$PER$$US-ALXN-202311USA000766US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
232008768$23200876$8$F$20230504$20240625$20231118$20240703$EXP$$US-ALXN-A202306074$ALEXION PHARMACEUTICALS$$51$YR$$F$Y$$$20240703$$CN$US$US
232009002$23200900$2$F$$20240814$20231118$20240820$30DAY$$KR-ABBVIE-5492470$ABBVIE$$$$$$Y$$$20240820$$MD$ES$KR
232009342$23200934$2$F$$20231108$20231118$20240710$PER$$US-ROCHE-3455519$ROCHE$$$$A$M$Y$$$20240628$$CN$US$US
232009877$23200987$7$F$20231001$20240702$20231118$20240709$EXP$$US-UNITED THERAPEUTICS-UNT-2023-032779$UNITED THERAPEUTICS$$78$YR$$M$Y$88.435$KG$20240709$$$US$US
232009975$23200997$5$F$20230903$20240801$20231118$20240822$PER$$US-TRAVERE-2023TVT00483$TRAVERE THERAPEUTICS$$52$YR$A$M$Y$$$20240822$$CN$US$US
232011462$23201146$2$F$$20240823$20231118$20240905$EXP$US-MACLEODS PHARMACEUTICALS US LTD-MAC2023044264$US-MACLEODS PHARMACEUTICALS US LTD-MAC2023044264$MACLEODS$$$$$$Y$$$20240904$$MD$US$US
232012406$23201240$6$F$$20240625$20231118$20240731$PER$$US-TRAVERE-2023TVT00539$TRAVERE THERAPEUTICS$$35$YR$A$F$Y$$$20240731$$CN$US$US
232012596$23201259$6$F$20231107$20240812$20231118$20240813$EXP$$NVSC2023DE244625$NOVARTIS$$$$A$F$Y$81$KG$20240813$$MD$DE$DE
232013334$23201333$4$F$$20240625$20231118$20240702$EXP$$US-TRAVERE-2023TVT00560$TRAVERE THERAPEUTICS$$40$YR$A$F$Y$$$20240702$$CN$US$US
232013484$23201348$4$F$$20240808$20231118$20240814$PER$$US-TRAVERE-2023TVT00566$TRAVERE THERAPEUTICS$$29$YR$A$M$Y$57.15$KG$20240814$$CN$US$US
232013694$23201369$4$F$20231003$20240717$20231118$20240815$PER$$US-TRAVERE-2023TVT00578$TRAVERE THERAPEUTICS$$36$YR$A$M$Y$$$20240815$$CN$US$US
232014132$23201413$2$F$$20240624$20231118$20240703$PER$$US-SA-2023SA351438$SANOFI AVENTIS$$15$YR$T$F$Y$62.7$KG$20240703$$MD$US$US
232014382$23201438$2$F$20230701$20240903$20231118$20240913$EXP$$JP-Eisai-EC-2023-146048$EISAI$Nakamura N. Uterine cancer: Focusing on LP therapy.. Eisai In-house Training Session..$51$YR$A$F$Y$$$20240913$$MD$JP$JP
232014572$23201457$2$F$$20240709$20231118$20240715$PER$$US-SA-2023SA352458$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240715$$MD$US$US
232015082$23201508$2$F$20230922$20240829$20231118$20240910$EXP$IT-MINISAL02-950491$IT-TEVA-2023-IT-2946031$TEVA$$73$YR$$F$Y$64$KG$20240906$$PH$IT$IT
232015532$23201553$2$F$20100101$20240731$20231118$20240806$EXP$$US-ALXN-202311USA000763US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$HP$US$US
232015973$23201597$3$F$20231101$20240703$20231118$20240710$EXP$$CA-ALXN-202310CAN000392CA$ALEXION PHARMACEUTICALS$$81$YR$$F$Y$$$20240710$$CN$CA$CA
232016032$23201603$2$F$20210501$20240829$20231118$20240905$EXP$FR-AFSSAPS-AN20211823$FR-TEVA-2023-FR-2945823$TEVA$$71$YR$$M$Y$$$20240905$$MD$FR$FR
232017653$23201765$3$F$20230901$20240626$20231120$20240702$EXP$$EG-SANDOZ INC.-SDZ2023EG055838$SANDOZ$$61$YR$$F$Y$$$20240702$$CN$EG$EG
232017753$23201775$3$F$20181022$20240327$20231120$20240819$EXP$$GB-TEVA-2023-GB-2945580$TEVA$$80$YR$$F$Y$$$20240819$$HP$GB$IE
232019493$23201949$3$F$20231001$20240912$20231120$20240918$EXP$$JP-009507513-2311JPN001561J$MERCK$$7$DEC$$F$Y$$$20240918$$MD$JP$JP
2320202312$23202023$12$F$$20240801$20231120$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202311009324$ELI LILLY AND CO$$55$YR$A$M$Y$99.773$KG$20240814$$CN$US$US
232020643$23202064$3$F$$20240814$20231120$20240822$EXP$$AU-CELLTRION INC.-2023AU014433$CELLTRION$$$$$$Y$$$20240822$$MD$AU$AU
232020694$23202069$4$F$20231101$20240808$20231120$20240814$EXP$$JP-SA-2023SA353660$SANOFI AVENTIS$$51$YR$A$M$Y$88.6$KG$20240814$$MD$JP$JP
232022413$23202241$3$F$20230208$20240807$20231120$20240812$EXP$$CA-JNJFOC-20230427152$JOHNSON AND JOHNSON$$62$YR$A$F$Y$66$KG$20240812$$HP$CA$CA
232023132$23202313$2$F$$20240628$20231120$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202311010489$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240702$$CN$US$US
232023355$23202335$5$F$20231012$20240716$20231120$20240723$EXP$FR-AFSSAPS-RS2023000896$FR-BIOVITRUM-2023-FR-018301$BIOVITRUM$$12$MON$$M$Y$8.8$KG$20240723$$MD$FR$FR
232024344$23202434$4$F$20231201$20240801$20231120$20240807$EXP$$CA-TAKEDA-2022TUS025056$TAKEDA$$59$YR$$M$Y$$$20240807$$HP$CA$CA
232024804$23202480$4$F$$20240911$20231120$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-10245$LUPIN$$$$$$Y$$$20240926$$CN$US$US
232025114$23202511$4$F$$20240815$20231120$20240819$EXP$$NVSC2023US246102$NOVARTIS$$$$$M$Y$$$20240819$$CN$US$US
232025192$23202519$2$F$$20240808$20231120$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004924$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
232025557$23202555$7$F$20090101$20240905$20231120$20240919$EXP$GB-MHRA-ADR 28066624$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-13778$ALKEM$$37$YR$$M$Y$$$20240919$$CN$GB$GB
232025562$23202556$2$F$$20240716$20231120$20240718$PER$$US-AMGEN-USASP2023203300$AMGEN$$67$YR$E$F$Y$$$20240718$$HP$US$US
232025942$23202594$2$F$$20240711$20231120$20240716$EXP$$US-TAKEDA-2022TUS085919$TAKEDA$$$$$M$Y$$$20240716$$CN$US$US
232027012$23202701$2$F$20231026$20240830$20231120$20240912$EXP$$FR-SANDOZ INC.-SDZ2023FR055786$SANDOZ$$24$YR$$F$Y$76$KG$20240912$$HP$FR$FR
232027784$23202778$4$F$20231001$20240819$20231120$20240828$PER$$US-SA-2023SA354489$SANOFI AVENTIS$$49$YR$A$F$Y$88.4$KG$20240828$$MD$US$US
232028232$23202823$2$F$$20240725$20231120$20240802$PER$$US-SA-2023SA354008$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240802$$MD$US$US
232028363$23202836$3$F$20230101$20240827$20231120$20240917$PER$$US-SA-2023SA355952$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240918$$CN$US$US
232029938$23202993$8$F$20230109$20240828$20231120$20240904$EXP$$US-OTSUKA-2023_000709$OTSUKA$$$$$M$Y$$$20240904$$HP$US$US
232030305$23203030$5$F$20231213$20240917$20231120$20240923$EXP$$CA-TAKEDA-2023TUS110672$TAKEDA$$45$YR$$M$Y$$$20240923$$CN$CA$CA
232030509$23203050$9$F$20230101$20240731$20231120$20240809$PER$$US-SA-2023SA354728$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240809$$MD$US$US
232030715$23203071$5$F$$20240730$20231120$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-164144$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$79.38$KG$20240731$$CN$US$US
232031062$23203106$2$F$$20240802$20231120$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202311008193$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240808$$CN$US$US
232032692$23203269$2$F$20231001$20240731$20231120$20240809$PER$$US-SA-2023SA354935$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240809$$MD$US$US
232033462$23203346$2$F$20231101$20240718$20231120$20240731$PER$$US-SA-2023SA355101$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240731$$MD$US$US
232034154$23203415$4$F$20181130$20240703$20231120$20240705$EXP$$US-TAKEDA-US201846757$TAKEDA$$57$YR$$F$Y$$$20240705$$HP$US$US
232035022$23203502$2$F$20230614$20240903$20231120$20240906$EXP$$IE-TAKEDA-2023TUS067147$TAKEDA$$61$YR$$F$Y$$$20240906$$CN$IE$IE
232035182$23203518$2$F$20231107$20240614$20231120$20240704$EXP$$FR-AMGEN-FRASP2023203686$AMGEN$$66$YR$E$M$Y$$$20240704$$HP$FR$FR
232035403$23203540$3$F$20230101$20240906$20231120$20240917$PER$$US-SA-2023SA355038$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240918$$MD$US$US
232038152$23203815$2$F$20230901$20240918$20231120$20240926$EXP$$NVSC2023US245012$NOVARTIS$$$$$$Y$$$20240926$$CN$US$US
232038392$23203839$2$F$$20240913$20231120$20240923$PER$$US-GSK-US2023156203$GLAXOSMITHKLINE$$$$$M$Y$$$20240923$$CN$US$US
232038653$23203865$3$F$$20240808$20231120$20240809$EXP$$JP-ASTELLAS-2023JP012716$ASTELLAS$Hirakawa Y, Takemoto N, Tsuji T, Takahashi R, Joyce M, Miyazaki H, et al.. A case of Crohn^s disease developed after cord blood transplantation and was treated with vedolizumab. The 85th Annual Meeting of the Japanese Society of Hematology (Program/Abstracts. 2023;P1-am2-4#9$65$YR$$M$Y$$$20240809$$MD$JP$JP
232038936$23203893$6$F$20231001$20240607$20231120$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004906$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240701$$CN$US$US
232040763$23204076$3$F$20240601$20240724$20231120$20240801$PER$$US-AMGEN-USASP2023198932$AMGEN$$64$YR$A$F$Y$$$20240801$$HP$US$US
232041912$23204191$2$F$20240801$20240904$20231120$20240911$EXP$$CO-GSK-CO2023AMR153775$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$CO$CO
232042102$23204210$2$F$$20240828$20231120$20240903$EXP$$IT-SANDOZ INC.-SDZ2023IT054454$SANDOZ$$68$YR$$F$Y$$$20240903$$HP$IT$IT
232043503$23204350$3$F$20230701$20240809$20231120$20240815$EXP$$JP-GSK-JP2023JPN157887$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$MD$JP$JP
232043664$23204366$4$F$20231201$20240709$20231120$20240710$EXP$$AU-TAKEDA-2023TUS111156$TAKEDA$$37$YR$$M$Y$$$20240710$$CN$AU$AU
232044822$23204482$2$F$$20240625$20231120$20240701$EXP$$CA-TAKEDA-2023TUS110726$TAKEDA$$$$$F$Y$$$20240701$$MD$CA$CA
232045702$23204570$2$F$$20240916$20231120$20240925$EXP$DE-MLMSERVICE-20231107-4643374-1$DE-STRIDES ARCOLAB LIMITED-2023SP017113$STRIDES$Rechtien L, Sollfrank L, Foerster Y, Berking C, Sticherling M. Case Report: The many faces of bullous pemphigoid. Frontiers in Immunology. 2023;14:1-5$43$YR$$F$Y$$$20240925$$MD$DE$DE
232047142$23204714$2$F$$20240718$20231120$20240724$EXP$$GR-AMGEN-GRCSP2023203816$AMGEN$$$$$F$Y$$$20240724$$MD$GR$GR
232047354$23204735$4$F$$20240214$20231120$20240925$PER$$US-GSK-US2023AMR156432$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
232047613$23204761$3$F$$20240812$20231120$20240816$EXP$GR-SEATTLE GENETICS-2023SGN11900$GR-ROCHE-3458484$ROCHE$$$$$F$Y$$$20240816$$MD$GR$GR
232047782$23204778$2$F$20231025$20240725$20231120$20240731$EXP$$BE-ALXN-202311GLO000503BE$ALEXION PHARMACEUTICALS$$69$YR$$M$Y$80$KG$20240731$$MD$BE$BE
2320479410$23204794$10$F$20220701$20240828$20231120$20240903$EXP$$CR-SANDOZ INC.-NVSC2022CR152470$SANDOZ$$57$YR$$F$Y$78$KG$20240903$$CN$CR$CR
232048244$23204824$4$F$20220101$20240813$20231120$20240819$EXP$$SK-MYLANLABS-2023M1122655$MYLAN$Doczyova D, Sykora T, Surgosova J, Fussiova M, Horakova J, Bodova I, Adamcakova J, Vargova S, Pozdechova M, Burman J, Svec P, Kolenova A.. Autologous transplantation of peripheral hematopoietic cells in multiple sclerosis - first experience in children in Slovakia.. Conference of pediatric hematologists and oncologists of the Czech and Slovak. 2023;113$17$YR$$F$Y$$$20240819$$MD$SK$SK
232048312$23204831$2$F$$20240703$20231120$20240708$EXP$$BE-MYLANLABS-2023M1102767$MYLAN$Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A, et. al.. PIK3CA copy-number gain and inhibitors of the P13K/AKT/mTOR pathway in triple-negative breast cancer. Cold-Spring-Harb-Mol-Case-Stud. 2023;9(2):1-16$30$YR$$F$Y$$$20240708$$HP$BE$BE
232049475$23204947$5$F$20230804$20240807$20231120$20240813$EXP$$DE-TAKEDA-2023TUS098069$TAKEDA$$34$YR$$M$Y$97$KG$20240813$$CN$DE$DE
232049855$23204985$5$F$$20240129$20231120$20240712$EXP$$NVSC2023DE246096$NOVARTIS$$10$YR$$F$Y$$$20240712$$MD$DE$DE
232052584$23205258$4$F$20200219$20240726$20231120$20240801$EXP$$CA-TAKEDA-2023TUS111585$TAKEDA$$48$YR$$F$Y$$$20240801$$CN$CA$CA
232052982$23205298$2$F$$20240805$20231120$20240816$EXP$$US-MYLANLABS-2023M1122319$MYLAN$Guntaka S, Barron C, Baer T, Cohen L, Regelmann M. Dexamethasone swish and spit, a cause of iatrogenic adrenal insufficiency. Horm-Res-Paediatr 2023;96 (Suppl. 3):13-14 abstr. 6242.$14$YR$$M$Y$$$20240816$$MD$US$US
232053736$23205373$6$F$$20240823$20231120$20240829$PER$$US-PFIZER INC-PV202300188795$PFIZER$$44$YR$$F$Y$$$20240829$$CN$US$US
232053774$23205377$4$F$20231114$20240911$20231120$20240916$EXP$$CO-ROCHE-3459143$ROCHE$$70$YR$E$M$Y$$$20240916$$MD$CO$CO
232053954$23205395$4$F$$20240919$20231120$20240924$PER$$US-PFIZER INC-PV202300188286$PFIZER$$79$YR$$M$Y$$$20240924$$MD$US$US
232053978$23205397$8$F$$20240829$20231120$20240904$PER$$US-PFIZER INC-PV202300161148$PFIZER$$94$YR$$F$Y$61.678$KG$20240904$$CN$US$US
232053983$23205398$3$F$$20240731$20231120$20240802$PER$$US-PFIZER INC-PV202300188909$PFIZER$$58$YR$$F$Y$$$20240802$$HP$US$US
232054152$23205415$2$F$20160101$20240711$20231120$20240715$EXP$$FR-MYLANLABS-2023M1120613$MYLAN$$50$YR$$F$Y$96$KG$20240715$$HP$FR$FR
232054503$23205450$3$F$$20240708$20231120$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-166340$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$43$KG$20240709$$MD$JP$JP
232055035$23205503$5$F$20170701$20240711$20231120$20240716$PER$$US-PFIZER INC-PV202300186757$PFIZER$$65$YR$$F$Y$65.76$KG$20240716$$CN$US$US
232055122$23205512$2$F$20231113$20240913$20231120$20240917$PER$$US-PFIZER INC-202300369809$PFIZER$$67$YR$$F$Y$$$20240917$$HP$US$US
232055662$23205566$2$F$20230914$20240701$20231120$20240705$EXP$$US-ABBVIE-5493450$ABBVIE$$52$YR$$F$Y$$$20240705$$CN$US$US
232055696$23205569$6$F$20230101$20240903$20231120$20240910$EXP$$CA-OTSUKA-2023_029887$OTSUKA$$$$$M$Y$$$20240910$$MD$CA$CA
232056644$23205664$4$F$20231001$20240702$20231120$20240710$EXP$$US-BIOGEN-2023BI01235314$BIOGEN$$54$YR$$M$Y$$$20240710$$MD$US$US
232057004$23205700$4$F$$20240906$20231120$20240912$EXP$$ES-MYLANLABS-2023M1122162$MYLAN$Quintero V, Bueno-S?nchez D, Mozo-Del-Castillo Y, Urtasun-Erburu A, Sisinni L, L?pez-Duarte M. Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow Failure. Transplantation and Cellular Therapy. 2023;29(10):621.e1-6$9$YR$$M$Y$$$20240912$$HP$ES$ES
232058902$23205890$2$F$$20240807$20231120$20240816$PER$$US-SA-2023SA352517$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240816$$MD$US$US
232059912$23205991$2$F$20231108$20240705$20231120$20240716$PER$$US-SA-2023SA353957$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240716$$MD$US$US
232060184$23206018$4$F$20231101$20240627$20231120$20240710$PER$$US-SA-2023SA352446$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240710$$MD$US$US
232060442$23206044$2$F$20210605$20240722$20231120$20240724$EXP$$JP-TAKEDA-2023TJP015342$TAKEDA$$13$YR$$F$Y$$$20240724$$MD$JP$JP
232060524$23206052$4$F$20231001$20240702$20231120$20240711$PER$$US-SA-2023SA355591$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240711$$MD$US$US
232060686$23206068$6$F$$20240805$20231120$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-166701$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240808$$CN$US$US
232061553$23206155$3$F$20240101$20240925$20231120$20240930$EXP$$US-SANDOZ INC.-NVSC2022US019485$SANDOZ$$$$$M$Y$19.955$KG$20240930$$CN$US$US
232062803$23206280$3$F$20230917$20240826$20231120$20240830$EXP$$FR-MYLANLABS-2023M1112365$MYLAN$$81$YR$$M$Y$52$KG$20240830$$MD$FR$FR
232063442$23206344$2$F$$20230624$20231120$20240728$PER$$US-UROVANT SCIENCES GMBH-202204-URV-000474$SUNOVION$$$$$F$Y$64.399$KG$20240728$$CN$US$US
232063576$23206357$6$F$$20240703$20231120$20240710$EXP$$US-TAKEDA-2023TUS111117$TAKEDA$$$$$M$Y$$$20240710$$CN$US$US
232063693$23206369$3$F$20221009$20240625$20231120$20240702$EXP$$NVSC2023DE243346$NOVARTIS$$53$YR$$F$Y$155$KG$20240702$$MD$DE$DE
232063792$23206379$2$F$$20240909$20231120$20240911$EXP$$FR-SANDOZ INC.-SDZ2023FR055660$SANDOZ$$39$YR$$F$Y$$$20240911$$HP$FR$FR
232064772$23206477$2$F$$20240724$20231120$20240801$EXP$$US-ALXN-202311USA001088US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
232067274$23206727$4$F$20230101$20240730$20231120$20240805$EXP$$US-INCYTE CORPORATION-2023IN011963$INCYTE$$$$$$Y$$$20240805$$CN$US$US
232070795$23207079$5$F$$20240913$20231120$20240919$EXP$$US-BIOGEN-2023BI01236715$BIOGEN$$$$$M$Y$93$KG$20240919$$CN$US$US
232070903$23207090$3$F$20230627$20240808$20231120$20240815$EXP$$JP-Eisai-EC-2023-143484$EISAI$Hikino K. Results of pembrolizumab/lenvatinib combination therapy at our hospital.. Japanese Journal of Gynecological Oncology.. 2024;(42(3)): 403-403.$65$YR$E$F$Y$80$KG$20240815$$MD$JP$JP
232071542$23207154$2$F$$20240822$20231120$20240823$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-273729$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240823$$CN$US$US
2320717313$23207173$13$F$20231106$20240821$20231120$20240902$EXP$$US-BEH-2023165480$CSL BEHRING$$62$YR$A$F$Y$162.36$KG$20240902$$HP$US$US
2320751828$23207518$28$F$20240330$20240902$20231120$20240909$EXP$$GB-ABBVIE-5493323$ABBVIE$$54$YR$$F$Y$71$KG$20240909$$MD$GB$GB
232077233$23207723$3$F$$20240916$20231120$20240924$EXP$$FR-CELLTRION INC.-2023FR022063$CELLTRION$Nault J.; Limousin W.; Laurent-puig P. et al.. Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab. Journal of Hepatology. 2023;1-17$$$$$Y$$$20240924$$MD$FR$FR
232077513$23207751$3$F$20230406$20240809$20231121$20240814$EXP$$BR-TAKEDA-2023TUS038270$TAKEDA$$39$YR$$F$Y$$$20240814$$CN$BR$BR
232077814$23207781$4$F$20230101$20240904$20231121$20240924$PER$$CA-TOLMAR, INC.-23CA044506$TOLMAR$$$$$M$Y$$$20240924$$CN$CA$CA
232079054$23207905$4$F$20200526$20240731$20231121$20240807$EXP$$CA-CELLTRION INC.-2020CA022689$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
232079532$23207953$2$F$20230929$20240723$20231121$20240801$EXP$FR-AFSSAPS-PV2023001039$FR-ALXN-202310GLO000470FR$ALEXION PHARMACEUTICALS$$14$YR$$M$Y$37$KG$20240801$$MD$FR$FR
232080542$23208054$2$F$$20240805$20231121$20240806$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2023-140002$REGENERON$Ueji N, Mase Y, Kubo A, Matsubara H, Chujo S, Matsui Y, et al.. Intraocular Inflammation Secondary to Intravitreal Brolucizumab Injection for Neovascular Age-Related Macular Degeneration in a Patient with Cognitive Impairment.. Medicina.. 2023;59:10$79$YR$$M$Y$$$20240806$$HP$JP$JP
232080682$23208068$2$F$$20240913$20231121$20240921$EXP$$CA-CELLTRION INC.-2023CA022056$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
232081102$23208110$2$F$$20240703$20231121$20240711$EXP$$CA-CELLTRION INC.-2023CA022057$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
232081516$23208151$6$F$20220101$20240911$20231121$20240919$EXP$$CA-CELLTRION INC.-2021CA019058$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
232081983$23208198$3$F$$20240917$20231121$20240920$EXP$$US-SANDOZ INC.-NVSC2022US124436$SANDOZ$$$$$M$Y$65.76$KG$20240920$$CN$US$US
232083374$23208337$4$F$20231101$20240816$20231121$20240828$PER$$US-SA-2023SA354013$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240828$$MD$US$US
232083389$23208338$9$F$20201119$20240821$20231121$20240827$EXP$$CA-TAKEDA-2022TUS087561$TAKEDA$$54$YR$$M$Y$$$20240827$$CN$CA$CA
232083644$23208364$4$F$20230101$20240918$20231121$20240928$PER$$US-SA-2023SA356813$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240928$$MD$US$US
232084302$23208430$2$F$$20240718$20231121$20240724$EXP$$GR-AMGEN-GRCSP2023202987$AMGEN$$$$$F$Y$$$20240724$$MD$GR$GR
232085074$23208507$4$F$20211116$20240726$20231121$20240801$EXP$$IT-TAKEDA-2021TUS074962$TAKEDA$$19$YR$$M$Y$$$20240801$$CN$IT$IT
2320856113$23208561$13$F$20220623$20240913$20231121$20240921$EXP$$CA-CELLTRION INC.-2022CA008129$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
232085764$23208576$4$F$20220729$20240918$20231121$20240924$EXP$$BR-TAKEDA-2022TUS053520$TAKEDA$$28$YR$$M$Y$$$20240924$$CN$BR$BR
232086283$23208628$3$F$20230101$20240718$20231121$20240720$EXP$$IT-TAKEDA-2023TUS043214$TAKEDA$$$$$F$Y$$$20240720$$HP$IT$IT
232086652$23208665$2$F$$20240712$20231121$20240720$EXP$$US-GSK-US2023158367$GLAXOSMITHKLINE$$$$$$Y$$$20240720$$CN$US$US
232087823$23208782$3$F$$20240712$20231121$20240717$EXP$$CA-SANDOZ INC.-NVSC2020CA102854$SANDOZ$$76$YR$$F$Y$$$20240717$$CN$CA$CA
232088996$23208899$6$F$20231125$20240820$20231121$20240822$EXP$$CA-TAKEDA-2023TUS110635$TAKEDA$$37$YR$$F$Y$$$20240822$$CN$CA$CA
232090303$23209030$3$F$20230830$20240626$20231121$20240703$EXP$$JP-009507513-2311JPN001799J$MERCK$$36$YR$$F$Y$$$20240703$$MD$JP$JP
232098683$23209868$3$F$20231101$20240628$20231121$20240704$PER$$US-BIOGEN-2023BI01236588$BIOGEN$$51$YR$$F$Y$$$20240704$$CN$US$US
232098974$23209897$4$F$20230808$20240918$20231121$20240925$EXP$$CA-TAKEDA-2023TUS078085$TAKEDA$$64$YR$$F$Y$$$20240925$$CN$CA$CA
232099372$23209937$2$F$$20240918$20231121$20240920$EXP$$CA-TAKEDA-2023TUS024152$TAKEDA$$$$$F$Y$$$20240920$$CN$CA$CA
232100015$23210001$5$F$20210723$20240731$20231121$20240812$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-13779$ALKEM$$46$YR$$F$Y$$$20240812$$CN$DE$DE
232100292$23210029$2$F$20231116$20240716$20231121$20240718$PER$$US-AMGEN-USASP2023207068$AMGEN$$64$YR$A$F$Y$$$20240717$$CN$US$US
232100302$23210030$2$F$20240815$20240907$20231121$20240913$EXP$$CO-GSK-CO2023AMR158935$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$CO$CO
232100446$23210044$6$F$$20240821$20231121$20240823$EXP$$CA-TAKEDA-2022TUS097999$TAKEDA$$$$$M$Y$$$20240823$$HP$CA$CA
232100912$23210091$2$F$20231029$20231102$20231121$20240816$EXP$$AU-JNJFOC-20231104751$JOHNSON AND JOHNSON$$21$YR$A$M$Y$90$KG$20240816$$CN$AU$AU
232101596$23210159$6$F$$20240916$20231121$20240924$EXP$$US-ROCHE-3459715$ROCHE$$61$YR$A$M$Y$$$20240924$$CN$US$US
2321017110$23210171$10$F$$20240624$20231121$20240701$EXP$$CA-MYLANLABS-2023M1122381$MYLAN$$65$YR$$M$Y$$$20240701$$HP$CA$CA
232101767$23210176$7$F$$20240906$20231121$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004936$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
232102093$23210209$3$F$$20240923$20231121$20240925$PER$$US-ASTELLAS-2023US028940$ASTELLAS$$58$YR$A$F$Y$$$20240925$$MD$US$US
232102403$23210240$3$F$$20240403$20231121$20240712$EXP$$US-ASTELLAS-2023US033613$ASTELLAS$$6$DEC$$F$Y$$$20240712$$CN$US$US
232103232$23210323$2$F$20211207$20240821$20231121$20240902$EXP$DE-EMA-20231017-AUTODUP-1697570397296$DE-Accord-390651$ACCORD$$$$E$F$Y$88$KG$20240902$$HP$DE$DE
232103413$23210341$3$F$20230101$20240918$20231121$20240925$EXP$$US-ABBVIE-5496235$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
232103523$23210352$3$F$20230918$20240811$20231121$20240816$EXP$$CA-TAKEDA-2023TUS056485$TAKEDA$$43$YR$$F$Y$86.18$KG$20240816$$CN$CA$CA
232103646$23210364$6$F$20230101$20240716$20231121$20240723$30DAY$$US-PFIZER INC-202300361738$PFIZER$$7$YR$$M$Y$31.6$KG$20240723$$CN$US$US
232103955$23210395$5$F$20240401$20240705$20231121$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-008525$JAZZ$$74$YR$$M$Y$$$20240710$$CN$US$US
2321040014$23210400$14$F$$20240923$20231121$20240930$EXP$$US-GSK-US2023AMR159323$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
232104345$23210434$5$F$20221013$20240816$20231121$20240821$EXP$$TW-TAKEDA-2022TUS073736$TAKEDA$$8$YR$$M$Y$$$20240821$$CN$TW$TW
232104843$23210484$3$F$20171025$20240918$20231121$20240923$EXP$$CA-TAKEDA-2018TUS004028$TAKEDA$$37$YR$$F$Y$$$20240923$$CN$CA$CA
232104854$23210485$4$F$20230926$20240807$20231121$20240814$EXP$$BR-CELLTRION INC.-2023BR001731$CELLTRION$$$$$$Y$$$20240814$$CN$BR$BR
2321052517$23210525$17$F$20231011$20240704$20231121$20240710$EXP$$AT-ABBVIE-5493273$ABBVIE$$73$YR$$F$Y$76$KG$20240710$$MD$AT$AT
232106022$23210602$2$F$$20231114$20231121$20240718$EXP$$US-Taiho Oncology Inc-2023-009093$TAIHO ONCOLOGY INC$$47$YR$A$M$Y$$$20240718$$CN$US$US
232106722$23210672$2$F$$20240918$20231121$20240926$EXP$$NVSC2023US246521$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
232106755$23210675$5$F$$20240803$20231121$20240807$EXP$$CA-SANDOZ INC.-NVSC2022CA240347$SANDOZ$$67$YR$$F$Y$34$KG$20240807$$HP$CA$CA
2321068516$23210685$16$F$20231026$20240903$20231121$20240911$EXP$$CO-TAKEDA-2023TUS105470$TAKEDA$$52$YR$$F$Y$61$KG$20240911$$CN$CO$CO
232107192$23210719$2$F$20231101$20240829$20231121$20240902$EXP$$US-PFIZER INC-202300370191$PFIZER$$69$YR$$F$Y$$$20240902$$CN$US$US
232108123$23210812$3$F$$20240729$20231121$20240808$EXP$$GR-ROCHE-3457542$ROCHE$$$$$F$Y$$$20240808$$MD$GR$GR
232108304$23210830$4$F$$20240923$20231121$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-167393$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240925$$CN$US$US
232108492$23210849$2$F$$20240923$20231121$20240930$EXP$$CA-TAKEDA-2023TUS111597$TAKEDA$$$$$M$Y$$$20240930$$MD$CA$CA
232108796$23210879$6$F$20230922$20240801$20231121$20240805$EXP$$DE-TAKEDA-2023TUS111867$TAKEDA$$69$YR$$M$Y$$$20240805$$HP$DE$DE
232109382$23210938$2$F$20231101$20240719$20231121$20240725$EXP$$CA-JNJFOC-20230870404$JOHNSON AND JOHNSON$$13$YR$T$F$Y$42$KG$20240725$$HP$CA$CA
232110822$23211082$2$F$20231101$20240912$20231121$20240923$PER$$US-SA-2023SA356766$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240923$$MD$US$US
232110882$23211088$2$F$20230101$20240730$20231121$20240807$PER$$US-SA-2023SA354284$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240807$$MD$US$US
232111223$23211122$3$F$20230920$20240724$20231121$20240802$PER$$US-SA-2023SA354208$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240802$$MD$US$US
232111244$23211124$4$F$20231104$20240730$20231121$20240809$PER$$US-SA-2023SA354803$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240809$$MD$US$US
232112393$23211239$3$F$$20240627$20231121$20240706$PER$$US-SA-2023SA360530$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240706$$HP$US$US
2321125110$23211251$10$F$20220101$20240725$20231121$20240801$EXP$$US-SA-2023SA358436$SANOFI AVENTIS$$47$YR$A$F$Y$58.9$KG$20240801$$MD$US$US
232112846$23211284$6$F$20240717$20240718$20231121$20240802$PER$$US-SA-2023SA360644$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240802$$MD$US$US
232112892$23211289$2$F$20231101$20240813$20231121$20240826$PER$$US-SA-2023SA360682$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240826$$CN$US$US
2321131815$23211318$15$F$$20240708$20231121$20240716$EXP$$US-VERTEX PHARMACEUTICALS-2023-017451$VERTEX$$36$YR$$M$Y$77$KG$20240716$$CN$US$US
232113436$23211343$6$F$20231114$20240813$20231121$20240816$EXP$$US-PFIZER INC-202300372565$PFIZER$$37$YR$$F$Y$117.93$KG$20240816$$CN$US$US
232113472$23211347$2$F$$20240627$20231121$20240702$EXP$$CA-PFIZER INC-202300373250$PFIZER$$83$YR$$F$Y$87$KG$20240702$$PH$CA$CA
232113657$23211365$7$F$20231027$20240618$20231121$20240701$EXP$$US-SA-2023SA361411$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240701$$MD$US$US
232113884$23211388$4$F$20230801$20240730$20231121$20240802$EXP$$CA-TAKEDA-2023TUS111181$TAKEDA$$56$YR$$F$Y$$$20240802$$CN$CA$CA
232114355$23211435$5$F$20230313$20240703$20231121$20240710$EXP$$US-TAKEDA-2023TUS021626$TAKEDA$$43$YR$$F$Y$66$KG$20240710$$CN$US$US
232114542$23211454$2$F$$20240809$20231121$20240813$EXP$$HR-PFIZER INC-202300367659$PFIZER$Rogoznica, M.. Reversible oligospermia in a patient with non-radiographic axial  spondylarthritis during treatment with salazopyrin - case presentation. Reumatizam. 2023;Vol. 70 Sup. 1$$$A$M$Y$$$20240813$$MD$HR$HR
232116193$23211619$3$F$20221101$20240809$20231121$20240816$EXP$$CA-SANDOZ INC.-PHHY2018CA061363$SANDOZ$$47$YR$$F$Y$$$20240816$$CN$CA$CA
232128202$23212820$2$F$20230101$20240828$20231121$20240902$PER$$US-009507513-2310USA012381$MERCK$$$$$M$Y$$$20240902$$CN$US$US
232128292$23212829$2$F$20220601$20240824$20231121$20240828$EXP$$CA-PFIZER INC-202201114671$PFIZER$$38$YR$$F$Y$$$20240828$$CN$CA$CA
232128403$23212840$3$F$$20240820$20231121$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-166949$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240829$$CN$US$US
232128862$23212886$2$F$20231116$20240709$20231121$20240712$EXP$$US-KYOWAKIRIN-2023KK018510$KYOWA$$$$$$Y$$$20240712$$PH$US$US
232128924$23212892$4$F$$20240909$20231121$20240910$PER$$NVSC2023US246097$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
232128977$23212897$7$F$20230627$20240724$20231121$20240729$EXP$$CO-TAKEDA-2023TUS070095$TAKEDA$$39$YR$$M$Y$69$KG$20240729$$CN$CO$CO
232129472$23212947$2$F$20231116$20240828$20231121$20240830$EXP$$US-PFIZER INC-PV202300189612$PFIZER$$57$YR$$F$Y$$$20240830$$HP$US$US
232129732$23212973$2$F$$20240805$20231121$20240808$EXP$$US-TAKEDA-2021TUS004982$TAKEDA$$$$$M$Y$28$KG$20240808$$CN$US$US
232129742$23212974$2$F$20240101$20240627$20231121$20240702$EXP$$US-SA-2023SA339500$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240702$$MD$US$US
232131133$23213113$3$F$20230101$20240722$20231121$20240805$EXP$$CH-SA-2023SA327372$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240805$$HP$CH$CH
232131465$23213146$5$F$20230225$20240822$20231121$20240827$EXP$$CO-TAKEDA-2023TUS021607$TAKEDA$$46$YR$$F$Y$79$KG$20240827$$CN$CO$CO
232131507$23213150$7$F$20230801$20240804$20231121$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-418401$RANBAXY$$73$YR$E$F$Y$67$KG$20240816$$MD$CN$CN
232133186$23213318$6$F$20221101$20240812$20231121$20240820$EXP$$US-SA-2023SA356653$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240820$$MD$US$US
232133276$23213327$6$F$20240301$20240813$20231121$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-167003$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240816$$CN$US$US
232133735$23213373$5$F$20220328$20240820$20231121$20240823$EXP$$FR-AMGEN-FRASP2023205088$AMGEN$$50$YR$A$F$Y$$$20240823$$HP$FR$FR
232133892$23213389$2$F$$20240816$20231121$20240823$PER$$US-INCYTE CORPORATION-2023IN011144$INCYTE$$$$$$Y$$$20240823$$CN$US$US
232135054$23213505$4$F$20231122$20240920$20231121$20240930$EXP$$CA-TAKEDA-2023TUS111662$TAKEDA$$22$YR$$M$Y$$$20240930$$CN$CA$CA
232135603$23213560$3$F$20230101$20240809$20231121$20240813$EXP$$CA-JNJFOC-20231136558$JOHNSON AND JOHNSON$$9$YR$C$F$Y$23$KG$20240813$$HP$CA$CA
2321359312$23213593$12$F$$20240802$20231121$20240809$EXP$$CA-TAKEDA-2023TUS111838$TAKEDA$$$$$M$Y$$$20240809$$MD$CA$CA
232136002$23213600$2$F$$20240807$20231121$20240813$EXP$$NVSC2022GB048271$NOVARTIS$$$$E$F$Y$$$20240813$$CN$GB$GB
232136072$23213607$2$F$20210408$20240828$20231121$20240904$EXP$$BR-TAKEDA-2021TUS024314$TAKEDA$$37$YR$$M$Y$$$20240904$$CN$BR$BR
232137082$23213708$2$F$20231110$20240105$20231121$20240701$EXP$$BR-AstraZeneca-2023A259944$ASTRAZENECA$$3501$WK$$F$Y$$$20240701$$CN$BR$
232137852$23213785$2$F$$20240805$20231121$20240813$EXP$$US-STRIDES ARCOLAB LIMITED-2023SP017185$STRIDES$Guntaka S, Barron C, Baer T, Cohen L, Regelmann M. Dexamethasone swish and spit, a cause of iatrogenic adrenal insufficiency. Hormone Research in Paediatrics. 2023;96 (Suppl. 3):13-14 abstr. 6242.$$$$$Y$$$20240813$$MD$US$US
232139882$23213988$2$F$$20240826$20231121$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-167824$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240828$$CN$US$US
232140753$23214075$3$F$20230727$20240709$20231121$20240717$EXP$$JP-009507513-2311JPN002255J$MERCK$$37$YR$$F$Y$$$20240717$$MD$JP$JP
232141223$23214122$3$F$$20240701$20231121$20240705$EXP$$US-JNJFOC-20231141574$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
232142683$23214268$3$F$20220215$20240904$20231121$20240909$EXP$$JP-Eisai-EC-2022-120057$EISAI$$71$YR$E$F$Y$58$KG$20240909$$MD$JP$JP
232143972$23214397$2$F$$20240923$20231121$20240924$PER$$US-PFIZER INC-202300319808$PFIZER$$64$YR$$F$Y$$$20240924$$CN$US$US
232144092$23214409$2$F$$20240715$20231121$20240718$EXP$$PL-BAUSCH-BL-2023-017285$BAUSCH AND LOMB$$27$YR$$F$Y$$$20240718$$CN$PL$PL
232144133$23214413$3$F$$20240716$20231121$20240722$EXP$$JP-009507513-2311JPN002265J$MERCK$$53$YR$$F$Y$$$20240722$$MD$JP$JP
232144493$23214449$3$F$20210902$20240909$20231121$20240923$EXP$$AT-GE HEALTHCARE-2023CSU010329$GE HEALTHCARE$$33$YR$$F$Y$70$KG$20240923$$HP$AT$AT
232144642$23214464$2$F$$20240816$20231121$20240823$PER$$US-INCYTE CORPORATION-2023IN011145$INCYTE$$$$$$Y$$$20240823$$CN$US$US
232145022$23214502$2$F$$20240816$20231121$20240823$PER$$US-INCYTE CORPORATION-2023IN011304$INCYTE$$$$$$Y$$$20240823$$CN$US$US
232145084$23214508$4$F$20230101$20240910$20231121$20240919$PER$$US-INCYTE CORPORATION-2023IN011983$INCYTE$$$$$$Y$$$20240919$$CN$US$US
232145156$23214515$6$F$$20240129$20231121$20240715$EXP$$DE-INCYTE CORPORATION-2023IN012103$INCYTE$$$$$$Y$$$20240715$$MD$DE$DE
232146482$23214648$2$F$20230801$20240723$20231121$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202311010808$ELI LILLY AND CO$$56$YR$A$M$Y$121$KG$20240802$$CN$US$US
232147043$23214704$3$F$$20240831$20231121$20240905$EXP$$GB-AMGEN-GBRSP2023207515$AMGEN$$67$YR$E$F$Y$$$20240905$$CN$GB$GB
232148492$23214849$2$F$20230101$20240710$20231121$20240801$PER$$US-SA-2023SA357581$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240719$$MD$US$US
232149789$23214978$9$F$20240401$20240918$20231122$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-167701$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240926$$CN$US$US
232150692$23215069$2$F$20240715$20240813$20231122$20240815$EXP$$US-ABBVIE-5498094$ABBVIE$$64$YR$$M$Y$$$20240815$$CN$US$US
232151315$23215131$5$F$20230101$20240618$20231122$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004803$ACADIA PHARMACEUTICALS$$29$YR$$F$Y$$$20240712$$CN$US$US
232152313$23215231$3$F$20231115$20240701$20231122$20240703$EXP$$JP-TAKEDA-2023TJP015484$TAKEDA$$8$DEC$$M$Y$$$20240703$$MD$JP$JP
232152334$23215233$4$F$20231119$20240719$20231122$20240724$PER$$US-AMGEN-USASP2023207992$AMGEN$$48$YR$A$M$Y$68.934$KG$20240724$$CN$US$US
232152358$23215235$8$F$20211210$20240813$20231122$20240820$EXP$$CA-CELLTRION INC.-2021CA018538$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
232153243$23215324$3$F$20220509$20240808$20231122$20240810$EXP$$GB-ROCHE-3094389$ROCHE$$24$YR$A$F$Y$$$20240810$$HP$GB$GB
232153774$23215377$4$F$$20240801$20231122$20240803$EXP$$US-TAKEDA-2017BLT002153$TAKEDA$$$$$F$Y$$$20240803$$HP$US$US
232154094$23215409$4$F$$20240909$20231122$20240913$EXP$$CA-SANDOZ INC.-SDZ2023CA055173$SANDOZ$$82$YR$$F$Y$83$KG$20240913$$MD$CA$CA
232154932$23215493$2$F$$20240724$20231122$20240725$EXP$$CA-SANDOZ INC.-SDZ2023CA057166$SANDOZ$$65$YR$$F$Y$78$KG$20240725$$CN$CA$CA
232155586$23215558$6$F$$20240913$20231122$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-165436$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240917$$CN$US$US
232156024$23215602$4$F$20240201$20240910$20231122$20240916$EXP$$US-AMGEN-USASP2023207095$AMGEN$$54$YR$A$F$Y$$$20240916$$HP$US$US
232156582$23215658$2$F$$20240712$20231122$20240716$EXP$$US-ABBVIE-5503101$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
232156665$23215666$5$F$20230604$20240705$20231122$20240715$EXP$$NL-CELLTRION INC.-2023NL022270$CELLTRION$$$$$$Y$$$20240715$$MD$NL$NL
232157052$23215705$2$F$$20240806$20231122$20240812$PER$$US-BIOGEN-2023BI01233006$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
232157462$23215746$2$F$20231102$20240705$20231122$20240715$EXP$GB-MHRA-MED-202311090941560550-VZJNW$GB-JUBILANT CADISTA PHARMACEUTICALS-2023GB001426$JUBILANT$$$$A$M$Y$$$20240715$$MD$GB$GB
232158185$23215818$5$F$20240601$20240628$20231122$20240707$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-166359$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$86.18$KG$20240708$$CN$US$US
232158396$23215839$6$F$20230101$20240712$20231122$20240723$PER$$US-SA-2023SA362225$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240723$$MD$US$US
232159142$23215914$2$F$20230101$20240722$20231122$20240731$PER$$US-SA-2023SA361948$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240731$$MD$US$US
232159813$23215981$3$F$$20240815$20231122$20240826$EXP$$US-ROCHE-3440057$ROCHE$$$$E$F$Y$$$20240826$$CN$US$US
232159873$23215987$3$F$$20240819$20231122$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-161637$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240826$$CN$US$US
232159955$23215995$5$F$20221227$20240826$20231122$20240829$PER$$US-ROCHE-3432768$ROCHE$$16$YR$T$F$Y$48.3$KG$20240829$$MD$US$US
232160144$23216014$4$F$20230101$20240726$20231122$20240806$PER$$US-SA-2023SA355562$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240806$$MD$US$US
232162794$23216279$4$F$20230728$20240711$20231122$20240717$EXP$$US-TAKEDA-2023TUS112569$TAKEDA$$37$YR$$M$Y$132$KG$20240717$$MD$US$US
232163662$23216366$2$F$$20240729$20231122$20240809$PER$$US-SA-2023SA360088$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
232164743$23216474$3$F$$20231031$20231122$20240916$EXP$$AU-SANDOZ INC.-SDZ2023AU056359$SANDOZ$$72$YR$$F$Y$$$20240916$$HP$AU$AU
232167346$23216734$6$F$20230309$20240917$20231122$20240924$EXP$$CA-TAKEDA-2020TUS025794$TAKEDA$$41$YR$$F$Y$$$20240924$$HP$CA$CA
232167772$23216777$2$F$20231118$20240727$20231122$20240730$PER$$US-AMGEN-USASP2023208795$AMGEN$$81$YR$E$M$Y$$$20240730$$CN$US$US
232168992$23216899$2$F$20230101$20240731$20231122$20240808$PER$$US-SA-2023SA301084$SANOFI AVENTIS$$$$E$F$Y$$$20240808$$MD$US$US
232169782$23216978$2$F$20231101$20240806$20231122$20240813$EXP$$US-ABBVIE-5503301$ABBVIE$$73$YR$$M$Y$$$20240813$$CN$US$US
232170916$23217091$6$F$$20240821$20231122$20240822$EXP$$CA-SANDOZ INC.-NVSC2020CA169641$SANDOZ$$72$YR$$F$Y$61$KG$20240822$$HP$CA$CA
232170995$23217099$5$F$$20240705$20231122$20240716$PER$$US-SA-2023SA361735$SANOFI AVENTIS$$29$YR$A$M$Y$106.5$KG$20240716$$MD$US$US
232171043$23217104$3$F$$20240626$20231122$20240703$EXP$$CA-TAKEDA-2023TUS111648$TAKEDA$$$$$F$Y$$$20240703$$MD$CA$CA
232171726$23217172$6$F$$20240614$20231122$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004961$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
232171745$23217174$5$F$$20240913$20231122$20240920$EXP$$AT-TAKEDA-2023TUS113179$TAKEDA$$$$$F$Y$$$20240920$$CN$AT$AT
232172493$23217249$3$F$20220101$20240903$20231122$20240911$EXP$$CA-TAKEDA-2023TUS011284$TAKEDA$$$$$F$Y$72$KG$20240911$$CN$CA$CA
232172693$23217269$3$F$$20240816$20231122$20240820$EXP$$US-TAKEDA-2023TUS083514$TAKEDA$$$$$M$Y$166$KG$20240820$$HP$US$US
232173276$23217327$6$F$20230101$20240717$20231122$20240726$PER$$US-SA-2023SA362352$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240726$$MD$US$US
232173615$23217361$5$F$20230615$20240626$20231122$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004948$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240719$$CN$US$US
232173703$23217370$3$F$$20231207$20231122$20240910$EXP$$JP-SA-2023SA358135$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240911$$HP$JP$JP
232173814$23217381$4$F$20231112$20240626$20231122$20240701$EXP$$CA-PFIZER INC-202300271873$PFIZER$$20$YR$$F$Y$$$20240701$$HP$CA$CA
232174284$23217428$4$F$20231121$20240624$20231122$20240702$EXP$$CA-TAKEDA-2023TUS070289$TAKEDA$$79$YR$$M$Y$$$20240702$$CN$CA$CA
232174443$23217444$3$F$20231115$20240710$20231122$20240722$EXP$$JP-009507513-2311JPN002269J$MERCK$$70$YR$$M$Y$$$20240719$$MD$JP$JP
232174454$23217445$4$F$$20240723$20231122$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-167352$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240725$$CN$US$US
232174672$23217467$2$F$20230514$20240830$20231122$20240906$EXP$$US-SA-2023SA360441$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240906$$CN$US$US
232174683$23217468$3$F$20230101$20240814$20231122$20240827$PER$$US-SA-2023SA358705$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240827$$MD$US$US
232174874$23217487$4$F$20231018$20240709$20231122$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-159990$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240712$$MD$JP$JP
232175964$23217596$4$F$20240101$20240808$20231122$20240814$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-000491$JAZZ$$$$$F$Y$$$20240814$$CN$US$US
232176044$23217604$4$F$20220101$20240625$20231122$20240701$EXP$$CA-PFIZER INC-202201138028$PFIZER$$72$YR$$F$Y$101$KG$20240701$$MD$CA$CA
232176493$23217649$3$F$$20240716$20231122$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-167830$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240722$$MD$JP$JP
232176877$23217687$7$F$$20240703$20231122$20240708$EXP$$CA-TAKEDA-2023TUS113154$TAKEDA$$$$$M$Y$$$20240708$$CN$CA$CA
232177657$23217765$7$F$$20240905$20231122$20240905$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-215553$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240905$$CN$US$US
232177972$23217797$2$F$$20240819$20231122$20240828$PER$$US-SA-2023SA276169$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240828$$MD$US$US
232178454$23217845$4$F$20230901$20240808$20231122$20240809$EXP$$US-PFIZER INC-PV202300170977$PFIZER$$27$YR$$M$Y$$$20240809$$HP$US$US
232180743$23218074$3$F$20231023$20240620$20231122$20240718$30DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134061$REGENERON$$$$$M$Y$$$20240718$$HP$US$US
232181124$23218112$4$F$20231118$20240918$20231122$20240926$EXP$$NVSC2023US248800$NOVARTIS$$37$YR$$M$Y$$$20240926$$CN$US$US
232181844$23218184$4$F$$20240821$20231122$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-10304$LUPIN$$$$$$Y$$$20240909$$PH$US$US
232183602$23218360$2$F$20230607$20240728$20231122$20240807$EXP$$IN-SANDOZ INC.-NVSC2023IN146061$SANDOZ$$33$YR$$F$Y$$$20240807$$CN$IN$IN
232184524$23218452$4$F$$20240821$20231122$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-167818$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240828$$CN$US$US
232185178$23218517$8$F$20230101$20240708$20231122$20240718$EXP$$JP-Eisai-EC-2023-153032$EISAI$$62$YR$A$M$Y$$$20240718$$MD$JP$JP
232185574$23218557$4$F$20231101$20240903$20231122$20240927$PER$$US-SA-2023SA362309$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240927$$CN$US$US
232185783$23218578$3$F$$20240815$20231122$20240821$EXP$$JP-Eisai-EC-2023-148012$EISAI$Muto Y, Okamoto T, Ogawa Y, Mitsui H, Shimada S, Kawamura T. A case of right frontal sinus-cutaneous fistula. Journal of the Japanese Dermatological Association. 2023;133 (11): 2616-2616.$71$YR$E$F$Y$$$20240821$$MD$JP$JP
232185813$23218581$3$F$20230101$20240828$20231122$20240904$EXP$$US-ALXN-A202312851AA$ALEXION PHARMACEUTICALS$$58$YR$$M$Y$$$20240904$$CN$US$US
232186295$23218629$5$F$$20240806$20231122$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-168665$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$49.9$KG$20240812$$CN$US$US
232186355$23218635$5$F$20231017$20240808$20231122$20240816$EXP$$CA-JNJFOC-20231149116$JOHNSON AND JOHNSON$$61$YR$A$F$Y$52$KG$20240816$$CN$CA$CA
232186558$23218655$8$F$$20240911$20231122$20240918$EXP$$CA-TAKEDA-2023TUS111626$TAKEDA$$$$$M$Y$$$20240918$$CN$CA$CA
232188046$23218804$6$F$20231101$20240805$20231122$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-166059$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240826$$CN$US$US
232188734$23218873$4$F$$20240822$20231122$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-165296$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240826$$HP$US$US
232188982$23218898$2$F$$20240912$20231122$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419008$RANBAXY$Sawada K, Momose S, Iijima Y, Takahashi T, Kaneko T, Yamamoto W, et al. EBV-positive mucocutaneous ulcer arising in methotrexatetreated rheumatoid arthritis patients: a clinicopathological study of 12 cases with analysis of PD-L1 expression. J Clin Exp Hematopathol. 2023;63(2):90-98$54$YR$$F$Y$$$20240927$$$JP$JP
232189135$23218913$5$F$20231106$20240804$20231122$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-418808$RANBAXY$$57$YR$A$M$Y$60$KG$20240816$$MD$CN$CN
232189192$23218919$2$F$$20240912$20231122$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419009$RANBAXY$Sawada K, Momose S, Iijima Y, Takahashi T, Kaneko T, Yamamoto W, et al. EBV-positive mucocutaneous ulcer arising in methotrexatetreated rheumatoid arthritis patients: a clinicopathological study of 12 cases with analysis of PD-L1 expression. J Clin Exp Hematopathol. 2023;63(2):90-98$73$YR$$M$Y$$$20240927$$HP$JP$JP
232189232$23218923$2$F$$20240912$20231122$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419005$RANBAXY$Sawada K, Momose S, Iijima Y, Takahashi T, Kaneko T, Yamamoto W, et al. EBV-positive mucocutaneous ulcer arising in methotrexatetreated rheumatoid arthritis patients: a clinicopathological study of 12 cases with analysis of PD-L1 expression. J Clin Exp Hematopathol. 2023;63(2):90-98$77$YR$$F$Y$$$20240927$$HP$JP$JP
232189242$23218924$2$F$$20240912$20231122$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419001$RANBAXY$Sawada K, Momose S, Iijima Y, Takahashi T, Kaneko T, Yamamoto W, et al. EBV-positive mucocutaneous ulcer arising in methotrexatetreated rheumatoid arthritis patients: a clinicopathological study of 12 cases with analysis of PD-L1 expression. J Clin Exp Hematopathol. 2023;63(2):90-98$80$YR$$M$Y$$$20240927$$HP$JP$JP
232189252$23218925$2$F$$20240912$20231122$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419006$RANBAXY$Sawada K, Momose S, Iijima Y, Takahashi T, Kaneko T, Yamamoto W, et al. EBV-positive mucocutaneous ulcer arising in methotrexatetreated rheumatoid arthritis patients: a clinicopathological study of 12 cases with analysis of PD-L1 expression. J Clin Exp Hematopathol. 2023;63(2):90-98$83$YR$$F$Y$$$20240927$$HP$JP$JP
232189262$23218926$2$F$$20240912$20231122$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419002$RANBAXY$Sawada K, Momose S, Iijima Y, Takahashi T, Kaneko T, Yamamoto W, et al. EBV-positive mucocutaneous ulcer arising in methotrexatetreated rheumatoid arthritis patients: a clinicopathological study of 12 cases with analysis of PD-L1 expression. J Clin Exp Hematopathol. 2023;63(2):90-98$82$YR$$F$Y$$$20240927$$HP$JP$JP
232189272$23218927$2$F$$20240912$20231122$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419010$RANBAXY$Sawada K, Momose S, Iijima Y, Takahashi T, Kaneko T, Yamamoto W, et al. EBV-positive mucocutaneous ulcer arising in methotrexatetreated rheumatoid arthritis patients: a clinicopathological study of 12 cases with analysis of PD-L1 expression. J Clin Exp Hematopathol. 2023;63(2):90-98$80$YR$$M$Y$$$20240927$$HP$JP$JP
232189512$23218951$2$F$$20240820$20231122$20240904$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417103$RANBAXY$Bhardwaj P, Chouhan O, Gehlot A, Rathore RK, Swami NK, Kumar J. Toxic Manifestations of Phenytoin Overdose in a Paediatric Head Injury Patient. Indian J Pharmacol. 2021;53(Suppl.1) 7:S554$$$C$$Y$$$20240904$$HP$IN$IN
232193073$23219307$3$F$20230101$20240819$20231122$20240823$EXP$$CA-BAUSCH-BL-2023-009965$BAUSCH AND LOMB$$49$YR$$M$Y$$$20240823$$CN$CA$CA
2321933812$23219338$12$F$20231111$20240906$20231122$20240909$EXP$$NVSC2023CL241054$NOVARTIS$$34$YR$$F$Y$$$20240909$$CN$CL$CL
232193496$23219349$6$F$20231109$20240813$20231122$20240814$EXP$$US-BAYER-2023A163740$BAYER$$52$YR$A$M$Y$$$20240814$$CN$US$US
232194135$23219413$5$F$20231020$20240617$20231122$20240731$PER$$US-TRAVERE-2023TVT00718$TRAVERE THERAPEUTICS$$80$YR$E$F$Y$$$20240731$$CN$US$US
232194684$23219468$4$F$20230412$20240912$20231122$20240918$EXP$$JP-Eisai-EC-2023-152932$EISAI$Iwai K. P-039 Experiences with Lenvatinib + Pembrolizumab Therapy for Endometrial Cancer. Japanese Journal of Gynecologic Oncology. 2024;(42(3)): 364.$51$YR$A$F$Y$$$20240918$$MD$JP$JP
232194704$23219470$4$F$20231023$20240903$20231122$20240911$EXP$$JP-Eisai-EC-2023-153038$EISAI$$62$YR$A$F$Y$55$KG$20240911$$MD$JP$JP
232195036$23219503$6$F$20231102$20240730$20231122$20240801$PER$$JP-Eisai-EC-2023-153037$EISAI$$57$YR$A$F$Y$76$KG$20240801$$MD$JP$JP
232195042$23219504$2$F$$20240710$20231122$20240718$PER$$JP-Eisai-EC-2023-153027$EISAI$$63$YR$A$M$Y$$$20240718$$MD$JP$JP
232195068$23219506$8$F$20230501$20240702$20231122$20240704$EXP$$CA-PFIZER INC-202300130388$PFIZER$$70$YR$$F$Y$$$20240704$$MD$CA$CA
232195292$23219529$2$F$$20240710$20231122$20240722$PER$$JP-Eisai-EC-2023-153031$EISAI$$58$YR$A$M$Y$$$20240719$$MD$JP$JP
2321953012$23219530$12$F$20230101$20240909$20231122$20240918$EXP$$JP-Eisai-EC-2023-152942$EISAI$$75$YR$E$F$Y$$$20240918$$MD$JP$JP
232195344$23219534$4$F$20220318$20240708$20231122$20240712$EXP$$DE-009507513-2311DEU007644$MERCK$$53$YR$$M$Y$115$KG$20240712$$MD$DE$DE
232196433$23219643$3$F$20230901$20240513$20231122$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00127$AVADEL CNS PHARMA$$54$YR$$F$Y$136.05$KG$20240822$$CN$US$US
232196656$23219665$6$F$20230101$20240903$20231122$20240918$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00185$AVADEL CNS PHARMA$$$$$F$Y$$$20240918$$CN$US$US
232196663$23219666$3$F$20230101$20240726$20231122$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00205$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$CN$US$US
232196762$23219676$2$F$20220101$20240710$20231122$20240718$PER$$JP-Eisai-EC-2023-133106$EISAI$$57$YR$A$F$Y$$$20240718$$MD$JP$JP
232196802$23219680$2$F$$20231116$20231122$20240718$EXP$$US-Taiho Oncology Inc-2023-010062$TAIHO ONCOLOGY INC$$$$A$F$Y$$$20240718$$CN$US$US
232197383$23219738$3$F$20200101$20240923$20231122$20240927$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2023-140015$REGENERON$De Lima SG, Hyrcza MD, Monzon JG. Treatment of Unresectable Cutaneous Squamous Cell Carcinoma with Cemiplimab in a Patient on Dialysis. Case Rep Oncol. 2023;16:143-8$70$YR$$M$Y$$$20240927$$HP$CA$CA
232197453$23219745$3$F$20230801$20240627$20231122$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00097$AVADEL CNS PHARMA$$41$YR$$F$Y$55.329$KG$20240822$$CN$US$US
232197534$23219753$4$F$20230801$20240501$20231122$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00086$AVADEL CNS PHARMA$$24$YR$$F$Y$48.481$KG$20240822$$CN$US$US
232197614$23219761$4$F$20230801$20240620$20231122$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00066$AVADEL CNS PHARMA$$29$YR$$F$Y$53.061$KG$20240822$$CN$US$US
232197652$23219765$2$F$20230101$20240530$20231122$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00062$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
232197734$23219773$4$F$20230801$20240513$20231122$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00065$AVADEL CNS PHARMA$$24$YR$$F$Y$88.435$KG$20240822$$CN$US$US
232198233$23219823$3$F$20230801$20240719$20231122$20240801$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00113$AVADEL CNS PHARMA$$26$YR$$M$Y$88.481$KG$20240801$$CN$US$US
232198262$23219826$2$F$20230101$20240619$20231122$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00092$AVADEL CNS PHARMA$$$$$F$Y$59.41$KG$20240822$$CN$US$US
232198272$23219827$2$F$20230801$20240711$20231122$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00106$AVADEL CNS PHARMA$$43$YR$$F$Y$$$20240822$$CN$US$US
232198313$23219831$3$F$20230801$20240530$20231122$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00084$AVADEL CNS PHARMA$$22$YR$$M$Y$$$20240822$$CN$US$US
232198533$23219853$3$F$20230901$20240528$20231122$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00146$AVADEL CNS PHARMA$$20$YR$$M$Y$46.259$KG$20240822$$CN$US$US
232198642$23219864$2$F$20230908$20240515$20231122$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00166$AVADEL CNS PHARMA$$35$YR$$F$Y$$$20240822$$CN$US$US
232198652$23219865$2$F$20230909$20240517$20231122$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00168$AVADEL CNS PHARMA$$38$YR$$F$Y$$$20240822$$CN$US$US
232199243$23219924$3$F$20230101$20240702$20231122$20240705$EXP$$CA-JNJFOC-20231139860$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240705$$PH$CA$CA
232199478$23219947$8$F$20211202$20240820$20231122$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-003517$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$60.3$KG$20240826$$MD$JP$JP
232201403$23220140$3$F$$20240805$20231123$20240814$EXP$$JP-009507513-2311JPN002124J$MERCK$$50$YR$$$Y$$$20240814$$MD$JP$JP
232202093$23220209$3$F$20231228$20240808$20231123$20240812$EXP$$US-AMGEN-USASP2023206961$AMGEN$$59$YR$A$F$Y$$$20240812$$HP$US$US
232202623$23220262$3$F$$20231120$20231123$20240909$PER$$NVSC2023US248807$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
232202673$23220267$3$F$$20240805$20231123$20240815$EXP$$JP-009507513-2311JPN002119J$MERCK$$67$YR$$$Y$$$20240815$$MD$JP$JP
232203213$23220321$3$F$20231101$20231211$20231123$20240926$PER$$US-GSK-US2023AMR157988$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240926$$CN$US$US
232204237$23220423$7$F$20231201$20240916$20231123$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-169450$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240917$$CN$US$US
232204382$23220438$2$F$$20240625$20231123$20240702$PER$$US-BIOGEN-2023BI01233732$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
232204614$23220461$4$F$20231105$20240715$20231123$20240722$EXP$$US-GSK-US2023156865$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$HP$US$US
232204652$23220465$2$F$$20240626$20231123$20240705$PER$$US-SA-2023SA358540$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240705$$MD$US$US
232204902$23220490$2$F$$20240701$20231123$20240708$EXP$$US-ALXN-A202309405AA$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
232205192$23220519$2$F$20231012$20240513$20231123$20240702$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023AMR158547$VIIV$$35$YR$$M$Y$$$20240702$$HP$US$US
232205503$23220550$3$F$20231027$20240811$20231123$20240820$PER$$US-SA-2023SA359567$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240820$$MD$US$US
232205883$23220588$3$F$$20240916$20231123$20240923$PER$$US-SA-2023SA358879$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240923$$MD$US$US
2322062016$23220620$16$F$20220624$20240906$20231123$20240912$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-215560$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$82.5$KG$20240912$$CN$US$US
232206512$23220651$2$F$20230228$20240902$20231123$20240903$EXP$$DE-SANDOZ INC.-NVSC2023DE098013$SANDOZ$$75$YR$$M$Y$77$KG$20240903$$MD$DE$DE
232206946$23220694$6$F$20231101$20240705$20231123$20240717$EXP$$NL-ABBVIE-5506662$ABBVIE$$76$YR$$M$Y$$$20240717$$HP$NL$NL
232207005$23220700$5$F$20231030$20240619$20231123$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004728$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240712$$CN$US$US
2322082411$23220824$11$F$20230920$20240809$20231123$20240817$EXP$$CA-CELLTRION INC.-2023CA016605$CELLTRION$$$$$$Y$$$20240817$$MD$CA$CA
232208332$23220833$2$F$20231115$20240709$20231123$20240716$EXP$$CO-GSK-CO2023AMR161439$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$CO$CO
232208422$23220842$2$F$20210520$20240905$20231123$20240914$EXP$$CA-CELLTRION INC.-2021CA013321$CELLTRION$$$$$$Y$$$20240914$$MD$CA$CA
232208512$23220851$2$F$20240101$20240731$20231123$20240808$PER$$US-SA-2023SA359812$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240808$$MD$US$US
232208603$23220860$3$F$$20240919$20231123$20240927$PER$$US-GSK-US2023157084$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
232209222$23220922$2$F$$20240828$20231123$20240903$PER$$US-SA-2023SA359844$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240903$$MD$US$US
232209522$23220952$2$F$20231110$20240822$20231123$20240918$PER$$US-SA-2023SA360490$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240918$$MD$US$US
232209753$23220975$3$F$$20240711$20231123$20240717$PER$$US-ALXN-202311USA001370US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
232209894$23220989$4$F$20230101$20240819$20231123$20240829$EXP$$US-INSMED, INC.-2023-04291-US$INSMED$$$$$F$Y$$$20240829$$CN$US$US
232210805$23221080$5$F$20211114$20240805$20231123$20240809$EXP$$DE-ROCHE-2974401$ROCHE$$55$YR$A$M$Y$$$20240809$$CN$DE$DE
232211372$23221137$2$F$20231115$20240808$20231123$20240816$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-021413$JAZZ$$53$YR$$F$Y$$$20240816$$HP$US$US
232211418$23221141$8$F$20230925$20240626$20231123$20240702$EXP$$MA-BIOGEN-2023BI01236441$BIOGEN$$41$YR$$M$Y$75$KG$20240702$$MD$MA$MA
232212342$23221234$2$F$20231101$20240821$20231123$20240826$EXP$$CA-JNJFOC-20231141843$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240826$$PH$CA$CA
232212804$23221280$4$F$20231201$20240814$20231123$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-167944$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240821$$HP$US$US
232213192$23221319$2$F$20220215$20240716$20231123$20240724$PER$$US-SA-2023SA359654$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240724$$MD$US$US
232213422$23221342$2$F$$20240723$20231123$20240729$PER$$US-SA-2023SA360218$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240729$$MD$US$US
232214043$23221404$3$F$20231201$20240731$20231123$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-167911$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240802$$CN$US$US
232214182$23221418$2$F$20231005$20240719$20231123$20240729$EXP$IT-MINISAL02-952264$IT-TEVA-2023-IT-2946971$TEVA$$78$YR$$F$Y$$$20240729$$MD$IT$IT
232214223$23221422$3$F$20230227$20240916$20231123$20240920$EXP$$TW-ASTELLAS-2023US035077$ASTELLAS$$68$YR$E$M$Y$$$20240920$$MD$TW$TW
232214434$23221443$4$F$20201110$20240731$20231123$20240806$EXP$$CA-TAKEDA-2020TUS003521$TAKEDA$$67$YR$$F$Y$$$20240806$$HP$CA$CA
232215522$23221552$2$F$20230629$20240912$20231123$20240916$EXP$$DE-ROCHE-3382885$ROCHE$$28$YR$A$F$Y$$$20240916$$CN$DE$DE
232216376$23221637$6$F$20231113$20240919$20231123$20240927$EXP$$CA-TAKEDA-CA201831350$TAKEDA$$75$YR$$M$Y$68$KG$20240927$$HP$CA$CA
232217494$23221749$4$F$20220331$20240807$20231123$20240808$EXP$$JP-ASTELLAS-2022JP008489$ASTELLAS$$81$YR$$M$Y$56.2$KG$20240808$$MD$JP$JP
232218062$23221806$2$F$$20240730$20231123$20240802$EXP$$GR-ROCHE-3461047$ROCHE$$$$$F$Y$$$20240802$$MD$GR$GR
232218273$23221827$3$F$$20240917$20231123$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2023157849$VIIV$$$$$M$Y$$$20240927$$MD$US$US
232218334$23221833$4$F$20231104$20240720$20231123$20240808$PER$$CA-TOLMAR, INC.-23CA044566$TOLMAR$$81$YR$$M$Y$$$20240808$$CN$CA$CA
232219014$23221901$4$F$20240202$20240807$20231123$20240812$EXP$$NVSC2023US246632$NOVARTIS$$67$YR$$F$Y$$$20240812$$CN$US$US
232219113$23221911$3$F$20231120$20240814$20231123$20240815$EXP$$US-TAKEDA-2023TUS113369$TAKEDA$$53$YR$$M$Y$$$20240815$$PH$US$US
232219493$23221949$3$F$20220101$20240823$20231123$20240918$PER$$US-SA-2023SA362504$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240918$$MD$US$US
232219844$23221984$4$F$20230101$20240624$20231123$20240704$EXP$$FR-INSMED, INC.-2023-02399-FR$INSMED$$$$$M$Y$108$KG$20240704$$CN$FR$FR
232219906$23221990$6$F$$20240823$20231123$20240904$EXP$$US-TRAVERE-2023TVT00750$TRAVERE THERAPEUTICS$$$$$M$Y$9.31$KG$20240904$$CN$US$US
232220953$23222095$3$F$20221222$20240703$20231123$20240712$EXP$$JP-ABBVIE-5483109$ABBVIE$$70$YR$$M$Y$56$KG$20240712$$PH$JP$JP
232221655$23222165$5$F$$20240705$20231123$20240715$PER$$US-SA-2023SA359930$SANOFI AVENTIS$$$$T$F$Y$49.8$KG$20240715$$MD$US$US
232221785$23222178$5$F$20230101$20240814$20231123$20240826$PER$$US-SA-2023SA363464$SANOFI AVENTIS$$13$YR$T$F$Y$57$KG$20240826$$MD$US$US
232221868$23222186$8$F$20230101$20240828$20231123$20240903$EXP$$CA-PFIZER INC-202300265931$PFIZER$$60$YR$$F$Y$$$20240903$$HP$CA$CA
232221937$23222193$7$F$$20240726$20231123$20240729$30DAY$$US-PFIZER INC-PV202300186294$PFIZER$$15$YR$$M$Y$$$20240729$$CN$US$US
232223062$23222306$2$F$$20240719$20231123$20240730$EXP$$AT-TEVA-2023-AT-2946733$TEVA$Morariu-Marina DC., Immunotherapy for cholangiocarcinoma: A Case Report, TOPAZ-1 and Real World Data, Spectrum Onkologie; 2023 (Nr. 6): p. 66-67.; MM D. Immuntherapie bei Gallengangskarzinom: Ein Fallbericht, TOPAZ-1 und Real World Data. Spectrum Onkologie 2023; (NR. 6): 66-67.; MM D. Immunotherapy for cholangiocarcinoma: A Case Report, TOPAZ-1 and Real World Data. Spectrum Onkologie 2023; (NR. 6): 66-67.$$$E$F$Y$$$20240730$$MD$AT$AT
232223135$23222313$5$F$20231101$20240731$20231123$20240731$30DAY$$US-PFIZER INC-PV202300187765$PFIZER$$12$YR$$M$Y$41.7$KG$20240731$$MD$US$US
232223453$23222345$3$F$20231115$20240911$20231123$20240912$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-147410$DAIICHI$$32$YR$$M$Y$$$20240913$$MD$US$US
2322235926$23222359$26$F$20230301$20240918$20231123$20240923$EXP$$US-PFIZER INC-PV202300189015$PFIZER$$26$YR$$F$Y$39.909$KG$20240923$$MD$US$US
232223756$23222375$6$F$$20240827$20231123$20240828$EXP$$CA-SANDOZ INC.-SDZ2023CA055795$SANDOZ$$60$YR$$M$Y$$$20240828$$HP$CA$CA
232224812$23222481$2$F$$20231024$20231123$20240710$PER$$BE-ROCHE-3446187$ROCHE$$$$$F$Y$$$20240628$$MD$BE$BE
232225765$23222576$5$F$20230801$20240911$20231123$20240918$EXP$$US-ABBVIE-5504491$ABBVIE$$68$YR$$M$Y$87$KG$20240918$$CN$US$US
232225847$23222584$7$F$20230101$20240916$20231123$20240925$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-147419$DAIICHI$$$$$F$Y$$$20240925$$CN$US$US
232226282$23222628$2$F$$20231115$20231123$20240711$PER$$JP-PFM-2023-06125$PIERRE FABRE MEDICAMENT$Kalambe AS, Sugihara K, Yamamoto K, Kawano S, Oyama C, Taketani T et al. PHACE(S) Syndrome with Ocular Involvements and No Periocular Hemangioma. Case Rep Ophthalmol. 2023;14:477-83$2$MON$$F$Y$$$20240711$$MD$JP$JP
232226385$23222638$5$F$20240716$20240720$20231123$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-167344$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240723$$CN$US$US
232228065$23222806$5$F$20231101$20231211$20231123$20240926$EXP$$US-GSK-US2023AMR157206$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
232228892$23222889$2$F$$20240913$20231123$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-419276$RANBAXY$$16$YR$$M$Y$$$20240927$$HP$FR$FR
232230114$23223011$4$F$20180524$20240708$20231123$20240712$EXP$$JP-ABBVIE-19K-087-3135603-00$ABBVIE$Okada K. Chronic lymphocytic leukaemia in which atrial fibrillation developed during the use of IBRUTINIB.$77$YR$$M$Y$53$KG$20240712$$MD$JP$JP
232230175$23223017$5$F$20231106$20240812$20231123$20240816$EXP$$US-ABBVIE-5504977$ABBVIE$$76$YR$$F$Y$$$20240816$$CN$US$US
232230326$23223032$6$F$20230101$20240724$20231123$20240729$EXP$$JP-AstraZeneca-2023A262046$ASTRAZENECA$$80$YR$$M$Y$54$KG$20240729$$MD$JP$
232230449$23223044$9$F$20240501$20240830$20231123$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-169030$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240905$$CN$US$US
232230473$23223047$3$F$20231025$20240904$20231123$20240909$EXP$$US-ABBVIE-5307962$ABBVIE$$69$YR$$F$Y$$$20240909$$CN$US$US
232231022$23223102$2$F$20231012$20240513$20231123$20240702$PER$$US-JNJFOC-20231165087$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240702$$HP$US$US
232231232$23223123$2$F$20230101$20240826$20231123$20240909$PER$$US-SA-2023SA360496$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240909$$MD$US$US
232231425$23223142$5$F$20230101$20240828$20231123$20240905$EXP$$JP-009507513-2305JPN003614J$MERCK$$63$YR$$F$Y$$$20240905$$MD$JP$JP
2322317610$23223176$10$F$20231104$20240801$20231123$20240811$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-027346$JAZZ$$29$YR$$F$Y$$$20240811$$HP$US$US
232234174$23223417$4$F$$20240702$20231123$20240703$EXP$$NVSC2023US250315$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
232234917$23223491$7$F$20230101$20240904$20231123$20240911$EXP$$US-ABBVIE-4768919$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
232235152$23223515$2$F$20230101$20240805$20231124$20240813$PER$$US-SA-2023SA360228$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240814$$MD$US$US
232235593$23223559$3$F$$20240805$20231124$20240812$EXP$$JP-009507513-2311JPN002127J$MERCK$$35$YR$$F$Y$$$20240812$$MD$JP$JP
232235874$23223587$4$F$20240830$20240904$20231124$20240914$EXP$$CA-UNITED THERAPEUTICS-UNT-2023-033177$UNITED THERAPEUTICS$$41$YR$$F$Y$$$20240914$$$CA$CA
232236613$23223661$3$F$$20240620$20231124$20240710$PER$$CA-TOLMAR, INC.-23CA044668$TOLMAR$$$$$M$Y$$$20240709$$CN$CA$CA
232236923$23223692$3$F$20230913$20240625$20231124$20240710$EXP$$IT-ROCHE-3458650$ROCHE$$54$YR$A$F$Y$$$20240710$$MD$IT$IT
232237774$23223777$4$F$20231103$20240624$20231124$20240704$PER$$US-SA-2023SA361141$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240704$$MD$US$US
232238553$23223855$3$F$20230101$20240823$20231124$20240903$PER$$US-SA-2023SA362634$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240903$$MD$US$US
232239072$23223907$2$F$$20240802$20231124$20240812$PER$$US-SA-2023SA359186$SANOFI AVENTIS$$$$C$F$Y$$$20240812$$MD$US$US
232239123$23223912$3$F$20231102$20240716$20231124$20240724$EXP$$US-UNITED THERAPEUTICS-UNT-2023-032176$UNITED THERAPEUTICS$$85$YR$$M$Y$66.213$KG$20240724$$$US$US
232239583$23223958$3$F$20230831$20240926$20231124$20240927$EXP$ES-AEMPS-1448782$ES-JNJFOC-20231154763$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240927$$MD$ES$ES
232239652$23223965$2$F$20230101$20240716$20231124$20240723$EXP$$US-SA-2023SA364330$SANOFI AVENTIS$$67$YR$E$F$Y$49$KG$20240723$$MD$US$US
232239705$23223970$5$F$20230824$20240710$20231124$20240715$EXP$$AU-TAKEDA-2023TUS083434$TAKEDA$$4$YR$$M$Y$$$20240715$$HP$AU$AU
232240186$23224018$6$F$20220601$20240816$20231124$20240823$EXP$$EC-SANDOZ INC.-NVSC2022EC166213$SANDOZ$$71$YR$$F$Y$$$20240823$$CN$EC$EC
2322406913$23224069$13$F$20230101$20240909$20231124$20240919$EXP$$JP-009507513-2311JPN001577J$MERCK$$75$YR$$F$Y$$$20240919$$MD$JP$JP
2322418019$23224180$19$F$20230323$20240910$20231124$20240913$EXP$$DE-ROCHE-3319899$ROCHE$$46$YR$A$M$Y$$$20240913$$CN$DE$DE
232241999$23224199$9$F$$20240814$20231124$20240816$PER$$NVSC2023US250579$NOVARTIS$$$$$F$Y$$$20240816$$HP$US$US
232242583$23224258$3$F$$20240618$20231124$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-10404$LUPIN$$$$$$Y$$$20240702$$CN$US$US
232242712$23224271$2$F$20231020$20231120$20231124$20240814$EXP$$NVSC2023NL249575$NOVARTIS$$58$YR$$F$Y$$$20240814$$CN$NL$NL
232242938$23224293$8$F$$20240619$20231124$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004610$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
232242944$23224294$4$F$20231023$20240610$20231124$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005026$ACADIA PHARMACEUTICALS$$64$YR$$F$Y$$$20240705$$HP$US$US
232242977$23224297$7$F$20230101$20240906$20231124$20240917$EXP$$US-UCBSA-2023052455$UCB$$$$$M$Y$$$20240917$$CN$US$US
232243037$23224303$7$F$20231012$20240909$20231124$20240917$EXP$$CA-CELLTRION INC.-2023CA020337$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
232243143$23224314$3$F$$20231214$20231124$20240925$EXP$$US-GSK-US2021170515$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
232243482$23224348$2$F$20201216$20240820$20231124$20240826$EXP$$EG-SANDOZ INC.-SDZ2023EG043718$SANDOZ$$4$YR$$M$Y$30$KG$20240826$$HP$EG$EG
232244005$23224400$5$F$$20240828$20231124$20240902$EXP$$CA-SANDOZ INC.-NVSC2022CA097884$SANDOZ$$$$$F$Y$$$20240902$$CN$CA$CA
232245124$23224512$4$F$20171020$20240708$20231124$20240710$EXP$$CA-TAKEDA-2019TUS058928$TAKEDA$$55$YR$$F$Y$$$20240710$$CN$CA$CA
232247683$23224768$3$F$$20240712$20231124$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-165833$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$60$KG$20240722$$MD$JP$JP
232248399$23224839$9$F$20220915$20240919$20231124$20240926$EXP$$CA-TAKEDA-2022TUS049918$TAKEDA$$59$YR$$M$Y$$$20240926$$HP$CA$CA
2322486811$23224868$11$F$$20240920$20231124$20240926$EXP$$US-TAKEDA-2021TUS064568$TAKEDA$$$$$M$Y$83$KG$20240926$$HP$US$US
232249633$23224963$3$F$$20240805$20231124$20240812$EXP$$JP-009507513-2311JPN002120J$MERCK$$79$YR$$$Y$$$20240812$$MD$JP$JP
232250323$23225032$3$F$20230101$20240624$20231124$20240701$EXP$$US-SA-2023SA364485$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240701$$MD$US$US
232250842$23225084$2$F$20200101$20240628$20231124$20240704$EXP$$US-ABBVIE-5503363$ABBVIE$$$$$F$Y$89$KG$20240704$$CN$US$US
232250852$23225085$2$F$$20240716$20231124$20240723$EXP$$CA-ROCHE-3463887$ROCHE$$$$A$F$Y$$$20240723$$CN$CA$CA
232250897$23225089$7$F$$20240801$20231124$20240806$EXP$$CA-ROCHE-3463805$ROCHE$$$$A$F$Y$$$20240806$$HP$CA$CA
232251288$23225128$8$F$20240805$20240826$20231124$20240829$EXP$$US-TAKEDA-2022TUS055820$TAKEDA$$65$YR$$F$Y$77$KG$20240829$$HP$US$US
2322515214$23225152$14$F$20230101$20240910$20231124$20240918$EXP$$CA-CELLTRION INC.-2023CA004947$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
232251542$23225154$2$F$$20240729$20231124$20240806$EXP$$CA-AMGEN-CANSP2018173358$AMGEN$$41$YR$A$M$Y$130$KG$20240805$$HP$CA$CA
232251983$23225198$3$F$20230101$20240626$20231124$20240705$EXP$$US-INSMED, INC.-2023-02908-US$INSMED$$$$$F$Y$$$20240705$$CN$US$US
232252175$23225217$5$F$20230901$20240812$20231124$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-016370$JAZZ$$76$YR$$M$Y$$$20240820$$CN$US$US
232252237$23225223$7$F$20230227$20240911$20231124$20240919$EXP$$BE-AUROBINDO-AUR-APL-2023-074165$AUROBINDO$$85$YR$$M$Y$$$20240919$$MD$BE$BE
232252302$23225230$2$F$$20240916$20231124$20240919$EXP$$CA-TAKEDA-2023TUS003368$TAKEDA$$$$$M$Y$$$20240919$$MD$CA$CA
232252912$23225291$2$F$$20240722$20231124$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-169138$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240724$$HP$US$US
232254204$23225420$4$F$$20240731$20231124$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-170006$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240801$$CN$US$US
232254922$23225492$2$F$20230113$20240821$20231124$20240829$EXP$$CA-TAKEDA-2022TUS094325$TAKEDA$$73$YR$$M$Y$$$20240829$$HP$CA$CA
232255832$23225583$2$F$20231101$20240701$20231124$20240705$EXP$$CA-JNJFOC-20231143136$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240705$$CN$CA$CA
232256493$23225649$3$F$$20240723$20231124$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-169762$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240726$$MD$JP$JP
232257092$23225709$2$F$$20240710$20231124$20240718$PER$$US-SA-2023SA360226$SANOFI AVENTIS$$2$YR$C$M$Y$15.4$KG$20240718$$MD$US$US
232257103$23225710$3$F$20230101$20240730$20231124$20240808$PER$$US-SA-2023SA360066$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240808$$MD$US$US
232257234$23225723$4$F$20230101$20240517$20231124$20240830$EXP$$US-SA-2023SA361122$SANOFI AVENTIS$$45$YR$A$M$Y$78.744$KG$20240830$$MD$US$US
232257278$23225727$8$F$$20240705$20231124$20240714$PER$$US-SA-2023SA359798$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240714$$MD$US$US
232257532$23225753$2$F$20231101$20240703$20231124$20240712$PER$$US-SA-2023SA359910$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240712$$MD$US$US
232257793$23225779$3$F$20230101$20240730$20231124$20240808$PER$$US-SA-2023SA360675$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240808$$MD$US$US
232257882$23225788$2$F$20230101$20240808$20231124$20240820$PER$$US-SA-2023SA365116$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240820$$MD$US$US
232257985$23225798$5$F$20231001$20240909$20231124$20240917$PER$$US-SA-2023SA364766$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240918$$MD$US$US
232258215$23225821$5$F$20230101$20240724$20231124$20240806$PER$$US-SA-2023SA364193$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240806$$MD$US$US
232258313$23225831$3$F$$20240830$20231124$20240912$PER$$US-SA-2023SA365258$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240912$$MD$US$US
232259872$23225987$2$F$20211101$20240923$20231124$20240926$EXP$$NVSC2023EG247793$NOVARTIS$$63$YR$$F$Y$$$20240927$$CN$EG$EG
232259963$23225996$3$F$20240617$20240808$20231124$20240812$EXP$$NVSC2023BR223818$NOVARTIS$$60$YR$$F$Y$$$20240812$$CN$BR$BR
232260712$23226071$2$F$$20240716$20231124$20240723$EXP$$NVSC2023CA249245$NOVARTIS$$72$YR$$F$Y$$$20240723$$CN$CA$CA
232261012$23226101$2$F$$20240703$20231124$20240712$PER$$US-TAKEDA-2023TUS113966$TAKEDA$$$$$F$Y$118$KG$20240712$$CN$US$US
232261864$23226186$4$F$$20240229$20231124$20240809$EXP$$NVSC2023US248801$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
232262162$23226216$2$F$20230101$20240821$20231124$20240920$PER$$US-SA-2023SA365871$SANOFI AVENTIS$$60$YR$A$F$Y$107$KG$20240920$$MD$US$US
232262475$23226247$5$F$20210101$20240816$20231124$20240822$EXP$$CA-BAUSCH-BL-2021-030041$BAUSCH AND LOMB$$65$YR$$M$Y$108.96$KG$20240822$$CN$CA$CA
232262543$23226254$3$F$$20240809$20231124$20240813$PER$$US-VERTEX PHARMACEUTICALS-2023-017485$VERTEX$$$$$$Y$$$20240813$$CN$US$US
232262787$23226278$7$F$20230505$20240704$20231124$20240709$EXP$$AR-MYLANLABS-2023M1123407$MYLAN$$15$YR$$F$Y$$$20240709$$CN$AR$AR
232263832$23226383$2$F$20130407$20240710$20231124$20240717$EXP$$GB-ALXN-A202301856$ALEXION PHARMACEUTICALS$$67$YR$$F$Y$$$20240717$$CN$GB$GB
232264533$23226453$3$F$$20240805$20231124$20240816$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK086606$GLENMARK$$$$$$Y$$$20240816$$HP$CA$CA
232264793$23226479$3$F$20231117$20240902$20231124$20240905$EXP$$JP-AstraZeneca-2023A264404$ASTRAZENECA$$80$YR$$M$Y$60$KG$20240905$$MD$JP$
232266083$23226608$3$F$20230725$20240704$20231124$20240711$EXP$$IE-JNJFOC-20230940685$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240711$$HP$IE$IE
232266574$23226657$4$F$20231001$20240816$20231124$20240823$PER$$US-INCYTE CORPORATION-2023IN011427$INCYTE$$$$$$Y$$$20240823$$MD$US$US
232266772$23226677$2$F$$20240627$20231124$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-419741$RANBAXY$$$$$F$Y$$$20240712$$PH$GB$GB
232267002$23226700$2$F$$20240617$20231124$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-420011$RANBAXY$$37$YR$$M$Y$$$20240702$$PH$FR$FR
232267106$23226710$6$F$20231107$20240830$20231124$20240906$30DAY$$AR-JNJFOC-20231127031$JOHNSON AND JOHNSON$$71$YR$E$F$Y$59$KG$20240906$$CN$AR$AR
232267198$23226719$8$F$$20240905$20231124$20240916$EXP$$CA-TAKEDA-2023TUS111012$TAKEDA$$$$$M$Y$$$20240916$$MD$CA$CA
232267273$23226727$3$F$$20240805$20231124$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419848$RANBAXY$Kesari S, Barron C, Cohen LE, Regelmann MO, Baer TG.. Dexamethasone swish and spit, a cause of iatrogenic adrenal insufficiency. Pediatr Blood Cancer. 2024;71 (9):e31138(1-2)$14$YR$$M$Y$$$20240820$$MD$US$US
232267824$23226782$4$F$20230911$20240821$20231124$20240822$EXP$GB-MHRA-MED-202311171935286160-GYJWV$NVSC2023GB250974$NOVARTIS$$75$YR$$F$Y$$$20240822$$MD$GB$GB
232267922$23226792$2$F$$20240912$20231124$20240927$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420099$RANBAXY$Liu Y, Sun J, Tuo K. Zanubrutinib in the Maintenance Treatment of Elderly People with Primary Central Nervous System Lymphoma: A Report of 2 Cases. Case Rep Oncol. 2023;16:233-239$75$YR$$M$Y$$$20240927$$HP$CN$CN
232269085$23226908$5$F$$20240427$20231124$20240711$PER$$US-PFM-2023-04964$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.8$KG$20240711$$CN$US$US
232269192$23226919$2$F$$20231117$20231124$20240801$EXP$$NVSC2023BR248653$NOVARTIS$$$$$F$Y$$$20240801$$CN$BR$BR
2322699910$23226999$10$F$$20240911$20231124$20240916$EXP$$US-TAKEDA-2023TUS050990$TAKEDA$$$$$F$Y$91$KG$20240916$$CN$US$US
2322704910$23227049$10$F$20210209$20240723$20231124$20240729$EXP$$CA-TAKEDA-2023TUS064844$TAKEDA$$45$YR$$M$Y$$$20240729$$CN$CA$CA
232272914$23227291$4$F$20220921$20240823$20231124$20240830$EXP$$US-ALXN-A202312183$ALEXION PHARMACEUTICALS$$67$YR$$F$Y$129.3$KG$20240830$$MD$US$US
232273234$23227323$4$F$$20240701$20231124$20240702$EXP$$US-PFIZER INC-PV202300191046$PFIZER$$74$YR$$F$Y$$$20240702$$CN$US$US
232273944$23227394$4$F$20230516$20240627$20231124$20240702$EXP$$CA-PFIZER INC-202300154176$PFIZER$$26$YR$$F$Y$$$20240702$$MD$CA$CA
232274706$23227470$6$F$20231021$20240805$20231124$20240808$EXP$$IN-PFIZER INC-202200765761$PFIZER$$36$YR$$M$Y$$$20240808$$CN$IN$IN
232274972$23227497$2$F$$20231120$20231124$20240718$EXP$$US-Taiho Oncology Inc-2023-010123$TAIHO ONCOLOGY INC$$$$A$F$Y$$$20240718$$CN$US$US
232275175$23227517$5$F$20231029$20240717$20231124$20240722$EXP$$US-SA-2023SA363116$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240722$$MD$US$US
232275383$23227538$3$F$$20240722$20231124$20240729$EXP$$US-ALXN-202311USA001466US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
232275723$23227572$3$F$$20240805$20231124$20240812$EXP$$JP-009507513-2311JPN002126J$MERCK$$48$YR$$$Y$$$20240812$$MD$JP$JP
232275753$23227575$3$F$$20240805$20231124$20240814$EXP$$JP-009507513-2311JPN002117J$MERCK$$47$YR$$$Y$$$20240814$$MD$JP$JP
232276783$23227678$3$F$$20240705$20231124$20240710$PER$$NVSC2023US251207$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
232277062$23227706$2$F$$20240704$20231125$20240715$EXP$$GB-ROCHE-3414968$ROCHE$$$$A$F$Y$$$20240715$$CN$GB$GB
232277388$23227738$8$F$$20240628$20231125$20240706$EXP$$DE-CELLTRION INC.-2023DE022590$CELLTRION$Stortz M, Shmanko K, Kraus D, Gairing S, Boedecker-Lips S, Forster F, et al. Plasma exchange for treatment of a therapy-related  thrombotic microangiopathy in a patient with advanced hepatocellular carcinoma-A case report.. Clinical Case Reports. 2023;11(11):e8124$$$$$Y$$$20240706$$HP$DE$DE
232277723$23227772$3$F$20210601$20240701$20231125$20240708$EXP$$US-JNJFOC-20231150462$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240709$$CN$US$US
232277873$23227787$3$F$$20240729$20231125$20240808$EXP$$IT-AUROBINDO-AUR-APL-2023-073566$AUROBINDO$Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Gian Paolo Ross et al.. Pickering Syndrome: An Overlooked Renovascular Cause of Recurrent Heart Failure.. Journal of the American Heart Association. 2023;12(19):e030474$79$YR$$M$Y$88$KG$20240809$$MD$IT$IT
2322790410$23227904$10$F$20230101$20240726$20231125$20240803$EXP$$CA-CELLTRION INC.-2023CA019044$CELLTRION$$$$$$Y$$$20240803$$CN$CA$CA
232279493$23227949$3$F$20230101$20231215$20231125$20240718$EXP$GB-MHRA-MED-202311171807479380-KTZVG$NVSC2023GB250971$NOVARTIS$$55$YR$$F$Y$$$20240718$$MD$GB$GB
232279603$23227960$3$F$20191217$20240823$20231125$20240904$EXP$DE-EMA-20231019-AUTODUP-1697743199379$DE-Accord-391386$ACCORD$$$$E$F$Y$91$KG$20240904$$HP$DE$DE
232280582$23228058$2$F$20180101$20240722$20231125$20240801$EXP$$FR-TEVA-2023-FR-2949168$TEVA$$51$YR$$F$Y$$$20240801$$LW$FR$FR
232280914$23228091$4$F$20230501$20240625$20231125$20240701$EXP$$DE-JNJFOC-20230706502$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240701$$HP$DE$DE
232281023$23228102$3$F$$20240812$20231125$20240820$EXP$$NVSC2023US249096$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
232283065$23228306$5$F$$20240917$20231125$20240924$EXP$$NVSC2023CA226313$NOVARTIS$$54$YR$$F$Y$$$20240924$$CN$CA$CA
232283516$23228351$6$F$$20240702$20231125$20240708$EXP$$US-TAKEDA-2023TUS109209$TAKEDA$$$$$M$Y$$$20240708$$MD$US$US
232283545$23228354$5$F$20231116$20240806$20231125$20240807$EXP$$NVSC2023GB246703$NOVARTIS$$38$YR$$F$Y$$$20240807$$CN$GB$GB
232283814$23228381$4$F$20231112$20240116$20231125$20240925$PER$$US-GSK-US2023AMR158550$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
232284123$23228412$3$F$$20240727$20231125$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-10391$LUPIN$$$$$$Y$$$20240817$$CN$US$US
232284543$23228454$3$F$$20240727$20231125$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-10480$LUPIN$$$$$$Y$$$20240818$$CN$US$US
232285162$23228516$2$F$20231115$20240918$20231125$20240919$PER$$US-BAYER-2023A166595$BAYER$$26$YR$A$F$Y$$$20240919$$HP$US$US
232285573$23228557$3$F$$20231115$20231125$20240823$EXP$$GB-JNJFOC-20231151557$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$CN$GB$GB
232285602$23228560$2$F$$20231115$20231125$20240823$EXP$$GB-JNJFOC-20231148053$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$CN$GB$GB
232288572$23228857$2$F$$20240201$20231126$20240923$PER$$US-ROCHE-3319878$ROCHE$$37$YR$A$F$Y$55.9$KG$20240923$$PH$US$US
232289722$23228972$2$F$20230801$20240826$20231126$20240904$PER$$US-INSUD PHARMA-2311US08133$INSUD PHARMA$$$$$$Y$$$20240904$$CN$US$US
232289952$23228995$2$F$$20240624$20231126$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-168147$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$PH$JP$JP
232290092$23229009$2$F$$20231211$20231126$20240717$EXP$$US-JNJFOC-20231145113$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240717$$MD$US$US
232290514$23229051$4$F$20230101$20240722$20231127$20240725$EXP$$US-UCBSA-2023045776$UCB$$$$$F$Y$109$KG$20240725$$CN$US$US
232291132$23229113$2$F$$20240621$20231127$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2023SP014101$STRIDES$LaCava AF, Fadugba OO.. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases.. Allergy, Asthma + Clinical Immunology. 2023;19(1):78$35$YR$$M$Y$$$20240816$$HP$US$US
232291527$23229152$7$F$20230928$20240704$20231127$20240712$EXP$$ES-AUROBINDO-AUR-APL-2023-074291$AUROBINDO$$44$YR$$M$Y$74$KG$20240712$$MD$ES$ES
232292863$23229286$3$F$20211001$20240625$20231127$20240702$EXP$$DE-ABBVIE-5506941$ABBVIE$$61$YR$$F$Y$100$KG$20240702$$MD$DE$DE
232294334$23229433$4$F$20230323$20240712$20231127$20240717$EXP$$FR-BAUSCH-BL-2023-017580$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240717$$HP$FR$FR
232294442$23229444$2$F$20231001$20240701$20231127$20240704$EXP$$US-UCBSA-2023055712$UCB$$30$YR$$F$Y$$$20240704$$HP$US$US
232294668$23229466$8$F$$20240916$20231127$20240923$EXP$$CA-ROCHE-3461967$ROCHE$$44$YR$A$F$Y$$$20240923$$HP$CA$CA
232294933$23229493$3$F$$20240723$20231127$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-169776$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240729$$MD$JP$JP
232295283$23229528$3$F$$20240612$20231127$20240711$EXP$$CA-ROCHE-3462014$ROCHE$$43$YR$A$F$Y$$$20240711$$HP$CA$CA
232295573$23229557$3$F$$20240910$20231127$20240924$EXP$$US-UCBSA-2023022300$UCB$$$$$F$Y$$$20240924$$CN$US$US
232295872$23229587$2$F$$20240621$20231127$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2023SP014102$STRIDES$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allergy, Asthma + Clinical Immunology. 2023;19(1):78$41$YR$$F$Y$$$20240816$$HP$US$US
232295922$23229592$2$F$$20240621$20231127$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2023SP014103$STRIDES$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allergy Asthma Clin Immunol. 2023;19(1):78$39$YR$$M$Y$$$20240816$$HP$US$US
2322969414$23229694$14$F$20230401$20240924$20231127$20240927$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-235720$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240927$$CN$US$US
232297402$23229740$2$F$$20240621$20231127$20240819$PER$$US-STRIDES ARCOLAB LIMITED-2023SP014104$STRIDES$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allergy, Asthma + Clinical Immunology. 2023;19(1):78$58$YR$$F$Y$$$20240819$$HP$US$US
232297432$23229743$2$F$$20240621$20231127$20240819$PER$$US-STRIDES ARCOLAB LIMITED-2023SP014100$STRIDES$Lacava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allergy, Asthma + Clinical Immunology. 2023;19(1):78$24$YR$$F$Y$$$20240819$$HP$US$US
232297722$23229772$2$F$$20240812$20231127$20240826$EXP$$US-AUROBINDO-AUR-APL-2023-074103$AUROBINDO$Murphy M, Jones K, Ruebner RL, Raabe E. Acute Onset of Abdominal Pain in a 3-year-old Boy with Acute Lymphoblastic Leukemia.. Pediatrics in Review. 2023;44(1):S106-9$3$YR$$M$Y$$$20240826$$MD$US$US
232297912$23229791$2$F$20230831$20231107$20231127$20240927$PER$$US-ROCHE-3429924$ROCHE$$$$$$Y$$$20240927$$CN$US$US
232297965$23229796$5$F$20230725$20240917$20231127$20240923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-170524$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240923$$MD$JP$JP
232298356$23229835$6$F$$20240722$20231127$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-167989$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240730$$CN$US$US
232298803$23229880$3$F$$20240715$20231127$20240717$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-171162$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240717$$CN$CA$CA
232300803$23230080$3$F$20231119$20240724$20231127$20240726$EXP$$IN-ROCHE-3464393$ROCHE$$78$YR$E$F$Y$$$20240726$$CN$IN$IN
232301114$23230111$4$F$20240701$20240812$20231127$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-003670$JAZZ$$57$YR$$F$Y$$$20240819$$HP$US$US
232302402$23230240$2$F$20230901$20240729$20231127$20240807$EXP$$CA-TAKEDA-2023TUS094219$TAKEDA$$79$YR$$M$Y$$$20240807$$CN$CA$CA
232302492$23230249$2$F$$20240812$20231127$20240815$EXP$$US-TAKEDA-2022TUS093519$TAKEDA$$$$$M$Y$$$20240815$$CN$US$US
232302804$23230280$4$F$$20240808$20231127$20240809$EXP$$CA-TAKEDA-2023TUS113691$TAKEDA$$$$$F$Y$$$20240809$$CN$CA$CA
232302832$23230283$2$F$$20240702$20231127$20240709$EXP$$CA-TAKEDA-2023TUS093524$TAKEDA$$$$$M$Y$$$20240709$$MD$CA$CA
232302868$23230286$8$F$20230524$20240903$20231127$20240909$EXP$$US-TAKEDA-2022TUS054138$TAKEDA$$69$YR$$M$Y$79$KG$20240909$$CN$US$US
232304272$23230427$2$F$$20240820$20231127$20240826$EXP$$CA-SANDOZ INC.-SDZ2023CA020343$SANDOZ$$$$$M$Y$$$20240826$$CN$CA$CA
232304375$23230437$5$F$$20240708$20231127$20240711$EXP$$CA-SANDOZ INC.-NVSC2022CA110997$SANDOZ$$40$YR$$M$Y$140$KG$20240711$$CN$CA$CA
232304543$23230454$3$F$$20240716$20231127$20240717$EXP$$DE-SANDOZ INC.-SDZ2023DE059877$SANDOZ$$10$YR$$F$Y$$$20240717$$MD$DE$DE
232304602$23230460$2$F$$20240715$20231127$20240726$EXP$$ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2023-019030$VALIDUS$$$$$$Y$$$20240726$$PH$ES$ES
232304692$23230469$2$F$20231001$20240923$20231127$20240926$EXP$$GB-SANDOZ INC.-NVSC2021GB293206$SANDOZ$$76$YR$$F$Y$$$20240926$$CN$GB$GB
232304742$23230474$2$F$$20240827$20231127$20240830$EXP$$US-SANDOZ INC.-SDZ2023US058886$SANDOZ$$$$$F$Y$$$20240830$$MD$US$US
232304872$23230487$2$F$20231120$20240919$20231127$20240923$EXP$$ZA-SANDOZ INC.-SDZ2023ZA046803$SANDOZ$$48$YR$$F$Y$$$20240923$$CN$ZA$ZA
232305025$23230502$5$F$20211015$20240827$20231127$20240903$EXP$$CA-SANDOZ INC.-NVSC2020CA117305$SANDOZ$$80$YR$$F$Y$$$20240903$$CN$CA$CA
232305052$23230505$2$F$$20240925$20231127$20240925$EXP$$US-SANDOZ INC.-SDZ2023US008383$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
232305312$23230531$2$F$20231026$20240917$20231127$20240918$EXP$$FR-ROCHE-3463491$ROCHE$$24$YR$A$F$Y$76$KG$20240918$$HP$FR$FR
232305455$23230545$5$F$$20240924$20231127$20240930$EXP$$CA-TAKEDA-2023TUS113180$TAKEDA$$$$$M$Y$$$20240930$$CN$CA$CA
232305773$23230577$3$F$$20240816$20231127$20240821$EXP$$US-TAKEDA-2023TUS113392$TAKEDA$$$$$M$Y$$$20240821$$MD$US$US
232306253$23230625$3$F$20210705$20240730$20231127$20240805$EXP$$CA-TAKEDA-2021TUS042727$TAKEDA$$71$YR$$F$Y$82$KG$20240805$$CN$CA$CA
232306853$23230685$3$F$20230724$20240911$20231127$20240918$EXP$$AU-TAKEDA-2023TUS038989$TAKEDA$$58$YR$$F$Y$$$20240918$$CN$AU$AU
232307104$23230710$4$F$20230101$20240709$20231127$20240717$PER$$US-SA-2023SA361749$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240717$$MD$US$US
232307192$23230719$2$F$20230101$20240819$20231127$20240828$PER$$US-SA-2023SA362186$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240828$$HP$US$US
232307203$23230720$3$F$20230101$20240709$20231127$20240717$PER$$US-SA-2023SA357679$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240717$$MD$US$US
232307382$23230738$2$F$20230101$20240828$20231127$20240906$PER$$US-SA-2023SA366527$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240906$$MD$US$US
232307604$23230760$4$F$20231001$20240722$20231127$20240731$PER$$US-SA-2023SA362147$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240731$$MD$US$US
232307862$23230786$2$F$$20240724$20231127$20240805$PER$$US-SA-2023SA265677$SANOFI AVENTIS$$93$YR$E$F$Y$$$20240805$$MD$US$US
232308625$23230862$5$F$20231110$20240903$20231127$20240909$EXP$$CA-TAKEDA-2023TUS110332$TAKEDA$$74$YR$$F$Y$$$20240909$$MD$CA$CA
232309144$23230914$4$F$20230701$20240807$20231127$20240814$EXP$$US-SA-2023SA310440$SANOFI AVENTIS$$62$YR$A$F$Y$102$KG$20240814$$MD$US$US
232309802$23230980$2$F$$20240705$20231127$20240720$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420388$RANBAXY$Ricci V, Salvo GD, Maina G. Lurasidone in first-episode psychosis with predominant depressive symptoms: a case report. Intern Clin Psychopharmacol. 2023;38:275-277$19$YR$$M$Y$$$20240719$$MD$IT$IT
232310042$23231004$2$F$$20240802$20231127$20240816$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420377$RANBAXY$Pang SA, Elkrief A, Capella MP, Miller WH Jr. Two Cases of Durable and Deep Responses to Immune Checkpoint Inhibition-Refractory Metastatic Melanoma after Addition of Camu Camu Prebiotic. Curr Oncol. 2023;30(9):7852-7859$71$YR$$F$Y$$$20240816$$HP$CA$CA
232310092$23231009$2$F$$20240903$20231127$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420358$RANBAXY$Zafar S, Mahali LP, Ahsan H.. Role of Octreotide in Sulfonylurea-Induced Hypoglycemia. J Endocr Soc. 2021;Apr-May;5(S1):A396$76$YR$$F$Y$$$20240918$$MD$US$US
232310243$23231024$3$F$$20240711$20231127$20240726$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419412$RANBAXY$$$$E$F$Y$$$20240726$$CN$AU$AU
232310483$23231048$3$F$$20240812$20231127$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-170760$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240814$$CN$US$US
232310843$23231084$3$F$20230713$20240705$20231127$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-420252$RANBAXY$$65$YR$$M$Y$$$20240730$$MD$FR$FR
232311062$23231106$2$F$$20240704$20231127$20240718$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420431$RANBAXY$Zhang F, Zhang BY, Fan R, Cheng T, Hu XR, Liu YQ, et al. Clinical efficacy of plasma exchange in systemic lupus erythematosus during pregnancy. Immun Inflamm Dis. 2023;11:e1041(-9)$32$YR$$F$Y$$$20240718$$HP$CN$CN
232311072$23231107$2$F$$20240704$20231127$20240718$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420426$RANBAXY$Zhang F, Zhang BY, Fan R, Cheng T, Hu XR, Liu YQ, et al. Clinical efficacy of plasma exchange in systemic lupus erythematosus during pregnancy. Immun Inflamm Dis. 2023;11:e1041(1-9)$32$YR$$F$Y$$$20240718$$HP$CN$CN
232311162$23231116$2$F$$20240802$20231127$20240816$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420272$RANBAXY$Gunther M, Jiang S, Maldonado JR. Bilateral Globus Pallidus Injury in the Setting of Lithium Toxicity: A Case Report. J Acad Consult Liaison Psychiatry. 2023;64(5):484-485$52$YR$$F$Y$$$20240816$$MD$CA$CA
232311562$23231156$2$F$$20240725$20231127$20240806$EXP$$CA-AUROBINDO-AUR-APL-2023-074004$AUROBINDO$Amarasekera R, Wood E. Worsening stimulant use disorder outcomes coinciding with off-label antipsychotic prescribing: a commonly unrecognised side effect?. BMJ case reports. 2023;16(10):e255129$30$YR$$M$Y$$$20240806$$MD$CA$CA
232311692$23231169$2$F$20231025$20240826$20231127$20240904$EXP$$NL-AUROBINDO-AUR-APL-2023-074299$AUROBINDO$$50$YR$$F$Y$59.3$KG$20240904$$MD$NL$NL
232312094$23231209$4$F$20231029$20240808$20231127$20240825$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-169020$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$94.3$KG$20240826$$CN$US$US
232312122$23231212$2$F$$20240722$20231127$20240725$EXP$$GB-SANDOZ INC.-NVSC2020GB245181$SANDOZ$$$$$M$Y$$$20240725$$CN$GB$GB
232313733$23231373$3$F$20230101$20240614$20231127$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00270$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
232313842$23231384$2$F$20230101$20240723$20231127$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00284$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
232313983$23231398$3$F$20231001$20240507$20231127$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00300$AVADEL CNS PHARMA$$56$YR$$F$Y$$$20240815$$CN$US$US
232314065$23231406$5$F$20231001$20240517$20231127$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00280$AVADEL CNS PHARMA$$62$YR$$M$Y$$$20240822$$MD$US$US
232314192$23231419$2$F$20231001$20240716$20231127$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00318$AVADEL CNS PHARMA$$20$YR$$M$Y$$$20240822$$CN$US$US
232314213$23231421$3$F$20231019$20240617$20231127$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00299$AVADEL CNS PHARMA$$48$YR$$F$Y$111.11$KG$20240822$$CN$US$US
232314344$23231434$4$F$20230101$20240613$20231127$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00324$AVADEL CNS PHARMA$$$$$M$Y$83.492$KG$20240822$$CN$US$US
232314622$23231462$2$F$20230101$20240604$20231127$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00232$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
232314722$23231472$2$F$20230101$20240724$20231127$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00234$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
232314943$23231494$3$F$20230101$20240912$20231127$20240918$PER$$JP-Eisai-EC-2023-145810$EISAI$Yokozeki H. Len-Pem treatment and adverse events in advanced renal cell carcinoma. Lenvatinib AE management Seminar in Tajima.$81$YR$E$F$Y$$$20240918$$MD$JP$JP
232315795$23231579$5$F$20231026$20240801$20231127$20240810$EXP$$CA-TAKEDA-2023TUS112578$TAKEDA$$72$YR$$M$Y$80$KG$20240810$$HP$CA$CA
232315953$23231595$3$F$$20240722$20231127$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-170712$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240723$$CN$US$US
232317662$23231766$2$F$20231102$20231125$20231127$20240918$EXP$FR-AFSSAPS-PV2023001099$FR-BAUSCH-BL-2023-017593$BAUSCH AND LOMB$$31$YR$$F$Y$56$KG$20240918$$PH$FR$FR
232318794$23231879$4$F$20200412$20240813$20231127$20240820$EXP$$US-SANDOZ INC.-NVSC2019US005699$SANDOZ$$38$YR$$F$Y$68.027$KG$20240820$$CN$US$US
232321353$23232135$3$F$20230601$20240704$20231127$20240710$EXP$$JP-009507513-2307JPN000366J$MERCK$$65$YR$$F$Y$$$20240710$$MD$JP$JP
232321674$23232167$4$F$20230708$20240626$20231127$20240701$EXP$$JP-AstraZeneca-2023A210916$ASTRAZENECA$$77$YR$$M$Y$64$KG$20240701$$MD$JP$
232321952$23232195$2$F$$20240816$20231127$20240828$PER$$US-INCYTE CORPORATION-2023IN011576$INCYTE$$$$$$Y$$$20240828$$CN$US$US
232322072$23232207$2$F$20230901$20240709$20231127$20240711$EXP$FR-AFSSAPS-LM2023000618$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-170482$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$99$KG$20240711$$MD$FR$FR
232322863$23232286$3$F$20231025$20240701$20231127$20240708$EXP$$JP-009507513-2311JPN003055J$MERCK$$6$DEC$$F$Y$$$20240708$$MD$JP$JP
232324382$23232438$2$F$20230714$20240619$20231128$20240716$PER$$CA-TOLMAR, INC.-23CA044601$TOLMAR$$69$YR$$M$Y$$$20240716$$CN$CA$CA
232324492$23232449$2$F$20231023$20240710$20231128$20240729$PER$$US-TOLMAR, INC.-23US044570$TOLMAR$$76$YR$$M$Y$$$20240729$$CN$US$US
232324633$23232463$3$F$20230101$20240821$20231128$20240827$EXP$$US-ABBVIE-5510027$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
232325142$23232514$2$F$$20240814$20231128$20240904$PER$$AU-TOLMAR, INC.-23AU044642$TOLMAR$$$$$M$Y$$$20240904$$CN$AU$AU
232325613$23232561$3$F$20231001$20240827$20231128$20240911$PER$$US-SA-2023SA362217$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240911$$MD$US$US
232325682$23232568$2$F$$20240905$20231128$20240913$EXP$$AU-EMD Serono-2023490005$EMD SERONO INC$$$$A$F$Y$$$20240913$$CN$AU$AU
232325712$23232571$2$F$$20240628$20231128$20240704$EXP$$CA-ABBVIE-5510367$ABBVIE$$$$$F$Y$$$20240704$$CN$CA$CA
232326075$23232607$5$F$$20240906$20231128$20240918$EXP$$IT-AUROBINDO-AUR-APL-2023-074579$AUROBINDO$Ricchiuto A, Antenora F, Valzano I, Montanaro V, Giorgio A, Manco A, et al. Diffuse alveolar hemorrhage associated with apixaban therapy. Respiration. 2023;102(8):704/111.$58$YR$$M$Y$$$20240918$$HP$IT$IT
232326244$23232624$4$F$$20240827$20231128$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-170664$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$88.9$KG$20240829$$CN$US$US
232326723$23232672$3$F$20221224$20240912$20231128$20240917$EXP$$GB-ABBVIE-5510221$ABBVIE$$42$YR$$F$Y$$$20240917$$MD$GB$GB
232326802$23232680$2$F$$20231113$20231128$20240911$PER$$US-ADAREPHARM-2023-US-000067$ADARE PHARMACEUTICALS$Li J, Kubbar A, Kim E, Nunez Pelaez D, Rodriguez G, Bahtiyar G..Primary Hyperaldosteronism in Pregancy: A Case Report.J Endocrine Soc.2021;5(1):A153.$41$YR$A$F$Y$$$20240911$$HP$US$US
232327412$23232741$2$F$$20240909$20231128$20240916$EXP$$JP-AMGEN-JPNSP2022183181$AMGEN$$64$YR$A$F$Y$$$20240916$$PH$JP$JP
232330017$23233001$7$F$$20240801$20231128$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-170813$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$77.11$KG$20240802$$CN$US$US
232330062$23233006$2$F$20230920$20240916$20231128$20240924$EXP$$AU-ROCHE-3426569$ROCHE$$76$YR$E$F$Y$$$20240924$$MD$AU$AU
232330548$23233054$8$F$20220322$20240722$20231128$20240730$EXP$$CA-ROCHE-2540803$ROCHE$$42$YR$A$F$Y$$$20240730$$CN$CA$CA
232330693$23233069$3$F$$20240809$20231128$20240814$EXP$$US-ABBVIE-5510301$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
232330815$23233081$5$F$20230101$20240819$20231128$20240828$EXP$$JP-UCBSA-2023056046$UCB$$$$$M$Y$73$KG$20240828$$PH$JP$JP
232331292$23233129$2$F$20230601$20240627$20231128$20240703$EXP$$US-ABBVIE-5510224$ABBVIE$$76$YR$$F$Y$$$20240703$$CN$US$US
232331457$23233145$7$F$20230101$20240816$20231128$20240830$PER$$US-SA-2023SA344593$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240830$$MD$US$US
232331666$23233166$6$F$20230704$20240822$20231128$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-170013$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$48$KG$20240904$$MD$JP$JP
232331832$23233183$2$F$20230901$20240627$20231128$20240708$PER$$US-SA-2023SA313011$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240708$$MD$US$US
232331943$23233194$3$F$20230615$20240830$20231128$20240905$EXP$$JP-009507513-2311JPN003349J$MERCK$$8$DEC$$M$Y$$$20240905$$MD$JP$JP
232332784$23233278$4$F$20230101$20240821$20231128$20240829$EXP$$DE-UCBSA-2023042533$UCB$$$$$F$Y$79$KG$20240829$$MD$DE$DE
232333602$23233360$2$F$20231108$20240709$20231128$20240712$EXP$FR-AFSSAPS-BR2023000986$FR-ROCHE-3463249$ROCHE$$79$YR$E$F$Y$64$KG$20240712$$MD$FR$FR
232334182$23233418$2$F$20231123$20240708$20231128$20240709$PER$$US-AMGEN-USASP2023211867$AMGEN$$67$YR$E$F$Y$$$20240709$$CN$US$US
2323366710$23233667$10$F$20230417$20240912$20231128$20240919$EXP$$US-Eisai-EC-2023-138882$EISAI$$46$YR$A$F$Y$$$20240919$$MD$US$US
232337214$23233721$4$F$20130601$20240805$20231128$20240809$EXP$$CA-SANDOZ INC.-PHHY2013CA077935$SANDOZ$$62$YR$$F$Y$88$KG$20240809$$CN$CA$CA
232338333$23233833$3$F$20231128$20240807$20231128$20240813$EXP$$CA-TAKEDA-2023TUS082370$TAKEDA$$20$YR$$M$Y$$$20240813$$CN$CA$CA
232338965$23233896$5$F$20040101$20240827$20231128$20240903$EXP$$CO-Ipsen Biopharmaceuticals, Inc.-2023-19999$IPSEN$$52$YR$A$M$Y$70$KG$20240903$$CN$CO$CO
232339125$23233912$5$F$20230101$20240710$20231128$20240718$EXP$$US-SA-2023SA363052$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240718$$MD$US$US
232339143$23233914$3$F$$20240620$20231128$20240702$PER$$US-SA-2023SA367313$SANOFI AVENTIS$$9$YR$C$M$Y$30.8$KG$20240702$$MD$US$US
232339162$23233916$2$F$20230901$20240821$20231128$20240905$PER$$US-SA-2023SA363393$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240905$$MD$US$US
232343167$23234316$7$F$20220601$20240909$20231128$20240912$EXP$$US-SANDOZ INC.-NVSC2021US281145$SANDOZ$$43$YR$$F$Y$71.655$KG$20240912$$CN$US$US
232343505$23234350$5$F$20230101$20240621$20231128$20240702$PER$$US-SA-2023SA363373$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240702$$MD$US$US
232343902$23234390$2$F$$20240814$20231128$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-022887$JAZZ$$$$$M$Y$$$20240819$$CN$US$US
232344062$23234406$2$F$20230201$20240815$20231128$20240817$EXP$$TH-TAKEDA-2023TUS031576$TAKEDA$$32$YR$$M$Y$$$20240817$$CN$TH$TH
2323440811$23234408$11$F$20240206$20240827$20231128$20240830$EXP$$CA-TAKEDA-2022TUS084371$TAKEDA$$25$YR$$F$Y$$$20240830$$MD$CA$CA
232344185$23234418$5$F$20220101$20240927$20231128$20240930$EXP$$CA-JNJFOC-20230757984$JOHNSON AND JOHNSON$$25$YR$A$F$Y$74$KG$20240930$$HP$CA$CA
232344305$23234430$5$F$20231009$20240917$20231128$20240923$EXP$$ZA-SANDOZ INC.-SDZ2023ZA060180$SANDOZ$$68$YR$$M$Y$$$20240923$$CN$ZA$ZA
232345174$23234517$4$F$20230901$20240709$20231128$20240711$EXP$$US-CIPLA LTD.-2023US05502$CIPLA$$$$$$Y$$$20240711$$CN$US$US
232345974$23234597$4$F$$20240807$20231128$20240809$EXP$$JP-ASTELLAS-2023JP012993$ASTELLAS$$45$YR$$M$Y$$$20240809$$MD$JP$JP
232346133$23234613$3$F$20230101$20240702$20231128$20240711$PER$$US-SA-2023SA367764$SANOFI AVENTIS$$25$YR$A$F$Y$79.37$KG$20240711$$MD$US$US
232346644$23234664$4$F$20231110$20240522$20231128$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003098$TG THERAPEUTICS$$51$YR$$F$Y$64.399$KG$20240715$$CN$US$US
232346812$23234681$2$F$$20240822$20231128$20240903$PER$$US-SA-2023SA259338$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240903$$MD$US$US
232347983$23234798$3$F$20230929$20240906$20231128$20240910$EXP$$FR-TAKEDA-2023TUS114759$TAKEDA$$58$YR$$F$Y$$$20240910$$HP$FR$FR
232348193$23234819$3$F$20230901$20240816$20231128$20240828$PER$$US-SA-2023SA362906$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240828$$MD$US$US
2323489810$23234898$10$F$20180821$20240905$20231128$20240912$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-009794$AMGEN$$75$YR$E$M$Y$$$20240912$$MD$US$US
232349352$23234935$2$F$20180918$20240701$20231128$20240702$EXP$$DE-SANDOZ INC.-SDZ2023DE059513$SANDOZ$$82$YR$$F$Y$$$20240702$$HP$DE$DE
232349755$23234975$5$F$$20240926$20231128$20240930$EXP$$CA-TAKEDA-2023TUS114208$TAKEDA$$$$$F$Y$$$20240930$$CN$CA$CA
232350854$23235085$4$F$20230701$20240627$20231128$20240701$EXP$$US-PFIZER INC-202300396482$PFIZER$$66$YR$$F$Y$75.75$KG$20240701$$CN$US$US
232351146$23235114$6$F$20210121$20240701$20231128$20240702$PER$$US-PFIZER INC-PV202300191959$PFIZER$$78$YR$$F$Y$74.376$KG$20240702$$CN$US$US
232351613$23235161$3$F$20240125$20240730$20231128$20240805$EXP$$US-PFIZER INC-PV202300188614$PFIZER$$84$YR$$F$Y$$$20240805$$HP$US$US
232352294$23235229$4$F$20230101$20240808$20231128$20240808$EXP$$CA-PFIZER INC-202300393003$PFIZER$$68$YR$$F$Y$$$20240808$$HP$CA$CA
2323523010$23235230$10$F$20230101$20240712$20231128$20240717$EXP$$CA-PFIZER INC-202300385663$PFIZER$$70$YR$$M$Y$$$20240717$$MD$CA$CA
232352322$23235232$2$F$$20240910$20231128$20240918$EXP$$JP-AMGEN-JPNSP2023209325$AMGEN$Okano Y.; Kowata S.; Kitamura S. et al.. A post-transplant relapsed Ph- acute lymphoblastic leukemia patient who was successfully treated with reduced dose of blinatumomab. 85th Congress of the Japanese Society of Hematology. 2023;1144$$$A$M$Y$$$20240918$$MD$JP$JP
232353383$23235338$3$F$20220601$20240911$20231128$20240918$EXP$$CA-TAKEDA-2022TUS089700$TAKEDA$$31$YR$$F$Y$$$20240918$$CN$CA$CA
232353933$23235393$3$F$20221001$20240717$20231128$20240717$EXP$$CA-PFIZER INC-202201191426$PFIZER$$31$YR$$M$Y$$$20240717$$MD$CA$CA
232354042$23235404$2$F$20220921$20240822$20231128$20240824$EXP$$US-TAKEDA-2022TUS044663$TAKEDA$$59$YR$$F$Y$66$KG$20240824$$HP$US$US
232354212$23235421$2$F$$20240702$20231128$20240704$EXP$$US-PFIZER INC-PV202300191268$PFIZER$$88$YR$$F$Y$$$20240704$$CN$US$US
2323544911$23235449$11$F$$20240818$20231128$20240819$30DAY$$CR-PFIZER INC-PV202300185452$PFIZER$$9$YR$$M$Y$$$20240819$$HP$CR$CR
232354514$23235451$4$F$20231120$20240710$20231128$20240712$EXP$$CA-PFIZER INC-202300312919$PFIZER$$27$YR$$F$Y$59$KG$20240712$$MD$CA$CA
232355097$23235509$7$F$20230101$20240905$20231128$20240905$EXP$$CA-PFIZER INC-202200489623$PFIZER$$60$YR$$M$Y$89$KG$20240905$$MD$CA$CA
232355785$23235578$5$F$$20240702$20231128$20240704$PER$$US-PFIZER INC-PV202300188231$PFIZER$$87$YR$$F$Y$$$20240704$$CN$US$US
232355973$23235597$3$F$20230329$20240625$20231128$20240702$EXP$$NVSC2023IN252012$NOVARTIS$$60$YR$$M$Y$$$20240702$$CN$IN$IN
232356606$23235660$6$F$$20240826$20231128$20240830$EXP$$IN-PFIZER INC-PV202300193363$PFIZER$$69$YR$$M$Y$$$20240830$$CN$IN$IN
232356765$23235676$5$F$20231101$20240709$20231128$20240711$PER$$US-PFIZER INC-202300377216$PFIZER$$74$YR$$F$Y$52.16$KG$20240711$$HP$US$US
232357683$23235768$3$F$20230927$20240723$20231128$20240731$EXP$$JP-AstraZeneca-2023A223055$ASTRAZENECA$$88$YR$$F$Y$44$KG$20240731$$MD$JP$
232357864$23235786$4$F$$20240925$20231128$20240927$PER$$US-PFIZER INC-202300391886$PFIZER$$65$YR$$M$Y$$$20240927$$CN$US$US
232357942$23235794$2$F$20230901$20240906$20231128$20240910$PER$$US-PFIZER INC-PV202300087197$PFIZER$$31$YR$$F$Y$$$20240910$$CN$US$US
232358022$23235802$2$F$$20240703$20231128$20240708$PER$$US-PFIZER INC-202300376504$PFIZER$$76$YR$$M$Y$$$20240708$$HP$US$US
232358235$23235823$5$F$20231115$20240823$20231128$20240829$PER$$US-PFIZER INC-PV202300168393$PFIZER$$75$YR$$M$Y$77$KG$20240829$$CN$US$US
232359394$23235939$4$F$20200101$20240726$20231128$20240730$EXP$$US-PFIZER INC-PV202300191329$PFIZER$$61$YR$$F$Y$$$20240730$$HP$US$US
2323599611$23235996$11$F$20230101$20240816$20231128$20240821$EXP$$US-PFIZER INC-202300400494$PFIZER$$61$YR$$M$Y$61.69$KG$20240821$$CN$US$US
232361266$23236126$6$F$20220301$20240829$20231128$20240902$EXP$$NVSC2022GB072533$NOVARTIS$$39$YR$$F$Y$112.49$KG$20240902$$CN$GB$GB
232361273$23236127$3$F$$20240722$20231128$20240731$EXP$$NVSC2023IE251745$NOVARTIS$O^Brien S, Griffin B, Dorman AM. Interesting biopsy of a patient with AKI on a background of systemic mastocytosis. J AM SOC NEPHROL. 2023;34:110-1$72$YR$$F$Y$$$20240731$$HP$IE$IE
232361523$23236152$3$F$$20240918$20231128$20240930$PER$$NVSC2023US249972$NOVARTIS$$$$$F$Y$48.073$KG$20240930$$CN$US$US
232362162$23236216$2$F$$20240912$20231128$20240927$EXP$$PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420747$RANBAXY$Sarfraz S, Wali RM, Jameel M. Lymphomatoid Granulomatosis: A Case Report and Literature Review of a Rare Pediatric Disorder From Pakistan. J Pediatr Hematol Oncol. 2023;Oct; 45(7):E927-E930$6$MON$$M$Y$$$20240927$$MD$PK$PK
232362472$23236247$2$F$$20240708$20231128$20240723$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-420875$RANBAXY$Zughaibi TA, Alharbi H, Al-Saadi A, Alzahrani AE, Al-Asmari AI.. 11-Nor-9-Carboxy Tetrahydrocannabinol Distribution in Fluid from the Chest Cavity in Cannabis-Related Post-Mortem Cases. Toxics. 2023;11(9):no pagination$22$YR$$$Y$$$20240723$$HP$SA$SA
232363362$23236336$2$F$$20240701$20231128$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421309$RANBAXY$$$$A$M$Y$$$20240712$$MD$US$US
2323637810$23236378$10$F$20231101$20240726$20231128$20240925$EXP$$US-GSK-US2023AMR159786$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
232364275$23236427$5$F$$20240715$20231128$20240723$EXP$$CA-SANDOZ INC.-PHHY2018CA019720$SANDOZ$$$$$M$Y$130$KG$20240723$$MD$CA$CA
2323645913$23236459$13$F$20231101$20240806$20231128$20240813$EXP$$US-GSK-US2023AMR162906$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
232365913$23236591$3$F$$20240702$20231128$20240703$PER$$NVSC2023US252903$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
232366872$23236687$2$F$$20231117$20231128$20240925$PER$$US-GSK-US2023AMR162915$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
232366922$23236692$2$F$$20240628$20231128$20240704$EXP$$US-GSK-US2023AMR163365$GLAXOSMITHKLINE$$$$$F$Y$109.9$KG$20240704$$CN$US$US
232367742$23236774$2$F$20231113$20240808$20231128$20240820$EXP$$US-VIIV HEALTHCARE LIMITED-US2023158928$VIIV$$24$YR$$M$Y$$$20240820$$HP$US$US
232367873$23236787$3$F$$20240729$20231128$20240802$EXP$$CA-AstraZeneca-2019SF89143$ASTRAZENECA$$97$YR$$F$Y$81$KG$20240802$$MD$CA$
232368622$23236862$2$F$20200707$20240816$20231128$20240820$EXP$$CA-TAKEDA-2023TUS114277$TAKEDA$$38$YR$$M$Y$$$20240820$$CN$CA$CA
232369424$23236942$4$F$20230101$20240622$20231128$20240701$PER$$US-SA-2023SA319646$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240701$$MD$US$US
232369766$23236976$6$F$20230601$20240908$20231128$20240910$EXP$$US-TAKEDA-2023TUS113986$TAKEDA$$64$YR$$F$Y$$$20240910$$HP$US$US
2323705011$23237050$11$F$20240101$20240715$20231128$20240722$EXP$$CO-GSK-CO2023AMR163172$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$CO$CO
2323705312$23237053$12$F$20240801$20240821$20231128$20240827$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-148389$DAIICHI$$47$YR$$F$Y$$$20240827$$CN$US$US
232371322$23237132$2$F$20231015$20240729$20231128$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004756$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240821$$HP$US$US
232371344$23237134$4$F$$20240613$20231128$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005028$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
232371382$23237138$2$F$20221101$20240610$20231128$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004236$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240705$$CN$US$US
232371453$23237145$3$F$20240501$20240624$20231128$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005038$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240718$$CN$US$US
232371503$23237150$3$F$20240314$20240619$20231128$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005051$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240712$$CN$US$US
232372473$23237247$3$F$20231001$20240830$20231128$20240911$PER$$US-SA-2023SA367322$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240911$$MD$US$US
232372912$23237291$2$F$$20240611$20231128$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005068$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
232373132$23237313$2$F$$20240607$20231128$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005070$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
232373763$23237376$3$F$$20240828$20231128$20240902$EXP$$ES-ROCHE-3463387$ROCHE$Pena M, Montane C, Paviglianiti A, Hurtado L, Gonzalez S, Carro I, Maluquer C, Domingo-Domenech E, Gonzalez-Barca E, Sureda A and Mussetti A. Outcomes of allogeneic hematopoietic cell transplantation after bispecific antibodies in non-Hodgkin lymphomas. DOI: 10.1038/s41409-023-02069-2. Bone Marrow Transplantation 2023 Nov;58 (11):1282-5.$57$YR$A$M$Y$$$20240902$$HP$ES$ES
232374564$23237456$4$F$20231101$20240807$20231128$20240816$EXP$$US-Eisai-EC-2023-153852$EISAI$$54$YR$A$M$Y$85.45$KG$20240816$$CN$US$US
2323755012$23237550$12$F$20231120$20240801$20231128$20240806$EXP$$US-TAKEDA-2023TUS111372$TAKEDA$$4$YR$$M$Y$18$KG$20240806$$PH$US$US
232375625$23237562$5$F$$20240716$20231128$20240718$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-148162$DAIICHI$$$$$F$Y$$$20240718$$CN$US$US
232375713$23237571$3$F$20231023$20240924$20231128$20240930$EXP$$DE-TAKEDA-2023TUS114922$TAKEDA$$74$YR$$M$Y$100$KG$20240930$$HP$DE$DE
232375802$23237580$2$F$$20240913$20231128$20240917$EXP$CA-HEALTHCANVIG-E2B_06169209$CA-PURDUE-USA-2023-0306169$PURDUE$$36$YR$$M$Y$$$20240917$$HP$CA$CA
232375945$23237594$5$F$20231116$20240702$20231128$20240709$EXP$$JP-BIOMARINAP-JP-2023-154105$BIOMARIN$$$$$$Y$$$20240709$$CN$JP$JP
232375993$23237599$3$F$$20240719$20231128$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-170611$BRISTOL MYERS SQUIBB$Mihara M, Yiriutishima H, Tumamoto A, Terasaki Y, Saito A, Yisoda A, et al. Experience with isatuximab monotherapy in patients with relapsed or refractory multiple myeloma at our hospital. The 85th Congress of the Japanese Society of Hematology (Programs and Abstracts; Web). 2023;$75$YR$E$M$Y$$$20240723$$MD$JP$JP
232376207$23237620$7$F$20220202$20240701$20231128$20240707$EXP$$NVSC2022JP276984$NOVARTIS$$58$YR$$F$Y$48.9$KG$20240708$$HP$JP$JP
232376292$23237629$2$F$$20240711$20231128$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-170042$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240719$$MD$JP$JP
232376349$23237634$9$F$$20240826$20231128$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-170191$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240902$$MD$JP$JP
232376432$23237643$2$F$$20240809$20231128$20240819$EXP$$FR-AUROBINDO-AUR-APL-2023-042166$AUROBINDO$Watson P, Lamiaux M, Lebas D, Modiano P. Stevens-Johnson syndrome induced by lacosamide: A rare adverse reaction.. Annales de Dermatologie et de V?n?r?ologie.. 2023;150 (3):223-224$69$YR$$M$Y$$$20240819$$MD$FR$FR
232377472$23237747$2$F$$20240801$20231128$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-171245$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$74.84$KG$20240809$$CN$US$US
232377524$23237752$4$F$$20240711$20231128$20240801$PER$$US-SA-2023SA365594$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240719$$MD$US$US
232378424$23237842$4$F$20210929$20240628$20231128$20240709$EXP$$CZ-CELLTRION INC.-2023CZ022478$CELLTRION$$$$$$Y$$$20240709$$MD$CZ$CZ
232378433$23237843$3$F$20211101$20240702$20231128$20240710$EXP$$IT-CELLTRION INC.-2023IT022686$CELLTRION$$$$$$Y$$$20240710$$MD$IT$IT
232378554$23237855$4$F$20210801$20240827$20231128$20240905$EXP$$AU-CELLTRION INC.-2022AU020204$CELLTRION$$$$$$Y$$$20240905$$MD$AU$AU
232378644$23237864$4$F$$20240903$20231128$20240910$EXP$$AU-CELLTRION INC.-2023AU020317$CELLTRION$$$$$$Y$$$20240910$$MD$AU$AU
232378724$23237872$4$F$20230101$20240711$20231128$20240720$EXP$$CA-CELLTRION INC.-2023CA009412$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
232379244$23237924$4$F$20231125$20240814$20231128$20240818$EXP$$NVSC2023US251758$NOVARTIS$$65$YR$$F$Y$$$20240818$$CN$US$US
232379783$23237978$3$F$20210928$20240909$20231129$20240916$EXP$$US-ABBVIE-5510506$ABBVIE$$58$YR$$M$Y$$$20240916$$CN$US$US
232380376$23238037$6$F$20231001$20240829$20231129$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-168175$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240911$$CN$US$US
232380432$23238043$2$F$$20240813$20231129$20240823$EXP$$US-NOVITIUMPHARMA-2023USNVP02042$NOVITIUM PHARMA$Shilpa Guntaka.Dexamethasone swish and spit, a cause of iatrogenic adrenal insufficiency.Hormone Research in Paediatrics.2023;96(3):13-14$14$YR$T$M$Y$$$20240823$$HP$US$US
232382103$23238210$3$F$20231012$20240904$20231129$20240912$PER$$US-SA-2023SA363974$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240912$$MD$US$US
232383402$23238340$2$F$$20240812$20231129$20240816$EXP$$IN-IPCA LABORATORIES LIMITED-IPC-2023-IN-002061$IPCA$Shreyashi Kukreti and Anamya Tomar. Warfarin-induced bleeding dyscrasia:  A case of bleeding in gums, hematuria, and bruises. International Journal of Academic Medicine and Pharmacy. 2023;5(3):1075-1077$$$$$Y$$$20240816$$HP$IN$IN
2323835311$23238353$11$F$20190904$20240910$20231129$20240916$EXP$$CA-SANDOZ INC.-PHHY2019CA215266$SANDOZ$$49$YR$$M$Y$128$KG$20240916$$CN$CA$CA
232383723$23238372$3$F$20220101$20240716$20231129$20240805$PER$$CO-TOLMAR, INC.-23CO044707$TOLMAR$$$$$M$Y$$$20240805$$CN$CO$CO
232384233$23238423$3$F$$20231120$20231129$20240710$PER$$US-PFM-2023-06561$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.342$KG$20240710$$CN$US$US
232384312$23238431$2$F$$20240729$20231129$20240807$PER$$US-SA-2023SA368328$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240807$$MD$US$US
232385023$23238502$3$F$20230101$20240918$20231129$20240927$PER$$US-SA-2023SA364064$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240927$$MD$US$US
232386006$23238600$6$F$$20240724$20231129$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-170196$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240731$$MD$JP$JP
232387282$23238728$2$F$20231030$20240710$20231129$20240723$EXP$$FR-AUROBINDO-AUR-APL-2023-074738$AUROBINDO$$71$YR$$F$Y$72$KG$20240719$$PH$FR$FR
232387583$23238758$3$F$20240623$20240627$20231129$20240703$EXP$$US-GSK-US2023159916$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$US$US
232388063$23238806$3$F$20230610$20240827$20231129$20240829$EXP$$US-ABBVIE-5510361$ABBVIE$$66$YR$$F$Y$111$KG$20240829$$CN$US$US
232388675$23238867$5$F$$20240911$20231129$20240919$EXP$$IT-AUROBINDO-AUR-APL-2022-026707$AUROBINDO$Cabrera Morales JS, Cambule S, Pileri P, Monni A, Galasso P, Poddighe A et al. Drug-induced cholestatic liver injury: a case report. Italian Journal of Medicine.. 2022;16(SUPPL 1):82$82$YR$$F$Y$$$20240919$$HP$IT$IT
232388813$23238881$3$F$$20240723$20231129$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-171526$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240724$$HP$US$US
232389222$23238922$2$F$20210614$20240628$20231129$20240711$EXP$$CA-INTERCEPT-PM2021002168$INTERCEPT PHARMACEUTICALS$$67$YR$$M$Y$$$20240711$$MD$CA$CA
232389792$23238979$2$F$$20231116$20231129$20240925$PER$$US-GSK-US2023AMR164702$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
232390346$23239034$6$F$$20240628$20231129$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-172452$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240704$$MD$JP$JP
232390555$23239055$5$F$$20240219$20231129$20240731$EXP$$CA-SA-2023SA366337$SANOFI AVENTIS$$48$YR$A$F$Y$68$KG$20240731$$HP$CA$CA
232390595$23239059$5$F$20230430$20240515$20231129$20240813$EXP$$CL-SANDOZ INC.-NVSC2023CL107678$SANDOZ$$36$YR$$F$Y$80$KG$20240813$$CN$CL$CL
232391084$23239108$4$F$$20240913$20231129$20240917$EXP$$CA-SANDOZ INC.-SDZ2023CA060426$SANDOZ$$41$YR$$F$Y$$$20240917$$HP$CA$CA
232391162$23239116$2$F$20230101$20240730$20231129$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-171173$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240731$$MD$JP$JP
232391286$23239128$6$F$$20240906$20231129$20240919$EXP$$US-INSMED, INC.-2023-00282-US$INSMED$$$$$F$Y$$$20240919$$CN$US$US
232391782$23239178$2$F$20201117$20240703$20231129$20240715$EXP$$CA-TAKEDA-2020TUS049882$TAKEDA$$73$YR$$M$Y$$$20240715$$CN$CA$CA
232392304$23239230$4$F$20231101$20240628$20231129$20240704$EXP$$DE-ABBVIE-5517777$ABBVIE$$79$YR$$F$Y$$$20240704$$CN$DE$DE
232393073$23239307$3$F$20230101$20240710$20231129$20240715$EXP$$CA-ABBVIE-5510227$ABBVIE$$$$$F$Y$$$20240715$$CN$CA$CA
232393102$23239310$2$F$20221001$20240918$20231129$20240924$PER$$NVSC2023US249179$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
232393112$23239311$2$F$$20240703$20231129$20240706$PER$$NVSC2023US253713$NOVARTIS$$$$$F$Y$$$20240706$$HP$US$US
232395222$23239522$2$F$20231007$20240708$20231129$20240711$PER$$US-AMGEN-USASP2023211408$AMGEN$$43$YR$A$F$Y$$$20240711$$HP$US$US
232396572$23239657$2$F$20231101$20231127$20231129$20240917$EXP$$DE-TORRENT-00025782$TORRENT$$$$A$M$Y$75$KG$20240917$$CN$DE$DE
232397182$23239718$2$F$$20231123$20231129$20240731$EXP$$CA-SA-2023SA368499$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240731$$HP$CA$CA
232397262$23239726$2$F$20210501$20240829$20231129$20240909$EXP$FR-AFSSAPS-AN20211823$FR-Accord-392006$ACCORD$$71$YR$E$M$Y$$$20240909$$MD$FR$FR
232397466$23239746$6$F$$20240918$20231129$20240925$EXP$$CA-GSK-CA2023AMR165214$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$CA$CA
232397605$23239760$5$F$$20240823$20231129$20240829$EXP$$CA-TAKEDA-2023TUS113251$TAKEDA$$$$$F$Y$$$20240829$$MD$CA$CA
232398013$23239801$3$F$20240101$20240913$20231129$20240926$EXP$$US-UCBSA-2023056147$UCB$$$$$F$Y$54.422$KG$20240926$$HP$US$US
232399773$23239977$3$F$20231117$20240923$20231129$20240925$PER$$US-PFIZER INC-202300381434$PFIZER$$79$YR$$M$Y$112.49$KG$20240925$$MD$US$US
232399984$23239998$4$F$$20240729$20231129$20240731$PER$$US-PFIZER INC-PV202300190824$PFIZER$$71$YR$$F$Y$$$20240731$$MD$US$US
232400785$23240078$5$F$$20240729$20231129$20240731$PER$$US-PFIZER INC-202300392785$PFIZER$$71$YR$$F$Y$$$20240731$$MD$US$US
232400865$23240086$5$F$$20240924$20231129$20240930$EXP$CA-MLMSERVICE-20231113-4658883-1$CA-JUBILANT CADISTA PHARMACEUTICALS-2023CA001469$JUBILANT$Amarasekera R, Wood E. Worsening stimulant use disorder outcomes coinciding with off-label antipsychotic prescribing: a commonly unrecognised side effect?. BMJ case reports. 2023;16(10):e255129$3$DEC$$M$Y$$$20240930$$MD$CA$CA
232401244$23240124$4$F$20240508$20240808$20231129$20240909$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000409$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
232401988$23240198$8$F$$20240628$20231129$20240703$EXP$$CA-PURDUE-USA-2023-0306171$PURDUE$$50$YR$$F$Y$68$KG$20240703$$HP$CA$CA
232402534$23240253$4$F$$20240808$20231129$20240814$EXP$$JP-009507513-2311JPN003071J$MERCK$Machigashira S, Mori T, Nakamura K, Noguchi Y, Kodama N, Nagata R, et al.. 22 A case of extraocular myositis due to irAE of pembrolizumab. The 241st Kyushu Regional Meeting of the Japanese Society of Neurology. 19$80$YR$$M$Y$$$20240814$$MD$JP$JP
232402623$23240262$3$F$$20240829$20231129$20240903$EXP$$CA-TAKEDA-2023TUS114514$TAKEDA$$$$$F$Y$$$20240903$$CN$CA$CA
232402637$23240263$7$F$20220212$20240905$20231129$20240910$EXP$$JP-009507513-2311JPN003000J$MERCK$Isahaya K, Kaburagi K, Soga K, Akamatsu S, Yamano Y. OD15-7 A case of 65-year-old male with renal pelvis and ureteric cancer who developed sensorimotor neuropathy after administration of pembrolizumab and enfortumab. Neurological Therapeutics/The 41st Annual Meeting of Japanese Society of Neurolo. 2023;40(6):S250$65$YR$$M$Y$$$20240910$$MD$JP$JP
232402965$23240296$5$F$$20240822$20231129$20240827$PER$$US-PFIZER INC-PV202300093467$PFIZER$$62$YR$$F$Y$$$20240827$$HP$US$US
232404082$23240408$2$F$20220709$20240725$20231129$20240809$EXP$$SE-BRAEBURN-SE-BRA-23-000528$BRAEBURN PHARMACEUTICALS$$32$YR$$F$Y$$$20240809$$MD$SE$SE
232404243$23240424$3$F$20230101$20240627$20231129$20240710$PER$$US-SA-2023SA364923$SANOFI AVENTIS$$56$YR$A$F$Y$91.429$KG$20240710$$MD$US$US
232404364$23240436$4$F$20231101$20240725$20231129$20240730$EXP$$US-SA-2023SA332340$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240730$$CN$US$US
232404402$23240440$2$F$20230101$20240801$20231129$20240809$PER$$US-SA-2023SA363920$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240809$$MD$US$US
232404702$23240470$2$F$20230101$20240806$20231129$20240813$PER$$US-SA-2023SA363813$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240814$$MD$US$US
232404914$23240491$4$F$20230101$20240712$20231129$20240801$EXP$$US-SA-2023SA316832$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240719$$MD$US$US
232405073$23240507$3$F$20231101$20240620$20231129$20240702$PER$$US-SA-2023SA366593$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240702$$MD$US$US
232405302$23240530$2$F$20230101$20240715$20231129$20240722$PER$$US-SA-2023SA368709$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240721$$MD$US$US
232407123$23240712$3$F$20230328$20240702$20231129$20240712$EXP$$CA-ROCHE-3323223$ROCHE$$61$YR$A$F$Y$$$20240712$$CN$CA$CA
232407222$23240722$2$F$$20240731$20231129$20240808$PER$$US-SA-2023SA364791$SANOFI AVENTIS$$$$A$F$Y$66.6$KG$20240808$$MD$US$US
232407593$23240759$3$F$20231120$20240724$20231129$20240727$PER$$US-AMGEN-USASP2023212480$AMGEN$$65$YR$E$M$Y$$$20240727$$CN$US$US
232407666$23240766$6$F$20230202$20240627$20231129$20240701$EXP$$CA-TAKEDA-2022TUS036244$TAKEDA$$43$YR$$F$Y$$$20240701$$HP$CA$CA
232408562$23240856$2$F$20200101$20240620$20231129$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202311012111$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240702$$CN$US$US
232409033$23240903$3$F$$20240903$20231129$20240905$EXP$$CA-TAKEDA-2023TUS114675$TAKEDA$$$$$F$Y$$$20240905$$CN$CA$CA
232409075$23240907$5$F$20240101$20240801$20231129$20240805$EXP$$NL-ABBVIE-5515835$ABBVIE$$77$YR$$M$Y$$$20240805$$CN$NL$NL
232409267$23240926$7$F$20231016$20240911$20231129$20240913$EXP$$ES-TAKEDA-2023TUS115347$TAKEDA$$4$YR$$M$Y$$$20240913$$HP$ES$ES
232409326$23240932$6$F$$20240708$20231129$20240710$EXP$$US-PFIZER INC-PV202300103721$PFIZER$$75$YR$$F$Y$62.585$KG$20240710$$CN$US$US
232410879$23241087$9$F$20210101$20240709$20231129$20240711$EXP$$IT-MYLANLABS-2023M1124425$MYLAN$Zoli S, Pellegrini C, Casadei B, Broccoli A, Argnani L, Nanni L, Stefoni V, Zinzani PL.. Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-cell Lymphoma, Leg-type: A Case Report.. Chemotherapy. 2023$85$YR$$F$Y$$$20240711$$HP$IT$IT
232411394$23241139$4$F$$20240627$20231129$20240702$EXP$$US-TAKEDA-2023TUS112915$TAKEDA$$$$$F$Y$$$20240702$$HP$US$US
232411499$23241149$9$F$20231020$20240624$20231129$20240701$EXP$$CA-OTSUKA-2022_026764$OTSUKA$$78$YR$$M$Y$83.9$KG$20240701$$MD$CA$CA
232411742$23241174$2$F$20231027$20240903$20231129$20240904$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-006686$JAZZ$$63$YR$$M$Y$$$20240903$$HP$US$US
232412372$23241237$2$F$20231030$20240712$20231129$20240715$EXP$$FR-PFIZER INC-202300396592$PFIZER$$71$YR$$F$Y$72$KG$20240715$$PH$FR$FR
2324124112$23241241$12$F$$20240904$20231129$20240909$EXP$$US-PFIZER INC-PV202300067106$PFIZER$$73$YR$$F$Y$78.912$KG$20240909$$HP$US$US
232412607$23241260$7$F$$20240828$20231129$20240903$EXP$$AU-PFIZER INC-202300405024$PFIZER$Limaye, S.. Successful use of subcutaneous anakinra in hemophagocytic lymphohistiocytosis precipitated by candidiasis in a patient with systemic lupus erythematosus: A case report and description of a novel therapeutic regimen. International Journal of Rheumatic Disease. 2023;26(11):2284-2287$43$YR$$F$Y$$$20240903$$MD$AU$AU
232412976$23241297$6$F$20230927$20240911$20231129$20240926$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-421082$RANBAXY$$85$YR$$M$Y$$$20240926$$HP$BE$BE
232413102$23241310$2$F$$20240904$20231129$20240919$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421245$RANBAXY$Zughaibi TA, Alharbi H, Al-Saadi A, Alzahrani AE, AlAsmari AI. 11-Nor-9-Carboxy Tetrahydrocannabinol Distribution in Fluid from the Chest Cavity in Cannabis-Related Post-Mortem Cases. Toxics. 2023;11(9):740(1-15)$50$YR$$$Y$$$20240919$$HP$SA$SA
232413615$23241361$5$F$20240119$20240922$20231129$20240926$EXP$$IN-PFIZER INC-PV202300192005$PFIZER$$75$YR$$F$Y$60.2$KG$20240926$$CN$IN$IN
232413632$23241363$2$F$20220101$20240920$20231129$20240925$EXP$$CA-PFIZER INC-202300401355$PFIZER$$80$YR$$M$Y$$$20240925$$MD$CA$CA
232413802$23241380$2$F$$20240618$20231129$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-420984$RANBAXY$$60$YR$$F$Y$$$20240703$$CN$GB$GB
232414567$23241456$7$F$20230227$20240827$20231129$20240902$EXP$$BE-ORGANON-O2311BEL002344$ORGANON$$85$YR$$M$Y$$$20240902$$MD$BE$BE
232415033$23241503$3$F$20231101$20231127$20231129$20240925$PER$$US-GSK-US2023AMR160941$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
232415176$23241517$6$F$$20240716$20231129$20240723$EXP$$GR-MYLANLABS-2023M1123428$MYLAN$Butari H et al.. Venlafaxine and Monitoring for Induced Platelet Dysfunction - Case Reports.. Haema. 2023;Vol14 Suppl.1:450-1$54$YR$$F$Y$$$20240723$$MD$GR$GR
232416042$23241604$2$F$20230822$20240826$20231129$20240830$EXP$FR-AFSSAPS-BS2023000804$FR-MYLANLABS-2023M1124844$MYLAN$$59$YR$$M$Y$100$KG$20240830$$MD$FR$FR
232416944$23241694$4$F$20210317$20240625$20231129$20240702$EXP$$DE-ABBVIE-5510944$ABBVIE$$71$YR$$M$Y$125$KG$20240702$$MD$DE$DE
232417714$23241771$4$F$20230824$20240903$20231129$20240912$EXP$$US-AGIOS-2311US03526$AGIOS PHARMACEUTICALS$$29$YR$$M$Y$$$20240912$$MD$US$US
232417882$23241788$2$F$20231002$20240122$20231129$20240926$EXP$$NVSC2023FR251349$NOVARTIS$$35$YR$$M$Y$$$20240926$$MD$FR$FR
232417963$23241796$3$F$20231016$20240710$20231129$20240716$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004343$AURINIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240716$$CN$US$US
232418242$23241824$2$F$$20240919$20231129$20240920$EXP$$NVSC2023US253021$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
232418282$23241828$2$F$20231121$20240723$20231129$20240805$30DAY$$US-GSK-US2023161728$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240805$$HP$US$US
232419317$23241931$7$F$20230716$20240816$20231129$20240822$EXP$$CN-TAKEDA-2023TUS092264$TAKEDA$$73$YR$$F$Y$45$KG$20240822$$MD$CN$CN
232419332$23241933$2$F$$20240724$20231129$20240801$EXP$$TR-AstraZeneca-2023A266303$ASTRAZENECA$Dogan SE, Kuskonmaz SM, Koc G, Aypar E, Culha C. Case Series: Exposure to Glucagon-like Peptide-1 Receptor Agonist in the First Trimester of Pregnancy in Two Siblings. Endocrine, Metabolic and Immune Disorders - Drug Targets (2024) 2024;24(10):1237-1239.$$$$F$Y$3.2$KG$20240801$$HP$TR$
232422426$23242242$6$F$20231117$20240906$20231129$20240913$EXP$$GB-MYLANLABS-2023M1124166$MYLAN$$38$YR$$M$Y$$$20240913$$HP$GB$GB
232422872$23242287$2$F$$20240731$20231129$20240806$EXP$$GB-TAKEDA-2023TUS094574$TAKEDA$$$$$M$Y$$$20240806$$CN$GB$GB
232423022$23242302$2$F$20230512$20240926$20231129$20240930$EXP$$FR-BAUSCH-BL-2023-017688$BAUSCH AND LOMB$$54$YR$$M$Y$68$KG$20240930$$HP$FR$FR
232423253$23242325$3$F$20230217$20231209$20231129$20240918$EXP$FR-AFSSAPS-AM2023001013$FR-BAUSCH-BL-2023-017692$BAUSCH AND LOMB$$28$YR$$F$Y$168$KG$20240918$$MD$FR$FR
232423314$23242331$4$F$20230417$20240708$20231129$20240717$EXP$$US-CHATTEMPRD-2023OHG015976$CHATTEM$$58$YR$A$M$Y$67.6$KG$20240717$$LW$US$US
232423462$23242346$2$F$$20240725$20231129$20240726$EXP$$CA-SANDOZ INC.-SDZ2023CA060784$SANDOZ$$77$YR$$F$Y$$$20240726$$CN$CA$CA
232423522$23242352$2$F$20230705$20240703$20231129$20240710$EXP$$US-CHATTEMPRD-2023OHG015978$CHATTEM$$70$YR$E$M$Y$$$20240710$$LW$US$US
232424083$23242408$3$F$20231117$20231226$20231129$20240922$EXP$$US-BAYER-2023A170424$BAYER$$30$YR$A$M$Y$$$20240922$$CN$US$US
232424784$23242478$4$F$$20240826$20231129$20240830$EXP$$US-INCYTE CORPORATION-2023IN012369$INCYTE$$$$$$Y$$$20240830$$CN$US$US
232424936$23242493$6$F$20231109$20240906$20231129$20240912$EXP$$US-DAIICHI SANKYO, INC.-DSU-2023-147945$DAIICHI$$56$YR$$F$Y$$$20240912$$CN$US$US
232425147$23242514$7$F$20230901$20240808$20231129$20240820$EXP$$US-INSMED, INC.-2023-00539-US$INSMED$$71$YR$$F$Y$$$20240820$$CN$US$US
232425544$23242554$4$F$$20240625$20231129$20240703$EXP$$CA-Novartis Pharma AG-NVSC2021CA007926$SANDOZ$$50$YR$$F$Y$$$20240703$$CN$CA$CA
232426874$23242687$4$F$$20240805$20231129$20240813$EXP$$US-BAUSCH-BL-2023-017751$BAUSCH AND LOMB$Vilayet S, Uehara G, Soliman K. When Hepatic Therapy Backfires: Unraveling the Intricacies of Rifaximin-Induced Rhabdomyolysis Post-Transplantation. Pharmacology: Kinetics, Genomics, Medication-Related Problems. 2023;.$56$YR$$M$Y$$$20240813$$HP$US$US
232427045$23242704$5$F$$20240911$20231129$20240917$EXP$$CA-BAUSCH-BL-2023-017463$BAUSCH AND LOMB$$48$YR$$F$Y$68$KG$20240918$$HP$CA$CA
232427092$23242709$2$F$$20240809$20231129$20240814$EXP$$GB-MYLANLABS-2023M1125628$MYLAN$$$$$M$Y$$$20240814$$CN$GB$GB
232427464$23242746$4$F$20230825$20240704$20231129$20240723$EXP$$JP-009507513-2311JPN003337J$MERCK$Yoshikawa T, Kawaguchi N, Naito A. B20 A Case of Breast Cancer with IrAE Liver Disorder during Treatment with Immune Checkpoint Inhibitor. Journal of Japan Surgical Association, Japan Surgical Association Aichi Branch [. 2024;85(6):826$62$YR$$F$Y$$$20240723$$MD$JP$JP
232428073$23242807$3$F$20231005$20240822$20231129$20240901$EXP$$BR-JNJFOC-20231065437$JOHNSON AND JOHNSON$$34$YR$A$M$Y$73$KG$20240901$$CN$BR$BR
2324289112$23242891$12$F$20230101$20240829$20231129$20240903$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-255945$BOEHRINGER INGELHEIM$$52$YR$A$F$Y$$$20240903$$CN$US$US
232428963$23242896$3$F$20180509$20240909$20231129$20240916$EXP$$GB-TAKEDA-GB201838111$TAKEDA$$$$A$M$Y$$$20240916$$MD$GB$GB
232429628$23242962$8$F$20230101$20240815$20231129$20240823$EXP$$CA-CELLTRION INC.-2023CA022814$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
232429652$23242965$2$F$20180227$20240815$20231129$20240819$EXP$$US-SHIRE-US201810755AA$TAKEDA$$66$YR$$F$Y$79$KG$20240819$$CN$US$US
232429808$23242980$8$F$20200701$20240828$20231129$20240906$EXP$$CA-CELLTRION INC.-2020CA024837$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
232431272$23243127$2$F$$20240724$20231130$20240801$EXP$$US-ALXN-A202311439$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
232431593$23243159$3$F$20231226$20240708$20231130$20240715$PER$$US-ALXN-202311USA001700US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240715$$HP$US$US
232431732$23243173$2$F$20231110$20240729$20231130$20240806$EXP$$US-ALXN-A202310320$ALEXION PHARMACEUTICALS$$66$YR$$F$Y$$$20240806$$MD$US$US
232432405$23243240$5$F$$20240704$20231130$20240708$PER$$US-ALXN-202311USA001560US$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240708$$CN$US$US
232433325$23243332$5$F$20211020$20240705$20231130$20240709$EXP$$CA-TAKEDA-2023TUS115358$TAKEDA$$66$YR$$M$Y$$$20240709$$CN$CA$CA
2324339312$23243393$12$F$20240101$20240703$20231130$20240708$PER$$US-SA-2023SA364821$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240708$$HP$US$US
232434784$23243478$4$F$20231101$20240822$20231130$20240906$EXP$$NL-ABBVIE-5518931$ABBVIE$$74$YR$$M$Y$$$20240906$$CN$NL$NL
232435384$23243538$4$F$20231121$20240805$20231130$20240808$EXP$$JP-ASTELLAS-2023JP013169$ASTELLAS$$81$YR$$F$Y$49$KG$20240808$$MD$JP$JP
232436745$23243674$5$F$$20240628$20231130$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-172420$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240704$$MD$JP$JP
232436932$23243693$2$F$$20240705$20231130$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-171302$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$MD$JP$JP
232438273$23243827$3$F$$20240712$20231130$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-172458$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240716$$HP$US$US
232438645$23243864$5$F$20231116$20240918$20231130$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-172807$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$44.45$KG$20240919$$CN$US$US
232439485$23243948$5$F$$20240628$20231130$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-172547$BRISTOL MYERS SQUIBB$Nakamura K, Ashida A, Kiniwa Y, Okuyama R. Summary of adjuvant therapy for advanced malignant melanoma in our department. Skin Cancer. 2021;36(3):212-7.$53$YR$A$M$Y$90.6$KG$20240704$$MD$JP$JP
232439553$23243955$3$F$$20240724$20231130$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-171464$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240731$$MD$JP$JP
232439945$23243994$5$F$$20240628$20231130$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-173108$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240704$$MD$JP$JP
232440085$23244008$5$F$$20240628$20231130$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-172554$BRISTOL MYERS SQUIBB$Nakamura K, Ashida A, Kiniwa Y, Okuyama R. Summary of adjuvant therapy for advanced malignant melanoma in our department. Skin Cancer. 2021;36(3):212-7.$81$YR$E$M$Y$$$20240704$$MD$JP$JP
232440115$23244011$5$F$$20240628$20231130$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-172521$BRISTOL MYERS SQUIBB$Nakamura K, Ashida A, Kiniwa Y, Okuyama R. Summary of adjuvant therapy for advanced malignant melanoma in our department. Skin Cancer. 2021;36(3):212-7.$57$YR$A$F$Y$$$20240704$$MD$JP$JP
232440124$23244012$4$F$$20240628$20231130$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-172577$BRISTOL MYERS SQUIBB$Nakamura K, Ashida A, Kiniwa Y, Okuyama R. Summary of adjuvant therapy for advanced malignant melanoma in our department. Skin Cancer. 2021;36(3):212-7.$58$YR$A$M$Y$$$20240704$$MD$JP$JP
232440165$23244016$5$F$$20240628$20231130$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-172578$BRISTOL MYERS SQUIBB$Nakamura K, Ashida A, Kiniwa Y, Okuyama R. Summary of adjuvant therapy for advanced malignant melanoma in our department. Skin Cancer. 2021;36(3):212-7.$74$YR$E$F$Y$$$20240704$$MD$JP$JP
232441023$23244102$3$F$20230329$20240625$20231130$20240703$EXP$$IN-SANDOZ INC.-SDZ2023IN061172$SANDOZ$$60$YR$$M$Y$$$20240703$$CN$IN$IN
232442102$23244210$2$F$20231128$20240730$20231130$20240801$PER$$US-AMGEN-USASP2023212993$AMGEN$$65$YR$E$F$Y$$$20240801$$CN$US$US
232442754$23244275$4$F$20231019$20240828$20231130$20240905$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003990$SAREPTA THERAPEUTICS$$19$YR$$M$Y$88.44$KG$20240905$$HP$US$US
232443356$23244335$6$F$$20240628$20231130$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-172543$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240705$$MD$JP$JP
232444383$23244438$3$F$20231101$20240815$20231130$20240819$EXP$$US-UCBSA-2023040120$UCB$$56$YR$$F$Y$$$20240819$$CN$US$US
232444894$23244489$4$F$20231127$20240909$20231130$20240910$EXP$$NVSC2023US253858$NOVARTIS$$42$YR$$M$Y$$$20240910$$CN$US$US
232445226$23244522$6$F$20231001$20240918$20231130$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-167731$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240920$$CN$US$US
232446352$23244635$2$F$$20240914$20231130$20240917$30DAY$$US-SANDOZ INC.-SDZ2023US061318$SANDOZ$$$$$F$Y$$$20240917$$CN$US$US
232446565$23244656$5$F$20230201$20240911$20231130$20240925$EXP$$CA-UCBSA-2023056118$UCB$$69$YR$$F$Y$$$20240925$$CN$CA$CA
232447414$23244741$4$F$20230101$20240730$20231130$20240807$PER$$CA-TOLMAR, INC.-23CA045000$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
232447747$23244774$7$F$20230825$20240620$20231130$20240715$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005120$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240715$$CN$US$US
232447955$23244795$5$F$$20240628$20231130$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-172549$BRISTOL MYERS SQUIBB$Nakamura K, Ashida A, Kiniwa Y, Okuyama R. Summary of adjuvant therapy for advanced malignant melanoma in our hospital. Skin Cancer. 2021;36(3):212-7.$38$YR$A$M$Y$$$20240704$$MD$JP$JP
232448389$23244838$9$F$20170808$20240813$20231130$20240822$EXP$$BE-CHATTEMPRD-2018SA003378$CHATTEM$$$$$M$Y$0.3$KG$20240822$$MD$BE$BE
2324492010$23244920$10$F$20230101$20240729$20231130$20240806$EXP$$CA-CELLTRION INC.-2023CA006191$CELLTRION$$$$$$Y$$$20240806$$MD$CA$CA
232449694$23244969$4$F$20220224$20240628$20231130$20240702$EXP$$JP-ASTELLAS-2023JP013206$ASTELLAS$$68$YR$$M$Y$50$KG$20240702$$MD$JP$JP
232449803$23244980$3$F$$20240829$20231130$20240904$30DAY$$CN-JNJFOC-20231144836$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$CN$CN
232450298$23245029$8$F$20200805$20240923$20231130$20240927$EXP$$CO-TAKEDA-2020TUS036766$TAKEDA$$47$YR$$F$Y$56$KG$20240927$$CN$CO$CO
232452354$23245235$4$F$20210816$20240726$20231130$20240731$EXP$$ES-JNJFOC-20210743453$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240731$$MD$ES$ES
232452398$23245239$8$F$$20240911$20231130$20240918$EXP$$CA-SANDOZ INC.-NVSC2023CA030825$SANDOZ$$72$YR$$M$Y$$$20240918$$CN$CA$CA
232452783$23245278$3$F$20231118$20240910$20231130$20240918$EXP$$CO-GSK-CO2023AMR165888$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$CO$CO
232452946$23245294$6$F$$20240628$20231130$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-172576$BRISTOL MYERS SQUIBB$Nakamura K, Ashida A, Kiniwa Y, Okuyama R. Summary of adjuvant therapy for advanced malignant melanoma in our department. Skin Cancer. 2021; 36(3): 212-7.$65$YR$E$F$Y$$$20240704$$MD$JP$JP
232454325$23245432$5$F$$20240628$20231130$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-173356$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240704$$MD$JP$JP
232454384$23245438$4$F$20230202$20240703$20231130$20240709$EXP$$JP-009507513-2302JPN000415J$MERCK$$55$YR$$M$Y$$$20240709$$MD$JP$JP
232454647$23245464$7$F$20231127$20240812$20231130$20240816$EXP$$NVSC2023US252781$NOVARTIS$$47$YR$$F$Y$$$20240816$$CN$US$US
232455094$23245509$4$F$$20240910$20231130$20240917$EXP$$CA-APOTEX-2023AP017065$APOTEX$$43$YR$$F$Y$$$20240917$$MD$CA$CA
232455308$23245530$8$F$20230101$20240924$20231130$20240930$EXP$$CA-JNJFOC-20230803599$JOHNSON AND JOHNSON$$12$YR$T$F$Y$45$KG$20240930$$HP$CA$CA
232455583$23245558$3$F$$20231220$20231130$20240827$EXP$$CN-ABBVIE-5519962$ABBVIE$Zhai A, Liu Y, Peng N, Gong L, Dou X, Wen L, et.al. Analysis of the Efficacy and Safety of Combination Regimens Containing BCL-2 Inhibitors in the Treatment of Relapsed/ Refractory Primary Systemic Light Chain Amyloidosis with t(11;14). Chinese Journal of Internal Medicine. 2023;62(11):1323-1328.; Jin L, Aili Z, Yang L, Nan P, Lizong G, Lei w et.al Efficacy and safety analysis of a combination regimen with BCL 2 inhibitor in relapsed/refractory primary systemic light chain amyloidosis with t ...$54$YR$$M$Y$$$20240827$$HP$CN$CN
232456232$23245623$2$F$$20240712$20231130$20240808$EXP$$JP-AstraZeneca-2023A270734$ASTRAZENECA$$48$YR$$$Y$$$20240808$$MD$JP$
232456452$23245645$2$F$$20231116$20231130$20240812$PER$$US-PURACAP-US-2023EPCSPO01784$PURACAP$$$$$F$Y$$$20240812$$PH$US$US
232456862$23245686$2$F$$20240627$20231130$20240702$EXP$$US-CHATTEMPRD-2023OHG015564$CHATTEM$$$$E$M$Y$$$20240702$$LW$US$US
232456894$23245689$4$F$20230815$20240911$20231130$20240917$EXP$$US-CHATTEMPRD-2023OHG015572$CHATTEM$$30$YR$A$M$Y$$$20240918$$LW$US$US
232456952$23245695$2$F$20231125$20240819$20231130$20240822$PER$$US-AMGEN-USASP2023211792$AMGEN$$75$YR$E$M$Y$$$20240821$$CN$US$US
232456985$23245698$5$F$20210814$20240626$20231130$20240701$EXP$$GB-TAKEDA-2021TUS059455$TAKEDA$$72$YR$$F$Y$$$20240701$$CN$GB$GB
232457232$23245723$2$F$20230101$20240812$20231130$20240815$EXP$$AU-009507513-2311AUS009429$MERCK$$75$YR$$M$Y$$$20240815$$MD$AU$AU
232457985$23245798$5$F$20191209$20240628$20231130$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-095972$BRISTOL MYERS SQUIBB$Nakamura K, Ashida A, Kiniwa Y, Okuyama R. Summary of adjuvant therapy for advanced malignant melanoma in our department. Skin Cancer. 2021;36(3):212-7.$71$YR$E$M$Y$$$20240704$$MD$JP$JP
232458063$23245806$3$F$$20240701$20231130$20240703$PER$$US-PFIZER INC-PV202300177927$PFIZER$$29$YR$$M$Y$81.65$KG$20240703$$CN$US$US
232458307$23245830$7$F$20230424$20240628$20231130$20240703$PER$$US-PFIZER INC-202300385741$PFIZER$$70$YR$$M$Y$$$20240703$$CN$US$US
2324589312$23245893$12$F$20230101$20240918$20231130$20240925$EXP$$NVSC2023BR175357$NOVARTIS$$$$$F$Y$$$20240925$$CN$BR$BR
232459038$23245903$8$F$20210211$20240729$20231130$20240805$EXP$$NVSC2021CA037979$NOVARTIS$$57$YR$$F$Y$$$20240805$$CN$CA$CA
232459693$23245969$3$F$$20240812$20231130$20240822$EXP$$CA-APOTEX-2023AP016931$APOTEX$$65$YR$$F$Y$34$KG$20240822$$HP$CA$CA
232460292$23246029$2$F$$20240801$20231130$20240806$EXP$$GB-MYLANLABS-2023M1124697$MYLAN$Joshi H, Earle K. SARS-CoV-2 Trigger in Severe Insulin Resistance With Acute Haemolytic Crisis in Diabetes and Glucose-6- phosphate Dehydrogenase Deciency. Journal of the Endocrine Society. 2021;5(Supplement 1):A397-A398$64$YR$$M$Y$75$KG$20240806$$MD$GB$GB
232460333$23246033$3$F$$20240910$20231130$20240919$EXP$$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-23-67371$HIKMA$$$$$$Y$$$20240919$$CN$GB$GB
232460532$23246053$2$F$20231121$20240701$20231130$20240705$EXP$$CZ-ABBVIE-5517253$ABBVIE$$31$YR$$F$Y$$$20240705$$HP$CZ$CZ
232460853$23246085$3$F$20210601$20240801$20231130$20240802$EXP$$DE-ROCHE-3436179$ROCHE$$48$YR$A$F$Y$$$20240802$$CN$DE$DE
232460972$23246097$2$F$$20240628$20231130$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-172749$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$77$KG$20240701$$CN$US$US
232462795$23246279$5$F$20230901$20240621$20231130$20240701$EXP$$JP-009507513-2310JPN003047J$MERCK$$80$YR$$M$Y$$$20240701$$MD$JP$JP
232463482$23246348$2$F$20230101$20240628$20231130$20240712$PER$$US-SA-2023SA364364$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240712$$MD$US$US
232463583$23246358$3$F$20230101$20240807$20231130$20240815$PER$$US-SA-2023SA364810$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240815$$MD$US$US
232463633$23246363$3$F$20230101$20240827$20231130$20240916$PER$$US-SA-2023SA364875$SANOFI AVENTIS$$7$YR$C$F$Y$20.45$KG$20240916$$MD$US$US
232463643$23246364$3$F$20231116$20240918$20231130$20240925$PER$$US-SA-2023SA364917$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240925$$MD$US$US
232463773$23246377$3$F$20231118$20240813$20231130$20240816$PER$$US-SA-2023SA365384$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240817$$MD$US$US
232463892$23246389$2$F$20230101$20240711$20231130$20240722$PER$$US-SA-2023SA364467$SANOFI AVENTIS$$49$YR$A$F$Y$74.61$KG$20240722$$MD$US$US
232464073$23246407$3$F$$20240801$20231130$20240810$PER$$US-SA-2023SA365425$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240810$$MD$US$US
232464683$23246468$3$F$20231101$20240620$20231130$20240702$PER$$US-SA-2023SA371355$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240702$$CN$US$US
232465038$23246503$8$F$20231115$20240924$20231130$20240926$30DAY$$US-PFIZER INC-202300377371$PFIZER$$15$YR$$M$Y$45.36$KG$20240926$$CN$US$US
232465502$23246550$2$F$20230606$20240711$20231130$20240715$EXP$FR-AFSSAPS-TS2023001354$FR-PFIZER INC-202300400703$PFIZER$$20$YR$$F$Y$$$20240715$$MD$FR$FR
232465842$23246584$2$F$$20240826$20231130$20240914$PER$$US-SA-2023SA370862$SANOFI AVENTIS$$55$YR$A$F$Y$57.6$KG$20240914$$MD$US$US
232465862$23246586$2$F$20230101$20240729$20231130$20240806$PER$$US-SA-2023SA366083$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240806$$MD$US$US
232466262$23246626$2$F$$20240708$20231130$20240723$EXP$$CA-SAMSUNG BIOEPIS-SB-2023-31482$SAMSUNG BIOEPIS$$28$YR$A$M$Y$86.1$KG$20240719$$HP$CA$CA
232466334$23246633$4$F$20220801$20240802$20231130$20240808$EXP$$US-Eisai-EC-2022-121111$EISAI$$84$YR$E$F$Y$$$20240808$$CN$US$US
232466725$23246672$5$F$20231116$20240708$20231130$20240713$EXP$$US-JAZZ-2023-US-001624$JAZZ$$79$YR$$M$Y$$$20240712$$CN$US$US
232466744$23246674$4$F$$20240719$20231130$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-173218$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240723$$HP$US$US
232466803$23246680$3$F$20231105$20240627$20231130$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202311016797$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240701$$CN$US$US
232467253$23246725$3$F$$20231209$20231130$20240801$EXP$$CA-SA-2023SA368277$SANOFI AVENTIS$$50$YR$A$F$Y$68$KG$20240801$$HP$CA$CA
232467286$23246728$6$F$20220601$20240625$20231130$20240703$EXP$$DE-EXELIXIS-CABO-23071073$EXELIXIS$$60$YR$$M$Y$$$20240703$$MD$DE$DE
232469539$23246953$9$F$20230606$20240919$20231130$20240924$EXP$$BR-PFIZER INC-PV202300101458$PFIZER$$65$YR$$F$Y$54$KG$20240924$$MD$BR$BR
232471233$23247123$3$F$20230610$20230616$20231130$20240716$PER$$US-NOVOPROD-1083040$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
232471952$23247195$2$F$$20240819$20231130$20240821$EXP$$SE-SANDOZ INC.-SDZ2023SE061408$SANDOZ$$7$YR$$M$Y$$$20240821$$HP$SE$SE
232471974$23247197$4$F$20231101$20240624$20231130$20240703$PER$$US-SA-2023SA365795$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240703$$MD$US$US
232472272$23247227$2$F$$20231122$20231130$20240906$EXP$$GB-BAUSCH-BL-2023-017510$BAUSCH AND LOMB$Pulley I. New mania post acoustic neuroma resection: More than a coincidence. Progress in Neurology and Psychiatry. 2023;27(4):15-18. doi:10.1002/pnp.809$65$YR$$F$Y$$$20240906$$MD$GB$GB
232472682$23247268$2$F$20231023$20240813$20231130$20240822$EXP$$US-GSK-US2023161843$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240822$$CN$US$US
232472852$23247285$2$F$$20240708$20231130$20240716$EXP$$CA-AstraZeneca-2020SF37817$ASTRAZENECA$$58$YR$$M$Y$$$20240716$$MD$CA$
232472973$23247297$3$F$$20240910$20231130$20240918$EXP$$US-ALXN-A202212997$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$HP$US$US
232473364$23247336$4$F$20201021$20240809$20231130$20240815$EXP$$JP-009507513-2311JPN002810J$MERCK$$57$YR$$M$Y$$$20240815$$MD$JP$JP
232473884$23247388$4$F$$20240916$20231130$20240923$EXP$$NVSC2023US254625$NOVARTIS$$$$E$F$Y$$$20240923$$CN$US$US
232474982$23247498$2$F$$20240911$20231130$20240913$EXP$$NVSC2023US254913$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
232476452$23247645$2$F$$20240813$20231130$20240819$EXP$$IN-PFIZER INC-PV202300194115$PFIZER$$53$YR$$F$Y$$$20240819$$CN$IN$IN
232476753$23247675$3$F$20230101$20240628$20231130$20240702$EXP$$US-PFIZER INC-PV202300194547$PFIZER$$46$YR$$F$Y$$$20240702$$HP$US$US
232476812$23247681$2$F$$20240718$20231130$20240722$EXP$$CA-PFIZER INC-202300410568$PFIZER$$42$YR$$F$Y$71$KG$20240722$$HP$CA$CA
232477336$23247733$6$F$$20240711$20231130$20240716$PER$$US-PFIZER INC-PV202300163831$PFIZER$$83$YR$$M$Y$$$20240716$$MD$US$US
232477735$23247773$5$F$20210501$20240905$20231130$20240912$EXP$$CA-TAKEDA-2021TUS035317$TAKEDA$$32$YR$$M$Y$$$20240912$$CN$CA$CA
232478172$23247817$2$F$20231030$20240715$20231130$20240718$EXP$$FR-FreseniusKabi-FK202319385$FRESENIUS KABI$$71$YR$E$F$Y$72$KG$20240718$$PH$FR$FR
232478292$23247829$2$F$$20240813$20231130$20240826$PER$$US-SA-2023SA365339$SANOFI AVENTIS$$$$A$M$Y$92.986$KG$20240826$$MD$US$US
232478393$23247839$3$F$20231109$20240807$20231130$20240809$EXP$$CA-JNJFOC-20231171064$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240809$$CN$CA$CA
232478674$23247867$4$F$20231113$20240917$20231130$20240923$EXP$$JP-009507513-2311JPN003230J$MERCK$$65$YR$$F$Y$$$20240923$$MD$JP$JP
232478964$23247896$4$F$20230912$20240904$20231130$20240910$EXP$$JP-009507513-2311JPN003807J$MERCK$$8$DEC$$F$Y$$$20240910$$MD$JP$JP
232479523$23247952$3$F$$20240729$20231130$20240805$EXP$$CA-Covis Pharma GmbH-2021COV20820$COVIS PHARMA$$97$YR$E$F$Y$81$KG$20240805$$MD$CA$CA
232480043$23248004$3$F$20230101$20240704$20231130$20240711$EXP$$JP-Eisai-EC-2023-149749$EISAI$$65$YR$E$F$Y$$$20240711$$MD$JP$JP
232480096$23248009$6$F$20231026$20240708$20231130$20240717$EXP$$CN-009507513-2311CHN006717$MERCK$$54$YR$$F$Y$59$KG$20240717$$MD$CN$CN
232480435$23248043$5$F$20231025$20240909$20231130$20240916$EXP$$US-BIOGEN-2023BI01237939$BIOGEN$$44$YR$$M$Y$$$20240916$$CN$US$US
232481854$23248185$4$F$20240228$20240805$20231130$20240807$EXP$$US-TAKEDA-US202030316$TAKEDA$$73$YR$$M$Y$$$20240807$$HP$US$US
232482893$23248289$3$F$20230101$20240910$20231130$20240917$EXP$$US-ABBVIE-5520173$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
232484003$23248400$3$F$$20240716$20231201$20240726$EXP$$IT-AUROBINDO-AUR-APL-2023-075382$AUROBINDO$Piro T, Paolo MD, Chiappini S, Dattoli L, Martinotti J. Trattamento complesso in un paziente con doppia diagnosi: il ruolo di lurasidone (Complex treatment in a patient with dual diagnosis: the role of lurasidone). Evidence-based Psychiatric Care. 2023;9(1 Suppl 3):4-6$24$YR$$F$Y$75$KG$20240726$$HP$IT$IT
232484063$23248406$3$F$20230901$20240812$20231201$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-168442$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240819$$CN$US$US
232484572$23248457$2$F$20230101$20240905$20231201$20240911$EXP$$US-ABBVIE-5516787$ABBVIE$$$$$F$Y$73.936$KG$20240911$$CN$US$US
232484808$23248480$8$F$20230401$20240822$20231201$20240826$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-238841$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240826$$CN$US$US
232484922$23248492$2$F$$20240701$20231201$20240708$PER$$US-ALXN-A202203051$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
232485583$23248558$3$F$20230728$20240902$20231201$20240903$EXP$$ES-BIOVITRUM-2023-ES-015530$BIOVITRUM$$63$YR$$M$Y$$$20240903$$HP$ES$ES
232486045$23248604$5$F$20230101$20240715$20231201$20240718$PER$$US-AMGEN-USASP2023213525$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
2324864213$23248642$13$F$20230807$20240715$20231201$20240724$EXP$$NZ-NOVOPROD-1145930$NOVO NORDISK$$58$YR$$M$Y$120$KG$20240724$$HP$NZ$NZ
232487122$23248712$2$F$20230913$20240430$20231201$20240712$EXP$$US-ALXN-A202312301$ALEXION PHARMACEUTICALS$$37$YR$$F$Y$$$20240712$$CN$US$US
232488072$23248807$2$F$$20240724$20231201$20240807$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2023-09863$ALKEM$Loar RW, Patterson MC, O Leary PW, et al.. Posterior reversible encephalopathy syndrome and hemorrhage associated with tacrolimus in a pediatric heart transplantation recipient. Pediatr Transplant. 2013;17(2):E67-70$10$YR$$$Y$$$20240807$$HP$US$US
232488735$23248873$5$F$20231201$20240731$20231201$20240805$30DAY$$US-GSK-US2023161670$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240805$$CN$US$US
232488752$23248875$2$F$$20231129$20231201$20240801$PER$$NVSC2023US255443$NOVARTIS$$60$YR$$M$Y$$$20240801$$CN$US$US
232489532$23248953$2$F$$20231129$20231201$20240731$PER$$NVSC2023US255453$NOVARTIS$$$$$F$Y$$$20240731$$HP$US$US
232490085$23249008$5$F$$20240628$20231201$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-173438$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240704$$MD$JP$JP
232490193$23249019$3$F$20231116$20240905$20231201$20240927$EXP$$CA-ABBVIE-5519050$ABBVIE$$81$YR$$F$Y$$$20240927$$MD$CA$CA
232490797$23249079$7$F$20231120$20240817$20231201$20240826$EXP$$CA-CELLTRION INC.-2023CA023024$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
232491392$23249139$2$F$20171101$20240909$20231201$20240920$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2023-173389$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240920$$MD$AU$AU
232491694$23249169$4$F$$20240719$20231201$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-173478$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240726$$MD$JP$JP
232491907$23249190$7$F$20190101$20240903$20231201$20240910$EXP$$US-GSK-US2023162608$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$HP$US$US
232492625$23249262$5$F$$20240909$20231201$20240919$EXP$$CA-APOTEX-2023AP016903$APOTEX$$65$YR$$F$Y$34$KG$20240919$$MD$CA$CA
232492773$23249277$3$F$20230101$20240701$20231201$20240708$EXP$$US-ORPHANEU-2023008183$RECORDATI$$$$$$Y$$$20240708$$CN$US$US
232493072$23249307$2$F$$20240802$20231201$20240805$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2023-US-002091$IPCA$Eibhlin S Goggins, Joel D.Murphy and Corey J Cavanaugh. A 35-year history of lupus nephritis without renal fibrosis or scarring: How is this possible? exostosin 2. Glomerular Diseases: Epidemiology and Case Reports. 2023$$$$$Y$$$20240805$$HP$US$US
232493262$23249326$2$F$20180101$20240805$20231201$20240810$EXP$$US-ABBVIE-5432849$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
232495632$23249563$2$F$$20240703$20231201$20240704$EXP$$JP-ASTELLAS-2023JP013134$ASTELLAS$Fujii T, Kobayashi K. A case of cryptococcosis showing giant soft tissue mass accompanying bone destruction and multiple pulmonary nodules. The Journal of the Japanese Association for Infectious Diseases (The 72nd Annual. 2024;98(1):204$83$YR$$F$Y$$$20240705$$$COUNTRY NOT SPECIFIED$JP
232495724$23249572$4$F$20230824$20240910$20231201$20240919$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-23-001999$AKEBIA THERAPEUTICS$$77$YR$$M$Y$69.7$KG$20240919$$MD$JP$JP
232496469$23249646$9$F$20231122$20240912$20231201$20240921$EXP$$CA-CELLTRION INC.-2023CA023019$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
232496892$23249689$2$F$$20240716$20231201$20240723$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2023-US-002111$IPCA$Mustafa Alam, Baha Abdelrahim, Mariam Alam et.al. Iatrogenic thyroid storm treated with plasmapheresis. Journal of the Endocrine Society. 2022;6(Suppl1):A768-A769$$$$$Y$$$20240723$$HP$US$US
232497146$23249714$6$F$$20240916$20231201$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-173154$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$84.82$KG$20240918$$CN$US$US
232497282$23249728$2$F$$20240723$20231201$20240725$EXP$$US-TAKEDA-2023TUS115499$TAKEDA$$$$$M$Y$104$KG$20240725$$HP$US$US
232497315$23249731$5$F$20230417$20240624$20231201$20240701$EXP$$CN-JNJFOC-20230550901$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240702$$HP$CN$CN
232497424$23249742$4$F$20230731$20240909$20231201$20240913$EXP$$US-ABBVIE-5520078$ABBVIE$$73$YR$$M$Y$$$20240913$$CN$US$US
232497692$23249769$2$F$20220505$20240916$20231201$20240924$EXP$$DE-CELLTRION INC.-2023DE022747$CELLTRION$$$$$$Y$$$20240924$$MD$DE$DE
232497993$23249799$3$F$20220324$20240712$20231201$20240716$EXP$$JP-ASTELLAS-2022JP005239$ASTELLAS$$79$YR$$F$Y$44$KG$20240716$$HP$JP$JP
232498232$23249823$2$F$20220111$20240625$20231201$20240702$EXP$$DE-ABBVIE-5520072$ABBVIE$$58$YR$$M$Y$91$KG$20240702$$MD$DE$DE
232498442$23249844$2$F$$20240909$20231201$20240917$EXP$$CA-JNJFOC-20231165389$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240917$$CN$CA$CA
232498755$23249875$5$F$20231101$20240405$20231201$20240925$PER$$US-GSK-US2023AMR164698$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240925$$CN$US$US
2324987610$23249876$10$F$20231101$20240514$20231201$20240925$EXP$$US-GSK-US2023AMR162901$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
232500112$23250011$2$F$$20240624$20231201$20240702$EXP$$KR-REGENERON PHARMACEUTICALS, INC.-2023-145602$REGENERON$$$$$M$Y$$$20240702$$MD$KR$KR
232501464$23250146$4$F$$20240611$20231201$20240704$EXP$$US-GSK-US2023AMR165074$GLAXOSMITHKLINE$$$$$F$Y$59.864$KG$20240704$$CN$US$US
232501572$23250157$2$F$$20240902$20231201$20240913$EXP$$GR-Accord-392134$ACCORD$Gole E, Mitsioni A, Darema M, Malakasioti G, Askiti V. Effect of Leflunomide on Treatment of Pediatric Renal Transplant Recipients With BK Virus Infection. Exp Clin Transplant. 2023 Oct;21(10):826-830.$15$YR$T$F$Y$$$20240913$$HP$GR$GR
232501602$23250160$2$F$$20240614$20231201$20240701$PER$$US-INCYTE CORPORATION-2023IN011974$INCYTE$$$$$$Y$$$20240701$$CN$US$US
232501983$23250198$3$F$20231101$20240708$20231201$20240708$PER$$US-ALXN-202311USA001814US$ALEXION PHARMACEUTICALS$$69$YR$$F$Y$$$20240708$$CN$US$US
232501996$23250199$6$F$20240328$20240729$20231201$20240801$EXP$$CA-JNJFOC-20231178492$JOHNSON AND JOHNSON$$39$YR$A$F$Y$110$KG$20240801$$HP$CA$CA
232502114$23250211$4$F$$20240806$20231201$20240814$EXP$$US-CHATTEMPRD-2023OHG014677$CHATTEM$$69$YR$E$F$Y$$$20240814$$LW$US$US
232502302$23250230$2$F$20221129$20240703$20231201$20240709$EXP$$US-CHATTEMPRD-2023OHG015272$CHATTEM$$81$YR$E$M$Y$$$20240709$$LW$US$US
232503563$23250356$3$F$$20240819$20231201$20240821$PER$$US-PFIZER INC-202300418611$PFIZER$$60$YR$$F$Y$$$20240821$$CN$US$US
232504092$23250409$2$F$20230101$20240807$20231201$20240810$EXP$$US-ABBVIE-5395392$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
232505702$23250570$2$F$$20240730$20231201$20240808$EXP$$BR-ROCHE-3465665$ROCHE$Bridi J, Ferreira Cardoso A, Bonilha Fernandes P, Gonzaga Lapa M, Schusterschitz S, Farias J, Salvino M, Higashi M, Giacon P, Pereira J, Delamain M and Castilho V. Retrospective Observational Study of the Long-Term Safety and Efficacy Outcomes of Rituximab Biosimilar: Partial Data of RTXM83-AC-01-11 Subanalysis Study. DOI: 10.1182/blood-2022-167101. Blood 2022 Nov 15;140 (SUP:1):13236-8.$$$$$Y$$$20240808$$HP$BR$BR
232506007$23250600$7$F$20231129$20240708$20231201$20240715$EXP$$CA-ROCHE-3467683$ROCHE$$35$YR$A$F$Y$$$20240715$$HP$CA$CA
232507156$23250715$6$F$20230101$20240918$20231201$20240925$EXP$$US-ABBVIE-5490047$ABBVIE$$$$$M$Y$72.574$KG$20240925$$CN$US$US
232507414$23250741$4$F$20211102$20240903$20231201$20240906$EXP$$NVSC2021GB261124$NOVARTIS$$59$YR$$F$Y$$$20240906$$HP$GB$GB
232509032$23250903$2$F$20231124$20240801$20231201$20240807$EXP$$CA-TAKEDA-2023TUS115052$TAKEDA$$41$YR$$M$Y$$$20240807$$MD$CA$CA
232509253$23250925$3$F$$20240702$20231201$20240709$EXP$$US-SA-2023SA373322$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240709$$MD$US$US
232509334$23250933$4$F$20231118$20240809$20231201$20240814$EXP$$NVSC2023RU253545$NOVARTIS$$61$YR$$M$Y$76$KG$20240814$$CN$RU$RU
232510344$23251034$4$F$$20240916$20231201$20240926$EXP$$CA-APOTEX-2023AP017266$APOTEX$$27$YR$$M$Y$$$20240926$$HP$CA$CA
232511116$23251111$6$F$20230320$20240704$20231201$20240709$EXP$$JP-Eisai-EC-2023-151899$EISAI$$81$YR$E$M$Y$66$KG$20240709$$MD$JP$JP
232511324$23251132$4$F$20230101$20240629$20231201$20240701$EXP$$CA-PFIZER INC-202200828889$PFIZER$$34$YR$$M$Y$$$20240701$$HP$CA$CA
232511856$23251185$6$F$$20240924$20231201$20240930$30DAY$$US-PFIZER INC-PV202300191238$PFIZER$$14$YR$$F$Y$$$20240930$$MD$US$US
232512173$23251217$3$F$20191128$20240903$20231201$20240905$EXP$$CA-TAKEDA-2019TUS068840$TAKEDA$$64$YR$$M$Y$$$20240905$$HP$CA$CA
232512842$23251284$2$F$20231121$20240625$20231201$20240701$EXP$$US-SA-2023SA370575$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240701$$MD$US$US
232513507$23251350$7$F$20231001$20240822$20231201$20240827$EXP$$US-OTSUKA-2023_030991$OTSUKA$$74$YR$$F$Y$78.2$KG$20240827$$CN$US$US
232513883$23251388$3$F$20230901$20240725$20231201$20240801$EXP$$JP-009507513-2309JPN002343J$MERCK$$7$DEC$$F$Y$$$20240801$$MD$JP$JP
232514535$23251453$5$F$20240116$20240712$20231201$20240717$EXP$$CA-TAKEDA-2021TUS073128$TAKEDA$$69$YR$$F$Y$57$KG$20240717$$MD$CA$CA
232515714$23251571$4$F$20240111$20240822$20231201$20240827$EXP$$CA-TAKEDA-2023TUS046137$TAKEDA$$69$YR$$M$Y$$$20240827$$MD$CA$CA
232515728$23251572$8$F$20230901$20240805$20231201$20240812$EXP$$US-GSK-US2023AMR164759$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
232515882$23251588$2$F$$20240702$20231201$20240711$EXP$$CA-PFIZER INC-202300414125$PFIZER$$71$YR$$M$Y$$$20240711$$CN$CA$CA
232516134$23251613$4$F$20230101$20240814$20231201$20240819$EXP$$US-SA-2023SA374191$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240819$$MD$US$US
232516493$23251649$3$F$$20240809$20231201$20240813$EXP$$CA-FreseniusKabi-FK202319083$FRESENIUS KABI$$43$YR$A$M$Y$$$20240813$$HP$CA$CA
232518214$23251821$4$F$$20240719$20231201$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-173484$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240726$$MD$JP$JP
232518999$23251899$9$F$20211210$20240820$20231201$20240822$EXP$$FR-GILEAD-2022-0583616$GILEAD$$$$A$F$Y$122$KG$20240822$$MD$FR$FR
232519345$23251934$5$F$20231106$20240717$20231201$20240723$PER$$FR-Eisai-EC-2023-154104$EISAI$$73$YR$E$M$Y$80$KG$20240723$$MD$FR$FR
232519423$23251942$3$F$20230905$20240802$20231201$20240807$EXP$$LT-MYLANLABS-2023M1127709$MYLAN$$8$DEC$$F$Y$70$KG$20240807$$MD$LT$LT
232519863$23251986$3$F$20231113$20240816$20231201$20240828$PER$$US-SA-2023SA366169$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240828$$MD$US$US
232519995$23251999$5$F$20230805$20240828$20231201$20240918$PER$$US-SA-2023SA365152$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240918$$MD$US$US
232520262$23252026$2$F$20230101$20240829$20231201$20240924$PER$$US-SA-2023SA368688$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240924$$MD$US$US
232520353$23252035$3$F$20231110$20240708$20231201$20240716$PER$$US-SA-2023SA367219$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240716$$MD$US$US
232520933$23252093$3$F$20231101$20240731$20231201$20240807$PER$$US-SA-2023SA372397$SANOFI AVENTIS$$$$E$M$Y$194$KG$20240807$$MD$US$US
232520954$23252095$4$F$20230101$20240621$20231201$20240702$PER$$US-SA-2023SA367573$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240702$$MD$US$US
232521113$23252111$3$F$20230101$20240816$20231201$20240830$PER$$US-SA-2023SA371798$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240830$$MD$US$US
232521434$23252143$4$F$$20240719$20231201$20240730$PER$$US-SA-2023SA371734$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240730$$MD$US$US
232521552$23252155$2$F$20231120$20240830$20231201$20240911$PER$$US-SA-2023SA373077$SANOFI AVENTIS$$64$YR$A$F$Y$103.86$KG$20240911$$MD$US$US
232521784$23252178$4$F$20230928$20240807$20231201$20240815$PER$$US-SA-2023SA374160$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240815$$MD$US$US
232521882$23252188$2$F$20240821$20240822$20231201$20240904$PER$$US-SA-2023SA372869$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240904$$MD$US$US
232521912$23252191$2$F$$20240826$20231201$20240909$PER$$US-SA-2023SA373140$SANOFI AVENTIS$$8$YR$C$M$Y$27.9$KG$20240909$$MD$US$US
232523082$23252308$2$F$$20240723$20231201$20240729$EXP$$PL-MYLANLABS-2023M1128163$MYLAN$$27$YR$$F$Y$$$20240729$$CN$PL$PL
232524139$23252413$9$F$$20240903$20231201$20240906$EXP$$CA-TAKEDA-2023TUS115439$TAKEDA$$$$$M$Y$80$KG$20240906$$MD$CA$CA
232525586$23252558$6$F$$20240822$20231201$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-173707$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$83.01$KG$20240826$$CN$US$US
232526243$23252624$3$F$20231127$20240710$20231201$20240711$PER$$US-PFIZER INC-202300410735$PFIZER$$74$YR$$M$Y$93.424$KG$20240711$$CN$US$US
232526476$23252647$6$F$$20240926$20231201$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-174090$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240927$$CN$US$US
232526507$23252650$7$F$20231101$20240628$20231201$20240704$EXP$$JP-009507513-2311JPN003331J$MERCK$$7$DEC$$M$Y$$$20240704$$MD$JP$JP
232527762$23252776$2$F$20230401$20240627$20231201$20240701$EXP$FR-AFSSAPS-PC2023000702$FR-PFIZER INC-202300409824$PFIZER$$54$YR$$F$Y$54$KG$20240701$$MD$FR$FR
232529212$23252921$2$F$20231001$20240709$20231201$20240717$EXP$$JP-009507513-2311JPN003902J$MERCK$$7$DEC$$F$Y$$$20240717$$MD$JP$JP
232530063$23253006$3$F$20231001$20240710$20231201$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-276063$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240715$$CN$US$US
232530743$23253074$3$F$$20240719$20231201$20240721$PER$$NVSC2023US256606$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
232531304$23253130$4$F$$20240712$20231202$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-170645$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$82$KG$20240725$$MD$JP$JP
232531832$23253183$2$F$20231026$20240912$20231202$20240919$EXP$$FR-AUROBINDO-AUR-APL-2023-075198$AUROBINDO$$57$YR$$M$Y$70$KG$20240919$$MD$FR$FR
232533074$23253307$4$F$$20240622$20231202$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004718$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
232535764$23253576$4$F$$20240729$20231202$20240731$PER$$NVSC2023US256842$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
232536529$23253652$9$F$$20240807$20231202$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005189$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
232541153$23254115$3$F$20231121$20240918$20231202$20240924$PER$$NVSC2023US256500$NOVARTIS$$58$YR$$F$Y$145$KG$20240924$$CN$US$US
232541392$23254139$2$F$20231130$20240718$20231202$20240722$PER$$US-AMGEN-USASP2023215722$AMGEN$$55$YR$A$F$Y$$$20240722$$CN$US$US
232541833$23254183$3$F$20230101$20240701$20231202$20240704$EXP$FR-AFSSAPS-CN2023000982$NVSC2023FR252066$NOVARTIS$$59$YR$$M$Y$$$20240704$$MD$FR$FR
232544263$23254426$3$F$20201009$20240712$20231202$20240723$EXP$$FR-ORPHANEU-2021005163$RECORDATI$$$$$$Y$$$20240723$$MD$FR$FR
232544935$23254493$5$F$$20240717$20231202$20240801$PER$$US-PURDUE-USA-2023-0305269$PURDUE$$$$$M$Y$145.15$KG$20240801$$CN$US$US
232545102$23254510$2$F$20231121$20240721$20231202$20240730$PER$$US-SA-2023SA367837$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240730$$MD$US$US
232546012$23254601$2$F$20230101$20240703$20231203$20240712$PER$$US-SA-2023SA366900$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240712$$MD$US$US
232546142$23254614$2$F$20230101$20240726$20231203$20240805$PER$$US-SA-2023SA367187$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240804$$MD$US$US
232546232$23254623$2$F$20230101$20240710$20231203$20240717$PER$$US-SA-2023SA372325$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240717$$MD$US$US
232554054$23255405$4$F$20230201$20240909$20231203$20240916$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202303009329$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240916$$CN$BR$BR
232554173$23255417$3$F$20231101$20240701$20231203$20240710$PER$$US-SA-2023SA367794$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240710$$MD$US$US
232554637$23255463$7$F$20230101$20240814$20231203$20240821$EXP$$CA-BIOGEN-2023BI01237986$BIOGEN$$$$$F$Y$$$20240821$$CN$CA$CA
232554666$23255466$6$F$20190703$20240913$20231203$20240919$EXP$$JP-GSK-JP2023JPN164732$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$JP$JP
232554774$23255477$4$F$$20240828$20231203$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-173247$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$MD$JP$JP
2325548119$23255481$19$F$20231107$20240703$20231203$20240711$EXP$$CA-JNJFOC-20231123532$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240711$$HP$CA$CA
232554843$23255484$3$F$$20240816$20231203$20240820$EXP$$NVSC2023DE252888$NOVARTIS$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert R, Fischer L et al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. CHILDREN. 2023;10(367):1-11$5$YR$$M$Y$$$20240820$$HP$DE$DE
232554872$23255487$2$F$$20240730$20231203$20240801$EXP$$NVSC2023DE252878$NOVARTIS$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert R, Fischer L et al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. CHILDREN. 2023;10(367):1-11$12$YR$$F$Y$$$20240801$$HP$DE$DE
232554892$23255489$2$F$$20240730$20231203$20240802$EXP$$NVSC2023DE252889$NOVARTIS$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert R, Fischer L et al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. CHILDREN. 2023;10(367):1-11$12$YR$$M$Y$$$20240802$$HP$DE$DE
232554902$23255490$2$F$$20240730$20231203$20240802$EXP$$NVSC2023DE252886$NOVARTIS$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. CHILDREN. 2023;10(367):1-11$4$YR$$M$Y$$$20240802$$HP$DE$DE
232554962$23255496$2$F$$20240730$20231203$20240801$EXP$$NVSC2023DE252885$NOVARTIS$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert R, Fischer L et al.. Experience with the mTOR inhibitor everolimus in pediatric liver graft recipients. CHILDREN. 2023;10(2):1-11$10$YR$$M$Y$$$20240801$$HP$DE$DE
232555002$23255500$2$F$$20240730$20231203$20240802$EXP$$NVSC2023DE252898$NOVARTIS$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. CHILDREN. 2023;10(367):1-11$15$YR$$M$Y$$$20240802$$HP$DE$DE
232555094$23255509$4$F$20220924$20240909$20231203$20240913$EXP$$NVSC2022CA230522$NOVARTIS$$61$YR$$M$Y$$$20240913$$CN$CA$CA
232555414$23255541$4$F$20230101$20240904$20231203$20240909$EXP$$CA-PFIZER INC-202300215166$PFIZER$$32$YR$$F$Y$$$20240909$$MD$CA$CA
232555824$23255582$4$F$20230628$20240806$20231203$20240807$EXP$$FR-JNJFOC-20231184018$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240807$$HP$FR$FR
232557773$23255777$3$F$$20240617$20231204$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005193$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
232559733$23255973$3$F$$20240715$20231204$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-174566$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240717$$CN$US$US
232560266$23256026$6$F$20240801$20240824$20231204$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202312000335$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240828$$CN$US$US
232560575$23256057$5$F$20231101$20240708$20231204$20240716$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-174307$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240716$$HP$JP$JP
232560696$23256069$6$F$20231105$20240610$20231204$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005170$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240705$$CN$US$US
232560744$23256074$4$F$$20240620$20231204$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005184$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
232560785$23256078$5$F$$20240802$20231204$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005177$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
232561726$23256172$6$F$$20240814$20231204$20240821$PER$$US-BIOGEN-2022BI01103810$BIOGEN$$$$$F$Y$$$20240821$$HP$US$US
232561953$23256195$3$F$20230101$20240802$20231204$20240808$PER$$US-SA-2023SA367358$SANOFI AVENTIS$$$$A$M$Y$$$20240809$$MD$US$US
232563152$23256315$2$F$20210201$20240808$20231204$20240814$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2023-146046$REGENERON$$$$$F$Y$$$20240814$$CN$US$US
232565393$23256539$3$F$$20231214$20231204$20240925$PER$$US-ALK-ABELLO A/S-2023AA004028$ALK-ABELLO$$$$$$Y$$$20240925$$MD$US$US
232567394$23256739$4$F$20230101$20240905$20231204$20240919$EXP$$US-SA-2023SA374650$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240919$$MD$US$US
232568197$23256819$7$F$$20240912$20231204$20240917$EXP$$US-SHIRE-US201903336AA$TAKEDA$$$$$F$Y$111$KG$20240917$$MD$US$US
232568543$23256854$3$F$20231130$20240919$20231204$20240920$PER$$US-AMGEN-USASP2023215024$AMGEN$$74$YR$E$M$Y$$$20240920$$MD$US$US
232568603$23256860$3$F$$20240821$20231204$20240825$EXP$$CA-ORGANON-O2311CAN003071$ORGANON$Unknown. Unknown. Unknown. Unk$41$YR$$F$Y$$$20240825$$HP$CA$CA
232569102$23256910$2$F$20150414$20240805$20231204$20240808$EXP$$BE-ABBVIE-5516695$ABBVIE$$70$YR$$M$Y$$$20240808$$MD$BE$BE
232569543$23256954$3$F$$20240903$20231204$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005176$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
232570042$23257004$2$F$$20240718$20231204$20240724$EXP$$CA-Orion Corporation ORION PHARMA-23_00026746$ORION$$42$YR$A$F$Y$71$KG$20240724$$HP$CA$
232570157$23257015$7$F$20221218$20240628$20231204$20240701$EXP$$DE-SANDOZ INC.-SDZ2023DE003117$SANDOZ$$72$YR$$M$Y$65$KG$20240701$$MD$DE$DE
232570496$23257049$6$F$$20240712$20231204$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-124778$BRISTOL MYERS SQUIBB$Araya T, Kita T, Takato H, Yamamoto Y, Tsuji T. A case of nivolumab + ipilimumab combination therapy-induced pleurisy as irAE successfully treated with high-dose steroid therapy. The 77th Hokuriku Branch Annual Meeting of the Japan Lung Cancer Society. 2023; 16.$72$YR$E$M$Y$$$20240723$$MD$JP$JP
232571712$23257171$2$F$$20240812$20231204$20240819$EXP$$PK-ROCHE-3465903$ROCHE$$63$YR$A$F$Y$$$20240819$$CN$PK$PK
232571994$23257199$4$F$$20240903$20231204$20240907$EXP$$US-TAKEDA-2023TUS079378$TAKEDA$$$$$M$Y$$$20240907$$CN$US$US
232572362$23257236$2$F$$20240820$20231204$20240829$EXP$$CA-ROCHE-3464249$ROCHE$$$$$M$Y$$$20240829$$MD$CA$CA
232572532$23257253$2$F$$20240626$20231204$20240701$EXP$$JP-ABBVIE-5519760$ABBVIE$$$$$$Y$$$20240701$$PH$JP$JP
232572604$23257260$4$F$$20240828$20231204$20240911$EXP$AU-MLMSERVICE-20231116-4665493-1$AU-STRIDES ARCOLAB LIMITED-2023SP017902$STRIDES$Xu G, Islam ST, Makarie-Rofail L, Barnsley L, Limaye S. Successful use of subcutaneous anakinra in hemophagocytic lymphohistiocytosis precipitated by candidiasis in a patient with systemic lupus erythematosus: A case report and description of a novel therapeutic regimen. International Journal of Rheumatic Diseases.. 2023;26(11):2284-2287$43$YR$$F$Y$$$20240911$$MD$AU$AU
232573883$23257388$3$F$$20240502$20231204$20240808$EXP$$NVSC2023BR255077$NOVARTIS$$$$$F$Y$99$KG$20240808$$CN$BR$BR
232573965$23257396$5$F$20230201$20240828$20231204$20240906$EXP$$BE-ROCHE-3450007$ROCHE$$63$YR$A$M$Y$85$KG$20240906$$MD$BE$BE
232574163$23257416$3$F$$20240909$20231204$20240917$EXP$$CA-ROCHE-3462660$ROCHE$Unknown U, Hart-Matyas M, Morgenstern D, Noone D, Campisi P. Renal Implications of Long-Term Systemic Bevacizumab for Recurrent Respiratory Papillomatosis. Sage journal-The Annals of otology, rhinology, and laryngology. 2023;1-5. doi:10.1177/00034894231184942.$$$$$Y$$$20240917$$HP$CA$CA
232574803$23257480$3$F$20240619$20240702$20231204$20240709$EXP$$US-MYLANLABS-2023M1113530$MYLAN$$44$YR$$F$Y$105$KG$20240709$$CN$US$US
232575192$23257519$2$F$$20240730$20231204$20240801$EXP$$NVSC2023DE252891$NOVARTIS$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L et al. Experience with the mTOR inhibitor everolimus in pediatric liver graft recipients. CHILDREN. 2023;10(367):1-11$16$YR$$M$Y$$$20240801$$HP$DE$DE
232575412$23257541$2$F$20220318$20240708$20231204$20240722$EXP$$DE-HIKMA PHARMACEUTICALS-DE-H14001-23-67679$HIKMA$$53$YR$$M$Y$115$KG$20240722$$MD$DE$DE
232575535$23257553$5$F$$20240917$20231204$20240923$EXP$$CA-TAKEDA-2023TUS115764$TAKEDA$$$$$F$Y$$$20240923$$CN$CA$CA
232576542$23257654$2$F$$20240821$20231204$20240827$EXP$$CA-TAKEDA-2023TUS115124$TAKEDA$$$$$M$Y$$$20240827$$CN$CA$CA
232576823$23257682$3$F$$20240805$20231204$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-171350$BRISTOL MYERS SQUIBB$$14$YR$T$F$Y$$$20240806$$HP$US$US
232578252$23257825$2$F$20240101$20240621$20231204$20240703$PER$$US-SA-2023SA368793$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240703$$MD$US$US
232578683$23257868$3$F$20230101$20240820$20231204$20240829$PER$$US-SA-2023SA370130$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240829$$MD$US$US
232578753$23257875$3$F$$20240725$20231204$20240730$PER$$US-SA-2023SA370794$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240730$$CN$US$US
232578794$23257879$4$F$20230101$20240906$20231204$20240916$PER$$US-SA-2023SA256252$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240916$$MD$US$US
232578812$23257881$2$F$20231031$20240715$20231204$20240722$PER$$US-SA-2023SA368084$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240720$$MD$US$US
232578943$23257894$3$F$20230101$20240625$20231204$20240704$PER$$US-SA-2023SA373708$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240704$$MD$US$US
232579818$23257981$8$F$20231219$20240904$20231204$20240911$EXP$$CA-TAKEDA-2023TUS057049$TAKEDA$$34$YR$$M$Y$$$20240911$$CN$CA$CA
232580772$23258077$2$F$$20240919$20231204$20240923$EXP$$US-TAKEDA-2023TUS116259$TAKEDA$$$$$F$Y$$$20240923$$CN$US$US
232581292$23258129$2$F$$20240627$20231204$20240707$PER$$US-SA-2023SA374044$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240707$$CN$US$US
232581352$23258135$2$F$$20240627$20231204$20240708$PER$$US-SA-2023SA374491$SANOFI AVENTIS$$$$A$F$Y$54.15$KG$20240708$$MD$US$US
232581424$23258142$4$F$20240325$20240920$20231204$20240924$EXP$$US-TAKEDA-2023TUS114680$TAKEDA$$55$YR$$F$Y$$$20240924$$CN$US$US
232581892$23258189$2$F$$20240805$20231204$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005227$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
232581994$23258199$4$F$$20240821$20231204$20240829$EXP$$JP-ROCHE-3467031$ROCHE$$50$YR$A$F$Y$$$20240829$$MD$JP$JP
232582073$23258207$3$F$20231019$20240725$20231204$20240801$EXP$$JP-009507513-2311JPN004261J$MERCK$$8$DEC$$M$Y$$$20240801$$MD$JP$JP
232582806$23258280$6$F$$20240918$20231204$20240926$EXP$$CA-TAKEDA-2023TUS079878$TAKEDA$$$$$F$Y$$$20240926$$CN$CA$CA
2325829810$23258298$10$F$20230101$20240829$20231204$20240903$EXP$$CA-PFIZER INC-202300267673$PFIZER$$14$YR$$M$Y$$$20240903$$MD$CA$CA
232583082$23258308$2$F$20230720$20240819$20231204$20240826$EXP$$JP-009507513-2308JPN002866J$MERCK$Matsuyama Y, Nagafune A, Sato A, Kuroda K, Hattori M, Suzuki Y, et al.. OS-087 Experience with pembrolizumab and lenvatinib combination therapy for recurrent corpus uteri carcinoma at our hospital. The journal of the Japan Society of Gynecologic Oncology The 66th Annual Meeting. 2024;42(3):279$6$DEC$$F$Y$$$20240826$$MD$JP$JP
232583473$23258347$3$F$$20240705$20231204$20240715$PER$$US-SA-2023SA368651$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240715$$MD$US$US
232583818$23258381$8$F$20231113$20240905$20231204$20240910$EXP$$JP-009507513-2311JPN004257J$MERCK$$73$YR$$F$Y$$$20240910$$MD$JP$JP
232583852$23258385$2$F$20221227$20240904$20231204$20240913$EXP$$DE-ROCHE-3339306$ROCHE$$26$YR$A$F$Y$$$20240913$$CN$DE$DE
232584393$23258439$3$F$$20240911$20231204$20240918$EXP$$JP-009507513-2311JPN004455J$MERCK$$$$$F$Y$$$20240918$$MD$JP$JP
232585282$23258528$2$F$20231130$20240722$20231204$20240725$EXP$$CA-BAYER-2023A172227$BAYER$$79$YR$E$M$Y$72$KG$20240725$$HP$CA$CA
232585334$23258533$4$F$20240201$20240829$20231204$20240923$PER$$US-SA-2023SA368684$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240923$$MD$US$US
232585352$23258535$2$F$$20240812$20231204$20240814$EXP$$US-TAKEDA-2023TUS084718$TAKEDA$$$$$F$Y$$$20240814$$CN$US$US
232585923$23258592$3$F$$20240730$20231204$20240730$PER$$US-PFIZER INC-202300418826$PFIZER$$73$YR$$M$Y$$$20240730$$HP$US$US
232585984$23258598$4$F$20240101$20240926$20231204$20240930$PER$$US-PFIZER INC-PV202300191211$PFIZER$$51$YR$$F$Y$$$20240930$$HP$US$US
232586094$23258609$4$F$20230807$20240717$20231204$20240718$PER$$US-PFIZER INC-PV202300195009$PFIZER$$21$YR$$F$Y$77.098$KG$20240718$$CN$US$US
232586163$23258616$3$F$$20240709$20231204$20240711$PER$$US-PFIZER INC-202300426718$PFIZER$$41$YR$$F$Y$$$20240711$$CN$US$US
232586238$23258623$8$F$$20240830$20231204$20240904$PER$$US-PFIZER INC-PV202300182145$PFIZER$$79$YR$$M$Y$64.853$KG$20240904$$CN$US$US
232586265$23258626$5$F$$20240702$20231204$20240708$PER$$US-PFIZER INC-PV202200098726$PFIZER$$66$YR$$M$Y$122.45$KG$20240708$$MD$US$US
232587518$23258751$8$F$20230701$20240628$20231204$20240704$EXP$$CA-TAKEDA-2023TUS115047$TAKEDA$$64$YR$$M$Y$$$20240704$$HP$CA$CA
232588924$23258892$4$F$20230501$20240713$20231204$20240715$EXP$$DE-TAKEDA-2023TUS115943$TAKEDA$$13$YR$$F$Y$$$20240715$$HP$DE$DE
232588942$23258894$2$F$20230101$20240626$20231204$20240701$EXP$$CA-PFIZER INC-202300102424$PFIZER$$49$YR$$F$Y$84$KG$20240701$$MD$CA$CA
232589382$23258938$2$F$20150101$20240903$20231204$20240910$EXP$$US-Eisai-EC-2015-004975$EISAI$$66$YR$E$M$Y$163$KG$20240910$$CN$US$US
232589742$23258974$2$F$$20240815$20231204$20240820$EXP$$NVSC2023US253733$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
232589813$23258981$3$F$$20240812$20231204$20240815$EXP$$NVSC2023DE252876$NOVARTIS$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L et al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. CHILDREN. 2023;10(2):1-11$13$YR$$M$Y$$$20240815$$HP$DE$DE
232590083$23259008$3$F$$20240408$20231204$20240718$EXP$$US-Taiho Oncology Inc-2023-010232$TAIHO ONCOLOGY INC$$54$YR$A$M$Y$54.89$KG$20240718$$CN$US$US
232590712$23259071$2$F$$20240805$20231204$20240924$EXP$$US-KYOWAKIRIN-2023KK019205$KYOWA$$$$$$Y$$$20240924$$HP$US$US
232591783$23259178$3$F$$20240911$20231204$20240917$EXP$$JP-009507513-2311JPN004461J$MERCK$$$$$F$Y$$$20240917$$MD$JP$JP
232593195$23259319$5$F$20230915$20240909$20231204$20240911$EXP$$NVSC2023KR256528$NOVARTIS$$72$YR$$F$Y$66.5$KG$20240911$$MD$KR$KR
232593293$23259329$3$F$$20240911$20231204$20240917$EXP$$JP-009507513-2311JPN004454J$MERCK$$$$$F$Y$$$20240917$$MD$JP$JP
232594434$23259443$4$F$20231103$20240906$20231204$20240916$EXP$$BR-Ipsen Biopharmaceuticals, Inc.-2023-26822$IPSEN$$40$YR$A$M$Y$127$KG$20240916$$CN$BR$BR
232594453$23259445$3$F$20231127$20240710$20231204$20240715$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-006383$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240715$$HP$US$US
232594633$23259463$3$F$$20240626$20231204$20240701$EXP$$JP-PFIZER INC-202300414246$PFIZER$Sonomura, K.. A Case of Minimal Change Nephrotic Syndrome Secondary to Methotrexate-associated Hodgkin Lymphoma.. Internal medicine. 2023;10.2169/internalmedicine.2572-$64$YR$$M$Y$73$KG$20240701$$MD$JP$JP
232595545$23259554$5$F$$20240905$20231204$20240911$PER$$NVSC2023US257655$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
2325956112$23259561$12$F$20231123$20240920$20231204$20240925$EXP$$US-TAKEDA-2022TUS072042$TAKEDA$$45$YR$$M$Y$$$20240925$$CN$US$US
232595786$23259578$6$F$20230504$20240710$20231204$20240716$EXP$$DE-TAKEDA-2023TUS114994$TAKEDA$$56$YR$$F$Y$120$KG$20240716$$HP$DE$DE
232596354$23259635$4$F$20230101$20240723$20231204$20240802$EXP$$JP-ARGENX-2023-ARGX-JP004080$ARGENX BVBA$$$$$$Y$$$20240802$$CN$JP$JP
232596837$23259683$7$F$20231121$20240826$20231204$20240829$EXP$$CA-PFIZER INC-PV202300191780$PFIZER$$55$YR$$M$Y$$$20240829$$CN$CA$CA
232596865$23259686$5$F$20140101$20240619$20231204$20240701$PER$$US-PFIZER INC-PV202300195370$PFIZER$$58$YR$$F$Y$63$KG$20240701$$CN$US$US
232597022$23259702$2$F$20231202$20240703$20231204$20240705$EXP$$IN-PFIZER INC-PV202300196886$PFIZER$$49$YR$$M$Y$$$20240705$$CN$IN$IN
232597473$23259747$3$F$$20240911$20231204$20240916$EXP$$JP-009507513-2311JPN004463J$MERCK$$$$$F$Y$$$20240916$$MD$JP$JP
232597514$23259751$4$F$$20240815$20231204$20240820$EXP$$US-PFIZER INC-PV202300113987$PFIZER$$84$YR$$F$Y$62.132$KG$20240820$$MD$US$US
232597633$23259763$3$F$$20240911$20231204$20240918$EXP$$JP-009507513-2311JPN004464J$MERCK$$$$$F$Y$$$20240918$$MD$JP$JP
232597823$23259782$3$F$$20240911$20231204$20240918$EXP$$JP-009507513-2311JPN004456J$MERCK$$$$$F$Y$$$20240918$$MD$JP$JP
232597883$23259788$3$F$$20240911$20231204$20240919$EXP$$JP-009507513-2311JPN004459J$MERCK$$$$$F$Y$$$20240919$$MD$JP$JP
232598217$23259821$7$F$20231120$20240812$20231204$20240815$EXP$$US-PFIZER INC-202300414965$PFIZER$Lim, N.. A Rare Cause of Acute Liver Failure. Gastroenterology. 2024;e1-e4$42$YR$$M$Y$89.4$KG$20240815$$MD$US$US
232599082$23259908$2$F$$20240730$20231204$20240805$EXP$$US-PFIZER INC-202300413922$PFIZER$$56$YR$$M$Y$86.168$KG$20240805$$CN$US$US
232599433$23259943$3$F$$20240911$20231204$20240918$EXP$$JP-009507513-2311JPN004458J$MERCK$$$$$F$Y$$$20240918$$MD$JP$JP
232599803$23259980$3$F$$20240911$20231204$20240918$EXP$$JP-009507513-2311JPN004457J$MERCK$$$$$F$Y$$$20240918$$MD$JP$JP
232599844$23259984$4$F$20231109$20240813$20231204$20240820$EXP$$JP-009507513-2311JPN003800J$MERCK$$74$YR$$F$Y$44$KG$20240820$$MD$JP$JP
232599892$23259989$2$F$$20240628$20231204$20240708$EXP$$JP-009507513-2311JPN004301J$MERCK$$$$$F$Y$$$20240708$$PH$JP$JP
232600393$23260039$3$F$20230901$20240708$20231204$20240712$EXP$$JP-009507513-2311JPN004129J$MERCK$$6$DEC$$M$Y$$$20240712$$MD$JP$JP
232600623$23260062$3$F$$20240911$20231204$20240919$EXP$$JP-009507513-2311JPN004460J$MERCK$$$$$F$Y$$$20240919$$MD$JP$JP
232600633$23260063$3$F$$20240911$20231204$20240916$EXP$$JP-009507513-2311JPN004462J$MERCK$$$$$F$Y$$$20240916$$MD$JP$JP
232600762$23260076$2$F$$20240807$20231204$20240821$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2023AST000686$ASSERTIO THERAPEUTICS$$$$$F$Y$97$KG$20240821$$HP$CA$CA
232600962$23260096$2$F$20230101$20240823$20231204$20240917$PER$$US-SA-2023SA367508$SANOFI AVENTIS$$17$YR$T$F$Y$53$KG$20240918$$MD$US$US
232601084$23260108$4$F$$20240624$20231204$20240702$EXP$$CA-CELLTRION INC.-2023CA022970$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
232601448$23260144$8$F$20230101$20240802$20231204$20240807$EXP$$US-ABBVIE-5518783$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
232601504$23260150$4$F$$20240808$20231204$20240813$EXP$$NVSJ2023JP017186$NOVARTIS$$63$YR$$F$Y$$$20240813$$MD$JP$JP
232601543$23260154$3$F$20230901$20240819$20231204$20240820$EXP$FR-AFSSAPS-NY2023001608$FR-JNJFOC-20231178625$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240821$$MD$FR$FR
232601808$23260180$8$F$20231022$20240926$20231204$20240930$EXP$$JP-TAKEDA-2023TJP014720$TAKEDA$$75$YR$$M$Y$67.8$KG$20240930$$MD$JP$JP
232602253$23260225$3$F$20230101$20240626$20231204$20240703$PER$$US-BAUSCHBL-2023BNL012320$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240704$$CN$US$US
232602576$23260257$6$F$20220601$20240625$20231204$20240705$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2023-174638$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240705$$MD$DE$DE
232602905$23260290$5$F$20230101$20240813$20231204$20240821$EXP$$US-ABBVIE-5355632$ABBVIE$$$$$F$Y$69$KG$20240821$$CN$US$US
232603493$23260349$3$F$20210701$20240625$20231204$20240701$EXP$$DE-ABBVIE-5519587$ABBVIE$$83$YR$$F$Y$83$KG$20240701$$MD$DE$DE
232603802$23260380$2$F$$20240910$20231204$20240923$EXP$$US-AUROBINDO-AUR-APL-2023-075326$AUROBINDO$Higgins E, Yuan J, Lange S, Boilson BA, Pritt BS, Rizza SA.. Fever, Cough, and Pancytopenia in a Transplant Recipient. Clinical Infectious Diseases. 2023;77(7):1065-7$19$YR$$M$Y$$$20240923$$MD$US$US
232605122$23260512$2$F$$20240813$20231205$20240814$EXP$$US-SANDOZ INC.-SDZ2023US063536$SANDOZ$$$$$F$Y$$$20240814$$CN$US$US
232605257$23260525$7$F$20231110$20240708$20231205$20240717$EXP$$CA-CELLTRION INC.-2023CA023214$CELLTRION$$$$$$Y$$$20240717$$HP$CA$CA
232606034$23260603$4$F$20230701$20240627$20231205$20240704$PER$$US-SA-2023SA311536$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240704$$MD$US$US
232606737$23260673$7$F$20230101$20240627$20231205$20240705$EXP$$CA-CELLTRION INC.-2022CA021086$CELLTRION$$$$$$Y$$$20240705$$MD$CA$CA
232607575$23260757$5$F$20220101$20240805$20231205$20240809$PER$$US-BIOGEN-2023BI01237387$BIOGEN$$$$$F$Y$$$20240809$$CN$US$US
232607613$23260761$3$F$20200706$20240725$20231205$20240731$EXP$$DE-ROCHE-2808755$ROCHE$$50$YR$A$M$Y$$$20240731$$CN$DE$DE
232607626$23260762$6$F$20230912$20240717$20231205$20240729$EXP$$DE-ROCHE-3429235$ROCHE$$48$YR$A$F$Y$$$20240729$$CN$DE$DE
232608077$23260807$7$F$20231101$20240906$20231205$20240916$EXP$$CA-CELLTRION INC.-2023CA022205$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
232609232$23260923$2$F$20231029$20240703$20231205$20240708$EXP$$US-SA-2023SA375459$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240708$$MD$US$US
232609924$23260992$4$F$20231124$20240828$20231205$20240904$EXP$$US-ABBVIE-4337076$ABBVIE$$51$YR$$M$Y$86$KG$20240904$$CN$US$US
232610843$23261084$3$F$20231202$20240918$20231205$20240926$PER$$NVSC2023US258092$NOVARTIS$$55$YR$$F$Y$$$20240927$$HP$US$US
232612193$23261219$3$F$20231117$20240726$20231205$20240815$PER$$CA-TOLMAR, INC.-23CA044907$TOLMAR$$70$YR$$M$Y$$$20240814$$CN$CA$CA
232612293$23261229$3$F$20210101$20240830$20231205$20240926$PER$$CO-TOLMAR, INC.-23CO044833$TOLMAR$$$$$M$Y$$$20240926$$CN$CO$CO
232612672$23261267$2$F$20230801$20240628$20231205$20240704$EXP$$JP-009507513-2307JPN004324J$MERCK$$79$YR$$M$Y$$$20240704$$MD$JP$JP
232612702$23261270$2$F$20231130$20240716$20231205$20240722$EXP$$US-TAKEDA-2022TUS099597$TAKEDA$$43$YR$$M$Y$68$KG$20240722$$HP$US$US
232613252$23261325$2$F$$20240821$20231205$20240824$EXP$$US-TAKEDA-2023TUS018332$TAKEDA$$$$$F$Y$40$KG$20240824$$HP$US$US
232613337$23261333$7$F$20230101$20240715$20231205$20240726$EXP$$US-INSMED, INC.-2023-03802-US$INSMED$$$$$F$Y$$$20240726$$CN$US$US
232614717$23261471$7$F$20231227$20240918$20231205$20240923$EXP$$CA-TAKEDA-2023TUS115951$TAKEDA$$61$YR$$F$Y$$$20240923$$CN$CA$CA
232614883$23261488$3$F$$20240625$20231205$20240715$PER$$CA-TOLMAR, INC.-23CA044726$TOLMAR$$$$$M$Y$$$20240715$$CN$CA$CA
232614893$23261489$3$F$20240306$20240712$20231205$20240717$PER$$CA-TOLMAR, INC.-23CA044727$TOLMAR$$72$YR$$M$Y$$$20240717$$CN$CA$CA
232615184$23261518$4$F$$20240702$20231205$20240705$EXP$$US-TAKEDA-2023TUS116561$TAKEDA$$$$$M$Y$81$KG$20240705$$CN$US$US
232616162$23261616$2$F$$20240802$20231205$20240808$PER$$US-ABBVIE-5522709$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
232617112$23261711$2$F$20231001$20240704$20231205$20240709$EXP$$GT-EMD Serono-2023491803$EMD SERONO INC$$59$YR$A$F$Y$$$20240710$$CN$GT$GT
232618223$23261822$3$F$20220722$20231128$20231205$20240708$EXP$$NVSC2023DE255834$NOVARTIS$$$$A$F$Y$$$20240708$$MD$DE$DE
232618324$23261832$4$F$20230401$20240712$20231205$20240720$EXP$$NVSC2023CA098175$NOVARTIS$$51$YR$$F$Y$$$20240719$$CN$CA$CA
232618362$23261836$2$F$20230726$20240625$20231205$20240709$EXP$$MY-ROCHE-3446057$ROCHE$$67$YR$E$F$Y$42$KG$20240702$$HP$MY$MY
232618383$23261838$3$F$$20240709$20231205$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-175458$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240710$$MD$JP$JP
232618485$23261848$5$F$20230801$20240719$20231205$20240723$EXP$$AR-ABBVIE-5431529$ABBVIE$$56$YR$$M$Y$$$20240723$$CN$AR$AR
232618702$23261870$2$F$$20240829$20231205$20240902$EXP$$CA-SANDOZ INC.-NVSC2023CA141126$SANDOZ$$39$YR$$M$Y$$$20240902$$HP$CA$CA
232618825$23261882$5$F$20221122$20240705$20231205$20240710$EXP$$CA-TAKEDA-2023TUS077795$TAKEDA$$33$YR$$F$Y$$$20240710$$CN$CA$CA
232619456$23261945$6$F$20220202$20240909$20231205$20240917$EXP$$JP-ROCHE-3467951$ROCHE$$75$YR$E$M$Y$45.5$KG$20240917$$MD$JP$JP
232620872$23262087$2$F$$20240627$20231205$20240708$EXP$$TN-MYLANLABS-2023M1129041$MYLAN$Ben Kahla A, Kassar O, Moalla K, Fakhfakh Y, Hentati Y, Elloumi M. Cerebral puncturevenous in a patient thrombosis with large after B cell firstlymphoma Methotrexate administration by lumbar. Tunis-Med 2023; 101 648-650.$24$YR$$M$Y$$$20240708$$HP$TN$TN
232622706$23262270$6$F$20240604$20240716$20231205$20240717$EXP$$GB-MYLANLABS-2023M1128626$MYLAN$$$$$F$Y$$$20240717$$MD$GB$GB
232623067$23262306$7$F$20240319$20240810$20231205$20240816$EXP$$CO-TAKEDA-2023TUS116058$TAKEDA$$71$YR$$M$Y$81$KG$20240816$$CN$CO$CO
232623763$23262376$3$F$$20240807$20231205$20240821$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2023AST000699$ASSERTIO THERAPEUTICS$$50$YR$$F$Y$68$KG$20240821$$HP$CA$CA
232623972$23262397$2$F$20200101$20240716$20231205$20240807$EXP$$GB-009507513-2009GBR000559$MERCK$$$$$M$Y$$$20240807$$CN$GB$GB
232624192$23262419$2$F$20231030$20240622$20231205$20240702$EXP$$US-SA-2023SA375883$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240702$$MD$US$US
232624208$23262420$8$F$$20240912$20231205$20240918$EXP$$US-TAKEDA-2023TUS116633$TAKEDA$$$$$F$Y$77$KG$20240918$$CN$US$US
232624552$23262455$2$F$$20240726$20231205$20240801$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-024168$JAZZ$$$$$M$Y$$$20240801$$CN$US$US
232624782$23262478$2$F$20230101$20240823$20231205$20240829$PER$$US-PFIZER INC-PV202300192176$PFIZER$$64$YR$$F$Y$$$20240829$$HP$US$US
232624923$23262492$3$F$$20240702$20231205$20240704$PER$$US-PFIZER INC-202300400857$PFIZER$$67$YR$$F$Y$$$20240704$$CN$US$US
232625012$23262501$2$F$$20240711$20231205$20240715$PER$$US-PFIZER INC-PV202300154846$PFIZER$$66$YR$$F$Y$$$20240715$$HP$US$US
232625086$23262508$6$F$$20240822$20231205$20240827$PER$$US-PFIZER INC-202300422363$PFIZER$$7$YR$$M$Y$$$20240827$$CN$US$US
232625345$23262534$5$F$20200101$20240918$20231205$20240924$EXP$$US-PFIZER INC-PV202300191355$PFIZER$$54$YR$$F$Y$$$20240924$$CN$US$US
232625522$23262552$2$F$20230101$20240730$20231205$20240805$PER$$US-AMGEN-USASP2023215970$AMGEN$$59$YR$A$M$Y$$$20240805$$HP$US$US
232625678$23262567$8$F$20231101$20240806$20231205$20240812$PER$$US-PFIZER INC-202300418963$PFIZER$$53$YR$$F$Y$52.154$KG$20240812$$CN$US$US
232626142$23262614$2$F$20220101$20240821$20231205$20240828$EXP$$UY-ABBVIE-5279777$ABBVIE$$$$$F$Y$$$20240828$$CN$UY$UY
232626495$23262649$5$F$$20240702$20231205$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-175668$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240705$$MD$JP$JP
232627065$23262706$5$F$20230919$20240702$20231205$20240802$EXP$$GB-MYLANLABS-2023M1101824$MYLAN$$69$YR$$M$Y$$$20240802$$MD$GB$GB
232627093$23262709$3$F$20230101$20240910$20231205$20240918$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2023CUR002932$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$CA$CA
232627823$23262782$3$F$20230522$20240807$20231205$20240808$PER$$US-ALXN-A202304425$ALEXION PHARMACEUTICALS$$78$YR$$M$Y$$$20240808$$HP$US$US
232627892$23262789$2$F$$20231129$20231205$20240808$EXP$$US-OTSUKA-2023_031204$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
232628892$23262889$2$F$$20240826$20231205$20240902$EXP$$CA-AstraZeneca-2020SF30707$ASTRAZENECA$$50$YR$$F$Y$$$20240902$$MD$CA$
232629522$23262952$2$F$$20240912$20231205$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421539$RANBAXY$Agarwal A, Falcone LM, James AJ. Methotrexate-induced hypersensitivity pneumonitis in a patient with bullous pemphigoid. Dermatol Online J. 2023;29 (4):17$69$YR$$F$Y$$$20240927$$HP$US$US
232629532$23262953$2$F$$20240625$20231205$20240710$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421575$RANBAXY$Park K, Kim JY, Park I, Shin SH, Lee HJ, Lee JL. Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice. Yonsei Med J. 2023;Feb; 64(2):86-93$$$$M$Y$$$20240710$$HP$KR$KR
2326299710$23262997$10$F$$20240830$20231205$20240903$EXP$$US-TAKEDA-2023TUS087817$TAKEDA$$$$$F$Y$29.025$KG$20240903$$HP$US$US
232630482$23263048$2$F$$20240829$20231205$20240903$EXP$$US-TAKEDA-2023TUS067789$TAKEDA$$$$$M$Y$$$20240903$$CN$US$US
232631602$23263160$2$F$$20240802$20231205$20240808$PER$$US-ABBVIE-5525065$ABBVIE$$87$YR$$F$Y$$$20240808$$CN$US$US
232632732$23263273$2$F$$20240724$20231205$20240730$EXP$$CA-APOTEX-2023AP017355$APOTEX$$$$$M$Y$$$20240730$$HP$CA$CA
232634167$23263416$7$F$20231128$20240913$20231205$20240916$EXP$$NVSC2023US254855$NOVARTIS$$56$YR$$M$Y$$$20240916$$CN$US$US
232634319$23263431$9$F$20231116$20240912$20231205$20240918$EXP$$MX-TAKEDA-2023TUS112726$TAKEDA$$14$YR$$M$Y$$$20240918$$CN$MX$MX
232634702$23263470$2$F$20230816$20240827$20231205$20240829$EXP$$US-GILEAD-2023-0653350$GILEAD$$51$YR$A$F$Y$$$20240829$$HP$US$US
232634934$23263493$4$F$20231129$20240126$20231205$20240828$30DAY$$BR-AstraZeneca-2023A274920$ASTRAZENECA$$3$YR$$F$Y$$$20240828$$CN$BR$
232635055$23263505$5$F$20221005$20240813$20231205$20240814$EXP$$ES-TAKEDA-2023TUS013693$TAKEDA$$18$YR$$M$Y$$$20240814$$HP$ES$ES
2326354912$23263549$12$F$20230828$20240906$20231205$20240912$EXP$$CA-GSK-CA2023AMR083618$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$HP$CA$CA
232636075$23263607$5$F$20240101$20240731$20231205$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-175273$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240802$$CN$US$US
232636717$23263671$7$F$20231001$20240731$20231205$20240815$EXP$$JP-009507513-2311JPN001168J$MERCK$Kudo H, Hashimoto M, Takeshima M, Morito M, Ijichi M, Kukota K, et al.. EP-1231 A Case of Triple-Negative Breast Cancer with Refractory Colitis after Resolution of Adrenal insufficiency by Concomitant Adjuvant Chemotherapy with Pembrolizumab. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 485$49$YR$$F$Y$$$20240815$$MD$JP$JP
232636982$23263698$2$F$20230101$20240717$20231205$20240725$PER$$US-SA-2023SA368732$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240725$$MD$US$US
232637463$23263746$3$F$20231123$20240627$20231205$20240711$PER$$US-SA-2023SA368253$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240711$$MD$US$US
232637912$23263791$2$F$$20240708$20231205$20240717$PER$$US-SA-2023SA368596$SANOFI AVENTIS$$$$A$M$Y$98$KG$20240717$$MD$US$US
232638142$23263814$2$F$20231001$20240830$20231205$20240912$PER$$US-SA-2023SA372946$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240912$$MD$US$US
232638434$23263843$4$F$20230101$20240716$20231205$20240725$PER$$US-SA-2023SA374820$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240725$$MD$US$US
232639072$23263907$2$F$20240301$20240625$20231205$20240702$PER$$US-SA-2023SA375738$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240702$$MD$US$US
232639302$23263930$2$F$20220101$20240829$20231205$20240923$PER$$US-SA-2023SA375885$SANOFI AVENTIS$$52$YR$A$F$Y$75.45$KG$20240923$$MD$US$US
232639316$23263931$6$F$20231101$20240913$20231205$20240918$EXP$$US-SA-2023SA375860$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240918$$MD$US$US
232639524$23263952$4$F$$20240821$20231205$20240917$PER$$US-SA-2023SA375884$SANOFI AVENTIS$$46$YR$A$F$Y$61.224$KG$20240918$$MD$US$US
232639644$23263964$4$F$20230901$20240724$20231205$20240801$PER$$US-SA-2023SA376580$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240801$$MD$US$US
232640163$23264016$3$F$$20240918$20231205$20240930$PER$$NVSC2023US258398$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
232641777$23264177$7$F$20230414$20240917$20231205$20240920$EXP$$US-PFIZER INC-PV202300196432$PFIZER$$76$YR$$F$Y$$$20240920$$MD$US$US
232641852$23264185$2$F$$20240823$20231205$20240827$EXP$$IT-GSK-IT2023GSK169336$GLAXOSMITHKLINE$Poletti de Chaurand V, Scandella G, Zicoia M, Arienti F, Fernicola F, Lanteri L, et al. Useful Clinical Criteria for Identifying Neonates with Congenital Cytomegalovirus Infection at Birth in the Context of an Expanded Targeted Screening Program. Viruses. 2024;16(7)$$$$$Y$$$20240827$$MD$IT$IT
232642313$23264231$3$F$$20240702$20231205$20240708$EXP$$JP-009507513-2311JPN004690J$MERCK$$8$DEC$$M$Y$$$20240708$$MD$JP$JP
232643177$23264317$7$F$20210717$20240807$20231205$20240813$EXP$$BE-PFIZER INC-202101053880$PFIZER$$73$YR$$F$Y$79.1$KG$20240813$$MD$BE$BE
232643463$23264346$3$F$20231006$20240705$20231205$20240709$EXP$$JP-AstraZeneca-2023A274145$ASTRAZENECA$$67$YR$$M$Y$56$KG$20240709$$MD$JP$
232643692$23264369$2$F$20231101$20240903$20231205$20240909$EXP$$US-LUNDBECK-DKLU3070986$LUNDBECK$$$$$$Y$$$20240910$$HP$US$US
232644274$23264427$4$F$20231101$20240715$20231205$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-175173$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$70.966$KG$20240722$$CN$US$US
232644283$23264428$3$F$$20240719$20231205$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-173526$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$58$KG$20240729$$MD$JP$JP
232644833$23264483$3$F$20230101$20240814$20231205$20240827$PER$$US-SA-2023SA373167$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240827$$MD$US$US
232645272$23264527$2$F$$20240716$20231205$20240718$EXP$$CA-SANDOZ INC.-NVSC2020CA237381$SANDOZ$$$$$F$Y$$$20240718$$CN$CA$CA
232645412$23264541$2$F$20230101$20240729$20231205$20240805$EXP$$US-SA-2023SA377412$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$MD$US$US
232645903$23264590$3$F$$20240719$20231205$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-172459$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$MD$JP$JP
232645957$23264595$7$F$$20240722$20231205$20240729$EXP$$US-TAKEDA-2023TUS116329$TAKEDA$$$$$F$Y$$$20240729$$CN$US$US
232647044$23264704$4$F$20230601$20240628$20231205$20240717$PER$$CA-TOLMAR, INC.-23CA044909$TOLMAR$$76$YR$$M$Y$$$20240717$$CN$CA$CA
232647072$23264707$2$F$$20240704$20231205$20240726$PER$$CA-TOLMAR, INC.-23CA044838$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
232647564$23264756$4$F$20231114$20240704$20231206$20240708$EXP$$IT-ALXN-202311EEA000857IT$ALEXION PHARMACEUTICALS$$41$YR$$F$Y$52$KG$20240708$$MD$IT$IT
232648557$23264855$7$F$$20240621$20231206$20240717$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005232$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
232648713$23264871$3$F$$20240912$20231206$20240917$EXP$$US-TAKEDA-2023TUS116568$TAKEDA$$$$$F$Y$109$KG$20240917$$HP$US$US
232650133$23265013$3$F$$20240102$20231206$20240925$PER$$US-GSK-US2023AMR169054$GLAXOSMITHKLINE$$$$$F$Y$87.7$KG$20240925$$HP$US$US
2326505312$23265053$12$F$20220908$20240813$20231206$20240914$EXP$$US-UCBSA-2023057269$UCB$$7$YR$$M$Y$21.3$KG$20240914$$CN$US$US
232651727$23265172$7$F$$20240703$20231206$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-175814$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240705$$CN$US$US
232653229$23265322$9$F$19630702$20240905$20231206$20240919$EXP$$US-UCBSA-2023057445$UCB$$0$YR$$F$Y$92.971$KG$20240919$$HP$US$US
232654683$23265468$3$F$20220404$20240624$20231206$20240703$EXP$$US-ORPHANEU-2023008512$RECORDATI$$$$$$Y$$$20240703$$CN$US$US
232655444$23265544$4$F$20230101$20240805$20231206$20240814$EXP$$US-UNITED THERAPEUTICS-UNT-2023-031489$UNITED THERAPEUTICS$$$$$M$Y$118.37$KG$20240814$$$US$US
232655497$23265549$7$F$20231201$20240822$20231206$20240905$EXP$$US-UCBSA-2023057502$UCB$$18$YR$$M$Y$$$20240905$$CN$US$US
232655532$23265553$2$F$$20240712$20231206$20240722$EXP$$DE-CELLTRION INC.-2023DE023125$CELLTRION$$$$$$Y$$$20240722$$MD$DE$DE
232656532$23265653$2$F$20231125$20240903$20231206$20240909$EXP$$JP-GENMAB-2023-02265$GENMAB$$84$YR$$F$Y$43.6$KG$20240909$$MD$JP$JP
232656639$23265663$9$F$20230101$20240924$20231206$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-171785$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240927$$CN$US$US
232656754$23265675$4$F$$20240718$20231206$20240726$EXP$$NL-TAKEDA-2023TUS115710$TAKEDA$$$$A$F$Y$$$20240726$$HP$NL$NL
232657987$23265798$7$F$$20240913$20231206$20240916$PER$$US-BIOVITRUM-2023-US-013805$BIOVITRUM$$74$YR$$F$Y$$$20240916$$CN$US$US
2326580812$23265808$12$F$20230101$20240719$20231206$20240727$EXP$$CA-CELLTRION INC.-2023CA017995$CELLTRION$$$$$$Y$$$20240727$$HP$CA$CA
232658413$23265841$3$F$$20240812$20231206$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-166621$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240813$$CN$US$US
232658502$23265850$2$F$$20240627$20231206$20240708$EXP$$TN-STRIDES ARCOLAB LIMITED-2023SP018104$STRIDES$Ben Kahla A, Kassar O, Moalla K, Fakhfakh Y, Hentati Y, Elloumi M. Cerebral puncturevenous in a patient thrombosis with large after B cell firstlymphoma Methotrexate administration by lumbar.. Tunis-Med.. 2023;101:648-650$24$YR$$M$Y$$$20240708$$HP$TN$TN
2326586010$23265860$10$F$20231124$20240808$20231206$20240815$EXP$$CA-CELLTRION INC.-2023CA023338$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
232658852$23265885$2$F$20170101$20240726$20231206$20240802$EXP$$CH-ABBVIE-5524605$ABBVIE$$$$$F$Y$$$20240802$$HP$CH$CH
232659635$23265963$5$F$20231201$20240819$20231206$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005247$ACADIA PHARMACEUTICALS$$9$YR$$F$Y$$$20240828$$CN$US$US
232659992$23265999$2$F$$20240806$20231206$20240814$EXP$IT-MLMSERVICE-20231120-4668394-1$IT-STRIDES ARCOLAB LIMITED-2023SP018062$STRIDES$Tramacere F, Pisani AR, Maggiulli E, Moschetta M, Sardaro A, Altini C, et al.. Effective management of a patient with secondary male breast cancer after neck radiotherapy for tonsillar lymphoma.. International Journal of Radiation Research. 2023;21(1):163-167$59$YR$$M$Y$$$20240814$$MD$IT$IT
232660034$23266003$4$F$20230101$20240814$20231206$20240823$PER$$US-AMGEN-USASP2023217112$AMGEN$$59$YR$A$F$Y$$$20240823$$HP$US$US
232660395$23266039$5$F$$20240712$20231206$20240716$EXP$$CA-SANDOZ INC.-PHHY2019CA096380$SANDOZ$$63$YR$$F$Y$$$20240716$$MD$CA$CA
232660964$23266096$4$F$$20240624$20231206$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005214$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
232661066$23266106$6$F$20220503$20240717$20231206$20240718$EXP$PT-INFARMED-T202311-348$PT-JNJFOC-20231182466$JOHNSON AND JOHNSON$$13$YR$T$M$Y$56$KG$20240718$$CN$PT$PT
232661174$23266117$4$F$20160630$20240909$20231206$20240916$EXP$$BR-GSK-BR2016GSK094875$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$BR$BR
232662653$23266265$3$F$20240801$20240822$20231206$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-176181$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240826$$CN$US$US
232662663$23266266$3$F$20231121$20240902$20231206$20240906$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2023-129706$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$70$KG$20240906$$CN$DE$DE
232663102$23266310$2$F$$20240730$20231206$20240801$EXP$$NVSC2023DE252892$NOVARTIS$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. CHILDREN. 2023;10 (367):1-11$9$YR$$M$Y$$$20240801$$HP$DE$DE
232663469$23266346$9$F$20231017$20240902$20231206$20240904$EXP$$AU-TAKEDA-2023TUS057166$TAKEDA$$69$YR$$M$Y$$$20240904$$HP$AU$AU
232663884$23266388$4$F$20240528$20240808$20231206$20240809$EXP$$CA-TAKEDA-2023TUS115130$TAKEDA$$67$YR$$F$Y$$$20240809$$CN$CA$CA
232664394$23266439$4$F$$20240911$20231206$20240916$EXP$$JP-009507513-2311JPN004283J$MERCK$$$$$F$Y$$$20240916$$MD$JP$JP
232664777$23266477$7$F$$20240708$20231206$20240717$EXP$$US-INSMED, INC.-2023-03835-US$INSMED$$$$$F$Y$$$20240717$$CN$US$US
232665142$23266514$2$F$20230901$20240708$20231206$20240715$EXP$$JP-ASTELLAS-2023JP013357$ASTELLAS$$4$DEC$$F$Y$$$20240715$$HP$JP$JP
232665304$23266530$4$F$20210901$20240406$20231206$20240808$EXP$$NVSC2022EG125865$NOVARTIS$$70$YR$$F$Y$$$20240808$$CN$EG$EG
232666282$23266628$2$F$$20230707$20231206$20240710$PER$$SG-ROCHE-3385123$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$SG$SG
232666504$23266650$4$F$20231130$20240722$20231206$20240728$EXP$$CA-TAKEDA-2023TUS079843$TAKEDA$$32$YR$$F$Y$$$20240728$$CN$CA$CA
232666654$23266665$4$F$$20240701$20231206$20240709$EXP$$IE-AstraZeneca-2023A272413$ASTRAZENECA$$$$$M$Y$$$20240709$$HP$IE$
2326667623$23266676$23$F$20230509$20240712$20231206$20240718$EXP$$FR-JNJFOC-20230543785$JOHNSON AND JOHNSON$$48$YR$A$F$Y$61$KG$20240718$$HP$FR$FR
232667262$23266726$2$F$20230101$20240903$20231206$20240925$PER$$US-SA-2023SA371848$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240925$$MD$US$US
232667415$23266741$5$F$20230101$20240912$20231206$20240919$EXP$$US-SA-2023SA372524$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240919$$CN$US$US
232667522$23266752$2$F$$20240731$20231206$20240809$PER$$US-SA-2023SA139414$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240809$$MD$US$US
232667554$23266755$4$F$20230905$20240731$20231206$20240805$EXP$$US-SA-2023SA372570$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240805$$MD$US$US
232667683$23266768$3$F$20230101$20240712$20231206$20240722$PER$$US-SA-2023SA372930$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240721$$MD$US$US
232668204$23266820$4$F$$20240726$20231206$20240801$EXP$$US-SA-2023SA375006$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240801$$MD$US$US
232668403$23266840$3$F$20231101$20240807$20231206$20240816$PER$$US-SA-2023SA373158$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240816$$MD$US$US
232668603$23266860$3$F$20231101$20240813$20231206$20240821$PER$$US-SA-2023SA377289$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240821$$MD$US$US
232668753$23266875$3$F$20231101$20240903$20231206$20240911$PER$$US-SA-2023SA378337$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240911$$MD$US$US
232670783$23267078$3$F$$20240627$20231206$20240702$EXP$$ZA-TAKEDA-2022TUS074379$TAKEDA$$$$$F$Y$$$20240702$$CN$ZA$ZA
232671062$23267106$2$F$$20231130$20231206$20240808$EXP$$US-OTSUKA-2023_031311$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
232672424$23267242$4$F$$20240828$20231206$20240903$EXP$$JP-009507513-2311JPN004277J$MERCK$$5$DEC$$F$Y$$$20240903$$MD$JP$JP
232672933$23267293$3$F$20231126$20240717$20231206$20240722$EXP$$US-PFIZER INC-202300422382$PFIZER$$59$YR$$F$Y$61.23$KG$20240722$$CN$US$US
232673312$23267331$2$F$20230101$20240712$20231206$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-024237$JAZZ$$$$$M$Y$$$20240722$$CN$US$US
232673353$23267335$3$F$$20240816$20231206$20240824$EXP$$GB-TAKEDA-2023TUS116860$TAKEDA$$$$$F$Y$$$20240824$$CN$GB$GB
232673402$23267340$2$F$20231101$20240827$20231206$20240903$EXP$$US-SA-2023SA377938$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240903$$MD$US$US
232673613$23267361$3$F$20200801$20240808$20231206$20240814$EXP$$JP-009507513-2306JPN000852J$MERCK$Nara E, Nakashima K, Kono K, Yoshihara K, Kawakado K, Kobayashi M, et al.. [60 A case of cytokine release syndrome (CRS) due to immune-related adverse events that developed more than 2 years after the introduction of pembrolizumab]. The 128th Chugoku Regional Meeting of the Japanese Society of Internal Medicine$74$YR$$M$Y$$$20240814$$MD$JP$JP
232673864$23267386$4$F$20231123$20240716$20231206$20240723$EXP$$CO-TAKEDA-2023TUS116509$TAKEDA$$26$YR$$M$Y$85$KG$20240723$$CN$CO$CO
232674845$23267484$5$F$20230306$20240909$20231206$20240916$EXP$$KR-OTSUKA-2023_028534$OTSUKA$$47$YR$$F$Y$$$20240916$$MD$KR$KR
232674913$23267491$3$F$20230101$20240624$20231206$20240701$EXP$$TW-AMGEN-TWNSP2023214990$AMGEN$$76$YR$E$F$Y$$$20240701$$CN$TW$TW
232676537$23267653$7$F$20230515$20240924$20231206$20240930$EXP$$BE-SA-2023SA377680$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240930$$HP$BE$BE
232678394$23267839$4$F$$20240712$20231206$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-175642$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240719$$MD$JP$JP
232679312$23267931$2$F$20230401$20240716$20231206$20240724$PER$$JP-Eisai-EC-2023-140038$EISAI$Shimoda N. Discussion from our experience with Pembrolizumab plus Lenvatinib.$68$YR$E$M$Y$$$20240724$$MD$JP$JP
232679413$23267941$3$F$20211101$20240913$20231206$20240916$EXP$$US-TAKEDA-2021TUS054534$TAKEDA$$66$YR$$M$Y$$$20240916$$HP$US$US
232679967$23267996$7$F$20230101$20240729$20231206$20240805$PER$$US-VERTEX PHARMACEUTICALS-2023-015054$VERTEX$$$$$M$Y$77$KG$20240805$$MD$US$US
232680002$23268000$2$F$20220827$20240715$20231206$20240717$EXP$$FR-PURDUE-USA-2023-0306347$PURDUE$$51$YR$$M$Y$70$KG$20240717$$MD$FR$FR
232680134$23268013$4$F$$20240701$20231206$20240703$EXP$$US-INCYTE CORPORATION-2023IN012717$INCYTE$$$$$$Y$$$20240703$$CN$US$US
232680723$23268072$3$F$20230901$20240730$20231206$20240807$PER$$US-SA-2023SA374818$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240807$$MD$US$US
232680754$23268075$4$F$20231101$20240705$20231206$20240711$EXP$$ZA-TAKEDA-2022TUS044129$TAKEDA$$81$YR$$M$Y$$$20240711$$MD$ZA$ZA
232681993$23268199$3$F$$20240702$20231206$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-176280$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240704$$CN$US$US
232682654$23268265$4$F$20231127$20240723$20231206$20240730$EXP$$CA-TAKEDA-2023TUS117309$TAKEDA$$70$YR$$M$Y$$$20240730$$HP$CA$CA
232683033$23268303$3$F$20231011$20240826$20231206$20240906$EXP$$IT-JNJFOC-20231210059$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240906$$HP$IT$IT
232683464$23268346$4$F$20230101$20240919$20231206$20240925$EXP$$US-ABBVIE-5522181$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
232684092$23268409$2$F$$20240807$20231206$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-174786$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240814$$PH$JP$JP
232684174$23268417$4$F$$20240822$20231206$20240828$EXP$$GR-MYLANLABS-2023M1128651$MYLAN$Kofopoulos Lymberis E, Bobetsi G, Bayas G, Latsonas P, Pikouli A, Pikoulis A, Kirkilesis G, Papakonstantinou D, Pikoulis E.. Rare gastrointestinal anastomosis leak after taking chemotherapy. 33rd panhellenic surgical congress and international surgical forum. 2023;470$67$YR$$F$Y$$$20240828$$MD$GR$GR
232684663$23268466$3$F$20230526$20240912$20231206$20240919$EXP$$NVSC2023GB024608$NOVARTIS$$$$$F$Y$$$20240919$$CN$GB$GB
232685084$23268508$4$F$$20240814$20231206$20240814$PER$$US-PFIZER INC-202300429312$PFIZER$$90$YR$$F$Y$49.9$KG$20240814$$HP$US$US
232685355$23268535$5$F$20231103$20240806$20231206$20240905$EXP$$US-BEH-2023166118$CSL BEHRING$$49$YR$A$F$Y$$$20240905$$HP$US$US
232685632$23268563$2$F$$20240826$20231206$20240903$EXP$$CA-Covis Pharma GmbH-2021COV19129$COVIS PHARMA$$50$YR$A$F$Y$$$20240903$$MD$CA$CA
232685723$23268572$3$F$20240501$20240920$20231206$20240923$EXP$$US-PFIZER INC-PV202300194066$PFIZER$$74$YR$$F$Y$$$20240923$$CN$US$US
232685912$23268591$2$F$20230101$20240701$20231206$20240703$PER$$US-PFIZER INC-PV202300192134$PFIZER$$45$YR$$F$Y$$$20240703$$CN$US$US
232686453$23268645$3$F$$20240708$20231206$20240711$PER$$US-PFIZER INC-PV202300195155$PFIZER$$54$YR$$F$Y$$$20240711$$HP$US$US
232686482$23268648$2$F$20231101$20240926$20231206$20240930$PER$$US-PFIZER INC-PV202300194559$PFIZER$$62$YR$$M$Y$$$20240930$$CN$US$US
232686562$23268656$2$F$$20240730$20231206$20240801$PER$$US-PFIZER INC-PV202300194067$PFIZER$$64$YR$$F$Y$$$20240801$$HP$US$US
232687295$23268729$5$F$20220101$20240823$20231206$20240828$EXP$$US-PFIZER INC-202300422479$PFIZER$$52$YR$$F$Y$58.97$KG$20240828$$CN$US$US
232687904$23268790$4$F$20231115$20240910$20231206$20240911$EXP$$US-TAKEDA-2023TUS117618$TAKEDA$$13$YR$$M$Y$$$20240911$$MD$US$US
232688132$23268813$2$F$20200205$20240905$20231206$20240912$EXP$$BR-TAKEDA-2020TUS017084$TAKEDA$$62$YR$$F$Y$$$20240912$$CN$BR$BR
232688373$23268837$3$F$$20240917$20231206$20240924$EXP$$CA-CELLTRION INC.-2023CA023114$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
232689072$23268907$2$F$$20240826$20231206$20240828$EXP$$CA-BAUSCH-BL-2023-017927$BAUSCH AND LOMB$$36$YR$$F$Y$$$20240828$$HP$CA$CA
232689112$23268911$2$F$20231120$20240719$20231206$20240724$EXP$$US-ABBVIE-5522597$ABBVIE$$47$YR$$F$Y$$$20240724$$CN$US$US
232689374$23268937$4$F$$20240808$20231206$20240815$EXP$$NVSJ2023JP017181$NOVARTIS$$51$YR$$M$Y$$$20240816$$MD$JP$JP
232689382$23268938$2$F$20231125$20240820$20231206$20240903$EXP$$CA-AMGEN-CANNI2023216564$AMGEN$$58$YR$A$M$Y$$$20240903$$CN$CA$CA
232689543$23268954$3$F$$20240624$20231206$20240701$EXP$$JP-SA-2023SA376739$SANOFI AVENTIS$Shimoyama Y, Yamaguchi M, Waseda Y, Hosokawa Y, Fukui M, Shimada A, et al.. 30: A case of eosinophilic pneumonia following treatment with anti-IL-4/13 receptor antibody.. The 253rd Hokuriku Regional Meeting of the Japanese Society of Internal Medicine. UNK;UNK:UNK$43$YR$A$F$Y$$$20240701$$MD$JP$JP
232689737$23268973$7$F$$20240605$20231206$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005203$ACADIA PHARMACEUTICALS$$$$$F$Y$54$KG$20240701$$CN$US$US
232689954$23268995$4$F$20220701$20240806$20231206$20240821$EXP$$CO-SANDOZ INC.-NVSC2022CO275319$SANDOZ$$78$YR$$M$Y$83$KG$20240821$$CN$CO$CO
232690082$23269008$2$F$20231204$20240809$20231206$20240812$PER$$US-AMGEN-USASP2023216712$AMGEN$$78$YR$E$M$Y$$$20240812$$CN$US$US
232690116$23269011$6$F$20220101$20240911$20231206$20240916$EXP$$US-SA-2023SA379232$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240916$$MD$US$US
232690416$23269041$6$F$$20240926$20231206$20240930$EXP$$BR-TAKEDA-2023TUS117075$TAKEDA$$$$$F$Y$44$KG$20240930$$MD$BR$BR
232691292$23269129$2$F$$20240708$20231206$20240709$EXP$$CA-ABBVIE-5522430$ABBVIE$$40$YR$$M$Y$130$KG$20240709$$HP$CA$CA
232691325$23269132$5$F$$20240808$20231206$20240816$EXP$$JP-009507513-2311JPN004151J$MERCK$Kondo K, Iwai M, Horiba A, Ishiguro T, Komaki C, Yoshida T. B-10 A Case of RA with Organizing Pneumonia during Pembrolizumab Combination Chemotherapy. The 142nd Tokai Branch Meeting of the Japanese Society for Tuberculosis and Nont. 28$75$YR$$M$Y$$$20240816$$MD$JP$JP
232691425$23269142$5$F$20230101$20240918$20231206$20240923$EXP$$CA-PFIZER INC-202300332341$PFIZER$$78$YR$$F$Y$$$20240923$$PH$CA$CA
232691442$23269144$2$F$20210721$20240827$20231206$20240830$EXP$$CA-PFIZER INC-202100951152$PFIZER$$80$YR$$F$Y$$$20240830$$HP$CA$CA
2326917310$23269173$10$F$20230101$20240925$20231207$20240927$PER$$US-BIOGEN-2023BI01238494$BIOGEN$$$$$M$Y$$$20240927$$CN$US$US
232692133$23269213$3$F$20231119$20240710$20231207$20240714$EXP$$US-ABBVIE-5526832$ABBVIE$$59$YR$$M$Y$$$20240714$$CN$US$US
232692543$23269254$3$F$20231101$20240626$20231207$20240705$PER$$US-SA-2023SA373447$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240705$$MD$US$US
232693785$23269378$5$F$20230101$20240822$20231207$20240830$EXP$$US-ABBVIE-5522493$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
232693892$23269389$2$F$$20240918$20231207$20240920$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2023-US-002155$IPCA$Loai Dweik, Pratik Rath and Natthavat Tanphaichitr. Unsettling lactate levels: A hint toward metformin toxicity. J Am Soc Nephrol. 2023;34:1104$$$$$Y$$$20240920$$HP$US$US
2326941010$23269410$10$F$20230101$20240815$20231207$20240824$EXP$$CA-CELLTRION INC.-2023CA002588$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
232694222$23269422$2$F$$20240717$20231207$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-177132$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240723$$CN$US$US
232694922$23269492$2$F$20231101$20240628$20231207$20240702$EXP$$US-BIOGEN-2023BI01213941$BIOGEN$$44$YR$$F$Y$$$20240702$$CN$US$US
2326950110$23269501$10$F$20230501$20240822$20231207$20240827$EXP$$US-BIOVITRUM-2023-US-013545$BIOVITRUM$$76$YR$$M$Y$$$20240827$$CN$US$US
232695996$23269599$6$F$20240325$20240821$20231207$20240826$EXP$$CA-TAKEDA-2023TUS117393$TAKEDA$$65$YR$$F$Y$$$20240826$$MD$CA$CA
232696512$23269651$2$F$$20240711$20231207$20240716$EXP$$CA-Orion Corporation ORION PHARMA-TREX2023-0285$ORION$Hitchon C, Mesa C. Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-center prospective cohort study. BMJ Open. 2023;13(5):1-11.$77$YR$E$F$Y$$$20240716$$MD$CA$
232698304$23269830$4$F$20231101$20240710$20231207$20240711$EXP$$BE-ROCHE-3470314$ROCHE$$41$YR$A$F$Y$59.4$KG$20240711$$MD$BE$BE
232698462$23269846$2$F$20230911$20240829$20231207$20240906$EXP$$IT-CELLTRION INC.-2023IT023391$CELLTRION$$$$$$Y$$$20240906$$MD$IT$IT
232699766$23269976$6$F$20230101$20240702$20231207$20240708$EXP$$US-SA-2023SA373844$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240708$$MD$US$US
232699794$23269979$4$F$20230101$20240806$20231207$20240815$PER$$US-SA-2023SA374248$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240815$$MD$US$US
232700093$23270009$3$F$$20240815$20231207$20240827$PER$$US-SA-2023SA373815$SANOFI AVENTIS$$$$T$M$Y$47.71$KG$20240827$$MD$US$US
232700816$23270081$6$F$20230901$20240712$20231207$20240722$EXP$$BR-CELLTRION INC.-2023BR023396$CELLTRION$$$$$$Y$$$20240722$$CN$BR$BR
232701102$23270110$2$F$20231129$20240702$20231207$20240709$EXP$$US-ALXN-202311USA002017US$ALEXION PHARMACEUTICALS$$1$YR$$M$Y$$$20240710$$HP$US$US
232701403$23270140$3$F$20230105$20240624$20231207$20240701$EXP$$US-ABBVIE-5524458$ABBVIE$$78$YR$$F$Y$$$20240701$$CN$US$US
232701525$23270152$5$F$20220513$20240730$20231207$20240805$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-170932$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240805$$CN$US$US
232701655$23270165$5$F$20200710$20240812$20231207$20240821$EXP$$CA-TAKEDA-2023TUS092453$TAKEDA$$24$YR$$F$Y$$$20240821$$MD$CA$CA
232701744$23270174$4$F$20230101$20240625$20231207$20240702$EXP$$US-SA-2023SA248087$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240702$$MD$US$US
232701872$23270187$2$F$$20240906$20231207$20240919$EXP$$US-AUROBINDO-AUR-APL-2023-075922$AUROBINDO$Ayub F, Hasan MR, Khan N, Homam WMB, Manchala VR.. Triple Jeopardy: Trialled Thrice in the Same Crime.. Journal of the American Society of Nephrology. 2023;34:325$41$YR$$M$Y$$$20240919$$MD$US$US
232702512$23270251$2$F$20170413$20240705$20231207$20240711$EXP$$CA-TAKEDA-2022TUS100001$TAKEDA$$28$YR$$M$Y$$$20240711$$CN$CA$CA
232702895$23270289$5$F$$20240705$20231207$20240710$EXP$$CA-TAKEDA-2023TUS116684$TAKEDA$$$$$F$Y$$$20240710$$MD$CA$CA
232703102$23270310$2$F$20231001$20240712$20231207$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-157957$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240719$$MD$JP$JP
232703462$23270346$2$F$20231017$20231128$20231207$20240807$PER$$US-LEO Pharma-365673$LEO PHARM$$74$YR$$F$Y$$$20240807$$HP$US$US
232704722$23270472$2$F$20211107$20240913$20231207$20240925$EXP$$IT-AUROBINDO-AUR-APL-2022-026712$AUROBINDO$$63$YR$$M$Y$$$20240925$$HP$IT$IT
232705613$23270561$3$F$20231127$20240912$20231207$20240927$PER$$US-SA-2023SA379108$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240927$$MD$US$US
232705633$23270563$3$F$20231101$20240814$20231207$20240827$PER$$US-SA-2023SA378918$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240827$$MD$US$US
232707474$23270747$4$F$20220101$20240905$20231207$20240909$EXP$$IT-MYLANLABS-2023M1123153$MYLAN$Pennese E, Salutari P, Carriero L, Restuccia F, De Filippis A, De Luca G, Giancola R, Guardalupi F, Corradi G, Fabi B, Baldoni S and Di Ianni M.. Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis. Frontiers in Immunology. 2023;14:1-5$55$YR$$F$Y$$$20240909$$HP$IT$IT
232708512$23270851$2$F$$20240802$20231207$20240807$EXP$$US-TAKEDA-2023TUS117799$TAKEDA$$$$$M$Y$133$KG$20240807$$HP$US$US
232709442$23270944$2$F$20230101$20240801$20231207$20240809$PER$$US-SA-2023SA379274$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240809$$MD$US$US
232710154$23271015$4$F$20240101$20240805$20231207$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-176955$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240807$$CN$US$US
232710673$23271067$3$F$20230601$20240815$20231207$20240821$EXP$$JP-009507513-2311JPN003873J$MERCK$$68$YR$$M$Y$$$20240821$$MD$JP$JP
232710723$23271072$3$F$$20240625$20231207$20240703$EXP$$CA-CELLTRION INC.-2023CA023193$CELLTRION$$$$$$Y$$$20240703$$MD$CA$CA
232712422$23271242$2$F$20231123$20240702$20231207$20240718$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000483$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
232712432$23271243$2$F$$20240823$20231207$20240903$PER$$US-ALXN-A202310149$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
232712487$23271248$7$F$20231106$20240904$20231207$20240923$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000489$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
232712806$23271280$6$F$20191226$20240627$20231207$20240702$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2023-147626$REGENERON$$$$$M$Y$$$20240702$$CN$US$US
232713213$23271321$3$F$20230701$20240709$20231207$20240715$EXP$$JP-009507513-2311JPN004311J$MERCK$$5$DEC$$F$Y$$$20240715$$MD$JP$JP
232713292$23271329$2$F$$20240705$20231207$20240717$PER$$US-SA-2023SA378390$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240717$$MD$US$US
232713764$23271376$4$F$20221101$20240722$20231207$20240725$EXP$$DE-TAKEDA-2023TUS118050$TAKEDA$$51$YR$$F$Y$$$20240725$$HP$DE$DE
232714062$23271406$2$F$$20240626$20231207$20240703$EXP$$IL-TAKEDA-2023TUS115638$TAKEDA$$$$$M$Y$$$20240703$$HP$IL$IL
232715583$23271558$3$F$$20240823$20231207$20240830$EXP$$JP-009507513-2306JPN000763J$MERCK$$50$YR$$F$Y$$$20240830$$MD$JP$JP
232715912$23271591$2$F$20210509$20231130$20231207$20240827$EXP$$NVSC2023GB255626$NOVARTIS$$$$A$F$Y$102.9$KG$20240827$$HP$GB$GB
232716423$23271642$3$F$20230101$20240703$20231207$20240708$EXP$$JP-009507513-2307JPN004263J$MERCK$$85$YR$$F$Y$$$20240708$$MD$JP$JP
232717112$23271711$2$F$$20240906$20231207$20240912$EXP$$US-ALXN-A202304406$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$MD$US$US
232717174$23271717$4$F$$20240911$20231207$20240916$EXP$$US-INCYTE CORPORATION-2023IN012480$INCYTE$$$$$$Y$$$20240916$$CN$US$US
232717203$23271720$3$F$20231101$20240105$20231207$20240925$PER$$US-GSK-US2023AMR166719$GLAXOSMITHKLINE$$63$YR$$F$Y$55.782$KG$20240925$$HP$US$US
232717723$23271772$3$F$20231021$20240828$20231207$20240902$EXP$$IN-PFIZER INC-PV202300192033$PFIZER$$51$YR$$M$Y$60$KG$20240902$$CN$IN$IN
232717766$23271776$6$F$20230101$20240722$20231207$20240724$EXP$$CA-PFIZER INC-202300427504$PFIZER$$4$YR$$F$Y$16$KG$20240724$$HP$CA$CA
232718584$23271858$4$F$20210101$20240913$20231207$20240923$EXP$$DE-EMD Serono-2023491641$EMD SERONO INC$$19$YR$A$M$Y$85$KG$20240923$$CN$DE$DE
232718754$23271875$4$F$$20240906$20231207$20240916$30DAY$$US-GSK-US2023165508$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
232718785$23271878$5$F$$20240905$20231207$20240911$EXP$$CA-TAKEDA-2023TUS117368$TAKEDA$$$$$F$Y$$$20240911$$MD$CA$CA
232718962$23271896$2$F$20231101$20240628$20231207$20240705$EXP$$JP-009507513-2311JPN004427J$MERCK$$$$$M$Y$$$20240705$$MD$JP$JP
232719713$23271971$3$F$$20240214$20231207$20240925$PER$$US-GSK-US2023AMR167310$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
232720083$23272008$3$F$20231130$20240719$20231207$20240726$PER$$US-SA-2023SA379450$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240726$$CN$US$US
232721113$23272111$3$F$20230101$20240723$20231207$20240726$PER$$US-AMGEN-USASP2023217741$AMGEN$$80$YR$E$M$Y$$$20240725$$HP$US$US
232721333$23272133$3$F$20240601$20240627$20231207$20240712$PER$$US-SA-2023SA374136$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240712$$MD$US$US
232721412$23272141$2$F$$20240916$20231207$20240917$EXP$$US-TAKEDA-2023TUS047875$TAKEDA$$$$$F$Y$$$20240917$$CN$US$US
232721573$23272157$3$F$$20240812$20231207$20240819$PER$$US-AGIOS-2312US03561$AGIOS PHARMACEUTICALS$$$$$M$Y$$$20240819$$HP$US$US
232721773$23272177$3$F$20240101$20240903$20231207$20240905$PER$$US-PFIZER INC-PV202300194910$PFIZER$$55$YR$$F$Y$$$20240905$$HP$US$US
232721842$23272184$2$F$20231201$20240813$20231207$20240815$EXP$$US-PFIZER INC-PV202300055880$PFIZER$$85$YR$$F$Y$$$20240815$$CN$US$US
232721914$23272191$4$F$$20240903$20231207$20240905$PER$$US-PFIZER INC-PV202300194586$PFIZER$$60$YR$$M$Y$$$20240905$$HP$US$US
232722382$23272238$2$F$20240101$20240821$20231207$20240904$EXP$$US-SA-2023SA378342$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240904$$MD$US$US
2327226110$23272261$10$F$20240117$20240703$20231207$20240722$EXP$$US-BEH-2023166125$CSL BEHRING$$43$YR$A$F$Y$$$20240719$$HP$US$US
232722843$23272284$3$F$$20240808$20231207$20240819$EXP$$CA-TAKEDA-2023TUS079824$TAKEDA$$$$$F$Y$$$20240819$$MD$CA$CA
232723382$23272338$2$F$$20240723$20231207$20240807$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421846$RANBAXY$Howard AJ, Frankston AJ. AKI in a Kidney Transplant Patient Started on Ranolazine. J Am Soc Nephrol. 2023;34:TH-PO066; 107$74$YR$$M$Y$$$20240807$$HP$US$US
232723542$23272354$2$F$$20240903$20231207$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422216$RANBAXY$Kim KY, Hwang J, Sam S. Two Cases Of Hypoglycemia From Inhalation Of Heroin Adulterated With A Sulfonylurea. J Endocr Soc. 2023;Oct-Nov; 7(S1):A545-A546/SAT156$61$YR$$F$Y$$$20240918$$MD$US$US
232723552$23272355$2$F$$20240912$20231207$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422224$RANBAXY$Iqbal M, Jiang L, Li KD, Moustafa MA, Kimbrough EO, Ansell SM, et al. Poly-lymphomatous Syndrome With Concurrent or Sequential Hodgkin and Non-Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk. 2023;Feb; 23(2):138-144$46$YR$$F$Y$$$20240927$$HP$US$US
232723622$23272362$2$F$20230612$20240617$20231207$20240702$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-421694$RANBAXY$$72$YR$$M$Y$105$KG$20240702$$HP$DE$DE
232724002$23272400$2$F$$20240802$20231207$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422297$RANBAXY$Nino JM, Wong R, Bracamonte ER, Thajudeen B. AvelumabInduced Thrombotic Microangiopathy: A Case Report.. J Am Soc Nephrol. 2023;34:279; TH-PO675$56$YR$$F$Y$$$20240816$$HP$US$US
232724252$23272425$2$F$$20240821$20231207$20240905$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422363$RANBAXY$Bose V, Martinez DS. Finasteride Induced Hyperglycemia. J Endocr Soc. 2023;7 (Suppl 1):A433 (THU372)$69$YR$$M$Y$$$20240905$$MD$US$US
232724523$23272452$3$F$$20240618$20231207$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421662$RANBAXY$Gumayan RLF, Kamdar HA, Twanow J. A Case of Levetiracetam-Induced Orofacial Dyskinesia and Encephalopathy. J Child Neurol. 2023;38(8-9):560-561$3$YR$$M$Y$$$20240703$$HP$US$US
232725152$23272515$2$F$$20231124$20231207$20240906$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420991$RANBAXY$$48$YR$$F$Y$$$20240906$$CN$AU$AU
232726732$23272673$2$F$20230101$20240821$20231207$20240824$PER$$US-AMGEN-USASP2023218869$AMGEN$$75$YR$E$F$Y$$$20240824$$CN$US$US
232727265$23272726$5$F$$20240903$20231207$20240924$30DAY$$CN-JNJFOC-20231153969$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$CN$CN
232727273$23272727$3$F$20210104$20240801$20231207$20240805$EXP$$KR-OTSUKA-2023_031342$OTSUKA$$54$YR$$M$Y$$$20240805$$MD$KR$KR
232727852$23272785$2$F$20231114$20240829$20231207$20240903$EXP$$ES-FERRINGPH-2023FE05800$FERRING$$$$$$Y$$$20240903$$MD$ES$ES
232727922$23272792$2$F$$20240826$20231207$20240909$PER$$US-SA-2023SA379234$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240909$$MD$US$US
232728062$23272806$2$F$20160615$20240911$20231207$20240917$EXP$$CA-AstraZeneca-2019SF90277$ASTRAZENECA$$69$YR$$M$Y$$$20240918$$MD$CA$
232730024$23273002$4$F$$20240828$20231207$20240906$EXP$$US-TEVA-VS-3134238$TEVA$Kesari S, Barron C, Cohen LE, Regelmann MO, Baer TG, Dexamethasone swish and spit: A cause of iatrogenic adrenal insufficiency. Pediatric Blood + Cancer 71: e31138, No. 9, Sep 2024.; Guntaka S, Barron C, Baer T, Cohen L, Regelmann M. Dexamethasone swish and spit, a cause of iatrogenic adrenal insufficiency. Horm-Res-Paediatr 2023; 96 (Suppl.) 13-14.; Guntaka S, Barron C, Baer T, Cohen L, Regelmann M. Dexamethasone swish and spit, a cause of iatrogenic adrenal insufficiency. Horm-Res-Paediatr ...$14$YR$$M$Y$$$20240906$$MD$US$US
232730282$23273028$2$F$20231101$20240628$20231207$20240710$EXP$$FR-ROCHE-3467221$ROCHE$$64$YR$A$M$Y$$$20240710$$MD$FR$FR
232730352$23273035$2$F$20201123$20240807$20231207$20240822$EXP$$FR-SERVIER-S21010605$SERVIER$$$$$$Y$$$20240822$$MD$FR$FR
232730436$23273043$6$F$20240123$20240811$20231207$20240812$EXP$$IL-TAKEDA-2023TUS117150$TAKEDA$$63$YR$$M$Y$$$20240812$$CN$IL$IL
232731823$23273182$3$F$20210106$20240904$20231207$20240905$EXP$GB-MHRA-ADR 28373356$GB-MYLANLABS-2023M1129807$MYLAN$Danbury G.. Tramadol-warfarin interaction.. Drug Ther. Bull.. 2024;62(3):36, 977$$$$F$Y$$$20240905$$HP$GB$GB
2327335229$23273352$29$F$20230101$20240925$20231207$20240930$EXP$$GB-009507513-2312GBR000229$MERCK$$$$$F$Y$$$20240930$$MD$GB$GB
232734437$23273443$7$F$20231121$20240915$20231207$20240918$EXP$$IN-PFIZER INC-PV202300196880$PFIZER$$52$YR$$F$Y$$$20240918$$CN$IN$IN
232734602$23273460$2$F$$20240701$20231207$20240709$PER$$US-INCYTE CORPORATION-2023IN012645$INCYTE$$$$$$Y$$$20240709$$CN$US$US
232735102$23273510$2$F$20230501$20240918$20231207$20240930$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000202$THERATECHNOLOGIES$$$$$$Y$$$20240930$$CN$US$US
232735512$23273551$2$F$$20231128$20231207$20240712$PER$$US-PFIZER INC-PV202300195072$PFIZER$$47$YR$$F$Y$$$20240712$$CN$US$US
232736024$23273602$4$F$20200601$20240816$20231207$20240821$EXP$$AR-SANDOZ INC.-NVSC2020AR193456$SANDOZ$$5$YR$$F$Y$20.3$KG$20240821$$HP$AR$AR
232736203$23273620$3$F$$20240809$20231207$20240814$EXP$$JP-009507513-2311JPN001868J$MERCK$Adachi T, Shimizu W, Yoshinaka, H, Kondo K, Tokumoto N, Hinohara J. PS1-10-3 A case of BRAF mutation-positive, MSI-H unresectable right-sided colorectal cancer in which only the primary tumor re-enlarged after cCR by Keytruda and radical resection was performed. The 78th Annual Meeting of The Japan Society of Coloproctology. 2023;76(9):A270$73$YR$$M$Y$$$20240814$$MD$JP$JP
232736446$23273644$6$F$20231101$20240117$20231207$20240711$EXP$$US-BEH-2023165799$CSL BEHRING$$32$YR$A$M$Y$107$KG$20240711$$CN$US$US
232736692$23273669$2$F$$20240702$20231207$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-174021$BRISTOL MYERS SQUIBB$Yamamoto A, Nakayama S, Kawase K, Wakabayashi Y, Kitazawa T et al. A case of disseminated nontuberculous mycobacteria during treatment of multiple myeloma with biologics. The 72nd Higashinihon Regional Meeting of the Japanese Association for Infectious Diseases, The 70th Higashinihon Regional Meeting of the Japanese Society of Chemotherapy, Joint Meeting Programs and abstracts, Web. 2023; : 183 {-}. :.$74$YR$E$M$Y$$$20240709$$MD$JP$JP
232737146$23273714$6$F$20231023$20240517$20231207$20240723$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-269293$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$68.9$KG$20240716$$MD$JP$JP
232737653$23273765$3$F$20230101$20240904$20231207$20240909$EXP$$US-ABBVIE-5524620$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
232738053$23273805$3$F$$20240625$20231207$20240701$EXP$$US-BIOGEN-2023BI01238589$BIOGEN$$$$$F$Y$$$20240630$$CN$US$US
232739263$23273926$3$F$20231121$20240704$20231207$20240726$PER$$CA-TOLMAR, INC.-23CA044949$TOLMAR$$78$YR$$M$Y$$$20240726$$CN$CA$CA
232739443$23273944$3$F$$20240917$20231207$20240920$PER$$US-JAZZ PHARMACEUTICALS-2022-US-002342$JAZZ$$$$$F$Y$72.5$KG$20240920$$CN$US$US
232739632$23273963$2$F$20230101$20240717$20231207$20240726$PER$$US-SA-2023SA379637$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
232739992$23273999$2$F$20231028$20231202$20231207$20240820$EXP$$JP-SA-2023SA357940$SANOFI AVENTIS$$50$YR$A$F$Y$55$KG$20240820$$MD$JP$JP
232740043$23274004$3$F$20230101$20240703$20231208$20240707$PER$$US-AMGEN-USASP2023217095$AMGEN$$21$YR$A$F$Y$$$20240707$$HP$US$US
232740143$23274014$3$F$20230907$20240711$20231208$20240801$PER$$US-SA-2023SA379824$SANOFI AVENTIS$$6$YR$C$F$Y$33$KG$20240719$$MD$US$US
232740622$23274062$2$F$$20240726$20231208$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-176820$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240815$$HP$US$US
232742053$23274205$3$F$20231115$20240724$20231208$20240819$PER$$CA-TOLMAR, INC.-23CA044814$TOLMAR$$73$YR$$M$Y$$$20240819$$CN$CA$CA
232742103$23274210$3$F$20231115$20240625$20231208$20240717$PER$$CA-TOLMAR, INC.-23CA044828$TOLMAR$$72$YR$$M$Y$$$20240717$$CN$CA$CA
232743293$23274329$3$F$$20240627$20231208$20240706$EXP$$US-AUROBINDO-AUR-APL-2023-075720$AUROBINDO$Thimmisetty RK, Venkatachalam T, Ernesto TF, Ramirez B. Epstein-Bar Virus (EBV)-Associated Plasmacytoma/Congophilic Lambda Light Chain (LC) Casts Four Months After Kidney Transplant Causing Death of the Patient.. Journal of the American Society of Nephrology. 2023;34:1158-9$66$YR$$F$Y$$$20240706$$MD$US$US
232743874$23274387$4$F$20230101$20240903$20231208$20240909$EXP$$PK-AMGEN-PAKSP2023217400$AMGEN$$37$YR$A$F$Y$$$20240908$$CN$PK$PK
232744066$23274406$6$F$20230101$20240814$20231208$20240820$PER$$US-AMGEN-USASP2023218883$AMGEN$$76$YR$E$F$Y$$$20240820$$CN$US$US
2327441811$23274418$11$F$20231130$20240829$20231208$20240905$EXP$$CO-TAKEDA-2023TUS117287$TAKEDA$$0$YR$$F$Y$$$20240905$$CN$CO$CO
232744363$23274436$3$F$$20240619$20231208$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005405$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
232744699$23274469$9$F$20240620$20240903$20231208$20240913$EXP$$US-GSK-US2023AMR167531$GLAXOSMITHKLINE$$40$YR$$F$Y$$$20240913$$CN$US$US
232744949$23274494$9$F$20230601$20240920$20231208$20240930$EXP$$CA-CELLTRION INC.-2023CA011787$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
232745015$23274501$5$F$20240101$20240730$20231208$20240805$EXP$$GB-UCBSA-2023057674$UCB$$$$$M$Y$$$20240805$$CN$GB$GB
232746255$23274625$5$F$$20240906$20231208$20240911$EXP$$ES-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00773$VELOXIS PHARMACEUTICALS$Pena M, Montane C, Paviglianiti A, Hurtado L, Gonzalez S, Mussetti A. et al.. Outcomes of allogeneic hematopoietic cell transplantation after bispecific antibodies in non-Hodgkin lymphomas.. Bone Marrow Transplantation. 2023;58 (11):1282-5.$57$YR$$M$Y$$$20240911$$MD$ES$ES
232746394$23274639$4$F$$20240822$20231208$20240911$PER$$US-APOTEX-2023AP014931$APOTEX$$$$A$F$Y$$$20240911$$MD$US$US
232746833$23274683$3$F$20230101$20240717$20231208$20240725$EXP$$US-RECORDATI-2023002009$RECORDATI$$$$$$Y$$$20240725$$CN$US$US
232747022$23274702$2$F$$20240719$20231208$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-176354$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$PH$JP$JP
232747873$23274787$3$F$20231122$20240820$20231208$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-174322$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$72.57$KG$20240828$$CN$US$US
232748233$23274823$3$F$20170101$20240722$20231208$20240729$EXP$$CA-TAKEDA-2018TUS017271$TAKEDA$$$$$M$Y$$$20240729$$MD$CA$CA
232748262$23274826$2$F$$20240808$20231208$20240821$EXP$$US-AUROBINDO-AUR-APL-2023-075745$AUROBINDO$Beavin S, Ahmed S.. Mind the Gap: Pyroglutamic Acidosis as a Not-so-Rare Cause of High Anion Gap Metabolic Acidosis (HAGMA). Journal of the American Society of Nephrology. 2023;34:202$39$YR$$M$Y$$$20240821$$MD$US$US
232749248$23274924$8$F$20240331$20240916$20231208$20240919$EXP$$US-TAKEDA-2023TUS118409$TAKEDA$$59$YR$$F$Y$76$KG$20240919$$CN$US$US
232749832$23274983$2$F$$20240922$20231208$20240930$EXP$$GB-TAKEDA-2023TUS117741$TAKEDA$$$$$F$Y$$$20240930$$CN$GB$GB
232749859$23274985$9$F$20231001$20240712$20231208$20240723$EXP$$CA-TAKEDA-2023TUS071520$TAKEDA$$67$YR$$M$Y$$$20240723$$HP$CA$CA
232750065$23275006$5$F$$20240712$20231208$20240718$EXP$$CA-ROCHE-3377671$ROCHE$$$$A$F$Y$$$20240718$$CN$CA$CA
232751513$23275151$3$F$$20240709$20231208$20240716$EXP$$JP-ROCHE-3471306$ROCHE$$87$YR$E$$Y$$$20240716$$MD$JP$JP
232753272$23275327$2$F$20230101$20240821$20231208$20240902$EXP$$CO-SA-2023SA361829$SANOFI AVENTIS$$11$YR$C$M$Y$44$KG$20240902$$HP$CO$CO
232753312$23275331$2$F$20231101$20240730$20231208$20240807$EXP$$US-SA-2023SA380595$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240807$$MD$US$US
232753533$23275353$3$F$20200101$20240722$20231208$20240801$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-2023-177698$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240801$$MD$AT$AT
232753912$23275391$2$F$$20240626$20231208$20240704$EXP$$US-AUROBINDO-AUR-APL-2023-075743$AUROBINDO$Antony MA, Gundlapally S, Joglekar M, Fritz BN, Patel S, Verma V, et al.. Clinical Implications Due To Long-term Delayed Diagnosis Of Macroprolactinemia.. Journal of the Endocrine Society. 2023;7(Supplement 1):A667- A668 abstr. FRI313$74$YR$$M$Y$$$20240704$$MD$US$US
232754104$23275410$4$F$$20240820$20231208$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-177249$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240822$$MD$JP$JP
232754125$23275412$5$F$$20240729$20231208$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-176723$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240730$$CN$US$US
232754653$23275465$3$F$20230101$20240718$20231208$20240725$EXP$$US-GSK-US2023AMR168310$GLAXOSMITHKLINE$$$$$F$Y$74.83$KG$20240725$$CN$US$US
232755054$23275505$4$F$20231101$20231229$20231208$20240925$PER$$US-GSK-US2023AMR167615$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
232755973$23275597$3$F$$20240704$20231208$20240708$PER$$US-ALXN-202312USA000218US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
232756064$23275606$4$F$20210601$20240830$20231208$20240906$EXP$CA-MLMSERVICE-20231113-4653164-1$CA-CHEPLA-2023015413$CHEPLAPHARM$Hashemi N, Yang D, Shergold D, Tennen G, Fan-Lun C. lozapine for Management of Neuropsychiatric Symptoms in Dementia with Lewy Bodies. Canadian Journal of Hospital Pharmacy. 2023;76(4):340-5. doi:10.4212/cjhp.3390.$76$YR$$M$Y$105$KG$20240906$$PH$COUNTRY NOT SPECIFIED$CA
232756702$23275670$2$F$20231101$20240627$20231208$20240708$PER$$US-SA-2023SA375137$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240708$$MD$US$US
232756812$23275681$2$F$$20240828$20231208$20240910$PER$$US-SA-2023SA373006$SANOFI AVENTIS$$22$YR$A$M$Y$127$KG$20240910$$MD$US$US
232757422$23275742$2$F$20240101$20240822$20231208$20240918$PER$$US-SA-2023SA380148$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240918$$MD$US$US
232757454$23275745$4$F$20230101$20240813$20231208$20240828$PER$$US-SA-2023SA381255$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240828$$MD$US$US
232757553$23275755$3$F$20240622$20240624$20231208$20240702$PER$$US-SA-2023SA380181$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240702$$MD$US$US
232757812$23275781$2$F$20230101$20240626$20231208$20240705$PER$$US-SA-2023SA380554$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240705$$MD$US$US
232758224$23275822$4$F$20230101$20240805$20231208$20240814$PER$$US-SA-2023SA381354$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240814$$MD$US$US
232758384$23275838$4$F$$20240923$20231208$20240926$EXP$$US-TAKEDA-2023TUS118197$TAKEDA$$$$$F$Y$$$20240926$$MD$US$US
232758504$23275850$4$F$20231124$20240909$20231208$20240911$EXP$$CA-ROCHE-3471842$ROCHE$$39$YR$A$F$Y$$$20240911$$CN$CA$CA
232759013$23275901$3$F$$20240918$20231208$20240927$EXP$$NVSC2023IT259292$NOVARTIS$Mannelli F, Crupi F, Zanotti R, Pagano L, Rapezzi D, Tanasi I, et al.. The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis. THERAPEUTIC ADVANCES IN HEMATOLOGY. 2023;14:1-14$61$YR$$M$Y$$$20240927$$HP$IT$IT
232761282$23276128$2$F$20240630$20240801$20231208$20240807$PER$$US-BEH-2023166152$CSL BEHRING$$21$YR$A$F$Y$$$20240807$$HP$US$US
232761476$23276147$6$F$20231116$20240823$20231208$20240910$EXP$$JP-009507513-2312JPN000161J$MERCK$Shinkura N, Inamoto T, Okino T, Emoto N. EP-1084 A Case of Triple negative Breast Cancer in which Venous thrombus Occurred during Preoperative Chemotherapy Containing Pembrolizumab. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 448$47$YR$$F$Y$69$KG$20240910$$MD$JP$JP
232762323$23276232$3$F$$20240715$20231208$20240720$EXP$$BR-TAKEDA-2023TUS117657$TAKEDA$$$$$F$Y$$$20240720$$CN$BR$BR
232762342$23276234$2$F$$20240723$20231208$20240730$EXP$$CA-TAKEDA-2023TUS116653$TAKEDA$$$$$M$Y$$$20240730$$CN$CA$CA
232763423$23276342$3$F$$20240822$20231208$20240827$EXP$$US-TAKEDA-2023TUS117066$TAKEDA$$$$$M$Y$$$20240827$$CN$US$US
232763935$23276393$5$F$20240401$20240620$20231208$20240701$PER$$US-SA-2023SA380273$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240701$$MD$US$US
232764244$23276424$4$F$20230801$20240823$20231208$20240827$EXP$$NVSC2023GB181783$NOVARTIS$$43$YR$$F$Y$$$20240827$$CN$GB$GB
232764763$23276476$3$F$$20240723$20231208$20240725$EXP$$CA-PFIZER INC-202300435646$PFIZER$$39$YR$$F$Y$$$20240725$$HP$CA$CA
232764916$23276491$6$F$20191229$20240916$20231208$20240920$EXP$$US-TAKEDA-2023TUS118623$TAKEDA$$17$YR$$M$Y$$$20240920$$HP$US$US
232764972$23276497$2$F$$20240816$20231208$20240821$EXP$$GB-MYLANLABS-2023M1129307$MYLAN$$$$A$M$Y$$$20240821$$PH$GB$GB
232765682$23276568$2$F$$20240913$20231208$20240924$EXP$$CA-B.Braun Medical Inc.-2149142$B BRAUN$$67$YR$$F$Y$$$20240924$$$CA$CA
232766217$23276621$7$F$$20240807$20231208$20240813$EXP$$BR-TAKEDA-2023TUS104905$TAKEDA$$$$$M$Y$85$KG$20240813$$CN$BR$BR
232766524$23276652$4$F$20220803$20240830$20231208$20240906$EXP$$CA-TAKEDA-2023TUS118324$TAKEDA$$72$YR$$F$Y$$$20240906$$HP$CA$CA
232767083$23276708$3$F$$20240702$20231208$20240710$EXP$$JP-Eisai-EC-2023-154093$EISAI$$$$E$M$Y$$$20240710$$MD$JP$JP
232767503$23276750$3$F$$20240702$20231208$20240710$PER$$JP-Eisai-EC-2023-154610$EISAI$$$$E$M$Y$$$20240710$$MD$JP$JP
232767603$23276760$3$F$$20231128$20231208$20240704$EXP$$PT-SANDOZ INC.-NVSC2022PT074381$SANDOZ$Monteiro C, Dias B, Vaz-Patto M. Headache as an adverse reaction to the use of medication in the elderly: a pharmacovigilance study. International Journal of Environmental Research and Public Health.. 2021;18 (2674):1-11$$$E$$Y$$$20240704$$HP$PT$PT
232769364$23276936$4$F$20231031$20240729$20231208$20240731$EXP$$CA-ROCHE-3471267$ROCHE$$58$YR$A$F$Y$$$20240731$$CN$CA$CA
232770753$23277075$3$F$20230101$20240905$20231208$20240919$EXP$$US-UCBSA-2023057935$UCB$$$$$F$Y$$$20240919$$HP$US$US
232771387$23277138$7$F$20211204$20240709$20231208$20240712$EXP$$US-SANDOZ INC.-NVSC2021US244452$SANDOZ$$54$YR$$F$Y$80.739$KG$20240712$$CN$US$US
232771735$23277173$5$F$$20240713$20231208$20240717$EXP$$IN-PFIZER INC-2019496450$PFIZER$$57$YR$$F$Y$$$20240717$$CN$IN$IN
232771974$23277197$4$F$20230801$20240822$20231208$20240828$EXP$$CL-JNJFOC-20231038191$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240828$$CN$CL$CL
232772362$23277236$2$F$$20240708$20231208$20240709$EXP$$CA-SANDOZ INC.-NVSC2020CA058057$SANDOZ$$71$YR$$F$Y$$$20240709$$CN$CA$CA
232772642$23277264$2$F$20231206$20240808$20231208$20240815$EXP$$US-BIOMARINAP-US-2023-154426$BIOMARIN$$$$$$Y$$$20240815$$CN$US$US
232773133$23277313$3$F$$20240911$20231208$20240913$PER$$US-PFIZER INC-PV202300195535$PFIZER$$69$YR$$F$Y$$$20240913$$CN$US$US
232773312$23277331$2$F$20230113$20240830$20231208$20240904$PER$$US-PFIZER INC-PV202300196486$PFIZER$$72$YR$$F$Y$$$20240904$$MD$US$US
232773425$23277342$5$F$$20240923$20231208$20240925$PER$$US-PFIZER INC-PV202300148169$PFIZER$$72$YR$$M$Y$$$20240925$$MD$US$US
232773533$23277353$3$F$20180101$20240702$20231208$20240708$PER$$US-PFIZER INC-2021168553$PFIZER$$76$YR$$F$Y$$$20240708$$HP$US$US
232774332$23277433$2$F$20220701$20231129$20231208$20240814$EXP$$US-SPECGX-T202201658$SPECGX$$47$YR$$F$Y$107$KG$20240814$$CN$US$US
232776592$23277659$2$F$$20240913$20231208$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421889$RANBAXY$Zhao MY, Charoenkijkajorn C, Pakravan M, Kavoussi SC, Lee AG. Papilledema detected by ultrasound in proliferative diabetic retinopathy with vitreous hemorrhage. Can J Ophthalmol. 2023;58(3):e141-e143$36$YR$$M$Y$$$20240927$$HP$US$US
232779573$23277957$3$F$$20240911$20231208$20240920$EXP$$JP-TAKEDA-2023TUS118537$TAKEDA$$23$YR$$M$Y$$$20240920$$MD$JP$JP
232779592$23277959$2$F$20230927$20240716$20231208$20240718$EXP$$US-TAKEDA-2023TUS118195$TAKEDA$$95$YR$$F$Y$70.76$KG$20240718$$HP$US$US
232781528$23278152$8$F$20231001$20240229$20231208$20240807$EXP$$BR-SANDOZ INC.-SDZ2023BR048902$SANDOZ$$75$YR$$F$Y$$$20240807$$CN$BR$BR
232782266$23278226$6$F$$20240820$20231208$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-177710$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240828$$CN$US$US
232782662$23278266$2$F$20230501$20240708$20231208$20240711$EXP$$DE-PFIZER INC-202300430026$PFIZER$$63$YR$$F$Y$$$20240711$$MD$DE$DE
232783584$23278358$4$F$$20240701$20231208$20240703$PER$$US-PFIZER INC-PV202300026796$PFIZER$$76$YR$$M$Y$$$20240703$$CN$US$US
232783603$23278360$3$F$$20240920$20231208$20240924$PER$$US-PFIZER INC-PV202300065131$PFIZER$$79$YR$$F$Y$$$20240924$$MD$US$US
232784779$23278477$9$F$20240401$20240805$20231208$20240810$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-173840$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$54.43$KG$20240810$$CN$US$US
232784783$23278478$3$F$$20240621$20231208$20240711$PER$$US-PHARMING-PHAUS2023000887$PHARMING GROUP$$$$$$Y$$$20240711$$CN$US$US
232785504$23278550$4$F$20200401$20240917$20231208$20240925$EXP$$NVSC2020CO180684$NOVARTIS$$51$YR$$M$Y$97$KG$20240926$$CN$CO$CO
232786907$23278690$7$F$$20240812$20231208$20240819$EXP$$US-SANDOZ INC.-SDZ2023US061468$SANDOZ$$$$$F$Y$90.703$KG$20240819$$CN$US$US
232787472$23278747$2$F$20230822$20240923$20231208$20240925$EXP$$ES-MYLANLABS-2023M1129341$MYLAN$$50$YR$$F$Y$$$20240925$$MD$ES$ES
232788202$23278820$2$F$$20231129$20231208$20240716$PER$$US-PFIZER INC-PV202300195508$PFIZER$$59$YR$$F$Y$$$20240716$$CN$US$US
232788553$23278855$3$F$20230729$20240625$20231208$20240703$EXP$$JP-Eisai-EC-2023-148820$EISAI$$79$YR$E$M$Y$60$KG$20240703$$MD$JP$JP
232788612$23278861$2$F$20211101$20220810$20231208$20240819$EXP$FR-AFSSAPS-LY20223768$FR-TAKEDA-2022TUS054768$TAKEDA$$61$YR$$M$Y$71$KG$20240819$$HP$FR$FR
232790073$23279007$3$F$20231124$20240131$20231209$20240701$PER$$US-UCBSA-2023057596$UCB$$$$$F$Y$$$20240701$$CN$US$US
232790982$23279098$2$F$20230101$20240716$20231209$20240723$PER$$US-SA-2023SA379629$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240723$$MD$US$US
232791534$23279153$4$F$$20240722$20231209$20240730$PER$$US-ALXN-A202312955$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
232791888$23279188$8$F$$20240815$20231209$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-178485$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240821$$HP$US$US
232791922$23279192$2$F$20240801$20240816$20231209$20240829$PER$$US-SA-2023SA374174$SANOFI AVENTIS$$78$YR$E$M$Y$92$KG$20240829$$MD$US$US
232792613$23279261$3$F$20230101$20240708$20231209$20240715$PER$$US-SA-2023SA381163$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240715$$MD$US$US
232792743$23279274$3$F$20230912$20240716$20231209$20240722$EXP$$US-SA-2023SA381479$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240722$$MD$US$US
232792822$23279282$2$F$20231101$20231130$20231209$20240925$PER$$US-GSK-US2023AMR169145$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240925$$CN$US$US
232793075$23279307$5$F$$20240927$20231209$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-177982$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$91.17$KG$20240930$$CN$US$US
232793212$23279321$2$F$20240101$20240829$20231209$20240911$PER$$US-SA-2023SA376363$SANOFI AVENTIS$$18$YR$A$F$Y$61.6$KG$20240911$$MD$US$US
2327944714$23279447$14$F$20230101$20240821$20231209$20240829$EXP$$CA-CELLTRION INC.-2023CA020229$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
232794553$23279455$3$F$20240328$20240709$20231209$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-178368$BRISTOL MYERS SQUIBB$$23$YR$A$M$Y$$$20240710$$CN$US$US
232794602$23279460$2$F$20230101$20231129$20231209$20240830$PER$$US-SA-2023SA378099$SANOFI AVENTIS$$$$$M$Y$$$20240830$$HP$US$US
232794702$23279470$2$F$20231128$20240624$20231209$20240702$PER$$US-SA-2023SA378389$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240702$$MD$US$US
232795232$23279523$2$F$$20240911$20231210$20240925$EXP$$US-AUROBINDO-AUR-APL-2023-076916$AUROBINDO$Sasidharan Pillai.S,Robilliard R,Meghan Fredette Me,Monica SerranoGonzalez, Kevin J  Scully kj. Persistent hypercalcemia mimicking hypophosphatasia after discontinuation of a ketogenic diet: a case report.. J Pediatr Endocrinol Metab. 2023;36:1109-1113$3$YR$$M$Y$12.9$KG$20240925$$HP$US$US
232795695$23279569$5$F$20230729$20240807$20231210$20240819$EXP$$ES-AUROBINDO-AUR-APL-2023-055192$AUROBINDO$$46$YR$$F$Y$$$20240819$$CN$ES$ES
232797142$23279714$2$F$$20240809$20231210$20240821$EXP$$US-AUROBINDO-AUR-APL-2023-075913$AUROBINDO$Chang M, Sedlacek M. An Unusual Cause of Cloudy Urine in a Patient with Sepsis.. Journal of the American Society of Nephrology.. 2023;34:109$71$YR$$F$Y$$$20240821$$MD$US$US
232797362$23279736$2$F$20231114$20240729$20231210$20240807$PER$$US-SA-2023SA379822$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240807$$MD$US$US
232798173$23279817$3$F$20240101$20240705$20231209$20240714$PER$$US-SA-2023SA382292$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240714$$MD$US$US
232798417$23279841$7$F$20231005$20240906$20231209$20240916$EXP$$CA-CELLTRION INC.-2023CA016917$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
232799272$23279927$2$F$20240701$20240807$20231209$20240816$PER$$US-SA-2023SA377649$SANOFI AVENTIS$$29$YR$A$M$Y$99.7$KG$20240816$$MD$US$US
232799443$23279944$3$F$$20240830$20231210$20240914$PER$$US-SA-2023SA378711$SANOFI AVENTIS$$$$$M$Y$$$20240914$$CN$US$US
232799872$23279987$2$F$$20240727$20231210$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-10949$LUPIN$$$$$$Y$$$20240816$$PH$US$US
232800644$23280064$4$F$20231116$20240814$20231210$20240823$EXP$$US-VIIV HEALTHCARE LIMITED-US2023168644$VIIV$$37$YR$$M$Y$$$20240823$$HP$US$US
232801493$23280149$3$F$20231003$20240913$20231210$20240924$EXP$$KR-JNJFOC-20231182997$JOHNSON AND JOHNSON$$65$YR$E$M$Y$64$KG$20240924$$MD$KR$KR
232801854$23280185$4$F$$20240730$20231210$20240805$EXP$$NVSC2023GB258052$NOVARTIS$$$$A$M$Y$$$20240803$$CN$GB$GB
232801915$23280191$5$F$20230601$20240718$20231210$20240724$EXP$$NVSC2023CA172120$NOVARTIS$$35$YR$$F$Y$98$KG$20240724$$HP$CA$CA
232802013$23280201$3$F$20231001$20240820$20231210$20240823$EXP$$US-ABBVIE-5530277$ABBVIE$$54$YR$$F$Y$$$20240823$$CN$US$US
232802345$23280234$5$F$$20240722$20231210$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-177685$BRISTOL MYERS SQUIBB$Manabe T, Yoshimatsu K, Mori M, Kaneyama M, Takenaka M, Kuroda K, et al. Use experience of ipilimumab/nivolumab for untreated advanced/recurrent non-small cell lung cancer at our hospital. Japanese Journal of Lung Cancer. 2023;63(5):587..$$$$$Y$$$20240729$$MD$JP$JP
232802574$23280257$4$F$20231129$20240702$20231210$20240710$EXP$$CA-CELLTRION INC.-2023CA023667$CELLTRION$$$$$$Y$$$20240710$$HP$CA$CA
232803144$23280314$4$F$$20240704$20231210$20240708$PER$$US-ALXN-202312USA000118US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
232803512$23280351$2$F$20231101$20240722$20231210$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-177923$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240724$$HP$US$US
232803763$23280376$3$F$20210908$20240705$20231210$20240722$EXP$$DE-ROCHE-3082013$ROCHE$$37$YR$A$F$Y$$$20240719$$CN$DE$DE
232804774$23280477$4$F$20231123$20240709$20231211$20240724$EXP$$DE-ROCHE-3471688$ROCHE$$40$YR$A$F$Y$$$20240724$$CN$DE$DE
232805426$23280542$6$F$20230101$20240913$20231211$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2023-033467$UNITED THERAPEUTICS$$$$$F$Y$58.957$KG$20240921$$$US$US
232805655$23280565$5$F$20230908$20240806$20231211$20240827$PER$$CA-TOLMAR, INC.-23CA044986$TOLMAR$$80$YR$$M$Y$$$20240827$$PH$CA$CA
232805663$23280566$3$F$20231122$20240703$20231211$20240726$PER$$CA-TOLMAR, INC.-23CA044988$TOLMAR$$76$YR$$M$Y$$$20240726$$CN$CA$CA
2328061814$23280618$14$F$20191209$20240920$20231211$20240927$EXP$$CA-TAKEDA-CA201943621$TAKEDA$$63$YR$$M$Y$70$KG$20240927$$HP$CA$CA
232806619$23280661$9$F$$20240917$20231211$20240923$EXP$$US-SANDOZ INC.-NVSC2023US136403$SANDOZ$$$$$M$Y$93.605$KG$20240923$$CN$US$US
232806953$23280695$3$F$20231108$20240703$20231211$20240711$EXP$$CA-CELLTRION INC.-2023CA021883$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
232810676$23281067$6$F$20220601$20240919$20231211$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-022632$JAZZ$$58$YR$$F$Y$$$20240923$$CN$US$US
232810963$23281096$3$F$20201101$20240729$20231211$20240802$EXP$$US-ABBVIE-5527423$ABBVIE$$50$YR$$M$Y$99.79$KG$20240802$$CN$US$US
232811113$23281111$3$F$$20240710$20231211$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-176372$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240717$$PH$JP$JP
232811522$23281152$2$F$20231204$20240925$20231211$20240926$PER$$US-AMGEN-USASP2023219202$AMGEN$$78$YR$E$M$Y$$$20240926$$CN$US$US
232812114$23281211$4$F$20231101$20240912$20231211$20240921$EXP$$US-UCBSA-2023057930$UCB$$76$YR$$F$Y$$$20240921$$HP$US$US
232812893$23281289$3$F$$20240725$20231211$20240729$EXP$$IN-ROCHE-3472599$ROCHE$$53$YR$A$M$Y$$$20240729$$CN$IN$IN
232813103$23281310$3$F$20231207$20240909$20231211$20240910$PER$$US-AMGEN-USASP2023219996$AMGEN$$65$YR$E$M$Y$$$20240910$$CN$US$US
232813453$23281345$3$F$20231103$20240610$20231211$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005304$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240705$$CN$US$US
232813475$23281347$5$F$20211216$20240709$20231211$20240711$EXP$$CA-TAKEDA-2022TUS000226$TAKEDA$$77$YR$$F$Y$$$20240711$$CN$CA$CA
232813565$23281356$5$F$20240502$20240625$20231211$20240701$EXP$$ZA-SA-2023SA380244$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240701$$MD$ZA$ZA
232813632$23281363$2$F$20231101$20240704$20231211$20240710$EXP$$FR-ABBVIE-5523733$ABBVIE$$64$YR$$M$Y$$$20240710$$MD$FR$FR
232814164$23281416$4$F$20231125$20240915$20231211$20240924$EXP$$CA-CELLTRION INC.-2023CA023685$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
232814283$23281428$3$F$20231001$20240620$20231211$20240726$PER$$US-AMGEN-USASP2023218200$AMGEN$$91$YR$A$M$Y$$$20240726$$CN$US$US
232814472$23281447$2$F$$20240704$20231211$20240711$EXP$$AR-GSK-AR2023AMR083786$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$AR$AR
232814485$23281448$5$F$20230101$20240627$20231211$20240705$EXP$$CA-CELLTRION INC.-2023CA023699$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
232814493$23281449$3$F$20211221$20240812$20231211$20240816$EXP$$CA-TAKEDA-2023TUS118072$TAKEDA$$24$YR$$F$Y$$$20240816$$MD$CA$CA
232814773$23281477$3$F$20240525$20240705$20231211$20240715$EXP$$CA-CELLTRION INC.-2023CA023684$CELLTRION$$$$$$Y$$$20240715$$CN$CA$CA
232815284$23281528$4$F$$20240724$20231211$20240801$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US001046$DECIPHERA PHARMACEUTICALS$$71$YR$E$M$Y$$$20240801$$CN$US$US
232815604$23281560$4$F$$20240719$20231211$20240728$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-178116$BRISTOL MYERS SQUIBB$$48$YR$A$$Y$$$20240729$$MD$JP$JP
232815705$23281570$5$F$$20240715$20231211$20240723$EXP$$CA-ROCHE-3470791$ROCHE$$$$A$F$Y$$$20240723$$CN$CA$CA
232815802$23281580$2$F$$20240903$20231211$20240905$EXP$$US-TAKEDA-US201718232$TAKEDA$$$$$M$Y$$$20240905$$CN$US$US
232815932$23281593$2$F$20231101$20240711$20231211$20240723$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000504$Unknown Manufacturer$$$$$$Y$$$20240723$$CN$US$US
232816442$23281644$2$F$$20240805$20231211$20240817$EXP$$US-AUROBINDO-AUR-APL-2023-077137$AUROBINDO$Rafeq R, Salzman M. Use of Concentrated Insulin in the Management of Calcium Channel Blocker Overdose: A Case Report. Journal of pharmacy practice. 2022;1-4$73$YR$$F$Y$69.9$KG$20240817$$MD$US$US
232816692$23281669$2$F$20220101$20240715$20231211$20240724$EXP$$US-ROCHE-3332275$ROCHE$$52$YR$A$F$Y$67.13$KG$20240724$$CN$US$US
232817104$23281710$4$F$20231124$20240729$20231211$20240812$EXP$$GB-AMGEN-GBRNI2023218426$AMGEN$$20$YR$A$M$Y$106.6$KG$20240811$$HP$GB$GB
232817425$23281742$5$F$20231101$20240618$20231211$20240718$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000490$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
232817893$23281789$3$F$$20231009$20231211$20240710$PER$$IN-ROCHE-3409196$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$IN$IN
232818972$23281897$2$F$$20240830$20231211$20240830$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-277438$BOEHRINGER INGELHEIM$$$$$$Y$$$20240831$$HP$US$US
232819362$23281936$2$F$$20240918$20231211$20240926$EXP$$NVSC2023US261424$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
2328198416$23281984$16$F$20180118$20240902$20231211$20240905$EXP$$AR-MYLANLABS-2023M1130091$MYLAN$$11$YR$$M$Y$$$20240905$$CN$AR$AR
232820643$23282064$3$F$20230415$20240709$20231211$20240711$EXP$$NZ-MYLANLABS-2023M1041821$MYLAN$$29$YR$$M$Y$$$20240711$$MD$NZ$NZ
232821252$23282125$2$F$$20240806$20231211$20240813$PER$$US-SA-2023SA377162$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240814$$MD$US$US
232821342$23282134$2$F$$20240826$20231211$20240916$PER$$US-SA-2023SA375504$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240916$$MD$US$US
232822472$23282247$2$F$$20240828$20231211$20240910$PER$$US-SA-2023SA379178$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240910$$MD$US$US
232823364$23282336$4$F$20231109$20240710$20231211$20240712$EXP$$US-INCYTE CORPORATION-2023IN012554$INCYTE$$$$$$Y$$$20240712$$CN$US$US
232823376$23282337$6$F$20230101$20240909$20231211$20240916$EXP$$US-ABBVIE-5489584$ABBVIE$$$$$M$Y$106$KG$20240916$$CN$US$US
232825446$23282544$6$F$$20240802$20231211$20240808$EXP$$CA-OTSUKA-2023_016589$OTSUKA$$$$$F$Y$$$20240808$$HP$CA$CA
232826014$23282601$4$F$20210927$20240830$20231211$20240909$30DAY$$US-GSK-US2023167655$GLAXOSMITHKLINE$$50$YR$$M$Y$$$20240909$$CN$US$US
232826162$23282616$2$F$$20231203$20231211$20240801$EXP$$NVSC2023PH257534$NOVARTIS$$$$$$Y$$$20240801$$MD$PH$PH
232826385$23282638$5$F$20231003$20240802$20231211$20240806$EXP$$AU-MYLANLABS-2023M1112627$MYLAN$$60$YR$$F$Y$143$KG$20240806$$HP$AU$AU
232826863$23282686$3$F$$20240809$20231211$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-178859$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$63.5$KG$20240813$$CN$US$US
232827072$23282707$2$F$$20231129$20231211$20240729$PER$$US-LEO Pharma-365763$LEO PHARM$$26$YR$$F$Y$$$20240729$$HP$US$US
232829542$23282954$2$F$20231101$20240805$20231211$20240809$PER$$US-TAKEDA-2023TUS118462$TAKEDA$$46$YR$$$Y$$$20240809$$MD$US$US
232830112$23283011$2$F$$20240708$20231211$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-23-00443$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$US$US
232833133$23283313$3$F$$20240820$20231211$20240830$PER$$US-SA-2023SA378168$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240830$$MD$US$US
232834133$23283413$3$F$$20240809$20231211$20240814$PER$$US-VERTEX PHARMACEUTICALS-2023-018379$VERTEX$$35$YR$$M$Y$$$20240814$$CN$US$US
232834825$23283482$5$F$20231128$20240701$20231211$20240708$EXP$$US-SA-2023SA382650$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240708$$MD$US$US
232834866$23283486$6$F$$20240809$20231211$20240827$EXP$$JP-009507513-2312JPN000504J$MERCK$Shibata N, Matsui C, Hirai C, Tada M, Yauchi Y, Kikawa Y, et al.. EP-0451 Treatment outcomes of the KYENOTE-522 regimen for early-stage triple-negative breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 290$65$YR$$F$Y$$$20240827$$MD$JP$JP
232835453$23283545$3$F$$20240708$20231211$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-176412$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240712$$PH$JP$JP
232835794$23283579$4$F$20180901$20240723$20231211$20240729$EXP$$CA-PFIZER INC-202300438950$PFIZER$Driedger, M.. Leprosy with type 1 reaction in a patient from Ontario, Canada without recent travel misdiagnosed as vasculitic neuropathy: a case report. BMC Infectious Diseases. 2023;23(1):10.1186/s12879-023-08811-x$84$YR$$M$Y$$$20240729$$MD$CA$CA
232836163$23283616$3$F$$20240730$20231211$20240807$EXP$$GB-SAMSUNG BIOEPIS-SB-2023-32516$SAMSUNG BIOEPIS$$$$$F$Y$$$20240807$$CN$GB$GB
232836842$23283684$2$F$20160810$20240905$20231211$20240912$EXP$$CA-SANDOZ INC.-PHHY2016CA112272$SANDOZ$$56$YR$$M$Y$$$20240912$$MD$CA$CA
232837124$23283712$4$F$$20240822$20231211$20240828$PER$$US-PFIZER INC-PV202300195845$PFIZER$$82$YR$$M$Y$$$20240828$$MD$US$US
232837373$23283737$3$F$20231001$20240722$20231211$20240725$EXP$$US-PFIZER INC-PV202300195654$PFIZER$$39$YR$$M$Y$$$20240725$$HP$US$US
232837425$23283742$5$F$20230101$20240816$20231211$20240821$EXP$$US-PFIZER INC-PV202300195544$PFIZER$$52$YR$$F$Y$$$20240821$$HP$US$US
232837762$23283776$2$F$20230101$20240725$20231211$20240730$PER$$US-PFIZER INC-PV202300196255$PFIZER$$64$YR$$F$Y$$$20240730$$HP$US$US
232838563$23283856$3$F$20230101$20240621$20231211$20240701$PER$$US-SA-2023SA355923$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240701$$MD$US$US
232838963$23283896$3$F$$20240820$20231211$20240822$EXP$$CA-SANDOZ INC.-NVSC2020CA248526$SANDOZ$$59$YR$$F$Y$$$20240822$$HP$CA$CA
232839144$23283914$4$F$20230101$20240722$20231211$20240724$EXP$$US-UCBSA-2023058220$UCB$$$$$M$Y$$$20240724$$HP$US$US
2328392610$23283926$10$F$20230101$20240909$20231211$20240916$EXP$$GB-SANDOZ INC.-SDZ2023GB066388$SANDOZ$$$$$F$Y$$$20240916$$MD$GB$GB
232839572$23283957$2$F$20230619$20240627$20231211$20240702$EXP$$IL-SANDOZ INC.-NVSC2023IL141021$SANDOZ$$53$YR$$F$Y$92$KG$20240702$$MD$IL$IL
232839638$23283963$8$F$$20240920$20231211$20240927$EXP$$US-GSK-US2023AMR171452$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
232840558$23284055$8$F$20090101$20240911$20231211$20240920$EXP$$JP-TAKEDA-2023TUS118885$TAKEDA$$50$YR$$F$Y$50.7$KG$20240920$$MD$JP$JP
232840603$23284060$3$F$$20240724$20231211$20240729$EXP$$US-ARGENX-2023-ARGX-US003301$ARGENX BVBA$$$$$$Y$$$20240729$$CN$US$US
232840882$23284088$2$F$$20240828$20231211$20240829$EXP$$US-SANDOZ INC.-SDZ2023US062581$SANDOZ$$27$YR$$M$Y$$$20240829$$HP$US$US
232840912$23284091$2$F$20231116$20240812$20231211$20240816$EXP$FR-AFSSAPS-ST2023001533$FR-FreseniusKabi-FK202319916$FRESENIUS KABI$$37$YR$A$F$Y$$$20240816$$HP$FR$FR
232841073$23284107$3$F$20221001$20240814$20231211$20240820$EXP$$GR-AMGEN-GRCSP2023217352$AMGEN$$47$YR$A$F$Y$$$20240820$$MD$GR$GR
232841697$23284169$7$F$$20240906$20231211$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005260$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
2328420713$23284207$13$F$20240809$20240925$20231211$20240930$EXP$$US-SANDOZ INC.-NVSC2022US229363$SANDOZ$$9$YR$$M$Y$28.571$KG$20240930$$CN$US$US
232842223$23284222$3$F$20230101$20240903$20231211$20240912$PER$$US-SA-2023SA380914$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240912$$MD$US$US
232842412$23284241$2$F$20231001$20240817$20231211$20240829$PER$$US-SA-2023SA381233$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240829$$MD$US$US
232842567$23284256$7$F$20230920$20240725$20231211$20240726$EXP$$AU-MYLANLABS-2023M1129718$MYLAN$$58$YR$$M$Y$$$20240726$$HP$AU$AU
232843045$23284304$5$F$$20240828$20231211$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-179126$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240830$$HP$US$US
232843332$23284333$2$F$$20240627$20231211$20240702$PER$$US-PFIZER INC-202300426538$PFIZER$$51$YR$$F$Y$$$20240702$$HP$US$US
232844043$23284404$3$F$20230730$20240730$20231211$20240731$PER$$US-PFIZER INC-202300440699$PFIZER$$55$YR$$F$Y$63.5$KG$20240731$$MD$US$US
232844283$23284428$3$F$$20240805$20231211$20240808$EXP$$US-TAKEDA-2023TUS094510$TAKEDA$$$$$M$Y$$$20240808$$CN$US$US
232844612$23284461$2$F$20230411$20240913$20231211$20240917$EXP$$IN-SANDOZ INC.-NVSC2023IN126983$SANDOZ$$39$YR$$F$Y$$$20240917$$CN$IN$IN
2328448113$23284481$13$F$20200311$20240723$20231211$20240724$EXP$$US-TAKEDA-US202012177$TAKEDA$$34$YR$$F$Y$$$20240724$$CN$US$US
232844875$23284487$5$F$20221201$20240205$20231211$20240809$EXP$$NVSC2023BR004601$NOVARTIS$$57$YR$$F$Y$55$KG$20240809$$CN$BR$BR
232845673$23284567$3$F$20230926$20240705$20231211$20240708$EXP$$US-PFIZER INC-PV202300198366$PFIZER$$73$YR$$F$Y$$$20240708$$MD$US$US
232846323$23284632$3$F$$20240617$20231211$20240712$EXP$$DE-ROCHE-3468695$ROCHE$$37$YR$A$F$Y$$$20240712$$MD$DE$DE
232846482$23284648$2$F$20230930$20240730$20231211$20240802$EXP$$JP-ABBVIE-4228836$ABBVIE$$64$YR$$M$Y$$$20240802$$CN$JP$JP
232847256$23284725$6$F$20231101$20240919$20231211$20240927$EXP$$US-BEH-2023166265$CSL BEHRING$$26$YR$A$M$Y$113.38$KG$20240927$$HP$US$US
232847976$23284797$6$F$20231106$20240927$20231211$20240927$EXP$$CA-PFIZER INC-202300260169$PFIZER$$58$YR$$F$Y$$$20240927$$HP$CA$CA
232848063$23284806$3$F$20231111$20240828$20231211$20240903$EXP$$US-INCYTE CORPORATION-2023IN012148$INCYTE$$$$$$Y$$$20240903$$CN$US$US
232850573$23285057$3$F$20230101$20240719$20231211$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-177282$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240723$$MD$JP$JP
232852603$23285260$3$F$20230413$20240806$20231211$20240814$EXP$$JP-AstraZeneca-2023A277960$ASTRAZENECA$$93$YR$$F$Y$$$20240814$$MD$JP$
232853405$23285340$5$F$20230630$20240730$20231211$20240802$EXP$$JP-AstraZeneca-2023A278718$ASTRAZENECA$$79$YR$$F$Y$51$KG$20240802$$MD$JP$
232854082$23285408$2$F$20160615$20240911$20231211$20240920$EXP$$CA-Covis Pharma GmbH-2023COV01931$COVIS PHARMA$$69$YR$E$M$Y$$$20240920$$MD$CA$CA
232854136$23285413$6$F$$20240911$20231211$20240916$EXP$$US-TAKEDA-2023TUS106573$TAKEDA$$$$$F$Y$54$KG$20240916$$CN$US$US
232854264$23285426$4$F$20230101$20240813$20231211$20240816$EXP$$US-ABBVIE-5527296$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
232854354$23285435$4$F$$20240722$20231211$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-178541$BRISTOL MYERS SQUIBB$Manabe A, Yoshimatsu K, Mori M, Kanayama M, Takenaka M, Kuroda K et al. Use experience of ipilimumab/nivolumab foruntreated advanced/recurrent non-small cell lung cancer at ourhospital. Japanese Journal of Lung Cancer. 2023;63(5):587..$$$$$Y$$$20240729$$MD$JP$JP
232857044$23285704$4$F$20221001$20240822$20231212$20240826$EXP$$NVSJ2023JP017288$NOVARTIS$$43$YR$$F$Y$55.8$KG$20240826$$MD$JP$JP
232857494$23285749$4$F$20231101$20240628$20231212$20240702$EXP$$US-ARGENX-2023-ARGX-US001696$ARGENX BVBA$$$$$$Y$$$20240702$$CN$US$US
232857574$23285757$4$F$20221220$20240627$20231212$20240704$EXP$$NVSC2023IT237248$NOVARTIS$$18$YR$$M$Y$100$KG$20240704$$MD$IT$IT
232857909$23285790$9$F$20230921$20240906$20231212$20240913$EXP$$CA-TAKEDA-2023TUS096853$TAKEDA$$55$YR$$F$Y$$$20240913$$CN$CA$CA
232858425$23285842$5$F$20230725$20240909$20231212$20240916$EXP$$AR-GSK-AR2023AMR102818$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$AR$AR
232858462$23285846$2$F$20230101$20240913$20231212$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2023-032932$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240920$$$US$US
2328584812$23285848$12$F$20240216$20240917$20231212$20240925$EXP$$US-TAKEDA-2023TUS119007$TAKEDA$$65$YR$$F$Y$$$20240925$$MD$US$US
232858663$23285866$3$F$20230821$20240924$20231212$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-179322$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$41.5$KG$20240926$$MD$JP$JP
232858893$23285889$3$F$$20240715$20231212$20240719$EXP$$CA-ABBVIE-5531875$ABBVIE$$$$$M$Y$$$20240719$$PH$CA$CA
232859452$23285945$2$F$20231201$20240725$20231212$20240730$EXP$$CO-TAKEDA-2022TUS061042$TAKEDA$$9$YR$$M$Y$26$KG$20240730$$CN$CO$CO
232859562$23285956$2$F$$20240829$20231212$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2023-034835$UNITED THERAPEUTICS$$$$$F$Y$58.05$KG$20240906$$$US$US
232859698$23285969$8$F$20231107$20240923$20231212$20240925$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-179379$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$110$KG$20240926$$HP$FR$FR
232859756$23285975$6$F$20230620$20240809$20231212$20240812$EXP$$CA-TAKEDA-2023TUS061916$TAKEDA$$12$YR$$M$Y$$$20240812$$HP$CA$CA
232859953$23285995$3$F$$20240813$20231212$20240824$EXP$$CA-Accord-394062$ACCORD$Gandhi P, Healy D, Bozinoff N. Severe alcohol use disorder after initiation of selective serotonin reuptake inhibitor therapy. CMAJ. Canadian Medical Association Journal. 2023;195(40):E1380-2. DOI: 10.1503/cmaj.231015.$52$YR$A$F$Y$$$20240824$$MD$CA$CA
232860193$23286019$3$F$$20240806$20231212$20240814$PER$$US-SA-2023SA379407$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240814$$MD$US$US
232860276$23286027$6$F$20230301$20240911$20231212$20240919$EXP$$CA-CELLTRION INC.-2023CA005002$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
232861235$23286123$5$F$20230101$20240726$20231212$20240813$EXP$$JP-009507513-2312JPN000225J$MERCK$Niimi K,Ikeda Y,Yoshida Y,Yoshiwara M,Tamauchi S,Shimizu Y, et al.. OS-111 Treatment of cervical cancer with pembrolizumab: A review of effective cases in use experience at our hospital. The journal of the Japan Society of Gynecologic Oncology  The 66th Annual Meetin. 2024;42(3):285$48$YR$$F$Y$$$20240813$$MD$JP$JP
232861773$23286177$3$F$$20240826$20231212$20240829$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-005567$JAZZ$$$$$M$Y$$$20240829$$HP$US$US
2328618110$23286181$10$F$20230101$20240909$20231212$20240912$EXP$$GB-SANDOZ INC.-SDZ2023GB063071$SANDOZ$$$$$F$Y$$$20240912$$MD$GB$GB
2328618510$23286185$10$F$20231101$20240905$20231212$20240914$EXP$$CA-CELLTRION INC.-2023CA022817$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
232861883$23286188$3$F$20231207$20240903$20231212$20240905$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007227$JAZZ$$45$YR$$M$Y$$$20240905$$CN$US$US
232862163$23286216$3$F$$20240821$20231212$20240912$PER$$US-SA-2023SA379605$SANOFI AVENTIS$$$$A$M$Y$92.9$KG$20240912$$MD$US$US
232862423$23286242$3$F$20230101$20240826$20231212$20240902$EXP$$US-SA-2023SA382766$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240902$$MD$US$US
232862522$23286252$2$F$$20240703$20231212$20240710$EXP$$AU-CELLTRION INC.-2023AU023719$CELLTRION$$$$$$Y$$$20240710$$MD$AU$AU
232862744$23286274$4$F$20220909$20240926$20231212$20240930$EXP$$JP-TAKEDA-2023TJP016521$TAKEDA$$11$YR$$F$Y$29.7$KG$20240930$$MD$JP$JP
232863263$23286326$3$F$$20231214$20231212$20240926$PER$$US-ALK-ABELLO A/S-2023AA003939$ALK-ABELLO$$$$$$Y$$$20240926$$HP$US$US
232863562$23286356$2$F$20231101$20240909$20231212$20240916$30DAY$$US-GSK-US2023169563$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240916$$CN$US$US
232864412$23286441$2$F$20231101$20240722$20231212$20240724$EXP$$US-UCBSA-2023058316$UCB$$37$YR$$F$Y$$$20240724$$HP$US$US
232864723$23286472$3$F$20230101$20240718$20231212$20240723$EXP$$US-ABBVIE-5504723$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
232864992$23286499$2$F$$20240705$20231212$20240715$EXP$$US-NOVOPROD-1148615$NOVO NORDISK$$$$E$F$Y$$$20240715$$CN$US$US
232865237$23286523$7$F$$20240621$20231212$20240717$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005284$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
232865286$23286528$6$F$20230101$20240801$20231212$20240809$EXP$$CA-CELLTRION INC.-2023CA020001$CELLTRION$$$$$$Y$$$20240809$$HP$CA$CA
232865823$23286582$3$F$20230316$20240730$20231212$20240807$PER$$US-SA-2023SA311691$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240807$$MD$US$US
232865882$23286588$2$F$$20240707$20231212$20240713$EXP$$FR-ABBVIE-5532706$ABBVIE$Marchal C, Deygas F, Deslandes M, Macher N, De Pouvourville G, Levy V. A retrospective observational study of ibrutinib in chronic lymphocytic leukaemia in a real-life setting in France using the national claims database (OSIRIS). Ann Hematol.; Choquet S, Macher N, Pouvourville G, Marchal C, Belhassen M, Jacoud F, Levy V, Deslandes M. Use of Ibrutinib in Real Life Settings in France: Results from a Retrospective Observational Study Using the Snds Database (OSIRIS). Blood.; Choquet S, Macher N...$$$E$$Y$$$20240713$$MD$FR$FR
232866033$23286603$3$F$20230413$20240905$20231212$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-231680$BOEHRINGER INGELHEIM$$86$YR$E$F$Y$$$20240905$$CN$US$US
232866979$23286697$9$F$20220601$20240829$20231212$20240907$EXP$$CA-CELLTRION INC.-2023CA019946$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
232868133$23286813$3$F$$20240802$20231212$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-178960$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240807$$CN$US$US
232868692$23286869$2$F$$20240711$20231212$20240715$PER$$NVSC2023US263588$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
2328693010$23286930$10$F$$20240611$20231212$20240815$EXP$$CL-SANDOZ INC.-NVSC2023CL132738$SANDOZ$$66$YR$$F$Y$$$20240815$$CN$CL$CL
232869675$23286967$5$F$$20240724$20231212$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-177327$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$MD$JP$JP
232869999$23286999$9$F$20231124$20240917$20231212$20240922$EXP$$US-JNJFOC-20231206592$JOHNSON AND JOHNSON$$56$YR$A$F$Y$49.3$KG$20240923$$HP$US$US
232870302$23287030$2$F$$20240719$20231212$20240725$EXP$$GB-STRIDES ARCOLAB LIMITED-2023SP018478$STRIDES$Rossi NP, Sathyanarayanan G, Mahmood M, Shakespeare D.. Toxic leukoencephalopathy versus delayed post-hypoxic leukoencephalopathy after oral morphine sulphate overdose. BMJ Case Rep. 2023;16(9):e255291$5$DEC$$M$Y$$$20240725$$HP$GB$GB
232870713$23287071$3$F$20220101$20240815$20231212$20240820$EXP$$US-SA-2023SA383444$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240820$$MD$US$US
232870862$23287086$2$F$20201009$20240808$20231212$20240815$EXP$$DE-ROCHE-2721337$ROCHE$$56$YR$A$F$Y$$$20240815$$CN$DE$DE
232871192$23287119$2$F$$20240829$20231212$20240905$EXP$$FR-AstraZeneca-2023A279890$ASTRAZENECA$$13514$DY$$F$Y$$$20240905$$MD$FR$
232872114$23287211$4$F$$20240725$20231212$20240730$PER$$US-PHARMING-PHAUS2023000928$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
232872632$23287263$2$F$$20240710$20231212$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20200300200$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240716$$CN$CA$CA
232872783$23287278$3$F$20231208$20240717$20231212$20240720$PER$$US-AMGEN-USASP2023221192$AMGEN$$64$YR$A$M$Y$$$20240720$$CN$US$US
232873403$23287340$3$F$$20240821$20231212$20240829$EXP$IL-MLMSERVICE-20231124-4688516-1$IL-STRIDES ARCOLAB LIMITED-2023SP018526$STRIDES$Levenberg G, Bleier J, Leibowitz A, Salomon O, Misgav M, Agmon-Levin N, et al.. NSAIDS linked to IGA-mediated hypersensitivity vasculitis and purpura fulminans-like eruption. European Journal of Case Reports in Internal Medicine. 2023;10(11):1-4$66$YR$$M$Y$$$20240829$$MD$IL$IL
232874442$23287444$2$F$$20240711$20231212$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202312005016$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240716$$CN$US$US
232874533$23287453$3$F$20230903$20240821$20231212$20240827$EXP$$US-TAKEDA-2023TUS081434$TAKEDA$$63$YR$$F$Y$$$20240827$$CN$US$US
232874982$23287498$2$F$$20230715$20231212$20240710$PER$$IN-ROCHE-3390884$ROCHE$$48$YR$A$M$Y$$$20240628$$MD$IN$IN
232875305$23287530$5$F$20230207$20240830$20231212$20240904$EXP$$CA-TAKEDA-2022TUS059307$TAKEDA$$30$YR$$F$Y$$$20240904$$CN$CA$CA
232876462$23287646$2$F$$20240626$20231212$20240709$EXP$$AU-COLLEGIUM PHARMACEUTICAL, INC.-20231100958$COLLEGIUM PHARMACEUTICAL$$86$YR$$F$Y$$$20240709$$HP$AU$AU
232876492$23287649$2$F$20231207$20240815$20231212$20240822$EXP$$CA-TAKEDA-2023TUS118717$TAKEDA$$51$YR$$M$Y$$$20240822$$CN$CA$CA
232876556$23287655$6$F$$20240625$20231212$20240708$EXP$$MY-MYLANLABS-2023M1129158$MYLAN$$$$$F$Y$$$20240708$$PH$MY$MY
232877623$23287762$3$F$$20240717$20231212$20240722$PER$$NVSC2023US262326$NOVARTIS$$$$$$Y$$$20240722$$CN$US$US
232877852$23287785$2$F$$20240719$20231212$20240801$EXP$$US-CIPLA LTD.-2023US07805$CIPLA$Sorabella RA, Gray WH, Dabal RJ, Padilla LA, Hock K, Clark MG et al.. Central extracorporeal membrane oxygenation support following calcium channel blocker overdose in children. ASAIO Journal. 2023;70(7):1 to 5$$$$$Y$$$20240801$$MD$US$US
232878433$23287843$3$F$20221001$20240816$20231212$20240821$EXP$$GR-ROCHE-3470003$ROCHE$$47$YR$A$F$Y$$$20240821$$MD$GR$GR
232878462$23287846$2$F$20231127$20240730$20231212$20240801$EXP$$CA-HLS-202302734$HLS THERAPEUTICS$$31$YR$A$M$Y$$$20240801$$HP$CA$CA
232878642$23287864$2$F$$20231208$20231212$20240805$PER$$US-ABBVIE-5533640$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
232878917$23287891$7$F$20230816$20240830$20231212$20240905$EXP$$CA-TAKEDA-2023TUS119412$TAKEDA$$76$YR$$F$Y$$$20240905$$CN$CA$CA
232878963$23287896$3$F$20231020$20240715$20231212$20240718$EXP$$NVSC2023GB232998$NOVARTIS$$$$$F$Y$$$20240719$$CN$GB$GB
232879733$23287973$3$F$$20240701$20231212$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-179401$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$66.68$KG$20240709$$CN$US$US
232880612$23288061$2$F$$20240802$20231212$20240809$EXP$$CZ-ABBVIE-5532459$ABBVIE$Weinbergerova B, Mayer J, Kabut T, Sperr WR, Stevkova J, Jonasova A, et al. Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis. Br J Haematol. 2024.19670.$65$YR$$$Y$$$20240809$$HP$CZ$CZ
232880638$23288063$8$F$$20240703$20231212$20240709$EXP$$US-TAKEDA-2023TUS118106$TAKEDA$$$$$F$Y$$$20240709$$CN$US$US
232880909$23288090$9$F$20230509$20240907$20231212$20240911$EXP$$IN-PFIZER INC-PV202200045829$PFIZER$$73$YR$$M$Y$$$20240911$$CN$IN$IN
232881892$23288189$2$F$$20240802$20231212$20240809$EXP$$CZ-ABBVIE-5534915$ABBVIE$Weinbergerova B, Mayer J, Kabut T, Sperr WR, Stevkova J, Jonasova A, et al. Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis. Br J Haematol. 2024.19670.$80$YR$$$Y$$$20240809$$HP$CZ$CZ
232882175$23288217$5$F$$20240916$20231212$20240926$EXP$$CA-APOTEX-2023AP011079$APOTEX$$52$YR$$M$Y$$$20240926$$HP$CA$CA
232882544$23288254$4$F$20200416$20240716$20231212$20240723$EXP$$CA-TAKEDA-2022TUS007401$TAKEDA$$50$YR$$F$Y$$$20240723$$MD$CA$CA
232883395$23288339$5$F$20230210$20240701$20231212$20240705$EXP$$US-OTSUKA-2023_003950$OTSUKA$$50$YR$$F$Y$$$20240705$$CN$US$US
232884044$23288404$4$F$$20240124$20231212$20240718$EXP$$US-Taiho Oncology Inc-2023-006528$TAIHO ONCOLOGY INC$$60$YR$A$F$Y$66.68$KG$20240718$$CN$US$US
2328844511$23288445$11$F$20230711$20240907$20231212$20240916$EXP$$CA-OTSUKA-2023_019726$OTSUKA$$40$YR$$M$Y$$$20240916$$HP$CA$CA
232884583$23288458$3$F$20230101$20240717$20231212$20240731$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00468$AVADEL CNS PHARMA$$$$$M$Y$96.599$KG$20240731$$CN$US$US
232885624$23288562$4$F$20230404$20240903$20231212$20240909$PER$$JP-Eisai-EC-2022-125356$EISAI$$60$YR$A$F$Y$67$KG$20240909$$MD$JP$JP
232886092$23288609$2$F$20230101$20240705$20231212$20240717$PER$$US-SA-2023SA378202$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240717$$MD$US$US
232886192$23288619$2$F$$20240819$20231212$20240829$PER$$US-SA-2023SA378177$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240829$$MD$US$US
232886313$23288631$3$F$$20240826$20231212$20240909$PER$$US-SA-2023SA372874$SANOFI AVENTIS$$$$A$M$Y$$$20240909$$MD$US$US
232886442$23288644$2$F$20231101$20240723$20231212$20240730$PER$$US-SA-2023SA381236$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240730$$MD$US$US
232886562$23288656$2$F$20231101$20240711$20231212$20240724$PER$$US-SA-2023SA378926$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240724$$MD$US$US
232886652$23288665$2$F$20221201$20240823$20231212$20240906$PER$$US-SA-2023SA379734$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240906$$MD$US$US
232886676$23288667$6$F$20230101$20240709$20231212$20240717$PER$$US-SA-2023SA379661$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240717$$MD$US$US
232887008$23288700$8$F$20231117$20240808$20231212$20240820$EXP$$US-SA-2023SA381172$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240820$$MD$US$US
232887354$23288735$4$F$20231205$20240708$20231212$20240717$PER$$US-SA-2023SA380428$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240717$$MD$US$US
232887512$23288751$2$F$20220401$20240828$20231212$20240910$PER$$US-SA-2023SA381371$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240910$$MD$US$US
232888292$23288829$2$F$$20240701$20231212$20240710$PER$$US-SA-2023SA382842$SANOFI AVENTIS$$66$YR$E$F$Y$95.254$KG$20240710$$MD$US$US
232888312$23288831$2$F$20230101$20240806$20231212$20240813$PER$$US-SA-2023SA381348$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240814$$MD$US$US
232889236$23288923$6$F$$20240722$20231212$20240725$EXP$$CA-BAUSCH-BL-2023-017997$BAUSCH AND LOMB$Fraser B, Munawar M, Halani S, Sabur N. Disseminated Cryptococcus neoformans presenting with an isolated pleural effusion in a patient receiving temozolomide and long- term steroids. BMJ Case Rep. 2023;16(11):1-5. doi:10.1136/bcr-2023- 256255$7$DEC$$F$Y$$$20240725$$HP$CA$CA
232889942$23288994$2$F$$20240627$20231212$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-421887$RANBAXY$$51$YR$$M$Y$$$20240712$$MD$GB$GB
232892303$23289230$3$F$20200101$20240828$20231212$20240903$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-199807$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240903$$CN$CA$CA
232892945$23289294$5$F$$20240906$20231212$20240916$EXP$$US-DECIPHERA PHARMACEUTICALS LLC-2023US001064$DECIPHERA PHARMACEUTICALS$$87$YR$E$M$Y$104.5$KG$20240916$$CN$US$US
232894373$23289437$3$F$$20240802$20231212$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-179955$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240806$$CN$US$US
232894712$23289471$2$F$20231116$20240814$20231212$20240816$EXP$$FR-AMERICAN REGENT INC-2023002867$AMERICAN REGENT$$37$YR$$F$Y$$$20240816$$HP$FR$FR
232894782$23289478$2$F$20230101$20240815$20231212$20240827$PER$$US-SA-2023SA382082$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240827$$MD$US$US
232894793$23289479$3$F$20231101$20240805$20231212$20240813$PER$$US-SA-2023SA382817$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240814$$MD$US$US
232895372$23289537$2$F$$20240815$20231212$20240821$EXP$$IT-MYLANLABS-2023M1130601$MYLAN$Iacovelli A, Migliarini A, Attilia I, Giannone S, Laguardia M, Sanzari M, Pasqualotto F, Tramontano A, Venturini C, Valente E and Palange P. A Case of Bronchiectasis Diagnosed after Renal Transplantation. Abstract number: ID# 152. Respiration. 2023;102 (8):723$68$YR$$F$Y$$$20240821$$MD$IT$IT
232896213$23289621$3$F$$20240711$20231212$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-179928$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240723$$HP$CA$CA
232896335$23289633$5$F$20231114$20240717$20231212$20240724$EXP$$US-BEH-2023166327$CSL BEHRING$$36$YR$A$F$Y$$$20240724$$HP$US$US
232896612$23289661$2$F$$20240710$20231212$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20191104031$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240716$$CN$CA$CA
232896622$23289662$2$F$$20240918$20231212$20240923$EXP$$GB-SANDOZ INC.-SDZ2023GB050736$SANDOZ$$$$$M$Y$$$20240923$$CN$GB$GB
232897323$23289732$3$F$$20240719$20231212$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-177397$BRISTOL MYERS SQUIBB$$65$YR$E$$Y$$$20240727$$MD$JP$JP
232897613$23289761$3$F$20231002$20240924$20231212$20240925$EXP$$CN-VER-202300002$VERITY PHARMACEUTICALS$$73$YR$E$M$Y$65$KG$20240925$$HP$CN$CN
232898696$23289869$6$F$20230801$20240820$20231212$20240827$EXP$$US-ZENPEP LLC-2023AIMT01350$AIMMUNE$$$$$$Y$$$20240827$$HP$US$US
232899424$23289942$4$F$20230101$20240725$20231212$20240801$EXP$$US-ABBVIE-5531800$ABBVIE$$$$$M$Y$104$KG$20240801$$CN$US$US
232899496$23289949$6$F$20240101$20240715$20231212$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-024515$JAZZ$$16$YR$$F$Y$$$20240722$$HP$US$US
232899502$23289950$2$F$$20240801$20231212$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-179755$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$95$KG$20240813$$CN$CA$CA
232901113$23290111$3$F$20240814$20240815$20231212$20240828$30DAY$$US-GSK-US2023AMR172843$GLAXOSMITHKLINE$$83$YR$$F$Y$$$20240828$$CN$US$US
232901924$23290192$4$F$20230101$20240711$20231213$20240716$EXP$$CA-JNJFOC-20230720088$JOHNSON AND JOHNSON$$49$YR$A$F$Y$105$KG$20240716$$CN$CA$CA
232902215$23290221$5$F$20170130$20240801$20231213$20240806$EXP$$CA-JNJFOC-20230447815$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240806$$HP$CA$CA
232902642$23290264$2$F$$20240625$20231213$20240702$PER$$US-JNJFOC-20231213034$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$HP$US$US
232902854$23290285$4$F$$20240819$20231213$20240827$PER$$US-ALXN-A202301208$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240827$$MD$US$US
232903094$23290309$4$F$$20240607$20231213$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005337$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
232903532$23290353$2$F$$20240710$20231213$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20190702673$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240717$$HP$CA$CA
232903694$23290369$4$F$$20240719$20231213$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-173779$BRISTOL MYERS SQUIBB$Toyuhara M,  Ohara M, Umeda K,  Shigeta K, Katsui M, Hara  S, et al. A case of pituitary adrenal cortex hypofunction and renal impairment after nivolumab + ipilimumab administration in a patient with renal cell carcinoma. The 67th Kanagawa Regional Meeting of the Japanese Urological Association. 2023; 8.$82$YR$E$M$Y$$$20240726$$MD$JP$JP
232904429$23290442$9$F$$20240703$20231213$20240716$PER$$NVSC2023US264043$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
232904744$23290474$4$F$$20240724$20231213$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-177264$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$MD$JP$JP
232904784$23290478$4$F$20230301$20240812$20231213$20240823$EXP$$US-UCBSA-2023013441$UCB$$3$YR$$M$Y$$$20240823$$CN$US$US
232904892$23290489$2$F$$20240904$20231213$20240905$EXP$$NVSC2023US259705$NOVARTIS$$$$$F$Y$$$20240905$$HP$US$US
232905062$23290506$2$F$20230808$20231128$20231213$20240722$EXP$FR-AFSSAPS-AVMA2023000437$FR-TEVA-VS-3135134$TEVA$$15$YR$$M$Y$$$20240722$$MD$FR$FR
232905694$23290569$4$F$20180901$20240723$20231213$20240726$EXP$$CA-Orion Corporation ORION PHARMA-23_00026868$ORION$Driedger M, Teo I. Leprosy with type 1 reaction in a patient from Ontario, Canada without recent travel misdiagnosed as vasculitic neuropathy: a case report. BMC Infectious Diseases. 2023;23(1):815:1-7.$84$YR$E$M$Y$$$20240726$$MD$CA$
232905884$23290588$4$F$20231208$20240821$20231213$20240823$EXP$$US-UCBSA-2023058326$UCB$$70$YR$$F$Y$$$20240823$$CN$US$US
232905973$23290597$3$F$$20240715$20231213$20240729$EXP$$IT-ROCHE-3413413$ROCHE$$64$YR$A$F$Y$71$KG$20240729$$MD$IT$IT
232906643$23290664$3$F$$20240621$20231213$20240705$EXP$$CA-ROCHE-2923687$ROCHE$$$$E$M$Y$$$20240705$$CN$CA$CA
232908662$23290866$2$F$$20240814$20231213$20240822$EXP$$CA-BIOGEN-2023BI01240105$BIOGEN$$$$$M$Y$$$20240822$$CN$CA$CA
232909252$23290925$2$F$$20231206$20231213$20240905$PER$$NVSC2023US260464$NOVARTIS$$$$A$F$Y$$$20240905$$HP$US$US
232909274$23290927$4$F$20230101$20240912$20231213$20240921$EXP$$US-UCBSA-2023058399$UCB$$$$$M$Y$$$20240921$$CN$US$US
232910052$23291005$2$F$$20240815$20231213$20240823$EXP$$US-ROCHE-3359481$ROCHE$$$$E$M$Y$$$20240823$$MD$US$US
232911784$23291178$4$F$20230101$20240731$20231213$20240803$PER$$US-AMGEN-USASP2023221917$AMGEN$$80$YR$E$F$Y$$$20240803$$CN$US$US
232911804$23291180$4$F$20230101$20240821$20231213$20240827$EXP$$JP-009507513-2312JPN001120J$MERCK$$5$DEC$$F$Y$$$20240827$$MD$JP$JP
232912102$23291210$2$F$20230101$20240709$20231213$20240722$EXP$$US-ORPHANEU-2023005795$RECORDATI$$$$$$Y$$$20240722$$CN$US$US
232912332$23291233$2$F$20180530$20240710$20231213$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210203228$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240716$$HP$CA$CA
232912634$23291263$4$F$20231002$20240627$20231213$20240709$EXP$$JP-AMGEN-JPNSP2023198271$AMGEN$$78$YR$E$F$Y$41.5$KG$20240709$$MD$JP$JP
232912692$23291269$2$F$$20240723$20231213$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-180318$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240725$$HP$US$US
232912763$23291276$3$F$20200101$20240711$20231213$20240719$EXP$$CA-GSK-CA2023AMR047802$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$MD$CA$CA
232912883$23291288$3$F$20220424$20240715$20231213$20240718$EXP$$CA-TAKEDA-2022TUS028001$TAKEDA$$57$YR$$M$Y$$$20240718$$CN$CA$CA
232912935$23291293$5$F$20231101$20240627$20231213$20240703$EXP$$CA-JNJFOC-20231046998$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240703$$HP$CA$CA
232913503$23291350$3$F$20231207$20240906$20231213$20240913$EXP$$CA-JNJFOC-20231225422$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240913$$CN$CA$CA
232914163$23291416$3$F$20230101$20240723$20231213$20240725$EXP$$US-UCBSA-2023041661$UCB$$$$$F$Y$110.67$KG$20240725$$HP$US$US
232915132$23291513$2$F$20230517$20240722$20231213$20240725$EXP$$ES-SANDOZ INC.-SDZ2023ES067327$SANDOZ$$69$YR$$M$Y$$$20240725$$MD$ES$ES
232915247$23291524$7$F$20231124$20240701$20231213$20240709$EXP$$US-TAKEDA-2023TUS098846$TAKEDA$$59$YR$$F$Y$$$20240709$$MD$US$US
232915303$23291530$3$F$$20240804$20231213$20240813$EXP$$IN-ROCHE-3471824$ROCHE$$59$YR$A$F$Y$$$20240813$$CN$IN$IN
232915506$23291550$6$F$20231202$20240916$20231213$20240923$EXP$$CO-TAKEDA-2023TUS119709$TAKEDA$$60$YR$$M$Y$56$KG$20240923$$CN$CO$CO
232915882$23291588$2$F$20230814$20240805$20231213$20240809$EXP$$NVSC2023IN186643$NOVARTIS$$68$YR$$M$Y$$$20240809$$CN$IN$IN
232916073$23291607$3$F$20231114$20240607$20231213$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005309$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240701$$CN$US$US
232916274$23291627$4$F$20240816$20240829$20231213$20240902$EXP$$US-TAKEDA-2023TUS101353$TAKEDA$$59$YR$$F$Y$$$20240902$$HP$US$US
232917112$23291711$2$F$$20240719$20231213$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202312006074$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240725$$CN$US$US
232917493$23291749$3$F$$20240823$20231213$20240827$EXP$$NVSC2023US259818$NOVARTIS$$$$$M$Y$$$20240827$$CN$US$US
232917592$23291759$2$F$20230101$20240820$20231213$20240822$EXP$$US-ABBVIE-5531695$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
232917832$23291783$2$F$$20240729$20231213$20240802$EXP$$JP-AMGEN-JPNSP2023218688$AMGEN$$$$E$F$Y$$$20240802$$PH$JP$JP
232920276$23292027$6$F$20230630$20240906$20231213$20240910$EXP$$US-TAKEDA-2023TUS095694$TAKEDA$$9$YR$$F$Y$50$KG$20240910$$CN$US$US
232920469$23292046$9$F$20230101$20240819$20231213$20240902$EXP$$CA-UCBSA-2023051811$UCB$$$$$F$Y$$$20240902$$CN$CA$CA
232921842$23292184$2$F$20231001$20231205$20231213$20240711$PER$$US-PFM-2023-05939$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
232922172$23292217$2$F$20220509$20240715$20231213$20240724$EXP$$FR-CELLTRION INC.-2023FR023449$CELLTRION$$$$$$Y$$$20240724$$MD$FR$FR
232922327$23292232$7$F$20230101$20240715$20231213$20240718$EXP$$CA-ABBVIE-5532208$ABBVIE$$$$$M$Y$$$20240718$$CN$CA$CA
232922973$23292297$3$F$20231123$20240829$20231213$20240909$EXP$$JP-ROCHE-3473942$ROCHE$$61$YR$A$M$Y$48$KG$20240909$$PH$JP$JP
232923214$23292321$4$F$20231122$20240704$20231213$20240709$EXP$$DE-JNJFOC-20231226378$JOHNSON AND JOHNSON$$60$YR$A$F$Y$73.6$KG$20240709$$MD$DE$DE
232924058$23292405$8$F$20231022$20240827$20231213$20240903$EXP$$DE-EXELIXIS-XL18423070464$EXELIXIS$$$$$$Y$$$20240903$$MD$DE$DE
232924099$23292409$9$F$20231117$20240729$20231213$20240806$EXP$$BE-EXELIXIS-XL18423071312$EXELIXIS$$$$$$Y$$$20240806$$MD$BE$BE
232924293$23292429$3$F$20231201$20231207$20231213$20240708$EXP$GB-MHRA-MED-202312061859234630-DNRVS$GB-MYLANLABS-2023M1130817$MYLAN$$34$YR$$F$Y$80$KG$20240708$$CN$GB$GB
232924394$23292439$4$F$$20240626$20231213$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-180064$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240701$$CN$US$US
232924442$23292444$2$F$20201217$20240725$20231213$20240801$EXP$SE-SEMPA-2023-016215$SE-ROCHE-3472402$ROCHE$$21$YR$A$F$Y$62$KG$20240801$$MD$SE$SE
232924665$23292466$5$F$20231218$20240923$20231213$20240930$EXP$$US-Blueprint Medicines Corporation-SP-US-2023-002012$BLUEPRINT MEDICINES$$53$YR$A$F$Y$$$20240930$$CN$US$US
232924806$23292480$6$F$20231205$20240730$20231213$20240807$EXP$$NVSC2023ZA259970$NOVARTIS$$65$YR$$M$Y$$$20240807$$HP$ZA$ZA
232925512$23292551$2$F$$20240916$20231213$20240924$EXP$$US-MYLANLABS-2023M1131251$MYLAN$$$$$M$Y$83.91$KG$20240924$$CN$US$US
232926054$23292605$4$F$20200101$20240626$20231213$20240705$PER$$US-SA-2023SA386805$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240705$$MD$US$US
232926152$23292615$2$F$$20240801$20231213$20240809$PER$$US-SA-2023SA273864$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240809$$MD$US$US
232926227$23292622$7$F$20230101$20240717$20231213$20240724$EXP$$US-SA-2023SA384545$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240724$$MD$US$US
232926263$23292626$3$F$20240101$20240708$20231213$20240717$PER$$US-SA-2023SA383655$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240717$$MD$US$US
232926343$23292634$3$F$20231001$20240802$20231213$20240812$PER$$US-SA-2023SA381741$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240812$$MD$US$US
232927534$23292753$4$F$20210101$20240923$20231213$20240927$EXP$$DE-SA-2023SA381715$SANOFI AVENTIS$Suhling H, Hinze CA, Welte T, Werfel T, Traidl S.. Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic Dermatitis.. Respiration. 2023;102(12):1016-9$25$YR$A$F$Y$$$20240927$$MD$DE$DE
232927823$23292782$3$F$20231101$20240823$20231213$20240906$PER$$US-SA-2023SA383164$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240906$$MD$US$US
232928072$23292807$2$F$20230101$20240919$20231213$20240930$PER$$US-SA-2023SA382006$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240930$$MD$US$US
232928988$23292898$8$F$20240105$20240607$20231213$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005306$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240701$$CN$US$US
232929032$23292903$2$F$20231203$20240912$20231213$20240920$PER$$US-SA-2023SA385623$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240920$$MD$US$US
232929173$23292917$3$F$$20240704$20231213$20240711$EXP$$JP-009507513-2312JPN000651J$MERCK$$68$YR$$M$Y$$$20240711$$MD$JP$JP
232929242$23292924$2$F$20231205$20240703$20231213$20240708$EXP$$US-SA-2023SA384498$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240708$$MD$US$US
232929615$23292961$5$F$20231101$20240725$20231213$20240729$EXP$$PR-PFIZER INC-202300239633$PFIZER$$70$YR$$F$Y$$$20240729$$HP$PR$PR
232929625$23292962$5$F$$20240904$20231213$20240906$EXP$$US-PFIZER INC-202300434852$PFIZER$$61$YR$$F$Y$$$20240906$$HP$US$US
232929806$23292980$6$F$20220601$20240913$20231213$20240920$EXP$$KR-OTSUKA-2023_031741$OTSUKA$$35$YR$$M$Y$$$20240920$$MD$KR$KR
232930282$23293028$2$F$20220101$20240725$20231213$20240731$EXP$$CA-PFIZER INC-202200526313$PFIZER$$59$YR$$F$Y$76$KG$20240731$$MD$CA$CA
232930293$23293029$3$F$20231002$20240723$20231213$20240726$EXP$FR-AFSSAPS-AM2023001042$FR-PFIZER INC-202300434244$PFIZER$$83$YR$$M$Y$73$KG$20240726$$MD$FR$FR
232931085$23293108$5$F$20230224$20231211$20231213$20240918$EXP$$FR-009507513-2312FRA004158$MERCK$$40$YR$$F$Y$$$20240918$$MD$FR$FR
232931838$23293183$8$F$20200513$20240906$20231213$20240910$EXP$$US-PFIZER INC-PV202300197543$PFIZER$$65$YR$$M$Y$108.84$KG$20240910$$HP$US$US
232932375$23293237$5$F$20231201$20240903$20231213$20240905$PER$$US-BIOGEN-2023BI01237908$BIOGEN$$43$YR$$F$Y$$$20240905$$CN$US$US
232932422$23293242$2$F$$20230222$20231213$20240806$EXP$$US-NOVOPROD-1035684$NOVO NORDISK$$$$$F$Y$$$20240806$$CN$US$US
232932673$23293267$3$F$$20231205$20231213$20240822$EXP$$HR-AstraZeneca-2023A278408$ASTRAZENECA$$68$YR$$F$Y$130$KG$20240822$$MD$HR$
232935392$23293539$2$F$20230727$20230727$20231213$20240716$PER$$US-NOVOPROD-1100841$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
232936482$23293648$2$F$20220301$20240122$20231213$20240723$PER$$US-NOVOPROD-1134317$NOVO NORDISK$$66$YR$$F$Y$219$KG$20240723$$CN$US$US
232937548$23293754$8$F$20240703$20240805$20231213$20240809$EXP$$CA-TAKEDA-2023TUS118964$TAKEDA$$77$YR$$F$Y$$$20240809$$CN$CA$CA
232937762$23293776$2$F$20230301$20240731$20231213$20240807$PER$$JP-Eisai-EC-2023-137822$EISAI$$57$YR$A$F$Y$$$20240807$$PH$JP$JP
232937833$23293783$3$F$20231128$20240726$20231213$20240802$PER$$KR-JAZZ PHARMACEUTICALS-2023-KR-024628$JAZZ$$64$YR$$M$Y$56.4$KG$20240802$$MD$KR$KR
232938033$23293803$3$F$$20240813$20231213$20240819$EXP$$IE-MYLANLABS-2023M1131920$MYLAN$O^Brien S, Griffin B, Dorman AM.. Interesting Biopsy of a Patient with AKI on a Background of Systemic Mastocytosis. J Am Soc Nephrol. 2023;34:110-111$74$YR$$F$Y$$$20240819$$MD$IE$IE
232938172$23293817$2$F$20220801$20240625$20231213$20240701$EXP$$DE-ABBVIE-5531980$ABBVIE$$58$YR$$M$Y$100$KG$20240701$$MD$DE$DE
232939052$23293905$2$F$20220101$20240815$20231213$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-177725$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$61.4$KG$20240820$$CN$US$US
232939292$23293929$2$F$$20240710$20231213$20240715$EXP$$US-TAKEDA-2022TUS088355$TAKEDA$$$$$M$Y$$$20240715$$MD$US$US
232939944$23293994$4$F$20231103$20240919$20231213$20240924$EXP$$US-BEH-2023166212$CSL BEHRING$$35$YR$A$F$Y$79.365$KG$20240924$$HP$US$US
232940205$23294020$5$F$20231016$20240722$20231213$20240730$EXP$$JP-AstraZeneca-2023A257206$ASTRAZENECA$$67$YR$$F$Y$57$KG$20240730$$MD$JP$
232940422$23294042$2$F$$20240730$20231213$20240802$EXP$$CA-SANDOZ INC.-NVSC2022CA025353$SANDOZ$$$$$M$Y$$$20240802$$CN$CA$CA
232940702$23294070$2$F$$20240816$20231213$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-176597$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$75.48$KG$20240826$$HP$US$US
232940932$23294093$2$F$$20240911$20231213$20240918$EXP$$CA-TAKEDA-2023TUS107295$TAKEDA$$$$$F$Y$$$20240918$$CN$CA$CA
232941003$23294100$3$F$20230101$20240705$20231213$20240717$EXP$$BY-ASTELLAS-2023US037067$ASTELLAS$$$$$F$Y$$$20240717$$CN$CH$BY
232941763$23294176$3$F$$20240814$20231213$20240816$PER$$US-PFIZER INC-202300430114$PFIZER$$74$YR$$M$Y$$$20240816$$MD$US$US
232941985$23294198$5$F$$20240810$20231213$20240816$EXP$$GB-TAKEDA-2023TUS119500$TAKEDA$$$$$F$Y$$$20240816$$CN$GB$GB
232942027$23294202$7$F$20231001$20240229$20231213$20240806$EXP$$NVSC2023BR228212$NOVARTIS$$75$YR$$F$Y$$$20240806$$CN$BR$BR
232942162$23294216$2$F$$20231208$20231213$20240906$EXP$$PL-BAUSCH-BL-2023-018238$BAUSCH AND LOMB$$71$YR$$$Y$$$20240906$$MD$PL$PL
232942187$23294218$7$F$20231204$20240715$20231213$20240723$EXP$$NVSC2023DE262668$NOVARTIS$$$$A$F$Y$75$KG$20240723$$HP$DE$DE
232945075$23294507$5$F$20231212$20240813$20231213$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-180904$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$70.76$KG$20240815$$CN$US$US
232946382$23294638$2$F$20210401$20240624$20231213$20240704$EXP$$JP-009507513-2306JPN001676J$MERCK$Nihei S. [Symposium 11 A male in his 60s who concomitantly had thyroid function decreased and adrenal hypofunction after ICI administration]. The 12th Tohoku Block Meeting of The Japanese Society of Hospital Pharmacist. 118$7$DEC$$M$Y$$$20240704$$PH$JP$JP
2329472113$23294721$13$F$20231201$20240701$20231213$20240715$PER$$US-Calliditas-2023CAL01579$CALLIDITAS THERAPEUTICS$$46$YR$A$M$Y$81$KG$20240715$$CN$US$US
232947223$23294722$3$F$$20240722$20231213$20240805$PER$$US-Calliditas-2023CAL01585$CALLIDITAS THERAPEUTICS$$45$YR$A$M$Y$$$20240805$$CN$US$US
232947293$23294729$3$F$20220101$20240710$20231213$20240722$EXP$$JP-009507513-2312JPN001365J$MERCK$Oshiro S, Nakamura H, Kuriyama M, Ariyama Y, Saito M, Soga E, et al.. ORIGINAL ARTICLE A report of 15 cases of lenvatinib plus pembrolizumab for advanced endometrial cancer. Tokyo journal of obstetrics and gynecology. 2024;73(2):153-6$55$YR$$F$Y$$$20240719$$MD$JP$JP
232947572$23294757$2$F$20231101$20240624$20231213$20240703$PER$$US-SA-2023SA384232$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240703$$CN$US$US
232947632$23294763$2$F$$20240904$20231213$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-278165$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240904$$CN$US$US
232947777$23294777$7$F$20231207$20240802$20231213$20240806$EXP$$JP-AstraZeneca-2023A280268$ASTRAZENECA$Kanayama T, et al.. V-16 Two cases of fulminant myocarditis after administration of durvalumab/tremelimumab for hepatocellular carcinoma.. The 272nd Kanto Koushinetsu Regional Meeting of the Japanese Circulation Society 2024;22.$82$YR$$M$Y$49$KG$20240806$$MD$JP$
232947833$23294783$3$F$20230801$20240830$20231213$20240904$EXP$$JP-009507513-2312JPN000661J$MERCK$$7$DEC$$M$Y$$$20240904$$HP$JP$JP
232948223$23294822$3$F$20231120$20231130$20231213$20240719$EXP$$CN-G1 THERAPEUTICS-2023G1CN0000167$G1 THERAPEUTICS$$$$$$Y$$$20240719$$MD$CN$CN
232948792$23294879$2$F$$20240819$20231213$20240828$PER$$US-SA-2023SA384559$SANOFI AVENTIS$$33$YR$A$F$Y$72.5$KG$20240828$$MD$US$US
232949043$23294904$3$F$20231201$20240815$20231213$20240821$EXP$$JP-009507513-2312JPN001102J$MERCK$$6$DEC$$M$Y$$$20240821$$MD$JP$JP
232949622$23294962$2$F$$20240710$20231213$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20200300211$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240716$$CN$CA$CA
232949684$23294968$4$F$20201222$20240814$20231213$20240821$EXP$$CA-CELLTRION INC.-2020CA034894$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
232950667$23295066$7$F$20230714$20240917$20231213$20240925$EXP$$CA-CELLTRION INC.-2023CA016562$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
232950784$23295078$4$F$20231101$20240901$20231213$20240909$EXP$$US-BEH-2023166278$CSL BEHRING$$57$YR$A$F$Y$79.819$KG$20240909$$HP$US$US
232951292$23295129$2$F$$20240819$20231213$20240829$EXP$$JP-ASTELLAS-2023JP013691$ASTELLAS$$89$YR$E$M$Y$$$20240827$$MD$JP$JP
2329513412$23295134$12$F$20221001$20240912$20231213$20240920$EXP$$CA-CELLTRION INC.-2023CA023183$CELLTRION$$$$$$Y$$$20240920$$MD$CA$CA
232952875$23295287$5$F$20230919$20240702$20231214$20240719$EXP$$JP-AstraZeneca-2023A278691$ASTRAZENECA$$58$YR$$M$Y$91$KG$20240719$$MD$JP$
232955537$23295553$7$F$20230117$20240717$20231214$20240718$EXP$$US-INCYTE CORPORATION-2023IN012819$INCYTE$$$$$$Y$$$20240718$$MD$US$US
232956292$23295629$2$F$20220501$20231207$20231214$20240926$EXP$$US-GSK-US2022AMR081688$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
232956542$23295654$2$F$$20240913$20231214$20240920$EXP$$CA-TAKEDA-2022TUS023923$TAKEDA$$$$$F$Y$$$20240920$$MD$CA$CA
232956643$23295664$3$F$20221001$20240814$20231214$20240821$EXP$$GR-JNJFOC-20231212669$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240821$$MD$GR$GR
2329566914$23295669$14$F$20230101$20240906$20231214$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2023-035593$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240914$$$US$US
232956702$23295670$2$F$20231212$20240729$20231214$20240730$EXP$$US-UCBSA-2023050641$UCB$$19$YR$$M$Y$$$20240730$$HP$US$US
2329577611$23295776$11$F$20231104$20240820$20231214$20240827$EXP$$CA-TAKEDA-2023TUS108124$TAKEDA$$39$YR$$M$Y$$$20240827$$HP$CA$CA
232957973$23295797$3$F$$20240619$20231214$20240703$EXP$$ES-SANDOZ INC.-SDZ2023ES067728$SANDOZ$$1$YR$$M$Y$$$20240703$$MD$ES$ES
232958034$23295803$4$F$20230429$20240716$20231214$20240722$EXP$$DE-SANDOZ INC.-NVSC2023DE113593$SANDOZ$$70$YR$$M$Y$$$20240722$$MD$DE$DE
232958355$23295835$5$F$20230101$20240912$20231214$20240919$EXP$$DE-TAKEDA-2023TUS118149$TAKEDA$$71$YR$$F$Y$64$KG$20240919$$MD$DE$DE
232958792$23295879$2$F$20240801$20240830$20231214$20240913$EXP$$CA-UCBSA-2023058534$UCB$$52$YR$$F$Y$$$20240913$$CN$CA$CA
232958802$23295880$2$F$$20240725$20231214$20240731$EXP$$CA-UCBSA-2023058279$UCB$$$$$M$Y$$$20240731$$HP$CA$CA
232959162$23295916$2$F$$20240827$20231214$20240828$EXP$$PT-SANDOZ INC.-SDZ2023PT067360$SANDOZ$$60$YR$$F$Y$$$20240828$$HP$PT$PT
232960932$23296093$2$F$20230101$20240827$20231214$20240909$PER$$US-SA-2023SA382685$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240909$$MD$US$US
232961052$23296105$2$F$20231101$20240620$20231214$20240702$PER$$US-SA-2023SA383470$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240702$$MD$US$US
232961272$23296127$2$F$$20240708$20231214$20240717$PER$$US-SA-2023SA383630$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240717$$MD$US$US
232961406$23296140$6$F$20230101$20240722$20231214$20240727$EXP$$US-SA-2023SA385076$SANOFI AVENTIS$$6$YR$C$M$Y$24.3$KG$20240727$$CN$US$US
232961722$23296172$2$F$20230101$20240813$20231214$20240826$PER$$US-SA-2023SA384460$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240826$$MD$US$US
232962363$23296236$3$F$20230101$20240706$20231214$20240708$EXP$$CA-PFIZER INC-202300227673$PFIZER$$70$YR$$F$Y$$$20240708$$MD$CA$CA
232962866$23296286$6$F$20230601$20240717$20231214$20240723$EXP$$CA-PFIZER INC-202300279871$PFIZER$$43$YR$$M$Y$$$20240723$$MD$CA$CA
232963727$23296372$7$F$20231207$20240829$20231214$20240904$EXP$$JP-009507513-2312JPN000925J$MERCK$$8$DEC$$M$Y$$$20240904$$MD$JP$JP
232963872$23296387$2$F$20230901$20240905$20231214$20240912$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-267262$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240912$$CN$CA$CA
232964569$23296456$9$F$$20240723$20231214$20240725$EXP$$CA-ROCHE-3473586$ROCHE$$$$A$M$Y$$$20240725$$HP$CA$CA
232965124$23296512$4$F$20230101$20240903$20231214$20240910$EXP$$JP-009507513-2312JPN001579J$MERCK$$63$YR$$F$Y$$$20240910$$MD$JP$JP
232965382$23296538$2$F$20231103$20240906$20231214$20240912$PER$$US-BAYER-2023A174978$BAYER$$$$$F$Y$$$20240912$$HP$US$US
232965547$23296554$7$F$20231101$20240814$20231214$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-181002$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$46$KG$20240819$$MD$JP$JP
232966692$23296669$2$F$$20240829$20231214$20240906$EXP$$DE-HIKMA PHARMACEUTICALS-DE-H14001-23-67715$HIKMA$Doubrovinskaja S, Korporal-Kuhnke M, Jarius S, Haas J, Wildemann B.. Doubrovinskaja S, Korporal-Kuhnke M, Jarius S, Haas J, Wildemann B. Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome.. Journal of Neurology.. 2023;271(5):2866-2870$$$$F$Y$$$20240906$$MD$DE$DE
232966913$23296691$3$F$20240718$20240814$20231214$20240819$EXP$$US-SHIRE-US201924473AA$TAKEDA$$62$YR$$M$Y$$$20240819$$HP$US$US
232967283$23296728$3$F$20231211$20231212$20231214$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202312007043$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240701$$HP$US$US
232967623$23296762$3$F$$20240823$20231214$20240829$EXP$$TR-PFIZER INC-PV202300198857$PFIZER$Gulmez, A.. A case report: Secondary cancers due to oncological treatment modalities. Journal of Cancer Research and Therapeutics. 2023;19(2):493-497$47$YR$$F$Y$$$20240829$$HP$TR$TR
232967642$23296764$2$F$$20240822$20231214$20240829$EXP$$IT-PFIZER INC-PV202300199299$PFIZER$Colussi, L.. Effect of the janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma. Pediatric Rheumatology. 2023;21(Supplement2):309$13$YR$$F$Y$$$20240829$$HP$IT$IT
232968842$23296884$2$F$20240901$20240918$20231214$20240925$EXP$$US-SA-2023SA383356$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240925$$MD$US$US
232969252$23296925$2$F$20230101$20240703$20231214$20240714$PER$$US-SA-2023SA382510$SANOFI AVENTIS$$54$YR$A$F$Y$62.14$KG$20240714$$MD$US$US
232969766$23296976$6$F$$20240809$20231214$20240827$EXP$$JP-009507513-2312JPN000495J$MERCK$Shibata N, Matsui C, Hirai C, Tada M, Yauchi Y, Kikawa Y, et al.. EP-0451 Treatment outcomes of the KYENOTE-522 regimen for early-stage triple-negative breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 290$48$YR$$F$Y$$$20240827$$MD$JP$JP
232970074$23297007$4$F$20231001$20240708$20231214$20240711$PER$$US-BIOGEN-2023BI01240164$BIOGEN$$42$YR$$F$Y$$$20240711$$CN$US$US
232970477$23297047$7$F$20230101$20240711$20231214$20240716$EXP$$CA-PFIZER INC-202200938470$PFIZER$$57$YR$$M$Y$$$20240716$$HP$CA$CA
232970522$23297052$2$F$20231127$20240703$20231214$20240704$EXP$$IN-PFIZER INC-PV202300202219$PFIZER$$73$YR$$F$Y$$$20240704$$CN$IN$IN
2329706012$23297060$12$F$20230101$20240726$20231214$20240730$EXP$$GB-PFIZER INC-202300441064$PFIZER$$$$$F$Y$$$20240730$$MD$GB$GB
232971735$23297173$5$F$20200101$20240216$20231214$20240801$EXP$$NVSC2023PL263625$NOVARTIS$$$$A$F$Y$$$20240801$$MD$PL$PL
232971853$23297185$3$F$$20240627$20231214$20240703$EXP$$US-OTSUKA-2023_032018$OTSUKA$$$$$F$Y$$$20240703$$MD$US$US
232972863$23297286$3$F$$20240913$20231214$20240923$PER$$US-GSK-US2023AMR171995$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
232972934$23297293$4$F$$20240626$20231214$20240703$EXP$$CA-OTSUKA-2023_032289$OTSUKA$$74$YR$$F$Y$$$20240703$$MD$CA$CA
232973163$23297316$3$F$$20240207$20231214$20240806$EXP$$CA-APOTEX-2023AP017779$APOTEX$$66$YR$$F$Y$$$20240806$$MD$CA$CA
232974972$23297497$2$F$$20240730$20231214$20240805$EXP$$JP-AMGEN-JPNSP2023220085$AMGEN$$$$$$Y$$$20240805$$PH$JP$JP
232975592$23297559$2$F$$20240702$20231214$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-181388$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240703$$CN$US$US
232975732$23297573$2$F$20231210$20240717$20231214$20240719$PER$$US-AMGEN-USASP2023221386$AMGEN$$66$YR$E$M$Y$$$20240719$$HP$US$US
232975892$23297589$2$F$20231211$20240709$20231214$20240710$PER$$US-AMGEN-USASP2023223078$AMGEN$$64$YR$A$M$Y$$$20240710$$CN$US$US
232976733$23297673$3$F$$20240701$20231214$20240708$EXP$$IT-AMGEN-ITASP2023219742$AMGEN$Persano M.; Rimini M.; Tada T. et al.. Lenvatinib (L) versus sorafenib (S) second-line therapy in hepatocellular carcinoma (HCC) patients progressed to atezolizumab plus bevacizumab (AB). Annals of Oncology. 2023;34 (S4):S1543$$$$$Y$$$20240708$$HP$IT$IT
232979753$23297975$3$F$20231118$20240627$20231214$20240902$PER$$US-ASTELLAS-2023US035771$ASTELLAS$$57$YR$A$F$Y$$$20240830$$CN$US$US
232980373$23298037$3$F$$20240724$20231214$20240726$EXP$$US-TAKEDA-2023TUS096003$TAKEDA$$$$$M$Y$68$KG$20240726$$CN$US$US
232980479$23298047$9$F$20231208$20240717$20231214$20240723$EXP$$CA-ROCHE-3475455$ROCHE$$53$YR$A$M$Y$$$20240723$$MD$CA$CA
232980483$23298048$3$F$20231101$20240815$20231214$20240822$EXP$$DE-ROCHE-3474398$ROCHE$$44$YR$A$F$Y$$$20240822$$CN$DE$DE
232980662$23298066$2$F$20231101$20240814$20231214$20240823$PER$$US-INCYTE CORPORATION-2023IN012759$INCYTE$$$$$$Y$$$20240823$$CN$US$US
232980683$23298068$3$F$$20240820$20231214$20240821$EXP$$CA-SANDOZ INC.-SDZ2023CA066967$SANDOZ$$64$YR$$M$Y$$$20240821$$MD$CA$CA
232980907$23298090$7$F$20240221$20240909$20231214$20240912$EXP$$CA-ROCHE-3402716$ROCHE$$52$YR$A$M$Y$$$20240912$$CN$CA$CA
232981273$23298127$3$F$$20240625$20231214$20240702$EXP$$CN-JNJFOC-20231209700$JOHNSON AND JOHNSON$$29$YR$A$$Y$67$KG$20240702$$CN$CN$CN
232981342$23298134$2$F$20231122$20240909$20231214$20240916$EXP$$FR-FreseniusKabi-FK202320312$FRESENIUS KABI$$45$YR$A$F$Y$$$20240916$$MD$FR$FR
232981602$23298160$2$F$$20240823$20231214$20240829$PER$$US-BAUSCH-BL-2023-018406$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240829$$CN$US$US
232982073$23298207$3$F$20230213$20240906$20231214$20240910$PER$$US-PFIZER INC-PV202200026902$PFIZER$$81$YR$$F$Y$$$20240910$$HP$US$US
232982123$23298212$3$F$$20240625$20231214$20240701$PER$$US-PFIZER INC-PV202300039926$PFIZER$$71$YR$$F$Y$$$20240701$$MD$US$US
232982605$23298260$5$F$20230112$20240806$20231214$20240808$EXP$$AR-MYLANLABS-2023M1005216$MYLAN$$23$YR$$M$Y$$$20240808$$HP$AR$AR
232982642$23298264$2$F$20230713$20240718$20231214$20240725$EXP$$NVSC2023IN265874$NOVARTIS$$50$YR$$F$Y$$$20240725$$CN$IN$IN
2329831314$23298313$14$F$20230801$20240920$20231214$20240930$EXP$$BR-SANDOZ INC.-SDZ2023BR045649$SANDOZ$$55$YR$$F$Y$$$20240930$$CN$BR$BR
232983433$23298343$3$F$20231001$20240913$20231214$20240917$EXP$$CA-SANDOZ INC.-NVSC2022CA002313$SANDOZ$$43$YR$$M$Y$$$20240917$$CN$CA$CA
232983832$23298383$2$F$$20231209$20231214$20240801$EXP$$NVSC2023GR264230$NOVARTIS$$$$$F$Y$$$20240801$$CN$GR$GR
232984035$23298403$5$F$$20240723$20231214$20240726$PER$$US-PFIZER INC-202300442646$PFIZER$$53$YR$$F$Y$$$20240726$$MD$US$US
232984053$23298405$3$F$$20240813$20231214$20240814$PER$$US-PFIZER INC-202300442040$PFIZER$$77$YR$$F$Y$$$20240814$$MD$US$US
232984584$23298458$4$F$20220916$20240624$20231214$20240701$EXP$$JP-JNJFOC-20231229659$JOHNSON AND JOHNSON$$73$YR$E$M$Y$59.1$KG$20240701$$MD$JP$JP
232984694$23298469$4$F$20230101$20240731$20231214$20240808$EXP$$CA-CELLTRION INC.-2023CA023904$CELLTRION$$$$$$Y$$$20240808$$HP$CA$CA
232984783$23298478$3$F$20230101$20240708$20231214$20240710$EXP$$US-ABBVIE-5532766$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
232984802$23298480$2$F$20230101$20240702$20231214$20240708$EXP$$US-ABBVIE-5532708$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
232984955$23298495$5$F$20230101$20240821$20231214$20240828$EXP$$US-ABBVIE-5537718$ABBVIE$$$$$M$Y$100$KG$20240828$$CN$US$US
232985166$23298516$6$F$$20240723$20231214$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-160282$BRISTOL MYERS SQUIBB$Sugai M. Investigation of the irAEs severity and prognosis between platinum preparations and ipilimumab + nivolumab combination therapy in unresectable advanced non-small cell lung cancer. The 64th Annual Meeting of the Japan Lung Cancer Society.$$$$$Y$$$20240809$$MD$JP$JP
232985412$23298541$2$F$$20240814$20231214$20240820$EXP$$JP-ABBVIE-5536012$ABBVIE$$$$$M$Y$$$20240820$$MD$JP$JP
232986133$23298613$3$F$$20240919$20231214$20240926$EXP$$US-ABBVIE-5535884$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
232986154$23298615$4$F$20231001$20240808$20231214$20240809$EXP$$NVSC2023US260967$NOVARTIS$$46$YR$$M$Y$$$20240809$$CN$US$US
232987395$23298739$5$F$20230101$20240807$20231214$20240815$PER$$US-SA-2023SA384984$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240815$$MD$US$US
232988175$23298817$5$F$20220101$20240716$20231215$20240722$EXP$$CO-JNJFOC-20230917597$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$97$KG$20240723$$HP$CO$CO
232988456$23298845$6$F$20230611$20240627$20231215$20240709$EXP$$AT-ELI_LILLY_AND_COMPANY-AT202309010562$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240709$$CN$AT$AT
232988582$23298858$2$F$$20240819$20231215$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005373$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
232989102$23298910$2$F$$20240702$20231215$20240705$EXP$$GB-JNJFOC-20231224823$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240705$$CN$GB$GB
232989692$23298969$2$F$$20240822$20231215$20240825$EXP$$JP-TAKEDA-2023TJP016549$TAKEDA$$$$C$M$Y$$$20240825$$MD$JP$JP
232991862$23299186$2$F$20230301$20240719$20231215$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-180810$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240726$$MD$JP$JP
232992166$23299216$6$F$20240101$20240806$20231215$20240808$EXP$$CA-JNJFOC-20231157855$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240809$$HP$CA$CA
232992993$23299299$3$F$20230101$20240626$20231215$20240705$PER$$US-SA-2023SA385144$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240705$$MD$US$US
232993002$23299300$2$F$$20240724$20231215$20240805$EXP$$NZ-JUBILANT CADISTA PHARMACEUTICALS-2023NZ001600$JUBILANT$Lee HK, Reiche L.. Lamotrigine-induced generalised pustular psoriasis. New Zealand Medical Journal. 2023;136(1586):99-101$23$YR$$F$Y$$$20240805$$HP$NZ$NZ
2329938110$23299381$10$F$$20240924$20231215$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-182005$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240925$$MD$US$US
232994392$23299439$2$F$$20240723$20231215$20240726$EXP$CA-LEO Pharma-365835$CA-LEO Pharma-365835$LEO PHARM$$71$YR$$M$Y$$$20240726$$CN$CA$CA
232994457$23299445$7$F$20231210$20240613$20231215$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005374$ACADIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240708$$CN$US$US
232995093$23299509$3$F$20231108$20240724$20231215$20240730$EXP$$CA-JNJFOC-20231122835$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240730$$HP$CA$CA
232995123$23299512$3$F$20230101$20240620$20231215$20240704$PER$$US-ROCHE-3471026$ROCHE$$47$YR$A$M$Y$$$20240704$$CN$US$US
232995322$23299532$2$F$20240627$20240816$20231215$20240904$PER$$CA-TOLMAR, INC.-23CA044875$TOLMAR$$74$YR$$M$Y$$$20240904$$CN$CA$CA
232995333$23299533$3$F$20231116$20240724$20231215$20240815$PER$$CA-TOLMAR, INC.-23CA044876$TOLMAR$$76$YR$$M$Y$$$20240814$$CN$CA$CA
232995764$23299576$4$F$20231212$20240821$20231215$20240824$PER$$US-AMGEN-USASP2023223642$AMGEN$$76$YR$E$M$Y$$$20240824$$CN$US$US
232996292$23299629$2$F$$20240807$20231215$20240821$EXP$$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2023-019051$VALIDUS$$$$$$Y$$$20240821$$CN$CA$CA
232996317$23299631$7$F$20231206$20240822$20231215$20240830$EXP$$CA-CELLTRION INC.-2023CA012255$CELLTRION$$$$$$Y$$$20240830$$MD$CA$CA
232996602$23299660$2$F$$20231204$20231215$20240827$EXP$$US-ABBVIE-5533676$ABBVIE$Dima D, Orland M, Ullah F, Anwer F, Mazzoni S, Raza S, et al. Clinical efficacy of retreatment with venetoclax-based therapy in relapsed-refractory t(11;14) multiple myeloma. Clinical Lymphoma Myeloma and Leukemia. 2023;23(11):857-860.$$$A$$Y$$$20240827$$MD$US$US
232996632$23299663$2$F$$20231204$20231215$20240827$EXP$$US-ABBVIE-5533784$ABBVIE$Dima D, Orland M, Ullah F, Anwer F, Mazzoni S, Raza S, et al. Clinical efficacy of retreatment with venetoclax-based therapy in relapsed-refractory t(11;14) multiple myeloma. Clinical Lymphoma Myeloma and Leukemia. 2023;23(11):857-860.$$$A$$Y$$$20240827$$MD$US$US
232997373$23299737$3$F$$20240924$20231215$20240930$EXP$$NVSC2023CA262024$NOVARTIS$$3$YR$$F$Y$$$20240930$$CN$CA$CA
232997465$23299746$5$F$20231227$20240418$20231215$20240822$EXP$$NVSC2023AR261020$NOVARTIS$$61$YR$$F$Y$$$20240822$$CN$AR$AR
232997903$23299790$3$F$20230516$20240830$20231215$20240911$EXP$$JP-AMGEN-JPNNI2023222315$AMGEN$$73$YR$E$F$Y$55$KG$20240910$$MD$JP$JP
232998087$23299808$7$F$20230101$20240710$20231215$20240715$EXP$$US-JNJFOC-20231228967$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$80.812$KG$20240715$$CN$US$US
232998162$23299816$2$F$20231212$20240920$20231215$20240924$PER$$US-AMGEN-USASP2023223151$AMGEN$$81$YR$E$M$Y$93$KG$20240924$$HP$US$US
232999808$23299980$8$F$20231114$20240828$20231215$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005378$ACADIA PHARMACEUTICALS$$29$YR$$F$Y$$$20240920$$CN$US$US
232999815$23299981$5$F$$20240621$20231215$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005371$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
232999862$23299986$2$F$$20240909$20231215$20240916$EXP$$JP-AstraZeneca-2023A281545$ASTRAZENECA$$42$YR$$F$Y$$$20240916$$MD$JP$
232999904$23299990$4$F$20210524$20240829$20231215$20240910$EXP$$JP-UCBSA-2023058755$UCB$Kadoguchi N et al.. A case of avoiding pacemaker implantation for suspected bradycardia due to lacosamide as a result of differentiation of brought-in medications. Abstract of The 33rd Annual Meeting of the Japanese Society of Pharmaceutical He. 2023;PM1:P0573-4$88$YR$$F$Y$42.1$KG$20240910$$PH$JP$JP
232999942$23299994$2$F$$20240913$20231215$20240923$PER$$US-GSK-US2023171605$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$HP$US$US
233000632$23300063$2$F$$20240909$20231215$20240917$EXP$$JP-AstraZeneca-2023A281549$ASTRAZENECA$$75$YR$$F$Y$$$20240917$$MD$JP$
233001375$23300137$5$F$$20240705$20231215$20240709$PER$$NVSC2023US266092$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
233001553$23300155$3$F$$20231220$20231215$20240925$PER$$US-GSK-US2023AMR172143$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
233002615$23300261$5$F$20220101$20240905$20231215$20240910$EXP$$US-ABBVIE-5532453$ABBVIE$$$$$F$Y$99.336$KG$20240910$$CN$US$US
233002732$23300273$2$F$$20240814$20231215$20240819$EXP$$JP-ABBVIE-5536036$ABBVIE$$$$$F$Y$$$20240819$$PH$JP$JP
233002772$23300277$2$F$$20240822$20231215$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-179857$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240830$$PH$JP$JP
233002797$23300279$7$F$20221212$20240729$20231215$20240805$EXP$$CN-TAKEDA-2023TUS068594$TAKEDA$$66$YR$$F$Y$43$KG$20240805$$MD$CN$CN
233003302$23300330$2$F$20231204$20240627$20231215$20240712$EXP$$IN-ROCHE-3476063$ROCHE$$62$YR$A$M$Y$$$20240712$$CN$IN$IN
233003863$23300386$3$F$20200307$20240703$20231215$20240710$EXP$$CA-ROCHE-2573777$ROCHE$$41$YR$A$F$Y$$$20240710$$CN$CA$CA
233004055$23300405$5$F$$20240717$20231215$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005657$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
233004413$23300441$3$F$20230615$20240826$20231215$20240905$EXP$$JP-HORIZON THERAPEUTICS-HZN-2023-005479$AMGEN$$62$YR$A$F$Y$42$KG$20240905$$MD$JP$JP
233005822$23300582$2$F$20211109$20240614$20231215$20240703$EXP$$DE-ROCHE-3220381$ROCHE$$48$YR$A$F$Y$$$20240703$$CN$DE$DE
233006064$23300606$4$F$20230101$20240730$20231215$20240809$EXP$$US-INSMED, INC.-2023-03796-US$INSMED$$$$$M$Y$$$20240809$$CN$US$US
233006793$23300679$3$F$$20240627$20231215$20240702$EXP$$JP-009507513-2312JPN000904J$MERCK$$71$YR$$F$Y$$$20240702$$MD$JP$JP
233007156$23300715$6$F$20231205$20240920$20231215$20240930$EXP$$CA-CELLTRION INC.-2023CA017275$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
233007883$23300788$3$F$$20240814$20231215$20240822$EXP$CA-SA-SAC20231214000209$CA-SA-2023SA389110$SANOFI AVENTIS$$40$YR$A$F$Y$73$KG$20240822$$HP$CA$CA
233008103$23300810$3$F$20231130$20240701$20231215$20240711$EXP$$US-GSK-US2023171730$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240711$$CN$US$US
233008254$23300825$4$F$20230101$20240710$20231215$20240711$EXP$$GB-UCBSA-2023043732$UCB$$$$A$F$Y$72.9$KG$20240711$$MD$GB$GB
233008276$23300827$6$F$$20240914$20231215$20240915$PER$$US-ALXN-202312USA000496US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
233008292$23300829$2$F$$20240719$20231215$20240801$EXP$$US-CIPLA LTD.-2023US07804$CIPLA$Sorabella RA, Gray WH, Dabal RJ, Padilla LA, Hock K, Clark MG et al.. Central extracorporeal membrane oxygenation support following calcium channel blocker overdose in children. ASAIO Journal. 2023;1 to 5$$$$$Y$$$20240801$$MD$US$US
233008342$23300834$2$F$$20240719$20231215$20240801$EXP$$US-CIPLA LTD.-2023US07806$CIPLA$Sorabekka RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al.. Central extracorporeal membrane oxygenation support following calcium channel blocker overdose in children.. ASAIO Journal.. 2024;70 (7):e92 to e96$$$$$Y$$$20240801$$MD$US$US
233010424$23301042$4$F$$20240829$20231215$20240903$EXP$$US-PFIZER INC-PV202300203202$PFIZER$Yang, A.. SUN-210 Testosterone Replacement Therapy Implicated in Osteonecrosis. Journal of the Endocrine Society. 2019;3(Supple 1):10.1210/js.2019-SUN-210$47$YR$$M$Y$$$20240903$$MD$US$US
233010512$23301051$2$F$20231106$20240812$20231215$20240823$EXP$$CA-GILEAD-2023-0650268$GILEAD$$56$YR$A$F$Y$$$20240823$$CN$CA$CA
233010552$23301055$2$F$$20240909$20231215$20240917$EXP$$JP-AstraZeneca-2023A281453$ASTRAZENECA$$44$YR$$F$Y$$$20240917$$MD$JP$
233011902$23301190$2$F$$20231209$20231215$20240731$EXP$$CA-SA-2023SA389103$SANOFI AVENTIS$$59$YR$A$F$Y$68$KG$20240731$$MD$CA$CA
233012464$23301246$4$F$20240115$20240911$20231215$20240919$EXP$$CA-TAKEDA-2023TUS119436$TAKEDA$$56$YR$$M$Y$$$20240919$$HP$CA$CA
2330125016$23301250$16$F$20231215$20240925$20231215$20240927$30DAY$$US-PFIZER INC-PV202300195954$PFIZER$$16$YR$$M$Y$58.957$KG$20240927$$MD$US$US
233012984$23301298$4$F$20231121$20240724$20231215$20240729$EXP$$CO-TAKEDA-2023TUS070837$TAKEDA$$72$YR$$F$Y$48$KG$20240729$$CN$CO$CO
233013273$23301327$3$F$$20240903$20231215$20240905$30DAY$$US-PFIZER INC-PV202300195946$PFIZER$$9$YR$$M$Y$$$20240905$$HP$US$US
233014523$23301452$3$F$20231209$20240814$20231215$20240820$EXP$$US-ARGENX-2023-ARGX-US004377AA$ARGENX BVBA$$$$$$Y$$$20240820$$CN$US$US
233015092$23301509$2$F$$20231209$20231215$20240731$EXP$$CA-SA-2023SA389068$SANOFI AVENTIS$$$$$F$Y$97$KG$20240731$$MD$CA$CA
233015525$23301552$5$F$20240101$20240722$20231215$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-181779$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$96.62$KG$20240725$$CN$US$US
233015802$23301580$2$F$$20240711$20231215$20240801$PER$$US-ALXN-A202306700$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
233016932$23301693$2$F$20220701$20240815$20231215$20240828$PER$$US-SA-2023SA382860$SANOFI AVENTIS$$6$YR$C$M$Y$27.215$KG$20240828$$MD$US$US
233017082$23301708$2$F$20240722$20240725$20231215$20240805$PER$$US-SA-2023SA382731$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240805$$MD$US$US
233017253$23301725$3$F$20231205$20240826$20231215$20240917$PER$$US-SA-2023SA383915$SANOFI AVENTIS$$62$YR$A$M$Y$65.76$KG$20240918$$MD$US$US
233017412$23301741$2$F$$20240820$20231215$20240916$PER$$US-SA-2023SA385807$SANOFI AVENTIS$$$$A$F$Y$113.38$KG$20240916$$MD$US$US
233017625$23301762$5$F$20230101$20240819$20231215$20240827$PER$$US-SA-2023SA387323$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240827$$MD$US$US
233017986$23301798$6$F$$20240716$20231215$20240801$EXP$$US-SA-2023SA079273$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240719$$CN$US$US
233018053$23301805$3$F$20231201$20240909$20231215$20240917$PER$$US-SA-2023SA389927$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240918$$MD$US$US
233018122$23301812$2$F$20240501$20240916$20231215$20240930$PER$$US-SA-2023SA387851$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240930$$CN$US$US
233018202$23301820$2$F$20210101$20240910$20231215$20240917$PER$$US-SA-2023SA384585$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240918$$HP$US$US
233018303$23301830$3$F$20230101$20240904$20231215$20240911$EXP$$US-ABBVIE-5416332$ABBVIE$$$$$F$Y$65.77$KG$20240911$$CN$US$US
233019143$23301914$3$F$20230401$20231211$20231215$20240718$EXP$$MA-ROCHE-3473474$ROCHE$$36$YR$A$F$Y$$$20240718$$MD$MA$MA
233019262$23301926$2$F$$20240723$20231215$20240801$PER$$US-SA-2023SA388903$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240801$$MD$US$US
233019354$23301935$4$F$20230301$20240830$20231215$20240903$EXP$$US-TAKEDA-2023TUS119485$TAKEDA$$60$YR$$F$Y$$$20240903$$CN$US$US
233019413$23301941$3$F$$20240916$20231215$20240927$EXP$$CA-CIPHER-2023-CA-000593$CIPHER$$44$YR$A$F$Y$70$KG$20240927$$HP$CA$CA
233019462$23301946$2$F$$20240719$20231215$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-181376$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240726$$PH$JP$JP
233019493$23301949$3$F$$20240725$20231215$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-181432$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240726$$CN$US$US
233020623$23302062$3$F$20230927$20240717$20231215$20240723$EXP$$AU-TAKEDA-2023TUS092634$TAKEDA$$61$YR$$M$Y$$$20240723$$CN$AU$AU
233021024$23302102$4$F$20230101$20240718$20231215$20240724$EXP$$US-ABBVIE-5346913$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
233021124$23302112$4$F$20240101$20240904$20231215$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-181597$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$71.21$KG$20240908$$CN$US$US
233021522$23302152$2$F$$20231207$20231215$20240806$EXP$$US-AstraZeneca-2023A250667$ASTRAZENECA$$$$$M$Y$81.6$KG$20240806$$CN$US$
233021538$23302153$8$F$20231201$20240617$20231215$20240709$EXP$$US-GSK-US2023AMR175196$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$US$US
233021804$23302180$4$F$$20240205$20231215$20240925$PER$$US-GSK-US2023AMR171884$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$HP$US$US
233022147$23302214$7$F$20230101$20240714$20231215$20240715$EXP$$CA-PFIZER INC-202300254705$PFIZER$$47$YR$$F$Y$$$20240715$$MD$CA$CA
233023014$23302301$4$F$$20240814$20231215$20240823$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US001095$DECIPHERA PHARMACEUTICALS$$48$YR$A$F$Y$$$20240823$$CN$US$US
233023763$23302376$3$F$20231127$20240826$20231215$20240901$PER$$US-BEH-2023166307$CSL BEHRING$$11$YR$C$M$Y$$$20240901$$HP$US$US
233023879$23302387$9$F$$20240701$20231215$20240702$PER$$US-PFIZER INC-PV202300199288$PFIZER$$72$YR$$F$Y$$$20240702$$CN$US$US
233023885$23302388$5$F$20190101$20240906$20231215$20240910$EXP$$US-PFIZER INC-PV202300197180$PFIZER$$60$YR$$F$Y$65.76$KG$20240910$$HP$US$US
233023914$23302391$4$F$20231001$20240827$20231215$20240830$PER$$US-PFIZER INC-PV202300062519$PFIZER$$83$YR$$F$Y$72.57$KG$20240830$$CN$US$US
233025282$23302528$2$F$20221201$20231205$20231215$20240802$EXP$$DE-BAYER-2023A175507$BAYER$$33$YR$A$F$Y$49$KG$20240802$$MD$DE$DE
233025412$23302541$2$F$$20240718$20231215$20240722$EXP$$NVSC2023DE266662$NOVARTIS$Austein T, Sommer MM, Morche M, Finck A. Uncommon diagnosis of malignant Melanoma by bone marrow smear. ONCOL RES TREAT. 2023;46 (Suppl.5):1-354$62$YR$$M$Y$$$20240722$$HP$DE$DE
233025605$23302560$5$F$20240323$20240628$20231215$20240702$EXP$$PR-PFIZER INC-202300443543$PFIZER$$64$YR$$F$Y$$$20240702$$HP$PR$PR
233026133$23302613$3$F$20230101$20240729$20231215$20240731$EXP$$US-PFIZER INC-PV202300200963$PFIZER$$75$YR$$M$Y$78.912$KG$20240731$$CN$US$US
233026193$23302619$3$F$$20240909$20231215$20240913$EXP$$JP-AstraZeneca-2023A281456$ASTRAZENECA$$55$YR$$F$Y$$$20240913$$MD$JP$
233026503$23302650$3$F$$20240920$20231215$20240925$EXP$$CA-TAKEDA-2022TUS071706$TAKEDA$$$$$M$Y$$$20240925$$MD$CA$CA
233026605$23302660$5$F$20240101$20240729$20231215$20240801$EXP$$CL-JNJFOC-20230703311$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240801$$CN$CL$CL
233026712$23302671$2$F$$20240731$20231215$20240801$EXP$$US-TAKEDA-2023TUS063822$TAKEDA$$$$$F$Y$$$20240801$$CN$US$US
233026912$23302691$2$F$$20240814$20231215$20240823$EXP$$CA-APOTEX-2023AP017863$APOTEX$$3$MON$$M$Y$$$20240823$$HP$CA$CA
233026942$23302694$2$F$$20240911$20231215$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-182088$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240912$$CN$US$US
233027213$23302721$3$F$20231006$20240807$20231215$20240821$EXP$$FR-VER-202300032$VERITY PHARMACEUTICALS$$67$YR$E$M$Y$74$KG$20240821$$HP$FR$FR
233028052$23302805$2$F$$20240708$20231215$20240717$EXP$$CA-APOTEX-2023AP017761$APOTEX$$$$$M$Y$$$20240717$$HP$CA$CA
233028762$23302876$2$F$20230101$20240822$20231215$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-179575$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240829$$MD$JP$JP
233030822$23303082$2$F$$20240617$20231215$20240702$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-423615$RANBAXY$Swarowska-Skuza M, Michalski M. Migraine from childhood to adulthood - a clinical case report of a patient who was successfully treated afer 28 years of the disease. Migrena News. 2023;6(2):59-62$36$YR$$F$Y$$$20240702$$HP$PL$PL
233032292$23303229$2$F$$20240909$20231215$20240913$EXP$$JP-AstraZeneca-2023A281397$ASTRAZENECA$$54$YR$$F$Y$$$20240913$$MD$JP$
233032462$23303246$2$F$$20240909$20231215$20240917$EXP$$JP-AstraZeneca-2023A281562$ASTRAZENECA$$42$YR$$F$Y$$$20240917$$MD$JP$
233032625$23303262$5$F$20231129$20240729$20231215$20240731$EXP$$US-KYOWAKIRIN-2023KK020044$KYOWA$$$$$$Y$$$20240731$$HP$US$US
233033074$23303307$4$F$$20240904$20231215$20240911$EXP$$JP-Eisai-EC-2023-154646$EISAI$$$$A$F$Y$$$20240911$$MD$JP$JP
233034462$23303446$2$F$$20240711$20231215$20240719$EXP$$CA-PFIZER INC-202300251153$PFIZER$$$$$$Y$$$20240719$$CN$CA$CA
233035693$23303569$3$F$$20231211$20231215$20240729$EXP$$NVSC2023CA263971$NOVARTIS$$77$YR$$F$Y$$$20240729$$HP$CA$CA
233036222$23303622$2$F$$20231206$20231215$20240925$EXP$$US-NORTHSTAR RX LLC-US-2023NSR000497$NORTHSTAR$Campbell A., Meehl A.. Allopurinol hypersensitivity syndrome complicated by respiratory distress, toxic epidermal necrolysis and multi-organ failure. J. Invest. Med.. 2023;71:7:(57-58)$81$YR$$M$Y$$$20240925$$HP$US$US
233036632$23303663$2$F$$20240703$20231215$20240704$EXP$$CA-BAUSCH-BL-2023-018464$BAUSCH AND LOMB$$56$YR$$F$Y$$$20240704$$HP$CA$CA
233036862$23303686$2$F$$20240731$20231215$20240801$EXP$$CA-BAUSCH-BL-2023-018455$BAUSCH AND LOMB$$55$YR$$F$Y$$$20240801$$CN$CA$CA
233037108$23303710$8$F$20231204$20240625$20231215$20240723$EXP$$CN-009507513-2312CHN004111$MERCK$$51$YR$$M$Y$90$KG$20240723$$MD$CN$CN
233037174$23303717$4$F$20231207$20240829$20231215$20240905$PER$$JP-Eisai-EC-2023-154643$EISAI$$$$E$F$Y$$$20240905$$MD$JP$JP
233039013$23303901$3$F$20220319$20240710$20231215$20240722$EXP$$JP-009507513-2312JPN001378J$MERCK$Oshiro S, Nakamura H, Kuriyama M, Ariyama Y, Saito M, Soga E, et al.. ORIGINAL ARTICLE A report of 15 cases of lenvatinib plus pembrolizumab for advanced endometrial cancer. Tokyo journal of obstetrics and gynecology. 2024;73(2):153-6$66$YR$$F$Y$$$20240719$$MD$JP$JP
2330392410$23303924$10$F$$20240919$20231215$20240923$PER$$US-PFIZER INC-PV202300008953$PFIZER$$23$YR$$F$Y$$$20240923$$MD$US$US
233039262$23303926$2$F$$20240904$20231215$20240906$PER$$US-PFIZER INC-PV202300198122$PFIZER$$60$YR$$F$Y$$$20240906$$HP$US$US
233039274$23303927$4$F$$20240819$20231215$20240826$PER$$US-PFIZER INC-PV202300198014$PFIZER$$75$YR$$F$Y$$$20240826$$CN$US$US
233039323$23303932$3$F$$20240627$20231215$20240701$PER$$US-PFIZER INC-202300441294$PFIZER$$80$YR$$F$Y$$$20240701$$MD$US$US
233039433$23303943$3$F$20231105$20240708$20231215$20240710$PER$$US-PFIZER INC-202300434958$PFIZER$$79$YR$$M$Y$$$20240710$$CN$US$US
233039522$23303952$2$F$20231204$20240910$20231215$20240912$PER$$US-PFIZER INC-PV202200097580$PFIZER$$65$YR$$F$Y$$$20240912$$CN$US$US
233039842$23303984$2$F$20231122$20240103$20231215$20240824$EXP$$US-AstraZeneca-2023A282279$ASTRAZENECA$$27530$DY$$$Y$$$20240823$$CN$US$
233040642$23304064$2$F$$20240801$20231218$20240813$PER$$US-SA-2023SA388684$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
233040733$23304073$3$F$20230101$20240703$20231218$20240712$PER$$US-SA-2023SA387502$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240712$$MD$US$US
233040843$23304084$3$F$$20240919$20231218$20240921$EXP$$CA-ROCHE-3474450$ROCHE$$39$YR$A$F$Y$$$20240921$$HP$CA$CA
233042543$23304254$3$F$$20240917$20231218$20240923$EXP$$CA-SANDOZ INC.-NVSC2023CA027756$SANDOZ$$65$YR$$F$Y$$$20240923$$CN$CA$CA
233043185$23304318$5$F$20230101$20240719$20231218$20240727$EXP$$CA-CELLTRION INC.-2023CA021916$CELLTRION$$$$$$Y$$$20240727$$HP$CA$CA
233043343$23304334$3$F$20231001$20240717$20231218$20240718$EXP$FR-AFSSAPS-RE2023001170$FR-ROCHE-3474802$ROCHE$$42$YR$A$F$Y$70.8$KG$20240718$$PH$FR$FR
2330434914$23304349$14$F$20231201$20240705$20231218$20240710$EXP$$NVSC2023MX264497$NOVARTIS$$46$YR$$M$Y$76$KG$20240710$$CN$MX$MX
233043654$23304365$4$F$20230101$20240718$20231218$20240727$EXP$$US-UNITED THERAPEUTICS-UNT-2023-025829$UNITED THERAPEUTICS$$$$$M$Y$90.703$KG$20240727$$$US$US
233044562$23304456$2$F$$20240724$20231218$20240801$EXP$$PL-TEVA-VS-3136133$TEVA$$27$YR$$F$Y$$$20240801$$CN$PL$PL
233045004$23304500$4$F$$20240913$20231218$20240926$EXP$$US-AUROBINDO-AUR-APL-2023-077244$AUROBINDO$Singh A, Chidharla A, Jain N, Debnath N, Dawoodi I, Kukreja G.. IgD Multiple Myeloma, Does It Still Have a Poor Prognosis.. Blood. 2022;140(supplimen1):12520$63$YR$$F$Y$$$20240926$$MD$US$US
2330453011$23304530$11$F$20231124$20240805$20231218$20240807$EXP$$US-TAKEDA-2023TUS115161$TAKEDA$$56$YR$$M$Y$$$20240807$$CN$US$US
2330453110$23304531$10$F$20230101$20240911$20231218$20240920$EXP$$CA-CELLTRION INC.-2023CA024112$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
233045392$23304539$2$F$20230101$20240912$20231218$20240921$EXP$$CA-CELLTRION INC.-2023CA024086$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
233045642$23304564$2$F$$20240918$20231218$20240924$PER$$NVSC2023US267298$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
233045934$23304593$4$F$$20240814$20231218$20240821$EXP$$US-GSK-US2023AMR173456$GLAXOSMITHKLINE$$$$$F$Y$115$KG$20240821$$CN$US$US
233046252$23304625$2$F$20230922$20240829$20231218$20240909$EXP$IT-MINISAL02-950491$IT-Accord-395349$ACCORD$$73$YR$E$F$Y$64$KG$20240909$$PH$IT$IT
233046584$23304658$4$F$$20240718$20231218$20240724$EXP$$CA-TAKEDA-2023TUS118954$TAKEDA$$$$$M$Y$$$20240724$$MD$CA$CA
233046782$23304678$2$F$$20240912$20231218$20240924$EXP$CA-MHPD-E2B_06604325$CA-Accord-395114$ACCORD$$36$YR$A$F$Y$$$20240924$$HP$CA$CA
233047097$23304709$7$F$20230101$20240821$20231218$20240829$EXP$$CA-CELLTRION INC.-2023CA024132$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
233047822$23304782$2$F$$20240814$20231218$20240816$EXP$$JP-ABBVIE-5536145$ABBVIE$$$$$$Y$$$20240816$$PH$JP$JP
233049194$23304919$4$F$20220424$20240326$20231218$20240814$EXP$$NVSC2022GB096967$NOVARTIS$$57$YR$$M$Y$$$20240814$$CN$GB$GB
233049752$23304975$2$F$20230826$20240917$20231218$20240920$EXP$FR-AFSSAPS-MP2023002276$FR-ELI_LILLY_AND_COMPANY-FR202312007476$ELI LILLY AND CO$$30$YR$A$F$Y$55$KG$20240920$$CN$FR$FR
233050102$23305010$2$F$$20240716$20231218$20240726$EXP$$IT-AUROBINDO-AUR-APL-2019-009211$AUROBINDO$Manuel G, Giovanni P, Claudia T, Icro M. et al.. Can a Low Dosage of Aripiprazole Modify Incentive Salience in Naive Bipolar Patients Who Gamble?.. Addictive Disorders and their Treatment.. 2018$40$YR$$M$Y$$$20240726$$MD$IT$IT
233050274$23305027$4$F$$20240105$20231218$20240905$PER$$NVSC2023US267275$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
233050282$23305028$2$F$20230101$20240911$20231218$20240918$PER$$US-SA-2023SA388003$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240918$$MD$US$US
233050293$23305029$3$F$20230101$20240710$20231218$20240717$PER$$US-SA-2023SA384567$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240717$$MD$US$US
233050362$23305036$2$F$$20240805$20231218$20240814$PER$$US-SA-2023SA384663$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240814$$MD$US$US
233050493$23305049$3$F$20230101$20240917$20231218$20240920$PER$$US-SA-2023SA388169$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240920$$MD$US$US
233051233$23305123$3$F$20240310$20240819$20231218$20240828$PER$$US-SA-2023SA385368$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240828$$MD$US$US
233051523$23305152$3$F$20230809$20240716$20231218$20240729$EXP$$JP-ROCHE-3473925$ROCHE$Ukai T, Kuzuya T, Ohno E, Kawabe N and Hirooka Y A Case of an irAE Pancreatitis, Which Developed During Combination Therapy with Atezolizumab + Bevacizumab for Advanced Hepatocellular Carcinoma.. The 29th Japan Association of Systemic Therapy for HCC 2024;:128-.$73$YR$E$M$Y$78.3$KG$20240729$$MD$JP$JP
233051803$23305180$3$F$20230101$20240701$20231218$20240705$EXP$$JP-JNJFOC-20231241532$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240705$$PH$JP$JP
233052322$23305232$2$F$$20240912$20231218$20240918$EXP$$IT-AMGEN-ITASP2023222963$AMGEN$Gicchino M. F.; Olivieri A. N.; Amodio A. et al.. A real-world experience on the efficacy of biosimilar adoption in children with juvenile idiopathic arthritis. Pediatric Rheumatology. 2023;21 (SUPPL_2):P093$$$$$Y$$$20240918$$HP$IT$IT
233052362$23305236$2$F$20240101$20240829$20231218$20240912$PER$$US-SA-2023SA387906$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240912$$MD$US$US
233052392$23305239$2$F$20231130$20240919$20231218$20240927$EXP$$US-BEH-2023166427$CSL BEHRING$$5$YR$C$M$Y$$$20240927$$CN$US$US
233052432$23305243$2$F$$20240916$20231218$20240925$EXP$$US-ROCHE-3075040$ROCHE$$67$YR$E$F$Y$$$20240925$$MD$US$US
233052778$23305277$8$F$20240701$20240826$20231218$20240902$EXP$$US-GSK-US2023AMR174953$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
233053122$23305312$2$F$$20240913$20231218$20240925$EXP$$DE-AUROBINDO-AUR-APL-2013-00984$AUROBINDO$Hermle L, Simon M, Ruchsow M, Geppert M. Hallucinogen-persisting perception disorder. Therapeutic Advances in Psychopharmacology. 2012;2 (5):199 - 205$33$YR$$F$Y$$$20240925$$MD$DE$DE
233053382$23305338$2$F$20230101$20240808$20231218$20240817$PER$$US-SA-2023SA384759$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240817$$MD$US$US
233053882$23305388$2$F$$20240708$20231218$20240717$PER$$US-SA-2023SA389846$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240717$$CN$US$US
233054222$23305422$2$F$$20240729$20231218$20240806$PER$$US-SA-2023SA390605$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240806$$CN$US$US
233054435$23305443$5$F$20240104$20240301$20231218$20240926$PER$$US-GSK-US2023AMR174136$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240926$$CN$US$US
233054572$23305457$2$F$$20240628$20231218$20240707$EXP$$JP-009507513-2312JPN001307J$MERCK$$65$YR$$F$Y$$$20240707$$MD$JP$JP
233055014$23305501$4$F$$20240925$20231218$20240927$EXP$$NVSC2022GB206864$NOVARTIS$$$$A$F$Y$$$20240927$$CN$GB$GB
233055052$23305505$2$F$$20240910$20231218$20240913$EXP$$NVSC2023US264795$NOVARTIS$$$$$F$Y$$$20240913$$HP$US$US
233055112$23305511$2$F$$20240829$20231218$20240902$EXP$$NVSC2023US265844$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
233055183$23305518$3$F$$20240828$20231218$20240902$PER$$US-ROCHE-3474286$ROCHE$$88$YR$E$M$Y$$$20240902$$HP$US$US
233055782$23305578$2$F$20230713$20240718$20231218$20240730$EXP$$IN-SANDOZ INC.-SDZ2023IN068711$SANDOZ$$50$YR$$F$Y$$$20240730$$CN$IN$IN
233055843$23305584$3$F$20080101$20240903$20231218$20240911$EXP$$US-ABBVIE-5454431$ABBVIE$$$$$M$Y$104$KG$20240911$$CN$US$US
233055863$23305586$3$F$$20240912$20231218$20240916$EXP$$CA-SANDOZ INC.-SDZ2023CA068511$SANDOZ$$68$YR$$M$Y$$$20240916$$CN$CA$CA
233056307$23305630$7$F$20230101$20240814$20231218$20240821$EXP$$CA-JNJFOC-20230464844$JOHNSON AND JOHNSON$$28$YR$A$F$Y$98$KG$20240821$$HP$CA$CA
233057395$23305739$5$F$20231116$20240911$20231218$20240920$EXP$$CA-CELLTRION INC.-2023CA023777$CELLTRION$$$$$$Y$$$20240920$$CN$CA$CA
233057404$23305740$4$F$20180419$20240801$20231218$20240809$EXP$$CA-TAKEDA-2018TUS009623$TAKEDA$$29$YR$$M$Y$$$20240809$$MD$CA$CA
233057812$23305781$2$F$20221013$20240711$20231218$20240723$EXP$$BE-AUROBINDO-AUR-APL-2023-077693$AUROBINDO$$73$YR$$M$Y$68.7$KG$20240723$$MD$BE$BE
233058132$23305813$2$F$$20240912$20231218$20240923$EXP$CA-MHPD-E2B_06620819$CA-Accord-394691$ACCORD$$64$YR$A$M$Y$$$20240923$$MD$CA$CA
233058857$23305885$7$F$20240222$20240809$20231218$20240813$EXP$$GB-TAKEDA-2023TUS120913$TAKEDA$$24$YR$$M$Y$$$20240813$$CN$GB$GB
233059342$23305934$2$F$20231203$20240806$20231218$20240813$EXP$$US-ROCHE-3147020$ROCHE$$40$YR$A$F$Y$$$20240814$$CN$US$US
233060053$23306005$3$F$20231214$20240701$20231218$20240705$EXP$$JP-TAKEDA-2023TJP016836$TAKEDA$$78$YR$$M$Y$58.5$KG$20240705$$MD$JP$JP
233060403$23306040$3$F$20230101$20240711$20231218$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-181825$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240717$$HP$US$US
233060794$23306079$4$F$$20240920$20231218$20240930$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2023-182311$BRISTOL MYERS SQUIBB$$78$YR$E$$Y$$$20240930$$HP$CZ$CZ
233061253$23306125$3$F$20231101$20240628$20231218$20240703$EXP$$US-UCBSA-2023058704$UCB$$49$YR$$F$Y$$$20240703$$HP$US$US
233061412$23306141$2$F$$20240812$20231218$20240823$EXP$$US-APOTEX-2023AP018022$APOTEX$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$56$YR$$M$Y$$$20240823$$MD$US$US
233061442$23306144$2$F$$20240708$20231218$20240715$EXP$$US-ABBVIE-5541386$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
233061632$23306163$2$F$20230108$20231203$20231218$20240723$EXP$FR-AFSSAPS-AVPA2023000694$FR-TEVA-VS-3136025$TEVA$$35$YR$$M$Y$$$20240723$$MD$FR$FR
233061713$23306171$3$F$20230801$20240718$20231218$20240725$EXP$$CO-AMGEN-COLSL2023224604$AMGEN$$68$YR$E$F$Y$$$20240725$$CN$CO$CO
233061874$23306187$4$F$$20240829$20231218$20240907$30DAY$$US-GSK-US2023173953$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$CN$US$US
233062522$23306252$2$F$$20240815$20231218$20240829$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2023-182258$BRISTOL MYERS SQUIBB$$65$YR$E$$Y$$$20240829$$HP$CZ$CZ
233062714$23306271$4$F$$20240711$20231218$20240722$30DAY$$PL-JNJFOC-20231184120$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$PL$PL
233063196$23306319$6$F$20231001$20240724$20231218$20240801$EXP$$US-SA-2023SA338151$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240801$$MD$US$US
233063233$23306323$3$F$20230101$20240621$20231218$20240702$EXP$$JP-ROCHE-3474843$ROCHE$$8$DEC$E$M$Y$$$20240702$$MD$JP$JP
233063315$23306331$5$F$20231120$20240918$20231218$20240925$EXP$$NVSC2023GB252530$NOVARTIS$$51$YR$$F$Y$$$20240925$$CN$GB$GB
233063843$23306384$3$F$20231018$20240911$20231218$20240920$EXP$$CA-CELLTRION INC.-2023CA020653$CELLTRION$$$$$$Y$$$20240920$$CN$CA$CA
233064402$23306440$2$F$$20231208$20231218$20240701$PER$$US-LEO Pharma-365995$LEO PHARM$$76$YR$$M$Y$$$20240701$$HP$US$US
233064613$23306461$3$F$20220930$20240819$20231218$20240902$EXP$$US-UCBSA-2022053444$UCB$$2$YR$$M$Y$$$20240902$$CN$US$US
233064732$23306473$2$F$$20240812$20231218$20240823$EXP$$US-APOTEX-2023AP018147$APOTEX$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$76$YR$$M$Y$$$20240823$$MD$US$US
233064763$23306476$3$F$20231130$20240729$20231218$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-178102$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240801$$CN$US$US
233064774$23306477$4$F$20230213$20240801$20231218$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-182828$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$61$KG$20240807$$MD$JP$JP
233064912$23306491$2$F$$20240812$20231218$20240823$EXP$$US-APOTEX-2023AP018150$APOTEX$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$55$YR$$F$Y$$$20240823$$MD$US$US
233065342$23306534$2$F$$20240812$20231218$20240822$EXP$$US-APOTEX-2023AP018148$APOTEX$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$51$YR$$F$Y$$$20240822$$MD$US$US
233065382$23306538$2$F$$20240812$20231218$20240823$EXP$$US-APOTEX-2023AP018151$APOTEX$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$70$YR$$M$Y$$$20240823$$MD$US$US
233065733$23306573$3$F$$20240626$20231218$20240712$30DAY$$US-VIIV HEALTHCARE LIMITED-US2023174652$VIIV$$$$$M$Y$$$20240712$$MD$US$US
233065813$23306581$3$F$20180901$20240723$20231218$20240802$EXP$$CA-AUROBINDO-AUR-APL-2023-077596$AUROBINDO$Driedger M, Teo I, Roth V.. Leprosy with type 1 reaction in a patient from Ontario, Canada without recent travel misdiagnosed as vasculitic neuropathy: a case report.. BMC Infectious Diseases.. 2023;23:815:1-7$84$YR$$M$Y$$$20240802$$MD$CA$CA
233065982$23306598$2$F$20231115$20240729$20231218$20240730$PER$$US-JNJFOC-20231227371$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240730$$CN$US$US
233066502$23306650$2$F$$20231206$20231218$20240711$EXP$$US-AVET LIFESCIENCES LTD-2023-AVET-000379$EMCURE$Westbroek ML, Rahim MQ, Ross MM, Rahrig AL.. A fluid relationship: Calcineurin inhibitors and pericardial effusions.. Pediatric Transplantation. 2023;e14672$1$YR$$M$Y$$$20240711$$HP$US$US
233067554$23306755$4$F$$20240822$20231218$20240904$EXP$$US-INSMED, INC.-2023-04731-US$INSMED$$$$$F$Y$$$20240904$$CN$US$US
233067953$23306795$3$F$20231208$20240724$20231218$20240806$EXP$$US-UCBSA-2023058502$UCB$$61$YR$$M$Y$$$20240807$$CN$US$US
233068053$23306805$3$F$20231001$20240823$20231218$20240904$EXP$$US-INSMED, INC.-2023-04092-US$INSMED$$85$YR$$F$Y$$$20240904$$CN$US$US
233068775$23306877$5$F$20230101$20240912$20231218$20240921$EXP$$CA-CELLTRION INC.-2023CA014414$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
233068833$23306883$3$F$$20240610$20231218$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005407$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
2330689110$23306891$10$F$20230103$20240911$20231218$20240919$EXP$$CA-CELLTRION INC.-2023CA000612$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
233069072$23306907$2$F$20231206$20240812$20231218$20240823$EXP$$DE-NOVOPROD-1152068$NOVO NORDISK$$61$YR$$M$Y$72$KG$20240823$$CN$DE$DE
233070843$23307084$3$F$20231125$20240719$20231218$20240809$PER$$CA-TOLMAR, INC.-23CA044863$TOLMAR$$85$YR$$M$Y$$$20240809$$CN$CA$CA
233070854$23307085$4$F$20231125$20240807$20231218$20240830$PER$$CA-TOLMAR, INC.-23CA045055$TOLMAR$$81$YR$$M$Y$$$20240830$$CN$CA$CA
233070883$23307088$3$F$20231116$20240706$20231218$20240726$PER$$CA-TOLMAR, INC.-23CA045064$TOLMAR$$91$YR$$M$Y$$$20240726$$CN$CA$CA
233071442$23307144$2$F$$20240729$20231218$20240812$EXP$$US-AUROBINDO-AUR-APL-2023-077657$AUROBINDO$Quo SW, Mederos N, Parianos M, Idrisov E.. Significant esophageal and intestiinal ulcerations in the setting of recent chemotherapy for pancreatic adenocarcinoma.. Gastroenterology. 2023;164(6)Supplemen:S-1209-10$72$YR$$M$Y$$$20240812$$MD$US$US
2330719311$23307193$11$F$20220101$20240919$20231218$20240928$EXP$$CA-CELLTRION INC.-2022CA015327$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
233072013$23307201$3$F$20220601$20240724$20231218$20240731$EXP$$PA-SANDOZ INC.-NVSC2022PA297759$SANDOZ$$49$YR$$F$Y$42$KG$20240731$$CN$PA$PA
233072116$23307211$6$F$20231129$20240818$20231218$20240822$EXP$$CA-JNJFOC-20231137242$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240822$$HP$CA$CA
233072769$23307276$9$F$20220511$20240611$20231218$20240703$EXP$$DE-ROCHE-3124348$ROCHE$$45$YR$A$F$Y$$$20240703$$CN$DE$DE
233072887$23307288$7$F$20210501$20240920$20231218$20240930$EXP$$CA-CELLTRION INC.-2021CA004045$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
233073102$23307310$2$F$$20240624$20231218$20240701$EXP$$TH-TAKEDA-2023TUS120388$TAKEDA$$49$YR$$M$Y$$$20240701$$CN$TH$TH
233073175$23307317$5$F$20230713$20240709$20231218$20240715$EXP$$US-ASTELLAS-2023US037347$ASTELLAS$$81$YR$$M$Y$$$20240715$$CN$US$US
233074903$23307490$3$F$$20240724$20231218$20240729$EXP$$GB-MYLANLABS-2023M1133828$MYLAN$$$$$M$Y$$$20240729$$HP$GB$GB
233075083$23307508$3$F$$20240827$20231218$20240828$PER$$US-ALXN-A202302783$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
233075333$23307533$3$F$20230101$20240701$20231218$20240708$EXP$$NVSC2023BR266838$NOVARTIS$$$$$M$Y$$$20240708$$CN$BR$BR
233075854$23307585$4$F$$20240815$20231218$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-180873$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240820$$HP$US$US
233076282$23307628$2$F$$20231205$20231218$20240807$EXP$$DE-BAYER-2023A175489$BAYER$$52$YR$A$F$Y$$$20240807$$MD$DE$DE
233076592$23307659$2$F$$20240917$20231218$20240918$PER$$NVSC2023US268427$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
233076972$23307697$2$F$20221201$20231206$20231218$20240725$EXP$$FR-AUROBINDO-AUR-APL-2023-077653$AUROBINDO$Assier H, Matei I, Weill A, Hareth KB, Ingen-Housz-Oro S. DRESS to loxapine and avoidable recurrence with clozapine. Contact Dermatitis.. Contact Dermatitis. 2023;1-2$24$YR$$F$Y$$$20240725$$MD$FR$FR
233077007$23307700$7$F$$20240729$20231218$20240731$EXP$$CA-TAKEDA-2023TUS119744$TAKEDA$$$$$M$Y$$$20240731$$CN$CA$CA
233077613$23307761$3$F$20231208$20240624$20231218$20240701$EXP$$AR-GSK-AR2023AMR129921$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$AR$AR
233077626$23307762$6$F$20240601$20240917$20231218$20240925$EXP$$CO-GSK-CO2023AMR174517$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$CO$CO
233077782$23307778$2$F$20231123$20231214$20231218$20240918$EXP$FR-AFSSAPS-AM2023001095$FR-BAUSCH-BL-2023-018795$BAUSCH AND LOMB$$66$YR$$F$Y$52$KG$20240918$$MD$FR$FR
233078134$23307813$4$F$20230804$20240705$20231218$20240709$EXP$$CA-TAKEDA-2023TUS120136$TAKEDA$$41$YR$$F$Y$165$KG$20240709$$CN$CA$CA
233078323$23307832$3$F$20220330$20240808$20231218$20240812$EXP$$US-TAKEDA-2022TUS022227$TAKEDA$$56$YR$$F$Y$102$KG$20240812$$MD$US$US
233078604$23307860$4$F$20230901$20240820$20231218$20240830$EXP$$US-INSMED, INC.-2023-04784-US$INSMED$$89$YR$$M$Y$$$20240830$$CN$US$US
233078922$23307892$2$F$20220905$20240806$20231218$20240812$EXP$$US-OTSUKA-2022_039407$OTSUKA$$23$YR$$F$Y$$$20240812$$CN$US$US
233079515$23307951$5$F$$20240819$20231218$20240819$EXP$$US-PFIZER INC-PV202300203178$PFIZER$$68$YR$$M$Y$126.98$KG$20240819$$CN$US$US
233079743$23307974$3$F$20230101$20240726$20231218$20240805$EXP$$JP-009507513-2312JPN001591J$MERCK$Tsuboi M, Miyagi T, and Takahashi K.. 102 A case of severe drug eruption caused by pembrolizumab.. The 53rd Annual Meeting of the Japanese Society for Cutaneous Immunology and All. 222$55$YR$$M$Y$$$20240805$$MD$JP$JP
233079993$23307999$3$F$$20240815$20231218$20240911$EXP$$US-BEH-2023166282$CSL BEHRING$$$$E$F$Y$$$20240911$$CN$US$US
233080143$23308014$3$F$$20240719$20231218$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-182492$BRISTOL MYERS SQUIBB$Tanaka I, Tyou S?Kubo K. A case of difficult-to-diagnose primary esophageal melanoma with a fulfilment course. The 76th Meeting and General Assembly of South Hokkaido Medical Association (Programs and Abstracts).2023;:20{-}.:$6$DEC$A$F$Y$$$20240725$$MD$JP$JP
233080764$23308076$4$F$20231204$20240821$20231218$20240828$EXP$CA-MMM-T8FVB69X$CA-GSK-CA2023108033$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$CA$CA
233081012$23308101$2$F$20231209$20240625$20231218$20240701$EXP$$CA-PFIZER INC-202300445007$PFIZER$$34$YR$$F$Y$$$20240701$$HP$CA$CA
233081182$23308118$2$F$$20240920$20231218$20240920$EXP$$CA-PFIZER INC-202300442865$PFIZER$$38$YR$$F$Y$$$20240920$$HP$CA$CA
233081432$23308143$2$F$$20240629$20231218$20240703$EXP$$NVSC2023AU263439$NOVARTIS$$$$$F$Y$$$20240703$$MD$AU$AU
233082357$23308235$7$F$20240101$20240814$20231218$20240822$EXP$$US-INSMED, INC.-2023-03813-US$INSMED$$$$$F$Y$$$20240822$$CN$US$US
233082412$23308241$2$F$20231023$20240705$20231218$20240718$EXP$$US-ORPHANEU-2023008885$RECORDATI$$$$$$Y$$$20240718$$CN$US$US
233082894$23308289$4$F$20230101$20240731$20231218$20240806$EXP$$US-SA-2023SA385586$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240806$$MD$US$US
233083155$23308315$5$F$20231121$20240830$20231218$20240923$PER$$US-SA-2023SA382779$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240923$$MD$US$US
233084007$23308400$7$F$20231218$20240705$20231218$20240715$PER$$US-SA-2023SA387985$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240715$$MD$US$US
233084232$23308423$2$F$$20240729$20231218$20240807$PER$$US-SA-2023SA388554$SANOFI AVENTIS$$$$A$M$Y$99.79$KG$20240807$$MD$US$US
233084585$23308458$5$F$20230101$20240717$20231218$20240724$EXP$$US-SA-2023SA389473$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240724$$MD$US$US
233085672$23308567$2$F$20230101$20240708$20231218$20240716$EXP$$US-ABBVIE-5541553$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
233087238$23308723$8$F$$20240909$20231218$20240912$EXP$$CA-TAKEDA-2022TUS050560$TAKEDA$$$$$F$Y$$$20240912$$MD$CA$CA
233087363$23308736$3$F$20230901$20240710$20231218$20240725$EXP$$JP-Eisai-EC-2023-149180$EISAI$Oshiro Sakiko. The 406th Meeting of Tokyo Society of Obstetrics and Gynecology.$63$YR$A$F$Y$$$20240725$$MD$JP$JP
233087394$23308739$4$F$20231001$20240731$20231218$20240809$EXP$$JP-ROCHE-3450915$ROCHE$$7$DEC$E$M$Y$$$20240809$$MD$JP$JP
233087844$23308784$4$F$20230101$20240911$20231218$20240918$PER$$JP-Eisai-EC-2023-155177$EISAI$$73$YR$E$M$Y$$$20240918$$MD$JP$JP
233088274$23308827$4$F$20240317$20240924$20231218$20240926$PER$$US-PFIZER INC-PV202300200134$PFIZER$$57$YR$$F$Y$$$20240926$$HP$US$US
233088332$23308833$2$F$$20240802$20231218$20240806$PER$$US-PFIZER INC-PV202300199479$PFIZER$$61$YR$$M$Y$$$20240806$$HP$US$US
233089375$23308937$5$F$$20240826$20231218$20240830$EXP$$US-TAKEDA-2023TUS119821$TAKEDA$$$$$F$Y$$$20240830$$CN$US$US
233090145$23309014$5$F$20240112$20240815$20231218$20240821$EXP$$US-GSK-US2023172514$GLAXOSMITHKLINE$$51$YR$$F$Y$131$KG$20240821$$CN$US$US
2330902310$23309023$10$F$20230321$20240920$20231218$20240925$EXP$$US-TAKEDA-2023TUS032302$TAKEDA$$37$YR$$F$Y$$$20240925$$MD$US$US
233092246$23309224$6$F$20231215$20240807$20231218$20240815$EXP$$CA-TAKEDA-2022TUS094504$TAKEDA$$86$YR$$M$Y$$$20240815$$CN$CA$CA
233092406$23309240$6$F$$20240906$20231218$20240910$EXP$$ES-MYLANLABS-2023M1132357$MYLAN$Pena M, Montane C, Paviglianiti A, Hurtado L, Gonzalez S, Carro I, Maluquer C, Domingo-Domenech E, Gonzalez-Barca E, Sureda A and Mussetti A. Outcomes of allogeneic hematopoietic cell transplantation after bispecific antibodies in non-Hodgkin lymphomas. Bone Marrow Transplantation. 2023;58 (11):1282-5$57$YR$$M$Y$$$20240910$$HP$ES$ES
233093032$23309303$2$F$$20240828$20231218$20240904$PER$$US-PFIZER INC-PV202300203435$PFIZER$$77$YR$$F$Y$$$20240904$$MD$US$US
2330934715$23309347$15$F$20230101$20240916$20231218$20240924$EXP$$CA-KARYOPHARM-2023KPT002194$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240924$$CN$CA$CA
233094112$23309411$2$F$$20240816$20231218$20240827$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2023-182548$BRISTOL MYERS SQUIBB$$75$YR$E$$Y$$$20240827$$HP$CZ$CZ
233094444$23309444$4$F$20231211$20240927$20231218$20240930$EXP$$KR-MYLANLABS-2023M1133036$MYLAN$$67$YR$$M$Y$68.5$KG$20240930$$HP$KR$KR
233094543$23309454$3$F$20220901$20240710$20231218$20240717$EXP$$JP-009507513-2306JPN004405J$MERCK$Oshiro S, Nakamura H, Kuriyama M, Ariyama Y, Saito M, Soga E, et al.. ORIGINAL ARTICLE Oshiro A report of 15 cases of lenvatinib plus pembrolizumab for advanced endometrial cancer. Tokyo journal of obstetrics and gynecology. 2024;73(2):153-6$63$YR$$F$Y$$$20240717$$MD$JP$JP
233094994$23309499$4$F$$20240826$20231218$20240829$PER$$US-PFIZER INC-PV202300089045$PFIZER$$69$YR$$F$Y$$$20240829$$CN$US$US
233095803$23309580$3$F$20240531$20240703$20231218$20240704$EXP$$AR-PFIZER INC-PV202300201842$PFIZER$$73$YR$$M$Y$$$20240704$$CN$AR$AR
233097072$23309707$2$F$$20240701$20231218$20240806$PER$$US-GALDERMA-US2023017706$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
233097909$23309790$9$F$20231210$20240829$20231218$20240830$EXP$$US-TAKEDA-2023TUS120063$TAKEDA$$55$YR$$F$Y$98$KG$20240830$$HP$US$US
233098032$23309803$2$F$20200921$20240723$20231218$20240730$EXP$$IE-SHIRE-IE202031035$TAKEDA$$30$YR$$F$Y$$$20240730$$CN$IE$IE
233098044$23309804$4$F$20231201$20240724$20231218$20240729$EXP$$JP-009507513-2312JPN001839J$MERCK$$69$YR$$M$Y$$$20240729$$PH$JP$JP
233098313$23309831$3$F$20220319$20240710$20231218$20240718$PER$$JP-Eisai-EC-2023-154753$EISAI$Oshiro S. A study of 15 cases of advanced or recurrent endometrial cancer treated with Lenvatinib/Pembrolizumab combination therapy. Tokyo Journal of Obstetrics and Gynecology. 2024;(73(2)): 153-156.$66$YR$E$F$Y$$$20240718$$MD$JP$JP
233098443$23309844$3$F$$20240626$20231218$20240715$PER$$US-JNJFOC-20231246980$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$MD$US$US
233099372$23309937$2$F$$20240904$20231218$20240906$PER$$US-PFIZER INC-202300434860$PFIZER$$47$YR$$M$Y$99.79$KG$20240906$$CN$US$US
233099603$23309960$3$F$20231212$20240730$20231218$20240805$EXP$$GB-MYLANLABS-2023M1133954$MYLAN$$40$YR$$M$Y$$$20240805$$MD$GB$GB
2330996124$23309961$24$F$20230101$20240705$20231218$20240709$EXP$$GB-MYLANLABS-2023M1134176$MYLAN$$$$$F$Y$$$20240709$$MD$GB$GB
233099682$23309968$2$F$$20240709$20231218$20240716$EXP$$US-BIOMARINAP-US-2023-154534$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
233099775$23309977$5$F$20230424$20240910$20231218$20240912$EXP$$GR-PFIZER INC-202300211241$PFIZER$$74$YR$$M$Y$64$KG$20240912$$MD$GR$GR
233101013$23310101$3$F$20231204$20240725$20231218$20240726$EXP$$CA-JNJFOC-20231242730$JOHNSON AND JOHNSON$$47$YR$A$F$Y$99$KG$20240726$$HP$CA$CA
233101312$23310131$2$F$$20240903$20231218$20240910$EXP$$CA-TAKEDA-2023TUS120201$TAKEDA$$$$$F$Y$$$20240910$$CN$CA$CA
233101385$23310138$5$F$20240828$20240828$20231218$20240830$EXP$$CA-TAKEDA-2023TUS038144$TAKEDA$$66$YR$$M$Y$$$20240830$$CN$CA$CA
233101913$23310191$3$F$$20240909$20231218$20240913$EXP$$JP-009507513-2312JPN001848J$MERCK$$$$$M$Y$$$20240913$$MD$JP$JP
233105638$23310563$8$F$20231112$20240807$20231218$20240819$EXP$$US-BEH-2023166453$CSL BEHRING$$18$YR$A$M$Y$$$20240819$$HP$US$US
233106155$23310615$5$F$$20240820$20231218$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-181961$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240829$$HP$US$US
233106183$23310618$3$F$20230527$20240716$20231218$20240731$EXP$$JP-AMGEN-JPNNI2023224769$AMGEN$$32$YR$A$M$Y$112.1$KG$20240731$$MD$JP$JP
233106472$23310647$2$F$$20240812$20231218$20240823$EXP$$US-APOTEX-2023AP018144$APOTEX$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$59$YR$$M$Y$$$20240823$$MD$US$US
233107093$23310709$3$F$$20240819$20231218$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-182457$BRISTOL MYERS SQUIBB$Misaki M, Ota M, Horisaki K, Akanabe H, Mori S, Akiyama M. A case of severe meningitis and liver disorder due to nivolumab/ipilimumab combination therapy for malignant melanoma. The 306th Meeting of the Tokai Division of Japanese Dermatological Association. 2023;13.$46$YR$A$M$Y$$$20240821$$MD$JP$JP
233107365$23310736$5$F$20231122$20240726$20231218$20240801$PER$$US-SA-2023SA386323$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240801$$MD$US$US
233110612$23311061$2$F$$20240806$20231218$20240807$PER$$NVSC2023US265584$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
233111853$23311185$3$F$20230101$20240716$20231219$20240718$EXP$$US-ABBVIE-5488483$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
233112904$23311290$4$F$20140301$20240805$20231219$20240813$EXP$JP-MMM-TYQD1VFW$JP-ABBVIE-5502896$ABBVIE$$58$YR$$F$Y$52$KG$20240813$$MD$JP$JP
233113223$23311322$3$F$20230101$20240711$20231219$20240717$PER$$US-AMGEN-USASP2023224987$AMGEN$$63$YR$A$F$Y$$$20240717$$CN$US$US
233113282$23311328$2$F$20230911$20240802$20231219$20240808$EXP$$ES-ABBVIE-5538701$ABBVIE$$58$YR$$M$Y$95$KG$20240808$$MD$ES$ES
233115342$23311534$2$F$$20240812$20231219$20240823$EXP$$US-APOTEX-2023AP018143$APOTEX$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al.. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$64$YR$$F$Y$$$20240823$$MD$US$US
233115752$23311575$2$F$$20240716$20231219$20240723$EXP$$SA-IPCA LABORATORIES LIMITED-IPC-2023-SA-002229$IPCA$Heba Alshammari, Alhanouf Alessa, Yasmin Elsharawy, et.al. Excessively high chronic propranolol overdose in infantile hemangioma: a case report. Am J Case Rep. 2023;24(e941765):1-5$$$$$Y$$$20240723$$HP$SA$SA
233115883$23311588$3$F$20230101$20240729$20231219$20240807$PER$$US-SA-2023SA387183$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240807$$MD$US$US
233115974$23311597$4$F$20220318$20240709$20231219$20240718$EXP$$DE-TEVA-VS-3135427$TEVA$$53$YR$$M$Y$115$KG$20240718$$MD$DE$DE
233116182$23311618$2$F$20230801$20240625$20231219$20240703$EXP$$DE-CELLTRION INC.-2023DE023760$CELLTRION$$$$$$Y$$$20240703$$MD$DE$DE
233117102$23311710$2$F$$20240812$20231219$20240827$PER$$US-SA-2023SA386663$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240827$$MD$US$US
233117192$23311719$2$F$20221115$20240807$20231219$20240815$PER$$US-SA-2023SA392385$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240815$$CN$US$US
233117294$23311729$4$F$20231101$20240708$20231219$20240712$PER$$US-SA-2023SA391293$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
233117322$23311732$2$F$20230101$20240731$20231219$20240808$PER$$US-SA-2023SA391383$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240808$$MD$US$US
233117434$23311743$4$F$$20240722$20231219$20240729$EXP$$US-SA-2023SA390606$SANOFI AVENTIS$$44$YR$A$F$Y$79.5$KG$20240729$$MD$US$US
233118222$23311822$2$F$$20240812$20231219$20240823$EXP$$US-APOTEX-2023AP018141$APOTEX$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$62$YR$$M$Y$$$20240823$$MD$US$US
233118463$23311846$3$F$$20240812$20231219$20240823$EXP$$US-APOTEX-2023AP018142$APOTEX$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$69$YR$$M$Y$$$20240823$$MD$US$US
233118474$23311847$4$F$20231122$20240920$20231219$20240928$EXP$$FR-AUROBINDO-AUR-APL-2023-078331$AUROBINDO$$45$YR$$F$Y$$$20240928$$MD$FR$FR
233118672$23311867$2$F$$20240903$20231219$20240911$EXP$$CA-JNJFOC-20221149182$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240911$$HP$CA$CA
233119582$23311958$2$F$$20231211$20231219$20240928$EXP$$CA-CELLTRION INC.-2023CA024222$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
233119772$23311977$2$F$$20231214$20231219$20240711$EXP$$US-TEVA-VS-3136103$TEVA$$$$$M$Y$$$20240711$$CN$US$US
233120173$23312017$3$F$20230101$20240924$20231219$20240928$EXP$$FR-SANDOZ INC.-NVSC2023FR100637$SANDOZ$$52$YR$$F$Y$$$20240928$$MD$FR$FR
233120273$23312027$3$F$20220724$20240715$20231219$20240724$EXP$$ES-AUROBINDO-AUR-APL-2023-078277$AUROBINDO$$62$YR$$M$Y$68$KG$20240724$$MD$ES$ES
233120623$23312062$3$F$$20240703$20231219$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-183631$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240704$$HP$US$US
233122452$23312245$2$F$$20231209$20231219$20240731$EXP$$CA-SA-2023SA391524$SANOFI AVENTIS$$$$$F$Y$$$20240731$$HP$CA$CA
233122476$23312247$6$F$20230401$20240730$20231219$20240806$EXP$$CA-AMGEN-CANSL2023222191$AMGEN$$53$YR$A$M$Y$$$20240806$$MD$CA$CA
233123939$23312393$9$F$$20240910$20231219$20240916$EXP$$US-TAKEDA-2023TUS118310$TAKEDA$$$$$F$Y$61$KG$20240916$$HP$US$US
233124208$23312420$8$F$20240507$20240829$20231219$20240906$EXP$$CA-CELLTRION INC.-2023CA024136$CELLTRION$$$$$$Y$$$20240906$$CN$CA$CA
233125702$23312570$2$F$$20240812$20231219$20240823$EXP$$US-APOTEX-2023AP018146$APOTEX$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$63$YR$$M$Y$$$20240823$$MD$US$US
233125717$23312571$7$F$20231208$20240812$20231219$20240820$EXP$$CA-CELLTRION INC.-2023CA024202$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
233126572$23312657$2$F$$20240812$20231219$20240823$EXP$$US-APOTEX-2023AP018145$APOTEX$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$60$YR$$F$Y$$$20240823$$MD$US$US
233127062$23312706$2$F$$20240812$20231219$20240823$EXP$$US-APOTEX-2023AP018149$APOTEX$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$74$YR$$M$Y$$$20240823$$MD$US$US
233127204$23312720$4$F$20231129$20240806$20231219$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-180932$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240808$$HP$US$US
233127712$23312771$2$F$$20240827$20231219$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-183127$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$PH$JP$JP
233128212$23312821$2$F$$20240620$20231219$20240702$EXP$$CA-APOTEX-2023AP017898$APOTEX$$5$YR$$F$Y$20$KG$20240702$$HP$CA$CA
233130252$23313025$2$F$$20240806$20231219$20240809$PER$$US-PFIZER INC-202300224065$PFIZER$$65$YR$$F$Y$$$20240809$$CN$US$US
233130286$23313028$6$F$$20240620$20231219$20240701$EXP$$CA-APOTEX-2023AP006278$APOTEX$$64$YR$$F$Y$$$20240701$$PH$CA$CA
233130603$23313060$3$F$$20240725$20231219$20240731$PER$$US-PFIZER INC-PV202300200779$PFIZER$$57$YR$$F$Y$$$20240731$$CN$US$US
233131043$23313104$3$F$$20240718$20231219$20240727$EXP$$JP-ABBVIE-5538728$ABBVIE$Sakamoto R, Fujita S, Nagatsuka Y, et al. 035 A case of atopic dermatitis with rapid rise in serum TARC and erythroderma due to administration of JAK inhibitor. The 53rd Annual Meeting of the Japanese Society for Cutaneous Immunology and Allergy (JSCIA) (2023), 205-205.; Sakamoto R, Fujita S, Nagatsuka Y, et al. 035 A case of atopic dermatitis with rapid rise in serum TARC and erythroderma due to administration of JAK inhibitor. The 53rd Annual Meeting of the Japanese Society for Cutaneous Im...$10$YR$$F$Y$$$20240727$$MD$JP$JP
233131172$23313117$2$F$$20240627$20231219$20240701$PER$$US-PFIZER INC-202300445217$PFIZER$$24$YR$$M$Y$67.59$KG$20240701$$CN$US$US
233131353$23313135$3$F$20231113$20240702$20231219$20240704$PER$$US-PFIZER INC-202300442835$PFIZER$$69$YR$$F$Y$68.95$KG$20240704$$CN$US$US
233132022$23313202$2$F$20230101$20240629$20231219$20240708$PER$$US-SA-2023SA330968$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240708$$MD$US$US
233132372$23313237$2$F$20230101$20240830$20231219$20240924$PER$$US-SA-2023SA389043$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240924$$MD$US$US
233133213$23313321$3$F$$20240816$20231219$20240828$PER$$US-SA-2023SA389889$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240828$$MD$US$US
233133233$23313323$3$F$$20240709$20231219$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-182071$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240710$$CN$US$US
233133382$23313338$2$F$$20231208$20231219$20240704$EXP$GB-MYLANLABS-2023M1128812$GB-TORRENT-00034341$TORRENT$$$$$F$Y$$$20240704$$MD$GB$GB
233133913$23313391$3$F$20231122$20240923$20231219$20240925$EXP$FR-AFSSAPS-AN2023001586$FR-PFIZER INC-202300442168$PFIZER$$45$YR$$F$Y$$$20240925$$MD$FR$FR
233134997$23313499$7$F$20230901$20240909$20231219$20240916$EXP$$NVSC2023GB227243$NOVARTIS$$$$A$M$Y$$$20240916$$CN$GB$GB
233135472$23313547$2$F$$20240624$20231219$20240702$EXP$$JP-AMGEN-JPNSP2023222049$AMGEN$Udeda R.; Watanabe K.; Asai M. et al.. Investigation of Efficacy and Safety of Sotorasib for KRAS Gene G12C Mutation-Positive Lung Cancer in Our Hospital. Japanese Journal of Lung Cancer. 2023;63 (5):615$$$$$Y$$$20240702$$HP$JP$JP
233136985$23313698$5$F$20230101$20240712$20231219$20240717$PER$$US-SA-2023SA387011$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240717$$MD$US$US
233137114$23313711$4$F$$20240722$20231219$20240723$EXP$$US-PFIZER INC-202300444260$PFIZER$$84$YR$$F$Y$$$20240723$$CN$US$US
233138233$23313823$3$F$20231205$20240710$20231219$20240713$PER$$US-AMGEN-USASP2023226103$AMGEN$$73$YR$E$M$Y$$$20240713$$CN$US$US
233139415$23313941$5$F$20230101$20240715$20231219$20240722$EXP$$US-PFIZER INC-202300360811$PFIZER$$68$YR$$F$Y$$$20240722$$CN$US$US
233139783$23313978$3$F$$20240904$20231219$20240916$EXP$$IT-AMGEN-ITASP2023224333$AMGEN$Caorsi, R.. Relapsing macrophage activation syndrome rescued by treatment with MAS825, an anti-il1 and Il-18 monoclonal antibody, in two patients with systemic onset juvenile idiopathic arthritis. Pediatric Rheumatology. 2023;21(Suppl2):111-112$20$YR$A$M$Y$$$20240916$$HP$IT$IT
233139996$23313999$6$F$$20240806$20231219$20240923$PER$$US-LUNDBECK-DKLU3070291$LUNDBECK$$$$$$Y$$$20240923$$CN$US$US
233140932$23314093$2$F$20230526$20240703$20231219$20240710$EXP$$US-JNJFOC-20231233452$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$HP$US$US
233141153$23314115$3$F$20231123$20240807$20231219$20240813$EXP$$AT-PFIZER INC-202300444900$PFIZER$$77$YR$$F$Y$75$KG$20240813$$MD$AT$AT
233141294$23314129$4$F$$20240827$20231219$20240827$PER$$NVSC2023US269269$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
2331417811$23314178$11$F$20221205$20240919$20231219$20240927$EXP$$US-TAKEDA-2022TUS042887$TAKEDA$$52$YR$$M$Y$69.84$KG$20240927$$HP$US$US
233142023$23314202$3$F$$20240923$20231219$20240927$PER$$US-PFIZER INC-PV202300135109$PFIZER$$67$YR$$F$Y$111.11$KG$20240927$$HP$US$US
2331421013$23314210$13$F$$20240819$20231219$20240821$30DAY$$US-PFIZER INC-202300435581$PFIZER$$15$YR$$F$Y$61.678$KG$20240821$$CN$US$US
233142294$23314229$4$F$20240223$20240701$20231219$20240703$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-151692$DAIICHI$$47$YR$$F$Y$$$20240703$$MD$US$US
233142552$23314255$2$F$20230101$20240909$20231219$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-024821$JAZZ$$$$$M$Y$$$20240912$$HP$US$US
233143293$23314329$3$F$$20240717$20231219$20240725$EXP$$US-ALXN-202312USA000749US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
233144073$23314407$3$F$20230601$20240723$20231219$20240731$EXP$$US-Axsome Therapeutics, Inc.-AXS202309-001253$AXSOME THERAPEUTICS$$29$YR$A$F$Y$61.2$KG$20240731$$HP$US$
233144592$23314459$2$F$20230101$20240722$20231219$20240731$PER$$US-SA-2023SA385879$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240731$$MD$US$US
233144734$23314473$4$F$$20240807$20231219$20240812$PER$$US-PFIZER INC-202300130476$PFIZER$$67$YR$$F$Y$52.62$KG$20240812$$CN$US$US
233145325$23314532$5$F$20220617$20240625$20231219$20240701$EXP$$CA-PFIZER INC-202200566010$PFIZER$$52$YR$$F$Y$107.5$KG$20240701$$MD$CA$CA
233146003$23314600$3$F$20231201$20240710$20231219$20240712$EXP$$CA-UCBSA-2023059293$UCB$$30$YR$$F$Y$$$20240712$$MD$CA$CA
233146692$23314669$2$F$$20240702$20231219$20240717$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-423639$RANBAXY$Shionoya K, Kobayashi M, Kako M, Masuda S, Makazu M, Koizumi K. A Case of Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct Syndrome. Intern Med. 2023;63(12):1719-1723$70$YR$$M$Y$$$20240717$$HP$JP$JP
233147456$23314745$6$F$20230101$20240805$20231219$20240812$EXP$$JP-JNJFOC-20231249724$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240812$$MD$JP$JP
233147462$23314746$2$F$20230101$20240730$20231219$20240801$EXP$$CA-UCBSA-2023019590$UCB$$$$$F$Y$$$20240801$$CN$CA$CA
233148375$23314837$5$F$$20240731$20231219$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-182312$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$73.03$KG$20240801$$CN$US$US
233148802$23314880$2$F$20230101$20240815$20231219$20240827$PER$$US-SA-2023SA387180$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240827$$MD$US$US
233149323$23314932$3$F$20201224$20240911$20231219$20240925$EXP$AU-TGA-0000769030$AU-CIPLA LTD.-2023AU08008$CIPLA$$$$$$Y$$$20240926$$CN$AU$AU
233149572$23314957$2$F$20230501$20240710$20231219$20240716$EXP$$DE-MYLANLABS-2023M1135058$MYLAN$$63$YR$$F$Y$$$20240716$$MD$DE$DE
233149763$23314976$3$F$$20240802$20231219$20240809$EXP$$CZ-MYLANLABS-2023M1115755$MYLAN$Masopust J, Kopecek M, Kalisova L, Hyza M, Risler M, Skrabalova T, et al.. Differences between brexpiprazole and aripiprazole in clinical practice case series. PSYCHIATRIE PRO PRAX. 2023;24(3):182-190$22$YR$$M$Y$$$20240809$$MD$CZ$CZ
233149904$23314990$4$F$20230901$20240820$20231219$20240906$EXP$$US-SA-2023SA240556$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240906$$MD$US$US
233150012$23315001$2$F$$20240724$20231219$20240726$EXP$$CA-BIOCON-BBL2023001323$BIOCON$$$$$$Y$$$20240726$$CN$CA$CA
233150114$23315011$4$F$$20240711$20231219$20240715$PER$$US-PFIZER INC-202300272622$PFIZER$$67$YR$$F$Y$$$20240715$$CN$US$US
233150552$23315055$2$F$$20240902$20231219$20240904$EXP$$CA-BAUSCH-BL-2023-018354$BAUSCH AND LOMB$$$$$F$Y$$$20240904$$HP$CA$CA
2331508919$23315089$19$F$20231212$20240827$20231219$20240904$EXP$$US-BEH-2023166594$CSL BEHRING$$52$YR$A$F$Y$58.503$KG$20240904$$HP$US$US
233151142$23315114$2$F$20230601$20240618$20231219$20240709$EXP$$DE-ROCHE-3376159$ROCHE$$59$YR$A$M$Y$105$KG$20240708$$MD$DE$DE
2331520912$23315209$12$F$20230817$20240826$20231219$20240828$EXP$$FR-GILEAD-2022-0607476$GILEAD$$$$A$F$Y$86$KG$20240828$$MD$FR$FR
233153223$23315322$3$F$$20240626$20231219$20240701$EXP$$DE-SANDOZ INC.-SDZ2023DE067040$SANDOZ$$$$$M$Y$$$20240701$$CN$DE$DE
233154023$23315402$3$F$$20240826$20231219$20240830$EXP$$US-TAKEDA-2023TUS121752$TAKEDA$$$$$M$Y$$$20240830$$CN$US$US
233154112$23315411$2$F$$20240703$20231219$20240709$EXP$$JP-AMGEN-JPNSP2023223628$AMGEN$$$$$M$Y$$$20240709$$MD$JP$JP
233154414$23315441$4$F$20231201$20240822$20231219$20240827$EXP$$US-TAKEDA-2023TUS120515$TAKEDA$$39$YR$$F$Y$$$20240827$$CN$US$US
233154533$23315453$3$F$20210101$20240917$20231219$20240918$PER$$US-ALXN-202312USA000621US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
233156535$23315653$5$F$20230301$20240917$20231219$20240927$EXP$$JP-NOVOPROD-1150115$NOVO NORDISK$$82$YR$$F$Y$62.6$KG$20240927$$MD$JP$JP
233157622$23315762$2$F$$20240722$20231219$20240730$EXP$$NVSC2023AR268649$NOVARTIS$$$$$F$Y$$$20240730$$CN$AR$AR
233158934$23315893$4$F$20240625$20240628$20231219$20240708$EXP$$IT-AKCEA THERAPEUTICS, INC.-2023IS002829$AKCEA THERAPEUTICS$$$$$$Y$$$20240703$$CN$IT$IT
233160812$23316081$2$F$20230101$20240607$20231219$20240806$PER$$US-GALDERMA-US2023016454$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
233161272$23316127$2$F$$20240704$20231219$20240709$PER$$JP-Eisai-EC-2023-155291$EISAI$$72$YR$E$F$Y$47$KG$20240709$$MD$JP$JP
233162722$23316272$2$F$20230514$20240925$20231219$20240928$PER$$US-ROCHE-3354680$ROCHE$$33$YR$A$M$Y$$$20240928$$CN$US$US
233163665$23316366$5$F$20240104$20240816$20231219$20240823$PER$$US-ROCHE-3362948$ROCHE$$41$YR$A$M$Y$$$20240823$$CN$US$US
233164403$23316440$3$F$20221022$20240925$20231219$20240928$PER$$US-ROCHE-3220963$ROCHE$$39$YR$A$M$Y$$$20240928$$CN$US$US
233164575$23316457$5$F$20221128$20240822$20231219$20240912$PER$$US-ROCHE-3240125$ROCHE$$9$YR$C$M$Y$$$20240912$$CN$US$US
233165183$23316518$3$F$20230410$20240816$20231219$20240820$PER$$US-ROCHE-3234370$ROCHE$$53$YR$A$M$Y$$$20240820$$CN$US$US
233165252$23316525$2$F$20230615$20240913$20231219$20240916$PER$$US-ROCHE-3376193$ROCHE$$16$YR$T$M$Y$$$20240916$$CN$US$US
233166172$23316617$2$F$20230704$20240913$20231219$20240916$PER$$US-ROCHE-3385532$ROCHE$$17$YR$T$M$Y$$$20240916$$CN$US$US
233169013$23316901$3$F$20230211$20240820$20231219$20240821$PER$$US-ROCHE-3290500$ROCHE$$15$YR$T$M$Y$$$20240821$$CN$US$US
233169042$23316904$2$F$20230203$20240823$20231219$20240827$PER$$US-ROCHE-3286451$ROCHE$$41$YR$A$M$Y$$$20240827$$CN$US$US
233169192$23316919$2$F$20230817$20240718$20231219$20240724$PER$$US-ROCHE-3410020$ROCHE$$42$YR$A$F$Y$$$20240724$$CN$US$US
233169643$23316964$3$F$20230121$20240912$20231219$20240913$PER$$US-ROCHE-3296589$ROCHE$$37$YR$A$M$Y$$$20240913$$CN$US$US
233170434$23317043$4$F$20240317$20240702$20231219$20240708$EXP$$US-ROCHE-3417375$ROCHE$$19$YR$A$M$Y$$$20240708$$CN$US$US
233170733$23317073$3$F$20230902$20240910$20231219$20240916$PER$$US-ROCHE-3422118$ROCHE$$52$YR$A$M$Y$$$20240916$$CN$US$US
233170813$23317081$3$F$20230305$20240802$20231219$20240806$PER$$US-ROCHE-3308186$ROCHE$$22$YR$A$M$Y$$$20240806$$CN$US$US
233171903$23317190$3$F$$20240627$20231219$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-183637$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$MD$JP$JP
233172652$23317265$2$F$20230126$20240912$20231219$20240916$PER$$US-ROCHE-3285220$ROCHE$$69$YR$E$M$Y$$$20240916$$CN$US$US
233173233$23317323$3$F$20230923$20240824$20231219$20240826$PER$$US-ROCHE-3432410$ROCHE$$13$YR$T$M$Y$113.4$KG$20240826$$CN$US$US
233173812$23317381$2$F$20230809$20240816$20231219$20240821$PER$$US-ROCHE-3385091$ROCHE$$61$YR$A$M$Y$$$20240821$$CN$US$US
233173982$23317398$2$F$20231005$20240920$20231219$20240923$PER$$US-ROCHE-3442815$ROCHE$$36$YR$A$M$Y$83.91$KG$20240923$$CN$US$US
233174462$23317446$2$F$20230227$20240910$20231219$20240912$PER$$US-ROCHE-3313832$ROCHE$$24$YR$A$M$Y$$$20240912$$CN$US$US
233174642$23317464$2$F$$20240919$20231219$20240925$PER$$US-ROCHE-3318998$ROCHE$$$$I$M$Y$$$20240925$$CN$US$US
233176872$23317687$2$F$$20240809$20231219$20240812$PER$$US-ROCHE-3420615$ROCHE$$$$A$M$Y$$$20240812$$CN$US$US
233178513$23317851$3$F$20240101$20240903$20231219$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-183576$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240904$$CN$US$US
233179083$23317908$3$F$20220620$20240625$20231219$20240701$EXP$$DE-ABBVIE-5546192$ABBVIE$$79$YR$$M$Y$90$KG$20240701$$MD$DE$DE
233180113$23318011$3$F$20230101$20240812$20231219$20240816$EXP$$PR-ABBVIE-5548049$ABBVIE$$$$$F$Y$74$KG$20240816$$CN$PR$PR
233180713$23318071$3$F$$20240710$20231219$20240715$EXP$$CA-SANDOZ INC.-NVSC2021CA300790$SANDOZ$$$$$F$Y$$$20240715$$CN$CA$CA
233181154$23318115$4$F$$20240705$20231220$20240726$PER$$CA-TOLMAR, INC.-23CA045135$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
233181163$23318116$3$F$$20240812$20231220$20240829$PER$$CA-TOLMAR, INC.-23CA045134$TOLMAR$$$$$M$Y$$$20240829$$CN$CA$CA
233182472$23318247$2$F$$20240903$20231220$20240920$PER$$AU-TOLMAR, INC.-23AU045114$TOLMAR$$$$$M$Y$$$20240919$$CN$AU$AU
233182564$23318256$4$F$20240101$20240618$20231220$20240709$PER$$CA-TOLMAR, INC.-23CA045087$TOLMAR$$$$$M$Y$$$20240709$$CN$CA$CA
233182702$23318270$2$F$$20240812$20231220$20240816$EXP$$US-ABBVIE-5546355$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
233182752$23318275$2$F$20231218$20240627$20231220$20240709$EXP$$IN-ROCHE-3478508$ROCHE$$79$YR$E$M$Y$$$20240709$$CN$IN$IN
233183072$23318307$2$F$20231115$20240719$20231220$20240725$EXP$$US-BEH-2023166647$CSL BEHRING$$24$YR$A$F$Y$$$20240725$$CN$US$US
233183783$23318378$3$F$20231101$20240710$20231220$20240718$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-002747$JAZZ$$39$YR$$F$Y$$$20240718$$MD$US$US
233184023$23318402$3$F$20230101$20240711$20231220$20240722$PER$$US-SA-2023SA387697$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240721$$MD$US$US
233184677$23318467$7$F$$20240612$20231220$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005439$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
233184885$23318488$5$F$20230101$20240819$20231220$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2023-035998$UNITED THERAPEUTICS$$$$$F$Y$64.853$KG$20240827$$$US$US
233185073$23318507$3$F$$20240724$20231220$20240725$EXP$$JP-ABBVIE-5549248$ABBVIE$$$$$$Y$$$20240725$$MD$JP$JP
233185682$23318568$2$F$20231115$20240906$20231220$20240911$EXP$$DE-JNJFOC-20231182422$JOHNSON AND JOHNSON$$69$YR$E$M$Y$106.4$KG$20240911$$MD$DE$DE
233187093$23318709$3$F$20231207$20240708$20231220$20240715$EXP$$CA-ROCHE-3477054$ROCHE$$48$YR$A$M$Y$$$20240715$$MD$CA$CA
233187205$23318720$5$F$20230101$20240705$20231220$20240709$EXP$$US-ABBVIE-4760383$ABBVIE$$$$$M$Y$62.595$KG$20240709$$CN$US$US
233187916$23318791$6$F$20231107$20240924$20231220$20240927$EXP$$FR-ORGANON-O2312FRA001261$ORGANON$$83$YR$$M$Y$110$KG$20240927$$HP$FR$FR
233188762$23318876$2$F$20130101$20240716$20231220$20240730$EXP$$CA-CHEPLA-2022003451$CHEPLAPHARM$$$$A$F$Y$47$KG$20240730$$MD$COUNTRY NOT SPECIFIED$CA
233189105$23318910$5$F$20230103$20240912$20231220$20240923$EXP$$DE-ROCHE-3262700$ROCHE$$65$YR$E$F$Y$$$20240923$$CN$DE$DE
233190993$23319099$3$F$20230101$20240702$20231220$20240709$EXP$$NL-ABBVIE-5299256$ABBVIE$$67$YR$$M$Y$$$20240709$$HP$NL$NL
233192933$23319293$3$F$$20240819$20231220$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-184691$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240821$$MD$JP$JP
233192952$23319295$2$F$$20240819$20231220$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-184705$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240822$$MD$JP$JP
233192992$23319299$2$F$$20240912$20231220$20240917$EXP$$US-SA-2023SA391734$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240917$$MD$US$US
233193815$23319381$5$F$$20240719$20231220$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-184186$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240729$$CN$US$US
233193873$23319387$3$F$$20240822$20231220$20240828$EXP$$JP-009507513-2312JPN001595J$MERCK$$63$YR$$M$Y$$$20240828$$MD$JP$JP
233194132$23319413$2$F$$20240902$20231220$20240917$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-23-65081$HIKMA$$74$YR$$M$Y$$$20240917$$HP$CA$CA
233195783$23319578$3$F$20240617$20240618$20231220$20240702$EXP$$CA-ROCHE-3477158$ROCHE$$46$YR$A$M$Y$$$20240702$$CN$CA$CA
233197633$23319763$3$F$20231101$20240725$20231220$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-180520$BRISTOL MYERS SQUIBB$$$$$$Y$70$KG$20240730$$MD$JP$JP
233198032$23319803$2$F$$20240822$20231220$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-178938$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240828$$PH$JP$JP
233198422$23319842$2$F$20231107$20240628$20231220$20240704$EXP$$JP-AMGEN-JPNSP2023224872$AMGEN$$84$YR$E$F$Y$59$KG$20240704$$MD$JP$JP
233198713$23319871$3$F$20230101$20240717$20231220$20240724$PER$$US-SA-2023SA393364$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240724$$MD$US$US
233199013$23319901$3$F$20230101$20240717$20231220$20240724$PER$$US-SA-2023SA393546$SANOFI AVENTIS$$27$YR$A$F$Y$122.4$KG$20240724$$CN$US$US
233199152$23319915$2$F$$20240920$20231220$20240926$EXP$$JP-ASTELLAS-2023JP013945$ASTELLAS$$8$DEC$E$F$Y$$$20240926$$PH$JP$JP
233199834$23319983$4$F$20231128$20240806$20231220$20240827$PER$$CA-TOLMAR, INC.-23CA045139$TOLMAR$$65$YR$$M$Y$$$20240827$$CN$CA$CA
233199886$23319988$6$F$20231001$20240719$20231220$20240725$EXP$$CA-JNJFOC-20231233967$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240725$$HP$CA$CA
233200392$23320039$2$F$$20240802$20231220$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-67964$HIKMA$$71$YR$$M$Y$$$20240813$$CN$CA$CA
233200413$23320041$3$F$20230101$20240816$20231220$20240830$PER$$US-SA-2023SA393441$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240830$$MD$US$US
233200744$23320074$4$F$20230405$20240815$20231220$20240821$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04403$AMNEAL$$84$YR$$M$Y$$$20240821$$CN$US$US
233200782$23320078$2$F$$20240819$20231220$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-184679$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240822$$MD$JP$JP
233201482$23320148$2$F$$20240902$20231220$20240912$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-67954$HIKMA$$63$YR$$M$Y$$$20240912$$HP$CA$CA
233201672$23320167$2$F$$20240705$20231220$20240719$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-23-01913$HIKMA$$48$YR$$F$Y$$$20240719$$CN$CA$CA
233202142$23320214$2$F$20220526$20231213$20231220$20240807$EXP$$NVSC2022GB113103$NOVARTIS$$54$YR$$F$Y$$$20240807$$CN$GB$GB
233202373$23320237$3$F$$20240819$20231220$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-183851$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240827$$MD$JP$JP
233202882$23320288$2$F$20230601$20240621$20231220$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-181550$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240711$$HP$US$US
233203055$23320305$5$F$20231211$20240820$20231220$20240827$EXP$$CO-GSK-CO2023AMR175578$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$CO$CO
233203197$23320319$7$F$20230101$20240822$20231220$20240828$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2023-149243$REGENERON$$$$$F$Y$$$20240828$$MD$US$US
233203742$23320374$2$F$20231015$20240627$20231220$20240703$EXP$$CA-TAKEDA-2023TUS102984$TAKEDA$$75$YR$$F$Y$$$20240703$$MD$CA$CA
233203785$23320378$5$F$$20240920$20231220$20240925$PER$$US-PFIZER INC-PV202300201828$PFIZER$$12$YR$$F$Y$$$20240925$$CN$US$US
233204107$23320410$7$F$20230101$20240828$20231220$20240903$EXP$$US-PFIZER INC-PV202300118843$PFIZER$$76$YR$$F$Y$78.47$KG$20240903$$MD$US$US
233204303$23320430$3$F$20240501$20240920$20231220$20240924$PER$$US-PFIZER INC-PV202300201127$PFIZER$$45$YR$$F$Y$$$20240924$$HP$US$US
233204445$23320444$5$F$20230301$20240807$20231220$20240809$PER$$US-PFIZER INC-PV202300201111$PFIZER$$62$YR$$F$Y$$$20240809$$HP$US$US
233204856$23320485$6$F$$20240916$20231220$20240917$PER$$US-PFIZER INC-202300446702$PFIZER$$67$YR$$F$Y$$$20240917$$HP$US$US
233204903$23320490$3$F$20230801$20240912$20231220$20240916$EXP$$US-PFIZER INC-202300443453$PFIZER$$64$YR$$M$Y$$$20240916$$CN$US$US
233205103$23320510$3$F$$20240729$20231220$20240801$EXP$$JP-PFIZER INC-202300445049$PFIZER$Horino, T.. Pulmonary Nocardiosis in a Patient with Rheumatoid Arthritis. Internal medicine. 2023;63:2107-2108$61$YR$$F$Y$$$20240801$$MD$JP$JP
233205562$23320556$2$F$$20240722$20231220$20240725$EXP$$US-ABBVIE-5540962$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
233205692$23320569$2$F$$20240701$20231220$20240703$PER$$US-PFIZER INC-202300444245$PFIZER$$64$YR$$F$Y$56.7$KG$20240703$$CN$US$US
233205723$23320572$3$F$20240706$20240726$20231220$20240729$PER$$US-PFIZER INC-202300446151$PFIZER$$81$YR$$F$Y$$$20240729$$HP$US$US
233205742$23320574$2$F$$20240711$20231220$20240712$PER$$US-PFIZER INC-PV202300199756$PFIZER$$75$YR$$F$Y$63.9$KG$20240712$$MD$US$US
233206326$23320632$6$F$20240109$20240806$20231220$20240813$PER$$US-SA-2023SA392034$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240814$$MD$US$US
233206918$23320691$8$F$20230101$20240715$20231220$20240719$EXP$$CA-PFIZER INC-202300444233$PFIZER$$17$YR$$M$Y$$$20240719$$MD$CA$CA
233207893$23320789$3$F$20231101$20240716$20231220$20240723$EXP$FR-AFSSAPS-ST2023001559$FR-009507513-2312FRA006484$MERCK$$35$YR$$F$Y$78$KG$20240723$$MD$FR$FR
233208676$23320867$6$F$20231129$20240809$20231220$20240813$30DAY$$CO-PFIZER INC-PV202300197392$PFIZER$$12$YR$$F$Y$$$20240813$$CN$CO$CO
233209442$23320944$2$F$$20240705$20231220$20240720$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-68135$HIKMA$$50$YR$$F$Y$55$KG$20240719$$HP$CA$CA
233209613$23320961$3$F$20181121$20240911$20231220$20240917$EXP$$DE-JNJFOC-20231233772$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240917$$MD$DE$DE
233210273$23321027$3$F$$20240902$20231220$20240912$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-68028$HIKMA$$71$YR$$F$Y$64$KG$20240912$$CN$CA$CA
233210772$23321077$2$F$$20240715$20231220$20240730$EXP$$HU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424574$RANBAXY$Cegledi A, Csukly Z, Fekete M, Kozma A, Szemlaky Z, Andrikovics H, et al. Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14). Pathol Oncol Res. 2023;29:1611375$73$YR$$M$Y$$$20240730$$HP$HU$HU
233211034$23321103$4$F$20210501$20240705$20231220$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-271012$RANBAXY$$81$YR$$F$Y$125.62$KG$20240719$$CN$US$US
233211362$23321136$2$F$20231101$20240708$20231220$20240709$EXP$FR-AFSSAPS-LM2023000675$NVSC2023FR269072$NOVARTIS$$87$YR$$F$Y$62$KG$20240709$$MD$FR$FR
233211805$23321180$5$F$20230101$20240626$20231220$20240711$PER$$US-SA-2023SA391045$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240711$$MD$US$US
233212282$23321228$2$F$20231201$20240807$20231220$20240816$PER$$US-SA-2023SA387917$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240816$$MD$US$US
233212302$23321230$2$F$20231201$20240826$20231220$20240902$EXP$$US-SA-2023SA393921$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240902$$CN$US$US
233212534$23321253$4$F$20220906$20240909$20231220$20240912$EXP$$JP-ABBVIE-5549270$ABBVIE$$48$YR$$M$Y$67$KG$20240912$$MD$JP$JP
233213182$23321318$2$F$20230101$20240702$20231220$20240708$EXP$$US-ABBVIE-5549230$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
233213275$23321327$5$F$20230811$20240708$20231220$20240711$EXP$$JP-DSJP-DSJ-2023-151171AA$DAIICHI$$75$YR$$F$Y$54$KG$20240711$$MD$JP$JP
233213675$23321367$5$F$$20240712$20231220$20240802$EXP$$JP-009507513-2312JPN002045J$MERCK$Katsura Y, Shirakawa Y, Ishida M, Chouda Y, Idani H, Matsukawa H, et al. p7-2 Treatment Strategies for Unresectable Advanced Oesophageal Carcinoma in Our Hospital. The 78th Annual Meeting of The Japan Esophageal Society. 200$69$YR$$F$Y$$$20240802$$MD$JP$JP
233213752$23321375$2$F$$20240725$20231220$20240729$EXP$$CA-TAKEDA-2023TUS121407$TAKEDA$$$$$F$Y$$$20240729$$CN$CA$CA
233215374$23321537$4$F$$20240906$20231220$20240910$EXP$$US-TAKEDA-2023TUS121037$TAKEDA$$$$$F$Y$$$20240910$$CN$US$US
2332155015$23321550$15$F$20230501$20240913$20231220$20240919$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2023XER02353$XERIS PHARMACEUTICALS$$69$YR$$F$Y$$$20240918$$CN$US$US
233215593$23321559$3$F$$20240821$20231220$20240826$EXP$$CA-JNJFOC-20231241433$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$HP$CA$CA
233215672$23321567$2$F$20231205$20240731$20231220$20240805$EXP$$TW-TAKEDA-2023TUS122182$TAKEDA$$6$YR$$M$Y$$$20240805$$CN$TW$TW
233215973$23321597$3$F$$20240911$20231220$20240924$EXP$$CA-APOTEX-2023AP017985$APOTEX$$52$YR$$F$Y$$$20240924$$HP$CA$CA
233216445$23321644$5$F$$20240912$20231220$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-184081$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$74.39$KG$20240913$$CN$US$US
233216652$23321665$2$F$20231101$20240702$20231220$20240708$EXP$$US-ROCHE-3474688$ROCHE$$78$YR$E$F$Y$$$20240708$$CN$US$US
233217375$23321737$5$F$20220801$20240826$20231220$20240904$EXP$$AR-SANDOZ INC.-SDZ2023AR061969$SANDOZ$$56$YR$$F$Y$$$20240904$$CN$AR$AR
233218258$23321825$8$F$20240328$20240823$20231220$20240829$EXP$$CA-TAKEDA-2023TUS122041$TAKEDA$$48$YR$$F$Y$$$20240829$$CN$CA$CA
233218532$23321853$2$F$$20240822$20231220$20240830$EXP$$CA-APOTEX-2023AP017987$APOTEX$$60$YR$$F$Y$$$20240830$$CN$CA$CA
233218793$23321879$3$F$$20240805$20231220$20240807$PER$$US-AMGEN-USASP2023225427$AMGEN$$59$YR$A$F$Y$$$20240806$$HP$US$US
233219334$23321933$4$F$$20240708$20231220$20240710$PER$$US-PFIZER INC-202300441769$PFIZER$$75$YR$$F$Y$54.431$KG$20240710$$CN$US$US
233219912$23321991$2$F$$20231218$20231220$20240813$PER$$US-GILEAD-2023-0655762$GILEAD$$37$YR$A$F$Y$$$20240813$$CN$US$US
233220115$23322011$5$F$20230719$20240911$20231220$20240912$EXP$$US-TAKEDA-2023TUS081062$TAKEDA$$41$YR$$F$Y$$$20240912$$CN$US$US
233220174$23322017$4$F$$20240820$20231220$20240826$EXP$$DE-MYLANLABS-2023M1134576$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert R, Fischer L et al... Experience with the mTOR inhibitor everolimus in pediatric liver graft recipients. CHILDREN. 2023;10(2):1-11$18$YR$$M$Y$$$20240826$$HP$DE$DE
233220635$23322063$5$F$20221201$20240801$20231220$20240806$PER$$US-VERTEX PHARMACEUTICALS-2023-018938$VERTEX$$23$YR$$$Y$$$20240806$$CN$US$US
233220702$23322070$2$F$$20240708$20231220$20240712$PER$$US-VERTEX PHARMACEUTICALS-2023-018986$VERTEX$$$$$$Y$$$20240712$$CN$US$US
233220735$23322073$5$F$20200101$20240915$20231220$20240920$EXP$$GB-VERTEX PHARMACEUTICALS-2023-018813$VERTEX$$35$YR$$M$Y$$$20240920$$CN$GB$GB
233222325$23322232$5$F$20231211$20240822$20231220$20240828$EXP$$JP-PFIZER INC-202300449705$PFIZER$$7$DEC$$F$Y$$$20240828$$MD$JP$JP
233222554$23322255$4$F$$20240920$20231220$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-184792$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$64.41$KG$20240925$$CN$US$US
2332226410$23322264$10$F$20231107$20240921$20231220$20240930$EXP$$US-BEH-2023166508$CSL BEHRING$$43$YR$A$F$Y$$$20240930$$HP$US$US
233223232$23322323$2$F$20231101$20240820$20231220$20240830$EXP$$US-TAKEDA-2023TUS122207$TAKEDA$$40$YR$$F$Y$73$KG$20240830$$MD$US$US
233223322$23322332$2$F$20231201$20240731$20231220$20240807$EXP$$JP-Eisai-EC-2023-155040$EISAI$$$$$F$Y$$$20240807$$MD$JP$JP
233223332$23322333$2$F$$20240923$20231220$20240926$EXP$$CA-Eisai-EC-2023-155381$EISAI$$80$YR$E$F$Y$$$20240926$$MD$CA$CA
233223432$23322343$2$F$20230101$20240801$20231220$20240805$EXP$$FR-PURDUE-USA-2023-0306662$PURDUE$$66$YR$$F$Y$50$KG$20240805$$CN$FR$FR
233223733$23322373$3$F$$20240611$20231220$20240815$PER$$US-PFIZER INC-PV202300201160$PFIZER$$69$YR$$F$Y$$$20240815$$HP$US$US
233223787$23322378$7$F$20231201$20240728$20231220$20240805$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-023323$JAZZ$$27$YR$$F$Y$$$20240803$$CN$US$US
233224193$23322419$3$F$20231201$20240731$20231220$20240806$EXP$$JP-009507513-2312JPN001881J$MERCK$$$$$F$Y$$$20240806$$MD$JP$JP
233224553$23322455$3$F$$20240819$20231220$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-183846$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240821$$MD$JP$JP
233224676$23322467$6$F$$20240626$20231220$20240704$EXP$$US-TAKEDA-2023TUS101009$TAKEDA$$$$$F$Y$$$20240704$$CN$US$US
233227765$23322776$5$F$20231113$20240906$20231220$20240911$EXP$$US-AstraZeneca-2023A288644$ASTRAZENECA$$77$YR$$M$Y$77.5$KG$20240911$$HP$US$
233229192$23322919$2$F$20231101$20240708$20231220$20240716$EXP$$US-UCBSA-2023059479$UCB$$23$YR$$F$Y$$$20240716$$HP$US$US
233229314$23322931$4$F$20231101$20240722$20231220$20240724$EXP$$US-UCBSA-2023059534$UCB$$29$YR$$F$Y$$$20240724$$HP$US$US
233229552$23322955$2$F$20221220$20240826$20231220$20240827$PER$$US-ROCHE-3036673$ROCHE$$60$YR$A$F$Y$$$20240827$$CN$US$US
233229813$23322981$3$F$$20240814$20231220$20240820$EXP$$JP-009507513-2312JPN000148J$MERCK$$8$DEC$$M$Y$$$20240820$$MD$JP$JP
233231623$23323162$3$F$20240803$20240903$20231220$20240913$30DAY$$US-GSK-US2023174613$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240913$$CN$US$US
233233276$23323327$6$F$20230101$20240712$20231220$20240722$EXP$$US-CELLTRION INC.-2023US024095$CELLTRION$$$$$$Y$$$20240722$$CN$US$US
233234383$23323438$3$F$20231203$20240711$20231220$20240716$EXP$$CA-JNJFOC-20231246051$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240716$$CN$CA$CA
233234742$23323474$2$F$20230201$20240703$20231220$20240715$PER$$US-ROCHE-3382718$ROCHE$$54$YR$A$F$Y$55.34$KG$20240715$$CN$US$US
233237762$23323776$2$F$20240613$20240625$20231220$20240702$EXP$$CO-GSK-CO2023AMR176208$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$CO$CO
233238224$23323822$4$F$$20240729$20231220$20240809$PER$$US-ROCHE-3451712$ROCHE$$$$E$M$Y$$$20240809$$MD$US$US
233238262$23323826$2$F$20220101$20240717$20231220$20240722$EXP$$JP-ABBVIE-22K-087-4359347-00$ABBVIE$$$$$F$Y$$$20240722$$CN$JP$JP
233239793$23323979$3$F$$20240610$20231221$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005434$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
233239804$23323980$4$F$$20240610$20231221$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005431$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
233239828$23323982$8$F$20231017$20240712$20231221$20240722$PER$$US-JAZZ PHARMACEUTICALS-2023-US-004902$JAZZ$$70$YR$$F$Y$$$20240722$$CN$US$US
233240093$23324009$3$F$20191204$20240723$20231221$20240731$EXP$$DE-ROCHE-2492832$ROCHE$$48$YR$A$M$Y$$$20240731$$CN$DE$DE
233240163$23324016$3$F$20230303$20240716$20231221$20240722$EXP$$US-ABBVIE-5549164$ABBVIE$$69$YR$$M$Y$$$20240719$$CN$US$US
233240394$23324039$4$F$20231202$20240808$20231221$20240830$PER$$CA-TOLMAR, INC.-23CA045253$TOLMAR$$67$YR$$M$Y$$$20240830$$CN$CA$CA
233240593$23324059$3$F$$20240626$20231221$20240701$EXP$$JP-TAKEDA-2023TJP016973$TAKEDA$Haruna Yokota, Eriko Hisamatsu, Tomoyuki Nagano, Shuichi Tsukamoto, Takayuki Kodama, Yu Taniguchi, et al.. A case of pulmonary hypertension which was complicated by polycythaemia vera and was later found to be pulmonary capillary haemangiomatosis on pathological autopsy. The 136th Kinki Regional Meeting of the Japanese Circulation Society. 2023;47$70$YR$$F$Y$$$20240701$$$COUNTRY NOT SPECIFIED$JP
233241383$23324138$3$F$20221201$20240726$20231221$20240806$EXP$MT-SEATTLE GENETICS-2023SGN12862$MT-ROCHE-3475693$ROCHE$$3$DEC$A$F$Y$$$20240806$$MD$MT$MT
233241413$23324141$3$F$20230101$20240724$20231221$20240731$EXP$$CA-ABBVIE-5549697$ABBVIE$$$$$M$Y$$$20240731$$MD$CA$CA
233242614$23324261$4$F$$20240726$20231221$20240801$EXP$$US-TAKEDA-2021TUS051015$TAKEDA$$$$$F$Y$77$KG$20240801$$CN$US$US
233242822$23324282$2$F$$20240717$20231221$20240726$PER$$US-SA-2023SA389742$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240726$$MD$US$US
233243673$23324367$3$F$20231214$20240612$20231221$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005445$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240705$$CN$US$US
233244382$23324438$2$F$$20240829$20231221$20240904$EXP$$IT-ROCHE-3474025$ROCHE$Colussi L, Dagri A, Pastore S, Taddio A andTommasini A. Effect of the janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma (Abstract No: P134) DOI: 10.1186/s12969-023-00879-8. Pediatric Rheumatology 2023 Oct;21 (SUP 2):137-.$13$YR$T$F$Y$$$20240904$$HP$IT$IT
233244515$23324451$5$F$20231120$20240709$20231221$20240716$EXP$$CA-JNJFOC-20231212841$JOHNSON AND JOHNSON$$22$YR$A$F$Y$83$KG$20240717$$HP$CA$CA
233245294$23324529$4$F$20231208$20240816$20231221$20240826$30DAY$$US-GSK-US2023173138$GLAXOSMITHKLINE$$76$YR$$M$Y$$$20240826$$MD$US$US
2332470118$23324701$18$F$20231128$20240912$20231221$20240919$EXP$$AT-ABBVIE-5524693$ABBVIE$$60$YR$$M$Y$79$KG$20240919$$MD$AT$AT
233247904$23324790$4$F$20210201$20240828$20231221$20240904$EXP$$DE-ROCHE-2766582$ROCHE$$56$YR$A$F$Y$$$20240904$$CN$DE$DE
233248822$23324882$2$F$$20240710$20231221$20240715$EXP$$US-ABBVIE-5551330$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
233250122$23325012$2$F$20230101$20240704$20231221$20240711$EXP$$JP-009507513-2301JPN003764J$MERCK$$4$DEC$$F$Y$$$20240711$$MD$JP$JP
233250282$23325028$2$F$$20231214$20231221$20240925$PER$$US-GSK-US2023AMR177826$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
233250293$23325029$3$F$$20240729$20231221$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-185431$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240806$$MD$JP$JP
233251007$23325100$7$F$$20240731$20231221$20240808$EXP$$US-Blueprint Medicines Corporation-SP-US-2023-002087$BLUEPRINT MEDICINES$$$$$F$Y$$$20240808$$CN$US$US
233251142$23325114$2$F$$20240826$20231221$20240830$EXP$$JP-GSK-JP2023JPN176905$GLAXOSMITHKLINE$Mafune Y, Hayashi K, Uchida M, Hoshiyama E, Wake K. P1-217 A Case of Aciclovir Nephropathy and Aciclovir Encephalopathy with Significant Response to Haemodialysis. The 51st Annual Meeting/Congress of Japanese Association for Acute Medicine. 563$$$$$Y$$$20240830$$MD$JP$JP
233251152$23325115$2$F$$20240627$20231221$20240703$PER$$US-Blueprint Medicines Corporation-SP-US-2023-002094$BLUEPRINT MEDICINES$$$$$F$Y$$$20240703$$CN$US$US
233251483$23325148$3$F$$20240624$20231221$20240704$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US001113$DECIPHERA PHARMACEUTICALS$$54$YR$A$F$Y$$$20240704$$CN$US$US
233253046$23325304$6$F$20230904$20240819$20231221$20240829$EXP$$JP-ASTELLAS-2023JP010397$ASTELLAS$Takeuchi I, Inaba M, Hotta E, Hara M, Hata K. A case of toxic epidermal necrolysis (TEN) and severe myelosuppression during the first cycle of enfortumab vedotin for metastases to liver and lymph node after surgery for left renal pelvis cancer and resulted in death. The 255th Kansai Regional Meeting of the Japanese Urological Association (Program/Abstracts) (2024.02.03). 2024;10.$78$YR$E$M$Y$65.5$KG$20240827$$MD$JP$JP
233253277$23325327$7$F$$20240909$20231221$20240914$EXP$CA-APOTEX-2023AP003825$CA-ApotexCA-000409$AVEVA$$71$YR$$F$Y$69$KG$20240915$$HP$CA$CA
233253313$23325331$3$F$20231001$20240711$20231221$20240720$30DAY$$US-GSK-US2023175864$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240720$$CN$US$US
233253732$23325373$2$F$$20240827$20231221$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-185468$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240903$$PH$JP$JP
233253773$23325377$3$F$20191206$20240705$20231221$20240709$EXP$$CA-TAKEDA-CA201943263$TAKEDA$$49$YR$$F$Y$$$20240709$$CN$CA$CA
233254604$23325460$4$F$$20240911$20231221$20240913$PER$$NVSC2023US271269$NOVARTIS$$$$$M$Y$$$20240913$$HP$US$US
233254722$23325472$2$F$20230101$20240801$20231221$20240810$PER$$US-SA-2023SA391249$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$MD$US$US
233255973$23325597$3$F$20200129$20240118$20231221$20240730$EXP$$US-GILEAD-2023-0655972$GILEAD$$48$YR$A$M$Y$$$20240730$$LW$US$US
233256234$23325623$4$F$20231201$20240126$20231221$20240925$PER$$US-GSK-US2023AMR176474$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240925$$CN$US$US
233256438$23325643$8$F$20230701$20240627$20231221$20240704$EXP$$NVSC2023CR199825$NOVARTIS$$48$YR$$F$Y$60$KG$20240704$$CN$CR$CR
233256636$23325663$6$F$20231201$20240709$20231221$20240722$EXP$$NVSJ2023JP017768$NOVARTIS$$58$YR$$F$Y$53.8$KG$20240722$$MD$JP$JP
233257152$23325715$2$F$20231001$20240628$20231221$20240706$EXP$$GB-TEVA-VS-3137168$TEVA$$$$$F$Y$$$20240706$$MD$GB$GB
233257282$23325728$2$F$$20240912$20231221$20240924$EXP$$CA-APOTEX-2023AP018038$APOTEX$$$$$M$Y$$$20240924$$MD$CA$CA
233258322$23325832$2$F$20231214$20240919$20231221$20240923$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-151905$DAIICHI$$61$YR$$M$Y$$$20240923$$HP$US$US
233258652$23325865$2$F$$20240827$20231221$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-183748$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240902$$PH$JP$JP
233258853$23325885$3$F$$20240723$20231221$20240730$EXP$$US-GSK-US2023AMR174307$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$US$US
233260847$23326084$7$F$20231207$20240219$20231221$20240808$EXP$$NVSC2023BR267033$NOVARTIS$$71$YR$$F$Y$$$20240808$$CN$BR$BR
233261663$23326166$3$F$20230901$20240722$20231221$20240726$EXP$$US-UCBSA-2023059380$UCB$$48$YR$$M$Y$$$20240726$$CN$US$US
2332617310$23326173$10$F$20230816$20240925$20231221$20240926$EXP$$AR-MYLANLABS-2023M1089020$MYLAN$$30$YR$$F$Y$$$20240926$$CN$AR$AR
233261774$23326177$4$F$$20240830$20231221$20240909$EXP$$CA-CELLTRION INC.-2020CA035308$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
233261832$23326183$2$F$$20240711$20231221$20240712$EXP$$GB-MYLANLABS-2023M1134121$MYLAN$$$$A$M$Y$$$20240712$$HP$GB$GB
233262133$23326213$3$F$20240701$20240820$20231221$20240828$EXP$$BR-GSK-BR2023AMR175669$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$BR$BR
233263613$23326361$3$F$$20240822$20231221$20240828$EXP$$CA-TAKEDA-2020TUS030211$TAKEDA$$$$$F$Y$$$20240828$$HP$CA$CA
233263633$23326363$3$F$20230401$20240911$20231221$20240918$EXP$$JP-Eisai-EC-2023-155057$EISAI$$70$YR$E$M$Y$$$20240918$$MD$JP$JP
233266334$23326633$4$F$20240701$20240719$20231221$20240723$PER$$US-PFIZER INC-PV202300187686$PFIZER$$59$YR$$F$Y$$$20240723$$HP$US$US
233266464$23326646$4$F$$20240627$20231221$20240710$PER$$US-PFIZER INC-PV202300201138$PFIZER$$75$YR$$F$Y$79.365$KG$20240710$$MD$US$US
233268062$23326806$2$F$20230721$20240820$20231221$20240823$EXP$$CA-PFIZER INC-202300258919$PFIZER$$62$YR$$F$Y$66.2$KG$20240823$$HP$CA$CA
233268482$23326848$2$F$20231109$20240818$20231221$20240819$EXP$$DE-BAUSCH-BL-2023-018980$BAUSCH AND LOMB$$79$YR$$M$Y$$$20240819$$MD$DE$DE
233268592$23326859$2$F$20231214$20231215$20231221$20240719$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202312009122$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240719$$CN$FR$FR
233268882$23326888$2$F$20230905$20240829$20231221$20240904$EXP$$CA-PFIZER INC-202300446803$PFIZER$$80$YR$$M$Y$$$20240904$$MD$CA$CA
233269143$23326914$3$F$$20240715$20231221$20240723$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2023-27874$IPSEN$$49$YR$A$M$Y$65.31$KG$20240723$$CN$US$US
233269405$23326940$5$F$20231001$20240709$20231221$20240712$EXP$$US-OTSUKA-2023_028844$OTSUKA$$67$YR$$M$Y$54.42$KG$20240712$$HP$US$US
233269683$23326968$3$F$20240101$20240920$20231221$20240924$EXP$$US-PFIZER INC-PV202300204471$PFIZER$$63$YR$$M$Y$$$20240924$$HP$US$US
233270812$23327081$2$F$$20231211$20231221$20240702$EXP$$JP-UCBSA-2023058811$UCB$Tamura M, Takeda T, Kitayama Y, Suichi T, Shibuya K, Harada-Kagitani S et al.. Neuropathological features of levodopa-responsive parkinsonism in multiple system atrophy: an autopsy case report and comparative neuropathological study.. Frontiers in Neurology. 2023;14:1-9$57$YR$$M$Y$$$20240702$$HP$JP$JP
233271282$23327128$2$F$$20231211$20231221$20240925$PER$$US-GSK-US2023AMR177752$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
233271443$23327144$3$F$20230701$20240822$20231221$20240828$EXP$$CA-SANDOZ INC.-NVSC2022CA114032$SANDOZ$$52$YR$$F$Y$$$20240828$$CN$CA$CA
233272432$23327243$2$F$20231218$20240807$20231221$20240808$EXP$$US-TAKEDA-2023TUS122490$TAKEDA$$48$YR$$F$Y$$$20240808$$MD$US$US
233272992$23327299$2$F$$20240909$20231221$20240913$EXP$$US-TAKEDA-2023TUS070449$TAKEDA$$$$$M$Y$$$20240913$$CN$US$US
233273022$23327302$2$F$20160101$20240805$20231221$20240806$EXP$$LT-SANDOZ INC.-PHHY2017LT189920$SANDOZ$$53$YR$$F$Y$$$20240806$$MD$LT$LT
233273552$23327355$2$F$20230101$20240903$20231221$20240911$EXP$$JP-Eisai-EC-2023-154860$EISAI$$63$YR$A$F$Y$$$20240911$$MD$JP$JP
233273687$23327368$7$F$$20240724$20231221$20240729$EXP$$US-TAKEDA-2023TUS043375$TAKEDA$$$$$F$Y$77$KG$20240729$$CN$US$US
233275492$23327549$2$F$20231206$20231206$20231221$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424787$RANBAXY$$17$YR$T$$Y$$$20240702$$MD$US$US
233275976$23327597$6$F$20220923$20240823$20231221$20240830$EXP$$US-ABBVIE-5546887$ABBVIE$$62$YR$$M$Y$$$20240830$$CN$US$US
233276846$23327684$6$F$20230601$20240723$20231221$20240731$PER$$JP-Eisai-EC-2023-154945$EISAI$$58$YR$A$F$Y$$$20240731$$MD$JP$JP
233278042$23327804$2$F$20231219$20240829$20231221$20240902$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2023-185787$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$70.31$KG$20240902$$CN$PR$PR
233278146$23327814$6$F$20240629$20240723$20231221$20240725$EXP$$CA-TAKEDA-2023TUS122652$TAKEDA$$33$YR$$F$Y$$$20240725$$CN$CA$CA
233278976$23327897$6$F$20231104$20240904$20231221$20240909$EXP$$US-MYLANLABS-2023M1134468$MYLAN$$73$YR$$M$Y$87.6$KG$20240909$$CN$US$US
233279364$23327936$4$F$$20240823$20231221$20240909$EXP$$JP-009507513-2312JPN001599J$MERCK$Honda T, Tabira K, Uto T, Nishio Y. 2-4-15 A Case of Diabetic Ketoacidosis Leading to Intestinal ischaemia during Treatment with Anti-PD-1 Antibody. The 61st Kyushu Regional Meeting of The Japan Diabetes Society. 182$50$YR$$M$Y$$$20240909$$MD$JP$JP
233279722$23327972$2$F$20230101$20240704$20231221$20240712$PER$$JP-Eisai-EC-2023-155515$EISAI$$$$A$F$Y$$$20240712$$MD$JP$JP
233279862$23327986$2$F$$20240730$20231221$20240805$EXP$$DE-MYLANLABS-2023M1135645$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel). 2023;10 (2):1-11$4$YR$$M$Y$$$20240805$$HP$DE$DE
2332806210$23328062$10$F$20210413$20240912$20231221$20240917$EXP$$US-SANDOZ INC.-NVSC2020US164824$SANDOZ$$61$YR$$F$Y$54.875$KG$20240917$$MD$US$US
233281714$23328171$4$F$$20240731$20231221$20240802$EXP$$CA-BAUSCH-BL-2023-018438$BAUSCH AND LOMB$$32$YR$$F$Y$$$20240802$$CN$CA$CA
233281782$23328178$2$F$$20231121$20231221$20240822$PER$$US-009507513-2311USA008251$MERCK$Kim DY, Swetter SM, Huhmann L, Dizon MP, Ferguson JM, Osborne TF, et al.. Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among Veteran cutaneous melanoma patients. Journal of the American Academy of Dermatology. 2023;90 (3)$81$YR$$M$Y$$$20240822$$HP$US$US
233281914$23328191$4$F$20231113$20240903$20231221$20240909$EXP$$DE-009507513-2312DEU007796$MERCK$$82$YR$$F$Y$52$KG$20240909$$MD$DE$DE
233283915$23328391$5$F$$20240905$20231221$20240912$EXP$$US-TAKEDA-2023TUS111000$TAKEDA$$$$$M$Y$$$20240912$$HP$US$US
233283973$23328397$3$F$$20240808$20231221$20240814$EXP$$JP-009507513-2312JPN007897$MERCK$Yoshimura K, Tamano Y, Canh HN, Zihan L, Thanh DL, Sato Y, et al. A novel pathologic marker, indoleamine 2,3?dioxygenase 1, for the cholangiopathy of immune checkpoint inhibitors?induced immune mediated hepatotoxicity as adverse events and the prediction of additional ursodeoxycholic acid treatment. Med Mol Morphol. 2023;56 (2):106-15$75$YR$$F$Y$$$20240814$$HP$JP$JP
233284063$23328406$3$F$$20240808$20231221$20240814$EXP$$JP-009507513-2312JPN007900$MERCK$Yoshimura K, Tamano Y, Canh HN, Zihan L, Thanh DL, Sato Y, et al. A novel pathologic marker, indoleamine 2,3?dioxygenase 1, for the cholangiopathy of immune checkpoint inhibitors?induced immune mediated hepatotoxicity as adverse events and the prediction of additional ursodeoxycholic acid treatment. Med Mol Morphol. 2023;56 (2):106-15$61$YR$$M$Y$$$20240814$$HP$JP$JP
233284193$23328419$3$F$20230801$20240822$20231221$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202312009479$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240826$$CN$US$US
233284284$23328428$4$F$$20240912$20231221$20240917$EXP$$CA-SANDOZ INC.-SDZ2023CA069299$SANDOZ$$$$$F$Y$$$20240917$$HP$CA$CA
233284424$23328442$4$F$20240703$20240719$20231221$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-182731$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240723$$CN$US$US
233284442$23328444$2$F$$20240902$20231221$20240905$EXP$$FR-ROCHE-3471207$ROCHE$Assaraf M, Chevet B, Wendling D, Philippe P, Cailliau E, Roux C, et al. Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicentre retrospective observational study. Rheumatol. 2024;63 (8):2065-73. doi:10.1093/rheumatology/kead426.$$$$$Y$$$20240905$$HP$FR$FR
233284963$23328496$3$F$$20240701$20231221$20240702$EXP$$BE-SANDOZ INC.-SDZ2023BE070130$SANDOZ$$66$YR$$F$Y$$$20240702$$HP$BE$BE
233285387$23328538$7$F$20231101$20240624$20231221$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005485$ACADIA PHARMACEUTICALS$$19$YR$$F$Y$$$20240718$$CN$US$US
233286352$23328635$2$F$$20240627$20231221$20240705$PER$$US-ALXN-A202312511$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240705$$MD$US$US
233286503$23328650$3$F$20230101$20240802$20231221$20240807$EXP$$US-ABBVIE-5551888$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
233286695$23328669$5$F$$20240820$20231221$20240826$PER$$US-ALXN-A202312663$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
233287313$23328731$3$F$$20240704$20231221$20240726$PER$$CA-TOLMAR, INC.-23CA045143$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
233287513$23328751$3$F$20210101$20240701$20231221$20240704$EXP$$US-ABBVIE-5432213$ABBVIE$$$$$F$Y$83.914$KG$20240704$$CN$US$US
233287712$23328771$2$F$$20240812$20231221$20240813$EXP$$DE-SANDOZ INC.-SDZ2023DE070267$SANDOZ$$54$YR$$$Y$$$20240813$$HP$DE$DE
233287722$23328772$2$F$$20240916$20231221$20240923$EXP$$ES-JNJFOC-20231244740$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$ES$ES
233289362$23328936$2$F$$20240830$20231222$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005555$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
233289422$23328942$2$F$$20240716$20231222$20240724$EXP$$CA-APOTEX-2023AP018053$APOTEX$$55$YR$$F$Y$$$20240724$$CN$CA$CA
233291376$23329137$6$F$20231201$20240729$20231222$20240805$EXP$$CA-CELLTRION INC.-2023CA024668$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
233291896$23329189$6$F$20231201$20240627$20231222$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-185693$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240705$$CN$US$US
233292023$23329202$3$F$$20240806$20231222$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202206004091$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240808$$CN$US$US
233292203$23329220$3$F$20231213$20240919$20231222$20240928$EXP$$CA-CELLTRION INC.-2023CA024577$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
233292425$23329242$5$F$20231001$20240814$20231222$20240821$PER$$US-BIOGEN-2023BI01236780$BIOGEN$$52$YR$$F$Y$$$20240821$$CN$US$US
233292752$23329275$2$F$$20231218$20231222$20240701$PER$$US-LEO Pharma-366150$LEO PHARM$$42$YR$$F$Y$$$20240701$$PH$US$US
233293239$23329323$9$F$20230101$20240919$20231222$20240928$EXP$$CA-CELLTRION INC.-2022CA019865$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
233293565$23329356$5$F$$20240910$20231222$20240923$EXP$$CA-APOTEX-2023AP017927$APOTEX$$75$YR$$F$Y$70$KG$20240923$$HP$CA$CA
233294052$23329405$2$F$20230101$20240710$20231222$20240712$EXP$$US-UCBSA-2023032686$UCB$$$$$F$Y$$$20240712$$CN$US$US
233294602$23329460$2$F$$20240814$20231222$20240819$EXP$$PH-TAKEDA-2022TUS014036$TAKEDA$$$$$F$Y$$$20240819$$CN$PH$PH
233294932$23329493$2$F$20231017$20240710$20231222$20240716$EXP$$JP-TAKEDA-2023TJP017150$TAKEDA$$21$YR$$F$Y$51.9$KG$20240716$$MD$JP$JP
233295442$23329544$2$F$$20231221$20231222$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202312012900$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240720$$CN$US$US
233295575$23329557$5$F$$20240701$20231222$20240702$EXP$$US-BIOVITRUM-2023-US-020725$BIOVITRUM$$6$MON$$M$Y$6.16$KG$20240702$$CN$US$US
233297022$23329702$2$F$$20240925$20231222$20240925$EXP$$US-SANDOZ INC.-SDZ2023US020411$SANDOZ$$$$$F$Y$$$20240925$$HP$US$US
233298596$23329859$6$F$20230101$20240802$20231222$20240809$PER$$US-SA-2023SA391183$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240809$$MD$US$US
233299082$23329908$2$F$$20240711$20231222$20240719$PER$$US-SA-2023SA391105$SANOFI AVENTIS$$$$A$M$Y$58.9$KG$20240719$$MD$US$US
233299333$23329933$3$F$$20240812$20231222$20240817$PER$$US-SA-2023SA395034$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240817$$MD$US$US
233299362$23329936$2$F$$20240805$20231222$20240813$PER$$US-SA-2023SA393211$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240814$$CN$US$US
233299482$23329948$2$F$$20240909$20231222$20240919$PER$$US-SA-2023SA394738$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240919$$MD$US$US
233300053$23330005$3$F$20230101$20240904$20231222$20240913$PER$$US-SA-2023SA394740$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240913$$MD$US$US
233300563$23330056$3$F$20230801$20240725$20231222$20240802$PER$$US-SA-2023SA391481$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240802$$MD$US$US
233300775$23330077$5$F$20231214$20240723$20231222$20240729$EXP$$US-AMGEN-USASP2023224660$AMGEN$$63$YR$A$F$Y$$$20240729$$HP$US$US
233300823$23330082$3$F$$20240827$20231222$20240906$EXP$$JP-009507513-2312JPN002444J$MERCK$$60$YR$$F$Y$$$20240906$$MD$JP$JP
233301046$23330104$6$F$20180101$20240726$20231222$20240803$EXP$$AU-CELLTRION INC.-2023AU024557$CELLTRION$$$$$$Y$$$20240803$$MD$AU$AU
233301055$23330105$5$F$$20240717$20231222$20240725$PER$$US-SA-2023SA391061$SANOFI AVENTIS$$52$YR$A$F$Y$73$KG$20240725$$MD$US$US
233301233$23330123$3$F$20231111$20240826$20231222$20240903$EXP$$BR-CELLTRION INC.-2023BR024280$CELLTRION$$$$$$Y$$$20240903$$CN$BR$BR
233301305$23330130$5$F$$20240826$20231222$20240905$EXP$$CA-APOTEX-2021AP035539$APOTEX$$42$YR$$F$Y$$$20240905$$HP$CA$CA
233301507$23330150$7$F$20230513$20240914$20231222$20240924$EXP$$JP-ROCHE-3475499$ROCHE$$18$YR$A$F$Y$43.2$KG$20240924$$MD$JP$JP
233301863$23330186$3$F$20230101$20240720$20231222$20240729$PER$$US-SA-2023SA393941$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240729$$MD$US$US
233301892$23330189$2$F$20231211$20240821$20231222$20240913$PER$$US-SA-2023SA275531$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240913$$MD$US$US
233302153$23330215$3$F$20230101$20240723$20231222$20240731$EXP$$JP-009507513-2312JPN002663J$MERCK$$8$DEC$$M$Y$$$20240731$$PH$JP$JP
233303143$23330314$3$F$20230101$20240701$20231222$20240710$PER$$US-SA-2023SA396015$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240710$$MD$US$US
233303182$23330318$2$F$20231101$20240802$20231222$20240812$PER$$US-SA-2023SA395896$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240812$$MD$US$US
233303414$23330341$4$F$20230101$20240808$20231222$20240816$PER$$US-SA-2023SA392416$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240816$$MD$US$US
2333037715$23330377$15$F$20231207$20240826$20231222$20240906$EXP$$US-UCBSA-2023058314$UCB$$66$YR$$M$Y$$$20240906$$CN$US$US
233303962$23330396$2$F$20240701$20240807$20231222$20240816$PER$$US-SA-2023SA391767$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
233304106$23330410$6$F$20230101$20240719$20231222$20240731$EXP$$US-INSMED, INC.-2023-03390-US$INSMED$$$$$F$Y$$$20240731$$CN$US$US
233304703$23330470$3$F$$20240722$20231222$20240803$EXP$$IT-Accord-396182$ACCORD$Vischini G, Speciale S, Przygocka A, Martano L, La Manna G, Baraldi O. Lessons for the clinical nephrologist: acute kidney injury during therapy with?apixaban. J-Nephrol. 2023;37:511-513.$81$YR$E$M$Y$$$20240803$$HP$IT$IT
233304983$23330498$3$F$20231212$20240716$20231222$20240724$PER$$US-SA-2023SA391720$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240724$$MD$US$US
233305062$23330506$2$F$20231201$20240809$20231222$20240820$PER$$US-SA-2023SA396385$SANOFI AVENTIS$$48$YR$A$F$Y$83.9$KG$20240820$$MD$US$US
233305332$23330533$2$F$$20240708$20231222$20240716$PER$$US-SA-2023SA394695$SANOFI AVENTIS$$57$YR$A$M$Y$75.2$KG$20240716$$MD$US$US
233305814$23330581$4$F$$20240903$20231222$20240906$EXP$$CA-SANDOZ INC.-NVSC2022CA209665$SANDOZ$$44$YR$$F$Y$97$KG$20240906$$HP$CA$CA
233306446$23330644$6$F$$20240917$20231222$20240921$PER$$NVSC2023US271538$NOVARTIS$$$$$F$Y$$$20240921$$CN$US$US
233307553$23330755$3$F$$20240619$20231222$20240910$EXP$$NVSJ2023JP018011$NOVARTIS$$67$YR$$M$Y$$$20240910$$MD$JP$JP
233307934$23330793$4$F$$20240820$20231222$20240903$EXP$$US-MYLANLABS-2023M1136057$MYLAN$$$$$F$Y$77.56$KG$20240903$$CN$US$US
233308104$23330810$4$F$$20240408$20231222$20240807$EXP$$NVSC2023HU270271$NOVARTIS$$$$A$F$Y$$$20240807$$HP$HU$HU
233308815$23330881$5$F$20231201$20240902$20231222$20240906$30DAY$$AR-JNJFOC-20231207333$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$CN$AR$AR
233310132$23331013$2$F$20230101$20240802$20231222$20240807$EXP$$US-ABBVIE-5553553$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
233310455$23331045$5$F$20230901$20240718$20231222$20240727$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-024815$JAZZ$$37$YR$$F$Y$$$20240727$$CN$US$US
233310473$23331047$3$F$$20240715$20231222$20240719$EXP$$US-OTSUKA-2023_032869$OTSUKA$$$$$F$Y$$$20240719$$CN$US$US
233311067$23331106$7$F$$20240812$20231222$20240816$EXP$$PL-PFIZER INC-202300451763$PFIZER$Welniak, A.. Toxic epidermal necrolysis - a study of 3 cases and review. Forum Dermatologicum. 2023;9(4):154-161$59$YR$$M$Y$$$20240816$$MD$PL$PL
233311474$23331147$4$F$20230101$20240620$20231222$20240702$PER$$US-SA-2023SA206759$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240702$$CN$US$US
233312055$23331205$5$F$$20240817$20231222$20240823$EXP$$NVSC2023AU268673$NOVARTIS$$$$$F$Y$$$20240823$$HP$AU$AU
233312164$23331216$4$F$20231211$20240926$20231222$20240930$PER$$US-PFIZER INC-202300445468$PFIZER$$13$YR$$M$Y$23.129$KG$20240930$$CN$US$US
233312523$23331252$3$F$$20240816$20231222$20240821$EXP$$DE-MYLANLABS-2023M1135635$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert R, Fischer Let et al. Experience with the mTOR inhibitor everolimus in pediatric liver graft recipients. Children-(Basel). 2023;10(2):1-11$10$YR$$M$Y$$$20240821$$HP$DE$DE
233312613$23331261$3$F$20220606$20240723$20231222$20240725$EXP$$ES-SANDOZ INC.-SDZ2023ES069547$SANDOZ$$67$YR$$M$Y$70$KG$20240725$$MD$ES$ES
233312674$23331267$4$F$$20240822$20231222$20240828$EXP$$DE-MYLANLABS-2023M1135602$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel). 2023;10(2):1-11$13$YR$$M$Y$$$20240828$$HP$DE$DE
233312715$23331271$5$F$20231213$20240912$20231222$20240918$EXP$$US-SA-2023SA396699$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240918$$MD$US$US
233313072$23331307$2$F$$20240827$20231222$20240828$EXP$$FR-PFIZER INC-PV202300204599$PFIZER$Otiniano, A.. Emphysematous pyelonephritis in a diabetic patient. Journal of Nephrology. 2023;36 (9):2621-2624$56$YR$$M$Y$69$KG$20240828$$HP$FR$FR
233314174$23331417$4$F$20230101$20240918$20231222$20240923$EXP$$CA-PFIZER INC-202300448974$PFIZER$$55$YR$$M$Y$$$20240923$$HP$CA$CA
233315613$23331561$3$F$$20240722$20231222$20240724$PER$$NVSC2023US269414$NOVARTIS$$$$$F$Y$$$20240724$$HP$US$US
2333168712$23331687$12$F$20240101$20240620$20231222$20240704$EXP$$US-BEH-2023166559$CSL BEHRING$$62$YR$A$F$Y$71$KG$20240704$$HP$US$US
233316892$23331689$2$F$20231205$20240829$20231222$20240904$EXP$$CA-JNJFOC-20231221730$JOHNSON AND JOHNSON$$53$YR$A$M$Y$85$KG$20240904$$HP$CA$CA
233317793$23331779$3$F$20231201$20240914$20231222$20240920$EXP$$JP-GENMAB-2023-02431$GENMAB$$49$YR$$F$Y$$$20240920$$MD$JP$JP
233317932$23331793$2$F$$20240807$20231222$20240817$EXP$$CA-BAXTER-2023BAX038877$BAXTER$$$$$M$Y$$$20240817$$HP$CA$CA
233318002$23331800$2$F$20231208$20240620$20231222$20240701$PER$$US-SA-2023SA389929$SANOFI AVENTIS$$51$YR$A$F$Y$74.84$KG$20240701$$MD$US$US
233318023$23331802$3$F$20231121$20240802$20231222$20240807$EXP$$US-SA-2023SA395546$SANOFI AVENTIS$$79$YR$E$M$Y$87$KG$20240807$$MD$US$US
233319102$23331910$2$F$20230601$20230603$20231222$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393759$RANBAXY$$15$YR$T$$Y$$$20240705$$CN$US$US
233319112$23331911$2$F$$20230627$20231222$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397873$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
233319122$23331912$2$F$20230703$20230703$20231222$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399619$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
233319132$23331913$2$F$$20230620$20231222$20240716$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396309$RANBAXY$$$$$$Y$$$20240716$$CN$US$US
233319142$23331914$2$F$20230628$20230705$20231222$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399709$RANBAXY$$15$YR$T$$Y$$$20240702$$CN$US$US
233319162$23331916$2$F$20230501$20230711$20231222$20240711$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400780$RANBAXY$$16$YR$T$F$Y$$$20240711$$CN$US$US
233319182$23331918$2$F$$20230711$20231222$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400785$RANBAXY$$$$$$Y$$$20240705$$CN$US$US
233319192$23331919$2$F$20230401$20230707$20231222$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400744$RANBAXY$$27$YR$A$$Y$$$20240702$$CN$US$US
233319202$23331920$2$F$$20230711$20231222$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401420$RANBAXY$$$$$F$Y$$$20240705$$CN$US$US
233319212$23331921$2$F$20230501$20230712$20231222$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401431$RANBAXY$$16$YR$T$F$Y$$$20240705$$CN$US$US
233319232$23331923$2$F$20230623$20230720$20231222$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401637$RANBAXY$$33$YR$A$$Y$$$20240705$$HP$US$US
233319242$23331924$2$F$$20230729$20231222$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403721$RANBAXY$$$$$F$Y$$$20240705$$CN$US$US
233319252$23331925$2$F$20230101$20230725$20231222$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403166$RANBAXY$$$$A$F$Y$$$20240705$$CN$US$US
233319272$23331927$2$F$20230713$20230718$20231222$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402621$RANBAXY$$40$YR$A$F$Y$$$20240705$$CN$US$US
233319362$23331936$2$F$20230701$20230728$20231222$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403728$RANBAXY$$78$YR$E$M$Y$$$20240702$$CN$US$US
233319372$23331937$2$F$20230718$20230803$20231222$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404307$RANBAXY$$19$YR$A$$Y$$$20240705$$CN$US$US
233319382$23331938$2$F$20230804$20230811$20231222$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405931$RANBAXY$$49$YR$A$$Y$$$20240705$$MD$US$US
233319392$23331939$2$F$20230814$20230814$20231222$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405952$RANBAXY$$2$YR$C$F$Y$$$20240705$$CN$US$US
233319402$23331940$2$F$20230814$20230815$20231222$20240709$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405957$RANBAXY$$18$YR$A$F$Y$$$20240710$$CN$US$US
233319412$23331941$2$F$20230811$20230814$20231222$20240709$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405956$RANBAXY$$15$YR$T$$Y$$$20240710$$CN$US$US
233319422$23331942$2$F$$20230814$20231222$20240711$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405953$RANBAXY$$$$$$Y$$$20240711$$MD$US$US
233319432$23331943$2$F$$20230814$20231222$20240709$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405958$RANBAXY$$$$$$Y$$$20240710$$MD$US$US
233319452$23331945$2$F$20230817$20230817$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406307$RANBAXY$$25$YR$A$$Y$$$20240710$$CN$US$US
233319462$23331946$2$F$$20230817$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406328$RANBAXY$$$$A$F$Y$$$20240710$$CN$US$US
233319472$23331947$2$F$$20230817$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406330$RANBAXY$$$$$F$Y$$$20240710$$CN$US$US
233319482$23331948$2$F$20230829$20230829$20231222$20240716$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407022$RANBAXY$$16$YR$T$$Y$$$20240716$$CN$US$US
233319492$23331949$2$F$20230823$20230823$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407200$RANBAXY$$22$YR$A$F$Y$$$20240710$$CN$US$US
233319502$23331950$2$F$20230501$20230831$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407205$RANBAXY$$32$YR$A$F$Y$$$20240710$$CN$US$US
233319512$23331951$2$F$$20230829$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407387$RANBAXY$$$$$F$Y$$$20240710$$MD$US$US
233319522$23331952$2$F$20230816$20230901$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407390$RANBAXY$$18$YR$A$F$Y$$$20240710$$CN$US$US
233319542$23331954$2$F$$20230823$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407367$RANBAXY$$$$A$F$Y$$$20240710$$MD$US$US
233319552$23331955$2$F$$20230906$20231222$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407752$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
233319562$23331956$2$F$$20230901$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408033$RANBAXY$$$$$$Y$$$20240710$$MD$US$US
233319572$23331957$2$F$$20230901$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408050$RANBAXY$$$$$F$Y$$$20240710$$CN$US$US
233319582$23331958$2$F$20230101$20230905$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408084$RANBAXY$$$$A$F$Y$$$20240710$$CN$US$US
233319592$23331959$2$F$20220901$20230901$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408054$RANBAXY$$40$YR$A$F$Y$$$20240710$$CN$US$US
233319602$23331960$2$F$20221212$20230906$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408681$RANBAXY$$14$YR$T$$Y$$$20240710$$MD$US$US
233319612$23331961$2$F$$20240408$20231222$20240716$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408541$RANBAXY$$$$A$F$Y$$$20240716$$CN$US$US
233319622$23331962$2$F$20230810$20230912$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408755$RANBAXY$$26$YR$A$M$Y$$$20240710$$HP$US$US
233319632$23331963$2$F$$20230914$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409130$RANBAXY$$$$T$F$Y$$$20240710$$HP$US$US
233319642$23331964$2$F$20230101$20230918$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408859$RANBAXY$$$$A$F$Y$$$20240710$$CN$US$US
233319652$23331965$2$F$$20230915$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409180$RANBAXY$$$$A$$Y$$$20240710$$CN$US$US
233319662$23331966$2$F$20230901$20230920$20231222$20240807$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409610$RANBAXY$$21$YR$A$F$Y$$$20240807$$MD$US$US
233319672$23331967$2$F$20230911$20230915$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409193$RANBAXY$$34$YR$A$M$Y$$$20240710$$CN$US$US
233319682$23331968$2$F$20230906$20230915$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409370$RANBAXY$$15$YR$T$F$Y$$$20240710$$MD$US$US
233319692$23331969$2$F$20230918$20230922$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410439$RANBAXY$$14$YR$T$$Y$$$20240710$$CN$US$US
233319702$23331970$2$F$20230831$20230918$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409367$RANBAXY$$15$YR$T$$Y$$$20240710$$CN$US$US
233319712$23331971$2$F$$20230925$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410309$RANBAXY$$$$$M$Y$$$20240710$$CN$US$US
233319722$23331972$2$F$20230911$20240103$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410433$RANBAXY$$16$YR$T$M$Y$$$20240710$$HP$US$US
233319732$23331973$2$F$20230918$20230927$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411663$RANBAXY$$29$YR$A$F$Y$$$20240710$$HP$US$US
233319742$23331974$2$F$20230901$20230927$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411660$RANBAXY$$19$YR$A$F$Y$$$20240710$$CN$US$US
233319752$23331975$2$F$20230924$20230928$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411898$RANBAXY$$20$YR$A$F$Y$$$20240710$$CN$US$US
233319762$23331976$2$F$$20231003$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-412157$RANBAXY$$$$$M$Y$$$20240710$$CN$US$US
233319812$23331981$2$F$20230530$20230712$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401425$RANBAXY$$15$YR$T$$Y$$$20240710$$MD$US$US
233319822$23331982$2$F$$20231026$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417417$RANBAXY$$$$A$F$Y$$$20240710$$MD$US$US
233319832$23331983$2$F$20230612$20230814$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405955$RANBAXY$$21$YR$A$$Y$$$20240710$$HP$US$US
233319852$23331985$2$F$$20230824$20231222$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407202$RANBAXY$$$$T$F$Y$$$20240710$$HP$US$US
233319884$23331988$4$F$20231128$20240709$20231222$20240712$EXP$$US-BAYER-2023A178754$BAYER$$48$YR$A$M$Y$$$20240712$$CN$US$US
233319952$23331995$2$F$$20240820$20231222$20240829$EXP$$CA-ASTELLAS-2023US038283$ASTELLAS$$59$YR$A$M$Y$$$20240829$$HP$CA$CA
233319963$23331996$3$F$$20240820$20231222$20240830$EXP$$CA-ASTELLAS-2023US038289$ASTELLAS$Unknown$40$YR$A$M$Y$$$20240830$$HP$CA$CA
233320662$23332066$2$F$20231024$20240617$20231222$20240702$EXP$$FR-CATALYST PHARMACEUTICALS, INC-FR-CATA-23-00705$CATALYST PHARMA$$$$$$Y$$$20240702$$MD$FR$FR
233320803$23332080$3$F$$20240901$20231222$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-186228$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$69.85$KG$20240903$$CN$US$US
233321176$23332117$6$F$$20240827$20231222$20240902$EXP$$CA-TAKEDA-2023TUS122130$TAKEDA$$$$$M$Y$$$20240902$$CN$CA$CA
233322783$23332278$3$F$20230601$20240627$20231222$20240705$EXP$$JP-009507513-2312JPN002414J$MERCK$$61$YR$$F$Y$$$20240705$$MD$JP$JP
233323213$23332321$3$F$20230822$20240923$20231222$20240925$EXP$ES-AEMPS-1422913$ES-MYLANLABS-2023M1135147$MYLAN$$50$YR$$F$Y$$$20240925$$MD$ES$ES
233323278$23332327$8$F$20231103$20240823$20231222$20240905$EXP$$US-UCBSA-2023013811$UCB$$13$YR$$F$Y$41$KG$20240905$$PH$US$US
233323283$23332328$3$F$$20240820$20231222$20240826$EXP$$DE-MYLANLABS-2023M1135385$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L et al.. Experience with the mtor inhibitor everolimus in pediatric liver graft recipients. Children. 2023;10(2):1-11$16$YR$$M$Y$$$20240826$$HP$DE$DE
233323966$23332396$6$F$$20240726$20231222$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-184043$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240730$$CN$US$US
233324064$23332406$4$F$20221021$20240826$20231222$20240830$EXP$$US-TAKEDA-2023TUS029478$TAKEDA$$59$YR$$F$Y$65.76$KG$20240830$$HP$US$US
233324137$23332413$7$F$20230101$20240731$20231222$20240805$EXP$$CA-PFIZER INC-202300448537$PFIZER$$58$YR$$F$Y$$$20240805$$HP$CA$CA
233325362$23332536$2$F$20230201$20240802$20231222$20240802$EXP$$AU-TAKEDA-2023TUS104159$TAKEDA$$42$YR$$M$Y$$$20240802$$HP$AU$AU
233326173$23332617$3$F$20200101$20240923$20231222$20240930$EXP$$NVSC2022BR045999$NOVARTIS$$$$$M$Y$$$20240930$$CN$BR$BR
233326334$23332633$4$F$20230901$20240909$20231222$20240919$EXP$$NVSC2023CA269550$NOVARTIS$$67$YR$$M$Y$85.9$KG$20240919$$MD$CA$CA
233326368$23332636$8$F$$20240905$20231222$20240911$EXP$$US-TAKEDA-2022TUS003007$TAKEDA$$$$$F$Y$53$KG$20240911$$MD$US$US
233326435$23332643$5$F$20231107$20240724$20231222$20240730$EXP$$US-TAKEDA-2023TUS100488$TAKEDA$$55$YR$$F$Y$47$KG$20240730$$MD$US$US
233326479$23332647$9$F$20230101$20240806$20231222$20240816$EXP$$JP-009507513-2311JPN002094J$MERCK$Nomura T, Iwata I, Kimura S, Miyata H, Kambayashi M, Shirai S, et al.. 54 A case of bilateral vocal fold insufficiency associated with pembrolizumab administration. The 301st Hokkaido Regional Meeting of the Japanese Society of Internal Medicine$62$YR$$M$Y$$$20240816$$MD$JP$JP
233327362$23332736$2$F$$20240709$20231222$20240712$PER$$US-PFIZER INC-202300445691$PFIZER$$61$YR$$F$Y$$$20240712$$HP$US$US
233327372$23332737$2$F$$20240809$20231222$20240813$PER$$US-PFIZER INC-PV202300202328$PFIZER$$51$YR$$F$Y$$$20240813$$HP$US$US
233327384$23332738$4$F$20231211$20240722$20231222$20240724$EXP$$US-PFIZER INC-202300444550$PFIZER$$71$YR$$M$Y$$$20240724$$CN$US$US
233327433$23332743$3$F$20230101$20240903$20231222$20240904$EXP$$US-PFIZER INC-PV202300202268$PFIZER$$36$YR$$F$Y$$$20240904$$HP$US$US
233327624$23332762$4$F$$20240708$20231222$20240710$PER$$US-PFIZER INC-PV202300202420$PFIZER$$66$YR$$M$Y$99.773$KG$20240710$$CN$US$US
233328312$23332831$2$F$$20240704$20231222$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-186117$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240711$$MD$JP$JP
233328502$23332850$2$F$$20240730$20231222$20240805$EXP$$DE-MYLANLABS-2023M1135517$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert R, Fischer L. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10(2):1-11$12$YR$$F$Y$$$20240805$$HP$DE$DE
233328513$23332851$3$F$$20240813$20231222$20240819$EXP$$DE-MYLANLABS-2023M1135523$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. CHILDREN. 2023;10(367):1-11$5$YR$$M$Y$$$20240819$$HP$DE$DE
233328522$23332852$2$F$$20240812$20231222$20240819$EXP$$DE-MYLANLABS-2023M1135641$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert R, Fischer L. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10(367):1-11$12$YR$$M$Y$$$20240819$$HP$DE$DE
233328695$23332869$5$F$20231109$20240920$20231222$20240927$EXP$$CA-TAKEDA-2023TUS050291$TAKEDA$$66$YR$$F$Y$$$20240927$$CN$CA$CA
233330044$23333004$4$F$$20240708$20231222$20240723$EXP$$MT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425157$RANBAXY$Farrugia S, Cachia M, Betts A, Clark E. Nodular vasculitis (erythema induratum) associated with systemic minocycline. Australas J Dermatol. 2024;65 (2):167-170$29$YR$$F$Y$$$20240723$$MD$MT$MT
233330092$23333009$2$F$$20240906$20231222$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422950$RANBAXY$$$$A$F$Y$$$20240920$$HP$US$US
233331543$23333154$3$F$$20240827$20231222$20240828$EXP$$CA-TAKEDA-2023TUS121943$TAKEDA$$$$$F$Y$$$20240828$$MD$CA$CA
233331764$23333176$4$F$20240101$20240913$20231222$20240917$PER$$US-PFIZER INC-PV202300157660$PFIZER$$46$YR$$M$Y$$$20240917$$HP$US$US
233331856$23333185$6$F$20231108$20240731$20231222$20240805$EXP$$NVSC2023RU271969$NOVARTIS$$75$YR$$F$Y$104$KG$20240805$$MD$RU$RU
233331994$23333199$4$F$20230101$20240820$20231222$20240822$PER$$US-PFIZER INC-PV202300200984$PFIZER$$66$YR$$F$Y$$$20240822$$CN$US$US
2333326111$23333261$11$F$20231209$20240702$20231222$20240709$EXP$$JP-Eisai-EC-2023-155572$EISAI$$63$YR$A$F$Y$$$20240709$$MD$JP$JP
233333633$23333363$3$F$20230503$20240628$20231222$20240703$EXP$$JP-009507513-2312JPN002624J$MERCK$Morikawa A, Takagi H, Murakami T, Takeshima F, Nishino T.. [O-50 A Case of MRSA Pyogenic Arthritis in a Hemodialysis Patient with Various Adverse Events during the Course of Treatment]. The 55th Annual Meeting of the Kyushu Society for Dialysis Therapy. 73$72$YR$$M$Y$57$KG$20240703$$MD$JP$JP
233333872$23333387$2$F$20231114$20240910$20231222$20240917$EXP$$US-BEH-2023166674$CSL BEHRING$$27$YR$A$F$Y$$$20240917$$HP$US$US
233334513$23333451$3$F$$20240916$20231222$20240927$EXP$$CA-CIPHER-2023-CA-000733$CIPHER$$$$$$Y$$$20240927$$HP$CA$CA
233334554$23333455$4$F$20231206$20240725$20231222$20240729$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-152365$DAIICHI$$53$YR$$M$Y$$$20240729$$CN$US$US
233336366$23333636$6$F$$20240813$20231222$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-185203$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240816$$CN$US$US
233336834$23333683$4$F$20231101$20240715$20231223$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-180570$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$96.62$KG$20240718$$CN$US$US
233337255$23333725$5$F$20231209$20240822$20231223$20240924$EXP$$CA-ABBVIE-5493935$ABBVIE$$85$YR$$M$Y$$$20240924$$MD$CA$CA
233337874$23333787$4$F$20230627$20240916$20231223$20240924$EXP$$BR-CELLTRION INC.-2023BR013550$CELLTRION$$$$$$Y$$$20240924$$CN$BR$BR
2333385210$23333852$10$F$20230629$20240711$20231223$20240718$EXP$$AU-JNJFOC-20231263820$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240718$$HP$AU$AU
233339548$23333954$8$F$$20240807$20231223$20240809$EXP$$NVSC2023US271495$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
233339602$23333960$2$F$20230101$20240624$20231223$20240703$PER$$US-SA-2023SA273549$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240703$$MD$US$US
233339902$23333990$2$F$$20240623$20231223$20240704$EXP$$US-ABBVIE-5554219$ABBVIE$Melani C, Lakhotia R, Pittaluga S, Phelan JD, Huang DW, Wright G, et al. Combination targeted therapy in relapsed diffuse large b-cell lymphoma. N Engl J Med. 2024;390(23):2143-2155.; Melani C, Lakhotia R, Pittaluga S, Phelan JD, Huang DW, Wright G, et al. Phase ib/ii study of multi-targeted therapy with venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (Vipor) in relapsed/refractory (R/r) diffuse large b-cell lymphoma(Dlbcl). Blood. 2023;142(Suppl 1):434-436.$$$$$Y$$$20240704$$MD$US$US
233340072$23334007$2$F$$20240703$20231223$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-186128$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240705$$HP$US$US
233340115$23334011$5$F$20231201$20240815$20231223$20240829$EXP$$CA-UCBSA-2023059939$UCB$$47$YR$$F$Y$$$20240829$$CN$CA$CA
233340255$23334025$5$F$$20240716$20231223$20240725$EXP$$CA-APOTEX-2023AP018201$APOTEX$$32$YR$$F$Y$$$20240725$$HP$CA$CA
233340992$23334099$2$F$20230920$20240830$20231223$20240912$EXP$$US-UCBSA-2023054088$UCB$$9$YR$$F$Y$$$20240912$$CN$US$US
233342245$23334224$5$F$20230101$20240816$20231223$20240830$PER$$US-SA-2023SA351026$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240830$$MD$US$US
233342384$23334238$4$F$20231218$20240813$20231223$20240814$PER$$US-AMGEN-USASP2023228663$AMGEN$$70$YR$E$F$Y$$$20240814$$CN$US$US
233342922$23334292$2$F$20231207$20240730$20231223$20240806$EXP$$JP-GENMAB-2023-02389$GENMAB$$68$YR$$M$Y$47$KG$20240806$$MD$JP$JP
233343053$23334305$3$F$20231217$20240829$20231223$20240903$PER$$US-ALXN-202312USA001112US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$HP$US$US
233343133$23334313$3$F$20231220$20231220$20231223$20240814$PER$$NVSC2023US272404$NOVARTIS$$45$YR$$F$Y$$$20240814$$CN$US$US
233343298$23334329$8$F$$20240318$20231223$20240731$PER$$NVSC2023US272811$NOVARTIS$$$$$F$Y$$$20240731$$HP$US$US
233345202$23334520$2$F$$20240718$20231224$20240724$PER$$US-SA-2023SA397169$SANOFI AVENTIS$$62$YR$A$F$Y$79.3$KG$20240725$$MD$US$US
233345806$23334580$6$F$20231115$20240910$20231224$20240917$EXP$$CO-GSK-CO2023AMR155690$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$CO$CO
233345934$23334593$4$F$$20240613$20231224$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005776$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
233346414$23334641$4$F$20230920$20240724$20231224$20240731$EXP$$NVSC2023IT271976$NOVARTIS$$$$$$Y$$$20240801$$MD$IT$IT
233346463$23334646$3$F$20240811$20240815$20231224$20240820$PER$$US-TRAVERE-2023TVT00767$TRAVERE THERAPEUTICS$$53$YR$A$F$Y$$$20240820$$CN$US$US
233346863$23334686$3$F$20231101$20240701$20231224$20240815$PER$$US-TRAVERE-2023TVT00789$TRAVERE THERAPEUTICS$$56$YR$$M$Y$96.16$KG$20240815$$CN$US$US
233346986$23334698$6$F$20230831$20240705$20231224$20240716$PER$$US-TRAVERE-2023TVT00795$TRAVERE THERAPEUTICS$$81$YR$E$M$Y$68.04$KG$20240716$$CN$US$US
2333471310$23334713$10$F$20240623$20240709$20231224$20240716$PER$$US-TRAVERE-2023TVT00813$TRAVERE THERAPEUTICS$$44$YR$A$F$Y$90.72$KG$20240716$$CN$US$US
233347793$23334779$3$F$$20240725$20231224$20240729$EXP$$CA-ROCHE-3480243$ROCHE$$35$YR$A$F$Y$$$20240729$$CN$CA$CA
233347855$23334785$5$F$20231218$20240725$20231224$20240730$EXP$$JP-ABBVIE-5552544$ABBVIE$$60$YR$$F$Y$$$20240730$$MD$JP$JP
233347973$23334797$3$F$$20240812$20231224$20240822$PER$$US-TRAVERE-2023TVT00817$TRAVERE THERAPEUTICS$$75$YR$E$M$Y$$$20240822$$CN$US$US
233347985$23334798$5$F$$20240819$20231224$20240917$PER$$US-TRAVERE-2023TVT00823$TRAVERE THERAPEUTICS$$50$YR$A$M$Y$$$20240917$$CN$US$US
233348113$23334811$3$F$20230729$20240822$20231224$20240917$PER$$US-TRAVERE-2023TVT00827$TRAVERE THERAPEUTICS$$23$YR$A$M$Y$$$20240917$$CN$US$US
233348172$23334817$2$F$20230101$20240830$20231224$20240913$PER$$US-SA-2023SA392942$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240913$$MD$US$US
233348212$23334821$2$F$20240101$20240801$20231224$20240810$PER$$US-SA-2023SA392875$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240810$$MD$US$US
233348463$23334846$3$F$$20240829$20231224$20240913$PER$$US-SA-2023SA397290$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240913$$MD$US$US
233348573$23334857$3$F$20221101$20240722$20231224$20240724$EXP$$CO-ABBVIE-5554201$ABBVIE$$84$YR$$M$Y$$$20240724$$CN$CO$CO
233348595$23334859$5$F$20231204$20240730$20231224$20240807$EXP$$NZ-BAXTER-2023BAX038641$BAXTER$$53$YR$$M$Y$78.2$KG$20240807$$MD$NZ$NZ
233348644$23334864$4$F$20231201$20240605$20231224$20240716$PER$$US-TRAVERE-2023TVT00845$TRAVERE THERAPEUTICS$$74$YR$E$F$Y$$$20240716$$CN$US$US
233348774$23334877$4$F$$20240705$20231224$20240815$PER$$US-TRAVERE-2023TVT00855$TRAVERE THERAPEUTICS$$26$YR$A$F$Y$$$20240815$$CN$US$US
233348974$23334897$4$F$20230101$20240906$20231224$20240917$PER$$US-SA-2023SA393559$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240918$$MD$US$US
233349522$23334952$2$F$$20240808$20231225$20240813$EXP$$US-TAKEDA-2023TUS122463$TAKEDA$$$$$M$Y$97.052$KG$20240813$$MD$US$US
233349984$23334998$4$F$20220728$20240826$20231225$20240829$EXP$$JP-TAKEDA-SH202209223$TAKEDA$$15$YR$$M$Y$51.6$KG$20240829$$MD$JP$JP
233350112$23335011$2$F$20231101$20240706$20231225$20240717$EXP$$FR-AUROBINDO-AUR-APL-2023-079205$AUROBINDO$$87$YR$$F$Y$62$KG$20240717$$MD$FR$FR
233350703$23335070$3$F$20230101$20240816$20231225$20240821$EXP$$US-SAKK-2023SA395121AA$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240821$$PH$US$US
233350985$23335098$5$F$20240428$20240614$20231225$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005564$ACADIA PHARMACEUTICALS$$18$YR$$F$Y$$$20240709$$CN$US$US
233351452$23335145$2$F$20221014$20240820$20231225$20240828$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-011006$AMGEN$$58$YR$A$M$Y$$$20240828$$LW$US$US
233351473$23335147$3$F$20230101$20240716$20231225$20240723$EXP$$US-SAKK-2023SA394003AA$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240723$$CN$US$US
233351762$23335176$2$F$$20240816$20231225$20240821$EXP$$CA-ROCHE-3479302$ROCHE$$60$YR$A$F$Y$$$20240821$$CN$CA$CA
233352366$23335236$6$F$$20240617$20231225$20240711$EXP$$JP-ROCHE-2985179$ROCHE$$55$YR$A$M$Y$64$KG$20240711$$MD$JP$JP
233353713$23335371$3$F$20210101$20240820$20231225$20240824$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-011008$AMGEN$$52$YR$A$F$Y$$$20240824$$LW$US$US
233353834$23335383$4$F$20230911$20240904$20231225$20240910$EXP$$NVSJ2023JP018055$NOVARTIS$$71$YR$$M$Y$64$KG$20240910$$MD$JP$JP
233354233$23335423$3$F$20240119$20240805$20231225$20240806$EXP$$AU-TAKEDA-2023TUS077196$TAKEDA$$24$YR$$M$Y$$$20240806$$CN$AU$AU
233354422$23335442$2$F$20230101$20240626$20231225$20240702$EXP$$US-AMGEN-USASP2023228290$AMGEN$$85$YR$E$M$Y$$$20240702$$MD$US$US
233355003$23335500$3$F$20211124$20240820$20231225$20240826$EXP$$US-HORIZON THERAPEUTICS-HZN-2021-009230$AMGEN$$61$YR$A$M$Y$130.2$KG$20240826$$LW$US$US
233355013$23335501$3$F$20230925$20240829$20231225$20240904$EXP$$BR-TAKEDA-2023TUS122316$TAKEDA$$26$YR$$M$Y$$$20240904$$CN$BR$BR
233356052$23335605$2$F$20231120$20240706$20231225$20240717$EXP$$US-Accord-397540$ACCORD$$17$YR$T$F$Y$$$20240717$$HP$US$US
233356182$23335618$2$F$20231114$20240823$20231225$20240829$EXP$$CA-TAKEDA-2023TUS121856$TAKEDA$$39$YR$$F$Y$$$20240829$$MD$CA$CA
233356313$23335631$3$F$20230101$20240723$20231225$20240806$EXP$$US-UCBSA-2023048592$UCB$$$$$M$Y$$$20240806$$MD$US$US
233356703$23335670$3$F$$20240614$20231225$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005503$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
233356803$23335680$3$F$$20240820$20231225$20240904$EXP$$CA-ASTELLAS-2023US038180$ASTELLAS$unk. unk. unk unk;unk:unk.$28$YR$A$F$Y$$$20240904$$MD$CA$CA
233356932$23335693$2$F$$20240820$20231225$20240830$EXP$$CA-ASTELLAS-2023US038282$ASTELLAS$$27$YR$A$M$Y$$$20240830$$HP$CA$CA
233356992$23335699$2$F$$20240820$20231225$20240903$EXP$$CA-ASTELLAS-2023US038303$ASTELLAS$Unknown$55$YR$A$F$Y$$$20240831$$HP$CA$CA
233358064$23335806$4$F$20240726$20240813$20231225$20240826$PER$$US-SA-2023SA394146$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240826$$CN$US$US
233358164$23335816$4$F$20231201$20240731$20231225$20240807$PER$$US-SA-2023SA395869$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240807$$MD$US$US
233358243$23335824$3$F$20240606$20240620$20231225$20240701$PER$$US-SA-2023SA394071$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240701$$MD$US$US
233358402$23335840$2$F$20230101$20240918$20231225$20240926$PER$$US-SA-2023SA398727$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240926$$MD$US$US
233359384$23335938$4$F$20240330$20240808$20231225$20240816$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-025189$JAZZ$$19$YR$$F$Y$$$20240816$$CN$US$US
233359425$23335942$5$F$20230905$20240912$20231225$20240919$EXP$$CA-TAKEDA-2023TUS103228$TAKEDA$$11$YR$$M$Y$$$20240919$$HP$CA$CA
233360812$23336081$2$F$20220301$20240823$20231225$20240830$EXP$$FR-AMGEN-FRASP2023225696$AMGEN$$72$YR$E$M$Y$$$20240830$$MD$FR$FR
233361163$23336116$3$F$20230101$20240829$20231225$20240909$PER$$US-SA-2023SA393685$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240909$$HP$US$US
233361285$23336128$5$F$20231130$20240715$20231225$20240720$EXP$$NVSC2023AR198353$NOVARTIS$$50$YR$$F$Y$$$20240719$$CN$AR$AR
233361434$23336143$4$F$20230101$20240419$20231225$20240808$EXP$$NVSC2023BR236613$NOVARTIS$$$$$F$Y$68$KG$20240808$$CN$BR$BR
2333622016$23336220$16$F$20231127$20240917$20231225$20240924$EXP$$JP-ROCHE-3470619$ROCHE$$71$YR$E$F$Y$42.9$KG$20240924$$MD$JP$JP
233363113$23336311$3$F$20230101$20240802$20231225$20240812$PER$$US-SA-2023SA393410$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240813$$MD$US$US
233365093$23336509$3$F$20231129$20240712$20231226$20240729$PER$$CA-TOLMAR, INC.-23CA045163$TOLMAR$$77$YR$$M$Y$$$20240729$$CN$CA$CA
233365124$23336512$4$F$20231130$20240813$20231226$20240906$PER$$CA-TOLMAR, INC.-23CA045165$TOLMAR$$64$YR$$M$Y$$$20240906$$CN$CA$CA
233365143$23336514$3$F$20231129$20240710$20231226$20240729$PER$$CA-TOLMAR, INC.-23CA045173$TOLMAR$$69$YR$$M$Y$$$20240729$$CN$CA$CA
233365183$23336518$3$F$20230801$20240712$20231226$20240729$PER$$CA-TOLMAR, INC.-23CA045180$TOLMAR$$69$YR$$M$Y$$$20240729$$CN$CA$CA
233366745$23336674$5$F$20231117$20240702$20231226$20240710$EXP$$JP-JNJFOC-20231268210$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240710$$MD$JP$JP
233366862$23336686$2$F$20231222$20240717$20231226$20240719$PER$$US-AMGEN-USASP2023230341$AMGEN$$71$YR$E$M$Y$$$20240719$$PH$US$US
233367182$23336718$2$F$$20240711$20231226$20240720$EXP$$GB-AUROBINDO-AUR-APL-2023-079657$AUROBINDO$$$$A$M$Y$$$20240720$$HP$GB$GB
233367653$23336765$3$F$20230710$20240827$20231226$20240828$EXP$$CA-TAKEDA-2023TUS119829$TAKEDA$$81$YR$$F$Y$$$20240828$$CN$CA$CA
233367942$23336794$2$F$20230419$20240806$20231226$20240813$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-278921$BOEHRINGER INGELHEIM$$85$YR$E$F$Y$$$20240813$$MD$AU$AU
233368178$23336817$8$F$$20240730$20231226$20240809$PER$$US-BIOGEN-2022BI01152028$BIOGEN$$$$$M$Y$$$20240809$$CN$US$US
233368204$23336820$4$F$20100101$20240813$20231226$20240819$EXP$$US-ABBVIE-5541306$ABBVIE$$$$$F$Y$55$KG$20240819$$CN$US$US
233368223$23336822$3$F$20220818$20240701$20231226$20240702$EXP$$NVSJ2023JP018138$NOVARTIS$$72$YR$$F$Y$62$KG$20240703$$MD$JP$JP
233368266$23336826$6$F$20240216$20240725$20231226$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-185024$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240801$$CN$US$US
233368594$23336859$4$F$$20240711$20231226$20240718$EXP$JP-MMM-RPSFDWNV$JP-VIIV HEALTHCARE LIMITED-JP2023178086$VIIV$Minami R. Current Status of Vocabria and Rekambys in the Context of the Experience at Kyushu Medical Centre. HIV UP-TO-DATE seminar. 2024$$$$$Y$$$20240718$$MD$JP$JP
233368872$23336887$2$F$20230101$20240703$20231226$20240711$EXP$$US-SA-2023SA399513$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240711$$MD$US$US
233368973$23336897$3$F$$20240821$20231226$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-178054$BRISTOL MYERS SQUIBB$Manabe A, Yoshimatsu K, Mori M, Kanayama M, Takenaka M, Kuroda K. Use experience of ipilimumab/nivolumab for untreated advanced/recurrent non-small cell lung cancer at our hospital. Japanese Journal of Lung Cancer. 2023;63(5):587..$$$$$Y$$$20240828$$MD$JP$JP
233369024$23336902$4$F$20240520$20240812$20231226$20240829$PER$$CA-TOLMAR, INC.-23CA045256$TOLMAR$$78$YR$$M$Y$$$20240829$$CN$CA$CA
233369053$23336905$3$F$$20240909$20231226$20240916$EXP$$JP-ROCHE-3481227$ROCHE$Kitahori K, Ishikawa K, Honda C, Hamada N, Soejima Y, Nakano H et al.. A case of steroid-resistant TAFRO syndrome successfully treated with tocilizumab [Abstract  number: O6-7]. The 33rd Scientific Meeting of Japan College of Rheumatology Kanto Branch 2023;:80-.$66$YR$E$F$Y$73.5$KG$20240917$$MD$JP$JP
233369192$23336919$2$F$$20240718$20231226$20240726$EXP$$GR-AMGEN-GRCSP2023229096$AMGEN$$$$$F$Y$$$20240726$$MD$GR$GR
233369672$23336967$2$F$20240101$20240628$20231226$20240710$PER$$US-SA-2023SA398241$SANOFI AVENTIS$$64$YR$A$F$Y$72.57$KG$20240710$$MD$US$US
233370582$23337058$2$F$$20240816$20231226$20240823$EXP$$US-JNJFOC-20231255289$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240823$$HP$FR$US
233370993$23337099$3$F$$20240708$20231226$20240716$EXP$$US-TAKEDA-2023TUS120585$TAKEDA$$$$$F$Y$58.967$KG$20240716$$CN$US$US
233371493$23337149$3$F$20230101$20240904$20231226$20240907$EXP$$CA-JNJFOC-20231263048$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240907$$HP$CA$CA
233372517$23337251$7$F$20230101$20240623$20231226$20240701$EXP$$CA-CELLTRION INC.-2023CA024729$CELLTRION$$$$$$Y$$$20240701$$HP$CA$CA
233372573$23337257$3$F$20231202$20240818$20231226$20240823$EXP$$NVSJ2023JP017310$NOVARTIS$$19$MON$$F$Y$9$KG$20240823$$MD$JP$JP
233372606$23337260$6$F$20230101$20240809$20231226$20240821$EXP$$US-CIPLA LTD.-2023US08152$CIPLA$$$$$$Y$$$20240821$$CN$US$US
233372713$23337271$3$F$20230101$20240820$20231226$20240829$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-005802$AMGEN$$59$YR$A$M$Y$$$20240828$$CN$US$US
233373102$23337310$2$F$20231208$20240923$20231226$20240926$EXP$$CA-ABBVIE-5556804$ABBVIE$$76$YR$$M$Y$$$20240926$$CN$CA$CA
233374392$23337439$2$F$20240501$20240819$20231226$20240909$PER$$CA-TOLMAR, INC.-23CA045224$TOLMAR$$68$YR$$M$Y$$$20240909$$CN$CA$CA
233374893$23337489$3$F$$20240802$20231226$20240807$EXP$$US-TAKEDA-2022TUS007142$TAKEDA$$$$$M$Y$$$20240807$$MD$US$US
233374978$23337497$8$F$20231218$20240909$20231226$20240916$EXP$$JP-ASTELLAS-2023JP014170$ASTELLAS$$75$YR$E$F$Y$49$KG$20240916$$MD$JP$JP
233375104$23337510$4$F$20200828$20240702$20231226$20240703$EXP$$US-TAKEDA-2023TUS123836$TAKEDA$$34$YR$$M$Y$$$20240703$$PH$US$US
233375572$23337557$2$F$20231108$20240708$20231226$20240711$EXP$FR-AFSSAPS-LM2023000677$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-185150$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240711$$MD$FR$FR
233375762$23337576$2$F$20230101$20240827$20231226$20240910$PER$$US-SA-2023SA398918$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240910$$MD$US$US
233376083$23337608$3$F$20220101$20240903$20231226$20240911$EXP$$CA-CELLTRION INC.-2022CA017369$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
233376483$23337648$3$F$20220705$20240716$20231226$20240726$EXP$$BE-AUROBINDO-AUR-APL-2023-079491$AUROBINDO$$72$YR$$M$Y$69$KG$20240726$$MD$BE$BE
233377624$23337762$4$F$20230918$20240903$20231226$20240910$EXP$$CO-GSK-CO2023AMR132860$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$CO$CO
233377853$23337785$3$F$20230101$20240909$20231226$20240917$EXP$$US-PFIZER INC-PV202300207071$PFIZER$$70$YR$$M$Y$$$20240917$$HP$US$US
233377973$23337797$3$F$$20240820$20231226$20240902$PER$$US-Ipsen Biopharmaceuticals, Inc.-2023-28129$IPSEN$$$$$F$Y$$$20240902$$HP$US$US
233378013$23337801$3$F$20190922$20240710$20231226$20240716$EXP$$CO-UCBSA-2023002039$UCB$$62$YR$$F$Y$65$KG$20240716$$CN$CO$CO
233378202$23337820$2$F$20160101$20231213$20231226$20240712$PER$$US-PFIZER INC-PV202300203207$PFIZER$$62$YR$$F$Y$$$20240712$$CN$US$US
233378212$23337821$2$F$$20240709$20231226$20240711$PER$$US-PFIZER INC-PV202300174352$PFIZER$$79$YR$$F$Y$58.503$KG$20240711$$CN$US$US
233378343$23337834$3$F$20231213$20240823$20231226$20240903$EXP$GB-MHRA-MED-202312131724394040-NBSRH$GB-ROCHE-3476724$ROCHE$$35$YR$A$F$Y$$$20240903$$HP$GB$GB
233379354$23337935$4$F$$20240625$20231226$20240702$EXP$$CA-CELLTRION INC.-2022CA022435$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
233379403$23337940$3$F$20230101$20240726$20231226$20240805$PER$$US-SA-2023SA398967$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240804$$MD$US$US
233379442$23337944$2$F$20231219$20240705$20231226$20240710$EXP$$US-TAKEDA-2023TUS084790$TAKEDA$$39$YR$$M$Y$$$20240710$$CN$US$US
233379514$23337951$4$F$20220820$20240822$20231226$20240826$EXP$$CA-TAKEDA-2022TUS064725$TAKEDA$$44$YR$$M$Y$$$20240826$$HP$CA$CA
233380256$23338025$6$F$20231217$20240717$20231226$20240725$EXP$$CA-TAKEDA-2023TUS122373$TAKEDA$$87$YR$$M$Y$$$20240725$$MD$CA$CA
233380492$23338049$2$F$20230717$20230720$20231226$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402517$RANBAXY$$20$YR$A$F$Y$$$20240705$$CN$US$US
233380559$23338055$9$F$20231106$20240906$20231226$20240910$EXP$$CN-ROCHE-3480299$ROCHE$$81$YR$E$M$Y$60$KG$20240910$$MD$CN$CN
233380582$23338058$2$F$20230101$20240713$20231226$20240828$EXP$$US-BLUEBIRD BIO-US-BBB-23-00082$BLUEBIRD BIO$$$$$$Y$$$20240828$$CN$US$US
233380636$23338063$6$F$$20240806$20231226$20240810$EXP$$NVSC2023CL272848$NOVARTIS$$69$YR$$F$Y$$$20240810$$CN$CL$CL
233380667$23338066$7$F$20231101$20240624$20231226$20240702$EXP$$NVSC2023US272365$NOVARTIS$$65$YR$$M$Y$$$20240702$$CN$US$US
233380682$23338068$2$F$20230101$20240909$20231226$20240913$EXP$$US-AMGEN-USASP2023226648$AMGEN$$70$YR$E$F$Y$$$20240913$$CN$US$US
233380693$23338069$3$F$20200916$20240821$20231226$20240826$EXP$$NVSJ2023JP018036$NOVARTIS$Sugiyama T, Fukuchi K, Kitauchi Y, Shimauchi T, Fujiyama T, Ito T, et al.. Drug-induced pancreatitis caused by BRAF Inhibitors in a patient with malignant  melanoma. Program and Abstracts for the 74th Annual Meeting of the Central Division of JDA. 2023;133$72$YR$$M$Y$$$20240826$$HP$JP$JP
233381008$23338100$8$F$20231106$20240830$20231226$20240904$EXP$$CA-TAKEDA-2023TUS122189$TAKEDA$$71$YR$$F$Y$$$20240904$$CN$CA$CA
233382132$23338213$2$F$$20240812$20231226$20240813$EXP$$CA-SANDOZ INC.-NVSC2023CA037964$SANDOZ$$66$YR$$F$Y$$$20240813$$CN$CA$CA
233382375$23338237$5$F$20231207$20240919$20231226$20240925$EXP$$JP-009507513-2312JPN002627J$MERCK$$52$YR$$F$Y$$$20240925$$MD$JP$JP
233382452$23338245$2$F$$20240815$20231226$20240823$EXP$$GB-SANDOZ INC.-SDZ2023GB071469$SANDOZ$$$$$M$Y$$$20240823$$CN$GB$GB
233383847$23338384$7$F$20231130$20240722$20231226$20240724$EXP$$IT-JNJFOC-20231262836$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240724$$HP$IT$IT
233384434$23338443$4$F$20230613$20240910$20231226$20240918$EXP$$CA-TAKEDA-2023TUS059258$TAKEDA$$67$YR$$F$Y$$$20240918$$CN$CA$CA
233384632$23338463$2$F$$20240822$20231226$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-186955$BRISTOL MYERS SQUIBB$$5$DEC$A$M$Y$$$20240828$$MD$JP$JP
233385072$23338507$2$F$$20240909$20231226$20240913$EXP$$CA-BAYER-2023A181838$BAYER$$53$YR$A$F$Y$$$20240913$$MD$CA$CA
233385202$23338520$2$F$20230829$20240829$20231226$20240906$EXP$$US-ABBVIE-5556910$ABBVIE$$58$YR$$M$Y$$$20240906$$CN$US$US
233385488$23338548$8$F$20231116$20240917$20231226$20240925$EXP$$JP-BIOGEN-2023BI01241193$BIOGEN$$54$YR$$F$Y$$$20240925$$MD$JP$JP
233385612$23338561$2$F$$20240827$20231226$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-186922$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240904$$PH$JP$JP
233386712$23338671$2$F$20231214$20231215$20231226$20240903$EXP$GB-MHRA-TPP23536635C7748392YC1702567739757$GB-TORRENT-00034436$TORRENT$$13$YR$T$M$Y$37$KG$20240903$$HP$GB$GB
233386747$23338674$7$F$20231212$20240813$20231226$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2023-036823$UNITED THERAPEUTICS$$60$YR$$F$Y$86.621$KG$20240821$$$US$US
233387342$23338734$2$F$$20240912$20231226$20240927$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-423794$RANBAXY$Noh H, Jang D, Oh SJ, Park JH, Lee JH, Lee DY. Cutaneous lymphomatoid granulomatosis without other organ involvement developed after long term treatment with immunosuppressive agents: a case report. Int J Dermatol. 2023;62(6):797-799$78$YR$$F$Y$$$20240927$$MD$KR$KR
233387756$23338775$6$F$20240724$20240724$20231226$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-186309$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240731$$HP$US$US
233389532$23338953$2$F$20231212$20240625$20231226$20240702$EXP$$US-BIOGEN-2023BI01242041$BIOGEN$$46$YR$$F$Y$84.4$KG$20240702$$CN$US$US
233389947$23338994$7$F$$20240705$20231226$20240711$EXP$$NVSC2023US273536$NOVARTIS$$$$$F$Y$$$20240711$$CN$US$US
233390614$23339061$4$F$$20240822$20231226$20240826$EXP$$US-TAKEDA-2023TUS100170$TAKEDA$$$$$F$Y$48$KG$20240826$$HP$US$US
233390952$23339095$2$F$20230101$20240827$20231226$20240905$PER$$US-SA-2023SA394185$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240905$$MD$US$US
233391182$23339118$2$F$20230101$20240912$20231226$20240919$EXP$$US-SA-2023SA398094$SANOFI AVENTIS$$66$YR$E$M$Y$74$KG$20240919$$MD$US$US
233391914$23339191$4$F$$20240826$20231226$20240830$EXP$$CA-OTSUKA-2023_023965$OTSUKA$$$$$F$Y$$$20240830$$HP$US$US
233391972$23339197$2$F$$20240822$20231226$20240909$EXP$$US-TAKEDA-2022TUS089325$TAKEDA$$$$$F$Y$$$20240909$$MD$US$US
233393595$23339359$5$F$20231215$20240725$20231226$20240730$EXP$$CA-PFIZER INC-202300449426$PFIZER$$42$YR$$M$Y$$$20240730$$CN$CA$CA
233394424$23339442$4$F$$20240702$20231226$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-187159$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$97.52$KG$20240703$$CN$US$US
233394432$23339443$2$F$$20240722$20231226$20240726$EXP$$US-TAKEDA-2023TUS111358$TAKEDA$$$$$M$Y$$$20240726$$CN$US$US
233396143$23339614$3$F$20201123$20240624$20231226$20240709$EXP$$DE-SANDOZ INC.-SDZ2023DE072128$SANDOZ$$$$A$F$Y$$$20240709$$MD$DE$DE
233396953$23339695$3$F$20230101$20240830$20231226$20240904$EXP$$JP-Eisai-EC-2023-155619$EISAI$$$$E$M$Y$$$20240904$$MD$JP$JP
233397033$23339703$3$F$20230101$20240708$20231226$20240712$EXP$$US-UNITED THERAPEUTICS-UNT-2023-033399$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240712$$PH$US$US
233397603$23339760$3$F$$20240821$20231226$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-186917$BRISTOL MYERS SQUIBB$Manabe A, Yoshimatsu K, Mori M, Kanayama M, Takenaka M, Kuroda K. Use experience of ipilimumab/nivolumab for untreated advanced/recurrent non-small cell lung cancer at our hospital. Japanese Journal of Lung Cancer. 2023;63(5):587.$$$$$Y$$$20240827$$MD$JP$JP
233397643$23339764$3$F$$20240821$20231226$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-186918$BRISTOL MYERS SQUIBB$Manabe A, Yoshimatsu K, Mori M, Kanayama M, Takenaka M, Kuroda K. Use experience of ipilimumab/nivolumab for untreated advanced/recurrent non-small cell lung cancer at our hospital. Japanese Journal of Lung Cancer. 2023;63(5):587.$$$$$Y$$$20240827$$MD$JP$JP
233397653$23339765$3$F$$20240821$20231226$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-186919$BRISTOL MYERS SQUIBB$Manabe A, Yoshimatsu K, Mori M, Kanayama M, Takenaka M, Kuroda K. Use experience of ipilimumab/nivolumab for untreated advanced/recurrent non-small cell lung cancer at our hospital. Japanese Journal of Lung Cancer. 2023;63(5):587.$$$$$Y$$$20240827$$MD$JP$JP
233397955$23339795$5$F$$20240902$20231226$20240910$30DAY$$CN-JNJFOC-20231229986$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$CN$CN
233398046$23339804$6$F$20190722$20240814$20231226$20240823$EXP$$DE-SANDOZ INC.-PHHY2019DE186078$SANDOZ$$$$E$F$Y$66$KG$20240823$$MD$DE$DE
2333981417$23339814$17$F$20231214$20240910$20231226$20240920$EXP$$JP-JNJFOC-20231265618$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240920$$CN$JP$JP
233398222$23339822$2$F$20231221$20240808$20231226$20240810$PER$$US-AMGEN-USASP2023229452$AMGEN$$70$YR$E$M$Y$$$20240809$$CN$US$US
233398302$23339830$2$F$$20240822$20231226$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-187017$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240829$$MD$JP$JP
233398323$23339832$3$F$20220606$20240902$20231226$20240909$EXP$$IL-ABBVIE-4262522$ABBVIE$$60$YR$$F$Y$60$KG$20240909$$MD$IL$IL
233398452$23339845$2$F$$20231130$20231226$20240808$PER$$US-009507513-2312USA000333$MERCK$Parker M, Kalluri A, Materi J, Gujar SK, Schreck K, Mukherjee D, et al.. Management and Molecular Characterization of Intraventricular Glioblastoma: A Single-Institution Case Series. International Journal of Molecular Sciences. 2023;24 (24):1- 13$71$YR$$M$Y$$$20240808$$HP$US$US
233398522$23339852$2$F$20190101$20240827$20231226$20240903$EXP$$UY-ABBVIE-5556184$ABBVIE$$$$$F$Y$$$20240903$$CN$UY$UY
233398683$23339868$3$F$20230101$20240709$20231226$20240718$PER$$US-SA-2023SA383305$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240718$$MD$US$US
233399012$23339901$2$F$$20231130$20231226$20240809$PER$$US-009507513-2312USA009490$MERCK$Parker M, Kalluri A, Materi J, Gujar SK, Schreck K, Mukherjee D, et al.. Management andMolecular Characterization of Intraventricular Glioblastoma: A Single-Institution Case Series. International Journal of Molecular Sciences. 2023;24 (24):1-13$61$YR$$F$Y$$$20240809$$HP$US$US
233399272$23339927$2$F$$20231130$20231226$20240809$PER$$US-009507513-2312USA009491$MERCK$Parker M, Kalluri A, Materi J, Gujar SK, Schreck K, Mukherjee D, et al.. Management andMolecular Characterization of Intraventricular Glioblastoma: A Single-Institution Case Series. International Journal of Molecular Sciences. 2023;24 (24):1-13$68$YR$$F$Y$$$20240809$$HP$US$US
233399332$23339933$2$F$$20240723$20231226$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202312013912$ELI LILLY AND CO$$86$YR$E$F$Y$$$20240725$$CN$US$US
233399434$23339943$4$F$$20240814$20231226$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-175565$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240819$$CN$US$US
233400406$23340040$6$F$20230101$20240627$20231227$20240705$EXP$$CA-CELLTRION INC.-2023CA023557$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
233400485$23340048$5$F$$20240718$20231227$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-187514$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240719$$CN$US$US
233401073$23340107$3$F$20230101$20240806$20231227$20240816$PER$$US-SA-2023SA394700$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240816$$MD$US$US
233401445$23340144$5$F$20230101$20240701$20231227$20240710$EXP$$US-SA-2023SA393148$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240710$$CN$US$US
233401904$23340190$4$F$20231101$20240813$20231227$20240821$PER$$US-SA-2023SA394699$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240821$$MD$US$US
233401992$23340199$2$F$20230101$20240813$20231227$20240819$PER$$US-SA-2023SA396487$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240819$$MD$US$US
233402052$23340205$2$F$$20240704$20231227$20240708$PER$$US-AMGEN-USASP2023230395$AMGEN$$$$A$F$Y$$$20240708$$HP$US$US
233402152$23340215$2$F$$20240717$20231227$20240725$PER$$US-SA-2023SA396804$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240725$$MD$US$US
233402673$23340267$3$F$20210401$20240827$20231227$20240917$PER$$CO-TOLMAR, INC.-23CO044705$TOLMAR$$65$YR$$M$Y$$$20240917$$CN$CO$CO
233403033$23340303$3$F$$20240911$20231227$20240919$EXP$$BR-EMD Serono-2023496297$EMD SERONO INC$$$$A$F$Y$$$20240919$$CN$BR$BR
233403055$23340305$5$F$20220101$20240214$20231227$20240805$EXP$$NVSC2023US271919$NOVARTIS$$$$$F$Y$$$20240805$$CN$US$US
233403065$23340306$5$F$20220418$20240813$20231227$20240819$EXP$$BR-TAKEDA-BR202011798$TAKEDA$$19$YR$$M$Y$79$KG$20240819$$CN$BR$BR
233403112$23340311$2$F$20230101$20240723$20231227$20240730$EXP$$BR-EMD Serono-2023496416$EMD SERONO INC$$32$YR$A$F$Y$$$20240730$$CN$BR$BR
233404052$23340405$2$F$$20240819$20231227$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-186944$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240821$$PH$JP$JP
233404445$23340444$5$F$20231128$20240703$20231227$20240711$EXP$$JP-GENMAB-2023-02281$GENMAB$$79$YR$$F$Y$46.2$KG$20240711$$MD$JP$JP
2334045615$23340456$15$F$20231211$20240624$20231227$20240701$EXP$$NVSC2023RU272819$NOVARTIS$$2$YR$$F$Y$9.5$KG$20240701$$CN$RU$RU
233404985$23340498$5$F$20220101$20240627$20231227$20240701$EXP$$US-UCBSA-2023053428$UCB$$$$$F$Y$$$20240701$$HP$US$US
233405665$23340566$5$F$$20240829$20231227$20240906$EXP$$US-ROCHE-3427364$ROCHE$$81$YR$E$F$Y$57.15$KG$20240906$$CN$US$US
233406062$23340606$2$F$$20240624$20231227$20240701$EXP$$BR-NOVOPROD-1153350$NOVO NORDISK$$839$MON$$M$Y$$$20240701$$CN$BR$BR
233406443$23340644$3$F$$20240805$20231227$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-185257$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240812$$CN$US$US
233407148$23340714$8$F$$20240625$20231227$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-185086$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240701$$CN$US$US
233407214$23340721$4$F$$20240703$20231227$20240708$EXP$$US-SANDOZ INC.-NVSC2023US147808$SANDOZ$$$$$F$Y$54.422$KG$20240708$$CN$US$US
233408055$23340805$5$F$20231106$20240704$20231227$20240714$EXP$$CA-ROCHE-3479392$ROCHE$$49$YR$A$M$Y$$$20240714$$MD$CA$CA
233408085$23340808$5$F$20240622$20240730$20231227$20240806$EXP$$BR-TAKEDA-2023TUS123808$TAKEDA$$59$YR$$F$Y$75$KG$20240806$$CN$BR$BR
233408613$23340861$3$F$$20240627$20231227$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-187030$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$MD$JP$JP
233410035$23341003$5$F$$20240729$20231227$20240821$PER$$CA-TOLMAR, INC.-23CA045288$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
233411199$23341119$9$F$20231215$20240920$20231227$20240930$EXP$$CA-CELLTRION INC.-2023CA024787$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
233411514$23341151$4$F$20231211$20240918$20231227$20240930$EXP$$JP-AMGEN-JPNCT2023229763$AMGEN$$65$YR$E$F$Y$$$20240930$$MD$JP$JP
233411604$23341160$4$F$$20240921$20231227$20240925$EXP$$CA-TAKEDA-2023TUS123305$TAKEDA$$$$$M$Y$73.7$KG$20240925$$HP$CA$CA
233411753$23341175$3$F$$20240808$20231227$20240812$EXP$$JP-JNJFOC-20231267506$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240812$$MD$JP$JP
233411982$23341198$2$F$20230214$20240703$20231227$20240713$EXP$SE-SEMPA-2023-016534$SE-ROCHE-3479240$ROCHE$$78$YR$E$F$Y$49$KG$20240713$$CN$SE$SE
233412072$23341207$2$F$$20240709$20231227$20240712$EXP$$JP-ABBVIE-5551926$ABBVIE$$65$YR$$F$Y$$$20240712$$MD$JP$JP
233412153$23341215$3$F$20240508$20240613$20231227$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005542$ACADIA PHARMACEUTICALS$$61$YR$$M$Y$$$20240708$$CN$US$US
233412353$23341235$3$F$20231222$20240731$20231227$20240803$PER$$US-AMGEN-USASP2023230914$AMGEN$$80$YR$E$F$Y$$$20240803$$CN$US$US
233412734$23341273$4$F$20201216$20240814$20231227$20240820$EXP$$CA-TAKEDA-2023TUS122470$TAKEDA$$59$YR$$F$Y$$$20240820$$CN$CA$CA
233414382$23341438$2$F$$20240829$20231227$20240911$EXP$$US-CIPLA LTD.-2023US08286$CIPLA$Yang A, Sarvaideo J.. Testosterone replacement therapy implicated in osteonecrosis. Journal of the Endocrine Society. 2019;13(Suppl 1)$$$$$Y$$$20240911$$MD$US$US
233414462$23341446$2$F$20231226$20240723$20231227$20240726$PER$$US-AMGEN-USASP2023230998$AMGEN$$52$YR$A$F$Y$$$20240726$$CN$US$US
233414642$23341464$2$F$20231225$20240718$20231227$20240724$PER$$US-AMGEN-USASP2023230895$AMGEN$$81$YR$E$M$Y$$$20240724$$CN$US$US
233415522$23341552$2$F$$20231220$20231227$20240923$EXP$$NVSC2023US273500$NOVARTIS$$$$$F$Y$$$20240923$$HP$US$US
233415672$23341567$2$F$$20240904$20231227$20240909$EXP$$CA-PFIZER INC-202300453474$PFIZER$$40$YR$$M$Y$$$20240909$$HP$CA$CA
233416132$23341613$2$F$20160101$20240709$20231227$20240722$EXP$$US-PERRIGO-23US014673$PERRIGO$$$$$F$Y$71.655$KG$20240722$$CN$US$US
233416384$23341638$4$F$20240730$20240828$20231227$20240904$EXP$$CO-GSK-CO2023AMR177477$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$CO$CO
233416786$23341678$6$F$20230914$20240806$20231227$20240826$EXP$$JP-AstraZeneca-2023A234552$ASTRAZENECA$Matsuzaki S, et al.. 36 A case of lung adenocarcinoma with immune checkpoint inhibitor-induced enteritis.. The 260th Japanese Respiratory Society Kanto Regional Meeting 2024;23-.$55$YR$$M$Y$55$KG$20240826$$MD$JP$
233417522$23341752$2$F$$20240628$20231227$20240701$EXP$$DE-SANDOZ INC.-SDZ2023DE033184$SANDOZ$$$$A$F$Y$$$20240701$$MD$DE$DE
233417533$23341753$3$F$20220208$20240701$20231227$20240702$EXP$$DE-SANDOZ INC.-SDZ2023DE072845$SANDOZ$$$$E$F$Y$$$20240702$$HP$DE$DE
233418282$23341828$2$F$$20240701$20231227$20240701$EXP$$BE-SANDOZ INC.-SDZ2023BE072828$SANDOZ$$$$$F$Y$$$20240701$$HP$BE$BE
233419224$23341922$4$F$20231215$20240705$20231227$20240722$EXP$$JP-009507513-2312JPN003020J$MERCK$Ikeda T, Abe T, Hashidate H, Kasahara T, Imai T, Kawakami Y. 3 A case of decreased platelets after administration of pembrolizumab. The 408th Niigata Regional Meeting of the Japanese Urological Association$9$DEC$$M$Y$$$20240719$$MD$JP$JP
233419632$23341963$2$F$20231101$20240621$20231227$20240703$PER$$US-SA-2023SA395191$SANOFI AVENTIS$$22$YR$A$F$Y$108.86$KG$20240703$$MD$US$US
233419744$23341974$4$F$20230101$20240919$20231227$20240930$PER$$US-SA-2023SA394827$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240930$$MD$US$US
233420023$23342002$3$F$20240301$20240701$20231227$20240707$PER$$US-SA-2023SA394714$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240708$$MD$US$US
233420243$23342024$3$F$20231101$20240626$20231227$20240704$PER$$US-SA-2023SA395003$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240704$$MD$US$US
233420263$23342026$3$F$20231201$20240821$20231227$20240905$PER$$US-SA-2023SA401063$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240905$$MD$US$US
233420335$23342033$5$F$20231201$20240709$20231227$20240718$PER$$US-SA-2023SA395051$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240718$$MD$US$US
233420453$23342045$3$F$20231110$20240808$20231227$20240815$PER$$US-SA-2023SA400771$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240815$$MD$US$US
233420652$23342065$2$F$$20240905$20231227$20240913$PER$$US-SA-2023SA401299$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240913$$MD$US$US
233421263$23342126$3$F$20230101$20240910$20231227$20240916$EXP$$US-SA-2023SA401443$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240916$$MD$US$US
233421332$23342133$2$F$$20240806$20231227$20240817$PER$$US-SA-2023SA401092$SANOFI AVENTIS$$68$YR$E$F$Y$154$KG$20240817$$MD$US$US
233422113$23342211$3$F$20231218$20240904$20231227$20240906$EXP$$US-BAUSCH-BL-2023-019199$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240906$$CN$US$US
233422426$23342242$6$F$$20240628$20231227$20240711$PER$$US-Ipsen Biopharmaceuticals, Inc.-2023-28015$IPSEN$$$$A$M$Y$$$20240711$$HP$US$US
233423463$23342346$3$F$$20240730$20231227$20240802$EXP$$GR-ROCHE-3479539$ROCHE$$$$$F$Y$$$20240802$$MD$GR$GR
233423873$23342387$3$F$$20240808$20231227$20240814$EXP$$DE-MYLANLABS-2023M1135533$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. CHILDREN. 2023;10(367):1-11$15$YR$$M$Y$$$20240814$$HP$DE$DE
233424083$23342408$3$F$20171110$20240702$20231227$20240707$EXP$$CA-TAKEDA-2018TUS027948$TAKEDA$$74$YR$$F$Y$$$20240707$$CN$CA$CA
233424605$23342460$5$F$20231201$20240715$20231227$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-024895$JAZZ$$32$YR$$F$Y$$$20240722$$HP$US$US
233425093$23342509$3$F$$20240821$20231227$20240829$EXP$$CA-JNJFOC-20230466775$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240829$$HP$CA$CA
233425345$23342534$5$F$$20240731$20231227$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419333$RANBAXY$Sasaki R, Osugi N, Nakagawa I. Electroencephalogram changes over time in zolpidem withdrawal seizure: A case study. Epileptic Disord. 2024;26 (1):154-157$33$YR$$M$Y$$$20240814$$HP$JP$JP
233426084$23342608$4$F$20231107$20240926$20231227$20240930$EXP$$FR-BAUSCH-BL-2023-018969$BAUSCH AND LOMB$$83$YR$$M$Y$110$KG$20240930$$HP$FR$FR
233427173$23342717$3$F$$20240811$20231227$20240819$EXP$$US-JNJFOC-20231254030$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
233427695$23342769$5$F$20231207$20240903$20231227$20240913$EXP$$CA-AMRYT PHARMACEUTICALS DAC-AEGR006714$AEGERION$$$$$$Y$$$20240913$$CN$CA$CA
233427852$23342785$2$F$20230101$20240814$20231227$20240828$PER$$US-SA-2023SA401058$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240828$$MD$US$US
233428083$23342808$3$F$20240201$20240910$20231227$20240920$EXP$$US-GSK-US2023177361$GLAXOSMITHKLINE$$89$YR$$M$Y$$$20240920$$CN$US$US
233428092$23342809$2$F$20230601$20231214$20231227$20240925$PER$$US-GSK-US2023AMR179453$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240925$$CN$US$US
233429052$23342905$2$F$20230101$20240722$20231227$20240729$EXP$$JP-009507513-2312JPN002884J$MERCK$$7$DEC$$F$Y$$$20240729$$MD$JP$JP
233429143$23342914$3$F$$20240712$20231227$20240717$EXP$$US-TAKEDA-2023TUS124091$TAKEDA$$$$$F$Y$72.56$KG$20240717$$HP$US$US
2334297010$23342970$10$F$20230101$20240925$20231227$20240930$EXP$$US-KARYOPHARM-2023KPT002287$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240930$$CN$US$US
233431032$23343103$2$F$20231201$20240730$20231227$20240807$PER$$US-SA-2023SA394600$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240807$$MD$US$US
233431505$23343150$5$F$20230101$20240621$20231227$20240702$PER$$US-SA-2023SA394902$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240702$$MD$US$US
233431712$23343171$2$F$20231117$20240718$20231227$20240726$EXP$$FR-AstraZeneca-2023A289756$ASTRAZENECA$$71$YR$$M$Y$57$KG$20240726$$MD$FR$
233431792$23343179$2$F$$20240621$20231227$20240720$PER$$US-JNJFOC-20231180050$JOHNSON AND JOHNSON$$78$DEC$E$F$Y$$$20240719$$CN$US$US
233432055$23343205$5$F$20230101$20240627$20231227$20240704$EXP$$US-SA-2023SA395258$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240704$$MD$US$US
233432323$23343232$3$F$$20240911$20231227$20240917$EXP$$JP-ABBVIE-5551849$ABBVIE$Hirai H, Akai Y, Ogata N, Ueda T. A case of cytomegalovirus retinitis during upadacitinib treatment. Ocular Infection, Inflammation and Allergy 2024 in Sapporo/The 60th Annual Meeting of Japanese Association for Ocular Infection. 2024:74.; Hirai H, Akai Y, Ogata N, Ueda T. A case of cytomegalovirus retinitis during upadacitinib treatment. Ocular Infection, Inflammation and Allergy 2024 in Sapporo/The 60th Annual Meeting of Japanese Association for Ocular Infection. 2024:74.; Hirai H, Akai Y, ...$79$YR$$F$Y$$$20240917$$MD$JP$JP
233432528$23343252$8$F$$20240910$20231227$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-186887$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240913$$HP$US$US
233433353$23343335$3$F$20220101$20240709$20231227$20240718$EXP$$JP-Eisai-EC-2023-145150$EISAI$$57$YR$A$M$Y$$$20240718$$MD$JP$JP
233434049$23343404$9$F$$20240806$20231227$20240809$EXP$$US-PFIZER INC-PV202300203862$PFIZER$$70$YR$$F$Y$$$20240809$$HP$US$US
233434073$23343407$3$F$20230101$20240819$20231227$20240821$EXP$$US-KYOWAKIRIN-2023KK020785$KYOWA$$$$$$Y$$$20240821$$HP$US$US
233434093$23343409$3$F$20230101$20240912$20231227$20240916$PER$$US-PFIZER INC-202300448262$PFIZER$$49$YR$$M$Y$86.168$KG$20240916$$HP$US$US
233434182$23343418$2$F$$20240816$20231227$20240822$PER$$US-PFIZER INC-PV202300204405$PFIZER$$50$YR$$F$Y$$$20240822$$HP$US$US
233434263$23343426$3$F$$20240918$20231227$20240920$PER$$US-PFIZER INC-PV202300202876$PFIZER$$72$YR$$M$Y$$$20240920$$HP$US$US
233434273$23343427$3$F$20210501$20240716$20231227$20240724$EXP$$CA-PFIZER INC-202300453612$PFIZER$Lafreniere, S.. Remission from severe treatment-resistant depression with moclobemide: a case report. L ^Encephale. 2023;49(6):649-650$65$YR$$F$Y$$$20240724$$HP$CA$CA
233434502$23343450$2$F$20240101$20240812$20231227$20240814$EXP$$US-PFIZER INC-PV202300074722$PFIZER$$52$YR$$F$Y$$$20240814$$HP$US$US
233434656$23343465$6$F$20240415$20240827$20231227$20240830$EXP$$GB-MYLANLABS-2023M1137493$MYLAN$$$$$M$Y$$$20240830$$PH$GB$GB
233434774$23343477$4$F$$20240712$20231227$20240716$PER$$US-PFIZER INC-PV202300204033$PFIZER$$51$YR$$F$Y$$$20240716$$CN$US$US
233435323$23343532$3$F$$20240917$20231227$20240919$EXP$$FR-MYLANLABS-2023M1136428$MYLAN$Briard M, Godet C, Mouren D, Weisenburger G, Mal H, Messika J, et al. [Cushing^s syndrome with inhaled corticosteroid: Drug interactions to avoid]. [French]. Rev-Mal-Respir 2023; 40 (9-10): 834-837.$29$YR$$F$Y$$$20240919$$HP$FR$FR
233436133$23343613$3$F$$20240911$20231227$20240917$EXP$$CA-BAUSCH-BL-2023-019083$BAUSCH AND LOMB$$$$$F$Y$$$20240917$$HP$CA$CA
233436424$23343642$4$F$$20240829$20231227$20240830$EXP$$US-PFIZER INC-202300450668$PFIZER$$87$YR$$F$Y$$$20240830$$HP$US$US
233436442$23343644$2$F$$20240808$20231227$20240809$PER$$US-PFIZER INC-PV202300208423$PFIZER$$61$YR$$M$Y$$$20240809$$HP$US$US
233436512$23343651$2$F$$20240730$20231227$20240731$PER$$US-PFIZER INC-202300451157$PFIZER$$66$YR$$M$Y$$$20240731$$MD$US$US
233437683$23343768$3$F$20231215$20240909$20231227$20240912$EXP$$US-PFIZER INC-202300449707$PFIZER$$71$YR$$F$Y$$$20240912$$CN$US$US
233438543$23343854$3$F$$20240830$20231227$20240912$EXP$$DE-INCYTE CORPORATION-2023IN013388$INCYTE$Maccari ME, Tron C, Speckmann C, Thalhammer J, Ehl S, Peters A et al.. JAKi salvage therapy followed by curative cord blood transplantation in a XIAP-deficient infant with relapsing HLH. JOURNAL OF CLINICAL IMMUNOLOGY. 2023;43:1178-81$$$$$Y$$$20240912$$HP$DE$DE
233438932$23343893$2$F$20240605$20240904$20231227$20240906$PER$$US-PFIZER INC-PV202300204888$PFIZER$$45$YR$$M$Y$$$20240906$$HP$US$US
233439304$23343930$4$F$20231201$20240628$20231227$20240709$EXP$$JP-Eisai-EC-2023-155522$EISAI$$79$YR$E$F$Y$43$KG$20240709$$MD$JP$JP
233439393$23343939$3$F$20230502$20240808$20231227$20240814$EXP$$JP-SA-2023SA399452$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240814$$MD$JP$JP
233441075$23344107$5$F$20230907$20240725$20231227$20240730$EXP$$US-ABBVIE-5559923$ABBVIE$$59$YR$$F$Y$86$KG$20240730$$CN$US$US
233441634$23344163$4$F$20230101$20240813$20231227$20240820$EXP$$US-ABBVIE-5559861$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
233441693$23344169$3$F$$20240815$20231227$20240829$PER$$US-SA-2023SA401712$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240829$$MD$US$US
233441893$23344189$3$F$20230101$20240802$20231227$20240806$EXP$$US-ABBVIE-5560439$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
233441922$23344192$2$F$20230101$20240816$20231227$20240822$EXP$$US-ABBVIE-5560791$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
233442172$23344217$2$F$20231022$20240820$20231228$20240824$EXP$$US-ABBVIE-5510812$ABBVIE$$81$YR$$F$Y$$$20240824$$CN$US$US
233442523$23344252$3$F$20231201$20240909$20231228$20240912$EXP$$UY-ABBVIE-5553635$ABBVIE$$68$YR$$M$Y$$$20240912$$CN$UY$UY
233443293$23344329$3$F$$20240723$20231228$20240801$EXP$$ES-JNJFOC-20231263308$JOHNSON AND JOHNSON$$98$YR$E$F$Y$75.3$KG$20240801$$MD$ES$ES
2334440718$23344407$18$F$20200101$20240902$20231228$20240917$EXP$DE-SA-SAC20210124000195$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15743$ALKEM$$80$YR$$M$Y$69$KG$20240917$$CN$DE$DE
233445754$23344575$4$F$20220901$20240829$20231228$20240907$EXP$$CA-CELLTRION INC.-2022CA016563$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
233445942$23344594$2$F$20220101$20240715$20231228$20240725$EXP$NZ-MEDSAFE-149010$NZ-NOVOPROD-1154399$NOVO NORDISK$$$$$M$Y$$$20240725$$CN$NZ$NZ
2334464315$23344643$15$F$20181221$20240815$20231228$20240824$EXP$$CA-CELLTRION INC.-2023CA024328$CELLTRION$$$$$$Y$$$20240824$$HP$CA$CA
233446696$23344669$6$F$$20240805$20231228$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005084$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
233446862$23344686$2$F$$20240912$20231228$20240913$EXP$$CA-SANDOZ INC.-SDZ2023CA070341$SANDOZ$$76$YR$$M$Y$$$20240913$$MD$CA$CA
233448022$23344802$2$F$20230101$20240822$20231228$20240828$EXP$$US-ABBVIE-5562107$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
233448193$23344819$3$F$$20240912$20231228$20240915$EXP$$US-GSK-US2023AMR179123$GLAXOSMITHKLINE$$$$$F$Y$$$20240915$$CN$US$US
233448364$23344836$4$F$20230928$20240705$20231228$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-187386$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$59.4$KG$20240711$$MD$JP$JP
233449322$23344932$2$F$20230801$20240723$20231228$20240729$EXP$$AR-GSK-AR2023AMR179660$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$AR$AR
233449403$23344940$3$F$$20240725$20231228$20240730$EXP$$US-TAKEDA-2023TUS109539$TAKEDA$$$$$M$Y$96$KG$20240730$$MD$US$US
233449604$23344960$4$F$$20240910$20231228$20240918$EXP$$CA-CELLTRION INC.-2020CA035310$CELLTRION$$$$$$Y$$$20240918$$CN$CA$CA
233449712$23344971$2$F$$20231221$20231228$20240926$PER$$US-GSK-US2023AMR179542$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
233449762$23344976$2$F$$20240701$20231228$20240702$EXP$$DE-SANDOZ INC.-SDZ2023DE072846$SANDOZ$$28$YR$$M$Y$$$20240702$$MD$DE$DE
233450002$23345000$2$F$$20240731$20231228$20240809$30DAY$$US-GSK-US2023176584$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$MD$US$US
233450356$23345035$6$F$$20240826$20231228$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-187917$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$77.11$KG$20240904$$CN$US$US
233450962$23345096$2$F$20231216$20240729$20231228$20240805$EXP$$CO-GSK-CO2023AMR179751$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$CO$CO
233451017$23345101$7$F$20231201$20240520$20231228$20240925$PER$$US-GSK-US2023AMR180167$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240925$$CN$US$US
233451142$23345114$2$F$20221005$20240909$20231228$20240910$EXP$$US-UCBSA-2023060912$UCB$$63$YR$$M$Y$83.447$KG$20240910$$HP$US$US
233451169$23345116$9$F$20240618$20240910$20231228$20240918$EXP$$CA-TAKEDA-2023TUS122706$TAKEDA$$71$YR$$M$Y$$$20240918$$CN$CA$CA
233451796$23345179$6$F$$20240715$20231228$20240722$EXP$$US-EMD Serono-2023496566$EMD SERONO INC$$$$E$F$Y$$$20240722$$CN$US$US
233451815$23345181$5$F$20231206$20240823$20231228$20240830$EXP$$JP-GENMAB-2023-02506$GENMAB$$53$YR$$M$Y$71$KG$20240830$$MD$JP$JP
233452383$23345238$3$F$20231208$20240109$20231228$20240802$EXP$$NVSC2023BR274333$NOVARTIS$$59$YR$$M$Y$$$20240802$$CN$BR$BR
233453847$23345384$7$F$$20240902$20231228$20240905$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-025376$JAZZ$$$$$M$Y$$$20240905$$CN$US$US
233454202$23345420$2$F$$20240909$20231228$20240911$EXP$$HU-SANDOZ INC.-PHHY2019HU156893$SANDOZ$$12$YR$$M$Y$$$20240911$$MD$HU$HU
233455144$23345514$4$F$$20240724$20231228$20240729$PER$$US-TAKEDA-2023TUS123128$TAKEDA$$$$$F$Y$$$20240729$$HP$US$US
233455672$23345567$2$F$$20240819$20231228$20240830$EXP$$SA-Accord-397713$ACCORD$Alessa M, Alhifany AA, Almatrafi NA, Bahaj AS, Alkaf HH, Alharbi J, Et al. Efficacy of docetaxel, cisplatin, and 5-fluorouracil as an induction chemotherapy in oral squamous cell carcinoma in a tertiary hospital in Saudi Arabia. Saudi Pharm J. 2024 Jan;32( 1):101885.$$$$$Y$$$20240830$$HP$SA$SA
233455882$23345588$2$F$$20240819$20231228$20240830$EXP$$SA-Accord-397717$ACCORD$Alessa M, Alhifany AA, Almatrafi NA, Bahaj AS, Alkaf HH, Alharbi J, Et al. Efficacy of docetaxel, cisplatin, and 5-fluorouracil as an induction chemotherapy in oral squamous cell carcinoma in a tertiary hospital in Saudi Arabia. Saudi Pharm J. 2024 Jan;32( 1):101885.$$$$$Y$$$20240830$$HP$SA$SA
233456203$23345620$3$F$20230901$20240911$20231228$20240918$EXP$$CO-GSK-CO2023AMR125519$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$CO$CO
233457012$23345701$2$F$20220501$20240826$20231228$20240827$EXP$FR-AFSSAPS-AN2023001616$FR-ROCHE-3477495$ROCHE$$72$YR$E$M$Y$$$20240827$$MD$FR$FR
233457172$23345717$2$F$20210511$20240705$20231228$20240710$EXP$$FR-AMGEN-FRASP2023230153$AMGEN$$69$YR$E$F$Y$$$20240710$$MD$FR$FR
233457942$23345794$2$F$20231101$20240819$20231228$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005607$ACADIA PHARMACEUTICALS$$90$YR$$F$Y$$$20240912$$HP$US$US
233458835$23345883$5$F$$20240614$20231228$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005648$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
233459154$23345915$4$F$20230508$20240708$20231228$20240711$EXP$$JP-AstraZeneca-2023A293721$ASTRAZENECA$$82$YR$$M$Y$47$KG$20240711$$MD$JP$
233459402$23345940$2$F$20231201$20240717$20231228$20240805$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000526$Unknown Manufacturer$$$$$$Y$$$20240805$$CN$US$US
233462232$23346223$2$F$20231201$20240628$20231228$20240705$EXP$$JP-009507513-2312JPN003495J$MERCK$$45$YR$$F$Y$$$20240705$$MD$JP$JP
233462267$23346226$7$F$20230901$20240524$20231228$20240813$EXP$$NVSC2023AR272622$NOVARTIS$$74$YR$$F$Y$$$20240813$$CN$AR$AR
233462453$23346245$3$F$20230101$20240624$20231228$20240705$EXP$$JP-AMGEN-JPNSP2023230415$AMGEN$$76$YR$E$M$Y$$$20240705$$PH$JP$JP
233462956$23346295$6$F$20230101$20240819$20231228$20240826$EXP$$CA-KARYOPHARM-2023KPT001790$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240826$$CN$CA$CA
233465097$23346509$7$F$20230101$20240813$20231228$20240828$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425301$RANBAXY$$67$YR$$F$Y$63.492$KG$20240828$$HP$US$US
233465193$23346519$3$F$$20240820$20231228$20240826$EXP$$DE-MYLANLABS-2023M1136312$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10 (2):1-11$9$YR$$M$Y$$$20240826$$HP$DE$DE
233465326$23346532$6$F$$20240903$20231228$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425239$RANBAXY$$$$E$M$Y$$$20240918$$CN$US$US
233465644$23346564$4$F$20230801$20240820$20231228$20240826$EXP$$JP-PFIZER INC-202300452075$PFIZER$$$$$F$Y$$$20240826$$MD$JP$JP
2334671610$23346716$10$F$$20240731$20231228$20240806$EXP$$CA-PFIZER INC-PV202300190890$PFIZER$$74$YR$$F$Y$71.1$KG$20240806$$MD$CA$CA
233467372$23346737$2$F$20221123$20240813$20231228$20240819$EXP$$CA-PFIZER INC-202201328906$PFIZER$$59$YR$$F$Y$48$KG$20240819$$HP$CA$CA
233468003$23346800$3$F$20230101$20240816$20231228$20240830$PER$$US-SA-2023SA396656$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240830$$MD$US$US
233468262$23346826$2$F$$20240820$20231228$20240830$PER$$US-SA-2023SA395016$SANOFI AVENTIS$$$$A$M$Y$$$20240830$$MD$US$US
233469103$23346910$3$F$20230101$20240904$20231228$20240913$PER$$US-SA-2023SA396810$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240913$$MD$US$US
233469445$23346944$5$F$20230101$20240730$20231228$20240806$EXP$$US-SA-2023SA395678$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240806$$MD$US$US
233469512$23346951$2$F$20231217$20240813$20231228$20240826$PER$$US-SA-2023SA403038$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240826$$MD$US$US
233470212$23347021$2$F$20230710$20240723$20231228$20240731$EXP$$JP-AstraZeneca-2023A251578$ASTRAZENECA$$66$YR$$F$Y$62$KG$20240731$$MD$JP$
233471894$23347189$4$F$20220228$20240923$20231228$20240925$EXP$$BR-TAKEDA-2023TUS123727$TAKEDA$$67$YR$$M$Y$$$20240925$$CN$BR$BR
233472932$23347293$2$F$20231211$20231225$20231228$20240918$EXP$FR-AFSSAPS-PV2023001291$FR-BAUSCH-BL-2023-019292$BAUSCH AND LOMB$$24$YR$$F$Y$118$KG$20240918$$MD$FR$FR
233473494$23347349$4$F$20230101$20240726$20231228$20240806$PER$$US-SA-2023SA394708$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240806$$MD$US$US
233473783$23347378$3$F$$20240625$20231228$20240701$EXP$$CA-SANDOZ INC.-NVSC2020CA072074$SANDOZ$$73$YR$$M$Y$$$20240701$$CN$CA$CA
233473802$23347380$2$F$$20240816$20231228$20240823$EXP$$CA-SANDOZ INC.-SDZ2023CA073423$SANDOZ$$60$YR$$F$Y$$$20240823$$CN$CA$CA
233473814$23347381$4$F$20230101$20240711$20231228$20240717$EXP$$JP-JNJFOC-20231268867$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240717$$MD$JP$JP
233473918$23347391$8$F$$20240820$20231228$20240826$EXP$$US-PFIZER INC-PV202300207547$PFIZER$$85$YR$$F$Y$$$20240826$$HP$US$US
233474352$23347435$2$F$$20240704$20231228$20240710$EXP$$DE-MYLANLABS-2023M1136862$MYLAN$Osmanodja B, Akifova A, Budde K, Beck J, Borneman-Kolatzki K, Schutz E, Oellerich M. Cell-free graft DNA for diagnosis and monitoring of antibody-mediated rejection after kidney transplantation.. Transfusion Medicine. 2023;13(04):196-200$49$YR$$M$Y$$$20240710$$MD$DE$DE
233474384$23347438$4$F$20230629$20240815$20231228$20240822$EXP$$IE-AstraZeneca-2023A166975$ASTRAZENECA$$15959$DY$$M$Y$$$20240822$$HP$IE$
233474643$23347464$3$F$$20240919$20231228$20240924$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-153653$DAIICHI$$$$$F$Y$$$20240924$$CN$US$US
233474964$23347496$4$F$20230101$20240911$20231228$20240927$PER$$US-SA-2023SA318134$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240927$$MD$US$US
233475175$23347517$5$F$20240101$20240730$20231228$20240801$EXP$$US-PFIZER INC-202300449344$PFIZER$$38$YR$$M$Y$90.72$KG$20240801$$CN$US$US
233475228$23347522$8$F$$20240718$20231228$20240723$PER$$US-PFIZER INC-PV202300121891$PFIZER$$65$YR$$F$Y$$$20240723$$HP$US$US
233475332$23347533$2$F$$20240925$20231228$20240927$PER$$US-PFIZER INC-PV202300205065$PFIZER$$67$YR$$$Y$$$20240927$$MD$US$US
233476012$23347601$2$F$20240424$20240806$20231228$20240813$EXP$$US-GSK-US2023179131$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
233476133$23347613$3$F$$20240820$20231228$20240826$EXP$$CA-TAKEDA-2021TUS042801$TAKEDA$$$$$F$Y$$$20240826$$CN$CA$CA
233476453$23347645$3$F$$20240716$20231228$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-188695$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240718$$CN$US$US
233477583$23347758$3$F$20231111$20240802$20231228$20240812$PER$$US-SA-2023SA397423$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240812$$MD$US$US
233478132$23347813$2$F$$20240701$20231228$20240701$EXP$$BE-SANDOZ INC.-SDZ2023BE073352$SANDOZ$$87$YR$$F$Y$$$20240701$$HP$BE$BE
233478793$23347879$3$F$20230514$20240813$20231228$20240820$PER$$US-JNJFOC-20231222607$JOHNSON AND JOHNSON$$35$YR$A$$Y$$$20240820$$CN$US$US
233479063$23347906$3$F$$20240816$20231228$20240823$PER$$US-INCYTE CORPORATION-2023IN012795$INCYTE$$$$$$Y$$$20240823$$CN$US$US
233479098$23347909$8$F$20240401$20240717$20231228$20240809$EXP$$BR-SANDOZ INC.-NVSC2022BR291046$SANDOZ$$67$YR$$F$Y$61$KG$20240809$$CN$BR$BR
233479842$23347984$2$F$20231220$20240821$20231228$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-186900$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240823$$CN$US$US
233480943$23348094$3$F$20230101$20240830$20231228$20240905$EXP$$JP-009507513-2312JPN003055J$MERCK$$8$DEC$$M$Y$$$20240905$$MD$JP$JP
233482923$23348292$3$F$20231109$20240813$20231228$20240821$EXP$$JP-Eisai-EC-2023-153645$EISAI$$74$YR$E$F$Y$44$KG$20240821$$MD$JP$JP
233482973$23348297$3$F$20231217$20240830$20231228$20240904$EXP$$US-BEH-2023166840$CSL BEHRING$$68$YR$E$F$Y$$$20240904$$CN$US$US
233482992$23348299$2$F$20231203$20240809$20231228$20240809$EXP$FR-AFSSAPS-PO2023001301$FR-ROCHE-3480412$ROCHE$$53$YR$A$M$Y$75$KG$20240809$$MD$FR$FR
233483102$23348310$2$F$20220111$20240720$20231228$20240724$EXP$$US-SANDOZ INC.-NVSC2022US019657$SANDOZ$$48$YR$$F$Y$104.31$KG$20240724$$CN$US$US
233483766$23348376$6$F$20231001$20240925$20231228$20240927$EXP$$CA-ROCHE-3482663$ROCHE$$38$YR$A$F$Y$77.11$KG$20240927$$CN$CA$CA
233484222$23348422$2$F$20231213$20240808$20231228$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-187631$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$57.61$KG$20240814$$HP$US$US
233484375$23348437$5$F$$20240917$20231228$20240924$EXP$$NL-ABBVIE-5562802$ABBVIE$$63$YR$$M$Y$$$20240924$$MD$NL$NL
233484492$23348449$2$F$$20240724$20231228$20240726$EXP$$CA-JNJFOC-20231149204$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240726$$HP$CA$CA
233485782$23348578$2$F$20200427$20240723$20231228$20240801$EXP$$AU-ABBVIE-5560514$ABBVIE$$80$YR$$F$Y$$$20240801$$MD$AU$AU
233485885$23348588$5$F$20231219$20240815$20231228$20240821$EXP$$US-ABBVIE-5561126$ABBVIE$$4$MON$$F$Y$3$KG$20240821$$HP$US$US
233487434$23348743$4$F$$20240808$20231229$20240815$30DAY$$US-GSK-US2023177971$GLAXOSMITHKLINE$$$$$F$Y$100.68$KG$20240815$$MD$US$US
233487754$23348775$4$F$20230101$20240624$20231229$20240702$PER$$US-SA-2023SA403137$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240702$$MD$US$US
233487982$23348798$2$F$$20240620$20231229$20240702$EXP$$CA-APOTEX-2023AP018359$APOTEX$$$$$F$Y$$$20240702$$MD$CA$CA
233488064$23348806$4$F$$20240903$20231229$20240906$EXP$$NVSC2023GB273762$NOVARTIS$$$$$F$Y$$$20240906$$CN$GB$GB
233488354$23348835$4$F$$20240904$20231229$20240913$EXP$$CA-AUROBINDO-AUR-APL-2021-002656$AUROBINDO$$63$YR$$M$Y$$$20240913$$HP$CA$CA
2334883711$23348837$11$F$$20240806$20231229$20240813$EXP$$US-GSK-US2023AMR179289$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
233488522$23348852$2$F$20230325$20231214$20231229$20240819$EXP$$GB-TEVA-VS-3138329$TEVA$$79$YR$$M$Y$114.1$KG$20240819$$MD$GB$GB
233489154$23348915$4$F$20231208$20240911$20231229$20240921$30DAY$$US-GSK-US2023178484$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240921$$HP$US$US
233489562$23348956$2$F$20231120$20240917$20231229$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-189101$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$97$KG$20240924$$HP$US$US
233489584$23348958$4$F$$20240703$20231229$20240711$EXP$$CA-ROCHE-3483277$ROCHE$$$$A$F$Y$$$20240711$$CN$CA$CA
233489826$23348982$6$F$$20240807$20231229$20240818$EXP$$PL-AUROBINDO-AUR-APL-2023-081474$AUROBINDO$Wetniak A, Lipska P, Watota W, Grabowska N, Marek-Jozefowicz L, Czajkowski R.. Toxic epidermal necrolysis - a study of 3 cases and review.. Forum Dermatologicum.. 2023;9(4):154-161$59$YR$$M$Y$$$20240818$$MD$PL$PL
233490547$23349054$7$F$20231201$20240923$20231229$20240930$EXP$$CA-JNJFOC-20230571445$JOHNSON AND JOHNSON$$39$YR$A$M$Y$73$KG$20240930$$HP$CA$CA
233490713$23349071$3$F$$20240812$20231229$20240823$EXP$$IT-AUROBINDO-AUR-APL-2023-080507$AUROBINDO$D^Onofrio G, Delrue M-A, Lortie A, Marquis C, Striano P, Jaworski M, et al.. Treatment of Refractory Epilepsy With MEK Inhibitor in Patients With RASopathy.. Pediatr-Neurol. 2023;148:148-151$7$YR$$F$Y$$$20240823$$HP$IT$IT
233490762$23349076$2$F$20230101$20231220$20231229$20240715$EXP$$US-NOVOPROD-1156993$NOVO NORDISK$$$$$$Y$$$20240715$$MD$US$US
233490974$23349097$4$F$20231127$20240830$20231229$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2023-037078$UNITED THERAPEUTICS$$51$YR$$F$Y$55.782$KG$20240906$$$US$US
233491482$23349148$2$F$20231214$20231215$20231229$20240813$EXP$GB-MHRA-TPP23536635C7748392YC1702567739757$GB-TEVA-VS-3138584$TEVA$$13$YR$$M$Y$37$KG$20240813$$HP$GB$GB
233491545$23349154$5$F$20231124$20240809$20231229$20240816$EXP$$DE-CHIESI-2023CHF06956$CHIESI$$$$A$M$Y$$$20240816$$CN$DE$DE
233491685$23349168$5$F$20230530$20240913$20231229$20240921$EXP$$CA-CELLTRION INC.-2023CA009550$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
233491808$23349180$8$F$20240103$20240807$20231229$20240812$EXP$$US-TAKEDA-2022TUS025803$TAKEDA$$69$YR$$F$Y$$$20240812$$CN$US$US
233491856$23349185$6$F$20230101$20240729$20231229$20240807$EXP$$CA-CELLTRION INC.-2023CA010654$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
233492135$23349213$5$F$20231214$20240415$20231229$20240926$EXP$$US-GSK-US2023AMR179804$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
233492532$23349253$2$F$20231226$20240821$20231229$20240824$PER$$US-AMGEN-USASP2023230764$AMGEN$$76$YR$E$M$Y$$$20240824$$CN$US$US
233493613$23349361$3$F$20230821$20240720$20231229$20240731$EXP$$DE-AUROBINDO-AUR-APL-2023-080506$AUROBINDO$$37$YR$$F$Y$$$20240731$$MD$DE$DE
233494005$23349400$5$F$20211214$20240919$20231229$20240924$EXP$$CA-JNJFOC-20211219440$JOHNSON AND JOHNSON$$11$YR$C$M$Y$43.7$KG$20240924$$HP$CA$CA
233494096$23349409$6$F$$20240917$20231229$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-189161$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$78.93$KG$20240919$$CN$US$US
233494106$23349410$6$F$20200101$20240805$20231229$20240812$EXP$$CA-CELLTRION INC.-2020CA023900$CELLTRION$$$$$$Y$$$20240812$$CN$CA$CA
233494512$23349451$2$F$20230101$20240709$20231229$20240717$PER$$US-SA-2023SA397009$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240717$$MD$US$US
233494822$23349482$2$F$$20240812$20231229$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-187730$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240813$$HP$US$US
233494845$23349484$5$F$$20240731$20231229$20240802$EXP$$CA-SANDOZ INC.-SDZ2023CA064291$SANDOZ$$$$$F$Y$$$20240802$$HP$CA$CA
233495032$23349503$2$F$$20240624$20231229$20240703$EXP$$AU-COLLEGIUM PHARMACEUTICAL, INC.-20231200984$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240703$$HP$AU$AU
233495123$23349512$3$F$20231101$20240923$20231229$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-188449$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240924$$HP$US$US
233495452$23349545$2$F$$20240708$20231229$20240717$PER$$US-SA-2023SA403393$SANOFI AVENTIS$$$$E$M$Y$$$20240717$$MD$US$US
233495695$23349569$5$F$20240101$20240830$20231229$20240908$EXP$$CA-CELLTRION INC.-2023CA024983$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
233496323$23349632$3$F$20240731$20240910$20231229$20240920$EXP$$CA-BIOCON-BBL2023001513$BIOCON$$$$$$Y$$$20240920$$CN$CA$CA
233496584$23349658$4$F$20230905$20240717$20231229$20240729$EXP$$BR-TAKEDA-2023TUS111927$TAKEDA$$15$YR$$M$Y$55$KG$20240729$$MD$BR$BR
233496853$23349685$3$F$20230101$20240703$20231229$20240708$EXP$$CA-JNJFOC-20231264617$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240708$$HP$CA$CA
233496987$23349698$7$F$20210501$20240911$20231229$20240918$EXP$$CA-CELLTRION INC.-2021CA018365$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
233497462$23349746$2$F$20220101$20240822$20231229$20240905$EXP$$JP-UCBSA-2023061197$UCB$$$$$$Y$$$20240905$$MD$JP$JP
233497543$23349754$3$F$20230101$20240710$20231229$20240718$PER$$US-SA-2023SA397769$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240718$$MD$US$US
233497625$23349762$5$F$20230101$20240830$20231229$20240909$EXP$$CA-CELLTRION INC.-2023CA024243$CELLTRION$$$$$$Y$$$20240909$$PH$CA$CA
233499192$23349919$2$F$$20240903$20231229$20240905$EXP$$CA-SANDOZ INC.-NVSC2023CA096239$SANDOZ$$63$YR$$F$Y$$$20240905$$HP$CA$CA
233499564$23349956$4$F$20231201$20240708$20231229$20240713$EXP$$US-SA-2023SA403094$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240713$$MD$US$US
233499642$23349964$2$F$$20240305$20231229$20240902$PER$$US-ASTELLAS-2023US037434$ASTELLAS$$$$E$M$Y$$$20240830$$CN$US$US
233499712$23349971$2$F$20231214$20240104$20231229$20240902$PER$$US-ASTELLAS-2023US037998$ASTELLAS$$62$YR$A$F$Y$$$20240830$$CN$US$US
233499732$23349973$2$F$$20240514$20231229$20240902$PER$$US-ASTELLAS-2023US037181$ASTELLAS$$$$E$F$Y$$$20240830$$CN$US$US
233499892$23349989$2$F$$20240110$20231229$20240902$PER$$US-ASTELLAS-2023US031203$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
233499912$23349991$2$F$20231006$20240110$20231229$20240903$PER$$US-ASTELLAS-2023US031428$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
233499932$23349993$2$F$$20240129$20231229$20240902$PER$$US-ASTELLAS-2023US032268$ASTELLAS$$$$$F$Y$$$20240830$$PH$US$US
233500122$23350012$2$F$20230901$20240129$20231229$20240902$PER$$US-ASTELLAS-2023US032472$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
233500152$23350015$2$F$$20240117$20231229$20240902$PER$$US-ASTELLAS-2023US031471$ASTELLAS$$64$YR$A$M$Y$$$20240830$$MD$US$US
233500202$23350020$2$F$20231201$20240215$20231229$20240902$PER$$US-ASTELLAS-2023US036828$ASTELLAS$$54$YR$A$M$Y$175$KG$20240830$$MD$US$US
233500222$23350022$2$F$$20231218$20231229$20240902$PER$$US-ASTELLAS-2023US028585$ASTELLAS$$70$YR$E$M$Y$$$20240830$$PH$US$US
233500242$23350024$2$F$$20240108$20231229$20240902$PER$$US-ASTELLAS-2023US030687$ASTELLAS$$8$DEC$E$F$Y$$$20240830$$HP$US$US
233500254$23350025$4$F$20221201$20240811$20231229$20240902$PER$$US-ASTELLAS-2023US027186$ASTELLAS$$75$YR$E$M$Y$$$20240830$$CN$US$US
233500262$23350026$2$F$$20240121$20231229$20240902$PER$$US-ASTELLAS-2023US031981$ASTELLAS$$9$DEC$E$$Y$$$20240830$$MD$US$US
233500272$23350027$2$F$$20240507$20231229$20240902$PER$$US-ASTELLAS-2023US026753$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
233500292$23350029$2$F$$20240125$20231229$20240902$PER$$US-ASTELLAS-2023US027703$ASTELLAS$$71$YR$E$M$Y$84.9$KG$20240830$$CN$US$US
233500517$23350051$7$F$20230101$20240703$20231229$20240715$EXP$GB-MHRA-ADR 28392804$GB-Accord-397818$ACCORD$$$$$F$Y$$$20240715$$MD$GB$GB
233501192$23350119$2$F$$20231221$20231229$20240923$PER$$CN-ROCHE-3480512$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
233502274$23350227$4$F$20231130$20240909$20231229$20240911$EXP$$NVSC2023GB230585$NOVARTIS$$54$YR$$F$Y$$$20240911$$CN$GB$GB
233502573$23350257$3$F$$20240722$20231229$20240808$PER$$CA-TOLMAR, INC.-23CA045347$TOLMAR$$$$$M$Y$$$20240808$$CN$CA$CA
233502583$23350258$3$F$20231206$20240809$20231229$20240830$PER$$CA-TOLMAR, INC.-23CA045341$TOLMAR$$74$YR$$M$Y$$$20240830$$CN$CA$CA
233502733$23350273$3$F$20231226$20240711$20231229$20240717$EXP$$US-KYOWAKIRIN-2023KK020872$KYOWA$$$$$$Y$$$20240717$$PH$US$US
233503462$23350346$2$F$20240101$20240817$20231229$20240829$PER$$US-SA-2023SA398706$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240829$$MD$US$US
233503598$23350359$8$F$20231201$20240828$20231229$20240905$EXP$$JP-009507513-2312JPN002858J$MERCK$$68$YR$$F$Y$$$20240905$$MD$JP$JP
233503865$23350386$5$F$20230101$20240624$20231229$20240704$EXP$$US-INSMED, INC.-2023-04969-US$INSMED$$$$$M$Y$$$20240704$$CN$US$US
233504482$23350448$2$F$$20240703$20231229$20240711$EXP$$CA-CELLTRION INC.-2023CA006970$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
233504652$23350465$2$F$$20240708$20231229$20240715$EXP$$US-AMGEN-USASP2023227828$AMGEN$Yan A.; Gailardo M.; Milani-nejad N. et al.. Successful Management of Extensive Cribriform Facial Scarring Secondary to PASH Syndrome with a Combination of Medical and Surgical Treatments. Dermatologic Surgery. 2023;49 (11):1049-1051$35$YR$A$M$Y$$$20240715$$HP$US$US
233505112$23350511$2$F$$20240812$20231229$20240815$EXP$$US-MYLANLABS-2023M1136370$MYLAN$$$$$F$Y$$$20240815$$CN$US$US
233505372$23350537$2$F$$20240803$20231229$20240807$EXP$$CA-ROCHE-3480477$ROCHE$$40$YR$A$F$Y$73$KG$20240807$$MD$CA$CA
233506852$23350685$2$F$20231101$20240711$20231229$20240717$EXP$FR-AFSSAPS-LM2023000675$FR-MYLANLABS-2023M1137904$MYLAN$$87$YR$$F$Y$62$KG$20240717$$MD$FR$FR
233507084$23350708$4$F$20231001$20240816$20231229$20240822$EXP$$UY-JNJFOC-20231048551$JOHNSON AND JOHNSON$$76$YR$E$F$Y$90$KG$20240822$$CN$UY$UY
233507202$23350720$2$F$20231017$20240709$20231229$20240715$PER$$US-INCYTE CORPORATION-2023IN013280$INCYTE$$$$$$Y$$$20240715$$MD$US$US
233507813$23350781$3$F$20230401$20240715$20231229$20240717$PER$$US-PFIZER INC-202300449958$PFIZER$$72$YR$$M$Y$83.9$KG$20240717$$CN$US$US
233508023$23350802$3$F$$20240820$20231229$20240822$PER$$US-PFIZER INC-PV202300205892$PFIZER$$58$YR$$F$Y$$$20240822$$CN$US$US
233508036$23350803$6$F$$20240917$20231229$20240919$PER$$US-PFIZER INC-PV202300204236$PFIZER$$46$YR$$F$Y$$$20240919$$CN$US$US
233508103$23350810$3$F$20231213$20240708$20231229$20240718$EXP$$US-FARMAPROD-202312-3738$DOMPE FARMACEUTICI$$39$YR$A$F$Y$$$20240718$$MD$US$US
233508423$23350842$3$F$$20240626$20231229$20240701$PER$$US-PFIZER INC-PV202300206073$PFIZER$$92$YR$$F$Y$$$20240701$$CN$US$US
233508794$23350879$4$F$20240112$20240722$20231229$20240729$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-010136$JAZZ$$60$YR$$M$Y$$$20240729$$CN$US$US
233508832$23350883$2$F$$20240702$20231229$20240713$EXP$$JP-UCBSA-2023061021$UCB$$74$YR$$F$Y$$$20240713$$MD$JP$JP
233508952$23350895$2$F$$20240803$20231229$20240806$EXP$$CA-ROCHE-3480483$ROCHE$$74$YR$E$F$Y$$$20240806$$HP$CA$CA
233509405$23350940$5$F$$20240620$20231229$20240701$EXP$$BE-BEH-2023166877$CSL BEHRING$$$$A$F$Y$$$20240701$$HP$BE$BE
233509473$23350947$3$F$20230513$20240718$20231229$20240725$EXP$$HR-TAKEDA-2023TUS123892$TAKEDA$$$$$$Y$$$20240725$$CN$HR$HR
233510355$23351035$5$F$20220115$20240708$20231229$20240712$EXP$$NVSC2022IE015216$NOVARTIS$$22$YR$$F$Y$$$20240712$$CN$IE$IE
233510522$23351052$2$F$20240701$20240802$20231229$20240808$EXP$$BR-TAKEDA-2023TUS065108$TAKEDA$$48$YR$$F$Y$$$20240808$$CN$BR$BR
233510637$23351063$7$F$20230101$20240918$20231229$20240923$PER$$US-PFIZER INC-PV202300152249$PFIZER$$57$YR$$M$Y$$$20240923$$MD$US$US
233510872$23351087$2$F$$20240909$20231229$20240911$PER$$US-PFIZER INC-PV202300205581$PFIZER$$79$YR$$F$Y$$$20240911$$CN$US$US
233510923$23351092$3$F$20230101$20240828$20231229$20240830$PER$$US-PFIZER INC-PV202300205875$PFIZER$$42$YR$$F$Y$$$20240830$$CN$US$US
233511812$23351181$2$F$$20240918$20231229$20240921$EXP$$BR-ROCHE-3482623$ROCHE$$$$E$F$Y$57$KG$20240921$$PH$BR$BR
233512043$23351204$3$F$$20240808$20231229$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-186552$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$56.7$KG$20240813$$CN$US$US
233513244$23351324$4$F$20230113$20240628$20231229$20240702$EXP$$US-UCBSA-2023002174$UCB$$13$YR$$F$Y$94.347$KG$20240702$$CN$US$US
233513874$23351387$4$F$$20240729$20231229$20240805$EXP$GR-SEATTLE GENETICS-2023SGN13222$GR-ROCHE-3481770$ROCHE$$$$$F$Y$$$20240805$$MD$GR$GR
233515865$23351586$5$F$$20240708$20231229$20240716$EXP$$FR-AstraZeneca-2023A295579$ASTRAZENECA$$5$MON$$F$Y$$$20240716$$MD$FR$
233516302$23351630$2$F$$20240821$20231229$20240828$EXP$$US-BIOGEN-2023BI01242535$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
233517084$23351708$4$F$20230101$20240712$20231229$20240718$PER$$US-SA-2023SA403047$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240718$$MD$US$US
233517096$23351709$6$F$20240101$20240715$20231229$20240723$PER$$US-SA-2023SA396203$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240723$$MD$US$US
233517916$23351791$6$F$20230913$20240918$20231229$20240923$EXP$$US-TAKEDA-2023TUS055310$TAKEDA$$73$YR$$F$Y$68$KG$20240923$$HP$US$US
233518754$23351875$4$F$$20240712$20231229$20240717$EXP$CA-GLAXOSMITHKLINE-CA2021GSK133817$CA-WW-2021-GSK-133817$Waylis$$72$YR$$M$Y$$$20240717$$MD$CA$CA
233518792$23351879$2$F$20230101$20240805$20231229$20240815$EXP$$JP-UCBSA-2023061034$UCB$$3$YR$$F$Y$$$20240815$$MD$JP$JP
233518982$23351898$2$F$20220101$20240822$20231229$20240905$EXP$$JP-UCBSA-2023061214$UCB$$38$YR$$F$Y$66.1$KG$20240905$$MD$JP$JP
233520282$23352028$2$F$20230101$20240117$20231229$20240701$EXP$$DE-TEVA-VS-3136045$TEVA$$29$YR$$F$Y$$$20240701$$MD$DE$DE
233520386$23352038$6$F$$20240822$20231229$20240828$EXP$$CA-ROCHE-3480208$ROCHE$$$$A$M$Y$$$20240828$$CN$CA$CA
233521162$23352116$2$F$$20231225$20231229$20240918$EXP$$US-BAUSCH-BL-2023-019327$BAUSCH AND LOMB$Kochiashvili A, Yabut J, Kwarta B, Gluck J. Bupropion Poisoning: Extracorporeal Membrane Oxygenation as a Rescue Strategy. Circulation. 2023 NOV 01;148 (SUPPLEMENT 1):. doi:10.1161/circ.148.suppl_1.17489$29$YR$$F$Y$$$20240918$$HP$US$US
233521182$23352118$2$F$$20240904$20231229$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-181080$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240905$$CN$US$US
233521293$23352129$3$F$20230623$20240818$20231229$20240823$EXP$$DE-BAUSCH-BL-2023-019143$BAUSCH AND LOMB$$67$YR$$M$Y$84.1$KG$20240823$$HP$DE$DE
233521304$23352130$4$F$20231201$20240626$20231229$20240703$EXP$$US-SA-2023SA398733$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240703$$MD$US$US
233521448$23352144$8$F$20110101$20240722$20231229$20240730$EXP$$FR-JNJFOC-20231239214$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$95$KG$20240730$$PH$FR$FR
233522352$23352235$2$F$$20240628$20231229$20240702$EXP$$US-INCYTE CORPORATION-2023IN013315$INCYTE$$$$$$Y$$$20240702$$CN$US$US
233522703$23352270$3$F$20211112$20240926$20231229$20240927$PER$$US-PFIZER INC-PV202300205330$PFIZER$$76$YR$$F$Y$114.74$KG$20240927$$MD$US$US
2335232514$23352325$14$F$20231201$20240731$20231229$20240813$EXP$$US-BEH-2023166913$CSL BEHRING$$40$YR$A$F$Y$$$20240813$$HP$US$US
233523557$23352355$7$F$20230427$20240913$20231229$20240913$EXP$$CA-PFIZER INC-202300452101$PFIZER$$53$YR$$M$Y$$$20240913$$HP$CA$CA
233524143$23352414$3$F$20231120$20240903$20231229$20240912$EXP$$DE-JNJFOC-20231169577$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240912$$HP$DE$DE
233524394$23352439$4$F$20230101$20240917$20231229$20240921$EXP$$CO-ABBVIE-5562832$ABBVIE$$$$$F$Y$47$KG$20240921$$CN$CO$CO
233524652$23352465$2$F$20230101$20240909$20231229$20240914$EXP$$CA-ABBVIE-4270001$ABBVIE$$$$$M$Y$$$20240914$$HP$CA$CA
233524984$23352498$4$F$$20240904$20231229$20240916$EXP$$PT-AUROBINDO-AUR-APL-2023-080075$AUROBINDO$Mendes C C, Monteiro H P, Lopes M J, de Lacerda P A.. Paradoxical Immune Reconstitution Inflammatory Syndrome in SARS-CoV-2 Infection After Improvement of Chemotherapy-Induced Aplasia.. Cureus.. 2023;15 (10):1-6$42$YR$$M$Y$$$20240916$$HP$PT$PT
233525013$23352501$3$F$20231101$20240710$20231229$20240717$PER$$US-SA-2023SA401572$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240717$$MD$US$US
233525042$23352504$2$F$20230101$20240628$20231229$20240703$EXP$$US-SA-2023SA405542$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240703$$MD$US$US
233525512$23352551$2$F$20231202$20240722$20231230$20240723$EXP$FR-AFSSAPS-AN2023001641$FR-UCBSA-2023060964$UCB$$51$YR$$M$Y$42.6$KG$20240723$$PH$FR$FR
233526053$23352605$3$F$20230101$20240710$20231230$20240717$PER$$US-SA-2023SA398760$SANOFI AVENTIS$$18$YR$A$F$Y$67.9$KG$20240717$$MD$US$US
233526332$23352633$2$F$$20240724$20231230$20240805$EXP$$CA-AUROBINDO-AUR-APL-2023-081554$AUROBINDO$$91$YR$$F$Y$$$20240805$$MD$CA$CA
233526422$23352642$2$F$$20240724$20231230$20240803$EXP$$CA-AUROBINDO-AUR-APL-2023-081540$AUROBINDO$$63$YR$$F$Y$85$KG$20240803$$HP$CA$CA
233526552$23352655$2$F$20160101$20240822$20231230$20240904$EXP$$JP-UCBSA-2023061196$UCB$$38$YR$$F$Y$$$20240904$$MD$JP$JP
233527502$23352750$2$F$20231220$20240715$20231230$20240724$EXP$$US-VIIV HEALTHCARE LIMITED-US2023180683$VIIV$$54$YR$$M$Y$$$20240724$$HP$US$US
233529235$23352923$5$F$20230501$20240711$20231230$20240712$EXP$$US-TAKEDA-2023TUS122890$TAKEDA$$79$YR$$F$Y$$$20240712$$HP$US$US
233529874$23352987$4$F$$20240708$20231230$20240716$EXP$$AU-ABBVIE-5563517$ABBVIE$$49$YR$$M$Y$129$KG$20240716$$CN$AU$AU
233530332$23353033$2$F$20231201$20240718$20231230$20240725$EXP$$US-GSK-US2023178608$GLAXOSMITHKLINE$$37$YR$$M$Y$$$20240725$$HP$US$US
233530685$23353068$5$F$$20240705$20231230$20240720$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK081167$GLENMARK$$$$$$Y$$$20240720$$HP$CA$CA
233530882$23353088$2$F$$20240910$20231230$20240920$EXP$$CH-TEVA-VS-3135352$TEVA$Lazic M, Brack T, Henzi A. What is your diagnosis? Tremor in the polimedic patient Internet-Doc 2023;104(24):56-58.; Lazic M, Brack T, Henzi A. What is your diagnosis? Tremor in the polimedic patient Internet-Doc 2023;104(24):56-58.$72$YR$$M$Y$$$20240920$$HP$CH$CH
233531143$23353114$3$F$$20240726$20231230$20240805$30DAY$$US-GSK-US2023178730$GLAXOSMITHKLINE$$$$$M$Y$$$20240804$$CN$US$US
233531992$23353199$2$F$20231124$20240722$20231230$20240725$PER$$US-AMGEN-USASP2023232221$AMGEN$$77$YR$E$F$Y$$$20240725$$HP$US$US
233532212$23353221$2$F$20231201$20231220$20231230$20240925$PER$$US-GSK-US2023AMR179326$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240925$$CN$US$US
233532265$23353226$5$F$20240918$20240925$20231230$20240927$EXP$$NVSC2023CO276221$NOVARTIS$$12$YR$$F$Y$55$KG$20240927$$CN$CO$CO
233532516$23353251$6$F$20231203$20240715$20231231$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005355$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240809$$CN$US$US
233532772$23353277$2$F$$20240724$20231231$20240803$EXP$$CA-AUROBINDO-AUR-APL-2023-081033$AUROBINDO$$74$YR$$F$Y$$$20240803$$HP$CA$CA
233533142$23353314$2$F$$20240829$20231231$20240909$EXP$$CA-AUROBINDO-AUR-APL-2023-081557$AUROBINDO$$35$YR$$M$Y$$$20240909$$HP$CA$CA
233533234$23353323$4$F$20230101$20240711$20231231$20240718$PER$$US-SA-2023SA403105$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240718$$MD$US$US
233533495$23353349$5$F$$20240924$20231231$20240928$EXP$$PL-AUROBINDO-AUR-APL-2023-080308$AUROBINDO$Woro? J, Siwek M. B?l brzucha jako niepo??dany efekt dzia?ania escitalopramu stosowanego w polifarmakoterapii.. [Abdominal pain as an undesirable effect of escitalopram used in polypharmacy]. 2023;6:s 45-46$58$YR$$F$Y$$$20240928$$MD$PL$PL
233533876$23353387$6$F$20231221$20240726$20231231$20240731$EXP$$CA-JNJFOC-20231272899$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240731$$HP$CA$CA
233533963$23353396$3$F$$20240717$20231231$20240725$EXP$$CA-JNJFOC-20231239398$JOHNSON AND JOHNSON$$43$YR$A$F$Y$68$KG$20240725$$HP$CA$CA
233534413$23353441$3$F$$20240827$20231231$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-11728$LUPIN$$$$$$Y$$$20240913$$PH$US$US
233534542$23353454$2$F$$20240625$20231231$20240705$PER$$US-BAYER-2023A184363$BAYER$$45$YR$A$F$Y$73.469$KG$20240705$$MD$US$US
233534742$23353474$2$F$$20240909$20231231$20240921$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK087792$GLENMARK$$$$$$Y$$$20240921$$PH$CA$CA
233535093$23353509$3$F$20220607$20240625$20231231$20240702$EXP$$NVSC2023DE273767$NOVARTIS$$$$A$M$Y$94$KG$20240702$$MD$DE$DE
233535102$23353510$2$F$20230901$20240819$20231231$20240822$EXP$$NVSC2023EG220613$NOVARTIS$$16$YR$$M$Y$100$KG$20240822$$CN$EG$EG
2335355111$23353551$11$F$20231222$20240709$20231231$20240713$EXP$$IL-ABBVIE-5563466$ABBVIE$$67$YR$$M$Y$$$20240713$$CN$IL$IL
233537472$23353747$2$F$$20240711$20240101$20240722$PER$$US-SA-2023SA404321$SANOFI AVENTIS$$$$A$F$Y$97.5$KG$20240721$$MD$US$US
233538273$23353827$3$F$20240301$20240711$20240101$20240722$PER$$US-SA-2023SA402764$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240722$$MD$US$US
233538783$23353878$3$F$20170101$20240724$20240101$20240805$EXP$$NL-AUROBINDO-AUR-APL-2023-080886$AUROBINDO$Noij DP, van den Bent M, Doorduijn JK, Wlazlo N. Relapse Primary Central Nervous System Lymphoma Successfully Consolidated with Allogeneic Stem Cell Transplantation with Thiotepa/Busulfan/Fludarabine Conditioning. Acta Haematologica. 2023;1-5$19$YR$$M$Y$$$20240805$$MD$NL$NL
233538813$23353881$3$F$20231127$20240809$20240101$20240819$PER$$US-SA-2023SA400320$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240819$$MD$US$US
233538822$23353882$2$F$20240601$20240721$20240101$20240729$PER$$US-SA-2023SA400555$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240729$$MD$US$US
233539023$23353902$3$F$$20240808$20240101$20240818$EXP$$DE-AUROBINDO-AUR-APL-2023-080827$AUROBINDO$Pottharst A, Schaumann F, Tritschler J, Bruder C, Brucker R, Hengstler H, et al.. Specialized Palliative Care in a 54 y/o pat with RAS G12Cmutated NSCLC in need of high-flow oxygen at dischargement: An ethical and logistic dilemma.. Oncology Research and Treatment. 2023;46 (Suppl 5):332$54$YR$$$Y$$$20240818$$HP$DE$DE
233539142$23353914$2$F$$20240922$20240101$20240924$EXP$$CA-BIOVITRUM-2023-CA-021436$BIOVITRUM$$62$YR$$M$Y$$$20240924$$CN$CA$CA
233539322$23353932$2$F$$20240718$20240101$20240727$EXP$$GR-AMGEN-GRCSP2023231120$AMGEN$$$$$F$Y$$$20240727$$MD$GR$GR
233541173$23354117$3$F$$20240910$20240101$20240930$PER$$US-SA-2023SA401027$SANOFI AVENTIS$$$$A$M$Y$$$20240930$$MD$US$US
233541533$23354153$3$F$$20240715$20240101$20240719$PER$$US-AMGEN-USASP2023232934$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
233541572$23354157$2$F$20231228$20240715$20240101$20240718$EXP$$CA-ROCHE-3483917$ROCHE$$49$YR$A$F$Y$$$20240718$$CN$CA$CA
233542007$23354200$7$F$20231026$20240925$20240101$20240927$EXP$$CA-TAKEDA-2023TUS104740$TAKEDA$$79$YR$$F$Y$$$20240927$$CN$CA$CA
233542452$23354245$2$F$20231101$20240812$20240101$20240821$PER$$US-SA-2023SA400366$SANOFI AVENTIS$$47$YR$A$M$Y$106.59$KG$20240821$$MD$US$US
233542472$23354247$2$F$$20231215$20240101$20240925$PER$$US-GSK-US2023AMR180445$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
233542946$23354294$6$F$$20240613$20240101$20240926$EXP$$US-GSK-US2023AMR180492$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
233543492$23354349$2$F$20230101$20240625$20240101$20240704$PER$$US-SA-2023SA401047$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240704$$CN$US$US
233544085$23354408$5$F$$20240312$20240101$20240926$EXP$$US-GSK-US2023AMR178783$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
233544178$23354417$8$F$$20240722$20240101$20240729$EXP$$DE-TAKEDA-2023TUS080679$TAKEDA$$20$YR$$$Y$$$20240729$$CN$DE$DE
233544584$23354458$4$F$20190901$20240726$20240101$20240808$EXP$$CO-ROCHE-3133284$ROCHE$$10$YR$C$F$Y$34$KG$20240808$$CN$CO$CO
233544642$23354464$2$F$20230401$20240709$20240101$20240718$30DAY$$US-GSK-US2023179214$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240718$$CN$US$US
233544705$23354470$5$F$20231101$20240916$20240101$20240920$PER$$US-SA-2023SA403590$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240920$$MD$US$US
233544732$23354473$2$F$20230412$20240819$20240101$20240820$EXP$$US-TAKEDA-2023TUS008685$TAKEDA$$43$YR$$F$Y$$$20240820$$HP$US$US
233545019$23354501$9$F$20231201$20240906$20240101$20240913$EXP$$US-GSK-US2023AMR179646$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$US$US
233545082$23354508$2$F$20230101$20240820$20240101$20240904$PER$$US-SA-2023SA401056$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240904$$MD$US$US
233545617$23354561$7$F$20230101$20240711$20240101$20240801$EXP$$US-SA-2023SA400411$SANOFI AVENTIS$$34$YR$A$M$Y$81.64$KG$20240719$$MD$US$US
233546123$23354612$3$F$20231201$20240822$20240101$20240826$EXP$$US-ROCHE-3484253$ROCHE$$62$YR$A$F$Y$$$20240826$$MD$US$US
233546206$23354620$6$F$20240103$20240806$20240101$20240812$EXP$$CA-TAKEDA-2023TUS124378$TAKEDA$$52$YR$$M$Y$$$20240812$$MD$CA$CA
233546454$23354645$4$F$$20240709$20240101$20240712$EXP$$CA-SANDOZ INC.-SDZ2023CA072111$SANDOZ$$41$YR$$F$Y$$$20240712$$MD$CA$CA
233546662$23354666$2$F$20230101$20240709$20240101$20240718$PER$$US-SA-2023SA400923$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240718$$MD$US$US
233547057$23354705$7$F$20231124$20240921$20240101$20240925$EXP$$FR-TAKEDA-2023TUS124639$TAKEDA$$68$YR$$F$Y$$$20240925$$HP$FR$FR
233547176$23354717$6$F$20231124$20240517$20240101$20240705$EXP$$JP-AstraZeneca-2023A285241$ASTRAZENECA$$82$YR$$M$Y$$$20240705$$MD$JP$
233547533$23354753$3$F$20231207$20240711$20240101$20240801$PER$$US-SA-2023SA400551$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240719$$MD$US$US
233547854$23354785$4$F$$20240622$20240101$20240701$EXP$$IN-TAKEDA-2023TUS124946$TAKEDA$$$$$F$Y$$$20240701$$CN$IN$IN
233547922$23354792$2$F$20231217$20240826$20240101$20240829$EXP$$MX-AstraZeneca-2023A295756$ASTRAZENECA$$3409$WK$$F$Y$65$KG$20240829$$CN$MX$
233548414$23354841$4$F$20230801$20240718$20240101$20240724$EXP$$CA-ROCHE-3483384$ROCHE$$50$YR$A$F$Y$$$20240724$$CN$CA$CA
233548493$23354849$3$F$$20240808$20240101$20240819$EXP$$CA-ROCHE-3480417$ROCHE$Roy G, Iordachescu I, Royal V, Lamarch C, Ahmad I, Nadeau-Fredette A, Laurin L Kidney Biopsy Findings Among Allogenic Hematopoietic Stem Cell Transplant Recipients With Kidney Injury: A Case Series. DOI:10.1016/j.xkme.2023.100674. Kidney Medicine 2023 Jul;5 (7):1-15.$40$YR$A$M$Y$$$20240819$$HP$CA$CA
233548543$23354854$3$F$20231222$20240801$20240101$20240808$EXP$$PK-AMGEN-PAKSP2023232338$AMGEN$$23$YR$A$M$Y$$$20240808$$CN$PK$PK
233548783$23354878$3$F$20231206$20240810$20240101$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005666$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240830$$CN$US$US
233548972$23354897$2$F$$20240724$20240101$20240803$EXP$$CA-AUROBINDO-AUR-APL-2023-081441$AUROBINDO$$78$YR$$F$Y$$$20240803$$HP$CA$CA
233549004$23354900$4$F$20231226$20240710$20240101$20240711$EXP$$US-TAKEDA-2023TUS125152$TAKEDA$$46$YR$$M$Y$$$20240711$$PH$US$US
233549022$23354902$2$F$$20240724$20240101$20240805$EXP$$CA-AUROBINDO-AUR-APL-2023-081458$AUROBINDO$$51$YR$$F$Y$$$20240805$$HP$CA$CA
233549723$23354972$3$F$20231120$20220613$20240101$20240809$EXP$$CA-CELLTRION INC.-2022CA022438$CELLTRION$$$$$$Y$$$20240809$$CN$CA$CA
233549783$23354978$3$F$20020101$20240827$20240101$20240919$PER$$US-SA-2023SA403268$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240919$$MD$US$US
233549902$23354990$2$F$$20240711$20240101$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-188763$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$97$KG$20240722$$HP$CA$CA
233550243$23355024$3$F$$20240709$20240101$20240717$PER$$US-SA-2023SA315404$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240717$$MD$US$US
233550262$23355026$2$F$$20240703$20240101$20240715$PER$$US-SA-2023SA404317$SANOFI AVENTIS$$2$YR$C$M$Y$16$KG$20240715$$MD$US$US
233550872$23355087$2$F$20231201$20240827$20240102$20240903$EXP$$JP-GENMAB-2023-02530$GENMAB$$74$YR$$M$Y$66.5$KG$20240903$$MD$JP$JP
233551093$23355109$3$F$20240521$20240814$20240102$20240824$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04454$AMNEAL$$1$YR$$F$Y$12.2$KG$20240824$$CN$US$US
233552033$23355203$3$F$20230101$20240708$20240102$20240713$PER$$US-SA-2023SA404683$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240713$$MD$US$US
2335525712$23355257$12$F$20231211$20240802$20240102$20240809$EXP$$US-GSK-US2023AMR180390$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$US$US
233552799$23355279$9$F$20231219$20240716$20240102$20240723$EXP$$US-JNJFOC-20231261452$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240722$$CN$US$US
233553027$23355302$7$F$20231127$20240718$20240102$20240726$EXP$$CA-CELLTRION INC.-2023CA024927$CELLTRION$$$$$$Y$$$20240726$$HP$CA$CA
233553736$23355373$6$F$$20240415$20240102$20240926$EXP$$US-GSK-US2023AMR179451$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
233553842$23355384$2$F$20240820$20240821$20240102$20240829$PER$$US-SA-2023SA403709$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240829$$CN$US$US
233554102$23355410$2$F$$20240703$20240102$20240711$EXP$$FR-CELLTRION INC.-2023FR024885$CELLTRION$Pezot M, Nocturne G, Belkhir R, Henry J, P1avy S, Seror R, et. al. Obinutuzumab in patients with Sjogren^s disease immunised against rituximab.. Annals of the rheumatic diseases. 2023;Nov 09:1-2$$$$$Y$$$20240711$$HP$FR$FR
233554142$23355414$2$F$$20240829$20240102$20240910$PER$$US-SA-2023SA404124$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240910$$HP$US$US
233555634$23355563$4$F$20230901$20240911$20240102$20240927$PER$$CA-TOLMAR, INC.-23CA045291$TOLMAR$$75$YR$$M$Y$$$20240927$$CN$CA$CA
233555693$23355569$3$F$20231205$20240717$20240102$20240809$PER$$CA-TOLMAR, INC.-23CA045314$TOLMAR$$78$YR$$M$Y$$$20240809$$CN$CA$CA
233555723$23355572$3$F$20230901$20240812$20240102$20240829$PER$$CA-TOLMAR, INC.-23CA045317$TOLMAR$$81$YR$$M$Y$$$20240829$$CN$CA$CA
233555768$23355576$8$F$20240301$20240820$20240102$20240823$EXP$$US-TAKEDA-2023TUS121339$TAKEDA$$18$YR$$M$Y$$$20240823$$CN$US$US
233555942$23355594$2$F$$20240717$20240102$20240801$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US001131$DECIPHERA PHARMACEUTICALS$$77$YR$E$F$Y$$$20240801$$CN$US$US
233556993$23355699$3$F$20230809$20240912$20240102$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-188435$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$51$KG$20240913$$MD$JP$JP
233557112$23355711$2$F$20231213$20240719$20240102$20240729$PER$$US-SA-2023SA403862$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240729$$MD$US$US
233557844$23355784$4$F$20230101$20240812$20240102$20240820$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US001136$DECIPHERA PHARMACEUTICALS$$50$YR$A$M$Y$$$20240820$$CN$US$US
233557904$23355790$4$F$$20240923$20240102$20240925$EXP$$NVSC2023US276334$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
233558818$23355881$8$F$20231110$20240902$20240102$20240911$EXP$$CA-CELLTRION INC.-2023CA022371$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
233559166$23355916$6$F$20240601$20240911$20240102$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-000153$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240913$$CN$US$US
233559662$23355966$2$F$20230101$20240711$20240102$20240801$PER$$US-SA-2023SA400363$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240719$$CN$US$US
233560303$23356030$3$F$$20240909$20240102$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-11711$LUPIN$$$$$$Y$$$20240921$$CN$US$US
233560936$23356093$6$F$20220923$20240813$20240102$20240826$EXP$$US-UCBSA-2023058979$UCB$$50$YR$$F$Y$74.376$KG$20240826$$HP$US$US
233561043$23356104$3$F$20230411$20240628$20240102$20240703$EXP$$CA-TAKEDA-2023TUS124868$TAKEDA$$72$YR$$F$Y$$$20240703$$MD$CA$CA
233561268$23356126$8$F$20230101$20240910$20240102$20240917$EXP$$CA-CELLTRION INC.-2023CA007589$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
233562903$23356290$3$F$20231201$20240830$20240102$20240912$EXP$$CA-UCBSA-2023061648$UCB$$59$YR$$F$Y$$$20240912$$CN$CA$CA
233562995$23356299$5$F$20210701$20240729$20240102$20240812$EXP$DE-BFARM-23009796$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-16358$ALKEM$$35$YR$$F$Y$$$20240812$$MD$DE$DE
233563853$23356385$3$F$20231009$20240709$20240102$20240711$EXP$$JP-ASTELLAS-2023JP013677$ASTELLAS$$8$DEC$$F$Y$$$20240711$$MD$JP$JP
233564096$23356409$6$F$$20240918$20240102$20240923$EXP$$CA-ROCHE-3483705$ROCHE$Roy G, Iordachescu I, Royal V, Lamarche C, Ahmad I. Kidney Biopsy Findings Among Allogenic Hematopoietic Stem Cell Transplant Recipients With Kidney Injury: A Case Series.. Kidney-Med. 2023;5 (7):$57$YR$A$M$Y$$$20240923$$HP$CA$CA
233564122$23356412$2$F$20230101$20240726$20240102$20240805$PER$$US-SA-2023SA403384$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240805$$MD$US$US
233564224$23356422$4$F$20240801$20240808$20240102$20240814$EXP$$CO-GSK-CO2023AMR181079$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$CO$CO
233564714$23356471$4$F$20231101$20240729$20240102$20240807$PER$$US-SA-2023SA404567$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240807$$MD$US$US
233564724$23356472$4$F$$20240823$20240102$20240910$PER$$US-SA-2023SA404656$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240910$$MD$US$US
233564762$23356476$2$F$$20240730$20240102$20240802$EXP$$AE-TAKEDA-2023TUS125119$TAKEDA$$$$$$Y$$$20240802$$CN$AE$AE
233564883$23356488$3$F$20230902$20240822$20240102$20240902$EXP$$DE-AUROBINDO-AUR-APL-2023-081898$AUROBINDO$$$$E$F$Y$59.5$KG$20240902$$MD$DE$DE
233565263$23356526$3$F$20230320$20240703$20240102$20240710$EXP$$CN-TAKEDA-2023TUS124076$TAKEDA$$60$YR$$M$Y$73$KG$20240710$$MD$CN$CN
233565322$23356532$2$F$20231127$20231229$20240102$20240918$EXP$FR-AFSSAPS-PP2023001717$FR-BAUSCH-BL-2023-019458$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240918$$MD$FR$FR
233565822$23356582$2$F$$20240805$20240102$20240813$PER$$US-SA-2023SA404811$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240814$$MD$US$US
233566402$23356640$2$F$$20240626$20240102$20240709$EXP$$CA-ROCHE-3483879$ROCHE$$42$YR$A$M$Y$$$20240709$$CN$CA$CA
233566653$23356665$3$F$$20231109$20240102$20240710$PER$$IN-ROCHE-3456583$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
233566682$23356668$2$F$20230101$20240910$20240102$20240918$PER$$US-SA-2023SA404546$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240918$$MD$US$US
233566923$23356692$3$F$20230101$20240905$20240102$20240926$PER$$US-Eisai-EC-2023-138377$EISAI$$74$YR$E$M$Y$84.4$KG$20240926$$CN$US$US
233567473$23356747$3$F$20231201$20240715$20240102$20240723$PER$$US-SA-2023SA403006$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240723$$MD$US$US
233567555$23356755$5$F$20231127$20240911$20240102$20240919$EXP$$US-Eisai-EC-2023-149404$EISAI$$67$YR$E$M$Y$$$20240919$$CN$US$US
233567622$23356762$2$F$20231201$20240809$20240102$20240814$EXP$$US-SA-2024SA000252$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240814$$MD$US$US
233567962$23356796$2$F$$20240702$20240102$20240703$PER$$NVSC2023US276957$NOVARTIS$$$$$M$Y$$$20240703$$HP$US$US
233568023$23356802$3$F$$20240920$20240102$20240924$EXP$$NVSC2023GB276413$NOVARTIS$$$$$M$Y$$$20240924$$CN$GB$GB
233568082$23356808$2$F$$20240808$20240102$20240814$EXP$$NVSC2023FR275880$NOVARTIS$Baber A, Legendre P, Palmic P, Lupo-Mansuet A, Burroni B, Azoulay C et al.. EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Spleen: Report of an Aggressive Form With Molecular Characterization. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY. 2023;32(1):150-4$79$YR$$F$Y$$$20240814$$HP$FR$FR
233568122$23356812$2$F$20231210$20231227$20240102$20240808$EXP$$NVSC2023CO276323$NOVARTIS$$43$YR$$F$Y$$$20240808$$CN$CO$CO
233568602$23356860$2$F$$20240814$20240102$20240817$EXP$$CA-ROCHE-3482433$ROCHE$$$$$F$Y$$$20240817$$HP$CA$CA
233569496$23356949$6$F$20230127$20240822$20240102$20240827$EXP$$AU-TAKEDA-2022TUS074833$TAKEDA$$62$YR$$F$Y$$$20240827$$CN$AU$AU
233569712$23356971$2$F$20221229$20240722$20240102$20240729$EXP$$JP-AMGEN-JPNSP2023232916$AMGEN$$78$YR$E$F$Y$47$KG$20240729$$MD$JP$JP
233569984$23356998$4$F$$20240701$20240102$20240708$EXP$$NVSC2023BE250630$NOVARTIS$Jadoul A, Huygen L, Leemans G, Grosber M, Krohn IK, Gutermuth J. JAK1/2 pathway-specific treatment of generalized granuloma annulare with baricitinib. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2023;143:S340$66$YR$$F$Y$$$20240708$$HP$BE$BE
233571374$23357137$4$F$20231201$20240809$20240102$20240817$PER$$US-SA-2023SA399503$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240817$$CN$US$US
233571434$23357143$4$F$20230101$20240903$20240102$20240909$EXP$$JP-009507513-2312JPN003544J$MERCK$$70$YR$$F$Y$$$20240909$$MD$JP$JP
233571632$23357163$2$F$$20240807$20240102$20240809$EXP$$JP-JNJFOC-20231275014$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240809$$PH$JP$JP
233572746$23357274$6$F$20231214$20240503$20240102$20240926$EXP$$US-GSK-US2023AMR180881$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$US$US
233572763$23357276$3$F$20230101$20240712$20240102$20240724$PER$$US-SA-2023SA402287$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240724$$MD$US$US
233572882$23357288$2$F$$20240716$20240102$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-177116$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240729$$HP$CA$CA
233573303$23357330$3$F$20231201$20240809$20240102$20240816$PER$$US-SA-2023SA402474$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240816$$MD$US$US
233573543$23357354$3$F$20231101$20240723$20240102$20240731$EXP$$JP-009507513-2312JPN003765J$MERCK$$9$DEC$$M$Y$$$20240731$$MD$JP$JP
233574374$23357437$4$F$20230222$20240911$20240102$20240911$EXP$$FR-PFIZER INC-PV202300108242$PFIZER$$72$YR$$F$Y$44$KG$20240911$$MD$FR$FR
233574562$23357456$2$F$$20231222$20240102$20240710$PER$$US-ROCHE-3481606$ROCHE$$83$YR$E$F$Y$$$20240628$$CN$US$US
233575762$23357576$2$F$$20240916$20240102$20240924$EXP$$US-MYLANLABS-2024M1000394$MYLAN$Barkhordarian M, Grijalva M, Jarri A, Belyayeva A, Weissman S. Rare or Disregarded; A Case of Autoimmune Myopathy. Circulation 2023; 148 (Suppl. 1) abstr. 16715.$69$YR$$M$Y$$$20240924$$HP$US$US
233575928$23357592$8$F$20240119$20240712$20240102$20240717$EXP$$IN-PFIZER INC-PV202400000019$PFIZER$$61$YR$$M$Y$$$20240717$$CN$IN$IN
233576724$23357672$4$F$20230101$20240716$20240102$20240806$EXP$$JP-009507513-2312JPN003533J$MERCK$Ito E, Hasegawa S, Hoshi M, Endo R, Asahi S. NM-1   Efficacy of Scalp Cooling system (Cell Guard) in prevention of breast cancer chemotherapy-induced alopecia in our hospital. The 21st Tohoku Regional Meeting of Japanese Breast Cancer Society. 28$77$YR$$F$Y$$$20240806$$MD$JP$JP
233577835$23357783$5$F$20231101$20240725$20240102$20240729$EXP$$US-UCBSA-2023061468$UCB$$57$YR$$F$Y$97.5$KG$20240729$$CN$US$US
233578972$23357897$2$F$$20240824$20240102$20240906$PER$$US-SA-2023SA400533$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240906$$MD$US$US
233580204$23358020$4$F$20211207$20240716$20240102$20240723$EXP$$CA-AMGEN-CANSL2023052540$AMGEN$$48$YR$A$M$Y$$$20240723$$HP$CA$CA
233580325$23358032$5$F$20230101$20240905$20240102$20240912$PER$$JP-Eisai-EC-2023-155761$EISAI$$75$YR$E$M$Y$$$20240912$$MD$JP$JP
233580795$23358079$5$F$$20240802$20240102$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-000509$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$93.89$KG$20240805$$CN$US$US
233581194$23358119$4$F$20231127$20240910$20240102$20240913$EXP$$ES-JNJFOC-20231266477$JOHNSON AND JOHNSON$$48$YR$A$M$Y$77$KG$20240913$$MD$ES$ES
233582083$23358208$3$F$$20240812$20240102$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-000444$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240813$$HP$US$US
233582098$23358209$8$F$20240101$20240625$20240102$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-189430$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240708$$CN$US$US
233582162$23358216$2$F$$20240904$20240102$20240910$EXP$$PH-OTSUKA-2023_033762$OTSUKA$$$$$M$Y$$$20240910$$CN$PH$PH
233582272$23358227$2$F$20211201$20240906$20240102$20240911$EXP$$US-ABBVIE-5566088$ABBVIE$$58$YR$$F$Y$$$20240911$$CN$US$US
233582652$23358265$2$F$20231009$20240628$20240102$20240705$EXP$$JP-009507513-2312JPN003600J$MERCK$$53$YR$$F$Y$49.7$KG$20240705$$PH$JP$JP
233583434$23358343$4$F$20230101$20240904$20240102$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-000476$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240906$$HP$US$US
233583454$23358345$4$F$$20240719$20240102$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-000224$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$57.61$KG$20240723$$CN$US$US
233584282$23358428$2$F$20231201$20240627$20240102$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-000315$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$74.39$KG$20240701$$PH$US$US
233584392$23358439$2$F$20221101$20240718$20240102$20240726$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2023-001675$SK LIFE SCIENCE$$$$$$Y$$$20240726$$CN$US$US
233584416$23358441$6$F$20231212$20240708$20240102$20240715$EXP$$ES-MYLANLABS-2023M1137947$MYLAN$$86$YR$$M$Y$77$KG$20240715$$MD$ES$ES
233585986$23358598$6$F$20231117$20240811$20240102$20240813$EXP$$IT-BAUSCH-BL-2023-019466$BAUSCH AND LOMB$$79$YR$$F$Y$66$KG$20240813$$HP$IT$IT
233586774$23358677$4$F$20230725$20240921$20240102$20240926$EXP$$CA-PFIZER INC-202300452838$PFIZER$$59$YR$$M$Y$$$20240926$$HP$CA$CA
2335873510$23358735$10$F$20231203$20240711$20240102$20240723$EXP$$AE-AstraZeneca-2023A291936$ASTRAZENECA$$68$YR$$F$Y$91$KG$20240723$$MD$AE$
2335875911$23358759$11$F$20220101$20240816$20240102$20240822$EXP$$IE-MYLANLABS-2023M1138365$MYLAN$$63$YR$$M$Y$$$20240822$$CN$IE$IE
233587695$23358769$5$F$20240820$20240928$20240102$20240930$30DAY$$US-PFIZER INC-202300452850$PFIZER$$13$YR$$M$Y$40.363$KG$20240930$$MD$US$US
233587964$23358796$4$F$20080101$20240909$20240102$20240918$EXP$$CA-PURDUE-USA-2023-0306840$PURDUE$$53$YR$$M$Y$$$20240918$$HP$CA$GB
233588112$23358811$2$F$20231208$20240814$20240102$20240913$PER$$US-Eisai-EC-2023-151441$EISAI$$66$YR$E$F$Y$44.5$KG$20240913$$HP$US$US
233589293$23358929$3$F$20230101$20240725$20240102$20240730$EXP$$US-PFIZER INC-PV202300208984$PFIZER$$52$YR$$F$Y$$$20240730$$HP$US$US
233589373$23358937$3$F$20240821$20240821$20240102$20240823$EXP$$US-PFIZER INC-PV202300209269$PFIZER$$88$YR$$F$Y$64.4$KG$20240823$$CN$US$US
233589386$23358938$6$F$$20240829$20240102$20240903$EXP$$US-PFIZER INC-PV202300209207$PFIZER$$82$YR$$F$Y$$$20240903$$CN$US$US
233590082$23359008$2$F$$20240909$20240102$20240916$PER$$US-MYLANLABS-2023M1131881$MYLAN$$$$$F$Y$102.06$KG$20240916$$CN$US$US
233590196$23359019$6$F$20240101$20240910$20240102$20240925$EXP$$US-BIOMARINAP-US-2023-154836$BIOMARIN$$$$$$Y$$$20240925$$CN$US$US
233590323$23359032$3$F$20230101$20240816$20240102$20240902$PER$$US-JNJFOC-20231238457$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240902$$CN$US$US
233590913$23359091$3$F$20231222$20240622$20240102$20240701$EXP$$PE-AMGEN-PERSP2023232937$AMGEN$$61$YR$A$F$Y$$$20240701$$CN$PE$PE
233591527$23359152$7$F$20231225$20240912$20240102$20240917$EXP$$JP-SA-2023SA406143$SANOFI AVENTIS$$59$YR$A$M$Y$49.7$KG$20240917$$MD$JP$JP
233593342$23359334$2$F$$20240726$20240102$20240807$EXP$$CA-AUROBINDO-AUR-APL-2023-081751$AUROBINDO$$63$YR$$M$Y$$$20240807$$MD$CA$CA
233593612$23359361$2$F$$20240726$20240103$20240807$EXP$$CA-AUROBINDO-AUR-APL-2023-081734$AUROBINDO$$74$YR$$M$Y$$$20240807$$HP$CA$CA
233593974$23359397$4$F$$20240801$20240103$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-186162$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240802$$CN$US$US
233594253$23359425$3$F$20240406$20240728$20240103$20240820$PER$$CA-TOLMAR, INC.-23CA045441$TOLMAR$$75$YR$$M$Y$$$20240820$$CN$CA$CA
233595073$23359507$3$F$$20240808$20240103$20240815$PER$$US-SA-2023SA402994$SANOFI AVENTIS$$$$A$F$Y$$$20240815$$MD$US$US
233595584$23359558$4$F$20231106$20240830$20240103$20240913$PER$$US-SA-2023SA406094$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240913$$MD$US$US
233595593$23359559$3$F$$20240731$20240103$20240808$PER$$US-SA-2023SA402555$SANOFI AVENTIS$$$$E$F$Y$$$20240808$$MD$US$US
233596342$23359634$2$F$20231007$20240705$20240103$20240711$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-020827$JAZZ$$29$YR$$M$Y$$$20240711$$CN$US$US
233596512$23359651$2$F$20230101$20240712$20240103$20240723$PER$$US-SA-2023SA405048$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240723$$MD$US$US
233596692$23359669$2$F$$20240711$20240103$20240719$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-025538$JAZZ$$$$$F$Y$$$20240719$$CN$US$US
233596982$23359698$2$F$$20240822$20240103$20240827$EXP$$CA-ROCHE-3483880$ROCHE$$60$YR$A$F$Y$$$20240827$$HP$CA$CA
233597094$23359709$4$F$$20240808$20240103$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-188379$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240813$$CN$US$US
233597193$23359719$3$F$$20240624$20240103$20240703$PER$$US-SA-2023SA405942$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240703$$MD$US$US
233597523$23359752$3$F$20191223$20240827$20240103$20240902$EXP$$CA-TAKEDA-2024TUS000436$TAKEDA$$25$YR$$F$Y$61$KG$20240902$$CN$CA$CA
233597673$23359767$3$F$20231027$20240731$20240103$20240801$EXP$$DE-JNJFOC-20231279440$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240801$$MD$DE$ZA
233597686$23359768$6$F$$20240614$20240103$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005705$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
233597832$23359783$2$F$20231210$20240628$20240103$20240702$EXP$$EG-SANDOZ INC.-SDZ2023EG066917$SANDOZ$$14$YR$$M$Y$40$KG$20240702$$CN$EG$EG
233598102$23359810$2$F$20230101$20240627$20240103$20240708$PER$$US-SA-2023SA403366$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240708$$MD$US$US
233598243$23359824$3$F$20230202$20240719$20240103$20240729$PER$$US-SA-2023SA402366$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240729$$HP$US$US
233599033$23359903$3$F$20231229$20240718$20240103$20240725$EXP$$US-AMGEN-USASP2023233642$AMGEN$$68$YR$E$F$Y$$$20240725$$MD$US$US
233599424$23359942$4$F$20231124$20240808$20240103$20240813$EXP$$BR-CELLTRION INC.-2023BR024986$CELLTRION$$$$$$Y$$$20240813$$CN$BR$BR
233599457$23359945$7$F$20231001$20240723$20240103$20240801$EXP$$CO-SANDOZ INC.-NVSC2023CO081483$SANDOZ$$76$YR$$F$Y$63$KG$20240801$$CN$CO$CO
233600312$23360031$2$F$$20240702$20240103$20240711$PER$$US-SA-2024SA000295$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$MD$US$US
233600493$23360049$3$F$20231001$20240806$20240103$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-000173$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240815$$HP$US$US
233601805$23360180$5$F$$20240809$20240103$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-000487$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$79.38$KG$20240813$$CN$US$US
233602014$23360201$4$F$20231222$20240715$20240103$20240726$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-00038$IPSEN$$76$YR$E$M$Y$64$KG$20240726$$CN$US$US
233602022$23360202$2$F$$20240909$20240103$20240911$EXP$$CA-SANDOZ INC.-NVSC2021CA040348$SANDOZ$$45$YR$$F$Y$95$KG$20240911$$CN$CA$CA
233602127$23360212$7$F$$20240828$20240103$20240904$EXP$$CA-SANDOZ INC.-SDZ2023CA073202$SANDOZ$$65$YR$$F$Y$34$KG$20240904$$HP$CA$CA
233602223$23360222$3$F$$20240705$20240103$20240713$PER$$US-SA-2023SA402932$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240713$$MD$US$US
233602787$23360278$7$F$$20240415$20240103$20240926$EXP$$US-GSK-US2023AMR181832$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
233602803$23360280$3$F$$20240722$20240103$20240730$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04581$AMNEAL$$$$$M$Y$$$20240730$$CN$US$US
233602915$23360291$5$F$20210708$20240724$20240103$20240801$EXP$$CA-CELLTRION INC.-2021CA006963$CELLTRION$$$$$$Y$$$20240801$$MD$CA$CA
233602972$23360297$2$F$20221104$20240621$20240103$20240701$EXP$$ES-AUROBINDO-AUR-APL-2023-003085$AUROBINDO$$46$YR$$F$Y$$$20240701$$CN$ES$ES
233603074$23360307$4$F$20240430$20240711$20240103$20240720$EXP$$GB-CELLTRION INC.-2023GB024612$CELLTRION$$$$$$Y$$$20240720$$CN$GB$GB
233603742$23360374$2$F$$20240722$20240103$20240731$PER$$US-SA-2023SA402720$SANOFI AVENTIS$$$$A$F$Y$71$KG$20240731$$MD$US$US
233604566$23360456$6$F$$20240702$20240103$20240715$PER$$US-Ipsen Biopharmaceuticals, Inc.-2023-28504$IPSEN$$64$YR$A$F$Y$54$KG$20240715$$CN$US$US
233605912$23360591$2$F$20211231$20240722$20240103$20240729$EXP$$JP-AMGEN-JPNSP2023232906$AMGEN$$71$YR$E$M$Y$74$KG$20240729$$MD$JP$JP
233606602$23360660$2$F$20231101$20240716$20240103$20240725$PER$$US-SA-2024SA002002$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240725$$MD$US$US
233606828$23360682$8$F$20231125$20240807$20240103$20240809$EXP$$BR-JNJFOC-20231277627$JOHNSON AND JOHNSON$$39$YR$A$F$Y$70$KG$20240809$$CN$BR$BR
233607553$23360755$3$F$20160608$20240624$20240103$20240703$EXP$$CR-ROCHE-1830554$ROCHE$$62$YR$A$F$Y$84$KG$20240703$$CN$CR$CR
233608152$23360815$2$F$20231201$20240623$20240103$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005701$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240716$$CN$US$US
233609093$23360909$3$F$20240401$20240620$20240103$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005455$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240712$$CN$US$US
233609322$23360932$2$F$20230731$20231123$20240103$20240923$EXP$LT-SMCA-4730$LT-TEVA-VS-3134873$TEVA$$29$YR$$F$Y$76$KG$20240923$$CN$LT$LT
233609933$23360993$3$F$20231201$20240207$20240103$20240926$PER$$US-GSK-US2023AMR181887$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240926$$CN$US$US
233609985$23360998$5$F$20230101$20240823$20240103$20240912$EXP$$US-SA-2023SA197152$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240912$$CN$US$US
233610528$23361052$8$F$$20240730$20240103$20240814$EXP$$US-INSMED, INC.-2023-05000-US$INSMED$$$$$M$Y$$$20240814$$CN$US$US
2336105314$23361053$14$F$20230101$20240923$20240103$20240926$30DAY$$CA-PFIZER INC-202300444018$PFIZER$$40$YR$$F$Y$$$20240926$$PH$CA$CA
233610564$23361056$4$F$20231206$20240904$20240103$20240905$30DAY$$AR-PFIZER INC-PV202300200449$PFIZER$$14$YR$$M$Y$$$20240905$$CN$AR$AR
233611634$23361163$4$F$$20240327$20240103$20240902$EXP$$CA-CHATTEMPRD-2023OHG015357$CHATTEM$$$$A$F$Y$$$20240902$$HP$CA$CA
233613312$23361331$2$F$$20240628$20240103$20240704$EXP$$CA-TAKEDA-2024TUS000012$TAKEDA$$$$$F$Y$$$20240704$$MD$CA$CA
233613613$23361361$3$F$20231017$20240618$20240103$20240705$PER$$US-Eisai-EC-2023-151289$EISAI$$65$YR$E$F$Y$$$20240705$$CN$US$US
233613942$23361394$2$F$20231201$20240801$20240103$20240810$PER$$US-SA-2023SA397847$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240810$$MD$US$US
233614102$23361410$2$F$20231226$20240722$20240103$20240731$PER$$US-SA-2023SA405719$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240731$$MD$US$US
233614346$23361434$6$F$20231201$20240628$20240103$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005692$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240723$$CN$US$US
233614834$23361483$4$F$$20240703$20240103$20240709$PER$$US-TAKEDA-2024TUS000374$TAKEDA$$$$$F$Y$$$20240709$$HP$US$US
233614972$23361497$2$F$20231227$20240904$20240103$20240912$EXP$$CA-TAKEDA-2023TUS125176$TAKEDA$$45$YR$$F$Y$$$20240912$$CN$CA$CA
233615513$23361551$3$F$$20240924$20240103$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001064$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240926$$CN$US$US
233616672$23361667$2$F$$20240628$20240103$20240712$EXP$GB-MHRA-MED-202312201658011650-GJSWR$GB-CIPLA LTD.-2023GB08440$CIPLA$$$$$$Y$$$20240712$$HP$GB$GB
233617392$23361739$2$F$$20240821$20240103$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001063$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240826$$CN$US$US
233617484$23361748$4$F$20231229$20240731$20240103$20240803$PER$$US-AMGEN-USASP2024000102$AMGEN$$59$YR$A$F$Y$$$20240802$$CN$US$US
233617562$23361756$2$F$$20240912$20240103$20240923$PER$$US-PHARMING-PHAUS2024000007$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
233617644$23361764$4$F$20170101$20240716$20240103$20240725$EXP$$US-AMGEN-USASL2023232203$AMGEN$$63$YR$A$M$Y$$$20240725$$CN$US$US
2336184710$23361847$10$F$$20240827$20240103$20240830$PER$$US-PFIZER INC-PV202400000301$PFIZER$$79$YR$$F$Y$63.492$KG$20240830$$HP$US$US
233618562$23361856$2$F$20230101$20240705$20240103$20240709$PER$$US-PFIZER INC-202300453094$PFIZER$$78$YR$$F$Y$$$20240709$$HP$US$US
233618922$23361892$2$F$20231001$20240830$20240103$20240830$PER$$NVSC2023US191078$NOVARTIS$$54$YR$$F$Y$$$20240830$$CN$US$US
233619042$23361904$2$F$20230101$20240628$20240103$20240705$EXP$$JP-009507513-2312JPN003986J$MERCK$$8$DEC$$F$Y$$$20240705$$MD$JP$JP
233619143$23361914$3$F$20230101$20240726$20240103$20240731$EXP$$US-PFIZER INC-202101136454$PFIZER$$59$YR$$F$Y$72.57$KG$20240731$$CN$US$US
233620933$23362093$3$F$$20240816$20240103$20240820$PER$$US-PFIZER INC-202300452303$PFIZER$$82$YR$$F$Y$$$20240820$$CN$US$US
233621733$23362173$3$F$20230627$20240802$20240103$20240820$EXP$$JP-ROCHE-3483402$ROCHE$$63$YR$A$F$Y$58.7$KG$20240820$$MD$JP$JP
233622363$23362236$3$F$$20240814$20240103$20240823$EXP$$CA-TAKEDA-2023TUS124410$TAKEDA$$$$$F$Y$$$20240823$$CN$CA$CA
233622652$23362265$2$F$20231201$20240805$20240103$20240807$PER$$US-PFIZER INC-PV202300209254$PFIZER$$59$YR$$M$Y$$$20240807$$HP$US$US
233622882$23362288$2$F$$20240624$20240103$20240701$PER$$US-PFIZER INC-202300457484$PFIZER$$60$YR$$M$Y$$$20240701$$MD$US$US
233622994$23362299$4$F$20230101$20240802$20240103$20240816$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00550$AVADEL CNS PHARMA$$$$$F$Y$$$20240816$$CN$US$US
233623013$23362301$3$F$20230101$20240708$20240103$20240717$PER$$US-SA-2023SA403376$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240717$$MD$US$US
233623442$23362344$2$F$$20231219$20240103$20240724$EXP$$US-TEVA-VS-3138814$TEVA$$51$YR$$F$Y$$$20240724$$CN$US$US
233624269$23362426$9$F$20230213$20240708$20240103$20240711$EXP$$BE-JNJFOC-20230321672$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240711$$HP$BE$BE
233624484$23362448$4$F$20231102$20240722$20240103$20240726$PER$$US-SA-2023SA403797$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240726$$MD$US$US
233624694$23362469$4$F$20231201$20240724$20240103$20240801$PER$$US-SA-2023SA401753$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240801$$MD$US$US
233625283$23362528$3$F$20240102$20240815$20240103$20240820$PER$$US-AMGEN-USASP2024000149$AMGEN$$68$YR$E$M$Y$$$20240820$$HP$US$US
233625573$23362557$3$F$20230101$20240719$20240103$20240730$PER$$US-SA-2023SA402812$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240730$$MD$US$US
2336258311$23362583$11$F$20231030$20240914$20240103$20240920$EXP$$CO-TAKEDA-2023TUS110172$TAKEDA$$43$YR$$M$Y$55$KG$20240920$$CN$CO$CO
233626663$23362666$3$F$20231201$20240830$20240103$20240911$PER$$US-SA-2023SA404517$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240911$$MD$US$US
233627283$23362728$3$F$20230901$20240724$20240103$20240806$PER$$US-SA-2023SA401756$SANOFI AVENTIS$$23$YR$A$M$Y$86.18$KG$20240806$$MD$US$US
233628727$23362872$7$F$20231229$20240828$20240103$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001043$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240909$$CN$US$US
233631322$23363132$2$F$20231009$20240628$20240103$20240708$EXP$$JP-Eisai-EC-2023-155778$EISAI$$53$YR$A$F$Y$50$KG$20240708$$PH$JP$JP
233631453$23363145$3$F$$20240307$20240103$20240905$EXP$$NVSC2024US000674$NOVARTIS$$30$YR$$F$Y$$$20240905$$MD$US$US
233632815$23363281$5$F$20231204$20240715$20240103$20240718$EXP$$FR-PFIZER INC-202300452290$PFIZER$$71$YR$$F$Y$66$KG$20240718$$MD$FR$FR
233632898$23363289$8$F$20231201$20240828$20240103$20240828$EXP$$CA-PFIZER INC-202300449566$PFIZER$$49$YR$$F$Y$$$20240828$$CN$CA$CA
233633652$23363365$2$F$20220301$20240708$20240103$20240711$EXP$$GB-PFIZER INC-202300452615$PFIZER$$66$YR$$M$Y$$$20240711$$MD$GB$GB
233633922$23363392$2$F$20230829$20240101$20240103$20240918$EXP$$GR-BAUSCH-BL-2024-000036$BAUSCH AND LOMB$$19$YR$$M$Y$$$20240918$$PH$GR$GR
233634148$23363414$8$F$$20240909$20240103$20240912$EXP$$PT-MYLANLABS-2023M1138847$MYLAN$Canelas Mendes C, Howell Monteiro P, Madeira Lopes J, Pais de Lacerda A.. Paradoxical Immune Reconstitution Inflammatory Syndrome in SARS-CoV-2 Infection After Improvement of Chemotherapy-Induced Aplasia.. Cureus. 2023;15(10):e46723$42$YR$$M$Y$$$20240912$$HP$PT$PT
233634182$23363418$2$F$20231207$20240627$20240103$20240705$PER$$US-Eisai-EC-2023-155298$EISAI$$77$YR$E$F$Y$$$20240705$$CN$US$US
233634202$23363420$2$F$20230601$20240821$20240103$20240919$PER$$US-Eisai-EC-2023-142405$EISAI$$67$YR$E$M$Y$99.7$KG$20240919$$CN$US$US
233634596$23363459$6$F$20220912$20240921$20240103$20240923$EXP$$CA-PFIZER INC-202200742439$PFIZER$$58$YR$$F$Y$$$20240923$$MD$CA$CA
233634814$23363481$4$F$20231005$20240807$20240103$20240821$EXP$$LT-VER-202300002$VERITY PHARMACEUTICALS$$75$YR$E$M$Y$99$KG$20240821$$HP$LT$LT
233634878$23363487$8$F$20230101$20240830$20240103$20240925$PER$$US-Eisai-EC-2023-147538$EISAI$$65$YR$E$F$Y$$$20240925$$CN$US$US
233635575$23363557$5$F$$20240812$20240103$20240821$EXP$$JP-TAKEDA-2024TUS000758$TAKEDA$Nagao S, Yabuuchi Y, Tanaka K, Morihisa Y, Kobayashi T, Akiyama S, et al. Multiple gastric neuroendocrine tumors associated with long-term use of a proton pump inhibitor and a potassium-competitive acid blocker. Internal Medicine. 2024;63(14):2001-2010$52$YR$$M$Y$$$20240821$$HP$JP$JP
233637253$23363725$3$F$20240601$20240822$20240103$20240902$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04532$AMNEAL$$75$YR$$F$Y$$$20240902$$CN$US$US
233637512$23363751$2$F$20230101$20240717$20240103$20240722$EXP$$US-ABBVIE-5522760$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
233638178$23363817$8$F$20230101$20240922$20240104$20240926$EXP$$GB-ABBVIE-5559546$ABBVIE$$73$YR$$M$Y$$$20240926$$HP$GB$GB
233638503$23363850$3$F$$20240712$20240104$20240813$PER$$US-TOLMAR, INC.-23US045267$TOLMAR$$$$$M$Y$$$20240813$$CN$US$US
233638682$23363868$2$F$$20240806$20240104$20240814$EXP$$JP-009507513-2312JPN004693$MERCK$Yokoyama R, Sato Y, Nakamura F, Kagemoto K, Mitsui Y, Okamoto K, et al. Efficacy of immune checkpoint inhibitors in patients with anorectal melanoma in association with immune-related adverse events: a case series. Clinical Journal of Gastroenterology. 2023;16:842-7$59$YR$$F$Y$$$20240814$$HP$JP$JP
233638832$23363883$2$F$20230828$20240813$20240104$20240906$PER$$CA-TOLMAR, INC.-23CA045262$TOLMAR$$79$YR$$M$Y$$$20240906$$CN$CA$CA
233639143$23363914$3$F$20231225$20240809$20240104$20240813$EXP$$CA-ROCHE-3484826$ROCHE$$33$YR$A$M$Y$$$20240813$$CN$CA$CA
233639165$23363916$5$F$20231101$20240814$20240104$20240820$EXP$$CA-ROCHE-3484709$ROCHE$$41$YR$A$F$Y$$$20240820$$CN$CA$CA
233639426$23363942$6$F$$20240617$20240104$20240709$EXP$$CA-ROCHE-3484688$ROCHE$$$$A$F$Y$$$20240701$$CN$CA$CA
233639653$23363965$3$F$20230101$20240807$20240104$20240827$PER$$US-APOTEX-2023AP009940$APOTEX$$$$$M$Y$$$20240827$$CN$US$US
233641292$23364129$2$F$20200101$20240906$20240104$20240909$EXP$$FR-SANDOZ INC.-NVSC2022FR262358$SANDOZ$$66$YR$$M$Y$44$KG$20240909$$MD$FR$FR
233641454$23364145$4$F$20240723$20240731$20240104$20240802$EXP$CA-MMM-M1U43Q2N$CA-GSK-CA2023137596$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$CA$CA
233642008$23364200$8$F$20231228$20240828$20240104$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2023-037387$UNITED THERAPEUTICS$$77$YR$$F$Y$92.971$KG$20240905$$$US$US
233642533$23364253$3$F$20230801$20240102$20240104$20240712$EXP$$CO-NOVOPROD-1158064$NOVO NORDISK$$55$YR$$F$Y$47$KG$20240712$$CN$CO$CO
233642732$23364273$2$F$20231117$20240709$20240104$20240718$EXP$$US-EMD Serono-2023497409$EMD SERONO INC$$62$YR$A$F$Y$$$20240718$$CN$US$US
233642942$23364294$2$F$20231228$20240701$20240104$20240708$EXP$$US-HALEON-USCH2023067492$Haleon PLC$$77$YR$$M$Y$$$20240705$$CN$US$US
233643582$23364358$2$F$20231220$20240716$20240104$20240716$EXP$FR-AFSSAPS-ST2023001714$FR-JNJFOC-20240104854$JOHNSON AND JOHNSON$$86$YR$E$F$Y$75$KG$20240717$$HP$FR$FR
233643683$23364368$3$F$$20240920$20240104$20240923$PER$$NVSC2024US000941$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
2336445012$23364450$12$F$20231201$20240912$20240104$20240916$EXP$$US-BEH-2024167048$CSL BEHRING$$40$YR$A$F$Y$83.447$KG$20240916$$HP$US$US
233645013$23364501$3$F$$20240924$20240104$20240930$EXP$$US-SA-2023SA405936$SANOFI AVENTIS$$92$YR$E$M$Y$$$20240930$$CN$US$US
233645084$23364508$4$F$$20240829$20240104$20240906$30DAY$$CN-JNJFOC-20231234526$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$CN$CN
233645162$23364516$2$F$20220804$20240723$20240104$20240730$EXP$$CA-SANDOZ INC.-NVSC2022CA176860$SANDOZ$$74$YR$$M$Y$$$20240730$$CN$CA$CA
233645425$23364542$5$F$$20240628$20240104$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-000062$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240705$$CN$US$US
233645585$23364558$5$F$20240501$20240709$20240104$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001292$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240711$$CN$US$US
233645702$23364570$2$F$$20240827$20240104$20240904$EXP$$PT-CELLTRION INC.-2024PT000005$CELLTRION$Leite S, Lemos C, Dias R, Faria R, and Marques L.. Nijmegen breakage syndrome: The importance of follow-up.. Nascer e Crescer - Birth and Growth Medical Journal. 2023;32 (3):214-16$$$$$Y$$$20240904$$HP$PT$PT
233646044$23364604$4$F$20231226$20240705$20240104$20240709$EXP$$JP-AstraZeneca-2023A295861$ASTRAZENECA$$33248$DY$$M$Y$55$KG$20240709$$MD$JP$
233646302$23364630$2$F$$20240730$20240104$20240801$EXP$$US-TAKEDA-2024TUS000162$TAKEDA$$$$$F$Y$$$20240801$$CN$US$US
233646362$23364636$2$F$$20240916$20240104$20240925$EXP$$US-APOTEX-2024AP000016$APOTEX$Barkhordarian M, Grijalva M, Jarri A, Belyayeva A, Weissman S.. Rare or Disregarded; A Case of Autoimmune Myopathy. Circulation. 2023;148 (Suppl. 1):1-3$69$YR$$M$Y$$$20240925$$HP$US$US
233646613$23364661$3$F$20231204$20240802$20240104$20240806$EXP$$JP-AstraZeneca-2023A295740$ASTRAZENECA$$25492$DY$$M$Y$55$KG$20240806$$MD$JP$
233646933$23364693$3$F$20230101$20240729$20240104$20240802$PER$$US-009507513-2401USA000522$MERCK$$67$YR$$M$Y$70.97$KG$20240802$$CN$US$US
233647823$23364782$3$F$$20240916$20240104$20240925$EXP$US-MLMSERVICE-20231221-4737788-1$US-LUPIN PHARMACEUTICALS INC.-2023-11844$LUPIN$Barkhordarian M, Grijalva M, Jarri A, Belyayeva A, Weissman S. Rare or disregarded; A case of autoimmune myopathy. Circulation. 2023;148(1):A16715$69$YR$$M$Y$$$20240925$$MD$US$US
233647927$23364792$7$F$20191213$20240819$20240104$20240827$EXP$$CA-CELLTRION INC.-2019CA027332$CELLTRION$$$$$$Y$$$20240827$$MD$CA$CA
233648353$23364835$3$F$$20240917$20240104$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202401000756$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240923$$CN$US$US
233648506$23364850$6$F$$20240927$20240104$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001244$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240930$$HP$US$US
233649003$23364900$3$F$20150101$20240718$20240104$20240722$EXP$$US-GILEAD-2024-0657142$GILEAD$$$$A$M$Y$$$20240719$$LW$US$US
233649012$23364901$2$F$$20240904$20240104$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202307017696$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240916$$HP$US$US
233649054$23364905$4$F$20231001$20240801$20240104$20240812$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US001151$DECIPHERA PHARMACEUTICALS$$74$YR$E$M$Y$$$20240812$$CN$US$US
233649287$23364928$7$F$20231227$20240919$20240104$20240928$EXP$$CA-CELLTRION INC.-2023CA025282$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
233650082$23365008$2$F$20231206$20240722$20240104$20240726$EXP$$FR-BAUSCH-BL-2024-000088$BAUSCH AND LOMB$$17$YR$$M$Y$54$KG$20240726$$MD$FR$FR
233650375$23365037$5$F$$20240829$20240104$20240909$EXP$$CA-AUROBINDO-AUR-APL-2023-081619$AUROBINDO$$40$YR$$F$Y$96$KG$20240909$$HP$CA$CA
233650392$23365039$2$F$20210101$20240718$20240104$20240722$PER$$US-GILEAD-2024-0657191$GILEAD$$$$A$F$Y$$$20240722$$LW$US$US
233650635$23365063$5$F$$20240708$20240104$20240723$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402620$RANBAXY$Fuentes-Valenzuela E, Carbajo AY, Fernandez-Prada SJ, Rubiales BM, Jimenez NC. Beyond Crohn^s disease: Deferasirox as possible agent for drug-induced ileocolitis. Gastroenterol Hepatol. 2024;Apr; 47 (4):380-381$72$YR$$F$Y$$$20240723$$HP$ES$ES
233651643$23365164$3$F$$20240814$20240104$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001097$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240821$$HP$US$US
233651685$23365168$5$F$20240126$20240712$20240104$20240717$EXP$$CA-TAKEDA-2024TUS000100$TAKEDA$$57$YR$$M$Y$$$20240717$$CN$CA$CA
233651693$23365169$3$F$20231231$20240708$20240104$20240709$PER$$US-AMGEN-USASP2024000793$AMGEN$$56$YR$A$M$Y$$$20240709$$CN$US$US
233651876$23365187$6$F$20170131$20240827$20240104$20240902$EXP$$CA-TAKEDA-2023TUS125277$TAKEDA$$50$YR$$F$Y$$$20240902$$HP$CA$CA
233653603$23365360$3$F$$20240719$20240104$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001669$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$88$KG$20240724$$CN$US$US
233654952$23365495$2$F$20231017$20240621$20240104$20240702$EXP$$AU-BAXTER-2024BAX009801$BAXTER$$30$YR$$F$Y$68$KG$20240702$$MD$AU$AU
233656262$23365626$2$F$20240818$20240911$20240104$20240916$EXP$$GB-SANDOZ INC.-SDZ2023GB043288$SANDOZ$$50$YR$$F$Y$$$20240916$$CN$GB$GB
233656734$23365673$4$F$20231225$20240822$20240104$20240912$EXP$$US-SA-2024SA003871$SANOFI AVENTIS$$10$MON$I$M$Y$$$20240912$$MD$US$US
233658025$23365802$5$F$20100205$20240916$20240104$20240918$PER$$US-GILEAD-2024-0657133$GILEAD$$39$YR$A$M$Y$$$20240918$$LW$US$US
233658253$23365825$3$F$20110101$20240718$20240104$20240722$EXP$$US-GILEAD-2024-0657188$GILEAD$$$$$M$Y$$$20240719$$LW$US$US
233658472$23365847$2$F$20160301$20240730$20240104$20240802$PER$$US-Eisai-EC-2016-015519$EISAI$$80$YR$E$F$Y$$$20240802$$CN$US$US
233659105$23365910$5$F$20231018$20240911$20240104$20240918$EXP$$US-ABBVIE-5483633$ABBVIE$$85$YR$$F$Y$$$20240918$$CN$US$US
233659664$23365966$4$F$20231102$20240717$20240104$20240821$PER$$US-Eisai-EC-2023-153173$EISAI$$64$YR$A$M$Y$108$KG$20240821$$MD$US$US
233659685$23365968$5$F$20231206$20240705$20240104$20240715$EXP$$NZ-TEVA-VS-3139518$TEVA$$83$YR$$F$Y$51.5$KG$20240715$$HP$NZ$NZ
233661562$23366156$2$F$20210101$20240821$20240104$20240829$PER$$US-BIOGEN-2021BI01032927$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
233661633$23366163$3$F$$20240812$20240104$20240819$EXP$$US-ABBVIE-5568606$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
233662353$23366235$3$F$20230101$20240506$20240104$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003034$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
233663722$23366372$2$F$20230901$20240402$20240104$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003087$TG THERAPEUTICS$$48$YR$$M$Y$$$20240715$$CN$US$US
233664273$23366427$3$F$20231205$20240417$20240104$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003160$TG THERAPEUTICS$$49$YR$$F$Y$101.13$KG$20240715$$CN$US$US
233664662$23366466$2$F$20231220$20240607$20240104$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003177$TG THERAPEUTICS$$44$YR$$F$Y$58.957$KG$20240715$$HP$US$US
233664772$23366477$2$F$20231128$20240621$20240104$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003190$TG THERAPEUTICS$$37$YR$$F$Y$86.168$KG$20240715$$CN$US$US
233665295$23366529$5$F$20240102$20240728$20240104$20240730$PER$$US-AMGEN-USASP2024001156$AMGEN$$58$YR$A$M$Y$$$20240730$$MD$US$US
233666065$23366606$5$F$20220429$20240703$20240104$20240708$EXP$$CN-PFIZER INC-PV202300209348$PFIZER$$54$YR$$M$Y$59$KG$20240708$$MD$CN$CN
233666344$23366634$4$F$$20240621$20240104$20240701$EXP$$US-ZENPEP LLC-2023AIMT01470$AIMMUNE$$$$$$Y$$$20240701$$HP$US$US
233666545$23366654$5$F$20231001$20240708$20240104$20240711$EXP$$MX-AstraZeneca-2023A295020$ASTRAZENECA$$3909$WK$$M$Y$60$KG$20240711$$CN$MX$
233667213$23366721$3$F$$20240904$20240104$20240906$EXP$$US-PFIZER INC-PV202400000867$PFIZER$$79$YR$$F$Y$$$20240906$$CN$US$US
233667715$23366771$5$F$20240102$20240730$20240104$20240801$PER$$US-AMGEN-USASP2024001225$AMGEN$$55$YR$A$M$Y$$$20240801$$CN$US$US
233667844$23366784$4$F$20231229$20240730$20240104$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002058$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240807$$CN$US$US
233667866$23366786$6$F$20230224$20240722$20240104$20240730$PER$$US-ALXN-A202302541$ALEXION PHARMACEUTICALS$$35$YR$$M$Y$$$20240730$$CN$US$US
233668872$23366887$2$F$$20240716$20240104$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001746$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240717$$HP$US$US
233670445$23367044$5$F$20190501$20240913$20240104$20240919$EXP$$CA-TAKEDA-2019TUS027875$TAKEDA$$79$YR$$F$Y$$$20240919$$CN$CA$CA
233671147$23367114$7$F$20231222$20240730$20240104$20240808$EXP$$FR-VERTEX PHARMACEUTICALS-2023-019744$VERTEX$$4$YR$$M$Y$15$KG$20240808$$MD$FR$FR
233671414$23367141$4$F$20231225$20240712$20240104$20240722$EXP$$JP-Eisai-EC-2023-155914$EISAI$$60$YR$A$M$Y$$$20240719$$MD$JP$JP
233671914$23367191$4$F$20240209$20240808$20240104$20240812$EXP$$CA-TAKEDA-2023TUS006013$TAKEDA$$52$YR$$M$Y$$$20240812$$CN$CA$CA
233671975$23367197$5$F$$20240911$20240104$20240913$EXP$$US-PFIZER INC-202300456139$PFIZER$$35$YR$$F$Y$55.34$KG$20240913$$CN$US$US
233672143$23367214$3$F$20240201$20240625$20240104$20240701$EXP$$US-PFIZER INC-202300455458$PFIZER$$87$YR$$F$Y$70.295$KG$20240701$$CN$US$US
233672882$23367288$2$F$20240101$20240826$20240104$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001004$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240828$$CN$US$US
233673444$23367344$4$F$20230915$20240712$20240104$20240801$EXP$$US-SA-2024SA003536$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240719$$MD$US$US
233673703$23367370$3$F$$20240717$20240104$20240723$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-002127$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$67.13$KG$20240719$$CN$PR$PR
233673908$23367390$8$F$20231215$20240701$20240104$20240715$PER$$US-Calliditas-2023CAL01710$CALLIDITAS THERAPEUTICS$$75$YR$E$F$Y$71.21$KG$20240715$$CN$US$US
233674693$23367469$3$F$20190101$20240717$20240104$20240722$EXP$$JP-009507513-1911JPN001627J$MERCK$$$$$M$Y$70$KG$20240719$$MD$JP$JP
233675234$23367523$4$F$20230101$20240905$20240104$20240913$PER$$JP-Eisai-EC-2023-155758$EISAI$Osawa Takahiro. Surgery and Drug Treatment for Renal Cell Carcinoma. Meeting to Discuss Tomorrow^s /Future Renal Carcinoma Treatment; 2024 Jan 20-; .$71$YR$E$M$Y$$$20240913$$MD$JP$JP
233675603$23367560$3$F$$20240807$20240104$20240812$PER$$US-PFIZER INC-PV202300053378$PFIZER$$81$YR$$F$Y$$$20240812$$CN$US$US
233675732$23367573$2$F$$20240711$20240104$20240712$PER$$US-PFIZER INC-202300456825$PFIZER$$76$YR$$F$Y$$$20240712$$CN$US$US
233675913$23367591$3$F$20230101$20240702$20240104$20240707$EXP$$US-PFIZER INC-202400000644$PFIZER$$60$YR$$F$Y$$$20240707$$CN$US$US
233676282$23367628$2$F$20230101$20240724$20240104$20240730$EXP$$US-009507513-2401USA000595$MERCK$$57$YR$$M$Y$94.4$KG$20240730$$CN$US$US
233676612$23367661$2$F$20230901$20240724$20240104$20240821$PER$$US-009507513-2401USA000365$MERCK$$62$YR$$F$Y$$$20240821$$CN$US$US
233676684$23367668$4$F$20230920$20240802$20240104$20240816$EXP$$DE-VER-202300012$VERITY PHARMACEUTICALS$$65$YR$E$M$Y$98$KG$20240816$$HP$DE$DE
233677052$23367705$2$F$$20240129$20240104$20240902$PER$$US-ASTELLAS-2023US032804$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
233677092$23367709$2$F$$20240108$20240104$20240902$PER$$US-ASTELLAS-2023US030817$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
233677102$23367710$2$F$$20240108$20240104$20240902$PER$$US-ASTELLAS-2023US030813$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
233677112$23367711$2$F$20231001$20240109$20240104$20240902$PER$$US-ASTELLAS-2023US036086$ASTELLAS$$61$YR$A$M$Y$$$20240830$$PH$US$US
233677122$23367712$2$F$20231101$20240227$20240104$20240902$PER$$US-ASTELLAS-2023US036815$ASTELLAS$$83$YR$E$M$Y$$$20240830$$PH$US$US
233677172$23367717$2$F$$20240306$20240104$20240902$PER$$US-ASTELLAS-2023US034625$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
233678377$23367837$7$F$20230101$20240704$20240104$20240710$EXP$$AT-ABBVIE-5390845$ABBVIE$$83$YR$$M$Y$84$KG$20240710$$MD$AT$AT
233678824$23367882$4$F$20231001$20240905$20240104$20240909$EXP$$CA-ROCHE-3485487$ROCHE$$62$YR$A$F$Y$$$20240909$$CN$CA$CA
233678836$23367883$6$F$20230925$20240820$20240104$20240822$EXP$$DE-ROCHE-3485232$ROCHE$$54$YR$A$F$Y$57$KG$20240822$$MD$DE$DE
233678916$23367891$6$F$20231229$20240716$20240104$20240723$EXP$$CA-ROCHE-3348977$ROCHE$$30$YR$A$M$Y$$$20240723$$CN$CA$CA
233678966$23367896$6$F$20180809$20240802$20240104$20240807$EXP$$JP-ABBVIE-4332651$ABBVIE$$60$YR$$M$Y$$$20240807$$MD$JP$JP
233678997$23367899$7$F$20240112$20240903$20240104$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001840$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240905$$CN$US$US
2336790512$23367905$12$F$20231126$20240919$20240104$20240921$EXP$$NL-ABBVIE-5570500$ABBVIE$$74$YR$$M$Y$$$20240921$$MD$NL$NL
233679153$23367915$3$F$$20240716$20240104$20240723$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-025370$JAZZ$$$$$M$Y$$$20240723$$HP$US$US
233680053$23368005$3$F$$20240611$20240105$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-006056$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
233680178$23368017$8$F$$20240910$20240105$20240911$EXP$$CA-SANDOZ INC.-PHHY2016CA096795$SANDOZ$$36$YR$$M$Y$$$20240911$$MD$CA$CA
233680186$23368018$6$F$$20240709$20240105$20240710$EXP$$CA-SANDOZ INC.-SDZ2023CA074566$SANDOZ$$58$YR$$M$Y$$$20240710$$HP$CA$CA
233680374$23368037$4$F$20231201$20240822$20240105$20240911$PER$$CA-TOLMAR, INC.-23CA045439$TOLMAR$$73$YR$$M$Y$$$20240911$$CN$CA$CA
233680454$23368045$4$F$$20240926$20240105$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001603$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240928$$CN$US$US
233681063$23368106$3$F$20231212$20240912$20240105$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-000103$JAZZ$$7$YR$$F$Y$$$20240916$$CN$US$US
233681323$23368132$3$F$$20240819$20240105$20240823$EXP$$CA-TAKEDA-2021TUS030708$TAKEDA$$$$$F$Y$$$20240823$$MD$CA$CA
233681652$23368165$2$F$20230530$20240909$20240105$20240912$EXP$$DE-SANDOZ INC.-SDZ2023DE075117$SANDOZ$$60$YR$$M$Y$67$KG$20240912$$HP$DE$DE
233682303$23368230$3$F$20240601$20240626$20240105$20240703$PER$$US-BIOGEN-2024BI01243573$BIOGEN$$60$YR$$M$Y$$$20240703$$CN$US$US
233682485$23368248$5$F$20231201$20240405$20240105$20240925$PER$$US-GSK-US2023AMR181758$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
233683454$23368345$4$F$20231201$20240715$20240105$20240722$EXP$$US-SA-2024SA002544$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240721$$MD$US$US
233684013$23368401$3$F$20231211$20240723$20240105$20240819$PER$$CA-TOLMAR, INC.-23CA045444$TOLMAR$$63$YR$$M$Y$$$20240814$$CN$CA$CA
233684024$23368402$4$F$20231129$20240821$20240105$20240911$PER$$CA-TOLMAR, INC.-23CA045464$TOLMAR$$74$YR$$M$Y$$$20240911$$CN$CA$CA
233684145$23368414$5$F$$20240812$20240105$20240820$EXP$$CA-ROCHE-3484728$ROCHE$$64$YR$A$M$Y$$$20240820$$CN$CA$CA
233684153$23368415$3$F$20231101$20240730$20240105$20240806$EXP$$US-BEH-2024167110$CSL BEHRING$$76$YR$E$M$Y$$$20240806$$HP$US$US
233684552$23368455$2$F$20230101$20240724$20240105$20240730$EXP$$US-009507513-2401USA000434$MERCK$$52$YR$$M$Y$$$20240730$$CN$US$US
233684824$23368482$4$F$20230101$20240902$20240105$20240904$EXP$$DE-SANDOZ INC.-SDZ2024DE000194$SANDOZ$$$$$M$Y$136.2$KG$20240904$$CN$DE$DE
233684872$23368487$2$F$20240908$20240910$20240105$20240918$PER$$US-AMGEN-USASP2024000933$AMGEN$$69$YR$E$F$Y$$$20240917$$CN$US$US
233685012$23368501$2$F$20231201$20240709$20240105$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002430$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240711$$HP$US$US
233685162$23368516$2$F$$20240905$20240105$20240913$EXP$$CA-CELLTRION INC.-2024CA000055$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
233686303$23368630$3$F$$20240214$20240105$20240710$PER$$LV-ROCHE-3466735$ROCHE$$71$YR$E$M$Y$$$20240628$$MD$LV$LV
233687305$23368730$5$F$$20240627$20240105$20240703$EXP$$NVSC2024CO001420$NOVARTIS$$$$$F$Y$73$KG$20240704$$CN$CO$CO
233688975$23368897$5$F$20231101$20240814$20240105$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001859$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$69.85$KG$20240822$$CN$US$US
233689468$23368946$8$F$$20240625$20240105$20240719$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005777$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
233689482$23368948$2$F$$20240627$20240105$20240703$EXP$$JP-JNJFOC-20240110573$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240703$$$COUNTRY NOT SPECIFIED$JP
233689696$23368969$6$F$$20240923$20240105$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001006$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240925$$CN$US$US
233689882$23368988$2$F$20230101$20240624$20240105$20240702$EXP$$FR-AUROBINDO-AUR-APL-2023-081491$AUROBINDO$$66$YR$$F$Y$56$KG$20240702$$MD$FR$FR
233689992$23368999$2$F$$20240627$20240105$20240703$EXP$$JP-JNJFOC-20240110534$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240703$$$COUNTRY NOT SPECIFIED$JP
233690314$23369031$4$F$20240117$20240814$20240105$20240818$EXP$$NVSC2024CA000994$NOVARTIS$$$$A$F$Y$$$20240818$$HP$CA$CA
233690583$23369058$3$F$$20240619$20240105$20240702$EXP$FR-AFSSAPS-RN2023001328$FR-ROCHE-3485534$ROCHE$$42$YR$A$M$Y$$$20240702$$MD$FR$FR
233691704$23369170$4$F$$20240819$20240105$20240903$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-188761$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$HP$CA$CA
233691974$23369197$4$F$$20240809$20240105$20240821$EXP$$CA-AUROBINDO-AUR-APL-2023-081807$AUROBINDO$Carter MT, Postma JK, Zambonin JL, Khouj E, Alyamani S, Graham JM, et al. Further clinical delineation of microcephaly-capillary malformation syndrome. American-Journal-Medical-Genetics-A part willey. 2022;188(11):3350-3357$15$YR$$F$Y$$$20240821$$HP$CA$CA
233692365$23369236$5$F$$20240717$20240105$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002511$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240718$$HP$US$US
233692394$23369239$4$F$20240301$20240801$20240105$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002287$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240802$$HP$US$US
233692583$23369258$3$F$20231225$20240815$20240105$20240816$EXP$$JP-ABBVIE-5572752$ABBVIE$$$$$M$Y$$$20240816$$CN$JP$JP
233693572$23369357$2$F$$20240709$20240105$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002037$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240710$$CN$US$US
233693762$23369376$2$F$$20240702$20240105$20240711$EXP$$IN-ROCHE-3485958$ROCHE$$72$YR$E$M$Y$$$20240711$$MD$IN$IN
233693853$23369385$3$F$20190722$20240821$20240105$20240902$EXP$$DE-AUROBINDO-AUR-APL-2022-026743$AUROBINDO$$$$E$F$Y$66$KG$20240902$$MD$DE$DE
233694222$23369422$2$F$$20240710$20240105$20240716$PER$$US-BIOGEN-2022BI01177287$BIOGEN$$$$$F$Y$$$20240716$$CN$US$US
233694872$23369487$2$F$20170911$20240621$20240105$20240701$EXP$$DE-AUROBINDO-AUR-APL-2023-081781$AUROBINDO$Ratuszny D, Skripuletz T, Wegner F, Gross M, Falk C, Jacobs R, et al. Case Report: Daratumumab in a Patient With Severe Refractory Anti-NMDA Receptor Encephalitis. Front-Neurol. 2020;11:602102$20$YR$$F$Y$$$20240701$$HP$DE$DE
233694902$23369490$2$F$20231201$20231226$20240105$20240925$PER$$US-GSK-US2023AMR180810$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240925$$CN$US$US
233694963$23369496$3$F$$20240801$20240105$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001856$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240806$$CN$US$US
233695466$23369546$6$F$$20240909$20240105$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002539$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240911$$CN$US$US
233696705$23369670$5$F$$20240808$20240105$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002053$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240813$$CN$US$US
233696842$23369684$2$F$$20240802$20240105$20240807$EXP$$BE-MYLANLABS-2023M1138218$MYLAN$Ruttens D, Philippet P, Neven B, Lagrou K, Moshous D, Bucciol G, et al.. Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide in High-Risk Chronic Granulomatous Disease Patient with Invasive Mucormycosis. J-Clin-Immunol. 2023;43:1758-1765$11$YR$$M$Y$$$20240807$$HP$BE$BE
233697795$23369779$5$F$20231214$20240625$20240105$20240709$EXP$DE-SERVIER-S23015041$DE-SERVIER-S23015041$SERVIER$$$$$$Y$$$20240709$$HP$DE$DE
233698183$23369818$3$F$$20240828$20240105$20240905$EXP$$FR-AstraZeneca-2024A001812$ASTRAZENECA$$$$$M$Y$96$KG$20240905$$MD$FR$
233698412$23369841$2$F$20201105$20240726$20240105$20240809$EXP$$FR-SERVIER-S23014966$SERVIER$$$$$$Y$$$20240809$$MD$FR$FR
233700064$23370006$4$F$20130501$20240730$20240105$20240801$PER$$US-GILEAD-2024-0657413$GILEAD$$63$YR$A$M$Y$$$20240801$$LW$US$US
233700585$23370058$5$F$20220101$20240827$20240105$20240910$EXP$$CA-UCBSA-2022057630$UCB$$$$$M$Y$$$20240910$$CN$CA$CA
233701253$23370125$3$F$20230101$20240716$20240105$20240718$PER$$US-PFIZER INC-202300455223$PFIZER$$62$YR$$F$Y$52.154$KG$20240718$$HP$US$US
233702162$23370216$2$F$20240103$20240821$20240105$20240824$PER$$US-AMGEN-USASP2024001506$AMGEN$$61$YR$A$M$Y$$$20240824$$CN$US$US
233702276$23370227$6$F$20230127$20240814$20240105$20240816$EXP$$CA-TAKEDA-2022TUS100288$TAKEDA$$76$YR$$F$Y$$$20240816$$HP$CA$CA
233702595$23370259$5$F$20230109$20240814$20240105$20240821$EXP$$FR-TAKEDA-2024TUS000778$TAKEDA$$75$YR$$F$Y$61$KG$20240821$$HP$FR$FR
233702618$23370261$8$F$20231201$20240620$20240105$20240704$EXP$$US-GSK-US2023180205$GLAXOSMITHKLINE$$64$YR$$F$Y$99$KG$20240704$$CN$US$US
233702653$23370265$3$F$20230101$20240730$20240105$20240808$PER$$US-SA-2023SA403283$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240808$$MD$US$US
233702894$23370289$4$F$20230101$20240624$20240105$20240703$PER$$US-SA-2023SA358151$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240703$$HP$US$US
233703192$23370319$2$F$$20240917$20240105$20240923$PER$$US-SA-2023SA404443$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240923$$MD$US$US
233703272$23370327$2$F$$20240620$20240105$20240701$PER$$US-SA-2023SA402340$SANOFI AVENTIS$$$$A$M$Y$$$20240701$$MD$US$US
233703672$23370367$2$F$$20240702$20240105$20240711$PER$$US-SA-2023SA404435$SANOFI AVENTIS$$$$A$M$Y$$$20240711$$MD$US$US
233703744$23370374$4$F$20231001$20240820$20240105$20240828$EXP$$US-SA-2023SA404404$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240828$$MD$US$US
233703874$23370387$4$F$20230101$20240821$20240105$20240913$PER$$US-SA-2023SA405050$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240913$$MD$US$US
233704112$23370411$2$F$20230101$20240805$20240105$20240813$PER$$US-SA-2023SA404327$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240814$$MD$US$US
233704162$23370416$2$F$$20240813$20240105$20240826$PER$$US-SA-2023SA404442$SANOFI AVENTIS$$16$YR$T$F$Y$58.96$KG$20240826$$MD$US$US
233705313$23370531$3$F$20230101$20240702$20240105$20240711$PER$$US-SA-2024SA000545$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240711$$MD$US$US
233705453$23370545$3$F$$20240911$20240105$20240923$PER$$US-SA-2023SA404562$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240923$$MD$US$US
233705616$23370561$6$F$20231201$20240814$20240105$20240828$PER$$US-SA-2024SA000626$SANOFI AVENTIS$$15$YR$T$M$Y$95.7$KG$20240828$$MD$US$US
233705853$23370585$3$F$$20240718$20240105$20240725$PER$$US-SA-2024SA001254$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240725$$MD$US$US
233705952$23370595$2$F$$20240806$20240105$20240813$PER$$US-SA-2024SA001109$SANOFI AVENTIS$$39$YR$A$F$Y$97.5$KG$20240813$$MD$US$US
233706204$23370620$4$F$20230101$20240724$20240105$20240731$PER$$US-SA-2023SA406070$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240801$$MD$US$US
233706212$23370621$2$F$$20240809$20240105$20240820$PER$$US-SA-2024SA000975$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240820$$MD$US$US
233706333$23370633$3$F$20231101$20240813$20240105$20240821$PER$$US-SA-2024SA000733$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240821$$MD$US$US
233706342$23370634$2$F$20231225$20240628$20240105$20240712$PER$$US-SA-2023SA406177$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240712$$MD$US$US
233706613$23370661$3$F$20230901$20240824$20240105$20240905$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202312014413$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240905$$CN$JP$JP
233706763$23370676$3$F$20231201$20240912$20240105$20240923$PER$$US-SA-2023SA406115$SANOFI AVENTIS$$4$YR$C$M$Y$19.05$KG$20240923$$MD$US$US
233706872$23370687$2$F$20230101$20240827$20240105$20240923$PER$$US-SA-2024SA002018$SANOFI AVENTIS$$34$YR$A$M$Y$81$KG$20240923$$MD$US$US
233706992$23370699$2$F$20230101$20240826$20240105$20240909$PER$$US-SA-2023SA405556$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240909$$MD$US$US
233707682$23370768$2$F$$20240511$20240105$20240911$PER$$US-SA-2024SA000767$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240911$$MD$US$US
233707774$23370777$4$F$20240101$20240831$20240105$20240915$PER$$US-SA-2024SA002024$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240915$$MD$US$US
233707812$23370781$2$F$$20240704$20240105$20240713$PER$$US-SA-2024SA000788$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240713$$MD$US$US
233707964$23370796$4$F$20231117$20240718$20240105$20240729$PER$$US-SA-2024SA002073$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240729$$MD$US$US
233708072$23370807$2$F$20230101$20240807$20240105$20240816$PER$$US-SA-2024SA002377$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240816$$MD$US$US
233708224$23370822$4$F$20231201$20240901$20240105$20240912$PER$$US-SA-2024SA000991$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240912$$MD$US$US
233708415$23370841$5$F$20231201$20240708$20240105$20240716$PER$$US-SA-2023SA397639$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240716$$MD$US$US
233708534$23370853$4$F$$20240730$20240105$20240807$PER$$US-SA-2024SA000504$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240807$$MD$US$US
233708674$23370867$4$F$$20240715$20240105$20240723$PER$$US-SA-2024SA002456$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240723$$MD$US$US
233708983$23370898$3$F$20230701$20240709$20240105$20240717$PER$$US-SA-2024SA003433$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240717$$MD$US$US
233709022$23370902$2$F$20230101$20240628$20240105$20240705$PER$$US-SA-2024SA001978$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240705$$MD$US$US
233709233$23370923$3$F$20230101$20240906$20240105$20240916$PER$$US-SA-2024SA005461$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240916$$MD$US$US
233709262$23370926$2$F$$20240911$20240105$20240926$PER$$US-SA-2024SA003337$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240926$$MD$US$US
233709483$23370948$3$F$$20240819$20240105$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002553$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240821$$CN$US$US
233709655$23370965$5$F$20110101$20240702$20240105$20240704$EXP$$FR-ORGANON-O2401FRA000270$ORGANON$$4$DEC$$M$Y$95$KG$20240704$$PH$FR$FR
233709718$23370971$8$F$$20240806$20240105$20240826$EXP$$AU-OTSUKA-2024_000438$OTSUKA$$$$$$Y$$$20240826$$CN$AU$AU
233709865$23370986$5$F$20231101$20240905$20240105$20240912$PER$$US-ALXN-202312USA001526US$ALEXION PHARMACEUTICALS$$59$YR$$F$Y$$$20240912$$HP$US$US
233710103$23371010$3$F$20230101$20240703$20240105$20240714$PER$$US-SA-2024SA004797$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240714$$MD$US$US
233710174$23371017$4$F$20230101$20240809$20240105$20240817$PER$$US-SA-2024SA004283$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240817$$CN$US$US
233710552$23371055$2$F$$20240819$20240105$20240829$PER$$US-SA-2024SA004116$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240829$$MD$US$US
233710744$23371074$4$F$20231101$20240813$20240105$20240821$EXP$$US-SA-2024SA004729$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240821$$MD$US$US
233710942$23371094$2$F$$20240722$20240105$20240730$PER$$US-SA-2024SA003932$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240730$$MD$US$US
233710975$23371097$5$F$20230101$20240712$20240105$20240722$PER$$US-SA-2024SA005137$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240720$$MD$US$US
233711242$23371124$2$F$20240703$20240703$20240105$20240714$PER$$US-SA-2024SA004966$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240714$$MD$US$US
233711272$23371127$2$F$20231202$20240710$20240105$20240718$PER$$US-SA-2024SA004108$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240718$$MD$US$US
233711954$23371195$4$F$20230901$20240828$20240105$20240906$PER$$US-SA-2024SA000462$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240906$$MD$US$US
233712792$23371279$2$F$20231213$20231229$20240105$20240801$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-00124$IPSEN$$73$YR$E$M$Y$88.3$KG$20240801$$MD$US$US
233712902$23371290$2$F$$20240628$20240105$20240703$PER$$US-PFIZER INC-PV202300209360$PFIZER$$$$$F$Y$$$20240703$$CN$US$US
233712972$23371297$2$F$$20240812$20240105$20240814$PER$$US-PFIZER INC-PV202300209520$PFIZER$$91$YR$$M$Y$$$20240814$$CN$US$US
233713362$23371336$2$F$20240701$20240701$20240105$20240703$PER$$US-PFIZER INC-PV202300209546$PFIZER$$55$YR$$F$Y$$$20240703$$HP$US$US
233713654$23371365$4$F$$20240809$20240105$20240809$PER$$US-PFIZER INC-PV202400000118$PFIZER$$45$YR$$F$Y$$$20240809$$CN$US$US
233713756$23371375$6$F$20231215$20240922$20240105$20240925$EXP$$US-TAKEDA-2024TUS001439$TAKEDA$$42$YR$$M$Y$$$20240925$$CN$US$US
233714642$23371464$2$F$$20240731$20240105$20240805$PER$$US-PFIZER INC-PV202300208502$PFIZER$$49$YR$$F$Y$$$20240805$$HP$US$US
233714674$23371467$4$F$$20240918$20240105$20240923$PER$$US-PFIZER INC-PV202300203451$PFIZER$$81$YR$$F$Y$$$20240923$$HP$US$US
233714793$23371479$3$F$$20240923$20240105$20240927$PER$$US-PFIZER INC-PV202300183684$PFIZER$$78$YR$$F$Y$$$20240927$$CN$US$US
233715174$23371517$4$F$20231201$20240715$20240105$20240717$EXP$$US-KYOWAKIRIN-2024KK000082$KYOWA$$$$$$Y$$$20240717$$HP$US$US
233715775$23371577$5$F$$20240305$20240105$20240829$EXP$$NVSC2023CA277678$NOVARTIS$$77$YR$$F$Y$$$20240829$$HP$CA$CA
233716052$23371605$2$F$20231212$20240801$20240105$20240805$EXP$$CN-PFIZER INC-PV202300210251$PFIZER$$72$YR$$M$Y$56$KG$20240805$$HP$CN$CN
233716233$23371623$3$F$$20240816$20240105$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002571$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$141.52$KG$20240820$$CN$US$US
233716803$23371680$3$F$$20240716$20240105$20240717$PER$$US-PFIZER INC-PV202300132344$PFIZER$$46$YR$$F$Y$86.182$KG$20240717$$CN$US$US
233717022$23371702$2$F$$20240829$20240105$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-001808$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$68.49$KG$20240902$$CN$US$US
233717366$23371736$6$F$20231201$20240917$20240105$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-012964$JAZZ$$45$YR$$F$Y$$$20240922$$HP$US$US
233718393$23371839$3$F$20231202$20240716$20240105$20240722$EXP$FR-AFSSAPS-AN2023001641$FR-PFIZER INC-202300455605$PFIZER$$51$YR$$M$Y$42.6$KG$20240722$$PH$FR$FR
233718494$23371849$4$F$$20240923$20240105$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003033$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$78.47$KG$20240926$$CN$US$US
233718794$23371879$4$F$20230101$20240807$20240105$20240807$EXP$$CA-PFIZER INC-202300034595$PFIZER$$50$YR$$M$Y$$$20240807$$HP$CA$CA
233719387$23371938$7$F$20230101$20240705$20240105$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002517$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240710$$CN$US$US
233720334$23372033$4$F$$20240913$20240105$20240916$PER$$US-PFIZER INC-202400002768$PFIZER$$22$YR$$M$Y$81.65$KG$20240916$$CN$US$US
233721404$23372140$4$F$$20240913$20240105$20240918$PER$$US-PFIZER INC-PV202300042577$PFIZER$$67$YR$$F$Y$$$20240918$$MD$US$US
233721634$23372163$4$F$20231201$20240731$20240105$20240806$EXP$$US-PFIZER INC-202300456336$PFIZER$$51$YR$$F$Y$152.41$KG$20240806$$HP$US$US
233722093$23372209$3$F$20190501$20240723$20240105$20240725$EXP$$DE-SANDOZ INC.-NVSC2020DE114113$SANDOZ$$41$YR$$F$Y$80$KG$20240725$$CN$DE$DE
233723253$23372325$3$F$$20240813$20240105$20240816$EXP$$CA-SANDOZ INC.-NVSC2023CA016964$SANDOZ$$81$YR$$F$Y$$$20240816$$HP$CA$CA
233728263$23372826$3$F$$20240814$20240105$20240816$PER$$US-PFIZER INC-202400000177$PFIZER$$56$YR$$F$Y$$$20240816$$MD$US$US
233730218$23373021$8$F$20231205$20240828$20240105$20240905$PER$$JP-Eisai-EC-2023-155536$EISAI$$68$YR$E$F$Y$$$20240905$$MD$JP$JP
233733429$23373342$9$F$20210819$20240917$20240105$20240924$EXP$$EG-SANDOZ INC.-NVSC2021EG192789$SANDOZ$$74$YR$$M$Y$$$20240924$$CN$EG$EG
233746634$23374663$4$F$20231001$20240821$20240105$20240823$EXP$$US-SANDOZ INC.-SDZ2024US000757$SANDOZ$$62$YR$$F$Y$$$20240823$$CN$US$US
233746722$23374672$2$F$20200108$20240809$20240105$20240816$EXP$$US-SANDOZ INC.-NVSC2020US007026$SANDOZ$$65$YR$$F$Y$53.968$KG$20240816$$CN$US$US
233747229$23374722$9$F$20231016$20240807$20240105$20240813$EXP$$US-ABBVIE-5570728$ABBVIE$$20$YR$$M$Y$114$KG$20240813$$MD$US$US
233748083$23374808$3$F$20231201$20240801$20240106$20240805$EXP$$US-UCBSA-2024000329$UCB$$40$YR$$F$Y$$$20240805$$HP$US$US
233748254$23374825$4$F$20230101$20240716$20240106$20240724$EXP$$US-SANDOZ INC.-SDZ2024US001343$SANDOZ$$$$$F$Y$63.49$KG$20240724$$CN$US$US
233748273$23374827$3$F$$20240902$20240106$20240903$EXP$$ES-SANDOZ INC.-NVSC2020ES206671$SANDOZ$$56$YR$$F$Y$$$20240903$$MD$ES$ES
2337487213$23374872$13$F$20230101$20240905$20240106$20240918$EXP$$CA-UCBSA-2023037933$UCB$$$$$F$Y$$$20240918$$CN$CA$CA
233748793$23374879$3$F$20221224$20240725$20240106$20240801$EXP$FR-AFSSAPS-PV2023001323$FR-ABBVIE-5570631$ABBVIE$$12$YR$$M$Y$42.5$KG$20240801$$MD$FR$FR
233748922$23374892$2$F$20231027$20240729$20240106$20240808$EXP$$DE-AUROBINDO-AUR-APL-2023-081950$AUROBINDO$$29$YR$$F$Y$$$20240808$$MD$DE$DE
233749412$23374941$2$F$20220526$20240808$20240106$20240815$EXP$$CA-CELLTRION INC.-2023CA025464$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
233749812$23374981$2$F$20231212$20240729$20240106$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04569$AMNEAL$$78$YR$$F$Y$$$20240806$$CN$US$US
233751053$23375105$3$F$20231201$20240819$20240106$20240830$EXP$$US-UCBSA-2024000583$UCB$$40$YR$$F$Y$$$20240830$$HP$US$US
233751396$23375139$6$F$20231228$20240715$20240106$20240722$EXP$$US-GSK-US2023180730$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
233751774$23375177$4$F$20231212$20240718$20240106$20240729$EXP$$ES-Accord-398867$ACCORD$$86$YR$E$M$Y$77$KG$20240729$$HP$ES$ES
233752113$23375211$3$F$$20240923$20240106$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003082$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240926$$CN$US$US
233752843$23375284$3$F$20230129$20240903$20240106$20240905$EXP$$FR-SANDOZ INC.-SDZ2023FR075278$SANDOZ$$61$YR$$M$Y$$$20240905$$HP$FR$FR
233753282$23375328$2$F$20240102$20240626$20240106$20240701$PER$$US-AMGEN-USASP2024001742$AMGEN$$80$YR$E$M$Y$$$20240701$$CN$US$US
233753575$23375357$5$F$20200810$20240710$20240106$20240716$EXP$$CO-SANDOZ INC.-NVSC2019CO072650$SANDOZ$$68$YR$$F$Y$60$KG$20240716$$CN$CO$CO
233756056$23375605$6$F$$20240910$20240107$20240919$PER$$US-BAUSCHBL-2023BNL005435$BAUSCH AND LOMB$$65$YR$$F$Y$74.84$KG$20240919$$CN$US$US
233757056$23375705$6$F$20240104$20240712$20240107$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002618$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$120.2$KG$20240717$$CN$US$US
233757267$23375726$7$F$20231201$20240910$20240107$20240920$EXP$$US-BEH-2024167107$CSL BEHRING$$33$YR$A$F$Y$$$20240920$$HP$US$US
233757462$23375746$2$F$$20240823$20240107$20240827$EXP$$US-TAKEDA-2020TUS050590$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
233758072$23375807$2$F$20231101$20240905$20240108$20240916$PER$$US-SA-2023SA404719$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240916$$MD$US$US
233758292$23375829$2$F$20230101$20240628$20240108$20240703$EXP$$US-ABBVIE-5571434$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
233758392$23375839$2$F$$20240731$20240108$20240811$EXP$$CA-AUROBINDO-AUR-APL-2023-082116$AUROBINDO$$28$YR$$F$Y$54$KG$20240812$$HP$CA$CA
233758405$23375840$5$F$20240103$20240826$20240108$20240910$PER$$US-SA-2024SA004799$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240910$$MD$US$US
233758493$23375849$3$F$$20240911$20240108$20240919$EXP$$ES-AUROBINDO-AUR-APL-2023-081820$AUROBINDO$Giangrande N, Carral Maseda A, Lopez Arias JA, Perez Casares L, Martin Lazaro J, Nunez Orjales R, et al.. Kounis syndrome during an oxaliplatin desensitization protocol.. Journal of investigational allergology + clinical immunology. 2023;34 (No.4):268$59$YR$$F$Y$$$20240919$$MD$ES$ES
233758634$23375863$4$F$20230622$20240719$20240108$20240801$PER$$US-SA-2024SA005998$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240801$$MD$US$US
233758692$23375869$2$F$20230101$20240803$20240108$20240809$EXP$$GB-ABBVIE-5571787$ABBVIE$$63$YR$$F$Y$$$20240809$$CN$GB$GB
233758863$23375886$3$F$20231116$20240710$20240108$20240729$PER$$CA-TOLMAR, INC.-23CA044924$TOLMAR$$72$YR$$M$Y$$$20240729$$CN$CA$CA
233758882$23375888$2$F$$20240708$20240108$20240710$EXP$$CA-TAKEDA-2023TUS104639$TAKEDA$$$$$M$Y$$$20240710$$CN$CA$CA
233759322$23375932$2$F$20240701$20240801$20240108$20240810$PER$$US-SA-2024SA005715$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240810$$MD$US$US
233759522$23375952$2$F$$20240710$20240108$20240723$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP000147$STRIDES$Sarper N, Cam I, Aylan Gelen S, Sonmez HE, Sakarya Gunes A, Zengin E.. Splenic Artery Embolization in a Patient With Intracranial Hemorrhage Due to Refractory Persistent Immune Thrombocytopenia.. J-Pediatr-Hematol-Oncol. 2023;45 (8):e988-e992.$16$YR$$F$Y$$$20240723$$MD$TR$TR
233759535$23375953$5$F$20230101$20240725$20240108$20240802$EXP$$CA-JNJFOC-20230713843$JOHNSON AND JOHNSON$$30$YR$A$F$Y$62$KG$20240802$$PH$CA$CA
233759863$23375986$3$F$20240701$20240807$20240108$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-000914$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240809$$CN$US$US
233760084$23376008$4$F$$20240813$20240108$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202401002548$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240817$$CN$US$US
233760522$23376052$2$F$20221020$20240718$20240108$20240730$EXP$$CA-INTERCEPT-PM2022002007$INTERCEPT PHARMACEUTICALS$$52$YR$$F$Y$$$20240730$$MD$CA$CA
233760592$23376059$2$F$20240105$20240731$20240108$20240805$PER$$US-AMGEN-USASP2024003136$AMGEN$$75$YR$E$M$Y$$$20240804$$CN$US$US
233760752$23376075$2$F$20230101$20240801$20240108$20240812$PER$$US-SA-2023SA406152$SANOFI AVENTIS$$16$YR$T$F$Y$61.235$KG$20240812$$MD$US$US
233760952$23376095$2$F$20240101$20240709$20240108$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-000881$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240710$$CN$US$US
233761027$23376102$7$F$$20240607$20240108$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005797$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
233761236$23376123$6$F$$20240730$20240108$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002056$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240802$$CN$US$US
233761634$23376163$4$F$20240101$20240806$20240108$20240813$PER$$US-SA-2024SA000542$SANOFI AVENTIS$$59$YR$A$M$Y$105$KG$20240814$$MD$US$US
233762234$23376223$4$F$$20240812$20240108$20240819$EXP$$US-SA-2024SA005575$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240819$$MD$US$US
233762533$23376253$3$F$$20240814$20240108$20240827$PER$$US-SA-2024SA005813$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240827$$MD$US$US
233762993$23376299$3$F$$20240625$20240108$20240701$EXP$$RO-CELLTRION INC.-2023RO025218$CELLTRION$Gaman M, Ionescu B, Croitoru A, Dinu I, Tatic A, Ghiaur A, et al.. Synchronous Diagnosis of Acute Myeloid Leukemia (AML) and Colorectal Adenocarcinoma (CRC) (Abstract no: AML-453). Clinical Lymphoma, Myeloma and Leukemia. 2023;23 (SUP: 1):S302-3$$$$$Y$$$20240702$$MD$RO$RO
233763572$23376357$2$F$20230101$20240709$20240108$20240717$PER$$US-SA-2024SA000799$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240717$$MD$US$US
233763773$23376377$3$F$$20240216$20240108$20240718$EXP$$CA-Taiho Oncology Inc-2023-010682$TAIHO ONCOLOGY INC$$61$YR$A$M$Y$$$20240718$$CN$CA$CA
233764022$23376402$2$F$20220106$20240814$20240108$20240815$EXP$$JP-ABBVIE-22K-087-4337764-00$ABBVIE$$85$YR$$F$Y$49$KG$20240815$$MD$JP$JP
233764952$23376495$2$F$$20240801$20240108$20240814$EXP$$CA-AUROBINDO-AUR-APL-2023-082071$AUROBINDO$$57$YR$$F$Y$$$20240814$$HP$CA$CA
233765316$23376531$6$F$$20240913$20240108$20240916$EXP$$CA-SANDOZ INC.-NVSC2022CA263482$SANDOZ$$30$YR$$M$Y$84$KG$20240916$$MD$CA$CA
233765553$23376555$3$F$$20240927$20240108$20240930$EXP$$CA-SANDOZ INC.-SDZ2024CA001007$SANDOZ$$52$YR$$F$Y$$$20240930$$HP$CA$CA
233765565$23376556$5$F$20231201$20240903$20240108$20240912$PER$$US-SA-2024SA002026$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240912$$MD$US$US
233765922$23376592$2$F$20231201$20240712$20240108$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000002$Unknown Manufacturer$$$$$$Y$$$20240805$$CN$US$US
233766675$23376667$5$F$$20240618$20240108$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005817$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
233767243$23376724$3$F$$20240704$20240108$20240712$EXP$$CA-AstraZeneca-2023A269054$ASTRAZENECA$$$$$F$Y$$$20240712$$HP$CA$
233767904$23376790$4$F$20231130$20240730$20240108$20240808$PER$$US-SA-2024SA000895$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240808$$MD$US$US
233768135$23376813$5$F$$20240730$20240108$20240731$EXP$$IE-ROCHE-3486852$ROCHE$$$$E$$Y$71.2$KG$20240731$$CN$IE$IE
233768555$23376855$5$F$20230830$20240923$20240108$20240930$EXP$$CO-GSK-CO2023AMR135720$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$CO$CO
233768702$23376870$2$F$$20240820$20240108$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002562$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240828$$HP$US$US
233768732$23376873$2$F$$20240708$20240108$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002615$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240715$$CN$US$US
233768882$23376888$2$F$20231101$20240905$20240108$20240915$PER$$US-SA-2024SA000297$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240915$$MD$US$US
233769162$23376916$2$F$20230703$20240718$20240108$20240723$EXP$$US-SA-2024SA006186$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240723$$MD$US$US
233769733$23376973$3$F$20231201$20240718$20240108$20240729$PER$$US-SA-2024SA001000$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240729$$MD$US$US
233770132$23377013$2$F$$20240801$20240108$20240814$EXP$$CA-AUROBINDO-AUR-APL-2023-082072$AUROBINDO$$65$YR$$F$Y$56$KG$20240814$$HP$CA$CA
233770302$23377030$2$F$$20240814$20240108$20240821$EXP$$BR-EMD Serono-2023471304$EMD SERONO INC$$$$A$F$Y$$$20240821$$CN$BR$BR
233770572$23377057$2$F$20231003$20240731$20240108$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-000200$AUROBINDO$$27$YR$$F$Y$$$20240813$$MD$FR$FR
233770604$23377060$4$F$20231001$20240826$20240108$20240905$EXP$$US-ASTELLAS-2023US035688$ASTELLAS$$68$YR$E$M$Y$$$20240905$$CN$US$US
233771084$23377108$4$F$$20240905$20240108$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002662$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240909$$CN$US$US
233771114$23377111$4$F$$20240702$20240108$20240704$EXP$$US-SANDOZ INC.-NVSC2021US003121$SANDOZ$$$$$F$Y$54.422$KG$20240704$$CN$US$US
233771982$23377198$2$F$20240105$20240628$20240108$20240702$PER$$US-AMGEN-USASP2024002978$AMGEN$$77$YR$E$F$Y$$$20240702$$CN$US$US
233772315$23377231$5$F$$20240719$20240108$20240725$EXP$$US-SA-2024SA005688$SANOFI AVENTIS$$$$E$F$Y$76.65$KG$20240725$$MD$US$US
233772366$23377236$6$F$20240129$20240904$20240108$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002020$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240916$$CN$US$US
233772472$23377247$2$F$$20240912$20240108$20240917$EXP$$CA-Orion Corporation ORION PHARMA-24_00027318$ORION$$80$YR$E$F$Y$$$20240917$$HP$CA$
233773393$23377339$3$F$20231201$20240701$20240108$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002677$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240703$$CN$US$US
2337740415$23377404$15$F$20231218$20240814$20240108$20240822$EXP$$CA-ROCHE-3485140$ROCHE$$30$YR$A$F$Y$$$20240822$$CN$CA$CA
233774402$23377440$2$F$$20240707$20240108$20240718$EXP$$US-Accord-398982$ACCORD$Brown B, Adam B, John S. An Unusual Case of Severe Hypertrophic Cardiomyopathy in a 23-Year-Old Systemic Lupus Erythematosus Patient on Hydroxychloroquine. Circulation. 2023;148(Supplement 1):A17085.$23$YR$A$F$Y$$$20240718$$HP$US$US
233774583$23377458$3$F$20240201$20240717$20240108$20240724$EXP$$US-SA-2024SA005967$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240724$$MD$US$US
233774975$23377497$5$F$20230101$20240507$20240108$20240719$EXP$$NL-TEVA-VS-3139904$TEVA$$62$YR$$F$Y$$$20240719$$CN$NL$NL
233775085$23377508$5$F$$20240823$20240108$20240827$EXP$$CA-ROCHE-3486906$ROCHE$$$$A$M$Y$$$20240827$$CN$CA$CA
233775122$23377512$2$F$20231231$20240806$20240108$20240808$PER$$US-AMGEN-USASP2024003028$AMGEN$$64$YR$A$F$Y$$$20240808$$CN$US$US
233775807$23377580$7$F$20231110$20240812$20240108$20240814$EXP$$NVSC2024DE001888$NOVARTIS$$$$A$F$Y$65.4$KG$20240814$$HP$DE$DE
233776153$23377615$3$F$20230101$20240911$20240108$20240930$EXP$$US-SA-2024SA005652$SANOFI AVENTIS$$58$YR$A$F$Y$55.79$KG$20240930$$MD$US$US
233777082$23377708$2$F$20231227$20240906$20240108$20240912$PER$$US-JNJFOC-20231278667$JOHNSON AND JOHNSON$$9$YR$C$M$Y$74.91$KG$20240912$$CN$US$US
233777122$23377712$2$F$$20240717$20240108$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2023-11944$LUPIN$$$$$$Y$$$20240801$$CN$US$US
233777233$23377723$3$F$20230101$20240905$20240108$20240912$PER$$US-SA-2024SA001229$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240912$$MD$US$US
233778552$23377855$2$F$$20240102$20240108$20240926$EXP$$US-GSK-US2024AMR000779$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
233778616$23377861$6$F$$20240723$20240108$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-147473$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240805$$CN$US$US
233778885$23377888$5$F$20240701$20240723$20240108$20240729$EXP$$US-SANDOZ INC.-NVSC2021US278928$SANDOZ$$41$YR$$F$Y$68.027$KG$20240729$$CN$US$US
233779073$23377907$3$F$$20240703$20240108$20240715$PER$$US-SA-2024SA000810$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240715$$MD$US$US
233779507$23377950$7$F$$20240830$20240108$20240904$30DAY$$CR-PFIZER INC-PV202300203312$PFIZER$$7$YR$$M$Y$$$20240904$$HP$CR$CR
233779692$23377969$2$F$20230801$20240709$20240108$20240715$PER$$US-BIOGEN-2024BI01243880$BIOGEN$$41$YR$$F$Y$$$20240715$$CN$US$US
233780622$23378062$2$F$20231003$20240806$20240108$20240812$EXP$FR-AFSSAPS-LY2023001981$FR-MYLANLABS-2024M1001472$MYLAN$$27$YR$$F$Y$$$20240812$$MD$FR$FR
233780867$23378086$7$F$20231116$20240906$20240108$20240906$EXP$$AT-PFIZER INC-202400000637$PFIZER$$26$YR$$F$Y$$$20240906$$MD$AT$AT
233781502$23378150$2$F$20231003$20240806$20240108$20240806$EXP$FR-AFSSAPS-LY2023001981$FR-PFIZER INC-202400000660$PFIZER$$27$YR$$F$Y$$$20240806$$MD$FR$FR
233782592$23378259$2$F$20231201$20240924$20240108$20240930$EXP$$CA-TAKEDA-2024TUS000665$TAKEDA$$68$YR$$M$Y$$$20240930$$CN$CA$CA
233782674$23378267$4$F$20240129$20240722$20240108$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003598$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$96.16$KG$20240729$$CN$US$US
233783352$23378335$2$F$20230101$20240801$20240108$20240810$PER$$US-SA-2024SA001115$SANOFI AVENTIS$$$$A$M$Y$63.5$KG$20240810$$MD$US$US
233784024$23378402$4$F$20230906$20240826$20240108$20240829$EXP$$IN-PFIZER INC-PV202300209284$PFIZER$$72$YR$$M$Y$71.4$KG$20240829$$CN$IN$IN
233784582$23378458$2$F$20231201$20240731$20240108$20240809$PER$$US-SA-2024SA001361$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240809$$MD$US$US
233785083$23378508$3$F$20230101$20240724$20240108$20240807$PER$$US-SA-2024SA001373$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240807$$CN$US$US
233785113$23378511$3$F$$20240808$20240108$20240813$EXP$$CN-PFIZER INC-PV202300209787$PFIZER$Li, Y.. Susceptive piperacillin-tazobactam-induced Evans syndrome after radical resection of esophageal cancer: A rare case report. Asian Journal of Surgery. 2023;46(12):5879-5881$68$YR$$M$Y$$$20240813$$HP$CN$CN
233785302$23378530$2$F$$20240801$20240108$20240805$PER$$US-TAKEDA-2024TUS001408$TAKEDA$$$$$$Y$$$20240805$$CN$US$US
233785392$23378539$2$F$$20240918$20240108$20240927$EXP$$NVSC2024US000772$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
233788114$23378811$4$F$20230101$20240703$20240108$20240708$PER$$US-SA-2024SA005724$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240708$$MD$US$US
233788374$23378837$4$F$$20240801$20240108$20240805$EXP$$US-SANDOZ INC.-NVSC2022US019134$SANDOZ$$$$$F$Y$93.878$KG$20240805$$CN$US$US
233788432$23378843$2$F$20230101$20240705$20240108$20240715$PER$$US-SA-2024SA003211$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240715$$MD$US$US
233788963$23378896$3$F$20230103$20240805$20240108$20240812$EXP$$US-TAKEDA-US202026001$TAKEDA$$71$YR$$F$Y$68$KG$20240812$$CN$US$US
233789365$23378936$5$F$$20240912$20240108$20240913$EXP$$CA-SANDOZ INC.-NVSC2023CA018127$SANDOZ$$30$YR$$M$Y$84$KG$20240913$$HP$CA$CA
233789702$23378970$2$F$$20240111$20240108$20240805$EXP$$NVSC2024SK001344$NOVARTIS$$$$A$M$Y$$$20240805$$HP$SK$SK
233790482$23379048$2$F$20231202$20240821$20240108$20240823$EXP$$FR-BAUSCH-BL-2024-000247$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240823$$HP$FR$FR
233790734$23379073$4$F$20240116$20240117$20240108$20240926$EXP$$US-GSK-US2024AMR000856$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
2337908011$23379080$11$F$20230420$20240924$20240108$20240927$EXP$$AR-MYLANLABS-2024M1002138$MYLAN$$16$YR$$M$Y$$$20240927$$CN$AR$AR
233790922$23379092$2$F$$20240103$20240108$20240925$PER$$US-GSK-US2024AMR000835$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
233791133$23379113$3$F$20231223$20240903$20240108$20240912$PER$$US-SA-2024SA002021$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240912$$MD$US$US
233792973$23379297$3$F$$20240821$20240108$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002025$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240829$$CN$US$US
233793133$23379313$3$F$$20240712$20240108$20240715$EXP$$CA-SANDOZ INC.-NVSC2023CA018004$SANDOZ$$63$YR$$M$Y$$$20240715$$HP$CA$CA
233793173$23379317$3$F$$20240919$20240108$20240920$PER$$US-BAUSCH-BL-2024-000208$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240920$$CN$US$US
233794293$23379429$3$F$20210415$20240118$20240108$20240918$EXP$FR-AFSSAPS-AM20211335$FR-BAUSCH-BL-2024-000260$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240918$$MD$FR$FR
233795062$23379506$2$F$20230919$20240624$20240108$20240708$EXP$$CA-VER-202300552$VERITY PHARMACEUTICALS$$67$YR$E$M$Y$$$20240708$$HP$CA$CA
2337952826$23379528$26$F$20230101$20240923$20240108$20240926$EXP$$US-PFIZER INC-202400001717$PFIZER$$74$YR$$F$Y$$$20240926$$MD$US$US
2337956910$23379569$10$F$20231207$20240729$20240108$20240802$EXP$$US-PFIZER INC-202300455268$PFIZER$$64$YR$$F$Y$87.982$KG$20240802$$PH$US$US
233796332$23379633$2$F$$20240716$20240108$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-000978$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240718$$HP$US$US
233797913$23379791$3$F$20120101$20240909$20240108$20240913$EXP$DE-CADRBFARM-2023325038$DE-SANDOZ INC.-SDZ2024DE001195$SANDOZ$$59$YR$$M$Y$83$KG$20240913$$CN$DE$DE
233798094$23379809$4$F$20240102$20240626$20240108$20240701$EXP$$JP-TAKEDA-2024TJP000014$TAKEDA$$32$YR$$F$Y$57$KG$20240701$$MD$JP$JP
233798365$23379836$5$F$20231219$20240227$20240108$20240806$PER$$US-AstraZeneca-2024A004342$ASTRAZENECA$$26259$DY$$M$Y$$$20240806$$CN$US$
233798465$23379846$5$F$20231201$20240711$20240108$20240716$EXP$$US-BIOGEN-2024BI01243735$BIOGEN$$41$YR$$F$Y$$$20240716$$CN$US$US
233799192$23379919$2$F$$20240828$20240108$20240910$EXP$DE-MLMSERVICE-20231127-4693254-1$DE-STRIDES ARCOLAB LIMITED-2023SP018429$STRIDES$Doubrovinskaja S, Korporal-Kuhnke M, Jarius S, Haas J, Wildemann B.. Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome.. Journal of Neurology.. 2023;271(5):2866-2870$16$YR$$F$Y$$$20240910$$MD$DE$DE
233799453$23379945$3$F$20231001$20240725$20240109$20240801$EXP$$DO-TOLMAR, INC.-23DO045418$TOLMAR$$80$YR$$M$Y$$$20240801$$CN$DO$DO
2337997212$23379972$12$F$20231215$20240911$20240109$20240918$EXP$$GB-JNJFOC-20231249363$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240918$$CN$GB$GB
233800042$23380004$2$F$$20240827$20240109$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-002425$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240903$$HP$JP$JP
233800153$23380015$3$F$$20240807$20240109$20240812$EXP$GR-SEATTLE GENETICS-2023SGN13576$GR-ROCHE-3485524$ROCHE$$$$$F$Y$$$20240812$$MD$GR$GR
233800993$23380099$3$F$20231201$20240626$20240109$20240703$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-280178$BOEHRINGER INGELHEIM$$55$YR$A$M$Y$$$20240703$$CN$US$US
233801015$23380101$5$F$20240401$20240618$20240109$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005344$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240712$$CN$US$US
233801672$23380167$2$F$20230417$20240912$20240109$20240919$EXP$$BR-TAKEDA-2023TUS114851$TAKEDA$$42$YR$$F$Y$$$20240919$$CN$BR$BR
233802392$23380239$2$F$$20240709$20240109$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003631$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240710$$CN$US$US
233803402$23380340$2$F$$20240710$20240109$20240711$PER$$US-AMGEN-USASP2024003139$AMGEN$$$$A$M$Y$$$20240711$$HP$US$US
233803556$23380355$6$F$$20240704$20240109$20240712$EXP$$ES-CELLTRION INC.-2024ES000206$CELLTRION$Garcia M, Fernandez F, Gonzalez H, Muino D, Morais L, Garcia M, et al. Intestinal stenosis developed after a complete response to chemotherapy in a patient with Crohn^s disease and lymphoma of the jejunum. Revista espanola de enfermedades digestivas. 2023$$$$$Y$$$20240712$$HP$ES$ES
233803985$23380398$5$F$$20240711$20240109$20240719$EXP$$DE-AstraZeneca-2024A002103$ASTRAZENECA$$20$YR$$$Y$$$20240719$$MD$DE$
233804352$23380435$2$F$$20240625$20240109$20240709$EXP$$IT-CELLTRION INC.-2024IT000193$CELLTRION$$$$$$Y$$$20240709$$MD$IT$IT
233805382$23380538$2$F$20230101$20240916$20240109$20240924$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2023-04343$IPSEN$$59$YR$A$M$Y$$$20240924$$CN$US$US
233806015$23380601$5$F$20231228$20240909$20240109$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003431$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240917$$CN$US$US
233806362$23380636$2$F$$20240718$20240109$20240731$EXP$$JP-ADVANZ PHARMA-202312012138$ADVANZ PHARMA$$$$$$Y$$$20240731$$MD$JP$JP
233806394$23380639$4$F$20231201$20240918$20240109$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003868$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$131.9$KG$20240923$$CN$US$US
233807477$23380747$7$F$20230901$20240729$20240109$20240806$EXP$$CA-CELLTRION INC.-2023CA019956$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
233808073$23380807$3$F$$20240809$20240109$20240820$EXP$$IT-AUROBINDO-AUR-APL-2023-080761$AUROBINDO$D^Onofrio G, Delrue M-A, Lortie A, Marquis C, Striano P, Jaworski M, et al.. Treatment of Refractory Epilepsy With MEK Inhibitor in Patients With RASopathy. Pediatr-Neurol. 2023;148:148-151$3$MON$$M$Y$$$20240820$$HP$IT$IT
233808254$23380825$4$F$20240103$20240727$20240109$20240730$PER$$US-AMGEN-USASP2024002222$AMGEN$$48$YR$A$F$Y$$$20240730$$CN$US$US
233808546$23380854$6$F$20231201$20240917$20240109$20240926$EXP$$US-UCBSA-2024000869$UCB$$48$YR$$F$Y$123.81$KG$20240926$$HP$US$US
233808613$23380861$3$F$20220319$20240823$20240109$20240829$EXP$$AU-TAKEDA-2022TUS019059$TAKEDA$$20$YR$$M$Y$$$20240829$$HP$AU$AU
233808735$23380873$5$F$$20240912$20240109$20240918$EXP$$CA-JNJFOC-20220928620$JOHNSON AND JOHNSON$$75$YR$E$F$Y$70$KG$20240918$$HP$CA$CA
233809823$23380982$3$F$20201113$20240828$20240109$20240830$EXP$$DE-ROCHE-2718260$ROCHE$$67$YR$E$M$Y$$$20240830$$CN$DE$DE
233810176$23381017$6$F$20230101$20240702$20240109$20240709$EXP$$CA-CELLTRION INC.-2024CA000311$CELLTRION$$$$$$Y$$$20240709$$HP$CA$CA
233810492$23381049$2$F$$20240815$20240109$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-001006$AUROBINDO$unknown. unknown. unknown$34$YR$$M$Y$$$20240828$$MD$CA$CA
233810504$23381050$4$F$20231229$20240701$20240109$20240709$EXP$$US-TAKEDA-2024TUS001942$TAKEDA$$47$YR$$M$Y$$$20240709$$MD$US$US
233810932$23381093$2$F$20231213$20240712$20240109$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-000204$AUROBINDO$$71$YR$$F$Y$66$KG$20240722$$MD$FR$FR
233810993$23381099$3$F$$20240905$20240109$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003750$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$52.6$KG$20240912$$CN$US$US
233812188$23381218$8$F$$20240916$20240109$20240923$EXP$$US-TAKEDA-2023TUS097422$TAKEDA$$$$$F$Y$62.5$KG$20240923$$HP$US$US
233812233$23381223$3$F$20230801$20240905$20240109$20240913$EXP$$CA-TAKEDA-2023TUS075965$TAKEDA$$59$YR$$M$Y$96$KG$20240913$$CN$CA$CA
233812824$23381282$4$F$20230705$20240812$20240109$20240813$EXP$$MX-ROCHE-3487775$ROCHE$$36$YR$A$M$Y$70$KG$20240813$$CN$MX$MX
233813253$23381325$3$F$20231229$20240624$20240109$20240704$EXP$$TW-NOVOPROD-1158546$NOVO NORDISK$$39$YR$$M$Y$50$KG$20240704$$HP$TW$TW
233813262$23381326$2$F$20230101$20240102$20240109$20240717$PER$$US-NOVOPROD-1159511$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
233813362$23381336$2$F$$20240827$20240109$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-003938$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240904$$PH$JP$JP
233813872$23381387$2$F$$20240105$20240109$20240703$EXP$$US-TORRENT-00013356$TORRENT$$56$YR$A$M$Y$$$20240702$$MD$US$US
233813992$23381399$2$F$20230816$20240710$20240109$20240720$EXP$PT-INFARMED-E202311-567$PT-Accord-399229$ACCORD$$82$YR$E$F$Y$$$20240720$$PH$PT$PT
233814775$23381477$5$F$$20240812$20240109$20240818$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003662$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240819$$CN$US$US
233814862$23381486$2$F$$20240909$20240109$20240910$EXP$$CA-BAUSCH-BL-2024-000315$BAUSCH AND LOMB$$3$YR$$M$Y$$$20240910$$HP$CA$CA
233815363$23381536$3$F$20231101$20240703$20240109$20240705$EXP$$US-UCBSA-2024000791$UCB$$35$YR$$F$Y$$$20240705$$HP$US$US
233815634$23381563$4$F$20231101$20240114$20240109$20240805$EXP$$NVSC2024EG002474$NOVARTIS$$63$YR$$M$Y$$$20240805$$CN$EG$EG
233816193$23381619$3$F$$20240826$20240109$20240902$EXP$$CA-AMGEN-CANSL2024001837$AMGEN$$59$YR$A$F$Y$$$20240902$$CN$CA$CA
233816293$23381629$3$F$$20240702$20240109$20240705$EXP$$CA-TAKEDA-2024TUS002109$TAKEDA$$$$$F$Y$$$20240705$$CN$CA$CA
233816423$23381642$3$F$20240601$20240724$20240109$20240731$30DAY$$US-GSK-US2024000913$GLAXOSMITHKLINE$$79$YR$$F$Y$$$20240731$$CN$US$US
233816572$23381657$2$F$$20240708$20240109$20240722$EXP$$CA-UCBSA-2024000516$UCB$$43$YR$$F$Y$68$KG$20240722$$HP$CA$CA
233817037$23381703$7$F$20230301$20240801$20240109$20240806$EXP$$CL-AMGEN-CHLSL2023038596$AMGEN$$76$YR$E$F$Y$75$KG$20240806$$CN$CL$CL
233817104$23381710$4$F$20240101$20240910$20240109$20240918$PER$$US-AMGEN-USASP2024003871$AMGEN$$43$YR$A$M$Y$$$20240918$$HP$US$US
233817212$23381721$2$F$20240813$20240814$20240109$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003988$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240819$$MD$US$US
233817555$23381755$5$F$20240901$20240919$20240109$20240923$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-100521$DAIICHI$$52$YR$$M$Y$$$20240923$$CN$US$US
233818213$23381821$3$F$$20240201$20240109$20240806$EXP$$BR-ASTELLAS-2024US000580$ASTELLAS$$73$YR$$M$Y$103$KG$20240806$$CN$BR$BR
233818809$23381880$9$F$20230714$20240722$20240109$20240731$EXP$$GB-TEVA-2023-GB-2940835$TEVA$$34$YR$$F$Y$$$20240731$$MD$GB$GB
233819139$23381913$9$F$20231228$20240906$20240109$20240916$EXP$$CA-CELLTRION INC.-2023CA025354$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
233819343$23381934$3$F$20231229$20240813$20240109$20240816$EXP$$GB-MYLANLABS-2024M1001057$MYLAN$$56$YR$$M$Y$$$20240816$$CN$GB$GB
233819503$23381950$3$F$20240701$20240916$20240109$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003267$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240917$$HP$US$US
233820192$23382019$2$F$20240607$20240611$20240109$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005854$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240705$$CN$US$US
233821075$23382107$5$F$20211118$20240830$20240109$20240906$EXP$$CA-TAKEDA-2021TUS047211$TAKEDA$$41$YR$$F$Y$$$20240906$$CN$CA$CA
233821167$23382116$7$F$20231217$20240913$20240109$20240918$30DAY$$US-PFIZER INC-PV202300206023$PFIZER$$14$YR$$M$Y$$$20240918$$CN$US$US
233821517$23382151$7$F$$20240828$20240109$20240904$30DAY$$US-PFIZER INC-202300450119$PFIZER$$15$YR$$M$Y$48.073$KG$20240904$$MD$US$US
233822695$23382269$5$F$20230206$20240819$20240109$20240822$EXP$$JP-ABBVIE-5577441$ABBVIE$$64$YR$$F$Y$56$KG$20240822$$MD$JP$JP
2338227211$23382272$11$F$20240322$20240907$20240109$20240919$EXP$$US-ACORDA-ACO_176147_2024$ACORDA$$54$YR$$F$Y$$$20240919$$HP$US$US
233822764$23382276$4$F$$20240627$20240109$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003679$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240701$$CN$US$US
233822792$23382279$2$F$20240102$20240729$20240109$20240803$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002345$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240803$$CN$US$US
233823082$23382308$2$F$20231221$20240701$20240109$20240710$EXP$IT-MINISAL02-963407$IT-BAXTER-2024BAX010049$BAXTER$$14$YR$$F$Y$39$KG$20240710$$PH$IT$IT
233823242$23382324$2$F$20231230$20240801$20240109$20240808$EXP$$US-SA-2024SA006698$SANOFI AVENTIS$$64$YR$A$F$Y$70.76$KG$20240808$$MD$US$US
233823304$23382330$4$F$20240107$20240805$20240109$20240807$PER$$US-AMGEN-USASP2024003971$AMGEN$$60$YR$A$M$Y$$$20240806$$CN$US$US
233823333$23382333$3$F$20230816$20240916$20240109$20240917$EXP$FR-AFSSAPS-LY2023001507$FR-SANDOZ INC.-SDZ2023FR075383$SANDOZ$$69$YR$$M$Y$$$20240917$$PH$FR$FR
233823995$23382399$5$F$20231025$20240812$20240109$20240814$EXP$$PL-PFIZER INC-202300392569$PFIZER$$59$YR$$M$Y$76.5$KG$20240814$$HP$PL$PL
233824032$23382403$2$F$20240105$20240718$20240109$20240723$PER$$US-AMGEN-USASP2024003686$AMGEN$$34$YR$A$F$Y$$$20240723$$CN$US$US
233824152$23382415$2$F$20231219$20240716$20240109$20240724$PER$$US-BAYER-2024A003397$BAYER$$44$YR$A$F$Y$$$20240724$$HP$US$US
233824652$23382465$2$F$$20240626$20240109$20240701$EXP$$US-MYLANLABS-2024M1001813$MYLAN$$$$$F$Y$$$20240701$$CN$US$US
233826218$23382621$8$F$20220101$20240715$20240109$20240717$EXP$$US-PFIZER INC-202300296296$PFIZER$$83$YR$$M$Y$86.168$KG$20240717$$CN$US$US
233826357$23382635$7$F$20201007$20240815$20240109$20240820$EXP$$CA-PFIZER INC-2020392352$PFIZER$$57$YR$$M$Y$98$KG$20240820$$HP$CA$CA
233827824$23382782$4$F$20230810$20240806$20240109$20240812$EXP$$US-INCYTE CORPORATION-2023IN013524$INCYTE$$$$$$Y$$$20240812$$MD$US$US
233828116$23382811$6$F$20240301$20240815$20240109$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004046$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240826$$PH$US$US
233828464$23382846$4$F$$20240702$20240109$20240709$EXP$$GB-MYLANLABS-2024M1001693$MYLAN$$$$$M$Y$$$20240709$$MD$GB$GB
233828817$23382881$7$F$20240101$20240813$20240109$20240822$EXP$$US-INSMED, INC.-2023-04497-US$INSMED$$$$$F$Y$$$20240822$$CN$US$US
233829018$23382901$8$F$$20240813$20240109$20240816$EXP$$PL-MYLANLABS-2024M1000078$MYLAN$Welniak A, Lipska P, Watota W, Grabowska N, Marek-Jozefowicz L, Czajkowski R.. Toxic epidermal necrolysis - a study of 3 cases and review.. Forum Dermatologicum. 2023;9(4):154-161$59$YR$$M$Y$$$20240816$$MD$PL$PL
233829234$23382923$4$F$20230101$20240815$20240109$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003687$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240820$$CN$US$US
233829313$23382931$3$F$20231229$20240918$20240109$20240930$PER$$NVSC2024US004027$NOVARTIS$$61$YR$$M$Y$$$20240930$$HP$US$US
233829526$23382952$6$F$20240828$20240918$20240109$20240925$EXP$$CA-OTSUKA-2023_019285$OTSUKA$$32$YR$$M$Y$$$20240925$$HP$CA$CA
233830126$23383012$6$F$20240101$20240731$20240109$20240807$EXP$$NVSC2023AU255762$NOVARTIS$$46$YR$$F$Y$$$20240807$$HP$AU$AU
233830594$23383059$4$F$20231001$20240710$20240109$20240712$EXP$$US-PFIZER INC-202300456357$PFIZER$$59$YR$$M$Y$$$20240712$$HP$US$US
233830686$23383068$6$F$20230101$20240916$20240109$20240919$EXP$$US-PFIZER INC-2020349680$PFIZER$$74$YR$$F$Y$67.129$KG$20240919$$CN$US$US
233831115$23383111$5$F$$20240701$20240109$20240703$PER$$US-PFIZER INC-202101090272$PFIZER$$63$YR$$F$Y$$$20240703$$MD$US$US
233832087$23383208$7$F$20231225$20240711$20240109$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-189442$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240719$$CN$US$US
233832853$23383285$3$F$$20240729$20240109$20240802$EXP$$US-AMGEN-USASP2024000444$AMGEN$$79$YR$E$M$Y$$$20240802$$CN$US$US
233833055$23383305$5$F$20231012$20240904$20240109$20240906$EXP$$NVSC2024US003428$NOVARTIS$$57$YR$$F$Y$96.599$KG$20240906$$CN$US$US
233833204$23383320$4$F$$20240628$20240109$20240711$PER$$US-SA-2023SA406062$SANOFI AVENTIS$$42$YR$A$F$Y$127$KG$20240711$$MD$US$US
233833432$23383343$2$F$20180101$20240627$20240109$20240708$PER$$US-SA-2024SA003279$SANOFI AVENTIS$$42$YR$A$M$Y$89.3$KG$20240708$$MD$US$US
233833712$23383371$2$F$20230101$20240804$20240109$20240813$PER$$US-SA-2024SA001970$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240814$$MD$US$US
233833852$23383385$2$F$$20240805$20240109$20240814$PER$$US-SA-2024SA002083$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240814$$MD$US$US
233833922$23383392$2$F$$20240906$20240109$20240916$PER$$US-SA-2024SA001298$SANOFI AVENTIS$$17$YR$T$F$Y$49$KG$20240916$$CN$US$US
233834052$23383405$2$F$$20240807$20240109$20240815$PER$$US-SA-2024SA002813$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240815$$MD$US$US
233834562$23383456$2$F$$20240701$20240109$20240703$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-004212$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240703$$HP$BR$BR
233835124$23383512$4$F$20240119$20240823$20240109$20240920$PER$$US-SA-2024SA004035$SANOFI AVENTIS$$55$YR$A$F$Y$88.45$KG$20240920$$MD$US$US
233835423$23383542$3$F$20231201$20240830$20240109$20240912$PER$$US-SA-2024SA001974$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240912$$MD$US$US
233835456$23383545$6$F$20230101$20240806$20240109$20240814$PER$$US-SA-2024SA003763$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240814$$MD$US$US
233835493$23383549$3$F$20231201$20240722$20240109$20240731$PER$$US-SA-2024SA002658$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240731$$MD$US$US
233835992$23383599$2$F$$20240712$20240109$20240723$PER$$US-SA-2024SA003658$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240723$$MD$US$US
233836024$23383602$4$F$20230101$20240814$20240109$20240828$PER$$US-SA-2023SA404556$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240828$$MD$US$US
233836162$23383616$2$F$20240101$20240620$20240109$20240703$PER$$US-SA-2024SA004743$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240703$$CN$US$US
233836182$23383618$2$F$20230101$20240717$20240109$20240725$PER$$US-SA-2024SA004214$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240725$$MD$US$US
233836555$23383655$5$F$20231201$20240725$20240109$20240805$PER$$US-SA-2024SA004613$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240805$$MD$US$US
233837324$23383732$4$F$$20240912$20240109$20240925$PER$$US-SA-2024SA006893$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
233837372$23383737$2$F$20240801$20240910$20240109$20240919$PER$$US-SA-2024SA005402$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240919$$MD$US$US
233837492$23383749$2$F$20240101$20240710$20240109$20240718$PER$$US-SA-2024SA004818$SANOFI AVENTIS$$97$YR$E$F$Y$$$20240718$$MD$US$US
233837612$23383761$2$F$20231201$20240903$20240109$20240912$PER$$US-SA-2024SA005657$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240912$$MD$US$US
233838222$23383822$2$F$20240101$20240730$20240109$20240808$PER$$US-SA-2024SA007084$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240808$$MD$US$US
233839607$23383960$7$F$$20240821$20240109$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003929$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240823$$CN$US$US
233840303$23384030$3$F$20080101$20240918$20240109$20240930$EXP$$GB-JNJFOC-20240112688$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240930$$HP$GB$CA
233840522$23384052$2$F$20240101$20240801$20240109$20240805$PER$$US-PFIZER INC-202300456807$PFIZER$$75$YR$$F$Y$$$20240805$$CN$US$US
2338414710$23384147$10$F$20240101$20240925$20240109$20240927$PER$$US-PFIZER INC-2019083798$PFIZER$$70$YR$$F$Y$$$20240927$$CN$US$US
233841623$23384162$3$F$20231216$20240725$20240109$20240815$PER$$CA-TOLMAR, INC.-23CA045564$TOLMAR$$64$YR$$M$Y$$$20240814$$CN$CA$CA
233841634$23384163$4$F$20231216$20240823$20240109$20240911$PER$$CA-TOLMAR, INC.-23CA045566$TOLMAR$$78$YR$$M$Y$$$20240911$$CN$CA$CA
233841713$23384171$3$F$$20240829$20240109$20240904$PER$$US-PFIZER INC-202300456278$PFIZER$$15$YR$$M$Y$$$20240904$$CN$US$US
233842913$23384291$3$F$$20240627$20240109$20240705$EXP$$US-EMD Serono-2024000826$EMD SERONO INC$$71$YR$E$M$Y$$$20240705$$CN$US$US
233843243$23384324$3$F$20240801$20240826$20240109$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004356$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240829$$HP$US$US
233843295$23384329$5$F$20230831$20240709$20240109$20240712$EXP$$JP-AstraZeneca-2024A004267$ASTRAZENECA$$81$YR$$M$Y$57$KG$20240712$$MD$JP$
233843706$23384370$6$F$20231201$20240816$20240109$20240820$EXP$$US-PFIZER INC-202400001732$PFIZER$$57$YR$$M$Y$73.016$KG$20240820$$CN$US$US
233843764$23384376$4$F$$20240806$20240109$20240809$PER$$US-PFIZER INC-PV202400000147$PFIZER$$46$YR$$F$Y$$$20240809$$CN$US$US
233843953$23384395$3$F$$20240911$20240109$20240917$EXP$$US-PFIZER INC-PV202400000365$PFIZER$$59$YR$$F$Y$$$20240917$$CN$US$US
233844023$23384402$3$F$20231201$20240905$20240109$20240909$PER$$US-PFIZER INC-PV202400000253$PFIZER$$60$YR$$F$Y$$$20240909$$HP$US$US
233844247$23384424$7$F$20240205$20240730$20240109$20240805$EXP$$US-Taiho Oncology Inc-2024-000117$TAIHO ONCOLOGY INC$$72$YR$E$M$Y$$$20240805$$CN$US$US
233844302$23384430$2$F$$20240705$20240109$20240710$PER$$US-PFIZER INC-202400001214$PFIZER$$$$$F$Y$$$20240710$$CN$US$US
233844823$23384482$3$F$$20240912$20240109$20240916$PER$$US-PFIZER INC-PV202300210106$PFIZER$$59$YR$$F$Y$$$20240916$$HP$US$US
233844943$23384494$3$F$20230101$20240906$20240109$20240911$EXP$$US-DSJP-DSU-2023-131788$DAIICHI$$$$$F$Y$101.3$KG$20240911$$HP$US$US
233844995$23384499$5$F$20220901$20240917$20240109$20240924$PER$$US-Eisai-EC-2023-145425$EISAI$$77$YR$E$F$Y$$$20240924$$CN$US$US
233845156$23384515$6$F$20240101$20240905$20240109$20240909$PER$$US-PFIZER INC-PV202400000251$PFIZER$$68$YR$$M$Y$81.633$KG$20240909$$HP$US$US
233845644$23384564$4$F$$20240716$20240109$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004016$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240719$$CN$US$US
233845744$23384574$4$F$$20240702$20240109$20240708$PER$$US-PFIZER INC-PV202400001646$PFIZER$$12$YR$$M$Y$45.351$KG$20240708$$CN$US$US
233845889$23384588$9$F$$20240817$20240109$20240821$EXP$$US-PFIZER INC-PV202400001570$PFIZER$$80$YR$$F$Y$$$20240821$$CN$US$US
233845962$23384596$2$F$$20240702$20240109$20240708$PER$$US-PFIZER INC-PV202400000121$PFIZER$$23$YR$$M$Y$$$20240708$$HP$US$US
233846104$23384610$4$F$$20240729$20240109$20240801$PER$$US-PFIZER INC-PV202400001252$PFIZER$$64$YR$$F$Y$$$20240801$$HP$US$US
233846353$23384635$3$F$20231201$20240903$20240109$20240906$PER$$US-PFIZER INC-PV202300127009$PFIZER$$49$YR$$F$Y$$$20240906$$HP$US$US
233846512$23384651$2$F$20231001$20240820$20240109$20240822$PER$$US-PFIZER INC-202400004520$PFIZER$$64$YR$$F$Y$$$20240822$$HP$US$US
233846733$23384673$3$F$$20240815$20240109$20240820$PER$$US-PFIZER INC-PV202300014713$PFIZER$$60$YR$$F$Y$$$20240820$$CN$US$US
233848323$23384832$3$F$20231130$20240722$20240109$20240726$EXP$$US-INCYTE CORPORATION-2024IN000023$INCYTE$$$$$$Y$$$20240726$$HP$US$US
233848563$23384856$3$F$20231101$20240827$20240109$20240829$EXP$$KR-ABBVIE-5574824$ABBVIE$$48$YR$$M$Y$78$KG$20240829$$MD$KR$KR
233848702$23384870$2$F$$20240809$20240109$20240815$EXP$$IE-TAKEDA-2024TUS002142$TAKEDA$$$$$M$Y$$$20240815$$CN$IE$IE
233849292$23384929$2$F$20240102$20240716$20240109$20240722$EXP$$CA-ROCHE-3488523$ROCHE$$71$YR$E$M$Y$$$20240722$$CN$CA$CA
233849573$23384957$3$F$20240101$20240726$20240109$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004112$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240802$$HP$US$US
233849783$23384978$3$F$20231213$20240722$20240109$20240808$PER$$CA-TOLMAR, INC.-23CA045502$TOLMAR$$74$YR$$M$Y$$$20240808$$CN$CA$CA
233849884$23384988$4$F$20240214$20240826$20240109$20240828$EXP$$CA-TAKEDA-2023TUS090276$TAKEDA$$63$YR$$M$Y$$$20240828$$CN$CA$CA
233849952$23384995$2$F$20231222$20240724$20240109$20240729$EXP$$CA-TAKEDA-2023TUS124353$TAKEDA$$66$YR$$F$Y$$$20240729$$MD$CA$CA
233850024$23385002$4$F$20230713$20240905$20240109$20240911$EXP$$US-ABBVIE-5575067$ABBVIE$$76$YR$$M$Y$92$KG$20240911$$HP$US$US
233850734$23385073$4$F$20231214$20240822$20240109$20240829$PER$$CA-TOLMAR, INC.-23CA045528$TOLMAR$$68$YR$$M$Y$$$20240829$$CN$CA$CA
233850814$23385081$4$F$$20240821$20240109$20240911$PER$$CA-TOLMAR, INC.-23CA045509$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
233850853$23385085$3$F$20240601$20240712$20240109$20240718$EXP$$US-ABBVIE-5577381$ABBVIE$$66$YR$$F$Y$$$20240718$$CN$US$US
233850983$23385098$3$F$20231220$20240703$20240109$20240705$30DAY$$US-GSK-US2024000628$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240705$$CN$US$US
233852093$23385209$3$F$$20240223$20240110$20240925$PER$$US-GSK-US2024AMR000415$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
233852323$23385232$3$F$20230101$20240712$20240110$20240722$PER$$US-SA-2023SA363133$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240720$$CN$US$US
233852382$23385238$2$F$$20240813$20240110$20240819$EXP$$US-TAKEDA-2020TUS038572$TAKEDA$$$$$F$Y$$$20240819$$CN$US$US
233852943$23385294$3$F$$20240909$20240110$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003896$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240916$$CN$US$US
2338530810$23385308$10$F$20230101$20240904$20240110$20240913$EXP$$CA-CELLTRION INC.-2024CA000363$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
233853112$23385311$2$F$$20240904$20240110$20240911$EXP$$BG-TAKEDA-2024TUS002156$TAKEDA$$$$$M$Y$$$20240911$$CN$BG$BG
233853335$23385333$5$F$$20240612$20240110$20240707$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005856$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240707$$CN$US$US
233853532$23385353$2$F$20230926$20240613$20240110$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005823$ACADIA PHARMACEUTICALS$$65$YR$$M$Y$$$20240708$$CN$US$US
233854692$23385469$2$F$$20240902$20240110$20240917$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-426260$RANBAXY$Gan L, Zhu X, Gao Y, Zhong M, Liao S, Huang G, et al. A review on nondiabetic hypoglycemia from various causes: Case series report. Medicine. 2023;102:E36273(1-6)$39$YR$$F$Y$$$20240917$$MD$CN$CN
233855114$23385511$4$F$20220101$20240708$20240110$20240716$EXP$$DE-CELLTRION INC.-2024DE000182$CELLTRION$Fischer D., Toenges R., Kiil K., Michalik S., Thalhammer A., Bug G. et. al.. Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia. Annals of Hematology. 2023;1-10$$$$$Y$$$20240716$$MD$DE$DE
233855152$23385515$2$F$20240701$20240712$20240110$20240723$PER$$US-SA-2024SA009061$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
233855222$23385522$2$F$$20240627$20240110$20240701$PER$$NVSC2024US004531$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
233855862$23385586$2$F$$20240620$20240110$20240703$PER$$US-SA-2024SA005918$SANOFI AVENTIS$$$$A$F$Y$76.2$KG$20240703$$MD$US$US
233856422$23385642$2$F$20240101$20240910$20240110$20240912$PER$$PR-ABBVIE-5579164$ABBVIE$$$$$F$Y$$$20240912$$MD$PR$PR
233856505$23385650$5$F$20180801$20240703$20240110$20240705$EXP$$ES-TAKEDA-ES202018578$TAKEDA$$29$YR$$F$Y$$$20240705$$MD$ES$ES
233856585$23385658$5$F$$20240701$20240110$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005830$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
233857294$23385729$4$F$20240101$20240814$20240110$20240821$EXP$$US-SA-2024SA007758$SANOFI AVENTIS$$64$YR$A$M$Y$89.342$KG$20240821$$MD$US$US
233858283$23385828$3$F$20230101$20240710$20240110$20240715$EXP$$US-ABBVIE-5528871$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
233859205$23385920$5$F$20200527$20240807$20240110$20240816$EXP$$BE-ASPEN-GLO2023BE008769$ASPEN$$$$$$Y$$$20240816$$HP$BE$BE
233859323$23385932$3$F$$20240809$20240110$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-000840$AUROBINDO$$54$YR$$F$Y$$$20240820$$HP$CA$CA
233859927$23385992$7$F$$20240829$20240110$20240910$EXP$$CA-SANDOZ INC.-SDZ2024CA002013$SANDOZ$$53$YR$$M$Y$$$20240910$$HP$CA$CA
233860146$23386014$6$F$20240101$20240708$20240110$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004169$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240719$$CN$US$US
233860335$23386033$5$F$20230101$20240826$20240110$20240903$EXP$$CA-CELLTRION INC.-2023CA017744$CELLTRION$$$$$$Y$$$20240903$$CN$CA$CA
233860392$23386039$2$F$$20240701$20240110$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004713$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240702$$CN$US$US
233860556$23386055$6$F$20120206$20240906$20240110$20240912$EXP$$CO-SANDOZ INC.-PHHY2017CO043126$SANDOZ$$61$YR$$F$Y$69$KG$20240912$$CN$CO$CO
233860784$23386078$4$F$20180122$20240821$20240110$20240829$EXP$$CA-CELLTRION INC.-2021CA018909$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
2338610810$23386108$10$F$20231101$20240920$20240110$20240927$EXP$$CA-JNJFOC-20231141483$JOHNSON AND JOHNSON$$45$YR$A$F$Y$73$KG$20240927$$HP$CA$CA
233861454$23386145$4$F$20231114$20240902$20240110$20240911$EXP$$FR-CELLTRION INC.-2024FR000305$CELLTRION$$$$$$Y$$$20240911$$MD$FR$FR
233861793$23386179$3$F$$20240910$20240110$20240920$EXP$$US-TEVA-VS-3135094$TEVA$Panvelker SS, Khan AN. Hypercalcemia Secondary to Calcitriol and PTHrP Cosecretion Only Responsive to Hydroxychloroquine. J-Endocr-Soc 2020; 4 (Suppl.) A347-A348 abstr. SAT-346.; Panvelker SS, Khan AN. Hypercalcemia Secondary to Calcitriol and PTHrP Cosecretion Only Responsive to Hydroxychloroquine. J-Endocr-Soc 2020; 4 (Suppl.) A347-A348 abstr. SAT-346.$62$YR$$F$Y$$$20240920$$MD$US$US
233862012$23386201$2$F$20230106$20240708$20240110$20240711$EXP$$CA-TAKEDA-2023TUS001021$TAKEDA$$36$YR$$F$Y$$$20240711$$MD$CA$CA
233862502$23386250$2$F$$20240917$20240110$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004259$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240919$$CN$US$US
233862586$23386258$6$F$20190527$20240719$20240110$20240724$EXP$$CA-TAKEDA-2019TUS038165$TAKEDA$$43$YR$$F$Y$$$20240724$$MD$CA$CA
233862922$23386292$2$F$20240106$20240717$20240110$20240721$PER$$US-AMGEN-USASP2024004422$AMGEN$$65$YR$E$F$Y$$$20240721$$CN$US$US
233862972$23386297$2$F$20231101$20240706$20240110$20240717$EXP$FR-AFSSAPS-LM2023000675$FR-Accord-399819$ACCORD$$87$YR$E$F$Y$62$KG$20240717$$MD$FR$FR
233862997$23386299$7$F$$20240612$20240110$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005869$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
233863533$23386353$3$F$20231228$20240912$20240110$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-006134$ACADIA PHARMACEUTICALS$$68$YR$$F$Y$$$20240923$$CN$US$US
2338636312$23386363$12$F$20230101$20240911$20240110$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-000436$UNITED THERAPEUTICS$$$$$M$Y$86.168$KG$20240921$$$US$US
233863993$23386399$3$F$20240107$20240918$20240110$20240921$PER$$US-AMGEN-USASP2024004452$AMGEN$$39$YR$A$F$Y$53.515$KG$20240921$$PH$US$US
233864162$23386416$2$F$$20240827$20240110$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-004930$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240904$$PH$JP$JP
233864672$23386467$2$F$$20240917$20240110$20240926$PER$$US-SA-2024SA005950$SANOFI AVENTIS$$$$E$M$Y$75.737$KG$20240926$$MD$US$US
233864752$23386475$2$F$20240201$20240621$20240110$20240703$PER$$US-SA-2024SA006086$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240703$$MD$US$US
233864912$23386491$2$F$$20240703$20240110$20240712$PER$$US-SA-2024SA005798$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240712$$MD$US$US
233866022$23386602$2$F$20231208$20240625$20240110$20240704$PER$$US-SA-2024SA008649$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240704$$MD$US$US
233866272$23386627$2$F$$20240819$20240110$20240823$EXP$$US-BAUSCHBL-2024BNL000160$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240823$$CN$US$US
233866463$23386646$3$F$20231222$20240626$20240110$20240709$EXP$$CA-BEH-2024167023$CSL BEHRING$$32$YR$A$M$Y$$$20240709$$CN$CA$CA
233867252$23386725$2$F$20240108$20240821$20240110$20240826$PER$$US-AMGEN-USASP2024004229$AMGEN$$86$YR$E$M$Y$$$20240825$$PH$US$US
233868204$23386820$4$F$20230901$20240624$20240110$20240702$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-276683$BOEHRINGER INGELHEIM$$69$YR$E$F$Y$$$20240702$$HP$JP$JP
233868342$23386834$2$F$$20240820$20240110$20240827$PER$$NVSC2024US004975$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
233868442$23386844$2$F$20240107$20240802$20240110$20240806$PER$$US-AMGEN-USASP2024004266$AMGEN$$79$YR$E$M$Y$$$20240806$$CN$US$US
233868506$23386850$6$F$20231215$20240823$20240110$20240828$EXP$$US-TAKEDA-2024TUS001965$TAKEDA$$6$YR$$M$Y$34$KG$20240828$$HP$US$US
233868874$23386887$4$F$20240110$20240822$20240110$20240823$EXP$$CA-TAKEDA-2021TUS004207$TAKEDA$$33$YR$$F$Y$$$20240823$$HP$CA$CA
233868923$23386892$3$F$20230810$20240716$20240110$20240720$EXP$$NVSC2023AU193254$NOVARTIS$$41$YR$$M$Y$$$20240719$$HP$AU$AU
233869572$23386957$2$F$20231031$20240819$20240110$20240823$EXP$$FR-JAZZ PHARMACEUTICALS-2024-FR-000367$JAZZ$$$$$$Y$$$20240823$$MD$FR$FR
233869912$23386991$2$F$20210901$20240903$20240110$20240911$EXP$$FR-ORPHANEU-2024000037$RECORDATI$$$$$$Y$$$20240911$$MD$FR$FR
233870262$23387026$2$F$$20240712$20240110$20240716$EXP$$US-SUNOVION-2024SUN000002$SUNOVION$$$$$$Y$$$20240716$$CN$US$US
233870277$23387027$7$F$20230302$20240702$20240110$20240709$EXP$$CA-TAKEDA-2023TUS090746$TAKEDA$$57$YR$$F$Y$$$20240709$$MD$CA$CA
233870415$23387041$5$F$$20240614$20240110$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005882$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
233870442$23387044$2$F$$20240705$20240110$20240716$EXP$$GB-CELLTRION INC.-2023GB003717$CELLTRION$$$$$$Y$$$20240716$$CN$GB$GB
233870592$23387059$2$F$20231227$20240820$20240110$20240829$EXP$$CA-TEVA-VS-3141443$TEVA$$76$YR$$M$Y$$$20240829$$CN$CA$CA
233870934$23387093$4$F$20240201$20240708$20240110$20240715$PER$$US-SA-2024SA009359$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240715$$MD$US$US
233871182$23387118$2$F$20230810$20240905$20240110$20240910$EXP$$NVSC2023GB180950$NOVARTIS$$39$YR$$M$Y$$$20240910$$CN$GB$GB
2338713614$23387136$14$F$20240330$20240923$20240110$20240925$EXP$$NVSC2023GB242817$NOVARTIS$$54$YR$$F$Y$71$KG$20240925$$MD$GB$DE
233871932$23387193$2$F$$20240719$20240110$20240724$EXP$$US-SA-2024SA010112$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240724$$MD$US$US
233872175$23387217$5$F$$20240612$20240110$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005891$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
2338728516$23387285$16$F$20230714$20240819$20240110$20240826$EXP$$GB-AMGEN-GBRSP2024000922$AMGEN$$34$YR$A$F$Y$$$20240826$$MD$GB$GB
233873393$23387339$3$F$$20240910$20240110$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA002348$SANDOZ$$46$YR$$F$Y$132$KG$20240912$$HP$CA$CA
233873774$23387377$4$F$20210629$20240814$20240110$20240816$EXP$$JP-ABBVIE-22K-087-4338894-00$ABBVIE$$76$YR$$F$Y$49$KG$20240816$$MD$JP$JP
233874753$23387475$3$F$20221228$20240701$20240110$20240703$EXP$$AT-PFIZER INC-202400007276$PFIZER$$74$YR$$F$Y$$$20240703$$MD$AT$AT
233874834$23387483$4$F$20231201$20240722$20240110$20240725$EXP$$US-PFIZER INC-PV202400001653$PFIZER$$88$YR$$M$Y$$$20240725$$CN$US$US
233874844$23387484$4$F$$20240730$20240110$20240802$EXP$$US-PFIZER INC-PV202400001280$PFIZER$$85$YR$$M$Y$$$20240802$$CN$US$US
233874883$23387488$3$F$20220324$20240716$20240110$20240722$EXP$$DE-PFIZER INC-202400000602$PFIZER$$$$A$F$Y$$$20240722$$MD$DE$DE
233875015$23387501$5$F$20240101$20240725$20240110$20240805$PER$$US-SA-2024SA005907$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240805$$MD$US$US
233875282$23387528$2$F$$20240725$20240110$20240730$EXP$$CA-PFIZER INC-202400007482$PFIZER$$$$$F$Y$$$20240730$$HP$CA$CA
233875962$23387596$2$F$20231201$20240712$20240110$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004721$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240715$$HP$US$US
2338761912$23387619$12$F$20230101$20240909$20240110$20240919$EXP$$US-INSMED, INC.-2021-07943-US$INSMED$$$$$F$Y$$$20240919$$CN$US$US
233876693$23387669$3$F$20231201$20240805$20240110$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003904$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240809$$CN$US$US
233876726$23387672$6$F$$20240912$20240110$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002658$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240916$$CN$US$US
233877015$23387701$5$F$$20240715$20240110$20240717$PER$$NVSC2024US004962$NOVARTIS$$$$$$Y$$$20240717$$MD$US$US
233877192$23387719$2$F$20240105$20240626$20240110$20240701$PER$$US-AMGEN-USASP2024004283$AMGEN$$71$YR$E$M$Y$$$20240701$$CN$US$US
233878693$23387869$3$F$$20240709$20240110$20240718$30DAY$$US-GSK-US2023015623$GLAXOSMITHKLINE$$$$$M$Y$$$20240718$$CN$US$US
233878992$23387899$2$F$$20240820$20240110$20240828$EXP$$CA-JNJFOC-20240104151$JOHNSON AND JOHNSON$$44$YR$A$M$Y$91$KG$20240828$$HP$CA$CA
233879176$23387917$6$F$20180101$20240711$20240110$20240712$EXP$$CA-SANDOZ INC.-PHHY2018CA081145$SANDOZ$$59$YR$$M$Y$$$20240712$$CN$CA$CA
233880273$23388027$3$F$$20240905$20240110$20240910$EXP$$CA-PFIZER INC-202400006686$PFIZER$$57$YR$$F$Y$$$20240910$$MD$CA$CA
233880302$23388030$2$F$20231001$20240805$20240110$20240806$EXP$$CA-PFIZER INC-202400007315$PFIZER$$62$YR$$M$Y$$$20240806$$HP$CA$CA
233880412$23388041$2$F$20240107$20240819$20240110$20240823$PER$$US-AMGEN-USASP2024004388$AMGEN$$75$YR$E$M$Y$$$20240823$$CN$US$US
233880852$23388085$2$F$$20240911$20240110$20240919$EXP$$NVSC2024CA004113$NOVARTIS$$43$YR$$F$Y$129$KG$20240919$$CN$CA$CA
233881383$23388138$3$F$20230911$20240830$20240110$20240909$EXP$$CA-Vifor (International) Inc.-VIT-2024-00160$VIFOR$$87$YR$$M$Y$$$20240909$$CN$CA$CA
233882012$23388201$2$F$$20240105$20240110$20240925$PER$$US-GSK-US2024AMR002662$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
233882816$23388281$6$F$20231231$20240702$20240110$20240710$EXP$$CA-TAKEDA-2024TUS000899$TAKEDA$$19$YR$$F$Y$$$20240710$$CN$CA$CA
233882842$23388284$2$F$$20240904$20240110$20240912$EXP$$BR-TEVA-VS-3139670$TEVA$$77$YR$$M$Y$$$20240912$$CN$BR$BR
233883133$23388313$3$F$20231201$20240826$20240110$20240909$PER$$US-SA-2023SA368865$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240909$$MD$US$US
233883492$23388349$2$F$20231106$20240821$20240110$20240829$EXP$FR-AFSSAPS-AM2023001182$FR-TAKEDA-2024TUS002382$TAKEDA$$83$YR$$M$Y$73$KG$20240829$$HP$FR$FR
233883524$23388352$4$F$$20240708$20240110$20240710$EXP$$GB-PFIZER INC-202300457834$PFIZER$$55$YR$$M$Y$$$20240710$$MD$GB$GB
233883657$23388365$7$F$20240101$20240903$20240110$20240926$PER$$US-SA-2024SA008772$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240926$$MD$US$US
233883712$23388371$2$F$$20231208$20240110$20240904$PER$$US-MYLANLABS-2023M1132367$MYLAN$$$$$F$Y$$$20240904$$CN$US$US
233883854$23388385$4$F$20231101$20240924$20240110$20240925$EXP$$US-PFIZER INC-PV202400002138$PFIZER$$77$YR$$F$Y$$$20240925$$CN$US$US
233884043$23388404$3$F$20240103$20240828$20240110$20240828$EXP$$US-PFIZER INC-PV202400002748$PFIZER$$61$YR$$F$Y$$$20240828$$HP$US$US
233884302$23388430$2$F$20231009$20240823$20240110$20240826$EXP$$US-PFIZER INC-PV202300173712$PFIZER$$72$YR$$F$Y$76.644$KG$20240826$$CN$US$US
233884502$23388450$2$F$20231127$20240701$20240110$20240705$EXP$ES-AEMPS-1468176$ES-TAKEDA-2024TUS001192$TAKEDA$$46$YR$$M$Y$90$KG$20240705$$HP$ES$ES
233884562$23388456$2$F$20231024$20240724$20240110$20240802$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2023-26767$IPSEN$$76$YR$E$F$Y$$$20240802$$CN$CA$CA
233885923$23388592$3$F$20231201$20240725$20240110$20240731$PER$$US-Eisai-EC-2024-156749$EISAI$$66$YR$E$F$Y$$$20240731$$CN$US$US
233886052$23388605$2$F$$20240919$20240110$20240925$EXP$$US-MYLANLABS-2023M1138540$MYLAN$$$$$F$Y$$$20240925$$CN$US$US
233886133$23388613$3$F$20240528$20240730$20240110$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005049$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240731$$HP$US$US
233886154$23388615$4$F$$20240718$20240110$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004771$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240730$$HP$US$US
233886784$23388678$4$F$$20240712$20240110$20240721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004364$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240722$$HP$US$US
233886883$23388688$3$F$$20240725$20240110$20240803$PER$$US-SA-2024SA007459$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240803$$MD$US$US
233886926$23388692$6$F$20220802$20240910$20240110$20240911$EXP$$US-TAKEDA-2022TUS053154$TAKEDA$$45$YR$$F$Y$$$20240911$$CN$US$US
233888482$23388848$2$F$20221201$20240924$20240110$20240930$EXP$$CA-BAUSCH-BL-2022-028355$BAUSCH AND LOMB$$36$YR$$M$Y$192.95$KG$20241001$$CN$CA$CA
233888952$23388895$2$F$$20240909$20240110$20240911$EXP$$CA-PURDUE-USA-2024-0307003$PURDUE$$97$YR$$F$Y$97$KG$20240911$$HP$CA$CA
233889145$23388914$5$F$20230901$20240925$20240110$20240926$PER$$US-PFIZER INC-PV202300175486$PFIZER$$67$YR$$F$Y$70.306$KG$20240926$$CN$US$US
233889242$23388924$2$F$20231207$20240426$20240110$20240716$PER$$US-GE HEALTHCARE-2023CSU011419$GE HEALTHCARE$$64$YR$$M$Y$72.1$KG$20240716$$PH$US$US
233889353$23388935$3$F$$20240813$20240110$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA002382$SANDOZ$$66$YR$$F$Y$$$20240819$$HP$CA$CA
233889624$23388962$4$F$20231123$20240715$20240110$20240718$EXP$$CA-SANDOZ INC.-SDZ2023CA021707$SANDOZ$$47$YR$$M$Y$$$20240718$$HP$CA$CA
233889654$23388965$4$F$20240102$20240726$20240110$20240801$PER$$US-ALKERMES INC.-ALK-2024-000038$ALKERMES$$53$YR$$M$Y$$$20240801$$MD$US$US
233889756$23388975$6$F$20231110$20240809$20240110$20240814$EXP$$DE-SANDOZ INC.-SDZ2024DE002176$SANDOZ$$$$A$F$Y$65.4$KG$20240814$$HP$DE$DE
233889966$23388996$6$F$20200101$20240717$20240110$20240723$EXP$$DE-MYLANLABS-2022M1084015$MYLAN$$$$E$F$Y$$$20240723$$MD$DE$DE
233890044$23389004$4$F$20231026$20240828$20240110$20240830$EXP$$DE-009507513-2401DEU004910$MERCK$$40$YR$$F$Y$53$KG$20240830$$MD$DE$DE
233890982$23389098$2$F$$20240828$20240110$20240904$PER$$US-PFIZER INC-PV202400004046$PFIZER$$85$YR$$F$Y$$$20240904$$CN$US$US
233890992$23389099$2$F$$20240626$20240110$20240701$PER$$US-PFIZER INC-202400006933$PFIZER$$83$YR$$F$Y$$$20240701$$MD$US$US
233891024$23389102$4$F$$20240806$20240110$20240809$PER$$US-PFIZER INC-202400004617$PFIZER$$10$YR$$M$Y$$$20240809$$CN$US$US
233891052$23389105$2$F$$20240626$20240110$20240701$PER$$US-PFIZER INC-PV202300122992$PFIZER$$85$YR$$F$Y$49.9$KG$20240701$$MD$US$US
233891094$23389109$4$F$$20240702$20240110$20240703$PER$$US-PFIZER INC-202400006948$PFIZER$$73$YR$$F$Y$$$20240703$$CN$US$US
233891142$23389114$2$F$$20240916$20240110$20240918$PER$$US-PFIZER INC-PV202400003510$PFIZER$$74$YR$$F$Y$$$20240918$$CN$US$US
233892674$23389267$4$F$20240716$20240725$20240110$20240730$EXP$$CA-TAKEDA-2024TUS002525$TAKEDA$$75$YR$$M$Y$$$20240730$$MD$CA$CA
233893732$23389373$2$F$$20240912$20240110$20240918$EXP$$US-ABBVIE-5579400$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
233893743$23389374$3$F$20230713$20240911$20240110$20240913$EXP$$US-TAKEDA-2023TUS071327$TAKEDA$$23$YR$$M$Y$$$20240913$$CN$US$US
233894043$23389404$3$F$$20240817$20240110$20240822$EXP$$CA-TAKEDA-2023TUS038231$TAKEDA$$$$$M$Y$54.7$KG$20240822$$CN$CA$CA
233894233$23389423$3$F$$20240912$20240110$20240918$EXP$$US-ABBVIE-5579325$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
233894342$23389434$2$F$$20240717$20240110$20240724$EXP$CA-DRL-USA-SPO/CAN/24/0000281$CA-RDY-SPO/CAN/24/0000281$DR REDDYS$$54$YR$A$M$Y$$$20240724$$MD$CA$CA
233895093$23389509$3$F$$20240726$20240110$20240802$PER$$US-ALXN-202401USA000412US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
233895353$23389535$3$F$$20240910$20240110$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-005090$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$62.3$KG$20240913$$MD$JP$JP
233895634$23389563$4$F$$20240628$20240110$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005172$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240702$$CN$US$US
233895802$23389580$2$F$20231202$20240624$20240110$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-006027$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240718$$CN$US$US
233896193$23389619$3$F$20210801$20240801$20240111$20240807$EXP$$US-HORIZON THERAPEUTICS-HZN-2022-000947$AMGEN$$53$YR$A$M$Y$$$20240807$$MD$US$US
233896234$23389623$4$F$20080101$20240918$20240111$20240928$EXP$$CA-AUROBINDO-AUR-APL-2022-006189$AUROBINDO$$53$YR$$M$Y$$$20240928$$MD$CA$GB
233896838$23389683$8$F$20200601$20240919$20240111$20240920$EXP$$DE-SANDOZ INC.-NVSC2021DE315934$SANDOZ$$80$YR$$M$Y$69$KG$20240920$$HP$DE$DE
233897344$23389734$4$F$$20240611$20240111$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-006057$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
233897405$23389740$5$F$20230101$20240820$20240111$20240903$EXP$$CA-UCBSA-2023048451$UCB$$$$$F$Y$$$20240903$$CN$CA$CA
233897772$23389777$2$F$$20240717$20240111$20240723$EXP$$US-TAKEDA-2022TUS027030$TAKEDA$$$$$F$Y$$$20240723$$CN$US$US
233898653$23389865$3$F$20240106$20240723$20240111$20240726$PER$$US-AMGEN-USASP2024003552$AMGEN$$59$YR$A$F$Y$$$20240726$$CN$US$US
233898873$23389887$3$F$20231201$20240813$20240111$20240827$PER$$US-SA-2024SA008275$SANOFI AVENTIS$$60$YR$A$F$Y$78.92$KG$20240827$$MD$US$US
233898902$23389890$2$F$$20240717$20240111$20240726$PER$$US-SA-2024SA006018$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240726$$MD$US$US
233898965$23389896$5$F$20230803$20240712$20240111$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-005186$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$57$KG$20240719$$MD$JP$JP
233899095$23389909$5$F$20231220$20240809$20240111$20240817$EXP$$NVSC2024US001277$NOVARTIS$$48$YR$$F$Y$$$20240817$$CN$US$US
233899972$23389997$2$F$$20240912$20240111$20240920$EXP$$CA-CELLTRION INC.-2022CA022444$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
233900434$23390043$4$F$20231001$20240731$20240111$20240808$PER$$US-SA-2024SA007005$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240808$$MD$US$US
233901304$23390130$4$F$20231128$20231129$20240111$20240705$PER$$US-RDY-SPO/USA/23/0187725$DR REDDYS$$3$YR$C$F$Y$14.7$KG$20240705$$CN$US$US
233901353$23390135$3$F$20180501$20240822$20240111$20240827$EXP$$CA-TAKEDA-2018TUS023387$TAKEDA$$29$YR$$F$Y$$$20240827$$HP$CA$CA
233902357$23390235$7$F$20231230$20240812$20240111$20240822$EXP$$US-GSK-US2024AMR001318$GLAXOSMITHKLINE$$60$YR$$F$Y$181$KG$20240822$$HP$US$US
233902538$23390253$8$F$20231228$20240729$20240111$20240806$EXP$$CA-CELLTRION INC.-2023CA025387$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
233903233$23390323$3$F$$20240723$20240111$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-426333$RANBAXY$$82$YR$$M$Y$$$20240807$$HP$FR$FR
233903522$23390352$2$F$$20240816$20240111$20240830$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-426578$RANBAXY$Todd CM, Yu A,Lay C, et al. Effect of testosterone therapy on migraine frequency and disability in two transgender patients: A case report. BMJ Case Rep. 2023;16:e251895(1-3)$$$$F$Y$$$20240830$$HP$CA$CA
233903562$23390356$2$F$20230404$20240702$20240111$20240717$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-426340$RANBAXY$$71$YR$$F$Y$$$20240717$$HP$FR$FR
233903572$23390357$2$F$$20240723$20240111$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-426326$RANBAXY$$$$$F$Y$$$20240807$$HP$FR$FR
233903693$23390369$3$F$20231202$20240823$20240111$20240828$EXP$$FR-AMGEN-FRANI2024003605$AMGEN$$64$YR$A$M$Y$$$20240828$$HP$FR$FR
233903842$23390384$2$F$$20240723$20240111$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-426353$RANBAXY$$73$YR$$M$Y$$$20240807$$HP$FR$FR
233904279$23390427$9$F$20231219$20240705$20240111$20240712$EXP$$CA-ROCHE-3489061$ROCHE$$36$YR$A$F$Y$$$20240712$$CN$CA$CA
2339047513$23390475$13$F$20140713$20240913$20240111$20240923$EXP$$US-HORIZON THERAPEUTICS-HZN-2022-003241$AMGEN$$65$YR$E$F$Y$63$KG$20240923$$MD$US$US
233905052$23390505$2$F$20230930$20240814$20240111$20240820$EXP$$JP-ABBVIE-22K-087-4338185-00$ABBVIE$$60$YR$$F$Y$50$KG$20240820$$MD$JP$JP
233905116$23390511$6$F$20230101$20240812$20240111$20240816$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-008428$AMGEN$$66$YR$E$F$Y$$$20240816$$LW$US$US
233905213$23390521$3$F$20221101$20240710$20240111$20240711$EXP$DE-BRISTOL-MYERS SQUIBB COMPANY-2022-132025$DE-SANDOZ INC.-SDZ2024DE000097$SANDOZ$$59$YR$$M$Y$101$KG$20240711$$MD$DE$DE
233905314$23390531$4$F$20240201$20240711$20240111$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005571$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240712$$HP$US$US
233905392$23390539$2$F$$20240909$20240111$20240921$EXP$$FR-Accord-399515$ACCORD$Additional literature reference added as Franchi V, Labussiere-Wallet H, Chouik Y, Heiblig M, Larcher M. Tandem duplications (tds) of the ubtf gene in acute myeloid leukaemia complicated by post hematopoietic stem cell transplantation venoocclusive disease treated by liver transplantation. LETTERS IN ONCOLOGY-HAEMATOLOGY. 2023;18 (6):349-51.$25$YR$A$M$Y$$$20240921$$HP$FR$FR
233906702$23390670$2$F$$20240903$20240111$20240911$EXP$$US-SA-2023SA256190$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240911$$MD$US$US
233907354$23390735$4$F$$20240725$20240111$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004873$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240729$$HP$US$US
233907383$23390738$3$F$20190927$20240731$20240111$20240806$EXP$$US-RDY-CLI/USA/23/0032329$DR REDDYS$$39$YR$A$F$Y$64$KG$20240806$$HP$US$US
233907853$23390785$3$F$20231225$20240904$20240111$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR003621$VIIV$$35$YR$$M$Y$$$20240911$$PH$US$US
233908422$23390842$2$F$$20240626$20240111$20240704$EXP$$DE-AUROBINDO-AUR-APL-2024-000753$AUROBINDO$$$$$F$Y$$$20240704$$MD$DE$DE
233908933$23390893$3$F$20231213$20240717$20240111$20240724$EXP$$CA-TAKEDA-2022TUS026481$TAKEDA$$62$YR$$F$Y$$$20240724$$CN$CA$CA
233909142$23390914$2$F$$20240108$20240111$20240829$EXP$$NVSC2024TR005126$NOVARTIS$$24$YR$$F$Y$$$20240829$$CN$TR$TR
233909896$23390989$6$F$20240114$20240716$20240111$20240725$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000049$BLUEPRINT MEDICINES$$63$YR$A$F$Y$$$20240725$$MD$US$US
233910385$23391038$5$F$20231128$20240727$20240111$20240805$EXP$$US-BEH-2024167086$CSL BEHRING$$2$YR$C$M$Y$$$20240805$$CN$US$US
233910415$23391041$5$F$20231201$20240903$20240111$20240911$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000011$DECIPHERA PHARMACEUTICALS$$61$YR$A$F$Y$$$20240911$$CN$US$US
233910964$23391096$4$F$$20240506$20240111$20240926$PER$$US-GSK-US2024AMR003572$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
233911452$23391145$2$F$20230101$20231211$20240111$20240723$PER$$US-TEVA-VS-3136127$TEVA$$65$YR$$M$Y$$$20240723$$HP$US$US
233911754$23391175$4$F$20231101$20240918$20240111$20240925$EXP$$US-BEH-2024167088$CSL BEHRING$$72$YR$E$F$Y$$$20240925$$CN$US$US
233911842$23391184$2$F$$20240723$20240111$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004175$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240725$$CN$US$US
233912592$23391259$2$F$$20240105$20240111$20240704$EXP$$US-TORRENT-00013218$TORRENT$$69$YR$E$F$Y$$$20240704$$MD$US$US
233913073$23391307$3$F$20240125$20240918$20240111$20240925$EXP$$CA-TAKEDA-2024TUS001862$TAKEDA$$42$YR$$M$Y$$$20240925$$CN$CA$CA
233914492$23391449$2$F$$20240515$20240111$20240702$PER$$US-LUNDBECK-DKLU3070607$LUNDBECK$$$$$$Y$$$20240702$$HP$US$US
233915748$23391574$8$F$20231227$20240725$20240111$20240803$PER$$US-SA-2024SA007945$SANOFI AVENTIS$$27$YR$A$M$Y$64.4$KG$20240803$$MD$US$US
233915762$23391576$2$F$20231229$20240820$20240111$20240903$PER$$US-SA-2024SA008247$SANOFI AVENTIS$$6$YR$C$F$Y$44.81$KG$20240903$$MD$US$US
233916802$23391680$2$F$$20240807$20240111$20240818$EXP$$AT-JNJFOC-20240119015$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240818$$HP$AT$AT
233917022$23391702$2$F$20231201$20240923$20240111$20240930$EXP$$CA-TAKEDA-2024TUS002078$TAKEDA$$60$YR$$M$Y$$$20240930$$CN$CA$CA
233918263$23391826$3$F$$20240626$20240111$20240702$PER$$US-INCYTE CORPORATION-2024IN000020$INCYTE$$$$$$Y$$$20240702$$MD$US$US
233919233$23391923$3$F$$20240809$20240111$20240814$EXP$$US-SA-2024SA010389$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240814$$CN$US$US
233919943$23391994$3$F$20231201$20240807$20240111$20240814$PER$$US-SA-2024SA006248$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240814$$MD$US$US
233920052$23392005$2$F$$20240703$20240111$20240714$PER$$US-SA-2024SA007143$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240714$$MD$US$US
233920063$23392006$3$F$20230101$20240920$20240111$20240925$PER$$US-SA-2024SA007135$SANOFI AVENTIS$$58$YR$A$F$Y$67.5$KG$20240925$$MD$US$US
233920333$23392033$3$F$20230101$20240806$20240111$20240816$PER$$US-SA-2023SA343281$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240816$$MD$US$US
233921002$23392100$2$F$20210505$20240620$20240111$20240702$PER$$US-SA-2024SA007194$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240702$$CN$US$US
233921032$23392103$2$F$$20240912$20240111$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005595$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240913$$CN$US$US
233921452$23392145$2$F$20230101$20240719$20240111$20240724$PER$$US-PFIZER INC-PV202400001838$PFIZER$$52$YR$$F$Y$$$20240724$$CN$US$US
233921486$23392148$6$F$20230816$20240716$20240111$20240718$PER$$US-PFIZER INC-202400005721$PFIZER$$35$YR$$F$Y$$$20240718$$HP$US$US
233921593$23392159$3$F$$20240813$20240111$20240819$EXP$$CA-TAKEDA-2023TUS116234$TAKEDA$$$$$F$Y$$$20240819$$CN$CA$CA
233921715$23392171$5$F$$20240909$20240111$20240911$PER$$US-PFIZER INC-PV202400004970$PFIZER$$83$YR$$F$Y$68.662$KG$20240911$$MD$US$US
233921973$23392197$3$F$20240401$20240731$20240111$20240808$EXP$$US-EMD Serono-2024001548$EMD SERONO INC$$71$YR$E$M$Y$$$20240808$$CN$US$US
233922183$23392218$3$F$20240401$20240822$20240111$20240828$PER$$US-PFIZER INC-PV202400002956$PFIZER$$59$YR$$F$Y$$$20240828$$HP$US$US
233922192$23392219$2$F$$20240719$20240111$20240724$PER$$US-PFIZER INC-202400009472$PFIZER$$57$YR$$F$Y$$$20240724$$CN$US$US
233922294$23392229$4$F$20220101$20240919$20240111$20240924$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2023-052216$REGENERON$$$$$M$Y$$$20240924$$CN$US$US
233922893$23392289$3$F$$20240704$20240111$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004145$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240726$$CN$US$US
233923393$23392339$3$F$20231227$20240802$20240111$20240809$EXP$$JP-ROCHE-3489696$ROCHE$$63$YR$A$F$Y$$$20240809$$MD$JP$JP
233925603$23392560$3$F$20240105$20240817$20240111$20240821$PER$$US-AMGEN-USASP2024002985$AMGEN$$58$YR$A$F$Y$$$20240820$$CN$US$US
233926187$23392618$7$F$20211230$20240619$20240111$20240702$EXP$$CA-ROCHE-3489943$ROCHE$$45$YR$A$F$Y$121$KG$20240702$$CN$CA$CA
233927603$23392760$3$F$$20240802$20240111$20240930$PER$$US-SA-2024SA007789$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
233928612$23392861$2$F$20220101$20231124$20240111$20240722$EXP$$SK-TEVA-VS-3135125$TEVA$$62$YR$$F$Y$$$20240722$$MD$SK$SK
233928763$23392876$3$F$20231214$20240903$20240111$20240915$EXP$$CA-UCBSA-2023059583$UCB$$30$YR$$F$Y$$$20240915$$CN$CA$CA
233928873$23392887$3$F$$20240710$20240111$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-005016$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$106$KG$20240716$$HP$CA$CA
233929182$23392918$2$F$$20230714$20240111$20240723$PER$$US-NOVOPROD-1095499$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
233929242$23392924$2$F$$20230713$20240111$20240723$PER$$US-NOVOPROD-1094729$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
233929532$23392953$2$F$$20230628$20240111$20240723$PER$$US-NOVOPROD-1089401$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
233929652$23392965$2$F$$20230609$20240111$20240723$PER$$US-NOVOPROD-1083087$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
233929802$23392980$2$F$$20230823$20240111$20240723$PER$$US-NOVOPROD-1111666$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
233929812$23392981$2$F$20231120$20231227$20240111$20240723$PER$$US-NOVOPROD-1145625$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
233929852$23392985$2$F$20230816$20231215$20240111$20240723$PER$$US-NOVOPROD-1147263$NOVO NORDISK$$82$YR$$F$Y$$$20240723$$CN$US$US
233929922$23392992$2$F$20230818$20231204$20240111$20240723$PER$$US-NOVOPROD-1136975$NOVO NORDISK$$32$YR$$F$Y$$$20240723$$HP$US$US
233929942$23392994$2$F$$20230921$20240111$20240723$PER$$US-NOVOPROD-1121509$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
233930002$23393000$2$F$20230805$20230815$20240111$20240723$PER$$US-NOVOPROD-1107019$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
233930112$23393011$2$F$20231012$20231204$20240111$20240723$PER$$US-NOVOPROD-1137911$NOVO NORDISK$$59$YR$$F$Y$$$20240723$$MD$US$US
233930132$23393013$2$F$20230821$20240605$20240111$20240723$PER$$US-NOVOPROD-1130247$NOVO NORDISK$$80$YR$$F$Y$$$20240723$$CN$US$US
233930322$23393032$2$F$20230401$20231205$20240111$20240723$PER$$US-NOVOPROD-1139677$NOVO NORDISK$$63$YR$$M$Y$$$20240723$$CN$US$US
233930602$23393060$2$F$$20231212$20240111$20240723$PER$$US-NOVOPROD-1123796$NOVO NORDISK$$$$A$F$Y$154.2$KG$20240723$$MD$US$US
233930612$23393061$2$F$$20231129$20240111$20240723$PER$$US-NOVOPROD-1110579$NOVO NORDISK$$$$E$M$Y$$$20240723$$MD$US$US
233930624$23393062$4$F$20230820$20231201$20240111$20240723$PER$$US-NOVOPROD-1138453$NOVO NORDISK$$70$YR$$M$Y$$$20240723$$CN$US$US
233930762$23393076$2$F$20231001$20231013$20240111$20240723$PER$$US-NOVOPROD-1129812$NOVO NORDISK$$69$YR$$F$Y$$$20240723$$CN$US$US
233930892$23393089$2$F$$20231205$20240111$20240723$PER$$US-NOVOPROD-1135391$NOVO NORDISK$$$$$F$Y$$$20240723$$MD$US$US
233930942$23393094$2$F$$20230912$20240111$20240723$PER$$US-NOVOPROD-1121008$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
233930952$23393095$2$F$20231027$20240304$20240111$20240723$PER$$US-NOVOPROD-1146990$NOVO NORDISK$$75$YR$$M$Y$$$20240723$$CN$US$US
233931062$23393106$2$F$$20231012$20240111$20240723$PER$$US-NOVOPROD-1128733$NOVO NORDISK$$$$A$M$Y$$$20240723$$HP$US$US
233931663$23393166$3$F$20230907$20240923$20240111$20240925$EXP$$NVSC2023GB200464$NOVARTIS$$29$YR$$F$Y$$$20240925$$CN$GB$GB
233932236$23393223$6$F$20200624$20240806$20240111$20240813$EXP$$BE-SANDOZ INC.-SDZ2024BE002562$SANDOZ$$79$YR$$F$Y$$$20240813$$HP$BE$BE
233933244$23393324$4$F$20230101$20240703$20240111$20240712$PER$$US-SA-2024SA008384$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240712$$MD$US$US
233933282$23393328$2$F$20231231$20240815$20240111$20240819$EXP$$JP-ABBVIE-5581267$ABBVIE$$73$YR$$M$Y$$$20240819$$CN$JP$JP
233933323$23393332$3$F$$20240827$20240111$20240910$EXP$$CA-UCBSA-2024001486$UCB$$$$$M$Y$$$20240910$$CN$CA$CA
233933343$23393334$3$F$20231130$20240704$20240111$20240710$EXP$$BR-TAKEDA-2024TUS002708$TAKEDA$$20$YR$$F$Y$$$20240710$$HP$BR$BR
2339335011$23393350$11$F$$20240814$20240111$20240820$EXP$$US-VERTEX PHARMACEUTICALS-2024-000309$VERTEX$$59$YR$$$Y$$$20240820$$CN$US$US
233933524$23393352$4$F$$20240126$20240111$20240701$PER$$US-UCBSA-2024000953$UCB$$$$A$M$Y$$$20240701$$CN$US$US
233933573$23393357$3$F$20230101$20240726$20240111$20240731$PER$$US-VERTEX PHARMACEUTICALS-2024-000216$VERTEX$$6$YR$$M$Y$$$20240731$$CN$US$US
233933883$23393388$3$F$20240501$20240708$20240111$20240711$EXP$$US-PFIZER INC-PV202400002839$PFIZER$$80$YR$$M$Y$$$20240711$$CN$US$US
233934452$23393445$2$F$20231020$20240712$20240111$20240724$EXP$$CN-PFIZER INC-PV202400002568$PFIZER$$93$YR$$M$Y$$$20240724$$HP$CN$CN
233934492$23393449$2$F$20231222$20240723$20240111$20240730$EXP$$CN-PFIZER INC-PV202400002587$PFIZER$$25$YR$$M$Y$$$20240730$$HP$CN$CN
233934695$23393469$5$F$20240104$20240726$20240111$20240801$EXP$$CA-PFIZER INC-202300355452$PFIZER$$65$YR$$F$Y$50$KG$20240801$$MD$CA$CA
233934725$23393472$5$F$20220117$20240828$20240111$20240902$EXP$$CA-PFIZER INC-202101416977$PFIZER$$57$YR$$M$Y$$$20240902$$MD$CA$CA
233934982$23393498$2$F$20231023$20240722$20240111$20240725$EXP$$IN-PFIZER INC-PV202400003378$PFIZER$$75$YR$$F$Y$$$20240725$$CN$IN$IN
233935033$23393503$3$F$$20240902$20240111$20240905$EXP$$IN-PFIZER INC-PV202400004838$PFIZER$$63$YR$$M$Y$$$20240905$$CN$IN$IN
233935147$23393514$7$F$$20240722$20240111$20240725$EXP$$US-PFIZER INC-PV202400003808$PFIZER$$83$YR$$M$Y$$$20240725$$CN$US$US
233935294$23393529$4$F$$20240320$20240111$20240819$EXP$$NVSC2024US003234$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
233935464$23393546$4$F$$20240710$20240111$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005127$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$94.35$KG$20240712$$CN$US$US
233936013$23393601$3$F$20201001$20240828$20240111$20240902$EXP$$US-PFIZER INC-202201196244$PFIZER$$89$YR$$M$Y$74.84$KG$20240902$$CN$US$US
233936783$23393678$3$F$20231222$20240819$20240111$20240821$EXP$$US-PFIZER INC-202400005437$PFIZER$$5$YR$$M$Y$17.7$KG$20240821$$CN$US$US
233937533$23393753$3$F$20230211$20240709$20240111$20240718$30DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134159$REGENERON$$$$$$Y$$$20240718$$HP$US$US
233938657$23393865$7$F$20220101$20240627$20240111$20240705$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-008097$AMGEN$$68$YR$E$F$Y$$$20240705$$MD$US$US
233939112$23393911$2$F$20231001$20240702$20240111$20240712$PER$$US-SA-2024SA007781$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240712$$MD$US$US
2339391921$23393919$21$F$20230101$20240912$20240111$20240916$EXP$$IN-PFIZER INC-PV202300178659$PFIZER$$53$YR$$M$Y$63$KG$20240916$$CN$IN$IN
233939692$23393969$2$F$$20240829$20240111$20240906$PER$$US-PHARMING-PHAUS2024000040$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
233942722$23394272$2$F$$20240724$20240111$20240730$PER$$US-009507513-2401USA000348$MERCK$$67$YR$$M$Y$$$20240730$$CN$US$US
233942733$23394273$3$F$$20240708$20240111$20240711$EXP$$IN-TAKEDA-2023TUS124956$TAKEDA$$$$$F$Y$$$20240711$$CN$IN$IN
233943482$23394348$2$F$$20240820$20240111$20240821$EXP$$CA-SANDOZ INC.-NVSC2019CA099631$SANDOZ$$18$YR$$F$Y$63$KG$20240821$$CN$CA$CA
233943644$23394364$4$F$20231117$20240819$20240111$20240829$PER$$US-SA-2024SA010781$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240829$$MD$US$US
233944022$23394402$2$F$20231121$20240805$20240111$20240813$PER$$US-SA-2024SA011393$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240814$$MD$US$US
233944514$23394451$4$F$20240101$20240806$20240111$20240811$EXP$$US-ABBVIE-5581326$ABBVIE$$47$YR$$F$Y$$$20240811$$CN$US$US
233944782$23394478$2$F$$20240726$20240111$20240805$PER$$US-SA-2024SA007206$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240805$$MD$US$US
233944942$23394494$2$F$20231201$20240716$20240111$20240724$PER$$US-SA-2024SA007153$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240724$$MD$US$US
233945042$23394504$2$F$20231201$20240708$20240111$20240716$PER$$US-SA-2024SA008461$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240716$$MD$US$US
233945223$23394522$3$F$$20240620$20240111$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005928$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
233945572$23394557$2$F$20230101$20240625$20240112$20240703$EXP$$CA-CELLTRION INC.-2023CA014264$CELLTRION$$$$$$Y$$$20240703$$MD$CA$CA
233945692$23394569$2$F$$20240627$20240112$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005931$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
233945736$23394573$6$F$$20240920$20240112$20240925$EXP$$US-TAKEDA-2023TUS055071$TAKEDA$$$$$F$Y$61$KG$20240925$$HP$US$US
233945875$23394587$5$F$$20240915$20240112$20240924$EXP$$CA-CELLTRION INC.-2023CA023300$CELLTRION$$$$$$Y$$$20240924$$CN$CA$CA
233946152$23394615$2$F$$20240815$20240112$20240904$PER$$CA-TOLMAR, INC.-23CA045598$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
233946173$23394617$3$F$20231219$20240726$20240112$20240815$PER$$CA-TOLMAR, INC.-23CA045615$TOLMAR$$74$YR$$M$Y$$$20240814$$CN$CA$CA
233946214$23394621$4$F$20231219$20240822$20240112$20240911$PER$$CA-TOLMAR, INC.-23CA045626$TOLMAR$$81$YR$$M$Y$$$20240911$$CN$CA$CA
233946222$23394622$2$F$20231219$20240619$20240112$20240710$PER$$CA-TOLMAR, INC.-23CA045628$TOLMAR$$75$YR$$M$Y$$$20240709$$CN$CA$CA
233946492$23394649$2$F$20230101$20240820$20240112$20240902$PER$$US-SA-2024SA010281$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240902$$MD$US$US
233946513$23394651$3$F$20230101$20240717$20240112$20240725$PER$$US-SA-2024SA011404$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240725$$MD$US$US
233946952$23394695$2$F$20230101$20240814$20240112$20240819$EXP$$US-ABBVIE-5581591$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
233947382$23394738$2$F$20220930$20240723$20240112$20240729$EXP$$AT-TAKEDA-2023TUS039176$TAKEDA$$53$YR$$F$Y$$$20240729$$HP$AT$AT
233947855$23394785$5$F$20230101$20240705$20240112$20240713$EXP$$CA-CELLTRION INC.-2023CA017210$CELLTRION$$$$$$Y$$$20240713$$HP$CA$CA
233947872$23394787$2$F$20240109$20240822$20240112$20240827$EXP$$JP-GSK-JP2024004894$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$PH$JP$JP
233947934$23394793$4$F$20231222$20240725$20240112$20240729$EXP$$DE-TAKEDA-2024TUS003047$TAKEDA$$12$YR$$F$Y$$$20240729$$HP$DE$DE
233948003$23394800$3$F$$20240710$20240112$20240718$30DAY$$US-GSK-US2024000228$GLAXOSMITHKLINE$$$$$M$Y$$$20240718$$HP$US$US
233949172$23394917$2$F$20231209$20240920$20240112$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024003873$VIIV$$12$YR$$M$Y$$$20240929$$HP$US$US
233949384$23394938$4$F$$20240706$20240112$20240712$EXP$$ES-AUROBINDO-AUR-APL-2024-000717$AUROBINDO$Pedrero Prieto M, Gorriz RD, Gomez RE, Perez M FC  and Casanova EB. Neuromyelitis optica associated with the use of Atezolizumab in a patient with advanced lung adenocarcinoma.. Neurological Sciences. 2023$47$YR$$M$Y$$$20240712$$HP$ES$ES
233949553$23394955$3$F$20230911$20240628$20240112$20240705$PER$$US-ALXN-A202311854$ALEXION PHARMACEUTICALS$$66$YR$$M$Y$$$20240705$$CN$US$US
233949645$23394964$5$F$$20240719$20240112$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005957$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240729$$CN$US$US
233950122$23395012$2$F$20230601$20240808$20240112$20240817$PER$$US-SA-2024SA012275$SANOFI AVENTIS$$69$YR$E$F$Y$71.6$KG$20240817$$MD$US$US
233950242$23395024$2$F$20231001$20240828$20240112$20240903$EXP$$BR-TAKEDA-2018TUS020669$TAKEDA$$39$YR$$M$Y$$$20240903$$CN$BR$BR
233950364$23395036$4$F$20231201$20240625$20240112$20240702$EXP$$CA-CELLTRION INC.-2024CA000528$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
233950755$23395075$5$F$$20240826$20240112$20240905$EXP$$JP-TEVA-VS-3142376$TEVA$Nagao S, Yabuuchi Y, Tanaka K, Morihisa Y, Kobayashi T, Akiyama S, et al. Multiple Gastric Neuroendocrine Tumors Associated with Long-term Use of a Proton Pump Inhibitor and a Potassium-competitive Acid Blocker. Intern-Med 2024; 63 (14): 2001-; Nagao S, Yabuuchi Y, Tanaka K, Morihisa Y, Kobayashi T, Akiyama S, et al. Multiple Gastric Neuroendocrine Tumors Associated with Long-term Use of a Proton Pump Inhibitor and a Potassium-competitive Acid Blocker. Intern-Med 2024; 63 (14): 2001-2010.; Na...$52$YR$$M$Y$$$20240905$$HP$JP$JP
233950865$23395086$5$F$$20240304$20240112$20240805$PER$$US-AstraZeneca-2024A008049$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
233951137$23395113$7$F$20231222$20240619$20240112$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005949$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240712$$CN$US$US
233951144$23395114$4$F$20240105$20240911$20240112$20240918$30DAY$$US-GSK-US2024001619$GLAXOSMITHKLINE$$86$YR$$F$Y$$$20240918$$MD$US$US
233951254$23395125$4$F$$20240809$20240112$20240819$EXP$$CA-AUROBINDO-AUR-APL-2024-001070$AUROBINDO$Sahly AN, Srour M, Buhas D, Scheffer IE, Myers KA.. The epileptology of Wiedemann Steiner syndrome: Electroclinical findings in five patients with KMT2A pathogenic variants. European Journal of Paediatric Neurology.. 2023;44:4446-50$25$YR$$F$Y$$$20240819$$HP$CA$CA
233952352$23395235$2$F$20240105$20240822$20240112$20240826$PER$$US-JNJFOC-20240124515$JOHNSON AND JOHNSON$$43$YR$A$F$Y$90.8$KG$20240826$$HP$US$US
233952527$23395252$7$F$20220101$20240906$20240112$20240910$EXP$$CA-SANDOZ INC.-NVSC2022CA235889$SANDOZ$$$$$M$Y$$$20240910$$CN$CA$CA
233952584$23395258$4$F$$20240716$20240112$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005402$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240725$$CN$US$US
233953012$23395301$2$F$$20240726$20240112$20240807$EXP$$CA-AUROBINDO-AUR-APL-2023-032451$AUROBINDO$Handelman K, Sumiya F. Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case Report. Brain-Science. 2022;12(8):1-14$17$YR$$M$Y$$$20240807$$HP$CA$CA
233953297$23395329$7$F$20231207$20240708$20240112$20240722$PER$$US-Calliditas-2024CAL00035$CALLIDITAS THERAPEUTICS$$33$YR$A$M$Y$$$20240722$$CN$US$US
233953634$23395363$4$F$20170608$20240917$20240112$20240920$EXP$$US-TAKEDA-2022TUS001790$TAKEDA$$52$YR$$F$Y$88$KG$20240920$$HP$US$US
233953803$23395380$3$F$$20240709$20240112$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005686$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240711$$HP$US$US
233953925$23395392$5$F$20240301$20240628$20240112$20240706$EXP$$CA-CELLTRION INC.-2024CA000538$CELLTRION$$$$$$Y$$$20240706$$HP$CA$CA
233953932$23395393$2$F$$20240705$20240112$20240710$EXP$$US-TAKEDA-2024TUS002719$TAKEDA$$$$$F$Y$48.07$KG$20240710$$HP$US$US
233954023$23395402$3$F$$20240729$20240112$20240806$EXP$$GB-ROCHE-3490072$ROCHE$$$$E$F$Y$$$20240806$$CN$GB$GB
233954713$23395471$3$F$$20240723$20240112$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000003$Unknown Manufacturer$$$$$$Y$$$20240805$$CN$US$US
233955106$23395510$6$F$20170316$20240828$20240112$20240905$EXP$$GB-RDY-SPO/UKI/23/0187889$DR REDDYS$$36$YR$A$M$Y$$$20240905$$CN$GB$GB
233955492$23395549$2$F$20231101$20240705$20240112$20240726$EXP$$DE-ROCHE-2884841$ROCHE$$22$YR$A$F$Y$52$KG$20240726$$MD$DE$DE
233956202$23395620$2$F$20231106$20240826$20240112$20240830$EXP$FR-AFSSAPS-AM2023001182$FR-ROCHE-3488626$ROCHE$$83$YR$E$M$Y$73$KG$20240830$$MD$FR$FR
233956213$23395621$3$F$20230602$20240820$20240112$20240902$EXP$$US-CIPLA LTD.-2024US00076$CIPLA$$$$$$Y$$$20240902$$CN$US$US
233956532$23395653$2$F$$20240918$20240112$20240927$EXP$$US-SANDOZ INC.-SDZ2024US001241$SANDOZ$$$$$M$Y$107.48$KG$20240927$$CN$US$US
233956622$23395662$2$F$20231221$20240701$20240112$20240710$EXP$IT-MINISAL02-963407$IT-RECORDATI-2024000016$RECORDATI$$$$$$Y$$$20240710$$PH$IT$IT
233956883$23395688$3$F$20240101$20240712$20240112$20240722$PER$$US-SA-2024SA008924$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240720$$MD$US$US
233957123$23395712$3$F$$20240717$20240112$20240725$PER$$US-SA-2024SA012698$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240725$$MD$US$US
233957162$23395716$2$F$20240801$20240905$20240112$20240913$30DAY$$US-GSK-US2024000586$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240913$$CN$US$US
233957425$23395742$5$F$20201101$20240911$20240112$20240919$EXP$$CA-ROCHE-2686622$ROCHE$$3$YR$C$M$Y$35$KG$20240919$$CN$CA$CA
233957702$23395770$2$F$$20240828$20240112$20240920$PER$$US-SA-2024SA008764$SANOFI AVENTIS$$52$YR$A$F$Y$78.01$KG$20240920$$MD$US$US
233958504$23395850$4$F$$20240906$20240112$20240912$EXP$$US-GILEAD-2024-0658177$GILEAD$$77$YR$E$M$Y$$$20240912$$MD$US$US
233958762$23395876$2$F$20231101$20240705$20240112$20240709$PER$$NVSC2024US007055$NOVARTIS$$48$YR$$M$Y$$$20240709$$HP$US$US
233959302$23395930$2$F$$20240829$20240112$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000013$DECIPHERA PHARMACEUTICALS$$57$YR$A$M$Y$47.5$KG$20240905$$CN$US$US
233959492$23395949$2$F$20231201$20240816$20240112$20240828$PER$$US-SA-2024SA014022$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240828$$MD$US$US
233959592$23395959$2$F$$20240809$20240112$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-001037$AUROBINDO$Espino PH, Burneo JG, Moscol G, Gofton T, MacDougall K, Marti AS.. Long-term outcomes after NORSE: treatment with vagus nerve stimulation.. EPILEPSIA OPEN. 2022;7:822-8$33$YR$$M$Y$$$20240820$$HP$CA$CA
233959734$23395973$4$F$$20240627$20240112$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005266$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240709$$CN$US$US
233960043$23396004$3$F$20240101$20240830$20240112$20240913$PER$$US-SA-2024SA012557$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240913$$MD$US$US
233960382$23396038$2$F$$20240711$20240112$20240715$PER$$NVSC2024US007104$NOVARTIS$$$$$M$Y$$$20240715$$HP$US$US
233960632$23396063$2$F$$20240109$20240112$20240925$PER$$US-GSK-US2024AMR004770$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
233961704$23396170$4$F$20230801$20240709$20240112$20240718$30DAY$$US-GSK-US2024003225$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240718$$CN$US$US
233961772$23396177$2$F$20231201$20240621$20240112$20240705$PER$$US-SA-2024SA009798$SANOFI AVENTIS$$22$YR$A$F$Y$63.492$KG$20240705$$MD$US$US
233961948$23396194$8$F$20220101$20240916$20240112$20240926$EXP$$US-INSMED-2022-00925-USAA$INSMED$$$$$F$Y$50$KG$20240926$$HP$US$US
233962532$23396253$2$F$20230828$20240705$20240112$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-426907$RANBAXY$$51$YR$$M$Y$108$KG$20240719$$MD$FR$FR
233963293$23396329$3$F$$20240625$20240112$20240702$PER$$US-AMGEN-USASP2024004497$AMGEN$$70$YR$E$M$Y$84.354$KG$20240702$$MD$US$US
233963618$23396361$8$F$20230101$20240918$20240112$20240927$EXP$$CA-CELLTRION INC.-2023CA004476$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
233964655$23396465$5$F$20231201$20240918$20240112$20240930$EXP$$NVSC2024US003418$NOVARTIS$$63$YR$$F$Y$93.25$KG$20240930$$CN$US$US
233965525$23396552$5$F$20240108$20240730$20240112$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006462$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$81.01$KG$20240801$$CN$US$US
233965924$23396592$4$F$$20240722$20240112$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005605$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240726$$HP$US$US
233965964$23396596$4$F$$20240823$20240112$20240827$EXP$$NVSC2024US006460$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
233966074$23396607$4$F$20240120$20240627$20240112$20240709$PER$$US-SA-2024SA007684$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240709$$HP$US$US
233966792$23396679$2$F$20230101$20240924$20240112$20240927$PER$$US-SA-2024SA012474$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240927$$MD$US$US
233967067$23396706$7$F$20231108$20240829$20240112$20240902$EXP$$US-JNJFOC-20231131997$JOHNSON AND JOHNSON$$46$YR$A$M$Y$96.4$KG$20240902$$HP$US$US
233968042$23396804$2$F$$20240827$20240112$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA003381$SANDOZ$$53$YR$$F$Y$$$20240830$$HP$CA$CA
233968313$23396831$3$F$20231201$20240711$20240112$20240718$EXP$$US-SA-2024SA013715$SANOFI AVENTIS$$53$YR$A$M$Y$172$KG$20240718$$MD$US$US
233969112$23396911$2$F$$20240912$20240112$20240926$PER$$US-SA-2024SA010401$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240926$$MD$US$US
233969732$23396973$2$F$20231106$20240823$20240112$20240903$EXP$FR-AFSSAPS-AM2023001182$FR-BAXTER-2024BAX010245$BAXTER$$83$YR$$M$Y$73$KG$20240903$$MD$FR$FR
233969973$23396997$3$F$20230101$20240731$20240112$20240802$PER$$US-DSJP-DSU-2024-100876$DAIICHI$$$$$F$Y$$$20240802$$CN$US$US
233970762$23397076$2$F$20220101$20240730$20240112$20240801$EXP$$US-PFIZER INC-202400005800$PFIZER$Gummin, D.. 2022 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023;61 (10):717-939$23$YR$$F$Y$$$20240801$$MD$US$US
233971524$23397152$4$F$$20240710$20240112$20240720$EXP$$CO-SANDOZ INC.-NVSC2021CO206539$SANDOZ$$$$$F$Y$69$KG$20240720$$CN$CO$CO
233972353$23397235$3$F$20230101$20240918$20240112$20240927$PER$$US-SA-2024SA008497$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240927$$MD$US$US
233972502$23397250$2$F$$20240820$20240112$20240829$EXP$FR-AFSSAPS-PA2023002508$FR-ELI_LILLY_AND_COMPANY-FR202401001551$ELI LILLY AND CO$$28$YR$A$M$Y$70$KG$20240829$$CN$FR$FR
233972605$23397260$5$F$20231101$20240729$20240112$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000010$Unknown Manufacturer$$$$$$Y$$$20240805$$CN$US$US
233973102$23397310$2$F$$20240708$20240112$20240713$30DAY$$US-ABBVIE-5580427$ABBVIE$$$$$$Y$$$20240713$$HP$US$US
233973142$23397314$2$F$20231101$20240916$20240112$20240923$PER$$US-SA-2024SA006598$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240923$$MD$US$US
233973323$23397332$3$F$$20240828$20240112$20240906$30DAY$$US-GSK-US2024000650$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$HP$US$US
233973632$23397363$2$F$$20240710$20240112$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006439$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240712$$CN$US$US
233974132$23397413$2$F$$20240704$20240112$20240709$EXP$$CA-PFIZER INC-202400009294$PFIZER$$37$YR$$F$Y$$$20240709$$HP$CA$CA
233975442$23397544$2$F$$20240730$20240112$20240802$PER$$US-PFIZER INC-PV202400001998$PFIZER$$$$$M$Y$$$20240802$$CN$US$US
233976802$23397680$2$F$$20240708$20240112$20240710$PER$$US-PFIZER INC-202400002611$PFIZER$$88$YR$$F$Y$$$20240710$$HP$US$US
2339779511$23397795$11$F$20231230$20240914$20240112$20240919$EXP$$IN-PFIZER INC-PV202400001584$PFIZER$$48$YR$$M$Y$$$20240919$$CN$IN$IN
233978006$23397800$6$F$20231227$20240716$20240112$20240717$EXP$$US-TAKEDA-2024TUS003364$TAKEDA$$53$YR$$M$Y$73$KG$20240717$$MD$US$US
233978033$23397803$3$F$20240601$20240820$20240112$20240826$EXP$$CA-SANDOZ INC.-NVSC2022CA069687$SANDOZ$$32$YR$$M$Y$$$20240826$$CN$CA$CA
233978832$23397883$2$F$$20240709$20240112$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005227$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240712$$CN$US$US
233979793$23397979$3$F$20240701$20240821$20240112$20240822$EXP$$US-PFIZER INC-PV202400003570$PFIZER$$75$YR$$M$Y$$$20240822$$CN$US$US
233980412$23398041$2$F$$20240911$20240112$20240919$EXP$$US-RDY-SPO/USA/24/0000441$DR REDDYS$$44$YR$A$M$Y$$$20240919$$MD$US$US
233980452$23398045$2$F$20230901$20240724$20240112$20240726$EXP$$US-PFIZER INC-202300122328$PFIZER$$69$YR$$F$Y$68.95$KG$20240726$$CN$US$US
233981535$23398153$5$F$20240621$20240731$20240112$20240805$EXP$$US-Taiho Oncology Inc-2024-000230$TAIHO ONCOLOGY INC$$56$YR$A$M$Y$68.86$KG$20240805$$CN$US$US
233982394$23398239$4$F$$20240819$20240112$20240821$EXP$$US-PFIZER INC-202400009657$PFIZER$$83$YR$$F$Y$$$20240821$$CN$US$US
233982866$23398286$6$F$$20240806$20240112$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006375$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$86.18$KG$20240813$$CN$US$US
233982892$23398289$2$F$20231201$20240807$20240112$20240816$PER$$US-SA-2024SA009506$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240816$$MD$US$US
233983372$23398337$2$F$$20240430$20240112$20240704$PER$$US-TAKEDA-2024TUS003562$TAKEDA$$$$$$Y$$$20240704$$CN$US$US
233984066$23398406$6$F$20230101$20240712$20240112$20240722$EXP$$US-VERTEX PHARMACEUTICALS-2024-000376$VERTEX$$$$A$F$Y$$$20240722$$CN$US$US
233984204$23398420$4$F$$20240916$20240112$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005165$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240923$$CN$US$US
233984243$23398424$3$F$20240107$20240814$20240112$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006450$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240816$$CN$US$US
233985012$23398501$2$F$$20240716$20240112$20240826$PER$$US-GALDERMA-US2023019591$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
233985193$23398519$3$F$$20240726$20240112$20240802$PER$$US-ALXN-202401USA000418US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
233985217$23398521$7$F$20230821$20240904$20240112$20240909$EXP$$NVSC2023CH262056$NOVARTIS$$$$E$F$Y$$$20240909$$MD$CH$CH
233986516$23398651$6$F$$20240712$20240112$20240718$EXP$$DE-MYLANLABS-2024M1002845$MYLAN$$20$YR$$$Y$$$20240718$$CN$DE$DE
233987713$23398771$3$F$20240605$20240819$20240112$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006620$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240828$$CN$US$US
233988095$23398809$5$F$$20240808$20240112$20240811$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005276$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$73.03$KG$20240812$$CN$US$US
233988252$23398825$2$F$20230618$20240903$20240112$20240906$EXP$$JP-Eisai-EC-2023-145336$EISAI$$74$YR$E$F$Y$66$KG$20240906$$MD$JP$JP
233988365$23398836$5$F$20231201$20240723$20240112$20240904$PER$$US-LUNDBECK-DKLU3071462$LUNDBECK$$$$$$Y$$$20240904$$CN$US$US
233988537$23398853$7$F$20231020$20240814$20240112$20240822$EXP$$US-Calliditas-2024CAL00029$CALLIDITAS THERAPEUTICS$$75$YR$E$M$Y$$$20240822$$CN$US$US
2339887314$23398873$14$F$20240101$20240910$20240112$20240912$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-101260$DAIICHI$$14$YR$$F$Y$$$20240912$$CN$US$US
233989213$23398921$3$F$$20240906$20240112$20240913$EXP$$US-GILEAD-2024-0658230$GILEAD$$50$YR$A$F$Y$$$20240913$$MD$US$US
233989244$23398924$4$F$$20240906$20240112$20240912$EXP$$US-GILEAD-2024-0658261$GILEAD$$84$YR$E$M$Y$$$20240912$$MD$US$US
233989253$23398925$3$F$$20240906$20240112$20240912$EXP$$US-GILEAD-2024-0658262$GILEAD$$46$YR$A$M$Y$$$20240912$$MD$US$US
233989343$23398934$3$F$$20240906$20240112$20240912$EXP$$US-GILEAD-2024-0658254$GILEAD$$61$YR$A$F$Y$$$20240912$$MD$US$US
233989543$23398954$3$F$$20240906$20240112$20240913$EXP$$US-GILEAD-2024-0658252$GILEAD$$64$YR$A$M$Y$$$20240913$$MD$US$US
233989559$23398955$9$F$$20240808$20240112$20240815$EXP$$US-GILEAD-2024-0658129$GILEAD$$68$YR$E$M$Y$89$KG$20240815$$MD$US$US
233990074$23399007$4$F$20221020$20240815$20240112$20240816$EXP$$JP-ABBVIE-5583769$ABBVIE$$75$YR$$M$Y$53$KG$20240816$$MD$JP$JP
233990815$23399081$5$F$$20240916$20240113$20240925$EXP$$GR-CELLTRION INC.-2023GR022712$CELLTRION$Tsekoura M, Varvara E, Zotou S, Mpelai Ch, Kapsalis I, Mitroudi M, et al.. Case of Leclercia Adecarboxylata Infection in A Paediatric Patient with Juvenile Idiopathic Arthritis. 15th Panhellenic Congress of the Hellenic Society of Infection Control. 2023$$$$$Y$$$20240925$$MD$GR$GR
233991063$23399106$3$F$$20240724$20240113$20240730$EXP$$US-ABBVIE-5583666$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
233992172$23399217$2$F$$20240708$20240113$20240715$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-013660$JAZZ$$$$$F$Y$$$20240715$$CN$US$US
233992696$23399269$6$F$20220101$20240715$20240113$20240723$EXP$$CA-CELLTRION INC.-2022CA021309$CELLTRION$$$$$$Y$$$20240723$$HP$CA$CA
233993272$23399327$2$F$$20240904$20240113$20240914$EXP$$FR-KOANAAP-SML-FR-2024-00024$SHILPA MEDICARE$Franchi V, Labussiere-Wallet H, Chouik Y, M H, M L. LAM UBTF-TD complicated by post-allogeneic MVO treated with liver transplantation. Correspondence in Onco-Hematology. nXVIII(6): 349-351.$25$YR$A$M$Y$$$20240914$$HP$FR$FR
233993853$23399385$3$F$20240110$20240903$20240113$20240907$PER$$US-AMGEN-USASP2024006887$AMGEN$$67$YR$E$F$Y$$$20240907$$CN$US$US
233993952$23399395$2$F$20240102$20240923$20240113$20240925$EXP$$CO-SA-2024SA011679$SANOFI AVENTIS$$20$YR$A$F$Y$52$KG$20240925$$PH$CO$CO
233994162$23399416$2$F$$20240811$20240113$20240822$PER$$US-AMGEN-USASP2024005935$AMGEN$Wilding H.; Aastha A.; De Macedo Filho L. M. et al.. INVESTIGATING MULTI-AGENT INTRATHECAL CHEMOTHERAPY AS A TREATMENT FOR PRIMARY AND SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA: SAFETY AND EFFICACY RESULTS FROM AN INSTITUTIONAL COHORT STUDY. Neuro-Oncology. 2023;25:v165$$$$$Y$$$20240822$$HP$US$US
233994307$23399430$7$F$20231221$20240911$20240113$20240919$EXP$$CA-CELLTRION INC.-2023CA025379$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
233995092$23399509$2$F$$20240711$20240113$20240722$EXP$CA-MHPD-E2B_001065588$CA-Accord-400236$ACCORD$$53$YR$A$M$Y$$$20240722$$HP$CA$CA
233995182$23399518$2$F$20220419$20240725$20240113$20240802$EXP$$CA-CELLTRION INC.-2021CA018432$CELLTRION$$$$$$Y$$$20240802$$MD$CA$CA
233995775$23399577$5$F$20240708$20240913$20240113$20240921$EXP$$CA-CELLTRION INC.-2023CA012052$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
233995872$23399587$2$F$20231101$20240731$20240113$20240807$EXP$$AU-AMGEN-AUSSP2024007128$AMGEN$$61$YR$A$F$Y$$$20240807$$MD$AU$AU
233996342$23399634$2$F$20240106$20240902$20240113$20240904$PER$$US-AMGEN-USASP2024004798$AMGEN$$83$YR$E$F$Y$$$20240903$$CN$US$US
2339967012$23399670$12$F$20230101$20240813$20240113$20240828$EXP$$US-UCBSA-2023058624$UCB$$$$$F$Y$$$20240828$$CN$US$US
233997225$23399722$5$F$20231023$20240827$20240114$20240903$EXP$$CA-JNJFOC-20231059006$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240903$$CN$CA$CA
233997783$23399778$3$F$$20240910$20240114$20240917$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP000389$STRIDES$Ushijima F, Hase T, Yamashita Y, Kim H, Shimokata T, Kondo C, et al.. Durvalumab plus carboplatin-etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature review.. Int-Canc-Conf-J. 2023;13(2):88-92$67$YR$$M$Y$$$20240917$$HP$JP$JP
233998032$23399803$2$F$$20240913$20240114$20240925$EXP$$ES-AUROBINDO-AUR-APL-2024-001040$AUROBINDO$Laiseca Garcia J, Moreno Mata E, Garcia Rodriguez C, Gonzalez Munoz M, Barrios Albajar M et al. Drug-induced enterocolitis syndrome with acetaminophen in an adult: a call for diagnostic tools and accurate management... J Investig Allergol Clin Immunol.. 2024;34(4):1-5$45$YR$$M$Y$$$20240925$$HP$ES$ES
233998114$23399811$4$F$$20240801$20240114$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-001228$AUROBINDO$$82$YR$$F$Y$83$KG$20240814$$HP$CA$CA
233999043$23399904$3$F$20231201$20240630$20240114$20240709$PER$$US-SA-2024SA008993$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240709$$MD$US$US
233999472$23399947$2$F$20230518$20240731$20240114$20240808$EXP$$AU-AMGEN-AUSSP2024006055$AMGEN$$60$YR$A$M$Y$$$20240807$$MD$AU$AU
234000222$23400022$2$F$$20240620$20240114$20240703$PER$$US-SA-2024SA007913$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240703$$MD$US$US
234000393$23400039$3$F$20231101$20240725$20240114$20240802$PER$$US-SA-2024SA008917$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240802$$MD$US$US
234000886$23400088$6$F$20240103$20240130$20240114$20240807$EXP$$NVSC2024IL003879$NOVARTIS$$66$YR$$F$Y$$$20240807$$HP$IL$IL
234001662$23400166$2$F$$20240813$20240114$20240820$EXP$$US-ABBVIE-5583647$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
234002262$23400226$2$F$20231128$20240616$20240114$20240711$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000024$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240711$$CN$US$US
234002503$23400250$3$F$20220720$20240626$20240114$20240701$EXP$$CA-TAKEDA-2022TUS059713$TAKEDA$$41$YR$$M$Y$$$20240701$$MD$CA$CA
234002783$23400278$3$F$$20240709$20240114$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006202$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240710$$CN$US$US
234003544$23400354$4$F$20230612$20240712$20240115$20240722$EXP$$CA-CELLTRION INC.-2023CA025377$CELLTRION$$$$$$Y$$$20240722$$CN$CA$CA
234004233$23400423$3$F$20221122$20240819$20240115$20240821$EXP$$DE-ROCHE-3229872$ROCHE$$31$YR$A$F$Y$$$20240821$$CN$DE$DE
234004445$23400444$5$F$20231216$20240618$20240115$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005919$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240712$$CN$US$US
234004577$23400457$7$F$20230101$20240721$20240115$20240729$EXP$$CA-CELLTRION INC.-2023CA015131$CELLTRION$$$$$$Y$$$20240729$$HP$CA$CA
234005434$23400543$4$F$$20240607$20240115$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000044$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
234005454$23400545$4$F$20240601$20240702$20240115$20240710$EXP$$BR-CELLTRION INC.-2023BR020556$CELLTRION$$$$$$Y$$$20240710$$CN$BR$BR
234005745$23400574$5$F$20210924$20240628$20240115$20240703$EXP$$CA-TAKEDA-2022TUS032674$TAKEDA$$35$YR$$M$Y$$$20240703$$CN$CA$CA
234006183$23400618$3$F$$20240625$20240115$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005960$ACADIA PHARMACEUTICALS$$$$$F$Y$65.76$KG$20240716$$CN$US$US
234006875$23400687$5$F$$20240829$20240115$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-001229$AUROBINDO$$76$YR$$M$Y$$$20240909$$HP$CA$CA
234007112$23400711$2$F$20240109$20240807$20240115$20240808$PER$$US-AMGEN-USASP2024006612$AMGEN$$64$YR$A$M$Y$$$20240808$$CN$US$US
234007582$23400758$2$F$$20240814$20240115$20240817$EXP$$US-TAKEDA-2024TUS002663$TAKEDA$$$$$M$Y$$$20240817$$CN$US$US
234007642$23400764$2$F$20231106$20240821$20240115$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-000982$AUROBINDO$$83$YR$$M$Y$73$KG$20240831$$MD$FR$FR
234007725$23400772$5$F$20231201$20240723$20240115$20240731$EXP$$CA-CELLTRION INC.-2024CA000721$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
234008095$23400809$5$F$20231201$20240709$20240115$20240711$EXP$$US-TAKEDA-2024TUS003476$TAKEDA$$31$YR$$F$Y$$$20240711$$CN$US$US
234008552$23400855$2$F$$20240906$20240115$20240916$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2023-28499$IPSEN$S T, UNKNOWN. A case of PRRT for pancreatic NET with conversion to functional insulinoma (in Japanese). The Journal of Japan Pancreas Society. 2024;39(3): A388(20)-A388(24).$$$A$M$Y$$$20240916$$MD$JP$JP
234008666$23400866$6$F$$20240617$20240115$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-005973$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
234008714$23400871$4$F$20180420$20240911$20240115$20240917$EXP$$CA-SANDOZ INC.-PHHY2018CA074367$SANDOZ$$69$YR$$M$Y$$$20240917$$CN$CA$CA
234008948$23400894$8$F$$20240719$20240115$20240728$EXP$$GB-AMGEN-GBRSP2024006475$AMGEN$$73$YR$E$F$Y$$$20240728$$CN$GB$GB
234009705$23400970$5$F$$20240910$20240115$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-005809$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240912$$CN$US$US
234009984$23400998$4$F$20240224$20240628$20240115$20240703$EXP$$CA-TAKEDA-2023TUS124366$TAKEDA$$19$YR$$M$Y$$$20240703$$HP$CA$CA
234010202$23401020$2$F$20231208$20240718$20240115$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006899$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$117.93$KG$20240722$$HP$US$US
234010624$23401062$4$F$20230622$20240703$20240115$20240708$EXP$$CA-TAKEDA-2023TUS061483$TAKEDA$$10$YR$$F$Y$$$20240708$$CN$CA$CA
234012713$23401271$3$F$20231001$20240805$20240115$20240808$EXP$$NVSC2023FI245531$NOVARTIS$$46$YR$$M$Y$$$20240808$$MD$FI$FI
234013672$23401367$2$F$$20240913$20240115$20240918$EXP$$US-ABBVIE-5584733$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
234013716$23401371$6$F$20230602$20240723$20240115$20240724$EXP$$ES-SANDOZ INC.-SDZ2023ES063080$SANDOZ$$64$YR$$M$Y$64$KG$20240724$$MD$ES$ES
234013745$23401374$5$F$$20240723$20240115$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006520$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240801$$CN$US$US
234014472$23401447$2$F$20231201$20240701$20240115$20240708$EXP$$US-SA-2024SA014626$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240708$$MD$US$US
234014514$23401451$4$F$$20240821$20240115$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-00176$LUPIN$$$$$$Y$$$20240909$$CN$US$US
234015333$23401533$3$F$20211118$20240826$20240115$20240829$PER$$US-PFIZER INC-PV202300066874$PFIZER$$70$YR$$F$Y$65.76$KG$20240829$$MD$US$US
234015822$23401582$2$F$$20230906$20240115$20240705$EXP$$TW-GILEAD-2024-0658294$GILEAD$$47$YR$A$F$Y$$$20240705$$CN$TW$TW
234016195$23401619$5$F$20231230$20240815$20240115$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006979$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240822$$CN$US$US
234016342$23401634$2$F$20230131$20240708$20240115$20240712$EXP$$CA-SANDOZ INC.-NVSC2019CA082688$SANDOZ$$$$A$M$Y$$$20240712$$CN$CA$CA
234016353$23401635$3$F$$20240102$20240115$20240710$PER$$BE-ROCHE-3484663$ROCHE$$$$$$Y$$$20240628$$HP$BE$BE
234016533$23401653$3$F$20230609$20240711$20240115$20240717$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2023092787$VIIV$$$$$$Y$$$20240717$$PH$CA$CA
234018433$23401843$3$F$$20240822$20240115$20240830$EXP$$HN-AstraZeneca-2024A009727$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$HN$
234018545$23401854$5$F$20160926$20240712$20240115$20240717$EXP$$CA-SANDOZ INC.-PHHY2016CA136786$SANDOZ$$72$YR$$F$Y$$$20240717$$CN$CA$CA
234019214$23401921$4$F$20230530$20240626$20240115$20240703$EXP$$CN-TAKEDA-2024TUS002274$TAKEDA$$31$YR$$M$Y$66$KG$20240703$$MD$CN$CN
234019224$23401922$4$F$20210101$20240709$20240115$20240711$EXP$DE-MLMSERVICE-20240105-4759782-1$DE-SA-2024SA014971$SANOFI AVENTIS$$74$YR$E$$Y$$$20240711$$MD$DE$DE
234019235$23401923$5$F$20240121$20240228$20240115$20240925$EXP$$US-GSK-US2024AMR005438$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
234019306$23401930$6$F$20220901$20240906$20240115$20240911$EXP$$US-TAKEDA-2022TUS069883$TAKEDA$$15$YR$$M$Y$37$KG$20240911$$HP$US$US
234019433$23401943$3$F$$20240924$20240115$20240926$EXP$$CA-SANDOZ INC.-NVSC2019CA100304$SANDOZ$$53$YR$$F$Y$$$20240926$$HP$CA$CA
234019472$23401947$2$F$$20240624$20240115$20240703$PER$$US-SA-2024SA010792$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240703$$MD$US$US
234019553$23401955$3$F$20230101$20240917$20240115$20240920$EXP$$US-SA-2024SA014609$SANOFI AVENTIS$$53$YR$A$F$Y$79.38$KG$20240920$$MD$US$US
234019833$23401983$3$F$$20240717$20240115$20240725$PER$$US-SA-2024SA012294$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240725$$MD$US$US
234019884$23401988$4$F$20240101$20240708$20240115$20240717$PER$$US-SA-2024SA014606$SANOFI AVENTIS$$19$YR$A$M$Y$79$KG$20240717$$MD$US$US
234019905$23401990$5$F$20240101$20240813$20240115$20240819$EXP$$US-SA-2024SA014875$SANOFI AVENTIS$$14$YR$T$F$Y$55$KG$20240819$$CN$US$US
234020152$23402015$2$F$$20240731$20240115$20240808$PER$$US-SA-2024SA014788$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240808$$MD$US$US
234021282$23402128$2$F$$20240820$20240115$20240826$EXP$$JP-009507513-2401JPN000773J$MERCK$$71$YR$$M$Y$$$20240826$$MD$JP$JP
234021603$23402160$3$F$20240108$20240627$20240115$20240703$EXP$$CA-OTSUKA-2024_000790$OTSUKA$$35$YR$$M$Y$$$20240703$$CN$CA$CA
234021913$23402191$3$F$$20240820$20240115$20240903$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI00019$NEUROCRINE BIOSCIENCES$$63$YR$$F$Y$$$20240904$$CN$US$US
234022153$23402215$3$F$$20240913$20240115$20240918$PER$$US-PFIZER INC-PV202400004935$PFIZER$$74$YR$$$Y$$$20240918$$CN$US$US
234022243$23402224$3$F$$20240708$20240115$20240710$PER$$US-PFIZER INC-PV202300018493$PFIZER$$69$YR$$F$Y$$$20240710$$CN$US$US
234022492$23402249$2$F$20240101$20240821$20240115$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007390$BRISTOL MYERS SQUIBB$$30$YR$A$M$Y$$$20240823$$HP$US$US
234022603$23402260$3$F$20220114$20240724$20240115$20240729$EXP$$US-AstraZeneca-2024A008209$ASTRAZENECA$$25561$DY$$F$Y$134.7$KG$20240729$$HP$US$
234023092$23402309$2$F$$20240717$20240115$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA002933$SANDOZ$$$$$M$Y$$$20240722$$HP$CA$CA
234023362$23402336$2$F$$20240711$20240115$20240716$EXP$$US-ABBVIE-5584723$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
234023414$23402341$4$F$$20240903$20240115$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007343$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240904$$HP$US$US
234023465$23402346$5$F$20240123$20240715$20240115$20240723$EXP$$CA-TAKEDA-2023TUS076911$TAKEDA$$74$YR$$M$Y$$$20240723$$MD$CA$CA
234023616$23402361$6$F$20231215$20240806$20240115$20240810$EXP$$JP-ABBVIE-5588091$ABBVIE$$70$YR$$F$Y$$$20240810$$PH$JP$JP
234024567$23402456$7$F$$20240815$20240115$20240821$EXP$$CA-JNJFOC-20240124503$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240821$$CN$CA$CA
234024604$23402460$4$F$$20240816$20240115$20240830$EXP$$JP-ROCHE-3488903$ROCHE$Shibuya R, Baba K, Furuta R, Maesaka H, Hirosawa H, Bando T, Oshima A, Onoda H, Nukui T, Dougu N, Joho S and Nakatsuji Y. A Case of Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab: A Case Report, DOI: 10.2169/internalmedicine.1801-23. Internal medicine (Tokyo, Japan) 2024 Jan 02;:-.$83$YR$E$M$Y$$$20240830$$HP$JP$JP
234024882$23402488$2$F$$20240708$20240115$20240716$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2024-015598$REGENERON$$$$$F$Y$$$20240716$$CN$GB$GB
234024902$23402490$2$F$20240110$20240722$20240115$20240725$PER$$US-AMGEN-USASP2024006680$AMGEN$$84$YR$E$F$Y$$$20240725$$CN$US$US
234025456$23402545$6$F$20230830$20240806$20240115$20240808$EXP$$NVSC2024CN007907$NOVARTIS$$58$YR$$M$Y$$$20240808$$MD$CN$CN
234025664$23402566$4$F$20211013$20240830$20240115$20240902$EXP$$NVSC2022RU078844$NOVARTIS$$72$YR$$F$Y$70$KG$20240902$$MD$RU$RU
234025973$23402597$3$F$20231201$20240702$20240115$20240704$EXP$$CA-JNJFOC-20240120307$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240704$$HP$CA$CA
234026596$23402659$6$F$20230101$20240808$20240115$20240909$EXP$$US-BAUSCH-BL-2023-014403$BAUSCH AND LOMB$$79$YR$$M$Y$76.726$KG$20240909$$MD$US$US
234027065$23402706$5$F$20231223$20240708$20240115$20240716$EXP$$DE-ROCHE-3489206$ROCHE$$57$YR$A$F$Y$89$KG$20240716$$MD$DE$DE
234027102$23402710$2$F$20231214$20240716$20240115$20240717$EXP$$CN-PFIZER INC-PV202400003984$PFIZER$$53$YR$$F$Y$54$KG$20240717$$HP$CN$CN
234027142$23402714$2$F$20240110$20240710$20240115$20240712$EXP$$US-PFIZER INC-202400009392$PFIZER$$57$YR$$F$Y$86.18$KG$20240712$$CN$US$US
234027182$23402718$2$F$$20240816$20240115$20240819$EXP$$CN-PFIZER INC-202400009572$PFIZER$$59$YR$$M$Y$$$20240819$$MD$CN$CN
234027382$23402738$2$F$20231106$20240823$20240115$20240829$EXP$FR-AFSSAPS-AM2023001182$FR-PFIZER INC-202400006797$PFIZER$$83$YR$$M$Y$73$KG$20240829$$MD$FR$FR
234027622$23402762$2$F$20200101$20240621$20240115$20240701$EXP$$CZ-TAKEDA-2024TUS003797$TAKEDA$$$$$M$Y$$$20240701$$MD$CZ$CZ
234027653$23402765$3$F$20240110$20240712$20240115$20240717$EXP$$CA-TAKEDA-2022TUS042088$TAKEDA$$62$YR$$M$Y$$$20240717$$MD$CA$CA
234028229$23402822$9$F$20230101$20240801$20240115$20240807$EXP$$CA-CELLTRION INC.-2022CA004513$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
234029204$23402920$4$F$20240106$20240916$20240115$20240924$EXP$$CA-CELLTRION INC.-2024CA000703$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
234029443$23402944$3$F$20240901$20240914$20240115$20240922$EXP$$GB-BIOGEN-2024BI01244964$BIOGEN$$58$YR$$F$Y$$$20240922$$CN$GB$GB
234029537$23402953$7$F$20231020$20240815$20240115$20240823$EXP$$CA-CELLTRION INC.-2023CA018055$CELLTRION$$$$$$Y$$$20240823$$MD$CA$CA
234029762$23402976$2$F$$20240708$20240115$20240711$EXP$$US-BIOGEN-2024BI01245073$BIOGEN$$$$$M$Y$$$20240711$$CN$US$US
234029902$23402990$2$F$$20240731$20240115$20240802$EXP$$US-TAKEDA-2024TUS004167$TAKEDA$$$$$F$Y$$$20240802$$CN$US$US
2340299811$23402998$11$F$20231201$20240911$20240115$20240919$EXP$$CA-CELLTRION INC.-2023CA025441$CELLTRION$$$$$$Y$$$20240919$$CN$CA$CA
234030533$23403053$3$F$$20240118$20240115$20240926$PER$$US-GSK-US2024AMR005305$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
234031163$23403116$3$F$20230810$20240726$20240116$20240731$EXP$$CA-TAKEDA-2023TUS084053$TAKEDA$$67$YR$$F$Y$61.3$KG$20240731$$HP$CA$CA
234031173$23403117$3$F$$20240726$20240116$20240805$PER$$US-SA-2024SA011616$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240804$$MD$US$US
234031233$23403123$3$F$$20240710$20240116$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-128543$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240717$$PH$JP$JP
234031384$23403138$4$F$20231222$20240827$20240116$20240917$PER$$CA-TOLMAR, INC.-23CA045692$TOLMAR$$90$YR$$M$Y$$$20240917$$CN$CA$CA
234031454$23403145$4$F$20231222$20240830$20240116$20240923$PER$$CA-TOLMAR, INC.-23CA045736$TOLMAR$$77$YR$$M$Y$$$20240923$$CN$CA$CA
234031612$23403161$2$F$20230104$20240708$20240116$20240716$EXP$$US-SA-2024SA012551$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240716$$MD$US$US
234031683$23403168$3$F$20240729$20240730$20240116$20240808$PER$$US-SA-2024SA014798$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240808$$CN$US$US
234033022$23403302$2$F$$20240813$20240116$20240814$PER$$US-AMGEN-USASP2024007684$AMGEN$$68$YR$E$M$Y$$$20240814$$PH$US$US
234033133$23403313$3$F$$20240126$20240116$20240701$PER$$US-UCBSA-2024000978$UCB$$$$$M$Y$$$20240701$$CN$US$US
234033423$23403342$3$F$$20240712$20240116$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007358$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240718$$CN$US$US
234034344$23403434$4$F$20220904$20240910$20240116$20240913$EXP$$US-TAKEDA-2022TUS028015$TAKEDA$$45$YR$$F$Y$99.773$KG$20240913$$HP$US$US
234035144$23403514$4$F$20231228$20240308$20240116$20240925$PER$$US-GSK-US2024AMR004951$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
234035593$23403559$3$F$20231211$20240820$20240116$20240822$PER$$US-AMGEN-USASP2024007745$AMGEN$$61$YR$A$M$Y$$$20240822$$CN$US$US
234036317$23403631$7$F$20230101$20240717$20240116$20240723$EXP$$US-009507513-2401USA005087$MERCK$$$$$F$Y$$$20240723$$CN$US$US
234036552$23403655$2$F$20240111$20240717$20240116$20240719$PER$$US-AMGEN-USASP2024007976$AMGEN$$70$YR$E$F$Y$$$20240719$$CN$US$US
234036663$23403666$3$F$$20240712$20240116$20240715$PER$$US-ALXN-202401USA000672US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
234037012$23403701$2$F$20201101$20240627$20240116$20240709$EXP$$CZ-Accord-400741$ACCORD$Zitko T. Upadacitinib in a patient with TNF inhibitor-induced sarcoidosis. FARMAKOTERAPIE. 2023;19(6):780, 782.$51$YR$A$F$Y$$$20240709$$MD$CZ$CZ
234037132$23403713$2$F$20231101$20240724$20240116$20240802$PER$$US-009507513-2401USA000427$MERCK$$72$YR$$M$Y$$$20240802$$CN$US$US
234037203$23403720$3$F$$20240731$20240116$20240805$EXP$$CA-TAKEDA-2021TUS020192$TAKEDA$$$$$F$Y$$$20240805$$CN$CA$CA
234037464$23403746$4$F$20231123$20240723$20240116$20240726$EXP$$CA-JNJFOC-20231227480$JOHNSON AND JOHNSON$$65$YR$E$F$Y$80$KG$20240726$$HP$CA$CA
234037594$23403759$4$F$$20240828$20240116$20240902$EXP$$CA-TAKEDA-2024TUS003474$TAKEDA$$15$WK$$M$Y$$$20240902$$HP$CA$CA
234037723$23403772$3$F$20231103$20240909$20240116$20240917$EXP$$KR-TAKEDA-2024TUS003638$TAKEDA$$63$YR$$M$Y$51$KG$20240917$$MD$KR$KR
234038102$23403810$2$F$$20240812$20240116$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-001117$AUROBINDO$$81$YR$$M$Y$$$20240822$$HP$CA$CA
234038672$23403867$2$F$$20240813$20240116$20240827$EXP$$CA-AUROBINDO-AUR-APL-2023-029530$AUROBINDO$Stogios N, Hahn MK, Lunsky Y, Desarkar P, Agarwal SM. Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities. Journal of psychiatry + neuroscience. 2023;48(2):E99-101$28$YR$$F$Y$$$20240827$$MD$CA$CA
234039343$23403934$3$F$$20240617$20240116$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005996$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
234039358$23403935$8$F$20240101$20240808$20240116$20240816$EXP$$CA-CELLTRION INC.-2024CA000903$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
234039495$23403949$5$F$$20240913$20240116$20240917$EXP$$US-GILEAD-2024-0657830$GILEAD$$$$T$F$Y$$$20240917$$CN$US$US
234039716$23403971$6$F$20240105$20240722$20240116$20240926$EXP$$US-GSK-US2024AMR004226$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
234040002$23404000$2$F$20220518$20240712$20240116$20240722$PER$$US-SA-2024SA012788$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240722$$MD$US$US
234040244$23404024$4$F$20221201$20240821$20240116$20240919$PER$$US-SA-2024SA012379$SANOFI AVENTIS$$82$YR$E$F$Y$53.64$KG$20240919$$CN$US$US
234040735$23404073$5$F$$20240626$20240116$20240702$30DAY$$US-GSK-US2024004448$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
234040864$23404086$4$F$20240101$20240821$20240116$20240905$PER$$US-SA-2024SA012515$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240905$$MD$US$US
234041002$23404100$2$F$20210101$20240704$20240116$20240710$EXP$DE-GERMAN-LIT/DEU/24/0000576$DE-RDY-LIT/DEU/24/0000576$DR REDDYS$Juarso AE, Entz S, Weissinger F. Durable response from fibroblast growth factor receptor inhibition in intrahepatic cholangiocarcinoma terminated by metachronous acute myeloid leukemia: a case report. Journal of Medical Case Reports. 2023 Dec 15;17(1):550$69$YR$E$M$Y$$$20240710$$HP$DE$DE
234041202$23404120$2$F$$20240710$20240116$20240717$EXP$$CA-ROCHE-3492086$ROCHE$$$$E$M$Y$$$20240717$$CN$CA$CA
234041337$23404133$7$F$20230719$20240906$20240116$20240920$EXP$$CA-CELLTRION INC.-2023CA015887$CELLTRION$$$$$$Y$$$20240920$$MD$CA$CA
234041404$23404140$4$F$$20240708$20240116$20240730$EXP$$HU-ASTELLAS-2023US035387$ASTELLAS$$26$YR$$$Y$49$KG$20240730$$CN$CH$HU
234041492$23404149$2$F$20230323$20231123$20240116$20240719$EXP$IT-MINISAL02-953826$IT-TEVA-VS-3134876$TEVA$$66$YR$$M$Y$$$20240719$$MD$IT$IT
234041803$23404180$3$F$20190822$20240920$20240116$20240924$EXP$$US-TAKEDA-US201927907$TAKEDA$$35$YR$$F$Y$$$20240924$$MD$US$US
234041993$23404199$3$F$20231001$20240809$20240116$20240823$EXP$$GB-UCBSA-2024001862$UCB$$59$YR$$F$Y$$$20240823$$CN$GB$GB
234042162$23404216$2$F$$20240903$20240116$20240916$EXP$$CA-BAXTER-2024BAX010662$BAXTER$$$$$F$Y$95$KG$20240916$$HP$CA$CA
234042562$23404256$2$F$$20240827$20240116$20240904$EXP$$CA-AUROBINDO-AUR-APL-2024-001224$AUROBINDO$$42$YR$$M$Y$$$20240904$$CN$CA$CA
234043763$23404376$3$F$$20240813$20240116$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007812$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240814$$CN$US$US
234043822$23404382$2$F$20240110$20240630$20240116$20240702$PER$$US-AMGEN-USASP2024007066$AMGEN$$73$YR$E$F$Y$$$20240702$$HP$US$US
234044013$23404401$3$F$20230324$20240501$20240116$20240923$EXP$$NVSC2023CA071892$NOVARTIS$$65$YR$$F$Y$$$20240923$$CN$CA$CA
234044183$23404418$3$F$$20240814$20240116$20240824$EXP$$US-GSK-US2024AMR006187$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
234044332$23404433$2$F$20240111$20240916$20240116$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202401008064$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240917$$CN$US$US
234044452$23404445$2$F$20231204$20240830$20240116$20240913$PER$$US-SA-2024SA011850$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240913$$MD$US$US
234044483$23404448$3$F$$20240813$20240116$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-001638$AUROBINDO$Reed P, Beauchesne M, Couillard S, Lachapelle P, Larivee P. A3081/P751 A rare case of  congenital defects in the newborn of a patient with uncontrolled asthma on dual  malizumab-dupilumab biological therapy.. AM J RESPIR CRIT CARE MED. 2023;207(1):A3081$$$$F$Y$$$20240826$$HP$CA$CA
234044582$23404458$2$F$20240101$20240626$20240116$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006388$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240702$$CN$US$US
234045242$23404524$2$F$20240104$20240826$20240116$20240831$PER$$US-RDY-SPO/USA/24/0000506$DR REDDYS$$20$YR$A$F$Y$$$20240831$$MD$US$US
234045343$23404534$3$F$$20240625$20240116$20240701$EXP$$IT-JNJFOC-20240116389$JOHNSON AND JOHNSON$$51$YR$A$F$Y$116$KG$20240701$$MD$IT$IT
234046514$23404651$4$F$20240123$20240822$20240116$20240828$EXP$$CA-TAKEDA-2024TUS003831$TAKEDA$$68$YR$$M$Y$$$20240828$$CN$CA$CA
234046822$23404682$2$F$$20240705$20240116$20240717$PER$$US-SA-2024SA016500$SANOFI AVENTIS$$$$C$M$Y$$$20240717$$MD$US$US
234047208$23404720$8$F$20230101$20240819$20240116$20240829$EXP$$US-INSMED, INC.-2023-03247-US$INSMED$$$$$F$Y$$$20240829$$HP$US$US
234047292$23404729$2$F$20240108$20240813$20240116$20240819$EXP$$US-AMGEN-USASP2024005836$AMGEN$$58$YR$A$F$Y$$$20240819$$CN$US$US
234047366$23404736$6$F$20231123$20240726$20240116$20240809$EXP$$US-INSMED, INC.-2023-04671-US$INSMED$$88$YR$$M$Y$$$20240809$$CN$US$US
234047764$23404776$4$F$20231201$20240827$20240116$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-000736$UNITED THERAPEUTICS$$78$YR$$M$Y$88.889$KG$20240906$$$US$US
234048094$23404809$4$F$$20240820$20240116$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007324$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240828$$CN$US$US
234048153$23404815$3$F$20231201$20240821$20240116$20240909$PER$$US-SA-2024SA015383$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240909$$MD$US$US
234048563$23404856$3$F$$20240816$20240116$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007038$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240826$$HP$US$US
234049887$23404988$7$F$$20240816$20240116$20240823$EXP$$CA-TAKEDA-2023TUS073916$TAKEDA$$$$$F$Y$$$20240823$$CN$CA$CA
234050114$23405011$4$F$$20240826$20240116$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006272$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240904$$CN$US$US
234050293$23405029$3$F$20230901$20240829$20240116$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007435$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240902$$CN$US$US
234050302$23405030$2$F$20230701$20240814$20240116$20240822$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-246790$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240822$$CN$US$US
234050432$23405043$2$F$20231224$20240723$20240116$20240724$EXP$$IN-ROCHE-3492543$ROCHE$$65$YR$E$M$Y$$$20240724$$CN$IN$IN
234051314$23405131$4$F$$20240320$20240116$20240807$EXP$$DK-BEH-2024167410$CSL BEHRING$$15$YR$T$M$Y$$$20240807$$HP$DK$DK
234051544$23405154$4$F$20231106$20240826$20240116$20240828$EXP$FR-AFSSAPS-AM2023001182$FR-SANDOZ INC.-SDZ2024FR003427$SANDOZ$$83$YR$$M$Y$73$KG$20240828$$MD$FR$FR
234051584$23405158$4$F$20170817$20240904$20240116$20240912$EXP$$CA-SANDOZ INC.-PHHY2017CA171486$SANDOZ$$52$YR$$M$Y$$$20240912$$CN$CA$CA
234051687$23405168$7$F$$20240621$20240116$20240730$EXP$$NVSC2023IN278495$NOVARTIS$$$$$F$Y$$$20240730$$CN$IN$IN
234051716$23405171$6$F$20240101$20240830$20240116$20240913$EXP$$CA-UCBSA-2024001856$UCB$$$$$M$Y$$$20240913$$CN$CA$CA
234052273$23405227$3$F$$20240807$20240116$20240830$PER$$CA-TOLMAR, INC.-23CA045743$TOLMAR$$$$$M$Y$$$20240830$$CN$CA$CA
234052293$23405229$3$F$20230901$20240806$20240116$20240827$PER$$CA-TOLMAR, INC.-23CA045744$TOLMAR$$68$YR$$M$Y$$$20240827$$CN$CA$CA
234052492$23405249$2$F$20230101$20240826$20240116$20240902$PER$$US-SA-2024SA014956$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240902$$MD$US$US
234052594$23405259$4$F$20231225$20240711$20240116$20240718$EXP$$NVSC2024BR007951$NOVARTIS$$68$YR$$F$Y$$$20240718$$HP$BR$BR
234052602$23405260$2$F$$20240712$20240116$20240717$EXP$$NVSC2023GB024192$NOVARTIS$$$$A$M$Y$$$20240717$$CN$GB$GB
234052803$23405280$3$F$$20240320$20240116$20240722$EXP$$DK-BEH-2024167411$CSL BEHRING$$81$YR$E$M$Y$$$20240722$$HP$DK$DK
234053242$23405324$2$F$20240102$20240716$20240116$20240724$PER$$CA-IGSA-BIG0027126$GRIFOLS$$74$YR$$M$Y$105$KG$20240724$$HP$CA$CA
234053403$23405340$3$F$$20240320$20240116$20240722$EXP$$DK-BEH-2024167412$CSL BEHRING$$67$YR$E$F$Y$$$20240722$$HP$DK$DK
234054054$23405405$4$F$$20240320$20240116$20240703$EXP$$DK-BEH-2024167413$CSL BEHRING$$50$YR$A$F$Y$$$20240703$$HP$DK$DK
234054462$23405446$2$F$$20240702$20240116$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007562$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240705$$HP$US$US
234054822$23405482$2$F$20231106$20240826$20240116$20240829$EXP$FR-AFSSAPS-AM2023001182$FR-FreseniusKabi-FK202400604$FRESENIUS KABI$$83$YR$E$M$Y$73$KG$20240829$$MD$FR$FR
234054882$23405488$2$F$20231106$20240626$20240116$20240704$EXP$$US-SANDOZ INC.-SDZ2024US003308$SANDOZ$$63$YR$$F$Y$50.7$KG$20240704$$MD$US$US
234055078$23405507$8$F$$20240925$20240116$20240930$EXP$$US-SANDOZ INC.-NVSC2022US244978$SANDOZ$$$$$F$Y$78.912$KG$20240930$$PH$US$US
234055283$23405528$3$F$$20240827$20240116$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-185084$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240829$$CN$US$US
234055292$23405529$2$F$$20240711$20240116$20240721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007414$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240722$$CN$US$US
234055392$23405539$2$F$$20240828$20240116$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202401008082$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240902$$CN$US$US
234055752$23405575$2$F$$20230824$20240116$20240813$PER$$US-SPECGX-T202301780$SPECGX$$$$$M$Y$$$20240813$$CN$US$US
234056244$23405624$4$F$20231201$20240731$20240116$20240806$EXP$$CA-PFIZER INC-202400011355$PFIZER$$77$YR$$M$Y$$$20240806$$CN$CA$CA
234056323$23405632$3$F$20231201$20240729$20240116$20240801$EXP$$CA-PFIZER INC-202400010181$PFIZER$$79$YR$$M$Y$$$20240801$$CN$CA$CA
234056882$23405688$2$F$$20240819$20240116$20240820$EXP$$CN-PFIZER INC-PV202400003908$PFIZER$Yang, L.. Clinical features of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with macrophage activation syndrome. Clinical and experimental rheumatology. 2023;10.55563/clinexprheumatol/2537$59$YR$$F$Y$$$20240820$$MD$CN$CN
234056902$23405690$2$F$$20240819$20240116$20240820$EXP$$CN-PFIZER INC-PV202400003292$PFIZER$Yang, L.. Clinical features of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with macrophage activation syndrome. Clinical and experimental rheumatology. 2023;10.55563/clinexprheumatol/2537$57$YR$$M$Y$$$20240820$$MD$CN$CN
234057124$23405712$4$F$20231201$20240813$20240116$20240826$PER$$US-SA-2024SA011043$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240826$$MD$US$US
234057593$23405759$3$F$20231222$20240624$20240116$20240701$EXP$$CA-JNJFOC-20240131028$JOHNSON AND JOHNSON$$87$YR$E$F$Y$66.284$KG$20240701$$HP$CA$CA
234057864$23405786$4$F$$20240620$20240116$20240701$EXP$$GB-AMGEN-GBRSP2024006389$AMGEN$$74$YR$E$F$Y$$$20240701$$CN$GB$GB
234057874$23405787$4$F$20231125$20240801$20240116$20240812$EXP$$CA-TAKEDA-2024TUS003260$TAKEDA$$78$YR$$F$Y$57$KG$20240812$$HP$CA$CA
234058003$23405800$3$F$20240101$20240919$20240116$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA003113$SANDOZ$$$$$F$Y$$$20240923$$CN$CA$CA
234058052$23405805$2$F$20231219$20240816$20240116$20240828$PER$$US-SA-2024SA011218$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240828$$MD$US$US
234058137$23405813$7$F$$20240731$20240116$20240806$30DAY$$US-PFIZER INC-202300456121$PFIZER$$13$YR$$M$Y$$$20240806$$CN$US$US
234058264$23405826$4$F$20230101$20240805$20240116$20240807$EXP$$CA-UCBSA-2024002009$UCB$$$$$F$Y$$$20240807$$CN$CA$CA
234059483$23405948$3$F$$20240705$20240116$20240708$PER$$NVSC2024US009312$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
234060267$23406026$7$F$20240112$20240620$20240116$20240724$PER$$US-AMGEN-USASP2024008459$AMGEN$$54$YR$A$M$Y$$$20240724$$MD$US$US
234061242$23406124$2$F$$20240716$20240116$20240719$EXP$$DE-SANDOZ INC.-SDZ2024DE004077$SANDOZ$$51$YR$$M$Y$$$20240719$$CN$DE$DE
234061307$23406130$7$F$20240115$20240815$20240116$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-188535$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240823$$CN$US$US
234061392$23406139$2$F$$20240709$20240116$20240715$PER$$US-PFIZER INC-PV202400005392$PFIZER$$27$YR$$M$Y$$$20240715$$CN$US$US
234061432$23406143$2$F$$20240807$20240116$20240814$PER$$US-PFIZER INC-PV202300201196$PFIZER$$54$YR$$F$Y$$$20240814$$HP$US$US
234062707$23406270$7$F$$20240718$20240116$20240722$PER$$US-PFIZER INC-202400010077$PFIZER$$67$YR$$F$Y$$$20240722$$CN$US$US
234063213$23406321$3$F$20231005$20240702$20240116$20240712$PER$$US-PFIZER INC-PV202400005417$PFIZER$$26$YR$$M$Y$$$20240712$$HP$US$US
234063512$23406351$2$F$20240105$20240708$20240116$20240717$PER$$US-BAYER-2024A002793$BAYER$$34$YR$A$M$Y$$$20240717$$CN$US$US
234064002$23406400$2$F$$20240723$20240116$20240725$PER$$NVSC2024US009415$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
234064394$23406439$4$F$$20240709$20240116$20240711$EXP$$US-TAKEDA-2023TUS119080$TAKEDA$$$$$M$Y$91$KG$20240711$$HP$US$US
234064523$23406452$3$F$20240112$20240209$20240116$20240720$EXP$$AU-ABBVIE-5590760$ABBVIE$$49$YR$$F$Y$43$KG$20240720$$HP$AU$AU
234064542$23406454$2$F$20230101$20240829$20240116$20240904$EXP$$US-ABBVIE-5587615$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
234064922$23406492$2$F$20230101$20240801$20240116$20240809$PER$$US-SA-2024SA012889$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240809$$MD$US$US
234065072$23406507$2$F$20230101$20240823$20240116$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007269$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240827$$CN$US$US
234067755$23406775$5$F$$20240919$20240116$20240924$PER$$US-VERTEX PHARMACEUTICALS-2023-006813$VERTEX$$32$YR$$$Y$$$20240924$$CN$US$US
234067852$23406785$2$F$$20240917$20240116$20240923$PER$$US-VERTEX PHARMACEUTICALS-2024-000646$VERTEX$$29$YR$$F$Y$$$20240923$$CN$US$US
234068825$23406882$5$F$20230101$20240822$20240116$20240828$EXP$$US-INCYTE CORPORATION-2024IN000106$INCYTE$$$$$$Y$$$20240828$$CN$US$US
234069522$23406952$2$F$20231001$20240813$20240116$20240823$PER$$US-JNJFOC-20231276574$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240823$$CN$US$US
234070453$23407045$3$F$$20240906$20240116$20240911$EXP$$US-GILEAD-2022-0587287$GILEAD$$64$YR$A$M$Y$$$20240911$$MD$US$US
234070563$23407056$3$F$$20240906$20240116$20240912$EXP$$US-GILEAD-2022-0595040$GILEAD$$58$YR$A$M$Y$$$20240912$$MD$US$US
234071582$23407158$2$F$20230101$20240806$20240116$20240808$EXP$$US-ABBVIE-5582416$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
234071702$23407170$2$F$$20240722$20240116$20240725$PER$$US-AMGEN-USASP2024009084$AMGEN$$$$A$F$Y$$$20240724$$HP$US$US
234071962$23407196$2$F$20240108$20240627$20240116$20240703$PER$$US-AMGEN-USASP2024007776$AMGEN$$32$YR$A$M$Y$$$20240703$$CN$US$US
234072206$23407220$6$F$20230101$20240620$20240116$20240703$EXP$$CA-BEH-2024167301$CSL BEHRING$$56$YR$A$F$Y$81.6$KG$20240703$$CN$CA$CA
234072222$23407222$2$F$20230101$20240920$20240116$20240926$EXP$$TN-ABBVIE-5589931$ABBVIE$$51$YR$$F$Y$$$20240926$$CN$TN$TN
234072302$23407230$2$F$20240714$20240723$20240116$20240801$PER$$US-SA-2024SA011773$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240801$$MD$US$US
234072512$23407251$2$F$20200425$20240102$20240116$20240715$PER$$US-NOVOPROD-1133422$NOVO NORDISK$$69$YR$$M$Y$$$20240715$$MD$US$US
234072612$23407261$2$F$$20240103$20240116$20240715$PER$$US-NOVOPROD-1141516$NOVO NORDISK$$72$YR$$F$Y$$$20240715$$CN$US$US
2340734311$23407343$11$F$20240101$20240918$20240116$20240926$EXP$$CA-JNJFOC-20240119591$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240926$$CN$CA$CA
234073454$23407345$4$F$20231001$20240829$20240116$20240926$PER$$CA-TOLMAR, INC.-23CA045739$TOLMAR$$70$YR$$M$Y$$$20240926$$CN$CA$CA
234073513$23407351$3$F$20231222$20240801$20240116$20240826$PER$$CA-TOLMAR, INC.-23CA045746$TOLMAR$$75$YR$$M$Y$$$20240826$$CN$CA$CA
234073615$23407361$5$F$$20240716$20240116$20240720$EXP$$BR-JNJFOC-20240132426$JOHNSON AND JOHNSON$$55$YR$A$F$Y$78$KG$20240719$$CN$BR$BR
234073704$23407370$4$F$20221013$20240918$20240116$20240918$EXP$$JP-ABBVIE-5589878$ABBVIE$$72$YR$$M$Y$67$KG$20240918$$MD$JP$JP
234074025$23407402$5$F$20230101$20240904$20240117$20240924$PER$$CA-TOLMAR, INC.-23CA045516$TOLMAR$$$$$M$Y$$$20240924$$MD$CA$CA
234074117$23407411$7$F$$20240911$20240117$20240919$PER$$CA-TOLMAR, INC.-23CA045651$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
234074134$23407413$4$F$20230101$20240827$20240117$20240904$PER$$CA-TOLMAR, INC.-23CA045661$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
234074176$23407417$6$F$20231124$20240825$20240117$20240902$EXP$$CA-CELLTRION INC.-2024CA000880$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
234074862$23407486$2$F$$20240904$20240117$20240906$EXP$$US-TAKEDA-2020TUS005778$TAKEDA$$$$$M$Y$$$20240906$$MD$US$US
234074905$23407490$5$F$$20240806$20240117$20240812$PER$$US-SA-2024SA015407$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240812$$HP$US$US
234075002$23407500$2$F$$20240820$20240117$20240825$EXP$CA-DRL-USA-SPO/CAN/24/0000547$CA-RDY-SPO/CAN/24/0000547$DR REDDYS$$69$YR$E$F$Y$$$20240825$$HP$CA$CA
234075093$23407509$3$F$20230715$20240729$20240117$20240731$EXP$$CA-ROCHE-3393354$ROCHE$$43$YR$A$F$Y$$$20240731$$CN$CA$CA
234075305$23407530$5$F$20240111$20240222$20240117$20240806$PER$$US-AstraZeneca-2024A010658$ASTRAZENECA$$69$YR$$F$Y$$$20240806$$CN$US$
234075612$23407561$2$F$$20240911$20240117$20240921$EXP$$CA-ROCHE-3489748$ROCHE$$43$YR$A$F$Y$129$KG$20240921$$CN$CA$CA
234076082$23407608$2$F$20240109$20240920$20240117$20240922$PER$$US-AMGEN-USASP2024008614$AMGEN$$78$YR$E$F$Y$$$20240922$$CN$US$US
234076432$23407643$2$F$20231201$20240718$20240117$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-008274$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240719$$HP$US$US
234076817$23407681$7$F$$20240628$20240117$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-006021$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
234076897$23407689$7$F$20231221$20240614$20240117$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-006022$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240709$$CN$US$US
234076984$23407698$4$F$$20240822$20240117$20240829$EXP$$CA-ROCHE-3488601$ROCHE$$$$A$F$Y$$$20240829$$CN$CA$CA
234077032$23407703$2$F$$20240718$20240117$20240720$PER$$NVSC2024US009486$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
234077195$23407719$5$F$$20240612$20240117$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-006019$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
234077272$23407727$2$F$20240111$20240919$20240117$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202401008156$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240920$$CN$US$US
234077672$23407767$2$F$$20240711$20240117$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006437$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240718$$CN$US$US
234077867$23407786$7$F$20231201$20240920$20240117$20240927$EXP$$US-BEH-2024167461$CSL BEHRING$$36$YR$A$F$Y$$$20240927$$CN$US$US
234078025$23407802$5$F$$20240702$20240117$20240704$EXP$$US-TAKEDA-US201721682$TAKEDA$$$$$F$Y$70$KG$20240704$$HP$US$US
234078113$23407811$3$F$20231229$20240827$20240117$20240909$PER$$US-SA-2024SA016471$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240909$$MD$US$US
234078254$23407825$4$F$20240101$20240812$20240117$20240820$PER$$US-SA-2024SA014789$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240820$$MD$US$US
234078328$23407832$8$F$20240401$20240914$20240117$20240924$EXP$$US-BEH-2024167465$CSL BEHRING$$55$YR$A$F$Y$$$20240924$$HP$US$US
234078952$23407895$2$F$20240101$20240806$20240117$20240814$EXP$$US-RECORDATI RARE DISEASE INC.-2024000204$RECORDATI$$$$$$Y$$$20240814$$CN$US$US
234078992$23407899$2$F$20230822$20240910$20240117$20240916$EXP$$US-ABBVIE-5588177$ABBVIE$$24$YR$$M$Y$$$20240916$$CN$US$US
2340790211$23407902$11$F$20240101$20240718$20240117$20240724$EXP$$PT-ABBVIE-5588845$ABBVIE$$79$YR$$M$Y$$$20240724$$CN$PT$PT
234079293$23407929$3$F$$20240617$20240117$20240711$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004786$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
2340796410$23407964$10$F$20230101$20240731$20240117$20240807$EXP$$CA-CELLTRION INC.-2024CA000996$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
234080152$23408015$2$F$20231106$20240827$20240117$20240909$EXP$FR-AFSSAPS-AM2023001182$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-102397$ZYDUS PHARM$$$$$$Y$$$20240909$$MD$FR$FR
234080363$23408036$3$F$20240111$20240627$20240117$20240701$PER$$US-AMGEN-USASP2024007833$AMGEN$$66$YR$E$M$Y$$$20240701$$CN$US$US
234080968$23408096$8$F$20240112$20240712$20240117$20240801$EXP$$US-SA-2024SA016423$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240719$$MD$US$US
234081023$23408102$3$F$20240801$20240801$20240117$20240806$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-016830$REGENERON$$$$$F$Y$$$20240806$$CN$CA$CA
234081073$23408107$3$F$$20240829$20240117$20240903$PER$$US-ALXN-A202308000$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
234081084$23408108$4$F$20240101$20240712$20240117$20240723$EXP$$US-BEH-2024167470$CSL BEHRING$$25$YR$A$M$Y$$$20240723$$CN$US$US
234081162$23408116$2$F$20231209$20240909$20240117$20240917$EXP$$JP-GENMAB-2023-02390AA$GENMAB$$72$YR$$F$Y$40$KG$20240917$$MD$JP$JP
234081195$23408119$5$F$20240714$20240716$20240117$20240725$EXP$$CA-CELLTRION INC.-2024CA000942$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
234081222$23408122$2$F$20230201$20240702$20240117$20240708$EXP$$US-ABBVIE-5587785$ABBVIE$$66$YR$$F$Y$$$20240708$$CN$US$US
234081495$23408149$5$F$20230722$20240823$20240117$20240906$EXP$$JP-AMGEN-JPNNI2024008378$AMGEN$Shirai K, Ichikawa D, Yoshitome A, Takayama S, Han W, Kiyomi O. A study of avacopan combination therapy in ANCA-associated vasculitis. The 67th Annual Meeting of the Japanese Society of Nephrology. 2024;66(4):606.$83$YR$E$F$Y$44.7$KG$20240905$$MD$JP$JP
234081876$23408187$6$F$20231101$20240830$20240117$20240904$EXP$$CA-JNJFOC-20231168322$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240904$$CN$CA$CA
234082186$23408218$6$F$20240601$20240903$20240117$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-008270$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240904$$CN$US$US
234083314$23408331$4$F$$20240828$20240117$20240902$EXP$$CA-JNJFOC-20240130918$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240902$$HP$CA$CA
234083672$23408367$2$F$20231101$20240625$20240117$20240702$EXP$$CA-CELLTRION INC.-2024CA000977$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
234084512$23408451$2$F$$20240112$20240117$20240730$EXP$$GB-CHATTEMPRD-2024OHG001348$CHATTEM$$$$$M$Y$$$20240730$$CN$GB$GB
234085443$23408544$3$F$20231225$20240710$20240117$20240711$EXP$$US-UCBSA-2024001854$UCB$$63$YR$$M$Y$175$KG$20240711$$CN$US$US
234085692$23408569$2$F$20230922$20240813$20240117$20240826$PER$$US-SA-2024SA014135$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240826$$MD$US$US
234085853$23408585$3$F$$20240802$20240117$20240813$PER$$US-SA-2024SA013844$SANOFI AVENTIS$$$$T$M$Y$66.6$KG$20240814$$MD$US$US
234085952$23408595$2$F$20231229$20240819$20240117$20240828$PER$$US-SA-2024SA014001$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240828$$MD$US$US
234085964$23408596$4$F$20220921$20240722$20240117$20240731$PER$$US-SA-2022SA398451$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240731$$MD$US$US
234086162$23408616$2$F$20240101$20240813$20240117$20240826$PER$$US-SA-2024SA016639$SANOFI AVENTIS$$50$YR$A$F$Y$72.57$KG$20240826$$MD$US$US
234086474$23408647$4$F$20230101$20240717$20240117$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202401008520$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240719$$HP$US$US
234086573$23408657$3$F$$20240729$20240117$20240807$PER$$US-SA-2024SA017664$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240807$$MD$US$US
234086883$23408688$3$F$20231228$20240628$20240117$20240703$EXP$$JP-DSJP-DSJ-2023-153997$DAIICHI$$$$$F$Y$$$20240703$$MD$JP$JP
234086982$23408698$2$F$$20240703$20240117$20240715$30DAY$$US-GSK-US2024003276$GLAXOSMITHKLINE$$$$$M$Y$$$20240715$$CN$US$US
234087786$23408778$6$F$20240101$20240919$20240117$20240928$EXP$$CA-CELLTRION INC.-2024CA000911$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
234088072$23408807$2$F$20231231$20240703$20240117$20240708$EXP$$US-SA-2024SA016676$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240708$$MD$US$US
234088296$23408829$6$F$20231215$20240912$20240117$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-007773$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$47.2$KG$20240920$$MD$JP$JP
234088623$23408862$3$F$$20240910$20240117$20240912$EXP$$NVSC2024CA009088$NOVARTIS$$36$YR$$M$Y$$$20240912$$HP$CA$CA
234088673$23408867$3$F$$20240910$20240117$20240912$EXP$$NVSC2024CA009108$NOVARTIS$$36$YR$$M$Y$$$20240912$$HP$CA$CA
234088877$23408887$7$F$20231001$20240917$20240117$20240926$EXP$$PT-ZAMBON SWITZERLAND LTD.-2024-ZAM-PT000003$PAREXEL$$$$$$Y$$$20240926$$CN$PT$PT
234089003$23408900$3$F$$20240813$20240117$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-001684$AUROBINDO$Reed P, Beauchesne M , Couillard S , Lachapelle P, Larivee P.. P751 A rare case of  congenital defects in the newborn of a patient with uncontrolled asthma on dual  omalizumab-dupilumab biological therapy.. AM J RESPIR CRIT CARE MED. 2023;207 (1)$35$YR$$F$Y$$$20240827$$HP$CA$CA
234089105$23408910$5$F$20240129$20240723$20240117$20240725$EXP$$CA-TAKEDA-2024TUS003892$TAKEDA$$70$YR$$M$Y$$$20240725$$CN$CA$CA
234089322$23408932$2$F$$20240710$20240117$20240715$EXP$$US-SA-2024SA016627$SANOFI AVENTIS$$$$E$F$Y$48.53$KG$20240715$$MD$US$US
234089913$23408991$3$F$$20240925$20240117$20240927$EXP$$NVSC2024US009511$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
234090353$23409035$3$F$20231009$20240909$20240117$20240910$EXP$$AU-MYLANLABS-2023M1107318$MYLAN$$19$YR$$F$Y$$$20240910$$HP$AU$AU
234091113$23409111$3$F$20171001$20240917$20240117$20240923$EXP$$CA-TAKEDA-2021TUS061735$TAKEDA$$61$YR$$F$Y$$$20240923$$HP$CA$CA
234091323$23409132$3$F$$20240219$20240117$20240801$EXP$$CA-SA-2024SA015379$SANOFI AVENTIS$$43$YR$A$F$Y$96$KG$20240801$$HP$CA$CA
234091714$23409171$4$F$20210101$20240207$20240117$20240807$EXP$$NVSC2024RO006442$NOVARTIS$$66$YR$$F$Y$$$20240807$$CN$RO$RO
234092414$23409241$4$F$$20240926$20240117$20240930$PER$$JP-PFIZER INC-PV202300206438$PFIZER$$$$$$Y$$$20240930$$CN$JP$JP
234092852$23409285$2$F$20231214$20240701$20240117$20240708$EXP$$GB-MYLANLABS-2023M1134982$MYLAN$$53$YR$$M$Y$$$20240708$$MD$GB$GB
234093022$23409302$2$F$$20240111$20240117$20240801$EXP$CA-SA-SAC20240115000204$CA-SA-2024SA015317$SANOFI AVENTIS$$43$YR$A$F$Y$97$KG$20240801$$HP$CA$CA
234093422$23409342$2$F$$20240805$20240117$20240809$EXP$$JP-PFIZER INC-PV202400004268$PFIZER$Sugita, Y.. A case of combined valvular disease due to methotrexate-associated lymphoproliferative disorder. The 13th Annual Meeting of the Japanese Society for Heart Valve Disease. 2023;13th:110$60$YR$$F$Y$40.3$KG$20240809$$HP$JP$JP
234093632$23409363$2$F$$20240807$20240117$20240813$EXP$$JP-PFIZER INC-202400011395$PFIZER$Tsujino, A.. A case of endocarditis infective resulting from Streptococcus dysgalactiae subsp. equisimilis (SDSE) bacteraemia with STSS. The 242nd Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2023;242nd$66$YR$$F$Y$75$KG$20240813$$HP$JP$JP
234093794$23409379$4$F$$20240816$20240117$20240822$EXP$$JP-JNJFOC-20240135276$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240822$$MD$JP$JP
2340938210$23409382$10$F$$20240704$20240117$20240712$EXP$$CA-ROCHE-3489689$ROCHE$$$$A$M$Y$$$20240712$$HP$CA$CA
234093834$23409383$4$F$20230811$20240906$20240117$20240916$EXP$$CA-ROCHE-3487669$ROCHE$$49$YR$A$F$Y$$$20240916$$CN$CA$CA
234094325$23409432$5$F$20230701$20240821$20240117$20240827$EXP$$CA-JNJFOC-20240131257$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240827$$HP$CA$CA
234094336$23409433$6$F$$20240628$20240117$20240703$EXP$$US-TAKEDA-2023TUS124108$TAKEDA$$$$$F$Y$$$20240703$$CN$US$US
234094573$23409457$3$F$20231120$20240827$20240117$20240903$EXP$$CA-OTSUKA-2023_030467$OTSUKA$$33$YR$$M$Y$$$20240903$$PH$CA$CA
234094624$23409462$4$F$20230101$20240719$20240117$20240731$PER$$US-SA-2024SA014618$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240731$$MD$US$US
234095622$23409562$2$F$$20240718$20240117$20240723$EXP$$GXKR2009ES05065$NOVARTIS$Vives S, Batlle M, Montane E, Ribera JM. Rhabdomyolysis and renal failure secondary to interaction between simvastatin, ciclosporin A and risperidone in an allogeneic stem cell transplantation patient. MEDICINA CLINICA. 2008;131(17):676$54$YR$$M$Y$$$20240723$$HP$ES$ES
234096345$23409634$5$F$20240518$20240628$20240117$20240702$30DAY$$US-PFIZER INC-202400010946$PFIZER$$61$YR$$F$Y$77.11$KG$20240702$$CN$US$US
234097002$23409700$2$F$20201009$20240828$20240117$20240902$EXP$$CA-SANDOZ INC.-NVSC2020CA275974$SANDOZ$$15$YR$$F$Y$$$20240902$$CN$CA$CA
234098034$23409803$4$F$$20240718$20240117$20240726$PER$$US-INCYTE CORPORATION-2024IN000185$INCYTE$$$$$$Y$$$20240726$$CN$US$US
234098093$23409809$3$F$$20240904$20240117$20240909$PER$$US-PFIZER INC-PV202300025971$PFIZER$$71$YR$$F$Y$$$20240909$$MD$US$US
234098105$23409810$5$F$$20240925$20240117$20240930$PER$$US-PFIZER INC-PV202400005610$PFIZER$$55$YR$$F$Y$$$20240930$$HP$US$US
234099182$23409918$2$F$$20240708$20240117$20240717$PER$$US-VERTEX PHARMACEUTICALS-2024-000336$VERTEX$$$$$$Y$$$20240717$$CN$US$US
234099345$23409934$5$F$$20240730$20240117$20240805$EXP$$NVSC2024IN006512$NOVARTIS$$$$$F$Y$$$20240805$$CN$IN$IN
234099545$23409954$5$F$20210126$20240920$20240117$20240925$EXP$$US-TAKEDA-2021TUS066729$TAKEDA$$19$YR$$F$Y$48.98$KG$20240925$$CN$US$US
234099703$23409970$3$F$20220801$20240826$20240117$20240904$EXP$$JP-009507513-2401JPN001141J$MERCK$$79$YR$$M$Y$$$20240904$$MD$JP$JP
234099785$23409978$5$F$20230112$20240902$20240117$20240909$EXP$$IN-GSK-IN2023APC005972$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$MD$IN$IN
234100252$23410025$2$F$20231001$20240718$20240117$20240724$EXP$$US-KYOWAKIRIN-2024KK000451$KYOWA$$$$$$Y$$$20240724$$PH$US$US
234100933$23410093$3$F$20240109$20240806$20240117$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202401008555$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240809$$CN$US$US
234101115$23410111$5$F$20230614$20240801$20240117$20240805$EXP$$JP-Eisai-EC-2023-142940$EISAI$$63$YR$A$F$Y$$$20240805$$MD$JP$JP
234102842$23410284$2$F$20230101$20240715$20240117$20240720$EXP$$GB-ABBVIE-5365169$ABBVIE$$59$YR$$M$Y$$$20240720$$CN$GB$GB
234102982$23410298$2$F$20240508$20240711$20240117$20240729$PER$$NI-TOLMAR, INC.-23NI045674$TOLMAR$$7$YR$$F$Y$$$20240729$$CN$NI$NI
234103124$23410312$4$F$20210101$20240415$20240117$20240906$EXP$$NVSC2020IN050739$NOVARTIS$$50$YR$$F$Y$$$20240906$$CN$IN$IN
234104302$23410430$2$F$$20240920$20240117$20240926$EXP$$CA-JNJFOC-20240129535$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$CA$CA
234104473$23410447$3$F$20240109$20240902$20240117$20240905$PER$$US-PFIZER INC-202400013405$PFIZER$$77$YR$$M$Y$77.11$KG$20240905$$CN$US$US
234104884$23410488$4$F$20240101$20240821$20240117$20240905$PER$$US-SA-2024SA014007$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240905$$MD$US$US
234105092$23410509$2$F$$20240712$20240117$20240718$PER$$US-JNJFOC-20240128960$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$HP$US$US
234105962$23410596$2$F$$20240722$20240117$20240726$EXP$$CA-JNJFOC-20240131342$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240726$$HP$CA$CA
234106173$23410617$3$F$20210101$20240912$20240117$20240924$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2022-000904$SK LIFE SCIENCE$$$$$$Y$$$20240924$$CN$US$US
234106732$23410673$2$F$20230101$20240708$20240117$20240715$EXP$$SA-GSK-SA2023EME070891$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$SA$SA
234107912$23410791$2$F$20231124$20240812$20240117$20240822$EXP$$CA-BAXTER-2023BAX039352$BAXTER$$$$$$Y$$$20240822$$CN$CA$CA
234108597$23410859$7$F$20240504$20240807$20240117$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-008685$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240809$$CN$US$US
234108983$23410898$3$F$$20240816$20240117$20240829$EXP$$ES-MYLANLABS-2024M1003378$MYLAN$Laiseca Garcia J, Moreno Mata E, Garcia Rodriguez C, Gonzalez Munoz M, Barrios Albajar M et al. Drug-induced enterocolitis syndrome with acetaminophen in an adult: a call for diagnostic tools and accurate management. J Investig Allergol Clin Immunol. 2024;34(4):1-5$45$YR$$M$Y$$$20240829$$HP$ES$ES
234109013$23410901$3$F$$20240819$20240117$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-008519$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240820$$HP$US$US
234109224$23410922$4$F$$20240626$20240117$20240703$EXP$$US-AstraZeneca-2024A012324$ASTRAZENECA$$67$YR$$F$Y$$$20240703$$CN$US$
234109533$23410953$3$F$$20240906$20240117$20240911$EXP$$US-GILEAD-2023-0621692$GILEAD$$31$YR$A$M$Y$$$20240911$$MD$US$US
234109934$23410993$4$F$20240315$20240709$20240117$20240717$EXP$$US-TAKEDA-2023TUS066194$TAKEDA$$84$YR$$F$Y$$$20240717$$CN$US$US
234111412$23411141$2$F$20231106$20240826$20240117$20240830$EXP$FR-AFSSAPS-AM2023001182$FR-MYLANLABS-2024M1003492$MYLAN$$83$YR$$M$Y$73$KG$20240830$$MD$FR$FR
234111543$23411154$3$F$$20240708$20240117$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-008321$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240710$$CN$US$US
234112732$23411273$2$F$20230101$20240807$20240117$20240815$PER$$US-ABBVIE-5588220$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
234113712$23411371$2$F$20240113$20240722$20240117$20240723$EXP$$IE-MYLANLABS-2024M1005467$MYLAN$$82$YR$$F$Y$$$20240723$$HP$IE$IE
234113862$23411386$2$F$$20240701$20240117$20240708$EXP$$TR-AMGEN-TURSP2024004709$AMGEN$Khanmammadov N.; Dogan I.; Okay N. S. et al.. Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer. Medicine. 2024;103 (1):1-7$$$$$Y$$$20240708$$MD$TR$TR
234114172$23411417$2$F$20230501$20240711$20240117$20240723$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2023-000573$SK LIFE SCIENCE$$$$$$Y$$$20240723$$CN$US$US
234114203$23411420$3$F$$20240702$20240117$20240709$EXP$$US-PFIZER INC-PV202400005835$PFIZER$$30$YR$$M$Y$$$20240709$$CN$US$US
234114505$23411450$5$F$20231214$20240712$20240117$20240716$EXP$$DE-MYLANLABS-2024M1004083$MYLAN$$5$YR$$M$Y$19.9$KG$20240716$$MD$DE$DE
234115482$23411548$2$F$20221031$20240627$20240117$20240703$EXP$$BR-ABBVIE-5585180$ABBVIE$$53$YR$$F$Y$67$KG$20240703$$CN$BR$BR
234115607$23411560$7$F$20240101$20240715$20240117$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-008557$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$66.68$KG$20240718$$CN$US$US
234116666$23411666$6$F$$20240918$20240117$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007461$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240924$$CN$US$US
234116975$23411697$5$F$20231023$20240715$20240117$20240718$EXP$$GB-MYLANLABS-2023M1114041$MYLAN$$67$YR$$M$Y$$$20240718$$MD$GB$GB
234117035$23411703$5$F$20231114$20240905$20240117$20240909$EXP$$AU-MYLANLABS-2023M1122731$MYLAN$$69$YR$$M$Y$$$20240909$$PH$AU$AU
234117494$23411749$4$F$$20240201$20240117$20240717$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-007694$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240717$$CN$ES$ES
234117663$23411766$3$F$20230101$20240801$20240117$20240806$EXP$$CO-ABBVIE-5591796$ABBVIE$$$$$F$Y$$$20240806$$CN$CO$CO
234119016$23411901$6$F$20230925$20240702$20240117$20240708$EXP$$GB-MYLANLABS-2023M1103129$MYLAN$$33$YR$$F$Y$$$20240708$$MD$GB$GB
234119394$23411939$4$F$20230101$20240920$20240117$20240927$EXP$$DE-009507513-2401DEU007092$MERCK$$69$YR$$F$Y$50$KG$20240927$$MD$DE$DE
234119642$23411964$2$F$$20230825$20240117$20240716$PER$$US-NOVOPROD-1112408$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234119683$23411968$3$F$20230831$20230901$20240117$20240716$PER$$US-NOVOPROD-1112521$NOVO NORDISK$$83$YR$$F$Y$$$20240717$$CN$US$US
234119722$23411972$2$F$$20230825$20240117$20240716$PER$$US-NOVOPROD-1112583$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
234119782$23411978$2$F$20230123$20230828$20240117$20240716$PER$$US-NOVOPROD-1112963$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234119802$23411980$2$F$$20240513$20240117$20240716$PER$$US-NOVOPROD-1112952$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234119942$23411994$2$F$$20230626$20240117$20240716$PER$$US-NOVOPROD-1067590$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234120062$23412006$2$F$$20230606$20240117$20240716$PER$$US-NOVOPROD-1079432$NOVO NORDISK$$$$A$F$Y$$$20240717$$PH$US$US
234120292$23412029$2$F$$20230608$20240117$20240716$PER$$US-NOVOPROD-1079561$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234120352$23412035$2$F$20221001$20230614$20240117$20240716$PER$$US-NOVOPROD-1079805$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234120402$23412040$2$F$20230605$20230614$20240117$20240716$PER$$US-NOVOPROD-1079662$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234120412$23412041$2$F$20230525$20240628$20240117$20240716$PER$$US-NOVOPROD-1080325$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
234120653$23412065$3$F$20230508$20230609$20240117$20240716$PER$$US-NOVOPROD-1080585$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
234120732$23412073$2$F$$20230613$20240117$20240716$PER$$US-NOVOPROD-1080983$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234120752$23412075$2$F$$20230609$20240117$20240716$PER$$US-NOVOPROD-1080687$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234120764$23412076$4$F$$20230601$20240117$20240716$PER$$US-NOVOPROD-1074385$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234120804$23412080$4$F$20240106$20240903$20240117$20240907$EXP$$JP-SHIONOGI INC.-2024000019$SHIONOGI$$$$$$Y$$$20240907$$MD$JP$JP
234120852$23412085$2$F$$20230607$20240117$20240716$PER$$US-NOVOPROD-1076607$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234121054$23412105$4$F$$20230603$20240117$20240716$PER$$US-NOVOPROD-1078134$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
234121082$23412108$2$F$20230511$20230602$20240117$20240716$PER$$US-NOVOPROD-1077684$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
234121132$23412113$2$F$$20230605$20240117$20240716$PER$$US-NOVOPROD-1077511$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234121182$23412118$2$F$20230512$20230612$20240117$20240716$PER$$US-NOVOPROD-1078061$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
234121372$23412137$2$F$20220301$20230619$20240117$20240716$PER$$US-NOVOPROD-1081614$NOVO NORDISK$$$$A$F$Y$152.8$KG$20240717$$CN$US$US
234121402$23412140$2$F$$20230608$20240117$20240716$PER$$US-NOVOPROD-1082585$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234121572$23412157$2$F$$20230612$20240117$20240716$PER$$US-NOVOPROD-1081853$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234121592$23412159$2$F$20230611$20230616$20240117$20240716$PER$$US-NOVOPROD-1082884$NOVO NORDISK$$67$YR$$F$Y$119.27$KG$20240717$$MD$US$US
234121723$23412172$3$F$$20230705$20240117$20240721$PER$$US-NOVOPROD-1083444$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234121744$23412174$4$F$$20230828$20240117$20240716$PER$$US-NOVOPROD-1083110$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234121762$23412176$2$F$$20230615$20240117$20240716$PER$$US-NOVOPROD-1083096$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234121782$23412178$2$F$20230613$20230619$20240117$20240716$PER$$US-NOVOPROD-1083307$NOVO NORDISK$$75$YR$$F$Y$175$KG$20240717$$CN$US$US
234122102$23412210$2$F$$20230619$20240117$20240716$PER$$US-NOVOPROD-1084026$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234122253$23412225$3$F$$20230620$20240117$20240716$PER$$US-NOVOPROD-1084582$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234122282$23412228$2$F$$20230620$20240117$20240716$PER$$US-NOVOPROD-1085010$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234122292$23412229$2$F$20230501$20230619$20240117$20240716$PER$$US-NOVOPROD-1084674$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234122332$23412233$2$F$$20230622$20240117$20240716$PER$$US-NOVOPROD-1084973$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234122432$23412243$2$F$20230614$20230620$20240117$20240716$PER$$US-NOVOPROD-1086077$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234122472$23412247$2$F$$20230621$20240117$20240716$PER$$US-NOVOPROD-1091136$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234122492$23412249$2$F$$20230629$20240117$20240716$PER$$US-NOVOPROD-1091263$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234122552$23412255$2$F$$20230601$20240117$20240716$PER$$US-NOVOPROD-1090920$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234122582$23412258$2$F$$20230622$20240117$20240716$PER$$US-NOVOPROD-1085957$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234122742$23412274$2$F$$20230711$20240117$20240716$PER$$US-NOVOPROD-1091450$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
234122792$23412279$2$F$$20230707$20240117$20240716$PER$$US-NOVOPROD-1092715$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234122932$23412293$2$F$20230224$20240528$20240117$20240716$PER$$US-NOVOPROD-1086760$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
234122993$23412299$3$F$20230620$20230627$20240117$20240716$PER$$US-NOVOPROD-1087070$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
234123134$23412313$4$F$20230601$20240109$20240117$20240716$PER$$US-NOVOPROD-1087659$NOVO NORDISK$$58$YR$$M$Y$$$20240717$$CN$US$US
234123152$23412315$2$F$20210101$20230620$20240117$20240716$PER$$US-NOVOPROD-1088128$NOVO NORDISK$$41$YR$$F$Y$$$20240717$$CN$US$US
234123182$23412318$2$F$20230620$20230621$20240117$20240716$PER$$US-NOVOPROD-1087541$NOVO NORDISK$$$$E$$Y$$$20240717$$CN$US$US
234123232$23412323$2$F$$20230626$20240117$20240716$PER$$US-NOVOPROD-1088282$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
234123242$23412324$2$F$$20230622$20240117$20240716$PER$$US-NOVOPROD-1088239$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234123282$23412328$2$F$$20230623$20240117$20240716$PER$$US-NOVOPROD-1089159$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234123292$23412329$2$F$$20230626$20240117$20240716$PER$$US-NOVOPROD-1088682$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$MD$US$US
234123302$23412330$2$F$$20240106$20240117$20240716$PER$$US-NOVOPROD-1088825$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234123322$23412332$2$F$$20230626$20240117$20240716$PER$$US-NOVOPROD-1089012$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234123472$23412347$2$F$20230623$20230623$20240117$20240716$PER$$US-NOVOPROD-1088679$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234123482$23412348$2$F$20230624$20230629$20240117$20240716$PER$$US-NOVOPROD-1088742$NOVO NORDISK$$80$YR$$M$Y$$$20240717$$CN$US$US
234123502$23412350$2$F$$20230811$20240117$20240716$PER$$US-NOVOPROD-1089271$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234123582$23412358$2$F$$20230627$20240117$20240716$PER$$US-NOVOPROD-1089804$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234123654$23412365$4$F$$20230731$20240117$20240716$PER$$US-NOVOPROD-1089995$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234123682$23412368$2$F$20230601$20230627$20240117$20240716$PER$$US-NOVOPROD-1089939$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234123922$23412392$2$F$$20230713$20240117$20240716$PER$$US-NOVOPROD-1093132$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234123932$23412393$2$F$20230710$20230711$20240117$20240716$PER$$US-NOVOPROD-1093113$NOVO NORDISK$$43$YR$$F$Y$$$20240717$$CN$US$US
234123962$23412396$2$F$$20230703$20240117$20240716$PER$$US-NOVOPROD-1090698$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234124212$23412421$2$F$$20240214$20240117$20240716$PER$$US-NOVOPROD-1093903$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234124333$23412433$3$F$$20230714$20240117$20240717$PER$$US-NOVOPROD-1094661$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234124402$23412440$2$F$$20230721$20240117$20240716$PER$$US-NOVOPROD-1094826$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234124532$23412453$2$F$$20230629$20240117$20240716$PER$$US-NOVOPROD-1095383$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234124652$23412465$2$F$$20230718$20240117$20240716$PER$$US-NOVOPROD-1095992$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234124662$23412466$2$F$20230627$20230707$20240117$20240716$PER$$US-NOVOPROD-1095387$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
234124712$23412471$2$F$$20230718$20240117$20240716$PER$$US-NOVOPROD-1095928$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234124802$23412480$2$F$$20230719$20240117$20240716$PER$$US-NOVOPROD-1097490$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234124832$23412483$2$F$$20230719$20240117$20240716$PER$$US-NOVOPROD-1096126$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234124872$23412487$2$F$$20230725$20240117$20240716$PER$$US-NOVOPROD-1097000$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
234124962$23412496$2$F$$20230718$20240117$20240716$PER$$US-NOVOPROD-1096269$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234125062$23412506$2$F$$20230712$20240117$20240716$PER$$US-NOVOPROD-1101267$NOVO NORDISK$$$$E$M$Y$$$20240717$$CN$US$US
234125114$23412511$4$F$20230701$20230728$20240117$20240716$PER$$US-NOVOPROD-1101379$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234125133$23412513$3$F$20240305$20240308$20240117$20240716$PER$$US-NOVOPROD-1101001$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
234125162$23412516$2$F$$20230727$20240117$20240716$PER$$US-NOVOPROD-1101186$NOVO NORDISK$$$$E$M$Y$$$20240717$$CN$US$US
234125372$23412537$2$F$$20230719$20240117$20240716$PER$$US-NOVOPROD-1102035$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234125582$23412558$2$F$$20230802$20240117$20240716$PER$$US-NOVOPROD-1103324$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234125602$23412560$2$F$$20230721$20240117$20240716$PER$$US-NOVOPROD-1098173$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234125614$23412561$4$F$$20230809$20240117$20240716$PER$$US-NOVOPROD-1103493$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234125662$23412566$2$F$20230701$20230725$20240117$20240716$PER$$US-NOVOPROD-1098581$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
234125672$23412567$2$F$20221207$20231218$20240117$20240716$PER$$US-NOVOPROD-1098416$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234125802$23412580$2$F$20230401$20230717$20240117$20240716$PER$$US-NOVOPROD-1098561$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
234125872$23412587$2$F$$20230724$20240117$20240716$PER$$US-NOVOPROD-1099245$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234125972$23412597$2$F$$20230724$20240117$20240716$PER$$US-NOVOPROD-1099087$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234126278$23412627$8$F$$20230726$20240117$20240721$PER$$US-NOVOPROD-1100473$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
234126292$23412629$2$F$20230501$20230726$20240117$20240716$PER$$US-NOVOPROD-1100472$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234126302$23412630$2$F$$20230726$20240117$20240716$PER$$US-NOVOPROD-1100458$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234126322$23412632$2$F$$20230725$20240117$20240716$PER$$US-NOVOPROD-1100463$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234126352$23412635$2$F$20230724$20230724$20240117$20240716$PER$$US-NOVOPROD-1100477$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234126472$23412647$2$F$$20230724$20240117$20240716$PER$$US-NOVOPROD-1100638$NOVO NORDISK$$80$YR$$F$Y$$$20240717$$CN$US$US
234126582$23412658$2$F$$20230809$20240117$20240716$PER$$US-NOVOPROD-1104125$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234126592$23412659$2$F$20230919$20230926$20240117$20240716$PER$$US-NOVOPROD-1104122$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
234126602$23412660$2$F$20180101$20230728$20240117$20240716$PER$$US-NOVOPROD-1103999$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234126613$23412661$3$F$$20230809$20240117$20240716$PER$$US-NOVOPROD-1103883$NOVO NORDISK$$$$A$M$Y$77.098$KG$20240717$$CN$US$US
234126682$23412668$2$F$$20230801$20240117$20240716$PER$$US-NOVOPROD-1103515$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234126732$23412673$2$F$20230731$20230809$20240117$20240716$PER$$US-NOVOPROD-1103636$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
234126752$23412675$2$F$$20230803$20240117$20240716$PER$$US-NOVOPROD-1104782$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234126772$23412677$2$F$$20230731$20240117$20240716$PER$$US-NOVOPROD-1104299$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
234126882$23412688$2$F$$20230810$20240117$20240716$PER$$US-NOVOPROD-1104388$NOVO NORDISK$$75$YR$$M$Y$$$20240717$$HP$US$US
234126922$23412692$2$F$20230725$20230802$20240117$20240716$PER$$US-NOVOPROD-1105193$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234126962$23412696$2$F$$20230807$20240117$20240716$PER$$US-NOVOPROD-1104328$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234127232$23412723$2$F$20230731$20230802$20240117$20240716$PER$$US-NOVOPROD-1105207$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234127242$23412724$2$F$$20230728$20240117$20240716$PER$$US-NOVOPROD-1105168$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234127273$23412727$3$F$20230411$20230808$20240117$20240716$PER$$US-NOVOPROD-1105393$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
234127362$23412736$2$F$20230511$20240211$20240117$20240716$PER$$US-NOVOPROD-1105844$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$MD$US$US
234127382$23412738$2$F$$20230807$20240117$20240716$PER$$US-NOVOPROD-1105846$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234127412$23412741$2$F$20230731$20230807$20240117$20240716$PER$$US-NOVOPROD-1106485$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234127612$23412761$2$F$$20230714$20240117$20240716$PER$$US-NOVOPROD-1106811$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234127653$23412765$3$F$20230811$20240321$20240117$20240716$PER$$US-NOVOPROD-1107002$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
234127712$23412771$2$F$$20230623$20240117$20240716$PER$$US-NOVOPROD-1106641$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234127942$23412794$2$F$$20230814$20240117$20240716$PER$$US-NOVOPROD-1107395$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234128472$23412847$2$F$$20230802$20240117$20240716$PER$$US-NOVOPROD-1107950$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234128542$23412854$2$F$20230101$20230807$20240117$20240716$PER$$US-NOVOPROD-1108379$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234128622$23412862$2$F$$20230811$20240117$20240716$PER$$US-NOVOPROD-1108637$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234128762$23412876$2$F$20230101$20230816$20240117$20240716$PER$$US-NOVOPROD-1108759$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234128783$23412878$3$F$$20230815$20240117$20240716$PER$$US-NOVOPROD-1109286$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234128792$23412879$2$F$$20230808$20240117$20240716$PER$$US-NOVOPROD-1109024$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234128802$23412880$2$F$20230501$20230804$20240117$20240716$PER$$US-NOVOPROD-1109048$NOVO NORDISK$$52$YR$$F$Y$$$20240717$$CN$US$US
234129272$23412927$2$F$20230101$20230920$20240117$20240717$PER$$US-NOVOPROD-1122511$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234129512$23412951$2$F$$20230928$20240117$20240717$PER$$US-NOVOPROD-1123954$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234129602$23412960$2$F$20230922$20231211$20240117$20240717$PER$$US-NOVOPROD-1123642$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
234129812$23412981$2$F$20230801$20231012$20240117$20240717$PER$$US-NOVOPROD-1124102$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
234129872$23412987$2$F$$20231201$20240117$20240717$PER$$US-NOVOPROD-1124402$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234129952$23412995$2$F$20230911$20230927$20240117$20240717$PER$$US-NOVOPROD-1125564$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
234129992$23412999$2$F$20230909$20240119$20240117$20240717$PER$$US-NOVOPROD-1125727$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234130022$23413002$2$F$20230927$20230927$20240117$20240717$PER$$US-NOVOPROD-1126190$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
234130042$23413004$2$F$$20230929$20240117$20240717$PER$$US-NOVOPROD-1126020$NOVO NORDISK$$$$E$M$Y$$$20240717$$MD$US$US
234130112$23413011$2$F$20230920$20231004$20240117$20240717$PER$$US-NOVOPROD-1126213$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
234130122$23413012$2$F$$20231005$20240117$20240717$PER$$US-NOVOPROD-1126154$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234130182$23413018$2$F$$20231006$20240117$20240717$PER$$US-NOVOPROD-1126851$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234130332$23413033$2$F$$20231005$20240117$20240717$PER$$US-NOVOPROD-1126731$NOVO NORDISK$$$$$F$Y$90.71$KG$20240717$$CN$US$US
234130352$23413035$2$F$20230101$20231004$20240117$20240717$PER$$US-NOVOPROD-1126904$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
234130413$23413041$3$F$20231201$20240730$20240117$20240801$EXP$$US-TAKEDA-2024TUS004813$TAKEDA$$25$YR$$F$Y$$$20240801$$CN$US$US
234130434$23413043$4$F$20230801$20231003$20240117$20240717$PER$$US-NOVOPROD-1129619$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
234130512$23413051$2$F$$20231002$20240117$20240717$PER$$US-NOVOPROD-1129371$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234130532$23413053$2$F$20230925$20231002$20240117$20240717$PER$$US-NOVOPROD-1129321$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234130542$23413054$2$F$20230927$20231002$20240117$20240717$PER$$US-NOVOPROD-1130259$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234130594$23413059$4$F$20231001$20231211$20240117$20240717$PER$$US-NOVOPROD-1129866$NOVO NORDISK$$77$YR$$M$Y$$$20240717$$CN$US$US
234130612$23413061$2$F$$20231013$20240117$20240717$PER$$US-NOVOPROD-1130019$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
234130642$23413064$2$F$20231006$20240124$20240117$20240717$PER$$US-NOVOPROD-1130317$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$MD$US$US
234130654$23413065$4$F$20230801$20240131$20240117$20240717$PER$$US-NOVOPROD-1130551$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
234130662$23413066$2$F$20231002$20231005$20240117$20240717$PER$$US-NOVOPROD-1130460$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234130672$23413067$2$F$20231001$20231222$20240117$20240717$PER$$US-NOVOPROD-1130372$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
234130692$23413069$2$F$$20231013$20240117$20240717$PER$$US-NOVOPROD-1130415$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234130722$23413072$2$F$$20231012$20240117$20240717$PER$$US-NOVOPROD-1131328$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234130802$23413080$2$F$$20231011$20240117$20240717$PER$$US-NOVOPROD-1130620$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234130812$23413081$2$F$20231008$20240201$20240117$20240717$PER$$US-NOVOPROD-1130647$NOVO NORDISK$$82$YR$$F$Y$$$20240717$$CN$US$US
234130892$23413089$2$F$$20231012$20240117$20240717$PER$$US-NOVOPROD-1131344$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234130902$23413090$2$F$$20231204$20240117$20240717$PER$$US-NOVOPROD-1131334$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234130912$23413091$2$F$20230928$20231012$20240117$20240717$PER$$US-NOVOPROD-1131139$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$MD$US$US
234130923$23413092$3$F$20231005$20231012$20240117$20240717$PER$$US-NOVOPROD-1131448$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
234131052$23413105$2$F$20230213$20240326$20240117$20240717$PER$$US-NOVOPROD-1127485$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
234131062$23413106$2$F$20230901$20231009$20240117$20240717$PER$$US-NOVOPROD-1127507$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
234131272$23413127$2$F$20210101$20230929$20240117$20240717$PER$$US-NOVOPROD-1128157$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
234131292$23413129$2$F$$20231012$20240117$20240717$PER$$US-NOVOPROD-1128658$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234131372$23413137$2$F$20230913$20231010$20240117$20240717$PER$$US-NOVOPROD-1128662$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
234131442$23413144$2$F$20231001$20231206$20240117$20240717$PER$$US-NOVOPROD-1128800$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234131454$23413145$4$F$20230913$20240105$20240117$20240717$PER$$US-NOVOPROD-1129031$NOVO NORDISK$$75$YR$$M$Y$$$20240717$$CN$US$US
234131542$23413154$2$F$$20231002$20240117$20240717$PER$$US-NOVOPROD-1128776$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234131632$23413163$2$F$$20231227$20240117$20240717$PER$$US-NOVOPROD-1137079$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
234131642$23413164$2$F$20231024$20231218$20240117$20240717$PER$$US-NOVOPROD-1136443$NOVO NORDISK$$65$YR$$F$Y$81.179$KG$20240717$$MD$US$US
234131813$23413181$3$F$$20231013$20240117$20240717$PER$$US-NOVOPROD-1131971$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234131872$23413187$2$F$20231018$20240307$20240117$20240717$PER$$US-NOVOPROD-1131527$NOVO NORDISK$$65$YR$$$Y$$$20240717$$CN$US$US
234131892$23413189$2$F$20230801$20231113$20240117$20240717$PER$$US-NOVOPROD-1131907$NOVO NORDISK$$82$YR$$M$Y$$$20240717$$CN$US$US
234131994$23413199$4$F$20231031$20231204$20240117$20240717$PER$$US-NOVOPROD-1137305$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
234132102$23413210$2$F$20230907$20230929$20240117$20240717$PER$$US-NOVOPROD-1127784$NOVO NORDISK$$78$YR$$M$Y$$$20240717$$CN$US$US
234132112$23413211$2$F$$20231010$20240117$20240717$PER$$US-NOVOPROD-1127912$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234132192$23413219$2$F$$20231012$20240117$20240717$PER$$US-NOVOPROD-1132550$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234132402$23413240$2$F$20231001$20240129$20240117$20240717$PER$$US-NOVOPROD-1134978$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
234132442$23413244$2$F$20230101$20240105$20240117$20240717$PER$$US-NOVOPROD-1134726$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
234132472$23413247$2$F$20231013$20240119$20240117$20240717$PER$$US-NOVOPROD-1134909$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
234132482$23413248$2$F$20231031$20231223$20240117$20240717$PER$$US-NOVOPROD-1134962$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
234132602$23413260$2$F$20230701$20240213$20240117$20240717$PER$$US-NOVOPROD-1134981$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
234132682$23413268$2$F$20231024$20231212$20240117$20240717$PER$$US-NOVOPROD-1135515$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
234132782$23413278$2$F$20231017$20231212$20240117$20240717$PER$$US-NOVOPROD-1135865$NOVO NORDISK$$82$YR$$M$Y$$$20240717$$CN$US$US
234132792$23413279$2$F$20231009$20231219$20240117$20240717$PER$$US-NOVOPROD-1135342$NOVO NORDISK$$80$YR$$F$Y$$$20240717$$CN$US$US
234132852$23413285$2$F$$20231208$20240117$20240717$PER$$US-NOVOPROD-1135626$NOVO NORDISK$$67$YR$$F$Y$92.063$KG$20240717$$HP$US$US
234132982$23413298$2$F$20230301$20231205$20240117$20240717$PER$$US-NOVOPROD-1140689$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234133082$23413308$2$F$20231110$20240119$20240117$20240717$PER$$US-NOVOPROD-1140863$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
234133282$23413328$2$F$20231030$20231215$20240117$20240717$PER$$US-NOVOPROD-1141518$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
234133422$23413342$2$F$20231029$20231221$20240117$20240717$PER$$US-NOVOPROD-1138017$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
234133544$23413354$4$F$$20231227$20240117$20240717$PER$$US-NOVOPROD-1138963$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
234133752$23413375$2$F$20231018$20240424$20240117$20240717$PER$$US-NOVOPROD-1139859$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
234133792$23413379$2$F$$20240216$20240117$20240717$PER$$US-NOVOPROD-1139918$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
234133822$23413382$2$F$$20231227$20240117$20240717$PER$$US-NOVOPROD-1139714$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
234133862$23413386$2$F$20231019$20231227$20240117$20240717$PER$$US-NOVOPROD-1139910$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
234133872$23413387$2$F$20231018$20231211$20240117$20240717$PER$$US-NOVOPROD-1139482$NOVO NORDISK$$31$YR$$F$Y$$$20240717$$CN$US$US
234133992$23413399$2$F$20231031$20231222$20240117$20240717$PER$$US-NOVOPROD-1139585$NOVO NORDISK$$49$YR$$M$Y$104.31$KG$20240717$$MD$US$US
234134112$23413411$2$F$20231109$20231206$20240117$20240717$PER$$US-NOVOPROD-1140130$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
234134272$23413427$2$F$20230923$20231012$20240117$20240717$PER$$US-NOVOPROD-1134384$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
234134282$23413428$2$F$$20231226$20240117$20240717$PER$$US-NOVOPROD-1141673$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234134382$23413438$2$F$20230801$20231211$20240117$20240717$PER$$US-NOVOPROD-1142018$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$PH$US$US
234134392$23413439$2$F$20180101$20240415$20240117$20240717$PER$$US-NOVOPROD-1141741$NOVO NORDISK$$$$E$M$Y$$$20240717$$CN$US$US
234134452$23413445$2$F$20230801$20231205$20240117$20240717$PER$$US-NOVOPROD-1142415$NOVO NORDISK$$71$YR$$$Y$$$20240717$$CN$US$US
234134472$23413447$2$F$20230801$20231229$20240117$20240717$PER$$US-NOVOPROD-1142256$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234134502$23413450$2$F$20231110$20231226$20240117$20240717$PER$$US-NOVOPROD-1142090$NOVO NORDISK$$71$YR$$F$Y$72.109$KG$20240717$$MD$US$US
234134664$23413466$4$F$20231220$20240103$20240117$20240717$PER$$US-NOVOPROD-1142720$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234134722$23413472$2$F$20230530$20240122$20240117$20240717$PER$$US-NOVOPROD-1142750$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
234134782$23413478$2$F$20231001$20231221$20240117$20240717$PER$$US-NOVOPROD-1142853$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
234134892$23413489$2$F$20231001$20240311$20240117$20240717$PER$$US-NOVOPROD-1143280$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$MD$US$US
234134932$23413493$2$F$$20231219$20240117$20240717$PER$$US-NOVOPROD-1143441$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234134942$23413494$2$F$$20240206$20240117$20240717$PER$$US-NOVOPROD-1143413$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234135002$23413500$2$F$20231118$20240102$20240117$20240717$PER$$US-NOVOPROD-1143712$NOVO NORDISK$$83$YR$$F$Y$$$20240717$$CN$US$US
234135136$23413513$6$F$20230501$20231221$20240117$20240717$PER$$US-NOVOPROD-1144101$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
234135172$23413517$2$F$20230701$20240111$20240117$20240717$PER$$US-NOVOPROD-1144044$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$HP$US$US
234135252$23413525$2$F$20230801$20240103$20240117$20240717$PER$$US-NOVOPROD-1144264$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
234135264$23413526$4$F$20231118$20231208$20240117$20240717$PER$$US-NOVOPROD-1145170$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
234135272$23413527$2$F$20231004$20231204$20240117$20240717$PER$$US-NOVOPROD-1145017$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
234135284$23413528$4$F$$20231211$20240117$20240717$PER$$US-NOVOPROD-1144292$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234135292$23413529$2$F$$20231227$20240117$20240717$PER$$US-NOVOPROD-1144969$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
234135322$23413532$2$F$20230801$20240220$20240117$20240717$PER$$US-NOVOPROD-1144573$NOVO NORDISK$$77$YR$$M$Y$91.61$KG$20240717$$MD$US$US
234135352$23413535$2$F$20220101$20231226$20240117$20240717$PER$$US-NOVOPROD-1145162$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
234135362$23413536$2$F$20211208$20240308$20240117$20240717$PER$$US-NOVOPROD-1145277$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
234135372$23413537$2$F$$20230630$20240117$20240716$PER$$US-NOVOPROD-1160498$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234135382$23413538$2$F$$20230801$20240117$20240717$PER$$US-NOVOPROD-1159944$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234135392$23413539$2$F$$20230622$20240117$20240717$PER$$US-NOVOPROD-1159873$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234135402$23413540$2$F$20231201$20240102$20240117$20240717$PER$$US-NOVOPROD-1145303$NOVO NORDISK$$61$YR$$$Y$$$20240717$$CN$US$US
234135412$23413541$2$F$$20230602$20240117$20240717$PER$$US-NOVOPROD-1159875$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135422$23413542$2$F$20230601$20230627$20240117$20240717$PER$$US-NOVOPROD-1159750$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234135472$23413547$2$F$$20230630$20240117$20240717$PER$$US-NOVOPROD-1159826$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135482$23413548$2$F$$20231006$20240117$20240717$PER$$US-NOVOPROD-1159867$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234135492$23413549$2$F$$20230623$20240117$20240716$PER$$US-NOVOPROD-1161671$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
234135502$23413550$2$F$$20230712$20240117$20240716$PER$$US-NOVOPROD-1160677$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135512$23413551$2$F$$20230706$20240117$20240717$PER$$US-NOVOPROD-1159833$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135522$23413552$2$F$$20230602$20240117$20240716$PER$$US-NOVOPROD-1160444$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135532$23413553$2$F$$20230707$20240117$20240717$PER$$US-NOVOPROD-1159834$NOVO NORDISK$$$$$$Y$$$20240717$$PH$US$US
234135542$23413554$2$F$$20230719$20240117$20240717$PER$$US-NOVOPROD-1159923$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135552$23413555$2$F$$20230803$20240117$20240716$PER$$US-NOVOPROD-1160955$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
234135562$23413556$2$F$$20230711$20240117$20240716$PER$$US-NOVOPROD-1160968$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135592$23413559$2$F$20230613$20230614$20240117$20240717$PER$$US-NOVOPROD-1159876$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135612$23413561$2$F$$20231011$20240117$20240717$PER$$US-NOVOPROD-1160044$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135622$23413562$2$F$$20230619$20240117$20240716$PER$$US-NOVOPROD-1161923$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135632$23413563$2$F$$20230628$20240117$20240716$PER$$US-NOVOPROD-1162216$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135642$23413564$2$F$$20230605$20240117$20240716$PER$$US-NOVOPROD-1162803$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135672$23413567$2$F$$20240223$20240117$20240716$PER$$US-NOVOPROD-1162783$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234135692$23413569$2$F$$20230627$20240117$20240716$PER$$US-NOVOPROD-1162238$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135702$23413570$2$F$20230813$20230817$20240117$20240716$PER$$US-NOVOPROD-1162705$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234135732$23413573$2$F$$20230627$20240117$20240716$PER$$US-NOVOPROD-1161979$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234135742$23413574$2$F$$20230711$20240117$20240716$PER$$US-NOVOPROD-1162774$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135752$23413575$2$F$$20231010$20240117$20240716$PER$$US-NOVOPROD-1162149$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135772$23413577$2$F$$20230629$20240117$20240716$PER$$US-NOVOPROD-1162805$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135792$23413579$2$F$$20240125$20240117$20240716$PER$$US-NOVOPROD-1162798$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234135802$23413580$2$F$$20230720$20240117$20240716$PER$$US-NOVOPROD-1162326$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135812$23413581$2$F$$20240208$20240117$20240716$PER$$US-NOVOPROD-1161983$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
234135822$23413582$2$F$$20231012$20240117$20240716$PER$$US-NOVOPROD-1162461$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234135832$23413583$2$F$$20230720$20240117$20240716$PER$$US-NOVOPROD-1161978$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135842$23413584$2$F$$20230729$20240117$20240716$PER$$US-NOVOPROD-1162749$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135852$23413585$2$F$$20231013$20240117$20240716$PER$$US-NOVOPROD-1162252$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135862$23413586$2$F$$20230821$20240117$20240716$PER$$US-NOVOPROD-1162737$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135872$23413587$2$F$$20230619$20240117$20240716$PER$$US-NOVOPROD-1161924$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135882$23413588$2$F$$20230727$20240117$20240716$PER$$US-NOVOPROD-1162797$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234135892$23413589$2$F$$20230626$20240117$20240716$PER$$US-NOVOPROD-1162765$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234135902$23413590$2$F$20230601$20230616$20240117$20240716$PER$$US-NOVOPROD-1162777$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234135912$23413591$2$F$$20231206$20240117$20240717$PER$$US-NOVOPROD-1145934$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234136002$23413600$2$F$20231124$20231213$20240117$20240717$PER$$US-NOVOPROD-1145665$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
234136042$23413604$2$F$$20240102$20240117$20240717$PER$$US-NOVOPROD-1146398$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
234136062$23413606$2$F$20231001$20231208$20240117$20240717$PER$$US-NOVOPROD-1146015$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
234136142$23413614$2$F$20231030$20231214$20240117$20240717$PER$$US-NOVOPROD-1145738$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
234136152$23413615$2$F$$20230619$20240117$20240716$PER$$US-NOVOPROD-1161922$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234136282$23413628$2$F$20231118$20240229$20240117$20240717$PER$$US-NOVOPROD-1146912$NOVO NORDISK$$39$YR$$F$Y$$$20240717$$MD$US$US
234136302$23413630$2$F$20231120$20231218$20240117$20240717$PER$$US-NOVOPROD-1146727$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
234136352$23413635$2$F$20231123$20240116$20240117$20240717$PER$$US-NOVOPROD-1147013$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
234136362$23413636$2$F$20231001$20231221$20240117$20240717$PER$$US-NOVOPROD-1147014$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
234136372$23413637$2$F$$20240105$20240117$20240717$PER$$US-NOVOPROD-1147090$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234136402$23413640$2$F$20220101$20240205$20240117$20240717$PER$$US-NOVOPROD-1147039$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
234136462$23413646$2$F$20230901$20240108$20240117$20240717$PER$$US-NOVOPROD-1147508$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
234136472$23413647$2$F$20231115$20231211$20240117$20240717$PER$$US-NOVOPROD-1148321$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
234136532$23413653$2$F$20230216$20240313$20240117$20240717$PER$$US-NOVOPROD-1147214$NOVO NORDISK$$48$YR$$M$Y$$$20240717$$HP$US$US
234136562$23413656$2$F$$20240205$20240117$20240717$PER$$US-NOVOPROD-1147585$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234136662$23413666$2$F$$20240208$20240117$20240717$PER$$US-NOVOPROD-1148157$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234136702$23413670$2$F$$20231206$20240117$20240717$PER$$US-NOVOPROD-1149419$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234136722$23413672$2$F$$20230619$20240117$20240717$PER$$US-NOVOPROD-1159235$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234136744$23413674$4$F$20231101$20231211$20240117$20240717$PER$$US-NOVOPROD-1149655$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
234136792$23413679$2$F$20230611$20230626$20240117$20240717$PER$$US-NOVOPROD-1157638$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
234136802$23413680$2$F$$20230623$20240117$20240716$PER$$US-NOVOPROD-1162806$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234136893$23413689$3$F$20200101$20240513$20240117$20240717$PER$$US-NOVOPROD-1148754$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
234137014$23413701$4$F$$20230816$20240117$20240716$PER$$US-NOVOPROD-1114020$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234137062$23413706$2$F$$20230825$20240117$20240716$PER$$US-NOVOPROD-1113121$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234137222$23413722$2$F$20230701$20230831$20240117$20240716$PER$$US-NOVOPROD-1115291$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
234137232$23413723$2$F$20230801$20231204$20240117$20240716$PER$$US-NOVOPROD-1115194$NOVO NORDISK$$86$YR$$M$Y$$$20240717$$CN$US$US
234137262$23413726$2$F$20230824$20230831$20240117$20240716$PER$$US-NOVOPROD-1114970$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
234137272$23413727$2$F$$20230828$20240117$20240716$PER$$US-NOVOPROD-1115127$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
234137322$23413732$2$F$20230831$20230901$20240117$20240716$PER$$US-NOVOPROD-1115458$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
234137372$23413737$2$F$20230825$20231002$20240117$20240716$PER$$US-NOVOPROD-1115210$NOVO NORDISK$$46$YR$$F$Y$$$20240717$$CN$US$US
234137382$23413738$2$F$$20230712$20240117$20240716$PER$$US-NOVOPROD-1115756$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234137632$23413763$2$F$$20230831$20240117$20240716$PER$$US-NOVOPROD-1117031$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234137792$23413779$2$F$20230813$20230911$20240117$20240716$PER$$US-NOVOPROD-1117256$NOVO NORDISK$$74$YR$$M$Y$$$20240717$$CN$US$US
234137822$23413782$2$F$$20230905$20240117$20240716$PER$$US-NOVOPROD-1117212$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234137842$23413784$2$F$$20240126$20240117$20240716$PER$$US-NOVOPROD-1118180$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234137952$23413795$2$F$20230828$20230907$20240117$20240716$PER$$US-NOVOPROD-1118736$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$PH$US$US
234138012$23413801$2$F$20230301$20230905$20240117$20240716$PER$$US-NOVOPROD-1118290$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
234138063$23413806$3$F$$20230908$20240117$20240716$PER$$US-NOVOPROD-1118299$NOVO NORDISK$$69$YR$$M$Y$114.29$KG$20240717$$CN$US$US
234138162$23413816$2$F$$20230911$20240117$20240716$PER$$US-NOVOPROD-1118466$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234138182$23413818$2$F$$20230911$20240117$20240716$PER$$US-NOVOPROD-1118963$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
234138222$23413822$2$F$20230802$20230912$20240117$20240716$PER$$US-NOVOPROD-1118982$NOVO NORDISK$$65$YR$$$Y$$$20240717$$CN$US$US
234138272$23413827$2$F$$20230911$20240117$20240716$PER$$US-NOVOPROD-1118974$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234138352$23413835$2$F$20230901$20230915$20240117$20240717$PER$$US-NOVOPROD-1121240$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$PH$US$US
234138362$23413836$2$F$20230903$20230915$20240117$20240717$PER$$US-NOVOPROD-1121272$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$MD$US$US
234138392$23413839$2$F$20230808$20231016$20240117$20240717$PER$$US-NOVOPROD-1121719$NOVO NORDISK$$67$YR$$F$Y$84.807$KG$20240717$$CN$US$US
234138522$23413852$2$F$$20230914$20240117$20240717$PER$$US-NOVOPROD-1121864$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
234138532$23413853$2$F$20230904$20230906$20240117$20240716$PER$$US-NOVOPROD-1119224$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
234138542$23413854$2$F$20230401$20230921$20240117$20240717$PER$$US-NOVOPROD-1121891$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$MD$US$US
234138582$23413858$2$F$$20230914$20240117$20240717$PER$$US-NOVOPROD-1121808$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
234138622$23413862$2$F$$20230912$20240117$20240716$PER$$US-NOVOPROD-1119401$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234138642$23413864$2$F$$20230912$20240117$20240716$PER$$US-NOVOPROD-1119525$NOVO NORDISK$$$$$F$Y$136.05$KG$20240717$$CN$US$US
234138662$23413866$2$F$20230308$20230914$20240117$20240716$PER$$US-NOVOPROD-1119799$NOVO NORDISK$$52$YR$$F$Y$$$20240717$$CN$US$US
234138732$23413873$2$F$$20230912$20240117$20240716$PER$$US-NOVOPROD-1119828$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234138742$23413874$2$F$$20231011$20240117$20240716$PER$$US-NOVOPROD-1119554$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
234139002$23413900$2$F$20230814$20240903$20240117$20240910$EXP$$CA-TAKEDA-2024TUS004475$TAKEDA$$53$YR$$F$Y$64$KG$20240910$$HP$CA$CA
234139052$23413905$2$F$20230101$20240102$20240117$20240717$PER$$US-NOVOPROD-1132840$NOVO NORDISK$$21$YR$$F$Y$$$20240717$$CN$US$US
234139182$23413918$2$F$$20231211$20240117$20240717$PER$$US-NOVOPROD-1134117$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
234139302$23413930$2$F$$20231003$20240117$20240716$PER$$US-NOVOPROD-1161561$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
234139402$23413940$2$F$$20231009$20240117$20240717$PER$$US-NOVOPROD-1133191$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
234139522$23413952$2$F$20221101$20240723$20240117$20240724$EXP$$PT-SANDOZ INC.-SDZ2024PT004468$SANDOZ$$65$YR$$M$Y$87$KG$20240724$$MD$PT$PT
234139843$23413984$3$F$$20240813$20240117$20240814$PER$$NVSC2024US010306$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
234140844$23414084$4$F$20231201$20240708$20240117$20240711$EXP$$US-ABBVIE-5587752$ABBVIE$$55$YR$$F$Y$$$20240711$$CN$US$US
234141302$23414130$2$F$20230111$20240705$20240117$20240707$PER$$US-AMGEN-USASP2024008240$AMGEN$$$$$M$Y$$$20240707$$CN$US$US
234141443$23414144$3$F$20240501$20240627$20240117$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-008703$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240703$$HP$US$US
234141708$23414170$8$F$20230101$20240821$20240117$20240829$EXP$$CA-CELLTRION INC.-2023CA014111$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
234142404$23414240$4$F$$20240807$20240118$20240808$PER$$US-ALXN-A202211959$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
234142592$23414259$2$F$20240108$20240111$20240118$20240923$PER$$US-ROCHE-3490296$ROCHE$$60$YR$A$F$Y$$$20240923$$CN$US$US
234142683$23414268$3$F$20240802$20240802$20240118$20240826$PER$$AU-TOLMAR, INC.-23AU045790$TOLMAR$$85$YR$$M$Y$$$20240826$$CN$AU$AU
234142855$23414285$5$F$20161201$20240829$20240118$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-001197$AUROBINDO$T. Labaigt, A. Berceanu. A bout de souffle [Breathless].. Correspondence in Onco-Hematology. 2023;XVIII(6):352- 354$53$YR$$F$Y$$$20240909$$MD$FR$FR
234142923$23414292$3$F$$20240715$20240118$20240723$EXP$$PL-AUROBINDO-AUR-APL-2024-001442$AUROBINDO$Siek J.. A pregnant patient infected with  influenza A virus - case report and  literature review.. ANESTEZJOLOGIA I  RATOWNICTWO. 2023;(4):225-232$29$YR$$F$Y$$$20240723$$MD$PL$PL
234143203$23414320$3$F$20240116$20240717$20240118$20240719$PER$$US-AMGEN-USASP2024010222$AMGEN$$60$YR$A$M$Y$$$20240719$$CN$US$US
234143753$23414375$3$F$$20240807$20240118$20240808$EXP$$RU-JNJFOC-20240127984$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240808$$CN$RU$RU
234144152$23414415$2$F$$20240702$20240118$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-008624$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240709$$CN$US$US
234144283$23414428$3$F$$20240821$20240118$20240823$EXP$$CA-TAKEDA-2023TUS050301$TAKEDA$$$$$F$Y$$$20240823$$CN$CA$CA
234144862$23414486$2$F$20231226$20240724$20240118$20240728$EXP$$CA-JNJFOC-20240130745$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240729$$HP$CA$CA
234144953$23414495$3$F$20231230$20240826$20240118$20240828$EXP$FR-AFSSAPS-RE2024000034$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-009022$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$85$KG$20240828$$PH$FR$FR
234145765$23414576$5$F$20240715$20240911$20240118$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-006024$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240923$$CN$US$US
234146156$23414615$6$F$$20240924$20240118$20240926$EXP$$CA-ROCHE-3375959$ROCHE$$$$A$M$Y$$$20240926$$CN$CA$CA
234146315$23414631$5$F$20230101$20240828$20240118$20240906$EXP$$CA-CELLTRION INC.-2020CA030539$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
234146743$23414674$3$F$20240101$20240718$20240118$20240726$PER$$US-SA-2024SA013931$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240726$$MD$US$US
234146764$23414676$4$F$20240109$20240806$20240118$20240813$PER$$US-SA-2024SA017980$SANOFI AVENTIS$$58$YR$A$M$Y$103$KG$20240814$$MD$US$US
234146773$23414677$3$F$20240101$20240719$20240118$20240730$PER$$US-SA-2024SA018477$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240730$$MD$US$US
234146982$23414698$2$F$$20240910$20240118$20240917$PER$$US-SA-2024SA018460$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$MD$US$US
234147533$23414753$3$F$20231201$20240911$20240118$20240920$PER$$US-SA-2024SA018266$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240920$$MD$US$US
234147635$23414763$5$F$20230603$20240906$20240118$20240913$EXP$$AU-TAKEDA-2023TUS055484$TAKEDA$$39$YR$$M$Y$$$20240913$$CN$AU$AU
234148225$23414822$5$F$$20240329$20240118$20240905$PER$$NVSC2024US010550$NOVARTIS$$$$$M$Y$$$20240905$$CN$US$US
234148473$23414847$3$F$20231201$20240808$20240118$20240817$PER$$US-SA-2024SA014826$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240817$$MD$US$US
234148853$23414885$3$F$20231127$20240725$20240118$20240729$EXP$$CA-ROCHE-3493409$ROCHE$$42$YR$A$M$Y$$$20240729$$CN$CA$CA
234148922$23414892$2$F$$20240809$20240118$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-008163$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240812$$CN$US$US
234149282$23414928$2$F$20231227$20240916$20240118$20240925$EXP$$IT-JNJFOC-20240123413$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240925$$MD$IT$IT
234149403$23414940$3$F$$20240610$20240118$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-006014$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$HP$US$US
234149444$23414944$4$F$20231101$20240624$20240118$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-006003$ACADIA PHARMACEUTICALS$$65$YR$$F$Y$$$20240718$$CN$US$US
234149816$23414981$6$F$20231102$20240815$20240118$20240821$EXP$$MX-TAKEDA-2023TUS105587$TAKEDA$$18$YR$$M$Y$$$20240821$$CN$MX$MX
234150167$23415016$7$F$20230808$20240910$20240118$20240918$EXP$$DE-TAKEDA-2023TUS075601$TAKEDA$$21$YR$$F$Y$73$KG$20240918$$MD$DE$DE
234150294$23415029$4$F$20210824$20240726$20240118$20240729$EXP$$CA-SANDOZ INC.-NVSC2021CA198156$SANDOZ$$59$YR$$F$Y$$$20240729$$HP$CA$CA
234150653$23415065$3$F$20240601$20240704$20240118$20240711$EXP$$CO-GSK-CO2024AMR006749$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$CO$CO
234151676$23415167$6$F$$20240819$20240118$20240903$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2022-025869$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$HP$CA$CA
234151734$23415173$4$F$20230925$20240806$20240118$20240814$EXP$$MX-BIOVITRUM-2023-MX-015472$BIOVITRUM$$34$DY$$M$Y$7.3$KG$20240814$$CN$MX$MX
234151795$23415179$5$F$20230101$20240905$20240118$20240913$PER$$US-BIOGEN-2024BI01245385$BIOGEN$$$$$M$Y$$$20240913$$CN$US$US
234153032$23415303$2$F$20240115$20240724$20240118$20240725$PER$$US-AMGEN-USASP2024009889$AMGEN$$64$YR$A$M$Y$$$20240725$$CN$US$US
234154342$23415434$2$F$$20240711$20240118$20240722$PER$$US-SA-2024SA018349$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240721$$MD$US$US
234154402$23415440$2$F$$20240808$20240118$20240815$PER$$US-SA-2024SA012215$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240815$$MD$US$US
2341544310$23415443$10$F$20231101$20240711$20240118$20240715$EXP$$US-UCBSA-2023057244$UCB$$5$YR$$F$Y$28.2$KG$20240715$$CN$US$US
234154582$23415458$2$F$20240601$20240628$20240118$20240704$30DAY$$US-GSK-US2024005622$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240704$$HP$US$US
234154594$23415459$4$F$$20240221$20240118$20240926$EXP$$US-GSK-US2024AMR004968$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
234154943$23415494$3$F$20230101$20240708$20240118$20240711$EXP$$US-ABBVIE-5591339$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
234155164$23415516$4$F$20210213$20240906$20240118$20240911$EXP$$CO-TAKEDA-2021TUS013400$TAKEDA$$9$YR$$M$Y$28$KG$20240911$$CN$CO$CO
234156813$23415681$3$F$$20240715$20240118$20240718$EXP$$NVSC2024CA009440$NOVARTIS$$43$YR$$F$Y$96$KG$20240719$$HP$CA$CA
234156854$23415685$4$F$20230101$20240917$20240118$20240926$EXP$$CA-CELLTRION INC.-2023CA025413$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
234157152$23415715$2$F$$20240912$20240118$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009149$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240913$$HP$US$US
234157217$23415721$7$F$20240801$20240915$20240118$20240923$EXP$$NVSC2024IN007982$NOVARTIS$$78$YR$$F$Y$63$KG$20240923$$CN$IN$IN
234158542$23415854$2$F$$20240801$20240118$20240809$PER$$US-SA-2024SA017926$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240809$$MD$US$US
234158572$23415857$2$F$$20240716$20240118$20240725$PER$$US-SA-2024SA014697$SANOFI AVENTIS$$77$YR$E$F$Y$77.11$KG$20240725$$MD$US$US
234159412$23415941$2$F$$20240716$20240118$20240722$EXP$$GB-SANDOZ INC.-NVSC2020GB185241$SANDOZ$$$$$F$Y$$$20240722$$CN$GB$GB
234160072$23416007$2$F$20220101$20240724$20240118$20240801$PER$$US-SA-2024SA018976$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240801$$MD$US$US
234161854$23416185$4$F$20231124$20240906$20240118$20240917$EXP$$US-UCBSA-2023056728$UCB$$64$YR$$M$Y$105.67$KG$20240917$$HP$US$US
234161972$23416197$2$F$20221212$20240115$20240118$20240918$EXP$IT-EMA-DD-20230929-7291047-070221$IT-SANDOZ INC.-SDZ2024IT004588$SANDOZ$$45$YR$$F$Y$65$KG$20240918$$MD$IT$IT
234162583$23416258$3$F$20240103$20240814$20240118$20240821$30DAY$$US-GSK-US2024003174$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240821$$CN$US$US
234162742$23416274$2$F$$20240722$20240118$20240801$EXP$$US-SERB S.A.S.-2151440$LABORATOIRES SERB$$5$YR$$F$Y$$$20240801$$PH$US$US
234163724$23416372$4$F$$20240906$20240118$20240910$EXP$$NVSC2023GB011618$NOVARTIS$$$$A$M$Y$$$20240910$$CN$GB$GB
234163853$23416385$3$F$$20240924$20240118$20240925$30DAY$$JP-PFIZER INC-202300454017$PFIZER$$$$$F$Y$20.6$KG$20240925$$PH$JP$JP
234164025$23416402$5$F$20240101$20240709$20240118$20240712$EXP$$CA-PFIZER INC-202400010942$PFIZER$$53$YR$$M$Y$$$20240712$$HP$CA$CA
234164055$23416405$5$F$20230101$20240810$20240118$20240812$EXP$$CA-PFIZER INC-202400009495$PFIZER$$44$YR$$M$Y$$$20240812$$CN$CA$CA
234164272$23416427$2$F$20240101$20240919$20240118$20240922$PER$$US-AMGEN-USASP2024009380$AMGEN$$74$YR$E$F$Y$$$20240922$$CN$US$US
234164882$23416488$2$F$20240103$20240724$20240118$20240731$PER$$US-BAYER-2024A004268$BAYER$$22$YR$A$F$Y$$$20240731$$MD$US$US
234165133$23416513$3$F$$20240830$20240118$20240906$30DAY$$CN-JNJFOC-20240101021$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$CN$CN
234165155$23416515$5$F$$20240923$20240118$20240930$PER$$US-ALXN-202401USA000826US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240930$$$US$US
234165913$23416591$3$F$$20240718$20240118$20240722$EXP$$US-UCBSA-2024002192$UCB$$$$$F$Y$77.098$KG$20240722$$HP$US$US
234166022$23416602$2$F$$20231218$20240118$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-003598$ENDO$$$$$F$Y$$$20240918$$$US$US
234166233$23416623$3$F$20240114$20240712$20240118$20240715$PER$$US-AMGEN-USASP2024009411$AMGEN$$64$YR$A$M$Y$$$20240715$$CN$US$US
234166266$23416626$6$F$20220901$20240812$20240118$20240816$EXP$$NVSC2022GB239377$NOVARTIS$$$$E$F$Y$$$20240817$$CN$GB$GB
234166474$23416647$4$F$20211105$20240812$20240118$20240916$EXP$$CH-SANDOZ INC.-NVSC2021CH268037$SANDOZ$$50$YR$$F$Y$82$KG$20240916$$MD$CH$CH
234166484$23416648$4$F$$20240911$20240118$20240918$EXP$$CA-GSK-CA2023130213$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$CA$CA
234166608$23416660$8$F$20231201$20240815$20240118$20240830$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00542$AVADEL CNS PHARMA$$21$YR$$M$Y$73.288$KG$20240830$$CN$US$US
234166887$23416688$7$F$20230101$20240718$20240118$20240724$EXP$$CA-JNJFOC-20230338772$JOHNSON AND JOHNSON$$58$YR$A$F$Y$77$KG$20240724$$CN$CA$CA
234167313$23416731$3$F$$20240820$20240118$20240822$PER$$US-AMGEN-USASP2024009285$AMGEN$$62$YR$A$F$Y$$$20240822$$CN$US$US
234167562$23416756$2$F$$20240716$20240118$20240718$PER$$US-PFIZER INC-PV202300157561$PFIZER$$64$YR$$F$Y$$$20240718$$MD$US$US
234169035$23416903$5$F$$20240709$20240118$20240712$PER$$US-PFIZER INC-PV202400007303$PFIZER$$71$YR$$F$Y$113.38$KG$20240712$$CN$US$US
234169044$23416904$4$F$20231101$20240904$20240118$20240909$PER$$US-PFIZER INC-PV202400006158$PFIZER$$66$YR$$F$Y$102.05$KG$20240909$$CN$US$US
234170915$23417091$5$F$$20240415$20240118$20240827$EXP$$NVSC2024CA010111$NOVARTIS$$77$YR$$F$Y$$$20240827$$HP$CA$CA
234171232$23417123$2$F$$20230606$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-002974$ENDO$$$$$$Y$$$20240712$$CN$US$US
234171606$23417160$6$F$20230101$20240920$20240118$20240920$EXP$$CA-PFIZER INC-202300202435$PFIZER$$53$YR$$M$Y$$$20240920$$MD$CA$CA
234171815$23417181$5$F$$20240626$20240118$20240701$EXP$$US-PFIZER INC-PV202300204364$PFIZER$$80$YR$$M$Y$80.4$KG$20240701$$HP$US$US
234172122$23417212$2$F$20240710$20240710$20240118$20240718$PER$$US-SA-2024SA018267$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240718$$CN$US$US
234172392$23417239$2$F$$20230606$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003147$ENDO$$$$$F$Y$$$20240712$$CN$US$US
234172688$23417268$8$F$$20240827$20240118$20240903$EXP$$NVSC2024CA009139$NOVARTIS$$40$YR$$F$Y$96$KG$20240903$$HP$CA$CA
234172953$23417295$3$F$$20240722$20240118$20240723$EXP$$GB-MYLANLABS-2024M1005714$MYLAN$$$$I$M$Y$$$20240723$$HP$GB$GB
234174703$23417470$3$F$$20240724$20240118$20240801$EXP$$CA-SA-2024SA014963$SANOFI AVENTIS$$40$YR$A$F$Y$96$KG$20240801$$HP$CA$CA
2341763011$23417630$11$F$20231226$20240920$20240118$20240930$EXP$$US-BEH-2024167546$CSL BEHRING$$48$YR$A$F$Y$$$20240930$$HP$US$US
234176833$23417683$3$F$20231201$20240911$20240118$20240916$PER$$US-SA-2024SA019296$SANOFI AVENTIS$$15$YR$T$F$Y$68$KG$20240916$$MD$US$US
234176942$23417694$2$F$20231231$20240712$20240118$20240722$EXP$$US-UCBSA-2024000264$UCB$$51$YR$$F$Y$48.625$KG$20240722$$CN$US$US
234177054$23417705$4$F$20240115$20240724$20240118$20240726$PER$$US-AMGEN-USASP2024009428$AMGEN$$55$YR$A$F$Y$$$20240726$$CN$US$US
2341770611$23417706$11$F$20231201$20240828$20240118$20240904$EXP$$US-BEH-2024167600$CSL BEHRING$$37$YR$A$F$Y$$$20240904$$CN$US$US
234177892$23417789$2$F$20230707$20240716$20240118$20240730$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-00948$SAMSUNG BIOEPIS$$69$YR$E$M$Y$121$KG$20240730$$HP$GB$GB
234178514$23417851$4$F$20231201$20240826$20240118$20240920$PER$$US-SA-2024SA018428$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240920$$MD$US$US
234179002$23417900$2$F$20131101$20230606$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003343$ENDO$$$$$M$Y$$$20240712$$CN$US$US
234179242$23417924$2$F$20231013$20240716$20240118$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-148155$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240719$$CN$CA$CA
234179332$23417933$2$F$$20230608$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003481$ENDO$$$$$M$Y$$$20240712$$CN$US$US
234179952$23417995$2$F$$20240423$20240118$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005538$ENDO$$$$$F$Y$$$20240916$$CN$US$US
234179983$23417998$3$F$20220713$20240729$20240118$20240803$EXP$$CA-ROCHE-3140802$ROCHE$$30$YR$A$F$Y$$$20240803$$CN$CA$CA
234180055$23418005$5$F$20231226$20240619$20240118$20240702$EXP$$US-BEH-2024167551$CSL BEHRING$$37$YR$A$F$Y$$$20240702$$CN$US$US
234180212$23418021$2$F$$20230604$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003108$ENDO$$$$$M$Y$$$20240712$$CN$US$US
234180552$23418055$2$F$$20240712$20240118$20240801$PER$$US-SA-2024SA018214$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240719$$MD$US$US
234180665$23418066$5$F$20231227$20240624$20240118$20240703$EXP$$US-AstraZeneca-2024A012416$ASTRAZENECA$$7$MON$$F$Y$2.1$KG$20240703$$HP$US$
234181952$23418195$2$F$$20230707$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-004238$ENDO$$$$$F$Y$$$20240712$$CN$US$US
234182175$23418217$5$F$$20231003$20240118$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-005486$ENDO$$$$$M$Y$$$20240918$$CN$US$US
234182183$23418218$3$F$$20231031$20240118$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-005698$ENDO$$$$$F$Y$$$20240917$$CN$US$US
234182212$23418221$2$F$$20231017$20240118$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-005529$ENDO$$$$$M$Y$$$20240918$$CN$US$US
234182224$23418222$4$F$20210101$20231003$20240118$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-005326$ENDO$$$$$F$Y$$$20240918$$CN$US$US
234182234$23418223$4$F$$20231010$20240118$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-005421$ENDO$$$$$M$Y$$$20240918$$CN$US$US
234182243$23418224$3$F$$20231114$20240118$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-005851$ENDO$$$$$M$Y$$$20240918$$CN$US$US
234182252$23418225$2$F$$20231025$20240118$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-005613$ENDO$$$$$M$Y$$$20240917$$CN$US$US
234182262$23418226$2$F$$20231025$20240118$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-005618$ENDO$$$$$F$Y$$$20240917$$CN$US$US
234182284$23418228$4$F$$20231102$20240118$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-005796$ENDO$$$$$M$Y$$$20240917$$CN$US$US
234182312$23418231$2$F$$20231003$20240118$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005320$ENDO$$$$$F$Y$$$20240916$$CN$US$US
234182334$23418233$4$F$$20231003$20240118$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-005329$ENDO$$$$$F$Y$$$20240918$$CN$US$US
234182358$23418235$8$F$20231128$20240823$20240118$20240827$EXP$$CA-JNJFOC-20231215935$JOHNSON AND JOHNSON$$8$YR$C$M$Y$22$KG$20240827$$HP$CA$CA
234182422$23418242$2$F$$20240916$20240118$20240925$EXP$$US-AMGEN-USASP2024009250$AMGEN$Abdelrahim M.; Xu J.; Burns E. et al.. OUTCOMES OF PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA WHO DEVELOPED AN INFECTION WHILE RECEIVING ATEZOLIZUMAB. Journal for ImmunoTherapy of Cancer. 2023;11 (SUPPL 1):A502$$$$$Y$$$20240924$$HP$US$US
234183453$23418345$3$F$$20240220$20240118$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-003535$ENDO$$$$$M$Y$$$20240916$$CN$US$US
234183653$23418365$3$F$$20240819$20240118$20240827$EXP$$CA-AstraZeneca-2024A012768$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$CA$
234184653$23418465$3$F$$20240812$20240118$20240827$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00007$Phathom Pharmaceuticals$Nagao S, Yabuuchi Y, Tanaka K, Morihisa Y, Kobayashi T, Akiyama S et al.. Multiple gastric neuroendocrine tumors associated with long-term use of a proton pump inhibitor and a potassium-competitive acid blocker. Internal Medicine. 2024;63(14):2001-2010$52$YR$$M$Y$$$20240827$$HP$JP$JP
234185813$23418581$3$F$$20240815$20240118$20240821$EXP$$US-SANDOZ INC.-SDZ2024US005647$SANDOZ$$$$$F$Y$$$20240821$$CN$US$US
234186542$23418654$2$F$$20240808$20240118$20240904$PER$$US-UROVANT SCIENCES GMBH-202310-URV-002052$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
234186772$23418677$2$F$$20240628$20240118$20240703$PER$$JP-Eisai-EC-2024-156975$EISAI$$$$$M$Y$$$20240703$$MD$JP$JP
234186922$23418692$2$F$$20240718$20240118$20240725$EXP$$ES-SANDOZ INC.-GXKR2009ES05065$SANDOZ$$54$YR$$M$Y$$$20240725$$MD$ES$ES
234187193$23418719$3$F$20240729$20240730$20240118$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009168$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$85.55$KG$20240731$$CN$US$US
234188363$23418836$3$F$$20240718$20240118$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007884$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240722$$CN$US$US
234188482$23418848$2$F$20240104$20240712$20240118$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-020555$JAZZ$$43$YR$$F$Y$$$20240722$$HP$US$US
234188504$23418850$4$F$20230222$20240729$20240118$20240731$EXP$$FR-BAUSCH-BL-2024-000607$BAUSCH AND LOMB$$74$YR$$M$Y$62$KG$20240731$$HP$FR$FR
234188576$23418857$6$F$20160101$20240805$20240118$20240806$EXP$$AT-SANDOZ INC.-NVSC2023AT122657$SANDOZ$$50$YR$$M$Y$$$20240806$$MD$AT$AT
234188622$23418862$2$F$20230717$20240711$20240118$20240714$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-015357$JAZZ$$55$YR$$M$Y$$$20240714$$CN$US$US
234190562$23419056$2$F$20231106$20240703$20240118$20240708$EXP$$US-PFIZER INC-PV202400004638$PFIZER$$63$YR$$F$Y$50.7$KG$20240708$$MD$US$US
234190644$23419064$4$F$20240101$20240624$20240118$20240701$EXP$$US-BAUSCH-BL-2024-000507$BAUSCH AND LOMB$$59$YR$$F$Y$$$20240701$$CN$US$US
234191123$23419112$3$F$$20231219$20240118$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-003623$ENDO$$$$$M$Y$$$20240918$$CN$US$US
234191512$23419151$2$F$$20230622$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003843$ENDO$$$$$F$Y$$$20240712$$CN$US$US
234191622$23419162$2$F$$20230621$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003932$ENDO$$$$$$Y$$$20240712$$CN$US$US
234191863$23419186$3$F$20240104$20240625$20240118$20240703$PER$$JP-Eisai-EC-2024-157357$EISAI$$$$E$F$Y$90$KG$20240703$$MD$JP$JP
234193176$23419317$6$F$20231201$20240806$20240118$20240816$EXP$$JP-JNJFOC-20240147588$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240816$$CN$JP$JP
234193502$23419350$2$F$$20230605$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-002836$ENDO$$$$$$Y$$$20240712$$CN$US$US
234193632$23419363$2$F$$20230603$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-002861$ENDO$$$$$$Y$$$20240712$$CN$US$US
234194153$23419415$3$F$$20230603$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003155$ENDO$$$$$M$Y$$$20240712$$CN$US$US
234194183$23419418$3$F$$20230607$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003117$ENDO$$$$$M$Y$$$20240712$$CN$US$US
234194267$23419426$7$F$$20240911$20240118$20240918$EXP$$CA-JNJFOC-20231148509$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240918$$HP$CA$CA
234194672$23419467$2$F$$20231025$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-005619$ENDO$$$$$$Y$$$20240712$$CN$US$US
234194714$23419471$4$F$$20231003$20240118$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005337$ENDO$$$$$M$Y$$$20240916$$CN$US$US
234194746$23419474$6$F$$20231025$20240118$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005616$ENDO$$$$$F$Y$$$20240916$$CN$US$US
234194796$23419479$6$F$$20231010$20240118$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-005433$ENDO$$$$$M$Y$$$20240918$$CN$US$US
234194802$23419480$2$F$$20231017$20240118$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-005530$ENDO$$$$$M$Y$$$20240917$$CN$US$US
234194834$23419483$4$F$$20231010$20240118$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-005423$ENDO$$$$$M$Y$$$20240917$$CN$US$US
234194844$23419484$4$F$$20231003$20240118$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-005322$ENDO$$$$$F$Y$$$20240918$$CN$US$US
234194903$23419490$3$F$$20231017$20240118$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-005526$ENDO$$$$$M$Y$$$20240917$$CN$US$US
234194942$23419494$2$F$$20231003$20240118$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005327$ENDO$$$$$M$Y$$$20240916$$CN$US$US
234194954$23419495$4$F$$20231107$20240118$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005797$ENDO$$$$$M$Y$$$20240916$$CN$US$US
234195792$23419579$2$F$20240115$20240726$20240118$20240730$PER$$US-AMGEN-USASP2024010295$AMGEN$$65$YR$E$M$Y$$$20240730$$CN$US$US
234195952$23419595$2$F$$20230703$20240118$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-004123$ENDO$$$$$M$Y$$$20240712$$CN$US$US
234196055$23419605$5$F$$20231003$20240118$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005328$ENDO$$$$$F$Y$$$20240916$$$US$US
234196084$23419608$4$F$$20231003$20240118$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005338$ENDO$$$$$M$Y$$$20240916$$CN$US$US
234196095$23419609$5$F$$20240220$20240118$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005324$ENDO$$$$$M$Y$$$20240916$$CN$US$US
234196185$23419618$5$F$$20231003$20240118$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005316$ENDO$$$$$F$Y$$$20240916$$CN$US$US
234196483$23419648$3$F$20220320$20231010$20240119$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005428$ENDO$$31$YR$$M$Y$$$20240916$$CN$US$US
234196514$23419651$4$F$$20231017$20240119$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005527$ENDO$$$$$M$Y$$$20240916$$CN$US$US
2341965213$23419652$13$F$$20240625$20240119$20240709$EXP$$US-MALLINCKRODT-MNK202400143$MALLINCKRODT$$84$YR$E$F$Y$$$20240709$$HP$US$US
234196533$23419653$3$F$$20231031$20240119$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-005679$ENDO$$$$$M$Y$$$20240712$$CN$US$US
234196542$23419654$2$F$$20231031$20240119$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005702$ENDO$$$$$M$Y$$$20240916$$CN$US$US
234196553$23419655$3$F$$20231114$20240119$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-005853$ENDO$$$$$F$Y$$$20240917$$CN$US$US
234196562$23419656$2$F$$20231114$20240119$20240805$PER$$US-ENDO PHARMACEUTICALS INC-2023-005850$ENDO$$$$$F$Y$$$20240805$$CN$US$US
234196617$23419661$7$F$$20231010$20240119$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005442$ENDO$$$$$M$Y$$$20240916$$CN$US$US
234196792$23419679$2$F$20190819$20240730$20240119$20240806$EXP$$JP-GSK-JP2024JPN006467$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$MD$JP$JP
234197182$23419718$2$F$20231020$20240722$20240119$20240729$EXP$FR-AFSSAPS-AM2023001042$FR-RDY-SPO/FRA/24/0000663$DR REDDYS$$83$YR$E$M$Y$73$KG$20240729$$MD$FR$FR
234197263$23419726$3$F$20201210$20240701$20240119$20240708$EXP$DE-002147023-NVSC2023DE017430$DE-RDY-CLI/GER/23/0176609$DR REDDYS$$70$YR$E$F$Y$73$KG$20240708$$HP$DE$DE
234197632$23419763$2$F$$20240705$20240119$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007709$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240708$$CN$US$US
234197664$23419766$4$F$20220211$20240814$20240119$20240821$EXP$$CO-TAKEDA-2020TUS052227$TAKEDA$$48$YR$$M$Y$65$KG$20240821$$HP$CO$CO
234197842$23419784$2$F$20240110$20240807$20240119$20240814$EXP$$CA-GSK-CA2024003904$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$CA$CA
234198132$23419813$2$F$20240108$20240109$20240119$20240913$PER$$US-ABBVIE-5585220$ABBVIE$$33$YR$$F$Y$69.4$KG$20240913$$MD$US$US
234198324$23419832$4$F$20231228$20240822$20240119$20240902$EXP$$US-BEH-2024167602$CSL BEHRING$$63$YR$A$F$Y$87.982$KG$20240902$$HP$US$US
234198383$23419838$3$F$20231217$20240709$20240119$20240711$EXP$$JP-TAKEDA-2023TJP016965$TAKEDA$$5$DEC$$F$Y$$$20240711$$MD$JP$JP
234199512$23419951$2$F$20240115$20240731$20240119$20240802$PER$$US-AMGEN-USASP2024011136$AMGEN$$69$YR$E$M$Y$$$20240802$$CN$US$US
234199595$23419959$5$F$20231201$20240828$20240119$20240904$EXP$$CO-GSK-CO2023AMR116676$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$CO$CO
234199602$23419960$2$F$20190102$20240717$20240119$20240724$EXP$$JP-GSK-JP2024JPN005896$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$JP$JP
234200032$23420003$2$F$20240116$20240722$20240119$20240727$PER$$US-AMGEN-USASP2024010967$AMGEN$$79$YR$E$M$Y$$$20240727$$CN$US$US
234200793$23420079$3$F$$20240902$20240119$20240905$EXP$$JP-GSK-JP2024JPN008281$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
234201022$23420102$2$F$20220622$20240813$20240119$20240815$EXP$$US-TAKEDA-2022TUS043048$TAKEDA$$54$YR$$F$Y$47$KG$20240815$$CN$US$US
234201154$23420115$4$F$20240103$20240206$20240119$20240906$EXP$$BR-TEVA-VS-3146288$TEVA$$52$YR$$M$Y$102$KG$20240906$$HP$BR$BR
234201232$23420123$2$F$$20240726$20240119$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-001840$AUROBINDO$$47$YR$$F$Y$$$20240807$$HP$CA$CA
234201544$23420154$4$F$20240102$20240710$20240119$20240808$PER$$US-AMGEN-USASP2024006972$AMGEN$$$$$$Y$$$20240808$$PH$US$US
234201604$23420160$4$F$20240118$20240213$20240119$20240925$PER$$US-GSK-US2024AMR007406$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
234201884$23420188$4$F$20231001$20240910$20240119$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-001021$JAZZ$$46$YR$$F$Y$$$20240913$$CN$US$US
234202082$23420208$2$F$$20240826$20240119$20240904$EXP$$US-GSK-US2023046648$GLAXOSMITHKLINE$$$$$F$Y$68.76$KG$20240904$$CN$US$US
234202285$23420228$5$F$$20240917$20240119$20240920$PER$$US-HALEON-USCH2024002325$Haleon PLC$$$$$F$Y$$$20240920$$CN$US$US
234202303$23420230$3$F$20220124$20240827$20240119$20240829$EXP$$JP-TAKEDA-2024TJP000491$TAKEDA$$10$YR$$M$Y$23.9$KG$20240829$$MD$JP$JP
234202534$23420253$4$F$20231127$20240826$20240119$20240904$EXP$$IL-CELLTRION INC.-2024IL000990$CELLTRION$$$$$$Y$$$20240904$$CN$IL$IL
234202546$23420254$6$F$$20240905$20240119$20240909$EXP$$US-TAKEDA-2023TUS121589$TAKEDA$$$$$M$Y$53.06$KG$20240909$$HP$US$US
234203092$23420309$2$F$20240806$20240829$20240119$20240830$EXP$$GB-SANDOZ INC.-SDZ2024GB005814$SANDOZ$$$$E$M$Y$$$20240830$$CN$GB$GB
234203114$23420311$4$F$$20240710$20240119$20240716$EXP$$CA-TAKEDA-2024TUS004669$TAKEDA$$$$$F$Y$$$20240716$$CN$CA$CA
234203582$23420358$2$F$20211128$20240724$20240119$20240726$EXP$CZ-CZSUKL-23004865$CZ-ORGANON-O2401CZE001262$ORGANON$$28$YR$$M$Y$$$20240726$$MD$CZ$CZ
234203924$23420392$4$F$$20240805$20240119$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009552$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240808$$CN$US$US
234203976$23420397$6$F$20230108$20240903$20240119$20240910$EXP$$CA-GSK-CA2023182229$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$HP$CA$CA
234205253$23420525$3$F$$20240124$20240119$20240910$EXP$GB-MHRA-ADR 28445554$GB-TEVA-VS-3144463$TEVA$$88$YR$$F$Y$$$20240910$$CN$GB$GB
234205412$23420541$2$F$$20240110$20240119$20240703$EXP$GB-MHRA-MED-202401091800570600-KDPQM$GB-TEVA-VS-3144448$TEVA$$71$YR$$M$Y$62$KG$20240703$$MD$GB$GB
234205459$23420545$9$F$20231221$20240806$20240119$20240812$EXP$$CA-JNJFOC-20231267727$JOHNSON AND JOHNSON$$15$YR$T$M$Y$53$KG$20240812$$CN$CA$CA
234205634$23420563$4$F$20240101$20240411$20240119$20240925$PER$$US-GSK-US2024AMR007529$GLAXOSMITHKLINE$$37$YR$$F$Y$$$20240925$$CN$US$US
234206233$23420623$3$F$$20240715$20240119$20240722$EXP$$DE-AMGEN-DEUSP2024008868$AMGEN$$42$YR$A$F$Y$$$20240722$$MD$DE$DE
234206683$23420668$3$F$$20240805$20240119$20240819$EXP$$JP-ROCHE-3491600$ROCHE$Yasuda C, Paku M, Onishi M, Nakai K, Koike M, Kakuda M, et al A Case of Self Injection of Subcutaneous Dalteparin for the Treatment of Cancer-Related Thrombosis. he 30th Annual Meeting of Japanese Society of Pulmonary Embolism Research 2023;:36-.$6$DEC$A$F$Y$$$20240819$$MD$JP$JP
234206782$23420678$2$F$20240113$20240722$20240119$20240724$PER$$US-AMGEN-USASP2024011181$AMGEN$$54$YR$A$M$Y$$$20240724$$CN$US$US
234206827$23420682$7$F$$20240708$20240119$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA005940$SANDOZ$$40$YR$$F$Y$96$KG$20240711$$HP$CA$CA
234207582$23420758$2$F$20240101$20240813$20240119$20240823$30DAY$$US-GSK-US2024004531$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240823$$PH$US$US
234208898$23420889$8$F$$20240910$20240119$20240920$EXP$$US-INSMED, INC.-2023-03263-US$INSMED$$$$$F$Y$$$20240920$$CN$US$US
234210423$23421042$3$F$20240601$20240826$20240119$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009876$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240829$$CN$US$US
234210514$23421051$4$F$$20240711$20240119$20240716$EXP$$US-TAKEDA-2024TUS000644$TAKEDA$$$$$M$Y$67.48$KG$20240716$$MD$US$US
234210972$23421097$2$F$20210101$20240826$20240119$20240909$EXP$$US-UCBSA-2024002817$UCB$$$$$F$Y$$$20240909$$HP$US$US
234211026$23421102$6$F$20240601$20240716$20240119$20240725$EXP$$JP-ABBVIE-5593630$ABBVIE$$60$YR$$F$Y$$$20240725$$CN$JP$JP
234211297$23421129$7$F$20240105$20240809$20240119$20240819$EXP$$US-BAXTER-2024BAX010718$BAXTER$$63$YR$$M$Y$$$20240819$$MD$US$US
234212973$23421297$3$F$20231201$20240628$20240119$20240701$EXP$$JP-BEH-2024167597$CSL BEHRING$$55$YR$A$M$Y$$$20240701$$MD$JP$JP
234213223$23421322$3$F$$20240830$20240119$20240903$EXP$$PH-TAKEDA-2024TUS004809$TAKEDA$$$$$F$Y$$$20240903$$MD$PH$PH
234213476$23421347$6$F$20150101$20240814$20240119$20240816$EXP$$CA-SANDOZ INC.-PHHY2015CA072899$SANDOZ$$60$YR$$F$Y$$$20240816$$CN$CA$CA
234213573$23421357$3$F$20240102$20240912$20240119$20240916$EXP$$US-BEH-2024167371$CSL BEHRING$$34$YR$A$M$Y$$$20240916$$HP$US$US
234213628$23421362$8$F$20240311$20240828$20240119$20240903$EXP$$CA-GSK-CA2023118510$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$HP$CA$CA
234213804$23421380$4$F$$20240902$20240119$20240912$EXP$$US-BEH-2024167416$CSL BEHRING$$$$A$F$Y$$$20240912$$MD$US$US
234213913$23421391$3$F$$20240715$20240119$20240716$EXP$$NVSC2024CA009468$NOVARTIS$$40$YR$$F$Y$96$KG$20240716$$HP$CA$CA
234214882$23421488$2$F$$20240111$20240119$20240801$EXP$$CA-SA-2024SA015374$SANOFI AVENTIS$$$$A$F$Y$97$KG$20240801$$HP$CA$CA
234215237$23421523$7$F$20240202$20240816$20240119$20240822$EXP$$CA-TAKEDA-2022TUS085245$TAKEDA$$74$YR$$M$Y$$$20240822$$MD$CA$CA
234215522$23421552$2$F$$20240105$20240119$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-427634$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
234215622$23421562$2$F$$20240805$20240119$20240820$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-428017$RANBAXY$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A, et al. B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature. Leuk Lymphoma. 2023;64(10):1701-1705$68$YR$$F$Y$$$20240820$$HP$ES$ES
234215652$23421565$2$F$20211201$20240716$20240119$20240731$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-428002$RANBAXY$$24$YR$$M$Y$100$KG$20240731$$CN$IT$IT
234215672$23421567$2$F$$20240826$20240119$20240910$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-428022$RANBAXY$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A, et al. B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature. Leuk Lymphoma. 2023;64(10):1701-1705$67$YR$$M$Y$$$20240910$$HP$ES$ES
234215695$23421569$5$F$$20240906$20240119$20240910$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-101475$DAIICHI$$$$$M$Y$$$20240910$$MD$US$US
234216183$23421618$3$F$20240701$20240807$20240119$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009571$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240809$$CN$US$US
234216729$23421672$9$F$20240109$20240923$20240119$20240930$EXP$$CA-GSK-CA2024006288$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$CA$CA
234216946$23421694$6$F$$20240905$20240119$20240924$PER$$CA-TOLMAR, INC.-23CA045779$TOLMAR$$$$$M$Y$82.086$KG$20240923$$CN$CA$CA
234216972$23421697$2$F$20240612$20240612$20240119$20240701$PER$$CA-TOLMAR, INC.-23CA045775$TOLMAR$$80$YR$$M$Y$$$20240701$$CN$CA$CA
234217102$23421710$2$F$$20240614$20240119$20240701$PER$$CA-TOLMAR, INC.-23CA045769$TOLMAR$$$$$M$Y$$$20240701$$CN$CA$CA
234217113$23421711$3$F$20231227$20240806$20240119$20240827$PER$$CA-TOLMAR, INC.-23CA045770$TOLMAR$$75$YR$$M$Y$$$20240827$$CN$CA$CA
234217153$23421715$3$F$20231227$20240806$20240119$20240827$PER$$CA-TOLMAR, INC.-23CA045772$TOLMAR$$74$YR$$M$Y$$$20240827$$CN$CA$CA
234217163$23421716$3$F$20230101$20240814$20240119$20240902$PER$$CA-TOLMAR, INC.-23CA045781$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
2342178211$23421782$11$F$20231201$20240917$20240119$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2019-US-018563$JAZZ$$75$YR$$F$Y$$$20240923$$MD$US$US
234218153$23421815$3$F$$20240710$20240119$20240712$PER$$US-PFIZER INC-202400016468$PFIZER$$77$YR$$F$Y$$$20240712$$CN$US$US
234218264$23421826$4$F$20240101$20240719$20240119$20240723$EXP$$US-PFIZER INC-PV202400007325$PFIZER$$79$YR$$F$Y$$$20240723$$HP$US$US
234218943$23421894$3$F$$20240813$20240119$20240819$EXP$$CA-SANDOZ INC.-NVSC2022CA223711$SANDOZ$$69$YR$$M$Y$$$20240819$$HP$CA$CA
234219052$23421905$2$F$$20240715$20240119$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009960$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240716$$HP$US$US
234219525$23421952$5$F$20231209$20240814$20240119$20240823$EXP$$DE-PFIZER INC-202400016530$PFIZER$$53$YR$$M$Y$$$20240823$$HP$DE$DE
234219552$23421955$2$F$$20240819$20240119$20240821$EXP$$US-PFIZER INC-PV202200128659$PFIZER$$58$YR$$F$Y$$$20240821$$CN$US$US
234219578$23421957$8$F$20240101$20240820$20240119$20240826$PER$$US-BIOGEN-2024BI01245736$BIOGEN$$78$YR$$F$Y$$$20240826$$CN$US$US
234220527$23422052$7$F$20221217$20240404$20240119$20240930$EXP$$US-TPU-TPU-2024-00003$TEIKOKU$$50$YR$A$F$Y$$$20240930$$CN$US$US
234220673$23422067$3$F$20240117$20240709$20240119$20240712$EXP$$US-GSK-US2024004567$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$HP$US$US
234221343$23422134$3$F$$20240626$20240119$20240917$PER$$US-BAYER-2024A005968$BAYER$$89$YR$E$F$Y$$$20240917$$CN$US$US
234221653$23422165$3$F$20220608$20240723$20240119$20240729$EXP$$DE-ROCHE-3306488$ROCHE$$37$YR$A$F$Y$55$KG$20240729$$MD$DE$DE
234221963$23422196$3$F$20240718$20240718$20240119$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009242$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240726$$HP$US$US
234222018$23422201$8$F$$20240626$20240119$20240701$EXP$$NVSC2024US007138$NOVARTIS$$$$$M$Y$$$20240701$$CN$US$US
234222134$23422213$4$F$20240103$20240807$20240119$20240812$EXP$$NVSC2024US010393$NOVARTIS$$68$YR$$F$Y$$$20240812$$CN$US$US
234222192$23422219$2$F$$20240919$20240119$20240925$EXP$$JP-SHIONOGI INC.-2024000037$SHIONOGI$$76$YR$E$M$Y$60.8$KG$20240925$$MD$JP$JP
234222442$23422244$2$F$$20240722$20240119$20240727$EXP$$US-SA-2024SA021115$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240727$$MD$US$US
234222882$23422288$2$F$$20240509$20240119$20240827$EXP$$CA-CHATTEMPRD-2023SA035304$CHATTEM$$65$YR$E$F$Y$69$KG$20240827$$HP$CA$CA
234222962$23422296$2$F$$20240724$20240119$20240731$EXP$$CA-CHATTEMPRD-2024OHG001844$CHATTEM$$40$YR$A$F$Y$$$20240731$$HP$CA$CA
234223002$23422300$2$F$$20240912$20240119$20240923$PER$$US-INCYTE CORPORATION-2024IN000558$INCYTE$$$$$$Y$$$20240923$$CN$US$US
234223262$23422326$2$F$$20240916$20240119$20240926$PER$$US-INCYTE CORPORATION-2024IN000491$INCYTE$$$$$$Y$$$20240926$$CN$US$US
234223584$23422358$4$F$20230423$20240626$20240119$20240702$PER$$US-BIOGEN-2023BI01201623$BIOGEN$$59$YR$$F$Y$$$20240702$$CN$US$US
234223975$23422397$5$F$$20240627$20240119$20240712$EXP$$JP-ROCHE-3492502$ROCHE$Hamada K, Tanaka A, Kiriyama T, Saito K, Sugie K, Tanimoto R et al. A case of occurrence of posterior reversible encephalopathy syndrome/reversible cerebral vasoconstriction syndrome during immunotherapy for Takayasu^s arteritis [Abstract number: 8].. The 242nd Kinki Regional Meeting of the Japanese Society of Internal Medicine 2023;:-.$33$YR$A$M$Y$$$20240712$$MD$JP$JP
234224485$23422448$5$F$20240113$20240830$20240119$20240902$PER$$US-AMGEN-USASP2024009878$AMGEN$$68$YR$E$M$Y$$$20240902$$CN$US$US
234224972$23422497$2$F$$20240709$20240119$20240716$EXP$$CA-GSK-CA2023030278$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$CA$CA
234225464$23422546$4$F$$20240819$20240119$20240823$EXP$$NVSC2024CA010439$NOVARTIS$$65$YR$$F$Y$95$KG$20240823$$HP$CA$CA
234225703$23422570$3$F$20240103$20240712$20240119$20240725$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00028$AVADEL CNS PHARMA$$47$YR$$F$Y$$$20240725$$CN$US$US
234225943$23422594$3$F$$20240912$20240119$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009830$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240916$$CN$US$US
234226042$23422604$2$F$$20240904$20240119$20240913$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-007634$BRISTOL MYERS SQUIBB$Franchi V, Labussiere-Wallet H, Chouik Y, Heiblig M, Larcher M. Tandem duplications (tds) of the ubtf gene in acute myeloid leukaemia complicated by post hematopoietic stem cell transplantation venoocclusive disease treated by liver transplantation. Letters in Oncology-Haematology. 2023;18(6):349-51.$25$YR$A$M$Y$$$20240913$$HP$FR$FR
234226112$23422611$2$F$$20240117$20240119$20240905$EXP$$NVSC2024US011246$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
234227174$23422717$4$F$$20240902$20240119$20240906$EXP$$CA-TAKEDA-2024TUS005579$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
234227284$23422728$4$F$$20240910$20240119$20240916$EXP$$US-TAKEDA-2024TUS004572$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
234227983$23422798$3$F$$20240709$20240119$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009913$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240711$$CN$US$US
234228113$23422811$3$F$20231223$20240701$20240119$20240705$EXP$FR-AFSSAPS-RE2024000024$FR-BAUSCH-BL-2024-000682$BAUSCH AND LOMB$$43$YR$$F$Y$60$KG$20240705$$MD$FR$FR
234228792$23422879$2$F$$20240701$20240119$20240710$PER$$US-SA-2024SA016949$SANOFI AVENTIS$$$$C$M$Y$$$20240710$$MD$US$US
234228864$23422886$4$F$20231201$20240821$20240119$20240917$PER$$US-SA-2024SA017812$SANOFI AVENTIS$$3$YR$C$M$Y$15.69$KG$20240918$$MD$US$US
234229053$23422905$3$F$$20240812$20240119$20240821$PER$$US-SA-2024SA017966$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240821$$MD$US$US
234229105$23422910$5$F$20240301$20240819$20240119$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009793$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240821$$CN$US$US
234229935$23422993$5$F$20240105$20240809$20240119$20240814$EXP$$US-FreseniusKabi-FK202400726$FRESENIUS KABI$$63$YR$A$M$Y$$$20240814$$HP$US$US
234230173$23423017$3$F$20231223$20240704$20240119$20240708$EXP$FR-AFSSAPS-RE2024000024$FR-MYLANLABS-2024M1005700$MYLAN$$43$YR$$F$Y$60$KG$20240708$$MD$FR$FR
234230732$23423073$2$F$$20240910$20240119$20240914$EXP$$CA-ABBVIE-5593577$ABBVIE$$$$$M$Y$$$20240914$$CN$CA$CA
234230745$23423074$5$F$20230128$20240725$20240119$20240730$EXP$$JP-ABBVIE-5538638$ABBVIE$$87$YR$$F$Y$51$KG$20240730$$MD$JP$JP
234230764$23423076$4$F$20231001$20240806$20240119$20240813$EXP$$CA-GSK-CA2023181128$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CA$CA
234231702$23423170$2$F$20230802$20240730$20240119$20240802$EXP$$JP-AstraZeneca-2024A014348$ASTRAZENECA$$57$YR$$M$Y$51$KG$20240802$$MD$JP$
234231872$23423187$2$F$20240201$20240715$20240119$20240722$EXP$$IE-TAKEDA-2024TUS003693$TAKEDA$$32$YR$$M$Y$$$20240722$$CN$IE$IE
234232737$23423273$7$F$20240117$20240822$20240119$20240823$EXP$$CA-TAKEDA-2024TUS003928$TAKEDA$$70$YR$$F$Y$$$20240823$$HP$CA$CA
234232783$23423278$3$F$$20240628$20240119$20240703$EXP$$US-Taiho Oncology Inc-2023-008336$TAIHO ONCOLOGY INC$$$$E$M$Y$$$20240703$$CN$US$US
234233313$23423331$3$F$20231128$20240808$20240119$20240815$EXP$$JP-009507513-2401JPN001316J$MERCK$$52$YR$$F$Y$$$20240815$$MD$JP$JP
234233525$23423352$5$F$20240509$20240920$20240119$20240930$EXP$$US-BEH-2024167519$CSL BEHRING$$37$YR$A$F$Y$$$20240930$$HP$US$US
234233663$23423366$3$F$20240110$20240918$20240119$20240925$EXP$$CN-VER-202400001$VERITY PHARMACEUTICALS$$59$YR$A$M$Y$72$KG$20240925$$HP$CN$CN
234233775$23423377$5$F$20240112$20240709$20240119$20240718$EXP$$JP-009507513-2401JPN001533J$MERCK$$54$YR$$F$Y$$$20240718$$MD$JP$JP
234234522$23423452$2$F$20230801$20240828$20240119$20240903$EXP$$MX-BIOMARINAP-MX-2024-155116$BIOMARIN$$$$$$Y$$$20240903$$CN$MX$MX
234234563$23423456$3$F$20230227$20240821$20240119$20240826$EXP$$JP-AstraZeneca-2024A014049$ASTRAZENECA$Hoshio H, et al.. R-049 A case of successfully treated cardiopulmonary arrest induced by QT prolongation during osimertinib readministration.. The 69th Chugoku/Shikoku Regional Meeting of the Japanese Respiratory Society 2023;67-.$69$YR$$F$Y$45$KG$20240826$$MD$JP$
234234982$23423498$2$F$20230401$20240711$20240119$20240715$EXP$$US-PFIZER INC-202400014042$PFIZER$$60$YR$$F$Y$$$20240715$$HP$US$US
234235007$23423500$7$F$20240601$20240823$20240119$20240828$EXP$$US-PFIZER INC-202400011987$PFIZER$$57$YR$$F$Y$75.3$KG$20240828$$CN$US$US
234235043$23423504$3$F$20230101$20240716$20240119$20240723$EXP$$CA-PFIZER INC-202300309641$PFIZER$$78$YR$$M$Y$$$20240723$$PH$CA$CA
234235645$23423564$5$F$20240101$20240903$20240119$20240912$EXP$$IT-BAUSCH-BL-2024-000834$BAUSCH AND LOMB$$69$YR$$F$Y$$$20240912$$CN$IT$IT
234236362$23423636$2$F$20240101$20240709$20240119$20240723$PER$$US-BEH-2024167496$CSL BEHRING$$63$YR$A$M$Y$$$20240723$$CN$US$US
234236473$23423647$3$F$20220913$20240626$20240119$20240711$EXP$$JP-LUNDBECK-DKLU3072770$LUNDBECK$$$$$$Y$$$20240711$$MD$JP$JP
234236964$23423696$4$F$$20240729$20240119$20240802$EXP$$CA-ROCHE-3493497$ROCHE$$$$A$M$Y$$$20240803$$CN$CA$CA
234236982$23423698$2$F$20240112$20240709$20240119$20240710$PER$$US-AMGEN-USASP2024009185$AMGEN$$68$YR$E$M$Y$$$20240710$$CN$US$US
234237492$23423749$2$F$$20240703$20240119$20240712$PER$$US-SA-2024SA019250$SANOFI AVENTIS$$$$E$M$Y$$$20240712$$MD$US$US
234237532$23423753$2$F$20230803$20240812$20240119$20240821$PER$$US-SA-2024SA020081$SANOFI AVENTIS$$20$YR$A$F$Y$78$KG$20240821$$CN$US$US
234237654$23423765$4$F$$20240830$20240119$20240924$PER$$US-SA-2024SA017757$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240924$$MD$US$US
234237683$23423768$3$F$20231201$20240621$20240119$20240701$PER$$US-SA-2024SA020020$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240701$$MD$US$US
234237877$23423787$7$F$20231101$20240815$20240119$20240820$PER$$US-SA-2024SA020032$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240820$$MD$US$US
234238143$23423814$3$F$20230101$20240708$20240119$20240713$PER$$US-SA-2024SA016760$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240713$$CN$US$US
234238225$23423822$5$F$20240501$20240905$20240119$20240920$EXP$$US-SA-2024SA020028$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240920$$MD$US$US
234238833$23423883$3$F$20231221$20240913$20240119$20240925$PER$$US-SA-2024SA017648$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240925$$MD$US$US
234239133$23423913$3$F$$20240624$20240119$20240702$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000025$DECIPHERA PHARMACEUTICALS$$73$YR$E$F$Y$$$20240702$$CN$US$US
234240394$23424039$4$F$$20240701$20240120$20240710$EXP$$FI-CELLTRION INC.-2024FI001174$CELLTRION$Honkaniemi J, Ortiz R.. Hemofagosyyttisen lymfohistiosytoosin neurologiset ilmenemismuodot. Laaketieteellinen Aikakauskirja Duodecim. 2024;140(1):27-34$$$$$Y$$$20240710$$HP$FI$FI
234240423$23424042$3$F$20211030$20240630$20240120$20240704$EXP$$US-AMGEN-USASP2024007446$AMGEN$$74$YR$E$F$Y$$$20240704$$CN$US$US
234240913$23424091$3$F$20240114$20240830$20240120$20240902$PER$$US-AMGEN-USASP2024009669$AMGEN$$70$YR$E$M$Y$$$20240902$$CN$US$US
234241772$23424177$2$F$20240114$20240705$20240120$20240707$PER$$US-AMGEN-USASP2024012013$AMGEN$$84$YR$E$F$Y$$$20240707$$CN$US$US
234241993$23424199$3$F$20240114$20240801$20240120$20240806$PER$$US-AMGEN-USASP2024010351$AMGEN$$52$YR$A$M$Y$$$20240806$$CN$US$US
234242822$23424282$2$F$20231219$20240108$20240120$20240702$EXP$$CN-TEVA-VS-3147138$TEVA$$58$YR$$M$Y$169$KG$20240702$$MD$CN$CN
234242993$23424299$3$F$$20240727$20240120$20240731$PER$$US-AMGEN-USASP2024010096$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
234243746$23424374$6$F$$20240729$20240120$20240806$EXP$$CA-ROCHE-3342105$ROCHE$$$$A$F$Y$$$20240806$$CN$CA$CA
234244102$23424410$2$F$20240115$20240726$20240120$20240731$PER$$US-AMGEN-USASP2024010163$AMGEN$$76$YR$E$F$Y$$$20240731$$CN$US$US
234244116$23424411$6$F$20240109$20240716$20240120$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-001160$UNITED THERAPEUTICS$$85$YR$$M$Y$69.841$KG$20240726$$$US$US
234244232$23424423$2$F$20221201$20240628$20240120$20240702$EXP$$GB-UCBSA-2023000052$UCB$$64$YR$$F$Y$$$20240702$$CN$GB$GB
234244495$23424449$5$F$20231110$20240814$20240120$20240827$EXP$$DE-AUROBINDO-AUR-APL-2024-001835$AUROBINDO$$$$A$F$Y$65.4$KG$20240827$$HP$DE$DE
2342446216$23424462$16$F$20240101$20240917$20240120$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-001303$UNITED THERAPEUTICS$$$$$F$Y$54.875$KG$20240926$$$US$US
234245612$23424561$2$F$20240115$20240727$20240120$20240730$PER$$US-AMGEN-USASP2024011092$AMGEN$$65$YR$E$M$Y$$$20240730$$CN$US$US
234245848$23424584$8$F$20240206$20240718$20240120$20240723$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-102233$DAIICHI$$34$YR$$M$Y$93.878$KG$20240723$$CN$US$US
234245854$23424585$4$F$20240116$20240731$20240120$20240801$EXP$$US-UCBSA-2024002633$UCB$$66$YR$$M$Y$$$20240801$$CN$US$US
234245925$23424592$5$F$20230101$20240815$20240120$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2023-035364$UNITED THERAPEUTICS$$$$$F$Y$58.503$KG$20240823$$$US$US
234246164$23424616$4$F$$20240708$20240120$20240711$30DAY$$US-GSK-US2024004467$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
234246823$23424682$3$F$20231001$20240723$20240120$20240728$EXP$$CA-JNJFOC-20240132554$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240728$$HP$CA$CA
234247072$23424707$2$F$20240601$20240620$20240120$20240702$EXP$$CO-MSNLABS-2024MSNSPO00129$MSN LABORATORIES$$$$$$Y$$$20240702$$CN$CO$CO
234247103$23424710$3$F$20230907$20240816$20240120$20240823$EXP$$DE-GSK-DE2024EME008148$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$DE$DE
234247283$23424728$3$F$20230901$20240731$20240120$20240807$EXP$$CA-GSK-CA2023146515$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$HP$CA$CA
234247782$23424778$2$F$$20240808$20240120$20240820$PER$$US-SA-2024SA019664$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240820$$MD$US$US
234248272$23424827$2$F$$20240712$20240121$20240722$EXP$$CA-APOTEX-2024AP001032$APOTEX$$$$$F$Y$$$20240722$$HP$CA$CA
234248442$23424844$2$F$$20240701$20240121$20240710$EXP$ES-RDY-LIT/ESP/24/0000554$ES-RDY-LIT/ESP/24/0000554$DR REDDYS$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A, et al. B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature. Leukemia and Lymphoma. 2023;64: 1701-1705. doi:10.1080/10428194.2023.2234527.$67$YR$E$M$Y$$$20240710$$HP$ES$ES
234248472$23424847$2$F$$20240710$20240121$20240719$PER$$US-SA-2024SA019596$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240719$$MD$US$US
234248592$23424859$2$F$$20240702$20240121$20240705$EXP$$CA-JNJFOC-20240108278$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240705$$HP$CA$CA
234249672$23424967$2$F$20230101$20240702$20240121$20240711$PER$$US-SA-2024SA016982$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240711$$MD$US$US
234249974$23424997$4$F$$20240806$20240121$20240809$EXP$$US-SANDOZ INC.-SDZ2023US055741$SANDOZ$$$$$F$Y$74.83$KG$20240809$$CN$US$US
234250005$23425000$5$F$$20240803$20240121$20240904$EXP$$NVSC2024CA010313$NOVARTIS$$44$YR$$F$Y$97$KG$20240904$$HP$CA$CA
234250012$23425001$2$F$$20240715$20240121$20240717$EXP$$NVSC2024CA009422$NOVARTIS$$44$YR$$F$Y$$$20240717$$HP$CA$CA
234250058$23425005$8$F$20231201$20240909$20240121$20240917$EXP$$NVSC2024BR009739$NOVARTIS$$66$YR$$F$Y$68$KG$20240918$$CN$BR$BR
234250104$23425010$4$F$20240110$20240208$20240121$20240808$EXP$$NVSC2024HU008777$NOVARTIS$$$$A$F$Y$$$20240808$$HP$HU$HU
234250223$23425022$3$F$20231201$20240911$20240121$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-009424$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$65$KG$20240920$$MD$JP$JP
234250394$23425039$4$F$$20240715$20240121$20240723$EXP$$CA-SANDOZ INC.-SDZ2023CA075640$SANDOZ$$44$YR$$F$Y$97$KG$20240723$$HP$CA$CA
234250615$23425061$5$F$20240115$20240919$20240121$20240927$EXP$$DE-SANDOZ INC.-SDZ2024DE006276$SANDOZ$$$$E$F$Y$$$20240927$$HP$DE$DE
234251032$23425103$2$F$20240101$20240805$20240121$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-008633$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240826$$CN$US$US
234251064$23425106$4$F$20240526$20240801$20240121$20240805$EXP$$US-TAKEDA-2023TUS068720$TAKEDA$$30$YR$$M$Y$86$KG$20240805$$CN$US$US
234251433$23425143$3$F$20230601$20240723$20240121$20240729$EXP$$US-ROCHE-3494785$ROCHE$$53$YR$A$F$Y$$$20240729$$CN$US$US
234251662$23425166$2$F$20240114$20240726$20240121$20240731$EXP$$CA-ROCHE-2977930$ROCHE$$53$YR$A$M$Y$$$20240731$$CN$CA$CA
234251892$23425189$2$F$20240115$20240709$20240121$20240710$PER$$US-AMGEN-USASP2024010381$AMGEN$$78$YR$E$F$Y$$$20240710$$CN$US$US
234252113$23425211$3$F$20240116$20240726$20240121$20240730$PER$$US-AMGEN-USASP2024010318$AMGEN$$53$YR$A$M$Y$$$20240730$$MD$US$US
234252504$23425250$4$F$20231201$20240802$20240121$20240826$PER$$PA-TOLMAR, INC.-23PA045740$TOLMAR$$91$YR$$M$Y$$$20240826$$CN$PA$PA
234252612$23425261$2$F$$20240815$20240121$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-001951$AUROBINDO$$75$YR$$F$Y$$$20240828$$HP$CA$CA
234252902$23425290$2$F$$20240626$20240122$20240701$EXP$$CA-TAKEDA-2023TUS103529$TAKEDA$$$$$M$Y$$$20240701$$CN$CA$CA
234254253$23425425$3$F$20231223$20240701$20240122$20240715$EXP$FR-AFSSAPS-RE2024000024$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-102574$ZYDUS PHARM$$$$$$Y$$$20240715$$MD$FR$FR
234255753$23425575$3$F$20220801$20240826$20240122$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-033631$JAZZ$$27$YR$$F$Y$$$20240828$$CN$US$US
234256652$23425665$2$F$20230717$20240716$20240122$20240726$EXP$$US-Accord-374330$ACCORD$$61$YR$A$M$Y$$$20240726$$MD$US$US
234256688$23425668$8$F$$20240814$20240122$20240821$30DAY$$IL-JNJFOC-20231271077$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$CN$IL$IL
234256714$23425671$4$F$20240117$20240712$20240122$20240715$PER$$US-AMGEN-USASP2024012372$AMGEN$$76$YR$E$M$Y$$$20240715$$CN$US$US
234257755$23425775$5$F$$20240731$20240122$20240805$EXP$$CA-SANDOZ INC.-SDZ2024CA006253$SANDOZ$$40$YR$$F$Y$$$20240805$$HP$CA$CA
234258653$23425865$3$F$20231201$20240708$20240122$20240711$EXP$$CA-GSK-CA2023121598$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$CA$CA
234259014$23425901$4$F$20231001$20240815$20240122$20240821$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-007912$AMGEN$$31$YR$A$F$Y$$$20240821$$HP$US$US
234259032$23425903$2$F$20240116$20240712$20240122$20240715$PER$$US-AMGEN-USASP2024012182$AMGEN$$79$YR$E$F$Y$$$20240714$$CN$US$US
234259077$23425907$7$F$20240701$20240920$20240122$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-000255$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240924$$CN$US$US
234259965$23425996$5$F$20231201$20240821$20240122$20240828$EXP$$CA-GSK-CA2023181135$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$CA$CA
234260053$23426005$3$F$$20240717$20240122$20240725$30DAY$$FR-JNJFOC-20240131280$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$PH$FR$FR
234260132$23426013$2$F$20230519$20240729$20240122$20240808$EXP$$FR-TEVA-VS-3145535$TEVA$$93$YR$$F$Y$50.8$KG$20240808$$PH$FR$FR
234260902$23426090$2$F$$20240816$20240122$20240823$EXP$$CN-ROCHE-2364051$ROCHE$$59$YR$A$M$Y$53$KG$20240823$$CN$CN$CN
234261453$23426145$3$F$20240113$20240830$20240122$20240904$EXP$$CO-TAKEDA-2024TUS004989$TAKEDA$$60$YR$$F$Y$69$KG$20240904$$HP$CO$CO
234261653$23426165$3$F$$20240513$20240122$20240916$EXP$$CA-CHATTEMPRD-2024OHG001903$CHATTEM$$44$YR$A$F$Y$63$KG$20240917$$MD$CA$CA
234262132$23426213$2$F$$20240911$20240122$20240919$EXP$$JP-GSK-JP2024009067$GLAXOSMITHKLINE$Hirokazu Naoi, Sanoyo Sakisaka, Mariko Tominaga, Misaki Kamio, Tomonori Sato, Tomoko Honda, et al. Investigation of niraparib maintenance therapy in patients not tested for HRD at our hospital. unk. 2024;42(3):269$$$$$Y$$$20240919$$MD$JP$JP
234262474$23426247$4$F$$20240827$20240122$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-001927$AUROBINDO$$74$YR$$F$Y$65$KG$20240905$$MD$CA$CA
234262953$23426295$3$F$$20240812$20240122$20240824$EXP$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-00037$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-00037$ALKEM$Suzuki Y, Ishiguro S, Shimada H, Ohgami M, Suzuki M.. Evaluation of mycophenolic acid exposure in a patient with immune-related hepatotoxicity caused by nivolumab and ipilimumab therapy for malignant melanoma: a case report. Cancer Chemotherapy and Pharmacology. 2023;unk:unk$75$YR$$M$Y$$$20240825$$PH$JP$JP
234263242$23426324$2$F$$20240826$20240122$20240903$EXP$$CZ-CELLTRION INC.-2024CZ000741$CELLTRION$Viktorova K, Macejova Z.. Tvari v tvar spondyloartritide [Facing spondyloarthritis].. Remedia. 2023;33(6):418-24$$$$$Y$$$20240903$$HP$CZ$CZ
234263407$23426340$7$F$20230112$20240830$20240122$20240907$EXP$$CA-TAKEDA-2024TUS001848$TAKEDA$$15$YR$$M$Y$$$20240907$$HP$CA$CA
234263613$23426361$3$F$$20240828$20240122$20240904$EXP$$CA-TAKEDA-2024TUS005067$TAKEDA$$$$$F$Y$$$20240904$$CN$CA$CA
234263643$23426364$3$F$20231110$20240701$20240122$20240705$EXP$$US-ABBVIE-5594034$ABBVIE$$67$YR$$F$Y$$$20240705$$CN$US$US
234264022$23426402$2$F$$20240712$20240122$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-006498$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240718$$CN$US$US
234264037$23426403$7$F$20230904$20240910$20240122$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-009993$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$39.2$KG$20240918$$MD$JP$JP
234264234$23426423$4$F$20240105$20240816$20240122$20240823$EXP$$CA-TAKEDA-2024TUS005026$TAKEDA$$25$YR$$F$Y$$$20240823$$CN$CA$CA
234264578$23426457$8$F$$20240730$20240122$20240810$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-008723$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240810$$CN$US$US
234264787$23426478$7$F$20240229$20240515$20240122$20240926$PER$$US-GSK-US2024AMR006075$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240926$$HP$US$US
234265006$23426500$6$F$20231225$20240628$20240122$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-006071$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240723$$CN$US$US
234265023$23426502$3$F$$20240715$20240122$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA006269$SANDOZ$$39$YR$$F$Y$$$20240717$$HP$CA$CA
234265734$23426573$4$F$$20240903$20240122$20240913$EXP$$CA-JNJFOC-20240139582$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240913$$HP$CA$CA
234266197$23426619$7$F$20240531$20240730$20240122$20240807$EXP$$CA-CELLTRION INC.-2024CA001212$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
234266203$23426620$3$F$20231201$20240705$20240122$20240710$30DAY$$US-GSK-US2024005778$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240710$$CN$US$US
234266707$23426670$7$F$$20240626$20240122$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-006045$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
234266793$23426679$3$F$$20240710$20240122$20240712$EXP$$CA-JNJFOC-20240132678$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240712$$HP$CA$CA
234267232$23426723$2$F$20170810$20240918$20240122$20240925$EXP$$BR-TAKEDA-2017TUS022107$TAKEDA$$41$YR$$F$Y$$$20240925$$CN$BR$BR
234267262$23426726$2$F$$20240725$20240122$20240727$EXP$$DE-ROCHE-3493460$ROCHE$$42$YR$A$F$Y$$$20240727$$MD$DE$DE
234267282$23426728$2$F$20220101$20240705$20240122$20240713$EXP$$US-ROCHE-3489391$ROCHE$$54$YR$A$F$Y$$$20240713$$CN$US$US
234267403$23426740$3$F$20230101$20240712$20240122$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-010742$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240722$$CN$US$US
234267624$23426762$4$F$20221207$20240816$20240122$20240822$EXP$$HU-ROCHE-3493793$ROCHE$Miru D, Sohajda Z Massive submacular haemorrhage and bleeding choroidal ablation following intravitreal injection of anti-VEGF. DOI: 10.55342/SZEMHUNGARICA.2023.160.4.198. Ophthalmology 2023;160 (4):198-202.$84$YR$E$F$Y$$$20240822$$MD$HU$HU
234268063$23426806$3$F$$20240723$20240122$20240730$EXP$$CO-SANDOZ INC.-NVSC2021CO187836$SANDOZ$$$$$F$Y$60$KG$20240730$$CN$CO$CO
234269002$23426900$2$F$$20240711$20240122$20240904$EXP$$PT-ROCHE-3491277$ROCHE$$$$$$Y$$$20240904$$MD$PT$PT
234270193$23427019$3$F$20231201$20240922$20240122$20240927$EXP$$SA-GSK-SA2023EME172854$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$SA$SA
234270372$23427037$2$F$20231201$20240622$20240122$20240702$EXP$FR-AFSSAPS-NT2023001379$FR-Accord-401823$ACCORD$$66$YR$E$F$Y$56$KG$20240702$$MD$FR$FR
234271472$23427147$2$F$$20240805$20240122$20240809$EXP$$US-BAUSCHBL-2024BNL000617$BAUSCH AND LOMB$Choi Y, Kong X. Pneumocystis jirovecii pneumonia infection in a patient with anaplastic astrocytoma and radiation necrosis in the setting of corticosteroid and pembrolizumab use. Neuro-Oncology. 2023 NOV 01;25 SUPPLEMENT 5:V154-V155. doi:10.1093/neuonc/noad179.0586$40$YR$$M$Y$$$20240809$$HP$US$US
234271536$23427153$6$F$$20240726$20240122$20240801$EXP$$NVSC2023GB233690$NOVARTIS$$73$YR$$F$Y$$$20240801$$CN$GB$GB
234271774$23427177$4$F$20240118$20240628$20240122$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-010898$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240701$$CN$US$US
234272264$23427226$4$F$20240101$20240826$20240122$20240902$EXP$$CA-GSK-CA2023161681$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$CA$CA
2342723611$23427236$11$F$20230714$20240822$20240122$20240830$EXP$$GB-TEVA-2023-GB-2930055$TEVA$$34$YR$$F$Y$$$20240830$$MD$GB$GB
234273267$23427326$7$F$20231117$20240918$20240122$20240923$EXP$$JP-009507513-2311JPN004432J$MERCK$$4$DEC$$F$Y$$$20240923$$MD$JP$JP
2342733019$23427330$19$F$$20240916$20240122$20240918$EXP$$GB-SANDOZ INC.-SDZ2023GB050268$SANDOZ$$38$YR$$M$Y$104$KG$20240918$$HP$GB$GB
234273314$23427331$4$F$20240119$20240912$20240122$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-010703$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240916$$CN$US$US
234274772$23427477$2$F$20230827$20240711$20240122$20240721$PER$$US-BAYER-2024A010549$BAYER$$54$YR$A$F$Y$$$20240719$$MD$US$US
234275184$23427518$4$F$20240115$20240822$20240122$20240902$PER$$US-AMGEN-USASP2024009575$AMGEN$$71$YR$E$M$Y$$$20240902$$MD$US$US
234275734$23427573$4$F$20231228$20240625$20240122$20240702$EXP$$CA-GSK-CA2024006322$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$CA$CA
234276353$23427635$3$F$20240118$20240925$20240122$20240926$PER$$US-AMGEN-USASP2024011642$AMGEN$$76$YR$E$M$Y$$$20240926$$CN$US$US
234276643$23427664$3$F$$20240731$20240122$20240805$EXP$$US-PFIZER INC-202400016651$PFIZER$Nahm, J.. IMPROVEMENT OF LEPTOMENINGEAL DISEASE (LMD) WITH MEK AND BRAF INHIBITORS, CRANIOSPINAL IRRADIATION (CSI), AND INTRATHECAL (IT) CHEMOTHERAPY IN ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA (PXA).. Neuro-Oncology. 2023;25(Supplement 5:v4$23$YR$$F$Y$$$20240805$$MD$US$US
234277635$23427763$5$F$20240112$20240822$20240122$20240829$EXP$$US-AMGEN-USASP2024009216$AMGEN$$64$YR$A$M$Y$$$20240829$$CN$US$US
234277963$23427796$3$F$20231201$20240709$20240122$20240711$PER$$US-AMGEN-USASP2024011133$AMGEN$$54$YR$A$M$Y$$$20240710$$CN$US$US
234278063$23427806$3$F$$20240812$20240122$20240814$EXP$$CA-GSK-CA2023158874$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$HP$CA$CA
234278443$23427844$3$F$$20240703$20240122$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-010584$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240704$$CN$US$US
234278944$23427894$4$F$20240903$20240924$20240122$20240925$PER$$US-AMGEN-USASP2024013317$AMGEN$$65$YR$E$M$Y$$$20240925$$CN$US$US
234279056$23427905$6$F$$20240815$20240122$20240820$PER$$US-PFIZER INC-PV202200120188$PFIZER$$80$YR$$F$Y$$$20240820$$CN$US$US
234279313$23427931$3$F$$20240718$20240122$20240722$PER$$US-PFIZER INC-PV202400007329$PFIZER$$39$YR$$F$Y$$$20240722$$HP$US$US
234279416$23427941$6$F$$20240916$20240122$20240919$EXP$$US-PFIZER INC-PV202400007909$PFIZER$$41$YR$$M$Y$$$20240919$$HP$US$US
234280113$23428011$3$F$20220715$20240708$20240122$20240716$EXP$$NVSC2022GB184527$NOVARTIS$$$$$M$Y$$$20240716$$CN$GB$GB
234280543$23428054$3$F$20240101$20240918$20240122$20240923$EXP$$US-PFIZER INC-202400018620$PFIZER$$55$YR$$M$Y$$$20240923$$HP$US$US
234280719$23428071$9$F$$20240828$20240122$20240904$EXP$CA-MMM-F0RB6KLV$CA-GSK-CA2023107508$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$HP$CA$CA
234281092$23428109$2$F$$20240708$20240122$20240715$EXP$$CA-APOTEX-2024AP001009$APOTEX$$43$YR$$F$Y$96$KG$20240715$$HP$CA$CA
234281373$23428137$3$F$$20240202$20240122$20240925$PER$$US-GSK-US2024AMR006112$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
234281475$23428147$5$F$20120101$20240703$20240122$20240711$EXP$$US-PFIZER INC-202400010639$PFIZER$$46$YR$$M$Y$$$20240711$$CN$US$US
234282268$23428226$8$F$20240101$20240903$20240122$20240906$EXP$$US-PFIZER INC-202300369781$PFIZER$$7$YR$$M$Y$20.41$KG$20240906$$CN$US$US
234282402$23428240$2$F$$20240716$20240122$20240718$PER$$US-PFIZER INC-202400015934$PFIZER$$65$YR$$M$Y$$$20240718$$PH$US$US
234282542$23428254$2$F$20240501$20240809$20240122$20240814$PER$$US-PFIZER INC-202400017378$PFIZER$$55$YR$$F$Y$$$20240814$$HP$US$US
234282787$23428278$7$F$$20240919$20240122$20240928$EXP$$CA-TEVA-202104_00011539$TEVA$$72$YR$$M$Y$$$20240928$$HP$CA$CA
234283484$23428348$4$F$20231001$20240719$20240122$20240724$EXP$$CA-PFIZER INC-202300327592$PFIZER$$46$YR$$F$Y$$$20240724$$HP$CA$CA
234284963$23428496$3$F$$20240709$20240122$20240711$PER$$US-AMGEN-USASP2024013481$AMGEN$$79$YR$E$F$Y$$$20240711$$HP$US$US
234285313$23428531$3$F$20240101$20240911$20240122$20240918$EXP$$CA-GSK-CA2024006996$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$CA$CA
234285695$23428569$5$F$$20240913$20240122$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009302$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240919$$CN$US$US
234286175$23428617$5$F$$20240709$20240122$20240716$EXP$$NVSC2023CA278559$NOVARTIS$$58$YR$$M$Y$$$20240716$$HP$CA$CA
234286406$23428640$6$F$20231228$20240712$20240122$20240719$EXP$$US-TAKEDA-2024TUS000287$TAKEDA$$79$YR$$F$Y$$$20240719$$CN$US$US
234286476$23428647$6$F$20230622$20240827$20240122$20240830$EXP$$JP-AstraZeneca-2023A222160$ASTRAZENECA$$87$YR$$M$Y$60$KG$20240830$$MD$JP$
234287662$23428766$2$F$$20240708$20240122$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-010601$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240709$$CN$US$US
234287735$23428773$5$F$20230906$20240719$20240122$20240725$EXP$$US-OTSUKA-2023_023738$OTSUKA$$$$$F$Y$$$20240725$$CN$US$US
234288115$23428811$5$F$20240101$20240730$20240122$20240802$EXP$$US-PFIZER INC-PV202400007459$PFIZER$$62$YR$$M$Y$$$20240802$$HP$US$US
234288178$23428817$8$F$$20240809$20240122$20240813$EXP$$US-PFIZER INC-PV202400007873$PFIZER$$81$YR$$M$Y$96.599$KG$20240813$$CN$US$US
234288194$23428819$4$F$20240101$20240705$20240122$20240709$EXP$$US-PFIZER INC-PV202400007720$PFIZER$$54$YR$$F$Y$$$20240709$$HP$US$US
234288287$23428828$7$F$20231224$20240909$20240122$20240912$30DAY$$GR-PFIZER INC-PV202300209491$PFIZER$$15$YR$$M$Y$55$KG$20240912$$CN$GR$GR
234288774$23428877$4$F$20230101$20240701$20240122$20240703$EXP$$US-PFIZER INC-PV202400006211$PFIZER$$57$YR$$F$Y$70.295$KG$20240703$$CN$US$US
234289102$23428910$2$F$20220101$20240725$20240122$20240731$EXP$$SK-OTSUKA-2024_001191$OTSUKA$$62$YR$$F$Y$$$20240731$$MD$SK$SK
234290382$23429038$2$F$$20240708$20240122$20240716$PER$$US-SA-2024SA018023$SANOFI AVENTIS$$7$YR$C$F$Y$31.7$KG$20240716$$MD$US$US
234290412$23429041$2$F$$20240823$20240122$20240909$PER$$US-SA-2024SA018511$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240909$$MD$US$US
234290462$23429046$2$F$$20240703$20240122$20240712$PER$$US-SA-2024SA018239$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240712$$MD$US$US
234290723$23429072$3$F$20240101$20240909$20240122$20240918$PER$$US-SA-2024SA018530$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240918$$MD$US$US
234290783$23429078$3$F$20240101$20240831$20240122$20240924$PER$$US-SA-2024SA016122$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240924$$MD$US$US
234291412$23429141$2$F$$20240716$20240122$20240724$PER$$US-SA-2024SA019266$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$MD$US$US
234291523$23429152$3$F$20240101$20240715$20240122$20240724$PER$$US-SA-2024SA018066$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240724$$MD$US$US
234291535$23429153$5$F$20230101$20240801$20240122$20240809$EXP$$US-SA-2024SA018327$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240809$$MD$US$US
234292002$23429200$2$F$20231206$20240825$20240122$20240917$PER$$US-SA-2024SA019515$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240918$$MD$US$US
234292362$23429236$2$F$$20240719$20240122$20240730$PER$$US-SA-2024SA021474$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240730$$MD$US$US
234292442$23429244$2$F$$20240725$20240122$20240805$PER$$US-SA-2024SA021586$SANOFI AVENTIS$$$$A$M$Y$$$20240803$$MD$US$US
234293042$23429304$2$F$20240101$20240717$20240122$20240726$PER$$US-SA-2024SA021475$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240726$$MD$US$US
234293103$23429310$3$F$$20240731$20240122$20240809$PER$$US-SA-2024SA021379$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240809$$MD$US$US
234293242$23429324$2$F$$20240813$20240122$20240826$PER$$US-SA-2024SA018501$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240826$$MD$US$US
2342934011$23429340$11$F$20221011$20240919$20240122$20240925$EXP$$CA-SANDOZ INC.-PHHY2017CA096465$SANDOZ$$71$YR$$F$Y$105$KG$20240925$$CN$CA$CA
234293463$23429346$3$F$$20240709$20240122$20240717$PER$$US-SA-2024SA020774$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240717$$MD$US$US
234293602$23429360$2$F$20240101$20240725$20240122$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202401009486$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240729$$CN$US$US
234293793$23429379$3$F$20230101$20240730$20240122$20240806$EXP$$JP-DSJP-DSJ-2024-102069$DAIICHI$Kawaguchi R, Ooiwa H, Akieda S, Iwamoto Y. A case of EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS complicated by PULMONARY ALVEOLAR HAEMORRHAGE. The 69th Mtg of Chugoku and Shikoku Chapter of the Japanese Respiratory Society. 2023;59$76$YR$$M$Y$60$KG$20240806$$MD$JP$JP
234294682$23429468$2$F$20231101$20240806$20240122$20240807$EXP$$US-PFIZER INC-202400018614$PFIZER$$83$YR$$F$Y$$$20240807$$HP$US$US
234294994$23429499$4$F$20230514$20240802$20240122$20240807$EXP$$US-PFIZER INC-202400013650$PFIZER$$71$YR$$M$Y$99.79$KG$20240807$$CN$US$US
234295633$23429563$3$F$$20240731$20240122$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202401010340$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240805$$CN$US$US
234295853$23429585$3$F$20231207$20240828$20240122$20240902$EXP$$PE-PFIZER INC-PV202300100051$PFIZER$$69$YR$$M$Y$$$20240902$$CN$PE$PE
234295867$23429586$7$F$20231016$20240911$20240122$20240913$EXP$$JP-PFIZER INC-202400018444$PFIZER$$75$YR$$M$Y$39.2$KG$20240913$$MD$JP$JP
234295872$23429587$2$F$20210928$20240629$20240122$20240708$EXP$$IN-PFIZER INC-2019428351$PFIZER$$64$YR$$F$Y$$$20240708$$CN$IN$IN
234295954$23429595$4$F$20220101$20240925$20240122$20240930$EXP$$IN-PFIZER INC-PV202200036784$PFIZER$$73$YR$$F$Y$$$20240930$$CN$IN$IN
234296063$23429606$3$F$$20240705$20240122$20240712$EXP$$DE-PFIZER INC-202400015600$PFIZER$$34$YR$$F$Y$$$20240712$$MD$DE$DE
234296235$23429623$5$F$20231101$20240827$20240122$20240902$EXP$$CA-PFIZER INC-202200282092$PFIZER$$58$YR$$F$Y$112$KG$20240902$$MD$CA$CA
234296363$23429636$3$F$$20240801$20240122$20240806$EXP$$US-PFIZER INC-202300234244$PFIZER$$15$YR$$M$Y$$$20240806$$CN$US$US
234297712$23429771$2$F$$20240514$20240122$20240703$PER$$US-LUNDBECK-DKLU3071352$LUNDBECK$$$$$$Y$$$20240703$$CN$US$US
234297848$23429784$8$F$20231108$20240903$20240122$20240913$PER$$US-Calliditas-2024CAL00062$CALLIDITAS THERAPEUTICS$$70$YR$E$M$Y$102.5$KG$20240913$$CN$US$US
234298024$23429802$4$F$20240712$20240716$20240122$20240730$EXP$$CA-HLS-202400136$HLS THERAPEUTICS$$40$YR$A$M$Y$$$20240730$$HP$CA$CA
2342982016$23429820$16$F$$20240909$20240122$20240916$EXP$CA-HEALTHCANVIG-06173580$CA-SANDOZ INC.-NVSC2023CA089704$SANDOZ$$$$$M$Y$$$20240916$$CN$CA$CA
234298473$23429847$3$F$$20240628$20240122$20240706$EXP$$JP-009507513-2401JPN001774J$MERCK$Yoshikawa T, Watanabe O, Takamatsu Y, Saito K, Sakai H, Kitano A, et al.. L-5 A Case of Severe Diarrhea and Pulmonary oedema during Preoperative Chemotherapy with Immune Checkpoint Inhibitor. The 19th Annual Meeting of the Japanese Breast Cancer Society KANTO Branch. 115$6$DEC$$F$Y$$$20240706$$MD$JP$JP
234298522$23429852$2$F$$20240725$20240122$20240729$EXP$CA-HEALTHCANVIG-E2B_00375068$CA-PURDUE-USA-2024-0307218$PURDUE$$62$YR$$F$Y$$$20240729$$CN$CA$CA
234298538$23429853$8$F$20231201$20240912$20240122$20240913$EXP$$JP-009507513-2312JPN000662J$MERCK$$63$YR$$M$Y$$$20240913$$MD$JP$JP
234298596$23429859$6$F$20231201$20240924$20240122$20240930$EXP$$JP-009507513-2401JPN001985J$MERCK$$5$DEC$$M$Y$$$20240930$$MD$JP$JP
234298912$23429891$2$F$20240101$20240725$20240122$20240730$EXP$$US-SA-2024SA021822$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240730$$CN$US$US
234299032$23429903$2$F$20231004$20240826$20240122$20240827$EXP$$NVSJ2024JP001149$NOVARTIS$$$$$F$Y$$$20240828$$PH$JP$JP
234299382$23429938$2$F$20230101$20240903$20240122$20240910$EXP$$CA-ABBVIE-5596943$ABBVIE$$64$YR$$M$Y$$$20240910$$CN$CA$CA
234299664$23429966$4$F$20220101$20240628$20240122$20240706$EXP$$CA-CELLTRION INC.-2022CA006857$CELLTRION$$$$$$Y$$$20240706$$MD$CA$CA
234299912$23429991$2$F$20240116$20240903$20240122$20240910$EXP$$SE-ABBVIE-5596698$ABBVIE$$59$YR$$M$Y$$$20240910$$HP$SE$SE
2342999527$23429995$27$F$$20240916$20240122$20240925$EXP$$CA-JNJFOC-20240124984$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240926$$CN$CA$CA
234300253$23430025$3$F$$20240810$20240122$20240821$EXP$$JP-TAKEDA-2024TJP000768$TAKEDA$$72$YR$$M$Y$$$20240821$$MD$JP$JP
2343002811$23430028$11$F$20230606$20240920$20240122$20240927$EXP$$CA-GSK-CA2023AMR041967$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$PH$CA$CA
234301167$23430116$7$F$$20240919$20240122$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-008725$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$64.86$KG$20240925$$CN$US$US
234301183$23430118$3$F$20200821$20240821$20240122$20240827$EXP$$CA-TAKEDA-2019TUS006762$TAKEDA$$57$YR$$M$Y$$$20240827$$CN$CA$CA
234301474$23430147$4$F$20240612$20240820$20240123$20240827$EXP$$CA-GSK-CA2023171064$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$CA$CA
234301496$23430149$6$F$20230101$20240916$20240123$20240920$EXP$$US-ABBVIE-5597363$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
234301572$23430157$2$F$20231201$20240806$20240123$20240816$PER$$US-SA-2024SA023062$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240816$$MD$US$US
234302233$23430223$3$F$20240119$20240716$20240123$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202401011482$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240729$$CN$US$US
234302247$23430224$7$F$20200101$20240625$20240123$20240710$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-428592$RANBAXY$$38$YR$$F$Y$$$20240710$$MD$DE$DE
234302943$23430294$3$F$$20240814$20240123$20240827$PER$$US-SA-2024SA022109$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240827$$CN$US$US
234303432$23430343$2$F$$20240905$20240123$20240912$EXP$$CA-GSK-CA2024AMR008255$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$CA$CA
234303453$23430345$3$F$20240202$20240820$20240123$20240827$EXP$$CA-GSK-CA2023148434$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$CA$CA
234304433$23430443$3$F$20240101$20240910$20240123$20240916$EXP$$US-BEH-2024167729$CSL BEHRING$$41$YR$A$F$Y$193$KG$20240916$$HP$US$US
234304784$23430478$4$F$$20240729$20240123$20240802$PER$$US-UNITED THERAPEUTICS-UNT-2024-001423$UNITED THERAPEUTICS$$$$$F$Y$$$20240802$$$US$US
234304944$23430494$4$F$$20240705$20240123$20240807$EXP$$CA-SANDOZ INC.-SDZ2024CA006014$SANDOZ$$44$YR$$F$Y$$$20240807$$HP$CA$CA
234305313$23430531$3$F$$20240319$20240123$20240806$PER$$US-AstraZeneca-2024A015997$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
234305496$23430549$6$F$20231220$20240910$20240123$20240917$30DAY$$FR-JNJFOC-20231272278$JOHNSON AND JOHNSON$$65$YR$E$M$Y$70$KG$20240917$$PH$FR$FR
234306503$23430650$3$F$20231228$20240904$20240123$20240924$PER$$CA-TOLMAR, INC.-23CA045787$TOLMAR$$77$YR$$M$Y$$$20240923$$CN$CA$CA
234306554$23430655$4$F$20231228$20240905$20240123$20240924$PER$$CA-TOLMAR, INC.-23CA045789$TOLMAR$$76$YR$$M$Y$$$20240923$$CN$CA$CA
234306696$23430669$6$F$20230101$20240828$20240123$20240910$EXP$$JP-ABBVIE-5599967$ABBVIE$Kojima A, Kato T, Yamada Y, Sakamoto H, Horai M, Taguchi M, et al. Chronic lymphocytic leukemia complicated with aplastic anemia-like symptoms during ibrutinib treatment. 2024;(64):95.; Kojima A, Kato T, Yamada Y, Sakamoto H, Horai M, Taguchi M, et al. Chronic lymphocytic leukemia complicated with aplastic anemia-like symptoms during ibrutinib treatment. 2024;(64):95.$73$YR$$M$Y$54$KG$20240910$$MD$JP$JP
234306933$23430693$3$F$20230713$20240620$20240123$20240731$EXP$$US-SA-2024SA012914$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240731$$MD$US$US
234307493$23430749$3$F$$20240813$20240123$20240815$EXP$$US-ABBVIE-5596982$ABBVIE$$$$$F$Y$45$KG$20240815$$CN$US$US
234307577$23430757$7$F$20231201$20240719$20240123$20240725$PER$$US-BIOGEN-2024BI01246636$BIOGEN$$44$YR$$M$Y$$$20240725$$CN$US$US
234307792$23430779$2$F$$20240805$20240123$20240815$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK088418$GLENMARK$$$$$$Y$$$20240815$$HP$CA$CA
234307953$23430795$3$F$$20240827$20240123$20240831$EXP$$US-ABBVIE-5595715$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
234308492$23430849$2$F$$20240720$20240123$20240729$PER$$US-SA-2024SA018155$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240729$$MD$US$US
234308544$23430854$4$F$20230101$20240809$20240123$20240814$EXP$$US-SA-2024SA019345$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240814$$MD$US$US
234308552$23430855$2$F$20230829$20240731$20240123$20240809$PER$$US-SA-2024SA018472$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240809$$MD$US$US
234308562$23430856$2$F$20240101$20240710$20240123$20240718$PER$$US-SA-2024SA019809$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240718$$MD$US$US
234308732$23430873$2$F$20240601$20240710$20240123$20240718$PER$$US-SA-2024SA019984$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240718$$MD$US$US
234309216$23430921$6$F$20240101$20240717$20240123$20240725$EXP$$CA-CELLTRION INC.-2024CA001401$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
234309523$23430952$3$F$20230607$20240711$20240123$20240717$EXP$$JP-GSK-JP2024007142$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$JP$JP
234309822$23430982$2$F$20231215$20240703$20240123$20240707$EXP$$CA-TAKEDA-2024TUS005836$TAKEDA$$76$YR$$F$Y$$$20240707$$MD$CA$CA
234309943$23430994$3$F$$20240708$20240123$20240716$EXP$$US-TAKEDA-2024TUS005284$TAKEDA$$$$$F$Y$$$20240716$$CN$US$US
234310054$23431005$4$F$20211201$20240923$20240123$20240927$EXP$$US-TAKEDA-2021TUS080323$TAKEDA$$68$YR$$F$Y$80$KG$20240927$$MD$US$US
234310062$23431006$2$F$$20240111$20240123$20240806$EXP$$CA-CHATTEMPRD-2024OHG001966$CHATTEM$$$$A$F$Y$97$KG$20240806$$HP$CA$CA
234310112$23431011$2$F$$20240715$20240123$20240801$PER$$US-SA-2024SA018938$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240719$$MD$US$US
234310173$23431017$3$F$$20240806$20240123$20240814$PER$$US-SA-2024SA019905$SANOFI AVENTIS$$$$A$F$Y$61.23$KG$20240814$$MD$US$US
234310447$23431044$7$F$$20240705$20240123$20240710$EXP$$CA-TAKEDA-2024TUS005970$TAKEDA$$$$$M$Y$$$20240710$$CN$CA$CA
234310464$23431046$4$F$20231219$20240719$20240123$20240730$EXP$$JP-ROCHE-3494695$ROCHE$$65$YR$E$M$Y$64.8$KG$20240730$$MD$JP$JP
234310535$23431053$5$F$20240529$20240625$20240123$20240703$EXP$$US-SA-2024SA019813$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240703$$MD$US$US
234310705$23431070$5$F$$20240709$20240123$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-011185$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$50$KG$20240718$$MD$JP$JP
234310764$23431076$4$F$$20240828$20240123$20240830$PER$$US-SA-2024SA019799$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240830$$MD$US$US
234310794$23431079$4$F$$20240709$20240123$20240712$EXP$$CA-TAKEDA-2022TUS070626$TAKEDA$$$$$F$Y$$$20240712$$MD$CA$CA
234310816$23431081$6$F$20240117$20240722$20240123$20240729$EXP$$CO-TAKEDA-2024TUS006113$TAKEDA$$73$YR$$F$Y$51$KG$20240729$$CN$CO$CO
234311023$23431102$3$F$$20240627$20240123$20240701$EXP$$US-TAKEDA-2024TUS005874$TAKEDA$$$$$F$Y$52$KG$20240701$$HP$US$US
234311122$23431112$2$F$20230915$20240909$20240123$20240913$EXP$$US-CHATTEMPRD-2024OHG001871$CHATTEM$$$$C$M$Y$$$20240913$$LW$US$US
234311263$23431126$3$F$20240114$20240911$20240123$20240920$30DAY$$US-GSK-US2024008793$GLAXOSMITHKLINE$$69$YR$$M$Y$$$20240920$$CN$US$US
234311853$23431185$3$F$$20240729$20240123$20240802$EXP$$NVSC2023CA219680$NOVARTIS$$41$YR$$F$Y$$$20240802$$CN$CA$CA
234313363$23431336$3$F$20230101$20240627$20240123$20240704$PER$$US-SA-2024SA023439$SANOFI AVENTIS$$57$YR$A$F$Y$131.08$KG$20240704$$MD$US$US
234314132$23431413$2$F$20231127$20240730$20240123$20240816$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00369$HIKMA$$14$YR$$F$Y$91.8$KG$20240816$$HP$US$US
234314283$23431428$3$F$$20240716$20240123$20240723$EXP$$CA-JNJFOC-20240151745$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240723$$CN$CA$CA
234314444$23431444$4$F$20230801$20240622$20240123$20240701$PER$$US-SA-2024SA022023$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240701$$MD$US$US
234315285$23431528$5$F$20220101$20240916$20240123$20240925$EXP$$CA-CELLTRION INC.-2021CA019278$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
234316093$23431609$3$F$20240616$20240625$20240123$20240704$PER$$US-SA-2024SA022976$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240704$$MD$US$US
234316177$23431617$7$F$20240104$20240723$20240123$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-001185$UNITED THERAPEUTICS$$64$YR$$M$Y$97.506$KG$20240726$$PH$US$US
234316533$23431653$3$F$20231220$20240918$20240123$20240926$PER$$NVSC2024US012608$NOVARTIS$$65$YR$$M$Y$68$KG$20240926$$MD$US$US
234316732$23431673$2$F$$20240118$20240123$20240925$PER$$US-GSK-US2024AMR009959$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
234316782$23431678$2$F$$20240715$20240123$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA005804$SANDOZ$$43$YR$$F$Y$96$KG$20240722$$HP$CA$CA
234316815$23431681$5$F$20230909$20240828$20240123$20240903$EXP$$CO-TAKEDA-2023TUS089496$TAKEDA$$35$YR$$F$Y$59$KG$20240903$$CN$CO$CO
234316853$23431685$3$F$20230928$20240624$20240123$20240703$PER$$US-SA-2024SA023099$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240703$$MD$US$US
234317333$23431733$3$F$20240520$20240913$20240123$20240918$EXP$$US-TAKEDA-2020TUS049304$TAKEDA$$69$YR$$M$Y$68$KG$20240918$$MD$US$US
234317462$23431746$2$F$20231107$20240821$20240123$20240831$EXP$FR-AFSSAPS-BR2023001100$FR-Accord-402106$ACCORD$$52$YR$A$F$Y$$$20240831$$MD$FR$FR
234317553$23431755$3$F$20231216$20240625$20240123$20240706$EXP$$DE-Accord-401991$ACCORD$$5$YR$C$M$Y$19.9$KG$20240706$$MD$DE$DE
234318183$23431818$3$F$$20240723$20240123$20240725$EXP$$GB-MYLANLABS-2024M1006286$MYLAN$Wikeley S, Bacon I, Greer O, Evans M, Hasan R, Pathak S. New-onset movement disorder in the immediate postpartum period. BMJ-Case-Rep 2023; 16 (12).$3$DEC$$F$Y$$$20240725$$MD$GB$GB
234318484$23431848$4$F$$20240824$20240123$20240830$EXP$$CA-TAKEDA-2020TUS049168$TAKEDA$$$$$M$Y$$$20240830$$CN$CA$CA
234318523$23431852$3$F$20240101$20240731$20240123$20240808$EXP$$US-SA-2024SA022501$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240808$$MD$US$US
234318562$23431856$2$F$$20240802$20240123$20240812$PER$$US-SA-2024SA023233$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240812$$MD$US$US
234318725$23431872$5$F$20230908$20240731$20240123$20240805$EXP$$JP-AstraZeneca-2024A015443$ASTRAZENECA$Amano Y, et al. P-107 A case of recurrent ovarian cancer with BRCA1 pathological variant presenting with treatment-related acute myeloid leukaemia during Olaparib maintenance therapy. The Journal of the Japan Society of Gynecologic Oncology 2024;42(3):381-.$60$YR$$F$Y$81$KG$20240805$$MD$JP$
234318812$23431881$2$F$$20240812$20240123$20240812$EXP$$GB-SCIEGENP-2024SCLIT00014$SCIEGEN$Couper MR, et al..Periportal necrosis and successful liver transplantation following Lamotrigine drug-induced liver injury in a child.BMJ Case Reports.NOV-2023;16 (11):e255787$$$C$F$Y$$$20240812$$HP$GB$GB
234319455$23431945$5$F$20220711$20240905$20240123$20240912$EXP$$CA-TAKEDA-2022TUS032876$TAKEDA$$79$YR$$M$Y$$$20240912$$CN$CA$CA
234319513$23431951$3$F$20231227$20240911$20240123$20240925$EXP$$US-UCBSA-2024001923$UCB$$11$YR$$M$Y$26$KG$20240925$$CN$US$US
234320252$23432025$2$F$20231101$20240918$20240123$20240924$EXP$$NVSC2024US014113$NOVARTIS$$63$YR$$M$Y$$$20240924$$MD$US$US
2343203813$23432038$13$F$20240518$20240812$20240123$20240813$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-148127$DAIICHI$$$$$F$Y$$$20240813$$CN$US$US
234320662$23432066$2$F$$20240820$20240123$20240823$EXP$$AU-BIOGEN-2023BI01211977$BIOGEN$$37$YR$$F$Y$$$20240823$$CN$AU$AU
234321064$23432106$4$F$20231201$20240626$20240123$20240718$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000529$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
234321125$23432112$5$F$$20240906$20240123$20240910$30DAY$$US-PFIZER INC-PV202400000199$PFIZER$$6$YR$$M$Y$$$20240910$$CN$US$US
234321232$23432123$2$F$20210101$20240704$20240123$20240716$EXP$$DE-Accord-401599$ACCORD$Juarso AE, Entz S, Weissinger F. Durable response from fibroblast growth factor receptor inhibition in intrahepatic cholangiocarcinoma terminated by metachronous acute myeloid leukemia: a case report. Journal of Medical Case Reports. 2023;17(1):550.$74$YR$E$$Y$$$20240716$$MD$DE$DE
234321273$23432127$3$F$20231101$20240827$20240123$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011409$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240829$$CN$US$US
234321525$23432152$5$F$20231111$20240806$20240123$20240809$EXP$$JP-AstraZeneca-2024A015087$ASTRAZENECA$Watanabe H, et al.. P2-55 A case of suspected acute coronary syndrome due to acalabrutinib.. The 32nd Clinical Pharmacy Symposium 2024;251-. .$59$YR$$F$Y$$$20240809$$MD$JP$
234321828$23432182$8$F$$20240920$20240123$20240925$EXP$$CA-PFIZER INC-202400013630$PFIZER$$48$YR$$F$Y$$$20240925$$MD$CA$CA
234322683$23432268$3$F$20230710$20240918$20240123$20240923$EXP$$JP-TAKEDA-2023TUS096321$TAKEDA$$71$YR$$M$Y$73$KG$20240923$$MD$JP$JP
234324283$23432428$3$F$$20240503$20240123$20240823$EXP$$US-SANDOZ INC.-SDZ2024US007050$SANDOZ$$$$$M$Y$$$20240823$$CN$US$US
234324684$23432468$4$F$20231201$20240830$20240123$20240903$EXP$$US-TAKEDA-2024TUS006335$TAKEDA$$61$YR$$M$Y$$$20240903$$CN$US$US
234324882$23432488$2$F$20240104$20240715$20240123$20240722$PER$$US-BAYER-2024A009842$BAYER$$28$YR$A$F$Y$$$20240722$$MD$US$US
234324906$23432490$6$F$20230929$20240915$20240123$20240927$EXP$$CN-GILEAD-2023-0650536$GILEAD$$44$YR$A$M$Y$$$20240927$$MD$CN$CN
234325418$23432541$8$F$20240118$20240904$20240123$20240911$EXP$$CA-GSK-CA2024007007$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$HP$CA$CA
234325524$23432552$4$F$20230101$20240816$20240123$20240821$EXP$$CA-PFIZER INC-202300304782$PFIZER$$40$YR$$F$Y$$$20240821$$HP$CA$CA
234325588$23432558$8$F$20230101$20240925$20240123$20240927$30DAY$$CA-PFIZER INC-202300165413$PFIZER$$50$YR$$M$Y$$$20240927$$HP$CA$CA
234325702$23432570$2$F$$20240709$20240123$20240715$EXP$$CA-TAKEDA-2024TUS005525$TAKEDA$$$$$M$Y$$$20240715$$CN$CA$CA
234325844$23432584$4$F$20230930$20240704$20240123$20240704$EXP$$CA-PFIZER INC-202400016742$PFIZER$$58$YR$$M$Y$$$20240704$$HP$CA$CA
234326164$23432616$4$F$$20240513$20240123$20240801$EXP$$CA-SANDOZ INC.-SDZ2024CA006636$SANDOZ$$43$YR$$F$Y$97$KG$20240801$$HP$CA$CA
234326203$23432620$3$F$20210101$20240823$20240123$20240828$EXP$$DE-PFIZER INC-202400017932$PFIZER$Suhling, H.. Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic Dermatitis. Respiration. 2023;102 (12):1016-1019$25$YR$$F$Y$$$20240828$$HP$DE$DE
234326702$23432670$2$F$$20240830$20240123$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011011$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240903$$CN$US$US
234328422$23432842$2$F$$20240821$20240123$20240823$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-011611$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240823$$PH$JP$JP
234328893$23432889$3$F$$20240316$20240123$20240723$EXP$$US-OTSUKA-2024_001259$OTSUKA$$$$$F$Y$57.61$KG$20240723$$CN$US$US
234329523$23432952$3$F$20231226$20240729$20240123$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011153$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240730$$CN$US$US
234329573$23432957$3$F$$20240909$20240123$20240912$PER$$US-BIOGEN-2024BI01246476$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
234329932$23432993$2$F$$20240826$20240123$20240918$PER$$US-SA-2024SA023144$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$MD$US$US
234329952$23432995$2$F$$20240807$20240123$20240812$EXP$$CA-SA-2024SA021229$SANOFI AVENTIS$$27$YR$A$F$Y$120$KG$20240812$$CN$CA$CA
234330012$23433001$2$F$20240101$20240830$20240123$20240927$PER$$US-SA-2024SA020651$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240927$$MD$US$US
234330322$23433032$2$F$20231001$20240828$20240123$20240904$EXP$$CA-GSK-CA2024007968$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$CA$CA
234330687$23433068$7$F$20240201$20240912$20240123$20240919$EXP$$CA-GSK-CA2023AMR063320$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$HP$CA$CA
234330732$23433073$2$F$$20240724$20240123$20240725$EXP$$US-SANDOZ INC.-SDZ2024US007040$SANDOZ$$$$$F$Y$$$20240725$$CN$US$US
234331254$23433125$4$F$20240109$20240624$20240123$20240701$EXP$$US-BAYER-2024A007329$BAYER$$26$YR$A$M$Y$138$KG$20240701$$HP$US$US
234331794$23433179$4$F$20231201$20240806$20240123$20240813$EXP$$US-GSK-US2024007881$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
234331875$23433187$5$F$20231201$20240618$20240123$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009325$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$74.39$KG$20240701$$CN$US$US
234331895$23433189$5$F$20240119$20240812$20240123$20240819$PER$$US-AMGEN-USASP2024013660$AMGEN$$64$YR$A$F$Y$$$20240819$$CN$US$US
234332753$23433275$3$F$20230207$20240625$20240123$20240701$EXP$$CA-OTSUKA-2021_010075$OTSUKA$$87$YR$$F$Y$$$20240701$$MD$CA$CA
234332914$23433291$4$F$20231220$20240802$20240123$20240805$PER$$US-PFIZER INC-PV202300029810$PFIZER$$70$YR$$F$Y$$$20240805$$MD$US$US
234332953$23433295$3$F$$20240701$20240123$20240703$PER$$US-PFIZER INC-PV202400008549$PFIZER$$61$YR$$F$Y$$$20240703$$CN$US$US
234333105$23433310$5$F$$20240718$20240123$20240722$PER$$US-PFIZER INC-PV202400008497$PFIZER$$78$YR$$F$Y$$$20240722$$CN$US$US
234333172$23433317$2$F$$20240829$20240123$20240904$PER$$US-PFIZER INC-PV202400009133$PFIZER$$25$YR$$M$Y$$$20240904$$HP$US$US
234333243$23433324$3$F$$20240723$20240123$20240725$PER$$US-PFIZER INC-PV202400008667$PFIZER$$48$YR$$F$Y$$$20240725$$HP$US$US
234333274$23433327$4$F$$20240718$20240123$20240722$PER$$US-PFIZER INC-PV202400008650$PFIZER$$48$YR$$F$Y$$$20240722$$HP$US$US
234333284$23433328$4$F$20231220$20240128$20240123$20240813$EXP$$NVSC2024EG010584$NOVARTIS$$47$YR$$F$Y$$$20240813$$CN$EG$EG
234333912$23433391$2$F$20240101$20240902$20240123$20240909$EXP$$ES-GSK-ES2024EME007677$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$CN$ES$ES
234334282$23433428$2$F$$20240709$20240123$20240717$PER$$US-SA-2024SA019053$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240717$$MD$US$US
234334462$23433446$2$F$$20240917$20240123$20240926$EXP$CA-drreddys-SPO/CAN/23/0163585$CA-RDY-SPO/CAN/23/0163585$DR REDDYS$$36$YR$A$F$Y$$$20240926$$HP$CA$CA
234335633$23433563$3$F$$20240807$20240123$20240812$PER$$US-PFIZER INC-202300366370$PFIZER$$16$YR$$F$Y$58.97$KG$20240812$$HP$US$US
234336932$23433693$2$F$20230101$20240801$20240123$20240805$EXP$$US-BAUSCH-BL-2024-000801$BAUSCH AND LOMB$$68$YR$$F$Y$59.928$KG$20240805$$MD$US$US
234337213$23433721$3$F$20231207$20240910$20240123$20240917$EXP$$CA-GSK-CA2023165177$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
234337714$23433771$4$F$20240117$20240701$20240123$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011858$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$74.39$KG$20240702$$CN$US$US
234338342$23433834$2$F$20131127$20240904$20240123$20240909$EXP$$US-MYLANLABS-2024M1003989$MYLAN$$69$YR$$M$Y$101$KG$20240909$$MD$US$US
234340043$23434004$3$F$$20240913$20240123$20240919$EXP$$JP-009507513-2401JPN002093J$MERCK$$7$DEC$$F$Y$$$20240919$$MD$JP$JP
234340158$23434015$8$F$20231001$20240718$20240123$20240718$EXP$$CA-PFIZER INC-202400018031$PFIZER$$26$YR$$F$Y$$$20240718$$HP$CA$CA
234341214$23434121$4$F$20240117$20240806$20240123$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-010179$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$77$KG$20240809$$CN$US$US
234341663$23434166$3$F$$20240708$20240123$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-012015$JAZZ$$$$$F$Y$$$20240717$$CN$US$US
234341812$23434181$2$F$20230621$20240903$20240123$20240909$EXP$$CA-PFIZER INC-202400019599$PFIZER$$39$YR$$M$Y$$$20240909$$CN$CA$CA
234341843$23434184$3$F$$20240709$20240123$20240712$EXP$$CA-PFIZER INC-202400019619$PFIZER$$62$YR$$F$Y$$$20240712$$HP$CA$CA
234342402$23434240$2$F$20230101$20240913$20240123$20240918$EXP$$CA-PFIZER INC-202300232808$PFIZER$$23$YR$$F$Y$$$20240918$$HP$CA$CA
234342473$23434247$3$F$20221103$20240710$20240123$20240715$EXP$$CA-PFIZER INC-202201209996$PFIZER$$73$YR$$M$Y$101$KG$20240715$$MD$CA$CA
234342533$23434253$3$F$20230602$20240827$20240123$20240830$EXP$$CA-BAUSCH-BL-2023-008754$BAUSCH AND LOMB$$35$YR$$M$Y$100$KG$20240830$$CN$CA$CA
234342912$23434291$2$F$20230201$20230814$20240123$20240721$PER$$US-NOVOPROD-1106666$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234342934$23434293$4$F$$20230815$20240123$20240721$PER$$US-NOVOPROD-1107374$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234342942$23434294$2$F$$20230829$20240123$20240721$PER$$US-NOVOPROD-1106109$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
234343012$23434301$2$F$$20230727$20240123$20240721$PER$$US-NOVOPROD-1104562$NOVO NORDISK$$$$A$$Y$$$20240721$$CN$US$US
234343373$23434337$3$F$20230701$20230807$20240123$20240721$PER$$US-NOVOPROD-1110638$NOVO NORDISK$$49$YR$$$Y$$$20240721$$CN$US$US
234343842$23434384$2$F$$20240106$20240123$20240721$PER$$US-NOVOPROD-1116572$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234343852$23434385$2$F$$20240109$20240123$20240721$PER$$US-NOVOPROD-1116021$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
234343982$23434398$2$F$20230803$20230914$20240123$20240721$PER$$US-NOVOPROD-1117911$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234344002$23434400$2$F$20230401$20240404$20240123$20240721$PER$$US-NOVOPROD-1117140$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
234344052$23434405$2$F$$20230906$20240123$20240721$PER$$US-NOVOPROD-1117647$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234344162$23434416$2$F$20230101$20230914$20240123$20240721$PER$$US-NOVOPROD-1118563$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234344172$23434417$2$F$20230905$20240305$20240123$20240721$PER$$US-NOVOPROD-1118522$NOVO NORDISK$$45$YR$$F$Y$$$20240721$$CN$US$US
234344472$23434447$2$F$$20231207$20240123$20240721$PER$$US-NOVOPROD-1120094$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234344482$23434448$2$F$$20230907$20240123$20240721$PER$$US-NOVOPROD-1120522$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234344552$23434455$2$F$20230917$20240313$20240123$20240721$PER$$US-NOVOPROD-1120811$NOVO NORDISK$$56$YR$$F$Y$$$20240721$$CN$US$US
234345122$23434512$2$F$20230913$20230927$20240123$20240721$PER$$US-NOVOPROD-1123934$NOVO NORDISK$$67$YR$$F$Y$$$20240721$$CN$US$US
234345222$23434522$2$F$20211128$20240724$20240123$20240730$EXP$CZ-CZSUKL-23004865$CZ-MYLANLABS-2024M1006302$MYLAN$$28$YR$$M$Y$$$20240730$$MD$CZ$CZ
234345332$23434533$2$F$$20230922$20240123$20240721$PER$$US-NOVOPROD-1124564$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234345434$23434543$4$F$20230612$20231204$20240123$20240721$PER$$US-NOVOPROD-1124922$NOVO NORDISK$$39$YR$$F$Y$$$20240721$$MD$US$US
234345702$23434570$2$F$$20231206$20240123$20240721$PER$$US-NOVOPROD-1127390$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
234345832$23434583$2$F$$20231002$20240123$20240721$PER$$US-NOVOPROD-1129390$NOVO NORDISK$$$$$F$Y$$$20240721$$PH$US$US
234345852$23434585$2$F$20230901$20231208$20240123$20240721$PER$$US-NOVOPROD-1128700$NOVO NORDISK$$53$YR$$F$Y$106.12$KG$20240721$$CN$US$US
234346022$23434602$2$F$20230501$20231213$20240123$20240721$PER$$US-NOVOPROD-1128104$NOVO NORDISK$$38$YR$$F$Y$91.156$KG$20240721$$MD$US$US
234346282$23434628$2$F$$20231212$20240123$20240721$PER$$US-NOVOPROD-1134174$NOVO NORDISK$$$$$$Y$$$20240721$$MD$US$US
234346412$23434641$2$F$20230801$20240411$20240123$20240721$PER$$US-NOVOPROD-1133972$NOVO NORDISK$$58$YR$$F$Y$$$20240721$$CN$US$US
234346452$23434645$2$F$20231018$20231212$20240123$20240721$PER$$US-NOVOPROD-1134152$NOVO NORDISK$$70$YR$$$Y$$$20240721$$MD$US$US
234346484$23434648$4$F$$20231220$20240123$20240721$PER$$US-NOVOPROD-1134337$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
234346492$23434649$2$F$20231007$20231212$20240123$20240721$PER$$US-NOVOPROD-1135352$NOVO NORDISK$$40$YR$$$Y$$$20240721$$MD$US$US
234346502$23434650$2$F$20231004$20231212$20240123$20240721$PER$$US-NOVOPROD-1134165$NOVO NORDISK$$44$YR$$$Y$$$20240721$$MD$US$US
234346522$23434652$2$F$20240601$20240722$20240123$20240726$EXP$$US-BAUSCH-BL-2024-000900$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240726$$CN$US$US
234346602$23434660$2$F$20230615$20231202$20240123$20240721$PER$$US-NOVOPROD-1136335$NOVO NORDISK$$60$YR$$F$Y$$$20240721$$CN$US$US
234346752$23434675$2$F$$20231218$20240123$20240721$PER$$US-NOVOPROD-1137823$NOVO NORDISK$$$$A$M$Y$$$20240721$$MD$US$US
234346762$23434676$2$F$20231027$20240119$20240123$20240721$PER$$US-NOVOPROD-1136893$NOVO NORDISK$$41$YR$$F$Y$$$20240721$$CN$US$US
234346852$23434685$2$F$$20240411$20240123$20240721$PER$$US-NOVOPROD-1139037$NOVO NORDISK$$$$$F$Y$57.143$KG$20240721$$CN$US$US
234347003$23434700$3$F$$20240130$20240123$20240721$PER$$US-NOVOPROD-1138976$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
234347022$23434702$2$F$20230701$20240309$20240123$20240721$PER$$US-NOVOPROD-1141839$NOVO NORDISK$$38$YR$$F$Y$$$20240721$$MD$US$US
234347052$23434705$2$F$$20240502$20240123$20240721$PER$$US-NOVOPROD-1142212$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234347092$23434709$2$F$20231001$20240302$20240123$20240721$PER$$US-NOVOPROD-1141327$NOVO NORDISK$$56$YR$$F$Y$$$20240721$$MD$US$US
234347152$23434715$2$F$20230103$20240515$20240123$20240721$PER$$US-NOVOPROD-1142013$NOVO NORDISK$$58$YR$$F$Y$$$20240721$$CN$US$US
234347182$23434718$2$F$20231121$20240102$20240123$20240721$PER$$US-NOVOPROD-1140475$NOVO NORDISK$$44$YR$$F$Y$$$20240721$$MD$US$US
234347202$23434720$2$F$20230901$20231222$20240123$20240721$PER$$US-NOVOPROD-1142027$NOVO NORDISK$$64$YR$$M$Y$$$20240721$$HP$US$US
234347232$23434723$2$F$$20231218$20240123$20240721$PER$$US-NOVOPROD-1141219$NOVO NORDISK$$$$$F$Y$85.714$KG$20240721$$HP$US$US
234347242$23434724$2$F$$20231211$20240123$20240721$PER$$US-NOVOPROD-1140171$NOVO NORDISK$$$$A$F$Y$$$20240721$$HP$US$US
234347262$23434726$2$F$20231005$20231206$20240123$20240721$PER$$US-NOVOPROD-1139864$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$CN$US$US
234347302$23434730$2$F$20231119$20231211$20240123$20240721$PER$$US-NOVOPROD-1145540$NOVO NORDISK$$32$YR$$M$Y$$$20240721$$CN$US$US
234347344$23434734$4$F$20230310$20240515$20240123$20240721$PER$$US-NOVOPROD-1142882$NOVO NORDISK$$52$YR$$F$Y$$$20240721$$CN$US$US
234347472$23434747$2$F$20231001$20231213$20240123$20240721$PER$$US-NOVOPROD-1142590$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
234347514$23434751$4$F$20231020$20231214$20240123$20240721$PER$$US-NOVOPROD-1146378$NOVO NORDISK$$49$YR$$F$Y$$$20240721$$CN$US$US
234347552$23434755$2$F$$20240115$20240123$20240721$PER$$US-NOVOPROD-1146884$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
234347592$23434759$2$F$20231101$20231206$20240123$20240721$PER$$US-NOVOPROD-1147351$NOVO NORDISK$$65$YR$$M$Y$$$20240721$$MD$US$US
234347602$23434760$2$F$20231123$20231221$20240123$20240721$PER$$US-NOVOPROD-1145789$NOVO NORDISK$$34$YR$$F$Y$$$20240721$$CN$US$US
234347622$23434762$2$F$$20240430$20240123$20240721$PER$$US-NOVOPROD-1145558$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
234347643$23434764$3$F$20231123$20240517$20240123$20240721$PER$$US-NOVOPROD-1147205$NOVO NORDISK$$65$YR$$F$Y$$$20240721$$CN$US$US
234347674$23434767$4$F$20230907$20231204$20240123$20240721$PER$$US-NOVOPROD-1146379$NOVO NORDISK$$33$YR$$F$Y$$$20240721$$CN$US$US
234347712$23434771$2$F$$20240125$20240123$20240721$PER$$US-NOVOPROD-1146786$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234347772$23434777$2$F$20230508$20230609$20240123$20240721$PER$$US-NOVOPROD-1076927$NOVO NORDISK$$37$YR$$F$Y$$$20240721$$HP$US$US
234347852$23434785$2$F$20230530$20230602$20240123$20240721$PER$$US-NOVOPROD-1078229$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234348042$23434804$2$F$$20230721$20240123$20240721$PER$$US-NOVOPROD-1077496$NOVO NORDISK$$53$YR$$M$Y$$$20240721$$CN$US$US
234348142$23434814$2$F$$20240718$20240123$20240801$EXP$$CA-CIPHER-2024-CA-000028$CIPHER$$$$$F$Y$$$20240801$$HP$CA$CA
234348242$23434824$2$F$20230101$20230620$20240123$20240721$PER$$US-NOVOPROD-1080832$NOVO NORDISK$$$$T$F$Y$$$20240721$$HP$US$US
234348272$23434827$2$F$20230221$20231130$20240123$20240721$PER$$US-NOVOPROD-1080993$NOVO NORDISK$$47$YR$$F$Y$$$20240721$$CN$US$US
234348412$23434841$2$F$$20230622$20240123$20240721$PER$$US-NOVOPROD-1163827$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234348422$23434842$2$F$$20240301$20240123$20240721$PER$$US-NOVOPROD-1165392$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
234348432$23434843$2$F$$20240311$20240123$20240721$PER$$US-NOVOPROD-1165445$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234348482$23434848$2$F$20230701$20240206$20240123$20240721$PER$$US-NOVOPROD-1158946$NOVO NORDISK$$58$YR$$F$Y$$$20240721$$CN$US$US
234348492$23434849$2$F$$20230831$20240123$20240721$PER$$US-NOVOPROD-1159821$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234348502$23434850$2$F$$20230627$20240123$20240721$PER$$US-NOVOPROD-1164349$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234348512$23434851$2$F$$20230920$20240123$20240721$PER$$US-NOVOPROD-1164779$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234348522$23434852$2$F$$20230725$20240123$20240721$PER$$US-NOVOPROD-1165115$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
234348532$23434853$2$F$20230714$20240301$20240123$20240721$PER$$US-NOVOPROD-1165822$NOVO NORDISK$$67$YR$$F$Y$$$20240721$$CN$US$US
234348542$23434854$2$F$$20230728$20240123$20240721$PER$$US-NOVOPROD-1165408$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234348552$23434855$2$F$20231001$20240528$20240123$20240721$PER$$US-NOVOPROD-1164913$NOVO NORDISK$$62$YR$$F$Y$$$20240721$$CN$US$US
234348562$23434856$2$F$$20230822$20240123$20240721$PER$$US-NOVOPROD-1164814$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
234348572$23434857$2$F$$20230605$20240123$20240721$PER$$US-NOVOPROD-1165331$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234348582$23434858$2$F$$20240506$20240123$20240721$PER$$US-NOVOPROD-1161674$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234348592$23434859$2$F$$20230922$20240123$20240721$PER$$US-NOVOPROD-1165285$NOVO NORDISK$$55$YR$$F$Y$$$20240721$$CN$US$US
234348602$23434860$2$F$$20230619$20240123$20240721$PER$$US-NOVOPROD-1164967$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
234348612$23434861$2$F$$20230628$20240123$20240721$PER$$US-NOVOPROD-1165289$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234348622$23434862$2$F$$20230705$20240123$20240721$PER$$US-NOVOPROD-1163824$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
234348632$23434863$2$F$$20240301$20240123$20240721$PER$$US-NOVOPROD-1165324$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234348642$23434864$2$F$$20230728$20240123$20240721$PER$$US-NOVOPROD-1165393$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
234348652$23434865$2$F$$20240229$20240123$20240721$PER$$US-NOVOPROD-1164832$NOVO NORDISK$$44$YR$$F$Y$$$20240721$$CN$US$US
234348662$23434866$2$F$$20240304$20240123$20240721$PER$$US-NOVOPROD-1165347$NOVO NORDISK$$72$YR$$F$Y$$$20240721$$CN$US$US
234348672$23434867$2$F$$20230815$20240123$20240721$PER$$US-NOVOPROD-1165288$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
234348812$23434881$2$F$$20230621$20240123$20240721$PER$$US-NOVOPROD-1083851$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
234348842$23434884$2$F$20230101$20230619$20240123$20240721$PER$$US-NOVOPROD-1083799$NOVO NORDISK$$58$YR$$F$Y$77.098$KG$20240721$$CN$US$US
234349002$23434900$2$F$$20231002$20240123$20240721$PER$$US-NOVOPROD-1086781$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234349382$23434938$2$F$$20230612$20240123$20240721$PER$$US-NOVOPROD-1088104$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
234349482$23434948$2$F$$20230627$20240123$20240721$PER$$US-NOVOPROD-1086818$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
234349512$23434951$2$F$20230629$20230703$20240123$20240721$PER$$US-NOVOPROD-1089378$NOVO NORDISK$$51$YR$$F$Y$$$20240721$$CN$US$US
234349672$23434967$2$F$20230701$20230712$20240123$20240721$PER$$US-NOVOPROD-1092519$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234349754$23434975$4$F$$20230702$20240123$20240721$PER$$US-NOVOPROD-1091333$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
234349762$23434976$2$F$20230101$20240104$20240123$20240721$PER$$US-NOVOPROD-1091261$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234349942$23434994$2$F$$20230710$20240123$20240721$PER$$US-NOVOPROD-1093097$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
234350058$23435005$8$F$20231222$20240912$20240123$20240919$PER$$ES-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00020$XERIS PHARMACEUTICALS$$39$YR$$F$Y$53.5$KG$20240918$$MD$ES$ES
234350182$23435018$2$F$$20230607$20240123$20240721$PER$$US-NOVOPROD-1094509$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
2343502710$23435027$10$F$$20231215$20240123$20240721$PER$$US-NOVOPROD-1096159$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
234350292$23435029$2$F$$20230719$20240123$20240721$PER$$US-NOVOPROD-1096129$NOVO NORDISK$$$$A$F$Y$$$20240721$$HP$US$US
234350492$23435049$2$F$$20240205$20240123$20240721$PER$$US-NOVOPROD-1098283$NOVO NORDISK$$32$YR$$M$Y$$$20240721$$HP$US$US
234350763$23435076$3$F$$20230727$20240123$20240721$PER$$US-NOVOPROD-1100380$NOVO NORDISK$$$$A$F$Y$$$20240721$$HP$US$US
234350962$23435096$2$F$$20230720$20240123$20240721$PER$$US-NOVOPROD-1102601$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
234351023$23435102$3$F$20230501$20231016$20240123$20240721$PER$$US-NOVOPROD-1095271$NOVO NORDISK$$$$E$F$Y$$$20240721$$CN$US$US
234351092$23435109$2$F$$20230804$20240123$20240721$PER$$US-NOVOPROD-1104274$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
234351122$23435112$2$F$$20230731$20240123$20240721$PER$$US-NOVOPROD-1103607$NOVO NORDISK$$48$YR$$F$Y$$$20240721$$CN$US$US
234351172$23435117$2$F$20230712$20231204$20240123$20240721$PER$$US-NOVOPROD-1095623$NOVO NORDISK$$63$YR$$F$Y$$$20240721$$CN$US$US
234351752$23435175$2$F$20240801$20240827$20240123$20240830$EXP$$US-BEH-2024167798$CSL BEHRING$$81$YR$E$M$Y$$$20240830$$HP$US$US
234351792$23435179$2$F$$20240821$20240123$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-010182$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240826$$PH$JP$JP
234351824$23435182$4$F$20231104$20240627$20240123$20240712$EXP$$NL-VER-202400010$VERITY PHARMACEUTICALS$$75$YR$E$M$Y$68$KG$20240712$$HP$NL$NL
234352162$23435216$2$F$20190101$20240723$20240123$20240730$EXP$$BR-BIOGEN-2024BI01246194$BIOGEN$$$$$F$Y$65$KG$20240730$$CN$BR$BR
234352574$23435257$4$F$20220301$20240710$20240123$20240716$EXP$$CA-TAKEDA-2022TUS020555$TAKEDA$$31$YR$$M$Y$125$KG$20240716$$HP$CA$CA
234352585$23435258$5$F$20231127$20240830$20240123$20240913$EXP$$JP-AMGEN-JPNSP2023233132$AMGEN$Shoichi F, Tomohisa U, Naoki I, Ayaka U, Momoko O, Keita F. Absence of Glucocorticoids Concomitant With Avacopan and Subsequent Liver Injury in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. The Journal of Rheumatology 2024. 2024;1-3. doi:10.3899/jrheum.2024-0340$85$YR$E$F$Y$52.5$KG$20240912$$MD$JP$JP
234353423$23435342$3$F$$20240703$20240123$20240704$EXP$$CA-SANDOZ INC.-SDZ2024CA006800$SANDOZ$$43$YR$$F$Y$68$KG$20240704$$HP$CA$CA
234354016$23435401$6$F$20231118$20240704$20240123$20240706$EXP$$AT-ABBVIE-5516415$ABBVIE$$73$YR$$M$Y$79$KG$20240706$$MD$AT$AT
234354373$23435437$3$F$$20240808$20240124$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-010015$BRISTOL MYERS SQUIBB$Omatsu R, Matsumoto A, Ogawa K, Nagatomo S, Seki M, Fujita N et al. A case of ileal perforation due to 2-drug combination therapy of immune checkpoint inhibitors (ICIs). The 119th Kinki Division Meeting of the Japanese Society of Gastroenterology. 2023;105$51$YR$A$F$Y$$$20240819$$MD$JP$JP
234354652$23435465$2$F$$20240620$20240124$20240701$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-001241$JAZZ$$$$$F$Y$$$20240630$$CN$US$US
234355042$23435504$2$F$20230101$20240730$20240124$20240805$EXP$$US-ABBVIE-5594044$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
234355094$23435509$4$F$20220101$20240917$20240124$20240924$EXP$$BR-GSK-BR2022AMR104107$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$BR$BR
234357023$23435702$3$F$20230601$20240628$20240124$20240705$EXP$$JP-009507513-2306JPN004364J$MERCK$$69$YR$$F$Y$$$20240705$$MD$JP$JP
234357085$23435708$5$F$20240101$20240703$20240124$20240711$EXP$$CA-CELLTRION INC.-2024CA001420$CELLTRION$$$$$$Y$$$20240711$$MD$CA$CA
234358612$23435861$2$F$$20240821$20240124$20240827$EXP$$CA-APOTEX-2024AP001195$APOTEX$$78$YR$$F$Y$$$20240827$$HP$CA$CA
234358762$23435876$2$F$20231020$20240913$20240124$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-004942$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240930$$HP$US$US
234358848$23435884$8$F$20231102$20240715$20240124$20240720$EXP$$CO-JNJFOC-20231213793$JOHNSON AND JOHNSON$$55$YR$A$M$Y$75$KG$20240719$$HP$CO$CO
234359372$23435937$2$F$$20240711$20240124$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-006136$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
234359648$23435964$8$F$20240101$20240912$20240124$20240920$PER$$CA-TOLMAR, INC.-24CA045873$TOLMAR$$$$$M$Y$$$20240920$$CN$CA$CA
234360202$23436020$2$F$20231107$20240830$20240124$20240909$EXP$$ES-CELLTRION INC.-2024ES001269$CELLTRION$$$$$$Y$$$20240909$$MD$ES$ES
234360502$23436050$2$F$20240121$20240816$20240124$20240820$PER$$US-AMGEN-USASP2024014455$AMGEN$$68$YR$E$M$Y$$$20240820$$CN$US$US
234360573$23436057$3$F$20231014$20240716$20240124$20240726$EXP$$CA-CELLTRION INC.-2023CA020504$CELLTRION$$$$$$Y$$$20240726$$HP$CA$CA
234361313$23436131$3$F$20240101$20240919$20240124$20240923$PER$$US-AMGEN-USASP2024013462$AMGEN$$46$YR$A$M$Y$$$20240923$$HP$US$US
234361364$23436136$4$F$20230101$20240916$20240124$20240924$EXP$$CA-CELLTRION INC.-2023CA018111$CELLTRION$$$$$$Y$$$20240924$$CN$CA$CA
234361562$23436156$2$F$20230101$20240730$20240124$20240808$EXP$$PK-AMGEN-PAKSP2023167861$AMGEN$$75$YR$E$F$Y$$$20240808$$CN$PK$PK
234362416$23436241$6$F$20240205$20240718$20240124$20240724$EXP$$CA-TAKEDA-2023TUS029928$TAKEDA$$40$YR$$M$Y$$$20240724$$CN$CA$CA
234362692$23436269$2$F$20220302$20240925$20240124$20240926$EXP$$DE-TAKEDA-2024TUS006648$TAKEDA$$33$YR$$F$Y$$$20240926$$HP$DE$DE
234362802$23436280$2$F$20210913$20240625$20240124$20240702$EXP$$DE-CELLTRION INC.-2024DE001637$CELLTRION$$$$$$Y$$$20240702$$MD$DE$DE
234363782$23436378$2$F$20240103$20240808$20240124$20240814$EXP$$BR-TAKEDA-2024TUS006642$TAKEDA$$61$YR$$M$Y$$$20240814$$CN$BR$BR
234365958$23436595$8$F$20200401$20240903$20240124$20240913$EXP$$US-ASTELLAS-2020US034487$ASTELLAS$$79$YR$E$M$Y$$$20240913$$CN$US$US
234366524$23436652$4$F$$20240809$20240124$20240813$EXP$$GB-TAKEDA-2024TUS006075$TAKEDA$$$$$F$Y$$$20240813$$CN$GB$GB
234366944$23436694$4$F$20240116$20240920$20240124$20240924$EXP$$US-TAKEDA-2024TUS006564$TAKEDA$$74$YR$$M$Y$$$20240924$$CN$US$US
234367353$23436735$3$F$$20240910$20240124$20240920$EXP$$NL-AUROBINDO-AUR-APL-2024-002489$AUROBINDO$Dolfing AI, Bank PCD, Kramers CK, de Man T, Schellekens AFA, Schulte, PFJR.. Dealing with opioid dependence and withdrawal in hospitals.. Nederlands tijdschrift voor geneeskunde.. 2023;167:55-59$30$YR$$$Y$$$20240920$$HP$NL$NL
234367522$23436752$2$F$$20240718$20240124$20240723$EXP$$US-TAKEDA-2024TUS005484$TAKEDA$$$$$M$Y$$$20240723$$CN$US$US
234367667$23436766$7$F$$20240625$20240124$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-006100$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
234368222$23436822$2$F$20240118$20240709$20240124$20240711$EXP$$CA-TAKEDA-2024TUS004795$TAKEDA$$75$YR$$M$Y$$$20240711$$CN$CA$CA
234368742$23436874$2$F$20220301$20240711$20240124$20240718$EXP$$NVSJ2023JP017940$NOVARTIS$Misaki Y, Murayama T, Hizume K, Yamamoto H, Nomura N, Fukata H et al. A case of organizing pneumonia induced by dabrafenib and trametinib in a patient with BRAF-positive lung cancer. (Program and Abstract Book for) the 102nd Kinki Regional Meeting of the Japanese. 2024;O-14-4$72$YR$$M$Y$$$20240718$$MD$JP$JP
234368993$23436899$3$F$20211128$20240717$20240124$20240725$EXP$$CZ-AUROBINDO-AUR-APL-2024-002580$AUROBINDO$$28$YR$$M$Y$$$20240725$$MD$CZ$CZ
234369513$23436951$3$F$$20240829$20240124$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011191$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240902$$CN$US$US
234369923$23436992$3$F$20240601$20240718$20240124$20240725$30DAY$$US-GSK-US2024008975$GLAXOSMITHKLINE$$85$YR$$M$Y$$$20240725$$MD$US$US
234369953$23436995$3$F$20240101$20240819$20240124$20240829$30DAY$$US-GSK-US2024006342$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240829$$CN$US$US
234370712$23437071$2$F$$20240823$20240124$20240903$EXP$$IL-ROCHE-3492068$ROCHE$$$$A$F$Y$$$20240903$$CN$IL$IL
234370753$23437075$3$F$20240705$20240716$20240124$20240724$EXP$$CA-TAKEDA-2024TUS006016$TAKEDA$$37$YR$$F$Y$58.9$KG$20240724$$CN$CA$CA
234370883$23437088$3$F$20240119$20240729$20240124$20240801$PER$$US-AMGEN-USASP2024013922$AMGEN$$58$YR$A$M$Y$$$20240801$$CN$US$US
2343710810$23437108$10$F$20230319$20240828$20240124$20240904$EXP$$CA-GSK-CA2023048435$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$HP$CA$CA
234372192$23437219$2$F$20231201$20240708$20240124$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011446$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240711$$HP$US$US
234372283$23437228$3$F$20240119$20240819$20240124$20240820$PER$$US-AMGEN-USASP2024014673$AMGEN$$53$YR$A$M$Y$$$20240820$$CN$US$US
234372852$23437285$2$F$20240118$20240730$20240124$20240802$PER$$US-AMGEN-USASP2024013266$AMGEN$$54$YR$A$M$Y$$$20240802$$CN$US$US
234374652$23437465$2$F$$20240726$20240124$20240801$EXP$$JP-SANDOZ INC.-SDZ2024JP007406$SANDOZ$$78$YR$$F$Y$$$20240801$$CN$JP$JP
234375322$23437532$2$F$$20240627$20240124$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-427959$RANBAXY$Siddiqi A, Challagulla S. An Interesting Case of Drug-Induced Hyperprolactinemia in a Patient Who Presented with Psychosis. J Endocr Soc. 2019;Apr 15; 3(Suppl:MON-427$67$YR$$F$Y$$$20240712$$MD$US$US
234375352$23437535$2$F$$20240809$20240124$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428012$RANBAXY$Riel-Romero RMS. A Rare Case of a UBA5-Related Disorder (Early Infantile Epileptic Encephalopathy Type 44): Clinical Findings and Course. J Child Neurol. 2023;38(8-9):565-566; 7$5$YR$$M$Y$$$20240823$$MD$US$US
234375742$23437574$2$F$$20240708$20240124$20240712$PER$$US-BIOGEN-2024BI01246762$BIOGEN$$$$$F$Y$81.72$KG$20240712$$CN$US$US
234375842$23437584$2$F$$20240805$20240124$20240820$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-428613$RANBAXY$Jimenez-Vicente C, Martinez-Roca A, Pomares H, Castano-Diez S, Guijarro F, Lopez-Guerra M, et al. Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease. Leuk Res. 2023;135:6 pages$65$YR$$F$Y$$$20240820$$HP$ES$ES
234375972$23437597$2$F$$20240726$20240124$20240730$EXP$$DK-TAKEDA-2024TUS006407$TAKEDA$$81$YR$$M$Y$$$20240730$$HP$DK$DK
234376032$23437603$2$F$$20240807$20240124$20240822$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428482$RANBAXY$Coco R, Pepe G, Pomi AL, Corica D, Lugara C, Valenzise M, et al. A male case of peripheral precocious puberty caused by testotoxicosis. Horm Res Paediatr. 2023;96 (suppl 4):547; P2-37$$$$M$Y$$$20240822$$HP$IT$IT
234376564$23437656$4$F$$20240813$20240124$20240820$EXP$$CA-GSK-CA2024008740$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$CA$CA
234376573$23437657$3$F$20231201$20240708$20240124$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-012214$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240709$$CN$US$US
234377606$23437760$6$F$20231029$20240819$20240124$20240826$EXP$$SA-GSK-SA2023EME154001$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$SA$SA
234377667$23437766$7$F$$20240920$20240124$20240920$30DAY$$US-PFIZER INC-PV202400001349$PFIZER$$11$YR$$M$Y$35.38$KG$20240920$$MD$US$US
234378082$23437808$2$F$20231227$20240901$20240124$20240910$EXP$$DE-ROCHE-3328527$ROCHE$$44$YR$A$F$Y$68$KG$20240910$$MD$DE$DE
234378162$23437816$2$F$$20240916$20240124$20240919$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-000417$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240919$$CN$US$US
234378452$23437845$2$F$$20240801$20240124$20240805$EXP$$US-TAKEDA-2024TUS006120$TAKEDA$$$$$M$Y$63$KG$20240805$$MD$US$US
234380172$23438017$2$F$20240121$20240730$20240124$20240801$PER$$US-AMGEN-USASP2024014470$AMGEN$$61$YR$A$F$Y$$$20240801$$CN$US$US
234380482$23438048$2$F$20210901$20240711$20240124$20240717$EXP$$US-GSK-US2022104340$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$US$US
234381074$23438107$4$F$20240201$20240619$20240124$20240701$EXP$$US-DSJP-DSU-2023-153002$DAIICHI$$57$YR$$F$Y$$$20240701$$CN$US$US
234381462$23438146$2$F$$20240919$20240124$20240926$EXP$$CA-GSK-CA2024007962$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CA$CA
234382242$23438224$2$F$20231216$20240708$20240124$20240709$PER$$US-BAYER-2024A004662$BAYER$$32$YR$A$M$Y$$$20240709$$HP$US$US
234382574$23438257$4$F$20240711$20240919$20240124$20240926$EXP$$AR-MYLANLABS-2024M1004472$MYLAN$$60$YR$$F$Y$$$20240926$$CN$AR$AR
234382582$23438258$2$F$20231201$20240717$20240124$20240725$EXP$$JP-AstraZeneca-2024A014533$ASTRAZENECA$Yamamoto K, et al.. 9 Two cases of non-small cell lung cancer, in which tocilizumab was effective against cytokine release syndrome (CRS) refractory to steroid pulse therapy induced by chemotherapy + anti-PD-L1 antibody + anti-CTLA-4 antibody.. The 120th Kansai Branch Academic Meeting of the Japan Lung Cancer Society 2024;49.$52$YR$$M$Y$$$20240725$$MD$JP$
234383013$23438301$3$F$20240101$20240826$20240124$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-012340$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240829$$PH$US$US
234383292$23438329$2$F$20240101$20240112$20240124$20240702$EXP$$US-TEVA-VS-3144942$TEVA$$73$YR$$F$Y$50.35$KG$20240702$$CN$US$US
234383523$23438352$3$F$20210101$20240730$20240124$20240802$EXP$$CA-PFIZER INC-2021852107$PFIZER$$62$YR$$M$Y$$$20240802$$HP$CA$CA
234383664$23438366$4$F$20240110$20240726$20240124$20240729$EXP$$NVSC2024US014975$NOVARTIS$$58$YR$$M$Y$$$20240729$$CN$US$US
234383812$23438381$2$F$$20240829$20240124$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-012427$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240902$$CN$US$US
234384462$23438446$2$F$$20240117$20240124$20240723$EXP$$US-TEVA-VS-3148298$TEVA$$68$YR$$F$Y$$$20240723$$CN$US$US
234384542$23438454$2$F$$20240821$20240124$20240826$EXP$$IT-JNJFOC-20240144103$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240826$$HP$IT$IT
234384552$23438455$2$F$$20240919$20240124$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-012311$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$81.65$KG$20240920$$CN$US$US
234384802$23438480$2$F$$20240807$20240124$20240814$EXP$$CA-SA-2024SA021405$SANOFI AVENTIS$$60$YR$A$F$Y$97$KG$20240814$$HP$CA$CA
234384823$23438482$3$F$20230727$20240904$20240124$20240910$EXP$$US-JNJFOC-20240152799$JOHNSON AND JOHNSON$$70$YR$E$M$Y$63.8$KG$20240911$$HP$US$US
234385162$23438516$2$F$$20240722$20240124$20240726$EXP$$GB-VERTEX PHARMACEUTICALS-2024-000983$VERTEX$$$$A$M$Y$$$20240726$$CN$GB$GB
234385782$23438578$2$F$20230101$20240701$20240124$20240710$EXP$$MX-AstraZeneca-2024A014683$ASTRAZENECA$$886$MON$$F$Y$72$KG$20240710$$CN$MX$
234385813$23438581$3$F$20231101$20240906$20240124$20240917$PER$$US-SA-2023SA382863$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240918$$MD$US$US
234385873$23438587$3$F$20240101$20240903$20240124$20240913$PER$$US-SA-2024SA018176$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240913$$MD$US$US
234386002$23438600$2$F$$20240717$20240124$20240726$PER$$US-SA-2024SA017794$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
234386112$23438611$2$F$$20240709$20240124$20240717$PER$$US-SA-2024SA020106$SANOFI AVENTIS$$$$A$M$Y$$$20240717$$MD$US$US
234386492$23438649$2$F$$20240722$20240124$20240730$PER$$US-SA-2024SA021455$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240730$$MD$US$US
234386942$23438694$2$F$$20240809$20240124$20240817$PER$$US-SA-2024SA018470$SANOFI AVENTIS$$$$A$F$Y$$$20240817$$CN$US$US
234387404$23438740$4$F$20240201$20240807$20240124$20240815$PER$$US-SA-2024SA025439$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240815$$MD$US$US
234388003$23438800$3$F$$20240822$20240124$20240903$PER$$US-SA-2024SA025115$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240903$$MD$US$US
234388304$23438830$4$F$20240101$20240711$20240124$20240723$PER$$US-SA-2024SA025602$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240723$$MD$US$US
234388842$23438884$2$F$$20240905$20240124$20240924$EXP$$US-SA-2024SA026946$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240924$$CN$US$US
234388954$23438895$4$F$$20240918$20240124$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-009450$BRISTOL MYERS SQUIBB$Ikeda S, Miyazaki H, Watanabe D, Ito Y, Okamoto N, Tokunaga E, et al. A case of immune-related enterocolitis complicated by megacolon. The 119th Kinki Division Meeting of the Japanese Society of Gastroenterology. 2023;125.$6$DEC$A$M$Y$$$20240927$$MD$JP$JP
234388963$23438896$3$F$$20240701$20240124$20240702$EXP$$DE-SANDOZ INC.-NVSC2021DE186607$SANDOZ$$77$YR$$F$Y$$$20240702$$MD$DE$DE
234389752$23438975$2$F$20231208$20240903$20240124$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-012630$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240911$$CN$US$US
234390042$23439004$2$F$20231201$20240705$20240124$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202401010368$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240709$$CN$US$US
234390053$23439005$3$F$20240101$20240807$20240124$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202401012603$ELI LILLY AND CO$$32$YR$A$$Y$$$20240815$$CN$US$US
234390124$23439012$4$F$20230101$20240801$20240124$20240805$EXP$$AU-UCBSA-2023053741$UCB$$$$$F$Y$$$20240805$$CN$AU$AU
234391992$23439199$2$F$$20240910$20240124$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202401009119$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240917$$CN$US$US
234392413$23439241$3$F$$20240726$20240124$20240730$EXP$$DK-TAKEDA-2024TUS006439$TAKEDA$$67$YR$$F$Y$$$20240730$$HP$DK$DK
234392824$23439282$4$F$20231031$20240904$20240124$20240918$EXP$$NL-ROCHE-3496847$ROCHE$$55$YR$A$F$Y$64$KG$20240918$$MD$NL$NL
234393235$23439323$5$F$20240101$20240802$20240124$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-010440$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240806$$CN$US$US
234393283$23439328$3$F$20200101$20240816$20240124$20240821$EXP$$CO-BIOGEN-2022BI01122389$BIOGEN$$$$$M$Y$80$KG$20240821$$CN$CO$CO
234394192$23439419$2$F$20220601$20240827$20240124$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-009357$BRISTOL MYERS SQUIBB$Kunisada K, Ogura M, Oda Y, Yogo M, Takei T, Sato K, et al. A case of local control of recurrent refractory multiple myeloma with radiation therapy in a very elderly patient. The 691st Kanto regional meeting of the Japanese Society of Internal Medicine hosted by the Kanto Branch (Programs and Abstracts). 2023; 37.$86$YR$E$M$Y$$$20240903$$MD$JP$JP
234395463$23439546$3$F$$20240624$20240124$20240701$EXP$$US-TAKEDA-2024TUS005997$TAKEDA$$$$$M$Y$$$20240701$$CN$US$US
234395733$23439573$3$F$20240320$20240730$20240124$20240906$EXP$$FR-PFIZER INC-PV202400005755$PFIZER$$$$$M$Y$$$20240906$$HP$FR$FR
234395892$23439589$2$F$20230918$20240813$20240124$20240821$EXP$$JP-AstraZeneca-2023A244188$ASTRAZENECA$$67$YR$$M$Y$56$KG$20240821$$MD$JP$
234396074$23439607$4$F$$20240903$20240124$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011037$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240904$$CN$US$US
234396402$23439640$2$F$$20240725$20240124$20240730$EXP$CA-HEALTHCANVIG-E2B_01896695$CA-PURDUE-USA-2024-0307269$PURDUE$$71$YR$$F$Y$$$20240730$$PH$CA$CA
234397522$23439752$2$F$$20240717$20240124$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-012013$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240718$$HP$US$US
234397823$23439782$3$F$$20240806$20240124$20240810$EXP$$US-ABBVIE-5601544$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
234398184$23439818$4$F$20231114$20240708$20240124$20240710$EXP$$JP-AMERICAN REGENT INC-2024000215$AMERICAN REGENT$$36$YR$$F$Y$$$20240710$$MD$JP$JP
234398605$23439860$5$F$20230101$20240702$20240124$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011303$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240716$$CN$US$US
234398794$23439879$4$F$20230706$20240822$20240124$20240826$EXP$$JP-AstraZeneca-2023A161903$ASTRAZENECA$Usui N et. all. P11-2 A case of hepatocellular carcinoma in which fulminant type 1 diabetes mellitus developed during durvalumab/tremelimumab administration. The 29th Japan Association of Systemic Therapy of HCC 2024;136.$64$YR$$M$Y$64$KG$20240826$$MD$JP$
234398955$23439895$5$F$20220301$20240815$20240124$20240819$EXP$$US-PFIZER INC-PV202400009253$PFIZER$$75$YR$$M$Y$$$20240819$$CN$US$US
234399039$23439903$9$F$20240101$20240830$20240124$20240904$EXP$$CA-PFIZER INC-202400020322$PFIZER$$55$YR$$M$Y$$$20240904$$CN$CA$CA
234399162$23439916$2$F$20240101$20240712$20240124$20240718$EXP$$CN-PFIZER INC-PV202400009046$PFIZER$$81$YR$$M$Y$46$KG$20240718$$HP$CN$CN
234399463$23439946$3$F$20240101$20240627$20240124$20240702$EXP$$US-PFIZER INC-202400020358$PFIZER$$75$YR$$F$Y$$$20240702$$HP$US$US
234400043$23440004$3$F$$20240826$20240124$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011980$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240829$$CN$US$US
234400096$23440009$6$F$20231120$20240722$20240124$20240728$PER$$JP-Eisai-EC-2024-157405$EISAI$$63$YR$A$M$Y$$$20240728$$MD$JP$JP
234400233$23440023$3$F$20231219$20240730$20240124$20240822$PER$$CA-TOLMAR, INC.-23CA045629$TOLMAR$$77$YR$$M$Y$$$20240822$$CN$CA$CA
234400253$23440025$3$F$$20240913$20240124$20240920$PER$$CA-TOLMAR, INC.-23CA045733$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
234400373$23440037$3$F$20231225$20240620$20240124$20240718$PER$$CA-TOLMAR, INC.-23CA045747$TOLMAR$$70$YR$$M$Y$$$20240718$$CN$CA$CA
234400942$23440094$2$F$20221011$20240828$20240124$20240830$EXP$$CA-TAKEDA-2024TUS006436$TAKEDA$$64$YR$$F$Y$$$20240830$$MD$CA$CA
234401062$23440106$2$F$20231115$20240725$20240124$20240731$EXP$FR-AFSSAPS-GR2024000010$FR-009507513-2401FRA009880$MERCK$$42$YR$$F$Y$98$KG$20240731$$MD$FR$FR
234401113$23440111$3$F$$20240729$20240124$20240802$EXP$$NVSC2024US016407$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
234401223$23440122$3$F$20231112$20240612$20240124$20240703$PER$$CA-TOLMAR, INC.-23CA045742$TOLMAR$$62$YR$$M$Y$$$20240703$$CN$CA$CA
234401372$23440137$2$F$$20240116$20240124$20240930$EXP$$JP-JNJFOC-20240164270$JOHNSON AND JOHNSON$Inoue Y, Fujieda Y, Miyamoto K, Kamata K, Oki Y, Hisada R, et al. [O23-7 3 cases of difficult to treat rheumatoid arthritis thought to be caused by reactivation of Epstein-Barr virus] The 38th Annual Meeting of the Japanese Society for Clinical Rheumatology and Related Research. 2023.11.18,19; 350$82$YR$E$M$Y$$$20240930$$MD$JP$JP
234401533$23440153$3$F$$20240223$20240124$20240920$EXP$$FR-009507513-2401FRA014066$MERCK$$$$$F$Y$$$20240920$$PH$FR$FR
234401782$23440178$2$F$20240117$20240712$20240124$20240717$EXP$$US-TAKEDA-2024TUS005768$TAKEDA$$6$YR$$M$Y$$$20240717$$MD$US$US
234401826$23440182$6$F$20240701$20240731$20240124$20240807$EXP$$CA-GSK-CA2023149309$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$HP$CA$CA
234402093$23440209$3$F$$20240813$20240124$20240814$EXP$$DK-TAKEDA-2024TUS006384$TAKEDA$$15$YR$$M$Y$$$20240814$$HP$DK$DK
234403854$23440385$4$F$20231111$20240627$20240124$20240702$EXP$$US-ABBVIE-5598951$ABBVIE$$56$YR$$M$Y$114$KG$20240702$$CN$US$US
234403897$23440389$7$F$20240101$20240918$20240124$20240925$PER$$US-BIOGEN-2024BI01246948$BIOGEN$$32$YR$$M$Y$$$20240925$$CN$US$US
234404072$23440407$2$F$$20240821$20240124$20240824$PER$$US-AMGEN-USASP2024014747$AMGEN$$$$$M$Y$$$20240824$$CN$US$US
234404263$23440426$3$F$$20240829$20240124$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-002119$AUROBINDO$Liu C, Zhou LL. Terbinafine-induced generalized pustular psoriasis (GPP) of von Zumbusch simulating toxic epidermal necrolysis (TEN).. JDDG - Journal of the German Society of Dermatology.. 2023;1-3$69$YR$$M$Y$$$20240910$$MD$CA$CA
234404456$23440445$6$F$20240120$20240731$20240124$20240802$EXP$$AU-TAKEDA-2024TUS007021$TAKEDA$$59$YR$$M$Y$$$20240802$$CN$AU$AU
234404803$23440480$3$F$20231218$20240910$20240125$20240920$PER$$US-SA-2024SA025760$SANOFI AVENTIS$$73$YR$E$M$Y$102.3$KG$20240920$$HP$US$US
234405003$23440500$3$F$20240413$20240729$20240125$20240807$PER$$US-SA-2024SA025699$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240807$$MD$US$US
234405034$23440503$4$F$20231226$20240801$20240125$20240814$EXP$$US-BEH-2024167734$CSL BEHRING$$35$YR$A$F$Y$63.492$KG$20240814$$HP$US$US
234405063$23440506$3$F$$20240815$20240125$20240822$EXP$$NVSC2024US015341$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
234405572$23440557$2$F$$20240708$20240125$20240712$EXP$$US-ABBVIE-5599779$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
234406333$23440633$3$F$$20240807$20240125$20240817$EXP$$PL-MACLEODS PHARMACEUTICALS US LTD-MAC2024045410$MACLEODS$$$$$$Y$$$20240817$$MD$PL$PL
234406733$23440673$3$F$20230401$20240712$20240125$20240717$EXP$$CA-TAKEDA-2023TUS039699$TAKEDA$$88$YR$$M$Y$$$20240717$$MD$CA$CA
234406822$23440682$2$F$20240101$20240822$20240125$20240917$PER$$US-SA-2024SA020752$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240918$$MD$US$US
234406934$23440693$4$F$$20240628$20240125$20240704$PER$$US-BIOGEN-2024BI01246729$BIOGEN$$$$$M$Y$$$20240704$$CN$US$US
234407123$23440712$3$F$$20240911$20240125$20240919$EXP$$CA-CELLTRION INC.-2024CA001247$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
234407465$23440746$5$F$20231201$20240712$20240125$20240722$EXP$$CA-CELLTRION INC.-2024CA001729$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
234407562$23440756$2$F$20231220$20240717$20240125$20240729$EXP$SE-SEMPA-2024-000250$SE-NOVOPROD-1162937$NOVO NORDISK$$56$YR$$F$Y$114$KG$20240729$$MD$SE$SE
234410072$23441007$2$F$20230508$20240619$20240125$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-428700$RANBAXY$$63$YR$$F$Y$$$20240704$$MD$IT$IT
234411002$23441100$2$F$$20240701$20240125$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428678$RANBAXY$$$$E$F$Y$$$20240712$$MD$US$US
234411376$23441137$6$F$20240101$20240722$20240125$20240729$EXP$$CA-GSK-CA2023030977$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$PH$CA$CA
234411474$23441147$4$F$$20240709$20240125$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013013$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240711$$CN$US$US
234411522$23441152$2$F$$20240814$20240125$20240824$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR010860$VIIV$$$$$$Y$$$20240824$$HP$US$US
234412202$23441220$2$F$20231218$20240710$20240125$20240722$30DAY$$US-GSK-US2024008700$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240722$$CN$US$US
234412225$23441222$5$F$20240122$20240826$20240125$20240829$EXP$$CA-ROCHE-3498234$ROCHE$$47$YR$A$F$Y$$$20240829$$CN$CA$CA
234412432$23441243$2$F$20231106$20240827$20240125$20240910$EXP$FR-AFSSAPS-AM2023001182$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-00550$HIKMA$$83$YR$$M$Y$73$KG$20240910$$MD$FR$FR
234412702$23441270$2$F$$20240722$20240125$20240724$30DAY$$US-ABBVIE-5604724$ABBVIE$$$$$$Y$$$20240724$$HP$US$US
234413626$23441362$6$F$20231201$20240816$20240125$20240821$EXP$$CA-JNJFOC-20240155141$JOHNSON AND JOHNSON$$31$YR$A$M$Y$98$KG$20240821$$HP$CA$CA
234414204$23441420$4$F$20231210$20240709$20240125$20240718$EXP$$ES-AUROBINDO-AUR-APL-2024-000405$AUROBINDO$$85$YR$$M$Y$85.1$KG$20240718$$MD$ES$ES
234414622$23441462$2$F$$20240813$20240125$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-002127$AUROBINDO$Kubinec CJ, Lamoureux D, Lester A, Sweet M, Bhambhwani V.. Drug-induced intracranial hypertension due to mirtazapine: case report and review of the literature.. Canadian journal of ophthalmology. Journal canadien d^ophtalmologie.. 2023;1-2$18$YR$$F$Y$$$20240826$$MD$CA$CA
234414763$23441476$3$F$$20240722$20240125$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011998$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240723$$CN$US$US
234414786$23441478$6$F$20240101$20240627$20240125$20240703$EXP$$US-BEH-2024167706$CSL BEHRING$$25$YR$A$M$Y$$$20240703$$MD$US$US
234415082$23441508$2$F$20240123$20240713$20240125$20240715$PER$$US-AMGEN-USASP2024016089$AMGEN$$62$YR$A$M$Y$$$20240715$$CN$US$US
234415094$23441509$4$F$20240217$20240905$20240125$20240911$EXP$$CO-AMGEN-COLSL2023227394$AMGEN$$57$YR$A$F$Y$$$20240911$$CN$CO$CO
234415672$23441567$2$F$$20240719$20240125$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-012778$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$59.87$KG$20240722$$CN$US$US
234415962$23441596$2$F$$20240822$20240125$20240823$EXP$$IL-ROCHE-3497140$ROCHE$$$$A$F$Y$$$20240823$$CN$IL$IL
234416128$23441612$8$F$20240111$20240809$20240125$20240820$EXP$$US-BEH-2024167851$CSL BEHRING$$28$YR$A$F$Y$157.82$KG$20240820$$HP$US$US
234416549$23441654$9$F$20240313$20240904$20240125$20240911$EXP$$CA-TAKEDA-2022TUS060805$TAKEDA$$32$YR$$M$Y$$$20240911$$HP$CA$CA
234416604$23441660$4$F$20190716$20240813$20240125$20240820$EXP$DE-002147023-PHHY2019DE168419$DE-RDY-CLI/GER/22/0153811$DR REDDYS$$79$YR$E$F$Y$56$KG$20240820$$MD$DE$DE
234416925$23441692$5$F$20220210$20240912$20240125$20240921$EXP$$JP-HORIZON THERAPEUTICS-HZN-2022-001817$AMGEN$$57$YR$A$F$Y$68.2$KG$20240921$$HP$JP$JP
234417085$23441708$5$F$$20240903$20240125$20240925$EXP$$CA-CELLTRION INC.-2023CA020056$CELLTRION$$$$$$Y$$$20240925$$CN$CA$CA
234417182$23441718$2$F$$20240905$20240125$20240917$EXP$$US-GSK-US2024006228$GLAXOSMITHKLINE$$$$$$Y$47.166$KG$20240917$$HP$US$US
234417612$23441761$2$F$$20240715$20240125$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR009028$VIIV$$$$$M$Y$$$20240725$$CN$US$US
234417662$23441766$2$F$$20240701$20240125$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428598$RANBAXY$$$$A$$Y$$$20240712$$HP$US$US
234418184$23441818$4$F$20200514$20240912$20240125$20240919$EXP$$CL-CHEPLA-2021005155$CHEPLAPHARM$$35$YR$$F$Y$$$20240919$$MD$COUNTRY NOT SPECIFIED$CL
234418302$23441830$2$F$$20240904$20240125$20240917$EXP$$CA-AUROBINDO-AUR-APL-2023-034336$AUROBINDO$Elkrief L, Payette O, Foucault J-N, Longpre-Poirier C, Richard M, Desbeaumes Miron J et al. Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report. Frontiers in psychiatry. 2022$43$YR$$M$Y$$$20240917$$HP$CA$CA
234418535$23441853$5$F$20210101$20240702$20240125$20240705$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-008099$AMGEN$$62$YR$A$M$Y$94.104$KG$20240705$$MD$US$US
234418605$23441860$5$F$$20240820$20240125$20240826$EXP$$CA-Orion Corporation ORION PHARMA-24_00027621$ORION$$33$YR$A$M$Y$$$20240826$$HP$CA$
234418622$23441862$2$F$$20240821$20240125$20240824$PER$$US-AMGEN-USASP2024016082$AMGEN$$$$$F$Y$$$20240824$$CN$US$US
234419052$23441905$2$F$20240124$20240725$20240125$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202401014020$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240728$$CN$US$US
234419243$23441924$3$F$$20240725$20240125$20240801$30DAY$$US-GSK-US2024AMR009148$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
234419897$23441989$7$F$$20240709$20240125$20240715$30DAY$$US-PFIZER INC-PV202400001247$PFIZER$$2$YR$$M$Y$$$20240715$$CN$US$US
234419972$23441997$2$F$$20240627$20240125$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000279$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
234420302$23442030$2$F$$20240920$20240125$20240930$PER$$US-GSK-US2023156547$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$CN$US$US
234420342$23442034$2$F$20201210$20240629$20240125$20240706$EXP$$DE-AUROBINDO-AUR-APL-2023-067635$AUROBINDO$$70$YR$$F$Y$70$KG$20240706$$MD$DE$DE
234420505$23442050$5$F$20231101$20240911$20240125$20240911$EXP$$US-PFIZER INC-PV202400008503$PFIZER$$1$YR$$M$Y$$$20240911$$CN$US$US
234420562$23442056$2$F$20230101$20240805$20240125$20240816$EXP$$FR-INSMED, INC.-2023-00270-FR$INSMED$$$$$F$Y$39$KG$20240816$$HP$FR$FR
234421138$23442113$8$F$20231215$20240910$20240125$20240930$PER$$US-TRAVERE-2023TVT00885$TRAVERE THERAPEUTICS$$58$YR$A$M$Y$$$20240930$$CN$US$US
234422152$23442215$2$F$$20240830$20240125$20240912$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-01426$SAMSUNG BIOEPIS$$77$YR$E$F$Y$$$20240912$$CN$GB$GB
234422374$23442237$4$F$20210101$20240704$20240125$20240712$EXP$$IT-AUROBINDO-AUR-APL-2023-069138$AUROBINDO$Luigi Zinzani P, Zoli S, Pellegrini C, Casadei B, Broccoli A, Argnani L, et al.. Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-cell Lymphoma, Leg-type: A Case Report.. Chemotherapy. 2023$85$YR$$F$Y$$$20240712$$MD$IT$IT
234422972$23442297$2$F$$20240722$20240125$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-012724$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240729$$HP$US$US
234423944$23442394$4$F$20240101$20240717$20240125$20240731$EXP$$US-CIPLA LTD.-2024US00695$CIPLA$$$$$$Y$$$20240731$$CN$US$US
234423963$23442396$3$F$20231101$20240621$20240125$20240701$EXP$$US-ROCHE-3494719$ROCHE$$34$YR$A$F$Y$$$20240701$$CN$US$US
234424158$23442415$8$F$$20240715$20240125$20240726$EXP$$CA-SANDOZ INC.-NVSC2022CA066668$SANDOZ$$43$YR$$F$Y$$$20240726$$HP$CA$CA
234424513$23442451$3$F$20061101$20240627$20240125$20240705$EXP$$CZ-AUROBINDO-AUR-APL-2024-002841$AUROBINDO$Stolfa J, Bubova K, Suchy D. Case report of a patient with psoriatic arthritis treated with ixekizumab ? joints, skin and nails under control (Kazuistika pacienta s psoriatickou artritidou leceneho ixekizumabem - klouby, kuze i nehty pod kontrolou). FARMAKOTERAPIE. 2023;19(6):793-794,796-797$70$YR$$M$Y$$$20240705$$MD$CZ$CZ
234424944$23442494$4$F$20231120$20240902$20240125$20240906$EXP$$NVSC2024EG015760$NOVARTIS$$77$YR$$F$Y$$$20240906$$CN$EG$EG
234425047$23442504$7$F$$20240911$20240125$20240916$30DAY$$US-PFIZER INC-PV202400002216$PFIZER$$11$YR$$F$Y$$$20240916$$CN$US$US
234425193$23442519$3$F$20231223$20240629$20240125$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-002864$AUROBINDO$$43$YR$$F$Y$60$KG$20240708$$MD$FR$FR
234425304$23442530$4$F$$20240717$20240125$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013235$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240722$$CN$US$US
234426125$23442612$5$F$20230118$20240703$20240125$20240708$EXP$$US-UCBSA-2023003396$UCB$$9$YR$$M$Y$$$20240708$$CN$US$US
234426233$23442623$3$F$20230801$20240708$20240125$20240711$EXP$$US-ABBVIE-5597832$ABBVIE$$62$YR$$M$Y$63$KG$20240711$$CN$US$US
234426667$23442666$7$F$20230821$20240916$20240125$20240918$EXP$$DE-SANDOZ INC.-SDZ2024DE007386$SANDOZ$$74$YR$$F$Y$59$KG$20240918$$MD$DE$DE
234426694$23442669$4$F$20231219$20240812$20240125$20240814$EXP$$US-TAKEDA-2023TUS122380$TAKEDA$$63$YR$$M$Y$$$20240814$$MD$US$US
234427504$23442750$4$F$$20240903$20240125$20240905$EXP$$CA-ROCHE-3420513$ROCHE$$$$A$F$Y$$$20240905$$HP$CA$CA
234427873$23442787$3$F$$20240916$20240125$20240925$EXP$$CA-APOTEX-2024AP001283$APOTEX$$60$YR$$F$Y$$$20240925$$HP$CA$CA
234428393$23442839$3$F$$20240812$20240125$20240814$EXP$$US-PFIZER INC-PV202400009981$PFIZER$Yabrodi, M.. Deep Sedation in Pediatric Patients With Single Ventricle Physiology Outside of the Operating Room. World Journal for Pediatric and Congenital Heart Surgery. 2024;15(4):488-493$4$YR$$$Y$$$20240814$$MD$US$US
234428402$23442840$2$F$$20240805$20240125$20240808$EXP$$US-PFIZER INC-202400022380$PFIZER$Yabrodi, M.. Deep Sedation in Pediatric Patients With Single Ventricle Physiology Outside of the Operating Room. World Journal for Pediatric and Congenital Heart Surgery. 2024;15(4):488-493$23$YR$$$Y$$$20240808$$MD$US$US
234428432$23442843$2$F$$20240805$20240125$20240808$EXP$$US-PFIZER INC-202400022477$PFIZER$Yabrodi, M.. Deep Sedation in Pediatric Patients With Single Ventricle Physiology Outside of the Operating Room. World Journal for Pediatric and Congenital Heart Surgery. 2024;15(14):488-493$23$YR$$$Y$$$20240808$$MD$US$US
234429064$23442906$4$F$20231101$20240911$20240125$20240919$EXP$$US-ROCHE-3496892$ROCHE$$10$YR$C$F$Y$$$20240919$$CN$US$US
234429143$23442914$3$F$20231201$20240828$20240125$20240904$PER$$US-Eisai-EC-2024-156101$EISAI$$56$YR$A$F$Y$$$20240904$$CN$US$US
234429284$23442928$4$F$$20240913$20240125$20240927$EXP$$GB-UCBSA-2024002580$UCB$$$$A$F$Y$$$20240927$$CN$GB$GB
234429906$23442990$6$F$20180522$20240919$20240125$20240926$EXP$$AT-AMGEN-AUTNI2022094016$AMGEN$$37$YR$A$F$Y$$$20240926$$MD$AT$AT
234430225$23443022$5$F$20240101$20240704$20240125$20240708$EXP$$CA-PFIZER INC-202400022156$PFIZER$$64$YR$$M$Y$$$20240708$$HP$CA$CA
234430283$23443028$3$F$$20240723$20240125$20240725$PER$$US-PFIZER INC-PV202400010680$PFIZER$$71$YR$$F$Y$$$20240725$$HP$US$US
234430468$23443046$8$F$$20240916$20240125$20240918$PER$$US-PFIZER INC-PV202400010520$PFIZER$$80$YR$$F$Y$$$20240918$$MD$US$US
234430523$23443052$3$F$$20240729$20240125$20240731$PER$$US-PFIZER INC-PV202400010669$PFIZER$$68$YR$$F$Y$$$20240731$$CN$US$US
234430646$23443064$6$F$20190715$20240819$20240125$20240828$EXP$$NVSC2023AU273769$NOVARTIS$$93$YR$$F$Y$74.2$KG$20240828$$MD$AU$AU
234430762$23443076$2$F$20221001$20240801$20240125$20240814$EXP$$US-UCBSA-2024002776$UCB$$43$YR$$F$Y$$$20240814$$HP$US$US
234431885$23443188$5$F$20230101$20240806$20240125$20240814$PER$$US-SA-2024SA021447$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240814$$MD$US$US
234432012$23443201$2$F$20230101$20240819$20240125$20240828$PER$$US-SA-2024SA021575$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240828$$MD$US$US
234432252$23443225$2$F$$20240701$20240125$20240710$PER$$US-SA-2024SA021783$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240710$$MD$US$US
234432524$23443252$4$F$$20240726$20240125$20240805$PER$$US-SA-2024SA021992$SANOFI AVENTIS$$8$YR$C$M$Y$23.58$KG$20240805$$MD$US$US
234432912$23443291$2$F$$20240722$20240125$20240729$EXP$$JP-009507513-2309JPN002090J$MERCK$Tanaka T, Sumida Y, Ikeda T. MO59-5 A rare case of intrahepatic cholangiocarcinoma with high frequency microsatellite instability (MSI-High) showing hyperprogression after Pembrolizumab. The 36th Meeting of Japanese Society of Hepato -Biliary -Pancreatic Surgery. 550$83$YR$$M$Y$$$20240729$$MD$JP$JP
234433393$23443339$3$F$$20240726$20240125$20240806$PER$$US-SA-2024SA025167$SANOFI AVENTIS$$73$YR$E$F$Y$50.34$KG$20240806$$MD$US$US
234434792$23443479$2$F$20230811$20240816$20240125$20240821$EXP$$US-SA-2024SA026400$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240821$$MD$US$US
234435482$23443548$2$F$$20240715$20240125$20240723$PER$$US-SA-2024SA018586$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240723$$MD$US$US
234435553$23443555$3$F$20240101$20240821$20240125$20240912$PER$$US-SA-2024SA021705$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240912$$MD$US$US
234435693$23443569$3$F$$20240730$20240125$20240912$PER$$US-MYLANLABS-2024M1005696$MYLAN$$$$$F$Y$$$20240912$$CN$US$US
234435813$23443581$3$F$20231120$20240812$20240125$20240813$EXP$$NVSC2024AT015185$NOVARTIS$$28$YR$$F$Y$$$20240813$$MD$AT$AT
234435972$23443597$2$F$$20240905$20240125$20240909$PER$$US-PFIZER INC-202400022786$PFIZER$$28$YR$$M$Y$$$20240909$$CN$US$US
234436028$23443602$8$F$20240101$20240709$20240125$20240712$EXP$$CA-PFIZER INC-202400021037$PFIZER$$27$YR$$F$Y$$$20240712$$HP$CA$CA
234437714$23443771$4$F$$20240807$20240125$20240809$EXP$$CA-ROCHE-3492993$ROCHE$$$$A$F$Y$$$20240809$$CN$CA$CA
234437806$23443780$6$F$20240410$20240814$20240125$20240823$EXP$$US-Calliditas-2024CAL00086$CALLIDITAS THERAPEUTICS$$50$YR$A$M$Y$$$20240823$$CN$US$US
234438024$23443802$4$F$$20240923$20240125$20240925$EXP$$US-TAKEDA-2021TUS018039$TAKEDA$$$$$M$Y$108$KG$20240925$$HP$US$US
234438335$23443833$5$F$$20240820$20240125$20240823$EXP$$CA-PFIZER INC-202400022595$PFIZER$$33$YR$$M$Y$$$20240823$$HP$CA$CA
2344386213$23443862$13$F$20231208$20240805$20240125$20240808$EXP$$DE-PFIZER INC-202400020779$PFIZER$$60$YR$$F$Y$$$20240808$$MD$DE$DE
234438852$23443885$2$F$20240101$20240702$20240125$20240704$EXP$CZ-CZSUKL-24000057$CZ-PFIZER INC-202400022062$PFIZER$$18$YR$$F$Y$$$20240704$$MD$CZ$CZ
234439166$23443916$6$F$$20240923$20240125$20240926$EXP$$DK-TAKEDA-2024TUS006430$TAKEDA$$50$YR$$F$Y$$$20240926$$HP$DK$DK
234439194$23443919$4$F$20240118$20240717$20240125$20240723$EXP$$BG-TAKEDA-2024TUS007204$TAKEDA$$12$YR$$M$Y$$$20240723$$CN$BG$BG
234439204$23443920$4$F$$20240715$20240125$20240722$EXP$$US-TAKEDA-2024TUS006849$TAKEDA$$$$$M$Y$76.644$KG$20240722$$CN$US$US
234439253$23443925$3$F$20231001$20240704$20240125$20240711$EXP$$US-PFIZER INC-PV202400010551$PFIZER$$61$YR$$F$Y$$$20240711$$CN$US$US
234439312$23443931$2$F$$20240709$20240125$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013115$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240711$$CN$US$US
234440875$23444087$5$F$20231201$20240627$20240125$20240708$PER$$US-SA-2024SA021614$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240708$$MD$US$US
234441036$23444103$6$F$20231201$20240823$20240125$20240906$EXP$$US-BIOMARINAP-US-2024-155408$BIOMARIN$$$$$$Y$$$20240906$$CN$US$US
234441373$23444137$3$F$$20240806$20240125$20240814$EXP$$US-ALXN-A202301735$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240814$$CN$US$US
234441462$23444146$2$F$20220201$20240916$20240125$20240917$EXP$$NL-SANDOZ INC.-SDZ2024NL007537$SANDOZ$$56$YR$$F$Y$$$20240917$$MD$NL$NL
234441733$23444173$3$F$20190101$20240809$20240125$20240814$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007195$JAZZ$$$$$F$Y$$$20240814$$MD$US$US
234442345$23444234$5$F$$20240814$20240125$20240819$EXP$$US-PFIZER INC-PV202400010036$PFIZER$$72$YR$$F$Y$74.376$KG$20240819$$CN$US$US
234442447$23444244$7$F$20231228$20240905$20240125$20240909$EXP$$DK-PFIZER INC-202400020817$PFIZER$$79$YR$$M$Y$87.1$KG$20240909$$MD$DK$DK
234442874$23444287$4$F$20210603$20240705$20240125$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2021-US-010392$JAZZ$$30$YR$$F$Y$$$20240710$$HP$US$US
234443036$23444303$6$F$20201101$20240227$20240125$20240723$EXP$$NVSC2024PT016360$NOVARTIS$Magno S, Freitas R, Brito M, Vaz F, Chaves A, Braga S. Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor - a case series. PORTUGUESE JOURNAL OF ONCOLOGY. 2023;6(4):56$55$YR$$F$Y$$$20240723$$HP$PT$PT
234444373$23444437$3$F$20240309$20240710$20240125$20240717$EXP$$US-GSK-US2024008739$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$US$US
234444464$23444446$4$F$20231227$20240718$20240125$20240724$EXP$$CA-TAKEDA-2024TUS006404$TAKEDA$$61$YR$$F$Y$$$20240724$$MD$CA$CA
234445232$23444523$2$F$$20240722$20240125$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013231$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240723$$CN$US$US
234445313$23444531$3$F$$20240712$20240125$20240722$PER$$US-SA-2024SA020696$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240720$$MD$US$US
234445784$23444578$4$F$20240515$20240916$20240125$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-012770$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$78.47$KG$20240919$$CN$US$US
234445872$23444587$2$F$20090101$20240705$20240125$20240710$EXP$$US-KYOWAKIRIN-2024KK001164$KYOWA$$$$$$Y$$$20240710$$HP$US$US
234445902$23444590$2$F$$20240827$20240125$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-009237$BRISTOL MYERS SQUIBB$Nakagawa H, Hamada K, Yamakawa N, Nakayama Y, Kirita T, Yoshida N, et al. A case of advanced melanoma successfully treated with retreatment of immune checkpoint inhibitors after administration of Dacarbazine. The 74th Annual Meeting of the Central Division of Japanese Dermatological Association. 2023; : 141 {-}. :$71$YR$E$F$Y$$$20240904$$MD$JP$JP
234446573$23444657$3$F$$20240813$20240125$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-010094$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240820$$CN$US$US
234446825$23444682$5$F$20231022$20240828$20240125$20240910$PER$$US-SA-2024SA026917$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240910$$MD$US$US
234446833$23444683$3$F$20240116$20240701$20240125$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-001339$JAZZ$$41$YR$$F$Y$$$20240708$$CN$US$US
234446952$23444695$2$F$20240121$20240905$20240125$20240906$PER$$US-AMGEN-USASP2024015770$AMGEN$$72$YR$E$F$Y$$$20240906$$CN$US$US
234446972$23444697$2$F$20230101$20240814$20240125$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-001315$JAZZ$$$$$F$Y$68$KG$20240820$$CN$US$US
234447052$23444705$2$F$$20240722$20240125$20240725$EXP$$CA-PFIZER INC-202400022140$PFIZER$Ong, M.. Continuous ketamine infusion for the management of opioid-induced hyperalgesia following amputation. BMJ Case Reports. 2024;17(1):e255333$7$DEC$$F$Y$$$20240725$$MD$CA$CA
234447314$23444731$4$F$20240122$20240709$20240125$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-012388$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$55.34$KG$20240710$$CN$US$US
234448293$23444829$3$F$20231216$20240801$20240125$20240810$PER$$US-SA-2024SA026331$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240810$$MD$US$US
234448912$23444891$2$F$20231201$20240627$20240125$20240703$PER$$JP-Eisai-EC-2024-157295$EISAI$$$$E$M$Y$$$20240703$$MD$JP$JP
234449222$23444922$2$F$$20240626$20240125$20240709$EXP$$US-MALLINCKRODT-MNK202400304$MALLINCKRODT$$$$E$F$Y$220$KG$20240709$$HP$US$US
234449822$23444982$2$F$$20240815$20240125$20240820$PER$$US-BIOMARINAP-US-2024-155229$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
234450962$23445096$2$F$$20240827$20240125$20240903$EXP$$US-TAKEDA-2023TUS034131$TAKEDA$$$$$M$Y$56.689$KG$20240903$$CN$US$US
234451326$23445132$6$F$$20240704$20240125$20240710$EXP$$GB-TAKEDA-2024TUS006466$TAKEDA$$$$$M$Y$$$20240710$$CN$GB$GB
234451344$23445134$4$F$20140101$20240913$20240125$20240918$EXP$$US-ABBVIE-5598688$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
234451497$23445149$7$F$20210416$20240924$20240125$20240927$EXP$$GB-TAKEDA-2021TUS020620$TAKEDA$$71$YR$$F$Y$$$20240927$$CN$GB$GB
234451703$23445170$3$F$$20240827$20240125$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011547$BRISTOL MYERS SQUIBB$$22$YR$A$F$Y$$$20240829$$HP$US$US
234451876$23445187$6$F$$20240703$20240125$20240708$EXP$$CA-TAKEDA-2023TUS120372$TAKEDA$$$$$F$Y$$$20240708$$CN$CA$CA
234452593$23445259$3$F$20230508$20240715$20240126$20240718$EXP$$CA-JNJFOC-20240149096$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240718$$HP$CA$CA
234452733$23445273$3$F$20231001$20240917$20240126$20240925$EXP$$CA-JNJFOC-20240146382$JOHNSON AND JOHNSON$$16$YR$T$M$Y$63$KG$20240925$$HP$CA$CA
234454035$23445403$5$F$20230701$20240828$20240126$20240904$EXP$$US-BIOGEN-2023BI01242869$BIOGEN$$36$YR$$M$Y$$$20240904$$CN$US$US
234454193$23445419$3$F$$20240815$20240126$20240820$EXP$$US-ABBVIE-5600709$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
234454524$23445452$4$F$$20240624$20240126$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-009824$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240702$$PH$JP$JP
234454577$23445457$7$F$20240101$20240708$20240126$20240926$PER$$US-GSK-US2024AMR010585$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240926$$HP$US$US
234454682$23445468$2$F$20230726$20240806$20240126$20240809$EXP$$FR-AstraZeneca-2024A016443$ASTRAZENECA$$21$YR$$F$Y$$$20240809$$MD$FR$
234454912$23445491$2$F$20231201$20240805$20240126$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013178$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$97.98$KG$20240807$$PH$US$US
234454935$23445493$5$F$$20240808$20240126$20240814$EXP$$US-GSK-US2024AMR009367$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$HP$US$US
234455664$23445566$4$F$20240121$20240305$20240126$20240705$PER$$US-AMGEN-USASP2024013668$AMGEN$$57$YR$A$M$Y$$$20240705$$CN$US$US
234455982$23445598$2$F$20231218$20240624$20240126$20240703$EXP$$JP-Eisai-EC-2024-157298$EISAI$$65$YR$E$F$Y$$$20240703$$MD$JP$JP
234456032$23445603$2$F$$20240705$20240126$20240715$EXP$$CA-CELLTRION INC.-2024CA001592$CELLTRION$$$$$$Y$$$20240715$$HP$CA$CA
234456303$23445630$3$F$$20240809$20240126$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013490$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240812$$CN$US$US
234456633$23445663$3$F$20240124$20240126$20240126$20240703$PER$$US-AMGEN-USASP2024015649$AMGEN$$72$YR$E$M$Y$$$20240703$$CN$US$US
234457067$23445706$7$F$20230531$20240718$20240126$20240724$EXP$$DE-ROCHE-3393561$ROCHE$$56$YR$A$F$Y$68$KG$20240724$$MD$DE$DE
234457303$23445730$3$F$$20240918$20240126$20240924$PER$$NVSC2024US016016$NOVARTIS$$67$YR$$M$Y$$$20240924$$CN$US$US
234457422$23445742$2$F$20230901$20240805$20240126$20240807$EXP$$US-ABBVIE-5603283$ABBVIE$$82$YR$$F$Y$$$20240807$$CN$US$US
234457545$23445754$5$F$20240101$20240717$20240126$20240722$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-003484$BOEHRINGER INGELHEIM$$84$YR$E$M$Y$$$20240722$$CN$US$US
234457599$23445759$9$F$20240117$20240920$20240126$20240930$EXP$$CA-CELLTRION INC.-2024CA001871$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
234457834$23445783$4$F$$20240807$20240126$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011831$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240814$$CN$US$US
234457904$23445790$4$F$20230401$20240807$20240126$20240808$EXP$FI-FIMEA-202400163$FI-ABBVIE-5606560$ABBVIE$$52$YR$$M$Y$$$20240808$$CN$FI$FI
234458073$23445807$3$F$$20240826$20240126$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013713$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240827$$CN$US$US
234458098$23445809$8$F$20240124$20240820$20240126$20240821$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-004631$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240821$$CN$JP$JP
234458132$23445813$2$F$20231001$20240709$20240126$20240723$EXP$$CA-INTERCEPT-PM2022002282$INTERCEPT PHARMACEUTICALS$$59$YR$$F$Y$$$20240723$$CN$CA$CA
234458316$23445831$6$F$20231128$20240806$20240126$20240809$EXP$$DE-ROCHE-3493564$ROCHE$$55$YR$A$M$Y$79$KG$20240809$$MD$DE$DE
234458545$23445854$5$F$20240117$20240911$20240126$20240920$EXP$$AU-TAKEDA-2021TUS050905$TAKEDA$$66$YR$$M$Y$$$20240920$$HP$AU$AU
234458652$23445865$2$F$20190221$20240717$20240126$20240731$EXP$$DE-ROCHE-2300983$ROCHE$$47$YR$A$M$Y$85$KG$20240731$$CN$DE$DE
234458692$23445869$2$F$20231201$20240826$20240126$20240830$EXP$$US-ABBVIE-5599996$ABBVIE$$63$YR$$M$Y$$$20240830$$CN$US$US
234458934$23445893$4$F$$20240911$20240126$20240916$EXP$$CA-TAKEDA-2020TUS049853$TAKEDA$$$$$F$Y$$$20240916$$MD$CA$CA
234458955$23445895$5$F$20240801$20240827$20240126$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013581$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$155.9$KG$20240903$$CN$US$US
234459227$23445922$7$F$20240913$20240916$20240126$20240919$EXP$$US-TAKEDA-2023TUS027446$TAKEDA$$65$YR$$F$Y$89$KG$20240919$$CN$US$US
234459313$23445931$3$F$20230801$20240815$20240126$20240823$EXP$$JP-009507513-2401JPN003998J$MERCK$$8$DEC$$F$Y$$$20240823$$MD$JP$JP
234459335$23445933$5$F$$20240809$20240126$20240827$EXP$$JP-009507513-2312JPN000513J$MERCK$Shibata N, Matsui C, Hirai C, Tada M, Yauchi Y, Kikawa Y, et al.. EP-0451 Treatment outcomes of the KYENOTE-522 regimen for early-stage triple-negative breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 290$52$YR$$F$Y$$$20240827$$MD$JP$JP
234459452$23445945$2$F$20240105$20240821$20240126$20240822$EXP$$CA-ROCHE-3498710$ROCHE$$48$YR$A$F$Y$$$20240822$$CN$CA$CA
234459613$23445961$3$F$20240711$20240715$20240126$20240720$EXP$$US-TAKEDA-2024TUS007145$TAKEDA$$64$YR$$M$Y$77.1$KG$20240720$$HP$US$US
234460133$23446013$3$F$20230822$20240816$20240126$20240821$EXP$$CO-TAKEDA-2023TUS082838$TAKEDA$$16$YR$$F$Y$45$KG$20240821$$HP$CO$CO
234460236$23446023$6$F$$20240620$20240126$20240926$PER$$US-GSK-US2024AMR008512$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
234461443$23446144$3$F$20230101$20240628$20240126$20240704$EXP$$JP-009507513-2401JPN002415J$MERCK$$47$YR$$F$Y$$$20240704$$MD$JP$JP
234461568$23446156$8$F$$20240917$20240126$20240924$EXP$$CA-TAKEDA-2024TUS006596$TAKEDA$$$$$F$Y$$$20240924$$CN$CA$CA
234461847$23446184$7$F$20230722$20240807$20240126$20240812$EXP$$CA-TAKEDA-2023TUS075692$TAKEDA$$18$YR$$F$Y$$$20240812$$CN$CA$CA
234462194$23446219$4$F$20240120$20240722$20240126$20240725$PER$$US-AMGEN-USASP2024015752$AMGEN$$70$YR$E$M$Y$$$20240725$$CN$US$US
234462205$23446220$5$F$20230227$20240915$20240126$20240919$EXP$$SA-ROCHE-3299926$ROCHE$$15$YR$T$F$Y$35$KG$20240919$$CN$SA$SA
234462223$23446222$3$F$20240113$20240718$20240126$20240724$EXP$$US-BEH-2024167815$CSL BEHRING$$30$YR$A$M$Y$$$20240724$$HP$US$US
234462316$23446231$6$F$20240101$20240701$20240126$20240711$EXP$$US-BEH-2024167817$CSL BEHRING$$22$YR$A$M$Y$$$20240711$$CN$US$US
234462452$23446245$2$F$20230701$20240731$20240126$20240812$EXP$$US-INSMED-2023-03073-USAA$INSMED$$56$YR$$F$Y$$$20240812$$CN$US$US
234462463$23446246$3$F$$20240926$20240126$20240930$EXP$$CA-TAKEDA-2024TUS006505$TAKEDA$$$$$M$Y$$$20240930$$CN$CA$CA
234464084$23446408$4$F$20231201$20240929$20240126$20240930$EXP$$CA-PFIZER INC-202400019499$PFIZER$$57$YR$$F$Y$$$20240930$$MD$CA$CA
234465122$23446512$2$F$20240105$20240815$20240126$20240827$EXP$$TR-TAKEDA-2024TUS002059$TAKEDA$$8$YR$$M$Y$28$KG$20240827$$CN$TR$TR
234465404$23446540$4$F$$20240620$20240126$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-001186$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
234466212$23446621$2$F$$20240729$20240126$20240806$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-001144$JAZZ$$$$$M$Y$25$KG$20240806$$CN$US$US
234466434$23446643$4$F$$20240816$20240126$20240820$EXP$$US-PFIZER INC-202400024668$PFIZER$$72$YR$$F$Y$63.492$KG$20240820$$CN$US$US
234466444$23446644$4$F$$20240917$20240126$20240919$PER$$US-PFIZER INC-202400023817$PFIZER$$72$YR$$F$Y$$$20240919$$CN$US$US
234466463$23446646$3$F$$20240822$20240126$20240828$PER$$US-PFIZER INC-202400023829$PFIZER$$69$YR$$M$Y$$$20240828$$HP$US$US
234466495$23446649$5$F$$20240718$20240126$20240723$PER$$US-PFIZER INC-PV202400004817$PFIZER$$58$YR$$F$Y$$$20240723$$HP$US$US
234466642$23446664$2$F$$20240711$20240126$20240712$PER$$PR-PFIZER INC-202400024258$PFIZER$$67$YR$$F$Y$$$20240712$$HP$PR$PR
234468234$23446823$4$F$20230101$20240802$20240126$20240812$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019739$JAZZ$$$$$M$Y$$$20240812$$CN$US$US
234468994$23446899$4$F$20240123$20240810$20240126$20240812$PER$$US-PFIZER INC-PV202400011234$PFIZER$$$$$F$Y$$$20240812$$CN$US$US
234469002$23446900$2$F$20240124$20240905$20240126$20240909$EXP$$US-PFIZER INC-202400025091$PFIZER$$51$YR$$M$Y$$$20240909$$HP$US$US
234469792$23446979$2$F$20240401$20240829$20240126$20240904$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202312001960$ELI LILLY AND CO$$73$YR$E$F$Y$50$KG$20240904$$CN$CN$CN
234470214$23447021$4$F$20221119$20240726$20240126$20240731$EXP$$IN-PFIZER INC-PV202300025192$PFIZER$$66$YR$$M$Y$69$KG$20240731$$CN$IN$IN
234470353$23447035$3$F$20231101$20240822$20240126$20240906$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00054$AVADEL CNS PHARMA$$74$YR$$M$Y$104.31$KG$20240906$$CN$US$US
234471473$23447147$3$F$$20240725$20240126$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013162$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240729$$CN$US$US
234472139$23447213$9$F$20240117$20240919$20240126$20240927$EXP$$US-BEH-2024167857$CSL BEHRING$$35$YR$A$F$Y$$$20240927$$HP$US$US
234472823$23447282$3$F$$20240224$20240126$20240701$EXP$$CA-DSJP-DSJ-2024-103765$DAIICHI$$$$$F$Y$$$20240701$$HP$CA$CA
234473047$23447304$7$F$20240123$20240803$20240126$20240815$PER$$US-Calliditas-2024CAL00068$CALLIDITAS THERAPEUTICS$$62$YR$A$M$Y$$$20240815$$CN$US$US
234473076$23447307$6$F$20240111$20240723$20240126$20240731$PER$$JP-Eisai-EC-2024-157979$EISAI$$58$YR$A$F$Y$$$20240731$$MD$JP$JP
234473426$23447342$6$F$20240404$20240627$20240126$20240702$EXP$$CA-TAKEDA-2024TUS006488$TAKEDA$$64$YR$$M$Y$$$20240702$$PH$CA$CA
234473492$23447349$2$F$$20240820$20240126$20240822$EXP$$CA-MYLANLABS-2024M1004301$MYLAN$$6$DY$$$Y$$$20240822$$CN$CA$CA
234473862$23447386$2$F$20231001$20240305$20240126$20240723$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1000507$MYOVANT SCIENCES$$32$YR$$F$Y$$$20240723$$CN$US$US
234474472$23447447$2$F$20230101$20240829$20240126$20240925$PER$$US-Eisai-EC-2024-156567$EISAI$$88$YR$E$M$Y$74$KG$20240925$$CN$US$US
234474672$23447467$2$F$$20240722$20240126$20240725$EXP$$CA-BAUSCH-BL-2024-001096$BAUSCH AND LOMB$$$$$F$Y$$$20240725$$HP$CA$CA
234475229$23447522$9$F$20231218$20240920$20240126$20240927$PER$$FR-Eisai-EC-2023-155756$EISAI$$58$YR$A$F$Y$$$20240927$$MD$FR$FR
234475932$23447593$2$F$$20240701$20240126$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000011$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
234476686$23447668$6$F$20230101$20240806$20240126$20240903$PER$$US-KARYOPHARM-2023KPT002179$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
234476802$23447680$2$F$20240601$20240725$20240126$20240730$PER$$US-PFIZER INC-202300253676$PFIZER$$59$YR$$F$Y$91.63$KG$20240730$$CN$US$US
234477222$23447722$2$F$20231222$20240709$20240126$20240710$EXP$$NVSC2024FR014966$NOVARTIS$$$$A$F$Y$$$20240710$$MD$FR$FR
234477642$23447764$2$F$20230801$20240820$20240126$20240917$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI0801017$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
234477682$23447768$2$F$20240109$20240729$20240126$20240826$PER$$US-Eisai-EC-2024-156642$EISAI$$73$YR$E$M$Y$115$KG$20240826$$CN$US$US
2344781910$23447819$10$F$20240101$20240729$20240126$20240807$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004279$SAREPTA THERAPEUTICS$$5$YR$$M$Y$21.2$KG$20240807$$MD$US$US
234478504$23447850$4$F$20231001$20240725$20240126$20240731$PER$$US-BIOGEN-2024BI01243724$BIOGEN$$34$YR$$M$Y$$$20240731$$CN$US$US
2344785110$23447851$10$F$20240401$20240909$20240126$20240917$EXP$$CA-GSK-CA2023AMR086222$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
234479502$23447950$2$F$20221201$20240304$20240126$20240812$EXP$IT-MINISAL02-952533$IT-TEVA-VS-3143771$TEVA$$61$YR$$M$Y$70$KG$20240812$$MD$IT$IT
234480103$23448010$3$F$$20240708$20240126$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013275$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240710$$CN$US$US
234480475$23448047$5$F$20240315$20240815$20240126$20240821$EXP$$CA-PFIZER INC-202300349324$PFIZER$$78$YR$$F$Y$$$20240821$$MD$CA$CA
234480793$23448079$3$F$$20240813$20240126$20240816$EXP$$US-PFIZER INC-PV202400011103$PFIZER$$83$YR$$M$Y$$$20240816$$HP$US$US
234480858$23448085$8$F$$20240912$20240126$20240918$EXP$$US-PFIZER INC-202400015961$PFIZER$$35$YR$$F$Y$$$20240918$$CN$US$US
234481143$23448114$3$F$20220301$20240724$20240126$20240731$EXP$$US-CHIESI USA, INC.-2024CHF00309$CHIESI$$28$YR$$M$Y$$$20240801$$CN$US$US
234481156$23448115$6$F$$20240710$20240126$20240718$PER$$JP-Eisai-EC-2024-157529$EISAI$$$$A$M$Y$$$20240718$$MD$JP$JP
234481423$23448142$3$F$20231122$20240823$20240126$20240828$EXP$$NVSC2023DE279047$NOVARTIS$$52$YR$$M$Y$88$KG$20240828$$CN$DE$DE
234481558$23448155$8$F$$20240601$20240126$20240710$PER$$US-TRAVERE-2023TVT00877$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240710$$CN$US$US
234481594$23448159$4$F$$20240916$20240126$20240930$PER$$US-TRAVERE-2023TVT00889$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
2344816610$23448166$10$F$$20240709$20240126$20240715$PER$$US-TRAVERE-2023TVT00882$TRAVERE THERAPEUTICS$$$$$M$Y$196$KG$20240715$$CN$US$US
234481732$23448173$2$F$20231218$20240605$20240126$20240717$PER$$US-TRAVERE-2023TVT00899$TRAVERE THERAPEUTICS$$60$YR$A$M$Y$$$20240717$$CN$US$US
234482263$23448226$3$F$20240123$20240902$20240126$20240904$PER$$US-AMGEN-USASP2024014705$AMGEN$$$$$M$Y$$$20240903$$CN$US$US
234482345$23448234$5$F$20240117$20240829$20240127$20240902$EXP$$CO-ABBVIE-5605477$ABBVIE$$50$YR$$M$Y$94$KG$20240902$$CN$CO$CO
234483132$23448313$2$F$20230101$20240712$20240127$20240717$EXP$$US-ABBVIE-5601762$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
234484475$23448447$5$F$20210831$20240723$20240127$20240726$EXP$$JP-ABBVIE-5610468$ABBVIE$$87$YR$$F$Y$$$20240726$$MD$JP$JP
234484564$23448456$4$F$$20240812$20240127$20240813$EXP$$US-TAKEDA-2022TUS013645$TAKEDA$$$$$M$Y$66$KG$20240813$$HP$US$US
234484844$23448484$4$F$20230101$20240910$20240127$20240920$EXP$$US-UCBSA-2023060290$UCB$$$$$F$Y$90.718$KG$20240920$$HP$US$US
234485139$23448513$9$F$20230101$20240805$20240127$20240816$EXP$$US-UCBSA-2023059205$UCB$$$$$F$Y$64.909$KG$20240816$$CN$US$US
234486239$23448623$9$F$20231220$20240826$20240127$20240917$PER$$US-TRAVERE-2023TVT00906$TRAVERE THERAPEUTICS$$63$YR$A$M$Y$$$20240917$$CN$US$US
234486412$23448641$2$F$$20240903$20240127$20240930$PER$$US-TRAVERE-2023TVT00919$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
234486423$23448642$3$F$20231218$20240829$20240127$20240917$PER$$US-TRAVERE-2023TVT00922$TRAVERE THERAPEUTICS$$40$YR$A$M$Y$$$20240917$$CN$US$US
234486473$23448647$3$F$$20240613$20240127$20240730$PER$$US-TRAVERE-2023TVT00927$TRAVERE THERAPEUTICS$$52$YR$A$M$Y$$$20240730$$CN$US$US
234486503$23448650$3$F$20231201$20240625$20240127$20240731$PER$$US-TRAVERE-2024TVT00001$TRAVERE THERAPEUTICS$$61$YR$A$F$Y$$$20240731$$CN$US$US
234486587$23448658$7$F$$20240921$20240127$20240927$EXP$$US-GSK-US2024008021$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
234486613$23448661$3$F$20240101$20240617$20240127$20240731$PER$$US-TRAVERE-2023TVT00925$TRAVERE THERAPEUTICS$$62$YR$A$M$Y$58.97$KG$20240731$$CN$US$US
234487333$23448733$3$F$$20240613$20240127$20240730$PER$$US-TRAVERE-2023TVT00857$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240730$$CN$US$US
234488072$23448807$2$F$$20240716$20240128$20240723$EXP$$CA-JNJFOC-20240158876$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$MD$CA$CA
234488332$23448833$2$F$$20240711$20240128$20240716$EXP$$US-GSK-US2024008836$GLAXOSMITHKLINE$$$$$F$Y$78$KG$20240716$$CN$US$US
234488352$23448835$2$F$20230524$20240729$20240128$20240805$EXP$$JP-JNJFOC-20230611466$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240805$$MD$JP$JP
234488622$23448862$2$F$$20240715$20240128$20240725$PER$$US-JNJFOC-20240169853$JOHNSON AND JOHNSON$$$$$M$Y$$$20240725$$CN$US$US
234489062$23448906$2$F$$20240118$20240128$20240926$PER$$US-GSK-US2024AMR009064$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
234489142$23448914$2$F$20191001$20240829$20240128$20240903$EXP$$US-SANDOZ INC.-NVSC2019US009236$SANDOZ$$47$YR$$F$Y$83$KG$20240903$$CN$US$US
234489203$23448920$3$F$20240118$20240730$20240128$20240806$30DAY$$US-GSK-US2024008888$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240806$$HP$US$US
234489356$23448935$6$F$20240101$20240821$20240128$20240830$EXP$$US-GSK-US2024AMR009059$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240830$$CN$US$US
234490423$23449042$3$F$20230101$20240830$20240128$20240905$EXP$$US-ABBVIE-5445627$ABBVIE$$$$$F$Y$73$KG$20240905$$CN$US$US
234490682$23449068$2$F$20181204$20240703$20240128$20240709$EXP$$JP-GSK-JP2023JPN091831$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$JP$JP
234491215$23449121$5$F$20240430$20240822$20240128$20240827$EXP$$AU-TAKEDA-2024TUS006591$TAKEDA$$25$YR$$M$Y$$$20240827$$HP$AU$AU
234491553$23449155$3$F$20240103$20240814$20240128$20240820$EXP$$CA-TAKEDA-2024TUS004603$TAKEDA$$77$YR$$F$Y$52$KG$20240820$$CN$CA$CA
234491593$23449159$3$F$20240214$20240820$20240128$20240826$EXP$$CA-TAKEDA-2024TUS007070$TAKEDA$$41$YR$$M$Y$$$20240826$$CN$CA$CA
234492102$23449210$2$F$20240122$20240711$20240129$20240713$PER$$US-AMGEN-USASP2024015407$AMGEN$$66$YR$E$M$Y$$$20240713$$CN$US$US
234492634$23449263$4$F$20240201$20240613$20240129$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000005$ACADIA PHARMACEUTICALS$$5$YR$$M$Y$$$20240708$$CN$US$US
234493543$23449354$3$F$20240120$20240717$20240129$20240724$PER$$US-AMGEN-USASP2024015183$AMGEN$$75$YR$E$F$Y$$$20240723$$CN$US$US
234493864$23449386$4$F$20240309$20240919$20240129$20240930$EXP$$US-BEH-2024167799$CSL BEHRING$$48$YR$A$F$Y$107.48$KG$20240930$$CN$US$US
234494602$23449460$2$F$$20240731$20240129$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011453$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240806$$CN$US$US
234495622$23449562$2$F$$20240701$20240129$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009269$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240702$$CN$US$US
234495783$23449578$3$F$$20240729$20240129$20240808$EXP$$JP-ROCHE-3496230$ROCHE$Fujimoto S, Eriguchi Y, Nakamura R, Kamikawa S, Yonekawa A, Miyake N, Ono N and Niiro H Streptococcal Toxic Shock Syndrome due to Streptococcus dysgalactiae subsp. equisimilis from Retroperitoneal Panniculitis during the treatment with anti-IL-6 receptor antibody: A Case Report. DOI:10.1093/mrcr/rxae001. Modern rheumatology case reports 2024 Jan 12;:1-9.$53$YR$A$M$Y$$$20240808$$HP$JP$JP
234495982$23449598$2$F$20240123$20240728$20240129$20240730$PER$$US-AMGEN-USASP2024015331$AMGEN$$64$YR$A$F$Y$$$20240730$$CN$US$US
234496083$23449608$3$F$20240121$20240712$20240129$20240715$PER$$US-AMGEN-USASP2024014556$AMGEN$$66$YR$E$M$Y$$$20240715$$CN$US$US
234496632$23449663$2$F$20220714$20240820$20240129$20240831$EXP$$DE-AUROBINDO-AUR-APL-2022-037900$AUROBINDO$$$$E$F$Y$58$KG$20240831$$MD$DE$DE
234496705$23449670$5$F$20230724$20240819$20240129$20240902$EXP$$CL-ORGANON-O2401CHL002129$ORGANON$$19$YR$$F$Y$70.1$KG$20240902$$HP$CL$CL
234497073$23449707$3$F$$20240815$20240129$20240823$EXP$$CA-GSK-CA2024010590$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$CA$CA
234497193$23449719$3$F$20180808$20240917$20240129$20240924$EXP$$CA-TAKEDA-2019TUS013591$TAKEDA$$28$YR$$F$Y$$$20240924$$MD$CA$CA
234497823$23449782$3$F$20240118$20240716$20240129$20240729$EXP$$CO-ORPHANEU-2024000454$RECORDATI$$$$$$Y$$$20240726$$MD$CO$CO
234498414$23449841$4$F$20200101$20240724$20240129$20240731$EXP$$CA-TAKEDA-2020TUS004825$TAKEDA$$66$YR$$F$Y$$$20240731$$MD$CA$CA
234498996$23449899$6$F$20231228$20240912$20240129$20240919$EXP$$US-BIOGEN-2024BI01247388$BIOGEN$$59$YR$$F$Y$$$20240919$$CN$US$US
234499473$23449947$3$F$$20240922$20240129$20240926$EXP$GB-MHRA-MED-202311011328553110-FZBVH$GB-ROCHE-3451812$ROCHE$$64$YR$A$M$Y$90$KG$20240926$$PH$GB$GB
234499762$23449976$2$F$20220801$20240701$20240129$20240704$EXP$$NVSC2022AU185986$NOVARTIS$$66$YR$$F$Y$$$20240704$$CN$AU$AU
234499983$23449998$3$F$20231227$20240828$20240129$20240902$EXP$$TR-ORGANON-O2401TUR001821$ORGANON$$33$YR$$F$Y$75$KG$20240902$$MD$TR$TR
234500145$23450014$5$F$20220601$20240904$20240129$20240910$EXP$$CO-TAKEDA-2023TUS033696$TAKEDA$$71$YR$$M$Y$63$KG$20240910$$CN$CO$CO
234500523$23450052$3$F$20240122$20240717$20240129$20240725$PER$$US-AMGEN-USASP2024015986$AMGEN$$65$YR$E$M$Y$$$20240725$$CN$US$US
234500538$23450053$8$F$20231010$20240816$20240129$20240822$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-271096$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240822$$CN$US$US
234501356$23450135$6$F$20230322$20240909$20240129$20240918$EXP$$CA-GSK-CA2022194622$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$CA$CA
234502182$23450218$2$F$20220420$20240806$20240129$20240811$EXP$$DE-ROCHE-3126980$ROCHE$$47$YR$A$M$Y$$$20240811$$MD$DE$DE
234502913$23450291$3$F$20240101$20240801$20240129$20240805$EXP$$NVSC2024US018654$NOVARTIS$$78$YR$$M$Y$$$20240804$$MD$US$US
234502952$23450295$2$F$20240119$20240916$20240129$20240924$PER$$US-AMGEN-USASP2024013406$AMGEN$$67$YR$E$F$Y$$$20240923$$CN$US$US
234503342$23450334$2$F$$20240723$20240129$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-012351$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240731$$CN$US$US
234503513$23450351$3$F$20240904$20240904$20240129$20240910$EXP$$CA-TAKEDA-2021TUS060214$TAKEDA$$36$YR$$F$Y$$$20240910$$MD$CA$CA
234503723$23450372$3$F$20230825$20240809$20240129$20240814$PER$$US-AMGEN-USASP2024008035$AMGEN$$68$YR$E$M$Y$75.5$KG$20240814$$HP$US$US
234505323$23450532$3$F$$20240703$20240129$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013993$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240704$$MD$US$US
234505724$23450572$4$F$20240701$20240717$20240129$20240724$EXP$$US-GSK-US2024009376$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$US$US
234506457$23450645$7$F$20220101$20240910$20240129$20240920$EXP$$US-INSMED, INC.-2023-04552-US$INSMED$$$$$F$Y$$$20240920$$CN$US$US
234507252$23450725$2$F$20190829$20240708$20240129$20240710$EXP$$CA-TAKEDA-2019TUS050481$TAKEDA$$80$YR$$M$Y$$$20240710$$HP$CA$CA
234507693$23450769$3$F$20200309$20240707$20240129$20240712$EXP$$CA-JNJFOC-20230209036$JOHNSON AND JOHNSON$$15$YR$T$M$Y$74.002$KG$20240712$$HP$CA$CA
234509422$23450942$2$F$20230705$20240731$20240129$20240806$EXP$$CA-PFIZER INC-202300202397$PFIZER$$71$YR$$F$Y$$$20240806$$MD$CA$CA
234509464$23450946$4$F$20240201$20240906$20240129$20240910$EXP$$US-PFIZER INC-202400023179$PFIZER$$30$YR$$M$Y$$$20240910$$MD$US$US
234509593$23450959$3$F$$20240801$20240129$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013091$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240808$$CN$US$US
234509612$23450961$2$F$$20240618$20240129$20240702$EXP$$CA-ABBVIE-5610838$ABBVIE$$42$YR$$M$Y$$$20240702$$HP$CA$CA
234510102$23451010$2$F$20231207$20240722$20240129$20240725$PER$$US-AMGEN-USASP2024014646$AMGEN$$73$YR$E$M$Y$$$20240725$$CN$US$US
234510802$23451080$2$F$$20240916$20240129$20240917$EXP$$CA-SANDOZ INC.-NVSC2023CA052321$SANDOZ$$51$YR$$F$Y$101$KG$20240917$$CN$CA$CA
234511064$23451106$4$F$20210522$20240630$20240129$20240704$EXP$$CA-PFIZER INC-2021722996$PFIZER$$67$YR$$M$Y$$$20240704$$MD$CA$CA
234511183$23451118$3$F$20000916$20240723$20240129$20240730$EXP$DE-ROCHE-313090$GB-RDY-SPO/GBR/24/0001273$DR REDDYS$$86$YR$E$F$Y$56$KG$20240730$$HP$GB$GB
234511244$23451124$4$F$$20240805$20240129$20240808$EXP$$US-PFIZER INC-PV202400011889$PFIZER$$57$YR$$F$Y$$$20240808$$CN$US$US
234511282$23451128$2$F$20231001$20240719$20240129$20240723$EXP$$CA-PFIZER INC-202300356447$PFIZER$$38$YR$$F$Y$$$20240723$$MD$CA$CA
234511663$23451166$3$F$20230101$20240723$20240129$20240729$EXP$$CA-PFIZER INC-202300224714$PFIZER$$27$YR$$F$Y$81.1$KG$20240729$$HP$CA$CA
234511812$23451181$2$F$20240122$20240814$20240129$20240819$PER$$US-AMGEN-USASP2024016288$AMGEN$$40$YR$A$M$Y$$$20240819$$CN$US$US
234512663$23451266$3$F$20240121$20240820$20240129$20240823$PER$$US-AMGEN-USASP2024018949$AMGEN$$75$YR$E$F$Y$$$20240823$$CN$US$US
234512734$23451273$4$F$20240101$20240710$20240129$20240716$EXP$$CA-Orion Corporation ORION PHARMA-24_00027684$ORION$$27$YR$A$F$Y$$$20240716$$HP$CA$
234513029$23451302$9$F$20220622$20240910$20240129$20240918$EXP$$JP-PFIZER INC-PV202400010330$PFIZER$$7$YR$$M$Y$28.2$KG$20240918$$MD$JP$JP
234513442$23451344$2$F$20240114$20240715$20240129$20240717$EXP$$IN-ROCHE-3500540$ROCHE$$59$YR$A$F$Y$$$20240717$$MD$IN$IN
234514312$23451431$2$F$20230101$20240723$20240129$20240731$PER$$US-SA-2024SA030137$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240731$$MD$US$US
234514444$23451444$4$F$20240101$20240719$20240129$20240726$PER$$US-SA-2024SA030465$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240726$$CN$US$US
234514702$23451470$2$F$$20240701$20240129$20240710$PER$$US-SA-2024SA028501$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240709$$CN$US$US
234514802$23451480$2$F$$20240729$20240129$20240807$PER$$US-SA-2024SA029157$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240807$$MD$US$US
234514932$23451493$2$F$20230901$20240829$20240129$20240925$PER$$US-SA-2024SA030203$SANOFI AVENTIS$$49$YR$A$F$Y$97$KG$20240925$$MD$US$US
234515123$23451512$3$F$20231101$20240828$20240129$20240909$EXP$$US-SA-2024SA031080$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240909$$MD$US$US
234515813$23451581$3$F$20230101$20240815$20240129$20240828$PER$$US-SA-2024SA023860$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240828$$MD$US$US
234515903$23451590$3$F$20240105$20240819$20240129$20240902$PER$$US-SA-2024SA021828$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240902$$MD$US$US
234516024$23451602$4$F$20230101$20240807$20240129$20240816$PER$$US-SA-2024SA023451$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240816$$MD$US$US
234516272$23451627$2$F$20231001$20240705$20240129$20240717$PER$$US-SA-2024SA023262$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240717$$MD$US$US
234516623$23451662$3$F$20240101$20240807$20240129$20240815$PER$$US-SA-2024SA021923$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240815$$MD$US$US
234516723$23451672$3$F$$20240910$20240129$20240917$PER$$US-SA-2024SA023537$SANOFI AVENTIS$$$$T$M$Y$$$20240918$$MD$US$US
234516823$23451682$3$F$20220101$20240830$20240129$20240912$PER$$US-SA-2024SA021372$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$MD$US$US
234517022$23451702$2$F$20240807$20240819$20240129$20240828$PER$$US-SA-2024SA023572$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240828$$MD$US$US
234517203$23451720$3$F$20240116$20240731$20240129$20240808$PER$$US-SA-2024SA022692$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240808$$MD$US$US
234517542$23451754$2$F$20231201$20240720$20240129$20240729$PER$$US-SA-2024SA023835$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240729$$MD$US$US
234517563$23451756$3$F$20240112$20240620$20240129$20240702$PER$$US-SA-2024SA025442$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240702$$MD$US$US
234518133$23451813$3$F$20240101$20240624$20240129$20240701$PER$$US-SA-2024SA027681$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240701$$MD$US$US
234518146$23451814$6$F$20240101$20240723$20240129$20240801$PER$$US-SA-2024SA029422$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240801$$MD$US$US
234518422$23451842$2$F$20240101$20240809$20240129$20240826$PER$$US-SA-2024SA028600$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240826$$MD$US$US
234518523$23451852$3$F$$20240903$20240129$20240912$PER$$US-SA-2024SA027705$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240912$$MD$US$US
234518782$23451878$2$F$20231201$20240725$20240129$20240805$PER$$US-SA-2024SA025021$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240805$$MD$US$US
234518832$23451883$2$F$20240819$20240819$20240129$20240829$PER$$US-SA-2024SA022891$SANOFI AVENTIS$$63$YR$A$F$Y$74.84$KG$20240829$$MD$US$US
234519765$23451976$5$F$20240315$20240906$20240129$20240911$EXP$$US-TAKEDA-2023TUS083333$TAKEDA$$74$YR$$F$Y$53$KG$20240911$$CN$US$US
234519946$23451994$6$F$$20240809$20240129$20240827$EXP$$JP-009507513-2312JPN000512J$MERCK$Shibata N, Matsui C, Hirai C, Tada M, Yauchi Y, Kikawa Y, et al.. EP-0451 Treatment outcomes of the KYENOTE-522 regimen for early-stage triple-negative breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 290$65$YR$$F$Y$$$20240827$$MD$JP$JP
234519999$23451999$9$F$20230325$20240805$20240129$20240812$EXP$$CA-GSK-CA2023AMR051232$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$HP$CA$CA
234520093$23452009$3$F$$20240911$20240129$20240916$PER$$US-PFIZER INC-PV202400012121$PFIZER$$55$YR$$F$Y$$$20240916$$HP$US$US
234520124$23452012$4$F$$20240726$20240129$20240801$PER$$US-PFIZER INC-PV202400011118$PFIZER$$66$YR$$F$Y$$$20240801$$HP$US$US
234520132$23452013$2$F$$20240709$20240129$20240711$PER$$US-PFIZER INC-PV202400011963$PFIZER$$84$YR$$F$Y$$$20240711$$CN$US$US
234520463$23452046$3$F$$20240913$20240129$20240917$EXP$$US-PFIZER INC-202400024914$PFIZER$$58$YR$$F$Y$$$20240917$$CN$US$US
234520714$23452071$4$F$20240205$20240920$20240129$20240927$EXP$$CA-TAKEDA-2024TUS005198$TAKEDA$$18$YR$$M$Y$$$20240927$$CN$CA$CA
234521086$23452108$6$F$20231212$20240721$20240129$20240801$EXP$$EG-ROCHE-3499083$ROCHE$$35$YR$A$F$Y$80$KG$20240801$$CN$EG$EG
234521773$23452177$3$F$$20240711$20240129$20240716$EXP$$US-OTSUKA-2024_001973$OTSUKA$$$$$F$Y$68.04$KG$20240716$$CN$US$US
234522363$23452236$3$F$$20240906$20240129$20240912$EXP$$US-GILEAD-2023-0637876$GILEAD$$84$YR$E$M$Y$$$20240912$$MD$US$US
234523475$23452347$5$F$20240101$20240626$20240129$20240701$PER$$US-PFIZER INC-202400026103$PFIZER$$50$YR$$M$Y$$$20240701$$HP$US$US
234523743$23452374$3$F$$20240809$20240129$20240819$EXP$$CA-TEVA-202112_00012549$TEVA$$62$YR$$M$Y$$$20240819$$HP$CA$CA
234523752$23452375$2$F$$20240125$20240129$20240930$EXP$$PL-SANDOZ INC.-SDZ2024PL008233$SANDOZ$$40$YR$$M$Y$$$20240930$$HP$PL$PL
234524393$23452439$3$F$$20240822$20240129$20240914$PER$$US-SA-2024SA025282$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240914$$MD$US$US
234524843$23452484$3$F$$20240924$20240129$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-133309$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240930$$MD$JP$JP
234525112$23452511$2$F$20230913$20240221$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003938$SAREPTA THERAPEUTICS$$14$YR$$M$Y$$$20240730$$HP$US$US
234525142$23452514$2$F$20231001$20240222$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003939$SAREPTA THERAPEUTICS$$30$YR$$$Y$$$20240730$$HP$US$US
234525152$23452515$2$F$20231010$20240201$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003933$SAREPTA THERAPEUTICS$$15$YR$$M$Y$37.4$KG$20240730$$HP$US$US
234525392$23452539$2$F$20240724$20240802$20240129$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013571$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$92.99$KG$20240809$$CN$US$US
234525562$23452556$2$F$20231113$20240124$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004034$SAREPTA THERAPEUTICS$$9$YR$$M$Y$54.4$KG$20240730$$HP$US$US
234525832$23452583$2$F$20231214$20240219$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004158$SAREPTA THERAPEUTICS$$23$YR$$M$Y$77.098$KG$20240730$$HP$US$US
234525872$23452587$2$F$20231120$20240222$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004065$SAREPTA THERAPEUTICS$$4$YR$$M$Y$16.3$KG$20240730$$HP$US$US
234525978$23452597$8$F$20230101$20240903$20240129$20240910$EXP$$CA-GSK-CA2023AMR095101$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$HP$CA$CA
234526092$23452609$2$F$20231222$20240410$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004184$SAREPTA THERAPEUTICS$$20$YR$$M$Y$47.619$KG$20240730$$HP$US$US
234526102$23452610$2$F$20231228$20240123$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004188$SAREPTA THERAPEUTICS$$14$YR$$M$Y$45.2$KG$20240730$$HP$US$US
234526112$23452611$2$F$$20240702$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004270$SAREPTA THERAPEUTICS$$21$YR$$M$Y$$$20240730$$CN$US$US
234526122$23452612$2$F$20231230$20240125$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004206$SAREPTA THERAPEUTICS$$19$YR$$M$Y$$$20240730$$HP$US$US
234526132$23452613$2$F$20231213$20240325$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004224$SAREPTA THERAPEUTICS$$21$YR$$M$Y$$$20240730$$HP$US$US
234526172$23452617$2$F$20240102$20240222$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004208$SAREPTA THERAPEUTICS$$4$YR$$M$Y$16.3$KG$20240730$$HP$US$US
234526182$23452618$2$F$20231226$20240123$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004183$SAREPTA THERAPEUTICS$$21$YR$$M$Y$81.633$KG$20240730$$HP$US$US
234526242$23452624$2$F$20231231$20240410$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004238$SAREPTA THERAPEUTICS$$19$YR$$M$Y$48.3$KG$20240730$$HP$US$US
234526252$23452625$2$F$20240111$20240126$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004260$SAREPTA THERAPEUTICS$$17$YR$$M$Y$76.66$KG$20240730$$HP$US$US
234526502$23452650$2$F$20240119$20240129$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004284$SAREPTA THERAPEUTICS$$26$YR$$M$Y$71.67$KG$20240730$$HP$US$US
2345266511$23452665$11$F$20240201$20240920$20240129$20240927$EXP$$CA-GSK-CA2023148370$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$CA$CA
234526812$23452681$2$F$20230803$20240614$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003674$SAREPTA THERAPEUTICS$$13$YR$$M$Y$52.3$KG$20240730$$HP$US$US
234526842$23452684$2$F$20230810$20240124$20240129$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003703$SAREPTA THERAPEUTICS$$17$YR$$M$Y$$$20240730$$HP$US$US
234527242$23452724$2$F$20231106$20240729$20240129$20240801$EXP$FR-AFSSAPS-PV2023001322$FR-INCYTE CORPORATION-2024IN000784$INCYTE$$$$$$Y$$$20240801$$MD$FR$FR
234527435$23452743$5$F$20221001$20240917$20240129$20240919$EXP$$US-PFIZER INC-202400023550$PFIZER$$89$YR$$M$Y$86.168$KG$20240919$$HP$US$US
234528456$23452845$6$F$20240112$20240917$20240129$20240923$EXP$$ES-TAKEDA-2024TUS005033$TAKEDA$$14$YR$$M$Y$$$20240923$$CN$ES$ES
234529626$23452962$6$F$$20240626$20240129$20240701$PER$$US-PFIZER INC-PV202200086697$PFIZER$$87$YR$$M$Y$$$20240701$$MD$US$US
234530422$23453042$2$F$$20240827$20240129$20240911$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429029$RANBAXY$Ranzato F, Roberti R,  Deluca C, Carta M, Peretti A,  Polo D, et al. Pilot study on the probability of drug?drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective. Neurol Sci. 2024;45:277-288$54$YR$$M$Y$97$KG$20240911$$HP$IT$IT
234530442$23453044$2$F$$20240827$20240129$20240911$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429039$RANBAXY$Ranzato F, Roberti R, Deluca C, Carta M, Peretti A, Polo D, et al. Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective. Neurol Sci. 2024;45:277- 288$84$YR$$M$Y$$$20240911$$HP$IT$IT
234530462$23453046$2$F$$20240913$20240129$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428761$RANBAXY$Lazar SM, Abid F. Pearls + Oy-sters: CACNA1A-Related Paroxysmal Tonic Upgaze With Ataxia Responsive to Acetazolamide. Neurology. 2024;102:1-4$9$MON$$M$Y$$$20240927$$MD$US$US
234531002$23453100$2$F$$20240827$20240129$20240911$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429031$RANBAXY$Ranzato F, Roberti R, Deluca C, Carta M, Peretti A, Polo D, et al. Pilot study on the probability of drug?drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective. Neurol Sci. 2024;45:277-288$80$YR$$F$Y$70$KG$20240911$$HP$IT$IT
234531062$23453106$2$F$20240101$20240816$20240129$20240821$PER$$US-Eisai-EC-2024-156781$EISAI$$68$YR$E$M$Y$$$20240821$$CN$US$US
234531844$23453184$4$F$20240121$20240918$20240129$20240927$PER$$US-AMGEN-USASP2024018333$AMGEN$$64$YR$A$M$Y$$$20240927$$CN$US$US
234532274$23453227$4$F$$20240712$20240129$20240729$PER$$CA-TOLMAR, INC.-23CA046338$TOLMAR$$$$$M$Y$$$20240729$$CN$CA$CA
234533152$23453315$2$F$20230701$20240819$20240129$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-004565$JAZZ$$65$YR$$F$Y$115$KG$20240822$$CN$US$US
2345333020$23453330$20$F$$20240918$20240129$20240923$EXP$GB-SANDOZ-SDZ2023GB050268$GB-MYLANLABS-2024M1007964$MYLAN$$38$YR$$M$Y$104$KG$20240923$$HP$GB$GB
234533542$23453354$2$F$$20240730$20240129$20240807$EXP$$CA-BEH-2024167875$CSL BEHRING$$16$YR$T$M$Y$49$KG$20240807$$CN$CA$CA
234533682$23453368$2$F$$20240719$20240129$20240725$EXP$$CA-PFIZER INC-202400025586$PFIZER$$40$YR$$F$Y$$$20240725$$MD$CA$CA
234533902$23453390$2$F$$20240725$20240129$20240730$EXP$CA-HEALTHCANVIG-001059855$CA-PURDUE-USA-2024-0307313$PURDUE$$$$$F$Y$97$KG$20240730$$MD$CA$CA
234533922$23453392$2$F$20150316$20240913$20240129$20240919$EXP$$US-INCYTE CORPORATION-2024IN000667$INCYTE$$$$$$Y$$$20240919$$CN$US$US
234534112$23453411$2$F$20240101$20240919$20240129$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-010024$JAZZ$$35$YR$$F$Y$$$20240924$$CN$US$US
234534634$23453463$4$F$20231020$20240625$20240129$20240702$EXP$$NVSC2023SA233738$NOVARTIS$$4$YR$$F$Y$15.4$KG$20240702$$CN$SA$SA
234534883$23453488$3$F$$20240711$20240129$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-014269$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240715$$HP$US$US
234537094$23453709$4$F$20240121$20240812$20240129$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013190$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240819$$CN$US$US
234537573$23453757$3$F$20240101$20240620$20240129$20240702$PER$$US-SA-2024SA024787$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240702$$MD$US$US
234537622$23453762$2$F$$20240802$20240129$20240805$EXP$$US-BAUSCH-BL-2024-001311$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240805$$CN$US$US
234537833$23453783$3$F$20230727$20240819$20240129$20240820$PER$$NVSC2024US017205$NOVARTIS$$39$YR$$F$Y$$$20240820$$CN$US$US
234538535$23453853$5$F$20240729$20240806$20240129$20240809$EXP$$TR-ABBVIE-5604611$ABBVIE$$80$YR$$M$Y$70$KG$20240809$$HP$TR$TR
234538712$23453871$2$F$20230101$20240813$20240129$20240821$PER$$US-SA-2024SA028714$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240821$$MD$US$US
234538823$23453882$3$F$20230101$20240812$20240129$20240820$EXP$$US-ABBVIE-5605042$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
234538963$23453896$3$F$20240122$20240626$20240129$20240702$EXP$$US-ABBVIE-5603940$ABBVIE$$55$YR$$F$Y$$$20240702$$CN$US$US
234539292$23453929$2$F$20230901$20240723$20240129$20240724$EXP$$ES-SANDOZ INC.-SDZ2024ES002721$SANDOZ$$47$YR$$M$Y$76.1$KG$20240724$$MD$ES$ES
234539482$23453948$2$F$$20240628$20240129$20240711$EXP$$PK-ROCHE-3498799$ROCHE$$46$YR$A$F$Y$$$20240711$$CN$PK$PK
234539494$23453949$4$F$$20240913$20240130$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-002637$AUROBINDO$Arce PS, Murad K. Thyroid Storm In Heart Failure: A Case Report. Journal of Cardiac Failure. 2024;30(1):178$36$YR$$M$Y$$$20240925$$MD$US$US
234539536$23453953$6$F$20240101$20240731$20240130$20240806$EXP$$CA-EMD Serono-2024005011$EMD SERONO INC$$70$YR$E$F$Y$$$20240806$$CN$CA$CA
234540097$23454009$7$F$20230630$20240726$20240130$20240730$EXP$$CA-TAKEDA-2024TUS007350$TAKEDA$$9$YR$$F$Y$$$20240730$$MD$CA$CA
234540464$23454046$4$F$20231223$20240905$20240130$20240911$EXP$$CA-TAKEDA-2024TUS007485$TAKEDA$$77$YR$$F$Y$$$20240911$$MD$CA$CA
234540694$23454069$4$F$20240401$20240812$20240130$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000098$ACADIA PHARMACEUTICALS$$62$YR$$F$Y$$$20240905$$CN$US$US
234541152$23454115$2$F$20240108$20240625$20240130$20240717$PER$$CA-TOLMAR, INC.-24CA046015$TOLMAR$$59$YR$$M$Y$$$20240717$$CN$CA$CA
234541513$23454151$3$F$20170923$20240906$20240130$20240910$PER$$US-GILEAD-2024-0660183$GILEAD$$58$YR$A$F$Y$$$20240910$$LW$US$US
234541763$23454176$3$F$$20240919$20240130$20240926$EXP$$CA-TAKEDA-2019TUS050093$TAKEDA$$$$$F$Y$$$20240926$$CN$CA$CA
234541813$23454181$3$F$20240122$20240702$20240130$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-014042$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240705$$MD$JP$JP
234542073$23454207$3$F$20190805$20240913$20240130$20240917$PER$$US-GILEAD-2024-0660180$GILEAD$$58$YR$A$F$Y$$$20240917$$LW$US$US
234542462$23454246$2$F$$20240814$20240130$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000102$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
234542842$23454284$2$F$$20240805$20240130$20240820$EXP$$TR-NOVOPROD-1167425$NOVO NORDISK$$870$MON$$F$Y$107$KG$20240820$$CN$TR$TR
234542962$23454296$2$F$$20240703$20240130$20240711$EXP$$CA-CELLTRION INC.-2024CA001802$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
234543213$23454321$3$F$20240101$20240827$20240130$20240910$EXP$$CA-CELLTRION INC.-2024CA002078$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
234543549$23454354$9$F$20240507$20240805$20240130$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011870$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240808$$CN$US$US
234544493$23454449$3$F$$20240809$20240130$20240819$EXP$$US-TEVA-VS-3148428$TEVA$Shuster, Joel. Dystonia Related to Scabies Therapy, Hospital Pharmacy 40 (2005): 558 - 562.; Shuster, Joel. Dystonia Related to Scabies Therapy, Hospital Pharmacy 40 (2005): 558 - 562.$28$YR$$M$Y$$$20240819$$HP$US$US
234544742$23454474$2$F$20240101$20240819$20240130$20240831$EXP$$CA-UCBSA-2024004149$UCB$$45$YR$$F$Y$$$20240831$$CN$CA$CA
234544826$23454482$6$F$20231206$20240918$20240130$20240924$EXP$$AU-SANDOZ INC.-SDZ2024AU009004$SANDOZ$$32$YR$$F$Y$$$20240924$$MD$AU$AU
234545234$23454523$4$F$$20240821$20240130$20240826$EXP$$NVSC2024US019989$NOVARTIS$$$$$F$Y$122.45$KG$20240826$$CN$US$US
234545646$23454564$6$F$20230101$20240909$20240130$20240923$EXP$$CA-UCBSA-2023040995$UCB$$$$$F$Y$$$20240923$$PH$CA$CA
234546042$23454604$2$F$20231208$20240829$20240130$20240918$PER$$US-SA-2024SA026609$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240918$$MD$US$US
234546894$23454689$4$F$20231004$20240618$20240130$20240703$EXP$$DE-ROCHE-3494717$ROCHE$$36$YR$A$F$Y$$$20240703$$MD$DE$DE
234547272$23454727$2$F$$20240717$20240130$20240726$EXP$$CA-APOTEX-2024AP001497$APOTEX$$57$YR$$F$Y$$$20240726$$HP$CA$CA
234547377$23454737$7$F$20240124$20240215$20240130$20240710$PER$$DE-ROCHE-3498965$ROCHE$$15$DY$N$F$Y$3.18$KG$20240701$$MD$DE$DE
234547512$23454751$2$F$$20240626$20240130$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-004019$ACADIA PHARMACEUTICALS$$$$$F$Y$41$KG$20240719$$CN$US$US
234547652$23454765$2$F$$20240830$20240130$20240904$EXP$$JP-ABBVIE-5603909$ABBVIE$$$$$$Y$$$20240904$$HP$JP$JP
234548154$23454815$4$F$$20240906$20240130$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429007$RANBAXY$$$$$F$Y$$$20240920$$CN$US$US
234548363$23454836$3$F$20140101$20240911$20240130$20240918$EXP$$US-GSK-US2024009936$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$US$US
234549262$23454926$2$F$20240122$20240819$20240130$20240823$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000014$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240823$$CN$US$US
234550302$23455030$2$F$$20240920$20240130$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-013859$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240927$$PH$JP$JP
234550312$23455031$2$F$20220101$20240716$20240130$20240718$PER$$US-AMGEN-USASP2024018292$AMGEN$$72$YR$E$F$Y$$$20240718$$CN$US$US
234550565$23455056$5$F$20230101$20240711$20240130$20240720$EXP$$CA-CELLTRION INC.-2024CA002142$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
234551052$23455105$2$F$20240101$20240827$20240130$20240911$EXP$$EU-ETHYPHARM-2024000094$ETHYPHARM$$$$$$Y$$$20240911$$CN$EU$EU
234551583$23455158$3$F$20220101$20240723$20240130$20240729$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-037828$JAZZ$$34$YR$$F$Y$$$20240729$$CN$US$US
234551714$23455171$4$F$$20240702$20240130$20240708$EXP$$US-BIOGEN-2024BI01247453$BIOGEN$$$$$M$Y$$$20240708$$CN$US$US
234552483$23455248$3$F$20230901$20240903$20240130$20240904$EXP$DE-BRISTOL-MYERS SQUIBB COMPANY-2023-142425$DE-SANDOZ INC.-SDZ2024DE007902$SANDOZ$$77$YR$$F$Y$92$KG$20240904$$MD$DE$DE
234552503$23455250$3$F$$20240701$20240130$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-013037$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240709$$PH$JP$JP
234552894$23455289$4$F$20220825$20240710$20240130$20240711$EXP$$DE-SANDOZ INC.-SDZ2024DE008311$SANDOZ$$67$YR$$F$Y$$$20240711$$HP$DE$DE
234553403$23455340$3$F$20231201$20240131$20240130$20240905$PER$$NVSC2024US019122$NOVARTIS$$49$YR$$F$Y$$$20240905$$MD$US$US
234554062$23455406$2$F$20230317$20240719$20240130$20240808$EXP$$ES-AMNEAL PHARMACEUTICALS-2023-AMRX-04676$AMNEAL$$$$$$Y$$$20240808$$MD$ES$ES
234554485$23455448$5$F$20240601$20240723$20240130$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-010042$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240730$$HP$US$US
234554556$23455455$6$F$20231202$20240920$20240130$20240930$EXP$$AU-TAKEDA-2024TUS006857$TAKEDA$$18$YR$$M$Y$$$20240930$$MD$AU$AU
234554982$23455498$2$F$20231201$20240710$20240130$20240717$PER$$US-SA-2024SA023740$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240717$$MD$US$US
234555062$23455506$2$F$$20240726$20240130$20240805$PER$$US-SA-2024SA022078$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240805$$CN$US$US
234555242$23455524$2$F$20230101$20240815$20240130$20240829$PER$$US-SA-2024SA024785$SANOFI AVENTIS$$16$YR$T$M$Y$96.16$KG$20240829$$MD$US$US
234555502$23455550$2$F$20230101$20240703$20240130$20240712$PER$$US-SA-2024SA028755$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240712$$MD$US$US
234555542$23455554$2$F$20240121$20240903$20240130$20240912$PER$$US-SA-2024SA030140$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240912$$MD$US$US
234555633$23455563$3$F$20240101$20240724$20240130$20240802$PER$$US-SA-2024SA027285$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240802$$MD$US$US
234555972$23455597$2$F$20240121$20240710$20240130$20240718$PER$$US-SA-2024SA029292$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240718$$MD$US$US
234556363$23455636$3$F$$20240828$20240130$20240906$EXP$$BR-CELLTRION INC.-2024BR001880$CELLTRION$$$$$$Y$$$20240906$$CN$BR$BR
234556783$23455678$3$F$$20240826$20240130$20240906$EXP$$US-AUROBINDO-AUR-APL-2024-002658$AUROBINDO$Osama M, Pendela VS, Mohamed M, Parikh V. Trigger-Point Bupivacaine Injection Causing A ?Heart-Break?. Journal of Cardiac Failure. 2024;30(1):276-277$59$YR$$F$Y$$$20240906$$MD$US$US
234557342$23455734$2$F$$20240903$20240130$20240926$PER$$US-SA-2024SA027361$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240926$$MD$US$US
234558307$23455830$7$F$20220101$20240708$20240130$20240716$EXP$$CA-CELLTRION INC.-2022CA010701$CELLTRION$$$$$$Y$$$20240716$$MD$CA$CA
234558333$23455833$3$F$20231214$20240530$20240130$20240725$PER$$US-LUNDBECK-DKLU3071722$LUNDBECK$$$$$$Y$$$20240725$$HP$US$US
2345586413$23455864$13$F$20231001$20240918$20240130$20240927$EXP$$CA-CELLTRION INC.-2023CA022254$CELLTRION$$$$$$Y$$$20240927$$PH$CA$CA
234559232$23455923$2$F$$20240820$20240130$20240827$EXP$$CA-ROCHE-3500181$ROCHE$$64$YR$A$M$Y$$$20240827$$CN$CA$CA
234559533$23455953$3$F$$20240805$20240130$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-058672$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240807$$CN$US$US
234559565$23455956$5$F$20240101$20240702$20240130$20240711$PER$$US-SA-2024SA025334$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240711$$MD$US$US
234559583$23455958$3$F$20231201$20240906$20240130$20240913$PER$$US-SA-2024SA027536$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240913$$MD$US$US
234560022$23456002$2$F$20231001$20240722$20240130$20240724$EXP$$CA-Orion Corporation ORION PHARMA-23_00026408$ORION$$38$YR$A$F$Y$$$20240724$$MD$CA$
234560043$23456004$3$F$20240601$20240626$20240130$20240703$PER$$US-BIOGEN-2024BI01247275$BIOGEN$$46$YR$$F$Y$$$20240703$$CN$US$US
234560058$23456005$8$F$20170724$20240918$20240130$20240924$EXP$$CO-SANDOZ INC.-PHHY2017CO112025$SANDOZ$$65$YR$$F$Y$56$KG$20240924$$CN$CO$CO
234560733$23456073$3$F$20230501$20240718$20240130$20240730$EXP$$DE-ROCHE-3498114$ROCHE$$40$YR$A$F$Y$$$20240730$$CN$DE$DE
234560892$23456089$2$F$$20240620$20240130$20240701$EXP$$CA-APOTEX-2021AP046657$APOTEX$$64$YR$$F$Y$67$KG$20240701$$HP$CA$CA
234560962$23456096$2$F$20230827$20240920$20240130$20240930$EXP$$JP-ROCHE-3497359$ROCHE$$90$YR$E$F$Y$48.3$KG$20240930$$MD$JP$JP
234561125$23456112$5$F$20240118$20240820$20240130$20240904$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-02901$SAMSUNG BIOEPIS$$74$YR$E$F$Y$75$KG$20240904$$MD$DE$DE
234561692$23456169$2$F$$20240628$20240130$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-429078$RANBAXY$$38$YR$$M$Y$$$20240712$$PH$FR$FR
234562512$23456251$2$F$20240101$20240715$20240130$20240718$EXP$$US-AMGEN-USASP2024017516$AMGEN$$57$YR$A$F$Y$$$20240718$$MD$US$US
234563295$23456329$5$F$$20240912$20240130$20240917$30DAY$$US-PFIZER INC-PV202400005197$PFIZER$$7$YR$$F$Y$$$20240917$$CN$US$US
2345633311$23456333$11$F$$20240925$20240130$20240930$30DAY$$US-PFIZER INC-PV202400005167$PFIZER$$11$YR$$F$Y$$$20240930$$CN$US$US
234563472$23456347$2$F$20240106$20240717$20240130$20240726$PER$$US-SA-2024SA028098$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240726$$MD$US$US
234564434$23456443$4$F$$20240625$20240130$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000035$ACADIA PHARMACEUTICALS$$$$$F$Y$47.627$KG$20240719$$CN$US$US
234564552$23456455$2$F$20240703$20240705$20240130$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202401015732$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240709$$CN$US$US
234564983$23456498$3$F$20240202$20240801$20240130$20240806$EXP$$CA-TAKEDA-2024TUS008438$TAKEDA$$33$YR$$F$Y$$$20240806$$CN$CA$CA
234565062$23456506$2$F$$20240625$20240130$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000050$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
234566394$23456639$4$F$20170329$20240702$20240130$20240704$EXP$$CA-TAKEDA-2017TUS007110$TAKEDA$$74$YR$$M$Y$$$20240704$$CN$CA$CA
234566492$23456649$2$F$$20240730$20240130$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015264$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240801$$CN$US$US
234566692$23456669$2$F$$20240122$20240130$20240724$PER$$US-TEVA-VS-3148892$TEVA$$54$YR$$F$Y$$$20240724$$CN$US$US
234567234$23456723$4$F$$20240731$20240130$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-109767$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240802$$CN$US$US
234567262$23456726$2$F$$20240709$20240130$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015217$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240711$$CN$US$US
234567528$23456752$8$F$20230401$20240628$20240130$20240703$EXP$$NVSC2023CO016283$NOVARTIS$$53$YR$$F$Y$61$KG$20240704$$CN$CO$CO
234567822$23456782$2$F$20231101$20240708$20240130$20240715$EXP$$NVSC2024MX018683$NOVARTIS$$54$YR$$F$Y$51$KG$20240715$$CN$MX$MX
234568114$23456811$4$F$$20240909$20240130$20240910$EXP$$US-PFIZER INC-PV202300094287$PFIZER$$77$YR$$F$Y$$$20240910$$CN$US$US
234568332$23456833$2$F$$20240910$20240130$20240925$EXP$$CA-ROCHE-3499278$ROCHE$$60$YR$A$F$Y$$$20240925$$HP$CA$CA
234568355$23456835$5$F$$20240809$20240130$20240827$EXP$$JP-009507513-2312JPN000516J$MERCK$Shibata N, Matsui C, Hirai C, Tada M, Yauchi Y, Kikawa Y, et al.. EP-0451 Treatment outcomes of the KYENOTE-522 regimen for early-stage triple-negative breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 290$44$YR$$F$Y$$$20240827$$MD$JP$JP
234568434$23456843$4$F$20231201$20240711$20240130$20240801$PER$$US-SA-2024SA023823$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240719$$MD$US$US
2345684712$23456847$12$F$20240208$20240829$20240130$20240912$EXP$$CA-GSK-CA2023134345$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$HP$CA$CA
234568623$23456862$3$F$20120916$20240909$20240130$20240912$EXP$$US-GILEAD-2024-0660182$GILEAD$$53$YR$A$F$Y$$$20240912$$LW$US$US
234568956$23456895$6$F$$20240730$20240130$20240802$EXP$$US-SANDOZ INC.-NVSC2021US206870$SANDOZ$$$$$F$Y$90.703$KG$20240802$$CN$US$US
234568964$23456896$4$F$20240125$20240705$20240130$20240708$PER$$US-AMGEN-USASP2024016812$AMGEN$$69$YR$E$F$Y$$$20240708$$CN$US$US
234569155$23456915$5$F$$20240809$20240130$20240827$EXP$$JP-009507513-2312JPN000517J$MERCK$Shibata N, Matsui C, Hirai C, Tada M, Yauchi Y, Kikawa Y, et al.. EP-0451 Treatment outcomes of the KYENOTE-522 regimen for early-stage triple-negative breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 290$58$YR$$F$Y$$$20240827$$MD$JP$JP
234569218$23456921$8$F$20231001$20240911$20240130$20240912$EXP$$US-KARYOPHARM-2023KPT002104$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240912$$CN$US$US
234569373$23456937$3$F$$20240705$20240130$20240711$PER$$US-ALXN-202401USA001419US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
234569402$23456940$2$F$20190120$20240624$20240130$20240703$EXP$$US-BAYER-2024A013659$BAYER$$48$YR$A$F$Y$$$20240703$$CN$US$US
234571427$23457142$7$F$20230201$20240903$20240130$20240910$EXP$$US-ABBVIE-5605339$ABBVIE$$76$YR$$F$Y$73$KG$20240910$$CN$US$US
234571584$23457158$4$F$$20240807$20240130$20240821$EXP$$JP-UCBSA-2024004483$UCB$$3$YR$$F$Y$$$20240821$$MD$JP$JP
234571965$23457196$5$F$$20240903$20240130$20240906$30DAY$$KR-PFIZER INC-PV202400004402$PFIZER$$$$$M$Y$$$20240906$$CN$KR$KR
234573059$23457305$9$F$20240110$20240910$20240130$20240913$PER$$CO-PFIZER INC-PV202400003037$PFIZER$$14$YR$$M$Y$48$KG$20240913$$CN$CO$CO
234573392$23457339$2$F$20231215$20240808$20240130$20240812$EXP$$DE-JNJFOC-20240164308$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240812$$HP$DE$DE
234573412$23457341$2$F$20210602$20240627$20240130$20240712$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00012$Phathom Pharmaceuticals$$77$YR$$M$Y$$$20240712$$MD$JP$JP
234573462$23457346$2$F$20230930$20240711$20240130$20240712$EXP$SE-SEMPA-2024-000586$SE-ABBVIE-5602214$ABBVIE$$64$YR$$M$Y$$$20240712$$MD$SE$SE
234573704$23457370$4$F$20230718$20240827$20240130$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-014365$BRISTOL MYERS SQUIBB$Yanai M, Shishido Y, Funaki Y, Morita M, Ono T, Nonaka T, et al. Two cases of radiation recall pneumonitis triggered by administration of immune checkpoint inhibitors. The 69th Chugoku-Shikoku Regional Meeting of the Japanese Respiratory Society/The 32nd Chugoku-Shikoku Branch Meeting of The Japan Society for Respiratory Endoscopy/The 74th Chugoku-Shikoku Branch Meeting of The Japanese Society for Tuberculosis and Nontuberculous Mycobacteriosis programs/Abstracts. 2023 Dec;71.$80$YR$E$M$Y$$$20240904$$MD$JP$JP
234574153$23457415$3$F$$20240716$20240130$20240718$PER$$NVSC2024US020370$NOVARTIS$$$$$F$Y$$$20240718$$CN$US$US
234574463$23457446$3$F$$20240717$20240130$20240724$EXP$$CA-GSK-CA2023135600$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$CA$CA
234574603$23457460$3$F$20231216$20240710$20240130$20240715$EXP$$DE-PFIZER INC-202400025474$PFIZER$$5$YR$$M$Y$19.9$KG$20240715$$HP$DE$DE
234574903$23457490$3$F$20210726$20240813$20240130$20240816$EXP$$CA-PFIZER INC-202400026373$PFIZER$$50$YR$$F$Y$61.2$KG$20240816$$HP$CA$CA
234575042$23457504$2$F$20220101$20240701$20240130$20240702$EXP$$ZA-PFIZER INC-PV202400012062$PFIZER$$48$YR$$F$Y$95$KG$20240702$$MD$ZA$ZA
234575443$23457544$3$F$20240101$20240719$20240130$20240724$EXP$$AU-SANDOZ INC.-SDZ2024AU008118$SANDOZ$$20$YR$$M$Y$68$KG$20240724$$CN$AU$AU
234575763$23457576$3$F$20230822$20240722$20240130$20240730$EXP$$CA-JNJFOC-20230972548$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240730$$HP$CA$CA
234577022$23457702$2$F$20231201$20240819$20240130$20240902$PER$$US-SA-2024SA025578$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240902$$MD$US$US
234577192$23457719$2$F$$20240830$20240130$20240902$PER$$NVSC2024US020273$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
234577282$23457728$2$F$$20240705$20240130$20240710$EXP$$IL-SANDOZ INC.-SDZ2024IL009323$SANDOZ$$$$A$M$Y$$$20240710$$CN$IL$IL
234577372$23457737$2$F$20231212$20240723$20240130$20240730$EXP$$CA-TAKEDA-2023TUS122152$TAKEDA$$79$YR$$M$Y$$$20240730$$CN$CA$CA
234577984$23457798$4$F$20230915$20240607$20240130$20240710$EXP$$JP-AstraZeneca-2023A215816$ASTRAZENECA$$81$YR$$M$Y$$$20240710$$MD$JP$
234578152$23457815$2$F$$20240128$20240130$20240906$PER$$NVSC2024US020393$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
234578604$23457860$4$F$$20240712$20240130$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA008465$SANDOZ$$87$YR$$M$Y$$$20240717$$HP$CA$CA
234578716$23457871$6$F$20230929$20240830$20240130$20240831$EXP$$JP-ABBVIE-5606580$ABBVIE$A Kumagai ,N Oshima ,Y Hirayama , et al.. (Case Report) Septic shock caused by ovarian abscess arisen in ovarian endometrioma in a patient complicated with rheumatoid arthritis. The Journal of Japan Society for Menopause and Women^s Health. 2024; 31 (4) 682-687; Kumagai A, Oshima N, Hirayama Y. O15-5: A case of infectious disseminated intravascular coagulation (DIC) caused by ovarian endometriotic cyst infection during treatment for rheumatoid arthritis. The 45th Academic Lecture of Japan Soc...$45$YR$$F$Y$38$KG$20240831$$MD$JP$JP
234579752$23457975$2$F$$20240814$20240130$20240902$PER$$AU-TOLMAR, INC.-24AU045870$TOLMAR$$$$$M$Y$$$20240902$$CN$AU$AU
234579773$23457977$3$F$20240101$20240709$20240130$20240730$PER$$AU-TOLMAR, INC.-24AU046020$TOLMAR$$70$YR$$M$Y$$$20240730$$CN$AU$AU
234580133$23458013$3$F$20220101$20240816$20240130$20240822$PER$$US-JNJFOC-20240110804$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240822$$CN$US$US
234580165$23458016$5$F$$20240809$20240130$20240827$EXP$$JP-009507513-2312JPN000514J$MERCK$Shibata N, Matsui C, Hirai C, Tada M, Yauchi Y, Kikawa Y, et al.. EP-0451 Treatment outcomes of the KYENOTE-522 regimen for early-stage triple-negative breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 290$55$YR$$F$Y$$$20240827$$MD$JP$JP
234580202$23458020$2$F$20231219$20240819$20240130$20240823$EXP$SE-SEMPA-2024-000505$SE-ABBVIE-5603820$ABBVIE$$73$YR$$F$Y$$$20240823$$MD$SE$SE
234580292$23458029$2$F$20231201$20240731$20240130$20240801$EXP$$JP-BAYER-2024A015133$BAYER$$68$YR$E$M$Y$$$20240801$$MD$JP$JP
234580562$23458056$2$F$$20240716$20240130$20240722$EXP$$DE-PFIZER INC-202400024364$PFIZER$$10$YR$$F$Y$$$20240722$$MD$DE$DE
234580653$23458065$3$F$$20240122$20240130$20240809$EXP$$NVSC2024US014983$NOVARTIS$$$$$F$Y$$$20240809$$MD$US$US
234581312$23458131$2$F$20240114$20240729$20240130$20240801$PER$$US-PFIZER INC-202400025823$PFIZER$$66$YR$$M$Y$$$20240801$$CN$US$US
234581373$23458137$3$F$20231101$20240812$20240130$20240814$PER$$US-PFIZER INC-202400027636$PFIZER$$82$YR$$F$Y$$$20240814$$CN$US$US
234581842$23458184$2$F$$20240626$20240130$20240701$PER$$US-PFIZER INC-202400027960$PFIZER$$70$YR$$F$Y$$$20240701$$CN$US$US
234581975$23458197$5$F$$20240809$20240130$20240827$EXP$$JP-009507513-2312JPN000496J$MERCK$Shibata N, Matsui C, Hirai C, Tada M, Yauchi Y, Kikawa Y, et al.. EP-0451 Treatment outcomes of the KYENOTE-522 regimen for early-stage triple-negative breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 290$74$YR$$F$Y$$$20240827$$MD$JP$JP
234582903$23458290$3$F$$20240628$20240130$20240702$EXP$$CA-PFIZER INC-202400023664$PFIZER$$66$YR$$F$Y$$$20240702$$HP$CA$CA
234583923$23458392$3$F$20230323$20240819$20240130$20240819$EXP$$NVSC2024AU020442$NOVARTIS$$78$YR$$M$Y$$$20240819$$MD$AU$AU
234584123$23458412$3$F$20190919$20240918$20240130$20240924$EXP$$DE-MYLANLABS-2024M1008350$MYLAN$$50$YR$$M$Y$120$KG$20240924$$CN$DE$DE
234584642$23458464$2$F$$20240308$20240130$20240826$EXP$$DE-OTSUKA-2024_001870$OTSUKA$$$$$$Y$$$20240826$$MD$DE$DE
234584664$23458466$4$F$$20240916$20240130$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-014188$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240920$$CN$US$US
234585662$23458566$2$F$$20240913$20240130$20240918$EXP$$NVSJ2024JP001525$NOVARTIS$$$$$$Y$$$20240918$$MD$JP$JP
234585804$23458580$4$F$$20240827$20240130$20240903$EXP$$US-ABBVIE-5604766$ABBVIE$$$$$F$Y$49$KG$20240903$$CN$US$US
234586222$23458622$2$F$$20240823$20240130$20240828$EXP$JP-MMM-56U9MN4K$JP-ABBVIE-5614027$ABBVIE$$78$YR$$F$Y$$$20240828$$MD$JP$JP
234586502$23458650$2$F$$20240904$20240130$20240918$EXP$$CA-BAXTER-2024BAX011624$BAXTER$$68$YR$$M$Y$$$20240918$$CN$CA$CA
234586544$23458654$4$F$$20240823$20240130$20240916$PER$$US-SA-2024SA030568$SANOFI AVENTIS$$$$E$F$Y$$$20240916$$MD$US$US
234587063$23458706$3$F$20240123$20240716$20240130$20240723$PER$$US-SA-2024SA031192$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240724$$MD$US$US
234587535$23458753$5$F$20231217$20240718$20240130$20240725$EXP$$CO-GSK-CO2023AMR178130$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$CO$CO
234587682$23458768$2$F$20240122$20240710$20240130$20240713$PER$$US-AMGEN-USASP2024018210$AMGEN$$75$YR$E$F$Y$61$KG$20240713$$HP$US$US
234587993$23458799$3$F$20230101$20240828$20240130$20240902$EXP$$US-ABBVIE-5608534$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
234588162$23458816$2$F$20230105$20240815$20240130$20240820$EXP$$US-ABBVIE-5380909$ABBVIE$$75$YR$$M$Y$$$20240820$$CN$US$US
234588203$23458820$3$F$20231101$20240822$20240131$20240828$EXP$$US-ABBVIE-5606715$ABBVIE$$86$YR$$F$Y$57$KG$20240828$$CN$US$US
234588282$23458828$2$F$$20240615$20240131$20240905$PER$$US-CIPLA LTD.-2023US04746$CIPLA$$$$$$Y$$$20240905$$HP$US$US
234588452$23458845$2$F$20240821$20240823$20240131$20240904$PER$$US-SA-2024SA031499$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240904$$CN$US$US
234588544$23458854$4$F$20231101$20240924$20240131$20240927$EXP$$US-AMGEN-USASP2024015014$AMGEN$$85$YR$E$F$Y$$$20240927$$MD$US$US
234588882$23458888$2$F$$20240829$20240131$20240907$EXP$$CA-AUROBINDO-AUR-APL-2022-057535$AUROBINDO$$45$YR$$F$Y$$$20240907$$HP$CA$CA
234588975$23458897$5$F$$20240830$20240131$20240925$PER$$US-SA-2024SA031255$SANOFI AVENTIS$$66$YR$E$F$Y$66.6$KG$20240925$$MD$US$US
234590133$23459013$3$F$20240101$20240725$20240131$20240806$PER$$US-ALXN-202401USA001680US$ALEXION PHARMACEUTICALS$$70$YR$$F$Y$$$20240806$$MD$US$US
234590235$23459023$5$F$$20240624$20240131$20240702$EXP$$DE-AUROBINDO-AUR-APL-2024-003276$AUROBINDO$$51$YR$$M$Y$118$KG$20240702$$MD$DE$DE
234590266$23459026$6$F$$20240917$20240131$20240920$EXP$$CA-ABBVIE-5616374$ABBVIE$$44$YR$$F$Y$97$KG$20240920$$MD$CA$CA
234590922$23459092$2$F$20210101$20240817$20240131$20240830$EXP$$DE-AUROBINDO-AUR-APL-2024-002644$AUROBINDO$Suhling H, Hinze CA, Welte T, Werfel T, Traidl S. Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic Dermatitis. Respiration. 2023;102(12):1016-9$3$DEC$$F$Y$$$20240830$$MD$DE$DE
234591862$23459186$2$F$20230508$20231203$20240131$20240705$EXP$FR-AFSSAPS-AVNY2023000067$FR-TEVA-VS-3144832$TEVA$$41$YR$$F$Y$46$KG$20240705$$MD$FR$FR
234592056$23459205$6$F$20230101$20240905$20240131$20240914$EXP$$CA-CELLTRION INC.-2023CA021663$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
234592112$23459211$2$F$$20240815$20240131$20240822$PER$$US-ALXN-202401USA001652US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
234592495$23459249$5$F$20220701$20240919$20240131$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-003312$AUROBINDO$$52$YR$$F$Y$72.5$KG$20240927$$MD$ES$ES
234592542$23459254$2$F$20230718$20240710$20240131$20240711$EXP$$CZ-SANDOZ INC.-SDZ2023CZ069018$SANDOZ$$76$YR$$M$Y$85$KG$20240711$$MD$CZ$CZ
234592662$23459266$2$F$$20240731$20240131$20240809$PER$$US-SA-2024SA027286$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240809$$MD$US$US
2345930711$23459307$11$F$20230621$20240918$20240131$20240925$EXP$$CA-GSK-CA2023085559$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$CA$CA
234593095$23459309$5$F$20220930$20240906$20240131$20240916$EXP$$CA-CELLTRION INC.-2022CA017138$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
2345937510$23459375$10$F$20230401$20240717$20240131$20240725$EXP$$CA-CELLTRION INC.-2023CA009137$CELLTRION$$$$$$Y$$$20240726$$HP$CA$CA
234594033$23459403$3$F$20231101$20240716$20240131$20240724$EXP$$US-NOVOPROD-1168006$NOVO NORDISK$$79$YR$$F$Y$$$20240724$$CN$US$US
234594202$23459420$2$F$20231227$20240624$20240131$20240705$EXP$$JP-UCBSA-2024004141$UCB$$91$YR$$F$Y$38.7$KG$20240705$$MD$JP$JP
234594453$23459445$3$F$$20240625$20240131$20240702$EXP$$CA-SANDOZ INC.-SDZ2024CA008998$SANDOZ$$43$YR$$F$Y$$$20240702$$HP$CA$CA
234594592$23459459$2$F$$20240716$20240131$20240717$EXP$$US-TAKEDA-2024TUS008951$TAKEDA$$$$$M$Y$$$20240717$$CN$US$US
234594676$23459467$6$F$20240201$20240828$20240131$20240902$EXP$$CA-TAKEDA-2023TUS111487$TAKEDA$$22$YR$$M$Y$$$20240902$$CN$CA$CA
2345948410$23459484$10$F$20240726$20240801$20240131$20240805$EXP$$US-SANDOZ INC.-NVSC2023US035247$SANDOZ$$69$YR$$M$Y$78.685$KG$20240805$$CN$US$US
234595403$23459540$3$F$20231113$20240724$20240131$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-013848$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240731$$MD$JP$JP
234595792$23459579$2$F$$20240627$20240131$20240703$EXP$$US-GSK-US2024011828$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$HP$US$US
234596127$23459612$7$F$20210815$20240911$20240131$20240919$EXP$$CA-TAKEDA-2023TUS080497$TAKEDA$$23$YR$$F$Y$$$20240919$$HP$CA$CA
234596693$23459669$3$F$20240101$20240705$20240131$20240712$EXP$$US-AMGEN-USASP2024015128$AMGEN$$$$A$F$Y$$$20240712$$HP$US$US
234596833$23459683$3$F$20231001$20240905$20240131$20240912$EXP$$CO-GSK-CO2023AMR145572$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$CO$CO
234597014$23459701$4$F$$20240705$20240131$20240708$PER$$NVSC2024US021434$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
234597854$23459785$4$F$20231219$20240625$20240131$20240704$30DAY$$CO-JNJFOC-20240109646$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$CO$CO
234598194$23459819$4$F$$20240815$20240131$20240823$30DAY$$US-GSK-US2024010012$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
234598494$23459849$4$F$$20240625$20240131$20240709$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-00803$ALKEM$$51$YR$$M$Y$118$KG$20240709$$CN$DE$DE
234598553$23459855$3$F$20240119$20240206$20240131$20240809$EXP$$NVSC2024US019471$NOVARTIS$$84$YR$$M$Y$67$KG$20240809$$HP$US$US
234598623$23459862$3$F$20240813$20240813$20240131$20240823$30DAY$$US-GSK-US2024007899$GLAXOSMITHKLINE$$70$YR$$M$Y$$$20240823$$CN$US$US
234598699$23459869$9$F$$20240808$20240131$20240819$EXP$$CA-ROCHE-2897537$ROCHE$$$$A$F$Y$$$20240819$$CN$CA$CA
234598782$23459878$2$F$$20240827$20240131$20240911$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429044$RANBAXY$Ranzato F, Roberti R, Deluca C, Carta M, Peretti A, Polo D, et al. Pilot study on the probability of drug?drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective. Neurol Sci. 2024;45:277-288$79$YR$$M$Y$82$KG$20240911$$HP$IT$IT
234599226$23459922$6$F$20231207$20240701$20240131$20240709$EXP$$JP-GENMAB-2023-02511AA$GENMAB$$61$YR$$M$Y$67.4$KG$20240709$$MD$JP$JP
234599363$23459936$3$F$20240321$20240913$20240131$20240920$EXP$$CA-GSK-CA2023167942$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CA$CA
234599442$23459944$2$F$20231124$20240819$20240131$20240826$EXP$$FR-AstraZeneca-2024A021364$ASTRAZENECA$$83$YR$$F$Y$82$KG$20240826$$MD$FR$
234600322$23460032$2$F$$20240715$20240131$20240722$EXP$$IN-ROCHE-3500549$ROCHE$$48$YR$A$M$Y$73$KG$20240722$$CN$IN$IN
234600583$23460058$3$F$$20240715$20240131$20240723$EXP$$FR-AstraZeneca-2024A021498$ASTRAZENECA$$$$$M$Y$68$KG$20240723$$MD$FR$
234601312$23460131$2$F$$20240902$20240131$20240910$EXP$$CA-APOTEX-2024AP001550$APOTEX$$$$$F$Y$$$20240910$$HP$CA$CA
234601722$23460172$2$F$20231106$20240821$20240131$20240828$EXP$FR-AFSSAPS-AM2023001182$FR-RDY-SPO/FRA/24/0001387$DR REDDYS$$83$YR$E$M$Y$73$KG$20240828$$MD$FR$FR
234601742$23460174$2$F$$20240801$20240131$20240808$EXP$$US-SA-2024SA031854$SANOFI AVENTIS$$$$E$M$Y$$$20240808$$MD$US$US
234601974$23460197$4$F$20240101$20240806$20240131$20240814$EXP$$US-SA-2024SA027739$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240814$$MD$US$US
234602083$23460208$3$F$20240101$20240816$20240131$20240830$PER$$US-SA-2024SA030337$SANOFI AVENTIS$$58$YR$A$F$Y$81.466$KG$20240830$$MD$US$US
234602402$23460240$2$F$$20240903$20240131$20240912$PER$$US-SA-2024SA030291$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240912$$HP$US$US
234602472$23460247$2$F$20240101$20240716$20240131$20240725$PER$$US-SA-2024SA031324$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240725$$CN$US$US
234602552$23460255$2$F$20231101$20240809$20240131$20240821$PER$$US-SA-2024SA032990$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240822$$MD$US$US
234602825$23460282$5$F$20231001$20240812$20240131$20240819$PER$$US-SA-2023SA381835$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240819$$MD$US$US
234602873$23460287$3$F$20240119$20240827$20240131$20240903$EXP$$DE-BAXTER-2024BAX011232$BAXTER$$72$YR$$F$Y$$$20240903$$HP$DE$DE
234602996$23460299$6$F$20240110$20240624$20240131$20240706$EXP$$KR-Accord-403345$ACCORD$$60$YR$A$M$Y$$$20240706$$MD$KR$KR
234603186$23460318$6$F$20230101$20240726$20240131$20240803$EXP$$CA-CELLTRION INC.-2024CA002217$CELLTRION$$$$$$Y$$$20240803$$HP$CA$CA
234603942$23460394$2$F$20231106$20240828$20240131$20240909$EXP$FR-AFSSAPS-AM2023001182$FR-Accord-403415$ACCORD$$83$YR$E$M$Y$73$KG$20240909$$MD$FR$FR
234604133$23460413$3$F$$20240814$20240131$20240827$PER$$US-SA-2024SA032352$SANOFI AVENTIS$$62$YR$A$M$Y$59.4$KG$20240827$$MD$US$US
234604573$23460457$3$F$$20240807$20240131$20240816$EXP$$US-INSMED, INC.-2024-00288-US$INSMED$$$$$M$Y$$$20240816$$CN$US$US
234605582$23460558$2$F$$20240722$20240131$20240731$PER$$US-SA-2024SA027145$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240731$$MD$US$US
234605673$23460567$3$F$$20240723$20240131$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015438$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240726$$CN$US$US
234605722$23460572$2$F$20240119$20240722$20240131$20240724$PER$$US-AMGEN-USASP2024017927$AMGEN$$58$YR$A$F$Y$$$20240724$$CN$US$US
234606453$23460645$3$F$20240104$20240910$20240131$20240917$EXP$$BR-GSK-BR2024AMR011286$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$BR$BR
234606673$23460667$3$F$$20240704$20240131$20240708$PER$$US-ALXN-202401USA000808US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
234606962$23460696$2$F$20230801$20240819$20240131$20240820$EXP$$DE-SANDOZ INC.-SDZ2024DE009585$SANDOZ$$64$YR$$F$Y$$$20240820$$MD$DE$DE
234607084$23460708$4$F$20230101$20240624$20240131$20240702$EXP$$CA-CELLTRION INC.-2024CA002315$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
234607112$23460711$2$F$20240801$20240821$20240131$20240903$PER$$US-SA-2024SA027748$SANOFI AVENTIS$$43$YR$A$F$Y$75.7$KG$20240903$$MD$US$US
234607372$23460737$2$F$$20240123$20240131$20240729$EXP$$US-MYLANLABS-2024M1008655$MYLAN$$$$$F$Y$74.39$KG$20240729$$CN$US$US
234607432$23460743$2$F$$20240906$20240131$20240919$PER$$US-SA-2024SA031835$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240919$$MD$US$US
234607544$23460754$4$F$20240106$20240628$20240131$20240710$EXP$$CA-ROCHE-3487896$ROCHE$$69$YR$E$F$Y$77$KG$20240710$$HP$CA$CA
234608864$23460886$4$F$20240814$20240904$20240131$20240910$EXP$$CA-TAKEDA-2023TUS019954$TAKEDA$$65$YR$$M$Y$$$20240910$$CN$CA$CA
234609852$23460985$2$F$$20240919$20240131$20240924$EXP$$CA-JNJFOC-20240167604$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240924$$CN$CA$CA
234610342$23461034$2$F$20240125$20240802$20240131$20240806$EXP$$US-PFIZER INC-PV202300163187$PFIZER$$68$YR$$F$Y$$$20240806$$CN$US$US
234610453$23461045$3$F$20230501$20240711$20240131$20240717$EXP$$CA-PFIZER INC-202300377351$PFIZER$$67$YR$$F$Y$87$KG$20240717$$MD$CA$CA
234611322$23461132$2$F$$20240816$20240131$20240822$EXP$$US-ABBVIE-5608252$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
234611602$23461160$2$F$$20240705$20240131$20240709$EXP$$NVSC2024US019403$NOVARTIS$$$$$F$Y$$$20240709$$MD$US$US
234611733$23461173$3$F$$20240702$20240131$20240710$PER$$US-INCYTE CORPORATION-2024IN000791$INCYTE$$$$$$Y$$$20240710$$CN$US$US
234612174$23461217$4$F$20231116$20240910$20240131$20240919$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2152375$JIANGSU HANSOH PHARMACEUTICAL$$$$$F$Y$$$20240919$$MD$CN$CN
234612629$23461262$9$F$20200726$20240925$20240131$20240930$EXP$$IL-PFIZER INC-2019466093$PFIZER$$57$YR$$M$Y$$$20240930$$HP$IL$IL
234612696$23461269$6$F$20240101$20240903$20240131$20240906$EXP$$US-INCYTE CORPORATION-2024IN000917$INCYTE$$$$$$Y$$$20240906$$CN$US$US
234613526$23461352$6$F$20240101$20240627$20240131$20240705$PER$$US-UNITED THERAPEUTICS-UNT-2024-002630$UNITED THERAPEUTICS$$$$$F$Y$67.574$KG$20240705$$$US$US
234613956$23461395$6$F$20220101$20240724$20240131$20240801$EXP$$JP-009507513-2401JPN005851J$MERCK$$7$DEC$$M$Y$$$20240801$$MD$JP$JP
234614623$23461462$3$F$20240124$20240717$20240131$20240720$PER$$US-AMGEN-USASP2024019258$AMGEN$$66$YR$E$M$Y$$$20240719$$HP$US$US
234615042$23461504$2$F$$20240808$20240131$20240813$PER$$US-BIOGEN-2024BI01247657$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
234615713$23461571$3$F$20200806$20240718$20240131$20240723$EXP$$JP-JNJFOC-20220342552$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240723$$MD$JP$JP
234617693$23461769$3$F$$20240819$20240131$20240822$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000173$BLUEPRINT MEDICINES$$$$$M$Y$$$20240822$$CN$US$US
234617764$23461776$4$F$20230619$20240529$20240131$20240823$EXP$$JP-Merz Pharmaceuticals GmbH-24-00294$MERZ$$77$YR$$F$Y$47.1$KG$20240823$$MD$JP$JP
234618892$23461889$2$F$$20240703$20240131$20240709$EXP$$US-AMGEN-USASP2024016299$AMGEN$Atallah J.; Alousi Y.A.; Guevara N. et al.. Unusual Presentation of B-Cell Chronic Lymphocytic Leukemia Accompanied by Pure Red Cell Aplasia: Case Report. Case Reports in Oncology. 2024;17:69-74$38$YR$A$F$Y$$$20240709$$HP$US$US
234619236$23461923$6$F$20240704$20240829$20240131$20240905$EXP$$CA-GSK-CA2024011807$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$CA$CA
234619266$23461926$6$F$20240103$20240917$20240131$20240920$EXP$$US-TAKEDA-2024TUS001830$TAKEDA$$58$YR$$F$Y$$$20240920$$MD$US$US
234619302$23461930$2$F$$20240110$20240131$20240802$EXP$$US-TEVA-VS-3143442$TEVA$$65$YR$$F$Y$$$20240802$$CN$US$US
234619782$23461978$2$F$20220809$20231219$20240131$20240723$EXP$$US-TEVA-VS-3141690$TEVA$$33$YR$$M$Y$$$20240723$$HP$US$US
234620894$23462089$4$F$20240101$20240828$20240131$20240924$PER$$US-SA-2024SA027354$SANOFI AVENTIS$$52$YR$A$F$Y$79.3$KG$20240924$$MD$US$US
234620944$23462094$4$F$20210125$20240808$20240131$20240815$EXP$$JP-ABBVIE-5612151$ABBVIE$$72$YR$$M$Y$55$KG$20240815$$MD$JP$JP
234621185$23462118$5$F$20240101$20240808$20240131$20240813$EXP$$KR-JNJFOC-20240172473$JOHNSON AND JOHNSON$$76$YR$E$M$Y$67$KG$20240813$$MD$KR$KR
234621382$23462138$2$F$$20240625$20240131$20240708$PER$$US-SA-2024SA029483$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
234621606$23462160$6$F$20210401$20240701$20240131$20240725$EXP$$NVSC2021GB119473$NOVARTIS$$$$A$F$Y$$$20240725$$CN$GB$GB
234621689$23462168$9$F$$20240911$20240131$20240918$EXP$$CA-GSK-CA2023AMR109050$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$CA$CA
234621952$23462195$2$F$$20240717$20240131$20240726$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR006878$AEGERION$$$$$M$Y$$$20240726$$CN$US$US
234622413$23462241$3$F$$20240710$20240131$20240712$EXP$$CA-TAKEDA-2024TUS008072$TAKEDA$$$$$F$Y$$$20240712$$CN$CA$CA
234622422$23462242$2$F$$20240814$20240131$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-005678$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240814$$CN$US$US
234622542$23462254$2$F$$20240823$20240131$20240828$EXP$$US-TAKEDA-2023TUS100399$TAKEDA$$$$$F$Y$$$20240828$$CN$US$US
234622572$23462257$2$F$$20240709$20240131$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015379$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240717$$CN$US$US
234622923$23462292$3$F$$20240724$20240131$20240726$EXP$$US-SANDOZ INC.-SDZ2024US008038$SANDOZ$$$$$M$Y$$$20240726$$CN$US$US
234623212$23462321$2$F$$20240802$20240131$20240808$EXP$$US-ABBVIE-5610945$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
234623362$23462336$2$F$$20240703$20240131$20240711$PER$$US-PFIZER INC-PV202400013194$PFIZER$$57$YR$$F$Y$$$20240711$$CN$US$US
234623573$23462357$3$F$20240101$20240831$20240131$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013073$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$54.9$KG$20240909$$CN$US$US
234624273$23462427$3$F$20240118$20240716$20240131$20240730$EXP$$CO-MYLANLABS-2024M1009737$MYLAN$$11$YR$$F$Y$11$KG$20240730$$MD$CO$CO
234624532$23462453$2$F$$20240826$20240131$20240828$EXP$$CA-TAKEDA-2024TUS008218$TAKEDA$$$$$M$Y$$$20240828$$MD$CA$CA
234624634$23462463$4$F$$20240712$20240131$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015885$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240722$$CN$US$US
234624863$23462486$3$F$20231201$20240710$20240131$20240717$EXP$$JP-009507513-2401JPN006730J$MERCK$$$$$F$Y$$$20240717$$MD$JP$JP
234624995$23462499$5$F$20231011$20240925$20240131$20240927$PER$$JP-Eisai-EC-2024-157889$EISAI$$74$YR$E$F$Y$$$20240927$$MD$JP$JP
234625014$23462501$4$F$$20240911$20240131$20240919$PER$$JP-Eisai-EC-2023-149178$EISAI$$$$E$F$Y$$$20240919$$MD$JP$JP
234625115$23462511$5$F$20230818$20240826$20240131$20240905$EXP$CA-MMM-P7X05K1Q$CA-GSK-CA2023107416$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$CA$CA
234625274$23462527$4$F$$20240425$20240131$20240910$EXP$$CA-SANDOZ INC.-NVSC2021CA074922$SANDOZ$$54$YR$$F$Y$$$20240910$$MD$CA$CA
234625282$23462528$2$F$20220502$20240819$20240131$20240823$EXP$$CA-TAKEDA-2024TUS008164$TAKEDA$$20$YR$$F$Y$$$20240823$$MD$CA$CA
234625664$23462566$4$F$20240416$20240823$20240131$20240828$EXP$$NVSC2024ZA020396$NOVARTIS$$17$YR$$M$Y$$$20240828$$CN$ZA$ZA
234626143$23462614$3$F$20240101$20240925$20240131$20240927$EXP$$US-INCYTE CORPORATION-2024IN000809$INCYTE$$$$$$Y$$$20240927$$HP$US$US
234626492$23462649$2$F$20230910$20240122$20240131$20240805$EXP$$CH-ABBVIE-5603661$ABBVIE$$$$N$M$Y$4$KG$20240805$$CN$CH$CH
234627325$23462732$5$F$20240101$20240917$20240131$20240926$PER$$JP-Eisai-EC-2024-157895$EISAI$$$$E$F$Y$$$20240926$$MD$JP$JP
234627463$23462746$3$F$$20240913$20240131$20240913$EXP$$CA-PFIZER INC-202200874939$PFIZER$$55$YR$$F$Y$$$20240913$$HP$CA$CA
234627507$23462750$7$F$$20240827$20240131$20240829$EXP$$US-PFIZER INC-202200521224$PFIZER$$75$YR$$F$Y$63$KG$20240829$$CN$US$US
234628162$23462816$2$F$20240128$20240816$20240131$20240821$EXP$$US-PFIZER INC-202400028226$PFIZER$$32$YR$$F$Y$$$20240821$$CN$US$US
234628352$23462835$2$F$20240101$20240820$20240131$20240822$PER$$US-PFIZER INC-202400028008$PFIZER$$63$YR$$M$Y$$$20240822$$CN$US$US
234629372$23462937$2$F$$20240723$20240131$20240729$PER$$US-PFIZER INC-PV202400013364$PFIZER$$77$YR$$F$Y$$$20240729$$CN$US$US
234629902$23462990$2$F$20230620$20240911$20240131$20240918$EXP$$JP-Eisai-EC-2023-144477$EISAI$$75$YR$E$M$Y$71.1$KG$20240918$$MD$JP$JP
234630116$23463011$6$F$20240118$20240823$20240131$20240905$EXP$$CA-BEH-2024167944$CSL BEHRING$$83$YR$E$M$Y$93.9$KG$20240905$$CN$CA$CA
234630143$23463014$3$F$20230101$20240906$20240131$20240911$EXP$$CA-BAUSCH-BL-2023-002499$BAUSCH AND LOMB$$59$YR$$M$Y$$$20240911$$CN$CA$CA
234631655$23463165$5$F$20240101$20240828$20240131$20240830$PER$$US-PFIZER INC-202400027847$PFIZER$$52$YR$$F$Y$$$20240830$$HP$US$US
234631823$23463182$3$F$20230701$20240726$20240131$20240801$EXP$$CA-PFIZER INC-202300267739$PFIZER$$71$YR$$M$Y$$$20240801$$HP$CA$CA
234631947$23463194$7$F$20230101$20240709$20240131$20240712$EXP$$US-PFIZER INC-202400004068$PFIZER$$72$YR$$M$Y$93.44$KG$20240712$$MD$US$US
234632282$23463228$2$F$$20240826$20240131$20240828$EXP$$CA-PFIZER INC-202400025884$PFIZER$$56$YR$$F$Y$44$KG$20240828$$HP$CA$CA
234632292$23463229$2$F$$20240729$20240131$20240731$EXP$$CA-PFIZER INC-202400025891$PFIZER$$65$YR$$M$Y$$$20240731$$PH$CA$CA
234632545$23463254$5$F$20230501$20240603$20240131$20240815$EXP$$BR-SANDOZ INC.-NVSC2023BR148369$SANDOZ$$57$YR$$F$Y$$$20240815$$CN$BR$BR
234632612$23463261$2$F$20240123$20240718$20240131$20240722$PER$$US-AMGEN-USASP2024018334$AMGEN$$78$YR$E$F$Y$$$20240722$$CN$US$US
234633694$23463369$4$F$$20240818$20240131$20240820$PER$$US-PFIZER INC-PV202400013250$PFIZER$$48$YR$$F$Y$$$20240820$$MD$US$US
234634316$23463431$6$F$20230424$20240903$20240131$20240904$EXP$$NVSJ2024JP001569$NOVARTIS$$71$YR$$F$Y$$$20240905$$MD$JP$JP
234634803$23463480$3$F$$20240725$20240131$20240801$PER$$US-SA-2024SA031362$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240801$$MD$US$US
234635526$23463552$6$F$$20240812$20240131$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-175986$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240820$$HP$US$US
234635593$23463559$3$F$20240111$20240723$20240131$20240727$EXP$$US-ABBVIE-5614230$ABBVIE$$60$YR$$F$Y$47$KG$20240727$$CN$US$US
234635823$23463582$3$F$$20240709$20240131$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015332$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240711$$CN$US$US
234636032$23463603$2$F$$20240717$20240131$20240724$PER$$US-SA-2024SA031107$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240724$$CN$US$US
234636478$23463647$8$F$$20240828$20240131$20240909$EXP$$IT-AUROBINDO-AUR-APL-2024-003629$AUROBINDO$Benevolo G, Bertuglia G, Bringhen S, Maletta F, Bruno B.. An atypical presentation of visceral leishmaniasis mimicking multiple myeloma relapse.. American Journal of Hematology.. 2024;99(1):137-41$79$YR$$M$Y$$$20240909$$MD$IT$IT
234637452$23463745$2$F$$20240820$20240201$20240829$PER$$US-SA-2024SA029938$SANOFI AVENTIS$$13$YR$T$M$Y$56$KG$20240829$$MD$US$US
234637652$23463765$2$F$$20240712$20240201$20240720$EXP$$CA-SANDOZ INC.-SDZ2023CA072052$SANDOZ$$$$$M$Y$$$20240720$$CN$CA$CA
234638022$23463802$2$F$$20240808$20240201$20240812$EXP$$US-ABBVIE-5565133$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
234638322$23463832$2$F$$20240625$20240201$20240717$PER$$CA-TOLMAR, INC.-24CA046021$TOLMAR$$$$$M$Y$$$20240717$$CN$CA$CA
234638353$23463835$3$F$$20240827$20240201$20240916$PER$$CA-TOLMAR, INC.-24CA046041$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
234638362$23463836$2$F$$20240625$20240201$20240717$PER$$CA-TOLMAR, INC.-24CA046050$TOLMAR$$$$$M$Y$$$20240717$$CN$CA$CA
234638512$23463851$2$F$20210601$20240729$20240201$20240806$EXP$$CO-TOLMAR, INC.-24CO045993$TOLMAR$$80$YR$$M$Y$$$20240806$$CN$CO$CO
234639452$23463945$2$F$20240108$20240830$20240201$20240916$PER$$CA-TOLMAR, INC.-24CA045968$TOLMAR$$75$YR$$M$Y$$$20240916$$CN$CA$CA
2346395112$23463951$12$F$20230101$20240909$20240201$20240916$EXP$$CA-GSK-CA2022AMR194733$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$CA$CA
234640322$23464032$2$F$20240715$20240715$20240201$20240723$PER$$US-SA-2024SA030256$SANOFI AVENTIS$$101$YR$E$F$Y$$$20240723$$MD$US$US
234640829$23464082$9$F$20230921$20240912$20240201$20240920$EXP$$CA-CELLTRION INC.-2023CA018728$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
234640903$23464090$3$F$20240101$20240220$20240201$20240808$EXP$$NVSC2024TR018540$NOVARTIS$$53$YR$$F$Y$70$KG$20240808$$MD$TR$TR
234640922$23464092$2$F$$20240627$20240201$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202401012607$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240708$$CN$US$US
234641743$23464174$3$F$20231201$20240816$20240201$20240822$EXP$$US-ABBVIE-5611122$ABBVIE$$58$YR$$M$Y$$$20240822$$CN$US$US
234641847$23464184$7$F$$20240923$20240201$20240930$EXP$$US-GSK-US2024AMR012482$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
234642695$23464269$5$F$$20240820$20240201$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015917$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240822$$HP$US$US
234643022$23464302$2$F$$20240129$20240201$20240723$EXP$$AU-TEVA-VS-3151112$TEVA$$$$$F$Y$$$20240723$$HP$AU$AU
234643044$23464304$4$F$20220520$20240319$20240201$20240724$EXP$$JP-GSK-JP2022JPN123352$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$JP$JP
234643553$23464355$3$F$20240101$20240802$20240201$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-014372$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$72.12$KG$20240805$$CN$US$US
234643803$23464380$3$F$20190225$20240711$20240201$20240716$EXP$$CA-TAKEDA-2019TUS010714$TAKEDA$$76$YR$$F$Y$$$20240716$$HP$CA$CA
234644422$23464442$2$F$20200101$20240822$20240201$20240829$EXP$$US-TAKEDA-2020TUS033514$TAKEDA$$$$$F$Y$47$KG$20240829$$CN$US$US
234645072$23464507$2$F$20240126$20240717$20240201$20240720$PER$$US-AMGEN-USASP2024019074$AMGEN$$70$YR$E$M$Y$$$20240720$$CN$US$US
234645314$23464531$4$F$$20240807$20240201$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015878$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$55.34$KG$20240814$$CN$US$US
234645573$23464557$3$F$20231201$20240626$20240201$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016153$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240701$$CN$US$US
234645642$23464564$2$F$$20240702$20240201$20240704$EXP$$US-TAKEDA-2021TUS044688$TAKEDA$$$$$M$Y$$$20240704$$CN$US$US
234646222$23464622$2$F$20240125$20240727$20240201$20240730$PER$$US-AMGEN-USASP2024018885$AMGEN$$80$YR$E$M$Y$$$20240730$$CN$US$US
234646302$23464630$2$F$$20240705$20240201$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016404$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$86.18$KG$20240709$$CN$US$US
234646355$23464635$5$F$20131116$20240918$20240201$20240923$EXP$$CA-SANDOZ INC.-PHHY2013CA139132$SANDOZ$$77$YR$$M$Y$$$20240923$$CN$CA$CA
234646678$23464667$8$F$20240101$20240819$20240201$20240827$EXP$$US-GSK-US2024AMR010993$GLAXOSMITHKLINE$$52$YR$$F$Y$78$KG$20240827$$MD$US$US
234646683$23464668$3$F$$20240222$20240201$20240926$PER$$US-GSK-US2024AMR010875$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
234647212$23464721$2$F$20210319$20240628$20240201$20240705$EXP$$DE-KOANAAP-SML-DE-2021-00591$Unknown Manufacturer$$73$YR$E$M$Y$98$KG$20240705$$MD$DE$DE
234647302$23464730$2$F$20240126$20240731$20240201$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015536$BRISTOL MYERS SQUIBB$$69$YR$A$M$Y$80.74$KG$20240806$$HP$US$US
234647462$23464746$2$F$$20240820$20240201$20240823$EXP$$US-TAKEDA-2024TUS007552$TAKEDA$$$$$M$Y$$$20240823$$CN$US$US
234647497$23464749$7$F$20230702$20240729$20240201$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017708$JAZZ$$41$YR$$F$Y$$$20240807$$PH$US$US
234647942$23464794$2$F$$20240704$20240201$20240720$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-429772$RANBAXY$$34$YR$$M$Y$$$20240719$$HP$ES$ES
234648192$23464819$2$F$20240128$20240717$20240201$20240720$PER$$US-AMGEN-USASP2024019829$AMGEN$$57$YR$A$M$Y$$$20240719$$MD$US$US
234648312$23464831$2$F$20230901$20240717$20240201$20240723$EXP$$AR-JNJFOC-20240166027$JOHNSON AND JOHNSON$$67$YR$E$F$Y$57$KG$20240723$$CN$AR$AR
234648344$23464834$4$F$$20240917$20240201$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015439$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240918$$CN$US$US
234648352$23464835$2$F$$20240929$20240201$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016191$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$83.01$KG$20240930$$CN$US$US
234648445$23464844$5$F$20231130$20240801$20240201$20240808$EXP$$JP-ROCHE-3500990$ROCHE$$85$YR$E$M$Y$62.4$KG$20240808$$MD$JP$JP
234648572$23464857$2$F$$20240717$20240201$20240723$EXP$$JP-009507513-2401JPN006735J$MERCK$$72$YR$$F$Y$$$20240723$$MD$JP$JP
234650323$23465032$3$F$20240612$20240709$20240201$20240712$EXP$$CA-TAKEDA-2024TUS006848$TAKEDA$$79$YR$$F$Y$$$20240712$$CN$CA$CA
234651346$23465134$6$F$$20240820$20240201$20240830$EXP$$ES-AUROBINDO-AUR-APL-2024-003728$AUROBINDO$$49$YR$$F$Y$$$20240830$$CN$ES$ES
234651875$23465187$5$F$20240105$20240910$20240201$20240919$EXP$$IT-ROCHE-3486793$ROCHE$$71$YR$E$M$Y$82$KG$20240919$$MD$IT$IT
234652083$23465208$3$F$$20240214$20240201$20240926$PER$$US-GSK-US2024AMR011491$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
234652356$23465235$6$F$20240101$20240905$20240201$20240906$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-016429$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$54.43$KG$20240906$$CN$PR$PR
2346523619$23465236$19$F$20231109$20240905$20240201$20240914$EXP$$CA-CELLTRION INC.-2023CA024247$CELLTRION$$$$$$Y$$$20240914$$MD$CA$CA
234652615$23465261$5$F$$20240916$20240201$20240920$EXP$$CA-BAYER-2024A013536$BAYER$$43$YR$A$F$Y$97$KG$20240920$$HP$CA$CA
234653832$23465383$2$F$$20240722$20240201$20240729$EXP$$CA-GSK-CA2024AMR012600$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$HP$CA$CA
234654372$23465437$2$F$$20240904$20240201$20240911$EXP$ES-BRISTOL-MYERS SQUIBB COMPANY-2023-103205$ES-RDY-SPO/ESP/24/0001432$DR REDDYS$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A, Arevalo CE, Montane C, Ribes-Amoros J, Zamora L, Granada I, Gamundi E, Arnan M, Sureda A. B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. report of three cases and review of the literature. Leukemia and Lymphoma. 2023 Jul 17;64(10):1701-5. doi:10.1080/10428194.2023.2234527. pub ahead of print. PMID: 37455651$69$YR$E$F$Y$$$20240911$$HP$ES$ES
234654416$23465441$6$F$20230725$20240909$20240201$20240917$EXP$$JP-HORIZON THERAPEUTICS-HZN-2023-007845$AMGEN$$48$YR$A$F$Y$49.3$KG$20240916$$HP$JP$JP
234655273$23465527$3$F$20231201$20240813$20240201$20240826$PER$$US-SA-2024SA033172$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240826$$MD$US$US
234656003$23465600$3$F$20240126$20240904$20240201$20240912$PER$$US-SA-2024SA033850$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240912$$HP$US$US
234656042$23465604$2$F$$20240823$20240201$20240914$PER$$US-SA-2024SA034316$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240914$$CN$US$US
234656064$23465606$4$F$20230701$20240725$20240201$20240802$PER$$US-SA-2024SA034991$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240802$$MD$US$US
234656142$23465614$2$F$$20240726$20240201$20240801$EXP$$US-SA-2024SA029076$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240801$$MD$US$US
234656282$23465628$2$F$$20240802$20240201$20240808$EXP$$BE-GSK-BE2023EME151295$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$BE$BE
234656565$23465656$5$F$20240101$20240724$20240201$20240730$EXP$$CA-PFIZER INC-202400025273$PFIZER$$71$YR$$F$Y$$$20240730$$MD$CA$CA
234656836$23465683$6$F$20240415$20240621$20240201$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000079$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240716$$CN$US$US
234657037$23465703$7$F$20240110$20240719$20240201$20240724$30DAY$$US-PFIZER INC-202400007988$PFIZER$$15$YR$$M$Y$54.43$KG$20240724$$CN$US$US
234657483$23465748$3$F$20220101$20240626$20240201$20240701$PER$$US-AMGEN-USASP2024019540$AMGEN$$21$YR$A$F$Y$$$20240630$$CN$US$US
234657593$23465759$3$F$$20240124$20240201$20240807$EXP$$NVSC2023CA110080$NOVARTIS$$62$YR$$F$Y$$$20240807$$CN$CA$CA
234658845$23465884$5$F$20230509$20240319$20240201$20240814$EXP$$UA-BRAEBURN-UA-BRA-23-000452$BRAEBURN PHARMACEUTICALS$$43$YR$$M$Y$$$20240814$$HP$UA$UA
234658934$23465893$4$F$$20240903$20240201$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013771$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240912$$CN$US$US
234659024$23465902$4$F$20220101$20240903$20240201$20240904$PER$$US-ALXN-202401USA001963US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$HP$US$US
234659147$23465914$7$F$20240106$20240719$20240201$20240724$EXP$$US-BEH-2024168005$CSL BEHRING$$14$YR$T$M$Y$$$20240724$$CN$US$US
234659432$23465943$2$F$20230101$20240731$20240201$20240809$PER$$US-SA-2024SA024525$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240809$$MD$US$US
2346599110$23465991$10$F$20240101$20240821$20240201$20240827$EXP$$US-PFIZER INC-202300159765$PFIZER$$76$YR$$F$Y$64.399$KG$20240827$$MD$US$US
234660033$23466003$3$F$20240101$20240927$20240201$20240927$EXP$$CA-PFIZER INC-202400009605$PFIZER$$84$YR$$F$Y$92$KG$20240927$$HP$CA$CA
234660093$23466009$3$F$20240127$20240916$20240201$20240926$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000016$Unknown Manufacturer$$$$$$Y$$$20240926$$MD$US$US
234661142$23466114$2$F$$20240730$20240201$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016737$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$158.76$KG$20240802$$CN$US$US
234661324$23466132$4$F$20230101$20240926$20240201$20240927$PER$$US-PFIZER INC-PV202300181368$PFIZER$$56$YR$$M$Y$$$20240927$$HP$US$US
234661592$23466159$2$F$20240127$20240727$20240201$20240730$PER$$US-AMGEN-USASP2024019794$AMGEN$$61$YR$A$M$Y$$$20240730$$CN$US$US
234661635$23466163$5$F$$20240904$20240201$20240911$EXP$$NVSC2024CA020547$NOVARTIS$$40$YR$$F$Y$$$20240912$$HP$CA$CA
234661853$23466185$3$F$20210101$20240821$20240201$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA009889$SANDOZ$$65$YR$$F$Y$$$20240828$$MD$CA$CA
234662003$23466200$3$F$20240105$20240814$20240201$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016295$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240822$$PH$US$US
234662053$23466205$3$F$20231226$20240806$20240201$20240813$PER$$US-SA-2024SA028995$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240814$$MD$US$US
234662772$23466277$2$F$$20240719$20240201$20240723$PER$$US-PFIZER INC-PV202400013673$PFIZER$$43$YR$$F$Y$$$20240723$$CN$US$US
234662853$23466285$3$F$$20240722$20240201$20240724$PER$$US-PFIZER INC-PV202400014152$PFIZER$$36$YR$$F$Y$$$20240724$$HP$US$US
234662895$23466289$5$F$20240903$20240903$20240201$20240905$PER$$US-PFIZER INC-202400027419$PFIZER$$70$YR$$F$Y$$$20240905$$CN$US$US
234663222$23466322$2$F$$20240710$20240201$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013757$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240717$$CN$US$US
234663903$23466390$3$F$$20240802$20240201$20240815$EXP$$US-INSMED, INC.-2023-04307-US$INSMED$$$$$F$Y$$$20240815$$CN$US$US
234664393$23466439$3$F$$20240709$20240201$20240711$EXP$$US-TAKEDA-2023TUS120631$TAKEDA$$$$$F$Y$$$20240711$$HP$US$US
234664733$23466473$3$F$20240117$20240923$20240201$20240925$EXP$$PK-PFIZER INC-PV202300157615$PFIZER$$28$YR$$M$Y$86$KG$20240925$$CN$PK$PK
234665703$23466570$3$F$20240101$20240910$20240201$20240930$PER$$US-Eisai-EC-2024-156915$EISAI$$79$YR$E$M$Y$$$20240930$$CN$US$US
234666142$23466614$2$F$20240101$20240723$20240201$20240731$EXP$$US-SA-2024SA034178$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240731$$MD$US$US
234666235$23466623$5$F$20240201$20240719$20240201$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017076$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240723$$HP$US$US
234666262$23466626$2$F$20240124$20240628$20240201$20240708$EXP$$JP-009507513-2401JPN006293J$MERCK$$60$YR$$F$Y$$$20240708$$MD$JP$JP
234666423$23466642$3$F$20240605$20240626$20240201$20240705$PER$$US-SA-2024SA025401$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240705$$MD$US$US
234666623$23466662$3$F$$20240807$20240201$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017040$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$132.45$KG$20240812$$CN$US$US
234666722$23466672$2$F$$20240701$20240201$20240704$EXP$$CA-BAUSCH-BL-2024-001464$BAUSCH AND LOMB$$45$YR$$F$Y$$$20240704$$HP$CA$CA
234667625$23466762$5$F$$20240809$20240201$20240827$EXP$$JP-009507513-2312JPN000515J$MERCK$Shibata N, Matsui C, Hirai C, Tada M, Yauchi Y, Kikawa Y, et al.. EP-0451 Treatment outcomes of the KYENOTE-522 regimen for early-stage triple-negative breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 290$61$YR$$F$Y$$$20240827$$MD$JP$JP
234668122$23466812$2$F$20231227$20240819$20240201$20240822$EXP$$GB-PFIZER INC-202400029768$PFIZER$$12$YR$$F$Y$51.4$KG$20240822$$PH$GB$GB
234668942$23466894$2$F$20240126$20240716$20240201$20240718$PER$$US-AMGEN-USASP2024020772$AMGEN$$81$YR$E$F$Y$$$20240717$$CN$US$US
234669472$23466947$2$F$20230515$20240123$20240201$20240808$EXP$$NVSC2023KW115060$NOVARTIS$$36$YR$$F$Y$$$20240808$$MD$KW$KW
234669573$23466957$3$F$$20240827$20240201$20240910$EXP$$US-BIOGEN-2024BI01247479$BIOGEN$$$$$M$Y$$$20240910$$CN$US$US
234669652$23466965$2$F$$20240918$20240201$20240926$PER$$NVSC2024US022711$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
234669683$23466968$3$F$20240117$20240702$20240201$20240709$EXP$$CO-Ipsen Biopharmaceuticals, Inc.-2024-01610$IPSEN$$68$YR$E$F$Y$58$KG$20240709$$CN$CO$CO
234669703$23466970$3$F$$20240927$20240201$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016995$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$86.64$KG$20240930$$CN$US$US
234669847$23466984$7$F$$20240701$20240201$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016063$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240702$$CN$US$US
234669896$23466989$6$F$$20240802$20240201$20240811$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000208$BLUEPRINT MEDICINES$$$$$M$Y$$$20240812$$MD$US$US
234669952$23466995$2$F$20231204$20240703$20240201$20240711$EXP$$JP-AstraZeneca-2024A022073$ASTRAZENECA$Touya T.. P-097 A case of interstitial pneumonia caused by Olaparib during NAC-IDS and PAOLA regimen in stage III ovarian cancer.. The 66th Annual Meeting of Japan Society of Gynecologic Oncology 2024;0-..$75$YR$$F$Y$$$20240711$$MD$JP$
234670822$23467082$2$F$20230101$20240715$20240201$20240716$EXP$$DE-SANDOZ INC.-NVSC2023DE133754$SANDOZ$$$$$M$Y$75.8$KG$20240716$$HP$DE$DE
234671667$23467166$7$F$20240207$20240911$20240201$20240916$EXP$$CA-TAKEDA-2024TUS003065$TAKEDA$$26$YR$$M$Y$$$20240916$$CN$CA$CA
234671812$23467181$2$F$20240129$20240713$20240201$20240716$PER$$US-AMGEN-USASP2024020625$AMGEN$$82$YR$E$M$Y$$$20240715$$HP$US$US
234671962$23467196$2$F$$20240131$20240201$20240723$PER$$US-BAYER-2024A018349$BAYER$$27$YR$A$F$Y$$$20240723$$CN$US$US
234671978$23467197$8$F$20230620$20240923$20240201$20240930$EXP$$NVSC2023IN088702$NOVARTIS$$59$YR$$F$Y$$$20240929$$CN$IN$IN
234673093$23467309$3$F$20220104$20240821$20240201$20240822$EXP$$CA-SANDOZ INC.-NVSC2022CA003262$SANDOZ$$74$YR$$F$Y$$$20240822$$MD$CA$CA
234673233$23467323$3$F$20240610$20240816$20240201$20240827$PER$$US-SA-2024SA030341$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240827$$MD$US$US
234673473$23467347$3$F$$20240626$20240201$20240703$EXP$$AU-TAKEDA-2024TUS007773$TAKEDA$$62$YR$$M$Y$$$20240703$$HP$AU$AU
234673486$23467348$6$F$20231201$20240821$20240201$20240826$EXP$$NVSC2024PE018265$NOVARTIS$$83$YR$$F$Y$$$20240826$$CN$PE$PE
234673513$23467351$3$F$20240108$20240916$20240201$20240925$EXP$$PY-Vifor (International) Inc.-VIT-2024-00831$VIFOR$$69$YR$$F$Y$$$20240925$$CN$PY$PY
234674052$23467405$2$F$$20240612$20240201$20240717$PER$$US-INCYTE CORPORATION-2021IN006652$INCYTE$$$$$$Y$$$20240717$$CN$US$US
234674693$23467469$3$F$$20240621$20240201$20240807$EXP$$US-GILEAD-2024-0659692$GILEAD$Ghilardi, G., et al. T-cell Lymphoma and Secondary Primary Malignancy Risk After Commercial CAR T-cell Therapy. Nature medicine. 2021;unk:unk. doi:10.1038/s41591-024-02826-w$63$YR$A$M$Y$$$20240807$$HP$US$US
234675063$23467506$3$F$20220104$20240807$20240201$20240812$EXP$$NVSC2022GB002634$NOVARTIS$$54$YR$$F$Y$$$20240812$$CN$GB$GB
234675072$23467507$2$F$20240128$20240730$20240201$20240801$PER$$US-AMGEN-USASP2024019720$AMGEN$$68$YR$E$F$Y$$$20240801$$CN$US$US
234675114$23467511$4$F$$20240627$20240201$20240703$PER$$US-BAUSCHBL-2024BNL001100$BAUSCH AND LOMB$$83$YR$$F$Y$63.5$KG$20240703$$CN$US$US
234675922$23467592$2$F$20240101$20240910$20240201$20240925$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429331$RANBAXY$$24$YR$A$F$Y$$$20240925$$HP$US$US
234676002$23467600$2$F$$20240923$20240201$20240925$EXP$$NVSC2024US021749$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
234676062$23467606$2$F$$20240710$20240201$20240717$PER$$JP-Eisai-EC-2024-157887$EISAI$$8$DEC$E$F$Y$$$20240717$$MD$JP$JP
234676074$23467607$4$F$20231120$20240830$20240201$20240905$PER$$JP-Eisai-EC-2024-157787$EISAI$$68$YR$E$F$Y$$$20240905$$HP$JP$JP
234676513$23467651$3$F$$20240902$20240201$20240917$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429945$RANBAXY$Somasundaram A, Gupta A, Sathishkumar D, Mathew L, George A, Thomas M. Rapid recovery in a child with febrile ulceronecrotic Mucha-Habermann disease following intravenous immunoglobulin administration. Pediatr Dermatol. 2024;Jan 17/41(3):(26)/518-522$5$YR$$M$Y$$$20240917$$MD$IN$IN
234676813$23467681$3$F$20231017$20240717$20240201$20240723$PER$$JP-Eisai-EC-2023-150344$EISAI$$76$YR$E$M$Y$$$20240723$$MD$JP$JP
234676878$23467687$8$F$20240120$20240909$20240201$20240913$EXP$$NVSC2024KR020263$NOVARTIS$$70$YR$$F$Y$58$KG$20240913$$MD$KR$KR
234677142$23467714$2$F$$20240801$20240201$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015977$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240802$$CN$US$US
234677493$23467749$3$F$20230801$20240826$20240201$20240909$EXP$$DK-NOVOPROD-1166294$NOVO NORDISK$$60$YR$$F$Y$78$KG$20240909$$MD$DK$DK
234678223$23467822$3$F$20231001$20240917$20240201$20240925$EXP$$JP-009507513-2311JPN000173J$MERCK$$68$YR$$M$Y$$$20240925$$MD$JP$JP
234678904$23467890$4$F$20221219$20240716$20240201$20240730$EXP$$ES-VER-202400001$VERITY PHARMACEUTICALS$$88$YR$E$M$Y$76$KG$20240730$$HP$ES$ES
234678962$23467896$2$F$20240124$20240823$20240201$20240910$EXP$$US-SA-2024SA032680$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240910$$HP$US$US
234679403$23467940$3$F$20230410$20240802$20240201$20240816$EXP$$LT-VER-202400002$VERITY PHARMACEUTICALS$$44$YR$A$M$Y$84$KG$20240816$$HP$LT$LT
234679447$23467944$7$F$20240124$20240730$20240201$20240802$EXP$$US-TAKEDA-2024TUS008547$TAKEDA$$67$YR$$M$Y$$$20240802$$MD$US$US
234679994$23467999$4$F$$20240702$20240201$20240710$EXP$$CA-ROCHE-3502305$ROCHE$$$$A$M$Y$$$20240710$$CN$CA$CA
234680023$23468002$3$F$$20240910$20240201$20240912$EXP$$CA-ROCHE-3502454$ROCHE$$$$A$F$Y$$$20240912$$CN$CA$CA
234680144$23468014$4$F$$20240730$20240201$20240805$EXP$$JP-009507513-2401JPN005883J$MERCK$$79$YR$$F$Y$$$20240805$$MD$JP$JP
234680234$23468023$4$F$20231101$20240705$20240201$20240711$EXP$$JP-009507513-2401JPN005325J$MERCK$$8$DEC$$F$Y$$$20240711$$MD$JP$JP
2346804610$23468046$10$F$$20240923$20240201$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-002044$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240925$$CN$US$US
234681182$23468118$2$F$20240101$20240626$20240201$20240702$EXP$$US-SA-2024SA035825$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240702$$MD$US$US
234681542$23468154$2$F$20230418$20240920$20240201$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-014986$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240927$$PH$JP$JP
234681724$23468172$4$F$$20240708$20240201$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015042$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240711$$CN$US$US
234681912$23468191$2$F$$20240711$20240201$20240718$EXP$$FR-ABBVIE-5603338$ABBVIE$$31$YR$$F$Y$76$KG$20240718$$CN$FR$FR
234682372$23468237$2$F$$20240712$20240201$20240720$EXP$$CA-TAKEDA-2022TUS091984$TAKEDA$$$$$M$Y$95$KG$20240720$$CN$CA$CA
234682433$23468243$3$F$20240701$20240822$20240201$20240914$PER$$US-SA-2024SA035429$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240914$$MD$US$US
234682793$23468279$3$F$20240123$20240710$20240201$20240712$PER$$US-AMGEN-USASP2024020326$AMGEN$$76$YR$E$M$Y$$$20240711$$MD$US$US
234682952$23468295$2$F$20240101$20240916$20240201$20240923$EXP$$NL-ABBVIE-5620014$ABBVIE$$$$E$M$Y$$$20240923$$CN$NL$NL
234683094$23468309$4$F$$20240801$20240201$20240809$PER$$US-SA-2024SA030197$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240809$$MD$US$US
234683162$23468316$2$F$$20240830$20240201$20240910$EXP$$CA-AUROBINDO-AUR-APL-2019-033868$AUROBINDO$$52$YR$$F$Y$$$20240910$$HP$CA$CA
234683215$23468321$5$F$20240821$20240821$20240201$20240829$EXP$$CA-TAKEDA-2023TUS120880$TAKEDA$$76$YR$$F$Y$$$20240829$$HP$CA$CA
234683243$23468324$3$F$20240307$20240905$20240201$20240912$EXP$$CA-TAKEDA-2024TUS003032$TAKEDA$$46$YR$$F$Y$$$20240912$$CN$CA$CA
234683512$23468351$2$F$$20240705$20240202$20240708$PER$$NVSC2024US022754$NOVARTIS$$$$$$Y$$$20240708$$MD$US$US
234683772$23468377$2$F$$20240624$20240202$20240701$EXP$$SA-GSK-SA2024EME012713$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$SA$SA
234683945$23468394$5$F$20231205$20240826$20240202$20240902$EXP$$CA-GSK-CA2023181597$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$HP$CA$CA
234684052$23468405$2$F$20240130$20240708$20240202$20240708$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-005646$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$132$KG$20240708$$MD$DE$DE
234684382$23468438$2$F$20230906$20240814$20240202$20240816$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-006013$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$$$20240816$$CN$CA$CA
234685004$23468500$4$F$$20240821$20240202$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000087$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
2346871112$23468711$12$F$$20240818$20240202$20240822$EXP$$CA-JNJFOC-20240175698$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240822$$PH$CA$CA
234687669$23468766$9$F$20240122$20240716$20240202$20240723$EXP$$US-GSK-US2024AMR010866$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
234688013$23468801$3$F$$20240726$20240202$20240802$PER$$US-SA-2024SA033308$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240802$$MD$US$US
234689352$23468935$2$F$20211201$20240624$20240202$20240709$EXP$FR-AFSSAPS-NT2024000004$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-102755$ZYDUS PHARM$$$$$$Y$$$20240709$$MD$FR$FR
234689382$23468938$2$F$20231201$20240617$20240202$20240701$EXP$FR-AFSSAPS-RE2024000052$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-102815$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$FR$FR
234689472$23468947$2$F$$20240629$20240202$20240702$PER$$US-TAKEDA-2024TUS009975$TAKEDA$$$$$F$Y$$$20240702$$CN$US$US
234689614$23468961$4$F$20240614$20240723$20240202$20240728$EXP$$CA-JNJFOC-20240178038$JOHNSON AND JOHNSON$$37$YR$A$F$Y$67$KG$20240728$$HP$CA$CA
234689804$23468980$4$F$20231001$20240730$20240202$20240803$EXP$$CA-JNJFOC-20240168506$JOHNSON AND JOHNSON$$59$YR$A$F$Y$94$KG$20240803$$HP$CA$CA
234689894$23468989$4$F$20240131$20240819$20240202$20240821$EXP$$CA-ROCHE-3503287$ROCHE$$41$YR$A$F$Y$$$20240821$$CN$CA$CA
234690036$23469003$6$F$20191205$20240809$20240202$20240815$EXP$$JP-GSK-JP2021JPN054541$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$MD$JP$JP
234690513$23469051$3$F$20230101$20240913$20240202$20240921$EXP$$CA-CELLTRION INC.-2023CA012903$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
234690582$23469058$2$F$$20240827$20240202$20240909$PER$$US-EMD Serono-2024005536$EMD SERONO INC$$$$A$M$Y$$$20240909$$CN$US$US
234690802$23469080$2$F$20230805$20240715$20240202$20240722$EXP$$GR-ROCHE-3502354$ROCHE$$75$YR$E$M$Y$90$KG$20240722$$MD$GR$GR
234691127$23469112$7$F$20150107$20240923$20240202$20240930$EXP$$US-GSK-US2024AMR012478$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
234691525$23469152$5$F$$20240814$20240202$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016909$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240821$$CN$US$US
234692294$23469229$4$F$20240207$20240723$20240202$20240725$EXP$$CA-TAKEDA-2022TUS000231$TAKEDA$$49$YR$$M$Y$$$20240725$$CN$CA$CA
234692532$23469253$2$F$20231201$20240119$20240202$20240708$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00051$Unknown Manufacturer$$$$$$Y$$$20240708$$CN$BR$BR
234692665$23469266$5$F$20240101$20240702$20240202$20240704$PER$$US-TAKEDA-2024TUS008783$TAKEDA$$13$YR$$M$Y$82$KG$20240704$$MD$US$US
234693022$23469302$2$F$$20240731$20240202$20240805$EXP$$GR-AMGEN-GRCSP2024020006$AMGEN$$$$$F$Y$$$20240805$$MD$GR$GR
234693133$23469313$3$F$$20240702$20240202$20240710$30DAY$$US-GSK-US2024AMR014499$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
234693393$23469339$3$F$20240126$20240717$20240202$20240722$PER$$US-AMGEN-USASP2024018535$AMGEN$$60$YR$A$F$Y$$$20240722$$CN$US$US
234693663$23469366$3$F$20190313$20240912$20240202$20240920$EXP$$CA-CELLTRION INC.-2024CA002403$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
234694025$23469402$5$F$$20240826$20240202$20240902$EXP$$CA-GSK-CA2023038082$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$CA$CA
234694177$23469417$7$F$$20240703$20240202$20240712$EXP$$GB-862174955-ML2024-00529$Unknown Manufacturer$$38$YR$A$M$Y$104$KG$20240712$$HP$GB$GB
234694552$23469455$2$F$20240125$20240801$20240202$20240806$PER$$US-AMGEN-USASP2024019085$AMGEN$$65$YR$E$M$Y$$$20240805$$CN$US$US
234694626$23469462$6$F$20240101$20240905$20240202$20240918$EXP$$DE-AUROBINDO-AUR-APL-2024-004002$AUROBINDO$$80$YR$$F$Y$57$KG$20240918$$MD$DE$DE
234694902$23469490$2$F$$20240918$20240202$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-003789$AUROBINDO$$31$YR$$M$Y$$$20240927$$MD$FR$FR
234695363$23469536$3$F$$20240830$20240202$20240904$EXP$$CA-JNJFOC-20240128886$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240904$$CN$CA$CA
234695393$23469539$3$F$20210118$20240712$20240202$20240715$EXP$$DE-SANDOZ INC.-NVSC2023DE063935$SANDOZ$$81$YR$$F$Y$60$KG$20240715$$MD$DE$DE
234695876$23469587$6$F$20240301$20240722$20240202$20240801$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000058$DECIPHERA PHARMACEUTICALS$$66$YR$A$F$Y$$$20240801$$CN$US$US
234696333$23469633$3$F$$20240716$20240202$20240723$EXP$$CA-JNJFOC-20240165195$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240722$$HP$CA$CA
234697698$23469769$8$F$20230101$20240802$20240202$20240812$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000088$DECIPHERA PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
234697714$23469771$4$F$20240117$20240827$20240202$20240910$PER$$US-JNJFOC-20240153749$JOHNSON AND JOHNSON$$36$YR$A$M$Y$90.8$KG$20240910$$CN$US$US
234697773$23469777$3$F$$20240627$20240202$20240704$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000082$DECIPHERA PHARMACEUTICALS$$74$YR$E$M$Y$$$20240704$$CN$US$US
234698052$23469805$2$F$$20240807$20240202$20240810$EXP$$GR-ROCHE-3502109$ROCHE$$$$$F$Y$$$20240810$$MD$GR$GR
234698192$23469819$2$F$$20240625$20240202$20240705$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-013388$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$84$KG$20240705$$PH$BR$BR
234698572$23469857$2$F$20240118$20240910$20240202$20240912$PER$$US-ALXN-202401USA001897US$ALEXION PHARMACEUTICALS$$82$YR$$M$Y$$$20240912$$CN$US$US
234698905$23469890$5$F$20240125$20240625$20240202$20240710$EXP$$IT-ROCHE-3500608$ROCHE$$59$YR$A$M$Y$78$KG$20240710$$MD$IT$IT
234699092$23469909$2$F$20240129$20240913$20240202$20240916$PER$$US-AMGEN-USASP2024021390$AMGEN$$70$YR$E$M$Y$$$20240916$$CN$US$US
234699194$23469919$4$F$20230328$20240910$20240202$20240916$EXP$$IE-TAKEDA-2023TUS034175$TAKEDA$$65$YR$$M$Y$$$20240916$$CN$IE$IE
234699636$23469963$6$F$20240914$20240916$20240202$20240920$EXP$$US-GSK-US2024AMR012594$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
234700483$23470048$3$F$20240109$20240730$20240202$20240802$EXP$$JP-VIATRISJAPAN-2024M1008540AA$MYLAN$$48$YR$$M$Y$$$20240802$$PH$JP$JP
234700532$23470053$2$F$20240101$20240816$20240202$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017071$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240827$$HP$US$US
234701136$23470113$6$F$$20240903$20240202$20240917$EXP$$ES-AUROBINDO-AUR-APL-2023-077417$AUROBINDO$Pena M, Montane C, Paviglianiti A, Hurtado L, Gonzalez S, Carro I et all.. Outcomes of allogeneic hematopoietic cell transplantation after bispecific antibodies in non-Hodgkin lymphomas.. Bone Marrow Transplantation. 2023;58 (11):1282-5.$57$YR$$M$Y$$$20240917$$MD$ES$ES
234701853$23470185$3$F$$20240814$20240202$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017579$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$118.39$KG$20240822$$CN$US$US
234701944$23470194$4$F$20231201$20240819$20240202$20240821$PER$$US-AMGEN-USASP2024019072$AMGEN$$74$YR$E$M$Y$$$20240821$$CN$US$US
234702103$23470210$3$F$$20240614$20240202$20240710$30DAY$$US-GSK-US2024011897$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
234702143$23470214$3$F$$20240701$20240202$20240705$EXP$$CA-BAUSCH-BL-2024-001445$BAUSCH AND LOMB$$15$WK$$M$Y$$$20240705$$CN$CA$CA
234702235$23470223$5$F$$20240905$20240202$20240920$EXP$$CA-SSPHARMA-CA-VDP-2021-000465$SS PHARMA$$$$$$Y$$$20240920$$HP$CA$CA
234703142$23470314$2$F$$20240822$20240202$20240828$EXP$$DE-MYLANLABS-2024M1009165$MYLAN$Suhling H, Hinze CA, Welte T, Werfel T, Traidl S. Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic Dermatitis. Respiration.. 2023;102(12):1016-9$25$YR$$F$Y$$$20240828$$MD$DE$DE
234703323$23470332$3$F$20240307$20240828$20240202$20240902$EXP$$CA-TAKEDA-2024TUS008966$TAKEDA$$58$YR$$F$Y$$$20240902$$CN$CA$CA
234703343$23470334$3$F$20240126$20240625$20240202$20240701$EXP$$CA-TAKEDA-2023TUS105718$TAKEDA$$62$YR$$M$Y$$$20240701$$CN$CA$CA
234703862$23470386$2$F$$20240131$20240202$20240906$EXP$$MX-BAYER-2024A018819$BAYER$$32$YR$A$M$Y$$$20240906$$CN$MX$MX
234704353$23470435$3$F$20240101$20240625$20240202$20240701$EXP$$CA-PFIZER INC-202400030156$PFIZER$$33$YR$$M$Y$$$20240701$$CN$CA$CA
234704924$23470492$4$F$20230824$20240820$20240202$20240823$EXP$$NVSC2023GB185447$NOVARTIS$$$$E$F$Y$$$20240823$$CN$GB$GB
234704963$23470496$3$F$$20240704$20240202$20240708$EXP$$DE-ALXN-202402EEA000004DE$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240708$$PH$DE$DE
234705072$23470507$2$F$$20240131$20240202$20240809$EXP$$NVSC2024US022512$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
234706254$23470625$4$F$$20240913$20240202$20240917$30DAY$$US-PFIZER INC-PV202400002856$PFIZER$$$$$F$Y$$$20240917$$CN$US$US
234706613$23470661$3$F$20240101$20240716$20240202$20240724$EXP$$US-ALXN-202401USA001764US$ALEXION PHARMACEUTICALS$$76$YR$$F$Y$$$20240724$$HP$US$US
234707763$23470776$3$F$20231026$20240625$20240202$20240710$EXP$$US-GSK-US2024AMR013267$GLAXOSMITHKLINE$$59$YR$$F$Y$118.38$KG$20240710$$CN$US$US
234708872$23470887$2$F$20230613$20240129$20240202$20240829$EXP$FR-AFSSAPS-LL2024000092$FR-UCBSA-2024004680$UCB$$1$YR$$F$Y$$$20240829$$MD$FR$FR
234709253$23470925$3$F$20240621$20240621$20240202$20240710$PER$$CA-TOLMAR, INC.-24CA045970$TOLMAR$$77$YR$$M$Y$$$20240710$$CN$CA$CA
234710193$23471019$3$F$20240712$20240801$20240202$20240806$EXP$$US-OTSUKA-2023_016157$OTSUKA$$83$YR$$M$Y$$$20240806$$HP$US$US
234710202$23471020$2$F$$20240722$20240202$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-006146$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240724$$CN$US$US
234710318$23471031$8$F$20231212$20240826$20240202$20240828$EXP$$NVSC2023IL268389$NOVARTIS$$76$YR$$F$Y$$$20240829$$HP$IL$IL
234710423$23471042$3$F$20240101$20240816$20240202$20240821$EXP$$US-SA-2024SA035699$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240821$$CN$US$US
234711933$23471193$3$F$20230719$20240625$20240202$20240708$EXP$FR-AFSSAPS-AN2024000115$FR-SAMSUNG BIOEPIS-SB-2024-03297$SAMSUNG BIOEPIS$$52$YR$A$F$Y$$$20240708$$PH$FR$FR
234711945$23471194$5$F$$20240722$20240202$20240731$PER$$US-VERTEX PHARMACEUTICALS-2024-001248$VERTEX$$42$YR$$$Y$$$20240731$$CN$US$US
234711964$23471196$4$F$$20240712$20240202$20240722$EXP$$US-VERTEX PHARMACEUTICALS-2024-001548$VERTEX$$$$$F$Y$$$20240722$$CN$US$US
234712353$23471235$3$F$20190301$20240719$20240202$20240725$EXP$$DE-SANDOZ INC.-PHHY2019DE058324$SANDOZ$$$$A$F$Y$64$KG$20240725$$MD$DE$DE
234712842$23471284$2$F$20230401$20240916$20240202$20240924$EXP$$US-RDY-SPO/USA/24/0001774$DR REDDYS$$71$YR$E$F$Y$$$20240924$$HP$US$US
234712932$23471293$2$F$20220908$20240731$20240202$20240802$EXP$$NVSC2022RU277152$NOVARTIS$$78$YR$$F$Y$65$KG$20240802$$MD$RU$RU
234712993$23471299$3$F$$20240909$20240202$20240924$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00092$AVADEL CNS PHARMA$$$$$F$Y$$$20240924$$CN$US$US
234713452$23471345$2$F$$20240822$20240202$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017418$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$73.03$KG$20240823$$CN$US$US
234713498$23471349$8$F$20230726$20240830$20240202$20240906$EXP$$CA-GSK-CA2023078996$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$CA$CA
234713785$23471378$5$F$20240101$20240826$20240202$20240903$EXP$$US-SA-2024SA036650$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240903$$MD$US$US
234713943$23471394$3$F$20230101$20240906$20240202$20240920$PER$$US-SA-2024SA029410$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240920$$MD$US$US
234714123$23471412$3$F$20240101$20240722$20240202$20240731$PER$$US-SA-2024SA030562$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240731$$MD$US$US
234714172$23471417$2$F$$20240724$20240202$20240802$PER$$US-SA-2024SA030374$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240802$$MD$US$US
234715193$23471519$3$F$20240101$20240705$20240202$20240713$PER$$US-SA-2024SA026308$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240713$$MD$US$US
234715393$23471539$3$F$20231201$20240729$20240202$20240807$PER$$US-SA-2024SA034321$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240807$$MD$US$US
234715492$23471549$2$F$20230815$20240717$20240202$20240725$PER$$US-SA-2024SA034794$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240725$$MD$US$US
234715635$23471563$5$F$$20240626$20240202$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000113$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
234716053$23471605$3$F$20220201$20240830$20240202$20240909$PER$$US-SA-2024SA035753$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240909$$MD$US$US
234716152$23471615$2$F$20230901$20240709$20240202$20240717$PER$$US-SA-2024SA036045$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240717$$MD$US$US
234716382$23471638$2$F$$20240823$20240202$20240826$EXP$PT-INFARMED-B202401-639$PT-TAKEDA-2024TUS009246$TAKEDA$$54$YR$$M$Y$80$KG$20240826$$HP$PT$PT
234716842$23471684$2$F$20221020$20240627$20240202$20240703$EXP$$NVSC2022GB241755$NOVARTIS$$41$YR$$M$Y$$$20240703$$CN$GB$GB
234716946$23471694$6$F$$20240820$20240202$20240828$PER$$US-TRAVERE-2024TVT00038$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240828$$CN$US$US
234717153$23471715$3$F$$20240628$20240202$20240705$EXP$$CA-GSK-CA2023AMR129549$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$CA$CA
234717842$23471784$2$F$$20240722$20240202$20240726$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-015830$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240726$$PH$CH$CH
234718153$23471815$3$F$$20240829$20240202$20240903$EXP$$CA-PFIZER INC-202300267798$PFIZER$$81$YR$$M$Y$$$20240903$$HP$CA$CA
234718212$23471821$2$F$$20240711$20240202$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016955$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$82.69$KG$20240716$$CN$US$US
234718782$23471878$2$F$20210101$20240819$20240202$20240823$EXP$$NVSC2021GB299205$NOVARTIS$$51$YR$$F$Y$$$20240824$$HP$GB$GB
234719492$23471949$2$F$20240109$20240627$20240202$20240709$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202401015420$ELI LILLY AND CO$$$$$F$Y$99$KG$20240709$$CN$GB$GB
234720002$23472000$2$F$20231108$20240911$20240202$20240918$EXP$$ES-AstraZeneca-2024A027523$ASTRAZENECA$$21$DY$$M$Y$4$KG$20240918$$MD$ES$
234720222$23472022$2$F$$20240715$20240202$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017495$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240723$$CN$US$US
234720263$23472026$3$F$$20240821$20240202$20240827$EXP$$US-PHARMING-PHAUS2024000060$PHARMING GROUP$$$$$$Y$$$20240827$$CN$US$US
234720727$23472072$7$F$20230101$20240909$20240202$20240916$EXP$$CA-GSK-CA2023AMR106168$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$CA$CA
234720822$23472082$2$F$20231201$20240913$20240202$20240917$EXP$$RU-ORGANON-O2402RUS000208$ORGANON$$13$YR$$M$Y$$$20240917$$MD$RU$RU
234721232$23472123$2$F$$20240126$20240202$20240930$EXP$$CA-BAUSCH-BL-2024-001700$BAUSCH AND LOMB$$86$YR$$F$Y$47.62$KG$20240930$$CN$CA$CA
234721265$23472126$5$F$20240105$20240716$20240202$20240722$EXP$$US-BAUSCH-BL-2024-001449$BAUSCH AND LOMB$$59$YR$$F$Y$$$20240719$$MD$US$US
234721455$23472145$5$F$$20240730$20240202$20240806$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000191$BLUEPRINT MEDICINES$$$$$F$Y$$$20240807$$CN$US$US
234722122$23472212$2$F$20240130$20240801$20240202$20240805$PER$$US-AMGEN-USASP2024022202$AMGEN$$23$YR$A$M$Y$$$20240805$$CN$US$US
234722362$23472236$2$F$20200414$20240126$20240202$20240816$EXP$$AR-KYOWAKIRIN-2024KK001716$KYOWA$$$$$$Y$$$20240816$$HP$AR$AR
234722397$23472239$7$F$20210601$20240812$20240202$20240816$EXP$$CA-BAUSCH-BL-2021-021735$BAUSCH AND LOMB$$50$YR$$F$Y$$$20240816$$CN$CA$CA
234722447$23472244$7$F$$20240723$20240202$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017003$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240725$$CN$US$US
234722665$23472266$5$F$$20240624$20240202$20240701$PER$$US-AMGEN-USASP2024022547$AMGEN$$84$YR$E$F$Y$69.388$KG$20240701$$MD$US$US
234722713$23472271$3$F$$20240913$20240202$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017381$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$68.95$KG$20240917$$CN$US$US
234723302$23472330$2$F$$20240123$20240202$20240725$EXP$$NL-TEVA-VS-3151189$TEVA$$18$YR$$F$Y$$$20240725$$HP$NL$NL
2347233110$23472331$10$F$20230822$20240906$20240202$20240923$EXP$$AR-SA-2024SA033800$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240923$$HP$AR$AR
234723524$23472352$4$F$20240122$20240808$20240202$20240813$PER$$US-SA-2024SA036137$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240814$$MD$US$US
234723623$23472362$3$F$$20240730$20240202$20240807$EXP$$US-MALLINCKRODT-MNK202400008$MALLINCKRODT$$$$$M$Y$$$20240807$$HP$US$US
234723875$23472387$5$F$$20240903$20240202$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016444$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240904$$HP$US$US
234723882$23472388$2$F$$20240827$20240202$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017657$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240830$$CN$US$US
234724013$23472401$3$F$20240101$20240726$20240202$20240802$EXP$$JP-009507513-2401JPN006729J$MERCK$$7$DEC$$M$Y$$$20240802$$MD$JP$JP
234724064$23472406$4$F$20201203$20240702$20240202$20240709$EXP$$MX-AstraZeneca-2024A026702$ASTRAZENECA$$77$YR$$F$Y$71$KG$20240709$$MD$MX$
234724133$23472413$3$F$$20240719$20240202$20240726$EXP$$NVSC2024AU020782$NOVARTIS$$$$$F$Y$75$KG$20240726$$MD$AU$AU
234725043$23472504$3$F$$20240813$20240202$20240913$EXP$$US-SUNOVION-2024SUN000074$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
234725185$23472518$5$F$$20240528$20240202$20240723$PER$$US-LUNDBECK-DKLU3072707$LUNDBECK$$$$$$Y$$$20240723$$CN$US$US
234725324$23472532$4$F$20230125$20240814$20240202$20240816$EXP$$CA-PFIZER INC-202400027792$PFIZER$$72$YR$$F$Y$$$20240816$$MD$CA$CA
234725423$23472542$3$F$$20240712$20240202$20240712$PER$$US-ALXN-202401USA001770US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
234725612$23472561$2$F$$20240814$20240202$20240816$PER$$NVSC2024US023708$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
234726365$23472636$5$F$20240112$20240628$20240202$20240704$EXP$$DE-009507513-2401DEU016671$MERCK$$48$YR$$M$Y$72$KG$20240704$$MD$DE$DE
234726533$23472653$3$F$20211201$20240627$20240202$20240705$EXP$$JP-009507513-2401JPN005175J$MERCK$Kobayashi Y, Yamane M, Suzuki T, Nakamura Y, Yasuda, S, Anabuki K, et al.. A Case of Radiation-induced Brain Necrosis That Was Difficult to Distinguish from Brain Metastasis. Japanese Journal of Lung Cancer. 2023;63(7):965-70$50$YR$$M$Y$63.4$KG$20240705$$MD$JP$JP
234726547$23472654$7$F$$20240802$20240202$20240807$EXP$$NVSC2024US000692$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
234726694$23472669$4$F$20231201$20240808$20240202$20240815$EXP$$US-ABBVIE-5612655$ABBVIE$$83$YR$$F$Y$81$KG$20240815$$CN$US$US
234726793$23472679$3$F$20231201$20240823$20240202$20240902$EXP$$DE-JNJFOC-20240168883$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240902$$MD$DE$DE
234727445$23472744$5$F$20230816$20240628$20240202$20240705$EXP$$US-ABBVIE-5617831$ABBVIE$$71$YR$$F$Y$$$20240705$$CN$US$US
234727703$23472770$3$F$20240117$20240809$20240202$20240812$PER$$US-AMGEN-USASP2024018851$AMGEN$$88$YR$E$F$Y$$$20240812$$CN$US$US
234727782$23472778$2$F$$20240129$20240202$20240721$EXP$$AU-TEVA-VS-3151624$TEVA$$58$YR$$M$Y$$$20240721$$HP$AU$AU
234728582$23472858$2$F$$20240723$20240203$20240729$EXP$$US-SA-2024SA036603$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$MD$US$US
2347287610$23472876$10$F$20210111$20240711$20240203$20240722$PER$$US-HORIZON THERAPEUTICS-HZN-2023-010297$AMGEN$$74$YR$E$F$Y$$$20240722$$LW$US$US
234729484$23472948$4$F$20240125$20240726$20240203$20240731$EXP$$US-ABBVIE-5612361$ABBVIE$$72$YR$$M$Y$$$20240731$$CN$US$US
234729913$23472991$3$F$20220301$20240719$20240203$20240723$EXP$$FR-ABBVIE-4276255$ABBVIE$$$$E$F$Y$57$KG$20240723$$MD$FR$FR
234729932$23472993$2$F$20231108$20240124$20240203$20240911$EXP$FR-AFSSAPS-AN2023001515$FR-TEVA-VS-3150995$TEVA$$37$YR$$F$Y$46$KG$20240911$$PH$FR$FR
234730472$23473047$2$F$$20240707$20240203$20240712$EXP$$IT-ABBVIE-5619402$ABBVIE$Cencini E, Fabbri A, Dragomir A, Franceschini M, Calomino N, Bocchia M. Long-term survival of patients with Mantle Cell Lymphoma. A Single-Center, Retrospective, 15-Year Real-Life Experience. Haematologica. 2024;109(s1):104-105.; Cencini E, Calomino N, Franceschini M, Dragomir A, Fredducci S, Esposito Vangone B, et al. Survival outcomes of patients with mantle cell lymphoma: a retrospective, 15-year, real-life study. Hematology Reports. 2024;16(1):50-62.$$$$$Y$$$20240712$$HP$IT$IT
234730494$23473049$4$F$20240101$20240913$20240203$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-002622$UNITED THERAPEUTICS$$78$YR$$M$Y$70.295$KG$20240920$$$US$US
234730565$23473056$5$F$20231201$20240711$20240203$20240715$PER$$US-AMGEN-USASP2024022009$AMGEN$$77$YR$E$M$Y$196$KG$20240715$$CN$US$US
234731312$23473131$2$F$20240715$20240715$20240203$20240723$PER$$US-SA-2024SA035875$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240723$$CN$US$US
234731592$23473159$2$F$$20240808$20240203$20240817$PER$$US-SA-2024SA020896$SANOFI AVENTIS$$48$YR$A$M$Y$124.73$KG$20240817$$MD$US$US
234732322$23473232$2$F$20240129$20240719$20240203$20240724$PER$$US-AMGEN-USASP2024020949$AMGEN$$64$YR$A$M$Y$$$20240724$$CN$US$US
234733652$23473365$2$F$$20240723$20240203$20240802$EXP$$CA-AUROBINDO-AUR-APL-2023-035541$AUROBINDO$Vijayashankar SS, Sanatani G, Franciosi S, Moodley S, Ting JY. Left ventricular dysfunction in the immediate post-natal period.. Transl-Pediatr. 2023;12(1):13-19$25$YR$$F$Y$$$20240802$$HP$CA$CA
234733923$23473392$3$F$20240101$20240808$20240203$20240821$PER$$US-SA-2024SA036286$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240821$$MD$US$US
234734314$23473431$4$F$20231119$20240708$20240203$20240710$EXP$$CA-TAKEDA-2023TUS113047$TAKEDA$$39$YR$$F$Y$$$20240710$$CN$CA$CA
234734642$23473464$2$F$$20240703$20240203$20240708$EXP$$JP-AMGEN-JPNSP2024020166$AMGEN$$$$$$Y$$$20240708$$MD$JP$JP
234734723$23473472$3$F$20190527$20240911$20240203$20240918$EXP$$FR-Ipsen Biopharmaceuticals, Inc.-2023-21299$IPSEN$$10$YR$C$F$Y$24.45$KG$20240918$$MD$FR$FR
234735822$23473582$2$F$20230601$20240816$20240203$20240826$EXP$$FR-Ipsen Biopharmaceuticals, Inc.-2024-01401$IPSEN$$52$YR$A$F$Y$51$KG$20240826$$MD$FR$FR
234736544$23473654$4$F$20240625$20240802$20240203$20240806$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-104903$DAIICHI$$22$YR$$M$Y$$$20240806$$MD$US$US
234737305$23473730$5$F$20221025$20240924$20240203$20240927$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-30808$IPSEN$$69$YR$E$F$Y$$$20240927$$MD$CA$CA
234737614$23473761$4$F$20240124$20240725$20240203$20240807$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-01411$IPSEN$$19$YR$A$F$Y$65.29$KG$20240807$$CN$US$US
234737923$23473792$3$F$20230908$20240914$20240203$20240927$EXP$$FR-JNJFOC-20231235071$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240927$$HP$FR$FR
234738047$23473804$7$F$20240101$20240521$20240203$20240710$EXP$$US-UCBSA-2024004568$UCB$$$$$M$Y$60.6$KG$20240710$$MD$US$US
234738642$23473864$2$F$20240201$20240730$20240203$20240801$PER$$US-AMGEN-USASP2024023719$AMGEN$$72$YR$E$F$Y$$$20240801$$CN$US$US
234738852$23473885$2$F$20240128$20240722$20240203$20240724$PER$$US-AMGEN-USASP2024023218$AMGEN$$55$YR$A$M$Y$$$20240724$$CN$US$US
234739132$23473913$2$F$20240130$20240723$20240203$20240726$PER$$US-AMGEN-USASP2024022169$AMGEN$$86$YR$E$F$Y$$$20240726$$CN$US$US
234739582$23473958$2$F$20221001$20240718$20240203$20240723$EXP$$US-ABBVIE-5614080$ABBVIE$$76$YR$$F$Y$$$20240723$$CN$US$US
234739663$23473966$3$F$20230719$20240808$20240203$20240813$EXP$$DE-ROCHE-3398185$ROCHE$$30$YR$A$F$Y$48$KG$20240813$$MD$DE$DE
234740515$23474051$5$F$20240124$20240725$20240204$20240731$30DAY$$US-AMGEN-USASP2024017243$AMGEN$$87$YR$E$M$Y$$$20240731$$PH$US$US
234741132$23474113$2$F$20240131$20240716$20240204$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017305$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240718$$CN$US$US
234761132$23476113$2$F$20230301$20240715$20240204$20240723$EXP$$BR-EXELIXIS-CABO-23061890$EXELIXIS$$20$YR$$F$Y$$$20240723$$HP$BR$BR
234772972$23477297$2$F$20230825$20240823$20240204$20240902$EXP$$GB-EXELIXIS-CABO-23067086$EXELIXIS$$19$YR$$M$Y$70.7$KG$20240902$$MD$GB$GB
234776433$23477643$3$F$$20240731$20240204$20240808$EXP$$AU-TAKEDA-2024TUS007852$TAKEDA$$68$YR$$M$Y$$$20240808$$CN$AU$AU
234779978$23477997$8$F$20210814$20240913$20240204$20240917$EXP$$JP-TAKEDA-2024TJP001874$TAKEDA$$12$YR$$M$Y$29.9$KG$20240917$$MD$JP$JP
234780313$23478031$3$F$$20240208$20240204$20240717$PER$$NVSC2024US023717$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
234780542$23478054$2$F$$20240625$20240204$20240702$EXP$US-MLMSERVICE-20230825-4506372-1$US-STRIDES ARCOLAB LIMITED-2023SP014062$STRIDES$Alsakha A, Marraffa JM.. Ifosfamide neurotoxicity treated with methylene blue complicated by serotonin toxicity.. Clinical Toxicology. 2023;61(Supplement1):106-107 abstr. 223$$$$$Y$$$20240702$$MD$US$US
234780632$23478063$2$F$20240127$20240727$20240204$20240730$PER$$US-AMGEN-USASP2024022855$AMGEN$$68$YR$E$M$Y$$$20240730$$CN$US$US
234780652$23478065$2$F$20240112$20240729$20240204$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202401018177$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240801$$CN$US$US
234788553$23478855$3$F$$20240909$20240205$20240918$EXP$$TW-EXELIXIS-CABO-23068316$EXELIXIS$$$$$M$Y$$$20240918$$CN$TW$TW
234788682$23478868$2$F$$20240708$20240205$20240711$EXP$$US-UCBSA-2024005554$UCB$$$$$M$Y$$$20240711$$CN$US$US
234789942$23478994$2$F$20231215$20240720$20240205$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-004158$AUROBINDO$$27$YR$$F$Y$65$KG$20240731$$MD$FR$FR
234789975$23478997$5$F$$20240628$20240205$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015533$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240705$$CN$US$US
234790027$23479002$7$F$20240105$20240624$20240205$20240704$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000128$ACADIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240704$$CN$US$US
234790042$23479004$2$F$$20240904$20240205$20240909$EXP$$CA-PFIZER INC-202400031020$PFIZER$$$$$F$Y$$$20240909$$CN$CA$CA
234790152$23479015$2$F$$20240729$20240205$20240812$EXP$$BR-AUROBINDO-AUR-APL-2024-005309$AUROBINDO$$80$YR$$F$Y$$$20240812$$MD$BR$BR
234790682$23479068$2$F$$20240806$20240205$20240808$EXP$$GR-ROCHE-3502124$ROCHE$$$$$F$Y$$$20240808$$MD$GR$GR
234790853$23479085$3$F$$20240611$20240205$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000114$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240707$$CN$US$US
234790973$23479097$3$F$20240127$20240914$20240205$20240924$EXP$$US-BEH-2024168123$CSL BEHRING$$30$YR$A$F$Y$$$20240924$$HP$US$US
234791134$23479113$4$F$20240112$20240624$20240205$20240702$EXP$$DE-AUROBINDO-AUR-APL-2024-004364$AUROBINDO$$48$YR$$M$Y$72$KG$20240702$$MD$DE$DE
234791153$23479115$3$F$20200625$20240828$20240205$20240906$EXP$$CA-CELLTRION INC.-2020CA023822$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
234791176$23479117$6$F$20240229$20240603$20240205$20240926$EXP$$US-GSK-US2024AMR013358$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
234791274$23479127$4$F$20240731$20240820$20240205$20240823$EXP$$NVSC2024US023394$NOVARTIS$$75$YR$$M$Y$$$20240823$$CN$US$US
234791385$23479138$5$F$20240101$20240628$20240205$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-014953$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240705$$MD$JP$JP
234791472$23479147$2$F$20240202$20240728$20240205$20240731$PER$$US-AMGEN-USASP2024024109$AMGEN$$57$YR$A$F$Y$$$20240731$$CN$US$US
234791653$23479165$3$F$20240105$20240624$20240205$20240702$30DAY$$US-JNJFOC-20240121990$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240702$$HP$US$US
234791752$23479175$2$F$20240106$20240828$20240205$20240905$PER$$US-JNJFOC-20240122681$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240905$$CN$US$US
234793162$23479316$2$F$20240128$20240719$20240205$20240725$PER$$US-AMGEN-USASP2024020244$AMGEN$$81$YR$E$F$Y$$$20240725$$CN$US$US
234793595$23479359$5$F$20240101$20240830$20240205$20240913$EXP$$US-UCBSA-2024001028$UCB$$$$$F$Y$47$KG$20240913$$HP$US$US
234793986$23479398$6$F$20231129$20240910$20240205$20240917$EXP$$CA-GSK-CA2023071119$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$CA$CA
234794042$23479404$2$F$20200131$20240626$20240205$20240703$EXP$$US-ABBVIE-5618582$ABBVIE$$76$YR$$F$Y$$$20240703$$CN$US$US
234794095$23479409$5$F$20230808$20240816$20240205$20240828$EXP$$ES-AUROBINDO-AUR-APL-2024-004221$AUROBINDO$$46$YR$$F$Y$$$20240828$$CN$ES$ES
234794633$23479463$3$F$20230601$20240808$20240205$20240822$PER$$US-TRAVERE-2024TVT00004$TRAVERE THERAPEUTICS$$57$YR$A$M$Y$$$20240822$$CN$US$US
234795404$23479540$4$F$20240803$20240814$20240205$20240819$EXP$$IL-TAKEDA-2024TUS009864$TAKEDA$$76$YR$$F$Y$$$20240819$$CN$IL$IL
234795513$23479551$3$F$20240513$20240809$20240205$20240816$EXP$$CA-GSK-CA2024013596$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$HP$CA$CA
234795595$23479559$5$F$$20240719$20240205$20240725$EXP$$US-TAKEDA-2024TUS009784$TAKEDA$$$$$M$Y$$$20240725$$MD$US$US
234795612$23479561$2$F$20240124$20240821$20240205$20240826$PER$$US-AMGEN-USASP2024020937$AMGEN$$76$YR$E$M$Y$$$20240825$$CN$US$US
234795715$23479571$5$F$20240101$20240709$20240205$20240718$EXP$$US-INTERCEPT-PM2024000170$INTERCEPT PHARMACEUTICALS$$71$YR$$F$Y$$$20240718$$CN$US$US
234796103$23479610$3$F$$20240812$20240205$20240820$30DAY$$CN-JNJFOC-20240143661$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$CN$CN
234796922$23479692$2$F$$20240723$20240205$20240802$EXP$$CA-AUROBINDO-AUR-APL-2023-035537$AUROBINDO$Vijayashankar SS, Sanatani G, Franciosi S, Moodley S, Ting JY.. Left ventricular dysfunction in the immediate post-natal period.. Transl-Pediatr. 2023;12(1):13-19$$$N$$Y$$$20240802$$HP$CA$CA
234797822$23479782$2$F$$20230606$20240205$20240701$PER$$US-UCBSA-2023028554$UCB$Harris S, Dupanloup A, Liao PT, Jukier T.. Case report: Recovery and sequential imaging of a patient with osmotic demyelination syndrome. Frontiers in Veterinary Science. 2023;10:-$4$YR$$M$Y$10.7$KG$20240701$$HP$US$US
234797873$23479787$3$F$20231228$20240822$20240205$20240828$EXP$$JP-009507513-2401JPN007738J$MERCK$$69$YR$$F$Y$$$20240828$$MD$JP$JP
234798364$23479836$4$F$20240201$20240806$20240205$20240811$EXP$$IE-TAKEDA-2024TUS008977$TAKEDA$$18$YR$$F$Y$$$20240811$$MD$IE$IE
234798402$23479840$2$F$$20230703$20240205$20240701$PER$$US-UCBSA-2023033848$UCB$Stulberg E, O^Connor P, Swartwood S.. High-Dose Levetiracetam: A Novel Post-Arrest Anti-Arrhythmic Medication?. Neurology. 2023;100(17):-$17$MON$$F$Y$$$20240701$$HP$US$US
234798513$23479851$3$F$20240116$20240716$20240205$20240722$EXP$$US-TAKEDA-2024TUS008784$TAKEDA$$16$YR$$M$Y$75$KG$20240722$$MD$US$US
234798525$23479852$5$F$20231001$20240722$20240205$20240802$EXP$$US-INSMED, INC.-2023-03407-US$INSMED$$84$YR$$F$Y$$$20240802$$CN$US$US
234798632$23479863$2$F$$20230814$20240205$20240701$PER$$US-UCBSA-2023040860$UCB$Calame DJ, Riaz M.. Pediatric craniocerebral firearm injuries: literature review, best practices in medical and surgical management, and case report. Child^s Nervous System. 2023;39(8):2195-9$2$YR$$F$Y$$$20240701$$HP$US$US
234798792$23479879$2$F$$20240729$20240205$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-004038$AUROBINDO$Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwari A.. OVERWHELMING CYTOCHROME P450 ISOENZYME ACTIVITY GENERATING DRUGINDUCED LIVER INJURY RESULTING IN FULMINANT LIVER FAILURE.. Hepatology. 2023;78(1):S643-4$41$YR$$F$Y$$$20240808$$MD$US$US
234798807$23479880$7$F$20230724$20240812$20240205$20240820$EXP$$CA-GSK-CA2023AMR102122$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$HP$CA$CA
234799062$23479906$2$F$$20230823$20240205$20240701$PER$$US-UCBSA-2023011818$UCB$Morgan RD, Chintagunta A, Vojtkofsky NA, Psaromatis KM, Baronia B, Belirgen M. Seizure Caused by Intraparenchymal Hemorrhage from Migration of Mandibular Dental Wire through Foramen Ovale in a Child: A Case Report. J Neurol Surg B Skull Base. 2023;84(S 01):S1-S344$12$YR$$M$Y$$$20240701$$MD$US$US
234799282$23479928$2$F$$20231002$20240205$20240701$PER$$US-UCBSA-2023047975$UCB$Akhlaq H, Zolezi S, Farhat F, Patel P, Kozlik A, Abu Homoud A, et al.. Covid-19 prophylaxis gone terribly wrong: case of ivermectin toxicity. Chest. 2023;164(4):A2340-1$34$YR$$M$Y$$$20240701$$HP$US$US
234799462$23479946$2$F$$20231003$20240205$20240701$PER$$US-UCBSA-2023048472$UCB$M?laga I, Avila A, Primeaux S, Park JY, Pascual JM. A concise study of acetazolamide in glucose transporter type 1 deficiency (G1D) epilepsy. Epilepsia. 2023;64(9):e184-9$25$YR$$F$Y$$$20240701$$HP$US$US
234799542$23479954$2$F$$20231009$20240205$20240701$PER$$US-UCBSA-2023048866$UCB$Osbourn SR, Ryan KE, Cannard KR, Ma Y.. A case of new onset refractory status epilepticus in a U.S. traveler with Japanese encephalitis. Journal of Neuroimmunology. 2023;383:1-4$37$YR$$F$Y$$$20240701$$HP$US$US
234799762$23479976$2$F$$20231106$20240205$20240701$PER$$US-UCBSA-2023053047$UCB$Ta J, Kang J, Jean Losso M, Crudele A, Singh P, Akkineni K. Late-use ketamine for transition from burst suppression in the treatment of SRSE. Journal of Clinical Neurophysiology. 2023;40(6):e71-2$62$YR$$M$Y$$$20240701$$MD$US$US
234799912$23479991$2$F$$20231016$20240205$20240701$PER$$US-UCBSA-2023049822$UCB$Bhave VM, Bernstock JD, Carlson JM, Kappel AD, Torio EF, Chen JA, et al. Surgical Management in Herpes Simplex Encephalitis: Illustrative Case Report and Systematic Review of the Literature. Neurosurgery. 2023;92(5):915-33$52$YR$$F$Y$$$20240701$$HP$US$US
234799922$23479992$2$F$$20231024$20240205$20240701$PER$$US-UCBSA-2023051255$UCB$Lynch M, Nedjat-Haiem M, Abeson K, Chang C. Limbic Encephalitis Associated with Human Herpesvirus-7 Infection in an Immunocompetent Adolescent. Child Neurology Open. 2023;10:1-5$17$YR$$M$Y$$$20240701$$MD$US$US
234800132$23480013$2$F$$20231120$20240205$20240701$PER$$US-UCBSA-2023048969$UCB$Haque T, Ravi S, Khan N, Brar JS. S.L.U.D.G.E.: A case of organophosphate toxicity. Chest. 2023;164(4):A2133-4$38$YR$$M$Y$$$20240701$$HP$US$US
234800182$23480018$2$F$$20231120$20240205$20240701$PER$$US-UCBSA-2023055243$UCB$Sari E, Batch JT, Sultan S. An Underrecognized Entity: Hypercalcemia Induced PRES. Journal of the Endocrine Society. 2022;6(supplement 1):A148-9$59$YR$$F$Y$$$20240701$$MD$US$US
234800402$23480040$2$F$20230101$20240710$20240205$20240712$EXP$$US-UCBSA-2024003891$UCB$$$$$F$Y$117.8$KG$20240712$$HP$US$US
234801054$23480105$4$F$$20240826$20240205$20240827$EXP$$US-TAKEDA-2024TUS008957$TAKEDA$$$$$F$Y$$$20240827$$HP$US$US
234801173$23480117$3$F$$20240807$20240205$20240809$EXP$$GR-ROCHE-3502359$ROCHE$$$$$F$Y$$$20240809$$MD$GR$GR
234801352$23480135$2$F$$20240924$20240205$20240926$EXP$$CA-TAKEDA-2020TUS016730$TAKEDA$$$$$F$Y$$$20240926$$CN$CA$CA
234801902$23480190$2$F$$20240920$20240205$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-017486$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240930$$PH$JP$JP
234802403$23480240$3$F$20211022$20240919$20240205$20240926$EXP$$JP-ABBVIE-5620900$ABBVIE$$72$YR$$M$Y$77.42$KG$20240926$$MD$JP$JP
234802692$23480269$2$F$20240111$20240809$20240205$20240816$EXP$$CA-GSK-CA2024013561$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$CA$CA
234802832$23480283$2$F$$20240809$20240205$20240814$EXP$$US-ALXN-202401USA002161US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240814$$HP$US$US
234804125$23480412$5$F$$20240701$20240205$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000161$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
234805423$23480542$3$F$20240101$20240619$20240205$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202401015484$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240701$$CN$US$US
234806272$23480627$2$F$20220901$20240724$20240205$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202402000606$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240726$$HP$US$US
234806502$23480650$2$F$$20240712$20240205$20240724$EXP$$CA-Accord-404166$ACCORD$Deng Y, Toy J, Wang JTF, Liu C. Ultraviolet recall phenomenon secondary to chemotherapy for metastatic rectal cancer. BMJ Case Reports. 2024;17(1):e257317.$5$DEC$A$F$Y$$$20240724$$MD$CA$CA
234806612$23480661$2$F$20231101$20240123$20240205$20240730$EXP$$BR-TEVA-VS-3149719$TEVA$$34$YR$$M$Y$$$20240730$$CN$BR$BR
234806802$23480680$2$F$$20240717$20240205$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-00601$LUPIN$$$$$$Y$$$20240821$$PH$US$US
234807102$23480710$2$F$$20240717$20240205$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-00602$LUPIN$$$$$$Y$$$20240821$$PH$US$US
234807222$23480722$2$F$20240111$20240129$20240205$20240820$EXP$$NVSC2024IT007724$NOVARTIS$$71$YR$$F$Y$$$20240820$$MD$IT$IT
234807832$23480783$2$F$$20240717$20240205$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-00605$LUPIN$$$$$$Y$$$20240825$$PH$US$US
234809002$23480900$2$F$$20240717$20240205$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-00619$LUPIN$$$$$$Y$$$20240819$$PH$US$US
234809092$23480909$2$F$20230101$20240716$20240205$20240722$EXP$$US-862174955-ML2023-06061$Unknown Manufacturer$$$$$M$Y$$$20240722$$LW$US$US
2348091114$23480911$14$F$$20240715$20240205$20240721$EXP$GB-SANDOZ-SDZ2023GB050268$GB-RDY-SPO/GBR/24/0001638$DR REDDYS$$38$YR$A$M$Y$104$KG$20240721$$HP$GB$GB
234809362$23480936$2$F$$20240717$20240205$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-00620$LUPIN$$$$$$Y$$$20240829$$PH$US$US
234809904$23480990$4$F$$20240911$20240205$20240917$EXP$$US-CHATTEMPRD-2024OHG003168$CHATTEM$$72$YR$E$M$Y$69.04$KG$20240917$$LW$US$US
234809994$23480999$4$F$$20240917$20240205$20240924$EXP$$CA-GSK-CA2024013571$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$CA$CA
234810052$23481005$2$F$20221013$20240816$20240205$20240821$EXP$$CA-TAKEDA-2024TUS009458$TAKEDA$$57$YR$$F$Y$$$20240821$$MD$CA$CA
234810162$23481016$2$F$$20240717$20240205$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-00622$LUPIN$$$$$$Y$$$20240826$$PH$US$US
234810682$23481068$2$F$20231201$20240711$20240205$20240717$EXP$$CO-ASTELLAS-2024US003299$ASTELLAS$$36$YR$$F$Y$$$20240717$$CN$CO$CO
234810803$23481080$3$F$$20240730$20240205$20240802$EXP$$US-ABBVIE-5621560$ABBVIE$$$$$M$Y$86$KG$20240802$$CN$US$US
234810872$23481087$2$F$20240125$20240903$20240205$20240911$EXP$$CA-CELLTRION INC.-2024CA002580$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
234811903$23481190$3$F$$20240807$20240205$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017726$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240808$$CN$US$US
234812512$23481251$2$F$$20240127$20240205$20240812$EXP$$AR-SANDOZ INC.-SDZ2024AR011363$SANDOZ$$$$$F$Y$$$20240812$$CN$AR$AR
234812973$23481297$3$F$20240102$20240702$20240205$20240703$EXP$$RO-JNJFOC-20240129401$JOHNSON AND JOHNSON$$68$YR$E$M$Y$90$KG$20240703$$MD$RO$RO
234813023$23481302$3$F$20231101$20240715$20240205$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016361$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240716$$CN$US$US
234813734$23481373$4$F$$20240812$20240205$20240817$PER$$US-AMGEN-USASP2024023039$AMGEN$$79$YR$E$F$Y$$$20240817$$MD$US$US
234813742$23481374$2$F$$20240722$20240205$20240729$EXP$$DE-MYLANLABS-2024M1009597$MYLAN$$10$YR$$F$Y$$$20240729$$MD$DE$DE
234813823$23481382$3$F$$20240801$20240205$20240806$EXP$$GB-MYLANLABS-2024M1009582$MYLAN$$59$YR$$F$Y$$$20240806$$HP$GB$GB
234814152$23481415$2$F$$20240730$20240205$20240801$PER$$US-AMGEN-USASP2024023804$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
234814415$23481441$5$F$$20240715$20240205$20240725$EXP$$GB-BAXTER-2024BAX010373$BAXTER$$$$$F$Y$$$20240725$$PH$GB$GB
234814534$23481453$4$F$20230701$20240812$20240205$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002045$JAZZ$$30$YR$$F$Y$$$20240819$$MD$US$US
234814603$23481460$3$F$$20240904$20240205$20240912$EXP$$JP-009507513-2401JPN006773J$MERCK$$62$YR$$M$Y$$$20240912$$MD$JP$JP
234814663$23481466$3$F$20231026$20240725$20240205$20240801$EXP$$NVSC2023GB226579$NOVARTIS$$$$$F$Y$$$20240801$$CN$GB$GB
234814672$23481467$2$F$20240122$20240710$20240205$20240717$EXP$$CN-BAYER-2024A019348$BAYER$$70$YR$E$M$Y$$$20240717$$MD$CN$CN
234814693$23481469$3$F$$20240228$20240205$20240912$EXP$$NVSC2024CA022619$NOVARTIS$$60$YR$$F$Y$$$20240912$$HP$CA$CA
234814812$23481481$2$F$20220712$20240808$20240205$20240812$EXP$$US-SANDOZ INC.-NVSC2022US009411$SANDOZ$$46$YR$$F$Y$74.83$KG$20240812$$CN$US$US
234815182$23481518$2$F$20240127$20240702$20240205$20240709$EXP$$US-MYLANLABS-2024M1009924$MYLAN$$61$YR$$M$Y$$$20240709$$HP$US$US
234816273$23481627$3$F$20230901$20240809$20240205$20240816$EXP$$JP-009507513-2309JPN003535J$MERCK$$6$DEC$$F$Y$$$20240816$$MD$JP$JP
234816385$23481638$5$F$20240127$20240705$20240205$20240712$EXP$$JP-GENMAB-2024-00251$GENMAB$$56$YR$$F$Y$51$KG$20240712$$PH$JP$JP
234816493$23481649$3$F$$20240818$20240205$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-018562$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$96.16$KG$20240820$$CN$US$US
234816543$23481654$3$F$$20240724$20240205$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017663$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240724$$CN$US$US
234816853$23481685$3$F$20231201$20240917$20240205$20240925$EXP$$JP-Eisai-EC-2024-158585$EISAI$$68$YR$E$M$Y$$$20240925$$MD$JP$JP
234817046$23481704$6$F$20230913$20240903$20240205$20240914$EXP$$SK-ROCHE-3497989$ROCHE$$62$YR$A$F$Y$52$KG$20240914$$MD$SK$SK
234817077$23481707$7$F$20240701$20240808$20240205$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017355$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240813$$CN$US$US
234817433$23481743$3$F$$20240212$20240205$20240909$EXP$$US-TEVA-VS-3149277$TEVA$Eid F, Takla A, Eid MM, Najim M, Mostafa MR. SUCCESSFUL MANAGEMENT OF SEVERE BUPROPION TOXICITY WITH LIPID EMULSION THERAPY: A COMPLEX CASE REPORT AND LITERATURE REVIEW. Eur-J-Case-Rep-Intern-Med 2023; 10 (12).; Eid F, Takla A, Eid MM, Najim M, Mostafa MR. SUCCESSFUL MANAGEMENT OF SEVERE BUPROPION TOXICITY WITH LIPID EMULSION THERAPY: A COMPLEX CASE REPORT AND LITERATURE REVIEW. Eur-J-Case-Rep-Intern-Med 2023; 10 (12):.; Eid F, Takla A, Eid MM, Najim M, Mostafa MR. SUCCESSFUL MANAGEMENT OF SE...$53$YR$$F$Y$$$20240909$$HP$US$US
234817682$23481768$2$F$20220101$20240719$20240205$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016216$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240729$$CN$US$US
234818004$23481800$4$F$20240101$20240903$20240205$20240910$PER$$US-VERTEX PHARMACEUTICALS-2024-001484$VERTEX$$$$$F$Y$$$20240910$$CN$US$US
234819213$23481921$3$F$20240201$20240727$20240205$20240731$PER$$US-AMGEN-USASP2024024400$AMGEN$$79$YR$E$M$Y$$$20240731$$CN$US$US
234819484$23481948$4$F$20221218$20240625$20240205$20240701$EXP$DE-BAXTER-2023BAX025246$DE-RDY-SPO/GER/23/0181063$DR REDDYS$$72$YR$E$M$Y$65$KG$20240701$$MD$DE$DE
234819583$23481958$3$F$20240126$20240919$20240205$20240923$EXP$$GB-MYLANLABS-2024M1011384$MYLAN$$34$YR$$M$Y$$$20240923$$MD$GB$GB
234820675$23482067$5$F$20240128$20240918$20240205$20240926$EXP$$NVSC2024US011720$NOVARTIS$$37$YR$$F$Y$$$20240926$$CN$US$US
234821393$23482139$3$F$20220201$20240718$20240205$20240720$EXP$$NVSC2022GB037766$NOVARTIS$$41$YR$$F$Y$$$20240720$$CN$GB$GB
234821415$23482141$5$F$$20240807$20240205$20240821$EXP$E2B_05173074$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000042$ASSERTIO THERAPEUTICS$$44$YR$$F$Y$70$KG$20240821$$HP$CA$CA
234822438$23482243$8$F$20240403$20240903$20240205$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002027$JAZZ$$61$YR$$M$Y$$$20240906$$CN$US$US
234823182$23482318$2$F$20240101$20240828$20240205$20240902$EXP$$US-PFIZER INC-PV202400015894$PFIZER$$81$YR$$F$Y$$$20240902$$HP$US$US
234823313$23482331$3$F$$20240828$20240205$20240831$EXP$$US-ROCHE-3501531$ROCHE$$81$YR$E$F$Y$$$20240831$$CN$US$US
234823584$23482358$4$F$$20240807$20240205$20240812$PER$$US-BIOGEN-2024BI01247007$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
234823794$23482379$4$F$$20240730$20240205$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-018582$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240801$$HP$US$US
234823963$23482396$3$F$20200101$20240816$20240205$20240820$EXP$$US-PFIZER INC-PV202400015400$PFIZER$$67$YR$$F$Y$$$20240820$$HP$US$US
234824472$23482447$2$F$$20240910$20240205$20240916$PER$$US-AGIOS-2401US03629$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
234825545$23482554$5$F$$20240620$20240205$20240705$EXP$$IT-ROCHE-3501546$ROCHE$$49$YR$A$F$Y$50$KG$20240705$$MD$IT$IT
234825704$23482570$4$F$20220603$20240821$20240205$20240828$EXP$$CA-SANDOZ INC.-NVSC2021CA218588$SANDOZ$$56$YR$$F$Y$$$20240828$$CN$CA$CA
234826063$23482606$3$F$$20240729$20240205$20240801$EXP$$NVSC2024US020414$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
234827492$23482749$2$F$$20240619$20240205$20240715$PER$$US-INCYTE CORPORATION-2024IN000480$INCYTE$$$$$$Y$$$20240715$$CN$US$US
234827523$23482752$3$F$$20240816$20240205$20240820$EXP$$IN-SANDOZ INC.-SDZ2024IN011021$SANDOZ$$$$$F$Y$$$20240820$$CN$IN$IN
234827643$23482764$3$F$20240101$20240731$20240205$20240807$EXP$$CA-PFIZER INC-202300307869$PFIZER$$40$YR$$M$Y$$$20240807$$MD$CA$CA
2348277616$23482776$16$F$$20240808$20240205$20240813$EXP$$IN-PFIZER INC-PV202400015401$PFIZER$$49$YR$$M$Y$$$20240813$$CN$IN$IN
234828142$23482814$2$F$20231220$20240723$20240205$20240726$EXP$$NVSC2024US013476$NOVARTIS$$72$YR$$F$Y$$$20240726$$CN$US$US
234828902$23482890$2$F$$20240911$20240205$20240918$EXP$$NVSC2024US023940$NOVARTIS$$$$E$F$Y$$$20240918$$MD$US$US
234829075$23482907$5$F$20240417$20240812$20240205$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015822$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240814$$CN$US$US
234829532$23482953$2$F$20240131$20240627$20240205$20240701$PER$$US-AMGEN-USASP2024023164$AMGEN$$70$YR$E$F$Y$$$20240701$$CN$US$US
234829762$23482976$2$F$$20240129$20240205$20240919$EXP$$IT-SANDOZ INC.-SDZ2024IT010460$SANDOZ$Irelli A, Ceriello L, Patruno LV, Tessitore A, Alesse E, Cannita K et al. Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer. Biomedicines. 2024;12$56$YR$$F$Y$$$20240919$$HP$IT$IT
234830023$23483002$3$F$$20240814$20240205$20240820$EXP$$CA-OTSUKA-2024_002383$OTSUKA$$$$$F$Y$$$20240820$$CN$CA$CA
234830117$23483011$7$F$20230406$20240722$20240205$20240725$PER$$US-PFIZER INC-PV202300071032$PFIZER$$78$YR$$F$Y$$$20240725$$CN$US$US
234830342$23483034$2$F$$20240628$20240205$20240703$PER$$US-PFIZER INC-202300293564$PFIZER$$64$YR$$M$Y$$$20240703$$CN$US$US
234831493$23483149$3$F$$20240916$20240205$20240918$PER$$US-PFIZER INC-PV202400015481$PFIZER$$74$YR$$F$Y$$$20240918$$CN$US$US
234831745$23483174$5$F$20240101$20240722$20240205$20240726$EXP$$US-PFIZER INC-202400029928$PFIZER$$50$YR$$F$Y$61.224$KG$20240726$$CN$US$US
234831912$23483191$2$F$20240108$20240812$20240205$20240816$EXP$$NZ-MYLANLABS-2024M1002943$MYLAN$$64$YR$$M$Y$$$20240816$$CN$NZ$NZ
234832005$23483200$5$F$20240501$20240830$20240205$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-013761$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240905$$CN$US$US
234832064$23483206$4$F$$20240830$20240205$20240902$EXP$$CA-SANDOZ INC.-SDZ2023CA061684$SANDOZ$$61$YR$$F$Y$$$20240902$$HP$CA$CA
234833075$23483307$5$F$$20240726$20240205$20240730$EXP$$US-PFIZER INC-PV202200094254$PFIZER$$80$YR$$M$Y$$$20240730$$HP$US$US
234833254$23483325$4$F$20240101$20240826$20240205$20240829$EXP$$CA-PFIZER INC-202400032454$PFIZER$$65$YR$$M$Y$$$20240829$$HP$CA$CA
234833323$23483332$3$F$20230118$20240903$20240205$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-018621$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$63.82$KG$20240906$$PH$US$US
234833514$23483351$4$F$20231116$20240730$20240205$20240806$EXP$$US-OTSUKA-2023_032863$OTSUKA$$82$YR$$F$Y$$$20240806$$CN$US$US
234833602$23483360$2$F$20240130$20240627$20240205$20240701$PER$$US-AMGEN-USASP2024023801$AMGEN$$54$YR$A$M$Y$$$20240701$$CN$US$US
234833842$23483384$2$F$20240101$20240911$20240205$20240917$EXP$$FR-MYLANLABS-2024M1009990$MYLAN$$$$$M$Y$$$20240917$$CN$FR$FR
234833862$23483386$2$F$20230801$20240809$20240205$20240814$EXP$FR-AFSSAPS-TS2024000032$FR-ABBVIE-5617476$ABBVIE$$59$YR$$M$Y$89$KG$20240814$$MD$FR$FR
234835792$23483579$2$F$$20240702$20240205$20240708$PER$$US-PFIZER INC-202400031392$PFIZER$$66$YR$$M$Y$92.99$KG$20240708$$CN$US$US
234836304$23483630$4$F$20210301$20240701$20240205$20240703$PER$$US-PFIZER INC-PV202300172343$PFIZER$$81$YR$$F$Y$50.7$KG$20240703$$MD$US$US
234836333$23483633$3$F$$20240619$20240205$20240701$PER$$US-PFIZER INC-202400029929$PFIZER$$86$YR$$M$Y$72.562$KG$20240701$$CN$US$US
234836435$23483643$5$F$20240122$20240808$20240205$20240821$EXP$$US-BEH-2024168120$CSL BEHRING$$12$YR$T$F$Y$$$20240821$$HP$US$US
234836962$23483696$2$F$$20240705$20240205$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-010620$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240708$$CN$US$US
234837142$23483714$2$F$$20240806$20240205$20240808$EXP$$US-PFIZER INC-PV202400016351$PFIZER$$57$YR$$F$Y$$$20240808$$HP$US$US
234837462$23483746$2$F$$20240807$20240205$20240821$EXP$CANSP2015095516$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000043$ASSERTIO THERAPEUTICS$$43$YR$$F$Y$97$KG$20240821$$HP$CA$CA
234837792$23483779$2$F$$20240807$20240205$20240821$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000040$ASSERTIO THERAPEUTICS$$97$YR$$F$Y$$$20240821$$HP$CA$CA
234838083$23483808$3$F$20240104$20240627$20240205$20240704$EXP$$JP-009507513-2401JPN007282J$MERCK$$7$DEC$$M$Y$$$20240704$$MD$JP$JP
234838282$23483828$2$F$$20240701$20240205$20240704$EXP$$NVSJ2024JP001728$NOVARTIS$$$$$$Y$$$20240704$$PH$JP$JP
234838322$23483832$2$F$20240124$20240820$20240205$20240823$PER$$US-AMGEN-USASP2024022961$AMGEN$$61$YR$A$F$Y$$$20240823$$CN$US$US
234838514$23483851$4$F$20230911$20240917$20240205$20240925$PER$$US-BIOGEN-2024BI01243335$BIOGEN$$24$YR$$F$Y$$$20240925$$CN$US$US
234838727$23483872$7$F$20220101$20240717$20240205$20240722$EXP$$US-JNJFOC-20240172637$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240722$$CN$US$US
234839072$23483907$2$F$20231210$20240719$20240205$20240724$EXP$$US-BIOGEN-2024BI01247471$BIOGEN$$62$YR$$F$Y$$$20240724$$CN$US$US
234839204$23483920$4$F$20240101$20240826$20240205$20240902$EXP$$JP-GENMAB-2024-00277$GENMAB$$80$YR$$F$Y$42$KG$20240902$$MD$JP$JP
234839532$23483953$2$F$20240127$20240912$20240205$20240918$EXP$$US-ABBVIE-5615045$ABBVIE$$25$YR$$F$Y$$$20240918$$CN$US$US
234839582$23483958$2$F$20240201$20240731$20240205$20240802$EXP$$JP-009507513-2402JPN000032J$MERCK$$73$YR$$M$Y$$$20240802$$PH$JP$JP
234839633$23483963$3$F$20231123$20240702$20240205$20240711$EXP$$IT-CELLTRION INC.-2024IT002465$CELLTRION$$$$$$Y$$$20240711$$MD$IT$IT
234839883$23483988$3$F$20240101$20240909$20240205$20240912$EXP$$US-ABBVIE-5618337$ABBVIE$$$$$M$Y$136$KG$20240912$$CN$PR$PR
234840082$23484008$2$F$20231228$20240905$20240205$20240911$EXP$$DE-ABBVIE-5618628$ABBVIE$$30$YR$$M$Y$172$KG$20240911$$MD$DE$DE
234840142$23484014$2$F$$20240724$20240205$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-005412$AUROBINDO$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer Induced Gastrointestinal Disease in 12 Patients with End Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15:No:3$42$YR$$F$Y$$$20240805$$MD$US$US
234840435$23484043$5$F$$20240809$20240205$20240813$EXP$$US-TAKEDA-2024TUS009913$TAKEDA$$$$$F$Y$$$20240813$$CN$US$US
2348405911$23484059$11$F$20240101$20240627$20240205$20240702$EXP$$PT-ABBVIE-5615715$ABBVIE$$73$YR$$M$Y$$$20240702$$CN$PT$PT
234840623$23484062$3$F$$20240627$20240205$20240703$EXP$$JP-009507513-2401JPN006801J$MERCK$Mizuno T, Sakakibara N, Kato T, Hikasa H, Miura K, Suzuka M, et al.. 2O-D13-1 Experiences with Pembrolizumab for Recurrent and Metastatic Oral Cancers in Our Department. The 42nd Annual meeting of Japanese Society of Oral Oncology. 2024;226$75$YR$$M$Y$$$20240703$$MD$JP$JP
234841322$23484132$2$F$$20240730$20240206$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-018241$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240801$$HP$US$US
234841522$23484152$2$F$$20240627$20240206$20240711$EXP$$CA-RDY-CLI/CAN/24/0001989$DR REDDYS$$68$YR$E$M$Y$$$20240711$$HP$CA$CA
234842372$23484237$2$F$$20240806$20240206$20240810$EXP$$US-ABBVIE-5617984$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
234842803$23484280$3$F$20210101$20240911$20240206$20240916$EXP$$CA-PFIZER INC-202400032102$PFIZER$$58$YR$$F$Y$$$20240916$$MD$CA$CA
234842814$23484281$4$F$20240131$20240924$20240206$20240927$EXP$$CA-PFIZER INC-202400031560$PFIZER$$28$YR$$F$Y$$$20240927$$HP$CA$CA
234843105$23484310$5$F$$20240305$20240206$20240703$EXP$$US-009507513-2402USA000382$MERCK$$$$$F$Y$$$20240703$$HP$US$US
234843202$23484320$2$F$$20240920$20240206$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-004614$AUROBINDO$$73$YR$$F$Y$45$KG$20240930$$MD$CA$CA
234843353$23484335$3$F$$20240828$20240206$20240830$EXP$$GB-SANDOZ INC.-NVSC2020GB020068$SANDOZ$$$$$F$Y$$$20240830$$CN$GB$GB
234843692$23484369$2$F$$20240719$20240206$20240729$EXP$$AU-SANDOZ INC.-SDZ2024AU011321$SANDOZ$$$$$F$Y$75$KG$20240729$$MD$AU$AU
234844132$23484413$2$F$20231101$20240709$20240206$20240715$EXP$$MX-JNJFOC-20240212143$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240715$$MD$MX$MX
234844895$23484489$5$F$$20240827$20240206$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000294$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
234845404$23484540$4$F$20240101$20240905$20240206$20240913$EXP$$CA-CELLTRION INC.-2024CA002676$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
234845892$23484589$2$F$$20240724$20240206$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-005409$AUROBINDO$Todd. J.,Saboori. S., Zeidan. J., Ahren. W., Jacobs. C., Moshiree.B.. Sevelamer Induced Gastrointestinal Disease in 12 Patients with End Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15No. 3$55$YR$$F$Y$$$20240805$$MD$US$US
234845982$23484598$2$F$$20240823$20240206$20240829$EXP$$CA-ROCHE-3501344$ROCHE$$74$YR$E$F$Y$$$20240829$$HP$CA$CA
234846514$23484651$4$F$20220322$20240730$20240206$20240805$EXP$$JP-009507513-2401JPN007308J$MERCK$Aoki T, Furuya R, Fukasawa M, Nozawa M, Takihana Y, Nakagomi H, et al.. Case Report Bladder cancer with urinary diversion by a sigmoid colon conduit after transverse colon stoma. IJU Case Reports. 2024;7(1):46-9$70$YR$$M$Y$$$20240805$$MD$JP$JP
234846542$23484654$2$F$20240101$20240730$20240206$20240803$PER$$US-AMGEN-USASP2024021269$AMGEN$$59$YR$A$F$Y$$$20240803$$CN$US$US
234846945$23484694$5$F$20221201$20240809$20240206$20240823$EXP$$US-UCBSA-2023003397$UCB$$39$YR$$F$Y$$$20240823$$CN$US$US
234847007$23484700$7$F$20210513$20240918$20240206$20240923$EXP$$KR-AMGEN-USASP2024017934$AMGEN$$79$YR$E$M$Y$53$KG$20240923$$MD$KR$KR
234847504$23484750$4$F$20231108$20240624$20240206$20240805$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000455$Unknown Manufacturer$$$$$$Y$$$20240805$$PH$US$US
234847574$23484757$4$F$$20240816$20240206$20240821$EXP$$FR-JNJFOC-20240177653$JOHNSON AND JOHNSON$$70$YR$E$M$Y$96$KG$20240821$$PH$FR$FR
234847643$23484764$3$F$20230816$20240718$20240206$20240726$EXP$$CA-CELLTRION INC.-2023CA013852$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
234847735$23484773$5$F$20240114$20240827$20240206$20240904$EXP$$US-BEH-2024168286$CSL BEHRING$$35$YR$A$F$Y$89.81$KG$20240904$$CN$US$US
234847793$23484779$3$F$$20240627$20240206$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-018949$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$50$KG$20240702$$MD$JP$JP
234848262$23484826$2$F$20231101$20240711$20240206$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-005984$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240712$$CN$US$US
234848666$23484866$6$F$20231231$20240830$20240206$20240909$EXP$$CA-ROCHE-3404054$ROCHE$$30$YR$A$F$Y$$$20240909$$CN$CA$CA
234848854$23484885$4$F$20240101$20240731$20240206$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-018849$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240802$$CN$US$US
234849096$23484909$6$F$20211004$20240805$20240206$20240809$EXP$$BG-TAKEDA-2021TUS062287$TAKEDA$$40$YR$$M$Y$$$20240809$$CN$BG$BG
234849402$23484940$2$F$20240131$20240805$20240206$20240807$EXP$$US-TAKEDA-2024TUS009531$TAKEDA$$56$YR$$F$Y$$$20240807$$CN$US$US
234849494$23484949$4$F$20240325$20240830$20240206$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-018862$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$82.2$KG$20240905$$CN$US$US
234849782$23484978$2$F$$20240710$20240206$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017509$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240712$$CN$US$US
234850504$23485050$4$F$20240101$20240911$20240206$20240913$PER$$US-AMGEN-USASP2024023733$AMGEN$$63$YR$A$F$Y$$$20240913$$HP$US$US
234850532$23485053$2$F$$20240129$20240206$20240704$EXP$$JP-SA-2024SA031980$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240704$$CN$JP$JP
234850592$23485059$2$F$$20240823$20240206$20240906$EXP$$US-SA-2024SA036742$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240906$$CN$US$US
234850703$23485070$3$F$20240430$20240807$20240206$20240812$EXP$$US-SA-2024SA037921$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240812$$MD$US$US
234851112$23485111$2$F$$20240624$20240206$20240701$EXP$$JP-SAKK-2024SA033835AA$SANOFI AVENTIS$Sakamoto R, Fujita S, Nagatsuka Y, Kimura Y, Sakamoto S, Kataoka Y.. O-023: A case of adult atopic dermatitis considered refractory to systemic drug therapy but remission was maintained with topical steroid and educational hospitalization.. 29th Symposium of Research Society for the Treatment of Atopic Dermatitis.. UNK;UNK:48$54$YR$A$F$Y$$$20240702$$MD$JP$JP
234851817$23485181$7$F$20240305$20240905$20240206$20240912$EXP$$CA-TAKEDA-2024TUS006341$TAKEDA$$41$YR$$M$Y$$$20240912$$CN$CA$CA
234851882$23485188$2$F$$20240821$20240206$20240903$PER$$US-SA-2024SA031296$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240903$$MD$US$US
234851922$23485192$2$F$20240101$20240725$20240206$20240802$PER$$US-SA-2024SA030606$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240802$$MD$US$US
234852182$23485218$2$F$$20240628$20240206$20240708$PER$$US-SA-2024SA031812$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240708$$MD$US$US
234852202$23485220$2$F$20230101$20240729$20240206$20240807$PER$$US-SA-2024SA031988$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240807$$MD$US$US
234852252$23485225$2$F$20240101$20240828$20240206$20240918$PER$$US-SA-2024SA031397$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240918$$MD$US$US
234852522$23485252$2$F$20231201$20240815$20240206$20240828$PER$$US-SA-2024SA033720$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240828$$MD$US$US
234852752$23485275$2$F$20240101$20240621$20240206$20240702$PER$$US-SA-2023SA284097$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240702$$CN$US$US
234852862$23485286$2$F$20240721$20240724$20240206$20240802$PER$$US-SA-2024SA031862$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240802$$MD$US$US
234852952$23485295$2$F$$20240724$20240206$20240801$PER$$US-SA-2024SA033066$SANOFI AVENTIS$$$$A$F$Y$119$KG$20240801$$MD$US$US
234853053$23485305$3$F$20240101$20240718$20240206$20240726$PER$$US-SA-2024SA033220$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240726$$CN$US$US
234853183$23485318$3$F$20240101$20240724$20240206$20240730$PER$$US-SA-2024SA031406$SANOFI AVENTIS$$67$YR$E$F$Y$65.89$KG$20240730$$MD$US$US
234853452$23485345$2$F$$20240718$20240206$20240728$PER$$US-SA-2024SA030590$SANOFI AVENTIS$$$$A$M$Y$$$20240728$$MD$US$US
234853483$23485348$3$F$20240106$20240819$20240206$20240828$PER$$US-SA-2024SA034679$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240828$$MD$US$US
234854073$23485407$3$F$20240101$20240830$20240206$20240913$PER$$US-SA-2024SA036277$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240913$$MD$US$US
234854382$23485438$2$F$20230701$20240904$20240206$20240927$PER$$US-SA-2024SA032810$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240927$$HP$US$US
234854473$23485447$3$F$$20240812$20240206$20240821$PER$$US-SA-2024SA034253$SANOFI AVENTIS$$$$E$M$Y$$$20240821$$MD$US$US
234854922$23485492$2$F$20240112$20240827$20240206$20240923$PER$$US-SA-2024SA036997$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240923$$MD$US$US
234855153$23485515$3$F$20240125$20240805$20240206$20240810$PER$$US-SA-2024SA035876$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240810$$MD$US$US
234855222$23485522$2$F$$20240816$20240206$20240828$PER$$US-SA-2024SA036280$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
234855352$23485535$2$F$20230101$20240807$20240206$20240814$PER$$US-SA-2024SA037268$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240814$$CN$US$US
234855472$23485547$2$F$$20240708$20240206$20240717$PER$$US-SA-2024SA037302$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240717$$MD$US$US
234855494$23485549$4$F$20240101$20240917$20240206$20240926$PER$$US-SA-2024SA037128$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240926$$MD$US$US
234855533$23485553$3$F$$20240829$20240206$20240911$PER$$US-SA-2024SA036964$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240911$$MD$US$US
234855992$23485599$2$F$20240101$20240730$20240206$20240807$PER$$US-SA-2024SA037768$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240807$$CN$US$US
234856514$23485651$4$F$$20240827$20240206$20240905$EXP$$JP-ASTELLAS-2024JP000917$ASTELLAS$$5$DEC$A$F$Y$$$20240905$$MD$JP$JP
234856883$23485688$3$F$$20240828$20240206$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019205$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$67.59$KG$20240829$$CN$US$US
234857386$23485738$6$F$20230804$20240712$20240206$20240717$EXP$$JP-GSK-JP2024013787$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$JP$JP
234857487$23485748$7$F$$20240628$20240206$20240702$EXP$$US-SANDOZ INC.-SDZ2023US054087$SANDOZ$$$$$F$Y$67.574$KG$20240702$$CN$US$US
234857592$23485759$2$F$$20240724$20240206$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-005402$AUROBINDO$Todd. J.,Saboori. S., Zeidan. J., Ahren. W., Jacobs. C., Moshiree.B.. Sevelamer Induced Gastrointestinal Disease in 12 Patients with End Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15:e00679$55$YR$$M$Y$$$20240805$$MD$US$US
234858378$23485837$8$F$20231122$20240905$20240206$20240912$EXP$$CA-GSK-CA2023172334$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$CA$CA
234858484$23485848$4$F$20230501$20240807$20240206$20240816$EXP$$JP-009507513-2401JPN007283J$MERCK$$67$YR$$F$Y$52$KG$20240816$$MD$JP$JP
234858512$23485851$2$F$20231101$20240129$20240206$20240807$EXP$$NVSC2024EG022914$NOVARTIS$$74$YR$$F$Y$$$20240807$$CN$EG$EG
234859702$23485970$2$F$20240101$20240711$20240206$20240722$EXP$$CO-TOLMAR, INC.-24CO046077$TOLMAR$$$$$M$Y$$$20240719$$CN$CO$CO
234860363$23486036$3$F$$20240724$20240206$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-005411$AUROBINDO$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer Induced Gastrointestinal Disease in 12 Patients with End Stage Renal Disease: A Case Series. Clin Transl Gastroenterol. 2024;15:No:3$63$YR$$M$Y$$$20240805$$MD$US$US
234860543$23486054$3$F$$20240625$20240206$20240701$EXP$$US-AMGEN-USASP2024021241$AMGEN$$73$YR$E$M$Y$$$20240701$$HP$US$US
234860883$23486088$3$F$20231201$20240813$20240206$20240820$EXP$$AU-GSK-AU2024APC014298$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$AU$AU
234861123$23486112$3$F$20230101$20240827$20240206$20240830$EXP$$US-BIOGEN-2024BI01244445$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
234861175$23486117$5$F$$20240723$20240206$20240726$EXP$$CA-JNJFOC-20240201193$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240726$$CN$CA$CA
234861466$23486146$6$F$20230101$20240715$20240206$20240723$EXP$$CA-CELLTRION INC.-2023CA011249$CELLTRION$$$$$$Y$$$20240723$$MD$CA$CA
234861573$23486157$3$F$$20240807$20240206$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-018048$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240814$$CN$US$US
234861652$23486165$2$F$$20240625$20240206$20240701$EXP$$US-SA-2024SA038806$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240701$$CN$US$US
234861694$23486169$4$F$20240120$20240814$20240206$20240821$EXP$$FR-ROCHE-3500834$ROCHE$$21$YR$A$F$Y$$$20240821$$PH$FR$FR
234862004$23486200$4$F$20230101$20240730$20240206$20240806$EXP$$CA-CELLTRION INC.-2023CA018201$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
234862145$23486214$5$F$$20240531$20240206$20240706$EXP$$CA-TEVA-202111_00012489$TEVA$$43$YR$$F$Y$$$20240706$$HP$CA$CA
234862326$23486232$6$F$20231101$20240725$20240206$20240801$EXP$$CA-GSK-CA2023AMR087065$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$HP$CA$CA
234862556$23486255$6$F$20231223$20240920$20240206$20240926$EXP$$CA-JNJFOC-20240178520$JOHNSON AND JOHNSON$$59$YR$A$F$Y$85$KG$20240926$$HP$CA$CA
234862669$23486266$9$F$20240211$20240831$20240206$20240905$EXP$$CA-SANDOZ INC.-NVSC2022CA277930$SANDOZ$$86$YR$$F$Y$$$20240905$$CN$CA$CA
234862715$23486271$5$F$$20240708$20240206$20240710$EXP$$CA-GSK-CA2023139700$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$HP$CA$CA
234863826$23486382$6$F$$20240920$20240206$20240927$EXP$$CA-GSK-CA2023167898$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$HP$CA$CA
234864642$23486464$2$F$20231120$20240130$20240206$20240813$EXP$$NVSC2024EG021945$NOVARTIS$$57$YR$$F$Y$$$20240813$$CN$EG$EG
234864652$23486465$2$F$$20240918$20240206$20240925$EXP$$NVSC2024US025547$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
234865886$23486588$6$F$20240101$20240812$20240206$20240820$EXP$$DE-INSMED, INC.-2024-00156-DE$INSMED$$59$YR$$F$Y$$$20240820$$CN$DE$DE
234866005$23486600$5$F$$20240709$20240206$20240723$EXP$$US-INSMED, INC.-2024-00349-US$INSMED$$$$$M$Y$$$20240723$$CN$US$US
234866565$23486656$5$F$$20240903$20240206$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-018369$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240910$$CN$US$US
234868422$23486842$2$F$$20240626$20240206$20240701$EXP$$US-PFIZER INC-202400033928$PFIZER$$84$YR$$F$Y$$$20240701$$CN$US$US
234868675$23486867$5$F$20230101$20240629$20240206$20240701$EXP$$CA-PFIZER INC-202300188712$PFIZER$$29$YR$$F$Y$$$20240701$$MD$CA$CA
234868704$23486870$4$F$20231001$20240904$20240206$20240909$EXP$$CA-PFIZER INC-202400030880$PFIZER$$70$YR$$F$Y$$$20240909$$PH$CA$CA
234869623$23486962$3$F$$20240722$20240206$20240725$PER$$US-AMGEN-USASP2024024914$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
234869652$23486965$2$F$20240110$20240805$20240206$20240808$EXP$$CN-JNJFOC-20240185443$JOHNSON AND JOHNSON$$$$$M$Y$1.4$KG$20240808$$HP$CN$CN
234869872$23486987$2$F$$20240705$20240206$20240715$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-00788$HIKMA$Cairns J, Feng TL, Ong MC. Cairns J, Feng TL, Ong MC. Continuous ketamine infusion for the management of opioid-induced hyperalgesia following amputation. BMJ Case Reports. 2024;17(1)$$$$$Y$$$20240715$$MD$CA$CA
234869933$23486993$3$F$20240129$20240723$20240206$20240725$EXP$$JP-EXELIXIS-CABO-24073467$EXELIXIS$$56$YR$$M$Y$58.4$KG$20240725$$MD$JP$JP
234869952$23486995$2$F$20230809$20240715$20240206$20240723$EXP$$KR-GILEAD-2024-0660978$GILEAD$$$$E$M$Y$31.746$KG$20240723$$MD$KR$KR
234870014$23487001$4$F$$20240725$20240206$20240809$EXP$$US-SA-2024SA040384$SANOFI AVENTIS$$$$E$M$Y$$$20240809$$CN$US$US
234870252$23487025$2$F$$20240827$20240206$20240903$EXP$$GB-MYLANLABS-2024M1011311$MYLAN$$$$$M$Y$$$20240903$$MD$GB$GB
234870323$23487032$3$F$$20240708$20240206$20240711$EXP$$CA-TAKEDA-2024TUS008975$TAKEDA$$$$$F$Y$$$20240711$$CN$CA$CA
234871772$23487177$2$F$$20240620$20240206$20240701$EXP$$US-ZENPEP LLC-2024AIMT00141$AIMMUNE$$$$$$Y$$$20240701$$CN$US$US
234871882$23487188$2$F$$20240722$20240206$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019364$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$72.12$KG$20240723$$CN$US$US
234872353$23487235$3$F$20231010$20240718$20240206$20240724$EXP$$JP-PHARMAESSENTIA CORPORATION-JP-2024-PEC-002962$PHARMAESSENTIA$$69$YR$$M$Y$$$20240724$$HP$JP$JP
234872474$23487247$4$F$20240104$20240905$20240206$20240918$EXP$$US-UCBSA-2024005210$UCB$$68$YR$$F$Y$105$KG$20240918$$HP$US$US
234872674$23487267$4$F$20240204$20240731$20240206$20240803$PER$$US-AMGEN-USASP2024025095$AMGEN$$72$YR$E$M$Y$$$20240802$$CN$US$US
234873054$23487305$4$F$20240101$20240917$20240206$20240919$EXP$$NVSC2024GB007358$NOVARTIS$$44$YR$$F$Y$$$20240919$$CN$GB$GB
234873662$23487366$2$F$20240120$20240712$20240206$20240718$EXP$$CN-PFIZER INC-PV202400016251$PFIZER$$101$YR$$M$Y$$$20240718$$HP$CN$CN
234873972$23487397$2$F$20230802$20240903$20240206$20240913$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2024FOS000120$RIGEL PHARMACEUTICALS$$80$YR$$M$Y$62.1$KG$20240913$$MD$JP$JP
234874122$23487412$2$F$$20240911$20240206$20240916$EXP$$US-MYLANLABS-2024M1009676$MYLAN$$$$$M$Y$104.33$KG$20240916$$CN$US$US
234874143$23487414$3$F$20230831$20240318$20240206$20240801$PER$$US-BAYER-2024A020224$BAYER$$16$YR$T$F$Y$$$20240801$$CN$US$US
234874282$23487428$2$F$$20240708$20240206$20240710$EXP$$CA-BAYER-2024A017926$BAYER$$$$A$F$Y$$$20240710$$HP$CA$CA
234874623$23487462$3$F$$20240814$20240206$20240820$PER$$US-BIOGEN-2015BI021487$BIOGEN$$$$$F$Y$$$20240820$$CN$US$US
234874934$23487493$4$F$20230101$20240731$20240206$20240806$EXP$$JP-009507513-2401JPN001313J$MERCK$$60$YR$$F$Y$$$20240806$$MD$JP$JP
234875007$23487500$7$F$$20240827$20240206$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019525$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240902$$CN$US$US
234875355$23487535$5$F$20240101$20240628$20240206$20240704$PER$$US-BIOGEN-2024BI01248011$BIOGEN$$$$$F$Y$$$20240704$$CN$US$US
234875673$23487567$3$F$$20240819$20240206$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002137$JAZZ$$$$$F$Y$$$20240821$$MD$US$US
234876506$23487650$6$F$20240117$20240710$20240206$20240719$EXP$$CN-BAXTER-2024BAX011789$BAXTER$$68$YR$$F$Y$72$KG$20240719$$MD$CN$CN
234876805$23487680$5$F$$20240910$20240206$20240913$EXP$$NVSC2024BR019871$NOVARTIS$$$$$F$Y$$$20240913$$CN$BR$BR
234877876$23487787$6$F$20240101$20240724$20240206$20240729$EXP$$CA-UCBSA-2024004825$UCB$$$$$F$Y$$$20240729$$CN$CA$CA
234878832$23487883$2$F$20230101$20240628$20240206$20240705$EXP$$JP-009507513-2310JPN001507J$MERCK$$84$YR$$F$Y$$$20240705$$MD$JP$JP
234879183$23487918$3$F$20221012$20240819$20240206$20240821$EXP$$DE-SANDOZ INC.-NVSC2022DE236720$SANDOZ$$56$YR$$F$Y$58$KG$20240821$$MD$DE$DE
234879842$23487984$2$F$$20240925$20240206$20240930$EXP$$CA-SANDOZ INC.-SDZ2023CA070641$SANDOZ$$59$YR$$F$Y$68$KG$20240930$$MD$CA$CA
234880447$23488044$7$F$20231127$20240920$20240206$20240925$EXP$$NVSC2024US015937$NOVARTIS$$48$YR$$M$Y$$$20240925$$CN$US$US
234880572$23488057$2$F$$20240904$20240206$20240905$PER$$NVSC2024US025819$NOVARTIS$$$$$F$Y$$$20240905$$HP$US$US
234881092$23488109$2$F$$20240130$20240206$20240726$EXP$$PHHY2018IT152719$NOVARTIS$Grossi G, Vigano M, Facchetti F, Labanca S, Loglio A, Dodero A et al.. Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and malignancies: two case reports. HAEMATOLOGICA. 2017;102(10):e423-e426$56$YR$$M$Y$$$20240726$$HP$IT$IT
234881173$23488117$3$F$20200910$20240911$20240206$20240913$EXP$$CA-TAKEDA-CA202029812$TAKEDA$$65$YR$$M$Y$72.7$KG$20240913$$MD$CA$CA
234881703$23488170$3$F$20230101$20240730$20240206$20240807$PER$$US-SA-2024SA033041$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240807$$MD$US$US
234881832$23488183$2$F$20240101$20240711$20240206$20240718$PER$$US-SA-2024SA034672$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240718$$MD$US$US
234882162$23488216$2$F$20220928$20240624$20240206$20240703$PER$$US-SA-2024SA034726$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240703$$HP$US$US
234882202$23488220$2$F$$20240905$20240206$20240916$PER$$US-SA-2024SA030100$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240916$$MD$US$US
234882222$23488222$2$F$20240701$20240722$20240206$20240730$PER$$US-SA-2024SA033206$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240730$$MD$US$US
234882863$23488286$3$F$$20240627$20240206$20240708$PER$$US-SA-2024SA035882$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240708$$MD$US$US
234883083$23488308$3$F$20231101$20240826$20240206$20240909$PER$$US-SA-2024SA034569$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240909$$MD$US$US
234883342$23488334$2$F$$20240701$20240206$20240709$PER$$US-SA-2024SA036297$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240709$$MD$US$US
234883423$23488342$3$F$$20240725$20240206$20240806$PER$$US-SA-2024SA035579$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240806$$MD$US$US
234883492$23488349$2$F$$20240723$20240206$20240801$PER$$US-SA-2024SA035656$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240801$$MD$US$US
234883532$23488353$2$F$20240101$20240727$20240206$20240808$PER$$US-SA-2024SA035834$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240808$$CN$US$US
234883543$23488354$3$F$20240101$20240708$20240206$20240717$PER$$US-SA-2024SA034716$SANOFI AVENTIS$$47$YR$A$M$Y$83.9$KG$20240717$$MD$US$US
234883932$23488393$2$F$$20240822$20240206$20240905$PER$$US-SA-2024SA035678$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240905$$MD$US$US
234883992$23488399$2$F$20240101$20240805$20240206$20240813$PER$$US-SA-2024SA037337$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240813$$CN$US$US
234884132$23488413$2$F$20240801$20240815$20240206$20240829$PER$$US-SA-2023SA349435$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240829$$MD$US$US
234884693$23488469$3$F$20231030$20240620$20240206$20240701$PER$$US-SA-2024SA038327$SANOFI AVENTIS$$61$YR$A$M$Y$72.57$KG$20240701$$MD$US$US
234885414$23488541$4$F$20240101$20240822$20240206$20240904$PER$$US-SA-2024SA038265$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240904$$MD$US$US
234885442$23488544$2$F$$20240915$20240206$20240924$PER$$US-SA-2024SA034422$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240924$$HP$US$US
2348866115$23488661$15$F$20191003$20240917$20240206$20240924$EXP$$AU-MYLANLABS-2024M1011882$MYLAN$$35$YR$$M$Y$$$20240924$$HP$AU$AU
234887262$23488726$2$F$$20240909$20240206$20240911$PER$$US-PFIZER INC-PV202400016606$PFIZER$$58$YR$$F$Y$$$20240911$$CN$US$US
234887896$23488789$6$F$20231002$20240919$20240206$20240924$EXP$$US-SA-2024SA035894$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240924$$MD$US$US
234887982$23488798$2$F$$20240828$20240206$20240904$PER$$US-PFIZER INC-PV202400017231$PFIZER$$65$YR$$M$Y$$$20240904$$HP$US$US
234888143$23488814$3$F$$20240731$20240206$20240805$PER$$US-PFIZER INC-PV202400017467$PFIZER$$17$YR$$F$Y$$$20240805$$HP$US$US
234888792$23488879$2$F$$20240829$20240206$20240905$EXP$CA-HEALTHCANVIG-E2B_06731228$CA-PURDUE-USA-2024-0307688$PURDUE$$80$YR$$M$Y$69$KG$20240905$$HP$CA$CA
234888925$23488892$5$F$20240201$20240808$20240206$20240812$PER$$US-PFIZER INC-202400032308$PFIZER$$59$YR$$F$Y$$$20240812$$CN$US$US
234889063$23488906$3$F$20230611$20240717$20240206$20240808$EXP$$JP-009507513-2310JPN002881J$MERCK$Suenaga T, Iwase H, Kaya S, Kukita A, Sue F, Funakura M, et al.. Y-13 A Case of recurrent corpus uteri carcinoma leading to grade 4 myocarditis with lenvatinib plus pembrolizumab therapy. Kanto Journal of Obstetrics and Gynecology, The 147th Meeting of the Kanto Socie. 2024;61(2):196$43$YR$$F$Y$$$20240808$$MD$JP$JP
234889223$23488922$3$F$$20240827$20240206$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019616$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240829$$HP$US$US
234890997$23489099$7$F$20231215$20240820$20240206$20240903$PER$$US-KARYOPHARM-2023KPT002319$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
234891223$23489122$3$F$20240128$20240909$20240206$20240924$PER$$US-SA-2024SA038831$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240924$$MD$US$US
234892212$23489221$2$F$$20240711$20240206$20240717$EXP$$JP-AMGEN-JPNSP2024025162$AMGEN$Michitaka Kuramoto, Daisuke Yamada, Shiho Nishimura, Akifumi Hayashi, Hiroyuki Konomi, Akihiko Uchiyama.. A Case of Laparoscopic Mies Surgery for Rb Rectal cancer after Radical Prostatectomy in which the Bladder Arm and Urethral injury were Omentally Filled with V-Loc resulting in favorable course. ;. 2023;2097$72$YR$E$M$Y$$$20240717$$MD$JP$JP
234892232$23489223$2$F$$20240202$20240206$20240920$EXP$$FR-SANDOZ INC.-SDZ2023FR005717$SANDOZ$$38$YR$$F$Y$$$20240920$$HP$FR$FR
234892382$23489238$2$F$$20240627$20240206$20240704$EXP$$JP-009507513-2311JPN002652J$MERCK$$$$$M$Y$$$20240704$$MD$JP$JP
234892952$23489295$2$F$$20240910$20240206$20240912$PER$$US-ROCHE-3438773$ROCHE$$44$YR$A$F$Y$$$20240913$$MD$US$US
234894532$23489453$2$F$$20240731$20240206$20240805$PER$$US-ROCHE-3456183$ROCHE$$$$A$F$Y$$$20240806$$CN$US$US
234895894$23489589$4$F$20220901$20231129$20240206$20240918$PER$$US-ROCHE-3459947$ROCHE$$28$YR$A$F$Y$75.75$KG$20240918$$CN$US$US
234898075$23489807$5$F$20240101$20240903$20240206$20240909$EXP$$US-ABBVIE-5617557$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
234898162$23489816$2$F$$20240828$20240206$20240830$PER$$US-ROCHE-3272689$ROCHE$$$$A$M$Y$$$20240830$$CN$US$US
234899782$23489978$2$F$20230724$20240719$20240206$20240724$PER$$US-ROCHE-3405420$ROCHE$$26$YR$A$M$Y$$$20240724$$CN$US$US
234900752$23490075$2$F$$20240910$20240206$20240920$EXP$$US-UCBSA-2024005911$UCB$$$$$F$Y$$$20240920$$CN$US$US
234901622$23490162$2$F$$20240626$20240206$20240705$PER$$US-ROCHE-3452336$ROCHE$$$$$$Y$$$20240705$$HP$US$US
234901712$23490171$2$F$$20240821$20240206$20240827$PER$$US-ROCHE-3407286$ROCHE$$21$YR$A$F$Y$$$20240827$$CN$US$US
234903163$23490316$3$F$$20240822$20240206$20240904$PER$$US-SA-2024SA036118$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240905$$MD$US$US
234903672$23490367$2$F$20221020$20240921$20240206$20240925$EXP$$JP-TAKEDA-2024TJP002010$TAKEDA$$34$YR$$M$Y$$$20240925$$MD$JP$JP
2349036910$23490369$10$F$$20240912$20240206$20240919$EXP$$CA-GSK-CA2023156892$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$CA$CA
234903807$23490380$7$F$20240715$20240801$20240206$20240805$EXP$$DE-TAKEDA-2024TUS010458$TAKEDA$$89$YR$$M$Y$$$20240805$$CN$DE$DE
234904742$23490474$2$F$$20240830$20240206$20240905$PER$$US-ROCHE-3483414$ROCHE$$15$YR$T$$Y$$$20240906$$PH$US$US
234905412$23490541$2$F$$20240619$20240206$20240703$PER$$US-ROCHE-3478332$ROCHE$$$$C$M$Y$29.94$KG$20240703$$CN$US$US
234908112$23490811$2$F$$20240922$20240206$20240930$PER$$US-ROCHE-3405514$ROCHE$$$$A$F$Y$$$20240930$$CN$US$US
234909344$23490934$4$F$20240216$20240814$20240206$20240816$EXP$$CA-TAKEDA-2024TUS010252$TAKEDA$$75$YR$$F$Y$$$20240816$$CN$CA$CA
234910184$23491018$4$F$20240118$20240725$20240206$20240805$PER$$US-SA-2024SA035414$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240804$$HP$US$US
234910552$23491055$2$F$$20240904$20240206$20240926$PER$$US-SA-2024SA034626$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240926$$CN$US$US
234910563$23491056$3$F$$20240722$20240206$20240731$PER$$US-SA-2024SA040118$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240731$$MD$US$US
234911103$23491110$3$F$20240101$20240731$20240207$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-018558$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240805$$MD$JP$JP
234912045$23491204$5$F$20240101$20240913$20240207$20240921$EXP$$CA-CELLTRION INC.-2024CA000638$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
234912223$23491222$3$F$20240204$20240730$20240207$20240801$PER$$US-AMGEN-USASP2024024995$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
234912392$23491239$2$F$20230801$20240620$20240207$20240710$PER$$CA-TOLMAR, INC.-24CA045864$TOLMAR$$80$YR$$M$Y$$$20240710$$CN$CA$CA
234912515$23491251$5$F$20240101$20240607$20240207$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000170$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240701$$CN$US$US
234912572$23491257$2$F$20240101$20240828$20240207$20240909$PER$$US-SA-2024SA036070$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240909$$MD$US$US
234912822$23491282$2$F$20240201$20240627$20240207$20240702$PER$$US-AMGEN-USASP2024024331$AMGEN$$55$YR$A$F$Y$$$20240702$$CN$US$US
234912983$23491298$3$F$20240101$20240709$20240207$20240722$EXP$$JP-ROCHE-3504496$ROCHE$$$$$F$Y$$$20240719$$MD$JP$JP
234913044$23491304$4$F$20200708$20240828$20240207$20240904$EXP$$CA-TAKEDA-CA202022313$TAKEDA$$22$YR$$M$Y$105$KG$20240904$$CN$CA$CA
234913294$23491329$4$F$20240301$20240704$20240207$20240709$EXP$$US-ABBVIE-5620333$ABBVIE$$82$YR$$M$Y$66$KG$20240709$$CN$US$US
234914493$23491449$3$F$20240624$20240624$20240207$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-TRF-003652$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240718$$CN$US$US
234914555$23491455$5$F$$20240815$20240207$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019235$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240823$$CN$US$US
234914822$23491482$2$F$$20240822$20240207$20240826$EXP$$CA-ROCHE-3502654$ROCHE$$67$YR$E$F$Y$73$KG$20240826$$MD$CA$CA
234915022$23491502$2$F$20240101$20240808$20240207$20240816$EXP$SE-SEMPA-2024-000633$SE-NOVOPROD-1169145$NOVO NORDISK$$36$YR$$F$Y$$$20240816$$PH$SE$SE
234915104$23491510$4$F$20231001$20240920$20240207$20240930$EXP$$HK-NOVOPROD-1153978$NOVO NORDISK$$77$YR$$M$Y$$$20240930$$CN$HK$HK
234915303$23491530$3$F$20240112$20240724$20240207$20240801$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202402000822$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240801$$CN$JP$JP
234915402$23491540$2$F$20231225$20240725$20240207$20240730$EXP$$IN-ROCHE-3505480$ROCHE$$65$YR$E$M$Y$$$20240730$$CN$IN$IN
234916222$23491622$2$F$20240101$20240809$20240207$20240813$EXP$$US-JNJFOC-20240183643$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240813$$HP$US$US
234916264$23491626$4$F$20230101$20240912$20240207$20240921$EXP$$CA-CELLTRION INC.-2023CA009348$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
234916354$23491635$4$F$20240901$20240926$20240207$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019414$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$46.27$KG$20240930$$CN$US$US
234916389$23491638$9$F$20230101$20240716$20240207$20240724$EXP$$CA-CELLTRION INC.-2023CA010680$CELLTRION$$$$$$Y$$$20240724$$MD$CA$CA
234916424$23491642$4$F$20220913$20240814$20240207$20240822$EXP$$CA-ROCHE-3064199$ROCHE$$36$YR$A$F$Y$$$20240822$$CN$CA$CA
234916646$23491664$6$F$20230629$20240618$20240207$20240703$EXP$$CA-GSK-CA2023090579$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$HP$CA$CA
234916752$23491675$2$F$$20240108$20240207$20240801$EXP$$US-RDY-SPO/USA/24/0001845$DR REDDYS$$34$YR$A$F$Y$$$20240801$$HP$US$US
234917265$23491726$5$F$$20240912$20240207$20240918$EXP$$US-TAKEDA-2024TUS011360$TAKEDA$$$$$F$Y$$$20240918$$MD$US$US
234917693$23491769$3$F$20240201$20240830$20240207$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016572$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240906$$PH$US$US
234917864$23491786$4$F$20240101$20240805$20240207$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-019703$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240808$$MD$JP$JP
234918334$23491833$4$F$20230101$20240729$20240207$20240805$EXP$$US-AMGEN-USASP2024024889$AMGEN$$74$YR$E$M$Y$$$20240804$$CN$US$US
234918656$23491865$6$F$20230501$20240716$20240207$20240724$EXP$$NVSC2024MX026298$NOVARTIS$$54$YR$$F$Y$$$20240724$$CN$MX$MX
234919714$23491971$4$F$$20240828$20240207$20240830$EXP$$CA-SANDOZ INC.-NVSC2022CA294347$SANDOZ$$42$YR$$F$Y$81$KG$20240830$$HP$CA$CA
234921222$23492122$2$F$$20240725$20240207$20240802$PER$$US-ROCHE-3411815$ROCHE$$33$YR$A$F$Y$$$20240802$$CN$US$US
234921612$23492161$2$F$$20240920$20240207$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-004684$AUROBINDO$$62$YR$$M$Y$$$20240930$$PH$CA$CA
234922285$23492228$5$F$$20240703$20240207$20240709$EXP$$US-TAKEDA-2023TUS090187$TAKEDA$$$$$F$Y$47$KG$20240709$$CN$US$US
2349224412$23492244$12$F$20240126$20240916$20240207$20240920$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-01941$IPSEN$$88$YR$E$F$Y$64$KG$20240920$$CN$US$US
234922722$23492272$2$F$20201001$20240910$20240207$20240913$EXP$$CA-TAKEDA-2020TUS037828$TAKEDA$$46$YR$$M$Y$$$20240913$$CN$CA$CA
234922742$23492274$2$F$20240205$20240807$20240207$20240808$EXP$$AU-TAKEDA-2024TUS011015$TAKEDA$$71$YR$$M$Y$$$20240808$$CN$AU$AU
234923144$23492314$4$F$20230903$20240817$20240207$20240827$EXP$$EG-ROCHE-3497946$ROCHE$$37$YR$A$M$Y$55$KG$20240827$$CN$EG$EG
234923433$23492343$3$F$$20240808$20240207$20240816$EXP$$CA-SA-2024SA036461$SANOFI AVENTIS$$43$YR$A$F$Y$68$KG$20240816$$HP$CA$CA
234923685$23492368$5$F$20220101$20240906$20240207$20240916$EXP$$CA-CELLTRION INC.-2022CA017506$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
234923707$23492370$7$F$20240620$20240909$20240207$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015872$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$104.33$KG$20240917$$CN$US$US
234924392$23492439$2$F$$20240703$20240207$20240715$EXP$$US-ABBVIE-5627555$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
234924912$23492491$2$F$20230101$20240910$20240207$20240915$EXP$$US-JNJFOC-20240180532$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240915$$HP$US$US
234926322$23492632$2$F$$20240701$20240207$20240708$PER$$US-AMGEN-USASP2024022521$AMGEN$Bhutania T.. Evaluating prevalence and consequence of residual disease in individuals with psoriasis receiving apremilast treatment: results from a US patient survey. Journal of Dermatological Treatment. 2024;35 (1):1-8$$$$$Y$$$20240708$$HP$US$US
234926333$23492633$3$F$20200504$20240702$20240207$20240708$EXP$$CA-JNJFOC-20231216832$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240708$$HP$CA$CA
234926384$23492638$4$F$$20240814$20240207$20240820$EXP$$CA-TAKEDA-2024TUS006837$TAKEDA$$$$$M$Y$$$20240820$$CN$CA$CA
234926932$23492693$2$F$$20240719$20240207$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019297$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$136.53$KG$20240722$$CN$US$US
234927042$23492704$2$F$$20240125$20240207$20240911$EXP$GB-MHRA-ADR 28484621$GB-TEVA-VS-3150071$TEVA$$95$YR$$M$Y$$$20240911$$PH$GB$GB
234927592$23492759$2$F$$20240627$20240207$20240705$EXP$CA-E2BLSMVVAL-CLI/CAN/24/0002137$CA-RDY-CLI/CAN/24/0002137$DR REDDYS$$71$YR$E$F$Y$$$20240705$$MD$CA$CA
234927945$23492794$5$F$20240312$20240712$20240207$20240716$EXP$$CA-TAKEDA-2023TUS113641$TAKEDA$$42$YR$$F$Y$$$20240716$$CN$CA$CA
234928035$23492803$5$F$$20240713$20240207$20240729$EXP$$JP-TAKEDA-2024TUS010943$TAKEDA$Ishida T. Up-to-date knowledge in multiple myeloma: including CAR-T, bispecific antibody. Luncheon Seminar of the 42nd Hokuriku Regional Meeting of the Japanese Society. 2024$70$YR$$$Y$$$20240729$$MD$JP$JP
234928817$23492881$7$F$20231117$20240730$20240207$20240806$EXP$$FR-EXELIXIS-XL18424073526$EXELIXIS$$$$$$Y$$$20240806$$MD$FR$FR
234928926$23492892$6$F$$20240624$20240207$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2024-000876$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240703$$$US$US
234930325$23493032$5$F$20240710$20240808$20240207$20240812$EXP$$GB-MYLANLABS-2024M1011867$MYLAN$$$$$M$Y$$$20240812$$MD$GB$GB
234930552$23493055$2$F$20240129$20240712$20240207$20240716$EXP$$CA-ABBVIE-5623100$ABBVIE$$$$A$M$Y$$$20240716$$HP$CA$CA
234930872$23493087$2$F$20240129$20240701$20240207$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019650$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240703$$CN$US$US
234931232$23493123$2$F$20240204$20240730$20240207$20240801$PER$$US-AMGEN-USASP2024025052$AMGEN$$74$YR$E$M$Y$$$20240801$$CN$US$US
234931252$23493125$2$F$20240201$20240710$20240207$20240712$PER$$US-AMGEN-USASP2024023809$AMGEN$$75$YR$E$M$Y$$$20240711$$CN$US$US
234931292$23493129$2$F$$20240712$20240207$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019450$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$68.95$KG$20240716$$CN$US$US
234931675$23493167$5$F$20230621$20240826$20240207$20240829$EXP$$US-TAKEDA-2023TUS065094$TAKEDA$$69$YR$$F$Y$78$KG$20240829$$HP$US$US
234932302$23493230$2$F$$20240628$20240207$20240705$EXP$$TW-GSK-TW2023APC104224$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$TW$TW
234932532$23493253$2$F$$20240711$20240207$20240715$EXP$$JP-EXELIXIS-CABO-24073588$EXELIXIS$$51$YR$$F$Y$$$20240715$$MD$JP$JP
234932612$23493261$2$F$$20240905$20240207$20240910$EXP$$US-TAKEDA-2024TUS009436$TAKEDA$$$$$M$Y$$$20240910$$CN$US$US
234932963$23493296$3$F$20230101$20240909$20240207$20240921$EXP$$US-UCBSA-2024002412$UCB$$$$$F$Y$$$20240921$$CN$US$US
2349333217$23493332$17$F$$20240909$20240207$20240918$30DAY$$US-PFIZER INC-PV202400009224$PFIZER$$11$YR$$M$Y$$$20240918$$MD$US$US
234933813$23493381$3$F$20240325$20240916$20240207$20240920$EXP$$US-TAKEDA-2024TUS010362$TAKEDA$$57$YR$$F$Y$$$20240920$$CN$US$US
234933953$23493395$3$F$20240101$20240715$20240207$20240719$EXP$$US-BAUSCH-BL-2024-001727$BAUSCH AND LOMB$$80$YR$$M$Y$89.892$KG$20240719$$CN$US$US
234934202$23493420$2$F$20240129$20240702$20240207$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020314$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240705$$CN$US$US
234934594$23493459$4$F$20240419$20240916$20240207$20240918$EXP$$AU-TAKEDA-2024TUS010667$TAKEDA$$74$YR$$M$Y$$$20240918$$HP$AU$AU
234934724$23493472$4$F$20230101$20240819$20240207$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019917$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240820$$CN$US$US
234935312$23493531$2$F$$20240731$20240207$20240814$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430440$RANBAXY$Miguel PJ, Moiteiro da CruzR, Costa-Reis P, Sandes AR, Esteves da SilvaJ. Paracetamol Induced Acute Interstitial Nephritis Pediatric Case Report. Acta Med Port. 2024;Jan;37(1):64-70$14$YR$$F$Y$$$20240814$$HP$PT$PT
234935946$23493594$6$F$20240116$20240824$20240207$20240903$EXP$$FR-UCBSA-2024006122$UCB$$63$YR$$M$Y$73$KG$20240903$$MD$FR$FR
234936023$23493602$3$F$20240101$20240925$20240207$20240927$EXP$$CA-PFIZER INC-202400032984$PFIZER$$36$YR$$M$Y$$$20240927$$HP$CA$CA
234936162$23493616$2$F$$20240125$20240207$20240712$30DAY$$HK-SA-2024SA032610$SANOFI AVENTIS$$$$$$Y$$$20240712$$HP$HK$HK
234936176$23493617$6$F$20240101$20240628$20240207$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015529$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$90.72$KG$20240704$$HP$US$US
234936312$23493631$2$F$20210901$20240715$20240207$20240723$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2021-23482$IPSEN$$85$YR$E$F$Y$$$20240723$$CN$US$US
234936473$23493647$3$F$20231230$20240704$20240207$20240725$PER$$CA-TOLMAR, INC.-24CA045868$TOLMAR$$71$YR$$M$Y$$$20240725$$CN$CA$CA
234936543$23493654$3$F$$20240702$20240207$20240724$PER$$CA-TOLMAR, INC.-24CA046084$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
234936552$23493655$2$F$20240606$20240709$20240207$20240730$PER$$CA-TOLMAR, INC.-24CA046088$TOLMAR$$73$YR$$M$Y$$$20240730$$CN$CA$CA
234936712$23493671$2$F$20231213$20240918$20240207$20240926$PER$$US-SA-2024SA035734$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240926$$MD$US$US
234936793$23493679$3$F$20230801$20240812$20240207$20240821$PER$$US-SA-2024SA036119$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240821$$MD$US$US
234936822$23493682$2$F$$20240809$20240207$20240817$PER$$US-SA-2024SA036012$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240817$$MD$US$US
234936932$23493693$2$F$20230101$20240716$20240207$20240725$PER$$US-SA-2024SA035560$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240725$$MD$US$US
234937342$23493734$2$F$20230801$20240905$20240207$20240913$PER$$US-SA-2024SA037181$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240913$$MD$US$US
234937362$23493736$2$F$$20240624$20240207$20240703$PER$$US-SA-2024SA037135$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
234937625$23493762$5$F$$20240705$20240207$20240712$EXP$$US-SA-2024SA040052$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240712$$MD$US$US
234938002$23493800$2$F$20231201$20240903$20240207$20240915$PER$$US-SA-2024SA038728$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240915$$MD$US$US
234938045$23493804$5$F$20240101$20240829$20240207$20240923$PER$$US-SA-2024SA006898$SANOFI AVENTIS$$61$YR$A$F$Y$122$KG$20240923$$CN$US$US
2349380712$23493807$12$F$20231010$20240913$20240207$20240923$EXP$$CA-CELLTRION INC.-2023CA016708$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
234938143$23493814$3$F$20231103$20240814$20240207$20240819$PER$$US-SA-2024SA039269$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240819$$MD$US$US
234938232$23493823$2$F$20240701$20240802$20240207$20240812$PER$$US-SA-2024SA038636$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240812$$MD$US$US
234938254$23493825$4$F$20240123$20240828$20240207$20240912$PER$$US-SA-2024SA038692$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240912$$MD$US$US
234938422$23493842$2$F$$20240805$20240207$20240813$PER$$US-SA-2024SA038642$SANOFI AVENTIS$$$$A$M$Y$80.6$KG$20240814$$MD$US$US
234938912$23493891$2$F$$20240717$20240207$20240801$PER$$US-SA-2024SA036267$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240801$$MD$US$US
234939072$23493907$2$F$20240701$20240808$20240207$20240820$PER$$US-SA-2024SA038534$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240820$$MD$US$US
234939213$23493921$3$F$20240101$20240709$20240207$20240717$PER$$US-SA-2024SA038465$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240717$$MD$US$US
234939493$23493949$3$F$20240201$20240913$20240207$20240920$EXP$$CA-GSK-CA2023AMR111459$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CA$CA
234939604$23493960$4$F$20230101$20240812$20240207$20240814$EXP$$CA-UCBSA-2023009133$UCB$$$$$F$Y$$$20240814$$CN$CA$CA
234940503$23494050$3$F$20231001$20240701$20240207$20240708$EXP$$FR-MYLANLABS-2024M1002048$MYLAN$$61$YR$$F$Y$54$KG$20240708$$CN$FR$FR
234940942$23494094$2$F$$20240902$20240207$20240916$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00035$Phathom Pharmaceuticals$Hiroko Suda, Masayuki Urata, Sachi Eto, Ayako Okuda, Yukihiro Koga, Takayuki Takeichi, et al.. A case of ADML noted after switch from vonoprazan to an H2 blocker. 123 Mtg of J Soc of Gastroenterol/117 Mtg of J Gastroenterol Endosc Soc (Kyushu). 144$76$YR$$M$Y$$$20240916$$MD$JP$JP
234941022$23494102$2$F$20240204$20240708$20240207$20240709$PER$$US-AMGEN-USASP2024025165$AMGEN$$77$YR$E$M$Y$$$20240709$$CN$US$US
234941272$23494127$2$F$20240204$20240704$20240207$20240706$PER$$US-AMGEN-USASP2024025720$AMGEN$$68$YR$E$M$Y$$$20240706$$CN$US$US
234942413$23494241$3$F$20231201$20240822$20240207$20240905$PER$$US-SA-2024SA039222$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240905$$MD$US$US
234942513$23494251$3$F$20240202$20240819$20240207$20240821$PER$$US-AMGEN-USASP2024025823$AMGEN$$66$YR$E$M$Y$$$20240821$$CN$US$US
234942582$23494258$2$F$20231021$20240923$20240207$20240925$EXP$$US-PFIZER INC-202400003720$PFIZER$$$$N$$Y$2.211$KG$20240925$$HP$US$US
234942603$23494260$3$F$$20240626$20240207$20240701$EXP$$US-PFIZER INC-202400033883$PFIZER$$66$YR$$M$Y$$$20240701$$CN$US$US
234942862$23494286$2$F$20231021$20240923$20240207$20240925$EXP$$US-PFIZER INC-202400003718$PFIZER$$$$N$$Y$2.01$KG$20240925$$HP$US$US
234943105$23494310$5$F$20230309$20240723$20240207$20240729$EXP$$AU-MYLANLABS-2024M1011742$MYLAN$$37$YR$$M$Y$$$20240729$$HP$AU$AU
234943462$23494346$2$F$20240201$20240725$20240207$20240726$PER$$US-AMGEN-USASP2024025102$AMGEN$$76$YR$E$M$Y$$$20240726$$CN$US$US
234943952$23494395$2$F$20240101$20240918$20240207$20240927$PER$$US-SA-2024SA038253$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240927$$MD$US$US
234943972$23494397$2$F$$20240725$20240207$20240801$PER$$US-BAYER-2024A020059$BAYER$$26$YR$A$F$Y$$$20240801$$CN$US$US
234943982$23494398$2$F$20240717$20240910$20240207$20240911$EXP$$US-TAKEDA-2024TUS010361$TAKEDA$$64$YR$$F$Y$$$20240911$$CN$US$US
234945183$23494518$3$F$$20240722$20240207$20240729$EXP$$CA-GSK-CA2024014803$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$CA$CA
234945973$23494597$3$F$20240204$20240722$20240207$20240724$PER$$US-AMGEN-USASP2024025365$AMGEN$$73$YR$E$M$Y$$$20240724$$MD$US$US
234946042$23494604$2$F$$20240718$20240207$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016175$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240726$$CN$US$US
234946316$23494631$6$F$$20240716$20240207$20240722$PER$$US-BIOVITRUM-2023-US-019719$BIOVITRUM$$78$YR$$F$Y$$$20240722$$CN$US$US
234946554$23494655$4$F$$20240717$20240207$20240722$EXP$$NVSC2024CN026050$NOVARTIS$$63$YR$$F$Y$$$20240722$$CN$CN$CN
234946852$23494685$2$F$$20240626$20240207$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202402002853$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240703$$CN$US$US
234946992$23494699$2$F$20240101$20240709$20240207$20240715$EXP$$US-SA-2024SA041411$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240715$$MD$US$US
234947735$23494773$5$F$20240101$20240723$20240207$20240729$EXP$$JP-009507513-2402JPN000350J$MERCK$$65$YR$$F$Y$$$20240729$$MD$JP$JP
234948232$23494823$2$F$$20240812$20240207$20240813$EXP$$US-KYOWAKIRIN-2024KK001927$KYOWA$$$$$$Y$$$20240813$$HP$US$US
234948242$23494824$2$F$$20240826$20240207$20240905$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK088781$GLENMARK$$$$$$Y$$$20240905$$HP$CA$CA
234948423$23494842$3$F$20240122$20240729$20240207$20240805$EXP$$CA-TAKEDA-2024TUS007592$TAKEDA$$64$YR$$F$Y$$$20240805$$HP$CA$CA
234948503$23494850$3$F$20220917$20240815$20240207$20240819$EXP$$JP-AstraZeneca-2024A010876$ASTRAZENECA$$88$YR$$F$Y$41$KG$20240819$$MD$JP$
234948675$23494867$5$F$20240109$20240814$20240207$20240821$EXP$$US-AstraZeneca-2024A031334$ASTRAZENECA$$1$MON$$F$Y$2.8$KG$20240821$$MD$US$
234949454$23494945$4$F$20240101$20240815$20240207$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017041$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240821$$CN$US$US
234950005$23495000$5$F$20231101$20240917$20240207$20240924$EXP$$IN-GSK-IN2023APC178264$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$IN$IN
234950432$23495043$2$F$20240108$20240823$20240207$20240902$30DAY$$US-GSK-US2024013076$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240902$$CN$US$US
234950519$23495051$9$F$$20240928$20240207$20240930$EXP$$US-PFIZER INC-202300360871$PFIZER$$70$YR$$F$Y$113.4$KG$20240930$$MD$US$US
234951674$23495167$4$F$$20240816$20240207$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020063$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240821$$CN$US$US
234951688$23495168$8$F$20240601$20240919$20240207$20240926$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-020256$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$75.75$KG$20240926$$CN$PR$PR
234952312$23495231$2$F$20231201$20240717$20240207$20240726$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00287$AMNEAL$$91$YR$$F$Y$$$20240726$$CN$US$US
234952343$23495234$3$F$20240101$20240813$20240207$20240820$PER$$US-SA-2024SA037674$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240820$$MD$US$US
234952643$23495264$3$F$$20240731$20240207$20240805$PER$$US-PFIZER INC-PV202400017092$PFIZER$$65$YR$$F$Y$$$20240805$$CN$US$US
234952964$23495296$4$F$20240205$20240731$20240207$20240805$PER$$US-PFIZER INC-202400022680$PFIZER$$77$YR$$F$Y$$$20240805$$MD$US$US
234953282$23495328$2$F$20231201$20240802$20240207$20240808$EXP$$US-ROCHE-3500794$ROCHE$$48$YR$A$M$Y$68.95$KG$20240808$$PH$US$US
234953307$23495330$7$F$20240301$20240920$20240207$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020192$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240924$$CN$US$US
234953683$23495368$3$F$$20240724$20240207$20240726$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-006247$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$US$US
234954827$23495482$7$F$$20240819$20240207$20240826$EXP$$US-TAKEDA-2023TUS065895$TAKEDA$$$$$M$Y$$$20240826$$CN$US$US
234955043$23495504$3$F$$20240715$20240207$20240716$PER$$US-PFIZER INC-202400033865$PFIZER$$72$YR$$F$Y$$$20240716$$MD$US$US
234955172$23495517$2$F$20240101$20240909$20240207$20240918$PER$$US-SA-2024SA037043$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240918$$MD$US$US
234955182$23495518$2$F$20240101$20240625$20240207$20240704$PER$$US-SA-2024SA040111$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240704$$CN$US$US
234955254$23495525$4$F$20230101$20240826$20240207$20240830$PER$$US-PFIZER INC-202400032833$PFIZER$$57$YR$$F$Y$65.77$KG$20240830$$CN$US$US
234955382$23495538$2$F$$20240821$20240207$20240827$PER$$US-BIOGEN-2024BI01247986$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
234955555$23495555$5$F$20231010$20240923$20240207$20240925$EXP$$US-ORGANON-O2402USA000537$ORGANON$$30$YR$$F$Y$83.46$KG$20240925$$HP$US$US
234955563$23495556$3$F$$20240717$20240207$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020004$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$54.43$KG$20240719$$CN$US$US
234955573$23495557$3$F$$20240820$20240207$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020250$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240823$$HP$US$US
234955663$23495566$3$F$$20240819$20240207$20240829$PER$$US-SA-2024SA037253$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240829$$MD$US$US
234955812$23495581$2$F$20240111$20240805$20240207$20240812$EXP$FR-AFSSAPS-BR2024000069$FR-MYLANLABS-2024M1010627$MYLAN$$46$YR$$F$Y$$$20240812$$MD$FR$FR
234956153$23495615$3$F$20220101$20240730$20240207$20240801$PER$$US-BIOGEN-2024BI01248132$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
234956543$23495654$3$F$20231225$20240628$20240207$20240708$PER$$JP-Eisai-EC-2023-156035$EISAI$$53$YR$A$M$Y$$$20240708$$MD$JP$JP
234957263$23495726$3$F$$20240722$20240207$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020359$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240723$$CN$US$US
234957706$23495770$6$F$20240123$20240911$20240207$20240923$EXP$$US-BEH-2024168270$CSL BEHRING$$43$YR$A$F$Y$$$20240923$$HP$US$US
234957728$23495772$8$F$20201118$20240913$20240207$20240919$EXP$$KR-OTSUKA-2023_027863$OTSUKA$$53$YR$$F$Y$$$20240919$$MD$KR$KR
234958105$23495810$5$F$20231201$20240829$20240207$20240905$EXP$$US-BEH-2024168277$CSL BEHRING$$33$YR$A$F$Y$$$20240905$$HP$US$US
234958613$23495861$3$F$20231101$20240724$20240207$20240801$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202402001793$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240801$$CN$JP$JP
234959152$23495915$2$F$$20240812$20240207$20240821$PER$$US-SA-2024SA036306$SANOFI AVENTIS$$$$T$M$Y$$$20240821$$MD$US$US
234959473$23495947$3$F$$20240713$20240207$20240725$EXP$$JP-TAKEDA-2024TUS011528$TAKEDA$Ishida T.. Up-to-date knowledge in multiple myeloma: including CAR-T, bispecific antibody$73$YR$$$Y$$$20240725$$MD$JP$JP
234961102$23496110$2$F$$20240812$20240207$20240815$PER$$US-ROCHE-3288522$ROCHE$$$$A$F$Y$$$20240815$$CN$US$US
234962352$23496235$2$F$$20240925$20240207$20240927$PER$$US-ROCHE-3412529$ROCHE$$25$YR$A$F$Y$$$20240927$$CN$US$US
234963472$23496347$2$F$$20240814$20240207$20240820$PER$$US-ROCHE-3299444$ROCHE$$$$A$F$Y$$$20240820$$CN$US$US
234963672$23496367$2$F$$20240616$20240207$20240716$PER$$US-ROCHE-3467184$ROCHE$$19$YR$A$F$Y$$$20240716$$CN$US$US
234964952$23496495$2$F$$20240813$20240208$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-006375$AUROBINDO$Pang M, Saleh H, Ailawadhi S, Pang S, Edgar M. Acute esophageal stricture after bone marrow transplant. Clinical Journal of Gastroenterology. 2023;17:1-5$58$YR$$M$Y$$$20240827$$HP$US$US
234965094$23496509$4$F$20240703$20240710$20240208$20240717$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00297$AMNEAL$$68$YR$$M$Y$84.354$KG$20240717$$CN$US$US
234967204$23496720$4$F$$20240713$20240207$20240725$EXP$$JP-TAKEDA-2024TUS011446$TAKEDA$Ishida T. Up to date knowledge in multiple myeloma: including CAR-T, bispecific antibody$73$YR$$$Y$$$20240725$$MD$JP$JP
234971164$23497116$4$F$20240122$20240906$20240208$20240912$30DAY$$US-PFIZER INC-202400023176$PFIZER$$14$YR$$M$Y$$$20240912$$CN$US$US
234971352$23497135$2$F$$20240725$20240207$20240729$PER$$US-ROCHE-3479746$ROCHE$$60$YR$A$F$Y$$$20240729$$CN$US$US
234971603$23497160$3$F$20240130$20240725$20240208$20240730$EXP$$JP-BAYER-2024A021896$BAYER$$56$YR$A$M$Y$73$KG$20240730$$MD$JP$JP
234971832$23497183$2$F$20231125$20240723$20240208$20240729$EXP$$NVSC2024CN025692$NOVARTIS$$$$A$M$Y$40$KG$20240729$$MD$CN$CN
234972246$23497224$6$F$20240128$20240904$20240208$20240911$EXP$$CA-GSK-CA2023167076$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$HP$CA$CA
234972484$23497248$4$F$$20240904$20240208$20240909$30DAY$$AR-PFIZER INC-PV202400008282$PFIZER$$12$YR$$F$Y$$$20240909$$CN$AR$AR
234972562$23497256$2$F$$20240826$20240207$20240829$PER$$US-ROCHE-3480113$ROCHE$$20$YR$A$F$Y$$$20240829$$MD$US$US
234973013$23497301$3$F$20230101$20240702$20240208$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020231$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240703$$CN$US$US
234973463$23497346$3$F$20230901$20240918$20240208$20240926$PER$$US-SA-2024SA042326$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240926$$MD$US$US
234973472$23497347$2$F$20240101$20240709$20240208$20240717$PER$$US-SA-2024SA042969$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240717$$MD$US$US
234973755$23497375$5$F$20240101$20240816$20240208$20240826$PER$$US-SA-2024SA039232$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240826$$MD$US$US
234973912$23497391$2$F$$20240815$20240208$20240828$PER$$US-SA-2024SA039245$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240828$$MD$US$US
234975022$23497502$2$F$$20240925$20240207$20240930$PER$$US-ROCHE-3388343$ROCHE$$$$$F$Y$$$20240930$$MD$US$US
234975124$23497512$4$F$20240101$20240726$20240208$20240807$PER$$US-SA-2024SA041538$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240807$$MD$US$US
234975774$23497577$4$F$20230101$20240624$20240208$20240703$PER$$US-SA-2024SA044021$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240703$$MD$US$US
234976703$23497670$3$F$20220101$20240806$20240208$20240809$EXP$$US-PFIZER INC-PV202400016399$PFIZER$$31$YR$$F$Y$$$20240809$$CN$US$US
234977163$23497716$3$F$$20240709$20240208$20240714$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017406$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$54.9$KG$20240715$$CN$US$US
234979193$23497919$3$F$20240721$20240722$20240207$20240830$PER$$US-ROCHE-3314674$ROCHE$$29$YR$A$F$Y$$$20240830$$CN$US$US
234981302$23498130$2$F$$20240819$20240207$20240821$PER$$US-ROCHE-3434412$ROCHE$$37$YR$A$F$Y$$$20240821$$HP$US$US
234981432$23498143$2$F$$20240809$20240207$20240815$PER$$US-ROCHE-3404195$ROCHE$$62$YR$A$F$Y$$$20240815$$MD$US$US
234981732$23498173$2$F$$20240722$20240207$20240723$PER$$US-ROCHE-3391203$ROCHE$$$$A$M$Y$$$20240723$$MD$US$US
234982023$23498202$3$F$20240308$20240816$20240207$20240829$PER$$US-SA-2024SA039348$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240829$$MD$US$US
234983034$23498303$4$F$20231101$20240903$20240207$20240909$EXP$$NL-ABBVIE-5623006$ABBVIE$$$$A$M$Y$83$KG$20240909$$CN$NL$NL
234983266$23498326$6$F$20231123$20240910$20240207$20240912$PER$$US-ROCHE-3368597$ROCHE$$35$YR$A$F$Y$125.19$KG$20240912$$CN$US$US
234984093$23498409$3$F$20240131$20240911$20240207$20240920$EXP$$US-BEH-2024168117$CSL BEHRING$$21$YR$A$M$Y$$$20240920$$HP$US$US
234984272$23498427$2$F$20230312$20240628$20240207$20240709$PER$$US-ROCHE-3317049$ROCHE$$46$YR$A$F$Y$$$20240705$$CN$US$US
234984452$23498445$2$F$$20240806$20240207$20240812$PER$$US-ALXN-202401USA002199US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
234984942$23498494$2$F$$20240805$20240208$20240815$EXP$$US-RADIUS HEALTH, INC.-2024US000544$RADIUS PHARM$$$$$F$Y$$$20240815$$CN$US$US
234985346$23498534$6$F$20100521$20240723$20240207$20240728$EXP$$CA-JNJFOC-20220907750$JOHNSON AND JOHNSON$$27$YR$A$F$Y$83$KG$20240728$$HP$CA$CA
234985613$23498561$3$F$$20240829$20240207$20240902$PER$$US-ROCHE-3322203$ROCHE$$$$A$F$Y$$$20240902$$CN$US$US
234986143$23498614$3$F$20210724$20240827$20240207$20240904$EXP$$JP-ROCHE-3011133$ROCHE$$37$YR$A$F$Y$80.2$KG$20240904$$MD$JP$JP
234986242$23498624$2$F$20231101$20240708$20240207$20240709$EXP$$US-ABBVIE-5621522$ABBVIE$$48$YR$$F$Y$$$20240709$$CN$US$US
234986376$23498637$6$F$20240126$20240607$20240207$20240702$30DAY$$US-JNJFOC-20240180130$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240702$$MD$US$US
234986402$23498640$2$F$20210101$20240716$20240207$20240722$EXP$$BR-TAKEDA-2024TUS011162$TAKEDA$$$$$M$Y$$$20240722$$CN$BR$BR
234986493$23498649$3$F$20240101$20240821$20240207$20240902$EXP$$US-BEH-2024168337$CSL BEHRING$$61$YR$A$F$Y$78.49$KG$20240902$$HP$US$US
234986673$23498667$3$F$20240627$20240627$20240207$20240701$EXP$$CA-TAKEDA-2024TUS010690$TAKEDA$$63$YR$$M$Y$$$20240701$$MD$CA$CA
234986688$23498668$8$F$20240101$20240903$20240207$20240906$EXP$$CA-TAKEDA-2024TUS010747$TAKEDA$$24$YR$$F$Y$$$20240906$$MD$CA$CA
234987262$23498726$2$F$$20240725$20240207$20240809$EXP$$CA-SSPHARMA-2024CASSP00005$SS PHARMA$$65$YR$A$M$Y$$$20240809$$HP$CA$CA
234987663$23498766$3$F$20231201$20240720$20240208$20240730$PER$$US-SA-2024SA041892$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240730$$MD$US$US
234988044$23498804$4$F$$20240628$20240208$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015321$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240701$$CN$US$US
234988182$23498818$2$F$20240205$20240819$20240208$20240821$PER$$US-AMGEN-USASP2024025054$AMGEN$$85$YR$E$F$Y$$$20240821$$CN$US$US
234988442$23498844$2$F$$20240626$20240208$20240703$EXP$$GR-CELLTRION INC.-2024GR002661$CELLTRION$Kougas N.. Differentiation of drug action in diseases with common pathogenetic mechanisms. The example of IBD.. 15th PANHELLENIC CONGRESS OF THE SCIENTIFIC SOCIETY FOR MUSCULOSKELETAL HEALTH. 2023$$$$$Y$$$20240703$$HP$GR$GR
234988452$23498845$2$F$20240201$20240715$20240208$20240722$EXP$$US-ABBVIE-5623583$ABBVIE$$68$YR$$F$Y$$$20240722$$CN$US$US
234988594$23498859$4$F$$20240805$20240208$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-018788$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240807$$HP$US$US
234988772$23498877$2$F$$20240903$20240208$20240911$EXP$$US-RDY-SPO/USA/24/0002229$DR REDDYS$$40$YR$A$M$Y$$$20240911$$HP$US$US
234989084$23498908$4$F$20240130$20240725$20240208$20240726$EXP$$GB-ABBVIE-5627749$ABBVIE$$23$YR$$F$Y$62.6$KG$20240726$$MD$GB$GB
234989324$23498932$4$F$$20240724$20240208$20240730$EXP$$BR-JNJFOC-20230914383$JOHNSON AND JOHNSON$$51$YR$A$F$Y$93$KG$20240730$$CN$BR$BR
234989902$23498990$2$F$$20240723$20240208$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020350$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240724$$CN$US$US
234990073$23499007$3$F$$20240831$20240208$20240912$PER$$US-AMGEN-USASP2024025537$AMGEN$$$$E$F$Y$$$20240911$$HP$US$US
234990124$23499012$4$F$20231228$20240805$20240208$20240820$EXP$$CN-ROCHE-3499656$ROCHE$$54$YR$A$M$Y$80$KG$20240820$$MD$CN$CN
234990472$23499047$2$F$$20240712$20240208$20240716$EXP$$JP-TAKEDA-2024TJP002178$TAKEDA$$78$YR$$M$Y$$$20240716$$MD$JP$JP
234990644$23499064$4$F$20231219$20240830$20240208$20240901$EXP$$NVSC2024US007251$NOVARTIS$$62$YR$$F$Y$$$20240902$$CN$US$US
234991172$23499117$2$F$20230101$20240711$20240208$20240720$EXP$$CA-CELLTRION INC.-2023CA007633$CELLTRION$$$$$$Y$$$20240720$$CN$CA$CA
234991454$23499145$4$F$$20240715$20240208$20240720$EXP$$US-ABBVIE-5529354$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
234991472$23499147$2$F$$20240819$20240208$20240827$PER$$US-ROCHE-3452621$ROCHE$Kuhar B, Bailey J, Blackorby B. Corneoscleral Melt After Implantation of a Ranibizumab Port Delivery System. Ophthalmology. 2024;131 (9):1075. doi:10.1016/j.ophtha.2023.09.030.$91$YR$E$F$Y$$$20240827$$MD$US$US
234991482$23499148$2$F$$20240815$20240208$20240826$PER$$US-ROCHE-3466445$ROCHE$$77$YR$E$M$Y$$$20240826$$CN$US$US
234991752$23499175$2$F$20240101$20240920$20240208$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017543$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240923$$CN$US$US
234993233$23499323$3$F$$20240909$20240208$20240913$EXP$$US-TAKEDA-2024TUS011204$TAKEDA$$$$$M$Y$$$20240913$$HP$US$US
234993425$23499342$5$F$20240201$20240611$20240208$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000462$ACADIA PHARMACEUTICALS$$17$YR$$F$Y$$$20240705$$CN$US$US
234993483$23499348$3$F$20231129$20240904$20240208$20240910$EXP$$DE-ROCHE-3505233$ROCHE$$81$YR$E$F$Y$$$20240910$$MD$DE$DE
234993583$23499358$3$F$$20240919$20240208$20240926$PER$$US-GSK-US2024012931$GLAXOSMITHKLINE$$$$$M$Y$$$20240926$$CN$US$US
234993693$23499369$3$F$20220510$20240729$20240208$20240802$EXP$$CO-TAKEDA-2022TUS032528$TAKEDA$$46$YR$$F$Y$62$KG$20240802$$CN$CO$CO
234993966$23499396$6$F$20230323$20240827$20240208$20240926$PER$$US-SA-2024SA036043$SANOFI AVENTIS$$56$YR$A$F$Y$56.6$KG$20240926$$MD$US$US
234994632$23499463$2$F$20231111$20240731$20240208$20240805$EXP$$CA-JNJFOC-20231253247$JOHNSON AND JOHNSON$$31$YR$A$M$Y$58$KG$20240805$$HP$CA$CA
234994962$23499496$2$F$$20240830$20240208$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020479$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240902$$HP$US$US
234994992$23499499$2$F$20240122$20240701$20240208$20240702$PER$$US-AMGEN-USASP2024025648$AMGEN$$63$YR$A$F$Y$$$20240701$$CN$US$US
234995365$23499536$5$F$$20240713$20240208$20240725$EXP$$JP-TAKEDA-2024TUS011522$TAKEDA$Ishida T.. New developments in treatment strategies for multiple myeloma; mainly focused on high-risk factors, MRD negativity, and CAR-T therap. Multiple Myeloma Seminar in Yamagata 2024. 2024$51$YR$$$Y$$$20240725$$MD$JP$JP
234995436$23499543$6$F$20240131$20240815$20240208$20240820$EXP$$CA-JNJFOC-20240210344$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240820$$HP$CA$CA
234995502$23499550$2$F$$20240709$20240208$20240716$EXP$$CA-GSK-CA2024015391$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$CA$CA
234995513$23499551$3$F$20240101$20240724$20240208$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020529$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240731$$CN$US$US
234995525$23499552$5$F$20180615$20240902$20240208$20240906$EXP$$JP-GILEAD-2019-0402932$GILEAD$$77$YR$E$M$Y$$$20240906$$MD$JP$JP
234996166$23499616$6$F$$20240906$20240208$20240910$EXP$$CA-JNJFOC-20240115883$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240910$$HP$CA$CA
234996463$23499646$3$F$$20240730$20240208$20240731$EXP$$GB-ROCHE-3505725$ROCHE$$$$I$F$Y$$$20240731$$HP$GB$GB
234997432$23499743$2$F$$20240826$20240208$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR016931$VIIV$$$$$$Y$$$20240905$$HP$US$US
234998414$23499841$4$F$20160926$20240708$20240208$20240821$EXP$$CA-TEVA-202008_00010229$TEVA$$72$YR$$F$Y$$$20240821$$HP$CA$CA
234998743$23499874$3$F$20240710$20240710$20240208$20240715$EXP$$CA-TAKEDA-2023TUS115107$TAKEDA$$56$YR$$F$Y$$$20240715$$HP$CA$CA
234998762$23499876$2$F$20240203$20240829$20240208$20240830$PER$$US-AMGEN-USASP2024025043$AMGEN$$56$YR$A$M$Y$$$20240830$$CN$US$US
234998772$23499877$2$F$20240201$20240730$20240208$20240803$PER$$US-AMGEN-USASP2024024810$AMGEN$$74$YR$E$F$Y$$$20240802$$CN$US$US
234999022$23499902$2$F$$20240124$20240208$20240923$PER$$AR-ROCHE-3498088$ROCHE$$$$$$Y$$$20240923$$MD$AR$AR
234999162$23499916$2$F$20211028$20240807$20240208$20240813$EXP$$CA-TAKEDA-2021TUS055393$TAKEDA$$38$YR$$F$Y$$$20240813$$MD$CA$CA
234999243$23499924$3$F$20231205$20240205$20240208$20240829$EXP$$US-009507513-2402USA002053$MERCK$$61$YR$$M$Y$$$20240829$$HP$US$US
234999395$23499939$5$F$20240202$20240709$20240208$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000041$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
234999466$23499946$6$F$20240106$20240823$20240208$20240902$EXP$$CA-GSK-CA2023088550$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$HP$CA$CA
234999602$23499960$2$F$20240131$20240814$20240208$20240816$PER$$US-AMGEN-USASP2024027044$AMGEN$$76$YR$E$M$Y$$$20240816$$MD$US$US
235000173$23500017$3$F$20210501$20240826$20240208$20240827$EXP$$FR-SANDOZ INC.-SDZ2024FR012439$SANDOZ$$71$YR$$M$Y$$$20240827$$MD$FR$FR
235000203$23500020$3$F$20240101$20240909$20240208$20240919$EXP$$US-UCBSA-2024005647$UCB$$$$$F$Y$97.506$KG$20240919$$HP$US$US
235000243$23500024$3$F$20240106$20240816$20240208$20240826$EXP$$CA-CELLTRION INC.-2024CA002833$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
235000284$23500028$4$F$20240118$20240722$20240208$20240805$EXP$$JP-ABBVIE-4160845$ABBVIE$$53$YR$$F$Y$$$20240805$$CN$JP$JP
235001773$23500177$3$F$$20240701$20240208$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020459$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240702$$CN$US$US
235001813$23500181$3$F$20230608$20240625$20240208$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-020266$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$60$KG$20240703$$MD$JP$JP
235002162$23500216$2$F$20220525$20240625$20240208$20240701$EXP$$DE-UCBSA-2022059889$UCB$$61$YR$$M$Y$84$KG$20240701$$MD$DE$DE
235002202$23500220$2$F$$20240723$20240208$20240728$EXP$$CA-JNJFOC-20240210666$JOHNSON AND JOHNSON$$$$$F$Y$$$20240728$$HP$CA$CA
235002303$23500230$3$F$$20240703$20240208$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020632$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$47.17$KG$20240704$$CN$US$US
235002322$23500232$2$F$$20240130$20240208$20240926$PER$$US-GSK-US2024AMR015127$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
235002816$23500281$6$F$20240101$20240917$20240208$20240926$EXP$$CA-CELLTRION INC.-2024CA002849$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
235003085$23500308$5$F$20231201$20240723$20240208$20240725$EXP$FR-AFSSAPS-AN2024000116$FR-JNJFOC-20240211190$JOHNSON AND JOHNSON$$71$YR$E$M$Y$118$KG$20240725$$PH$FR$FR
235003113$23500311$3$F$20231201$20240912$20240208$20240921$EXP$$US-UCBSA-2024005929$UCB$$30$YR$$F$Y$$$20240922$$HP$US$US
235003204$23500320$4$F$20240131$20240920$20240208$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-020020$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$MD$JP$JP
235004006$23500400$6$F$20230101$20240719$20240208$20240725$EXP$$CA-UCBSA-2023012101$UCB$$$$$M$Y$91.36$KG$20240725$$CN$CA$CA
235004385$23500438$5$F$$20240827$20240208$20240902$EXP$$US-TAKEDA-2024TUS008530$TAKEDA$$$$$M$Y$76$KG$20240902$$HP$US$US
235005142$23500514$2$F$20230705$20240705$20240208$20240709$EXP$$DE-UCBSA-2023045658$UCB$$67$YR$$F$Y$66$KG$20240709$$MD$DE$DE
235005623$23500562$3$F$$20240715$20240208$20240724$EXP$$GB-Accord-405774$ACCORD$$81$YR$E$M$Y$$$20240724$$CN$GB$GB
235005815$23500581$5$F$20240131$20240829$20240208$20240906$EXP$$CA-CELLTRION INC.-2023CA025327$CELLTRION$$$$$$Y$$$20240906$$MD$CA$CA
235005906$23500590$6$F$20230829$20240920$20240208$20240925$PER$$US-BIOGEN-2023BI01225449$BIOGEN$$75$YR$$F$Y$$$20240925$$CN$US$US
235005994$23500599$4$F$$20240627$20240208$20240705$EXP$$US-ALXN-202401USA002207US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240705$$MD$US$US
235006503$23500650$3$F$20230817$20240731$20240208$20240806$EXP$$BR-TAKEDA-2023TUS086535$TAKEDA$$53$YR$$M$Y$$$20240806$$CN$BR$BR
235007113$23500711$3$F$$20240711$20240208$20240721$EXP$$US-BAYER-2024A020979$BAYER$$64$YR$A$M$Y$$$20240719$$CN$US$US
235008172$23500817$2$F$$20240709$20240208$20240712$EXP$$JP-ALXN-202401JPN002281JP$ALEXION PHARMACEUTICALS$$47$YR$$M$Y$$$20240712$$MD$JP$JP
235008662$23500866$2$F$20240104$20240716$20240208$20240718$EXP$$CN-PFIZER INC-PV202400017262$PFIZER$$57$YR$$F$Y$60$KG$20240718$$HP$CN$CN
235008905$23500890$5$F$$20240828$20240208$20240902$EXP$$NVSC2024US024837$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
235009662$23500966$2$F$$20240205$20240208$20240723$PER$$US-BAYER-2024A020914$BAYER$$79$YR$E$F$Y$$$20240723$$CN$US$US
235009903$23500990$3$F$$20240830$20240208$20240905$EXP$$US-TAKEDA-2023TUS121967$TAKEDA$$$$$F$Y$$$20240905$$CN$US$US
235010614$23501061$4$F$$20240821$20240208$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-00735$LUPIN$$$$$$Y$$$20240905$$CN$US$US
235010672$23501067$2$F$$20240715$20240208$20240723$PER$$US-INCYTE CORPORATION-2024IN001115$INCYTE$$$$$$Y$$$20240723$$CN$US$US
235010952$23501095$2$F$$20240129$20240208$20240925$PER$$US-GSK-US2022021521$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
2350136010$23501360$10$F$$20240903$20240208$20240910$EXP$$HR-ABBVIE-5628042$ABBVIE$$56$YR$$F$Y$$$20240910$$MD$HR$HR
235013617$23501361$7$F$$20240731$20240208$20240805$EXP$$CA-JNJFOC-20240155502$JOHNSON AND JOHNSON$$73$YR$E$M$Y$81$KG$20240805$$PH$CA$CA
235013715$23501371$5$F$$20240814$20240208$20240821$EXP$$US-SA-2024SA044674$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240821$$MD$US$US
235013993$23501399$3$F$20240101$20240628$20240208$20240705$PER$$US-SA-2024SA041522$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240705$$MD$US$US
235014744$23501474$4$F$$20240713$20240208$20240725$EXP$$JP-TAKEDA-2024TUS011477$TAKEDA$Ishida T. Up-to-date knowledge in multiple myeloma: including CAR-T, bispecific antibody. 2024$73$YR$$$Y$$$20240725$$MD$JP$JP
235015435$23501543$5$F$20240501$20240905$20240208$20240911$EXP$$CA-GSK-CA2023133716$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$HP$CA$CA
235016014$23501601$4$F$20240206$20240829$20240208$20240902$PER$$US-AMGEN-USASP2024026934$AMGEN$$78$YR$E$F$Y$$$20240901$$CN$US$US
235016033$23501603$3$F$20230823$20240724$20240208$20240801$EXP$$JP-AstraZeneca-2023A252921$ASTRAZENECA$$79$YR$$F$Y$43$KG$20240801$$MD$JP$
235016242$23501624$2$F$20231011$20240703$20240208$20240708$EXP$$US-ABBVIE-5624249$ABBVIE$$70$YR$$F$Y$$$20240708$$CN$US$US
235016285$23501628$5$F$20231101$20240712$20240208$20240721$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000266$BLUEPRINT MEDICINES$$71$YR$E$M$Y$$$20240719$$CN$US$US
235016782$23501678$2$F$$20240314$20240208$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088508$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
235017223$23501722$3$F$$20240918$20240208$20240930$PER$$NVSC2024US028194$NOVARTIS$$$$$F$Y$83$KG$20240930$$MD$US$US
235017542$23501754$2$F$$20240722$20240208$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020046$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240723$$CN$US$US
235018212$23501821$2$F$20240507$20240621$20240208$20240812$PER$$US-ANIPHARMA-2023-US-044853$ANI$$48$YR$$M$Y$$$20240812$$HP$US$US
2350191211$23501912$11$F$20240212$20240708$20240208$20240711$EXP$$US-PFIZER INC-PV202400018282$PFIZER$$74$YR$$M$Y$77.11$KG$20240711$$CN$US$US
235019344$23501934$4$F$$20240920$20240208$20240924$PER$$US-PFIZER INC-202300315091$PFIZER$$55$YR$$F$Y$$$20240924$$CN$US$US
235019464$23501946$4$F$$20240711$20240208$20240715$PER$$US-PFIZER INC-202300022015$PFIZER$$69$YR$$F$Y$100.24$KG$20240715$$CN$US$US
235019592$23501959$2$F$$20240813$20240208$20240819$PER$$US-PFIZER INC-202400036067$PFIZER$$30$YR$$M$Y$$$20240819$$CN$US$US
235019852$23501985$2$F$$20240715$20240208$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202402005125$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240731$$CN$US$US
235020275$23502027$5$F$20231103$20240730$20240208$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202402000790$ELI LILLY AND CO$$41$YR$A$F$Y$59$KG$20240809$$CN$JP$JP
235020423$23502042$3$F$20211130$20240826$20240208$20240830$EXP$$DE-PFIZER INC-202201265545$PFIZER$$$$E$F$Y$$$20240830$$MD$DE$DE
235020554$23502055$4$F$$20240826$20240208$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020729$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240902$$CN$US$US
235020803$23502080$3$F$$20240802$20240208$20240805$30DAY$$US-SANDOZ INC.-SDZ2023US075749$SANDOZ$$$$$$Y$$$20240805$$HP$US$US
235021073$23502107$3$F$20240101$20240328$20240208$20240930$PER$$US-SA-2024SA036791$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240930$$HP$US$US
235021082$23502108$2$F$$20240911$20240208$20240918$EXP$$PT-009507513-2401PRT013276$MERCK$Vale C, Matias P, Toste A, Pinheiro I, Sousa S, Goncalves M, et al.. Tubulointerstitial nephritis due to pembrolizumab. Abstract book - 30 Internal Medicine National Congress.. 2024;652$45$YR$$F$Y$$$20240918$$MD$PT$PT
235021153$23502115$3$F$20240131$20240626$20240208$20240701$EXP$$US-OTSUKA-2024_002775$OTSUKA$$42$YR$$F$Y$$$20240701$$MD$US$US
235021652$23502165$2$F$20240112$20240724$20240208$20240726$EXP$$CN-PFIZER INC-PV202400017182$PFIZER$$32$YR$$F$Y$$$20240726$$HP$CN$CN
235022004$23502200$4$F$$20240926$20240208$20240928$PER$$US-DAIICHI SANKYO, INC.-DSU-2023-143688$DAIICHI$$$$$F$Y$79.4$KG$20240928$$MD$US$US
235022113$23502211$3$F$$20240731$20240208$20240906$PER$$US-LUNDBECK-DKLU3072334$LUNDBECK$$$$$$Y$$$20240906$$CN$US$US
235032493$23503249$3$F$20240722$20240723$20240208$20240904$PER$$US-LUNDBECK-DKLU3072370$LUNDBECK$$$$$$Y$$$20240904$$HP$US$US
235033654$23503365$4$F$$20240611$20240208$20240703$30DAY$$FR-JNJFOC-20240166957$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$FR$FR
235033713$23503371$3$F$20240101$20240725$20240208$20240806$PER$$US-SA-2024SA041932$SANOFI AVENTIS$$66$YR$E$F$Y$80.73$KG$20240806$$MD$US$US
235034103$23503410$3$F$20240101$20240905$20240208$20240912$EXP$$US-ABBVIE-5624674$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
235034142$23503414$2$F$20230101$20240626$20240208$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-000180$AUROBINDO$$61$YR$$F$Y$54$KG$20240704$$CN$FR$FR
235034273$23503427$3$F$$20240809$20240208$20240815$PER$$US-ALXN-202402USA000103US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240815$$CN$US$US
235034533$23503453$3$F$20231201$20240703$20240208$20240706$EXP$$CA-TAKEDA-2023TUS118256$TAKEDA$$67$YR$$M$Y$$$20240706$$HP$CA$CA
235034579$23503457$9$F$20230612$20240909$20240208$20240917$EXP$$CA-GSK-CA2023AMR063835$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$CA$CA
235034885$23503488$5$F$20230101$20240820$20240208$20240828$EXP$$CA-CELLTRION INC.-2023CA023371$CELLTRION$$$$$$Y$$$20240828$$CN$CA$CA
235035018$23503501$8$F$$20240913$20240208$20240917$EXP$$CA-ROCHE-3505968$ROCHE$$$$A$F$Y$$$20240917$$CN$CA$CA
235035144$23503514$4$F$$20240717$20240208$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020808$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240719$$HP$US$US
2350354711$23503547$11$F$$20240801$20240209$20240806$PER$$US-ROCHE-3506013$ROCHE$$$$A$M$Y$$$20240806$$CN$US$US
235035532$23503553$2$F$$20240705$20240209$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-021532$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240711$$PH$US$US
235035724$23503572$4$F$$20240909$20240208$20240914$EXP$$US-ABBVIE-5629055$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
235036547$23503654$7$F$20231201$20240902$20240208$20240911$EXP$$GB-CELLTRION INC.-2024GB002797$CELLTRION$$$$$$Y$$$20240911$$HP$GB$GB
235037262$23503726$2$F$$20240723$20240209$20240726$EXP$$CA-JNJFOC-20240205057$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240726$$HP$CA$CA
235037544$23503754$4$F$20240101$20240725$20240209$20240808$EXP$$US-UCBSA-2024006213$UCB$$$$$F$Y$$$20240808$$CN$US$US
235038005$23503800$5$F$20231212$20240624$20240209$20240702$EXP$$JP-ABBVIE-5623742$ABBVIE$$84$YR$$F$Y$52$KG$20240702$$MD$JP$JP
235038144$23503814$4$F$$20240917$20240209$20240925$EXP$$IT-CELLTRION INC.-2024IT002877$CELLTRION$Angeletti, A.. Efficacy of Combined Rituximab and Daratumumab Treatment in Post-Transplant Recurrent FSGS.. American journal of transplantation.. 2023$$$$$Y$$$20240925$$MD$IT$IT
235038476$23503847$6$F$$20240713$20240209$20240727$EXP$$JP-TAKEDA-2024TUS012368$TAKEDA$$56$YR$$$Y$$$20240727$$MD$JP$JP
235038724$23503872$4$F$20231101$20240819$20240209$20240823$EXP$$DE-BIOGEN-2024BI01248780$BIOGEN$$29$YR$$F$Y$$$20240823$$MD$DE$DE
235039094$23503909$4$F$$20240813$20240209$20240821$EXP$$JP-ABBVIE-5422514$ABBVIE$$$$$F$Y$$$20240821$$MD$JP$JP
235039293$23503929$3$F$20240112$20240722$20240209$20240723$EXP$CZ-CZSUKL-24000252$CZ-PFIZER INC-202400033502$PFIZER$$86$YR$$F$Y$47$KG$20240723$$MD$CZ$CZ
235039732$23503973$2$F$20180101$20240729$20240209$20240809$EXP$$US-NOVOPROD-1171064$NOVO NORDISK$$61$YR$$M$Y$$$20240809$$CN$US$US
235039807$23503980$7$F$20240101$20240802$20240209$20240810$EXP$$CA-CELLTRION INC.-2024CA002184$CELLTRION$$$$$$Y$$$20240810$$HP$CA$CA
235039942$23503994$2$F$20240101$20240130$20240209$20240926$PER$$US-GSK-US2024AMR014292$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240926$$CN$US$US
235039965$23503996$5$F$20240101$20240605$20240209$20240926$PER$$US-GSK-US2024AMR014814$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240926$$CN$US$US
235040074$23504007$4$F$20240205$20240624$20240209$20240701$EXP$$US-SHIRE-US201727941$TAKEDA$$77$YR$$F$Y$$$20240701$$HP$US$US
235040497$23504049$7$F$20240101$20240724$20240209$20240727$EXP$$US-UNITED THERAPEUTICS-UNT-2024-003127$UNITED THERAPEUTICS$$53$YR$$M$Y$82.54$KG$20240727$$$US$US
235040865$23504086$5$F$$20240718$20240209$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202402004698$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240722$$HP$US$US
235041092$23504109$2$F$20240202$20240728$20240209$20240730$PER$$US-AMGEN-USASP2024024464$AMGEN$$69$YR$E$F$Y$$$20240730$$CN$US$US
235041113$23504111$3$F$$20240918$20240209$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-021335$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240923$$CN$US$US
235041132$23504113$2$F$20240131$20240704$20240209$20240711$EXP$CA-MMM-GXBJAMC4$CA-GSK-CA2023102947$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$CA$CA
235041173$23504117$3$F$20231201$20240813$20240209$20240823$EXP$$AU-GILEAD-2024-0661159$GILEAD$$32$YR$A$F$Y$$$20240823$$CN$AU$AU
235041234$23504123$4$F$20220101$20240903$20240209$20240913$EXP$$AU-ROCHE-3505903$ROCHE$Dessauer A, Hussey D, Khan S, McLean C and Gardiner B Cytomegalovirus and Aspergillus co-infection in an immunocompetent patient with severe COVID-19, DOI :10.1016/j.pathol.2023.05.018. Pathology 2024 Feb;56 (1):110-4.$48$YR$A$M$Y$$$20240913$$MD$AU$AU
235041692$23504169$2$F$20240201$20240723$20240209$20240726$PER$$US-AMGEN-USASP2024027316$AMGEN$$54$YR$A$F$Y$$$20240726$$CN$US$US
235041872$23504187$2$F$20240207$20240710$20240209$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202402004956$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240722$$CN$US$US
235041904$23504190$4$F$$20240723$20240209$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-021138$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$71.67$KG$20240724$$CN$US$US
235041965$23504196$5$F$$20240903$20240209$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-021119$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240904$$CN$US$US
235042243$23504224$3$F$20211104$20240805$20240209$20240806$EXP$$DE-SANDOZ INC.-NVSC2022DE106712$SANDOZ$$57$YR$$M$Y$$$20240806$$MD$DE$DE
235042273$23504227$3$F$20231219$20240809$20240209$20240813$EXP$$CA-JNJFOC-20240204341$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240813$$HP$CA$CA
235042286$23504228$6$F$20080101$20240724$20240209$20240802$PER$$US-ABBVIE-5624482$ABBVIE$$$$$F$Y$92.532$KG$20240802$$CN$US$US
235043212$23504321$2$F$20231006$20240801$20240209$20240813$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00853$HIKMA$$12$YR$$F$Y$39.4$KG$20240813$$HP$US$US
235043384$23504338$4$F$$20240703$20240209$20240703$PER$$US-ALXN-202402USA000177US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$MD$US$US
235043632$23504363$2$F$$20240628$20240209$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202402004456$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240701$$CN$US$US
235045304$23504530$4$F$20200401$20240918$20240209$20240930$EXP$$AT-KOANAAP-SML-AT-2023-00787$UNKNOWN$$51$YR$A$M$Y$73$KG$20240930$$MD$AT$AT
235046006$23504600$6$F$20220823$20240828$20240209$20240905$EXP$$CA-CELLTRION INC.-2022CA014093$CELLTRION$$$$$$Y$$$20240905$$MD$CA$CA
235046044$23504604$4$F$20200729$20240717$20240209$20240725$EXP$$CA-CELLTRION INC.-2021CA018465$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
235046535$23504653$5$F$20220101$20240912$20240209$20240923$PER$$US-ABBVIE-2236441US$ABBVIE$$$$$F$Y$86$KG$20240923$$CN$US$US
2350475811$23504758$11$F$20231001$20240917$20240209$20240924$EXP$$CA-GSK-CA2023138975$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$CA$CA
235047662$23504766$2$F$20240831$20240909$20240209$20240918$EXP$$US-RDY-SPO/USA/24/0002167$DR REDDYS$$31$YR$A$M$Y$$$20240918$$HP$US$US
235048192$23504819$2$F$20220413$20240708$20240209$20240711$EXP$$JP-GILEAD-2022-0609264$GILEAD$$37$YR$A$F$Y$$$20240711$$MD$JP$JP
235048475$23504847$5$F$$20240614$20240209$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000247$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
235050505$23505050$5$F$20230101$20240917$20240209$20240919$PER$$US-AMGEN-USASP2024027170$AMGEN$$66$YR$E$F$Y$$$20240919$$CN$US$US
235050584$23505058$4$F$20210127$20240731$20240209$20240805$EXP$$US-SA-2021SA052317$SANOFI AVENTIS$$59$YR$A$M$Y$63.3$KG$20240805$$HP$US$US
235052384$23505238$4$F$$20240911$20240209$20240914$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-006868$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$96$KG$20240914$$HP$CA$CA
235052756$23505275$6$F$20231207$20240625$20240209$20240704$EXP$$DE-JNJFOC-20240205944$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240705$$HP$DE$DE
235052903$23505290$3$F$20230901$20240705$20240209$20240711$EXP$$JP-ROCHE-3455117$ROCHE$$74$YR$E$M$Y$49.6$KG$20240711$$MD$JP$JP
235056006$23505600$6$F$20240101$20240917$20240209$20240924$EXP$$CA-TAKEDA-2024TUS010773$TAKEDA$$$$$F$Y$$$20240924$$HP$CA$CA
235056353$23505635$3$F$$20240829$20240209$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-021280$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240906$$HP$US$US
235056793$23505679$3$F$20231208$20240704$20240209$20240711$EXP$$CA-CELLTRION INC.-2024CA003072$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
235057023$23505702$3$F$$20240926$20240209$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-018446$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240930$$CN$US$US
235057099$23505709$9$F$20230420$20240814$20240209$20240821$EXP$$CA-GSK-CA2023059671$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$CA$CA
235057293$23505729$3$F$20240101$20240717$20240209$20240725$EXP$$CA-CELLTRION INC.-2024CA003077$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
235057453$23505745$3$F$$20240118$20240209$20240813$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024ARB000046$AZURITY PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
235057502$23505750$2$F$$20240819$20240209$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020963$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240827$$CN$US$US
235058923$23505892$3$F$20231201$20240718$20240209$20240725$EXP$$CA-GSK-CA2023AMR088563$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$CA$CA
235060703$23506070$3$F$20230101$20240806$20240209$20240816$EXP$$US-INSMED-2023-04706-USAA$INSMED$$$$$F$Y$$$20240816$$CN$US$US
235061064$23506106$4$F$$20240924$20240209$20240930$EXP$$US-AMGEN-USASP2024024954$AMGEN$$85$YR$E$F$Y$$$20240930$$CN$US$US
235061252$23506125$2$F$20240207$20240821$20240209$20240826$PER$$US-AMGEN-USASP2024027674$AMGEN$$71$YR$E$F$Y$$$20240826$$CN$US$US
235061282$23506128$2$F$$20240716$20240209$20240723$30DAY$$US-GSK-US2024014174$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$CN$US$US
2350615613$23506156$13$F$20240101$20240821$20240209$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-003672$UNITED THERAPEUTICS$$$$$M$Y$74.83$KG$20240830$$$US$US
235062874$23506287$4$F$20240101$20240625$20240209$20240704$EXP$$US-UNITED THERAPEUTICS-UNT-2024-003582$UNITED THERAPEUTICS$$71$YR$$F$Y$59.864$KG$20240704$$$US$US
235063242$23506324$2$F$$20240216$20240209$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088749$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
235064483$23506448$3$F$$20240723$20240209$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-021185$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240725$$CN$US$US
235064773$23506477$3$F$20231004$20240725$20240209$20240725$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-007429$BOEHRINGER INGELHEIM$$59$YR$A$M$Y$70$KG$20240725$$MD$JP$JP
235065632$23506563$2$F$20231201$20240628$20240209$20240704$EXP$$JP-009507513-2402JPN000411J$MERCK$$75$YR$$M$Y$$$20240704$$MD$JP$JP
235065973$23506597$3$F$$20240722$20240209$20240724$EXP$$US-UCBSA-2024005907$UCB$$$$$F$Y$92.971$KG$20240724$$HP$US$US
235066203$23506620$3$F$$20240808$20240209$20240815$EXP$$US-TAKEDA-2024TUS003159$TAKEDA$$$$$F$Y$$$20240815$$MD$US$US
235067078$23506707$8$F$20240209$20240625$20240209$20240701$EXP$$US-TAKEDA-2024TUS008670$TAKEDA$$69$YR$$F$Y$86$KG$20240701$$CN$US$US
235067115$23506711$5$F$$20240701$20240209$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020755$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240703$$CN$US$US
235067756$23506775$6$F$20240130$20240821$20240209$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-022844$JAZZ$$72$YR$$M$Y$$$20240827$$MD$US$US
235067859$23506785$9$F$20230601$20240722$20240209$20240726$EXP$$CA-GSK-CA2023AMR088535$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$HP$CA$CA
235067983$23506798$3$F$20240202$20240213$20240209$20240809$EXP$$NVSC2024US028458$NOVARTIS$$71$YR$$M$Y$$$20240809$$CN$US$US
235068263$23506826$3$F$20240807$20240809$20240209$20240814$30DAY$US-MMM-ZCIBFVMH$US-GSK-US2024014317$GLAXOSMITHKLINE$$68$YR$$M$Y$$$20240814$$CN$US$US
235068412$23506841$2$F$20230601$20240719$20240209$20240724$EXP$$CA-ABBVIE-5501594$ABBVIE$$$$E$M$Y$$$20240724$$CN$CA$CA
235068485$23506848$5$F$20240101$20240811$20240209$20240818$EXP$$JP-GENMAB-2024-00317$GENMAB$$76$YR$$M$Y$60$KG$20240819$$MD$JP$JP
235068972$23506897$2$F$20240120$20240828$20240209$20240903$30DAY$$US-GSK-US2024014979$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240903$$CN$US$US
235068983$23506898$3$F$20240118$20240814$20240209$20240823$30DAY$$US-GSK-US2024014987$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240823$$MD$US$US
235069837$23506983$7$F$20240101$20240815$20240209$20240822$EXP$$JP-GENMAB-2024-00278$GENMAB$$76$YR$$M$Y$77.9$KG$20240822$$MD$JP$JP
235069864$23506986$4$F$$20240701$20240209$20240710$EXP$$US-UNITED THERAPEUTICS-UNT-2023-037257$UNITED THERAPEUTICS$$$$$F$Y$$$20240710$$$US$US
235070447$23507044$7$F$$20240912$20240209$20240924$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-02144$IPSEN$$66$YR$E$M$Y$121.5$KG$20240924$$CN$US$US
235070802$23507080$2$F$20240207$20240802$20240209$20240805$EXP$$ZA-SANDOZ INC.-SDZ2024ZA012930$SANDOZ$$30$YR$$F$Y$$$20240805$$HP$ZA$ZA
235070946$23507094$6$F$20230717$20240718$20240209$20240723$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-008050$JAZZ$$29$YR$$F$Y$$$20240722$$HP$US$US
235071152$23507115$2$F$$20240904$20240209$20240911$EXP$$CA-GSK-CA2024015431$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$MD$CA$CA
235071266$23507126$6$F$20220418$20240725$20240209$20240731$EXP$$CA-TAKEDA-2020TUS033877$TAKEDA$$70$YR$$M$Y$$$20240731$$CN$CA$CA
235071272$23507127$2$F$20230803$20231128$20240209$20240720$EXP$FR-AFSSAPS-AVMA2023000433$FR-TEVA-VS-3134911$TEVA$$44$YR$$M$Y$$$20240720$$MD$FR$FR
235071662$23507166$2$F$20240126$20240827$20240209$20240829$EXP$$US-PFIZER INC-202400035746$PFIZER$$83$YR$$M$Y$$$20240829$$CN$US$US
235071692$23507169$2$F$20240101$20240724$20240209$20240729$EXP$$US-UCBSA-2024005932$UCB$$$$$M$Y$$$20240729$$CN$US$US
235072782$23507278$2$F$20231201$20240724$20240209$20240815$PER$$AU-TOLMAR, INC.-24AU046209$TOLMAR$$79$YR$$M$Y$$$20240814$$CN$AU$AU
235072822$23507282$2$F$$20240627$20240209$20240722$PER$$CA-TOLMAR, INC.-24CA046174$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
235072914$23507291$4$F$$20240920$20240209$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-021778$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240925$$CN$US$US
235073112$23507311$2$F$20230412$20240919$20240209$20240926$EXP$$CA-GSK-CA2023072346$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CA$CA
235073173$23507317$3$F$20231201$20240725$20240209$20240729$EXP$FR-AFSSAPS-AN2024000116$FR-MYLANLABS-2024M1011777$MYLAN$$71$YR$$M$Y$118$KG$20240729$$PH$FR$FR
235073646$23507364$6$F$20240111$20240626$20240209$20240704$EXP$$FI-BAXTER-2024BAX011626$BAXTER$$70$YR$$F$Y$96$KG$20240704$$MD$FI$FI
235073902$23507390$2$F$20240101$20240906$20240209$20240916$PER$$US-SA-2024SA042313$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240916$$MD$US$US
235073964$23507396$4$F$20240302$20240625$20240209$20240705$PER$$US-SA-2024SA038370$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240705$$MD$US$US
235074012$23507401$2$F$$20240722$20240209$20240731$PER$$US-SA-2023SA272774$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240731$$MD$US$US
235074073$23507407$3$F$$20240626$20240209$20240705$PER$$US-SA-2024SA038406$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240705$$MD$US$US
235074104$23507410$4$F$20240401$20240806$20240209$20240813$PER$$US-SA-2024SA037421$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240814$$MD$US$US
235074112$23507411$2$F$$20240828$20240209$20240910$PER$$US-SA-2024SA044044$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$MD$US$US
235074207$23507420$7$F$20240101$20240820$20240209$20240827$EXP$$US-SA-2024SA025840$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240827$$MD$US$US
235074303$23507430$3$F$20231224$20240724$20240209$20240802$PER$$US-SA-2024SA042971$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240802$$MD$US$US
235074503$23507450$3$F$20231201$20240822$20240209$20240905$PER$$US-SA-2024SA038221$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240905$$MD$US$US
235074582$23507458$2$F$20240113$20240903$20240209$20240930$PER$$US-SA-2024SA039425$SANOFI AVENTIS$$24$YR$A$F$Y$49$KG$20240930$$MD$US$US
235074632$23507463$2$F$20240101$20240823$20240209$20240906$PER$$US-SA-2024SA038386$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240906$$MD$US$US
235074822$23507482$2$F$$20240813$20240209$20240820$PER$$US-SA-2024SA035655$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240820$$MD$US$US
235074892$23507489$2$F$$20240802$20240209$20240813$PER$$US-SA-2024SA043446$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240814$$MD$US$US
235075063$23507506$3$F$20240701$20240710$20240209$20240718$PER$$US-SA-2024SA043055$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240718$$MD$US$US
235075312$23507531$2$F$$20240708$20240209$20240717$PER$$US-SA-2024SA042850$SANOFI AVENTIS$$27$YR$A$F$Y$68.03$KG$20240717$$MD$US$US
235075483$23507548$3$F$20240130$20240630$20240209$20240709$PER$$US-SA-2024SA043375$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240709$$MD$US$US
235075883$23507588$3$F$20231001$20240626$20240209$20240705$PER$$US-SA-2024SA043960$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240705$$MD$US$US
235075913$23507591$3$F$20240101$20240802$20240209$20240812$PER$$US-SA-2024SA043540$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240812$$MD$US$US
235076012$23507601$2$F$$20240715$20240209$20240722$PER$$US-SA-2024SA043206$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240721$$CN$US$US
235077112$23507711$2$F$20231201$20240815$20240209$20240816$EXP$$JP-PFIZER INC-202300372551$PFIZER$$5$DEC$$F$Y$$$20240816$$PH$JP$JP
235077122$23507712$2$F$$20240827$20240209$20240902$EXP$$US-PFIZER INC-PV202400019517$PFIZER$$75$YR$$M$Y$$$20240902$$CN$US$US
235077384$23507738$4$F$20240101$20240829$20240209$20240829$EXP$$US-PFIZER INC-202400036273$PFIZER$$82$YR$$F$Y$$$20240829$$MD$US$US
235077633$23507763$3$F$20240101$20240917$20240209$20240920$EXP$$CA-PFIZER INC-202400035991$PFIZER$$73$YR$$F$Y$$$20240920$$CN$CA$CA
235077693$23507769$3$F$$20240924$20240209$20240927$PER$$US-PFIZER INC-202200277134$PFIZER$$71$YR$$F$Y$$$20240927$$CN$US$US
235078325$23507832$5$F$20240101$20240920$20240209$20240930$EXP$$FR-UCBSA-2024005981$UCB$$$$$F$Y$23$KG$20240930$$MD$FR$FR
235079042$23507904$2$F$$20240914$20240209$20240919$EXP$$IN-PFIZER INC-PV202400019148$PFIZER$$47$YR$$M$Y$$$20240919$$CN$IN$IN
235079123$23507912$3$F$$20240911$20240209$20240919$EXP$$CA-BEH-2024168428$CSL BEHRING$$53$YR$A$F$Y$82$KG$20240919$$CN$CA$CA
235079446$23507944$6$F$20240202$20240830$20240209$20240904$EXP$$US-BEH-2024168441$CSL BEHRING$$37$YR$A$F$Y$$$20240904$$HP$US$US
235079483$23507948$3$F$$20240715$20240209$20240722$PER$$US-ALXN-202402USA000092US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$HP$US$US
235080593$23508059$3$F$$20240705$20240209$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-021500$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240708$$PH$US$US
235080843$23508084$3$F$20240117$20240718$20240209$20240723$EXP$$US-OTSUKA-2024_001459$OTSUKA$$34$YR$$F$Y$$$20240723$$CN$US$US
235081282$23508128$2$F$20240101$20240827$20240209$20240911$PER$$US-SA-2024SA045469$SANOFI AVENTIS$$43$YR$A$F$Y$115$KG$20240911$$MD$US$US
235081372$23508137$2$F$20230205$20240728$20240209$20240730$PER$$US-AMGEN-USASP2024027192$AMGEN$$57$YR$A$M$Y$$$20240730$$CN$US$US
235081712$23508171$2$F$$20240130$20240209$20240903$EXP$$GB-JNJFOC-20240202158$JOHNSON AND JOHNSON$$$$$M$Y$100$KG$20240903$$HP$GB$GB
235081983$23508198$3$F$20230101$20240904$20240209$20240910$PER$$US-BAYER-2024A022463$BAYER$$28$YR$A$F$Y$145.24$KG$20240910$$MD$US$US
235083163$23508316$3$F$$20240708$20240209$20240711$EXP$$JP-AstraZeneca-2023A267949$ASTRAZENECA$Kaneda H.. Uses of the POSEIDON regimen in advanced-stage NSCLC: Based on a performance survey of long-term survival data and real-world data.. Academic Seminar #1 in the 120th Kansai Branch Academic Meeting of the Japan Lung Cancer Society. 2024;0:$79$YR$$M$Y$$$20240711$$MD$JP$
235083902$23508390$2$F$$20240908$20240209$20240916$PER$$US-AMGEN-USASP2024026182$AMGEN$Maverakis E.; Le S.T.; Herbert S. et al.. Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid. JAMA Dermatology. 2024;160 (1):107-109$$$E$M$Y$$$20240916$$MD$US$US
235084052$23508405$2$F$$20240908$20240209$20240916$PER$$US-AMGEN-USASP2024026198$AMGEN$Maverakis EMaverakis E.; Le S.T.; Herbert S. et al.. Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid. JAMA Dermatology. 2024;160 (1):107-109$$$$M$Y$$$20240915$$MD$US$US
235084532$23508453$2$F$$20240908$20240209$20240917$PER$$US-AMGEN-USASP2024026192$AMGEN$Maverakis E.; Le S.T.; Herbert S. et al.. Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid. JAMA Dermatology. 2024;160 (1):107-109$$$$F$Y$$$20240917$$MD$US$US
235084592$23508459$2$F$20240117$20240819$20240209$20240823$PER$$US-PHARMING-PHAUS2024000077$PHARMING GROUP$$$$$$Y$$$20240823$$CN$US$US
235085153$23508515$3$F$$20240708$20240209$20240722$PER$$US-Calliditas-2024CAL00172$CALLIDITAS THERAPEUTICS$$66$YR$E$M$Y$$$20240722$$CN$US$US
235085214$23508521$4$F$20210717$20240722$20240209$20240724$EXP$$BE-SANDOZ INC.-NVSC2021BE185681$SANDOZ$$73$YR$$F$Y$79.1$KG$20240724$$MD$BE$BE
235085715$23508571$5$F$20230904$20240912$20240209$20240919$EXP$$US-ABBVIE-5485755$ABBVIE$$72$YR$$M$Y$$$20240919$$CN$US$US
235085973$23508597$3$F$$20240729$20240209$20240802$EXP$$CA-ABBVIE-5629265$ABBVIE$$$$$M$Y$$$20240802$$PH$CA$CA
235086122$23508612$2$F$$20240827$20240209$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR015992$VIIV$$$$$$Y$$$20240906$$HP$US$US
235086902$23508690$2$F$20231227$20240207$20240209$20240813$EXP$$NVSC2024US027690$NOVARTIS$$67$YR$$M$Y$$$20240813$$HP$US$US
235087645$23508764$5$F$20230101$20240915$20240209$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-003595$UNITED THERAPEUTICS$$$$$M$Y$117.91$KG$20240919$$$US$US
2350876910$23508769$10$F$20231218$20240902$20240209$20240910$EXP$$CN-VER-202400004$VERITY PHARMACEUTICALS$$58$YR$A$M$Y$70$KG$20240910$$HP$CN$CN
235087776$23508777$6$F$$20240910$20240209$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-018884$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240919$$CN$US$US
2350879712$23508797$12$F$20230101$20240717$20240209$20240724$EXP$$US-UNITED THERAPEUTICS-UNT-2023-037521$UNITED THERAPEUTICS$$$$$M$Y$69.388$KG$20240724$$$US$US
235087994$23508799$4$F$20240131$20240816$20240209$20240823$EXP$$AE-Taiho Oncology Inc-2024-001247$TAIHO ONCOLOGY INC$$61$YR$A$M$Y$$$20240823$$CN$AE$AE
235088144$23508814$4$F$20230527$20240716$20240209$20240919$EXP$$JP-UROVANT SCIENCES GMBH-202401-URV-000159$SUNOVION$$$$$$Y$$$20240919$$MD$JP$JP
235088212$23508821$2$F$$20240813$20240209$20240828$EXP$$CA-HLS-202400416$HLS THERAPEUTICS$$50$YR$A$M$Y$$$20240828$$MD$CA$CA
235088704$23508870$4$F$$20240801$20240209$20240809$EXP$$CA-PURDUE-USA-2024-0307749$PURDUE$$40$YR$$F$Y$$$20240809$$HP$CA$CA
235088765$23508876$5$F$20231205$20240801$20240209$20240806$PER$$US-GILEAD-2024-0661563$GILEAD$$69$YR$E$F$Y$85.5$KG$20240806$$HP$US$US
235089002$23508900$2$F$20140101$20240702$20240209$20240717$EXP$$DE-VER-202400001$VERITY PHARMACEUTICALS$$48$YR$A$M$Y$$$20240717$$HP$DE$DE
235090726$23509072$6$F$20230605$20240905$20240209$20240912$EXP$$US-ABBVIE-5629713$ABBVIE$$74$YR$$F$Y$$$20240912$$CN$US$US
235090842$23509084$2$F$$20240730$20240209$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-033419$JAZZ$$$$$M$Y$$$20240807$$MD$US$US
235091052$23509105$2$F$$20240716$20240210$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-007471$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240717$$CN$US$US
235091503$23509150$3$F$$20240831$20240210$20240916$PER$$US-SA-2024SA045148$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
235092382$23509238$2$F$20240109$20240813$20240210$20240814$PER$$US-JNJFOC-20240156058$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$US$US
235092452$23509245$2$F$20230101$20240911$20240210$20240916$EXP$$US-ABBVIE-5630214$ABBVIE$$$$$F$Y$68$KG$20240916$$CN$US$US
235092652$23509265$2$F$20240202$20240727$20240210$20240802$EXP$$US-AMGEN-USASP2024024401$AMGEN$$92$YR$E$F$Y$$$20240801$$CN$US$US
235092917$23509291$7$F$$20240730$20240210$20240808$PER$$US-SA-2024SA038679$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240808$$MD$US$US
235093193$23509319$3$F$20231209$20240916$20240210$20240925$EXP$$CA-CELLTRION INC.-2024CA003101$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
235093522$23509352$2$F$$20240907$20240210$20240920$PER$$US-SA-2024SA045351$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240920$$MD$US$US
235093715$23509371$5$F$20230526$20240909$20240210$20240917$EXP$$CA-CELLTRION INC.-2023CA011439$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
235094252$23509425$2$F$$20240917$20240210$20240930$PER$$US-TRAVERE-2024TVT00033$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
235094406$23509440$6$F$20240111$20240823$20240210$20240831$EXP$$CA-CELLTRION INC.-2024CA003125$CELLTRION$$$$$$Y$$$20240831$$CN$CA$CA
235094444$23509444$4$F$$20240801$20240210$20240822$PER$$US-TRAVERE-2024TVT00039$TRAVERE THERAPEUTICS$$58$YR$A$M$Y$$$20240822$$CN$US$US
235094454$23509445$4$F$$20240903$20240210$20240930$PER$$US-TRAVERE-2024TVT00041$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
235094622$23509462$2$F$20240114$20240625$20240210$20240731$PER$$US-TRAVERE-2024TVT00049$TRAVERE THERAPEUTICS$$47$YR$A$M$Y$$$20240731$$CN$US$US
235094702$23509470$2$F$20240101$20240612$20240210$20240730$PER$$US-TRAVERE-2024TVT00057$TRAVERE THERAPEUTICS$$42$YR$A$M$Y$$$20240730$$CN$US$US
235094732$23509473$2$F$$20240905$20240210$20240930$PER$$US-TRAVERE-2024TVT00061$TRAVERE THERAPEUTICS$$48$YR$A$M$Y$$$20240930$$CN$US$US
235094854$23509485$4$F$$20240730$20240210$20240815$PER$$US-TRAVERE-2024TVT00071$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$CN$US$US
235094864$23509486$4$F$$20240606$20240210$20240718$PER$$US-TRAVERE-2024TVT00076$TRAVERE THERAPEUTICS$$76$YR$E$M$Y$$$20240718$$CN$US$US
235094933$23509493$3$F$20240202$20240605$20240210$20240716$PER$$US-TRAVERE-2024TVT00073$TRAVERE THERAPEUTICS$$44$YR$A$F$Y$$$20240716$$CN$US$US
2350953812$23509538$12$F$20220101$20240826$20240210$20240829$EXP$$AU-ABBVIE-5629449$ABBVIE$$35$YR$$F$Y$$$20240829$$MD$AU$AU
235095553$23509555$3$F$$20240719$20240210$20240815$PER$$US-TRAVERE-2024TVT00078$TRAVERE THERAPEUTICS$$28$YR$A$F$Y$$$20240815$$CN$US$US
235095672$23509567$2$F$20240130$20240905$20240210$20240930$PER$$US-TRAVERE-2024TVT00086$TRAVERE THERAPEUTICS$$40$YR$A$F$Y$$$20240930$$CN$US$US
235095684$23509568$4$F$$20240905$20240210$20240930$PER$$US-TRAVERE-2024TVT00087$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
235095907$23509590$7$F$20240201$20240820$20240210$20240917$PER$$US-TRAVERE-2024TVT00102$TRAVERE THERAPEUTICS$$32$YR$A$F$Y$$$20240917$$CN$US$US
235095943$23509594$3$F$20230101$20240801$20240210$20240806$EXP$$US-SA-2024SA046116$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240806$$MD$US$US
235095973$23509597$3$F$$20240625$20240210$20240731$PER$$US-TRAVERE-2024TVT00117$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240731$$CN$US$US
235096162$23509616$2$F$$20240823$20240210$20240827$EXP$$NVSC2024US024622$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
235096379$23509637$9$F$20221001$20240712$20240210$20240716$EXP$FR-AFSSAPS-PV2023001270$FR-ROCHE-3500480$ROCHE$$17$YR$T$M$Y$62$KG$20240716$$MD$FR$FR
235096772$23509677$2$F$$20240827$20240210$20240909$PER$$US-SA-2024SA045701$SANOFI AVENTIS$$$$E$F$Y$$$20240909$$CN$US$US
235097003$23509700$3$F$20230619$20231016$20240210$20240808$EXP$$NVSC2022IN194288$NOVARTIS$$71$YR$$F$Y$$$20240808$$CN$IN$IN
235097204$23509720$4$F$20240101$20240802$20240210$20240812$PER$$US-SA-2024SA039455$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240812$$MD$US$US
235097314$23509731$4$F$20231204$20240814$20240210$20240819$EXP$$NVSC2023US259472$NOVARTIS$$30$YR$$F$Y$$$20240819$$CN$US$US
235097413$23509741$3$F$20231226$20240806$20240210$20240807$EXP$$FR-TAKEDA-2024TUS012603$TAKEDA$$66$YR$$M$Y$$$20240807$$HP$FR$FR
235097467$23509746$7$F$20230401$20240916$20240210$20240923$EXP$$NVSC2023BR103480$NOVARTIS$$41$YR$$F$Y$$$20240923$$CN$BR$BR
235098306$23509830$6$F$20240201$20240808$20240210$20240813$EXP$$US-SA-2024SA038268$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240813$$MD$US$US
235098313$23509831$3$F$20240101$20240725$20240210$20240802$PER$$US-SA-2024SA038335$SANOFI AVENTIS$$83$YR$E$F$Y$58$KG$20240802$$MD$US$US
235098892$23509889$2$F$20240118$20240712$20240211$20240723$PER$$US-SA-2024SA045418$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240723$$MD$US$US
235098942$23509894$2$F$$20240719$20240211$20240730$PER$$US-SA-2024SA045331$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240730$$MD$US$US
235099392$23509939$2$F$$20240205$20240211$20240925$EXP$$US-GSK-US2021AMR222544$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
235099682$23509968$2$F$$20240621$20240211$20240705$PER$$US-SA-2024SA040032$SANOFI AVENTIS$$$$A$F$Y$81.6$KG$20240705$$MD$US$US
235100044$23510004$4$F$$20240807$20240211$20240815$PER$$US-SA-2024SA038524$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240815$$MD$US$US
235100253$23510025$3$F$20240701$20240806$20240211$20240815$PER$$US-SA-2024SA042249$SANOFI AVENTIS$$63$YR$A$M$Y$84$KG$20240815$$MD$US$US
235100364$23510036$4$F$20240110$20240710$20240211$20240718$EXP$$JP-JNJFOC-20240228580$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240718$$MD$JP$JP
235100402$23510040$2$F$20231101$20240710$20240211$20240718$PER$$US-SA-2024SA038638$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240718$$MD$US$US
235100962$23510096$2$F$20240101$20240712$20240211$20240722$PER$$US-SA-2024SA046118$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240720$$MD$US$US
235100992$23510099$2$F$$20240815$20240211$20240827$PER$$US-SA-2024SA046308$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240827$$MD$US$US
235101074$23510107$4$F$20240101$20240722$20240211$20240730$PER$$US-SA-2024SA039249$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240730$$MD$US$US
235101153$23510115$3$F$20200115$20240627$20240211$20240705$EXP$$DE-AUROBINDO-AUR-APL-2024-005581$AUROBINDO$$76$YR$$M$Y$64$KG$20240705$$MD$DE$DE
235101292$23510129$2$F$$20240830$20240211$20240924$PER$$US-SA-2024SA040123$SANOFI AVENTIS$$$$E$M$Y$$$20240924$$MD$US$US
235101403$23510140$3$F$$20240724$20240211$20240806$30DAY$$DE-JNJFOC-20240163821$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$DE$DE
235102592$23510259$2$F$$20240918$20240211$20240927$PER$$NVSC2024US029268$NOVARTIS$$$$$M$Y$$$20240927$$MD$US$US
235102613$23510261$3$F$$20240925$20240211$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-021691$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240930$$MD$JP$JP
235103473$23510347$3$F$20231202$20240722$20240211$20240730$EXP$$CA-CELLTRION INC.-2024CA003249$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
235103593$23510359$3$F$20230101$20240709$20240211$20240717$PER$$US-BIOGEN-2023BI01240568$BIOGEN$$$$$F$Y$$$20240717$$CN$US$US
235103642$23510364$2$F$20231213$20240718$20240211$20240725$EXP$$US-ABBVIE-5533474$ABBVIE$$27$YR$$F$Y$$$20240725$$CN$US$US
235103764$23510376$4$F$20240105$20240723$20240211$20240729$PER$$US-PCCINC-2024-PPL-000066$PIRAMAL$$$$$$Y$$$20240730$$HP$US$US
235103802$23510380$2$F$20230101$20240710$20240211$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-016897$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240718$$CN$US$US
235103963$23510396$3$F$20240831$20240904$20240211$20240905$EXP$$US-TAKEDA-US201922778$TAKEDA$$77$YR$$F$Y$$$20240905$$CN$US$US
235104402$23510440$2$F$20221201$20240830$20240211$20240903$EXP$$DE-ROCHE-3357566$ROCHE$$45$YR$A$F$Y$$$20240903$$CN$DE$DE
235104615$23510461$5$F$20240126$20240625$20240211$20240704$EXP$$CA-MYLANLABS-2023M1125043$BIOCON$$$$$$Y$$$20240704$$MD$CA$CA
235104872$23510487$2$F$20240101$20240916$20240211$20240925$EXP$$US-UCBSA-2024006437$UCB$$39$YR$$F$Y$$$20240925$$HP$US$US
235104894$23510489$4$F$$20240820$20240211$20240821$EXP$$CA-ROCHE-3267530$ROCHE$$$$A$F$Y$$$20240821$$CN$CA$CA
235104942$23510494$2$F$20240206$20240725$20240211$20240729$PER$$US-AMGEN-USASP2024027589$AMGEN$$71$YR$E$F$Y$$$20240729$$PH$US$US
235105132$23510513$2$F$20240203$20240628$20240211$20240702$EXP$$US-PFIZER INC-202400034231$PFIZER$$94$YR$$F$Y$52.154$KG$20240702$$CN$US$US
235107453$23510745$3$F$20240207$20240718$20240212$20240722$PER$$US-AMGEN-USASP2024028684$AMGEN$$58$YR$A$M$Y$$$20240722$$CN$US$US
235107582$23510758$2$F$20240202$20240702$20240212$20240711$PER$$US-SA-2024SA046618$SANOFI AVENTIS$$86$YR$E$M$Y$92.9$KG$20240711$$MD$US$US
235107602$23510760$2$F$20240207$20240729$20240212$20240731$PER$$US-AMGEN-USASP2024028667$AMGEN$$72$YR$E$F$Y$$$20240731$$CN$US$US
235107645$23510764$5$F$20211111$20240722$20240212$20240726$EXP$$CO-UCBSA-2023057940$UCB$$64$YR$$F$Y$73$KG$20240726$$CN$CO$CO
235108333$23510833$3$F$20230301$20240826$20240212$20240902$EXP$$BR-TAKEDA-2023TUS036956$TAKEDA$$57$YR$$F$Y$$$20240902$$CN$BR$BR
235108514$23510851$4$F$20240530$20240815$20240212$20240819$EXP$$US-TAKEDA-2023TUS043684$TAKEDA$$9$YR$$M$Y$$$20240819$$MD$US$US
235108675$23510867$5$F$20230401$20240924$20240212$20240926$EXP$$IL-ABBVIE-5340749$ABBVIE$$80$YR$$F$Y$73$KG$20240926$$MD$IL$IL
235109033$23510903$3$F$20240719$20240719$20240212$20240730$EXP$$CA-TAKEDA-2024TUS010347$TAKEDA$$33$YR$$F$Y$$$20240730$$MD$CA$CA
235109084$23510908$4$F$$20240916$20240212$20240923$EXP$$CA-GSK-CA2024016055$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$HP$CA$CA
235109863$23510986$3$F$20160825$20240816$20240212$20240823$EXP$$CA-TAKEDA-2016TUS014479$TAKEDA$$45$YR$$M$Y$$$20240823$$HP$CA$CA
235110152$23511015$2$F$$20240908$20240212$20240917$PER$$US-AMGEN-USASP2024026185$AMGEN$Maverakis E.; Le S.T.; Herbert S. et al.. Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid. JAMA Dermatology. 2024;160 (1):107-109$$$$F$Y$$$20240916$$MD$US$US
235110332$23511033$2$F$$20240202$20240212$20240926$PER$$US-GSK-US2024AMR015698$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
235110422$23511042$2$F$20240101$20240722$20240212$20240725$PER$$US-AMGEN-USASP2024023920$AMGEN$$73$YR$E$M$Y$$$20240725$$CN$US$US
235110503$23511050$3$F$$20240908$20240212$20240916$PER$$US-AMGEN-USASP2024026194$AMGEN$Maverakis E.; Le S.T.; Herbert S. et al.. Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid. JAMA Dermatology. 2024;160 (1):107-109$$$E$F$Y$$$20240916$$MD$US$US
235112072$23511207$2$F$20240101$20240808$20240212$20240817$PER$$US-SA-2024SA046168$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240817$$MD$US$US
235112186$23511218$6$F$20200320$20240913$20240212$20240918$EXP$$DE-ROCHE-2676871$ROCHE$$51$YR$A$M$Y$75$KG$20240918$$MD$DE$DE
235112307$23511230$7$F$$20240809$20240212$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017990$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240814$$CN$US$US
235113072$23511307$2$F$$20240731$20240212$20240802$PER$$US-AMGEN-USASP2024028020$AMGEN$$$$$M$Y$$$20240802$$MD$US$US
235113122$23511312$2$F$$20240823$20240212$20240906$PER$$US-SA-2024SA041575$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240906$$MD$US$US
235113242$23511324$2$F$20240120$20240730$20240212$20240802$EXP$$CA-JNJFOC-20240215374$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240802$$HP$CA$CA
235113622$23511362$2$F$$20240708$20240212$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202402005964$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240709$$CN$US$US
235113736$23511373$6$F$20240125$20240704$20240212$20240710$EXP$$IE-TAKEDA-2024TUS008928$TAKEDA$$57$YR$$F$Y$$$20240710$$MD$IE$IE
235113942$23511394$2$F$20240620$20240821$20240212$20240827$PER$$US-AMGEN-USASP2024028402$AMGEN$$54$YR$A$F$Y$$$20240826$$HP$US$US
235114205$23511420$5$F$$20240722$20240212$20240726$EXP$$US-AMGEN-USASP2024028447$AMGEN$$$$A$F$Y$$$20240726$$HP$US$US
235114342$23511434$2$F$$20240818$20240212$20240827$PER$$US-SA-2024SA043232$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240827$$MD$US$US
235114454$23511445$4$F$$20240710$20240212$20240717$EXP$$NVSC2024PL028224$NOVARTIS$$62$YR$$F$Y$$$20240717$$MD$PL$PL
235114464$23511446$4$F$$20240910$20240212$20240923$EXP$$CA-APOTEX-2024AP001952$APOTEX$$56$YR$$F$Y$71$KG$20240923$$HP$CA$CA
235114765$23511476$5$F$$20240827$20240212$20240903$EXP$$GB-TAKEDA-2024TUS012604$TAKEDA$$$$$F$Y$$$20240903$$CN$GB$GB
235114985$23511498$5$F$20240116$20240916$20240212$20240919$EXP$$US-BEH-2024168282$CSL BEHRING$$35$YR$A$M$Y$$$20240919$$HP$US$US
235115763$23511576$3$F$20230828$20240903$20240212$20240906$EXP$$CA-TAKEDA-2023TUS084525$TAKEDA$$19$YR$$M$Y$$$20240906$$CN$CA$CA
235116135$23511613$5$F$20230907$20240808$20240212$20240812$EXP$$CA-TAKEDA-2023TUS088035$TAKEDA$$14$YR$$M$Y$$$20240812$$CN$CA$CA
235116188$23511618$8$F$20240124$20240709$20240212$20240710$EXP$$AU-TAKEDA-2024TUS008470$TAKEDA$$62$YR$$F$Y$45$KG$20240710$$MD$AU$AU
235116556$23511655$6$F$$20240822$20240212$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000292$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
235116907$23511690$7$F$$20240706$20240212$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-00861$LUPIN$$$$$$Y$$$20240731$$HP$US$US
235117102$23511710$2$F$20240206$20240819$20240212$20240820$PER$$US-AMGEN-USASP2024027319$AMGEN$$79$YR$E$M$Y$$$20240819$$CN$US$US
235117753$23511775$3$F$20240101$20240716$20240212$20240719$EXP$$US-AMGEN-USASP2024027100$AMGEN$$60$YR$A$F$Y$$$20240719$$HP$US$US
235117902$23511790$2$F$$20240813$20240212$20240815$EXP$$ES-SANDOZ INC.-SDZ2024ES013221$SANDOZ$$9$YR$$M$Y$$$20240815$$HP$ES$ES
235117923$23511792$3$F$20240213$20240829$20240212$20240902$EXP$$CA-TAKEDA-2016TUS008358$TAKEDA$$39$YR$$M$Y$$$20240902$$CN$CA$CA
235118092$23511809$2$F$$20240903$20240212$20240910$EXP$$ES-SANDOZ INC.-SDZ2024ES013219$SANDOZ$$11$YR$$F$Y$$$20240910$$HP$ES$ES
235118356$23511835$6$F$$20240917$20240212$20240921$EXP$$NVSC2024US029616$NOVARTIS$$$$$F$Y$$$20240921$$CN$US$US
235118464$23511846$4$F$20230424$20240916$20240212$20240924$PER$$US-SA-2024SA045372$SANOFI AVENTIS$$53$YR$A$F$Y$112.4$KG$20240924$$MD$US$US
235118786$23511878$6$F$20240426$20240913$20240212$20240917$EXP$$CA-GSK-CA2023073878$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$CA$CA
235119022$23511902$2$F$20231201$20240730$20240212$20240801$EXP$$BR-JNJFOC-20240223900$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240801$$MD$BR$BR
235119252$23511925$2$F$20240101$20240727$20240212$20240730$PER$$US-AMGEN-USASP2024028103$AMGEN$$81$YR$E$F$Y$$$20240730$$CN$US$US
235119653$23511965$3$F$$20240918$20240212$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-021824$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240920$$CN$US$US
2351200411$23512004$11$F$20240305$20240829$20240212$20240904$EXP$$CA-JNJFOC-20231169052$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240904$$HP$CA$CA
235120123$23512012$3$F$$20240925$20240212$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022101$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240926$$HP$US$US
235120144$23512014$4$F$$20240827$20240212$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022289$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$86.18$KG$20240829$$CN$US$US
235120765$23512076$5$F$20230308$20240902$20240212$20240909$EXP$$NVSC2023AU190311$NOVARTIS$$51$YR$$F$Y$60$KG$20240909$$MD$AU$AU
235121273$23512127$3$F$20240207$20240719$20240212$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202402005557$ELI LILLY AND CO$$22$YR$A$M$Y$$$20240724$$CN$US$US
235122386$23512238$6$F$20230101$20240717$20240212$20240724$EXP$$US-SA-2024SA046487$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240724$$CN$US$US
235122555$23512255$5$F$20240201$20240625$20240212$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000288$ACADIA PHARMACEUTICALS$$1$YR$$F$Y$$$20240718$$CN$US$US
235122633$23512263$3$F$20240207$20240717$20240212$20240722$EXP$$NVSC2024US028947$NOVARTIS$$6$YR$$M$Y$$$20240722$$HP$US$US
235122713$23512271$3$F$$20240918$20240212$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022290$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240924$$CN$US$US
235122942$23512294$2$F$$20240626$20240212$20240705$PER$$US-SA-2024SA045790$SANOFI AVENTIS$$$$E$F$Y$62.2$KG$20240705$$MD$US$US
235123887$23512388$7$F$$20240909$20240212$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020462$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240911$$CN$US$US
235124712$23512471$2$F$20240101$20240715$20240212$20240723$PER$$US-SA-2024SA043691$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240723$$MD$US$US
235125782$23512578$2$F$20240101$20240731$20240212$20240809$PER$$US-SA-2024SA046245$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240809$$MD$US$US
235126044$23512604$4$F$20240206$20240723$20240212$20240729$EXP$$CA-TAKEDA-2023TUS101304$TAKEDA$$49$YR$$M$Y$$$20240729$$HP$CA$CA
235127292$23512729$2$F$$20240725$20240212$20240730$EXP$$US-SA-2023SA105760$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240730$$MD$US$US
235127363$23512736$3$F$20240101$20240829$20240212$20240905$EXP$$JP-009507513-2402JPN000878J$MERCK$$4$DEC$$F$Y$$$20240905$$MD$JP$JP
235128693$23512869$3$F$$20240624$20240212$20240701$EXP$$JP-ABBVIE-5634510$ABBVIE$Arai K, Nonaka M, Shimada S, Nakamura M. Vortioxetine as a potential alternative for patients with escitalopram induced jitteriness/anxiety syndrome: A report of three cases. PCN Reports. 2023 Dec;2(4):e158.$3$DEC$$F$Y$$$20240701$$MD$JP$JP
235129152$23512915$2$F$$20240814$20240212$20240820$EXP$$PL-AUROBINDO-AUR-APL-2024-002109$AUROBINDO$Stepien B, Gajdecki J, Brzezinska O, Makowska J. Opinc-Rosiak A.. Calcinosis cutis in the course of systemic sclerosis overlapped by anti-MDA5 positive dermatomyositis: a case report.. ALLERGY ASTHMA IMMUNOLOGY. 2023;28(4):124-128.$57$YR$$F$Y$$$20240820$$MD$PL$PL
235129166$23512916$6$F$20231014$20240910$20240212$20240917$EXP$$CA-GSK-CA2023088473$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
235129383$23512938$3$F$$20240701$20240212$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020988$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$92.99$KG$20240709$$CN$US$US
235129752$23512975$2$F$20230420$20240201$20240212$20240710$PER$$JP-PFM-2023-06883$PIERRE FABRE MEDICAMENT$Fujii H. A case of preterm extremely low birth weight infant with infantile hemangioma treated with a prudent propranolol dose increase. Japan Society for Neonatal Health and Development. 2023;35(3):645$1$MON$$F$Y$1.22$KG$20240710$$MD$JP$JP
235130212$23513021$2$F$20240101$20240715$20240212$20240723$PER$$US-SA-2024SA045807$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240723$$MD$US$US
235130522$23513052$2$F$$20240628$20240212$20240713$EXP$$US-TEVA-VS-3153817$TEVA$$$$$$Y$$$20240713$$CN$US$US
235130634$23513063$4$F$20220815$20240916$20240212$20240919$EXP$$DE-SANDOZ INC.-SDZ2024DE013560$SANDOZ$$$$E$F$Y$69.5$KG$20240919$$HP$DE$DE
235130772$23513077$2$F$20230101$20240712$20240212$20240717$EXP$$US-KYOWAKIRIN-2024KK002074$KYOWA$$$$$$Y$$$20240717$$PH$US$US
235130805$23513080$5$F$$20240913$20240212$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020431$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240918$$CN$US$US
235130962$23513096$2$F$$20240918$20240212$20240923$PER$$US-PFIZER INC-202400037547$PFIZER$$53$YR$$F$Y$$$20240923$$CN$US$US
235131242$23513124$2$F$20240109$20240923$20240212$20240930$EXP$$US-BEH-2024168490$CSL BEHRING$$8$YR$C$M$Y$$$20240930$$CN$US$US
235131534$23513153$4$F$20240110$20240701$20240212$20240708$EXP$$US-INCYTE CORPORATION-2024IN001184$INCYTE$$$$$$Y$$$20240708$$MD$US$US
235131734$23513173$4$F$$20240712$20240212$20240802$EXP$$JP-009507513-2402JPN000922J$MERCK$Katsura Y, Shirakawa Y, Ishida M, Chouda Y, Idani H, Matsukawa H, et al.. p7-2 Treatment Strategies for Unresectable Advanced Oesophageal Carcinoma in Our Hospital. The 78th Annual Meeting of The Japan Esophageal Society. 200$8$DEC$$M$Y$$$20240802$$MD$JP$JP
235132684$23513268$4$F$$20240918$20240212$20240920$EXP$$NVSC2023IN279240$NOVARTIS$$$$$M$Y$$$20240920$$CN$IN$IN
235132722$23513272$2$F$20230101$20240123$20240212$20240814$EXP$$NVSC2023BR094469$NOVARTIS$$$$$F$Y$92$KG$20240814$$CN$BR$BR
235133423$23513342$3$F$$20240909$20240212$20240916$EXP$$CA-APOTEX-2024AP001953$APOTEX$$43$YR$$F$Y$$$20240916$$HP$CA$CA
235133437$23513343$7$F$$20240627$20240212$20240701$PER$$NVSC2024US029900$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
235133702$23513370$2$F$20240126$20240711$20240212$20240801$PER$$US-SA-2024SA045803$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240719$$MD$US$US
235133862$23513386$2$F$$20240628$20240212$20240708$EXP$$US-TEVA-VS-3153809$TEVA$$$$$$Y$$$20240708$$CN$US$US
235134253$23513425$3$F$20240101$20240830$20240212$20240904$EXP$$CA-PFIZER INC-202400037471$PFIZER$$48$YR$$F$Y$$$20240904$$HP$CA$CA
235134512$23513451$2$F$$20240821$20240212$20240826$PER$$US-VERTEX PHARMACEUTICALS-2024-001986$VERTEX$$$$$$Y$$$20240826$$CN$US$US
235134522$23513452$2$F$$20240202$20240212$20240701$EXP$$CA-VERTEX PHARMACEUTICALS-2024-001988$VERTEX$$17$YR$$F$Y$48$KG$20240701$$CN$CA$CA
235135204$23513520$4$F$$20240710$20240212$20240722$EXP$IN-MLMSERVICE-20240131-4789069-1$IN-STRIDES ARCOLAB LIMITED-2024SP001454$STRIDES$Patil S, Patil MV, Bagalkotkar A, Wali S.. Cyclophosphamide Toxicity in Pediatric Nephrotic Syndrome Patient: A Case Report and Literature Review.. Current drug safety.. 2024;19 (4)$5$YR$$M$Y$$$20240722$$HP$IN$IN
235135392$23513539$2$F$$20240309$20240212$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088436$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
235135432$23513543$2$F$$20240224$20240212$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088691$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
235135442$23513544$2$F$$20240229$20240212$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088162$GLENMARK$$$$$$Y$$$20240930$$PH$US$US
235135612$23513561$2$F$$20240903$20240212$20240911$PER$$US-BAYER-2024A023116$BAYER$$37$YR$A$F$Y$105.22$KG$20240911$$CN$US$US
235135856$23513585$6$F$20240101$20240722$20240212$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-021658$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240730$$CN$US$US
235136194$23513619$4$F$$20240701$20240212$20240703$EXP$$US-PFIZER INC-PV202300189611$PFIZER$$75$YR$$F$Y$58.957$KG$20240703$$MD$US$US
235136343$23513634$3$F$20240101$20240909$20240212$20240917$PER$$US-SA-2024SA040094$SANOFI AVENTIS$$28$MON$C$M$Y$$$20240918$$MD$US$US
235136648$23513664$8$F$20240508$20240722$20240212$20240729$EXP$$US-GSK-US2024AMR018468$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
235136862$23513686$2$F$20240101$20240807$20240212$20240812$EXP$$US-PFIZER INC-202400038283$PFIZER$$80$YR$$M$Y$97.8$KG$20240812$$HP$US$US
235136975$23513697$5$F$$20240909$20240212$20240911$EXP$$IT-PFIZER INC-202400036695$PFIZER$$49$YR$$F$Y$50$KG$20240911$$MD$IT$IT
235137386$23513738$6$F$20240126$20240827$20240212$20240910$PER$$US-Calliditas-2024CAL00163$CALLIDITAS THERAPEUTICS$$79$YR$E$M$Y$$$20240910$$CN$US$US
235137484$23513748$4$F$20240203$20240718$20240212$20240724$PER$$US-ALKERMES INC.-ALK-2024-000309$ALKERMES$$65$YR$$M$Y$$$20240724$$MD$US$US
235138157$23513815$7$F$20191101$20240819$20240212$20240826$EXP$$HR-SANDOZ INC.-NVSC2021HR042645$SANDOZ$$56$YR$$F$Y$$$20240826$$MD$HR$HR
235138172$23513817$2$F$$20240201$20240212$20240812$EXP$$NVSC2024BR025065$NOVARTIS$$$$$F$Y$$$20240812$$CN$BR$BR
235138194$23513819$4$F$20240102$20240919$20240212$20240924$EXP$$CA-MYLANLABS-2024M1013089$MYLAN$$79$YR$$F$Y$$$20240924$$CN$CA$CA
235138479$23513847$9$F$20230601$20240704$20240212$20240709$EXP$$CH-MYLANLABS-2024M1011933$MYLAN$$79$YR$$M$Y$93$KG$20240709$$HP$CH$CH
235138712$23513871$2$F$$20240628$20240212$20240713$EXP$$US-TEVA-VS-3153822$TEVA$$$$$$Y$$$20240713$$CN$US$US
235139093$23513909$3$F$$20240917$20240212$20240920$PER$$US-AMGEN-USASP2024027939$AMGEN$$83$YR$E$F$Y$$$20240920$$CN$US$US
235139102$23513910$2$F$$20240628$20240212$20240712$EXP$$US-TEVA-VS-3153827$TEVA$$$$$$Y$$$20240712$$CN$US$US
235139312$23513931$2$F$20240207$20240822$20240212$20240902$PER$$US-SA-2024SA047955$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240902$$MD$US$US
235139625$23513962$5$F$$20240917$20240212$20240924$30DAY$$US-PFIZER INC-202400022794$PFIZER$$5$YR$$F$Y$$$20240924$$CN$US$US
235140182$23514018$2$F$$20240807$20240212$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-048407$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240809$$CN$US$US
235141623$23514162$3$F$$20240906$20240212$20240909$PER$$US-PFIZER INC-PV202400020035$PFIZER$$60$YR$$F$Y$$$20240909$$HP$US$US
235141664$23514166$4$F$$20240731$20240212$20240805$PER$$US-PFIZER INC-PV202400018760$PFIZER$$77$YR$$M$Y$106.12$KG$20240805$$HP$US$US
235141862$23514186$2$F$$20240710$20240212$20240712$PER$$US-PFIZER INC-2020097641$PFIZER$$75$YR$$F$Y$$$20240712$$CN$US$US
235141934$23514193$4$F$$20240905$20240212$20240909$PER$$US-PFIZER INC-PV202400018864$PFIZER$$75$YR$$F$Y$$$20240909$$HP$US$US
235142003$23514200$3$F$$20240627$20240212$20240704$PER$$US-PFIZER INC-PV202400019664$PFIZER$$67$YR$$F$Y$$$20240704$$HP$US$US
235142024$23514202$4$F$$20240712$20240212$20240715$PER$$US-PFIZER INC-PV202300143182$PFIZER$$53$YR$$F$Y$$$20240715$$CN$US$US
235142132$23514213$2$F$20230529$20240719$20240212$20240722$EXP$$JP-AstraZeneca-2023A199312$ASTRAZENECA$Saeki I.. Treatment approaches focusing on combined immunotherapy for unresectable hepatic cancer.. The 30th Japan Association of Systemic Therapy for HCC, Sponsored session 2024;No.2(2024):0-0.$86$YR$$F$Y$43$KG$20240722$$MD$JP$
235142233$23514223$3$F$20240101$20240712$20240212$20240725$PER$$US-ALXN-202402USA000284US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$HP$US$US
235142275$23514227$5$F$$20240830$20240212$20240909$30DAY$$AR-JNJFOC-20240152460$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$AR$AR
235142493$23514249$3$F$20220513$20240828$20240212$20240904$EXP$$EG-SANDOZ INC.-NVSC2023EG083026$SANDOZ$$47$YR$$F$Y$104$KG$20240904$$CN$EG$EG
235143702$23514370$2$F$20220330$20240725$20240212$20240807$PER$$US-SA-2024SA040231$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240807$$MD$US$US
235143883$23514388$3$F$$20240823$20240212$20240828$PER$$US-PFIZER INC-PV202200102172$PFIZER$$69$YR$$M$Y$$$20240828$$CN$US$US
235144592$23514459$2$F$20240108$20240924$20240212$20240926$EXP$FR-AFSSAPS-AM2024000057$FR-MYLANLABS-2024M1012141$MYLAN$$19$YR$$M$Y$75$KG$20240926$$PH$FR$FR
235144606$23514460$6$F$20240301$20240825$20240212$20240828$EXP$$CA-HLS-202400467$HLS THERAPEUTICS$$66$YR$E$F$Y$$$20240828$$HP$CA$CA
235144804$23514480$4$F$$20240729$20240212$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022472$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240802$$CN$US$US
235144923$23514492$3$F$20240206$20240827$20240212$20240902$EXP$$JP-009507513-2402JPN001167J$MERCK$$$$$F$Y$$$20240902$$MD$JP$JP
235145023$23514502$3$F$20220120$20240703$20240212$20240708$PER$$US-PFIZER INC-2020060976$PFIZER$$71$YR$$F$Y$71$KG$20240708$$MD$US$US
235145372$23514537$2$F$$20240814$20240212$20240816$EXP$$US-PFIZER INC-202400037286$PFIZER$$82$YR$$M$Y$$$20240816$$MD$US$US
235145522$23514552$2$F$20240208$20240627$20240212$20240703$PER$$US-AMGEN-USASP2024027840$AMGEN$$80$YR$E$F$Y$$$20240703$$HP$US$US
235146132$23514613$2$F$$20240920$20240212$20240930$EXP$$JP-009507513-2402JPN003903$MERCK$$83$YR$$F$Y$$$20240930$$MD$JP$JP
235146356$23514635$6$F$20240101$20240918$20240212$20240924$EXP$$US-PFIZER INC-202400035842$PFIZER$$75$YR$$M$Y$107.48$KG$20240924$$CN$US$US
235147792$23514779$2$F$$20240627$20240212$20240704$EXP$$JP-009507513-2402JPN000910J$MERCK$$5$DEC$$F$Y$$$20240704$$MD$JP$JP
235148603$23514860$3$F$20191023$20240722$20240212$20240725$EXP$$JP-GSK-JP2020JPN203267$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$JP$JP
235148843$23514884$3$F$$20240908$20240212$20240917$PER$$US-AMGEN-USASP2024026187$AMGEN$Maverakis E.; Le S.T.; Herbert S. et al.. Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid. JAMA Dermatology. 2024;160 (1):107-109$$$E$F$Y$$$20240917$$MD$US$US
235149072$23514907$2$F$$20240813$20240212$20240828$EXP$$CA-HLS-202400381$HLS THERAPEUTICS$$35$YR$A$F$Y$70$KG$20240828$$MD$CA$CA
235149103$23514910$3$F$20240207$20240826$20240212$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022439$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240903$$HP$US$US
235149393$23514939$3$F$20230701$20240827$20240212$20240902$EXP$$CA-ROCHE-3404568$ROCHE$$21$YR$A$F$Y$$$20240902$$CN$CA$CA
235150358$23515035$8$F$20240124$20240903$20240212$20240909$EXP$$US-TAKEDA-2024TUS005409$TAKEDA$$55$YR$$M$Y$$$20240909$$CN$US$US
235150462$23515046$2$F$$20240814$20240212$20240820$EXP$$US-ABBVIE-5633116$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
235151392$23515139$2$F$20240202$20240626$20240213$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019392$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$54.4$KG$20240701$$CN$US$US
235151662$23515166$2$F$20230101$20240702$20240213$20240724$PER$$CA-TOLMAR, INC.-24CA046203$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
235151672$23515167$2$F$20240116$20240702$20240213$20240724$PER$$CA-TOLMAR, INC.-24CA046213$TOLMAR$$70$YR$$M$Y$$$20240724$$CN$CA$CA
235152033$23515203$3$F$20231213$20240826$20240213$20240903$EXP$$ES-CELLTRION INC.-2024ES003008$CELLTRION$$$$$$Y$$$20240903$$MD$ES$ES
235152043$23515204$3$F$20230501$20240716$20240213$20240717$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-236938$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240717$$CN$FR$FR
235152126$23515212$6$F$20240114$20240902$20240213$20240907$EXP$$DE-TAKEDA-2024TUS011946$TAKEDA$$67$YR$$F$Y$$$20240907$$CN$DE$DE
235152393$23515239$3$F$20240118$20240523$20240213$20240718$PER$$BR-TOLMAR, INC.-24BR046318$TOLMAR$$9$YR$$F$Y$$$20240718$$CN$BR$BR
235152672$23515267$2$F$$20240628$20240213$20240712$EXP$$US-TEVA-VS-3153830$TEVA$$$$$$Y$$$20240712$$CN$US$US
235152694$23515269$4$F$20240601$20240627$20240213$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022598$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240701$$CN$US$US
235152703$23515270$3$F$20231201$20240807$20240213$20240811$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022123$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240812$$CN$US$US
235153864$23515386$4$F$20221222$20240801$20240213$20240806$EXP$$CN-TAKEDA-2023TUS042766$TAKEDA$$18$YR$$M$Y$54$KG$20240806$$MD$CN$CN
235153973$23515397$3$F$$20240709$20240213$20240718$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000123$DECIPHERA PHARMACEUTICALS$$68$YR$A$F$Y$$$20240718$$CN$US$US
235154153$23515415$3$F$$20240725$20240213$20240803$EXP$$GB-TEVA-VS-3154671$TEVA$$38$YR$$F$Y$$$20240803$$PH$GB$GB
235154342$23515434$2$F$$20240715$20240213$20240722$PER$$US-ALXN-202402USA000328US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
235154425$23515442$5$F$$20240927$20240213$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022670$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$137.44$KG$20240930$$CN$US$US
235154612$23515461$2$F$20190726$20240717$20240213$20240723$EXP$PL-URPL-1-3787-2019$PL-ABBVIE-5627011$ABBVIE$$34$YR$$F$Y$65$KG$20240723$$MD$PL$PL
235154622$23515462$2$F$20230101$20240716$20240213$20240725$30DAY$$US-UCBSA-2023049304$UCB$$$$$F$Y$$$20240725$$CN$US$US
235155085$23515508$5$F$20221021$20240724$20240213$20240801$EXP$$CA-CELLTRION INC.-2022CA018308$CELLTRION$$$$$$Y$$$20240801$$HP$CA$CA
235155292$23515529$2$F$$20240918$20240213$20240925$EXP$$US-BEH-2024168386$CSL BEHRING$$50$YR$A$F$Y$120$KG$20240925$$CN$US$US
235155458$23515545$8$F$20240101$20240827$20240213$20240904$EXP$$CA-CELLTRION INC.-2024CA003199$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
235155545$23515554$5$F$20240101$20240822$20240213$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000078$DECIPHERA PHARMACEUTICALS$$61$YR$A$M$Y$$$20240905$$CN$US$US
235155656$23515565$6$F$$20240621$20240213$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000306$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
235155772$23515577$2$F$$20240701$20240213$20240707$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020667$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240708$$HP$US$US
235156275$23515627$5$F$20210721$20240917$20240213$20240926$EXP$$CA-CELLTRION INC.-2021CA010358$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
235156283$23515628$3$F$$20240715$20240213$20240720$EXP$$CA-JNJFOC-20240223609$JOHNSON AND JOHNSON$$45$YR$A$M$Y$136$KG$20240720$$HP$CA$CA
235156843$23515684$3$F$$20240627$20240213$20240708$EXP$$CA-APOTEX-2024AP001965$APOTEX$$40$YR$$F$Y$50$KG$20240708$$MD$CA$CA
235156856$23515685$6$F$20240401$20240816$20240213$20240825$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020469$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240826$$CN$US$US
235156974$23515697$4$F$20240308$20240731$20240213$20240806$EXP$$CA-TAKEDA-2024TUS012642$TAKEDA$$18$YR$$F$Y$$$20240806$$CN$CA$CA
235157012$23515701$2$F$$20240130$20240213$20240930$EXP$$JP-AMGEN-JPNSP2024029764$AMGEN$Numao Y, et al... Successful treatment with ivabradine for haemodynamically unstable junctional ectopic tachycardia occurring early after ST-elevation myocardial infarction.. BMJ Case Reports.. 2024;17:doi:e258901$8$DEC$E$F$Y$$$20240930$$MD$JP$JP
235157986$23515798$6$F$20231101$20240809$20240213$20240821$EXP$$ES-AUROBINDO-AUR-APL-2024-005719$AUROBINDO$$46$YR$$F$Y$$$20240821$$CN$ES$ES
235158095$23515809$5$F$$20240718$20240213$20240917$EXP$$CA-TEVA-202210_00013562$TEVA$Austin E, Maratta C. Acute thiamine deficiency as a complication of insulin euglycemic therapy for an amlodipine overdose. Clinical Toxicology. 2022;60(2):124; Austin E, Maratta C. Acute thiamine deficiency as a complication of insulin euglycemic therapy for an amlodipine overdose. Clinical Toxicology. 2022;60(2):124; Austin E, Maratta C. Acute thiamine deficiency as a complication of insulin euglycemic therapy for an amlodipine overdose. Clinical Toxicology. 2022;60(2):124; Austin E, Maratta...$15$YR$$F$Y$54$KG$20240917$$HP$CA$CA
235158113$23515811$3$F$$20240620$20240213$20240822$EXP$$CA-CELLTRION INC.-2024CA003185$CELLTRION$Berco E, Elsliger S, Weinberg T, Ghannam W, Shoham-Hazon N. Triple Trouble with Triple Solutions: A Unique Case Report of a Severe Exudative Retinal Detachment Accompanied by Retinal Traction and Two Retinal Holes in Coats Disease. Case Rep Ophthalmol. 2024;15:84-91$$$$$Y$$$20240822$$HP$CA$CA
235159832$23515983$2$F$20240101$20240826$20240213$20240830$EXP$$US-BIOGEN-2024BI01249610$BIOGEN$$58$YR$$F$Y$$$20240830$$HP$US$US
235160063$23516006$3$F$$20240712$20240213$20240722$EXP$$NL-CELLTRION INC.-2024NL002970$CELLTRION$Kwakernaak, Arjan J.. Auto-immuniteit en auto-inflammatie als uitingen van een primaire immuundeficientie: herkenning diagnostiek en behandeling.. Nederlands Tijdschrift voor Reumatologie. 2023;26(4):90-98$$$$$Y$$$20240722$$MD$NL$NL
235160343$23516034$3$F$20240206$20240813$20240213$20240821$EXP$$AU-CELLTRION INC.-2024AU003447$CELLTRION$$$$$$Y$$$20240821$$MD$AU$AU
235160382$23516038$2$F$$20240715$20240213$20240718$EXP$$KR-ABBVIE-5637430$ABBVIE$$83$YR$$F$Y$$$20240718$$MD$KR$KR
235160412$23516041$2$F$20240701$20240710$20240213$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022656$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$49.08$KG$20240714$$CN$US$US
235160458$23516045$8$F$20220501$20240918$20240213$20240925$EXP$$CA-GSK-CA2023134308$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$CA$CA
235160983$23516098$3$F$20240131$20240724$20240213$20240729$EXP$$JP-TAKEDA-2024TJP002199$TAKEDA$$40$YR$$M$Y$$$20240729$$MD$JP$JP
235161033$23516103$3$F$$20240905$20240213$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022605$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240906$$CN$US$US
235161326$23516132$6$F$20240220$20240814$20240213$20240816$EXP$$CA-TAKEDA-2024TUS011465$TAKEDA$$36$YR$$M$Y$$$20240816$$CN$CA$CA
235161543$23516154$3$F$$20240812$20240213$20240820$EXP$$CA-APOTEX-2024AP001977$APOTEX$$60$YR$$F$Y$$$20240820$$HP$CA$CA
235161772$23516177$2$F$$20240808$20240213$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019651$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240816$$HP$US$US
235162794$23516279$4$F$$20240712$20240213$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020293$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240716$$CN$US$US
235163058$23516305$8$F$20230901$20240826$20240213$20240902$EXP$$US-BIOGEN-2024BI01249924$BIOGEN$$45$YR$$F$Y$$$20240902$$CN$US$US
235163113$23516311$3$F$20231221$20240820$20240213$20240830$EXP$$CA-GSK-CA2023118548$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$HP$CA$CA
235163122$23516312$2$F$$20240708$20240213$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022661$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$175$KG$20240709$$CN$US$US
235164992$23516499$2$F$$20240702$20240213$20240710$EXP$$IT-AUROBINDO-AUR-APL-2024-005249$AUROBINDO$Grifoni G, Haissaguerre M, Bongiorni MG, Benali K, Soldati E, Zucchelli G.. Short-coupled Purkinje ectopy inducible by pharmacological and hyperventilation tests.. Heart Rhythm Case Reports.. 2024;10(1):68-71$50$YR$$M$Y$$$20240710$$MD$IT$IT
235165133$23516513$3$F$$20240815$20240213$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022933$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$105.23$KG$20240822$$CN$US$US
235165213$23516521$3$F$20240205$20240912$20240213$20240918$EXP$$US-AMGEN-USASP2024026413$AMGEN$$90$YR$E$F$Y$82.5$KG$20240917$$HP$US$US
235165552$23516555$2$F$$20240705$20240213$20240711$PER$$US-ALXN-202402USA000407US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
235166013$23516601$3$F$20231114$20240821$20240213$20240831$EXP$CZ-CZSUKL-23004500$CZ-TEVA-VS-3153135$TEVA$$62$YR$$M$Y$73$KG$20240831$$MD$CZ$CZ
235166024$23516602$4$F$20240208$20240725$20240213$20240730$PER$$US-AMGEN-USASP2024029646$AMGEN$$64$YR$A$F$Y$$$20240730$$CN$US$US
235166636$23516663$6$F$20240101$20240702$20240213$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2023-034275$UNITED THERAPEUTICS$$$$$F$Y$57.596$KG$20240709$$$US$US
235166645$23516664$5$F$20240202$20240812$20240213$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019708$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240820$$CN$US$US
235166867$23516686$7$F$20230901$20240806$20240213$20240813$EXP$$CA-GSK-CA2023132381$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CA$CA
235167162$23516716$2$F$20231215$20240723$20240213$20240726$EXP$$US-ABBVIE-5632450$ABBVIE$$58$YR$$F$Y$$$20240726$$CN$US$US
235167182$23516718$2$F$20240301$20240725$20240213$20240802$PER$$US-RDY-SPO/USA/24/0001671$DR REDDYS$$58$YR$A$F$Y$$$20240802$$CN$US$US
235168664$23516866$4$F$20240101$20240725$20240213$20240802$EXP$$IT-TEVA-VS-3153236$TEVA$$29$YR$$M$Y$$$20240802$$CN$IT$IT
235169344$23516934$4$F$20240119$20240903$20240213$20240904$EXP$$NVSC2024GB020873$NOVARTIS$$24$YR$$F$Y$$$20240904$$CN$GB$GB
235169906$23516990$6$F$20240101$20240909$20240213$20240912$30DAY$$GR-PFIZER INC-PV202400009405$PFIZER$$13$YR$$M$Y$60$KG$20240912$$CN$GR$GR
235170693$23517069$3$F$20240101$20240905$20240213$20240909$PER$$US-PFIZER INC-202400037319$PFIZER$$90$YR$$F$Y$$$20240909$$HP$US$US
235171362$23517136$2$F$20240206$20240801$20240213$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA044848$SANDOZ$$72$YR$$F$Y$$$20240806$$CN$CA$CA
235171688$23517168$8$F$20220720$20240821$20240213$20240826$EXP$$GB-MYLANLABS-2023M1122658$MYLAN$$55$YR$$M$Y$$$20240826$$CN$GB$GB
235171972$23517197$2$F$20240212$20240724$20240213$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023453$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240726$$HP$US$US
235172072$23517207$2$F$$20240909$20240213$20240921$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK088854$GLENMARK$$$$$$Y$$$20240921$$MD$CA$CA
235172096$23517209$6$F$20240829$20240916$20240213$20240923$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000248$BLUEPRINT MEDICINES$$87$YR$E$M$Y$$$20240923$$CN$US$US
235172773$23517277$3$F$20240826$20240829$20240213$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022781$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$46.27$KG$20240830$$CN$US$US
235172782$23517278$2$F$$20240715$20240213$20240717$PER$$NVSC2024US030790$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
235174243$23517424$3$F$20240207$20240701$20240213$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202402006146$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240710$$CN$US$US
235174523$23517452$3$F$20231101$20240716$20240213$20240723$EXP$$US-ABBVIE-5633120$ABBVIE$$82$YR$$M$Y$$$20240723$$CN$US$US
235174672$23517467$2$F$20240124$20240703$20240213$20240704$EXP$FR-AFSSAPS-LL2024000232$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-022390$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240704$$MD$FR$FR
235175225$23517522$5$F$$20240729$20240213$20240801$30DAY$$US-PFIZER INC-PV202400014042$PFIZER$$11$YR$$M$Y$$$20240801$$CN$US$US
235175578$23517557$8$F$$20240921$20240213$20240923$PER$$US-PFIZER INC-PV202300125106$PFIZER$$8$MON$$$Y$$$20240923$$HP$US$US
235175632$23517563$2$F$20240206$20240220$20240213$20240731$PER$$US-BAYER-2024A023649$BAYER$$21$YR$A$F$Y$$$20240731$$HP$US$US
235176033$23517603$3$F$$20240822$20240213$20240829$EXP$$CN-PFIZER INC-202400038248$PFIZER$Xie, L.. The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma. BMC Cancer. 2024;24 (1):10.1186/s12885-024-11921-7$$$A$$Y$$$20240829$$HP$CN$CN
235176703$23517670$3$F$20231001$20240725$20240213$20240801$EXP$$CA-GSK-CA2024016626$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$MD$CA$CA
235177042$23517704$2$F$20230201$20240815$20240213$20240820$EXP$$CA-OTSUKA-2024_003785$OTSUKA$$28$YR$$M$Y$108$KG$20240820$$CN$CA$CA
235177414$23517741$4$F$$20240723$20240213$20240726$PER$$US-PFIZER INC-PV202300027893$PFIZER$$83$YR$$F$Y$$$20240726$$MD$US$US
235177522$23517752$2$F$$20240722$20240213$20240730$PER$$US-PFIZER INC-PV202400020060$PFIZER$$72$YR$$M$Y$$$20240730$$CN$US$US
235177603$23517760$3$F$$20240916$20240213$20240918$PER$$US-PFIZER INC-PV202400019826$PFIZER$$75$YR$$F$Y$$$20240918$$CN$US$US
235177633$23517763$3$F$$20240909$20240213$20240911$PER$$US-PFIZER INC-PV202400019856$PFIZER$$67$YR$$F$Y$$$20240911$$CN$US$US
235177682$23517768$2$F$$20240826$20240213$20240913$PER$$US-TEVA-VS-3140660$TEVA$$$$$F$Y$$$20240913$$CN$US$US
235177974$23517797$4$F$20240116$20240827$20240213$20240903$EXP$$FR-INCYTE CORPORATION-2024IN001473$INCYTE$$$$$$Y$$$20240903$$HP$FR$FR
235178072$23517807$2$F$$20240625$20240213$20240703$EXP$$US-SA-2024SA049380$SANOFI AVENTIS$$$$A$F$Y$86.168$KG$20240703$$MD$US$US
235178964$23517896$4$F$20240620$20240807$20240213$20240816$EXP$$IN-SANDOZ INC.-SDZ2024IN013316$SANDOZ$$50$YR$$M$Y$$$20240816$$CN$IN$IN
235179023$23517902$3$F$20221201$20240322$20240213$20240816$EXP$$BR-SANDOZ INC.-NVSC2023BR008004$SANDOZ$$65$YR$$F$Y$62$KG$20240816$$CN$BR$BR
235179125$23517912$5$F$20230530$20240916$20240213$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-091174$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240920$$MD$JP$JP
235179516$23517951$6$F$20240101$20240912$20240213$20240920$EXP$$CL-JNJFOC-20240224613$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240920$$CN$CL$CL
235179982$23517998$2$F$$20240211$20240213$20240821$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086809$GLENMARK$$$$$$Y$$$20240821$$PH$US$US
235180112$23518011$2$F$$20240307$20240213$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087351$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
235180653$23518065$3$F$20230101$20240921$20240213$20240927$EXP$$CA-TAKEDA-2023TUS008284$TAKEDA$$72$YR$$F$Y$$$20240927$$CN$CA$CA
235180713$23518071$3$F$$20240826$20240213$20240903$PER$$US-AGIOS-2402US03645$AGIOS PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
235180784$23518078$4$F$$20240705$20240213$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002524$ACADIA PHARMACEUTICALS$$$$$M$Y$82.54$KG$20240729$$CN$US$US
235181505$23518150$5$F$20230101$20240801$20240213$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019673$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240816$$CN$US$US
235181722$23518172$2$F$$20240729$20240213$20240730$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-007984$BOEHRINGER INGELHEIM$$$$$$Y$$$20240730$$CN$US$US
235182535$23518253$5$F$20211202$20240812$20240213$20240814$EXP$$CN-PFIZER INC-202400037788$PFIZER$Wan, J.. Case Report: A case report of acute pain syndrome induced by paclitaxel. Anti-tumor Pharmacy. 2023$55$YR$$F$Y$61$KG$20240814$$PH$CN$CN
235184354$23518435$4$F$20240123$20240723$20240213$20240729$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202402003881$ELI LILLY AND CO$$51$YR$A$M$Y$63$KG$20240729$$CN$JP$JP
235185965$23518596$5$F$$20240710$20240213$20240710$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-105905$DAIICHI$$$$$F$Y$$$20240710$$CN$US$US
235187003$23518700$3$F$$20240826$20240213$20240829$EXP$$US-PFIZER INC-PV202400020631$PFIZER$$64$YR$$F$Y$$$20240829$$CN$US$US
235187262$23518726$2$F$20230101$20240212$20240213$20240711$PER$$US-DSJP-DSU-2024-106836$DAIICHI$$$$$F$Y$$$20240711$$MD$US$US
235187442$23518744$2$F$$20240702$20240213$20240708$PER$$US-MYLANLABS-2024M1010982$MYLAN$$$$$F$Y$$$20240708$$CN$US$US
235187813$23518781$3$F$20211026$20240702$20240213$20240708$EXP$$JP-Taiho Oncology Inc-2024-001189$TAIHO ONCOLOGY INC$Moritani Y, et al. Clinicopathological Conference Case of viral pneumonia during chemotherapy for transverse colon cancer. Yamagata Saiseikan Medical Journal. 2023 January 01;48(1):177-178.$78$YR$E$M$Y$55$KG$20240708$$HP$JP$JP
235188243$23518824$3$F$20231201$20240725$20240213$20240726$EXP$$FR-PURDUE-USA-2024-0307827$PURDUE$$71$YR$$M$Y$118$KG$20240726$$PH$FR$FR
235188605$23518860$5$F$$20240904$20240213$20240906$EXP$$CA-PFIZER INC-202400016063$PFIZER$$23$YR$$M$Y$$$20240906$$HP$CA$CA
235188622$23518862$2$F$20230101$20240815$20240213$20240826$PER$$US-Kiniksa Pharmaceuticals Ltd.-2023KPU000492$KINIKSA PHARMACEUTICALS$$93$YR$E$F$Y$$$20240823$$CN$US$US
235189157$23518915$7$F$$20240913$20240213$20240920$EXP$$PT-ELI_LILLY_AND_COMPANY-PT202402005171$ELI LILLY AND CO$$$$E$$Y$$$20240920$$HP$PT$PT
235189243$23518924$3$F$20220628$20240730$20240213$20240801$PER$$US-PFIZER INC-202200908310$PFIZER$$84$YR$$F$Y$$$20240801$$CN$US$US
235190083$23519008$3$F$20240206$20240625$20240213$20240731$PER$$US-TRAVERE-2024TVT00123$TRAVERE THERAPEUTICS$$58$YR$A$M$Y$$$20240731$$CN$US$US
235190362$23519036$2$F$20240203$20240917$20240213$20240930$PER$$US-TRAVERE-2024TVT00129$TRAVERE THERAPEUTICS$$73$YR$E$F$Y$$$20240930$$CN$US$US
235190372$23519037$2$F$20230101$20240722$20240213$20240730$EXP$$US-ABBVIE-5634857$ABBVIE$$$$$M$Y$76$KG$20240730$$CN$US$US
2351908019$23519080$19$F$20240101$20240830$20240213$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-004315$UNITED THERAPEUTICS$$$$$F$Y$$$20240906$$$US$US
235191073$23519107$3$F$$20240618$20240213$20240828$EXP$$US-PHARMING-PHAUS2024000104$PHARMING GROUP$$$$$$Y$$$20240805$$CN$US$US
235191225$23519122$5$F$$20240812$20240213$20240819$EXP$$CA-BAUSCH-BL-2024-001942$BAUSCH AND LOMB$Hamze H, Tai T, Harris D. Strongyloides hyperinfection syndrome precipitated by immunosuppressive therapy for rheumatoid arthritis and COVID-19 pneumonia. Tropical Diseases, Travel Medicine and Vaccines. 2023 OCT 05;9(15):1-5. doi:10.1186/s40794-023-00201-0$64$YR$$M$Y$$$20240819$$HP$CA$CA
235191464$23519146$4$F$$20240710$20240213$20240712$EXP$$CA-BAUSCH-BL-2024-002051$BAUSCH AND LOMB$$$$$F$Y$$$20240712$$HP$CA$CA
235192092$23519209$2$F$$20240205$20240213$20240813$EXP$$NVSC2023BR147999$NOVARTIS$$$$$F$Y$$$20240813$$CN$BR$BR
235192292$23519229$2$F$20240801$20240812$20240213$20240820$PER$$US-SA-2024SA040106$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240820$$MD$US$US
235192542$23519254$2$F$$20240708$20240213$20240821$PER$$US-LUNDBECK-DKLU3072797$LUNDBECK$$$$$$Y$$$20240821$$HP$US$US
235192623$23519262$3$F$$20240725$20240213$20240802$PER$$US-SA-2024SA041936$SANOFI AVENTIS$$10$YR$C$M$Y$29.937$KG$20240802$$MD$US$US
235192662$23519266$2$F$$20240827$20240213$20240910$PER$$US-SA-2024SA043070$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240910$$HP$US$US
235192672$23519267$2$F$$20240806$20240213$20240813$PER$$US-SA-2024SA042604$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240814$$MD$US$US
235192984$23519298$4$F$20230801$20240922$20240213$20240930$PER$$US-SA-2024SA044046$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240930$$MD$US$US
235193062$23519306$2$F$$20240628$20240213$20240707$PER$$US-SA-2024SA041893$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240708$$MD$US$US
235193352$23519335$2$F$$20240731$20240213$20240808$PER$$US-SA-2024SA041733$SANOFI AVENTIS$$$$E$F$Y$$$20240808$$MD$US$US
235193612$23519361$2$F$20240101$20240808$20240213$20240816$PER$$US-SA-2024SA042815$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240816$$MD$US$US
235193643$23519364$3$F$20240201$20240802$20240213$20240809$PER$$US-SA-2024SA041986$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240809$$MD$US$US
235193792$23519379$2$F$20240115$20240719$20240213$20240730$PER$$US-SA-2024SA043183$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240730$$MD$US$US
235193982$23519398$2$F$$20240703$20240213$20240712$PER$$US-SA-2024SA043632$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240712$$MD$US$US
235193993$23519399$3$F$$20240711$20240213$20240718$PER$$US-SA-2024SA043390$SANOFI AVENTIS$$68$YR$E$F$Y$81.19$KG$20240718$$MD$US$US
235194042$23519404$2$F$20240101$20240701$20240213$20240708$PER$$US-SA-2024SA043958$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240708$$MD$US$US
235194113$23519411$3$F$20240101$20240904$20240213$20240930$PER$$US-SA-2024SA043609$SANOFI AVENTIS$$53$YR$A$F$Y$86$KG$20240930$$MD$US$US
235194172$23519417$2$F$20231207$20240802$20240213$20240813$PER$$US-SA-2024SA044065$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240814$$MD$US$US
235194302$23519430$2$F$$20240820$20240213$20240829$PER$$US-SA-2024SA044529$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240829$$MD$US$US
235194347$23519434$7$F$20240101$20240719$20240213$20240726$EXP$$US-SA-2024SA043407$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240726$$MD$US$US
235194673$23519467$3$F$20240405$20240917$20240213$20240926$PER$$US-SA-2024SA047717$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240926$$MD$US$US
235194745$23519474$5$F$20240101$20240724$20240213$20240801$EXP$$US-SA-2024SA047292$SANOFI AVENTIS$$71$YR$E$M$Y$113$KG$20240801$$MD$US$US
235194802$23519480$2$F$$20240828$20240213$20240909$PER$$US-SA-2024SA044556$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240909$$CN$US$US
235195042$23519504$2$F$$20240702$20240213$20240711$PER$$US-SA-2024SA047338$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240711$$MD$US$US
235195153$23519515$3$F$20240101$20240822$20240213$20240903$PER$$US-SA-2024SA047701$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240903$$MD$US$US
235195173$23519517$3$F$20240101$20240725$20240213$20240730$PER$$US-SA-2024SA048995$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240730$$MD$US$US
235195242$23519524$2$F$$20240806$20240213$20240814$PER$$US-SA-2024SA045052$SANOFI AVENTIS$$$$E$F$Y$$$20240814$$MD$US$US
235195354$23519535$4$F$20240801$20240828$20240213$20240905$EXP$$US-SA-2024SA049025$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240905$$CN$US$US
235195562$23519556$2$F$$20240729$20240213$20240807$PER$$US-SA-2024SA047143$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240807$$MD$US$US
235195676$23519567$6$F$20240201$20240904$20240213$20240912$PER$$US-SA-2023SA384608$SANOFI AVENTIS$$2$YR$C$M$Y$13.5$KG$20240912$$MD$US$US
235195772$23519577$2$F$20200101$20240821$20240213$20240918$PER$$US-SA-2024SA048329$SANOFI AVENTIS$$54$YR$A$M$Y$81$KG$20240918$$MD$US$US
235196002$23519600$2$F$20240101$20240816$20240213$20240829$PER$$US-SA-2024SA045106$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240829$$MD$US$US
235196232$23519623$2$F$$20240829$20240213$20240909$PER$$US-SA-2024SA048127$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240909$$MD$US$US
235196508$23519650$8$F$$20240904$20240213$20240919$EXP$$CA-HLS-202400470$HLS THERAPEUTICS$$$$E$F$Y$$$20240919$$CN$CA$CA
235196815$23519681$5$F$$20240705$20240213$20240711$EXP$$GB-SANDOZ INC.-NVSC2021GB106538$SANDOZ$$$$A$M$Y$$$20240711$$CN$GB$GB
235197053$23519705$3$F$$20240812$20240213$20240814$EXP$$CA-JNJFOC-20231157408$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240814$$HP$CA$CA
235197176$23519717$6$F$20230101$20240624$20240213$20240701$EXP$$BR-BIOGEN-2023BI01220912$BIOGEN$$$$$F$Y$75$KG$20240630$$CN$BR$BR
235197212$23519721$2$F$20190201$20240731$20240213$20240806$EXP$$JP-GSK-JP2019JPN032697$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$MD$JP$JP
235197653$23519765$3$F$20211212$20240808$20240213$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022047$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240814$$PH$US$US
235198032$23519803$2$F$$20240626$20240213$20240702$EXP$$US-ABBVIE-5633296$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
235198313$23519831$3$F$$20240722$20240213$20240729$EXP$$US-EMD Serono-2023494763$EMD SERONO INC$$$$A$M$Y$67$KG$20240729$$HP$US$US
235199612$23519961$2$F$20240213$20240912$20240213$20240912$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-008118$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240912$$CN$US$US
235199877$23519987$7$F$20230101$20240627$20240214$20240702$EXP$$ES-ABBVIE-5571368$ABBVIE$$$$$M$Y$$$20240702$$CN$ES$ES
235200174$23520017$4$F$20240101$20240611$20240214$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000316$ACADIA PHARMACEUTICALS$$21$YR$$F$Y$$$20240705$$CN$US$US
235200263$23520026$3$F$20231214$20240919$20240214$20240924$EXP$$CA-TAKEDA-2022TUS030142$TAKEDA$$56$YR$$M$Y$$$20240924$$MD$CA$CA
235200323$23520032$3$F$20240101$20240715$20240214$20240718$EXP$$CA-UCBSA-2024006873$UCB$$$$$F$Y$$$20240718$$CN$CA$CA
235200443$23520044$3$F$20240517$20240827$20240214$20240910$EXP$$US-UCBSA-2024006952$UCB$$6$YR$$M$Y$$$20240910$$CN$US$US
235200563$23520056$3$F$20231226$20240912$20240214$20240917$EXP$$US-ABBVIE-5637872$ABBVIE$$66$YR$$F$Y$106$KG$20240917$$HP$US$US
235200873$23520087$3$F$$20240827$20240214$20240904$EXP$$CA-CELLTRION INC.-2024CA002973$CELLTRION$$$$$$Y$$$20240904$$CN$CA$CA
235201402$23520140$2$F$20231205$20240905$20240214$20240912$EXP$$BR-TAKEDA-2023TUS078772$TAKEDA$$57$YR$$F$Y$$$20240912$$CN$BR$BR
235202013$23520201$3$F$20230601$20240912$20240214$20240925$PER$$US-GSK-US2024015963$GLAXOSMITHKLINE$$77$YR$$M$Y$$$20240925$$HP$US$US
235202153$23520215$3$F$20231201$20240627$20240214$20240708$PER$$US-SA-2024SA047644$SANOFI AVENTIS$$61$YR$A$F$Y$63.04$KG$20240708$$MD$US$US
235202402$23520240$2$F$$20240815$20240214$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020456$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240823$$CN$US$US
235202704$23520270$4$F$20231101$20240904$20240214$20240912$EXP$$CA-TOLMAR, INC.-24CA046258$TOLMAR$$80$YR$$M$Y$$$20240912$$CN$CA$CA
235203204$23520320$4$F$20231211$20240828$20240214$20240905$EXP$$CA-CELLTRION INC.-2023CA024527$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
235203223$23520322$3$F$$20240717$20240214$20240726$EXP$$CA-ROCHE-2467166$ROCHE$$$$A$F$Y$$$20240726$$HP$CA$CA
235203315$23520331$5$F$20231201$20240809$20240214$20240813$EXP$$CA-UCBSA-2023060715$UCB$$48$YR$$F$Y$$$20240813$$CN$CA$CA
235203372$23520337$2$F$20211001$20240828$20240214$20240909$EXP$$US-NOVOPROD-1171891$NOVO NORDISK$$51$YR$$F$Y$$$20240909$$CN$US$US
235203464$23520346$4$F$$20240830$20240214$20240905$EXP$$CA-GSK-CA2023082974$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$CA$CA
235203964$23520396$4$F$20210902$20240816$20240214$20240821$EXP$$CA-ROCHE-2905254$ROCHE$$33$YR$A$F$Y$$$20240821$$CN$CA$CA
235204054$23520405$4$F$$20240829$20240214$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020413$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240902$$CN$US$US
235204095$23520409$5$F$20230101$20240822$20240214$20240830$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-000582$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240830$$CN$US$US
235204452$23520445$2$F$20240202$20240621$20240214$20240702$PER$$US-SA-2024SA048661$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240702$$MD$US$US
235204503$23520450$3$F$20240301$20240708$20240214$20240716$PER$$US-SA-2024SA045834$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240716$$MD$US$US
235204522$23520452$2$F$$20240621$20240214$20240703$PER$$US-SA-2024SA044576$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240703$$MD$US$US
235205353$23520535$3$F$20240101$20240801$20240214$20240809$EXP$$CA-CELLTRION INC.-2024CA003535$CELLTRION$$$$$$Y$$$20240809$$CN$CA$CA
235205432$23520543$2$F$20240101$20240815$20240214$20240826$PER$$US-SA-2024SA044671$SANOFI AVENTIS$$32$YR$A$F$Y$65.77$KG$20240826$$MD$US$US
235205592$23520559$2$F$20240501$20240628$20240214$20240711$PER$$US-SA-2024SA048902$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240711$$MD$US$US
235205817$23520581$7$F$20240227$20240718$20240214$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000297$BLUEPRINT MEDICINES$$71$YR$E$M$Y$$$20240726$$CN$US$US
235206013$23520601$3$F$$20240717$20240214$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004923$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240718$$CN$US$US
235206162$23520616$2$F$20240206$20240718$20240214$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202402006881$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240725$$CN$US$US
235206355$23520635$5$F$20240501$20240809$20240214$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023418$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240816$$CN$US$US
235206495$23520649$5$F$20240221$20240618$20240214$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000329$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240712$$CN$US$US
235206533$23520653$3$F$$20240229$20240214$20240926$PER$$US-GSK-US2024AMR018489$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
235206935$23520693$5$F$$20240905$20240214$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022272$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240909$$CN$US$US
235207097$23520709$7$F$20240501$20240829$20240214$20240902$EXP$$US-SA-2024SA049029$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240902$$MD$US$US
2352072012$23520720$12$F$20230201$20240822$20240214$20240829$EXP$$CA-CELLTRION INC.-2024CA003501$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
235207678$23520767$8$F$20231113$20240916$20240214$20240924$EXP$$CA-GSK-CA2023128762$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$CA$CA
235208005$23520800$5$F$20240618$20240703$20240214$20240731$EXP$$CA-CELLTRION INC.-2024CA003550$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
235208152$23520815$2$F$$20240624$20240214$20240701$EXP$$FR-CELLTRION INC.-2024FR003305$CELLTRION$$$$$$Y$$$20240701$$MD$FR$FR
235209063$23520906$3$F$$20240712$20240214$20240716$PER$$US-AMGEN-USASP2024028965$AMGEN$$68$YR$E$F$Y$$$20240716$$HP$US$US
235209113$23520911$3$F$20230101$20240918$20240214$20240927$EXP$$CA-CELLTRION INC.-2024CA003609$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
235210055$23521005$5$F$$20240826$20240214$20240830$EXP$$US-TAKEDA-2024TUS013332$TAKEDA$$$$$M$Y$109$KG$20240830$$CN$US$US
235210084$23521008$4$F$$20240821$20240214$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-00910$LUPIN$$$$$$Y$$$20240909$$CN$US$US
235210152$23521015$2$F$20240102$20240827$20240214$20240902$EXP$$US-BIOGEN-2024BI01249449$BIOGEN$$64$YR$$F$Y$$$20240902$$CN$US$US
235210268$23521026$8$F$20231001$20240527$20240214$20240903$EXP$$CA-UCBSA-2023052487$UCB$$73$YR$$F$Y$$$20240903$$CN$CA$CA
235211114$23521111$4$F$$20240918$20240214$20240925$EXP$$CA-TAKEDA-2023TUS092458$TAKEDA$$$$$M$Y$$$20240925$$CN$CA$CA
235212032$23521203$2$F$$20231116$20240214$20240723$EXP$$US-TEVA-VS-3141472$TEVA$$$$$F$Y$$$20240723$$CN$US$US
235212482$23521248$2$F$$20240910$20240214$20240918$EXP$$AU-ROCHE-3503673$ROCHE$$$$$$Y$$$20240918$$MD$AU$AU
235212567$23521256$7$F$20240207$20240827$20240214$20240903$EXP$$CA-GSK-CA2023145164$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$HP$CA$CA
235212622$23521262$2$F$20240101$20240903$20240214$20240915$EXP$$CA-UCBSA-2024005764$UCB$$$$$F$Y$$$20240915$$CN$CA$CA
235212734$23521273$4$F$20230101$20240912$20240214$20240923$EXP$$US-INSMED, INC.-2023-04781-US$INSMED$$$$$F$Y$$$20240923$$CN$US$US
235212895$23521289$5$F$20240516$20240711$20240214$20240717$EXP$$CA-TAKEDA-2024TUS013205$TAKEDA$$49$YR$$M$Y$$$20240717$$CN$CA$CA
235213684$23521368$4$F$20240117$20240705$20240214$20240710$EXP$$CA-JNJFOC-20240223072$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240710$$CN$CA$CA
235214065$23521406$5$F$$20240821$20240214$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019830$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240826$$CN$US$US
235214078$23521407$8$F$20240206$20240812$20240214$20240818$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020412$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240819$$CN$US$US
235214184$23521418$4$F$20230101$20240719$20240214$20240725$EXP$$US-ABBVIE-5391371$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
235215624$23521562$4$F$20240202$20240716$20240214$20240718$PER$$US-AMGEN-USASP2024029231$AMGEN$$62$YR$A$M$Y$$$20240718$$CN$US$US
235215752$23521575$2$F$$20240710$20240214$20240712$EXP$$CA-BAUSCH-BL-2024-002072$BAUSCH AND LOMB$$43$YR$$F$Y$97$KG$20240712$$MD$CA$CA
235215932$23521593$2$F$$20240806$20240214$20240814$EXP$$US-SA-2024SA049395$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240814$$MD$US$US
235216143$23521614$3$F$20240202$20240730$20240214$20240806$EXP$$US-SA-2024SA048689$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240806$$MD$US$US
235216182$23521618$2$F$$20240729$20240214$20240802$EXP$$GB-SANDOZ INC.-NVSC2021GB183794$SANDOZ$$$$$M$Y$$$20240802$$CN$GB$GB
235216254$23521625$4$F$$20240711$20240214$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023679$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240715$$CN$US$US
235217233$23521723$3$F$20240707$20240712$20240214$20240717$EXP$$GB-MYLANLABS-2024M1013348$MYLAN$$$$$M$Y$$$20240717$$CN$GB$GB
2352176117$23521761$17$F$20240101$20240819$20240214$20240827$EXP$$US-UNITED THERAPEUTICS-UNT-2024-004040$UNITED THERAPEUTICS$$$$$F$Y$93.424$KG$20240827$$$US$US
235217713$23521771$3$F$20240117$20240926$20240214$20240930$EXP$$NVSC2024GB016339$NOVARTIS$$63$YR$$F$Y$$$20240930$$HP$GB$GB
235218044$23521804$4$F$20231107$20240712$20240214$20240719$EXP$$AR-MYLANLABS-2023M1121968$MYLAN$$59$YR$$F$Y$$$20240719$$CN$AR$AR
235218197$23521819$7$F$$20240801$20240214$20240816$30DAY$$KR-PFIZER INC-PV202400010597$PFIZER$$13$YR$$M$Y$$$20240816$$CN$KR$KR
235218428$23521842$8$F$$20240725$20240214$20240730$EXP$$US-PFIZER INC-PV202400018732$PFIZER$$49$YR$$M$Y$$$20240730$$CN$US$US
235219048$23521904$8$F$$20240917$20240214$20240919$EXP$$AU-TAKEDA-2021TUS064884$TAKEDA$$$$$M$Y$$$20240919$$CN$AU$AU
235219154$23521915$4$F$20240111$20240724$20240214$20240729$EXP$$CA-TAKEDA-2020TUS035922$TAKEDA$$45$YR$$F$Y$$$20240729$$CN$CA$CA
235219324$23521932$4$F$20230921$20240708$20240214$20240711$EXP$$CA-TAKEDA-2024TUS013101$TAKEDA$$37$YR$$F$Y$$$20240711$$CN$CA$CA
235219692$23521969$2$F$$20240226$20240214$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088068$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
235219872$23521987$2$F$20231113$20240216$20240214$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087003$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
235219975$23521997$5$F$20231207$20240702$20240214$20240708$EXP$$JP-009507513-2402JPN001756J$MERCK$$73$YR$$F$Y$$$20240708$$MD$JP$JP
235220438$23522043$8$F$$20240912$20240214$20240919$EXP$$NVSC2024US031021$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
235220745$23522074$5$F$20231101$20240820$20240214$20240904$PER$$US-SA-2024SA042275$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240904$$MD$US$US
235221292$23522129$2$F$20230801$20240829$20240214$20240925$PER$$US-SA-2024SA049346$SANOFI AVENTIS$$61$YR$A$M$Y$68.027$KG$20240925$$MD$US$US
235221313$23522131$3$F$$20240806$20240214$20240816$PER$$US-SA-2023SA353517$SANOFI AVENTIS$$63$YR$A$F$Y$83$KG$20240816$$MD$US$US
235222075$23522207$5$F$$20240921$20240214$20240923$30DAY$$US-PFIZER INC-PV202400014048$PFIZER$$16$YR$$M$Y$$$20240923$$HP$US$US
235222172$23522217$2$F$$20240710$20240214$20240722$EXP$$CA-APOTEX-2024AP002057$APOTEX$$$$$F$Y$$$20240722$$HP$CA$CA
235222444$23522244$4$F$20181001$20240215$20240214$20240718$EXP$$NVSC2024FR030998$NOVARTIS$$74$YR$$M$Y$$$20240718$$MD$FR$FR
235222623$23522262$3$F$20240205$20240221$20240214$20240808$EXP$$NVSC2024HU028479$NOVARTIS$$$$E$F$Y$$$20240808$$MD$HU$HU
235222683$23522268$3$F$$20240824$20240214$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202402006930$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240827$$CN$US$US
235222932$23522293$2$F$$20240908$20240214$20240916$PER$$US-AMGEN-USASP2024026181$AMGEN$Maverakis E.; Le S. T.; Herbert S. et al.. Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid. JAMA Dermatology. 2024;160 (1):107-109$$$$F$Y$$$20240916$$MD$US$US
235222972$23522297$2$F$$20240730$20240214$20240801$EXP$$US-UCBSA-2024006674$UCB$$$$$F$Y$79.274$KG$20240801$$HP$US$US
235222982$23522298$2$F$$20240908$20240214$20240917$PER$$US-AMGEN-USASP2024026189$AMGEN$Maverakis E.; Le S. T.; Herbert S. et al.. Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid. JAMA Dermatology. 2024;160 (1):107-109$$$$M$Y$$$20240917$$MD$US$US
235223112$23522311$2$F$$20240701$20240214$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022191$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240702$$CN$US$US
235223152$23522315$2$F$$20240908$20240214$20240917$PER$$US-AMGEN-USASP2024026205$AMGEN$Maverakis E.; Le S. T.; Herbert S. et al.. Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid. JAMA Dermatology. 2024;160 (1):107-109$$$A$F$Y$$$20240916$$MD$US$US
235223473$23522347$3$F$$20240709$20240214$20240716$PER$$US-VERTEX PHARMACEUTICALS-2024-002280$VERTEX$$$$A$F$Y$$$20240716$$CN$US$US
235223742$23522374$2$F$20240109$20240923$20240214$20240930$EXP$$US-SA-2024SA048362$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240930$$CN$US$US
2352243113$23522431$13$F$20240101$20240906$20240214$20240912$EXP$$US-BEH-2024168292$CSL BEHRING$$44$YR$A$F$Y$$$20240912$$CN$US$US
235224692$23522469$2$F$$20240619$20240214$20240703$EXP$$CA-TEVA-VS-3152771$TEVA$$72$YR$$M$Y$$$20240703$$CN$CA$CA
235224982$23522498$2$F$$20240809$20240214$20240817$PER$$US-SA-2024SA047308$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240817$$MD$US$US
235225504$23522550$4$F$$20240710$20240214$20240716$30DAY$$US-PFIZER INC-202400032944$PFIZER$$14$YR$$F$Y$$$20240716$$MD$US$US
235225683$23522568$3$F$20230330$20240716$20240214$20240731$PER$$US-RISINGPHARMA-US-2024RISSPO00038$RISING PHARMACEUTICALS$$56$YR$A$M$Y$$$20240731$$CN$US$US
235225742$23522574$2$F$20240202$20240722$20240214$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-003697$UNITED THERAPEUTICS$$64$YR$$F$Y$86.621$KG$20240727$$$US$US
235226014$23522601$4$F$20231201$20240722$20240214$20240802$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-01186$HIKMA$$40$YR$$F$Y$$$20240802$$HP$GB$GB
235226092$23522609$2$F$$20240624$20240214$20240701$EXP$$JP-009507513-2310JPN003845J$MERCK$$$$$F$Y$$$20240701$$MD$JP$JP
235226445$23522644$5$F$20240101$20240821$20240214$20240827$PER$$US-Eisai-EC-2024-157678$EISAI$$58$YR$A$M$Y$83.9$KG$20240827$$CN$US$US
235226744$23522674$4$F$$20240905$20240214$20240909$PER$$US-ALXN-202402USA000036US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
235227392$23522739$2$F$20240208$20240215$20240214$20240731$PER$$US-BAYER-2024A024476$BAYER$$49$YR$A$F$Y$$$20240731$$HP$US$US
235227582$23522758$2$F$20230804$20240207$20240214$20240807$EXP$$NVSC2023KW173009$NOVARTIS$$63$YR$$F$Y$$$20240807$$CN$KW$KW
235228024$23522802$4$F$20220101$20240828$20240214$20240903$EXP$$AU-PFIZER INC-202400040055$PFIZER$Dessauer, A.. Cytomegalovirus and Aspergillus co-infection in an immunocompetent patient with severe COVID-19. Pathology. 2024;56(1):110-114$48$YR$$M$Y$$$20240903$$MD$AU$AU
235228252$23522825$2$F$20231201$20240822$20240214$20240911$EXP$$US-SA-2024SA050827$SANOFI AVENTIS$$63$YR$A$M$Y$133.79$KG$20240911$$MD$US$US
235228533$23522853$3$F$$20240709$20240214$20240715$EXP$$CZ-MYLANLABS-2024M1013029$MYLAN$Janikova A.. The first experiences and a successful therapy with a new drug ? the anti-CD20/CD3 bispecific antibody mosunetuzumab.. Farmakoterapie. 2023;19 (6):817-819$59$YR$$M$Y$$$20240715$$MD$CZ$CZ
235228693$23522869$3$F$$20240830$20240214$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023430$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240903$$CN$US$US
235229113$23522911$3$F$20240115$20240822$20240214$20240828$EXP$$MX-BIOVITRUM-2024-MX-002507$BIOVITRUM$$242$DY$$M$Y$8.3$KG$20240828$$HP$MX$MX
235229779$23522977$9$F$20240430$20240919$20240214$20240927$EXP$$US-UCBSA-2024000844$UCB$$30$YR$$F$Y$111.11$KG$20240927$$HP$US$US
235229986$23522998$6$F$20240204$20240905$20240214$20240910$EXP$$NL-ABBVIE-5634077$ABBVIE$$76$YR$$M$Y$$$20240910$$HP$NL$NL
235229995$23522999$5$F$20230623$20240717$20240214$20240720$EXP$$CA-TAKEDA-2019TUS056546$TAKEDA$$82$YR$$M$Y$$$20240720$$CN$CA$CA
235230242$23523024$2$F$$20240925$20240214$20240930$EXP$$US-TAKEDA-2022TUS085413$TAKEDA$$$$$M$Y$73$KG$20240930$$HP$US$US
235230545$23523054$5$F$$20240926$20240214$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023680$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240927$$CN$US$US
235230673$23523067$3$F$20201013$20240917$20240214$20240925$EXP$$CA-TAKEDA-2024TUS014172$TAKEDA$$74$YR$$F$Y$$$20240925$$HP$CA$CA
235230802$23523080$2$F$$20240908$20240214$20240916$EXP$$US-AMGEN-USASP2024028098$AMGEN$Maverakis E.; Le S. T.; Herbert S. et al.. Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid. JAMA Dermatology. 2024;160 (1):107-109$$$$$Y$$$20240916$$MD$US$US
235230952$23523095$2$F$20230728$20240712$20240214$20240717$EXP$$DE-PFIZER INC-202400037804$PFIZER$$72$YR$$F$Y$$$20240717$$MD$DE$DE
235231333$23523133$3$F$$20240829$20240214$20240916$PER$$CA-TOLMAR, INC.-24CA046330$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
235231382$23523138$2$F$$20240902$20240214$20240918$PER$$CA-TOLMAR, INC.-24CA046356$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
235231392$23523139$2$F$20240101$20240717$20240214$20240807$PER$$CO-TOLMAR, INC.-24CO046277$TOLMAR$$70$YR$$M$Y$$$20240806$$CN$CO$CO
235232134$23523213$4$F$20240101$20240816$20240214$20240820$EXP$$NVSC2024GT031126$NOVARTIS$$33$YR$$F$Y$$$20240820$$CN$GT$GT
235232205$23523220$5$F$$20240913$20240214$20240927$PER$$US-SA-2024SA047150$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240927$$MD$US$US
235232365$23523236$5$F$20231001$20240628$20240214$20240703$EXP$$JP-AstraZeneca-2024A033546$ASTRAZENECA$$63$YR$$F$Y$71$KG$20240703$$MD$JP$
235233712$23523371$2$F$$20240820$20240214$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024272$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$92.99$KG$20240822$$CN$US$US
235233822$23523382$2$F$20240207$20240724$20240214$20240731$PER$$US-Eisai-EC-2024-158894$EISAI$$66$YR$E$M$Y$$$20240731$$CN$US$US
235233863$23523386$3$F$$20240709$20240214$20240712$EXP$$JP-ABBVIE-5639728$ABBVIE$$$$$M$Y$72$KG$20240712$$MD$JP$JP
235234085$23523408$5$F$$20240619$20240214$20240704$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-431118$RANBAXY$Kumar C, Kuhn M, Herrmann K, Leuchten N, Aringer M. Severe methotrexate toxicity in elderly patients under diuretics/ Mucositis and bone marrow suppression: 12 case reports. RMD Open. 2024;10(1):1-8$75$YR$$F$Y$$$20240704$$HP$DE$DE
235234675$23523467$5$F$20210303$20240806$20240214$20240813$EXP$$DE-TEVA-VS-3154188$TEVA$$45$YR$$M$Y$79$KG$20240813$$MD$DE$DE
235235052$23523505$2$F$20240628$20240628$20240214$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202311003599$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240701$$CN$US$US
235235102$23523510$2$F$20231025$20240827$20240214$20240828$EXP$$NL-SANDOZ INC.-SDZ2024NL013888$SANDOZ$$50$YR$$F$Y$59.3$KG$20240828$$MD$NL$NL
235235483$23523548$3$F$20240701$20240725$20240214$20240806$PER$$US-SA-2024SA046874$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
235236072$23523607$2$F$20240301$20240628$20240214$20240705$EXP$$IN-PFIZER INC-PV202400020501$PFIZER$$49$YR$$M$Y$$$20240705$$CN$IN$IN
235236963$23523696$3$F$$20240913$20240214$20240917$EXP$$PT-MYLANLABS-2024M1014000$MYLAN$Monteiro C, Dias B, Vaz-Patto M.. Headache as an adverse reaction to the use of medication in the elderly: A pharmacovigilance study.. International Journal of Environmental Research and Public Health.. 2021;18(5):1-11$$$E$$Y$$$20240917$$HP$PT$PT
235237282$23523728$2$F$$20240906$20240214$20240926$PER$$US-TEVA-VS-3157311$TEVA$$75$YR$$F$Y$$$20240926$$CN$US$US
235237652$23523765$2$F$20240101$20240913$20240214$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024058$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240917$$CN$US$US
235237875$23523787$5$F$$20240816$20240214$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022652$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240819$$CN$US$US
235238153$23523815$3$F$20230902$20240822$20240214$20240903$PER$$US-INCYTE CORPORATION-2024IN001232$INCYTE$$$$$$Y$$$20240903$$CN$US$US
235238853$23523885$3$F$20231111$20240815$20240214$20240824$EXP$$JP-AstraZeneca-2024A037185$ASTRAZENECA$$64$YR$$$Y$$$20240823$$MD$JP$
235238942$23523894$2$F$20240801$20240812$20240214$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202402006207$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240815$$HP$US$US
235238982$23523898$2$F$20220101$20240730$20240214$20240731$EXP$$US-PFIZER INC-202400039732$PFIZER$$63$YR$$F$Y$$$20240731$$CN$US$US
235239154$23523915$4$F$20230801$20240709$20240214$20240725$EXP$$JP-ABBVIE-5640273$ABBVIE$$85$YR$$F$Y$42$KG$20240725$$MD$JP$JP
235239214$23523921$4$F$$20240919$20240214$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024242$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$72.12$KG$20240923$$CN$US$US
235239762$23523976$2$F$$20240715$20240214$20240717$PER$$US-PFIZER INC-PV202400020012$PFIZER$$67$YR$$F$Y$$$20240717$$CN$US$US
235240014$23524001$4$F$$20240711$20240214$20240716$EXP$$GB-MYLANLABS-2024M1013650$MYLAN$$73$YR$$M$Y$$$20240716$$CN$GB$GB
235240584$23524058$4$F$20240101$20240508$20240214$20240812$PER$$US-KARYOPHARM-2024KPT000181$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240812$$CN$US$US
235240753$23524075$3$F$20240130$20240229$20240214$20240918$EXP$FR-AFSSAPS-TS2024000148$FR-BAUSCH-BL-2024-002383$BAUSCH AND LOMB$$77$YR$$F$Y$60$KG$20240918$$MD$FR$FR
235240792$23524079$2$F$20240101$20240715$20240214$20240717$EXP$$US-PFIZER INC-PV202400019998$PFIZER$$91$YR$$F$Y$$$20240717$$CN$US$US
235241074$23524107$4$F$$20240909$20240214$20240912$PER$$US-PFIZER INC-PV202400017529$PFIZER$$80$YR$$M$Y$90.72$KG$20240912$$MD$US$US
235241113$23524111$3$F$$20240910$20240214$20240912$PER$$US-PFIZER INC-202400041059$PFIZER$$68$YR$$M$Y$$$20240912$$HP$US$US
235242163$23524216$3$F$20230901$20240820$20240214$20240823$EXP$$FR-Eisai-EC-2024-159127$EISAI$$80$YR$E$F$Y$54$KG$20240823$$MD$FR$FR
235242292$23524229$2$F$20231001$20240903$20240214$20240912$PER$$JP-Eisai-EC-2023-151705$EISAI$$59$YR$A$F$Y$$$20240912$$MD$JP$JP
235242332$23524233$2$F$20240112$20240624$20240214$20240723$PER$$US-009507513-2402USA003786$MERCK$$48$YR$$F$Y$$$20240723$$HP$US$US
235242463$23524246$3$F$20230823$20240710$20240214$20240718$EXP$$JP-Eisai-EC-2023-148241$EISAI$$$$E$F$Y$$$20240718$$MD$JP$JP
235242933$23524293$3$F$$20240708$20240214$20240720$30DAY$$CN-JNJFOC-20240201719$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$CN$CN$CN
235242972$23524297$2$F$$20240730$20240214$20240801$PER$$US-BIOMARINAP-US-2024-155800$BIOMARIN$$$$$$Y$$$20240801$$CN$US$US
235243122$23524312$2$F$$20240908$20240214$20240916$PER$$US-AMGEN-USASP2024026170$AMGEN$Maverakis E.; Le S. T.; Herbert S. et al.. Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid. JAMA Dermatology. 2024;160 (1):107-109$$$E$F$Y$$$20240916$$MD$US$US
235243212$23524321$2$F$20240112$20240809$20240214$20240816$EXP$$US-ABBVIE-5636840$ABBVIE$$51$YR$$M$Y$$$20240816$$CN$US$US
235243703$23524370$3$F$20220711$20240826$20240214$20240827$EXP$$BG-SANDOZ INC.-NVSC2022BG164006$SANDOZ$$65$YR$$F$Y$80$KG$20240827$$MD$BG$BG
235244062$23524406$2$F$20240208$20240911$20240214$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-023126$BRISTOL MYERS SQUIBB$$7$DEC$E$$Y$$$20240919$$MD$JP$JP
235244093$23524409$3$F$20240701$20240815$20240214$20240822$EXP$$US-TAKEDA-2024TUS012272$TAKEDA$$40$YR$$F$Y$$$20240822$$CN$US$US
235244144$23524414$4$F$20240101$20240717$20240214$20240723$EXP$$CA-ABBVIE-5631333$ABBVIE$$75$YR$$M$Y$$$20240723$$CN$CA$CA
235244332$23524433$2$F$20231218$20240625$20240214$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023440$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$67.8$KG$20240704$$HP$US$US
235244402$23524440$2$F$$20240910$20240214$20240924$EXP$$US-ENDO PHARMACEUTICALS INC-2023-006188$ENDO$$$$$M$Y$$$20240924$$CN$US$US
235244933$23524493$3$F$20240111$20240831$20240214$20240906$EXP$$CA-GSK-CA2023126681$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$HP$CA$CA
235245242$23524524$2$F$$20240702$20240214$20240709$EXP$$US-GSK-US2024017670$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$HP$US$US
235245446$23524544$6$F$20160802$20240813$20240214$20240822$EXP$$CA-SANDOZ INC.-PHHY2016CA107522$SANDOZ$$53$YR$$F$Y$53$KG$20240822$$CN$CA$CA
235245987$23524598$7$F$20240101$20240819$20240215$20240822$EXP$$US-ABBVIE-5547239$ABBVIE$$51$YR$$F$Y$129$KG$20240822$$CN$US$US
235246042$23524604$2$F$20240201$20240828$20240215$20240904$PER$$US-JNJFOC-20240207486$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240904$$PH$US$US
235246202$23524620$2$F$20240101$20240805$20240215$20240819$EXP$$JP-AMGEN-JPNSP2024028995$AMGEN$$$$$F$Y$$$20240819$$CN$JP$JP
235246695$23524669$5$F$20231228$20240705$20240215$20240718$EXP$$FR-CELLTRION INC.-2024FR003258$CELLTRION$$$$$$Y$$$20240718$$MD$FR$FR
235246713$23524671$3$F$$20240723$20240215$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011364$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240724$$CN$US$US
2352476110$23524761$10$F$20240101$20240913$20240215$20240923$EXP$$IE-ABBVIE-5637303$ABBVIE$$79$YR$$M$Y$$$20240923$$HP$IE$IE
235247913$23524791$3$F$20240209$20240731$20240215$20240805$PER$$US-AMGEN-USASP2024030425$AMGEN$$62$YR$A$F$Y$$$20240804$$CN$US$US
235248163$23524816$3$F$20240101$20240711$20240215$20240722$EXP$$CA-TOLMAR, INC.-24CA046733$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
235248222$23524822$2$F$$20240716$20240215$20240723$EXP$$FR-IPCA LABORATORIES LIMITED-IPC-2024-FR-000289$IPCA$Guillaume Drevin, Stephane Malbranque, Nathalie Jousset et al.. Pharmacobezoar-related fatalities: A case report and a review of the literature. Ther Drug Monit. 2024;46 (1):1-5$$$$$Y$$$20240723$$MD$FR$FR
235248352$23524835$2$F$20240719$20240719$20240215$20240801$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000140$DECIPHERA PHARMACEUTICALS$$62$YR$A$F$Y$$$20240801$$CN$US$US
235248753$23524875$3$F$20240101$20240801$20240215$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020280$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$89.36$KG$20240802$$CN$US$US
235249262$23524926$2$F$$20240812$20240215$20240819$EXP$$US-TAKEDA-2023TUS063460$TAKEDA$$$$$F$Y$$$20240819$$CN$US$US
235249596$23524959$6$F$20180101$20240712$20240215$20240912$EXP$$US-TEVA-VS-3154435$TEVA$$44$YR$$F$Y$$$20240912$$CN$US$US
235249602$23524960$2$F$$20240913$20240215$20240925$EXP$$IE-AUROBINDO-AUR-APL-2023-002875$AUROBINDO$Courtney A, Hill A, Smith D, Agha A.. Familial hypocalciuric hypercalcaemia type 1 caused by a novel heterozygous missense variant in the CaSR gene, p(His41Arg): two case reports.. BMC Endocr Disord.. 2022;22(1):1-5.$50$YR$$F$Y$$$20240925$$MD$IE$IE
235249682$23524968$2$F$$20240708$20240215$20240718$EXP$CA-HEALTHCANVIG-E2B_06770819$CA-NOVOPROD-1173854$NOVO NORDISK$$60$YR$$M$Y$$$20240718$$CN$CA$CA
235249752$23524975$2$F$20230815$20240828$20240215$20240909$EXP$SE-SEMPA-2024-000910$SE-NOVOPROD-1172420$NOVO NORDISK$$59$YR$$F$Y$94$KG$20240909$$MD$SE$SE
235250175$23525017$5$F$20240101$20240910$20240215$20240917$PER$$US-SA-2024SA048359$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240918$$MD$US$US
235250213$23525021$3$F$$20240802$20240215$20240812$PER$$US-SA-2024SA048352$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
235250412$23525041$2$F$20240801$20240904$20240215$20240926$PER$$US-SA-2024SA049944$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240926$$MD$US$US
235250424$23525042$4$F$20240101$20240820$20240215$20240829$PER$$US-SA-2024SA050073$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240829$$MD$US$US
235251184$23525118$4$F$$20240715$20240215$20240722$PER$$US-ALXN-202402USA000612US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
235251302$23525130$2$F$$20240807$20240215$20240814$30DAY$$US-GSK-US2024015972$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
235251927$23525192$7$F$$20240918$20240215$20240920$PER$$US-BIOGEN-2024BI01249948$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
235252104$23525210$4$F$20240123$20240628$20240215$20240712$EXP$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000063$PAREXEL$$$$$$Y$$$20240712$$CN$US$US
235252522$23525252$2$F$$20240924$20240215$20240927$EXP$IT-EMA-DD-20240206-7482707-094710$IT-RDY-SPO/ITA/24/0002438$DR REDDYS$Benevolo G, Bringhen S, Maletta F, Bruno B, Bertuglia G. An atypical presentation of visceral leishmaniasis mimicking multiple myeloma relapse. Am J Hematol. 2023 NOV 20;99:137-141.$79$YR$E$M$Y$$$20240927$$HP$IT$IT
235252556$23525255$6$F$20230819$20240906$20240215$20240908$EXP$$JP-ABBVIE-21K-087-4206908-00$ABBVIE$$88$YR$$M$Y$$$20240908$$MD$JP$JP
235253074$23525307$4$F$20240118$20240808$20240215$20240815$EXP$$CA-CELLTRION INC.-2023CA025498$CELLTRION$$$$$$Y$$$20240815$$MD$CA$CA
235253222$23525322$2$F$$20230810$20240215$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64407$HIKMA$$$$$$Y$$$20240812$$MD$US$US
2352533912$23525339$12$F$20240101$20240816$20240215$20240828$EXP$$US-INSMED, INC.-2024-00042-US$INSMED$$$$$F$Y$$$20240828$$CN$US$US
235253496$23525349$6$F$$20240913$20240215$20240925$30DAY$$AE-JNJFOC-20240185821$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$AE$AE
235254532$23525453$2$F$20240101$20240629$20240215$20240710$EXP$CZ-CZSUKL-24000057$CZ-Accord-406500$ACCORD$$18$YR$A$F$Y$$$20240710$$MD$CZ$CZ
235254583$23525458$3$F$$20240716$20240215$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024501$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240718$$CN$US$US
235254594$23525459$4$F$20240206$20240715$20240215$20240720$EXP$$CA-JNJFOC-20240231010$JOHNSON AND JOHNSON$$94$YR$E$F$Y$$$20240719$$HP$CA$CA
235254793$23525479$3$F$20240101$20240819$20240215$20240826$EXP$$JP-GENMAB-2024-00386$GENMAB$$77$YR$$F$Y$53.7$KG$20240826$$MD$JP$JP
235255504$23525550$4$F$20240101$20240703$20240215$20240711$EXP$$CL-JNJFOC-20240224541$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240711$$CN$CL$CL
235255554$23525555$4$F$20231201$20240702$20240215$20240711$EXP$$US-INSMED-2023-04961-USAA$INSMED$$64$YR$$F$Y$$$20240711$$CN$US$US
235255774$23525577$4$F$20240101$20240801$20240215$20240815$EXP$$US-INSMED, INC.-2024-00479-US$INSMED$$$$$F$Y$$$20240815$$CN$US$US
235255853$23525585$3$F$20240211$20240722$20240215$20240724$PER$$US-AMGEN-USASP2024030312$AMGEN$$61$YR$A$F$Y$$$20240724$$CN$US$US
235257656$23525765$6$F$20230919$20240829$20240215$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-006240$AUROBINDO$$51$YR$$F$Y$47$KG$20240909$$HP$FR$FR
235258023$23525802$3$F$$20240722$20240215$20240731$PER$$US-SA-2024SA047218$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240731$$MD$US$US
235258174$23525817$4$F$$20240808$20240215$20240817$PER$$US-SA-2024SA048936$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240817$$MD$US$US
235258222$23525822$2$F$$20240628$20240215$20240709$PER$$US-SA-2024SA048895$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240709$$MD$US$US
235258362$23525836$2$F$20240201$20240801$20240215$20240813$PER$$US-SA-2024SA049799$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240814$$MD$US$US
235258402$23525840$2$F$$20240806$20240215$20240813$PER$$US-SA-2024SA048415$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240814$$MD$US$US
235258643$23525864$3$F$$20240820$20240215$20240830$PER$$US-SA-2024SA050072$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240830$$MD$US$US
235258653$23525865$3$F$$20240710$20240215$20240718$PER$$US-SA-2024SA051054$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240718$$MD$US$US
235258883$23525888$3$F$20230801$20240830$20240215$20240909$EXP$$CA-GSK-CA2023116281$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$HP$CA$CA
235258993$23525899$3$F$20231218$20240801$20240215$20240809$EXP$$BR-CELLTRION INC.-2024BR003362$CELLTRION$$$$$$Y$$$20240809$$CN$BR$BR
235259032$23525903$2$F$$20240712$20240215$20240717$EXP$$JP-SANDOZ INC.-SDZ2023JP015351$SANDOZ$Kitayama S, Torai R, Kataoka K, Mori S, Furukawa F, Mizawa M, etc. Valacyclovir-induced drug reaction with eosinophilia and systemic symptoms (DRESS). The Nishinihon Journal of Dermatology. 2023;85(3):236$101$YR$$F$Y$$$20240717$$MD$JP$JP
235259555$23525955$5$F$$20240823$20240215$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023627$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240903$$CN$US$US
235259732$23525973$2$F$20230914$20240814$20240215$20240821$EXP$$US-MYLANLABS-2023M1065958$MYLAN$$28$YR$$F$Y$79.37$KG$20240821$$CN$US$US
235260043$23526004$3$F$20230601$20240722$20240215$20240730$EXP$$NVSC2024IN028840$NOVARTIS$$60$YR$$F$Y$$$20240730$$CN$IN$IN
235260383$23526038$3$F$20240122$20240815$20240215$20240825$30DAY$$US-GSK-US2024018272$GLAXOSMITHKLINE$$59$YR$$F$Y$47$KG$20240825$$CN$US$US
235260944$23526094$4$F$$20240823$20240215$20240828$EXP$$CA-JNJFOC-20240231224$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240828$$HP$CA$CA
235261013$23526101$3$F$$20240917$20240215$20240927$EXP$$JP-ASTELLAS-2024JP000553$ASTELLAS$$79$YR$E$F$Y$$$20240927$$MD$JP$JP
235261183$23526118$3$F$$20240731$20240215$20240807$PER$$US-ALXN-202402USA000546US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$HP$US$US
235261212$23526121$2$F$$20240823$20240215$20240906$EXP$$CA-UCBSA-2024006737$UCB$$$$$M$Y$$$20240906$$MD$CA$CA
235261403$23526140$3$F$20190619$20240910$20240215$20240919$EXP$$DE-ROCHE-2344669$ROCHE$$48$YR$A$M$Y$$$20240919$$CN$DE$DE
235261423$23526142$3$F$20180508$20240830$20240215$20240906$EXP$$DE-ROCHE-2129449$ROCHE$$32$YR$A$F$Y$$$20240906$$CN$DE$DE
235262055$23526205$5$F$20240131$20240913$20240215$20240920$EXP$$AU-TAKEDA-2024TUS013475$TAKEDA$$57$YR$$F$Y$$$20240920$$CN$AU$AU
235262103$23526210$3$F$20240101$20240621$20240215$20240702$PER$$US-SA-2024SA050063$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240702$$MD$US$US
235262914$23526291$4$F$20240131$20240910$20240215$20240918$EXP$$US-GSK-US2024016086$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$US$US
235263272$23526327$2$F$$20240715$20240215$20240722$EXP$$US-JAZZ-2017-US-008438$JAZZ$$$$$F$Y$$$20240722$$MD$US$US
235263694$23526369$4$F$20240209$20240705$20240215$20240708$PER$$US-ALXN-202402USA000637US$ALEXION PHARMACEUTICALS$$9$YR$$M$Y$$$20240708$$CN$US$US
235263843$23526384$3$F$20240101$20240625$20240215$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2024-003681$UNITED THERAPEUTICS$$$$$F$Y$48.526$KG$20240703$$$US$US
235265122$23526512$2$F$20240110$20240924$20240215$20240927$EXP$$AU-TAKEDA-2024TUS013467$TAKEDA$$37$YR$$M$Y$$$20240927$$CN$AU$AU
235265323$23526532$3$F$$20240905$20240215$20240907$EXP$$NVSC2023US267677$NOVARTIS$$$$$F$Y$$$20240907$$CN$US$US
235265582$23526558$2$F$20231201$20240729$20240215$20240805$EXP$SE-SEMPA-2024-001006$SE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-007962$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$$$20240805$$MD$SE$SE
235265649$23526564$9$F$20240514$20240925$20240215$20240930$30DAY$$US-PFIZER INC-202400032914$PFIZER$$14$YR$$M$Y$49.9$KG$20240930$$CN$US$US
235265682$23526568$2$F$$20240903$20240215$20240918$PER$$US-SA-2024SA051000$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240918$$CN$US$US
2352657411$23526574$11$F$$20240903$20240215$20240909$30DAY$$US-PFIZER INC-PV202400016877$PFIZER$$10$YR$$F$Y$$$20240909$$CN$US$US
235265753$23526575$3$F$20230901$20240702$20240215$20240710$EXP$$JP-009507513-2309JPN003865J$MERCK$$46$YR$$F$Y$45$KG$20240710$$MD$JP$JP
235266348$23526634$8$F$$20240725$20240215$20240729$30DAY$$US-PFIZER INC-202400034837$PFIZER$$55$YR$$M$Y$122.47$KG$20240729$$MD$US$US
235266552$23526655$2$F$20240211$20240703$20240215$20240712$EXP$$US-VIIV HEALTHCARE LIMITED-US2024019500$VIIV$$35$YR$$M$Y$$$20240712$$CN$US$US
235266722$23526672$2$F$20231101$20240715$20240215$20240724$EXP$FR-AFSSAPS-LM2023000675$FR-TEVA-VS-3157254$TEVA$$87$YR$$F$Y$62$KG$20240724$$MD$FR$FR
235267255$23526725$5$F$20240301$20240916$20240215$20240921$EXP$$US-ABBVIE-5638168$ABBVIE$$58$YR$$F$Y$$$20240921$$CN$US$US
235267473$23526747$3$F$20230710$20240902$20240215$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-023144$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$55.2$KG$20240917$$MD$JP$JP
235267702$23526770$2$F$20230316$20240808$20240215$20240813$PER$$US-BAYER-2024A024277$BAYER$$41$YR$A$F$Y$$$20240813$$HP$US$US
235268055$23526805$5$F$20240207$20240726$20240215$20240801$EXP$$CO-TAKEDA-2024TUS014452$TAKEDA$$65$YR$$F$Y$64$KG$20240801$$CN$CO$CO
235268363$23526836$3$F$20231130$20240628$20240215$20240708$EXP$FR-AFSSAPS-LY2024000154$FR-MYLANLABS-2024M1013382$MYLAN$$71$YR$$F$Y$$$20240708$$PH$FR$FR
235268602$23526860$2$F$20231122$20240826$20240215$20240827$EXP$$JP-BAYER-2024A024891$BAYER$$88$YR$E$M$Y$$$20240827$$MD$JP$JP
235268727$23526872$7$F$20240601$20240925$20240215$20240930$EXP$$NVSC2023GB270855$NOVARTIS$$$$A$F$Y$$$20240930$$CN$GB$GB
235269535$23526953$5$F$20240206$20240625$20240215$20240701$EXP$$GB-MYLANLABS-2024M1013093$MYLAN$$47$YR$$M$Y$$$20240701$$CN$GB$GB
235270185$23527018$5$F$20240214$20240816$20240215$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002779$JAZZ$$12$YR$$M$Y$$$20240827$$CN$US$US
235270192$23527019$2$F$$20240821$20240215$20240824$EXP$$IL-ALXN-202402ISR000709IL$ALEXION PHARMACEUTICALS$$60$YR$$F$Y$$$20240824$$MD$IL$IL
235270693$23527069$3$F$$20240827$20240215$20240904$EXP$$CA-JNJFOC-20240218760$JOHNSON AND JOHNSON$$12$YR$T$M$Y$40$KG$20240904$$HP$CA$CA
235271153$23527115$3$F$20230728$20240820$20240215$20240822$EXP$$FR-Eisai-EC-2024-159206$EISAI$$81$YR$E$F$Y$63$KG$20240822$$MD$FR$FR
235271183$23527118$3$F$$20240820$20240215$20240826$EXP$$GB-TAKEDA-2024TUS014120$TAKEDA$$$$$F$Y$$$20240826$$CN$GB$GB
235271652$23527165$2$F$20230901$20240823$20240215$20240830$EXP$$JP-AstraZeneca-2024A034541$ASTRAZENECA$$84$YR$$M$Y$$$20240830$$MD$JP$
235271834$23527183$4$F$$20240906$20240215$20240910$PER$$US-BIOGEN-2023BI01183627$BIOGEN$$$$$M$Y$$$20240910$$CN$US$US
235272163$23527216$3$F$$20240212$20240215$20240826$EXP$$NVSC2024CA031532$NOVARTIS$$52$YR$$F$Y$$$20240826$$HP$CA$CA
235272293$23527229$3$F$$20240712$20240215$20240717$EXP$$JP-009507513-2402JPN000944J$MERCK$Hishinuma S, Namiki T, Koh E, Hasegawa M. 8-2 A Case of Secondary Adrenocortical Hypofunction due to Immune Checkpoint Inhibitor Treatment of Lung Cancer Complicated with Immune Checkpoint Inhibitor-Related Lung Disorder. The 460th Kanto Regional Meeting of the Japan Radiological Society. 47$83$YR$$M$Y$$$20240717$$MD$JP$JP
235272614$23527261$4$F$20230101$20240913$20240215$20240918$EXP$$CA-PFIZER INC-202400041264$PFIZER$$62$YR$$F$Y$$$20240918$$HP$CA$CA
235272712$23527271$2$F$20231214$20240729$20240215$20240801$EXP$FR-AFSSAPS-LY2024000209$FR-PFIZER INC-202400039130$PFIZER$$62$YR$$F$Y$57$KG$20240801$$HP$FR$FR
235272815$23527281$5$F$$20240905$20240215$20240906$PER$$NVSC2024US032541$NOVARTIS$$$$$F$Y$$$20240906$$HP$US$US
235272962$23527296$2$F$20231006$20240801$20240215$20240806$EXP$FR-AFSSAPS-SE2024000100$FR-PFIZER INC-202400039167$PFIZER$$68$YR$$M$Y$70$KG$20240806$$MD$FR$FR
235273185$23527318$5$F$20211001$20240830$20240215$20240830$EXP$$DE-PFIZER INC-PV202400020817$PFIZER$$43$YR$$F$Y$61$KG$20240830$$MD$DE$DE
235273262$23527326$2$F$20240101$20240720$20240215$20240802$EXP$$US-UCBSA-2024007033$UCB$$$$$F$Y$$$20240802$$HP$US$US
235273332$23527333$2$F$$20240702$20240215$20240710$EXP$$AU-TAKEDA-2024TUS012655$TAKEDA$$23$YR$$F$Y$$$20240710$$HP$AU$AU
235273815$23527381$5$F$20200101$20240709$20240215$20240711$EXP$$US-PFIZER INC-PV202400021073$PFIZER$$66$YR$$F$Y$49.887$KG$20240711$$CN$US$US
235273952$23527395$2$F$20240212$20240704$20240215$20240710$PER$$US-PFIZER INC-PV202400021234$PFIZER$$66$YR$$F$Y$$$20240710$$CN$US$US
235274044$23527404$4$F$20231227$20240805$20240215$20240808$EXP$$US-BIOVITRUM-2024-US-002378$BIOVITRUM$$16$MON$$M$Y$9.2$KG$20240808$$CN$US$US
235274093$23527409$3$F$20231201$20240802$20240215$20240809$EXP$$JP-009507513-2402JPN001378J$MERCK$$60$YR$$M$Y$$$20240809$$MD$JP$JP
235274214$23527421$4$F$20231030$20240911$20240215$20240916$EXP$$IT-MYLANLABS-2024M1013806$MYLAN$$49$YR$$F$Y$50$KG$20240916$$MD$IT$IT
235274392$23527439$2$F$$20240625$20240215$20240701$PER$$US-PFIZER INC-202300318800$PFIZER$$52$YR$$M$Y$$$20240701$$CN$US$US
235275123$23527512$3$F$20231201$20240917$20240215$20240924$EXP$FR-AFSSAPS-PV2024000099$FR-VERTEX PHARMACEUTICALS-2024-002319$VERTEX$$46$YR$$F$Y$70$KG$20240924$$MD$FR$FR
235275275$23527527$5$F$20240301$20240821$20240215$20240830$EXP$$KR-AstraZeneca-2024A034146$ASTRAZENECA$$777$MON$$F$Y$$$20240830$$CN$KR$
235275432$23527543$2$F$$20240911$20240215$20240925$EXP$$AU-CIPLA LTD.-2024AU01690$CIPLA$$$$$$Y$$$20240926$$CN$AU$AU
235275463$23527546$3$F$20240601$20240710$20240215$20240722$PER$$US-SA-2024SA051720$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240722$$MD$US$US
235275623$23527562$3$F$$20240206$20240215$20240808$EXP$$NVSC2024TH026870$NOVARTIS$$$$$F$Y$$$20240808$$CN$TH$TH
235276314$23527631$4$F$20240101$20240401$20240215$20240814$EXP$$NVSC2024BR030163$NOVARTIS$$57$YR$$F$Y$$$20240814$$CN$BR$BR
235276943$23527694$3$F$20230901$20240916$20240215$20240923$EXP$$US-SA-2024SA050478$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240923$$MD$US$US
235278005$23527800$5$F$20130101$20240724$20240215$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025033$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$80.29$KG$20240731$$CN$US$US
235278504$23527850$4$F$20231103$20240628$20240215$20240702$EXP$$NVSC2023US259400$NOVARTIS$$51$YR$$F$Y$$$20240702$$CN$US$US
235278853$23527885$3$F$$20240216$20240215$20240812$EXP$FR-AFSSAPS-AVCN2024000076$FR-OTSUKA-2024_003914$OTSUKA$$39$YR$$F$Y$$$20240812$$HP$FR$FR
235278994$23527899$4$F$$20240712$20240215$20240802$EXP$$JP-009507513-2402JPN000923J$MERCK$Katsura Y, Shirakawa Y, Ishida M, Chouda Y, Idani H, Matsukawa H , et al. p7-2 Treatment Strategies for Unresectable Advanced Oesophageal Carcinoma in Our Hospital. The 78th Annual Meeting of The Japan Esophageal Society. 200$8$DEC$$M$Y$$$20240802$$MD$JP$JP
235279022$23527902$2$F$20231001$20240815$20240215$20240823$EXP$$CA-OTSUKA-2024_003792$OTSUKA$$4$DEC$$F$Y$$$20240823$$MD$CA$CA
2352795913$23527959$13$F$20240118$20240920$20240215$20240927$EXP$$FR-SA-2024SA045293$SANOFI AVENTIS$$57$YR$A$M$Y$90$KG$20240927$$HP$FR$FR
235279696$23527969$6$F$20240101$20240620$20240215$20240701$EXP$$US-SA-2023SA297005$SANOFI AVENTIS$$4$YR$C$M$Y$14$KG$20240701$$MD$US$US
235279922$23527992$2$F$20230822$20240205$20240215$20240730$EXP$$CZ-SAMSUNG BIOEPIS-SB-2024-04147$SAMSUNG BIOEPIS$$74$YR$E$M$Y$$$20240730$$MD$CZ$CZ
235280552$23528055$2$F$$20240813$20240215$20240814$PER$$NVSC2024US032757$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
235281615$23528161$5$F$$20240916$20240215$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024238$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240917$$CN$US$US
235282555$23528255$5$F$20231201$20240813$20240215$20240819$EXP$$US-PFIZER INC-202400041776$PFIZER$$7$YR$$M$Y$24.95$KG$20240819$$CN$US$US
235283394$23528339$4$F$20230101$20240823$20240215$20240828$EXP$$PR-PFIZER INC-202300298027$PFIZER$$78$YR$$F$Y$92.971$KG$20240828$$HP$PR$PR
235283402$23528340$2$F$20230630$20240722$20240215$20240724$EXP$ES-AEMPS-1483545$ES-PFIZER INC-202400039295$PFIZER$$59$YR$$M$Y$$$20240724$$HP$ES$ES
235283836$23528383$6$F$$20240717$20240215$20240725$EXP$$IN-INCYTE CORPORATION-2024IN001672$INCYTE$$$$$$Y$$$20240725$$CN$IN$IN
235283952$23528395$2$F$20230601$20240705$20240215$20240710$EXP$$IN-PFIZER INC-2021082307$PFIZER$$42$YR$$F$Y$$$20240710$$CN$IN$IN
235284122$23528412$2$F$$20240812$20240215$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202402004481$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240823$$CN$US$US
235284194$23528419$4$F$$20240809$20240215$20240828$PER$$US-PHARMING-PHAUS2024000067$PHARMING GROUP$$$$$$Y$$$20240819$$CN$US$US
235284202$23528420$2$F$$20240715$20240215$20240718$PER$$US-PHARMING-PHAUS2024000066$PHARMING GROUP$$$$$$Y$$$20240718$$CN$US$US
235284483$23528448$3$F$$20240726$20240215$20240805$PER$$US-SA-2024SA047796$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240805$$MD$US$US
235284952$23528495$2$F$20220920$20240802$20240215$20240809$EXP$$CA-TAKEDA-2022TUS076739$TAKEDA$$62$YR$$M$Y$$$20240809$$CN$CA$CA
235285327$23528532$7$F$$20240731$20240215$20240806$EXP$$GB-TAKEDA-2024TUS013768$TAKEDA$$$$$M$Y$$$20240806$$CN$GB$GB
235285353$23528535$3$F$20240601$20240621$20240215$20240701$PER$$US-SA-2024SA049956$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240701$$CN$US$US
2352854815$23528548$15$F$20240202$20240724$20240215$20240806$EXP$$US-BEH-2024168547$CSL BEHRING$$31$YR$A$F$Y$73$KG$20240806$$MD$US$US
235286622$23528662$2$F$20240212$20240726$20240215$20240727$PER$$US-AMGEN-USASP2024030408$AMGEN$$66$YR$E$M$Y$$$20240727$$CN$US$US
235286813$23528681$3$F$20240212$20240705$20240215$20240708$PER$$US-ALXN-202402USA000801US$ALEXION PHARMACEUTICALS$$84$YR$$F$Y$57.596$KG$20240708$$MD$US$US
235287145$23528714$5$F$20230918$20240909$20240215$20240913$EXP$$NVSJ2024JP002093$NOVARTIS$$43$YR$$F$Y$60.6$KG$20240913$$MD$JP$JP
235287182$23528718$2$F$20240116$20240212$20240215$20240827$EXP$$US-ABBVIE-5637320$ABBVIE$$74$YR$$M$Y$$$20240827$$CN$US$US
235288365$23528836$5$F$20240216$20240610$20240215$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000326$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240705$$CN$US$US
235288803$23528880$3$F$20240101$20240711$20240215$20240722$PER$$US-SA-2024SA045352$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240722$$MD$US$US
235288893$23528889$3$F$$20240812$20240215$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000353$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
235288902$23528890$2$F$20240101$20240718$20240215$20240731$EXP$$CA-AMGEN-CANNI2024031818$AMGEN$$$$$F$Y$$$20240731$$CN$CA$CA
235289035$23528903$5$F$20221218$20240705$20240215$20240708$PER$$US-ALXN-202402USA000766US$ALEXION PHARMACEUTICALS$$75$YR$$M$Y$$$20240708$$CN$US$US
235289552$23528955$2$F$$20240730$20240215$20240808$EXP$$CN-ABBVIE-5640197$ABBVIE$Li W, Chang Y, Liu X, Chen Z, Sun J, Geng Z, et al. Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study. Ann Hematol. 2024.$$$$$Y$$$20240808$$HP$CN$CN
235289702$23528970$2$F$20240113$20240805$20240215$20240806$EXP$FR-AFSSAPS-PV2024000107$FR-SANDOZ INC.-SDZ2024FR014640$SANDOZ$$14$YR$$F$Y$67$KG$20240806$$PH$FR$FR
235290102$23529010$2$F$$20240703$20240216$20240715$EXP$$US-ELI_LILLY_AND_COMPANY-US202402007540$ELI LILLY AND CO$$$$$F$Y$47.4$KG$20240715$$HP$US$US
235290283$23529028$3$F$20240210$20240628$20240216$20240702$PER$$US-AMGEN-USASP2024031763$AMGEN$$48$YR$A$M$Y$$$20240702$$CN$US$US
235290352$23529035$2$F$$20240816$20240216$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024247$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240820$$CN$US$US
235290422$23529042$2$F$20240101$20240624$20240216$20240703$PER$$US-SA-2024SA048324$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240703$$MD$US$US
235290564$23529056$4$F$20230101$20240626$20240216$20240705$PER$$US-SA-2024SA047507$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240705$$MD$US$US
235290573$23529057$3$F$20220101$20240827$20240216$20240910$EXP$$NL-ABBVIE-4271610$ABBVIE$$74$YR$$M$Y$$$20240910$$CN$NL$NL
235290982$23529098$2$F$$20240809$20240216$20240814$30DAY$$US-SANDOZ INC.-SDZ2024US014828$SANDOZ$$$$$M$Y$$$20240814$$CN$US$US
235291742$23529174$2$F$20240101$20240806$20240216$20240816$PER$$US-SA-2024SA045842$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240816$$MD$US$US
235291816$23529181$6$F$20240201$20240703$20240216$20240709$PER$$US-BIOGEN-2024BI01249327$BIOGEN$$71$YR$$F$Y$$$20240709$$CN$US$US
235292114$23529211$4$F$20240723$20240927$20240216$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023540$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240930$$CN$US$US
235292532$23529253$2$F$$20240620$20240216$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-00959$LUPIN$$$$$$Y$$$20240703$$CN$US$US
235292662$23529266$2$F$20231212$20240702$20240216$20240709$EXP$$US-JNJFOC-20240223684$JOHNSON AND JOHNSON$$60$YR$A$F$Y$86.6$KG$20240710$$CN$US$US
235292693$23529269$3$F$$20240815$20240216$20240822$EXP$$US-TAKEDA-2023TUS095315$TAKEDA$$$$$M$Y$$$20240822$$MD$US$US
235292712$23529271$2$F$20240208$20240730$20240216$20240802$PER$$US-AMGEN-USASP2024029866$AMGEN$$81$YR$E$F$Y$$$20240802$$CN$US$US
235292984$23529298$4$F$20221216$20240911$20240216$20240920$EXP$$ES-KOANAAP-SML-ES-2024-00106$Unknown Manufacturer$$45$YR$A$F$Y$53$KG$20240920$$MD$ES$ES
235293942$23529394$2$F$$20220419$20240216$20240801$EXP$$CA-CELLTRION INC.-2022CA022477$CELLTRION$$$$$$Y$$$20240801$$MD$CA$CA
235295164$23529516$4$F$20240207$20240715$20240216$20240722$EXP$$CA-AMGEN-CANSP2024031722$AMGEN$$61$YR$A$F$Y$$$20240722$$MD$CA$CA
235295368$23529536$8$F$$20240701$20240216$20240705$30DAY$$US-GSK-US2024017667$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
235295442$23529544$2$F$$20240729$20240216$20240808$EXP$$PT-CELLTRION INC.-2024PT003711$CELLTRION$Costa S, Veiga P., Bartosch C.. Four cases of mesonephric adenocarcinoma of the cervix: rare histology. REVISTA PORTUGUESA DE ONCOLOGIA. 2023;6:35$$$$$Y$$$20240808$$HP$PT$PT
235295572$23529557$2$F$$20240206$20240216$20240926$PER$$US-GSK-US2024AMR019215$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
235296063$23529606$3$F$20231115$20240730$20240216$20240812$EXP$$JP-AMGEN-JPNNI2024031570$AMGEN$$78$YR$E$F$Y$31.4$KG$20240812$$MD$JP$JP
235296074$23529607$4$F$$20240619$20240216$20240708$30DAY$$US-GSK-US2024017760$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$PH$US$US
235296882$23529688$2$F$$20240913$20240216$20240920$PER$$US-SA-2024SA047230$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240920$$MD$US$US
235297072$23529707$2$F$$20240703$20240216$20240708$PER$$US-ABBVIE-5636862$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
235297084$23529708$4$F$$20240830$20240216$20240924$PER$$US-SA-2024SA047457$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240924$$CN$US$US
235297165$23529716$5$F$20240101$20240826$20240216$20240905$PER$$US-SA-2024SA047042$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240905$$MD$US$US
235297192$23529719$2$F$$20240710$20240216$20240801$PER$$US-SA-2024SA047775$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240719$$MD$US$US
235297303$23529730$3$F$20240101$20240802$20240216$20240812$PER$$US-SA-2024SA051801$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240812$$MD$US$US
235297654$23529765$4$F$20230907$20240711$20240216$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024857$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240715$$HP$US$US
235298165$23529816$5$F$$20240912$20240216$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025391$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240913$$CN$US$US
235299135$23529913$5$F$20230801$20240920$20240216$20240926$EXP$$JP-009507513-2401JPN001825J$MERCK$Terashima Y, Matsumoto M, Mitsugi R, Fukuizumi A, Ozaki S, Nakagawa M, et al.. 14 A Case of IgA vasculitis as irAE developed during pembrolizumab treatment for advanced-stage squamous cell carcinoma of lung. The 197th Kanto Branch Meeting of the Japan Lung Cancer Society. 12$73$YR$$M$Y$$$20240926$$MD$JP$JP
235299582$23529958$2$F$20191101$20240212$20240216$20240723$EXP$$US-TEVA-VS-3158950$TEVA$$57$YR$$M$Y$85$KG$20240723$$LW$US$US
235299602$23529960$2$F$$20240812$20240216$20240814$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219645$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240814$$CN$CA$CA
235299646$23529964$6$F$20240201$20240718$20240216$20240724$EXP$$US-UNITED THERAPEUTICS-UNT-2024-004365$UNITED THERAPEUTICS$$38$YR$$F$Y$86.168$KG$20240724$$$US$US
235299986$23529998$6$F$20240125$20240805$20240216$20240808$EXP$$PE-JNJFOC-20240207184$JOHNSON AND JOHNSON$$75$YR$E$F$Y$57$KG$20240808$$HP$PE$PE
235300184$23530018$4$F$$20240506$20240216$20240808$PER$$US-LEO Pharma-367715$LEO PHARM$$76$YR$$M$Y$$$20240808$$PH$US$US
235300313$23530031$3$F$20230202$20240913$20240216$20240923$EXP$$JP-ARGENX-2024-ARGX-JP000217AA$ARGENX BVBA$$$$$$Y$$$20240923$$MD$JP$JP
235300684$23530068$4$F$20230517$20240719$20240216$20240726$EXP$$JP-JNJFOC-20240244954$JOHNSON AND JOHNSON$Suzuki M, Ukichi R, Yokota T, and Nishimura R. [O-057 A case of drug-induced lactic acidosis complicated with euglycemic ketoacidosis.] The 61st Kanto Koshinetsu Regional Annual Meeting of  the Japan Diabetes Society. 2024.1.20;84$54$YR$A$M$Y$$$20240726$$MD$JP$JP
235301114$23530111$4$F$$20240904$20240216$20240910$EXP$$US-TAKEDA-2021TUS021353$TAKEDA$$$$$F$Y$83.9$KG$20240910$$HP$US$US
235301265$23530126$5$F$20200101$20240709$20240216$20240718$EXP$$ES-CELLTRION INC.-2024ES003705$CELLTRION$Silvia S, Yllera-Gutierrez C, Moran-Castano C and Caminal-Montero L. Entities inside one another: VEXAS, a matryoshka-type disease. Reumatologia Clinica. 2024;20 (1):57-58$$$$$Y$$$20240718$$HP$ES$ES
235301834$23530183$4$F$20240203$20240718$20240216$20240723$PER$$US-AMGEN-USASP2024029825$AMGEN$$75$YR$E$F$Y$$$20240723$$CN$US$US
235302342$23530234$2$F$20231225$20240706$20240216$20240717$EXP$FR-AFSSAPS-2024002499$FR-Accord-406213$ACCORD$$54$YR$A$M$Y$64$KG$20240717$$MD$FR$FR
235302602$23530260$2$F$20240119$20240729$20240216$20240823$PER$$US-009507513-2401USA015589$MERCK$$64$YR$$F$Y$$$20240823$$CN$US$US
2353026711$23530267$11$F$20231201$20240909$20240216$20240918$EXP$$US-UCBSA-2024007477$UCB$$7$YR$$F$Y$20.4$KG$20240918$$CN$US$US
235302913$23530291$3$F$$20240731$20240216$20240805$EXP$$NVSC2024CA031672$NOVARTIS$$40$YR$$F$Y$96$KG$20240806$$HP$CA$CA
235303273$23530327$3$F$20240822$20240911$20240216$20240914$EXP$$US-ABBVIE-5641183$ABBVIE$$81$YR$$F$Y$$$20240914$$CN$US$US
235303434$23530343$4$F$$20240715$20240216$20240726$EXP$$IT-ROCHE-3509225$ROCHE$Broccoli A, Argnani L, Gugliotta G, Pellegrini C, Casadei B, Bagnato G, Gentilini M, Stefoni V and Zinzani P The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Munster Protocol With Rituximab and Consolidative Autologous Transplantation. DOI: 10.1093/oncolo/oyae017. The oncologist 2024 Feb 10;:1-7.$$$$$Y$$$20240726$$MD$IT$IT
235303603$23530360$3$F$$20240717$20240216$20240724$EXP$$CA-TAKEDA-2024TUS004294$TAKEDA$$$$$M$Y$$$20240724$$HP$CA$CA
235303905$23530390$5$F$20220101$20240626$20240216$20240710$EXP$$US-SA-2024SA052325$SANOFI AVENTIS$$60$YR$A$F$Y$58.957$KG$20240710$$MD$US$US
235304062$23530406$2$F$$20240628$20240216$20240708$EXP$$CA-TAKEDA-2024TUS013279$TAKEDA$$$$$F$Y$$$20240708$$HP$CA$CA
235304644$23530464$4$F$20210723$20240709$20240216$20240718$EXP$$CA-CELLTRION INC.-2021CA013027$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
235304715$23530471$5$F$20230101$20240723$20240216$20240729$EXP$$US-ABBVIE-5639438$ABBVIE$$$$$F$Y$62.142$KG$20240729$$CN$US$US
235305065$23530506$5$F$20230601$20240815$20240216$20240824$EXP$$US-ABBVIE-5632796$ABBVIE$$49$YR$$F$Y$83.46$KG$20240824$$CN$US$US
235305074$23530507$4$F$20210601$20240903$20240216$20240909$EXP$$NVSC2023IN012810$NOVARTIS$$75$YR$$F$Y$$$20240909$$CN$IN$IN
235305553$23530555$3$F$$20240904$20240216$20240909$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-025103$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240909$$MD$GB$GB
235305864$23530586$4$F$20210523$20240916$20240216$20240927$EXP$$PK-AMGEN-PAKSP2021096705$AMGEN$$43$YR$A$M$Y$$$20240927$$CN$PK$PK
235307207$23530720$7$F$$20240702$20240216$20240706$EXP$$PT-CELLTRION INC.-2024PT003695$CELLTRION$Argyropoulou D, Freitas A, Cravo M, Rosa J, Cabecadas J, Argyropoulou D, et al.. A rare T-cell lymphoma in an ankylosing spondylitis patient under immunosuppression with tumor necrosis factor inhibitor. Portuguese Journal of Dermatology and Venereology. 2023;81 (4):267-272$$$$$Y$$$20240706$$MD$PT$PT
235307693$23530769$3$F$20240123$20240722$20240216$20240803$EXP$$KR-Accord-406995$ACCORD$$73$YR$E$M$Y$$$20240803$$MD$KR$KR
235308582$23530858$2$F$20201001$20240920$20240216$20240927$EXP$$NVSC2024RU025805$NOVARTIS$Chichagova NA, Gogolev DV, Kuzmin DO, Ananiev AN, Kutenkov AA, Galkin AA et al.. Myeloid sarcoma of kidney transplant: clinical observation and relevance of interdisciplinary approach in therapy and diagnosis. CLINICAL TRANSPLANTOLOGY. 2023;25(4):86-95$29$YR$$F$Y$$$20240927$$HP$RU$RU
235308794$23530879$4$F$20220215$20240912$20240216$20240916$EXP$$NVSC2022FR164885$NOVARTIS$$$$E$M$Y$92$KG$20240916$$MD$FR$FR
235308972$23530897$2$F$20231223$20240207$20240216$20240807$EXP$$NVSC2024AR003243$NOVARTIS$$56$YR$$F$Y$$$20240807$$CN$AR$AR
235309343$23530934$3$F$20220101$20240828$20240216$20240902$EXP$$AU-BAUSCH-BL-2024-002269$BAUSCH AND LOMB$Dessauer A, Hussey D, Khan S, McLean C, Gardiner B. Cytomegalovirus and Aspergillus co-infection in an immunocompetent patient with severe COVID-19. Pathology. 2024;56 (1):110-114.$48$YR$$M$Y$$$20240902$$HP$AU$AU
235309492$23530949$2$F$$20240829$20240216$20240918$PER$$US-TEVA-VS-3142171$TEVA$$$$$M$Y$$$20240918$$CN$US$US
235309596$23530959$6$F$20240724$20240906$20240216$20240916$EXP$$CA-CELLTRION INC.-2024CA003821$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
235309793$23530979$3$F$20231223$20240822$20240216$20240824$PER$$US-JNJFOC-20240175340$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240824$$CN$US$US
235309802$23530980$2$F$$20240710$20240216$20240711$EXP$$PL-SANDOZ INC.-NVSC2022PL239664$SANDOZ$$6$YR$$M$Y$$$20240711$$MD$PL$PL
235310432$23531043$2$F$20230813$20240617$20240216$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-431469$RANBAXY$$35$YR$$M$Y$$$20240702$$PH$FR$FR
235310735$23531073$5$F$$20240924$20240216$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-004485$UNITED THERAPEUTICS$$$$$F$Y$95.238$KG$20240928$$$US$US
235311022$23531102$2$F$$20240912$20240216$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430019$RANBAXY$Onafowokan O, Rodgers W, Gruber E. EPSTEIN-BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER OF THE ORAL CAVITY IN A POST TRANSPLANT PATIENT. Int J Surg. 2018;Sep;55 (S7):S66/0058$56$YR$$M$Y$$$20240927$$HP$GB$GB
235311063$23531106$3$F$$20240912$20240216$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-024751$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240918$$MD$JP$JP
235311112$23531111$2$F$$20240730$20240216$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025133$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240801$$CN$US$US
235311332$23531133$2$F$$20240628$20240216$20240705$EXP$$JP-009507513-2402JPN000907J$MERCK$$$$$F$Y$$$20240705$$MD$JP$JP
235311783$23531178$3$F$20240205$20240705$20240216$20240712$EXP$$CA-AMERICAN REGENT INC-2024000443$AMERICAN REGENT$$46$YR$$F$Y$68$KG$20240712$$HP$CA$CA
235311832$23531183$2$F$$20240214$20240216$20240911$EXP$$NVSC2024US032915$NOVARTIS$$$$$M$Y$$$20240911$$CN$US$US
235312063$23531206$3$F$20240130$20240207$20240216$20240710$PER$$JP-PFM-2024-00840$PIERRE FABRE MEDICAMENT$$2$MON$$$Y$$$20240710$$MD$JP$JP
235312513$23531251$3$F$$20240918$20240216$20240919$30DAY$$JP-PFIZER INC-PV202400014335$PFIZER$$$$$$Y$$$20240919$$CN$JP$JP
235315503$23531550$3$F$$20240814$20240216$20240823$EXP$$US-INSMED, INC.-2024-00523-US$INSMED$$$$$M$Y$$$20240823$$CN$US$US
235315663$23531566$3$F$20240502$20240802$20240216$20240808$EXP$$CA-UCBSA-2024007070$UCB$$22$YR$$F$Y$$$20240808$$CN$CA$CA
235316183$23531618$3$F$$20240821$20240216$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01082$LUPIN$$$$$$Y$$$20240909$$CN$US$US
235316217$23531621$7$F$20231201$20240814$20240216$20240821$EXP$$CA-GSK-CA2023178599$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$CA$CA
235316233$23531623$3$F$$20240826$20240216$20240904$EXP$GB-MLMSERVICE-20240201-4812889-1$GB-STRIDES ARCOLAB LIMITED-2024SP001740$STRIDES$Johnson N, Solkar M, Sehgal R, Riyad K.. Non-steroidal anti-inflammatory drug induced intestinal stricturing: diaphragm disease.. Journal of Surgical Case Reports.. 2024;2024 (1):1-4$$$$$Y$$$20240904$$MD$GB$GB
235316412$23531641$2$F$$20240826$20240216$20240904$EXP$GB-MLMSERVICE-20240201-4807632-1$GB-STRIDES ARCOLAB LIMITED-2024SP001733$STRIDES$Johnson N, Solkar M, Sehgal R, Riyad K.. Non-steroidal anti-inflammatory drug induced intestinal stricturing: diaphragm disease.. Journal of Surgical Case Reports.. 2024;2024 (1):1-4$$$$$Y$$$20240904$$MD$GB$GB
235316422$23531642$2$F$20240210$20240727$20240216$20240731$PER$$US-AMGEN-USASP2024030366$AMGEN$$78$YR$E$M$Y$$$20240730$$CN$US$US
235316453$23531645$3$F$20240131$20240910$20240216$20240918$EXP$$CA-JNJFOC-20231283563$JOHNSON AND JOHNSON$$59$YR$A$M$Y$96$KG$20240919$$HP$CA$CA
235316532$23531653$2$F$$20240205$20240216$20240712$EXP$$IN-TORRENT-00003467$TORRENT$$56$YR$A$F$Y$$$20240712$$MD$IN$IN
235316673$23531667$3$F$$20240626$20240216$20240704$EXP$ES-MLMSERVICE-20240202-4810662-1$ES-STRIDES ARCOLAB LIMITED-2024SP001782$STRIDES$Rubio I, de la Puente EM, Boveda O, Jimenez I, Pena I.. Green neutrophilic inclusions in patient with drug intoxication: a case report. Journal of Laboratory and Precision Medicine.. 2024;9:9$54$YR$$F$Y$$$20240704$$MD$ES$ES
235316934$23531693$4$F$20240522$20240801$20240216$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024747$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240807$$CN$US$US
235317126$23531712$6$F$20240131$20240806$20240216$20240815$EXP$$CA-JNJFOC-20240214429$JOHNSON AND JOHNSON$$54$YR$A$M$Y$93$KG$20240815$$HP$CA$CA
235317224$23531722$4$F$$20240725$20240216$20240731$EXP$$US-TAKEDA-2024TUS013303$TAKEDA$$$$$M$Y$$$20240731$$MD$US$US
235317422$23531742$2$F$$20240705$20240216$20240717$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-04677$SAMSUNG BIOEPIS$$68$YR$E$F$Y$$$20240717$$CN$GB$GB
235317456$23531745$6$F$$20240617$20240216$20240701$EXP$$NVSC2024CA031690$NOVARTIS$$40$YR$$F$Y$$$20240701$$HP$CA$CA
235317612$23531761$2$F$$20240718$20240216$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025757$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240722$$CN$US$US
235318803$23531880$3$F$$20240815$20240216$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023478$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240819$$CN$US$US
235318813$23531881$3$F$$20240830$20240216$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024471$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240902$$CN$US$US
235318824$23531882$4$F$$20240814$20240216$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025552$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240821$$CN$US$US
235318832$23531883$2$F$20240211$20240826$20240216$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025026$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$82.1$KG$20240828$$HP$US$US
235319022$23531902$2$F$20231201$20240814$20240216$20240821$PER$$US-SA-2024SA047501$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240822$$MD$US$US
235319413$23531941$3$F$20240329$20240812$20240216$20240820$PER$$US-SA-2024SA048535$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240820$$MD$US$US
235319434$23531943$4$F$20240202$20240709$20240216$20240718$PER$$US-SA-2023SA346140$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240718$$MD$US$US
235319503$23531950$3$F$20240503$20240809$20240216$20240816$PER$$US-SA-2024SA047343$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240816$$MD$US$US
235319572$23531957$2$F$20240101$20240726$20240216$20240806$PER$$US-SA-2024SA051012$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240806$$MD$US$US
235319663$23531966$3$F$20231201$20240628$20240216$20240712$PER$$US-SA-2024SA047506$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240712$$MD$US$US
235319812$23531981$2$F$$20240901$20240216$20240910$PER$$US-SA-2024SA047140$SANOFI AVENTIS$$$$E$M$Y$$$20240910$$MD$US$US
235320002$23532000$2$F$20240101$20240904$20240216$20240930$PER$$US-SA-2024SA052438$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240930$$MD$US$US
235320292$23532029$2$F$$20240621$20240216$20240702$PER$$US-SA-2024SA052034$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240702$$MD$US$US
235320364$23532036$4$F$$20240827$20240216$20240909$PER$$US-SA-2024SA052127$SANOFI AVENTIS$$8$YR$C$M$Y$23.6$KG$20240909$$CN$US$US
235320643$23532064$3$F$20221001$20240624$20240216$20240701$PER$$US-SA-2024SA051667$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240701$$MD$US$US
235321473$23532147$3$F$20240101$20240910$20240216$20240916$PER$$US-SA-2024SA047171$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240916$$MD$US$US
235321482$23532148$2$F$20231204$20240814$20240216$20240820$PER$$US-SA-2024SA047239$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240820$$MD$US$US
235321722$23532172$2$F$$20240709$20240216$20240724$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-01092$LUPIN$$53$YR$$M$Y$$$20240724$$CN$CA$CA
235322177$23532217$7$F$20240115$20240828$20240216$20240829$PER$$NVSC2024US033641$NOVARTIS$$$$$F$Y$$$20240829$$HP$US$US
235322564$23532256$4$F$$20240625$20240216$20240701$EXP$$NVSC2024CA031794$NOVARTIS$$$$A$F$Y$$$20240701$$MD$CA$CA
235323583$23532358$3$F$20240101$20240722$20240216$20240723$EXP$$US-KARYOPHARM-2024KPT000086$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240723$$CN$US$US
235323662$23532366$2$F$20240212$20240912$20240216$20240918$PER$$US-BAYER-2024A024867$BAYER$$28$YR$A$F$Y$$$20240918$$HP$US$US
235326013$23532601$3$F$$20240822$20240216$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024450$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$70.76$KG$20240830$$CN$US$US
235326023$23532602$3$F$$20240820$20240216$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025927$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240826$$CN$US$US
235326152$23532615$2$F$20240701$20240906$20240216$20240916$PER$$US-SA-2024SA051365$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240916$$MD$US$US
235326193$23532619$3$F$20240124$20240703$20240216$20240709$EXP$FR-AFSSAPS-LL2024000232$FR-PFIZER INC-202400039244$PFIZER$$88$YR$$M$Y$$$20240709$$MD$FR$FR
235326315$23532631$5$F$$20240805$20240216$20240808$EXP$$CA-PFIZER INC-202400041670$PFIZER$$73$YR$$F$Y$$$20240808$$CN$CA$CA
235328032$23532803$2$F$20230912$20240801$20240216$20240808$EXP$$IE-TAKEDA-2023TUS090774$TAKEDA$$64$YR$$F$Y$$$20240808$$MD$IE$IE
235328053$23532805$3$F$20231111$20240703$20240216$20240712$EXP$IT-MINISAL02-960943$IT-TEVA-VS-3154738$TEVA$$10$YR$$F$Y$27$KG$20240712$$PH$IT$IT
235328144$23532814$4$F$$20240903$20240216$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025995$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240904$$CN$US$US
235328245$23532824$5$F$$20240911$20240216$20240916$PER$$US-AMGEN-USASP2024033563$AMGEN$$72$YR$E$M$Y$$$20240916$$CN$US$US
235328483$23532848$3$F$20230101$20240226$20240216$20240709$EXP$$NVSC2024CH009397$NOVARTIS$$$$C$M$Y$47$KG$20240709$$MD$CH$CH
235328942$23532894$2$F$20230908$20240816$20240216$20240820$EXP$FR-AFSSAPS-CF2024000051$FR-PFIZER INC-202400040316$PFIZER$$36$YR$$F$Y$105$KG$20240820$$MD$FR$FR
235329367$23532936$7$F$20240203$20240913$20240216$20240917$30DAY$$CL-PFIZER INC-PV202400017771$PFIZER$$8$YR$$M$Y$$$20240917$$CN$CL$CL
235330222$23533022$2$F$20231101$20240718$20240216$20240809$PER$$CA-TOLMAR, INC.-24CA046345$TOLMAR$$82$YR$$M$Y$$$20240809$$CN$CA$CA
235330283$23533028$3$F$20240122$20240705$20240216$20240725$PER$$CA-TOLMAR, INC.-24CA046363$TOLMAR$$71$YR$$M$Y$$$20240725$$CN$CA$CA
235330323$23533032$3$F$20240101$20240710$20240216$20240730$PER$$CA-TOLMAR, INC.-24CA046366$TOLMAR$$59$YR$$M$Y$$$20240730$$CN$CA$CA
235330823$23533082$3$F$20240101$20240620$20240216$20240701$PER$$US-SA-2024SA051950$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240701$$MD$US$US
235331303$23533130$3$F$20230316$20240814$20240216$20240819$EXP$$NVSC2023CA064159$NOVARTIS$$42$YR$$F$Y$$$20240819$$CN$CA$CA
235331385$23533138$5$F$20230701$20240902$20240216$20240909$EXP$$NVSC2024MX022952$NOVARTIS$$42$YR$$F$Y$70$KG$20240909$$CN$MX$MX
235332442$23533244$2$F$20240123$20240207$20240216$20240809$EXP$$NVSC2024BR030348$NOVARTIS$$52$YR$$F$Y$$$20240809$$CN$BR$BR
235332704$23533270$4$F$20231201$20240806$20240216$20240808$EXP$$CA-JNJFOC-20240232043$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240808$$HP$CA$CA
235332975$23533297$5$F$20240101$20240724$20240216$20240828$PER$$ES-TRAVERE-2024TVT00151$TRAVERE THERAPEUTICS$$45$YR$A$F$Y$$$20240828$$MD$ES$ES
235333124$23533312$4$F$$20240715$20240216$20240720$EXP$$NVSC2024CA031624$NOVARTIS$$44$YR$$F$Y$$$20240719$$HP$CA$CA
235333576$23533357$6$F$$20240718$20240216$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023999$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240723$$CN$US$US
235333744$23533374$4$F$20240206$20240209$20240216$20240911$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-04634$SAMSUNG BIOEPIS$$65$YR$$M$Y$$$20240911$$HP$CA$CA
235333963$23533396$3$F$20120101$20240715$20240216$20240719$EXP$$US-ABBVIE-5642653$ABBVIE$$$$$M$Y$91$KG$20240719$$CN$US$US
235334044$23533404$4$F$$20240911$20240216$20240912$EXP$$IL-TAKEDA-2024TUS013817$TAKEDA$$$$$F$Y$$$20240912$$CN$IL$IL
235334173$23533417$3$F$20230315$20240920$20240216$20240925$EXP$$US-ABBVIE-5639254$ABBVIE$$74$YR$$F$Y$54.431$KG$20240925$$CN$US$US
235334334$23533433$4$F$$20240815$20240216$20240823$EXP$$CA-OTSUKA-2024_003776$OTSUKA$$9$YR$$M$Y$$$20240823$$PH$CA$CA
235334442$23533444$2$F$20240214$20240808$20240216$20240822$EXP$$NL-VER-202400017$VERITY PHARMACEUTICALS$$67$YR$E$M$Y$$$20240822$$CN$NL$NL
235334513$23533451$3$F$$20240830$20240216$20240904$EXP$$ES-JNJFOC-20240230723$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$HP$ES$ES
235335607$23533560$7$F$20220401$20240712$20240216$20240715$EXP$$US-PFIZER INC-202101170582$PFIZER$$63$YR$$M$Y$77.098$KG$20240715$$MD$US$US
235335892$23533589$2$F$$20240723$20240216$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024452$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240725$$MD$US$US
235335902$23533590$2$F$20240201$20240710$20240216$20240716$EXP$$US-SA-2024SA051471$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240716$$CN$US$US
235336205$23533620$5$F$20240101$20240905$20240216$20240913$PER$$US-PHARMING-PHAUS2024000116$PHARMING GROUP$$$$$$Y$$$20240913$$CN$US$US
235337404$23533740$4$F$20240501$20240729$20240216$20240801$EXP$$US-PFIZER INC-PV202400020931$PFIZER$$55$YR$$F$Y$$$20240801$$CN$US$US
235337718$23533771$8$F$20110101$20240820$20240216$20240826$EXP$$US-ORGANON-O2402USA001533$ORGANON$$$$$F$Y$$$20240826$$MD$US$US
235337902$23533790$2$F$$20240715$20240216$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024386$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$67.13$KG$20240716$$CN$US$US
235339012$23533901$2$F$20230101$20240108$20240216$20240701$PER$$US-GALDERMA-US2024000727$GALDERMA$$$$$$Y$$$20240701$$CN$US$US
235339494$23533949$4$F$20230701$20240710$20240216$20240717$PER$$US-BIOGEN-2023BI01240278$BIOGEN$$22$YR$$F$Y$$$20240717$$CN$US$US
235339623$23533962$3$F$20230331$20240827$20240216$20240905$PER$$JP-Eisai-EC-2023-136973$EISAI$Sai Hiroki et.al.. 24 A case of right renal cell carcinoma resectable with lenvatinib/pembrolizumab (Len/Pem) combination therapy. 294th Tokai Regional Meeting of the Japanese Urological Association : 9-.$35$YR$A$M$Y$$$20240905$$MD$JP$JP
235339687$23533968$7$F$20231201$20240805$20240216$20240808$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000328$BLUEPRINT MEDICINES$$76$YR$E$M$Y$$$20240808$$MD$US$US
235340242$23534024$2$F$20200101$20240822$20240216$20240827$EXP$$US-VERTEX PHARMACEUTICALS-2024-002472$VERTEX$$$$A$$Y$$$20240827$$CN$US$US
235340334$23534033$4$F$20240209$20240729$20240216$20240805$EXP$$JP-AMGEN-JPNSP2024029185$AMGEN$$72$YR$E$M$Y$$$20240805$$MD$JP$JP
235340856$23534085$6$F$20230829$20240722$20240216$20240726$EXP$$CA-LUNDBECK-DKLU3070584$LUNDBECK$$$$$$Y$$$20240726$$HP$CA$CA
235341065$23534106$5$F$20240101$20240910$20240216$20240926$EXP$$US-RADIUS HEALTH INC.-2024US000784$RADIUS PHARM$$$$$F$Y$50.34$KG$20240926$$CN$US$US
235341162$23534116$2$F$20240206$20240725$20240216$20240729$EXP$$IN-ROCHE-3510868$ROCHE$$42$YR$A$M$Y$$$20240729$$CN$IN$IN
235342213$23534221$3$F$20240101$20240705$20240216$20240715$30DAY$$US-GSK-US2024017304$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240715$$CN$US$US
235342722$23534272$2$F$20240121$20240823$20240216$20240831$EXP$IT-MINISAL02-968063$IT-ABBVIE-5641401$ABBVIE$$87$YR$$F$Y$55$KG$20240831$$MD$IT$IT
235342914$23534291$4$F$20230101$20240705$20240217$20240708$EXP$$CA-ABBVIE-5638289$ABBVIE$$68$YR$$M$Y$$$20240708$$CN$CA$CA
235342942$23534294$2$F$20231202$20240722$20240217$20240731$EXP$FR-AFSSAPS-AN2023001641$FR-TEVA-VS-3156099$TEVA$$51$YR$$M$Y$42.6$KG$20240731$$PH$FR$FR
235343035$23534303$5$F$20240101$20240816$20240217$20240824$EXP$$CA-CELLTRION INC.-2024CA002412$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
235343109$23534310$9$F$20240123$20240918$20240217$20240927$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-004008$UNITED THERAPEUTICS$$60$YR$$M$Y$62$KG$20240927$$MD$JP$JP
235343303$23534330$3$F$20240101$20240730$20240217$20240808$PER$$US-SA-2024SA052048$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240808$$MD$US$US
235343704$23534370$4$F$20231201$20240628$20240217$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2023-036884$UNITED THERAPEUTICS$$64$YR$$F$Y$74.376$KG$20240706$$$US$US
235344384$23534438$4$F$20240229$20240913$20240217$20240921$EXP$$CA-CELLTRION INC.-2023CA004378$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
235344543$23534454$3$F$20240120$20240830$20240217$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US016066$SANDOZ$$4$YR$$F$Y$$$20240903$$CN$US$US
235344743$23534474$3$F$20231001$20240828$20240217$20240911$PER$$US-SA-2024SA048542$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240911$$CN$US$US
235344853$23534485$3$F$20230901$20240705$20240217$20240710$EXP$$CA-ABBVIE-5641735$ABBVIE$$75$YR$$F$Y$$$20240710$$CN$CA$CA
2353450110$23534501$10$F$20230519$20240920$20240217$20240930$EXP$$CA-CELLTRION INC.-2023CA010399$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
235345122$23534512$2$F$$20240916$20240217$20240924$EXP$$DE-CELLTRION INC.-2023DE016797$CELLTRION$$$$$$Y$$$20240924$$CN$DE$DE
235345492$23534549$2$F$20230101$20240903$20240217$20240911$EXP$$CA-CELLTRION INC.-2024CA003924$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
235345653$23534565$3$F$20231215$20240708$20240217$20240716$EXP$$CA-CELLTRION INC.-2024CA003926$CELLTRION$$$$$$Y$$$20240716$$CN$CA$CA
235346095$23534609$5$F$$20240701$20240217$20240708$PER$$US-SA-2024SA053557$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240708$$MD$US$US
235346693$23534669$3$F$$20240910$20240217$20240917$EXP$$NVSC2024CA031623$NOVARTIS$$43$YR$$F$Y$68$KG$20240917$$HP$CA$CA
235347472$23534747$2$F$$20240212$20240217$20240807$EXP$$NVSC2024TH030520$NOVARTIS$$$$$F$Y$$$20240807$$CN$TH$TH
235347862$23534786$2$F$$20240828$20240217$20240905$EXP$$JP-AMGEN-JPNSP2024030672$AMGEN$$$$$$Y$$$20240905$$PH$JP$JP
235348073$23534807$3$F$20240510$20240703$20240217$20240710$EXP$$CA-GSK-CA2023080887$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$CA$CA
235348134$23534813$4$F$20240105$20240802$20240217$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-001555$UNITED THERAPEUTICS$$76$YR$$F$Y$95.238$KG$20240807$$$US$US
235348255$23534825$5$F$$20240827$20240217$20240910$EXP$$CA-UCBSA-2024007384$UCB$$$$$F$Y$$$20240910$$CN$CA$CA
235348812$23534881$2$F$$20240821$20240217$20240903$PER$$US-SA-2024SA052941$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240903$$MD$US$US
235349275$23534927$5$F$$20240711$20240217$20240722$PER$$US-SA-2024SA048416$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240721$$MD$US$US
235349605$23534960$5$F$$20240830$20240217$20240903$EXP$$NVSC2023US276594$NOVARTIS$$$$$F$Y$$$20240903$$CN$US$US
235349612$23534961$2$F$$20240618$20240217$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01171$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235349742$23534974$2$F$$20240708$20240217$20240717$PER$$US-SA-2024SA051124$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
235350053$23535005$3$F$20240101$20240731$20240217$20240814$PER$$US-SA-2024SA048463$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240814$$MD$US$US
235350103$23535010$3$F$20240101$20240729$20240217$20240806$EXP$$CA-TAKEDA-2023TUS123340$TAKEDA$$77$YR$$M$Y$$$20240806$$HP$CA$CA
235350182$23535018$2$F$$20240816$20240217$20240829$PER$$US-SA-2024SA048588$SANOFI AVENTIS$$$$E$F$Y$$$20240829$$MD$US$US
235350455$23535045$5$F$20231201$20240703$20240217$20240709$EXP$$TW-JNJFOC-20240219826$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240710$$HP$TW$TW
235350592$23535059$2$F$$20240807$20240217$20240812$EXP$$NVSC2024US032586$NOVARTIS$$$$$M$Y$$$20240812$$CN$US$US
235350653$23535065$3$F$$20240709$20240217$20240712$EXP$$BR-JNJFOC-20240158611$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240712$$CN$BR$BR
235350802$23535080$2$F$$20240723$20240217$20240725$EXP$$GB-SANDOZ INC.-SDZ2023GB073362$SANDOZ$$$$$F$Y$$$20240725$$CN$GB$GB
235351393$23535139$3$F$$20240705$20240218$20240713$PER$$US-SA-2024SA052336$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240713$$MD$US$US
235351444$23535144$4$F$$20240813$20240218$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA015838$SANDOZ$$44$YR$$F$Y$70$KG$20240814$$HP$CA$CA
235351552$23535155$2$F$20231010$20240926$20240218$20240927$EXP$$DE-SANDOZ INC.-SDZ2024DE014791$SANDOZ$$71$YR$$M$Y$$$20240927$$MD$DE$DE
235351774$23535177$4$F$20240130$20240716$20240218$20240723$EXP$$US-SA-2024SA050405$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240723$$MD$US$US
235351846$23535184$6$F$20240101$20240815$20240218$20240829$PER$$US-SA-2024SA052921$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240829$$MD$US$US
235352642$23535264$2$F$$20240829$20240218$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-006259$AUROBINDO$Javidi S, El-khazen Dupuis J, Javidi E, Rouleau J. Leber^s hereditary optic neuropathy associated with idiopathic intracranial hypertension.. Can J Ophthalmol. 2023;58(6):e262-e265$21$YR$$F$Y$$$20240909$$HP$CA$CA
235353192$23535319$2$F$$20240909$20240218$20240919$30DAY$$US-GSK-US2024017347$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
235353462$23535346$2$F$20230331$20240920$20240218$20240930$EXP$$IT-AUROBINDO-AUR-APL-2024-006707$AUROBINDO$Irelli A, Ceriello L, Patruno LV, Tessitore A, Alesse E, Cannita K, Fabiani D.. Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer. Biomedicines. 2024;12(1):179$56$YR$$F$Y$$$20240930$$MD$IT$IT
235355125$23535512$5$F$$20240722$20240218$20240730$PER$$US-SA-2024SA052856$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240730$$HP$US$US
235355722$23535572$2$F$20240101$20240716$20240218$20240722$EXP$$US-ABBVIE-5643746$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
235355767$23535576$7$F$20240122$20240702$20240218$20240705$EXP$$JP-ABBVIE-5641769$ABBVIE$$18$YR$$F$Y$52$KG$20240705$$MD$JP$JP
235356054$23535605$4$F$20190620$20240722$20240218$20240725$EXP$$JP-GSK-JP2020JPN088103$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$JP$JP
235356082$23535608$2$F$20231101$20240730$20240218$20240801$EXP$FR-AFSSAPS-LY2024000234$FR-ABBVIE-5637944$ABBVIE$$68$YR$$F$Y$55$KG$20240801$$PH$FR$FR
235356095$23535609$5$F$20230406$20240701$20240218$20240705$EXP$$JP-GSK-JP2024JPN003430$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$JP$JP
235356534$23535653$4$F$20240101$20240718$20240218$20240723$EXP$$US-ABBVIE-5639576$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
235356704$23535670$4$F$20230901$20240913$20240218$20240917$EXP$$US-ROCHE-3510685$ROCHE$$54$YR$A$F$Y$81.65$KG$20240917$$CN$US$US
235356932$23535693$2$F$20240627$20240628$20240218$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002555$JAZZ$$52$YR$$M$Y$$$20240704$$CN$US$US
235357262$23535726$2$F$20220208$20240910$20240218$20240912$EXP$$CA-TAKEDA-2024TUS015007$TAKEDA$$60$YR$$M$Y$$$20240912$$CN$CA$CA
235357535$23535753$5$F$20240123$20240906$20240218$20240925$PER$$US-JNJFOC-20240203508$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240925$$PH$US$US
235357632$23535763$2$F$20231201$20240730$20240218$20240731$EXP$$CA-JNJFOC-20240230706$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240731$$HP$CA$CA
235358314$23535831$4$F$20230401$20240618$20240218$20240724$PER$$JP-WW-2024-JPN-006469$Waylis$Tsunoda M, Nakajima Y, Shimizu T, Nakasute K, Kawai T. A case of male pattern baldness in which the patient presented with unilateral gynaecomastia after starting oral dutasteride therapy. The Japanese Journal of Dermatology 2024; 134(6): 1686.$46$YR$$M$Y$$$20240724$$HP$JP$JP
235358662$23535866$2$F$$20240614$20240219$20240704$PER$$CA-TOLMAR, INC.-24CA046394$TOLMAR$$$$$M$Y$$$20240704$$CN$CA$CA
235358693$23535869$3$F$20240123$20240902$20240219$20240918$PER$$CA-TOLMAR, INC.-24CA046396$TOLMAR$$79$YR$$M$Y$$$20240918$$CN$CA$CA
235359042$23535904$2$F$$20240715$20240219$20240718$EXP$$CA-TAKEDA-2024TUS013550$TAKEDA$$$$$M$Y$$$20240718$$CN$CA$CA
235359185$23535918$5$F$20240101$20240710$20240219$20240720$EXP$$CA-CELLTRION INC.-2024CA003925$CELLTRION$$$$$$Y$$$20240720$$PH$CA$CA
235359362$23535936$2$F$$20240912$20240219$20240918$PER$$US-TAKEDA-2024TUS014989$TAKEDA$$$$$$Y$$$20240918$$CN$US$US
235359423$23535942$3$F$20201228$20240722$20240219$20240724$EXP$$JP-ABBVIE-21K-087-3979479-00$ABBVIE$$77$YR$$M$Y$68$KG$20240724$$MD$JP$JP
235359502$23535950$2$F$$20240918$20240219$20240924$EXP$$JP-SANDOZ INC.-SDZ2023JP000787$SANDOZ$Huiling W. A Case of Forced Delivery Due to the Appearance of Highly Prolonged Foetal Bradycardia During the Course of Painless Delivery under Epidural Analgesia. Programme and Abstracts of the 10th Annual Meeting of Japanese Society of Region. 2023;134$$$$$Y$$$20240924$$MD$JP$JP
235360012$23536001$2$F$20230810$20240703$20240219$20240705$EXP$$NVSC2024PL033632$NOVARTIS$$73$YR$$M$Y$$$20240705$$MD$PL$PL
235360414$23536041$4$F$20240511$20240627$20240219$20240705$EXP$$US-GSK-US2024AMR018484$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240705$$CN$US$US
235360516$23536051$6$F$$20240716$20240219$20240725$EXP$$GB-TERSERA THERAPEUTICS LLC-2024TRS000768$TERSERA THERAPEUTICS$$$$$$Y$$$20240725$$MD$GB$GB
235360573$23536057$3$F$$20240705$20240219$20240708$PER$$US-ALXN-202402USA000743US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
235360672$23536067$2$F$$20240709$20240219$20240710$EXP$$CA-SANDOZ INC.-SDZ2023CA063668$SANDOZ$$53$YR$$F$Y$$$20240710$$MD$CA$CA
235361642$23536164$2$F$20240214$20240728$20240219$20240730$PER$$US-AMGEN-USASP2024032454$AMGEN$$74$YR$E$F$Y$$$20240730$$CN$US$US
235361942$23536194$2$F$$20240827$20240219$20240906$EXP$$US-SA-2024SA055317$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240906$$MD$US$US
235362432$23536243$2$F$20231225$20240719$20240219$20240731$PER$$US-SA-2024SA048636$SANOFI AVENTIS$$71$YR$E$F$Y$55.79$KG$20240731$$MD$US$US
235362786$23536278$6$F$20240101$20240716$20240219$20240725$PER$$US-SA-2024SA047581$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240725$$MD$US$US
235362864$23536286$4$F$20240212$20240918$20240219$20240926$PER$$US-SA-2024SA054276$SANOFI AVENTIS$$5$YR$C$F$Y$21.27$KG$20240926$$MD$US$US
235362894$23536289$4$F$20240101$20240705$20240219$20240712$EXP$$US-SA-2024SA053595$SANOFI AVENTIS$$67$YR$E$F$Y$192$KG$20240712$$MD$US$US
235362932$23536293$2$F$20240101$20240910$20240219$20240917$PER$$US-SA-2024SA053874$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240918$$MD$US$US
235363082$23536308$2$F$$20240830$20240219$20240924$PER$$US-SA-2024SA054568$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240924$$CN$US$US
235363792$23536379$2$F$$20240304$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005002$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235363802$23536380$2$F$$20240304$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004989$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235363872$23536387$2$F$20240209$20240321$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005046$AURINIA PHARMACEUTICALS$$60$YR$$F$Y$$$20240731$$CN$US$US
235363882$23536388$2$F$$20240423$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005049$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
235364032$23536403$2$F$$20240319$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004997$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
235364042$23536404$2$F$$20240423$20240219$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005043$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235364102$23536410$2$F$20240101$20240821$20240219$20240916$PER$$US-SA-2024SA048658$SANOFI AVENTIS$$6$YR$C$M$Y$37.68$KG$20240916$$MD$US$US
235364242$23536424$2$F$20240101$20240514$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005057$AURINIA PHARMACEUTICALS$$50$YR$$M$Y$$$20240731$$CN$US$US
235364322$23536432$2$F$20240118$20240228$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005092$AURINIA PHARMACEUTICALS$$42$YR$$F$Y$$$20240731$$CN$US$US
235364412$23536441$2$F$20240115$20240417$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005074$AURINIA PHARMACEUTICALS$$41$YR$$F$Y$$$20240731$$CN$US$US
235364552$23536455$2$F$$20240412$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005099$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235364562$23536456$2$F$$20240422$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005048$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235364572$23536457$2$F$20231222$20240126$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004988$AURINIA PHARMACEUTICALS$$55$YR$$F$Y$113.83$KG$20240731$$CN$US$US
235364582$23536458$2$F$$20240227$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005016$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
235364632$23536463$2$F$20240106$20240405$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004980$AURINIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240731$$CN$US$US
235364782$23536478$2$F$20240203$20240528$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004990$AURINIA PHARMACEUTICALS$$48$YR$$F$Y$$$20240731$$CN$US$US
235364792$23536479$2$F$$20240304$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005020$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235364802$23536480$2$F$$20240129$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004998$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235364864$23536486$4$F$20240101$20240829$20240219$20240911$PER$$US-SA-2024SA048379$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240911$$MD$US$US
235364912$23536491$2$F$20231201$20240417$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004872$AURINIA PHARMACEUTICALS$$68$YR$$F$Y$64.399$KG$20240731$$CN$US$US
235364942$23536494$2$F$20231023$20240220$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004749$AURINIA PHARMACEUTICALS$$44$YR$$F$Y$$$20240731$$CN$US$US
235365042$23536504$2$F$$20240410$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004891$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235365142$23536514$2$F$$20240219$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004864$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235365272$23536527$2$F$20231214$20240506$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004893$AURINIA PHARMACEUTICALS$$68$YR$$F$Y$$$20240731$$CN$US$US
235365282$23536528$2$F$20231201$20240205$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004929$AURINIA PHARMACEUTICALS$$50$YR$$F$Y$53.061$KG$20240731$$CN$US$US
235365342$23536534$2$F$$20240829$20240219$20240904$EXP$$IN-BIOCON BIOLOGICS LIMITED-BBL2024000984$BIOCON$Rahul Kumar Gupta, Amita Mason, Ankit Batra, Vinayak, Rakhee Khanduri, Manoj Kumar et.al. Sarcoidosis associated with Trastuzumab in a young female with carcinoma of breast.. Indian journal of tuberculosis.. 2024;71:96-98$$$$$Y$$$20240904$$HP$IN$IN
235365552$23536555$2$F$$20240305$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004700$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
235365652$23536565$2$F$$20240429$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004970$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
235365682$23536568$2$F$$20240416$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004973$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
235365792$23536579$2$F$$20240315$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004964$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235365802$23536580$2$F$$20240328$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004852$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235365812$23536581$2$F$20231219$20240328$20240219$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004502$AURINIA PHARMACEUTICALS$$25$YR$$F$Y$119.64$KG$20240731$$CN$US$US
235365902$23536590$2$F$$20240701$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004756$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235365912$23536591$2$F$$20240408$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004763$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235365962$23536596$2$F$$20240618$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004842$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235366042$23536604$2$F$$20240105$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004979$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
235366345$23536634$5$F$20200101$20240911$20240219$20240917$EXP$$US-ABBVIE-21K-163-4124423-00$ABBVIE$$$$$M$Y$93$KG$20240917$$CN$US$US
235366552$23536655$2$F$$20240515$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004682$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
235366582$23536658$2$F$$20240705$20240219$20240713$PER$$US-SA-2024SA054632$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240713$$HP$US$US
235366602$23536660$2$F$$20240902$20240219$20240912$PER$$US-SA-2024SA048745$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240912$$CN$US$US
235366785$23536678$5$F$20231225$20240814$20240219$20240821$EXP$$IE-ABBVIE-5620059$ABBVIE$$82$YR$$M$Y$$$20240821$$HP$IE$IE
235366912$23536691$2$F$20231016$20240305$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004454$AURINIA PHARMACEUTICALS$$32$YR$$F$Y$93.878$KG$20240731$$CN$US$US
235366932$23536693$2$F$$20240227$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004766$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235366962$23536696$2$F$20240118$20240827$20240219$20240904$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-004740$AURINIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240904$$CN$US$US
235367162$23536716$2$F$20231201$20240321$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004761$AURINIA PHARMACEUTICALS$$35$YR$$F$Y$$$20240731$$CN$US$US
235367402$23536740$2$F$$20240131$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004804$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235367452$23536745$2$F$$20240305$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004614$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235367612$23536761$2$F$$20240709$20240219$20240711$EXP$$JP-ALXN-202402JPN000285JP$ALEXION PHARMACEUTICALS$$63$YR$$F$Y$$$20240711$$MD$JP$JP
235367702$23536770$2$F$20211228$20240716$20240219$20240718$EXP$$JP-TAKEDA-2022TJP069627$TAKEDA$$53$YR$$F$Y$47.8$KG$20240718$$HP$JP$JP
235367882$23536788$2$F$$20240718$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003975$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
235368132$23536813$2$F$20240201$20240311$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003996$AURINIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240731$$CN$US$US
235368412$23536841$2$F$20230701$20240209$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004034$AURINIA PHARMACEUTICALS$$21$YR$$F$Y$$$20240731$$CN$US$US
235368452$23536845$2$F$$20240628$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004066$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235368652$23536865$2$F$$20240422$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004078$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
235369172$23536917$2$F$20230801$20240702$20240219$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004134$AURINIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240731$$CN$US$US
235369282$23536928$2$F$$20240820$20240219$20240826$EXP$$CA-SANDOZ INC.-NVSC2023CA022957$SANDOZ$$46$YR$$M$Y$$$20240826$$CN$CA$CA
235369872$23536987$2$F$$20240702$20240219$20240708$EXP$$AU-TAKEDA-2024TUS013933$TAKEDA$$$$A$$Y$$$20240708$$HP$AU$AU
235370124$23537012$4$F$20240114$20240515$20240219$20240711$EXP$$JP-ROCHE-3509339$ROCHE$$73$YR$E$F$Y$89.1$KG$20240711$$MD$JP$JP
235370505$23537050$5$F$$20240807$20240219$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022703$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240816$$CN$US$US
235370529$23537052$9$F$20231201$20240722$20240219$20240729$EXP$$CA-AMGEN-CANSL2023174943$AMGEN$$67$YR$E$M$Y$94$KG$20240729$$CN$CA$CA
235370673$23537067$3$F$20240220$20240627$20240219$20240702$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004243$AURINIA PHARMACEUTICALS$$19$YR$$F$Y$$$20240702$$CN$US$US
235370842$23537084$2$F$$20240212$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004302$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
235370873$23537087$3$F$20240101$20240730$20240219$20240807$PER$$US-SA-2024SA055083$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240807$$MD$US$US
235370962$23537096$2$F$$20240617$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004062$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
235371722$23537172$2$F$$20240821$20240219$20240829$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-004403$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
235371732$23537173$2$F$$20240409$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004139$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235371832$23537183$2$F$20230928$20240701$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004328$AURINIA PHARMACEUTICALS$$30$YR$$F$Y$86.2$KG$20240731$$CN$US$US
235371862$23537186$2$F$$20240215$20240219$20240718$PER$$NVSC2024US033988$NOVARTIS$$$$$F$Y$$$20240718$$CN$US$US
235372202$23537220$2$F$$20240806$20240219$20240808$EXP$$CA-JNJFOC-20240234625$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240808$$HP$CA$CA
235372222$23537222$2$F$$20240821$20240219$20240823$EXP$$US-TAKEDA-US202026954$TAKEDA$$$$$F$Y$$$20240823$$HP$US$US
235372252$23537225$2$F$$20240816$20240219$20240826$EXP$$CA-APOTEX-2024AP002177$APOTEX$$21$YR$$F$Y$$$20240826$$MD$CA$CA
235372472$23537247$2$F$$20240606$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004447$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235372557$23537255$7$F$20240101$20240726$20240219$20240802$EXP$$CO-AMGEN-COLSL2024032074$AMGEN$$71$YR$E$F$Y$$$20240802$$MD$CO$CO
235372672$23537267$2$F$20230802$20240207$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004595$AURINIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240731$$CN$US$US
235372682$23537268$2$F$$20240314$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004607$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235372702$23537270$2$F$20230619$20240325$20240219$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-003940$AURINIA PHARMACEUTICALS$$36$YR$$M$Y$$$20240731$$HP$US$US
235372772$23537277$2$F$$20240703$20240219$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004272$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
235372814$23537281$4$F$20240507$20240723$20240219$20240729$EXP$$US-TAKEDA-2024TUS014543$TAKEDA$$60$YR$$F$Y$$$20240729$$MD$US$US
235372963$23537296$3$F$20231201$20240717$20240219$20240725$PER$$US-SA-2024SA054062$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240725$$MD$US$US
235373062$23537306$2$F$$20240524$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003991$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
235373112$23537311$2$F$$20240826$20240219$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026353$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240828$$CN$US$US
235373122$23537312$2$F$20240215$20240909$20240219$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202402010201$ELI LILLY AND CO$$87$YR$E$M$Y$$$20240910$$CN$US$US
235373332$23537333$2$F$20230809$20240423$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004091$AURINIA PHARMACEUTICALS$$69$YR$$F$Y$100.7$KG$20240731$$CN$US$US
235373452$23537345$2$F$$20240325$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004212$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235373662$23537366$2$F$$20240327$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004480$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235373812$23537381$2$F$$20240301$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004371$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235373822$23537382$2$F$$20240711$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004797$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235373915$23537391$5$F$20240201$20240729$20240219$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007541$JAZZ$$62$YR$$M$Y$105$KG$20240807$$MD$US$US
235374022$23537402$2$F$20231207$20240227$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004814$AURINIA PHARMACEUTICALS$$59$YR$$M$Y$$$20240731$$CN$US$US
235374032$23537403$2$F$$20240226$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004393$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235374052$23537405$2$F$$20240716$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004820$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235374232$23537423$2$F$20231101$20240702$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004626$AURINIA PHARMACEUTICALS$$52$YR$$F$Y$$$20240731$$CN$US$US
235374242$23537424$2$F$$20240216$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004862$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235374302$23537430$2$F$20231220$20240329$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004895$AURINIA PHARMACEUTICALS$$40$YR$$F$Y$$$20240731$$CN$US$US
235374532$23537453$2$F$$20240325$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004451$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235374562$23537456$2$F$20240101$20240325$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004474$AURINIA PHARMACEUTICALS$$36$YR$$F$Y$$$20240731$$CN$US$US
235374752$23537475$2$F$20231228$20240220$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004923$AURINIA PHARMACEUTICALS$$46$YR$$F$Y$$$20240731$$CN$US$US
235374892$23537489$2$F$20240101$20240625$20240219$20240704$PER$$US-SA-2024SA048917$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240704$$MD$US$US
235375102$23537510$2$F$$20240426$20240219$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004914$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235375162$23537516$2$F$20240101$20240805$20240219$20240813$PER$$US-SA-2024SA050033$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240814$$MD$US$US
235375212$23537521$2$F$20240101$20240828$20240219$20240909$PER$$US-SA-2024SA048983$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240909$$MD$US$US
235375292$23537529$2$F$20231101$20240223$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004542$AURINIA PHARMACEUTICALS$$47$YR$$F$Y$$$20240731$$CN$US$US
235375302$23537530$2$F$$20240123$20240219$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004978$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235375322$23537532$2$F$$20240220$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004974$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235375332$23537533$2$F$$20240130$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004967$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235375342$23537534$2$F$$20240129$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004951$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
235375352$23537535$2$F$$20240326$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004874$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235375372$23537537$2$F$$20240517$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004851$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
235375382$23537538$2$F$20231012$20240122$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004673$AURINIA PHARMACEUTICALS$$36$YR$$M$Y$$$20240731$$CN$US$US
235375392$23537539$2$F$20240830$20240906$20240219$20240913$EXP$$US-BEH-2024168690$CSL BEHRING$$8$YR$C$M$Y$$$20240913$$HP$US$US
235375432$23537543$2$F$20240124$20240926$20240219$20240930$EXP$PT-INFARMED-J202401-715$PT-009507513-2402PRT004848$MERCK$$79$YR$$M$Y$$$20240930$$MD$PT$PT
235375442$23537544$2$F$$20240215$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004734$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235375452$23537545$2$F$$20240209$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004515$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235375462$23537546$2$F$$20240205$20240219$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004465$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235375472$23537547$2$F$$20240206$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003926$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235375492$23537549$2$F$$20240408$20240219$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004624$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
235375502$23537550$2$F$$20240205$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004917$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235375532$23537553$2$F$$20240718$20240219$20240723$PER$$US-JNJFOC-20240229649$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$PH$US$US
235375944$23537594$4$F$$20240709$20240219$20240710$30DAY$$US-JNJFOC-20240228109$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
235376384$23537638$4$F$$20240711$20240219$20240716$EXP$$GB-SAMIL-GLO2023GB007343$ASPEN$$$$$$Y$$$20240716$$CN$GB$GB
235377243$23537724$3$F$$20240729$20240219$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026247$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240730$$HP$US$US
235377632$23537763$2$F$20240110$20240503$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004021$AURINIA PHARMACEUTICALS$$30$YR$$F$Y$$$20240731$$CN$US$US
235377652$23537765$2$F$20231124$20240429$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004704$AURINIA PHARMACEUTICALS$$26$YR$$F$Y$58.957$KG$20240731$$CN$US$US
235377733$23537773$3$F$$20240704$20240219$20240708$EXP$$CA-JNJFOC-20240235729$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240708$$$COUNTRY NOT SPECIFIED$CA
235377902$23537790$2$F$$20240301$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004503$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235377933$23537793$3$F$20240207$20240410$20240219$20240710$PER$$JP-ROCHE-3509822$ROCHE$$86$YR$E$M$Y$$$20240628$$MD$JP$JP
235377972$23537797$2$F$$20240517$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004808$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
235378032$23537803$2$F$20231211$20240220$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004816$AURINIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240731$$CN$US$US
2353781011$23537810$11$F$20231229$20240815$20240219$20240819$EXP$$GB-SANDOZ INC.-SDZ2023GB075148$SANDOZ$$78$YR$$F$Y$$$20240819$$CN$GB$GB
235378296$23537829$6$F$20240201$20240821$20240219$20240827$EXP$$CA-TAKEDA-2023TUS109964$TAKEDA$$35$YR$$M$Y$$$20240827$$HP$CA$CA
235378402$23537840$2$F$20231201$20240213$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004937$AURINIA PHARMACEUTICALS$$61$YR$$F$Y$$$20240731$$CN$US$US
235378432$23537843$2$F$20231222$20240614$20240219$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004910$AURINIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240731$$CN$US$US
235378442$23537844$2$F$20240122$20240220$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004883$AURINIA PHARMACEUTICALS$$43$YR$$F$Y$$$20240731$$CN$US$US
235378462$23537846$2$F$20231127$20240603$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004942$AURINIA PHARMACEUTICALS$$33$YR$$F$Y$60$KG$20240731$$HP$US$US
235378664$23537866$4$F$20240101$20240716$20240219$20240723$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-004958$AURINIA PHARMACEUTICALS$$31$YR$$F$Y$$$20240723$$CN$US$US
235378802$23537880$2$F$20240116$20240221$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004994$AURINIA PHARMACEUTICALS$$36$YR$$F$Y$$$20240731$$CN$US$US
235378925$23537892$5$F$20240101$20240822$20240219$20240829$EXP$$US-UCBSA-2024007587$UCB$$$$$M$Y$$$20240829$$HP$US$US
235379022$23537902$2$F$$20240301$20240219$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005058$AURINIA PHARMACEUTICALS$$$$$F$Y$91.7$KG$20240731$$CN$US$US
235379042$23537904$2$F$$20240223$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005082$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235379052$23537905$2$F$20240101$20240326$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005036$AURINIA PHARMACEUTICALS$$26$YR$$F$Y$$$20240731$$CN$US$US
235379072$23537907$2$F$$20240319$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005067$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235379112$23537911$2$F$20231109$20240128$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004806$AURINIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240731$$CN$US$US
235379182$23537918$2$F$20240125$20240212$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004662$AURINIA PHARMACEUTICALS$$35$YR$$M$Y$$$20240731$$CN$US$US
235379192$23537919$2$F$20231229$20240521$20240219$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004890$AURINIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240731$$CN$US$US
235379202$23537920$2$F$$20240209$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005001$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235379212$23537921$2$F$20240101$20240205$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005055$AURINIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240731$$CN$US$US
235379222$23537922$2$F$$20240208$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005096$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$MD$US$US
235379232$23537923$2$F$$20240130$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004825$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235379242$23537924$2$F$$20240206$20240219$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-003002$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
235379264$23537926$4$F$20231130$20240702$20240219$20240703$EXP$$IT-ROCHE-3510800$ROCHE$$56$YR$A$F$Y$55$KG$20240703$$MD$IT$IT
235379362$23537936$2$F$$20240903$20240219$20240909$EXP$$CA-JNJFOC-20240242477$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240909$$CN$CA$CA
235380224$23538022$4$F$20240101$20240703$20240219$20240711$EXP$$CO-ROCHE-3116512$ROCHE$$57$YR$A$F$Y$62$KG$20240711$$CN$CO$CO
235380315$23538031$5$F$20191212$20240902$20240219$20240903$EXP$$IT-SANDOZ INC.-SDZ2023IT064444$SANDOZ$$40$YR$$F$Y$$$20240903$$MD$IT$IT
235380712$23538071$2$F$20230101$20240703$20240219$20240705$EXP$$JP-ASTELLAS-2024JP001207$ASTELLAS$$$$$M$Y$$$20240705$$MD$JP$JP
235380792$23538079$2$F$$20240816$20240219$20240826$EXP$$CA-APOTEX-2023AP007164$APOTEX$$19$YR$$M$Y$98$KG$20240826$$HP$CA$CA
235380813$23538081$3$F$20240705$20240705$20240219$20240713$PER$$US-SA-2024SA049460$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240713$$CN$US$US
235380832$23538083$2$F$20240301$20240821$20240219$20240918$PER$$US-SA-2024SA050572$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
235381053$23538105$3$F$20240101$20240909$20240219$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025877$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240910$$HP$US$US
235381405$23538140$5$F$$20240918$20240219$20240926$EXP$$CA-TAKEDA-2024TUS014868$TAKEDA$$$$$F$Y$$$20240926$$MD$CA$CA
235381443$23538144$3$F$20240306$20240724$20240219$20240821$PER$$CA-TOLMAR, INC.-24CA046379$TOLMAR$$94$YR$$M$Y$$$20240821$$PH$CA$CA
235381462$23538146$2$F$$20240717$20240219$20240809$PER$$CA-TOLMAR, INC.-24CA046392$TOLMAR$$$$$M$Y$$$20240809$$CN$CA$CA
235381483$23538148$3$F$20240101$20240904$20240219$20240924$PER$$CA-TOLMAR, INC.-24CA046376$TOLMAR$$70$YR$$M$Y$$$20240923$$CN$CA$CA
235381647$23538164$7$F$$20240923$20240219$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025966$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240926$$CN$US$US
235381802$23538180$2$F$20240201$20240924$20240219$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202402010343$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240930$$CN$US$US
235382304$23538230$4$F$20240101$20240708$20240219$20240717$PER$$US-SA-2024SA055177$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240717$$MD$US$US
235382334$23538233$4$F$$20240710$20240219$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023082$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240712$$CN$US$US
235382682$23538268$2$F$$20240812$20240219$20240820$EXP$$CA-APOTEX-2024AP002124$APOTEX$$26$YR$$F$Y$$$20240820$$MD$CA$CA
235382713$23538271$3$F$$20240717$20240219$20240726$PER$$US-SA-2024SA049015$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240726$$MD$US$US
235383142$23538314$2$F$$20240215$20240219$20240702$PER$$US-ABBVIE-5644507$ABBVIE$$$$A$F$Y$$$20240702$$HP$US$US
235383322$23538332$2$F$$20240812$20240219$20240819$EXP$$CA-APOTEX-2024AP002120$APOTEX$$72$YR$$F$Y$$$20240819$$HP$CA$CA
235383534$23538353$4$F$20231001$20240719$20240219$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026791$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240723$$CN$US$US
235383914$23538391$4$F$20240212$20240828$20240219$20240902$EXP$$CA-TAKEDA-2024TUS014570$TAKEDA$$37$YR$$F$Y$$$20240902$$CN$CA$CA
235384345$23538434$5$F$20240101$20240911$20240219$20240926$PER$$US-SA-2024SA050665$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240926$$MD$US$US
235384592$23538459$2$F$20240214$20240805$20240219$20240807$PER$$US-AMGEN-USASP2024032140$AMGEN$$73$YR$E$F$Y$$$20240807$$CN$US$US
235384702$23538470$2$F$20240201$20240812$20240219$20240814$PER$$US-PFIZER INC-202400042993$PFIZER$$63$YR$$F$Y$$$20240814$$HP$US$US
235384712$23538471$2$F$20240210$20240703$20240219$20240704$PER$$US-PFIZER INC-202400041180$PFIZER$$48$YR$$F$Y$54.422$KG$20240704$$CN$US$US
235385114$23538511$4$F$$20240920$20240219$20240925$PER$$US-PFIZER INC-PV202400023150$PFIZER$$45$YR$$F$Y$$$20240925$$HP$US$US
235385194$23538519$4$F$20240201$20240711$20240219$20240717$EXP$$JP-009507513-2401JPN001797J$MERCK$$54$YR$$F$Y$$$20240717$$MD$JP$JP
235385732$23538573$2$F$20231102$20240712$20240219$20240723$EXP$$DE-AUROBINDO-AUR-APL-2024-006403$AUROBINDO$$89$YR$$F$Y$68$KG$20240723$$MD$DE$DE
235386012$23538601$2$F$20240213$20240626$20240219$20240701$PER$$US-AMGEN-USASP2024032397$AMGEN$$72$YR$E$M$Y$$$20240630$$CN$US$US
235386107$23538610$7$F$20240101$20240903$20240219$20240911$PER$$US-SA-2024SA053720$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240911$$HP$US$US
235386113$23538611$3$F$$20240724$20240219$20240805$PER$$US-SA-2024SA054985$SANOFI AVENTIS$$$$E$F$Y$58.9$KG$20240805$$MD$US$US
235386642$23538664$2$F$$20240212$20240219$20240820$EXP$$GB-BAUSCHBL-2024BNL001907$BAUSCH AND LOMB$Dixon L, Varley J, Gontsarova A, Mallon D, Tona F, Muir D, Luqmani A, Jenkins I, Nicholas R, Jones B, Everitt A. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurology: Neuroimmunology + Neuroinflammation. 2020 SEP;7(5):E789. doi:10.1212/NXI.0000000000000789$59$YR$$F$Y$$$20240820$$MD$GB$GB
235386762$23538676$2$F$$20240903$20240219$20240906$EXP$$JP-DSJP-DSJ-2024-107159$DAIICHI$Inoue K, Kobayashi R, Asaeda K, Iwai N, Hirose R, Doi T, et al.. Endoscopic unroofing technique for small intestinal lipomas. Journal of Japanese Gastroenterological Association/20th Annual Meeting of JGA. 2024;8:208$8$DEC$$M$Y$78.5$KG$20240906$$MD$JP$JP
235386802$23538680$2$F$20240201$20240731$20240219$20240808$PER$$US-SA-2024SA049698$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240808$$MD$US$US
235386912$23538691$2$F$20240115$20240728$20240219$20240731$EXP$FR-AFSSAPS-LM2024000067$FR-BAUSCH-BL-2024-002660$BAUSCH AND LOMB$$69$YR$$M$Y$90$KG$20240731$$MD$FR$FR
235386992$23538699$2$F$$20240913$20240219$20240918$EXP$$US-SANDOZ INC.-SDZ2024US015944$SANDOZ$$$$$M$Y$$$20240918$$CN$US$US
235387162$23538716$2$F$$20240826$20240219$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US016246$SANDOZ$$$$$F$Y$$$20240827$$CN$US$US
235387463$23538746$3$F$20230511$20240729$20240219$20240802$EXP$FR-AFSSAPS-TO2024000319$FR-ABBVIE-5644797$ABBVIE$$63$YR$$F$Y$$$20240802$$PH$FR$FR
235387482$23538748$2$F$$20240809$20240219$20240814$EXP$$NVSC2024GB034064$NOVARTIS$$$$E$F$Y$$$20240814$$CN$GB$GB
235387503$23538750$3$F$20231201$20240802$20240219$20240806$EXP$$US-TAKEDA-2024TUS014678$TAKEDA$$77$YR$$F$Y$$$20240806$$CN$US$US
235387673$23538767$3$F$$20240902$20240219$20240910$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2023002046$BIOCON$$$$$$Y$$$20240910$$CN$CA$CA
235387867$23538786$7$F$20240101$20240726$20240219$20240802$EXP$$US-SA-2024SA055875$SANOFI AVENTIS$$51$YR$A$M$Y$54$KG$20240802$$MD$US$US
235387932$23538793$2$F$$20240830$20240219$20240909$EXP$AU-SANOFI-AVENTIS-2013SA061932$AU-PERRIGO-13AU016552$PERRIGO$$1$DY$$M$Y$2.65$KG$20240909$$HP$AU$AU
235388042$23538804$2$F$20240208$20240916$20240219$20240923$PER$$US-JNJFOC-20240228234$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240923$$CN$US$US
235388137$23538813$7$F$$20240903$20240219$20240912$EXP$$NVSC2024CA031594$NOVARTIS$$43$YR$$F$Y$96$KG$20240912$$HP$CA$CA
235388163$23538816$3$F$$20240821$20240219$20240826$EXP$$CA-MYLANLABS-2024M1012872$MYLAN$$77$YR$$F$Y$$$20240826$$CN$CA$CA
235388532$23538853$2$F$20230828$20240620$20240219$20240701$EXP$FR-AFSSAPS-NT2023001053$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-01223$HIKMA$$49$YR$$F$Y$$$20240701$$PH$FR$FR
235388864$23538886$4$F$$20240625$20240219$20240702$EXP$$NVSC2024CA031625$NOVARTIS$$62$YR$$F$Y$$$20240702$$HP$CA$CA
235389073$23538907$3$F$20240101$20240705$20240219$20240708$EXP$FR-AFSSAPS-RN2024000119$FR-PFIZER INC-202400043943$PFIZER$$51$YR$$M$Y$$$20240708$$MD$FR$FR
235389402$23538940$2$F$20240206$20240702$20240219$20240711$EXP$$CA-DSJP-DSJ-2024-107536$DAIICHI$$66$YR$$F$Y$42.5$KG$20240711$$MD$CA$CA
235389462$23538946$2$F$20230728$20240715$20240219$20240722$EXP$$DE-MYLANLABS-2024M1015047$MYLAN$$72$YR$$F$Y$$$20240722$$MD$DE$DE
235389552$23538955$2$F$20240101$20240822$20240219$20240826$EXP$$US-BAUSCH-BL-2024-002552$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240826$$CN$US$US
235389596$23538959$6$F$20210127$20240918$20240219$20240928$EXP$$FR-CELLTRION INC.-2024FR003775$CELLTRION$$$$$$Y$$$20240928$$MD$FR$FR
235389613$23538961$3$F$$20240705$20240219$20240808$EXP$$CA-SANDOZ INC.-SDZ2024CA016290$SANDOZ$$44$YR$$F$Y$70$KG$20240808$$HP$CA$CA
235389812$23538981$2$F$20231001$20240829$20240219$20240904$EXP$$FR-AMGEN-FRASP2024031267$AMGEN$$36$YR$A$F$Y$$$20240904$$MD$FR$FR
235389843$23538984$3$F$20240203$20240814$20240219$20240822$PER$$US-AMGEN-USASP2024031536$AMGEN$$71$YR$E$F$Y$$$20240821$$CN$US$US
2353899911$23538999$11$F$20240128$20240905$20240219$20240909$30DAY$$KR-PFIZER INC-PV202400013017$PFIZER$$10$YR$$M$Y$$$20240909$$CN$KR$KR
235390112$23539011$2$F$$20240710$20240219$20240718$EXP$$PL-CELLTRION INC.-2024PL003553$CELLTRION$$$$$$Y$$$20240718$$CN$PL$PL
235390362$23539036$2$F$$20240808$20240219$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025576$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240819$$CN$US$US
235390404$23539040$4$F$20240201$20240629$20240219$20240712$PER$$US-SA-2024SA048721$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240712$$MD$US$US
235390902$23539090$2$F$20230101$20240209$20240219$20240710$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-106793$DAIICHI$$$$$F$Y$$$20240710$$MD$US$US
235391213$23539121$3$F$20231026$20240816$20240219$20240822$PER$$US-BAYER-2024A020021$BAYER$$34$YR$A$F$Y$$$20240822$$MD$US$US
235391366$23539136$6$F$20240101$20240706$20240219$20240711$PER$$US-SA-2024SA056378$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240711$$MD$US$US
235391707$23539170$7$F$20231213$20240823$20240219$20240903$EXP$$US-INSMED, INC.-2023-04862-US$INSMED$$77$YR$$F$Y$$$20240903$$CN$US$US
235391713$23539171$3$F$$20240808$20240219$20240822$EXP$$US-INSMED, INC.-2024-00518-US$INSMED$$$$$$Y$$$20240822$$CN$US$US
2353917710$23539177$10$F$20240219$20240710$20240219$20240710$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-107643$DAIICHI$$16$YR$$F$Y$$$20240710$$HP$US$US
235392072$23539207$2$F$20240101$20240729$20240219$20240805$PER$$US-RDY-SPO/USA/24/0002504$DR REDDYS$$16$YR$A$M$Y$$$20240805$$HP$US$US
235393432$23539343$2$F$20231101$20240801$20240219$20240801$EXP$FR-AFSSAPS-LY2024000234$FR-PFIZER INC-202400042210$PFIZER$$68$YR$$F$Y$55$KG$20240801$$PH$FR$FR
235393442$23539344$2$F$20231002$20240711$20240219$20240715$EXP$FR-AFSSAPS-AN2024000179$FR-PFIZER INC-202400042366$PFIZER$$74$YR$$M$Y$$$20240715$$MD$FR$FR
235393674$23539367$4$F$$20240823$20240219$20240903$EXP$$GB-MYLANLABS-2024M1015240$MYLAN$$$$$M$Y$$$20240903$$PH$GB$GB
235393852$23539385$2$F$20240101$20240823$20240219$20240913$PER$$US-SA-2024SA051859$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240913$$MD$US$US
235393932$23539393$2$F$$20240717$20240219$20240718$EXP$$CA-ORGANON-O2402CAN001694$ORGANON$$53$YR$$M$Y$$$20240718$$CN$CA$CA
235394172$23539417$2$F$20240101$20240814$20240219$20240819$PER$$US-BAYER-2024A026022$BAYER$$34$YR$A$F$Y$$$20240819$$MD$US$US
235394312$23539431$2$F$20231102$20240716$20240219$20240729$EXP$$JP-UCBSA-2023058610$UCB$$12$YR$$F$Y$$$20240729$$MD$JP$JP
235394354$23539435$4$F$20230901$20240919$20240219$20240927$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR006811$AEGERION$$$$$$Y$$$20240927$$MD$DE$DE
235394362$23539436$2$F$$20240725$20240219$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026262$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$56.7$KG$20240801$$CN$US$US
235394382$23539438$2$F$20240206$20240719$20240219$20240730$PER$$US-SA-2024SA052156$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240730$$HP$US$US
235394442$23539444$2$F$20240101$20240705$20240219$20240717$PER$$US-SA-2024SA052421$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240717$$MD$US$US
235395056$23539505$6$F$$20240911$20240219$20240913$EXP$$IE-009507513-2402GBR005566$MERCK$$40$YR$$F$Y$$$20240913$$HP$IE$IE
235395072$23539507$2$F$20240101$20240905$20240219$20240913$PER$$US-SA-2024SA051985$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240913$$MD$US$US
235395092$23539509$2$F$20240212$20240718$20240219$20240722$PER$$US-AMGEN-USASP2024031614$AMGEN$$78$YR$E$M$Y$$$20240722$$CN$US$US
235396132$23539613$2$F$20220318$20240705$20240219$20240708$EXP$$DE-SANDOZ INC.-SDZ2024DE015789$SANDOZ$$53$YR$$M$Y$115$KG$20240708$$MD$DE$DE
235396582$23539658$2$F$$20240716$20240219$20240724$PER$$US-SA-2024SA050369$SANOFI AVENTIS$$7$YR$C$F$Y$26.5$KG$20240724$$MD$US$US
235396662$23539666$2$F$20180529$20240812$20240219$20240813$EXP$$DE-SANDOZ INC.-NVSC2021DE143792$SANDOZ$$47$YR$$F$Y$$$20240813$$MD$DE$DE
235396863$23539686$3$F$$20240812$20240219$20240818$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024259$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240819$$CN$US$US
235397644$23539764$4$F$20240101$20240815$20240219$20240828$PER$$US-SA-2024SA049503$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240828$$CN$US$US
235398277$23539827$7$F$$20240719$20240219$20240725$EXP$$US-BAYER-2024A023943$BAYER$$37$YR$A$M$Y$72.562$KG$20240725$$CN$US$US
235398292$23539829$2$F$20230101$20240716$20240219$20240723$EXP$$US-ABBVIE-5642445$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
235398765$23539876$5$F$20240124$20240814$20240219$20240816$EXP$$US-TAKEDA-2024TUS013720$TAKEDA$$62$YR$$M$Y$$$20240816$$CN$US$US
235398893$23539889$3$F$$20240924$20240219$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024986$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240926$$CN$US$US
235398912$23539891$2$F$$20240718$20240219$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024462$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240724$$MD$US$US
235399573$23539957$3$F$20240209$20240702$20240219$20240705$EXP$$CA-JNJFOC-20240246460$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240705$$HP$CA$CA
235399683$23539968$3$F$20100101$20240904$20240219$20240913$EXP$$NL-PFIZER INC-202400040344$PFIZER$$$$$F$Y$$$20240913$$CN$NL$NL
235400702$23540070$2$F$20230501$20240828$20240219$20240903$EXP$$US-ABBVIE-5310240$ABBVIE$$68$YR$$F$Y$$$20240903$$CN$US$US
235401032$23540103$2$F$20231206$20240708$20240219$20240722$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2024FOS000152$RIGEL PHARMACEUTICALS$$58$YR$$F$Y$42.7$KG$20240722$$MD$JP$JP
235401243$23540124$3$F$$20240717$20240219$20240725$EXP$$CA-TAKEDA-2024TUS015601$TAKEDA$$$$$$Y$$$20240725$$HP$CA$CA
235401252$23540125$2$F$20240212$20240814$20240219$20240816$PER$$US-AMGEN-USASP2024032966$AMGEN$$72$YR$E$F$Y$$$20240816$$CN$US$US
235401593$23540159$3$F$20240212$20240701$20240219$20240705$EXP$$NVSC2024NL034041$NOVARTIS$$$$E$M$Y$$$20240705$$HP$NL$NL
235401714$23540171$4$F$$20240814$20240219$20240821$EXP$$CA-PURDUE-USA-2024-0307926$PURDUE$$9$YR$$M$Y$$$20240821$$CN$CA$CA
235402047$23540204$7$F$$20240829$20240219$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026679$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240905$$CN$US$US
235402342$23540234$2$F$$20240504$20240219$20240723$PER$$US-Stemline Therapeutics, Inc.-2023ST004437$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
235402853$23540285$3$F$$20240924$20240219$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026082$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240925$$HP$US$US
235404252$23540425$2$F$$20240529$20240219$20240723$PER$$US-Stemline Therapeutics, Inc.-2023ST004158$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$CN$US$US
235404864$23540486$4$F$20240207$20240719$20240219$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026014$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240723$$CN$US$US
235404982$23540498$2$F$20240103$20240613$20240219$20240724$PER$$US-Stemline Therapeutics, Inc.-2023ST004766$STEMLINE THERAPEUTICS$$42$YR$A$F$Y$$$20240718$$CN$US$US
235405972$23540597$2$F$20230501$20240710$20240219$20240712$EXP$$DE-SANDOZ INC.-SDZ2024DE015763$SANDOZ$$63$YR$$F$Y$$$20240712$$MD$DE$DE
235406243$23540624$3$F$20231004$20240430$20240219$20240723$PER$$US-Stemline Therapeutics, Inc.-2023ST004929$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240718$$CN$US$US
235407023$23540702$3$F$$20240731$20240219$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026446$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240806$$CN$US$US
235408013$23540801$3$F$20240101$20240516$20240219$20240723$PER$$US-Stemline Therapeutics, Inc.-2023ST005473$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$54.48$KG$20240718$$CN$US$US
235409373$23540937$3$F$$20240503$20240219$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000418$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240718$$CN$US$US
235409576$23540957$6$F$20240206$20240620$20240219$20240701$EXP$$ZA-MYLANLABS-2024M1015422$MYLAN$$20$YR$$M$Y$56.5$KG$20240701$$CN$ZA$ZA
235409674$23540967$4$F$20240207$20240729$20240219$20240812$EXP$$BE-JAZZ PHARMACEUTICALS-2024-BE-002978$JAZZ$$$$$$Y$$$20240812$$MD$BE$BE
235409883$23540988$3$F$$20240502$20240219$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000516$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240718$$CN$US$US
235409943$23540994$3$F$$20240517$20240219$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000526$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
235410423$23541042$3$F$$20240516$20240219$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000064$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240718$$CN$US$US
235410962$23541096$2$F$$20240502$20240219$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST000157$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240718$$CN$US$US
235411234$23541123$4$F$20220126$20240814$20240219$20240821$EXP$$ZA-ROCHE-3163664$ROCHE$$46$YR$A$M$Y$$$20240821$$MD$ZA$ZA
235412243$23541224$3$F$$20240613$20240219$20240723$PER$$US-Stemline Therapeutics, Inc.-2023ST005049$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
235412373$23541237$3$F$$20240518$20240219$20240723$PER$$US-Stemline Therapeutics, Inc.-2023ST005071$STEMLINE THERAPEUTICS$$62$YR$A$M$Y$$$20240718$$CN$US$US
235412772$23541277$2$F$$20240529$20240219$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST000240$STEMLINE THERAPEUTICS$$47$YR$A$F$Y$$$20240718$$CN$US$US
235413132$23541313$2$F$20240122$20240605$20240219$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000553$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$HP$US$US
235413466$23541346$6$F$$20240625$20240219$20240704$EXP$$CA-SANDOZ INC.-SDZ2024CA016276$SANDOZ$$44$YR$$F$Y$$$20240704$$HP$CA$CA
235413743$23541374$3$F$20220101$20240723$20240219$20240726$EXP$IT-UCBSA-2023028465$IT-SANDOZ INC.-SDZ2024IT014720$SANDOZ$$27$YR$$F$Y$144$KG$20240726$$HP$IT$IT
235414482$23541448$2$F$20240101$20240624$20240219$20240703$PER$$US-SA-2024SA055329$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240703$$MD$US$US
235414652$23541465$2$F$$20240807$20240219$20240816$PER$$US-INCYTE CORPORATION-2024IN001505$INCYTE$$$$$$Y$$$20240816$$CN$US$US
235414705$23541470$5$F$$20240624$20240219$20240716$EXP$$PT-ABBVIE-5640694$ABBVIE$$$$E$$Y$$$20240716$$HP$PT$PT
235414902$23541490$2$F$20240101$20240717$20240219$20240725$PER$$US-SA-2024SA049646$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240725$$MD$US$US
235415119$23541511$9$F$$20240819$20240219$20240821$EXP$$NVSC2024CA031635$NOVARTIS$$43$YR$$F$Y$96$KG$20240821$$HP$CA$CA
235415454$23541545$4$F$20230101$20240912$20240219$20240926$EXP$$NL-ABBVIE-5645091$ABBVIE$$$$E$M$Y$$$20240926$$CN$NL$NL
235416232$23541623$2$F$$20240827$20240219$20240830$EXP$$US-TAKEDA-2021TUS046102$TAKEDA$$$$$F$Y$78$KG$20240830$$CN$US$US
235416424$23541642$4$F$20231104$20240905$20240219$20240911$EXP$$GB-ABBVIE-5644982$ABBVIE$$27$YR$$M$Y$67.2$KG$20240911$$MD$GB$GB
235416467$23541646$7$F$20230301$20240702$20240219$20240816$EXP$$US-ABBVIE-5643265$ABBVIE$$79$YR$$F$Y$129$KG$20240816$$HP$US$US
235416536$23541653$6$F$$20240809$20240219$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023359$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240819$$HP$US$US
235417124$23541712$4$F$$20240822$20240219$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026039$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240826$$CN$US$US
235417812$23541781$2$F$20240206$20240829$20240220$20240904$EXP$$US-ALXN-202402USA000867US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$MD$US$US
235418337$23541833$7$F$20240124$20240628$20240220$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2024-002539$UNITED THERAPEUTICS$$25$YR$$F$Y$68.027$KG$20240706$$$US$US
235418423$23541842$3$F$20230301$20240222$20240220$20240913$EXP$$FR-TEVA-VS-3149978$TEVA$$67$YR$$M$Y$85.5$KG$20240913$$CN$FR$FR
235419953$23541995$3$F$$20240626$20240220$20240701$EXP$$NVSC2024CA031637$NOVARTIS$$44$YR$$F$Y$97$KG$20240701$$MD$CA$CA
235420034$23542003$4$F$20240101$20240619$20240220$20240703$PER$$US-SA-2024SA051363$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240703$$MD$US$US
235420192$23542019$2$F$20240126$20240908$20240220$20240910$EXP$$CA-TAKEDA-2024TUS006329$TAKEDA$$35$YR$$F$Y$$$20240910$$CN$CA$CA
235420293$23542029$3$F$$20240730$20240220$20240806$PER$$US-SA-2024SA053638$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240806$$MD$US$US
235420664$23542066$4$F$$20240918$20240220$20240926$EXP$$GB-TAKEDA-2024TUS015395$TAKEDA$$$$$F$Y$$$20240926$$CN$GB$GB
235420712$23542071$2$F$$20240703$20240220$20240712$PER$$US-SA-2024SA052026$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240712$$MD$US$US
235420774$23542077$4$F$20231223$20240725$20240220$20240802$EXP$$DE-NOVOPROD-1168652$NOVO NORDISK$$888$MON$$M$Y$$$20240802$$PH$DE$DE
235421063$23542106$3$F$$20240725$20240220$20240729$EXP$$US-TAKEDA-2024TUS002369$TAKEDA$$$$$F$Y$$$20240729$$MD$US$US
235421294$23542129$4$F$20240101$20240717$20240220$20240726$EXP$$CA-CELLTRION INC.-2023CA018968$CELLTRION$$$$$$Y$$$20240726$$PH$CA$CA
235421336$23542133$6$F$20240614$20240912$20240220$20240918$EXP$$US-AMGEN-USASL2024031967$AMGEN$$43$YR$A$F$Y$66.1$KG$20240918$$PH$US$US
235421432$23542143$2$F$20240205$20240214$20240220$20240808$EXP$$NVSC2024IL005315$NOVARTIS$$82$YR$$F$Y$$$20240808$$HP$IL$IL
235421753$23542175$3$F$$20240423$20240220$20240930$PER$$US-ROCHE-3389513$ROCHE$$21$YR$A$F$Y$56.5$KG$20240930$$PH$US$US
235422003$23542200$3$F$$20240904$20240220$20240924$PER$$CA-TOLMAR, INC.-24CA046152$TOLMAR$$$$$M$Y$$$20240923$$CN$CA$CA
235422414$23542241$4$F$20240101$20240910$20240220$20240915$EXP$$CA-JNJFOC-20240242769$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240916$$CN$CA$CA
235422653$23542265$3$F$20240201$20240918$20240220$20240925$EXP$$NVSJ2024JP002141$NOVARTIS$Toyama T, Ymaguchi T and Matsuda. Idiopathic Thrombocytopenic Purpura after Initiation of Eltrombopag which developed Thrombosis. The 345th Kyushu Regional Meeting of the Japanese Society of Internal Medicine (. 2024;64$$$E$F$Y$$$20240926$$PH$JP$JP
235422772$23542277$2$F$$20240703$20240220$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-023476$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240704$$CN$US$US
235422782$23542278$2$F$20240101$20240917$20240220$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027170$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240919$$HP$US$US
235422932$23542293$2$F$$20240213$20240220$20240926$EXP$$US-GSK-US2024AMR021362$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
235423335$23542333$5$F$20240207$20240701$20240220$20240711$EXP$$JP-ROCHE-3510451$ROCHE$$67$YR$E$M$Y$67.1$KG$20240711$$MD$JP$JP
235423374$23542337$4$F$20240101$20240726$20240220$20240803$EXP$$CA-CELLTRION INC.-2024CA004141$CELLTRION$$$$$$Y$$$20240803$$HP$CA$CA
235423413$23542341$3$F$20230626$20240731$20240220$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-024719$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240802$$PH$JP$JP
235423692$23542369$2$F$20240101$20240209$20240220$20240828$EXP$$US-ORPHANEU-2024001050$RECORDATI$$$$$$Y$$$20240828$$CN$US$US
235423784$23542378$4$F$20230901$20240826$20240220$20240909$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000087$DECIPHERA PHARMACEUTICALS$$66$YR$A$F$Y$$$20240909$$CN$US$US
235423914$23542391$4$F$20240204$20240906$20240220$20240910$EXP$$US-GSK-US2024019441$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
235424103$23542410$3$F$$20240722$20240220$20240729$PER$$US-SA-2024SA057192$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240729$$CN$US$US
235424122$23542412$2$F$$20240729$20240220$20240805$EXP$$US-SA-2024SA053220$SANOFI AVENTIS$$57$YR$A$M$Y$182.9$KG$20240805$$CN$US$US
235424214$23542421$4$F$20221201$20240723$20240220$20240731$EXP$$CA-CELLTRION INC.-2022CA021423$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
235424263$23542426$3$F$20200201$20240701$20240220$20240705$EXP$$CA-ORGANON-O2402CAN001747$ORGANON$$8$YR$$F$Y$$$20240705$$CN$CA$CA
235424692$23542469$2$F$$20240722$20240220$20240724$EXP$$IN-ROCHE-3512200$ROCHE$$69$YR$E$M$Y$$$20240724$$CN$IN$IN
235424722$23542472$2$F$$20240213$20240220$20240806$EXP$$NVSC2024US032376$NOVARTIS$$$$$$Y$$$20240806$$MD$US$US
235424852$23542485$2$F$20231208$20240801$20240220$20240803$EXP$SE-SEMPA-2024-000884$SE-ROCHE-3507804$ROCHE$$83$YR$E$F$Y$$$20240803$$MD$SE$SE
235425262$23542526$2$F$20240205$20240829$20240220$20240905$PER$$US-JNJFOC-20240216953$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240906$$CN$US$US
235425832$23542583$2$F$20231012$20240814$20240220$20240822$EXP$$CZ-CELLTRION INC.-2024CZ003739$CELLTRION$$$$$$Y$$$20240822$$MD$CZ$CZ
235425892$23542589$2$F$$20240916$20240220$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027236$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$88.45$KG$20240917$$CN$US$US
235425953$23542595$3$F$$20240704$20240220$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027206$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240705$$CN$US$US
235426782$23542678$2$F$$20240628$20240220$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027204$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$101.15$KG$20240701$$CN$US$US
235426887$23542688$7$F$$20240801$20240220$20240806$EXP$$NVSC2024US034508$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
235427216$23542721$6$F$20231228$20240807$20240220$20240814$EXP$$US-BIOGEN-2024BI01249392$BIOGEN$$59$YR$$F$Y$56.75$KG$20240814$$MD$US$US
235427385$23542738$5$F$$20240812$20240220$20240815$EXP$$US-BIOGEN-2023BI01237273$BIOGEN$$$$$M$Y$$$20240815$$CN$US$US
235427694$23542769$4$F$20240206$20240716$20240220$20240722$EXP$$US-BIOGEN-2024BI01250724$BIOGEN$$5$YR$$F$Y$$$20240722$$CN$US$US
235428222$23542822$2$F$$20240815$20240220$20240822$PER$$US-ALXN-202402USA000930US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
235428523$23542852$3$F$$20240806$20240220$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01160$LUPIN$$$$$$Y$$$20240828$$CN$US$US
235428684$23542868$4$F$20221001$20240715$20240220$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027076$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$74.39$KG$20240716$$CN$US$US
235428692$23542869$2$F$$20240709$20240220$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027041$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$48.99$KG$20240710$$CN$US$US
235428975$23542897$5$F$20231122$20240706$20240220$20240709$EXP$$IT-BAUSCH-BL-2024-002767$BAUSCH AND LOMB$$75$YR$$M$Y$57$KG$20240709$$MD$IT$IT
235429262$23542926$2$F$$20240830$20240220$20240904$EXP$$JP-ABBVIE-5643925$ABBVIE$$61$YR$$M$Y$$$20240904$$MD$JP$JP
235429342$23542934$2$F$$20240820$20240220$20240825$EXP$CA-DRL-USA-SPO/CAN/24/0002859$CA-RDY-SPO/CAN/24/0002859$DR REDDYS$$66$YR$E$F$Y$$$20240825$$HP$CA$CA
235429353$23542935$3$F$$20240820$20240220$20240826$EXP$CA-DRL-USA-SPO/CAN/24/0002903$CA-RDY-SPO/CAN/24/0002903$DR REDDYS$$5$YR$C$F$Y$$$20240826$$HP$CA$CA
235429544$23542954$4$F$20240118$20240824$20240220$20240830$EXP$$CO-GSK-CO2024AMR020382$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$CO$CO
235429952$23542995$2$F$$20240916$20240220$20240918$EXP$$AT-SANDOZ INC.-SDZ2024AT015515$SANDOZ$$$$A$M$Y$$$20240918$$HP$AT$AT
235429973$23542997$3$F$$20240916$20240220$20240925$EXP$$CA-CELLTRION INC.-2023CA024780$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
235430142$23543014$2$F$$20240816$20240220$20240828$EXP$$PL-Accord-407270$ACCORD$Welniak A, lipska P, Watola W, grabowska N, Jozefowicz M, Cazjkowski R. Toxic epidermal necrolysis: a study of 3 cases and review. Forum Dermatologicum. 2023,VOL 9 (NO 4):154-161$59$YR$A$M$Y$$$20240828$$MD$PL$PL
235430326$23543032$6$F$20220607$20240823$20240220$20240831$EXP$$CA-TAKEDA-2023TUS088558$TAKEDA$$75$YR$$F$Y$$$20240831$$MD$CA$CA
235430362$23543036$2$F$20240101$20240717$20240220$20240725$PER$$US-SA-2024SA051165$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240725$$MD$US$US
235430603$23543060$3$F$20240201$20240917$20240220$20240919$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-009280$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240919$$CN$US$US
235430682$23543068$2$F$$20240726$20240220$20240802$EXP$$JP-ROCHE-3512681$ROCHE$$8$DEC$E$F$Y$$$20240802$$PH$JP$JP
235431054$23543105$4$F$20231027$20240805$20240220$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027062$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$95.5$KG$20240813$$HP$US$US
235431132$23543113$2$F$20231001$20240628$20240220$20240706$EXP$$GR-CELLTRION INC.-2024GR003990$CELLTRION$$$$$$Y$$$20240706$$MD$GR$GR
235431203$23543120$3$F$$20240916$20240220$20240920$EXP$$US-JNJFOC-20240242776$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$LW$US$US
235431343$23543134$3$F$$20240912$20240220$20240920$EXP$$CA-TEVA-VS-3158373$TEVA$$28$YR$$F$Y$$$20240920$$HP$CA$CA
235431822$23543182$2$F$20230901$20240717$20240220$20240724$EXP$FR-AFSSAPS-TO2024000215$FR-SA-2024SA054776$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240724$$MD$FR$FR
235431834$23543183$4$F$20240101$20240813$20240220$20240821$PER$$US-SA-2024SA056382$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240821$$MD$US$US
235432044$23543204$4$F$20231201$20240717$20240220$20240724$EXP$$JP-ASTELLAS-2023JP013498$ASTELLAS$$7$DEC$$M$Y$$$20240724$$MD$JP$JP
235432246$23543224$6$F$20240123$20240722$20240220$20240729$EXP$$JP-ASTELLAS-2024JP000591$ASTELLAS$$77$YR$$M$Y$$$20240729$$MD$JP$JP
235432545$23543254$5$F$20230816$20240911$20240220$20240917$EXP$$NI-EMD Serono-2024008826$EMD SERONO INC$$55$YR$A$F$Y$$$20240917$$CN$NI$NI
235432632$23543263$2$F$$20240816$20240220$20240830$EXP$$TH-ASTELLAS-2024US005082$ASTELLAS$$$$E$$Y$$$20240830$$MD$TH$TH
235432733$23543273$3$F$$20240618$20240220$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01195$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235432922$23543292$2$F$$20240811$20240220$20240817$PER$$US-SA-2024SA051330$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240817$$MD$US$US
235432982$23543298$2$F$$20240826$20240220$20240916$PER$$US-SA-2024SA051259$SANOFI AVENTIS$$$$A$F$Y$72.5$KG$20240916$$MD$US$US
235433203$23543320$3$F$$20240814$20240220$20240828$PER$$US-SA-2024SA053008$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
235433233$23543323$3$F$20230101$20240830$20240220$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2023-028345$UNITED THERAPEUTICS$$$$$F$Y$115.65$KG$20240906$$$US$US
235433293$23543329$3$F$20231130$20240625$20240220$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-006781$AUROBINDO$$71$YR$$F$Y$$$20240703$$MD$FR$FR
235433563$23543356$3$F$$20240819$20240220$20240828$EXP$$CA-APOTEX-2020AP015867$APOTEX$$19$YR$$F$Y$72$KG$20240828$$HP$CA$CA
235433702$23543370$2$F$20231014$20240727$20240220$20240802$EXP$$NVSC2024IN034903$NOVARTIS$$58$YR$$M$Y$$$20240802$$CN$IN$IN
235433722$23543372$2$F$$20240805$20240220$20240808$EXP$$NVSC2023GB069373$NOVARTIS$$49$YR$$F$Y$$$20240808$$PH$GB$GB
235434362$23543436$2$F$20240216$20240627$20240220$20240702$PER$$US-AMGEN-USASP2024034160$AMGEN$$57$YR$A$M$Y$$$20240701$$CN$US$US
235434826$23543482$6$F$20240127$20240903$20240220$20240913$EXP$$US-SECURA BIO, INC.-2024-SECUR-US000019$PAREXEL$$$$$$Y$$$20240913$$HP$US$US
235435092$23543509$2$F$20220801$20240214$20240220$20240805$EXP$$NVSC2022CA176191$NOVARTIS$$53$YR$$M$Y$$$20240805$$CN$CA$CA
235435178$23543517$8$F$$20240821$20240220$20240830$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-01185$HIKMA$$61$YR$$M$Y$51.3$KG$20240830$$CN$US$US
235435282$23543528$2$F$20240115$20240731$20240220$20240807$EXP$FR-AFSSAPS-LM2024000067$FR-EMD Serono-2024008841$EMD SERONO INC$$69$YR$E$M$Y$90$KG$20240808$$MD$FR$FR
235435402$23543540$2$F$$20240709$20240220$20240720$EXP$$DE-TAKEDA-2022TUS002591$TAKEDA$$23$YR$$M$Y$$$20240720$$CN$DE$DE
235435572$23543557$2$F$20230701$20240624$20240220$20240708$EXP$$US-PROCTER_AND_GAMBLE-GS24016654$PROCTER AND GAMBLE$$57$YR$$F$Y$86.168$KG$20240708$$CN$US$US
235435724$23543572$4$F$$20240910$20240220$20240923$EXP$JP-MACLEODS PHARMACEUTICALS US LTD-MAC2024045910$JP-MACLEODS PHARMACEUTICALS US LTD-MAC2024045910$MACLEODS$Sasaki T, Mizoguchi K, Genda K, Endo S, Kondo Y, Mikami T, et al..Primary role of dextromethorphan in prolonged toxic encephalopathy with intermittent rhythmic slow-wave activity on electroencephalogram: A case report.Psychiatry and Clinical Neurosciences.2023;78(3):212-4$$$$$Y$$$20240923$$MD$JP$JP
235435902$23543590$2$F$20230713$20240717$20240220$20240724$EXP$CA-MMM-KUN9OGXV$CA-GSK-CA2023108007$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$CA$CA
235436368$23543636$8$F$20240101$20240827$20240220$20240904$EXP$$CA-CELLTRION INC.-2024CA004225$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
235437786$23543778$6$F$20240101$20240916$20240220$20240924$EXP$$US-ASTELLAS-2024US003799$ASTELLAS$$73$YR$E$F$Y$$$20240924$$CN$US$US
235438354$23543835$4$F$20240201$20240905$20240220$20240909$EXP$$CA-JNJFOC-20240242356$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240909$$HP$CA$CA
235438773$23543877$3$F$20240131$20240228$20240220$20240731$PER$$US-BAYER-2024A026838$BAYER$$24$YR$A$F$Y$$$20240731$$HP$US$US
235438972$23543897$2$F$20230801$20240719$20240220$20240723$EXP$$CA-UCBSA-2024007845$UCB$$25$YR$$F$Y$$$20240723$$MD$CA$CA
2354392311$23543923$11$F$20231201$20240923$20240220$20240928$EXP$$CA-JNJFOC-20231250070$JOHNSON AND JOHNSON$$28$YR$A$F$Y$78$KG$20240928$$HP$CA$CA
235439365$23543936$5$F$$20240812$20240220$20240820$EXP$$US-INSMED, INC.-2024-00528-US$INSMED$$$$$M$Y$$$20240820$$CN$US$US
235439732$23543973$2$F$20240101$20240718$20240220$20240722$PER$$US-AMGEN-USASP2024034069$AMGEN$$80$YR$E$F$Y$$$20240722$$CN$US$US
235439744$23543974$4$F$$20240812$20240220$20240820$PER$$US-SA-2024SA057481$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240820$$CN$US$US
235441172$23544117$2$F$20240124$20240708$20240220$20240715$EXP$FR-AFSSAPS-LL2024000232$FR-MYLANLABS-2024M1015115$MYLAN$$88$YR$$M$Y$$$20240715$$MD$FR$FR
235441246$23544124$6$F$20240101$20240731$20240220$20240731$EXP$$CA-PFIZER INC-202400041037$PFIZER$$80$YR$$M$Y$$$20240731$$HP$CA$CA
235441293$23544129$3$F$20240214$20240827$20240220$20240831$PER$$US-AMGEN-USASP2024033591$AMGEN$$58$YR$A$M$Y$$$20240831$$PH$US$US
235441995$23544199$5$F$20240101$20240829$20240220$20240913$PER$$US-SA-2024SA051137$SANOFI AVENTIS$$57$YR$A$F$Y$125$KG$20240913$$MD$US$US
235442033$23544203$3$F$20230928$20240701$20240220$20240708$EXP$$SA-GSK-SA2023EME139527$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$SA$SA
235442202$23544220$2$F$20231222$20240709$20240220$20240717$PER$$US-SA-2024SA053359$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240717$$MD$US$US
235442222$23544222$2$F$20240101$20240627$20240220$20240708$PER$$US-SA-2024SA055022$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240708$$MD$US$US
235442382$23544238$2$F$20240204$20240718$20240220$20240729$EXP$$US-SANDOZ INC.-SDZ2024US014934$SANDOZ$$67$YR$$M$Y$87.982$KG$20240729$$MD$US$US
235442554$23544255$4$F$20230801$20240828$20240220$20240904$PER$$US-VERTEX PHARMACEUTICALS-2024-002414$VERTEX$$5$YR$$M$Y$26$KG$20240904$$MD$US$US
235442662$23544266$2$F$20231213$20240803$20240220$20240814$EXP$$AU-TAKEDA-2023TUS121454$TAKEDA$$32$YR$$F$Y$$$20240814$$CN$AU$AU
235442742$23544274$2$F$20240201$20240718$20240220$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-001888$JAZZ$$62$YR$$M$Y$$$20240724$$MD$US$US
235443028$23544302$8$F$20210607$20240529$20240220$20240809$EXP$$NVSC2021US229314$NOVARTIS$$10$MON$$M$Y$8.3$KG$20240809$$HP$US$US
235443033$23544303$3$F$20231026$20240814$20240220$20240820$EXP$$CA-TAKEDA-2023TUS104632$TAKEDA$$23$YR$$M$Y$$$20240820$$CN$CA$CA
235443123$23544312$3$F$20240101$20240830$20240220$20240904$PER$$US-SA-2024SA057308$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240904$$MD$US$US
235443232$23544323$2$F$$20240116$20240220$20240808$EXP$$NVSC2023US254173$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
235443364$23544336$4$F$20230801$20240826$20240220$20240830$EXP$$CA-GSK-CA2023AMR087514$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$CA$CA
235443522$23544352$2$F$$20240624$20240220$20240701$EXP$$JP-009507513-2402JPN002317J$MERCK$$8$DEC$$M$Y$$$20240701$$MD$JP$JP
235443882$23544388$2$F$$20240717$20240220$20240725$PER$$US-Marksans Pharma Limited-2153413$MARKSANS$$$$$F$Y$$$20240725$$$US$US
235443913$23544391$3$F$$20240627$20240220$20240703$PER$$US-BIOGEN-2023BI01190458$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
235444603$23544460$3$F$20240124$20240819$20240220$20240820$EXP$$DE-ROCHE-3510291$ROCHE$$15$DY$N$F$Y$3.175$KG$20240820$$MD$DE$DE
235445133$23544513$3$F$20230702$20240729$20240220$20240801$EXP$$US-ABBVIE-5645066$ABBVIE$$64$YR$$F$Y$$$20240801$$CN$US$US
235445224$23544522$4$F$$20240710$20240220$20240712$EXP$$US-UCBSA-2024007776$UCB$$$$$F$Y$74.83$KG$20240712$$HP$US$US
235446002$23544600$2$F$$20240715$20240220$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027457$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240716$$CN$US$US
235446563$23544656$3$F$$20240820$20240220$20240822$PER$$US-PFIZER INC-PV202300206200$PFIZER$$45$YR$$F$Y$$$20240822$$HP$US$US
235446752$23544675$2$F$$20240806$20240220$20240809$PER$$US-PFIZER INC-PV202300122502$PFIZER$$89$YR$$F$Y$$$20240809$$CN$US$US
235446924$23544692$4$F$$20240724$20240220$20240729$PER$$US-PFIZER INC-PV202300195736$PFIZER$$78$YR$$F$Y$$$20240729$$MD$US$US
235447132$23544713$2$F$20231201$20240730$20240220$20240802$EXP$$US-PFIZER INC-202400041927$PFIZER$$68$YR$$M$Y$$$20240802$$HP$US$US
235447472$23544747$2$F$20240101$20240628$20240220$20240702$PER$$US-PFIZER INC-202400041865$PFIZER$$16$YR$$F$Y$$$20240702$$HP$US$US
235447784$23544778$4$F$20221201$20240819$20240220$20240829$EXP$$JP-009507513-2312JPN001100J$MERCK$$8$DEC$$M$Y$$$20240829$$MD$JP$JP
235448573$23544857$3$F$20240110$20240828$20240220$20240903$EXP$$GB-MYLANLABS-2024M1013334$MYLAN$$54$YR$$M$Y$98.3$KG$20240903$$MD$GB$GB
235448786$23544878$6$F$$20240911$20240220$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026980$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240913$$CN$US$US
235448912$23544891$2$F$20240101$20240403$20240220$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000048$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
235449023$23544902$3$F$20231206$20240716$20240220$20240719$EXP$$PH-OTSUKA-2024_003730$OTSUKA$$62$YR$$M$Y$$$20240719$$CN$PH$PH
235449246$23544924$6$F$20231230$20240827$20240220$20240830$EXP$$CA-JNJFOC-20231251404$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240830$$HP$CA$CA
235449513$23544951$3$F$20240213$20240815$20240220$20240821$PER$$US-BIOGEN-2024BI01251305$BIOGEN$$50$YR$$M$Y$$$20240821$$CN$US$US
235449664$23544966$4$F$20240401$20240716$20240220$20240718$EXP$$US-PFIZER INC-202400043108$PFIZER$$75$YR$$M$Y$56.689$KG$20240718$$HP$US$US
235450273$23545027$3$F$$20240301$20240220$20240906$EXP$$NVSC2024US034694$NOVARTIS$$40$YR$$F$Y$$$20240906$$MD$US$US
235450502$23545050$2$F$20240210$20240828$20240220$20240916$PER$$US-JNJFOC-20240239018$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240916$$CN$US$US
235450763$23545076$3$F$$20240718$20240220$20240722$PER$$US-PFIZER INC-PV202300103095$PFIZER$$79$YR$$M$Y$$$20240722$$CN$US$US
235451022$23545102$2$F$20240101$20240924$20240220$20240926$PER$$US-PFIZER INC-202400041460$PFIZER$$82$YR$$F$Y$89.36$KG$20240926$$CN$US$US
235451053$23545105$3$F$20240128$20240724$20240220$20240726$PER$$US-PFIZER INC-US-GBT-021304$PFIZER$$54$YR$$F$Y$60.78$KG$20240726$$HP$US$US
235451074$23545107$4$F$$20240814$20240220$20240820$PER$$US-PFIZER INC-PV202300203466$PFIZER$$71$YR$$M$Y$$$20240820$$MD$US$US
235451456$23545145$6$F$20231215$20240805$20240220$20240806$EXP$$US-PFIZER INC-202400042809$PFIZER$$53$YR$$F$Y$83.91$KG$20240806$$CN$US$US
235451623$23545162$3$F$20240209$20240809$20240220$20240815$PER$$US-AMGEN-USASP2024031449$AMGEN$$75$YR$E$M$Y$62.3$KG$20240815$$PH$US$US
2354519112$23545191$12$F$20240101$20240822$20240220$20240827$EXP$$JP-JNJFOC-20240225974$JOHNSON AND JOHNSON$$76$YR$E$M$Y$59$KG$20240827$$HP$JP$JP
235452053$23545205$3$F$20240204$20240424$20240220$20240911$EXP$$NVSC2024US025923$NOVARTIS$$48$YR$$F$Y$$$20240911$$CN$US$US
235452374$23545237$4$F$$20240723$20240220$20240726$EXP$$GB-MYLANLABS-2024M1013788$MYLAN$Wikeley S, Bacon I, Greer O, Evans M, Hasan R, Pathak S. New-onset movement disorder in the immediate postpartum period. BMJ case reports. 2023;16(12):e254132$3$DEC$$F$Y$$$20240726$$MD$GB$GB
235453002$23545300$2$F$$20240627$20240220$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01240$LUPIN$$$$$$Y$$$20240712$$CN$US$US
235453113$23545311$3$F$20240205$20240702$20240220$20240705$EXP$$NZ-PFIZER INC-202400044069$PFIZER$$78$YR$$F$Y$49$KG$20240705$$CN$NZ$NZ
235453332$23545333$2$F$20230101$20240906$20240220$20240911$EXP$$CA-PFIZER INC-202300114732$PFIZER$$44$YR$$M$Y$$$20240911$$HP$CA$CA
235453432$23545343$2$F$$20240213$20240220$20240807$EXP$$NVSC2023IE247502$NOVARTIS$$44$YR$$F$Y$$$20240807$$CN$IE$IE
235453547$23545354$7$F$20240213$20240816$20240220$20240823$EXP$$NVSC2022AU084974$NOVARTIS$$46$YR$$M$Y$$$20240823$$CN$AU$AU
235453972$23545397$2$F$20240101$20240712$20240220$20240722$EXP$$DE-009507513-2402DEU005388$MERCK$$63$YR$$M$Y$$$20240719$$PH$DE$DE
235454013$23545401$3$F$$20240717$20240220$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000351$BLUEPRINT MEDICINES$$$$$F$Y$$$20240726$$CN$US$US
235454604$23545460$4$F$$20240905$20240220$20240909$EXP$$US-PFIZER INC-PV202400023620$PFIZER$$53$YR$$F$Y$$$20240909$$CN$US$US
235455595$23545559$5$F$$20240813$20240220$20240828$EXP$$CA-VERTICAL PHARMACEUTICALS-2024ALO00036$Alora Pharma$$44$YR$$F$Y$70$KG$20240828$$HP$CA$CA
235456065$23545606$5$F$$20240819$20240220$20240905$EXP$$CA-ORGANON-O2402CAN001569$ORGANON$$65$YR$$M$Y$$$20240905$$HP$CA$CA
235457053$23545705$3$F$$20240919$20240220$20240926$EXP$$CA-TAKEDA-2024TUS015473$TAKEDA$$29$YR$$F$Y$52$KG$20240926$$HP$CA$CA
235457102$23545710$2$F$$20240730$20240220$20240802$EXP$CA-HEALTHCANVIG-001062185$CA-PURDUE-USA-2024-0307933$PURDUE$$43$YR$$F$Y$96$KG$20240802$$HP$CA$CA
235458237$23545823$7$F$$20240704$20240220$20240710$EXP$$PT-SANDOZ INC.-SDZ2024PT017250$SANDOZ$$$$E$$Y$$$20240710$$HP$PT$PT
235459332$23545933$2$F$20240205$20240722$20240220$20240731$EXP$$CL-ROCHE-3507985$ROCHE$$52$YR$A$F$Y$95$KG$20240731$$CN$CL$CL
235459362$23545936$2$F$20240101$20240725$20240220$20240729$EXP$$US-KYOWAKIRIN-2024KK002652$KYOWA$$$$$$Y$$$20240729$$HP$US$US
235459572$23545957$2$F$20240101$20240816$20240220$20240819$EXP$$US-KYOWAKIRIN-2024KK002639$KYOWA$$$$$$Y$$$20240819$$HP$US$US
235459995$23545999$5$F$20240101$20240722$20240220$20240731$EXP$$US-BEH-2024168579$CSL BEHRING$$60$YR$A$F$Y$$$20240731$$HP$US$US
235460184$23546018$4$F$$20240730$20240220$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024961$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$98.43$KG$20240801$$CN$US$US
235460313$23546031$3$F$$20240212$20240220$20240808$EXP$$US-OTSUKA-2024_003814$OTSUKA$$$$A$M$Y$$$20240808$$HP$US$US
235460532$23546053$2$F$$20240628$20240220$20240705$EXP$$JP-009507513-2402JPN002354J$MERCK$$8$DEC$$$Y$$$20240705$$MD$JP$JP
235460962$23546096$2$F$$20240815$20240220$20240821$EXP$$US-MYLANLABS-2020M1079633$MYLAN$$$$$M$Y$85.72$KG$20240821$$CN$US$US
235461025$23546102$5$F$20240201$20240626$20240220$20240702$EXP$$CA-OTSUKA-2024_004201$OTSUKA$$75$YR$$F$Y$$$20240702$$CN$CA$CA
235461137$23546113$7$F$$20240816$20240220$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027693$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$73.94$KG$20240826$$CN$US$US
235461212$23546121$2$F$20230816$20240729$20240220$20240806$EXP$$CA-Eisai-EC-2024-159598$EISAI$$70$YR$E$F$Y$$$20240806$$HP$CA$CA
235461732$23546173$2$F$20231128$20240705$20240220$20240715$EXP$IT-MINISAL02-961467$IT-TEVA-VS-3155649$TEVA$$13$YR$$F$Y$42$KG$20240715$$PH$IT$IT
235461884$23546188$4$F$20210401$20240701$20240220$20240703$EXP$$US-UCBSA-2024007291$UCB$$68$YR$$F$Y$$$20240703$$CN$US$US
235462182$23546218$2$F$20231107$20240820$20240220$20240830$EXP$FR-AFSSAPS-BR2023001100$FR-TEVA-VS-3156794$TEVA$$52$YR$$F$Y$$$20240830$$MD$FR$FR
235462994$23546299$4$F$$20240923$20240220$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025814$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240924$$CN$US$US
235463742$23546374$2$F$20231201$20240701$20240220$20240709$EXP$FR-AFSSAPS-NT2023001379$FR-TEVA-VS-3156459$TEVA$$66$YR$$F$Y$56$KG$20240709$$MD$FR$FR
235464092$23546409$2$F$20221101$20240710$20240220$20240717$EXP$$CA-GSK-CA2023AMR068580$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$HP$CA$CA
235464632$23546463$2$F$20240801$20240809$20240220$20240816$EXP$$US-GSK-US2024019842$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$US$US
235465182$23546518$2$F$$20240812$20240221$20240820$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00522$AMNEAL$$$$$M$Y$12.018$KG$20240820$$CN$US$US
235465344$23546534$4$F$20200101$20240216$20240221$20240719$EXP$$US-ABBVIE-5643274$ABBVIE$$$$$M$Y$$$20240719$$CN$US$US
235465362$23546536$2$F$20231101$20240704$20240221$20240725$PER$$CA-TOLMAR, INC.-24CA046466$TOLMAR$$72$YR$$M$Y$$$20240725$$CN$CA$CA
235465403$23546540$3$F$20240126$20240903$20240221$20240926$PER$$CA-TOLMAR, INC.-24CA046509$TOLMAR$$81$YR$$M$Y$$$20240926$$CN$CA$CA
235465412$23546541$2$F$20240101$20240712$20240221$20240730$PER$$CA-TOLMAR, INC.-24CA046507$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
235465433$23546543$3$F$20240126$20240712$20240221$20240730$PER$$CA-TOLMAR, INC.-24CA046516$TOLMAR$$80$YR$$M$Y$$$20240730$$CN$CA$CA
235466068$23546606$8$F$20231209$20240626$20240221$20240702$EXP$$JP-JNJFOC-20240257882$JOHNSON AND JOHNSON$$75$YR$E$F$Y$34$KG$20240702$$MD$JP$JP
235466173$23546617$3$F$20240215$20240728$20240221$20240730$PER$$US-AMGEN-USASP2024034710$AMGEN$$80$YR$E$F$Y$$$20240730$$HP$US$US
235466332$23546633$2$F$20240214$20240806$20240221$20240807$PER$$US-AMGEN-USASP2024033594$AMGEN$$70$YR$E$F$Y$$$20240807$$CN$US$US
235466742$23546674$2$F$20240215$20240716$20240221$20240719$PER$$US-AMGEN-USASP2024035158$AMGEN$$74$YR$E$M$Y$$$20240719$$CN$US$US
235466774$23546677$4$F$$20240808$20240221$20240813$EXP$$CA-ROCHE-3508211$ROCHE$$$$A$F$Y$$$20240813$$CN$CA$CA
235466793$23546679$3$F$20230101$20240903$20240221$20240913$EXP$$US-ROCHE-3512552$ROCHE$$85$YR$E$M$Y$$$20240913$$MD$US$US
235467205$23546720$5$F$20240101$20240702$20240221$20240709$EXP$$US-SA-2024SA053790$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240709$$CN$US$US
235467433$23546743$3$F$20210201$20240823$20240221$20240827$EXP$$DE-SANDOZ INC.-NVSC2022DE191969$SANDOZ$$$$A$M$Y$$$20240827$$MD$DE$DE
235467534$23546753$4$F$20231120$20240816$20240221$20240830$PER$$US-SA-2024SA056496$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240830$$MD$US$US
235467842$23546784$2$F$20231221$20240725$20240221$20240730$EXP$$AU-TAKEDA-2023TUS031574$TAKEDA$$62$YR$$F$Y$$$20240730$$CN$AU$AU
235468232$23546823$2$F$$20240703$20240221$20240705$EXP$$US-TAKEDA-2024TUS015543$TAKEDA$$$$$M$Y$$$20240705$$CN$US$US
235468282$23546828$2$F$$20240903$20240221$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024816$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240904$$HP$US$US
235468326$23546832$6$F$20240101$20240905$20240221$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-004676$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240912$$$US$US
235468403$23546840$3$F$20240215$20240731$20240221$20240802$PER$$US-AMGEN-USASP2024035298$AMGEN$$68$YR$E$F$Y$$$20240802$$MD$US$US
235468472$23546847$2$F$$20240621$20240221$20240702$PER$$US-SA-2024SA039510$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240702$$MD$US$US
235468577$23546857$7$F$20240101$20240731$20240221$20240807$EXP$$CA-CELLTRION INC.-2024CA001463$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
235468586$23546858$6$F$20240216$20240913$20240221$20240923$EXP$$JP-ASTELLAS-2024JP001268$ASTELLAS$$63$YR$A$M$Y$84$KG$20240923$$MD$JP$JP
235468596$23546859$6$F$20230101$20240705$20240221$20240713$EXP$$CA-CELLTRION INC.-2023CA015230$CELLTRION$$$$$$Y$$$20240713$$HP$CA$CA
235468723$23546872$3$F$20231001$20240624$20240221$20240704$EXP$$FR-DECIPHERA PHARMACEUTICALS LLC-2024FR000147$DECIPHERA PHARMACEUTICALS$$67$YR$A$M$Y$$$20240704$$MD$FR$FR
235469012$23546901$2$F$$20240207$20240221$20240906$EXP$$CN-NOVOPROD-1176494$NOVO NORDISK$JIANG Xuesong, LI Jia. Exogenous insulin autoimmune syndrome combined with mitochondrial diabetes mellitus: A case report and literature review. Academic Journal of Chinese PLA Medical School. 2024$35$YR$$M$Y$55$KG$20240906$$HP$CN$CN
235469197$23546919$7$F$20240101$20240709$20240221$20240718$EXP$$CA-CELLTRION INC.-2024CA004215$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
235470007$23547000$7$F$20240626$20240731$20240221$20240807$EXP$$CA-CELLTRION INC.-2023CA025495$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
235470282$23547028$2$F$$20240724$20240221$20240802$PER$$US-SA-2024SA053880$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240802$$MD$US$US
235470392$23547039$2$F$$20240718$20240221$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-027392$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240726$$PH$JP$JP
235470802$23547080$2$F$20231101$20240719$20240221$20240730$PER$$US-SA-2024SA056993$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240730$$MD$US$US
235470932$23547093$2$F$20230101$20240910$20240221$20240918$EXP$$CA-CELLTRION INC.-2023CA021716$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
235471432$23547143$2$F$20231223$20240703$20240221$20240711$EXP$$DE-CELLTRION INC.-2024DE003835$CELLTRION$$$$$$Y$$$20240711$$MD$DE$DE
235471465$23547146$5$F$20240101$20240912$20240221$20240924$EXP$$NL-ABBVIE-5624087$ABBVIE$$73$YR$$F$Y$$$20240924$$HP$NL$NL
235471612$23547161$2$F$20240101$20240821$20240221$20240824$PER$$US-AMGEN-USASP2024034254$AMGEN$$63$YR$A$F$Y$$$20240824$$HP$US$US
235471823$23547182$3$F$20231228$20240819$20240221$20240829$EXP$$JP-ABBVIE-5628935$ABBVIE$$71$YR$$M$Y$$$20240829$$MD$JP$JP
235472004$23547200$4$F$$20240719$20240221$20240723$PER$$US-JNJFOC-20240245718$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$CN$US$US
235472022$23547202$2$F$20240217$20240723$20240221$20240725$PER$$US-AMGEN-USASP2024035328$AMGEN$$85$YR$E$F$Y$$$20240725$$CN$US$US
235472072$23547207$2$F$20240115$20240215$20240221$20240813$EXP$$NVSC2024US029473$NOVARTIS$$74$YR$$M$Y$$$20240813$$HP$US$US
235472412$23547241$2$F$$20240715$20240221$20240722$EXP$$CA-GSK-CA2024AMR020959$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$CA$CA
235472503$23547250$3$F$$20240729$20240221$20240813$EXP$$US-862174955-ML2024-00795$MICRO LABS$$42$YR$A$F$Y$54.43$KG$20240813$$CN$US$US
235472582$23547258$2$F$20240216$20240920$20240221$20240924$PER$$US-AMGEN-USASP2024034451$AMGEN$$62$YR$A$F$Y$$$20240924$$CN$US$US
235472684$23547268$4$F$20240704$20240704$20240221$20240708$EXP$$CA-TAKEDA-2022TUS025997$TAKEDA$$43$YR$$F$Y$$$20240708$$HP$CA$CA
235472864$23547286$4$F$$20240910$20240221$20240920$EXP$$JP-Accord-407190$ACCORD$Sasaki T, Mizoguchi K, Genda K, Endo S, Kondo Y, Mikami T, et al. Primary role of dextromethorphan in prolonged toxic encephalopathy with intermittent rhythmic slow-wave activity on electroencephalogram: A case report. Psychiatry and Clinical Neurosciences. 2023.$19$YR$A$F$Y$55$KG$20240920$$MD$JP$JP
235473522$23547352$2$F$$20240912$20240221$20240920$EXP$$CA-TAKEDA-2024TUS015414$TAKEDA$$$$$M$Y$120$KG$20240920$$HP$CA$CA
235473703$23547370$3$F$$20240822$20240221$20240828$EXP$$JP-GSK-JP2024JPN013804$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$JP$JP
235473932$23547393$2$F$$20240826$20240221$20240904$EXP$$CA-APOTEX-2024AP002329$APOTEX$$80$YR$$F$Y$$$20240904$$CN$CA$CA
235473964$23547396$4$F$20240201$20240723$20240221$20240730$EXP$$US-SA-2024SA058666$SANOFI AVENTIS$$$$E$F$Y$54$KG$20240730$$MD$US$US
235473974$23547397$4$F$20230301$20240508$20240221$20240926$EXP$$US-GSK-US2024AMR021102$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
235473982$23547398$2$F$20240122$20240214$20240221$20240926$PER$$US-GSK-US2024AMR020371$GLAXOSMITHKLINE$$63$YR$$M$Y$$$20240926$$CN$US$US
235474004$23547400$4$F$$20240318$20240221$20240926$EXP$$US-GSK-US2024AMR020753$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
235474115$23547411$5$F$20230101$20240708$20240221$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-009592$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240712$$CN$US$US
235474124$23547412$4$F$20230905$20240729$20240221$20240731$EXP$$ES-JNJFOC-20240167329$JOHNSON AND JOHNSON$$70$YR$E$F$Y$106$KG$20240801$$PH$ES$ES
235474173$23547417$3$F$20240213$20240806$20240221$20240814$EXP$$CA-CELLTRION INC.-2024CA004342$CELLTRION$$$$$$Y$$$20240814$$HP$CA$CA
235474504$23547450$4$F$20240101$20240709$20240221$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027195$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240718$$CN$US$US
235474716$23547471$6$F$20230721$20240903$20240221$20240906$EXP$$JP-ABBVIE-5643180$ABBVIE$Kondo Y. 70 A case of pneumocystis pneumonia with onset after administration of upadacitinib for?severe ulcerative colitis. The 344th Kyushu Regional Meeting of the Japanese Society of Internal Medicine (2024).; Kondo Y. 70 A case of pneumocystis pneumonia developed after administration of Upadacitinib for severe colitis ulcerative. The 344th Kyushu branch meeting of the Japanese Society of Internal Medicine (2024).$45$YR$$M$Y$80$KG$20240906$$MD$JP$JP
235474752$23547475$2$F$20240101$20240819$20240221$20240824$EXP$$GB-ROCHE-3161891$ROCHE$$25$YR$A$F$Y$$$20240824$$HP$GB$GB
235475292$23547529$2$F$20201130$20240802$20240221$20240805$EXP$$AT-ROCHE-3511326$ROCHE$$63$YR$A$F$Y$55$KG$20240805$$MD$AT$AT
235475663$23547566$3$F$$20240711$20240221$20240718$EXP$$NL-AUROBINDO-AUR-APL-2024-007012$AUROBINDO$$74$YR$$M$Y$76$KG$20240718$$CN$NL$NL
235476162$23547616$2$F$$20240828$20240221$20240829$EXP$$US-TAKEDA-2023TUS086704$TAKEDA$$$$$F$Y$$$20240829$$CN$US$US
235476922$23547692$2$F$$20240617$20240221$20240702$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-431909$RANBAXY$Redecker TM, Jeung-Maarse H, Brandt C. Panic disorder in epilepsy. Epilepsy Behav Rep. 2024;25:1-6$51$YR$$F$Y$$$20240702$$MD$DE$DE
235477222$23547722$2$F$$20240630$20240221$20240703$EXP$$JP-ABBVIE-5588358$ABBVIE$$$$$F$Y$$$20240703$$PH$JP$JP
235477422$23547742$2$F$20230329$20240709$20240221$20240718$EXP$$JP-ROCHE-3511926$ROCHE$$66$YR$E$M$Y$$$20240718$$MD$JP$JP
235477642$23547764$2$F$$20240710$20240221$20240730$PER$$CA-TOLMAR, INC.-24CA046408$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
235478012$23547801$2$F$$20240214$20240221$20240722$EXP$$CA-GSK-CA2024AMR020472$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$HP$CA$CA
235478335$23547833$5$F$$20240805$20240221$20240810$EXP$$GB-TAKEDA-2024TUS015375$TAKEDA$$$$$F$Y$$$20240810$$CN$GB$GB
235478752$23547875$2$F$20231022$20240206$20240221$20240722$EXP$FR-AFSSAPS-AVPO2023000255$FR-TEVA-VS-3155009$TEVA$$17$YR$$F$Y$68$KG$20240722$$PH$FR$FR
235478832$23547883$2$F$20240101$20240806$20240221$20240808$EXP$$CA-JNJFOC-20240140403$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240808$$HP$CA$CA
235478944$23547894$4$F$20240412$20240618$20240221$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000433$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240712$$CN$US$US
235478984$23547898$4$F$20230101$20240823$20240221$20240903$EXP$$US-INSMED, INC.-2023-04770-US$INSMED$$$$$F$Y$$$20240903$$CN$US$US
235479343$23547934$3$F$$20240319$20240221$20240808$EXP$$NVSC2024US033379$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
235479623$23547962$3$F$$20240509$20240221$20240925$EXP$$CA-TEVA-VS-3149967$TEVA$$65$YR$$M$Y$96$KG$20240925$$CN$CA$CA
235479703$23547970$3$F$20240214$20240730$20240221$20240808$EXP$$CA-JNJFOC-20240115567$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240808$$CN$CA$CA
235481214$23548121$4$F$$20240628$20240221$20240701$30DAY$$US-PFIZER INC-PV202400014002$PFIZER$$52$YR$$F$Y$$$20240701$$CN$US$US
235481414$23548141$4$F$20240101$20240827$20240221$20240829$EXP$$NVSC2024GB018731$NOVARTIS$$52$YR$$M$Y$$$20240829$$CN$GB$GB
235481682$23548168$2$F$20240109$20240702$20240221$20240710$EXP$$JP-009507513-2402JPN002685J$MERCK$$74$YR$$M$Y$$$20240710$$MD$JP$JP
235481952$23548195$2$F$$20240814$20240221$20240821$EXP$$CA-GSK-CA2023122390$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$CA$CA
235482342$23548234$2$F$20240108$20240827$20240221$20240830$EXP$$NVSC2024KZ034068$NOVARTIS$$58$YR$$F$Y$68$KG$20240830$$MD$KZ$KZ
235482443$23548244$3$F$20230408$20240918$20240221$20240927$EXP$$IT-AUROBINDO-AUR-APL-2024-007107$AUROBINDO$$65$YR$$F$Y$$$20240927$$MD$IT$IT
235482464$23548246$4$F$20240711$20240712$20240221$20240716$PER$$US-TRAVERE-2024TVT00148$TRAVERE THERAPEUTICS$$71$YR$E$M$Y$$$20240716$$CN$US$US
235482792$23548279$2$F$20240215$20240705$20240221$20240712$EXP$$GB-ALXN-202402GBR001154GB$ALEXION PHARMACEUTICALS$$59$YR$$$Y$$$20240712$$MD$GB$GB
235482843$23548284$3$F$$20240704$20240221$20240712$EXP$$US-ABBVIE-5644756$ABBVIE$Senchyna F, Murugesan K, Rotunno W, Nadimpalli SS, Deresinski S, Banaei N. Sequential treatment failure with aztreonam-ceftazidime-avibactam followed by cefiderocol due to preexisting and acquired mechanisms in a new delhi metallo- -lactamase-producing escherichia coli causing fatal bloodstream infection. Clinical Infectious Diseases. 2024;78(6):1425-8.$12$YR$$M$Y$$$20240712$$HP$US$US
235482903$23548290$3$F$20230101$20240805$20240221$20240822$PER$$US-CHIESI-2023CHF06475$CHIESI$$$$$F$Y$$$20240822$$HP$US$US
235482958$23548295$8$F$20230101$20240628$20240221$20240704$EXP$$CA-JNJFOC-20230618636$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240704$$HP$CA$CA
235483704$23548370$4$F$$20240828$20240221$20240904$EXP$$CA-JNJFOC-20240239721$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$HP$CA$CA
235483886$23548388$6$F$20220101$20240816$20240221$20240828$EXP$$CA-UCBSA-2022033683$UCB$$$$$M$Y$$$20240829$$HP$CA$CA
235484115$23548411$5$F$$20240904$20240221$20240913$EXP$$US-ROCHE-3509098$ROCHE$$65$YR$E$F$Y$164.2$KG$20240913$$CN$US$US
2354846610$23548466$10$F$20240101$20240911$20240221$20240919$EXP$$CA-CELLTRION INC.-2024CA004124$CELLTRION$$$$$$Y$$$20240919$$CN$CA$CA
235484872$23548487$2$F$20230927$20240804$20240221$20240805$EXP$$NVSJ2023JP018635$NOVARTIS$$$$A$F$Y$$$20240806$$CN$JP$JP
235486023$23548602$3$F$20240129$20240906$20240221$20240924$PER$$CA-TOLMAR, INC.-24CA046544$TOLMAR$$73$YR$$M$Y$$$20240924$$CN$CA$CA
235486043$23548604$3$F$$20240716$20240221$20240808$PER$$CA-TOLMAR, INC.-24CA046555$TOLMAR$$$$$M$Y$$$20240808$$CN$CA$CA
235486447$23548644$7$F$20240206$20240920$20240221$20240924$EXP$$GB-SANDOZ INC.-SDZ2024GB013187$SANDOZ$$66$YR$$F$Y$$$20240924$$CN$GB$GB
235488092$23548809$2$F$$20240717$20240221$20240722$EXP$$US-PFIZER INC-202400027047$PFIZER$$69$YR$$F$Y$$$20240722$$HP$US$US
235488142$23548814$2$F$20240809$20240905$20240221$20240910$EXP$$US-PFIZER INC-PV202400024275$PFIZER$$93$YR$$M$Y$$$20240910$$CN$US$US
235488783$23548878$3$F$$20240820$20240221$20240827$EXP$$SA-PFIZER INC-202400045726$PFIZER$Alnuhait, M.. Case Series: Sacubitril/Valsartan Role for Chemotherapy-Induced Cardiotoxicity: An in-Depth Investigation in Saudi Arabia.. International Medical Case Reports Journal. 2024;17:35-41$67$YR$$F$Y$$$20240827$$PH$SA$SA
235488954$23548895$4$F$20220101$20240809$20240221$20240813$EXP$$NVSC2024US034475$NOVARTIS$$$$$F$Y$$$20240813$$CN$US$US
235489069$23548906$9$F$20240208$20240624$20240221$20240701$EXP$$US-PFIZER INC-202400044528$PFIZER$$88$YR$$F$Y$95.3$KG$20240701$$CN$US$US
235489143$23548914$3$F$20231103$20240709$20240221$20240711$EXP$ES-AEMPS-1486477$ES-PFIZER INC-202400043567$PFIZER$$55$YR$$F$Y$$$20240711$$MD$ES$ES
235490023$23549002$3$F$20240213$20240725$20240221$20240730$PER$$US-JAZZ PHARMACEUTICALS-2022-US-036592$JAZZ$$54$YR$$F$Y$$$20240730$$HP$US$US
235490283$23549028$3$F$20230501$20240806$20240221$20240806$EXP$SE-SEMPA-2024-001201$SE-PFIZER INC-202400044989$PFIZER$$18$YR$$M$Y$80$KG$20240806$$CN$SE$SE
235490624$23549062$4$F$20201230$20240921$20240221$20240926$EXP$$IN-PFIZER INC-2019181756$PFIZER$$66$YR$$F$Y$79$KG$20240926$$CN$IN$IN
235491043$23549104$3$F$20240208$20240912$20240221$20240921$EXP$$JP-ROCHE-3511230$ROCHE$$8$DEC$E$M$Y$60$KG$20240921$$MD$JP$JP
235491253$23549125$3$F$20240101$20240627$20240221$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028194$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$81.19$KG$20240701$$CN$US$US
235491702$23549170$2$F$20231003$20240807$20240221$20240815$EXP$FR-AFSSAPS-LY2023001981$FR-TEVA-VS-3156260$TEVA$$27$YR$$F$Y$$$20240815$$MD$FR$FR
235491802$23549180$2$F$20231001$20240918$20240221$20240920$PER$$US-PFIZER INC-202400045462$PFIZER$$44$YR$$F$Y$$$20240920$$HP$US$US
235492502$23549250$2$F$$20240729$20240221$20240731$PER$$US-PFIZER INC-PV202400023029$PFIZER$$78$YR$$F$Y$$$20240731$$CN$US$US
235492764$23549276$4$F$$20240708$20240221$20240711$EXP$$US-PFIZER INC-202400042044$PFIZER$$76$YR$$F$Y$$$20240711$$HP$US$US
235493067$23549306$7$F$20240801$20240926$20240221$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028083$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240930$$CN$US$US
235493292$23549329$2$F$20240123$20240514$20240221$20240913$EXP$GB-MHRA-MED-202402091855469740-PWGRV$GB-TEVA-VS-3157634$TEVA$$63$YR$$F$Y$71$KG$20240913$$MD$GB$GB
235493362$23549336$2$F$$20240911$20240221$20240916$EXP$$US-TAKEDA-2024TUS015894$TAKEDA$$$$$M$Y$$$20240916$$CN$US$US
235493462$23549346$2$F$20240213$20240809$20240221$20240812$PER$$US-AMGEN-USASP2024034403$AMGEN$$67$YR$E$F$Y$$$20240812$$CN$US$US
235493542$23549354$2$F$20220815$20240916$20240221$20240917$EXP$$NVSC2024DE027101$NOVARTIS$$$$E$F$Y$69.5$KG$20240917$$HP$DE$DE
235493572$23549357$2$F$20230916$20240712$20240221$20240715$EXP$$DE-DSJP-DSE-2024-107825$DAIICHI$$50$YR$$F$Y$73$KG$20240715$$PH$DE$DE
235493852$23549385$2$F$20240101$20240801$20240221$20240809$EXP$$JP-009507513-2402JPN002333J$MERCK$$4$DEC$$F$Y$$$20240809$$MD$JP$JP
2354946110$23549461$10$F$20240101$20240807$20240221$20240819$EXP$$US-INSMED, INC.-2024-00622-US$INSMED$$$$$F$Y$$$20240819$$CN$US$US
235494744$23549474$4$F$20230201$20240920$20240221$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025183$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240924$$CN$US$US
235494862$23549486$2$F$20230808$20240726$20240221$20240729$EXP$$DE-SANDOZ INC.-SDZ2024DE017265$SANDOZ$$69$YR$$M$Y$$$20240729$$MD$DE$DE
235495094$23549509$4$F$20220401$20240909$20240221$20240911$EXP$$PL-SANDOZ INC.-NVSC2023PL039018$SANDOZ$$65$YR$$F$Y$66.5$KG$20240911$$MD$PL$PL
235495253$23549525$3$F$20231013$20240710$20240221$20240715$EXP$$AU-TAKEDA-2023TUS071492$TAKEDA$$34$YR$$F$Y$$$20240715$$CN$AU$AU
235495474$23549547$4$F$20220722$20240802$20240221$20240808$EXP$$AU-TAKEDA-2021TUS001489$TAKEDA$$51$YR$$F$Y$$$20240808$$HP$AU$AU
235495877$23549587$7$F$20230816$20240826$20240221$20240909$EXP$$US-UCBSA-2023053977$UCB$$0$YR$$F$Y$9.524$KG$20240909$$CN$US$US
235496193$23549619$3$F$20230101$20240626$20240221$20240709$EXP$$JP-JNJFOC-20240200232$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240709$$MD$JP$JP
235496944$23549694$4$F$20240219$20240709$20240221$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028140$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$$$20240715$$CN$US$US
235496982$23549698$2$F$$20240715$20240221$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028253$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240717$$CN$US$US
235497225$23549722$5$F$20240120$20240814$20240221$20240815$PER$$NVSC2024US036751$NOVARTIS$$57$YR$$F$Y$$$20240816$$CN$US$US
235497273$23549727$3$F$20240131$20240628$20240221$20240705$EXP$$JP-AMGEN-JPNSP2024034712$AMGEN$$66$YR$E$M$Y$63.4$KG$20240704$$MD$JP$JP
235497304$23549730$4$F$20240112$20240709$20240221$20240723$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-04985$SAMSUNG BIOEPIS$$66$YR$E$F$Y$$$20240723$$HP$CA$CA
235497383$23549738$3$F$$20240730$20240221$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027312$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240801$$CN$US$US
235497622$23549762$2$F$20120101$20240825$20240221$20240904$EXP$DE-CADRBFARM-2023325038$DE-TEVA-VS-3156338$TEVA$$59$YR$$M$Y$84$KG$20240904$$CN$DE$DE
235497643$23549764$3$F$$20240827$20240221$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027904$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240830$$HP$US$US
235497688$23549768$8$F$20240420$20240806$20240221$20240807$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-108135$DAIICHI$$30$YR$$F$Y$$$20240807$$CN$US$US
235500112$23550011$2$F$$20240702$20240221$20240710$EXP$$FR-AstraZeneca-2023A136231$ASTRAZENECA$$$$$M$Y$95$KG$20240710$$MD$FR$
235500452$23550045$2$F$$20240708$20240221$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027183$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$81.56$KG$20240711$$CN$US$US
235500877$23550087$7$F$$20240718$20240221$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024812$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240731$$CN$US$US
235503023$23550302$3$F$$20240813$20240221$20240821$EXP$$AU-JNJFOC-20240238255$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240821$$HP$AU$AU
235503172$23550317$2$F$$20240723$20240221$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027778$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240729$$HP$US$US
235503194$23550319$4$F$20240313$20240805$20240221$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024862$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240807$$CN$US$US
235503212$23550321$2$F$$20240806$20240221$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027458$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240807$$CN$US$US
235503315$23550331$5$F$20221115$20240708$20240221$20240711$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202401007412$ELI LILLY AND CO$$51$YR$A$F$Y$48$KG$20240711$$MD$JP$JP
235503382$23550338$2$F$20240212$20240709$20240221$20240720$PER$$US-TAKEDA-2024TUS013424$TAKEDA$$54$YR$$M$Y$73$KG$20240720$$MD$US$US
235503393$23550339$3$F$$20240820$20240221$20240822$EXP$$US-INCYTE CORPORATION-2024IN001749$INCYTE$$$$$$Y$$$20240822$$CN$US$US
235503485$23550348$5$F$20240201$20240712$20240221$20240716$EXP$$US-JNJFOC-20240228730$JOHNSON AND JOHNSON$$70$YR$E$F$Y$90.346$KG$20240716$$CN$US$US
235503843$23550384$3$F$$20240722$20240221$20240727$EXP$$CA-ABBVIE-5647378$ABBVIE$$$$$M$Y$$$20240727$$HP$CA$CA
235504214$23550421$4$F$20240102$20240704$20240221$20240711$EXP$$ES-MYLANLABS-2024M1015686$MYLAN$$53$YR$$F$Y$$$20240711$$PH$ES$ES
235504654$23550465$4$F$20221021$20240808$20240221$20240809$PER$$PR-JNJFOC-20240256829$JOHNSON AND JOHNSON$$64$YR$A$M$Y$89$KG$20240809$$CN$PR$PR
235504843$23550484$3$F$20240101$20240924$20240221$20240927$EXP$$CO-SANDOZ INC.-SDZ2024CO017407$SANDOZ$$$$$F$Y$89$KG$20240927$$CN$CO$CO
235505214$23550521$4$F$$20240627$20240221$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022930$BRISTOL MYERS SQUIBB$$6$YR$C$F$Y$$$20240702$$CN$US$US
235505417$23550541$7$F$20240301$20240812$20240221$20240818$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-027036$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$88$KG$20240819$$CN$PR$PR
235505476$23550547$6$F$$20240621$20240221$20240703$EXP$$NVSC2023AU255637$NOVARTIS$$$$$F$Y$138$KG$20240703$$HP$AU$AU
235505742$23550574$2$F$20240209$20240803$20240221$20240816$PER$$US-BEH-2024168700$CSL BEHRING$$47$YR$A$M$Y$$$20240816$$HP$US$US
235506182$23550618$2$F$20230322$20240717$20240221$20240725$EXP$$IN-INCYTE CORPORATION-2024IN001790$INCYTE$$$$$$Y$$$20240725$$CN$IN$IN
235506253$23550625$3$F$20240314$20240920$20240221$20240930$EXP$$US-BEH-2024168914$CSL BEHRING$$29$YR$A$M$Y$$$20240930$$MD$US$US
2355062710$23550627$10$F$20240118$20240825$20240221$20240827$EXP$$FR-BAUSCH-BL-2024-002716$BAUSCH AND LOMB$$57$YR$$M$Y$90$KG$20240827$$HP$FR$FR
235506597$23550659$7$F$20231101$20240919$20240221$20240924$EXP$$CA-LUNDBECK-DKLU3073001$LUNDBECK$$$$$$Y$$$20240924$$HP$CA$CA
235506652$23550665$2$F$20230926$20240529$20240221$20240725$PER$$US-LUNDBECK-DKLU3073636$LUNDBECK$$$$$$Y$$$20240725$$CN$US$US
235506824$23550682$4$F$$20240808$20240221$20240812$EXP$$GB-SANDOZ INC.-NVSC2023GB062902$SANDOZ$$$$$M$Y$$$20240812$$CN$GB$GB
235507262$23550726$2$F$20231201$20240708$20240221$20240716$EXP$$JP-009507513-2402JPN002329J$MERCK$$7$DEC$$M$Y$$$20240716$$MD$JP$JP
235507762$23550776$2$F$$20240705$20240221$20240710$EXP$$CA-JNJFOC-20240241940$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240710$$HP$CA$CA
235508527$23550852$7$F$20200618$20240916$20240221$20240925$EXP$$CA-CELLTRION INC.-2020CA022030$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
235508595$23550859$5$F$$20240626$20240221$20240701$EXP$$US-TAKEDA-2021TUS071374$TAKEDA$$$$$F$Y$48$KG$20240701$$MD$US$US
235508813$23550881$3$F$20240207$20240807$20240221$20240813$EXP$$GB-ABBVIE-5646629$ABBVIE$$63$YR$$M$Y$68.5$KG$20240813$$MD$GB$GB
235509045$23550904$5$F$20240301$20240628$20240221$20240703$EXP$$CA-TAKEDA-2024TUS015239$TAKEDA$$38$YR$$M$Y$$$20240703$$HP$CA$CA
235509712$23550971$2$F$20231001$20240729$20240221$20240805$EXP$$US-AMGEN-USASP2024035466$AMGEN$$79$YR$E$F$Y$$$20240805$$CN$US$US
235509782$23550978$2$F$20240201$20240625$20240221$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026767$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240704$$PH$US$US
235509852$23550985$2$F$$20240214$20240222$20240926$PER$$US-GSK-US2024AMR021331$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
235509992$23550999$2$F$$20240214$20240222$20240926$PER$$US-GSK-US2024AMR021329$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
235510133$23551013$3$F$20240209$20240710$20240222$20240716$EXP$$NVSC2024US031208$NOVARTIS$$44$YR$$F$Y$$$20240716$$CN$US$US
235510192$23551019$2$F$20240116$20240717$20240222$20240809$PER$$AU-TOLMAR, INC.-24AU046148$TOLMAR$$76$YR$$M$Y$$$20240809$$MD$AU$AU
235510284$23551028$4$F$20240101$20240912$20240222$20240918$EXP$$NL-ABBVIE-5648410$ABBVIE$$70$YR$$M$Y$$$20240918$$HP$NL$NL
235510612$23551061$2$F$20181022$20240613$20240222$20240703$EXP$$DE-ROCHE-2841776$ROCHE$$68$YR$E$M$Y$89$KG$20240703$$CN$DE$DE
235510814$23551081$4$F$20231101$20240725$20240222$20240731$EXP$$US-ABBVIE-5648399$ABBVIE$$76$YR$$F$Y$68$KG$20240731$$CN$US$US
235511274$23551127$4$F$$20240819$20240222$20240827$EXP$$CA-APOTEX-2024AP002395$APOTEX$$69$YR$$F$Y$$$20240827$$MD$CA$CA
235511282$23551128$2$F$$20240917$20240222$20240924$EXP$CA-DRL-USA-SPO/CAN/24/0002885$CA-RDY-SPO/CAN/24/0002885$DR REDDYS$$67$YR$E$F$Y$73$KG$20240924$$MD$CA$CA
235511517$23551151$7$F$$20240703$20240222$20240704$EXP$$DE-JNJFOC-20240259233$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$CN$DE$DE
235511652$23551165$2$F$$20240628$20240222$20240703$30DAY$$US-GSK-US2024019834$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
235511833$23551183$3$F$20240207$20240820$20240222$20240823$PER$$US-AMGEN-USASP2024034655$AMGEN$$60$YR$A$M$Y$$$20240822$$CN$US$US
235511852$23551185$2$F$$20240812$20240222$20240814$EXP$$FR-JNJFOC-20240248184$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$MD$FR$FR
235511863$23551186$3$F$20230807$20240918$20240222$20240926$EXP$$NVSC2024US036185$NOVARTIS$$71$YR$$F$Y$65$KG$20240926$$HP$US$US
235511977$23551197$7$F$$20240909$20240222$20240923$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK089057$GLENMARK$$$$$$Y$$$20240923$$HP$CA$CA
235512164$23551216$4$F$$20240806$20240222$20240807$PER$$US-ALXN-202402USA001208US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
235512763$23551276$3$F$20231227$20240716$20240222$20240723$EXP$$GB-JNJFOC-20240251140$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20240723$$HP$GB$GB
235513109$23551310$9$F$$20240730$20240222$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027393$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240806$$CN$US$US
235513113$23551311$3$F$20230128$20240821$20240222$20240901$EXP$$PK-AMGEN-PAKSP2021210215$AMGEN$$57$YR$A$F$Y$$$20240901$$CN$PK$PK
235513135$23551313$5$F$20240101$20240906$20240222$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-027446$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240913$$MD$JP$JP
235513762$23551376$2$F$$20240627$20240222$20240708$EXP$$US-ROCHE-3510005$ROCHE$$88$YR$E$F$Y$$$20240708$$CN$US$US
235514564$23551456$4$F$20170418$20240711$20240222$20240720$EXP$$IT-CELLTRION INC.-2021IT008292$CELLTRION$$$$$$Y$$$20240720$$MD$IT$IT
235514622$23551462$2$F$$20240626$20240222$20240703$PER$$US-ALXN-202402USA001245US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
235514692$23551469$2$F$$20240916$20240222$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020675$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240923$$CN$US$US
235515283$23551528$3$F$20231113$20240306$20240222$20240926$PER$$US-ALK-ABELLO A/S-2024AA000659$ALK-ABELLO$$$$$$Y$$$20240926$$HP$US$US
235515342$23551534$2$F$$20240729$20240222$20240807$PER$$US-RDY-SPO/USA/24/0002465$DR REDDYS$$33$YR$A$F$Y$$$20240808$$MD$US$US
235516233$23551623$3$F$$20240911$20240222$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024758$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240912$$CN$US$US
235516612$23551661$2$F$$20240708$20240222$20240821$PER$$US-LUNDBECK-DKLU3073702$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
235517464$23551746$4$F$$20240813$20240222$20240814$PER$$US-AMGEN-USASP2024035954$AMGEN$$$$$M$Y$$$20240814$$CN$US$US
235518082$23551808$2$F$$20240716$20240222$20240719$EXP$$JP-GSK-JP2024JPN022249$GLAXOSMITHKLINE$Kadoguchi H, Kobayashi K, Yamamoto H, Tane S, Matsuda W, Sasaki R, et al. D-14 A case of lethal arrhythmia confirmed by LC/MS/MS drug toxicology screening as lamotrigine and atomoxetine poisoning. Journal of the Kanto Regional Meeting of the Japanese Association of Acute Medic. 2024;45:76$$$$$Y$$$20240719$$MD$JP$JP
235518143$23551814$3$F$20240212$20240821$20240222$20240829$30DAY$$US-GSK-US2024018897$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240829$$CN$US$US
235518192$23551819$2$F$$20240713$20240222$20240802$PER$$CA-TOLMAR, INC.-24CA046497$TOLMAR$$$$$M$Y$$$20240802$$CN$CA$CA
235518395$23551839$5$F$20240214$20240807$20240222$20240808$EXP$$NVSC2024DE036933$NOVARTIS$$$$A$F$Y$109$KG$20240808$$MD$DE$DE
235518913$23551891$3$F$20180511$20240703$20240222$20240709$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2024JPN022868$VIIV$$$$$$Y$$$20240709$$MD$JP$JP
235519393$23551939$3$F$20240309$20240725$20240222$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202402012692$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240729$$CN$US$US
235519953$23551995$3$F$20240202$20240730$20240222$20240801$EXP$$JP-TAKEDA-2024TJP002768$TAKEDA$$$$$$Y$$$20240801$$MD$JP$JP
235520765$23552076$5$F$20240216$20240729$20240222$20240801$EXP$$US-TAKEDA-2024TUS016236$TAKEDA$$42$YR$$F$Y$59$KG$20240801$$MD$US$US
235521023$23552102$3$F$20240208$20240626$20240222$20240701$PER$$US-AMGEN-USASP2024035240$AMGEN$$68$YR$E$M$Y$$$20240701$$CN$US$US
235521106$23552110$6$F$20231115$20240917$20240222$20240927$EXP$$US-TEVA-VS-3138743$TEVA$$23$YR$$F$Y$$$20240927$$HP$US$US
235521142$23552114$2$F$20231214$20240726$20240222$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-007313$AUROBINDO$$62$YR$$F$Y$57$KG$20240807$$HP$FR$FR
235521594$23552159$4$F$20240211$20240702$20240222$20240703$EXP$$NVSC2024ZA031804$NOVARTIS$$45$YR$$M$Y$75$KG$20240703$$HP$ZA$ZA
235523243$23552324$3$F$$20240627$20240222$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202402012031$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240709$$CN$US$US
235524052$23552405$2$F$20240215$20240904$20240222$20240905$PER$$US-AMGEN-USASP2024033898$AMGEN$$67$YR$E$F$Y$$$20240905$$CN$US$US
235524485$23552448$5$F$$20240815$20240222$20240823$EXP$$CA-ROCHE-2643794$ROCHE$$$$A$F$Y$$$20240823$$CN$CA$CA
235524613$23552461$3$F$20240101$20240903$20240222$20240909$EXP$$NL-ABBVIE-5593516$ABBVIE$$79$YR$$M$Y$$$20240909$$CN$NL$NL
235524764$23552476$4$F$$20240730$20240222$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027949$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$49.44$KG$20240731$$CN$US$US
235524876$23552487$6$F$20240101$20240911$20240222$20240919$EXP$$CA-CELLTRION INC.-2024CA000940$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
235524894$23552489$4$F$20230515$20240822$20240222$20240830$EXP$$US-ABBVIE-5584830$ABBVIE$$66$YR$$M$Y$95$KG$20240830$$CN$US$US
235525055$23552505$5$F$20230808$20240716$20240222$20240723$EXP$$NVSC2023KR230051$NOVARTIS$$51$YR$$M$Y$87.3$KG$20240723$$MD$KR$KR
235525217$23552521$7$F$20240206$20240617$20240222$20240813$EXP$$NVSC2024CA035513$NOVARTIS$$48$YR$$F$Y$$$20240813$$MD$CA$CA
235525603$23552560$3$F$20240131$20240912$20240222$20240917$30DAY$$KR-PFIZER INC-PV202400014804$PFIZER$$10$YR$$F$Y$$$20240917$$CN$KR$KR
235525862$23552586$2$F$20240201$20240723$20240222$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026088$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240729$$HP$US$US
235526233$23552623$3$F$20220405$20240816$20240222$20240816$EXP$$KP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-432095$RANBAXY$$64$YR$$M$Y$36$KG$20240816$$HP$KP$KP
235526622$23552662$2$F$20230401$20240720$20240222$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-007327$AUROBINDO$$51$YR$$F$Y$$$20240731$$MD$FR$FR
235526822$23552682$2$F$$20240716$20240222$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028720$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$86.64$KG$20240718$$CN$US$US
235527246$23552724$6$F$20230101$20240823$20240222$20240829$EXP$$CA-PFIZER INC-202300289044$PFIZER$$27$YR$$F$Y$$$20240829$$MD$CA$CA
235527772$23552777$2$F$$20240703$20240222$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028590$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$70.76$KG$20240703$$CN$US$US
235527798$23552779$8$F$20240101$20240813$20240222$20240821$EXP$$CA-CELLTRION INC.-2024CA004287$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
235527932$23552793$2$F$20240106$20240921$20240222$20240921$EXP$FR-AFSSAPS-TO2024000285$FR-ROCHE-3511214$ROCHE$$70$YR$E$M$Y$85$KG$20240921$$PH$FR$FR
235528253$23552825$3$F$$20240829$20240222$20240905$EXP$$CA-GSK-CA2023AMR121520$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$CA$CA
235528493$23552849$3$F$20240116$20240326$20240222$20240725$PER$$US-BAYER-2024A025020$BAYER$$16$YR$T$F$Y$$$20240725$$MD$US$US
235528594$23552859$4$F$$20240827$20240222$20240829$EXP$$CA-PFIZER INC-202300178080$PFIZER$$45$YR$$M$Y$100$KG$20240829$$HP$CA$CA
235528762$23552876$2$F$$20240708$20240222$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202402012392$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240710$$CN$US$US
235529063$23552906$3$F$20240125$20240707$20240222$20240718$EXP$$IN-ROCHE-3504783$ROCHE$$71$YR$E$F$Y$$$20240718$$CN$IN$IN
235529475$23552947$5$F$20240216$20240725$20240222$20240801$EXP$$NVSC2024US037226$NOVARTIS$$33$YR$$F$Y$$$20240801$$CN$US$US
235529673$23552967$3$F$20240308$20240807$20240222$20240828$PER$$US-BIOGEN-2024BI01251598$BIOGEN$$33$YR$$F$Y$$$20240828$$CN$US$US
235529855$23552985$5$F$20240101$20240816$20240222$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028596$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240823$$CN$US$US
235529964$23552996$4$F$20240202$20240909$20240222$20240912$30DAY$$GR-PFIZER INC-PV202400015772$PFIZER$$12$YR$$M$Y$31$KG$20240912$$CN$GR$GR
235530302$23553030$2$F$20231101$20240716$20240222$20240722$EXP$$US-PFIZER INC-202400046451$PFIZER$$34$YR$$F$Y$$$20240722$$HP$US$US
235530314$23553031$4$F$$20240717$20240222$20240723$30DAY$$KR-PFIZER INC-PV202400016070$PFIZER$$$$$$Y$$$20240723$$CN$KR$KR
235530646$23553064$6$F$20231228$20240903$20240222$20240905$EXP$$AU-SANDOZ INC.-SDZ2024AU017369$SANDOZ$$73$YR$$M$Y$$$20240905$$MD$AU$AU
235531715$23553171$5$F$20240124$20240805$20240222$20240813$EXP$$CN-ROCHE-3512909$ROCHE$$75$YR$E$F$Y$$$20240813$$MD$CN$CN
235532094$23553209$4$F$20240101$20240802$20240222$20240814$EXP$$US-INSMED, INC.-2024-00616-US$INSMED$$$$$F$Y$55.329$KG$20240814$$CN$US$US
235532424$23553242$4$F$$20240712$20240222$20240717$EXP$$US-SANDOZ INC.-SDZ2024US017475$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
235532893$23553289$3$F$20240117$20240629$20240222$20240708$EXP$$FR-TAKEDA-2024TUS016704$TAKEDA$$37$YR$$F$Y$$$20240708$$HP$FR$FR
235533634$23553363$4$F$$20240731$20240222$20240802$PER$$US-PFIZER INC-202400047541$PFIZER$$56$YR$$F$Y$93.6$KG$20240802$$MD$US$US
235533934$23553393$4$F$20230201$20240913$20240222$20240920$EXP$$US-CHATTEMPRD-2023OHG018489$CHATTEM$$49$YR$A$M$Y$$$20240920$$LW$US$US
235533982$23553398$2$F$$20240625$20240222$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01235$LUPIN$$$$$$Y$$$20240705$$CN$US$US
235534082$23553408$2$F$20240203$20240717$20240222$20240719$PER$$US-AMGEN-USASP2024036890$AMGEN$$45$YR$A$F$Y$$$20240719$$CN$US$US
235534202$23553420$2$F$20240115$20240802$20240222$20240808$EXP$FR-AFSSAPS-LM2024000067$FR-MYLANLABS-2024M1015752$MYLAN$$69$YR$$M$Y$90$KG$20240808$$MD$FR$FR
235534263$23553426$3$F$$20240709$20240222$20240715$EXP$$PL-MYLANLABS-2024M1016471$MYLAN$$62$YR$$F$Y$$$20240715$$MD$PL$PL
235534304$23553430$4$F$20231030$20240628$20240222$20240708$EXP$FR-AFSSAPS-NY2024000195$FR-MYLANLABS-2024M1016026$MYLAN$$44$YR$$F$Y$$$20240708$$MD$FR$FR
235534343$23553434$3$F$$20240708$20240222$20240722$EXP$$IE-SAMSUNG BIOEPIS-SB-2024-04941$SAMSUNG BIOEPIS$Cunneen B, Hussein H, OSullivan J, Yearoo I. Calcific constrictive pericarditis following tumour necrosis factor-alpha inhibition. European heart journal. 2024 JAN 20;8(2):1-5. doi:10.1093/ehjcr/ytae027$63$YR$A$F$Y$$$20240722$$HP$IE$IE
235534535$23553453$5$F$$20240717$20240222$20240720$EXP$$NVSC2024NL037510$NOVARTIS$$23$YR$$F$Y$52$KG$20240719$$PH$NL$NL
235535054$23553505$4$F$20240305$20240701$20240222$20240711$EXP$$US-BEH-2024168388$CSL BEHRING$$65$YR$E$M$Y$$$20240711$$HP$US$US
235535086$23553508$6$F$$20240617$20240222$20240701$EXP$$CZ-MYLANLABS-2024M1014202$MYLAN$Vorisek J M. Clinical experience with ixekizumab in the treatment of psoriatic arthritis. Pharmacotherapy. 2024;20(3):270, 272-3$59$YR$$M$Y$$$20240701$$MD$CZ$CZ
235536232$23553623$2$F$20231002$20240712$20240222$20240718$EXP$FR-AFSSAPS-AN2024000179$FR-MYLANLABS-2024M1015657$MYLAN$$74$YR$$M$Y$$$20240718$$MD$FR$FR
235536442$23553644$2$F$$20240628$20240222$20240704$EXP$$JP-009507513-2402JPN002520J$MERCK$$50$YR$$$Y$$$20240704$$MD$JP$JP
235536782$23553678$2$F$20240101$20240724$20240222$20240802$EXP$$CA-Vifor (International) Inc.-VIT-2024-01520$VIFOR$$81$YR$$M$Y$$$20240802$$CN$CA$CA
235536904$23553690$4$F$20240208$20240829$20240222$20240902$EXP$$NVSC2023CA089262$NOVARTIS$$53$YR$$F$Y$$$20240903$$CN$CA$CA
235537022$23553702$2$F$$20240805$20240222$20240807$EXP$$SE-TAKEDA-2024TUS016535$TAKEDA$$$$$F$Y$$$20240807$$CN$SE$SE
235537313$23553731$3$F$20240201$20240917$20240222$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-004143$UNITED THERAPEUTICS$$72$YR$$F$Y$61.678$KG$20240926$$$US$US
235537892$23553789$2$F$20230825$20240920$20240222$20240930$PER$$US-INCYTE CORPORATION-2024IN001584$INCYTE$$$$$$Y$$$20240930$$CN$US$US
235538293$23553829$3$F$$20240717$20240222$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01292$LUPIN$$$$$$Y$$$20240821$$CN$US$US
235538417$23553841$7$F$20210801$20240829$20240222$20240903$EXP$$US-PFIZER INC-PV202400024282$PFIZER$$73$YR$$M$Y$101.13$KG$20240903$$CN$US$US
235538775$23553877$5$F$20230101$20240823$20240222$20240828$EXP$$US-PFIZER INC-202400045642$PFIZER$$60$YR$$F$Y$47.63$KG$20240828$$CN$US$US
235538844$23553884$4$F$$20240729$20240222$20240801$EXP$$IN-PFIZER INC-PV202300132029$PFIZER$$74$YR$$F$Y$$$20240801$$CN$IN$IN
235539352$23553935$2$F$$20240729$20240222$20240802$EXP$$CA-Eisai-EC-2024-159639$EISAI$$67$YR$E$F$Y$52$KG$20240802$$MD$CA$CA
235539452$23553945$2$F$20240109$20240702$20240222$20240710$PER$$JP-Eisai-EC-2024-159796$EISAI$$74$YR$E$M$Y$$$20240710$$MD$JP$JP
235539756$23553975$6$F$20240116$20240806$20240222$20240812$EXP$$US-ABBVIE-5646712$ABBVIE$$52$YR$$F$Y$143$KG$20240812$$CN$US$US
235540242$23554024$2$F$$20240715$20240222$20240722$PER$$US-ALXN-202402USA001243US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
235540772$23554077$2$F$$20240626$20240222$20240702$EXP$$JP-009507513-2402JPN002678J$MERCK$$$$$F$Y$$$20240702$$HP$JP$JP
235540804$23554080$4$F$$20240805$20240222$20240812$PER$$US-ALXN-202402USA001220US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
235541164$23554116$4$F$20240120$20240716$20240222$20240719$EXP$$US-JNJFOC-20240251615$JOHNSON AND JOHNSON$$86$YR$E$M$Y$49.9$KG$20240719$$CN$US$US
235541582$23554158$2$F$20231001$20240813$20240222$20240816$PER$$US-Eisai-EC-2023-152357$EISAI$$50$YR$A$M$Y$106.5$KG$20240816$$CN$US$US
235541883$23554188$3$F$$20240806$20240222$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028935$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240808$$CN$US$US
235541992$23554199$2$F$$20240206$20240222$20240808$PER$$US-MYLANLABS-2024M1012625$MYLAN$$$$$F$Y$$$20240808$$CN$US$US
235542032$23554203$2$F$20240218$20240725$20240222$20240729$PER$$US-AMGEN-USASP2024036466$AMGEN$$49$YR$A$M$Y$$$20240729$$CN$US$US
235542313$23554231$3$F$20230601$20240911$20240222$20240912$EXP$$NVSC2023GB136843$NOVARTIS$$68$YR$$F$Y$$$20240912$$HP$GB$GB
235542493$23554249$3$F$$20240916$20240222$20240926$EXP$$NVSC2024FR034227$NOVARTIS$Franchi V, Labussiere-Wallet H, Chouik Y, Heiblig M, Larcher M. Tandem duplications (tds) of the ubtf gene in acute myeloid leukaemia complicated by post hematopoietic stem cell transplantation venoocclusive disease treated by liver transplantation. LETTERS IN ONCOLOGY-HAEMATOLOGY. 2023;18 (6):349-51$25$YR$$M$Y$$$20240926$$HP$FR$FR
235542724$23554272$4$F$20240814$20240814$20240222$20240819$EXP$$CA-TAKEDA-2019TUS055330$TAKEDA$$83$YR$$F$Y$$$20240819$$CN$CA$CA
235543573$23554357$3$F$$20240920$20240222$20240930$PER$$US-GSK-US2024AMR020059$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
235543792$23554379$2$F$$20240722$20240222$20240723$PER$$US-PFIZER INC-202200789275$PFIZER$$76$YR$$F$Y$$$20240723$$CN$US$US
235543814$23554381$4$F$$20240923$20240222$20240925$PER$$US-PFIZER INC-PV202400023832$PFIZER$$73$YR$$F$Y$$$20240925$$CN$US$US
235543822$23554382$2$F$20240101$20240627$20240222$20240701$PER$$US-PFIZER INC-PV202300200958$PFIZER$$66$YR$$F$Y$$$20240701$$HP$US$US
235544053$23554405$3$F$20240301$20240904$20240222$20240906$PER$$US-PFIZER INC-202101828697$PFIZER$$88$YR$$F$Y$$$20240906$$CN$US$US
235544173$23554417$3$F$$20240916$20240222$20240917$PER$$US-PFIZER INC-202400029161$PFIZER$$74$YR$$F$Y$53.515$KG$20240917$$MD$US$US
235544966$23554496$6$F$20240101$20240910$20240222$20240912$PER$$US-KARYOPHARM-2024KPT000441$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240912$$CN$US$US
235545584$23554558$4$F$20240223$20240906$20240222$20240911$EXP$$CA-TAKEDA-2024TUS013634$TAKEDA$$22$YR$$F$Y$$$20240911$$HP$CA$CA
235545684$23554568$4$F$20240214$20240712$20240222$20240718$EXP$$US-UCBSA-2024008410$UCB$$36$YR$$M$Y$129.3$KG$20240718$$MD$US$US
235545716$23554571$6$F$20240101$20240910$20240222$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028137$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240918$$CN$US$US
235545772$23554577$2$F$$20240920$20240222$20240924$EXP$$JP-ABBVIE-5650102$ABBVIE$$$$$M$Y$$$20240924$$PH$JP$JP
235546314$23554631$4$F$20201005$20240820$20240222$20240829$EXP$$US-BIOGEN-2024BI01251377$BIOGEN$$56$YR$$F$Y$$$20240829$$CN$US$US
235549845$23554984$5$F$$20240705$20240222$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029024$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240708$$CN$US$US
235550353$23555035$3$F$$20240807$20240222$20240812$PER$$US-ALXN-202401USA000448US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
235551462$23555146$2$F$20231123$20240808$20240222$20240808$EXP$$AT-SANDOZ INC.-SDZ2024AT017244$SANDOZ$$76$YR$$F$Y$84$KG$20240808$$MD$AT$AT
235551992$23555199$2$F$$20240828$20240222$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029029$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240902$$CN$US$US
235552032$23555203$2$F$$20240802$20240222$20240807$PER$$US-ABBVIE-5649887$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
235552675$23555267$5$F$20211001$20240905$20240222$20240909$EXP$$DE-MYLANLABS-2024M1017008$MYLAN$$43$YR$$F$Y$61$KG$20240909$$MD$DE$DE
235553083$23555308$3$F$20240101$20240710$20240222$20240715$EXP$$US-KYOWAKIRIN-2024KK002800$KYOWA$$$$$$Y$$$20240715$$HP$US$US
235553774$23555377$4$F$$20240701$20240222$20240705$EXP$$PT-BAUSCH-BL-2024-002712$BAUSCH AND LOMB$$$$E$$Y$$$20240705$$HP$PT$PT
235554675$23555467$5$F$$20240705$20240222$20240715$EXP$$GR-MYLANLABS-2024M1016926$MYLAN$Serbis A, Nikolaou E, Makariou S, Zioga E, Vlachos A, Miliotis C, Siomou E. A female adolescent with recent onset of type 2 diabetes mellitus and heterozygous familial hypercholesterolemia, treated with statin as a pre-toddler. 33rd ANNUAL CONGRESS:CONTINUOUS EDUCATION OF THE PEDIATRICIAN. 2024;32$14$YR$$F$Y$$$20240715$$MD$GR$GR
235556163$23555616$3$F$20240401$20240809$20240222$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029233$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$83.46$KG$20240813$$CN$US$US
235556253$23555625$3$F$$20240221$20240222$20240812$EXP$$AR-SANDOZ INC.-SDZ2024AR017673$SANDOZ$$$$$F$Y$$$20240812$$MD$AR$AR
235557532$23555753$2$F$$20230929$20240222$20240717$PER$$US-NOVOPROD-1131463$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
235557992$23555799$2$F$$20230526$20240222$20240716$PER$$US-NOVOPROD-1167566$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
235558132$23555813$2$F$$20240918$20240222$20240925$EXP$$US-BEH-2024168546$CSL BEHRING$$$$A$M$Y$$$20240925$$HP$US$US
235558362$23555836$2$F$$20240815$20240222$20240821$EXP$$CA-TAKEDA-2023TUS011244$TAKEDA$$$$$F$Y$60$KG$20240821$$CN$CA$CA
235558852$23555885$2$F$20240103$20240626$20240222$20240702$PER$$US-AMGEN-USASP2024035898$AMGEN$$59$YR$A$F$Y$$$20240702$$HP$US$US
235559202$23555920$2$F$20240201$20240821$20240222$20240903$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004370$SAREPTA THERAPEUTICS$$14$YR$$M$Y$47.63$KG$20240903$$HP$US$US
235559223$23555922$3$F$20240101$20240701$20240222$20240704$EXP$$US-TAKEDA-2023TUS108088$TAKEDA$$64$YR$$M$Y$98$KG$20240704$$HP$US$US
235559343$23555934$3$F$20230131$20240919$20240222$20240927$EXP$$CN-009507513-2402CHN007258$MERCK$$74$YR$$M$Y$72$KG$20240927$$MD$CN$CN
235559994$23555999$4$F$20240415$20240917$20240222$20240927$EXP$$US-BEH-2024169002$CSL BEHRING$$50$YR$A$F$Y$90.703$KG$20240927$$CN$US$US
235560244$23556024$4$F$$20240628$20240222$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024451$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240702$$CN$US$US
235560462$23556046$2$F$20240219$20240716$20240222$20240717$PER$$US-AMGEN-USASP2024037208$AMGEN$$64$YR$A$F$Y$$$20240717$$CN$US$US
235560513$23556051$3$F$20220606$20240719$20240222$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-2022M1044949$BIOCON$$$$$$Y$$$20240819$$CN$US$US
235560915$23556091$5$F$20240318$20240814$20240222$20240819$EXP$$CA-TAKEDA-2024TUS016230$TAKEDA$$31$YR$$M$Y$$$20240819$$CN$CA$CA
235561255$23556125$5$F$$20240903$20240222$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024947$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240905$$CN$US$US
2355618318$23556183$18$F$20160101$20240715$20240223$20240730$EXP$FR-ELERTE-202400010$FR-STRIDES ARCOLAB LIMITED-2024SP002092$STRIDES$$34$YR$$M$Y$79$KG$20240730$$HP$FR$FR
235561842$23556184$2$F$20240124$20240703$20240223$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-007617$AUROBINDO$$88$YR$$M$Y$$$20240710$$MD$FR$FR
235562255$23556225$5$F$20240101$20240802$20240223$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-012571$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240805$$CN$US$US
235562703$23556270$3$F$20150101$20240815$20240223$20240826$EXP$$US-NOVOPROD-1143297$NOVO NORDISK$$62$YR$$F$Y$$$20240826$$CN$US$US
235562852$23556285$2$F$20231211$20240716$20240223$20240725$EXP$SE-SEMPA-2024-001137$SE-NOVOPROD-1177397$NOVO NORDISK$$61$YR$$F$Y$100$KG$20240725$$PH$SE$SE
235563676$23556367$6$F$20240218$20240917$20240223$20240926$EXP$$US-ROCHE-3513265$ROCHE$$49$YR$A$M$Y$76.66$KG$20240926$$CN$US$US
235563744$23556374$4$F$20240624$20240828$20240223$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028995$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240904$$CN$US$US
235563838$23556383$8$F$20240109$20240731$20240223$20240809$EXP$$US-BEH-2024168705$CSL BEHRING$$43$YR$A$F$Y$52.608$KG$20240809$$HP$US$US
235563985$23556398$5$F$20230401$20240819$20240223$20240824$EXP$$US-ABBVIE-5649365$ABBVIE$$52$YR$$F$Y$71.667$KG$20240823$$CN$US$US
235564146$23556414$6$F$20240219$20240722$20240223$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028643$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240729$$CN$US$US
235564162$23556416$2$F$20231010$20240615$20240223$20240710$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000472$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240710$$CN$US$US
235564253$23556425$3$F$$20240624$20240223$20240702$EXP$$ES-AUROBINDO-AUR-APL-2024-007016$AUROBINDO$Rubio I, de la Puente EM, Boveda O, Jimenez I, Pena I. Green neutrophilic inclusions in patient with drug intoxication: a case report. Journal of Laboratory and Precision Medicine. 2024;9:9$54$YR$$F$Y$$$20240702$$MD$ES$ES
235564306$23556430$6$F$20240309$20240619$20240223$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000475$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240712$$CN$US$US
235564633$23556463$3$F$20240101$20240910$20240223$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-005242$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240920$$$US$US
235564703$23556470$3$F$20230724$20240807$20240223$20240810$EXP$$US-ABBVIE-5376485$ABBVIE$$62$YR$$M$Y$145$KG$20240810$$CN$US$US
235564932$23556493$2$F$$20240924$20240223$20240930$EXP$$BE-AUROBINDO-AUR-APL-2024-007014$AUROBINDO$Zorzi S, Ayako Minemura Ordinola A, Cunha De Souza Lima E, Martins Teixeira G, Salvagno M, Sterchele ED, et al.. A glimpse into multimodal neuromonitoring in acute liver failure: a case report.. Annals of Medicine + Surgery.. 2024;86(1):539-544$56$YR$$M$Y$$$20240930$$MD$BE$BE
2355653919$23556539$19$F$20240101$20240708$20240223$20240717$EXP$$US-UNITED THERAPEUTICS-UNT-2024-005194$UNITED THERAPEUTICS$$$$$F$Y$$$20240717$$$US$US
235565563$23556556$3$F$20220822$20240904$20240223$20240911$EXP$$JP-009507513-2208JPN002804J$MERCK$$7$DEC$$F$Y$$$20240911$$MD$JP$JP
235565722$23556572$2$F$20240601$20240627$20240223$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028683$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240703$$HP$US$US
235565732$23556573$2$F$$20240627$20240223$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000506$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
235566373$23556637$3$F$20240214$20240626$20240223$20240704$EXP$$US-JNJFOC-20240243347$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$MD$US$US
235566727$23556672$7$F$20231127$20240808$20240223$20240814$EXP$$CA-TAKEDA-2023TUS117805$TAKEDA$$67$YR$$M$Y$$$20240814$$PH$CA$CA
235567453$23556745$3$F$20230901$20240415$20240223$20240718$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-03888$SAMSUNG BIOEPIS$$48$YR$A$F$Y$$$20240718$$CN$CA$CA
2355679510$23556795$10$F$$20240822$20240223$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430736$RANBAXY$$$$A$F$Y$92.517$KG$20240906$$CN$US$US
235568402$23556840$2$F$$20240724$20240223$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1093280$BIOCON$$$$$$Y$$$20240816$$CN$US$US
235569092$23556909$2$F$20231101$20240715$20240223$20240722$EXP$$BG-ASTELLAS-2024US005453$ASTELLAS$$78$YR$$M$Y$$$20240722$$MD$BG$BG
235569843$23556984$3$F$20040215$20240723$20240223$20240725$PER$$US-AMGEN-USASP2024037530$AMGEN$$45$YR$A$M$Y$$$20240725$$CN$US$US
235569876$23556987$6$F$20240510$20240722$20240223$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029078$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240723$$CN$US$US
235570003$23557000$3$F$20221001$20240830$20240223$20240903$EXP$$CA-GSK-CA2023095270$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$MD$CA$CA
235570352$23557035$2$F$$20240701$20240223$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028905$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240702$$CN$US$US
235571062$23557106$2$F$20240101$20240726$20240223$20240730$PER$$US-AMGEN-USASP2024036596$AMGEN$$91$YR$E$M$Y$$$20240730$$CN$US$US
235571222$23557122$2$F$20231002$20240716$20240223$20240719$EXP$$FR-AstraZeneca-2024A039049$ASTRAZENECA$$74$YR$$M$Y$$$20240719$$MD$FR$
235571262$23557126$2$F$20231003$20240529$20240223$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1105405$BIOCON$$$$$$Y$$$20240819$$CN$US$US
235571295$23557129$5$F$20120101$20240703$20240223$20240713$EXP$$US-TAKEDA-2016BLT002357$TAKEDA$$$$$F$Y$63$KG$20240713$$CN$US$US
235571455$23557145$5$F$20231001$20240627$20240223$20240702$EXP$$CA-TAKEDA-2023TUS060026$TAKEDA$$58$YR$$F$Y$$$20240702$$MD$CA$CA
235571583$23557158$3$F$20230901$20240916$20240223$20240924$EXP$$BR-TAKEDA-2024TUS015608$TAKEDA$$32$YR$$F$Y$$$20240924$$CN$BR$BR
235572122$23557212$2$F$$20240617$20240223$20240701$EXP$$CZ-IBIGEN-2024-014810$ISTITUTO BICHIMICO ITALIANO GIOVANNI LORENZINI (IBIGEN)$Zvarova E, Kurasova J. Myasthenia gravis u geriatricke pacientky (Myasthenia gravis in a geriatric patient). Geriatrie a gerontologie. 2023; 12(4):193-6.$83$YR$$F$Y$$$20240617$$MD$CZ$
235572703$23557270$3$F$20240101$20240821$20240223$20240828$EXP$$JP-GENMAB-2024-00185AA$GENMAB$$72$YR$$M$Y$$$20240828$$HP$JP$JP
235573115$23557311$5$F$20200101$20240808$20240223$20240816$EXP$$CA-CELLTRION INC.-2020CA022240$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
235573322$23557332$2$F$20240219$20240724$20240223$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202402012329$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240802$$CN$US$US
235573352$23557335$2$F$20240215$20240628$20240223$20240702$PER$$US-AMGEN-USASP2024036957$AMGEN$$64$YR$A$F$Y$$$20240702$$CN$US$US
235573783$23557378$3$F$$20240705$20240223$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1116997$BIOCON$$$$$$Y$$$20240819$$CN$US$US
235573835$23557383$5$F$20221026$20240712$20240223$20240719$EXP$$JP-AMGEN-JPNSP2024035310$AMGEN$$85$YR$E$F$Y$$$20240719$$MD$JP$JP
235574112$23557411$2$F$$20240809$20240223$20240819$EXP$$CA-BIOGEN-2024BI01248986$BIOGEN$$$$$M$Y$$$20240819$$CN$CA$CA
235574683$23557468$3$F$20231113$20240709$20240223$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1123083$BIOCON$$66$YR$$M$Y$$$20240819$$CN$US$US
235575724$23557572$4$F$$20240711$20240223$20240720$EXP$$GB-AUROBINDO-AUR-APL-2024-007578$AUROBINDO$$73$YR$$M$Y$$$20240720$$HP$GB$GB
235576142$23557614$2$F$$20240925$20240223$20240927$EXP$$US-TAKEDA-2024TUS014958$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
235576427$23557642$7$F$20231010$20240911$20240223$20240919$EXP$$CA-CELLTRION INC.-2023CA014424$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
235576454$23557645$4$F$20240221$20240918$20240223$20240920$EXP$$NVSC2024CA038150$NOVARTIS$$51$YR$$M$Y$124.2$KG$20240920$$HP$CA$CA
235576883$23557688$3$F$20231211$20240509$20240223$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2023001308$BIOCON$$$$$$Y$$$20240816$$CN$US$US
235576933$23557693$3$F$$20240724$20240223$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2023001364$BIOCON$$$$$$Y$$$20240819$$CN$US$US
235576982$23557698$2$F$20240129$20240829$20240223$20240923$30DAY$$FR-JNJFOC-20240181146$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240923$$PH$FR$FR
235577073$23557707$3$F$$20240708$20240223$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2023001433$BIOCON$$$$$$Y$$$20240819$$CN$US$US
235577733$23557773$3$F$$20240721$20240223$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2023001901$BIOCON$$$$$$Y$$$20240816$$CN$US$US
235577982$23557798$2$F$20230101$20240708$20240223$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-010087$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$$$20240710$$CN$US$US
235578004$23557800$4$F$$20240913$20240223$20240924$EXP$$US-ROCHE-3512285$ROCHE$Shukla K, Chaudhari R and Asgharpour A Spontaneous Hepatic Hemorrhage Causing Acute Liver Failure Requiring Liver Transplant. DOI: 10.14309/crj.0000000000001268. ACG Case Reports Journal 2024 Feb 02;11 (2):1-3.$59$YR$A$F$Y$$$20240924$$HP$US$US
235578663$23557866$3$F$$20240618$20240223$20240819$PER$$US-FDA PERIODIC-BBL2024000034$BIOCON$$$$$$Y$$$20240819$$CN$US$US
235578733$23557873$3$F$$20240627$20240223$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000055$BIOCON$$$$$$Y$$$20240819$$PH$US$US
235578763$23557876$3$F$$20240515$20240223$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000095$BIOCON$$$$$$Y$$$20240819$$PH$US$US
235578883$23557888$3$F$$20240613$20240223$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000060$BIOCON$$$$$$Y$$$20240816$$CN$US$US
235578943$23557894$3$F$20240109$20240807$20240223$20240822$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000171$BIOCON$$$$$$Y$$$20240822$$CN$US$US
235579023$23557902$3$F$20240108$20240718$20240223$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000244$BIOCON$$$$$$Y$$$20240816$$CN$US$US
235579112$23557911$2$F$20240218$20240723$20240223$20240726$PER$$US-AMGEN-USASP2024036333$AMGEN$$57$YR$A$M$Y$$$20240726$$CN$US$US
235580884$23558088$4$F$20240223$20240715$20240223$20240722$EXP$$CA-TAKEDA-2023TUS087466$TAKEDA$$44$YR$$F$Y$$$20240722$$HP$CA$CA
2355809811$23558098$11$F$$20240916$20240223$20240920$EXP$$CA-AMGEN-CANSP2024035179$AMGEN$$43$YR$A$F$Y$70$KG$20240920$$HP$CA$CA
235581134$23558113$4$F$$20240624$20240223$20240704$EXP$$CA-GSK-CA2024AMR020785$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$HP$CA$CA
235581283$23558128$3$F$$20240627$20240223$20240710$EXP$$JP-ROCHE-3514822$ROCHE$Kataoka S, Nishikawa Y, Funakoshi T, Horimatsu T, Sakuragi M, Uchino E, Hiragi S, Yamamoto S, Sakai K, Matsubara T, Yanagita M and Muto M Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study. DOI: 10.1007/s10147-024-02474-7. International journal of clinical oncology 2024 Feb 14;29 (4):398-406.$63$YR$A$M$Y$$$20240710$$HP$JP$JP
235581336$23558133$6$F$20240530$20240626$20240223$20240701$EXP$$CA-TAKEDA-2024TUS015829$TAKEDA$$66$YR$$M$Y$$$20240701$$CN$CA$CA
235581485$23558148$5$F$$20240712$20240223$20240801$EXP$$JP-009507513-2402JPN002796J$MERCK$Higashimoto K, Yoshida S, Shiina R, Fujita T. 3 A case of corpus uteri carcinoma thought in which aortic dissection occurred during combination therapy with lenvatinib and pembrolizumab. The Journal of Fukuoka College of Obstetricians and Gynecologists, The 167th Ann. 2024;47(2):28$76$YR$$F$Y$$$20240801$$MD$JP$JP
235581514$23558151$4$F$$20240814$20240223$20240822$PER$$US-TRAVERE-2024TVT00167$TRAVERE THERAPEUTICS$$61$YR$A$M$Y$$$20240822$$CN$US$US
235581672$23558167$2$F$20240101$20240904$20240223$20240919$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00201$AVADEL CNS PHARMA$$$$$F$Y$$$20240919$$CN$US$US
235581682$23558168$2$F$$20240710$20240223$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026587$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$83.01$KG$20240712$$CN$US$US
235581702$23558170$2$F$20240218$20240722$20240223$20240724$PER$$US-AMGEN-USASP2024036429$AMGEN$$82$YR$E$F$Y$$$20240723$$CN$US$US
235581873$23558187$3$F$20230801$20240723$20240223$20240801$EXP$$JP-009507513-2402JPN003023J$MERCK$$8$DEC$$F$Y$$$20240801$$MD$JP$JP
235581902$23558190$2$F$20240220$20240819$20240223$20240821$PER$$US-AMGEN-USASP2024037971$AMGEN$$73$YR$E$M$Y$$$20240821$$CN$US$US
2355828114$23558281$14$F$20240101$20240916$20240223$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-004651$UNITED THERAPEUTICS$$$$$F$Y$142.4$KG$20240926$$$US$US
235583744$23558374$4$F$$20240624$20240223$20240722$PER$$US-BEIGENE-BGN-2024-002595$BEIGENE$$$$$$Y$$$20240722$$CN$US$US
235583782$23558378$2$F$$20240808$20240223$20240816$30DAY$$US-GSK-US2024019403$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
235584322$23558432$2$F$20240215$20240727$20240223$20240801$EXP$$US-AMGEN-USASP2024033607$AMGEN$$70$YR$E$F$Y$$$20240801$$CN$US$US
235584403$23558440$3$F$$20240702$20240223$20240724$EXP$$JP-AstraZeneca-2024A044760$ASTRAZENECA$Not Reported. Not Reported. Not Reported$78$YR$$M$Y$$$20240724$$MD$JP$
235585024$23558502$4$F$$20240729$20240223$20240801$EXP$$NVSC2024ZA035585$NOVARTIS$$24$YR$$F$Y$$$20240801$$CN$ZA$ZA
235585363$23558536$3$F$$20240624$20240223$20240708$30DAY$$US-GSK-US2024019426$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$CN$US$US
235585675$23558567$5$F$$20240906$20240223$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026877$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240911$$HP$US$US
235586103$23558610$3$F$20240211$20240815$20240223$20240821$PER$$US-AMGEN-USASP2024033630$AMGEN$$69$YR$E$M$Y$$$20240820$$CN$US$US
235586117$23558611$7$F$$20240830$20240223$20240902$PER$$US-AMGEN-USASP2024036775$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
235586686$23558668$6$F$20240101$20240831$20240223$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-003355$UNITED THERAPEUTICS$$55$YR$$M$Y$82.993$KG$20240905$$$US$US
235587707$23558770$7$F$$20240923$20240223$20240926$EXP$$NVSC2023GB228858$NOVARTIS$$31$YR$$F$Y$$$20240926$$CN$GB$GB
235588103$23558810$3$F$20230702$20240709$20240223$20240723$EXP$$CA-SAMSUNG BIOEPIS-SB-2023-18361$SAMSUNG BIOEPIS$$20$YR$A$F$Y$$$20240723$$HP$CA$CA
235588122$23558812$2$F$20201028$20240730$20240223$20240806$EXP$$IL-ABBVIE-21K-082-3858902-00$ABBVIE$$67$YR$$M$Y$86$KG$20240806$$MD$IL$IL
235588174$23558817$4$F$20231201$20240808$20240223$20240815$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-035506$REGENERON$$85$YR$$F$Y$$$20240815$$HP$CO$CO
235588202$23558820$2$F$$20240627$20240223$20240706$EXP$$CA-TEVA-VS-3159872$TEVA$$34$YR$$M$Y$$$20240706$$MD$CA$CA
235588502$23558850$2$F$20200101$20240718$20240223$20240726$EXP$$US-ALXN-202402USA001393US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
235588633$23558863$3$F$20160916$20240806$20240223$20240812$EXP$$US-OTSUKA-2024_004029$OTSUKA$$48$YR$$F$Y$$$20240812$$CN$US$US
235588753$23558875$3$F$20240201$20240828$20240223$20240903$EXP$$JP-ABBVIE-5650367$ABBVIE$$$$$M$Y$$$20240903$$MD$JP$JP
235589423$23558942$3$F$$20240715$20240223$20240722$PER$$US-ALXN-202402USA001367US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
235589603$23558960$3$F$20240130$20240903$20240223$20240904$EXP$$US-UCBSA-2024007258$UCB$$41$YR$$F$Y$$$20240904$$CN$US$US
235589892$23558989$2$F$20240219$20240809$20240223$20240812$PER$$US-AMGEN-USASP2024036900$AMGEN$$71$YR$E$M$Y$$$20240812$$CN$US$US
235589952$23558995$2$F$$20240708$20240223$20240716$EXP$$JP-AstraZeneca-2024A044685$ASTRAZENECA$Kaneda H.. Uses of the POSEIDON regimen in advanced-stage NSCLC: Based on a performance survey of long-term survival data and real-world data.. Academic Seminar #1 in the 120th Kansai Branch Academic Meeting of the Japan Lung Cancer Society. 2024;0-.$75$YR$$M$Y$$$20240716$$MD$JP$
235589983$23558998$3$F$$20240910$20240223$20240911$EXP$$US-TAKEDA-2024TUS016635$TAKEDA$$$$$F$Y$$$20240911$$MD$US$US
235590282$23559028$2$F$$20240828$20240223$20240830$PER$$US-BAYER-2024A028686$BAYER$$40$YR$A$F$Y$$$20240830$$HP$US$US
235590323$23559032$3$F$$20240813$20240223$20240816$EXP$$CA-TAKEDA-2022TUS078449$TAKEDA$$$$$F$Y$$$20240816$$CN$CA$CA
235590658$23559065$8$F$$20240808$20240223$20240809$EXP$$US-PFIZER INC-PV202400024320$PFIZER$$79$YR$$F$Y$$$20240809$$CN$US$US
235590792$23559079$2$F$$20240626$20240223$20240701$PER$$US-PFIZER INC-PV202300133487$PFIZER$$70$YR$$F$Y$$$20240701$$MD$US$US
235590823$23559082$3$F$$20240701$20240223$20240703$PER$$US-PFIZER INC-202400037366$PFIZER$$78$YR$$F$Y$$$20240703$$MD$US$US
235590833$23559083$3$F$20240220$20240807$20240223$20240812$PER$$US-PFIZER INC-PV202400024618$PFIZER$$46$YR$$F$Y$$$20240812$$HP$US$US
235590882$23559088$2$F$20240219$20240705$20240223$20240708$PER$$US-PFIZER INC-202400046357$PFIZER$$76$YR$$F$Y$64.41$KG$20240708$$HP$US$US
235591002$23559100$2$F$$20240917$20240223$20240920$PER$$US-PFIZER INC-PV202400024539$PFIZER$$52$YR$$F$Y$$$20240920$$HP$US$US
235591012$23559101$2$F$$20240726$20240223$20240730$PER$$US-PFIZER INC-PV202200124040$PFIZER$$57$YR$$F$Y$$$20240730$$HP$US$US
235591042$23559104$2$F$20240101$20240826$20240223$20240830$PER$$US-PFIZER INC-PV202300190717$PFIZER$$69$YR$$F$Y$$$20240830$$HP$US$US
235591175$23559117$5$F$$20240812$20240223$20240816$EXP$$US-TAKEDA-2024TUS008450$TAKEDA$$$$$F$Y$$$20240816$$CN$US$US
235591442$23559144$2$F$20240130$20240702$20240223$20240703$EXP$$JP-PFIZER INC-PV202400015468$PFIZER$$10$YR$$M$Y$31.7$KG$20240703$$MD$JP$JP
235591822$23559182$2$F$$20240802$20240223$20240816$EXP$$TH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432698$RANBAXY$Pitanupong J, Jittpratoom C, Anantapong K. Chronic kidney disease incidences in Thai outpatients diagnosed with psychiatric illnesses receiving lithium maintenance therapy: a university hospital-based study. BMC Psychiatry. 2024;24:80$60$YR$$M$Y$81$KG$20240816$$HP$TH$TH
235591852$23559185$2$F$$20240829$20240223$20240913$EXP$$TH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432699$RANBAXY$Pitanupong J, Jittpratoom C, Anantapong K. Chronic kidney disease incidences in Thai outpatients diagnosed with psychiatric illnesses receiving lithium maintenance therapy: a university hospital-based study. BMC Psychiatry. 2024;24:80$27$YR$$M$Y$86.9$KG$20240913$$HP$TH$TH
235592142$23559214$2$F$$20240829$20240223$20240913$EXP$$TH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432701$RANBAXY$Pitanupong J, Jittpratoom C, Anantapong K. Chronic kidney disease incidences in Thai outpatients diagnosed with psychiatric illnesses receiving lithium maintenance therapy: a university hospital-based study. BMC Psychiatry. 2024;24:80$53$YR$$M$Y$79.7$KG$20240913$$HP$TH$TH
235592183$23559218$3$F$20230101$20240909$20240223$20240913$EXP$$CA-ABBVIE-5650688$ABBVIE$$63$YR$$M$Y$$$20240913$$CN$CA$CA
235592382$23559238$2$F$20240216$20240728$20240223$20240730$PER$$US-AMGEN-USASP2024036907$AMGEN$$70$YR$E$F$Y$$$20240730$$CN$US$US
235592742$23559274$2$F$$20240213$20240223$20240702$EXP$$US-BAYER-2024A025991$BAYER$Kaur S, Isaac S, Westerman J.. Life threatening hematologic emergency from low dose methotrexate.. Southern Medical Journal.. 2023;116(7):641-2.$63$YR$A$F$Y$$$20240702$$MD$US$US
235593596$23559359$6$F$20231101$20240913$20240223$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026876$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240919$$CN$US$US
235593842$23559384$2$F$20240219$20240626$20240223$20240701$PER$$US-AMGEN-USASP2024037351$AMGEN$$79$YR$E$M$Y$$$20240701$$PH$US$US
235593912$23559391$2$F$$20240806$20240223$20240812$EXP$$CA-TAKEDA-2024TUS000025$TAKEDA$$$$$F$Y$$$20240812$$MD$CA$CA
235594644$23559464$4$F$20240116$20240903$20240223$20240913$EXP$$AU-BAXTER-2024BAX013184$BAXTER$$73$YR$$M$Y$$$20240913$$MD$AU$AU
235594792$23559479$2$F$$20240628$20240223$20240705$EXP$$JP-009507513-2310JPN003263J$MERCK$$8$DEC$$F$Y$$$20240705$$MD$JP$JP
235595047$23559504$7$F$$20240903$20240223$20240911$EXP$$CA-AMGEN-CANSP2024035037$AMGEN$$43$YR$A$F$Y$96$KG$20240911$$HP$CA$CA
235595094$23559509$4$F$20240201$20240730$20240223$20240806$EXP$$US-BEH-2024168799$CSL BEHRING$$64$YR$A$F$Y$$$20240806$$HP$US$US
235595552$23559555$2$F$20231201$20240909$20240223$20240917$EXP$FR-AFSSAPS-LM2024000065$FR-ASTELLAS-2024EU001448$ASTELLAS$$59$YR$A$M$Y$89$KG$20240917$$MD$FR$FR
235595712$23559571$2$F$20150628$20240711$20240223$20240716$EXP$FR-AFSSAPS-RS2024000170$FR-PFIZER INC-202400044937$PFIZER$$53$YR$$M$Y$79$KG$20240716$$MD$FR$FR
235595823$23559582$3$F$20230101$20240903$20240223$20240905$EXP$$US-PFIZER INC-202400048802$PFIZER$$58$YR$$M$Y$$$20240905$$HP$US$US
235595863$23559586$3$F$20230801$20240904$20240223$20240909$EXP$$CA-PFIZER INC-PV202300138367$PFIZER$$50$YR$$F$Y$85.4$KG$20240909$$HP$CA$CA
235595912$23559591$2$F$20230919$20240709$20240223$20240711$EXP$ES-AEMPS-1488279$ES-PFIZER INC-202400046254$PFIZER$$66$YR$$F$Y$$$20240711$$MD$ES$ES
235596133$23559613$3$F$20240101$20240711$20240223$20240730$PER$$US-MYLANLABS-2024M1014833$MYLAN$$$$$F$Y$$$20240730$$CN$US$US
235596724$23559672$4$F$$20240716$20240223$20240723$EXP$$CA-OTSUKA-2024_001476$OTSUKA$$$$$F$Y$$$20240723$$HP$CA$CA
235596895$23559689$5$F$20210729$20240812$20240223$20240820$EXP$$DE-TAKEDA-2022TUS039777$TAKEDA$$34$YR$$M$Y$$$20240820$$CN$DE$DE
235598376$23559837$6$F$20240119$20240828$20240223$20240911$EXP$$CH-OPKO PHARMACEUTICALS, LLC.-2024OPK00044$OPKO HEALTH$$$$$$Y$48$KG$20240909$$CN$CH$DE
235598427$23559842$7$F$$20240722$20240223$20240730$EXP$$US-AMGEN-USASP2024037112$AMGEN$$55$YR$A$F$Y$$$20240730$$HP$US$US
235598494$23559849$4$F$$20240704$20240223$20240711$EXP$$CA-PFIZER INC-202200600412$PFIZER$$41$YR$$F$Y$$$20240711$$HP$CA$CA
235598554$23559855$4$F$20220707$20240725$20240223$20240801$EXP$$DE-PFIZER INC-202201269693$PFIZER$$54$YR$$M$Y$103$KG$20240801$$HP$DE$DE
235598693$23559869$3$F$20230101$20240907$20240223$20240913$EXP$$CA-JNJFOC-20231069504$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240913$$CN$CA$CA
235598805$23559880$5$F$20240311$20240703$20240223$20240708$EXP$$CA-TAKEDA-2024TUS016805$TAKEDA$$65$YR$$M$Y$$$20240708$$HP$CA$CA
235598894$23559889$4$F$20240222$20240903$20240223$20240910$EXP$$CA-ROCHE-3514992$ROCHE$$29$YR$A$F$Y$$$20240910$$CN$CA$CA
235599642$23559964$2$F$$20240217$20240223$20240701$EXP$$FR-AstraZeneca-2024A044293$ASTRAZENECA$$80$YR$$M$Y$$$20240701$$MD$FR$
235599933$23559993$3$F$20190805$20240709$20240223$20240715$EXP$$DE-SANDOZ INC.-PHHY2019DE186260$SANDOZ$$$$A$F$Y$57$KG$20240715$$MD$DE$DE
235600295$23560029$5$F$20240626$20240716$20240223$20240718$EXP$$CA-TAKEDA-2024TUS015721$TAKEDA$$57$YR$$M$Y$$$20240718$$MD$CA$CA
235600317$23560031$7$F$$20240819$20240223$20240822$EXP$$CA-TAKEDA-2024TUS017143$TAKEDA$$$$$M$Y$$$20240822$$MD$CA$CA
235600376$23560037$6$F$$20240627$20240223$20240708$EXP$$ES-MYLANLABS-2024M1016489$MYLAN$Rubio I, de la Puente EM, Boveda O, Jimenez I, Pena I.. Green neutrophilic inclusions in patient with drug intoxication: a case report.. J. Lab. Precis. Med.. 2024;9$54$YR$$F$Y$$$20240708$$HP$ES$ES
235600528$23560052$8$F$20240101$20240926$20240223$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026025$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240930$$CN$US$US
235600712$23560071$2$F$20240208$20240712$20240223$20240717$EXP$$CN-PFIZER INC-PV202400024826$PFIZER$$62$YR$$M$Y$80$KG$20240717$$HP$CN$CN
235600782$23560078$2$F$20240217$20240712$20240223$20240717$EXP$$CN-PFIZER INC-PV202400024830$PFIZER$$50$YR$$M$Y$60$KG$20240717$$HP$CN$CN
235601104$23560110$4$F$$20240903$20240223$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029527$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240905$$HP$US$US
235601112$23560111$2$F$$20240701$20240223$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024609$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240709$$CN$US$US
235601212$23560121$2$F$20210501$20240826$20240223$20240828$EXP$$IT-SANDOZ INC.-SDZ2024IT018196$SANDOZ$$55$YR$$F$Y$$$20240828$$HP$IT$IT
235601423$23560142$3$F$20210301$20240923$20240223$20240927$EXP$$BR-TAKEDA-2023TUS094593$TAKEDA$$45$YR$$M$Y$95$KG$20240927$$CN$BR$BR
235601593$23560159$3$F$$20240625$20240223$20240701$PER$$US-PFIZER INC-202400048716$PFIZER$$61$YR$$M$Y$$$20240701$$CN$US$US
235601833$23560183$3$F$20230101$20240903$20240223$20240905$EXP$$US-PFIZER INC-202400047634$PFIZER$$24$YR$$F$Y$68.934$KG$20240905$$CN$US$US
235602202$23560220$2$F$20240101$20240813$20240223$20240816$EXP$$CA-JNJFOC-20240259447$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240816$$CN$CA$CA
2356023810$23560238$10$F$20240107$20240616$20240223$20240814$EXP$$NVSC2024IL006513$NOVARTIS$$46$YR$$F$Y$$$20240814$$HP$IL$IL
235602682$23560268$2$F$20231221$20240705$20240223$20240715$EXP$IT-MINISAL02-963407$IT-TEVA-VS-3157590$TEVA$$14$YR$$F$Y$39$KG$20240715$$PH$IT$IT
235603672$23560367$2$F$$20240704$20240223$20240710$EXP$$AU-TAKEDA-2024TUS015896$TAKEDA$$$$A$F$Y$$$20240710$$CN$AU$AU
235603784$23560378$4$F$20231201$20240906$20240223$20240911$EXP$$CA-PFIZER INC-202400044495$PFIZER$$83$YR$$M$Y$83$KG$20240911$$HP$CA$CA
235603944$23560394$4$F$20231122$20240709$20240223$20240712$EXP$$IT-MYLANLABS-2024M1017245$MYLAN$$75$YR$$M$Y$57$KG$20240712$$MD$IT$IT
235604202$23560420$2$F$20240101$20240716$20240223$20240722$EXP$$US-UCBSA-2024000777$UCB$$19$YR$$F$Y$64.082$KG$20240722$$HP$US$US
235604672$23560467$2$F$20231224$20240725$20240223$20240730$EXP$$DE-PFIZER INC-202400046039$PFIZER$$74$YR$$F$Y$$$20240730$$MD$DE$DE
235604723$23560472$3$F$$20240913$20240223$20240917$EXP$$CA-PURDUE-USA-2024-0307036$PURDUE$$26$YR$$F$Y$75$KG$20240917$$CN$CA$CA
235604872$23560487$2$F$20240201$20240806$20240223$20240816$EXP$IT-MINISAL02-969380$IT-GUERBET / LLC-IT-20240010$GUERBET$$67$YR$E$F$Y$71$KG$20240816$$MD$IT$IT
235605022$23560502$2$F$$20240628$20240223$20240816$PER$$US-LUNDBECK-DKLU3074423$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
235605262$23560526$2$F$20231106$20240828$20240223$20240906$EXP$FR-AFSSAPS-AM2023001182$FR-TEVA-VS-3157236$TEVA$$83$YR$$M$Y$73$KG$20240906$$MD$FR$FR
235605477$23560547$7$F$$20240905$20240223$20240909$PER$$US-PFIZER INC-PV202400025046$PFIZER$$77$YR$$F$Y$$$20240909$$CN$US$US
235606032$23560603$2$F$$20240821$20240223$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029781$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240826$$HP$US$US
235606223$23560622$3$F$20240725$20240729$20240223$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-010126$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240801$$CN$US$US
235606302$23560630$2$F$20210306$20240730$20240223$20240731$EXP$FR-AFSSAPS-LM2024000080$FR-PFIZER INC-202400046103$PFIZER$$43$YR$$F$Y$55$KG$20240731$$MD$FR$FR
235606593$23560659$3$F$$20240813$20240223$20240815$EXP$$US-KYOWAKIRIN-2024KK002871$KYOWA$$$$$$Y$$$20240815$$HP$US$US
235606702$23560670$2$F$20240202$20240818$20240223$20240904$EXP$$US-RADIUS HEALTH, INC.-2024US000905$RADIUS PHARM$$43$YR$$F$Y$$$20240904$$CN$US$US
235607105$23560710$5$F$20240101$20240717$20240223$20240718$PER$$US-PFIZER INC-202400048935$PFIZER$$48$YR$$F$Y$$$20240718$$CN$US$US
235607226$23560722$6$F$$20240628$20240223$20240918$EXP$$JP-009507513-2402JPN002783J$MERCK$Fujinuma C, Suzuki T, Iwasawa U, Ishii G. [Case Report: A Case of Axillary Lymph Node Metastasis Considered from Recurrence at Abdominal Ports after Surgery for Lung Cancer]. Japanese Journal of Clinical Dermatology. 2024;78(2):143-8$73$YR$$M$Y$$$20240918$$MD$JP$JP
235607364$23560736$4$F$20240201$20240826$20240223$20240904$EXP$$US-Calliditas-2024CAL00228$CALLIDITAS THERAPEUTICS$$42$YR$A$F$Y$$$20240904$$CN$US$US
235607745$23560774$5$F$20240101$20240826$20240223$20240912$PER$$US-KARYOPHARM-2024KPT000452$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240912$$CN$US$US
235608582$23560858$2$F$20230925$20240625$20240223$20240703$EXP$FR-AFSSAPS-CN2023001173$FR-009507513-2402FRA008119$MERCK$$46$YR$$F$Y$63$KG$20240703$$HP$FR$FR
235608618$23560861$8$F$20240102$20240830$20240223$20240919$EXP$$US-BEH-2024169001$CSL BEHRING$$43$YR$A$F$Y$$$20240919$$CN$US$US
235608692$23560869$2$F$$20240906$20240223$20240913$EXP$$US-GILEAD-2024-0663216$GILEAD$$63$YR$A$M$Y$$$20240913$$HP$US$US
235608752$23560875$2$F$$20240906$20240223$20240913$EXP$$US-GILEAD-2024-0663222$GILEAD$$65$YR$E$M$Y$$$20240913$$MD$US$US
235608763$23560876$3$F$$20240906$20240223$20240911$EXP$$US-GILEAD-2024-0663225$GILEAD$$68$YR$E$M$Y$$$20240911$$MD$US$US
235608792$23560879$2$F$$20240906$20240223$20240911$EXP$$US-GILEAD-2024-0663226$GILEAD$$65$YR$E$M$Y$$$20240911$$MD$US$US
235608852$23560885$2$F$$20240906$20240223$20240912$EXP$$US-GILEAD-2024-0663221$GILEAD$$65$YR$E$M$Y$$$20240912$$MD$US$US
235609083$23560908$3$F$20231205$20240813$20240223$20240820$EXP$$NVSC2023IN263624$NOVARTIS$$68$YR$$M$Y$$$20240820$$CN$IN$IN
235609402$23560940$2$F$20240128$20240822$20240223$20240827$PER$$US-AMGEN-USASP2024038052$AMGEN$$61$YR$A$F$Y$$$20240827$$CN$US$US
235609522$23560952$2$F$20240221$20240729$20240224$20240801$PER$$US-AMGEN-USASP2024038011$AMGEN$$44$YR$A$F$Y$$$20240801$$CN$US$US
2356095814$23560958$14$F$20240101$20240813$20240224$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-001205$UNITED THERAPEUTICS$$$$$F$Y$71.202$KG$20240817$$PH$US$US
235609853$23560985$3$F$20240101$20240826$20240224$20240829$PER$$US-AMGEN-USASP2024036544$AMGEN$$60$YR$A$F$Y$$$20240829$$CN$US$US
235609875$23560987$5$F$20231220$20240916$20240224$20240924$EXP$$CA-CELLTRION INC.-2023CA025271$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
235609976$23560997$6$F$$20240910$20240224$20240912$EXP$$NVSC2024US037781$NOVARTIS$$$$$F$Y$91.17$KG$20240912$$CN$US$US
235610032$23561003$2$F$$20240925$20240224$20240925$30DAY$$US-SANDOZ INC.-SDZ2023US020277$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
235610072$23561007$2$F$$20240624$20240224$20240701$EXP$$NL-CELLTRION INC.-2024NL004210$CELLTRION$$$$$$Y$$$20240701$$MD$NL$NL
235611078$23561107$8$F$20231017$20240911$20240224$20240919$EXP$$CA-CELLTRION INC.-2023CA024264$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
235611223$23561122$3$F$$20240222$20240224$20240711$PER$$US-UNITED THERAPEUTICS-UNT-2024-005547$UNITED THERAPEUTICS$$$$$M$Y$70.295$KG$20240711$$$US$US
235611892$23561189$2$F$20231224$20240723$20240224$20240802$EXP$$DE-AUROBINDO-AUR-APL-2024-008668$AUROBINDO$$75$YR$$F$Y$$$20240802$$MD$DE$DE
235612572$23561257$2$F$20231201$20240219$20240224$20240808$EXP$$NVSC2024US035647$NOVARTIS$$54$YR$$F$Y$$$20240808$$CN$US$US
235612822$23561282$2$F$20231222$20240722$20240224$20240726$EXP$$US-AMGEN-USASP2024034889$AMGEN$$70$YR$E$M$Y$$$20240726$$CN$US$US
2356128910$23561289$10$F$20240101$20240702$20240224$20240711$EXP$$US-UNITED THERAPEUTICS-UNT-2024-005506$UNITED THERAPEUTICS$$$$$F$Y$50.794$KG$20240711$$$US$US
235613718$23561371$8$F$20240105$20240718$20240224$20240726$EXP$$FR-JNJFOC-20240171644$JOHNSON AND JOHNSON$$76$YR$E$F$Y$85$KG$20240726$$MD$FR$FR
235613823$23561382$3$F$20240221$20240806$20240224$20240809$PER$$US-AMGEN-USASP2024038339$AMGEN$$51$YR$A$M$Y$$$20240809$$CN$US$US
235613852$23561385$2$F$20220916$20240820$20240224$20240830$EXP$$JP-ROCHE-3514456$ROCHE$Amioka S, Mitsumoto Y, Yorioka Y, Fujiishi S, Fujinami M, Watanabe K, et al. A Case in Which Platelets Decreased in the Slow Course with Atezolizumab + Bevacizumab Combination Therapy for Non-resectable Hepatocellular Carcinoma, Leading to a Diagnosis of Immune Thrombocytopenia.. The 120th Kinki Regional Conference of the Japanese Society of Gastroenterology 2024;:103-.$8$DEC$E$M$Y$$$20240830$$MD$JP$JP
235614584$23561458$4$F$$20240815$20240225$20240820$EXP$$US-SANDOZ INC.-SDZ2024US016992$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
235614772$23561477$2$F$$20240813$20240225$20240818$EXP$$BR-JNJFOC-20240264673$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$CN$BR$BR
235615243$23561524$3$F$$20240626$20240225$20240708$30DAY$$LB-JNJFOC-20240222686$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$CN$LB$LB
235615285$23561528$5$F$$20240409$20240225$20240806$PER$$US-AstraZeneca-2024A035240$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
235615345$23561534$5$F$20240102$20240629$20240225$20240706$EXP$$ES-AUROBINDO-AUR-APL-2024-007717$AUROBINDO$$53$YR$$F$Y$$$20240706$$PH$ES$ES
235615643$23561564$3$F$20240131$20240610$20240225$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000766$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240705$$CN$US$US
235616182$23561618$2$F$$20240905$20240225$20240911$EXP$$US-RDY-SPO/USA/24/0003062$DR REDDYS$$14$YR$T$F$Y$$$20240911$$CN$US$US
235616383$23561638$3$F$20240212$20240304$20240225$20240926$PER$$US-GSK-US2024AMR022244$GLAXOSMITHKLINE$$44$YR$$M$Y$$$20240926$$CN$US$US
235616552$23561655$2$F$$20240702$20240225$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-007410$AUROBINDO$Kibby D, Trinkman H.. Methotrexate level discrepancy post-glucarpidase: A pediatric case series and review of literature.. Pediatric Blood and Cancer. 2024;71(3):e30831$9$YR$$F$Y$49$KG$20240710$$PH$US$US
235616702$23561670$2$F$$20240826$20240225$20240827$PER$$US-JNJFOC-20240256361$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240827$$PH$US$US
235617342$23561734$2$F$20240220$20240820$20240225$20240823$PER$$US-AMGEN-USASP2024038133$AMGEN$$72$YR$E$M$Y$$$20240823$$CN$US$US
235617392$23561739$2$F$20231101$20240807$20240225$20240814$EXP$$US-ABBVIE-5650339$ABBVIE$$56$YR$$F$Y$$$20240814$$CN$US$US
235617412$23561741$2$F$20240223$20240814$20240225$20240816$PER$$US-AMGEN-USASP2024038729$AMGEN$$52$YR$A$M$Y$$$20240816$$CN$US$US
235617854$23561785$4$F$$20240712$20240225$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024294$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240719$$CN$US$US
235618423$23561842$3$F$$20240918$20240225$20240925$EXP$$US-ABBVIE-5651868$ABBVIE$$$$$F$Y$48$KG$20240925$$CN$US$US
235618552$23561855$2$F$20240221$20240731$20240225$20240806$EXP$JP-MMM-TQVGH40I$JP-GSK-JP2024023092$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$HP$JP$JP
235618773$23561877$3$F$20240101$20240730$20240225$20240801$PER$$US-AMGEN-USASP2024039546$AMGEN$$73$YR$E$F$Y$74$KG$20240801$$MD$US$US
235618822$23561882$2$F$20240115$20240701$20240225$20240703$EXP$IT-MINISAL02-971183$IT-JNJFOC-20240264416$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240703$$MD$IT$IT
235619032$23561903$2$F$20230818$20240718$20240225$20240725$EXP$$BR-TAKEDA-2023TUS064326$TAKEDA$$45$YR$$F$Y$$$20240725$$CN$BR$BR
235619094$23561909$4$F$20240128$20240718$20240225$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202402013513$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240731$$CN$US$US
235619215$23561921$5$F$20200101$20240704$20240225$20240711$EXP$$CA-CELLTRION INC.-2020CA024720$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
235619224$23561922$4$F$20160331$20240709$20240225$20240715$EXP$$CA-TAKEDA-2016TUS006377$TAKEDA$$50$YR$$F$Y$$$20240715$$CN$CA$CA
235619502$23561950$2$F$$20240920$20240225$20240928$EXP$$PT-AUROBINDO-AUR-APL-2024-007690$AUROBINDO$Vale C, Matias P, Toste A, Pinheiro I, Sousa S, Goncalves M, et al.. Tubulointerstitial nephritis due to pembrolizumab. Abstract book - 30 Internal Medicine National Congress.. 2024;652$45$YR$$F$Y$$$20240928$$MD$PT$PT
235619653$23561965$3$F$20240220$20240801$20240225$20240805$PER$$US-AMGEN-USASP2024039612$AMGEN$$86$YR$E$M$Y$$$20240805$$CN$US$US
235619783$23561978$3$F$20240223$20240728$20240225$20240802$PER$$US-AMGEN-USASP2024039514$AMGEN$$90$YR$E$M$Y$$$20240802$$CN$US$US
235619932$23561993$2$F$$20240814$20240226$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027237$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240823$$CN$US$US
235620002$23562000$2$F$$20240702$20240226$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-007419$AUROBINDO$Kibby D, Trinkman H.. Methotrexate level discrepancy post-glucarpidase: A pediatric case series and review of literature.. Pediatric Blood and Cancer. 2024;71(3):e30831$5$YR$$F$Y$27$KG$20240711$$PH$US$US
235620212$23562021$2$F$20240126$20240729$20240226$20240729$EXP$$CZ-AstraZeneca-2024A043519$ASTRAZENECA$$75$YR$$M$Y$80$KG$20240729$$MD$CZ$
235620603$23562060$3$F$$20240917$20240226$20240925$EXP$CA-DRL-USA-SPO/CAN/24/0002838$CA-RDY-SPO/CAN/24/0002838$DR REDDYS$$$$$F$Y$$$20240925$$HP$CA$CA
235620903$23562090$3$F$20240222$20240729$20240226$20240731$PER$$US-AMGEN-USASP2024039273$AMGEN$$50$YR$A$M$Y$$$20240731$$CN$US$US
235621002$23562100$2$F$20240122$20240924$20240226$20240927$EXP$$US-TAKEDA-2023TUS034424$TAKEDA$$63$YR$$M$Y$$$20240927$$CN$US$US
235621122$23562112$2$F$20240725$20240809$20240226$20240828$PER$$CA-TOLMAR, INC.-24CA046560$TOLMAR$$76$YR$$M$Y$$$20240828$$CN$CA$CA
235621143$23562114$3$F$$20240910$20240226$20240930$PER$$CA-TOLMAR, INC.-24CA046601$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
235622153$23562215$3$F$$20240805$20240226$20240813$EXP$$IL-TAKEDA-2024TUS015257$TAKEDA$$$$$F$Y$$$20240813$$CN$IL$IL
235622233$23562223$3$F$20230731$20240216$20240226$20240716$EXP$$GB-AMGEN-GBRSP2024035872$AMGEN$$19$YR$A$F$Y$74.3$KG$20240715$$HP$GB$GB
235622635$23562263$5$F$20240101$20240814$20240226$20240822$EXP$$CL-SA-2024SA026645$SANOFI AVENTIS$$22$YR$A$F$Y$92.7$KG$20240823$$MD$CL$CL
235622823$23562282$3$F$20240101$20240722$20240226$20240730$EXP$$US-SA-2024SA058550$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240730$$MD$US$US
235622922$23562292$2$F$$20240919$20240226$20240923$EXP$$CA-SA-2024SA059037$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240923$$HP$CA$CA
235623162$23562316$2$F$$20240919$20240226$20240926$EXP$CA-SA-SAC20240220001213$CA-SA-2024SA059299$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$HP$CA$CA
235623203$23562320$3$F$$20240919$20240226$20240924$EXP$CA-SA-SAC20240221000166$CA-SA-2024SA060017$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240924$$HP$CA$CA
235623233$23562323$3$F$$20240711$20240226$20240718$EXP$$CA-SA-2024SA060040$SANOFI AVENTIS$$$$$F$Y$$$20240718$$MD$CA$CA
235623392$23562339$2$F$20230427$20240826$20240226$20240903$EXP$FR-AFSSAPS-DJ2023001371$FR-SA-2023SA368663$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240903$$MD$FR$FR
235623442$23562344$2$F$20230901$20240711$20240226$20240716$EXP$CA-SA-SAC20240221000982$CA-SA-2024SA060982$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240716$$CN$CA$CA
235623475$23562347$5$F$20240209$20240812$20240226$20240819$EXP$$ZA-TAKEDA-2024TUS014344$TAKEDA$$68$YR$$F$Y$$$20240819$$PH$ZA$ZA
235623522$23562352$2$F$$20240708$20240226$20240713$PER$$US-SA-2024SA049740$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240713$$MD$US$US
235623532$23562353$2$F$20240812$20240906$20240226$20240920$PER$$US-SA-2024SA050569$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240920$$MD$US$US
235623612$23562361$2$F$$20240830$20240226$20240923$PER$$US-SA-2024SA051290$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240923$$CN$US$US
235623724$23562372$4$F$20230901$20240830$20240226$20240913$PER$$US-SA-2024SA053143$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240913$$MD$US$US
235623835$23562383$5$F$20240201$20240830$20240226$20240906$EXP$$JP-GENMAB-2024-00532$GENMAB$$75$YR$$F$Y$$$20240906$$MD$JP$JP
235624842$23562484$2$F$$20240913$20240226$20240923$PER$$US-SA-2024SA055243$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$MD$US$US
235625052$23562505$2$F$20240101$20240826$20240226$20240909$PER$$US-SA-2024SA053879$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240909$$MD$US$US
235625172$23562517$2$F$20240813$20240827$20240226$20240918$PER$$US-SA-2024SA057969$SANOFI AVENTIS$$5$YR$C$F$Y$26.36$KG$20240918$$MD$US$US
235625232$23562523$2$F$20230101$20240816$20240226$20240829$PER$$US-SA-2024SA054614$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240829$$MD$US$US
235625282$23562528$2$F$$20240801$20240226$20240809$PER$$US-SA-2024SA056888$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240809$$MD$US$US
235625432$23562543$2$F$$20240823$20240226$20240902$PER$$US-SA-2024SA055139$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240902$$MD$US$US
235625562$23562556$2$F$20230101$20240709$20240226$20240717$PER$$US-SA-2023SA355951$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240717$$MD$US$US
235625573$23562557$3$F$20240813$20240829$20240226$20240923$PER$$US-SA-2024SA055876$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240923$$MD$US$US
235625603$23562560$3$F$20240101$20240904$20240226$20240926$PER$$US-SA-2024SA056719$SANOFI AVENTIS$$88$YR$E$F$Y$69.09$KG$20240926$$MD$US$US
235625753$23562575$3$F$20240101$20240705$20240226$20240715$PER$$US-SA-2024SA056674$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240715$$MD$US$US
235625822$23562582$2$F$20240101$20240823$20240226$20240916$PER$$US-SA-2024SA054845$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240916$$MD$US$US
235626093$23562609$3$F$20240101$20240806$20240226$20240814$PER$$US-SA-2024SA055772$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240814$$MD$US$US
235626344$23562634$4$F$20240101$20240911$20240226$20240919$PER$$US-SA-2024SA056899$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240919$$MD$US$US
235626772$23562677$2$F$$20240724$20240226$20240801$PER$$US-SA-2024SA056092$SANOFI AVENTIS$$$$A$F$Y$61.2$KG$20240801$$MD$US$US
235626814$23562681$4$F$$20240725$20240226$20240802$PER$$US-SA-2024SA054704$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240802$$MD$US$US
235626892$23562689$2$F$20240212$20240621$20240226$20240701$PER$$US-SA-2024SA053899$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240701$$MD$US$US
235626913$23562691$3$F$20240101$20240703$20240226$20240716$PER$$US-SA-2024SA057335$SANOFI AVENTIS$$50$YR$A$F$Y$95.2$KG$20240716$$MD$US$US
235626932$23562693$2$F$20231201$20240624$20240226$20240703$PER$$US-SA-2024SA058347$SANOFI AVENTIS$$59$YR$A$M$Y$80.28$KG$20240703$$MD$US$US
235627183$23562718$3$F$20240101$20240701$20240226$20240710$PER$$US-SA-2024SA056560$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240710$$MD$US$US
235627622$23562762$2$F$$20240212$20240226$20240830$PER$$US-SA-2024SA055364$SANOFI AVENTIS$$$$A$M$Y$81.6$KG$20240830$$MD$US$US
235628254$23562825$4$F$20240101$20240620$20240226$20240702$PER$$US-SA-2024SA056939$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240702$$MD$US$US
235628492$23562849$2$F$$20240725$20240226$20240805$PER$$US-SA-2024SA055588$SANOFI AVENTIS$$25$YR$A$F$Y$113$KG$20240805$$MD$US$US
235628523$23562852$3$F$20240101$20240711$20240226$20240801$PER$$US-SA-2024SA055487$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240719$$MD$US$US
235628702$23562870$2$F$$20240903$20240226$20240925$PER$$US-SA-2024SA057261$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240925$$CN$US$US
235628773$23562877$3$F$20240401$20240711$20240226$20240718$PER$$US-SA-2024SA054269$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240718$$MD$US$US
235628913$23562891$3$F$20240101$20240731$20240226$20240807$PER$$US-SA-2024SA054894$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240807$$MD$US$US
235628932$23562893$2$F$20240130$20240620$20240226$20240704$PER$$US-SA-2024SA055001$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240704$$MD$US$US
235628962$23562896$2$F$$20240801$20240226$20240810$PER$$US-SA-2024SA058331$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240810$$MD$US$US
235629187$23562918$7$F$20231201$20240914$20240226$20240923$PER$$US-SA-2024SA057128$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240923$$CN$US$US
235629292$23562929$2$F$$20240722$20240226$20240731$PER$$US-SA-2024SA056776$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240731$$MD$US$US
235629322$23562932$2$F$$20240726$20240226$20240802$PER$$US-SA-2024SA055037$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240802$$MD$US$US
235629482$23562948$2$F$20240201$20240725$20240226$20240805$PER$$US-SA-2024SA054050$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240805$$MD$US$US
235629882$23562988$2$F$20230101$20240820$20240226$20240830$PER$$US-SA-2024SA058674$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240830$$MD$US$US
235629903$23562990$3$F$20240101$20240904$20240226$20240912$PER$$US-SA-2024SA057508$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240912$$MD$US$US
235629912$23562991$2$F$20240112$20240829$20240226$20240911$PER$$US-SA-2024SA057762$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240911$$MD$US$US
235630254$23563025$4$F$20231216$20240728$20240226$20240806$PER$$US-SA-2024SA058757$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240806$$MD$US$US
235630332$23563033$2$F$$20240827$20240226$20240919$PER$$US-SA-2024SA057728$SANOFI AVENTIS$$63$YR$A$F$Y$104$KG$20240919$$MD$US$US
235630682$23563068$2$F$20240701$20240722$20240226$20240731$PER$$US-SA-2024SA058173$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240731$$MD$US$US
235631005$23563100$5$F$20240101$20240725$20240226$20240806$PER$$US-SA-2024SA059054$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240806$$MD$US$US
235631144$23563114$4$F$$20240716$20240226$20240723$PER$$US-SA-2024SA057937$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240723$$HP$US$US
235631212$23563121$2$F$$20240812$20240226$20240819$PER$$US-SA-2024SA058812$SANOFI AVENTIS$$$$E$F$Y$$$20240819$$MD$US$US
235631412$23563141$2$F$20240901$20240913$20240226$20240923$PER$$US-SA-2024SA057742$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240923$$MD$US$US
235631492$23563149$2$F$20240101$20240904$20240226$20240913$PER$$US-SA-2024SA058486$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240913$$MD$US$US
235631554$23563155$4$F$20231201$20240905$20240226$20240915$PER$$US-SA-2024SA060014$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240915$$MD$US$US
235631633$23563163$3$F$20240814$20240816$20240226$20240830$PER$$US-SA-2024SA061190$SANOFI AVENTIS$$60$YR$A$F$Y$73$KG$20240830$$MD$US$US
235631702$23563170$2$F$20200901$20240813$20240226$20240826$PER$$US-SA-2024SA060364$SANOFI AVENTIS$$66$YR$E$M$Y$99.7$KG$20240826$$MD$US$US
235631712$23563171$2$F$20240102$20240622$20240226$20240701$PER$$US-SA-2024SA057768$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240701$$MD$US$US
235631784$23563178$4$F$20230101$20240702$20240226$20240711$PER$$US-SA-2024SA058731$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240711$$MD$US$US
235631823$23563182$3$F$20240215$20240624$20240226$20240703$PER$$US-SA-2024SA059740$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240703$$MD$US$US
235631852$23563185$2$F$20240101$20240731$20240226$20240809$PER$$US-SA-2024SA059697$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240809$$MD$US$US
235632773$23563277$3$F$20240601$20240620$20240226$20240703$PER$$US-SA-2024SA059973$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240703$$MD$US$US
235632822$23563282$2$F$$20240828$20240226$20240906$PER$$US-SA-2024SA060828$SANOFI AVENTIS$$3$YR$C$M$Y$14$KG$20240906$$CN$US$US
235633172$23563317$2$F$$20240829$20240226$20240916$PER$$US-SA-2024SA060116$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240916$$MD$US$US
235633312$23563331$2$F$20240101$20240719$20240226$20240729$PER$$US-SA-2024SA060933$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240729$$MD$US$US
235633363$23563336$3$F$$20240724$20240226$20240802$PER$$US-SA-2024SA060987$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240802$$MD$US$US
235633393$23563339$3$F$$20240807$20240226$20240816$PER$$US-SA-2024SA060539$SANOFI AVENTIS$$51$YR$A$F$Y$79.37$KG$20240816$$MD$US$US
235633553$23563355$3$F$20240101$20240830$20240226$20240911$PER$$US-SA-2024SA059849$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240911$$MD$US$US
235633658$23563365$8$F$20240101$20240827$20240226$20240913$PER$$US-SA-2024SA062757$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240913$$HP$US$US
235633662$23563366$2$F$$20240826$20240226$20240916$PER$$US-SA-2024SA061715$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240916$$MD$US$US
235633784$23563378$4$F$20220201$20240702$20240226$20240711$PER$$US-SA-2024SA060937$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240711$$MD$US$US
235633793$23563379$3$F$$20240625$20240226$20240704$PER$$US-SA-2024SA061544$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240704$$MD$US$US
235633892$23563389$2$F$20231001$20240828$20240226$20240911$PER$$US-SA-2024SA061998$SANOFI AVENTIS$$47$YR$A$F$Y$203$KG$20240911$$MD$US$US
235634104$23563410$4$F$20240112$20240828$20240226$20240909$30DAY$$IL-JNJFOC-20240204620$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$PH$IL$IL
235634534$23563453$4$F$20221107$20240925$20240226$20240926$EXP$$NVSJ2024JP001732$NOVARTIS$$26$YR$$M$Y$66.1$KG$20240926$$MD$JP$JP
235634652$23563465$2$F$$20240809$20240226$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029981$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$92.53$KG$20240813$$CN$US$US
235634782$23563478$2$F$20240401$20240611$20240226$20240707$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000553$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240707$$CN$US$US
235634814$23563481$4$F$$20240819$20240226$20240823$PER$$US-BIOGEN-2024BI01251867$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
235635014$23563501$4$F$20230906$20240809$20240226$20240817$EXP$$CA-CELLTRION INC.-2023CA002428$CELLTRION$$$$$$Y$$$20240817$$MD$CA$CA
235635274$23563527$4$F$$20240730$20240226$20240801$EXP$$CA-ROCHE-3342039$ROCHE$$29$YR$A$F$Y$$$20240801$$CN$CA$CA
235635309$23563530$9$F$20231201$20240909$20240226$20240916$EXP$$CA-GSK-CA2023181191$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$CA$CA
235635313$23563531$3$F$$20240801$20240226$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-027232$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240809$$MD$JP$JP
235635324$23563532$4$F$$20240912$20240226$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029068$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240913$$CN$US$US
235635543$23563554$3$F$$20240531$20240226$20240726$PER$$US-LUNDBECK-DKLU3073871$LUNDBECK$$$$$$Y$$$20240726$$CN$US$US
235635792$23563579$2$F$20240115$20240729$20240226$20240808$EXP$FR-AFSSAPS-LM2024000067$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-103655$ZYDUS PHARM$$$$$$Y$$$20240808$$MD$FR$FR
235635913$23563591$3$F$20240201$20240909$20240226$20240930$PER$$US-TRAVERE-2024TVT00137$TRAVERE THERAPEUTICS$$50$YR$A$M$Y$$$20240930$$CN$US$US
235635922$23563592$2$F$20231120$20240710$20240226$20240710$EXP$$DE-SANDOZ INC.-SDZ2024DE018546$SANDOZ$$34$YR$$F$Y$47$KG$20240710$$MD$DE$DE
2356360712$23563607$12$F$20231230$20240813$20240226$20240820$EXP$$CA-JNJFOC-20240104964$JOHNSON AND JOHNSON$$10$YR$C$F$Y$45.4$KG$20240820$$HP$CA$CA
235636162$23563616$2$F$$20240820$20240226$20240828$EXP$$US-EMD Serono-2024008960$EMD SERONO INC$$$$A$F$Y$$$20240828$$CN$US$US
235636452$23563645$2$F$$20240214$20240226$20240730$EXP$$US-SAMSUNG BIOEPIS-SB-2024-05658$SAMSUNG BIOEPIS$$68$YR$E$F$Y$$$20240730$$MD$US$US
235636632$23563663$2$F$20240222$20240729$20240226$20240731$PER$$US-AMGEN-USASP2024038481$AMGEN$$62$YR$A$F$Y$$$20240730$$CN$US$US
235637116$23563711$6$F$20220218$20240903$20240226$20240917$EXP$$US-UCBSA-2024007540$UCB$$22$YR$$M$Y$108.84$KG$20240917$$MD$US$US
235637125$23563712$5$F$20231003$20240919$20240226$20240926$EXP$$US-TAKEDA-2024TUS001207$TAKEDA$$34$YR$$F$Y$72$KG$20240926$$HP$US$US
235637902$23563790$2$F$$20240215$20240226$20240813$EXP$$PA-SANDOZ INC.-NVSC2023PA099817$SANDOZ$$$$$F$Y$$$20240813$$CN$PA$PA
235638034$23563803$4$F$$20240814$20240226$20240820$EXP$$CA-JAZZ PHARMACEUTICALS-2023-CA-008513$JAZZ$$$$$F$Y$$$20240820$$HP$CA$CA
235638253$23563825$3$F$$20240923$20240226$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029538$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240924$$CN$US$US
235638479$23563847$9$F$20231122$20240807$20240226$20240808$EXP$$US-SANDOZ INC.-SDZ2024US018177$SANDOZ$$66$YR$$M$Y$51.2$KG$20240808$$MD$US$US
235638673$23563867$3$F$20220707$20240731$20240226$20240805$EXP$$CA-TAKEDA-2022TUS035962$TAKEDA$$65$YR$$M$Y$$$20240804$$MD$CA$CA
235638736$23563873$6$F$20230101$20240729$20240226$20240802$EXP$$US-UCBSA-2023028246$UCB$$$$$M$Y$76$KG$20240802$$CN$US$US
235638775$23563877$5$F$20240109$20240624$20240226$20240702$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000160$DECIPHERA PHARMACEUTICALS$$76$YR$E$M$Y$$$20240702$$MD$US$US
235638848$23563884$8$F$20231101$20240829$20240226$20240906$EXP$$DE-ROCHE-3458307$ROCHE$$36$YR$A$F$Y$70$KG$20240906$$MD$DE$DE
235638896$23563889$6$F$$20240916$20240226$20240923$EXP$$US-TAKEDA-2024TUS014423$TAKEDA$$$$$F$Y$88$KG$20240923$$HP$US$US
235639222$23563922$2$F$$20240919$20240226$20240926$EXP$$CA-TAKEDA-2024TUS017557$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
235639362$23563936$2$F$$20240710$20240226$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026321$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240712$$CN$US$US
235639682$23563968$2$F$$20240725$20240226$20240801$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000384$BLUEPRINT MEDICINES$$$$E$M$Y$$$20240801$$CN$US$US
235640214$23564021$4$F$20240213$20240809$20240226$20240816$30DAY$$US-JNJFOC-20240239760$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240816$$CN$US$US
235640452$23564045$2$F$20230831$20240919$20240226$20240922$30DAY$$US-SANDOZ INC.-SDZ2023US029254$SANDOZ$$14$YR$$M$Y$$$20240922$$CN$US$US
235641063$23564106$3$F$20240215$20240814$20240226$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028639$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240822$$CN$US$US
235641073$23564107$3$F$20240212$20240729$20240226$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025758$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240731$$HP$US$GU
235641194$23564119$4$F$20240101$20240724$20240226$20240801$EXP$$US-ORPHANEU-2024001273$RECORDATI$$$$$$Y$$$20240801$$CN$US$US
235641234$23564123$4$F$20221008$20240724$20240226$20240805$EXP$$BR-TAKEDA-2022TUS084394$TAKEDA$$52$YR$$F$Y$$$20240805$$CN$BR$BR
235641353$23564135$3$F$20240213$20240715$20240226$20240717$PER$$US-AMGEN-USASP2024039588$AMGEN$$75$YR$E$F$Y$$$20240716$$CN$US$US
235641422$23564142$2$F$20240201$20240627$20240226$20240704$EXP$$CA-JNJFOC-20240259417$JOHNSON AND JOHNSON$$57$YR$A$M$Y$83$KG$20240704$$HP$CA$CA
235641433$23564143$3$F$20240201$20240820$20240226$20240822$EXP$$DO-JNJFOC-20240262088$JOHNSON AND JOHNSON$$32$YR$A$F$Y$35$KG$20240823$$MD$DO$DO
235641563$23564156$3$F$20240201$20240624$20240226$20240702$PER$$US-ALXN-202402USA001437US$ALEXION PHARMACEUTICALS$$45$YR$$F$Y$$$20240702$$CN$US$US
235641642$23564164$2$F$$20240828$20240226$20240829$EXP$$NVSC2024GB038919$NOVARTIS$$$$$$Y$$$20240829$$CN$GB$GB
235641665$23564166$5$F$20140101$20240808$20240226$20240813$EXP$$US-BAUSCH-BL-2024-002785$BAUSCH AND LOMB$$83$YR$$F$Y$51.302$KG$20240813$$CN$US$US
235641852$23564185$2$F$$20240722$20240226$20240727$EXP$$GB-ROCHE-3513759$ROCHE$$40$YR$A$F$Y$$$20240727$$HP$GB$GB
2356418910$23564189$10$F$20230101$20240906$20240226$20240918$EXP$$US-INSMED, INC.-2023-01243-US$INSMED$$$$$F$Y$$$20240918$$HP$US$US
235642163$23564216$3$F$$20240808$20240226$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029828$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240812$$CN$US$US
235642232$23564223$2$F$$20240215$20240226$20240923$PER$$RU-ROCHE-3512325$ROCHE$$$$$F$Y$$$20240923$$MD$RU$RU
235642403$23564240$3$F$$20240911$20240226$20240925$EXP$JP-MLMSERVICE-20240208-4824757-1$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-02830$ALKEM$Sasaki T, Mizoguchi K, Genda K, Endo S, Kondo Y, Mikami T, et al.. Primary role of dextromethorphan in prolonged toxic encephalopathy with intermittent rhythmic slow-wave activity on electroencephalogram: A case report. Psychiatry and Clinical Neurosciences. 2023;78(3):212-4$19$YR$$F$Y$55$KG$20240925$$MD$JP$JP
235642526$23564252$6$F$20240101$20240620$20240226$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000422$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240712$$CN$US$US
235642686$23564268$6$F$20240301$20240819$20240226$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029275$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240827$$CN$US$US
235642815$23564281$5$F$20240523$20240729$20240226$20240731$EXP$$CA-TAKEDA-2024TUS016436$TAKEDA$$36$YR$$F$Y$$$20240731$$CN$CA$CA
235642982$23564298$2$F$$20240806$20240226$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029797$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240810$$CN$US$US
235643356$23564335$6$F$20240709$20240709$20240226$20240712$EXP$$CA-GSK-CA2024000614$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$HP$CA$CA
235643373$23564337$3$F$20240217$20240617$20240226$20240704$30DAY$$US-GSK-US2024022097$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240704$$CN$US$US
235644102$23564410$2$F$20240601$20240702$20240226$20240704$EXP$$US-UCBSA-2024008779$UCB$$23$YR$$M$Y$56.236$KG$20240704$$MD$US$US
235644333$23564433$3$F$$20240710$20240226$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028546$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240715$$CN$US$US
235645142$23564514$2$F$20230928$20240723$20240226$20240729$EXP$$FR-ASTELLAS-2023US036741$ASTELLAS$$74$YR$$F$Y$$$20240729$$PH$FR$FR
235645744$23564574$4$F$20220501$20240808$20240226$20240819$EXP$$JP-JNJFOC-20240152083$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20240819$$CN$JP$JP
235646274$23564627$4$F$$20240709$20240226$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030215$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$74.39$KG$20240712$$CN$US$US
235646583$23564658$3$F$$20240809$20240226$20240813$PER$$US-TRAVERE-2024TVT00166$TRAVERE THERAPEUTICS$$43$YR$A$M$Y$$$20240813$$CN$US$US
235646666$23564666$6$F$$20240829$20240226$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030154$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$123.38$KG$20240902$$CN$US$US
235646862$23564686$2$F$20231201$20240705$20240226$20240715$EXP$IT-MINISAL02-960328$IT-TEVA-VS-3158339$TEVA$$14$YR$$F$Y$41$KG$20240715$$PH$IT$IT
235647258$23564725$8$F$20240101$20240822$20240226$20240921$EXP$$CA-CELLTRION INC.-2024CA004715$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
235647312$23564731$2$F$20240101$20240823$20240226$20240906$EXP$$US-UCBSA-2024008619$UCB$$$$$F$Y$$$20240906$$HP$US$US
235647885$23564788$5$F$$20240809$20240226$20240813$30DAY$$KR-PFIZER INC-PV202300195319$PFIZER$$6$YR$$F$Y$$$20240813$$CN$KR$KR
235647964$23564796$4$F$$20240813$20240226$20240815$30DAY$$SE-PFIZER INC-PV202400018289$PFIZER$$$$A$$Y$$$20240815$$PH$SE$SE
235648112$23564811$2$F$20240101$20240806$20240226$20240816$EXP$$CA-SAMSUNG BIOEPIS-SB-2022-17579$SAMSUNG BIOEPIS$$66$YR$E$F$Y$$$20240816$$HP$CA$CA
235648672$23564867$2$F$20240216$20240725$20240226$20240729$PER$$US-AMGEN-USASP2024039146$AMGEN$$63$YR$A$M$Y$$$20240729$$CN$US$US
235648852$23564885$2$F$$20240712$20240226$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030376$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240716$$CN$US$US
235649043$23564904$3$F$$20240721$20240226$20240829$EXP$$US-BAYER-2024A026673$BAYER$$$$$$Y$$$20240829$$CN$US$US
235649133$23564913$3$F$20240116$20240711$20240226$20240715$EXP$$CA-TAKEDA-2024TUS017359$TAKEDA$$51$YR$$M$Y$$$20240715$$CN$CA$CA
235649277$23564927$7$F$20240130$20240820$20240226$20240822$30DAY$$US-PFIZER INC-202400036131$PFIZER$$16$YR$$M$Y$$$20240822$$CN$US$US
235649553$23564955$3$F$$20240321$20240226$20240807$EXP$$US-AstraZeneca-2024A042168$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
235649805$23564980$5$F$20240314$20240628$20240226$20240705$EXP$$US-BAYER-2024A027225$BAYER$$39$YR$A$M$Y$80.726$KG$20240705$$HP$US$US
235650133$23565013$3$F$$20240910$20240226$20240912$EXP$$CA-PFIZER INC-202400049085$PFIZER$$70$YR$$F$Y$$$20240912$$PH$CA$CA
235650694$23565069$4$F$20240301$20240607$20240226$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000789$ACADIA PHARMACEUTICALS$$2$YR$$M$Y$$$20240701$$CN$US$US
235651032$23565103$2$F$20220710$20240704$20240226$20240718$EXP$$AU-LUPIN HEALTHCARE (UK) LIMITED-2024-01315$LUPIN$$53$YR$$F$Y$$$20240718$$CN$AU$AU
235651142$23565114$2$F$20230321$20240920$20240226$20240924$EXP$$CN-PFIZER INC-PV202400024198$PFIZER$Tian, Z.. A case of immune myocarditis induced by serplulimab combined with Axitinib. Herald of Medicine. 2024;43(9):1496-1498$57$YR$$M$Y$65$KG$20240924$$PH$CN$CN
235651544$23565154$4$F$$20240703$20240226$20240708$PER$$US-PFIZER INC-PV202400025096$PFIZER$$83$YR$$F$Y$$$20240708$$CN$US$US
235651624$23565162$4$F$$20240913$20240226$20240918$EXP$$US-PFIZER INC-PV202400024587$PFIZER$$76$YR$$F$Y$63.492$KG$20240918$$CN$US$US
235651812$23565181$2$F$20230408$20231018$20240226$20240814$EXP$$NVSC2023IN279642$NOVARTIS$$64$YR$$F$Y$$$20240814$$CN$IN$IN
235651824$23565182$4$F$20240210$20240813$20240226$20240820$PER$$US-PFIZER INC-PV202400023716$PFIZER$$64$YR$$F$Y$$$20240820$$CN$US$US
235652216$23565221$6$F$20240101$20240920$20240226$20240927$EXP$$CA-JNJFOC-20231067773$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240927$$CN$CA$CA
235652254$23565225$4$F$20240101$20240816$20240226$20240821$PER$$US-PFIZER INC-PV202400025266$PFIZER$$18$YR$$M$Y$$$20240821$$HP$US$US
235652313$23565231$3$F$20210101$20240918$20240226$20240920$PER$$US-PFIZER INC-PV202400025521$PFIZER$$53$YR$$F$Y$$$20240920$$HP$US$US
235652333$23565233$3$F$$20240822$20240226$20240827$PER$$US-PFIZER INC-PV202200076055$PFIZER$$74$YR$$F$Y$$$20240827$$MD$US$US
235652343$23565234$3$F$20240101$20240703$20240226$20240708$PER$$US-PFIZER INC-202400049525$PFIZER$$69$YR$$F$Y$$$20240708$$CN$US$US
235652362$23565236$2$F$$20240724$20240226$20240731$PER$$US-PFIZER INC-PV202400025971$PFIZER$$59$YR$$F$Y$$$20240731$$HP$US$US
235652683$23565268$3$F$20111201$20240816$20240226$20240822$EXP$$AR-PFIZER INC-PV202400015087$PFIZER$$66$YR$$F$Y$$$20240822$$CN$AR$AR
235652732$23565273$2$F$20230830$20240919$20240226$20240923$EXP$$CA-SA-2024SA059111$SANOFI AVENTIS$$75$YR$E$F$Y$80$KG$20240923$$MD$CA$CA
235653332$23565333$2$F$20230326$20240903$20240226$20240904$EXP$$US-TAKEDA-2023TUS033419$TAKEDA$$33$YR$$F$Y$45.805$KG$20240904$$CN$US$US
235653344$23565334$4$F$20220519$20240904$20240226$20240910$EXP$$ZA-TAKEDA-2022TUS004149$TAKEDA$$48$YR$$M$Y$$$20240910$$MD$ZA$ZA
235653622$23565362$2$F$$20240919$20240226$20240926$EXP$$CA-SA-2024SA059552$SANOFI AVENTIS$$43$YR$A$F$Y$70$KG$20240926$$HP$CA$CA
235653645$23565364$5$F$20240301$20240920$20240226$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030390$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240925$$CN$US$US
235654922$23565492$2$F$$20240627$20240226$20240704$EXP$$CA-APOTEX-2024AP002423$APOTEX$$13$YR$$M$Y$$$20240704$$HP$CA$CA
235655462$23565546$2$F$$20240906$20240226$20240912$EXP$$US-GILEAD-2024-0663235$GILEAD$$68$YR$E$M$Y$$$20240912$$MD$US$US
235655572$23565557$2$F$$20240906$20240226$20240911$EXP$$US-GILEAD-2024-0663244$GILEAD$$66$YR$E$M$Y$$$20240911$$MD$US$US
235656156$23565615$6$F$20230902$20240905$20240226$20240912$EXP$$CO-TAKEDA-2023TUS082239$TAKEDA$$39$YR$$M$Y$70$KG$20240912$$CN$CO$CO
235656192$23565619$2$F$20240101$20240819$20240226$20240829$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00111$XERIS PHARMACEUTICALS$$$$$M$Y$$$20240828$$HP$US$US
235656282$23565628$2$F$20231110$20240214$20240226$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202402008659$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240828$$CN$US$US
235657005$23565700$5$F$20231027$20240808$20240226$20240813$PER$$US-PFIZER INC-PV202400020948$PFIZER$$71$YR$$F$Y$$$20240813$$MD$US$US
235657202$23565720$2$F$20220731$20240826$20240226$20240829$EXP$$US-TAKEDA-2022TUS056190$TAKEDA$$63$YR$$F$Y$54$KG$20240829$$CN$US$US
235657333$23565733$3$F$$20240813$20240226$20240816$EXP$$GB-SANDOZ INC.-NVSC2020GB175136$SANDOZ$$$$$M$Y$$$20240816$$CN$GB$GB
235657423$23565742$3$F$$20240919$20240226$20240924$EXP$$CA-SA-2024SA059110$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240924$$HP$CA$CA
235657665$23565766$5$F$20191016$20240904$20240226$20240912$EXP$$JP-ABBVIE-5653246$ABBVIE$$58$YR$$M$Y$76$KG$20240912$$MD$JP$JP
235657722$23565772$2$F$20240101$20240903$20240226$20240906$PER$$US-BAYER-2024A027357$BAYER$$31$YR$A$F$Y$$$20240906$$HP$US$US
235658492$23565849$2$F$20230101$20240730$20240226$20240805$EXP$$US-ABBVIE-5650401$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
235659132$23565913$2$F$20240222$20240718$20240226$20240722$PER$$US-AMGEN-USASP2024039659$AMGEN$$68$YR$E$F$Y$$$20240722$$CN$US$US
235659317$23565931$7$F$20240325$20240715$20240226$20240718$EXP$$US-PFIZER INC-PV202400024464$PFIZER$$55$YR$$F$Y$$$20240718$$HP$US$US
235659795$23565979$5$F$20240101$20240829$20240226$20240912$EXP$$US-UCBSA-2024006263$UCB$$64$YR$$M$Y$69.841$KG$20240912$$HP$US$US
235659922$23565992$2$F$20240101$20240709$20240226$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-015706$JAZZ$$$$$F$Y$$$20240716$$CN$US$US
235659975$23565997$5$F$20240513$20240905$20240226$20240910$EXP$$BR-TAKEDA-2022TUS026043$TAKEDA$$53$YR$$M$Y$77$KG$20240910$$CN$BR$BR
235660082$23566008$2$F$20230917$20240711$20240226$20240718$EXP$$CA-SA-2024SA060063$SANOFI AVENTIS$$53$YR$A$F$Y$122.47$KG$20240718$$PH$CA$CA
235660282$23566028$2$F$20240101$20240813$20240226$20240816$EXP$$CA-JNJFOC-20240258796$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240816$$HP$CA$CA
235660618$23566061$8$F$20231101$20240612$20240226$20240705$EXP$$DE-ROCHE-3454594$ROCHE$$35$YR$A$M$Y$$$20240705$$MD$DE$DE
235660864$23566086$4$F$20231213$20240716$20240226$20240718$EXP$$FR-SANDOZ INC.-SDZ2024FR018417$SANDOZ$$71$YR$$F$Y$66$KG$20240718$$MD$FR$FR
235661022$23566102$2$F$$20240820$20240226$20240828$EXP$$CA-GALDERMA-CA2024002753$GALDERMA$$$$$$Y$$$20240828$$HP$CA$CA
235662292$23566229$2$F$$20240906$20240226$20240912$EXP$$US-GILEAD-2024-0663217$GILEAD$$65$YR$E$M$Y$$$20240912$$MD$US$US
235662452$23566245$2$F$20240221$20240813$20240226$20240819$EXP$$CA-JNJFOC-20240266839$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240819$$HP$CA$CA
2356625715$23566257$15$F$20230501$20240712$20240226$20240716$EXP$$GB-AMGEN-GBRSP2023137058$AMGEN$$$$A$F$Y$88$KG$20240716$$MD$GB$GB
235662922$23566292$2$F$20040618$20240711$20240226$20240718$EXP$$CA-SA-2024SA060050$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240718$$HP$CA$CA
235662942$23566294$2$F$$20240906$20240226$20240913$EXP$$US-GILEAD-2024-0663231$GILEAD$$69$YR$E$M$Y$$$20240913$$MD$US$US
235663252$23566325$2$F$20240101$20240722$20240226$20240726$EXP$$US-SA-2024SA062998$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240726$$MD$US$US
235663562$23566356$2$F$20240127$20240628$20240226$20240702$PER$$FR-JAZZ PHARMACEUTICALS-2024-FR-003368$JAZZ$$$$$$Y$$$20240702$$HP$FR$FR
235663572$23566357$2$F$$20240813$20240226$20240820$EXP$$PH-OTSUKA-2024_004329$OTSUKA$$$$$M$Y$$$20240820$$CN$PH$PH
235663642$23566364$2$F$$20240906$20240226$20240913$EXP$$US-GILEAD-2024-0663234$GILEAD$$73$YR$E$M$Y$$$20240913$$MD$US$US
235663722$23566372$2$F$$20240906$20240226$20240911$EXP$$US-GILEAD-2024-0663242$GILEAD$$70$YR$E$M$Y$$$20240911$$MD$US$US
235663862$23566386$2$F$$20240906$20240226$20240912$EXP$$US-GILEAD-2024-0663232$GILEAD$$74$YR$E$M$Y$$$20240912$$MD$US$US
235664235$23566423$5$F$$20240826$20240226$20240831$EXP$$GB-TAKEDA-2024TUS017600$TAKEDA$$$$$F$Y$$$20240831$$CN$GB$GB
235664902$23566490$2$F$$20240903$20240226$20240910$EXP$$US-ABBVIE-5645723$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
235665834$23566583$4$F$20240101$20240820$20240226$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030627$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240828$$CN$US$US
235666103$23566610$3$F$$20240822$20240226$20240828$PER$$US-BIOGEN-2024BI01251958$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
235666845$23566684$5$F$20231012$20240701$20240226$20240703$PER$$JP-Eisai-EC-2024-159940$EISAI$$84$YR$E$F$Y$51$KG$20240703$$MD$JP$JP
235667753$23566775$3$F$20230101$20240607$20240226$20240812$EXP$$NVSC2024BR001562$NOVARTIS$$$$$F$Y$$$20240812$$CN$BR$BR
235668526$23566852$6$F$20240126$20240816$20240226$20240821$EXP$$NVSC2024FR039719$NOVARTIS$$$$A$F$Y$$$20240821$$MD$FR$FR
235668934$23566893$4$F$20230718$20240726$20240226$20240802$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02557$AMNEAL$$61$YR$$M$Y$$$20240802$$CN$US$US
235669022$23566902$2$F$$20240906$20240226$20240912$EXP$$US-GILEAD-2024-0663236$GILEAD$$66$YR$E$M$Y$$$20240912$$MD$US$US
235669722$23566972$2$F$$20240802$20240226$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030662$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240805$$CN$US$US
235669812$23566981$2$F$$20240906$20240226$20240912$EXP$$US-GILEAD-2024-0663233$GILEAD$$80$YR$E$F$Y$$$20240912$$MD$US$US
235669972$23566997$2$F$$20240702$20240226$20240709$EXP$$US-PFIZER INC-PV202400025537$PFIZER$$26$YR$$F$Y$$$20240709$$CN$US$US
235670003$23567000$3$F$$20240815$20240226$20240819$EXP$$US-PFIZER INC-PV202400004132$PFIZER$$63$YR$$F$Y$$$20240819$$HP$US$US
235670225$23567022$5$F$20220620$20240820$20240226$20240822$EXP$$CA-PFIZER INC-202200986193$PFIZER$$82$YR$$F$Y$$$20240822$$MD$CA$CA
235670577$23567057$7$F$$20240617$20240226$20240702$EXP$$CA-PFIZER INC-202400049312$PFIZER$$40$YR$$F$Y$$$20240702$$HP$CA$CA
235670622$23567062$2$F$$20240726$20240226$20240802$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04263$AMNEAL$$$$$F$Y$$$20240802$$CN$US$US
235670662$23567066$2$F$$20240906$20240226$20240911$EXP$$US-GILEAD-2024-0663228$GILEAD$$82$YR$E$F$Y$$$20240911$$MD$US$US
235670932$23567093$2$F$$20240906$20240226$20240912$EXP$$US-GILEAD-2024-0663237$GILEAD$$62$YR$A$M$Y$$$20240912$$MD$US$US
235670962$23567096$2$F$$20240906$20240226$20240912$EXP$$US-GILEAD-2024-0663240$GILEAD$$61$YR$A$M$Y$$$20240912$$MD$US$US
235670973$23567097$3$F$$20240627$20240226$20240703$EXP$$US-ANIPHARMA-2024-US-010678$ANI$$$$$F$Y$$$20240703$$HP$US$US
235671484$23567148$4$F$20220101$20240627$20240226$20240701$EXP$$JP-OTSUKA-2024_004609$OTSUKA$$75$YR$$M$Y$66.7$KG$20240701$$MD$JP$JP
235671685$23567168$5$F$20240207$20240725$20240226$20240730$EXP$$BE-PFIZER INC-202400048267$PFIZER$$74$YR$$M$Y$85$KG$20240730$$MD$BE$BE
235671782$23567178$2$F$$20240718$20240226$20240722$EXP$$CA-PFIZER INC-202400048810$PFIZER$$76$YR$$M$Y$$$20240722$$CN$CA$CA
235671863$23567186$3$F$20240223$20240816$20240226$20240821$PER$$US-AMGEN-USASP2024039589$AMGEN$$76$YR$E$M$Y$$$20240820$$CN$US$US
235672103$23567210$3$F$20230101$20240708$20240226$20240710$EXP$$US-PFIZER INC-202400049778$PFIZER$$69$YR$$F$Y$90.703$KG$20240710$$CN$US$US
235672154$23567215$4$F$20240101$20240904$20240226$20240911$EXP$$CA-PFIZER INC-202400039423$PFIZER$$30$YR$$F$Y$129$KG$20240911$$HP$CA$CA
235672424$23567242$4$F$$20240903$20240226$20240906$EXP$$GR-MYLANLABS-2024M1016892$MYLAN$Gole E, Mitsioni A, Darema M, Malakasioti G, Askiti V. Effect of Leflunomide on Treatment of Pediatric Renal Transplant Recipients With BK Virus Infection. EXPERIMENTAL AND CLINICAL TRANSFORMATION. 2023;21 (10):826-30$15$YR$$F$Y$$$20240906$$HP$GR$GR
235673244$23567324$4$F$20230510$20240703$20240226$20240709$EXP$$JP-DSJP-DSJ-2024-108183$DAIICHI$$46$YR$$F$Y$78$KG$20240709$$MD$JP$JP
235673849$23567384$9$F$$20240722$20240226$20240726$PER$$US-PFIZER INC-PV202400025405$PFIZER$$68$YR$$F$Y$63.2$KG$20240726$$MD$US$US
235673922$23567392$2$F$$20240830$20240226$20240903$30DAY$$ZA-SANDOZ INC.-SDZ2024ZA013434$SANDOZ$$$$$F$Y$$$20240903$$CN$ZA$ZA
235674394$23567439$4$F$20240220$20240905$20240226$20240925$PER$$US-JNJFOC-20240261412$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240925$$HP$US$US
235674455$23567445$5$F$$20240910$20240226$20240913$EXP$$US-SANDOZ INC.-NVSC2021US192569$SANDOZ$$$$$F$Y$64.853$KG$20240913$$CN$US$US
235674644$23567464$4$F$$20240724$20240226$20240805$EXP$$TN-BEH-2024168730$CSL BEHRING$$15$YR$T$F$Y$$$20240805$$HP$TN$TN
235675294$23567529$4$F$20240220$20240816$20240226$20240821$PER$$US-AMGEN-USASP2024037761$AMGEN$$54$YR$A$F$Y$66.667$KG$20240821$$MD$US$US
235675842$23567584$2$F$$20240805$20240226$20240806$EXP$$DE-SANDOZ INC.-SDZ2024DE018432$SANDOZ$$54$YR$$$Y$$$20240806$$HP$DE$DE
235675952$23567595$2$F$$20240919$20240226$20240923$EXP$$FR-ABBVIE-5652571$ABBVIE$$$$$F$Y$$$20240923$$MD$FR$FR
235676114$23567611$4$F$20231109$20240807$20240226$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030673$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$99.8$KG$20240814$$HP$US$US
235676253$23567625$3$F$$20240905$20240226$20240912$EXP$$US-ABBVIE-4345574$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
235676393$23567639$3$F$20230612$20240903$20240226$20240911$EXP$$CA-CELLTRION INC.-2023CA002642$CELLTRION$$$$$$Y$$$20240911$$MD$CA$CA
235676864$23567686$4$F$$20240806$20240226$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027709$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240809$$CN$US$US
235677082$23567708$2$F$20240218$20240821$20240226$20240825$EXP$$US-ABBVIE-5652393$ABBVIE$$71$YR$$M$Y$$$20240825$$CN$US$US
235677523$23567752$3$F$$20240909$20240226$20240916$EXP$$CA-GSK-CA2024023254$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$CA$CA
235677713$23567771$3$F$20240211$20240909$20240226$20240927$PER$$US-SA-2024SA057081$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240927$$MD$US$US
235678025$23567802$5$F$20230801$20240610$20240226$20240705$PER$$US-SA-2024SA056622$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240705$$MD$US$US
235678422$23567842$2$F$20240701$20240829$20240226$20240911$PER$$US-SA-2024SA058162$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240911$$MD$US$US
235678587$23567858$7$F$20240101$20240812$20240226$20240821$PER$$US-SA-2024SA059113$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240821$$MD$US$US
235678613$23567861$3$F$$20240711$20240226$20240718$PER$$US-SA-2024SA058041$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240718$$MD$US$US
235678772$23567877$2$F$20240101$20240726$20240226$20240805$PER$$US-SA-2024SA057924$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240804$$MD$US$US
235678842$23567884$2$F$$20240805$20240226$20240814$PER$$US-SA-2024SA057702$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240814$$MD$US$US
235678873$23567887$3$F$$20240625$20240226$20240703$PER$$US-ALXN-202402USA001411US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
235678972$23567897$2$F$$20240626$20240226$20240705$PER$$US-SA-2024SA058156$SANOFI AVENTIS$$$$T$M$Y$$$20240705$$MD$US$US
235679352$23567935$2$F$20230801$20240911$20240226$20240916$PER$$US-SA-2024SA059546$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240916$$MD$US$US
235679362$23567936$2$F$20240101$20240702$20240226$20240711$PER$$US-SA-2024SA060083$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240711$$MD$US$US
235679462$23567946$2$F$20240801$20240826$20240226$20240905$PER$$US-SA-2024SA060379$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240905$$MD$US$US
235679504$23567950$4$F$$20240806$20240226$20240817$EXP$$US-SA-2024SA060891$SANOFI AVENTIS$$9$YR$C$M$Y$60.32$KG$20240817$$MD$US$US
235679563$23567956$3$F$20240302$20240916$20240226$20240923$PER$$US-SA-2024SA060377$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240923$$MD$US$US
235679792$23567979$2$F$20240101$20240805$20240226$20240813$PER$$US-SA-2024SA059397$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240814$$MD$US$US
235679852$23567985$2$F$$20240712$20240226$20240722$EXP$$CA-CELLTRION INC.-2024CA004256$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
235679924$23567992$4$F$20240101$20240829$20240226$20240911$PER$$US-SA-2024SA063149$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240911$$MD$US$US
235679953$23567995$3$F$20240201$20240731$20240226$20240808$PER$$US-SA-2024SA061484$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240808$$MD$US$US
235680022$23568002$2$F$20240101$20240731$20240226$20240808$PER$$US-SA-2024SA063176$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240808$$CN$US$US
235680104$23568010$4$F$$20240621$20240226$20240702$PER$$US-SA-2024SA061103$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240702$$HP$US$US
235680152$23568015$2$F$$20240819$20240226$20240828$PER$$US-SA-2024SA062221$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240828$$CN$US$US
235680182$23568018$2$F$20240101$20240625$20240226$20240704$PER$$US-SA-2024SA062450$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240704$$MD$US$US
235680213$23568021$3$F$$20240916$20240226$20240923$PER$$US-SA-2024SA061968$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240923$$MD$US$US
235680302$23568030$2$F$20240214$20240620$20240226$20240703$PER$$US-SA-2024SA062098$SANOFI AVENTIS$$50$YR$A$M$Y$83.9$KG$20240703$$MD$US$US
235680663$23568066$3$F$20240201$20240913$20240226$20240924$PER$$US-SA-2024SA062938$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240924$$MD$US$US
235680703$23568070$3$F$20240101$20240821$20240226$20240916$PER$$US-SA-2024SA063370$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240916$$HP$US$US
235680812$23568081$2$F$20240219$20240626$20240226$20240709$PER$$US-SA-2024SA061594$SANOFI AVENTIS$$67$YR$E$F$Y$93.8$KG$20240709$$MD$US$US
235680863$23568086$3$F$$20240816$20240226$20240829$PER$$US-SA-2024SA060365$SANOFI AVENTIS$$$$C$M$Y$$$20240829$$MD$US$US
235681185$23568118$5$F$20240125$20240909$20240226$20240915$EXP$$US-SA-2024SA062992$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240915$$MD$US$US
235681322$23568132$2$F$20231219$20240709$20240226$20240716$PER$$US-SA-2024SA062214$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240716$$MD$US$US
235681473$23568147$3$F$20240101$20240816$20240226$20240830$PER$$US-SA-2023SA357135$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240830$$MD$US$US
235681677$23568167$7$F$$20240903$20240226$20240913$EXP$$CA-PFIZER INC-202400049454$PFIZER$$43$YR$$F$Y$96$KG$20240913$$HP$CA$CA
235681892$23568189$2$F$20230703$20240801$20240226$20240808$EXP$$BR-TAKEDA-2023TUS078238$TAKEDA$$67$YR$$M$Y$$$20240808$$CN$BR$BR
235682792$23568279$2$F$$20240717$20240227$20240809$PER$$CA-TOLMAR, INC.-24CA046451$TOLMAR$$$$$M$Y$$$20240809$$PH$CA$CA
235682823$23568282$3$F$20231201$20240716$20240227$20240808$PER$$CA-TOLMAR, INC.-24CA046478$TOLMAR$$60$YR$$M$Y$$$20240808$$CN$CA$CA
235683014$23568301$4$F$$20240613$20240227$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000499$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
235683783$23568378$3$F$20240219$20240622$20240227$20240708$30DAY$$US-GSK-US2024023342$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
235683804$23568380$4$F$20190301$20240315$20240227$20240912$EXP$$JP-GSK-JP2019JPN170072$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$JP$JP
235683892$23568389$2$F$20240131$20240730$20240227$20240822$PER$$CA-TOLMAR, INC.-24CA046565$TOLMAR$$68$YR$$M$Y$$$20240822$$CN$CA$CA
235684013$23568401$3$F$$20240625$20240227$20240702$EXP$CA-ALLERGAN-2110282US$CA-ABBVIE-2110282US$ABBVIE$$53$YR$$M$Y$$$20240702$$MD$CA$CA
235684162$23568416$2$F$$20240703$20240227$20240712$30DAY$$KR-JNJFOC-20240241366$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$KR$KR
235684605$23568460$5$F$$20240821$20240227$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029980$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240830$$CN$US$US
235685163$23568516$3$F$20240210$20240705$20240227$20240711$EXP$$US-HALEON-USCH2024AMR010069$Haleon PLC$$$$I$M$Y$2.268$KG$20240711$$HP$US$US
235685382$23568538$2$F$$20240807$20240227$20240811$30DAY$$IL-JNJFOC-20240238470$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$PH$IL$IL
235685475$23568547$5$F$20240210$20240723$20240227$20240729$EXP$$US-HALEON-USCH2024AMR010070$Haleon PLC$$$$$F$Y$1.361$KG$20240726$$HP$US$US
235685722$23568572$2$F$$20240829$20240227$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-007721$AUROBINDO$Snyder HE, Pai N, Meaney B, Sloan Birbeck C, Whitney R, Johnson N, K. Jones et al.,. Significant vomiting and weight loss in a pediatric epilepsy patient secondary to vagus nerve stimulation: A case report and review of the literatur. Epilepsy-Behav-Rep. 2023;24:241-5$17$YR$$F$Y$$$20240910$$HP$CA$CA
235685932$23568593$2$F$$20240729$20240227$20240807$EXP$$CN-NOVOPROD-1179370$NOVO NORDISK$$44$YR$$M$Y$82$KG$20240807$$CN$CN$CN
235685952$23568595$2$F$20211001$20240910$20240227$20240925$EXP$$US-NOVOPROD-1178896$NOVO NORDISK$$65$YR$$F$Y$$$20240925$$CN$US$US
235686254$23568625$4$F$20240223$20240731$20240227$20240803$PER$$US-AMGEN-USASP2024038860$AMGEN$$51$YR$A$F$Y$$$20240803$$CN$US$US
235686292$23568629$2$F$$20240624$20240227$20240702$EXP$$PL-AUROBINDO-AUR-APL-2024-007917$AUROBINDO$$62$YR$$F$Y$$$20240702$$MD$PL$PL
235686312$23568631$2$F$$20240621$20240227$20240701$EXP$CA-LEO Pharma-367991$CA-LEO Pharma-367991$LEO PHARM$$22$YR$$M$Y$$$20240701$$HP$CA$CA
235686572$23568657$2$F$$20240726$20240227$20240805$EXP$$JP-ROCHE-3515552$ROCHE$$65$YR$E$M$Y$$$20240805$$PH$JP$JP
235687873$23568787$3$F$20240206$20240729$20240227$20240802$EXP$$NVSC2024GB040291$NOVARTIS$$48$YR$$F$Y$101$KG$20240802$$CN$GB$GB
235688413$23568841$3$F$20231213$20240713$20240227$20240716$EXP$$NVSC2024IN038845$NOVARTIS$$47$YR$$F$Y$$$20240716$$CN$IN$IN
235688552$23568855$2$F$$20240705$20240227$20240708$EXP$$NVSC2024CO033767$NOVARTIS$$$$$M$Y$72$KG$20240708$$CN$CO$CO
235688673$23568867$3$F$20240314$20240909$20240227$20240913$EXP$$US-GSK-US2024AMR023921$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240913$$HP$US$US
235689662$23568966$2$F$20230101$20240722$20240227$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202402013831$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240725$$CN$US$US
235689832$23568983$2$F$$20240910$20240227$20240917$EXP$$ZA-TAKEDA-2023TUS111145$TAKEDA$$$$$F$Y$$$20240917$$CN$ZA$ZA
235690033$23569003$3$F$$20240826$20240227$20240829$PER$$US-ALXN-202402USA001517US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
235690234$23569023$4$F$20240201$20240628$20240227$20240703$PER$$US-AMGEN-USASP2024039403$AMGEN$$36$YR$A$F$Y$$$20240703$$HP$US$US
235690773$23569077$3$F$$20240807$20240227$20240812$EXP$$CA-TAKEDA-2024TUS017972$TAKEDA$$$$$F$Y$$$20240812$$CN$CA$CA
235690846$23569084$6$F$20240101$20240826$20240227$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030945$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240827$$CN$US$US
235690876$23569087$6$F$$20240826$20240227$20240902$EXP$$CA-GSK-CA2023076561$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$HP$CA$CA
235691333$23569133$3$F$20240101$20240816$20240227$20240821$EXP$$PT-SA-2024SA063897$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240821$$MD$PT$PT
235691342$23569134$2$F$$20240819$20240227$20240826$EXP$$AS-ABBVIE-5653783$ABBVIE$$$$E$M$Y$$$20240826$$CN$AS$AS
235691382$23569138$2$F$20240826$20240912$20240227$20240914$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-269921$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240914$$CN$US$US
235691393$23569139$3$F$$20240226$20240227$20240801$EXP$$CA-SA-2024SA059109$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240801$$HP$CA$CA
235691492$23569149$2$F$20220801$20240801$20240227$20240808$EXP$$BR-CELLTRION INC.-2023BR001380$CELLTRION$$$$$$Y$$$20240808$$CN$BR$BR
235691833$23569183$3$F$20200115$20240807$20240227$20240815$EXP$$DE-ROCHE-2551361$ROCHE$$49$YR$A$M$Y$$$20240815$$CN$DE$DE
235692072$23569207$2$F$$20240912$20240227$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030920$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240916$$HP$US$US
235692963$23569296$3$F$20240201$20240718$20240227$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031089$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240722$$PH$US$US
235693243$23569324$3$F$$20240729$20240227$20240803$EXP$$US-ABBVIE-5653610$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
235693672$23569367$2$F$20230917$20240711$20240227$20240718$EXP$$CA-SA-2024SA060444$SANOFI AVENTIS$$53$YR$A$F$Y$122.47$KG$20240718$$PH$CA$CA
235693963$23569396$3$F$$20240829$20240227$20240830$EXP$$GR-ROCHE-3515843$ROCHE$$$$$F$Y$$$20240831$$MD$GR$GR
235694022$23569402$2$F$$20240920$20240227$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029805$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240924$$CN$US$US
235694244$23569424$4$F$20210706$20240702$20240227$20240705$EXP$$US-TAKEDA-2021TUS043890$TAKEDA$$80$YR$$F$Y$80$KG$20240705$$CN$US$US
235694642$23569464$2$F$20190301$20240731$20240227$20240805$EXP$$FR-AMGEN-FRASP2024037626$AMGEN$$43$YR$A$F$Y$55$KG$20240805$$MD$FR$FR
235694695$23569469$5$F$20221201$20240731$20240227$20240801$EXP$$FR-JNJFOC-20240255144$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240802$$MD$FR$FR
235695342$23569534$2$F$$20240724$20240227$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030426$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240726$$HP$US$US
235695502$23569550$2$F$20230109$20240730$20240227$20240806$EXP$$AU-TAKEDA-2023TUS003418$TAKEDA$$50$YR$$F$Y$$$20240806$$CN$AU$AU
235695563$23569556$3$F$20240201$20240716$20240227$20240722$EXP$$JP-ASTELLAS-2024JP001445$ASTELLAS$$9$DEC$$M$Y$$$20240722$$PH$JP$JP
235695673$23569567$3$F$$20240715$20240227$20240722$EXP$$US-TAKEDA-2024TUS005452$TAKEDA$$$$$F$Y$$$20240722$$CN$US$US
235695722$23569572$2$F$20230101$20240716$20240227$20240726$EXP$$US-INSMED, INC.-2023-04561-US$INSMED$$$$$F$Y$$$20240726$$CN$US$US
235695833$23569583$3$F$20210901$20240219$20240227$20240812$EXP$$NVSC2021IN214172$NOVARTIS$$71$YR$$F$Y$$$20240812$$CN$IN$IN
235696094$23569609$4$F$20240207$20240829$20240227$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202402013887$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240902$$CN$US$US
235696305$23569630$5$F$20240101$20240816$20240227$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020556$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240826$$CN$US$US
235696335$23569633$5$F$20240101$20240911$20240227$20240925$EXP$$US-UCBSA-2024008767$UCB$$$$$F$Y$$$20240925$$CN$US$US
235696342$23569634$2$F$20231101$20240805$20240227$20240808$EXP$FR-AFSSAPS-LY2024000234$FR-UCBSA-2024008455$UCB$$68$YR$$F$Y$55$KG$20240808$$PH$FR$FR
235696363$23569636$3$F$20240701$20240816$20240227$20240822$EXP$$US-SA-2024SA063996$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240822$$MD$US$US
235696642$23569664$2$F$20240115$20240726$20240227$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-008282$AUROBINDO$$69$YR$$M$Y$90$KG$20240806$$MD$FR$FR
235696802$23569680$2$F$20220504$20240911$20240227$20240915$EXP$SE-SEMPA-2024-000815$SE-REGENERON PHARMACEUTICALS, INC.-2024-037400$REGENERON$$71$YR$$M$Y$$$20240915$$MD$SE$SE
235697343$23569734$3$F$20230701$20240909$20240227$20240916$EXP$$US-BIOGEN-2023BI01218641$BIOGEN$$62$YR$$F$Y$$$20240916$$CN$US$US
235697522$23569752$2$F$$20240702$20240227$20240709$EXP$$JP-AstraZeneca-2024A038026$ASTRAZENECA$$83$YR$$M$Y$$$20240709$$MD$JP$
235697823$23569782$3$F$20231002$20240630$20240227$20240708$EXP$$BR-TAKEDA-2024TUS017785$TAKEDA$$26$YR$$F$Y$$$20240708$$CN$BR$BR
235698064$23569806$4$F$$20240906$20240227$20240911$EXP$$CA-TAKEDA-2024TUS017466$TAKEDA$$$$$M$Y$$$20240911$$CN$CA$CA
235698282$23569828$2$F$$20240726$20240227$20240801$EXP$$US-SA-2024SA064946$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240801$$MD$US$US
235698992$23569899$2$F$20240101$20240925$20240227$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030714$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240925$$HP$US$US
235699942$23569994$2$F$$20240911$20240227$20240919$EXP$$US-MYLANLABS-2024M1017708$MYLAN$Kido K, Carey B, Caccamo M, Bianco C, Sokos G. Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy. J-Am-Pharm-Assoc 2023; 64 (1): 169-173.$69$YR$$M$Y$$$20240919$$PH$US$US
235699952$23569995$2$F$$20240911$20240227$20240924$EXP$$US-MYLANLABS-2024M1017705$MYLAN$Kido K, Carey B, Caccamo M, Bianco C, Sokos G. Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy. J-Am-Pharmacists-Assoc 2024; 64 (1): 169-173.$63$YR$$M$Y$$$20240924$$PH$US$US
235699972$23569997$2$F$$20240911$20240227$20240923$EXP$$US-MYLANLABS-2024M1017707$MYLAN$Kido K, Carey B, Caccamo M, Bianco C, Sokos G. Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy. J-Am-Pharmacists-Assoc 2024; 64 (1): 169-173.$64$YR$$M$Y$$$20240923$$PH$US$US
235700043$23570004$3$F$$20240918$20240227$20240924$EXP$$US-KYOWAKIRIN-2024KK003072$KYOWA$$$$$$Y$$$20240924$$HP$US$US
235700702$23570070$2$F$$20240809$20240227$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433226$RANBAXY$Marulanda E, Tornes L. Obstetric and Gynecologic Disorders and the Nervous System. Part II. Medycyna Praktyczna - Ginekologia i Po?oznictwo. 2024;-:-$15$YR$$F$Y$$$20240823$$HP$US$US
235700902$23570090$2$F$$20240829$20240227$20240913$EXP$$TH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432700$RANBAXY$Pitanupong J, Jittpratoom C, Anantapong K. Chronic kidney disease incidences in Thai outpatients diagnosed with psychiatric illnesses receiving lithium maintenance therapy: a university hospital-based study. BMC Psychiatry. 2024;24:80$47$YR$$F$Y$67.2$KG$20240913$$HP$TH$TH
235700993$23570099$3$F$$20240920$20240227$20240924$EXP$$IT-SANDOZ INC.-SDZ2024IT018378$SANDOZ$$20$YR$$M$Y$$$20240924$$HP$IT$IT
235701164$23570116$4$F$20240101$20240916$20240227$20240919$PER$$US-BAYER-2024A018070$BAYER$$43$YR$A$F$Y$$$20240919$$CN$US$US
235701392$23570139$2$F$$20240913$20240227$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202402009720$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240925$$PH$US$US
235701662$23570166$2$F$20230808$20240712$20240227$20240716$EXP$$GB-MYLANLABS-2023M1084349$MYLAN$$37$YR$$M$Y$$$20240716$$MD$GB$GB
235701888$23570188$8$F$20240215$20240704$20240227$20240710$EXP$$CA-TAKEDA-2024TUS015938$TAKEDA$$64$YR$$M$Y$$$20240710$$CN$CA$CA
235701923$23570192$3$F$20230727$20240830$20240227$20240903$EXP$$NVSC2023IE175426$NOVARTIS$$67$YR$$F$Y$$$20240903$$MD$IE$IE
235701933$23570193$3$F$20240101$20240703$20240227$20240705$EXP$$US-BAYER-2024A025528$BAYER$$26$YR$A$F$Y$106.12$KG$20240705$$CN$US$US
235701975$23570197$5$F$20211001$20240909$20240227$20240913$EXP$DE-PFIZER INC-PV202400020817$DE-UCBSA-2024009671$UCB$$43$YR$$F$Y$61$KG$20240913$$MD$DE$DE
235702912$23570291$2$F$20220728$20240823$20240227$20240903$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-01372$LUPIN$$57$YR$$F$Y$$$20240903$$CN$AU$AU
235703933$23570393$3$F$20231229$20240627$20240227$20240702$EXP$$CA-UCBSA-2024003320$UCB$$31$YR$$F$Y$$$20240702$$CN$CA$CA
235704327$23570432$7$F$20190701$20240706$20240227$20240712$EXP$$NVSC2021AR106876$NOVARTIS$$13$YR$$M$Y$$$20240712$$CN$AR$AR
235704643$23570464$3$F$$20240904$20240227$20240912$EXP$$CA-GSK-CA2024011978$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$HP$CA$CA
235705102$23570510$2$F$$20240716$20240227$20240731$EXP$$CA-ROCHE-3512176$ROCHE$$$$$F$Y$$$20240731$$HP$CA$CA
235705605$23570560$5$F$$20240909$20240227$20240912$EXP$$US-TAKEDA-2023TUS123990$TAKEDA$$$$$M$Y$$$20240912$$MD$US$US
235706266$23570626$6$F$20240221$20240712$20240227$20240718$EXP$$US-GSK-US2024AMR024883$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$US$US
235706332$23570633$2$F$20230731$20240717$20240227$20240724$EXP$$NVSC2023AR178208$NOVARTIS$$18$YR$$F$Y$$$20240724$$CN$AR$AR
235706342$23570634$2$F$20201001$20240913$20240227$20240923$EXP$$CO-SANDOZ INC.-NVSC2020CO271987$SANDOZ$$10$YR$$F$Y$29$KG$20240923$$CN$CO$CO
235707262$23570726$2$F$$20240802$20240227$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031085$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240806$$CN$US$US
235708593$23570859$3$F$$20240710$20240227$20240717$EXP$$US-SA-2024SA064986$SANOFI AVENTIS$$$$A$M$Y$90.72$KG$20240717$$MD$US$US
235708952$23570895$2$F$$20240725$20240227$20240730$PER$$US-PFIZER INC-PV202400025853$PFIZER$$50$YR$$F$Y$$$20240730$$HP$US$US
235709222$23570922$2$F$20221011$20240805$20240227$20240808$EXP$FR-SA-SAC20231215000963$FR-SANDOZ INC.-SDZ2023FR075557$SANDOZ$$72$YR$$F$Y$48$KG$20240808$$HP$FR$FR
235709502$23570950$2$F$$20240819$20240227$20240822$PER$$US-PFIZER INC-PV202400026672$PFIZER$$19$YR$$F$Y$$$20240822$$CN$US$US
235709743$23570974$3$F$$20240815$20240227$20240820$PER$$US-PFIZER INC-PV202400026448$PFIZER$$48$YR$$F$Y$$$20240820$$HP$US$US
235709794$23570979$4$F$20210124$20240903$20240227$20240905$PER$$US-PFIZER INC-202400051381$PFIZER$$13$YR$$M$Y$35.828$KG$20240905$$CN$US$US
235709852$23570985$2$F$$20240925$20240227$20240930$PER$$US-PFIZER INC-PV202400025916$PFIZER$$65$YR$$F$Y$72.7$KG$20240930$$MD$US$US
235710193$23571019$3$F$20240209$20240229$20240227$20240801$PER$$US-BAYER-2024A028967$BAYER$$40$YR$A$F$Y$$$20240801$$CN$US$US
235711257$23571125$7$F$20240328$20240910$20240227$20240918$EXP$$CA-OTSUKA-2024_004814$OTSUKA$$35$YR$$M$Y$$$20240918$$HP$CA$CA
235711752$23571175$2$F$$20240923$20240227$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-025980$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240925$$CN$US$US
235711762$23571176$2$F$20230101$20240702$20240227$20240702$EXP$$FR-SANDOZ INC.-SDZ2024FR018295$SANDOZ$$3$YR$$M$Y$14.5$KG$20240702$$MD$FR$FR
235711852$23571185$2$F$$20240903$20240227$20240904$EXP$$PT-SANDOZ INC.-SDZ2024PT020138$SANDOZ$$$$E$$Y$$$20240904$$HP$PT$PT
235712102$23571210$2$F$20230101$20240706$20240227$20240708$EXP$$CA-PFIZER INC-202300256125$PFIZER$$59$YR$$F$Y$$$20240708$$HP$CA$CA
235712453$23571245$3$F$$20240826$20240227$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-027504$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240830$$CN$US$US
235712522$23571252$2$F$$20240225$20240227$20240801$EXP$$NVSC2024US041017$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
235712602$23571260$2$F$20231122$20240808$20240227$20240813$EXP$$US-SA-2024SA065278$SANOFI AVENTIS$$52$YR$A$F$Y$74$KG$20240813$$MD$US$US
235713304$23571330$4$F$20231001$20240709$20240227$20240716$EXP$$NVSC2024AU039582$NOVARTIS$$47$YR$$F$Y$$$20240716$$CN$AU$AU
235713613$23571361$3$F$$20240624$20240227$20240708$EXP$$CA-Ascend Therapeutics US, LLC-2153742$ASCEND$$44$YR$$F$Y$70$KG$20240708$$$CA$CA
235713664$23571366$4$F$$20240827$20240227$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026736$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240828$$CN$US$US
235713714$23571371$4$F$20240213$20240628$20240227$20240705$PER$$FR-JAZZ PHARMACEUTICALS-2024-FR-003255$JAZZ$$$$$$Y$$$20240705$$MD$FR$FR
235713844$23571384$4$F$20231128$20240305$20240227$20240712$EXP$$EG-ABBVIE-5656026$ABBVIE$$$$N$$Y$$$20240712$$HP$EG$EG
235713883$23571388$3$F$20231114$20240820$20240227$20240822$EXP$$US-PFIZER INC-202300413937$PFIZER$$27$YR$$F$Y$$$20240822$$CN$US$US
235713895$23571389$5$F$20240403$20240802$20240227$20240806$EXP$$US-PFIZER INC-PV202400025888$PFIZER$$80$YR$$F$Y$$$20240806$$HP$US$US
235713902$23571390$2$F$20240213$20240628$20240227$20240703$EXP$$US-PFIZER INC-202400047660$PFIZER$$85$YR$$M$Y$$$20240703$$HP$US$US
235713943$23571394$3$F$$20240926$20240227$20240930$EXP$$CA-PFIZER INC-202400048610$PFIZER$$58$YR$$F$Y$65$KG$20240930$$HP$CA$CA
235714085$23571408$5$F$20240208$20240827$20240227$20240830$EXP$$US-PFIZER INC-202400049254$PFIZER$$41$YR$$M$Y$$$20240830$$CN$US$US
235714204$23571420$4$F$$20240726$20240227$20240729$EXP$$CA-SANDOZ INC.-NVSC2022CA079060$SANDOZ$$$$$M$Y$97.7$KG$20240729$$MD$CA$CA
235714282$23571428$2$F$20231001$20240903$20240227$20240905$EXP$SE-SEMPA-2024-001129$SE-009507513-2402SWE008561$MERCK$$68$YR$$F$Y$$$20240905$$MD$SE$SE
235714334$23571433$4$F$$20240909$20240227$20240911$PER$$US-BIOGEN-2023BI01212698$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
235714893$23571489$3$F$20210601$20240621$20240227$20240704$EXP$$CN-Accord-408167$ACCORD$Dai L, Jin X, Wang L, Wang H, Yan Z, Wang G, et al. Efficacy of disitamab vedotin in treating HER22+/FISH- gastric cancer. OncoTargets and Therapy. 2022;15:267-75$56$YR$A$F$Y$$$20240703$$MD$CN$CN
235715243$23571524$3$F$20240201$20240903$20240227$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202402013374$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240912$$CN$US$US
235715724$23571572$4$F$20240102$20240802$20240227$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-008191$AUROBINDO$$73$YR$$M$Y$48$KG$20240814$$MD$FR$FR
235715822$23571582$2$F$20231002$20240709$20240227$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-008317$AUROBINDO$$74$YR$$M$Y$$$20240718$$MD$FR$FR
235716226$23571622$6$F$$20240819$20240227$20240826$EXP$$CA-SANDOZ INC.-SDZ2024CA017441$SANDOZ$$$$A$F$Y$$$20240826$$HP$CA$CA
235716367$23571636$7$F$$20240926$20240227$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030430$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240930$$CN$US$US
235716572$23571657$2$F$$20240809$20240227$20240815$PER$$US-MYLANLABS-2024M1016586$MYLAN$$$$$F$Y$$$20240815$$CN$US$US
235716785$23571678$5$F$$20240807$20240227$20240814$EXP$$NVSC2024US039909$NOVARTIS$$$$$$Y$$$20240814$$CN$AU$AU
235717302$23571730$2$F$$20240715$20240227$20240722$PER$$US-ALXN-202402USA001649US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
235717432$23571743$2$F$20240707$20240708$20240227$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202402013115$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240710$$CN$US$US
235717693$23571769$3$F$$20240705$20240227$20240708$PER$$US-ALXN-202402USA001502US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
235717722$23571772$2$F$20240217$20240822$20240227$20240828$PER$$US-AMGEN-USASP2024038990$AMGEN$$69$YR$E$F$Y$$$20240828$$CN$US$US
235718053$23571805$3$F$$20240808$20240227$20240924$PER$$US-LUNDBECK-DKLU3074014$LUNDBECK$$$$$$Y$$$20240924$$HP$US$US
235718082$23571808$2$F$$20240717$20240227$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031177$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240722$$HP$US$US
235718405$23571840$5$F$20240219$20240814$20240227$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031425$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240823$$CN$US$US
235718515$23571851$5$F$20230501$20240731$20240227$20240807$EXP$GB-MHRA-DEV27987835$GB-BAYER-2024A025492$BAYER$$30$YR$A$F$Y$$$20240807$$MD$GB$GB
235718694$23571869$4$F$$20240807$20240227$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031229$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$68.95$KG$20240808$$CN$US$US
235718862$23571886$2$F$20240209$20240708$20240227$20240710$EXP$$DE-JNJFOC-20240264707$JOHNSON AND JOHNSON$$68$YR$E$M$Y$50$KG$20240710$$MD$DE$DE
235718904$23571890$4$F$20240401$20240912$20240227$20240916$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-009926$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240916$$CN$CA$CA
235719003$23571900$3$F$$20240826$20240227$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031314$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240828$$HP$US$US
235719112$23571911$2$F$$20240906$20240227$20240923$PER$$US-BAYER-2024A026737$BAYER$$79$YR$E$F$Y$$$20240923$$CN$US$US
235719222$23571922$2$F$20240801$20240830$20240227$20240903$EXP$$ZA-PFIZER INC-PV202400024525$PFIZER$$53$YR$$F$Y$68.2$KG$20240903$$MD$ZA$ZA
235719453$23571945$3$F$$20240705$20240227$20240716$PER$$US-SA-2024SA059011$SANOFI AVENTIS$$$$E$M$Y$$$20240716$$MD$US$US
2357198010$23571980$10$F$20231001$20240918$20240227$20240926$PER$$US-SA-2023SA345357$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240926$$MD$US$US
235719823$23571982$3$F$20240201$20240903$20240227$20240926$PER$$US-SA-2024SA060231$SANOFI AVENTIS$$21$YR$A$M$Y$81.6$KG$20240926$$MD$US$US
235719833$23571983$3$F$20240101$20240830$20240227$20240913$PER$$US-SA-2024SA059621$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240913$$MD$US$US
235719912$23571991$2$F$$20240703$20240227$20240712$PER$$US-SA-2024SA060620$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240712$$MD$US$US
235719942$23571994$2$F$20240101$20240823$20240227$20240904$PER$$US-SA-2024SA059604$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240904$$MD$US$US
235720012$23572001$2$F$20240101$20240905$20240227$20240914$PER$$US-SA-2024SA059597$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240914$$MD$US$US
235720144$23572014$4$F$20240101$20240703$20240227$20240708$EXP$$US-SA-2024SA060622$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240708$$MD$US$US
235720182$23572018$2$F$20240501$20240724$20240227$20240802$PER$$US-SA-2024SA063180$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240802$$MD$US$US
235720192$23572019$2$F$$20240621$20240227$20240702$PER$$US-SA-2024SA063431$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240702$$MD$US$US
235720393$23572039$3$F$20240101$20240730$20240227$20240807$PER$$US-SA-2024SA059201$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240807$$MD$US$US
235720413$23572041$3$F$20240216$20240701$20240227$20240710$PER$$US-SA-2024SA059356$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240710$$MD$US$US
235720424$23572042$4$F$20231219$20240729$20240227$20240806$PER$$US-SA-2024SA059805$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240806$$MD$US$US
235720434$23572043$4$F$20240108$20240913$20240227$20240923$PER$$US-SA-2024SA060349$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240923$$MD$US$US
235720464$23572046$4$F$20240101$20240821$20240227$20240905$PER$$US-SA-2024SA059980$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240905$$MD$US$US
235720512$23572051$2$F$20240801$20240813$20240227$20240821$PER$$US-SA-2024SA064138$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240821$$MD$US$US
235720712$23572071$2$F$20240101$20240719$20240227$20240802$PER$$US-SA-2024SA062138$SANOFI AVENTIS$$49$YR$A$F$Y$99.79$KG$20240802$$MD$US$US
235720813$23572081$3$F$20230101$20240503$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00512$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235720853$23572085$3$F$20230101$20240701$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00390$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235720863$23572086$3$F$20231201$20240508$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00566$AVADEL CNS PHARMA$$29$YR$$M$Y$34.921$KG$20240822$$CN$US$US
235720904$23572090$4$F$20230101$20240717$20240227$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00383$AVADEL CNS PHARMA$$$$$F$Y$112.93$KG$20240822$$CN$US$US
235720953$23572095$3$F$20231101$20240513$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00449$AVADEL CNS PHARMA$$21$YR$$F$Y$$$20240820$$CN$US$US
235721054$23572105$4$F$20240101$20240517$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00121$AVADEL CNS PHARMA$$34$YR$$$Y$$$20240822$$CN$US$US
235721183$23572118$3$F$20240101$20240509$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00160$AVADEL CNS PHARMA$$$$$F$Y$79.274$KG$20240822$$CN$US$US
235721234$23572123$4$F$20240701$20240711$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00039$AVADEL CNS PHARMA$$22$YR$$M$Y$79.637$KG$20240822$$CN$US$US
235721253$23572125$3$F$20240101$20240515$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00146$AVADEL CNS PHARMA$$36$YR$$F$Y$$$20240822$$CN$US$US
235721423$23572142$3$F$20220516$20240812$20240227$20240821$PER$$US-SA-2024SA063156$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240821$$HP$US$US
235721563$23572156$3$F$20240101$20240812$20240227$20240821$PER$$US-SA-2024SA060962$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240821$$MD$US$US
235722012$23572201$2$F$20240501$20240625$20240227$20240704$PER$$US-SA-2024SA060205$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240704$$MD$US$US
235722082$23572208$2$F$20230101$20240828$20240227$20240909$PER$$US-SA-2024SA063259$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240909$$MD$US$US
235722463$23572246$3$F$20240829$20240826$20240227$20240926$PER$$US-SA-2024SA060511$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240926$$MD$PR$PR
235722483$23572248$3$F$20240101$20240722$20240227$20240731$PER$$US-SA-2024SA060268$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240731$$MD$US$US
235722822$23572282$2$F$$20240808$20240227$20240816$PER$$US-SA-2024SA061370$SANOFI AVENTIS$$64$YR$A$M$Y$70$KG$20240816$$MD$US$US
235723332$23572333$2$F$$20240501$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00087$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235723362$23572336$2$F$20231201$20240719$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00097$AVADEL CNS PHARMA$$49$YR$$M$Y$$$20240822$$CN$US$US
235723373$23572337$3$F$20240404$20240508$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00147$AVADEL CNS PHARMA$$26$YR$$M$Y$$$20240822$$CN$US$US
235723432$23572343$2$F$20240101$20240702$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00122$AVADEL CNS PHARMA$$25$YR$$F$Y$$$20240822$$CN$US$US
235723452$23572345$2$F$20240101$20240705$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00128$AVADEL CNS PHARMA$$52$YR$$F$Y$$$20240819$$CN$US$US
235723462$23572346$2$F$20240115$20240507$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00131$AVADEL CNS PHARMA$$69$YR$$F$Y$$$20240822$$CN$US$US
235723522$23572352$2$F$$20240710$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00135$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235723542$23572354$2$F$20240128$20240521$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00138$AVADEL CNS PHARMA$$39$YR$$F$Y$$$20240822$$CN$US$US
235723552$23572355$2$F$20240101$20240705$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00139$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235723733$23572373$3$F$20231113$20240724$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00063$AVADEL CNS PHARMA$$24$YR$$M$Y$$$20240822$$CN$US$US
235723775$23572377$5$F$$20240830$20240227$20240912$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00070$AVADEL CNS PHARMA$$$$$M$Y$$$20240912$$CN$US$US
235723802$23572380$2$F$20231201$20240509$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00071$AVADEL CNS PHARMA$$47$YR$$M$Y$72.472$KG$20240822$$CN$US$US
235723862$23572386$2$F$20240101$20240502$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00053$AVADEL CNS PHARMA$$58$YR$$F$Y$$$20240822$$CN$US$US
235723943$23572394$3$F$20230101$20240621$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00041$AVADEL CNS PHARMA$$$$$F$Y$78.458$KG$20240822$$CN$US$US
235723954$23572395$4$F$20240101$20240819$20240227$20240821$PER$$US-BEH-2024168791$CSL BEHRING$$65$YR$E$F$Y$$$20240821$$HP$US$US
235724093$23572409$3$F$20240101$20240822$20240227$20240830$EXP$FR-AFSSAPS-LL2024000248$FR-009507513-2402FRA006820$MERCK$$46$YR$$F$Y$63$KG$20240830$$MD$FR$FR
235724175$23572417$5$F$$20240904$20240227$20240910$EXP$$US-TAKEDA-2024TUS007972$TAKEDA$$$$$F$Y$86$KG$20240910$$CN$US$US
235724385$23572438$5$F$$20240909$20240227$20240916$EXP$$CA-PURDUE-USA-2024-0308044$PURDUE$$44$YR$$F$Y$97$KG$20240917$$MD$CA$CA
235724482$23572448$2$F$20240223$20240822$20240227$20240827$EXP$$MX-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-010743$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240827$$CN$MX$MX
235724702$23572470$2$F$20240107$20240820$20240227$20240822$PER$$FR-Eisai-EC-2024-160290$EISAI$$82$YR$E$F$Y$63$KG$20240822$$MD$FR$FR
235724982$23572498$2$F$20240215$20240711$20240227$20240719$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-012971$JAZZ$$12$YR$$M$Y$$$20240718$$CN$US$US
235725094$23572509$4$F$20240922$20240923$20240227$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US019606$SANDOZ$$10$YR$$F$Y$$$20240926$$CN$US$US
235725342$23572534$2$F$$20240529$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00447$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$HP$US$US
235725372$23572537$2$F$20230101$20240520$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00357$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235725672$23572567$2$F$20230101$20240722$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00381$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235725682$23572568$2$F$20231104$20240710$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00392$AVADEL CNS PHARMA$$57$YR$$F$Y$$$20240822$$CN$US$US
235725793$23572579$3$F$20230101$20240705$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00391$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235725842$23572584$2$F$20231101$20240503$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00439$AVADEL CNS PHARMA$$60$YR$$F$Y$86.621$KG$20240822$$CN$US$US
235725852$23572585$2$F$20230101$20240522$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00464$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235725862$23572586$2$F$20230101$20240501$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00434$AVADEL CNS PHARMA$$$$$F$Y$79.365$KG$20240822$$CN$US$US
235725892$23572589$2$F$20231101$20240502$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00441$AVADEL CNS PHARMA$$62$YR$$F$Y$$$20240822$$CN$US$US
235725903$23572590$3$F$20231101$20240502$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00473$AVADEL CNS PHARMA$$38$YR$$F$Y$96.145$KG$20240822$$MD$US$US
235726002$23572600$2$F$20230101$20240515$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00484$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235726013$23572601$3$F$20231101$20240603$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00407$AVADEL CNS PHARMA$$72$YR$$F$Y$$$20240822$$CN$US$US
235726023$23572602$3$F$20230101$20240627$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00406$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
235726092$23572609$2$F$20230101$20240723$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00482$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235726333$23572633$3$F$20231201$20240507$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00522$AVADEL CNS PHARMA$$27$YR$$F$Y$68.027$KG$20240822$$CN$US$US
235726383$23572638$3$F$20231201$20240604$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00527$AVADEL CNS PHARMA$$29$YR$$F$Y$$$20240822$$CN$US$US
235726443$23572644$3$F$20230101$20240723$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00492$AVADEL CNS PHARMA$$$$$F$Y$106.49$KG$20240822$$CN$US$US
235726452$23572645$2$F$20231122$20240619$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00495$AVADEL CNS PHARMA$$40$YR$$F$Y$$$20240822$$CN$US$US
235726532$23572653$2$F$20231201$20240509$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00552$AVADEL CNS PHARMA$$36$YR$$M$Y$$$20240822$$CN$US$US
235726553$23572655$3$F$20230101$20240909$20240227$20240924$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00555$AVADEL CNS PHARMA$$$$$F$Y$$$20240924$$CN$US$US
235726582$23572658$2$F$20230101$20240716$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00559$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235726602$23572660$2$F$20231220$20240709$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00562$AVADEL CNS PHARMA$$33$YR$$F$Y$$$20240821$$CN$US$US
235726662$23572666$2$F$20231201$20240522$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00573$AVADEL CNS PHARMA$$50$YR$$F$Y$115.19$KG$20240822$$CN$US$US
235726682$23572668$2$F$20230901$20240730$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00502$AVADEL CNS PHARMA$$17$YR$$F$Y$$$20240822$$CN$US$US
235726832$23572683$2$F$20230101$20240820$20240227$20240904$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00533$AVADEL CNS PHARMA$$$$$F$Y$$$20240904$$CN$US$US
235726883$23572688$3$F$20231201$20240610$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2023AVA00543$AVADEL CNS PHARMA$$21$YR$$F$Y$$$20240822$$CN$US$US
235726932$23572693$2$F$20231201$20240617$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00003$AVADEL CNS PHARMA$$21$YR$$F$Y$61.224$KG$20240822$$CN$US$US
235726983$23572698$3$F$20231219$20240610$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00008$AVADEL CNS PHARMA$$35$YR$$M$Y$$$20240822$$CN$US$US
235727002$23572700$2$F$20240515$20240611$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00010$AVADEL CNS PHARMA$$40$YR$$M$Y$$$20240822$$CN$US$US
235727062$23572706$2$F$$20240717$20240227$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00018$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
235727554$23572755$4$F$$20240709$20240227$20240717$EXP$$US-Stemline Therapeutics, Inc.-2024ST001169$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240716$$CN$US$US
235727693$23572769$3$F$20240101$20240702$20240227$20240718$PER$$US-BEH-2024168708$CSL BEHRING$$49$YR$A$F$Y$$$20240718$$MD$US$US
235727754$23572775$4$F$20230929$20240903$20240227$20240909$EXP$$IN-INCYTE CORPORATION-2023IN013667$INCYTE$$$$$$Y$$$20240909$$CN$IN$IN
235728043$23572804$3$F$20231201$20240911$20240227$20240917$EXP$FR-AFSSAPS-LM2024000065$FR-009507513-2402FRA006872$MERCK$$59$YR$$M$Y$89$KG$20240917$$MD$FR$FR
235728172$23572817$2$F$$20240514$20240227$20240702$PER$$US-LUNDBECK-DKLU3074104$LUNDBECK$$$$$$Y$$$20240702$$HP$US$US
235728884$23572888$4$F$20231219$20240709$20240227$20240711$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202401011134$ELI LILLY AND CO$$67$YR$E$F$Y$46$KG$20240711$$CN$JP$JP
235728942$23572894$2$F$20160101$20240909$20240227$20240925$EXP$$US-ELI_LILLY_AND_COMPANY-US202402009993$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240925$$CN$US$US
235729312$23572931$2$F$20221119$20240814$20240227$20240819$EXP$$US-TAKEDA-2022TUS094381$TAKEDA$$67$YR$$F$Y$115$KG$20240819$$CN$US$US
235729342$23572934$2$F$20231004$20240917$20240227$20240926$EXP$$CA-CELLTRION INC.-2023CA019710$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
235729953$23572995$3$F$$20240816$20240227$20240826$30DAY$$IL-JNJFOC-20240262260$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$PH$IL$IL
235730022$23573002$2$F$$20240711$20240227$20240724$30DAY$$AU-JNJFOC-20240255164$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$PH$AU$AU
235730332$23573033$2$F$$20240830$20240227$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028957$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240903$$CN$US$US
235730902$23573090$2$F$$20240827$20240227$20240829$PER$$US-JNJFOC-20240229622$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240829$$CN$US$US
235730995$23573099$5$F$$20240923$20240227$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029984$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240928$$CN$US$US
235731007$23573100$7$F$$20240903$20240227$20240910$EXP$$GB-GSK-GB2024EME024027$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$HP$GB$GB
235731062$23573106$2$F$20230101$20240912$20240227$20240917$EXP$$US-ABBVIE-5487470$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
235731645$23573164$5$F$20230101$20240711$20240227$20240717$EXP$$US-ABBVIE-5654046$ABBVIE$$$$$F$Y$59$KG$20240717$$CN$US$US
235732562$23573256$2$F$20240209$20240717$20240228$20240718$PER$$US-JNJFOC-20240229683$JOHNSON AND JOHNSON$$50$YR$A$F$Y$61$KG$20240718$$PH$US$US
235732642$23573264$2$F$$20240718$20240228$20240809$PER$$CA-TOLMAR, INC.-24CA046684$TOLMAR$$$$$M$Y$$$20240809$$CN$CA$CA
235732653$23573265$3$F$20240201$20240806$20240228$20240830$PER$$CA-TOLMAR, INC.-24CA046688$TOLMAR$$78$YR$$M$Y$$$20240830$$CN$CA$CA
235732662$23573266$2$F$20240717$20240812$20240228$20240829$PER$$CA-TOLMAR, INC.-24CA046693$TOLMAR$$90$YR$$M$Y$$$20240829$$CN$CA$CA
235732732$23573273$2$F$20240202$20240720$20240228$20240808$PER$$CA-TOLMAR, INC.-24CA046740$TOLMAR$$68$YR$$M$Y$$$20240808$$CN$CA$CA
235732743$23573274$3$F$20240202$20240719$20240228$20240809$PER$$CA-TOLMAR, INC.-24CA046742$TOLMAR$$60$YR$$M$Y$$$20240809$$CN$CA$CA
235732823$23573282$3$F$$20240920$20240228$20240930$EXP$$CA-ROCHE-3513177$ROCHE$$$$A$F$Y$$$20240930$$CN$CA$CA
235733032$23573303$2$F$20230801$20240815$20240228$20240820$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-254900$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240820$$CN$US$US
235733273$23573327$3$F$20240113$20240712$20240228$20240717$EXP$$IT-JNJFOC-20240255322$JOHNSON AND JOHNSON$$54$YR$A$M$Y$79$KG$20240717$$HP$IT$IT
235733344$23573334$4$F$20240103$20240920$20240228$20240930$EXP$$US-TAKEDA-2024TUS015103$TAKEDA$$32$YR$$M$Y$$$20240930$$CN$US$US
235733352$23573335$2$F$$20240617$20240228$20240704$30DAY$$US-GSK-US2024022119$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
235733732$23573373$2$F$20230324$20240917$20240228$20240926$EXP$$JP-NOVOPROD-1179388$NOVO NORDISK$$9$DEC$$M$Y$$$20240926$$HP$JP$JP
235734252$23573425$2$F$$20240801$20240228$20240826$PER$$AU-TOLMAR, INC.-24AU046671$TOLMAR$$$$$M$Y$$$20240826$$CN$AU$AU
235734326$23573432$6$F$20240101$20240724$20240228$20240731$EXP$$CA-CELLTRION INC.-2024CA004898$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
235734456$23573445$6$F$20231101$20240701$20240228$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202402009954$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240711$$CN$US$US
235734662$23573466$2$F$$20240715$20240228$20240718$EXP$$US-TAKEDA-2024TUS017394$TAKEDA$$$$$M$Y$$$20240718$$CN$US$US
235734864$23573486$4$F$20240101$20240802$20240228$20240807$EXP$$US-BIOGEN-2024BI01249554$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
235734873$23573487$3$F$20240219$20240805$20240228$20240814$EXP$$JP-ROCHE-3515515$ROCHE$$65$YR$E$F$Y$55$KG$20240814$$PH$JP$JP
235735005$23573500$5$F$20240101$20240722$20240228$20240728$EXP$$US-SA-2024SA061931$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240728$$HP$US$US
235735352$23573535$2$F$20240223$20240727$20240228$20240730$PER$$US-AMGEN-USASP2024039527$AMGEN$$70$YR$E$M$Y$$$20240730$$CN$US$US
235736202$23573620$2$F$$20240809$20240228$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000404$BLUEPRINT MEDICINES$$$$$M$Y$$$20240814$$CN$US$US
235736694$23573669$4$F$$20240304$20240228$20240712$EXP$$EG-ABBVIE-5656087$ABBVIE$$1$DY$$M$Y$$$20240712$$HP$EG$EG
235736994$23573699$4$F$$20240812$20240228$20240820$EXP$$CA-JNJFOC-20240270433$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$HP$CA$CA
235737104$23573710$4$F$20240222$20240820$20240228$20240821$EXP$$GB-TAKEDA-2024TUS017521$TAKEDA$$66$YR$$F$Y$$$20240821$$MD$GB$GB
235737454$23573745$4$F$20240215$20240717$20240228$20240730$30DAY$$US-JNJFOC-20240250318$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240731$$CN$US$US
235737732$23573773$2$F$20240101$20240819$20240228$20240826$EXP$$JP-009507513-2402JPN002893J$MERCK$$73$YR$$F$Y$$$20240826$$PH$JP$JP
235737754$23573775$4$F$20230428$20240712$20240228$20240722$EXP$$DE-CELLTRION INC.-2024DE004625$CELLTRION$$$$$$Y$$$20240722$$HP$DE$DE
235737822$23573782$2$F$20231217$20240918$20240228$20240923$EXP$$NVSC2024US041474$NOVARTIS$$84$YR$$M$Y$$$20240923$$CN$US$US
235737933$23573793$3$F$20240101$20240828$20240228$20240910$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-02503$SAMSUNG BIOEPIS$$76$YR$E$F$Y$67$KG$20240910$$CN$CA$CA
235738034$23573803$4$F$$20240717$20240228$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01434$LUPIN$$$$$$Y$$$20240821$$CN$US$US
235738266$23573826$6$F$20240612$20240723$20240228$20240731$EXP$$CA-CELLTRION INC.-2024CA004703$CELLTRION$$$$$$Y$$$20240731$$CN$CA$CA
235738664$23573866$4$F$$20240716$20240228$20240722$EXP$$US-Taiho Oncology Inc-2023-009343$TAIHO ONCOLOGY INC$$$$A$M$Y$$$20240722$$CN$US$US
235738742$23573874$2$F$$20240220$20240228$20240807$EXP$$NVSC2024US037252$NOVARTIS$$$$$M$Y$$$20240807$$HP$US$US
235738812$23573881$2$F$20220101$20240702$20240228$20240710$EXP$$US-ROCHE-3513112$ROCHE$$45$YR$A$F$Y$82.55$KG$20240710$$CN$US$US
235738972$23573897$2$F$$20240626$20240228$20240702$EXP$$US-CHATTEMPRD-2024OHG005832$CHATTEM$$$$E$F$Y$$$20240702$$LW$US$US
235739403$23573940$3$F$$20240913$20240228$20240917$PER$$US-AMGEN-USASP2024040643$AMGEN$$$$E$F$Y$$$20240916$$HP$US$US
235739508$23573950$8$F$20240101$20240920$20240228$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031571$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240924$$CN$US$US
235739782$23573978$2$F$20240214$20240306$20240228$20240920$EXP$$IT-BEH-2024168819$CSL BEHRING$$75$YR$E$M$Y$$$20240920$$HP$IT$IT
235740043$23574004$3$F$20221128$20240730$20240228$20240802$EXP$$JP-TAKEDA-2022TJP078661$TAKEDA$$66$YR$$F$Y$$$20240802$$MD$JP$JP
235740222$23574022$2$F$20230901$20240711$20240228$20240723$EXP$CA-SA-SAC20240221000982$CA-CHATTEMPRD-2024OHG005867$CHATTEM$$74$YR$E$M$Y$$$20240723$$HP$CA$CA
235740343$23574034$3$F$20150410$20240902$20240228$20240910$EXP$$US-AstraZeneca-2024A043031$ASTRAZENECA$$56$YR$$F$Y$$$20240910$$CN$US$
235740433$23574043$3$F$$20240619$20240228$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01437$LUPIN$$$$$$Y$$$20240702$$CN$US$US
235740695$23574069$5$F$20240202$20240905$20240228$20240912$EXP$$DE-ROCHE-3513688$ROCHE$$43$YR$A$F$Y$61$KG$20240912$$MD$DE$DE
235740983$23574098$3$F$20240206$20240809$20240228$20240819$EXP$$JP-009507513-2402JPN001168J$MERCK$$7$DEC$$M$Y$$$20240819$$MD$JP$JP
235741024$23574102$4$F$20240416$20240830$20240228$20240904$EXP$$CA-TAKEDA-2024TUS018017$TAKEDA$$26$YR$$M$Y$$$20240904$$CN$CA$CA
235741234$23574123$4$F$20240101$20240819$20240228$20240826$EXP$$CA-CELLTRION INC.-2024CA004970$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
235741273$23574127$3$F$20240501$20240824$20240228$20240911$EXP$$US-SA-2024SA062203$SANOFI AVENTIS$$63$YR$A$M$Y$95.7$KG$20240911$$MD$US$US
235741512$23574151$2$F$$20240625$20240228$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031630$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240701$$CN$US$US
235742813$23574281$3$F$20230109$20240723$20240228$20240729$PER$$US-ALXN-202402USA001599US$ALEXION PHARMACEUTICALS$$38$YR$$F$Y$$$20240729$$CN$US$US
235742833$23574283$3$F$$20240827$20240228$20240904$EXP$$US-ABBVIE-5655718$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
235743792$23574379$2$F$$20240701$20240228$20240710$EXP$$DE-TEVA-VS-3162314$TEVA$$57$YR$$F$Y$$$20240710$$MD$DE$DE
235743995$23574399$5$F$20240201$20240912$20240228$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028201$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240920$$CN$US$US
235744402$23574440$2$F$$20240702$20240228$20240705$EXP$$CA-JNJFOC-20240111765$JOHNSON AND JOHNSON$$36$YR$A$M$Y$72$KG$20240705$$HP$CA$CA
235745023$23574502$3$F$20221216$20240709$20240228$20240716$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-027559$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$74$KG$20240716$$MD$DE$DE
235745033$23574503$3$F$20231223$20240708$20240228$20240716$EXP$FR-AFSSAPS-RE2024000024$FR-TEVA-VS-3159637$TEVA$$43$YR$$F$Y$60$KG$20240716$$MD$FR$FR
235745503$23574550$3$F$20231229$20240730$20240228$20240808$EXP$FR-AFSSAPS-PO2024000120$FR-TEVA-VS-3160342$TEVA$$51$YR$$M$Y$80$KG$20240808$$MD$FR$FR
235745583$23574558$3$F$$20240906$20240228$20240916$EXP$$GB-MYLANLABS-2024M1017966$MYLAN$Mutsago T, Kazzazi D, Ibrahim Y, Kazzazi F, Patel H, Pafitanis G. Phenytoin induced purple glove syndrome: an effective management technique. Hosp-Pharm. 2024;59 (3):276-281$2$YR$$M$Y$20$KG$20240916$$HP$GB$GB
235745762$23574576$2$F$$20240830$20240228$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029579$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240905$$HP$US$US
235745854$23574585$4$F$20240216$20240715$20240228$20240718$PER$$US-JNJFOC-20240250180$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240718$$CN$US$US
235746073$23574607$3$F$$20240718$20240228$20240802$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432769$RANBAXY$Joyce S, Lea S,Woolner M and Leddy A. Treatment of Gamma Hydroxybutyrate Withdrawal in a Pregnant Female-A Case Report. J Addict Med. 2024;May/June;18 (3):342-344$32$YR$$F$Y$$$20240802$$HP$CA$CA
235746153$23574615$3$F$$20240718$20240228$20240802$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432770$RANBAXY$Joyce S, Lea S,Woolner M and Leddy A. Treatment of Gamma Hydroxybutyrate Withdrawal in a Pregnant Female-A Case Report. J Addict Med. 2024;May/June;18 (3):342-344$$$N$M$Y$$$20240802$$HP$CA$CA
235746192$23574619$2$F$$20240820$20240228$20240830$EXP$$SA-Accord-408231$ACCORD$Alshammari A, Qasem BA, Almatrafi NA, Alharbi LM, Alhuthali AA, Khobrani AA, et al. Case Series: Sacubitril/Valsartan Role for Chemotherapy-Induced Cardiotoxicity: An in-Depth Investigation in Saudi Arabia. International Medical Case Reports Journal. 2024;17:35-41$67$YR$E$F$Y$$$20240830$$PH$SA$SA
235746333$23574633$3$F$$20240718$20240228$20240726$EXP$$CA-CELLTRION INC.-2024CA004897$CELLTRION$$$$$$Y$$$20240726$$CN$CA$CA
235746442$23574644$2$F$20231219$20240224$20240228$20240918$EXP$FR-AFSSAPS-RE2024000161$FR-BAUSCH-BL-2024-003151$BAUSCH AND LOMB$$74$YR$$M$Y$100$KG$20240918$$MD$FR$FR
235747542$23574754$2$F$20240219$20240827$20240228$20240828$PER$$US-JNJFOC-20240256907$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240829$$CN$US$US
235747783$23574778$3$F$20231115$20240812$20240228$20240815$EXP$$DE-ROCHE-3512720$ROCHE$$46$YR$A$M$Y$73$KG$20240815$$MD$DE$DE
235748182$23574818$2$F$$20240812$20240228$20240813$PER$$NVSC2024US042101$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
235748234$23574823$4$F$20240809$20240816$20240228$20240830$EXP$$US-UCBSA-2024007484$UCB$$4$YR$$M$Y$$$20240830$$CN$US$US
235748394$23574839$4$F$20240210$20240710$20240228$20240720$EXP$$US-JNJFOC-20240275997$JOHNSON AND JOHNSON$$0$YR$$F$Y$1.7$KG$20240719$$HP$US$US
235748464$23574846$4$F$20240218$20240812$20240228$20240819$EXP$$JP-AMGEN-JPNSP2024036016$AMGEN$$72$YR$E$M$Y$38$KG$20240819$$MD$JP$JP
235748923$23574892$3$F$20240625$20240806$20240228$20240808$EXP$$US-GSK-US2024021430$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$HP$US$US
235749272$23574927$2$F$$20240715$20240228$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031974$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$48.53$KG$20240717$$CN$US$US
235749794$23574979$4$F$20240220$20240812$20240228$20240821$PER$$US-SA-2024SA061129$SANOFI AVENTIS$$9$MON$I$M$Y$$$20240821$$MD$US$US
235749943$23574994$3$F$20240625$20240625$20240228$20240709$PER$$US-SA-2024SA063349$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240709$$MD$US$US
235750003$23575000$3$F$20240101$20240725$20240228$20240802$PER$$US-SA-2021SA421063$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240802$$MD$US$US
235750305$23575030$5$F$20240201$20240703$20240228$20240712$PER$$US-SA-2024SA059847$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240712$$MD$US$US
235750443$23575044$3$F$20240101$20240826$20240228$20240917$PER$$US-SA-2024SA065405$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240918$$CN$US$US
235750492$23575049$2$F$$20240625$20240228$20240704$PER$$US-SA-2024SA064536$SANOFI AVENTIS$$$$E$F$Y$$$20240704$$MD$US$US
235750522$23575052$2$F$20231127$20240725$20240228$20240802$PER$$US-SA-2023SA397389$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240802$$MD$US$US
235750614$23575061$4$F$20230911$20240904$20240228$20240911$EXP$$DE-AMGEN-DEUSP2024037687$AMGEN$$43$YR$A$F$Y$61$KG$20240911$$MD$DE$DE
235750703$23575070$3$F$20240101$20240822$20240228$20240916$PER$$US-SA-2024SA065712$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240916$$MD$US$US
235750832$23575083$2$F$$20240906$20240228$20240916$PER$$US-SA-2024SA065434$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240916$$MD$US$US
235750872$23575087$2$F$$20240906$20240228$20240924$PER$$US-SA-2024SA066396$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240924$$MD$US$US
235750962$23575096$2$F$20240127$20240918$20240228$20240926$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-03494$SAMSUNG BIOEPIS$$37$YR$A$F$Y$$$20240926$$CN$CA$CA
235751603$23575160$3$F$20240101$20240918$20240228$20240927$PER$$US-SA-2024SA062415$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240927$$MD$US$US
235751614$23575161$4$F$20240218$20240717$20240228$20240724$EXP$$US-SA-2024SA061532$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240724$$MD$US$US
235751924$23575192$4$F$20231204$20240826$20240228$20240902$EXP$$KR-GSK-KR2024APC017374$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$KR$KR
235751938$23575193$8$F$20240517$20240831$20240228$20240906$EXP$$CO-GSK-CO2024AMR022864$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$CO$CO
235752354$23575235$4$F$20240101$20240807$20240228$20240809$EXP$$NVSC2024US041477$NOVARTIS$$43$YR$$F$Y$$$20240809$$CN$US$US
235752363$23575236$3$F$$20240918$20240228$20240927$EXP$$DE-ROCHE-3513179$ROCHE$$80$YR$E$M$Y$$$20240927$$CN$DE$DE
235752422$23575242$2$F$20240201$20240912$20240228$20240917$PER$$US-SA-2024SA064527$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240918$$MD$US$US
235752442$23575244$2$F$20240717$20240802$20240228$20240812$PER$$US-SA-2024SA061729$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240812$$MD$US$US
235752465$23575246$5$F$20231201$20240708$20240228$20240716$PER$$US-SA-2024SA061904$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240716$$MD$US$US
235752493$23575249$3$F$20240101$20240809$20240228$20240819$PER$$US-SA-2024SA061650$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240819$$MD$US$US
235753633$23575363$3$F$$20240725$20240228$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030888$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240730$$CN$US$US
235754033$23575403$3$F$20240101$20240719$20240228$20240729$PER$$US-SA-2024SA062690$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240729$$MD$US$US
235754393$23575439$3$F$20240101$20240916$20240228$20240924$PER$$US-SA-2024SA061591$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240924$$CN$US$US
235754442$23575444$2$F$20240101$20240912$20240228$20240920$PER$$US-SA-2024SA065067$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240920$$MD$US$US
235754535$23575453$5$F$$20240729$20240228$20240802$EXP$$GB-AMGEN-GBRSP2024037198$AMGEN$$57$YR$A$F$Y$$$20240801$$MD$GB$GB
235754693$23575469$3$F$$20240723$20240228$20240819$PER$$US-BEH-2024168689$CSL BEHRING$$$$A$F$Y$$$20240819$$HP$US$US
235754825$23575482$5$F$20240301$20240730$20240228$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031979$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240802$$HP$US$US
235754864$23575486$4$F$$20240802$20240228$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028573$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240808$$HP$US$US
235754972$23575497$2$F$20240601$20240820$20240228$20240902$PER$$US-SA-2023SA370266$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240902$$MD$US$US
235755132$23575513$2$F$20220201$20240913$20240228$20240921$EXP$$US-TAKEDA-2024TUS016955$TAKEDA$$56$YR$$F$Y$$$20240921$$CN$US$US
235755194$23575519$4$F$20240101$20240304$20240228$20240711$EXP$$EG-ABBVIE-5656788$ABBVIE$$1$DY$$$Y$$$20240711$$HP$EG$EG
235755332$23575533$2$F$20231222$20240708$20240228$20240713$EXP$$JP-ROCHE-3516485$ROCHE$$71$YR$E$M$Y$66$KG$20240713$$PH$JP$JP
235755722$23575572$2$F$$20240213$20240228$20240710$EXP$NL-LRB-00937358$NL-TEVA-VS-3159305$TEVA$$34$YR$$M$Y$82$KG$20240710$$CN$NL$NL
235755783$23575578$3$F$20240201$20240912$20240228$20240916$EXP$$NVSC2023US272334$NOVARTIS$$65$YR$$M$Y$$$20240916$$CN$US$US
235755863$23575586$3$F$20240224$20240724$20240228$20240802$EXP$$IN-ROCHE-3515866$ROCHE$$6$YR$C$M$Y$18$KG$20240802$$CN$IN$IN
235756168$23575616$8$F$$20240726$20240228$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031888$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$90.72$KG$20240729$$CN$US$US
235756172$23575617$2$F$20240101$20240923$20240228$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031193$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240924$$HP$US$US
235756372$23575637$2$F$$20240215$20240228$20240808$PER$$US-EPICPHARMA-US-2024EPCSPO00261$EPIC PHARM$$$$$$Y$$$20240808$$CN$US$US
235756526$23575652$6$F$20240208$20240723$20240228$20240729$EXP$$US-BAYER-2024A029348$BAYER$$41$YR$A$M$Y$$$20240729$$CN$US$US
235756793$23575679$3$F$$20240329$20240228$20240718$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-05827$SAMSUNG BIOEPIS$$$$$F$Y$$$20240718$$CN$GB$GB
235757323$23575732$3$F$$20240621$20240228$20240703$EXP$CA-LEO Pharma-367940$CA-LEO Pharma-367940$LEO PHARM$Seyyon Satkunanathan, Mina Boshra, Janis Chang and Reetesh Bose$61$YR$$M$Y$$$20240703$$MD$CA$CA
235757332$23575733$2$F$$20240827$20240228$20240829$EXP$$NVSC2024AU042046$NOVARTIS$$$$$M$Y$$$20240829$$HP$AU$AU
235757432$23575743$2$F$$20240822$20240228$20240827$EXP$$FR-DSJP-DSE-2024-108519$DAIICHI$$$$A$F$Y$$$20240827$$MD$FR$FR
235757697$23575769$7$F$20240201$20240913$20240228$20240916$PER$$US-PFIZER INC-PV202400018209$PFIZER$$77$YR$$F$Y$$$20240916$$CN$US$US
235757785$23575778$5$F$$20240820$20240228$20240823$EXP$$JP-009507513-2402JPN003477J$MERCK$Nio K, Kusano W, Matsushita Y, Shimazaki A, Kaneshiro K, Satake M, et al.. P91-4 A case of Immune Checkpoint Inhibitor-Associated Myasthenia Gravis in Advanced Breast Cancer. The 21st Annual Meeting of the Japanese Society of Medical Oncology. 2024$56$YR$$F$Y$$$20240823$$MD$JP$JP
235758442$23575844$2$F$$20240715$20240228$20240717$EXP$$CA-SANDOZ INC.-NVSC2020CA105172$SANDOZ$$$$$F$Y$$$20240717$$MD$CA$CA
235758544$23575854$4$F$20231101$20240719$20240228$20240725$EXP$$JP-009507513-2401JPN006249J$MERCK$$47$YR$$F$Y$100$KG$20240725$$MD$JP$JP
235758663$23575866$3$F$$20240924$20240228$20240930$PER$$US-BIOGEN-2023BI01205667$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
235758772$23575877$2$F$20240209$20240805$20240228$20240809$EXP$FR-AFSSAPS-LM2024000090$FR-PFIZER INC-202400050274$PFIZER$$52$YR$$M$Y$90$KG$20240809$$MD$FR$FR
235758853$23575885$3$F$20231218$20240403$20240228$20240805$EXP$$NVSC2024BR008843$NOVARTIS$$45$YR$$F$Y$$$20240805$$CN$BR$BR
235758942$23575894$2$F$20240201$20240724$20240228$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030557$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$81.65$KG$20240726$$CN$US$US
235758972$23575897$2$F$$20240827$20240228$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029464$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240828$$CN$US$US
235759602$23575960$2$F$$20240808$20240228$20240813$PER$$US-BIOGEN-2024BI01252362$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
235759772$23575977$2$F$$20240716$20240228$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028502$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240718$$CN$US$US
235760107$23576010$7$F$$20240820$20240228$20240826$EXP$$US-PFIZER INC-PV202400027112$PFIZER$$75$YR$$F$Y$$$20240826$$HP$US$US
235760713$23576071$3$F$20240101$20240708$20240228$20240711$PER$$US-PFIZER INC-202400049965$PFIZER$$68$YR$$F$Y$87.982$KG$20240711$$CN$US$US
235761004$23576100$4$F$$20240731$20240228$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030410$BRISTOL MYERS SQUIBB$$63$YR$E$F$Y$$$20240807$$HP$US$US
235761143$23576114$3$F$$20240827$20240228$20240902$EXP$$JP-009507513-2402JPN003498J$MERCK$Mekaru K, Seguchi K, Koguchi O, Oba T, Aoki S, Kontani H, et al.. P95-2 A case of irAE-related adult-onset Still^s disease developed during KEYNOTE522  (pembrolizumab+carboplatin+paclitaxel). The 21st Annual Meeting of the Japanese Society of Medical Oncology. 2024$55$YR$$F$Y$$$20240902$$MD$JP$JP
235761242$23576124$2$F$$20240820$20240228$20240822$EXP$$US-PFIZER INC-2020106948$PFIZER$$81$YR$$M$Y$$$20240822$$CN$US$US
235761584$23576158$4$F$$20240731$20240228$20240807$EXP$$CA-OTSUKA-2021_015860$OTSUKA$$$$$M$Y$$$20240807$$MD$CA$CA
235762252$23576225$2$F$20231208$20240704$20240228$20240709$EXP$BE-FAMHP-DHH-N2024-121595$BE-PFIZER INC-202400049064$PFIZER$$47$YR$$F$Y$$$20240709$$PH$BE$BE
235762594$23576259$4$F$$20240625$20240228$20240704$EXP$$CA-SANDOZ INC.-SDZ2024CA016511$SANDOZ$$40$YR$$F$Y$$$20240704$$HP$CA$CA
235762814$23576281$4$F$20231201$20240821$20240228$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01401$LUPIN$$$$$$Y$$$20240909$$CN$US$US
235762863$23576286$3$F$$20240801$20240228$20240805$EXP$$CA-TAKEDA-2024TUS018606$TAKEDA$$$$$M$Y$$$20240805$$CN$CA$CA
235763228$23576322$8$F$20231201$20240702$20240228$20240705$EXP$$US-UCBSA-2023059022$UCB$$66$YR$$M$Y$$$20240705$$HP$US$US
235763596$23576359$6$F$$20240903$20240228$20240910$EXP$$CA-SANDOZ INC.-SDZ2024CA017282$SANDOZ$$43$YR$$F$Y$96$KG$20240910$$HP$CA$CA
235764223$23576422$3$F$$20240808$20240228$20240813$PER$$US-PFIZER INC-PV202400027083$PFIZER$$81$YR$$M$Y$75.737$KG$20240813$$CN$US$US
235764285$23576428$5$F$20240101$20240905$20240228$20240909$PER$$US-PFIZER INC-202400051078$PFIZER$$76$YR$$M$Y$97.52$KG$20240909$$CN$US$US
235764963$23576496$3$F$20240228$20240806$20240228$20240819$EXP$$US-BIOMARINAP-US-2024-156126$BIOMARIN$$$$$$Y$$$20240819$$CN$US$US
235765024$23576502$4$F$20240208$20240626$20240228$20240701$EXP$$US-TAKEDA-2024TUS018033$TAKEDA$$57$YR$$F$Y$$$20240701$$MD$US$US
235765252$23576525$2$F$20240216$20240812$20240228$20240813$EXP$$CN-PFIZER INC-PV202400026223$PFIZER$$66$YR$$M$Y$50$KG$20240813$$HP$CN$CN
235765364$23576536$4$F$20240101$20240830$20240228$20240905$PER$$US-PFIZER INC-PV202400026068$PFIZER$$19$YR$$M$Y$$$20240905$$CN$US$US
235765744$23576574$4$F$20200601$20240813$20240228$20240820$EXP$US-BoehringerIngelheim-2021-BI-077035$DE-SANDOZ INC.-NVSC2021DE155474$SANDOZ$$80$YR$$M$Y$69$KG$20240820$$HP$DE$DE
235766703$23576670$3$F$20220710$20240830$20240228$20240906$30DAY$$EG-SANDOZ INC.-SDZ2024EG020026$SANDOZ$$12$YR$$F$Y$50$KG$20240906$$CN$EG$EG
235767513$23576751$3$F$$20240813$20240228$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032122$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240816$$CN$US$US
235767562$23576756$2$F$$20240820$20240228$20240822$EXP$$US-TAKEDA-2021TUS075178$TAKEDA$$$$$M$Y$104$KG$20240822$$HP$US$US
235767792$23576779$2$F$$20240801$20240228$20240803$PER$$US-AMGEN-USASP2024040464$AMGEN$$$$$M$Y$$$20240803$$CN$US$US
235768232$23576823$2$F$$20240911$20240228$20240916$EXP$$CA-JNJFOC-20240263739$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$HP$CA$CA
235768435$23576843$5$F$$20240924$20240228$20240926$PER$$NVSC2024US042190$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
235768554$23576855$4$F$20240101$20240813$20240228$20240821$PER$$US-SA-2024SA003303$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240821$$MD$US$US
235768632$23576863$2$F$$20240730$20240228$20240801$PER$$US-PFIZER INC-PV202400027757$PFIZER$$71$YR$$F$Y$$$20240801$$HP$US$US
235768672$23576867$2$F$20211215$20240213$20240228$20240906$EXP$FR-AFSSAPS-NY2023001860$FR-TEVA-VS-3147295$TEVA$$74$YR$$M$Y$74.1$KG$20240906$$PH$FR$FR
235768903$23576890$3$F$20210329$20240820$20240228$20240829$EXP$$FR-Eisai-EC-2024-160275$EISAI$$63$YR$A$F$Y$80$KG$20240829$$MD$FR$FR
235768943$23576894$3$F$20240216$20240805$20240228$20240814$PER$$JP-Eisai-EC-2024-160218$EISAI$$$$E$F$Y$$$20240814$$MD$JP$JP
235769012$23576901$2$F$$20240703$20240228$20240715$PER$$US-MYLANLABS-2024M1017911$MYLAN$$$$$M$Y$$$20240715$$CN$US$US
235769212$23576921$2$F$$20240912$20240228$20240918$EXP$$CA-ABBVIE-5656718$ABBVIE$$$$$F$Y$$$20240918$$HP$CA$CA
235769292$23576929$2$F$20240219$20240725$20240228$20240801$EXP$$JP-009507513-2402JPN003182J$MERCK$$72$YR$$F$Y$$$20240801$$MD$JP$JP
235769342$23576934$2$F$20231110$20240915$20240228$20240918$EXP$$CN-Eisai-EC-2024-160106$EISAI$$78$YR$E$M$Y$$$20240918$$MD$CN$CN
235770153$23577015$3$F$$20240620$20240228$20240704$PER$$US-RDY-SPO/USA/24/0002861$DR REDDYS$$2$YR$C$F$Y$11.61$KG$20240704$$MD$US$US
235770324$23577032$4$F$20240201$20240917$20240228$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202402016268$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240919$$CN$US$US
235770444$23577044$4$F$20240206$20240709$20240228$20240815$PER$$US-TRAVERE-2024TVT00181$TRAVERE THERAPEUTICS$$76$YR$E$F$Y$$$20240815$$CN$US$US
235770456$23577045$6$F$20240221$20240923$20240228$20240930$PER$$US-TRAVERE-2024TVT00185$TRAVERE THERAPEUTICS$$37$YR$A$F$Y$$$20240930$$CN$US$US
235770463$23577046$3$F$$20240621$20240228$20240731$PER$$US-TRAVERE-2024TVT00184$TRAVERE THERAPEUTICS$$51$YR$A$M$Y$$$20240731$$CN$US$US
235770484$23577048$4$F$20240111$20240819$20240228$20240828$PER$$US-TRAVERE-2024TVT00183$TRAVERE THERAPEUTICS$$53$YR$A$F$Y$54.52$KG$20240828$$CN$US$US
235770832$23577083$2$F$$20240607$20240228$20240718$PER$$US-TRAVERE-2024TVT00189$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240718$$CN$US$US
235770852$23577085$2$F$$20240624$20240228$20240731$PER$$US-TRAVERE-2024TVT00191$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240731$$CN$US$US
235770867$23577086$7$F$20240423$20240711$20240228$20240716$EXP$$US-TRAVERE-2024TVT00190$TRAVERE THERAPEUTICS$$61$YR$A$F$Y$128.37$KG$20240716$$CN$US$US
235770922$23577092$2$F$20240219$20240710$20240228$20240723$EXP$$DE-GILEAD-2024-0663263$GILEAD$$0$YR$N$M$Y$2.9$KG$20240723$$HP$DE$DE
235771092$23577109$2$F$$20240823$20240228$20240829$PER$$US-PFIZER INC-PV202400027733$PFIZER$$76$YR$$F$Y$$$20240829$$HP$US$US
235771763$23577176$3$F$20240201$20240917$20240228$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032208$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240919$$HP$US$US
235771783$23577178$3$F$$20240708$20240228$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028369$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240715$$CN$US$US
235771797$23577179$7$F$20230101$20240621$20240228$20240702$EXP$$NVSC2023BR273194$NOVARTIS$$$$$F$Y$63$KG$20240702$$CN$BR$BR
235771804$23577180$4$F$$20240405$20240228$20240718$EXP$$NVSC2024CZ039223$NOVARTIS$Benesova V. Ribociclib (Kisqali) v lecbe metastatickeho karcinomu prsu [Ribociclib (Kisqali) in the treatment of metastatic cancer.]. ACTA MEDICINAE. 2024;13:8-9$69$YR$$F$Y$$$20240718$$HP$CZ$CZ
235771914$23577191$4$F$$20240722$20240228$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032263$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240724$$CN$US$US
235772002$23577200$2$F$20240101$20240829$20240228$20240904$EXP$$US-ABBVIE-5653735$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
235772284$23577228$4$F$$20240808$20240228$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032398$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240815$$CN$US$US
235772472$23577247$2$F$20240201$20240716$20240228$20240724$PER$$US-SA-2024SA064590$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240724$$MD$US$US
235772516$23577251$6$F$20230101$20240822$20240228$20240829$PER$$US-VERTEX PHARMACEUTICALS-2024-003097$VERTEX$$$$$M$Y$19$KG$20240829$$MD$US$US
235773114$23577311$4$F$20240710$20240710$20240228$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029284$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240716$$CN$US$US
235773593$23577359$3$F$$20240710$20240228$20240723$PER$$US-Calliditas-2024CAL00249$CALLIDITAS THERAPEUTICS$$78$YR$E$M$Y$$$20240723$$CN$US$US
2357738715$23577387$15$F$20231024$20240721$20240228$20240722$EXP$$CA-PFIZER INC-PV202300177081$PFIZER$$53$YR$$M$Y$96.2$KG$20240722$$HP$CA$CA
235773885$23577388$5$F$$20240911$20240228$20240918$EXP$$CA-JNJFOC-20240267433$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$HP$CA$CA
235774195$23577419$5$F$20220101$20240925$20240228$20240927$EXP$$US-BAUSCH-BL-2024-003282$BAUSCH AND LOMB$Russe J, Abdelhamid I, Meier R, Giblen G, Maheshwari A. Overwhelming cytochrome p450 isoenzyme activity generating drug-induced liver injury resulting in fulminant liver failure. Hepatology. 2023 OCT 01;78 (SUPPLEMENT 1):S643-S644. doi:10.1097/HEP.0000000000000580$40$YR$$F$Y$54.5$KG$20240927$$HP$US$US
235774342$23577434$2$F$20240710$20240711$20240228$20240718$EXP$$US-Stemline Therapeutics, Inc.-2024ST001242$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240716$$CN$US$US
235774593$23577459$3$F$20230901$20240805$20240228$20240812$EXP$$JP-009507513-2309JPN001237J$MERCK$$7$DEC$$F$Y$$$20240812$$MD$JP$JP
235774813$23577481$3$F$20200527$20240806$20240228$20240807$EXP$$BE-SANDOZ INC.-SDZ2024BE018983$SANDOZ$$77$YR$$F$Y$$$20240807$$HP$BE$BE
235777623$23577762$3$F$20240215$20240706$20240228$20240715$EXP$$US-BEH-2024169101$CSL BEHRING$$6$YR$C$M$Y$$$20240715$$HP$US$US
235778132$23577813$2$F$$20240807$20240228$20240813$EXP$$IN-SANDOZ INC.-SDZ2024IN020666$SANDOZ$$$$$M$Y$$$20240813$$CN$IN$IN
235778244$23577824$4$F$20240201$20240828$20240228$20240902$EXP$$CL-JNJFOC-20240274705$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240903$$HP$CL$CL
235778393$23577839$3$F$20240210$20240716$20240228$20240718$PER$$US-JNJFOC-20240230899$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240718$$MD$US$US
235778436$23577843$6$F$20240501$20240909$20240228$20240913$EXP$$US-GSK-US2024AMR024126$GLAXOSMITHKLINE$$42$YR$$F$Y$$$20240913$$HP$US$US
235778842$23577884$2$F$20240819$20240819$20240228$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-033227$JAZZ$$8$YR$$F$Y$$$20240821$$CN$US$US
235778852$23577885$2$F$20231115$20240812$20240228$20240815$EXP$IT-MINISAL02-972183$IT-ABBVIE-5654582$ABBVIE$$68$YR$$F$Y$$$20240815$$MD$IT$IT
235778863$23577886$3$F$$20240821$20240228$20240826$EXP$$US-ABBVIE-5653898$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
235779087$23577908$7$F$20230101$20240726$20240228$20240805$EXP$$US-ABBVIE-5656510$ABBVIE$$59$YR$$M$Y$74$KG$20240805$$CN$US$US
235779344$23577934$4$F$20240107$20240419$20240228$20240913$EXP$$NL-NOVOPROD-1169359$NOVO NORDISK$$71$YR$$M$Y$104$KG$20240913$$MD$NL$NL
235779402$23577940$2$F$20240101$20240711$20240228$20240723$EXP$$US-NOVOPROD-1181041$NOVO NORDISK$$50$YR$$F$Y$$$20240723$$CN$US$US
235779523$23577952$3$F$$20240911$20240228$20240918$EXP$$CA-GSK-CA2024023841$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$CA$CA
235780033$23578003$3$F$$20240906$20240229$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032312$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240912$$CN$US$US
235780297$23578029$7$F$20231001$20240924$20240229$20240930$EXP$$NVSC2024MX041457$NOVARTIS$$74$YR$$F$Y$53.5$KG$20240930$$CN$MX$MX
235780522$23578052$2$F$$20240906$20240229$20240911$EXP$$FR-AUROBINDO-AUR-APL-2024-008730$AUROBINDO$Strube N, Vigot-Matter L, Chaux AG, Hoornaert A.. Sinus lift vestibular approach: complications and failures.. Clinic.. 2024;45(434):39-45$55$YR$$F$Y$$$20240911$$MD$FR$FR
235780562$23578056$2$F$$20240806$20240229$20240827$PER$$AU-TOLMAR, INC.-24AU046704$TOLMAR$$$$$M$Y$$$20240827$$CN$AU$AU
235780804$23578080$4$F$20240223$20240719$20240229$20240725$PER$$US-AMGEN-USASP2024041106$AMGEN$$85$YR$E$F$Y$$$20240725$$CN$US$US
235780813$23578081$3$F$20240101$20240918$20240229$20240924$EXP$$US-BEH-2024168694$CSL BEHRING$$61$YR$A$F$Y$151.93$KG$20240924$$CN$US$US
235780963$23578096$3$F$20240224$20240819$20240229$20240821$PER$$US-AMGEN-USASP2024041306$AMGEN$$78$YR$E$F$Y$$$20240821$$CN$US$US
235781083$23578108$3$F$20240203$20240806$20240229$20240812$EXP$$AU-TAKEDA-2024TUS018374$TAKEDA$$67$YR$$M$Y$$$20240812$$CN$AU$AU
235781243$23578124$3$F$$20240812$20240229$20240813$EXP$$PL-SANDOZ INC.-SDZ2024PL020599$SANDOZ$$59$YR$$M$Y$$$20240813$$MD$PL$PL
235782063$23578206$3$F$$20240216$20240229$20240710$PER$$US-ROCHE-3508447$ROCHE$$68$YR$E$$Y$$$20240628$$MD$US$US
235782674$23578267$4$F$20240225$20240716$20240229$20240717$PER$$US-AMGEN-USASP2024041130$AMGEN$$60$YR$A$F$Y$$$20240717$$CN$US$US
235783022$23578302$2$F$20240205$20240727$20240229$20240823$PER$$CA-TOLMAR, INC.-24CA046755$TOLMAR$$74$YR$$M$Y$$$20240823$$CN$CA$CA
235783523$23578352$3$F$$20240805$20240229$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032670$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240808$$CN$US$US
235783712$23578371$2$F$20240223$20240626$20240229$20240701$PER$$US-AMGEN-USASP2024039542$AMGEN$$66$YR$E$F$Y$$$20240701$$CN$US$US
235783773$23578377$3$F$$20240702$20240229$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031009$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240711$$MD$US$US
235784363$23578436$3$F$$20240226$20240229$20240821$PER$$US-UCBSA-2023060622$UCB$$$$$F$Y$58.4$KG$20240821$$HP$US$US
235784383$23578438$3$F$20230101$20240812$20240229$20240821$PER$$US-UCBSA-2023051284$UCB$$$$$M$Y$$$20240821$$HP$US$US
235784502$23578450$2$F$20231008$20240605$20240229$20240821$PER$$US-UCBSA-2023051282$UCB$$73$YR$$F$Y$$$20240821$$HP$US$US
235785012$23578501$2$F$20231110$20240809$20240229$20240809$EXP$$US-SANDOZ INC.-SDZ2024US019978$SANDOZ$$52$YR$$M$Y$93.4$KG$20240809$$CN$US$US
235785244$23578524$4$F$20240201$20240723$20240229$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029836$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240731$$CN$US$US
235785382$23578538$2$F$20240123$20240813$20240229$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-008067$AUROBINDO$$72$YR$$F$Y$48$KG$20240826$$MD$FR$FR
235785513$23578551$3$F$20240128$20240327$20240229$20240906$EXP$$JP-BAUSCH-BL-2024-003274$BAUSCH AND LOMB$$82$YR$$M$Y$$$20240906$$MD$JP$JP
235785693$23578569$3$F$20231212$20240718$20240229$20240725$EXP$$US-SANDOZ INC.-SDZ2023US073231$SANDOZ$$86$YR$$M$Y$77$KG$20240725$$CN$US$US
235786073$23578607$3$F$$20240628$20240229$20240701$EXP$$JP-GSK-JP2024JPN025170$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$JP$JP
235786913$23578691$3$F$$20240628$20240229$20240701$EXP$$JP-GSK-JP2024JPN025173$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$JP$JP
235786953$23578695$3$F$20240102$20240805$20240229$20240814$EXP$FR-AFSSAPS-LM2024000056$FR-009507513-2402FRA009044$MERCK$$73$YR$$M$Y$48$KG$20240814$$MD$FR$FR
235787103$23578710$3$F$20240201$20240801$20240229$20240805$PER$$US-AMGEN-USASP2024040361$AMGEN$$76$YR$E$F$Y$$$20240805$$PH$US$US
235787412$23578741$2$F$$20240729$20240229$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-008222$AUROBINDO$Zubair N, Isaac S, Westerman J.. Drug-induced Euglycemic Diabetic Ketoacidosis in a Patient with Systemic Sarcoidosis.. Southern Medical Journal.. 2023;116(1):93$78$YR$$F$Y$$$20240809$$MD$US$US
235788336$23578833$6$F$20231001$20240808$20240229$20240814$EXP$$CA-GSK-CA2023136983$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$CA$CA
235788514$23578851$4$F$20240101$20240715$20240229$20240730$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00233$AVADEL CNS PHARMA$$$$$F$Y$$$20240730$$CN$US$US
235789073$23578907$3$F$20231001$20240718$20240229$20240725$EXP$$IL-BIOGEN-2023BI01236609$BIOGEN$$27$YR$$F$Y$$$20240725$$HP$IL$IL
235789132$23578913$2$F$20210301$20240419$20240229$20240702$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-032306$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240702$$PH$CH$CH
235789203$23578920$3$F$$20240913$20240229$20240925$30DAY$$CN-JNJFOC-20240241388$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$CN$CN
235789484$23578948$4$F$$20240801$20240229$20240811$EXP$$US-GSK-US2024AMR022857$GLAXOSMITHKLINE$$$$$F$Y$$$20240811$$CN$US$US
235789633$23578963$3$F$20240224$20240918$20240229$20240926$EXP$$NVSC2024US042323$NOVARTIS$$63$YR$$M$Y$108.2$KG$20240926$$CN$US$US
235789793$23578979$3$F$$20240916$20240229$20240918$PER$$US-AMGEN-USASP2024041281$AMGEN$$$$$M$Y$$$20240918$$HP$US$US
235789923$23578992$3$F$$20240903$20240229$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032271$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240905$$CN$US$US
235790202$23579020$2$F$$20240917$20240229$20240930$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-01370$HIKMA$Weinstein T, Altshuler D, Lafond E, Katz A.. Weinstein T, Altshuler D, Lafond E, Katz A. Elevated Anti-Xa in the Setting of Prophylactic Unfractionated Subcutaneous Heparin Administration. Journal of Pharmacy Practice. 2024;37(5):1209-1213$66$YR$$M$Y$66.2$KG$20240930$$PH$US$US
235791142$23579114$2$F$$20240917$20240229$20240925$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-01373$HIKMA$Weinstein T, Altshuler D, Lafond E, Katz A.. Weinstein T, Altshuler D, Lafond E, Katz A. Elevated Anti-Xa in the Setting of Prophylactic Unfractionated Subcutaneous Heparin Administration. Journal of Pharmacy Practice. 2024;37(13):1209-13$32$YR$$F$Y$50.4$KG$20240925$$MD$US$US
235791212$23579121$2$F$$20240917$20240229$20240925$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-01374$HIKMA$Weinstein T, Altshuler D, Lafond E, Katz A.. Weinstein T, Altshuler D, Lafond E, Katz A. Elevated Anti-Xa in the Setting of Prophylactic Unfractionated Subcutaneous Heparin Administration. Journal of Pharmacy Practice. 2024;37(5):1209-13$89$YR$$M$Y$76.3$KG$20240925$$MD$US$US
235791333$23579133$3$F$20240205$20240724$20240229$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032164$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240724$$CN$US$US
235791412$23579141$2$F$$20240222$20240229$20240926$PER$$US-GSK-US2024AMR024139$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
235791582$23579158$2$F$20240225$20240728$20240229$20240730$PER$$US-AMGEN-USASP2024040375$AMGEN$$80$YR$E$M$Y$$$20240730$$CN$US$US
235791944$23579194$4$F$20240205$20240815$20240229$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030315$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240827$$HP$US$US
235792334$23579233$4$F$20210602$20240813$20240229$20240820$EXP$$CA-MYLANLABS-2021M1033406$BIOCON$$$$$$Y$$$20240820$$HP$CA$CA
235792732$23579273$2$F$$20240830$20240229$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-025461$BRISTOL MYERS SQUIBB$$5$DEC$A$F$Y$$$20240909$$HP$JP$JP
235792764$23579276$4$F$$20240726$20240229$20240730$EXP$$US-GSK-US2024AMR022899$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$CN$US$US
235792773$23579277$3$F$20230101$20240807$20240229$20240814$EXP$$US-ABBVIE-5656384$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
235792814$23579281$4$F$20231129$20240703$20240229$20240705$EXP$$FR-EXELIXIS-CABO-24074428$EXELIXIS$$67$YR$$M$Y$$$20240705$$HP$FR$FR
235793712$23579371$2$F$$20240619$20240229$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01456$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235793984$23579398$4$F$20240201$20240809$20240229$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-017868$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240812$$CN$US$US
235794363$23579436$3$F$20231113$20240905$20240229$20240910$EXP$$NVSC2024CA009570$NOVARTIS$$48$YR$$F$Y$$$20240910$$HP$CA$CA
2357944414$23579444$14$F$20231229$20240826$20240229$20240903$EXP$$GB-MYLANLABS-2024M1017654$MYLAN$$78$YR$$F$Y$$$20240903$$CN$GB$GB
235794452$23579445$2$F$20231024$20240906$20240229$20240914$EXP$$BR-TAKEDA-2024TUS018354$TAKEDA$$67$YR$$M$Y$$$20240914$$CN$BR$BR
235794702$23579470$2$F$$20240627$20240229$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-433161$RANBAXY$$38$YR$$M$Y$$$20240712$$MD$FR$FR
235794772$23579477$2$F$$20240724$20240229$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-433010$RANBAXY$Caillet A, Houillier C, Sourdeau E, Gazzano M, Uzunov M, Friser V, et al. Successful treatment by CAR T-cells in multi-refractory mantle cell lymphoma with central nervous system involvement. Ann Hematol. 2023;102:3295-3297$48$YR$$M$Y$$$20240808$$HP$FR$FR
235794953$23579495$3$F$$20240912$20240229$20240927$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433211$RANBAXY$Sangepu S, Manthram V. Methotrexate induced hypersensitivity pneumonitis. Indian J Rheumatol. 2023;18 (Suppl.):S344-S345 abstr. CAS103$56$YR$$F$Y$$$20240927$$HP$IN$IN
235796012$23579601$2$F$20240127$20240813$20240229$20240815$EXP$$MX-JNJFOC-20240212687$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240816$$MD$MX$MX
235796475$23579647$5$F$20230821$20240819$20240229$20240826$EXP$$CA-GSK-CA2023083805$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$HP$CA$CA
235797212$23579721$2$F$$20240913$20240229$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432866$RANBAXY$O^Dea A, Khan M, Haines HI, Kimler BF, Nye LE, Sharma P, et al. Fixed dose, dose-dense capecitabine in metastatic breast cancer. J Clin Oncol. 2019;May 26; 37 (15):e12593$$$$$Y$$$20240927$$HP$US$US
235797602$23579760$2$F$20210910$20240812$20240229$20240816$EXP$FR-GSKCCFEMEA-Case-01552516_AE-61111$FR-GSK-FR2021254675$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$FR$FR
235797822$23579782$2$F$$20240916$20240229$20240927$EXP$$US-UCBSA-2024009543$UCB$$$$$F$Y$$$20240927$$CN$US$US
235797862$23579786$2$F$20240101$20240805$20240229$20240816$EXP$$US-UCBSA-2024009731$UCB$$39$YR$$F$Y$$$20240816$$HP$US$US
235798066$23579806$6$F$20240221$20240726$20240229$20240801$EXP$$NVSC2024GB042741$NOVARTIS$$30$YR$$M$Y$$$20240801$$CN$GB$GB
235798422$23579842$2$F$20240101$20240716$20240229$20240718$EXP$SE-SEMPA-2024-000652$SE-SANDOZ INC.-SDZ2024SE021030$SANDOZ$$70$YR$$F$Y$83$KG$20240718$$MD$SE$SE
235798553$23579855$3$F$20240101$20240809$20240229$20240817$EXP$$CA-CELLTRION INC.-2024CA005052$CELLTRION$$$$$$Y$$$20240817$$CN$CA$CA
235798684$23579868$4$F$20240101$20240910$20240229$20240927$EXP$$US-SA-2024SA066602$SANOFI AVENTIS$$46$YR$A$F$Y$95.2$KG$20240927$$MD$US$US
235798954$23579895$4$F$$20240919$20240229$20240919$EXP$$GB-ROCHE-3503737$ROCHE$$40$YR$A$F$Y$$$20240919$$HP$GB$GB
235799268$23579926$8$F$$20240905$20240229$20240909$30DAY$$US-PFIZER INC-202400039629$PFIZER$$12$YR$$F$Y$$$20240909$$CN$US$US
235799836$23579983$6$F$$20240731$20240229$20240809$EXP$$US-TAKEDA-2024TUS018607$TAKEDA$$$$$M$Y$69$KG$20240809$$CN$US$US
235799892$23579989$2$F$20240226$20240729$20240229$20240802$PER$$US-AMGEN-USASP2024040582$AMGEN$$69$YR$E$M$Y$$$20240801$$CN$US$US
235800934$23580093$4$F$$20240717$20240229$20240724$PER$$US-ALXN-202402USA001476US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
235801113$23580111$3$F$20240101$20240815$20240229$20240826$PER$$US-BIOGEN-2024BI01252079$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
235801182$23580118$2$F$$20240221$20240229$20240808$EXP$$NVSC2024US037628$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
235801753$23580175$3$F$20220905$20240703$20240229$20240707$EXP$$US-ABBVIE-5657342$ABBVIE$$73$YR$$M$Y$82$KG$20240707$$CN$US$US
235801832$23580183$2$F$20240115$20240814$20240229$20240822$EXP$$FR-JNJFOC-20240280791$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240822$$PH$FR$FR
235802102$23580210$2$F$$20240619$20240229$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01499$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235802123$23580212$3$F$20240201$20240805$20240229$20240816$EXP$$JP-UCBSA-2024008138$UCB$$12$YR$$M$Y$35$KG$20240816$$PH$JP$JP
235802294$23580229$4$F$20240301$20240724$20240229$20240815$PER$$US-TRAVERE-2024TVT00170$TRAVERE THERAPEUTICS$$67$YR$E$F$Y$$$20240815$$CN$US$US
235802303$23580230$3$F$$20240916$20240229$20240930$PER$$US-TRAVERE-2024TVT00169$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
235802418$23580241$8$F$20240126$20240820$20240229$20240827$EXP$$CA-GSK-CA2024004582$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$HP$CA$CA
235802682$23580268$2$F$20180621$20240917$20240229$20240925$EXP$$CA-TAKEDA-2018TUS020534$TAKEDA$$64$YR$$F$Y$$$20240925$$HP$CA$CA
235802833$23580283$3$F$$20240709$20240229$20240715$EXP$$US-OTSUKA-2023_018518$OTSUKA$$$$$F$Y$$$20240715$$MD$US$US
235803463$23580346$3$F$$20240619$20240229$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01500$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235803677$23580367$7$F$20240411$20240816$20240229$20240820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-031531$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$50$KG$20240820$$MD$JP$JP
235803683$23580368$3$F$$20240802$20240229$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028233$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240808$$CN$US$US
235803763$23580376$3$F$$20240801$20240229$20240805$EXP$$CA-HORIZON THERAPEUTICS-HZN-2024-001342$AMGEN$$9$YR$C$F$Y$15$KG$20240805$$CN$CA$CA
235803912$23580391$2$F$$20240918$20240229$20240927$PER$$US-INCYTE CORPORATION-2024IN001909$INCYTE$$$$$$Y$$$20240927$$CN$US$US
235803983$23580398$3$F$$20240627$20240229$20240703$EXP$$CA-JNJFOC-20240135270$JOHNSON AND JOHNSON$$58$YR$A$F$Y$88$KG$20240703$$HP$CA$CA
235804132$23580413$2$F$$20240918$20240229$20240926$PER$$US-INCYTE CORPORATION-2024IN001864$INCYTE$$$$$$Y$$$20240926$$CN$US$US
235804374$23580437$4$F$20240201$20240807$20240229$20240812$EXP$$US-INCYTE CORPORATION-2024IN001638$INCYTE$$$$$$Y$$$20240812$$MD$US$US
235804607$23580460$7$F$20240101$20240712$20240229$20240718$EXP$$US-UCBSA-2024002811$UCB$$70$YR$$F$Y$$$20240718$$CN$US$US
235805033$23580503$3$F$20240201$20240819$20240229$20240826$EXP$$JP-GENMAB-2024-00511$GENMAB$$86$YR$$M$Y$55.3$KG$20240826$$MD$JP$JP
235805247$23580524$7$F$$20240918$20240229$20240926$EXP$$US-Calliditas-2024CAL00302$CALLIDITAS THERAPEUTICS$$51$YR$A$M$Y$$$20240926$$CN$US$US
235805442$23580544$2$F$$20240830$20240229$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US019624$SANDOZ$$$$$F$Y$$$20240903$$CN$US$US
235805714$23580571$4$F$20240124$20240717$20240229$20240723$EXP$$DE-AMGEN-DEUSP2024038810$AMGEN$$$$$F$Y$$$20240723$$MD$DE$DE
235805772$23580577$2$F$20240701$20240827$20240229$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032638$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240904$$HP$US$US
235805784$23580578$4$F$$20240906$20240229$20240916$EXP$$CA-OTSUKA-2024_002410$OTSUKA$$$$$F$Y$$$20240916$$HP$CA$CA
235805823$23580582$3$F$$20240826$20240229$20240909$PER$$US-Calliditas-2024CAL00208$CALLIDITAS THERAPEUTICS$$39$YR$A$F$Y$207.74$KG$20240909$$CN$US$US
235806465$23580646$5$F$20240216$20240822$20240229$20240828$EXP$$US-Calliditas-2024CAL00271$CALLIDITAS THERAPEUTICS$$42$YR$A$F$Y$44$KG$20240828$$CN$US$US
235806823$23580682$3$F$20200915$20240802$20240229$20240809$EXP$$FR-SERVIER-S24001989$SERVIER$$$$$$Y$$$20240809$$MD$FR$FR
235807437$23580743$7$F$20231201$20240708$20240229$20240716$EXP$$US-Calliditas-2024CAL00269$CALLIDITAS THERAPEUTICS$$51$YR$A$M$Y$106$KG$20240716$$CN$US$US
235808114$23580811$4$F$20240213$20240415$20240229$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003347$TG THERAPEUTICS$$54$YR$$M$Y$$$20240715$$CN$US$US
235808314$23580831$4$F$$20240704$20240229$20240715$EXP$$DE-ROCHE-3517018$ROCHE$Perl M, Herfeld K, Harrer D, Hoepting M, Schweiger M, Sterz U, Knoedler L, Hansmann L, Herr W, Poeck H, Wolff D, Edinger M and  Hart C Tocilizumab Administration in CAR-T Cell Associated Cytokine Release Syndrome Induces Hypofibrinogenemia. DOI: 10.1182/blood-2023-186878. Blood 2023 Nov 28;141 (1):5493-5.$$$$$Y$$$20240715$$HP$DE$DE
235808402$23580840$2$F$$20240826$20240229$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019783$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240828$$CN$US$US
235808694$23580869$4$F$20240415$20240621$20240229$20240902$PER$$US-ASTELLAS-2024US005446$ASTELLAS$$58$YR$A$F$Y$$$20240830$$MD$US$US
235809242$23580924$2$F$$20240731$20240229$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032798$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240802$$CN$US$US
235809302$23580930$2$F$$20240822$20240229$20240828$30DAY$$US-SANDOZ INC.-SDZ2024US019674$SANDOZ$$$$$F$Y$$$20240828$$CN$US$US
235809506$23580950$6$F$20231227$20240628$20240229$20240702$EXP$$US-ABBVIE-5653946$ABBVIE$$62$YR$$M$Y$96.161$KG$20240702$$HP$US$US
235810072$23581007$2$F$20200101$20240215$20240229$20240715$EXP$FR-AFSSAPS-AVLL2023000206$FR-TEVA-VS-3160211$TEVA$$17$YR$$F$Y$$$20240715$$MD$FR$FR
235810622$23581062$2$F$20231222$20240226$20240229$20240918$EXP$$NL-BAUSCH-BL-2024-003299$BAUSCH AND LOMB$$23$YR$$F$Y$62$KG$20240918$$CN$NL$NL
235810692$23581069$2$F$$20240729$20240229$20240730$EXP$$CA-BAUSCH-BL-2024-003228$BAUSCH AND LOMB$$45$YR$$M$Y$136$KG$20240730$$HP$CA$CA
235810752$23581075$2$F$$20240709$20240229$20240720$EXP$CZ-CZSUKL-23004356$CZ-TEVA-VS-3159631$TEVA$$26$YR$$F$Y$$$20240720$$MD$CZ$CZ
235810794$23581079$4$F$20240225$20240726$20240229$20240730$PER$$US-AMGEN-USASP2024042319$AMGEN$$70$YR$E$F$Y$$$20240730$$CN$US$US
235811156$23581115$6$F$20240425$20240816$20240229$20240820$PER$$US-PFIZER INC-PV202400027729$PFIZER$$86$YR$$F$Y$55.8$KG$20240820$$CN$US$US
2358112012$23581120$12$F$20240101$20240802$20240229$20240806$PER$$US-PFIZER INC-PV202400028476$PFIZER$$66$YR$$F$Y$$$20240806$$HP$US$US
235811307$23581130$7$F$$20240702$20240229$20240704$PER$$US-PFIZER INC-PV202400028483$PFIZER$$67$YR$$F$Y$$$20240704$$HP$US$US
235811373$23581137$3$F$$20240823$20240229$20240828$PER$$US-PFIZER INC-PV202300113993$PFIZER$$66$YR$$F$Y$77.098$KG$20240828$$CN$US$US
235811893$23581189$3$F$20240216$20240722$20240229$20240726$EXP$$US-BIOGEN-2024BI01252506$BIOGEN$$68$YR$$F$Y$$$20240726$$CN$US$US
235812079$23581207$9$F$$20240710$20240229$20240716$EXP$$PT-ELI_LILLY_AND_COMPANY-PT202402014123$ELI LILLY AND CO$$$$E$$Y$$$20240716$$CN$PT$PT
235812662$23581266$2$F$20211201$20240628$20240229$20240708$EXP$FR-AFSSAPS-NT2024000004$FR-TEVA-VS-3160580$TEVA$$77$YR$$F$Y$60$KG$20240708$$MD$FR$FR
235812763$23581276$3$F$$20240822$20240229$20240826$EXP$$CA-PURDUE-USA-2024-0308104$PURDUE$$82$YR$$F$Y$$$20240826$$CN$CA$CA
235813453$23581345$3$F$$20240815$20240229$20240819$PER$$US-PFIZER INC-202400052946$PFIZER$$68$YR$$F$Y$$$20240819$$CN$US$US
235813984$23581398$4$F$20230101$20240624$20240229$20240701$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000170$DECIPHERA PHARMACEUTICALS$$33$YR$A$F$Y$$$20240701$$CN$US$US
235814152$23581415$2$F$$20240709$20240229$20240710$PER$$US-PFIZER INC-202400052309$PFIZER$$79$YR$$M$Y$$$20240710$$MD$US$US
235814303$23581430$3$F$$20240716$20240229$20240719$PER$$US-PFIZER INC-PV202400028269$PFIZER$$77$YR$$F$Y$$$20240719$$HP$US$US
235815452$23581545$2$F$20231207$20240716$20240229$20240726$EXP$$CN-PFIZER INC-PV202400026822$PFIZER$$50$YR$$F$Y$70$KG$20240726$$HP$CN$CN
235815583$23581558$3$F$20171214$20240731$20240229$20240805$EXP$$US-PFIZER INC-2017537280$PFIZER$$66$YR$$M$Y$$$20240804$$CN$US$US
235815714$23581571$4$F$20220101$20240919$20240229$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031538$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240923$$CN$US$US
2358160016$23581600$16$F$$20240821$20240229$20240827$EXP$$IN-PFIZER INC-PV202400027046$PFIZER$$56$YR$$M$Y$$$20240827$$CN$IN$IN
235816554$23581655$4$F$$20240725$20240229$20240730$EXP$$US-TAKEDA-US202024951$TAKEDA$$$$$F$Y$73$KG$20240730$$HP$US$US
235817012$23581701$2$F$20240212$20240712$20240229$20240717$EXP$$CN-PFIZER INC-PV202400027693$PFIZER$$77$YR$$M$Y$$$20240717$$HP$CN$CN
235817104$23581710$4$F$$20240903$20240229$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031528$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240904$$CN$US$US
235817353$23581735$3$F$20240101$20240628$20240229$20240702$EXP$$US-Eisai-EC-2024-158586$EISAI$$76$YR$E$F$Y$$$20240702$$CN$US$US
235818033$23581803$3$F$20240101$20240725$20240229$20240731$EXP$$US-BAUSCHBL-2024BNL002331$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240731$$CN$US$US
235818043$23581804$3$F$20230101$20240723$20240229$20240729$EXP$$JP-009507513-2402JPN003426J$MERCK$Fujii K, Iyobe R, Sawada K, Oishi K, Maeda S, Hamaguchi Y, et al.. 79 A case of malignant melanoma causing panniculitis during treatment with anti-PD-1 antibody. The 75th Annual Meeting of the Western Japan Division of Japanese Dermatological. 220$82$YR$$F$Y$$$20240729$$MD$JP$JP
235818333$23581833$3$F$20240216$20240808$20240229$20240814$PER$$US-ALKERMES INC.-ALK-2024-000453$ALKERMES$$54$YR$$M$Y$$$20240814$$MD$US$US
235818833$23581883$3$F$$20240606$20240229$20240724$PER$$US-BAUSCH-BL-2024-003159$BAUSCH AND LOMB$$$$$M$Y$$$20240724$$CN$US$US
235818996$23581899$6$F$20240205$20240807$20240229$20240808$EXP$$US-SANDOZ INC.-SDZ2024US019743$SANDOZ$$25$YR$$F$Y$63.9$KG$20240808$$CN$US$US
235819142$23581914$2$F$20240205$20240816$20240229$20240823$EXP$$CA-GE HEALTHCARE-2024CSU001782$GE HEALTHCARE$$40$YR$$F$Y$$$20240823$$HP$CA$CA
235819573$23581957$3$F$$20240802$20240229$20240806$PER$$NVSC2024US042869$NOVARTIS$$$$$F$Y$$$20240806$$HP$US$US
235819733$23581973$3$F$$20240822$20240229$20240827$EXP$$US-LUNDBECK-DKLU3074454$LUNDBECK$$$$$$Y$$$20240827$$CN$US$US
235820183$23582018$3$F$20231020$20240722$20240229$20240728$EXP$$JP-BEH-2024169138$CSL BEHRING$$49$YR$A$F$Y$65$KG$20240728$$MD$JP$JP
235820263$23582026$3$F$20240101$20240903$20240229$20240930$PER$$US-SA-2024SA029946$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240930$$MD$US$US
235820323$23582032$3$F$$20240704$20240229$20240716$PER$$US-SA-2024SA063211$SANOFI AVENTIS$$$$A$F$Y$48$KG$20240716$$MD$US$US
235820422$23582042$2$F$20240101$20240703$20240229$20240711$PER$$US-SA-2024SA063273$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240712$$MD$US$US
235820433$23582043$3$F$$20240917$20240229$20240925$PER$$US-SA-2024SA063248$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240925$$MD$US$US
235820533$23582053$3$F$20240101$20240726$20240229$20240805$PER$$US-SA-2024SA064057$SANOFI AVENTIS$$29$YR$A$M$Y$81.19$KG$20240805$$MD$US$US
235820963$23582096$3$F$$20240829$20240229$20240913$PER$$US-SA-2024SA061577$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240913$$MD$US$US
235821092$23582109$2$F$20240201$20240830$20240229$20240923$PER$$US-SA-2024SA061988$SANOFI AVENTIS$$78$YR$E$F$Y$70$KG$20240923$$MD$US$US
235821192$23582119$2$F$20231201$20240731$20240229$20240808$PER$$US-SA-2024SA064241$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240808$$HP$US$US
235821203$23582120$3$F$20230101$20240807$20240229$20240816$PER$$US-SA-2024SA061586$SANOFI AVENTIS$$19$YR$A$F$Y$81.19$KG$20240816$$MD$US$US
235821332$23582133$2$F$$20240620$20240229$20240705$PER$$US-SA-2024SA063932$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240705$$MD$US$US
235821433$23582143$3$F$20230428$20240723$20240229$20240805$PER$$US-SA-2024SA063794$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240805$$MD$US$US
235821475$23582147$5$F$20240101$20240819$20240229$20240827$EXP$$US-SA-2024SA063261$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240827$$MD$US$US
235821553$23582155$3$F$20240211$20240809$20240229$20240820$PER$$US-SA-2024SA066181$SANOFI AVENTIS$$43$YR$A$M$Y$115$KG$20240820$$MD$US$US
235821964$23582196$4$F$20240101$20240802$20240229$20240812$PER$$US-SA-2024SA063300$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240812$$MD$US$US
235822332$23582233$2$F$$20240808$20240229$20240826$PER$$US-SA-2024SA063906$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240826$$MD$US$US
235822472$23582247$2$F$$20240911$20240229$20240919$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP002294$STRIDES$Kido K, Carey B, Caccamo M, Bianco C, Sokos G.. Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy.. J-Am-Pharmacists-Assoc. 2023;64 (1):169-173$64$YR$$M$Y$$$20240919$$PH$US$US
235822572$23582257$2$F$20240101$20240802$20240229$20240812$PER$$US-SA-2024SA062128$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240812$$CN$US$US
235822782$23582278$2$F$20240101$20240802$20240229$20240812$PER$$US-SA-2024SA065895$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240812$$MD$US$US
235822902$23582290$2$F$20240601$20240711$20240229$20240801$PER$$US-SA-2024SA066267$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240719$$MD$US$US
235822982$23582298$2$F$20240101$20240723$20240229$20240730$PER$$US-SA-2024SA063658$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240730$$HP$US$US
235823219$23582321$9$F$20220701$20240925$20240229$20240930$PER$$US-SA-2024SA066173$SANOFI AVENTIS$$29$YR$A$F$Y$134.69$KG$20240930$$CN$US$US
235823482$23582348$2$F$20240223$20240823$20240229$20240902$PER$$US-SA-2024SA064178$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240902$$MD$US$US
235823616$23582361$6$F$20240207$20240806$20240229$20240819$EXP$$US-BEH-2024169072$CSL BEHRING$$60$YR$A$F$Y$$$20240819$$HP$US$US
235823802$23582380$2$F$20240221$20240718$20240229$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032612$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$88.9$KG$20240722$$CN$US$US
235823992$23582399$2$F$20240101$20240731$20240229$20240809$PER$$US-SA-2024SA064824$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240809$$MD$US$US
235824042$23582404$2$F$$20240805$20240229$20240813$PER$$US-SA-2024SA067734$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240814$$MD$US$US
235824132$23582413$2$F$20230801$20240701$20240229$20240710$PER$$US-SA-2024SA067486$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240710$$MD$US$US
235824413$23582441$3$F$$20240807$20240229$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032721$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$110.68$KG$20240809$$CN$US$US
235824572$23582457$2$F$$20240627$20240229$20240704$EXP$$JP-009507513-2402JPN003046J$MERCK$$$$$F$Y$$$20240704$$MD$JP$JP
235824902$23582490$2$F$$20240223$20240229$20240925$PER$$US-GSK-US2024AMR024640$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
235825298$23582529$8$F$20240110$20240724$20240229$20240730$EXP$$US-ABBVIE-5655303$ABBVIE$$35$YR$$F$Y$$$20240730$$HP$US$US
235825435$23582543$5$F$20230916$20240712$20240229$20240716$EXP$$NVSJ2024JP002598$NOVARTIS$$77$YR$$M$Y$50.9$KG$20240717$$PH$JP$JP
235825614$23582561$4$F$$20240821$20240229$20240826$EXP$$CA-TAKEDA-2024TUS013907$TAKEDA$$$$$M$Y$$$20240826$$CN$CA$CA
235825702$23582570$2$F$20240109$20240828$20240229$20240904$EXP$$FR-MALLINCKRODT-MNK202401367$MALLINCKRODT$$25$YR$A$M$Y$78$KG$20240904$$MD$FR$FR
235825752$23582575$2$F$20240726$20240731$20240229$20240802$PER$$NVSC2024US043394$NOVARTIS$$20$YR$$F$Y$$$20240802$$HP$US$US
235826204$23582620$4$F$$20240923$20240229$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202402016986$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240927$$CN$US$US
235826264$23582626$4$F$20240206$20240627$20240229$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000629$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240723$$CN$US$US
235827082$23582708$2$F$20240101$20240802$20240229$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000637$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
235827145$23582714$5$F$20240110$20240705$20240229$20240715$EXP$$US-HALEON-USCH2024AMR009838$Haleon PLC$$$$A$F$Y$$$20240712$$HP$US$US
235827164$23582716$4$F$20230101$20240812$20240229$20240819$EXP$$US-ABBVIE-5583662$ABBVIE$$$$$M$Y$78.017$KG$20240819$$CN$US$US
235827734$23582773$4$F$20211001$20240831$20240301$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-008700$AUROBINDO$$43$YR$$F$Y$61$KG$20240910$$MD$DE$DE
235827767$23582776$7$F$20240101$20240627$20240301$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-004942$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240704$$$US$US
235827882$23582788$2$F$20230101$20240816$20240301$20240820$EXP$$US-ABBVIE-5658248$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
235828102$23582810$2$F$$20240828$20240301$20240909$PER$$US-JNJFOC-20240238094$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240910$$CN$US$US
235828883$23582888$3$F$20210104$20240829$20240301$20240902$EXP$$DE-ROCHE-2873999$ROCHE$$28$YR$A$M$Y$65$KG$20240903$$MD$DE$DE
235834087$23583408$7$F$20240112$20240906$20240301$20240913$EXP$$CA-TAKEDA-2023TUS089016$TAKEDA$$62$YR$$M$Y$74.55$KG$20240913$$HP$CA$CA
235839102$23583910$2$F$$20240628$20240301$20240706$EXP$$US-AUROBINDO-AUR-APL-2024-008415$AUROBINDO$Howland M, Vatti T, Mahajan A.. C-L service Initiates Palliative ECT for Catatonia in a Terminal Cancer Patient: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64(Supplement):S63$78$YR$$M$Y$$$20240706$$MD$US$US
235839182$23583918$2$F$$20240715$20240301$20240717$PER$$US-ABBVIE-5655369$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
235839353$23583935$3$F$$20240403$20240301$20240731$EXP$$DE-JNJFOC-20240263737$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240731$$MD$DE$DE
235839425$23583942$5$F$$20240625$20240301$20240702$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000419$BLUEPRINT MEDICINES$$$$$M$Y$$$20240702$$CN$US$US
235839732$23583973$2$F$$20240704$20240301$20240718$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-04092$ALKEM$Lee DO, Lee CD.. Serotonin syndrome in a child associated with erythromycin and sertraline. Pharmacotherapy. 1999;19(7):894-6$12$YR$$M$Y$$$20240718$$HP$US$US
235839803$23583980$3$F$$20240731$20240301$20240816$PER$$US-AstraZeneca-2024A038710$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
235840013$23584001$3$F$$20240722$20240301$20240725$EXP$$ES-ROCHE-3517010$ROCHE$$$$$F$Y$$$20240725$$MD$ES$ES
235840224$23584022$4$F$20230801$20240821$20240301$20240831$30DAY$$US-GSK-US2024023230$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240831$$HP$US$US
235840893$23584089$3$F$20240213$20240828$20240301$20240906$PER$$US-JNJFOC-20240240933$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240906$$CN$US$US
235840904$23584090$4$F$$20240813$20240301$20240820$EXP$$CA-JNJFOC-20240254821$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240820$$HP$CA$CA
235841046$23584104$6$F$20240301$20240730$20240301$20240819$EXP$$US-BEH-2024169316$CSL BEHRING$$52$YR$A$F$Y$$$20240819$$HP$US$US
235841104$23584110$4$F$20240101$20240829$20240301$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032955$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240902$$CN$US$US
235841592$23584159$2$F$20231226$20240717$20240301$20240723$EXP$$AT-AMGEN-AUTSP2024036606$AMGEN$$43$YR$A$F$Y$$$20240723$$MD$AT$AT
235841737$23584173$7$F$20230421$20240829$20240301$20240903$EXP$$NVSC2023US117270$NOVARTIS$$9$YR$$M$Y$38.3$KG$20240903$$MD$US$US
235842022$23584202$2$F$$20240813$20240301$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033154$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240815$$CN$US$US
235842533$23584253$3$F$$20240828$20240301$20240910$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004338$SAREPTA THERAPEUTICS$$$$$M$Y$80.4$KG$20240910$$HP$US$US
235843105$23584310$5$F$20240530$20240628$20240301$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000575$ACADIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240723$$CN$US$US
235843253$23584325$3$F$$20240704$20240301$20240705$EXP$$DE-ALXN-202402EEA001946DE$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240705$$MD$DE$DE
235843357$23584335$7$F$20240222$20240627$20240301$20240703$EXP$$JP-ABBVIE-5659072$ABBVIE$$59$YR$$M$Y$55$KG$20240703$$MD$JP$JP
235843433$23584343$3$F$20230217$20240702$20240301$20240710$EXP$$BR-CELLTRION INC.-2024BR004759$CELLTRION$$$$$$Y$$$20240710$$CN$BR$BR
235843683$23584368$3$F$20240101$20240713$20240301$20240802$PER$$CA-TOLMAR, INC.-24CA046519$TOLMAR$$66$YR$$M$Y$$$20240802$$CN$CA$CA
235843792$23584379$2$F$20240201$20240806$20240301$20240830$PER$$NL-TOLMAR, INC.-24NL046746$TOLMAR$$85$YR$$M$Y$$$20240830$$CN$NL$NL
235844422$23584442$2$F$20231122$20240704$20240301$20240713$EXP$$IT-AUROBINDO-AUR-APL-2024-008774$AUROBINDO$$75$YR$$M$Y$57$KG$20240713$$MD$IT$IT
235844462$23584446$2$F$20230831$20240627$20240301$20240710$EXP$$AU-BEH-2024169006$CSL BEHRING$$70$YR$E$M$Y$70$KG$20240710$$MD$AU$AU
235844502$23584450$2$F$20230531$20240830$20240301$20240904$EXP$$BR-TAKEDA-2023TUS063834$TAKEDA$$32$YR$$F$Y$$$20240904$$CN$BR$BR
235844544$23584454$4$F$20200214$20240909$20240301$20240911$EXP$$CA-TAKEDA-2020TUS036604$TAKEDA$$49$YR$$M$Y$$$20240911$$CN$CA$CA
235844575$23584457$5$F$20240328$20240918$20240301$20240924$EXP$$CA-TAKEDA-2024TUS018875$TAKEDA$$27$YR$$M$Y$$$20240924$$CN$CA$CA
235844593$23584459$3$F$$20240712$20240301$20240722$EXP$$IE-TEVA-VS-3160860$TEVA$$$$E$$Y$71.2$KG$20240722$$MD$IE$IE
235844696$23584469$6$F$20240223$20240919$20240301$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-006091$UNITED THERAPEUTICS$$58$YR$$F$Y$114.29$KG$20240927$$$US$US
235844902$23584490$2$F$$20240812$20240301$20240813$PER$$US-JNJFOC-20240238207$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
235845146$23584514$6$F$20240101$20240724$20240301$20240801$EXP$$CA-CELLTRION INC.-2024CA005003$CELLTRION$$$$$$Y$$$20240801$$HP$CA$CA
235845373$23584537$3$F$20240101$20240725$20240301$20240729$EXP$$US-UCBSA-2024009920$UCB$$52$YR$$F$Y$$$20240729$$HP$US$US
235845524$23584552$4$F$20220504$20240910$20240301$20240916$EXP$SE-SEMPA-2024-000815$SE-ROCHE-3514047$ROCHE$$71$YR$E$M$Y$$$20240916$$HP$SE$SE
235845532$23584553$2$F$20231201$20240806$20240301$20240809$EXP$$US-ABBVIE-5659465$ABBVIE$$77$YR$$F$Y$$$20240809$$CN$US$US
235846182$23584618$2$F$$20240907$20240301$20240927$PER$$US-TEVA-VS-3151054$TEVA$$43$YR$$F$Y$$$20240927$$CN$US$US
235846424$23584642$4$F$20230525$20240708$20240301$20240710$EXP$$JP-JNJFOC-20240167004$JOHNSON AND JOHNSON$$83$YR$E$M$Y$60$KG$20240710$$PH$JP$JP
235847102$23584710$2$F$$20240729$20240301$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033342$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$118.39$KG$20240730$$CN$US$US
235847612$23584761$2$F$20240227$20240820$20240301$20240822$PER$$US-AMGEN-USASP2024042649$AMGEN$$67$YR$E$M$Y$$$20240822$$CN$US$US
235848535$23584853$5$F$20240423$20240813$20240301$20240819$EXP$$CA-TAKEDA-2024TUS002720$TAKEDA$$86$YR$$F$Y$$$20240819$$CN$CA$CA
235848732$23584873$2$F$20240226$20240816$20240301$20240820$PER$$US-AMGEN-USASP2024042634$AMGEN$$85$YR$E$M$Y$$$20240820$$CN$US$US
235848935$23584893$5$F$20240201$20240830$20240301$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030615$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240903$$CN$US$US
235849182$23584918$2$F$$20240305$20240301$20240903$PER$$US-CIPLA LTD.-2023US07099$CIPLA$$$$$$Y$$$20240903$$CN$US$US
235849303$23584930$3$F$$20240909$20240301$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031600$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240913$$CN$US$US
235849442$23584944$2$F$20240226$20240628$20240301$20240702$PER$$US-AMGEN-USASP2024040894$AMGEN$$76$YR$E$F$Y$$$20240702$$CN$US$US
235849673$23584967$3$F$$20240916$20240301$20240917$PER$$NVSC2024US044424$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
235849977$23584997$7$F$20030101$20240917$20240301$20240921$EXP$$US-ABBVIE-5657259$ABBVIE$$48$YR$$F$Y$$$20240921$$CN$US$US
235850623$23585062$3$F$$20240621$20240301$20240702$30DAY$$US-GSK-US2024022710$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
235851022$23585102$2$F$20240217$20240715$20240301$20240718$EXP$$US-KAMADA LIMITED-2020US008307$TAKEDA$$75$YR$$F$Y$47$KG$20240718$$HP$US$US
235851053$23585105$3$F$$20240306$20240301$20240926$PER$$US-GSK-US2024AMR023600$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
235851135$23585113$5$F$20240210$20240716$20240301$20240724$EXP$$US-ABBVIE-5655326$ABBVIE$$0$YR$$F$Y$$$20240724$$HP$US$US
235851545$23585154$5$F$20240210$20240716$20240301$20240724$EXP$$US-ABBVIE-5658821$ABBVIE$$0$YR$$M$Y$$$20240724$$CN$US$US
235851662$23585166$2$F$$20240904$20240301$20240905$EXP$$CA-BAUSCH-BL-2024-003373$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240905$$HP$CA$CA
235851784$23585178$4$F$$20240816$20240301$20240828$EXP$$IT-Accord-409550$ACCORD$Collini A, Ongaro A, Favi E, Lazzi S, Micheletti G, Ruggieri G. Tacrolimus-Associated Terminal Ileitis After Kidney Transplantation, Mimicking Crohn Disease: A Case Report. Transplantation Proceedings. 2024.$33$YR$A$M$Y$$$20240828$$HP$IT$IT
235852202$23585220$2$F$20240225$20240726$20240301$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202402015552$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240730$$CN$US$US
235853437$23585343$7$F$$20240916$20240301$20240920$EXP$$US-TAKEDA-2023TUS098501$TAKEDA$$$$$F$Y$108$KG$20240920$$CN$US$US
235853543$23585354$3$F$20240226$20240828$20240301$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032095$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240902$$CN$US$US
235853822$23585382$2$F$20240228$20240813$20240301$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033406$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$101.15$KG$20240821$$CN$US$US
235853872$23585387$2$F$20220827$20240215$20240301$20240701$EXP$FR-AFSSAPS-NY2023001863$FR-TEVA-VS-3160487$TEVA$$55$YR$$F$Y$$$20240701$$PH$FR$FR
235854623$23585462$3$F$$20240705$20240301$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032140$BRISTOL MYERS SQUIBB$$28$YR$A$F$Y$$$20240709$$CN$US$US
235855603$23585560$3$F$$20240801$20240301$20240806$EXP$$NVSC2024CA043848$NOVARTIS$$39$YR$$F$Y$$$20240807$$CN$CA$CA
235856015$23585601$5$F$$20240808$20240301$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434136$RANBAXY$$$$E$F$Y$$$20240821$$CN$US$US
235856375$23585637$5$F$$20240626$20240301$20240703$EXP$$CA-Orion Corporation ORION PHARMA-24_00028612$ORION$$40$YR$A$F$Y$$$20240703$$HP$CA$
235856963$23585696$3$F$$20240716$20240301$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-031814$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240722$$MD$JP$JP
235857202$23585720$2$F$20230801$20240826$20240301$20240830$EXP$$FR-MYLANLABS-2024M1017982$MYLAN$$59$YR$$M$Y$100$KG$20240830$$HP$FR$FR
235857482$23585748$2$F$20240227$20240725$20240301$20240730$PER$$US-AMGEN-USASP2024042602$AMGEN$$73$YR$E$M$Y$$$20240729$$CN$US$US
235857542$23585754$2$F$$20240823$20240301$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033420$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240826$$CN$US$US
235858345$23585834$5$F$20220101$20240909$20240301$20240913$EXP$$PA-SANDOZ INC.-SDZ2023PA017818$SANDOZ$$$$$F$Y$$$20240913$$CN$PA$PA
235858662$23585866$2$F$$20240628$20240301$20240712$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-01577$HIKMA$Howland M, Vatti T, Mahajan A.. Howland M, Vatti T, Mahajan A. C-L service Initiates Palliative ECT for Catatonia in a Terminal Cancer Patient: A Case Report.. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64:S6:2 pgs$78$YR$$M$Y$$$20240712$$MD$US$US
235858822$23585882$2$F$20210723$20230727$20240301$20240808$EXP$$NVSC2021ZA196471$NOVARTIS$$56$YR$$F$Y$$$20240808$$CN$ZA$ZA
235859894$23585989$4$F$20231201$20240710$20240301$20240713$EXP$$GB-ABBVIE-5659057$ABBVIE$$47$YR$$M$Y$$$20240713$$CN$GB$GB
235860043$23586004$3$F$$20240626$20240301$20240703$EXP$$CA-JNJFOC-20240270694$JOHNSON AND JOHNSON$$7$YR$C$M$Y$25$KG$20240703$$HP$CA$CA
235860312$23586031$2$F$$20240830$20240301$20240916$30DAY$$KR-JNJFOC-20240242526$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$KR$KR
235860695$23586069$5$F$$20240918$20240301$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033784$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240919$$HP$US$US
235860752$23586075$2$F$$20240925$20240301$20240930$PER$$US-BAYER-2024A024962$BAYER$$61$YR$A$F$Y$$$20240930$$CN$US$US
235861053$23586105$3$F$$20240918$20240301$20240923$EXP$$US-SANDOZ INC.-NVSC2022US213770$SANDOZ$$$$$F$Y$254$KG$20240923$$CN$US$US
235861152$23586115$2$F$20240222$20240718$20240301$20240724$PER$$US-AMGEN-USASP2024042780$AMGEN$$75$YR$E$F$Y$$$20240724$$CN$US$US
235861813$23586181$3$F$$20240712$20240301$20240715$EXP$$US-PFIZER INC-202400052082$PFIZER$Marsh, J.. Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion. American journal of health-system pharmacy. 2024;81(13):e345-e352$43$YR$$M$Y$191$KG$20240715$$PH$US$US
235861833$23586183$3$F$$20240712$20240301$20240715$EXP$$US-PFIZER INC-202400052085$PFIZER$Marsh, J.. Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion. American journal of health-system pharmacy. 2024;81(13):e345-e352$57$YR$$M$Y$93$KG$20240715$$PH$US$US
235861883$23586188$3$F$20240205$20240730$20240301$20240805$EXP$$US-JNJFOC-20240268164$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240806$$CN$US$US
235863457$23586345$7$F$20240318$20240906$20240301$20240913$EXP$$CA-TAKEDA-2024TUS019322$TAKEDA$$56$YR$$F$Y$$$20240913$$CN$CA$CA
235863969$23586396$9$F$$20240630$20240301$20240701$30DAY$$US-PFIZER INC-202400050926$PFIZER$$12$YR$$M$Y$$$20240701$$CN$US$US
235864793$23586479$3$F$20190101$20240731$20240301$20240806$EXP$$JP-009507513-2402JPN002881J$MERCK$$78$YR$$M$Y$$$20240806$$MD$JP$JP
235865274$23586527$4$F$20240130$20240826$20240301$20240829$PER$$US-BIOVITRUM-2024-US-002899$BIOVITRUM$$62$YR$$F$Y$$$20240829$$CN$US$US
235865313$23586531$3$F$$20240910$20240301$20240930$PER$$US-TRAVERE-2024TVT00207$TRAVERE THERAPEUTICS$$43$YR$A$M$Y$$$20240930$$HP$US$US
235865836$23586583$6$F$20240501$20240815$20240301$20240820$EXP$$CA-TAKEDA-2019TUS061889$TAKEDA$$67$YR$$M$Y$$$20240820$$CN$CA$CA
235865982$23586598$2$F$$20240709$20240301$20240716$EXP$$CA-GSK-CA2024025677$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$CA$CA
235866193$23586619$3$F$20240101$20240724$20240301$20240801$EXP$$US-SA-2024SA069128$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240801$$MD$US$US
235866502$23586650$2$F$$20240924$20240301$20240926$EXP$$GB-SANDOZ INC.-SDZ2024GB021819$SANDOZ$$$$$M$Y$$$20240926$$CN$GB$GB
235866664$23586666$4$F$$20240729$20240301$20240801$EXP$$CA-JNJFOC-20240268529$JOHNSON AND JOHNSON$$$$A$M$Y$119.8$KG$20240801$$HP$CA$CA
235867167$23586716$7$F$20240101$20240920$20240301$20240926$PER$$US-PFIZER INC-PV202400029201$PFIZER$$64$YR$$F$Y$$$20240926$$HP$US$US
2358673311$23586733$11$F$20210201$20240721$20240301$20240724$EXP$$US-PFIZER INC-PV202400027544$PFIZER$$62$YR$$F$Y$77.098$KG$20240724$$CN$US$US
235867373$23586737$3$F$$20240917$20240301$20240918$EXP$$US-PFIZER INC-202400053533$PFIZER$$82$YR$$F$Y$51.701$KG$20240918$$CN$US$US
235867405$23586740$5$F$20240101$20240909$20240301$20240911$PER$$US-PFIZER INC-PV202400028886$PFIZER$$67$YR$$F$Y$$$20240911$$CN$US$US
235867602$23586760$2$F$$20240730$20240301$20240731$EXP$$HU-SANDOZ INC.-SDZ2024HU021610$SANDOZ$$70$YR$$F$Y$$$20240731$$MD$HU$HU
235868243$23586824$3$F$$20240625$20240301$20240701$PER$$US-PFIZER INC-202400053721$PFIZER$$17$YR$$M$Y$$$20240701$$CN$US$US
235868273$23586827$3$F$$20240707$20240301$20240710$PER$$US-PFIZER INC-202400053604$PFIZER$$31$YR$$F$Y$$$20240710$$CN$US$US
235868454$23586845$4$F$20240515$20240808$20240301$20240812$PER$$US-PFIZER INC-PV202400028896$PFIZER$$14$YR$$F$Y$52.154$KG$20240812$$CN$US$US
235868485$23586848$5$F$20240101$20240821$20240301$20240827$PER$$US-PFIZER INC-202400054072$PFIZER$$42$YR$$F$Y$63.5$KG$20240827$$CN$US$US
235868582$23586858$2$F$$20240910$20240301$20240912$PER$$US-PFIZER INC-202400053427$PFIZER$$32$YR$$F$Y$95.25$KG$20240912$$CN$US$US
235868642$23586864$2$F$20240501$20240711$20240301$20240715$EXP$$US-PFIZER INC-202101313760$PFIZER$$58$YR$$F$Y$$$20240715$$CN$US$US
235868763$23586876$3$F$20090106$20240626$20240301$20240702$EXP$$CA-JNJFOC-20240151506$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240702$$HP$CA$CA
235869242$23586924$2$F$$20240730$20240301$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033413$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240801$$CN$US$US
235869783$23586978$3$F$20240215$20240812$20240301$20240822$EXP$$LU-TEVA-VS-3163048$TEVA$$58$YR$$M$Y$100$KG$20240822$$PH$LU$LU
235870089$23587008$9$F$20231228$20240829$20240301$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-001420$UNITED THERAPEUTICS$$66$YR$$F$Y$108.84$KG$20240905$$$US$US
235870587$23587058$7$F$20240227$20240912$20240301$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032870$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240917$$CN$US$US
235870595$23587059$5$F$$20240913$20240301$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032335$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240920$$CN$US$US
235870998$23587099$8$F$20240201$20240813$20240301$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-005079$UNITED THERAPEUTICS$$83$YR$$M$Y$100.68$KG$20240821$$$US$US
235871093$23587109$3$F$20230101$20240802$20240301$20240807$PER$$US-BIOGEN-2023BI01242016$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
235871396$23587139$6$F$20240201$20240913$20240301$20240918$PER$$US-KARYOPHARM-2024KPT000616$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240918$$CN$US$US
235871543$23587154$3$F$$20240703$20240301$20240709$EXP$$CA-TAKEDA-2024TUS018472$TAKEDA$$$$$F$Y$$$20240709$$CN$CA$CA
235871552$23587155$2$F$20240830$20240903$20240301$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-029861$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240906$$CN$US$US
235871673$23587167$3$F$20240201$20240719$20240301$20240730$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-06226$SAMSUNG BIOEPIS$$19$YR$A$M$Y$$$20240730$$CN$CA$CA
235872484$23587248$4$F$20240224$20240703$20240301$20240708$EXP$$US-AstraZeneca-2024A047975$ASTRAZENECA$$23308$DY$$F$Y$$$20240708$$CN$US$
235873025$23587302$5$F$20240107$20240715$20240301$20240730$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202402016103$ELI LILLY AND CO$$68$YR$E$M$Y$104$KG$20240730$$CN$BE$BE
235873344$23587334$4$F$20230101$20240909$20240301$20240912$EXP$$US-ABBVIE-5659123$ABBVIE$$79$YR$$M$Y$68.038$KG$20240912$$CN$US$US
235873492$23587349$2$F$$20240819$20240301$20240822$EXP$$NL-SANDOZ INC.-SDZ2024NL021444$SANDOZ$$77$YR$$M$Y$$$20240822$$MD$NL$NL
235873722$23587372$2$F$20120101$20240819$20240301$20240823$PER$IT-MINISAL02-889576$IT-Eisai-EC-2022-126024$EISAI$$50$YR$A$F$Y$$$20240823$$MD$IT$IT
235873752$23587375$2$F$20240201$20240814$20240301$20240816$EXP$$US-PFIZER INC-202200278160$PFIZER$$68$YR$$F$Y$$$20240816$$MD$US$US
235873792$23587379$2$F$20230101$20240801$20240301$20240806$EXP$$US-PFIZER INC-202400053975$PFIZER$$82$YR$$M$Y$98.88$KG$20240806$$CN$US$US
235873833$23587383$3$F$20240101$20240910$20240301$20240912$PER$$US-PFIZER INC-202300367503$PFIZER$$10$YR$$M$Y$62.7$KG$20240912$$CN$US$US
235873853$23587385$3$F$$20240719$20240301$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033018$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$73.48$KG$20240723$$CN$US$US
235873864$23587386$4$F$$20240708$20240301$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033649$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240710$$HP$US$US
235874102$23587410$2$F$20231101$20240904$20240301$20240906$EXP$$CA-PFIZER INC-202400014766$PFIZER$$19$YR$$M$Y$$$20240906$$HP$CA$CA
235874212$23587421$2$F$20240101$20240912$20240301$20240917$EXP$$CA-PFIZER INC-202400049602$PFIZER$$34$YR$$F$Y$$$20240917$$HP$CA$CA
235874535$23587453$5$F$20240201$20240628$20240301$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-168847$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240702$$CN$US$US
235874688$23587468$8$F$20240301$20240808$20240301$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-000236$UNITED THERAPEUTICS$$36$YR$$M$Y$77.098$KG$20240816$$PH$US$US
235874752$23587475$2$F$20230413$20240710$20240301$20240715$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-231406$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240715$$CN$CA$CA
235875232$23587523$2$F$$20240905$20240301$20240930$PER$$US-SA-2024SA066112$SANOFI AVENTIS$$$$T$M$Y$81.64$KG$20240930$$MD$US$US
235875242$23587524$2$F$$20240830$20240301$20240919$PER$$US-SA-2024SA064176$SANOFI AVENTIS$$$$E$M$Y$$$20240919$$MD$US$US
235875432$23587543$2$F$$20240820$20240301$20240829$PER$$US-SA-2024SA063154$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240829$$MD$US$US
235875583$23587558$3$F$20240101$20240830$20240301$20240913$PER$$US-SA-2024SA065586$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240913$$MD$US$US
235875593$23587559$3$F$20240216$20240820$20240301$20240830$PER$$US-SA-2024SA066244$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240830$$MD$US$US
235875713$23587571$3$F$$20240821$20240301$20240910$PER$$US-SA-2024SA063570$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240910$$CN$US$US
235875722$23587572$2$F$$20240813$20240301$20240821$PER$$US-SA-2024SA064217$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240821$$MD$US$US
235875782$23587578$2$F$20240226$20240227$20240301$20240830$EXP$$BR-ROCHE-3517805$ROCHE$$41$YR$A$F$Y$70$KG$20240830$$PH$BR$BR
235875942$23587594$2$F$20231227$20240731$20240301$20240809$PER$$US-SA-2024SA065462$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240809$$MD$US$US
235875952$23587595$2$F$20240201$20240826$20240301$20240910$PER$$US-SA-2024SA066084$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240910$$MD$US$US
235875963$23587596$3$F$20240201$20240725$20240301$20240805$PER$$US-SA-2024SA048348$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240805$$MD$US$US
235876153$23587615$3$F$$20240812$20240301$20240821$PER$$US-SA-2024SA063089$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240821$$CN$US$US
235876242$23587624$2$F$20230901$20240624$20240301$20240703$PER$$US-SA-2024SA065988$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240703$$MD$US$US
235876517$23587651$7$F$20240101$20240718$20240301$20240730$PER$$US-SA-2024SA067772$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240731$$MD$US$US
235876533$23587653$3$F$20240101$20240801$20240301$20240809$PER$$US-SA-2024SA066206$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240809$$MD$US$US
235876682$23587668$2$F$$20240825$20240301$20240909$PER$$US-SA-2024SA067530$SANOFI AVENTIS$$$$A$F$Y$$$20240909$$MD$US$US
235876775$23587677$5$F$20240223$20240718$20240301$20240726$PER$$US-SA-2024SA065307$SANOFI AVENTIS$$69$YR$E$F$Y$73.5$KG$20240726$$MD$US$US
235876854$23587685$4$F$20240223$20240708$20240301$20240715$PER$$US-SA-2024SA067299$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240715$$PH$US$US
235877432$23587743$2$F$20230101$20240806$20240301$20240813$PER$$US-SA-2024SA066757$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240814$$MD$US$US
235877594$23587759$4$F$20240101$20240911$20240301$20240918$PER$$US-SA-2024SA067309$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240918$$MD$US$US
235877723$23587772$3$F$20240101$20240717$20240301$20240725$PER$$US-SA-2024SA067825$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240725$$MD$US$US
235877806$23587780$6$F$20240101$20240916$20240301$20240925$PER$$US-SA-2024SA066697$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240925$$MD$US$US
235878023$23587802$3$F$$20240812$20240301$20240819$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000430$BLUEPRINT MEDICINES$$$$$F$Y$$$20240819$$CN$US$US
235878562$23587856$2$F$$20240711$20240301$20240806$PER$$US-GALDERMA-US2024002170$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
235878842$23587884$2$F$$20240815$20240301$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033841$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240823$$CN$US$US
235878993$23587899$3$F$20210429$20240823$20240301$20240829$EXP$$JP-BAUSCH-BL-2023-009051$BAUSCH AND LOMB$$69$YR$$F$Y$66.5$KG$20240829$$$COUNTRY NOT SPECIFIED$JP
235879043$23587904$3$F$$20240909$20240301$20240918$PER$$JP-Eisai-EC-2024-160571$EISAI$$63$YR$A$F$Y$$$20240918$$MD$JP$JP
235879063$23587906$3$F$$20240729$20240301$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-015370$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240730$$CN$US$US
235879134$23587913$4$F$20240101$20240808$20240301$20240813$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-109133$DAIICHI$$$$$F$Y$$$20240813$$CN$US$US
235879156$23587915$6$F$20231210$20240827$20240301$20240903$EXP$$US-BEH-2024169080$CSL BEHRING$$54$YR$A$F$Y$$$20240903$$HP$US$US
235879383$23587938$3$F$20220101$20240823$20240301$20240827$30DAY$$EG-SANDOZ INC.-NVSC2023EG144917$SANDOZ$$$$$M$Y$47$KG$20240827$$CN$EG$EG
235879503$23587950$3$F$$20240827$20240301$20240828$30DAY$$US-SANDOZ INC.-SDZ2024US021480$SANDOZ$$$$$F$Y$$$20240828$$CN$US$US
235879643$23587964$3$F$$20240808$20240301$20240828$PER$$US-PHARMING-PHAUS2024000178$PHARMING GROUP$$$$$$Y$$$20240815$$CN$US$US
235880042$23588004$2$F$20240103$20240710$20240301$20240711$EXP$$FR-TAKEDA-2024TUS019345$TAKEDA$$58$YR$$M$Y$$$20240711$$HP$FR$FR
235880083$23588008$3$F$20230424$20240711$20240301$20240718$EXP$$CA-BEH-2023158190$CSL BEHRING$$64$YR$A$M$Y$85$KG$20240718$$HP$CA$CA
235880482$23588048$2$F$20240101$20240828$20240301$20240917$PER$$US-SA-2024SA067388$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240918$$MD$US$US
235881152$23588115$2$F$20231020$20240730$20240302$20240809$EXP$FR-AFSSAPS-AM2023001042$FR-TEVA-VS-3161664$TEVA$$83$YR$$M$Y$73$KG$20240809$$MD$FR$FR
235881472$23588147$2$F$20231230$20240619$20240302$20240703$EXP$FR-AFSSAPS-RE2024000049$FR-TEVA-VS-3161567$TEVA$$38$YR$$F$Y$46.2$KG$20240703$$MD$FR$FR
235881536$23588153$6$F$$20240725$20240302$20240801$EXP$$US-UNITED THERAPEUTICS-UNT-2024-006199$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240801$$$US$US
235881942$23588194$2$F$20240226$20240714$20240302$20240715$PER$$US-AMGEN-USASP2024043465$AMGEN$$70$YR$E$F$Y$$$20240715$$CN$US$US
235882042$23588204$2$F$20220711$20240820$20240302$20240830$EXP$$DE-AUROBINDO-AUR-APL-2024-008885$AUROBINDO$$67$YR$$M$Y$$$20240830$$MD$DE$DE
235882293$23588229$3$F$20240224$20240628$20240302$20240705$PER$$US-AMGEN-USASP2024041394$AMGEN$$59$YR$A$M$Y$$$20240705$$CN$US$US
235882402$23588240$2$F$20240701$20240806$20240302$20240813$PER$$US-SA-2024SA068488$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240814$$MD$US$US
235882662$23588266$2$F$$20240716$20240302$20240724$PER$$US-SA-2024SA068569$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240724$$MD$US$US
235882732$23588273$2$F$20231225$20240715$20240302$20240902$EXP$FR-AFSSAPS-LM2024000019$FR-TEVA-VS-3161663$TEVA$$54$YR$$M$Y$64$KG$20240902$$MD$FR$FR
235883153$23588315$3$F$20240227$20240923$20240302$20240926$EXP$$NVSC2024US042338$NOVARTIS$$64$YR$$F$Y$$$20240926$$CN$US$US
235883413$23588341$3$F$20230101$20240712$20240302$20240722$EXP$$BR-CELLTRION INC.-2024BR004968$CELLTRION$$$$$$Y$$$20240722$$CN$BR$BR
235884012$23588401$2$F$$20240815$20240302$20240826$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024023882$VIIV$$$$$M$Y$$$20240826$$CN$US$US
235884172$23588417$2$F$$20240827$20240302$20240828$EXP$$CA-ORGANON-O2402CAN002141$ORGANON$$60$YR$$F$Y$$$20240828$$HP$CA$CA
235884275$23588427$5$F$20240201$20240715$20240302$20240724$EXP$$CA-CELLTRION INC.-2024CA002866$CELLTRION$$$$$$Y$$$20240724$$HP$CA$CA
235884402$23588440$2$F$20211022$20240722$20240302$20240731$EXP$$US-UCBSA-2024005590$UCB$$57$YR$$F$Y$$$20240731$$HP$US$US
235884433$23588443$3$F$20240224$20240926$20240302$20240930$PER$$US-AMGEN-USASP2024043263$AMGEN$$66$YR$E$F$Y$$$20240930$$HP$US$US
235884593$23588459$3$F$20240201$20240430$20240302$20240812$EXP$$NVSC2024EG041390$NOVARTIS$$57$YR$$F$Y$$$20240812$$CN$EG$EG
235884902$23588490$2$F$20240101$20240716$20240302$20240729$EXP$$US-UCBSA-2024009322$UCB$$$$$M$Y$$$20240729$$CN$US$US
235885058$23588505$8$F$20230101$20240822$20240302$20240907$EXP$$CA-CELLTRION INC.-2023CA020741$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
235885222$23588522$2$F$$20240222$20240302$20240808$EXP$$BR-SANDOZ INC.-NVSC2022BR140611$SANDOZ$$$$$F$Y$$$20240808$$CN$BR$BR
235885322$23588532$2$F$$20240619$20240302$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01653$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235885733$23588573$3$F$$20240911$20240302$20240921$EXP$GB-MHRA-ADR 28548411$GB-Accord-409873$ACCORD$$40$YR$A$F$Y$$$20240921$$HP$GB$GB
235886156$23588615$6$F$$20240814$20240302$20240821$EXP$$GB-TAKEDA-2024TUS019414$TAKEDA$$$$$M$Y$$$20240821$$CN$GB$GB
235886432$23588643$2$F$$20240704$20240302$20240705$EXP$$NVSC2024US036375$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
235886462$23588646$2$F$$20240227$20240302$20240808$EXP$$NVSC2024RU043504$NOVARTIS$$80$YR$$$Y$$$20240808$$MD$RU$RU
235886644$23588664$4$F$20240221$20240815$20240302$20240826$EXP$$US-GSK-US2024AMR024104$GLAXOSMITHKLINE$$63$YR$$F$Y$70.295$KG$20240826$$CN$US$US
235887012$23588701$2$F$20231202$20240222$20240302$20240813$EXP$$CO-SANDOZ INC.-SDZ2024CO022053$SANDOZ$$52$YR$$F$Y$70$KG$20240813$$CN$CO$CO
235887712$23588771$2$F$$20240703$20240303$20240712$PER$$US-SA-2024SA067787$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240712$$MD$US$US
235888412$23588841$2$F$$20240815$20240303$20240826$PER$$US-JNJFOC-20240305911$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
235888892$23588889$2$F$$20240717$20240303$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01550$LUPIN$$$$$$Y$$$20240827$$CN$US$US
235889512$23588951$2$F$$20240227$20240304$20240808$EXP$$NVSC2024US042357$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
235889743$23588974$3$F$$20240829$20240304$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-034253$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240902$$CN$US$US
235889882$23588988$2$F$20240829$20240903$20240303$20240913$EXP$$US-GSK-US2024023970$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240913$$CN$US$US
235890273$23589027$3$F$$20240826$20240303$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032841$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240827$$CN$US$US
235890292$23589029$2$F$$20240625$20240303$20240702$PER$$US-ALXN-A202302153$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240702$$CN$US$US
235890512$23589051$2$F$20240101$20240807$20240303$20240812$EXP$$AR-JNJFOC-20230314982$JOHNSON AND JOHNSON$$76$YR$E$F$Y$92$KG$20240812$$CN$AR$AR
235890574$23589057$4$F$$20240924$20240303$20240925$EXP$$PT-SANDOZ INC.-SDZ2024PT021703$SANDOZ$$$$E$$Y$$$20240925$$HP$PT$PT
235891063$23589106$3$F$20240209$20240716$20240303$20240718$EXP$$US-JNJFOC-20240266445$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240718$$PH$US$US
235891133$23589113$3$F$$20240823$20240303$20240830$EXP$$US-ABBVIE-5658176$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
235891372$23589137$2$F$20240601$20240819$20240303$20240826$EXP$$US-ABBVIE-5397066$ABBVIE$$57$YR$$F$Y$$$20240826$$CN$US$US
235891583$23589158$3$F$20240129$20240823$20240303$20240828$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-008705$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240828$$CN$US$US
235892033$23589203$3$F$20210101$20240914$20240303$20240920$EXP$$JP-ABBVIE-21K-087-4178128-00$ABBVIE$Long-term management of IBRUTINIB in initially diagnosed SLL. B-cell malignancy Conference in Saitama. 2024 MAR 01;.$77$YR$$F$Y$$$20240920$$MD$JP$JP
235892413$23589241$3$F$$20240624$20240303$20240702$PER$$US-ALXN-202402USA001923US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240702$$CN$US$US
235892562$23589256$2$F$$20240916$20240303$20240924$PER$$US-SA-2024SA065607$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240924$$MD$US$US
235893442$23589344$2$F$20240210$20240824$20240304$20240913$PER$$CA-TOLMAR, INC.-24CA046884$TOLMAR$$88$YR$$M$Y$$$20240913$$CN$CA$CA
235893583$23589358$3$F$20230101$20240813$20240304$20240814$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-247907$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$$$20240814$$CN$CA$CA
235893703$23589370$3$F$20240120$20240827$20240304$20240923$PER$$US-SA-2024SA063228$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240923$$PH$US$US
235893963$23589396$3$F$$20240720$20240304$20240801$PER$$US-SA-2024SA068290$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240801$$MD$US$US
235894134$23589413$4$F$$20240805$20240304$20240810$EXP$$US-ABBVIE-5657315$ABBVIE$$$$$M$Y$148$KG$20240810$$CN$US$US
235894352$23589435$2$F$20240225$20240813$20240304$20240814$PER$$US-AMGEN-USASP2024041327$AMGEN$$60$YR$A$M$Y$$$20240814$$CN$US$US
235894613$23589461$3$F$$20240815$20240304$20240817$PER$$US-JNJFOC-20240283865$JOHNSON AND JOHNSON$$$$$F$Y$$$20240817$$CN$US$US
235894683$23589468$3$F$20231201$20240827$20240304$20240831$EXP$$US-ABBVIE-5659935$ABBVIE$$47$YR$$F$Y$$$20240831$$MD$US$US
2358947910$23589479$10$F$20220101$20240809$20240304$20240816$EXP$$CA-CELLTRION INC.-2024CA005192$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
235894984$23589498$4$F$$20240919$20240304$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202403000742$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240923$$CN$US$US
235895252$23589525$2$F$20240228$20240728$20240304$20240730$PER$$US-AMGEN-USASP2024044052$AMGEN$$$$$M$Y$$$20240730$$CN$US$US
235895272$23589527$2$F$$20240229$20240304$20240726$EXP$$PY-ABBVIE-5660249$ABBVIE$$63$YR$$F$Y$$$20240726$$MD$PY$PY
235896423$23589642$3$F$$20240702$20240304$20240715$EXP$$CA-JUBILANT CADISTA PHARMACEUTICALS-2016CA000819$JUBILANT$Gardner DM, Abidi S, Ursuliak Z, Morrison J, Teehan MD, Tibbo PG.. Incidence of Oculogyric Crisis and Long-Term Outcomes With Second-Generation Antipsychotics in a First-Episode Psychosis Program. .. Journal of Clinical Psychopharmacology. 2015$22$YR$$F$Y$$$20240715$$PH$CA$CA
235896503$23589650$3$F$20240101$20240814$20240304$20240819$EXP$$US-ABBVIE-5659927$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
235896883$23589688$3$F$20240312$20240815$20240304$20240819$EXP$$CA-TAKEDA-2023TUS002799$TAKEDA$$45$YR$$F$Y$$$20240819$$CN$CA$CA
235897422$23589742$2$F$$20240910$20240304$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202402017867$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240915$$CN$US$US
235897742$23589774$2$F$20171115$20240807$20240304$20240814$EXP$$CA-CELLTRION INC.-2021CA018887$CELLTRION$$$$$$Y$$$20240814$$HP$CA$CA
235897924$23589792$4$F$20230519$20240726$20240304$20240802$EXP$$CA-GSK-CA2023AMR098945$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$CA$CA
235897984$23589798$4$F$20240101$20240909$20240304$20240916$EXP$$CA-CELLTRION INC.-2024CA000795$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
235898493$23589849$3$F$20090410$20240909$20240304$20240917$PER$$US-SA-2024SA069341$SANOFI AVENTIS$$46$YR$A$M$Y$81.633$KG$20240918$$MD$US$US
235898692$23589869$2$F$$20240625$20240304$20240703$EXP$$NL-TEVA-VS-3163350$TEVA$$$$A$M$Y$$$20240703$$MD$NL$NL
235898823$23589882$3$F$$20240903$20240304$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-003493$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240905$$CN$US$US
235899442$23589944$2$F$20231231$20240905$20240304$20240914$EXP$FR-AFSSAPS-LM2024000028$FR-TEVA-VS-3161997$TEVA$$90$YR$$F$Y$61$KG$20240914$$MD$FR$FR
235899924$23589992$4$F$20240221$20240828$20240304$20240906$EXP$$CA-CELLTRION INC.-2024CA005082$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
235899958$23589995$8$F$20240221$20240717$20240304$20240827$EXP$$AU-BEH-2024169189$CSL BEHRING$$7$YR$C$M$Y$31.7$KG$20240827$$CN$AU$AU
235900353$23590035$3$F$$20240809$20240304$20240816$30DAY$$BR-JNJFOC-20240228200$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$CN$BR$BR
235900644$23590064$4$F$20240601$20240725$20240304$20240801$EXP$$CA-GSK-CA2024025644$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$CA$CA
235900662$23590066$2$F$20240301$20240731$20240304$20240806$EXP$$JP-GSK-JP2024026709$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$PH$JP$JP
235900673$23590067$3$F$$20240729$20240304$20240805$EXP$$CA-GSK-CA2024025036$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$CA$CA
235900745$23590074$5$F$20240206$20240620$20240304$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000589$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240712$$CN$US$US
235900792$23590079$2$F$20240216$20240830$20240304$20240902$PER$$US-AMGEN-USASP2024044443$AMGEN$$67$YR$E$F$Y$$$20240902$$CN$US$US
235900803$23590080$3$F$20230926$20240822$20240304$20240827$EXP$$AU-TAKEDA-2023TUS094105$TAKEDA$$43$YR$$F$Y$$$20240827$$MD$AU$AU
235901203$23590120$3$F$$20240717$20240304$20240731$EXP$$US-CIPLA LTD.-2024US02241$CIPLA$$$$$$Y$$$20240731$$CN$US$US
235901307$23590130$7$F$$20240911$20240304$20240918$EXP$$CA-CELLTRION INC.-2024CA005085$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
235901954$23590195$4$F$20240227$20240819$20240304$20240821$PER$$US-AMGEN-USASP2024042702$AMGEN$$57$YR$A$F$Y$$$20240821$$HP$US$US
235902113$23590211$3$F$20230601$20240821$20240304$20240903$EXP$$DE-UCBSA-2024010192$UCB$$$$E$F$Y$$$20240903$$MD$DE$DE
235902183$23590218$3$F$20240226$20240701$20240304$20240708$PER$$US-AMGEN-USASP2024041299$AMGEN$$81$YR$E$M$Y$$$20240708$$CN$US$US
235902213$23590221$3$F$20240101$20240829$20240304$20240908$PER$$US-BAUSCHBL-2024BNL002423$BAUSCH AND LOMB$$85$YR$$F$Y$$$20240909$$CN$US$US
235902302$23590230$2$F$20220701$20240703$20240304$20240709$EXP$$US-ABBVIE-4318470$ABBVIE$$77$YR$$F$Y$$$20240709$$CN$US$US
235902375$23590237$5$F$20240201$20240826$20240304$20240829$EXP$$CL-JNJFOC-20240284345$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240829$$CN$CL$CL
235902712$23590271$2$F$20231201$20240711$20240304$20240719$EXP$$CO-ABBVIE-5660220$ABBVIE$$65$YR$$M$Y$$$20240719$$CN$CO$CO
235904385$23590438$5$F$20240101$20240703$20240304$20240709$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-033819$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$86$KG$20240709$$HP$CA$CA
235904462$23590446$2$F$$20240820$20240304$20240831$EXP$TN-MACLEODS PHARMACEUTICALS US LTD-MAC2024046107$TN-MACLEODS PHARMACEUTICALS US LTD-MAC2024046107$MACLEODS$$$$$$Y$$$20240831$$MD$TN$TN
235905073$23590507$3$F$$20240823$20240304$20240830$EXP$$US-ABBVIE-5659925$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
235905535$23590553$5$F$20240119$20240808$20240304$20240815$EXP$$BR-SERVIER-S24001718$SERVIER$$$$$$Y$$$20240815$$MD$BR$BR
235905682$23590568$2$F$$20240916$20240304$20240919$EXP$$US-TAKEDA-2023TUS099344$TAKEDA$$$$$F$Y$64$KG$20240919$$HP$US$US
235905772$23590577$2$F$$20240708$20240304$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033587$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240718$$HP$US$US
235905795$23590579$5$F$20240501$20240814$20240304$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-034102$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240816$$CN$US$US
235905872$23590587$2$F$$20240628$20240304$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202403000881$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240702$$CN$US$US
235906316$23590631$6$F$$20240626$20240304$20240706$EXP$$CA-CELLTRION INC.-2024CA005167$CELLTRION$$$$$$Y$$$20240706$$HP$CA$CA
235906473$23590647$3$F$20240219$20240716$20240304$20240717$PER$$US-JNJFOC-20240257520$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240717$$HP$US$US
235906763$23590676$3$F$20240808$20240809$20240304$20240817$EXP$$CA-CELLTRION INC.-2024CA005178$CELLTRION$$$$$$Y$$$20240817$$HP$CA$CA
235907013$23590701$3$F$20240101$20240726$20240304$20240803$EXP$$CA-CELLTRION INC.-2024CA005193$CELLTRION$$$$$$Y$$$20240803$$HP$CA$CA
235907842$23590784$2$F$$20240902$20240304$20240906$EXP$$JP-ROCHE-3518787$ROCHE$Nishiofuku H, Mori M, Yokomichi N, Sakuma Y, Sugiyama K, Takashina Y, Miyagi A, Ishizuka M, Imai K and Morita T Successful management of terminal delirium with transdermal blonanserin patch in a terminally ill cancer patient. DOI: 10.1089/jpm.2023.0584. Journal of palliative medicine 2024 Feb 09;:1-5.$73$YR$E$M$Y$$$20240906$$MD$JP$JP
235907915$23590791$5$F$$20240425$20240304$20240730$EXP$PL-EMA-DD-20240220-7482691-133422$PL-SAMSUNG BIOEPIS-SB-2024-06608$SAMSUNG BIOEPIS$Jarmolinski T, Rosa M, Rybka B, Ryczan-Krawczyk R, Gajek K, Bogunia-Kubik K, et al.. Case Report: Liver as a Source of Hematopoietic Stem Cells After Liver Transplantation Following Hematopoietic Stem Cell Transplantation. Frontiers in Pediatrics. 2022;10:861692:1-5. doi:10.3389/fped.2022.861692$13$YR$T$F$Y$$$20240730$$HP$PL$PL
235908463$23590846$3$F$20240219$20240801$20240304$20240807$EXP$$DE-MYLANLABS-2024M1019980$MYLAN$$38$WK$$M$Y$2.9$KG$20240807$$HP$DE$DE
235908472$23590847$2$F$$20240716$20240304$20240719$EXP$$JP-GSK-JP2023151226$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$MD$JP$JP
235908906$23590890$6$F$20240321$20240904$20240304$20240910$EXP$$US-GSK-US2024AMR025472$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240910$$CN$US$US
235908953$23590895$3$F$$20240625$20240304$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-033651$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240703$$MD$JP$JP
235909062$23590906$2$F$$20240618$20240304$20240703$EXP$$JP-TEVA-VS-3163348$TEVA$Moriya K, Hara R, Tomooka F, Shimozato N, Nishimura N, Kawaratani H, et al. Concurrent Ulcerative Colitis in a Pregnant Patient with Rheumatoid Arthritis. Intern-Med 2024; 63 (3): 385-391.; Moriya K, Hara R, Tomooka F, Shimozato N, Nishimura N, Kawaratani H, et al. Concurrent Ulcerative Colitis in a Pregnant Patient with Rheumatoid Arthritis. Intern-Med 2024; 63 (3): 385-391.$32$YR$$F$Y$$$20240703$$HP$JP$JP
235909592$23590959$2$F$20240101$20240826$20240304$20240905$EXP$$CO-VA000000605-2024001456$RECORDATI$$$$$$Y$$$20240905$$CN$CO$CO
235909923$23590992$3$F$20240221$20240725$20240304$20240731$EXP$$IN-ROCHE-3507753$ROCHE$$69$YR$E$M$Y$$$20240731$$CN$IN$IN
235910132$23591013$2$F$20191216$20240222$20240304$20240715$EXP$GB-MHRA-EYC 00250326$GB-TEVA-VS-3162205$TEVA$$5$YR$$M$Y$$$20240715$$CN$GB$GB
235910462$23591046$2$F$$20240709$20240304$20240712$EXP$$US-BAYER-2024A027349$BAYER$$25$YR$A$F$Y$$$20240712$$MD$US$US
235911082$23591108$2$F$20180613$20240723$20240304$20240725$EXP$DE-ROCHE-2141017$DE-SANDOZ INC.-NVSC2020DE081377$SANDOZ$$70$YR$$M$Y$$$20240725$$CN$DE$DE
235911586$23591158$6$F$20240222$20240912$20240304$20240920$EXP$$CA-CELLTRION INC.-2024CA005127$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
235911732$23591173$2$F$$20240726$20240304$20240807$PER$$US-JNJFOC-20240270994$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$US$US
235912303$23591230$3$F$$20240619$20240304$20240916$EXP$$BG-TEVA-VS-3163551$TEVA$Tchernev G, Kordeva S. MULTIPLE BCCS AND DYSPLASTIC NEVI AFTER ACE INHIBITORS (ENALAPRIL/PERINDOPRIL): THE ROLE OF NITROSAMINE CONTAMINATION/AVAILABILITY AS SUBSTANTIAL SKIN CANCER TRIGGERING FACTOR. Georgian-Med-News 2023; (335): 90-94.; Tchernev G, Kordeva S. MULTIPLE BCCS AND DYSPLASTIC NEVI AFTER ACE INHIBITORS (ENALAPRIL/PERINDOPRIL): THE ROLE OF NITROSAMINE CONTAMINATION/AVAILABILITY AS SUBSTANTIAL SKIN CANCER TRIGGERING FACTOR. Georgian-Med-News 2023; (335): 90-94.$72$YR$$M$Y$$$20240916$$HP$BG$BG
235912482$23591248$2$F$$20240701$20240304$20240704$EXP$$IN-TAKEDA-2023TUS107265$TAKEDA$$$$$M$Y$$$20240704$$CN$IN$IN
235912683$23591268$3$F$$20240826$20240304$20240828$EXP$$NVSC2024GB045360$NOVARTIS$$31$YR$$F$Y$$$20240828$$CN$GB$GB
235912702$23591270$2$F$20231004$20240712$20240304$20240716$EXP$$FR-TAKEDA-2024TUS019850$TAKEDA$$79$YR$$M$Y$$$20240716$$HP$FR$FR
235912974$23591297$4$F$$20240721$20240304$20240724$PER$$US-AMGEN-USASP2024042864$AMGEN$$81$YR$E$M$Y$$$20240724$$MD$US$US
235913242$23591324$2$F$20230319$20240819$20240304$20240822$EXP$$US-TAKEDA-2022TUS080670$TAKEDA$$53$YR$$F$Y$52.6$KG$20240822$$CN$US$US
235913365$23591336$5$F$$20240805$20240304$20240812$EXP$$JP-PFIZER INC-PV202400028948$PFIZER$Akamatsu, H.. Effect of rifampicin administration on CYP induction in a dermatomyositis patient with vasospastic angina attributable to nilmatrelvir/ritonavir-induced blood tacrolimus elevation: A case report. Journal of infection and chemotherapy. 2024;30(9):928-933$60$YR$$M$Y$$$20240812$$HP$JP$JP
235913462$23591346$2$F$$20240806$20240304$20240812$EXP$$US-INCYTE CORPORATION-2024IN002161$INCYTE$$$$$$Y$$$20240812$$CN$US$US
235913517$23591351$7$F$20230320$20240807$20240304$20240812$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005130$AURINIA PHARMACEUTICALS$$34$YR$$F$Y$$$20240812$$CN$US$US
235913543$23591354$3$F$20230530$20240911$20240304$20240913$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2023079136$VIIV$$$$$$Y$$$20240913$$HP$CA$CA
235913754$23591375$4$F$20231121$20240404$20240304$20240802$EXP$$NVSC2023KR260478$NOVARTIS$$70$YR$$F$Y$52.9$KG$20240802$$HP$KR$KR
235913852$23591385$2$F$$20240916$20240304$20240917$EXP$$US-KYOWAKIRIN-2024KK003694$KYOWA$$$$$$Y$$$20240917$$HP$US$US
235913862$23591386$2$F$20230101$20240628$20240304$20240704$EXP$$JP-009507513-2312JPN001316J$MERCK$$9$DEC$$M$Y$$$20240704$$MD$JP$JP
235914092$23591409$2$F$20240226$20240722$20240304$20240723$EXP$$GB-MYLANLABS-2024M1018999$MYLAN$$71$YR$$M$Y$$$20240723$$CN$GB$GB
235914312$23591431$2$F$$20240904$20240304$20240910$EXP$$US-PFIZER INC-PV202400028743$PFIZER$Chelius, M.. Safety of Total Skin Electron Therapy with Concurrent Systemic Therapy. Blood. 2023;142(Suppl 1):6182-6184$$$$$Y$$$20240910$$MD$US$US
235914933$23591493$3$F$20231211$20240703$20240304$20240712$PER$$US-SA-2024SA065525$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240712$$MD$US$US
235915033$23591503$3$F$20231001$20240725$20240304$20240806$PER$$US-SA-2024SA066764$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240806$$CN$US$US
235915312$23591531$2$F$20240124$20240627$20240304$20240708$PER$$US-SA-2024SA066236$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240708$$MD$US$US
235915612$23591561$2$F$20240201$20240812$20240304$20240820$PER$$US-SA-2024SA066873$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240820$$MD$US$US
235915812$23591581$2$F$20240201$20240801$20240304$20240810$PER$$US-SA-2024SA067384$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240810$$MD$US$US
235916022$23591602$2$F$$20240826$20240304$20240909$PER$$US-SA-2024SA070026$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240909$$MD$US$US
235916082$23591608$2$F$$20240819$20240304$20240829$PER$$US-SA-2024SA068957$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240829$$MD$US$US
235916132$23591613$2$F$20240201$20240905$20240304$20240916$PER$$US-SA-2024SA066720$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240916$$MD$US$US
235916512$23591651$2$F$$20240807$20240304$20240816$PER$$US-SA-2024SA070335$SANOFI AVENTIS$$$$E$F$Y$56.699$KG$20240816$$MD$US$US
235916923$23591692$3$F$20240912$20240916$20240304$20240923$PER$$US-SA-2024SA068789$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240923$$CN$US$US
235916932$23591693$2$F$20240601$20240721$20240304$20240729$PER$$US-SA-2024SA070786$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240729$$MD$US$US
235917382$23591738$2$F$$20240229$20240304$20240906$PER$$NVSC2024US044954$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
235917672$23591767$2$F$$20240702$20240304$20240711$PER$$US-SA-2024SA066101$SANOFI AVENTIS$$$$E$M$Y$$$20240711$$MD$US$US
235917902$23591790$2$F$20240101$20240821$20240304$20240905$PER$$US-SA-2024SA070709$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240905$$MD$US$US
235918283$23591828$3$F$$20240718$20240304$20240723$EXP$$US-INCYTE CORPORATION-2024IN001935$INCYTE$$$$$$Y$$$20240723$$CN$US$US
235918333$23591833$3$F$20220123$20240808$20240304$20240813$EXP$$DE-ROCHE-3138439$ROCHE$$37$YR$A$F$Y$$$20240813$$MD$DE$DE
235918913$23591891$3$F$20240506$20240806$20240304$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033109$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240806$$CN$US$US
235918973$23591897$3$F$20240201$20240725$20240304$20240731$EXP$IT-MINISAL02-971870$IT-MYLANLABS-2024M1018781$MYLAN$$73$YR$$M$Y$$$20240731$$MD$IT$IT
235919153$23591915$3$F$$20240709$20240304$20240711$EXP$$PT-ORGANON-O2402PRT002646$ORGANON$Martins DO, Pinho M, Caldas F, Pereira EG. Visual Hallucinations After Duloxetine Use. Prim Care Companion CNS Disord. 2024;26(1)$62$YR$$F$Y$$$20240711$$MD$PT$PT
235920043$23592004$3$F$20240101$20240730$20240304$20240808$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000150$DECIPHERA PHARMACEUTICALS$$76$YR$E$F$Y$$$20240808$$CN$US$US
235920072$23592007$2$F$20240701$20240731$20240304$20240805$EXP$$IT-UCBSA-2023023210$UCB$$$$E$F$Y$$$20240805$$CN$IT$IT
235920183$23592018$3$F$20240201$20240711$20240304$20240715$PER$$US-PFIZER INC-PV202400002266$PFIZER$$68$YR$$M$Y$$$20240715$$HP$US$US
235920655$23592065$5$F$20240109$20240802$20240304$20240806$EXP$$GB-MYLANLABS-2024M1015894$MYLAN$$41$YR$$M$Y$$$20240806$$MD$GB$GB
235920715$23592071$5$F$$20240710$20240304$20240716$EXP$$PT-MYLANLABS-2024M1016929$MYLAN$Martins DO, Pinho M, Caldas F, Pereira EG.. Visual Hallucinations After Duloxetine Use.. Primary Care Companion for CNS Disorders.. 2024;26(1):23cr03595$62$YR$$F$Y$$$20240716$$MD$PT$PT
235920802$23592080$2$F$$20240630$20240304$20240723$PER$$CA-TOLMAR, INC.-24CA046634$TOLMAR$$$$$M$Y$$$20240723$$CN$CA$CA
235922394$23592239$4$F$20240101$20240916$20240304$20240920$PER$$US-SA-2024SA069486$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240920$$MD$US$US
235922523$23592252$3$F$20240301$20240911$20240304$20240913$PER$$US-AMGEN-USASP2024045049$AMGEN$$47$YR$A$M$Y$$$20240913$$CN$US$US
235922982$23592298$2$F$$20240905$20240304$20240910$30DAY$$US-SANDOZ INC.-SDZ2024US021972$SANDOZ$$$$$F$Y$$$20240910$$CN$US$US
235923275$23592327$5$F$$20240729$20240304$20240807$EXP$$DE-ROCHE-3515875$ROCHE$$$$$F$Y$$$20240807$$MD$DE$DE
235923368$23592336$8$F$20231229$20240821$20240304$20240902$EXP$$GB-AUROBINDO-AUR-APL-2024-009328$AUROBINDO$$78$YR$$F$Y$$$20240902$$HP$GB$GB
235923613$23592361$3$F$$20240720$20240304$20240729$PER$$US-RDY-SPO/USA/24/0003165$DR REDDYS$$22$MON$C$M$Y$13.02$KG$20240729$$MD$US$US
235923737$23592373$7$F$20231208$20240805$20240304$20240806$EXP$$DE-SANDOZ INC.-SDZ2024DE020556$SANDOZ$$60$YR$$F$Y$$$20240806$$MD$DE$DE
235923792$23592379$2$F$20240220$20240618$20240304$20240711$PER$$US-PHARMING-PHAUS2024000170$PHARMING GROUP$$$$$$Y$$$20240711$$CN$US$US
235923982$23592398$2$F$$20240912$20240304$20240913$PER$$US-BAYER-2024A032555$BAYER$$24$YR$A$F$Y$$$20240913$$CN$US$US
235924066$23592406$6$F$20240406$20240808$20240304$20240814$EXP$$US-BAYER-2024A031621$BAYER$$32$YR$A$M$Y$61.678$KG$20240814$$CN$US$US
235924112$23592411$2$F$$20240801$20240304$20240805$EXP$$IE-FreseniusKabi-FK202403310$FRESENIUS KABI$$40$YR$A$F$Y$$$20240805$$HP$IE$IE
235924142$23592414$2$F$$20240705$20240304$20240710$EXP$$US-UCBSA-2023061363$UCB$$$$$F$Y$155$KG$20240710$$CN$US$US
235924355$23592435$5$F$$20240726$20240304$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-034755$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240802$$CN$US$US
235924463$23592446$3$F$$20240821$20240304$20240903$EXP$$CA-UCBSA-2024010018$UCB$$$$$M$Y$$$20240903$$CN$CA$CA
235924522$23592452$2$F$20230207$20240830$20240304$20240923$PER$$US-SA-2024SA066071$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240923$$MD$US$US
235926133$23592613$3$F$20210513$20240301$20240304$20240919$EXP$$AT-SANDOZ INC.-SDZ2024AT022004$SANDOZ$$47$YR$$F$Y$$$20240919$$MD$AT$AT
235926763$23592676$3$F$20220525$20240827$20240304$20240906$30DAY$$EG-SANDOZ INC.-SDZ2024EG017855$SANDOZ$$5$YR$$M$Y$18$KG$20240906$$CN$EG$EG
235927242$23592724$2$F$$20240730$20240304$20240802$PER$$US-PFIZER INC-PV202400029329$PFIZER$$43$YR$$F$Y$$$20240802$$HP$US$US
235927263$23592726$3$F$$20240814$20240304$20240816$PER$$US-PFIZER INC-202400055037$PFIZER$$84$YR$$F$Y$$$20240816$$CN$US$US
235927643$23592764$3$F$$20240306$20240304$20240706$EXP$$US-JNJFOC-20240275387$JOHNSON AND JOHNSON$$$$$$Y$$$20240706$$PH$US$US
235928168$23592816$8$F$$20240731$20240304$20240828$EXP$$CA-AMGEN-CANSP2024040704$AMGEN$$43$YR$A$F$Y$96$KG$20240828$$HP$CA$CA
235928236$23592823$6$F$20240101$20240628$20240304$20240702$EXP$$JP-AstraZeneca-2024A051510$ASTRAZENECA$$70$YR$$M$Y$61$KG$20240702$$MD$JP$
235928542$23592854$2$F$20231210$20240805$20240304$20240807$EXP$FR-AFSSAPS-LM2024000104$NVSC2024FR043756$NOVARTIS$$64$YR$$F$Y$73$KG$20240807$$MD$FR$FR
235928872$23592887$2$F$$20240814$20240304$20240902$PER$$AU-TOLMAR, INC.-24AU046779$TOLMAR$$$$$M$Y$$$20240902$$HP$AU$AU
235929123$23592912$3$F$$20240826$20240304$20240829$PER$$US-PFIZER INC-2021130127$PFIZER$$79$YR$$F$Y$$$20240829$$MD$US$US
235929193$23592919$3$F$20240101$20240806$20240304$20240809$PER$$US-PFIZER INC-PV202400029843$PFIZER$$58$YR$$F$Y$$$20240809$$HP$US$US
235929247$23592924$7$F$20240229$20240626$20240304$20240701$PER$$US-PFIZER INC-PV202400029559$PFIZER$$73$YR$$F$Y$$$20240701$$HP$US$US
235929313$23592931$3$F$$20240911$20240304$20240913$PER$$US-PFIZER INC-PV202400025073$PFIZER$$58$YR$$M$Y$$$20240913$$CN$US$US
235929414$23592941$4$F$20230801$20240703$20240304$20240709$EXP$$US-PFIZER INC-202400054932$PFIZER$$76$YR$$F$Y$76.644$KG$20240709$$HP$US$US
235929618$23592961$8$F$20240101$20240729$20240304$20240801$EXP$$US-PFIZER INC-PV202400029887$PFIZER$$50$YR$$F$Y$72.562$KG$20240801$$HP$US$US
235929622$23592962$2$F$$20240708$20240304$20240710$EXP$$GB-PFIZER INC-202400052972$PFIZER$$38$YR$$F$Y$$$20240710$$MD$GB$GB
235929734$23592973$4$F$20240301$20240919$20240304$20240923$PER$$US-PFIZER INC-202400055426$PFIZER$$20$YR$$F$Y$47.17$KG$20240923$$CN$US$US
235930587$23593058$7$F$20240701$20240815$20240304$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-025160$JAZZ$$55$YR$$M$Y$$$20240821$$MD$US$US
235930603$23593060$3$F$$20240906$20240304$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033870$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240911$$CN$US$US
235931452$23593145$2$F$$20240222$20240304$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202402014190$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
235931643$23593164$3$F$$20240806$20240304$20240813$EXP$$CO-SANDOZ INC.-NVSC2021CO228383$SANDOZ$$$$$F$Y$84$KG$20240813$$CN$CO$CO
235931732$23593173$2$F$20240101$20240708$20240304$20240716$EXP$CZ-CZSUKL-24000057$CZ-TEVA-VS-3163075$TEVA$$18$YR$$F$Y$$$20240716$$MD$CZ$CZ
235931743$23593174$3$F$$20240725$20240304$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033648$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240731$$CN$US$US
235931753$23593175$3$F$$20240624$20240304$20240702$EXP$$CA-GSK-CA2024AMR025470$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$MD$CA$CA
235932022$23593202$2$F$20240227$20240819$20240304$20240821$PER$$US-AMGEN-USASP2024044768$AMGEN$$61$YR$A$F$Y$$$20240821$$CN$US$US
235932453$23593245$3$F$$20240911$20240304$20240916$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-003757$JAZZ$$$$$F$Y$$$20240916$$HP$US$US
235932473$23593247$3$F$20240101$20240829$20240304$20240903$EXP$$US-OTSUKA-2024_004984$OTSUKA$$$$$F$Y$$$20240903$$CN$US$US
235932573$23593257$3$F$$20240926$20240304$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-034827$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240930$$CN$US$US
235932817$23593281$7$F$20240304$20240701$20240304$20240708$EXP$$GB-MYLANLABS-2024M1018917$MYLAN$$$$$M$Y$$$20240708$$CN$GB$GB
235932892$23593289$2$F$$20240702$20240304$20240709$EXP$$EG-AMGEN-EGYSP2024041948$AMGEN$$50$YR$A$F$Y$$$20240708$$CN$EG$EG
235933224$23593322$4$F$20240105$20240813$20240304$20240821$EXP$$US-Calliditas-2024CAL00285$CALLIDITAS THERAPEUTICS$$71$YR$E$F$Y$60.7$KG$20240821$$CN$US$US
235933272$23593327$2$F$20230101$20240820$20240304$20240830$EXP$$JP-AMRYT PHARMACEUTICALS DAC-AEGR006944$AEGERION$$$$$$Y$$$20240830$$MD$JP$JP
235933832$23593383$2$F$$20240823$20240304$20240828$PER$$US-009507513-2402USA009935$MERCK$$$$$M$Y$$$20240828$$CN$US$US
235933853$23593385$3$F$20240528$20240624$20240304$20240703$PER$$US-Calliditas-2024CAL00296$CALLIDITAS THERAPEUTICS$$20$YR$A$F$Y$$$20240703$$CN$US$US
235933932$23593393$2$F$20240216$20240913$20240304$20240924$EXP$$US-BEH-2024169426$CSL BEHRING$$41$YR$A$F$Y$78.005$KG$20240924$$CN$US$US
235934172$23593417$2$F$20210101$20240829$20240304$20240904$EXP$$CA-SANDOZ INC.-NVSC2021CA135442$SANDOZ$$46$YR$$F$Y$$$20240904$$CN$CA$CA
235934692$23593469$2$F$$20240903$20240304$20240906$EXP$$JP-009507513-2403JPN000207$MERCK$Fujimiya T, Azuma K, Togashi Y, Kuwata K, Unezaki S, Takeuchi H.. Pembrolizumab-induced secondary adrenal insufficiency due to adrenocorticotrophic hormone deficiency in a patient with non-small-cell lung carcinoma: a case report. Journal of Pharmaceutical Health Care and Sciences. 2024;10 (1)$$$A$M$Y$$$20240906$$HP$JP$JP
235934825$23593482$5$F$$20240722$20240304$20240729$PER$$US-ALXN-202402USA002008US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
235935032$23593503$2$F$20240201$20240705$20240304$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202403000469$ELI LILLY AND CO$$39$YR$A$F$Y$82$KG$20240711$$MD$US$US
235935253$23593525$3$F$20230101$20240819$20240304$20240821$EXP$$DE-SANDOZ INC.-SDZ2024DE023298$SANDOZ$$35$YR$$M$Y$$$20240821$$HP$DE$DE
235935322$23593532$2$F$20230601$20240903$20240304$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202306002611$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240913$$CN$US$US
235935352$23593535$2$F$$20240724$20240304$20240729$EXP$$NVSJ2024JP002878$NOVARTIS$$56$YR$$F$Y$$$20240729$$PH$JP$JP
235935653$23593565$3$F$20240101$20240821$20240304$20240905$PER$$US-SA-2024SA070737$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240905$$MD$US$US
235936234$23593623$4$F$20240101$20240911$20240304$20240918$EXP$$US-ABBVIE-5633934$ABBVIE$$83$YR$$F$Y$72$KG$20240918$$CN$US$US
235936383$23593638$3$F$20240101$20240725$20240304$20240730$EXP$$US-ABBVIE-5657429$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
235936513$23593651$3$F$$20240805$20240304$20240812$PER$$US-ALXN-202402USA002095US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
235937123$23593712$3$F$20240501$20240710$20240304$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-012438$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240711$$CN$US$US
235937295$23593729$5$F$20240301$20240703$20240304$20240705$PER$$US-AMGEN-USASP2024043992$AMGEN$$71$YR$E$F$Y$$$20240705$$CN$US$US
235937353$23593735$3$F$20240301$20240801$20240304$20240803$PER$$US-AMGEN-USASP2024043984$AMGEN$$63$YR$A$M$Y$$$20240803$$CN$US$US
235937442$23593744$2$F$20240726$20240731$20240304$20240807$30DAY$$US-GSK-US2024024321$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240807$$CN$US$US
235937453$23593745$3$F$20230701$20240910$20240304$20240917$EXP$$IN-GSK-IN2023APC103948$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$IN$IN
235937544$23593754$4$F$20240301$20240716$20240304$20240717$PER$$US-AMGEN-USASP2024043978$AMGEN$$43$YR$A$M$Y$$$20240717$$CN$US$US
235937642$23593764$2$F$$20240704$20240304$20240710$EXP$$NL-ABBVIE-5662911$ABBVIE$$$$E$M$Y$$$20240710$$CN$NL$NL
235937703$23593770$3$F$$20240906$20240304$20240915$EXP$$US-SA-2024SA070675$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240915$$MD$US$US
235937907$23593790$7$F$$20240816$20240304$20240821$EXP$CA-GLAXOSMITHKLINE-CA2021268668$CA-WW-2021-CA-268668$Waylis$$65$YR$$M$Y$96$KG$20240821$$CN$CA$CA
235938132$23593813$2$F$20240229$20240729$20240304$20240801$PER$$US-AMGEN-USASP2024044516$AMGEN$$77$YR$E$M$Y$$$20240801$$CN$US$US
235938683$23593868$3$F$20230101$20240710$20240305$20240722$EXP$$JP-009507513-2402JPN003881J$MERCK$$7$DEC$$M$Y$$$20240719$$MD$JP$JP
235938825$23593882$5$F$20240223$20240906$20240305$20240916$EXP$$CA-CELLTRION INC.-2024CA003752$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
235939684$23593968$4$F$20240601$20240729$20240305$20240806$EXP$$NL-ABBVIE-5661977$ABBVIE$$17$YR$$F$Y$$$20240806$$MD$NL$NL
235939982$23593998$2$F$20240101$20240808$20240305$20240813$EXP$$US-ABBVIE-5662964$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
235940003$23594000$3$F$$20240816$20240305$20240821$EXP$$NVSC2024ZA044376$NOVARTIS$$44$YR$$M$Y$$$20240821$$CN$ZA$ZA
235940224$23594022$4$F$$20240731$20240305$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-034760$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$63.05$KG$20240806$$CN$US$US
235940393$23594039$3$F$20240716$20240813$20240305$20240815$EXP$$CA-JNJFOC-20240301687$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240816$$HP$CA$CA
235940435$23594043$5$F$20240213$20240621$20240305$20240801$EXP$$JP-ROCHE-3519220$ROCHE$$75$YR$E$M$Y$46$KG$20240802$$MD$JP$JP
235941132$23594113$2$F$20240101$20240717$20240305$20240727$EXP$$CA-TEVA-VS-3164944$TEVA$$32$YR$$F$Y$73$KG$20240727$$HP$CA$CA
235941503$23594150$3$F$$20240809$20240305$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000684$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
235941514$23594151$4$F$20230901$20240628$20240305$20240711$PER$$US-ROCHE-3515402$ROCHE$$35$YR$A$F$Y$75.8$KG$20240711$$HP$US$US
235941695$23594169$5$F$20240112$20240824$20240305$20240902$EXP$$CA-CELLTRION INC.-2024CA001577$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
235941872$23594187$2$F$$20240612$20240305$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000697$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240707$$CN$US$US
235942333$23594233$3$F$$20240712$20240305$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202403000817$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240717$$CN$US$US
235942552$23594255$2$F$20221022$20240731$20240305$20240805$EXP$$CO-CHEPLA-2024002557$CHEPLAPHARM$$78$YR$$F$Y$$$20240805$$MD$COUNTRY NOT SPECIFIED$CO
235942822$23594282$2$F$20240201$20240718$20240305$20240725$EXP$$IT-AUROBINDO-AUR-APL-2024-009609$AUROBINDO$$73$YR$$M$Y$$$20240725$$MD$IT$IT
235942853$23594285$3$F$$20240820$20240305$20240826$EXP$$CA-JNJFOC-20240279382$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$HP$CA$CA
235943073$23594307$3$F$$20240828$20240305$20240829$PER$$NVSC2024US045818$NOVARTIS$$$$$$Y$$$20240829$$CN$US$US
235943183$23594318$3$F$20240301$20240822$20240305$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202403001304$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240904$$CN$US$US
235943344$23594334$4$F$20240117$20240624$20240305$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000595$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240718$$CN$US$US
235943594$23594359$4$F$20240223$20240802$20240305$20240805$PER$$NVSC2024US045828$NOVARTIS$$5$MON$$$Y$$$20240805$$MD$US$US
235943973$23594397$3$F$20240301$20240808$20240305$20240812$PER$$NVSC2024US045651$NOVARTIS$$74$YR$$F$Y$$$20240812$$CN$US$US
235944032$23594403$2$F$20240124$20240901$20240305$20240905$EXP$$CA-ROCHE-3520354$ROCHE$$40$YR$A$M$Y$$$20240905$$CN$CA$CA
235944103$23594410$3$F$20231212$20240910$20240305$20240917$EXP$$CA-GSK-CA2023176637$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$CA$CA
235944144$23594414$4$F$$20240809$20240305$20240812$PER$$NVSC2024US045803$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
235944164$23594416$4$F$20240104$20240820$20240305$20240827$EXP$$CA-GSK-CA2023154311$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$HP$CA$CA
235944442$23594444$2$F$20240129$20240910$20240305$20240916$EXP$$AU-TAKEDA-2024TUS009235$TAKEDA$$25$YR$$M$Y$$$20240916$$HP$AU$AU
235944622$23594462$2$F$20220815$20240919$20240305$20240927$EXP$$DE-AUROBINDO-AUR-APL-2024-009990$AUROBINDO$$$$E$F$Y$69.5$KG$20240927$$HP$DE$DE
235945142$23594514$2$F$$20240619$20240305$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01742$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235945822$23594582$2$F$20231001$20240711$20240305$20240720$EXP$$JP-009507513-2402JPN004013J$MERCK$$8$DEC$$F$Y$$$20240720$$MD$JP$JP
235946452$23594645$2$F$$20240619$20240305$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01598$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235946763$23594676$3$F$20240715$20240725$20240305$20240730$EXP$$US-TAKEDA-2024TUS019939$TAKEDA$$41$YR$$F$Y$$$20240730$$MD$US$US
235947023$23594702$3$F$20230601$20240731$20240305$20240807$EXP$$CA-GSK-CA2023121601$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$HP$CA$CA
235947062$23594706$2$F$$20240701$20240305$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202403001602$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240708$$CN$US$US
235947193$23594719$3$F$20240301$20240819$20240305$20240822$PER$$US-AMGEN-USASP2024043963$AMGEN$$69$YR$E$F$Y$$$20240822$$CN$US$US
235947214$23594721$4$F$$20240906$20240305$20240912$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-011665$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240912$$CN$CA$CA
235947363$23594736$3$F$20231001$20240817$20240305$20240821$EXP$$IN-GSK-IN2023APC180422$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$IN$IN
235947692$23594769$2$F$20210201$20240829$20240305$20240909$EXP$$DE-AUROBINDO-AUR-APL-2024-009458$AUROBINDO$$$$A$M$Y$$$20240909$$MD$DE$DE
235947724$23594772$4$F$20240801$20240904$20240305$20240911$EXP$$NVSC2024CA046357$NOVARTIS$$37$YR$$F$Y$$$20240911$$HP$CA$CA
235947753$23594775$3$F$20240125$20240806$20240305$20240815$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-06370$SAMSUNG BIOEPIS$$80$YR$E$M$Y$75.4$KG$20240815$$CN$CA$CA
235947883$23594788$3$F$$20240731$20240305$20240807$EXP$$US-GSK-US2024AMR028136$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
235948123$23594812$3$F$$20240619$20240305$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01595$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235948323$23594832$3$F$20240116$20240813$20240305$20240821$EXP$$US-BIOGEN-2024BI01253373$BIOGEN$$53$YR$$M$Y$$$20240821$$CN$US$US
235948663$23594866$3$F$$20240911$20240305$20240918$EXP$$CA-GSK-CA2023073161$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$CA$CA
235948763$23594876$3$F$$20240711$20240305$20240716$EXP$$CA-JNJFOC-20231279859$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$HP$CA$CA
235948845$23594884$5$F$20240103$20240807$20240305$20240808$PER$$NVSC2024US045780$NOVARTIS$$51$YR$$F$Y$$$20240808$$CN$US$US
235949013$23594901$3$F$20231201$20240910$20240305$20240918$EXP$$US-ABBVIE-5659201$ABBVIE$$59$YR$$F$Y$$$20240918$$CN$US$US
235949075$23594907$5$F$$20240710$20240305$20240724$EXP$$DE-LAURUS LABS LIMITED-2024LAU000017$LAURUS LABS LIMITED$$$$$M$Y$2.9$KG$20240723$$HP$DE$DE
235949342$23594934$2$F$20240216$20240820$20240305$20240823$EXP$$CA-JNJFOC-20240305491$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240823$$HP$CA$CA
235949363$23594936$3$F$$20240619$20240305$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01664$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235949932$23594993$2$F$$20240619$20240305$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01524$LUPIN$$$$$$Y$$$20240702$$CN$US$US
235949962$23594996$2$F$$20240709$20240305$20240711$EXP$$JP-ASTELLAS-2024JP001653$ASTELLAS$$94$YR$$M$Y$$$20240711$$PH$JP$JP
235950492$23595049$2$F$$20240911$20240305$20240926$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434262$RANBAXY$Kido K, Carey B, Caccamo M, Bianco C, Sokos G. Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy. J Am Pharm Assoc. 2024;64:169-173$64$YR$$M$Y$104.31$KG$20240926$$PH$US$US
235950572$23595057$2$F$$20240911$20240305$20240926$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434263$RANBAXY$Kido K, Carey B, Caccamo M, Bianco C, Sokos G. Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy. J Am Pharmacists Assoc. 2024;64:169-173$69$YR$$M$Y$76.19$KG$20240926$$PH$US$US
235950683$23595068$3$F$20240101$20240807$20240305$20240814$EXP$$GB-ABBVIE-5661981$ABBVIE$$$$A$M$Y$$$20240814$$CN$GB$GB
235951034$23595103$4$F$20240101$20240812$20240305$20240822$30DAY$$TR-JNJFOC-20240224088$JOHNSON AND JOHNSON$$24$YR$A$M$Y$75$KG$20240822$$PH$TR$TR
235951085$23595108$5$F$20240207$20240704$20240305$20240709$EXP$$CA-TAKEDA-2023TUS110785$TAKEDA$$33$YR$$F$Y$81$KG$20240709$$HP$CA$CA
235951112$23595111$2$F$20190528$20240729$20240305$20240805$EXP$$CA-TAKEDA-CA201917621$TAKEDA$$66$YR$$F$Y$90.7$KG$20240805$$CN$CA$CA
235952085$23595208$5$F$20240107$20240813$20240305$20240819$EXP$$CA-JNJFOC-20231011716$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240819$$CN$CA$CA
235952203$23595220$3$F$20231225$20240808$20240305$20240816$EXP$$JP-009507513-2402JPN003998J$MERCK$$7$DEC$$M$Y$$$20240816$$MD$JP$JP
235952374$23595237$4$F$$20240717$20240305$20240726$EXP$DE-MACLEODS PHARMACEUTICALS US LTD-MAC2024046117$DE-MACLEODS PHARMACEUTICALS US LTD-MAC2024046117$MACLEODS$$$$$$Y$$$20240726$$HP$DE$DE
235952743$23595274$3$F$20230101$20240920$20240305$20240930$EXP$$CA-CELLTRION INC.-2023CA010539$CELLTRION$$$$$$Y$$$20240930$$PH$CA$CA
235952904$23595290$4$F$20240227$20240708$20240305$20240711$EXP$$AT-TAKEDA-2024TUS020008$TAKEDA$$69$YR$$M$Y$$$20240711$$CN$AT$AT
235953424$23595342$4$F$20230610$20240826$20240305$20240903$EXP$$CA-CELLTRION INC.-2023CA011352$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
235954112$23595411$2$F$20190522$20240808$20240305$20240813$EXP$$CA-TAKEDA-2019TUS026065$TAKEDA$$40$YR$$F$Y$$$20240813$$HP$CA$CA
235954662$23595466$2$F$$20231123$20240305$20240724$EXP$$US-TEVA-VS-3141849$TEVA$$$$$$Y$$$20240724$$CN$US$US
235955023$23595502$3$F$20240221$20240711$20240305$20240715$EXP$$US-BAYER-2024A032161$BAYER$$69$YR$E$M$Y$$$20240715$$CN$US$US
235955042$23595504$2$F$20231130$20240905$20240305$20240919$EXP$$US-UCBSA-2024000820$UCB$$41$YR$$F$Y$$$20240919$$CN$US$US
235955415$23595541$5$F$20240207$20240817$20240305$20240819$30DAY$$CO-PFIZER INC-PV202400019617$PFIZER$$11$YR$$M$Y$$$20240819$$CN$CO$CO
235955592$23595559$2$F$20240101$20240611$20240305$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000678$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240707$$CN$US$US
235955743$23595574$3$F$20240301$20240822$20240305$20240824$PER$$US-AMGEN-USASP2024044941$AMGEN$$77$YR$E$M$Y$$$20240824$$CN$US$US
235956033$23595603$3$F$20240101$20240620$20240305$20240702$EXP$$JP-TAKEDA-2024TUS020102$TAKEDA$$8$DEC$$F$Y$$$20240702$$MD$JP$JP
235956187$23595618$7$F$20240214$20240822$20240305$20240826$EXP$$MX-TAKEDA-2024TUS019709$TAKEDA$$60$YR$$M$Y$80$KG$20240826$$MD$MX$MX
235956255$23595625$5$F$$20240826$20240305$20240905$EXP$$NC-JNJFOC-20230856283$JOHNSON AND JOHNSON$$77$YR$E$F$Y$75$KG$20240905$$MD$NC$NC
235956504$23595650$4$F$20240225$20240627$20240305$20240702$EXP$$CA-UCBSA-2024010281$UCB$$52$YR$$F$Y$$$20240702$$CN$CA$CA
235957313$23595731$3$F$$20240704$20240305$20240713$EXP$$AU-ROCHE-3517459$ROCHE$$52$YR$A$F$Y$$$20240713$$MD$AU$AU
235957703$23595770$3$F$20240201$20240708$20240305$20240716$EXP$$PT-AstraZeneca-2024A046818$ASTRAZENECA$$63$YR$$F$Y$86$KG$20240716$$MD$PT$
235958152$23595815$2$F$20231221$20240222$20240305$20240912$EXP$$GB-TEVA-VS-3162263$TEVA$$81$YR$$M$Y$57$KG$20240912$$HP$GB$GB
235959172$23595917$2$F$$20240724$20240305$20240725$EXP$$CA-PFIZER INC-202400056465$PFIZER$$44$YR$$M$Y$$$20240725$$HP$CA$CA
235959353$23595935$3$F$20230111$20240731$20240305$20240805$EXP$$CO-TAKEDA-2023TUS010717$TAKEDA$$56$YR$$M$Y$62$KG$20240805$$CN$CO$CO
235959704$23595970$4$F$20240101$20240906$20240305$20240912$EXP$$JP-GENMAB-2024-00246AA$GENMAB$$78$YR$$M$Y$50$KG$20240912$$PH$JP$JP
235959883$23595988$3$F$20240224$20240809$20240305$20240816$PER$$US-JNJFOC-20240271060$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240816$$CN$US$US
235960084$23596008$4$F$20240229$20240713$20240305$20240716$PER$$US-AMGEN-USASP2024044970$AMGEN$$69$YR$E$M$Y$$$20240715$$CN$US$US
235960096$23596009$6$F$20231107$20240904$20240305$20240911$EXP$$CA-TAKEDA-2023TUS108342$TAKEDA$$61$YR$$M$Y$$$20240911$$MD$CA$CA
235960124$23596012$4$F$20240101$20240805$20240305$20240827$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000149$DECIPHERA PHARMACEUTICALS$$45$YR$A$M$Y$$$20240827$$MD$US$US
235960602$23596060$2$F$20240712$20240712$20240305$20240718$EXP$$TW-EXELIXIS-CABO-24074596$EXELIXIS$$60$YR$$F$Y$$$20240718$$CN$TW$TW
235960952$23596095$2$F$$20240828$20240305$20240904$PER$$US-PFIZER INC-PV202400030101$PFIZER$$73$YR$$F$Y$$$20240904$$CN$US$US
235961013$23596101$3$F$$20240731$20240305$20240805$PER$$US-PFIZER INC-202400055779$PFIZER$$58$YR$$F$Y$$$20240805$$CN$US$US
235961552$23596155$2$F$$20240619$20240305$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01627$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235961703$23596170$3$F$20230101$20240730$20240305$20240806$EXP$$JP-009507513-2312JPN001409J$MERCK$$$$$M$Y$$$20240806$$MD$JP$JP
235961712$23596171$2$F$$20240619$20240305$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01625$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235962122$23596212$2$F$20240101$20240730$20240305$20240808$PER$$US-SA-2024SA067553$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240808$$MD$US$US
235962192$23596219$2$F$20240627$20240628$20240305$20240709$PER$$US-SA-2024SA067381$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240709$$MD$US$US
235962232$23596223$2$F$20240601$20240713$20240305$20240722$PER$$US-SA-2024SA067737$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240721$$MD$US$US
235962282$23596228$2$F$$20240828$20240305$20240910$PER$$US-SA-2024SA066075$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240910$$MD$US$US
235962323$23596232$3$F$20231108$20240904$20240305$20240913$PER$$US-SA-2024SA066294$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240913$$MD$US$US
235962412$23596241$2$F$20240101$20240804$20240305$20240813$PER$$US-SA-2024SA067809$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240814$$MD$US$US
235962423$23596242$3$F$$20240823$20240305$20240917$PER$$US-SA-2024SA067647$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$MD$US$US
235962572$23596257$2$F$20231223$20240617$20240305$20240704$EXP$$CA-GSK-CA2024006268$GLAXOSMITHKLINE$$61$YR$$M$Y$$$20240704$$MD$CA$CA
235962602$23596260$2$F$20240101$20240911$20240305$20240926$PER$$US-SA-2024SA067504$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
235962722$23596272$2$F$20230101$20240627$20240305$20240708$PER$$US-SA-2024SA070724$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240708$$MD$US$US
235962832$23596283$2$F$$20240711$20240305$20240722$PER$$US-SA-2024SA068595$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240722$$MD$US$US
235963032$23596303$2$F$$20240904$20240305$20240926$PER$$US-SA-2024SA070848$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
235963062$23596306$2$F$$20240619$20240305$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01685$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235963542$23596354$2$F$20240101$20240805$20240305$20240813$PER$$US-SA-2024SA070738$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240814$$MD$US$US
235963752$23596375$2$F$20231201$20240624$20240305$20240703$PER$$US-SA-2024SA070843$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240703$$MD$US$US
235963922$23596392$2$F$20240227$20240718$20240305$20240727$PER$$US-SA-2024SA070748$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240727$$MD$US$US
235964122$23596412$2$F$20240101$20240718$20240305$20240726$PER$$US-SA-2024SA072543$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240726$$MD$US$US
235964164$23596416$4$F$20240101$20240718$20240305$20240723$PER$$US-SA-2024SA070977$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240723$$MD$US$US
235964264$23596426$4$F$20240101$20240815$20240305$20240828$PER$$US-SA-2024SA067609$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240828$$MD$US$US
235964482$23596448$2$F$20240101$20240822$20240305$20240906$PER$$US-SA-2024SA070392$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240906$$MD$US$US
235964514$23596451$4$F$20240201$20240827$20240305$20240909$PER$$US-SA-2024SA068798$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240909$$MD$US$US
235964793$23596479$3$F$20240101$20240815$20240305$20240828$PER$$US-SA-2024SA069974$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240828$$MD$US$US
235964942$23596494$2$F$20240601$20240701$20240305$20240709$PER$$US-SA-2024SA071633$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240709$$MD$US$US
235965012$23596501$2$F$20231201$20240719$20240305$20240730$PER$$US-SA-2024SA067596$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240730$$MD$US$US
235965072$23596507$2$F$20240101$20240806$20240305$20240813$PER$$US-SA-2024SA071476$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240814$$MD$US$US
235965088$23596508$8$F$20240101$20240919$20240305$20240930$PER$$US-SA-2024SA071365$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240930$$MD$US$US
235965424$23596542$4$F$$20240628$20240305$20240702$PER$$US-BIOVITRUM-2024-US-003499$BIOVITRUM$$71$YR$$F$Y$$$20240702$$CN$US$US
235965563$23596556$3$F$20200909$20240903$20240305$20240906$EXP$$US-TAKEDA-US202029444$TAKEDA$$53$YR$$F$Y$$$20240906$$HP$US$US
235965672$23596567$2$F$$20240910$20240305$20240917$PER$$US-SA-2024SA067817$SANOFI AVENTIS$$10$MON$I$M$Y$$$20240918$$MD$US$US
235965925$23596592$5$F$$20240925$20240305$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035149$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240930$$CN$US$US
235965958$23596595$8$F$20240226$20240706$20240305$20240802$EXP$$CO-GSK-CO2024AMR026637$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$CO$CO
235966692$23596669$2$F$$20240916$20240305$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033719$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240917$$CN$US$US
235967217$23596721$7$F$20240101$20240709$20240305$20240715$EXP$$US-SA-2024SA072629$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240715$$MD$US$US
235967325$23596732$5$F$$20240704$20240305$20240709$EXP$$IN-PFIZER INC-PV202300112139$PFIZER$$45$YR$$M$Y$$$20240709$$CN$IN$IN
235967337$23596733$7$F$20230101$20240813$20240305$20240820$EXP$$JP-PFIZER INC-202300455177$PFIZER$$35$YR$$F$Y$$$20240820$$MD$JP$JP
235967632$23596763$2$F$20240223$20240716$20240305$20240726$EXP$$CN-PFIZER INC-PV202400029028$PFIZER$$71$YR$$F$Y$56$KG$20240726$$HP$CN$CN
235967823$23596782$3$F$20240229$20240822$20240305$20240826$EXP$$CA-PFIZER INC-202400055211$PFIZER$$50$YR$$F$Y$$$20240826$$HP$CA$CA
235967882$23596788$2$F$$20240905$20240305$20240912$EXP$$US-PFIZER INC-2021391365$PFIZER$$71$YR$$F$Y$$$20240912$$CN$US$US
235968002$23596800$2$F$$20240701$20240305$20240703$EXP$$US-OTSUKA-2024_002736$OTSUKA$$$$$F$Y$68.9$KG$20240703$$CN$US$US
235968013$23596801$3$F$20231018$20240723$20240305$20240730$EXP$$US-OTSUKA-2023_031824$OTSUKA$$70$YR$$F$Y$$$20240730$$PH$US$US
235968112$23596811$2$F$20240101$20240815$20240305$20240820$EXP$$US-SA-2024SA036709$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240820$$MD$US$US
235968868$23596886$8$F$20230101$20240711$20240305$20240712$EXP$$US-UCBSA-2023005962$UCB$$2$YR$$M$Y$12$KG$20240712$$CN$US$US
235969323$23596932$3$F$$20240723$20240305$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035168$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240724$$CN$US$US
235969533$23596953$3$F$20231101$20240828$20240305$20240920$EXP$$US-SA-2024SA072706$SANOFI AVENTIS$$62$YR$A$F$Y$56.24$KG$20240920$$MD$US$US
235969629$23596962$9$F$$20240921$20240305$20240925$30DAY$$US-PFIZER INC-202400040083$PFIZER$$8$YR$$M$Y$22.68$KG$20240925$$MD$US$US
235969972$23596997$2$F$$20240906$20240305$20240906$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-012636$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240906$$CN$US$US
235971252$23597125$2$F$20240101$20240709$20240305$20240717$PER$$US-SA-2024SA071906$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240717$$MD$US$US
235972085$23597208$5$F$$20240722$20240305$20240731$EXP$$US-UNITED THERAPEUTICS-UNT-2024-006426$UNITED THERAPEUTICS$$$$$M$Y$81.633$KG$20240731$$$US$US
235972626$23597262$6$F$20240201$20240923$20240305$20240930$EXP$$CO-TAKEDA-2024TUS020284$TAKEDA$$46$YR$$M$Y$69$KG$20240929$$CN$CO$CO
235973032$23597303$2$F$20240212$20240729$20240305$20240821$PER$$CA-TOLMAR, INC.-24CA046880$TOLMAR$$78$YR$$M$Y$$$20240821$$CN$CA$CA
235973042$23597304$2$F$$20240729$20240305$20240821$PER$$CA-TOLMAR, INC.-24CA046824$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
235973792$23597379$2$F$20230428$20240828$20240305$20240909$EXP$$US-UCBSA-2024009081$UCB$$29$YR$$F$Y$87.075$KG$20240909$$MD$US$US
235974032$23597403$2$F$20231120$20240904$20240305$20240910$EXP$$CA-VER-202400186$VERITY PHARMACEUTICALS$$76$YR$E$M$Y$$$20240910$$HP$CA$CA
235974282$23597428$2$F$20240101$20240724$20240305$20240802$PER$$US-SA-2023SA071026$SANOFI AVENTIS$$12$YR$T$M$Y$38.1$KG$20240802$$MD$US$US
235974832$23597483$2$F$20210201$20240903$20240305$20240909$EXP$$DE-MYLANLABS-2022M1085655$MYLAN$$$$A$M$Y$$$20240909$$MD$DE$DE
235975443$23597544$3$F$20231128$20240712$20240305$20240717$EXP$$CN-PFIZER INC-PV202400029796$PFIZER$$95$YR$$M$Y$75$KG$20240717$$HP$CN$CN
235975805$23597580$5$F$20240204$20240829$20240305$20240902$EXP$$NVSC2024CN042393$NOVARTIS$$57$YR$$M$Y$57$KG$20240902$$MD$CN$CN
235976317$23597631$7$F$20240328$20240905$20240305$20240910$EXP$$CA-TAKEDA-2024TUS020300$TAKEDA$$62$YR$$M$Y$$$20240910$$CN$CA$CA
235976602$23597660$2$F$20231107$20240916$20240305$20240919$EXP$$FR-SANDOZ INC.-SDZ2024FR020231$SANDOZ$$83$YR$$M$Y$110$KG$20240919$$HP$FR$FR
235976944$23597694$4$F$20231212$20240909$20240305$20240912$EXP$$NVSC2024BR011695$NOVARTIS$$48$YR$$F$Y$53$KG$20240912$$CN$BR$BR
235977543$23597754$3$F$20240901$20240909$20240305$20240918$PER$$US-SA-2024SA072997$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240918$$MD$US$US
235977702$23597770$2$F$$20240830$20240305$20240911$PER$$US-INCYTE CORPORATION-2024IN002118$INCYTE$$$$$$Y$$$20240911$$CN$US$US
235977752$23597775$2$F$$20240811$20240305$20240813$EXP$$SA-SANDOZ INC.-SDZ2024SA023187$SANDOZ$$$$$F$Y$$$20240813$$CN$SA$SA
235978003$23597800$3$F$$20240701$20240305$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202402013635$ELI LILLY AND CO$$54$YR$A$F$Y$69.4$KG$20240703$$MD$US$US
235978192$23597819$2$F$20240227$20240229$20240305$20240731$PER$$US-BAYER-2024A031839$BAYER$$20$YR$A$F$Y$$$20240731$$MD$US$US
235978292$23597829$2$F$20240201$20240802$20240305$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035264$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$54.88$KG$20240805$$CN$US$US
235978304$23597830$4$F$20240221$20240627$20240305$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033780$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$57.4$KG$20240701$$HP$US$KR
235978345$23597834$5$F$20240101$20240805$20240305$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035664$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$65.32$KG$20240809$$CN$US$US
235978374$23597837$4$F$20240223$20240910$20240305$20240913$EXP$$US-BAYER-2024A033022$BAYER$$40$YR$A$M$Y$$$20240913$$CN$US$US
235978442$23597844$2$F$20230101$20240822$20240305$20240828$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-001294$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240828$$MD$FR$FR
235978522$23597852$2$F$20231229$20240706$20240305$20240710$EXP$$NVSC2023CA228863$NOVARTIS$$$$A$M$Y$$$20240710$$CN$CA$CA
235978893$23597889$3$F$20240101$20240710$20240305$20240715$EXP$$US-PFIZER INC-202400025270$PFIZER$$84$YR$$F$Y$$$20240715$$HP$US$US
235979088$23597908$8$F$20240205$20240904$20240305$20240910$EXP$$NVSC2024US034307$NOVARTIS$$56$YR$$F$Y$$$20240910$$CN$US$US
2359794110$23597941$10$F$20240403$20240717$20240305$20240723$EXP$$IE-MYLANLABS-2024M1019872$MYLAN$$63$YR$$M$Y$$$20240723$$MD$IE$IE
235979482$23597948$2$F$$20240729$20240305$20240801$EXP$$CA-009507513-2403CAN001090$MERCK$$67$YR$$F$Y$52$KG$20240801$$MD$CA$CA
235979742$23597974$2$F$20240329$20240819$20240305$20240826$EXP$$US-MYLANLABS-2024M1020564$MYLAN$$23$YR$$F$Y$105.2$KG$20240826$$MD$US$US
235979784$23597978$4$F$20240226$20240627$20240305$20240709$EXP$$US-BEH-2024169281$CSL BEHRING$$58$YR$A$M$Y$$$20240709$$HP$US$US
235979792$23597979$2$F$$20240902$20240305$20240904$EXP$$CA-BAUSCH-BL-2024-003234$BAUSCH AND LOMB$$26$YR$$F$Y$$$20240904$$MD$CA$CA
235979903$23597990$3$F$20240101$20240715$20240305$20240723$PER$$US-SA-2024SA068064$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240723$$MD$US$US
235980178$23598017$8$F$20230101$20240717$20240305$20240719$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-110034$DAIICHI$$$$$F$Y$$$20240719$$MD$US$US
235980502$23598050$2$F$20240201$20240628$20240305$20240704$EXP$$JP-009507513-2402JPN003616J$MERCK$$79$YR$$F$Y$$$20240704$$MD$JP$JP
235980643$23598064$3$F$20230701$20240821$20240305$20240827$PER$$US-ALXN-202403USA000066US$ALEXION PHARMACEUTICALS$$69$YR$$M$Y$$$20240827$$CN$US$US
235980676$23598067$6$F$20240216$20240729$20240305$20240806$EXP$$JP-AstraZeneca-2024A052956$ASTRAZENECA$$66$YR$$M$Y$54$KG$20240806$$MD$JP$
235980753$23598075$3$F$$20240801$20240305$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-034771$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$CN$JP$JP
235980874$23598087$4$F$20240206$20240624$20240305$20240705$PER$$US-BEH-2024169164$CSL BEHRING$$24$YR$A$F$Y$$$20240705$$HP$US$US
235981153$23598115$3$F$$20240827$20240305$20240902$EXP$$ES-SANDOZ INC.-SDZ2024ES020559$SANDOZ$$57$YR$$M$Y$$$20240902$$HP$ES$ES
235981184$23598118$4$F$20230923$20240830$20240305$20240912$EXP$$CA-BEH-2024169324$CSL BEHRING$$65$YR$E$M$Y$76$KG$20240912$$MD$CA$CA
235981373$23598137$3$F$20231101$20240709$20240305$20240711$EXP$$US-BIOGEN-2024BI01253217$BIOGEN$$46$YR$$F$Y$$$20240711$$CN$US$US
235981926$23598192$6$F$$20240819$20240305$20240827$PER$$US-BAUSCHBL-2024BNL002567$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240828$$CN$US$US
235982323$23598232$3$F$20230101$20240912$20240305$20240917$EXP$$JP-009507513-2310JPN001493J$MERCK$Matsuoka M, Yamada Y, Takeda K, Minami Y, Yamamoto K, Kamibayashi J, et al.. 12 A case of myocarditis during lenvatinib/pembrolizumab therapy for advanced corpus uteri carcinoma. Advances in Obstetrics and Gynecology, The 149th meeting of the Obstetrical and. 2023;75(4):561$61$YR$$F$Y$$$20240917$$MD$JP$JP
235982333$23598233$3$F$20240531$20240827$20240305$20240903$EXP$$BR-CELLTRION INC.-2024BR005274$CELLTRION$$$$$$Y$$$20240903$$CN$BR$BR
235982392$23598239$2$F$20240101$20240909$20240305$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035152$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$116.21$KG$20240916$$CN$US$US
235982545$23598254$5$F$20240224$20240809$20240305$20240814$EXP$$US-INCYTE CORPORATION-2024IN002254$INCYTE$$$$$$Y$$$20240814$$CN$US$US
235982603$23598260$3$F$20240430$20240715$20240305$20240724$EXP$$GB-CELLTRION INC.-2024GB005154$CELLTRION$$$$$$Y$$$20240724$$HP$GB$GB
235982686$23598268$6$F$$20240816$20240305$20240822$PER$$US-ALXN-202403USA000079US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$MD$US$US
235983142$23598314$2$F$20220920$20240904$20240305$20240911$EXP$$CA-GSK-CA2018GSK220184$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$MD$CA$CA
235983163$23598316$3$F$20240131$20240815$20240305$20240822$EXP$$CA-GSK-CA2024000949$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$MD$CA$CA
235983262$23598326$2$F$20240301$20240813$20240305$20240814$PER$$US-AMGEN-USASP2024044784$AMGEN$$47$YR$A$M$Y$$$20240814$$CN$US$US
235983482$23598348$2$F$$20240813$20240305$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035441$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240816$$CN$US$US
235983507$23598350$7$F$$20240918$20240305$20240927$EXP$$IT-CELLTRION INC.-2024IT005040$CELLTRION$Burlo F, Tumminelli C, Pastore S, Stocco G, Curci D, Lucafo M. Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report. PEDIATR-RHEUMATOL. 2023;21:1-6$$$$$Y$$$20240927$$HP$IT$IT
235983692$23598369$2$F$20210525$20240903$20240305$20240906$EXP$FR-AFSSAPS-AN20214761$FR-SANDOZ INC.-NVSC2021FR300720$SANDOZ$$49$YR$$F$Y$$$20240906$$MD$FR$FR
235984285$23598428$5$F$20240101$20240822$20240306$20240918$PER$$US-SA-2024SA070470$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240918$$MD$US$US
235984522$23598452$2$F$20231129$20240924$20240306$20240927$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-032191$JAZZ$$74$YR$$F$Y$92.26$KG$20240927$$CN$US$US
235984803$23598480$3$F$20231212$20240621$20240306$20240715$PER$$GT-TOLMAR, INC.-24GT046896$TOLMAR$$64$YR$$M$Y$$$20240715$$CN$GT$GT
235984872$23598487$2$F$20230911$20240812$20240306$20240904$PER$$NL-TOLMAR, INC.-24NL046841$TOLMAR$$65$YR$$M$Y$$$20240904$$CN$NL$NL
235984943$23598494$3$F$$20240807$20240306$20240902$PER$$US-TOLMAR, INC.-24US046883$TOLMAR$$$$$M$Y$$$20240902$$CN$US$US
235985693$23598569$3$F$$20240910$20240306$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035863$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240912$$CN$US$US
235985723$23598572$3$F$$20240904$20240306$20240914$EXP$$US-ABBVIE-5665399$ABBVIE$Lin C, Anderson CE, Scobie MR, Rodgers TD, Kelley MJ, Friedman DR. Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction. Br J Haematol. 2024;19737.; Lin C, Scobie M, Rodgers T, Kelley M, Friedman D, Anderson C. Tolerability and Outcomes of Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia in Patients with Severe Renal Dysfunction. Blood. 2023;142(Suppl.1):4648-4649.$$$$$Y$$$20240914$$HP$US$US
235985904$23598590$4$F$20240208$20240617$20240306$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000692$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240712$$CN$US$US
2359860010$23598600$10$F$20230801$20240924$20240306$20240926$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-012767$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240926$$CN$JP$JP
235986103$23598610$3$F$20231229$20240710$20240306$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-011293$JAZZ$$57$YR$$F$Y$$$20240716$$CN$US$US
235986133$23598613$3$F$$20240812$20240306$20240821$30DAY$$US-GSK-US2024025098$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
235986382$23598638$2$F$$20240715$20240306$20240725$30DAY$$US-NOVOPROD-1138558$NOVO NORDISK$$$$E$M$Y$$$20240725$$CN$US$US
235986663$23598666$3$F$$20240809$20240306$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026041$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240813$$CN$US$US
235986793$23598679$3$F$20240223$20240807$20240306$20240815$EXP$$US-BEH-2024169430$CSL BEHRING$$20$YR$A$M$Y$$$20240815$$HP$US$US
235986803$23598680$3$F$$20240320$20240306$20240806$EXP$$NVSC2023CO065384$NOVARTIS$$$$$F$Y$82$KG$20240806$$CN$CO$CO
235986982$23598698$2$F$20180101$20240820$20240306$20240827$PER$$US-BIOGEN-2024BI01253541$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
235987634$23598763$4$F$20240223$20240826$20240306$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-031533$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240830$$CN$US$US
235988202$23598820$2$F$20240226$20240704$20240306$20240708$PER$$US-AMGEN-USASP2024045188$AMGEN$$75$YR$E$F$Y$$$20240708$$CN$US$US
235988623$23598862$3$F$20240209$20240718$20240306$20240725$30DAY$$FR-JNJFOC-20240238874$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240726$$PH$FR$FR
235988786$23598878$6$F$20230801$20240718$20240306$20240724$EXP$$CA-GSK-CA2023112636$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$CA$CA
235989223$23598922$3$F$20240101$20240905$20240306$20240918$EXP$$US-UCBSA-2024009445$UCB$$$$$M$Y$52$KG$20240918$$MD$US$US
235989553$23598955$3$F$20240120$20240708$20240306$20240716$EXP$$US-UNITED THERAPEUTICS-UNT-2024-003003$UNITED THERAPEUTICS$$86$YR$$M$Y$49.887$KG$20240716$$$US$US
235989572$23598957$2$F$$20240821$20240306$20240824$EXP$$CA-ROCHE-3517280$ROCHE$$29$YR$A$F$Y$$$20240824$$HP$CA$CA
235989586$23598958$6$F$$20240903$20240306$20240905$PER$$NVSC2024US045730$NOVARTIS$$$$$$Y$$$20240905$$CN$US$US
235989812$23598981$2$F$20240201$20240807$20240306$20240815$EXP$$FR-AstraZeneca-2024A051526$ASTRAZENECA$$69$YR$$M$Y$68.4$KG$20240815$$MD$FR$
235989845$23598984$5$F$20201225$20240702$20240306$20240705$EXP$$JP-ABBVIE-21K-087-4034860-00$ABBVIE$$80$YR$$F$Y$$$20240705$$MD$JP$JP
235989902$23598990$2$F$$20240809$20240306$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026155$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$97.98$KG$20240812$$CN$US$US
235990963$23599096$3$F$$20240530$20240306$20240725$PER$$US-LUNDBECK-DKLU3074749$LUNDBECK$$$$$$Y$$$20240725$$CN$US$US
235991625$23599162$5$F$20231101$20240722$20240306$20240725$EXP$$NVSC2024US047394$NOVARTIS$$61$YR$$F$Y$$$20240726$$CN$US$US
235992035$23599203$5$F$20240101$20240830$20240306$20240909$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000174$DECIPHERA PHARMACEUTICALS$$66$YR$A$M$Y$92.4$KG$20240909$$CN$US$US
235992046$23599204$6$F$$20240910$20240306$20240917$EXP$$US-AMGEN-USASP2024044367$AMGEN$$$$A$F$Y$$$20240916$$HP$US$US
235992083$23599208$3$F$20240228$20240724$20240306$20240725$EXP$$US-UCBSA-2024010411$UCB$$2$YR$$F$Y$$$20240725$$CN$US$US
235992163$23599216$3$F$20240229$20240724$20240306$20240730$EXP$$CA-TAKEDA-2024TUS006762$TAKEDA$$53$YR$$F$Y$$$20240730$$MD$CA$CA
235992658$23599265$8$F$20220101$20240725$20240306$20240802$EXP$$CA-CELLTRION INC.-2022CA019463$CELLTRION$$$$$$Y$$$20240802$$HP$CA$CA
235992963$23599296$3$F$20230308$20240703$20240306$20240708$PER$$US-BIOVITRUM-2024-US-003404$BIOVITRUM$$8$YR$$M$Y$$$20240708$$CN$US$US
235994012$23599401$2$F$20230101$20240221$20240306$20240723$EXP$$US-TEVA-VS-3163702$TEVA$$$$$$Y$$$20240723$$CN$US$US
235994053$23599405$3$F$$20240815$20240306$20240819$EXP$$US-ABBVIE-5664637$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
235994513$23599451$3$F$$20240619$20240306$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01677$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235994533$23599453$3$F$20220601$20240820$20240306$20240827$EXP$$JP-RECORDATI RARE DISEASE INC.-2024001498$RECORDATI$$$$$$Y$$$20240827$$MD$JP$JP
235994652$23599465$2$F$$20240619$20240306$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01622$LUPIN$$$$$$Y$$$20240702$$CN$US$US
235994702$23599470$2$F$$20240301$20240306$20240906$PER$$NVSC2024US045738$NOVARTIS$$$$$F$Y$$$20240906$$MD$US$US
235994902$23599490$2$F$$20240619$20240306$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01620$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235994913$23599491$3$F$$20240619$20240306$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01674$LUPIN$$$$$$Y$$$20240702$$CN$US$US
235995102$23599510$2$F$$20240619$20240306$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01676$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235995372$23599537$2$F$$20240619$20240306$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01686$LUPIN$$$$$$Y$$$20240701$$CN$US$US
235995417$23599541$7$F$20240101$20240919$20240306$20240928$EXP$$CA-CELLTRION INC.-2024CA005380$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
235995533$23599553$3$F$$20240828$20240306$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035829$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$92.99$KG$20240904$$CN$US$US
235995872$23599587$2$F$$20240624$20240306$20240702$EXP$$IT-AMGEN-ITASP2024042296$AMGEN$Bringhen, S.. Carfilzomib-Lenalidomide-Dexamethasone (KRd) Vs. Lenalidomide-Dexamethasone (Rd) in Newly Diagnosed Fit or Intermediate-Fit Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation (Phase III EMN20 Trial): Analysis of Sustained Undetectable Minimal Residual Disease (MRD). Blood. 2023;142 (Suppl 1):205-205$$$$$Y$$$20240702$$MD$IT$IT
235996402$23599640$2$F$20240210$20240918$20240306$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035171$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240919$$CN$US$US
235996524$23599652$4$F$20230801$20240906$20240306$20240912$EXP$$NL-TAKEDA-2024TUS019757$TAKEDA$$$$A$F$Y$$$20240912$$HP$NL$NL
235996853$23599685$3$F$20240209$20240620$20240306$20240703$EXP$$DE-BEH-2024169171$CSL BEHRING$$$$A$F$Y$68$KG$20240703$$MD$DE$DE
235997004$23599700$4$F$20230530$20240319$20240306$20240706$EXP$FR-AFSSAPS-TO2023001488$FR-TEVA-202309_00014490$TEVA$$61$YR$$M$Y$$$20240706$$PH$FR$FR
235997232$23599723$2$F$$20240920$20240306$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035908$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240924$$CN$US$US
235997403$23599740$3$F$20231120$20240722$20240306$20240724$EXP$$CA-UCBSA-2023053120$UCB$$59$YR$$F$Y$$$20240724$$MD$CA$CA
235997435$23599743$5$F$20231130$20240829$20240306$20240907$EXP$$CA-CELLTRION INC.-2024CA005502$CELLTRION$$$$$$Y$$$20240907$$CN$CA$CA
235997553$23599755$3$F$20240220$20240624$20240306$20240704$EXP$$US-BEH-2024169494$CSL BEHRING$$50$YR$A$F$Y$145$KG$20240704$$CN$US$US
235998086$23599808$6$F$20240213$20240712$20240306$20240716$EXP$$NVSC2024GB032916$NOVARTIS$$75$YR$$F$Y$$$20240716$$CN$GB$GB
235998564$23599856$4$F$20230920$20240918$20240306$20240925$EXP$$CA-TAKEDA-2023TUS091250$TAKEDA$$57$YR$$F$Y$84.6$KG$20240925$$HP$CA$CA
235998746$23599874$6$F$20240101$20240717$20240306$20240724$EXP$$PT-ROCHE-3517654$ROCHE$$$$E$$Y$$$20240724$$HP$PT$PT
235998862$23599886$2$F$$20240814$20240306$20240822$EXP$$GB-ROCHE-3518655$ROCHE$$$$E$F$Y$$$20240822$$CN$GB$GB
235999204$23599920$4$F$20240219$20240722$20240306$20240727$EXP$$US-SA-2024SA072439$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240727$$MD$US$US
235999337$23599933$7$F$20240223$20240716$20240306$20240722$EXP$$CA-UCBSA-2024010508$UCB$$79$YR$$F$Y$$$20240719$$CN$CA$CA
235999632$23599963$2$F$20220418$20240830$20240306$20240902$EXP$$CA-ROCHE-3090219$ROCHE$$29$YR$A$F$Y$$$20240902$$CN$CA$CA
235999662$23599966$2$F$$20240807$20240306$20240819$EXP$$JP-Accord-409976$ACCORD$Shinohara K, Itoi S, Nakamura S, Miyazaki Y, Mutoh Y, Hagiwara S, Ohmagari N. Micafungin-breakthrough Coniochaeta hoffmannii (Lecythophora hoffmannii) fungemia following cord blood transplant in a patient with acute myeloid leukemia successfully treated with voriconazole. J Infect Chemother. 2024 Feb 16:S1341-321X(24)00046-1.$48$YR$A$F$Y$$$20240819$$MD$JP$JP
235999822$23599982$2$F$20240124$20240703$20240306$20240715$EXP$FR-AFSSAPS-LL2024000232$FR-Accord-410297$ACCORD$$88$YR$E$M$Y$$$20240715$$MD$FR$FR
235999986$23599998$6$F$$20240911$20240306$20240912$EXP$$NVSC2024US047918$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
236000094$23600009$4$F$20240620$20240624$20240306$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000681$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240718$$CN$US$US
236000123$23600012$3$F$$20240712$20240306$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202403000835$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240719$$CN$US$US
236000393$23600039$3$F$20240228$20240906$20240306$20240916$EXP$$CA-CELLTRION INC.-2024CA005580$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
236000524$23600052$4$F$$20240808$20240306$20240815$EXP$$NVSC2020DE043427$NOVARTIS$Topp MS, Duell J, Guijarro AMA, Odin M, Nielsen T, Rajeswaran A et al.. Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma. HAEMATOLOGICA. 2020;105(5):e256-e60$68$YR$$M$Y$$$20240815$$HP$DE$DE
236000614$23600061$4$F$20240101$20240729$20240306$20240809$EXP$$US-INSMED, INC.-2024-00786-US$INSMED$$$$$F$Y$$$20240809$$CN$US$US
236001064$23600106$4$F$$20240314$20240306$20240925$PER$$US-GSK-US2024AMR027835$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
236001074$23600107$4$F$20240216$20240710$20240306$20240718$EXP$$US-GSK-US2024AMR027834$GLAXOSMITHKLINE$$62$YR$$F$Y$65$KG$20240718$$MD$US$US
236001293$23600129$3$F$20200324$20240813$20240306$20240821$EXP$$CO-TAKEDA-2020TUS018820$TAKEDA$$35$YR$$F$Y$56$KG$20240821$$CN$CO$CO
236001693$23600169$3$F$$20240813$20240306$20240819$EXP$$JP-009507513-2402JPN004196J$MERCK$$50$YR$$M$Y$$$20240819$$MD$JP$JP
236002232$23600223$2$F$$20240829$20240306$20240904$EXP$$JP-AMGEN-JPNSP2024043613$AMGEN$$74$YR$E$F$Y$$$20240904$$MD$JP$JP
236002592$23600259$2$F$20240201$20240628$20240306$20240704$EXP$$JP-009507513-2402JPN003808J$MERCK$$8$DEC$$M$Y$$$20240704$$MD$JP$JP
236002753$23600275$3$F$20240301$20240925$20240306$20240926$PER$$US-AMGEN-USASP2024045713$AMGEN$$60$YR$A$F$Y$$$20240926$$CN$US$US
236002827$23600282$7$F$20240101$20240716$20240306$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-005734$UNITED THERAPEUTICS$$$$$F$Y$$$20240719$$$US$US
236003153$23600315$3$F$$20240619$20240306$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01691$LUPIN$$$$$$Y$$$20240701$$PH$US$US
236003946$23600394$6$F$20240226$20240801$20240306$20240806$EXP$$JO-PFIZER INC-202400050795$PFIZER$$$$$$Y$$$20240806$$HP$JO$JO
236003955$23600395$5$F$20240226$20240801$20240306$20240806$EXP$$JO-PFIZER INC-202400052827$PFIZER$$$$$$Y$$$20240806$$HP$JO$JO
236003995$23600399$5$F$20240226$20240801$20240306$20240806$EXP$$JO-PFIZER INC-202400052828$PFIZER$$$$$$Y$$$20240806$$HP$JO$JO
236005002$23600500$2$F$20240305$20240812$20240306$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036250$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$89.9$KG$20240819$$CN$US$US
236005652$23600565$2$F$$20240619$20240306$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01734$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236005827$23600582$7$F$20240706$20240718$20240306$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035786$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240808$$HP$US$US
236005918$23600591$8$F$$20240910$20240306$20240918$30DAY$$US-PFIZER INC-202400041121$PFIZER$$17$YR$$F$Y$45.81$KG$20240918$$CN$US$US
236006013$23600601$3$F$20240216$20240826$20240306$20240829$EXP$$CA-TAKEDA-2024TUS020370$TAKEDA$$72$YR$$F$Y$$$20240829$$MD$CA$CA
236006143$23600614$3$F$20231001$20240718$20240306$20240722$EXP$$CA-UCBSA-2023048442$UCB$$52$YR$$M$Y$$$20240722$$CN$CA$CA
2360061710$23600617$10$F$20240103$20240710$20240306$20240716$EXP$$US-TAKEDA-2024TUS001748$TAKEDA$$62$YR$$F$Y$53$KG$20240716$$HP$US$US
236006702$23600670$2$F$20240301$20240729$20240306$20240731$PER$$US-AMGEN-USASP2024043888$AMGEN$$74$YR$E$M$Y$$$20240730$$CN$US$US
236006713$23600671$3$F$$20240619$20240306$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01735$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236006892$23600689$2$F$$20240719$20240306$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035899$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240723$$CN$US$US
236006934$23600693$4$F$20220307$20240830$20240306$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-032859$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240912$$MD$JP$JP
236007183$23600718$3$F$20240214$20240829$20240306$20240903$EXP$$JP-009507513-2402JPN003985J$MERCK$$7$DEC$$M$Y$$$20240903$$MD$JP$JP
236007233$23600723$3$F$20240222$20240912$20240306$20240926$EXP$$US-009507513-2403USA000878$MERCK$$68$YR$$F$Y$99$KG$20240926$$MD$US$US
236007304$23600730$4$F$$20240808$20240306$20240809$PER$$US-PFIZER INC-2021329216$PFIZER$$59$YR$$F$Y$68.95$KG$20240809$$HP$US$US
236007522$23600752$2$F$$20240624$20240306$20240701$EXP$$JP-AMGEN-JPNSP2024043543$AMGEN$$61$YR$A$F$Y$$$20240701$$MD$JP$JP
236007715$23600771$5$F$20240608$20240712$20240306$20240716$EXP$$US-TAKEDA-2023TUS111243$TAKEDA$$54$YR$$F$Y$$$20240716$$CN$US$US
236007796$23600779$6$F$$20240819$20240306$20240823$EXP$$CA-TAKEDA-2024TUS020152$TAKEDA$$$$$M$Y$$$20240823$$CN$CA$CA
236008882$23600888$2$F$20210305$20240823$20240306$20240829$PER$$DE-Eisai-EC-2021-090060$EISAI$$60$YR$A$F$Y$59.5$KG$20240829$$MD$DE$DE
236009334$23600933$4$F$$20240724$20240306$20240729$PER$$US-BIOVITRUM-2024-US-003586$BIOVITRUM$$59$YR$$F$Y$$$20240729$$CN$US$US
236009382$23600938$2$F$20231213$20240701$20240306$20240703$EXP$FR-AFSSAPS-DJ2024000205$FR-SANDOZ INC.-SDZ2024FR023926$SANDOZ$$62$YR$$M$Y$75$KG$20240703$$MD$FR$FR
236009676$23600967$6$F$20240101$20240813$20240306$20240821$EXP$$ES-ABBVIE-5662682$ABBVIE$$$$$F$Y$$$20240821$$CN$ES$ES
236009682$23600968$2$F$$20240619$20240306$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01732$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236009962$23600996$2$F$$20240913$20240306$20240919$EXP$$US-AMGEN-USASP2024041957$AMGEN$$77$YR$E$F$Y$$$20240919$$CN$US$US
236010442$23601044$2$F$$20240811$20240306$20240821$EXP$$US-AMGEN-USASP2024042993$AMGEN$Abedrabo S.. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142 (supp 1):7078$$$$$Y$$$20240821$$MD$US$US
236010592$23601059$2$F$$20240730$20240306$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036125$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240801$$CN$US$US
236011227$23601122$7$F$20240313$20240711$20240306$20240716$EXP$$US-PFIZER INC-PV202400014885$PFIZER$$63$YR$$F$Y$$$20240716$$CN$US$US
236011593$23601159$3$F$$20240717$20240306$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036364$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240719$$CN$US$US
236011686$23601168$6$F$$20240626$20240306$20240702$EXP$$CA-TAKEDA-2024TUS020597$TAKEDA$$$$$M$Y$$$20240702$$MD$CA$CA
236011772$23601177$2$F$$20240619$20240306$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01730$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236012032$23601203$2$F$$20240826$20240306$20240830$EXP$$JP-AMGEN-JPNSP2024043741$AMGEN$$$$E$$Y$$$20240830$$MD$JP$JP
236012222$23601222$2$F$$20240619$20240306$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01725$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236012353$23601235$3$F$$20240619$20240306$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01731$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236012423$23601242$3$F$20231201$20240726$20240306$20240803$EXP$FR-AFSSAPS-AN2024000116$FR-TEVA-VS-3163273$TEVA$$71$YR$$M$Y$118$KG$20240803$$PH$FR$FR
236012566$23601256$6$F$20240301$20240809$20240306$20240813$PER$$US-JNJFOC-20240308915$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
236013152$23601315$2$F$$20240821$20240306$20240827$EXP$$NVSC2024GB047355$NOVARTIS$$$$A$F$Y$$$20240827$$CN$GB$GB
236013244$23601324$4$F$$20240904$20240306$20240905$EXP$GB-ADVANZ PHARMA-202402001466$GB-MYLANLABS-2024M1020429$MYLAN$Tramadol-warfarin interaction.. Drug Ther. Bull.. 2024;0(0):977$$$$F$Y$$$20240905$$HP$GB$GB
236013272$23601327$2$F$20240201$20240220$20240306$20240731$PER$$US-BAYER-2024A027477$BAYER$$29$YR$A$F$Y$$$20240731$$HP$US$US
236013502$23601350$2$F$$20240816$20240306$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036284$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240819$$CN$US$US
236013532$23601353$2$F$20231020$20240802$20240306$20240812$EXP$$FR-ROCHE-3508092$ROCHE$$83$YR$E$M$Y$73$KG$20240812$$MD$FR$FR
236013582$23601358$2$F$20240222$20240223$20240306$20240731$PER$$US-BAYER-2024A029495$BAYER$$26$YR$A$F$Y$$$20240731$$HP$US$US
236013844$23601384$4$F$$20240909$20240306$20240912$EXP$$AT-SANDOZ INC.-SDZ2024AT023373$SANDOZ$$51$YR$$M$Y$73$KG$20240912$$MD$AT$AT
236013894$23601389$4$F$$20240730$20240306$20240801$EXP$$CA-SANDOZ INC.-SDZ2023CA019563$SANDOZ$$$$$F$Y$$$20240801$$CN$CA$CA
236014005$23601400$5$F$20240213$20240801$20240306$20240809$EXP$$AT-BEH-2024169148$CSL BEHRING$$79$YR$E$M$Y$77.007$KG$20240809$$MD$AT$AT
236014863$23601486$3$F$$20240918$20240306$20240930$EXP$$US-AUROBINDO-AUR-APL-2024-009411$AUROBINDO$Kido K, Carey B, Caccamo M, Bianco C, Sokos G.. Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy.. Journal of the American Pharmacists Association.. 2024;64(1):169-173$64$YR$$M$Y$$$20240930$$PH$US$US
236015113$23601511$3$F$$20240709$20240306$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036398$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240719$$CN$US$US
236015252$23601525$2$F$20190101$20240626$20240306$20240711$EXP$$CA-HLS-202400651$HLS THERAPEUTICS$$82$YR$E$F$Y$$$20240711$$MD$CA$CA
236016202$23601620$2$F$$20240830$20240306$20240901$30DAY$$US-SANDOZ INC.-SDZ2024US022602$SANDOZ$$$$$F$Y$$$20240901$$CN$US$US
236016422$23601642$2$F$$20240903$20240306$20240906$30DAY$$US-SANDOZ INC.-SDZ2024US023093$SANDOZ$$$$$F$Y$$$20240906$$CN$US$US
236016573$23601657$3$F$$20240918$20240306$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US023065$SANDOZ$$$$$M$Y$$$20240923$$CN$US$US
236017303$23601730$3$F$$20240719$20240306$20240724$EXP$$NVSC2024US046329$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
236017912$23601791$2$F$20230725$20240722$20240306$20240730$EXP$$JP-AstraZeneca-2023A183506$ASTRAZENECA$$69$YR$$M$Y$72$KG$20240730$$MD$JP$
236017942$23601794$2$F$$20240904$20240306$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US022807$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
236018212$23601821$2$F$$20240913$20240306$20240915$EXP$$US-ALXN-202403USA000094US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
236019192$23601919$2$F$$20240906$20240306$20240912$EXP$$US-GILEAD-2024-0664639$GILEAD$$72$YR$E$M$Y$$$20240912$$MD$US$US
236019292$23601929$2$F$$20240906$20240306$20240912$EXP$$US-GILEAD-2024-0664646$GILEAD$$52$YR$A$M$Y$$$20240912$$MD$US$US
236019913$23601991$3$F$20230825$20240827$20240306$20240915$PER$$US-SA-2023SA363184$SANOFI AVENTIS$$79$YR$E$F$Y$97.73$KG$20240915$$MD$US$US
236020024$23602002$4$F$20240101$20240709$20240306$20240715$EXP$$US-SA-2024SA068740$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240715$$MD$US$US
236020052$23602005$2$F$20240101$20240620$20240306$20240702$PER$$US-SA-2024SA068110$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240702$$MD$US$US
236020093$23602009$3$F$20240101$20240725$20240306$20240805$PER$$US-SA-2024SA073160$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240805$$MD$US$US
236020183$23602018$3$F$20240201$20240830$20240306$20240924$PER$$US-SA-2024SA070361$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240924$$MD$US$US
236020353$23602035$3$F$20240101$20240701$20240306$20240710$PER$$US-SA-2024SA071435$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240710$$MD$US$US
236020414$23602041$4$F$20240101$20240703$20240306$20240711$EXP$$US-SA-2024SA033291$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240711$$MD$US$US
236020432$23602043$2$F$20240201$20240724$20240306$20240802$PER$$US-SA-2024SA069963$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240802$$MD$US$US
236020653$23602065$3$F$20240224$20240816$20240306$20240827$PER$$US-SA-2024SA069703$SANOFI AVENTIS$$39$YR$A$M$Y$65.77$KG$20240827$$MD$US$US
236020665$23602066$5$F$20240101$20240711$20240306$20240723$PER$$US-SA-2024SA070837$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240723$$MD$US$US
236020682$23602068$2$F$$20240906$20240306$20240918$PER$$US-SA-2024SA070883$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240918$$MD$US$US
236020704$23602070$4$F$20240610$20240730$20240306$20240806$EXP$$US-SA-2024SA073293$SANOFI AVENTIS$$33$YR$A$F$Y$70.3$KG$20240806$$MD$US$US
236021112$23602111$2$F$20240101$20240709$20240306$20240716$PER$$US-SA-2024SA069437$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240716$$MD$US$US
236021182$23602118$2$F$20240201$20240724$20240306$20240801$PER$$US-SA-2024SA069827$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240801$$MD$US$US
236021333$23602133$3$F$20230824$20240523$20240306$20240814$EXP$$NVSC2023AR202576$NOVARTIS$$68$YR$$F$Y$$$20240814$$CN$AR$AR
236021433$23602143$3$F$20240101$20240806$20240306$20240813$PER$$US-SA-2024SA070280$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240814$$MD$US$US
236021673$23602167$3$F$20230101$20240826$20240306$20240909$PER$$US-SA-2024SA069571$SANOFI AVENTIS$$74$YR$E$F$Y$73$KG$20240909$$HP$US$US
236021702$23602170$2$F$20200101$20240911$20240306$20240926$PER$$US-SA-2024SA071887$SANOFI AVENTIS$$42$YR$A$F$Y$93.878$KG$20240926$$MD$US$US
236021732$23602173$2$F$$20240910$20240306$20240916$PER$$US-SA-2024SA070215$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240916$$MD$US$US
236021803$23602180$3$F$20240908$20240909$20240306$20240918$PER$$US-SA-2024SA072184$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240918$$MD$US$US
236022016$23602201$6$F$20240101$20240826$20240306$20240909$PER$$US-SA-2024SA073111$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240909$$MD$US$US
236022163$23602216$3$F$20240101$20240909$20240306$20240916$PER$$US-SA-2024SA073118$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240916$$MD$US$US
236022393$23602239$3$F$$20240625$20240306$20240704$PER$$US-SA-2024SA072793$SANOFI AVENTIS$$$$E$M$Y$$$20240704$$MD$US$US
236022422$23602242$2$F$20240101$20240708$20240306$20240715$PER$$US-SA-2024SA071335$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240715$$MD$US$US
236022472$23602247$2$F$20231128$20240829$20240306$20240924$PER$$US-SA-2024SA073054$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240924$$MD$US$US
236022643$23602264$3$F$$20240717$20240306$20240725$PER$$US-SA-2024SA074084$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240725$$MD$US$US
236022655$23602265$5$F$20240101$20240814$20240306$20240822$EXP$$US-SA-2023SA000506$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240822$$MD$US$US
236022962$23602296$2$F$$20240801$20240306$20240809$PER$$US-SA-2024SA074123$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240809$$CN$US$US
236023212$23602321$2$F$$20240702$20240306$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035118$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240703$$CN$US$US
236023492$23602349$2$F$$20240820$20240306$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036574$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$73.48$KG$20240826$$CN$US$US
236023582$23602358$2$F$$20240628$20240306$20240703$EXP$CA-HEALTHCANVIG-001068151$CA-PURDUE-USA-2024-0308209$PURDUE$$$$$F$Y$$$20240703$$HP$CA$CA
236023623$23602362$3$F$$20240731$20240306$20240807$EXP$$CA-PURDUE-USA-2024-0308170$PURDUE$$43$YR$$F$Y$70$KG$20240807$$HP$CA$CA
236024684$23602468$4$F$20230701$20240701$20240306$20240703$PER$$US-PFIZER INC-202400056962$PFIZER$$39$YR$$M$Y$$$20240703$$CN$US$US
236024823$23602482$3$F$20240207$20240916$20240306$20240927$PER$$US-INCYTE CORPORATION-2024IN001474$INCYTE$$$$$$Y$$$20240927$$CN$US$US
236025443$23602544$3$F$$20240911$20240306$20240916$PER$$US-PFIZER INC-202300049635$PFIZER$$92$YR$$F$Y$54.43$KG$20240916$$CN$US$US
236025883$23602588$3$F$$20240711$20240306$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035807$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240715$$CN$US$US
236025945$23602594$5$F$20180523$20240816$20240306$20240820$EXP$$DE-SANDOZ INC.-NVSC2021DE172634$SANDOZ$$52$YR$$F$Y$62$KG$20240820$$MD$DE$DE
236026845$23602684$5$F$$20240909$20240306$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032688$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240910$$CN$US$US
236027043$23602704$3$F$$20240814$20240306$20240820$EXP$$CA-MYLANLABS-2024M1020181$MYLAN$$$$$F$Y$$$20240820$$CN$CA$CA
236027335$23602733$5$F$20231205$20240729$20240306$20240805$EXP$$US-TAKEDA-2023TUS121931$TAKEDA$$63$YR$$M$Y$103.1$KG$20240805$$CN$US$US
236028702$23602870$2$F$20231101$20240718$20240306$20240726$EXP$$DE-ABBVIE-5662143$ABBVIE$$55$YR$$F$Y$$$20240726$$CN$DE$DE
236028775$23602877$5$F$20240223$20240625$20240306$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-036089$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240702$$PH$JP$JP
236029107$23602910$7$F$20231101$20240702$20240306$20240709$EXP$$FR-BIOGEN-2023BI01231033$BIOGEN$$70$YR$$F$Y$66$KG$20240709$$MD$FR$FR
236029534$23602953$4$F$20240227$20240808$20240306$20240813$EXP$$US-ABBVIE-5662771$ABBVIE$$60$YR$$M$Y$83.914$KG$20240813$$CN$US$US
236029653$23602965$3$F$20240226$20240719$20240306$20240724$PER$$US-AMGEN-USASP2024044875$AMGEN$$69$YR$E$F$Y$$$20240724$$CN$US$US
236029662$23602966$2$F$20231201$20240712$20240306$20240719$EXP$$GB-ABBVIE-5608270$ABBVIE$$65$YR$$M$Y$$$20240719$$CN$GB$GB
236030012$23603001$2$F$20240101$20240923$20240306$20240927$EXP$$US-ABBVIE-5665418$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
236030552$23603055$2$F$$20240819$20240306$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035266$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240822$$CN$US$US
236030642$23603064$2$F$$20240702$20240306$20240708$EXP$$CA-JNJFOC-20240111550$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240708$$$COUNTRY NOT SPECIFIED$CA
236030979$23603097$9$F$20240201$20240923$20240306$20240930$EXP$$US-GSK-US2024AMR026303$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
2360311511$23603115$11$F$20240214$20240909$20240306$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017606$JAZZ$$44$YR$$F$Y$$$20240912$$MD$US$US
236031413$23603141$3$F$20240229$20240826$20240306$20240828$PER$$US-AMGEN-USASP2024045033$AMGEN$$68$YR$E$M$Y$$$20240827$$CN$US$US
236031522$23603152$2$F$20240302$20240820$20240306$20240824$PER$$US-AMGEN-USASP2024045731$AMGEN$$65$YR$E$M$Y$$$20240823$$CN$US$US
236031628$23603162$8$F$$20240826$20240307$20240828$PER$$NVSC2024US047926$NOVARTIS$$54$YR$$$Y$$$20240828$$CN$US$US
236031912$23603191$2$F$$20240815$20240307$20240902$PER$$AU-TOLMAR, INC.-24AU046904$TOLMAR$$$$$M$Y$$$20240902$$CN$AU$AU
236031953$23603195$3$F$20240213$20240730$20240307$20240822$PER$$CA-TOLMAR, INC.-24CA046903$TOLMAR$$75$YR$$M$Y$$$20240822$$CN$CA$CA
236032075$23603207$5$F$$20240716$20240307$20240723$PER$$NVSC2024US048582$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
236032153$23603215$3$F$$20240814$20240307$20240821$30DAY$$CA-JNJFOC-20240266189$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$PH$CA$CA
236032273$23603227$3$F$20230501$20240820$20240307$20240823$PER$$US-AMGEN-USASP2024045991$AMGEN$$61$YR$A$M$Y$$$20240823$$CN$US$US
236032433$23603243$3$F$$20240801$20240307$20240826$PER$$CA-TOLMAR, INC.-24CA046981$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
236033322$23603332$2$F$$20240703$20240307$20240710$EXP$$JP-009507513-2310JPN003802J$MERCK$$5$DEC$$M$Y$$$20240710$$MD$JP$JP
236033772$23603377$2$F$$20240226$20240307$20240910$EXP$$US-NOVOPROD-1183172$NOVO NORDISK$$75$YR$$M$Y$$$20240910$$CN$US$US
2360340814$23603408$14$F$$20240919$20240307$20240930$EXP$$NVSC2023CO182712$NOVARTIS$$$$$F$Y$78$KG$20240930$$CN$CO$CO
236034604$23603460$4$F$20230808$20240731$20240307$20240802$EXP$$NVSC2023RU189386$NOVARTIS$$72$YR$$F$Y$67$KG$20240802$$MD$RU$RU
236035292$23603529$2$F$20200401$20240624$20240307$20240701$EXP$$ES-CELLTRION INC.-2024ES005340$CELLTRION$Montero, S.. IgA nephropathy after long-term treatment with infliximab for Crohn^s disease: A review of two cases. NEPHROLOGY. 2024$$$$$Y$$$20240701$$HP$ES$ES
236035542$23603554$2$F$20240302$20240719$20240307$20240724$PER$$US-AMGEN-USASP2024047020$AMGEN$$73$YR$E$F$Y$$$20240723$$CN$US$US
236035644$23603564$4$F$$20240821$20240307$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035410$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240827$$CN$US$US
236035734$23603573$4$F$20240101$20240920$20240307$20240927$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-000199$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$110.7$KG$20240927$$CN$US$US
236035899$23603589$9$F$20240101$20240919$20240307$20240928$EXP$$CA-CELLTRION INC.-2024CA005503$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
236035955$23603595$5$F$20200706$20240905$20240307$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000677$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240916$$CN$US$US
236036122$23603612$2$F$$20240626$20240307$20240701$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-012103$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240701$$CN$US$US
236036176$23603617$6$F$$20240612$20240307$20240926$EXP$$US-GSK-US2024AMR025333$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
236036183$23603618$3$F$20181204$20240621$20240307$20240701$EXP$$DE-AUROBINDO-AUR-APL-2019-006773$AUROBINDO$$62$YR$$M$Y$80.4$KG$20240701$$MD$DE$DE
236036502$23603650$2$F$$20240119$20240307$20240723$EXP$$AU-TEVA-VS-3148817$TEVA$$$$$$Y$$$20240723$$HP$AU$AU
236036615$23603661$5$F$20230106$20240628$20240307$20240703$PER$$US-JNJFOC-20240304924$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240704$$MD$US$US
236036813$23603681$3$F$$20240619$20240307$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01736$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236036942$23603694$2$F$20240302$20240820$20240307$20240822$PER$$US-AMGEN-USASP2024045281$AMGEN$$55$YR$A$F$Y$$$20240822$$CN$US$US
236037012$23603701$2$F$20240208$20240905$20240307$20240909$EXP$$CA-JNJFOC-20240305779$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20240910$$HP$CA$CA
236037062$23603706$2$F$$20240909$20240307$20240917$EXP$$PT-TEVA-VS-3163834$TEVA$$$$E$$Y$$$20240917$$HP$PT$PT
236037132$23603713$2$F$$20240619$20240307$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01721$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236037232$23603723$2$F$$20240712$20240307$20240724$30DAY$$KR-JNJFOC-20240268639$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$KR$KR
236037326$23603732$6$F$20230701$20240919$20240307$20240923$EXP$$US-ABBVIE-5666610$ABBVIE$$69$YR$$M$Y$145$KG$20240923$$CN$US$US
236037384$23603738$4$F$20240205$20240812$20240307$20240816$EXP$$US-ABBVIE-5666073$ABBVIE$$48$YR$$M$Y$$$20240816$$CN$US$US
236037392$23603739$2$F$$20240619$20240307$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01733$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236037622$23603762$2$F$$20240619$20240307$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01737$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236037682$23603768$2$F$$20240830$20240307$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US022084$SANDOZ$$$$$F$Y$$$20240904$$CN$US$US
236038652$23603865$2$F$$20240704$20240307$20240709$EXP$$CA-TAKEDA-2024TUS020871$TAKEDA$$$$$M$Y$$$20240709$$MD$CA$CA
236038783$23603878$3$F$20231030$20240702$20240307$20240710$EXP$$IT-CELLTRION INC.-2024IT005345$CELLTRION$$$$$$Y$$$20240710$$MD$IT$IT
236038884$23603888$4$F$$20240716$20240307$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035554$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240718$$CN$US$US
236038973$23603897$3$F$$20240912$20240307$20240918$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000457$BLUEPRINT MEDICINES$$$$$F$Y$$$20240918$$CN$US$US
236039103$23603910$3$F$20240327$20240814$20240307$20240820$EXP$$CA-TAKEDA-2023TUS110890$TAKEDA$$69$YR$$M$Y$$$20240820$$HP$CA$CA
236039393$23603939$3$F$20230801$20240911$20240307$20240916$EXP$$CA-ROCHE-3341843$ROCHE$$38$YR$A$F$Y$54.43$KG$20240916$$CN$CA$CA
236039413$23603941$3$F$20201201$20240705$20240307$20240712$EXP$$US-CELLTRION INC.-2024US005458$CELLTRION$$$$$$Y$$$20240712$$MD$US$US
236039714$23603971$4$F$20240301$20240716$20240307$20240721$30DAY$$US-AMGEN-USASP2024044824$AMGEN$$74$YR$E$F$Y$$$20240721$$CN$US$US
236039742$23603974$2$F$20240101$20240821$20240307$20240823$PER$$US-AMGEN-USASP2024045891$AMGEN$$59$YR$A$F$Y$$$20240823$$CN$US$US
236040113$23604011$3$F$20240101$20240912$20240307$20240918$EXP$$US-ABBVIE-5665063$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
236040322$23604032$2$F$$20240619$20240307$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01741$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236040482$23604048$2$F$$20240619$20240307$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01740$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236040506$23604050$6$F$20240301$20240828$20240307$20240831$PER$$US-AMGEN-USASP2024045793$AMGEN$$82$YR$E$M$Y$$$20240831$$HP$US$US
236041344$23604134$4$F$$20240731$20240307$20240805$EXP$$JP-JNJFOC-20240316724$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$MD$JP$JP
236041412$23604141$2$F$$20240902$20240307$20240905$PER$$US-JNJFOC-20240273321$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240905$$CN$US$US
236041435$23604143$5$F$20240220$20240716$20240307$20240718$EXP$$JP-ASTELLAS-2024JP001723$ASTELLAS$$9$DEC$$M$Y$$$20240718$$MD$JP$JP
236041943$23604194$3$F$$20240717$20240307$20240807$30DAY$$IT-JNJFOC-20240235812$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$MD$IT$IT
236041953$23604195$3$F$$20240611$20240307$20240707$30DAY$$DE-JNJFOC-20240248286$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$PH$DE$DE
236042122$23604212$2$F$20230728$20240715$20240307$20240716$EXP$$DE-SANDOZ INC.-SDZ2024DE023986$SANDOZ$$72$YR$$F$Y$$$20240716$$MD$DE$DE
236042333$23604233$3$F$20240123$20240708$20240307$20240712$EXP$$US-ASTELLAS-2024US006957$ASTELLAS$$$$$F$Y$$$20240712$$CN$US$US
236042482$23604248$2$F$20240201$20240919$20240307$20240924$PER$$US-RDY-SPO/USA/24/0003737$DR REDDYS$$16$YR$T$$Y$$$20240924$$CN$US$US
236042782$23604278$2$F$20210315$20240816$20240307$20240827$EXP$$US-ROCHE-3002866$ROCHE$$24$YR$A$F$Y$$$20240827$$MD$US$US
236042843$23604284$3$F$20240101$20240806$20240307$20240810$EXP$$US-ABBVIE-5668346$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
236043213$23604321$3$F$20240304$20240912$20240307$20240914$PER$$US-AMGEN-USASP2024046363$AMGEN$$55$YR$A$F$Y$$$20240914$$CN$US$US
236043422$23604342$2$F$20231101$20240627$20240307$20240711$EXP$$US-ALIMERA SCIENCES INC.-US-A16013-24-000170$ALIMERA$$61$YR$$F$Y$$$20240711$$MD$US$US
236043442$23604344$2$F$20240227$20240724$20240307$20240802$EXP$$JP-ROCHE-3521369$ROCHE$$5$DEC$A$M$Y$$$20240802$$MD$JP$JP
236043732$23604373$2$F$$20240710$20240307$20240718$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-034566$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$69$KG$20240718$$HP$CA$CA
236043852$23604385$2$F$20240226$20240806$20240307$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000993$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240829$$CN$US$US
236043872$23604387$2$F$20231218$20240702$20240307$20240703$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-000370$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240703$$CN$CA$CA
236044054$23604405$4$F$$20240719$20240307$20240801$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK089174$GLENMARK$$$$$$Y$$$20240801$$HP$US$US
236044513$23604451$3$F$20240623$20240624$20240307$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000985$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240718$$CN$US$US
236044552$23604455$2$F$$20240718$20240307$20240724$EXP$$US-TAKEDA-US201723918$TAKEDA$$$$$F$Y$91.61$KG$20240724$$MD$US$US
236044567$23604456$7$F$$20240702$20240307$20240716$EXP$$US-INSMED, INC.-2024-00509-US$INSMED$$$$$M$Y$$$20240716$$HP$US$US
236044713$23604471$3$F$20230929$20240725$20240307$20240729$EXP$$JP-JNJFOC-20240318186$JOHNSON AND JOHNSON$$57$YR$A$M$Y$82.5$KG$20240729$$MD$JP$JP
236045043$23604504$3$F$$20240628$20240307$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-036965$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240704$$MD$JP$JP
236046075$23604607$5$F$20230101$20240730$20240307$20240814$EXP$$US-INSMED, INC.-2023-02345-US$INSMED$$$$$F$Y$$$20240814$$CN$US$US
236046132$23604613$2$F$20240215$20240731$20240307$20240826$PER$$CA-TOLMAR, INC.-24CA047002$TOLMAR$$75$YR$$M$Y$$$20240826$$CN$CA$CA
236046192$23604619$2$F$20240216$20240726$20240307$20240821$PER$$CA-TOLMAR, INC.-24CA047018$TOLMAR$$80$YR$$M$Y$$$20240821$$CN$CA$CA
236046285$23604628$5$F$20230113$20240815$20240307$20240822$EXP$$NVSC2024AR046865$NOVARTIS$$5$YR$$F$Y$$$20240822$$CN$AR$AR
236046394$23604639$4$F$$20240910$20240307$20240918$EXP$$CL-JNJFOC-20240304470$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240918$$CN$CL$CL
236046453$23604645$3$F$$20240710$20240307$20240712$EXP$$PL-SANDOZ INC.-SDZ2024PL024137$SANDOZ$$62$YR$$F$Y$$$20240712$$MD$PL$PL
236046913$23604691$3$F$$20240812$20240307$20240819$30DAY$$US-GSK-US2024AMR026781$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
236046926$23604692$6$F$20220930$20240912$20240307$20240919$EXP$CA-MMM-UOPB0Q1L$CA-GSK-CA2023112643$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$HP$CA$CA
236047466$23604746$6$F$20240216$20240716$20240307$20240723$EXP$$CA-TAKEDA-2023TUS117583$TAKEDA$$41$YR$$M$Y$75$KG$20240723$$HP$CA$CA
236048104$23604810$4$F$20240221$20240731$20240307$20240802$EXP$$US-BAYER-2024A031632$BAYER$$35$YR$A$M$Y$$$20240802$$CN$US$US
236048473$23604847$3$F$20240222$20240808$20240307$20240815$EXP$$NVSC2024GB033093$NOVARTIS$$$$$F$Y$$$20240815$$CN$GB$GB
236049243$23604924$3$F$20210517$20240920$20240307$20240930$EXP$FR-AFSSAPS-AM2024000147$FR-KOANAAP-SML-FR-2024-00166$SHILPA MEDICARE$$62$YR$A$M$Y$$$20240930$$MD$FR$FR
236049823$23604982$3$F$20231101$20240819$20240307$20240827$EXP$$JP-009507513-2402JPN004172J$MERCK$$70$YR$$M$Y$$$20240827$$MD$JP$JP
236050073$23605007$3$F$20231101$20240423$20240307$20240806$PER$$US-AstraZeneca-2024A046143$ASTRAZENECA$$705$MON$$F$Y$$$20240806$$CN$US$
236050412$23605041$2$F$$20240811$20240307$20240821$EXP$$US-AMGEN-USASP2024043006$AMGEN$Abedrabo, S. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142 (Supp 1):7078$$$$$Y$$$20240821$$MD$US$US
236050765$23605076$5$F$$20240628$20240307$20240704$30DAY$$US-PFIZER INC-202400043167$PFIZER$$13$YR$$F$Y$$$20240704$$MD$US$US
236050952$23605095$2$F$20230501$20240820$20240307$20240826$EXP$$US-AMGEN-USASP2024044748$AMGEN$$63$YR$A$F$Y$$$20240826$$CN$US$US
236051706$23605170$6$F$20240220$20240830$20240307$20240905$EXP$$AT-TAKEDA-2024TUS017400$TAKEDA$$72$YR$$F$Y$$$20240905$$CN$AT$AT
236051875$23605187$5$F$20240216$20240905$20240307$20240906$30DAY$$US-PFIZER INC-202400045450$PFIZER$$13$YR$$M$Y$80.29$KG$20240906$$MD$US$US
236052214$23605221$4$F$$20240619$20240307$20240926$PER$$US-GSK-US2024AMR025911$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
236052226$23605222$6$F$$20240819$20240307$20240821$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-110256$DAIICHI$$$$$M$Y$$$20240821$$MD$US$US
236052962$23605296$2$F$20190301$20240222$20240307$20240829$EXP$DK-DKMA-WBS-1007279$DK-TEVA-VS-3162721$TEVA$$48$YR$$F$Y$50$KG$20240829$$HP$DK$DK
236053112$23605311$2$F$20240201$20240906$20240307$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036479$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240909$$HP$US$US
2360533010$23605330$10$F$$20240924$20240307$20240926$30DAY$$US-PFIZER INC-202400047777$PFIZER$$12$YR$$M$Y$38.549$KG$20240926$$CN$US$US
236053365$23605336$5$F$$20240712$20240307$20240712$30DAY$$US-PFIZER INC-202400047801$PFIZER$$15$YR$$M$Y$37.19$KG$20240712$$CN$US$US
236053585$23605358$5$F$20240218$20240816$20240307$20240826$EXP$$CA-ROCHE-3471347$ROCHE$$56$YR$A$M$Y$$$20240826$$CN$CA$CA
236054877$23605487$7$F$20240101$20240919$20240307$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-005505$UNITED THERAPEUTICS$$$$$M$Y$81.633$KG$20240926$$$US$US
236054892$23605489$2$F$$20240718$20240307$20240725$EXP$$US-SA-2024SA074748$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240725$$MD$US$US
236054922$23605492$2$F$20170501$20240828$20240307$20240910$EXP$$US-SA-2024SA074911$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240910$$CN$US$US
236055312$23605531$2$F$20240101$20240809$20240307$20240819$PER$$US-SA-2024SA072138$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240819$$MD$US$US
236055792$23605579$2$F$20240201$20240815$20240307$20240828$PER$$US-SA-2024SA072035$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240828$$MD$US$US
236055842$23605584$2$F$$20240827$20240307$20240919$PER$$US-SA-2024SA070932$SANOFI AVENTIS$$$$A$M$Y$108.86$KG$20240919$$MD$US$US
236055942$23605594$2$F$20240201$20240715$20240307$20240723$PER$$US-SA-2024SA071876$SANOFI AVENTIS$$69$YR$E$F$Y$68$KG$20240723$$MD$US$US
236056183$23605618$3$F$20240101$20240814$20240307$20240829$PER$$US-SA-2024SA070882$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240829$$MD$US$US
236056203$23605620$3$F$$20240530$20240307$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-019861$REGENERON$$$$$F$Y$$$20240911$$CN$US$US
236056292$23605629$2$F$20230101$20240726$20240307$20240805$PER$$US-SA-2024SA070478$SANOFI AVENTIS$$29$YR$A$F$Y$66.22$KG$20240805$$MD$US$US
236056333$23605633$3$F$20240201$20240821$20240307$20240829$PER$$US-SA-2024SA071102$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240829$$MD$US$US
236056572$23605657$2$F$20240101$20240626$20240307$20240705$PER$$US-SA-2024SA070784$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240705$$CN$US$US
236056582$23605658$2$F$$20240628$20240307$20240709$PER$$US-SA-2024SA069954$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240709$$CN$US$US
236056654$23605665$4$F$20240101$20240916$20240307$20240920$PER$$US-SA-2024SA070950$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240920$$MD$US$US
236056903$23605690$3$F$20240101$20240731$20240307$20240809$PER$$US-SA-2023SA370317$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240809$$HP$US$US
236056983$23605698$3$F$20240101$20240909$20240307$20240920$PER$$US-SA-2024SA073545$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240920$$MD$US$US
236057075$23605707$5$F$$20240909$20240307$20240918$PER$$US-SA-2024SA070777$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240918$$MD$US$US
236057143$23605714$3$F$20231211$20240717$20240307$20240725$PER$$US-SA-2024SA073174$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240725$$MD$US$US
236057203$23605720$3$F$$20240626$20240307$20240705$PER$$US-SA-2024SA074011$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240705$$MD$US$US
236057232$23605723$2$F$20240101$20240821$20240307$20240916$PER$$US-SA-2024SA072495$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240916$$MD$US$US
236057284$23605728$4$F$20240101$20240622$20240307$20240705$PER$$US-SA-2024SA073407$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240705$$MD$US$US
236057442$23605744$2$F$$20240906$20240307$20240917$PER$$US-SA-2024SA073646$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240918$$MD$US$US
236057492$23605749$2$F$20230101$20240624$20240307$20240703$PER$$US-SA-2024SA071454$SANOFI AVENTIS$$$$A$M$Y$$$20240703$$MD$US$US
236057802$23605780$2$F$$20240912$20240307$20240920$PER$$US-SA-2024SA073917$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240920$$MD$US$US
236058383$23605838$3$F$$20240626$20240307$20240704$EXP$$US-BIOCON BIOLOGICS LIMITED-BBL2024001267$BIOCON$$$$$$Y$$$20240704$$CN$US$US
236058562$23605856$2$F$$20240726$20240307$20240802$PER$$US-AMGEN-USASP2024042787$AMGEN$$76$YR$E$F$Y$$$20240802$$CN$US$US
236058662$23605866$2$F$$20240624$20240307$20240701$EXP$$CA-DSJP-DSJ-2024-110058$DAIICHI$$41$YR$$F$Y$$$20240701$$MD$CA$CA
236059192$23605919$2$F$20240214$20240806$20240307$20240814$EXP$$ES-ABBVIE-5669168$ABBVIE$$81$YR$$M$Y$68$KG$20240814$$MD$ES$ES
236059443$23605944$3$F$20240302$20240722$20240307$20240725$PER$$US-AMGEN-USASP2024046923$AMGEN$$75$YR$E$F$Y$$$20240725$$MD$US$US
236059587$23605958$7$F$20240507$20240918$20240307$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-034512$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240923$$CN$US$US
236059604$23605960$4$F$$20240918$20240307$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-018471$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240920$$CN$US$US
236060372$23606037$2$F$20240220$20240910$20240307$20240917$PER$$CA-Eisai-EC-2024-161043$EISAI$$58$YR$A$F$Y$$$20240917$$CN$CA$CA
236060464$23606046$4$F$20240101$20240812$20240307$20240910$PER$$US-009507513-2402USA004923$MERCK$$$$$F$Y$$$20240910$$CN$US$US
236060842$23606084$2$F$20240123$20240712$20240307$20240715$EXP$FR-AFSSAPS-NT2024000145$FR-PFIZER INC-202400056172$PFIZER$$74$YR$$F$Y$81.9$KG$20240715$$MD$FR$FR
2360610410$23606104$10$F$20240101$20240819$20240307$20240821$EXP$$US-PFIZER INC-PV202400031702$PFIZER$$72$YR$$F$Y$58.957$KG$20240821$$CN$US$US
236061254$23606125$4$F$20230402$20240902$20240307$20240909$EXP$$NVSC2023BR097551$NOVARTIS$$41$YR$$F$Y$$$20240909$$CN$BR$BR
236061773$23606177$3$F$$20240909$20240307$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037240$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240912$$HP$US$US
236062245$23606224$5$F$20230801$20240909$20240307$20240925$PER$$US-SA-2024SA073234$SANOFI AVENTIS$$51$YR$A$F$Y$58.97$KG$20240925$$MD$US$US
236062543$23606254$3$F$$20240621$20240307$20240702$PER$$US-SA-2024SA073967$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$MD$US$US
236062772$23606277$2$F$$20240905$20240307$20240917$EXP$$CA-AstraZeneca-2024A052814$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$CA$
236062843$23606284$3$F$$20240619$20240307$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01985$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236063173$23606317$3$F$20231229$20240820$20240307$20240821$EXP$$US-GILEAD-2024-0664758$GILEAD$$67$YR$E$F$Y$69.8$KG$20240821$$HP$US$US
236063342$23606334$2$F$$20240723$20240307$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036845$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240724$$HP$US$US
236063502$23606350$2$F$$20240903$20240307$20240908$30DAY$$EG-SANDOZ INC.-SDZ2024EG021770$SANDOZ$$$$$M$Y$20.5$KG$20240908$$CN$EG$EG
236063772$23606377$2$F$$20240729$20240307$20240806$PER$$US-SA-2024SA071378$SANOFI AVENTIS$$4$YR$C$F$Y$18.7$KG$20240806$$MD$US$US
236063832$23606383$2$F$$20240819$20240307$20240828$PER$$US-SA-2024SA070401$SANOFI AVENTIS$$$$A$M$Y$78.005$KG$20240828$$MD$US$US
236064002$23606400$2$F$$20240429$20240307$20240913$PER$$US-KARYOPHARM-2023KPT001957$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240913$$MD$US$US
236064584$23606458$4$F$20240101$20240723$20240307$20240730$PER$$US-BIOGEN-2024BI01251673$BIOGEN$$$$$F$Y$$$20240730$$CN$US$US
236064672$23606467$2$F$$20240722$20240307$20240723$30DAY$$US-SANDOZ INC.-SDZ2024US024901$SANDOZ$$$$$M$Y$$$20240723$$HP$US$US
236064873$23606487$3$F$$20240918$20240307$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037192$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240920$$CN$US$US
236065023$23606502$3$F$20240202$20240809$20240307$20240815$EXP$$JP-009507513-2403JPN000187J$MERCK$$7$DEC$$M$Y$$$20240815$$MD$JP$JP
236065223$23606522$3$F$$20240322$20240307$20240704$30DAY$$JP-SA-2024SA070677$SANOFI AVENTIS$$$$$$Y$$$20240704$$HP$JP$JP
236065294$23606529$4$F$$20240918$20240307$20240920$EXP$$US-BIOVITRUM-2024-US-003732$BIOVITRUM$$78$YR$$F$Y$$$20240920$$CN$US$US
236065554$23606555$4$F$20220101$20240719$20240307$20240729$PER$$US-SA-2024SA070276$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240729$$CN$US$US
236066064$23606606$4$F$20240101$20240807$20240307$20240814$PER$$US-SA-2024SA071650$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240814$$MD$US$US
236066113$23606611$3$F$$20240712$20240307$20240715$PER$$US-PFIZER INC-PV202400030368$PFIZER$$64$YR$$F$Y$$$20240715$$HP$US$US
236066133$23606613$3$F$20240101$20240820$20240307$20240823$PER$$US-PFIZER INC-202400057581$PFIZER$$71$YR$$F$Y$95.25$KG$20240823$$CN$US$US
236066273$23606627$3$F$$20240627$20240307$20240701$PER$$US-PFIZER INC-202400058066$PFIZER$$12$YR$$F$Y$$$20240701$$MD$US$US
236066362$23606636$2$F$$20240619$20240307$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01761$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236066752$23606675$2$F$$20240619$20240307$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01772$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236066805$23606680$5$F$20240101$20240731$20240307$20240807$EXP$$JP-009507513-2401JPN005108J$MERCK$$70$YR$$M$Y$$$20240807$$MD$JP$JP
236066858$23606685$8$F$20240223$20240711$20240307$20240721$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000461$BLUEPRINT MEDICINES$$76$YR$E$F$Y$$$20240719$$CN$US$US
236066985$23606698$5$F$$20240819$20240307$20240828$EXP$$CA-ROCHE-3517488$ROCHE$$$$A$M$Y$$$20240828$$CN$CA$CA
236067193$23606719$3$F$20211027$20240729$20240307$20240801$EXP$$US-PFIZER INC-202200404706$PFIZER$$57$YR$$M$Y$$$20240801$$CN$US$US
236067262$23606726$2$F$20240301$20240906$20240307$20240911$30DAY$$EG-SANDOZ INC.-SDZ2024EG023224$SANDOZ$$7$YR$$F$Y$17$KG$20240911$$CN$EG$EG
236067303$23606730$3$F$$20240619$20240307$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01820$LUPIN$$$$$$Y$$$20240701$$PH$US$US
236067342$23606734$2$F$20240224$20240731$20240307$20240806$30DAY$$US-GSK-US2024025090$GLAXOSMITHKLINE$$68$YR$$M$Y$$$20240806$$CN$US$US
236067612$23606761$2$F$$20240619$20240307$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01821$LUPIN$$$$$$Y$$$20240701$$PH$US$US
236067733$23606773$3$F$20230101$20240625$20240307$20240704$EXP$$JP-JNJFOC-20230719946$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240705$$CN$JP$JP
236067763$23606776$3$F$$20240809$20240307$20240816$EXP$$NVSC2024US045765$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
236067935$23606793$5$F$$20240801$20240307$20240814$PER$$US-SA-2024SA074683$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240814$$MD$US$US
236067972$23606797$2$F$20240201$20240711$20240307$20240801$PER$$US-SA-2024SA071609$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240719$$MD$US$US
236067998$23606799$8$F$20240101$20240918$20240307$20240925$EXP$$CA-ABBVIE-5669316$ABBVIE$$58$YR$$M$Y$65$KG$20240925$$MD$CA$CA
236068132$23606813$2$F$20220101$20240626$20240307$20240705$PER$$US-SA-2024SA071868$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240705$$MD$US$US
236068216$23606821$6$F$20240127$20240703$20240307$20240705$EXP$$IL-GILEAD-2024-0661194$GILEAD$$72$YR$E$F$Y$$$20240705$$HP$IL$IL
236068453$23606845$3$F$20240101$20240702$20240307$20240711$PER$$US-SA-2024SA071940$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240711$$MD$US$US
236068662$23606866$2$F$20240209$20240716$20240307$20240719$EXP$$CN-ABBVIE-5666854$ABBVIE$$44$YR$$M$Y$60$KG$20240719$$HP$CN$CN
236068683$23606868$3$F$20230514$20240711$20240307$20240721$EXP$IT-MINISAL02-968673$IT-TEVA-VS-3164252$TEVA$$69$YR$$M$Y$74$KG$20240721$$PH$IT$IT
236068939$23606893$9$F$20220809$20240624$20240307$20240701$EXP$$ES-MYLANLABS-2024M1019821$MYLAN$Naya Rios L., Santos Garcia D., Cores Bartalome C., Docampo Carro I.. Serotonin syndrome induced by amoxicillin clavulanic.. Neurologia. 2024;S2173:5808$78$YR$$F$Y$60$KG$20240701$$MD$ES$ES
236069122$23606912$2$F$$20240229$20240307$20240912$EXP$$NVSC2024BR046101$NOVARTIS$$$$$F$Y$$$20240912$$CN$BR$BR
236069653$23606965$3$F$20230413$20240723$20240307$20240724$EXP$$FR-SANDOZ INC.-SDZ2024FR024126$SANDOZ$$76$YR$$M$Y$54$KG$20240724$$MD$FR$FR
236069703$23606970$3$F$$20240911$20240307$20240916$EXP$$US-TAKEDA-US201832804$TAKEDA$$$$$M$Y$$$20240916$$CN$US$US
236070082$23607008$2$F$$20240730$20240307$20240808$EXP$$GR-TEVA-VS-3163221$TEVA$The position of Apremilast to achieve the goals of the patient and the doctor in Psoriatic Arthritis. The pan hellenic SUMMAR SYMPOSIUM musculoskeletal health. Scientific association for musculoskeletal health. Jun 15-18, 2023: Slide 6-8; Literature Reference: The position of Apremilast to achieve the goals of the patient and the doctor in Psoriatic Arthritis. The pan hellenic SUMMAR SYMPOSIUM musculoskeletal health. Scientific association for musculoskeletal health. Jun 15-18, 2023$55$YR$$M$Y$$$20240808$$MD$GR$GR
236070574$23607057$4$F$20230801$20240418$20240307$20240805$EXP$$CA-AstraZeneca-2023A128868$ASTRAZENECA$$23559$DY$$F$Y$73.9$KG$20240805$$PH$CA$
236070692$23607069$2$F$20231001$20240909$20240307$20240927$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1100006$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
236071022$23607102$2$F$$20240730$20240307$20240827$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1100057$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
236071142$23607114$2$F$$20240909$20240307$20240912$EXP$$FR-PFIZER INC-PV202400029918$PFIZER$Varnier, R.. Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study. Digestive and Liver Disease. 2024;56(9):1605-1613$$$A$$Y$$$20240912$$HP$FR$FR
236072092$23607209$2$F$$20240730$20240307$20240807$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1100260$SUNOVION$$$$$M$Y$$$20240807$$CN$US$US
236072342$23607234$2$F$$20240805$20240307$20240829$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1100298$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
236072442$23607244$2$F$$20240723$20240307$20240729$PER$$US-INCYTE CORPORATION-2024IN002167$INCYTE$$$$$$Y$$$20240729$$CN$US$US
236072992$23607299$2$F$20240101$20240910$20240307$20240919$EXP$$CA-JNJFOC-20230946244$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240919$$HP$CA$CA
236073172$23607317$2$F$$20240711$20240307$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-003930$JAZZ$$$$$M$Y$$$20240716$$CN$US$US
236073614$23607361$4$F$20220914$20240821$20240307$20240826$EXP$$JP-Eisai-EC-2022-125018$EISAI$$59$YR$A$F$Y$$$20240826$$MD$JP$JP
236073722$23607372$2$F$20231002$20240715$20240307$20240716$EXP$FR-AFSSAPS-AN2024000179$FR-SANDOZ INC.-SDZ2024FR023969$SANDOZ$$74$YR$$M$Y$$$20240716$$MD$FR$FR
236074326$23607432$6$F$20240101$20240816$20240307$20240820$EXP$$CO-ABBVIE-5669171$ABBVIE$$$$$F$Y$58$KG$20240820$$CN$CO$CO
236074655$23607465$5$F$$20240826$20240307$20240904$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000445$BLUEPRINT MEDICINES$$$$$F$Y$$$20240905$$CN$US$US
236075595$23607559$5$F$20240301$20240719$20240307$20240724$EXP$$DE-PFIZER INC-PV202400030338$PFIZER$$82$YR$$F$Y$$$20240724$$MD$DE$DE
236076582$23607658$2$F$$20240826$20240307$20240923$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1000758$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
236077332$23607733$2$F$20240304$20240917$20240307$20240920$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-036852$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$74.84$KG$20240920$$CN$PR$PR
236078225$23607822$5$F$$20240919$20240307$20240924$EXP$$US-ANIPHARMA-2024-US-013532$ANI$$74$YR$$M$Y$$$20240924$$HP$US$US
236078252$23607825$2$F$$20240702$20240307$20240710$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-026385$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240710$$CN$GB$GB
236078265$23607826$5$F$20240101$20240722$20240307$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036960$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$92.08$KG$20240731$$PH$US$US
236079225$23607922$5$F$20240221$20240813$20240307$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032881$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240814$$CN$US$US
236079235$23607923$5$F$20240301$20240927$20240307$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037275$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240930$$CN$US$US
236079383$23607938$3$F$$20240716$20240307$20240723$EXP$$JP-009507513-2403JPN000209J$MERCK$$59$YR$$F$Y$$$20240723$$MD$JP$JP
236079442$23607944$2$F$$20240830$20240307$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036290$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$105.69$KG$20240903$$CN$US$US
236079742$23607974$2$F$20240229$20240712$20240307$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036380$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240715$$CN$US$US
236080006$23608000$6$F$20240501$20240924$20240307$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036090$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240926$$CN$US$US
236080112$23608011$2$F$$20240730$20240307$20240802$PER$$US-PFIZER INC-PV202400031662$PFIZER$$81$YR$$F$Y$$$20240802$$MD$US$US
236080143$23608014$3$F$20230201$20240627$20240307$20240703$PER$$US-PFIZER INC-202400057953$PFIZER$$21$YR$$M$Y$$$20240703$$HP$US$US
236080179$23608017$9$F$20240101$20240917$20240307$20240923$EXP$$CA-PFIZER INC-202400049076$PFIZER$$59$YR$$F$Y$$$20240923$$MD$CA$CA
236080213$23608021$3$F$$20240625$20240307$20240701$PER$$US-PFIZER INC-PV202400031344$PFIZER$$39$YR$$F$Y$$$20240701$$CN$US$US
236080542$23608054$2$F$$20240302$20240307$20240820$EXP$$GB-BAUSCHBL-2024BNL002703$BAUSCH AND LOMB$Ramadan K, McKenna K, Morris T. Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma. Lancet Oncology. 2006;7:958-59.$6$DEC$$M$Y$$$20240820$$MD$GB$GB
236080914$23608091$4$F$20240115$20240823$20240307$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-006976$JAZZ$$50$YR$$M$Y$$$20240826$$HP$US$US
236081412$23608141$2$F$$20240916$20240307$20240923$EXP$$CA-BEH-2024169551$CSL BEHRING$$48$YR$A$F$Y$70$KG$20240923$$CN$CA$CA
236081793$23608179$3$F$$20240826$20240307$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005251$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
236082036$23608203$6$F$$20240902$20240307$20240903$EXP$$DE-SANDOZ INC.-NVSC2020DE043427$SANDOZ$$68$YR$$M$Y$$$20240903$$MD$DE$DE
236082133$23608213$3$F$20230530$20240911$20240307$20240918$EXP$$CA-JNJFOC-20230625665$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240918$$CN$CA$CA
236082183$23608218$3$F$20230101$20240719$20240307$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036124$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240722$$CN$US$US
236082194$23608219$4$F$20240101$20240819$20240307$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036320$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$62$KG$20240821$$CN$US$US
236082213$23608221$3$F$$20240802$20240307$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036493$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240808$$CN$US$US
236082222$23608222$2$F$$20240902$20240307$20240910$EXP$$AR-EMD Serono-2024012082$EMD SERONO INC$$$$E$M$Y$$$20240910$$CN$AR$AR
236082313$23608231$3$F$20240207$20240718$20240307$20240722$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-035308$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$92.99$KG$20240722$$CN$PR$PR
236082436$23608243$6$F$20240101$20240918$20240307$20240927$EXP$$JP-JNJFOC-20240211152$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240927$$CN$JP$JP
236083073$23608307$3$F$20240101$20240913$20240307$20240918$EXP$$US-ABBVIE-5668731$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
236083212$23608321$2$F$$20240919$20240307$20240923$EXP$$US-JNJFOC-20240315693$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240923$$HP$US$US
236083254$23608325$4$F$$20240806$20240307$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036333$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240808$$CN$US$US
236083632$23608363$2$F$20240101$20240829$20240307$20240905$EXP$$CA-ABBVIE-5668232$ABBVIE$$70$YR$$F$Y$$$20240905$$CN$CA$CA
236083925$23608392$5$F$20230301$20240716$20240307$20240725$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-277158$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240725$$CN$JP$JP
236084033$23608403$3$F$$20230905$20240307$20240710$PER$$IN-ROCHE-3406363$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$IN$IN
236084152$23608415$2$F$$20240731$20240307$20240806$EXP$$GB-JNJFOC-20240312029$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240806$$CN$GB$GB
236084203$23608420$3$F$20240111$20240701$20240307$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037200$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240701$$PH$US$US
236084255$23608425$5$F$20240101$20240719$20240307$20240725$EXP$$JP-GENMAB-2024-00639$GENMAB$$80$YR$$M$Y$50.4$KG$20240725$$MD$JP$JP
236084413$23608441$3$F$20240101$20240706$20240307$20240709$EXP$$US-ABBVIE-5668419$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
236084546$23608454$6$F$20230101$20240826$20240307$20240829$EXP$$US-ABBVIE-5521794$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
236084813$23608481$3$F$20240222$20240621$20240307$20240705$PER$$US-Eisai-EC-2024-160387$EISAI$$89$YR$E$F$Y$78$KG$20240705$$CN$US$US
236084973$23608497$3$F$$20240626$20240307$20240701$EXP$$CA-ABBVIE-5669068$ABBVIE$$$$A$F$Y$$$20240701$$CN$CA$CA
236085082$23608508$2$F$$20240722$20240308$20240725$PER$$NVSC2024US043666$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
236085212$23608521$2$F$20231101$20240808$20240308$20240924$PER$$US-LUNDBECK-DKLU3074725$LUNDBECK$$$$$$Y$$$20240924$$CN$US$US
236085633$23608563$3$F$20230801$20240903$20240308$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-025080$JAZZ$$31$YR$$F$Y$$$20240905$$CN$US$US
236086153$23608615$3$F$20240301$20240714$20240308$20240717$PER$$US-AMGEN-USASP2024046042$AMGEN$$84$YR$E$F$Y$$$20240717$$CN$US$US
236086263$23608626$3$F$$20240820$20240308$20240827$PER$$US-AMGEN-USASP2024046681$AMGEN$$$$A$F$Y$$$20240827$$HP$US$US
236086382$23608638$2$F$$20240722$20240308$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036895$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240723$$CN$US$US
236086622$23608662$2$F$$20240628$20240308$20240711$EXP$$JP-ADVANZ PHARMA-202402001868$ADVANZ PHARMA$$$$$$Y$$$20240711$$PH$JP$JP
236087302$23608730$2$F$20240101$20240903$20240308$20240911$PER$$US-SA-2024SA075283$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240911$$MD$US$US
236087635$23608763$5$F$20240123$20240715$20240308$20240722$EXP$$CA-GSK-CA2023155397$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$MD$CA$CA
236087763$23608776$3$F$20240209$20240807$20240308$20240814$EXP$$CA-GSK-CA2024029077$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$CA$CA
236087982$23608798$2$F$$20240723$20240308$20240725$EXP$$BR-BEIGENE-BGN-2024-003510$BEIGENE$$$$$$Y$$$20240725$$MD$BR$BR
236088092$23608809$2$F$20240201$20240621$20240308$20240705$PER$$US-SA-2024SA073428$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240705$$MD$US$US
236088182$23608818$2$F$$20240802$20240308$20240812$PER$$US-SA-2024SA072589$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240812$$MD$US$US
236088804$23608880$4$F$$20240722$20240308$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036403$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240731$$CN$US$US
236088972$23608897$2$F$20240304$20240625$20240308$20240704$PER$$US-SA-2024SA075269$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240704$$MD$US$US
236089212$23608921$2$F$20240108$20240227$20240308$20240904$EXP$GB-MHRA-TPP18078221C943091YC1707496578780$GB-TORRENT-00035245$TORRENT$$13$YR$T$M$Y$46$KG$20240904$$MD$GB$GB
236089292$23608929$2$F$20230828$20240621$20240308$20240705$EXP$FR-AFSSAPS-NT2023001053$FR-TEVA-VS-3163665$TEVA$$49$YR$$F$Y$$$20240705$$PH$FR$FR
236089472$23608947$2$F$20200301$20240816$20240308$20240823$EXP$$CA-SANDOZ INC.-NVSC2020CA086112$SANDOZ$$64$YR$$F$Y$$$20240823$$CN$CA$CA
236089782$23608978$2$F$$20240726$20240308$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037082$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240801$$HP$US$US
236090002$23609000$2$F$$20240807$20240308$20240815$PER$$US-SA-2024SA072484$SANOFI AVENTIS$$$$A$F$Y$117.9$KG$20240815$$MD$US$US
236090243$23609024$3$F$20180101$20240702$20240308$20240711$PER$$US-SA-2024SA076469$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240712$$MD$US$US
236090433$23609043$3$F$$20240619$20240308$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01847$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236090552$23609055$2$F$$20240619$20240308$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01846$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236091102$23609110$2$F$20240304$20240717$20240308$20240718$EXP$$US-TAKEDA-2024TUS020282$TAKEDA$$33$YR$$M$Y$$$20240718$$PH$US$US
236091233$23609123$3$F$$20240628$20240308$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036642$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240701$$CN$US$US
236091405$23609140$5$F$$20240919$20240308$20240926$PER$$US-GSK-US2024AMR026183$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
236091413$23609141$3$F$20231001$20240724$20240308$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036755$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240801$$HP$US$US
236091492$23609149$2$F$$20240909$20240308$20240911$EXP$$US-TAKEDA-2023TUS100394$TAKEDA$$$$$M$Y$$$20240911$$HP$US$US
236091533$23609153$3$F$$20240812$20240308$20240816$EXP$$CA-TAKEDA-2024TUS012021$TAKEDA$$$$$F$Y$$$20240816$$CN$CA$CA
236091583$23609158$3$F$20240212$20240920$20240308$20240930$EXP$$CA-CELLTRION INC.-2024CA003468$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
236091742$23609174$2$F$20240201$20240708$20240308$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037035$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240709$$PH$US$US
236091813$23609181$3$F$20240222$20240906$20240308$20240918$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-IBA-000071$THERATECHNOLOGIES$$$$$$Y$$$20240918$$MD$US$US
236091962$23609196$2$F$$20240620$20240308$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01767$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236092233$23609223$3$F$20240101$20240807$20240308$20240810$EXP$$US-ABBVIE-5669732$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
236092242$23609224$2$F$$20240620$20240308$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01885$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236092422$23609242$2$F$$20240620$20240308$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01886$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236092519$23609251$9$F$20200101$20240920$20240308$20240923$EXP$$US-TAKEDA-2023TUS113096$TAKEDA$$$$$F$Y$63$KG$20240923$$HP$US$US
236092653$23609265$3$F$$20240619$20240308$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01779$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236092742$23609274$2$F$$20240301$20240308$20240708$PER$$US-AMGEN-USASP2024045274$AMGEN$$$$$$Y$$$20240708$$MD$US$US
236095072$23609507$2$F$$20240827$20240308$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037735$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$83.01$KG$20240829$$CN$US$US
236095193$23609519$3$F$20230101$20240307$20240308$20240814$EXP$$NVSC2023BR263364$NOVARTIS$$$$$F$Y$$$20240814$$CN$BR$BR
236095338$23609533$8$F$20240101$20240916$20240308$20240925$EXP$$US-INSMED, INC.-2024-00802-US$INSMED$$$$$M$Y$$$20240925$$CN$US$US
236095632$23609563$2$F$20240101$20240820$20240308$20240826$EXP$$US-SANDOZ INC.-NVSC2023US147907$SANDOZ$$17$YR$$M$Y$66.667$KG$20240826$$CN$US$US
236095844$23609584$4$F$20240222$20240625$20240308$20240702$EXP$$BE-BAXTER-2024BAX014165$BAXTER$$75$YR$$F$Y$77$KG$20240702$$MD$BE$BE
236095873$23609587$3$F$$20240619$20240308$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01823$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236096122$23609612$2$F$20240201$20240910$20240308$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037595$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240912$$HP$US$US
236096302$23609630$2$F$$20240619$20240308$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01853$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236096893$23609689$3$F$$20240820$20240308$20240827$EXP$$PT-ROCHE-3522439$ROCHE$Fonseca N, Navarro D, Gois M, Sousa H, Aires I, Nolasco F. Streamlining diagnosis with urinary sediment microscopy: a case of deteriorating renal function in a kidney transplant patient. Portuguese Journal of Nephrology and Hypertension.. 2018;32 (4):381-4.$71$YR$E$M$Y$$$20240827$$MD$PT$PT
236096952$23609695$2$F$20240302$20240713$20240308$20240716$PER$$US-AMGEN-USASP2024046719$AMGEN$$48$YR$A$M$Y$$$20240715$$CN$US$US
236097732$23609773$2$F$$20240619$20240308$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01825$LUPIN$$$$$$Y$$$20240701$$PH$US$US
236098062$23609806$2$F$$20240708$20240308$20240709$EXP$$NZ-BRISTOL-MYERS SQUIBB COMPANY-2024-035209$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240709$$PH$NZ$NZ
236098196$23609819$6$F$$20240822$20240308$20240829$EXP$$MA-ROCHE-3516889$ROCHE$$49$YR$A$M$Y$$$20240829$$MD$MA$MA
236098522$23609852$2$F$20190625$20240919$20240308$20240927$EXP$$JP-AMGEN-JPNSP2022137308$AMGEN$$79$YR$E$M$Y$54$KG$20240927$$MD$JP$JP
236099094$23609909$4$F$20240101$20240913$20240308$20240925$EXP$$US-INSMED, INC.-2024-00386-US$INSMED$$$$$F$Y$$$20240925$$CN$US$US
236099362$23609936$2$F$20240303$20240820$20240308$20240823$PER$$US-AMGEN-USASP2024046495$AMGEN$$72$YR$E$F$Y$$$20240823$$CN$US$US
236099644$23609964$4$F$20240101$20240711$20240308$20240724$EXP$$US-BIOCODEX2-2024000093$BIOCODEX$$20$YR$$M$Y$134.5$KG$20240722$$MD$US$US
236099815$23609981$5$F$20240101$20240820$20240308$20240828$EXP$$US-UCBSA-2024010816$UCB$$$$$M$Y$145$KG$20240828$$HP$US$US
236099992$23609999$2$F$20231219$20240227$20240308$20240715$EXP$FR-AFSSAPS-AVPO2024000033$FR-TEVA-VS-3165420$TEVA$$41$YR$$M$Y$89$KG$20240715$$PH$FR$FR
236100243$23610024$3$F$$20240726$20240308$20240731$EXP$$GB-MYLANLABS-2024M1021105$MYLAN$$$$$M$Y$$$20240731$$HP$GB$GB
236100352$23610035$2$F$$20240822$20240308$20240903$EXP$CA-MHPD-E2B_06785278$CA-Accord-410038$ACCORD$$74$YR$E$M$Y$$$20240903$$HP$CA$CA
2361011211$23610112$11$F$20231023$20240822$20240308$20240830$EXP$$CA-CELLTRION INC.-2024CA005672$CELLTRION$$$$$$Y$$$20240830$$CN$CA$CA
236101212$23610121$2$F$$20240802$20240308$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433718$RANBAXY$Gunther M, Jiang S, Maldonado J. Irreversible Lithium Neurotoxicity: A Review and Case of Toxicity Leading to Bilateral Globus Pallidus Injury. J Acad Consult Liaison Psychiatry. 2023;nov/dec;64:S129-S130$52$YR$$F$Y$$$20240816$$HP$US$US
236101802$23610180$2$F$$20240223$20240308$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-435012$RANBAXY$$$$T$M$Y$$$20240702$$MD$US$US
236101932$23610193$2$F$$20240627$20240308$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-435088$RANBAXY$$31$YR$$F$Y$$$20240712$$MD$FR$FR
236102113$23610211$3$F$20240223$20240731$20240308$20240814$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-435247$RANBAXY$$74$YR$$F$Y$$$20240814$$HP$FR$FR
236102533$23610253$3$F$20231201$20240918$20240308$20240927$PER$$US-SA-2024SA073370$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240927$$MD$US$US
236102566$23610256$6$F$$20240802$20240308$20240812$PER$$US-SA-2024SA074052$SANOFI AVENTIS$$19$YR$A$F$Y$56.6$KG$20240812$$MD$US$US
236102693$23610269$3$F$20240101$20240913$20240308$20240926$PER$$US-SA-2024SA074308$SANOFI AVENTIS$$15$YR$T$F$Y$96.34$KG$20240926$$MD$US$US
236102803$23610280$3$F$20230101$20240801$20240308$20240810$PER$$US-SA-2024SA076003$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240810$$MD$US$US
236102813$23610281$3$F$20240101$20240628$20240308$20240703$PER$$US-SA-2024SA075089$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240703$$MD$US$US
236103014$23610301$4$F$20240101$20240808$20240308$20240817$PER$$US-SA-2024SA075202$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240817$$MD$US$US
236103033$23610303$3$F$$20240829$20240308$20240925$PER$$US-SA-2024SA076076$SANOFI AVENTIS$$$$E$F$Y$64.8$KG$20240925$$MD$US$US
236103062$23610306$2$F$20220101$20240911$20240308$20240919$PER$$US-SA-2024SA075967$SANOFI AVENTIS$$78$YR$E$F$Y$61.36$KG$20240919$$MD$US$US
236103372$23610337$2$F$$20240701$20240308$20240710$PER$$US-SA-2024SA073947$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240710$$MD$US$US
236103435$23610343$5$F$20240731$20240828$20240308$20240912$PER$$US-SA-2024SA075047$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240912$$MD$US$US
236103553$23610355$3$F$$20240627$20240308$20240708$PER$$US-SA-2024SA073933$SANOFI AVENTIS$$$$E$M$Y$$$20240708$$MD$US$US
236103583$23610358$3$F$20240815$20240816$20240308$20240830$PER$$US-SA-2024SA076598$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240830$$MD$US$US
236104083$23610408$3$F$20240305$20240823$20240308$20240904$EXP$$US-BAYER-2024A034286$BAYER$$37$YR$A$M$Y$$$20240904$$CN$US$US
236104232$23610423$2$F$$20240703$20240308$20240712$PER$$US-SA-2024SA073570$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240712$$MD$US$US
236104292$23610429$2$F$20240101$20240722$20240308$20240729$PER$$US-SA-2024SA075123$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240729$$MD$US$US
236104362$23610436$2$F$20240101$20240725$20240308$20240806$PER$$US-SA-2024SA075112$SANOFI AVENTIS$$20$YR$A$F$Y$70.3$KG$20240806$$MD$US$US
236104413$23610441$3$F$20240101$20240712$20240308$20240722$PER$$US-SA-2024SA075624$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240722$$MD$US$US
236104432$23610443$2$F$20240301$20240815$20240308$20240828$PER$$US-SA-2024SA073765$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240828$$MD$US$US
236104856$23610485$6$F$20240201$20240827$20240308$20240829$EXP$$BR-JNJFOC-20240308524$JOHNSON AND JOHNSON$$64$YR$A$M$Y$75$KG$20240829$$CN$BR$BR
236105722$23610572$2$F$$20240620$20240308$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01883$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236105906$23610590$6$F$20240201$20240715$20240308$20240723$EXP$$NVSC2024GB044001$NOVARTIS$$21$YR$$F$Y$$$20240723$$CN$GB$GB
236106325$23610632$5$F$$20240625$20240308$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01849$LUPIN$$$$$$Y$$$20240708$$CN$US$US
236106332$23610633$2$F$20240229$20240812$20240308$20240813$EXP$$US-UCBSA-2023043341$UCB$$65$YR$$F$Y$160$KG$20240813$$CN$US$US
236107515$23610751$5$F$20240319$20240725$20240308$20240802$EXP$$US-ARGENX-2024-ARGX-US001507$ARGENX BVBA$$$$$$Y$$$20240802$$CN$US$US
236107812$23610781$2$F$$20240620$20240308$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01774$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236107852$23610785$2$F$$20240625$20240308$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01871$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236108003$23610800$3$F$$20240620$20240308$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01778$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236108464$23610846$4$F$20230628$20240904$20240308$20240911$EXP$$JP-ROCHE-3441595$ROCHE$$78$YR$E$M$Y$53.2$KG$20240911$$MD$JP$JP
236108595$23610859$5$F$$20240916$20240308$20240923$EXP$$US-GSK-US2024026979$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$US$US
236108624$23610862$4$F$$20240923$20240308$20240926$EXP$$FR-MYLANLABS-2024M1020632$MYLAN$Nevez G., Guillerm G., Talarmin J.-P., Quinio D., Iriart X., Lissillour P.-L., Rezig S., Fangous M.-S., Ranty M., Bodenes L., Aubron C., Couturier M.-A., Le Gal S. Hormographiella aspergillata pulmonary infections: Detection and identification of the fungus using pan-fungal PCR assays and DNA sequencing.. Journal of Medical Mycology. 2024;34 (1):101463$30$YR$$F$Y$$$20240926$$HP$FR$FR
236108853$23610885$3$F$$20240905$20240308$20240909$EXP$$CA-PFIZER INC-202400057744$PFIZER$$9$YR$$M$Y$$$20240909$$HP$CA$CA
236108872$23610887$2$F$20231001$20240731$20240308$20240802$EXP$$US-PFIZER INC-202300317581$PFIZER$$84$YR$$F$Y$$$20240802$$HP$US$US
236109027$23610902$7$F$20240101$20240702$20240308$20240705$30DAY$$CA-PFIZER INC-202400012925$PFIZER$$60$YR$$F$Y$$$20240705$$MD$CA$CA
236109075$23610907$5$F$20240101$20240924$20240308$20240927$EXP$$CA-PFIZER INC-202400058511$PFIZER$$42$YR$$M$Y$$$20240927$$HP$CA$CA
236109576$23610957$6$F$$20240806$20240308$20240809$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-110469$DAIICHI$$$$$M$Y$$$20240809$$CN$US$US
236109842$23610984$2$F$20240101$20240629$20240308$20240704$PER$$US-SA-2024SA075264$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240704$$MD$US$US
236110032$23611003$2$F$$20240711$20240308$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037810$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240712$$HP$US$US
236110103$23611010$3$F$20240101$20240801$20240308$20240810$PER$$US-SA-2024SA073886$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240810$$MD$US$US
236110304$23611030$4$F$$20240716$20240308$20240718$EXP$$JP-PFIZER INC-202400059113$PFIZER$Fukumoto, K.. Lymphoproliferative disorder progressing after partial remission following immunosuppressive drugs withdrawal in a patient with rheumatoid arthritis. Modern rheumatology case reports. 2024;1-6$73$YR$$F$Y$$$20240718$$MD$JP$JP
236110692$23611069$2$F$$20240620$20240308$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01884$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236111665$23611166$5$F$20240101$20240917$20240308$20240926$PER$$US-SA-2024SA071158$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240926$$MD$US$US
236111932$23611193$2$F$20231028$20240730$20240308$20240802$EXP$$AT-SERVIER-S23012423$SERVIER$$$$$$Y$$$20240802$$MD$AT$AT
236112077$23611207$7$F$20230222$20240827$20240308$20240830$EXP$$CA-PFIZER INC-202300081285$PFIZER$$70$YR$$F$Y$$$20240830$$HP$CA$CA
236112123$23611212$3$F$20221229$20240722$20240308$20240729$EXP$$JP-009507513-2301JPN001024J$MERCK$$7$DEC$$F$Y$37$KG$20240729$$MD$JP$JP
236112164$23611216$4$F$20240226$20240710$20240308$20240710$EXP$$NVSC2024RU049171$NOVARTIS$$63$YR$$F$Y$87$KG$20240710$$MD$RU$RU
236112422$23611242$2$F$$20240429$20240308$20240913$PER$$US-KARYOPHARM-2023KPT001954$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240913$$MD$US$US
236112712$23611271$2$F$$20240429$20240308$20240913$PER$$US-KARYOPHARM-2023KPT001955$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63$$$$$Y$$$20240913$$MD$US$US
236112882$23611288$2$F$$20240429$20240308$20240913$PER$$US-KARYOPHARM-2023KPT001956$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240913$$MD$US$US
236113262$23611326$2$F$$20240703$20240308$20240715$EXP$$JP-009507513-2402JPN003407J$MERCK$$64$YR$$M$Y$$$20240715$$MD$JP$JP
236113322$23611332$2$F$$20240429$20240308$20240913$PER$$US-KARYOPHARM-2023KPT001958$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240913$$MD$US$US
236113632$23611363$2$F$$20240716$20240308$20240723$EXP$$PT-JNJFOC-20240284821$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$MD$PT$PT
236113882$23611388$2$F$$20240429$20240308$20240913$PER$$US-KARYOPHARM-2023KPT001960$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240913$$MD$US$US
236113892$23611389$2$F$$20240429$20240308$20240913$PER$$US-KARYOPHARM-2023KPT001959$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240913$$MD$US$US
236114002$23611400$2$F$20240111$20240228$20240308$20240808$EXP$$NVSC2024US013063$NOVARTIS$$74$YR$$F$Y$$$20240808$$CN$US$US
236114172$23611417$2$F$$20240429$20240308$20240913$PER$$US-KARYOPHARM-2023KPT001961$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240913$$MD$US$US
236114262$23611426$2$F$$20240429$20240308$20240913$PER$$US-KARYOPHARM-2023KPT001962$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240913$$MD$US$US
236114654$23611465$4$F$20231228$20240827$20240308$20240905$EXP$$DK-BAXTER-2024BAX014019$BAXTER$$79$YR$$M$Y$87.1$KG$20240905$$HP$DK$DK
236114882$23611488$2$F$20240101$20240710$20240308$20240715$EXP$$JP-009507513-2403JPN000184J$MERCK$$39$YR$$F$Y$$$20240715$$MD$JP$JP
236114914$23611491$4$F$20230101$20240619$20240308$20240701$PER$$US-KARYOPHARM-2023KPT002203$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240701$$CN$US$US
236115002$23611500$2$F$$20240429$20240308$20240913$PER$$US-KARYOPHARM-2023KPT001963$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240913$$MD$US$US
236116057$23611605$7$F$20240222$20240731$20240308$20240801$EXP$$US-TAKEDA-2024TUS016251$TAKEDA$$70$YR$$F$Y$$$20240801$$MD$US$US
236117022$23611702$2$F$$20240718$20240308$20240720$PER$$US-JNJFOC-20240317662$JOHNSON AND JOHNSON$$$$$$Y$$$20240720$$MD$US$US
236117392$23611739$2$F$20240201$20240802$20240308$20240808$EXP$$US-SA-2024SA076041$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240808$$MD$US$US
236117565$23611756$5$F$20240107$20240716$20240308$20240717$EXP$$BE-SANDOZ INC.-SDZ2024BE025062$SANDOZ$$$$E$M$Y$104$KG$20240717$$MD$BE$BE
236117923$23611792$3$F$20240304$20240627$20240308$20240702$EXP$$JP-AstraZeneca-2024A055764$ASTRAZENECA$$77$YR$$F$Y$45$KG$20240702$$MD$JP$
2361180912$23611809$12$F$$20240919$20240308$20240924$PER$$NVSC2024US050591$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
236118882$23611888$2$F$20231210$20240802$20240308$20240814$EXP$FR-AFSSAPS-LM2024000104$FR-ELI_LILLY_AND_COMPANY-FR202402016817$ELI LILLY AND CO$$64$YR$A$F$Y$73$KG$20240814$$CN$FR$FR
236118942$23611894$2$F$20230314$20240911$20240308$20240919$EXP$$GB-ROCHE-3311989$ROCHE$$64$YR$A$F$Y$$$20240919$$HP$GB$GB
236119173$23611917$3$F$20230201$20240802$20240308$20240806$EXP$$US-PFIZER INC-202400058681$PFIZER$$75$YR$$F$Y$$$20240806$$CN$US$US
236119272$23611927$2$F$20150701$20240812$20240308$20240819$EXP$PL-EMA-DD-20240216-7482715-121506$PL-SANDOZ INC.-SDZ2024PL024740$SANDOZ$$65$YR$$M$Y$$$20240819$$MD$PL$PL
236119514$23611951$4$F$$20240708$20240308$20240709$PER$$US-ALXN-202403USA000348US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240709$$CN$US$US
236120272$23612027$2$F$$20240822$20240308$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038183$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$64.86$KG$20240827$$CN$US$US
236120372$23612037$2$F$20231201$20240703$20240308$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202403003470$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240704$$CN$US$US
236120625$23612062$5$F$$20240715$20240308$20240720$EXP$$NVSC2024CA048347$NOVARTIS$$44$YR$$F$Y$$$20240719$$HP$CA$CA
236121305$23612130$5$F$20240116$20240906$20240308$20240909$EXP$$NVSC2024US013395$NOVARTIS$$57$YR$$F$Y$$$20240909$$CN$US$US
236121572$23612157$2$F$20240101$20240626$20240308$20240705$PER$$US-SA-2024SA075324$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240705$$MD$US$US
236121793$23612179$3$F$$20240802$20240308$20240809$EXP$$US-DSJP-DSU-2024-110271$DAIICHI$$$$$F$Y$$$20240809$$CN$US$US
236122223$23612222$3$F$$20240628$20240308$20240702$EXP$$CA-PURDUE-USA-2024-0308286$PURDUE$$36$YR$$F$Y$$$20240702$$CN$CA$CA
236122712$23612271$2$F$20240101$20240826$20240308$20240828$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-110466$DAIICHI$$22$YR$$F$Y$$$20240828$$CN$US$US
236123392$23612339$2$F$20231201$20240813$20240308$20240909$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1200752$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
236123973$23612397$3$F$20240319$20240813$20240308$20240819$PER$$US-PFIZER INC-PV202400032115$PFIZER$$66$YR$$F$Y$54.43$KG$20240819$$CN$US$US
236123985$23612398$5$F$20230701$20240829$20240308$20240904$PER$$US-PFIZER INC-PV202400007186$PFIZER$$71$YR$$F$Y$73.9$KG$20240904$$CN$US$US
236124052$23612405$2$F$$20240924$20240308$20240927$PER$$US-PFIZER INC-PV202400032125$PFIZER$$73$YR$$F$Y$$$20240927$$HP$US$US
236124502$23612450$2$F$$20240820$20240308$20240917$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1201018$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
236124584$23612458$4$F$$20240624$20240308$20240705$EXP$$CO-AMRYT PHARMACEUTICALS DAC-AEGR006962$AEGERION$$$$$$Y$$$20240705$$CN$CO$CO
236125142$23612514$2$F$$20240715$20240308$20240721$EXP$$GB-MYLANLABS-2024M1020964$MYLAN$$$$$M$Y$$$20240719$$PH$GB$GB
236125343$23612534$3$F$20210201$20240710$20240308$20240715$EXP$$JP-Eisai-EC-2023-153297$EISAI$$15$YR$T$F$Y$$$20240715$$MD$JP$JP
236125597$23612559$7$F$$20240821$20240308$20240827$PER$$US-PFIZER INC-202400058499$PFIZER$$53$YR$$F$Y$$$20240827$$CN$US$US
236126182$23612618$2$F$$20240820$20240308$20240822$EXP$$TN-BAUSCH-BL-2024-003743$BAUSCH AND LOMB$Laroussi S, Bouattour N, Daoud S, Moalla K, Sakka S, Damak M, Farhat N, Mhiri C. Demence reversible et des crises epileptiques secondaires a un deficit en vitamine B12 induit par la metformine. L Encephale. 2023;1-4. doi:10.1016/j.encep.2023.11.030$64$YR$$F$Y$$$20240822$$HP$TN$TN
236126412$23612641$2$F$20231116$20240907$20240308$20240925$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1100700$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
236126602$23612660$2$F$$20240821$20240308$20240917$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1100785$SUNOVION$$$$$$Y$$$20240917$$$US$US
236127142$23612714$2$F$$20240828$20240308$20240923$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1100902$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
236127272$23612727$2$F$$20240716$20240308$20240814$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1100924$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
236127514$23612751$4$F$20240101$20240806$20240308$20240812$PER$$US-PFIZER INC-202400059324$PFIZER$$57$YR$$M$Y$$$20240812$$HP$US$US
236128703$23612870$3$F$20240220$20240726$20240308$20240805$EXP$$ES-AURINIA PHARMACEUTICALS INC.-AUR-005365$AURINIA PHARMACEUTICALS$$$$$$Y$$$20240805$$MD$ES$ES
236128842$23612884$2$F$20231205$20240820$20240308$20240917$PER$$US-MYOVANT SCIENCES GMBH-2023MYSCI1200154$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
236129347$23612934$7$F$20240101$20240913$20240308$20240917$PER$$US-PFIZER INC-202400059655$PFIZER$$53$YR$$F$Y$54.43$KG$20240917$$CN$US$US
236130585$23613058$5$F$$20240710$20240308$20240710$PER$$US-PFIZER INC-PV202400032173$PFIZER$$78$YR$$F$Y$90.1$KG$20240710$$HP$US$US
236130702$23613070$2$F$20240722$20240724$20240308$20240731$EXP$$US-JAZZ-2019-US-003773$JAZZ$$42$YR$$F$Y$$$20240731$$HP$US$US
236130726$23613072$6$F$$20240715$20240308$20240719$EXP$$US-Taiho Oncology Inc-2023-000864$TAIHO ONCOLOGY INC$$$$A$F$Y$$$20240719$$CN$US$US
236130872$23613087$2$F$20231215$20240828$20240308$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-013558$BOEHRINGER INGELHEIM$$85$YR$E$F$Y$$$20240829$$CN$US$US
236131837$23613183$7$F$20230301$20240903$20240308$20240905$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-000272$JAZZ$$33$YR$$F$Y$$$20240905$$MD$US$US
236135332$23613533$2$F$$20240819$20240308$20240822$EXP$$AU-009507513-2403AUS001194$MERCK$$71$YR$$F$Y$$$20240822$$MD$AU$AU
236135732$23613573$2$F$20240302$20240708$20240309$20240709$PER$$US-AMGEN-USASP2024046429$AMGEN$$83$YR$E$M$Y$$$20240709$$CN$US$US
236135942$23613594$2$F$20240303$20240714$20240309$20240716$PER$$US-AMGEN-USASP2024048401$AMGEN$$53$YR$A$M$Y$$$20240716$$CN$US$US
236136133$23613613$3$F$20240201$20240701$20240309$20240708$PER$$US-SA-2024SA075075$SANOFI AVENTIS$$58$YR$A$F$Y$113.4$KG$20240708$$MD$US$US
236136144$23613614$4$F$20240201$20240830$20240309$20240904$EXP$$CA-JNJFOC-20240303961$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240904$$HP$CA$CA
236136492$23613649$2$F$20231201$20240809$20240309$20240812$PER$$US-AMGEN-USASP2024047495$AMGEN$$77$YR$E$M$Y$$$20240812$$CN$US$US
236136773$23613677$3$F$20240303$20240702$20240309$20240704$PER$$US-AMGEN-USASP2024049036$AMGEN$$47$YR$A$M$Y$$$20240704$$CN$US$US
236136963$23613696$3$F$20240303$20240822$20240309$20240824$PER$$US-AMGEN-USASP2024045368$AMGEN$$61$YR$A$M$Y$$$20240824$$CN$US$US
236137603$23613760$3$F$20240221$20240614$20240310$20240702$30DAY$$BR-JNJFOC-20240265906$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$BR$BR
236137665$23613766$5$F$20240304$20240722$20240310$20240731$30DAY$$US-GSK-US2024028522$GLAXOSMITHKLINE$$81$YR$$M$Y$$$20240731$$CN$US$US
236137822$23613782$2$F$$20240903$20240310$20240916$EXP$$US-AUROBINDO-AUR-APL-2024-009750$AUROBINDO$Zhang Y, Malik F. An Unfortunate Trio: Esophageal Kaposi Sarcoma, Immune Thrombocytopenia, And Uremia-Induced Platelet Dysfunction.. South-Med-J. 2022;115:539-540$46$YR$$M$Y$$$20240916$$MD$US$US
236138134$23613813$4$F$20240107$20240715$20240310$20240725$EXP$$BE-AUROBINDO-AUR-APL-2024-010216$AUROBINDO$$$$E$M$Y$104$KG$20240725$$MD$BE$BE
236138182$23613818$2$F$20240107$20240801$20240310$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-010522$AUROBINDO$$17$YR$$M$Y$$$20240809$$PH$FR$FR
236138223$23613822$3$F$20071001$20240813$20240310$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-010514$AUROBINDO$Machouart M, Debourgogne A, Vasbien M, Clement L, Collomb J, Plenat F, Salmon A, et al. Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature.. Clinical Microbiology and Infection. 2010;16 (5):508-12$38$YR$$F$Y$$$20240826$$HP$FR$FR
236138392$23613839$2$F$20231101$20240814$20240310$20240828$PER$$US-SA-2024SA074943$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240828$$MD$US$US
236138943$23613894$3$F$20230101$20240627$20240310$20240704$EXP$$US-SA-2024SA072106$SANOFI AVENTIS$$66$YR$E$F$Y$97.97$KG$20240704$$MD$US$US
236139193$23613919$3$F$$20240715$20240310$20240722$PER$$US-ALXN-202403USA000341US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
236139372$23613937$2$F$$20240809$20240310$20240817$PER$$US-SA-2024SA073919$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240817$$MD$US$US
236139443$23613944$3$F$20240303$20240714$20240310$20240716$PER$$US-AMGEN-USASP2024048140$AMGEN$$67$YR$E$M$Y$$$20240716$$CN$US$US
236139703$23613970$3$F$$20240911$20240310$20240914$30DAY$$US-SANDOZ INC.-SDZ2024US025638$SANDOZ$$$$$F$Y$$$20240914$$CN$US$US
236139744$23613974$4$F$$20240904$20240310$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US022918$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
236140423$23614042$3$F$$20240702$20240310$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038189$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240710$$CN$US$US
236141124$23614112$4$F$20240128$20240702$20240310$20240705$EXP$$CN-ABBVIE-5651971$ABBVIE$$29$YR$$F$Y$52$KG$20240705$$MD$CN$CN
236141674$23614167$4$F$20240204$20240802$20240310$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-037231$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240807$$MD$JP$JP
236141834$23614183$4$F$$20240911$20240310$20240915$EXP$$US-ABBVIE-5670838$ABBVIE$$$$$M$Y$71.667$KG$20240915$$CN$US$US
236142182$23614218$2$F$$20240710$20240310$20240717$EXP$$JP-009507513-2403JPN000702J$MERCK$$62$YR$$F$Y$$$20240717$$MD$JP$JP
236142273$23614227$3$F$20231021$20240701$20240310$20240704$EXP$$FR-JAZZ PHARMACEUTICALS-2023-FR-023559$JAZZ$$$$$$Y$$$20240704$$MD$FR$FR
236142312$23614231$2$F$$20240624$20240310$20240703$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-033906$BRISTOL MYERS SQUIBB$Salter B, Ge S, Khalaf D, Mccready E, Tam A, Butcher D, et al. Concurrent BCR::-ABL1 and CBFB rearrangement in de novo acute myeloid leukemia. Blood. 2023 Nov 02;142(Supplement 1):5866. doi:10.1182/blood-2023-186092.$62$YR$A$M$Y$$$20240703$$MD$CA$CA
236142393$23614239$3$F$$20240729$20240310$20240806$EXP$$US-ALXN-202403USA000300US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$HP$US$US
236143443$23614344$3$F$20240101$20240622$20240311$20240701$PER$$CA-TOLMAR, INC.-24CA047430$TOLMAR$$74$YR$$M$Y$$$20240701$$CN$CA$CA
236143682$23614368$2$F$$20240612$20240311$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000754$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240707$$CN$US$US
236143934$23614393$4$F$20240226$20240710$20240311$20240723$EXP$$JP-AMGEN-JPNSP2024047209$AMGEN$$82$YR$E$F$Y$31.5$KG$20240723$$MD$JP$JP
236144032$23614403$2$F$$20240829$20240311$20240910$PER$$US-SA-2024SA072483$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240910$$MD$US$US
236144074$23614407$4$F$$20240625$20240311$20240703$PER$$US-ALXN-202403USA000254US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
236144103$23614410$3$F$$20240822$20240311$20240828$EXP$$GB-TAKEDA-2024TUS021350$TAKEDA$$$$$F$Y$$$20240828$$CN$GB$GB
236144154$23614415$4$F$$20240607$20240311$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000750$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
236144312$23614431$2$F$20240124$20240626$20240311$20240704$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024025723$VIIV$$50$YR$$M$Y$$$20240704$$CN$US$US
236144603$23614460$3$F$20240226$20240814$20240311$20240822$EXP$$US-ALXN-202403USA000322US$ALEXION PHARMACEUTICALS$$68$YR$$F$Y$$$20240822$$CN$US$US
236144613$23614461$3$F$20240401$20240906$20240311$20240913$PER$$US-JAZZ PHARMACEUTICALS-2023-US-010690$JAZZ$$70$YR$$F$Y$$$20240913$$MD$US$US
236144875$23614487$5$F$20240211$20240614$20240311$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000730$ACADIA PHARMACEUTICALS$$9$YR$$F$Y$$$20240709$$CN$US$US
236144982$23614498$2$F$20240518$20240614$20240311$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000799$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240709$$HP$US$US
236144993$23614499$3$F$$20240619$20240311$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01744$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236145093$23614509$3$F$20240101$20240806$20240311$20240809$EXP$$US-ABBVIE-5618395$ABBVIE$$$$$M$Y$86.182$KG$20240809$$CN$US$US
236145143$23614514$3$F$20231227$20240909$20240311$20240920$EXP$$IT-AUROBINDO-AUR-APL-2024-000953$AUROBINDO$$58$YR$$M$Y$72$KG$20240920$$HP$IT$IT
236145313$23614531$3$F$$20240708$20240311$20240715$PER$$US-SA-2024SA072436$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240715$$MD$US$US
236145508$23614550$8$F$20230926$20240821$20240311$20240903$EXP$$US-UCBSA-2024010939$UCB$$32$YR$$M$Y$76.19$KG$20240903$$CN$US$US
236146363$23614636$3$F$$20240619$20240311$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01873$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236146372$23614637$2$F$$20240620$20240311$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01872$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236146402$23614640$2$F$$20240620$20240311$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01899$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236146412$23614641$2$F$$20240801$20240311$20240806$EXP$$CA-TAKEDA-2018TUS036745$TAKEDA$$$$$M$Y$$$20240806$$CN$CA$CA
236147504$23614750$4$F$$20240904$20240311$20240913$EXP$$CA-TAKEDA-2024TUS021241$TAKEDA$$$$$M$Y$$$20240913$$CN$CA$CA
236147542$23614754$2$F$20240218$20240308$20240311$20240821$EXP$IT-MINISAL02-973484$IT-JNJFOC-20240322876$JOHNSON AND JOHNSON$$79$YR$E$M$Y$75$KG$20240821$$MD$IT$IT
236147583$23614758$3$F$$20240619$20240311$20240703$30DAY$$CA-JNJFOC-20240262257$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$CA$CA
236147652$23614765$2$F$20220804$20240805$20240311$20240812$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-002751$AMGEN$$65$YR$E$F$Y$$$20240811$$MD$US$US
236147873$23614787$3$F$20200301$20240702$20240311$20240705$EXP$$CA-TAKEDA-2024TUS021673$TAKEDA$$57$YR$$F$Y$$$20240705$$MD$CA$CA
236148295$23614829$5$F$20240101$20240709$20240311$20240715$EXP$$CA-TAKEDA-2024TUS021016$TAKEDA$$45$YR$$M$Y$$$20240715$$MD$CA$CA
236148382$23614838$2$F$$20240802$20240311$20240813$PER$$US-SA-2024SA072425$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
236148473$23614847$3$F$20231208$20240806$20240311$20240809$EXP$$CA-JNJFOC-20240110852$JOHNSON AND JOHNSON$$45$YR$A$F$Y$113$KG$20240809$$HP$CA$CA
236148572$23614857$2$F$$20240925$20240311$20240930$EXP$$CA-SANDOZ INC.-SDZ2024CA025446$SANDOZ$$$$$F$Y$$$20240930$$CN$CA$CA
236148734$23614873$4$F$20240215$20240912$20240311$20240918$EXP$$JP-GSK-JP2024JPN029304$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$PH$JP$JP
236148822$23614882$2$F$$20240816$20240311$20240829$PER$$US-SA-2024SA072218$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240829$$MD$US$US
236148844$23614884$4$F$20240831$20240904$20240311$20240917$PER$$US-SA-2024SA052032$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240918$$MD$US$US
236148932$23614893$2$F$20240101$20240621$20240311$20240702$PER$$US-SA-2024SA076696$SANOFI AVENTIS$$$$E$F$Y$$$20240702$$MD$US$US
236148992$23614899$2$F$$20240906$20240311$20240920$PER$$US-SA-2024SA073109$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240920$$MD$US$US
236149222$23614922$2$F$20230101$20240822$20240311$20240916$PER$$US-SA-2024SA076748$SANOFI AVENTIS$$47$YR$A$F$Y$130$KG$20240916$$MD$US$US
236149452$23614945$2$F$20230701$20240708$20240311$20240712$EXP$$CA-ABBVIE-5450185$ABBVIE$$39$YR$$M$Y$$$20240712$$CN$CA$CA
236149682$23614968$2$F$20240209$20240613$20240311$20240701$30DAY$$AU-JNJFOC-20240243245$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$AU$AU
236149743$23614974$3$F$20240306$20240905$20240311$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001042$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240916$$CN$US$US
236149864$23614986$4$F$$20240703$20240311$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037894$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$104.2$KG$20240705$$CN$US$US
236149953$23614995$3$F$20240101$20240802$20240311$20240812$PER$$US-SA-2024SA077133$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240812$$MD$US$US
236149964$23614996$4$F$$20240722$20240311$20240731$PER$$US-SA-2024SA072911$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240731$$HP$US$US
236150283$23615028$3$F$20240101$20240812$20240311$20240813$PER$$US-JNJFOC-20240255259$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240813$$CN$US$US
236150333$23615033$3$F$$20240621$20240311$20240808$PER$$US-ABBVIE-5667207$ABBVIE$$$$A$F$Y$$$20240808$$HP$US$US
236150733$23615073$3$F$$20240807$20240311$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202403003613$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240813$$MD$US$US
236151472$23615147$2$F$20211201$20240822$20240311$20240830$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-002756$AMGEN$$79$YR$E$F$Y$$$20240830$$LW$US$US
236151753$23615175$3$F$20180221$20240712$20240311$20240722$EXP$$DE-CELLTRION INC.-2019DE019133$CELLTRION$$$$$$Y$$$20240722$$HP$DE$DE
236151872$23615187$2$F$$20240722$20240311$20240801$30DAY$$US-GSK-US2024027768$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
236151932$23615193$2$F$$20240708$20240311$20240715$EXP$$JP-009507513-2403JPN000177J$MERCK$$68$YR$$F$Y$$$20240715$$MD$JP$JP
236151943$23615194$3$F$20240101$20240827$20240311$20240905$EXP$$JP-009507513-2403JPN000188J$MERCK$$$$$F$Y$$$20240905$$MD$JP$JP
236152023$23615202$3$F$$20240802$20240311$20240808$PER$$US-ABBVIE-5667871$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
236152282$23615228$2$F$20240302$20240701$20240311$20240702$PER$$US-AMGEN-USASP2024047027$AMGEN$$82$YR$E$F$Y$$$20240702$$CN$US$US
236152478$23615247$8$F$20240101$20240913$20240311$20240923$EXP$$CA-CELLTRION INC.-2024CA005673$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
236152663$23615266$3$F$$20240903$20240311$20240912$EXP$$PT-CELLTRION INC.-2024PT005404$CELLTRION$$$$$$Y$$$20240912$$HP$PT$PT
236152993$23615299$3$F$$20240813$20240311$20240819$EXP$$BE-BEH-2023166289$CSL BEHRING$$$$A$M$Y$$$20240819$$HP$BE$BE
236153334$23615333$4$F$$20240916$20240311$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-010628$AUROBINDO$Nevez G, Guillerm G, Talarmin JP, Quinio D, Iriart X, Lissillour PL, et.al.. Hormographiella aspergillata pulmonary infections: Detection and identification of the fungus using pan-fungal PCR assays and DNA sequencing.. Journal of Medical Mycology. 2024;34(1):101463$30$YR$$F$Y$$$20240926$$MD$FR$FR
236153903$23615390$3$F$$20240919$20240311$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038318$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240923$$CN$US$US
236154072$23615407$2$F$$20240624$20240311$20240703$30DAY$$KR-JNJFOC-20240272094$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$KR$KR
2361549311$23615493$11$F$20240221$20240913$20240311$20240919$EXP$$CA-TAKEDA-2024TUS017705$TAKEDA$$4$YR$$F$Y$$$20240919$$CN$CA$CA
236155058$23615505$8$F$20240527$20240823$20240311$20240826$EXP$$CA-TAKEDA-2024TUS002191$TAKEDA$$45$YR$$F$Y$$$20240826$$CN$CA$CA
236155123$23615512$3$F$$20240705$20240311$20240709$PER$$US-ALXN-202403USA000412US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240709$$CN$US$US
236155262$23615526$2$F$20240229$20240913$20240311$20240923$EXP$$US-BEH-2024169437$CSL BEHRING$$12$YR$T$M$Y$$$20240923$$HP$US$US
236155612$23615561$2$F$$20240712$20240311$20240724$30DAY$$KR-JNJFOC-20240268566$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$KR$KR
236155955$23615595$5$F$20240829$20240913$20240311$20240917$EXP$$JP-TAKEDA-2024TJP003544$TAKEDA$$8$DEC$$M$Y$$$20240917$$MD$JP$JP
236156184$23615618$4$F$20240129$20240725$20240311$20240801$EXP$$CA-GSK-CA2023152121$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$HP$CA$CA
236156263$23615626$3$F$$20240705$20240311$20240711$EXP$$JP-009507513-2403JPN000531J$MERCK$$6$DEC$$F$Y$$$20240711$$MD$JP$JP
236156483$23615648$3$F$$20240905$20240311$20240912$EXP$$CA-GSK-CA2024029066$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$CA$CA
236156923$23615692$3$F$$20240708$20240311$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038312$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240729$$CN$US$US
236158003$23615800$3$F$$20240812$20240311$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038415$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$95.71$KG$20240813$$CN$US$US
236158472$23615847$2$F$20230101$20240906$20240311$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202403003637$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240911$$CN$US$US
236159492$23615949$2$F$$20240620$20240311$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01913$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236159512$23615951$2$F$$20240620$20240311$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01911$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236159522$23615952$2$F$$20240620$20240311$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01927$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236159532$23615953$2$F$$20240620$20240311$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01918$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236159542$23615954$2$F$$20240620$20240311$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01910$LUPIN$$$$$$Y$$$20240702$$PH$US$US
236159552$23615955$2$F$$20240620$20240311$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01928$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236159612$23615961$2$F$20210806$20240822$20240311$20240829$EXP$$US-HORIZON THERAPEUTICS-HZN-2021-006772$AMGEN$$50$YR$A$F$Y$$$20240829$$CN$US$US
236159932$23615993$2$F$20240303$20240714$20240311$20240716$PER$$US-AMGEN-USASP2024047871$AMGEN$$63$YR$A$M$Y$$$20240715$$CN$US$US
236160292$23616029$2$F$$20240620$20240311$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01916$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236160624$23616062$4$F$$20240918$20240311$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037813$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240919$$CN$US$US
236160783$23616078$3$F$20211014$20240821$20240311$20240827$EXP$$JP-GILEAD-2024-0664443$GILEAD$$3$DEC$A$M$Y$$$20240827$$MD$JP$JP
236160832$23616083$2$F$$20240626$20240311$20240702$EXP$$US-CHATTEMPRD-2024OHG007352$CHATTEM$$79$YR$E$M$Y$$$20240702$$LW$US$US
236161382$23616138$2$F$$20240301$20240311$20240711$EXP$$DK-EMD Serono-2024011750$EMD SERONO INC$$33$YR$A$F$Y$$$20240711$$MD$DK$DK
236161433$23616143$3$F$20240213$20240710$20240311$20240712$EXP$$JP-ASTELLAS-2024JP001753$ASTELLAS$$79$YR$$M$Y$$$20240712$$MD$JP$JP
236162243$23616224$3$F$$20240103$20240311$20240923$PER$$PK-ROCHE-3485551$ROCHE$$45$YR$A$F$Y$$$20240923$$CN$PK$PK
236162312$23616231$2$F$20201001$20240916$20240311$20240920$EXP$GB-MHRA-ADR 27092216$GB-SANDOZ INC.-NVSC2021GB155461$SANDOZ$$68$YR$$F$Y$92$KG$20240920$$MD$GB$GB
236162433$23616243$3$F$$20240705$20240311$20240711$EXP$$JP-009507513-2403JPN000530J$MERCK$$8$DEC$$F$Y$$$20240711$$MD$JP$JP
236162542$23616254$2$F$20230906$20240822$20240311$20240830$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-002755$AMGEN$$55$YR$A$F$Y$$$20240829$$LW$US$US
236162633$23616263$3$F$20240124$20240711$20240311$20240716$EXP$$JP-DSJP-DSJ-2024-110398$DAIICHI$$89$YR$$F$Y$32$KG$20240716$$MD$JP$JP
236163303$23616330$3$F$$20240312$20240311$20240808$EXP$$NVSC2024US047518$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
236163552$23616355$2$F$20240101$20240712$20240311$20240722$PER$$US-SA-2024SA075334$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240720$$MD$US$US
236164052$23616405$2$F$$20240726$20240311$20240806$PER$$US-SA-2024SA075268$SANOFI AVENTIS$$6$YR$C$M$Y$59$KG$20240806$$MD$US$US
236164182$23616418$2$F$$20240624$20240311$20240703$PER$$US-SA-2024SA075985$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240703$$MD$US$US
236164442$23616444$2$F$$20240830$20240311$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US023479$SANDOZ$$$$$M$Y$$$20240904$$HP$US$US
236164474$23616447$4$F$20161104$20240904$20240311$20240912$EXP$$JP-GILEAD-2024-0664605$GILEAD$Shibutani K, Mori N. ?PICTURES IN CLINICAL MEDICINE? A Surviving Case of Progressive Multifocal Leukoencephalopathy. Internal?Medicine. 2024;63(4):625-626. doi:10.2169/internalmedicine.2049-23$46$YR$A$M$Y$66.3$KG$20240912$$MD$JP$JP
236164785$23616478$5$F$20180206$20240916$20240311$20240924$EXP$$CA-TAKEDA-2022TUS077838$TAKEDA$$51$YR$$M$Y$$$20240924$$HP$CA$CA
236165462$23616546$2$F$20240306$20240725$20240311$20240726$PER$$US-AMGEN-USASP2024048505$AMGEN$$51$YR$A$M$Y$$$20240726$$PH$US$US
236165824$23616582$4$F$$20240916$20240311$20240923$EXP$$CA-GSK-CA2023AMR088737$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$CA$CA
236166122$23616612$2$F$20240311$20240731$20240311$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-013767$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$$$20240731$$CN$US$US
236166213$23616621$3$F$20240201$20240628$20240311$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037506$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240701$$CN$US$US
236166344$23616634$4$F$20231001$20240709$20240311$20240718$EXP$$NZ-009507513-2403NZL001968$MERCK$$52$YR$$M$Y$129$KG$20240718$$MD$NZ$NZ
236166763$23616676$3$F$20210701$20240819$20240311$20240826$EXP$$BA-PFIZER INC-PV202400032916$PFIZER$Hadzibeganovic, A.. Toxic Cardiomyopathy in a Young Patient Treated for Her2-Positive Early Breast Cancer: Case Report and Literature Review. Acta medica academica. 2023;52(3):225-230$38$YR$$F$Y$$$20240826$$MD$BA$BA
236166812$23616681$2$F$$20230821$20240311$20240814$EXP$$NVSC2023BR129895$NOVARTIS$$$$$F$Y$$$20240814$$HP$BR$BR
236167772$23616777$2$F$20240304$20240712$20240311$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038351$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240717$$CN$US$US
236167792$23616779$2$F$$20240812$20240311$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038533$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240815$$CN$US$US
236168273$23616827$3$F$20240201$20240822$20240311$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037804$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$99.79$KG$20240827$$CN$US$US
236168314$23616831$4$F$20231201$20240606$20240311$20240920$EXP$FR-AFSSAPS-DJ2024000106$FR-Ipsen Biopharmaceuticals, Inc.-2024-03416$IPSEN$$79$YR$E$F$Y$88$KG$20240920$$MD$FR$FR
236168438$23616843$8$F$20170101$20240820$20240311$20240826$PER$$US-BIOGEN-2024BI01253719$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
236168445$23616844$5$F$$20240703$20240311$20240709$PER$$US-BIOGEN-2024BI01253320$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
236169912$23616991$2$F$20240201$20240805$20240311$20240806$EXP$FR-AFSSAPS-RE2024000206$FR-SANDOZ INC.-SDZ2024FR025916$SANDOZ$$69$YR$$M$Y$$$20240806$$PH$FR$FR
236170264$23617026$4$F$$20240728$20240311$20240802$EXP$$IL-TAKEDA-2023TUS025728$TAKEDA$$$$$F$Y$$$20240802$$CN$IL$IL
236170372$23617037$2$F$$20240716$20240311$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-034590$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$73$KG$20240726$$MD$CA$CA
236170622$23617062$2$F$20231221$20240819$20240311$20240827$EXP$$CA-GSK-CA2024001041$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$PH$CA$CA
236170707$23617070$7$F$20231220$20240815$20240311$20240823$EXP$$CA-TAKEDA-2023TUS122445$TAKEDA$$2$YR$$M$Y$$$20240823$$HP$CA$CA
236171052$23617105$2$F$$20240715$20240311$20240722$EXP$$CA-FreseniusKabi-FK202403682$FRESENIUS KABI$$$$$F$Y$$$20240719$$HP$CA$CA
236171382$23617138$2$F$20240215$20240618$20240311$20240702$30DAY$$US-JNJFOC-20240257741$JOHNSON AND JOHNSON$$64$YR$A$F$Y$79.45$KG$20240702$$CN$US$US
236171542$23617154$2$F$$20240816$20240311$20240821$EXP$$US-MYLANLABS-2024M1021428$MYLAN$$$$$M$Y$$$20240821$$HP$US$US
236172112$23617211$2$F$$20240229$20240311$20240923$PER$$CN-ROCHE-3519378$ROCHE$Liu Z, Wang F, Zhang Y, Lu J and Yang Y. Combination treatment with anti-HER2 therapeutic antibody RC48, PD-1 inhibitor, radiotherapy, and granulocyte macrophage-colony stimulating factor (GM-CSF) in patient with metastatic gastric cancer: a case report. Frontiers in Immunology. DOI: 10.3389/fimmu.2024.1321946 2024;15:-.$$$$$Y$$$20240923$$HP$CN$CN
236173012$23617301$2$F$20240607$20240710$20240311$20240720$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-043526$REGENERON$$81$YR$$M$Y$$$20240719$$HP$CO$CO
236173113$23617311$3$F$20240124$20240827$20240311$20240905$EXP$$CA-BEH-2024169374$CSL BEHRING$$81$YR$E$M$Y$$$20240905$$HP$CA$CA
236173232$23617323$2$F$20231213$20240704$20240311$20240713$EXP$FR-AFSSAPS-DJ2024000205$FR-TEVA-VS-3165404$TEVA$$62$YR$$M$Y$75$KG$20240713$$MD$FR$FR
236173684$23617368$4$F$$20240702$20240311$20240710$EXP$$US-TEVA-VS-3165243$TEVA$Niu I,Hsiao E,Wustrack R,Wysolmerski J,Dann P,Masharani U. A Case of Hypercalcemia From PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy. Journal of the Endocrine Society 6: A212-A213, Nov-Dec 2022.].; Niu I, Hsiao EC, Wustrack R, Wysolmerski JJ, Dann P, Masharani U. A Case of Hypercalcemia from PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy. Calcif-Tissue-Int 2023; 113 (2): 246-253.; Niu I, Hsiao EC, Wustrack R, Wysolmerski JJ, Dann P, Mashar...$70$YR$$M$Y$$$20240710$$MD$US$US
236174113$23617411$3$F$20240109$20240730$20240311$20240808$EXP$CZ-CZSUKL-24000371$CZ-TEVA-VS-3166450$TEVA$$72$YR$$F$Y$75$KG$20240808$$MD$CZ$CZ
236174342$23617434$2$F$$20240815$20240311$20240822$EXP$$SE-EMD Serono-2024013178$EMD SERONO INC$$$$A$F$Y$$$20240822$$CN$SE$SE
236174542$23617454$2$F$20230709$20240716$20240311$20240730$EXP$$US-Kiniksa Pharmaceuticals Ltd.-2023KPU000840$KINIKSA PHARMACEUTICALS$$25$YR$A$M$Y$$$20240727$$MD$US$US
236174592$23617459$2$F$$20240229$20240311$20240926$PER$$US-GSK-US2024AMR027226$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
236174754$23617475$4$F$20240201$20240909$20240311$20240919$EXP$$US-GSK-US2024AMR027385$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240919$$CN$US$US
236174767$23617476$7$F$20240402$20240813$20240311$20240820$EXP$$US-GSK-US2024AMR027466$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240820$$HP$US$US
236174792$23617479$2$F$20240228$20240805$20240311$20240815$EXP$$US-GSK-US2024AMR027839$GLAXOSMITHKLINE$$47$YR$$F$Y$62.132$KG$20240815$$CN$US$US
236175244$23617524$4$F$20240220$20240626$20240311$20240704$EXP$$US-BEH-2024169685$CSL BEHRING$$17$YR$T$M$Y$$$20240704$$MD$US$US
236175602$23617560$2$F$20240225$20240702$20240311$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037150$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240712$$PH$US$US
236175622$23617562$2$F$$20240815$20240311$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037601$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$81.19$KG$20240819$$CN$US$US
236175662$23617566$2$F$20240221$20240920$20240311$20240930$EXP$$US-TEVA-VS-3168606$TEVA$$17$YR$$M$Y$$$20240930$$HP$US$US
236175952$23617595$2$F$$20240805$20240311$20240813$PER$$US-SA-2024SA073339$SANOFI AVENTIS$$$$C$M$Y$14$KG$20240814$$MD$US$US
236176163$23617616$3$F$20240201$20240722$20240311$20240731$PER$$US-SA-2024SA074710$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240731$$MD$US$US
236176173$23617617$3$F$20240101$20240719$20240311$20240731$PER$$US-SA-2024SA077127$SANOFI AVENTIS$$64$YR$A$F$Y$95.254$KG$20240731$$MD$US$US
236176232$23617623$2$F$20230228$20240711$20240311$20240801$PER$$US-SA-2024SA074524$SANOFI AVENTIS$$56$YR$A$M$Y$95$KG$20240719$$MD$US$US
236176382$23617638$2$F$20240101$20240801$20240311$20240810$PER$$US-SA-2024SA075187$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240810$$MD$US$US
236176392$23617639$2$F$20240111$20240912$20240311$20240916$EXP$$NVSC2024GB011658$NOVARTIS$$48$YR$$F$Y$$$20240916$$CN$GB$GB
236176542$23617654$2$F$$20240723$20240311$20240801$PER$$US-SA-2024SA073204$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240801$$MD$US$US
236176582$23617658$2$F$20240701$20240710$20240311$20240718$PER$$US-SA-2024SA073216$SANOFI AVENTIS$$30$YR$A$F$Y$98.88$KG$20240718$$MD$US$US
236176693$23617669$3$F$20240101$20240814$20240311$20240828$PER$$US-SA-2024SA076054$SANOFI AVENTIS$$86$YR$E$M$Y$86.18$KG$20240828$$MD$US$US
236176783$23617678$3$F$20240101$20240816$20240311$20240826$PER$$US-SA-2024SA074374$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240826$$MD$US$US
236176873$23617687$3$F$20240301$20240627$20240311$20240708$PER$$US-SA-2024SA074453$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240708$$MD$US$US
236176962$23617696$2$F$$20240624$20240311$20240702$PER$$US-SA-2024SA077519$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240702$$MD$US$US
236177203$23617720$3$F$20240101$20240831$20240311$20240905$EXP$$US-MYLANLABS-2024M1008706$MYLAN$$91$YR$$F$Y$54.9$KG$20240905$$CN$US$US
236177282$23617728$2$F$20240101$20240819$20240311$20240829$PER$$US-SA-2024SA078043$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240829$$MD$US$US
236177462$23617746$2$F$20240101$20240828$20240311$20240911$PER$$US-SA-2024SA078332$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240911$$MD$US$US
236177742$23617774$2$F$20230701$20240913$20240311$20240923$PER$$US-SA-2023SA396339$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240923$$MD$US$US
236177804$23617780$4$F$20240701$20240807$20240311$20240814$EXP$$US-SA-2024SA078475$SANOFI AVENTIS$$68$YR$E$F$Y$61.2$KG$20240814$$MD$US$US
236177892$23617789$2$F$$20240730$20240311$20240808$PER$$US-SA-2024SA077961$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240808$$MD$US$US
236177962$23617796$2$F$$20240626$20240311$20240705$PER$$US-SA-2024SA077451$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240705$$MD$US$US
236178002$23617800$2$F$$20240912$20240311$20240920$PER$$US-SA-2024SA077679$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240920$$MD$US$US
236178103$23617810$3$F$$20240729$20240311$20240807$PER$$US-SA-2024SA077709$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240807$$MD$US$US
236178114$23617811$4$F$20231211$20240807$20240311$20240816$PER$$US-SA-2024SA078067$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240816$$MD$US$US
236178172$23617817$2$F$20240701$20240715$20240311$20240723$PER$$US-SA-2024SA077436$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240723$$MD$US$US
236178194$23617819$4$F$20240101$20240912$20240311$20240918$EXP$$US-SA-2024SA077535$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240918$$MD$US$US
236178382$23617838$2$F$20230101$20240703$20240311$20240708$PER$$US-SA-2023SA355845$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240708$$MD$US$US
236178514$23617851$4$F$20240201$20240807$20240311$20240816$PER$$US-SA-2024SA075228$SANOFI AVENTIS$$25$YR$A$F$Y$60$KG$20240816$$MD$US$US
236178752$23617875$2$F$$20240826$20240311$20240903$EXP$$JP-JNJFOC-20240316557$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240903$$MD$JP$JP
236178964$23617896$4$F$20240302$20240917$20240311$20240919$EXP$$NVSC2024US050743$NOVARTIS$$62$YR$$F$Y$$$20240919$$CN$US$US
236179062$23617906$2$F$$20240910$20240311$20240918$PER$$US-SA-2024SA073979$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240918$$MD$US$US
236179153$23617915$3$F$20240101$20240626$20240311$20240703$EXP$$US-GSK-US2024028505$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$US$US
236179222$23617922$2$F$$20240708$20240311$20240717$EXP$$US-UCBSA-2024011128$UCB$$$$$F$Y$$$20240717$$HP$US$US
236179942$23617994$2$F$20240101$20240703$20240311$20240712$PER$$US-SA-2024SA077515$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240712$$MD$US$US
236180092$23618009$2$F$20240216$20240305$20240311$20240705$EXP$$RU-SA-2024SA077632$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240705$$MD$RU$RU
236180263$23618026$3$F$20210517$20240923$20240311$20240924$EXP$FR-AFSSAPS-AM2024000147$NVSC2024FR048422$NOVARTIS$$62$YR$$M$Y$$$20240924$$MD$FR$FR
236180383$23618038$3$F$$20240620$20240311$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01915$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236180494$23618049$4$F$20220901$20240910$20240311$20240921$EXP$$US-UCBSA-2024011115$UCB$$62$YR$$M$Y$$$20240921$$HP$US$US
236180725$23618072$5$F$20240305$20240711$20240311$20240712$EXP$$GB-MYLANLABS-2024M1021509$MYLAN$$52$YR$$M$Y$88$KG$20240712$$CN$GB$GB
236180742$23618074$2$F$$20240712$20240311$20240716$PER$$US-PFIZER INC-PV202400032689$PFIZER$$60$YR$$F$Y$$$20240716$$CN$US$US
236180833$23618083$3$F$20240207$20240805$20240311$20240807$PER$$US-PFIZER INC-202400059523$PFIZER$$51$YR$$F$Y$$$20240807$$CN$US$US
236180992$23618099$2$F$$20240619$20240311$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01912$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236181163$23618116$3$F$20220914$20240902$20240311$20240909$EXP$$SA-GSK-SA2022EME135427$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$MD$SA$SA
236181424$23618142$4$F$$20240819$20240311$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038563$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240827$$CN$US$US
236181652$23618165$2$F$20240201$20240627$20240311$20240703$EXP$$JP-Eisai-EC-2024-160772$EISAI$$$$E$$Y$$$20240703$$MD$JP$JP
236181683$23618168$3$F$20240101$20240806$20240311$20240814$PER$$US-SA-2024SA074102$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240814$$MD$US$US
236181802$23618180$2$F$$20240703$20240311$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038584$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$63.7$KG$20240705$$CN$US$US
236181943$23618194$3$F$20231101$20240905$20240311$20240909$EXP$$US-PFIZER INC-202300362028$PFIZER$$22$YR$$M$Y$77$KG$20240909$$HP$US$US
236182186$23618218$6$F$$20240731$20240311$20240813$EXP$$CA-PFIZER INC-202400056877$PFIZER$$43$YR$$F$Y$96$KG$20240813$$HP$CA$CA
236182833$23618283$3$F$20240101$20240808$20240311$20240821$PER$$US-SA-2024SA074441$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240821$$MD$US$US
236182894$23618289$4$F$20240117$20240913$20240311$20240923$EXP$$JP-ABBVIE-5671938$ABBVIE$$69$YR$$M$Y$53$KG$20240923$$MD$JP$JP
236183224$23618322$4$F$20240601$20240703$20240311$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038815$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240704$$CN$US$US
236183864$23618386$4$F$$20240726$20240311$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038866$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240729$$CN$US$US
236183993$23618399$3$F$20240207$20240726$20240311$20240729$EXP$$BE-SANDOZ INC.-SDZ2024BE024163$SANDOZ$$74$YR$$M$Y$85$KG$20240729$$MD$BE$BE
236184183$23618418$3$F$$20240306$20240311$20240909$PER$$NVSC2024US051750$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
236184273$23618427$3$F$20230301$20240909$20240311$20240911$EXP$$DE-SANDOZ INC.-SDZ2024DE025807$SANDOZ$$52$YR$$M$Y$$$20240911$$MD$DE$DE
236184734$23618473$4$F$20240101$20240906$20240311$20240917$PER$$US-TRAVERE-2024TVT00223$TRAVERE THERAPEUTICS$$55$YR$A$F$Y$$$20240917$$CN$US$US
236184816$23618481$6$F$20240214$20240816$20240311$20240825$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038849$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240826$$CN$US$US
236184876$23618487$6$F$20221201$20240812$20240311$20240812$EXP$$NL-SANDOZ INC.-SDZ2024NL025907$SANDOZ$$17$YR$$F$Y$$$20240812$$MD$NL$NL
236184997$23618499$7$F$20210101$20240724$20240311$20240725$EXP$$CA-SANDOZ INC.-SDZ2023CA036364$SANDOZ$$$$$M$Y$$$20240725$$MD$CA$CA
236185322$23618532$2$F$20240201$20240906$20240311$20240910$PER$$US-PFIZER INC-PV202400033164$PFIZER$$56$YR$$F$Y$$$20240910$$HP$US$US
236185363$23618536$3$F$$20240911$20240311$20240913$EXP$$US-PFIZER INC-202400058057$PFIZER$$33$YR$$M$Y$$$20240913$$CN$US$US
236185443$23618544$3$F$$20240624$20240311$20240701$PER$$US-PFIZER INC-202400059646$PFIZER$$29$YR$$M$Y$$$20240701$$CN$US$US
236185462$23618546$2$F$$20240722$20240311$20240723$PER$$US-PFIZER INC-PV202400032708$PFIZER$$76$YR$$M$Y$$$20240723$$CN$US$US
236185542$23618554$2$F$$20240716$20240311$20240717$PER$$US-PFIZER INC-PV202400024473$PFIZER$$50$YR$$F$Y$$$20240717$$HP$US$US
236185723$23618572$3$F$20231227$20240705$20240311$20240715$EXP$IT-MINISAL02-964798$IT-TEVA-VS-3165192$TEVA$$15$YR$$F$Y$83$KG$20240715$$PH$IT$IT
236185743$23618574$3$F$$20240710$20240311$20240716$PER$$NVSC2024US052245$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
236185763$23618576$3$F$$20240718$20240311$20240815$PER$$US-TRAVERE-2024TVT00221$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$CN$US$US
236186433$23618643$3$F$$20240712$20240311$20240715$PER$$US-PFIZER INC-PV202400029357$PFIZER$$63$YR$$F$Y$$$20240715$$HP$US$US
236186482$23618648$2$F$$20240827$20240311$20240830$PER$$US-PFIZER INC-PV202400004813$PFIZER$$58$YR$$F$Y$$$20240830$$HP$US$US
236186504$23618650$4$F$$20240725$20240311$20240730$PER$$US-PFIZER INC-202400060628$PFIZER$$13$YR$$M$Y$$$20240730$$HP$US$US
236186803$23618680$3$F$20200401$20240730$20240311$20240808$EXP$$AT-TEVA-VS-3164784$TEVA$$51$YR$$M$Y$73$KG$20240808$$MD$AT$AT
236186914$23618691$4$F$20230818$20240708$20240311$20240716$EXP$$US-ABBVIE-5674237$ABBVIE$$81$YR$$F$Y$$$20240716$$CN$US$US
236186922$23618692$2$F$$20240725$20240311$20240730$EXP$$CA-PURDUE-USA-2024-0308244$PURDUE$$44$YR$$F$Y$97$KG$20240730$$HP$CA$CA
236187204$23618720$4$F$20240306$20240919$20240311$20240925$EXP$$CA-PFIZER INC-202300260189$PFIZER$$35$YR$$F$Y$80$KG$20240925$$MD$CA$CA
236187295$23618729$5$F$20240101$20240810$20240311$20240812$EXP$$CA-PFIZER INC-202400058569$PFIZER$$76$YR$$F$Y$$$20240812$$HP$CA$CA
236187753$23618775$3$F$20220707$20240911$20240311$20240913$EXP$$US-PFIZER INC-PV202300189648$PFIZER$$78$YR$$M$Y$78.912$KG$20240913$$CN$US$US
236187813$23618781$3$F$20240301$20240722$20240311$20240725$PER$$US-PFIZER INC-PV202400032835$PFIZER$$86$YR$$F$Y$67.13$KG$20240725$$CN$US$US
236188203$23618820$3$F$$20240828$20240311$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038850$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240830$$CN$US$US
236188513$23618851$3$F$$20240624$20240311$20240701$PER$$US-PFIZER INC-PV202400033345$PFIZER$$71$YR$$F$Y$$$20240701$$CN$US$US
236188653$23618865$3$F$20221001$20240628$20240311$20240708$EXP$$CZ-MYLANLABS-2024M1017051$MYLAN$Kolarova Z.. How to get the most out of high-line treatment for colorectal cancer and pancreatic cancer. MEDICAL TRIBUNE. 2024;20(2):D3-D4$68$YR$$F$Y$56$KG$20240708$$MD$CZ$CZ
236188814$23618881$4$F$$20240812$20240311$20240820$PER$$US-AMGEN-USASP2024046000$AMGEN$Citta A.; Alford C.; Lynch E. et al.. Avatrombopag Safe and Effective in Treatment of Severe Refractory Thrombocytopenia in a Pediatric Patient with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2024;30 (2):S423$14$YR$T$M$Y$$$20240820$$HP$US$US
236190088$23619008$8$F$20230420$20240730$20240311$20240802$EXP$$DE-PFIZER INC-202400059530$PFIZER$$49$YR$$F$Y$95$KG$20240802$$HP$DE$DE
236190244$23619024$4$F$20240204$20240701$20240311$20240709$EXP$$CH-JAZZ PHARMACEUTICALS-2024-CH-004155$JAZZ$$64$YR$$M$Y$65$KG$20240709$$HP$CH$CH
236191182$23619118$2$F$20240601$20240626$20240311$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036267$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$61.69$KG$20240701$$CN$US$US
236191346$23619134$6$F$20240101$20240909$20240311$20240912$EXP$$US-AMGEN-USASP2024049105$AMGEN$$77$YR$E$M$Y$$$20240912$$CN$US$US
236191702$23619170$2$F$$20240710$20240311$20240718$EXP$$JP-009507513-2403JPN000719J$MERCK$$63$YR$$F$Y$$$20240718$$MD$JP$JP
236192312$23619231$2$F$$20240724$20240311$20240801$EXP$$GB-AstraZeneca-2022A403087$ASTRAZENECA$$$$$$Y$$$20240801$$MD$GB$
236192385$23619238$5$F$20240601$20240918$20240311$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038071$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240925$$HP$US$US
236192523$23619252$3$F$$20240719$20240311$20240806$EXP$$US-ALXN-202403USA000397US$ALEXION PHARMACEUTICALS$$$$$M$Y$61.2$KG$20240806$$MD$US$US
236192562$23619256$2$F$20240302$20240730$20240311$20240801$PER$$US-AMGEN-USASP2024049380$AMGEN$$67$YR$E$M$Y$$$20240801$$CN$US$US
236193263$23619326$3$F$$20240903$20240311$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-036803$BRISTOL MYERS SQUIBB$Kimura Y, Takakuwa T, Okamura H, Nishimoto M, Nakashima Y, Nakamae M. Well-controlled multiple myeloma treated with isatuximab/dexamethasone therapy after two times of ICU management. The 119th Kinki Regional Meeting of the Japanese Society of Hematology (Program and Abstracts). 2023;33.$53$YR$A$F$Y$$$20240911$$MD$JP$JP
236193353$23619335$3$F$20230101$20240827$20240311$20240830$EXP$$US-ABBVIE-5671745$ABBVIE$$69$YR$$F$Y$69$KG$20240830$$CN$US$US
236193532$23619353$2$F$$20240613$20240311$20240707$30DAY$$DE-JNJFOC-20240272232$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$CN$DE$DE
236193833$23619383$3$F$20240116$20240624$20240311$20240702$EXP$$JP-009507513-2402JPN003628J$MERCK$$62$YR$$M$Y$$$20240702$$MD$JP$JP
236193853$23619385$3$F$20231115$20240813$20240311$20240819$EXP$$US-ABBVIE-5673661$ABBVIE$$65$YR$$M$Y$$$20240819$$CN$US$US
2361944510$23619445$10$F$20240304$20240831$20240311$20240906$EXP$$CA-GSK-CA2024029024$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$CA$CA
236194614$23619461$4$F$20240101$20240911$20240311$20240917$EXP$$US-ABBVIE-5669196$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
236195042$23619504$2$F$20220701$20240531$20240312$20240718$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-008510$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240718$$MD$SK$SK
236195063$23619506$3$F$20240401$20240717$20240312$20240725$PER$$US-SA-2024SA075110$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240725$$MD$US$US
236195083$23619508$3$F$$20240910$20240312$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-038287$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240918$$MD$JP$JP
236195482$23619548$2$F$$20240912$20240312$20240920$PER$$US-SA-2024SA075217$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240921$$MD$US$US
236196014$23619601$4$F$20240101$20240829$20240312$20240910$EXP$$US-MALLINCKRODT-MNK202401592$MALLINCKRODT$$70$YR$E$F$Y$$$20240910$$CN$US$US
236196162$23619616$2$F$20240101$20240807$20240312$20240814$EXP$$JP-GENMAB-2024-00697$GENMAB$$62$YR$$M$Y$$$20240814$$MD$JP$JP
236196262$23619626$2$F$20231201$20240719$20240312$20240726$EXP$$CO-TOLMAR, INC.-24CO046612$TOLMAR$$66$YR$$M$Y$$$20240726$$CN$CO$CO
236196513$23619651$3$F$$20240823$20240312$20240830$EXP$$JP-GENMAB-2024-00723$GENMAB$$86$YR$$M$Y$44$KG$20240830$$MD$JP$JP
236196962$23619696$2$F$$20240809$20240312$20240821$PER$$US-SA-2024SA075864$SANOFI AVENTIS$$58$YR$A$M$Y$112.03$KG$20240821$$MD$US$US
236196982$23619698$2$F$$20240726$20240312$20240805$PER$$US-SA-2024SA075769$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240805$$MD$US$US
236197252$23619725$2$F$20240101$20240722$20240312$20240731$PER$$US-SA-2024SA077586$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240731$$MD$US$US
236197392$23619739$2$F$20240123$20240712$20240312$20240715$EXP$FR-AFSSAPS-RE2024000226$FR-JNJFOC-20240326985$JOHNSON AND JOHNSON$$68$YR$E$M$Y$90$KG$20240715$$MD$FR$FR
236197522$23619752$2$F$20240101$20240716$20240312$20240725$PER$$US-SA-2024SA076042$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240725$$MD$US$US
236197642$23619764$2$F$20220101$20240820$20240312$20240826$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-002826$AMGEN$$49$YR$A$F$Y$$$20240826$$LW$US$US
236197984$23619798$4$F$20240215$20240621$20240312$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000814$ACADIA PHARMACEUTICALS$$84$YR$$F$Y$$$20240716$$CN$US$US
236198232$23619823$2$F$$20240812$20240312$20240820$PER$$US-SA-2024SA076353$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240820$$MD$US$US
236198663$23619866$3$F$20240229$20240806$20240312$20240808$PER$$US-AMGEN-USASP2024050188$AMGEN$$73$YR$E$F$Y$$$20240808$$CN$US$US
236198762$23619876$2$F$$20240710$20240312$20240717$EXP$$JP-009507513-2403JPN000708J$MERCK$$74$YR$$F$Y$$$20240717$$MD$JP$JP
236201672$23620167$2$F$$20240716$20240312$20240721$EXP$$US-TAKEDA-2024TUS009241$TAKEDA$$$$$F$Y$88$KG$20240721$$HP$US$US
236201883$23620188$3$F$20240121$20240725$20240312$20240802$EXP$PT-INFARMED-T202402-314$PT-TEVA-VS-3166839$TEVA$$81$YR$$F$Y$$$20240802$$CN$PT$PT
236202063$23620206$3$F$$20240704$20240312$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-036780$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$MD$JP$JP
236202214$23620221$4$F$20240201$20240718$20240312$20240722$PER$$US-AMGEN-USASP2024050041$AMGEN$$71$YR$E$F$Y$$$20240722$$CN$US$US
236202282$23620228$2$F$$20240301$20240312$20240826$EXP$$CA-TERSERA THERAPEUTICS LLC-2024TRS001123$TERSERA THERAPEUTICS$$$$$$Y$$$20240826$$MD$CA$CA
236202352$23620235$2$F$20240109$20240815$20240312$20240822$EXP$$AR-ROCHE-3520304$ROCHE$$0$DY$N$M$Y$10$KG$20240822$$MD$AR$AR
236202412$23620241$2$F$$20240829$20240312$20240906$30DAY$$US-GSK-US2024028931$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
236202523$23620252$3$F$20240201$20240904$20240312$20240913$PER$$US-SA-2024SA075251$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240913$$MD$US$US
236202682$23620268$2$F$$20240719$20240312$20240730$PER$$US-SA-2024SA075308$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240730$$MD$US$US
236203243$23620324$3$F$20240201$20240708$20240312$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039364$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240709$$HP$US$US
236203253$23620325$3$F$$20240718$20240312$20240723$EXP$$US-TAKEDA-2024TUS021321$TAKEDA$$$$$M$Y$$$20240723$$CN$US$US
236203333$23620333$3$F$$20240708$20240312$20240712$PER$$US-ALXN-202403USA000446US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240712$$HP$US$US
236203343$23620334$3$F$$20240723$20240312$20240730$PER$$US-ALXN-202403USA000478US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
236203572$23620357$2$F$20240301$20240814$20240312$20240822$EXP$$CA-CELLTRION INC.-2024CA005918$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
236203743$23620374$3$F$$20240402$20240312$20240731$EXP$$DE-JNJFOC-20240323135$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240731$$HP$DE$DE
236203903$23620390$3$F$20231210$20240820$20240312$20240823$EXP$$CA-JNJFOC-20240306489$JOHNSON AND JOHNSON$$20$YR$A$M$Y$70$KG$20240823$$HP$CA$CA
236203912$23620391$2$F$$20240704$20240312$20240709$EXP$$CA-JNJFOC-20240311276$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240709$$CN$CA$CA
236204184$23620418$4$F$20240305$20240307$20240312$20240724$PER$$US-AMGEN-USASP2024049259$AMGEN$$86$YR$E$F$Y$$$20240724$$CN$US$US
236204333$23620433$3$F$20240110$20240923$20240312$20240927$EXP$$US-PAREXEL-2021US002900$TAKEDA$$67$YR$$M$Y$96$KG$20240927$$CN$US$US
236204353$23620435$3$F$20231101$20240624$20240312$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202403000965$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240705$$CN$US$US
236204534$23620453$4$F$$20240904$20240312$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-020684$JAZZ$$$$$M$Y$$$20240906$$CN$US$US
236204577$23620457$7$F$20231212$20240917$20240312$20240925$EXP$$CA-GSK-CA2023AMR077969$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$PH$CA$CA
236204636$23620463$6$F$20210301$20240918$20240312$20240926$EXP$$CA-TAKEDA-2021TUS024336$TAKEDA$$32$YR$$F$Y$68$KG$20240926$$CN$CA$CA
236204982$23620498$2$F$20240128$20240909$20240312$20240917$EXP$$CA-ROCHE-3418060$ROCHE$$60$YR$A$F$Y$$$20240917$$CN$CA$CA
236205203$23620520$3$F$$20240319$20240312$20240701$PER$$US-UCBSA-2024009714$UCB$$$$$M$Y$$$20240701$$CN$US$US
236205792$23620579$2$F$$20240904$20240312$20240912$EXP$$FR-CELLTRION INC.-2024FR005643$CELLTRION$$$$$$Y$$$20240912$$MD$FR$FR
236205993$23620599$3$F$$20240708$20240312$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038946$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240709$$HP$US$US
236206004$23620600$4$F$20231029$20240909$20240312$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-020517$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$66$KG$20240912$$MD$JP$JP
236206483$23620648$3$F$$20240812$20240312$20240816$EXP$$US-ABBVIE-5672781$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
236206524$23620652$4$F$$20240829$20240312$20240904$EXP$$GB-TAKEDA-2024TUS022497$TAKEDA$$$$$F$Y$$$20240904$$CN$GB$GB
236206767$23620676$7$F$20240331$20240730$20240312$20240806$EXP$$US-CHIESI-2024CHF01242$CHIESI$$15$YR$$F$Y$53.2$KG$20240806$$MD$US$US
236208002$23620800$2$F$20240229$20240807$20240312$20240828$EXP$$US-862174955-ML2024-01471$Unknown Manufacturer$$63$YR$A$F$Y$91$KG$20240828$$PH$US$US
236208032$23620803$2$F$20230720$20240828$20240312$20240906$EXP$$JP-ROCHE-3521390$ROCHE$$88$YR$E$M$Y$$$20240906$$MD$JP$JP
236208342$23620834$2$F$20240201$20240731$20240312$20240811$EXP$$FR-AUROBINDO-AUR-APL-2024-010753$AUROBINDO$$69$YR$$M$Y$$$20240812$$PH$FR$FR
236208487$23620848$7$F$20240101$20240715$20240312$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-006834$UNITED THERAPEUTICS$$$$$F$Y$93.424$KG$20240719$$$US$US
236208547$23620854$7$F$20240601$20240711$20240312$20240718$EXP$$CA-GSK-CA2024027573$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$HP$CA$CA
236208566$23620856$6$F$$20240821$20240312$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039311$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240823$$HP$US$US
236208584$23620858$4$F$20240202$20240912$20240312$20240919$EXP$$CA-JNJFOC-20240308307$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240919$$HP$CA$CA
236208703$23620870$3$F$$20240715$20240312$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202403005195$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240809$$CN$US$US
236208943$23620894$3$F$20240601$20240708$20240312$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000787$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240730$$CN$US$US
236209852$23620985$2$F$20220901$20240726$20240312$20240807$EXP$AU-LUPIN HEALTHCARE (UK) LIMITED-2024-01815$AU-LUPIN HEALTHCARE (UK) LIMITED-2024-01815$LUPIN$$$$$$Y$$$20240807$$CN$AU$AU
236210093$23621009$3$F$20240101$20240626$20240312$20240701$EXP$$US-SA-2024SA078042$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240701$$MD$US$US
236210318$23621031$8$F$20240305$20240913$20240312$20240916$EXP$$NVSC2024US052702$NOVARTIS$$67$YR$$M$Y$$$20240916$$CN$US$US
236210613$23621061$3$F$$20240703$20240312$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-038943$BRISTOL MYERS SQUIBB$$9$DEC$E$F$Y$$$20240704$$MD$JP$JP
236210754$23621075$4$F$20240219$20240906$20240312$20240917$EXP$$CN-AMGEN-CHNNI2024048146$AMGEN$$$$$F$Y$55$KG$20240917$$MD$CN$CN
236211045$23621104$5$F$$20240924$20240312$20240930$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-036009$BRISTOL MYERS SQUIBB$Goubeau L, Guilbert Z, Saadi M, Picard F, Perrin L, Capdevila L, et al. Bleeding episode during a long-term anticoagulation with direct oral anticoagulant: an unusual revelation of a severe factor V deficiency. Research and Practice in Thrombosis and Haemostasis. 2023 Oct 01;7(Suppl 2):668. doi:10.1016/j.rpth.2023.101257.$81$YR$E$M$Y$$$20240930$$HP$FR$FR
236211122$23621112$2$F$$20240807$20240312$20240809$EXP$$GB-SANDOZ INC.-SDZ2024GB022017$SANDOZ$$$$$M$Y$$$20240809$$CN$GB$GB
236211332$23621133$2$F$$20240716$20240312$20240717$EXP$$US-TAKEDA-2020TUS048923$TAKEDA$$$$$M$Y$$$20240717$$CN$US$US
236211903$23621190$3$F$20240221$20240903$20240312$20240909$EXP$$CA-ROCHE-3522768$ROCHE$$58$YR$A$F$Y$$$20240909$$MD$CA$CA
236212093$23621209$3$F$20240111$20240628$20240312$20240708$EXP$$FI-CELLTRION INC.-2024FI004092$CELLTRION$$$$$$Y$$$20240708$$MD$FI$FI
236212262$23621226$2$F$20230814$20240724$20240312$20240731$EXP$$CA-SA-2023SA390472$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240731$$MD$CA$CA
236212273$23621227$3$F$20230101$20240629$20240312$20240708$EXP$$CA-SA-2024SA002622$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240708$$MD$CA$CA
236212422$23621242$2$F$$20240730$20240312$20240806$EXP$$US-BEH-2024169431$CSL BEHRING$$19$YR$A$M$Y$$$20240806$$HP$US$US
236212503$23621250$3$F$20240305$20240630$20240312$20240703$PER$$US-AMGEN-USASP2024048850$AMGEN$$75$YR$E$F$Y$$$20240703$$CN$US$US
2362127914$23621279$14$F$20220606$20240921$20240312$20240927$EXP$$CH-ABBVIE-22K-151-4503562-00$ABBVIE$$78$YR$$F$Y$58$KG$20240927$$MD$CH$CH
236213052$23621305$2$F$$20240607$20240312$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000782$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
236213553$23621355$3$F$20240216$20240712$20240312$20240723$EXP$$CN-Accord-410652$ACCORD$$54$YR$A$F$Y$70$KG$20240723$$HP$CN$CN
236213732$23621373$2$F$20240228$20240730$20240312$20240802$EXP$$CO-TAKEDA-2024TUS022219$TAKEDA$$6$YR$$M$Y$19$KG$20240802$$CN$CO$CO
236213823$23621382$3$F$20231101$20240913$20240312$20240917$EXP$$US-ABBVIE-5674336$ABBVIE$$60$YR$$M$Y$120$KG$20240917$$HP$US$US
2362142617$23621426$17$F$$20240904$20240312$20240916$EXP$GB-MHRA-ADR 28568694$GB-Accord-411608$ACCORD$$38$YR$A$M$Y$104$KG$20240916$$HP$GB$GB
236214432$23621443$2$F$20240304$20240827$20240312$20240829$PER$$US-AMGEN-USASP2024050098$AMGEN$$86$YR$E$M$Y$$$20240829$$CN$US$US
236214544$23621454$4$F$20240101$20240729$20240312$20240802$EXP$$US-UCBSA-2024011425$UCB$$$$$F$Y$109.3$KG$20240802$$HP$US$US
236214922$23621492$2$F$$20240808$20240312$20240816$EXP$$CA-JNJFOC-20240319446$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$HP$CA$CA
236215662$23621566$2$F$$20240704$20240312$20240720$EXP$$HK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434964$RANBAXY$Ng IHY, Cheung EYN. Pituitary Macroadenoma Masked by Iatrogenic Adrenal Insufficiency: A Diagnostic Blind Spot. J Endocrine Soc. 2021;5 (Suppl.):A151$48$YR$$F$Y$$$20240719$$HP$HK$HK
236215783$23621578$3$F$$20240905$20240312$20240912$EXP$$US-ABBVIE-5674422$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
236216262$23621626$2$F$$20240730$20240312$20240801$EXP$$ZA-MYLANLABS-2024M1021825$MYLAN$$$$$$Y$$$20240801$$HP$ZA$ZA
236216424$23621642$4$F$20240101$20240910$20240312$20240917$EXP$$CA-CELLTRION INC.-2024CA001926$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
236216492$23621649$2$F$20240219$20240625$20240312$20240710$EXP$$CA-GSK-CA2023143096$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$CA$CA
236216763$23621676$3$F$$20240701$20240312$20240710$EXP$$CA-SA-2024SA077005$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$HP$CA$CA
236216862$23621686$2$F$$20240620$20240312$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02008$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236216943$23621694$3$F$20240501$20240916$20240312$20240919$EXP$$US-SA-2024SA078774$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240919$$MD$US$US
236217063$23621706$3$F$$20240619$20240312$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01982$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236217072$23621707$2$F$20230101$20240702$20240312$20240708$EXP$$JP-DSJP-DSJ-2023-129067$DAIICHI$$77$YR$$M$Y$$$20240708$$CN$JP$JP
2362172210$23621722$10$F$20240101$20240711$20240312$20240730$EXP$$CA-CELLTRION INC.-2024CA004456$CELLTRION$$$$$$Y$$$20240730$$MD$CA$CA
236217563$23621756$3$F$$20240620$20240312$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01965$LUPIN$$$$$$Y$$$20240703$$CN$US$US
236217924$23621792$4$F$20231209$20240814$20240312$20240820$30DAY$$US-AMGEN-USASP2024046682$AMGEN$$65$YR$E$F$Y$$$20240820$$PH$US$US
236218185$23621818$5$F$20240201$20240710$20240312$20240716$PER$$US-AMGEN-USASP2024047702$AMGEN$$69$YR$E$$Y$$$20240716$$PH$US$US
236218395$23621839$5$F$20240303$20240913$20240312$20240917$EXP$$NVSJ2024JP003201$NOVARTIS$$76$YR$$F$Y$38.2$KG$20240917$$MD$JP$JP
236218486$23621848$6$F$$20240717$20240312$20240724$EXP$$NVSC2024GB052783$NOVARTIS$$$$A$F$Y$$$20240724$$CN$GB$GB
236218537$23621853$7$F$$20240912$20240312$20240918$EXP$$GB-ROCHE-3468826$ROCHE$$$$A$M$Y$$$20240918$$CN$GB$GB
236218573$23621857$3$F$20240307$20240805$20240312$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-039277$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240809$$MD$JP$JP
236218644$23621864$4$F$20240101$20240704$20240312$20240708$EXP$$US-KYOWAKIRIN-2024KK004670$KYOWA$$$$$$Y$$$20240708$$HP$US$US
236219099$23621909$9$F$20240216$20240911$20240312$20240916$30DAY$$US-PFIZER INC-202400044195$PFIZER$$80$YR$$F$Y$45.36$KG$20240916$$CN$US$US
236219363$23621936$3$F$20240220$20240820$20240312$20240826$30DAY$$CA-JNJFOC-20240264041$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240826$$HP$CA$CA
236219572$23621957$2$F$$20240924$20240312$20240927$EXP$$CA-ROCHE-3520823$ROCHE$$67$YR$E$F$Y$73$KG$20240927$$MD$CA$CA
236219722$23621972$2$F$20240102$20240729$20240312$20240806$EXP$$FR-AstraZeneca-2024A053059$ASTRAZENECA$$75$YR$$M$Y$105$KG$20240806$$MD$FR$
236219942$23621994$2$F$20220803$20240725$20240312$20240805$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-01811$LUPIN$$31$YR$$M$Y$$$20240805$$CN$AU$AU
236219963$23621996$3$F$20240304$20240723$20240312$20240725$PER$$US-AMGEN-USASP2024048886$AMGEN$$77$YR$E$F$Y$$$20240725$$CN$US$US
236220444$23622044$4$F$$20240820$20240312$20240826$30DAY$$US-PFIZER INC-202400048089$PFIZER$$13$YR$$M$Y$$$20240826$$CN$US$US
236220972$23622097$2$F$20240306$20240726$20240312$20240730$PER$$US-AMGEN-USASP2024048914$AMGEN$$75$YR$E$F$Y$$$20240730$$CN$US$US
236221112$23622111$2$F$20201006$20240708$20240312$20240716$EXP$$ES-CELLTRION INC.-2024ES005731$CELLTRION$$$$$$Y$$$20240716$$PH$ES$ES
236221252$23622125$2$F$20240201$20240702$20240312$20240711$EXP$$JP-009507513-2401JPN005818J$MERCK$$56$YR$$F$Y$$$20240711$$MD$JP$JP
236221422$23622142$2$F$20240305$20240809$20240312$20240820$EXP$$LB-ROCHE-3521464$ROCHE$$61$YR$A$F$Y$$$20240820$$CN$LB$LB
236221603$23622160$3$F$$20240809$20240312$20240814$EXP$$JP-009507513-2403JPN000637J$MERCK$$9$DEC$$M$Y$$$20240814$$MD$JP$JP
236221682$23622168$2$F$$20240919$20240312$20240926$EXP$$JP-GSK-JP2024031839$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$JP$JP
236221962$23622196$2$F$$20240701$20240312$20240707$PER$$US-ALXN-202403USA000548US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240707$$HP$US$US
2362221612$23622216$12$F$$20240920$20240312$20240925$30DAY$$US-PFIZER INC-PV202400025342$PFIZER$$14$YR$$M$Y$49.887$KG$20240925$$CN$US$US
236222204$23622220$4$F$20220609$20240321$20240312$20240913$EXP$$JP-AMGEN-JPNSP2021038942$AMGEN$$66$YR$E$F$Y$$$20240913$$PH$JP$JP
236223065$23622306$5$F$20240222$20240819$20240312$20240821$30DAY$$US-PFIZER INC-202400049238$PFIZER$$11$YR$$M$Y$36.29$KG$20240821$$MD$US$US
236223553$23622355$3$F$20240306$20240813$20240312$20240821$PER$$US-AMGEN-USASP2024049846$AMGEN$$73$YR$E$M$Y$$$20240821$$HP$US$US
236224193$23622419$3$F$$20240704$20240312$20240712$EXP$$PT-SANDOZ INC.-SDZ2024PT024216$SANDOZ$$$$E$$Y$$$20240712$$HP$PT$PT
236224274$23622427$4$F$$20240910$20240312$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039429$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$102.97$KG$20240912$$CN$US$US
236224283$23622428$3$F$20240209$20240906$20240312$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-038896$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$44$KG$20240911$$PH$JP$JP
236224382$23622438$2$F$20240101$20240917$20240312$20240923$PER$$US-SA-2024SA075073$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240923$$MD$US$US
236224402$23622440$2$F$20240201$20240628$20240312$20240709$PER$$US-SA-2024SA070913$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240709$$MD$US$US
236224462$23622446$2$F$20240201$20240901$20240312$20240910$PER$$US-SA-2024SA073824$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240910$$MD$US$US
236224502$23622450$2$F$20240101$20240722$20240312$20240730$PER$$US-SA-2024SA073474$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240730$$MD$US$US
236224552$23622455$2$F$20240101$20240903$20240312$20240923$PER$$US-SA-2024SA074955$SANOFI AVENTIS$$61$YR$A$F$Y$68$KG$20240923$$MD$US$US
236224752$23622475$2$F$20231101$20240815$20240312$20240828$PER$$US-SA-2024SA076887$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240828$$MD$US$US
236224772$23622477$2$F$$20240819$20240312$20240902$PER$$US-SA-2024SA076642$SANOFI AVENTIS$$17$YR$T$M$Y$62$KG$20240902$$CN$US$US
236224783$23622478$3$F$20230101$20240828$20240312$20240912$PER$$US-SA-2024SA076702$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240912$$MD$US$US
236225172$23622517$2$F$20240101$20240722$20240312$20240730$PER$$US-SA-2024SA075692$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240730$$MD$US$US
236225193$23622519$3$F$20240101$20240820$20240312$20240910$PER$$US-SA-2024SA079293$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240910$$MD$US$US
236225322$23622532$2$F$20240101$20240911$20240312$20240923$PER$$US-SA-2024SA076199$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240923$$MD$US$US
236225524$23622552$4$F$20240101$20240718$20240312$20240730$PER$$US-SA-2024SA076794$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240730$$MD$US$US
236225543$23622554$3$F$20240101$20240809$20240312$20240820$PER$$US-SA-2024SA076502$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240820$$MD$US$US
236225732$23622573$2$F$20240201$20240717$20240312$20240725$PER$$US-SA-2024SA077581$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240725$$MD$US$US
236225892$23622589$2$F$$20240701$20240312$20240710$PER$$US-SA-2024SA075167$SANOFI AVENTIS$$$$A$F$Y$70$KG$20240710$$MD$US$US
236225922$23622592$2$F$$20240730$20240312$20240808$PER$$US-SA-2024SA076190$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240808$$MD$US$US
236225964$23622596$4$F$20240101$20240812$20240312$20240819$PER$$US-SA-2024SA076635$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240819$$MD$US$US
236225982$23622598$2$F$20240123$20240906$20240312$20240916$EXP$$GR-CELLTRION INC.-2024GR005607$CELLTRION$$$$$$Y$$$20240916$$CN$GR$GR
236226155$23622615$5$F$20230303$20240625$20240312$20240705$EXP$$JP-JNJFOC-20240323619$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240705$$MD$JP$JP
236226212$23622621$2$F$20240201$20240711$20240312$20240723$PER$$US-SA-2024SA079295$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240723$$MD$US$US
236226502$23622650$2$F$20240801$20240910$20240312$20240925$PER$$US-SA-2024SA077110$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240925$$MD$US$US
236226562$23622656$2$F$20240107$20240724$20240312$20240802$PER$$US-SA-2024SA076202$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240802$$MD$US$US
236226612$23622661$2$F$20240801$20240829$20240312$20240924$PER$$US-SA-2024SA076193$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240924$$MD$US$US
236226642$23622664$2$F$20240304$20240802$20240312$20240813$PER$$US-SA-2024SA075485$SANOFI AVENTIS$$50$YR$A$F$Y$157$KG$20240814$$MD$US$US
236226652$23622665$2$F$$20240708$20240312$20240716$PER$$US-SA-2024SA079504$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240716$$MD$US$US
236226772$23622677$2$F$20231026$20240723$20240312$20240730$PER$$US-SA-2024SA077859$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240730$$MD$US$US
236227143$23622714$3$F$20231108$20240918$20240312$20240925$EXP$$CA-GSK-CA2023140556$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$CA$CA
236227393$23622739$3$F$20240304$20240723$20240312$20240726$PER$$US-AMGEN-USASP2024050531$AMGEN$$$$A$F$Y$$$20240726$$HP$US$US
236227683$23622768$3$F$$20240906$20240312$20240912$EXP$$US-AGIOS-2402US03673$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
2362277214$23622772$14$F$20160101$20240905$20240312$20240913$PER$$FR-Waylis Therapeutics LLC-ATNAHS20210100032$Waylis$$34$YR$A$M$Y$79$KG$20240912$$HP$FR$FR
236228084$23622808$4$F$$20240624$20240312$20240701$EXP$$US-PFIZER INC-202400059965$PFIZER$Shahlapour, M.. Novel uses of methadone under the ^72-hour rule^ to facilitate transitions of care and low-dose buprenorphine induction in an outpatient bridge clinic. J Addict Med.. 2024;10.1097/ADM.0000000000001281$36$YR$$M$Y$$$20240701$$MD$US$US
236228634$23622863$4$F$$20240730$20240312$20240731$PER$$US-PFIZER INC-202400061881$PFIZER$$72$YR$$F$Y$83.9$KG$20240731$$CN$US$US
236228722$23622872$2$F$$20240711$20240312$20240715$PER$$US-PFIZER INC-202400060481$PFIZER$$15$YR$$F$Y$$$20240715$$CN$US$US
236228763$23622876$3$F$20231215$20240730$20240312$20240802$PER$$US-PFIZER INC-PV202400033506$PFIZER$$44$YR$$F$Y$$$20240802$$HP$US$US
236229432$23622943$2$F$$20240717$20240312$20240724$EXP$$NVSC2024US051571$NOVARTIS$Wilson P, Rosenstengle C, Spak C. Underrecognized cause diarrhea in solid organ transplant: areport of astroviridae enteritis in liver transplant. WILEY PERIODICALS LLC. 2024;e14257$72$YR$$M$Y$$$20240724$$HP$US$US
236229573$23622957$3$F$20230101$20240510$20240312$20240912$EXP$$NVSC2024US050210$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
236229702$23622970$2$F$20240201$20240709$20240312$20240716$EXP$$JP-009507513-2403JPN000684J$MERCK$$$$$F$Y$$$20240716$$MD$JP$JP
236229904$23622990$4$F$20240221$20240523$20240312$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-036497$BRISTOL MYERS SQUIBB$$17$YR$T$M$Y$67.3$KG$20240814$$MD$US$US
236229934$23622993$4$F$20240101$20240729$20240312$20240806$PER$$US-SA-2024SA076764$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240806$$MD$US$US
236230236$23623023$6$F$20240201$20240630$20240312$20240701$30DAY$$US-PFIZER INC-PV202400023134$PFIZER$$4$YR$$M$Y$$$20240701$$CN$US$US
236230324$23623032$4$F$20240320$20240912$20240312$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202403005512$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240913$$CN$US$US
236230403$23623040$3$F$20220101$20240918$20240312$20240926$EXP$$NVSC2024US053069$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
236230852$23623085$2$F$$20240819$20240312$20240829$EXP$$US-BEH-2024169327$CSL BEHRING$$$$A$F$Y$75.737$KG$20240829$$HP$US$US
236230894$23623089$4$F$20240101$20240729$20240312$20240807$PER$$US-SA-2024SA076807$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240807$$MD$US$US
236231612$23623161$2$F$$20240906$20240312$20240912$EXP$$US-GILEAD-2023-0631306$GILEAD$$78$YR$E$M$Y$$$20240912$$MD$US$US
236231813$23623181$3$F$$20240722$20240312$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039202$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240724$$CN$US$US
236232212$23623221$2$F$$20240906$20240312$20240912$EXP$$US-GILEAD-2024-0665329$GILEAD$$62$YR$A$M$Y$$$20240912$$MD$US$US
236232744$23623274$4$F$20230821$20240822$20240312$20240829$EXP$$TW-ABBVIE-5426851$ABBVIE$$$$$$Y$$$20240829$$MD$TW$TW
236233042$23623304$2$F$$20231205$20240312$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-006168$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236233243$23623324$3$F$$20240704$20240312$20240708$EXP$$NVSC2024US052707$NOVARTIS$$39$YR$$M$Y$$$20240708$$CN$US$US
236233362$23623336$2$F$$20231218$20240312$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-006362$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236233372$23623337$2$F$$20231218$20240312$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-006388$ENDO$$$$$F$Y$$$20240918$$CN$US$US
236233395$23623339$5$F$$20231218$20240312$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000018$ENDO$$$$$F$Y$$$20240918$$CN$US$US
236233413$23623341$3$F$$20231219$20240312$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000030$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236233424$23623342$4$F$$20231218$20240312$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-006420$ENDO$$$$$F$Y$$$20240918$$CN$US$US
236233435$23623343$5$F$$20231218$20240312$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000040$ENDO$$$$$F$Y$$$20240916$$CN$US$US
236233564$23623356$4$F$20240306$20240730$20240312$20240801$PER$$US-AMGEN-USASP2024048246$AMGEN$$61$YR$A$F$Y$$$20240801$$CN$US$US
236233582$23623358$2$F$$20240626$20240312$20240701$30DAY$$US-ABBVIE-5671609$ABBVIE$$$$$$Y$$$20240701$$HP$US$US
236233592$23623359$2$F$20210112$20240821$20240312$20240828$EXP$$CA-TAKEDA-2019TUS058136$TAKEDA$$21$YR$$M$Y$$$20240828$$MD$CA$CA
236233603$23623360$3$F$20161114$20240806$20240312$20240809$EXP$$CA-TAKEDA-2016TUS020855$TAKEDA$$48$YR$$F$Y$$$20240809$$MD$CA$CA
236233892$23623389$2$F$20240101$20240730$20240312$20240806$EXP$$US-GSK-US2024029806$GLAXOSMITHKLINE$$35$YR$$F$Y$$$20240806$$CN$US$US
236234062$23623406$2$F$$20240723$20240312$20240727$PER$$US-AMGEN-USASP2024049262$AMGEN$$$$$F$Y$$$20240727$$HP$US$US
236234326$23623432$6$F$$20240726$20240312$20240730$EXP$$US-BIOVITRUM-2024-US-003974$BIOVITRUM$$72$YR$$M$Y$$$20240730$$CN$US$US
236234835$23623483$5$F$20240502$20240710$20240312$20240715$EXP$$CA-TAKEDA-2024TUS022196$TAKEDA$$60$YR$$F$Y$$$20240715$$CN$CA$CA
236234935$23623493$5$F$$20240917$20240312$20240925$EXP$$US-TAKEDA-2024TUS022078$TAKEDA$$$$$M$Y$$$20240925$$CN$US$US
236235223$23623522$3$F$20240201$20240717$20240312$20240722$EXP$$CA-PFIZER INC-202400060752$PFIZER$$59$YR$$M$Y$$$20240722$$HP$CA$CA
236235393$23623539$3$F$$20240717$20240312$20240722$EXP$$AU-MYLANLABS-2024M1019441$MYLAN$$$$$M$Y$97$KG$20240722$$HP$AU$AU
236235472$23623547$2$F$20240225$20240911$20240312$20240912$EXP$IT-MINISAL02-974407$IT-PFIZER INC-202400062065$PFIZER$$48$YR$$M$Y$$$20240912$$MD$IT$IT
236235503$23623550$3$F$$20240702$20240312$20240709$EXP$$US-PFIZER INC-202400060356$PFIZER$$$$E$F$Y$$$20240709$$PH$US$US
236235612$23623561$2$F$20240304$20240725$20240312$20240730$EXP$$CN-PFIZER INC-PV202400033640$PFIZER$$81$YR$$F$Y$65$KG$20240730$$HP$CN$CN
236235662$23623566$2$F$20230101$20240723$20240312$20240725$EXP$$US-PFIZER INC-202400061785$PFIZER$$78$YR$$M$Y$59.864$KG$20240725$$CN$US$US
236235682$23623568$2$F$20230818$20240715$20240312$20240719$EXP$IT-MINISAL02-973975$IT-PFIZER INC-202400061283$PFIZER$$2$MON$$M$Y$$$20240719$$MD$IT$IT
236236212$23623621$2$F$$20240702$20240312$20240708$EXP$$AU-TAKEDA-2024TUS022820$TAKEDA$$$$$F$Y$$$20240708$$HP$AU$AU
236236295$23623629$5$F$20240101$20240318$20240312$20240916$EXP$$UY-009507513-2403URY002659$MERCK$$67$YR$$F$Y$$$20240916$$MD$UY$UY
236236313$23623631$3$F$20180101$20240906$20240312$20240909$EXP$$PL-SANDOZ INC.-SDZ2024PL026542$SANDOZ$$62$YR$$M$Y$$$20240909$$MD$PL$PL
236236332$23623633$2$F$$20240906$20240312$20240911$EXP$$US-GILEAD-2024-0665332$GILEAD$$57$YR$A$F$Y$$$20240911$$MD$US$US
236236443$23623644$3$F$20220601$20240903$20240312$20240904$EXP$$DE-SANDOZ INC.-NVSC2023DE100784$SANDOZ$$50$YR$$F$Y$$$20240904$$MD$DE$DE
236236652$23623665$2$F$20240601$20240620$20240312$20240701$PER$$US-SA-2024SA079054$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240701$$MD$US$US
236236758$23623675$8$F$20240309$20240912$20240312$20240919$EXP$$US-BAYER-2024A036448$BAYER$$62$YR$A$F$Y$92.517$KG$20240919$$CN$US$US
236237362$23623736$2$F$$20240905$20240312$20240909$EXP$$CA-SANDOZ INC.-NVSC2023CA140993$SANDOZ$$$$$M$Y$$$20240909$$CN$CA$CA
236237602$23623760$2$F$20240307$20240722$20240312$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039973$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240724$$CN$US$US
236237763$23623776$3$F$$20240705$20240312$20240709$EXP$$GB-SANDOZ INC.-SDZ2023GB065416$SANDOZ$$$$$F$Y$$$20240709$$CN$GB$GB
236237773$23623777$3$F$20220614$20240726$20240312$20240730$EXP$$CA-SANDOZ INC.-NVSC2022CA141390$SANDOZ$$75$YR$$F$Y$$$20240730$$CN$CA$CA
236237963$23623796$3$F$20230215$20240808$20240312$20240814$EXP$$DE-MYLANLABS-2024M1022348$MYLAN$$$$$F$Y$$$20240814$$HP$DE$DE
236238043$23623804$3$F$20240101$20240627$20240312$20240709$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-000418$SK LIFE SCIENCE$$$$$$Y$$$20240709$$HP$CA$CA
236238283$23623828$3$F$$20240730$20240312$20240802$EXP$$US-TAKEDA-2024TUS021989$TAKEDA$$$$$F$Y$61$KG$20240802$$HP$US$US
236238653$23623865$3$F$$20240705$20240312$20240712$EXP$$JP-009507513-2403JPN000651J$MERCK$$7$DEC$$F$Y$$$20240712$$MD$JP$JP
236238734$23623873$4$F$20220719$20240821$20240312$20240828$PER$$JP-Eisai-EC-2022-121192$EISAI$Inuzuka R. A case of hypocalcaemia and hypomagnesaemia prolonged after lenvatinib plus pembrolizumab combination therapy for endometrial cancer.. Annual Meeting of Japanese Society of Pharmaceutical Oncology. 2024;155-155.$59$YR$A$F$Y$$$20240828$$PH$JP$JP
236238793$23623879$3$F$$20240829$20240312$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202403005620$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240903$$CN$US$US
236239452$23623945$2$F$$20240629$20240312$20240705$EXP$$US-ABBVIE-5670925$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
236239762$23623976$2$F$$20240829$20240312$20240909$PER$$US-INCYTE CORPORATION-2024IN002359$INCYTE$$$$$$Y$$$20240909$$CN$US$US
236240515$23624051$5$F$$20240827$20240312$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039464$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240829$$CN$US$US
236241032$23624103$2$F$$20240812$20240312$20240813$EXP$$CA-BAUSCH-BL-2024-004029$BAUSCH AND LOMB$$18$YR$$F$Y$72$KG$20240813$$HP$CA$CA
236241142$23624114$2$F$20231019$20240906$20240312$20240909$EXP$$IT-BAUSCH-BL-2024-004053$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240909$$HP$IT$IT
236241303$23624130$3$F$$20240626$20240312$20240710$EXP$$US-Calliditas-2024CAL00357$CALLIDITAS THERAPEUTICS$$73$YR$E$M$Y$$$20240710$$CN$US$US
236241792$23624179$2$F$20231105$20240705$20240312$20240709$EXP$FR-AFSSAPS-NT2024000168$FR-BAUSCH-BL-2024-004086$BAUSCH AND LOMB$$27$YR$$F$Y$$$20240709$$MD$FR$FR
236241823$23624182$3$F$$20240624$20240312$20240701$EXP$$US-PFIZER INC-202400059967$PFIZER$Shahlapour, M.. Novel uses of methadone under the ^72-hour rule^ to facilitate transitions of care and low-dose buprenorphine induction in an outpatient bridge clinic. J Addict Med. 2024;10.1097/ADM.0000000000001281$46$YR$$F$Y$$$20240701$$MD$US$US
236242252$23624225$2$F$$20240819$20240312$20240823$EXP$$AU-009507513-2403AUS002728$MERCK$$$$$M$Y$$$20240823$$HP$AU$AU
236242292$23624229$2$F$$20240730$20240312$20240809$EXP$$CA-ANIPHARMA-2024-CA-001552$ANI$$61$YR$$F$Y$58$KG$20240809$$HP$CA$CA
236242665$23624266$5$F$20231225$20240918$20240312$20240919$PER$$US-JNJFOC-20240321664$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240919$$CN$US$US
236242726$23624272$6$F$20240214$20240625$20240312$20240710$EXP$$JP-AMGEN-JPNSP2024049174$AMGEN$$39$YR$A$M$Y$75.8$KG$20240710$$MD$JP$JP
236242802$23624280$2$F$20240301$20240705$20240312$20240711$EXP$$JP-009507513-2403JPN000827J$MERCK$$7$DEC$$M$Y$$$20240711$$MD$JP$JP
236242843$23624284$3$F$20230907$20240618$20240312$20240701$EXP$$JP-AMGEN-JPNSP2024049178$AMGEN$Norimatsu K, Suzuki T, Kawakami E, Tsuji S, Kawakami J. A study of 3 cases of elderly-onset ANCA-associated vasculitis at this hospital. Abstracts in the 67th Meeting of Kyushu College of Rheumatology. 108.$91$YR$E$F$Y$$$20240630$$MD$JP$JP
236243292$23624329$2$F$20240219$20240702$20240312$20240706$EXP$$US-ABBVIE-5671655$ABBVIE$$69$YR$$F$Y$$$20240706$$CN$US$US
236243373$23624337$3$F$20230301$20240710$20240312$20240718$PER$$US-SA-2024SA076309$SANOFI AVENTIS$$11$YR$C$M$Y$32.1$KG$20240718$$MD$US$US
236243562$23624356$2$F$20230818$20240915$20240312$20240919$EXP$$US-INCYTE CORPORATION-2024IN002387$INCYTE$$$$$$Y$$$20240919$$CN$US$US
236243672$23624367$2$F$$20240710$20240312$20240722$EXP$$JP-009507513-2403JPN000720J$MERCK$$47$YR$$F$Y$$$20240719$$MD$JP$JP
236243952$23624395$2$F$20240131$20240710$20240312$20240718$EXP$$NL-CELLTRION INC.-2024NL005797$CELLTRION$$$$$$Y$$$20240718$$MD$NL$NL
236243963$23624396$3$F$$20240805$20240312$20240826$PER$$US-BEIGENE-BGN-2024-003656$BEIGENE$$$$$$Y$$$20240826$$CN$US$US
236244012$23624401$2$F$20231001$20240708$20240312$20240713$EXP$$US-ABBVIE-5670456$ABBVIE$$60$YR$$F$Y$$$20240713$$CN$US$US
236244035$23624403$5$F$20240227$20240628$20240312$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2024-004873$UNITED THERAPEUTICS$$82$YR$$F$Y$76.19$KG$20240706$$$US$US
236244102$23624410$2$F$$20240726$20240312$20240805$EXP$$CA-TAKEDA-2024TUS022765$TAKEDA$$44$YR$$M$Y$$$20240805$$CN$CA$CA
2362441413$23624414$13$F$20240101$20240717$20240312$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-006978$UNITED THERAPEUTICS$$$$$M$Y$58.503$KG$20240725$$$US$US
236244256$23624425$6$F$20240101$20240722$20240312$20240731$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007359$UNITED THERAPEUTICS$$$$$F$Y$48.526$KG$20240731$$$US$US
236244312$23624431$2$F$20231025$20240809$20240312$20240813$EXP$$ES-ABBVIE-5654452$ABBVIE$$78$YR$$M$Y$75$KG$20240813$$MD$ES$ES
236244462$23624446$2$F$20231001$20240911$20240312$20240916$EXP$$US-TAKEDA-2024TUS022721$TAKEDA$$3$YR$$F$Y$15$KG$20240916$$CN$US$US
236244928$23624492$8$F$$20240926$20240313$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039718$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240927$$CN$US$US
236244935$23624493$5$F$$20240826$20240313$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039329$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$78.02$KG$20240902$$CN$US$US
236244962$23624496$2$F$$20240902$20240313$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-010616$AUROBINDO$Gaston FN, Chatterjee T. Spontaneous Iliac Artery Dissection in a 66-Year Old Male Complicated By Hemorrhage, GI Bleeding, and Bilateral DVT/PE. Blood. 2023;142(1):5416-5417$66$YR$$M$Y$$$20240913$$MD$US$US
236245713$23624571$3$F$$20240710$20240313$20240718$PER$$US-SA-2024SA080201$SANOFI AVENTIS$$49$YR$A$M$Y$74.83$KG$20240718$$MD$US$US
236246212$23624621$2$F$$20240709$20240313$20240717$EXP$$US-BEH-2024169422$CSL BEHRING$$24$YR$A$F$Y$$$20240717$$CN$US$US
236246975$23624697$5$F$20230101$20240814$20240313$20240822$EXP$$CA-CELLTRION INC.-2023CA005893$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
236247374$23624737$4$F$20240215$20240906$20240313$20240912$EXP$$JP-ROCHE-3522999$ROCHE$$80$YR$E$F$Y$52$KG$20240912$$MD$JP$JP
236247523$23624752$3$F$20240301$20240809$20240313$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040286$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240812$$CN$US$US
236247602$23624760$2$F$20230105$20240725$20240313$20240805$EXP$$US-NOVOPROD-1186335$NOVO NORDISK$$66$YR$$F$Y$$$20240805$$CN$US$US
236247952$23624795$2$F$20240222$20240628$20240313$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038576$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240701$$HP$US$US
236248512$23624851$2$F$$20240730$20240313$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202403003362$ELI LILLY AND CO$$$$E$M$Y$$$20240801$$MD$US$US
236248765$23624876$5$F$20240101$20240919$20240313$20240923$PER$$US-BIOGEN-2024BI01243371$BIOGEN$$77$YR$$F$Y$$$20240923$$CN$US$US
236249312$23624931$2$F$$20240619$20240313$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01983$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236249433$23624943$3$F$$20240229$20240313$20240723$EXP$$US-TEVA-VS-3166082$TEVA$$54$YR$$F$Y$$$20240723$$CN$US$US
236249472$23624947$2$F$$20240716$20240313$20240730$EXP$$JP-AMGEN-JPNSP2024049148$AMGEN$Handa H, Uzawa A, Mori M, Yasuda M, Onishi Y, Akamine H, et al.. Effects of Denosumab and Bisphosphonates on Glucocorticoid-induced Osteoporosis in Patients with Neuroimmunological Disorders. Internal Medicine. 2024$$$$F$Y$$$20240730$$MD$JP$JP
236249512$23624951$2$F$$20240620$20240313$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02001$LUPIN$$$$$$Y$$$20240704$$CN$US$US
236249933$23624993$3$F$20210101$20240628$20240313$20240709$EXP$$GB-ROCHE-3523289$ROCHE$$36$YR$A$F$Y$$$20240703$$MD$GB$GB
236250034$23625003$4$F$20231206$20240910$20240313$20240915$EXP$$CA-JNJFOC-20231229398$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240915$$CN$CA$CA
236250234$23625023$4$F$20240101$20240906$20240313$20240913$EXP$$JP-GENMAB-2024-00601AA$GENMAB$$77$YR$$M$Y$69.4$KG$20240913$$MD$JP$JP
236250273$23625027$3$F$20240621$20240718$20240313$20240721$PER$$NVSC2024US053602$NOVARTIS$$$$$F$Y$$$20240722$$CN$US$US
236250333$23625033$3$F$20240307$20240821$20240313$20240823$PER$$US-AMGEN-USASP2024051099$AMGEN$$68$YR$E$F$Y$$$20240823$$HP$US$US
236250624$23625062$4$F$20230906$20240916$20240313$20240921$EXP$$US-ABBVIE-5672215$ABBVIE$$82$YR$$F$Y$94.8$KG$20240921$$HP$US$US
236250713$23625071$3$F$20240101$20240821$20240313$20240828$EXP$$CA-CELLTRION INC.-2024CA001286$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
236251345$23625134$5$F$20240212$20240816$20240313$20240820$EXP$$CA-TAKEDA-2024TUS017470$TAKEDA$$85$YR$$M$Y$$$20240820$$CN$CA$CA
236251683$23625168$3$F$$20240911$20240313$20240924$EXP$$CA-TEVA-VS-3168982$TEVA$$43$YR$$F$Y$96$KG$20240924$$HP$CA$CA
236251754$23625175$4$F$20240215$20240610$20240313$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000844$ACADIA PHARMACEUTICALS$$30$YR$$F$Y$$$20240705$$CN$US$US
236251894$23625189$4$F$20240101$20240731$20240313$20240809$PER$$US-SA-2024SA077533$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240809$$MD$US$US
236251933$23625193$3$F$20240101$20240828$20240313$20240911$PER$$US-SA-2024SA080072$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240911$$MD$US$US
236251952$23625195$2$F$20240101$20240816$20240313$20240829$PER$$US-SA-2024SA075399$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240829$$MD$US$US
236252032$23625203$2$F$20240601$20240828$20240313$20240910$PER$$US-SA-2024SA077140$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240910$$MD$US$US
236252203$23625220$3$F$$20231219$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000147$ENDO$$$$$F$Y$$$20240918$$CN$US$US
236252214$23625221$4$F$$20231219$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000171$ENDO$$$$$F$Y$$$20240918$$CN$US$US
236252224$23625222$4$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000085$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236252233$23625223$3$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000156$ENDO$$$$$$Y$$$20240916$$CN$US$US
236252242$23625224$2$F$19790101$20231218$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000060$ENDO$$3$DEC$$F$Y$$$20240916$$CN$US$US
236252253$23625225$3$F$$20240514$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000100$ENDO$$$$$F$Y$$$20240918$$CN$US$US
236252266$23625226$6$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000187$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236252275$23625227$5$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000197$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236252282$23625228$2$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000113$ENDO$$$$$$Y$$$20240916$$CN$US$US
236252293$23625229$3$F$$20231218$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000047$ENDO$$$$$F$Y$$$20240916$$CN$US$US
236252326$23625232$6$F$$20240109$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000305$ENDO$$$$$M$Y$$$20240918$$CN$US$US
236252333$23625233$3$F$$20231219$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000223$ENDO$$$$$M$Y$$$20240918$$CN$US$US
236252353$23625235$3$F$$20231218$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-001086$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236252542$23625254$2$F$$20231218$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-006368$ENDO$$$$$M$Y$$$20240918$$CN$US$US
236252554$23625255$4$F$$20231219$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000022$ENDO$$$$$F$Y$$$20240918$$CN$US$US
236252563$23625256$3$F$$20231218$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-006338$ENDO$$$$$M$Y$$$20240918$$CN$US$US
236252572$23625257$2$F$20150819$20231218$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-006397$ENDO$$$$$F$Y$$$20240916$$CN$US$US
236252584$23625258$4$F$$20240827$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-006105$ENDO$$$$$F$Y$$$20240918$$CN$US$US
236252595$23625259$5$F$$20231226$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000032$ENDO$$$$$M$Y$$$20240918$$CN$US$US
236252622$23625262$2$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000007$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236252652$23625265$2$F$$20231218$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000145$ENDO$$$$$F$Y$$$20240916$$CN$US$US
236252672$23625267$2$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000172$ENDO$$$$$F$Y$$$20240916$$CN$US$US
236252692$23625269$2$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000149$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236252704$23625270$4$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000055$ENDO$$$$$F$Y$$$20240916$$CN$US$US
236252712$23625271$2$F$$20231219$20240313$20240806$PER$$US-ENDO PHARMACEUTICALS INC-2024-000092$ENDO$$$$$F$Y$$$20240806$$CN$US$US
236252723$23625272$3$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000104$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236252763$23625276$3$F$20200101$20231218$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000076$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236252774$23625277$4$F$$20231219$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000044$ENDO$$$$$F$Y$$$20240918$$CN$US$US
236252793$23625279$3$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000199$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236252804$23625280$4$F$$20240116$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000356$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236252812$23625281$2$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000225$ENDO$$$$$F$Y$$$20240916$$CN$US$US
236252925$23625292$5$F$20240301$20240805$20240313$20240807$PER$$US-AMGEN-USASP2024050369$AMGEN$$74$YR$E$M$Y$$$20240807$$MD$US$US
236253142$23625314$2$F$$20231003$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005325$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236253348$23625334$8$F$20240201$20240925$20240313$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038826$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240926$$CN$US$US
236253552$23625355$2$F$20231209$20240809$20240313$20240830$PER$$NL-TOLMAR, INC.-24NL046931$TOLMAR$$78$YR$$M$Y$$$20240830$$CN$NL$NL
236253712$23625371$2$F$20240307$20240801$20240313$20240805$PER$$US-AMGEN-USASP2024050860$AMGEN$$64$YR$A$F$Y$$$20240805$$CN$US$US
236253852$23625385$2$F$$20240130$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2023-005615$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236254083$23625408$3$F$20240222$20240816$20240313$20240826$EXP$$CA-CELLTRION INC.-2024CA005161$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
236254386$23625438$6$F$20240101$20240917$20240313$20240926$EXP$$CA-CELLTRION INC.-2024CA005206$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
236254502$23625450$2$F$$20240129$20240313$20240723$EXP$$AU-TEVA-VS-3151014$TEVA$$$$$M$Y$$$20240723$$HP$AU$AU
236255254$23625525$4$F$20240216$20240718$20240313$20240723$EXP$$CA-TAKEDA-2024TUS016679$TAKEDA$$1$YR$$M$Y$11$KG$20240723$$HP$CA$CA
236255492$23625549$2$F$$20240619$20240313$20240701$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-02007$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236255653$23625565$3$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000025$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236255673$23625567$3$F$$20231218$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000016$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236255687$23625568$7$F$$20231205$20240313$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-006107$ENDO$$$$$M$Y$$$20240917$$CN$US$US
236255693$23625569$3$F$$20231218$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-006348$ENDO$$$$$F$Y$$$20240918$$CN$US$US
236255703$23625570$3$F$$20231218$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2023-006381$ENDO$$$$$F$Y$$$20240918$$CN$US$US
236255804$23625580$4$F$20240206$20240614$20240313$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000618$ACADIA PHARMACEUTICALS$$22$YR$$F$Y$$$20240709$$CN$US$US
236255877$23625587$7$F$20240306$20240823$20240313$20240828$EXP$$FR-GSK-FR2024EME031542$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$FR$FR
236255902$23625590$2$F$$20240731$20240313$20240802$30DAY$$US-SANDOZ INC.-SDZ2024US011408$SANDOZ$$$$$M$Y$$$20240802$$CN$US$US
236255962$23625596$2$F$20240216$20240625$20240313$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000811$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240719$$CN$US$US
236256553$23625655$3$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000155$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236256562$23625656$2$F$$20231219$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000056$ENDO$$$$$M$Y$$$20240918$$CN$US$US
236256574$23625657$4$F$$20231218$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000045$ENDO$$$$$M$Y$$$20240918$$CN$US$US
236256593$23625659$3$F$$20231219$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000185$ENDO$$$$$$Y$$$20240918$$CN$US$US
236256603$23625660$3$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000106$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236256614$23625661$4$F$$20231226$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000034$ENDO$$$$$M$Y$$$20240918$$CN$US$US
236256626$23625662$6$F$$20231218$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000077$ENDO$$$$$M$Y$$$20240918$$CN$US$US
236256652$23625665$2$F$$20231218$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000146$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236256852$23625685$2$F$$20240726$20240313$20240730$EXP$$CA-SANDOZ INC.-NVSC2022CA077873$SANDOZ$$$$$F$Y$$$20240730$$CN$CA$CA
236256962$23625696$2$F$$20240722$20240313$20240724$EXP$$US-ROCHE-3521696$ROCHE$$$$$F$Y$$$20240724$$CN$US$US
236257283$23625728$3$F$$20240708$20240313$20240716$EXP$$RO-CELLTRION INC.-2024RO005826$CELLTRION$$$$$$Y$$$20240716$$MD$RO$RO
236257376$23625737$6$F$$20240809$20240313$20240817$EXP$$CA-CELLTRION INC.-2024CA006085$CELLTRION$$$$$$Y$$$20240817$$HP$CA$CA
236257632$23625763$2$F$$20240821$20240313$20240823$EXP$$NVSC2024HR051218$NOVARTIS$$$$$M$Y$$$20240823$$MD$HR$HR
236257685$23625768$5$F$$20240812$20240313$20240820$PER$$US-ALXN-202403USA000263US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
236258062$23625806$2$F$$20240710$20240313$20240725$EXP$$CA-SERVIER-S24002384$SERVIER$Jiang MR, Ahmet A, Lawrence S, Bassal M, Speckert M, Geraghty MT, et al. Hypoglycemia Associated With PEG-asparaginase and 6-MP Therapy During Treatment of Acute Lymphoblastic Leukemia in Pediatric Patients: A Case Series. Journal of pediatric hematology oncology. 2024;46(2):e121-e126$$$$$Y$$$20240725$$HP$CA$CA
236258202$23625820$2$F$20240305$20240725$20240313$20240730$PER$$US-AMGEN-USASP2024051172$AMGEN$$63$YR$A$F$Y$$$20240730$$CN$US$US
236258212$23625821$2$F$20240308$20240820$20240313$20240823$PER$$US-AMGEN-USASP2024050978$AMGEN$$64$YR$A$M$Y$$$20240823$$CN$US$US
236258355$23625835$5$F$$20240807$20240313$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-038543$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240814$$MD$JP$JP
236258414$23625841$4$F$20240301$20240704$20240313$20240709$EXP$$NVSC2024CA053802$NOVARTIS$$66$YR$$F$Y$$$20240709$$CN$CA$CA
236258722$23625872$2$F$20240308$20240730$20240313$20240801$PER$$US-AMGEN-USASP2024051025$AMGEN$$57$YR$A$F$Y$$$20240801$$CN$US$US
236258775$23625877$5$F$$20240708$20240313$20240712$EXP$$US-ASTELLAS-2024EU002296$ASTELLAS$$$$$M$Y$$$20240712$$CN$US$US
236258914$23625891$4$F$$20240801$20240313$20240805$EXP$$US-ROCHE-3519719$ROCHE$$66$YR$E$M$Y$$$20240805$$CN$US$US
236259082$23625908$2$F$20230313$20240702$20240313$20240710$EXP$$DE-CELLTRION INC.-2024DE005647$CELLTRION$$$$$$Y$$$20240710$$MD$DE$DE
236259213$23625921$3$F$$20240806$20240313$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040008$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240807$$CN$US$US
236259422$23625942$2$F$$20240709$20240313$20240720$EXP$$CA-TEVA-201905_00003600$TEVA$Wong JY, Kuzel P, Mullen J, Lien D, Mahmood M, Conrad C et al. Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment. Pediatr Transplant. 2014;18(6):E200-7; Wong JY, Kuzel P, Mullen J, Lien D, Mahmood M, Conrad C et al. Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment. Pediatr Transplant. 2014;18(6):E200-7; Wong JY, Kuzel P, Mullen J, Lien D, Mahmood M, Conrad C et al. Cuta...$15$YR$$F$Y$$$20240720$$HP$CA$CA
236259983$23625998$3$F$20230101$20240815$20240313$20240827$EXP$$CA-UCBSA-2023053307$UCB$$$$$M$Y$$$20240827$$CN$CA$CA
236260153$23626015$3$F$$20240116$20240313$20240918$PER$$US-ENDO PHARMACEUTICALS INC-2024-000357$ENDO$$$$$M$Y$$$20240918$$CN$US$US
236260183$23626018$3$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000192$ENDO$$$$$F$Y$$$20240916$$CN$US$US
236260193$23626019$3$F$$20231219$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000208$ENDO$$$$$F$Y$$$20240916$$CN$US$US
236260203$23626020$3$F$$20240102$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-000242$ENDO$$$$$M$Y$$$20240916$$CN$US$US
236260213$23626021$3$F$$20231218$20240313$20240916$PER$$US-ENDO PHARMACEUTICALS INC-2024-001298$ENDO$$$$$F$Y$$$20240916$$CN$US$US
236260222$23626022$2$F$$20240730$20240313$20240805$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-044122$REGENERON$$$$$M$Y$$$20240805$$CN$US$US
236260253$23626025$3$F$$20240916$20240313$20240926$EXP$$GB-ROCHE-2711017$ROCHE$$$$E$F$Y$$$20240926$$CN$GB$GB
236260413$23626041$3$F$20240315$20240705$20240313$20240710$EXP$$CA-TAKEDA-2024TUS021913$TAKEDA$$46$YR$$F$Y$$$20240710$$CN$CA$CA
236260422$23626042$2$F$$20240620$20240313$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01981$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236261365$23626136$5$F$20240101$20240827$20240313$20240911$EXP$$US-RADIUS HEALTH, INC.-2024US001342$RADIUS PHARM$$$$$F$Y$$$20240911$$CN$US$US
236261642$23626164$2$F$20240623$20240626$20240313$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000810$ACADIA PHARMACEUTICALS$$91$YR$$F$Y$$$20240719$$CN$US$US
236261724$23626172$4$F$20230111$20240730$20240313$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-010810$AUROBINDO$$25$YR$$F$Y$54$KG$20240812$$MD$FR$FR
236262212$23626221$2$F$20231217$20240919$20240313$20240920$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2154341$JIANGSU HANSOH PHARMACEUTICAL$$$$$M$Y$$$20240920$$MD$CN$CN
236262474$23626247$4$F$20240101$20240830$20240313$20240911$EXP$$US-UCBSA-2024011604$UCB$$$$$M$Y$$$20240911$$CN$US$US
236262513$23626251$3$F$$20240701$20240313$20240708$PER$$US-ALXN-202403USA000441US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
236262543$23626254$3$F$20230101$20240724$20240313$20240801$EXP$$US-ALXN-202403USA000419US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
236262572$23626257$2$F$$20240715$20240313$20240718$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-200947$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240718$$CN$CA$CA
236262632$23626263$2$F$20240306$20240820$20240313$20240822$PER$$US-AMGEN-USASP2024050640$AMGEN$$73$YR$E$M$Y$$$20240822$$CN$US$US
236262782$23626278$2$F$20240302$20240611$20240313$20240729$PER$$US-TRAVERE-2024TVT00238$TRAVERE THERAPEUTICS$$52$YR$A$F$Y$$$20240729$$CN$US$US
236263113$23626311$3$F$20240801$20240916$20240313$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040294$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240918$$CN$US$US
236263162$23626316$2$F$$20240619$20240313$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02006$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236263342$23626334$2$F$$20240530$20240313$20240822$PER$$US-TRAVERE-2024TVT00246$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
236263962$23626396$2$F$$20240710$20240313$20240725$EXP$$CA-SERVIER-S24002415$SERVIER$Jiang MR, Ahmet A, Lawrence S, Bassal M, Speckert M, Geraghty MT et al.. Hypoglycemia Associated With PEG-asparaginase and 6-MP Therapy During Treatment of Acute Lymphoblastic Leukemia in Pediatric Patients: A Case Series. Pediatric Hematology and Oncology. 2024;46(2):e121-e126$$$$$Y$$$20240725$$MD$CA$CA
236264773$23626477$3$F$20240119$20240916$20240313$20240920$EXP$$AU-TAKEDA-2023TUS048481$TAKEDA$$40$YR$$F$Y$$$20240920$$HP$AU$AU
236264913$23626491$3$F$$20240620$20240313$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-01963$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236264962$23626496$2$F$$20240710$20240313$20240725$EXP$$CA-SERVIER-S24002424$SERVIER$Jiang MR, Ahmet A., Lawrence S., Bassal M., Speckert M., Geraghty MT et al.. Hypoglycemia associated with PEG-asparaginase and 6-MP therapy during treatment of acute lymphoblastic leukemia in pediatric patients: A case series.. Journal of Pediatric Hematology Oncology. 2024;46(2):e121-e126$$$$$Y$$$20240725$$MD$CA$CA
236265015$23626501$5$F$$20240910$20240313$20240920$EXP$$PT-CELLTRION INC.-2024PT005886$CELLTRION$Machado AI, Marques M, Vieira M.. Cystoid Macular Edema: A Rare Adverse Reaction to Rituximab.. Cureus. 2024$$$$$Y$$$20240920$$MD$PT$PT
236265132$23626513$2$F$$20240826$20240313$20240829$EXP$$CA-Orion Corporation ORION PHARMA-24_00028829$ORION$$46$YR$A$M$Y$$$20240829$$HP$CA$
236265934$23626593$4$F$$20240812$20240313$20240814$EXP$$GB-ABBVIE-5669219$ABBVIE$$35$YR$$M$Y$$$20240814$$MD$GB$GB
236266396$23626639$6$F$20240221$20240730$20240313$20240801$EXP$$CA-INCYTE CORPORATION-2024IN001995$INCYTE$$$$$$Y$$$20240801$$MD$CA$CA
236266722$23626672$2$F$20231214$20240805$20240313$20240814$EXP$FR-AFSSAPS-LY2024000209$FR-TEVA-VS-3166244$TEVA$$62$YR$$F$Y$57$KG$20240814$$HP$FR$FR
236267232$23626723$2$F$$20240816$20240313$20240820$PER$$US-PFIZER INC-202400063054$PFIZER$$65$YR$$F$Y$$$20240820$$CN$US$US
236267254$23626725$4$F$20210723$20240924$20240313$20240930$PER$$US-PFIZER INC-202400063218$PFIZER$$60$YR$$F$Y$86.18$KG$20240930$$CN$US$US
236267374$23626737$4$F$$20240820$20240313$20240823$30DAY$$KR-PFIZER INC-PV202400023105$PFIZER$$7$YR$$$Y$$$20240823$$HP$KR$KR
236267872$23626787$2$F$$20240825$20240313$20240828$EXP$$CA-PFIZER INC-202400061861$PFIZER$$46$YR$$M$Y$$$20240828$$CN$CA$CA
236268144$23626814$4$F$$20240625$20240313$20240709$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-01962$LUPIN$$$$$$Y$$$20240709$$CN$US$US
236268454$23626845$4$F$20240301$20240815$20240313$20240826$PER$$CA-BRACCO-2024CA01017$BRACCO$$60$YR$$M$Y$$$20240826$$HP$CA$CA
236268693$23626869$3$F$$20240705$20240313$20240709$EXP$$CA-PFIZER INC-202400059392$PFIZER$$7$YR$$M$Y$31$KG$20240709$$HP$CA$CA
236268723$23626872$3$F$20240131$20240815$20240313$20240816$EXP$$JP-PFIZER INC-202400061840$PFIZER$$71$YR$$M$Y$57.7$KG$20240816$$PH$JP$JP
236268757$23626875$7$F$20230228$20240924$20240313$20240926$EXP$$BR-PFIZER INC-PV202300039797$PFIZER$$51$YR$$M$Y$84$KG$20240926$$MD$BR$BR
236268862$23626886$2$F$20240228$20240830$20240313$20240903$PER$$US-AMGEN-USASP2024051496$AMGEN$$$$$F$Y$$$20240903$$CN$US$US
236269305$23626930$5$F$20231120$20240919$20240313$20240925$EXP$$CA-PFIZER INC-202300359365$PFIZER$$50$YR$$F$Y$$$20240925$$HP$CA$CA
236269372$23626937$2$F$$20240702$20240313$20240705$EXP$$CA-PFIZER INC-202400062342$PFIZER$$60$YR$$M$Y$65$KG$20240705$$HP$CA$CA
2362701512$23627015$12$F$20240101$20240903$20240313$20240911$PER$$US-UNITED THERAPEUTICS-UNT-2024-006614$UNITED THERAPEUTICS$$$$$F$Y$87.075$KG$20240911$$$US$US
236270526$23627052$6$F$20240101$20240808$20240313$20240919$PER$$US-KARYOPHARM-2024KPT000599$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240919$$MD$US$US
236270572$23627057$2$F$$20240307$20240313$20240925$PER$$US-GSK-US2024AMR031289$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
236270694$23627069$4$F$20240423$20240712$20240313$20240721$EXP$$US-SPRINGWORKS THERAPEUTICS-SW-001247$SPRINGWORKS THERAPEUTIC$$43$YR$$F$Y$$$20240719$$CN$US$US
236270922$23627092$2$F$$20240906$20240313$20240910$PER$$US-ALXN-202403USA000555US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
236271784$23627178$4$F$20240306$20240722$20240313$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202402017345$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240725$$CN$US$US
236271888$23627188$8$F$20211220$20240704$20240313$20240711$EXP$$JP-PFIZER INC-PV202400033614$PFIZER$Komatsu, S.. Disseminated intravascular coagulation induced by the combination therapy of encorafenib and binimetinib in a melanoma case. Japanese Dermatological Association. 2024;1-2$51$YR$$M$Y$$$20240711$$HP$JP$JP
236272413$23627241$3$F$20230301$20240912$20240313$20240918$EXP$$DE-MYLANLABS-2024M1021746$MYLAN$$52$YR$$M$Y$$$20240918$$MD$DE$DE
236273192$23627319$2$F$$20240304$20240313$20240926$PER$$US-GSK-US2024AMR030665$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
236273293$23627329$3$F$$20240731$20240313$20240806$PER$$US-BIOGEN-2024BI01253352$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
236273353$23627335$3$F$20240123$20240327$20240313$20240731$PER$$US-BAYER-2024A037072$BAYER$$41$YR$A$F$Y$$$20240731$$CN$US$US
236273482$23627348$2$F$20240307$20240911$20240313$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US027308$SANDOZ$$23$YR$$M$Y$$$20240912$$HP$US$US
236273559$23627355$9$F$$20240803$20240313$20240807$30DAY$$US-PFIZER INC-202400046425$PFIZER$$9$YR$$F$Y$23.13$KG$20240807$$CN$US$US
236273592$23627359$2$F$20240307$20240315$20240313$20240801$PER$$US-BAYER-2024A037194$BAYER$$45$YR$A$F$Y$$$20240801$$HP$US$US
236273892$23627389$2$F$20240110$20240815$20240313$20240821$EXP$$ZA-Vifor (International) Inc.-VIT-2024-02166$VIFOR$$48$YR$$M$Y$$$20240821$$CN$ZA$ZA
236273903$23627390$3$F$20240220$20240820$20240313$20240828$EXP$$CA-TAKEDA-2024TUS022544$TAKEDA$$45$YR$$M$Y$$$20240828$$MD$CA$CA
236274172$23627417$2$F$20240401$20240705$20240313$20240710$EXP$$US-SA-2024SA079823$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240710$$CN$US$US
236274494$23627449$4$F$$20240801$20240313$20240811$EXP$$DE-TEVA-VS-3137867$TEVA$$$$$F$Y$$$20240811$$CN$DE$DE
236275023$23627502$3$F$20181022$20240326$20240313$20240911$EXP$$XI-TEVA-VS-3166527$TEVA$$80$YR$$F$Y$$$20240911$$HP$GB$GB
236275242$23627524$2$F$20230901$20240801$20240313$20240816$PER$$US-GRANULES-US-2024GRASPO00049$GRANULES INDIA$$60$YR$A$F$Y$170$KG$20240816$$CN$US$US
236275553$23627555$3$F$$20240703$20240313$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-039843$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240709$$MD$JP$JP
236275845$23627584$5$F$20211021$20240820$20240313$20240826$EXP$$CO-TAKEDA-2021TUS034380$TAKEDA$$38$YR$$F$Y$63$KG$20240826$$CN$CO$CO
236276062$23627606$2$F$20240101$20240227$20240313$20240812$PER$$US-PURACAP-US-2024EPCSPO00275$PURACAP$$79$YR$E$M$Y$97.5$KG$20240812$$PH$US$US
236276082$23627608$2$F$$20240306$20240313$20240906$EXP$$NVSC2024US050037$NOVARTIS$$$$$F$Y$$$20240907$$CN$US$US
236276202$23627620$2$F$20240209$20240625$20240313$20240709$EXP$$FR-VER-202400002$VERITY PHARMACEUTICALS$$67$YR$E$M$Y$80$KG$20240709$$MD$FR$FR
236276574$23627657$4$F$$20240823$20240313$20240830$EXP$$US-ABBVIE-5674942$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
236276863$23627686$3$F$$20240909$20240313$20240911$PER$$US-PFIZER INC-202400061485$PFIZER$$61$YR$$F$Y$$$20240911$$HP$US$US
236277242$23627724$2$F$$20240304$20240313$20240716$EXP$NL-LRB-00947164$NL-TEVA-VS-3168187$TEVA$$67$YR$$M$Y$88$KG$20240716$$MD$NL$NL
236277314$23627731$4$F$$20240820$20240313$20240912$PER$$US-BEH-2024169323$CSL BEHRING$$61$YR$A$F$Y$$$20240912$$HP$US$US
236277895$23627789$5$F$20240201$20240910$20240313$20240912$EXP$$NVSC2024AU004616$NOVARTIS$$50$YR$$F$Y$$$20240912$$HP$AU$AU
236278034$23627803$4$F$$20240910$20240313$20240912$PER$$US-AMGEN-USASP2024050045$AMGEN$$54$YR$A$F$Y$$$20240912$$HP$US$US
236278042$23627804$2$F$20190101$20240920$20240313$20240926$EXP$$US-AMGEN-USASP2024051219$AMGEN$$71$YR$E$M$Y$$$20240926$$CN$US$US
236278072$23627807$2$F$$20240625$20240313$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02010$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236278132$23627813$2$F$$20240723$20240313$20240802$PER$$US-BIOVITRUM-CTI2023US04375$BIOVITRUM$$69$YR$$F$Y$$$20240802$$CN$US$US
236278762$23627876$2$F$20231002$20240716$20240313$20240726$EXP$FR-AFSSAPS-AN2024000179$FR-TEVA-VS-3166971$TEVA$$74$YR$$M$Y$$$20240726$$MD$FR$FR
236279502$23627950$2$F$20230101$20240306$20240313$20240827$EXP$$AU-009507513-2403AUS001857$MERCK$$48$YR$$F$Y$$$20240827$$MD$AU$AU
236279754$23627975$4$F$20231101$20240716$20240313$20240718$EXP$$US-ABBVIE-5675463$ABBVIE$$38$YR$$M$Y$91$KG$20240718$$MD$US$US
236279762$23627976$2$F$20240201$20240610$20240313$20240730$EXP$$DE-TEVA-VS-3161764$TEVA$$27$YR$$F$Y$$$20240730$$CN$DE$DE
236280012$23628001$2$F$20230818$20240715$20240313$20240722$EXP$IT-MINISAL02-973975$IT-ABBVIE-5676377$ABBVIE$$2$MON$$M$Y$$$20240722$$MD$IT$IT
236280323$23628032$3$F$20230808$20240703$20240313$20240715$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2023FOS000933$RIGEL PHARMACEUTICALS$$80$YR$$M$Y$60$KG$20240715$$MD$JP$JP
236281082$23628108$2$F$$20240716$20240313$20240722$EXP$$US-SA-2024SA080635$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240722$$MD$US$US
236281223$23628122$3$F$20240226$20240830$20240313$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-038409$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240904$$MD$JP$JP
236281546$23628154$6$F$20240628$20240828$20240313$20240905$EXP$$US-Calliditas-2024CAL00369$CALLIDITAS THERAPEUTICS$$74$YR$E$M$Y$94.8$KG$20240905$$CN$US$US
236281642$23628164$2$F$$20240625$20240313$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02037$LUPIN$$$$$$Y$$$20240709$$CN$US$US
236281653$23628165$3$F$20240221$20240627$20240313$20240703$EXP$$KR-VALIDUS PHARMACEUTICALS LLC-KR-VDP-2024-019154$VALIDUS$$$$$$Y$$$20240703$$MD$KR$KR
236281673$23628167$3$F$20230401$20240919$20240313$20240926$EXP$$CA-GSK-CA2024031618$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CA$CA
236281743$23628174$3$F$20231105$20240802$20240313$20240806$EXP$$NVSC2024US050212$NOVARTIS$$78$YR$$F$Y$$$20240806$$CN$US$US
236282112$23628211$2$F$$20240920$20240313$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039172$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240925$$CN$US$US
236282163$23628216$3$F$$20240625$20240313$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02036$LUPIN$$$$$$Y$$$20240709$$CN$US$US
236282403$23628240$3$F$$20240626$20240313$20240718$PER$$US-INCYTE CORPORATION-2024IN000632$INCYTE$$$$$$Y$$$20240718$$CN$US$US
236282573$23628257$3$F$$20240815$20240313$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039332$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240822$$HP$US$US
236282697$23628269$7$F$20240322$20240614$20240313$20240702$30DAY$$US-JNJFOC-20240318499$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240702$$CN$US$US
236282946$23628294$6$F$$20240917$20240313$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040494$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240925$$CN$US$US
236283113$23628311$3$F$20230401$20240625$20240313$20240715$PER$$SV-TOLMAR, INC.-22SV035276$TOLMAR$$73$YR$$M$Y$$$20240715$$CN$SV$SV
236283324$23628332$4$F$20240101$20240628$20240313$20240705$EXP$$US-SA-2024SA080292$SANOFI AVENTIS$$62$YR$A$F$Y$72.57$KG$20240705$$MD$US$US
236283563$23628356$3$F$20240306$20240813$20240313$20240814$PER$$US-AMGEN-USASP2024050892$AMGEN$$68$YR$E$F$Y$$$20240814$$MD$US$US
236283725$23628372$5$F$20231201$20240523$20240313$20240813$EXP$$NVSC2024AR004188$NOVARTIS$$70$YR$$F$Y$$$20240813$$CN$AR$AR
236283753$23628375$3$F$$20240801$20240313$20240809$PER$$US-SA-2024SA077501$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240809$$CN$US$US
236283873$23628387$3$F$20230101$20240731$20240313$20240805$PER$$US-SA-2024SA077383$SANOFI AVENTIS$$53$YR$A$F$Y$92.533$KG$20240805$$MD$US$US
236283882$23628388$2$F$20240301$20240904$20240313$20240913$PER$$US-SA-2024SA078341$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240913$$MD$US$US
236283982$23628398$2$F$$20240820$20240313$20240829$PER$$US-SA-2024SA079978$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240829$$MD$US$US
236284107$23628410$7$F$20240201$20240814$20240313$20240828$PER$$US-SA-2024SA075275$SANOFI AVENTIS$$45$YR$A$M$Y$90.71$KG$20240828$$MD$US$US
236284542$23628454$2$F$$20240624$20240313$20240703$PER$$US-SA-2024SA077536$SANOFI AVENTIS$$$$C$M$Y$$$20240703$$MD$US$US
236284683$23628468$3$F$20240401$20240708$20240313$20240716$PER$$US-SA-2024SA077427$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240716$$MD$US$US
236284722$23628472$2$F$20240101$20240730$20240313$20240808$PER$$US-SA-2024SA078205$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240808$$MD$US$US
236284892$23628489$2$F$$20240903$20240313$20240912$PER$$US-SA-2024SA076847$SANOFI AVENTIS$$31$YR$A$M$Y$74.376$KG$20240912$$MD$US$US
236284943$23628494$3$F$20240101$20240814$20240313$20240828$PER$$US-SA-2024SA078313$SANOFI AVENTIS$$12$YR$T$F$Y$64$KG$20240829$$MD$US$US
236285083$23628508$3$F$$20240819$20240313$20240829$PER$$US-SA-2024SA079754$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240829$$MD$US$US
236285354$23628535$4$F$$20240813$20240313$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA026871$SANDOZ$$$$$M$Y$$$20240828$$MD$CA$CA
236285394$23628539$4$F$$20240911$20240313$20240918$EXP$$JP-009507513-2402JPN002670J$MERCK$$7$DEC$$F$Y$$$20240918$$MD$JP$JP
236285842$23628584$2$F$$20240809$20240313$20240821$PER$$US-SA-2024SA030605$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240821$$CN$US$US
236285913$23628591$3$F$$20240725$20240313$20240730$PER$$US-SA-2024SA079911$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240730$$MD$US$US
236285982$23628598$2$F$$20240720$20240313$20240729$PER$$US-SA-2024SA080293$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240729$$MD$US$US
236286444$23628644$4$F$$20240624$20240313$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038818$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240702$$CN$US$US
236286454$23628645$4$F$$20240806$20240313$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038159$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240809$$CN$US$US
236286712$23628671$2$F$20160919$20240809$20240313$20240816$EXP$$BR-GSK-BR2016GSK093283$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$BR$BR
236286922$23628692$2$F$$20240902$20240313$20240903$EXP$$DE-SANDOZ INC.-NVSC2023DE071665$SANDOZ$$14$MON$$M$Y$$$20240903$$MD$DE$DE
236287055$23628705$5$F$20240301$20240711$20240313$20240718$PER$$US-Eisai-EC-2024-161352$EISAI$$$$$M$Y$166$KG$20240718$$MD$US$US
236287502$23628750$2$F$20240122$20240812$20240313$20240814$EXP$FR-AFSSAPS-NT2024000162$FR-PFIZER INC-202400061207$PFIZER$$67$YR$$M$Y$$$20240814$$PH$FR$FR
236287725$23628772$5$F$20240302$20240705$20240313$20240709$EXP$$NVSC2024US052156$NOVARTIS$$1$YR$$M$Y$$$20240709$$CN$US$US
236287784$23628778$4$F$20230111$20240805$20240313$20240812$EXP$$FR-MYLANLABS-2024M1022172$MYLAN$$25$YR$$F$Y$54$KG$20240812$$HP$FR$FR
236288273$23628827$3$F$20240101$20240801$20240313$20240810$PER$$US-SA-2024SA078080$SANOFI AVENTIS$$40$YR$A$M$Y$100$KG$20240810$$MD$US$US
236288382$23628838$2$F$20240812$20240813$20240313$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202403006275$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240815$$CN$US$US
236288443$23628844$3$F$$20240808$20240313$20240815$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000523$BLUEPRINT MEDICINES$$$$$F$Y$$$20240816$$CN$US$US
236288834$23628883$4$F$$20240813$20240313$20240819$EXP$$CA-PFIZER INC-202400061949$PFIZER$$71$YR$$M$Y$$$20240819$$HP$CA$CA
236289093$23628909$3$F$$20240711$20240313$20240717$PER$$US-PFIZER INC-PV202400034736$PFIZER$$67$YR$$M$Y$95.238$KG$20240717$$CN$US$US
236289264$23628926$4$F$$20240819$20240313$20240829$EXP$$CA-CIPHER-2024-CA-000158$CIPHER$$41$YR$A$F$Y$$$20240829$$HP$CA$CA
236289373$23628937$3$F$$20240715$20240313$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040784$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240718$$CN$US$US
236289852$23628985$2$F$20240311$20240731$20240313$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040599$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$$$20240805$$HP$US$US
236289873$23628987$3$F$20240208$20240823$20240313$20240829$EXP$$JP-009507513-2403JPN001028J$MERCK$$67$YR$$M$Y$$$20240829$$HP$JP$JP
236290454$23629045$4$F$20240206$20240912$20240313$20240919$PER$$NL-Eisai-EC-2024-159228$EISAI$$68$YR$E$M$Y$$$20240919$$MD$NL$NL
236290512$23629051$2$F$$20240814$20240313$20240828$PER$$US-SA-2024SA078277$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240828$$MD$US$US
236290522$23629052$2$F$$20240726$20240313$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-035790$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$85.73$KG$20240730$$CN$US$US
236291063$23629106$3$F$20230101$20240910$20240313$20240919$PER$$JP-Eisai-EC-2023-148610$EISAI$$$$E$F$Y$$$20240919$$MD$JP$JP
236291134$23629113$4$F$20240208$20240808$20240313$20240813$PER$$JP-Eisai-EC-2024-161214$EISAI$$75$YR$E$M$Y$62$KG$20240813$$PH$JP$JP
236291143$23629114$3$F$20240201$20240803$20240313$20240813$EXP$$JP-Eisai-EC-2024-161403$EISAI$$44$YR$A$M$Y$$$20240813$$MD$JP$JP
236291173$23629117$3$F$20230911$20240626$20240313$20240703$PER$$JP-Eisai-EC-2023-152224$EISAI$Taniguchi H. A case of metastatic renal cancer with pulmonary lymphangitic carcinomatosis treated with pembrolizumab plus lenvatinib. The 111th Annual Meeting of the Japanese Urological Association (Program and Abstracts). 2024;$$$E$F$Y$46$KG$20240703$$MD$JP$JP
236291414$23629141$4$F$20231019$20240719$20240313$20240724$PER$$JP-Eisai-EC-2024-161207$EISAI$$$$E$M$Y$53$KG$20240724$$MD$JP$JP
236291537$23629153$7$F$20240801$20240828$20240313$20240905$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000506$BLUEPRINT MEDICINES$$65$YR$E$M$Y$$$20240906$$CN$US$US
236292854$23629285$4$F$20230911$20240626$20240313$20240702$EXP$$JP-009507513-2309JPN003781J$MERCK$Taniguchi H, Iwamoto K. PP-58-02 A case of metastatic renal cancer with pulmonary lymphangitic carcinomatosis treated with pembrolizumab plus lenvatinib. The 111th Annual Meeting of the Japanese Urological Association. 1099$8$DEC$$F$Y$$$20240702$$MD$JP$JP
236293302$23629330$2$F$$20240723$20240313$20240726$EXP$$CA-ABBVIE-5676300$ABBVIE$$$$A$M$Y$$$20240726$$CN$CA$CA
236293784$23629378$4$F$20240101$20240701$20240313$20240703$EXP$$HU-ABBVIE-5674296$ABBVIE$$$$$F$Y$$$20240703$$CN$HU$HU
236294046$23629404$6$F$20231218$20240719$20240313$20240729$EXP$$CA-CELLTRION INC.-2023CA025048$CELLTRION$$$$$$Y$$$20240729$$CN$CA$CA
236294473$23629447$3$F$20240305$20240708$20240313$20240723$EXP$$JP-ALXN-202403JPN000316JP$ALEXION PHARMACEUTICALS$$73$YR$$F$Y$42.6$KG$20240723$$MD$JP$JP
236295262$23629526$2$F$20240303$20240701$20240314$20240711$30DAY$$US-GSK-US2024028314$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240711$$CN$US$US
236295515$23629551$5$F$20221201$20240812$20240314$20240813$EXP$$NL-JNJFOC-20240327452$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240813$$MD$NL$NL
236295984$23629598$4$F$$20240725$20240314$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-041004$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240801$$MD$JP$JP
236296392$23629639$2$F$20220101$20240724$20240314$20240821$PER$$CA-TOLMAR, INC.-24CA046816$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
236296414$23629641$4$F$20240209$20240906$20240314$20240916$EXP$$CN-AMGEN-CHNNI2024048993$AMGEN$$$$$F$Y$55$KG$20240915$$MD$CN$CN
236296902$23629690$2$F$$20240916$20240314$20240920$EXP$$US-AMGEN-USASP2024047822$AMGEN$$$$A$M$Y$$$20240919$$HP$US$US
2362969810$23629698$10$F$20240101$20240917$20240314$20240926$EXP$$CA-CELLTRION INC.-2024CA000783$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
236297177$23629717$7$F$$20240924$20240314$20240927$EXP$$US-TAKEDA-2023TUS107978$TAKEDA$$$$$F$Y$$$20240927$$MD$US$US
236297383$23629738$3$F$$20240903$20240314$20240907$EXP$$NVSC2024GB051203$NOVARTIS$$$$$M$Y$$$20240907$$CN$GB$GB
236297562$23629756$2$F$$20240701$20240314$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038649$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240703$$CN$US$US
236297672$23629767$2$F$$20240704$20240314$20240712$EXP$$NL-CELLTRION INC.-2024NL005646$CELLTRION$$$$$$Y$$$20240712$$HP$NL$NL
236297822$23629782$2$F$20230101$20240620$20240314$20240704$EXP$$US-ROCHE-3525147$ROCHE$$84$YR$E$F$Y$$$20240704$$CN$US$US
236298155$23629815$5$F$20231111$20240730$20240314$20240806$EXP$$US-VIIV HEALTHCARE LIMITED-US2024029858$VIIV$$$$$$Y$$$20240806$$MD$US$US
236298222$23629822$2$F$$20240625$20240314$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02002$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236298263$23629826$3$F$20240101$20240708$20240314$20240711$EXP$$JP-JNJFOC-20240334918$JOHNSON AND JOHNSON$$23$YR$A$M$Y$65.6$KG$20240712$$PH$JP$JP
236298522$23629852$2$F$20240308$20240709$20240314$20240711$PER$$US-AMGEN-USASP2024052015$AMGEN$$56$YR$A$F$Y$$$20240710$$CN$US$US
236298716$23629871$6$F$20240229$20240722$20240314$20240730$30DAY$$US-AMGEN-USASL2024048843$AMGEN$$74$YR$E$F$Y$$$20240729$$PH$US$US
236299242$23629924$2$F$20240115$20240826$20240314$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-011054$AUROBINDO$$54$YR$$M$Y$$$20240904$$PH$FR$FR
236299253$23629925$3$F$$20240731$20240314$20240819$EXP$$CA-HALEON-CACH2024AMR012532$Haleon PLC$$43$YR$$F$Y$68$KG$20240816$$HP$CA$CA
236299646$23629964$6$F$20240309$20240924$20240314$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039771$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$89.81$KG$20240927$$CN$US$US
236299682$23629968$2$F$20240221$20240611$20240314$20240703$PER$$CA-TOLMAR, INC.-24CA047093$TOLMAR$$76$YR$$M$Y$$$20240703$$CN$CA$CA
236299703$23629970$3$F$20240221$20240809$20240314$20240828$PER$$CA-TOLMAR, INC.-24CA047124$TOLMAR$$75$YR$$M$Y$$$20240828$$CN$CA$CA
236299822$23629982$2$F$$20240802$20240314$20240808$EXP$$NVSC2024US054168$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
236300272$23630027$2$F$20230101$20240909$20240314$20240912$30DAY$$EG-SANDOZ INC.-SDZ2024EG023932$SANDOZ$$$$$M$Y$$$20240912$$CN$EG$EG
236300842$23630084$2$F$20240201$20240709$20240314$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040829$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240710$$HP$US$US
236301352$23630135$2$F$$20240723$20240314$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001152$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$CN$US$US
236302424$23630242$4$F$20240201$20240814$20240314$20240826$EXP$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000227$DECIPHERA PHARMACEUTICALS$$48$YR$A$F$Y$$$20240826$$CN$US$US
236302604$23630260$4$F$20171030$20240815$20240314$20240822$EXP$$BE-ABBVIE-17K-013-3089505-00$ABBVIE$$71$YR$$M$Y$$$20240822$$MD$BE$BE
236303772$23630377$2$F$20240306$20240819$20240314$20240822$PER$$US-AMGEN-USASP2024049941$AMGEN$$52$YR$A$F$Y$$$20240822$$CN$US$US
236303813$23630381$3$F$$20240919$20240314$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041082$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$72.57$KG$20240920$$CN$US$US
236303898$23630389$8$F$20230101$20240908$20240314$20240920$EXP$$CA-UCBSA-2023039319$UCB$$$$$F$Y$$$20240920$$CN$CA$CA
236303972$23630397$2$F$20230101$20240912$20240314$20240925$EXP$$CA-UCBSA-2023061508$UCB$$$$$F$Y$$$20240925$$CN$CA$CA
236305013$23630501$3$F$20240101$20240808$20240314$20240812$EXP$$US-ABBVIE-5676551$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
236305074$23630507$4$F$20200214$20240702$20240314$20240706$EXP$$US-ABBVIE-4767732$ABBVIE$$46$YR$$M$Y$$$20240706$$CN$US$US
236305092$23630509$2$F$20231101$20240916$20240314$20240920$EXP$$US-ABBVIE-5676053$ABBVIE$$71$YR$$M$Y$$$20240920$$CN$US$US
236305633$23630563$3$F$$20240702$20240314$20240708$EXP$$PT-AUROBINDO-AUR-APL-2024-010996$AUROBINDO$Pedro F. Moura, Ana Silva, Lara Maia, Pedro Neves, Isabel MD.MD. Freitas, In?s Albuquerque, et al. UNCOMMON SKIN RASH ON PUERPERAL WOMAN.. European Journal of Case Reports in Internal Medicine ? EFIM 2021.. 2021;335$28$YR$$F$Y$$$20240708$$HP$PT$PT
236305975$23630597$5$F$20240215$20240626$20240314$20240708$EXP$$RU-ROCHE-3513918$ROCHE$$42$YR$A$M$Y$$$20240708$$HP$RU$RU
236306144$23630614$4$F$$20240725$20240314$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-041289$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240802$$MD$JP$JP
236306252$23630625$2$F$$20240710$20240314$20240712$PER$$NVSC2024US055586$NOVARTIS$$$$$$Y$$$20240712$$HP$US$US
236306354$23630635$4$F$20231030$20240702$20240314$20240712$EXP$FR-AFSSAPS-NY2024000195$FR-TEVA-VS-3166924$TEVA$$44$YR$$F$Y$$$20240712$$MD$FR$FR
236306872$23630687$2$F$$20240709$20240314$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040838$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240711$$CN$US$US
236307103$23630710$3$F$$20240730$20240314$20240809$EXP$US-STRIDES ARCOLAB LIMITED-2024SP002999$US-STRIDES ARCOLAB LIMITED-2024SP002999$STRIDES$Le V, Surineni K, Elias G.. A Case of Partially Reversible Oral-buccal-lingual Dyskinesia after Prolonged Levetiracetam Exposure.. Am-J-Geriatr-Psychiatry. 2024;32 (Suppl.) (4):S106.$86$YR$$F$Y$$$20240809$$MD$US$US
236307119$23630711$9$F$20240101$20240815$20240314$20240823$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000190$DECIPHERA PHARMACEUTICALS$$78$YR$E$F$Y$58.9$KG$20240823$$MD$US$US
236307273$23630727$3$F$20240211$20240906$20240314$20240912$EXP$$AU-TAKEDA-2023TUS099287$TAKEDA$$27$YR$$F$Y$$$20240912$$CN$AU$AU
236307442$23630744$2$F$20240308$20240821$20240314$20240824$PER$$US-AMGEN-USASP2024050639$AMGEN$$56$YR$A$F$Y$$$20240824$$CN$US$US
236307622$23630762$2$F$$20240711$20240314$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000207$DECIPHERA PHARMACEUTICALS$$36$YR$A$M$Y$$$20240731$$CN$US$US
236307732$23630773$2$F$20240123$20240619$20240314$20240704$EXP$FR-AFSSAPS-RE2024000105$FR-TEVA-VS-3166808$TEVA$$71$YR$$F$Y$61$KG$20240704$$MD$FR$FR
236307763$23630776$3$F$20240201$20240701$20240314$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-038618$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240705$$MD$JP$JP
236307883$23630788$3$F$20240301$20240625$20240314$20240711$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000213$DECIPHERA PHARMACEUTICALS$$74$YR$E$F$Y$$$20240711$$CN$US$US
236308023$23630802$3$F$$20240503$20240314$20240731$EXP$$US-AstraZeneca-2024A056604$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
236308572$23630857$2$F$20240113$20240808$20240314$20240818$EXP$FR-AFSSAPS-PV2024000107$FR-TEVA-VS-3166183$TEVA$$14$YR$$F$Y$67$KG$20240818$$PH$FR$FR
236308732$23630873$2$F$20240219$20240725$20240314$20240807$EXP$$DE-AUROBINDO-AUR-APL-2024-010992$AUROBINDO$$38$WK$$M$Y$2.9$KG$20240807$$HP$DE$DE
236309122$23630912$2$F$$20240625$20240314$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02016$LUPIN$$$$$$Y$$$20240709$$CN$US$US
236309233$23630923$3$F$20240507$20240708$20240314$20240717$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007511$UNITED THERAPEUTICS$$56$YR$$M$Y$60.771$KG$20240717$$$US$US
236309302$23630930$2$F$20240215$20240919$20240314$20240923$EXP$$JP-EMD Serono-2024011883$EMD SERONO INC$$82$YR$E$M$Y$54$KG$20240923$$MD$JP$JP
236309632$23630963$2$F$20240310$20240311$20240314$20240927$PER$$US-AMGEN-USASP2024050343$AMGEN$$55$YR$A$M$Y$$$20240927$$CN$US$US
236309673$23630967$3$F$20240101$20240820$20240314$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007274$UNITED THERAPEUTICS$$$$$F$Y$91.61$KG$20240829$$$US$US
236309697$23630969$7$F$20231201$20240828$20240314$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007307$UNITED THERAPEUTICS$$66$YR$$M$Y$82.54$KG$20240906$$$US$US
236309743$23630974$3$F$20240112$20240819$20240314$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040424$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240826$$CN$US$US
236309834$23630983$4$F$20240216$20240410$20240314$20240808$EXP$$NVSC2024RU048449$NOVARTIS$$57$YR$$F$Y$$$20240808$$HP$RU$RU
236310303$23631030$3$F$20230116$20240715$20240314$20240723$EXP$$GB-JNJFOC-20240315683$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240722$$MD$GB$GB
236310376$23631037$6$F$$20240909$20240314$20240911$EXP$$FR-SANDOZ INC.-NVSC2020FR043746$SANDOZ$$9$YR$$M$Y$$$20240911$$MD$FR$FR
236310642$23631064$2$F$$20240808$20240314$20240819$EXP$$US-ROCHE-3525499$ROCHE$$80$YR$E$M$Y$$$20240819$$CN$US$US
236310722$23631072$2$F$$20240702$20240314$20240709$EXP$$BR-GSK-BR2024AMR004685$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$BR$BR
236310842$23631084$2$F$20231201$20240719$20240314$20240724$EXP$$CA-JNJFOC-20231263586$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240724$$CN$CA$CA
236311033$23631103$3$F$$20240723$20240314$20240724$EXP$$GB-SANDOZ INC.-SDZ2024GB027145$SANDOZ$$$$$M$Y$$$20240724$$CN$GB$GB
236311354$23631135$4$F$$20240628$20240314$20240702$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-041299$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$45.36$KG$20240703$$CN$PR$PR
236311466$23631146$6$F$20240202$20240911$20240314$20240920$EXP$$FR-CELLTRION INC.-2024FR005712$CELLTRION$$$$$$Y$$$20240920$$MD$FR$FR
236311563$23631156$3$F$20240306$20240823$20240314$20240831$EXP$$CA-CELLTRION INC.-2024CA006268$CELLTRION$$$$$$Y$$$20240831$$HP$CA$CA
236311574$23631157$4$F$20150101$20240904$20240314$20240905$EXP$$NVSC2024AU054898$NOVARTIS$$33$YR$$F$Y$$$20240905$$MD$AU$AU
236311618$23631161$8$F$$20240923$20240314$20240926$EXP$$US-TAKEDA-2024TUS010327$TAKEDA$$$$$F$Y$73$KG$20240926$$CN$US$US
236311762$23631176$2$F$$20240912$20240314$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-435911$RANBAXY$Heis F, Khan M, Mohan G, Weiner SM. Methotrexate-Induced Hypersensitivity Pneumonitis. Am J Respir Crit Care Med. 2023;207:-$72$YR$$F$Y$$$20240927$$HP$US$US
236311822$23631182$2$F$20230608$20240703$20240314$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-436367$RANBAXY$$70$YR$$M$Y$$$20240718$$PH$ES$ES
236312222$23631222$2$F$20230101$20240628$20240314$20240701$EXP$$JP-DSJP-DSJ-2024-110663AA$DAIICHI$$71$YR$$F$Y$39.4$KG$20240701$$MD$JP$JP
236312253$23631225$3$F$$20240705$20240314$20240709$PER$$US-ALXN-202403USA000608US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
236312372$23631237$2$F$$20240701$20240314$20240709$EXP$$UY-MYLANLABS-2024M1023858$MYLAN$Cunetti L, Oricchio F, Vazquez M, Peyraube R, Manzo L, Nalerio C, et al. Drug-Drug Interaction Between Cannabidiol, Cyclosporine, and Mycophenolate Mofetil: A Case Report. Transplant-Proc 2024; 56 (1): 252-256.$50$YR$$M$Y$$$20240709$$HP$UY$UY
236312452$23631245$2$F$20230604$20240807$20240314$20240812$EXP$$SA-GSK-SA2023EME097226$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$SA$SA
236312712$23631271$2$F$$20240702$20240314$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039562$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240711$$CN$US$US
236312806$23631280$6$F$20240201$20240906$20240314$20240916$EXP$$CA-CELLTRION INC.-2024CA006265$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
2363131915$23631319$15$F$$20240915$20240314$20240919$30DAY$$US-PFIZER INC-PV202400032127$PFIZER$$15$YR$$M$Y$68.027$KG$20240919$$HP$US$US
236313303$23631330$3$F$20240101$20240813$20240314$20240823$EXP$$US-UCBSA-2024011868$UCB$$$$$F$Y$$$20240823$$HP$US$US
236313472$23631347$2$F$$20240625$20240314$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02054$LUPIN$$$$$$Y$$$20240709$$CN$US$US
236314412$23631441$2$F$20240101$20240913$20240314$20240917$PER$$US-PFIZER INC-PV202400034498$PFIZER$$32$YR$$F$Y$$$20240917$$HP$US$US
236314582$23631458$2$F$20240401$20240730$20240314$20240801$EXP$$US-PFIZER INC-PV202300195891$PFIZER$$60$YR$$F$Y$$$20240801$$HP$US$US
236314646$23631464$6$F$20240325$20240816$20240314$20240822$PER$$US-PFIZER INC-202400063699$PFIZER$$72$YR$$F$Y$45.805$KG$20240822$$CN$US$US
236314742$23631474$2$F$$20240809$20240314$20240814$PER$$US-PFIZER INC-PV202300180204$PFIZER$$72$YR$$F$Y$$$20240814$$MD$US$US
236314803$23631480$3$F$$20240916$20240314$20240919$PER$$US-PFIZER INC-PV202400035135$PFIZER$$57$YR$$M$Y$$$20240919$$HP$US$US
236315053$23631505$3$F$20240101$20240709$20240314$20240718$EXP$$US-ABBVIE-5667562$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
236315134$23631513$4$F$20240308$20240805$20240314$20240809$EXP$$US-PFIZER INC-202400062568$PFIZER$$86$YR$$M$Y$90.72$KG$20240809$$CN$US$US
236315152$23631515$2$F$20240101$20240911$20240314$20240916$EXP$$CA-PFIZER INC-202400024847$PFIZER$$49$YR$$F$Y$$$20240916$$HP$CA$CA
236315212$23631521$2$F$20240101$20240916$20240314$20240919$EXP$$CA-PFIZER INC-202400019724$PFIZER$$62$YR$$F$Y$$$20240919$$CN$CA$CA
236315393$23631539$3$F$20240312$20240805$20240314$20240808$EXP$$JP-PFIZER INC-202400063244$PFIZER$$62$YR$$M$Y$57.8$KG$20240808$$MD$JP$JP
236315424$23631542$4$F$20240205$20240925$20240314$20240930$EXP$$IN-PFIZER INC-PV202300075887$PFIZER$$44$YR$$M$Y$75.3$KG$20240930$$CN$IN$IN
236315676$23631567$6$F$20240205$20240829$20240314$20240902$EXP$$SA-ROCHE-3508953$ROCHE$$6$YR$C$M$Y$24.9$KG$20240902$$CN$SA$SA
236315702$23631570$2$F$$20240805$20240314$20240806$EXP$$ES-SANDOZ INC.-SDZ2024ES026397$SANDOZ$$65$YR$$F$Y$$$20240806$$HP$ES$ES
236316243$23631624$3$F$$20240823$20240314$20240903$PER$$US-ALXN-202403USA000567US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
236316457$23631645$7$F$20240101$20240904$20240314$20240914$EXP$$US-UCBSA-2024012019$UCB$$$$$F$Y$97.522$KG$20240914$$HP$US$US
236316483$23631648$3$F$$20240625$20240314$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02056$LUPIN$$$$$$Y$$$20240709$$CN$US$US
236316989$23631698$9$F$20240209$20240915$20240314$20240919$30DAY$$US-PFIZER INC-202400047845$PFIZER$$13$YR$$M$Y$31.75$KG$20240919$$CN$US$US
236317242$23631724$2$F$$20240820$20240314$20240829$PER$$US-INCYTE CORPORATION-2024IN002434$INCYTE$$$$$$Y$$$20240829$$CN$US$US
236317282$23631728$2$F$20240201$20240716$20240314$20240723$PER$$JP-Eisai-EC-2024-160987$EISAI$$$$A$M$Y$$$20240723$$MD$JP$JP
236317732$23631773$2$F$20240102$20240710$20240314$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040201$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$60.78$KG$20240711$$CN$US$US
236318283$23631828$3$F$$20240722$20240314$20240802$EXP$$US-INSMED, INC.-2024-00966-US$INSMED$$$$$M$Y$$$20240802$$CN$US$US
236318322$23631832$2$F$20240201$20240625$20240314$20240701$PER$$US-PFIZER INC-PV202400035033$PFIZER$$45$YR$$F$Y$$$20240701$$CN$US$US
236318593$23631859$3$F$$20240619$20240314$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02052$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236319392$23631939$2$F$20240307$20240813$20240314$20240814$PER$$US-AMGEN-USASP2024051573$AMGEN$$68$YR$E$M$Y$$$20240814$$CN$US$US
236319492$23631949$2$F$20230108$20240710$20240314$20240717$PER$$JP-Eisai-EC-2024-161463$EISAI$$56$YR$A$M$Y$$$20240717$$MD$JP$JP
236319534$23631953$4$F$20240731$20240731$20240314$20240806$EXP$$US-TAKEDA-2024TUS023562$TAKEDA$$28$YR$$M$Y$$$20240806$$CN$US$US
236319852$23631985$2$F$20070101$20240909$20240314$20240916$EXP$FI-EMA-DD-20240304-7482655-050421$FI-MYLANLABS-2024M1023313$MYLAN$$$$A$M$Y$$$20240916$$CN$FI$FI
236319994$23631999$4$F$20240310$20240810$20240314$20240812$PER$$US-AMGEN-USASP2024052591$AMGEN$$64$YR$A$M$Y$$$20240812$$CN$US$US
236320402$23632040$2$F$20240119$20240830$20240314$20240910$EXP$FR-AFSSAPS-RE2024000187$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-02033$HIKMA$$50$YR$$F$Y$62$KG$20240906$$MD$FR$FR
236320594$23632059$4$F$$20240723$20240314$20240724$EXP$$US-TAKEDA-2024TUS023627$TAKEDA$$$$$M$Y$$$20240724$$PH$US$US
236320833$23632083$3$F$$20240709$20240314$20240715$EXP$$CA-TAKEDA-2023TUS117317$TAKEDA$$$$$M$Y$$$20240715$$MD$CA$CA
236321055$23632105$5$F$$20240725$20240314$20240729$EXP$$US-PFIZER INC-2020038886$PFIZER$$71$YR$$F$Y$$$20240729$$HP$US$US
236321134$23632113$4$F$$20240904$20240314$20240912$PER$$US-SA-2024SA078537$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$MD$US$US
236321222$23632122$2$F$20240101$20240904$20240314$20240930$PER$$US-SA-2024SA081604$SANOFI AVENTIS$$66$YR$E$F$Y$92.98$KG$20240930$$MD$US$US
236321315$23632131$5$F$20240224$20240816$20240314$20240828$PER$$US-SA-2024SA077446$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240828$$MD$US$US
236321702$23632170$2$F$20240101$20240701$20240314$20240710$PER$$US-SA-2024SA079094$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240710$$MD$US$US
236322072$23632207$2$F$20240101$20240816$20240314$20240829$PER$$US-SA-2024SA081409$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240829$$MD$US$US
236322164$23632216$4$F$20240430$20240814$20240314$20240827$PER$$US-SA-2024SA080400$SANOFI AVENTIS$$48$YR$A$F$Y$59$KG$20240827$$MD$US$US
236322293$23632229$3$F$$20240924$20240314$20240927$EXP$$AU-PFIZER INC-202400061814$PFIZER$Jayawardena, T.. Successful Liver Retransplantation in a Patient With Disseminated Aspergillosis and Nocardiosis: A Case Report. Transplantation Proceedings. 2024;56(1):244-248$26$YR$$M$Y$$$20240927$$MD$AU$AU
236322442$23632244$2$F$$20240706$20240314$20240709$PER$$NVSC2024US052994$NOVARTIS$$$$$$Y$$$20240709$$CN$US$US
236322804$23632280$4$F$$20240904$20240314$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041234$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240905$$CN$US$US
236323083$23632308$3$F$$20240827$20240314$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA027377$SANDOZ$$3$MON$$M$Y$$$20240829$$CN$CA$CA
236323502$23632350$2$F$$20240823$20240314$20240917$PER$$US-SA-2024SA081316$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240918$$MD$US$US
236323552$23632355$2$F$20220101$20240702$20240314$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040955$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$94.8$KG$20240703$$CN$US$US
236323723$23632372$3$F$$20240709$20240314$20240716$PER$$US-SA-2024SA080431$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240716$$CN$US$US
236323768$23632376$8$F$20240101$20240807$20240314$20240814$EXP$$US-SA-2024SA081321$SANOFI AVENTIS$$66$YR$E$M$Y$61.23$KG$20240814$$MD$US$US
236323772$23632377$2$F$$20240703$20240314$20240712$PER$$US-SA-2024SA081553$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240712$$MD$US$US
236324082$23632408$2$F$20240216$20240701$20240314$20240708$EXP$$AU-ALXN-202403OCE000416AU$ALEXION PHARMACEUTICALS$$24$YR$$F$Y$$$20240708$$PH$AU$AU
236324152$23632415$2$F$$20240625$20240314$20240704$PER$$US-SA-2024SA081169$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240704$$MD$US$US
236324422$23632442$2$F$$20240909$20240314$20240925$PER$$US-SA-2024SA082238$SANOFI AVENTIS$$$$E$F$Y$$$20240925$$MD$US$US
236324512$23632451$2$F$$20240719$20240314$20240729$PER$$US-SA-2024SA082172$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240729$$MD$US$US
236324662$23632466$2$F$20240101$20240816$20240314$20240828$PER$$US-SA-2024SA082311$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240828$$MD$US$US
236324932$23632493$2$F$$20240717$20240314$20240725$PER$$US-SA-2024SA081954$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240725$$MD$US$US
236325052$23632505$2$F$$20240920$20240314$20240924$PER$$US-PFIZER INC-PV202400034136$PFIZER$$82$YR$$F$Y$$$20240924$$HP$US$US
236325132$23632513$2$F$$20240725$20240314$20240729$PER$$US-PFIZER INC-202400062522$PFIZER$$$$$$Y$$$20240729$$CN$US$US
236325202$23632520$2$F$$20240829$20240314$20240904$PER$$US-PFIZER INC-PV202200087211$PFIZER$$81$YR$$F$Y$$$20240904$$CN$US$US
236325232$23632523$2$F$20230101$20240702$20240314$20240712$PER$$US-PFIZER INC-PV202400034452$PFIZER$$28$YR$$F$Y$$$20240712$$CN$US$US
2363256410$23632564$10$F$20240101$20240821$20240314$20240826$EXP$$JP-JNJFOC-20240213736$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240827$$MD$JP$JP
236325882$23632588$2$F$$20240823$20240314$20240917$PER$$US-SA-2024SA079016$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
236326252$23632625$2$F$$20240903$20240314$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041296$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240906$$CN$US$US
236326322$23632632$2$F$$20240701$20240314$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040055$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240701$$CN$US$US
236326332$23632633$2$F$20240105$20240802$20240314$20240805$EXP$FR-AFSSAPS-PV2024000189$NVSC2024FR052257$NOVARTIS$$3$YR$$F$Y$16$KG$20240805$$MD$FR$FR
236326356$23632635$6$F$20240101$20240703$20240314$20240710$EXP$$US-UNITED THERAPEUTICS-UNT-2024-003380$UNITED THERAPEUTICS$$$$$F$Y$68.934$KG$20240710$$$US$US
236328187$23632818$7$F$$20240709$20240314$20240716$EXP$$US-ARGENX-2024-ARGX-US000303$ARGENX BVBA$$$$$$Y$$$20240716$$CN$US$US
236329003$23632900$3$F$$20240827$20240314$20240906$EXP$$CA-FreseniusKabi-FK202403656$FRESENIUS KABI$$82$YR$E$F$Y$$$20240906$$CN$CA$CA
236329773$23632977$3$F$20240325$20240812$20240314$20240815$EXP$$US-INCYTE CORPORATION-2024IN002525$INCYTE$$$$$$Y$$$20240815$$MD$US$US
236329862$23632986$2$F$20240223$20240813$20240314$20240827$PER$$US-SA-2024SA079983$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240827$$MD$US$US
236329962$23632996$2$F$$20240628$20240314$20240703$PER$$US-JNJFOC-20240321988$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$MD$US$US
236330004$23633000$4$F$20240203$20240705$20240314$20240717$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202401002873$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240717$$CN$ES$ES
236330272$23633027$2$F$20240307$20240703$20240314$20240705$PER$$US-AMGEN-USASP2024052287$AMGEN$$73$YR$E$F$Y$$$20240705$$CN$US$US
236330439$23633043$9$F$$20240618$20240314$20240814$EXP$$NVSC2024US051680$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
236330682$23633068$2$F$$20240625$20240314$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02057$LUPIN$$$$$$Y$$$20240709$$CN$US$US
236331152$23633115$2$F$$20240918$20240314$20240925$EXP$$NVSC2024US055004$NOVARTIS$$$$$F$Y$79.3$KG$20240925$$CN$US$US
236331272$23633127$2$F$$20240625$20240314$20240704$PER$$US-SA-2024SA079575$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240704$$MD$US$US
236331282$23633128$2$F$$20240625$20240314$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02066$LUPIN$$$$$$Y$$$20240710$$CN$US$US
236332014$23633201$4$F$$20240719$20240314$20240726$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000527$BLUEPRINT MEDICINES$$$$$F$Y$$$20240726$$CN$US$US
236332182$23633218$2$F$20230701$20240718$20240314$20240729$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI02194$NEUROCRINE BIOSCIENCES$$55$YR$$F$Y$$$20240729$$HP$US$US
236332206$23633220$6$F$20221011$20240803$20240314$20240806$EXP$$FR-BAUSCH-BL-2023-019469$BAUSCH AND LOMB$$72$YR$$F$Y$48$KG$20240806$$HP$FR$FR
236332584$23633258$4$F$20240214$20240805$20240314$20240809$EXP$$JP-PFIZER INC-PV202400033186$PFIZER$$76$YR$$F$Y$45$KG$20240809$$PH$JP$JP
236332632$23633263$2$F$$20240312$20240314$20240830$EXP$$DE-ABBVIE-5679145$ABBVIE$$$$$M$Y$80$KG$20240830$$MD$DE$DE
236332662$23633266$2$F$20240729$20240729$20240314$20240807$PER$$US-SA-2024SA079639$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240807$$HP$US$US
236332892$23633289$2$F$20221208$20240820$20240314$20240829$EXP$PL-EMA-DD-20240301-7482655-074919$PL-BAXTER-2024BAX014196$BAXTER$$$$E$M$Y$$$20240829$$CN$CH$PL
236332982$23633298$2$F$$20240625$20240314$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02067$LUPIN$$$$$$Y$$$20240709$$CN$US$US
236333183$23633318$3$F$20230706$20240708$20240314$20240711$EXP$$NVSC2023GB158253$NOVARTIS$$31$YR$$F$Y$$$20240712$$CN$GB$GB
236333192$23633319$2$F$$20240827$20240314$20240902$EXP$$CA-JNJFOC-20240326571$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$HP$CA$CA
236333373$23633337$3$F$20220301$20240807$20240314$20240812$EXP$$US-INCYTE CORPORATION-2024IN002681$INCYTE$$$$$$Y$$$20240812$$CN$US$US
236333722$23633372$2$F$20240310$20240820$20240314$20240823$PER$$US-AMGEN-USASP2024052503$AMGEN$$55$YR$A$M$Y$$$20240823$$CN$US$US
236333832$23633383$2$F$20230101$20240806$20240314$20240830$PER$$CA-TOLMAR, INC.-24CA047209$TOLMAR$$$$$M$Y$$$20240830$$CN$CA$CA
236333852$23633385$2$F$20240220$20240809$20240314$20240828$PER$$CA-TOLMAR, INC.-24CA047212$TOLMAR$$76$YR$$M$Y$$$20240828$$CN$CA$CA
236334612$23633461$2$F$20240115$20240805$20240314$20240815$EXP$FR-AFSSAPS-LM2024000067$FR-TEVA-VS-3167369$TEVA$$69$YR$$M$Y$90$KG$20240815$$MD$FR$FR
236334684$23633468$4$F$$20240718$20240314$20240801$EXP$$CA-CIPHER-2024-CA-000166$CIPHER$$53$YR$A$M$Y$$$20240801$$HP$CA$CA
236334802$23633480$2$F$$20240311$20240314$20240711$EXP$$JP-AstraZeneca-2024A061428$ASTRAZENECA$$$$A$$Y$$$20240711$$MD$JP$
236334973$23633497$3$F$20231228$20240909$20240314$20240919$EXP$$NVSC2024RO051214$NOVARTIS$$59$YR$$M$Y$$$20240919$$MD$RO$RO
236335073$23633507$3$F$20231201$20240701$20240314$20240730$EXP$$DK-TEVA-VS-3137893$TEVA$$74$YR$$F$Y$$$20240730$$CN$DK$DK
236335163$23633516$3$F$20240308$20240718$20240314$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040994$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240723$$HP$US$US
236335233$23633523$3$F$20230101$20240904$20240314$20240911$EXP$$BR-JNJFOC-20240320668$JOHNSON AND JOHNSON$$28$YR$A$F$Y$43$KG$20240911$$CN$BR$BR
236335333$23633533$3$F$$20240229$20240314$20240920$PER$$US-BRAEBURN-US-BRA-24-000199$BRAEBURN PHARMACEUTICALS$$$$$M$Y$52.608$KG$20240920$$HP$US$US
236335442$23633544$2$F$20240101$20240712$20240314$20240722$EXP$$JP-009507513-2403JPN001248J$MERCK$$$$$F$Y$$$20240719$$MD$JP$JP
236335473$23633547$3$F$$20240910$20240314$20240912$EXP$$NVSC2024CA054090$NOVARTIS$$40$YR$$F$Y$97$KG$20240912$$HP$CA$CA
236336042$23633604$2$F$20210101$20240909$20240314$20240918$PER$$US-SA-2024SA081726$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240918$$MD$US$US
236336292$23633629$2$F$$20240808$20240314$20240813$EXP$$DE-BIOVITRUM-2024-DE-003838$BIOVITRUM$$68$YR$$M$Y$$$20240813$$HP$DE$DE
236337072$23633707$2$F$20240201$20240726$20240314$20240802$EXP$IT-MINISAL02-971870$IT-TEVA-VS-3169264$TEVA$$73$YR$$M$Y$$$20240802$$MD$IT$IT
236337613$23633761$3$F$20240214$20240909$20240314$20240913$EXP$$FR-AstraZeneca-2024A060280$ASTRAZENECA$$78$YR$$F$Y$82$KG$20240913$$MD$FR$
236337732$23633773$2$F$20240311$20240715$20240314$20240716$PER$$US-AMGEN-USASP2024053097$AMGEN$$63$YR$A$M$Y$91.61$KG$20240716$$MD$US$US
236337863$23633786$3$F$$20240905$20240314$20240908$30DAY$$US-SANDOZ INC.-SDZ2024US027444$SANDOZ$$$$$$Y$$$20240908$$CN$US$US
236338173$23633817$3$F$20190501$20240703$20240314$20240710$EXP$$CA-TAKEDA-2019TUS029209$TAKEDA$$54$YR$$M$Y$$$20240710$$MD$CA$CA
236338304$23633830$4$F$$20240827$20240314$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041218$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240829$$CN$US$US
236338312$23633831$2$F$$20240904$20240314$20240904$PER$$NVSC2024US055979$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
236338445$23633844$5$F$$20240821$20240314$20240823$EXP$$FR-MYLANLABS-2024M1023298$MYLAN$Amandine Darres, Arnaud Del Bello, Olivier Marion, Xavier de Lamballerie, Denis Malvy, Jacques Izopet and Nassim Kamar. Failure of favipiravir to treat chronic norovirus infection in a kidney-transplant patient. Transplant Infectious Disease. 2024;26 (1):1-2$64$YR$$M$Y$$$20240823$$HP$FR$FR
236338524$23633852$4$F$20230731$20240628$20240314$20240705$EXP$$JP-ALXN-202403JPN000092JP$ALEXION PHARMACEUTICALS$$49$YR$$F$Y$49.1$KG$20240705$$MD$JP$JP
236338812$23633881$2$F$$20240830$20240314$20240903$EXP$$GB-SANDOZ INC.-SDZ2024GB027588$SANDOZ$$$$A$M$Y$$$20240903$$CN$GB$GB
236338825$23633882$5$F$20240227$20240924$20240314$20240928$EXP$$JP-009507513-2403JPN000652J$MERCK$$57$YR$$F$Y$$$20240928$$MD$JP$JP
236338992$23633899$2$F$$20240909$20240314$20240910$EXP$$CA-BAUSCH-BL-2024-004093$BAUSCH AND LOMB$$53$YR$$M$Y$$$20240910$$CN$CA$CA
236339024$23633902$4$F$$20240812$20240314$20240819$EXP$$CA-SANDOZ INC.-SDZ2023CA016097$SANDOZ$$$$$F$Y$$$20240819$$CN$CA$CA
236339085$23633908$5$F$$20240801$20240314$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202403007058$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240806$$CN$US$US
236339192$23633919$2$F$$20240229$20240314$20240712$EXP$NL-LRB-00947292$NL-TEVA-VS-3167410$TEVA$$76$YR$$F$Y$106$KG$20240712$$MD$NL$NL
236339477$23633947$7$F$20240225$20240903$20240314$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041279$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$50.35$KG$20240905$$CN$US$US
2363397210$23633972$10$F$20230605$20240815$20240314$20240823$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2023-16715$IPSEN$$75$YR$E$M$Y$$$20240823$$MD$CA$CA
236340342$23634034$2$F$$20240703$20240314$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041641$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240710$$HP$US$US
236340442$23634044$2$F$$20240910$20240314$20240912$EXP$$NVSC2024CA054105$NOVARTIS$$36$YR$$M$Y$$$20240912$$HP$CA$CA
236340542$23634054$2$F$$20240711$20240314$20240712$EXP$$GB-MYLANLABS-2024M1024019$MYLAN$$$$$M$Y$$$20240712$$CN$GB$GB
236340622$23634062$2$F$$20240627$20240314$20240701$PER$$US-JNJFOC-20240334658$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$HP$US$US
236340792$23634079$2$F$20220101$20240627$20240314$20240703$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2022CUR021594$CURRAX PHARMACEUTICALS$$$$$F$Y$65.306$KG$20240703$$CN$CA$CA
236340822$23634082$2$F$$20240824$20240314$20240826$PER$GB-MHRA-MIDB-4ca8d936-a349-43df-97eb-5dea7e160a7c$GB-PFIZER INC-202400063609$PFIZER$$81$YR$$M$Y$$$20240826$$PH$GB$GB
236341113$23634111$3$F$$20240617$20240314$20240702$EXP$$CA-MYLANLABS-2023M1065923$MYLAN$$42$YR$$M$Y$$$20240702$$CN$CA$CA
236341323$23634132$3$F$$20240708$20240314$20240716$EXP$$JP-009507513-2403JPN000441J$MERCK$Sudo A, Miura Y, Kobayashi K, Kagamu H, Kaira K, Imai H, et al.. 6 A case of lung adenocarcinoma with pseud-progression after administration of pembrolizumab. The 61st Meeting of the Saitama Medical Society. 43$70$YR$$M$Y$$$20240716$$MD$JP$JP
236341373$23634137$3$F$$20240830$20240314$20240903$EXP$$TW-PFIZER INC-PV202400034954$PFIZER$$$$E$M$Y$$$20240903$$MD$TW$TW
236341752$23634175$2$F$$20240906$20240314$20240912$EXP$$US-GILEAD-2023-0614264$GILEAD$$64$YR$A$M$Y$$$20240912$$MD$US$US
236341842$23634184$2$F$$20240906$20240314$20240912$EXP$$US-GILEAD-2023-0618572$GILEAD$$79$YR$E$M$Y$$$20240912$$MD$US$US
236341892$23634189$2$F$$20240906$20240314$20240912$EXP$$US-GILEAD-2023-0620908$GILEAD$$63$YR$A$M$Y$$$20240912$$HP$US$US
236341912$23634191$2$F$$20240906$20240314$20240912$EXP$$US-GILEAD-2023-0631481$GILEAD$$79$YR$E$M$Y$$$20240912$$MD$US$US
236342112$23634211$2$F$$20240806$20240314$20240809$PER$$US-BIOMARINAP-US-2024-156456$BIOMARIN$$$$$$Y$$$20240809$$CN$US$US
236342272$23634227$2$F$$20240906$20240314$20240912$EXP$$US-GILEAD-2023-0631291$GILEAD$$70$YR$E$F$Y$$$20240912$$MD$US$US
236342402$23634240$2$F$$20240906$20240314$20240911$EXP$$US-GILEAD-2023-0621762$GILEAD$$65$YR$E$F$Y$$$20240911$$HP$US$US
236342422$23634242$2$F$$20240906$20240314$20240912$EXP$$US-GILEAD-2023-0619392$GILEAD$$67$YR$E$M$Y$$$20240912$$HP$US$US
236342535$23634253$5$F$20240101$20240916$20240314$20240923$EXP$$US-GILEAD-2024-0665633$GILEAD$$$$A$F$Y$38.1$KG$20240923$$HP$US$US
236342552$23634255$2$F$$20240906$20240314$20240913$EXP$$US-GILEAD-2021-0511348$GILEAD$$65$YR$E$F$Y$$$20240913$$HP$US$US
236342632$23634263$2$F$$20240906$20240314$20240912$EXP$$US-GILEAD-2023-0628525$GILEAD$$54$YR$A$F$Y$$$20240912$$MD$US$US
236342652$23634265$2$F$$20240906$20240314$20240911$EXP$$US-GILEAD-2023-0628844$GILEAD$$63$YR$A$F$Y$$$20240911$$MD$US$US
236342683$23634268$3$F$20240205$20240819$20240314$20240822$PER$$US-AMGEN-USASP2024052427$AMGEN$$73$YR$E$F$Y$$$20240822$$HP$US$US
236343185$23634318$5$F$20191122$20240704$20240314$20240710$EXP$$JP-GSK-JP2024JPN031250$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$JP$JP
236343522$23634352$2$F$$20240918$20240314$20240925$EXP$$CA-AMGEN-CANNI2024050407$AMGEN$$$$A$M$Y$$$20240925$$CN$CA$CA
236343633$23634363$3$F$20240101$20240702$20240314$20240710$PER$$US-SA-2024SA082849$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240710$$MD$US$US
236343744$23634374$4$F$20240221$20240912$20240314$20240923$EXP$$IT-JNJFOC-20240339388$JOHNSON AND JOHNSON$$68$YR$E$M$Y$99$KG$20240923$$MD$IT$IT
236344303$23634430$3$F$20240217$20240701$20240314$20240707$EXP$$US-ABBVIE-5677359$ABBVIE$$78$YR$$M$Y$$$20240707$$CN$US$US
236344642$23634464$2$F$20240225$20240614$20240315$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000358$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240709$$CN$US$US
236344977$23634497$7$F$20210718$20240808$20240315$20240814$EXP$$CO-TAKEDA-2021TUS046504$TAKEDA$$20$YR$$M$Y$46$KG$20240814$$HP$CO$CO
236345202$23634520$2$F$20230125$20240719$20240315$20240724$EXP$$US-ABBVIE-5678524$ABBVIE$$61$YR$$M$Y$$$20240724$$CN$US$US
236345282$23634528$2$F$20240310$20240714$20240315$20240715$PER$$US-AMGEN-USASP2024053457$AMGEN$$67$YR$E$F$Y$$$20240715$$CN$US$US
236345522$23634552$2$F$20210304$20240620$20240315$20240702$EXP$$JP-JNJFOC-20240327289$JOHNSON AND JOHNSON$Kido S. Efforts toward transition utilizing characteristics of theregion considered from congenital heart disease and pulmonary hypertension cases: full operation with available measures. 2024;.$35$YR$A$F$Y$$$20240702$$MD$JP$JP
236345562$23634556$2$F$$20240916$20240315$20240923$PER$$US-SA-2024SA077602$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240923$$MD$US$US
236345683$23634568$3$F$$20240719$20240315$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000834$ACADIA PHARMACEUTICALS$$$$$F$Y$50$KG$20240813$$HP$US$US
236346013$23634601$3$F$$20240909$20240315$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000882$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
236346463$23634646$3$F$$20240708$20240315$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041091$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240711$$CN$US$US
236346514$23634651$4$F$20240225$20240730$20240315$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-004659$UNITED THERAPEUTICS$$31$YR$$F$Y$63.946$KG$20240809$$$US$US
236346684$23634668$4$F$20191001$20240726$20240315$20240805$EXP$$CA-CELLTRION INC.-2019CA025462$CELLTRION$$$$$$Y$$$20240805$$MD$CA$CA
236346852$23634685$2$F$20230201$20240910$20240315$20240912$EXP$$DE-ROCHE-3414789$ROCHE$$36$YR$A$F$Y$67$KG$20240912$$MD$DE$DE
236347067$23634706$7$F$$20240701$20240315$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041546$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240709$$CN$US$US
236347083$23634708$3$F$$20240725$20240315$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-041266$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240801$$MD$JP$JP
236347193$23634719$3$F$20240201$20240805$20240315$20240813$PER$$US-SA-2024SA081977$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240814$$MD$US$US
236347242$23634724$2$F$20230904$20240630$20240315$20240710$EXP$$US-NOVOPROD-1188558$NOVO NORDISK$$64$YR$$M$Y$$$20240710$$CN$US$US
236347272$23634727$2$F$20200101$20240916$20240315$20240930$EXP$$US-NOVOPROD-1186552$NOVO NORDISK$$41$YR$$M$Y$$$20240930$$CN$US$US
236347533$23634753$3$F$20230110$20240724$20240315$20240801$EXP$$JP-EMD Serono-2024013189$EMD SERONO INC$$69$YR$E$F$Y$71$KG$20240801$$MD$JP$JP
236347626$23634762$6$F$20240201$20240827$20240315$20240829$PER$$US-AMGEN-USASP2024052381$AMGEN$$49$YR$A$F$Y$$$20240829$$CN$US$US
236347692$23634769$2$F$20240219$20240613$20240315$20240704$PER$$CA-TOLMAR, INC.-24CA047060$TOLMAR$$68$YR$$M$Y$$$20240704$$CN$CA$CA
236347713$23634771$3$F$20240219$20240808$20240315$20240828$PER$$CA-TOLMAR, INC.-24CA047054$TOLMAR$$72$YR$$M$Y$$$20240828$$CN$CA$CA
236347803$23634780$3$F$20240101$20240812$20240315$20240829$PER$$CA-TOLMAR, INC.-24CA047155$TOLMAR$$77$YR$$M$Y$$$20240829$$CN$CA$CA
236347975$23634797$5$F$20240101$20240829$20240315$20240904$EXP$$DE-JNJFOC-20240132720$JOHNSON AND JOHNSON$$80$YR$E$F$Y$57$KG$20240904$$MD$DE$DE
236347993$23634799$3$F$20240301$20240808$20240315$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-037911$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240815$$MD$JP$JP
236348142$23634814$2$F$20240103$20240829$20240315$20240927$PER$$US-SA-2024SA079019$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240927$$MD$US$US
236348393$23634839$3$F$20240527$20240725$20240315$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000899$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240816$$CN$US$US
236348412$23634841$2$F$$20240820$20240315$20240828$EXP$$CA-JNJFOC-20240332811$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240828$$PH$CA$CA
236348516$23634851$6$F$20240101$20240809$20240315$20240817$EXP$$CA-CELLTRION INC.-2024CA006257$CELLTRION$$$$$$Y$$$20240817$$HP$CA$CA
236348727$23634872$7$F$20240101$20240918$20240315$20240927$EXP$$CA-CELLTRION INC.-2024CA004339$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
236349083$23634908$3$F$20240306$20240823$20240315$20240902$EXP$$CA-CELLTRION INC.-2024CA006233$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
236349143$23634914$3$F$20231129$20240723$20240315$20240725$EXP$$JP-TAKEDA-2024TJP003870$TAKEDA$$75$YR$$M$Y$$$20240725$$MD$JP$JP
236349202$23634920$2$F$$20240806$20240315$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041843$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$63.5$KG$20240807$$CN$US$US
236349282$23634928$2$F$$20240625$20240315$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02071$LUPIN$$$$$$Y$$$20240709$$PH$US$US
236350384$23635038$4$F$20240101$20240809$20240315$20240925$PER$$US-LUNDBECK-DKLU3074931$LUNDBECK$$$$$$Y$$$20240925$$CN$US$US
2363505210$23635052$10$F$20240101$20240918$20240315$20240927$EXP$$CA-CELLTRION INC.-2024CA006264$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
236350883$23635088$3$F$$20240725$20240315$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-041803$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240801$$MD$JP$JP
236351064$23635106$4$F$$20240725$20240315$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-041918$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240806$$MD$JP$JP
236351102$23635110$2$F$$20240802$20240315$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-02020$HIKMA$$40$YR$$F$Y$$$20240813$$MD$CA$CA
236351732$23635173$2$F$20240101$20240827$20240315$20240904$EXP$$CA-CELLTRION INC.-2024CA006279$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
236351785$23635178$5$F$20231218$20240910$20240315$20240917$EXP$$AU-TAKEDA-2023TUS112272$TAKEDA$$81$YR$$M$Y$$$20240917$$CN$AU$AU
236351992$23635199$2$F$$20240715$20240315$20240718$EXP$$US-TAKEDA-US202028898$TAKEDA$$$$$F$Y$$$20240718$$HP$US$US
236352102$23635210$2$F$20240101$20240814$20240315$20240816$EXP$$CA-UCBSA-2024012245$UCB$$$$$F$Y$$$20240816$$CN$CA$CA
236352114$23635211$4$F$20201026$20240730$20240315$20240806$EXP$$CA-CELLTRION INC.-2020CA027982$CELLTRION$$$$$$Y$$$20240806$$MD$CA$CA
236352374$23635237$4$F$$20240715$20240315$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042086$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240719$$CN$US$US
236352434$23635243$4$F$20240404$20240621$20240315$20240813$PER$$US-LUNDBECK-DKLU3075018$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
236352794$23635279$4$F$20230314$20240711$20240315$20240712$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-015032$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240712$$CN$JP$JP
236352822$23635282$2$F$$20240712$20240315$20240715$EXP$$NVSC2024AR053023$NOVARTIS$$$$$F$Y$$$20240715$$CN$AR$AR
236352904$23635290$4$F$20240310$20240806$20240315$20240812$PER$$US-ALXN-202403USA000712US$ALEXION PHARMACEUTICALS$$70$YR$$F$Y$$$20240812$$CN$US$US
236352994$23635299$4$F$20191201$20240514$20240315$20240720$EXP$$NVSC2022CH099321$NOVARTIS$$$$A$M$Y$$$20240719$$MD$CH$CH
236353006$23635300$6$F$20240101$20240821$20240315$20240828$EXP$$CA-CELLTRION INC.-2023CA002210$CELLTRION$$$$$$Y$$$20240828$$CN$CA$CA
236353574$23635357$4$F$$20240725$20240315$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-041934$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240801$$MD$JP$JP
236353832$23635383$2$F$$20240909$20240315$20240911$EXP$$CA-BAUSCH-BL-2024-004040$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240911$$PH$CA$CA
236353902$23635390$2$F$20240305$20240722$20240315$20240725$EXP$$CA-JNJFOC-20240326542$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240725$$HP$CA$CA
236354542$23635454$2$F$$20240805$20240315$20240806$EXP$$CN-TAKEDA-2024TUS022097$TAKEDA$$$$$M$Y$$$20240806$$CN$CN$CN
236354583$23635458$3$F$20240101$20240731$20240315$20240803$EXP$$IL-ABBVIE-5679662$ABBVIE$$$$$M$Y$56$KG$20240803$$CN$IL$IL
236354802$23635480$2$F$20240312$20240702$20240315$20240705$PER$$US-AMGEN-USASP2024052857$AMGEN$$66$YR$E$M$Y$$$20240705$$CN$US$US
236354813$23635481$3$F$20240101$20240808$20240315$20240814$EXP$$US-ABBVIE-5596635$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
236355653$23635565$3$F$$20240625$20240315$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02068$LUPIN$$$$$$Y$$$20240709$$CN$US$US
236356182$23635618$2$F$$20240906$20240315$20240916$PER$$US-RDY-SPO/USA/24/0003843$DR REDDYS$$71$YR$E$M$Y$$$20240916$$CN$US$US
236356263$23635626$3$F$$20240924$20240315$20240927$PER$$US-LEO Pharma-368616$LEO PHARM$$45$YR$$F$Y$$$20240927$$PH$US$US
236356392$23635639$2$F$$20240916$20240315$20240918$30DAY$$FR-SANDOZ INC.-SDZ2024FR027144$SANDOZ$$$$$F$Y$$$20240918$$PH$FR$FR
236356422$23635642$2$F$$20240724$20240315$20240727$EXP$$CA-SANDOZ INC.-NVSC2023CA038400$SANDOZ$$75$YR$$F$Y$91$KG$20240727$$CN$CA$CA
236356894$23635689$4$F$20240519$20240809$20240315$20240813$EXP$$US-TAKEDA-2023TUS082196$TAKEDA$$70$YR$$M$Y$$$20240813$$HP$US$US
236357133$23635713$3$F$$20240619$20240315$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02141$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236357707$23635770$7$F$20231101$20240911$20240315$20240918$EXP$$CA-GSK-CA2023157629$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$CA$CA
236357782$23635778$2$F$$20240730$20240315$20240808$EXP$$JP-EMD Serono-2024013703$EMD SERONO INC$$46$YR$A$F$Y$$$20240808$$MD$JP$JP
236357862$23635786$2$F$20230101$20240913$20240315$20240918$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-04214$IPSEN$$63$YR$A$M$Y$67$KG$20240918$$MD$CA$CA
236357872$23635787$2$F$$20240821$20240315$20240826$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-04161$IPSEN$$$$$M$Y$$$20240826$$CN$GB$GB
236358052$23635805$2$F$20240306$20240620$20240315$20240704$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000149$BECTON DICKINSON$$$$$$Y$$$20240704$$CN$GB$GB
236358227$23635822$7$F$$20240725$20240315$20240803$EXP$$GB-BAXTER-2024BAX014709$BAXTER$$$$A$M$Y$$$20240803$$CN$GB$GB
236358412$23635841$2$F$$20240829$20240315$20240909$EXP$$CA-ROCHE-3438867$ROCHE$$$$A$M$Y$$$20240909$$CN$CA$CA
236358522$23635852$2$F$$20240710$20240315$20240725$EXP$$CA-SERVIER-S24002420$SERVIER$Jiang MR, Ahmet A., Lawrence S., Bassal M., Speckert M., Geraghty MT et al.. Hypoglycemia associated with PEG-asparaginase and 6-MP therapy during treatment of acute lymphoblastic leukemia in pediatric patients: A case series. J Pediatr Hematol Oncol.. 2024;46 (2):121-126$$$$$Y$$$20240725$$MD$CA$CA
236359204$23635920$4$F$$20240725$20240315$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042046$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240731$$MD$JP$JP
236359393$23635939$3$F$20071001$20240903$20240315$20240905$EXP$$FR-SANDOZ INC.-PHHY2010FR52885$SANDOZ$$38$YR$$F$Y$$$20240905$$MD$FR$FR
236360002$23636000$2$F$$20240716$20240315$20240718$EXP$$JP-ABBVIE-5680621$ABBVIE$$18$YR$$M$Y$$$20240718$$MD$JP$JP
236360132$23636013$2$F$20240301$20240711$20240315$20240716$EXP$$US-SA-2024SA082872$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240716$$MD$US$US
236360155$23636015$5$F$20240101$20240808$20240315$20240815$EXP$$CA-CELLTRION INC.-2024CA006262$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
236360242$23636024$2$F$20240311$20240729$20240315$20240802$PER$$US-AMGEN-USASP2024053714$AMGEN$$49$YR$A$M$Y$$$20240802$$CN$US$US
236360293$23636029$3$F$$20240911$20240315$20240920$EXP$$US-EMD Serono-2024013898$EMD SERONO INC$$$$E$M$Y$$$20240920$$CN$US$US
236360393$23636039$3$F$$20240625$20240315$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02058$LUPIN$$$$$$Y$$$20240709$$CN$US$US
236360684$23636068$4$F$$20240923$20240315$20240926$EXP$$US-ABBVIE-5679038$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
236360722$23636072$2$F$$20240823$20240315$20240830$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-003041$AMGEN$$$$$M$Y$$$20240830$$LW$US$US
236360772$23636077$2$F$$20240221$20240315$20240715$EXP$NL-LRB-00937094$NL-TEVA-VS-3162840$TEVA$$69$YR$$F$Y$68$KG$20240715$$CN$NL$NL
236361082$23636108$2$F$20231201$20240723$20240315$20240728$EXP$$US-ABBVIE-5678489$ABBVIE$$67$YR$$M$Y$$$20240728$$CN$US$US
236361244$23636124$4$F$$20240725$20240315$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042054$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240802$$MD$JP$JP
236361314$23636131$4$F$20240307$20240701$20240315$20240704$EXP$$NVSJ2024JP003123$NOVARTIS$$78$YR$$M$Y$$$20240704$$MD$JP$JP
236361742$23636174$2$F$$20240826$20240315$20240902$EXP$$DE-ABBVIE-5673230$ABBVIE$$$$$M$Y$$$20240902$$MD$DE$DE
236362513$23636251$3$F$$20240725$20240315$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042080$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240801$$MD$JP$JP
236362524$23636252$4$F$$20240725$20240315$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042077$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240801$$MD$JP$JP
236362872$23636287$2$F$$20240625$20240315$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02053$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236363013$23636301$3$F$$20240725$20240315$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042060$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240801$$MD$JP$JP
236363073$23636307$3$F$20240308$20240409$20240315$20240710$PER$$MX-ROCHE-3526863$ROCHE$$49$YR$A$F$Y$67$KG$20240628$$CN$MX$MX
236363653$23636365$3$F$$20240806$20240315$20240830$PER$$CA-TOLMAR, INC.-24CA047059$TOLMAR$$$$$M$Y$$$20240830$$CN$CA$CA
236363702$23636370$2$F$20240201$20240910$20240315$20240918$EXP$$US-SA-2024SA082218$SANOFI AVENTIS$$$$E$M$Y$90.45$KG$20240918$$MD$US$US
236363824$23636382$4$F$$20240802$20240315$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038184$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240806$$CN$US$US
236364223$23636422$3$F$20240304$20240703$20240315$20240710$EXP$$AU-TAKEDA-2024TUS024214$TAKEDA$$78$YR$$F$Y$$$20240710$$CN$AU$AU
236364262$23636426$2$F$20230901$20240716$20240315$20240724$EXP$$FR-AstraZeneca-2024A056739$ASTRAZENECA$$69$YR$$M$Y$92$KG$20240724$$MD$FR$
236364434$23636443$4$F$20240201$20240726$20240315$20240730$EXP$$NVSC2024CA053173$NOVARTIS$$42$YR$$F$Y$$$20240730$$CN$CA$CA
236364992$23636499$2$F$$20240715$20240315$20240718$EXP$$JP-PFIZER INC-PV202400035024$PFIZER$Torii, S.. Successful pre-surgical treatment with carboplatin and gemcitabine chemotherapy for a patient with muscle-invasive bladder cancer and severe renal dysfunction. International Cancer Conference Journal. 2024;13(3):230-4$72$YR$$M$Y$$$20240718$$HP$JP$JP
236365572$23636557$2$F$20230715$20240813$20240315$20240826$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406812$RANBAXY$$30$YR$$F$Y$$$20240826$$MD$IN$IN
236366023$23636602$3$F$$20240625$20240315$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02015$LUPIN$$$$$$Y$$$20240709$$CN$US$US
236366053$23636605$3$F$$20240717$20240315$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR032505$VIIV$$$$$$Y$$$20240725$$HP$US$US
236366363$23636636$3$F$$20240626$20240315$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02100$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236367542$23636754$2$F$20240201$20240830$20240315$20240904$EXP$$US-MYLANLABS-2024M1023035$MYLAN$$16$YR$$F$Y$$$20240904$$MD$US$US
236368052$23636805$2$F$20231201$20240730$20240315$20240802$PER$$US-PFIZER INC-PV202400035784$PFIZER$$69$YR$$F$Y$$$20240802$$HP$US$US
2363680710$23636807$10$F$20230911$20240823$20240315$20240829$EXP$$US-PFIZER INC-202400064852$PFIZER$$66$YR$$F$Y$81.633$KG$20240829$$CN$US$US
236368095$23636809$5$F$20240225$20240729$20240315$20240801$EXP$$AU-TAKEDA-2024TUS023719$TAKEDA$$32$YR$$F$Y$$$20240801$$CN$AU$AU
236368282$23636828$2$F$$20240625$20240315$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02073$LUPIN$$$$$$Y$$$20240709$$CN$US$US
236368943$23636894$3$F$20240201$20240625$20240315$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02122$LUPIN$$$$$$Y$$$20240710$$CN$US$US
236369062$23636906$2$F$20191022$20240911$20240315$20240916$EXP$$NVSC2020IN057798$NOVARTIS$$47$YR$$M$Y$$$20240917$$CN$IN$IN
236369344$23636934$4$F$$20240911$20240315$20240916$EXP$$CA-PFIZER INC-2021057679$PFIZER$$19$YR$$F$Y$72$KG$20240916$$HP$CA$CA
236369502$23636950$2$F$$20240802$20240315$20240807$EXP$$US-MYLANLABS-2024M1023929$MYLAN$$$$$F$Y$$$20240807$$HP$US$US
236369572$23636957$2$F$20240312$20240816$20240315$20240821$PER$$US-AMGEN-USASP2024053398$AMGEN$$75$YR$E$F$Y$$$20240820$$CN$US$US
236369742$23636974$2$F$$20240905$20240315$20240911$PER$$US-VERTEX PHARMACEUTICALS-2024-004022$VERTEX$$$$$$Y$$$20240911$$CN$US$US
236369804$23636980$4$F$$20240625$20240315$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02074$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236369812$23636981$2$F$$20240906$20240315$20240912$EXP$$US-GILEAD-2022-0597189$GILEAD$$64$YR$A$M$Y$$$20240912$$MD$US$US
236370322$23637032$2$F$20240101$20240827$20240315$20240904$EXP$$US-ABBVIE-5679806$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
236370502$23637050$2$F$20230331$20240213$20240315$20240710$EXP$FR-AFSSAPS-BX2024000025$FR-TEVA-VS-3158112$TEVA$$81$YR$$M$Y$69$KG$20240710$$PH$FR$FR
236370512$23637051$2$F$$20240906$20240315$20240912$EXP$$US-GILEAD-2023-0611721$GILEAD$$63$YR$A$M$Y$$$20240912$$MD$US$US
236370545$23637054$5$F$20240209$20240910$20240315$20240913$30DAY$$US-PFIZER INC-PV202400025737$PFIZER$$42$YR$$F$Y$$$20240913$$CN$US$US
236370872$23637087$2$F$$20240906$20240315$20240911$EXP$$US-GILEAD-2023-0612890$GILEAD$$76$YR$E$M$Y$$$20240911$$MD$US$US
236371276$23637127$6$F$20240219$20240709$20240315$20240712$EXP$$ES-PFIZER INC-202400062076$PFIZER$$55$YR$$M$Y$78.8$KG$20240712$$MD$ES$ES
236371334$23637133$4$F$$20240618$20240315$20240702$EXP$$CA-ABBVIE-5680250$ABBVIE$$42$YR$$M$Y$$$20240702$$HP$CA$CA
236371642$23637164$2$F$20240310$20240722$20240315$20240727$EXP$$US-TAKEDA-2023TUS073699$TAKEDA$$72$YR$$F$Y$$$20240727$$CN$US$US
236371723$23637172$3$F$20210322$20240918$20240315$20240926$EXP$$JP-ROCHE-3523300$ROCHE$$36$YR$A$F$Y$84$KG$20240926$$MD$JP$JP
236371743$23637174$3$F$20240306$20240830$20240315$20240903$EXP$$US-BAYER-2024A038455$BAYER$$22$YR$A$M$Y$$$20240903$$CN$US$US
2363718510$23637185$10$F$20240606$20240729$20240315$20240801$PER$$US-PFIZER INC-PV202400035165$PFIZER$$76$YR$$F$Y$$$20240801$$HP$US$US
236372033$23637203$3$F$$20240708$20240315$20240712$EXP$$US-TAKEDA-2024TUS023124$TAKEDA$$$$$F$Y$$$20240712$$HP$US$US
236372104$23637210$4$F$20230101$20240910$20240315$20240922$EXP$$CA-UCBSA-2023045077$UCB$$$$$F$Y$$$20240922$$CN$CA$CA
236372323$23637232$3$F$20231220$20240711$20240315$20240716$EXP$$CA-TAKEDA-2023TUS122717$TAKEDA$$35$YR$$F$Y$$$20240716$$CN$CA$CA
236372392$23637239$2$F$20190206$20240701$20240315$20240705$EXP$$NVSC2023IN280204$NOVARTIS$$48$YR$$F$Y$$$20240705$$CN$IN$IN
236372742$23637274$2$F$$20240710$20240315$20240718$EXP$$JP-Eisai-EC-2024-161105$EISAI$$$$$F$Y$$$20240718$$PH$JP$JP
236372962$23637296$2$F$20200305$20240806$20240315$20240813$EXP$$NVSC2020IN070776$NOVARTIS$$27$YR$$M$Y$$$20240813$$CN$IN$IN
236373195$23637319$5$F$20231201$20240924$20240315$20240927$EXP$$GB-MYLANLABS-2023M1137789$MYLAN$$19$YR$$F$Y$$$20240927$$PH$GB$GB
236373575$23637357$5$F$20240201$20240705$20240315$20240710$EXP$$US-BIOVITRUM-CTI2024US04449$BIOVITRUM$$52$YR$$F$Y$$$20240710$$CN$US$US
236373592$23637359$2$F$20231117$20240619$20240315$20240704$EXP$FR-AFSSAPS-NT2024000089$FR-TEVA-VS-3167653$TEVA$$47$YR$$F$Y$98$KG$20240704$$MD$FR$FR
236374012$23637401$2$F$20240301$20240705$20240315$20240711$EXP$$JP-Eisai-EC-2024-161204$EISAI$$$$$M$Y$$$20240711$$MD$JP$JP
236374032$23637403$2$F$20240307$20240806$20240315$20240813$PER$$JP-Eisai-EC-2024-161215$EISAI$$$$A$F$Y$$$20240813$$MD$JP$JP
236374072$23637407$2$F$20230401$20240627$20240315$20240704$EXP$$CA-GSK-CA2024031018$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$CA$CA
236374203$23637420$3$F$$20240725$20240315$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-041050$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240802$$MD$JP$JP
236374253$23637425$3$F$$20240702$20240315$20240704$EXP$$AT-JNJFOC-20240334963$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$MD$AT$AT
236374352$23637435$2$F$$20240710$20240315$20240725$EXP$$CA-SERVIER-S24002416$SERVIER$Jiang MR, Ahmet A, Lawrence S, Bassal M, Speckert M, Geraghty MT, et al.. Hypoglycemia Associated With PEG-asparaginase and 6-MP Therapy During Treatment of Acute Lymphoblastic Leukemia in Pediatric Patients: A Case Series. Pediatric Hematology and Oncology. 2024;46(2):e121-e126$$$$$Y$$$20240725$$MD$CA$CA
236374632$23637463$2$F$$20240625$20240315$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02089$LUPIN$$$$$$Y$$$20240710$$CN$US$US
236374652$23637465$2$F$$20240826$20240315$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042292$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240827$$CN$US$US
236374712$23637471$2$F$20240229$20240913$20240315$20240918$EXP$$MX-BIOMARINAP-MX-2024-156250$BIOMARIN$$$$$$Y$$$20240918$$CN$MX$MX
236374842$23637484$2$F$20240208$20240830$20240315$20240920$EXP$$US-SA-2024SA083162$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240920$$MD$US$US
236374884$23637488$4$F$20240124$20240715$20240315$20240823$PER$$US-Eisai-EC-2024-158743$EISAI$$75$YR$E$M$Y$96$KG$20240823$$HP$US$US
236374914$23637491$4$F$20240301$20240629$20240315$20240705$EXP$$DE-UCBSA-2024012660$UCB$$29$YR$$F$Y$$$20240705$$MD$DE$DE
236375273$23637527$3$F$20230510$20240829$20240315$20240923$PER$$US-SA-2024SA081429$SANOFI AVENTIS$$90$YR$E$M$Y$$$20240923$$MD$US$US
236375442$23637544$2$F$$20240708$20240315$20240715$PER$$US-SA-2024SA078428$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240715$$MD$US$US
236375572$23637557$2$F$20231001$20240828$20240315$20240924$PER$$US-SA-2024SA081346$SANOFI AVENTIS$$69$YR$E$F$Y$84.09$KG$20240924$$MD$US$US
236375742$23637574$2$F$20231103$20240702$20240315$20240711$PER$$US-SA-2024SA079681$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240711$$MD$US$US
236375802$23637580$2$F$20181201$20240620$20240315$20240703$PER$$US-SA-2024SA081302$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240703$$MD$US$US
236376042$23637604$2$F$20230101$20240627$20240315$20240706$PER$$US-SA-2024SA081564$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240706$$MD$US$US
236376117$23637611$7$F$20231201$20240710$20240315$20240722$PER$$US-SA-2024SA080369$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240721$$MD$US$US
236376302$23637630$2$F$20240101$20240709$20240315$20240716$PER$$US-SA-2024SA079319$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240716$$CN$US$US
236376344$23637634$4$F$20230406$20240712$20240315$20240723$EXP$$JP-ORPHANEU-2024001758$RECORDATI$$$$$$Y$$$20240723$$MD$JP$JP
236376472$23637647$2$F$20240101$20240715$20240315$20240723$PER$$US-SA-2024SA081617$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240723$$MD$US$US
236376533$23637653$3$F$20240101$20240710$20240315$20240718$PER$$US-SA-2024SA081030$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240718$$MD$US$US
236376543$23637654$3$F$20240305$20240812$20240315$20240821$PER$$US-SA-2024SA028112$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240821$$MD$US$US
236376563$23637656$3$F$20210306$20240909$20240315$20240917$PER$$US-SA-2024SA080335$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240918$$MD$US$US
236376842$23637684$2$F$20240301$20240710$20240315$20240801$PER$$US-SA-2024SA080177$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240719$$MD$US$US
236376862$23637686$2$F$20240201$20240903$20240315$20240930$PER$$US-SA-2024SA049001$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240930$$CN$US$US
236376872$23637687$2$F$$20240710$20240315$20240725$EXP$$CA-SERVIER-S24002423$SERVIER$Jiang MR, Ahmet A., Lawrence S., Bassal M., Speckert M., Geraghty MT et al.. Hypoglycemia associated with PEG-asparaginase and 6-MP therapy during treatment of acute lymphoblastic leukemia in pediatric patients: A case series.. Journal of Pediatric Hematology Oncology. 2024;46(2):e121-e126$$$$$Y$$$20240725$$MD$CA$CA
236377295$23637729$5$F$20240101$20240709$20240315$20240715$PER$$US-SA-2024SA081889$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240715$$MD$US$US
236377412$23637741$2$F$$20240627$20240315$20240708$PER$$US-SA-2024SA082914$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240708$$MD$US$US
2363777110$23637771$10$F$20240101$20240802$20240315$20240814$PER$$US-SA-2024SA065791$SANOFI AVENTIS$$60$YR$A$F$Y$83$KG$20240814$$MD$US$US
236377812$23637781$2$F$20240101$20240722$20240315$20240730$PER$$US-SA-2024SA083120$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240730$$MD$US$US
236378043$23637804$3$F$20231201$20240829$20240315$20240912$PER$$US-SA-2024SA082391$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240912$$MD$US$US
236378064$23637806$4$F$20240101$20240918$20240315$20240927$PER$$US-SA-2024SA083348$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240927$$MD$US$US
236378244$23637824$4$F$20240101$20240823$20240315$20240910$PER$$US-SA-2024SA081417$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240910$$MD$US$US
236378364$23637836$4$F$$20240706$20240315$20240712$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR031211$VIIV$$$$$$Y$$$20240712$$CN$US$US
236378565$23637856$5$F$20240313$20240702$20240315$20240717$EXP$$CA-HLS-202400740$HLS THERAPEUTICS$$44$YR$A$M$Y$$$20240717$$CN$CA$CA
236378592$23637859$2$F$$20240625$20240315$20240701$EXP$$JP-INCYTE CORPORATION-2024IN002682$INCYTE$$$$$$Y$$$20240701$$MD$JP$JP
236378635$23637863$5$F$$20240628$20240315$20240702$PER$$US-PFIZER INC-202200468999$PFIZER$$76$YR$$F$Y$$$20240702$$CN$US$US
236378682$23637868$2$F$20240101$20240708$20240315$20240716$PER$$US-SA-2024SA080318$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240716$$MD$US$US
236378764$23637876$4$F$$20240918$20240315$20240919$PER$$US-PFIZER INC-202400061812$PFIZER$$69$YR$$M$Y$$$20240919$$CN$US$US
236379002$23637900$2$F$20240201$20240704$20240315$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041809$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240705$$HP$US$US
236379884$23637988$4$F$$20240701$20240315$20240705$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-033085$JAZZ$$$$$F$Y$$$20240705$$HP$US$US
236380042$23638004$2$F$$20240625$20240315$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02104$LUPIN$$$$$$Y$$$20240710$$CN$US$US
236380524$23638052$4$F$$20240816$20240315$20240821$EXP$$NVSC2024FR050477$NOVARTIS$Darres A, Del Bello A, Marion O, De Lamballerie X, Malvy D, Izopet J et al.. Failure of favipiravir to treat chronic norovirus infection in a kidney-transplant patient (Letter to the Editor). TRANSPLANT INFECTIOUS DISEASE. 2024;26 (1):1-2$64$YR$$M$Y$$$20240821$$HP$FR$FR
236380733$23638073$3$F$$20240620$20240315$20240703$EXP$$CA-ANIPHARMA-2024-CA-001539$ANI$$40$YR$$F$Y$96$KG$20240703$$HP$CA$CA
236381104$23638110$4$F$20240301$20240627$20240315$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040070$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240710$$PH$US$US
236381252$23638125$2$F$20240501$20240718$20240315$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-040236$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240722$$CN$US$US
236381523$23638152$3$F$$20240916$20240315$20240925$PER$$US-BIOGEN-2024BI01254381$BIOGEN$$$$$M$Y$$$20240925$$CN$US$US
236381932$23638193$2$F$20240306$20240910$20240315$20240918$PER$$US-BIOGEN-2024BI01254731$BIOGEN$$47$YR$$F$Y$$$20240918$$CN$US$US
236382244$23638224$4$F$$20240806$20240315$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-040513$BRISTOL MYERS SQUIBB$Emi R, Yosida J, Oowaki S, Satou M, Katou K, Sugiyama K. et al. A case of grade 4 cytokine release syndrome due to immune checkpoint inhibitor (ICI). The 252nd Tokai Regional Meeting of the Japanese Society of Internal Medicine(Abstract). 2024;87.$57$YR$A$F$Y$$$20240814$$MD$JP$JP
236382312$23638231$2$F$$20240906$20240315$20240913$EXP$$US-GILEAD-2024-0665860$GILEAD$$70$YR$E$F$Y$$$20240913$$MD$US$US
236382443$23638244$3$F$20240209$20240628$20240315$20240705$EXP$$CN-ROCHE-3524848$ROCHE$$41$YR$A$F$Y$$$20240705$$MD$CN$CN
236383422$23638342$2$F$$20240906$20240315$20240912$EXP$$US-GILEAD-2021-0524611$GILEAD$$69$YR$E$F$Y$$$20240912$$HP$US$US
236383473$23638347$3$F$20221103$20240715$20240315$20240716$EXP$$ES-JNJFOC-20240274318$JOHNSON AND JOHNSON$$82$YR$E$M$Y$59$KG$20240716$$MD$ES$ES
236383523$23638352$3$F$$20240820$20240315$20240824$EXP$$NVSC2022GB105358$NOVARTIS$$$$A$F$Y$$$20240824$$CN$GB$GB
236383573$23638357$3$F$20230302$20240724$20240315$20240815$PER$$US-TRAVERE-2024TVT00256$TRAVERE THERAPEUTICS$$30$YR$A$M$Y$$$20240815$$CN$US$US
236383753$23638375$3$F$$20240716$20240315$20240718$EXP$$JP-ABBVIE-5680982$ABBVIE$$35$YR$$F$Y$$$20240718$$MD$JP$JP
236383833$23638383$3$F$$20240808$20240315$20240812$PER$$US-PFIZER INC-202400064985$PFIZER$$49$YR$$F$Y$$$20240812$$HP$US$US
236383844$23638384$4$F$$20240912$20240315$20240916$EXP$$US-PFIZER INC-202300276823$PFIZER$$57$YR$$F$Y$$$20240916$$HP$US$US
236383993$23638399$3$F$20240301$20240628$20240315$20240702$PER$$US-AMGEN-USASP2024050476$AMGEN$$65$YR$E$F$Y$$$20240702$$CN$US$US
236384109$23638410$9$F$20240213$20240702$20240315$20240705$EXP$$PL-PFIZER INC-202400063688$PFIZER$$45$YR$$M$Y$78$KG$20240705$$MD$PL$PL
236384242$23638424$2$F$20240223$20240912$20240315$20240917$30DAY$$US-SANDOZ INC.-SDZ2024US027924$SANDOZ$$13$YR$$F$Y$$$20240917$$CN$US$US
236384334$23638433$4$F$20240601$20240820$20240315$20240829$PER$$US-SA-2024SA081385$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240829$$MD$US$US
236384552$23638455$2$F$$20240814$20240315$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042269$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240816$$CN$US$US
2363845714$23638457$14$F$20160905$20240617$20240315$20240710$EXP$$FR-LUNDBECK-DKLU3075338$LUNDBECK$$$$$$Y$$$20240710$$CN$FR$FR
236384692$23638469$2$F$$20240906$20240315$20240912$EXP$$US-GILEAD-2021-0527939$GILEAD$$68$YR$E$M$Y$$$20240912$$HP$US$US
236384712$23638471$2$F$$20240626$20240315$20240705$PER$$US-SA-2024SA080336$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240705$$MD$US$US
236384753$23638475$3$F$$20240401$20240315$20240808$EXP$$NVSC2024US045650$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
236385253$23638525$3$F$$20240903$20240315$20240918$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436517$RANBAXY$Gervais C, Auclin E, Saltel-Fulero A, Clair G, Oudard S, Mirghani H. Nivolumab immunotherapy rechallenge for progressive laryngeal squamous-cell carcinoma after failure of conventional treatment: A CARE case report. Eur Ann Otorhinolaryngol Head Neck Dis. 2024;Feb 27/141:Online ahead of print/224-228$70$YR$$M$Y$$$20240918$$HP$FR$FR
236386024$23638602$4$F$20240227$20240807$20240315$20240814$EXP$$JP-GENMAB-2024-00835$GENMAB$$76$YR$$M$Y$$$20240814$$PH$JP$JP
236386402$23638640$2$F$$20240304$20240315$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436771$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
236386656$23638665$6$F$$20240712$20240315$20240726$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436734$RANBAXY$Diaz DD, Mata C, Herrejon EP, Perez LL. Adult respiratory distress syndrome (ARDS) due to omeprazole induced drug reaction with eosinophilia and systemic symptoms (DRESS): case report and review of the literature. Rev Esp Anestesiol Reanim (Engl Ed). 2024;Mar 1:S2341-1929(38431048)$52$YR$$F$Y$$$20240726$$HP$ES$ES
236386873$23638687$3$F$20231201$20240524$20240315$20240704$EXP$$IE-ABBVIE-5680153$ABBVIE$$59$YR$$F$Y$$$20240704$$HP$IE$IE
236387384$23638738$4$F$$20240916$20240315$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042344$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240923$$CN$US$US
236388004$23638800$4$F$20231006$20240819$20240315$20240826$EXP$$IN-PFIZER INC-PV202300106530$PFIZER$$59$YR$$F$Y$$$20240826$$CN$IN$IN
236388212$23638821$2$F$$20240915$20240315$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US028453$SANDOZ$$$$$M$Y$$$20240919$$CN$US$US
236388302$23638830$2$F$20221201$20240705$20240315$20240712$EXP$$NL-AstraZeneca-2024A058248$ASTRAZENECA$$15$YR$$F$Y$$$20240712$$MD$NL$
236388612$23638861$2$F$20240309$20240807$20240315$20240809$PER$$US-AMGEN-USASP2024054275$AMGEN$$57$YR$A$M$Y$$$20240809$$CN$US$US
236388762$23638876$2$F$20240301$20240731$20240315$20240803$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004522$JAZZ$$18$YR$$M$Y$$$20240803$$CN$US$US
236389222$23638922$2$F$20201203$20240702$20240315$20240708$EXP$$MX-009507513-2401MEX015788$MERCK$$77$YR$$F$Y$71$KG$20240708$$MD$MX$MX
236389532$23638953$2$F$20240311$20240714$20240315$20240717$PER$$US-AMGEN-USASP2024052886$AMGEN$$89$YR$E$M$Y$$$20240716$$CN$US$US
236389764$23638976$4$F$20240313$20240729$20240315$20240805$PER$$US-AMGEN-USASP2024053760$AMGEN$$73$YR$E$F$Y$$$20240804$$CN$US$US
236391002$23639100$2$F$$20240906$20240315$20240912$EXP$$US-GILEAD-2022-0597693$GILEAD$$75$YR$E$M$Y$$$20240912$$MD$US$US
236391042$23639104$2$F$$20240906$20240315$20240912$EXP$$US-GILEAD-2022-0598429$GILEAD$$31$YR$A$F$Y$$$20240912$$HP$US$US
236391564$23639156$4$F$$20240909$20240315$20240920$PER$$NVSC2024US055735$NOVARTIS$$$$$M$Y$133$KG$20240920$$CN$US$US
236392953$23639295$3$F$$20240624$20240316$20240704$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024030516$VIIV$$$$$M$Y$$$20240704$$PH$US$US
236392962$23639296$2$F$$20240913$20240316$20240923$EXP$$GB-TEVA-VS-3170547$TEVA$$27$YR$$M$Y$$$20240923$$CN$GB$GB
236393202$23639320$2$F$$20240307$20240316$20240724$EXP$$US-TEVA-VS-3168300$TEVA$$64$YR$$M$Y$77.11$KG$20240724$$CN$US$US
236393385$23639338$5$F$20240101$20240823$20240316$20240904$EXP$$US-SA-2024SA082899$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240904$$MD$US$US
236393503$23639350$3$F$20240306$20240801$20240316$20240805$EXP$$NVSC2024US054989$NOVARTIS$$0$YR$$M$Y$$$20240805$$CN$US$US
236393762$23639376$2$F$20240119$20240625$20240316$20240703$EXP$$DE-TEVA-VS-3168345$TEVA$$88$YR$$F$Y$80$KG$20240703$$MD$DE$DE
236393822$23639382$2$F$20240305$20240823$20240316$20240827$PER$$US-AMGEN-USASP2024052922$AMGEN$$65$YR$E$F$Y$$$20240827$$CN$US$US
236394012$23639401$2$F$20240312$20240701$20240316$20240704$PER$$US-AMGEN-USASP2024054358$AMGEN$$66$YR$E$F$Y$$$20240704$$CN$US$US
236394182$23639418$2$F$20240303$20240902$20240316$20240903$PER$$US-AMGEN-USASP2024053448$AMGEN$$81$YR$E$M$Y$$$20240903$$CN$US$US
236394392$23639439$2$F$20220601$20240909$20240316$20240910$EXP$DE-MYLANLABS-2022M1128478$DE-UCBSA-2023022659$UCB$$50$YR$$F$Y$$$20240910$$MD$DE$DE
236394443$23639444$3$F$20240305$20240719$20240316$20240723$PER$$US-AMGEN-USASP2024052934$AMGEN$$67$YR$E$M$Y$$$20240723$$CN$US$US
236394463$23639446$3$F$$20240805$20240316$20240816$EXP$$US-ROCHE-3525182$ROCHE$$53$YR$A$F$Y$$$20240816$$HP$US$US
236394662$23639466$2$F$20240303$20240709$20240316$20240718$30DAY$$US-GSK-US2024AMR031863$GLAXOSMITHKLINE$$88$YR$$F$Y$$$20240718$$HP$US$US
236394842$23639484$2$F$20240201$20240702$20240316$20240704$PER$$US-AMGEN-USASP2024054042$AMGEN$$70$YR$E$F$Y$$$20240704$$CN$US$US
236394874$23639487$4$F$20240101$20240530$20240316$20240705$EXP$$CA-CELLTRION INC.-2024CA006322$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
236395153$23639515$3$F$20240122$20240613$20240316$20240912$EXP$IT-MINISAL02-967667$IT-TEVA-VS-3168764$TEVA$$24$YR$$M$Y$$$20240912$$MD$IT$IT
236395182$23639518$2$F$20240308$20240726$20240316$20240730$PER$$US-AMGEN-USASP2024054439$AMGEN$$51$YR$A$F$Y$$$20240730$$CN$US$US
236395202$23639520$2$F$20180301$20240822$20240316$20240905$EXP$$US-UCBSA-2023015260$UCB$$52$YR$$M$Y$113.39$KG$20240905$$CN$US$US
236395632$23639563$2$F$20240313$20240728$20240316$20240730$PER$$US-AMGEN-USASP2024054485$AMGEN$$78$YR$E$M$Y$$$20240730$$CN$US$US
236395872$23639587$2$F$20240307$20240904$20240316$20240913$EXP$$CA-CELLTRION INC.-2024CA006282$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
236396044$23639604$4$F$20240805$20240805$20240316$20240817$EXP$GB-MHRA-ADR 28586926$GB-Accord-413116$ACCORD$$63$YR$A$M$Y$80$KG$20240817$$CN$GB$GB
236396507$23639650$7$F$$20240919$20240316$20240926$EXP$$US-GSK-US2023133218$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
236396654$23639665$4$F$20231201$20240619$20240316$20240702$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-00842$AMNEAL$$57$YR$$M$Y$51.2$KG$20240702$$HP$JP$JP
236396722$23639672$2$F$$20240729$20240316$20240808$EXP$$US-TEVA-VS-3144167$TEVA$$73$YR$$M$Y$$$20240808$$CN$US$US
236396762$23639676$2$F$20240101$20240715$20240316$20240729$EXP$$ES-TEVA-VS-3169143$TEVA$$80$YR$$F$Y$32$KG$20240729$$CN$ES$ES
236397002$23639700$2$F$20240311$20240703$20240316$20240705$PER$$US-AMGEN-USASP2024054544$AMGEN$$56$YR$A$F$Y$$$20240705$$CN$US$US
236397023$23639702$3$F$20240313$20240719$20240316$20240729$PER$$US-AMGEN-USASP2024054511$AMGEN$$79$YR$E$F$Y$$$20240729$$CN$US$US
236397312$23639731$2$F$$20240311$20240316$20240807$EXP$$NVSC2024GB054664$NOVARTIS$$60$YR$$M$Y$$$20240807$$CN$GB$GB
236398042$23639804$2$F$20240311$20240713$20240316$20240716$PER$$US-AMGEN-USASP2024053005$AMGEN$$76$YR$E$M$Y$$$20240716$$CN$US$US
236398052$23639805$2$F$20240211$20240912$20240316$20240914$PER$$US-AMGEN-USASP2024052192$AMGEN$$51$YR$A$F$Y$93.424$KG$20240914$$MD$US$US
236398454$23639845$4$F$20240101$20240715$20240316$20240723$PER$$US-SA-2024SA080228$SANOFI AVENTIS$$18$YR$A$M$Y$81.6$KG$20240723$$MD$US$US
236398472$23639847$2$F$$20240806$20240316$20240820$EXP$$JP-UCBSA-2024012572$UCB$$$$$$Y$$$20240820$$MD$JP$JP
236398702$23639870$2$F$20240314$20240718$20240316$20240723$PER$$US-AMGEN-USASP2024054853$AMGEN$$54$YR$A$M$Y$$$20240723$$HP$US$US
236398913$23639891$3$F$20231001$20240829$20240316$20240902$EXP$$NVSC2024AE057062$NOVARTIS$$30$YR$$F$Y$$$20240902$$MD$AE$AE
236399152$23639915$2$F$$20240902$20240316$20240915$PER$US-MLMSERVICE-20240301-4853734-1$US-RDY-SPO/USA/24/0004251$DR REDDYS$Santistevan L, Lonergan D, Eyvazzadeh AD. First case report of serous otitis media as a complication of severe ovarian hyperstimulation syndrome: Case report and literature review. International Journal of Gynecology and Obstetrics. 2024;164(3):843-7. DOI: 10.1002/ijgo.15022.$30$YR$A$F$Y$52.2$KG$20240915$$MD$US$US
236399262$23639926$2$F$20240708$20240711$20240316$20240722$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-04232$IPSEN$$70$YR$E$F$Y$61$KG$20240719$$CN$US$US
236399316$23639931$6$F$20240226$20240828$20240316$20240911$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-03714$IPSEN$$82$YR$E$F$Y$70$KG$20240911$$CN$US$US
236399384$23639938$4$F$$20240828$20240316$20240906$EXP$$US-GSK-US2024AMR031318$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
236399548$23639954$8$F$$20240905$20240316$20240909$EXP$$NVSC2024US031599$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
236399603$23639960$3$F$$20240910$20240316$20240918$EXP$$NVSC2024IT057125$NOVARTIS$Moccia M, Affinito G, Fumo MG, Giordana R, Gennaro MD, Mercogliano M et al.. Fertility, pregnancy and childbirth in women with multiple sclerosis: a population-based study from 2018 to 2020. J NEUROL NEUROSURG PSYCHIATRY. 2023;1-9$$$N$M$Y$2.85$KG$20240918$$HP$IT$IT
236399654$23639965$4$F$20231201$20240730$20240316$20240801$EXP$$NVSC2024FR054658$NOVARTIS$$$$A$F$Y$67$KG$20240801$$MD$FR$FR
236399672$23639967$2$F$20240313$20240627$20240316$20240703$PER$$US-AMGEN-USASP2024054378$AMGEN$$75$YR$E$M$Y$$$20240702$$CN$US$US
236399754$23639975$4$F$$20240827$20240316$20240830$EXP$$NVSC2024US056219$NOVARTIS$$$$$F$Y$$$20240830$$HP$US$US
236399793$23639979$3$F$$20240701$20240316$20240705$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-04146$IPSEN$$82$YR$E$M$Y$79.37$KG$20240705$$HP$US$US
236399962$23639996$2$F$20240315$20240810$20240316$20240812$PER$$US-AMGEN-USASP2024055292$AMGEN$$79$YR$E$F$Y$$$20240812$$CN$US$US
236400164$23640016$4$F$20240101$20240620$20240317$20240701$PER$$US-SA-2024SA080233$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240701$$MD$US$US
236400442$23640044$2$F$20240101$20240723$20240317$20240731$PER$$US-SA-2024SA079904$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240731$$MD$US$US
236400512$23640051$2$F$20170301$20240919$20240317$20240924$EXP$$FR-SANDOZ INC.-PHHY2017FR194206$SANDOZ$$27$YR$$M$Y$72$KG$20240924$$MD$FR$FR
236400544$23640054$4$F$$20240911$20240317$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA028243$SANDOZ$$40$YR$$F$Y$$$20240913$$HP$CA$CA
236401585$23640158$5$F$20240217$20240718$20240317$20240729$EXP$$TW-Accord-411595$ACCORD$$59$YR$A$M$Y$49.3$KG$20240729$$HP$TW$TW
236401613$23640161$3$F$$20240624$20240317$20240705$PER$$US-JNJFOC-20240347440$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$PH$US$US
236401855$23640185$5$F$20240418$20240723$20240317$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000865$ACADIA PHARMACEUTICALS$$35$YR$$F$Y$$$20240816$$CN$US$US
236402122$23640212$2$F$20240225$20240909$20240317$20240911$EXP$IT-MINISAL02-974407$IT-ABBVIE-5674089$ABBVIE$$48$YR$$M$Y$$$20240911$$MD$IT$IT
236402293$23640229$3$F$20240207$20240826$20240317$20240924$PER$$US-Eisai-EC-2024-159008$EISAI$$81$YR$E$F$Y$$$20240924$$CN$US$US
236402504$23640250$4$F$20240301$20240729$20240317$20240805$EXP$$NVSC2024DE052260$NOVARTIS$$82$YR$$F$Y$$$20240805$$MD$DE$DE
236402704$23640270$4$F$20240123$20240712$20240317$20240719$EXP$$JP-ROCHE-3526975$ROCHE$$85$YR$E$M$Y$55$KG$20240719$$MD$JP$JP
236402822$23640282$2$F$20240311$20240725$20240317$20240729$PER$$US-AMGEN-USASP2024051414$AMGEN$$60$YR$A$F$Y$$$20240728$$CN$US$US
236402904$23640290$4$F$20240601$20240812$20240317$20240815$EXP$$NL-AMGEN-NLDNI2024049078$AMGEN$$17$YR$T$F$Y$57$KG$20240815$$MD$NL$NL
236403232$23640323$2$F$$20240628$20240317$20240710$PER$$US-SA-2024SA081523$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240710$$MD$US$US
236403242$23640324$2$F$20231201$20240718$20240317$20240729$PER$$US-SA-2024SA079971$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240729$$MD$US$US
236403315$23640331$5$F$20240101$20240624$20240317$20240702$30DAY$$GB-JNJFOC-20240275875$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240703$$CN$GB$GB
236403774$23640377$4$F$20230810$20240617$20240317$20240701$EXP$$JP-AMGEN-JPNSP2024054590$AMGEN$Yamada A, Minatoguchi S, Hishinuma M, Umeda R, Koide S, Hayashi H. A case of severe cholestatic liver injury after induction of remission after administration of avacopan for microscopic polyangiitis. Abstracts in the 252nd Tokai regional meeting of the Japanese society of internal medicine. 2024 FEB 18;.$67$YR$E$M$Y$61$KG$20240701$$MD$JP$JP
236404193$23640419$3$F$$20240829$20240317$20240909$30DAY$$CN-JNJFOC-20240272460$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$CN$CN
236404203$23640420$3$F$20231201$20240710$20240317$20240716$EXP$$US-ABBVIE-5299352$ABBVIE$$82$YR$$F$Y$$$20240716$$HP$US$US
236404403$23640440$3$F$20240315$20240718$20240317$20240722$PER$$US-AMGEN-USASP2024055242$AMGEN$$73$YR$E$M$Y$$$20240722$$CN$US$US
236404533$23640453$3$F$20230101$20240627$20240317$20240706$PER$$US-SA-2024SA083476$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240706$$MD$US$US
236404552$23640455$2$F$20240101$20240711$20240317$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-014039$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$$$20240712$$CN$US$US
236404692$23640469$2$F$20230913$20240702$20240317$20240704$EXP$$AU-TAKEDA-2023TUS094128$TAKEDA$$26$YR$$F$Y$$$20240704$$CN$AU$AU
236404804$23640480$4$F$$20240805$20240317$20240806$EXP$$ES-SANDOZ INC.-NVSC2020ES125476$SANDOZ$$65$YR$$F$Y$$$20240806$$MD$ES$ES
236404852$23640485$2$F$20240301$20240624$20240317$20240703$EXP$$US-BEH-2024169541$CSL BEHRING$$69$YR$E$M$Y$$$20240703$$HP$US$US
236405192$23640519$2$F$20240601$20240703$20240318$20240712$PER$$US-SA-2024SA083455$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240712$$MD$US$US
236405307$23640530$7$F$20231212$20240906$20240318$20240912$EXP$$CA-GSK-CA2023AMR058782$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$CA$CA
236405422$23640542$2$F$$20240712$20240318$20240718$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-014448$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240718$$CN$CA$CA
236405855$23640585$5$F$20240301$20240716$20240318$20240724$EXP$$US-BEH-2024169673$CSL BEHRING$$74$YR$E$F$Y$$$20240724$$HP$US$US
236405872$23640587$2$F$20240205$20240622$20240318$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000873$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240716$$CN$US$US
236405883$23640588$3$F$20240227$20240701$20240318$20240710$EXP$$DE-BEH-2024169692$CSL BEHRING$$$$A$M$Y$83$KG$20240710$$CN$DE$DE
236406224$23640622$4$F$20240201$20240815$20240318$20240829$EXP$$US-UCBSA-2024012500$UCB$$37$YR$$F$Y$$$20240829$$HP$US$US
2364064410$23640644$10$F$20190401$20240905$20240318$20240913$EXP$$DE-ROCHE-3525943$ROCHE$$67$YR$E$M$Y$$$20240913$$CN$DE$DE
236406453$23640645$3$F$20240101$20240726$20240318$20240802$EXP$$US-SA-2023SA371337$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240802$$MD$US$US
236406652$23640665$2$F$20240201$20240724$20240318$20240801$PER$$US-SA-2024SA081034$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240801$$MD$US$US
236406894$23640689$4$F$$20240712$20240318$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-039696$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240719$$CN$US$US
236407203$23640720$3$F$$20240702$20240318$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-040181$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240705$$MD$JP$JP
236407406$23640740$6$F$20230619$20240923$20240318$20240930$EXP$$CA-GSK-CA2023AMR092216$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$CA$CA
236408212$23640821$2$F$20240308$20240903$20240318$20240917$PER$$US-JNJFOC-20240326044$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240917$$CN$US$US
236408242$23640824$2$F$$20240913$20240318$20240926$PER$$US-SA-2023SA301745$SANOFI AVENTIS$$92$YR$E$F$Y$$$20240926$$MD$US$US
236408402$23640840$2$F$$20240710$20240318$20240717$EXP$$CA-APOTEX-2024AP003419$APOTEX$$$$$M$Y$$$20240717$$MD$CA$CA
236408662$23640866$2$F$20170101$20240902$20240318$20240913$EXP$$FR-Accord-412964$ACCORD$Labaigt T, Berceanu A. A bout de souffle (Breathless). Correspondence in Onco-Hematology. XVIII(6): 352-354.$53$YR$A$F$Y$$$20240913$$HP$FR$FR
236409122$23640912$2$F$$20240906$20240318$20240911$EXP$$US-GILEAD-2023-0613393$GILEAD$$87$YR$E$M$Y$$$20240911$$HP$US$US
236409272$23640927$2$F$$20240716$20240318$20240718$EXP$$CA-TAKEDA-2023TUS122389$TAKEDA$$$$$M$Y$$$20240718$$CN$CA$CA
236409954$23640995$4$F$20240223$20240313$20240318$20240717$EXP$$NVSC2024FR051670$NOVARTIS$$56$YR$$M$Y$$$20240717$$MD$FR$FR
236410034$23641003$4$F$$20240801$20240318$20240807$EXP$$US-EMD Serono-2023493841$EMD SERONO INC$$$$A$F$Y$$$20240808$$CN$US$US
236410074$23641007$4$F$20230726$20240711$20240318$20240712$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-253938$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240712$$CN$US$US
236410132$23641013$2$F$20230401$20240818$20240318$20240820$EXP$$NVSC2024EG049556$NOVARTIS$$63$YR$$M$Y$$$20240820$$CN$EG$EG
236410184$23641018$4$F$$20240909$20240318$20240916$EXP$$CA-TAKEDA-2024TUS011097$TAKEDA$$$$$F$Y$$$20240916$$CN$CA$CA
236410353$23641035$3$F$$20240624$20240318$20240702$EXP$$GB-SANDOZ INC.-NVSC2021GB040756$SANDOZ$$$$I$M$Y$$$20240702$$CN$GB$GB
236410822$23641082$2$F$$20240705$20240318$20240716$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-02048$HIKMA$$$$$$Y$$$20240716$$HP$CA$CA
236411002$23641100$2$F$$20240821$20240318$20240826$EXP$$JP-GSK-JP2024034585$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$JP$JP
236411136$23641113$6$F$$20240912$20240318$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038854$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240916$$CN$US$US
236411192$23641119$2$F$$20240705$20240318$20240715$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-02049$HIKMA$$$$$F$Y$$$20240715$$HP$CA$CA
236411272$23641127$2$F$$20240801$20240318$20240808$PER$$NVSC2024US056009$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
236411764$23641176$4$F$$20240731$20240318$20240813$PER$$US-LUNDBECK-DKLU3075033$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
236411902$23641190$2$F$20220101$20240812$20240318$20240815$EXP$$DE-ROCHE-3277376$ROCHE$$72$YR$E$M$Y$$$20240815$$CN$DE$DE
236411912$23641191$2$F$$20240814$20240318$20240822$EXP$$JP-009507513-2403JPN001479J$MERCK$$6$DEC$$M$Y$$$20240822$$MD$JP$JP
236412627$23641262$7$F$20240101$20240730$20240318$20240808$EXP$$JP-009507513-2403JPN001245J$MERCK$$83$YR$$M$Y$$$20240808$$MD$JP$JP
236412692$23641269$2$F$$20240619$20240318$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02132$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236412813$23641281$3$F$$20240619$20240318$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02090$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236412902$23641290$2$F$20231201$20240919$20240318$20240930$EXP$$JP-ROCHE-3524502$ROCHE$$6$DEC$A$F$Y$52$KG$20240930$$MD$JP$JP
236413153$23641315$3$F$$20240730$20240318$20240808$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP003000$STRIDES$Le V, Surineni K, Elias G. A Case of Partially Reversible Oral-buccal-lingual Dyskinesia after Prolonged Levetiracetam Exposure.. Am-J-Geriatr-Psychiatry. 2024;32 (Suppl.) (4):S106$9$DEC$$F$Y$$$20240808$$MD$US$US
236413173$23641317$3$F$$20240725$20240318$20240802$PER$$US-ALXN-202403USA000763US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$HP$US$US
236413302$23641330$2$F$20230314$20240801$20240318$20240802$EXP$$ZA-GILEAD-2024-0665810$GILEAD$$24$YR$A$F$Y$$$20240802$$HP$ZA$ZA
236413322$23641332$2$F$$20240620$20240318$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000909$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
236413404$23641340$4$F$20240216$20240731$20240318$20240810$EXP$$US-TEVA-VS-3171387$TEVA$$17$YR$$M$Y$65.9$KG$20240810$$HP$US$US
236413606$23641360$6$F$20230101$20240823$20240318$20240902$EXP$CZ-CZSUKL-24000513$CZ-TEVA-VS-3170265$TEVA$$68$YR$$F$Y$68$KG$20240902$$MD$CZ$CZ
236413973$23641397$3$F$$20240703$20240318$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042100$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$61.23$KG$20240704$$CN$US$US
236414422$23641442$2$F$$20240910$20240318$20240911$EXP$$NVSC2024CA055276$NOVARTIS$$61$YR$$F$Y$$$20240911$$MD$CA$CA
236414953$23641495$3$F$20220401$20240703$20240318$20240711$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-14738$IPSEN$$56$YR$A$F$Y$$$20240711$$CN$CA$CA
236415032$23641503$2$F$20231125$20240627$20240318$20240702$EXP$$JP-009507513-2312JPN002430J$MERCK$$64$YR$$F$Y$$$20240702$$MD$JP$JP
236415112$23641511$2$F$20240201$20240717$20240318$20240724$EXP$$CA-GSK-CA2024015365$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$CA$CA
236415482$23641548$2$F$$20240708$20240318$20240715$EXP$$CA-APOTEX-2021AP005836$APOTEX$$66$YR$$F$Y$$$20240715$$HP$CA$CA
236415512$23641551$2$F$20221201$20240813$20240318$20240819$EXP$$NL-TAKEDA-2024TUS022731$TAKEDA$$15$YR$$F$Y$$$20240819$$HP$NL$NL
236415783$23641578$3$F$20240312$20240731$20240318$20240803$PER$$US-AMGEN-USASP2024055555$AMGEN$$61$YR$A$F$Y$$$20240802$$CN$US$US
236415833$23641583$3$F$20240321$20240903$20240318$20240907$EXP$$CA-JNJFOC-20220802460$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240907$$HP$CA$CA
236416064$23641606$4$F$20240101$20240904$20240318$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042515$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240905$$HP$US$US
236416125$23641612$5$F$20240328$20240613$20240318$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000891$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240708$$CN$US$US
236416153$23641615$3$F$$20240626$20240318$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02011$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236416592$23641659$2$F$20240306$20240717$20240318$20240722$EXP$$JP-009507513-2403JPN001528J$MERCK$$74$YR$$$Y$$$20240719$$MD$JP$JP
236416602$23641660$2$F$20240201$20240628$20240318$20240704$EXP$$JP-009507513-2403JPN001649J$MERCK$$7$DEC$$F$Y$$$20240704$$MD$JP$JP
236416972$23641697$2$F$$20240627$20240318$20240702$PER$$US-JNJFOC-20240343233$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
236417004$23641700$4$F$20240308$20240903$20240318$20240909$EXP$$CA-JNJFOC-20240331014$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240909$$HP$CA$CA
236417322$23641732$2$F$$20240724$20240318$20240802$PER$$US-SA-2024SA082954$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240802$$MD$US$US
236417513$23641751$3$F$$20240725$20240318$20240802$PER$$US-SA-2024SA081102$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240802$$MD$US$US
236417633$23641763$3$F$20240101$20240604$20240318$20240613$PER$$US-SA-2024SA084381$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240613$$MD$US$US
236417693$23641769$3$F$20240101$20240807$20240318$20240816$PER$$US-SA-2024SA081014$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240816$$MD$US$US
236417722$23641772$2$F$20240101$20240802$20240318$20240812$PER$$US-SA-2023SA313818$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240812$$MD$US$US
236417784$23641778$4$F$20240101$20240827$20240318$20240910$PER$$US-SA-2024SA082929$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240910$$MD$US$US
236417804$23641780$4$F$20240201$20240806$20240318$20240813$PER$$US-SA-2024SA084210$SANOFI AVENTIS$$58$YR$A$F$Y$102.05$KG$20240814$$MD$US$US
236417852$23641785$2$F$$20240703$20240318$20240712$PER$$US-SA-2024SA084543$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240712$$MD$US$US
236417993$23641799$3$F$$20240625$20240318$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02051$LUPIN$$$$$$Y$$$20240711$$PH$US$US
236418552$23641855$2$F$$20240802$20240318$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042755$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240805$$HP$US$US
236418832$23641883$2$F$20230601$20240813$20240318$20240826$PER$$US-SA-2024SA084706$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240826$$MD$US$US
236419464$23641946$4$F$20240301$20240624$20240318$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000910$ACADIA PHARMACEUTICALS$$2$YR$$M$Y$$$20240718$$CN$US$US
236419595$23641959$5$F$$20240816$20240318$20240819$EXP$$NVSC2024CA054144$NOVARTIS$$43$YR$$F$Y$70$KG$20240819$$HP$CA$CA
236419875$23641987$5$F$$20240821$20240318$20240831$EXP$$US-GSK-US2024AMR032014$GLAXOSMITHKLINE$$$$$F$Y$$$20240831$$CN$US$US
236419972$23641997$2$F$$20240716$20240318$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-038257$BRISTOL MYERS SQUIBB$$$$$F$Y$97$KG$20240729$$MD$CA$CA
236420032$23642003$2$F$$20240713$20240318$20240723$PER$$US-SA-2024SA082755$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
236420162$23642016$2$F$$20240701$20240318$20240709$EXP$$UY-STRIDES ARCOLAB LIMITED-2024SP003045$STRIDES$Cunetti L, Oricchio F, Vazquez M, Peyraube R, Manzo L, Nalerio C, et al.. Drug-Drug Interaction Between Cannabidiol, Cyclosporine, and Mycophenolate Mofetil: A Case Report.. Transplant-Proc. 2024;56 (1):252-256$50$YR$$M$Y$$$20240709$$HP$UY$UY
236420202$23642020$2$F$$20240826$20240318$20240903$EXP$$CA-CELLTRION INC.-2024CA006571$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
236420552$23642055$2$F$20230928$20240827$20240318$20240902$EXP$$AU-TAKEDA-2023TUS094353$TAKEDA$$56$YR$$M$Y$$$20240902$$CN$AU$AU
236421383$23642138$3$F$$20240619$20240318$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02099$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236421817$23642181$7$F$20230919$20240730$20240318$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-041314$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$67$KG$20240807$$MD$JP$JP
236421923$23642192$3$F$$20240709$20240318$20240813$EXP$$US-ROCHE-3524648$ROCHE$$$$$$Y$$$20240717$$CN$US$US
236421932$23642193$2$F$20240303$20240621$20240318$20240709$EXP$$IN-ROCHE-3423568$ROCHE$$71$YR$E$M$Y$$$20240701$$CN$IN$IN
236422035$23642203$5$F$$20240813$20240318$20240816$PER$$NVSC2024US055769$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
236422304$23642230$4$F$20211213$20240905$20240318$20240909$EXP$GB-MHRA-MED-202403142052023200-ZNCFW$GB-DSJP-DSE-2024-111931$DAIICHI$$88$YR$$M$Y$99$KG$20240909$$CN$GB$GB
236422556$23642255$6$F$$20240814$20240318$20240827$EXP$$FR-AUROBINDO-AUR-APL-2024-011726$AUROBINDO$Darres A, Del Bello A,Marion O, de Lamballerie X, Malvy D, Nassim K ET ALL.. Failure of favipiravir to treat chronic norovirus infection in a kidney-transplant patient (Letter to the Editor).. Transplant Infectious Disease. 2024;26 (1):1-2.$64$YR$$M$Y$$$20240827$$HP$FR$FR
236422752$23642275$2$F$$20240619$20240318$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02136$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236422844$23642284$4$F$20231201$20240805$20240318$20240810$EXP$$US-AMGEN-USASP2024055029$AMGEN$$69$YR$E$F$Y$$$20240810$$CN$US$US
236423062$23642306$2$F$20210909$20240827$20240318$20240905$EXP$$US-HORIZON THERAPEUTICS-HZN-2021-006886$AMGEN$$83$YR$E$F$Y$$$20240905$$LW$US$US
236423312$23642331$2$F$20220301$20240821$20240318$20240827$EXP$$NVSC2022CA056110$NOVARTIS$$61$YR$$F$Y$$$20240827$$CN$CA$CA
236423352$23642335$2$F$20201210$20240822$20240318$20240830$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-003044$AMGEN$$60$YR$A$F$Y$$$20240830$$LW$US$US
236423422$23642342$2$F$$20240619$20240318$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02135$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236423532$23642353$2$F$$20240812$20240318$20240819$EXP$$CA-GSK-CA2022107172$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$HP$CA$CA
236423546$23642354$6$F$20240222$20240919$20240318$20240926$EXP$$CA-GSK-CA2024005109$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$CA$CA
236424442$23642444$2$F$20231101$20240903$20240318$20240912$PER$$US-SA-2024SA084638$SANOFI AVENTIS$$28$YR$A$F$Y$87$KG$20240912$$MD$US$US
236424573$23642457$3$F$20231201$20240806$20240318$20240814$EXP$$JP-009507513-2312JPN003032J$MERCK$$86$YR$$F$Y$$$20240814$$MD$JP$JP
236424763$23642476$3$F$20240517$20240607$20240318$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000916$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240701$$CN$US$US
236424882$23642488$2$F$20230424$20240620$20240318$20240705$PER$$US-Eisai-EC-2023-139211$EISAI$$67$YR$E$F$Y$48.99$KG$20240705$$CN$US$US
236425302$23642530$2$F$$20240806$20240318$20240807$EXP$$PT-SANDOZ INC.-PHHY2018PT198015$SANDOZ$$71$YR$$M$Y$$$20240807$$MD$PT$PT
236426082$23642608$2$F$20240101$20240627$20240318$20240701$PER$$US-AMGEN-USASP2024055256$AMGEN$$59$YR$A$F$Y$$$20240701$$CN$US$US
236427166$23642716$6$F$20240101$20240711$20240318$20240720$EXP$$CA-CELLTRION INC.-2024CA006541$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
236427242$23642724$2$F$$20240821$20240318$20240828$EXP$$HR-INCYTE CORPORATION-2024IN002712$INCYTE$$$$$$Y$$$20240828$$MD$HR$HR
236427262$23642726$2$F$$20240821$20240318$20240828$EXP$$HR-INCYTE CORPORATION-2024IN002765$INCYTE$$$$$$Y$$$20240828$$MD$HR$HR
236427782$23642778$2$F$20240223$20240710$20240318$20240715$EXP$$US-KYOWAKIRIN-2024KK005194$KYOWA$$$$$$Y$$$20240715$$CN$US$US
236427962$23642796$2$F$$20240903$20240318$20240905$EXP$$CA-JNJFOC-20240332340$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240905$$HP$CA$CA
236428112$23642811$2$F$20231215$20240619$20240318$20240704$EXP$FR-AFSSAPS-RE2024000196$FR-TEVA-VS-3170273$TEVA$$68$YR$$M$Y$79$KG$20240704$$MD$FR$FR
236428236$23642823$6$F$20240501$20240718$20240318$20240723$EXP$$US-SA-2024SA084651$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240723$$MD$US$US
236428263$23642826$3$F$20211201$20240912$20240318$20240917$EXP$$US-MYLANLABS-2024M1012602$MYLAN$$58$YR$$F$Y$$$20240917$$CN$US$US
236429223$23642922$3$F$$20240704$20240318$20240710$EXP$$CA-TAKEDA-2024TUS024805$TAKEDA$$$$$M$Y$$$20240710$$CN$CA$CA
236429413$23642941$3$F$$20240806$20240318$20240808$EXP$$US-KYOWAKIRIN-2024KK004903$KYOWA$$$$$$Y$$$20240808$$HP$US$US
236429483$23642948$3$F$$20240711$20240318$20240715$EXP$$GB-MYLANLABS-2024M1025077$MYLAN$$$$$F$Y$$$20240715$$CN$GB$GB
236429554$23642955$4$F$$20240522$20240318$20240902$EXP$$US-ROCHE-3525041$ROCHE$$$$$$Y$$$20240902$$CN$US$US
236429582$23642958$2$F$20240301$20240703$20240318$20240708$EXP$GB-MHRA-EMIS-3984-acddb543-c910-4a4c-b39f-cd64ce95bafc$GB-MYLANLABS-2024M1023785$MYLAN$$66$YR$$M$Y$75$KG$20240708$$MD$GB$GB
236430332$23643033$2$F$$20240716$20240318$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-042611$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240729$$HP$CA$CA
236430532$23643053$2$F$20240223$20240718$20240318$20240723$PER$$US-AMGEN-USASP2024055597$AMGEN$$63$YR$A$M$Y$$$20240723$$HP$US$US
236430957$23643095$7$F$20240303$20240813$20240318$20240815$PER$$US-PFIZER INC-202400065146$PFIZER$$67$YR$$F$Y$81.64$KG$20240815$$CN$US$US
236431072$23643107$2$F$$20240807$20240318$20240812$PER$$US-PFIZER INC-202400065682$PFIZER$$71$YR$$F$Y$$$20240812$$HP$US$US
236431169$23643116$9$F$20240101$20240729$20240318$20240801$EXP$$US-PFIZER INC-PV202400036057$PFIZER$$56$YR$$F$Y$$$20240801$$HP$US$US
236431197$23643119$7$F$20240802$20240806$20240318$20240808$EXP$$CA-PFIZER INC-PV202400035451$PFIZER$$60$YR$$M$Y$$$20240808$$HP$CA$CA
236431479$23643147$9$F$20240101$20240924$20240318$20240930$EXP$$JP-AMGEN-JPNSP2024035975$AMGEN$$$$A$F$Y$$$20240930$$MD$JP$JP
236431716$23643171$6$F$20230321$20240924$20240318$20240930$EXP$$IN-PFIZER INC-PV202300065974$PFIZER$$77$YR$$F$Y$$$20240930$$CN$IN$IN
236431852$23643185$2$F$20111031$20240910$20240318$20240913$EXP$$ZA-PFIZER INC-PV202400035272$PFIZER$$32$YR$$F$Y$126$KG$20240913$$MD$ZA$ZA
236431965$23643196$5$F$$20240822$20240318$20240826$EXP$$US-PFIZER INC-2020270488$PFIZER$$67$YR$$F$Y$$$20240826$$CN$US$US
236432204$23643220$4$F$$20240618$20240318$20240703$EXP$CA-MMM-R7XJE01T$CA-GSK-CA2023101876$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CA$CA
236432254$23643225$4$F$20240101$20240826$20240318$20240910$PER$$US-SA-2024SA085533$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240910$$MD$US$US
236432853$23643285$3$F$20240101$20240826$20240318$20240902$PER$$US-BIOGEN-2024BI01255368$BIOGEN$$$$$M$Y$$$20240902$$CN$US$US
236432932$23643293$2$F$20240213$20240904$20240318$20240912$EXP$FR-AFSSAPS-BX2024000373$FR-TEVA-VS-3170271$TEVA$$91$YR$$F$Y$42$KG$20240912$$PH$FR$FR
236432954$23643295$4$F$$20240823$20240318$20240827$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-000868$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240827$$CN$US$US
236432963$23643296$3$F$$20240313$20240318$20240806$PER$$US-AstraZeneca-2024A062528$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
236432992$23643299$2$F$20240311$20240820$20240318$20240823$EXP$$US-AMGEN-USASP2024053412$AMGEN$$64$YR$A$M$Y$$$20240823$$HP$US$US
236433362$23643336$2$F$20180611$20240207$20240318$20240923$PER$$BG-ROCHE-3468146$ROCHE$$65$YR$E$F$Y$54$KG$20240923$$MD$BG$BG
236433473$23643347$3$F$20240110$20240917$20240318$20240924$EXP$$SA-GSK-SA2024EME012838$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$SA$SA
236433982$23643398$2$F$$20240913$20240318$20240923$EXP$$CA-GSK-CA2024029111$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$CA$CA
236434213$23643421$3$F$20240101$20240729$20240318$20240806$PER$$US-SA-2024SA084693$SANOFI AVENTIS$$9$YR$C$M$Y$28.1$KG$20240806$$MD$US$US
236434352$23643435$2$F$$20240108$20240318$20240718$EXP$$US-TEVA-VS-3143270$TEVA$$$$$$Y$$$20240718$$CN$US$US
236434362$23643436$2$F$$20240624$20240318$20240701$EXP$$CA-GSK-CA2024AMR032259$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$CA$CA
236434395$23643439$5$F$20230101$20240717$20240318$20240724$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-014472$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$55$KG$20240724$$CN$BR$BR
236434463$23643446$3$F$$20240619$20240318$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02170$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236434566$23643456$6$F$20230719$20240628$20240318$20240708$PER$$US-JAZZ PHARMACEUTICALS-2023-US-000059$JAZZ$$54$YR$$F$Y$$$20240708$$HP$US$US
236435255$23643525$5$F$20240101$20240807$20240318$20240809$EXP$$US-ORGANON-O2403USA001440$ORGANON$$$$$F$Y$52.16$KG$20240809$$MD$US$US
236435356$23643535$6$F$20230228$20240906$20240318$20240912$EXP$$JP-AstraZeneca-2023A056308$ASTRAZENECA$Ehara Y. et al.. 17 A case of acneiform rash during treatment with selumetinib sulfate capsules in plexiform neurofibroma of type 1 neurofibromatosis.. The 153rd Hiroshima Regional Meeting of the Japanese Dermatological Association - Inaugural Commemoration of Prof. Akio Tanaka 2023;$16$YR$$F$Y$50$KG$20240913$$PH$JP$
236435853$23643585$3$F$$20240723$20240318$20240729$EXP$$GB-MYLANLABS-2024M1023798$MYLAN$$$$$M$Y$$$20240729$$PH$GB$GB
236435863$23643586$3$F$$20240627$20240318$20240708$EXP$IE-HPRA-2024-111022$IE-MYLANLABS-2024M1023665$MYLAN$$37$YR$$M$Y$$$20240708$$HP$IE$IE
236436173$23643617$3$F$20230701$20240924$20240318$20240930$EXP$$JP-009507513-2312JPN001089J$MERCK$$72$YR$$M$Y$$$20240930$$MD$JP$JP
236436344$23643634$4$F$20230105$20240627$20240318$20240703$EXP$$US-TAKEDA-2022TUS048407$TAKEDA$$44$YR$$F$Y$68$KG$20240703$$CN$US$US
236436537$23643653$7$F$20240101$20240917$20240318$20240920$PER$$US-PFIZER INC-PV202400036460$PFIZER$$72$YR$$F$Y$58.5$KG$20240920$$HP$US$US
236436572$23643657$2$F$$20240709$20240318$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042457$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240710$$CN$US$US
236436702$23643670$2$F$20240227$20240712$20240318$20240919$EXP$$US-FERRINGPH-2024FE01034$FERRING$$34$YR$$F$Y$45.351$KG$20240919$$PH$US$US
236436733$23643673$3$F$20220928$20240814$20240318$20240818$PER$$US-ORGANON-O2402USA002619$ORGANON$$27$YR$$F$Y$86.168$KG$20240818$$HP$US$US
236436832$23643683$2$F$20231226$20240806$20240318$20240815$EXP$FR-AFSSAPS-TO2024000378$FR-BAXTER-2024BAX014683$BAXTER$$77$YR$$F$Y$$$20240815$$PH$FR$FR
236437563$23643756$3$F$20240304$20240810$20240318$20240819$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-046383$REGENERON$$67$YR$$F$Y$$$20240819$$HP$CO$CO
236437943$23643794$3$F$$20240807$20240318$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-038585$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240812$$CN$US$US
236438033$23643803$3$F$20240115$20240729$20240318$20240801$EXP$$US-JNJFOC-20240327943$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240802$$HP$US$US
236438082$23643808$2$F$20240625$20240626$20240318$20240705$EXP$$CA-APOTEX-2024AP003558$APOTEX$$80$YR$E$M$Y$$$20240705$$HP$CA$CA
236438093$23643809$3$F$$20240730$20240318$20240823$EXP$$US-LUPIN EUROPE GMBH-2024-02177$LUPIN$Le V, Surineni K, Elias G. A case of partially reversible oral-buccal-lingual dyskinesia after prolonged Levetiracetam exposure. The American Journal of Geriatric Psychiatry. 2024;32(4):S106$86$YR$$F$Y$$$20240823$$MD$US$US
236438247$23643824$7$F$20240301$20240725$20240318$20240802$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000551$BLUEPRINT MEDICINES$$67$YR$E$M$Y$$$20240802$$MD$US$US
236438514$23643851$4$F$20240612$20240731$20240318$20240814$PER$$US-Calliditas-2024CAL00390$CALLIDITAS THERAPEUTICS$$28$YR$A$M$Y$76.2$KG$20240813$$CN$US$US
236438672$23643867$2$F$20230801$20240813$20240318$20240819$EXP$$JP-009507513-2310JPN002076J$MERCK$$29$YR$$F$Y$$$20240819$$MD$JP$JP
236438713$23643871$3$F$$20240627$20240318$20240701$EXP$$CA-TAKEDA-2024TUS024171$TAKEDA$$$$$F$Y$$$20240701$$MD$CA$CA
236438744$23643874$4$F$$20240912$20240318$20240916$30DAY$$US-SANDOZ INC.-SDZ2024US028065$SANDOZ$$$$$F$Y$$$20240916$$CN$US$US
236438822$23643882$2$F$20240122$20240827$20240318$20240830$PER$$US-AMGEN-USASP2024055476$AMGEN$$73$YR$E$M$Y$$$20240830$$CN$US$US
236439144$23643914$4$F$$20240809$20240318$20240817$EXP$$US-TAKEDA-2024TUS020013$TAKEDA$$$$$F$Y$98$KG$20240817$$CN$US$US
236439202$23643920$2$F$20240127$20240821$20240318$20240829$EXP$$DE-JNJFOC-20240339360$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240829$$MD$DE$DE
236439212$23643921$2$F$$20240619$20240318$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02130$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236439318$23643931$8$F$20240201$20240913$20240318$20240918$30DAY$$US-PFIZER INC-202400051169$PFIZER$$14$YR$$M$Y$$$20240918$$PH$US$US
236439612$23643961$2$F$$20240619$20240318$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02131$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236440023$23644002$3$F$20231201$20240820$20240318$20240822$EXP$$US-SA-2024SA084081$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240822$$MD$US$US
236440083$23644008$3$F$20240601$20240814$20240318$20240820$EXP$$NL-MYLANLABS-2024M1023454$MYLAN$$17$YR$$F$Y$$$20240820$$MD$NL$NL
236440372$23644037$2$F$$20240629$20240318$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043122$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$91.17$KG$20240702$$CN$US$US
236440822$23644082$2$F$$20240619$20240318$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02137$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236440864$23644086$4$F$20231017$20240918$20240318$20240926$PER$$US-SA-2024SA082408$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240926$$MD$US$US
236440933$23644093$3$F$$20240701$20240318$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042241$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240705$$MD$JP$JP
236440963$23644096$3$F$$20240702$20240318$20240711$PER$$US-SA-2024SA081814$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240711$$MD$US$US
236441375$23644137$5$F$$20240912$20240318$20240917$30DAY$$US-PFIZER INC-PV202400027901$PFIZER$$9$YR$$F$Y$20.862$KG$20240917$$MD$US$US
236441625$23644162$5$F$20240301$20240725$20240318$20240801$EXP$$US-SA-2024SA083154$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240801$$MD$US$US
236441643$23644164$3$F$20240101$20240722$20240318$20240731$PER$$US-SA-2024SA084472$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240731$$MD$US$US
236441792$23644179$2$F$$20240703$20240318$20240708$PER$$US-SA-2024SA085060$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
236441872$23644187$2$F$20240101$20240802$20240318$20240813$PER$$US-SA-2024SA083029$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240813$$MD$US$US
236441894$23644189$4$F$20220401$20240715$20240318$20240722$PER$$US-SA-2022SA347857$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240722$$CN$US$US
236441982$23644198$2$F$$20240917$20240318$20240924$PER$$US-SA-2024SA083713$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240924$$CN$US$US
236442182$23644218$2$F$$20240715$20240318$20240722$PER$$US-SA-2024SA082551$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240721$$MD$US$US
236442625$23644262$5$F$20240101$20240814$20240318$20240821$PER$$US-SA-2024SA084221$SANOFI AVENTIS$$43$YR$A$F$Y$78$KG$20240821$$MD$US$US
236442682$23644268$2$F$20231101$20240916$20240318$20240920$PER$$US-SA-2024SA082608$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240920$$MD$US$US
236442722$23644272$2$F$$20240702$20240318$20240710$PER$$US-SA-2024SA081959$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240710$$MD$US$US
236442812$23644281$2$F$$20240820$20240318$20240828$PER$$US-SA-2023SA113579$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240828$$MD$US$US
236442953$23644295$3$F$20240101$20240628$20240318$20240711$PER$$US-SA-2024SA081355$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240711$$MD$US$US
236443134$23644313$4$F$20230101$20240920$20240318$20240927$EXP$$US-SA-2024SA082982$SANOFI AVENTIS$$82$YR$E$F$Y$108$KG$20240927$$MD$US$US
236443232$23644323$2$F$$20240619$20240318$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02098$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236443293$23644329$3$F$$20240705$20240318$20240712$EXP$$JP-009507513-2312JPN000497J$MERCK$Tamiya T, Kobayashi S, Tanabe K, Konishi T, Noro A. 11 Experience with Pembrolizumab + Lenvatinib in 4 patients with dialysis and investigation of its safety. The 92th Saitama Regional Meeting of the Japan Urological Association. 16$58$YR$$M$Y$$$20240712$$MD$JP$JP
236443422$23644342$2$F$20240220$20240705$20240318$20240710$EXP$IT-MINISAL02-975289$IT-PFIZER INC-202400065362$PFIZER$$74$YR$$F$Y$65$KG$20240710$$MD$IT$IT
236443446$23644344$6$F$$20240913$20240318$20240918$30DAY$$US-PFIZER INC-202400052450$PFIZER$$11$YR$$F$Y$26.594$KG$20240918$$CN$US$US
236443692$23644369$2$F$20240301$20240624$20240318$20240702$PER$$US-SA-2024SA080533$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240702$$MD$US$US
236443963$23644396$3$F$20231201$20240820$20240318$20240917$PER$$US-SA-2024SA081545$SANOFI AVENTIS$$59$YR$A$M$Y$73.469$KG$20240918$$MD$US$US
236444062$23644406$2$F$$20240619$20240318$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02144$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236444112$23644411$2$F$$20240809$20240318$20240817$PER$$US-SA-2024SA083456$SANOFI AVENTIS$$$$C$F$Y$$$20240817$$MD$US$US
236444192$23644419$2$F$20240207$20240913$20240318$20240923$PER$$US-SA-2024SA081680$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240923$$MD$US$US
236444292$23644429$2$F$20240306$20240307$20240318$20240913$EXP$GB-MHRA-MED-202403060832321650-RLTDV$GB-TORRENT-00035727$TORRENT$$62$YR$A$M$Y$80$KG$20240913$$CN$GB$GB
236444454$23644445$4$F$20240119$20240703$20240318$20240712$PER$$US-SA-2024SA080141$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240712$$MD$US$US
236444782$23644478$2$F$$20240619$20240318$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02196$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236444975$23644497$5$F$20231222$20240715$20240318$20240724$EXP$$US-BIOMARINAP-US-2024-156523$BIOMARIN$$$$$$Y$$$20240724$$CN$US$US
236445012$23644501$2$F$20240101$20240808$20240318$20240816$PER$$US-SA-2024SA082935$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240816$$MD$US$US
236445172$23644517$2$F$$20240925$20240318$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202403008321$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240927$$CN$US$US
236445323$23644532$3$F$$20240917$20240318$20240920$PER$$NVSC2024US050632$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
236445422$23644542$2$F$$20240626$20240318$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02225$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236445474$23644547$4$F$$20240807$20240318$20240808$PER$$US-JNJFOC-20240349559$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240808$$CN$US$US
236445592$23644559$2$F$$20240625$20240318$20240702$PER$$US-SA-2024SA082788$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240702$$PH$US$US
236446534$23644653$4$F$$20240628$20240318$20240711$PER$$US-Calliditas-2024CAL00418$CALLIDITAS THERAPEUTICS$$73$YR$E$M$Y$81.2$KG$20240711$$CN$US$US
236447443$23644744$3$F$$20240624$20240318$20240703$EXP$$US-Calliditas-2024CAL00320$CALLIDITAS THERAPEUTICS$$42$YR$A$M$Y$98.9$KG$20240703$$CN$US$US
236447642$23644764$2$F$$20240826$20240318$20240829$EXP$$US-MYLANLABS-2024M1024127$MYLAN$$$$$M$Y$77$KG$20240829$$HP$US$US
236447952$23644795$2$F$$20240903$20240318$20240909$EXP$$GB-INCYTE CORPORATION-2024IN002713$INCYTE$$$$$$Y$$$20240909$$MD$GB$GB
236448103$23644810$3$F$$20240628$20240318$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042884$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240702$$MD$JP$JP
236448204$23644820$4$F$20240225$20240426$20240318$20240720$EXP$$NVSC2024US049954$NOVARTIS$$72$YR$$F$Y$63.5$KG$20240719$$HP$US$US
236448306$23644830$6$F$$20240820$20240318$20240821$EXP$$NVSC2024CA054857$NOVARTIS$$$$$$Y$$$20240821$$CN$CA$CA
236448313$23644831$3$F$$20240819$20240318$20240821$EXP$$CA-ROCHE-3528081$ROCHE$$$$A$M$Y$$$20240821$$CN$CA$CA
236448648$23644864$8$F$20220201$20240809$20240318$20240814$EXP$$DE-ROCHE-3092225$ROCHE$$49$YR$A$M$Y$$$20240814$$MD$DE$DE
236449406$23644940$6$F$$20240706$20240318$20240711$EXP$$NVSC2024US058226$NOVARTIS$$$$$$Y$$$20240711$$CN$US$US
236449662$23644966$2$F$20190701$20240723$20240318$20240730$EXP$$DE-ROCHE-2364531$ROCHE$$51$YR$A$M$Y$$$20240730$$CN$DE$DE
236449954$23644995$4$F$20240301$20240722$20240318$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043185$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240724$$CN$US$US
236449973$23644997$3$F$$20240724$20240318$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA028300$SANDOZ$$6$YR$$M$Y$$$20240726$$HP$CA$CA
236450142$23645014$2$F$$20240716$20240318$20240722$EXP$$JP-009507513-2403JPN001337J$MERCK$$67$YR$$M$Y$$$20240722$$MD$JP$JP
236450182$23645018$2$F$$20240828$20240318$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042797$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240902$$CN$US$US
236451022$23645102$2$F$$20240729$20240318$20240802$EXP$$US-MYLANLABS-2024M1024715$MYLAN$On S, Domingo W, Cheung E, Johnston L. Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation. Transplant-Cell-Ther 2024; 30 (Suppl.) (2): S163 abstr. 211.$$$A$$Y$$$20240802$$HP$US$US
236451052$23645105$2$F$$20240729$20240318$20240809$EXP$$US-MYLANLABS-2024M1024746$MYLAN$On S, Domingo W, Cheung E, Johnston L. Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation. Transplant-Cell-Ther 2024; 30 (Suppl.) (2): S163 abstr. 211.$$$A$$Y$$$20240809$$HP$US$US
236451085$23645108$5$F$20240201$20240723$20240318$20240730$EXP$$NVSC2024FR030714$NOVARTIS$$73$YR$$M$Y$71$KG$20240730$$MD$FR$FR
236451115$23645111$5$F$20240313$20240618$20240318$20240701$PER$$US-Calliditas-2024CAL00430$CALLIDITAS THERAPEUTICS$$73$YR$E$M$Y$87.3$KG$20240701$$HP$US$US
236451228$23645122$8$F$20101012$20240813$20240318$20240815$EXP$$US-PFIZER INC-202400065164$PFIZER$$67$YR$$F$Y$81.646$KG$20240815$$CN$US$US
236451303$23645130$3$F$$20240905$20240318$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042024$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240908$$CN$US$US
236452084$23645208$4$F$$20240815$20240318$20240820$PER$$US-BIOMARINAP-US-2024-156470$BIOMARIN$$$$$$Y$$$20240820$$HP$US$US
236452244$23645224$4$F$20240126$20240628$20240318$20240704$EXP$$JP-009507513-2402JPN002080J$MERCK$$76$YR$$F$Y$$$20240704$$MD$JP$JP
236452252$23645225$2$F$20210121$20240702$20240318$20240708$EXP$$JP-009507513-2402JPN002515J$MERCK$$78$YR$$F$Y$$$20240708$$MD$JP$JP
236452514$23645251$4$F$20210501$20240719$20240318$20240724$EXP$$GB-JNJFOC-20240349514$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240725$$CN$GB$GB
236453323$23645332$3$F$20230914$20240628$20240318$20240702$PER$$US-JNJFOC-20240324663$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240703$$MD$US$US
236453342$23645334$2$F$20240308$20240715$20240318$20240723$PER$$US-BIOGEN-2024BI01255445$BIOGEN$$$$$$Y$$$20240723$$CN$US$US
236453393$23645339$3$F$20230607$20240628$20240318$20240702$PER$$US-JNJFOC-20240324656$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240702$$MD$US$US
236453412$23645341$2$F$20231001$20240903$20240318$20240904$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-003358$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240904$$CN$US$US
236453502$23645350$2$F$20230721$20240628$20240318$20240703$PER$$US-JNJFOC-20240324662$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240704$$MD$US$US
236453793$23645379$3$F$$20240716$20240318$20240722$EXP$$US-SANDOZ INC.-SDZ2024US028792$SANDOZ$$$$$$Y$$$20240722$$CN$US$US
236454195$23645419$5$F$20240101$20240711$20240318$20240723$EXP$$US-MALLINCKRODT-MNK202401737$MALLINCKRODT$$48$YR$A$F$Y$308$KG$20240723$$HP$US$US
236454283$23645428$3$F$$20240820$20240318$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041894$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240828$$CN$US$US
236454295$23645429$5$F$20231012$20240911$20240318$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-041144$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$41.5$KG$20240919$$MD$JP$JP
236454482$23645448$2$F$$20240625$20240318$20240703$PER$$NVSC2024US053861$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
236454613$23645461$3$F$20240101$20240828$20240319$20240910$PER$$US-SA-2024SA084508$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240910$$MD$US$US
236454712$23645471$2$F$20240101$20240715$20240319$20240726$PER$$US-SA-2024SA082557$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240726$$MD$US$US
236454875$23645487$5$F$$20240920$20240319$20240927$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-015843$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240927$$CN$CA$CA
236454952$23645495$2$F$$20240729$20240319$20240808$PER$$NVSC2024US053519$NOVARTIS$$24$YR$$M$Y$$$20240808$$CN$US$US
236455452$23645545$2$F$20240312$20240802$20240319$20240805$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-015851$BOEHRINGER INGELHEIM$$63$YR$A$F$Y$$$20240805$$CN$US$US
236455784$23645578$4$F$$20240628$20240319$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-028240$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$MD$JP$JP
236455872$23645587$2$F$20240201$20240716$20240319$20240722$EXP$$US-UCBSA-2024013129$UCB$$25$YR$$F$Y$$$20240719$$HP$US$US
236455922$23645592$2$F$20240304$20240706$20240319$20240716$EXP$$AR-EMD Serono-2024013716$EMD SERONO INC$$6$YR$C$F$Y$$$20240716$$CN$AR$AR
236456882$23645688$2$F$20231214$20240902$20240319$20240921$PER$$US-TEVA-VS-3139551$TEVA$$65$YR$$F$Y$50.35$KG$20240921$$CN$US$US
236456894$23645689$4$F$20240201$20240610$20240319$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000641$ACADIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240708$$CN$US$US
236457003$23645700$3$F$20221201$20240808$20240319$20240820$EXP$$NL-AUROBINDO-AUR-APL-2024-011774$AUROBINDO$$17$YR$$F$Y$$$20240820$$MD$NL$NL
236457432$23645743$2$F$20230501$20240826$20240319$20240903$EXP$$CA-CELLTRION INC.-2024CA006432$CELLTRION$$$$$$Y$$$20240903$$CN$CA$CA
236457445$23645744$5$F$20240101$20240916$20240319$20240924$EXP$$CA-CELLTRION INC.-2024CA006433$CELLTRION$$$$$$Y$$$20240924$$CN$CA$CA
236457632$23645763$2$F$20240107$20240808$20240319$20240816$EXP$FR-AFSSAPS-BX2024000392$FR-TEVA-VS-3171347$TEVA$$17$YR$$M$Y$$$20240816$$PH$FR$FR
236457793$23645779$3$F$$20240319$20240319$20240828$EXP$$FR-ROCHE-3526797$ROCHE$$43$YR$A$F$Y$$$20240828$$MD$FR$FR
236458096$23645809$6$F$20230801$20240710$20240319$20240720$EXP$$CA-CELLTRION INC.-2023CA017643$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
236458703$23645870$3$F$20240101$20240701$20240319$20240707$EXP$$US-ABBVIE-5679202$ABBVIE$$$$$F$Y$93.893$KG$20240707$$CN$US$US
236458762$23645876$2$F$20240201$20240918$20240319$20240918$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-015872$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$$$20240919$$CN$CA$CA
236459035$23645903$5$F$$20240905$20240319$20240913$EXP$$IN-ROCHE-3478454$ROCHE$$21$YR$A$M$Y$$$20240913$$MD$IN$IN
236459112$23645911$2$F$$20240822$20240319$20240829$EXP$$US-HORIZON THERAPEUTICS-HZN-2022-001989$AMGEN$$66$YR$E$F$Y$$$20240829$$CN$US$US
236459282$23645928$2$F$20240311$20240421$20240319$20240715$EXP$$SA-UCBSA-2024012625$UCB$$21$YR$$F$Y$$$20240715$$CN$SA$SA
236459353$23645935$3$F$$20240828$20240319$20240916$PER$$CA-TOLMAR, INC.-24CA047326$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
236459412$23645941$2$F$20240228$20240718$20240319$20240809$PER$$CA-TOLMAR, INC.-24CA047331$TOLMAR$$71$YR$$M$Y$$$20240809$$CN$CA$CA
236459423$23645942$3$F$20240101$20240814$20240319$20240911$PER$$CA-TOLMAR, INC.-24CA047333$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
236459452$23645945$2$F$20240228$20240812$20240319$20240903$PER$$CA-TOLMAR, INC.-24CA047332$TOLMAR$$80$YR$$M$Y$$$20240903$$CN$CA$CA
236459722$23645972$2$F$$20240716$20240319$20240722$PER$$US-JNJFOC-20240343589$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$HP$US$US
236459934$23645993$4$F$20240201$20240627$20240319$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000952$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240723$$CN$US$US
236460384$23646038$4$F$$20240611$20240319$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000900$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
236460424$23646042$4$F$20230911$20240708$20240319$20240711$EXP$$IT-TAKEDA-2023TUS091413$TAKEDA$$76$YR$$F$Y$$$20240711$$CN$IT$IT
236460663$23646066$3$F$$20240718$20240319$20240802$EXP$$CA-SUNPHARMA-2024R1-434582AA$RANBAXY$$44$YR$$F$Y$70$KG$20240802$$HP$CA$CA
236460772$23646077$2$F$$20240619$20240319$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02142$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236461164$23646116$4$F$$20240717$20240319$20240726$EXP$$CA-ROCHE-3523799$ROCHE$$34$YR$A$F$Y$$$20240726$$CN$CA$CA
236461173$23646117$3$F$20180201$20240708$20240319$20240718$EXP$$CA-ROCHE-3131763$ROCHE$$65$YR$E$F$Y$$$20240718$$MD$CA$CA
236461453$23646145$3$F$$20240829$20240319$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043594$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240830$$CN$US$US
236461502$23646150$2$F$$20240619$20240319$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02143$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236461912$23646191$2$F$20240312$20240826$20240319$20240830$EXP$$US-TAKEDA-2024TUS024060$TAKEDA$$24$YR$$F$Y$$$20240830$$PH$US$US
236461972$23646197$2$F$$20240822$20240319$20240830$EXP$$CA-AstraZeneca-2024A062242$ASTRAZENECA$$42$YR$$F$Y$$$20240830$$MD$CA$
236462082$23646208$2$F$20240301$20240801$20240319$20240807$EXP$$GR-ABBVIE-5682925$ABBVIE$$82$YR$$F$Y$$$20240807$$CN$GR$GR
236462154$23646215$4$F$$20240801$20240319$20240808$EXP$$RO-ROCHE-3527533$ROCHE$$73$YR$E$F$Y$90$KG$20240808$$CN$RO$RO
236462584$23646258$4$F$$20240725$20240319$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042870$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240731$$MD$JP$JP
236462692$23646269$2$F$$20240917$20240319$20240924$EXP$$US-ROCHE-3525930$ROCHE$$72$YR$E$F$Y$$$20240924$$HP$US$US
236463752$23646375$2$F$$20240702$20240319$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043398$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240704$$CN$US$US
236463795$23646379$5$F$20230403$20240702$20240319$20240709$EXP$$CA-TAKEDA-2024TUS014433$TAKEDA$$73$YR$$F$Y$$$20240709$$HP$CA$CA
236464075$23646407$5$F$$20240709$20240319$20240712$EXP$$CA-TAKEDA-2024TUS003843$TAKEDA$$$$$F$Y$$$20240712$$CN$CA$CA
236464103$23646410$3$F$$20240813$20240319$20240815$EXP$$CA-ABBVIE-5682430$ABBVIE$$43$YR$$F$Y$97$KG$20240815$$HP$CA$CA
236464253$23646425$3$F$20240425$20240919$20240319$20240926$EXP$$CA-TAKEDA-2024TUS024388$TAKEDA$$42$YR$$M$Y$$$20240926$$CN$CA$CA
236464262$23646426$2$F$20220928$20240925$20240319$20240927$EXP$$CA-TAKEDA-2022TUS080789$TAKEDA$$70$YR$$F$Y$$$20240927$$MD$CA$CA
236464352$23646435$2$F$$20240706$20240319$20240710$EXP$$GB-TAKEDA-2024TUS024233$TAKEDA$$$$E$M$Y$$$20240710$$CN$GB$GB
236465052$23646505$2$F$20231014$20240702$20240319$20240709$EXP$$CA-CELLTRION INC.-2023CA009271$CELLTRION$$$$$$Y$$$20240709$$MD$CA$CA
236465915$23646591$5$F$$20240715$20240319$20240718$EXP$$CA-SANDOZ INC.-SDZ2024CA028570$SANDOZ$$44$YR$$F$Y$97$KG$20240718$$CN$CA$CA
236466373$23646637$3$F$20240101$20240729$20240319$20240731$EXP$$US-ABBVIE-5680592$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
236466743$23646674$3$F$20240201$20240703$20240319$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042361$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$120.2$KG$20240711$$HP$US$US
236467253$23646725$3$F$20240226$20240813$20240319$20240904$PER$$CA-TOLMAR, INC.-24CA047243$TOLMAR$$64$YR$$M$Y$$$20240904$$CN$CA$CA
236467283$23646728$3$F$20240226$20240812$20240319$20240903$PER$$CA-TOLMAR, INC.-24CA047266$TOLMAR$$69$YR$$M$Y$$$20240903$$CN$CA$CA
236467292$23646729$2$F$20231107$20240617$20240319$20240709$PER$$CA-TOLMAR, INC.-24CA047253$TOLMAR$$63$YR$$M$Y$$$20240709$$CN$CA$CA
236467302$23646730$2$F$20240226$20240617$20240319$20240709$PER$$CA-TOLMAR, INC.-24CA047257$TOLMAR$$79$YR$$M$Y$$$20240709$$CN$CA$CA
236467812$23646781$2$F$$20240312$20240319$20240725$EXP$$CA-HALEON-CACH2024AMR013599$Haleon PLC$$$$$F$Y$$$20240718$$HP$CA$CA
236467916$23646791$6$F$20231116$20240730$20240319$20240731$EXP$$AU-TAKEDA-2023TUS113169$TAKEDA$$49$YR$$F$Y$$$20240731$$CN$AU$AU
236467972$23646797$2$F$$20240716$20240319$20240724$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-039435$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240724$$HP$CA$CA
236468305$23646830$5$F$20240201$20240910$20240319$20240924$EXP$$US-UCBSA-2024013163$UCB$$64$YR$$F$Y$$$20240924$$HP$US$US
236468334$23646833$4$F$20230701$20240724$20240319$20240807$EXP$$US-UCBSA-2024004739$UCB$$72$YR$$F$Y$85.714$KG$20240807$$HP$US$US
236468352$23646835$2$F$20230214$20240822$20240319$20240823$EXP$$US-TAKEDA-2024TUS024723$TAKEDA$$76$YR$$M$Y$$$20240823$$HP$US$US
236468454$23646845$4$F$$20240910$20240319$20240912$EXP$$NVSC2024CA055198$NOVARTIS$$60$YR$$F$Y$$$20240912$$CN$CA$CA
236468552$23646855$2$F$$20240819$20240319$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042974$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240819$$CN$US$US
236469372$23646937$2$F$20240314$20240820$20240319$20240823$PER$$US-AMGEN-USASP2024055932$AMGEN$$66$YR$E$F$Y$$$20240822$$CN$US$US
236469443$23646944$3$F$$20240709$20240319$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043366$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240710$$CN$US$US
236469702$23646970$2$F$20240101$20240827$20240319$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007453$UNITED THERAPEUTICS$$$$$M$Y$92.517$KG$20240904$$$US$US
236469912$23646991$2$F$$20240726$20240319$20240731$EXP$$NVSC2024CA058446$NOVARTIS$$65$YR$$F$Y$56$KG$20240731$$PH$CA$CA
236470023$23647002$3$F$$20240619$20240319$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02164$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236470173$23647017$3$F$20240301$20240917$20240319$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-006794$UNITED THERAPEUTICS$$82$YR$$F$Y$70.748$KG$20240926$$$US$US
236470293$23647029$3$F$$20240909$20240319$20240911$EXP$$CA-SANDOZ INC.-SDZ2024CA028682$SANDOZ$$4$DEC$$F$Y$102$KG$20240911$$CN$CA$CA
236470984$23647098$4$F$20231226$20240812$20240319$20240815$EXP$FR-AFSSAPS-TO2024000378$FR-ROCHE-3525584$ROCHE$$77$YR$E$F$Y$$$20240815$$PH$FR$FR
236471136$23647113$6$F$20220903$20240828$20240319$20240910$EXP$$CA-UCBSA-2022040224$UCB$$38$YR$$F$Y$$$20240910$$CN$CA$CA
236471252$23647125$2$F$20200523$20240826$20240319$20240902$EXP$$DE-EXELIXIS-XL18420030949$EXELIXIS$$$$$$Y$$$20240901$$MD$DE$DE
236471402$23647140$2$F$20230101$20240712$20240319$20240718$EXP$$US-ASTELLAS-2024US007932$ASTELLAS$$$$E$M$Y$$$20240718$$CN$US$US
236471594$23647159$4$F$$20240716$20240319$20240721$EXP$$US-MYLANLABS-2023M1084315$MYLAN$$$$$F$Y$63.5$KG$20240719$$CN$US$US
236471712$23647171$2$F$20240317$20240719$20240319$20240722$PER$$US-AMGEN-USASP2024056319$AMGEN$$74$YR$E$F$Y$$$20240722$$CN$US$US
236472277$23647227$7$F$20240601$20240717$20240319$20240723$EXP$$CA-GSK-CA2023AMR115569$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$HP$CA$CA
236472372$23647237$2$F$$20240911$20240319$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041975$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240912$$HP$US$US
236472392$23647239$2$F$$20240626$20240319$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02181$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236472754$23647275$4$F$$20240627$20240319$20240701$30DAY$$TR-PFIZER INC-PV202400024424$PFIZER$$13$YR$$M$Y$$$20240701$$PH$TR$TR
236472946$23647294$6$F$20240101$20240620$20240319$20240703$EXP$$US-INSMED, INC.-2024-00991-US$INSMED$$$$$M$Y$$$20240703$$CN$US$US
236473003$23647300$3$F$20240309$20240729$20240319$20240805$EXP$$US-AMGEN-USASP2024051766$AMGEN$$71$YR$E$F$Y$$$20240805$$CN$US$US
236473052$23647305$2$F$$20240916$20240319$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043410$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240918$$CN$US$US
236473162$23647316$2$F$20230106$20240827$20240319$20240903$EXP$$US-HORIZON THERAPEUTICS-HZN-2022-007577$AMGEN$$66$YR$E$M$Y$$$20240903$$LW$US$US
236473212$23647321$2$F$20240201$20240702$20240319$20240704$PER$$US-AMGEN-USASP2024055700$AMGEN$$64$YR$A$F$Y$$$20240703$$CN$US$US
236474724$23647472$4$F$20240303$20240702$20240319$20240717$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00372$AVADEL CNS PHARMA$$40$YR$$F$Y$54.422$KG$20240717$$CN$US$US
236474922$23647492$2$F$$20240816$20240319$20240823$PER$$US-INCYTE CORPORATION-2024IN002003$INCYTE$$$$$$Y$$$20240823$$PH$US$US
236475144$23647514$4$F$20240721$20240723$20240319$20240801$PER$$US-SA-2024SA081623$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240801$$MD$US$US
236475243$23647524$3$F$20240509$20240625$20240319$20240704$PER$$US-SA-2024SA082593$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240704$$MD$US$US
236475284$23647528$4$F$20240101$20240807$20240319$20240816$PER$$US-SA-2024SA082469$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240816$$MD$US$US
236475323$23647532$3$F$20240101$20240708$20240319$20240716$PER$$US-SA-2024SA081969$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240716$$MD$US$US
236475624$23647562$4$F$$20240910$20240319$20240916$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004508$JAZZ$$$$$M$Y$107.04$KG$20240915$$CN$US$US
236475736$23647573$6$F$20240101$20240722$20240319$20240730$PER$$US-SA-2024SA083310$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240730$$MD$US$US
236476392$23647639$2$F$$20240718$20240319$20240730$EXP$$US-BAYER-2024A040596$BAYER$$55$YR$A$F$Y$48.98$KG$20240730$$CN$US$US
236477232$23647723$2$F$20230101$20240807$20240319$20240816$PER$$US-SA-2024SA084322$SANOFI AVENTIS$$$$A$F$Y$47$KG$20240816$$MD$US$US
236477552$23647755$2$F$20240101$20240726$20240319$20240805$PER$$US-SA-2024SA084470$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240805$$MD$US$US
236477632$23647763$2$F$$20240701$20240319$20240710$PER$$US-SA-2023SA387056$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240710$$MD$US$US
236477855$23647785$5$F$$20240916$20240319$20240919$PER$$US-PFIZER INC-PV202300131964$PFIZER$$81$YR$$F$Y$$$20240919$$MD$US$US
236477922$23647792$2$F$$20240702$20240319$20240709$EXP$$JP-009507513-2403JPN001455J$MERCK$$76$YR$$M$Y$$$20240709$$MD$JP$JP
236478252$23647825$2$F$$20240724$20240319$20240801$PER$$US-SA-2024SA083512$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240801$$MD$US$US
236478303$23647830$3$F$20030601$20240703$20240319$20240712$PER$$US-SA-2024SA084665$SANOFI AVENTIS$$22$YR$A$F$Y$65$KG$20240712$$MD$US$US
236478474$23647847$4$F$20240201$20240719$20240319$20240731$PER$$US-SA-2024SA083238$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240731$$MD$US$US
236478512$23647851$2$F$20240301$20240705$20240319$20240716$PER$$US-SA-2024SA083973$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240716$$MD$US$US
236478543$23647854$3$F$20240101$20240814$20240319$20240827$PER$$US-SA-2024SA084248$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240827$$MD$US$US
236478572$23647857$2$F$20240101$20240712$20240319$20240725$PER$$US-SA-2024SA083268$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240725$$MD$US$US
236478602$23647860$2$F$$20240912$20240319$20240923$PER$$US-SA-2024SA085802$SANOFI AVENTIS$$6$YR$C$M$Y$29.932$KG$20240923$$MD$US$US
236478692$23647869$2$F$20240101$20240910$20240319$20240919$PER$$US-SA-2024SA083065$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240919$$MD$US$US
236478714$23647871$4$F$20240101$20240705$20240319$20240717$PER$$US-SA-2024SA082931$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240717$$MD$US$US
236478762$23647876$2$F$20240101$20240911$20240319$20240919$PER$$US-SA-2023SA222696$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240919$$MD$US$US
236478892$23647889$2$F$$20240716$20240319$20240722$PER$$US-SA-2024SA085176$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240720$$MD$US$US
236479042$23647904$2$F$20240301$20240723$20240319$20240801$PER$$US-SA-2024SA081089$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240801$$MD$US$US
236479282$23647928$2$F$20240301$20240724$20240319$20240801$PER$$US-SA-2024SA086774$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240801$$MD$US$US
236479313$23647931$3$F$20230101$20240829$20240319$20240904$EXP$$JP-009507513-2403JPN001308J$MERCK$$8$DEC$$M$Y$$$20240904$$MD$JP$JP
236479453$23647945$3$F$20231226$20240626$20240319$20240703$PER$$JP-Eisai-EC-2024-161277$EISAI$Taniguchi H. A case of metastatic renal cancer with pulmonary lymphangitic carcinomatosis treated with pembrolizumab plus lenvatinib. The 111th Annual Meeting of theJapanese Urological Association (Program and Abstracts). 2024;$$$E$F$Y$46$KG$20240703$$MD$JP$JP
236479472$23647947$2$F$20240221$20240221$20240319$20240905$PER$$US-ALIMERA SCIENCES INC.-US-A16013-24-000163$ALIMERA$$72$YR$$M$Y$$$20240905$$MD$US$US
236479552$23647955$2$F$20240624$20240626$20240319$20240705$PER$$US-SA-2024SA085256$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240705$$MD$US$US
236479653$23647965$3$F$$20240709$20240319$20240718$PER$$US-SA-2024SA085186$SANOFI AVENTIS$$$$E$F$Y$$$20240718$$MD$US$US
236479712$23647971$2$F$20240101$20240703$20240319$20240712$PER$$US-SA-2024SA085443$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240712$$MD$US$US
236479775$23647977$5$F$20230717$20240920$20240319$20240924$EXP$$FR-JNJFOC-20231200322$JOHNSON AND JOHNSON$$55$YR$A$M$Y$75$KG$20240925$$MD$FR$FR
236479824$23647982$4$F$20231201$20240905$20240319$20240919$EXP$$CA-UCBSA-2024013020$UCB$$25$YR$$F$Y$$$20240919$$CN$CA$CA
236479896$23647989$6$F$20240101$20240722$20240319$20240728$PER$$US-SA-2024SA085495$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240728$$MD$US$US
236479912$23647991$2$F$20240625$20240625$20240319$20240704$PER$$US-SA-2024SA033942$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240704$$MD$US$US
236480263$23648026$3$F$20070314$20240911$20240319$20240920$EXP$$AR-JNJFOC-20240347904$JOHNSON AND JOHNSON$$34$YR$A$F$Y$48$KG$20240920$$MD$AR$AR
236480373$23648037$3$F$$20240830$20240319$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA029542$SANDOZ$$9$YR$$M$Y$$$20240902$$CN$CA$CA
236480433$23648043$3$F$20240501$20240808$20240319$20240819$PER$$US-SA-2024SA083757$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240819$$MD$US$US
236480526$23648052$6$F$$20240807$20240319$20240816$PER$$US-INCYTE CORPORATION-2024IN002671$INCYTE$$$$$$Y$$$20240816$$CN$US$US
236480582$23648058$2$F$$20240723$20240319$20240729$EXP$$US-MYLANLABS-2024M1025114$MYLAN$$$$$F$Y$$$20240729$$HP$US$US
236480854$23648085$4$F$20210906$20240717$20240319$20240724$EXP$$US-MYLANLABS-2024M1022540$MYLAN$$$$$$Y$$$20240724$$CN$US$US
236481954$23648195$4$F$20240209$20240920$20240319$20240925$EXP$$GB-MYLANLABS-2024M1025222$MYLAN$$$$$F$Y$$$20240925$$CN$GB$GB
236481982$23648198$2$F$$20240905$20240319$20240910$EXP$$GB-MYLANLABS-2024M1024907$MYLAN$$27$YR$$M$Y$$$20240910$$CN$GB$GB
236482493$23648249$3$F$20240301$20240913$20240319$20240923$PER$$JP-Eisai-EC-2024-161640$EISAI$$82$YR$E$F$Y$$$20240923$$MD$JP$JP
236482576$23648257$6$F$20240101$20240720$20240319$20240724$EXP$$US-JNJFOC-20240338384$JOHNSON AND JOHNSON$$78$YR$E$F$Y$61.7$KG$20240724$$CN$US$US
236482593$23648259$3$F$$20240719$20240319$20240723$EXP$$NVSC2024US057370$NOVARTIS$$$$$F$Y$$$20240723$$HP$US$US
236482823$23648282$3$F$20210101$20240904$20240319$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004610$JAZZ$$42$YR$$F$Y$$$20240906$$MD$US$US
236483532$23648353$2$F$20200704$20240924$20240319$20240926$EXP$$CA-ROCHE-2638056$ROCHE$$40$YR$A$M$Y$$$20240926$$CN$CA$CA
236483982$23648398$2$F$$20240723$20240319$20240725$PER$$US-PFIZER INC-PV202400037152$PFIZER$$53$YR$$F$Y$$$20240725$$HP$US$US
236484002$23648400$2$F$$20240829$20240319$20240904$PER$$US-PFIZER INC-PV202400036841$PFIZER$$26$YR$$F$Y$$$20240904$$HP$US$US
236484034$23648403$4$F$20240317$20240731$20240319$20240802$PER$$US-PFIZER INC-PV202400037125$PFIZER$$67$YR$$F$Y$$$20240802$$HP$US$US
236484082$23648408$2$F$$20240807$20240319$20240812$EXP$$JP-009507513-2403JPN001632J$MERCK$$$$$F$Y$$$20240812$$MD$JP$JP
236484143$23648414$3$F$20240101$20240726$20240319$20240803$EXP$$US-TEVA-VS-3167391$TEVA$$76$YR$$F$Y$$$20240803$$CN$US$US
236484714$23648471$4$F$$20240821$20240319$20240828$30DAY$$US-PFIZER INC-202400052966$PFIZER$$10$YR$$M$Y$23.59$KG$20240828$$HP$US$US
236484793$23648479$3$F$20240315$20240827$20240319$20240829$PER$$US-AMGEN-USASP2024056073$AMGEN$$70$YR$E$M$Y$$$20240829$$CN$US$US
236484809$23648480$9$F$20240601$20240731$20240319$20240805$EXP$$US-Taiho Oncology Inc-2023-011187$TAIHO ONCOLOGY INC$$80$YR$E$F$Y$$$20240805$$CN$US$US
236484974$23648497$4$F$20240101$20240725$20240319$20240725$EXP$$CA-PFIZER INC-202400030088$PFIZER$$62$YR$$F$Y$60$KG$20240725$$MD$CA$CA
236485042$23648504$2$F$20230501$20240702$20240319$20240703$EXP$FR-AFSSAPS-TO2024000441$FR-PFIZER INC-202400064452$PFIZER$$67$YR$$M$Y$72$KG$20240703$$PH$FR$FR
236485106$23648510$6$F$20240226$20240912$20240319$20240916$30DAY$$US-PFIZER INC-202400053983$PFIZER$$2$YR$$M$Y$13.61$KG$20240916$$CN$US$US
236485302$23648530$2$F$20190702$20240626$20240319$20240702$EXP$$CO-SANDOZ INC.-PHHY2019CO170563$SANDOZ$$71$YR$$F$Y$59$KG$20240702$$CN$CO$CO
236485642$23648564$2$F$$20240708$20240319$20240710$EXP$$US-PFIZER INC-PV202400037046$PFIZER$$75$YR$$F$Y$$$20240710$$CN$US$US
236485863$23648586$3$F$$20240709$20240319$20240725$PER$$US-INCYTE CORPORATION-2024IN002098$INCYTE$$$$$$Y$$$20240725$$MD$US$US
236485912$23648591$2$F$$20240726$20240319$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA027414$SANDOZ$$40$YR$$F$Y$$$20240729$$HP$CA$CA
236486036$23648603$6$F$20240718$20240815$20240319$20240827$EXP$$CA-UCBSA-2024013039$UCB$$39$YR$$F$Y$$$20240827$$MD$CA$CA
236486212$23648621$2$F$20200101$20240828$20240319$20240905$EXP$$US-JNJFOC-20240331474$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240906$$CN$US$US
236486312$23648631$2$F$$20240823$20240319$20240828$EXP$$US-ALXN-202403USA000889US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240828$$HP$US$US
236486615$23648661$5$F$20240101$20240830$20240319$20240911$PER$$US-SA-2024SA083226$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240911$$MD$US$US
236486653$23648665$3$F$20240313$20240722$20240319$20240729$PER$$US-AMGEN-USASP2024055651$AMGEN$$80$YR$E$M$Y$$$20240728$$MD$US$US
236486755$23648675$5$F$20200101$20240717$20240319$20240722$EXP$$CA-ORGANON-O2306CAN001911$ORGANON$Feschuk AM, Pratt ME. Topical steroid withdrawal syndrome in a mother and son: A case report. SAGE Open Medical Case Reports. 2023;11:1-4$42$YR$$F$Y$$$20240722$$MD$CA$CA
236486853$23648685$3$F$20191223$20240702$20240319$20240708$EXP$$JP-009507513-2403JPN001678J$MERCK$$76$YR$$M$Y$$$20240708$$MD$JP$JP
236486982$23648698$2$F$20240101$20240628$20240319$20240708$EXP$$US-SA-2024SA086378$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240708$$CN$US$US
236487284$23648728$4$F$$20240717$20240319$20240720$EXP$$NVSC2024US058603$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
236487522$23648752$2$F$20231201$20240918$20240319$20240923$EXP$$IE-PFIZER INC-202400066680$PFIZER$$40$YR$$F$Y$$$20240923$$HP$IE$IE
236488302$23648830$2$F$20240101$20240819$20240319$20240827$PER$$US-MYLANLABS-2024M1020980$MYLAN$$$$$F$Y$78.47$KG$20240827$$CN$US$US
236488524$23648852$4$F$20231128$20240625$20240319$20240702$EXP$$CA-GSK-CA2023147217$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$CA$CA
236488946$23648894$6$F$20240220$20240723$20240319$20240729$EXP$$US-BIOVITRUM-CTI2024US04565$BIOVITRUM$$75$YR$$M$Y$$$20240729$$CN$US$US
236489772$23648977$2$F$20240201$20240807$20240319$20240817$EXP$FR-AFSSAPS-RE2024000206$FR-TEVA-VS-3171743$TEVA$$69$YR$$M$Y$$$20240817$$PH$FR$FR
236490076$23649007$6$F$20231027$20240909$20240319$20240910$EXP$$NVSC2023GB236428$NOVARTIS$$$$$M$Y$$$20240910$$CN$GB$GB
236490212$23649021$2$F$20230101$20240311$20240319$20240712$EXP$SE-SEMPA-2023-011275$SE-TEVA-VS-3171735$TEVA$$70$YR$$F$Y$$$20240712$$MD$SE$SE
236490282$23649028$2$F$20240303$20240308$20240319$20240704$EXP$GB-ABBVIE-5661981$GB-TORRENT-00035753$TORRENT$$$$A$M$Y$$$20240704$$CN$GB$GB
236490325$23649032$5$F$20240101$20240825$20240319$20240914$EXP$$US-SA-2024SA085233$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240914$$MD$US$US
236490353$23649035$3$F$20240115$20240730$20240319$20240807$EXP$$US-SA-2024SA086657$SANOFI AVENTIS$$48$YR$A$F$Y$70$KG$20240807$$MD$US$US
236490542$23649054$2$F$$20240715$20240319$20240718$EXP$$CA-JNJFOC-20240345712$JOHNSON AND JOHNSON$$$$$M$Y$72$KG$20240718$$HP$CA$CA
236490573$23649057$3$F$20231113$20240821$20240319$20240902$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2024FOS000336$RIGEL PHARMACEUTICALS$$78$YR$$M$Y$64$KG$20240902$$MD$JP$JP
236490583$23649058$3$F$20230728$20240821$20240319$20240828$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2024FOS000337$RIGEL PHARMACEUTICALS$$71$YR$$F$Y$56.2$KG$20240828$$MD$JP$JP
236490613$23649061$3$F$20240316$20240722$20240319$20240725$PER$$US-AMGEN-USASP2024056351$AMGEN$$50$YR$A$F$Y$$$20240725$$CN$US$US
236490705$23649070$5$F$$20240905$20240319$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043592$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240906$$CN$US$US
236490722$23649072$2$F$20240228$20240906$20240319$20240911$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007694$UNITED THERAPEUTICS$$81$YR$$M$Y$77.098$KG$20240911$$$US$US
236490794$23649079$4$F$$20240703$20240319$20240708$EXP$$US-AMGEN-USASP2024052626$AMGEN$$97$YR$E$F$Y$$$20240708$$MD$US$US
236491032$23649103$2$F$$20240709$20240319$20240716$EXP$$JP-009507513-2403JPN001471J$MERCK$$$$$F$Y$$$20240716$$MD$JP$JP
236491332$23649133$2$F$20240101$20240627$20240319$20240712$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000031$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240712$$MD$US$US
236491522$23649152$2$F$$20240820$20240319$20240827$EXP$$CA-JNJFOC-20240335044$JOHNSON AND JOHNSON$$62$YR$A$F$Y$96$KG$20240827$$PH$CA$CA
236491975$23649197$5$F$20230101$20240811$20240319$20240819$EXP$$SA-SANDOZ INC.-SDZ2024SA027652$SANDOZ$$52$YR$$F$Y$$$20240819$$CN$SA$SA
236492024$23649202$4$F$20230505$20240913$20240319$20240918$EXP$$US-OTSUKA-2022_040540$OTSUKA$$79$YR$$M$Y$73.48$KG$20240918$$CN$US$US
236492982$23649298$2$F$$20240703$20240319$20240708$EXP$$CA-GSK-CA2023114019$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$CA$CA
236493002$23649300$2$F$$20240920$20240319$20240923$EXP$$GB-PFIZER INC-PV202400035995$PFIZER$Ponsford, M.. ADENOSINE DEAMINASE 2 (ADA2) DEFICIENCY - INSIGHTS INTO VASCULAR AND SYSTEMIC INFLAMMATION. Clinical and Experimental Immunology. 2015;182(Supple 1):4-5$$$$M$Y$$$20240923$$HP$GB$GB
236493195$23649319$5$F$20240101$20240820$20240319$20240903$PER$$US-KARYOPHARM-2024KPT000762$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
236493304$23649330$4$F$$20240716$20240319$20240718$EXP$$US-PFIZER INC-PV202400036405$PFIZER$$69$YR$$F$Y$111.11$KG$20240718$$HP$US$US
236493733$23649373$3$F$20240101$20240927$20240319$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043808$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240930$$CN$US$US
236493782$23649378$2$F$$20240907$20240319$20240910$PER$$NVSC2024US059141$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
236493872$23649387$2$F$20240126$20240814$20240319$20240820$EXP$FR-AFSSAPS-NT2024000162$FR-MYLANLABS-2024M1024370$MYLAN$$67$YR$$M$Y$$$20240820$$PH$FR$FR
236494032$23649403$2$F$$20240724$20240319$20240801$PER$$US-JNJFOC-20240331246$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$HP$US$US
236494412$23649441$2$F$$20240627$20240319$20240710$PER$$US-Calliditas-2024CAL00356$CALLIDITAS THERAPEUTICS$$43$YR$A$M$Y$81$KG$20240710$$CN$US$US
236494574$23649457$4$F$$20240726$20240319$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044164$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240730$$CN$US$US
236495092$23649509$2$F$$20240715$20240319$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA029631$SANDOZ$$35$YR$$F$Y$$$20240723$$MD$CA$CA
236495134$23649513$4$F$20231201$20240918$20240319$20240920$EXP$$NVSC2024GB059171$NOVARTIS$$$$$F$Y$$$20240920$$CN$GB$GB
236495173$23649517$3$F$20240206$20240820$20240319$20240822$EXP$$NVSC2024FR054624$NOVARTIS$$$$E$F$Y$$$20240822$$MD$FR$FR
2364952716$23649527$16$F$20240315$20240626$20240319$20240710$EXP$$CA-HLS-202400716$HLS THERAPEUTICS$$68$YR$E$F$Y$$$20240710$$HP$CA$CA
2364957212$23649572$12$F$20240101$20240626$20240319$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007525$UNITED THERAPEUTICS$$$$$F$Y$84.354$KG$20240705$$$US$US
236495932$23649593$2$F$20240221$20240709$20240319$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-030893$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$104.78$KG$20240712$$PH$US$US
236496022$23649602$2$F$$20240731$20240319$20240808$PER$$US-RDY-SPO/USA/24/0004125$DR REDDYS$$18$YR$A$$Y$$$20240808$$MD$US$US
236496063$23649606$3$F$$20240729$20240319$20240730$PER$$NVSC2024US058762$NOVARTIS$$$$$$Y$$$20240730$$CN$US$US
236496442$23649644$2$F$20240101$20240827$20240319$20240830$EXP$$CA-PFIZER INC-202400054274$PFIZER$$33$YR$$F$Y$$$20240830$$PH$CA$CA
236496462$23649646$2$F$20240304$20240830$20240319$20240910$EXP$$CA-HLS-202400769$HLS THERAPEUTICS$$65$YR$E$F$Y$$$20240910$$CN$CA$CA
236496563$23649656$3$F$20240131$20240724$20240319$20240729$EXP$$JP-AstraZeneca-2024A064861$ASTRAZENECA$$76$YR$$F$Y$49$KG$20240729$$MD$JP$
236496792$23649679$2$F$$20240911$20240319$20240919$PER$$US-INCYTE CORPORATION-2024IN002734$INCYTE$$$$$$Y$$$20240919$$CN$US$US
236496835$23649683$5$F$20230118$20240705$20240319$20240709$EXP$$GB-ORGANON-O2403GBR001326$ORGANON$$82$YR$$M$Y$72.2$KG$20240709$$MD$GB$GB
236497282$23649728$2$F$20240301$20240730$20240319$20240808$EXP$$US-ROCHE-3524749$ROCHE$$77$YR$E$F$Y$$$20240808$$CN$US$US
236497304$23649730$4$F$20231209$20240812$20240319$20240824$EXP$$KR-JAZZ PHARMACEUTICALS-2024-KR-004624$JAZZ$$47$YR$$M$Y$80$KG$20240824$$MD$KR$KR
236497473$23649747$3$F$20240104$20240524$20240319$20240724$PER$$US-LUNDBECK-DKLU3075570$LUNDBECK$$$$$$Y$$$20240724$$CN$US$US
236497712$23649771$2$F$$20240821$20240319$20240905$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-07721$SAMSUNG BIOEPIS$$72$YR$E$F$Y$$$20240905$$PH$GB$GB
236498062$23649806$2$F$20240206$20240806$20240319$20240808$EXP$$US-BEH-2024169789$CSL BEHRING$$5$YR$C$F$Y$$$20240808$$HP$US$US
236498293$23649829$3$F$$20240628$20240319$20240709$EXP$$US-PHARMING-PHAUS2024000232$PHARMING GROUP$$$$$$Y$$$20240709$$CN$US$US
236501193$23650119$3$F$20240101$20240719$20240319$20240724$EXP$$CO-ABBVIE-5683895$ABBVIE$$$$$F$Y$76$KG$20240724$$CN$CO$CO
2365015316$23650153$16$F$$20240715$20240319$20240715$EXP$$GB-JNJFOC-20231110626$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$HP$GB$GB
236501742$23650174$2$F$20230608$20240628$20240319$20240708$PER$$US-JNJFOC-20240324657$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240708$$MD$US$US
236501853$23650185$3$F$$20240827$20240319$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042839$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240829$$CN$US$US
236501912$23650191$2$F$$20240822$20240319$20240827$EXP$$CA-TAKEDA-2024TUS024128$TAKEDA$$$$$F$Y$57.85$KG$20240827$$CN$CA$CA
236501933$23650193$3$F$20230601$20240716$20240319$20240720$EXP$$CH-JNJFOC-20240335031$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240719$$MD$CH$CH
236502052$23650205$2$F$20231101$20240626$20240319$20240703$EXP$$PE-AMGEN-PERSP2024055832$AMGEN$$66$YR$E$F$Y$$$20240702$$CN$PE$PE
236502063$23650206$3$F$20240318$20240626$20240319$20240701$PER$$US-AMGEN-USASP2024056758$AMGEN$$66$YR$E$F$Y$$$20240701$$CN$US$US
236502203$23650220$3$F$$20240625$20240319$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000918$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
236502433$23650243$3$F$20240101$20240723$20240319$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043451$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$77.56$KG$20240725$$CN$US$US
236502442$23650244$2$F$$20240307$20240319$20240717$PER$$US-JNJFOC-20240344968$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240717$$CN$US$US
236502482$23650248$2$F$20240130$20240909$20240319$20240912$EXP$IT-MINISAL02-975556$IT-ABBVIE-5678822$ABBVIE$$76$YR$$M$Y$$$20240912$$MD$IT$IT
236502682$23650268$2$F$$20240619$20240319$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02162$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236502783$23650278$3$F$$20240822$20240319$20240828$EXP$$ZA-TAKEDA-2023TUS086192$TAKEDA$$$$$F$Y$$$20240828$$CN$ZA$ZA
236502802$23650280$2$F$20240316$20240703$20240319$20240705$PER$$US-AMGEN-USASP2024056360$AMGEN$$73$YR$E$M$Y$$$20240705$$CN$US$US
236503102$23650310$2$F$20231207$20231212$20240320$20240820$PER$$US-ROCHE-3475330$ROCHE$$$$$F$Y$87.09$KG$20240820$$MD$US$US
236503292$23650329$2$F$20240223$20240830$20240320$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US021967$SANDOZ$$13$YR$$M$Y$$$20240903$$CN$US$US
236503593$23650359$3$F$20231114$20240308$20240320$20240710$PER$$US-ROCHE-3470195$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$US$US
236503892$23650389$2$F$20231130$20240701$20240320$20240704$PER$$US-JNJFOC-20240324665$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240705$$MD$US$US
236504012$23650401$2$F$$20240624$20240320$20240702$EXP$$JP-AMGEN-JPNSP2024052132$AMGEN$$88$YR$E$F$Y$$$20240702$$PH$JP$JP
236504132$23650413$2$F$20240101$20240917$20240320$20240922$PER$$US-SA-2024SA085882$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240923$$MD$US$US
236504232$23650423$2$F$20240101$20240923$20240320$20240927$EXP$$US-BIOGEN-2024BI01255710$BIOGEN$$$$$F$Y$$$20240927$$CN$US$US
236504242$23650424$2$F$$20240902$20240320$20240912$EXP$$JP-BIOGEN-2024BI01255278$BIOGEN$$$$$F$Y$54$KG$20240912$$MD$JP$JP
236504274$23650427$4$F$20240101$20240621$20240320$20240703$PER$$US-SA-2024SA086977$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240703$$MD$US$US
236504322$23650432$2$F$$20240725$20240320$20240731$EXP$$JP-AMGEN-JPNSP2023234773$AMGEN$$$$$F$Y$$$20240730$$MD$JP$JP
236504464$23650446$4$F$$20240828$20240320$20240904$EXP$$CA-TAKEDA-2020TUS042371$TAKEDA$$$$$F$Y$$$20240904$$MD$CA$CA
236504473$23650447$3$F$$20240909$20240320$20240916$EXP$$US-BIOGEN-2024BI01255898$BIOGEN$$$$$M$Y$$$20240916$$CN$US$US
236504542$23650454$2$F$20230901$20240628$20240320$20240703$EXP$$US-ABBVIE-5613087$ABBVIE$$57$YR$$M$Y$$$20240703$$CN$US$US
236504902$23650490$2$F$$20240619$20240320$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02183$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236504952$23650495$2$F$20190101$20240703$20240320$20240705$EXP$$US-ABBVIE-5676746$ABBVIE$$$$$M$Y$87$KG$20240705$$CN$US$US
236505992$23650599$2$F$$20240911$20240320$20240915$30DAY$$US-SANDOZ INC.-SDZ2024US028374$SANDOZ$$$$$F$Y$$$20240915$$MD$US$US
236506112$23650611$2$F$$20240829$20240320$20240909$EXP$$ES-AUROBINDO-AUR-APL-2020-036999$AUROBINDO$Cases-Corona C, Shabaka A, Gonzalez-Lopez A, Martin-Segarra O, Moreno de la Higuera MA, Lucena R et al.. Fulminant ephysematous pyelonephritis by candida glabrata in a kidney allograft. Nephron clinical practice. 2020;144(6):304-309$53$YR$$F$Y$$$20240909$$MD$ES$ES
236506902$23650690$2$F$20240315$20240723$20240320$20240725$PER$$US-AMGEN-USASP2024056887$AMGEN$$66$YR$E$M$Y$$$20240725$$CN$US$US
236507092$23650709$2$F$20240316$20240627$20240320$20240702$PER$$US-AMGEN-USASP2024056591$AMGEN$$64$YR$A$M$Y$$$20240701$$CN$US$US
236507662$23650766$2$F$$20240717$20240320$20240723$EXP$CA-DRL-USA-LIT/CAN/24/0004277$CA-RDY-LIT/CAN/24/0004277$DR REDDYS$$35$YR$A$F$Y$$$20240723$$HP$CA$CA
236507982$23650798$2$F$20240101$20240802$20240320$20240814$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000217$DECIPHERA PHARMACEUTICALS$$61$YR$A$M$Y$$$20240814$$CN$US$US
236508105$23650810$5$F$$20240805$20240320$20240820$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000230$DECIPHERA PHARMACEUTICALS$$30$YR$A$F$Y$$$20240820$$CN$US$US
236508143$23650814$3$F$20240208$20240924$20240320$20240928$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-008093$UNITED THERAPEUTICS$$60$YR$$F$Y$27.6$KG$20240928$$$JP$JP
236508252$23650825$2$F$20240201$20240730$20240320$20240801$PER$$US-AMGEN-USASP2024056001$AMGEN$$62$YR$A$M$Y$$$20240801$$CN$US$US
236508303$23650830$3$F$$20240801$20240320$20240807$EXP$$US-TAKEDA-2024TUS018281$TAKEDA$$$$$F$Y$36.281$KG$20240807$$MD$US$US
236508663$23650866$3$F$20240318$20240808$20240320$20240809$PER$$US-AMGEN-USASP2024056496$AMGEN$$83$YR$E$M$Y$$$20240809$$HP$US$US
236508924$23650892$4$F$20240315$20240716$20240320$20240717$PER$$US-AMGEN-USASP2024055846$AMGEN$$63$YR$A$F$Y$$$20240717$$MD$US$US
236509013$23650901$3$F$$20240708$20240320$20240715$EXP$$CA-APOTEX-2022AP015207$APOTEX$$50$YR$$F$Y$110$KG$20240715$$MD$CA$CA
236509022$23650902$2$F$20240211$20240416$20240320$20240701$PER$$US-TWI PHARMACEUTICAL, INC-2024SCTW000027$TWI PHARMACEUTICALS$$$$$$Y$$$20240624$$CN$US$US
236509042$23650904$2$F$$20240622$20240320$20240701$PER$$US-SA-2024SA087582$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240701$$MD$US$US
236509262$23650926$2$F$$20240729$20240320$20240806$PER$$US-SA-2024SA084189$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240806$$MD$US$US
236509433$23650943$3$F$20240101$20240830$20240320$20240902$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-016252$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240902$$CN$US$US
236509534$23650953$4$F$20230201$20240718$20240320$20240723$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-015437$JAZZ$$48$YR$$F$Y$$$20240723$$HP$US$US
236509824$23650982$4$F$20240201$20240719$20240320$20240724$EXP$$CA-JNJFOC-20240307739$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240724$$HP$CA$CA
236510022$23651002$2$F$20231117$20240820$20240320$20240830$EXP$FR-AFSSAPS-PO2024000208$FR-TEVA-VS-3172175$TEVA$$43$YR$$F$Y$65$KG$20240830$$MD$FR$FR
236510193$23651019$3$F$20231011$20240826$20240320$20240829$EXP$$HK-SA-2023SA316212$SANOFI AVENTIS$$74$YR$E$F$Y$44$KG$20240830$$HP$HK$HK
236510215$23651021$5$F$20240321$20240731$20240320$20240806$PER$$US-BIOGEN-2024BI01255498$BIOGEN$$49$YR$$F$Y$$$20240806$$CN$US$US
236510632$23651063$2$F$20220320$20240819$20240320$20240827$EXP$$JP-ROCHE-3526472$ROCHE$$67$YR$E$F$Y$50.6$KG$20240827$$MD$JP$JP
236510672$23651067$2$F$$20240819$20240320$20240902$PER$$US-SA-2024SA084397$SANOFI AVENTIS$$$$A$F$Y$$$20240902$$MD$US$US
236510692$23651069$2$F$20230808$20240819$20240320$20240828$EXP$$JP-ROCHE-3526912$ROCHE$$60$YR$A$M$Y$67$KG$20240828$$MD$JP$JP
236510712$23651071$2$F$$20240625$20240320$20240704$PER$$US-SA-2024SA085739$SANOFI AVENTIS$$$$A$M$Y$$$20240704$$MD$US$US
236510743$23651074$3$F$20240301$20240808$20240320$20240814$PER$$US-SA-2024SA085870$SANOFI AVENTIS$$87$YR$E$F$Y$60.78$KG$20240814$$MD$US$US
236510768$23651076$8$F$20240311$20240726$20240320$20240805$EXP$$CA-CELLTRION INC.-2024CA006798$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
236511016$23651101$6$F$20240311$20240827$20240320$20240904$EXP$$CA-CELLTRION INC.-2024CA006735$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
236511084$23651108$4$F$20240101$20240724$20240320$20240801$EXP$$CA-CELLTRION INC.-2024CA006885$CELLTRION$$$$$$Y$$$20240801$$HP$CA$CA
236511334$23651133$4$F$20230101$20240812$20240320$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041561$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240816$$CN$US$US
236511757$23651175$7$F$20240101$20240912$20240320$20240920$EXP$$CA-CELLTRION INC.-2024CA006827$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
236511812$23651181$2$F$$20240829$20240320$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA029710$SANDOZ$$74$YR$$M$Y$$$20240902$$HP$CA$CA
236512092$23651209$2$F$20240312$20240726$20240320$20240729$PER$$US-AMGEN-USASP2024053146$AMGEN$$63$YR$A$M$Y$$$20240729$$CN$US$US
236512312$23651231$2$F$$20240711$20240320$20240715$EXP$$CH-ABBVIE-5681834$ABBVIE$$$$$M$Y$$$20240715$$HP$CH$CH
236512912$23651291$2$F$$20240722$20240320$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042798$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240723$$CN$US$US
236512964$23651296$4$F$$20240809$20240320$20240817$PER$$US-SA-2024SA083652$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240817$$MD$US$US
236513762$23651376$2$F$20240314$20240723$20240320$20240725$PER$$US-AMGEN-USASP2024056944$AMGEN$$87$YR$E$F$Y$$$20240725$$CN$US$US
236514072$23651407$2$F$20230101$20240716$20240320$20240724$EXP$$JP-009507513-2403JPN001956J$MERCK$$$$$M$Y$$$20240724$$MD$JP$JP
236514193$23651419$3$F$20231001$20240921$20240320$20240927$EXP$$NVSC2024EG057794$NOVARTIS$$40$YR$$F$Y$$$20240927$$CN$EG$EG
236514203$23651420$3$F$20230101$20240830$20240320$20240910$EXP$$CA-CELLTRION INC.-2024CA001173$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
236514253$23651425$3$F$$20240626$20240320$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02163$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236514413$23651441$3$F$20240315$20240822$20240320$20240824$PER$$US-AMGEN-USASP2024056417$AMGEN$$54$YR$A$F$Y$$$20240824$$CN$US$US
236514442$23651444$2$F$$20240722$20240320$20240731$PER$$US-SA-2024SA084692$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240731$$MD$US$US
236514822$23651482$2$F$$20240812$20240320$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043772$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240813$$CN$US$US
236514942$23651494$2$F$$20240311$20240320$20240701$PER$$US-UCBSA-2024010888$UCB$$$$$M$Y$$$20240701$$HP$US$US
236515062$23651506$2$F$$20240910$20240320$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-011954$AUROBINDO$Santistevan L, Lonergan D, Eyvazzadeh AD. First case report of serous otitis media as a complication of severe ovarian hyperstimulation syndrome: Case report and literature review. International Journal of Gynecology and Obstetrics. 2024;164(3):843-7$30$YR$$F$Y$53.5$KG$20240923$$MD$US$US
236515262$23651526$2$F$20230101$20240904$20240320$20240923$EXP$$US-SA-2024SA086335$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240923$$MD$US$US
236515282$23651528$2$F$$20240626$20240320$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02180$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236515473$23651547$3$F$20180523$20240828$20240320$20240905$EXP$DE-ROCHE-2669047$DE-RDY-CLI/GER/21/0137822$DR REDDYS$$52$YR$A$F$Y$62$KG$20240905$$CN$DE$DE
236515484$23651548$4$F$20220418$20240726$20240320$20240731$EXP$$US-SA-2024SA084060$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240731$$CN$US$US
236515723$23651572$3$F$$20240705$20240320$20240709$PER$$US-ALXN-202403USA000713US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$MD$US$US
236516143$23651614$3$F$$20240828$20240320$20240902$EXP$$CA-TAKEDA-2024TUS024501$TAKEDA$$$$$M$Y$$$20240902$$MD$CA$CA
236516255$23651625$5$F$20231219$20240814$20240320$20240820$PER$$US-AMGEN-USASP2024046499$AMGEN$$84$YR$E$F$Y$$$20240820$$PH$US$US
236516632$23651663$2$F$$20240705$20240320$20240708$EXP$$JP-ASTELLAS-2024JP002002$ASTELLAS$$10$DEC$$M$Y$$$20240708$$PH$JP$JP
236516702$23651670$2$F$$20240626$20240320$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02208$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236516794$23651679$4$F$$20240919$20240320$20240923$EXP$$US-SANDOZ INC.-SDZ2024US029961$SANDOZ$$$$$M$Y$$$20240923$$CN$US$US
236517373$23651737$3$F$$20240709$20240320$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-176575$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240711$$MD$JP$JP
236517402$23651740$2$F$$20240711$20240320$20240722$EXP$$US-TAKEDA-2024TUS025481$TAKEDA$$$$$F$Y$$$20240722$$MD$US$US
236517523$23651752$3$F$20220729$20240827$20240320$20240904$EXP$$CA-CELLTRION INC.-2022CA013126$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
236517682$23651768$2$F$$20240906$20240320$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436940$RANBAXY$Estrella AM, Chester JG,Kuhns DB, Lau KP, Marshall-Batty KR, Holland SM, et al. Necrotizing Pneumonia in an Adult Woman Due to P40phox (NCF4) Deficiency. Am J Respir Crit Care Med. 2023;207:A1340$37$YR$$F$Y$$$20240920$$HP$US$US
236518202$23651820$2$F$$20240912$20240320$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436985$RANBAXY$Espinosa C, Mendez Morente LI, Acosta D, Alvarez A, Kovacevic J. Methotrexate-Induced Interstitial Pneumonitis in a Patient With Ulcerative Colitis. Am J Respir Crit Care Med. 2023;207:-$79$YR$$F$Y$$$20240927$$HP$US$US
236518632$23651863$2$F$20240216$20240716$20240320$20240730$EXP$IT-MINISAL02-973499$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-02145$HIKMA$$62$YR$$F$Y$$$20240730$$MD$IT$IT
236518822$23651882$2$F$20240318$20240628$20240320$20240703$PER$$US-AMGEN-USASP2024057592$AMGEN$$73$YR$E$F$Y$$$20240703$$CN$US$US
236518992$23651899$2$F$$20240813$20240320$20240826$PER$$US-SA-2024SA085998$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
236519102$23651910$2$F$$20240308$20240320$20240822$PER$$US-AstraZeneca-2024A063847$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
236519252$23651925$2$F$20240227$20240826$20240320$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044502$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240828$$CN$US$US
236519294$23651929$4$F$20240130$20240819$20240320$20240828$EXP$$FR-SA-2024SA085317$SANOFI AVENTIS$$76$YR$E$M$Y$70$KG$20240828$$HP$FR$FR
236519403$23651940$3$F$$20240814$20240320$20240821$EXP$$US-ABBVIE-5684181$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
236519448$23651944$8$F$20231001$20240923$20240320$20240930$EXP$$CN-ABBVIE-5682239$ABBVIE$$61$YR$$F$Y$53$KG$20240930$$MD$CN$CN
236519514$23651951$4$F$20240318$20240725$20240320$20240729$PER$$US-AMGEN-USASP2024056730$AMGEN$$70$YR$E$M$Y$$$20240728$$MD$US$US
236519542$23651954$2$F$20230101$20240311$20240320$20240718$EXP$$NVSC2024US054767$NOVARTIS$$$$$F$Y$$$20240718$$CN$US$US
236519762$23651976$2$F$20240222$20240701$20240320$20240704$30DAY$$CA-SANDOZ INC.-SDZ2024CA020345$SANDOZ$$47$YR$$F$Y$$$20240704$$CN$CA$CA
236520023$23652002$3$F$$20240729$20240320$20240813$EXP$$US-862174955-ML2024-01519$MICRO LABS$$21$YR$A$F$Y$$$20240813$$CN$US$US
236520772$23652077$2$F$20111031$20240910$20240320$20240912$EXP$$ZA-PFIZER INC-202400067654$PFIZER$$32$YR$$F$Y$126$KG$20240912$$MD$ZA$ZA
236520795$23652079$5$F$20240101$20240822$20240320$20240828$EXP$$US-PFIZER INC-PV202400037504$PFIZER$$80$YR$$F$Y$$$20240828$$CN$US$US
236521022$23652102$2$F$$20240807$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-16346$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10:367$11$YR$$M$Y$$$20240918$$HP$DE$DE
236521042$23652104$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15764$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mtor inhibitor everolimus in pediatric liver graft recipients. Children. 2023;10(2):1-11$16$YR$$F$Y$$$20240918$$HP$DE$DE
236521062$23652106$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15769$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E. Experience with the mtor inhibitor everolimus in pediatric liver graft recipients. Children. 2023;10(367):1-11$2$YR$$M$Y$$$20240918$$HP$DE$DE
236521072$23652107$2$F$$20240903$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15766$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Florian Brinkert, Fischer L, Grabhor E.. Experience with the mtor inhibitor everolimus in pediatric liver graft recipients. Children. 2023;10(2):367$12$YR$$M$Y$$$20240918$$HP$DE$DE
236521102$23652110$2$F$$20240821$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15503$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10(367):1-11$5$YR$$M$Y$$$20240918$$HP$DE$DE
236521112$23652111$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15480$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10:367$12$YR$$M$Y$$$20240918$$HP$DE$DE
236521122$23652112$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15578$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10:367$3$MON$$M$Y$$$20240918$$HP$DE$DE
236521142$23652114$2$F$$20240809$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15500$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert R, Fischer L, et.al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10(2):367$12$YR$$F$Y$$$20240918$$HP$DE$DE
236521152$23652115$2$F$$20240812$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15501$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10 (2):367$10$YR$$M$Y$$$20240918$$HP$DE$DE
236521172$23652117$2$F$$20240821$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15650$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10(2):1-11$4$YR$$M$Y$$$20240918$$HP$DE$DE
236521182$23652118$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15751$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10 (2):367$4$YR$$M$Y$$$20240918$$HP$DE$DE
236521192$23652119$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15502$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10(367):1-11$4$YR$$M$Y$$$20240918$$HP$DE$DE
236521202$23652120$2$F$$20240812$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15576$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10 (2):367$13$YR$$M$Y$$$20240918$$HP$DE$DE
236521212$23652121$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15768$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mtor inhibitor everolimus in pediatric liver graft recipients. Children. 2023;10(2):367$5$YR$$F$Y$$$20240918$$HP$DE$DE
236521232$23652123$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15651$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10(2):1-11$3$YR$$M$Y$$$20240918$$HP$DE$DE
236521242$23652124$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15748$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10 (367):1-11$15$YR$$M$Y$$$20240918$$HP$DE$DE
236521252$23652125$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15753$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L et.al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10(2):1-11$2$YR$$F$Y$$$20240918$$HP$DE$DE
236521262$23652126$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15684$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10:367$9$YR$$M$Y$$$20240918$$HP$DE$DE
236521292$23652129$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15481$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mTOR inhibitor everolimus in pediatric liver graft recipients. Children. 2023;10 (2):1-11$18$YR$$M$Y$$$20240918$$HP$DE$DE
236521302$23652130$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15649$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children. 2023;10(2):367$12$YR$$F$Y$$$20240918$$HP$DE$DE
236521312$23652131$2$F$$20240812$20240320$20240824$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15757$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mtor inhibitor everolimus in pediatric liver graft recipients. Children. 2023;10 (2):1-11$4$YR$$M$Y$$$20240825$$HP$DE$DE
236521422$23652142$2$F$$20240813$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15577$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E. Experience with the mtor inhibitor Everolimus in pediatric liver graft recipients. Children. 2023;10 (2):367$16$YR$$M$Y$$$20240918$$HP$DE$DE
236521442$23652144$2$F$$20240812$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15763$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mtor inhibitor everolimus in pediatric liver graft recipients. Children. 2023;10 (2):367$14$YR$$M$Y$$$20240918$$HP$DE$DE
236521452$23652145$2$F$$20240812$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15767$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Florian Brinkert, Fischer L, Grabhor E.. Experience with the mtor inhibitor everolimus in pediatric liver graft recipients. Children. 2023;10 (2):367$13$YR$$F$Y$$$20240918$$HP$DE$DE
236521472$23652147$2$F$$20240805$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-16342$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter, A, Hegen, B, Brinkert F, Fischer L et al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. CHILDREN. 2023;10(367):1-11$1$YR$$M$Y$$$20240918$$HP$DE$DE
236521492$23652149$2$F$$20240809$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15579$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, Grabhorn E.. Experience with the mtor inhibitor everolimus in pediatric liver graft recipients. Children. 2023;10(2):367$15$YR$$M$Y$$$20240918$$HP$DE$DE
236521502$23652150$2$F$$20240812$20240320$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15765$ALKEM$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert R, Fischer L et al.. Experience with the mTOR inhibitor Everolimus in pediatric liver graft recipients. Children. 2023;10(2):367$8$YR$$F$Y$$$20240918$$HP$DE$DE
236521584$23652158$4$F$20240219$20240621$20240320$20240703$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00234$UPSHER-SMITH$$17$YR$$F$Y$$$20240703$$HP$US$US
236521662$23652166$2$F$20240312$20240725$20240320$20240805$PER$$US-SA-2024SA085479$SANOFI AVENTIS$$$$$$Y$$$20240804$$HP$US$US
236521853$23652185$3$F$20240214$20240318$20240320$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202403010648$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240826$$CN$US$US
236522012$23652201$2$F$$20240722$20240320$20240725$EXP$$IN-ROCHE-3515920$ROCHE$$68$YR$E$M$Y$$$20240725$$CN$IN$IN
236522123$23652212$3$F$20240301$20240802$20240320$20240814$PER$$US-SA-2024SA084520$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240814$$MD$US$US
236522152$23652215$2$F$$20240814$20240320$20240823$EXP$$CA-APOTEX-2024AP003374$APOTEX$$76$YR$$F$Y$$$20240823$$HP$CA$CA
236522284$23652228$4$F$$20240830$20240320$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044597$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240904$$CN$US$US
236522453$23652245$3$F$$20240710$20240320$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043441$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$62.14$KG$20240716$$CN$US$US
236522464$23652246$4$F$20240301$20240709$20240320$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044423$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$81.65$KG$20240712$$CN$US$US
236522702$23652270$2$F$20240101$20240625$20240320$20240704$PER$$US-SA-2024SA084097$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240704$$MD$US$US
236523012$23652301$2$F$20160101$20240819$20240320$20240827$EXP$$JP-ROCHE-3522832$ROCHE$Matsushima H, Kikuchi M, Kita H, Ando T, Shintani T, Komeyama S. PS1-6 A case of new cardiac dysfunction during the 111st course of trastuzumab for breast cancer. The 7th Annual Meeting of the Japanese Onco-cardiology Society. 2024;107.$83$YR$E$F$Y$$$20240827$$MD$JP$JP
236523165$23652316$5$F$$20240628$20240320$20240702$PER$$NVSC2024US059609$NOVARTIS$$$$$M$Y$$$20240702$$HP$US$US
236523212$23652321$2$F$20240101$20240710$20240320$20240718$PER$$US-SA-2024SA084526$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240718$$MD$US$US
236523288$23652328$8$F$20240202$20240813$20240320$20240826$EXP$$US-UCBSA-2024006096$UCB$$33$YR$$F$Y$34$KG$20240826$$MD$US$US
236524164$23652416$4$F$20240310$20240805$20240320$20240809$PER$$US-AMGEN-USASP2024051954$AMGEN$$79$YR$E$F$Y$$$20240809$$CN$US$US
236524882$23652488$2$F$20220101$20240625$20240320$20240704$EXP$$JP-ROCHE-3450190$ROCHE$$59$YR$A$F$Y$64.8$KG$20240704$$MD$JP$JP
236525022$23652502$2$F$$20240829$20240320$20240911$EXP$$JP-UCBSA-2024012189$UCB$Ito Y, Aoki K, Kawamoto S, Kurosawa H. Cardiac dysfunction and biphasic neurological symptoms due to head trauma. Pediatrics International. 2024;66(1):1-3$4$MON$$M$Y$$$20240911$$HP$JP$JP
236525914$23652591$4$F$20240101$20240807$20240320$20240821$EXP$$US-INSMED, INC.-2024-00768-US$INSMED$$$$$$Y$$$20240821$$CN$US$US
236525979$23652597$9$F$20231201$20240902$20240320$20240909$EXP$$NVSC2024CO060179$NOVARTIS$$55$YR$$M$Y$125$KG$20240909$$CN$CO$CO
236526043$23652604$3$F$20240409$20240923$20240320$20240926$EXP$$US-BAYER-2024A039979$BAYER$$20$YR$A$M$Y$74.83$KG$20240926$$HP$US$US
236526302$23652630$2$F$20231105$20240708$20240320$20240711$EXP$FR-AFSSAPS-NT2024000168$FR-MYLANLABS-2024M1024356$MYLAN$$27$YR$$F$Y$$$20240711$$MD$FR$FR
236526474$23652647$4$F$20240101$20240719$20240320$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008244$UNITED THERAPEUTICS$$$$$F$Y$$$20240726$$$US$US
236526523$23652652$3$F$20240101$20240701$20240320$20240708$EXP$$US-SA-2024SA087933$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240708$$MD$US$US
236526578$23652657$8$F$$20240910$20240320$20240912$30DAY$$CL-PFIZER INC-PV202400027359$PFIZER$$13$YR$$M$Y$$$20240912$$CN$CL$CL
236527113$23652711$3$F$20240401$20240712$20240320$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202403010542$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240722$$CN$US$US
236527322$23652732$2$F$$20240619$20240320$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02206$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236527363$23652736$3$F$20240101$20240710$20240320$20240718$PER$$US-SA-2024SA086911$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240718$$MD$US$US
236527452$23652745$2$F$$20240624$20240320$20240703$PER$$US-SA-2024SA085829$SANOFI AVENTIS$$39$YR$A$M$Y$86.182$KG$20240703$$MD$US$US
236527653$23652765$3$F$$20240821$20240320$20240823$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024EME035648$VIIV$$$$$$Y$$$20240823$$PH$GB$GB
236527683$23652768$3$F$$20240909$20240320$20240912$EXP$$NVSC2024GB059911$NOVARTIS$$$$A$F$Y$$$20240913$$CN$GB$GB
236527898$23652789$8$F$20240317$20240628$20240320$20240708$EXP$$CA-TAKEDA-2024TUS014833$TAKEDA$$60$YR$$F$Y$$$20240708$$CN$CA$CA
236527914$23652791$4$F$$20240906$20240320$20240909$EXP$$NVSC2023US256743$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
236528076$23652807$6$F$20240317$20240730$20240320$20240801$PER$$US-AMGEN-USASP2024057573$AMGEN$$80$YR$E$F$Y$$$20240801$$CN$US$US
236528122$23652812$2$F$$20240626$20240320$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02211$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236528153$23652815$3$F$20240301$20240318$20240320$20240926$EXP$$US-GSK-US2024AMR034558$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
236528722$23652872$2$F$20240214$20240827$20240320$20240903$EXP$FR-AFSSAPS-BX2024000444$FR-MYLANLABS-2024M1024256$MYLAN$$78$YR$$F$Y$82$KG$20240903$$MD$FR$FR
236528863$23652886$3$F$20191201$20240709$20240320$20240715$EXP$$HU-PFIZER INC-202400065327$PFIZER$Cegledi, A.. TMA occurring in the eleventh month of carfilzomib treatment. Hematologia - Transzfuziologia. 2024;57(1):36$47$YR$$F$Y$$$20240715$$MD$HU$HU
236529034$23652903$4$F$20240301$20240731$20240320$20240802$EXP$$CH-ABBVIE-5682902$ABBVIE$$74$YR$$M$Y$62$KG$20240802$$HP$CH$CH
236529304$23652930$4$F$20240229$20240913$20240320$20240919$30DAY$$US-PFIZER INC-202400055405$PFIZER$$13$YR$$M$Y$31.75$KG$20240919$$CN$US$US
236529442$23652944$2$F$$20240708$20240320$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA029835$SANDOZ$$$$$F$Y$$$20240709$$HP$CA$CA
236529587$23652958$7$F$$20240813$20240320$20240816$30DAY$$US-PFIZER INC-202400054400$PFIZER$$11$YR$$F$Y$$$20240816$$CN$US$US
236529802$23652980$2$F$20210501$20240912$20240320$20240921$EXP$$US-UCBSA-2024012910$UCB$$30$YR$$F$Y$$$20240921$$HP$US$US
236530203$23653020$3$F$$20240626$20240320$20240701$EXP$$US-PFIZER INC-202200505370$PFIZER$$62$YR$$F$Y$65.32$KG$20240701$$CN$US$US
236530323$23653032$3$F$$20240815$20240320$20240819$EXP$$BR-PFIZER INC-PV202400037412$PFIZER$$73$YR$$M$Y$93$KG$20240819$$HP$BR$BR
236530385$23653038$5$F$20240312$20240709$20240320$20240711$EXP$$JP-PFIZER INC-202400067014$PFIZER$$70$YR$$M$Y$72$KG$20240711$$PH$JP$JP
236530642$23653064$2$F$$20240725$20240320$20240730$EXP$$US-PFIZER INC-202400066028$PFIZER$$68$YR$$F$Y$$$20240730$$HP$US$US
236530953$23653095$3$F$20240124$20240705$20240320$20240712$EXP$$DE-PFIZER INC-202400049285$PFIZER$$$$$F$Y$$$20240712$$MD$DE$DE
236531203$23653120$3$F$20240317$20240701$20240320$20240703$PER$$US-AMGEN-USASP2024056655$AMGEN$$62$YR$A$F$Y$$$20240703$$CN$US$US
236531212$23653121$2$F$$20240621$20240320$20240712$EXP$$GB-AMGEN-GBRSP2024026533$AMGEN$$73$YR$E$F$Y$$$20240712$$CN$GB$GB
236531323$23653132$3$F$20240308$20240820$20240320$20240821$EXP$$ES-SANDOZ INC.-SDZ2024ES029925$SANDOZ$$10$YR$$F$Y$23.7$KG$20240821$$MD$ES$ES
236531536$23653153$6$F$20240312$20240723$20240320$20240729$EXP$$CO-TAKEDA-2024TUS016416$TAKEDA$$73$YR$$M$Y$64$KG$20240729$$CN$CO$CO
236531703$23653170$3$F$20230601$20240821$20240320$20240828$EXP$$US-UCBSA-2023050501$UCB$$24$YR$$M$Y$$$20240828$$CN$US$US
236532054$23653205$4$F$$20240820$20240320$20240827$PER$$US-PFIZER INC-202300327476$PFIZER$$54$YR$$M$Y$71.667$KG$20240827$$CN$US$US
236532243$23653224$3$F$$20240702$20240320$20240709$EXP$$CA-TAKEDA-2024TUS025211$TAKEDA$$$$$F$Y$$$20240709$$CN$CA$CA
236532275$23653227$5$F$20231201$20240820$20240320$20240821$EXP$$US-TAKEDA-2024TUS022438$TAKEDA$$60$YR$$M$Y$$$20240821$$MD$US$US
236532342$23653234$2$F$20240101$20240627$20240320$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02204$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236532513$23653251$3$F$$20240626$20240320$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02241$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236532552$23653255$2$F$20240101$20240917$20240320$20240923$PER$$US-SA-2024SA087576$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240923$$MD$US$US
236532712$23653271$2$F$$20240703$20240320$20240708$EXP$$CA-PFIZER INC-202400066848$PFIZER$$27$YR$$F$Y$$$20240708$$HP$CA$CA
236532722$23653272$2$F$20240201$20240828$20240320$20240902$EXP$$US-PFIZER INC-PV202300144165$PFIZER$$68$YR$$M$Y$$$20240902$$CN$US$US
236532813$23653281$3$F$20240301$20240821$20240320$20240827$EXP$$US-PFIZER INC-202400068032$PFIZER$$5$YR$$F$Y$$$20240827$$CN$US$US
236533002$23653300$2$F$20240318$20240723$20240320$20240725$PER$$US-AMGEN-USASP2024057352$AMGEN$$65$YR$E$F$Y$$$20240725$$CN$US$US
236533192$23653319$2$F$20231001$20240815$20240320$20240823$EXP$$CA-TAKEDA-CA202023833$TAKEDA$$64$YR$$F$Y$95$KG$20240823$$CN$CA$CA
236533225$23653322$5$F$20240201$20240917$20240320$20240924$EXP$$CA-PFIZER INC-202400066875$PFIZER$$79$YR$$F$Y$$$20240924$$HP$CA$CA
236533552$23653355$2$F$$20240315$20240320$20240911$EXP$$NVSC2024US007416$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
236533612$23653361$2$F$20240113$20240917$20240320$20240927$EXP$CH-SM-2024-10333$CH-BEH-2024169701$CSL BEHRING$$63$YR$A$M$Y$67$KG$20240927$$HP$CH$CH
236533896$23653389$6$F$20240101$20240913$20240320$20240916$30DAY$$US-PFIZER INC-202400057865$PFIZER$$36$YR$$M$Y$$$20240916$$HP$US$US
236533923$23653392$3$F$$20240912$20240320$20240919$EXP$$NVSC2024ZA018734$NOVARTIS$$48$YR$$F$Y$$$20240919$$HP$ZA$ZA
236534052$23653405$2$F$20240315$20240703$20240320$20240704$PER$$US-AMGEN-USASP2024056249$AMGEN$$66$YR$E$F$Y$$$20240704$$CN$US$US
236534203$23653420$3$F$20231228$20240801$20240320$20240807$EXP$$US-OTSUKA-2024_000658$OTSUKA$$33$YR$$F$Y$$$20240807$$HP$US$US
236534502$23653450$2$F$20240315$20240819$20240320$20240821$PER$$US-AMGEN-USASP2024055131$AMGEN$$54$YR$A$F$Y$$$20240821$$CN$US$US
236534544$23653454$4$F$$20240923$20240320$20240925$EXP$$NVSC2024AU059852$NOVARTIS$$$$$M$Y$$$20240926$$HP$AU$AU
236534572$23653457$2$F$20240130$20240801$20240320$20240808$PER$$US-RDY-SPO/USA/24/0004271$DR REDDYS$$15$YR$T$M$Y$$$20240808$$CN$US$US
236534692$23653469$2$F$$20240626$20240320$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02201$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236534912$23653491$2$F$$20240626$20240320$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02203$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236534995$23653499$5$F$$20240917$20240320$20240920$EXP$$US-PFIZER INC-202400067786$PFIZER$$24$YR$$M$Y$$$20240920$$CN$US$US
236535213$23653521$3$F$20240901$20240917$20240320$20240923$PER$$US-PFIZER INC-PV202400036379$PFIZER$$60$YR$$F$Y$$$20240923$$CN$US$US
236535273$23653527$3$F$$20240626$20240320$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02239$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236535543$23653554$3$F$20240601$20240716$20240320$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044119$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$63.5$KG$20240719$$CN$US$US
236535714$23653571$4$F$$20240627$20240320$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02243$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236535783$23653578$3$F$$20240626$20240320$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02254$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236536082$23653608$2$F$$20240626$20240320$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02284$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236536242$23653624$2$F$20230606$20240701$20240320$20240705$PER$$US-JNJFOC-20240324653$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240705$$MD$US$US
236536652$23653665$2$F$$20240821$20240320$20240827$EXP$$JP-009507513-2403JPN001957J$MERCK$$9$DEC$$F$Y$$$20240827$$MD$JP$JP
236536834$23653683$4$F$20240101$20240730$20240320$20240805$PER$$US-BIOGEN-2024BI01254860$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
236537222$23653722$2$F$$20240628$20240320$20240703$PER$$US-AMGEN-USASP2024057331$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
236537492$23653749$2$F$$20240826$20240320$20240913$PER$$US-TEVA-VS-3149370$TEVA$$$$$$Y$$$20240913$$CN$US$US
236537535$23653753$5$F$$20240711$20240320$20240711$30DAY$$CL-PFIZER INC-PV202400028027$PFIZER$$12$YR$$F$Y$$$20240711$$CN$CL$CL
236537642$23653764$2$F$$20240702$20240320$20240705$EXP$$US-TAKEDA-2024TUS025159$TAKEDA$$$$$M$Y$$$20240705$$CN$US$US
236537693$23653769$3$F$$20240815$20240320$20240816$EXP$$US-TAKEDA-2024TUS025620$TAKEDA$$$$$M$Y$$$20240816$$CN$US$US
236537712$23653771$2$F$20240301$20240703$20240320$20240713$EXP$GB-MHRA-EMIS-3984-acddb543-c910-4a4c-b39f-cd64ce95bafc$GB-TEVA-VS-3171935$TEVA$$66$YR$$M$Y$75$KG$20240713$$MD$GB$GB
236537773$23653777$3$F$$20240802$20240320$20240808$PER$$US-BIOGEN-2024BI01256041$BIOGEN$$$$$M$Y$$$20240808$$CN$US$US
236538202$23653820$2$F$20240101$20240917$20240320$20240924$EXP$$US-SA-2024SA088573$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240924$$MD$US$US
236538352$23653835$2$F$$20240715$20240320$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044546$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240716$$CN$US$US
236538362$23653836$2$F$$20240708$20240320$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044374$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240716$$CN$US$US
236539073$23653907$3$F$20240320$20240724$20240320$20240725$PER$$US-AMGEN-USASP2024057965$AMGEN$$62$YR$A$M$Y$$$20240725$$CN$US$US
236539125$23653912$5$F$$20240710$20240320$20240710$30DAY$$GB-PFIZER INC-PV202400028049$PFIZER$$11$YR$$F$Y$$$20240710$$CN$GB$GB
236539467$23653946$7$F$20240821$20240925$20240320$20240930$EXP$$US-SANDOZ INC.-SDZ2024US024886$SANDOZ$$29$YR$$F$Y$186$KG$20240930$$CN$US$US
236539472$23653947$2$F$20240601$20240624$20240320$20240701$EXP$$US-SA-2024SA086374$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240701$$MD$US$US
236539502$23653950$2$F$20131201$20240812$20240320$20240816$EXP$$FR-SANDOZ INC.-SDZ2024FR029871$SANDOZ$$65$YR$$M$Y$$$20240816$$HP$FR$FR
236539523$23653952$3$F$20230101$20240724$20240320$20240731$EXP$$NVSC2024DE056822$NOVARTIS$$$$A$F$Y$$$20240731$$CN$DE$DE
236540063$23654006$3$F$20240408$20240924$20240320$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044616$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240925$$CN$US$US
236540114$23654011$4$F$$20240307$20240320$20240828$EXP$$US-BRAEBURN-US-BRA-24-000206$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
236540372$23654037$2$F$20231001$20240718$20240320$20240725$EXP$$US-ABBVIE-5683518$ABBVIE$$17$YR$$F$Y$$$20240725$$CN$US$US
236540833$23654083$3$F$$20240917$20240320$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA030117$SANDOZ$$72$YR$$F$Y$61$KG$20240919$$CN$CA$CA
236540953$23654095$3$F$$20240823$20240320$20240901$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044740$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240902$$CN$US$US
236540962$23654096$2$F$20240308$20240904$20240320$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044359$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$108$KG$20240910$$PH$US$US
236541152$23654115$2$F$20240228$20240717$20240320$20240723$EXP$$JP-009507513-2403JPN001984J$MERCK$$5$DEC$$F$Y$$$20240723$$MD$JP$JP
236541836$23654183$6$F$$20240828$20240320$20240903$EXP$$US-Taiho Oncology Inc-2024-000501$TAIHO ONCOLOGY INC$$65$YR$E$F$Y$$$20240903$$CN$US$US
236542342$23654234$2$F$20230101$20240805$20240320$20240813$PER$$US-SA-2024SA085247$SANOFI AVENTIS$$37$YR$A$M$Y$190$KG$20240814$$MD$US$US
236543443$23654344$3$F$20240201$20240312$20240320$20240814$EXP$$NVSC2024AR037387$NOVARTIS$$55$YR$$F$Y$$$20240814$$CN$AR$AR
236543463$23654346$3$F$20240101$20240709$20240320$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044212$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240716$$CN$US$US
236543752$23654375$2$F$$20240904$20240320$20240911$EXP$GB-MLMSERVICE-20240305-4866179-1$GB-STRIDES ARCOLAB LIMITED-2024SP003157$STRIDES$Hong L, Witton LD, Jolly EC.. Pneumocystis jirovecii pneumonia presenting with severe, refractory hypercalcemia in an immunosuppressed renal transplant patient: Review of the literature and novel biochemical insights.. Clinical Medicine, Journal of the Royal College of Physicians of London.. 2024;24(1):1-3.$$$$$Y$$$20240912$$MD$GB$GB
236543995$23654399$5$F$20240214$20240717$20240320$20240724$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000562$BLUEPRINT MEDICINES$$72$YR$E$M$Y$$$20240724$$CN$US$US
236544036$23654403$6$F$20240208$20240731$20240320$20240802$PER$$US-BIOVITRUM-CTI2024US04556$BIOVITRUM$$68$YR$$F$Y$$$20240802$$CN$US$US
236544183$23654418$3$F$20240803$20240812$20240320$20240819$EXP$$NVSC2024US060217$NOVARTIS$$72$YR$$F$Y$$$20240819$$HP$US$US
236544704$23654470$4$F$20220607$20240812$20240320$20240814$EXP$$US-BIOVITRUM-CTI2023US04121$BIOVITRUM$$81$YR$$M$Y$$$20240814$$CN$US$US
236545682$23654568$2$F$20240101$20240730$20240320$20240808$PER$$US-SA-2024SA085199$SANOFI AVENTIS$$73$YR$E$F$Y$92$KG$20240808$$MD$US$US
236545692$23654569$2$F$20230301$20240625$20240320$20240704$PER$$US-SA-2024SA085816$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240704$$CN$US$US
236545762$23654576$2$F$$20240627$20240320$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02213$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236545862$23654586$2$F$$20240715$20240320$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-033506$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240717$$CN$US$US
236545913$23654591$3$F$20240213$20240628$20240320$20240703$EXP$$CH-JNJFOC-20240341916$JOHNSON AND JOHNSON$$67$YR$E$M$Y$112$KG$20240703$$MD$CH$CH
236545922$23654592$2$F$$20240627$20240320$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02242$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236546042$23654604$2$F$20231019$20240909$20240320$20240912$EXP$$IT-MYLANLABS-2024M1024500$MYLAN$$76$YR$$M$Y$$$20240912$$HP$IT$IT
236546329$23654632$9$F$20231101$20240827$20240320$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004401$JAZZ$$36$YR$$M$Y$42$KG$20240827$$MD$US$US
236546642$23654664$2$F$20230101$20240904$20240320$20240905$EXP$$CL-JNJFOC-20240346688$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240905$$CN$CL$CL
236546954$23654695$4$F$20240101$20240828$20240320$20240903$EXP$$JP-009507513-2403JPN000841J$MERCK$$5$DEC$$F$Y$$$20240903$$MD$JP$JP
236547014$23654701$4$F$$20240730$20240320$20240801$EXP$$CA-SANDOZ INC.-NVSC2023CA037280$SANDOZ$$56$YR$$F$Y$$$20240801$$CN$CA$CA
236547463$23654746$3$F$$20240828$20240320$20240904$PER$$US-BIOMARINAP-US-2024-156540$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
236547752$23654775$2$F$$20240710$20240320$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043847$BRISTOL MYERS SQUIBB$$65$YR$A$M$Y$$$20240712$$CN$US$US
236547972$23654797$2$F$$20240709$20240320$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202403006826$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240719$$CN$US$US
236548012$23654801$2$F$20240126$20240808$20240320$20240820$EXP$FR-AFSSAPS-NT2024000162$FR-ELI_LILLY_AND_COMPANY-FR202403004946$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240820$$CN$FR$FR
236548092$23654809$2$F$20230528$20240808$20240320$20240809$EXP$$FR-SANDOZ INC.-SDZ2024FR029921$SANDOZ$$20$YR$$F$Y$60$KG$20240809$$MD$FR$FR
236548114$23654811$4$F$20240129$20240725$20240320$20240801$EXP$$US-TAKEDA-2024TUS012162$TAKEDA$$58$YR$$M$Y$$$20240801$$MD$US$US
236548406$23654840$6$F$20240308$20240816$20240320$20240906$EXP$$US-BEH-2024169971$CSL BEHRING$$13$YR$T$F$Y$$$20240906$$HP$US$US
236548642$23654864$2$F$$20240305$20240320$20240830$PER$$US-MYLANLABS-2024M1021936$MYLAN$$$$$$Y$$$20240830$$CN$US$US
236548995$23654899$5$F$20240101$20240830$20240320$20240903$EXP$$US-BEH-2024169979$CSL BEHRING$$64$YR$A$F$Y$$$20240903$$HP$US$US
236549043$23654904$3$F$20240501$20240909$20240320$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044584$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240910$$CN$US$US
236549493$23654949$3$F$$20240702$20240320$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST001746$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240704$$CN$US$US
236549832$23654983$2$F$20240223$20240715$20240320$20240718$EXP$FR-AFSSAPS-AM2024000186$FR-PFIZER INC-202400067744$PFIZER$$35$YR$$F$Y$79$KG$20240718$$PH$FR$FR
236549874$23654987$4$F$20231003$20240730$20240320$20240805$EXP$$CA-PFIZER INC-202300318456$PFIZER$$65$YR$$F$Y$$$20240804$$HP$CA$CA
236550162$23655016$2$F$$20240628$20240320$20240705$EXP$$JP-009507513-2403JPN002000J$MERCK$$8$DEC$$F$Y$$$20240705$$MD$JP$JP
236550182$23655018$2$F$20240315$20240627$20240320$20240702$EXP$$JP-009507513-2403JPN002159J$MERCK$$69$YR$$M$Y$$$20240702$$MD$JP$JP
236550572$23655057$2$F$20240101$20240627$20240320$20240708$PER$$US-SA-2024SA084799$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240708$$MD$US$US
236550682$23655068$2$F$$20240925$20240320$20240926$PER$$US-PFIZER INC-PV202400037726$PFIZER$$66$YR$$F$Y$$$20240926$$CN$US$US
236550725$23655072$5$F$20240303$20240904$20240320$20240906$EXP$$CN-PFIZER INC-PV202400034298$PFIZER$$58$YR$$F$Y$66.5$KG$20240906$$MD$CN$CN
236550754$23655075$4$F$20240301$20240917$20240320$20240920$EXP$$US-PFIZER INC-202400067966$PFIZER$$54$YR$$F$Y$$$20240920$$HP$US$US
236550804$23655080$4$F$20240301$20240705$20240320$20240718$PER$$US-SA-2024SA084994$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240718$$MD$US$US
236550822$23655082$2$F$20240301$20240813$20240320$20240827$PER$$US-SA-2024SA086039$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240827$$MD$US$US
236551054$23655105$4$F$20240206$20240807$20240320$20240812$EXP$$US-DSJP-DSU-2024-108136$DAIICHI$$52$YR$$F$Y$62$KG$20240812$$HP$US$US
236551102$23655110$2$F$$20240628$20240320$20240708$EXP$$NO-MYLANLABS-2024M1025424$MYLAN$Askeland FB, Haukas  E, Slordahl T S, Klostergaard A, Alexandersen T, Schjoll D et al. Replacing steroids in transplant-ineligible multiple myeloma: the phase 2 isatuximab-bortezomib-lenalidomide-dexamethasone rest study. Blood. 2023;142 (1):3381$$$E$$Y$$$20240708$$MD$NO$NO
236551112$23655111$2$F$$20240628$20240320$20240708$EXP$$NO-MYLANLABS-2024M1025503$MYLAN$Askeland FB, Haukas  E, Slordahl T S, Klostergaard A, Alexandersen T, Schjoll D et al. Replacing steroids in transplant-ineligible multiple myeloma: the phase 2 isatuximab-bortezomib-lenalidomide-dexamethasone rest study. Blood. 2023;142 (1):3381$$$E$$Y$$$20240708$$MD$NO$NO
236551162$23655116$2$F$$20240626$20240320$20240726$EXP$DE-BFARM-24001397$DE-TEVA-VS-3170973$TEVA$$17$MON$$F$Y$$$20240726$$MD$DE$DE
236551507$23655150$7$F$20210101$20240904$20240320$20240909$EXP$$US-PFIZER INC-202400067218$PFIZER$$78$YR$$M$Y$80.74$KG$20240909$$CN$US$US
236552334$23655233$4$F$$20240823$20240320$20240828$PER$$NVSC2024US059588$NOVARTIS$$$$$$Y$$$20240828$$CN$US$US
236552382$23655238$2$F$20240201$20240711$20240320$20240718$EXP$$JP-009507513-2403JPN001972J$MERCK$$6$DEC$$F$Y$$$20240718$$MD$JP$JP
236552463$23655246$3$F$$20240703$20240320$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044763$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240705$$CN$US$US
236552493$23655249$3$F$$20240725$20240320$20240801$EXP$$JP-009507513-2403JPN001318J$MERCK$$7$DEC$$F$Y$$$20240801$$MD$JP$JP
236552545$23655254$5$F$$20240912$20240320$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044846$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240916$$CN$US$US
236552863$23655286$3$F$$20240314$20240320$20240711$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-07952$SAMSUNG BIOEPIS$$$$$F$Y$$$20240711$$CN$DE$DE
236552885$23655288$5$F$$20240715$20240320$20240720$EXP$$NVSC2024CA060162$NOVARTIS$$43$YR$$F$Y$96$KG$20240719$$HP$CA$CA
236554182$23655418$2$F$$20240905$20240320$20240912$EXP$$US-ABBVIE-5683254$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
236554252$23655425$2$F$20220801$20240724$20240320$20240726$EXP$$US-TAKEDA-2022TUS052200$TAKEDA$$74$YR$$F$Y$$$20240726$$MD$US$US
236554313$23655431$3$F$20200327$20240805$20240320$20240812$EXP$$CO-TAKEDA-CO202011851$TAKEDA$$56$YR$$F$Y$57$KG$20240812$$HP$CO$CO
236554424$23655442$4$F$20221230$20240926$20240320$20240930$EXP$$CA-BIOGEN-2023BI01185117$BIOGEN$$41$YR$$F$Y$$$20240930$$PH$CA$CA
236554452$23655445$2$F$20230101$20240828$20240320$20240902$EXP$$US-ABBVIE-5678617$ABBVIE$$59$YR$$F$Y$$$20240902$$CN$US$US
236554663$23655466$3$F$20240227$20240806$20240320$20240808$EXP$$DE-ABBVIE-5686898$ABBVIE$$44$YR$$M$Y$$$20240808$$HP$DE$DE
236555012$23655501$2$F$$20240710$20240320$20240715$EXP$$US-ABBVIE-5685276$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
236555234$23655523$4$F$$20240712$20240320$20240715$EXP$$US-TAKEDA-2023TUS048139$TAKEDA$$$$$M$Y$68$KG$20240715$$CN$US$US
236555432$23655543$2$F$20220304$20240708$20240321$20240713$EXP$$US-ABBVIE-4294356$ABBVIE$$69$YR$$M$Y$$$20240713$$CN$US$US
236555544$23655554$4$F$20240101$20240614$20240321$20240701$PER$$US-APOTEX-2024AP003451$APOTEX$$$$E$M$Y$$$20240701$$CN$US$US
236556272$23655627$2$F$20240318$20240723$20240321$20240725$PER$$US-AMGEN-USASP2024057617$AMGEN$$41$YR$A$M$Y$$$20240725$$CN$US$US
236556315$23655631$5$F$$20240823$20240321$20240830$EXP$$US-ABBVIE-5679580$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
236556612$23655661$2$F$20240206$20240806$20240321$20240813$EXP$$US-ABBVIE-5684185$ABBVIE$$66$YR$$F$Y$$$20240813$$CN$US$US
236557273$23655727$3$F$20240101$20240911$20240321$20240919$EXP$$CA-CELLTRION INC.-2024CA006839$CELLTRION$$$$$$Y$$$20240919$$CN$CA$CA
236557343$23655734$3$F$20231201$20240627$20240321$20240702$EXP$$JP-009507513-2403JPN001467J$MERCK$Ishikawa S, Hirano A, Anzai H, Fujita S, Yukawa H, Ishibashi Y, et al.. 16 A Case of Hepatic function disorder as an immune-related adverse event caused by immune checkpoint inhibitor in Breast Cancer. The 18th Cases Report Meeting by Resident Physicians of Tokyo Women^s Medical Un. 10$68$YR$$F$Y$$$20240702$$MD$JP$JP
236557644$23655764$4$F$20240314$20240819$20240321$20240826$EXP$$JP-BEH-2024169926$CSL BEHRING$$9$YR$C$M$Y$40.3$KG$20240826$$MD$JP$JP
236558042$23655804$2$F$20240101$20240911$20240321$20240927$EXP$$US-SA-2024SA088390$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240927$$MD$US$US
236558532$23655853$2$F$20240301$20240626$20240321$20240701$PER$$US-AMGEN-USASP2024056411$AMGEN$$21$YR$A$F$Y$$$20240701$$CN$US$US
236558752$23655875$2$F$$20240909$20240321$20240919$EXP$US-MLMSERVICE-20240307-4871346-3$US-STRIDES ARCOLAB LIMITED-2024SP003274$STRIDES$Janowski JPB, Suarez L, Allen ND, Sampson SM.. A Case Series of 11 Patients With Subacute Serotonin Syndrome.. Journal of the Academy of Consultation-Liaison Psychiatry.. 2024;65(1):33-38$$$$$Y$$$20240919$$MD$US$US
236558812$23655881$2$F$$20240626$20240321$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02209$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236558822$23655882$2$F$20240201$20240715$20240321$20240724$EXP$$US-ROCHE-3528933$ROCHE$$75$YR$E$M$Y$$$20240724$$CN$US$US
236558832$23655883$2$F$$20240909$20240321$20240920$EXP$US-MLMSERVICE-20240307-4871346-4$US-STRIDES ARCOLAB LIMITED-2024SP003275$STRIDES$Janowski JPB, Suarez L, Allen ND, Sampson SM.. A Case Series of 11 Patients With Subacute Serotonin Syndrome.. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65(1):33-38$$$$$Y$$$20240920$$MD$US$US
236558912$23655891$2$F$$20240909$20240321$20240920$EXP$US-MLMSERVICE-20240307-4871346-5$US-STRIDES ARCOLAB LIMITED-2024SP003276$STRIDES$Janowski JPB, Suarez L, Allen ND, Sampson SM.. A Case Series of 11 Patients With Subacute Serotonin Syndrome.. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65(1):33-38$$$$$Y$$$20240920$$MD$US$US
236558942$23655894$2$F$$20240909$20240321$20240920$EXP$US-MLMSERVICE-20240307-4871346-6$US-STRIDES ARCOLAB LIMITED-2024SP003278$STRIDES$Janowski JPB, Suarez L, Allen ND, Sampson SM.. A Case Series of 11 Patients With Subacute Serotonin Syndrome.. Journal of the Academy of Consultation-Liaison Psychiatry.. 2024;65(1):33-38$$$$$Y$$$20240920$$MD$US$US
236559193$23655919$3$F$20240301$20240801$20240321$20240806$EXP$$US-BEH-2024169695$CSL BEHRING$$39$YR$A$F$Y$73.03$KG$20240806$$CN$US$US
236559366$23655936$6$F$20240101$20240624$20240321$20240702$EXP$$CA-CELLTRION INC.-2024CA006910$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
236559462$23655946$2$F$$20240814$20240321$20240827$EXP$$AR-ALKEM LABORATORIES LIMITED-AR-ALKEM-2024-04648$ALKEM$Di Fonzo H, Villegas Gutsch M, Castroagudin A, Cabrera MV, Mazzei ME, Rueda D. Agranulocytosis induced by vancomycin. Case report and literature review. Am. J. Case Rep. 2018;19:1053-1056$38$YR$$M$Y$$$20240827$$HP$AR$AR
236559595$23655959$5$F$$20240912$20240321$20240920$PER$$US-BIOGEN-2024BI01255773$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
236559603$23655960$3$F$20240305$20240710$20240321$20240717$EXP$$US-BEH-2024169739$CSL BEHRING$$34$YR$A$M$Y$$$20240717$$HP$US$US
236559774$23655977$4$F$20240101$20240627$20240321$20240705$EXP$$CA-CELLTRION INC.-2024CA005113$CELLTRION$$$$$$Y$$$20240705$$CN$CA$CA
236560044$23656004$4$F$20240101$20240708$20240321$20240710$EXP$$US-UCBSA-2024011496$UCB$$$$$F$Y$$$20240710$$HP$US$US
236560194$23656019$4$F$$20240924$20240321$20240924$PER$$NVSC2024US059832$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
236560254$23656025$4$F$$20240701$20240321$20240708$EXP$$FR-GSK-FR2024035362$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$PH$FR$FR
236560552$23656055$2$F$20230824$20240724$20240321$20240725$EXP$$JP-TAKEDA-2024TJP004246$TAKEDA$$$$$$Y$$$20240725$$PH$JP$JP
236560732$23656073$2$F$$20240903$20240321$20240910$PER$$US-BIOGEN-2024BI01255774$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
236560743$23656074$3$F$20240101$20240614$20240321$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000924$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240709$$CN$US$US
236560762$23656076$2$F$$20240626$20240321$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02210$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236560883$23656088$3$F$20240229$20240704$20240321$20240923$PER$$CA-TOLMAR, INC.-24CA047368$TOLMAR$$60$YR$$M$Y$$$20240923$$CN$CA$CA
236560902$23656090$2$F$20240229$20240829$20240321$20240916$PER$$CA-TOLMAR, INC.-24CA047381$TOLMAR$$70$YR$$M$Y$$$20240916$$CN$CA$CA
236560922$23656092$2$F$$20240817$20240321$20240911$PER$$CA-TOLMAR, INC.-24CA047423$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
236560932$23656093$2$F$20240217$20240715$20240321$20240807$PER$$CO-TOLMAR, INC.-24CO047349$TOLMAR$$8$YR$$F$Y$$$20240807$$CN$CO$CO
236561495$23656149$5$F$20240305$20240628$20240321$20240702$PER$$NVSC2024US060794$NOVARTIS$$31$YR$$M$Y$$$20240702$$CN$US$US
236561563$23656156$3$F$20240528$20240626$20240321$20240703$EXP$$CA-JNJFOC-20231169098$JOHNSON AND JOHNSON$$70$YR$E$F$Y$68$KG$20240703$$HP$CA$CA
236561652$23656165$2$F$$20240723$20240321$20240730$PER$$US-BIOGEN-2024BI01253742$BIOGEN$$$$$F$Y$$$20240730$$CN$US$US
236562167$23656216$7$F$20231219$20240405$20240321$20240904$PER$$US-ROCHE-3527770$ROCHE$$47$YR$A$F$Y$$$20240904$$MD$US$US
236562243$23656224$3$F$20240314$20240820$20240321$20240826$EXP$$CA-TAKEDA-2024TUS025172$TAKEDA$$25$YR$$F$Y$$$20240826$$MD$CA$CA
236562337$23656233$7$F$20230101$20240705$20240321$20240711$EXP$$NVSC2024AR052467$NOVARTIS$$$$$F$Y$$$20240711$$CN$AR$AR
236562902$23656290$2$F$$20240315$20240321$20240807$EXP$$NVSC2024AU057558$NOVARTIS$$$$$M$Y$$$20240807$$MD$AU$AU
236563014$23656301$4$F$20240215$20240702$20240321$20240713$EXP$$NL-BAXTER-2024BAX013377$BAXTER$$66$YR$$M$Y$75.6$KG$20240713$$MD$NL$NL
236563053$23656305$3$F$$20240913$20240321$20240919$EXP$GB-TORRENT-00035613$GB-RDY-SPO/GBR/24/0004649$DR REDDYS$$27$YR$A$M$Y$$$20240919$$CN$GB$GB
236563712$23656371$2$F$$20240913$20240321$20240917$EXP$$US-TAKEDA-2022TUS019066$TAKEDA$$$$$F$Y$$$20240917$$CN$US$US
236563773$23656377$3$F$$20240730$20240321$20240805$30DAY$$IT-JNJFOC-20240331934$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$IT$IT
236563824$23656382$4$F$$20240827$20240321$20240903$EXP$$US-ABBVIE-5685877$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
236563926$23656392$6$F$20240101$20240725$20240321$20240806$EXP$$CA-BEH-2024169947$CSL BEHRING$$44$YR$A$F$Y$86$KG$20240806$$CN$CA$CA
236563963$23656396$3$F$20240226$20240911$20240321$20240918$EXP$$CA-TAKEDA-2024TUS018541$TAKEDA$$3$YR$$M$Y$$$20240918$$MD$CA$CA
236564364$23656436$4$F$$20240816$20240321$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043687$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240826$$HP$US$US
236564422$23656442$2$F$20240801$20240913$20240321$20240926$EXP$$US-UCBSA-2024012937$UCB$$75$YR$$F$Y$$$20240926$$HP$US$US
236564763$23656476$3$F$$20240626$20240321$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02200$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236564793$23656479$3$F$$20240904$20240321$20240911$EXP$$CA-TAKEDA-2024TUS025470$TAKEDA$$$$$F$Y$$$20240911$$MD$CA$CA
236564875$23656487$5$F$20240201$20240815$20240321$20240819$EXP$$NZ-BEH-2024169889$CSL BEHRING$$67$YR$E$M$Y$$$20240819$$HP$NZ$NZ
236564897$23656489$7$F$20231208$20240905$20240321$20240913$EXP$$CA-CELLTRION INC.-2023CA025186$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
236564923$23656492$3$F$$20240709$20240321$20240717$EXP$$US-SA-2024SA086383$SANOFI AVENTIS$$77$YR$E$M$Y$79.819$KG$20240717$$MD$US$US
236565085$23656508$5$F$20240221$20240813$20240321$20240816$PER$$US-BIOVITRUM-2024-US-004349$BIOVITRUM$$70$YR$$M$Y$$$20240816$$CN$US$US
236565202$23656520$2$F$$20240918$20240321$20240928$EXP$$US-AUROBINDO-AUR-APL-2024-011929$AUROBINDO$Moran Viacava F, Bandres MV, Mishkin A.. A case of skin and soft tissue infection in a lung transplant recipient.. Transplant Infectious Disease. 2024;26(1):e14210$65$YR$$M$Y$$$20240928$$MD$US$US
236565264$23656526$4$F$20240307$20240620$20240321$20240701$30DAY$$US-NOVOPROD-1189038$NOVO NORDISK$$64$YR$$F$Y$77$KG$20240701$$HP$US$US
236565382$23656538$2$F$$20240812$20240321$20240823$EXP$CA-HEALTHCANVIG-E2B_06871372$CA-NOVOPROD-1191451$NOVO NORDISK$$13$YR$$M$Y$$$20240823$$MD$CA$CA
236565473$23656547$3$F$$20240812$20240321$20240821$EXP$CA-HEALTHCANVIG-E2B_06863590$CA-NOVOPROD-1191426$NOVO NORDISK$$49$YR$$F$Y$86$KG$20240821$$HP$CA$CA
236565602$23656560$2$F$$20240911$20240321$20240919$EXP$$BR-CELLTRION INC.-2022BR022498$CELLTRION$$$$$$Y$$$20240919$$CN$BR$BR
236565833$23656583$3$F$20240101$20240829$20240321$20240906$EXP$$US-ABBVIE-5686146$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
236565942$23656594$2$F$20240101$20240814$20240321$20240821$EXP$$US-ORPHANEU-2023008911$RECORDATI$$$$$$Y$$$20240821$$CN$US$US
236565962$23656596$2$F$$20240904$20240321$20240905$PER$$NVSC2024US061574$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
236566352$23656635$2$F$20231101$20240813$20240321$20240828$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-437700$RANBAXY$$71$YR$$F$Y$$$20240828$$MD$IT$IT
236566733$23656673$3$F$20240319$20240703$20240321$20240704$PER$$US-AMGEN-USASP2024058064$AMGEN$$71$YR$E$M$Y$$$20240704$$CN$US$US
236566772$23656677$2$F$20240101$20240813$20240321$20240823$EXP$$US-TEVA-VS-3173164$TEVA$$16$YR$$M$Y$$$20240823$$HP$US$US
236566903$23656690$3$F$20240309$20240322$20240321$20240926$PER$$US-GSK-US2024AMR032648$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240926$$CN$US$US
236567022$23656702$2$F$$20240715$20240321$20240718$EXP$$CA-AMGEN-CANSP2024057530$AMGEN$$77$YR$E$F$Y$$$20240718$$CN$CA$CA
236567093$23656709$3$F$$20240723$20240321$20240803$EXP$$ES-AUROBINDO-AUR-APL-2024-012219$AUROBINDO$Calvo-Barcelo M, Vidal-Burdeus M, Barrabes JA. Answer: Shock with electrocardiogram deterioration. European Heart Journal: Acute Cardiovascular Care. 2024;13(1):185-6$60$YR$$F$Y$$$20240803$$MD$ES$ES
236567204$23656720$4$F$$20240801$20240321$20240808$EXP$$US-GSK-US2024AMR032514$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
236567222$23656722$2$F$$20240627$20240321$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02212$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236567294$23656729$4$F$20240301$20240716$20240321$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045320$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240724$$HP$US$US
236567322$23656732$2$F$$20240626$20240321$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02265$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236567393$23656739$3$F$20240306$20240923$20240321$20240927$EXP$$US-TAKEDA-2021TUS051369$TAKEDA$$24$YR$$M$Y$109$KG$20240927$$HP$US$US
236567412$23656741$2$F$$20240802$20240321$20240805$EXP$$DE-IPCA LABORATORIES LIMITED-IPC-2024-DE-000660$IPCA$Amelie Friederike Menke, Barbara Heitplatz, Veerle Van Marck, et al. Hydroxychloroquine-induced renal phospholipidosis: case report and review ofdifferential diagnoses. Case Reports in Nephrology  and Dialysis. 2024;14:20-29$$$$$Y$$$20240805$$HP$DE$DE
236567546$23656754$6$F$20240212$20240913$20240321$20240920$EXP$$CA-GSK-CA2023149383$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CA$CA
236567802$23656780$2$F$20231215$20240221$20240321$20240801$PER$$US-AstraZeneca-2023A292489$ASTRAZENECA$$21215$DY$$M$Y$$$20240801$$CN$US$
236567862$23656786$2$F$$20240626$20240321$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02253$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236567922$23656792$2$F$20230405$20240624$20240321$20240702$EXP$$JP-UCBSA-2023026839$UCB$$3$YR$$M$Y$14$KG$20240702$$MD$JP$JP
236568242$23656824$2$F$$20240726$20240321$20240729$EXP$$GB-GILEAD-2024-0666311$GILEAD$$$$A$M$Y$$$20240729$$CN$GB$GB
236568422$23656842$2$F$20240101$20240708$20240321$20240716$EXP$$CA-AMGEN-CANSP2024055429$AMGEN$$68$YR$E$M$Y$$$20240715$$PH$CA$CA
236568432$23656843$2$F$20240319$20240627$20240321$20240702$PER$$US-AMGEN-USASP2024057461$AMGEN$$79$YR$E$M$Y$$$20240701$$CN$US$US
236568463$23656846$3$F$$20240411$20240321$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04450$AMNEAL$$$$$$Y$$$20240715$$HP$US$US
236568472$23656847$2$F$$20240619$20240321$20240927$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00858$AMNEAL$$$$$$Y$$$20240927$$CN$US$US
236568482$23656848$2$F$$20240619$20240321$20240927$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00317$AMNEAL$$$$$F$Y$$$20240927$$HP$US$US
236568747$23656874$7$F$20240223$20240902$20240321$20240913$30DAY$$AR-JNJFOC-20240280807$JOHNSON AND JOHNSON$$62$YR$A$F$Y$70$KG$20240913$$CN$AR$AR
236568952$23656895$2$F$$20240314$20240321$20240809$EXP$$NVSC2024US056830$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
236568983$23656898$3$F$$20240715$20240321$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045281$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240716$$HP$US$US
236569013$23656901$3$F$20240319$20240704$20240321$20240705$PER$$US-AMGEN-USASP2024058336$AMGEN$$72$YR$E$M$Y$$$20240705$$CN$US$US
236569383$23656938$3$F$20210623$20240702$20240321$20240708$EXP$$JP-009507513-2403JPN001459J$MERCK$$78$YR$$F$Y$$$20240708$$MD$JP$JP
236570222$23657022$2$F$$20240714$20240321$20240718$EXP$$FR-JNJFOC-20240333287$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240718$$CN$FR$FR
236570297$23657029$7$F$20240329$20240812$20240321$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007613$UNITED THERAPEUTICS$$31$YR$$M$Y$140.59$KG$20240821$$$US$US
236570673$23657067$3$F$20230801$20240924$20240321$20240930$EXP$$EG-SANDOZ INC.-SDZ2024EG029681$SANDOZ$$61$YR$$F$Y$110$KG$20240930$$HP$EG$EG
236570764$23657076$4$F$20240118$20240801$20240321$20240813$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-02109$HIKMA$$17$YR$$M$Y$29.887$KG$20240813$$HP$US$US
236570803$23657080$3$F$20230515$20240718$20240321$20240724$EXP$$IL-UCBSA-2023025477$UCB$$10$YR$$M$Y$$$20240724$$MD$IL$IL
236571042$23657104$2$F$$20240626$20240321$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02283$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236571172$23657117$2$F$20231031$20240715$20240321$20240716$EXP$FR-AFSSAPS-RE2024000278$FR-PFIZER INC-202400066553$PFIZER$$35$YR$$F$Y$54$KG$20240716$$MD$FR$FR
236571422$23657142$2$F$$20240909$20240321$20240919$EXP$US-MLMSERVICE-20240307-4871346-1$US-STRIDES ARCOLAB LIMITED-2024SP003271$STRIDES$Janowski JPB, Suarez L, Allen ND, Sampson SM.. A Case Series of 11 Patients With Subacute Serotonin Syndrome.. Journal of the Academy of Consultation-Liaison Psychiatry.. 2024;65(1):33-38$$$$$Y$$$20240919$$MD$US$US
236571542$23657154$2$F$$20240909$20240321$20240919$EXP$US-MLMSERVICE-20240307-4871346-2$US-STRIDES ARCOLAB LIMITED-2024SP003272$STRIDES$Janowski JPB, Suarez L, Allen ND, Sampson SM.. A Case Series of 11 Patients With Subacute Serotonin Syndrome. Journal of the Academy of Consultation-Liaison Psychiatry.. 2024;65(1):33-38.$$$$$Y$$$20240919$$MD$US$US
236571564$23657156$4$F$$20240814$20240321$20240822$EXP$$US-INSMED, INC.-2024-01007-US$INSMED$$$$$F$Y$$$20240822$$CN$US$US
236571572$23657157$2$F$20230831$20240624$20240321$20240703$EXP$$RO-ASTELLAS-2024US008218$ASTELLAS$$48$YR$$M$Y$$$20240703$$CN$RO$RO
236571632$23657163$2$F$$20240909$20240321$20240918$EXP$US-MLMSERVICE-20240307-4871346-7$US-STRIDES ARCOLAB LIMITED-2024SP003280$STRIDES$Janowski JPB, Suarez L, Allen ND, Sampson SM.. A Case Series of 11 Patients With Subacute Serotonin Syndrome.. Journal of the Academy of Consultation-Liaison Psychiatry.. 2024;65(1):33-38$$$$$Y$$$20240918$$MD$US$US
236571826$23657182$6$F$$20240913$20240321$20240918$30DAY$$US-PFIZER INC-202400055406$PFIZER$$74$YR$$M$Y$113.4$KG$20240918$$PH$US$US
236571876$23657187$6$F$20220901$20240720$20240321$20240729$30DAY$$US-PFIZER INC-202400055567$PFIZER$$13$YR$$M$Y$40.82$KG$20240729$$CN$US$US
236571926$23657192$6$F$$20240905$20240321$20240909$30DAY$$US-PFIZER INC-202400056460$PFIZER$$3$YR$$M$Y$$$20240909$$CN$US$US
236571962$23657196$2$F$$20240703$20240321$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044967$BRISTOL MYERS SQUIBB$$30$YR$A$M$Y$$$20240705$$HP$US$US
236572992$23657299$2$F$20240313$20240710$20240321$20240712$EXP$$JP-BAYER-2024A039162$BAYER$$67$YR$E$F$Y$$$20240712$$MD$JP$JP
236573203$23657320$3$F$$20240731$20240321$20240805$EXP$$US-PFIZER INC-202400068211$PFIZER$$39$YR$$F$Y$$$20240805$$CN$US$US
236573272$23657327$2$F$$20240716$20240321$20240719$EXP$$CA-ABBVIE-5686002$ABBVIE$$$$A$F$Y$$$20240719$$CN$CA$CA
236573534$23657353$4$F$20240314$20240822$20240321$20240829$EXP$$CO-GSK-CO2024AMR035603$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$CO$CO
236573773$23657377$3$F$$20240830$20240321$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045245$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$105.69$KG$20240904$$CN$US$US
236573964$23657396$4$F$20231001$20240925$20240321$20240927$EXP$$CA-PFIZER INC-202300216216$PFIZER$$33$YR$$M$Y$109$KG$20240927$$MD$CA$CA
236574022$23657402$2$F$$20240716$20240321$20240723$EXP$$JP-ROCHE-3528281$ROCHE$$67$YR$E$M$Y$$$20240723$$PH$JP$JP
236574092$23657409$2$F$$20240627$20240321$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02297$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236574434$23657443$4$F$$20240821$20240321$20240827$EXP$$NVSC2024US061055$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
236574862$23657486$2$F$$20240306$20240321$20240722$EXP$$US-SCPHARMACEUTICALS-2024-SCPH-US000091$PAREXEL$$$$$$Y$$$20240722$$CN$US$US
236574905$23657490$5$F$$20240912$20240321$20240917$30DAY$$US-PFIZER INC-PV202400031987$PFIZER$$75$YR$$M$Y$$$20240917$$MD$US$US
236575152$23657515$2$F$$20240701$20240321$20240703$PER$$NVSC2024US059115$NOVARTIS$$$$$F$Y$$$20240703$$MD$US$US
236575288$23657528$8$F$$20240813$20240321$20240816$PER$$US-PFIZER INC-PV202300019038$PFIZER$$73$YR$$M$Y$$$20240816$$CN$US$US
236576185$23657618$5$F$20240322$20240701$20240321$20240705$EXP$$US-JNJFOC-20240346922$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240705$$CN$US$US
236576255$23657625$5$F$20180201$20240726$20240321$20240730$EXP$$BR-PFIZER INC-2018331897$PFIZER$$51$YR$$F$Y$84$KG$20240730$$MD$BR$BR
236576432$23657643$2$F$$20240716$20240321$20240718$PER$$US-PFIZER INC-202400057425$PFIZER$$67$YR$$F$Y$$$20240718$$CN$US$US
236576445$23657644$5$F$20240201$20240724$20240321$20240724$PER$$US-PFIZER INC-202400067090$PFIZER$$55$YR$$F$Y$82.55$KG$20240724$$CN$US$US
236576922$23657692$2$F$20240320$20240628$20240321$20240702$PER$$US-AMGEN-USASP2024058712$AMGEN$$62$YR$A$F$Y$$$20240702$$CN$US$US
236576982$23657698$2$F$$20240627$20240321$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02299$LUPIN$$$$$$Y$$$20240714$$PH$US$US
236577222$23657722$2$F$$20240627$20240321$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02247$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236577288$23657728$8$F$20240101$20240820$20240321$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-004701$UNITED THERAPEUTICS$$$$$M$Y$131.52$KG$20240829$$$US$US
236578002$23657800$2$F$$20240823$20240321$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043814$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240828$$CN$US$US
236578265$23657826$5$F$20240524$20240718$20240321$20240722$EXP$$NVSC2024ZA054434$NOVARTIS$$41$YR$$F$Y$$$20240723$$CN$ZA$ZA
236578343$23657834$3$F$20240117$20240702$20240321$20240718$PER$$US-Eisai-EC-2024-157940$EISAI$$73$YR$E$M$Y$90$KG$20240718$$MD$US$US
236578355$23657835$5$F$20240101$20240618$20240321$20240705$PER$$US-Eisai-EC-2024-159432$EISAI$$72$YR$E$F$Y$$$20240705$$CN$US$US
236578412$23657841$2$F$$20240805$20240321$20240814$EXP$$CA-TEVA-VS-3170788$TEVA$$61$YR$$F$Y$58$KG$20240814$$HP$CA$CA
236578444$23657844$4$F$$20240812$20240321$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045344$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240814$$CN$US$US
236579226$23657922$6$F$20240223$20240909$20240321$20240911$EXP$$US-TAKEDA-2024TUS019143$TAKEDA$$70$YR$$M$Y$$$20240911$$MD$US$US
236579622$23657962$2$F$$20240909$20240321$20240924$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000154$BECTON DICKINSON$$$$$$Y$$$20240924$$CN$GB$GB
236580016$23658001$6$F$20240306$20240822$20240321$20240829$30DAY$$US-PFIZER INC-PV202400032604$PFIZER$$4$YR$$M$Y$$$20240829$$CN$US$US
236580602$23658060$2$F$$20240801$20240321$20240805$EXP$$IN-PFIZER INC-PV202400038367$PFIZER$$66$YR$$M$Y$$$20240805$$CN$IN$IN
236580702$23658070$2$F$20231225$20240722$20240321$20240726$EXP$$JP-DSJP-DSJ-2024-109839$DAIICHI$$87$YR$$F$Y$56.9$KG$20240726$$MD$JP$JP
236580772$23658077$2$F$$20240830$20240321$20240905$PER$$FR-PFM-2024-01572$PIERRE FABRE MEDICAMENT$Fath l, Simon F, Levy R, Boccara O, Couloigner V. Dangers and therapeutic difficulties of intracranial hemangioma in infants: A CARE case report. European Annals of Otorhinolaryngology, Head and Neck Diseases.. 2024;1-4$$$$$Y$$$20240905$$HP$FR$FR
236580882$23658088$2$F$$20240730$20240321$20240806$EXP$US-MLMSERVICE-20240307-4871856-1$US-RDY-SPO/USA/24/0004534$DR REDDYS$Surineni K, Le VY, Jones D. A Case of Oral-Buccal-Lingual Dyskinesia and Neuropsychiatric Symptoms After Prolonged Levetiracetam Exposure. Cureus. 2024;16(6):e62692. DOI:10.7759/cureus.62692.$86$YR$E$F$Y$$$20240806$$MD$US$US
236580972$23658097$2$F$20230928$20240628$20240321$20240704$PER$$US-JNJFOC-20240324664$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240705$$MD$US$US
236581193$23658119$3$F$20240101$20240906$20240321$20240913$EXP$$US-ABBVIE-5683026$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
236581292$23658129$2$F$20230720$20240301$20240321$20240716$PER$$US-JNJFOC-20240324659$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240716$$MD$US$US
236581533$23658153$3$F$$20240812$20240321$20240819$EXP$$CA-GSK-CA2023100478$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$MD$CA$CA
236581592$23658159$2$F$20240201$20240730$20240321$20240805$EXP$$GR-SA-2024SA070454$SANOFI AVENTIS$$$$$M$Y$$$20240805$$MD$GR$GR
236581972$23658197$2$F$20080702$20240909$20240321$20240920$EXP$$US-SA-2024SA079473$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240920$$MD$US$US
236582146$23658214$6$F$20240307$20240903$20240321$20240905$30DAY$$US-PFIZER INC-PV202400033392$PFIZER$$2$YR$$M$Y$$$20240905$$HP$US$US
236582612$23658261$2$F$$20240708$20240321$20240710$PER$$US-PFIZER INC-202400068040$PFIZER$$61$YR$$M$Y$68.04$KG$20240710$$CN$US$US
236582622$23658262$2$F$$20240903$20240321$20240905$PER$$US-PFIZER INC-PV202400037037$PFIZER$$84$YR$$F$Y$$$20240905$$CN$US$US
236583032$23658303$2$F$20240203$20240716$20240321$20240722$EXP$FR-AFSSAPS-PP2024000221$FR-009507513-2403FRA005853$MERCK$$71$YR$$F$Y$$$20240722$$PH$FR$FR
236583176$23658317$6$F$20240228$20240909$20240321$20240912$30DAY$$US-PFIZER INC-202400064263$PFIZER$$5$YR$$M$Y$$$20240912$$CN$US$US
236583533$23658353$3$F$20220901$20240726$20240321$20240801$EXP$$CA-VERTEX PHARMACEUTICALS-2024-002698$VERTEX$$32$YR$$M$Y$$$20240801$$HP$CA$CA
236583546$23658354$6$F$20230707$20240904$20240321$20240906$EXP$$US-BIOVITRUM-CTI2024US04496$BIOVITRUM$$87$YR$$F$Y$$$20240906$$CN$US$US
236583618$23658361$8$F$20230601$20240912$20240321$20240923$EXP$$US-UCBSA-2023043193$UCB$$18$YR$$F$Y$46$KG$20240923$$CN$US$US
236584653$23658465$3$F$$20240808$20240321$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044913$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240810$$CN$US$US
236585233$23658523$3$F$$20240801$20240321$20240806$EXP$DE-BFARM-18000390$DE-SA-2024SA088948$SANOFI AVENTIS$$$$$F$Y$$$20240806$$PH$DE$DE
236585442$23658544$2$F$$20240725$20240321$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045395$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240729$$CN$US$US
236585483$23658548$3$F$20240523$20240718$20240321$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041435$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240723$$CN$US$US
2365857617$23658576$17$F$20240314$20240913$20240321$20240920$EXP$$CO-TAKEDA-2024TUS025496$TAKEDA$$44$YR$$F$Y$59$KG$20240920$$CN$CO$CO
236585923$23658592$3$F$$20240923$20240321$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045479$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240923$$CN$US$US
236585982$23658598$2$F$$20240923$20240321$20240923$PER$$NVSC2024US061920$NOVARTIS$$$$$$Y$$$20240924$$HP$US$US
236586272$23658627$2$F$$20240711$20240321$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-042071$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240715$$CN$US$US
236586456$23658645$6$F$20231128$20240820$20240321$20240822$EXP$$NVSC2024CA054774$NOVARTIS$$81$YR$$M$Y$$$20240822$$HP$CA$CA
236586495$23658649$5$F$20201001$20240913$20240321$20240924$EXP$GB-JUBILANT PHARMA LTD-2021GB000618$GB-JUBILANT PHARMA LTD-2021GB000961$JUBILANT$$68$YR$$F$Y$92$KG$20240924$$MD$GB$GB
236586683$23658668$3$F$$20240705$20240321$20240708$EXP$$PL-ALXN-202403EEA001311PL$ALEXION PHARMACEUTICALS$$4$YR$$M$Y$$$20240708$$MD$PL$PL
2365867611$23658676$11$F$20240401$20240910$20240321$20240917$EXP$$CA-GSK-CA2023158902$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$CA$CA
236586903$23658690$3$F$20240201$20240807$20240321$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044867$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240809$$HP$US$US
236587002$23658700$2$F$$20240708$20240321$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA030617$SANDOZ$$52$YR$$M$Y$$$20240710$$CN$CA$CA
236587092$23658709$2$F$$20240724$20240321$20240725$EXP$$CL-PFIZER INC-PV202400037474$PFIZER$Huidobro, E.. PTLD Suspected by Visualization of Atypical Urinary Lymphocytes. American Journal of Transplantation. 2022;22(Supple 3):783$39$YR$$F$Y$$$20240725$$HP$CL$CL
236587194$23658719$4$F$$20240722$20240321$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045606$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240730$$CN$US$US
236587333$23658733$3$F$20231201$20240710$20240321$20240712$EXP$$AT-ABBVIE-5686677$ABBVIE$$43$YR$$M$Y$$$20240712$$CN$AT$AT
236587603$23658760$3$F$$20240619$20240321$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02256$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236588282$23658828$2$F$20240305$20240822$20240321$20240829$EXP$$BE-JNJFOC-20240337461$JOHNSON AND JOHNSON$$$$E$M$Y$65$KG$20240829$$MD$BE$BE
236589122$23658912$2$F$20240228$20240917$20240321$20240920$EXP$$US-KYOWAKIRIN-2024KK005699$KYOWA$$$$$$Y$$$20240920$$CN$US$US
236589216$23658921$6$F$20230227$20240829$20240321$20240904$EXP$$GB-AMGEN-GBRNI2023071087$AMGEN$$82$YR$E$F$Y$$$20240904$$MD$GB$GB
236589352$23658935$2$F$20240308$20240310$20240321$20240802$EXP$GB-MHRA-TPP7594145C7439958YC1709916714745$GB-TORRENT-00035782$TORRENT$$52$YR$A$F$Y$89$KG$20240802$$MD$GB$GB
236590036$23659003$6$F$20240331$20240913$20240321$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044728$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240920$$CN$US$US
236590122$23659012$2$F$$20240717$20240321$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044343$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240719$$CN$US$US
236590402$23659040$2$F$$20240619$20240321$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02307$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236590532$23659053$2$F$20210601$20240701$20240321$20240702$EXP$FR-AFSSAPS-CN2024000224$FR-PFIZER INC-202400066315$PFIZER$$28$YR$$F$Y$95$KG$20240702$$MD$FR$FR
236590844$23659084$4$F$20240101$20240711$20240321$20240718$PER$$JP-Eisai-EC-2024-161710$EISAI$$$$E$M$Y$$$20240718$$MD$JP$JP
236590852$23659085$2$F$20230101$20240709$20240321$20240718$PER$$JP-Eisai-EC-2023-144532$EISAI$$65$YR$E$F$Y$$$20240718$$MD$JP$JP
236591492$23659149$2$F$$20240625$20240321$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-043819$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240702$$MD$JP$JP
2365915410$23659154$10$F$$20240718$20240321$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045561$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240722$$CN$US$US
236591873$23659187$3$F$20240621$20240703$20240321$20240704$EXP$$US-TAKEDA-2024TUS026254$TAKEDA$$65$YR$$M$Y$$$20240704$$CN$US$US
236591936$23659193$6$F$20240301$20240628$20240321$20240701$EXP$$GB-MYLANLABS-2024M1025299$MYLAN$$$$$M$Y$$$20240701$$CN$GB$GB
236592043$23659204$3$F$20240319$20240912$20240321$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045410$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$79.83$KG$20240913$$CN$US$US
236592713$23659271$3$F$20240501$20240628$20240321$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044730$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240704$$CN$US$US
236592842$23659284$2$F$$20240906$20240321$20240913$EXP$$US-GILEAD-2024-0666556$GILEAD$$62$YR$A$M$Y$$$20240913$$HP$US$US
236592882$23659288$2$F$20240107$20240227$20240321$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0100404$MYOVANT SCIENCES$$35$YR$$F$Y$$$20240723$$CN$US$US
236594202$23659420$2$F$$20240801$20240321$20240809$PER$$US-ABBVIE-5684413$ABBVIE$$$$$$Y$$$20240809$$CN$US$US
236594853$23659485$3$F$20240101$20240918$20240321$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044776$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240920$$CN$US$US
236594892$23659489$2$F$20230815$20240912$20240321$20240919$EXP$$US-JNJFOC-20240345106$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$HP$US$US
236594903$23659490$3$F$$20240906$20240321$20240913$EXP$$US-GILEAD-2024-0666460$GILEAD$$57$YR$A$F$Y$$$20240913$$MD$US$US
236595092$23659509$2$F$$20240221$20240321$20240708$PER$$US-TEVA-VS-3161228$TEVA$$51$YR$$F$Y$$$20240708$$MD$US$US
236595102$23659510$2$F$$20240726$20240321$20240806$EXP$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2023XER02346$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
236595932$23659593$2$F$20240305$20240621$20240321$20240701$PER$$US-MYLANLABS-2024M1023549$MYLAN$$75$YR$$F$Y$$$20240701$$CN$US$US
236596122$23659612$2$F$$20240627$20240321$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02246$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236596492$23659649$2$F$$20240925$20240321$20240926$EXP$$CA-BAUSCH-BL-2024-004460$BAUSCH AND LOMB$$$$$F$Y$$$20240926$$HP$CA$CA
236596503$23659650$3$F$20230101$20240719$20240321$20240724$EXP$$CA-SA-2023SA364558$SANOFI AVENTIS$$5$YR$C$F$Y$19$KG$20240724$$MD$CA$CA
236596633$23659663$3$F$20240315$20240710$20240321$20240712$EXP$$CO-BAYER-2024A041252$BAYER$$68$YR$E$F$Y$$$20240712$$CN$CO$CO
236596653$23659665$3$F$$20240311$20240321$20240920$PER$$US-BRAEBURN-US-BRA-24-000215$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
236596835$23659683$5$F$20240301$20240731$20240321$20240805$EXP$$NVSC2024US060252$NOVARTIS$$43$YR$$F$Y$143$KG$20240804$$CN$US$US
236596853$23659685$3$F$$20240812$20240321$20240820$EXP$$DE-SANDOZ INC.-PHHY2013DE014295$SANDOZ$$69$YR$$M$Y$$$20240820$$MD$DE$DE
236596943$23659694$3$F$20240101$20240805$20240321$20240807$EXP$$US-KARYOPHARM-2024KPT000610$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240807$$MD$US$US
236597154$23659715$4$F$20230101$20240917$20240321$20240923$EXP$$CA-PFIZER INC-202300304775$PFIZER$$59$YR$$F$Y$$$20240923$$MD$CA$CA
236597174$23659717$4$F$20230101$20240727$20240321$20240729$EXP$$CA-PFIZER INC-202201192774$PFIZER$$63$YR$$F$Y$$$20240729$$HP$CA$CA
236597208$23659720$8$F$20080101$20240828$20240321$20240903$EXP$$US-PFIZER INC-202400068000$PFIZER$$65$YR$$F$Y$86.168$KG$20240903$$CN$US$US
236597253$23659725$3$F$$20240703$20240321$20240708$PER$$US-SA-2024SA085752$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240708$$MD$US$US
236597272$23659727$2$F$20240101$20240729$20240321$20240806$PER$$US-SA-2024SA086076$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240807$$MD$US$US
236597292$23659729$2$F$20240101$20240821$20240321$20240912$PER$$US-SA-2024SA087281$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240912$$MD$US$US
236597593$23659759$3$F$20240727$20240807$20240321$20240816$PER$$US-SA-2024SA085334$SANOFI AVENTIS$$57$YR$A$F$Y$72.5$KG$20240816$$MD$US$US
236597652$23659765$2$F$$20240917$20240321$20240923$PER$$US-SA-2024SA085103$SANOFI AVENTIS$$$$A$M$Y$$$20240923$$MD$US$US
236597694$23659769$4$F$20240101$20240819$20240321$20240828$PER$$US-SA-2024SA085486$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240828$$MD$US$US
236597712$23659771$2$F$20240101$20240809$20240321$20240814$PER$$US-SA-2024SA085118$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240814$$MD$US$US
236597853$23659785$3$F$20240101$20240627$20240321$20240712$PER$$US-SA-2024SA085806$SANOFI AVENTIS$$$$A$F$Y$67.1$KG$20240712$$MD$US$US
236598013$23659801$3$F$20240101$20240805$20240321$20240813$PER$$US-SA-2024SA088326$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240814$$CN$US$US
236598037$23659803$7$F$20240101$20240919$20240321$20240924$EXP$$US-SA-2024SA085546$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240924$$MD$US$US
236598202$23659820$2$F$20240311$20240709$20240321$20240717$PER$$US-SA-2024SA085173$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240717$$MD$US$US
236598222$23659822$2$F$$20240705$20240321$20240717$PER$$US-SA-2024SA085413$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240717$$MD$US$US
236598273$23659827$3$F$20231101$20240821$20240321$20240905$PER$$US-SA-2024SA086841$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240905$$MD$US$US
236598552$23659855$2$F$20190301$20240716$20240321$20240724$PER$$US-SA-2024SA087768$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240724$$MD$US$US
236598602$23659860$2$F$20240601$20240705$20240321$20240715$PER$$US-SA-2024SA087800$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240715$$MD$US$US
236598863$23659886$3$F$20240314$20240807$20240321$20240816$PER$$US-SA-2024SA085284$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240816$$MD$US$US
236598884$23659888$4$F$20240314$20240620$20240321$20240701$PER$$US-SA-2024SA087097$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240701$$MD$US$US
236598912$23659891$2$F$20230101$20240905$20240321$20240911$PER$$US-BAYER-2024A040522$BAYER$$43$YR$A$F$Y$$$20240911$$MD$US$US
236599172$23659917$2$F$$20240912$20240321$20240920$PER$$US-SA-2024SA087693$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240920$$MD$US$US
236599212$23659921$2$F$$20240802$20240321$20240813$PER$$US-SA-2024SA087273$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240814$$MD$US$US
236599232$23659923$2$F$20240301$20240826$20240321$20240910$PER$$US-SA-2024SA087586$SANOFI AVENTIS$$7$MON$I$F$Y$$$20240910$$MD$US$US
236599283$23659928$3$F$20230601$20240701$20240321$20240704$EXP$$US-SA-2024SA088938$SANOFI AVENTIS$$103$YR$E$F$Y$$$20240704$$PH$US$US
236599313$23659931$3$F$20240313$20240703$20240321$20240712$PER$$US-SA-2024SA079198$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240712$$MD$US$US
236599603$23659960$3$F$20240313$20240805$20240321$20240813$PER$$US-SA-2024SA088403$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240814$$MD$US$US
236599774$23659977$4$F$20240101$20240701$20240321$20240710$PER$$US-SA-2024SA088969$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240710$$MD$US$US
236600612$23660061$2$F$20190814$20240311$20240321$20240702$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002539$AKCEA THERAPEUTICS$$$$$$Y$$$20240701$$HP$US$US
236601773$23660177$3$F$$20240619$20240321$20240806$PER$$US-LUNDBECK-DKLU3075423$LUNDBECK$$$$$$Y$$$20240806$$HP$US$US
236601985$23660198$5$F$20240229$20240905$20240321$20240911$PER$$CN-Eisai-EC-2024-161856$EISAI$$44$YR$A$F$Y$69$KG$20240911$$MD$CN$CN
236602004$23660200$4$F$20240319$20240910$20240321$20240916$PER$$US-JNJFOC-20240355653$JOHNSON AND JOHNSON$$47$YR$$F$Y$$$20240916$$CN$US$US
236602084$23660208$4$F$20230415$20240924$20240321$20240925$EXP$FR-AFSSAPS-BS2024000136$FR-SA-2024SA088818$SANOFI AVENTIS$$55$YR$A$F$Y$99$KG$20240925$$HP$FR$FR
236602153$23660215$3$F$$20240625$20240321$20240702$PER$$US-INCYTE CORPORATION-2024IN002790$INCYTE$$$$$$Y$$$20240702$$CN$US$US
236602693$23660269$3$F$20211223$20240401$20240321$20240919$EXP$$PT-SANDOZ INC.-NVSC2023PT000754$SANDOZ$$76$YR$$F$Y$$$20240919$$MD$PT$PT
236603092$23660309$2$F$$20240628$20240321$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042627$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240705$$PH$JP$JP
236603393$23660339$3$F$$20240710$20240321$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044284$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240712$$CN$US$US
236603405$23660340$5$F$20240313$20240701$20240321$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044478$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$81$KG$20240709$$PH$US$US
236603975$23660397$5$F$$20240824$20240321$20240829$EXP$$NVSC2024IN058920$NOVARTIS$$$$$F$Y$$$20240829$$CN$IN$IN
236604203$23660420$3$F$20240101$20240627$20240321$20240703$EXP$$ES-ABBVIE-5555290$ABBVIE$$$$$F$Y$$$20240703$$CN$ES$ES
236604284$23660428$4$F$$20240809$20240321$20240814$EXP$$US-TAKEDA-2023TUS001698$TAKEDA$$$$$M$Y$62$KG$20240814$$CN$US$US
236604314$23660431$4$F$20240314$20240805$20240321$20240814$PER$$US-SA-2024SA088820$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240814$$MD$US$US
236604433$23660443$3$F$$20240704$20240321$20240709$EXP$$JP-AMGEN-JPNSP2024054266$AMGEN$$$$E$$Y$$$20240708$$MD$JP$JP
236604642$23660464$2$F$$20240324$20240322$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089062$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
236604714$23660471$4$F$20240101$20240806$20240322$20240810$EXP$$US-ABBVIE-5685003$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
236604753$23660475$3$F$20240101$20240819$20240322$20240821$EXP$$US-ABBVIE-5685961$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
236604772$23660477$2$F$$20240913$20240322$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-012766$AUROBINDO$$27$YR$$M$Y$$$20240925$$CN$GB$GB
236604812$23660481$2$F$$20240724$20240322$20240726$EXP$$US-TAKEDA-US202012990$TAKEDA$$$$$F$Y$$$20240726$$CN$US$US
236604892$23660489$2$F$20240101$20240812$20240322$20240818$EXP$$US-ABBVIE-5686518$ABBVIE$$40$YR$$F$Y$$$20240818$$CN$US$US
236605712$23660571$2$F$20240320$20240918$20240322$20240921$PER$$US-AMGEN-USASP2024058758$AMGEN$$71$YR$E$M$Y$$$20240921$$CN$US$US
236605722$23660572$2$F$20220901$20240917$20240322$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-045196$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$43$KG$20240920$$MD$JP$JP
236605942$23660594$2$F$$20240628$20240322$20240712$EXP$$US-TEVA-VS-3151872$TEVA$$$$$$Y$$$20240712$$CN$US$US
236606132$23660613$2$F$20240201$20240821$20240322$20240826$EXP$CH-SM-2024-11133$CH-JNJFOC-20240336480$JOHNSON AND JOHNSON$$87$YR$E$F$Y$48$KG$20240827$$MD$CH$CH
236606143$23660614$3$F$20240301$20240704$20240322$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-041875$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$49.8$KG$20240705$$PH$JP$JP
236606243$23660624$3$F$20240225$20240628$20240322$20240704$PER$$US-AMGEN-USASL2024054507$AMGEN$$66$YR$E$M$Y$$$20240704$$CN$US$US
236606544$23660654$4$F$20240114$20240711$20240322$20240717$EXP$$GB-AMGEN-GBRSP2024057366$AMGEN$$87$YR$E$F$Y$$$20240717$$CN$GB$GB
236606552$23660655$2$F$$20240627$20240322$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02202$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236607106$23660710$6$F$$20240912$20240322$20240920$PER$$NVSC2024US057500$NOVARTIS$$60$YR$$$Y$$$20240920$$CN$US$US
236607312$23660731$2$F$$20240627$20240322$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02315$LUPIN$$$$$$Y$$$20240714$$CN$US$US
2366075411$23660754$11$F$$20240913$20240322$20240917$PER$$NVSC2024US059449$NOVARTIS$$$$$$Y$$$20240917$$CN$US$US
236607582$23660758$2$F$20240320$20240826$20240322$20240828$PER$$US-AMGEN-USASP2024058964$AMGEN$$61$YR$A$M$Y$$$20240828$$CN$US$US
236607793$23660779$3$F$20240101$20240703$20240322$20240709$EXP$$CA-JNJFOC-20240347814$JOHNSON AND JOHNSON$$28$YR$A$F$Y$94$KG$20240709$$HP$CA$CA
236607962$23660796$2$F$$20240610$20240322$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001008$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
236608002$23660800$2$F$20211101$20240806$20240322$20240809$EXP$$DE-ROCHE-2972751$ROCHE$$23$YR$A$M$Y$94$KG$20240809$$MD$DE$DE
236608422$23660842$2$F$20201201$20240314$20240322$20240812$EXP$$PA-SANDOZ INC.-NVSC2020PA115698$SANDOZ$$60$YR$$F$Y$$$20240812$$CN$PA$PA
236608792$23660879$2$F$$20240731$20240322$20240806$EXP$$DE-JNJFOC-20240339711$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$DE$DE
236608912$23660891$2$F$$20240829$20240322$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001028$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
236609052$23660905$2$F$20240222$20240702$20240322$20240705$EXP$$CA-UCBSA-2024013843$UCB$$38$YR$$F$Y$$$20240705$$HP$CA$CA
236609062$23660906$2$F$20231105$20240703$20240322$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-012533$AUROBINDO$$27$YR$$F$Y$$$20240710$$MD$FR$FR
236609816$23660981$6$F$$20240917$20240322$20240918$PER$$NVSC2024US061964$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
236609994$23660999$4$F$$20240709$20240322$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042010$BRISTOL MYERS SQUIBB$Uba T, Fukui Y, Aihara S, Nishimoto K, Soeda T, Anada N. A case of skin eruption/adrenal insufficiency and myocarditis during nivolumab/ipilimumab therapy. The 51st Annual Meeting of the Japanese Society of Intensive Care Medicine. 2024;743.$83$YR$E$F$Y$$$20240711$$MD$JP$JP
236610043$23661004$3$F$20240318$20240827$20240322$20240829$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-043765$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$71.21$KG$20240829$$CN$PR$PR
236610143$23661014$3$F$20240201$20240628$20240322$20240704$EXP$$CA-JNJFOC-20240344114$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240704$$HP$CA$CA
236610304$23661030$4$F$20240101$20240816$20240322$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043133$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$93.71$KG$20240826$$CN$US$US
236610317$23661031$7$F$$20240916$20240322$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044196$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240918$$CN$US$US
236610762$23661076$2$F$$20240312$20240322$20240806$EXP$$ZA-ROCHE-3527702$ROCHE$$40$YR$A$M$Y$$$20240806$$MD$ZA$ZA
236610774$23661077$4$F$20240201$20240729$20240322$20240731$EXP$$CO-Ipsen Biopharmaceuticals, Inc.-2024-04645$IPSEN$$36$YR$A$F$Y$83$KG$20240731$$CN$CO$CO
236611022$23661102$2$F$$20240912$20240322$20240918$EXP$$JP-BIOGEN-2024BI01255765$BIOGEN$$$$$F$Y$$$20240918$$MD$JP$JP
236611282$23661128$2$F$$20240627$20240322$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02317$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236611444$23661144$4$F$$20240919$20240322$20240930$EXP$$AU-ROCHE-3509980$ROCHE$$$$E$F$Y$$$20240930$$MD$AU$AU
236611574$23661157$4$F$20240314$20240729$20240322$20240731$EXP$$AU-TAKEDA-2024TUS025784$TAKEDA$$73$YR$$M$Y$$$20240731$$CN$AU$AU
236611582$23661158$2$F$$20240319$20240322$20240729$EXP$$NVSC2024CA060838$NOVARTIS$$$$$F$Y$$$20240729$$MD$CA$CA
236611722$23661172$2$F$$20240619$20240322$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02323$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236611745$23661174$5$F$20231206$20240822$20240322$20240904$EXP$$JP-AMGEN-JPNSP2024057289$AMGEN$$77$YR$E$F$Y$46$KG$20240904$$MD$JP$JP
236612242$23661224$2$F$20240319$20240725$20240322$20240729$PER$$US-AMGEN-USASP2024058142$AMGEN$$33$YR$A$M$Y$$$20240729$$CN$US$US
236612315$23661231$5$F$$20240829$20240322$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA030930$SANDOZ$$76$YR$$M$Y$105$KG$20240902$$HP$CA$CA
2366126512$23661265$12$F$20230701$20240916$20240322$20240920$EXP$$NVSC2024US057901$NOVARTIS$$30$YR$$M$Y$$$20240920$$CN$US$US
236613072$23661307$2$F$$20240627$20240322$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02396$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236613612$23661361$2$F$$20240619$20240322$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02296$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236614053$23661405$3$F$20220314$20240704$20240322$20240710$EXP$$UY-ABBVIE-5687115$ABBVIE$$61$YR$$F$Y$70$KG$20240710$$MD$UY$UY
236614423$23661442$3$F$20240318$20240705$20240322$20240709$EXP$$FR-ABBVIE-5687759$ABBVIE$$34$YR$$F$Y$57$KG$20240709$$MD$FR$FR
236614475$23661447$5$F$20240101$20240719$20240322$20240729$EXP$$BR-AMGEN-BRASL2024057450$AMGEN$$47$YR$A$M$Y$$$20240729$$CN$BR$BR
236614592$23661459$2$F$20240703$20240724$20240322$20240729$EXP$$BR-AstraZeneca-2024A066252$ASTRAZENECA$$31668$DY$$M$Y$61$KG$20240729$$CN$BR$
236614625$23661462$5$F$20240101$20240726$20240322$20240803$EXP$$CA-CELLTRION INC.-2024CA006863$CELLTRION$$$$$$Y$$$20240803$$PH$CA$CA
236614672$23661467$2$F$20240129$20240802$20240322$20240806$EXP$$US-ABBVIE-5686463$ABBVIE$$21$YR$$F$Y$$$20240806$$CN$US$US
236614692$23661469$2$F$$20240705$20240322$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045517$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$79.92$KG$20240709$$PH$US$US
236614922$23661492$2$F$$20240909$20240322$20240916$EXP$$JP-ASTELLAS-2024JP002015$ASTELLAS$Matsuura M, Kawashima I, Fujihara M, Inoue T, Hyuga H, Nakadate A, et al.. Veno-occlusive disease/sinusoidal obstruction syndrome (SOS/VOD) that appeared 10 years after allogeneic haematopoietic stem cell transplantation. The 46th Annual Meeting of the Japanese Society for Transplantation and Cellular 2024:O52-3.$38$YR$A$F$Y$$$20240916$$MD$JP$JP
236616022$23661602$2$F$20240101$20240815$20240322$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-005793$UNITED THERAPEUTICS$$$$$M$Y$$$20240823$$$US$US
236616086$23661608$6$F$20240409$20240911$20240322$20240918$EXP$$CA-TAKEDA-2024TUS011426$TAKEDA$$38$YR$$M$Y$$$20240918$$HP$CA$CA
236616412$23661641$2$F$$20240619$20240322$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02308$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236616433$23661643$3$F$$20240701$20240322$20240705$PER$$NVSC2024US060823$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
236616484$23661648$4$F$$20240828$20240322$20240830$30DAY$$GB-SANDOZ INC.-SDZ2024GB031093$SANDOZ$$$$$F$Y$$$20240830$$CN$GB$GB
236616563$23661656$3$F$20231107$20240819$20240322$20240821$EXP$$FR-TAKEDA-2024TUS026196$TAKEDA$$57$YR$$M$Y$76$KG$20240821$$HP$FR$FR
236616872$23661687$2$F$20240321$20240703$20240322$20240705$PER$$US-AMGEN-USASP2024059422$AMGEN$$58$YR$A$M$Y$$$20240705$$CN$US$US
236616942$23661694$2$F$20231105$20240708$20240322$20240722$EXP$FR-AFSSAPS-NT2024000168$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-104540$ZYDUS PHARM$$$$$$Y$$$20240722$$MD$FR$FR
236616994$23661699$4$F$20240215$20240827$20240322$20240830$EXP$$CA-TAKEDA-2021TUS062045$TAKEDA$$60$YR$$M$Y$$$20240830$$CN$CA$CA
236617052$23661705$2$F$20240318$20240819$20240322$20240821$PER$$US-AMGEN-USASP2024056752$AMGEN$$65$YR$E$M$Y$$$20240821$$CN$US$US
236617154$23661715$4$F$$20240725$20240322$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-045313$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240801$$MD$JP$JP
236617355$23661735$5$F$$20240906$20240322$20240916$30DAY$$US-GSK-US2024032357$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
236618103$23661810$3$F$20240302$20240827$20240322$20240916$PER$$CA-TOLMAR, INC.-24CA047417$TOLMAR$$54$YR$$M$Y$$$20240916$$HP$CA$CA
236618112$23661811$2$F$$20240624$20240322$20240715$PER$$CA-TOLMAR, INC.-24CA047426$TOLMAR$$$$$M$Y$$$20240715$$CN$CA$CA
236618594$23661859$4$F$20240413$20240626$20240322$20240709$EXP$$JP-INSMED, INC.-2024-01056-JP$INSMED$$79$YR$$M$Y$$$20240709$$PH$JP$JP
236618654$23661865$4$F$20240101$20240629$20240322$20240704$EXP$$US-ABBVIE-5685479$ABBVIE$$$$$M$Y$86.636$KG$20240704$$CN$US$US
236619234$23661923$4$F$20240320$20240906$20240322$20240909$PER$$US-AMGEN-USASP2024058251$AMGEN$$72$YR$E$F$Y$$$20240909$$CN$US$US
236619434$23661943$4$F$20240307$20240725$20240322$20240730$EXP$$US-TAKEDA-2024TUS023156$TAKEDA$$74$YR$$M$Y$$$20240730$$CN$US$US
236620802$23662080$2$F$20240322$20240718$20240322$20240725$EXP$$CA-TAKEDA-2024TUS025595$TAKEDA$$59$YR$$F$Y$$$20240725$$CN$CA$CA
236620972$23662097$2$F$20240301$20240704$20240322$20240712$EXP$GB-MHRA-EMIS-3984-acddb543-c910-4a4c-b39f-cd64ce95bafc$GB-MSNLABS-2024MSNSPO00604$MSN LABORATORIES$$$$$$Y$$$20240712$$MD$GB$GB
236621054$23662105$4$F$$20240902$20240322$20240904$EXP$$FR-ORGANON-1711FRA011680$ORGANON$Priez-Barallon C, Carlier J, Boyer B, Benslima M, Fanton L, Mazoyer C, et al.. Quantification of pregabalin using hydrophilic interaction HPLC-high-resolution MS in postmortem human samples: eighteen case reports.. Journal of Analytical Toxicology. 2014;38(3):143-8$39$YR$$M$Y$$$20240904$$HP$FR$FR
236621063$23662106$3$F$20240119$20240731$20240322$20240807$EXP$$JP-GENMAB-2024-00230AA$GENMAB$$75$YR$$M$Y$67.5$KG$20240807$$MD$JP$JP
236621152$23662115$2$F$20240801$20240821$20240322$20240823$EXP$$US-TAKEDA-2024TUS024435$TAKEDA$$26$YR$$M$Y$$$20240823$$PH$US$US
236621273$23662127$3$F$20230918$20240816$20240322$20240822$EXP$$DE-AMGEN-DEUNI2024055450$AMGEN$$61$YR$A$F$Y$89$KG$20240822$$MD$DE$DE
236621713$23662171$3$F$20240313$20240320$20240322$20240805$EXP$$NVSC2024US059780$NOVARTIS$$73$YR$$F$Y$166$KG$20240805$$HP$US$US
236621992$23662199$2$F$$20240722$20240322$20240725$EXP$$NVSJ2024JP003457$NOVARTIS$$$$$$Y$$$20240725$$MD$JP$JP
236622023$23662202$3$F$20231222$20240708$20240322$20240709$EXP$$NVSC2024DE059443$NOVARTIS$$$$A$F$Y$$$20240709$$HP$DE$DE
236622184$23662218$4$F$20230131$20240801$20240322$20240809$EXP$$JP-AstraZeneca-2024A066768$ASTRAZENECA$Nishida Y.. The key focus of intervention against neurofibromatosis type 1 by specialists in bone and soft-tissue tumors.. The 57th Annual Musculoskeletal Tumor Meeting of The Japanese Orthopaedic Association in Fukui. 2024;0-.$4747$DY$$M$Y$$$20240809$$MD$JP$
236622243$23662224$3$F$$20240708$20240322$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046251$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240714$$HP$US$US
236622332$23662233$2$F$$20240729$20240322$20240806$EXP$$US-APOTEX-2024AP003887$APOTEX$On S, Domingo W, Cheung E, Johnston L.. Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2024;30 (2):S163$$$A$$Y$$$20240806$$HP$US$US
236622364$23662236$4$F$$20240624$20240322$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000962$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
236623343$23662334$3$F$20240317$20240822$20240322$20240824$PER$$US-AMGEN-USASP2024056740$AMGEN$$56$YR$A$F$Y$$$20240824$$CN$US$US
236623383$23662338$3$F$20240101$20240814$20240322$20240819$EXP$$CA-UCBSA-2024013921$UCB$$$$$F$Y$$$20240819$$CN$CA$CA
236623842$23662384$2$F$20240429$20240626$20240322$20240702$EXP$$US-SA-2024SA090952$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240702$$MD$US$US
236623994$23662399$4$F$20240313$20240909$20240322$20240912$30DAY$$US-PFIZER INC-202400065137$PFIZER$$5$YR$$M$Y$$$20240912$$CN$US$US
2366241815$23662418$15$F$20240314$20240925$20240322$20240930$30DAY$$US-PFIZER INC-202400066561$PFIZER$$8$MON$$M$Y$8.96$KG$20240930$$MD$US$US
236624633$23662463$3$F$$20240619$20240322$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02295$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236624902$23662490$2$F$20240321$20240713$20240322$20240716$PER$$US-AMGEN-USASP2024059444$AMGEN$$61$YR$A$F$Y$$$20240716$$CN$US$US
236626062$23662606$2$F$$20240822$20240322$20240902$EXP$$CA-APOTEX-2024AP003589$APOTEX$$41$YR$$F$Y$$$20240902$$CN$CA$CA
236626073$23662607$3$F$$20240805$20240322$20240808$30DAY$$US-PFIZER INC-202400055174$PFIZER$$$$$$Y$$$20240808$$CN$US$US
236626323$23662632$3$F$$20240831$20240322$20240906$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000574$BLUEPRINT MEDICINES$$$$$M$Y$$$20240906$$CN$US$US
2366263611$23662636$11$F$$20240912$20240322$20240916$30DAY$$US-PFIZER INC-202400056759$PFIZER$$11$YR$$F$Y$27.22$KG$20240916$$CN$US$US
236626603$23662660$3$F$20240101$20240701$20240322$20240711$EXP$$US-BIOCODEX2-2024000096$BIOCODEX$$16$YR$$F$Y$55$KG$20240708$$MD$US$US
2366273610$23662736$10$F$20240301$20240912$20240322$20240916$30DAY$$US-PFIZER INC-202400056831$PFIZER$$11$YR$$F$Y$27.22$KG$20240916$$CN$US$US
236627412$23662741$2$F$20231112$20240313$20240322$20240723$EXP$$BR-TEVA-VS-3171996$TEVA$$50$YR$$F$Y$61$KG$20240723$$PH$BR$BR
236627553$23662755$3$F$$20240909$20240322$20240911$EXP$$US-PFIZER INC-PV202400037533$PFIZER$Suffian, H.. COMPLICATIONS POST-CHEMOTHERAPY IN A CHILD WITH T-CELL LEUKEMIA AND ATAXIA TELANGIECTASIA. Annals of Allergy, Asthma and Immunology. 2023;131(5 Supple 1):S156$4$YR$$M$Y$$$20240911$$HP$US$US
236627743$23662774$3$F$20240320$20240627$20240322$20240702$PER$$US-AMGEN-USASP2024059430$AMGEN$$75$YR$E$M$Y$$$20240702$$CN$US$US
236628642$23662864$2$F$20240311$20240724$20240322$20240816$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000163$BECTON DICKINSON$$$$$$Y$$$20240816$$CN$GB$GB
236628652$23662865$2$F$20240311$20240724$20240322$20240816$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000165$BECTON DICKINSON$$$$$$Y$$$20240816$$CN$GB$GB
236628662$23662866$2$F$20240313$20240909$20240322$20240924$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000166$BECTON DICKINSON$$$$$$Y$$$20240924$$CN$GB$GB
236628682$23662868$2$F$20240311$20240724$20240322$20240816$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000162$BECTON DICKINSON$$$$$$Y$$$20240816$$CN$GB$GB
236628832$23662883$2$F$$20240709$20240322$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-437465$RANBAXY$Stover KR, Jordan TE, Wagner JL, Barber KE. High-dose amphotericin: yay or nay? A case series and literature review. Drugs Cont. 2024;13$$$$$Y$$$20240724$$HP$US$US
236629112$23662911$2$F$$20240722$20240322$20240806$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-438020$RANBAXY$$62$YR$$M$Y$$$20240806$$MD$DE$DE
236629223$23662922$3$F$$20240715$20240322$20240720$EXP$$NVSC2024CA055857$NOVARTIS$$43$YR$$F$Y$96$KG$20240719$$HP$CA$CA
236629506$23662950$6$F$20240201$20240801$20240322$20240805$30DAY$$GR-PFIZER INC-PV202400029356$PFIZER$$9$YR$$F$Y$26$KG$20240805$$HP$GR$GR
236629622$23662962$2$F$$20240612$20240322$20240703$EXP$$CA-TEVA-VS-3172941$TEVA$$40$YR$$F$Y$96$KG$20240703$$HP$CA$CA
236629895$23662989$5$F$$20240911$20240322$20240918$30DAY$$US-PFIZER INC-202400057449$PFIZER$$9$YR$$M$Y$30.84$KG$20240918$$HP$US$US
236630053$23663005$3$F$20240201$20240918$20240322$20240924$EXP$$US-INCYTE CORPORATION-2024IN003072$INCYTE$$$$$$Y$$$20240924$$CN$US$US
236630285$23663028$5$F$20240301$20240701$20240322$20240705$EXP$$NVSC2024DE059717$NOVARTIS$$$$E$F$Y$65$KG$20240705$$PH$DE$DE
236630764$23663076$4$F$20230101$20240729$20240322$20240809$EXP$$JP-ROCHE-3529082$ROCHE$$51$YR$A$F$Y$$$20240809$$PH$JP$JP
236630793$23663079$3$F$$20240704$20240322$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042816$BRISTOL MYERS SQUIBB$Komatsu S, Horimoto K, Kato J, Sato S, Kobayashi E, Matsuda I, et al. Disseminated intravascular coagulation induced by the combination therapy of encorafenib and binimetinib in a melanoma case. The Journal of Dermatology. 2024 Jan 31;51(6):e218-9. doi:10.1111/1346-8138.17124.$51$YR$A$M$Y$$$20240710$$MD$JP$JP
236630885$23663088$5$F$20240218$20240814$20240322$20240821$EXP$$DE-EMD Serono-2024015406$EMD SERONO INC$$50$YR$A$F$Y$$$20240821$$MD$DE$DE
236631543$23663154$3$F$20230101$20240725$20240322$20240803$EXP$$US-UNITED THERAPEUTICS-UNT-2023-029107$UNITED THERAPEUTICS$$$$$F$Y$97.506$KG$20240803$$$US$US
236631812$23663181$2$F$$20240715$20240322$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046316$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240717$$CN$US$US
236631922$23663192$2$F$20240130$20240909$20240322$20240912$EXP$IT-MINISAL02-975556$IT-RDY-SPO/ITA/24/0004569$DR REDDYS$$76$YR$E$M$Y$$$20240912$$MD$IT$IT
236631996$23663199$6$F$$20240821$20240322$20240903$30DAY$$US-PFIZER INC-202400056893$PFIZER$$14$YR$$M$Y$45.36$KG$20240903$$HP$US$US
236632029$23663202$9$F$$20240913$20240322$20240918$30DAY$$US-PFIZER INC-PV202400030538$PFIZER$$15$YR$$M$Y$$$20240918$$CN$US$US
236632072$23663207$2$F$$20240717$20240322$20240725$EXP$$CA-APOTEX-2024AP003700$APOTEX$$19$YR$$M$Y$98$KG$20240725$$HP$CA$CA
236632305$23663230$5$F$$20240903$20240322$20240906$EXP$$CA-TAKEDA-2024TUS026223$TAKEDA$$$$$F$Y$112.7$KG$20240906$$CN$CA$CA
236632314$23663231$4$F$20240220$20240712$20240322$20240718$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005466$AURINIA PHARMACEUTICALS$$66$YR$$F$Y$$$20240718$$CN$US$US
236632444$23663244$4$F$20240315$20240801$20240322$20240806$PER$$NVSC2024US059621$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
236632906$23663290$6$F$$20240802$20240322$20240807$EXP$$CA-TAKEDA-2024TUS026315$TAKEDA$$$$$M$Y$$$20240807$$MD$CA$CA
236633292$23663329$2$F$$20240718$20240322$20240731$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-02449$HIKMA$$$$$F$Y$$$20240731$$CN$US$US
236633515$23663351$5$F$20240101$20240827$20240322$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046375$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240829$$CN$US$US
236633785$23663378$5$F$20240101$20240802$20240322$20240807$EXP$$US-ABBVIE-5679176$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
236633812$23663381$2$F$$20240705$20240322$20240705$PER$$US-ALXN-202403USA001222US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240705$$PH$US$US
236634122$23663412$2$F$20231023$20240801$20240322$20240809$PER$$US-SA-2024SA085874$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240809$$MD$US$US
236634392$23663439$2$F$20240307$20240827$20240322$20240909$PER$$US-SA-2023SA263008$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240909$$MD$US$US
236634493$23663449$3$F$20240101$20240626$20240322$20240705$PER$$US-SA-2024SA086008$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240705$$MD$US$US
236634502$23663450$2$F$20240625$20240801$20240322$20240810$PER$$US-SA-2024SA079785$SANOFI AVENTIS$$64$YR$A$F$Y$61.224$KG$20240810$$MD$US$US
236634892$23663489$2$F$$20240910$20240322$20240918$PER$$US-SA-2024SA087362$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240918$$MD$US$US
236634944$23663494$4$F$20240101$20240801$20240322$20240807$EXP$$US-ABBVIE-5624468$ABBVIE$$$$$M$Y$110.67$KG$20240807$$CN$US$US
2366349917$23663499$17$F$$20240903$20240322$20240906$EXP$$GB-Orion Corporation ORION PHARMA-23_00026340$ORION$$$$$M$Y$$$20240906$$MD$GB$
236635062$23663506$2$F$20240303$20240628$20240322$20240709$PER$$US-SA-2024SA090231$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240709$$MD$US$US
236635182$23663518$2$F$20240101$20240724$20240322$20240802$PER$$US-SA-2024SA090506$SANOFI AVENTIS$$61$YR$A$M$Y$62$KG$20240802$$MD$US$US
236635272$23663527$2$F$$20240816$20240322$20240830$PER$$US-SA-2024SA088734$SANOFI AVENTIS$$$$A$F$Y$$$20240830$$MD$US$US
236635403$23663540$3$F$20240901$20240916$20240322$20240930$PER$$US-SA-2024SA089494$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240930$$CN$US$US
236635503$23663550$3$F$20240101$20240708$20240322$20240716$PER$$US-SA-2024SA090682$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240716$$CN$US$US
236635554$23663555$4$F$$20240718$20240322$20240725$PER$$US-SA-2024SA090072$SANOFI AVENTIS$$95$YR$E$F$Y$$$20240725$$MD$US$US
236635694$23663569$4$F$20240316$20240726$20240322$20240805$PER$$US-SA-2024SA090516$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240805$$MD$US$US
236635882$23663588$2$F$20240719$20240806$20240322$20240813$PER$$US-SA-2024SA090531$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240814$$MD$US$US
236636053$23663605$3$F$20240101$20240809$20240322$20240819$PER$$US-SA-2024SA089659$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240819$$MD$US$US
236636682$23663668$2$F$$20240318$20240322$20240801$EXP$$BR-GSK-BR2024AMR035725$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$MD$BR$BR
236636722$23663672$2$F$$20240715$20240322$20240717$EXP$$CA-BAUSCH-BL-2024-004482$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240717$$HP$CA$CA
236636953$23663695$3$F$20230101$20240924$20240322$20240927$EXP$$CH-PFIZER INC-PV202400037399$PFIZER$$60$YR$$F$Y$$$20240927$$MD$CH$CH
236636963$23663696$3$F$$20240905$20240322$20240909$30DAY$$US-PFIZER INC-PV202400030557$PFIZER$$75$YR$$$Y$$$20240909$$CN$US$US
236636983$23663698$3$F$20231215$20240812$20240322$20240815$EXP$LU-ALMPS-202404211$LU-PFIZER INC-202400067519$PFIZER$$83$YR$$F$Y$69$KG$20240815$$PH$LU$LU
236637092$23663709$2$F$20240215$20240829$20240322$20240904$EXP$$FR-PFIZER INC-202400070012$PFIZER$$70$YR$$M$Y$81$KG$20240904$$MD$FR$FR
236637463$23663746$3$F$$20240812$20240322$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045135$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240821$$CN$US$US
236637485$23663748$5$F$$20240723$20240322$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045957$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240725$$CN$US$US
236637592$23663759$2$F$$20240726$20240322$20240729$PER$$NVSC2024US060808$NOVARTIS$$$$$$Y$$$20240729$$CN$US$US
236637634$23663763$4$F$20230914$20240730$20240322$20240805$EXP$$CA-PFIZER INC-202300303496$PFIZER$$72$YR$$M$Y$98$KG$20240805$$HP$CA$CA
236637645$23663764$5$F$20230904$20240624$20240322$20240709$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2024FOS000340$RIGEL PHARMACEUTICALS$Nagano T. et al. A case of idiopathic thrombocytopenic purpura successfully treated with fostamatinib disodium and thrombopoietin receptor agonist [in Japanese]. 2024 Mar 16-:25-$84$YR$$M$Y$43$KG$20240709$$MD$JP$JP
236638043$23663804$3$F$20240314$20240709$20240322$20240717$EXP$$US-TAKEDA-2024TUS026408$TAKEDA$$44$YR$$F$Y$$$20240717$$MD$US$US
236638092$23663809$2$F$20240309$20240315$20240322$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000081$THERATECHNOLOGIES$$$$$$Y$$$20240909$$MD$US$US
236638224$23663822$4$F$20240208$20240717$20240322$20240722$EXP$GB-MHRA-MED-202403181618414590-SLYNJ$GB-GILEAD-2024-0666632$GILEAD$$53$YR$A$M$Y$81$KG$20240719$$MD$GB$GB
236638462$23663846$2$F$20240310$20240729$20240322$20240731$EXP$$US-BAYER-2024A039878$BAYER$$7$YR$C$M$Y$$$20240731$$CN$US$US
236638613$23663861$3$F$20140101$20240719$20240322$20240726$EXP$$BR-ABBVIE-5687686$ABBVIE$$$$$M$Y$98$KG$20240726$$CN$BR$BR
236638633$23663863$3$F$20240301$20240712$20240322$20240715$PER$$US-AMGEN-USASP2024059530$AMGEN$$72$YR$E$F$Y$$$20240715$$CN$US$US
236638744$23663874$4$F$20211224$20240710$20240322$20240718$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-00130$IPSEN$$66$YR$E$M$Y$68$KG$20240718$$CN$CA$CA
236638785$23663878$5$F$20240416$20240904$20240322$20240906$EXP$$CA-TAKEDA-2024TUS025777$TAKEDA$$51$YR$$M$Y$$$20240906$$HP$CA$CA
236638832$23663883$2$F$$20240702$20240322$20240705$EXP$$JP-OTSUKA-2024_007428$OTSUKA$Ito S, Saito A, Sakurai A, Watanabe K, Karakawa S, Miyamura T, et al.. Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance. Bone Marrow Transplantation. 2024;59(3):315-24$6$YR$$M$Y$$$20240705$$MD$JP$JP
236640122$23664012$2$F$20240121$20240320$20240322$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240060$IRONSHORE PHARMA$$7$YR$C$M$Y$16.798$KG$20240801$$MD$US$US
236640442$23664044$2$F$20231202$20240718$20240322$20240725$EXP$$CA-OTSUKA-2023_021613$OTSUKA$$44$YR$$M$Y$$$20240725$$CN$CA$CA
236640586$23664058$6$F$20240605$20240829$20240322$20240903$EXP$$US-TAKEDA-2024TUS024362$TAKEDA$$61$YR$$F$Y$78$KG$20240903$$CN$US$US
236640614$23664061$4$F$20240614$20240724$20240322$20240731$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000577$BLUEPRINT MEDICINES$$72$YR$E$M$Y$$$20240731$$CN$US$US
236640822$23664082$2$F$20240321$20240730$20240322$20240801$PER$$US-AMGEN-USASP2024059451$AMGEN$$60$YR$A$F$Y$$$20240801$$CN$US$US
236641132$23664113$2$F$$20240701$20240322$20240705$EXP$$NVSC2024US056257$NOVARTIS$$$$$M$Y$$$20240705$$CN$US$US
236641223$23664122$3$F$20231201$20240731$20240322$20240805$EXP$$JP-Taiho Oncology Inc-2024-000413$TAIHO ONCOLOGY INC$$52$YR$A$F$Y$51$KG$20240805$$MD$JP$JP
236641242$23664124$2$F$$20240909$20240322$20240917$EXP$$BR-TAKEDA-2021TUS011968$TAKEDA$$$$$F$Y$$$20240917$$CN$BR$BR
236641872$23664187$2$F$20240301$20240703$20240322$20240705$PER$$US-AMGEN-USASP2024058087$AMGEN$$78$YR$E$F$Y$$$20240705$$PH$US$US
236642204$23664220$4$F$20240101$20240806$20240322$20240808$EXP$$CA-JNJFOC-20240280401$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240808$$HP$CA$CA
236642223$23664222$3$F$20230101$20240730$20240322$20240807$EXP$$JP-ALXN-A202306709AA$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$MD$JP$JP
236642453$23664245$3$F$20230901$20240805$20240322$20240812$EXP$$FR-JAZZ PHARMACEUTICALS-2024-FR-004830$JAZZ$$$$$$Y$$$20240812$$PH$FR$FR
236642706$23664270$6$F$20240319$20240904$20240322$20240905$PER$$US-AMGEN-USASP2024059527$AMGEN$$61$YR$A$M$Y$$$20240905$$HP$US$US
236642832$23664283$2$F$$20240625$20240322$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-046227$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240702$$MD$JP$JP
236642842$23664284$2$F$$20240619$20240322$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02298$LUPIN$$$$$$Y$$$20240702$$CN$US$US
236643323$23664332$3$F$$20240627$20240322$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02390$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236643793$23664379$3$F$$20240722$20240322$20240724$EXP$$US-ROCHE-3527904$ROCHE$$$$E$F$Y$$$20240724$$CN$US$US
236643882$23664388$2$F$$20240619$20240322$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02410$LUPIN$$$$$$Y$$$20240701$$CN$US$US
236645403$23664540$3$F$20240101$20240820$20240322$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046302$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240821$$HP$US$US
236646353$23664635$3$F$$20240830$20240322$20240904$PER$$US-VERTEX PHARMACEUTICALS-2024-004855$VERTEX$$$$$$Y$$$20240904$$CN$US$US
236646904$23664690$4$F$$20240806$20240322$20240809$EXP$$NVSC2024US062830$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
236647123$23664712$3$F$20120719$20240627$20240322$20240701$EXP$$US-PFIZER INC-PV202400026963$PFIZER$$36$YR$$F$Y$81.633$KG$20240701$$CN$US$US
236647342$23664734$2$F$$20240715$20240322$20240723$EXP$$CA-PFIZER INC-202400069433$PFIZER$$77$YR$$F$Y$$$20240723$$CN$CA$CA
236647463$23664746$3$F$$20240710$20240322$20240712$EXP$$VE-PFIZER INC-PV202400038686$PFIZER$$56$YR$$F$Y$$$20240712$$MD$VE$VE
236647612$23664761$2$F$20240311$20240731$20240322$20240805$EXP$$CL-PFIZER INC-PV202400039246$PFIZER$$51$YR$$M$Y$$$20240805$$CN$CL$CL
236647832$23664783$2$F$$20240906$20240322$20240913$EXP$$US-GILEAD-2024-0666751$GILEAD$$74$YR$E$M$Y$$$20240913$$MD$US$US
236648132$23664813$2$F$$20240819$20240322$20240821$EXP$$CA-BAUSCH-BL-2024-004528$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240821$$CN$CA$CA
236648302$23664830$2$F$$20240806$20240322$20240808$EXP$$NVSC2024US059345$NOVARTIS$$$$$M$Y$$$20240808$$CN$US$US
236648623$23664862$3$F$20231120$20240530$20240322$20240705$PER$$US-Eisai-EC-2024-159659$EISAI$$87$YR$E$F$Y$50.9$KG$20240705$$CN$US$US
236648637$23664863$7$F$20240201$20240725$20240322$20240731$PER$$US-Eisai-EC-2024-160314$EISAI$$62$YR$A$F$Y$108.6$KG$20240731$$CN$US$US
236648772$23664877$2$F$20240801$20240923$20240322$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046084$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240925$$CN$US$US
236648863$23664886$3$F$$20240625$20240322$20240708$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-07821$SAMSUNG BIOEPIS$$$$$F$Y$$$20240708$$HP$CA$CA
236649342$23664934$2$F$20240101$20240814$20240322$20240816$PER$$US-PFIZER INC-202400069843$PFIZER$$78$YR$$M$Y$$$20240816$$HP$US$US
236649602$23664960$2$F$$20240910$20240322$20240912$PER$$US-PFIZER INC-202400069388$PFIZER$$57$YR$$M$Y$86.18$KG$20240912$$CN$US$US
236649694$23664969$4$F$20220101$20240904$20240322$20240910$EXP$$DE-ROCHE-3261398$ROCHE$$40$YR$A$F$Y$$$20240911$$CN$DE$DE
236649732$23664973$2$F$$20240820$20240322$20240822$EXP$$NVSC2024CA055216$NOVARTIS$$41$YR$$F$Y$$$20240822$$CN$CA$CA
236649916$23664991$6$F$$20240627$20240322$20240702$30DAY$$US-SANDOZ INC.-SDZ2024US030993$SANDOZ$$$$$F$Y$$$20240702$$HP$US$US
236649992$23664999$2$F$$20240715$20240322$20240722$EXP$$NVSC2024CA054833$NOVARTIS$$97$YR$$F$Y$81$KG$20240722$$CN$CA$CA
236650062$23665006$2$F$20230626$20240627$20240322$20240709$EXP$$US-GSK-US2023AMR103880$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$HP$US$US
236650083$23665008$3$F$$20240822$20240322$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046786$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$63.5$KG$20240824$$CN$US$US
236650352$23665035$2$F$$20240315$20240322$20240719$EXP$$CA-AstraZeneca-2020SF27766$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$CA$
236650382$23665038$2$F$$20240701$20240322$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US031135$SANDOZ$$$$$M$Y$$$20240703$$CN$US$US
236650794$23665079$4$F$20240312$20240829$20240322$20240903$EXP$$CA-FERRINGPH-2024FE01259$FERRING$$$$$$Y$$$20240903$$HP$CA$CA
236650972$23665097$2$F$$20240821$20240322$20240826$PER$$US-PFIZER INC-202400069856$PFIZER$$61$YR$$F$Y$$$20240826$$MD$US$US
236650992$23665099$2$F$$20240919$20240322$20240923$PER$$US-PFIZER INC-PV202400038930$PFIZER$$61$YR$$F$Y$$$20240923$$HP$US$US
236651094$23665109$4$F$$20240702$20240322$20240710$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000581$BLUEPRINT MEDICINES$$$$$F$Y$$$20240710$$CN$US$US
236651243$23665124$3$F$$20240521$20240322$20240710$PER$$US-LUNDBECK-DKLU3075240$LUNDBECK$$$$$$Y$$$20240710$$CN$US$US
236651252$23665125$2$F$$20240716$20240322$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045618$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240719$$CN$US$US
236651882$23665188$2$F$$20240627$20240322$20240702$EXP$$JP-009507513-2403JPN002162J$MERCK$$81$YR$$F$Y$$$20240702$$MD$JP$JP
236652002$23665200$2$F$$20240803$20240322$20240807$PER$$NVSC2024US063082$NOVARTIS$$$$$$Y$$$20240807$$CN$US$US
236652114$23665211$4$F$$20240823$20240322$20240904$EXP$$US-BEH-2024170153$CSL BEHRING$$44$YR$A$F$Y$129.71$KG$20240904$$CN$US$US
236652283$23665228$3$F$$20240823$20240322$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000605$BLUEPRINT MEDICINES$$$$$F$Y$$$20240830$$CN$US$US
236652514$23665251$4$F$$20240708$20240322$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004886$JAZZ$$$$$F$Y$$$20240710$$HP$US$US
236652564$23665256$4$F$20240301$20240717$20240322$20240725$EXP$$CA-AstraZeneca-2024A063118$ASTRAZENECA$$657$MON$$F$Y$$$20240725$$MD$CA$
236652612$23665261$2$F$$20240807$20240322$20240812$EXP$$US-TAKEDA-2024TUS008535$TAKEDA$$$$$F$Y$$$20240812$$CN$US$US
236653052$23665305$2$F$$20240313$20240322$20240925$PER$$US-GSK-US2024AMR033887$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
236653182$23665318$2$F$20231130$20240826$20240322$20240830$EXP$$US-ABBVIE-5685243$ABBVIE$$70$YR$$M$Y$$$20240829$$CN$US$US
236653233$23665323$3$F$20240208$20240703$20240322$20240706$EXP$$AR-ABBVIE-5644411$ABBVIE$$42$YR$$F$Y$$$20240706$$CN$AR$AR
236653517$23665351$7$F$20230712$20240418$20240322$20240718$EXP$$US-ABBVIE-5681019$ABBVIE$$73$YR$$F$Y$69.853$KG$20240718$$CN$US$US
236653712$23665371$2$F$20240101$20240710$20240322$20240718$PER$$US-SA-2024SA090653$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240718$$MD$US$US
236654055$23665405$5$F$20221220$20240911$20240323$20240919$EXP$$CA-CELLTRION INC.-2023CA024594$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
236654072$23665407$2$F$20240224$20240805$20240323$20240808$EXP$$CO-ABBVIE-5663785$ABBVIE$$75$YR$$F$Y$45$KG$20240808$$HP$CO$CO
236654135$23665413$5$F$20240101$20240905$20240323$20240911$EXP$$US-ABBVIE-5677805$ABBVIE$$$$$F$Y$84$KG$20240911$$CN$US$US
236654182$23665418$2$F$$20240711$20240323$20240718$EXP$$CA-APOTEX-2024AP003562$APOTEX$$45$YR$$F$Y$$$20240718$$HP$CA$CA
236654272$23665427$2$F$$20240710$20240323$20240715$EXP$$US-JNJFOC-20240360166$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
236654332$23665433$2$F$$20240110$20240323$20240723$EXP$$US-TEVA-VS-3143417$TEVA$$75$YR$$M$Y$$$20240723$$CN$US$US
236654592$23665459$2$F$$20240202$20240323$20240711$EXP$$US-TEVA-VS-3152620$TEVA$$27$YR$$F$Y$$$20240711$$CN$US$US
236654636$23665463$6$F$20240101$20240712$20240323$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-004583$UNITED THERAPEUTICS$$$$$F$Y$$$20240719$$$US$US
236655229$23665522$9$F$20240401$20240726$20240323$20240803$EXP$$IE-ABBVIE-5689982$ABBVIE$$50$YR$$M$Y$$$20240803$$CN$IE$IE
236655473$23665547$3$F$20231231$20240702$20240323$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-003855$JAZZ$$8$YR$$F$Y$$$20240710$$CN$US$US
236655494$23665549$4$F$20240301$20240728$20240323$20240730$PER$$US-AMGEN-USASP2024058807$AMGEN$$71$YR$E$F$Y$$$20240730$$CN$US$US
236655972$23665597$2$F$20240321$20240819$20240323$20240821$PER$$US-AMGEN-USASP2024060021$AMGEN$$50$YR$A$F$Y$$$20240821$$CN$US$US
236656214$23665621$4$F$20231027$20240802$20240323$20240810$EXP$$CA-CELLTRION INC.-2023CA021442$CELLTRION$$$$$$Y$$$20240810$$HP$CA$CA
236656472$23665647$2$F$$20240829$20240323$20240906$EXP$$CA-TEVA-VS-3173370$TEVA$$26$YR$$M$Y$$$20240906$$HP$CA$CA
236656878$23665687$8$F$20180524$20240807$20240323$20240815$EXP$$CA-CELLTRION INC.-2021CA013577$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
236656895$23665689$5$F$20240101$20240708$20240323$20240716$EXP$$CA-CELLTRION INC.-2024CA006563$CELLTRION$$$$$$Y$$$20240716$$MD$CA$CA
236657023$23665702$3$F$20240101$20240911$20240323$20240919$EXP$$CA-CELLTRION INC.-2024CA007112$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
236657124$23665712$4$F$20240610$20240611$20240323$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000989$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240705$$CN$US$US
236657332$23665733$2$F$20231216$20240708$20240323$20240716$EXP$$CA-CELLTRION INC.-2023CA022400$CELLTRION$$$$$$Y$$$20240716$$MD$CA$CA
236657624$23665762$4$F$20240101$20240718$20240323$20240722$EXP$$US-UCBSA-2024013233$UCB$$$$$F$Y$$$20240719$$CN$US$US
236657695$23665769$5$F$20240318$20240725$20240323$20240821$PER$$US-AstraZeneca-2024A058717$ASTRAZENECA$$19381$DY$$F$Y$88$KG$20240821$$HP$US$
236657805$23665780$5$F$20240508$20240722$20240323$20240726$EXP$$CA-UCBSA-2024011670$UCB$$39$YR$$M$Y$$$20240726$$CN$CA$CA
236657818$23665781$8$F$20240122$20240829$20240323$20240904$EXP$$JP-ABBVIE-5689111$ABBVIE$$66$YR$$M$Y$78$KG$20240904$$MD$JP$JP
236658672$23665867$2$F$$20240828$20240323$20240903$EXP$$CA-JNJFOC-20240360937$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$HP$CA$CA
236658803$23665880$3$F$20240312$20240713$20240323$20240716$PER$$US-AMGEN-USASP2024059832$AMGEN$$79$YR$E$F$Y$$$20240716$$CN$US$US
236659082$23665908$2$F$$20240318$20240323$20240808$EXP$$NVSC2024US033977$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
236659422$23665942$2$F$20240316$20240702$20240323$20240703$PER$$US-AMGEN-USASP2024059427$AMGEN$$68$YR$E$M$Y$$$20240703$$CN$US$US
236659523$23665952$3$F$$20240627$20240323$20240701$PER$$NVSC2024US062626$NOVARTIS$$$$$M$Y$$$20240701$$CN$US$US
236659552$23665955$2$F$20240321$20240718$20240323$20240723$PER$$US-AMGEN-USASP2024060087$AMGEN$$76$YR$E$F$Y$$$20240722$$CN$US$US
236659722$23665972$2$F$20230118$20240709$20240323$20240720$EXP$$GB-TEVA-VS-3173831$TEVA$$82$YR$$M$Y$72$KG$20240720$$MD$GB$GB
236660492$23666049$2$F$20240301$20240912$20240323$20240919$PER$$US-SA-2024SA090119$SANOFI AVENTIS$$60$YR$A$M$Y$113$KG$20240919$$MD$US$US
236660573$23666057$3$F$$20240726$20240323$20240806$EXP$$NVSC2016CA007899$NOVARTIS$$65$YR$$F$Y$$$20240806$$CN$CA$CA
236660642$23666064$2$F$20240321$20240903$20240323$20240906$PER$$US-AMGEN-USASP2024059621$AMGEN$$76$YR$E$M$Y$$$20240906$$CN$US$US
236660733$23666073$3$F$20240317$20240805$20240323$20240808$PER$$US-AMGEN-USASP2024060091$AMGEN$$67$YR$E$M$Y$$$20240807$$CN$US$US
236660813$23666081$3$F$20240206$20240708$20240323$20240722$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-08205$SAMSUNG BIOEPIS$$29$YR$A$M$Y$80$KG$20240722$$CN$CA$CA
236660856$23666085$6$F$$20240909$20240323$20240911$EXP$$US-GSK-US2024AMR034725$GLAXOSMITHKLINE$$$$$F$Y$59.864$KG$20240911$$HP$US$US
236661704$23666170$4$F$20240301$20240725$20240324$20240806$EXP$$DE-AUROBINDO-AUR-APL-2024-012478$AUROBINDO$$82$YR$$F$Y$$$20240806$$MD$DE$DE
236662442$23666244$2$F$20240307$20240506$20240324$20240731$PER$$US-AstraZeneca-2024A057446$ASTRAZENECA$$27483$DY$$$Y$$$20240731$$CN$US$
236662463$23666246$3$F$20240101$20240730$20240324$20240807$PER$$US-SA-2024SA088120$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240807$$MD$US$US
236662512$23666251$2$F$20240306$20240813$20240324$20240822$30DAY$$US-GSK-US2024033456$GLAXOSMITHKLINE$$79$YR$$F$Y$$$20240822$$CN$US$US
236662542$23666254$2$F$$20240703$20240324$20240712$PER$$US-SA-2024SA088135$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240712$$MD$US$US
236663002$23666300$2$F$20230301$20240305$20240324$20240704$EXP$SE-SEMPA-2023-010705$SE-TEVA-VS-3168779$TEVA$$25$YR$$F$Y$62$KG$20240704$$CN$SE$SE
236663692$23666369$2$F$20240214$20240822$20240324$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-012142$AUROBINDO$$78$YR$$F$Y$82$KG$20240902$$MD$FR$FR
236664003$23666400$3$F$$20240514$20240324$20240725$PER$$US-AstraZeneca-2024A064939$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$US$
236664313$23666431$3$F$$20240410$20240324$20240809$EXP$$NVSC2024IL051426$NOVARTIS$$67$YR$$F$Y$$$20240809$$HP$IL$IL
236664326$23666432$6$F$20201001$20240806$20240324$20240813$EXP$$US-GSK-US2020TSO008097$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
236664443$23666444$3$F$$20240801$20240324$20240809$30DAY$$US-GSK-US2024034458$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
236664473$23666447$3$F$$20240816$20240324$20240826$EXP$FR-GERMAN-LIT/FRA/24/0004597$FR-RDY-LIT/FRA/24/0004597$DR REDDYS$Darres A, Bello AD, Marion O, Lamballerie Xd, Malvy D, Izopet J, et al. Failure of favipiravir to treat chronic norovirus infection in a kidney-transplant patient. Transplant Infectious Disease. 2024 Feb;1(26): 1-2. doi:https://dx.doi.org/10.1111/tid.14235.$64$YR$A$M$Y$$$20240826$$HP$FR$FR
236664542$23666454$2$F$20240320$20240729$20240324$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202403012672$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240802$$CN$US$US
236664772$23666477$2$F$20240205$20240229$20240324$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240042$IRONSHORE PHARMA$$13$YR$T$F$Y$$$20240801$$HP$US$US
236665316$23666531$6$F$20240301$20240909$20240324$20240918$EXP$$US-BEH-2024169822$CSL BEHRING$$62$YR$A$F$Y$$$20240918$$CN$US$US
236665382$23666538$2$F$20230706$20240628$20240324$20240704$PER$$US-JNJFOC-20240324658$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240705$$MD$US$US
236665523$23666552$3$F$$20240709$20240324$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-045384$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240710$$MD$JP$JP
236665584$23666558$4$F$20240301$20240625$20240324$20240702$EXP$$US-SA-2024SA091769$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240702$$CN$US$US
236665783$23666578$3$F$20240319$20240705$20240324$20240709$EXP$$US-ABBVIE-5687889$ABBVIE$$53$YR$$M$Y$$$20240709$$CN$US$US
236665923$23666592$3$F$$20240917$20240324$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044369$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240918$$CN$US$US
236665952$23666595$2$F$20240318$20240909$20240324$20240924$PER$$US-SA-2024SA089916$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240924$$PH$US$US
236665992$23666599$2$F$$20240619$20240324$20240704$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-046663$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240704$$CN$CA$CA
236666193$23666619$3$F$$20240903$20240324$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045335$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$36.29$KG$20240906$$CN$US$US
236666363$23666636$3$F$20240101$20240829$20240325$20240905$EXP$$CA-JNJFOC-20240350652$JOHNSON AND JOHNSON$$62$YR$A$F$Y$55$KG$20240905$$HP$CA$CA
236666474$23666647$4$F$20240201$20240610$20240325$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000986$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240705$$CN$US$US
236666553$23666655$3$F$20240111$20240725$20240325$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-013244$AUROBINDO$$93$YR$$F$Y$54.8$KG$20240805$$PH$FR$FR
236666743$23666674$3$F$$20240628$20240325$20240702$30DAY$$US-SANDOZ INC.-SDZ2024US031068$SANDOZ$$$$$M$Y$$$20240702$$CN$US$US
236666752$23666675$2$F$$20240628$20240325$20240702$30DAY$$US-SANDOZ INC.-SDZ2024US031082$SANDOZ$$$$$F$Y$$$20240702$$CN$US$US
236667094$23666709$4$F$20240501$20240621$20240325$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001030$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240716$$CN$US$US
236667467$23666746$7$F$20240101$20240730$20240325$20240801$EXP$$JP-TAKEDA-2024TJP004299$TAKEDA$$9$YR$$M$Y$$$20240801$$MD$JP$JP
236667843$23666784$3$F$$20240718$20240325$20240725$PER$$US-ALXN-A202313265$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
236667873$23666787$3$F$$20240822$20240325$20240912$EXP$$DE-SA-2024SA091256$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240912$$MD$DE$DE
236667933$23666793$3$F$20240101$20240805$20240325$20240810$PER$$US-SA-2024SA088690$SANOFI AVENTIS$$$$C$M$Y$$$20240810$$MD$US$US
236668082$23666808$2$F$20230101$20240812$20240325$20240816$EXP$$CA-UCBSA-2023058836$UCB$$$$$F$Y$$$20240816$$CN$CA$CA
236668295$23666829$5$F$20240227$20240821$20240325$20240828$EXP$$CA-CELLTRION INC.-2024CA006108$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
236668572$23666857$2$F$20220101$20240801$20240325$20240807$EXP$$KR-JNJFOC-20220436532$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240808$$CN$KR$KR
236668973$23666897$3$F$20240206$20240918$20240325$20240926$EXP$$DE-JNJFOC-20240352912$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240926$$HP$DE$DE
236669632$23666963$2$F$20240316$20240724$20240325$20240730$EXP$$AU-AMGEN-AUSSP2024056026$AMGEN$$59$YR$A$M$Y$$$20240730$$CN$AU$AU
236669682$23666968$2$F$20220922$20240628$20240325$20240704$EXP$$JP-009507513-2403JPN002426J$MERCK$$8$DEC$$M$Y$$$20240704$$MD$JP$JP
2366697310$23666973$10$F$20240301$20240914$20240325$20240923$EXP$$CA-CELLTRION INC.-2024CA007161$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
236669752$23666975$2$F$$20240815$20240325$20240822$EXP$$CA-CELLTRION INC.-2024CA007109$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
236669846$23666984$6$F$$20240703$20240325$20240712$EXP$$SE-NOVOPROD-1191461$NOVO NORDISK$$80$YR$$F$Y$60$KG$20240712$$CN$SE$SE
236670062$23667006$2$F$20231201$20240705$20240325$20240717$EXP$$US-NOVOPROD-1192048$NOVO NORDISK$$41$YR$$F$Y$65.7$KG$20240717$$MD$US$US
236670333$23667033$3$F$20230801$20240924$20240325$20240927$EXP$FR-AFSSAPS-RE2024000284$NVSC2024FR062525$NOVARTIS$$54$YR$$M$Y$70$KG$20240927$$MD$FR$FR
236670704$23667070$4$F$$20240711$20240325$20240717$PER$$US-AMGEN-USASP2024058751$AMGEN$$$$$M$Y$$$20240717$$HP$US$US
236670812$23667081$2$F$$20240610$20240325$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001309$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
236670852$23667085$2$F$20230606$20240913$20240325$20240921$EXP$$CA-CELLTRION INC.-2024CA004461$CELLTRION$$$$$$Y$$$20240921$$CN$CA$CA
236671182$23667118$2$F$20240229$20240730$20240325$20240801$EXP$$NVSC2024US058235$NOVARTIS$$5$YR$$F$Y$22.2$KG$20240801$$MD$US$US
236671512$23667151$2$F$20231201$20240730$20240325$20240801$EXP$$US-UCBSA-2024000026$UCB$$10$YR$$F$Y$$$20240801$$MD$US$US
236671602$23667160$2$F$20240223$20240710$20240325$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-012970$AUROBINDO$$35$YR$$F$Y$79$KG$20240720$$PH$FR$FR
236673347$23667334$7$F$20201001$20240808$20240325$20240813$EXP$$DE-ROCHE-3276879$ROCHE$$29$YR$A$F$Y$59$KG$20240813$$MD$DE$DE
236673513$23667351$3$F$$20240726$20240325$20240731$EXP$$US-SA-2024SA089925$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240731$$MD$US$US
236673912$23667391$2$F$20230101$20240708$20240325$20240711$EXP$$CA-TAKEDA-2024TUS026900$TAKEDA$$44$YR$$F$Y$68$KG$20240711$$HP$CA$CA
236673953$23667395$3$F$20240219$20240703$20240325$20240708$EXP$$US-UCBSA-2024008738$UCB$$16$YR$$M$Y$$$20240708$$MD$US$US
236674036$23667403$6$F$$20240802$20240325$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046802$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240802$$CN$US$US
236674054$23667405$4$F$$20240822$20240325$20240827$EXP$$CA-ROCHE-3528314$ROCHE$$44$YR$A$F$Y$97$KG$20240827$$HP$CA$CA
236674674$23667467$4$F$$20240819$20240325$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045357$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240828$$CN$US$US
236674692$23667469$2$F$$20240709$20240325$20240710$PER$$US-BIOVITRUM-2024-US-004427$BIOVITRUM$$8$MON$$M$Y$$$20240710$$CN$US$US
236674864$23667486$4$F$$20240517$20240325$20240726$EXP$$US-GSK-US2024AMR034515$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
236675233$23667523$3$F$20240226$20240816$20240325$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043473$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240826$$HP$US$US
236675374$23667537$4$F$$20240606$20240325$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047053$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240715$$CN$US$US
236675792$23667579$2$F$$20240814$20240325$20240820$EXP$$US-TAKEDA-2024TUS024658$TAKEDA$$$$$M$Y$$$20240820$$CN$US$US
236675812$23667581$2$F$$20240627$20240325$20240702$EXP$$JP-009507513-2403JPN002163J$MERCK$$44$YR$$M$Y$$$20240702$$MD$JP$JP
236675893$23667589$3$F$20240101$20240828$20240325$20240916$EXP$$US-SA-2024SA089411$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240916$$MD$US$US
236675902$23667590$2$F$20240101$20240909$20240325$20240913$EXP$$US-009507513-2403USA006412$MERCK$$$$$F$Y$$$20240913$$CN$US$US
236676033$23667603$3$F$$20240916$20240325$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046917$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$67.59$KG$20240917$$CN$US$US
236676094$23667609$4$F$20220118$20240715$20240325$20240718$EXP$$CA-TAKEDA-2019TUS012427$TAKEDA$$34$YR$$M$Y$$$20240718$$CN$CA$CA
236676954$23667695$4$F$$20240628$20240325$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044238$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240701$$CN$US$US
236677163$23667716$3$F$$20240306$20240325$20240923$PER$$US-ROCHE-3522118$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
236677765$23667776$5$F$20231121$20240710$20240325$20240712$EXP$$KR-ABBVIE-5689513$ABBVIE$$39$YR$$F$Y$53$KG$20240712$$MD$KR$KR
236677855$23667785$5$F$20240327$20240613$20240325$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001016$ACADIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240708$$CN$US$US
236677893$23667789$3$F$20231024$20240626$20240325$20240705$EXP$$JP-ROCHE-3528884$ROCHE$$77$YR$E$F$Y$45.2$KG$20240705$$MD$JP$JP
236677952$23667795$2$F$20231201$20240624$20240325$20240703$EXP$$JP-009507513-2312JPN002655J$MERCK$$65$YR$$F$Y$$$20240703$$HP$JP$JP
236678034$23667803$4$F$$20240723$20240325$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-046655$BRISTOL MYERS SQUIBB$Yoshida Y, Shoji T, Yonemura H, Okuda T, Tsuji K, Sato M, et al. A case of immune-related adverse event (irAE) cholangitis during nivolumab + ipilimumab administration in a patient with lung adenocarcinoma. The 79th Hokkaido Branch Meeting of the Japanese Society for Tuberculosis and Nontuberculous Mycobacteriosis. 2024;E-1.$66$YR$E$M$Y$$$20240731$$MD$JP$JP
236678212$23667821$2$F$20200101$20240730$20240325$20240807$EXP$$JP-AMGEN-JPNSP2024037811$AMGEN$$81$YR$E$M$Y$$$20240806$$MD$JP$JP
236678372$23667837$2$F$20240301$20240628$20240325$20240705$EXP$$US-GSK-US2024AMR036009$GLAXOSMITHKLINE$$53$YR$$F$Y$84$KG$20240705$$CN$US$US
236678443$23667844$3$F$20231101$20240717$20240325$20240722$EXP$$US-SA-2024SA090970$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240722$$MD$US$US
236678625$23667862$5$F$20240303$20240920$20240325$20240924$30DAY$$US-PFIZER INC-202400056589$PFIZER$$13$YR$$M$Y$$$20240924$$CN$US$US
236678764$23667876$4$F$$20240628$20240325$20240708$EXP$$US-GSK-US2024AMR036481$GLAXOSMITHKLINE$$$$$F$Y$154$KG$20240708$$CN$US$US
236678922$23667892$2$F$20240828$20240829$20240325$20240911$EXP$$BR-UCBSA-2024013687$UCB$$60$YR$$F$Y$$$20240911$$CN$BR$BR
236679464$23667946$4$F$20240801$20240909$20240325$20240920$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202403009068$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240920$$CN$CA$CA
236679652$23667965$2$F$$20240628$20240325$20240704$EXP$$US-BIOCON BIOLOGICS LIMITED-BBL2024001878$BIOCON$Huang Y, Khan F, Saraiya NV, Punjabi OS, Gulati V, Yeh S et al.,. Vogt-Koyanagi-Harada-like syndrome induced by checkpoint inhibitor cemiplimab. J Immunother. 2023;46(8):295-298$$$$$Y$$$20240704$$HP$US$US
236679752$23667975$2$F$$20240628$20240325$20240702$30DAY$$GB-SANDOZ INC.-SDZ2024GB031473$SANDOZ$$$$$F$Y$$$20240702$$CN$GB$GB
236679993$23667999$3$F$$20240713$20240325$20240716$EXP$$JP-ROCHE-3526494$ROCHE$Kimura M, Yamada S, Go M, Yasuda S, Toyoda H and Usami E Evaluation of Atezolizumab Plus Bevacizumab Versus Modified Lenvatinib Therapy in Child-Pugh A Unresectable Hepatocellular Carcinoma. Doi;10.21873/cdp.10297.. Cancer diagnosis + prognosis 2024 Mar 03;4 (2):122-8.$$$$$Y$$$20240716$$HP$JP$JP
236680013$23668001$3$F$20240101$20240624$20240325$20240703$EXP$$US-ORPHANEU-2024001988$RECORDATI$$$$$$Y$$$20240703$$MD$US$US
236680062$23668006$2$F$20240206$20240719$20240325$20240809$PER$$CA-TOLMAR, INC.-24CA047023$TOLMAR$$88$YR$$M$Y$$$20240809$$CN$CA$CA
236680092$23668009$2$F$20240129$20240621$20240325$20240710$PER$$CA-TOLMAR, INC.-24CA047062$TOLMAR$$83$YR$$M$Y$$$20240710$$CN$CA$CA
236680392$23668039$2$F$$20240912$20240325$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA030909$SANDOZ$$67$YR$$F$Y$$$20240913$$PH$CA$CA
236680453$23668045$3$F$$20240717$20240325$20240723$EXP$$US-SANDOZ INC.-SDZ2024US029153$SANDOZ$$$$$F$Y$$$20240723$$MD$US$US
236680482$23668048$2$F$20240201$20240920$20240325$20240930$PER$$US-GSK-US2024034437$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240930$$CN$US$US
236680605$23668060$5$F$20240306$20240715$20240325$20240722$EXP$$US-BEH-2024169868$CSL BEHRING$$18$YR$A$M$Y$$$20240722$$HP$US$US
236680653$23668065$3$F$20240908$20240912$20240325$20240917$EXP$$US-SANDOZ INC.-SDZ2024US025809$SANDOZ$$66$YR$$F$Y$106.12$KG$20240917$$CN$US$US
236680693$23668069$3$F$$20240710$20240325$20240714$EXP$$CA-SANDOZ INC.-SDZ2024CA031090$SANDOZ$$$$A$F$Y$$$20240714$$HP$CA$CA
236680854$23668085$4$F$20240303$20240913$20240325$20240918$30DAY$$GR-PFIZER INC-PV202400030746$PFIZER$$15$YR$$M$Y$61$KG$20240918$$CN$GR$GR
236681042$23668104$2$F$$20240918$20240325$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US030363$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
236681135$23668113$5$F$20240101$20240903$20240325$20240910$EXP$$US-PFIZER INC-202400016340$PFIZER$$9$YR$$F$Y$21.77$KG$20240910$$CN$US$US
236682237$23668223$7$F$$20240914$20240325$20240919$30DAY$$US-PFIZER INC-PV202400031695$PFIZER$$$$$M$Y$$$20240919$$CN$US$US
236682318$23668231$8$F$20240101$20240712$20240325$20240712$30DAY$$US-PFIZER INC-202400058814$PFIZER$$70$YR$$M$Y$83.01$KG$20240712$$CN$US$US
236682562$23668256$2$F$$20240523$20240325$20240927$EXP$$US-VIVUS LLC-2024V1000300$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
236682613$23668261$3$F$$20240802$20240325$20240812$EXP$$JP-ROCHE-3528773$ROCHE$$5$DEC$A$F$Y$$$20240813$$MD$JP$JP
236683627$23668362$7$F$$20240802$20240325$20240808$EXP$$US-PFIZER INC-202400066825$PFIZER$$$$A$F$Y$$$20240808$$CN$US$US
236684032$23668403$2$F$$20240715$20240325$20240722$EXP$$FR-AUROBINDO-AUR-APL-2021-014379$AUROBINDO$Sastre C, Baillif-Couniou V, Gaulier J-M, Allorge D, Piercecchi M-D, Leonetti G, et al.. Usage d?tourn? de la pr?gabaline : ? propos de trois cas de d?c?s en r?gion marseillaise(Diverted use of pregabalin: about three cases of death in the Marseille region.. Toxic-Analyt-Cliniqu. 2020;32(4):S33-S34$43$YR$$M$Y$$$20240722$$MD$FR$FR
236684335$23668433$5$F$20211129$20240807$20240325$20240809$EXP$$DE-SANDOZ INC.-NVSC2021DE277399$SANDOZ$$$$A$F$Y$78$KG$20240809$$HP$DE$DE
236684852$23668485$2$F$20240201$20240820$20240325$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044679$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240829$$CN$US$US
236685427$23668542$7$F$20231211$20240912$20240325$20240916$EXP$$AR-MYLANLABS-2023M1133858$MYLAN$$58$YR$$M$Y$$$20240916$$CN$AR$AR
236685444$23668544$4$F$$20240923$20240325$20240926$EXP$$US-TAKEDA-2024TUS027284$TAKEDA$$$$$F$Y$$$20240926$$MD$US$US
236685989$23668598$9$F$$20240924$20240325$20240927$30DAY$$GR-PFIZER INC-PV202400031518$PFIZER$$6$YR$$M$Y$16$KG$20240927$$CN$GR$GR
236686025$23668602$5$F$20240304$20240903$20240325$20240913$30DAY$$GR-PFIZER INC-PV202400030847$PFIZER$$11$YR$$F$Y$30$KG$20240913$$CN$GR$GR
236686034$23668603$4$F$20231216$20240808$20240325$20240814$EXP$$FR-PFIZER INC-202400068297$PFIZER$$46$YR$$F$Y$73$KG$20240814$$MD$FR$FR
236686043$23668604$3$F$$20240718$20240325$20240719$EXP$$US-PFIZER INC-PV202400038478$PFIZER$$65$YR$$F$Y$$$20240719$$CN$US$US
236686975$23668697$5$F$20240302$20240909$20240325$20240910$30DAY$$UY-PFIZER INC-PV202400031025$PFIZER$$13$YR$$F$Y$$$20240910$$CN$UY$UY
236687294$23668729$4$F$20240314$20240624$20240325$20240701$PER$$JP-Eisai-EC-2024-162257$EISAI$$8$DEC$E$M$Y$50$KG$20240701$$PH$JP$JP
236687362$23668736$2$F$$20240805$20240325$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047470$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240806$$CN$US$US
236687668$23668766$8$F$$20240912$20240325$20240919$EXP$$PT-MYLANLABS-2024M1026296$MYLAN$$$$E$$Y$$$20240919$$CN$PT$PT
236687803$23668780$3$F$20230711$20240906$20240325$20240912$EXP$$CA-LUNDBECK-DKLU3068588$LUNDBECK$$$$$$Y$$$20240912$$HP$CA$CA
236688002$23668800$2$F$$20240716$20240325$20240721$EXP$$GB-MYLANLABS-2024M1026738$MYLAN$$$$$M$Y$$$20240719$$PH$GB$GB
236688052$23668805$2$F$20230118$20240709$20240325$20240715$EXP$$GB-MYLANLABS-2024M1026655$MYLAN$$82$YR$$M$Y$72.2$KG$20240715$$MD$GB$GB
236688545$23668854$5$F$20230525$20240822$20240325$20240828$EXP$$US-PFIZER INC-PV202400039028$PFIZER$$80$YR$$$Y$$$20240828$$CN$US$US
236688566$23668856$6$F$20230101$20240812$20240325$20240815$EXP$$CA-PFIZER INC-202200634003$PFIZER$$47$YR$$F$Y$97$KG$20240815$$MD$CA$CA
236688793$23668879$3$F$20240201$20240709$20240325$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047027$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240711$$CN$US$US
236689225$23668922$5$F$$20240904$20240325$20240909$EXP$$CA-AstraZeneca-2024A068845$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$CA$
236689252$23668925$2$F$$20240925$20240325$20240926$EXP$$GB-MYLANLABS-2024M1027410$MYLAN$$21$YR$$F$Y$$$20240926$$CN$GB$GB
236689292$23668929$2$F$$20240905$20240325$20240910$EXP$$GB-MYLANLABS-2024M1027447$MYLAN$$27$YR$$M$Y$$$20240910$$CN$GB$GB
236689342$23668934$2$F$$20240905$20240325$20240910$EXP$$GB-MYLANLABS-2024M1027301$MYLAN$$27$YR$$M$Y$$$20240910$$CN$GB$GB
236689612$23668961$2$F$20240322$20240704$20240325$20240705$PER$$US-AMGEN-USASP2024060863$AMGEN$$66$YR$E$F$Y$$$20240705$$CN$US$US
236689623$23668962$3$F$$20240829$20240325$20240903$EXP$$GB-MYLANLABS-2024M1027266$MYLAN$$$$$M$Y$$$20240903$$PH$GB$GB
236689985$23668998$5$F$20240101$20240724$20240325$20240801$PER$$US-SA-2024SA088865$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240801$$MD$US$US
236690042$23669004$2$F$20230101$20240802$20240325$20240813$PER$$US-SA-2024SA088078$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240814$$MD$US$US
236690393$23669039$3$F$20240201$20240709$20240325$20240715$PER$$US-SA-2024SA091029$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240715$$MD$US$US
236690452$23669045$2$F$$20240703$20240325$20240712$PER$$US-SA-2024SA090011$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240712$$MD$US$US
236690583$23669058$3$F$20240309$20240904$20240325$20240924$EXP$$US-SA-2024SA091684$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240924$$MD$US$US
236690633$23669063$3$F$20240520$20240722$20240325$20240726$EXP$$US-OTSUKA-2024_007551$OTSUKA$$72$YR$$M$Y$97.07$KG$20240726$$CN$US$US
236691332$23669133$2$F$$20240906$20240325$20240913$EXP$$US-GILEAD-2024-0666842$GILEAD$$55$YR$A$M$Y$$$20240913$$MD$US$US
236691972$23669197$2$F$20240318$20240719$20240325$20240724$PER$$US-AMGEN-USASP2024057949$AMGEN$$59$YR$A$M$Y$$$20240724$$CN$US$US
236692353$23669235$3$F$$20240815$20240325$20240820$PER$$US-PFIZER INC-PV202400033361$PFIZER$$52$YR$$F$Y$90.703$KG$20240820$$CN$US$US
236692423$23669242$3$F$$20240903$20240325$20240905$PER$$US-PFIZER INC-202400071011$PFIZER$$36$YR$$F$Y$$$20240905$$CN$US$US
236692736$23669273$6$F$$20240918$20240325$20240930$EXP$$GB-ROCHE-3528471$ROCHE$$69$YR$E$M$Y$$$20240930$$HP$GB$GB
236693052$23669305$2$F$$20240904$20240325$20240912$PER$$US-SA-2024SA091697$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240912$$MD$US$US
236693232$23669323$2$F$20240101$20240909$20240325$20240919$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000250$DECIPHERA PHARMACEUTICALS$$88$YR$E$M$Y$$$20240919$$CN$US$US
236693292$23669329$2$F$$20240912$20240325$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047556$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240913$$CN$US$US
236693315$23669331$5$F$20240101$20240819$20240325$20240909$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000246$DECIPHERA PHARMACEUTICALS$$84$YR$E$M$Y$$$20240909$$CN$US$US
236693372$23669337$2$F$$20240711$20240325$20240717$EXP$$CA-TAKEDA-2023TUS087674$TAKEDA$$$$$M$Y$$$20240717$$CN$CA$CA
236693624$23669362$4$F$20240102$20240809$20240325$20240816$EXP$$JP-009507513-2401JPN002100J$MERCK$$8$DEC$$M$Y$$$20240816$$MD$JP$JP
236693964$23669396$4$F$20221101$20240729$20240325$20240805$EXP$$IN-GSK-IN2023APC023902$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$IN$IN
236694952$23669495$2$F$20240617$20240718$20240325$20240722$EXP$$AU-MYLANLABS-2024M1000799$MYLAN$$26$YR$$M$Y$$$20240722$$HP$AU$AU
236694963$23669496$3$F$20240101$20240807$20240325$20240809$EXP$$CA-UCBSA-2024004033$UCB$$$$$F$Y$$$20240809$$CN$CA$CA
236695352$23669535$2$F$$20240712$20240325$20240715$EXP$$HU-ALXN-202403EEA001145HU$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$MD$HU$HU
236695697$23669569$7$F$20240315$20240920$20240325$20240927$EXP$$JP-009507513-2403JPN002410J$MERCK$$77$YR$$F$Y$$$20240927$$MD$JP$JP
236696753$23669675$3$F$$20240715$20240325$20240718$PER$$US-PFIZER INC-202400069842$PFIZER$$81$YR$$F$Y$98.413$KG$20240718$$CN$US$US
236697012$23669701$2$F$20230101$20240722$20240325$20240724$EXP$$US-PFIZER INC-PV202400039512$PFIZER$$58$YR$$F$Y$$$20240724$$HP$US$US
236697112$23669711$2$F$$20240911$20240325$20240913$EXP$$IN-PFIZER INC-2021373839$PFIZER$$52$YR$$F$Y$65$KG$20240913$$CN$IN$IN
236697165$23669716$5$F$20220331$20240731$20240325$20240806$EXP$$CA-PFIZER INC-202200511799$PFIZER$$59$YR$$F$Y$140$KG$20240806$$HP$CA$CA
236697912$23669791$2$F$$20240806$20240325$20240826$PER$$US-GALDERMA-US2024003359$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
236699233$23669923$3$F$20240101$20240731$20240325$20240806$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004974$JAZZ$$$$$M$Y$$$20240806$$CN$US$US
236699284$23669928$4$F$20240101$20240916$20240325$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-021935$JAZZ$$$$$F$Y$$$20240923$$MD$US$US
236699302$23669930$2$F$$20240802$20240325$20240806$PER$$US-PFIZER INC-202400070550$PFIZER$$14$YR$$M$Y$$$20240806$$CN$US$US
236699555$23669955$5$F$$20240805$20240325$20240807$PER$$US-PFIZER INC-202400070768$PFIZER$$69$YR$$F$Y$54.875$KG$20240807$$HP$US$US
236699615$23669961$5$F$20240501$20240927$20240325$20240930$PER$$US-PFIZER INC-202400069983$PFIZER$$16$YR$$M$Y$63.492$KG$20240930$$CN$US$US
236699624$23669962$4$F$$20240729$20240325$20240802$EXP$$US-Taiho Oncology Inc-2024-002243$TAIHO ONCOLOGY INC$$62$YR$A$F$Y$125.19$KG$20240802$$CN$US$US
236699949$23669994$9$F$20240501$20240916$20240325$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047467$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240926$$CN$US$US
236699972$23669997$2$F$$20240919$20240325$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047420$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240923$$CN$US$US
236699993$23669999$3$F$20240307$20240815$20240325$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047297$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240816$$CN$US$US
236700052$23670005$2$F$$20240926$20240325$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045485$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240928$$CN$US$US
236700142$23670014$2$F$$20240814$20240325$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047306$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$73.03$KG$20240815$$CN$US$US
236700423$23670042$3$F$$20240819$20240325$20240826$EXP$$CA-SANDOZ INC.-NVSC2021CA224553$SANDOZ$$60$YR$$M$Y$$$20240826$$HP$CA$CA
236700483$23670048$3$F$$20240724$20240325$20240725$EXP$$GB-SANDOZ INC.-SDZ2024GB031380$SANDOZ$$$$$M$Y$$$20240725$$CN$GB$GB
236700557$23670055$7$F$20240305$20240710$20240325$20240711$EXP$PL-ROCHE-3522178$PL-SANDOZ INC.-SDZ2024PL029385$SANDOZ$$74$YR$$M$Y$80$KG$20240711$$MD$PL$PL
236700722$23670072$2$F$20200101$20240823$20240325$20240829$EXP$$US-009507513-2403USA006571$MERCK$$$$$M$Y$$$20240829$$CN$US$US
236700753$23670075$3$F$20240213$20240904$20240325$20240910$PER$$JP-Eisai-EC-2024-162123$EISAI$$55$YR$A$F$Y$$$20240910$$MD$JP$JP
236700996$23670099$6$F$$20240822$20240325$20240918$PER$$US-LUNDBECK-DKLU3075758$LUNDBECK$$$$$$Y$$$20240918$$CN$US$US
236701233$23670123$3$F$$20240827$20240325$20240829$EXP$$NVSC2021CA318086$NOVARTIS$$43$YR$$F$Y$96$KG$20240829$$HP$CA$CA
236701342$23670134$2$F$$20240917$20240325$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046358$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240923$$CN$US$US
236701563$23670156$3$F$$20240731$20240325$20240805$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000611$BLUEPRINT MEDICINES$$$$$M$Y$$$20240805$$CN$US$US
236702013$23670201$3$F$20240301$20240923$20240325$20240927$EXP$$US-ABBVIE-5690013$ABBVIE$$71$YR$$F$Y$$$20240927$$CN$US$US
236702232$23670223$2$F$$20240709$20240325$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-437684$RANBAXY$Juan Y-H, Saboo SS Lin Y-C, Conner JR, Jacobson FL Khandelwal A. Reverse halo sign in pulmonary mucormyosis. QJM. 2014;104:777-778$59$YR$$M$Y$$$20240724$$HP$US$US
236702544$23670254$4$F$20240608$20240807$20240325$20240813$EXP$$CA-TAKEDA-2024TUS027243$TAKEDA$$57$YR$$M$Y$$$20240813$$CN$CA$CA
236702552$23670255$2$F$$20240812$20240325$20240814$EXP$IT-EMA-DD-20180625-ishaevhp-093255$IT-SANDOZ INC.-PHHY2018IT055138$SANDOZ$$42$YR$$F$Y$$$20240814$$MD$IT$IT
236702625$23670262$5$F$$20240819$20240325$20240828$EXP$$CA-TAKEDA-2024TUS026800$TAKEDA$$$$$F$Y$$$20240828$$CN$CA$CA
236702632$23670263$2$F$20171228$20240812$20240325$20240819$EXP$$CA-TAKEDA-2024TUS026677$TAKEDA$$59$YR$$F$Y$$$20240819$$CN$CA$CA
236702654$23670265$4$F$20240412$20240823$20240325$20240826$EXP$$CA-TAKEDA-2024TUS026805$TAKEDA$$53$YR$$M$Y$$$20240826$$CN$CA$CA
236703112$23670311$2$F$$20240712$20240325$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-017035$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240715$$CN$US$US
236704232$23670423$2$F$$20240828$20240326$20240903$EXP$$CA-JNJFOC-20240357088$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240903$$MD$CA$CA
236704432$23670443$2$F$20240301$20240703$20240326$20240710$EXP$$GB-AUROBINDO-AUR-APL-2024-012857$AUROBINDO$$66$YR$$M$Y$75$KG$20240710$$MD$GB$GB
236704502$23670450$2$F$20230501$20240629$20240326$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-012925$AUROBINDO$$67$YR$$M$Y$72$KG$20240708$$PH$FR$FR
236704722$23670472$2$F$20240208$20240718$20240326$20240724$EXP$$US-ABBVIE-5691196$ABBVIE$$65$YR$$F$Y$$$20240724$$CN$US$US
236704793$23670479$3$F$20240401$20240903$20240326$20240910$EXP$$NL-ABBVIE-5688685$ABBVIE$$$$E$M$Y$$$20240910$$CN$NL$NL
236705072$23670507$2$F$20231108$20240624$20240326$20240703$EXP$$CA-TAKEDA-2024TUS026519$TAKEDA$$74$YR$$M$Y$$$20240703$$HP$CA$CA
236705092$23670509$2$F$20220901$20240726$20240326$20240801$EXP$$JP-AMGEN-JPNSP2024059957$AMGEN$$8$DEC$E$M$Y$$$20240801$$MD$JP$JP
236705234$23670523$4$F$20230623$20240718$20240326$20240729$EXP$$CA-TAKEDA-2024TUS025834$TAKEDA$$49$YR$$F$Y$116$KG$20240729$$HP$CA$CA
236705242$23670524$2$F$$20240708$20240326$20240710$EXP$$CA-TAKEDA-2024TUS026824$TAKEDA$$71$YR$$F$Y$70$KG$20240710$$HP$CA$CA
236705252$23670525$2$F$$20240726$20240326$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA031504$SANDOZ$$$$$F$Y$$$20240729$$CN$CA$CA
236705322$23670532$2$F$$20240710$20240326$20240718$EXP$$CA-TAKEDA-2024TUS027251$TAKEDA$$60$YR$$F$Y$$$20240718$$HP$CA$CA
236705503$23670550$3$F$20240228$20240711$20240326$20240722$EXP$$DE-AUROBINDO-AUR-APL-2024-013013$AUROBINDO$$88$YR$$F$Y$71$KG$20240722$$MD$DE$DE
236706036$23670603$6$F$$20240816$20240326$20240819$PER$$NVSC2024US064265$NOVARTIS$$$$$M$Y$$$20240819$$CN$US$US
236706105$23670610$5$F$20220101$20240802$20240326$20240809$EXP$$CA-CELLTRION INC.-2023CA014924$CELLTRION$$$$$$Y$$$20240809$$HP$CA$CA
236706634$23670663$4$F$20231201$20240916$20240326$20240923$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-008021$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240923$$CN$US$US
236706772$23670677$2$F$$20240627$20240326$20240711$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-02305$LUPIN$$$$$$Y$$$20240711$$CN$US$US
236707122$23670712$2$F$$20240625$20240326$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02371$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236707143$23670714$3$F$20231101$20240620$20240326$20240710$PER$$BR-TOLMAR, INC.-24BR047286$TOLMAR$$10$YR$$F$Y$$$20240709$$CN$BR$BR
236707213$23670721$3$F$20240822$20240822$20240326$20240912$PER$$CA-TOLMAR, INC.-24CA047056$TOLMAR$$80$YR$$M$Y$$$20240912$$CN$CA$CA
236707983$23670798$3$F$20240129$20240624$20240326$20240703$EXP$$JP-NOVOPROD-1192820$NOVO NORDISK$$17$YR$$M$Y$45.8$KG$20240703$$MD$JP$JP
236708215$23670821$5$F$20240101$20240815$20240326$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044336$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$108.41$KG$20240826$$CN$US$US
236708352$23670835$2$F$20230925$20240822$20240326$20240830$EXP$$DE-AMGEN-DEUNI2024058563$AMGEN$$66$YR$E$M$Y$$$20240829$$MD$DE$DE
236708375$23670837$5$F$20240101$20240808$20240326$20240820$PER$$US-SA-2024SA088385$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240820$$MD$US$US
236708647$23670864$7$F$20230801$20240903$20240326$20240912$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-001366$Alvotech$$69$YR$$F$Y$$$20240912$$MD$CA$CA
236708672$23670867$2$F$20240101$20240916$20240326$20240925$EXP$$CA-CELLTRION INC.-2024CA007209$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
236708902$23670890$2$F$$20240523$20240326$20240710$PER$$US-ROCHE-3429432$ROCHE$$$$A$M$Y$$$20240701$$MD$US$US
236709062$23670906$2$F$20240701$20240705$20240326$20240711$PER$$US-ROCHE-3463692$ROCHE$$28$YR$A$F$Y$$$20240711$$CN$US$US
236709203$23670920$3$F$$20240716$20240326$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-045385$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240719$$MD$JP$JP
236709862$23670986$2$F$20231127$20240220$20240326$20240710$PER$$US-ROCHE-3472577$ROCHE$$57$YR$A$M$Y$34$KG$20240701$$CN$US$US
236710052$23671005$2$F$20240201$20240701$20240326$20240708$EXP$$US-UCBSA-2024014325$UCB$$47$YR$$M$Y$$$20240708$$HP$US$US
236710136$23671013$6$F$$20240703$20240326$20240709$EXP$$NVSC2024US037775$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
236710173$23671017$3$F$20240315$20240729$20240326$20240731$EXP$$CA-ROCHE-3529491$ROCHE$$66$YR$E$F$Y$57$KG$20240731$$HP$CA$CA
236710276$23671027$6$F$20230501$20240812$20240326$20240816$EXP$$US-SANDOZ INC.-NVSC2023US118469$SANDOZ$$75$YR$$M$Y$114$KG$20240816$$CN$US$US
236710595$23671059$5$F$$20240918$20240326$20240925$EXP$$JP-AMGEN-JPNSP2024058503$AMGEN$$64$YR$A$F$Y$$$20240925$$MD$JP$JP
236710693$23671069$3$F$$20240820$20240326$20240916$PER$$CA-TOLMAR, INC.-24CA047066$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
236711013$23671101$3$F$20200601$20240810$20240326$20240817$EXP$$JP-AMGEN-JPNSP2024058962$AMGEN$$$$$M$Y$$$20240817$$MD$JP$JP
236711052$23671105$2$F$20240322$20240713$20240326$20240716$PER$$US-AMGEN-USASP2024060791$AMGEN$$38$YR$A$F$Y$$$20240715$$CN$US$US
236711153$23671115$3$F$20240101$20240325$20240326$20240806$PER$$US-AstraZeneca-2024A058719$ASTRAZENECA$$70$YR$$F$Y$$$20240806$$CN$US$
236711272$23671127$2$F$20240101$20240904$20240326$20240913$PER$$US-SA-2024SA092697$SANOFI AVENTIS$$$$A$M$Y$$$20240913$$MD$US$US
236711412$23671141$2$F$$20240705$20240326$20240711$EXP$$JP-GSK-JP2024JPN036561$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$JP$JP
236711524$23671152$4$F$$20240731$20240326$20240813$EXP$$PT-AUROBINDO-AUR-APL-2024-011915$AUROBINDO$Conde MG,Encarnacao UJD.. GEST?O DA HIPERTENS?O NUM DOENTE COM HIPOTENS?O ORTOST?TICA - UM RELATO DE  CASO(MANAGEMENT  OF HYPERTENSION IN A PATIENT WITH  ORTHOSTATIC HYPOTENSION - A CASE  REPORT). Portuguese Congress on Hypertension and Global Cardiovascular Risk. 2024;99(Suplemento).:18$76$YR$$M$Y$$$20240813$$MD$PT$PT
236711745$23671174$5$F$20240301$20240613$20240326$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001229$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240708$$CN$US$US
236711822$23671182$2$F$20240313$20240625$20240326$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02384$LUPIN$$$$$$Y$$$20240715$$CN$US$US
236711873$23671187$3$F$$20240726$20240326$20240731$30DAY$$IT-JNJFOC-20240337448$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$IT$IT
236711972$23671197$2$F$$20240712$20240326$20240716$PER$$US-JNJFOC-20240363921$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
236712073$23671207$3$F$$20240612$20240326$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000075$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
236712323$23671232$3$F$20240301$20240731$20240326$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047897$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240801$$CN$US$US
236712352$23671235$2$F$$20240712$20240326$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044315$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240715$$CN$US$US
236712363$23671236$3$F$$20240909$20240326$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047014$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240912$$CN$US$US
236712444$23671244$4$F$20240301$20240816$20240326$20240823$30DAY$$AR-JNJFOC-20240316166$JOHNSON AND JOHNSON$$48$YR$A$M$Y$92$KG$20240823$$CN$AR$AR
236712524$23671252$4$F$20240318$20240626$20240326$20240717$PER$$US-BEH-2024170155$CSL BEHRING$$68$YR$E$F$Y$$$20240717$$CN$US$US
236712795$23671279$5$F$$20240625$20240326$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02383$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236712832$23671283$2$F$20240320$20240418$20240326$20240918$EXP$$US-UCBSA-2024014461$UCB$$20$YR$$M$Y$52$KG$20240918$$CN$US$US
236713602$23671360$2$F$$20240806$20240326$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047801$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240812$$CN$US$US
236713712$23671371$2$F$20240101$20240923$20240326$20240926$EXP$$CA-JNJFOC-20240361071$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240926$$HP$CA$CA
236714312$23671431$2$F$20240317$20240627$20240326$20240702$PER$$US-AMGEN-USASP2024059210$AMGEN$$59$YR$A$M$Y$$$20240702$$CN$US$US
236714796$23671479$6$F$20240321$20240910$20240326$20240912$EXP$$CA-JNJFOC-20240368224$JOHNSON AND JOHNSON$$73$YR$E$M$Y$61$KG$20240912$$HP$CA$CA
236714963$23671496$3$F$20240101$20240820$20240326$20240909$PER$$US-SA-2024SA092668$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240909$$MD$US$US
236715143$23671514$3$F$20240209$20240909$20240326$20240917$EXP$$CO-ROCHE-3528720$ROCHE$$51$YR$A$F$Y$50$KG$20240917$$CN$CO$CO
236715153$23671515$3$F$20230101$20240716$20240326$20240723$EXP$$US-SA-2024SA019483$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240722$$MD$US$US
236715682$23671568$2$F$20240101$20240628$20240326$20240705$EXP$$US-ABBVIE-5671912$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
236716223$23671622$3$F$20240309$20240730$20240326$20240808$PER$$US-RDY-SPO/USA/24/0004553$DR REDDYS$$35$YR$A$M$Y$$$20240808$$CN$US$US
236716544$23671654$4$F$20240318$20240625$20240326$20240702$PER$$US-AMGEN-USASP2024060132$AMGEN$$56$YR$A$M$Y$$$20240701$$HP$US$US
236716742$23671674$2$F$$20240814$20240326$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046649$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240822$$CN$US$US
236716912$23671691$2$F$20140101$20240624$20240326$20240702$EXP$$PA-BIOGEN-2024BI01256801$BIOGEN$$$$$F$Y$89.81$KG$20240702$$CN$PA$PA
236716974$23671697$4$F$20240121$20240628$20240326$20240702$EXP$$JP-AstraZeneca-2024A070228$ASTRAZENECA$$49$YR$$M$Y$57$KG$20240702$$MD$JP$
236716984$23671698$4$F$20221201$20240412$20240326$20240807$EXP$$NVSC2023CR256862$NOVARTIS$$61$YR$$F$Y$50.1$KG$20240807$$CN$CR$CR
236717055$23671705$5$F$20240312$20240827$20240326$20240903$EXP$$NVSC2024DE063094$NOVARTIS$$57$YR$$M$Y$110$KG$20240903$$MD$DE$DE
236717172$23671717$2$F$20230805$20240827$20240326$20240903$EXP$$SA-GSK-SA2023EME122870$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$SA$SA
236717513$23671751$3$F$20240201$20240715$20240326$20240801$EXP$$BE-BEH-2024169991$CSL BEHRING$$$$E$F$Y$41.8$KG$20240801$$HP$BE$BE
236717572$23671757$2$F$$20240819$20240326$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202403014265$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240826$$CN$US$US
236717733$23671773$3$F$$20240904$20240326$20240909$PER$$US-ALXN-202403USA001299US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
236718562$23671856$2$F$$20240710$20240326$20240723$EXP$$DE-AUROBINDO-AUR-APL-2021-013104$AUROBINDO$Paul LD,  Welter-Luedeke J, Penzel S, Zangl A, Graw M, Brueckner I. Alpha-Pyrrolidinopentiothiophenone (-PVT): A forensic case study including plasma concentrations. Journal of Analytical Toxicology. 2021;321:110721$26$YR$$F$Y$$$20240719$$HP$DE$DE
236718712$23671871$2$F$20240315$20240711$20240326$20240801$PER$$US-SA-2024SA089606$SANOFI AVENTIS$$80$YR$E$F$Y$65$KG$20240719$$MD$US$US
236719353$23671935$3$F$20240314$20240705$20240326$20240711$EXP$$JP-AMGEN-JPNSP2024057069$AMGEN$$$$$$Y$$$20240711$$PH$JP$JP
236720044$23672004$4$F$$20240812$20240326$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048077$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240813$$CN$US$US
236721052$23672105$2$F$20240317$20240711$20240326$20240712$PER$$US-AMGEN-USASP2024060754$AMGEN$$66$YR$E$M$Y$$$20240712$$CN$US$US
236721072$23672107$2$F$$20240823$20240326$20240902$EXP$$US-SA-2024SA090931$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240902$$MD$US$US
236721273$23672127$3$F$$20240919$20240326$20240924$EXP$$JP-ASTELLAS-2024JP002033$ASTELLAS$Endo M, Miura S, Yoshida T, Oikawa K. A case of Fanconi anemia with a healthy baby after haploidentical stem cell transplantation. The 46th JSTCT Annual Meeting (JSTCT2024) Japanese Society for Transplantation a 2024:P-032.$$$N$$Y$1.9$KG$20240924$$MD$JP$JP
236721333$23672133$3$F$$20240919$20240326$20240925$EXP$$JP-ASTELLAS-2024JP002030$ASTELLAS$Endo M, Miura S, Yoshida T, Oikawa K. A case of Fanconi anemia with a healthy baby after haploidentical stem cell transplantation. The 46th JSTCT Annual Meeting (JSTCT2024) Japanese Society for Transplantation a 2024:P-032.$4$DEC$A$F$Y$$$20240925$$MD$JP$JP
236721653$23672165$3$F$20240201$20240911$20240326$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008358$UNITED THERAPEUTICS$$74$YR$$F$Y$55.329$KG$20240920$$$US$US
236722063$23672206$3$F$20240320$20240812$20240326$20240817$PER$$US-AMGEN-USASP2024059730$AMGEN$$78$YR$E$F$Y$$$20240817$$MD$US$US
236722192$23672219$2$F$20240222$20240318$20240326$20240729$EXP$$NVSC2024FR063428$NOVARTIS$$78$YR$$M$Y$69$KG$20240729$$MD$FR$FR
236722677$23672267$7$F$20230422$20240923$20240326$20240927$EXP$$CO-TAKEDA-2023TUS042822$TAKEDA$$12$YR$$M$Y$22$KG$20240927$$CN$CO$CO
236722732$23672273$2$F$$20240708$20240326$20240716$EXP$$US-ASTELLAS-2024US008861$ASTELLAS$Khosla H, Bhatt S, Wang M, Gignac G, Mittal K, Patel J. Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis. Journal of Oncology Pharmacy Practice. 2024;Vol:30 (5):941-944$59$YR$$M$Y$101.1$KG$20240716$$HP$US$US
236722753$23672275$3$F$$20240709$20240326$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-045386$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240709$$MD$JP$JP
236723103$23672310$3$F$20240224$20240925$20240326$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047878$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240926$$HP$US$US
236723252$23672325$2$F$20211214$20240703$20240326$20240711$EXP$NO-NOMAADVRE-RELISSO-2024-Vzb4nj$NO-EMD Serono-2024015050$EMD SERONO INC$$44$YR$A$F$Y$$$20240711$$MD$NO$NO
236723432$23672343$2$F$$20240820$20240326$20240903$EXP$$US-AUROBINDO-AUR-APL-2024-012723$AUROBINDO$Mohamed MS, Wojciechowski K, Osama M, Hashem A, Patel J, Mahmoud A, et al.. The Missed Culprit For A Complex Case Of Non-ischemic Cardiomyopathy.2024;30(1):157-8.  DOI: 10.1016/j.cardfail.2023.10.100.. Journal of Cardiac Failure.. 2024;30(1):157-8$60$YR$$F$Y$$$20240903$$MD$US$US
236723572$23672357$2$F$$20240916$20240326$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-012503$AUROBINDO$Janowski JPB, Suarez L, Allen ND, Sampson SM.. A Case Series of 11 Patients With Subacute Serotonin Syndrome.. Journal of the Academy of Consultation-Liaison Psychiatry.. 2024;65(1):33-8$44$YR$$M$Y$$$20240927$$MD$US$US
236723613$23672361$3$F$20240321$20240718$20240326$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047954$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$82.1$KG$20240722$$CN$US$US
236723942$23672394$2$F$20240320$20240719$20240326$20240722$PER$$US-AMGEN-USASP2024060125$AMGEN$$82$YR$E$F$Y$$$20240722$$CN$US$US
236723953$23672395$3$F$$20240913$20240326$20240923$PER$$US-SA-2024SA092422$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240923$$CN$US$US
236723972$23672397$2$F$$20240629$20240326$20240708$PER$$US-SA-2022SA444610$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240708$$HP$US$US
236724162$23672416$2$F$$20240916$20240326$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-012505$AUROBINDO$Sampson SM, Janowski JPB, Suarez L, Allen ND.. A Case Series of 11 Patients With Subacute Serotonin Syndrome.. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65(1):33-8$20$YR$$F$Y$$$20240927$$MD$US$US
236724192$23672419$2$F$$20240716$20240326$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-032713$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240718$$CN$US$US
236724245$23672424$5$F$$20240925$20240326$20240926$30DAY$$US-PFIZER INC-202400060079$PFIZER$$10$YR$$M$Y$32.1$KG$20240926$$CN$US$US
236724257$23672425$7$F$$20240923$20240326$20240926$30DAY$$US-PFIZER INC-202400060486$PFIZER$$16$YR$$M$Y$58.967$KG$20240926$$CN$US$US
236724295$23672429$5$F$$20240921$20240326$20240925$30DAY$$US-PFIZER INC-202400059784$PFIZER$$11$YR$$F$Y$$$20240925$$CN$US$US
236724306$23672430$6$F$$20240815$20240326$20240821$30DAY$$US-PFIZER INC-202400060698$PFIZER$$10$YR$$F$Y$23.59$KG$20240821$$HP$US$US
236724319$23672431$9$F$20240301$20240828$20240326$20240903$30DAY$$US-PFIZER INC-202400058679$PFIZER$$11$YR$$M$Y$$$20240903$$CN$US$US
236724356$23672435$6$F$$20240816$20240326$20240821$30DAY$$US-PFIZER INC-202400061096$PFIZER$$15$YR$$M$Y$$$20240821$$CN$US$US
236724423$23672442$3$F$20170807$20240812$20240326$20240821$EXP$$US-JNJFOC-20240353042$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240821$$CN$US$US
236724642$23672464$2$F$$20240916$20240326$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-012721$AUROBINDO$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome.. Journal of the Academy of Consultation-Liaison Psychiatry.. 2024;65(1):33-8$64$YR$$M$Y$$$20240927$$MD$US$US
236724687$23672468$7$F$20240101$20240917$20240326$20240923$30DAY$$US-PFIZER INC-PV202200000715$PFIZER$$15$YR$$M$Y$64.86$KG$20240923$$CN$US$US
2367247512$23672475$12$F$20240316$20240909$20240326$20240916$30DAY$$US-PFIZER INC-202400059664$PFIZER$$14$YR$$M$Y$40.816$KG$20240916$$CN$US$US
236724768$23672476$8$F$20240308$20240909$20240326$20240911$30DAY$$US-PFIZER INC-202400061655$PFIZER$$30$YR$$M$Y$117.93$KG$20240911$$CN$US$US
236724843$23672484$3$F$20240101$20240911$20240326$20240926$PER$$US-SA-2024SA088737$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240926$$MD$US$US
236724942$23672494$2$F$20230118$20240709$20240326$20240712$EXP$GB-009507513-2302GBR000371$GB-SANDOZ INC.-SDZ2024US030651$SANDOZ$$82$YR$$M$Y$72$KG$20240712$$MD$GB$GB
236724993$23672499$3$F$$20240829$20240326$20240904$EXP$$BR-JNJFOC-20240365971$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$MD$BR$BR
236725468$23672546$8$F$$20240914$20240326$20240920$30DAY$$US-PFIZER INC-PV202400033772$PFIZER$$12$YR$$M$Y$40.82$KG$20240920$$MD$US$US
236725476$23672547$6$F$$20240913$20240326$20240918$30DAY$$US-PFIZER INC-202400063017$PFIZER$$13$YR$$M$Y$39.46$KG$20240918$$CN$US$US
236725488$23672548$8$F$20240402$20240917$20240326$20240920$30DAY$$US-PFIZER INC-202400061651$PFIZER$$11$YR$$F$Y$$$20240920$$CN$US$US
236725543$23672554$3$F$20210101$20240906$20240326$20240914$EXP$$JP-ABBVIE-5692590$ABBVIE$Hino K, Katayama Y, Ikeda R, Kochi Y, Nunomura T, Okatani T, et al. ALL that developed Sweet syndrome after use of ibrutinib for steroid-dependent chronic GvHD. Proceedings of the 46th JSTCT Annual Meeting (JSTCT2024) Japanese Society for Transplantation and Cellular Therapy. 2024;314.; Hino K, Katayama Y, Ikeda R, Kochi Y, Nunomura T, Okatani T, et al. ALL that developed Sweet syndrome after use of ibrutinib for steroid-dependent chronic GvHD. Proceedings of the 46th JSTCT Annual Meeting (JS...$60$YR$$M$Y$$$20240914$$MD$JP$JP
236725902$23672590$2$F$20240101$20240722$20240326$20240731$PER$$US-SA-2024SA092439$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240731$$MD$US$US
236725912$23672591$2$F$20240601$20240918$20240326$20240927$PER$$US-SA-2024SA086830$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240927$$HP$US$US
236726042$23672604$2$F$$20240625$20240326$20240705$EXP$$CA-SANDOZ INC.-SDZ2024CA031968$SANDOZ$$44$YR$$F$Y$97$KG$20240705$$HP$CA$CA
236726133$23672613$3$F$$20240803$20240326$20240806$PER$$NVSC2024US064444$NOVARTIS$$43$YR$$F$Y$$$20240806$$CN$US$US
236726642$23672664$2$F$$20240918$20240326$20240924$EXP$$CA-Orion Corporation ORION PHARMA-24_00029121$ORION$$73$YR$E$M$Y$$$20240924$$HP$CA$
236726683$23672668$3$F$20210712$20240816$20240326$20240819$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116320$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240819$$CN$CA$CA
236727096$23672709$6$F$$20240912$20240326$20240918$30DAY$$US-PFIZER INC-202400064209$PFIZER$$10$YR$$F$Y$$$20240918$$CN$US$US
236727129$23672712$9$F$$20240923$20240326$20240926$30DAY$$US-PFIZER INC-PV202400034551$PFIZER$$14$YR$$M$Y$48.53$KG$20240926$$CN$US$US
236727268$23672726$8$F$20240312$20240916$20240326$20240919$30DAY$$US-PFIZER INC-202400063871$PFIZER$$14$YR$$M$Y$$$20240919$$CN$US$US
236727342$23672734$2$F$$20240910$20240326$20240912$EXP$$CA-ROCHE-3527777$ROCHE$$$$A$M$Y$$$20240912$$CN$CA$CA
236727388$23672738$8$F$20240311$20240915$20240326$20240919$30DAY$$US-PFIZER INC-202400063343$PFIZER$$12$YR$$M$Y$48.99$KG$20240919$$CN$US$US
236727418$23672741$8$F$$20240903$20240326$20240909$30DAY$$US-PFIZER INC-202400064017$PFIZER$$13$YR$$F$Y$$$20240909$$CN$US$US
236727508$23672750$8$F$$20240914$20240326$20240919$30DAY$$US-PFIZER INC-202400064030$PFIZER$$11$YR$$M$Y$$$20240919$$CN$US$US
236727573$23672757$3$F$20240301$20240729$20240326$20240807$PER$$US-SA-2024SA092901$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240807$$MD$US$US
236727588$23672758$8$F$20220101$20240926$20240326$20240930$30DAY$$US-PFIZER INC-202400064680$PFIZER$$4$YR$$F$Y$9.497$KG$20240930$$CN$US$US
236728142$23672814$2$F$$20240730$20240326$20240806$EXP$$US-SA-2024SA092903$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240806$$MD$US$US
236728312$23672831$2$F$$20240724$20240326$20240801$PER$$US-SA-2024SA092579$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240801$$MD$US$US
236728552$23672855$2$F$$20240904$20240326$20240912$PER$$US-SA-2024SA088901$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240912$$MD$US$US
236728682$23672868$2$F$$20240627$20240326$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02470$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236728932$23672893$2$F$$20240701$20240326$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019812$JAZZ$$$$$F$Y$81.7$KG$20240708$$CN$US$US
236729146$23672914$6$F$$20240820$20240326$20240830$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000613$BLUEPRINT MEDICINES$$$$$F$Y$$$20240830$$CN$US$US
236729462$23672946$2$F$20240101$20240628$20240326$20240709$PER$$US-SA-2024SA089530$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240709$$MD$US$US
236729706$23672970$6$F$20240315$20240802$20240326$20240807$30DAY$$US-PFIZER INC-202400065750$PFIZER$$78$YR$$M$Y$$$20240807$$CN$US$US
236729734$23672973$4$F$20240306$20240627$20240326$20240702$EXP$$DE-AstraZeneca-2024A069830$ASTRAZENECA$$20094$DY$$F$Y$56$KG$20240702$$MD$DE$
236730512$23673051$2$F$$20240711$20240326$20240801$PER$$US-SA-2024SA092002$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240719$$MD$US$US
236730615$23673061$5$F$20240318$20240911$20240326$20240917$30DAY$$US-PFIZER INC-202400067967$PFIZER$$9$YR$$F$Y$25.4$KG$20240917$$CN$US$US
236731067$23673106$7$F$$20240911$20240326$20240913$30DAY$$US-PFIZER INC-202400069095$PFIZER$$1$YR$$F$Y$9.07$KG$20240913$$CN$US$US
236731092$23673109$2$F$20230801$20240924$20240326$20240926$EXP$FR-AFSSAPS-RE2024000284$FR-PFIZER INC-202400070064$PFIZER$$54$YR$$M$Y$70$KG$20240926$$MD$FR$FR
236732352$23673235$2$F$20210719$20240905$20240326$20240912$EXP$$KR-Vifor (International) Inc.-VIT-2024-02543$VIFOR$$79$YR$$M$Y$63$KG$20240912$$HP$KR$KR
2367323911$23673239$11$F$20240401$20240925$20240326$20240927$EXP$$US-PFIZER INC-PV202400034486$PFIZER$$65$YR$$F$Y$67.13$KG$20240927$$HP$US$US
236732952$23673295$2$F$20240310$20240801$20240326$20240802$EXP$$CN-PFIZER INC-PV202400038886$PFIZER$$22$YR$$F$Y$$$20240802$$HP$CN$CN
236733142$23673314$2$F$$20240711$20240326$20240718$EXP$$CA-OTSUKA-2024_007667$OTSUKA$$$$$M$Y$$$20240718$$HP$CA$CA
236733297$23673329$7$F$20231116$20240924$20240326$20240927$EXP$$CA-GSK-CA2023177935$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$CA$CA
236733474$23673347$4$F$$20240822$20240326$20240828$EXP$$US-VERTEX PHARMACEUTICALS-2024-004846$VERTEX$$$$$$Y$$$20240828$$CN$US$US
236733714$23673371$4$F$$20240627$20240326$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02393$LUPIN$$$$$$Y$$$20240712$$CN$US$US
236733752$23673375$2$F$20170427$20240821$20240326$20240823$EXP$$CA-TAKEDA-2017MPI005243$TAKEDA$$70$YR$$F$Y$63$KG$20240823$$CN$CA$CA
236733833$23673383$3$F$20240301$20240703$20240326$20240712$PER$$US-SA-2024SA089049$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240712$$MD$US$US
236733853$23673385$3$F$20240101$20240810$20240326$20240821$PER$$US-SA-2024SA089560$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240821$$MD$US$US
236734102$23673410$2$F$$20240905$20240326$20240910$EXP$$GB-MYLANLABS-2024M1026563$MYLAN$$27$YR$$M$Y$$$20240910$$CN$GB$GB
236734305$23673430$5$F$20230322$20240925$20240326$20240925$PER$$US-PFIZER INC-202400071876$PFIZER$$27$YR$$M$Y$$$20240925$$MD$US$US
236734623$23673462$3$F$20240130$20240916$20240326$20240927$EXP$$CH-SA-2024SA076302$SANOFI AVENTIS$$18$YR$A$F$Y$63$KG$20240927$$MD$CH$CH
236734713$23673471$3$F$20231201$20240322$20240326$20240805$EXP$$NVSC2024IN051306$NOVARTIS$$70$YR$$F$Y$$$20240805$$CN$IN$IN
236734722$23673472$2$F$$20240726$20240326$20240730$EXP$$CA-TAKEDA-2024TUS028113$TAKEDA$$$$$M$Y$$$20240730$$CN$CA$CA
236734764$23673476$4$F$$20240808$20240326$20240812$EXP$$US-GSK-US2024AMR035622$GLAXOSMITHKLINE$$$$$F$Y$71.202$KG$20240812$$MD$US$US
236734837$23673483$7$F$$20240909$20240326$20240911$30DAY$$US-PFIZER INC-202400065331$PFIZER$$12$YR$$F$Y$27.664$KG$20240911$$CN$US$US
236734847$23673484$7$F$$20240912$20240326$20240918$30DAY$$US-PFIZER INC-202400066730$PFIZER$$6$YR$$F$Y$17.234$KG$20240918$$CN$US$US
236734855$23673485$5$F$$20240731$20240326$20240805$30DAY$$US-PFIZER INC-202400065025$PFIZER$$11$YR$$M$Y$$$20240805$$CN$US$US
236735037$23673503$7$F$20231101$20240920$20240326$20240924$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-232683$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$$$20240925$$CN$US$US
236735604$23673560$4$F$$20240808$20240326$20240815$EXP$$JP-PFIZER INC-202400072020$PFIZER$Ishimaru, S.. Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial. International Journal of Clinical Oncology. 2024;29(2):89-95$$$$$Y$$$20240815$$MD$JP$JP
236735634$23673563$4$F$20210301$20240708$20240326$20240711$EXP$$IN-PFIZER INC-PV202400039631$PFIZER$$66$YR$$M$Y$60$KG$20240711$$CN$IN$IN
236735733$23673573$3$F$$20240625$20240326$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02382$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236736183$23673618$3$F$$20240919$20240326$20240930$PER$$US-SA-2024SA089006$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240930$$MD$US$US
236736287$23673628$7$F$20240309$20240904$20240326$20240906$30DAY$$GR-PFIZER INC-PV202400034008$PFIZER$$15$YR$$M$Y$53$KG$20240906$$CN$GR$GR
236736359$23673635$9$F$20240306$20240914$20240326$20240919$30DAY$$GR-PFIZER INC-PV202400032209$PFIZER$$14$YR$$F$Y$38$KG$20240919$$HP$GR$GR
236736372$23673637$2$F$$20240625$20240326$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02451$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236736388$23673638$8$F$20240307$20240914$20240326$20240924$30DAY$$GR-PFIZER INC-PV202400032192$PFIZER$$4$YR$$F$Y$14$KG$20240924$$CN$GR$GR
236736398$23673639$8$F$20240311$20240924$20240326$20240926$30DAY$$GR-PFIZER INC-202400063487$PFIZER$$$$$F$Y$$$20240926$$CN$GR$GR
236736403$23673640$3$F$$20240703$20240326$20240710$PER$$NVSC2024US064858$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
236736643$23673664$3$F$$20240813$20240326$20240821$PER$$US-SA-2024SA092046$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240821$$MD$US$US
236736983$23673698$3$F$20240101$20240626$20240326$20240701$EXP$$US-SA-2024SA092989$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240701$$MD$US$US
236737092$23673709$2$F$20240221$20240221$20240326$20240711$EXP$$US-TEVA-VS-3161148$TEVA$$$$$F$Y$$$20240711$$CN$US$US
236737112$23673711$2$F$20230704$20240827$20240326$20240830$EXP$$US-ABBVIE-5689022$ABBVIE$$60$YR$$F$Y$$$20240830$$CN$US$US
236737134$23673713$4$F$20240313$20240830$20240326$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045108$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240903$$PH$US$US
236737375$23673737$5$F$20200101$20240909$20240326$20240921$EXP$$CA-UCBSA-2023002132$UCB$$$$$F$Y$$$20240921$$HP$CA$CA
236737392$23673739$2$F$20230824$20240706$20240326$20240715$EXP$$JP-ARGENX-2023-ARGX-JP003635AA$ARGENX BVBA$$$$$$Y$$$20240715$$CN$JP$JP
236737412$23673741$2$F$20230101$20240909$20240326$20240911$PER$$US-BIOGEN-2024BI01256513$BIOGEN$$$$$M$Y$$$20240911$$CN$US$US
236737552$23673755$2$F$$20240909$20240326$20240916$EXP$$US-RDY-CLI/USA/24/0004867$DR REDDYS$$23$YR$A$M$Y$76.2$KG$20240916$$CN$US$US
236737737$23673773$7$F$20230811$20240426$20240326$20240910$EXP$$ES-ABBVIE-5691781$ABBVIE$$63$YR$$F$Y$$$20240910$$MD$ES$ES
236737862$23673786$2$F$20240322$20240725$20240326$20240727$PER$$US-AMGEN-USASP2024061698$AMGEN$$61$YR$A$M$Y$$$20240727$$CN$US$US
236738014$23673801$4$F$$20240625$20240326$20240702$EXP$$NVSC2024US063997$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
236738092$23673809$2$F$$20240815$20240326$20240827$EXP$$GB-AMICUS THERAPEUTICS, INC.-AMI_2998$AMICUS THERAPEUTICS$$$$$M$Y$$$20240827$$HP$GB$GB
236738132$23673813$2$F$20240310$20240715$20240326$20240730$PER$$FR-PFIZER INC-PV202400034027$PFIZER$$9$YR$$M$Y$$$20240730$$CN$FR$FR
236738192$23673819$2$F$20240101$20240801$20240326$20240806$PER$$US-SA-2024SA092693$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240806$$MD$US$US
236738283$23673828$3$F$20240130$20240614$20240326$20240705$PER$$US-Eisai-EC-2024-159286$EISAI$$67$YR$E$F$Y$107.4$KG$20240705$$HP$US$US
236738422$23673842$2$F$$20240822$20240326$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048079$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$79.38$KG$20240910$$PH$US$US
236738644$23673864$4$F$$20240715$20240326$20240722$PER$$US-ALXN-202403USA001331US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
236739002$23673900$2$F$20240314$20240714$20240326$20240717$PER$$US-AMGEN-USASP2024056928$AMGEN$$69$YR$E$M$Y$$$20240716$$CN$US$US
236739682$23673968$2$F$20231227$20240725$20240326$20240726$EXP$FR-AFSSAPS-RN2024000284$FR-PFIZER INC-202400070108$PFIZER$$76$YR$$F$Y$$$20240726$$MD$FR$FR
236739957$23673995$7$F$20240217$20240716$20240326$20240722$EXP$$US-BIOGEN-2024BI01257091$BIOGEN$$58$YR$$F$Y$$$20240722$$CN$US$US
236740292$23674029$2$F$20240321$20240814$20240326$20240816$PER$$US-AMGEN-USASP2024060844$AMGEN$$47$YR$A$M$Y$$$20240816$$CN$US$US
236740412$23674041$2$F$$20240730$20240326$20240809$EXP$$US-CIPLA LTD.-2024US02822$CIPLA$Le V, Surineni K, Elias G.. A case of partially reversible oral-buccal-lingual dyskinesia after prolonged Levetiracetam exposure. The American Journal of Geriatric Psychiatry. 2024;32 (4):S106$$$$$Y$$$20240809$$MD$US$US
236740534$23674053$4$F$$20240830$20240326$20240904$EXP$$NVSC2023GB103426$NOVARTIS$$$$A$F$Y$$$20240904$$CN$GB$GB
236740542$23674054$2$F$$20240711$20240326$20240723$PER$$US-SA-2024SA092055$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240723$$MD$US$US
236740603$23674060$3$F$20240301$20240819$20240326$20240823$PER$$US-BIOGEN-2024BI01256957$BIOGEN$$56$YR$$F$Y$$$20240823$$CN$US$US
236740645$23674064$5$F$$20240917$20240326$20240919$PER$$US-PFIZER INC-PV202400039003$PFIZER$$67$YR$$F$Y$$$20240919$$HP$US$US
236740788$23674078$8$F$20240101$20240911$20240326$20240913$EXP$$US-PFIZER INC-202400071713$PFIZER$$75$YR$$F$Y$80.74$KG$20240913$$CN$US$US
236740842$23674084$2$F$20240229$20240711$20240326$20240718$EXP$$BE-BEH-2024170057$CSL BEHRING$$87$YR$E$M$Y$85$KG$20240718$$HP$BE$BE
236741092$23674109$2$F$$20240717$20240326$20240723$EXP$$JP-009507513-2403JPN002759J$MERCK$$61$YR$$F$Y$$$20240723$$MD$JP$JP
236741168$23674116$8$F$20240131$20240918$20240326$20240926$EXP$$CA-JNJFOC-20240205314$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240926$$HP$CA$CA
236741203$23674120$3$F$20240101$20240903$20240326$20240912$EXP$$US-SA-2024SA092247$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240912$$MD$US$US
236741273$23674127$3$F$20240301$20240821$20240326$20240923$PER$$US-SA-2024SA090364$SANOFI AVENTIS$$64$YR$A$F$Y$54.43$KG$20240923$$MD$US$US
236741393$23674139$3$F$$20240806$20240326$20240811$EXP$$DE-JNJFOC-20240366279$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240811$$MD$DE$DE
236741432$23674143$2$F$$20240805$20240326$20240813$PER$$US-SA-2024SA094097$SANOFI AVENTIS$$$$A$F$Y$49.4$KG$20240814$$MD$US$US
236741534$23674153$4$F$20240215$20240703$20240326$20240710$PER$$US-INCYTE CORPORATION-2024IN002820$INCYTE$$$$$$Y$$$20240710$$MD$US$US
236741704$23674170$4$F$20240101$20240918$20240326$20240926$PER$$US-SA-2024SA092331$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240926$$MD$US$US
236741803$23674180$3$F$$20240904$20240326$20240904$PER$$NVSC2024US065100$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
236741812$23674181$2$F$$20240715$20240326$20240718$EXP$$NVSC2024CA063920$NOVARTIS$$27$YR$$F$Y$$$20240718$$HP$CA$CA
236741832$23674183$2$F$$20240923$20240326$20240924$EXP$$CA-ORGANON-O2403CAN002568$ORGANON$$48$YR$$F$Y$68$KG$20240924$$HP$CA$CA
236741977$23674197$7$F$20240301$20240716$20240326$20240726$EXP$$US-BEH-2024170178$CSL BEHRING$$50$YR$A$F$Y$63.2$KG$20240726$$CN$US$US
236742292$23674229$2$F$20240312$20240902$20240326$20240912$EXP$$US-BEH-2024170053$CSL BEHRING$$9$YR$C$M$Y$$$20240912$$HP$US$US
236742303$23674230$3$F$$20240819$20240326$20240830$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-046112$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$69$KG$20240830$$HP$CA$CA
2367423810$23674238$10$F$20210101$20240822$20240326$20240828$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219252$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$72.1$KG$20240828$$CN$US$US
236742663$23674266$3$F$$20240618$20240326$20240702$30DAY$$TR-JNJFOC-20240364237$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$TR$TR
236742722$23674272$2$F$$20240625$20240326$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02488$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236742852$23674285$2$F$20240322$20240801$20240326$20240805$PER$$US-AMGEN-USASP2024060410$AMGEN$$70$YR$E$F$Y$$$20240805$$CN$US$US
236742925$23674292$5$F$20240315$20240817$20240326$20240819$30DAY$$CL-PFIZER INC-PV202400036712$PFIZER$$8$YR$$F$Y$$$20240819$$CN$CL$CL
236743346$23674334$6$F$$20240716$20240326$20240718$PER$$US-PFIZER INC-PV202400040350$PFIZER$$78$YR$$F$Y$$$20240718$$HP$US$US
236743444$23674344$4$F$20240701$20240830$20240326$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048302$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240903$$CN$US$US
236744104$23674410$4$F$20240301$20240705$20240326$20240709$PER$$US-PFIZER INC-202400071772$PFIZER$$74$YR$$F$Y$$$20240709$$HP$US$US
236744193$23674419$3$F$20230619$20240624$20240326$20240701$EXP$$GB-MYLANLABS-2023M1065713$MYLAN$$57$YR$$M$Y$$$20240701$$MD$GB$GB
236744242$23674424$2$F$20240301$20240917$20240326$20240919$PER$$US-AMGEN-USASP2024061559$AMGEN$$72$YR$E$F$Y$$$20240918$$PH$US$US
236744285$23674428$5$F$20240409$20240827$20240326$20240903$EXP$$US-SA-2024SA092037$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240903$$CN$US$US
236744504$23674450$4$F$$20240801$20240326$20240802$PER$$US-PFIZER INC-PV202400039846$PFIZER$$62$YR$$F$Y$$$20240802$$HP$US$US
236745032$23674503$2$F$$20240312$20240326$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438097$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
236745622$23674562$2$F$20240301$20240723$20240326$20240815$PER$$US-TRAVERE-2024TVT00267$TRAVERE THERAPEUTICS$$60$YR$A$F$Y$$$20240815$$CN$US$US
236745653$23674565$3$F$20240101$20240829$20240326$20240912$PER$$US-SA-2024SA092682$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240912$$MD$US$US
236745742$23674574$2$F$20240219$20240904$20240326$20240911$EXP$$BR-TAKEDA-2023TUS109819$TAKEDA$$22$YR$$M$Y$27.8$KG$20240911$$MD$BR$BR
236745872$23674587$2$F$$20240830$20240326$20240905$EXP$$DE-OTSUKA-2018_000652$OTSUKA$Kaschka WP, Steyer J, Kaschka IN, Jandl M, Hodgkinson S.. The chemo brain: Severe cognitive decline following chemotherapy of breast cancer. Unknown. 2017;2:4-6$43$YR$$F$Y$$$20240905$$HP$DE$DE
236745992$23674599$2$F$20240201$20240613$20240326$20240730$PER$$US-TRAVERE-2024TVT00271$TRAVERE THERAPEUTICS$$34$YR$A$M$Y$$$20240730$$CN$US$US
236746044$23674604$4$F$$20240705$20240326$20240711$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000616$BLUEPRINT MEDICINES$$$$$M$Y$$$20240711$$CN$US$US
236746184$23674618$4$F$$20240923$20240326$20240925$30DAY$$CL-PFIZER INC-PV202400037424$PFIZER$$$$$$Y$$$20240925$$CN$CL$CL
236746342$23674634$2$F$$20240717$20240326$20240815$PER$$US-TRAVERE-2024TVT00277$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240815$$CN$US$US
236746353$23674635$3$F$20240101$20240731$20240326$20240805$PER$$US-KARYOPHARM-2024KPT000790$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240805$$CN$US$US
236746493$23674649$3$F$$20240913$20240326$20240918$30DAY$$CR-PFIZER INC-PV202400033532$PFIZER$$1$YR$$F$Y$$$20240918$$HP$CR$CR
236746514$23674651$4$F$$20240708$20240326$20240716$EXP$$US-TAKEDA-2024TUS028541$TAKEDA$$$$$F$Y$$$20240716$$MD$US$US
236746554$23674655$4$F$20240301$20240705$20240326$20240710$PER$$US-KARYOPHARM-2024KPT000798$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240710$$CN$US$US
236746562$23674656$2$F$20240124$20240820$20240326$20240827$EXP$$CA-TAKEDA-2024TUS016213$TAKEDA$$71$YR$$M$Y$$$20240827$$PH$CA$CA
236746635$23674663$5$F$20240301$20240816$20240326$20240822$PER$$US-TRAVERE-2024TVT00278$TRAVERE THERAPEUTICS$$64$YR$$M$Y$$$20240822$$CN$US$US
236746882$23674688$2$F$$20240919$20240326$20240925$EXP$$US-INCYTE CORPORATION-2024IN002968$INCYTE$$$$$$Y$$$20240925$$CN$US$US
236747052$23674705$2$F$20240304$20240902$20240326$20240905$EXP$SE-SEMPA-2024-002175$SE-009507513-2403SWE007600$MERCK$$54$YR$$F$Y$84$KG$20240905$$MD$SE$SE
236747129$23674712$9$F$$20240731$20240326$20240815$PER$$US-TRAVERE-2024TVT00281$TRAVERE THERAPEUTICS$$47$YR$A$M$Y$$$20240815$$CN$US$US
236747142$23674714$2$F$20231110$20240716$20240326$20240815$PER$$US-TRAVERE-2024TVT00282$TRAVERE THERAPEUTICS$$35$YR$A$M$Y$86.18$KG$20240815$$CN$US$US
236747304$23674730$4$F$$20240909$20240326$20240920$EXP$$US-PFIZER INC-202400071741$PFIZER$$61$YR$$M$Y$$$20240920$$CN$US$US
236747383$23674738$3$F$$20240918$20240326$20240920$EXP$$CA-PFIZER INC-2019467131$PFIZER$$55$YR$$F$Y$$$20240920$$HP$CA$CA
236747464$23674746$4$F$$20240706$20240326$20240709$PER$$NVSC2024US064842$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
236747522$23674752$2$F$20240301$20240821$20240326$20240827$EXP$$JP-009507513-2403JPN002900J$MERCK$$8$DEC$$M$Y$$$20240827$$MD$JP$JP
236747693$23674769$3$F$$20240701$20240326$20240815$PER$$US-TRAVERE-2024TVT00255$TRAVERE THERAPEUTICS$$33$YR$A$F$Y$$$20240815$$CN$US$US
236747724$23674772$4$F$20240322$20240708$20240326$20240722$PER$$US-Calliditas-2024CAL00481$CALLIDITAS THERAPEUTICS$$53$YR$A$M$Y$143$KG$20240722$$CN$US$US
236747734$23674773$4$F$20240320$20240709$20240326$20240722$PER$$US-Calliditas-2024CAL00479$CALLIDITAS THERAPEUTICS$$39$YR$A$F$Y$82.55$KG$20240722$$CN$US$US
236748282$23674828$2$F$$20240912$20240326$20240930$PER$$US-TRAVERE-2024TVT00292$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
236748293$23674829$3$F$$20240805$20240326$20240808$EXP$$US-Taiho Oncology Inc-2023-005516$TAIHO ONCOLOGY INC$$$$E$F$Y$$$20240808$$CN$US$US
236748455$23674845$5$F$$20240820$20240326$20240917$PER$$US-TRAVERE-2024TVT00265$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
236748543$23674854$3$F$20210916$20240723$20240326$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA032126$SANDOZ$$75$YR$$F$Y$$$20240731$$MD$CA$CA
236748803$23674880$3$F$$20240319$20240326$20240812$EXP$$AR-SANDOZ INC.-SDZ2024AR032470$SANDOZ$$$$$F$Y$$$20240812$$CN$AR$AR
236749472$23674947$2$F$20240207$20240702$20240326$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US032563$SANDOZ$$14$YR$$M$Y$$$20240703$$CN$US$US
236749994$23674999$4$F$$20240805$20240326$20240811$EXP$$RO-009507513-2403ROU007077$MERCK$Cavasi A, Stoleru I, Buzias M, Rusu I. Challenges in the management of checkpoint inhibitor induced liver injury. Journal of Gastrointestinal and Liver Diseases. 2023;32 (4):560-2$52$YR$$F$Y$$$20240811$$HP$RO$RO
236750033$23675003$3$F$20211023$20240718$20240326$20240726$EXP$$JP-ROCHE-3532166$ROCHE$Paku K, Shiraki T, Niki M, Tanaka G, Sato S and Yamaguchi T, Two Cases in Which Atezolizumab Was Used for Cardiac Metastasis of Hepatocellular Carcinoma.. The 56th Meeting of Japan Research for Appropriate Cancer Chemotherapy 2024;:48-.$80$YR$E$M$Y$51.1$KG$20240726$$MD$JP$JP
236750196$23675019$6$F$20240101$20240626$20240326$20240712$EXP$$US-BEH-2024170194$CSL BEHRING$$29$YR$A$F$Y$141$KG$20240712$$CN$US$US
236750464$23675046$4$F$$20240718$20240326$20240724$EXP$$CA-TAKEDA-2024TUS027344$TAKEDA$$72$YR$$F$Y$$$20240724$$HP$CA$CA
236750512$23675051$2$F$$20240322$20240326$20240814$EXP$$NVSC2024BR064303$NOVARTIS$$$$$F$Y$$$20240814$$CN$BR$BR
236750544$23675054$4$F$20240103$20240705$20240326$20240711$EXP$$CA-JNJFOC-20240109368$JOHNSON AND JOHNSON$$15$YR$T$M$Y$111$KG$20240712$$PH$CA$CA
236750702$23675070$2$F$20230801$20240923$20240326$20240924$EXP$FR-AFSSAPS-RE2024000284$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-045436$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$70$KG$20240925$$MD$FR$FR
236750752$23675075$2$F$$20240712$20240326$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-045192$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240712$$MD$JP$JP
236751003$23675100$3$F$20240101$20240802$20240326$20240807$EXP$$US-ABBVIE-5690048$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
236751482$23675148$2$F$$20240625$20240326$20240704$PER$$US-SA-2024SA093955$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240704$$CN$US$US
236751554$23675155$4$F$20240701$20240823$20240326$20240903$EXP$$US-SA-2024SA091644$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240903$$MD$US$US
236751696$23675169$6$F$20240201$20240702$20240326$20240708$EXP$$US-BIOGEN-2024BI01256845$BIOGEN$$39$YR$$F$Y$$$20240708$$CN$US$US
236752123$23675212$3$F$20210101$20240826$20240326$20240830$EXP$$US-ABBVIE-5691780$ABBVIE$$$$$F$Y$76$KG$20240830$$HP$US$US
236752204$23675220$4$F$20230305$20240705$20240326$20240728$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001324$ACADIA PHARMACEUTICALS$$93$YR$$F$Y$$$20240729$$CN$US$US
236752263$23675226$3$F$20230101$20240909$20240326$20240916$EXP$$US-ABBVIE-5690016$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
236752312$23675231$2$F$$20240712$20240327$20240717$EXP$$US-ABBVIE-5691325$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
236752586$23675258$6$F$20230101$20240808$20240327$20240812$EXP$$US-SA-2023SA258796$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240812$$MD$US$US
236752752$23675275$2$F$20240601$20240617$20240327$20240711$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001320$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240711$$HP$US$US
236753582$23675358$2$F$20240301$20240712$20240327$20240722$PER$$US-SA-2024SA087612$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240721$$MD$US$US
236753672$23675367$2$F$20240323$20240717$20240327$20240720$PER$$US-AMGEN-USASP2024061731$AMGEN$$73$YR$E$F$Y$$$20240720$$CN$US$US
236753744$23675374$4$F$20240101$20240913$20240327$20240921$EXP$$CA-CELLTRION INC.-2024CA002481$CELLTRION$$$$$$Y$$$20240921$$CN$CA$CA
236753954$23675395$4$F$20240124$20240822$20240327$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-013309$AUROBINDO$$57$YR$$F$Y$$$20240903$$MD$DE$DE
236754102$23675410$2$F$20240301$20240626$20240327$20240711$PER$$US-APOTEX-2024AP003630$APOTEX$$$$$M$Y$$$20240711$$CN$US$US
236754335$23675433$5$F$20240401$20240708$20240327$20240717$PER$$US-SA-2024SA092937$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240717$$MD$US$US
236754493$23675449$3$F$20221107$20240923$20240327$20240927$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-190961$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240927$$CN$CA$CA
236754632$23675463$2$F$$20240711$20240327$20240712$EXP$$CA-SANDOZ INC.-SDZ2024CA031283$SANDOZ$$$$$M$Y$$$20240712$$MD$CA$CA
236754712$23675471$2$F$20230601$20240814$20240327$20240823$EXP$$US-NOVOPROD-1194285$NOVO NORDISK$$$$$F$Y$$$20240823$$CN$US$US
236754748$23675474$8$F$20240101$20240708$20240327$20240717$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007846$UNITED THERAPEUTICS$$$$$F$Y$104.31$KG$20240717$$$US$US
236754862$23675486$2$F$$20240625$20240327$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02447$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236754943$23675494$3$F$20200916$20240917$20240327$20240918$EXP$$DE-SANDOZ INC.-SDZ2024DE030765$SANDOZ$$29$YR$$F$Y$$$20240918$$CN$DE$DE
236755022$23675502$2$F$20220726$20240709$20240327$20240718$EXP$$CA-CELLTRION INC.-2024CA004890$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
236755182$23675518$2$F$$20240625$20240327$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02503$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236755223$23675522$3$F$20240304$20240902$20240327$20240906$EXP$$JP-ABBVIE-5693252$ABBVIE$$86$YR$$M$Y$50$KG$20240906$$MD$JP$JP
236755387$23675538$7$F$$20240818$20240327$20240820$PER$$NVSC2024US065153$NOVARTIS$$$$$$Y$$$20240820$$CN$US$US
236755413$23675541$3$F$20240324$20240828$20240327$20240829$PER$$US-AMGEN-USASP2024061345$AMGEN$$58$YR$A$M$Y$$$20240829$$CN$US$US
236755636$23675563$6$F$$20240905$20240327$20240915$EXP$$ES-AUROBINDO-AUR-APL-2024-013241$AUROBINDO$Villanueva Sanchez, Elena, Heras Benito, Manuel.. Reversible renal impairment after administration of a single dose of Azacitidine. Medicina Cl?nica.. 2024;S0025- 7753(24:00065-4$74$YR$$F$Y$$$20240915$$HP$ES$ES
236755744$23675574$4$F$20240226$20240627$20240327$20240703$EXP$$CA-JNJFOC-20240356661$JOHNSON AND JOHNSON$$33$YR$A$M$Y$104$KG$20240703$$HP$CA$CA
236756212$23675621$2$F$$20240710$20240327$20240716$EXP$$GB-SANDOZ INC.-SDZ2024GB032261$SANDOZ$$$$$F$Y$$$20240716$$CN$GB$GB
236756433$23675643$3$F$20240101$20240906$20240327$20240926$PER$$US-SA-2024SA090520$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240926$$MD$US$US
236756483$23675648$3$F$20240323$20240718$20240327$20240723$PER$$US-AMGEN-USASP2024061714$AMGEN$$63$YR$A$M$Y$$$20240723$$CN$US$US
236756592$23675659$2$F$$20240722$20240327$20240729$EXP$$US-HETERO-HET2024US00781$HETERO$Pires KD, Bloom J, Golob S, Sahagun BE, Greco AA, Chebolu E et.al.. Successful Treatment of Confirmed Severe Bupropion Cardiotoxicity With Veno-Arterial Extracorporeal Membrane Oxygenation Initiation Prior to Cardiac Arrest. Cureus. 2024;16(2):1-6$32$YR$$$Y$49.9$KG$20240729$$HP$US$US
236756643$23675664$3$F$$20240624$20240327$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047907$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$108.66$KG$20240710$$CN$US$US
236756766$23675676$6$F$20240101$20240712$20240327$20240722$EXP$$CA-CELLTRION INC.-2024CA007354$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
236756972$23675697$2$F$$20240803$20240327$20240808$PER$$NVSC2024US065193$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
236757166$23675716$6$F$20220829$20240920$20240327$20240930$EXP$$CA-CELLTRION INC.-2022CA006245$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
236757273$23675727$3$F$20230101$20240709$20240327$20240718$EXP$$CA-CELLTRION INC.-2023CA008384$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
236757295$23675729$5$F$20220506$20240822$20240327$20240827$EXP$$US-ABBVIE-5689086$ABBVIE$$52$YR$$F$Y$72$KG$20240827$$HP$US$US
236757324$23675732$4$F$20230101$20240626$20240327$20240704$EXP$$US-UNITED THERAPEUTICS-UNT-2024-002914$UNITED THERAPEUTICS$$$$$M$Y$75.465$KG$20240704$$$US$US
236757423$23675742$3$F$$20240723$20240327$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048726$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240725$$HP$US$US
236757542$23675754$2$F$$20240625$20240327$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02493$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236757562$23675756$2$F$$20240718$20240327$20240726$EXP$$CA-SHIRE-CA201912161AA$TAKEDA$$$$$M$Y$$$20240726$$CN$CA$CA
236757613$23675761$3$F$20240301$20240626$20240327$20240930$PER$$US-ARDELYX-2024ARDX000733$ARDELYX$$63$YR$$F$Y$59$KG$20240930$$CN$US$US
236757675$23675767$5$F$$20240718$20240327$20240725$PER$$NVSC2024US060812$NOVARTIS$$32$YR$$F$Y$$$20240725$$CN$US$US
236757702$23675770$2$F$$20240724$20240327$20240728$EXP$$CA-JNJFOC-20240353499$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240729$$HP$CA$CA
236757752$23675775$2$F$$20240301$20240327$20240723$PER$$US-TEVA-VS-3166982$TEVA$$$$A$F$Y$$$20240723$$CN$US$US
236757767$23675776$7$F$$20240625$20240327$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02456$LUPIN$$$$$$Y$$$20240705$$CN$US$US
236757962$23675796$2$F$20231101$20240822$20240327$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2023-033403$UNITED THERAPEUTICS$$77$YR$$F$Y$51.701$KG$20240831$$PH$US$US
236758582$23675858$2$F$$20240221$20240327$20240723$EXP$$US-TEVA-VS-3161158$TEVA$$$$$F$Y$$$20240723$$CN$US$US
236758602$23675860$2$F$20240101$20240816$20240327$20240829$PER$$US-SA-2024SA092944$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240829$$MD$US$US
236758754$23675875$4$F$20240503$20240729$20240327$20240806$EXP$$CA-CELLTRION INC.-2024CA007373$CELLTRION$$$$$$Y$$$20240806$$CN$CA$CA
236758853$23675885$3$F$20240301$20240923$20240327$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046682$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240926$$PH$US$US
236759192$23675919$2$F$$20240620$20240327$20240930$PER$$US-ARDELYX-2023ARDX000990$ARDELYX$$$$$F$Y$84$KG$20240930$$HP$US$US
236759532$23675953$2$F$20231101$20240221$20240327$20240723$EXP$$US-TEVA-VS-3161256$TEVA$$76$YR$$F$Y$$$20240723$$CN$US$US
236759582$23675958$2$F$$20240627$20240327$20240706$EXP$$JP-ROCHE-3533208$ROCHE$$$$E$M$Y$$$20240706$$MD$JP$JP
236759763$23675976$3$F$20130101$20240805$20240327$20240812$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-016466$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$$$20240812$$CN$US$US
236760276$23676027$6$F$$20240918$20240327$20240927$EXP$$US-TAKEDA-2024TUS027734$TAKEDA$$$$$F$Y$$$20240927$$HP$US$US
236760812$23676081$2$F$20240324$20240810$20240327$20240812$PER$$US-AMGEN-USASP2024061932$AMGEN$$77$YR$E$F$Y$$$20240812$$CN$US$US
236761073$23676107$3$F$$20240321$20240327$20240806$EXP$$NVSC2024US015682$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
236761142$23676114$2$F$20231109$20240906$20240327$20240910$EXP$PT-INFARMED-R202403-496$PT-JNJFOC-20240372684$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240910$$MD$PT$PT
236761452$23676145$2$F$20240215$20240917$20240327$20240920$EXP$$NVSC2024FR063663$NOVARTIS$$$$E$F$Y$57$KG$20240920$$MD$FR$FR
236761593$23676159$3$F$$20240625$20240327$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02487$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236761693$23676169$3$F$20231227$20240626$20240327$20240706$EXP$$JP-ROCHE-3532879$ROCHE$$70$YR$E$F$Y$37.8$KG$20240706$$MD$JP$JP
236761704$23676170$4$F$20231215$20240724$20240327$20240729$EXP$$AM-ROCHE-3533180$ROCHE$$64$YR$A$M$Y$$$20240729$$CN$AM$AM
236761713$23676171$3$F$$20240625$20240327$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02500$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236761834$23676183$4$F$$20240918$20240327$20240926$EXP$$NVSC2024US065085$NOVARTIS$$$$$F$Y$$$20240927$$MD$US$US
236761932$23676193$2$F$$20240625$20240327$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02504$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236762042$23676204$2$F$20240124$20240802$20240327$20240809$PER$$CA-TOLMAR, INC.-24CA047506$TOLMAR$$74$YR$$M$Y$$$20240809$$CN$CA$CA
236762454$23676245$4$F$20240228$20240626$20240327$20240703$EXP$$CA-GSK-CA2023132449$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$CA$CA
236762495$23676249$5$F$20240318$20240910$20240327$20240920$EXP$$US-GSK-US2024AMR037624$GLAXOSMITHKLINE$$62$YR$$F$Y$65.76$KG$20240920$$CN$US$US
236762583$23676258$3$F$20240101$20240826$20240327$20240919$PER$$AU-TOLMAR, INC.-24AU047378$TOLMAR$$$$$M$Y$$$20240919$$CN$AU$AU
236762813$23676281$3$F$$20240830$20240327$20240902$EXP$$US-SANDOZ INC.-SDZ2023US005753$SANDOZ$$$$$M$Y$77.11$KG$20240902$$MD$US$US
236763224$23676322$4$F$20240205$20240816$20240327$20240828$EXP$$NL-AUROBINDO-AUR-APL-2024-013448$AUROBINDO$$67$YR$$F$Y$60.3$KG$20240828$$MD$NL$NL
236763623$23676362$3$F$20240311$20240723$20240327$20240802$EXP$$BE-BEH-2023165760$CSL BEHRING$$61$YR$A$M$Y$$$20240802$$HP$BE$BE
236763833$23676383$3$F$$20240625$20240327$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02457$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236763862$23676386$2$F$$20240710$20240327$20240715$30DAY$$US-SANDOZ INC.-SDZ2023US010705$SANDOZ$$$$$M$Y$88.45$KG$20240715$$HP$US$US
236763923$23676392$3$F$$20240820$20240327$20240826$EXP$$US-TAKEDA-2023TUS121262$TAKEDA$$$$$F$Y$$$20240826$$HP$US$US
236764183$23676418$3$F$$20240625$20240327$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02458$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236764222$23676422$2$F$$20240729$20240327$20240806$EXP$$US-APOTEX-2024AP003752$APOTEX$On S, Domingo W, Cheung E, Johnston L.. Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2024;30 (2):S163$$$A$$Y$$$20240806$$HP$US$US
236764592$23676459$2$F$20191128$20240805$20240327$20240809$EXP$$US-TAKEDA-US201943759$TAKEDA$$65$YR$$F$Y$$$20240809$$HP$US$US
236764627$23676462$7$F$20231108$20240718$20240327$20240727$EXP$$JP-ABBVIE-5517672$ABBVIE$$69$YR$$M$Y$65$KG$20240727$$MD$JP$JP
236764884$23676488$4$F$20240107$20240628$20240327$20240706$EXP$$DE-BAXTER-2024BAX010595$BAXTER$$52$YR$$F$Y$$$20240706$$HP$DE$DE
236765205$23676520$5$F$$20240802$20240327$20240812$EXP$$US-862174955-ML2024-01911$MICRO LABS$$64$YR$A$M$Y$81.6$KG$20240812$$CN$US$US
236765332$23676533$2$F$$20240903$20240327$20240910$EXP$$US-TAKEDA-2024TUS027949$TAKEDA$$$$$M$Y$$$20240910$$CN$US$US
236765654$23676565$4$F$20230930$20240708$20240327$20240715$EXP$$DE-TAKEDA-2023TUS118719$TAKEDA$$50$YR$$F$Y$63$KG$20240715$$MD$DE$DE
236766393$23676639$3$F$$20240805$20240327$20240806$EXP$$PT-AUROBINDO-AUR-APL-2024-013455$AUROBINDO$S? B, Lopes M, Robalo J. Voluntary drug intoxication in adolescents: impact of COVID-19 pandemic. Portuguese Journal of Pediatrics. 2024;55(1):20-26$17$YR$$F$Y$$$20240806$$HP$PT$PT
236766452$23676645$2$F$$20240804$20240327$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048566$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$85.28$KG$20240805$$CN$US$US
236766483$23676648$3$F$$20240723$20240327$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048930$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240724$$HP$US$US
236767022$23676702$2$F$$20240822$20240327$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048605$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240824$$HP$US$US
236767052$23676705$2$F$$20240911$20240327$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048730$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240912$$CN$US$US
236767223$23676722$3$F$20240215$20240905$20240327$20240911$EXP$$JP-ROCHE-3532874$ROCHE$$42$YR$A$F$Y$65$KG$20240911$$MD$JP$JP
236767242$23676724$2$F$$20240729$20240327$20240731$EXP$$US-TAKEDA-2023TUS095020$TAKEDA$$$$$F$Y$$$20240731$$CN$US$US
236767293$23676729$3$F$$20240624$20240327$20240702$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000659$BLUEPRINT MEDICINES$$$$$F$Y$$$20240702$$CN$US$US
236767593$23676759$3$F$$20240830$20240327$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047933$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240905$$CN$US$US
236767842$23676784$2$F$$20240718$20240327$20240730$EXP$$CA-TAKEDA-2024TUS026908$TAKEDA$$32$YR$$F$Y$$$20240730$$HP$CA$CA
236767984$23676798$4$F$$20240912$20240327$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048978$BRISTOL MYERS SQUIBB$$31$YR$A$F$Y$$$20240917$$HP$US$US
236768432$23676843$2$F$20240324$20240728$20240327$20240730$PER$$US-AMGEN-USASP2024062110$AMGEN$$49$YR$A$M$Y$$$20240730$$CN$US$US
236768484$23676848$4$F$20240405$20240710$20240327$20240712$EXP$$CA-TAKEDA-2024TUS028181$TAKEDA$$28$YR$$M$Y$$$20240712$$CN$CA$CA
236768752$23676875$2$F$$20240711$20240327$20240713$EXP$$GB-ABBVIE-5694026$ABBVIE$$$$E$M$Y$$$20240713$$CN$GB$GB
236768804$23676880$4$F$$20240701$20240327$20240711$EXP$$US-INSMED, INC.-2024-01095-US$INSMED$$$$$F$Y$$$20240711$$CN$US$US
236768832$23676883$2$F$20240201$20240909$20240327$20240916$EXP$$CA-GSK-CA2023AMR083027$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$CA$CA
236768914$23676891$4$F$$20240710$20240327$20240715$PER$$US-BIOVITRUM-2024-US-004699$BIOVITRUM$$70$YR$$F$Y$$$20240715$$MD$US$US
236769082$23676908$2$F$20240324$20240711$20240327$20240712$PER$$US-AMGEN-USASP2024061931$AMGEN$$57$YR$A$F$Y$$$20240712$$CN$US$US
236769482$23676948$2$F$20230101$20240319$20240327$20240802$EXP$$NVSC2024PL062031$NOVARTIS$$23$YR$$F$Y$$$20240802$$MD$PL$PL
236770042$23677004$2$F$20240319$20240710$20240327$20240712$PER$$US-AMGEN-USASP2024060423$AMGEN$$63$YR$A$M$Y$$$20240712$$CN$US$US
236770082$23677008$2$F$20240323$20240706$20240327$20240708$PER$$NVSC2024US064932$NOVARTIS$$39$YR$$M$Y$$$20240708$$CN$US$US
236770496$23677049$6$F$20240301$20240731$20240327$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-008508$UNITED THERAPEUTICS$$68$YR$$F$Y$90.249$KG$20240809$$$US$US
236770633$23677063$3$F$20240313$20240719$20240327$20240730$EXP$$JP-ROCHE-3530795$ROCHE$$76$YR$E$M$Y$73.4$KG$20240730$$PH$JP$JP
236770843$23677084$3$F$$20240910$20240327$20240912$EXP$$CL-JNJFOC-20240280795$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240912$$CN$CL$CL
236771035$23677103$5$F$20230802$20240716$20240327$20240723$EXP$$CA-GSK-CA2023105649$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$HP$CA$CA
236771405$23677140$5$F$$20240913$20240327$20240918$30DAY$$US-PFIZER INC-202400067118$PFIZER$$15$YR$$M$Y$46.27$KG$20240918$$CN$US$US
236771617$23677161$7$F$20240318$20240923$20240327$20240926$30DAY$$US-PFIZER INC-202400068548$PFIZER$$13$YR$$M$Y$68.027$KG$20240926$$CN$US$US
236771628$23677162$8$F$20240101$20240913$20240327$20240918$30DAY$$US-PFIZER INC-202400067064$PFIZER$$16$YR$$M$Y$$$20240918$$CN$US$US
236771645$23677164$5$F$$20240811$20240327$20240812$30DAY$$US-PFIZER INC-202400068111$PFIZER$$28$YR$$F$Y$168.74$KG$20240812$$CN$US$US
236771712$23677171$2$F$20240215$20240906$20240327$20240913$EXP$$NVSC2024FR064476$NOVARTIS$$70$YR$$M$Y$81$KG$20240913$$MD$FR$FR
236771834$23677183$4$F$20240315$20240710$20240327$20240720$EXP$$BR-TAKEDA-2024TUS026953$TAKEDA$$53$YR$$F$Y$54$KG$20240720$$CN$BR$BR
236771937$23677193$7$F$20240401$20240809$20240327$20240816$EXP$$CA-GSK-CA2024036816$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$HP$CA$CA
236772048$23677204$8$F$$20240924$20240327$20240926$30DAY$$US-PFIZER INC-202400067969$PFIZER$$13$YR$$M$Y$$$20240926$$CN$US$US
236772065$23677206$5$F$$20240919$20240327$20240926$30DAY$$US-PFIZER INC-202400068257$PFIZER$$16$YR$$M$Y$52.16$KG$20240926$$CN$US$US
236772302$23677230$2$F$$20240909$20240327$20240919$EXP$$NVSJ2024JP003623$NOVARTIS$Shindo T, Sakurai M, Inoue T, Masuda K, Fujii T, Nakayasu M, et al. Two DLBCL cases of pseudo-progression following CAR-T cell therapy. Program and Abstracts for The 46th Annual Meeting of Japanese Society for Transp. 2024;O3-4$48$YR$$F$Y$$$20240919$$HP$JP$JP
236772312$23677231$2$F$$20240909$20240327$20240918$EXP$$NVSJ2024JP003624$NOVARTIS$Shindo T, Sakurai M, Inoue T, Masuda K, Fujii T, Nakayasu M, et al. Two DLBCL cases of pseudo-progression following CAR-T cell therapy. Program and Abstracts for The 46th Annual Meeting of Japanese Society for Transp. 2024;O3-4$71$YR$$F$Y$$$20240918$$HP$JP$JP
236772343$23677234$3$F$20220603$20240619$20240327$20240814$EXP$$NVSC2023IN280311$NOVARTIS$$79$YR$$F$Y$$$20240814$$CN$IN$IN
236772452$23677245$2$F$20230101$20240731$20240327$20240807$EXP$$JP-009507513-2310JPN001680J$MERCK$$7$DEC$$M$Y$$$20240807$$MD$JP$JP
236772735$23677273$5$F$20240102$20240819$20240327$20240827$EXP$$CN-ROCHE-3530426$ROCHE$$25$WK$I$F$Y$1$KG$20240827$$MD$CN$CN
236772816$23677281$6$F$20230628$20240904$20240327$20240911$EXP$$CA-GSK-CA2023AMR097071$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$HP$CA$CA
236773805$23677380$5$F$$20240806$20240327$20240807$PER$$US-ALXN-202403USA001287US$ALEXION PHARMACEUTICALS$$$$$M$Y$15.2$KG$20240807$$MD$US$US
236773852$23677385$2$F$20240304$20240620$20240327$20240710$PER$$CA-TOLMAR, INC.-24CA047419$TOLMAR$$67$YR$$M$Y$$$20240710$$CN$CA$CA
236773983$23677398$3$F$$20240722$20240327$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US031821$SANDOZ$$$$$M$Y$$$20240724$$CN$US$US
236774812$23677481$2$F$$20240716$20240327$20240816$PER$$US-Eisai-EC-2024-157569$EISAI$$67$YR$E$F$Y$$$20240816$$MD$US$US
236775003$23677500$3$F$$20240827$20240327$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-047464$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240829$$MD$JP$JP
236775374$23677537$4$F$$20240914$20240327$20240919$30DAY$$GB-PFIZER INC-PV202400034150$PFIZER$$22$YR$$F$Y$$$20240919$$CN$GB$GB
236775895$23677589$5$F$20221201$20240830$20240327$20240906$EXP$$CA-JNJFOC-20230211705$JOHNSON AND JOHNSON$$50$YR$A$M$Y$97$KG$20240906$$HP$CA$CA
236776002$23677600$2$F$20231218$20240821$20240327$20240822$EXP$PT-INFARMED-B202403-203$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-043906$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240822$$MD$PT$PT
236776293$23677629$3$F$20240220$20240603$20240327$20240821$EXP$$JP-ROCHE-3531348$ROCHE$$78$YR$E$M$Y$$$20240821$$MD$JP$JP
236776583$23677658$3$F$20240311$20240627$20240327$20240702$EXP$$JP-GENMAB-2024-00956$GENMAB$$89$YR$$F$Y$$$20240702$$MD$JP$JP
236776733$23677673$3$F$$20240805$20240327$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047054$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240807$$CN$US$US
236776852$23677685$2$F$$20240918$20240327$20240918$PER$$NVSC2024US065770$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
236777083$23677708$3$F$$20240909$20240327$20240919$PER$$US-ABBVIE-5690588$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
236777113$23677711$3$F$20231101$20240723$20240327$20240730$EXP$$CA-ROCHE-3332643$ROCHE$$51$YR$A$F$Y$54.9$KG$20240730$$CN$CA$CA
236777904$23677790$4$F$20240322$20240805$20240327$20240808$EXP$$CA-TAKEDA-2024TUS028141$TAKEDA$$27$YR$$M$Y$$$20240808$$MD$CA$CA
236777912$23677791$2$F$$20240909$20240327$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048853$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$86.64$KG$20240910$$CN$US$US
236778598$23677859$8$F$20240307$20240701$20240327$20240703$30DAY$$CN-PFIZER INC-PV202400032427$PFIZER$$36$YR$$M$Y$$$20240703$$CN$CN$CN
236778985$23677898$5$F$20240220$20240718$20240327$20240724$PER$$US-AMGEN-USASP2024062026$AMGEN$$43$YR$A$M$Y$$$20240724$$CN$US$US
236779012$23677901$2$F$20230915$20240807$20240327$20240814$EXP$$US-ABBVIE-5691242$ABBVIE$$42$YR$$M$Y$$$20240814$$CN$US$US
236779134$23677913$4$F$$20240625$20240327$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02461$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236779656$23677965$6$F$$20240626$20240327$20240704$EXP$$NVSC2023CA280373$NOVARTIS$$44$YR$$F$Y$70$KG$20240704$$HP$CA$CA
236779822$23677982$2$F$20240315$20240702$20240327$20240705$EXP$$CA-JNJFOC-20240362822$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240705$$CN$CA$CA
236779882$23677988$2$F$$20240716$20240327$20240724$EXP$$BE-BEH-2024170147$CSL BEHRING$$$$A$F$Y$65$KG$20240724$$HP$BE$BE
236780292$23678029$2$F$$20240715$20240327$20240722$PER$$US-ALXN-202403USA001068US$ALEXION PHARMACEUTICALS$$$$A$M$Y$$$20240722$$CN$US$US
236780323$23678032$3$F$$20240826$20240327$20240904$30DAY$$MX-PFIZER INC-PV202400036741$PFIZER$$$$$F$Y$$$20240904$$CN$MX$MX
236780332$23678033$2$F$20230723$20240703$20240327$20240703$EXP$$FR-PFIZER INC-PV202300195083$PFIZER$$69$YR$$F$Y$47$KG$20240703$$MD$FR$FR
236780442$23678044$2$F$$20240726$20240327$20240729$EXP$$CA-SANDOZ INC.-NVSC2022CA115847$SANDOZ$$$$$M$Y$$$20240729$$CN$CA$CA
236780683$23678068$3$F$$20240918$20240327$20240920$EXP$$MX-PFIZER INC-PV202400039327$PFIZER$$$$T$F$Y$$$20240920$$CN$MX$MX
236781184$23678118$4$F$20240314$20240702$20240327$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048540$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$117.9$KG$20240702$$CN$US$US
236781302$23678130$2$F$20240316$20240814$20240327$20240821$EXP$$ZA-Vifor (International) Inc.-VIT-2024-02689$VIFOR$$65$YR$$F$Y$$$20240821$$HP$ZA$ZA
236781405$23678140$5$F$20240201$20240730$20240327$20240806$EXP$$DE-009507513-2403DEU007353$MERCK$$$$$M$Y$$$20240806$$CN$DE$DE
236781684$23678168$4$F$$20240705$20240327$20240709$PER$$NVSC2024US065625$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
236782042$23678204$2$F$$20240822$20240327$20240827$PER$$US-VERTEX PHARMACEUTICALS-2024-005079$VERTEX$$$$A$$Y$$$20240827$$CN$US$US
236782072$23678207$2$F$20240101$20240625$20240327$20240702$EXP$$GB-VERTEX PHARMACEUTICALS-2024-005387$VERTEX$$$$A$M$Y$$$20240702$$CN$GB$GB
236782303$23678230$3$F$20231214$20240912$20240327$20240919$EXP$$CA-TAKEDA-2024TUS028095$TAKEDA$$62$YR$$M$Y$$$20240919$$CN$CA$CA
236782352$23678235$2$F$20230306$20240911$20240327$20240916$EXP$$CN-Eisai-EC-2023-142995$EISAI$$66$YR$E$F$Y$43$KG$20240916$$MD$CN$CN
236782453$23678245$3$F$20231101$20240730$20240327$20240803$EXP$$US-ABBVIE-5506804$ABBVIE$$58$YR$$F$Y$$$20240803$$CN$US$US
236782492$23678249$2$F$20240310$20240913$20240327$20240919$EXP$$CA-TAKEDA-2024TUS025345$TAKEDA$$56$YR$$M$Y$$$20240919$$CN$CA$CA
236782649$23678264$9$F$20240101$20240801$20240327$20240809$EXP$$CA-PFIZER INC-202400071723$PFIZER$$36$YR$$F$Y$$$20240809$$MD$CA$CA
236783013$23678301$3$F$$20240822$20240327$20240905$PER$$US-SA-2024SA091044$SANOFI AVENTIS$$$$A$F$Y$102$KG$20240905$$MD$US$US
236783222$23678322$2$F$$20240708$20240327$20240717$PER$$US-SA-2024SA092156$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240717$$MD$US$US
236783402$23678340$2$F$20240201$20240712$20240327$20240723$PER$$US-SA-2024SA092222$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240723$$MD$US$US
236783683$23678368$3$F$$20240703$20240327$20240712$PER$$US-SA-2024SA092728$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240712$$MD$US$US
236783803$23678380$3$F$20240101$20240715$20240327$20240723$PER$$US-SA-2024SA094334$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240723$$MD$US$US
236783912$23678391$2$F$$20240722$20240327$20240731$PER$$US-SA-2023SA076871$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240731$$HP$US$US
236784173$23678417$3$F$20240201$20240815$20240327$20240822$EXP$$US-BAYER-2024A043497$BAYER$$28$YR$A$M$Y$$$20240822$$CN$US$US
236784252$23678425$2$F$$20240913$20240327$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA032809$SANDOZ$$23$YR$$F$Y$$$20240916$$HP$CA$CA
236784744$23678474$4$F$20220425$20240726$20240327$20240809$EXP$$US-UCBSA-2023042173$UCB$$2$YR$$M$Y$$$20240809$$MD$US$US
236784812$23678481$2$F$20240222$20240920$20240327$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048270$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240925$$HP$US$US
236784912$23678491$2$F$$20240715$20240327$20240724$EXP$$CA-AMGEN-CANSP2024055075$AMGEN$$40$YR$A$F$Y$96$KG$20240724$$HP$CA$CA
236785152$23678515$2$F$$20240726$20240327$20240802$PER$$US-SA-2024SA090146$SANOFI AVENTIS$$$$A$F$Y$96.61$KG$20240802$$MD$US$US
236785263$23678526$3$F$20231227$20240717$20240327$20240725$EXP$$JP-AstraZeneca-2024A070179$ASTRAZENECA$$80$YR$$F$Y$48$KG$20240725$$MD$JP$
236785463$23678546$3$F$$20240828$20240327$20240903$EXP$$CA-JNJFOC-20240363842$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240903$$HP$CA$CA
236785853$23678585$3$F$20240318$20240319$20240327$20240809$EXP$$NVSC2023US269268$NOVARTIS$$75$YR$$F$Y$$$20240809$$CN$US$US
236786162$23678616$2$F$20240309$20240709$20240327$20240722$EXP$$TH-ROCHE-3533346$ROCHE$$78$YR$E$M$Y$$$20240719$$CN$TH$TH
236786202$23678620$2$F$20240227$20240315$20240327$20240801$EXP$$US-SCPHARMACEUTICALS-2024-SCPH-US000117$PAREXEL$$89$YR$$M$Y$58.957$KG$20240801$$CN$US$US
236786365$23678636$5$F$20240101$20240805$20240327$20240807$EXP$$US-PFIZER INC-202400070897$PFIZER$$66$YR$$M$Y$98.88$KG$20240807$$CN$US$US
236786512$23678651$2$F$$20240712$20240327$20240717$EXP$$US-PFIZER INC-PV202400007864$PFIZER$$62$YR$$M$Y$$$20240717$$HP$US$US
236786684$23678668$4$F$$20240726$20240327$20240730$30DAY$$TR-PFIZER INC-202400051998$PFIZER$$13$YR$$F$Y$59$KG$20240730$$PH$TR$TR
236786832$23678683$2$F$$20240625$20240327$20240701$EXP$$CA-Atnahs Limited-2020SF15804$Atnahs Healthcare$$53$YR$A$M$Y$$$20240701$$MD$CA$CA
236786922$23678692$2$F$20240101$20240730$20240327$20240807$PER$$US-SA-2024SA091405$SANOFI AVENTIS$$41$YR$A$F$Y$108.8$KG$20240807$$MD$US$US
236787212$23678721$2$F$$20240702$20240327$20240705$EXP$$US-AGIOS-2403US03697$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
236787273$23678727$3$F$$20240531$20240327$20240806$EXP$$NVSC2024US062743$NOVARTIS$Sebastian W, Omar KO, Anees R, Nagaraju S, Chaitanya M. A Rare Case of Donor-Derived Renal Cell Carcinoma in a Kidney Transplant Recipient. AMERICAL JOURNAL OF CASE REPORT. 2024;25:e941214-4$71$YR$$F$Y$$$20240806$$HP$US$US
236787405$23678740$5$F$20240220$20240722$20240327$20240725$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-001666$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240725$$HP$US$US
236787613$23678761$3$F$20240326$20240806$20240327$20240808$PER$$US-AMGEN-USASP2024062623$AMGEN$$77$YR$E$F$Y$$$20240808$$CN$US$US
236788135$23678813$5$F$20230811$20240919$20240327$20240920$EXP$$US-TAKEDA-2023TUS081549$TAKEDA$$51$YR$$F$Y$$$20240920$$CN$US$US
236788175$23678817$5$F$20240325$20240716$20240327$20240722$EXP$$GB-MYLANLABS-2024M1022982$MYLAN$$45$YR$$M$Y$$$20240722$$MD$GB$GB
236788545$23678854$5$F$20240201$20240826$20240327$20240831$EXP$$NVSC2023BR193352$NOVARTIS$$62$YR$$M$Y$$$20240831$$CN$BR$BR
236788606$23678860$6$F$20240402$20240625$20240327$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044319$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240702$$CN$US$US
236788652$23678865$2$F$20220204$20240722$20240327$20240731$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-137864$BRISTOL MYERS SQUIBB$Arnould B, Miranda S, Mignon F, Camus V. G-CSF-induced TIPIC syndrome and large vessel vasculitis: a case report. Clinical Case Reports. 2023 Sep 01;11(9):1-5. doi:10.1002/ccr3.7918.$73$YR$E$F$Y$$$20240731$$HP$FR$FR
236788733$23678873$3$F$20240226$20240723$20240327$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047040$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240725$$HP$US$US
236788952$23678895$2$F$20240814$20240814$20240327$20240828$PER$$US-SA-2024SA094400$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240828$$MD$US$US
236788993$23678899$3$F$$20240821$20240327$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02479$LUPIN$$$$$$Y$$$20240909$$CN$US$US
236789006$23678900$6$F$20240301$20240704$20240327$20240710$EXP$$MA-EMD Serono-2024015643$EMD SERONO INC$$19$YR$A$F$Y$$$20240710$$CN$MA$MA
236789522$23678952$2$F$20240326$20240725$20240327$20240726$PER$$US-AMGEN-USASP2024062886$AMGEN$$40$YR$A$M$Y$$$20240726$$CN$US$US
236790072$23679007$2$F$$20240905$20240327$20240910$EXP$$GB-MYLANLABS-2024M1027439$MYLAN$Menzies V.. Anxiety drug pregabalin killed my son and hundreds more are dying from it.. The Sunday Times.. 2024$45$YR$$F$Y$$$20240910$$CN$GB$GB
236791714$23679171$4$F$20240101$20240701$20240327$20240710$PER$$US-SA-2024SA090452$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240710$$MD$US$US
236792093$23679209$3$F$20240101$20240917$20240327$20240924$PER$$US-SA-2024SA090536$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240924$$MD$US$US
236792112$23679211$2$F$20240101$20240726$20240327$20240807$PER$$US-SA-2024SA092729$SANOFI AVENTIS$$63$YR$A$M$Y$96$KG$20240807$$MD$US$US
236792384$23679238$4$F$20240101$20240821$20240327$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048001$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240823$$CN$US$US
236792526$23679252$6$F$20240315$20240820$20240327$20240912$EXP$$AR-BIOMARINAP-AR-2024-156794$BIOMARIN$$$$$$Y$$$20240912$$HP$AR$AR
236793119$23679311$9$F$20240301$20240709$20240327$20240713$EXP$$PT-ABBVIE-5679932$ABBVIE$$75$YR$$F$Y$$$20240713$$CN$PT$PT
236793244$23679324$4$F$20240204$20240913$20240327$20240918$EXP$$CH-AMERICAN REGENT INC-2024001069$AMERICAN REGENT$$87$YR$$F$Y$48$KG$20240918$$MD$CH$CH
236793442$23679344$2$F$$20240719$20240327$20240722$PER$$US-PFIZER INC-PV202400040497$PFIZER$$85$YR$$F$Y$$$20240722$$CN$US$US
236793662$23679366$2$F$$20240625$20240327$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02489$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236793792$23679379$2$F$$20240709$20240327$20240717$EXP$$JP-009507513-2403JPN002909J$MERCK$Imao M, Tanaka Y, Ikeuchi M, Yamamoto H, Kume S, Inao T, et al.. An Autopsy of a Patient with Strongly PD-L1-positive SMARCA4-deficient Large Cell Lung Cancer Treated with Pembrolizumab Who Died of Hyperprogressive Disease. Japanese journal of lung cancer. 2024;64(1):22-7$87$YR$$M$Y$45.1$KG$20240717$$MD$JP$JP
236793802$23679380$2$F$$20240626$20240327$20240703$EXP$$CO-GSK-CO2024AMR037959$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CO$CO
236793932$23679393$2$F$20240310$20240627$20240327$20240701$EXP$$US-KARYOPHARM-2024KPT000828$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240701$$CN$US$US
236794052$23679405$2$F$20220101$20240722$20240327$20240726$EXP$FR-EMA-DD-20240319-7482663-063957$FR-RDY-SPO/FRA/24/0004818$DR REDDYS$Arnould B, Miranda S, Mignon F, Camus V. G-CSF-induced TIPIC syndrome and large vessel vasculitis: A case report. Clinical Case Reports. 2023 Sep 01;11(9): doi:10.1002/ccr3.7918$73$YR$E$F$Y$$$20240726$$HP$FR$FR
236794612$23679461$2$F$20230701$20240725$20240327$20240731$EXP$$JP-009507513-2307JPN001769J$MERCK$$8$DEC$$M$Y$$$20240731$$PH$JP$JP
236794953$23679495$3$F$20230101$20240614$20240327$20240703$PER$$US-TEVA-VS-3165965$TEVA$$56$YR$$F$Y$$$20240703$$CN$US$US
236794972$23679497$2$F$20240326$20240627$20240327$20240702$PER$$US-AMGEN-USASP2024062907$AMGEN$$78$YR$E$F$Y$$$20240701$$MD$US$US
236795232$23679523$2$F$20240101$20240822$20240327$20240912$PER$$US-SA-2024SA093470$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240912$$CN$US$US
236795342$23679534$2$F$$20240621$20240327$20240702$EXP$$US-ROCHE-2760916$ROCHE$$$$A$F$Y$$$20240702$$MD$US$US
236795524$23679552$4$F$20240503$20240726$20240327$20240808$PER$$US-Ipsen Biopharmaceuticals, Inc.-2023-23147$IPSEN$$81$YR$E$F$Y$57$KG$20240808$$MD$US$US
236795542$23679554$2$F$$20240213$20240327$20240704$PER$$US-TEVA-VS-3158403$TEVA$$$$$F$Y$$$20240704$$CN$US$US
236795587$23679558$7$F$$20240916$20240327$20240925$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000626$BLUEPRINT MEDICINES$$$$$M$Y$$$20240925$$HP$US$US
236795802$23679580$2$F$20231101$20240702$20240327$20240711$PER$$US-SA-2024SA090552$SANOFI AVENTIS$$8$YR$C$M$Y$46.9$KG$20240711$$MD$US$US
236795875$23679587$5$F$20240101$20240820$20240327$20240828$EXP$$US-ABBVIE-5652380$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
236795902$23679590$2$F$20240206$20240826$20240327$20240829$EXP$PT-INFARMED-B202403-599$PT-DSJP-DSE-2024-113249$DAIICHI$$68$YR$$M$Y$$$20240829$$PH$PT$PT
236795917$23679591$7$F$20240313$20240916$20240327$20240918$30DAY$$AR-PFIZER INC-PV202400039989$PFIZER$$13$YR$$F$Y$$$20240918$$CN$AR$AR
236795924$23679592$4$F$$20240620$20240327$20240701$30DAY$$DE-PFIZER INC-PV202400034193$PFIZER$$24$YR$$F$Y$$$20240701$$CN$DE$DE
236795963$23679596$3$F$$20240711$20240327$20240718$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000656$BLUEPRINT MEDICINES$$$$$F$Y$$$20240718$$CN$US$US
236796092$23679609$2$F$$20240909$20240327$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048896$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240911$$CN$US$US
236796152$23679615$2$F$$20240717$20240327$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048582$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240722$$CN$US$US
236796292$23679629$2$F$20231117$20240919$20240327$20240921$EXP$SE-SEMPA-2024-002005$SE-009507513-2403SWE008607$MERCK$$45$YR$$F$Y$63$KG$20240921$$MD$SE$SE
236796373$23679637$3$F$20230701$20240623$20240327$20240701$PER$$US-Calliditas-2024CAL00470$CALLIDITAS THERAPEUTICS$$60$YR$A$M$Y$$$20240701$$CN$US$US
236796522$23679652$2$F$20230101$20240821$20240327$20240905$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-439067$RANBAXY$$66$YR$$F$Y$56$KG$20240905$$MD$FR$FR
236796582$23679658$2$F$$20240708$20240327$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-439131$RANBAXY$$38$YR$$M$Y$$$20240723$$MD$FR$FR
236796682$23679668$2$F$20240222$20240618$20240327$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-439046$RANBAXY$$76$YR$$M$Y$$$20240703$$PH$GB$GB
236797154$23679715$4$F$20221109$20240705$20240327$20240711$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438226$RANBAXY$De Preter M, Van Mieghem H, Florence E. Approach to and management of simultaneous invasive nocardiosis, aspergillosis, and Verruconis gallopava central nervous system infection. Pol Arch Med Wewn. 2023;133 (Suppl.):14$43$YR$$M$Y$$$20240711$$HP$BE$BE
236797514$23679751$4$F$20240318$20240819$20240327$20240827$EXP$$JP-009507513-2403JPN002746J$MERCK$$52$YR$$F$Y$$$20240827$$MD$JP$JP
236797532$23679753$2$F$$20240715$20240327$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049035$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240717$$CN$US$US
236797923$23679792$3$F$$20240821$20240327$20240826$EXP$$CA-PURDUE-USA-2024-0308622$PURDUE$$$$$F$Y$$$20240826$$HP$CA$CA
236798442$23679844$2$F$20240229$20240923$20240327$20240926$EXP$FR-AFSSAPS-AN2024000382$FR-MYLANLABS-2024M1027644$MYLAN$$39$YR$$M$Y$$$20240926$$MD$FR$FR
236798622$23679862$2$F$$20240626$20240327$20240709$EXP$$CA-ANIPHARMA-2024-CA-001808$ANI$$72$YR$$F$Y$$$20240709$$CN$CA$CA
236798703$23679870$3$F$20220215$20240723$20240327$20240729$EXP$$US-INCYTE CORPORATION-2024IN003028$INCYTE$$$$$$Y$$$20240729$$MD$US$US
236798743$23679874$3$F$20240101$20240729$20240327$20240805$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR001470$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$CA$CA
236798924$23679892$4$F$20240318$20240920$20240327$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US032584$SANDOZ$$13$YR$$M$Y$74.8$KG$20240923$$PH$US$US
236799004$23679900$4$F$20231019$20240628$20240327$20240702$30DAY$$US-SANDOZ INC.-SDZ2024US032631$SANDOZ$$5$YR$$F$Y$15$KG$20240702$$MD$US$US
236799012$23679901$2$F$$20240919$20240327$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US031452$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
236799612$23679961$2$F$20220101$20240906$20240327$20240911$30DAY$$CA-SANDOZ INC.-NVSC2022CA171873$SANDOZ$$$$$F$Y$$$20240911$$CN$CA$CA
236799673$23679967$3$F$$20240725$20240327$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA031909$SANDOZ$$$$$M$Y$$$20240729$$MD$CA$CA
236799754$23679975$4$F$20240319$20240807$20240327$20240813$30DAY$$GB-SANDOZ INC.-SDZ2024GB031617$SANDOZ$$41$YR$$M$Y$$$20240813$$CN$GB$GB
236799772$23679977$2$F$$20240716$20240327$20240718$EXP$$CA-INCYTE CORPORATION-2024IN002851$INCYTE$$$$$$Y$$$20240718$$HP$CA$CA
236799822$23679982$2$F$$20240703$20240327$20240705$EXP$$GB-SANDOZ INC.-SDZ2023GB050896$SANDOZ$$$$$F$Y$$$20240705$$CN$GB$GB
236800092$23680009$2$F$20240314$20240626$20240327$20240703$EXP$$JP-Eisai-EC-2024-162345$EISAI$$$$A$F$Y$$$20240703$$MD$JP$JP
236800276$23680027$6$F$20240201$20240716$20240327$20240722$EXP$$JP-Eisai-EC-2024-162606$EISAI$Yokozeki H. Len-Pem treatment and adverse events in advanced renal cell carcinoma.. Lenvatinib AE management Seminar in Tajima. 2024 Jul;$63$YR$A$M$Y$$$20240722$$MD$JP$JP
236800432$23680043$2$F$$20240717$20240327$20240723$EXP$$JP-Eisai-EC-2024-162380$EISAI$$61$YR$A$F$Y$$$20240723$$MD$JP$JP
236800613$23680061$3$F$$20240920$20240327$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US031408$SANDOZ$$$$$M$Y$$$20240923$$CN$US$US
236800699$23680069$9$F$20240701$20240806$20240327$20240812$EXP$$US-BIOGEN-2024BI01256979$BIOGEN$$52$YR$$F$Y$$$20240812$$CN$US$US
236801322$23680132$2$F$$20240708$20240327$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-047983$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240710$$MD$JP$JP
236801724$23680172$4$F$20240311$20240723$20240327$20240727$EXP$$US-ABBVIE-5691852$ABBVIE$$75$YR$$F$Y$79$KG$20240727$$CN$US$US
236801774$23680177$4$F$20240301$20240823$20240327$20240903$EXP$$DE-JNJFOC-20240356025$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240903$$MD$DE$DE
236802233$23680223$3$F$20230201$20240823$20240327$20240828$EXP$$US-ABBVIE-5691698$ABBVIE$$49$YR$$M$Y$$$20240828$$CN$US$US
236802242$23680224$2$F$20240101$20240719$20240327$20240727$EXP$$NL-ABBVIE-5639628$ABBVIE$$76$YR$$M$Y$$$20240727$$HP$NL$NL
236802453$23680245$3$F$20240101$20240705$20240327$20240710$EXP$$US-ABBVIE-5694918$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
236802472$23680247$2$F$20240301$20240807$20240327$20240813$EXP$$CA-JNJFOC-20240361019$JOHNSON AND JOHNSON$$44$YR$$M$Y$$$20240813$$HP$CA$CA
236803073$23680307$3$F$$20240827$20240328$20240903$EXP$$GB-BEH-2024168642$CSL BEHRING$$33$YR$A$F$Y$45$KG$20240903$$PH$GB$GB
236803843$23680384$3$F$20240101$20240702$20240328$20240702$PER$$US-JNJFOC-20240353769$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$HP$US$US
236803882$23680388$2$F$20240229$20240808$20240328$20240816$EXP$$CA-ABBVIE-22K-028-4503598-00$ABBVIE$$68$YR$$M$Y$$$20240816$$CN$CA$CA
236803943$23680394$3$F$$20240717$20240328$20240723$EXP$$US-TAKEDA-2024TUS023807$TAKEDA$$$$$F$Y$78.29$KG$20240723$$MD$US$US
236804004$23680400$4$F$$20240913$20240328$20240923$EXP$$GB-TAKEDA-2024TUS028506$TAKEDA$$$$$M$Y$$$20240923$$CN$GB$GB
236804043$23680404$3$F$20230101$20240813$20240328$20240827$PER$$US-SA-2024SA089062$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240827$$CN$US$US
236804133$23680413$3$F$20240325$20240807$20240328$20240809$PER$$US-AMGEN-USASP2024062781$AMGEN$$87$YR$E$M$Y$$$20240809$$MD$US$US
236804222$23680422$2$F$20240226$20240703$20240328$20240726$PER$$US-TOLMAR, INC.-24US047341$TOLMAR$$86$YR$$M$Y$$$20240726$$HP$US$US
236804383$23680438$3$F$20081128$20240624$20240328$20240716$EXP$$NVSC2024AU066100$NOVARTIS$$39$YR$$F$Y$$$20240716$$CN$AU$AU
236804873$23680487$3$F$$20240628$20240328$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US031202$SANDOZ$$$$$F$Y$$$20240703$$CN$US$US
236805062$23680506$2$F$20231201$20240619$20240328$20240930$PER$$US-ARDELYX-2024ARDX000793$ARDELYX$$63$YR$$F$Y$$$20240930$$MD$US$US
2368052510$23680525$10$F$20200307$20240808$20240328$20240822$EXP$$CA-CELLTRION INC.-2020CA020663$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
236805352$23680535$2$F$20240201$20240624$20240328$20240703$PER$$US-SA-2024SA091909$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240703$$MD$US$US
236805382$23680538$2$F$20240316$20240729$20240328$20240805$PER$$US-SA-2024SA092454$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240805$$MD$US$US
236805414$23680541$4$F$20240121$20240918$20240328$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-001224$JAZZ$$44$YR$$F$Y$$$20240924$$CN$US$US
236805492$23680549$2$F$20240301$20240809$20240328$20240813$EXP$$CA-JNJFOC-20240364912$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240813$$HP$CA$CA
236805515$23680551$5$F$20200125$20240830$20240328$20240904$EXP$$CO-TAKEDA-CO202002066$TAKEDA$$63$YR$$M$Y$83$KG$20240904$$HP$CO$CO
2368056611$23680566$11$F$20240315$20240829$20240328$20240917$PER$$US-SA-2024SA093904$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240918$$MD$US$US
236805705$23680570$5$F$20240214$20240806$20240328$20240809$EXP$$CO-TAKEDA-2024TUS016208$TAKEDA$$35$YR$$M$Y$55$KG$20240809$$CN$CO$CO
236805814$23680581$4$F$20240322$20240819$20240328$20240821$PER$$US-AMGEN-USASP2024060723$AMGEN$$85$YR$E$M$Y$$$20240821$$HP$US$US
236807042$23680704$2$F$$20240626$20240328$20240708$30DAY$$US-NOVOPROD-1194153$NOVO NORDISK$$$$$F$Y$$$20240708$$CN$US$US
236807097$23680709$7$F$$20240822$20240328$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-011829$AUROBINDO$Descamps V.. Carbamazepine: a  potentially DRESS-inducing agent (La carbamaz?pine : un agent  potentiellement inducteur de DRESS). Letter from the neurologist /La Lettre du Neurologue. 2024;XXVIII (1-2):56- 58$56$YR$$F$Y$$$20240902$$MD$FR$FR
236807464$23680746$4$F$$20240925$20240328$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048658$BRISTOL MYERS SQUIBB$$8$YR$C$F$Y$$$20240927$$HP$US$US
236808002$23680800$2$F$20230118$20240709$20240328$20240716$EXP$$US-SYNTHON BV-IN51PV24_73811$SYNTHON$$82$YR$$M$Y$72$KG$20240716$$MD$US$US
236808172$23680817$2$F$20240312$20240806$20240328$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049218$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240807$$CN$US$US
236808362$23680836$2$F$20190401$20240723$20240328$20240731$EXP$$DE-ROCHE-3532793$ROCHE$$39$YR$A$F$Y$$$20240731$$CN$DE$DE
236808582$23680858$2$F$20230817$20240905$20240328$20240909$EXP$$DE-ROCHE-3410244$ROCHE$$49$YR$A$F$Y$$$20240909$$CN$DE$DE
236808615$23680861$5$F$20240320$20240913$20240328$20240916$PER$$US-AMGEN-USASP2024060655$AMGEN$$64$YR$A$F$Y$$$20240915$$HP$US$US
236808812$23680881$2$F$$20240802$20240328$20240806$PER$$NVSC2024US066033$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
236809032$23680903$2$F$20240101$20240708$20240328$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048509$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240712$$CN$US$US
236809233$23680923$3$F$20240101$20240905$20240328$20240914$EXP$$CA-CELLTRION INC.-2024CA007508$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
236809573$23680957$3$F$20240322$20240628$20240328$20240703$PER$$US-AMGEN-USASP2024060824$AMGEN$$78$YR$E$F$Y$$$20240703$$CN$US$US
236809592$23680959$2$F$20240301$20240703$20240328$20240705$EXP$$NVSC2024US064111$NOVARTIS$$53$YR$$F$Y$$$20240705$$MD$US$US
236809652$23680965$2$F$20240320$20240705$20240328$20240716$EXP$$IN-ROCHE-3527395$ROCHE$$83$YR$E$M$Y$$$20240716$$MD$IN$IN
236809944$23680994$4$F$20240219$20240819$20240328$20240822$EXP$$NVSJ2024JP003588$NOVARTIS$$36$YR$$F$Y$80$KG$20240822$$MD$JP$JP
236810102$23681010$2$F$20231201$20240404$20240328$20240722$EXP$DE-AMK-272261$DE-ACS-20240106$ACS DOBFAR$$82$YR$E$M$Y$80$KG$20240717$$PH$DE$DE
236810452$23681045$2$F$$20240722$20240328$20240724$EXP$$GR-ABBVIE-5676944$ABBVIE$$39$YR$$F$Y$$$20240724$$CN$GR$GR
236810953$23681095$3$F$$20240625$20240328$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02490$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236811092$23681109$2$F$$20240710$20240328$20240715$30DAY$$US-SANDOZ INC.-SDZ2023US021526$SANDOZ$$$$$$Y$53.968$KG$20240715$$HP$US$US
236811144$23681114$4$F$$20240625$20240328$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02462$LUPIN$$$$$$Y$$$20240715$$CN$US$US
236811153$23681115$3$F$$20240625$20240328$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02499$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236811198$23681119$8$F$20220717$20240712$20240328$20240719$EXP$$CO-GSK-CO2023AMR163952$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$CN$CO$CO
236811236$23681123$6$F$$20240807$20240328$20240814$EXP$$CA-GSK-CA2023AMR055031$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$HP$CA$CA
236811413$23681141$3$F$$20240910$20240328$20240918$EXP$$NVSC2024CA064399$NOVARTIS$$61$YR$$F$Y$70$KG$20240919$$HP$CA$CA
236811502$23681150$2$F$$20240924$20240328$20240927$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-017801$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240927$$CN$US$US
236811562$23681156$2$F$$20240731$20240328$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048406$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$86.18$KG$20240801$$CN$US$US
236811712$23681171$2$F$20240220$20240911$20240328$20240912$PER$$US-AMGEN-USASP2024063377$AMGEN$$44$YR$A$M$Y$$$20240912$$CN$US$US
236811772$23681177$2$F$$20240812$20240328$20240816$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-000766$IPCA$Malcolm M. Kates, Calvin L. McNelly, Nathan A. Fischer et al.. Bilateral spontaneous retrobulbar hemorrhage due to warfarin misuse after sinus lavage. The American Society of Ophthalmic Plastic and Reconstructive Surgery. 2024;40(2):e36-e38$$$$$Y$$$20240816$$MD$US$US
236812272$23681227$2$F$$20240830$20240328$20240904$PER$$US-AMGEN-USASP2024059447$AMGEN$$$$$$Y$$$20240904$$CN$US$US
236812302$23681230$2$F$20240101$20240918$20240328$20240925$PER$$NVSC2024US066091$NOVARTIS$$$$$$Y$$$20240925$$MD$US$US
236812314$23681231$4$F$$20240906$20240328$20240911$EXP$$NVSC2024US065772$NOVARTIS$$$$$M$Y$$$20240911$$CN$US$US
236812678$23681267$8$F$20230824$20240820$20240328$20240828$EXP$$CA-CELLTRION INC.-2023CA017705$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
236812752$23681275$2$F$$20240808$20240328$20240821$EXP$IT-EMA-DD-20180625-ishaevhp-093255$IT-CIPLA LTD.-2024IT02940$CIPLA$Alfano G, Fontana F, Francesca D, Assirati G, Magistri P, Tarantino G et al.. Gastric mucormycosis in a liver and kidney transplant recipient: Case report and concise review of literature. Transplant-Proc. 2018;50(3):905 to 909.$$$$$Y$$$20240821$$HP$IT$IT
236813863$23681386$3$F$$20240829$20240328$20240904$EXP$FR-EMA-DD-20200323-agrahari_P-151601$FR-CHEPLA-3000007852$CHEPLAPHARM$$71$YR$$M$Y$$$20240904$$HP$COUNTRY NOT SPECIFIED$FR
236813982$23681398$2$F$$20240709$20240328$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047971$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240710$$CN$US$US
236815135$23681513$5$F$$20240706$20240328$20240712$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-05039$IPSEN$$81$YR$E$M$Y$61$KG$20240712$$CN$US$US
236815144$23681514$4$F$$20240910$20240328$20240917$EXP$$US-TAKEDA-2024TUS021813$TAKEDA$$$$$M$Y$80.286$KG$20240917$$PH$US$US
236815226$23681522$6$F$20240301$20240808$20240328$20240813$EXP$$US-TAKEDA-2024TUS020495$TAKEDA$$54$YR$$F$Y$$$20240813$$MD$US$US
236815432$23681543$2$F$20240326$20240715$20240328$20240717$PER$$US-AMGEN-USASP2024062732$AMGEN$$38$YR$A$M$Y$$$20240717$$HP$US$US
236815512$23681551$2$F$20240324$20240806$20240328$20240808$PER$$US-AMGEN-USASP2024062056$AMGEN$$70$YR$E$F$Y$$$20240808$$CN$US$US
236815552$23681555$2$F$$20240711$20240328$20240712$EXP$$US-SCIEGENP-2024SCLIT00154$SCIEGEN$AY Soleiman.High-dose Insulin Therapy in Management of Refractory Shock From Multiple Drug Overdose.American Journal of Respiratory and Critical Care Medicine.May-2023;207:1$53$YR$A$M$Y$$$20240712$$HP$US$US
236815662$23681566$2$F$20181017$20240917$20240328$20240924$EXP$$FR-ABBVIE-5688745$ABBVIE$$$$A$F$Y$66$KG$20240924$$LW$FR$FR
236815793$23681579$3$F$20231201$20240912$20240328$20240916$EXP$$US-ABBVIE-5695368$ABBVIE$$71$YR$$F$Y$$$20240916$$CN$US$US
236815875$23681587$5$F$$20240705$20240328$20240708$PER$$NVSC2024US066809$NOVARTIS$$$$$F$Y$$$20240708$$CN$US$US
236815903$23681590$3$F$$20240904$20240328$20240911$EXP$$GB-TAKEDA-2022TUS061478$TAKEDA$$$$$F$Y$$$20240911$$CN$GB$GB
236815946$23681594$6$F$20240322$20240820$20240328$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008892$UNITED THERAPEUTICS$$77$YR$$F$Y$61.224$KG$20240828$$$US$US
236815955$23681595$5$F$$20240822$20240328$20240903$EXP$$IT-AUROBINDO-AUR-APL-2018-028383$AUROBINDO$Alfano G, Fontana F, Francesca D, Assirati G, Magistri P, Tarantino G, et al. Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature. Transplant-Proc. 2018;50(3):905-09$42$YR$$F$Y$$$20240903$$MD$IT$IT
236815972$23681597$2$F$$20240815$20240328$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049461$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$63.5$KG$20240819$$CN$US$US
236816004$23681600$4$F$$20240816$20240328$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048994$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240826$$MD$US$US
236816102$23681610$2$F$$20240926$20240328$20240926$EXP$$US-CIPLA LTD.-2024US03050$CIPLA$Bonkovsky HL, Ghabril M, Nicoletti P, Dellinger A, Fontana RJ, Barnhart H et.al. Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA?Update with genetic correlations. Liver Int. 2024$$$$$Y$$$20240926$$MD$US$US
236816152$23681615$2$F$$20240918$20240328$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048210$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$66.22$KG$20240919$$CN$US$US
236816264$23681626$4$F$20230101$20240812$20240328$20240829$PER$$US-ASTELLAS-2024US008953$ASTELLAS$$63$YR$A$M$Y$$$20240823$$CN$US$US
236816655$23681665$5$F$$20240927$20240328$20240930$PER$$NVSC2024US066659$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
236816662$23681666$2$F$20240131$20240726$20240328$20240805$EXP$$JP-ROCHE-3531380$ROCHE$$76$YR$E$F$Y$69.1$KG$20240805$$MD$JP$JP
236817042$23681704$2$F$20170101$20240801$20240328$20240806$EXP$$DE-ABBVIE-5694592$ABBVIE$$$$$F$Y$$$20240806$$CN$DE$DE
236817162$23681716$2$F$20230101$20240724$20240328$20240731$EXP$$CO-Ipsen Biopharmaceuticals, Inc.-2023-22298$IPSEN$$54$YR$A$F$Y$83$KG$20240731$$CN$CO$CO
236817193$23681719$3$F$20221101$20240812$20240328$20240822$EXP$$CA-ALVOTECHPMS-2022-ALVOTECHPMS-000249$Alvotech$$54$YR$$M$Y$$$20240822$$HP$CA$CA
236817203$23681720$3$F$20231101$20240626$20240328$20240702$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001675$Alvotech$$30$YR$$F$Y$$$20240702$$CN$CA$CA
236817893$23681789$3$F$20240711$20240725$20240328$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049789$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$88.9$KG$20240730$$CN$US$US
236817982$23681798$2$F$$20240719$20240328$20240719$EXP$$US-SCIEGENP-2024SCLIT00156$SCIEGEN$Ayat P, et al..Cardiac Tamponade From a Blood Pressure Pill: An Unusual Presentation of Hydralazine Induced Lupus.American Journal of Respiratory and Critical Care Medicine.21-MAY-2023;207:1$54$YR$A$M$Y$$$20240719$$HP$US$US
236818073$23681807$3$F$20230502$20240912$20240328$20240923$EXP$$JP-AMGEN-JPNNI2024061670$AMGEN$$74$YR$E$M$Y$58.6$KG$20240922$$MD$JP$JP
236818125$23681812$5$F$20240306$20240625$20240328$20240701$30DAY$$GB-PFIZER INC-202400060860$PFIZER$$$$T$M$Y$$$20240701$$HP$GB$GB
236818242$23681824$2$F$$20240925$20240328$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048883$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240925$$CN$US$US
236818783$23681878$3$F$$20240924$20240328$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049854$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240925$$CN$US$US
236819056$23681905$6$F$20240101$20240913$20240328$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008733$UNITED THERAPEUTICS$$$$$F$Y$57.143$KG$20240921$$$US$US
236819252$23681925$2$F$20221005$20240812$20240328$20240815$EXP$$US-TAKEDA-2022TUS071928$TAKEDA$$53$YR$$M$Y$$$20240815$$CN$US$US
236819353$23681935$3$F$20240101$20240727$20240328$20240730$PER$$US-AMGEN-USASP2024062717$AMGEN$$54$YR$A$M$Y$$$20240730$$HP$US$US
236819502$23681950$2$F$20240322$20240806$20240328$20240812$EXP$$US-BAYER-2024A044647$BAYER$$69$YR$E$F$Y$$$20240812$$CN$US$US
236819592$23681959$2$F$20181001$20240709$20240328$20240715$EXP$$PHHY2018CA126451$NOVARTIS$$71$YR$$F$Y$$$20240715$$HP$CA$CA
236819962$23681996$2$F$$20240625$20240328$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02564$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236820053$23682005$3$F$$20240918$20240328$20240926$EXP$$PH-TAKEDA-2024TUS028284$TAKEDA$$$$$F$Y$$$20240926$$MD$PH$PH
236820843$23682084$3$F$$20240626$20240328$20240705$30DAY$$US-GSK-US2024036324$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$HP$US$US
236821062$23682106$2$F$20240201$20240808$20240328$20240820$EXP$FR-AFSSAPS-RE2024000206$FR-Accord-414938$ACCORD$$69$YR$E$M$Y$$$20240820$$PH$FR$FR
236821743$23682174$3$F$20211001$20240715$20240328$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202403011877$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240729$$CN$US$US
236822103$23682210$3$F$20240101$20240925$20240328$20240927$EXP$$CA-JNJFOC-20240368586$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240927$$HP$CA$CA
236822173$23682217$3$F$$20240903$20240328$20240906$EXP$$CA-TAKEDA-2024TUS023890$TAKEDA$$$$$F$Y$$$20240906$$HP$CA$CA
236822483$23682248$3$F$20240315$20240731$20240328$20240805$30DAY$$US-AMGEN-USASP2024062050$AMGEN$$87$YR$E$M$Y$78$KG$20240805$$PH$US$US
236822653$23682265$3$F$$20240701$20240328$20240706$EXP$$GB-TAKEDA-2023TUS123420$TAKEDA$$$$A$M$Y$$$20240706$$CN$GB$GB
236822752$23682275$2$F$$20240731$20240328$20240808$EXP$$CA-LEO Pharma-369003$LEO PHARM$$62$YR$$$Y$$$20240808$$CN$CA$CA
236822842$23682284$2$F$20231006$20240708$20240328$20240715$EXP$$CA-TAKEDA-2024TUS028066$TAKEDA$$$$A$F$Y$$$20240715$$HP$CA$CA
236823023$23682302$3$F$20240327$20240724$20240328$20240729$PER$$US-AMGEN-USASP2024063780$AMGEN$$67$YR$E$F$Y$$$20240729$$CN$US$US
236823113$23682311$3$F$20231201$20240814$20240328$20240822$EXP$$IT-AstraZeneca-2024A067941$ASTRAZENECA$$53$YR$$M$Y$$$20240822$$MD$IT$
236823192$23682319$2$F$$20240710$20240328$20240720$EXP$$CA-TAKEDA-2024TUS028775$TAKEDA$$29$YR$$F$Y$$$20240720$$HP$CA$CA
236823254$23682325$4$F$$20240703$20240328$20240711$EXP$$CO-SANDOZ INC.-NVSC2021CO257787$SANDOZ$$$$$F$Y$69$KG$20240711$$CN$CO$CO
236823265$23682326$5$F$20240315$20240719$20240328$20240719$30DAY$$CO-PFIZER INC-PV202400037369$PFIZER$$14$YR$$M$Y$$$20240719$$CN$CO$CO
236823323$23682332$3$F$20130101$20240826$20240328$20240827$EXP$DE-EMA-DD-20230420-6644853-072016$DE-SANDOZ INC.-SDZ2024DE031925$SANDOZ$$3$YR$$M$Y$$$20240827$$MD$DE$DE
236823393$23682339$3$F$20240101$20240730$20240328$20240802$PER$$JP-Eisai-EC-2024-162258$EISAI$$$$A$F$Y$$$20240802$$MD$JP$JP
236823492$23682349$2$F$$20240906$20240328$20240909$EXP$$FR-SANDOZ INC.-SDZ2024FR033160$SANDOZ$$40$YR$$M$Y$44$KG$20240909$$HP$FR$FR
236823564$23682356$4$F$$20240621$20240328$20240813$PER$$US-LUNDBECK-DKLU3076000$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
236823802$23682380$2$F$20240223$20240628$20240328$20240726$PER$$US-Vifor (International) Inc.-VIT-2024-02588$VIFOR$$68$YR$$M$Y$92$KG$20240726$$HP$US$US
236823862$23682386$2$F$$20240319$20240328$20240919$EXP$$DE-SANDOZ INC.-PHHY2018DE000769$SANDOZ$$43$YR$$F$Y$$$20240919$$MD$DE$DE
236823964$23682396$4$F$$20240903$20240328$20240906$EXP$$CA-SANDOZ INC.-SDZ2024CA030871$SANDOZ$$62$YR$$F$Y$$$20240906$$HP$CA$CA
236824234$23682423$4$F$$20240724$20240328$20240729$EXP$$PK-PFIZER INC-PV202300160410$PFIZER$$34$YR$$M$Y$62$KG$20240729$$CN$PK$PK
236824845$23682484$5$F$$20240916$20240328$20240919$30DAY$$CO-PFIZER INC-PV202400038105$PFIZER$$13$YR$$M$Y$$$20240919$$CN$CO$CO
236824886$23682488$6$F$$20240910$20240328$20240918$30DAY$$CO-PFIZER INC-PV202400038648$PFIZER$$8$YR$$F$Y$$$20240918$$CN$CO$CO
236824962$23682496$2$F$20240304$20240627$20240328$20240722$PER$$CA-TOLMAR, INC.-24CA047440$TOLMAR$$73$YR$$M$Y$$$20240719$$CN$CA$CA
236824982$23682498$2$F$$20240624$20240328$20240715$PER$$CA-TOLMAR, INC.-24CA047442$TOLMAR$$$$$M$Y$$$20240715$$CN$CA$CA
236824992$23682499$2$F$20240304$20240624$20240328$20240715$PER$$CA-TOLMAR, INC.-24CA047537$TOLMAR$$78$YR$$M$Y$$$20240715$$CN$CA$CA
236825002$23682500$2$F$20240301$20240822$20240328$20240910$PER$$CA-TOLMAR, INC.-24CA047553$TOLMAR$$70$YR$$M$Y$$$20240909$$CN$CA$CA
236825012$23682501$2$F$20230817$20240620$20240328$20240705$EXP$$JP-ROCHE-3412665$ROCHE$$79$YR$E$M$Y$61$KG$20240705$$MD$JP$JP
236825315$23682531$5$F$20240101$20240927$20240328$20240927$EXP$$CA-PFIZER INC-202400072967$PFIZER$$68$YR$$F$Y$$$20240927$$HP$CA$CA
236826262$23682626$2$F$20240224$20240823$20240328$20240827$EXP$PT-INFARMED-B202403-332$PT-PFIZER INC-202400072480$PFIZER$$43$YR$$F$Y$$$20240827$$PH$PT$PT
236826662$23682666$2$F$20240322$20240719$20240328$20240722$PER$$US-AMGEN-USASP2024063718$AMGEN$$79$YR$E$F$Y$$$20240722$$CN$US$US
236826693$23682669$3$F$$20240817$20240328$20240823$EXP$$FR-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00134$VELOXIS PHARMACEUTICALS$Darres A, Del Bello A,Marion O, de Lamballerie X, Malvy D, Kamar N et al.. Failure of favipiravir to treat chronic norovirus infection in a kidney-transplant patient (Letter to the editor).. Transplant infectious disease. 2024;26 (1):1-2$64$YR$$M$Y$$$20240823$$HP$FR$FR
236826773$23682677$3$F$20230826$20240404$20240328$20240802$EXP$DE-BFARM-24001932$DE-TORRENT-00026444$TORRENT$$85$YR$E$M$Y$83$KG$20240802$$MD$DE$DE
236826942$23682694$2$F$$20240822$20240328$20240831$EXP$CA-HEALTH CANADA-06727353$CA-ABBVIE-5696206$ABBVIE$$49$YR$$M$Y$126$KG$20240831$$HP$CA$CA
236826965$23682696$5$F$20240101$20240703$20240328$20240704$EXP$$JP-009507513-2403JPN000687J$MERCK$$36$YR$$F$Y$48$KG$20240704$$MD$JP$JP
236826983$23682698$3$F$$20240719$20240328$20240812$PER$$US-RDY-SPO/USA/23/0175128$DR REDDYS$$5$YR$C$M$Y$21.3$KG$20240812$$MD$US$US
236827046$23682704$6$F$20231001$20240708$20240328$20240716$EXP$$CA-CELLTRION INC.-2023CA021557$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
236827562$23682756$2$F$$20240724$20240328$20240731$PER$$US-BIOGEN-2024BI01246301$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
236827726$23682772$6$F$$20240706$20240328$20240708$30DAY$$US-PFIZER INC-202400068657$PFIZER$$13$YR$$M$Y$$$20240708$$CN$US$US
236827777$23682777$7$F$$20240903$20240328$20240905$30DAY$$US-PFIZER INC-202400069562$PFIZER$$15$YR$$M$Y$61.23$KG$20240905$$CN$US$US
236828246$23682824$6$F$$20240912$20240328$20240916$EXP$$US-PFIZER INC-202400071890$PFIZER$$10$YR$$F$Y$28.1$KG$20240916$$HP$US$US
236828262$23682826$2$F$$20240911$20240328$20240915$EXP$$US-AMGEN-USASP2024059778$AMGEN$$$$$F$Y$$$20240915$$HP$US$US
236828457$23682845$7$F$20240319$20240924$20240328$20240927$30DAY$$US-PFIZER INC-202400069334$PFIZER$$13$YR$$F$Y$71.67$KG$20240927$$MD$US$US
236828694$23682869$4$F$20220924$20240904$20240328$20240906$PER$$US-PFIZER INC-202201321583$PFIZER$$60$YR$$F$Y$$$20240906$$CN$US$US
236829152$23682915$2$F$20240301$20240918$20240328$20240920$PER$$US-AMGEN-USASP2024059764$AMGEN$$69$YR$E$M$Y$$$20240920$$CN$US$US
236830564$23683056$4$F$20201001$20240525$20240328$20240704$EXP$GB-MHRA-ADR24455339$GB-TEVA-VS-3163211$TEVA$$68$YR$$F$Y$92$KG$20240704$$CN$GB$GB
236831082$23683108$2$F$$20240625$20240328$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02496$LUPIN$$$$$$Y$$$20240716$$PH$US$US
236831602$23683160$2$F$$20240719$20240328$20240722$EXP$$GB-SANDOZ INC.-SDZ2024GB033431$SANDOZ$$$$$M$Y$$$20240722$$CN$GB$GB
236831643$23683164$3$F$$20240320$20240328$20240910$PER$$NVSC2024US066416$NOVARTIS$$$$$F$Y$$$20240910$$CN$US$US
236832015$23683201$5$F$20240318$20240709$20240328$20240722$PER$$US-Calliditas-2024CAL00484$CALLIDITAS THERAPEUTICS$$77$YR$E$M$Y$83$KG$20240722$$CN$US$US
236832353$23683235$3$F$$20240902$20240328$20240904$30DAY$$US-PFIZER INC-202400069969$PFIZER$$77$YR$$F$Y$$$20240904$$CN$US$US
236832535$23683253$5$F$20240318$20240710$20240328$20240717$EXP$$CA-GSK-CA2024037418$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$CA$CA
236832589$23683258$9$F$$20240913$20240328$20240918$30DAY$$US-PFIZER INC-202400071793$PFIZER$$5$YR$$M$Y$$$20240918$$CN$US$US
236832598$23683259$8$F$20240101$20240820$20240328$20240827$30DAY$$US-PFIZER INC-202400071869$PFIZER$$11$YR$$M$Y$$$20240827$$CN$US$US
236832605$23683260$5$F$20240301$20240904$20240328$20240909$30DAY$$US-PFIZER INC-202400070820$PFIZER$$6$YR$$M$Y$$$20240909$$HP$US$US
236832812$23683281$2$F$$20240625$20240328$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02463$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236833232$23683323$2$F$$20240821$20240328$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202403011338$ELI LILLY AND CO$$76$YR$E$F$Y$59.1$KG$20240830$$HP$US$US
236833332$23683333$2$F$20231101$20240701$20240328$20240715$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202403011225$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240715$$MD$DE$DE
236833562$23683356$2$F$20240327$20240630$20240328$20240704$PER$$US-AMGEN-USASP2024063765$AMGEN$$65$YR$E$F$Y$$$20240704$$CN$US$US
236833725$23683372$5$F$20240715$20240807$20240328$20240814$EXP$$CA-GSK-CA2024037299$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$CA$CA
236834152$23683415$2$F$$20240815$20240328$20240819$EXP$$US-TAKEDA-2023TUS078932$TAKEDA$$$$$M$Y$$$20240819$$HP$US$US
236834522$23683452$2$F$$20240627$20240328$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02551$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236834702$23683470$2$F$$20240813$20240328$20240828$EXP$$CA-HLS-202400829$HLS THERAPEUTICS$$56$YR$A$M$Y$$$20240828$$MD$CA$CA
236834813$23683481$3$F$$20240625$20240328$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02565$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236835282$23683528$2$F$20240301$20240725$20240328$20240802$PER$$US-SA-2024SA025831$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240802$$MD$US$US
236835453$23683545$3$F$20230801$20240916$20240328$20240923$PER$$US-SA-2024SA091465$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240923$$MD$US$US
236835523$23683552$3$F$20190101$20240802$20240328$20240813$PER$$US-SA-2024SA027960$SANOFI AVENTIS$$26$YR$A$F$Y$50.8$KG$20240814$$MD$US$US
236835742$23683574$2$F$20240101$20240806$20240328$20240817$PER$$US-SA-2024SA089187$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240817$$MD$US$US
236835832$23683583$2$F$20240320$20240628$20240328$20240709$PER$$US-SA-2024SA092389$SANOFI AVENTIS$$56$YR$A$F$Y$81.19$KG$20240709$$MD$US$US
236835932$23683593$2$F$$20240716$20240328$20240724$PER$$US-SA-2024SA090652$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240724$$MD$US$US
236836062$23683606$2$F$$20240820$20240328$20240910$PER$$US-SA-2024SA094548$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$HP$US$US
236836082$23683608$2$F$20240201$20240724$20240328$20240802$PER$$US-SA-2024SA091172$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240802$$MD$US$US
236836322$23683632$2$F$20240301$20240729$20240328$20240807$PER$$US-SA-2024SA095155$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240807$$MD$US$US
236836384$23683638$4$F$$20240820$20240328$20240829$EXP$$US-TEVA-VS-3174334$TEVA$On S, Domingo W, Cheung E, Johnston L. Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation. Transplant-Cell-Ther 2024; 30 (Suppl.) (2): S163 abstr. 211.; On S, Domingo W, Cheung E, Johnston L. Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen with Methotrexate-Based GvHD Prophylaxis. Blood 142 (Suppl. 1):  2023-11-02; Literature Reference: On S, Domingo W, Cheung E, Johnston L. Clofarabine and High-Dose M...$$$A$$Y$$$20240829$$HP$US$US
236836463$23683646$3$F$20240101$20240715$20240328$20240723$PER$$US-SA-2024SA095641$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240723$$MD$US$US
236836532$23683653$2$F$$20240729$20240328$20240806$PER$$US-SA-2024SA095113$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240806$$MD$US$US
236836605$23683660$5$F$$20240725$20240328$20240730$PER$$US-SA-2024SA095945$SANOFI AVENTIS$$$$A$F$Y$$$20240730$$MD$US$US
236836652$23683665$2$F$$20240812$20240328$20240820$PER$$US-SA-2023SA305516$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240820$$MD$US$US
236836834$23683683$4$F$20240101$20240626$20240328$20240701$EXP$$US-SA-2024SA095760$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240701$$MD$US$US
236836892$23683689$2$F$$20240627$20240328$20240708$PER$$US-SA-2024SA095951$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240708$$MD$US$US
236837022$23683702$2$F$20240324$20240723$20240328$20240729$PER$$US-SA-2024SA095547$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240729$$CN$US$US
236837052$23683705$2$F$20240101$20240816$20240328$20240827$PER$$US-SA-2024SA095631$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240827$$MD$US$US
236837443$23683744$3$F$20240101$20240722$20240328$20240731$PER$$US-SA-2024SA091578$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240731$$MD$US$US
236837484$23683748$4$F$20240301$20240910$20240328$20240923$PER$$US-SA-2024SA091418$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240923$$MD$US$US
236837972$23683797$2$F$20240319$20240925$20240328$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045748$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240925$$CN$US$US
236837987$23683798$7$F$$20240923$20240328$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047996$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240923$$CN$US$US
236838012$23683801$2$F$20240327$20240813$20240328$20240814$PER$$US-AMGEN-USASP2024064097$AMGEN$$45$YR$A$F$Y$$$20240814$$CN$US$US
236838623$23683862$3$F$$20240628$20240328$20240710$PER$$JP-Eisai-EC-2024-162146$EISAI$Shiomi Mayu et al.. Experience using lenvatinib and pembrolizumab therapy for endometrial cancer at our hospital. The 76th Annual Congress of the Japan Society of Obstetrics and Gynecology (2024.4.19-21); 2024 Apr 16-2024 Apr 21; : P-43-8-P-43-8.$65$YR$E$F$Y$$$20240710$$MD$JP$JP
236838952$23683895$2$F$$20240319$20240328$20240903$EXP$$ES-JNJFOC-20240360709$JOHNSON AND JOHNSON$$$$$F$Y$54$KG$20240903$$MD$ES$ES
236839064$23683906$4$F$20231206$20240905$20240328$20240909$EXP$$CA-JNJFOC-20231241219$JOHNSON AND JOHNSON$$75$YR$E$F$Y$62.7$KG$20240909$$HP$CA$CA
236839102$23683910$2$F$$20240621$20240328$20240702$PER$$US-SA-2024SA095653$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240702$$CN$US$US
236839132$23683913$2$F$20240101$20240627$20240328$20240704$EXP$$US-SA-2024SA092727$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240704$$MD$US$US
236839252$23683925$2$F$$20240625$20240328$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02494$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236839373$23683937$3$F$20220929$20240710$20240328$20240719$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-047961$BRISTOL MYERS SQUIBB$Sekiguchi Y, Tsutsumi H, Gomyo A, Kudo M, Maseki N, Iizaki Y, et al. A case of relapsed/refractory CD56-positive acute promyelocytic leukemia, in which complete molecular remission was achieved following combination therapy with venetoclax and azacitidine. Japan Journal of Cancer + Chemotherapy. 2024 Mar 01;51(3):291-7.$84$YR$E$F$Y$$$20240719$$HP$JP$JP
236839412$23683941$2$F$$20240711$20240328$20240715$30DAY$$US-GSK-US2024035348$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
236839782$23683978$2$F$$20240626$20240328$20240704$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000259$DECIPHERA PHARMACEUTICALS$$70$YR$E$M$Y$$$20240704$$MD$US$US
236840274$23684027$4$F$$20231215$20240328$20240718$EXP$$US-BAUSCHBL-2024BNL003729$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240718$$CN$US$US
236840423$23684042$3$F$$20240625$20240328$20240702$PER$$US-ALXN-202403USA001471US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
236840535$23684053$5$F$$20240903$20240328$20240912$30DAY$$FR-JNJFOC-20240332674$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$FR$FR
236840863$23684086$3$F$20240301$20240701$20240328$20240708$EXP$$US-TAKEDA-2024TUS023115$TAKEDA$$50$YR$$F$Y$101.95$KG$20240708$$HP$US$US
236840992$23684099$2$F$$20240712$20240328$20240717$EXP$$US-PFIZER INC-PV202400041006$PFIZER$$45$YR$$F$Y$$$20240717$$CN$US$US
236841174$23684117$4$F$$20240806$20240328$20240812$EXP$$PT-MYLANLABS-2024M1021491$MYLAN$Margarida Gil C, Encarnacao UJD. Management of hypertension in a patient with orthostatic hypotension - a case report. 18th Portuguese Congress on Hypertension and Global Cardiovascular Risk. 2024;17-18$76$YR$$M$Y$$$20240812$$MD$PT$PT
236841483$23684148$3$F$$20240722$20240328$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049795$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240723$$CN$US$US
236841673$23684167$3$F$20240101$20240816$20240328$20240916$PER$$US-Eisai-EC-2024-160372$EISAI$$67$YR$E$F$Y$$$20240916$$CN$US$US
236841734$23684173$4$F$20240813$20240814$20240328$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050023$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240820$$CN$US$US
236841798$23684179$8$F$20170101$20240813$20240328$20240827$EXP$$ES-TAKEDA-2024TUS029595$TAKEDA$$51$YR$$F$Y$$$20240827$$MD$ES$ES
236841912$23684191$2$F$$20240823$20240328$20240829$EXP$$CA-TAKEDA-2024TUS026816$TAKEDA$$$$$M$Y$$$20240829$$CN$CA$CA
236842042$23684204$2$F$20240228$20240823$20240328$20240829$EXP$PT-INFARMED-B202403-241$PT-MYLANLABS-2024M1027420$MYLAN$$48$YR$$M$Y$$$20240829$$MD$PT$PT
236842522$23684252$2$F$$20240828$20240328$20240903$EXP$DE-EMA-DD-20210405-pawar_p-143426$DE-RDY-SPO/DEU/24/0004660$DR REDDYS$Paul LD, Welter-Luedeke J, Penzel S, Zangl A, Graw M. Alpha-Pyrrolidinopentiothiophenone (-PVT): A forensic case study including plasma concentrations. Forensic Sci Int 2021; 321: 110721. DOI: 10.1016/j.forsciint.2021.110721.$31$YR$A$M$Y$$$20240903$$HP$DE$DE
236843903$23684390$3$F$20240114$20240722$20240328$20240724$EXP$$US-PFIZER INC-202400072917$PFIZER$$74$YR$$M$Y$58.05$KG$20240724$$HP$US$US
236843994$23684399$4$F$$20240717$20240328$20240917$PER$$US-PFIZER INC-202400056644$PFIZER$$63$YR$$F$Y$$$20240917$$HP$US$US
236845923$23684592$3$F$20230910$20240808$20240328$20240820$EXP$$KR-JAZZ PHARMACEUTICALS-2023-KR-020029$JAZZ$$84$YR$$M$Y$77$KG$20240820$$MD$KR$KR
236846613$23684661$3$F$$20240823$20240328$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050097$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240829$$CN$US$US
236847007$23684700$7$F$20240401$20240904$20240328$20240906$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-113285$DAIICHI$$$$$F$Y$$$20240906$$CN$US$US
236847872$23684787$2$F$$20240925$20240328$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US031411$SANDOZ$$$$$F$Y$$$20240929$$CN$US$US
236847922$23684792$2$F$20240319$20240711$20240328$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046894$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240715$$HP$US$US
236848012$23684801$2$F$$20240906$20240328$20240912$EXP$$FR-SANDOZ INC.-SDZ2024FR031600$SANDOZ$$30$YR$$F$Y$$$20240912$$HP$FR$FR
236848022$23684802$2$F$$20240806$20240328$20240808$EXP$$HU-SANDOZ INC.-SDZ2024HU033242$SANDOZ$$45$YR$$F$Y$$$20240808$$HP$HU$HU
236848353$23684835$3$F$$20240923$20240328$20240926$EXP$$US-SANDOZ INC.-SDZ2024US018765$SANDOZ$$$$$F$Y$58.957$KG$20240926$$CN$US$US
236848643$23684864$3$F$20240305$20240619$20240328$20240809$PER$$US-LUNDBECK-DKLU3075235$LUNDBECK$$$$$$Y$$$20240809$$CN$US$US
236848702$23684870$2$F$20240229$20240919$20240328$20240927$EXP$FR-AFSSAPS-AN2024000382$FR-009507513-2403FRA006927$MERCK$$39$YR$$M$Y$$$20240927$$MD$FR$FR
236848822$23684882$2$F$$20240621$20240328$20240702$PER$$US-INCYTE CORPORATION-2024IN002960$INCYTE$$$$$$Y$$$20240702$$CN$US$US
236848892$23684889$2$F$$20240709$20240328$20240715$EXP$$US-INCYTE CORPORATION-2024IN002988$INCYTE$$$$$$Y$$$20240715$$HP$US$US
236848922$23684892$2$F$$20240830$20240328$20240904$EXP$$US-INCYTE CORPORATION-2024IN002971$INCYTE$$$$$$Y$$$20240904$$CN$US$US
236849224$23684922$4$F$20240229$20240717$20240328$20240723$EXP$$CA-JNJFOC-20240364868$JOHNSON AND JOHNSON$$68$YR$E$F$Y$96$KG$20240723$$HP$CA$CA
236849443$23684944$3$F$$20240624$20240328$20240705$30DAY$$TR-JNJFOC-20240362861$JOHNSON AND JOHNSON$$50$YR$A$F$Y$51$KG$20240705$$CN$TR$TR
236850372$23685037$2$F$$20240910$20240328$20240911$EXP$$BR-JNJFOC-20240371139$JOHNSON AND JOHNSON$$67$YR$E$F$Y$64$KG$20240911$$CN$BR$BR
236850924$23685092$4$F$20230406$20240709$20240329$20240716$EXP$$NVSJ2024JP003716$NOVARTIS$$$$E$M$Y$63.8$KG$20240716$$MD$JP$JP
236852202$23685220$2$F$$20240709$20240329$20240717$PER$$US-SA-2024SA092791$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240717$$MD$US$US
236852302$23685230$2$F$$20240716$20240329$20240719$EXP$$CA-TAKEDA-2024TUS027552$TAKEDA$$$$$M$Y$$$20240719$$CN$CA$CA
236852624$23685262$4$F$$20240719$20240329$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001110$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
236852718$23685271$8$F$20240124$20240919$20240329$20240930$EXP$$FR-NOVOPROD-1192001$NOVO NORDISK$$47$YR$$F$Y$$$20240930$$CN$FR$FR
236852953$23685295$3$F$$20240702$20240329$20240708$PER$$US-TAKEDA-2024TUS029256$TAKEDA$$$$$F$Y$$$20240708$$CN$US$US
236853022$23685302$2$F$20240110$20240722$20240329$20240725$EXP$$FR-ABBVIE-5696385$ABBVIE$$50$YR$$M$Y$$$20240725$$MD$FR$FR
236853115$23685311$5$F$$20240903$20240329$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049533$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240904$$CN$US$US
236853433$23685343$3$F$20240311$20240627$20240329$20240722$PER$$US-AstraZeneca-2024A063616$ASTRAZENECA$$27076$DY$$M$Y$$$20240722$$HP$US$
236853513$23685351$3$F$20231011$20240906$20240329$20240911$EXP$$US-ABBVIE-5694753$ABBVIE$$79$YR$$F$Y$$$20240911$$CN$US$US
236853536$23685353$6$F$20240101$20240729$20240329$20240806$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008870$UNITED THERAPEUTICS$$$$$F$Y$57.596$KG$20240806$$$US$US
236853602$23685360$2$F$$20240625$20240329$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02543$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236853622$23685362$2$F$20240325$20240626$20240329$20240701$EXP$$NVSC2024CN067194$NOVARTIS$$$$$$Y$$$20240701$$MD$CN$CN
236853663$23685366$3$F$20240326$20240712$20240329$20240716$EXP$$US-BIOGEN-2024BI01257486$BIOGEN$$37$YR$$F$Y$$$20240716$$CN$US$US
2368537610$23685376$10$F$20240101$20240710$20240329$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-004560$UNITED THERAPEUTICS$$$$$F$Y$118.37$KG$20240719$$$US$US
236853802$23685380$2$F$$20240702$20240329$20240703$PER$$US-JNJFOC-20240380592$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240703$$CN$US$US
236853933$23685393$3$F$20240123$20240715$20240329$20240717$EXP$$ES-BIOGEN-2024BI01257233$BIOGEN$$$$$$Y$$$20240717$$MD$ES$ES
236853973$23685397$3$F$20231215$20240830$20240329$20240906$EXP$$CA-GSK-CA2023176536$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$HP$CA$CA
236854362$23685436$2$F$20240301$20240326$20240329$20240805$PER$$US-ABBVIE-5698307$ABBVIE$$16$YR$$F$Y$$$20240805$$CN$US$US
236854642$23685464$2$F$20240324$20240722$20240329$20240724$PER$$US-AMGEN-USASP2024061907$AMGEN$$61$YR$A$F$Y$$$20240724$$CN$US$US
236855032$23685503$2$F$20210601$20240805$20240329$20240808$EXP$$GB-JNJFOC-20240357369$JOHNSON AND JOHNSON$$55$YR$A$M$Y$124$KG$20240809$$MD$GB$GB
236855332$23685533$2$F$20230401$20240730$20240329$20240807$EXP$$MX-SANDOZ INC.-NVSC2023MX146665$SANDOZ$$54$YR$$F$Y$57$KG$20240807$$CN$MX$MX
236855405$23685540$5$F$20240130$20240703$20240329$20240710$EXP$$JP-GENMAB-2024-00452AA$GENMAB$$66$YR$$M$Y$56$KG$20240710$$MD$JP$JP
236855412$23685541$2$F$20240301$20240910$20240329$20240918$PER$$US-SA-2024SA096811$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240918$$MD$US$US
236855432$23685543$2$F$20231201$20240621$20240329$20240705$PER$$US-SA-2024SA097348$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240705$$MD$US$US
236855593$23685559$3$F$$20240719$20240329$20240724$PER$$US-SA-2024SA096434$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240724$$MD$US$US
236855652$23685565$2$F$20240101$20240909$20240329$20240913$EXP$$US-SA-2024SA096548$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240913$$MD$US$US
236855703$23685570$3$F$$20240723$20240329$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050214$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240725$$CN$US$US
236855752$23685575$2$F$20230925$20240902$20240329$20240906$EXP$$DE-ABBVIE-5694611$ABBVIE$$66$YR$$M$Y$$$20240906$$MD$DE$DE
236855836$23685583$6$F$20240715$20240904$20240329$20240918$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-174960$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240918$$PH$CA$CA
236855933$23685593$3$F$20240101$20240709$20240329$20240718$EXP$$US-UNITED THERAPEUTICS-UNT-2024-000427$UNITED THERAPEUTICS$$$$$M$Y$77.551$KG$20240718$$$US$US
236855984$23685598$4$F$20240320$20240903$20240329$20240907$EXP$$US-JNJFOC-20240357490$JOHNSON AND JOHNSON$$$$$F$Y$$$20240907$$HP$US$US
236856013$23685601$3$F$20240101$20240828$20240329$20240926$PER$$US-SA-2024SA097118$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240926$$MD$US$US
236856252$23685625$2$F$20240222$20240917$20240329$20240920$EXP$$US-ABBVIE-5696881$ABBVIE$$62$YR$$F$Y$$$20240920$$CN$US$US
236856394$23685639$4$F$20240101$20240702$20240329$20240711$PER$$US-SA-2024SA091230$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240711$$MD$US$US
236856476$23685647$6$F$20240301$20240913$20240329$20240917$EXP$$FR-TAKEDA-2024TUS028022$TAKEDA$$10$YR$$F$Y$14$KG$20240917$$HP$FR$FR
236856652$23685665$2$F$20231108$20240729$20240329$20240807$EXP$$JP-009507513-2311JPN002073J$MERCK$$78$YR$$M$Y$$$20240807$$MD$JP$JP
236856672$23685667$2$F$20230501$20240620$20240329$20240702$EXP$$JP-ROCHE-3351319$ROCHE$$69$YR$E$F$Y$48.1$KG$20240702$$MD$JP$JP
236856933$23685693$3$F$20240303$20240718$20240329$20240724$PER$$US-AMGEN-USASP2024064231$AMGEN$$69$YR$E$F$Y$$$20240724$$CN$US$US
236857036$23685703$6$F$20240101$20240912$20240329$20240913$EXP$$JP-GSK-JP2024JPN038716$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$JP$JP
236857273$23685727$3$F$$20240807$20240329$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049205$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240813$$CN$US$US
236857494$23685749$4$F$20240428$20240710$20240329$20240715$EXP$$CA-JNJFOC-20240381204$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240715$$HP$CA$CA
236857573$23685757$3$F$20240326$20240613$20240329$20240701$PER$$US-AMGEN-USASP2024061755$AMGEN$$81$YR$E$M$Y$$$20240701$$CN$US$US
236857602$23685760$2$F$$20240709$20240329$20240717$EXP$$GB-ADVANZ PHARMA-E2B_00011602$ADVANZ PHARMA$$$$$$Y$$$20240717$$MD$GB$GB
236857615$23685761$5$F$20240314$20240603$20240329$20240718$EXP$$DE-JNJFOC-20240360550$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$70$KG$20240718$$MD$DE$DE
236857653$23685765$3$F$$20240625$20240329$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02486$LUPIN$$$$$$Y$$$20240713$$CN$US$US
236858456$23685845$6$F$20240311$20240719$20240329$20240910$30DAY$$GR-TAKEDA-2024TUS023951$TAKEDA$$35$YR$$F$Y$$$20240910$$CN$GR$GR
236859214$23685921$4$F$20210323$20240711$20240329$20240718$EXP$$CO-TAKEDA-2020TUS038745$TAKEDA$$28$YR$$M$Y$40$KG$20240718$$HP$CO$CO
236859225$23685922$5$F$20231128$20240909$20240329$20240913$EXP$$CA-TAKEDA-2024TUS005462$TAKEDA$$88$YR$$F$Y$62.7$KG$20240913$$CN$CA$CA
236859234$23685923$4$F$20160606$20240920$20240329$20240930$EXP$$CA-TAKEDA-2024TUS028618$TAKEDA$$75$YR$$M$Y$$$20240930$$MD$CA$CA
236859423$23685942$3$F$$20240625$20240329$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02465$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236859452$23685945$2$F$$20240702$20240329$20240704$EXP$$NVSC2024US065087$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
236859513$23685951$3$F$20240101$20240822$20240329$20240903$EXP$$US-INSMED, INC.-2023-05004-US$INSMED$$$$$M$Y$$$20240903$$CN$US$US
236860133$23686013$3$F$$20240902$20240329$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-050201$BRISTOL MYERS SQUIBB$Hoshiyama T, Hotta M, Iwama A, Tsubokura Y, Yoshimura A, Fujita S, et al. A case of refractory multiple myeloma with laryngeal edema as local CRS after CART cell therapy. The 46th Annual Meeting of Japanese Society for Transplantation and Cellular Therapy (Programs and Abstracts) . 2024; 318.$58$YR$A$F$Y$69.6$KG$20240911$$MD$JP$JP
236861503$23686150$3$F$20240101$20240819$20240329$20240826$EXP$$AR-JNJFOC-20240366663$JOHNSON AND JOHNSON$$42$YR$A$F$Y$60$KG$20240826$$CN$AR$AR
236862102$23686210$2$F$$20240909$20240329$20240916$EXP$$US-BAUSCHBL-2024BNL003764$BAUSCH AND LOMB$Suffian H, Le T, Pandya A. COMPLICATIONS POST-CHEMOTHERAPY IN A CHILD WITH T-CELL LEUKEMIA AND ATAXIA TELANGIECTASIA. Annals of Allergy, Asthma and Immunology. 2023 NOV 01;131 (5):S156. doi:10.1016/j.anai.2023.08.477$4$YR$$M$Y$$$20240916$$HP$US$US
236862182$23686218$2$F$20221205$20240726$20240329$20240805$EXP$$JP-009507513-2212JPN001076J$MERCK$$9$DEC$$M$Y$$$20240805$$MD$JP$JP
236862313$23686231$3$F$20240321$20240910$20240329$20240912$EXP$$CA-JNJFOC-20240366268$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240912$$HP$CA$CA
236862552$23686255$2$F$$20240625$20240329$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02547$LUPIN$$$$$$Y$$$20240715$$CN$US$US
236862572$23686257$2$F$$20240712$20240329$20240725$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-07236$SAMSUNG BIOEPIS$$43$YR$A$F$Y$$$20240725$$CN$CA$CA
236862662$23686266$2$F$$20240918$20240329$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050151$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240918$$CN$US$US
236862747$23686274$7$F$20240719$20240814$20240329$20240815$EXP$$CA-TAKEDA-2024TUS028390$TAKEDA$$31$YR$$F$Y$$$20240815$$CN$CA$CA
236862832$23686283$2$F$$20240912$20240329$20240913$EXP$$NVSC2024US061532$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
236862852$23686285$2$F$20240201$20240705$20240329$20240711$EXP$$JP-009507513-2403JPN003097J$MERCK$$7$DEC$$M$Y$$$20240711$$MD$JP$JP
236862942$23686294$2$F$20240501$20240717$20240329$20240724$EXP$$CA-TAKEDA-2024TUS028829$TAKEDA$$82$YR$$M$Y$$$20240724$$CN$CA$CA
236863173$23686317$3$F$20210101$20240712$20240329$20240717$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-050473$REGENERON$$$$$M$Y$$$20240717$$CN$US$US
236863192$23686319$2$F$$20240710$20240329$20240711$EXP$$TR-JNJFOC-20240364722$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240711$$MD$TR$TR
236863293$23686329$3$F$$20240625$20240329$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02566$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236863344$23686334$4$F$20240414$20240716$20240329$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049639$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$51.3$KG$20240719$$CN$US$US
236863563$23686356$3$F$$20240731$20240329$20240813$EXP$$PL-AUROBINDO-AUR-APL-2024-013825$AUROBINDO$Dyzma A, Kasprzak K, Chmielewska I.. Vitiligo in the course of combined pembrolizumab and chemotherapy treatment of non small cell lung cancer in the first line setting. Onkol Prakt Klin Edu. 2022;8 (Suppl B):B18-21$63$YR$$F$Y$$$20240813$$HP$PL$PL
236863733$23686373$3$F$20230120$20240823$20240329$20240903$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-000356$Alvotech$$42$YR$$F$Y$$$20240903$$CN$CA$CA
236863742$23686374$2$F$$20240625$20240329$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02501$LUPIN$$$$$$Y$$$20240708$$CN$US$US
236863842$23686384$2$F$20240315$20240814$20240329$20240821$EXP$$US-AMGEN-USASP2024061784$AMGEN$$67$YR$E$F$Y$$$20240821$$CN$US$US
236864123$23686412$3$F$20081128$20240819$20240329$20240823$EXP$$AU-JNJFOC-20240350181$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240823$$CN$AU$AU
236864183$23686418$3$F$$20240625$20240329$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02546$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236864204$23686420$4$F$20230615$20240711$20240329$20240715$EXP$$US-BIOVITRUM-2024-US-004934$BIOVITRUM$$62$YR$$F$Y$$$20240715$$CN$US$US
236864634$23686463$4$F$$20240624$20240329$20240702$PER$$US-UNITED THERAPEUTICS-UNT-2024-009229$UNITED THERAPEUTICS$$$$$M$Y$85.261$KG$20240702$$$US$US
236864904$23686490$4$F$20240101$20240709$20240329$20240712$EXP$$CA-UCBSA-2024014972$UCB$$$$$F$Y$$$20240712$$CN$CA$CA
236864913$23686491$3$F$20200630$20240909$20240329$20240912$EXP$$CA-TAKEDA-2020TUS031195$TAKEDA$$53$YR$$F$Y$$$20240912$$MD$CA$CA
236865013$23686501$3$F$$20240719$20240329$20240723$EXP$$US-TAKEDA-2024TUS028517$TAKEDA$$$$$M$Y$$$20240723$$HP$US$US
236865682$23686568$2$F$$20240823$20240329$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049049$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240827$$CN$US$US
236865722$23686572$2$F$20240201$20240815$20240329$20240823$30DAY$$US-GSK-US2024036884$GLAXOSMITHKLINE$$31$YR$$F$Y$$$20240823$$CN$US$US
236865842$23686584$2$F$$20240625$20240329$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02575$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236865904$23686590$4$F$20240326$20240704$20240329$20240709$EXP$$NVSJ2024JP003800$NOVARTIS$$$$A$F$Y$$$20240709$$MD$JP$JP
236865992$23686599$2$F$20240101$20240805$20240329$20240810$EXP$$US-AMGEN-USASP2024062093$AMGEN$$71$YR$E$F$Y$$$20240810$$MD$US$US
236866382$23686638$2$F$$20240625$20240329$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02568$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236867432$23686743$2$F$20240311$20240821$20240329$20240824$EXP$$US-TAKEDA-2024TUS028601$TAKEDA$$27$YR$$F$Y$$$20240824$$MD$US$US
236867576$23686757$6$F$$20240905$20240329$20240913$EXP$$CA-OTSUKA-2024_008128$OTSUKA$$$$$F$Y$$$20240913$$MD$CA$CA
236867843$23686784$3$F$$20240706$20240329$20240708$PER$$NVSC2024US067598$NOVARTIS$$$$$M$Y$$$20240708$$CN$US$US
236868022$23686802$2$F$$20240910$20240329$20240912$EXP$$CL-JNJFOC-20240366974$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240912$$CN$CL$CL
236868122$23686812$2$F$20240313$20240914$20240329$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046001$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240916$$HP$US$US
236868272$23686827$2$F$$20240709$20240329$20240724$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-439823$RANBAXY$Matei MC, Ramirez SC, Sanz SS, Cazana TG, Gomez Lopez CL, Arnau NM, et al.. Pediatric cutaneous mucormicosis.. Dermatol Online J. 2023;29 (6):1-4$9$YR$$M$Y$$$20240724$$MD$ES$ES
236868462$23686846$2$F$$20240627$20240329$20240703$PER$$US-BIOGEN-2021BI01032946$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
236868863$23686886$3$F$$20240808$20240329$20240810$PER$$US-TAKEDA-2024TUS028187$TAKEDA$$$$$$Y$$$20240810$$CN$US$US
236869026$23686902$6$F$$20240819$20240329$20240821$EXP$$CA-ROCHE-3532823$ROCHE$$$$A$F$Y$$$20240821$$CN$CA$CA
236869164$23686916$4$F$$20240723$20240329$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050478$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240725$$CN$US$US
236869574$23686957$4$F$$20240628$20240329$20240704$PER$$US-BIOGEN-2024BI01257214$BIOGEN$$$$$F$Y$$$20240704$$CN$US$US
236869726$23686972$6$F$20240101$20240909$20240329$20240916$EXP$$JP-009507513-2403JPN003326J$MERCK$$65$YR$$F$Y$$$20240916$$MD$JP$JP
236870123$23687012$3$F$$20240624$20240329$20240706$EXP$$ES-COSETTE-CP2024ES000038$COSETTE PHARMACEUTICALS$$75$YR$E$M$Y$$$20240706$$HP$ES$ES
236870582$23687058$2$F$20220704$20240919$20240329$20240925$EXP$$DE-MYLANLABS-2024M1027611$MYLAN$$53$YR$$F$Y$$$20240925$$CN$DE$DE
236870992$23687099$2$F$$20240715$20240329$20240726$EXP$$US-BIOCODEX2-2024000440$BIOCODEX$$$$$F$Y$36.8$KG$20240723$$CN$US$US
236871013$23687101$3$F$20240129$20240724$20240329$20240802$EXP$$MX-LUNDBECK-DKLU3073898$LUNDBECK$$$$$$Y$$$20240802$$CN$MX$MX
236871114$23687111$4$F$$20240628$20240329$20240702$30DAY$$US-SANDOZ INC.-SDZ2024US033303$SANDOZ$$$$$M$Y$$$20240702$$CN$US$US
236871135$23687113$5$F$20240101$20240820$20240329$20240826$EXP$$CA-SANDOZ INC.-SDZ2023CA013699$SANDOZ$$$$$F$Y$$$20240826$$HP$CA$CA
236871424$23687142$4$F$$20240626$20240329$20240802$EXP$$CA-Covis Pharma GmbH-2024COV00352$COVIS PHARMA$$72$YR$E$F$Y$$$20240802$$CN$CA$CA
236871523$23687152$3$F$$20240920$20240329$20240926$EXP$$US-TAKEDA-2024TUS029825$TAKEDA$$$$$F$Y$65$KG$20240926$$CN$US$US
236871563$23687156$3$F$20240301$20240715$20240329$20240722$EXP$$CA-SA-2024SA094827$SANOFI AVENTIS$$$$$F$Y$$$20240722$$MD$CA$CA
236871822$23687182$2$F$20240101$20240830$20240329$20240903$EXP$$CA-ABBVIE-5696213$ABBVIE$$55$YR$$F$Y$$$20240903$$CN$CA$CA
236871864$23687186$4$F$20230801$20240625$20240329$20240701$EXP$$NVSC2024RU064178$NOVARTIS$$70$YR$$F$Y$$$20240701$$MD$RU$RU
236872142$23687214$2$F$20240305$20240322$20240329$20240801$PER$$US-BAYER-2024A043751$BAYER$$47$YR$A$F$Y$$$20240801$$HP$US$US
2368727210$23687272$10$F$20240627$20240917$20240329$20240919$EXP$$US-PFIZER INC-202400074081$PFIZER$$54$YR$$F$Y$66.68$KG$20240919$$HP$US$US
236872954$23687295$4$F$20240909$20240909$20240329$20240916$EXP$$CA-TAKEDA-2024TUS028894$TAKEDA$$67$YR$$F$Y$$$20240916$$MD$CA$CA
236873103$23687310$3$F$20230901$20240718$20240329$20240723$EXP$$US-AMGEN-USASP2024059565$AMGEN$$60$YR$A$M$Y$$$20240723$$CN$US$US
236873362$23687336$2$F$20240327$20240718$20240329$20240722$PER$$US-AMGEN-USASP2024064753$AMGEN$$68$YR$E$F$Y$$$20240721$$CN$US$US
236873472$23687347$2$F$$20240726$20240329$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050593$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240729$$CN$US$US
236874452$23687445$2$F$20240321$20240716$20240329$20240718$EXP$$CN-PFIZER INC-PV202400040800$PFIZER$$42$YR$$M$Y$85$KG$20240718$$HP$CN$CN
236875096$23687509$6$F$20230906$20240724$20240329$20240730$EXP$$ES-SA-2023SA354147$SANOFI AVENTIS$$64$YR$A$F$Y$80$KG$20240731$$HP$ES$ES
2368752710$23687527$10$F$20230814$20240913$20240329$20240919$EXP$$JP-INCYTE CORPORATION-2024IN003321$INCYTE$Shinomiya R, Sato Y, Yoshimoto T, Kawaguchi T, Hirao A, Okamoto K, Kawano Y, Sogabe M, Miyamoto H, Takayama T. A case of treatment-resistant advanced gastric cancer with FGFR2 gene alteration successfully treated with pemigatinib. International Cancer Conference Journal. 2024$$$$$Y$$$20240919$$MD$JP$JP
236875572$23687557$2$F$20240101$20240617$20240329$20240712$30DAY$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00136$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
236875673$23687567$3$F$20231222$20240805$20240329$20240814$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00238$CATALYST PHARMA$$39$YR$$F$Y$116.1$KG$20240814$$CN$US$US
236875853$23687585$3$F$20240321$20240714$20240329$20240718$EXP$$CA-ASTELLAS-2024US009412$ASTELLAS$$8$YR$$M$Y$$$20240718$$CN$CA$CA
236876364$23687636$4$F$$20240702$20240329$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050212$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240703$$CN$US$US
236876627$23687662$7$F$$20240830$20240329$20240905$EXP$$PL-AUROBINDO-AUR-APL-2024-014001$AUROBINDO$Szlauer-Stefanska A, Kaminska-Winciorek G. Patient with chronic cutaneous and mucosal form of graft versus host disease.. Postgraduate Dermatology [Dermatologia po Dyplomie]. 2024;2$30$YR$$M$Y$$$20240905$$MD$PL$PL
236876683$23687668$3$F$$20240816$20240329$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA033814$SANDOZ$$43$YR$$F$Y$$$20240822$$MD$CA$CA
236876853$23687685$3$F$$20240702$20240329$20240705$EXP$$JP-OTSUKA-2024_008146$OTSUKA$Suwabe T, Furuyama Y, Yonezawa H, Katagiri T, Fuse K, Shibasaki Y, et al.. A case of aplastic anemia with fatal COVID-19 due to SARS-CoV-2 reactivation after allo-SCT. The 46th JSTCT Annual Meeting (JSTCT2024) Japanese Society for Transplantation a. 2024;00(00):P-093$42$YR$$M$Y$$$20240705$$MD$JP$JP
236877063$23687706$3$F$$20240923$20240329$20240925$EXP$$BR-PFIZER INC-202400073859$PFIZER$$$$E$$Y$$$20240925$$HP$BR$BR
236877092$23687709$2$F$$20240702$20240329$20240703$EXP$$US-PFIZER INC-PV202400041930$PFIZER$$$$$F$Y$$$20240703$$CN$US$US
236877173$23687717$3$F$20240121$20240730$20240329$20240802$EXP$$US-PFIZER INC-202400053362$PFIZER$$71$YR$$F$Y$92.971$KG$20240802$$CN$US$US
236877854$23687785$4$F$20240319$20240819$20240329$20240829$EXP$$JP-Eisai-EC-2024-162229$EISAI$$52$YR$A$F$Y$$$20240829$$MD$JP$JP
236878572$23687857$2$F$20240301$20240628$20240329$20240703$PER$$NVSC2024US067987$NOVARTIS$$$$$M$Y$$$20240703$$HP$US$US
236878842$23687884$2$F$20240304$20240726$20240329$20240801$EXP$$JP-009507513-2403JPN003311J$MERCK$$8$DEC$$F$Y$$$20240801$$PH$JP$JP
236878866$23687886$6$F$20220101$20240716$20240329$20240723$EXP$$NVSC2024MX067970$NOVARTIS$$$$$F$Y$61$KG$20240723$$CN$MX$MX
236878873$23687887$3$F$20230101$20240904$20240329$20240911$EXP$$US-BIOGEN-2024BI01247469$BIOGEN$$$$$M$Y$$$20240911$$CN$US$US
236879403$23687940$3$F$20240408$20240813$20240329$20240817$EXP$$NVSC2024CA068284$NOVARTIS$$74$YR$$F$Y$$$20240817$$CN$CA$CA
236879852$23687985$2$F$$20240625$20240329$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02567$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236880048$23688004$8$F$20200601$20240308$20240329$20240809$EXP$$CA-TEVA-202306_00014271$TEVA$$80$YR$$M$Y$69$KG$20240809$$MD$CA$CA
236880654$23688065$4$F$20240101$20240709$20240329$20240717$PER$$US-SA-2024SA092623$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240717$$MD$US$US
236880732$23688073$2$F$20240301$20240703$20240329$20240712$PER$$US-SA-2024SA090851$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240712$$MD$US$US
236880882$23688088$2$F$20231201$20240812$20240329$20240816$PER$$US-SA-2024SA095262$SANOFI AVENTIS$$67$YR$E$M$Y$79.3$KG$20240816$$MD$US$US
236880904$23688090$4$F$$20240705$20240329$20240710$PER$$US-SA-2024SA095059$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$MD$US$US
236881032$23688103$2$F$$20240627$20240329$20240710$PER$$US-SA-2024SA097397$SANOFI AVENTIS$$$$C$F$Y$$$20240710$$MD$US$US
236881314$23688131$4$F$20230701$20240813$20240329$20240821$EXP$$US-SA-2023SA275658$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240821$$MD$US$US
236881342$23688134$2$F$20230101$20240830$20240329$20240930$PER$$US-SA-2024SA095509$SANOFI AVENTIS$$65$YR$E$M$Y$122.4$KG$20240930$$MD$US$US
236881352$23688135$2$F$$20240715$20240329$20240723$PER$$US-SA-2024SA096045$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240723$$MD$US$US
236881382$23688138$2$F$20240516$20240715$20240329$20240723$PER$$US-SA-2024SA097071$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240723$$CN$US$US
236881413$23688141$3$F$20230101$20240920$20240329$20240927$PER$$US-SA-2023SA215994$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240927$$MD$US$US
236881613$23688161$3$F$20230118$20240712$20240329$20240801$EXP$$GB-SA-2024SA094606$SANOFI AVENTIS$$82$YR$E$M$Y$72.2$KG$20240719$$MD$GB$GB
236881972$23688197$2$F$20240201$20240726$20240329$20240805$PER$$US-SA-2024SA091598$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240805$$MD$US$US
236882172$23688217$2$F$20231026$20240625$20240329$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-435154$RANBAXY$$86$YR$$M$Y$$$20240710$$PH$GB$GB
236882602$23688260$2$F$20240304$20240726$20240329$20240731$PER$$JP-Eisai-EC-2024-162451$EISAI$$$$$F$Y$$$20240731$$PH$JP$JP
236882672$23688267$2$F$20240101$20240916$20240329$20240924$PER$$US-SA-2024SA092581$SANOFI AVENTIS$$8$YR$C$F$Y$40.82$KG$20240924$$MD$US$US
236883323$23688332$3$F$$20240702$20240329$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-048704$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240821$$PH$JP$JP
236883573$23688357$3$F$20240325$20240730$20240329$20240801$PER$$US-AMGEN-USASP2024064506$AMGEN$$80$YR$E$M$Y$$$20240801$$CN$US$US
236883816$23688381$6$F$20240415$20240620$20240329$20240925$PER$$US-GSK-US2024AMR037352$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240925$$CN$US$US
236884423$23688442$3$F$20240229$20240716$20240329$20240717$EXP$$BR-JNJFOC-20231252491$JOHNSON AND JOHNSON$$13$YR$T$F$Y$51$KG$20240717$$CN$BR$BR
236884454$23688445$4$F$20220619$20240702$20240329$20240708$30DAY$$EG-SANDOZ INC.-SDZ2024EG027555$SANDOZ$$4$YR$$F$Y$18$KG$20240708$$CN$EG$EG
236884604$23688460$4$F$$20240814$20240329$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048754$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240821$$CN$US$US
236884756$23688475$6$F$20240312$20240710$20240329$20240724$30DAY$$CO-JNJFOC-20240354227$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240724$$CN$CO$CO
236884774$23688477$4$F$$20240731$20240329$20240805$EXP$$US-SANDOZ INC.-NVSC2021US182426$SANDOZ$$$$$F$Y$68.798$KG$20240805$$CN$US$US
236884923$23688492$3$F$20240313$20240808$20240329$20240820$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR036129$VIIV$$42$YR$$F$Y$87.3$KG$20240820$$MD$US$US
236884953$23688495$3$F$$20240628$20240329$20240702$30DAY$$US-SANDOZ INC.-SDZ2024US033195$SANDOZ$$$$$F$Y$$$20240702$$CN$US$US
236885117$23688511$7$F$20231012$20240716$20240329$20240720$EXP$$AU-TAKEDA-2023TUS099962$TAKEDA$$42$YR$$F$Y$$$20240720$$HP$AU$AU
236885123$23688512$3$F$20210706$20240819$20240329$20240828$EXP$$US-TAKEDA-2024TUS029194$TAKEDA$$46$YR$$F$Y$$$20240828$$MD$US$US
236885322$23688532$2$F$$20240702$20240329$20240702$PER$$US-JNJFOC-20240362942$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$MD$US$US
236885472$23688547$2$F$$20240822$20240329$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050836$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240827$$CN$US$US
236885662$23688566$2$F$20221019$20240808$20240329$20240813$PER$$US-TAKEDA-2022TUS084678$TAKEDA$$58$YR$$F$Y$$$20240813$$MD$US$US
236885843$23688584$3$F$$20240910$20240329$20240912$EXP$$CA-JNJFOC-20240364534$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240912$$PH$CA$CA
236886213$23688621$3$F$$20240827$20240329$20240830$PER$$US-PFIZER INC-PV202400041728$PFIZER$$72$YR$$F$Y$$$20240830$$CN$US$US
236886713$23688671$3$F$$20240902$20240329$20240905$EXP$$US-AstraZeneca-2024A076508$ASTRAZENECA$Vartak, N; Song, P; Avancena, P; Vorchheimer, D A. TICAGRELOR ASSOCIATED ACQUIRED HEMOPHILIA A AND HEMORRHAGIC SHOCK POST CORONARY STENTING. Journal of the American College of Cardiology 2024;83(13 Supplement (3354)):$68$YR$$M$Y$$$20240905$$HP$US$
236886824$23688682$4$F$20240101$20240909$20240329$20240912$EXP$$JP-Eisai-EC-2024-162545$EISAI$Taketani Y. Adverse events in LEN-PEM treatment and how to deal with them - based on experience at the reporting hospital.$65$YR$E$F$Y$$$20240912$$MD$JP$JP
236886842$23688684$2$F$20240220$20240710$20240329$20240715$EXP$$DE-JNJFOC-20240376546$JOHNSON AND JOHNSON$$86$YR$E$M$Y$68$KG$20240715$$MD$DE$DE
236887092$23688709$2$F$20231216$20240712$20240329$20240717$EXP$$NL-JNJFOC-20240368042$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240717$$HP$NL$NL
236887246$23688724$6$F$20240101$20240709$20240329$20240715$EXP$$CA-BAUSCH-BL-2024-004997$BAUSCH AND LOMB$$63$YR$$M$Y$$$20240715$$HP$CA$CA
236887572$23688757$2$F$$20240906$20240329$20240913$EXP$$US-GILEAD-2024-0667581$GILEAD$$70$YR$E$F$Y$$$20240913$$MD$US$US
236887704$23688770$4$F$20240220$20240918$20240329$20240923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-049116$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$64$KG$20240923$$MD$JP$JP
236887852$23688785$2$F$$20240906$20240329$20240913$EXP$$US-GILEAD-2024-0667524$GILEAD$$54$YR$A$M$Y$$$20240913$$MD$US$US
236888123$23688812$3$F$20240322$20240731$20240329$20240806$EXP$$JP-GILEAD-2024-0667177$GILEAD$$82$YR$E$F$Y$52$KG$20240806$$PH$JP$JP
236888282$23688828$2$F$$20240813$20240329$20240813$EXP$$ES-GILEAD-2024-0667220$GILEAD$$$$$$Y$$$20240813$$HP$ES$ES
236888292$23688829$2$F$$20240813$20240329$20240813$EXP$$ES-GILEAD-2024-0667222$GILEAD$$$$$$Y$$$20240813$$HP$ES$ES
236888892$23688889$2$F$$20240827$20240329$20240830$EXP$$US-MYLANLABS-2024M1028018$MYLAN$$$$$M$Y$$$20240830$$HP$US$US
236888975$23688897$5$F$20230317$20240919$20240329$20240924$PER$$JP-Eisai-EC-2024-162397$EISAI$$66$YR$E$F$Y$83$KG$20240924$$MD$JP$JP
236889106$23688910$6$F$$20240811$20240329$20240813$EXP$$NVSC2024US057276$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
236889523$23688952$3$F$20240324$20240328$20240329$20240919$PER$$US-MYLANLABS-2024M1028693$MYLAN$$68$YR$$F$Y$$$20240919$$CN$US$US
236889932$23688993$2$F$$20240703$20240329$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048080$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240704$$PH$US$US
236889982$23688998$2$F$$20240430$20240329$20240710$PER$$US-Merz Pharmaceuticals GmbH-24-01004$MERZ$$$$A$F$Y$$$20240710$$MD$US$US
236890204$23689020$4$F$$20240627$20240329$20240701$30DAY$$US-SANDOZ INC.-SDZ2024US032586$SANDOZ$$$$$F$Y$$$20240701$$CN$US$US
236890222$23689022$2$F$$20240628$20240329$20240702$30DAY$$US-SANDOZ INC.-SDZ2024US033826$SANDOZ$$$$$F$Y$$$20240702$$CN$US$US
236890462$23689046$2$F$20231101$20240827$20240329$20240906$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202402004368$ELI LILLY AND CO$$15$YR$T$M$Y$49$KG$20240906$$CN$JP$JP
236890953$23689095$3$F$$20240725$20240330$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-005271$JAZZ$$$$$M$Y$$$20240729$$CN$US$US
236891043$23689104$3$F$20211101$20240712$20240330$20240720$EXP$$US-ABBVIE-5506411$ABBVIE$$74$YR$$M$Y$82$KG$20240720$$CN$US$US
236891063$23689106$3$F$20240326$20240926$20240330$20240928$EXP$$JP-ABBVIE-5698404$ABBVIE$$$$$F$Y$$$20240928$$MD$JP$JP
236891076$23689107$6$F$20240101$20240718$20240330$20240726$EXP$$CA-CELLTRION INC.-2024CA007609$CELLTRION$$$$$$Y$$$20240726$$HP$CA$CA
236891086$23689108$6$F$20230117$20240826$20240330$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-001122$JAZZ$$28$YR$$F$Y$$$20240830$$MD$US$US
236891112$23689111$2$F$$20240703$20240330$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-048866$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$MD$JP$JP
236891229$23689122$9$F$20240101$20240909$20240330$20240917$EXP$$CA-CELLTRION INC.-2024CA007613$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
236891502$23689150$2$F$20240101$20240718$20240330$20240729$PER$$US-SA-2024SA097056$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240729$$MD$US$US
236891744$23689174$4$F$$20240628$20240330$20240708$EXP$$ES-AUROBINDO-AUR-APL-2024-014473$AUROBINDO$Blanco LS, Suarez BF, Rivas MG, Gomez AG.. Association of microscopic colitis and enteropathy due to olmesartan.. Spanish journal of digestive diseases.. 2024$75$YR$$M$Y$$$20240708$$MD$ES$ES
236891783$23689178$3$F$20240310$20240710$20240330$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-014642$AUROBINDO$$88$YR$$F$Y$$$20240718$$PH$FR$FR
236891955$23689195$5$F$20240307$20240823$20240330$20240830$EXP$$CA-JNJFOC-20240368852$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240830$$HP$CA$CA
236891973$23689197$3$F$20230101$20240702$20240330$20240704$EXP$$US-JNJFOC-20240369006$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240704$$CN$US$US
236892202$23689220$2$F$$20240702$20240330$20240703$EXP$$US-JNJFOC-20240369771$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$MD$US$US
236892402$23689240$2$F$$20240710$20240330$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048356$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240717$$HP$US$US
236892652$23689265$2$F$20240316$20240628$20240330$20240707$EXP$$US-RDY-CLI/USA/24/0004854$DR REDDYS$$24$YR$A$F$Y$$$20240707$$MD$US$US
236892693$23689269$3$F$20240327$20240802$20240330$20240806$PER$$US-AMGEN-USASP2024064574$AMGEN$$65$YR$E$F$Y$$$20240805$$CN$US$US
236892762$23689276$2$F$20130101$20240821$20240330$20240828$EXP$DE-drreddys-SPO/GER/23/0175320$DE-RDY-SPO/GER/23/0175320$DR REDDYS$Wiemer-Kruel A. Ketogenic diet therapy under special consideration of treatment of the myoclonic-astatic epilepsy. Journal of Epileptology volume. 2021;34: 154-60. doi:10.1007/s10309-020-00394-w.$3$YR$C$M$Y$$$20240828$$MD$DE$DE
236892902$23689290$2$F$20240327$20240630$20240330$20240703$EXP$$IN-SANDOZ INC.-SDZ2024IN033046$SANDOZ$$55$YR$$F$Y$$$20240703$$CN$IN$IN
236893592$23689359$2$F$$20240628$20240331$20240702$30DAY$$US-SANDOZ INC.-SDZ2024US032302$SANDOZ$$$$$M$Y$$$20240702$$CN$US$US
236894273$23689427$3$F$$20240716$20240331$20240729$PER$$US-ROCHE-3531878$ROCHE$$$$A$F$Y$$$20240729$$MD$US$US
236894555$23689455$5$F$20240101$20240625$20240331$20240703$EXP$$CO-JNJFOC-20240383681$JOHNSON AND JOHNSON$$56$YR$A$F$Y$70$KG$20240703$$HP$CO$CO
236894572$23689457$2$F$20240301$20240620$20240331$20240701$PER$$US-SA-2024SA094972$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240701$$MD$US$US
236894883$23689488$3$F$20240307$20240808$20240331$20240821$PER$$US-JNJFOC-20240387249$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240821$$MD$US$US
236895192$23689519$2$F$$20240725$20240331$20240802$EXP$$IN-STERISCIENCE B.V.-2024-ST-000330$Steriscience PTE$Kapoor R, Sadda S, Tyagi M.. Suspected Retinal Toxicity After Multiple Intravitreal Ganciclovir Injections in a Patient of CMV Retinitis. Ocul Immunol Inflamm. 2024;32(5):525-528$69$YR$$M$Y$$$20240802$$MD$IN$IN
236895233$23689523$3$F$$20240909$20240331$20240919$30DAY$$US-GSK-US2024036860$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
236895413$23689541$3$F$20191224$20240827$20240331$20240903$EXP$$AT-AMGEN-AUTNI2023108256$AMGEN$$32$YR$A$F$Y$62$KG$20240903$$MD$AT$AT
236895592$23689559$2$F$20240101$20240826$20240331$20240909$PER$$US-SA-2024SA093260$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240909$$MD$US$US
236895912$23689591$2$F$$20240805$20240331$20240814$EXP$$US-TEVA-VS-3174207$TEVA$On S, Domingo W, Cheung E, Johnston L. Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation. Transplant-Cell-Ther 2024; 30 (Suppl.) (2): S163 abstr. 211.; On S, Domingo W, Cheung E, Johnston L. Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation. Transplant-Cell-Ther 2024; 30 (Suppl.) (2): S163 abstr. 211.$$$A$$Y$$$20240814$$HP$US$US
236896403$23689640$3$F$20220501$20240715$20240331$20240722$PER$$US-SA-2024SA093497$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240722$$MD$US$US
236896672$23689667$2$F$20240101$20240702$20240331$20240703$PER$$US-JNJFOC-20240372829$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240703$$CN$US$US
236896894$23689689$4$F$20240101$20240826$20240331$20240903$EXP$$CA-CELLTRION INC.-2024CA007560$CELLTRION$$$$$$Y$$$20240903$$MD$CA$CA
236896902$23689690$2$F$$20240625$20240331$20240702$EXP$$CA-CELLTRION INC.-2024CA007157$CELLTRION$$$$$$Y$$$20240702$$MD$CA$CA
236897024$23689702$4$F$$20240724$20240331$20240725$EXP$NL-EMA-DD-20240321-7482831-120358$NL-ORGANON-O2403NLD002918$ORGANON$Achten NB, Been JV, Schoenmakers S, Vermont CL, Verdijk RM, Reiss IKM, Taal HR.. Fatal early-onset sepsis caused by intrauterine transmission of serogroup y meningococcus.. THE PEDIATRIC INFECTIOUS DISEASES JOURNAL.. 2022;41:517-9$$$I$M$Y$1.59$KG$20240725$$HP$NL$NL
236897062$23689706$2$F$$20240705$20240331$20240708$EXP$$JP-TAKEDA-2024TJP004517$TAKEDA$$7$DEC$$$Y$$$20240708$$MD$JP$JP
236897114$23689711$4$F$20231002$20240828$20240331$20240902$EXP$$JP-TAKEDA-2024TJP003228$TAKEDA$$7$DEC$$F$Y$$$20240902$$MD$JP$JP
236897534$23689753$4$F$$20240916$20240331$20240918$EXP$$CA-ROCHE-3535089$ROCHE$$$$A$F$Y$$$20240918$$CN$CA$CA
236897832$23689783$2$F$20240327$20240717$20240331$20240718$PER$$US-AMGEN-USASP2024065141$AMGEN$$65$YR$E$M$Y$$$20240718$$CN$US$US
236897953$23689795$3$F$20240219$20240703$20240331$20240708$EXP$$JP-JNJFOC-20240376875$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240708$$MD$JP$JP
236898073$23689807$3$F$20240201$20240703$20240331$20240705$30DAY$$US-SANDOZ INC.-SDZ2024US032681$SANDOZ$$16$YR$$M$Y$$$20240705$$CN$US$US
236898385$23689838$5$F$20240301$20240705$20240331$20240708$EXP$$NVSC2024BE067313$NOVARTIS$$45$YR$$F$Y$$$20240708$$MD$BE$BE
236898403$23689840$3$F$20240319$20240820$20240331$20240823$EXP$$NVSC2024US006876$NOVARTIS$$40$YR$$F$Y$$$20240823$$CN$US$US
236898422$23689842$2$F$$20240830$20240331$20240903$EXP$$NVSC2024TH063943$NOVARTIS$$$$$F$Y$$$20240903$$CN$TH$TH
236898438$23689843$8$F$20240317$20240815$20240331$20240823$EXP$$NVSC2024US065565$NOVARTIS$$40$YR$$F$Y$$$20240823$$CN$US$US
236898485$23689848$5$F$$20240920$20240331$20240924$PER$$NVSC2024US068089$NOVARTIS$$$$$M$Y$$$20240924$$CN$US$US
236898606$23689860$6$F$$20240716$20240331$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202403003379$ELI LILLY AND CO$$54$YR$A$F$Y$71.111$KG$20240725$$CN$US$US
236899162$23689916$2$F$20201201$20240821$20240401$20240909$PER$$US-SA-2024SA098388$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240909$$MD$US$US
236899172$23689917$2$F$20240329$20240701$20240401$20240703$PER$$US-AMGEN-USASP2024065762$AMGEN$$75$YR$E$M$Y$$$20240703$$CN$US$US
236899282$23689928$2$F$20190101$20240716$20240401$20240718$EXP$$US-ABBVIE-22K-163-4412784-00$ABBVIE$$$$$F$Y$86$KG$20240718$$CN$US$US
236899512$23689951$2$F$20230118$20240709$20240401$20240722$EXP$GB-MACLEODS PHARMA EU LTD-MAC2024046518$GB-MACLEODS PHARMA EU LTD-MAC2024046518$MACLEODS$$$$$$Y$$$20240722$$MD$GB$GB
236899592$23689959$2$F$20240321$20240717$20240401$20240725$PER$$US-SA-2024SA092443$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240725$$MD$US$US
236899612$23689961$2$F$20230724$20240731$20240401$20240809$PER$$US-SA-2024SA092441$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240809$$MD$US$US
236899652$23689965$2$F$20230101$20240828$20240401$20240904$EXP$$US-ABBVIE-5697467$ABBVIE$$83$YR$$M$Y$$$20240904$$CN$US$US
236899682$23689968$2$F$20240321$20240917$20240401$20240927$PER$$US-JNJFOC-20240363515$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240927$$CN$US$US
236899942$23689994$2$F$20240101$20240719$20240401$20240726$EXP$$US-SA-2024SA097592$SANOFI AVENTIS$$11$YR$C$M$Y$51.7$KG$20240726$$CN$US$US
236900472$23690047$2$F$20230101$20240821$20240401$20240828$EXP$$GB-UCBSA-2024014751$UCB$$$$$F$Y$$$20240828$$CN$GB$GB
236900762$23690076$2$F$$20240904$20240401$20240911$EXP$$IT-AUROBINDO-AUR-APL-2024-014143$AUROBINDO$Moccia M, Affinito G, Fumo MG, Giordana R, Gennaro MD, Mercogliano M et al... Fertility, pregnancy and childbirth in women with multiple sclerosis: a population-based study from 2018 to 2020. .. J NEUROL NEUROSURG PSYCHIATRY. 2023;1-9$$$N$M$Y$2.85$KG$20240911$$HP$IT$IT
236900802$23690080$2$F$20240601$20240624$20240401$20240703$PER$$US-SA-2024SA093410$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240703$$MD$US$US
236900832$23690083$2$F$20240101$20240712$20240401$20240723$PER$$US-SA-2024SA092430$SANOFI AVENTIS$$13$YR$T$F$Y$45$KG$20240723$$MD$US$US
236901023$23690102$3$F$20240101$20240716$20240401$20240723$PER$$US-SA-2024SA097079$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240723$$MD$US$US
236901312$23690131$2$F$20240201$20240717$20240401$20240807$PER$$CO-TOLMAR, INC.-24CO047493$TOLMAR$$69$YR$$M$Y$$$20240806$$CN$CO$CO
236901383$23690138$3$F$$20240820$20240401$20240916$PER$$CA-TOLMAR, INC.-24CA047521$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
236901472$23690147$2$F$$20240822$20240401$20240910$PER$$CA-TOLMAR, INC.-24CA047561$TOLMAR$$$$$M$Y$$$20240909$$CN$CA$CA
236901522$23690152$2$F$20240308$20240823$20240401$20240910$PER$$CA-TOLMAR, INC.-24CA047600$TOLMAR$$65$YR$$M$Y$$$20240909$$CN$CA$CA
236901723$23690172$3$F$$20240731$20240401$20240813$EXP$$BE-AUROBINDO-AUR-APL-2024-013873$AUROBINDO$Verhe M, De Somer T, Defoort B, Vanderstraeten E, Monsaert E, Bouderez V, et al. The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report. CaseRep-Oncol. 2023;16:453-460$73$YR$$M$Y$$$20240813$$HP$BE$BE
236901894$23690189$4$F$20220505$20240729$20240401$20240806$EXP$$CA-CELLTRION INC.-2022CA005839$CELLTRION$$$$$$Y$$$20240806$$MD$CA$CA
236902426$23690242$6$F$20240101$20240717$20240401$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-008896$UNITED THERAPEUTICS$$$$$F$Y$57.596$KG$20240724$$$US$US
236902465$23690246$5$F$20230101$20240628$20240401$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2023-027122$UNITED THERAPEUTICS$$$$$F$Y$$$20240703$$$US$US
236902557$23690255$7$F$20240101$20240724$20240401$20240801$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008017$UNITED THERAPEUTICS$$$$$F$Y$61.678$KG$20240801$$$US$US
236902624$23690262$4$F$20240320$20240805$20240401$20240814$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008774$UNITED THERAPEUTICS$$73$YR$$F$Y$87.075$KG$20240814$$$US$US
236902792$23690279$2$F$$20240722$20240401$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050318$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240724$$HP$US$US
236902876$23690287$6$F$$20240625$20240401$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02563$LUPIN$$$$$$Y$$$20240719$$CN$US$US
236903042$23690304$2$F$20231003$20240916$20240401$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050374$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$53.52$KG$20240923$$HP$US$US
236903143$23690314$3$F$20240124$20240708$20240401$20240719$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI00785$NEUROCRINE BIOSCIENCES$$58$YR$$F$Y$$$20240719$$MD$JP$JP
236903253$23690325$3$F$20240201$20240807$20240401$20240808$EXP$$JP-GSK-JP2024JPN039378$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$MD$JP$JP
236903363$23690336$3$F$20231001$20240910$20240401$20240911$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-020509$JAZZ$$13$YR$$M$Y$97$KG$20240911$$CN$US$US
236903652$23690365$2$F$20220101$20240628$20240401$20240705$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-003145$BOEHRINGER INGELHEIM$$69$YR$E$F$Y$71$KG$20240705$$CN$BR$BR
236903802$23690380$2$F$$20240904$20240401$20240924$PER$$AU-TOLMAR, INC.-24AU047396$TOLMAR$$$$$M$Y$$$20240923$$CN$AU$AU
236903992$23690399$2$F$$20240628$20240401$20240704$30DAY$$US-SANDOZ INC.-SDZ2024US030343$SANDOZ$$$$$M$Y$$$20240704$$CN$US$US
236904064$23690406$4$F$$20240814$20240401$20240822$EXP$$US-BIOGEN-2024BI01257280$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
236904134$23690413$4$F$20240327$20240628$20240401$20240705$PER$$US-AMGEN-USASP2024064689$AMGEN$$52$YR$A$M$Y$$$20240704$$CN$US$US
236904212$23690421$2$F$$20240702$20240401$20240711$PER$$US-SA-2024SA098066$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$MD$US$US
236904463$23690446$3$F$20200916$20240916$20240401$20240926$EXP$$DE-AUROBINDO-AUR-APL-2024-014081$AUROBINDO$$29$YR$$F$Y$$$20240926$$CN$DE$DE
236904492$23690449$2$F$20230101$20240702$20240401$20240703$PER$$US-JNJFOC-20240364055$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240703$$CN$US$US
236904793$23690479$3$F$20240301$20240614$20240401$20240701$PER$$US-APOTEX-2024AP003660$APOTEX$$$$$$Y$$$20240701$$HP$US$US
236904833$23690483$3$F$$20240819$20240401$20240821$EXP$$FR-SANDOZ INC.-SDZ2024FR033153$SANDOZ$$64$YR$$M$Y$$$20240821$$HP$FR$FR
236904922$23690492$2$F$20240320$20240705$20240401$20240717$PER$$US-SA-2024SA096427$SANOFI AVENTIS$$19$YR$A$M$Y$54.4$KG$20240717$$MD$US$US
236905112$23690511$2$F$20240326$20240627$20240401$20240703$PER$$US-AMGEN-USASP2024063802$AMGEN$$58$YR$A$F$Y$$$20240703$$CN$US$US
236905422$23690542$2$F$$20240701$20240401$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-050083$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$PH$JP$JP
236905872$23690587$2$F$$20240704$20240401$20240705$EXP$$DE-TAKEDA-2024TUS027894$TAKEDA$$$$$M$Y$$$20240705$$HP$DE$DE
236906042$23690604$2$F$20230101$20240711$20240401$20240802$PER$$CO-TOLMAR, INC.-24CO047516$TOLMAR$$$$$M$Y$$$20240801$$CN$CO$CO
236906073$23690607$3$F$20221201$20240826$20240401$20240913$PER$$CO-TOLMAR, INC.-24CO047536$TOLMAR$$84$YR$$M$Y$$$20240913$$CN$CO$CO
236906204$23690620$4$F$20231201$20240816$20240401$20240823$EXP$$US-ABBVIE-5699844$ABBVIE$$69$YR$$M$Y$$$20240823$$CN$US$US
236906333$23690633$3$F$20200101$20240716$20240401$20240724$EXP$$US-ABBVIE-5699484$ABBVIE$$48$YR$$M$Y$76$KG$20240724$$CN$US$US
236906642$23690664$2$F$$20240822$20240401$20240826$EXP$$US-TAKEDA-2024TUS029633$TAKEDA$$$$$F$Y$22.67$KG$20240826$$HP$US$US
236906655$23690665$5$F$$20240828$20240401$20240906$EXP$$BR-TAKEDA-2023TUS060650$TAKEDA$$$$$F$Y$71$KG$20240906$$PH$BR$BR
236906992$23690699$2$F$$20240718$20240401$20240723$PER$$US-JNJFOC-20240378673$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240722$$CN$US$US
236907092$23690709$2$F$$20240806$20240401$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051077$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240807$$CN$US$US
236907592$23690759$2$F$20230118$20240709$20240401$20240718$EXP$GB-009507513-2302GBR000371$GB-RDY-SPO/GBR/24/0004889$DR REDDYS$$82$YR$E$M$Y$72.2$KG$20240718$$MD$GB$GB
236907672$23690767$2$F$20240320$20240701$20240401$20240705$PER$$US-AMGEN-USASP2024065578$AMGEN$$70$YR$E$M$Y$$$20240704$$CN$US$US
236907824$23690782$4$F$20230801$20240726$20240401$20240802$EXP$$CO-ABBVIE-5696840$ABBVIE$$53$YR$$F$Y$77$KG$20240802$$CN$CO$CO
236907932$23690793$2$F$20240315$20240725$20240401$20240801$EXP$$US-TAKEDA-2023TUS049403$TAKEDA$$66$YR$$M$Y$$$20240801$$CN$US$US
236907982$23690798$2$F$$20240715$20240401$20240722$PER$$US-ALXN-202403USA001678US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
236908052$23690805$2$F$$20240708$20240401$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-050208$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240709$$MD$JP$JP
236908852$23690885$2$F$20240301$20240803$20240401$20240806$PER$$US-AMGEN-USASP2024063418$AMGEN$$35$YR$A$F$Y$$$20240806$$MD$US$US
236909172$23690917$2$F$20240327$20240716$20240401$20240723$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-049764$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240723$$CN$PR$PR
236909182$23690918$2$F$$20240723$20240401$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051127$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$70.76$KG$20240724$$CN$US$US
236909232$23690923$2$F$$20240820$20240401$20240823$PER$$US-ALXN-202403USA001693US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
236909822$23690982$2$F$$20240712$20240401$20240716$PER$$US-TAKEDA-2024TUS029986$TAKEDA$$$$$F$Y$$$20240716$$HP$US$US
236909942$23690994$2$F$$20240923$20240401$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051026$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$67.13$KG$20240924$$CN$US$US
236909985$23690998$5$F$20231207$20240716$20240401$20240718$EXP$$DE-SANDOZ INC.-SDZ2024DE033174$SANDOZ$$67$YR$$F$Y$$$20240718$$MD$DE$DE
236910152$23691015$2$F$$20240524$20240401$20240704$EXP$$US-TEVA-VS-3176993$TEVA$$64$YR$$F$Y$200$KG$20240704$$LW$US$US
236910305$23691030$5$F$20240101$20240904$20240401$20240912$EXP$$CA-CELLTRION INC.-2023CA023822$CELLTRION$$$$$$Y$$$20240912$$MD$CA$CA
236910442$23691044$2$F$20231121$20240712$20240401$20240722$EXP$$CA-CELLTRION INC.-2023CA022770$CELLTRION$$$$$$Y$$$20240722$$CN$CA$CA
236910712$23691071$2$F$20240120$20240802$20240401$20240805$EXP$GB-MHRA-MED-202401272002259090-DVYGJ$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-000788$IPCA$$$$$$Y$$$20240805$$CN$GB$GB
236910802$23691080$2$F$20240129$20240703$20240401$20240709$EXP$$JP-EXELIXIS-CABO-24075687$EXELIXIS$$84$YR$$F$Y$39.6$KG$20240708$$MD$JP$JP
236910828$23691082$8$F$20240229$20240724$20240401$20240802$EXP$$CA-ROCHE-3531146$ROCHE$$76$YR$E$M$Y$$$20240802$$CN$CA$CA
236910908$23691090$8$F$20210527$20240816$20240401$20240823$EXP$$US-TAKEDA-US202016271$TAKEDA$$51$YR$$F$Y$70$KG$20240823$$HP$US$US
2369113211$23691132$11$F$$20240918$20240401$20240930$EXP$GB-MHRA-ADR 28553972$GB-Accord-410589$ACCORD$$$$$M$Y$$$20240930$$CN$GB$GB
236911932$23691193$2$F$$20240701$20240401$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050876$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$PH$US$US
236912243$23691224$3$F$$20240412$20240401$20240925$EXP$$US-GSK-US2024AMR039131$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
236912286$23691228$6$F$20240301$20240708$20240401$20240926$PER$$US-GSK-US2024AMR037792$GLAXOSMITHKLINE$$65$YR$$F$Y$73$KG$20240926$$CN$US$US
236912404$23691240$4$F$$20240827$20240401$20240905$30DAY$$US-GSK-US2024AMR038111$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$PH$US$US
236912624$23691262$4$F$$20240807$20240401$20240820$EXP$$US-GSK-US2022120089$GLAXOSMITHKLINE$$$$$F$Y$$$20240820$$CN$US$US
236912666$23691266$6$F$20240217$20240712$20240401$20240926$PER$$US-GSK-US2024AMR036487$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240926$$CN$US$US
236912712$23691271$2$F$$20240714$20240401$20240727$EXP$$DE-Indicus Pharma-001009$INDICUS$Baskal S, Posma RA, Bollenbach A, Dieperink W, Bakker SJL, Nijsten MW, et.al. GC-MS analysis of 4-hydroxyproline: elevated proline hydroxylation in metformin-associated lactic acidosis and metformin-treated Becker muscular dystrophy patients. Amino Acids. 2024 Mar 10;56(1):21.$70$YR$E$F$Y$84$KG$20240727$$HP$DE$DE
236912864$23691286$4$F$20240307$20240729$20240401$20240806$EXP$$IE-ROCHE-3530119$ROCHE$$$$$F$Y$$$20240806$$HP$IE$IE
236913102$23691310$2$F$20240301$20240918$20240401$20240926$PER$$NVSC2024US069120$NOVARTIS$$87$YR$$F$Y$56.7$KG$20240926$$CN$US$US
236913794$23691379$4$F$20220101$20240430$20240401$20240925$PER$$US-GSK-US2022027536$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240925$$CN$US$US
236913803$23691380$3$F$$20240708$20240401$20240711$EXP$$CA-TAKEDA-2024TUS030174$TAKEDA$$$$$M$Y$$$20240711$$MD$CA$CA
236913947$23691394$7$F$20240325$20240723$20240401$20240729$EXP$$CA-TAKEDA-2024TUS028921$TAKEDA$$38$YR$$M$Y$$$20240729$$MD$CA$CA
236914112$23691411$2$F$20240328$20240701$20240401$20240703$PER$$US-AMGEN-USASP2024065580$AMGEN$$60$YR$A$M$Y$$$20240703$$CN$US$US
236914272$23691427$2$F$20240220$20240708$20240401$20240717$EXP$DE-DCGMA-24202985$DE-RDY-SPO/DEU/24/0004898$DR REDDYS$$86$YR$E$M$Y$68$KG$20240717$$MD$DE$DE
236914314$23691431$4$F$$20240705$20240401$20240710$30DAY$$US-GSK-US2024037511$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
236914432$23691443$2$F$20240227$20240714$20240401$20240718$EXP$$DE-BAUSCH-BL-2024-004817$BAUSCH AND LOMB$$71$YR$$M$Y$107$KG$20240718$$HP$DE$DE
236914742$23691474$2$F$20230118$20240709$20240401$20240718$EXP$$GB-862174955-ML2024-01957$Unknown Manufacturer$$82$YR$E$M$Y$72$KG$20240718$$MD$GB$US
236914812$23691481$2$F$$20240714$20240401$20240727$EXP$$DE-Inventia-000714$INVENTIA HEALTHCARE$Baskal S, Posma RA, Bollenbach A, Dieperink W, Bakker SJL, Nijsten MW, et.al. GC-MS analysis of 4-hydroxyproline: elevated proline hydroxylation in metformin-associated lactic acidosis and metformin-treated Becker muscular dystrophy patients. Amino Acids. 2024 Mar 10;56(1):21.$70$YR$E$F$Y$84$KG$20240727$$HP$DE$DE
236915429$23691542$9$F$20240101$20240920$20240401$20240930$EXP$$CA-CELLTRION INC.-2024CA007524$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
236915522$23691552$2$F$$20240826$20240401$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051446$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$88$KG$20240827$$CN$US$US
236915652$23691565$2$F$$20240627$20240401$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02556$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236916015$23691601$5$F$$20240919$20240401$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051107$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240925$$CN$US$US
236916413$23691641$3$F$$20240719$20240401$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-049712$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240729$$MD$JP$JP
236916422$23691642$2$F$$20240711$20240401$20240909$EXP$$CA-TAKEDA-2024TUS029462$TAKEDA$$$$$F$Y$$$20240909$$CN$CA$CA
236916752$23691675$2$F$20240301$20240322$20240401$20240815$EXP$$JP-BAUSCH-BL-2024-005124$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240815$$CN$JP$JP
236917085$23691708$5$F$20240101$20240921$20240401$20240925$30DAY$$GR-PFIZER INC-PV202400034089$PFIZER$$4$YR$$M$Y$$$20240925$$CN$GR$GR
236917104$23691710$4$F$20230101$20240816$20240401$20240821$EXP$$CA-PFIZER INC-202300290177$PFIZER$$54$YR$$F$Y$$$20240821$$HP$CA$CA
236917176$23691717$6$F$20240301$20240718$20240401$20240723$30DAY$$US-PFIZER INC-202400063649$PFIZER$$$$$$Y$$$20240723$$CN$US$US
236917512$23691751$2$F$$20240627$20240401$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02616$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236917624$23691762$4$F$20240327$20240718$20240401$20240728$PER$$US-AMGEN-USASP2024064543$AMGEN$$55$YR$A$F$Y$$$20240728$$CN$US$US
236917832$23691783$2$F$20240201$20240708$20240401$20240715$EXP$$CA-Orion Corporation ORION PHARMA-24_00029184$ORION$$59$YR$A$F$Y$$$20240715$$HP$CA$
236918162$23691816$2$F$$20240627$20240401$20240705$EXP$$JP-ROCHE-3534036$ROCHE$$75$YR$E$F$Y$$$20240706$$MD$JP$JP
236918202$23691820$2$F$$20240628$20240401$20240704$30DAY$$US-GSK-US2024037477$GLAXOSMITHKLINE$$$$$M$Y$$$20240704$$CN$US$US
236918293$23691829$3$F$20231115$20240815$20240401$20240829$EXP$$US-UCBSA-2023054963$UCB$$10$YR$$F$Y$$$20240829$$CN$US$US
236918413$23691841$3$F$$20240705$20240401$20240709$PER$$NVSC2024US068922$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
236918812$23691881$2$F$$20240320$20240401$20240710$PER$$AU-ROCHE-3530479$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
236918825$23691882$5$F$$20240904$20240401$20240909$EXP$$PL-ORGANON-O2403POL003240$ORGANON$Szlauer-Stefanska A, Kaminska-Winciorek G. Patient with chronic cutaneous and mucosal form of graft versus host disease.. Postgraduate Dermatology [Dermatologia po Dyplomie]. 2024;2$30$YR$$M$Y$$$20240909$$MD$PL$PL
236919113$23691911$3$F$$20240912$20240401$20240919$EXP$$CA-TAKEDA-2023TUS122672$TAKEDA$$$$$M$Y$$$20240919$$CN$CA$CA
236919823$23691982$3$F$$20240911$20240401$20240916$EXP$$CA-TAKEDA-2023TUS001800$TAKEDA$$$$$M$Y$$$20240916$$MD$CA$CA
236919984$23691998$4$F$20240301$20240723$20240401$20240725$PER$$US-AMGEN-USASP2024065290$AMGEN$$64$YR$A$F$Y$$$20240725$$CN$US$US
236920124$23692012$4$F$20240301$20240625$20240401$20240701$EXP$$US-ABBVIE-5698991$ABBVIE$$71$YR$$F$Y$63$KG$20240701$$CN$US$US
236920763$23692076$3$F$20240321$20240916$20240401$20240919$EXP$$US-MYLANLABS-2024M1028593$MYLAN$$64$YR$$F$Y$$$20240919$$HP$US$US
236921283$23692128$3$F$20240118$20240627$20240401$20240706$EXP$$CA-SA-2024SA047048$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240706$$MD$CA$CA
236921513$23692151$3$F$$20240429$20240401$20240923$EXP$$GB-TEVA-VS-3176748$TEVA$Maye JA, Baker O, Sheikh N. Resolution of gastric antral vascular ectasia following cessation of imatinib. BMJ-Case-Rep 2024; 17 (2):.; Maye JA, Baker O, Sheikh N. Resolution of gastric antral vascular ectasia following cessation of imatinib. BMJ-Case-Rep 2024; 17 (2):.; Maye JA, Baker O, Sheikh N. Resolution of gastric antral vascular ectasia following cessation of imatinib. BMJ-Case-Rep 2024; 17 (2):.$$$E$F$Y$$$20240923$$HP$GB$GB
236921532$23692153$2$F$$20240902$20240401$20240909$EXP$$FR-OTSUKA-2024_008174$OTSUKA$F?rst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R et. al.. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease. Bone Marrow Transplantation. 2024;59(7):918-927$30$YR$$F$Y$$$20240909$$HP$FR$FR
236921812$23692181$2$F$$20240902$20240401$20240909$EXP$$FR-OTSUKA-2024_008170$OTSUKA$Furst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R et al.. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease. Bone Marrow Transplantation. 2024;59(7):918-27$46$YR$$F$Y$$$20240909$$HP$FR$FR
236921832$23692183$2$F$20231223$20240926$20240401$20240930$EXP$$GB-ROCHE-3535827$ROCHE$$45$YR$A$F$Y$$$20240930$$HP$GB$GB
236922076$23692207$6$F$20231122$20240807$20240401$20240809$EXP$$US-PFIZER INC-PV202400024910$PFIZER$$66$YR$$M$Y$51.2$KG$20240809$$MD$US$US
236922483$23692248$3$F$20231229$20240718$20240401$20240722$PER$$US-AMGEN-USASP2024064804$AMGEN$$85$YR$E$F$Y$$$20240721$$HP$US$US
236922684$23692268$4$F$20240101$20240704$20240401$20240828$PER$$US-KARYOPHARM-2024KPT000786$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
236923194$23692319$4$F$20240101$20240911$20240401$20240919$EXP$$JP-GENMAB-2024-00524$GENMAB$$83$YR$$M$Y$$$20240919$$MD$JP$JP
236923485$23692348$5$F$20230228$20240730$20240401$20240801$EXP$$US-UCBSA-2024015289$UCB$$41$YR$$F$Y$$$20240801$$CN$US$US
236923804$23692380$4$F$20220101$20240919$20240401$20240925$EXP$$US-PFIZER INC-202200502824$PFIZER$$50$YR$$M$Y$100.5$KG$20240925$$CN$US$US
236923822$23692382$2$F$$20240823$20240401$20240827$EXP$$US-PFIZER INC-PV202400040663$PFIZER$$89$YR$$F$Y$$$20240827$$CN$US$US
236924172$23692417$2$F$$20240703$20240401$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-050204$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240709$$MD$JP$JP
236924536$23692453$6$F$20240509$20240710$20240401$20240712$EXP$$CA-TAKEDA-2024TUS020210$TAKEDA$$18$YR$$F$Y$$$20240712$$CN$CA$CA
236924692$23692469$2$F$$20240610$20240401$20240710$PER$$US-TEVA-VS-3151907$TEVA$$35$YR$$F$Y$$$20240710$$CN$US$US
236924722$23692472$2$F$20230101$20240816$20240401$20240827$EXP$$US-SA-2024SA047734$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240827$$MD$US$US
236925112$23692511$2$F$$20240708$20240401$20240716$EXP$$GB-CELLTRION INC.-2023GB025596$CELLTRION$$$$$$Y$$$20240716$$CN$GB$GB
236925224$23692522$4$F$20240101$20240718$20240401$20240723$EXP$$JP-JNJFOC-20240271759$JOHNSON AND JOHNSON$$77$YR$E$M$Y$61$KG$20240724$$$COUNTRY NOT SPECIFIED$JP
236925453$23692545$3$F$20230731$20240327$20240401$20240812$EXP$$NVSC2023AR144093$NOVARTIS$$48$YR$$F$Y$$$20240812$$CN$AR$AR
236925533$23692553$3$F$20240201$20240711$20240401$20240712$EXP$$CA-PFIZER INC-202400074252$PFIZER$$59$YR$$F$Y$$$20240712$$HP$CA$CA
236925612$23692561$2$F$20220201$20240624$20240401$20240703$PER$$US-SA-2024SA092910$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240703$$MD$US$US
236925836$23692583$6$F$20240316$20240805$20240401$20240815$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004472$SAREPTA THERAPEUTICS$$7$YR$$M$Y$24.9$KG$20240815$$CN$US$US
236926132$23692613$2$F$20200521$20240731$20240401$20240806$EXP$$CA-AKCEA THERAPEUTICS, INC.-2024IS002859$AKCEA THERAPEUTICS$$$$$$Y$$$20240805$$MD$CA$CA
236926606$23692660$6$F$$20240923$20240401$20240926$30DAY$$US-PFIZER INC-202400074084$PFIZER$$9$YR$$M$Y$20.7$KG$20240926$$HP$US$US
236926617$23692661$7$F$$20240919$20240401$20240923$30DAY$$US-PFIZER INC-202400067282$PFIZER$$9$YR$$F$Y$$$20240923$$MD$US$US
236926809$23692680$9$F$20230329$20240920$20240401$20240930$EXP$$US-UCBSA-2023011360$UCB$$38$YR$$M$Y$54.431$KG$20240930$$CN$US$US
236926893$23692689$3$F$$20240408$20240401$20240926$PER$$US-GSK-US2024AMR039385$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
236926903$23692690$3$F$$20240910$20240401$20240918$EXP$$CA-TAKEDA-2023TUS118041$TAKEDA$$$$$M$Y$$$20240918$$HP$CA$CA
236927072$23692707$2$F$20240312$20240716$20240401$20240726$EXP$$CN-PFIZER INC-PV202400041556$PFIZER$$98$YR$$M$Y$$$20240726$$HP$CN$CN
236927212$23692721$2$F$$20240905$20240401$20240911$PER$$US-BIOGEN-2019BI00711663$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
236927363$23692736$3$F$$20240815$20240401$20240821$EXP$$CZ-MYLANLABS-2024M1029161$MYLAN$Psenickova M.. Pulmonary embolism as the first sign of nephrotic syndrome - a case study. POSTGRADUALNI NEFROLOGIE. 2024;22(1):36-38$38$YR$$M$Y$$$20240821$$MD$CZ$CZ
236927507$23692750$7$F$$20240911$20240401$20240917$30DAY$$US-PFIZER INC-202400069832$PFIZER$$13$YR$$M$Y$$$20240917$$CN$US$US
236927636$23692763$6$F$20230401$20240820$20240401$20240823$EXP$$NVSC2023DE188813$NOVARTIS$$$$E$F$Y$$$20240823$$HP$DE$DE
236927982$23692798$2$F$20240101$20240726$20240401$20240801$EXP$$CA-VERTEX PHARMACEUTICALS-2024-005536$VERTEX$$33$YR$$M$Y$$$20240801$$HP$CA$CA
236928592$23692859$2$F$$20240702$20240401$20240711$PER$$US-SA-2024SA093767$SANOFI AVENTIS$$$$E$M$Y$90$KG$20240711$$MD$US$US
236928602$23692860$2$F$$20240703$20240401$20240712$PER$$US-SA-2024SA094403$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240712$$MD$US$US
236928713$23692871$3$F$20240101$20240802$20240401$20240812$PER$$US-SA-2024SA091694$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240812$$MD$US$US
236928903$23692890$3$F$20230101$20240820$20240401$20240902$PER$$US-SA-2024SA092926$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240902$$MD$US$US
236929033$23692903$3$F$20240101$20240813$20240401$20240826$PER$$US-SA-2024SA093232$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240826$$MD$US$US
236929234$23692923$4$F$$20240828$20240401$20240903$30DAY$$US-PFIZER INC-202400071070$PFIZER$$11$YR$$M$Y$$$20240903$$CN$US$US
236929302$23692930$2$F$20240101$20240626$20240401$20240705$PER$$US-SA-2024SA098330$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240705$$MD$US$US
236929352$23692935$2$F$20240101$20240621$20240401$20240701$PER$$US-SA-2024SA098533$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240701$$CN$US$US
236929365$23692936$5$F$20240101$20240625$20240401$20240704$PER$$US-SA-2024SA097995$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240704$$MD$US$US
236929493$23692949$3$F$$20240820$20240401$20240903$PER$$US-SA-2024SA097226$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240903$$MD$US$US
236929702$23692970$2$F$$20240719$20240401$20240730$PER$$US-SA-2024SA098412$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240730$$MD$US$US
236929862$23692986$2$F$20240301$20240823$20240401$20240904$PER$$US-SA-2024SA098643$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240904$$MD$US$US
236930523$23693052$3$F$$20240704$20240401$20240708$30DAY$$US-SANDOZ INC.-SDZ2024US033284$SANDOZ$$$$$F$Y$$$20240708$$CN$US$US
236930602$23693060$2$F$20231018$20240710$20240401$20240716$EXP$$CA-TAKEDA-2024TUS028781$TAKEDA$$79$YR$$F$Y$60$KG$20240716$$HP$CA$CA
236931123$23693112$3$F$20240201$20240716$20240401$20240724$PER$$US-SA-2024SA093798$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240724$$MD$US$US
236931213$23693121$3$F$$20240709$20240401$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-046922$BRISTOL MYERS SQUIBB$Kawase S, Sakurai M, Inoue K, Masuda K, Kimu H, Fujii T. Three DLBCL cases of cervical edema accompanied with CRS following CAR-T cell therapy. The 46th Annual Meeting of Japanese Society for Transplantation and Cellular Therapy (Programs and Abstracts). 2024; 225.$75$YR$E$M$Y$$$20240711$$MD$JP$JP
236931406$23693140$6$F$20231101$20240821$20240401$20240823$EXP$$JP-ALXN-202403JPN002001JP$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$MD$JP$JP
236931933$23693193$3$F$20240101$20240716$20240401$20240725$PER$$US-SA-2024SA093485$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240725$$MD$US$US
236932153$23693215$3$F$20231205$20240813$20240401$20240822$EXP$$CA-GSK-CA2024000651$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$CA$CA
236932183$23693218$3$F$$20240812$20240401$20240820$EXP$$CA-GSK-CA2024037865$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$MD$CA$CA
236932262$23693226$2$F$$20240830$20240401$20240905$EXP$$CA-SANDOZ INC.-NVSC2022CA016014$SANDOZ$$$$$F$Y$$$20240905$$CN$CA$CA
236932412$23693241$2$F$20240322$20240628$20240401$20240705$EXP$$US-EXELIXIS-CABO-24075572$EXELIXIS$$70$YR$$M$Y$$$20240705$$CN$US$US
236933022$23693302$2$F$20240328$20240717$20240401$20240723$PER$$US-AMGEN-USASP2024065546$AMGEN$$73$YR$E$M$Y$$$20240723$$CN$US$US
236933262$23693326$2$F$$20240627$20240401$20240701$EXP$$JP-AstraZeneca-2024A075633$ASTRAZENECA$$70$YR$$M$Y$$$20240701$$MD$JP$
236933303$23693330$3$F$20231001$20240814$20240401$20240820$EXP$$US-PFIZER INC-PV202400041778$PFIZER$$82$YR$$M$Y$55$KG$20240820$$HP$US$US
236933345$23693334$5$F$20240101$20240906$20240401$20240910$PER$$US-PFIZER INC-PV202400023474$PFIZER$$72$YR$$M$Y$100.1$KG$20240910$$MD$US$US
236933443$23693344$3$F$$20240628$20240401$20240703$PER$$US-PFIZER INC-PV202400042394$PFIZER$$76$YR$$F$Y$$$20240703$$CN$US$US
236933552$23693355$2$F$$20240826$20240401$20240830$PER$$US-PFIZER INC-202400074886$PFIZER$$17$YR$$F$Y$$$20240830$$MD$US$US
236933622$23693362$2$F$20240601$20240724$20240401$20240729$EXP$$US-PFIZER INC-PV202300098241$PFIZER$$77$YR$$F$Y$62.6$KG$20240729$$MD$US$US
236934132$23693413$2$F$20221010$20240327$20240401$20240925$EXP$$US-GSK-US2020AMR053192$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
236934385$23693438$5$F$20240325$20240620$20240401$20240705$EXP$$JP-GENMAB-2024-00986$GENMAB$$72$YR$$F$Y$58$KG$20240705$$MD$JP$JP
236934473$23693447$3$F$20240101$20240814$20240401$20240821$EXP$$US-SA-2024SA099146$SANOFI AVENTIS$$93$YR$E$M$Y$83$KG$20240821$$MD$US$US
236934612$23693461$2$F$20240310$20240913$20240401$20240916$PER$$US-AMGEN-USASP2024064813$AMGEN$$76$YR$E$M$Y$$$20240915$$CN$US$US
236934745$23693474$5$F$20230101$20240626$20240401$20240701$EXP$$US-SA-2024SA096075$SANOFI AVENTIS$$57$YR$A$M$Y$95.25$KG$20240701$$MD$US$US
236934772$23693477$2$F$20240329$20240724$20240401$20240727$PER$$US-AMGEN-USASP2024065761$AMGEN$$69$YR$E$F$Y$$$20240726$$CN$US$US
236934982$23693498$2$F$20240314$20240709$20240401$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004852$JAZZ$$71$YR$$F$Y$$$20240716$$HP$US$US
236935134$23693513$4$F$$20240715$20240401$20240717$EXP$$NVSC2024CA068812$NOVARTIS$$44$YR$$F$Y$97$KG$20240717$$HP$CA$CA
236935643$23693564$3$F$20240301$20240716$20240401$20240719$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202403016889$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240719$$CN$JP$JP
236935783$23693578$3$F$$20240910$20240401$20240920$EXP$$CA-APOTEX-2024AP003893$APOTEX$$82$YR$$F$Y$$$20240920$$HP$CA$CA
236935853$23693585$3$F$$20240813$20240401$20240820$EXP$FR-EMA-DD-20240325-7482663-111732$FR-SANDOZ INC.-SDZ2024FR034195$SANDOZ$$2$YR$$F$Y$$$20240820$$HP$FR$FR
236935922$23693592$2$F$20240326$20240730$20240401$20240801$PER$$US-AMGEN-USASP2024064838$AMGEN$$63$YR$A$F$Y$$$20240801$$CN$US$US
236935992$23693599$2$F$20240101$20240808$20240401$20240817$PER$$US-SA-2024SA095991$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240817$$MD$US$US
236936772$23693677$2$F$$20240701$20240401$20240701$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-047959$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$MD$IT$IT
236936783$23693678$3$F$$20240701$20240401$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-051299$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$MD$JP$JP
236936913$23693691$3$F$20231001$20240905$20240401$20240909$PER$$US-PFIZER INC-PV202300174767$PFIZER$$29$YR$$F$Y$$$20240909$$CN$US$US
236937153$23693715$3$F$20240204$20240911$20240401$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051564$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$107.95$KG$20240920$$PH$US$US
236937342$23693734$2$F$20240101$20240806$20240401$20240813$PER$$US-SA-2024SA092781$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240814$$MD$US$US
236937352$23693735$2$F$20230529$20240628$20240401$20240703$EXP$$JP-ABBVIE-5696565$ABBVIE$$91$YR$$F$Y$44$KG$20240703$$MD$JP$JP
236937403$23693740$3$F$20240424$20240812$20240401$20240821$EXP$$CA-TAKEDA-2020TUS035044$TAKEDA$$33$YR$$F$Y$$$20240821$$CN$CA$CA
236937523$23693752$3$F$20230201$20240708$20240401$20240710$EXP$$JP-ABBVIE-5698901$ABBVIE$$83$YR$$M$Y$54.8$KG$20240710$$MD$JP$JP
236937543$23693754$3$F$20240430$20240719$20240401$20240723$EXP$$CA-TAKEDA-2024TUS029810$TAKEDA$$21$YR$$F$Y$$$20240723$$CN$CA$CA
236937594$23693759$4$F$20240321$20240909$20240401$20240912$EXP$$CA-TAKEDA-2023TUS021590$TAKEDA$$70$YR$$F$Y$$$20240912$$HP$CA$CA
236937665$23693766$5$F$$20240712$20240401$20240717$PER$$NVSC2024US069073$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
236938042$23693804$2$F$20240329$20240806$20240401$20240808$PER$$US-AMGEN-USASP2024065964$AMGEN$$70$YR$E$F$Y$$$20240808$$HP$US$US
236938332$23693833$2$F$$20240729$20240401$20240731$PER$$US-PFIZER INC-202400074876$PFIZER$$47$YR$$F$Y$$$20240731$$HP$US$US
236938352$23693835$2$F$20100101$20240722$20240401$20240726$EXP$$DE-MYLANLABS-2024M1028414$MYLAN$$$$$F$Y$62$KG$20240726$$CN$DE$DE
236938422$23693842$2$F$20090101$20240722$20240401$20240726$EXP$$DE-MYLANLABS-2024M1028747$MYLAN$$$$$F$Y$62$KG$20240726$$CN$DE$DE
236938692$23693869$2$F$20240329$20240729$20240401$20240731$PER$$US-AMGEN-USASP2024065813$AMGEN$$66$YR$E$F$Y$$$20240731$$CN$US$US
236938867$23693886$7$F$20210415$20240910$20240401$20240917$EXP$$US-ABBVIE-5696904$ABBVIE$$52$YR$$F$Y$77.11$KG$20240917$$CN$US$US
236938927$23693892$7$F$20201124$20240916$20240401$20240917$EXP$$GB-SANDOZ INC.-NVSC2021GB001611$SANDOZ$$72$YR$$F$Y$62$KG$20240917$$MD$GB$GB
236939022$23693902$2$F$20230101$20240624$20240401$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202403013119$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240705$$CN$US$US
236939095$23693909$5$F$20240220$20240627$20240401$20240703$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202403016085$ELI LILLY AND CO$$86$YR$E$M$Y$45$KG$20240703$$CN$JP$JP
236939113$23693911$3$F$20240323$20240403$20240401$20240807$EXP$$AR-GILEAD-2024-0667133$GILEAD$$37$YR$A$F$Y$$$20240807$$MD$AR$AR
236939242$23693924$2$F$$20240717$20240401$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02553$LUPIN$$$$$$Y$$$20240829$$CN$US$US
236939474$23693947$4$F$$20240828$20240401$20240904$EXP$$CA-ANIPHARMA-2024-CA-001850$ANI$$56$YR$$F$Y$$$20240904$$HP$CA$CA
236939763$23693976$3$F$20230101$20240730$20240401$20240806$EXP$$BR-BAUSCH-BL-2024-005210$BAUSCH AND LOMB$$68$YR$$M$Y$64$KG$20240806$$CN$BR$BR
236940113$23694011$3$F$20240301$20240624$20240401$20240703$EXP$$US-Eisai-EC-2024-162850$EISAI$$68$YR$E$F$Y$107.4$KG$20240703$$HP$US$US
236940312$23694031$2$F$20231228$20240328$20240401$20240730$EXP$$GB-MYLANLABS-2023M1139080$MYLAN$$$$$M$Y$$$20240730$$MD$GB$GB
236940362$23694036$2$F$$20240820$20240401$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051567$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240821$$CN$US$US
236941102$23694110$2$F$$20240708$20240401$20240710$EXP$$JP-OTSUKA-2024_008192$OTSUKA$Watanuki M. Scedosporium infection disseminated during treatment with L-AMB after allo-HSCT. The 46th JSTCT Annual Meeting (JSTCT2024) Japanese Society for Transplantation. 2024;00(00):O34-4$69$YR$$F$Y$$$20240710$$MD$JP$JP
236941362$23694136$2$F$$20240812$20240401$20240815$30DAY$$DE-ABBVIE-5698101$ABBVIE$$$$$$Y$$$20240815$$HP$DE$DE
236943232$23694323$2$F$20240227$20240715$20240401$20240718$EXP$$DE-SANDOZ INC.-SDZ2024DE033339$SANDOZ$$71$YR$$M$Y$107$KG$20240718$$HP$DE$DE
236943273$23694327$3$F$20240212$20240705$20240401$20240719$EXP$$CA-HLS-202400888$HLS THERAPEUTICS$$75$YR$E$F$Y$$$20240719$$CN$CA$CA
236943305$23694330$5$F$$20240826$20240401$20240828$30DAY$$GB-SANDOZ INC.-SDZ2024GB034076$SANDOZ$$$$$M$Y$$$20240828$$CN$GB$GB
236943412$23694341$2$F$20240101$20240828$20240401$20240905$PER$$US-AMGEN-USASP2024062128$AMGEN$$54$YR$A$F$Y$$$20240905$$HP$US$US
236943782$23694378$2$F$20240624$20240709$20240401$20240718$PER$$US-SA-2024SA093907$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240718$$MD$US$US
236943832$23694383$2$F$$20240703$20240401$20240705$PER$$US-AMGEN-USASP2024065086$AMGEN$Liu M.C.; Lizaola-mayo B.; Jayasekera C.R. et al.. Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant. Journal of Gastrointestinal cancer. 2024;1-6$70$YR$E$M$Y$$$20240705$$HP$US$US
236943842$23694384$2$F$$20240703$20240401$20240708$PER$$US-AMGEN-USASP2024065098$AMGEN$Liu M.C.; Lizaola-mayo B.; Jayasekera C.R. et al.. Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant. Journal of Gastrointestinal cancer. 2024;1-6$63$YR$A$M$Y$$$20240707$$HP$US$US
236943862$23694386$2$F$$20240703$20240401$20240707$PER$$US-AMGEN-USASP2024065116$AMGEN$Liu M.C.; Lizaola-mayo B.; Jayasekera C.R. et al.. Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant. Journal of Gastrointestinal cancer. 2024;1-6$67$YR$E$M$Y$$$20240707$$HP$US$US
236944114$23694411$4$F$20181128$20240813$20240401$20240820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-050357$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$43.9$KG$20240821$$MD$JP$JP
236944343$23694434$3$F$20240327$20240821$20240401$20240823$EXP$$AU-TAKEDA-2024TUS029907$TAKEDA$$56$YR$$F$Y$$$20240823$$CN$AU$AU
236944385$23694438$5$F$20240216$20240711$20240401$20240717$EXP$JP-MMM-QTOIFW2H$JP-GSK-JP2024039402$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$JP$JP
236944393$23694439$3$F$$20240625$20240401$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-043891$BRISTOL MYERS SQUIBB$Ogura K, Fujino T, Nakamura T, Miyashita A, Oonishi A, Fuchida S, et al. Pancytopenia with myelofibrosis after ide-cel successfully treated with autologous stem cell boosting. The 46th Annual Meeting of Japanese Society for Transplantation and Cellular Therapy (JSTCT2024) . 2024.$52$YR$A$M$Y$$$20240701$$MD$JP$JP
236944503$23694450$3$F$$20240705$20240401$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-047925$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$JP$JP
236944642$23694464$2$F$$20240702$20240401$20240705$EXP$$US-JNJFOC-20240370598$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$MD$US$US
236944832$23694483$2$F$$20240701$20240401$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-051447$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$PH$JP$JP
236945272$23694527$2$F$$20240805$20240401$20240807$EXP$$US-TAKEDA-2024TUS029560$TAKEDA$$$$$M$Y$$$20240807$$HP$US$US
236945302$23694530$2$F$$20240925$20240401$20240927$EXP$$CA-TAKEDA-2024TUS030028$TAKEDA$$$$$F$Y$$$20240927$$CN$CA$CA
236945332$23694533$2$F$20220808$20240716$20240401$20240719$EXP$$US-TAKEDA-2022TUS055318$TAKEDA$$76$YR$$F$Y$71.65$KG$20240719$$HP$US$US
236945743$23694574$3$F$20240123$20240911$20240402$20240917$EXP$$CA-JNJFOC-20240201182$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240917$$CN$CA$CA
236945832$23694583$2$F$20240301$20240812$20240402$20240813$PER$$US-JNJFOC-20240348663$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240813$$CN$US$US
236945863$23694586$3$F$20240801$20240830$20240402$20240912$PER$$US-SA-2024SA093455$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240912$$MD$US$US
236946016$23694601$6$F$20240101$20240920$20240402$20240930$EXP$$CA-CELLTRION INC.-2024CA007621$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
236946023$23694602$3$F$$20240710$20240402$20240723$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP003758$STRIDES$Valadas A, Fatela N, Sepulveda Santos T, Carvalho ML.. Whipple^s disease - A typical endoscopic finding of a rare disease.. Revista espanola de enfermedades digestivas. 2024;116 (3):157-158$5$DEC$$F$Y$$$20240723$$HP$PT$PT
236946354$23694635$4$F$$20240911$20240402$20240924$EXP$$CA-ABBVIE-5702210$ABBVIE$$$$$M$Y$$$20240924$$CN$CA$CA
236946594$23694659$4$F$20240301$20240731$20240402$20240805$EXP$$US-ABBVIE-5697044$ABBVIE$$54$YR$$M$Y$$$20240805$$CN$US$US
236946762$23694676$2$F$$20240711$20240402$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-051831$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240712$$MD$JP$JP
236947222$23694722$2$F$20240101$20240826$20240402$20240904$PER$$US-SA-2024SA094412$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240904$$MD$US$US
236948072$23694807$2$F$$20240718$20240402$20240718$PER$$US-JNJFOC-20240379397$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$US$US
236948243$23694824$3$F$20240308$20240911$20240402$20240918$EXP$$BE-JNJFOC-20240369991$JOHNSON AND JOHNSON$$34$YR$A$M$Y$94$KG$20240918$$MD$BE$BE
236948502$23694850$2$F$$20240820$20240402$20240830$EXP$$CA-APOTEX-2023AP011401$APOTEX$$63$YR$$M$Y$96$KG$20240830$$HP$CA$CA
236948672$23694867$2$F$$20240905$20240402$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202404000340$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240920$$CN$US$US
236948814$23694881$4$F$20170213$20240719$20240402$20240729$EXP$$JP-SA-2024SA093179$SANOFI AVENTIS$$60$YR$A$M$Y$64$KG$20240730$$MD$JP$JP
236949432$23694943$2$F$20230707$20240807$20240402$20240822$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-439571$RANBAXY$$55$YR$$M$Y$94$KG$20240822$$MD$IT$IT
236949482$23694948$2$F$20231113$20240625$20240402$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-439934$RANBAXY$$55$YR$$F$Y$$$20240710$$MD$IT$IT
236949734$23694973$4$F$$20240910$20240402$20240916$PER$$US-AMGEN-USASP2024065653$AMGEN$$$$$M$Y$$$20240916$$HP$US$US
236949753$23694975$3$F$20240303$20240909$20240402$20240911$PER$$NVSC2024US065090$NOVARTIS$$73$YR$$F$Y$$$20240911$$HP$US$US
236949794$23694979$4$F$20240513$20240619$20240402$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001137$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240712$$CN$US$US
236949932$23694993$2$F$$20240625$20240402$20240702$EXP$$JP-AMGEN-JPNSP2024061923$AMGEN$$$$T$M$Y$$$20240702$$MD$JP$JP
236950022$23695002$2$F$$20240709$20240402$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA028658$SANDOZ$$8$YR$$F$Y$28.8$KG$20240711$$MD$CA$CA
236950392$23695039$2$F$20240301$20240816$20240402$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001145$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240910$$CN$US$US
2369506111$23695061$11$F$20231201$20240917$20240402$20240926$EXP$$CA-CELLTRION INC.-2023CA023743$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
236950732$23695073$2$F$$20240321$20240402$20240906$EXP$$CN-NOVOPROD-1195682$NOVO NORDISK$$79$YR$$F$Y$59$KG$20240906$$MD$CN$CN
236950743$23695074$3$F$20240101$20240719$20240402$20240731$PER$$US-SA-2024SA098835$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240801$$MD$US$US
236951544$23695154$4$F$20240101$20240801$20240402$20240807$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000300$DECIPHERA PHARMACEUTICALS$$69$YR$E$M$Y$$$20240807$$HP$US$US
236951812$23695181$2$F$20220101$20240823$20240402$20240904$EXP$PL-EMA-DD-20240301-7482655-074919$PL-Accord-414633$ACCORD$$$$E$M$Y$$$20240904$$MD$PL$PL
236952336$23695233$6$F$20240328$20240909$20240402$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202404000324$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240912$$CN$US$US
236952383$23695238$3$F$20240220$20240628$20240402$20240723$PER$$US-ALK-ABELLO A/S-2024AA001126$ALK-ABELLO$$$$$$Y$$$20240723$$CN$US$US
236952393$23695239$3$F$20240227$20240628$20240402$20240723$PER$$US-ALK-ABELLO A/S-2024AA001125$ALK-ABELLO$$$$$$Y$$$20240723$$CN$US$US
236952443$23695244$3$F$$20240705$20240402$20240709$PER$$US-ALXN-202403USA001810US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240709$$CN$US$US
236952513$23695251$3$F$$20240715$20240402$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA032871$SANDOZ$$43$YR$$F$Y$96$KG$20240723$$HP$CA$CA
236952672$23695267$2$F$$20240926$20240402$20240930$EXP$$US-PAREXEL-2021-KAM-US003529$TAKEDA$$$$$M$Y$$$20240930$$CN$US$US
236952922$23695292$2$F$20240328$20240627$20240402$20240703$PER$$US-AMGEN-USASP2024065454$AMGEN$$64$YR$A$F$Y$$$20240703$$CN$US$US
236953082$23695308$2$F$20240328$20240711$20240402$20240716$PER$$US-AMGEN-USASP2024065533$AMGEN$$69$YR$E$M$Y$$$20240716$$CN$US$US
236953183$23695318$3$F$20240101$20240831$20240402$20240911$EXP$$US-SA-2024SA098555$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240911$$MD$US$US
236953413$23695341$3$F$20240601$20240626$20240402$20240702$EXP$$US-TAKEDA-2024TUS030412$TAKEDA$$58$YR$$F$Y$$$20240702$$MD$US$US
236953544$23695354$4$F$$20240626$20240402$20240703$PER$$NVSC2024US069396$NOVARTIS$$$$$F$Y$$$20240703$$HP$US$US
236953692$23695369$2$F$20230801$20240823$20240402$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-035927$JAZZ$$48$YR$$F$Y$$$20240827$$CN$US$US
236954076$23695407$6$F$20240219$20240702$20240402$20240723$EXP$$JP-AstraZeneca-2024A076397$ASTRAZENECA$$76$YR$$M$Y$$$20240723$$MD$JP$
236954163$23695416$3$F$20240301$20240812$20240402$20240818$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050390$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240819$$CN$US$US
236954422$23695442$2$F$20240327$20240723$20240402$20240725$PER$$US-AMGEN-USASP2024065638$AMGEN$$71$YR$E$F$Y$$$20240725$$CN$US$US
236954644$23695464$4$F$$20240529$20240402$20240723$PER$$US-LUNDBECK-DKLU3075668$LUNDBECK$$$$$$Y$$$20240723$$CN$US$US
2369547210$23695472$10$F$20240305$20240704$20240402$20240716$EXP$$JP-AMGEN-JPNSP2024065191$AMGEN$$81$YR$E$M$Y$51.8$KG$20240715$$MD$JP$JP
236954832$23695483$2$F$20240326$20240726$20240402$20240730$PER$$US-AMGEN-USASP2024064851$AMGEN$$8$YR$C$M$Y$$$20240729$$CN$US$US
236954888$23695488$8$F$20240101$20240918$20240402$20240927$EXP$$CA-CELLTRION INC.-2024CA007740$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
236954944$23695494$4$F$20200101$20240513$20240402$20240718$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-019307$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240718$$CN$US$US
236955014$23695501$4$F$20240502$20240812$20240402$20240820$EXP$$CA-CELLTRION INC.-2024CA007625$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
236955042$23695504$2$F$20240101$20240904$20240402$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-047074$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240913$$CN$US$US
236955063$23695506$3$F$$20240704$20240402$20240707$PER$$NVSC2024US068102$NOVARTIS$$$$$$Y$$$20240708$$PH$US$US
236955302$23695530$2$F$20230901$20240729$20240402$20240805$EXP$$BR-GSK-BR2023AMR106362$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$BR$BR
236955506$23695550$6$F$20240101$20240920$20240402$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050516$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240930$$CN$US$US
236955577$23695557$7$F$$20240404$20240402$20240807$EXP$$GB-SANDOZ INC.-NVSC2022GB089673$SANDOZ$$29$YR$$M$Y$$$20240807$$MD$GB$GB
236955832$23695583$2$F$$20240710$20240402$20240722$EXP$$JP-ROCHE-3534824$ROCHE$$$$$F$Y$$$20240719$$HP$JP$JP
236956062$23695606$2$F$$20240628$20240402$20240704$EXP$$CO-GSK-CO2023AMR151676$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$CO$CO
236956343$23695634$3$F$$20240627$20240402$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051541$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240709$$CN$US$US
236956392$23695639$2$F$$20240812$20240402$20240816$EXP$$IR-IPCA LABORATORIES LIMITED-IPC-2024-IR-000833$IPCA$Maryam Favaedi, Yeganeh Paseban, Ali Kabiri et al. A case of unexplained warfarin resistance: A case report and literature review. The Journal of Tehran University Heart Center. 2023;18(4):303-307$$$$$Y$$$20240816$$MD$IR$IR
236956622$23695662$2$F$$20240904$20240402$20240916$EXP$$ES-AUROBINDO-AUR-APL-2024-013653$AUROBINDO$Mansilla-Polo M, Escutia-Munoz B, Llavador-Ros M, Botella-Estrada R. Skin lesions in a lung transplant recipient. Enfermedades Infecciosas y Microbiologia Clinica. 2024;42(3):160-2$31$YR$$M$Y$$$20240916$$MD$ES$ES
236956644$23695664$4$F$20240101$20240704$20240402$20240711$EXP$$CA-CELLTRION INC.-2024CA007577$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
236956702$23695670$2$F$20240325$20240820$20240402$20240830$30DAY$$US-GSK-US2024037983$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240830$$CN$US$US
236956934$23695693$4$F$20240331$20240705$20240402$20240708$PER$$US-AMGEN-USASP2024066122$AMGEN$$64$YR$A$M$Y$$$20240708$$CN$US$US
236957867$23695786$7$F$20240410$20240917$20240402$20240924$EXP$$CA-TAKEDA-2024TUS027559$TAKEDA$$77$YR$$M$Y$$$20240924$$HP$CA$CA
236957942$23695794$2$F$$20240829$20240402$20240907$30DAY$$US-GSK-US2024AMR036300$GLAXOSMITHKLINE$$$$$M$Y$$$20240907$$CN$US$US
236957964$23695796$4$F$20240418$20240701$20240402$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051628$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240701$$CN$US$US
236958323$23695832$3$F$$20240912$20240402$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048062$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240916$$CN$US$US
236958714$23695871$4$F$$20240924$20240402$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049767$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240925$$CN$US$US
236958724$23695872$4$F$20240405$20240812$20240402$20240816$PER$$US-BIOGEN-2024BI01257575$BIOGEN$$40$YR$$F$Y$$$20240816$$CN$US$US
236959302$23695930$2$F$$20240723$20240402$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-051260$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240723$$PH$JP$JP
236959483$23695948$3$F$$20240701$20240402$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050116$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240701$$CN$US$US
236959532$23695953$2$F$20230201$20240715$20240402$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052100$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240716$$HP$US$US
236960222$23696022$2$F$20240201$20240701$20240402$20240703$EXP$$US-TAKEDA-2024TUS030033$TAKEDA$$22$YR$$M$Y$$$20240703$$MD$US$US
2369603611$23696036$11$F$20240125$20240906$20240402$20240919$EXP$$JP-AMGEN-JPNSP2024065934$AMGEN$$65$YR$E$M$Y$$$20240919$$HP$JP$JP
236960444$23696044$4$F$20240301$20240703$20240402$20240709$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-002815$AMGEN$$50$YR$A$F$Y$$$20240709$$HP$US$US
236960532$23696053$2$F$20240331$20240814$20240402$20240817$PER$$US-AMGEN-USASP2024066410$AMGEN$$61$YR$A$F$Y$$$20240816$$CN$US$US
236960543$23696054$3$F$20240331$20240718$20240402$20240723$PER$$US-AMGEN-USASP2024066142$AMGEN$$$$$$Y$$$20240723$$CN$US$US
236960583$23696058$3$F$$20240917$20240402$20240920$EXP$$US-SHIRE-US201916018$TAKEDA$$$$$F$Y$$$20240920$$MD$US$US
236960744$23696074$4$F$$20240617$20240402$20240808$EXP$PT-ABBVIE-5640694$NVSC2024PT069365$NOVARTIS$$$$E$$Y$$$20240808$$HP$PT$PT
236960752$23696075$2$F$20240705$20240715$20240402$20240722$EXP$$CO-GSK-CO2023AMR140712$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$CO$CO
236960934$23696093$4$F$20231101$20240430$20240402$20240812$EXP$$NVSC2024EG067481$NOVARTIS$$59$YR$$F$Y$$$20240812$$PH$EG$EG
236961123$23696112$3$F$$20240820$20240402$20240825$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-051236$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240826$$MD$JP$JP
236961353$23696135$3$F$20240401$20240718$20240402$20240723$PER$$US-AMGEN-USASP2024066294$AMGEN$$74$YR$E$F$Y$$$20240723$$CN$US$US
236961362$23696136$2$F$20240330$20240719$20240402$20240724$PER$$US-AMGEN-USASP2024066216$AMGEN$$71$YR$E$M$Y$$$20240724$$CN$US$US
236961575$23696157$5$F$20240101$20240702$20240402$20240704$EXP$$US-UCBSA-2024012599$UCB$$$$$F$Y$$$20240704$$CN$US$US
236962253$23696225$3$F$$20240917$20240402$20240930$EXP$$JP-AMGEN-JPNSP2024065374$AMGEN$$78$YR$E$F$Y$$$20240930$$CN$JP$JP
236962532$23696253$2$F$20240220$20240909$20240402$20240916$EXP$$BE-JNJFOC-20240369789$JOHNSON AND JOHNSON$$59$YR$A$M$Y$113$KG$20240916$$MD$BE$BE
236962792$23696279$2$F$$20240717$20240402$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02554$LUPIN$$$$$$Y$$$20240826$$CN$US$US
236962953$23696295$3$F$$20240821$20240402$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02604$LUPIN$$$$$$Y$$$20240909$$CN$US$US
236963192$23696319$2$F$20240401$20240627$20240402$20240701$PER$$US-AMGEN-USASP2024066391$AMGEN$$64$YR$A$F$Y$$$20240701$$CN$US$US
236963423$23696342$3$F$20230922$20240710$20240402$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202401009983$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240712$$HP$US$US
236963814$23696381$4$F$20240331$20240828$20240402$20240831$PER$$US-AMGEN-USASP2024066065$AMGEN$$66$YR$E$F$Y$$$20240831$$CN$US$US
236963892$23696389$2$F$$20240807$20240402$20240813$EXP$$FR-ROCHE-3515673$ROCHE$Darres A, Del Bello A,Marion O, de Lamballerie X, Malvy D, Izopet J and Kamar N Failure of favipiravir to treat chronic norovirus infection in a kidney-transplant patient (Letter to the Editor). DOI:10.1111/tid.14235. Transplant Infectious Disease 2024 Feb;26 (1):1-2.$64$YR$A$M$Y$$$20240813$$HP$FR$FR
236963992$23696399$2$F$$20240625$20240402$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02614$LUPIN$$$$$$Y$$$20240715$$PH$US$US
236964082$23696408$2$F$20231025$20240711$20240402$20240723$EXP$$PL-AUROBINDO-AUR-APL-2024-014758$AUROBINDO$$59$YR$$M$Y$76.5$KG$20240719$$HP$PL$PL
236964122$23696412$2$F$$20240819$20240402$20240902$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-05558$ALKEM$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al.. Valproate: Aortic arch anomaly and complex malformations: 2 case reports.. Reactions. 2019;1772:unk$$$$$Y$$$20240902$$HP$DE$DE
236964262$23696426$2$F$$20240819$20240402$20240902$EXP$CN-MLMSERVICE-20240315-4878632-1$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-06181$ALKEM$Li S, Feng T, Hao X, Wang Y, Zhang J. Successful treatment of a kidney transplant patient with severe novel coronavirus pneumonia: A case report. Transplant Immunology. 2024;83:102017$69$YR$$F$Y$$$20240902$$MD$CN$CN
236964392$23696439$2$F$$20240611$20240402$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001486$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
236964732$23696473$2$F$$20240625$20240402$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02557$LUPIN$$$$$$Y$$$20240715$$CN$US$US
236964843$23696484$3$F$20240416$20240814$20240402$20240819$EXP$$CA-TAKEDA-2024TUS029178$TAKEDA$$34$YR$$M$Y$$$20240819$$CN$CA$CA
2369649110$23696491$10$F$20240723$20240917$20240402$20240930$EXP$$CA-TAKEDA-2024TUS025372$TAKEDA$$29$YR$$F$Y$$$20240930$$CN$CA$CA
236964972$23696497$2$F$20240331$20240724$20240402$20240727$PER$$US-AMGEN-USASP2024066223$AMGEN$$75$YR$E$F$Y$$$20240727$$CN$US$US
236965212$23696521$2$F$$20240625$20240402$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02615$LUPIN$$$$$$Y$$$20240716$$CN$US$US
236965502$23696550$2$F$$20240910$20240402$20240923$EXP$$CA-APOTEX-2024AP004083$APOTEX$$66$YR$$F$Y$61$KG$20240923$$HP$CA$CA
236965514$23696551$4$F$$20240807$20240402$20240812$PER$$US-BIOGEN-2023BI01235969$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
236965553$23696555$3$F$$20240704$20240402$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-050293$BRISTOL MYERS SQUIBB$$$$A$M$Y$$$20240709$$MD$JP$JP
236965622$23696562$2$F$$20240918$20240402$20240923$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-001710$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240923$$CN$US$US
236965766$23696576$6$F$$20240708$20240402$20240710$PER$$NVSC2024US069773$NOVARTIS$$$$$F$Y$$$20240710$$HP$US$US
236966026$23696602$6$F$20230801$20240808$20240402$20240813$EXP$$US-ROCHE-3505888$ROCHE$$47$YR$A$F$Y$102$KG$20240813$$HP$US$US
236966482$23696648$2$F$20240101$20240820$20240402$20240830$PER$$US-Eisai-EC-2024-158006$EISAI$$75$YR$E$M$Y$$$20240830$$CN$US$US
236966556$23696655$6$F$20240201$20240627$20240402$20240709$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-000378$SK LIFE SCIENCE$$$$$$Y$$$20240709$$HP$CA$CA
236966564$23696656$4$F$$20240701$20240402$20240714$PER$$US-AMGEN-USASP2024066085$AMGEN$$$$$$Y$$$20240714$$CN$US$US
236966842$23696684$2$F$$20240715$20240402$20240722$EXP$$CA-GSK-CA2024AMR040142$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$HP$CA$CA
236966962$23696696$2$F$$20240717$20240402$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02595$LUPIN$$$$$$Y$$$20240821$$CN$US$US
236967252$23696725$2$F$$20240909$20240402$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-007853$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240916$$CN$US$US
236967423$23696742$3$F$$20240717$20240402$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02629$LUPIN$$$$$$Y$$$20240826$$CN$US$US
236967583$23696758$3$F$$20240717$20240402$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02600$LUPIN$$$$$$Y$$$20240825$$CN$US$US
236967622$23696762$2$F$$20240827$20240402$20240911$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439726$RANBAXY$Mansilla-Polo M, Escutia-Munnoz B, Llavador-Ros M,  Botella-Estrada R. Skin lesions in a lung transplant recipient. Enfermedades Infecciosas y Microbiologia Clinica. 2024;42:160-162$31$YR$$M$Y$$$20240911$$HP$ES$ES
236967722$23696772$2$F$$20240717$20240402$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02601$LUPIN$$$$$$Y$$$20240829$$CN$US$US
236968312$23696831$2$F$$20240912$20240402$20240916$EXP$$CA-PFIZER INC-202400075588$PFIZER$$90$YR$$M$Y$$$20240916$$HP$CA$CA
236968333$23696833$3$F$20230101$20240710$20240402$20240710$EXP$$US-PFIZER INC-202400074934$PFIZER$$$$$F$Y$$$20240710$$CN$US$US
236968502$23696850$2$F$$20240726$20240402$20240730$EXP$$US-GILEAD-2024-0667720$GILEAD$$$$E$M$Y$$$20240730$$CN$US$US
236968705$23696870$5$F$20240312$20240704$20240402$20240710$30DAY$$CL-PFIZER INC-PV202400035330$PFIZER$$15$YR$$M$Y$$$20240710$$CN$CL$CL
236968762$23696876$2$F$$20240717$20240402$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02606$LUPIN$$$$$$Y$$$20240826$$CN$US$US
236968972$23696897$2$F$20240101$20240821$20240402$20240823$PER$$JP-Eisai-EC-2024-158472$EISAI$$66$YR$E$M$Y$$$20240823$$MD$JP$JP
236969482$23696948$2$F$$20240702$20240402$20240702$PER$$US-JNJFOC-20240366732$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$US$US
236969544$23696954$4$F$$20240909$20240402$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051277$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240916$$CN$US$US
236969633$23696963$3$F$$20240717$20240402$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02628$LUPIN$$$$$$Y$$$20240821$$CN$US$US
236969803$23696980$3$F$$20240910$20240402$20240913$EXP$$US-PFIZER INC-PV202400043013$PFIZER$$84$YR$$M$Y$$$20240913$$CN$US$US
236970002$23697000$2$F$$20240725$20240402$20240730$EXP$$CA-PFIZER INC-202300132967$PFIZER$$60$YR$$M$Y$$$20240730$$HP$CA$CA
236970082$23697008$2$F$$20240717$20240402$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02636$LUPIN$$$$$$Y$$$20240825$$CN$US$US
236970733$23697073$3$F$$20240717$20240402$20240816$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-02605$LUPIN$$$$$$Y$$$20240816$$CN$US$US
236970842$23697084$2$F$$20240904$20240402$20240905$PER$$US-AMGEN-USASP2024066195$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
236971422$23697142$2$F$$20240715$20240402$20240722$PER$$US-ALXN-202403USA001734US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
236971542$23697154$2$F$$20240909$20240402$20240924$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000173$BECTON DICKINSON$$$$$$Y$$$20240924$$CN$GB$GB
236971702$23697170$2$F$20240318$20240826$20240402$20240830$PER$$JP-Eisai-EC-2024-162542$EISAI$$6$DEC$A$F$Y$$$20240830$$MD$JP$JP
236971834$23697183$4$F$$20240708$20240402$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02655$LUPIN$$$$$$Y$$$20240805$$CN$US$US
236971943$23697194$3$F$$20240807$20240402$20240812$EXP$FR-EMA-DD-20240325-7482663-111732$FR-SA-2024SA099377$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240812$$HP$FR$FR
236972154$23697215$4$F$$20240717$20240402$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02642$LUPIN$$$$$$Y$$$20240828$$CN$US$US
236972362$23697236$2$F$20231201$20240826$20240402$20240904$EXP$$FI-TEVA-VS-3175568$TEVA$$87$YR$$F$Y$$$20240904$$CN$FI$FI
236972418$23697241$8$F$20240101$20240819$20240402$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-008937$UNITED THERAPEUTICS$$$$$F$Y$44.444$KG$20240824$$$US$US
236972454$23697245$4$F$20240318$20240619$20240402$20240809$PER$$US-LUNDBECK-DKLU3075817$LUNDBECK$$$$$$Y$$$20240809$$HP$US$US
236972482$23697248$2$F$$20240919$20240402$20240923$EXP$$US-MYLANLABS-2024M1029173$MYLAN$$$$$F$Y$75$KG$20240923$$HP$US$US
236972542$23697254$2$F$20240325$20240807$20240402$20240812$EXP$$US-MYLANLABS-2024M1029125$MYLAN$$28$YR$$$Y$$$20240812$$HP$US$US
236973022$23697302$2$F$$20240913$20240402$20240920$EXP$$US-EMD Serono-2024017608$EMD SERONO INC$$$$A$F$Y$$$20240920$$CN$US$US
236973032$23697303$2$F$$20240627$20240402$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02650$LUPIN$$$$$$Y$$$20240714$$CN$US$US
236973142$23697314$2$F$20240101$20240702$20240402$20240710$EXP$$RU-TAKEDA-2024TUS029585$TAKEDA$$52$YR$$M$Y$$$20240710$$CN$RU$RU
236973164$23697316$4$F$$20240903$20240402$20240910$EXP$$NVSC2024CA067445$NOVARTIS$$62$YR$$F$Y$$$20240910$$HP$CA$CA
236973302$23697330$2$F$20240229$20240809$20240402$20240815$EXP$FR-AFSSAPS-PV2024000241$FR-ROCHE-3535658$ROCHE$$18$YR$A$F$Y$32.6$KG$20240815$$MD$FR$FR
236973375$23697337$5$F$$20240911$20240402$20240916$30DAY$$US-PFIZER INC-202400071009$PFIZER$$14$YR$$M$Y$$$20240916$$HP$US$US
236973543$23697354$3$F$$20240726$20240402$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052051$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240804$$CN$US$US
236973632$23697363$2$F$$20240717$20240402$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02644$LUPIN$$$$$$Y$$$20240821$$CN$US$US
236973644$23697364$4$F$20240321$20240730$20240402$20240802$30DAY$$US-PFIZER INC-PV202400039368$PFIZER$$10$YR$$M$Y$$$20240802$$CN$US$US
236973714$23697371$4$F$$20240730$20240402$20240801$30DAY$$US-PFIZER INC-202400071479$PFIZER$$27$YR$$M$Y$$$20240801$$CN$US$US
236973735$23697373$5$F$$20240924$20240402$20240926$30DAY$$US-PFIZER INC-202400070856$PFIZER$$13$YR$$M$Y$54.43$KG$20240926$$CN$US$US
236973783$23697378$3$F$$20240427$20240402$20240702$PER$$US-LEO Pharma-368984$LEO PHARM$$35$YR$$F$Y$$$20240702$$PH$US$US
236974002$23697400$2$F$20210306$20240729$20240402$20240808$EXP$FR-AFSSAPS-LM2024000080$FR-BIOCON BIOLOGICS LIMITED-BBL2024001129$BIOCON$$$$$$Y$$$20240808$$MD$FR$FR
236974054$23697405$4$F$20230503$20240725$20240402$20240802$EXP$$CA-OTSUKA-2023_031778$OTSUKA$$17$YR$$M$Y$$$20240802$$MD$CA$CA
236974103$23697410$3$F$$20240828$20240402$20240902$EXP$$CA-SANDOZ INC.-NVSC2023CA100273$SANDOZ$$$$$F$Y$$$20240902$$HP$CA$CA
236974392$23697439$2$F$$20240801$20240402$20240809$EXP$$JP-009507513-2403JPN003669J$MERCK$$$$$F$Y$$$20240809$$MD$JP$JP
236974422$23697442$2$F$20220101$20240809$20240402$20240814$EXP$$US-SA-2024SA099184$SANOFI AVENTIS$$47$YR$A$F$Y$74.7$KG$20240814$$MD$US$US
236974456$23697445$6$F$$20240909$20240402$20240919$30DAY$$US-PFIZER INC-202400069888$PFIZER$$14$YR$$M$Y$56.7$KG$20240919$$CN$US$US
236974463$23697446$3$F$$20240829$20240402$20240903$EXP$$CA-SANDOZ INC.-PHHY2015CA096506$SANDOZ$$77$YR$$F$Y$$$20240903$$MD$CA$CA
236974532$23697453$2$F$$20240717$20240402$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02652$LUPIN$$$$$$Y$$$20240821$$CN$US$US
236974542$23697454$2$F$20240628$20240703$20240402$20240708$EXP$$CA-SANDOZ INC.-SDZ2024CA031787$SANDOZ$$74$YR$$M$Y$$$20240708$$MD$CA$CA
236974672$23697467$2$F$$20240628$20240402$20240703$EXP$$CA-TAKEDA-2024TUS030515$TAKEDA$$$$$M$Y$$$20240703$$CN$CA$CA
236974993$23697499$3$F$$20240715$20240402$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA034933$SANDOZ$$44$YR$$F$Y$$$20240723$$HP$CA$CA
236975302$23697530$2$F$20240329$20240718$20240402$20240723$PER$$US-AMGEN-USASP2024065565$AMGEN$$63$YR$A$M$Y$$$20240723$$CN$US$US
236975447$23697544$7$F$20240426$20240718$20240402$20240725$EXP$$CA-TAKEDA-2024TUS030168$TAKEDA$$44$YR$$M$Y$$$20240725$$MD$CA$CA
236975522$23697552$2$F$20180101$20240827$20240402$20240903$EXP$$DE-ROCHE-3530301$ROCHE$$51$YR$A$M$Y$$$20240903$$CN$DE$DE
236975804$23697580$4$F$20220101$20240804$20240402$20240812$EXP$$FR-JNJFOC-20240384515$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240812$$HP$FR$FR
236976152$23697615$2$F$20240401$20240718$20240402$20240722$PER$$US-AMGEN-USASP2024066423$AMGEN$$63$YR$A$M$Y$$$20240722$$CN$US$US
236976794$23697679$4$F$$20240924$20240402$20240930$EXP$$GB-MYLANLABS-2024M1029854$MYLAN$$$$$F$Y$$$20240930$$PH$GB$GB
236976883$23697688$3$F$20240229$20240621$20240402$20240701$EXP$$US-OTSUKA-2024_005724$OTSUKA$$86$YR$$M$Y$$$20240701$$CN$US$US
236976936$23697693$6$F$20240314$20240916$20240402$20240919$30DAY$$HN-PFIZER INC-PV202400036764$PFIZER$$8$YR$$M$Y$$$20240919$$HP$HN$HN
236977205$23697720$5$F$$20240906$20240402$20240910$30DAY$$US-PFIZER INC-PV202400040480$PFIZER$$14$YR$$F$Y$$$20240910$$CN$US$US
236977373$23697737$3$F$$20240916$20240402$20240918$EXP$$GB-MYLANLABS-2024M1028796$MYLAN$$$$$F$Y$$$20240918$$HP$GB$GB
236977423$23697742$3$F$20231018$20240827$20240402$20240830$EXP$$CA-OTSUKA-2023_027777$OTSUKA$$68$YR$$M$Y$$$20240830$$MD$CA$CA
236977435$23697743$5$F$20240301$20240705$20240402$20240712$EXP$$US-GSK-US2024039090$GLAXOSMITHKLINE$$72$YR$$F$Y$105$KG$20240712$$CN$US$US
236977534$23697753$4$F$20240318$20240807$20240402$20240813$30DAY$$US-PFIZER INC-202400072312$PFIZER$$8$YR$$M$Y$26.9$KG$20240813$$CN$US$US
236977604$23697760$4$F$20240223$20240909$20240402$20240911$30DAY$$US-PFIZER INC-202400074819$PFIZER$$13$YR$$F$Y$34.02$KG$20240911$$HP$US$US
236977636$23697763$6$F$$20240909$20240402$20240911$30DAY$$US-PFIZER INC-202400072241$PFIZER$$12$YR$$F$Y$30.94$KG$20240911$$CN$US$US
236977926$23697792$6$F$20240401$20240712$20240402$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052198$BRISTOL MYERS SQUIBB$$66$YR$A$F$Y$$$20240717$$CN$US$US
236978125$23697812$5$F$$20240909$20240402$20240913$30DAY$$US-PFIZER INC-202400074173$PFIZER$$14$YR$$M$Y$$$20240913$$HP$US$US
236978144$23697814$4$F$$20240809$20240402$20240813$30DAY$$US-PFIZER INC-202400074310$PFIZER$$14$YR$$M$Y$56.7$KG$20240813$$CN$US$US
236978152$23697815$2$F$$20240809$20240402$20240816$30DAY$$US-PFIZER INC-202400074138$PFIZER$$17$YR$$M$Y$$$20240816$$CN$US$US
236978176$23697817$6$F$$20240910$20240402$20240913$30DAY$$US-PFIZER INC-202400074122$PFIZER$$17$YR$$M$Y$$$20240913$$CN$US$US
236978188$23697818$8$F$$20240627$20240402$20240701$30DAY$$US-PFIZER INC-202400073362$PFIZER$$11$YR$$F$Y$52.16$KG$20240701$$CN$US$US
236978204$23697820$4$F$$20240920$20240402$20240923$30DAY$$FR-PFIZER INC-202400068394$PFIZER$$52$YR$$M$Y$$$20240923$$PH$FR$FR
236978283$23697828$3$F$$20240909$20240402$20240912$30DAY$$US-PFIZER INC-202400074527$PFIZER$$15$YR$$M$Y$39.46$KG$20240912$$CN$US$US
236978325$23697832$5$F$$20240925$20240402$20240927$30DAY$$US-PFIZER INC-202400073338$PFIZER$$15$YR$$M$Y$$$20240927$$HP$US$US
236978622$23697862$2$F$$20240703$20240402$20240708$PER$$US-AMGEN-USASP2024065149$AMGEN$Liu M.C.; Lizaola-mayo B.; Jayasekera C.R. et al.. Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant. Journal of Gastrointestinal cancer. 2024;1-6$71$YR$E$M$Y$$$20240707$$HP$US$US
236978737$23697873$7$F$20240301$20240802$20240402$20240812$EXP$$NVSC2024MX068925$NOVARTIS$$36$YR$$F$Y$70$KG$20240812$$CN$MX$MX
236978873$23697887$3$F$20240201$20240702$20240402$20240704$EXP$$US-PFIZER INC-PV202400042860$PFIZER$$71$YR$$F$Y$51.338$KG$20240704$$CN$US$US
236979033$23697903$3$F$20240101$20240916$20240402$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052180$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$54.43$KG$20240919$$CN$US$US
236979043$23697904$3$F$$20240711$20240402$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-051308$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240712$$MD$JP$JP
236979053$23697905$3$F$$20240711$20240402$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-051251$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$96$KG$20240723$$HP$CA$CA
236979243$23697924$3$F$20231201$20240902$20240402$20240909$PER$$JP-Eisai-EC-2024-162644$EISAI$$80$YR$E$M$Y$53.7$KG$20240909$$PH$JP$JP
236979272$23697927$2$F$$20240904$20240402$20240909$EXP$$GB-ABBVIE-5695110$ABBVIE$$$$E$M$Y$$$20240909$$CN$GB$GB
236979332$23697933$2$F$$20240821$20240402$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA034328$SANDOZ$$54$YR$$F$Y$$$20240822$$HP$CA$CA
236979552$23697955$2$F$$20240917$20240402$20240919$EXP$$JP-OTSUKA-2024_008360AA$OTSUKA$Noguchi M, Kumano A, Katsura T, Minagawa H, Yokoi T, Nomura M, et al. A case of female AR-CGD patient with surgical excision of a liver abscess prior to HSCT. 46th JSTCT Annual Meeting (JSTCT2024) Japanese Society for Transplantation and C. 2024;00(00):O5-2$9$YR$$F$Y$$$20240919$$MD$JP$JP
236980182$23698018$2$F$20240221$20240330$20240402$20240813$EXP$$NVSC2024EG069053$NOVARTIS$$50$YR$$F$Y$$$20240813$$CN$EG$EG
236980813$23698081$3$F$$20240813$20240402$20240816$EXP$$RO-SANDOZ INC.-SDZ2024RO034747$SANDOZ$$73$YR$$F$Y$90$KG$20240816$$CN$RO$RO
236981242$23698124$2$F$$20240717$20240402$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02592$LUPIN$$$$$$Y$$$20240821$$CN$US$US
236981384$23698138$4$F$$20240716$20240402$20240722$EXP$$US-SANDOZ INC.-SDZ2024US034719$SANDOZ$$$$$F$Y$77.098$KG$20240722$$CN$US$US
236982062$23698206$2$F$20240328$20240716$20240402$20240722$PER$$US-AMGEN-USASP2024066549$AMGEN$$76$YR$E$M$Y$$$20240722$$CN$US$US
236982103$23698210$3$F$20240101$20240821$20240402$20240905$PER$$US-SA-2024SA100197$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240905$$MD$US$US
236982122$23698212$2$F$$20240709$20240402$20240710$EXP$$US-JNJFOC-20240369904$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240710$$CN$US$US
236982232$23698223$2$F$$20240630$20240402$20240709$EXP$$NL-JNJFOC-20240370246$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$MD$NL$NL
236983692$23698369$2$F$20230710$20240829$20240402$20240830$EXP$$JP-BAYER-2024A045241$BAYER$Matsukuma K, Fukuoka K, Yamamura S, Yoshida N, Tsuji M, Katsuta M, et.al. 30P-am453S A case of suspected adverse drug reaction to a renally excreted drug due to decreased renal function in the early stages of finelenone administration. The 144 Annual Meeting of the Pharmaceutical Society of Japan(Yokohama). 2024$7$DEC$E$M$Y$62.2$KG$20240830$$HP$JP$JP
236983842$23698384$2$F$$20240701$20240402$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052171$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240701$$CN$US$US
236983892$23698389$2$F$$20240701$20240402$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052140$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240701$$CN$US$US
236983912$23698391$2$F$$20240701$20240402$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052141$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240701$$CN$US$US
236983962$23698396$2$F$20230704$20240801$20240402$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-051293$BRISTOL MYERS SQUIBB$Takao K, et al. A case of pemphigoid during administration of anti-PD-1 antibody for gastric cancer. The 96th Annual Meeting of Japanese Gastric Cancer Association. 2024;OB15-4$74$YR$E$M$Y$$$20240807$$MD$JP$JP
236983982$23698398$2$F$$20240807$20240402$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051603$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240809$$HP$US$US
236984262$23698426$2$F$20240301$20240906$20240402$20240918$PER$$US-SA-2024SA095409$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240918$$MD$US$US
236984323$23698432$3$F$20240101$20240909$20240402$20240930$PER$$US-SA-2024SA093137$SANOFI AVENTIS$$50$YR$A$F$Y$78$KG$20240930$$MD$US$US
236984363$23698436$3$F$20231201$20240626$20240402$20240708$PER$$US-SA-2024SA094660$SANOFI AVENTIS$$54$YR$A$F$Y$73.4$KG$20240708$$MD$US$US
236984452$23698445$2$F$$20240805$20240402$20240814$PER$$US-SA-2024SA095887$SANOFI AVENTIS$$$$C$M$Y$$$20240814$$MD$US$US
236984492$23698449$2$F$20240220$20240722$20240402$20240725$PER$$US-INCYTE CORPORATION-2024IN003184$INCYTE$$$$$$Y$$$20240725$$MD$US$US
236984502$23698450$2$F$20240201$20240819$20240402$20240828$PER$$US-SA-2024SA096615$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240828$$MD$US$US
236984602$23698460$2$F$$20240712$20240402$20240722$PER$$US-SA-2024SA092620$SANOFI AVENTIS$$$$A$F$Y$113.4$KG$20240720$$MD$US$US
236984682$23698468$2$F$20240101$20240916$20240402$20240923$PER$$US-SA-2024SA095546$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240923$$MD$US$US
236984722$23698472$2$F$20240101$20240719$20240402$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052415$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$61.4$KG$20240725$$CN$US$US
236984752$23698475$2$F$$20240701$20240402$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049050$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240701$$CN$US$US
236984762$23698476$2$F$$20240701$20240402$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052183$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240701$$PH$US$US
236984954$23698495$4$F$20240101$20240712$20240402$20240722$PER$$US-SA-2024SA095993$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240720$$MD$US$US
236985002$23698500$2$F$$20240917$20240402$20240925$PER$$US-SA-2024SA095143$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240925$$MD$US$US
236985043$23698504$3$F$20240101$20240716$20240402$20240724$PER$$US-SA-2024SA094712$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240724$$MD$US$US
236985312$23698531$2$F$$20240701$20240402$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052163$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240701$$CN$US$US
236985422$23698542$2$F$20240301$20240620$20240402$20240701$PER$$US-SA-2024SA095072$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240701$$MD$US$US
236985532$23698553$2$F$$20240710$20240402$20240718$PER$$US-SA-2024SA095538$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240718$$MD$US$US
236985743$23698574$3$F$20240101$20240903$20240402$20240912$PER$$US-SA-2024SA094737$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240912$$MD$US$US
236985802$23698580$2$F$20240301$20240708$20240402$20240717$PER$$US-SA-2024SA094950$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240717$$MD$US$US
236985812$23698581$2$F$$20240621$20240402$20240702$PER$$US-SA-2024SA094716$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240702$$MD$US$US
236986012$23698601$2$F$20240301$20240710$20240402$20240718$PER$$US-SA-2024SA096662$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240718$$MD$US$US
236986363$23698636$3$F$20240101$20240626$20240402$20240705$PER$$US-SA-2024SA096475$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240705$$MD$US$US
236986433$23698643$3$F$20231120$20240722$20240402$20240731$PER$$US-SA-2024SA097193$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240731$$MD$US$US
236986445$23698644$5$F$20240101$20240724$20240402$20240802$PER$$US-SA-2024SA098324$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240802$$MD$US$US
236986534$23698653$4$F$20240101$20240823$20240402$20240906$PER$$US-SA-2024SA099391$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240906$$MD$US$US
236986562$23698656$2$F$20230101$20240826$20240402$20240913$PER$$US-SA-2024SA098951$SANOFI AVENTIS$$70$YR$E$M$Y$60.3$KG$20240913$$MD$US$US
236986642$23698664$2$F$20240301$20240805$20240402$20240813$PER$$US-SA-2024SA099390$SANOFI AVENTIS$$41$YR$A$M$Y$74.8$KG$20240814$$MD$US$US
236986842$23698684$2$F$$20240820$20240402$20240830$PER$$US-SA-2024SA099400$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240830$$MD$US$US
236986882$23698688$2$F$20240101$20240722$20240402$20240731$PER$$US-SA-2024SA098139$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240731$$MD$US$US
236987034$23698703$4$F$$20240709$20240402$20240717$PER$$US-SA-2024SA099660$SANOFI AVENTIS$$6$YR$C$F$Y$27$KG$20240717$$MD$US$US
236987302$23698730$2$F$20240622$20240624$20240402$20240703$PER$$US-SA-2024SA097367$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240703$$CN$US$US
236987432$23698743$2$F$20240101$20240709$20240402$20240717$PER$$US-SA-2024SA098915$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240717$$MD$US$US
236987722$23698772$2$F$20240101$20240620$20240402$20240701$PER$$US-SA-2024SA096969$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240701$$MD$US$US
236987903$23698790$3$F$20240502$20240708$20240402$20240715$PER$$US-SA-2024SA100024$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240715$$MD$US$US
236987992$23698799$2$F$20240101$20240626$20240402$20240701$PER$$US-SA-2024SA056984$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240701$$MD$US$US
236988272$23698827$2$F$$20240918$20240402$20240926$PER$$US-SA-2024SA099787$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240926$$MD$US$US
236988302$23698830$2$F$20231001$20240801$20240402$20240809$PER$$US-SA-2024SA099627$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240809$$MD$US$US
236988522$23698852$2$F$$20240716$20240402$20240723$PER$$US-SA-2024SA096997$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240723$$MD$US$US
236988574$23698857$4$F$$20240729$20240402$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046398$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240802$$CN$US$US
236988722$23698872$2$F$$20240718$20240402$20240728$PER$$US-SA-2024SA099974$SANOFI AVENTIS$$$$A$M$Y$$$20240728$$MD$US$US
236988752$23698875$2$F$$20240722$20240402$20240731$PER$$US-SA-2024SA100148$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240801$$MD$US$US
236988825$23698882$5$F$20240201$20240828$20240402$20240902$EXP$$CA-TAKEDA-2024TUS030098$TAKEDA$$25$YR$$M$Y$$$20240902$$HP$CA$CA
236989192$23698919$2$F$20230101$20240802$20240402$20240813$PER$$US-SA-2024SA091053$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240814$$CN$US$US
236989535$23698953$5$F$20240101$20240826$20240402$20240830$EXP$$DE-ABBVIE-5701933$ABBVIE$$$$$M$Y$$$20240830$$CN$DE$DE
236989612$23698961$2$F$$20240812$20240402$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202404000066$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240823$$CN$US$US
236989794$23698979$4$F$20240101$20240711$20240402$20240715$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-037316$JAZZ$$$$$M$Y$$$20240715$$HP$US$US
236989862$23698986$2$F$$20240802$20240402$20240808$EXP$$CA-TAKEDA-2024TUS028786$TAKEDA$$$$$F$Y$$$20240808$$CN$CA$CA
236989913$23698991$3$F$20240101$20240726$20240402$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051652$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240730$$HP$US$US
236989994$23698999$4$F$$20240724$20240402$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052172$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$68.4$KG$20240725$$PH$US$US
236990515$23699051$5$F$$20240712$20240402$20240722$PER$$NVSC2024US069722$NOVARTIS$$$$$$Y$$$20240722$$CN$US$US
236990523$23699052$3$F$$20240909$20240402$20240919$EXP$$US-TEVA-VS-3174222$TEVA$Gutierrez RA, Smith P, Kranyak A, Davis M, Koo J. Pimozide-induced tardive dyskinesia in the treatment of delusions of infestation. JAAD-Case-Rep 2024; 45 71-73.; Literature Reference: Gutierrez RA, Smith P, Kranyak A, Davis M, Koo J. Pimozide-induced tardive dyskinesia in the treatment of delusions of infestation. JAAD Case Rep. 2024 Jan 20;45:71-73.; Gutierrez RA, Smith P, Kranyak A, Davis M, Koo J. Pimozide-induced tardive dyskinesia in the treatment of delusions of infestation. JAAD Case ...$52$YR$$F$Y$$$20240919$$HP$US$US
236990758$23699075$8$F$20240101$20240830$20240402$20240905$EXP$$US-PFIZER INC-202400075450$PFIZER$$73$YR$$F$Y$$$20240905$$HP$US$US
236990762$23699076$2$F$$20240401$20240402$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202404001123$ELI LILLY AND CO$$71$YR$E$$Y$$$20240712$$CN$US$US
236991212$23699121$2$F$20240101$20240730$20240402$20240807$PER$$US-SA-2024SA099905$SANOFI AVENTIS$$63$YR$A$F$Y$88.4$KG$20240807$$MD$US$US
236991303$23699130$3$F$$20240718$20240402$20240730$PER$$US-PHARMING-PHAUS2024000276$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
236991344$23699134$4$F$$20240923$20240402$20240927$PER$$US-PHARMING-PHAUS2024000269$PHARMING GROUP$$$$$$Y$$$20240927$$CN$US$US
236991555$23699155$5$F$20240501$20240827$20240402$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052338$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$110.2$KG$20240903$$CN$US$US
236992224$23699222$4$F$$20240927$20240402$20240927$EXP$$US-PFIZER INC-PV202400019400$PFIZER$$24$YR$$M$Y$$$20240927$$HP$US$US
236992233$23699223$3$F$20240101$20240729$20240402$20240801$PER$$US-PFIZER INC-202400036338$PFIZER$$40$YR$$M$Y$75.75$KG$20240801$$CN$US$US
236992272$23699227$2$F$$20240724$20240402$20240729$PER$$US-PFIZER INC-PV202400042773$PFIZER$$53$YR$$M$Y$$$20240729$$HP$US$US
236992302$23699230$2$F$$20240829$20240402$20240904$PER$$US-PFIZER INC-PV202400042564$PFIZER$$75$YR$$F$Y$$$20240904$$CN$US$US
236992502$23699250$2$F$$20240816$20240402$20240820$EXP$$PL-BAUSCH-BL-2024-004826$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240820$$MD$PL$PL
236992732$23699273$2$F$$20240702$20240402$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052214$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240702$$HP$US$US
236992912$23699291$2$F$$20240730$20240402$20240812$EXP$$IN-INCYTE CORPORATION-2024IN003195$INCYTE$$$$$$Y$$$20240812$$CN$IN$IN
236992944$23699294$4$F$$20240805$20240402$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052036$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240807$$CN$US$US
236993244$23699324$4$F$20240327$20240701$20240402$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050880$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240701$$CN$US$US
236993255$23699325$5$F$20240318$20240730$20240402$20240802$PER$$US-ALXN-202403USA001871US$ALEXION PHARMACEUTICALS$$76$YR$$F$Y$$$20240802$$CN$US$US
236993292$23699329$2$F$$20240703$20240402$20240705$PER$$US-AMGEN-USASP2024065139$AMGEN$Liu M. C.; Lizaola-mayo B.; Jayasekera C. R. et al.. Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant. Journal of Gastrointestinal cancer. 2024;1-6$69$YR$E$M$Y$$$20240704$$HP$US$US
236993382$23699338$2$F$20230101$20240801$20240402$20240809$PER$$US-ALXN-202403USA001918US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240809$$HP$US$US
236993642$23699364$2$F$$20240816$20240402$20240829$PER$$US-SA-2024SA099481$SANOFI AVENTIS$$$$A$F$Y$$$20240829$$MD$US$US
236993863$23699386$3$F$20100503$20240904$20240402$20240906$EXP$FR-EMA-DD-20240326-7482655-061913$FR-SANDOZ INC.-SDZ2024FR034818$SANDOZ$$67$YR$$M$Y$74$KG$20240906$$MD$FR$FR
236994467$23699446$7$F$$20240830$20240402$20240913$30DAY$$FR-JNJFOC-20240333780$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$PH$FR$FR
236994622$23699462$2$F$20221021$20240917$20240402$20240920$EXP$$JP-JNJFOC-20231008730$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240920$$MD$JP$JP
236994772$23699477$2$F$20240201$20240722$20240402$20240729$EXP$$US-ABBVIE-5699823$ABBVIE$$74$YR$$F$Y$$$20240729$$CN$US$US
236994943$23699494$3$F$$20240704$20240402$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-050292$BRISTOL MYERS SQUIBB$$$$A$M$Y$$$20240709$$MD$JP$JP
236995214$23699521$4$F$$20240812$20240402$20240817$EXP$$GB-TAKEDA-2024TUS029971$TAKEDA$$$$$M$Y$$$20240817$$CN$GB$GB
236995374$23699537$4$F$20230101$20240724$20240402$20240731$PER$$US-BIOGEN-2023BI01241347$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
236995482$23699548$2$F$20240301$20240918$20240402$20240925$EXP$$CA-BIOGEN-2024BI01258113$BIOGEN$$65$YR$$F$Y$$$20240925$$CN$CA$CA
236995544$23699554$4$F$20240301$20240916$20240402$20240925$EXP$$CA-JNJFOC-20240356271$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240925$$HP$CA$CA
236995843$23699584$3$F$20240317$20240905$20240402$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202403015668$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240917$$CN$US$US
236995853$23699585$3$F$20240101$20240618$20240402$20240701$EXP$$US-MALLINCKRODT-MNK202402100$MALLINCKRODT$$$$A$F$Y$$$20240701$$HP$US$US
236996002$23699600$2$F$$20240801$20240403$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052362$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$105.69$KG$20240807$$CN$US$US
236996024$23699602$4$F$20240327$20240726$20240403$20240802$EXP$$CA-GSK-CA2023131706$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$CA$CA
236996044$23699604$4$F$20240219$20240904$20240403$20240905$EXP$$JP-TAKEDA-2024TJP000397$TAKEDA$$58$YR$$M$Y$75$KG$20240905$$MD$JP$JP
236996122$23699612$2$F$20240226$20240628$20240403$20240703$EXP$$US-ABBVIE-5701476$ABBVIE$$39$YR$$F$Y$$$20240703$$CN$US$US
236997194$23699719$4$F$20240401$20240729$20240403$20240802$PER$$US-AMGEN-USASP2024066578$AMGEN$$59$YR$A$M$Y$$$20240802$$CN$US$US
236997262$23699726$2$F$20240401$20240718$20240403$20240722$PER$$US-AMGEN-USASP2024066603$AMGEN$$63$YR$A$M$Y$$$20240722$$CN$US$US
236997302$23699730$2$F$20240301$20240828$20240403$20240912$EXP$$US-SA-2024SA096751$SANOFI AVENTIS$$76$YR$E$M$Y$103.4$KG$20240912$$MD$US$US
236997414$23699741$4$F$$20240915$20240403$20240919$EXP$$IL-ABBVIE-5701749$ABBVIE$$$$$M$Y$$$20240919$$CN$IL$IL
236997462$23699746$2$F$20240401$20240628$20240403$20240702$PER$$US-AMGEN-USASP2024066346$AMGEN$$62$YR$A$F$Y$$$20240702$$CN$US$US
236997482$23699748$2$F$$20240701$20240403$20240704$EXP$$NVSC2024FR067627$NOVARTIS$$$$C$F$Y$6.31$KG$20240704$$MD$FR$FR
236997513$23699751$3$F$$20240704$20240403$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-050294$BRISTOL MYERS SQUIBB$$$$A$M$Y$$$20240711$$MD$JP$JP
236997703$23699770$3$F$20230101$20240616$20240403$20240709$PER$$US-TOLMAR, INC.-23US047863$TOLMAR$$$$$M$Y$77$KG$20240709$$CN$US$US
236997743$23699774$3$F$$20240731$20240403$20240803$PER$$US-AMGEN-USASP2024066856$AMGEN$$$$$M$Y$$$20240803$$CN$US$US
236997902$23699790$2$F$20240327$20240722$20240403$20240725$PER$$US-AMGEN-USASP2024065065$AMGEN$$44$YR$A$M$Y$$$20240724$$CN$US$US
236997912$23699791$2$F$20240401$20240719$20240403$20240724$PER$$US-AMGEN-USASP2024066457$AMGEN$$64$YR$A$F$Y$$$20240723$$CN$US$US
236998183$23699818$3$F$20240326$20240711$20240403$20240801$PER$$US-SA-2024SA099312$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240719$$MD$US$US
236998802$23699880$2$F$$20240324$20240403$20240715$EXP$$US-NOVOPROD-1196976$NOVO NORDISK$$$$$$Y$$$20240715$$CN$US$US
236998972$23699897$2$F$$20240702$20240403$20240711$EXP$$FR-NOVOPROD-1197314$NOVO NORDISK$$$$A$F$Y$$$20240711$$CN$FR$FR
236999212$23699921$2$F$20240324$20240702$20240403$20240703$EXP$$US-JNJFOC-20240370510$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$MD$US$US
236999282$23699928$2$F$20240330$20240711$20240403$20240713$PER$$US-AMGEN-USASP2024066433$AMGEN$$65$YR$E$M$Y$$$20240713$$CN$US$US
236999292$23699929$2$F$20230401$20240719$20240403$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-049570$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240723$$MD$JP$JP
236999474$23699947$4$F$20240311$20240827$20240403$20240903$EXP$$CA-JNJFOC-20240339593$JOHNSON AND JOHNSON$$42$YR$A$F$Y$63.2$KG$20240903$$HP$CA$CA
236999599$23699959$9$F$20240623$20240716$20240403$20240724$EXP$$US-UNITED THERAPEUTICS-UNT-2024-001570$UNITED THERAPEUTICS$$58$YR$$F$Y$$$20240724$$$US$US
236999603$23699960$3$F$20090304$20240908$20240403$20240917$EXP$$CA-JNJFOC-20230139603$JOHNSON AND JOHNSON$$49$YR$A$M$Y$120$KG$20240917$$HP$CA$CA
236999612$23699961$2$F$$20240704$20240403$20240712$PER$$US-ALXN-202312USA001415US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
236999693$23699969$3$F$$20240711$20240403$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-049250$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$96$KG$20240725$$HP$CA$CA
237000172$23700017$2$F$$20240701$20240403$20240703$EXP$$PK-BRISTOL-MYERS SQUIBB COMPANY-2024-050217$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$HP$PK$PK
237000342$23700034$2$F$20240201$20240912$20240403$20240925$EXP$$GB-UCBSA-2024009250$UCB$$39$YR$$F$Y$$$20240925$$CN$GB$GB
237000533$23700053$3$F$20240101$20240721$20240403$20240724$PER$$US-AMGEN-USASP2024066851$AMGEN$$28$YR$A$F$Y$$$20240724$$HP$US$US
237000563$23700056$3$F$20231005$20240910$20240403$20240919$EXP$$CA-ROCHE-3444797$ROCHE$$54$YR$A$F$Y$$$20240919$$CN$CA$CA
237000682$23700068$2$F$20240301$20240905$20240403$20240912$EXP$$US-ABBVIE-5701005$ABBVIE$$70$YR$$F$Y$$$20240912$$CN$US$US
237000752$23700075$2$F$20240117$20240627$20240403$20240707$EXP$$JP-ROCHE-3533812$ROCHE$$7$DEC$E$M$Y$$$20240707$$MD$JP$JP
237000812$23700081$2$F$$20240709$20240403$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001202$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
237000863$23700086$3$F$20240903$20240906$20240403$20240917$PER$$US-SA-2024SA098459$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240918$$CN$US$US
237000952$23700095$2$F$$20240917$20240403$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052522$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240918$$CN$US$US
237001312$23700131$2$F$$20240701$20240403$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052355$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240701$$CN$US$US
237001473$23700147$3$F$$20240903$20240403$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02675$LUPIN$$$$$$Y$$$20240919$$CN$US$US
237001542$23700154$2$F$20230101$20240725$20240403$20240730$EXP$$JP-009507513-2310JPN001333J$MERCK$$45$YR$$F$Y$$$20240730$$MD$JP$JP
237001642$23700164$2$F$20240201$20240807$20240403$20240808$PER$$US-AMGEN-USASP2024065815$AMGEN$$62$YR$A$F$Y$$$20240808$$CN$US$US
237001693$23700169$3$F$20220621$20240705$20240403$20240712$EXP$$EG-SANDOZ INC.-SDZ2024EG032416$SANDOZ$$10$YR$$M$Y$39$KG$20240712$$CN$EG$EG
237001722$23700172$2$F$$20240717$20240403$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02625$LUPIN$$$$$$Y$$$20240821$$CN$US$US
237001842$23700184$2$F$$20240628$20240403$20240709$PER$$US-SA-2024SA101162$SANOFI AVENTIS$$12$YR$T$F$Y$31.8$KG$20240709$$MD$US$US
237001885$23700188$5$F$20240319$20240628$20240403$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02647$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237002022$23700202$2$F$$20240717$20240403$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052074$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$120.2$KG$20240725$$CN$US$US
237002042$23700204$2$F$20240216$20240717$20240403$20240725$EXP$IT-MINISAL02-973499$IT-TEVA-VS-3177395$TEVA$$62$YR$$F$Y$$$20240725$$MD$IT$IT
237002092$23700209$2$F$20240102$20240821$20240403$20240910$PER$$CA-TOLMAR, INC.-24CA047463$TOLMAR$$83$YR$$M$Y$$$20240909$$CN$CA$CA
237002102$23700210$2$F$20230101$20240904$20240403$20240910$PER$$CA-TOLMAR, INC.-24CA047466$TOLMAR$$$$$M$Y$$$20240909$$CN$CA$CA
237002112$23700211$2$F$20240815$20240815$20240403$20240911$PER$$CA-TOLMAR, INC.-24CA047486$TOLMAR$$63$YR$$M$Y$$$20240911$$CN$CA$CA
237002123$23700212$3$F$20240307$20240822$20240403$20240910$PER$$CA-TOLMAR, INC.-24CA047510$TOLMAR$$69$YR$$M$Y$$$20240909$$CN$CA$CA
237002172$23700217$2$F$$20240717$20240403$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02702$LUPIN$$$$$$Y$$$20240818$$CN$US$US
237002205$23700220$5$F$20240101$20240913$20240403$20240921$EXP$$CA-CELLTRION INC.-2024CA007757$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
237002233$23700223$3$F$20240311$20240730$20240403$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000237$DECIPHERA PHARMACEUTICALS$$66$YR$A$F$Y$$$20240806$$CN$US$US
237002264$23700226$4$F$$20240429$20240403$20240703$EXP$$US-HALEON-USCH2024015954$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
237002385$23700238$5$F$20240101$20240809$20240403$20240817$PER$$US-SA-2024SA097512$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240817$$MD$US$US
237002476$23700247$6$F$$20240727$20240403$20240801$EXP$$GB-TAKEDA-2024TUS024239$TAKEDA$$$$$F$Y$$$20240801$$CN$GB$GB
237002642$23700264$2$F$$20240802$20240403$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052646$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240805$$CN$US$US
237002782$23700278$2$F$20230925$20240903$20240403$20240904$EXP$$DE-SANDOZ INC.-SDZ2024DE035123$SANDOZ$$66$YR$$M$Y$$$20240904$$MD$DE$DE
237002957$23700295$7$F$20240101$20240708$20240403$20240713$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009486$UNITED THERAPEUTICS$$$$$F$Y$57.143$KG$20240713$$$US$US
237003066$23700306$6$F$20210101$20240827$20240403$20240902$EXP$$US-ROCHE-3533902$ROCHE$$68$YR$E$F$Y$80.376$KG$20240902$$CN$US$US
237003313$23700331$3$F$20240324$20240328$20240403$20240905$PER$$US-HALEON-USCH2024016093$Haleon PLC$$30$YR$$F$Y$$$20240905$$CN$US$US
237003362$23700336$2$F$20240301$20240905$20240403$20240918$EXP$$US-SA-2024SA100498$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240918$$MD$US$US
237003382$23700338$2$F$$20240702$20240403$20240714$PER$$US-SA-2024SA098284$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240714$$MD$US$US
237003413$23700341$3$F$$20240415$20240403$20240702$PER$$US-SA-2024SA097332$SANOFI AVENTIS$$$$E$F$Y$$$20240702$$MD$US$US
237003424$23700342$4$F$20240301$20240822$20240403$20240910$PER$$US-SA-2024SA098450$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240910$$MD$US$US
237003472$23700347$2$F$20240201$20240711$20240403$20240722$PER$$US-SA-2024SA100709$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240721$$MD$US$US
237003753$23700375$3$F$20240117$20240716$20240403$20240722$EXP$$US-ABBVIE-5702635$ABBVIE$$67$YR$$F$Y$$$20240719$$CN$US$US
237003953$23700395$3$F$20230301$20240624$20240403$20240701$EXP$$US-CHIESI-2024CHF01754$CHIESI$$2$YR$$M$Y$$$20240701$$MD$US$US
237004054$23700405$4$F$20240101$20240827$20240403$20240903$EXP$$US-ABBVIE-5654427$ABBVIE$$$$$M$Y$101$KG$20240903$$CN$US$US
237004332$23700433$2$F$$20240701$20240403$20240710$EXP$$TR-TEVA-VS-3176157$TEVA$Ferhatoglu F, Paksoy N, Khanmammadov N, Yildiz A, Ahmed MA, Gulbas Z, et al. Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study. Medicine 2024; 103 (8):.; Ferhatoglu F, Paksoy N, Khanmammadov N, Yildiz A, Ahmed MA, Gulbas Z, et al. Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients:...$44$YR$$M$Y$$$20240710$$MD$TR$TR
237004348$23700434$8$F$20240401$20240920$20240403$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052025$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240930$$CN$US$US
237004482$23700448$2$F$20240101$20240821$20240403$20240830$EXP$$JP-009507513-2401JPN006790J$MERCK$$66$YR$$M$Y$$$20240830$$MD$JP$JP
237004552$23700455$2$F$$20240327$20240403$20240812$EXP$$NVSC2024US067218$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
237005702$23700570$2$F$$20240716$20240403$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050913$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$92.53$KG$20240717$$CN$US$US
2370057210$23700572$10$F$20240123$20240906$20240403$20240910$EXP$$JP-GSK-JP2024JPN040691$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$JP$JP
237005772$23700577$2$F$20240331$20240819$20240403$20240822$PER$$US-AMGEN-USASP2024066750$AMGEN$$73$YR$E$M$Y$$$20240822$$CN$US$US
237005869$23700586$9$F$20240101$20240729$20240403$20240806$EXP$$CA-CELLTRION INC.-2024CA007811$CELLTRION$$$$$$Y$$$20240806$$CN$CA$CA
237005902$23700590$2$F$20210201$20240823$20240403$20240827$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-261348$BOEHRINGER INGELHEIM$$57$YR$A$F$Y$71.7$KG$20240827$$CN$US$US
237006153$23700615$3$F$$20240814$20240403$20240827$EXP$$PL-AUROBINDO-AUR-APL-2024-014568$AUROBINDO$$66$YR$$F$Y$$$20240827$$MD$PL$PL
237006622$23700662$2$F$$20240701$20240403$20240709$EXP$$US-TEVA-VS-3176177$TEVA$Kakes J, Cayley WE Jr, Sporleder J. A Case of Doxycycline-Induced Pancreatitis. WMJ 2024; 123 (1): 43-47.; Kakes J, Cayley WE Jr, Sporleder J. A Case of Doxycycline-Induced Pancreatitis. WMJ 2024; 123 (1): 43-47.$64$YR$$M$Y$$$20240709$$MD$US$US
237007532$23700753$2$F$20240401$20240731$20240403$20240801$PER$$US-AMGEN-USASP2024066371$AMGEN$$79$YR$E$M$Y$$$20240801$$CN$US$US
237007542$23700754$2$F$20240329$20240731$20240403$20240803$PER$$US-AMGEN-USASP2024066751$AMGEN$$52$YR$A$M$Y$$$20240803$$CN$US$US
237007562$23700756$2$F$$20240723$20240403$20240730$EXP$$US-CHATTEMPRD-2024OHG010458$CHATTEM$$74$YR$E$M$Y$$$20240730$$LW$US$US
237007612$23700761$2$F$$20240708$20240403$20240723$EXP$$CA-TEVA-202103_00011445$TEVA$$76$YR$$F$Y$$$20240723$$MD$CA$CA
237007632$23700763$2$F$$20240709$20240403$20240718$EXP$$PH-ROCHE-3537171$ROCHE$$36$YR$A$M$Y$$$20240718$$MD$PH$PH
237007773$23700777$3$F$20240213$20240708$20240403$20240723$EXP$$JP-VERICEL-JP-VCEL-24-000065$VERICEL$$87$YR$$M$Y$47.9$KG$20240723$$MD$JP$JP
237008413$23700841$3$F$$20240409$20240403$20240725$EXP$FR-AFSSAPS-RS2024000277$FR-ROCHE-3536490$ROCHE$$83$YR$E$M$Y$$$20240725$$PH$FR$FR
237008883$23700888$3$F$20240330$20240726$20240403$20240730$PER$$US-AMGEN-USASP2024066273$AMGEN$$30$YR$A$M$Y$$$20240730$$HP$US$US
237008902$23700890$2$F$20240401$20240704$20240403$20240705$PER$$US-AMGEN-USASP2024067368$AMGEN$$57$YR$A$M$Y$$$20240705$$CN$US$US
237009083$23700908$3$F$$20240704$20240403$20240708$30DAY$$US-SANDOZ INC.-SDZ2024US034631$SANDOZ$$$$$F$Y$$$20240708$$CN$US$US
237009463$23700946$3$F$20240219$20240701$20240403$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-052046$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240705$$MD$JP$JP
237009602$23700960$2$F$20240316$20240822$20240403$20240826$EXP$$US-BAYER-2024A046205$BAYER$$52$YR$A$M$Y$$$20240826$$HP$US$US
237009755$23700975$5$F$20230726$20240910$20240403$20240913$EXP$$FR-TAKEDA-2024TUS027931$TAKEDA$$65$YR$$F$Y$$$20240913$$HP$FR$FR
237009853$23700985$3$F$$20240702$20240403$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052062$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240705$$CN$US$US
237009872$23700987$2$F$$20240702$20240403$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052197$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240702$$CN$US$US
237009958$23700995$8$F$20240326$20240913$20240403$20240920$EXP$$US-GSK-US2024AMR039130$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240920$$CN$US$US
237010124$23701012$4$F$20240301$20240725$20240403$20240729$PER$$US-BIOVITRUM-2024-US-004845$BIOVITRUM$$71$YR$$F$Y$$$20240729$$CN$US$US
237010133$23701013$3$F$20240418$20240724$20240403$20240726$EXP$$CA-TAKEDA-2024TUS011427$TAKEDA$$35$YR$$M$Y$$$20240726$$CN$CA$CA
237010143$23701014$3$F$20240404$20240627$20240403$20240701$EXP$$CA-TAKEDA-2024TUS031447$TAKEDA$$54$YR$$F$Y$$$20240701$$CN$CA$CA
237010383$23701038$3$F$20230511$20240919$20240403$20240926$EXP$$BR-SANDOZ INC.-NVSC2023BR124101$SANDOZ$$61$YR$$F$Y$$$20240926$$CN$BR$BR
237010442$23701044$2$F$$20240823$20240403$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052632$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$57.15$KG$20240827$$CN$US$US
237010505$23701050$5$F$20240325$20240625$20240403$20240705$EXP$$DE-JNJFOC-20240384378$JOHNSON AND JOHNSON$$39$YR$A$F$Y$54.3$KG$20240705$$HP$DE$DE
237010582$23701058$2$F$20240401$20240726$20240403$20240729$PER$$US-AMGEN-USASP2024066590$AMGEN$$67$YR$E$F$Y$$$20240729$$CN$US$US
237010593$23701059$3$F$20240326$20240729$20240403$20240815$EXP$$JP-AMGEN-JPNSP2024063633$AMGEN$$84$YR$E$F$Y$$$20240815$$CN$JP$JP
237010642$23701064$2$F$$20240321$20240403$20240920$EXP$$IL-ALVOGEN-2024093289$ALVOGEN$Hershkowitz I, Cahn A, Keidar Haran T, Hershko AY. Oxycodone-Acetaminophen Abuse by Inhalation. IMAJ. 2024 Jan;26:54-55.$26$YR$$M$Y$$$20240920$$MD$IL$IL
237010654$23701065$4$F$20230101$20240801$20240403$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2023-034768$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240810$$$US$US
237010736$23701073$6$F$20220325$20240712$20240403$20240722$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-003827$AMGEN$$61$YR$A$M$Y$$$20240722$$LW$US$US
237011122$23701112$2$F$$20240327$20240403$20240819$EXP$$NVSC2024US070231$NOVARTIS$$$$$$Y$$$20240819$$CN$US$US
237011472$23701147$2$F$$20240702$20240403$20240710$EXP$$US-ROCHE-3521360$ROCHE$$$$$$Y$$$20240710$$CN$US$US
237011742$23701174$2$F$20240322$20240730$20240403$20240805$EXP$$US-ABBVIE-5697112$ABBVIE$$59$YR$$M$Y$88.45$KG$20240805$$CN$US$US
237011815$23701181$5$F$20240401$20240925$20240403$20240928$EXP$$CA-JNJFOC-20240373559$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240928$$HP$CA$CA
237011833$23701183$3$F$20240308$20240916$20240403$20240927$EXP$$NL-BAXTER-2024BAX015955$BAXTER$$77$YR$$F$Y$57.5$KG$20240927$$MD$NL$NL
237011937$23701193$7$F$20240101$20240920$20240403$20240930$EXP$$CA-CELLTRION INC.-2024CA007816$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
237011942$23701194$2$F$$20240816$20240403$20240826$EXP$$NL-TEVA-VS-3175038$TEVA$$35$YR$$F$Y$$$20240826$$CN$NL$NL
237012062$23701206$2$F$$20240715$20240403$20240722$PER$$US-ALXN-202403USA001959US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
237012492$23701249$2$F$20230118$20240709$20240403$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-014501$AUROBINDO$$82$YR$$M$Y$72.2$KG$20240718$$MD$GB$GB
237012592$23701259$2$F$20220101$20240617$20240403$20240704$30DAY$$US-GSK-US2024038580$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240704$$CN$US$US
237012652$23701265$2$F$$20240710$20240403$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052565$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240712$$HP$US$US
237012772$23701277$2$F$20240320$20240910$20240403$20240918$EXP$$BR-CELLTRION INC.-2024BR007709$CELLTRION$$$$$$Y$$$20240919$$CN$BR$BR
237012832$23701283$2$F$20240120$20240702$20240403$20240709$EXP$$NVSC2024US069531$NOVARTIS$$69$YR$$F$Y$$$20240709$$CN$US$US
237013222$23701322$2$F$$20240326$20240403$20240829$EXP$$US-BSC-2024000022$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$MD$US$US
237013602$23701360$2$F$$20240712$20240403$20240718$PER$$US-BIOGEN-2024BI01257921$BIOGEN$$$$$F$Y$$$20240718$$CN$US$US
2370136310$23701363$10$F$$20240910$20240403$20240919$EXP$$NVSC2024PL070299$NOVARTIS$Szlauer-stefanska A, Kaminska-winciorek G. Patient with chronic cutaneous and mucosal forms of graft- versus-host disease. DERMATOLOGIA PO DYPLOMIE. 2024;2$30$YR$$M$Y$$$20240919$$HP$PL$PL
237013672$23701367$2$F$$20240821$20240403$20240830$EXP$$CA-ASTELLAS-2024US009529$ASTELLAS$No Information. No Information. No Information unk;unk:unk.$39$YR$A$M$Y$$$20240830$$HP$CA$CA
237013903$23701390$3$F$$20240709$20240403$20240712$30DAY$$US-GSK-US2024038039$GLAXOSMITHKLINE$$$$$M$Y$$$20240712$$CN$US$US
237014142$23701414$2$F$$20240717$20240403$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02648$LUPIN$$$$$$Y$$$20240825$$CN$US$US
237014182$23701418$2$F$$20240701$20240403$20240710$EXP$$US-TEVA-VS-3176891$TEVA$Sannareddy A, Turer L, Lee J, Gaines K, Patel H, Abraham P, et al. Incidence of Invasive Fungal Infections in CAR T-Cell Therapy Recipients: A Single-Center Retrospective Analysis. Blood 2023; 142 (Suppl. 1) 6921.; Sannareddy A, Turer L, Lee J, Gaines K, Patel H, Abraham P, et al. Incidence of Invasive Fungal Infections in CAR T-Cell Therapy Recipients: A Single-Center Retrospective Analysis. Blood 2023; 142 (Suppl. 1) 6921.$$$$$Y$$$20240710$$HP$US$US
237014423$23701442$3$F$$20240628$20240403$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02751$LUPIN$$$$$$Y$$$20240716$$PH$US$US
237014512$23701451$2$F$20220226$20240808$20240403$20240816$EXP$$NVSJ2022JP098550$NOVARTIS$$22$YR$$M$Y$53$KG$20240816$$MD$JP$JP
237014652$23701465$2$F$20230101$20240821$20240403$20240827$EXP$$PR-ABBVIE-5703679$ABBVIE$$$$$M$Y$77$KG$20240827$$CN$PR$PR
237014883$23701488$3$F$$20240821$20240403$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02617$LUPIN$$$$$$Y$$$20240909$$HP$US$US
237014963$23701496$3$F$20240201$20240819$20240403$20240826$EXP$$JP-009507513-2403JPN003751J$MERCK$$72$YR$$M$Y$$$20240826$$MD$JP$JP
237015172$23701517$2$F$$20240916$20240403$20240922$PER$$NVSC2024US069515$NOVARTIS$$$$$$Y$$$20240922$$HP$US$US
237015454$23701545$4$F$$20240718$20240403$20240728$EXP$$CA-TEVA-VS-3175924$TEVA$$72$YR$$F$Y$$$20240728$$CN$CA$CA
237016182$23701618$2$F$20240301$20240724$20240403$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049307$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240729$$CN$US$US
237016322$23701632$2$F$$20240701$20240403$20240709$EXP$$US-TEVA-VS-3176145$TEVA$Chakravorty S, Raya R, Shlobin OA, Malik A, Singh P, Nathan SD, et al. RP ILD and Anti MDA5 Antibody Dermatomyositis, A Case Series. Am-J-Respir-Crit-Care-Med 2023; 207 (plus Poster).; Chakravorty S, Raya R, Shlobin OA, Malik A, Singh P, Nathan SD, et al. RP ILD and Anti MDA5 Antibody Dermatomyositis, A Case Series. Am-J-Respir-Crit-Care-Med 2023; 207 (plus Poster).$54$YR$$M$Y$$$20240709$$HP$US$US
237016376$23701637$6$F$20240501$20240820$20240403$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-000798$UNITED THERAPEUTICS$$84$YR$$F$Y$52.154$KG$20240829$$$US$US
237016602$23701660$2$F$$20240829$20240403$20240903$EXP$$CA-PFIZER INC-202400077654$PFIZER$$56$YR$$F$Y$$$20240903$$HP$CA$CA
237016812$23701681$2$F$$20240620$20240403$20240704$PER$$US-RDY-CLI/USA/24/0004951$DR REDDYS$$7$YR$C$M$Y$22$KG$20240704$$CN$US$US
237017073$23701707$3$F$$20240910$20240403$20240917$EXP$$NVSC2024CA068746$NOVARTIS$$43$YR$$F$Y$68$KG$20240917$$HP$CA$CA
237017133$23701713$3$F$20240401$20240719$20240403$20240723$PER$$US-AMGEN-USASP2024066902$AMGEN$$66$YR$E$F$Y$$$20240723$$CN$US$US
237017153$23701715$3$F$$20240729$20240403$20240731$EXP$$CA-PFIZER INC-202400077667$PFIZER$$57$YR$$M$Y$$$20240731$$HP$CA$CA
237017882$23701788$2$F$$20240819$20240403$20240826$EXP$$CA-JNJFOC-20240387436$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$LW$CA$CA
237017943$23701794$3$F$$20240923$20240403$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052560$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240925$$CN$US$US
237018069$23701806$9$F$$20240918$20240403$20240930$EXP$$NVSC2024CA068828$NOVARTIS$$50$YR$$F$Y$68$KG$20240930$$HP$CA$CA
237018642$23701864$2$F$$20240716$20240403$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-052117$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$68$KG$20240730$$HP$CA$CA
237018802$23701880$2$F$$20240708$20240403$20240716$EXP$$US-SA-2024SA100812$SANOFI AVENTIS$$62$YR$A$F$Y$113.39$KG$20240716$$MD$US$US
237018823$23701882$3$F$20240101$20240715$20240403$20240716$PER$$US-AMGEN-USASP2024067328$AMGEN$$65$YR$E$F$Y$$$20240716$$CN$US$US
2370194215$23701942$15$F$20240306$20240822$20240403$20240829$EXP$$GB-PFIZER INC-202400076770$PFIZER$$9$YR$$F$Y$26.9$KG$20240829$$MD$GB$GB
237019593$23701959$3$F$$20240711$20240403$20240715$PER$$NVSC2024US070268$NOVARTIS$$$$$M$Y$$$20240715$$CN$US$US
237019912$23701991$2$F$20210114$20240826$20240403$20240827$EXP$$US-TAKEDA-2022TUS054004$TAKEDA$$18$YR$$F$Y$95$KG$20240827$$HP$US$US
237020224$23702022$4$F$$20240807$20240403$20240814$30DAY$$US-PFIZER INC-202400075306$PFIZER$$14$YR$$M$Y$$$20240814$$CN$US$US
237020235$23702023$5$F$20240328$20240910$20240403$20240912$30DAY$$US-PFIZER INC-202400075601$PFIZER$$10$YR$$M$Y$32.66$KG$20240912$$CN$US$US
237020242$23702024$2$F$$20240717$20240403$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02651$LUPIN$$$$$$Y$$$20240821$$CN$US$US
237020252$23702025$2$F$$20240717$20240403$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02640$LUPIN$$$$$$Y$$$20240829$$PH$US$US
237020294$23702029$4$F$20230116$20240628$20240403$20240707$EXP$$IT-ROCHE-3535786$ROCHE$$52$YR$A$M$Y$78$KG$20240707$$MD$IT$IT
237020366$23702036$6$F$20240101$20240905$20240403$20240911$EXP$$US-BAYER-2024A042729$BAYER$$61$YR$A$M$Y$$$20240911$$CN$US$US
237020522$23702052$2$F$20240331$20240718$20240403$20240724$PER$$US-AMGEN-USASP2024067523$AMGEN$$69$YR$E$M$Y$$$20240724$$CN$US$US
237020795$23702079$5$F$$20240801$20240403$20240806$30DAY$$US-PFIZER INC-202400076082$PFIZER$$13$YR$$M$Y$$$20240806$$HP$US$US
237020852$23702085$2$F$$20240717$20240403$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02645$LUPIN$$$$$$Y$$$20240827$$CN$US$US
237020912$23702091$2$F$$20240719$20240403$20240724$PER$$US-AMGEN-USASP2024067206$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
237020953$23702095$3$F$$20240702$20240403$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053031$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240702$$CN$US$US
237021033$23702103$3$F$$20240717$20240403$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02703$LUPIN$$$$$$Y$$$20240821$$CN$US$US
237021117$23702111$7$F$$20240802$20240403$20240806$30DAY$$US-PFIZER INC-202400075813$PFIZER$$9$YR$$F$Y$23.59$KG$20240806$$CN$US$US
237021392$23702139$2$F$$20240701$20240403$20240709$EXP$$US-TEVA-VS-3176149$TEVA$Al-Samkari H. Thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia: a new solution for an old problem. Hematology-Am-Soc-Hematol-Educ-Program 2022; 2022 (1): 286-295.; Al-Samkari H. Thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia: a new solution for an old problem. Hematology-Am-Soc-Hematol-Educ-Program 2022; 2022 (1): 286-295.$44$YR$$M$Y$$$20240709$$HP$US$US
237021442$23702144$2$F$$20240805$20240403$20240807$EXP$$PL-SANDOZ INC.-NVSC2022PL218246$SANDOZ$$63$YR$$F$Y$$$20240807$$MD$PL$PL
237021553$23702155$3$F$20240201$20240819$20240403$20240828$PER$$US-SA-2024SA094961$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240828$$MD$US$US
237021612$23702161$2$F$20240101$20240830$20240403$20240924$PER$$US-SA-2024SA095496$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240924$$MD$US$US
237021632$23702163$2$F$20240101$20240626$20240403$20240705$PER$$US-SA-2024SA097412$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240705$$MD$US$US
237021973$23702197$3$F$$20240717$20240403$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02643$LUPIN$$$$$$Y$$$20240821$$CN$US$US
237021992$23702199$2$F$$20240823$20240403$20240828$EXP$$BR-SANDOZ INC.-SDZ2023BR065133$SANDOZ$$$$$F$Y$$$20240828$$CN$BR$BR
237022072$23702207$2$F$$20240716$20240403$20240718$EXP$$IT-SANDOZ INC.-SDZ2024IT035004$SANDOZ$$22$YR$$F$Y$$$20240718$$MD$IT$IT
237022703$23702270$3$F$20240101$20240913$20240403$20240920$PER$$US-SA-2024SA100819$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240920$$MD$US$US
237022734$23702273$4$F$20240101$20240923$20240403$20240927$PER$$US-SA-2024SA097334$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240927$$MD$US$US
237022763$23702276$3$F$20240101$20240705$20240403$20240716$PER$$US-SA-2024SA101093$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240716$$MD$US$US
237023367$23702336$7$F$20240101$20240702$20240403$20240710$EXP$$US-SA-2024SA101079$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240710$$CN$US$US
237023412$23702341$2$F$20240801$20240909$20240403$20240923$PER$$US-SA-2024SA098295$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240923$$MD$US$US
237023534$23702353$4$F$$20240830$20240403$20240906$EXP$$PL-SANDOZ INC.-SDZ2024PL035250$SANDOZ$$30$YR$$M$Y$$$20240906$$MD$PL$PL
237023762$23702376$2$F$20240314$20240702$20240403$20240711$PER$$US-SA-2024SA100777$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240711$$MD$US$US
237023863$23702386$3$F$20240101$20240819$20240403$20240829$PER$$US-SA-2024SA099805$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240829$$MD$US$US
237023872$23702387$2$F$$20240906$20240403$20240926$PER$$US-SA-2024SA100637$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240926$$MD$US$US
237024253$23702425$3$F$20240301$20240910$20240403$20240918$EXP$$CA-TAKEDA-2024TUS030458$TAKEDA$$77$YR$$F$Y$$$20240918$$HP$CA$CA
237024362$23702436$2$F$20240101$20240812$20240403$20240820$EXP$$US-SA-2024SA100867$SANOFI AVENTIS$$62$YR$A$M$Y$98.88$KG$20240820$$MD$US$US
237024395$23702439$5$F$20160722$20240717$20240403$20240724$EXP$$CA-TAKEDA-2022TUS096587$TAKEDA$$53$YR$$M$Y$$$20240724$$HP$CA$CA
237024782$23702478$2$F$20231227$20240816$20240403$20240821$EXP$$NVSC2023US275125$NOVARTIS$$81$YR$$M$Y$$$20240821$$CN$US$US
237025122$23702512$2$F$20240228$20240628$20240403$20240703$EXP$$US-ABBVIE-5700555$ABBVIE$$63$YR$$M$Y$$$20240703$$CN$US$US
237025132$23702513$2$F$$20240326$20240403$20240809$EXP$$NVSC2024CA001122$NOVARTIS$$74$YR$$F$Y$$$20240809$$CN$CA$CA
237025284$23702528$4$F$20240314$20240807$20240403$20240816$PER$$US-INCYTE CORPORATION-2024IN003259$INCYTE$$$$$$Y$$$20240816$$CN$US$US
237025312$23702531$2$F$$20240328$20240403$20240808$EXP$$NVSC2024CA070281$NOVARTIS$$67$YR$$F$Y$$$20240808$$MD$CA$CA
237025492$23702549$2$F$20240229$20240830$20240403$20240909$EXP$$JP-SHIONOGI + CO. LTD-2024000787$SHIONOGI$$$$$$Y$$$20240909$$MD$JP$JP
237025592$23702559$2$F$$20240628$20240403$20240702$EXP$$US-MYLANLABS-2024M1029623$MYLAN$Ragunanthan BV, Block CA, Remillard BD, Hopley CW. Nonsteroidal Anti-Inflammatory Drug-Induced Type I (Distal) Renal Tubular Acidosis. J-Am-Soc-Nephrol 2023; 34 199 abstr. TH-PO386.$38$YR$$M$Y$$$20240702$$HP$US$US
237025643$23702564$3$F$$20240828$20240403$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA033539$SANDOZ$$43$YR$$F$Y$$$20240829$$HP$CA$CA
237025822$23702582$2$F$$20240826$20240403$20240903$EXP$$US-VERTEX PHARMACEUTICALS-2024-005543$VERTEX$McKinzie CJ, Kam CW, Jones MC, Gifford LB, Loughlin CE, Noah TL, et al.. Elevated creatine phosphokinase and rhabdomyolysis associated with elexacaftor/tezacaftor/ivacaftor use in cystic fibrosis. Pediatr Pulmonol. 2024;1-3$19$YR$$F$Y$$$20240903$$PH$US$US
237025914$23702591$4$F$$20240704$20240403$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051728$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240704$$CN$US$US
237026084$23702608$4$F$$20240725$20240403$20240731$EXP$$NVSC2024GB069666$NOVARTIS$$$$A$F$Y$$$20240731$$CN$GB$GB
237026352$23702635$2$F$$20240701$20240403$20240710$EXP$$JP-TEVA-VS-3177201$TEVA$Matsuda T, Haga T, Sakaguchi T, Kan T, Otsuka Y. A case of anti-NPX-2 antibody-positive dermatomyositis resulting in massive haemothorax with acquired factor XIII deficiency. Mod-Rheumatol-Case-Rep 2024; 8 (1): 91-94.; Matsuda T, Haga T, Sakaguchi T, Kan T, Otsuka Y. A case of anti-NPX-2 antibody-positive dermatomyositis resulting in massive haemothorax with acquired factor XIII deficiency. Mod-Rheumatol-Case-Rep 2024; 8 (1): 91-94.$35$YR$$F$Y$$$20240709$$HP$JP$JP
237026682$23702668$2$F$$20240812$20240403$20240826$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK089636$GLENMARK$Rajpurkar M, Buck S, Lafferty J, Wakeling E, Ravindranath Y, Savasan S.. Acquired Pure Red Cell Aplasia and Acquired Amegakaryocytic Thrombocytopenia Associated with Clonal Expansion of T-Cell Large Granular Lymphocytes in a Patient with Lipopolysaccharide-responsive Beige-like Anchor (LRBA) Protein Deficiency.. Journal of Pediatric Hematology/Oncology.. 2019;41(8):E542-E545$$$$$Y$$$20240826$$MD$US$US
237026775$23702677$5$F$$20240710$20240403$20240710$PER$$US-PFIZER INC-202400075897$PFIZER$$15$YR$$M$Y$$$20240710$$CN$US$US
237026942$23702694$2$F$20100101$20240705$20240403$20240709$EXP$$US-BIOGEN-2024BI01257895$BIOGEN$$$$$F$Y$$$20240709$$CN$US$JP
237026972$23702697$2$F$20230901$20240711$20240403$20240716$EXP$$US-TAKEDA-2023TUS097395$TAKEDA$$75$YR$$F$Y$56.689$KG$20240716$$HP$US$US
237027546$23702754$6$F$$20240923$20240403$20240930$EXP$$CA-GSK-CA2023167081$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$CA$CA
237027612$23702761$2$F$$20240917$20240403$20240919$EXP$$US-MYLANLABS-2024M1029450$MYLAN$$$$$F$Y$$$20240919$$MD$US$US
237027664$23702766$4$F$20240301$20240510$20240403$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089702$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
237027695$23702769$5$F$$20240816$20240403$20240829$EXP$$NVSC2024IT066955$NOVARTIS$Lazzari L, Bongiovanni L, Ronchi P, Bergonzi GM, Gariazzo C, Diral E et al.. Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura. CURRENT RESEARCH IN TRANSLATIONAL MEDICINE. 2024;72(1):1-3$65$YR$$M$Y$$$20240829$$HP$IT$IT
237027704$23702770$4$F$20240915$20240917$20240403$20240920$PER$$US-BIOGEN-2024BI01257894$BIOGEN$$47$YR$$F$Y$$$20240920$$CN$US$US
237028032$23702803$2$F$20240220$20240711$20240403$20240716$PER$$US-INCYTE CORPORATION-2024IN003220$INCYTE$$$$$$Y$$$20240716$$HP$US$US
237028683$23702868$3$F$20240101$20240813$20240403$20240819$EXP$$JP-009507513-2403JPN003704J$MERCK$$8$DEC$$F$Y$$$20240819$$MD$JP$JP
237028713$23702871$3$F$$20240702$20240403$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053098$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240702$$CN$US$US
237028722$23702872$2$F$$20240812$20240403$20240820$EXP$PL-EMA-DD-20240327-7482831-183306$PL-SANDOZ INC.-SDZ2024PL035087$SANDOZ$$65$YR$$M$Y$$$20240820$$MD$PL$PL
237028742$23702874$2$F$$20240702$20240403$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052981$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240702$$MD$US$US
237028823$23702882$3$F$20230901$20240705$20240403$20240713$PER$$US-SA-2024SA099566$SANOFI AVENTIS$$63$YR$A$F$Y$75.2$KG$20240713$$MD$US$US
237028912$23702891$2$F$20240327$20240620$20240403$20240701$PER$$US-SA-2024SA101117$SANOFI AVENTIS$$31$YR$A$F$Y$77.1$KG$20240701$$MD$US$US
237028962$23702896$2$F$20230601$20240829$20240403$20240905$EXP$$CA-OTSUKA-2023_017012$OTSUKA$$40$YR$$F$Y$$$20240905$$HP$CA$CA
237029002$23702900$2$F$20240101$20240621$20240403$20240703$EXP$$US-RIGEL PHARMACEUTICALS, INC.-2024FOS000376$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240703$$CN$US$US
237029022$23702902$2$F$$20240911$20240403$20240913$EXP$$CA-SANDOZ INC.-NVSC2019CA077570$SANDOZ$$73$YR$$M$Y$$$20240913$$CN$CA$CA
237029292$23702929$2$F$20240119$20240903$20240403$20240906$EXP$FR-AFSSAPS-PO2024000307$FR-JNJFOC-20240389339$JOHNSON AND JOHNSON$$54$YR$A$F$Y$62$KG$20240906$$MD$FR$FR
237029472$23702947$2$F$$20240717$20240403$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02646$LUPIN$$$$$$Y$$$20240829$$CN$US$US
237029532$23702953$2$F$20231101$20240912$20240403$20240917$EXP$$JP-PFIZER INC-PV202400042907$PFIZER$$81$YR$$M$Y$49.5$KG$20240917$$PH$JP$JP
237029682$23702968$2$F$$20240717$20240403$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02732$LUPIN$$$$$$Y$$$20240827$$CN$US$US
237029734$23702973$4$F$20240402$20240910$20240403$20240911$PER$$US-AMGEN-USASP2024067586$AMGEN$$67$YR$E$F$Y$$$20240911$$CN$US$US
237029802$23702980$2$F$20240304$20240917$20240403$20240920$EXP$$CA-JNJFOC-20240382337$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240920$$PH$CA$CA
237029842$23702984$2$F$20230101$20240710$20240403$20240713$EXP$$NVSC2024US068183$NOVARTIS$$$$$$Y$$$20240713$$CN$US$US
237029913$23702991$3$F$20240101$20240709$20240403$20240717$PER$$US-SA-2024SA098398$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
237029942$23702994$2$F$$20240703$20240403$20240705$EXP$$US-TAKEDA-2024TUS031031$TAKEDA$$$$$M$Y$$$20240705$$CN$US$US
237030165$23703016$5$F$20240102$20240704$20240403$20240709$EXP$$CA-ABBVIE-5703475$ABBVIE$$$$E$M$Y$$$20240709$$PH$CA$CA
237030333$23703033$3$F$$20240702$20240403$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053021$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240702$$CN$US$US
237030383$23703038$3$F$$20240826$20240403$20240829$EXP$$CA-TAKEDA-2024TUS030948$TAKEDA$$$$$F$Y$$$20240829$$CN$CA$CA
237030552$23703055$2$F$$20240702$20240403$20240704$PER$$NVSC2024US069590$NOVARTIS$$53$YR$$F$Y$$$20240705$$CN$US$US
237030733$23703073$3$F$$20240702$20240403$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052991$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240702$$CN$US$US
237030833$23703083$3$F$$20240717$20240403$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02730$LUPIN$$$$$$Y$$$20240821$$CN$US$US
237030906$23703090$6$F$20240101$20240614$20240403$20240719$EXP$$FR-AstraZeneca-2024A073007$ASTRAZENECA$$68$YR$$F$Y$$$20240719$$MD$FR$
237030973$23703097$3$F$$20240627$20240403$20240705$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000683$BLUEPRINT MEDICINES$$$$$M$Y$$$20240705$$CN$US$US
237031243$23703124$3$F$20210101$20240628$20240403$20240702$EXP$$GB-INCYTE CORPORATION-2024IN003121$INCYTE$$$$$$Y$$$20240702$$MD$GB$GB
237031252$23703125$2$F$$20240912$20240403$20240921$EXP$$CA-JNJFOC-20240387869$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$HP$CA$CA
237031332$23703133$2$F$$20240326$20240403$20240814$EXP$$NVSC2023BR092410$NOVARTIS$$$$$F$Y$$$20240814$$CN$BR$BR
237031622$23703162$2$F$$20240716$20240403$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-048042$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$68$KG$20240730$$HP$CA$CA
237031692$23703169$2$F$$20240819$20240403$20240826$EXP$$JP-009507513-2403JPN003325J$MERCK$$8$DEC$$M$Y$$$20240826$$MD$JP$JP
237032102$23703210$2$F$$20240826$20240403$20240905$EXP$$US-VERTEX PHARMACEUTICALS-2024-005725$VERTEX$McKinzie CJ, Kam CW, Jones MC, Gifford LB, Loughlin CE, Noah TL, et al.. Elevated creatine phosphokinase and rhabdomyolysis associated with elexacaftor/tezacaftor/ivacaftor use in cystic fibrosis. Pediatr Pulmonol. 2024$14$YR$$M$Y$$$20240905$$PH$US$US
237032433$23703243$3$F$20240301$20240718$20240403$20240723$EXP$$US-ABBVIE-5701641$ABBVIE$$68$YR$$F$Y$$$20240723$$CN$US$US
237032822$23703282$2$F$20240331$20240727$20240403$20240730$PER$$US-AMGEN-USASP2024067304$AMGEN$$48$YR$A$M$Y$$$20240730$$CN$US$US
237032972$23703297$2$F$$20240808$20240403$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053143$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240812$$HP$US$US
237033143$23703314$3$F$$20240711$20240403$20240712$PER$$NVSC2024US070042$NOVARTIS$$$$$M$Y$$$20240712$$CN$US$US
237033172$23703317$2$F$20240401$20240722$20240403$20240724$PER$$US-AMGEN-USASP2024067437$AMGEN$$80$YR$E$F$Y$$$20240724$$CN$US$US
237033684$23703368$4$F$$20240725$20240403$20240730$30DAY$$US-PFIZER INC-202400073884$PFIZER$$$$$$Y$$$20240730$$PH$US$US
237033703$23703370$3$F$20240319$20240903$20240403$20240904$30DAY$$CO-PFIZER INC-PV202400041327$PFIZER$$16$YR$$M$Y$$$20240904$$CN$CO$CO
237033873$23703387$3$F$$20240715$20240403$20240718$EXP$$CA-SANDOZ INC.-SDZ2024CA035037$SANDOZ$$44$YR$$F$Y$97$KG$20240718$$HP$CA$CA
237033955$23703395$5$F$$20240625$20240403$20240701$30DAY$$US-PFIZER INC-PV202400039369$PFIZER$$$$$F$Y$$$20240701$$CN$US$US
237034012$23703401$2$F$20240402$20240719$20240403$20240724$PER$$US-AMGEN-USASP2024067434$AMGEN$$86$YR$E$M$Y$$$20240724$$CN$US$US
237034173$23703417$3$F$20230922$20240816$20240403$20240821$EXP$$JP-Eisai-EC-2023-151555$EISAI$$67$YR$E$F$Y$$$20240821$$MD$JP$JP
237034256$23703425$6$F$20240310$20240830$20240403$20240830$30DAY$$ES-PFIZER INC-PV202400038688$PFIZER$$$$$$Y$$$20240830$$CN$ES$ES
237034352$23703435$2$F$$20240730$20240403$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202404001910$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240805$$CN$US$US
237034503$23703450$3$F$20240118$20240827$20240403$20240924$PER$$US-Eisai-EC-2024-158319$EISAI$$84$YR$E$M$Y$79$KG$20240924$$CN$US$US
237034514$23703451$4$F$20240313$20240816$20240403$20240821$PER$$JP-Eisai-EC-2024-162741$EISAI$$65$YR$E$M$Y$$$20240821$$MD$JP$JP
237035042$23703504$2$F$20230106$20240829$20240403$20240904$PER$$JP-Eisai-EC-2023-132561$EISAI$Hirabayashi T. Case Discussion: Considering treatment options for advanced renal cell carcinoma. Lecture.$69$YR$E$M$Y$$$20240904$$MD$JP$JP
237035072$23703507$2$F$20230101$20240904$20240403$20240911$EXP$$JP-Eisai-EC-2024-162806$EISAI$$$$E$F$Y$$$20240911$$PH$JP$JP
237035193$23703519$3$F$20240307$20240823$20240403$20240827$EXP$$CA-TAKEDA-2024TUS031258$TAKEDA$$23$YR$$F$Y$$$20240827$$MD$CA$CA
237035333$23703533$3$F$$20240703$20240403$20240705$EXP$CA-HEALTHCANVIG-E2B_06715433$CA-PURDUE-USA-2024-0308773$PURDUE$$62$YR$$F$Y$$$20240705$$CN$CA$CA
237035522$23703552$2$F$20240215$20240723$20240403$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053229$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240725$$CN$US$US
237035573$23703557$3$F$20240401$20240726$20240403$20240801$PER$$US-AMGEN-USASP2024067472$AMGEN$$57$YR$A$M$Y$$$20240731$$CN$US$US
237035913$23703591$3$F$$20240906$20240403$20240911$EXP$$US-INCYTE CORPORATION-2024IN002328$INCYTE$$$$$$Y$$$20240911$$CN$US$US
237035932$23703593$2$F$$20240902$20240403$20240912$EXP$$CA-TEVA-2020-CA-1176317$TEVA$$$$$$Y$$$20240912$$HP$CA$CA
237036732$23703673$2$F$20240614$20240702$20240403$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053163$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240703$$HP$US$US
237037073$23703707$3$F$20240101$20240829$20240403$20240911$EXP$$US-UCBSA-2024016133$UCB$$$$$F$Y$$$20240911$$CN$US$US
237037232$23703723$2$F$$20240729$20240403$20240801$EXP$$CA-JNJFOC-20240352923$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$HP$CA$CA
237037293$23703729$3$F$20240101$20240912$20240403$20240921$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-114567$DAIICHI$$$$$F$Y$$$20240921$$CN$US$US
237037442$23703744$2$F$$20240916$20240403$20240918$30DAY$$US-ABBVIE-5704501$ABBVIE$$$$$$Y$$$20240918$$CN$US$US
237037612$23703761$2$F$20240321$20240716$20240403$20240717$EXP$$JP-CARA THERAPEUTICS, INC.-2024-00181-JP$CARA THERAPEUTICS$$91$YR$$M$Y$53$KG$20240717$$HP$JP$JP
237037742$23703774$2$F$20240311$20240716$20240403$20240717$EXP$$JP-CARA THERAPEUTICS, INC.-2024-00183-JP$CARA THERAPEUTICS$$90$YR$$F$Y$50.5$KG$20240717$$HP$JP$JP
237037894$23703789$4$F$$20240731$20240403$20240802$PER$$US-PFIZER INC-PV202400042958$PFIZER$$82$YR$$F$Y$$$20240802$$CN$US$US
237038012$23703801$2$F$20230101$20240711$20240403$20240715$PER$$US-ABBVIE-5699971$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
237038223$23703822$3$F$20240401$20240723$20240403$20240725$PER$$US-AMGEN-USASP2024067389$AMGEN$$65$YR$E$F$Y$$$20240725$$CN$US$US
237038322$23703832$2$F$$20240927$20240403$20240930$PER$$US-PFIZER INC-PV202400043180$PFIZER$$53$YR$$F$Y$$$20240930$$CN$US$US
237038784$23703878$4$F$$20240719$20240403$20240723$EXP$$US-SANDOZ INC.-SDZ2024US035634$SANDOZ$$$$$$Y$$$20240723$$CN$US$US
237038862$23703886$2$F$$20240717$20240403$20240722$PER$$US-BIOMARINAP-US-2024-156921$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
237039012$23703901$2$F$$20240702$20240403$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052160$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240702$$CN$US$US
237039022$23703902$2$F$$20240703$20240403$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053038$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240703$$CN$US$US
237039222$23703922$2$F$20230419$20240322$20240403$20240702$EXP$$PL-AKCEA THERAPEUTICS, INC.-2024IS003065$AKCEA THERAPEUTICS$$$$$$Y$$$20240701$$MD$PL$PL
237039493$23703949$3$F$20240326$20240903$20240403$20240906$EXP$$JP-009507513-2403JPN003344J$MERCK$$$$$F$Y$$$20240906$$MD$JP$JP
237040002$23704000$2$F$20240331$20240719$20240403$20240723$PER$$US-AMGEN-USASP2024066599$AMGEN$$54$YR$A$M$Y$$$20240723$$CN$US$US
237040176$23704017$6$F$20240104$20240805$20240403$20240805$EXP$FR-AFSSAPS-RE2024000304$FR-JNJFOC-20240409482$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240805$$PH$FR$FR
237040222$23704022$2$F$$20240704$20240403$20240709$PER$$US-BIOGEN-2023BI01239628$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
237040272$23704027$2$F$20220501$20240712$20240403$20240718$30DAY$$EG-SANDOZ INC.-SDZ2024EG035253$SANDOZ$$9$YR$$F$Y$$$20240718$$CN$EG$EG
237040303$23704030$3$F$20240301$20240710$20240403$20240718$EXP$$CO-AMGEN-COLSL2024063299$AMGEN$$50$YR$A$F$Y$$$20240718$$CN$CO$CO
237040483$23704048$3$F$20240316$20240827$20240403$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048106$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$101.6$KG$20240903$$CN$US$US
237040642$23704064$2$F$$20240829$20240403$20240905$EXP$$CA-JNJFOC-20240385423$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$LW$CA$CA
237040693$23704069$3$F$$20240814$20240403$20240820$EXP$$CA-TAKEDA-CA202030210$TAKEDA$$$$$M$Y$$$20240820$$CN$CA$CA
237040732$23704073$2$F$20240329$20240705$20240403$20240706$PER$$US-AMGEN-USASP2024066823$AMGEN$$68$YR$E$M$Y$$$20240706$$CN$US$US
237040983$23704098$3$F$$20240907$20240403$20240910$PER$$NVSC2024US071559$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
237041163$23704116$3$F$$20240716$20240403$20240720$PER$$NVSC2024US071322$NOVARTIS$$$$$F$Y$67.13$KG$20240719$$CN$US$US
237041202$23704120$2$F$20171222$20240712$20240403$20240717$EXP$FR-AFSSAPS-LM2024000179$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-052246$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$48.5$KG$20240717$$MD$FR$FR
237041312$23704131$2$F$20240301$20240702$20240403$20240708$EXP$$US-ABBVIE-5704418$ABBVIE$$38$YR$$M$Y$$$20240708$$CN$US$US
237041324$23704132$4$F$$20240716$20240403$20240722$PER$$NVSC2024US071513$NOVARTIS$$$$$M$Y$$$20240722$$CN$US$US
237041382$23704138$2$F$$20240918$20240403$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR041529$VIIV$$$$$$Y$$$20240927$$HP$US$US
237041456$23704145$6$F$20240430$20240710$20240403$20240721$EXP$$CA-CELLTRION INC.-2024CA007861$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
237041572$23704157$2$F$20240330$20240718$20240404$20240724$PER$$US-AMGEN-USASP2024067287$AMGEN$$75$YR$E$M$Y$$$20240724$$CN$US$US
237041637$23704163$7$F$20240321$20240802$20240404$20240808$EXP$$CA-GSK-CA2024041093$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$HP$CA$CA
237041996$23704199$6$F$20221116$20240712$20240404$20240717$EXP$$JP-JNJFOC-20230421086$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240717$$MD$JP$JP
237042103$23704210$3$F$20240312$20240702$20240404$20240710$EXP$$US-JNJFOC-20240340397$JOHNSON AND JOHNSON$$43$YR$A$M$Y$162.53$KG$20240710$$CN$US$US
237042142$23704214$2$F$$20240702$20240404$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052147$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240704$$CN$US$US
237042217$23704221$7$F$20240308$20240826$20240404$20240828$EXP$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-027100$DE-SANDOZ INC.-SDZ2024DE026026$SANDOZ$$62$YR$$M$Y$$$20240828$$MD$DE$DE
237042552$23704255$2$F$20230101$20240702$20240404$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049981$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240702$$CN$US$US
237042613$23704261$3$F$$20240705$20240404$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439185$RANBAXY$Preston H, Cannon E, Watson S. Plasma exchange for the management of digoxin toxicity in an individual with an acute kidney injury: A case report. J R Coll Physicians Edinb. 2024;Mar 18:Online ahead of print(15)$80$YR$$M$Y$$$20240719$$HP$GB$GB
237042703$23704270$3$F$$20240807$20240404$20240822$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439413$RANBAXY$Chunara Z, Garcia- Pittman E. ^Ooh...He^s Got Double Vision:^ Lithium-Induced Ocular Myasthenia Gravis in An Older Adult Male. Am J Geriatr Psychiatry. 2024;32 (Suppl.) (4):abstr. EI44,  S75-S76$67$YR$$M$Y$$$20240822$$HP$US$US
237042732$23704273$2$F$$20240812$20240404$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-014107$AUROBINDO$Rajpurkar M, Buck S, Lafferty J, Wakeling E, Ravindranath Y, Sava?an S.. Acquired Pure Red Cell Aplasia and Acquired Amegakaryocytic Thrombocytopenia Associated with Clonal Expansion of T-Cell Large Granular Lymphocytes in a Patient with Lipopolysaccharide-responsive Beige-like Anchor (LRBA) Protein Deficiency.. Journal of Pediatric Hematology/Oncology.. 2019;41(8)::E542-E545$16$YR$$M$Y$$$20240826$$MD$US$US
237042786$23704278$6$F$20240301$20240813$20240404$20240820$EXP$$CA-CELLTRION INC.-2024CA007833$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
237042872$23704287$2$F$$20240703$20240404$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053009$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240703$$CN$US$US
237042972$23704297$2$F$$20240626$20240404$20240711$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-440309$RANBAXY$Ossola Revilla ME, Sajonia-Coburgo M, Antona EM, Eguizabal PT, Dominguez Serrano MI, Pernaute AS et al.. Successful conversion surgery for stage III gastric cancer with a complete pathological response to nivolumab: a case report. Eur J Surg Oncol. 2024;50 (2):107320$39$YR$$M$Y$$$20240711$$HP$ES$ES
237043174$23704317$4$F$20240101$20240707$20240404$20240715$EXP$$CA-CELLTRION INC.-2024CA007834$CELLTRION$$$$$$Y$$$20240715$$HP$CA$CA
237043263$23704326$3$F$20240222$20240704$20240404$20240712$EXP$$BR-CELLTRION INC.-2023BR019569$CELLTRION$$$$$$Y$$$20240712$$CN$BR$BR
237043282$23704328$2$F$20240329$20240702$20240404$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051921$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240702$$HP$US$US
237043442$23704344$2$F$$20240627$20240404$20240701$EXP$$JP-JNJFOC-20240406675$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$JP$JP
237043472$23704347$2$F$20240101$20240718$20240404$20240727$EXP$$CA-CELLTRION INC.-2024CA002807$CELLTRION$$$$$$Y$$$20240727$$CN$CA$CA
237043492$23704349$2$F$20240309$20240309$20240404$20240708$PER$$CA-TOLMAR, INC.-24CA047570$TOLMAR$$80$YR$$M$Y$$$20240708$$CN$CA$CA
237043542$23704354$2$F$$20240826$20240404$20240919$PER$$CA-TOLMAR, INC.-24CA047606$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
237043672$23704367$2$F$20231214$20240627$20240404$20240703$EXP$$BR-TAKEDA-2023TUS123229$TAKEDA$$71$YR$$M$Y$$$20240703$$CN$BR$BR
237043683$23704368$3$F$20240324$20240705$20240404$20240709$EXP$$US-ALXN-202403USA002086US$ALEXION PHARMACEUTICALS$$56$YR$$F$Y$$$20240709$$CN$US$US
237043742$23704374$2$F$20231101$20240826$20240404$20240903$EXP$$US-EMD Serono-2024017794$EMD SERONO INC$$60$YR$A$M$Y$$$20240903$$CN$US$US
237043813$23704381$3$F$20240101$20240906$20240404$20240916$EXP$$CA-CELLTRION INC.-2024CA001774$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
237043917$23704391$7$F$$20240628$20240404$20240705$EXP$$CA-TAKEDA-2024TUS031438$TAKEDA$$$$$M$Y$$$20240705$$MD$CA$CA
237044373$23704437$3$F$$20240828$20240404$20240911$PER$$US-SA-2024SA098317$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240911$$MD$US$US
237044513$23704451$3$F$20240101$20240627$20240404$20240708$PER$$US-SA-2024SA097415$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240708$$MD$US$US
237044523$23704452$3$F$20240101$20240706$20240404$20240715$PER$$US-SA-2024SA098463$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240715$$MD$US$US
237044633$23704463$3$F$20240101$20240703$20240404$20240712$PER$$US-SA-2024SA098476$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240712$$MD$US$US
237044662$23704466$2$F$20240101$20240901$20240404$20240923$PER$$US-SA-2024SA100947$SANOFI AVENTIS$$$$A$M$Y$$$20240923$$MD$US$US
237044763$23704476$3$F$$20240719$20240404$20240729$PER$$US-SA-2024SA100950$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240729$$MD$US$US
237044862$23704486$2$F$$20240624$20240404$20240703$PER$$US-SA-2024SA100822$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240703$$MD$US$US
237044873$23704487$3$F$20240101$20240726$20240404$20240802$PER$$US-SA-2024SA101088$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240802$$MD$US$US
237045002$23704500$2$F$20240402$20240712$20240404$20240713$PER$$US-AMGEN-USASP2024067551$AMGEN$$43$YR$A$F$Y$$$20240713$$CN$US$US
237045103$23704510$3$F$20210101$20240815$20240404$20240829$PER$$US-SA-2024SA099507$SANOFI AVENTIS$$63$YR$A$F$Y$64.41$KG$20240829$$MD$US$US
237045263$23704526$3$F$20240322$20240823$20240404$20240909$PER$$US-SA-2024SA098141$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240909$$MD$US$US
237045502$23704550$2$F$20230101$20240325$20240404$20240712$EXP$$NO-NOVOPROD-1164516$NOVO NORDISK$$40$YR$$F$Y$128$KG$20240712$$MD$NO$NO
237045523$23704552$3$F$20231201$20240708$20240404$20240717$EXP$$IE-NOVOPROD-1197958$NOVO NORDISK$$37$YR$$F$Y$103$KG$20240717$$MD$IE$IE
237045762$23704576$2$F$20240311$20240702$20240404$20240711$EXP$$US-NOVOPROD-1197484$NOVO NORDISK$$65$YR$$F$Y$$$20240711$$CN$US$US
237046142$23704614$2$F$$20240621$20240404$20240702$PER$$US-SA-2024SA100933$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240702$$MD$US$US
237046272$23704627$2$F$$20240812$20240404$20240820$PER$$US-ALXN-202403USA002057US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
237046583$23704658$3$F$$20240823$20240404$20240906$PER$$US-SA-2024SA098061$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240906$$MD$US$US
237046622$23704662$2$F$20240101$20240701$20240404$20240722$PER$$CA-TOLMAR, INC.-24CA047605$TOLMAR$$$$$M$Y$$$20240722$$CN$CA$CA
237046642$23704664$2$F$$20240827$20240404$20240916$PER$$CA-TOLMAR, INC.-24CA047612$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
237046662$23704666$2$F$20240311$20240701$20240404$20240722$PER$$CA-TOLMAR, INC.-24CA047615$TOLMAR$$70$YR$$M$Y$$$20240722$$CN$COUNTRY NOT SPECIFIED$CA
237046692$23704669$2$F$20240311$20240627$20240404$20240722$PER$$CA-TOLMAR, INC.-24CA047637$TOLMAR$$70$YR$$M$Y$$$20240719$$CN$CA$CA
237046884$23704688$4$F$$20240801$20240404$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052907$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240806$$CN$US$US
237046962$23704696$2$F$20231230$20240826$20240404$20240902$PER$$US-SA-2024SA098749$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240902$$MD$US$US
237047114$23704711$4$F$20240401$20240624$20240404$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001178$ACADIA PHARMACEUTICALS$$17$YR$$F$Y$56.689$KG$20240718$$CN$US$US
237047235$23704723$5$F$$20240816$20240404$20240821$EXP$$NVSC2022CA237513$NOVARTIS$Geerlinks AV, Dvorak AM. A case of XIAP deficiency successfully managed with tadekinig alfa (rhIL-18BP). JOURNAL OF CLINICAL IMMUNOLOGY. 2022;42:901-3$8$YR$$M$Y$$$20240821$$HP$CA$CA
237047263$23704726$3$F$20231201$20240726$20240404$20240808$EXP$$DE-AUROBINDO-AUR-APL-2024-014919$AUROBINDO$$86$YR$$M$Y$68$KG$20240809$$MD$DE$DE
237047413$23704741$3$F$20240329$20240701$20240404$20240702$PER$$US-AMGEN-USASP2024066232$AMGEN$$56$YR$A$M$Y$$$20240702$$CN$US$US
237047724$23704772$4$F$20240201$20240801$20240404$20240809$EXP$$CA-CELLTRION INC.-2024CA006951$CELLTRION$$$$$$Y$$$20240809$$MD$CA$CA
237047917$23704791$7$F$20210316$20240920$20240404$20240930$EXP$$CA-CELLTRION INC.-2020CA028095$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
237048334$23704833$4$F$20170101$20240809$20240404$20240812$EXP$$DE-JNJFOC-20240407773$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$DE$DE
237048743$23704874$3$F$20240402$20240711$20240404$20240713$PER$$US-AMGEN-USASP2024067691$AMGEN$$76$YR$E$F$Y$$$20240713$$CN$US$US
237048763$23704876$3$F$20231114$20240820$20240404$20240822$EXP$$FR-TAKEDA-2024TUS030569$TAKEDA$$79$YR$$F$Y$$$20240822$$HP$FR$FR
237048852$23704885$2$F$$20240701$20240404$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051502$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240701$$CN$US$US
237049042$23704904$2$F$20240401$20240724$20240404$20240725$PER$$US-AMGEN-USASP2024067649$AMGEN$$80$YR$E$M$Y$$$20240725$$CN$US$US
237049093$23704909$3$F$20220101$20240723$20240404$20240725$EXP$$CL-ORGANON-O2310CHL002438$ORGANON$$27$YR$$F$Y$$$20240725$$HP$CL$CL
237049452$23704945$2$F$20240531$20240826$20240404$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052835$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$66.68$KG$20240829$$HP$US$US
237049575$23704957$5$F$20240101$20240805$20240404$20240812$EXP$$CA-CELLTRION INC.-2024CA004186$CELLTRION$$$$$$Y$$$20240812$$MD$CA$CA
237049752$23704975$2$F$$20240729$20240404$20240806$EXP$$US-PADAGIS-2024PAD00518$PADAGIS$Barrison L, Hoskins E. Cervical cancer in a transgender man: lessons learnt to improve care. BMJ Case Report. 2024;17(3):e258903$$$$$Y$$$20240806$$HP$US$US
237049793$23704979$3$F$20240318$20240618$20240404$20240703$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-440455$RANBAXY$$63$YR$$M$Y$105.8$KG$20240703$$HP$DE$DE
237049803$23704980$3$F$$20240827$20240404$20240828$EXP$IT-ALLERGAN-2048385US$IT-SANDOZ INC.-NVSC2021IT001026$SANDOZ$$30$YR$$M$Y$$$20240828$$MD$IT$IT
237049882$23704988$2$F$$20240703$20240404$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-049394$BRISTOL MYERS SQUIBB$$10$DEC$E$F$Y$$$20240703$$MD$US$US
237049943$23704994$3$F$$20240626$20240404$20240705$EXP$$US-GSK-US2024AMR038143$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
237050522$23705052$2$F$20240101$20240814$20240404$20240827$PER$$US-SA-2024SA048595$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240827$$CN$US$US
237050532$23705053$2$F$$20240819$20240404$20240829$PER$$US-SA-2024SA099684$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240829$$CN$US$US
237050602$23705060$2$F$20231201$20240726$20240404$20240809$EXP$DE-DCGMA-24202985$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-05863$ALKEM$$86$YR$$M$Y$68$KG$20240809$$MD$DE$DE
237050973$23705097$3$F$20240331$20240727$20240404$20240730$PER$$US-AMGEN-USASP2024066262$AMGEN$$58$YR$A$M$Y$$$20240730$$CN$US$US
237051332$23705133$2$F$$20240702$20240404$20240702$EXP$$US-JNJFOC-20240376431$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240702$$CN$US$US
2370513711$23705137$11$F$20240304$20240924$20240404$20240930$EXP$$JP-GENMAB-2024-00738AA$GENMAB$$53$YR$$F$Y$40.7$KG$20240930$$MD$JP$JP
237051534$23705153$4$F$$20240708$20240404$20240710$PER$$NVSC2024US070962$NOVARTIS$$$$$M$Y$$$20240710$$CN$US$US
237051572$23705157$2$F$20240101$20240819$20240404$20240829$PER$$US-SA-2024SA099736$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240829$$MD$US$US
237051674$23705167$4$F$20240101$20240730$20240404$20240806$EXP$$US-ROCHE-3537814$ROCHE$$32$YR$A$M$Y$70.31$KG$20240806$$CN$US$US
237051793$23705179$3$F$$20240816$20240404$20240823$EXP$$NL-EMD Serono-2024017245$EMD SERONO INC$$39$YR$A$F$Y$$$20240823$$CN$NL$NL
237052054$23705205$4$F$20240101$20240621$20240404$20240705$PER$$US-SA-2024SA102830$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240705$$MD$US$US
237052072$23705207$2$F$$20240719$20240404$20240730$PER$$US-SA-2024SA099102$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240730$$MD$US$US
237052312$23705231$2$F$20240330$20240724$20240404$20240725$PER$$US-AMGEN-USASP2024066593$AMGEN$$55$YR$A$M$Y$$$20240725$$CN$US$US
237052392$23705239$2$F$$20240705$20240404$20240711$PER$$US-ALXN-202403USA002018US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$HP$US$US
237052472$23705247$2$F$20240301$20240620$20240404$20240701$PER$$US-SA-2024SA099396$SANOFI AVENTIS$$75$YR$E$F$Y$106$KG$20240701$$MD$US$US
237052603$23705260$3$F$$20240905$20240404$20240906$PER$$NVSC2024US071977$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
237052632$23705263$2$F$$20240627$20240404$20240705$EXP$$CA-APOTEX-2024AP001960$APOTEX$$63$YR$$F$Y$$$20240705$$MD$CA$CA
237052712$23705271$2$F$$20240402$20240404$20240808$EXP$$NVSC2024HU070699$NOVARTIS$$$$$F$Y$$$20240808$$HP$HU$HU
237052733$23705273$3$F$20170101$20240916$20240404$20240924$EXP$$CA-TAKEDA-2017TUS027043$TAKEDA$$$$$M$Y$$$20240924$$HP$CA$CA
237052972$23705297$2$F$$20240805$20240404$20240806$EXP$$JP-GILEAD-2024-0667674$GILEAD$$9$DEC$E$M$Y$$$20240806$$MD$JP$JP
237053212$23705321$2$F$$20240701$20240404$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052384$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240701$$CN$US$US
237053584$23705358$4$F$20240101$20240917$20240404$20240925$PER$$US-SA-2024SA102220$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240925$$MD$US$US
237054083$23705408$3$F$$20240726$20240404$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA035604$SANDOZ$$40$YR$$F$Y$96$KG$20240730$$HP$CA$CA
237054333$23705433$3$F$$20240819$20240404$20240829$EXP$$US-GSK-US2024AMR039705$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
237054534$23705453$4$F$$20240828$20240404$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052692$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240904$$CN$US$US
237054722$23705472$2$F$$20240725$20240404$20240806$PER$$US-SA-2024SA101672$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240806$$MD$US$US
237054845$23705484$5$F$20200721$20240911$20240404$20240919$EXP$$CA-CELLTRION INC.-2022CA006961$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
237054983$23705498$3$F$$20240717$20240404$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02677$LUPIN$$$$$$Y$$$20240829$$CN$US$US
237055132$23705513$2$F$$20240403$20240404$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053484$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240708$$CN$US$US
237055322$23705532$2$F$$20240628$20240404$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02716$LUPIN$$$$$$Y$$$20240715$$CN$US$US
237055422$23705542$2$F$$20240628$20240404$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02594$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237055586$23705558$6$F$20240430$20240910$20240404$20240917$EXP$$CA-GSK-CA2024029096$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
237055664$23705566$4$F$20240327$20240912$20240404$20240916$EXP$$CZ-Ipsen Biopharmaceuticals, Inc.-2024-05182$IPSEN$$5$YR$C$F$Y$20$KG$20240916$$MD$CZ$CZ
237055802$23705580$2$F$20220131$20240715$20240404$20240723$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-003831$AMGEN$$59$YR$A$F$Y$$$20240723$$LW$US$US
237056154$23705615$4$F$20240726$20240727$20240404$20240731$EXP$$US-TAKEDA-2024TUS019040$TAKEDA$$68$YR$$M$Y$102$KG$20240731$$CN$US$US
237056177$23705617$7$F$20240214$20240626$20240404$20240911$EXP$$NVSC2024US072072$NOVARTIS$$68$YR$$M$Y$65.76$KG$20240911$$HP$US$US
237056424$23705642$4$F$$20240923$20240404$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052937$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240925$$CN$US$US
237056732$23705673$2$F$$20240711$20240404$20240722$PER$$US-SA-2024SA099669$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240721$$MD$US$US
237057442$23705744$2$F$20231024$20240802$20240404$20240808$EXP$$NL-AMGEN-NLDSL2024065146$AMGEN$$85$YR$E$F$Y$$$20240808$$MD$NL$NL
237057453$23705745$3$F$20240403$20240903$20240404$20240904$PER$$US-AMGEN-USASP2024067976$AMGEN$$60$YR$A$F$Y$$$20240904$$CN$US$US
237057522$23705752$2$F$$20230919$20240404$20240710$PER$$US-ROCHE-3425565$ROCHE$$47$YR$A$M$Y$$$20240628$$CN$US$US
237057712$23705771$2$F$20240226$20240703$20240404$20240726$PER$$US-TOLMAR, INC.-24US047345$TOLMAR$$83$YR$$M$Y$$$20240726$$HP$US$US
237058064$23705806$4$F$20190101$20240715$20240404$20240722$PER$$US-SA-2024SA103153$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240723$$HP$US$US
237058352$23705835$2$F$$20240703$20240404$20240709$PER$$US-AMGEN-USASP2024067931$AMGEN$$70$YR$E$M$Y$63.5$KG$20240709$$CN$US$US
237058434$23705843$4$F$$20240802$20240404$20240806$EXP$$US-JNJFOC-20240407062$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240806$$CN$US$US
237058575$23705857$5$F$20230405$20240806$20240404$20240813$EXP$$CA-GSK-CA2023AMR030931$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$CA$CA
237059212$23705921$2$F$$20240627$20240404$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02708$LUPIN$$$$$$Y$$$20240712$$PH$US$US
237060304$23706030$4$F$20240321$20240709$20240404$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053567$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240716$$CN$US$US
237060332$23706033$2$F$20221208$20240802$20240404$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-123983$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$74.1$KG$20240806$$PH$JP$JP
237060393$23706039$3$F$20231201$20240823$20240404$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-015064$AUROBINDO$$$$A$F$Y$61$KG$20240903$$MD$DE$DE
237060672$23706067$2$F$$20240820$20240404$20240830$EXP$CA-MHPD-E2B_06846846$CA-Accord-416307$ACCORD$$$$$M$Y$$$20240830$$MD$CA$CA
237060862$23706086$2$F$20240306$20240805$20240404$20240812$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-050075$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240812$$CN$PR$PR
237060924$23706092$4$F$20231215$20240923$20240404$20240930$EXP$$CA-SA-2023SA297330$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240930$$CN$CA$CA
237061422$23706142$2$F$20240401$20240727$20240404$20240730$PER$$US-AMGEN-USASP2024068060$AMGEN$$84$YR$E$F$Y$$$20240730$$CN$US$US
237061443$23706144$3$F$$20240722$20240404$20240730$EXP$$CA-GSK-CA2024039947$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$CA$CA
237061562$23706156$2$F$20240401$20240717$20240404$20240722$PER$$US-AMGEN-USASP2024068058$AMGEN$$82$YR$E$M$Y$$$20240722$$CN$US$US
237061582$23706158$2$F$20240101$20240917$20240404$20240927$EXP$$US-TEVA-VS-3165988$TEVA$$44$YR$$F$Y$$$20240927$$HP$US$US
237061614$23706161$4$F$$20240711$20240404$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053330$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$87.09$KG$20240712$$CN$US$US
237061793$23706179$3$F$20240101$20240723$20240404$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050033$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$70.31$KG$20240802$$CN$US$US
237061823$23706182$3$F$$20240703$20240404$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053661$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240703$$CN$US$US
237061834$23706183$4$F$20240328$20240531$20240404$20240924$EXP$$FR-CHATTEMPRD-2024OHG010662$CHATTEM$$76$YR$E$F$Y$$$20240924$$CN$FR$FR
237061942$23706194$2$F$20240406$20240912$20240404$20240918$EXP$$US-MYLANLABS-2024M1029224$MYLAN$$75$YR$$F$Y$71.62$KG$20240918$$CN$US$US
237062594$23706259$4$F$20240101$20240716$20240404$20240723$PER$$US-SA-2024SA102622$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240723$$MD$US$US
237063422$23706342$2$F$$20240625$20240404$20240704$PER$$US-SA-2024SA103785$SANOFI AVENTIS$$$$A$F$Y$55.79$KG$20240704$$MD$US$US
237063772$23706377$2$F$$20240628$20240404$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02690$LUPIN$$$$$$Y$$$20240715$$CN$US$US
237064243$23706424$3$F$$20240830$20240404$20240912$PER$$US-SA-2024SA098998$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240912$$MD$US$US
237064272$23706427$2$F$$20240911$20240404$20240920$PER$$US-SA-2024SA102662$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240920$$MD$US$US
237065154$23706515$4$F$20240412$20240823$20240404$20240827$EXP$$CA-TAKEDA-2024TUS031531$TAKEDA$$42$YR$$M$Y$$$20240827$$HP$CA$CA
237065552$23706555$2$F$$20240906$20240404$20240916$PER$$US-SA-2024SA099518$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240916$$MD$US$US
237066016$23706601$6$F$20240319$20240603$20240404$20240702$PER$$US-JNJFOC-20240385874$JOHNSON AND JOHNSON$$83$YR$E$M$Y$68.009$KG$20240702$$CN$US$US
237066257$23706625$7$F$$20240814$20240404$20240819$30DAY$$US-PFIZER INC-202400074961$PFIZER$$9$YR$$F$Y$$$20240819$$CN$US$US
2370669310$23706693$10$F$20240322$20240627$20240404$20240702$EXP$$DE-PFIZER INC-202400079082$PFIZER$$72$YR$$F$Y$90$KG$20240702$$HP$DE$DE
237067082$23706708$2$F$20240101$20240702$20240404$20240705$EXP$$US-PFIZER INC-PV202400042499$PFIZER$$59$YR$$M$Y$66.49$KG$20240705$$CN$US$US
237067144$23706714$4$F$$20240801$20240404$20240802$EXP$$US-PFIZER INC-PV202400044052$PFIZER$$64$YR$$F$Y$$$20240802$$CN$US$US
237067163$23706716$3$F$20230101$20240905$20240404$20240910$EXP$$CA-PFIZER INC-202400076857$PFIZER$$30$YR$$F$Y$$$20240910$$MD$CA$CA
237067402$23706740$2$F$20240312$20240808$20240404$20240814$EXP$$CA-Orion Corporation ORION PHARMA-24_00029208$ORION$$7$YR$C$F$Y$29.1$KG$20240814$$MD$CA$
237067422$23706742$2$F$20240401$20240806$20240404$20240808$PER$$US-AMGEN-USASP2024068442$AMGEN$$84$YR$E$M$Y$$$20240808$$CN$US$US
237067462$23706746$2$F$20240216$20240718$20240404$20240723$EXP$$NVSC2024GB071646$NOVARTIS$$$$$F$Y$$$20240723$$CN$GB$GB
237067546$23706754$6$F$$20240805$20240404$20240808$30DAY$$US-PFIZER INC-202400075803$PFIZER$$14$YR$$M$Y$$$20240808$$HP$US$US
237067574$23706757$4$F$$20240822$20240404$20240828$30DAY$$US-PFIZER INC-202400072023$PFIZER$$14$YR$$M$Y$$$20240828$$MD$US$US
237067722$23706772$2$F$20240209$20240725$20240404$20240806$EXP$FR-AFSSAPS-LM2024000159$FR-RDY-SPO/FRA/24/0005100$DR REDDYS$$80$YR$E$M$Y$59$KG$20240806$$MD$FR$FR
237067892$23706789$2$F$20230501$20240830$20240404$20240909$PER$$JP-Eisai-EC-2024-162823$EISAI$$68$YR$E$M$Y$$$20240909$$MD$JP$JP
237068192$23706819$2$F$20240303$20240718$20240404$20240722$PER$$US-AMGEN-USASP2024068151$AMGEN$$77$YR$E$M$Y$$$20240721$$CN$US$US
237068203$23706820$3$F$20240401$20240806$20240404$20240808$PER$$US-AMGEN-USASP2024067651$AMGEN$$87$YR$E$F$Y$$$20240808$$HP$US$US
237068232$23706823$2$F$$20240628$20240404$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02693$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237068292$23706829$2$F$20240301$20240918$20240404$20240926$PER$$US-SA-2024SA099801$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240926$$MD$US$US
237068472$23706847$2$F$$20240423$20240404$20240805$PER$$US-BAUSCHBL-2024BNL003905$BAUSCH AND LOMB$$$$$F$Y$$$20240805$$CN$US$US
237068512$23706851$2$F$$20240905$20240404$20240912$PER$$US-RDY-CLI/USA/24/0004949$DR REDDYS$$25$YR$A$F$Y$49.2$KG$20240912$$HP$US$US
237068543$23706854$3$F$$20240710$20240404$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02718$LUPIN$$$$$$Y$$$20240809$$CN$US$US
237068652$23706865$2$F$$20240628$20240404$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02709$LUPIN$$$$$$Y$$$20240715$$CN$US$US
237068852$23706885$2$F$20240301$20240514$20240404$20240715$PER$$US-KARYOPHARM-2024KPT000800$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
237069342$23706934$2$F$20240402$20240814$20240404$20240820$PER$$US-AMGEN-USASP2024068178$AMGEN$$79$YR$E$M$Y$$$20240820$$CN$US$US
237069682$23706968$2$F$$20240702$20240404$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050837$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240702$$HP$US$US
237069722$23706972$2$F$20240315$20240816$20240404$20240821$EXP$$US-TAKEDA-2024TUS008652$TAKEDA$$69$YR$$F$Y$63$KG$20240821$$CN$US$US
237069953$23706995$3$F$20240329$20240701$20240404$20240708$PER$$US-SA-2024SA102804$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240708$$HP$US$US
237069962$23706996$2$F$$20240917$20240404$20240923$PER$$US-SA-2024SA101048$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240923$$MD$US$US
237070202$23707020$2$F$20231201$20240808$20240404$20240815$PER$$US-SA-2024SA099342$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240815$$MD$US$US
237070312$23707031$2$F$$20240327$20240404$20240724$PER$$US-BAYER-2024A046440$BAYER$$59$YR$A$F$Y$$$20240724$$PH$US$US
237070333$23707033$3$F$20240101$20240726$20240404$20240730$PER$$US-AMGEN-USASP2024068012$AMGEN$$72$YR$E$F$Y$59.1$KG$20240730$$HP$US$US
237070702$23707070$2$F$20240402$20240718$20240404$20240724$PER$$US-AMGEN-USASP2024068269$AMGEN$$86$YR$E$M$Y$$$20240724$$CN$US$US
237071202$23707120$2$F$20240122$20240917$20240404$20240925$EXP$$US-TEVA-VS-3158880$TEVA$$43$YR$$M$Y$$$20240925$$MD$US$US
237071693$23707169$3$F$20240403$20240730$20240404$20240802$PER$$US-AMGEN-USASP2024068263$AMGEN$$70$YR$E$M$Y$$$20240802$$CN$US$US
237072012$23707201$2$F$$20240325$20240404$20240917$EXP$$CA-ALXN-202403CAN001714CA$ALEXION PHARMACEUTICALS$$42$YR$$M$Y$108$KG$20240917$$HP$CA$CA
237072302$23707230$2$F$$20240708$20240404$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053554$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240711$$CN$US$US
237072343$23707234$3$F$$20240923$20240404$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050671$BRISTOL MYERS SQUIBB$Koelmeyer H, Feradov D, Kotch N. Complete heart block in a patient undergoing combination immune checkpoint inhibitor therapy. Journal of the American College of Cardiology. 2024 Apr 02;83(13 Suppl A):2908.$68$YR$E$F$Y$$$20240927$$HP$US$US
237072402$23707240$2$F$20230930$20240702$20240404$20240710$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024036273$VIIV$$24$YR$$M$Y$$$20240710$$HP$US$US
237072472$23707247$2$F$$20240628$20240404$20240703$EXP$$GB-MYLANLABS-2024M1029184$MYLAN$$$$$M$Y$$$20240703$$HP$GB$GB
237072643$23707264$3$F$20240402$20240718$20240404$20240724$PER$$US-AMGEN-USASP2024068064$AMGEN$$79$YR$E$F$Y$$$20240724$$CN$US$US
237073222$23707322$2$F$20240402$20240729$20240404$20240801$PER$$US-AMGEN-USASP2024068517$AMGEN$$79$YR$E$M$Y$$$20240801$$CN$US$US
237073443$23707344$3$F$20240402$20240725$20240404$20240730$PER$$US-AMGEN-USASP2024068361$AMGEN$$82$YR$E$M$Y$$$20240729$$CN$US$US
237073602$23707360$2$F$20240328$20240725$20240404$20240727$PER$$US-AMGEN-USASP2024068571$AMGEN$$53$YR$A$M$Y$$$20240727$$CN$US$US
237073642$23707364$2$F$20240402$20240820$20240404$20240823$PER$$US-AMGEN-USASP2024068246$AMGEN$$57$YR$A$M$Y$$$20240822$$CN$US$US
237073863$23707386$3$F$$20240618$20240404$20240705$PER$$US-Eisai-EC-2024-161151$EISAI$$$$E$F$Y$$$20240705$$MD$US$US
237074027$23707402$7$F$20200101$20240924$20240404$20240926$EXP$$AR-MYLANLABS-2024M1030588$MYLAN$$$$$M$Y$$$20240926$$CN$AR$AR
237074282$23707428$2$F$$20240809$20240404$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053642$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240812$$HP$US$US
237074545$23707454$5$F$20240101$20240806$20240404$20240817$PER$$US-SA-2024SA102543$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240817$$MD$US$US
237074574$23707457$4$F$$20240822$20240404$20240828$PER$$US-VERTEX PHARMACEUTICALS-2024-002301$VERTEX$$$$$$Y$$$20240828$$CN$US$US
237074915$23707491$5$F$$20240918$20240404$20240924$EXP$$NVSC2023US258114$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
237075085$23707508$5$F$20240212$20240704$20240404$20240716$EXP$$KR-Accord-409867$ACCORD$$77$YR$E$M$Y$46$KG$20240716$$MD$KR$KR
237075153$23707515$3$F$20231101$20240528$20240404$20240708$EXP$$NVSC2024FR057803$NOVARTIS$$$$A$F$Y$54$KG$20240708$$MD$FR$FR
237075183$23707518$3$F$$20240712$20240404$20240718$30DAY$$US-GSK-US2024038054$GLAXOSMITHKLINE$$$$$M$Y$$$20240718$$CN$US$US
237075292$23707529$2$F$$20240724$20240404$20240801$PER$$US-SA-2024SA102784$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240801$$MD$US$US
237075662$23707566$2$F$20240401$20240716$20240404$20240720$30DAY$$US-SANDOZ INC.-SDZ2024US035562$SANDOZ$$12$YR$$M$Y$$$20240720$$CN$US$US
2370757912$23707579$12$F$$20240903$20240404$20240910$EXP$GB-MHRA-ADR 28304985$GB-SANDOZ INC.-SDZ2023GB048792$SANDOZ$$$$$M$Y$$$20240910$$CN$GB$GB
237075824$23707582$4$F$20240321$20240711$20240404$20240712$EXP$$ZA-SANDOZ INC.-SDZ2024ZA033264$SANDOZ$$47$YR$$F$Y$$$20240712$$HP$ZA$ZA
237076972$23707697$2$F$20240402$20240731$20240404$20240802$PER$$US-AMGEN-USASP2024068106$AMGEN$$77$YR$E$F$Y$$$20240802$$CN$US$US
237077003$23707700$3$F$20240401$20240710$20240404$20240712$PER$$US-AMGEN-USASP2024068245$AMGEN$$82$YR$E$F$Y$$$20240711$$CN$US$US
237077362$23707736$2$F$20240101$20240723$20240404$20240801$PER$$US-SA-2024SA100252$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240801$$CN$US$US
237077433$23707743$3$F$20240722$20240722$20240404$20240724$EXP$$AU-TAKEDA-2024TUS031825$TAKEDA$$39$YR$$M$Y$$$20240724$$CN$AU$AU
237077452$23707745$2$F$$20240627$20240404$20240702$EXP$$CA-TAKEDA-2024TUS030845$TAKEDA$$$$$F$Y$$$20240702$$MD$CA$CA
237077684$23707768$4$F$$20240812$20240404$20240821$PER$$US-JNJFOC-20240381109$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$CN$US$US
237077875$23707787$5$F$$20240624$20240404$20240702$PER$$US-ALXN-202403USA001854US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
237078274$23707827$4$F$$20240713$20240404$20240724$PER$$US-IDORSIA-007789-2024-US$IDORSIA PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
237078692$23707869$2$F$$20240731$20240404$20240805$EXP$$CA-BIOVITRUM-2024-CA-005232$BIOVITRUM$$33$YR$$F$Y$104$KG$20240805$$HP$CA$CA
237078825$23707882$5$F$$20240813$20240404$20240820$EXP$$FR-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00401$VELOXIS PHARMACEUTICALS$Delbet J, Hogan J, Parmentier C, Ulinski T, Dossier C.. Successful global anti-B-cell strategy with daratumumab in a patient with post-transplant nephrotic syndrome recurrence unresponsive to immunoadsorption and obinutuzumab.. Pediatric transplantation. 2023;E14544$2$YR$$F$Y$$$20240820$$HP$FR$FR
237078842$23707884$2$F$20240309$20240814$20240404$20240913$PER$$US-Eisai-EC-2024-161560$EISAI$$77$YR$E$F$Y$73$KG$20240913$$CN$US$US
237079212$23707921$2$F$$20240820$20240404$20240916$PER$$US-SA-2024SA099491$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240916$$CN$US$US
237079577$23707957$7$F$20240405$20240822$20240404$20240823$EXP$$CA-TAKEDA-2024TUS031341$TAKEDA$$43$YR$$F$Y$$$20240823$$HP$CA$CA
237079892$23707989$2$F$20240119$20240903$20240404$20240909$EXP$FR-AFSSAPS-PO2024000307$FR-TAKEDA-2024TUS031751$TAKEDA$$54$YR$$F$Y$62$KG$20240909$$HP$FR$FR
237079953$23707995$3$F$20230916$20240621$20240404$20240701$EXP$$FR-BAXTER-2023BAX031762$BAXTER$$79$YR$$M$Y$80$KG$20240701$$MD$FR$FR
237080013$23708001$3$F$20230912$20240819$20240404$20240828$EXP$$NZ-BAXTER-2024BAX015959$BAXTER$$53$YR$$M$Y$74.4$KG$20240828$$MD$NZ$NZ
237080413$23708041$3$F$$20240828$20240404$20240829$EXP$$NVSC2024CA071551$NOVARTIS$$43$YR$$F$Y$$$20240829$$HP$CA$CA
237080583$23708058$3$F$20240821$20240821$20240404$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053059$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240828$$CN$US$US
237080635$23708063$5$F$$20240708$20240404$20240715$EXP$$US-BIOVITRUM-2024-US-005229$BIOVITRUM$$81$YR$$M$Y$$$20240715$$CN$US$US
237080812$23708081$2$F$20240331$20240826$20240404$20240828$PER$$US-AMGEN-USASP2024068293$AMGEN$$69$YR$E$M$Y$$$20240828$$CN$US$US
237081093$23708109$3$F$20240403$20240729$20240404$20240801$PER$$US-AMGEN-USASP2024068391$AMGEN$$78$YR$E$F$Y$$$20240801$$CN$US$US
237081192$23708119$2$F$$20240906$20240404$20240911$EXP$$US-GILEAD-2024-0668171$GILEAD$$61$YR$A$F$Y$$$20240911$$MD$US$US
237081333$23708133$3$F$20240101$20240809$20240404$20240821$EXP$$US-SA-2024SA098758$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240821$$MD$US$US
237081543$23708154$3$F$$20240830$20240404$20240903$EXP$$GB-SANDOZ INC.-SDZ2024GB035371$SANDOZ$$$$$F$Y$$$20240903$$CN$GB$GB
237081622$23708162$2$F$$20240703$20240404$20240707$PER$$US-AMGEN-USASP2024065069$AMGEN$Liu M.C.; Lizaola-mayo B.; Jayasekera C.R. et al.. Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant. Journal of Gastrointestinal cancer. 2024;1-6$61$YR$A$M$Y$$$20240707$$HP$US$US
237082106$23708210$6$F$$20240911$20240404$20240920$PER$$US-SA-2024SA100427$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240920$$MD$US$US
237082176$23708217$6$F$20230828$20240906$20240404$20240912$EXP$$CA-TAKEDA-2024TUS030794$TAKEDA$$58$YR$$F$Y$$$20240912$$CN$CA$CA
237082943$23708294$3$F$$20240328$20240404$20240701$EXP$$US-BIOGEN-2024BI01258134$BIOGEN$$$$$M$Y$$$20240701$$CN$US$US
237083022$23708302$2$F$$20240703$20240404$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053700$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240703$$CN$US$US
237083113$23708311$3$F$20240201$20240628$20240404$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202404002004$ELI LILLY AND CO$$74$YR$E$F$Y$68$KG$20240704$$MD$US$US
237083133$23708313$3$F$$20240620$20240404$20240902$PER$$US-ASTELLAS-2024US010006$ASTELLAS$$$$A$F$Y$$$20240830$$HP$US$US
237083745$23708374$5$F$20240401$20240910$20240404$20240918$PER$$US-Calliditas-2024CAL00525$CALLIDITAS THERAPEUTICS$$58$YR$A$M$Y$76$KG$20240918$$CN$US$US
237083903$23708390$3$F$20240324$20240708$20240404$20240710$PER$$US-AMGEN-USASP2024068392$AMGEN$$70$YR$E$F$Y$$$20240710$$MD$US$US
237083932$23708393$2$F$20240307$20240815$20240404$20240913$PER$$US-Eisai-EC-2024-161175$EISAI$$61$YR$A$F$Y$$$20240913$$CN$US$US
237083983$23708398$3$F$$20240910$20240404$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050400$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240916$$CN$US$US
237084416$23708441$6$F$$20240718$20240404$20240723$EXP$$US-JNJFOC-20240380966$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240723$$CN$US$US
237084443$23708444$3$F$$20240729$20240404$20240802$EXP$$US-ALXN-202403USA002056US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
237084503$23708450$3$F$20240101$20240715$20240404$20240724$PER$$US-SA-2024SA101156$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240724$$MD$US$US
237084572$23708457$2$F$$20240718$20240404$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA035219$SANDOZ$$68$YR$$M$Y$$$20240722$$CN$CA$CA
237084883$23708488$3$F$20230101$20240329$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003320$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
237085164$23708516$4$F$$20240924$20240404$20240926$30DAY$$US-PFIZER INC-202400076151$PFIZER$$9$YR$$M$Y$$$20240926$$CN$US$US
237085212$23708521$2$F$$20240625$20240404$20240701$PER$$US-PFIZER INC-202400076897$PFIZER$$17$YR$$F$Y$$$20240701$$MD$US$US
237085272$23708527$2$F$$20240729$20240404$20240731$PER$$US-PFIZER INC-202400077351$PFIZER$$76$YR$$M$Y$$$20240731$$CN$US$US
237085282$23708528$2$F$$20240731$20240404$20240806$PER$$US-PFIZER INC-202400076977$PFIZER$$89$YR$$F$Y$$$20240806$$CN$US$US
237085315$23708531$5$F$20240301$20240628$20240404$20240702$EXP$$US-PFIZER INC-202400076791$PFIZER$$66$YR$$F$Y$72.57$KG$20240702$$CN$US$US
237085325$23708532$5$F$20240330$20240809$20240404$20240814$30DAY$$US-PFIZER INC-202400076387$PFIZER$$11$YR$$F$Y$$$20240814$$CN$US$US
237085366$23708536$6$F$$20240728$20240404$20240730$30DAY$$US-PFIZER INC-202400075753$PFIZER$$8$YR$$M$Y$$$20240730$$CN$US$US
237085552$23708555$2$F$$20240403$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003402$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
237085602$23708560$2$F$$20240605$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003392$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
237085643$23708564$3$F$20240322$20240606$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003391$TG THERAPEUTICS$$47$YR$$M$Y$78.912$KG$20240715$$HP$US$US
237085862$23708586$2$F$20240403$20240829$20240404$20240830$PER$$US-AMGEN-USASP2024068425$AMGEN$$82$YR$E$F$Y$$$20240830$$CN$US$US
237085932$23708593$2$F$$20240909$20240404$20240911$PER$$US-PFIZER INC-PV202400043690$PFIZER$$77$YR$$M$Y$$$20240911$$CN$US$US
237085982$23708598$2$F$$20240710$20240404$20240712$PER$$US-PFIZER INC-PV202400043605$PFIZER$$75$YR$$F$Y$$$20240712$$CN$US$US
237086043$23708604$3$F$20240101$20240919$20240404$20240920$PER$$US-PFIZER INC-PV202400043467$PFIZER$$91$YR$$M$Y$$$20240920$$CN$US$US
237086132$23708613$2$F$20240208$20240515$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003430$TG THERAPEUTICS$$48$YR$$F$Y$$$20240715$$CN$US$US
237086172$23708617$2$F$$20240515$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003431$TG THERAPEUTICS$$$$$F$Y$63.492$KG$20240715$$CN$US$US
237086242$23708624$2$F$$20240628$20240404$20240710$EXP$$US-GSK-US2024AMR041055$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
237086265$23708626$5$F$20240109$20240829$20240404$20240905$EXP$$JP-GENMAB-2024-00170AA$GENMAB$Fujita M, Okamoto T, Mihashi T, Kidoguchi K, Kusaba K, Sano H, et al. Relapsed and refractory DLBCL with pseudoprogression due to epcoritamab. The 14th Japanese Society of Hematology Kyushu Association. 2024$71$YR$$M$Y$$$20240905$$MD$JP$JP
237086603$23708660$3$F$20240328$20240808$20240404$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050830$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$98.4$KG$20240815$$CN$US$US
237086773$23708677$3$F$20240304$20240408$20240404$20240926$PER$$US-Eisai-EC-2024-161050$EISAI$$81$YR$E$F$Y$$$20240926$$MD$US$US
237087012$23708701$2$F$$20240627$20240404$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052756$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240701$$CN$US$US
237087472$23708747$2$F$20240307$20240415$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003394$TG THERAPEUTICS$$54$YR$$M$Y$$$20240715$$CN$US$US
237087563$23708756$3$F$20240328$20240913$20240404$20240917$EXP$$US-TAKEDA-2024TUS030519$TAKEDA$$46$YR$$M$Y$$$20240917$$CN$US$US
237087592$23708759$2$F$20240208$20240514$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003385$TG THERAPEUTICS$$29$YR$$F$Y$81.633$KG$20240715$$CN$US$US
237087752$23708775$2$F$$20240402$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003310$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
237087762$23708776$2$F$$20240719$20240404$20240726$EXP$$US-AstraZeneca-2024A078515$ASTRAZENECA$$67$YR$$F$Y$$$20240726$$HP$US$
237087972$23708797$2$F$20240326$20240417$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003436$TG THERAPEUTICS$$48$YR$$M$Y$$$20240715$$MD$US$US
237087992$23708799$2$F$$20240411$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003423$TG THERAPEUTICS$$$$$M$Y$106.12$KG$20240715$$HP$US$US
237088002$23708800$2$F$20240318$20240514$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003405$TG THERAPEUTICS$$33$YR$$M$Y$$$20240715$$MD$US$US
237088032$23708803$2$F$20231018$20240404$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003424$TG THERAPEUTICS$$39$YR$$$Y$63.492$KG$20240715$$PH$US$US
237088162$23708816$2$F$$20240329$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003443$TG THERAPEUTICS$$$$$M$Y$$$20240715$$HP$US$US
237088413$23708841$3$F$20220321$20240912$20240404$20240918$EXP$$US-TAKEDA-2022TUS026949$TAKEDA$$37$YR$$M$Y$$$20240918$$CN$US$US
237088604$23708860$4$F$20230101$20240611$20240404$20240705$PER$$US-Eisai-EC-2024-161948$EISAI$$64$YR$A$M$Y$88$KG$20240705$$CN$US$US
237088662$23708866$2$F$20240212$20240417$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003326$TG THERAPEUTICS$$48$YR$$M$Y$64$KG$20240715$$HP$US$US
237088773$23708877$3$F$20240331$20240724$20240404$20240726$PER$$US-AMGEN-USASP2024068174$AMGEN$$70$YR$E$F$Y$$$20240726$$CN$US$US
237088992$23708899$2$F$20231211$20240507$20240404$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003215$TG THERAPEUTICS$$47$YR$$F$Y$$$20240715$$CN$US$US
237089533$23708953$3$F$20240226$20240812$20240404$20240814$EXP$$NVSC2024US042793$NOVARTIS$$31$YR$$F$Y$$$20240814$$CN$US$US
237089873$23708987$3$F$$20240912$20240404$20240916$PER$$US-PFIZER INC-PV202400043879$PFIZER$$34$YR$$F$Y$$$20240916$$HP$US$US
237090002$23709000$2$F$$20240820$20240404$20240822$PER$$US-PFIZER INC-202400075809$PFIZER$$46$YR$$F$Y$$$20240822$$CN$US$US
237090052$23709005$2$F$$20240717$20240404$20240718$PER$$US-PFIZER INC-PV202400044519$PFIZER$$84$YR$$F$Y$$$20240718$$CN$US$US
237090173$23709017$3$F$20240501$20240711$20240404$20240716$EXP$$US-PFIZER INC-PV202400044826$PFIZER$$62$YR$$F$Y$$$20240716$$HP$US$US
237090273$23709027$3$F$20240101$20240813$20240404$20240816$PER$$US-PFIZER INC-PV202400043081$PFIZER$$72$YR$$F$Y$$$20240816$$MD$US$US
237090692$23709069$2$F$$20240802$20240404$20240808$PER$$US-PFIZER INC-PV202400042420$PFIZER$$67$YR$$F$Y$$$20240808$$CN$US$US
237090932$23709093$2$F$$20240711$20240404$20240716$EXP$$US-TAKEDA-2024TUS031394$TAKEDA$$$$$F$Y$66$KG$20240716$$MD$US$US
237090982$23709098$2$F$$20240703$20240404$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053879$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$PH$US$US
237091135$23709113$5$F$20240311$20240809$20240404$20240820$EXP$$SE-GENMAB-2024-01112$GENMAB$$78$YR$$M$Y$$$20240820$$MD$SE$SE
237091372$23709137$2$F$20240320$20240710$20240404$20240815$PER$$US-Eisai-EC-2024-162302$EISAI$$76$YR$E$M$Y$$$20240815$$CN$US$US
237091442$23709144$2$F$$20240712$20240404$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053934$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$66.68$KG$20240716$$CN$US$US
237091734$23709173$4$F$20240101$20240624$20240404$20240701$EXP$$MX-AstraZeneca-2024A040181$ASTRAZENECA$$863$MON$$F$Y$102$KG$20240701$$CN$MX$
237091822$23709182$2$F$20240301$20240719$20240404$20240815$PER$$US-TRAVERE-2024TVT00298$TRAVERE THERAPEUTICS$$37$YR$A$F$Y$$$20240815$$CN$US$US
237092342$23709234$2$F$20220101$20240725$20240404$20240805$EXP$GR-GREOF-202400211$GR-ELI_LILLY_AND_COMPANY-GR202403013705$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240805$$CN$GR$GR
2370925214$23709252$14$F$20240318$20240918$20240404$20240926$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-05404$IPSEN$$67$YR$E$F$Y$$$20240926$$CN$US$US
237092992$23709299$2$F$20231101$20240830$20240404$20240905$EXP$$JP-009507513-2311JPN003608J$MERCK$$7$DEC$$M$Y$$$20240905$$MD$JP$JP
237093592$23709359$2$F$20230930$20240702$20240404$20240711$PER$$US-JNJFOC-20240413056$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240711$$HP$US$US
237093952$23709395$2$F$20220101$20240708$20240404$20240717$PER$$JP-Eisai-EC-2024-157695$EISAI$$$$$F$Y$$$20240717$$MD$JP$JP
237094063$23709406$3$F$$20240628$20240404$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST002051$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240704$$CN$US$US
237094132$23709413$2$F$$20240712$20240404$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051522$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240712$$CN$US$US
237094262$23709426$2$F$20240301$20240703$20240404$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053914$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240703$$CN$US$US
237094445$23709444$5$F$$20240820$20240404$20240827$PER$$US-ALXN-202403USA002155US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
237095002$23709500$2$F$$20240703$20240404$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053595$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240703$$CN$US$US
237095112$23709511$2$F$20240310$20240801$20240404$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053022$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240804$$CN$US$US
237095126$23709512$6$F$$20240719$20240404$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-009629$UNITED THERAPEUTICS$$$$$M$Y$73.469$KG$20240727$$$US$US
237095292$23709529$2$F$20240327$20240716$20240404$20240722$PER$$US-ALXN-202403USA002004US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240723$$HP$US$US
237095713$23709571$3$F$20220619$20240703$20240404$20240704$EXP$$NVSC2023JP011020$NOVARTIS$$73$YR$$M$Y$58.2$KG$20240705$$HP$JP$JP
237095873$23709587$3$F$20240223$20240710$20240404$20240716$EXP$$CA-JNJFOC-20240384492$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240716$$HP$CA$CA
237095904$23709590$4$F$$20240919$20240404$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053953$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240923$$CN$US$US
237096612$23709661$2$F$$20240727$20240404$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053901$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$78.47$KG$20240729$$CN$US$US
237096733$23709673$3$F$$20240709$20240404$20240711$EXP$$US-TAKEDA-2024TUS029364$TAKEDA$$$$$M$Y$$$20240711$$CN$US$US
237096862$23709686$2$F$20231201$20240716$20240404$20240719$EXP$$JP-009507513-2403JPN003844J$MERCK$$57$YR$$M$Y$$$20240719$$MD$JP$JP
237097354$23709735$4$F$20240301$20240710$20240404$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053298$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240712$$HP$US$US
237097372$23709737$2$F$$20240329$20240404$20240730$PER$$NVSC2024US070468$NOVARTIS$$$$$M$Y$73.47$KG$20240730$$CN$US$US
237097424$23709742$4$F$20240124$20240905$20240404$20240913$EXP$$US-ABBVIE-5702641$ABBVIE$$35$YR$$F$Y$71$KG$20240913$$HP$US$US
237097554$23709755$4$F$20240101$20240715$20240404$20240801$EXP$$US-SA-2024SA101753$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240719$$MD$US$US
237097692$23709769$2$F$20221230$20240814$20240405$20240815$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-019513$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240815$$CN$US$US
237098832$23709883$2$F$$20240715$20240405$20240724$EXP$$GR-CELLTRION INC.-2024GR007754$CELLTRION$$$$$$Y$$$20240724$$CN$GR$GR
237098843$23709884$3$F$20240101$20240904$20240405$20240918$PER$$US-SA-2024SA100924$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240918$$MD$US$US
237098893$23709889$3$F$20240301$20240626$20240405$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001029$ACADIA PHARMACEUTICALS$$23$YR$$F$Y$$$20240719$$CN$US$US
237099184$23709918$4$F$20240101$20240625$20240405$20240704$PER$$US-SA-2024SA100823$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240704$$MD$US$US
237099432$23709943$2$F$20080705$20240705$20240405$20240711$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-440598$RANBAXY$$67$YR$$M$Y$65$KG$20240711$$MD$GB$GB
237099632$23709963$2$F$$20240626$20240405$20240821$EXP$$CN-ROCHE-3536093$ROCHE$$$$$$Y$$$20240821$$MD$CN$CN
237099942$23709994$2$F$20240101$20240828$20240405$20240909$PER$$US-SA-2024SA099437$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240909$$MD$US$US
237100535$23710053$5$F$20240325$20240705$20240405$20240711$EXP$$IT-JNJFOC-20240377184$JOHNSON AND JOHNSON$$68$YR$E$F$Y$54$KG$20240711$$MD$IT$IT
237100544$23710054$4$F$$20240801$20240405$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052778$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240802$$CN$US$US
237100602$23710060$2$F$$20240901$20240405$20240904$PER$$NVSC2024US072479$NOVARTIS$$$$$$Y$$$20240904$$CN$US$US
237100782$23710078$2$F$$20240712$20240405$20240723$PER$$US-SA-2024SA099291$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240723$$MD$US$US
237100912$23710091$2$F$$20240719$20240405$20240729$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-005129$JAZZ$$$$$F$Y$$$20240728$$CN$US$US
237100993$23710099$3$F$20240301$20240614$20240405$20240701$PER$$US-APOTEX-2024AP003745$APOTEX$$$$$F$Y$$$20240701$$CN$US$US
237101002$23710100$2$F$20220503$20240623$20240405$20240701$EXP$$CA-CELLTRION INC.-2022CA008801$CELLTRION$$$$$$Y$$$20240701$$MD$CA$CA
237101065$23710106$5$F$20240329$20240808$20240405$20240809$PER$$US-BIOVITRUM-2024-US-005224$BIOVITRUM$$67$YR$$M$Y$$$20240809$$CN$US$US
237101145$23710114$5$F$$20240805$20240405$20240814$PER$$US-BIOVITRUM-CTI2024US04504$BIOVITRUM$$74$YR$$M$Y$$$20240814$$CN$US$US
237101152$23710115$2$F$20240101$20240622$20240405$20240703$PER$$US-SA-2024SA101726$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240703$$MD$US$US
237101265$23710126$5$F$$20240722$20240405$20240724$30DAY$$AU-JNJFOC-20240339913$JOHNSON AND JOHNSON$$68$YR$E$M$Y$109$KG$20240724$$HP$AU$AU
237101362$23710136$2$F$20240301$20240821$20240405$20240905$PER$$US-SA-2024SA073910$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240905$$MD$US$US
237101554$23710155$4$F$$20240909$20240405$20240912$EXP$$CA-ROCHE-3538253$ROCHE$$$$A$F$Y$$$20240912$$CN$CA$CA
237101732$23710173$2$F$$20240722$20240405$20240725$PER$$US-AMGEN-USASP2024067169$AMGEN$$$$$M$Y$$$20240725$$CN$US$US
237101963$23710196$3$F$20220301$20240513$20240405$20240704$EXP$$GB-TEVA-VS-3122758$TEVA$$20$YR$$M$Y$78$KG$20240704$$MD$GB$GB
237101982$23710198$2$F$$20240727$20240405$20240805$PER$$US-SA-2024SA102702$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240805$$MD$US$US
237102063$23710206$3$F$20211015$20240718$20240405$20240727$EXP$$CA-CELLTRION INC.-2021CA010532$CELLTRION$$$$$$Y$$$20240727$$HP$CA$CA
237102332$23710233$2$F$20240101$20240626$20240405$20240705$PER$$US-SA-2024SA102844$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240705$$MD$US$US
237102357$23710235$7$F$20230301$20240912$20240405$20240920$EXP$$CA-CELLTRION INC.-2023CA007208$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
237102843$23710284$3$F$$20240624$20240405$20240701$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002755$JAZZ$$$$$F$Y$$$20240701$$CN$US$US
237102883$23710288$3$F$20240101$20240815$20240405$20240824$EXP$$CA-CELLTRION INC.-2024CA003996$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
237102963$23710296$3$F$20230907$20240725$20240405$20240802$EXP$$CA-CELLTRION INC.-2023CA009504$CELLTRION$$$$$$Y$$$20240802$$HP$CA$CA
237103072$23710307$2$F$20240101$20240729$20240405$20240731$PER$$US-AMGEN-USASP2024068072$AMGEN$$66$YR$E$M$Y$$$20240730$$CN$US$US
237103283$23710328$3$F$$20240618$20240405$20240703$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440521$RANBAXY$Yin Y, Shen K, Li H, Zhang L. Pneumocystis Jiroveci Pneumonia Secondary to Blinatumomab  Therapy: A Case Report. Chemotherapy. 2024;Mar 20:Online ahead of print(19)$70$YR$$F$Y$$$20240703$$HP$CN$CN
237103752$23710375$2$F$$20240722$20240405$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053300$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240723$$HP$US$US
237103862$23710386$2$F$$20240912$20240405$20240920$EXP$$CA-TAKEDA-2020TUS021484$TAKEDA$$$$$M$Y$$$20240920$$MD$CA$CA
237104483$23710448$3$F$20240329$20240719$20240405$20240724$PER$$US-AMGEN-USASP2024067465$AMGEN$$77$YR$E$F$Y$$$20240724$$CN$US$US
237104732$23710473$2$F$20240301$20240917$20240405$20240921$EXP$$US-ABBVIE-5704836$ABBVIE$$18$YR$$F$Y$$$20240921$$CN$US$US
237104855$23710485$5$F$20190507$20240813$20240405$20240819$EXP$$CA-JNJFOC-20240385972$JOHNSON AND JOHNSON$$22$YR$A$F$Y$46$KG$20240819$$HP$CA$CA
237104933$23710493$3$F$$20240712$20240405$20240806$PER$$US-ALXN-202404USA000033US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
237105073$23710507$3$F$$20240918$20240405$20240923$EXP$$NVSC2024US071393$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
237105082$23710508$2$F$20240322$20240902$20240405$20240905$EXP$$CA-JNJFOC-20240386772$JOHNSON AND JOHNSON$$17$YR$T$F$Y$93$KG$20240905$$HP$CA$CA
237105333$23710533$3$F$20240403$20240716$20240405$20240718$PER$$NVSC2024US072636$NOVARTIS$$78$YR$$M$Y$$$20240718$$CN$US$US
237105373$23710537$3$F$20240710$20240829$20240405$20240907$EXP$$CA-CELLTRION INC.-2024CA008034$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
237105382$23710538$2$F$20231018$20240823$20240405$20240902$EXP$$JP-009507513-2404JPN000438J$MERCK$$79$YR$$M$Y$59$KG$20240902$$MD$JP$JP
237105402$23710540$2$F$20240702$20240724$20240405$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202404003482$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240729$$CN$US$US
237105482$23710548$2$F$20240314$20240710$20240405$20240715$30DAY$$US-SANDOZ INC.-SDZ2024US033989$SANDOZ$$11$YR$$F$Y$$$20240715$$CN$US$US
237105962$23710596$2$F$20230101$20240815$20240405$20240823$EXP$$JP-009507513-2311JPN003878J$MERCK$$72$YR$$M$Y$$$20240823$$MD$JP$JP
237106272$23710627$2$F$$20240924$20240405$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA036136$SANDOZ$$66$YR$$F$Y$61$KG$20240925$$MD$CA$CA
237106284$23710628$4$F$20240101$20240716$20240405$20240725$EXP$$CA-CELLTRION INC.-2024CA007922$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
237106542$23710654$2$F$20210416$20240718$20240405$20240726$EXP$$CO-TAKEDA-2021TUS026059$TAKEDA$$15$YR$$F$Y$60$KG$20240726$$CN$CO$CO
237106692$23710669$2$F$20231228$20240620$20240405$20240709$EXP$$US-ROCHE-3532937$ROCHE$$63$YR$A$M$Y$$$20240702$$CN$US$US
237106905$23710690$5$F$20240404$20240916$20240405$20240918$PER$$NVSC2024US072640$NOVARTIS$$64$YR$$F$Y$$$20240918$$CN$US$US
237106946$23710694$6$F$20231101$20240822$20240405$20240905$EXP$$CA-UCBSA-2023061337$UCB$$76$YR$$F$Y$$$20240905$$HP$CA$CA
237107132$23710713$2$F$$20240725$20240405$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053988$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240726$$CN$US$US
237107564$23710756$4$F$20240805$20240910$20240405$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051478$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240911$$CN$US$US
237107722$23710772$2$F$$20240517$20240405$20240704$EXP$$US-TEVA-VS-3174709$TEVA$$$$$$Y$$$20240704$$HP$US$US
237107733$23710773$3$F$20240311$20240911$20240405$20240927$30DAY$$US-BECTON DICKINSON-US-BD-24-000184$BECTON DICKINSON$$$$$$Y$$$20240927$$CN$US$US
237107864$23710786$4$F$20240401$20240715$20240405$20240723$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-053618$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$80.29$KG$20240719$$HP$PR$PR
237107996$23710799$6$F$$20240829$20240405$20240905$EXP$$US-GSK-US2024AMR041682$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$US$US
237108074$23710807$4$F$20100503$20240827$20240405$20240830$EXP$FR-EMA-DD-20240326-7482655-061913$FR-SA-2024SA102056$SANOFI AVENTIS$$67$YR$E$M$Y$74$KG$20240830$$MD$FR$FR
237108092$23710809$2$F$$20240702$20240405$20240705$EXP$$JP-AMGEN-JPNSP2024068176$AMGEN$Murata, T.. Uveitis in a psoriasis vulgaris patient receiving deucravacitinib: a case report. Journal of Cutaneous Immunology and Allergy. 2024;7$55$YR$A$M$Y$$$20240705$$MD$JP$JP
237108133$23710813$3$F$$20240705$20240405$20240710$EXP$$CA-TAKEDA-2024TUS030994$TAKEDA$$$$$M$Y$$$20240710$$CN$CA$CA
237108302$23710830$2$F$20240301$20240702$20240405$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052504$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240703$$HP$US$US
237108482$23710848$2$F$$20240618$20240405$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02746$LUPIN$$$$$$Y$$$20240701$$CN$US$US
237109502$23710950$2$F$20240402$20240725$20240405$20240726$PER$$US-AMGEN-USASP2024068512$AMGEN$$63$YR$A$M$Y$$$20240726$$CN$US$US
237109534$23710953$4$F$20240404$20240903$20240405$20240904$PER$$US-AMGEN-USASP2024068877$AMGEN$$69$YR$E$M$Y$$$20240904$$CN$US$US
237109573$23710957$3$F$$20240822$20240405$20240828$EXP$$CA-SANDOZ INC.-PHHY2016CA062015$SANDOZ$$68$YR$$F$Y$$$20240828$$HP$CA$CA
237109732$23710973$2$F$$20240214$20240405$20240802$EXP$$US-Accord-390972$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
237109925$23710992$5$F$$20240919$20240405$20240926$EXP$$US-GSK-US2024AMR040977$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
237110013$23711001$3$F$20240101$20240415$20240405$20240720$EXP$$CA-CELLTRION INC.-2024CA008050$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
237110152$23711015$2$F$20240403$20240718$20240405$20240724$PER$$US-AMGEN-USASP2024068173$AMGEN$$70$YR$E$M$Y$$$20240724$$CN$US$US
237110246$23711024$6$F$20240101$20240814$20240405$20240826$EXP$$US-INSMED, INC.-2024-00979-US$INSMED$$$$$F$Y$$$20240826$$CN$US$US
237110564$23711056$4$F$20230101$20240709$20240405$20240711$EXP$$CA-UCBSA-2023033273$UCB$$$$$F$Y$$$20240711$$CN$CA$CA
237110783$23711078$3$F$$20240902$20240405$20240904$EXP$$CA-BAUSCH-BL-2024-005314$BAUSCH AND LOMB$$34$YR$$F$Y$$$20240904$$CN$CA$CA
2371113511$23711135$11$F$20240322$20240721$20240405$20240725$EXP$$NVSC2024IL063729$NOVARTIS$$62$YR$$F$Y$$$20240725$$HP$IL$IL
237111362$23711136$2$F$$20240716$20240405$20240718$EXP$$CA-TAKEDA-2024TUS031460$TAKEDA$$$$$F$Y$$$20240718$$CN$CA$CA
237111456$23711145$6$F$$20240909$20240405$20240912$EXP$$CA-TAKEDA-2024TUS031515$TAKEDA$$$$$M$Y$$$20240912$$MD$CA$CA
237112583$23711258$3$F$20231201$20240911$20240405$20240916$EXP$$JP-009507513-2402JPN001808J$MERCK$$6$DEC$$F$Y$$$20240916$$MD$JP$JP
237112736$23711273$6$F$$20240724$20240405$20240801$EXP$$CA-MYLANLABS-2023M1089121$BIOCON$$$$$$Y$$$20240801$$CN$CA$CA
237112852$23711285$2$F$20240601$20240726$20240405$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202404003385$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240730$$CN$US$US
237113034$23711303$4$F$20230101$20240910$20240405$20240917$EXP$$CA-CELLTRION INC.-2023CA008556$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
237113984$23711398$4$F$$20240912$20240405$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052841$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240916$$MD$US$US
237114132$23711413$2$F$$20240816$20240405$20240826$EXP$$CA-TAKEDA-2023TUS120048$TAKEDA$$$$$M$Y$$$20240826$$CN$CA$CA
237114556$23711455$6$F$20240424$20240805$20240405$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053655$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240807$$CN$US$US
237114642$23711464$2$F$$20240709$20240405$20240714$EXP$$CA-SANDOZ INC.-SDZ2024CA036038$SANDOZ$$44$YR$$F$Y$97$KG$20240714$$MD$CA$CA
237114763$23711476$3$F$20240101$20240705$20240405$20240715$EXP$$CA-BEH-2024170299$CSL BEHRING$$74$YR$E$F$Y$$$20240715$$CN$CA$CA
237115422$23711542$2$F$$20240704$20240405$20240709$EXP$$JP-AMGEN-JPNSP2024065382$AMGEN$$$$$$Y$$$20240709$$PH$JP$JP
237115773$23711577$3$F$$20240622$20240405$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001507$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
237115827$23711582$7$F$20240327$20240813$20240405$20240823$EXP$$US-GILEAD-2024-0668337$GILEAD$$68$YR$E$M$Y$63.946$KG$20240823$$MD$US$US
237116062$23711606$2$F$20240318$20240807$20240405$20240817$30DAY$$US-GSK-US2024039117$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240817$$CN$US$US
237116182$23711618$2$F$$20240704$20240405$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-041457$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240704$$HP$US$US
237116942$23711694$2$F$20240101$20240805$20240405$20240810$EXP$$US-SA-2024SA104049$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240810$$MD$US$US
237117093$23711709$3$F$$20240708$20240405$20240709$PER$$US-ALXN-202404USA000057US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240709$$CN$US$US
237117872$23711787$2$F$20240301$20240621$20240405$20240705$PER$$US-Eisai-EC-2024-162795$EISAI$$56$YR$A$F$Y$$$20240705$$CN$US$US
237118442$23711844$2$F$20240326$20240814$20240405$20240819$EXP$RU- RZN-2289846$RU-BAYER-2024A050181$BAYER$$83$YR$E$F$Y$$$20240819$$HP$RU$RU
237119034$23711903$4$F$$20240705$20240405$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054308$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240709$$CN$US$US
237119053$23711905$3$F$20240213$20240701$20240405$20240710$EXP$$JP-ROCHE-3538324$ROCHE$$90$YR$E$M$Y$54$KG$20240710$$MD$JP$JP
237119324$23711932$4$F$20240101$20240911$20240405$20240927$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-055010$REGENERON$$58$YR$$M$Y$$$20240927$$HP$CO$CO
237120272$23712027$2$F$$20240628$20240405$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02689$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237120985$23712098$5$F$20240301$20240710$20240405$20240710$30DAY$$AR-PFIZER INC-PV202400040600$PFIZER$$12$YR$$F$Y$$$20240710$$HP$AR$AR
237121182$23712118$2$F$20240403$20240718$20240405$20240724$PER$$US-AMGEN-USASP2024068669$AMGEN$$49$YR$A$F$Y$$$20240724$$CN$US$US
237121387$23712138$7$F$20240327$20240805$20240405$20240807$30DAY$$AR-PFIZER INC-202400076389$PFIZER$$11$YR$$F$Y$$$20240807$$CN$AR$AR
237121465$23712146$5$F$$20240803$20240405$20240809$30DAY$$DE-PFIZER INC-202400066628$PFIZER$$$$$$Y$$$20240809$$PH$DE$DE
237121712$23712171$2$F$20220101$20240724$20240405$20240726$EXP$$US-PFIZER INC-202400078777$PFIZER$$74$YR$$F$Y$$$20240726$$HP$US$US
237121752$23712175$2$F$20240101$20240626$20240405$20240705$PER$$US-Eisai-EC-2024-160838$EISAI$$71$YR$E$F$Y$$$20240705$$CN$US$US
237122955$23712295$5$F$20240323$20240411$20240405$20240812$EXP$$ES-BIOVITRUM-2024-ES-004926$ADC THERAPEUTICS$$80$YR$$M$Y$$$20240812$$MD$ES$ES
237124113$23712411$3$F$20240722$20240731$20240405$20240805$EXP$$US-OTSUKA-2024_009084$OTSUKA$$76$YR$$F$Y$$$20240805$$CN$US$US
237124132$23712413$2$F$20240301$20240625$20240405$20240701$EXP$$US-MYLANLABS-2024M1027775$MYLAN$$15$YR$$F$Y$69.6$KG$20240701$$MD$US$US
237124482$23712448$2$F$20240315$20240603$20240405$20240705$PER$$US-Eisai-EC-2024-162289$EISAI$$69$YR$E$M$Y$$$20240705$$HP$US$US
237124794$23712479$4$F$$20240716$20240405$20240718$30DAY$$US-SANDOZ INC.-SDZ2024US035550$SANDOZ$$$$$F$Y$$$20240718$$CN$US$US
237124823$23712482$3$F$$20240924$20240405$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA036137$SANDOZ$$64$YR$$F$Y$71$KG$20240925$$HP$CA$CA
237125172$23712517$2$F$20240304$20240807$20240405$20240809$EXP$$JP-ROCHE-3538287$ROCHE$$18$YR$A$M$Y$$$20240809$$MD$JP$JP
237125445$23712544$5$F$20240330$20240702$20240405$20240705$EXP$$US-TAKEDA-2024TUS030145$TAKEDA$$73$YR$$F$Y$$$20240705$$HP$US$US
237125642$23712564$2$F$20200101$20240713$20240405$20240718$EXP$$US-AMGEN-USASP2024065766$AMGEN$$71$YR$E$F$Y$$$20240718$$CN$US$US
237125825$23712582$5$F$20240330$20240909$20240405$20240912$EXP$$GR-PFIZER INC-PV202400043148$PFIZER$$10$YR$$F$Y$$$20240912$$CN$GR$GR
237126203$23712620$3$F$20240401$20240731$20240405$20240802$PER$$US-AMGEN-USASP2024066736$AMGEN$$43$YR$A$F$Y$$$20240802$$CN$US$US
237126254$23712625$4$F$$20240718$20240405$20240722$PER$$NVSC2024US072820$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
237126413$23712641$3$F$$20240708$20240405$20240710$PER$$US-PFIZER INC-202400074928$PFIZER$$66$YR$$F$Y$$$20240710$$CN$US$US
237126423$23712642$3$F$$20240711$20240405$20240715$PER$$NVSC2024US072845$NOVARTIS$$$$$M$Y$$$20240715$$CN$US$US
237126722$23712672$2$F$$20240820$20240405$20240829$PER$$US-MYLANLABS-2024M1026439$MYLAN$$$$$M$Y$78.01$KG$20240829$$CN$US$US
237126954$23712695$4$F$$20240812$20240405$20240819$EXP$$US-TAKEDA-2024TUS032247$TAKEDA$$$$$F$Y$72$KG$20240819$$HP$US$US
237127225$23712722$5$F$20240327$20240704$20240405$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054435$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240704$$CN$US$US
237127442$23712744$2$F$20230913$20240926$20240405$20240930$EXP$$JP-BAYER-2024A048498$BAYER$$14$YR$T$M$Y$57.4$KG$20240930$$MD$JP$JP
237127453$23712745$3$F$20240405$20240730$20240405$20240805$PER$$US-BIOGEN-2024BI01258461$BIOGEN$$69$YR$$F$Y$$$20240805$$CN$US$US
237127833$23712783$3$F$20240329$20240627$20240405$20240701$PER$$US-AMGEN-USASP2024066282$AMGEN$$75$YR$E$F$Y$$$20240701$$CN$US$US
237128044$23712804$4$F$20240212$20240805$20240405$20240911$PER$$US-Eisai-EC-2024-161012$EISAI$$80$YR$E$F$Y$$$20240911$$HP$US$US
237128224$23712822$4$F$20240402$20240813$20240405$20240814$PER$$US-AMGEN-USASP2024068325$AMGEN$$74$YR$E$M$Y$$$20240814$$PH$US$US
237128662$23712866$2$F$$20240813$20240405$20240819$EXP$$IN-PFIZER INC-PV202300178313$PFIZER$$65$YR$$F$Y$$$20240819$$CN$IN$IN
237128862$23712886$2$F$$20240208$20240405$20240710$PER$$GB-ROCHE-3508099$ROCHE$$$$$$Y$$$20240701$$MD$GB$GB
237128934$23712893$4$F$$20240829$20240405$20240903$EXP$$US-PFIZER INC-202400078394$PFIZER$Bhopalwala, H.. ANABOLIC STEROID-INDUCED CARDIOMYOPATHY IN MIDDLE AGE: A CASE REPORT AND LITERATURE REVIEW. Journal of the American College of Cardiology. 2024;83 (13 Suppl):2968$44$YR$$M$Y$$$20240903$$MD$US$US
237129082$23712908$2$F$20240101$20240626$20240405$20240705$PER$$US-Eisai-EC-2024-157097$EISAI$$59$YR$A$F$Y$$$20240705$$CN$US$US
237129269$23712926$9$F$20240301$20240626$20240405$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008495$UNITED THERAPEUTICS$$29$YR$$F$Y$$$20240705$$$US$US
237129863$23712986$3$F$$20240813$20240405$20240821$EXP$$US-BIOGEN-2024BI01258598$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
237130173$23713017$3$F$$20240913$20240405$20240923$EXP$$JP-TEVA-VS-3178475$TEVA$Akihiko Nakaya, Kimihiko Kaneko, Arifumi Matsumoto, Yuki Matsumoto, Yasuhiko Matsumori, Isao Nagano. Reversible cerebral vasoconstriction syndrome developed during treatment of Parkinsons disease with rasagiline mesylate: A case report. Journal: Cephalalgia Reports. 2024, Vol 7; Nakaya A, MatsumoriY. A case of reversible cerebral vaso-constriction syndrome during oral intake of rasagiline mesylate. Pages: 459 ?? ??Akihiko Nakaya, Kimihiko Kaneko, Arifumi Matsumoto, Yuki Matsumoto, Yasuhiko Ma...$59$YR$$F$Y$$$20240923$$HP$JP$JP
237130552$23713055$2$F$$20240712$20240405$20240720$30DAY$$EG-SANDOZ INC.-SDZ2024EG035736$SANDOZ$$$$$M$Y$$$20240720$$CN$EG$EG
237130843$23713084$3$F$20240305$20240722$20240405$20240822$PER$$US-Eisai-EC-2024-162700$EISAI$$67$YR$E$M$Y$103.2$KG$20240822$$HP$US$US
237130902$23713090$2$F$$20240730$20240405$20240801$PER$$NVSC2024US073261$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
237130923$23713092$3$F$$20240702$20240405$20240705$EXP$$CA-OTSUKA-2024_009087$OTSUKA$$$$$M$Y$$$20240705$$MD$CA$CA
237131293$23713129$3$F$20240327$20240715$20240405$20240812$PER$$US-Eisai-EC-2024-162732$EISAI$$82$YR$E$F$Y$$$20240812$$CN$US$US
237131403$23713140$3$F$20240101$20240716$20240405$20240723$EXP$$US-SA-2024SA105086$SANOFI AVENTIS$$81$YR$E$F$Y$67.1$KG$20240723$$CN$US$US
237131472$23713147$2$F$20240101$20240823$20240405$20240829$PER$$US-BIOGEN-2024BI01251688$BIOGEN$$$$$M$Y$$$20240829$$CN$US$US
237131552$23713155$2$F$$20240716$20240405$20240723$PER$$US-MYLANLABS-2024M1026515$MYLAN$$$$$M$Y$83.91$KG$20240723$$CN$US$US
237131902$23713190$2$F$20240301$20240719$20240405$20240726$EXP$$JP-AstraZeneca-2024A078503$ASTRAZENECA$$50$YR$$M$Y$$$20240726$$MD$JP$
237132183$23713218$3$F$20210101$20240812$20240405$20240814$EXP$$BE-JNJFOC-20240377723$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240814$$MD$BE$BE
237132292$23713229$2$F$20240404$20240731$20240405$20240805$PER$$US-AMGEN-USASP2024069187$AMGEN$$71$YR$E$F$Y$$$20240805$$CN$US$US
237132436$23713243$6$F$20240330$20240903$20240405$20240912$EXP$$RU-AstraZeneca-2024A080997$ASTRAZENECA$$$$C$F$Y$$$20240912$$MD$RU$
237132685$23713268$5$F$20231019$20240725$20240405$20240801$EXP$$US-SA-2024SA104630$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240801$$MD$US$US
237132802$23713280$2$F$20231122$20240924$20240405$20240927$EXP$$KR-JNJFOC-20231238423$JOHNSON AND JOHNSON$$75$YR$E$M$Y$55.6$KG$20240927$$MD$KR$KR
237132823$23713282$3$F$$20240905$20240405$20240911$EXP$$CA-PURDUE-USA-2024-0308770$PURDUE$$40$YR$$F$Y$$$20240911$$HP$CA$CA
237132843$23713284$3$F$20240101$20240923$20240405$20240926$PER$$US-PFIZER INC-PV202400043861$PFIZER$$55$YR$$F$Y$$$20240926$$HP$US$US
237133072$23713307$2$F$$20240619$20240405$20240701$EXP$$CA-CARA THERAPEUTICS, INC.-2024-00190-CA$CARA THERAPEUTICS$$$$E$M$Y$$$20240701$$MD$CA$CA
237133163$23713316$3$F$$20240920$20240405$20240923$PER$$US-PFIZER INC-202400076931$PFIZER$$61$YR$$M$Y$$$20240923$$HP$US$US
237133393$23713339$3$F$$20240702$20240405$20240705$EXP$$US-TAKEDA-2024TUS032139$TAKEDA$$$$$M$Y$$$20240705$$MD$US$US
237133482$23713348$2$F$$20240729$20240405$20240731$PER$$US-PFIZER INC-PV202400044373$PFIZER$$62$YR$$M$Y$$$20240731$$CN$US$US
237133512$23713351$2$F$20240301$20240823$20240405$20240828$PER$$US-PFIZER INC-202400077829$PFIZER$$66$YR$$F$Y$$$20240828$$HP$US$US
237133532$23713353$2$F$20240101$20240730$20240405$20240731$EXP$$US-PFIZER INC-PV202400044486$PFIZER$$21$YR$$M$Y$$$20240731$$HP$US$US
237133543$23713354$3$F$$20240627$20240405$20240702$PER$$US-PFIZER INC-PV202400043031$PFIZER$$82$YR$$F$Y$$$20240702$$CN$US$US
237134052$23713405$2$F$20190101$20240711$20240405$20240715$EXP$$US-PFIZER INC-202400078786$PFIZER$$81$YR$$M$Y$$$20240715$$HP$US$US
237134117$23713411$7$F$20240327$20240628$20240405$20240701$PER$$US-PFIZER INC-202400077716$PFIZER$$79$YR$$M$Y$78.1$KG$20240701$$PH$US$US
237134242$23713424$2$F$$20240624$20240405$20240702$PER$$US-ALXN-202404USA000063US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
237134625$23713462$5$F$$20240822$20240405$20240822$EXP$$PK-PFIZER INC-PV202300204384$PFIZER$$36$YR$$M$Y$44$KG$20240822$$CN$PK$PK
237134923$23713492$3$F$20240212$20240806$20240405$20240814$PER$$JP-Eisai-EC-2024-163037$EISAI$$75$YR$E$M$Y$50$KG$20240814$$MD$JP$JP
237135102$23713510$2$F$20240101$20240807$20240405$20240904$PER$$US-Eisai-EC-2024-162154$EISAI$$71$YR$E$M$Y$$$20240904$$CN$US$US
237135252$23713525$2$F$20240101$20240827$20240405$20240909$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-01066$IPSEN$$91$YR$E$F$Y$$$20240909$$CN$CA$CA
237135292$23713529$2$F$20240315$20240522$20240405$20240705$PER$$US-Eisai-EC-2024-162315$EISAI$$57$YR$$M$Y$$$20240705$$CN$US$US
237135585$23713558$5$F$$20240716$20240405$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052918$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240719$$CN$US$US
237135844$23713584$4$F$20220801$20240509$20240405$20240816$EXP$$BR-SANDOZ INC.-NVSC2022BR178516$SANDOZ$$55$YR$$F$Y$51$KG$20240816$$CN$BR$BR
237135922$23713592$2$F$$20240805$20240405$20240813$EXP$$US-TAKEDA-2023TUS124722$TAKEDA$$$$$M$Y$$$20240813$$CN$US$US
237136122$23713612$2$F$$20240827$20240405$20240829$EXP$$CA-PFIZER INC-202400076411$PFIZER$$69$YR$$F$Y$$$20240829$$HP$CA$CA
237136664$23713666$4$F$$20240830$20240405$20240902$PER$$NVSC2024US073332$NOVARTIS$$$$$$Y$$$20240902$$HP$US$US
237137573$23713757$3$F$$20240828$20240405$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA036117$SANDOZ$$39$YR$$M$Y$$$20240830$$HP$CA$CA
237138063$23713806$3$F$20240301$20240905$20240405$20240911$EXP$$US-ABBVIE-5672096$ABBVIE$$62$YR$$F$Y$117.93$KG$20240911$$CN$US$US
237138083$23713808$3$F$$20240715$20240405$20240717$30DAY$$US-SANDOZ INC.-SDZ2024US035686$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
237138102$23713810$2$F$$20240718$20240405$20240722$30DAY$$CA-SANDOZ INC.-SDZ2023CA072141$SANDOZ$$$$$M$Y$$$20240722$$CN$CA$CA
237138612$23713861$2$F$$20240821$20240405$20240911$EXP$$CA-ASTELLAS-2024US009733$ASTELLAS$$40$YR$A$F$Y$$$20240911$$HP$CA$CA
237138712$23713871$2$F$$20240925$20240405$20240926$EXP$$CA-PFIZER INC-202400078925$PFIZER$$56$YR$$F$Y$$$20240926$$CN$CA$CA
237139665$23713966$5$F$20240402$20240626$20240405$20240710$EXP$$CA-HLS-202400905$HLS THERAPEUTICS$$64$YR$A$M$Y$$$20240710$$CN$CA$CA
237139773$23713977$3$F$20231120$20240801$20240405$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042995$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$62$KG$20240807$$MD$JP$JP
237139782$23713978$2$F$20231201$20240708$20240405$20240716$EXP$DE-DCGMA-24202985$DE-INCYTE CORPORATION-2024IN003243$INCYTE$$$$$$Y$$$20240716$$MD$DE$DE
237139925$23713992$5$F$20240325$20240809$20240405$20240815$EXP$$US-GILEAD-2024-0668264$GILEAD$$64$YR$A$F$Y$$$20240815$$MD$US$US
237140472$23714047$2$F$$20240813$20240405$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054392$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240814$$CN$US$US
237141213$23714121$3$F$20231001$20240710$20240405$20240718$PER$$US-SA-2024SA101934$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240718$$MD$US$US
237141313$23714131$3$F$$20240724$20240405$20240802$PER$$US-SA-2024SA099279$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240802$$MD$US$US
237141363$23714136$3$F$20240101$20240726$20240405$20240807$PER$$US-SA-2024SA098935$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240807$$MD$US$US
237141372$23714137$2$F$$20240716$20240405$20240724$PER$$US-SA-2024SA097923$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$MD$US$US
237141582$23714158$2$F$20221201$20240715$20240405$20240723$PER$$US-SA-2024SA100596$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240723$$MD$US$US
237141733$23714173$3$F$20240601$20240723$20240405$20240731$PER$$US-SA-2024SA101115$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240731$$MD$US$US
237141752$23714175$2$F$20240101$20240904$20240405$20240915$PER$$US-SA-2024SA100961$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240915$$MD$US$US
237141852$23714185$2$F$$20240703$20240405$20240712$PER$$US-SA-2024SA099306$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240712$$MD$US$US
237141943$23714194$3$F$20240101$20240724$20240405$20240802$PER$$US-SA-2024SA101164$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240802$$MD$US$US
237141973$23714197$3$F$$20240724$20240405$20240729$PER$$US-SA-2024SA100759$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240729$$MD$US$US
237142002$23714200$2$F$20240101$20240709$20240405$20240717$PER$$US-SA-2024SA102612$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240717$$MD$US$US
237142092$23714209$2$F$20240718$20240718$20240405$20240729$PER$$US-SA-2024SA102454$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240729$$MD$US$US
237142104$23714210$4$F$20231201$20240904$20240405$20240913$PER$$US-SA-2024SA102564$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240913$$CN$US$US
237142212$23714221$2$F$$20240821$20240405$20240910$PER$$US-SA-2024SA100996$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240910$$MD$US$US
237142303$23714230$3$F$20240101$20240705$20240405$20240715$PER$$US-SA-2023SA387745$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240715$$MD$US$US
237142382$23714238$2$F$20240101$20240903$20240405$20240928$PER$$US-SA-2024SA102899$SANOFI AVENTIS$$60$YR$A$F$Y$74.83$KG$20240928$$MD$US$US
237142482$23714248$2$F$20230101$20240703$20240405$20240711$PER$$US-SA-2024SA104011$SANOFI AVENTIS$$53$YR$A$M$Y$101$KG$20240711$$MD$US$US
237142663$23714266$3$F$20240101$20240711$20240405$20240716$PER$$US-SA-2024SA103958$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240716$$MD$US$US
237142683$23714268$3$F$$20240820$20240405$20240826$PER$$US-SA-2024SA104182$SANOFI AVENTIS$$$$C$M$Y$$$20240826$$MD$US$US
237142762$23714276$2$F$20240101$20240715$20240405$20240724$PER$$US-SA-2024SA103328$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240724$$MD$US$US
237143252$23714325$2$F$$20240702$20240405$20240704$EXP$$CA-ABBVIE-5707742$ABBVIE$$$$E$M$Y$$$20240704$$HP$CA$CA
237143352$23714335$2$F$20240325$20240920$20240405$20240930$EXP$$JP-ROCHE-3537716$ROCHE$$58$YR$A$M$Y$$$20240930$$PH$JP$JP
237144332$23714433$2$F$$20240708$20240406$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-015223$AUROBINDO$Preston H,Cannon E, Watson S. Plasma exchange for the management of digoxin toxicity in an individual with an acute kidney injury: A case report. J R Coll Physicians Edinb. 2024;54(1):55-58$80$YR$$M$Y$$$20240718$$HP$GB$GB
237144502$23714450$2$F$20240404$20240809$20240406$20240812$PER$$US-AMGEN-USASP2024069557$AMGEN$$73$YR$E$F$Y$$$20240812$$CN$US$US
237144732$23714473$2$F$20240401$20240718$20240406$20240723$PER$$US-AMGEN-USASP2024067723$AMGEN$$59$YR$A$M$Y$$$20240723$$CN$US$US
237144932$23714493$2$F$20240101$20240806$20240406$20240814$EXP$$US-ABBVIE-5707325$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
237145132$23714513$2$F$20240401$20240724$20240406$20240726$PER$$US-AMGEN-USASP2024067715$AMGEN$$41$YR$A$M$Y$$$20240726$$CN$US$US
237145402$23714540$2$F$20240120$20240702$20240406$20240711$EXP$$US-ABBVIE-5704709$ABBVIE$$69$YR$$F$Y$$$20240711$$CN$US$US
237145443$23714544$3$F$20240328$20240828$20240406$20240829$PER$$US-AMGEN-USASP2024068584$AMGEN$$85$YR$E$F$Y$$$20240829$$CN$US$US
237145532$23714553$2$F$$20240812$20240406$20240821$PER$$US-SA-2024SA103304$SANOFI AVENTIS$$$$A$F$Y$54.4$KG$20240821$$MD$US$US
237145622$23714562$2$F$$20240715$20240406$20240718$EXP$$FR-AUROBINDO-AUR-APL-2022-003848$AUROBINDO$Sastre, C, Baillif-Couniou . V., Fabresse. N.,  Ameline . A., Kintz.l P., Allorge. D., et.al. Multiple drugs: Fatal respiratory depression following polysubstance abuse: 3 case reports.. 2021;1849$34$YR$$M$Y$$$20240718$$MD$FR$FR
237145743$23714574$3$F$20230623$20240807$20240406$20240814$EXP$$CZ-CELLTRION INC.-2024CZ007870$CELLTRION$$$$$$Y$$$20240814$$MD$CZ$CZ
237145952$23714595$2$F$20240101$20240916$20240406$20240917$PER$$US-AMGEN-USASP2024067197$AMGEN$$80$YR$E$F$Y$$$20240917$$CN$US$US
237146112$23714611$2$F$$20240704$20240406$20240708$30DAY$$US-SANDOZ INC.-SDZ2023US076127$SANDOZ$$$$$M$Y$$$20240708$$CN$US$US
237146303$23714630$3$F$20230601$20240827$20240406$20240902$EXP$$US-ABBVIE-5311821$ABBVIE$$64$YR$$F$Y$$$20240902$$CN$US$US
237146342$23714634$2$F$20240101$20240830$20240406$20240924$PER$$US-SA-2024SA103534$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240924$$MD$US$US
237146813$23714681$3$F$20240220$20240906$20240406$20240911$EXP$$FR-AUROBINDO-AUR-APL-2024-015279$AUROBINDO$$18$YR$$F$Y$55$KG$20240911$$MD$FR$FR
237147012$23714701$2$F$20240402$20240726$20240406$20240730$PER$$US-AMGEN-USASP2024068682$AMGEN$$76$YR$E$F$Y$$$20240730$$CN$US$US
237147063$23714706$3$F$$20240826$20240406$20240830$EXP$$US-ALXN-202404USA000009US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
237147172$23714717$2$F$20240404$20240725$20240406$20240725$PER$$US-AMGEN-USASP2024069520$AMGEN$$82$YR$E$F$Y$$$20240725$$CN$US$US
237147422$23714742$2$F$20231201$20240717$20240406$20240725$EXP$$ES-TEVA-VS-3179375$TEVA$$37$YR$$M$Y$$$20240725$$HP$ES$ES
237147722$23714772$2$F$20210101$20240730$20240406$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-015305$AUROBINDO$$31$YR$$F$Y$$$20240808$$PH$FR$FR
237147753$23714775$3$F$20240402$20240827$20240406$20240829$PER$$US-AMGEN-USASP2024067664$AMGEN$$74$YR$E$F$Y$$$20240829$$MD$US$US
237147774$23714777$4$F$20240101$20240718$20240406$20240722$EXP$$US-UCBSA-2024016010$UCB$$$$$F$Y$90.7$KG$20240722$$CN$US$US
237147863$23714786$3$F$20240108$20240712$20240406$20240720$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-000439$JAZZ$$52$YR$$F$Y$$$20240720$$CN$US$US
237147882$23714788$2$F$20240907$20240912$20240406$20240914$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-008927$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240914$$CN$CA$CA
237147932$23714793$2$F$20230901$20240828$20240406$20240907$EXP$$FR-AUROBINDO-AUR-APL-2024-015287$AUROBINDO$$78$YR$$M$Y$69$KG$20240907$$MD$FR$FR
237148042$23714804$2$F$20240328$20240812$20240406$20240820$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-10259$SAMSUNG BIOEPIS$$58$YR$A$M$Y$$$20240820$$CN$CA$CA
237148082$23714808$2$F$20231116$20240624$20240406$20240702$EXP$$DE-AUROBINDO-AUR-APL-2024-015331$AUROBINDO$$$$A$F$Y$114$KG$20240702$$MD$DE$DE
237148223$23714822$3$F$$20240812$20240406$20240823$EXP$$US-Accord-417016$ACCORD$Gibbens Y, Lake J, Lim N. A Rare Cause of Acute Liver Failure. Gastroenterology. 2024:e1-e4. DOI: 10.1053/j.gastro.2024.01.048$42$YR$A$M$Y$89.4$KG$20240823$$MD$US$US
237148434$23714843$4$F$$20240712$20240406$20240718$EXP$$NVSC2024ZA058164$NOVARTIS$$54$YR$$F$Y$$$20240718$$CN$ZA$ZA
237148602$23714860$2$F$$20240916$20240406$20240919$EXP$$US-ABBVIE-5672516$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
237149092$23714909$2$F$20240101$20240913$20240406$20240923$EXP$$CA-CELLTRION INC.-2023CA017394$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
237149302$23714930$2$F$$20240819$20240406$20240826$EXP$$US-ABBVIE-5637878$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
237149405$23714940$5$F$20170801$20240620$20240406$20240708$EXP$$CA-JNJFOC-20240413039$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240708$$MD$CA$CA
237149484$23714948$4$F$20240101$20240807$20240406$20240814$EXP$$US-ABBVIE-5623507$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
237149492$23714949$2$F$20240401$20240807$20240406$20240808$PER$$US-AMGEN-USASP2024067518$AMGEN$$69$YR$E$M$Y$$$20240808$$CN$US$US
237149684$23714968$4$F$20240101$20240704$20240406$20240713$EXP$$CA-CELLTRION INC.-2024CA006088$CELLTRION$$$$$$Y$$$20240713$$HP$CA$CA
237149762$23714976$2$F$20240310$20240820$20240406$20240822$PER$$US-AMGEN-USASP2024069252$AMGEN$$61$YR$A$M$Y$$$20240822$$CN$US$US
237149955$23714995$5$F$20240312$20240902$20240406$20240909$30DAY$$FR-JNJFOC-20240340842$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240910$$PH$FR$FR
237150024$23715002$4$F$20240313$20240911$20240406$20240918$30DAY$$CA-JNJFOC-20240348024$JOHNSON AND JOHNSON$$95$YR$E$M$Y$$$20240919$$HP$CA$CA
237150232$23715023$2$F$$20240812$20240406$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-015292$AUROBINDO$St-Denis A, Hooker M, L^Abbee Lacas K, Corriveau I, Pirmoradi M, Simard-Tremblay E, et al. Awake Craniotomy Language Mapping in Children With Drug-Resistant Epilepsy due to Focal Cortical Dysplasia. Pediatr-Neurol. 2023;14:439-43$$$$F$Y$$$20240826$$HP$CA$CA
237150332$23715033$2$F$$20240326$20240406$20240807$PER$$US-AstraZeneca-2024A073945$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
237150762$23715076$2$F$20240206$20240724$20240406$20240729$EXP$$US-UCBSA-2024016170$UCB$$32$YR$$F$Y$$$20240729$$CN$US$US
237151283$23715128$3$F$20240401$20240719$20240407$20240723$PER$$US-AMGEN-USASP2024068736$AMGEN$$75$YR$E$F$Y$$$20240723$$CN$US$US
237151442$23715144$2$F$20240101$20240819$20240407$20240828$PER$$US-SA-2024SA104454$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240828$$MD$US$US
237151572$23715157$2$F$$20240626$20240407$20240703$EXP$$CA-SANDOZ INC.-SDZ2024CA021552$SANDOZ$$44$YR$$F$Y$97$KG$20240703$$MD$CA$CA
237152165$23715216$5$F$$20240718$20240407$20240722$EXP$$AT-ROCHE-3535793$ROCHE$$$$A$M$Y$$$20240722$$MD$AT$AT
237152822$23715282$2$F$$20240327$20240407$20240806$PER$$US-AstraZeneca-2024A075365$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
237153274$23715327$4$F$20240101$20240905$20240407$20240917$PER$$US-SA-2024SA103625$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240917$$MD$US$US
237153442$23715344$2$F$20240315$20240903$20240407$20240913$PER$$US-SA-2024SA104622$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240913$$MD$US$US
237153702$23715370$2$F$$20240709$20240407$20240710$EXP$$US-JNJFOC-20240405941$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
237153804$23715380$4$F$$20240626$20240407$20240703$EXP$$NVSC2024AU071709$NOVARTIS$$$$$F$Y$$$20240703$$HP$AU$AU
237153874$23715387$4$F$20240322$20240702$20240407$20240704$EXP$$CA-ABBVIE-5705717$ABBVIE$$66$YR$$M$Y$106.8$KG$20240704$$MD$CA$CA
237153904$23715390$4$F$$20240904$20240407$20240911$PER$$US-BIOGEN-2024BI01258143$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
237154422$23715442$2$F$20240325$20240725$20240407$20240729$EXP$$JP-TAKEDA-2024TJP004939$TAKEDA$$54$YR$$M$Y$$$20240729$$MD$JP$JP
237154912$23715491$2$F$20231101$20240905$20240407$20240912$EXP$$US-ABBVIE-5706867$ABBVIE$$65$YR$$F$Y$$$20240912$$CN$US$US
237154933$23715493$3$F$$20240726$20240407$20240805$30DAY$$US-GSK-US2024AMR041833$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
237154952$23715495$2$F$20230914$20240709$20240407$20240710$EXP$$US-JNJFOC-20240388903$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240710$$CN$US$US
237155012$23715501$2$F$20240101$20240627$20240407$20240703$EXP$$US-ABBVIE-5593595$ABBVIE$$70$YR$$M$Y$$$20240703$$CN$US$US
237155492$23715549$2$F$20230313$20240903$20240408$20240905$EXP$$US-ABBVIE-5704447$ABBVIE$$54$YR$$F$Y$$$20240905$$CN$US$US
237155642$23715564$2$F$$20240702$20240408$20240709$PER$$US-JNJFOC-20240387475$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$101.24$KG$20240709$$HP$US$US
237155792$23715579$2$F$20240225$20240703$20240408$20240703$EXP$$PK-BRISTOL-MYERS SQUIBB COMPANY-2024-051936$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$PH$PK$PK
237155923$23715592$3$F$$20240704$20240408$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-054357$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240704$$MD$JP$JP
237155955$23715595$5$F$20240215$20240827$20240408$20240903$EXP$$US-ABBVIE-5708206$ABBVIE$$42$YR$$F$Y$$$20240903$$CN$US$US
237156012$23715601$2$F$$20240902$20240408$20240916$EXP$CA-ALLERGAN-2004287US$CA-ABBVIE-2004287US$ABBVIE$$$$$$Y$$$20240916$$HP$CA$CA
237156053$23715605$3$F$20240401$20240708$20240408$20240709$EXP$$JP-TAKEDA-2024TJP004900$TAKEDA$$$$$M$Y$$$20240709$$MD$JP$JP
237156179$23715617$9$F$20231117$20240704$20240408$20240717$EXP$$CA-BEH-2023165835$CSL BEHRING$$64$YR$A$F$Y$60$KG$20240717$$MD$CA$CA
237156264$23715626$4$F$20231201$20240705$20240408$20240716$PER$$US-SA-2024SA102262$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240716$$MD$US$US
237156332$23715633$2$F$20240311$20240711$20240408$20240716$EXP$$US-AMGEN-USASP2024066534$AMGEN$$81$YR$E$F$Y$$$20240715$$CN$US$US
237156372$23715637$2$F$20240101$20240828$20240408$20240903$EXP$$US-ABBVIE-5708309$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
237156413$23715641$3$F$20240501$20240703$20240408$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019620$JAZZ$$45$YR$$F$Y$89.628$KG$20240710$$CN$US$US
237156443$23715644$3$F$20240301$20240620$20240408$20240710$PER$$CA-TOLMAR, INC.-24CA047647$TOLMAR$$87$YR$$M$Y$$$20240710$$CN$CA$CA
237156573$23715657$3$F$20240601$20240828$20240408$20240916$PER$$CA-TOLMAR, INC.-24CA047717$TOLMAR$$79$YR$$M$Y$$$20240916$$CN$CA$CA
237156803$23715680$3$F$$20240624$20240408$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001237$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
237157632$23715763$2$F$20240404$20240718$20240408$20240722$PER$$US-AMGEN-USASP2024069967$AMGEN$$69$YR$E$F$Y$$$20240722$$CN$US$US
237159063$23715906$3$F$$20240417$20240408$20240806$PER$$US-AstraZeneca-2024A066242$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
237159152$23715915$2$F$$20240729$20240408$20240806$PER$$US-SA-2024SA104311$SANOFI AVENTIS$$7$YR$C$F$Y$26.762$KG$20240806$$MD$US$US
237159332$23715933$2$F$20240114$20240821$20240408$20240823$EXP$$AT-ABBVIE-5708815$ABBVIE$$27$YR$$M$Y$98$KG$20240823$$MD$AT$AT
237159772$23715977$2$F$20240328$20240731$20240408$20240802$PER$$US-AMGEN-USASP2024068140$AMGEN$$56$YR$A$F$Y$$$20240802$$CN$US$US
237159952$23715995$2$F$$20240628$20240408$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02739$LUPIN$$$$$$Y$$$20240715$$CN$US$US
237160382$23716038$2$F$$20240918$20240408$20240925$EXP$$CA-TAKEDA-2024TUS032301$TAKEDA$$$$$M$Y$$$20240925$$CN$CA$CA
237160672$23716067$2$F$$20240628$20240408$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02736$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237160802$23716080$2$F$$20240701$20240408$20240703$EXP$$JP-ABBVIE-5630107$ABBVIE$$40$YR$$M$Y$$$20240703$$MD$JP$JP
237160883$23716088$3$F$$20240628$20240408$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02801$LUPIN$$$$$$Y$$$20240715$$CN$US$US
237160936$23716093$6$F$$20240813$20240408$20240821$EXP$$RO-JNJFOC-20240414512$JOHNSON AND JOHNSON$$73$YR$E$F$Y$90$KG$20240821$$CN$RO$RO
237161004$23716100$4$F$$20240322$20240408$20240710$PER$$FR-ROCHE-3533459$ROCHE$$$$$$Y$$$20240628$$MD$FR$FR
237161242$23716124$2$F$20240401$20240626$20240408$20240701$EXP$$IT-ABBVIE-5708957$ABBVIE$$73$YR$$F$Y$$$20240701$$CN$IT$IT
237161334$23716133$4$F$$20240627$20240408$20240701$EXP$$US-BIOGEN-2024BI01258603$BIOGEN$$$$$F$Y$$$20240701$$CN$US$US
237161523$23716152$3$F$$20240628$20240408$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02819$LUPIN$$$$$$Y$$$20240715$$CN$US$US
237161553$23716155$3$F$$20240711$20240408$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02806$LUPIN$$$$$$Y$$$20240807$$PH$US$US
237161633$23716163$3$F$$20240628$20240408$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02793$LUPIN$$$$$$Y$$$20240718$$PH$US$US
237161832$23716183$2$F$20240301$20240717$20240408$20240726$PER$$US-SA-2024SA101950$SANOFI AVENTIS$$4$YR$C$M$Y$16$KG$20240726$$MD$US$US
237161843$23716184$3$F$$20240628$20240408$20240711$PER$$US-SA-2024SA102590$SANOFI AVENTIS$$$$A$F$Y$72.562$KG$20240711$$MD$US$US
237162022$23716202$2$F$20240601$20240716$20240408$20240724$PER$$US-SA-2024SA102562$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240724$$MD$US$US
237162042$23716204$2$F$$20240909$20240408$20240927$PER$$US-SA-2024SA105098$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240927$$CN$US$US
237162562$23716256$2$F$$20240628$20240408$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02792$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237162612$23716261$2$F$20240608$20240625$20240408$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001208$ACADIA PHARMACEUTICALS$$86$YR$$F$Y$$$20240719$$CN$US$US
237162802$23716280$2$F$$20240924$20240408$20240927$EXP$$CA-JNJFOC-20240416946$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20240927$$HP$CA$CA
237162882$23716288$2$F$20240214$20240829$20240408$20240906$EXP$FR-AFSSAPS-BX2024000444$FR-TEVA-VS-3176416$TEVA$$78$YR$$F$Y$82$KG$20240906$$MD$FR$FR
237162907$23716290$7$F$20240319$20240710$20240408$20240718$EXP$$GR-BRISTOL-MYERS SQUIBB COMPANY-2024-051918$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$65.5$KG$20240718$$HP$GR$GR
237162953$23716295$3$F$20181021$20240904$20240408$20240906$PER$$US-GILEAD-2024-0668443$GILEAD$$55$YR$A$M$Y$$$20240906$$LW$US$US
237163094$23716309$4$F$20240201$20240719$20240408$20240725$EXP$$US-BEH-2024170298$CSL BEHRING$$44$YR$A$F$Y$$$20240725$$HP$US$US
237163142$23716314$2$F$20240101$20240628$20240408$20240705$EXP$$US-ABBVIE-5708572$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
237163244$23716324$4$F$$20240717$20240408$20240720$EXP$$CA-SANDOZ INC.-NVSC2023CA089097$SANDOZ$$62$YR$$M$Y$$$20240720$$HP$CA$CA
237163474$23716347$4$F$$20240823$20240408$20240829$EXP$$US-TAKEDA-2024TUS016203$TAKEDA$$$$$F$Y$$$20240829$$MD$US$US
237163982$23716398$2$F$$20240828$20240408$20240831$EXP$$CA-SANDOZ INC.-SDZ2024CA036643$SANDOZ$$37$YR$$M$Y$$$20240831$$HP$CA$CA
237164283$23716428$3$F$20240301$20240628$20240408$20240712$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-02734$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237164313$23716431$3$F$20180101$20240722$20240408$20240723$PER$$US-GILEAD-2024-0668454$GILEAD$$48$YR$A$F$Y$$$20240723$$LW$US$US
237164483$23716448$3$F$$20240628$20240408$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02827$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237165192$23716519$2$F$20220905$20240719$20240408$20240729$EXP$$CA-SA-2024SA103683$SANOFI AVENTIS$$70$YR$E$M$Y$62$KG$20240729$$HP$CA$CA
237165272$23716527$2$F$20240317$20240911$20240408$20240913$EXP$FR-AFSSAPS-AN2024000477$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-054487$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240913$$MD$FR$FR
237165283$23716528$3$F$20240614$20240827$20240408$20240829$EXP$$CA-TAKEDA-2024TUS030101$TAKEDA$$58$YR$$F$Y$$$20240829$$HP$CA$CA
237165477$23716547$7$F$20240205$20240815$20240408$20240819$EXP$$US-BIOVITRUM-CTI2024US04555$BIOVITRUM$$71$YR$$F$Y$$$20240819$$CN$US$US
237165753$23716575$3$F$20200831$20240826$20240408$20240904$EXP$$JP-TAKEDA-2024TUS032040$TAKEDA$$7$DEC$$M$Y$$$20240904$$MD$JP$JP
237166214$23716621$4$F$$20240917$20240408$20240923$EXP$CA-ABBVIE-5703783$CA-ABBVIE-5703783$ABBVIE$$43$YR$$F$Y$96$KG$20240923$$HP$CA$CA
237166502$23716650$2$F$20230323$20240716$20240408$20240725$EXP$$BR-CELLTRION INC.-2023BR011340$CELLTRION$$$$$$Y$$$20240725$$CN$BR$BR
237166552$23716655$2$F$$20240829$20240408$20240902$EXP$$GB-SANDOZ INC.-SDZ2024GB036596$SANDOZ$$$$$M$Y$$$20240902$$CN$GB$GB
237166584$23716658$4$F$20240101$20240808$20240408$20240821$EXP$$US-UCBSA-2024016700$UCB$$$$$F$Y$$$20240821$$CN$US$US
237166672$23716667$2$F$20240229$20240731$20240408$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-015710$AUROBINDO$$18$YR$$F$Y$32.6$KG$20240813$$MD$FR$FR
237166753$23716675$3$F$$20240712$20240408$20240717$PER$$NVSC2024US073251$NOVARTIS$$$$$$Y$$$20240717$$CN$US$US
237166902$23716690$2$F$$20240820$20240408$20240826$EXP$$CA-Orion Corporation ORION PHARMA-TREX2024-0068$ORION$Baxter C, Martin E. Very severe hypertriglyceridemia complicating pediatric acute lymphoblastic leukemia treatment: a call for management guidelines. J Pediatr Endocrinol Metab. 2023 JUL 06;36(10):978-82.$7$YR$C$M$Y$$$20240826$$MD$CA$
237166977$23716697$7$F$$20240806$20240408$20240807$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-020431$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240807$$CN$US$US
237167442$23716744$2$F$20240301$20240725$20240408$20240808$EXP$$US-UCBSA-2024016583$UCB$$55$YR$$M$Y$$$20240808$$HP$US$US
237167682$23716768$2$F$$20240625$20240408$20240701$EXP$$DE-AMGEN-DEUSP2024066963$AMGEN$$72$YR$E$M$Y$$$20240701$$MD$DE$DE
237167733$23716773$3$F$$20240628$20240408$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02717$LUPIN$$$$$$Y$$$20240715$$CN$US$US
237167772$23716777$2$F$$20240628$20240408$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02729$LUPIN$$$$$$Y$$$20240715$$CN$US$US
237168178$23716817$8$F$$20240726$20240408$20240802$EXP$$CA-TAKEDA-2020TUS016710$TAKEDA$$$$$M$Y$$$20240802$$HP$CA$CA
237168203$23716820$3$F$$20240806$20240408$20240808$EXP$$GB-UCBSA-2024015777$UCB$Chou M, Lai L, Neveu M, Ritchie A. Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy. BMJ case reports.. 2024;17(3):1-5$$$T$M$Y$$$20240808$$HP$GB$GB
237168482$23716848$2$F$20240316$20240711$20240408$20240726$PER$$US-JNJFOC-20240357082$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240726$$CN$US$US
237168564$23716856$4$F$20240701$20240912$20240408$20240918$EXP$$NVSC2023MX078139$NOVARTIS$$85$YR$$M$Y$$$20240919$$CN$MX$MX
237168802$23716880$2$F$20090101$20240913$20240408$20240918$PER$$US-GILEAD-2024-0668457$GILEAD$$51$YR$A$M$Y$$$20240918$$LW$US$US
237168843$23716884$3$F$$20240716$20240408$20240724$EXP$$IN-ROCHE-3536539$ROCHE$$84$YR$E$M$Y$$$20240724$$CN$IN$IN
237168872$23716887$2$F$$20240703$20240408$20240709$PER$$NVSC2024US072638$NOVARTIS$$$$$F$Y$51.26$KG$20240709$$HP$US$US
237168976$23716897$6$F$$20240620$20240408$20240701$PER$$NVSC2024US073800$NOVARTIS$$37$YR$$$Y$$$20240701$$CN$US$US
237168983$23716898$3$F$$20240902$20240408$20240905$EXP$$NVSC2024GB072468$NOVARTIS$$$$A$M$Y$$$20240905$$CN$GB$GB
237169002$23716900$2$F$20240404$20240718$20240408$20240722$PER$$US-AMGEN-USASP2024070120$AMGEN$$84$YR$E$F$Y$$$20240722$$CN$US$US
237169124$23716912$4$F$$20240708$20240408$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054508$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240708$$CN$US$US
237169202$23716920$2$F$$20240815$20240408$20240822$EXP$$JP-009507513-2404JPN000282J$MERCK$Nanbu K, Yoshii N, Yamashita T, Matsui E, Ueno S, Sawa N, et al.. 257 A case of mesenteric metastasis of lung cancer with imaging findings similar to walled-off necrosis after pancreatitis. The 243rd Kinki Regional Meeting of the Japanese Society of Internal Medicine$63$YR$$M$Y$$$20240822$$MD$JP$JP
237169394$23716939$4$F$20240301$20240904$20240408$20240914$EXP$$US-TEVA-VS-3177139$TEVA$$34$YR$$F$Y$$$20240914$$CN$US$US
237169452$23716945$2$F$$20240628$20240408$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02882$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237169502$23716950$2$F$$20240913$20240408$20240919$EXP$$JP-ASTELLAS-2024JP002302$ASTELLAS$$82$YR$E$M$Y$$$20240919$$PH$JP$JP
237169662$23716966$2$F$$20240731$20240408$20240802$EXP$$JP-ASTELLAS-2024JP002261$ASTELLAS$$9$DEC$$F$Y$$$20240802$$PH$JP$JP
237169683$23716968$3$F$$20240627$20240408$20240701$PER$$US-ALXN-202404USA000060US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
237169783$23716978$3$F$$20240827$20240408$20240914$EXP$$US-SA-2024SA104291$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240914$$MD$US$US
237169912$23716991$2$F$$20240628$20240408$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02820$LUPIN$$$$$$Y$$$20240715$$CN$US$US
237169923$23716992$3$F$20240101$20240708$20240408$20240716$EXP$$CA-AstraZeneca-2024A081144$ASTRAZENECA$$80$YR$$M$Y$$$20240716$$CN$CA$
237169983$23716998$3$F$20230926$20240502$20240408$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003446$TG THERAPEUTICS$$51$YR$$F$Y$70$KG$20240715$$CN$US$US
237170082$23717008$2$F$$20240716$20240408$20240718$EXP$$US-JNJFOC-20240406705$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
237170473$23717047$3$F$20130121$20240621$20240408$20240701$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2023-10587$IPSEN$$75$YR$E$F$Y$$$20240701$$MD$JP$JP
237170662$23717066$2$F$20240101$20240725$20240408$20240808$PER$$US-CHATTEMPRD-2024OHG011339$CHATTEM$$83$YR$E$F$Y$74.84$KG$20240808$$CN$US$US
237171142$23717114$2$F$$20240628$20240408$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02740$LUPIN$$$$$$Y$$$20240715$$CN$US$US
237171242$23717124$2$F$20240301$20240808$20240408$20240812$EXP$$US-ABBVIE-5709621$ABBVIE$$67$YR$$M$Y$$$20240812$$CN$US$US
237171312$23717131$2$F$20240221$20240731$20240408$20240806$EXP$FR-AFSSAPS-PV2024000302$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-053434$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$60$KG$20240806$$MD$FR$FR
237171403$23717140$3$F$$20240627$20240408$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02783$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237171704$23717170$4$F$$20240821$20240408$20240920$EXP$$CA-ASTELLAS-2024US009708$ASTELLAS$$40$YR$A$F$Y$96$KG$20240920$$HP$CA$CA
237171764$23717176$4$F$20231212$20240712$20240408$20240720$EXP$$JP-AMGEN-JPNSP2024066702$AMGEN$$82$YR$E$M$Y$$$20240720$$MD$JP$JP
237171862$23717186$2$F$20230101$20240627$20240408$20240702$EXP$$US-ASTELLAS-2024US003238$ASTELLAS$$$$$M$Y$$$20240702$$CN$US$US
237172012$23717201$2$F$$20240716$20240408$20240716$EXP$$GB-JNJFOC-20240404692$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$GB$GB
237172322$23717232$2$F$20240101$20240626$20240408$20240705$PER$$US-SA-2024SA102611$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240705$$MD$US$US
237172683$23717268$3$F$$20240806$20240408$20240812$PER$$US-SA-2024SA101299$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240812$$MD$US$US
237172703$23717270$3$F$$20240626$20240408$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02835$LUPIN$$$$$$Y$$$20240711$$CN$US$US
237172892$23717289$2$F$$20240705$20240408$20240715$PER$$US-SA-2024SA101294$SANOFI AVENTIS$$64$YR$A$F$Y$45.35$KG$20240715$$MD$US$US
237172922$23717292$2$F$20240601$20240713$20240408$20240722$PER$$US-SA-2024SA102242$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240722$$MD$US$US
237172932$23717293$2$F$$20240703$20240408$20240712$PER$$US-SA-2024SA105169$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240712$$MD$US$US
237173182$23717318$2$F$$20240918$20240408$20240923$EXP$$US-CIPLA LTD.-2024US03131$CIPLA$Suffian H, Le T, Pandya A,. Complications post-chemotherapy in a child with T-cell leukemia and ataxia telangiectasia. Annals of Allergy, Asthma and Immunology. 2023;131(5))(Supp 1):S 156$$$$$Y$$$20240923$$MD$US$US
237173242$23717324$2$F$$20240916$20240408$20240925$EXP$CA-MHPD-E2B_06847225$CA-Accord-417113$ACCORD$$37$YR$A$M$Y$$$20240925$$MD$CA$CA
237173492$23717349$2$F$20240408$20240724$20240408$20240803$EXP$$PL-ROCHE-3535841$ROCHE$$80$YR$E$F$Y$$$20240803$$MD$PL$PL
237173532$23717353$2$F$20240126$20240816$20240408$20240828$EXP$FR-AFSSAPS-NT2024000162$FR-Accord-416905$ACCORD$$67$YR$E$M$Y$$$20240828$$PH$FR$FR
237173564$23717356$4$F$20240301$20240703$20240408$20240718$EXP$$TR-SA-2024SA088675$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240718$$MD$TR$TR
237173572$23717357$2$F$20230501$20240629$20240408$20240710$EXP$FR-AFSSAPS-TO2024000441$FR-Accord-416903$ACCORD$$67$YR$E$M$Y$72$KG$20240710$$PH$FR$FR
237173732$23717373$2$F$19710701$20240723$20240408$20240730$EXP$$US-CHATTEMPRD-2024OHG011054$CHATTEM$$52$YR$A$F$Y$$$20240730$$LW$US$US
237174142$23717414$2$F$20240401$20240708$20240408$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054540$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240708$$HP$US$US
237174363$23717436$3$F$$20240730$20240408$20240806$PER$$US-SA-2024SA027119$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240806$$MD$US$US
237174542$23717454$2$F$$20240403$20240408$20240926$PER$$NVSC2024US072580$NOVARTIS$$$$A$F$Y$$$20240926$$MD$US$US
237174574$23717457$4$F$20240323$20240823$20240408$20240904$EXP$$US-SA-2024SA099035$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240904$$MD$US$US
237175412$23717541$2$F$20240319$20240717$20240408$20240809$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000185$BECTON DICKINSON$$$$$$Y$$$20240809$$CN$GB$GB
237175472$23717547$2$F$20240319$20240718$20240408$20240809$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000187$BECTON DICKINSON$$$$$$Y$$$20240809$$CN$GB$GB
237175652$23717565$2$F$20240319$20240718$20240408$20240809$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000186$BECTON DICKINSON$$$$$$Y$$$20240809$$CN$GB$GB
237175665$23717566$5$F$20231001$20240911$20240408$20240921$EXP$$US-ABBVIE-5545809$ABBVIE$$50$YR$$M$Y$138$KG$20240921$$CN$US$US
237175832$23717583$2$F$$20240828$20240408$20240906$PER$$US-VERTEX PHARMACEUTICALS-2024-006105$VERTEX$$61$YR$$F$Y$$$20240906$$HP$US$US
237175849$23717584$9$F$20240322$20240923$20240408$20240925$EXP$$CN-ROCHE-3538129$ROCHE$$72$YR$E$F$Y$$$20240925$$MD$CN$CN
237176273$23717627$3$F$$20240709$20240408$20240716$EXP$$US-GSK-US2024AMR042928$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$US$US
237177286$23717728$6$F$20240501$20240920$20240408$20240926$EXP$$CA-TAKEDA-2019TUS068233$TAKEDA$$49$YR$$M$Y$$$20240926$$HP$CA$CA
237177722$23717772$2$F$$20240903$20240408$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202404003653$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240906$$CN$US$US
237177812$23717781$2$F$20240101$20240705$20240408$20240715$PER$$US-SA-2024SA100734$SANOFI AVENTIS$$$$A$F$Y$$$20240715$$MD$US$US
237177863$23717786$3$F$20240325$20240813$20240408$20240816$EXP$$NVSC2024FR073270$NOVARTIS$$$$A$F$Y$49$KG$20240816$$MD$FR$FR
237177892$23717789$2$F$$20240724$20240408$20240726$EXP$$JP-GILEAD-2024-0667976$GILEAD$Madokoro S, Miyazato A, Ishihara T, Okamoto K.. P129-3 A Fatal Case of Staphylococcus Aureus Necrotizing Pneumonia Following COVID-19. The 51st Annual Meeting of the Japanese Society of Intensive Care Medicine. 2024;unk:716$78$YR$E$M$Y$$$20240726$$MD$JP$JP
237178272$23717827$2$F$$20240703$20240408$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055003$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240704$$HP$US$US
237178283$23717828$3$F$$20240924$20240408$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004392$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240925$$CN$US$US
237178752$23717875$2$F$$20240722$20240408$20240826$PER$$US-GALDERMA-US2024004539$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
237179562$23717956$2$F$$20240705$20240408$20240806$PER$$US-GALDERMA-US2024004803$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
237180133$23718013$3$F$$20240826$20240408$20240829$EXP$$US-ALXN-202404USA000194US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
237180435$23718043$5$F$$20240912$20240408$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054997$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240916$$CN$US$US
237180882$23718088$2$F$20240214$20240815$20240408$20240828$PER$$US-SA-2024SA102118$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240828$$MD$US$US
237181072$23718107$2$F$20240326$20240708$20240408$20240715$EXP$$CA-GSK-CA2024041490$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$CA$CA
237181282$23718128$2$F$$20240827$20240408$20240905$EXP$$CA-TEVA-VS-3179550$TEVA$$14$YR$$F$Y$$$20240905$$HP$CA$CA
237181463$23718146$3$F$$20240924$20240408$20240930$EXP$$US-SHIRE-US201848856$TAKEDA$$$$$M$Y$138$KG$20240930$$CN$US$US
237182214$23718221$4$F$20240402$20240916$20240408$20240925$30DAY$$US-JNJFOC-20240406921$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240926$$PH$US$US
237182533$23718253$3$F$20240101$20240917$20240408$20240920$EXP$$US-PFIZER INC-202400079825$PFIZER$$80$YR$$F$Y$$$20240920$$HP$US$US
237182543$23718254$3$F$20240101$20240821$20240408$20240827$PER$$US-PFIZER INC-202400080086$PFIZER$$69$YR$$F$Y$$$20240827$$HP$US$US
237182622$23718262$2$F$$20240626$20240408$20240702$PER$$US-PFIZER INC-PV202400045605$PFIZER$$6$DEC$$F$Y$$$20240702$$HP$US$US
237182672$23718267$2$F$$20240802$20240408$20240807$PER$$US-PFIZER INC-202400079190$PFIZER$$15$YR$$M$Y$$$20240807$$CN$US$US
237182782$23718278$2$F$20231201$20240723$20240408$20240801$EXP$$JP-ROCHE-3538682$ROCHE$$81$YR$E$F$Y$54.1$KG$20240802$$PH$JP$JP
237183013$23718301$3$F$20240101$20240826$20240408$20240905$EXP$$US-SA-2024SA100748$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240905$$MD$US$US
237183114$23718311$4$F$$20240912$20240408$20240912$PER$$US-ALXN-202404USA000185US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
237183283$23718328$3$F$20220926$20240701$20240408$20240704$EXP$$IN-PFIZER INC-PV202300072042$PFIZER$$41$YR$$F$Y$$$20240704$$CN$IN$IN
237183642$23718364$2$F$20231018$20240715$20240408$20240717$EXP$FR-AFSSAPS-LM2024000179$FR-PFIZER INC-202400078372$PFIZER$$84$YR$$F$Y$48.5$KG$20240717$$MD$FR$FR
237183805$23718380$5$F$20240123$20240807$20240408$20240812$EXP$$JP-PFIZER INC-202400079026$PFIZER$$57$YR$$F$Y$$$20240812$$PH$JP$JP
237183812$23718381$2$F$$20240705$20240408$20240711$EXP$$IT-PFIZER INC-202400078223$PFIZER$$22$YR$$F$Y$$$20240711$$MD$IT$IT
237183893$23718389$3$F$20200101$20240725$20240408$20240730$EXP$$US-PFIZER INC-PV202400044963$PFIZER$$65$YR$$F$Y$114.73$KG$20240730$$CN$US$US
237183944$23718394$4$F$$20240820$20240408$20240820$EXP$$KR-PFIZER INC-PV202400045697$PFIZER$$56$YR$$F$Y$$$20240820$$CN$KR$KR
237184064$23718406$4$F$20240111$20240708$20240408$20240710$EXP$$US-PFIZER INC-202400079712$PFIZER$$20$YR$$F$Y$72.6$KG$20240710$$HP$US$US
237184342$23718434$2$F$20240301$20240319$20240408$20240808$PER$$US-AstraZeneca-2024A067488$ASTRAZENECA$$748$MON$$M$Y$$$20240808$$CN$US$
237184792$23718479$2$F$20240301$20240813$20240408$20240821$EXP$$US-SA-2024SA105627$SANOFI AVENTIS$$24$YR$A$F$Y$74.8$KG$20240821$$MD$US$US
237184853$23718485$3$F$20240201$20240709$20240408$20240715$EXP$$US-TAKEDA-2024TUS012107$TAKEDA$$47$YR$$F$Y$$$20240715$$CN$US$US
237185242$23718524$2$F$$20240716$20240408$20240724$PER$$US-SA-2024SA105066$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240724$$MD$US$US
237185422$23718542$2$F$20231201$20240715$20240408$20240719$EXP$$US-TAKEDA-2024TUS032546$TAKEDA$$57$YR$$F$Y$$$20240719$$MD$US$US
237185442$23718544$2$F$20220510$20240730$20240408$20240805$EXP$$CA-TAKEDA-2024TUS031899$TAKEDA$$40$YR$$M$Y$$$20240805$$CN$CA$CA
237185504$23718550$4$F$20240529$20240918$20240408$20240924$EXP$$CA-TAKEDA-2024TUS032508$TAKEDA$$42$YR$$F$Y$$$20240924$$MD$CA$CA
237185595$23718559$5$F$$20240902$20240408$20240909$EXP$$JP-ALXN-202403JPN002165JP$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$MD$JP$JP
237185612$23718561$2$F$$20240726$20240408$20240731$PER$$US-VERTEX PHARMACEUTICALS-2024-006009$VERTEX$$$$$F$Y$$$20240731$$CN$US$US
237185632$23718563$2$F$$20240723$20240408$20240730$PER$$US-ABBVIE-5703249$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
237185762$23718576$2$F$20230901$20240902$20240408$20240904$EXP$FR-AFSSAPS-NT2024000317$FR-MYLANLABS-2024M1030490$MYLAN$$78$YR$$M$Y$69$KG$20240904$$MD$FR$FR
237186144$23718614$4$F$20240423$20240714$20240408$20240715$EXP$$CA-PFIZER INC-202400077576$PFIZER$$59$YR$$F$Y$$$20240715$$HP$CA$CA
237186252$23718625$2$F$20230818$20240705$20240408$20240710$EXP$$CA-SA-2024SA105503$SANOFI AVENTIS$$$$A$$Y$89$KG$20240710$$HP$CA$CA
237186284$23718628$4$F$20231001$20240723$20240408$20240729$EXP$$CA-PFIZER INC-202400077652$PFIZER$$58$YR$$F$Y$$$20240729$$MD$CA$CA
237186483$23718648$3$F$20240119$20240709$20240408$20240717$EXP$$US-UCBSA-2024004006$UCB$$31$YR$$F$Y$42.9$KG$20240717$$CN$US$US
237186764$23718676$4$F$$20240628$20240408$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02824$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237186804$23718680$4$F$$20240722$20240408$20240726$EXP$$US-TAKEDA-2024TUS032077$TAKEDA$$$$$F$Y$$$20240726$$HP$US$US
237186815$23718681$5$F$20240622$20240722$20240408$20240724$EXP$$US-TAKEDA-2024TUS031900$TAKEDA$$60$YR$$F$Y$$$20240724$$HP$US$US
237187072$23718707$2$F$$20240909$20240408$20240913$EXP$$US-TAKEDA-2023TUS070865$TAKEDA$$$$$F$Y$72$KG$20240913$$CN$US$US
237187285$23718728$5$F$20230116$20240815$20240408$20240823$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-054861$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$34$KG$20240823$$MD$JP$JP
237187345$23718734$5$F$$20240923$20240408$20240925$EXP$$US-TAKEDA-2023TUS124136$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
237187567$23718756$7$F$20240124$20240705$20240408$20240715$EXP$$CO-TAKEDA-2024TUS008716$TAKEDA$$21$YR$$F$Y$48$KG$20240715$$CN$CO$CO
237187812$23718781$2$F$20240201$20240703$20240408$20240703$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-052049$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240703$$HP$IL$IL
237188082$23718808$2$F$$20240729$20240408$20240805$EXP$$CA-APOTEX-2023AP011068$APOTEX$$39$YR$$F$Y$$$20240805$$HP$CA$CA
237188172$23718817$2$F$$20240904$20240408$20240909$EXP$$JP-OTSUKA-2024_009081$OTSUKA$$54$YR$$F$Y$$$20240909$$PH$JP$JP
237188202$23718820$2$F$20240301$20240919$20240408$20240926$PER$$JP-Eisai-EC-2024-163049$EISAI$$50$YR$A$F$Y$$$20240926$$MD$JP$JP
237188338$23718833$8$F$20210929$20240821$20240408$20240827$EXP$$CA-TAKEDA-2024TUS026455$TAKEDA$$53$YR$$F$Y$$$20240827$$CN$CA$CA
237188363$23718836$3$F$$20240923$20240408$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053249$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240925$$CN$US$US
237188412$23718841$2$F$$20240328$20240408$20240726$EXP$$US-TORRENT-00013504$TORRENT$$60$YR$A$F$Y$$$20240726$$HP$US$US
237188552$23718855$2$F$20220627$20240821$20240408$20240830$EXP$$JP-009507513-2212JPN003801J$MERCK$Shimazaki M, Suzuki J, Honda R, Kato S, Tsuda A, Kuroda T, et al.. S-03 [Experiences with Lenvatinib/Pembrolizumab Combination Therapy for Corpus Uteri Carcinoma in Our Hospital]. Kanto Jounal of Obstetrics and Gynecology The 145th Meeting of the Kanto Society. 2023;60(2):257$65$YR$$F$Y$$$20240830$$MD$JP$JP
237188682$23718868$2$F$20240301$20240705$20240408$20240709$EXP$$US-BAUSCH-BL-2023-018165$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240709$$CN$US$US
237188804$23718880$4$F$20240306$20240708$20240408$20240716$EXP$IE-HPRA-2024-111662$IE-BAXTER-2024BAX016129$BAXTER$$45$YR$$F$Y$57$KG$20240716$$HP$IE$IE
237189033$23718903$3$F$$20240905$20240408$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053498$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240909$$CN$US$US
237189162$23718916$2$F$20240402$20240918$20240408$20240924$EXP$$CA-JNJFOC-20240407664$JOHNSON AND JOHNSON$$14$YR$T$F$Y$53$KG$20240924$$PH$CA$CA
237189322$23718932$2$F$20240119$20240905$20240408$20240917$EXP$FR-PHOENIX-2024039397$NVSC2024FR073998$NOVARTIS$$54$YR$$F$Y$62$KG$20240917$$CN$FR$FR
237189382$23718938$2$F$20240325$20240808$20240408$20240816$EXP$$CA-ROCHE-3536094$ROCHE$$43$YR$A$F$Y$$$20240816$$CN$CA$CA
237189492$23718949$2$F$$20240920$20240408$20240925$EXP$$US-TAKEDA-2024TUS031950$TAKEDA$$$$$F$Y$$$20240925$$HP$US$US
237189532$23718953$2$F$$20240806$20240408$20240808$EXP$$GB-SANDOZ INC.-SDZ2024GB035756$SANDOZ$$$$T$M$Y$$$20240808$$HP$GB$GB
237189613$23718961$3$F$20240101$20240826$20240408$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-005658$JAZZ$$$$$F$Y$$$20240828$$MD$US$US
237190062$23719006$2$F$20230501$20240722$20240408$20240801$EXP$$DE-NORDICGR-055546$NORDIC PHARMA$$63$YR$$F$Y$$$20240730$$MD$DE$DE
237190092$23719009$2$F$20200730$20240624$20240408$20240708$EXP$$DE-NORDICGR-055547$NORDIC PHARMA$$$$A$M$Y$$$20240705$$MD$DE$DE
237190142$23719014$2$F$$20240708$20240408$20240715$PER$$US-BIOGEN-2024BI01254670$BIOGEN$$$$$M$Y$$$20240715$$CN$US$US
237190392$23719039$2$F$20240404$20240731$20240408$20240801$EXP$$US-TAKEDA-US201910051$TAKEDA$$57$YR$$F$Y$$$20240801$$HP$US$US
237190482$23719048$2$F$$20240708$20240408$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-044831$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240708$$HP$US$US
237191093$23719109$3$F$20240219$20240819$20240408$20240826$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-053473$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240826$$HP$CO$CO
237191255$23719125$5$F$20240329$20240913$20240408$20240917$EXP$$US-BAYER-2024A048146$BAYER$$29$YR$A$M$Y$$$20240917$$CN$US$US
237191352$23719135$2$F$$20240722$20240408$20240729$EXP$$CA-DSJP-DSJ-2024-115637$DAIICHI$$70$YR$$F$Y$$$20240729$$MD$CA$CA
237191812$23719181$2$F$$20240725$20240408$20240731$EXP$$US-BAYER-2024A047630$BAYER$$54$YR$A$M$Y$92$KG$20240731$$HP$US$US
237191934$23719193$4$F$20240424$20240813$20240408$20240814$EXP$$CA-TAKEDA-2024TUS031518$TAKEDA$$20$YR$$F$Y$$$20240814$$CN$CA$CA
237192472$23719247$2$F$20240201$20240404$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000100$AMARIN$$62$YR$A$M$Y$$$20240709$$CN$US$US
237192562$23719256$2$F$20240301$20240411$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000109$AMARIN$$60$YR$A$M$Y$$$20240709$$CN$US$US
237192742$23719274$2$F$$20240411$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000135$AMARIN$$77$YR$E$F$Y$$$20240709$$CN$US$US
237192762$23719276$2$F$20240301$20240411$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000141$AMARIN$$63$YR$A$M$Y$$$20240709$$CN$US$US
237192782$23719278$2$F$20240301$20240412$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000132$AMARIN$$72$YR$E$F$Y$$$20240709$$CN$US$US
237192792$23719279$2$F$20240301$20240411$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000145$AMARIN$$65$YR$E$F$Y$$$20240709$$CN$US$US
237192802$23719280$2$F$$20240411$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000144$AMARIN$$71$YR$E$M$Y$$$20240709$$CN$US$US
237193033$23719303$3$F$20240213$20240710$20240408$20240710$EXP$$KR-ACERUSPHRM-2024-KR-000001$ACERUS PHARMACEUTICALS$$73$YR$E$M$Y$73$KG$20240710$$HP$KR$KR
237193152$23719315$2$F$$20240404$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000083$AMARIN$$$$$F$Y$$$20240709$$CN$US$US
237193192$23719319$2$F$20240301$20240404$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000113$AMARIN$$66$YR$A$F$Y$$$20240709$$CN$US$US
237193202$23719320$2$F$$20240404$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000121$AMARIN$$70$YR$E$M$Y$$$20240709$$CN$US$US
237193212$23719321$2$F$$20240412$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000127$AMARIN$$65$YR$E$M$Y$$$20240709$$CN$US$US
237193222$23719322$2$F$20240301$20240404$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000120$AMARIN$$50$YR$A$F$Y$$$20240709$$CN$US$US
237193233$23719323$3$F$$20240708$20240408$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000112$AMARIN$$52$YR$A$F$Y$$$20240729$$CN$US$US
237193242$23719324$2$F$20240301$20240404$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000122$AMARIN$$35$YR$A$M$Y$$$20240709$$CN$US$US
237193262$23719326$2$F$$20240412$20240408$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000128$AMARIN$$65$YR$E$F$Y$$$20240709$$CN$US$US
237193802$23719380$2$F$20240625$20240709$20240408$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-034232$JAZZ$$57$YR$$F$Y$$$20240716$$CN$US$US
237193953$23719395$3$F$$20240625$20240408$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02782$LUPIN$$$$$$Y$$$20240710$$CN$US$US
237194042$23719404$2$F$20240326$20240705$20240408$20240708$EXP$$FR-ALXN-202403EEA002128FR$ALEXION PHARMACEUTICALS$$23$YR$$M$Y$86$KG$20240708$$MD$FR$FR
237194104$23719410$4$F$20240301$20240712$20240408$20240722$PER$$US-SA-2024SA100409$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240721$$MD$US$US
237194113$23719411$3$F$20240326$20240807$20240408$20240808$PER$$US-AMGEN-USASP2024070345$AMGEN$$$$$M$Y$$$20240808$$CN$US$US
237194154$23719415$4$F$20240101$20240801$20240408$20240806$EXP$$CA-PFIZER INC-202400079144$PFIZER$$34$YR$$F$Y$$$20240806$$HP$CA$CA
237194522$23719452$2$F$$20240830$20240408$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA036856$SANDOZ$$$$$M$Y$$$20240902$$CN$CA$CA
237194825$23719482$5$F$20240301$20240801$20240408$20240806$30DAY$$US-PFIZER INC-202400071126$PFIZER$$4$YR$$F$Y$11.79$KG$20240806$$CN$US$US
237195382$23719538$2$F$20100503$20240828$20240408$20240904$EXP$$FR-AstraZeneca-2024A076443$ASTRAZENECA$$67$YR$$M$Y$74$KG$20240904$$MD$FR$
237195542$23719554$2$F$$20240825$20240408$20240829$EXP$$GB-TAKEDA-2024TUS032871$TAKEDA$$$$$F$Y$$$20240829$$CN$GB$GB
237196434$23719643$4$F$20230906$20240805$20240408$20240808$EXP$$ES-AMGEN-ESPNI2024067920$AMGEN$$64$YR$A$F$Y$80$KG$20240808$$HP$ES$ES
237196633$23719663$3$F$20240301$20240701$20240408$20240708$PER$$US-SA-2024SA101644$SANOFI AVENTIS$$64$YR$A$M$Y$98.883$KG$20240708$$MD$US$US
237196722$23719672$2$F$20240325$20240709$20240408$20240710$EXP$$US-ALXN-202404USA000177US$ALEXION PHARMACEUTICALS$$69$YR$$M$Y$$$20240710$$CN$US$US
237196815$23719681$5$F$$20240830$20240408$20240903$30DAY$$US-PFIZER INC-PV202400044219$PFIZER$$$$$$Y$$$20240903$$HP$US$US
237196822$23719682$2$F$20230712$20240801$20240408$20240806$30DAY$$US-PFIZER INC-PV202400044335$PFIZER$$$$$$Y$$$20240806$$HP$US$US
237196835$23719683$5$F$$20240806$20240408$20240809$30DAY$$US-PFIZER INC-202400076360$PFIZER$$5$YR$$F$Y$27.21$KG$20240809$$CN$US$US
237197423$23719742$3$F$20240301$20240726$20240408$20240805$PER$$US-SA-2024SA106320$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240805$$MD$US$US
237197682$23719768$2$F$20240101$20240801$20240408$20240808$PER$$US-SA-2024SA106247$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240808$$MD$US$US
237198102$23719810$2$F$20240101$20240325$20240408$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00106$BRAINTREE$$$$$M$Y$$$20240709$$CN$US$US
237198283$23719828$3$F$20231130$20240618$20240408$20240925$EXP$$FR-SA-2024SA103326$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240925$$MD$FR$FR
237199124$23719912$4$F$20240328$20240821$20240408$20240829$EXP$$US-OTSUKA-2023_027946$OTSUKA$$57$YR$$F$Y$$$20240829$$MD$US$US
237199132$23719913$2$F$$20240708$20240408$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055190$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240708$$CN$US$US
237199362$23719936$2$F$20240312$20240808$20240408$20240817$EXP$$CA-TEVA-VS-3179125$TEVA$$7$YR$$F$Y$29$KG$20240817$$HP$CA$CA
237199902$23719990$2$F$20240328$20240730$20240408$20240810$EXP$$US-ELI_LILLY_AND_COMPANY-US202403017517$ELI LILLY AND CO$$59$YR$A$F$Y$95$KG$20240810$$MD$US$US
237200086$23720008$6$F$$20240905$20240408$20240911$30DAY$$US-PFIZER INC-202400075948$PFIZER$$10$YR$$M$Y$$$20240911$$HP$US$US
237200253$23720025$3$F$$20240917$20240408$20240927$EXP$$US-ROCHE-3454947$ROCHE$$89$YR$E$F$Y$$$20240927$$CN$US$US
237200362$23720036$2$F$$20240709$20240408$20240715$EXP$$CA-SANDOZ INC.-SDZ2023CA075075$SANDOZ$$$$$F$Y$$$20240715$$CN$CA$CA
237200384$23720038$4$F$20240115$20240701$20240408$20240702$EXP$$US-TAKEDA-2024TUS030387$TAKEDA$$33$YR$$M$Y$$$20240702$$CN$US$US
237200544$23720054$4$F$20240201$20240701$20240408$20240708$EXP$$US-TAKEDA-2024TUS019692$TAKEDA$$66$YR$$F$Y$82.086$KG$20240708$$HP$US$US
237200566$23720056$6$F$$20240905$20240408$20240909$30DAY$$US-PFIZER INC-202400077611$PFIZER$$12$YR$$F$Y$$$20240909$$CN$US$US
237200602$23720060$2$F$$20240801$20240408$20240806$30DAY$$US-PFIZER INC-PV202400044731$PFIZER$$$$$$Y$$$20240806$$HP$US$US
237200645$23720064$5$F$$20240806$20240408$20240812$30DAY$$US-PFIZER INC-202400076190$PFIZER$$78$YR$$M$Y$$$20240812$$CN$US$US
237201153$23720115$3$F$$20240703$20240408$20240711$EXP$$US-PFIZER INC-PV202400045299$PFIZER$$20$YR$$F$Y$$$20240711$$CN$US$US
237201262$23720126$2$F$$20240708$20240408$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-054819$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240708$$MD$JP$JP
237201273$23720127$3$F$$20240924$20240408$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055172$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240926$$CN$US$US
237201552$23720155$2$F$$20240708$20240408$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055174$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240708$$CN$US$US
237201612$23720161$2$F$20180213$20240802$20240408$20240807$EXP$$IT-MYLANLABS-2024M1030879$MYLAN$$57$YR$$F$Y$$$20240807$$HP$IT$IT
237201792$23720179$2$F$$20240715$20240408$20240723$PER$$US-MYLANLABS-2024M1028556$MYLAN$$$$$F$Y$$$20240723$$CN$US$US
237201842$23720184$2$F$$20240918$20240408$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202404003651$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240923$$CN$US$US
237201902$23720190$2$F$20240129$20240712$20240408$20240717$PER$$JP-Eisai-EC-2024-163289$EISAI$$60$YR$A$M$Y$$$20240717$$MD$JP$JP
237202162$23720216$2$F$20240101$20240726$20240408$20240731$EXP$$GB-MYLANLABS-2024M1030214$MYLAN$$$$$M$Y$$$20240731$$MD$GB$GB
237202333$23720233$3$F$20240101$20240821$20240408$20240826$EXP$$JP-AstraZeneca-2024A082423$ASTRAZENECA$$77$YR$$F$Y$70$KG$20240826$$MD$JP$
237202602$23720260$2$F$$20240627$20240408$20240711$EXP$$US-FreseniusKabi-FK202405400$FRESENIUS KABI$$57$YR$A$M$Y$$$20240709$$LW$US$US
237202662$23720266$2$F$$20240708$20240408$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055255$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240708$$CN$US$US
237202752$23720275$2$F$20231101$20240813$20240408$20240816$PER$$US-PFIZER INC-PV202400044968$PFIZER$$54$YR$$F$Y$$$20240816$$HP$US$US
237202972$23720297$2$F$20240404$20240821$20240408$20240824$PER$$US-AMGEN-USASP2024070662$AMGEN$$83$YR$E$F$Y$$$20240824$$CN$US$US
237203024$23720302$4$F$$20240826$20240408$20240902$EXP$$JP-009507513-2404JPN000274J$MERCK$Ochiai M, Fujito S, Imamura H, Saito F, Motohara T, Kondo E. P-30-10 Points to consider when using pembrolizumab for advanced or recurrent cervical cancer: Experience with adverse events thought to be specific to cervical cancer. Acta Obstetrica et Gynaecologica Japonica The 76th Annual Congress of the Japan. 2024;76(S):S499$$$A$F$Y$$$20240902$$MD$JP$JP
237203553$23720355$3$F$20240404$20240717$20240408$20240720$PER$$NVSC2024US074460$NOVARTIS$$62$YR$$F$Y$$$20240719$$CN$US$US
237203712$23720371$2$F$$20240723$20240408$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055350$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240725$$CN$US$US
237204013$23720401$3$F$$20240731$20240408$20240809$PER$$US-SA-2024SA105299$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240809$$MD$US$US
237204114$23720411$4$F$20240325$20240722$20240408$20240728$EXP$$US-ABBVIE-5709711$ABBVIE$$83$YR$$M$Y$$$20240728$$CN$US$US
237204172$23720417$2$F$$20240708$20240408$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054711$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240709$$CN$US$US
237205294$23720529$4$F$$20240902$20240408$20240906$30DAY$$CA-JNJFOC-20240357764$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$HP$CA$CA
237205374$23720537$4$F$$20240902$20240408$20240910$EXP$$CA-CELLTRION INC.-2024CA007941$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
237205423$23720542$3$F$$20240717$20240408$20240718$PER$$NVSC2024US074006$NOVARTIS$$$$$F$Y$$$20240718$$CN$US$US
237205604$23720560$4$F$20221116$20240716$20240408$20240723$EXP$$NVSJ2024JP004039$NOVARTIS$$34$YR$$F$Y$$$20240723$$MD$JP$JP
237205814$23720581$4$F$20240218$20240916$20240408$20240918$EXP$$US-TAKEDA-2024TUS017462$TAKEDA$$15$YR$$M$Y$$$20240918$$CN$US$US
237205855$23720585$5$F$$20240916$20240408$20240920$EXP$$US-INCYTE CORPORATION-2024IN003355$INCYTE$$$$$$Y$$$20240920$$CN$US$US
237205873$23720587$3$F$$20240727$20240408$20240802$EXP$$US-TAKEDA-2023TUS041007$TAKEDA$$$$$F$Y$$$20240802$$CN$US$US
237206302$23720630$2$F$$20240625$20240408$20240702$EXP$$CA-SANDOZ INC.-SDZ2024CA028249$SANDOZ$$58$YR$$M$Y$$$20240702$$MD$CA$CA
237206403$23720640$3$F$$20240717$20240409$20240722$PER$$NVSC2024US072854$NOVARTIS$$$$$M$Y$$$20240722$$CN$US$US
237206543$23720654$3$F$$20240806$20240409$20240812$EXP$$JP-009507513-2404JPN000424J$MERCK$$56$YR$$F$Y$$$20240812$$MD$JP$JP
237206693$23720669$3$F$$20240717$20240409$20240719$PER$$NVSC2024US074458$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
237206742$23720674$2$F$$20240801$20240409$20240807$PER$$US-BIOGEN-2024BI01258969$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
237206977$23720697$7$F$20230101$20240829$20240409$20240904$EXP$$US-ABBVIE-5710403$ABBVIE$$$$$F$Y$83.914$KG$20240904$$CN$US$US
237207052$23720705$2$F$20240404$20240711$20240409$20240715$PER$$US-AMGEN-USASP2024070197$AMGEN$$73$YR$E$M$Y$$$20240715$$CN$US$US
237207352$23720735$2$F$20240707$20240720$20240409$20240808$PER$$CA-TOLMAR, INC.-24CA047805$TOLMAR$$58$YR$$M$Y$$$20240808$$CN$CA$CA
237207485$23720748$5$F$20240318$20240815$20240409$20240822$EXP$$CA-GSK-CA2024024859$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$CA$CA
237207744$23720774$4$F$$20240801$20240409$20240809$PER$$US-SA-2024SA102351$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240809$$MD$US$US
237207782$23720778$2$F$$20240807$20240409$20240828$PER$$CA-TOLMAR, INC.-24CA047585$TOLMAR$$$$$M$Y$$$20240828$$CN$CA$CA
237207902$23720790$2$F$20240312$20240828$20240409$20240916$PER$$CA-TOLMAR, INC.-24CA047681$TOLMAR$$66$YR$$M$Y$$$20240916$$CN$CA$CA
237207913$23720791$3$F$20240301$20240703$20240409$20240730$PER$$FR-TOLMAR, INC.-24FR047622$TOLMAR$$76$YR$$M$Y$$$20240730$$PH$FR$FR
237207982$23720798$2$F$$20240404$20240409$20240814$EXP$$NVSC2023CA243262$NOVARTIS$$76$YR$$F$Y$$$20240814$$CN$CA$CA
237208102$23720810$2$F$$20240723$20240409$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054998$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240725$$CN$US$US
237208162$23720816$2$F$20240404$20240805$20240409$20240809$PER$$US-AMGEN-USASP2024070059$AMGEN$$67$YR$E$M$Y$$$20240809$$CN$US$US
237208335$23720833$5$F$20210917$20240816$20240409$20240822$EXP$$US-SA-2023SA377497$SANOFI AVENTIS$$63$YR$A$M$Y$99.5$KG$20240822$$HP$US$US
237209122$23720912$2$F$20240101$20240911$20240409$20240924$EXP$$CA-UCBSA-2024016415$UCB$$$$$F$Y$$$20240924$$CN$CA$CA
237209304$23720930$4$F$20240328$20240822$20240409$20240829$EXP$$CA-CELLTRION INC.-2024CA008359$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
237209503$23720950$3$F$20240101$20240820$20240409$20240827$EXP$$US-SA-2024SA106706$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240827$$MD$US$US
237209552$23720955$2$F$20240301$20240809$20240409$20240813$PER$$US-BIOGEN-2024BI01258216$BIOGEN$$47$YR$$F$Y$$$20240813$$CN$US$US
237210222$23721022$2$F$20240403$20240726$20240409$20240729$PER$$US-AMGEN-USASP2024070230$AMGEN$$81$YR$E$F$Y$$$20240729$$PH$US$US
237210292$23721029$2$F$$20240808$20240409$20240814$EXP$$JP-009507513-2404JPN000727J$MERCK$$7$DEC$$F$Y$$$20240814$$MD$JP$JP
237210332$23721033$2$F$20240405$20240801$20240409$20240805$PER$$US-AMGEN-USASP2024070427$AMGEN$$56$YR$A$M$Y$$$20240805$$CN$US$US
237210374$23721037$4$F$$20240723$20240409$20240724$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-004209$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240724$$CN$CA$CA
237210442$23721044$2$F$20240404$20240802$20240409$20240806$PER$$US-AMGEN-USASP2024070332$AMGEN$$72$YR$E$F$Y$$$20240806$$PH$US$US
237210602$23721060$2$F$20180101$20240709$20240409$20240709$EXP$$US-JNJFOC-20240402114$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240710$$CN$US$US
237210732$23721073$2$F$20240405$20240718$20240409$20240722$PER$$US-AMGEN-USASP2024070705$AMGEN$$69$YR$E$M$Y$$$20240722$$CN$US$US
237210863$23721086$3$F$20240410$20240710$20240409$20240715$EXP$$CA-TAKEDA-2023TUS118961$TAKEDA$$21$YR$$F$Y$$$20240715$$CN$CA$CA
237210923$23721092$3$F$20240304$20240923$20240409$20240930$EXP$$JP-009507513-2404JPN000759J$MERCK$$70$YR$$F$Y$50$KG$20240930$$PH$JP$JP
237210945$23721094$5$F$20240331$20240729$20240409$20240805$PER$$US-JNJFOC-20240422468$JOHNSON AND JOHNSON$$51$YR$A$F$Y$106.58$KG$20240805$$CN$US$US
237211003$23721100$3$F$20231201$20240708$20240409$20240708$EXP$$UY-BRISTOL-MYERS SQUIBB COMPANY-2024-053539$BRISTOL MYERS SQUIBB$$40$YR$A$M$Y$$$20240708$$MD$UY$UY
237211014$23721101$4$F$$20240911$20240409$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054651$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$81.65$KG$20240912$$CN$US$US
237211054$23721105$4$F$20221006$20240724$20240409$20240730$EXP$$CA-TAKEDA-2024TUS003677$TAKEDA$$60$YR$$F$Y$$$20240730$$MD$CA$CA
237211085$23721108$5$F$20240326$20240917$20240409$20240925$EXP$$CA-JNJFOC-20240411883$JOHNSON AND JOHNSON$$3$YR$C$M$Y$$$20240925$$CN$CA$CA
237211232$23721123$2$F$$20240708$20240409$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055179$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240708$$CN$US$US
237211252$23721125$2$F$20240101$20240726$20240409$20240730$EXP$FR-AFSSAPS-LM2024000180$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-055031$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240730$$MD$FR$FR
237211294$23721129$4$F$20231228$20240815$20240409$20240822$EXP$$CA-GSK-CA2023181899$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$CA$CA
237212092$23721209$2$F$$20240709$20240409$20240821$PER$$US-LUNDBECK-DKLU3076006$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
237212123$23721212$3$F$$20240617$20240409$20240808$PER$$US-LUNDBECK-DKLU3075866$LUNDBECK$$$$$$Y$$$20240808$$CN$US$US
237212182$23721218$2$F$$20240716$20240409$20240724$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-003947$AMGEN$$$$$M$Y$$$20240724$$LW$US$US
237212362$23721236$2$F$$20240820$20240409$20240823$EXP$CA-DRL-USA-LIT/CAN/24/0005423$CA-RDY-LIT/CAN/24/0005423$DR REDDYS$Blain S, Payette N, Bittencourt H, Johnston D. Gemtuzumab Ozogamicin Monotherapy Is a Well-tolerated Palliative Chemotherapy Option in Pediatric Multiply Relapsed Acute Myeloid Leukemia: A Multicenter Case Series and Review of the Literature. Journal of Pediatric Hematology/Oncology. 2023 Nov;45(8): 436-444. doi:10.1097/MPH.0000000000002760.$15$YR$T$F$Y$$$20240823$$HP$CA$CA
237212414$23721241$4$F$20230227$20240829$20240409$20240903$EXP$$CA-JNJFOC-20230137231$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240903$$HP$CA$CA
237212602$23721260$2$F$20240101$20240719$20240409$20240726$EXP$$US-SA-2024SA106713$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240726$$MD$US$US
237212692$23721269$2$F$20240205$20240220$20240409$20240709$PER$$US-ASTELLAS-2024US006052$ASTELLAS$$35$YR$$F$Y$142$KG$20240709$$HP$US$US
237212752$23721275$2$F$$20240403$20240409$20240724$EXP$$CN-HALEON-2165995$Haleon PLC$TanY-W, LiuL-P, ZhangK. Double plasma molecular adsorption system for Stevens-Johnson syndrome/toxic epidermal necrolysis: A case report. World?Journal of Clinical Cases. #PY#;12(7):1371. https://dx.doi.org/10.12998/wjcc.v12.i7.1371; TanY-W, LiuL-P, ZhangK. Double plasma molecular adsorption system for Stevens-Johnson syndrome/toxic epidermal necrolysis: A case report. World?Journal of Clinical Cases. #PY#;12(7):1371. https://dx.doi.org/10.12998/wjcc.v12.i7.1371; Tan YW, Liu LP, Zhang K. Doub...$$$A$F$Y$$$20240723$$MD$CN$CN
237212942$23721294$2$F$$20240904$20240409$20240909$EXP$$US-ROCHE-3537453$ROCHE$$42$YR$A$F$Y$$$20240909$$CN$US$US
237213042$23721304$2$F$$20240722$20240409$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053699$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240723$$CN$US$US
237213204$23721320$4$F$20230101$20240801$20240409$20240815$EXP$$IT-ROCHE-3532631$ROCHE$$22$YR$A$F$Y$$$20240815$$HP$IT$IT
237213214$23721321$4$F$20240406$20240717$20240409$20240723$PER$$NVSC2024US074901$NOVARTIS$$47$YR$$F$Y$$$20240723$$CN$US$US
237213574$23721357$4$F$20240101$20240703$20240409$20240711$EXP$$CA-CELLTRION INC.-2024CA008363$CELLTRION$$$$$$Y$$$20240711$$CN$CA$CA
237213613$23721361$3$F$$20240913$20240409$20240919$PER$$NVSC2024US074805$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
237214072$23721407$2$F$20240404$20240725$20240409$20240727$PER$$US-AMGEN-USASP2024070152$AMGEN$$69$YR$E$F$Y$$$20240727$$CN$US$US
237214216$23721421$6$F$20191204$20240813$20240409$20240819$EXP$$JP-ABBVIE-5710883$ABBVIE$$69$YR$$M$Y$69$KG$20240819$$MD$JP$JP
237214353$23721435$3$F$$20240619$20240409$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001246$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
237214372$23721437$2$F$$20240621$20240409$20240717$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001248$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
237214463$23721446$3$F$$20240904$20240409$20240905$EXP$$CA-SANDOZ INC.-SDZ2024CA036581$SANDOZ$$$$A$F$Y$$$20240905$$MD$CA$CA
237214652$23721465$2$F$20240405$20240827$20240409$20240830$PER$$US-AMGEN-USASP2024070422$AMGEN$$73$YR$E$M$Y$$$20240830$$CN$US$US
237214692$23721469$2$F$$20240628$20240409$20240705$EXP$$JP-009507513-2404JPN000580J$MERCK$$7$DEC$$F$Y$$$20240705$$PH$JP$JP
237214753$23721475$3$F$20230601$20240718$20240409$20240724$EXP$$US-ABBVIE-5709610$ABBVIE$$74$YR$$F$Y$$$20240724$$CN$US$US
237214923$23721492$3$F$20240305$20240819$20240409$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055222$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240819$$CN$US$US
237214942$23721494$2$F$$20240815$20240409$20240822$EXP$$US-GSK-US2024041509$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$US$US
237215087$23721508$7$F$20240101$20240916$20240409$20240924$EXP$$CA-JNJFOC-20240411949$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240925$$HP$CA$CA
237215143$23721514$3$F$20230903$20240906$20240409$20240920$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-418066$RANBAXY$$75$YR$E$F$Y$49$KG$20240920$$MD$CN$CN
237215233$23721523$3$F$20231115$20240804$20240409$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425529$RANBAXY$$83$YR$E$M$Y$71$KG$20240816$$MD$CN$CN
237215302$23721530$2$F$20231220$20240625$20240409$20240710$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-440757$RANBAXY$$92$YR$$F$Y$$$20240710$$MD$ES$ES
237215594$23721559$4$F$$20240712$20240409$20240718$PER$$NVSC2024US074021$NOVARTIS$$$$$F$Y$$$20240718$$CN$US$US
237215693$23721569$3$F$20240101$20240624$20240409$20240702$EXP$$CA-CELLTRION INC.-2024CA006354$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
237215845$23721584$5$F$20040101$20240717$20240409$20240723$PER$$US-BIOGEN-2024BI01258157$BIOGEN$$$$$F$Y$$$20240723$$CN$US$US
237215972$23721597$2$F$$20240709$20240409$20240709$EXP$$US-JNJFOC-20240411991$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240710$$HP$US$US
237215982$23721598$2$F$20240404$20240705$20240409$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055529$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$77.11$KG$20240708$$CN$US$US
237216002$23721600$2$F$$20240731$20240409$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055464$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240801$$CN$US$US
237216216$23721621$6$F$20240101$20240708$20240409$20240710$PER$$US-AMGEN-USASP2024071035$AMGEN$$39$YR$A$F$Y$$$20240709$$HP$US$US
237216342$23721634$2$F$$20240812$20240409$20240819$EXP$$CA-TAKEDA-2024TUS032473$TAKEDA$$$$$M$Y$$$20240819$$CN$CA$CA
237216414$23721641$4$F$20150801$20240807$20240409$20240813$EXP$$US-ORGANON-O2404USA000914$ORGANON$$24$YR$$F$Y$65.3$KG$20240812$$MD$US$US
237216452$23721645$2$F$20240401$20240711$20240409$20240712$PER$$US-AMGEN-USASP2024067454$AMGEN$$62$YR$A$M$Y$$$20240712$$CN$US$US
237216484$23721648$4$F$20240404$20240701$20240409$20240708$PER$$US-ALXN-202404USA000289US$ALEXION PHARMACEUTICALS$$70$YR$$M$Y$$$20240708$$CN$US$US
237216544$23721654$4$F$20240306$20240730$20240409$20240803$EXP$$NVSC2024GB073411$NOVARTIS$$58$YR$$F$Y$$$20240803$$CN$GB$GB
237216563$23721656$3$F$$20240619$20240409$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001240$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
237216642$23721664$2$F$$20240628$20240409$20240703$EXP$$NVSC2024US074351$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
237216665$23721666$5$F$20240204$20240706$20240409$20240715$EXP$$ES-SA-2024SA103107$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240715$$MD$ES$ES
237217103$23721710$3$F$$20240729$20240409$20240730$EXP$$US-UCBSA-2024016410$UCB$$$$$M$Y$$$20240730$$CN$US$US
237217263$23721726$3$F$20240131$20240516$20240409$20240813$EXP$$NVSC2024CA073014$NOVARTIS$$42$YR$$F$Y$51.5$KG$20240813$$CN$CA$CA
237217354$23721735$4$F$$20240627$20240409$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001251$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
237217707$23721770$7$F$$20240826$20240409$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055234$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240829$$HP$US$US
237217723$23721772$3$F$20180101$20240624$20240409$20240702$EXP$$JP-AMGEN-JPNSP2024068727$AMGEN$$59$YR$A$M$Y$$$20240702$$MD$JP$JP
237217782$23721778$2$F$20240101$20240405$20240409$20240711$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-115625$DAIICHI$$45$YR$$F$Y$$$20240711$$HP$US$US
237217912$23721791$2$F$$20240702$20240409$20240704$EXP$$JP-ASTELLAS-2024JP002346$ASTELLAS$$10$DEC$$M$Y$$$20240704$$MD$JP$JP
237218366$23721836$6$F$$20240702$20240409$20240712$EXP$PL-MACLEODS PHARMACEUTICALS US LTD-MAC2024046793$PL-MACLEODS PHARMACEUTICALS US LTD-MAC2024046793$MACLEODS$$$$$$Y$$$20240712$$MD$PL$PL
237218532$23721853$2$F$$20240717$20240409$20240724$EXP$$CO-GSK-CO2024AMR041905$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$CO$CO
237218832$23721883$2$F$20240404$20240717$20240409$20240718$PER$$US-AMGEN-USASP2024069619$AMGEN$$68$YR$E$F$Y$$$20240718$$CN$US$US
237218903$23721890$3$F$20240403$20240626$20240409$20240703$EXP$$FR-SA-2024SA105079$SANOFI AVENTIS$$12$YR$T$F$Y$35$KG$20240703$$MD$FR$FR
237219435$23721943$5$F$$20240909$20240409$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001383$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$HP$US$US
237219504$23721950$4$F$$20240828$20240409$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-013463$AUROBINDO$Goubeau L, Guilbert Z, Saadi M, Picard F, Perrin L, Capdevila L, et al.. Bleeding episode during a long-term anticoagulation with direct oral anticoagulant: an unusual revelation of a severe factor v deficiency.. Research and Practice in Thrombosis and Haemostasis.. 2023;7(Suppl 2):668$81$YR$$M$Y$$$20240909$$HP$FR$FR
237219623$23721962$3$F$$20240923$20240409$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055494$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240924$$HP$US$US
237219826$23721982$6$F$20160101$20240702$20240409$20240705$EXP$$AU-UCBSA-2024016444$UCB$$$$$F$Y$$$20240705$$MD$AU$AU
237219854$23721985$4$F$20240320$20240701$20240409$20240708$EXP$$PL-JNJFOC-20240414728$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240709$$HP$PL$PL
237219942$23721994$2$F$20220901$20240919$20240409$20240924$EXP$$US-AMGEN-USASP2024070136$AMGEN$$85$YR$E$M$Y$$$20240924$$CN$US$US
237221032$23722103$2$F$$20240809$20240409$20240812$EXP$$US-ASTELLAS-2024US007582$ASTELLAS$$$$$M$Y$$$20240812$$CN$US$US
237221053$23722105$3$F$20230101$20240816$20240409$20240828$EXP$$US-INSMED-2023-00087-USAA$INSMED$$$$$F$Y$$$20240828$$HP$US$US
237221083$23722108$3$F$20240404$20240820$20240409$20240823$PER$$US-AMGEN-USASP2024070156$AMGEN$$41$YR$A$F$Y$$$20240823$$CN$US$US
237221142$23722114$2$F$20230309$20240731$20240409$20240810$EXP$$US-TEVA-VS-3177440$TEVA$$16$YR$$M$Y$$$20240810$$HP$US$US
237221552$23722155$2$F$20240401$20240819$20240409$20240822$EXP$$US-SA-2024SA106671$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240822$$MD$US$US
237221842$23722184$2$F$20240101$20240730$20240409$20240731$EXP$$AU-UCBSA-2024016465$UCB$$$$$M$Y$$$20240731$$CN$AU$AU
237222213$23722221$3$F$$20240627$20240409$20240704$PER$$US-ALXN-202404USA000222US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240704$$CN$US$US
237222294$23722229$4$F$20230901$20240625$20240409$20240701$EXP$$DE-MYLANLABS-2024M1031054$MYLAN$$$$A$F$Y$$$20240701$$MD$DE$DE
237222534$23722253$4$F$$20240902$20240409$20240905$EXP$$KR-PFIZER INC-PV202400045449$PFIZER$$10$YR$$M$Y$$$20240905$$CN$KR$KR
237222652$23722265$2$F$20230101$20240403$20240409$20240814$EXP$$NVSC2024BR040313$NOVARTIS$$$$$F$Y$73$KG$20240814$$CN$BR$BR
237223012$23722301$2$F$$20240703$20240409$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053904$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240704$$HP$US$US
237223252$23722325$2$F$20240320$20240618$20240409$20240703$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000189$BECTON DICKINSON$$$$$$Y$$$20240703$$CN$GB$GB
237223263$23722326$3$F$20240312$20240911$20240409$20240927$30DAY$$US-BECTON DICKINSON-US-BD-24-000196$BECTON DICKINSON$$$$$$Y$$$20240927$$CN$US$US
237223542$23722354$2$F$$20240326$20240409$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000066$PAREXEL$$21$YR$$F$Y$$$20240710$$HP$US$US
237223602$23722360$2$F$20240208$20240322$20240409$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000161$PAREXEL$$11$YR$$M$Y$$$20240710$$CN$US$US
237223612$23722361$2$F$$20240404$20240409$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000209$PAREXEL$$$$$M$Y$$$20240710$$CN$US$US
237223622$23722362$2$F$$20240404$20240409$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000210$PAREXEL$$$$$M$Y$$$20240710$$CN$US$US
237223632$23722363$2$F$$20240404$20240409$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000205$PAREXEL$$$$$M$Y$$$20240710$$CN$US$US
237223642$23722364$2$F$$20240408$20240409$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000219$PAREXEL$$26$YR$$F$Y$77.098$KG$20240710$$MD$US$US
237223662$23722366$2$F$$20240408$20240409$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000231$PAREXEL$$$$$F$Y$$$20240710$$HP$US$US
237223672$23722367$2$F$20240201$20240423$20240409$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000287$PAREXEL$$17$YR$$F$Y$$$20240710$$MD$US$US
237223692$23722369$2$F$$20240423$20240409$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000298$PAREXEL$$10$YR$$M$Y$$$20240710$$MD$US$US
237223702$23722370$2$F$$20240405$20240409$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000325$PAREXEL$$52$YR$$F$Y$$$20240710$$CN$US$US
237223712$23722371$2$F$$20240426$20240409$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000288$PAREXEL$$20$YR$$F$Y$$$20240710$$CN$US$US
237224052$23722405$2$F$$20240916$20240409$20240918$EXP$$US-MYLANLABS-2024M1031272$MYLAN$$$$$M$Y$$$20240918$$HP$US$US
237224173$23722417$3$F$$20240716$20240409$20240717$30DAY$$US-PFIZER INC-PV202400044098$PFIZER$$$$$$Y$$$20240717$$CN$US$US
237224182$23722418$2$F$$20240712$20240409$20240717$30DAY$$US-PFIZER INC-PV202400044115$PFIZER$$$$$$Y$$$20240717$$CN$US$US
237224204$23722420$4$F$$20240805$20240409$20240808$30DAY$$US-PFIZER INC-PV202400044122$PFIZER$$$$$$Y$$$20240808$$HP$US$US
237224214$23722421$4$F$$20240809$20240409$20240819$30DAY$$US-PFIZER INC-202400077940$PFIZER$$$$$$Y$$$20240819$$HP$US$US
237224233$23722423$3$F$$20240802$20240409$20240807$30DAY$$US-PFIZER INC-PV202400044103$PFIZER$$$$$$Y$$$20240807$$HP$US$US
237224257$23722425$7$F$$20240806$20240409$20240809$30DAY$$US-PFIZER INC-202400077876$PFIZER$$7$YR$$M$Y$$$20240809$$MD$US$US
237224313$23722431$3$F$$20240816$20240409$20240823$30DAY$$US-PFIZER INC-PV202400044140$PFIZER$$$$$$Y$$$20240823$$HP$US$US
237224363$23722436$3$F$$20240713$20240409$20240717$30DAY$$US-PFIZER INC-PV202400044129$PFIZER$$$$$$Y$$$20240717$$CN$US$US
237224374$23722437$4$F$$20240810$20240409$20240814$30DAY$$US-PFIZER INC-PV202400044161$PFIZER$$$$$$Y$$$20240814$$HP$US$US
237224452$23722445$2$F$$20240712$20240409$20240717$30DAY$$US-PFIZER INC-PV202400044168$PFIZER$$$$$$Y$$$20240717$$CN$US$US
237224563$23722456$3$F$$20240806$20240409$20240822$30DAY$$US-PFIZER INC-PV202400044293$PFIZER$$$$$$Y$$$20240822$$HP$US$US
237224572$23722457$2$F$$20240920$20240409$20240926$30DAY$$US-PFIZER INC-PV202400044163$PFIZER$$$$$$Y$$$20240926$$HP$US$US
237224762$23722476$2$F$20231118$20240902$20240409$20240909$PER$$JP-Eisai-EC-2024-163051$EISAI$$52$YR$A$M$Y$81$KG$20240909$$PH$JP$JP
237224814$23722481$4$F$$20240710$20240409$20240716$PER$$US-ALXN-202404USA000129US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
237224964$23722496$4$F$$20240804$20240409$20240808$EXP$$US-PFIZER INC-202400079927$PFIZER$$$$$F$Y$$$20240808$$CN$US$US
237225014$23722501$4$F$$20240711$20240409$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-005685$JAZZ$$$$$F$Y$$$20240722$$CN$US$US
237225152$23722515$2$F$$20240404$20240409$20240812$EXP$$NVSC2024US059037$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
237225184$23722518$4$F$$20240712$20240409$20240717$PER$$US-PFIZER INC-PV202400044472$PFIZER$$$$$$Y$$$20240717$$HP$US$US
237225402$23722540$2$F$20240101$20240805$20240409$20240808$EXP$$GB-VERTEX PHARMACEUTICALS-2024-006127$VERTEX$$$$A$F$Y$$$20240808$$CN$GB$GB
237225462$23722546$2$F$20210101$20240815$20240409$20240821$EXP$$CA-VERTEX PHARMACEUTICALS-2024-006196$VERTEX$$$$$$Y$$$20240821$$HP$CA$CA
237225493$23722549$3$F$20240401$20240910$20240409$20240917$EXP$$GB-VERTEX PHARMACEUTICALS-2024-006121$VERTEX$$$$E$F$Y$$$20240917$$CN$GB$GB
237225594$23722559$4$F$$20240703$20240409$20240706$PER$$US-AMGEN-USASP2024070810$AMGEN$$83$YR$E$F$Y$$$20240706$$MD$US$US
237225702$23722570$2$F$$20240315$20240409$20240812$PER$$US-AstraZeneca-2024A064752$ASTRAZENECA$$$$$$Y$$$20240812$$CN$US$
237225713$23722571$3$F$20240403$20240715$20240409$20240718$EXP$$AU-AstraZeneca-2024A082857$ASTRAZENECA$$24979$DY$$F$Y$$$20240719$$MD$AU$
237225842$23722584$2$F$$20240924$20240409$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055840$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$83.91$KG$20240926$$CN$US$US
237225922$23722592$2$F$20220101$20240628$20240409$20240704$EXP$$CA-JNJFOC-20221024064$JOHNSON AND JOHNSON$$14$YR$T$M$Y$46.9$KG$20240704$$HP$CA$CA
237226152$23722615$2$F$$20240805$20240409$20240811$PER$$US-RDY-SPO/USA/24/0005256$DR REDDYS$$43$YR$A$F$Y$$$20240811$$MD$US$US
237226354$23722635$4$F$20240415$20240422$20240409$20240926$PER$$US-GSK-US2024AMR042132$GLAXOSMITHKLINE$$84$YR$$F$Y$$$20240926$$CN$US$US
237226405$23722640$5$F$20240328$20240716$20240409$20240723$EXP$$CA-GSK-CA2023113934$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$HP$CA$CA
237226523$23722652$3$F$20230101$20240905$20240409$20240909$EXP$$US-PFIZER INC-202400079119$PFIZER$$60$YR$$M$Y$$$20240909$$HP$US$US
237226793$23722679$3$F$20230607$20240704$20240409$20240712$EXP$$NVSC2023IN135172$NOVARTIS$$66$YR$$F$Y$$$20240712$$CN$IN$IN
237226983$23722698$3$F$$20240711$20240409$20240716$PER$$US-PFIZER INC-202400080731$PFIZER$$57$YR$$F$Y$47.63$KG$20240716$$HP$US$US
2372270312$23722703$12$F$$20240730$20240409$20240801$EXP$$US-PFIZER INC-PV202200124939$PFIZER$$72$YR$$F$Y$80.74$KG$20240801$$CN$US$US
237227042$23722704$2$F$20240403$20240803$20240409$20240806$PER$$US-PFIZER INC-202400082091$PFIZER$$13$YR$$M$Y$$$20240806$$CN$US$US
237227322$23722732$2$F$$20240913$20240409$20240916$PER$$US-PFIZER INC-PV202300178540$PFIZER$$74$YR$$F$Y$$$20240916$$CN$US$US
237227642$23722764$2$F$20240402$20240716$20240409$20240718$EXP$$CN-PFIZER INC-PV202400045566$PFIZER$$53$YR$$F$Y$$$20240718$$HP$CN$CN
237227743$23722774$3$F$20240101$20240923$20240409$20240926$EXP$$CA-PFIZER INC-202300249419$PFIZER$$67$YR$$F$Y$97$KG$20240926$$MD$CA$CA
237228092$23722809$2$F$$20240708$20240409$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054844$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240708$$CN$US$US
237228105$23722810$5$F$20240222$20240705$20240409$20240709$EXP$$CO-GSK-CO2024AMR043170$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$CO$CO
237228202$23722820$2$F$20240101$20240719$20240409$20240723$EXP$$CA-PFIZER INC-202400071986$PFIZER$$47$YR$$F$Y$67$KG$20240723$$HP$CA$CA
237228252$23722825$2$F$$20240814$20240409$20240819$EXP$$FR-PFIZER INC-202400078368$PFIZER$$71$YR$$F$Y$$$20240819$$MD$FR$FR
237228312$23722831$2$F$$20240709$20240409$20240710$EXP$$US-JNJFOC-20240402946$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
237228492$23722849$2$F$$20240826$20240409$20240902$EXP$$CA-GSK-CA2024042092$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$CA$CA
237229122$23722912$2$F$20230901$20240722$20240409$20240726$EXP$$JP-009507513-2404JPN000417J$MERCK$$6$DEC$$M$Y$$$20240726$$MD$JP$JP
237229273$23722927$3$F$$20240625$20240409$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202404005143$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240702$$CN$US$US
237229473$23722947$3$F$20240327$20240909$20240409$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-029987$JAZZ$$52$YR$$F$Y$$$20240913$$HP$US$US
237229496$23722949$6$F$20240101$20240918$20240409$20240923$EXP$$CA-PFIZER INC-202300210115$PFIZER$$52$YR$$M$Y$85.9$KG$20240923$$MD$CA$CA
237229602$23722960$2$F$$20240912$20240409$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055836$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240917$$HP$US$US
237229982$23722998$2$F$20171001$20240704$20240409$20240708$EXP$$CA-PFIZER INC-202400080287$PFIZER$$81$YR$$F$Y$$$20240708$$CN$CA$CA
237230144$23723014$4$F$20230827$20240723$20240409$20240725$EXP$$CA-PFIZER INC-202300289180$PFIZER$$64$YR$$F$Y$63.1$KG$20240725$$HP$CA$CA
237230205$23723020$5$F$$20240827$20240409$20240829$EXP$$US-009507513-2404USA005383$MERCK$Grabie M, Cyr A M, Copeland-Halperin R S. Abatacept and ruxolitinib for pembrolizumab induced myocarditis with cardiogenic shock refractory to high dose steroids. Journal of the American College of Cardiology. 2024;83 (13):3614$68$YR$$M$Y$$$20240829$$MD$US$US
237230342$23723034$2$F$$20240715$20240409$20240716$30DAY$$GB-SANDOZ INC.-SDZ2024GB017629$SANDOZ$$$$$M$Y$$$20240716$$CN$GB$GB
237230352$23723035$2$F$20230501$20240401$20240409$20240816$EXP$$BR-SANDOZ INC.-SDZ2024BR037165$SANDOZ$$52$YR$$F$Y$$$20240816$$CN$BR$BR
237230363$23723036$3$F$20180802$20240822$20240409$20240826$EXP$$CA-SANDOZ INC.-PHHY2009CA16890$SANDOZ$$78$YR$$M$Y$$$20240826$$HP$CA$CA
237230524$23723052$4$F$$20240715$20240409$20240718$30DAY$$GB-SANDOZ INC.-SDZ2024GB006325$SANDOZ$$$$$F$Y$$$20240718$$CN$GB$GB
237231084$23723108$4$F$$20240708$20240409$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055767$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240710$$CN$US$US
237231213$23723121$3$F$$20240710$20240409$20240712$EXP$$US-SANDOZ INC.-SDZ2024US037426$SANDOZ$$$$$F$Y$$$20240712$$CN$US$US
237231443$23723144$3$F$20240311$20240723$20240409$20240726$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-001906$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240726$$MD$US$US
237231463$23723146$3$F$20240301$20240627$20240409$20240703$EXP$$JP-Eisai-EC-2024-163143$EISAI$$$$A$F$Y$$$20240703$$MD$JP$JP
237231953$23723195$3$F$$20240925$20240409$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052331$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240926$$CN$US$US
237231972$23723197$2$F$20240401$20240815$20240409$20240819$PER$$NVSC2024US075273$NOVARTIS$$50$YR$$M$Y$98$KG$20240819$$CN$US$US
237232802$23723280$2$F$20240404$20240822$20240409$20240826$PER$$US-JNJFOC-20240414724$JOHNSON AND JOHNSON$$20$YR$A$M$Y$79.45$KG$20240826$$PH$US$US
237232923$23723292$3$F$20230101$20240806$20240409$20240812$EXP$$JP-009507513-2404JPN000422J$MERCK$$52$YR$$F$Y$$$20240812$$MD$JP$JP
237232937$23723293$7$F$20240304$20240717$20240409$20240724$EXP$$CA-GSK-CA2024029812$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$CA$CA
237233502$23723350$2$F$$20240805$20240409$20240807$30DAY$$US-PFIZER INC-PV202400044179$PFIZER$$$$$F$Y$$$20240807$$HP$US$US
237233553$23723355$3$F$$20240812$20240409$20240814$PER$$NVSC2024US074148$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
237233633$23723363$3$F$$20240621$20240409$20240706$EXP$$IT-ROCHE-3535839$ROCHE$$3$YR$C$M$Y$$$20240706$$MD$IT$IT
237233722$23723372$2$F$20240404$20240718$20240409$20240719$PER$$US-JNJFOC-20240415143$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240719$$CN$US$US
237233743$23723374$3$F$$20240906$20240409$20240910$30DAY$$US-PFIZER INC-202400075974$PFIZER$$71$YR$$M$Y$$$20240910$$CN$US$US
237234015$23723401$5$F$20240515$20240828$20240409$20240905$EXP$$ZA-TAKEDA-2024TUS032922$TAKEDA$$5$YR$$M$Y$$$20240905$$CN$ZA$ZA
237234082$23723408$2$F$20240401$20240712$20240409$20240801$EXP$$US-SA-2023SA254648$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240719$$MD$US$US
237234153$23723415$3$F$$20240723$20240409$20240729$EXP$$JP-SA-2024SA107635$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240729$$MD$JP$JP
237234254$23723425$4$F$20240101$20240912$20240409$20240925$EXP$$US-SA-2024SA107587$SANOFI AVENTIS$$63$YR$A$F$Y$67.574$KG$20240925$$MD$US$US
237234325$23723432$5$F$$20240625$20240409$20240702$EXP$$PT-SA-2024SA105649$SANOFI AVENTIS$$$$E$$Y$$$20240702$$CN$CH$PT
237234483$23723448$3$F$20240329$20240823$20240409$20240906$PER$$US-SA-2024SA103388$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240906$$MD$US$US
237234552$23723455$2$F$20240101$20240918$20240409$20240926$PER$$US-SA-2024SA103179$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240926$$MD$US$US
237234662$23723466$2$F$20240101$20240826$20240409$20240909$PER$$US-SA-2024SA102598$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240909$$MD$US$US
237234672$23723467$2$F$$20240917$20240409$20240924$PER$$US-SA-2024SA103971$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240924$$MD$US$US
237234934$23723493$4$F$$20240805$20240409$20240808$30DAY$$US-PFIZER INC-PV202400044109$PFIZER$$$$$$Y$$$20240808$$HP$US$US
237234973$23723497$3$F$$20240706$20240409$20240715$PER$$US-SA-2024SA103584$SANOFI AVENTIS$$$$A$F$Y$$$20240715$$MD$US$US
237235175$23723517$5$F$20240101$20240725$20240409$20240805$PER$$US-SA-2024SA105530$SANOFI AVENTIS$$16$YR$T$M$Y$44.9$KG$20240805$$CN$US$US
237235182$23723518$2$F$20240401$20240627$20240409$20240709$PER$$US-SA-2024SA106658$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240709$$MD$US$US
237235482$23723548$2$F$$20240701$20240409$20240710$PER$$US-SA-2024SA105562$SANOFI AVENTIS$$91$YR$E$M$Y$$$20240710$$MD$US$US
237235514$23723551$4$F$20240101$20240717$20240409$20240723$PER$$US-SA-2024SA095424$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240722$$MD$US$US
237235693$23723569$3$F$$20240725$20240409$20240805$PER$$US-SA-2024SA105444$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240804$$MD$US$US
237235912$23723591$2$F$20240201$20240816$20240409$20240829$PER$$US-SA-2024SA106405$SANOFI AVENTIS$$63$YR$A$F$Y$86.18$KG$20240829$$MD$US$US
237235933$23723593$3$F$$20240628$20240409$20240708$PER$$US-SA-2024SA100894$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240708$$MD$US$US
237235973$23723597$3$F$20240405$20240722$20240409$20240725$PER$$US-PFIZER INC-202300257101$PFIZER$$40$YR$$M$Y$60.78$KG$20240725$$CN$US$US
237236054$23723605$4$F$$20240823$20240409$20240829$PER$$US-PFIZER INC-PV202400047167$PFIZER$$61$YR$$M$Y$$$20240829$$HP$US$US
237236073$23723607$3$F$20240101$20240903$20240409$20240905$PER$$US-PFIZER INC-PV202400046258$PFIZER$$61$YR$$F$Y$$$20240905$$HP$US$US
237236442$23723644$2$F$20240329$20240830$20240409$20240903$EXP$$US-MYLANLABS-2024M1030727$MYLAN$$47$YR$$F$Y$$$20240903$$HP$US$US
237236524$23723652$4$F$20240129$20240910$20240409$20240917$EXP$$JP-EMD Serono-2024012436$EMD SERONO INC$$75$YR$E$M$Y$68$KG$20240917$$MD$JP$JP
237236723$23723672$3$F$20240701$20240711$20240409$20240716$EXP$$NVSC2024US075376$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
237236932$23723693$2$F$20240403$20240708$20240409$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054436$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240708$$CN$US$US
237237112$23723711$2$F$20090311$20240710$20240409$20240711$EXP$$CH-PFIZER INC-202100932996$PFIZER$$29$YR$$F$Y$$$20240711$$CN$CH$CH
237237222$23723722$2$F$20240405$20240913$20240409$20240917$PER$$CA-BRACCO-2024CA01838$BRACCO$$23$YR$$M$Y$$$20240917$$HP$CA$CA
237237252$23723725$2$F$20231105$20240710$20240409$20240720$EXP$FR-AFSSAPS-NT2024000168$FR-TEVA-VS-3178555$TEVA$$27$YR$$F$Y$$$20240720$$MD$FR$FR
237237543$23723754$3$F$$20240806$20240409$20240814$EXP$$CA-TEVA-VS-3179991$TEVA$$65$YR$$M$Y$$$20240814$$HP$CA$CA
237237843$23723784$3$F$$20240711$20240409$20240712$30DAY$$US-PFIZER INC-PV202400044123$PFIZER$$$$$$Y$$$20240712$$HP$US$US
237237936$23723793$6$F$$20240830$20240409$20240903$30DAY$$US-PFIZER INC-202400077896$PFIZER$$$$$$Y$$$20240903$$HP$US$US
237237942$23723794$2$F$$20240805$20240409$20240807$30DAY$$US-PFIZER INC-PV202400044518$PFIZER$$$$$$Y$$$20240807$$HP$US$US
237238243$23723824$3$F$$20240827$20240409$20240831$EXP$$NVSC2024CO052522$NOVARTIS$$$$$F$Y$60$KG$20240831$$CN$CO$CO
237238572$23723857$2$F$$20240802$20240409$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439951$RANBAXY$Wong EA, Wu M. A rare case of flecainide-induced encephalopathy. HeartRhythm Case Rep. 2024;10 (3):201-202$71$YR$$F$Y$$$20240816$$MD$US$US
237238702$23723870$2$F$$20240625$20240409$20240710$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440134$RANBAXY$Kurtov M, Kilic P, Ikic L, Kurtov K, Dorcic G, Vodanovic M, et al.. Ciprofloxacin-Induced Anaphylactic Reaction Followed by Negative Provocation Test in Response to Levofloxacin: A Case Report. MedicinaKaunas. 2023;59:1784$33$YR$$M$Y$$$20240710$$HP$HR$HR
237239392$23723939$2$F$$20240917$20240409$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202404000730$ELI LILLY AND CO$$$$$F$Y$$$20240924$$CN$US$US
237239553$23723955$3$F$$20240917$20240409$20240921$EXP$$CA-TEVA-VS-3179889$TEVA$$62$YR$$M$Y$$$20240921$$MD$CA$CA
237239563$23723956$3$F$$20240917$20240409$20240927$EXP$$CA-TEVA-VS-3179662$TEVA$$68$YR$$M$Y$$$20240927$$MD$CA$CA
237239702$23723970$2$F$$20240709$20240409$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056128$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240709$$CN$US$US
237239952$23723995$2$F$$20240903$20240409$20240909$EXP$$ES-SANDOZ INC.-SDZ2024ES037340$SANDOZ$$57$YR$$M$Y$$$20240909$$MD$ES$ES
237240003$23724000$3$F$$20240804$20240409$20240809$EXP$$US-JNJFOC-20240424072$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$MD$US$US
237240195$23724019$5$F$20240329$20240627$20240409$20240702$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-001945$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240702$$MD$US$US
237240522$23724052$2$F$20240311$20240802$20240409$20240809$EXP$$FR-AstraZeneca-2024A083856$ASTRAZENECA$$22194$DY$$F$Y$62$KG$20240809$$MD$FR$
237240612$23724061$2$F$20240407$20240802$20240409$20240806$PER$$US-AMGEN-USASP2024071018$AMGEN$$64$YR$A$M$Y$$$20240806$$CN$US$US
237240732$23724073$2$F$$20240729$20240409$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056099$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240730$$CN$US$US
237240753$23724075$3$F$$20240912$20240409$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056021$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$73.94$KG$20240913$$CN$US$US
237241492$23724149$2$F$20240301$20240912$20240409$20240919$EXP$$US-BIOGEN-2024BI01258533$BIOGEN$$56$YR$$F$Y$$$20240919$$HP$US$US
237241522$23724152$2$F$20240207$20240912$20240409$20240913$EXP$$JP-GENMAB-2024-00448AA$GENMAB$$74$YR$$F$Y$82.5$KG$20240913$$MD$JP$JP
237241613$23724161$3$F$$20240705$20240409$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055729$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240708$$CN$US$US
237241683$23724168$3$F$20240810$20240826$20240409$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055713$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240829$$HP$US$US
237242212$23724221$2$F$20240407$20240802$20240409$20240806$PER$$US-AMGEN-USASP2024071003$AMGEN$$53$YR$A$M$Y$$$20240806$$CN$US$US
237242273$23724227$3$F$$20240805$20240409$20240807$EXP$$BE-009507513-2404BEL001414$MERCK$Verhe M, De Somer T, Defoort B, Vanderstraeten E, Monsaert E, Bouderez V et al. The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report. Case Reports in Oncology. 2023;16 (1):438-445$73$YR$$M$Y$$$20240807$$HP$BE$BE
237242284$23724228$4$F$20240101$20240702$20240409$20240709$PER$$US-KARYOPHARM-2024KPT000888$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240709$$CN$US$US
237242463$23724246$3$F$20240101$20240717$20240409$20240819$PER$$US-KARYOPHARM-2024KPT000881$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240819$$CN$US$US
237242932$23724293$2$F$$20240614$20240409$20240709$PER$$US-SA-2024SA103746$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240709$$MD$US$US
237242952$23724295$2$F$20240309$20240709$20240409$20240718$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009183$UNITED THERAPEUTICS$$60$YR$$F$Y$66.667$KG$20240718$$$US$US
237243312$23724331$2$F$$20240909$20240409$20240910$EXP$$CA-BAUSCH-BL-2024-005702$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240910$$MD$CA$CA
237243353$23724335$3$F$$20240708$20240409$20240709$EXP$$CA-BAUSCH-BL-2024-005703$BAUSCH AND LOMB$$44$YR$$M$Y$$$20240709$$CN$CA$CA
237243372$23724337$2$F$$20240909$20240409$20240910$EXP$$CA-BAUSCH-BL-2024-005717$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240910$$HP$CA$CA
237243442$23724344$2$F$$20240801$20240409$20240807$EXP$$AU-AstraZeneca-2024A081789$ASTRAZENECA$$$$$F$Y$$$20240807$$MD$AU$
237243512$23724351$2$F$$20240722$20240409$20240726$EXP$$US-LUNDBECK-DKLU3076365$LUNDBECK$$$$$$Y$$$20240726$$CN$US$US
237243622$23724362$2$F$20240301$20240722$20240409$20240803$PER$$US-SA-2024SA105723$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240803$$MD$US$US
237246702$23724670$2$F$20240404$20240727$20240409$20240730$PER$$US-AMGEN-USASP2024070416$AMGEN$$68$YR$E$F$Y$$$20240729$$CN$US$US
237246732$23724673$2$F$20240207$20240902$20240409$20240909$EXP$$JP-009507513-2404JPN000464J$MERCK$$57$YR$$F$Y$80.1$KG$20240909$$PH$JP$JP
237247453$23724745$3$F$20230101$20240814$20240409$20240820$EXP$$CO-ABBVIE-5711326$ABBVIE$$$$$M$Y$72$KG$20240820$$CN$CO$CO
237247463$23724746$3$F$20240301$20240705$20240409$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055563$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240708$$CN$US$US
237247563$23724756$3$F$$20240708$20240409$20240717$EXP$$US-BEH-2024170470$CSL BEHRING$$$$$$Y$$$20240717$$HP$US$US
237247596$23724759$6$F$20240322$20240628$20240409$20240703$PER$$US-AMGEN-USASP2024071155$AMGEN$$73$YR$E$F$Y$$$20240702$$CN$US$US
237247642$23724764$2$F$$20240708$20240409$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055281$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240708$$HP$US$US
237247833$23724783$3$F$$20240708$20240409$20240717$EXP$$US-BEH-2024170469$CSL BEHRING$$$$$$Y$$$20240717$$HP$US$US
237247854$23724785$4$F$$20240819$20240409$20240828$EXP$$JP-JNJFOC-20240407918$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$HP$JP$JP
237248232$23724823$2$F$20220815$20240625$20240409$20240701$EXP$$IT-AMGEN-ITANI2024069659$AMGEN$$64$YR$A$M$Y$83$KG$20240701$$MD$IT$IT
237248773$23724877$3$F$20231028$20240909$20240410$20240913$EXP$$CO-TAKEDA-2023TUS105879$TAKEDA$$37$YR$$M$Y$64$KG$20240913$$CN$CO$CO
237248813$23724881$3$F$$20240708$20240410$20240718$EXP$$US-BEH-2024170316$CSL BEHRING$$$$$$Y$$$20240718$$HP$US$US
237248852$23724885$2$F$20240201$20240715$20240410$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001032$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240809$$CN$US$US
237248933$23724893$3$F$20240401$20240702$20240410$20240703$EXP$$NVSJ2024JP004259$NOVARTIS$$$$$$Y$$$20240704$$MD$JP$JP
237249053$23724905$3$F$$20240708$20240410$20240717$EXP$$US-BEH-2024170315$CSL BEHRING$$$$$$Y$$$20240717$$HP$US$US
237249205$23724920$5$F$20240101$20240909$20240410$20240917$EXP$$CA-CELLTRION INC.-2024CA008358$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
237249292$23724929$2$F$$20240725$20240410$20240731$PER$$NVSC2024US074395$NOVARTIS$$$$$F$Y$$$20240731$$CN$US$US
237249502$23724950$2$F$20240101$20240911$20240410$20240912$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-004593$BOEHRINGER INGELHEIM$$84$YR$E$M$Y$$$20240912$$CN$US$US
237249773$23724977$3$F$$20240708$20240410$20240717$EXP$$US-BEH-2024170314$CSL BEHRING$$$$$$Y$$$20240717$$HP$US$US
237250152$23725015$2$F$$20240711$20240410$20240722$PER$$US-SA-2024SA105355$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240722$$MD$US$US
237250233$23725023$3$F$$20240708$20240410$20240717$EXP$$US-BEH-2024170313$CSL BEHRING$$$$$$Y$$$20240717$$HP$US$US
237250302$23725030$2$F$20240201$20240816$20240410$20240829$PER$$US-SA-2024SA105485$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240829$$MD$US$US
237250324$23725032$4$F$20240101$20240724$20240410$20240802$PER$$US-SA-2024SA102320$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240802$$MD$US$US
237250515$23725051$5$F$20240126$20240718$20240410$20240725$EXP$$JP-AMGEN-JPNSP2024070817$AMGEN$$$$E$F$Y$$$20240725$$MD$JP$JP
237251013$23725101$3$F$$20240819$20240410$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-009529$UNITED THERAPEUTICS$$$$$F$Y$79.365$KG$20240827$$$US$US
2372510210$23725102$10$F$20240101$20240916$20240410$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-009761$UNITED THERAPEUTICS$$$$$F$Y$70.748$KG$20240921$$$US$US
237251082$23725108$2$F$20231213$20240711$20240410$20240715$EXP$$JP-TAKEDA-2024TJP005154$TAKEDA$$82$YR$$F$Y$$$20240715$$MD$JP$JP
237251233$23725123$3$F$20240407$20240820$20240410$20240824$PER$$US-AMGEN-USASP2024071012$AMGEN$$62$YR$A$M$Y$$$20240824$$CN$US$US
237251323$23725132$3$F$$20240916$20240410$20240918$EXP$$CA-ROCHE-3540635$ROCHE$$$$A$F$Y$$$20240918$$CN$CA$CA
237251443$23725144$3$F$20230101$20240628$20240410$20240709$30DAY$$US-NOVOPROD-1200316$NOVO NORDISK$$$$$F$Y$$$20240709$$CN$US$US
237251523$23725152$3$F$$20240807$20240410$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055802$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240812$$CN$US$US
237251572$23725157$2$F$20240319$20240718$20240410$20240725$EXP$$CA-NOVOPROD-1199407$NOVO NORDISK$$947$YR$$M$Y$98$KG$20240725$$MD$CA$CA
237251966$23725196$6$F$20230628$20240919$20240410$20240926$EXP$$CA-GSK-CA2023AMR078408$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$CA$CA
237252184$23725218$4$F$20240101$20240923$20240410$20240930$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-008906$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$$$20240930$$CN$US$US
237252386$23725238$6$F$20240418$20240917$20240410$20240925$EXP$$US-GSK-US2024AMR043178$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
237252593$23725259$3$F$20230417$20240916$20240410$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-056073$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$63.9$KG$20240916$$PH$JP$JP
237253012$23725301$2$F$$20240812$20240410$20240813$EXP$$CA-BAUSCH-BL-2024-005680$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240813$$HP$CA$CA
237253022$23725302$2$F$$20240626$20240410$20240704$EXP$$CA-ABBVIE-5560819$ABBVIE$$$$$F$Y$$$20240704$$HP$CA$CA
237253152$23725315$2$F$20240222$20240619$20240410$20240704$EXP$FR-AFSSAPS-AM2024000190$FR-TEVA-VS-3178227$TEVA$$40$YR$$F$Y$$$20240704$$MD$FR$FR
237253232$23725323$2$F$20240406$20240722$20240410$20240724$PER$$US-AMGEN-USASP2024071034$AMGEN$$86$YR$E$M$Y$$$20240723$$CN$US$US
237253432$23725343$2$F$20240404$20240729$20240410$20240731$PER$$US-AMGEN-USASP2024070450$AMGEN$$75$YR$E$F$Y$$$20240731$$CN$US$US
237253712$23725371$2$F$$20240809$20240410$20240823$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440139$RANBAXY$Jain RS, Srivastava T, Sharma P, Pemawat A. Levetiracetam?Mediated Drug?Induced Liver Injury - A Rare Presentation and Review of Literature. Ann Indian Acad Neurol. 2024;27 (1):87-90$30$YR$$M$Y$$$20240823$$HP$IN$IN
237253796$23725379$6$F$20240101$20240920$20240410$20240930$EXP$$CA-CELLTRION INC.-2024CA008436$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
237253802$23725380$2$F$$20240809$20240410$20240813$PER$$NVSC2024US074840$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
237253863$23725386$3$F$20240402$20240911$20240410$20240918$EXP$$SA-GSK-SA2023EME003340$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$SA$SA
237253872$23725387$2$F$$20240724$20240410$20240731$EXP$$CA-GSK-CA2024043299$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$CA$CA
237253884$23725388$4$F$20240402$20240626$20240410$20240703$30DAY$$US-AMGEN-USASP2024069588$AMGEN$$69$YR$E$M$Y$74.6$KG$20240702$$PH$US$US
237253932$23725393$2$F$20240408$20240813$20240410$20240814$PER$$US-AMGEN-USASP2024070849$AMGEN$$51$YR$A$M$Y$$$20240814$$CN$US$US
237254072$23725407$2$F$20240301$20240819$20240410$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052940$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240823$$CN$US$US
237254082$23725408$2$F$$20240705$20240410$20240717$EXP$$IN-ROCHE-3533386$ROCHE$$63$YR$A$M$Y$$$20240717$$MD$IN$IN
237254202$23725420$2$F$20230101$20240805$20240410$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202404005142$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240808$$CN$US$US
237254222$23725422$2$F$20240101$20240911$20240410$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202404005710$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240919$$CN$US$US
237254434$23725443$4$F$20230101$20240717$20240410$20240722$PER$$US-AMGEN-USASP2024071481$AMGEN$$81$YR$E$F$Y$$$20240722$$CN$US$US
237254463$23725446$3$F$$20240626$20240410$20240703$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000301$DECIPHERA PHARMACEUTICALS$$59$YR$A$F$Y$$$20240703$$CN$US$US
237254492$23725449$2$F$20240407$20240806$20240410$20240808$PER$$US-AMGEN-USASP2024071477$AMGEN$$78$YR$E$F$Y$$$20240808$$CN$US$US
237254523$23725452$3$F$$20240915$20240410$20240924$EXP$$CA-CELLTRION INC.-2024CA008294$CELLTRION$$$$$$Y$$$20240924$$CN$CA$CA
237254572$23725457$2$F$20240405$20240718$20240410$20240725$PER$$US-AMGEN-USASP2024070430$AMGEN$$41$YR$A$M$Y$$$20240725$$CN$US$US
237255142$23725514$2$F$20240301$20240902$20240410$20240919$PER$$CO-TOLMAR, INC.-24CO047753$TOLMAR$$80$YR$$M$Y$$$20240918$$CN$CO$CO
237255162$23725516$2$F$20240313$20240902$20240410$20240910$EXP$$CO-TOLMAR, INC.-24CO047766$TOLMAR$$84$YR$$M$Y$$$20240910$$CN$CO$CO
237255412$23725541$2$F$20240312$20240806$20240410$20240830$30DAY$$US-BECTON DICKINSON-US-BD-24-000191$BECTON DICKINSON$$$$$$Y$$$20240830$$CN$US$US
237255504$23725550$4$F$20240306$20240726$20240410$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055050$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240729$$CN$US$US
237255572$23725557$2$F$20240407$20240720$20240410$20240725$PER$$US-AMGEN-USASP2024071380$AMGEN$$64$YR$A$F$Y$$$20240725$$CN$US$US
237256033$23725603$3$F$$20240617$20240410$20240711$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001275$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
237256232$23725623$2$F$20231226$20240812$20240410$20240821$EXP$FR-AFSSAPS-TO2024000378$FR-TEVA-VS-3178327$TEVA$$77$YR$$F$Y$$$20240821$$PH$FR$FR
237256314$23725631$4$F$$20240905$20240410$20240916$EXP$$GB-TAKEDA-2024TUS028016$TAKEDA$$$$$M$Y$$$20240916$$CN$GB$GB
237256334$23725633$4$F$20240325$20240825$20240410$20240828$EXP$$US-TAKEDA-2024TUS030327$TAKEDA$$64$YR$$F$Y$81.769$KG$20240828$$CN$US$US
237256582$23725658$2$F$$20240709$20240410$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056061$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240709$$CN$US$US
237257052$23725705$2$F$20240402$20240719$20240410$20240724$PER$$US-AMGEN-USASP2024069941$AMGEN$$84$YR$E$F$Y$$$20240724$$CN$US$US
237257323$23725732$3$F$20240301$20240405$20240410$20240808$EXP$$NVSC2024US074260$NOVARTIS$$42$YR$$F$Y$$$20240808$$CN$US$US
237257345$23725734$5$F$$20240909$20240410$20240917$EXP$$CA-JNJFOC-20240419603$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240917$$PH$CA$CA
237257394$23725739$4$F$20230810$20240912$20240410$20240926$EXP$$JP-UCBSA-2023045359$UCB$$16$YR$$M$Y$47$KG$20240926$$MD$JP$JP
237257523$23725752$3$F$20240306$20240716$20240410$20240717$PER$$US-AMGEN-USASP2024071488$AMGEN$$66$YR$E$M$Y$$$20240716$$CN$US$US
237257542$23725754$2$F$$20240718$20240410$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055824$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240719$$CN$US$US
237257704$23725770$4$F$$20240718$20240410$20240723$PER$$NVSC2024US075687$NOVARTIS$$64$YR$$M$Y$$$20240723$$HP$US$US
237258073$23725807$3$F$20240301$20240729$20240410$20240801$EXP$$US-TAKEDA-2024TUS033023$TAKEDA$$63$YR$$M$Y$$$20240801$$CN$US$US
237258132$23725813$2$F$20240101$20240719$20240410$20240729$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-056632$REGENERON$$82$YR$$M$Y$$$20240729$$HP$CO$CO
237258462$23725846$2$F$$20240704$20240410$20240709$EXP$$NVSC2024GB009589$NOVARTIS$$$$$F$Y$$$20240709$$CN$GB$GB
237258492$23725849$2$F$20240325$20240704$20240410$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-055989$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$49.2$KG$20240712$$MD$JP$JP
237258754$23725875$4$F$20240101$20240905$20240410$20240914$EXP$$CA-CELLTRION INC.-2024CA006783$CELLTRION$$$$$$Y$$$20240914$$MD$CA$CA
237258822$23725882$2$F$$20240404$20240410$20240725$EXP$$US-009507513-2404USA004169$MERCK$Sanchez C, Alhusain R, Ray JC, Perez-Downes J. A case of immune check point inhibitor mediated myopericarditis: managing a rare adverse reaction. Journal of the American College of Cardiology. 2024;83(13) Suppl A:3204$54$YR$$M$Y$$$20240725$$HP$US$US
237258862$23725886$2$F$20240301$20240402$20240410$20240720$EXP$$CA-CELLTRION INC.-2024CA008373$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
237259263$23725926$3$F$$20240709$20240410$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056509$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240709$$CN$US$US
237259275$23725927$5$F$20240301$20240723$20240410$20240725$PER$$US-AMGEN-USASP2024071590$AMGEN$$67$YR$E$M$Y$$$20240725$$CN$US$US
237259482$23725948$2$F$20240331$20240718$20240410$20240724$EXP$$US-AMGEN-USASP2024069099$AMGEN$$66$YR$E$F$Y$$$20240724$$CN$US$US
237259743$23725974$3$F$20240407$20240716$20240410$20240718$PER$$US-AMGEN-USASP2024071137$AMGEN$$58$YR$A$F$Y$$$20240718$$CN$US$US
237261412$23726141$2$F$20240402$20240716$20240410$20240717$EXP$$US-TAKEDA-2024TUS033073$TAKEDA$$63$YR$$F$Y$$$20240717$$CN$US$US
237261502$23726150$2$F$20240101$20240904$20240410$20240912$EXP$$US-SA-2024SA105679$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$MD$US$US
237261516$23726151$6$F$20240201$20240726$20240410$20240807$PER$$US-JNJFOC-20240418877$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240807$$CN$US$US
237261778$23726177$8$F$$20240812$20240410$20240822$EXP$$FR-AUROBINDO-AUR-APL-2023-040764$AUROBINDO$Delbet J, Hogan J, Parmentier C, Ulinski T, Dossier C.. Successful global anti-B-cell strategy with daratumumab in a patient with post-transplant nephrotic syndrome recurrence unresponsive to immunoadsorption and obinutuzumab. PEDIATRIC TRANSPLANTATION. 2023;27:14544$2$YR$$F$Y$$$20240822$$MD$FR$FR
237262174$23726217$4$F$20240408$20240708$20240410$20240710$EXP$$JP-ASTELLAS-2024JP002376$ASTELLAS$$$$E$$Y$$$20240710$$MD$JP$JP
237262292$23726229$2$F$$20240702$20240410$20240703$EXP$$NVSC2024DE075287$NOVARTIS$$$$A$F$Y$$$20240704$$CN$DE$DE
237262314$23726231$4$F$$20240731$20240410$20240802$EXP$$NVSC2024VE075483$NOVARTIS$$$$A$M$Y$$$20240802$$CN$VE$VE
237262544$23726254$4$F$20240305$20240809$20240410$20240823$EXP$$DE-UCBSA-2024017199$UCB$$$$A$M$Y$100$KG$20240823$$MD$DE$DE
237262873$23726287$3$F$20240404$20240801$20240410$20240816$PER$$US-AMGEN-USASP2024069165$AMGEN$$82$YR$E$F$Y$68.299$KG$20240816$$HP$US$US
237263282$23726328$2$F$20240408$20240725$20240410$20240729$PER$$US-AMGEN-USASP2024070943$AMGEN$$77$YR$E$F$Y$$$20240729$$CN$US$US
237263292$23726329$2$F$20240407$20240724$20240410$20240725$PER$$US-AMGEN-USASP2024072030$AMGEN$$62$YR$A$M$Y$$$20240725$$PH$US$US
237263542$23726354$2$F$20220713$20240701$20240410$20240708$EXP$$SA-GSK-SA2022EME111361$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$SA$SA
237263552$23726355$2$F$20240104$20240918$20240410$20240930$PER$$NVSC2024US075872$NOVARTIS$$53$YR$$M$Y$88$KG$20240930$$HP$US$US
237263822$23726382$2$F$20240101$20240802$20240410$20240808$EXP$$US-ABBVIE-5711785$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
2372638510$23726385$10$F$20240301$20240917$20240410$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-006823$UNITED THERAPEUTICS$$37$YR$$F$Y$68.481$KG$20240927$$$US$US
237263915$23726391$5$F$20220901$20240923$20240410$20240930$EXP$$CA-GSK-CA2023131665$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$CA$CA
237263952$23726395$2$F$20240404$20240822$20240410$20240827$PER$$US-AMGEN-USASP2024071112$AMGEN$$63$YR$A$F$Y$$$20240826$$CN$US$US
237264073$23726407$3$F$20231224$20240712$20240410$20240722$EXP$$JP-009507513-2312JPN003990J$MERCK$$60$YR$$M$Y$$$20240722$$MD$JP$JP
237264572$23726457$2$F$$20240725$20240410$20240802$EXP$FR-AFSSAPS-AVNT2024000208$FR-SA-2024SA104099$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240803$$PH$FR$FR
237264613$23726461$3$F$20160501$20240828$20240410$20240903$EXP$$CA-TAKEDA-2016TUS009166$TAKEDA$$66$YR$$F$Y$$$20240903$$MD$CA$CA
237264772$23726477$2$F$$20240830$20240410$20240916$PER$$CA-TOLMAR, INC.-24CA047749$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
237264782$23726478$2$F$20240314$20240830$20240410$20240918$PER$$CA-TOLMAR, INC.-24CA047750$TOLMAR$$68$YR$$M$Y$$$20240918$$CN$CA$CA
237265616$23726561$6$F$20240101$20240724$20240410$20240801$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010333$UNITED THERAPEUTICS$$$$$F$Y$55.782$KG$20240801$$$US$US
237265918$23726591$8$F$20240531$20240924$20240410$20240925$PER$$US-BIOVITRUM-2024-US-005477$BIOVITRUM$$59$YR$$M$Y$$$20240925$$CN$US$US
237266013$23726601$3$F$20240514$20240809$20240410$20240816$EXP$$CA-GSK-CA2023131684$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$HP$CA$CA
237266092$23726609$2$F$$20240708$20240410$20240715$EXP$$US-ROCHE-3538801$ROCHE$$$$E$M$Y$$$20240715$$CN$US$US
237266794$23726679$4$F$20240405$20240725$20240410$20240729$PER$$US-AMGEN-USASP2024071226$AMGEN$$70$YR$E$F$Y$$$20240729$$CN$US$US
237266803$23726680$3$F$20240407$20240807$20240410$20240809$PER$$US-AMGEN-USASP2024071452$AMGEN$$58$YR$A$F$Y$$$20240809$$CN$US$US
237266812$23726681$2$F$20240301$20240717$20240410$20240726$EXP$$JP-009507513-2404JPN000739J$MERCK$$76$YR$$M$Y$$$20240726$$MD$JP$JP
237267244$23726724$4$F$$20240807$20240410$20240812$EXP$$US-TAKEDA-2024TUS019723$TAKEDA$$$$$M$Y$$$20240812$$CN$US$US
237267952$23726795$2$F$20240408$20240725$20240410$20240730$PER$$US-AMGEN-USASP2024071001$AMGEN$$61$YR$A$M$Y$$$20240730$$CN$US$US
237268163$23726816$3$F$$20240731$20240410$20240814$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440571$RANBAXY$Stoppa A, Roda E, Garcia-Esteve L, Roca-Lecumberri A. A case of pregnancy with severe polyhydramnios related to long-term use of lithium. Bipolar Disord. 2024;26:405-408$42$YR$$F$Y$$$20240814$$HP$ES$ES
237268854$23726885$4$F$20240329$20240712$20240410$20240723$PER$$US-SA-2024SA104741$SANOFI AVENTIS$$72$YR$E$F$Y$66$KG$20240723$$MD$US$US
237268953$23726895$3$F$$20240715$20240410$20240723$PER$$US-SA-2024SA103624$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240723$$MD$US$US
237269042$23726904$2$F$$20240718$20240410$20240801$PER$$US-SA-2024SA103966$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240801$$MD$US$US
237269352$23726935$2$F$20231211$20240702$20240410$20240709$PER$$US-SA-2024SA104491$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240709$$MD$US$US
237269422$23726942$2$F$20240301$20240806$20240410$20240816$PER$$US-SA-2024SA102092$SANOFI AVENTIS$$16$MON$I$M$Y$$$20240816$$MD$US$US
237269442$23726944$2$F$$20240903$20240410$20240926$PER$$US-SA-2024SA104301$SANOFI AVENTIS$$$$A$F$Y$119.7$KG$20240926$$MD$US$US
237269602$23726960$2$F$$20240802$20240410$20240813$PER$$US-SA-2024SA107661$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
237269893$23726989$3$F$20240101$20240827$20240410$20240911$PER$$US-SA-2024SA104713$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240911$$MD$US$US
237269982$23726998$2$F$20240101$20240703$20240410$20240712$PER$$US-SA-2024SA106607$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240712$$MD$US$US
237270052$23727005$2$F$20240101$20240820$20240410$20240830$PER$$US-SA-2024SA103877$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240830$$CN$US$US
237270163$23727016$3$F$$20240910$20240410$20240930$PER$$AU-TOLMAR, INC.-24AU047631$TOLMAR$$$$$M$Y$$$20240930$$CN$AU$AU
237270184$23727018$4$F$20240101$20240819$20240410$20240828$PER$$US-SA-2024SA103282$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240828$$MD$US$US
237270192$23727019$2$F$$20240912$20240410$20240920$PER$$US-SA-2024SA106683$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240921$$MD$US$US
237270462$23727046$2$F$$20240913$20240410$20240920$PER$$US-SA-2024SA106604$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240920$$HP$US$US
237270562$23727056$2$F$20240101$20240620$20240410$20240702$PER$$US-SA-2024SA104858$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240702$$MD$US$US
237270697$23727069$7$F$20231214$20240715$20240410$20240801$PER$$US-SA-2024SA030812$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240719$$MD$US$US
237270722$23727072$2$F$$20240726$20240410$20240805$PER$$US-SA-2024SA104696$SANOFI AVENTIS$$$$A$$Y$$$20240805$$PH$US$US
237270882$23727088$2$F$20240101$20240925$20240410$20240930$PER$$US-SA-2024SA108297$SANOFI AVENTIS$$61$YR$A$M$Y$97.52$KG$20240930$$MD$US$US
237270942$23727094$2$F$20240101$20240620$20240410$20240703$PER$$US-SA-2024SA107798$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240703$$MD$US$US
237270966$23727096$6$F$20240101$20240817$20240410$20240830$PER$$US-SA-2024SA107055$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240830$$CN$US$US
237271072$23727107$2$F$$20240722$20240410$20240730$PER$$US-SA-2024SA107495$SANOFI AVENTIS$$14$YR$T$M$Y$51.18$KG$20240730$$MD$US$US
237271093$23727109$3$F$$20240725$20240410$20240802$PER$$US-SA-2024SA104162$SANOFI AVENTIS$$9$YR$C$F$Y$27.66$KG$20240802$$MD$US$US
237271235$23727123$5$F$$20240704$20240410$20240705$EXP$$NVSC2024GB074624$NOVARTIS$$$$A$F$Y$$$20240705$$HP$GB$GB
237271313$23727131$3$F$20230101$20240924$20240410$20240926$EXP$FR-AFSSAPS-BR2024000307$FR-SA-2024SA107805$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240926$$MD$FR$FR
237271532$23727153$2$F$20231219$20240708$20240410$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054595$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240708$$MD$US$US
237271592$23727159$2$F$20240301$20240705$20240410$20240718$PER$$US-APOTEX-2024AP004057$APOTEX$$$$$F$Y$$$20240718$$CN$US$US
237272303$23727230$3$F$20240407$20240718$20240410$20240722$PER$$NVSC2024US075280$NOVARTIS$$65$YR$$F$Y$$$20240722$$CN$US$US
237272742$23727274$2$F$20230807$20240404$20240410$20240814$EXP$$NVSC2023CL178234$NOVARTIS$$62$YR$$F$Y$$$20240814$$HP$CL$CL
237273032$23727303$2$F$20180101$20240715$20240410$20240717$EXP$$NVSC2024FR074398$NOVARTIS$$58$YR$$M$Y$$$20240717$$PH$FR$FR
237273464$23727346$4$F$20240322$20240705$20240410$20240711$EXP$$CN-PFIZER INC-PV202400046096$PFIZER$$50$YR$$F$Y$47$KG$20240711$$HP$CN$CN
237273702$23727370$2$F$20231201$20240718$20240410$20240729$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202401010585$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240729$$CN$JP$JP
237274212$23727421$2$F$20240225$20240916$20240410$20240924$EXP$IT-MINISAL02-974407$IT-TEVA-VS-3179084$TEVA$$48$YR$$M$Y$$$20240924$$MD$IT$IT
237274523$23727452$3$F$$20240626$20240410$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02788$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237274532$23727453$2$F$20240919$20240926$20240410$20240930$PER$$US-BAYER-2024A049775$BAYER$$39$YR$A$F$Y$$$20240930$$HP$US$US
237274662$23727466$2$F$20230701$20240709$20240410$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056567$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$70.31$KG$20240709$$CN$US$US
237274962$23727496$2$F$20231120$20240912$20240410$20240919$EXP$$JP-009507513-2402JPN000683J$MERCK$$85$YR$$F$Y$53$KG$20240919$$PH$JP$JP
237275272$23727527$2$F$$20240815$20240410$20240820$EXP$$JP-009507513-2404JPN000286J$MERCK$Tamayama M, Oe A, Kageyama T, Hatori H, Oka A, Ninomiya K, et al.. 164 A case of hypothyroidism and isolated ACTH deficiency developed after administration of pembrolizumab. The 243rd Kinki Regional Meeting of the Japanese Society of Internal Medicine$70$YR$$F$Y$$$20240820$$MD$JP$JP
237275292$23727529$2$F$$20240730$20240410$20240805$EXP$$JP-009507513-2404JPN000294J$MERCK$Horikawa M, Suzuki Y, Midorikawa H, Kumata Y, Sotomura S, Kiyokawa T, et al.. O28-5 A case of gastric ulcer perforation developed during treatment with pembrolizumab for esophageal cancer. Journal of Abdominal Emergency Medicine, The 60th Annual Meeting of the Japanese. 2024;44(2):364$8$DEC$$M$Y$$$20240805$$HP$JP$JP
237275712$23727571$2$F$$20240709$20240410$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053032$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240709$$CN$US$US
237275732$23727573$2$F$$20240628$20240410$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02821$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237275943$23727594$3$F$20240101$20240701$20240410$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-009268$UNITED THERAPEUTICS$$$$$F$Y$113.38$KG$20240706$$$US$US
237275962$23727596$2$F$20240310$20240611$20240410$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001348$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240705$$CN$US$US
237276292$23727629$2$F$20240314$20240717$20240410$20240723$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000041$Unknown Manufacturer$$$$$$Y$$$20240723$$CN$US$US
237276313$23727631$3$F$20240401$20240906$20240410$20240918$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000044$Unknown Manufacturer$$$$$$Y$$$20240918$$CN$US$US
237277612$23727761$2$F$20240206$20240911$20240410$20240919$EXP$$JP-ROCHE-3543323$ROCHE$$76$YR$E$M$Y$50$KG$20240919$$MD$JP$JP
237277653$23727765$3$F$$20240911$20240410$20240920$EXP$$CA-TAKEDA-2024TUS033432$TAKEDA$$$$$F$Y$$$20240920$$MD$CA$CA
237277662$23727766$2$F$$20240628$20240410$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001609$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
237278105$23727810$5$F$$20240720$20240410$20240724$PER$$US-BIOVITRUM-2024-US-005420$BIOVITRUM$$77$YR$$M$Y$$$20240724$$CN$US$US
237278173$23727817$3$F$20240405$20240916$20240410$20240919$PER$$US-AMGEN-USASP2024072089$AMGEN$$61$YR$A$M$Y$$$20240918$$CN$US$US
237278323$23727832$3$F$20240410$20240410$20240410$20240717$EXP$$NVSC2024ZA071351$NOVARTIS$$38$YR$$F$Y$$$20240717$$HP$ZA$ZA
237278393$23727839$3$F$$20240716$20240410$20240723$PER$$US-BIOGEN-2024BI01258988$BIOGEN$$$$$F$Y$$$20240723$$HP$US$US
237278664$23727866$4$F$20230101$20240821$20240410$20240829$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00186$XERIS PHARMACEUTICALS$$$$$M$Y$104.31$KG$20240829$$CN$US$US
237279053$23727905$3$F$$20240708$20240410$20240711$EXP$$US-UCBSA-2024015352$UCB$$$$$F$Y$$$20240711$$HP$US$US
237279064$23727906$4$F$20240301$20240717$20240410$20240723$PER$$US-Eisai-EC-2024-162568$EISAI$$73$YR$E$F$Y$85.9$KG$20240723$$CN$US$US
237279072$23727907$2$F$$20240628$20240410$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02834$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237279522$23727952$2$F$$20240812$20240410$20240819$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000706$BLUEPRINT MEDICINES$$$$$F$Y$$$20240819$$CN$US$US
237279552$23727955$2$F$$20240626$20240410$20240702$EXP$$NVSC2024US074827$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
237279572$23727957$2$F$$20240627$20240410$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02879$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237279582$23727958$2$F$$20240913$20240410$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056693$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240916$$CN$US$US
237279642$23727964$2$F$20220702$20240705$20240410$20240713$EXP$$CA-SA-2024SA105450$SANOFI AVENTIS$$58$YR$A$M$Y$132$KG$20240713$$PH$CA$CA
237280084$23728008$4$F$20240318$20240924$20240410$20240927$EXP$$JP-Eisai-EC-2024-163055$EISAI$$56$YR$A$F$Y$52$KG$20240927$$MD$JP$JP
237280192$23728019$2$F$$20240709$20240410$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-056353$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240709$$MD$JP$JP
237280475$23728047$5$F$$20240902$20240410$20240913$30DAY$$AR-JNJFOC-20240365898$JOHNSON AND JOHNSON$$60$YR$A$F$Y$56$KG$20240913$$CN$AR$AR
237280565$23728056$5$F$20240329$20240924$20240410$20240930$PER$$JP-Eisai-EC-2024-163056$EISAI$$77$YR$E$F$Y$49$KG$20240930$$MD$JP$JP
237280882$23728088$2$F$$20240806$20240410$20240821$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-02899$LUPIN$$$$$$Y$$$20240821$$CN$AU$AU
237281056$23728105$6$F$20240101$20240920$20240410$20240926$PER$$US-KARYOPHARM-2024KPT000841$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240926$$CN$US$US
237281412$23728141$2$F$$20240404$20240410$20240807$EXP$$NVSC2024US073592$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
237281703$23728170$3$F$$20240924$20240410$20240925$EXP$$CA-SANDOZ INC.-SDZ2021CA000051$SANDOZ$$$$C$M$Y$$$20240925$$HP$CA$CA
237281716$23728171$6$F$20240101$20240828$20240410$20240909$PER$$US-SA-2024SA105724$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240909$$MD$US$US
237282052$23728205$2$F$$20240807$20240410$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-004568$JAZZ$$$$$M$Y$$$20240812$$HP$US$US
237282122$23728212$2$F$20240301$20240808$20240410$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054511$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240813$$PH$US$US
237282312$23728231$2$F$20240101$20240624$20240410$20240703$PER$$US-SA-2024SA104936$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240703$$MD$US$US
237282695$23728269$5$F$20240302$20240701$20240410$20240715$PER$$US-Calliditas-2024CAL00544$CALLIDITAS THERAPEUTICS$$58$YR$A$M$Y$$$20240715$$CN$US$US
237282894$23728289$4$F$$20240905$20240410$20240910$PER$$US-ALXN-202404USA000396US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
237283002$23728300$2$F$$20240715$20240410$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054927$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240716$$CN$US$US
237283022$23728302$2$F$20240819$20240820$20240410$20240826$EXP$$CA-JNJFOC-20240418109$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240826$$HP$CA$CA
237283163$23728316$3$F$$20240916$20240410$20240919$EXP$$CA-PFIZER INC-202400040622$PFIZER$$67$YR$$M$Y$$$20240919$$PH$CA$CA
237283182$23728318$2$F$20240101$20240711$20240410$20240716$EXP$$US-PFIZER INC-202400080719$PFIZER$$77$YR$$F$Y$$$20240716$$HP$US$US
237283282$23728328$2$F$$20240628$20240410$20240702$EXP$$US-PFIZER INC-202400058673$PFIZER$$22$YR$$M$Y$70.76$KG$20240702$$CN$US$US
237283334$23728333$4$F$20240405$20240724$20240410$20240724$EXP$$CA-PFIZER INC-202400081450$PFIZER$$31$YR$$F$Y$$$20240724$$CN$CA$CA
237283562$23728356$2$F$$20240828$20240410$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054910$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240902$$CN$US$US
237284562$23728456$2$F$20240311$20240730$20240410$20240802$EXP$$CA-JNJFOC-20240416851$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240802$$HP$CA$CA
237284722$23728472$2$F$$20240703$20240410$20240709$EXP$$US-SANDOZ INC.-SDZ2024US036898$SANDOZ$$17$YR$$$Y$$$20240709$$CN$US$US
237284802$23728480$2$F$20240301$20240729$20240410$20240731$PER$$US-AMGEN-USASP2024070439$AMGEN$$69$YR$E$M$Y$$$20240731$$CN$US$US
237284833$23728483$3$F$$20240709$20240410$20240710$PER$$US-ALXN-202404USA000127US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
237285133$23728513$3$F$20240301$20240627$20240410$20240705$EXP$$JP-009507513-2404JPN000431J$MERCK$$6$DEC$$F$Y$$$20240705$$MD$JP$JP
237285832$23728583$2$F$$20240709$20240410$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056859$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240709$$HP$US$US
237285873$23728587$3$F$20231101$20240828$20240410$20240905$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007031$AEGERION$$32$YR$$F$Y$$$20240905$$MD$US$US
237285892$23728589$2$F$20240409$20240813$20240410$20240816$PER$$US-AMGEN-USASP2024072186$AMGEN$$67$YR$E$F$Y$$$20240816$$CN$US$US
237286272$23728627$2$F$20230801$20240715$20240410$20240716$EXP$$US-PFIZER INC-PV202400047162$PFIZER$$82$YR$$M$Y$69.4$KG$20240716$$CN$US$US
237286594$23728659$4$F$20240101$20240725$20240410$20240801$EXP$$US-SA-2024SA108376$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240801$$CN$US$US
237287035$23728703$5$F$$20240919$20240410$20240924$EXP$$NVSC2024US075850$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
237287902$23728790$2$F$$20240715$20240410$20240724$PER$$US-Calliditas-2024CAL00549$CALLIDITAS THERAPEUTICS$$59$YR$A$M$Y$87.5$KG$20240724$$CN$US$US
237288034$23728803$4$F$20240101$20240729$20240410$20240801$EXP$$US-AMGEN-USASP2024071393$AMGEN$$68$YR$E$F$Y$$$20240801$$CN$US$US
237288293$23728829$3$F$$20240715$20240410$20240717$30DAY$$US-SANDOZ INC.-SDZ2024US036411$SANDOZ$$$$$F$Y$$$20240717$$HP$US$US
237288433$23728843$3$F$20240201$20240708$20240410$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-055242$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$53$KG$20240708$$PH$JP$JP
237288552$23728855$2$F$$20240905$20240410$20240911$EXP$$DE-MYLANLABS-2024M1032247$MYLAN$$66$YR$$M$Y$$$20240911$$MD$DE$DE
237288672$23728867$2$F$$20240805$20240410$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202404001352$ELI LILLY AND CO$$$$A$F$Y$$$20240819$$MD$US$US
237288926$23728892$6$F$20240401$20240909$20240410$20240912$EXP$$CA-TAKEDA-2021TUS016157$TAKEDA$$23$YR$$M$Y$$$20240912$$CN$CA$CA
237289007$23728900$7$F$20240101$20240708$20240410$20240715$PER$$US-SA-2024SA105499$SANOFI AVENTIS$$51$YR$A$F$Y$108$KG$20240715$$MD$US$US
237289012$23728901$2$F$20240301$20240731$20240410$20240808$PER$$US-SA-2024SA106928$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240808$$MD$US$US
237289273$23728927$3$F$$20240717$20240410$20240724$PER$$US-SA-2024SA007374$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240724$$MD$US$US
237289373$23728937$3$F$20240404$20240709$20240410$20240719$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404004113$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$JP$JP
237289503$23728950$3$F$$20240808$20240410$20240815$30DAY$$US-Kaleo, Inc.-2024KL000004$KALEO$$37$YR$A$M$Y$$$20240813$$CN$US$US
237289705$23728970$5$F$20231106$20240716$20240410$20240722$PER$$JP-Eisai-EC-2024-163244$EISAI$$86$YR$E$F$Y$53$KG$20240722$$MD$JP$JP
237290342$23729034$2$F$$20240816$20240410$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056250$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$88.9$KG$20240819$$CN$US$US
237290442$23729044$2$F$$20240627$20240410$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202404006023$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240702$$CN$US$US
237290565$23729056$5$F$20240101$20240821$20240410$20240903$PER$$US-SA-2024SA108167$SANOFI AVENTIS$$18$YR$A$F$Y$46.26$KG$20240903$$MD$US$US
237291072$23729107$2$F$$20240529$20240410$20240731$PER$$CO-MEN-2024-094204$MENARINI$$83$YR$$M$Y$$$20240731$$MD$CO$CO
237291213$23729121$3$F$$20240828$20240410$20240903$EXP$$FR-MYLANLABS-2024M1026356$MYLAN$Goubeau L, Guilbert Z, Saadi M, Picard F, Perrin L, Capdevila L, et al.. Bleeding episode during a long-term anticoagulation with direct oral anticoagulant: an unusual revelation of a severe factor v deficiency. Res-Pract-Thromb-Haemost. 2023;7(Suppl 2):668$81$YR$$M$Y$$$20240903$$HP$FR$FR
237291534$23729153$4$F$20230818$20240918$20240410$20240926$EXP$$CA-BEH-2024168066$CSL BEHRING$$32$YR$A$F$Y$60$KG$20240926$$CN$CA$CA
237292013$23729201$3$F$$20240731$20240410$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057029$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240801$$CN$US$US
237292312$23729231$2$F$20240405$20240817$20240410$20240822$PER$$US-AMGEN-USASP2024072105$AMGEN$$75$YR$E$M$Y$$$20240822$$CN$US$US
237293462$23729346$2$F$20240501$20240702$20240410$20240706$EXP$$US-ABBVIE-5712752$ABBVIE$$72$YR$$F$Y$$$20240706$$CN$US$US
237294092$23729409$2$F$20240308$20240813$20240410$20240820$EXP$$US-BIOGEN-2024BI01258741$BIOGEN$$28$YR$$M$Y$$$20240820$$CN$US$US
237294162$23729416$2$F$20231115$20240612$20240410$20240802$PER$$US-LUNDBECK-DKLU3075915$LUNDBECK$$$$$$Y$$$20240802$$HP$US$US
237294266$23729426$6$F$20240101$20240712$20240410$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-008460$UNITED THERAPEUTICS$$$$$F$Y$$$20240718$$$US$US
237294414$23729441$4$F$20231124$20240704$20240410$20240711$EXP$$JP-009507513-2312JPN000020J$MERCK$Matsuzaki S, Kagiyama Y, Nagasaka K, Noda T, Hayashi T, Yano A, et al.. 11 A case of irAE encephalitis caused by pembrolizumab.. The 113th Shikoku Branch Meeting of the Japanese Urological Association. 24$70$YR$$F$Y$61$KG$20240711$$MD$JP$JP
237294487$23729448$7$F$$20240919$20240410$20240924$EXP$$NVSC2024US075322$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
237294772$23729477$2$F$$20240404$20240410$20240723$EXP$$PT-GILEAD-2024-0668710$GILEAD$$$$A$$Y$$$20240723$$MD$PT$PT
237294825$23729482$5$F$$20240710$20240410$20240731$PER$$US-INCYTE CORPORATION-2024IN003520$INCYTE$$$$$$Y$$$20240801$$CN$US$US
237294853$23729485$3$F$20231109$20240722$20240410$20240801$PER$$US-INCYTE CORPORATION-2024IN003487$INCYTE$$$$$$Y$$$20240801$$MD$US$US
237295712$23729571$2$F$20240408$20240809$20240410$20240812$PER$$US-AMGEN-USASP2024072414$AMGEN$$40$YR$A$F$Y$$$20240811$$CN$US$US
237295833$23729583$3$F$20240318$20240730$20240410$20240801$EXP$$JP-SA-2024SA086242$SANOFI AVENTIS$$74$YR$E$F$Y$52.3$KG$20240802$$MD$JP$JP
237295862$23729586$2$F$20240408$20240920$20240410$20240923$PER$$US-AMGEN-USASP2024072057$AMGEN$$71$YR$E$M$Y$$$20240923$$CN$US$US
237295903$23729590$3$F$$20240702$20240410$20240705$EXP$$US-TAKEDA-2023TUS108618$TAKEDA$$$$$F$Y$68$KG$20240705$$HP$US$US
237296064$23729606$4$F$20240101$20240906$20240410$20240918$EXP$$CA-SA-2024SA023064$SANOFI AVENTIS$$13$YR$T$M$Y$41$KG$20240918$$MD$CA$CA
237296082$23729608$2$F$$20240812$20240410$20240813$EXP$$US-TAKEDA-2024TUS033757$TAKEDA$$$$$F$Y$$$20240813$$HP$US$US
237296402$23729640$2$F$20240405$20240823$20240411$20240827$PER$$US-AMGEN-USASP2024070424$AMGEN$$84$YR$E$F$Y$$$20240827$$CN$US$US
237296562$23729656$2$F$20240308$20240521$20240411$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000072$ARCUTIS$$$$$$Y$$$20240701$$CN$US$US
237296618$23729661$8$F$20240101$20240816$20240411$20240826$EXP$$CA-CELLTRION INC.-2024CA008449$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
237296622$23729662$2$F$20240408$20240826$20240411$20240827$PER$$US-AMGEN-USASP2024071700$AMGEN$$60$YR$A$$Y$$$20240826$$CN$US$US
237296825$23729682$5$F$20240224$20240827$20240411$20240829$EXP$$US-BEH-2024170329$CSL BEHRING$$30$YR$A$F$Y$$$20240829$$CN$US$US
237297122$23729712$2$F$20240501$20240715$20240411$20240720$EXP$$US-ABBVIE-5712681$ABBVIE$$73$YR$$F$Y$$$20240720$$CN$US$US
237297315$23729731$5$F$20240514$20240725$20240411$20240802$EXP$$US-TAKEDA-2024TUS033744$TAKEDA$$47$YR$$F$Y$70$KG$20240802$$CN$US$US
237297563$23729756$3$F$20240101$20240709$20240411$20240729$PER$$IL-TOLMAR, INC.-24IL047703$TOLMAR$$$$$M$Y$$$20240729$$PH$IL$IL
237297644$23729764$4$F$20240101$20240905$20240411$20240910$EXP$$US-ABBVIE-5710247$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
237297684$23729768$4$F$20240101$20240711$20240411$20240716$EXP$$US-ABBVIE-5712857$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
237297944$23729794$4$F$20240101$20240717$20240411$20240730$PER$$US-SA-2024SA105476$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240730$$MD$US$US
237298082$23729808$2$F$20240301$20240705$20240411$20240717$PER$$US-SA-2024SA107252$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240717$$MD$US$US
237298472$23729847$2$F$20240125$20240809$20240411$20240813$PER$$US-AMGEN-USASP2024070838$AMGEN$$74$YR$E$F$Y$$$20240813$$CN$US$US
237298503$23729850$3$F$20240409$20240712$20240411$20240716$EXP$$CA-ABBVIE-5713414$ABBVIE$$82$YR$$M$Y$$$20240716$$CN$CA$CA
237298653$23729865$3$F$20240407$20240719$20240411$20240723$PER$$US-AMGEN-USASP2024072377$AMGEN$$87$YR$E$F$Y$$$20240723$$CN$US$US
237298722$23729872$2$F$20220701$20240715$20240411$20240725$EXP$$FR-NOVOPROD-1198067$NOVO NORDISK$$$$E$M$Y$102$KG$20240725$$MD$FR$FR
237299015$23729901$5$F$20240331$20240727$20240411$20240806$EXP$$US-NOVOPROD-1201446$NOVO NORDISK$$26$YR$$F$Y$90.703$KG$20240806$$MD$US$US
237299213$23729921$3$F$20240101$20240716$20240411$20240725$EXP$$CA-CELLTRION INC.-2024CA008445$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
237299813$23729981$3$F$$20240628$20240411$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02881$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237300724$23730072$4$F$20231201$20240815$20240411$20240822$PER$$US-BIOGEN-2023BI01241468$BIOGEN$$59$YR$$F$Y$$$20240822$$CN$US$US
237300923$23730092$3$F$20220601$20240902$20240411$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-055785$BRISTOL MYERS SQUIBB$Irita H, et al. A case of alveolar proteinosis associated with overlapping cancers of acute myeloid leukaemia and multiple myeloma. The 694th Kanto Regional Meeting of the Japanese Society of Internal Medicine. 2024 Mar 16.$8$DEC$E$F$Y$$$20240911$$HP$JP$JP
237301142$23730114$2$F$20240409$20240823$20240411$20240827$PER$$US-AMGEN-USASP2024072618$AMGEN$$66$YR$E$F$Y$$$20240827$$CN$US$US
237301638$23730163$8$F$20240101$20240919$20240411$20240923$PER$$US-BIOGEN-2024BI01259468$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
237301675$23730167$5$F$20240310$20240724$20240411$20240726$EXP$$NVSJ2024JP004283$NOVARTIS$$50$YR$$F$Y$$$20240726$$MD$JP$JP
237302163$23730216$3$F$20240301$20240821$20240411$20240904$EXP$$CA-CELLTRION INC.-2024CA008538$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
237302192$23730219$2$F$20190307$20240919$20240411$20240925$EXP$$CA-ROCHE-2282135$ROCHE$$56$YR$A$F$Y$$$20240925$$HP$CA$CA
237302332$23730233$2$F$20240404$20240712$20240411$20240715$PER$$NVSC2024US076414$NOVARTIS$$57$YR$$M$Y$$$20240715$$CN$US$US
237302424$23730242$4$F$20231201$20240905$20240411$20240914$EXP$$CA-CELLTRION INC.-2024CA000448$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
237302452$23730245$2$F$$20240822$20240411$20240828$PER$$US-JAZZ PHARMACEUTICALS-2023-US-010668$JAZZ$$$$$F$Y$$$20240828$$CN$US$US
237302603$23730260$3$F$$20240717$20240411$20240719$EXP$$JP-GSK-JP2024JPN045672$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$MD$JP$JP
237302702$23730270$2$F$$20240703$20240411$20240710$PER$$US-ALXN-202404USA000320US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
237302869$23730286$9$F$20240101$20240815$20240411$20240824$EXP$$US-JNJFOC-20240416219$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240824$$CN$US$US
237303162$23730316$2$F$$20240618$20240411$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02915$LUPIN$$$$$$Y$$$20240701$$PH$US$US
237303233$23730323$3$F$$20240710$20240411$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-054211$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240711$$MD$JP$JP
237303322$23730332$2$F$$20240814$20240411$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001285$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
237303573$23730357$3$F$20240112$20240917$20240411$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-055721$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$50$KG$20240925$$PH$JP$JP
237303632$23730363$2$F$$20240911$20240411$20240915$PER$$US-ALXN-202404USA000404US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
237303742$23730374$2$F$20240208$20240620$20240411$20240705$EXP$$IN-ROCHE-3450749$ROCHE$$58$YR$A$F$Y$$$20240705$$MD$IN$IN
237304003$23730400$3$F$20240306$20240917$20240411$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-056587$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$50$KG$20240925$$PH$JP$JP
237304142$23730414$2$F$20240120$20240426$20240411$20240710$PER$$US-MankindUS-000137$MANKIND PHARMA$$6$YR$C$F$Y$22.68$KG$20240710$$CN$US$US
237304363$23730436$3$F$20240403$20240627$20240411$20240701$EXP$$US-ALXN-202404USA000253US$ALEXION PHARMACEUTICALS$$55$YR$$F$Y$63.492$KG$20240701$$MD$US$US
237304773$23730477$3$F$20240406$20240820$20240411$20240823$PER$$US-AMGEN-USASP2024071364$AMGEN$$76$YR$E$M$Y$$$20240822$$CN$US$US
237304836$23730483$6$F$20231209$20240910$20240411$20240912$EXP$$CA-TAKEDA-2023TUS086782$TAKEDA$$75$YR$$F$Y$$$20240912$$CN$CA$CA
237304863$23730486$3$F$20230208$20240704$20240411$20240710$EXP$$NVSC2023AR034323$NOVARTIS$$60$YR$$F$Y$$$20240710$$CN$AR$AR
237305492$23730549$2$F$$20240718$20240411$20240724$EXP$$US-SA-2024SA108394$SANOFI AVENTIS$$$$E$F$Y$$$20240724$$MD$US$US
237305682$23730568$2$F$20240401$20240912$20240411$20240918$EXP$$US-VIIV HEALTHCARE LIMITED-US2024042134$VIIV$$33$YR$$M$Y$$$20240918$$CN$US$US
237306155$23730615$5$F$20220408$20240808$20240411$20240812$EXP$$CA-UCBSA-2022018262$UCB$$64$YR$$F$Y$$$20240812$$MD$CA$CA
237306304$23730630$4$F$$20240820$20240411$20240903$EXP$$US-UCBSA-2024016910$UCB$$$$$F$Y$54.38$KG$20240903$$HP$US$US
237306783$23730678$3$F$$20240611$20240411$20240819$EXP$$CA-SANDOZ-SDZ2024CA029594$Haleon PLC$$53$YR$$M$Y$$$20240819$$HP$CA$CA
237306993$23730699$3$F$20240406$20240718$20240411$20240724$30DAY$$US-AMGEN-USASP2024071188$AMGEN$$73$YR$E$F$Y$85.1$KG$20240724$$HP$US$US
237307224$23730722$4$F$$20240826$20240411$20240828$30DAY$$US-GSK-US2024041164$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$CN$US$US
237307232$23730723$2$F$$20240826$20240411$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055360$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$107.95$KG$20240827$$HP$US$US
237307833$23730783$3$F$20100503$20240820$20240411$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-015780$AUROBINDO$$67$YR$$M$Y$74$KG$20240830$$MD$FR$FR
237307932$23730793$2$F$20240402$20240822$20240411$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009879$UNITED THERAPEUTICS$$86$YR$$M$Y$78.005$KG$20240831$$$US$US
237307972$23730797$2$F$$20240730$20240411$20240801$EXP$$US-TAKEDA-US201906598$TAKEDA$$$$$F$Y$$$20240801$$HP$US$US
237308164$23730816$4$F$20230701$20240724$20240411$20240731$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-10315$SAMSUNG BIOEPIS$$74$YR$E$M$Y$$$20240731$$CN$CA$CA
237308563$23730856$3$F$20240409$20240827$20240411$20240905$EXP$$JP-ASTELLAS-2024JP002415$ASTELLAS$$78$YR$E$$Y$$$20240905$$MD$JP$JP
2373085913$23730859$13$F$20240101$20240718$20240411$20240727$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010222$UNITED THERAPEUTICS$$$$$F$Y$79.819$KG$20240727$$PH$US$US
237309193$23730919$3$F$$20240715$20240411$20240717$EXP$$CA-TAKEDA-2024TUS033615$TAKEDA$$$$$M$Y$$$20240717$$CN$CA$CA
237309262$23730926$2$F$20240111$20240814$20240411$20240821$EXP$$US-INTERCEPT-PM2024000703$INTERCEPT PHARMACEUTICALS$$90$YR$$M$Y$$$20240821$$CN$US$US
237309362$23730936$2$F$$20240802$20240411$20240813$EXP$US-MLMSERVICE-20240328-4916226-1$US-RDY-SPO/USA/24/0005446$DR REDDYS$Garofalo V, Walgamage M, Cuell LN, Wester K, Robinson S, Gemayel CY. ANAPLASMOSIS: FROM MULTI-SYSTEM MAYHEM TO VENTRICULAR TACHYCARDIA IN A HEARTBEAT. Journal of the American College of Cardiology. 2024 Apr 02;83 (13): 4506. doi:10.1016/S0735-1097(24)06496-9.$78$YR$E$M$Y$$$20240813$$HP$US$US
237309503$23730950$3$F$20220701$20240627$20240411$20240701$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-008806$JAZZ$$44$YR$$F$Y$$$20240701$$HP$US$US
237310114$23731011$4$F$$20240625$20240411$20240702$EXP$$US-ROCHE-3541474$ROCHE$$$$A$M$Y$$$20240702$$CN$US$US
237310124$23731012$4$F$20240625$20240805$20240411$20240810$EXP$$NVSC2024ZA074375$NOVARTIS$$47$YR$$F$Y$$$20240810$$HP$ZA$ZA
237310153$23731015$3$F$$20240627$20240411$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02880$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237310512$23731051$2$F$20240326$20240716$20240411$20240718$EXP$$US-JNJFOC-20240417743$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$CN$US$US
237311302$23731130$2$F$$20240404$20240411$20240710$EXP$$NVSC2024TH072108$NOVARTIS$$34$YR$$M$Y$$$20240710$$MD$TH$TH
237311352$23731135$2$F$$20240709$20240411$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054958$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240712$$MD$US$US
237311373$23731137$3$F$20240101$20240909$20240411$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000252$DECIPHERA PHARMACEUTICALS$$53$YR$A$M$Y$$$20240927$$CN$US$US
237311893$23731189$3$F$20231201$20240911$20240411$20240920$EXP$$GR-VA000000605-2024002452$RECORDATI$$$$$$Y$$$20240920$$CN$GR$GR
237312085$23731208$5$F$20230601$20240808$20240411$20240813$EXP$$US-ROCHE-3532038$ROCHE$$66$YR$E$F$Y$86.2$KG$20240813$$CN$US$US
237312972$23731297$2$F$20181001$20240729$20240411$20240801$EXP$$DE-ROCHE-2428882$ROCHE$$53$YR$A$F$Y$$$20240801$$CN$DE$DE
237313213$23731321$3$F$20230901$20240806$20240411$20240821$EXP$$US-INSMED, INC.-2023-03570-US$INSMED$$58$YR$$M$Y$$$20240821$$CN$US$US
237313542$23731354$2$F$20240119$20240904$20240411$20240909$EXP$FR-AFSSAPS-PO2024000307$FR-MYLANLABS-2024M1031762$MYLAN$$54$YR$$F$Y$62$KG$20240909$$MD$FR$FR
237313582$23731358$2$F$20220401$20240920$20240411$20240930$EXP$$US-MYLANLABS-2024M1031394$MYLAN$$48$YR$$F$Y$104.33$KG$20240930$$CN$US$US
237313892$23731389$2$F$20230801$20240612$20240411$20240806$PER$$US-GALDERMA-US2024000519$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
237314962$23731496$2$F$20230101$20240701$20240411$20240806$PER$$US-GALDERMA-US2024001206$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
237315362$23731536$2$F$20240101$20240605$20240411$20240806$PER$$US-GALDERMA-US2024004824$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
237315442$23731544$2$F$$20240701$20240411$20240806$PER$$US-GALDERMA-US2024004903$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
237315944$23731594$4$F$20240301$20240802$20240411$20240809$30DAY$$BR-AMGEN-BRASP2024070964$AMGEN$$$$$$Y$$$20240808$$PH$BR$BR
237316574$23731657$4$F$20230303$20240723$20240411$20240729$EXP$$CO-TAKEDA-2023TUS029725$TAKEDA$$31$YR$$M$Y$65$KG$20240729$$HP$CO$CO
237316686$23731668$6$F$20230611$20240909$20240411$20240916$EXP$$AT-PERRIGO-23AT015201$PERRIGO$$67$YR$$M$Y$75$KG$20240916$$MD$AT$AT
237316922$23731692$2$F$20231116$20240923$20240411$20240927$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00109$CATALYST PHARMA$$4$YR$$M$Y$18.095$KG$20240927$$CN$US$US
237316952$23731695$2$F$20240201$20240625$20240411$20240702$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00259$CATALYST PHARMA$$72$YR$$F$Y$139.23$KG$20240702$$CN$US$US
237317332$23731733$2$F$20240101$20240709$20240411$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-006070$VERTEX$$$$$F$Y$$$20240715$$CN$US$US
237317452$23731745$2$F$$20240801$20240411$20240809$30DAY$$US-PFIZER INC-PV202400044128$PFIZER$$$$$$Y$$$20240809$$HP$US$US
237317514$23731751$4$F$$20240702$20240411$20240704$30DAY$$US-PFIZER INC-PV202400044213$PFIZER$$$$$$Y$$$20240704$$HP$US$US
237317814$23731781$4$F$$20240805$20240411$20240814$30DAY$$US-PFIZER INC-PV202400044229$PFIZER$$$$$$Y$$$20240814$$HP$US$US
237317825$23731782$5$F$$20240826$20240411$20240828$30DAY$$US-PFIZER INC-202400079147$PFIZER$$13$YR$$M$Y$40.82$KG$20240828$$CN$US$US
237318002$23731800$2$F$20240322$20240711$20240411$20240717$30DAY$$PT-PFIZER INC-PV202400039273$PFIZER$$$$$$Y$$$20240717$$MD$PT$PT
237318023$23731802$3$F$20230630$20240809$20240411$20240814$30DAY$$US-PFIZER INC-PV202400044189$PFIZER$$$$$$Y$$$20240814$$HP$US$US
237318062$23731806$2$F$$20240904$20240411$20240906$30DAY$$US-PFIZER INC-PV202400044186$PFIZER$$$$$$Y$$$20240906$$HP$US$US
237318083$23731808$3$F$$20240806$20240411$20240812$30DAY$$US-PFIZER INC-PV202400044340$PFIZER$$$$$$Y$$$20240812$$HP$US$US
237318093$23731809$3$F$$20240806$20240411$20240812$30DAY$$US-PFIZER INC-202400077916$PFIZER$$$$$$Y$$$20240812$$HP$US$US
237318102$23731810$2$F$$20240801$20240411$20240806$30DAY$$US-PFIZER INC-PV202400044732$PFIZER$$$$$$Y$$$20240806$$HP$US$US
237318125$23731812$5$F$20230123$20240802$20240411$20240809$EXP$$JP-ALXN-202404JPN000080JP$ALEXION PHARMACEUTICALS$$74$YR$$M$Y$101.5$KG$20240809$$MD$JP$JP
237318215$23731821$5$F$20240101$20240703$20240411$20240710$EXP$$GR-ROCHE-3523473$ROCHE$$56$YR$A$F$Y$60$KG$20240710$$CN$GR$GR
237318413$23731841$3$F$20240403$20240709$20240411$20240710$EXP$$DK-PFIZER INC-PV202400044697$PFIZER$$$$$$Y$$$20240710$$HP$DK$DK
237318552$23731855$2$F$20240327$20240624$20240411$20240702$EXP$$DE-BAXTER-2024BAX016458$BAXTER$$74$YR$$F$Y$$$20240702$$HP$DE$DE
237318836$23731883$6$F$20240405$20240909$20240411$20240911$30DAY$$US-PFIZER INC-202400076302$PFIZER$$12$YR$$F$Y$29.1$KG$20240911$$CN$US$US
237319072$23731907$2$F$$20240805$20240411$20240808$EXP$$NL-OTSUKA-2024_010354$OTSUKA$Van der Made CI, Kersten S, Chorin O, Engelhardt KR, Ramakrishnan G, Griffin H et al.. Expanding the PRAAS spectrum: De novo mutations of immunoproteasome subunit ?-type 10 in six infants with SCID-Omenn syndrome. American Journal of Human Genetics. 2024;111(4):791-804$11$WK$$F$Y$$$20240808$$HP$NL$NL
237319084$23731908$4$F$20240401$20240710$20240411$20240712$PER$$US-AMGEN-USASP2024072677$AMGEN$$54$YR$A$M$Y$245$KG$20240711$$CN$US$US
237319284$23731928$4$F$$20240913$20240411$20240921$EXP$$DE-TEVA-VS-3180034$TEVA$Posma RA, Bakker SJL, Nijsten MW, Touw DJ, Tsikas D Comprehensive GC-MS Measurement of Amino Acids, Metabolites, and Malondialdehyde in Metformin-Associated Lactic Acidosis at Admission and during Renal Replacement Treatment. Journal of Clinical Medicine. 2024-07, 13 No. 13]; Baskal S, Posma RA, Bollenbach A, Dieperink W, Bakker SJL, Nijsten MW, et al. GC-MS analysis of 4-hydroxyproline: elevated proline hydroxylation in metformin-associated lactic acidosis and metformin-treated Becker muscul...$70$YR$$F$Y$84$KG$20240921$$HP$DE$DE
237319412$23731941$2$F$$20240624$20240411$20240709$EXP$$GB-NORDICGR-055634$NORDIC PHARMA$$$$A$F$Y$$$20240708$$CN$GB$GB
237319842$23731984$2$F$20240404$20240404$20240411$20240731$PER$$US-BAYER-2024A050453$BAYER$$20$YR$A$F$Y$$$20240731$$MD$US$US
237319903$23731990$3$F$20240328$20240724$20240411$20240730$EXP$$NVSC2024DE076429$NOVARTIS$$2$YR$$F$Y$12$KG$20240730$$CN$DE$DE
237320085$23732008$5$F$$20240716$20240411$20240722$EXP$$GB-PFIZER INC-202400084022$PFIZER$Ritchie, A.. Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy. BMJ case reports.. 2024;17(3):10.1136/bcr-2023-256961$$$T$M$Y$$$20240722$$MD$GB$GB
237320464$23732046$4$F$20240101$20240703$20240411$20240710$PER$$US-Calliditas-2024CAL00556$CALLIDITAS THERAPEUTICS$$49$YR$A$F$Y$$$20240710$$CN$US$US
237320592$23732059$2$F$20230901$20240723$20240411$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202404001088$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240802$$CN$US$US
237320792$23732079$2$F$20240101$20240816$20240411$20240819$PER$$RU-Eisai-EC-2024-163557$EISAI$$15$YR$T$M$Y$60$KG$20240819$$MD$RU$RU
237320802$23732080$2$F$20240101$20240823$20240411$20240830$EXP$$JP-Eisai-EC-2024-163563$EISAI$Ota Y. Treatment experience with Lenvatinib plus Pembrolizumab. Renal Cell Carcinoma Seminar in MIKAWA.$65$YR$E$M$Y$$$20240830$$MD$JP$JP
237321342$23732134$2$F$20230324$20240823$20240411$20240829$EXP$$NVSC2024IN029608$NOVARTIS$$63$YR$$F$Y$$$20240829$$CN$IN$IN
237322012$23732201$2$F$20240201$20240823$20240411$20240904$EXP$FR-AFSSAPS-SE2024000273$FR-ELI_LILLY_AND_COMPANY-FR202404003918$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240904$$CN$FR$FR
237322383$23732238$3$F$20240131$20240710$20240411$20240712$EXP$$IT-ORGANON-O2404ITA001400$ORGANON$$36$YR$$F$Y$$$20240712$$MD$IT$IT
237322402$23732240$2$F$$20240708$20240411$20240712$EXP$$IL-JNJFOC-20240407003$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$MD$IL$IL
237322422$23732242$2$F$20231009$20240715$20240411$20240720$EXP$$GB-JNJFOC-20240371098$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240719$$MD$GB$GB
237322732$23732273$2$F$20230914$20240709$20240411$20240712$EXP$$FR-PFIZER INC-PV202300158969$PFIZER$$43$YR$$M$Y$56.4$KG$20240712$$MD$FR$FR
237322813$23732281$3$F$$20240801$20240411$20240801$EXP$$CA-PFIZER INC-202400082023$PFIZER$$70$YR$$F$Y$$$20240801$$MD$CA$CA
237322885$23732288$5$F$$20240812$20240411$20240814$30DAY$$US-PFIZER INC-202400081375$PFIZER$$4$YR$$M$Y$$$20240814$$CN$US$US
237322895$23732289$5$F$20240112$20240703$20240411$20240710$EXP$FR-AFSSAPS-LL2024000581$FR-PFIZER INC-202400080267$PFIZER$$57$YR$$F$Y$65$KG$20240710$$MD$FR$FR
237323192$23732319$2$F$20220217$20240827$20240411$20240902$EXP$$GB-TAKEDA-2022TUS008483$TAKEDA$$60$YR$$M$Y$$$20240902$$HP$GB$GB
237323254$23732325$4$F$$20240830$20240411$20240903$PER$$US-PFIZER INC-202400078809$PFIZER$$1$YR$$F$Y$$$20240903$$CN$US$US
237323317$23732331$7$F$$20240917$20240411$20240920$30DAY$$US-PFIZER INC-202400077923$PFIZER$$59$YR$$F$Y$74.376$KG$20240920$$CN$US$US
237323504$23732350$4$F$20240101$20240701$20240411$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009924$UNITED THERAPEUTICS$$$$$F$Y$86.168$KG$20240705$$$US$US
237324517$23732451$7$F$20240311$20240802$20240411$20240812$EXP$$DE-JNJFOC-20240348917$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240812$$HP$DE$DE
237324582$23732458$2$F$$20240918$20240411$20240922$EXP$$US-BAYER-2024A047514$BAYER$$$$$$Y$$$20240922$$CN$US$US
237324612$23732461$2$F$$20240628$20240411$20240705$EXP$$US-SA-2024SA108077$SANOFI AVENTIS$$$$E$M$Y$$$20240705$$MD$US$US
237324795$23732479$5$F$20240101$20240624$20240411$20240701$EXP$$US-SA-2024SA104342$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240701$$MD$US$US
237324873$23732487$3$F$$20240722$20240411$20240731$PER$$US-SA-2024SA103887$SANOFI AVENTIS$$$$A$F$Y$$$20240731$$MD$US$US
237324912$23732491$2$F$$20240712$20240411$20240722$PER$$US-SA-2024SA104994$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240722$$MD$US$US
237325083$23732508$3$F$$20240620$20240411$20240705$PER$$US-SA-2024SA104348$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240705$$MD$US$US
237325112$23732511$2$F$20231001$20240626$20240411$20240705$PER$$US-SA-2024SA107285$SANOFI AVENTIS$$43$YR$A$F$Y$111$KG$20240705$$MD$US$US
237325212$23732521$2$F$$20240905$20240411$20240914$PER$$US-SA-2024SA104966$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240914$$MD$US$US
237325224$23732522$4$F$20240101$20240810$20240411$20240819$PER$$US-SA-2024SA105807$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240819$$CN$US$US
237325492$23732549$2$F$20231201$20240826$20240411$20240910$PER$$US-SA-2024SA103470$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240910$$MD$US$US
237325593$23732559$3$F$20240101$20240917$20240411$20240926$PER$$US-SA-2024SA103482$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240926$$MD$US$US
237325633$23732563$3$F$20240301$20240807$20240411$20240815$PER$$US-SA-2024SA105585$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240815$$MD$US$US
237325835$23732583$5$F$20230801$20240821$20240411$20240909$PER$$US-SA-2024SA107789$SANOFI AVENTIS$$1$YR$I$M$Y$16.3$KG$20240909$$MD$US$US
237326273$23732627$3$F$20240101$20240919$20240411$20240930$PER$$US-SA-2024SA108519$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240930$$MD$US$US
237326282$23732628$2$F$20240101$20240822$20240411$20240910$PER$$US-SA-2024SA109325$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240910$$MD$US$US
237326352$23732635$2$F$20240328$20240708$20240411$20240717$PER$$US-SA-2024SA109872$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240717$$MD$US$US
237326382$23732638$2$F$20240101$20240701$20240411$20240710$PER$$US-SA-2024SA109088$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240710$$MD$US$US
237326403$23732640$3$F$20240301$20240801$20240411$20240809$PER$$US-SA-2024SA108508$SANOFI AVENTIS$$$$E$F$Y$83$KG$20240809$$MD$US$US
237326532$23732653$2$F$20240701$20240830$20240411$20240912$PER$$US-SA-2024SA108168$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240912$$MD$US$US
237326803$23732680$3$F$20240101$20240711$20240411$20240722$PER$$US-SA-2024SA109227$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240722$$MD$US$US
237326834$23732683$4$F$$20240725$20240411$20240730$EXP$$US-SA-2024SA109583$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240730$$CN$US$US
237326932$23732693$2$F$20240201$20240724$20240411$20240801$PER$$US-SA-2024SA108592$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240801$$MD$US$US
237326972$23732697$2$F$$20240812$20240411$20240821$PER$$US-SA-2024SA108398$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$HP$US$US
237327012$23732701$2$F$$20240722$20240411$20240731$PER$$US-SA-2024SA109268$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240731$$MD$US$US
237327022$23732702$2$F$20240101$20240826$20240411$20240913$PER$$US-SA-2024SA108541$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240913$$CN$US$US
237327312$23732731$2$F$20240215$20240808$20240411$20240823$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-057215$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$81.5$KG$20240823$$MD$FR$FR
237327452$23732745$2$F$20230801$20240715$20240411$20240725$EXP$$FR-NOVOPROD-1198256$NOVO NORDISK$$$$E$M$Y$77$KG$20240725$$MD$FR$FR
237327463$23732746$3$F$$20240815$20240411$20240822$PER$$US-ALXN-202404USA000447US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
237327473$23732747$3$F$20240417$20240702$20240411$20240711$PER$$US-SA-2024SA105445$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240711$$MD$US$US
2373275210$23732752$10$F$20240101$20240812$20240411$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009624$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240816$$PH$US$US
237327605$23732760$5$F$$20240906$20240411$20240911$PER$$US-PFIZER INC-202400082377$PFIZER$$1$YR$$F$Y$$$20240911$$HP$US$US
2373276110$23732761$10$F$20240330$20240918$20240411$20240923$30DAY$$US-PFIZER INC-202400081364$PFIZER$$71$YR$$M$Y$83.91$KG$20240923$$CN$US$US
237327802$23732780$2$F$$20240809$20240411$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055779$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240813$$CN$US$US
237327814$23732781$4$F$$20240807$20240411$20240809$EXP$$CA-TAKEDA-2024TUS034024$TAKEDA$$$$$F$Y$$$20240809$$CN$CA$CA
237327846$23732784$6$F$20240408$20240906$20240411$20240912$EXP$$US-PFIZER INC-202400082092$PFIZER$$7$YR$$F$Y$17.234$KG$20240912$$CN$US$US
237327853$23732785$3$F$$20240806$20240411$20240809$30DAY$$US-PFIZER INC-202400078717$PFIZER$$3$YR$$M$Y$13.79$KG$20240809$$PH$US$US
237327945$23732794$5$F$20231105$20240724$20240411$20240801$EXP$$US-UNITED THERAPEUTICS-UNT-2023-032388$UNITED THERAPEUTICS$$63$YR$$M$Y$62.132$KG$20240801$$$US$US
237328265$23732826$5$F$20240301$20240703$20240411$20240704$EXP$$US-PFIZER INC-PV202400046531$PFIZER$$75$YR$$F$Y$92.517$KG$20240704$$CN$US$US
237328362$23732836$2$F$$20240627$20240411$20240701$PER$$US-PFIZER INC-202300045767$PFIZER$$73$YR$$F$Y$$$20240701$$CN$US$US
237328604$23732860$4$F$$20240805$20240411$20240813$30DAY$$US-PFIZER INC-202400078834$PFIZER$$2$YR$$M$Y$$$20240813$$CN$US$US
237328665$23732866$5$F$$20240905$20240411$20240906$30DAY$$US-PFIZER INC-202400079642$PFIZER$$10$YR$$M$Y$$$20240906$$CN$US$US
237328752$23732875$2$F$$20240724$20240411$20240726$PER$$US-PFIZER INC-202400084490$PFIZER$$71$YR$$F$Y$$$20240726$$CN$US$US
237328943$23732894$3$F$20240301$20240823$20240411$20240830$EXP$$JP-009507513-2403JPN000018J$MERCK$$76$YR$$M$Y$$$20240830$$MD$JP$JP
237329024$23732902$4$F$$20240731$20240411$20240813$30DAY$$US-PFIZER INC-202400079202$PFIZER$$9$YR$$M$Y$$$20240813$$CN$US$US
237329372$23732937$2$F$$20240906$20240411$20240909$EXP$$US-PFIZER INC-202400082128$PFIZER$$80$YR$$M$Y$$$20240909$$CN$US$US
237329563$23732956$3$F$$20240826$20240411$20240829$EXP$$US-PFIZER INC-202300369410$PFIZER$$40$YR$$M$Y$$$20240829$$CN$US$US
237329574$23732957$4$F$20240101$20240827$20240411$20240904$PER$$US-PFIZER INC-PV202400047346$PFIZER$$59$YR$$F$Y$$$20240904$$HP$US$US
237329712$23732971$2$F$20240101$20240719$20240411$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-004904$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240723$$CN$US$US
237330095$23733009$5$F$20240403$20240924$20240411$20240926$30DAY$$US-PFIZER INC-202400078888$PFIZER$$6$YR$$F$Y$$$20240926$$PH$US$US
237330179$23733017$9$F$20240401$20240910$20240411$20240919$EXP$$US-Calliditas-2024CAL00559$CALLIDITAS THERAPEUTICS$$27$YR$A$F$Y$102$KG$20240919$$CN$US$US
237330233$23733023$3$F$$20240806$20240411$20240809$30DAY$$US-PFIZER INC-202400079051$PFIZER$$62$YR$$F$Y$86.18$KG$20240809$$CN$US$US
237330312$23733031$2$F$20240403$20240803$20240411$20240807$PER$$US-PFIZER INC-PV202400046748$PFIZER$$13$YR$$M$Y$$$20240807$$CN$US$US
237330334$23733033$4$F$$20240815$20240411$20240819$PER$$US-PFIZER INC-PV202400047038$PFIZER$$$$$F$Y$$$20240819$$HP$US$US
237330356$23733035$6$F$$20240908$20240411$20240909$30DAY$$US-PFIZER INC-202400081164$PFIZER$$10$YR$$F$Y$15.873$KG$20240909$$HP$US$US
237330373$23733037$3$F$$20240822$20240411$20240827$PER$$US-PFIZER INC-PV202400043612$PFIZER$$90$YR$$F$Y$$$20240827$$CN$US$US
237330413$23733041$3$F$$20240701$20240411$20240704$PER$$US-PFIZER INC-202400072654$PFIZER$$67$YR$$F$Y$$$20240704$$HP$US$US
237331186$23733118$6$F$$20240916$20240411$20240919$PER$$US-PFIZER INC-PV202400047744$PFIZER$$82$YR$$M$Y$$$20240919$$CN$US$US
237331323$23733132$3$F$$20240808$20240411$20240812$EXP$$JP-PFIZER INC-PV202400047369$PFIZER$$66$YR$$$Y$$$20240812$$MD$JP$JP
237331355$23733135$5$F$$20240923$20240411$20240926$PER$$US-PFIZER INC-PV202300141879$PFIZER$$43$YR$$M$Y$$$20240926$$CN$US$US
237331442$23733144$2$F$20240311$20240624$20240411$20240705$EXP$FR-AFSSAPS-DJ2024000517$FR-ELI_LILLY_AND_COMPANY-FR202404000602$ELI LILLY AND CO$$72$YR$E$M$Y$60$KG$20240705$$CN$FR$FR
237331553$23733155$3$F$$20240627$20240411$20240704$EXP$$US-ALXN-202404USA000358US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
237331662$23733166$2$F$$20240628$20240411$20240703$PER$$US-PFIZER INC-PV202400046378$PFIZER$$8$DEC$$F$Y$$$20240703$$CN$US$US
237331726$23733172$6$F$20240501$20240715$20240411$20240724$PER$$US-AGIOS-2404US03723$AGIOS PHARMACEUTICALS$$47$YR$$F$Y$$$20240724$$CN$US$US
237331873$23733187$3$F$20240319$20240830$20240411$20240903$EXP$$US-BEH-2024170436$CSL BEHRING$$57$YR$A$F$Y$$$20240903$$CN$US$US
237331922$23733192$2$F$20180308$20240629$20240411$20240704$EXP$$CA-TAKEDA-2018TUS005546$TAKEDA$$56$YR$$M$Y$$$20240704$$CN$CA$CA
237331984$23733198$4$F$20240401$20240705$20240411$20240705$EXP$$CA-PFIZER INC-PV202400046718$PFIZER$$69$YR$$F$Y$$$20240705$$CN$CA$CA
237332162$23733216$2$F$20240305$20240716$20240411$20240726$EXP$$CN-PFIZER INC-PV202400046807$PFIZER$$54$YR$$F$Y$$$20240726$$HP$CN$CN
237332212$23733221$2$F$$20240716$20240411$20240722$EXP$$IT-MYLANLABS-2024M1032306$MYLAN$$22$YR$$F$Y$$$20240722$$MD$IT$IT
237332293$23733229$3$F$20240101$20240918$20240411$20240926$EXP$$US-BEH-2024170426$CSL BEHRING$$55$YR$A$M$Y$96.145$KG$20240926$$HP$US$US
237332392$23733239$2$F$20240313$20240719$20240411$20240726$PER$$US-ALXN-202404USA000324US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240726$$HP$US$US
237332462$23733246$2$F$$20240702$20240411$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053978$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240703$$HP$US$US
237332854$23733285$4$F$20230615$20240911$20240411$20240918$PER$$FR-Eisai-EC-2023-142746$EISAI$$64$YR$A$M$Y$$$20240918$$MD$FR$FR
237333192$23733319$2$F$20240101$20240709$20240411$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056596$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$79.11$KG$20240709$$HP$US$US
237333544$23733354$4$F$$20240723$20240411$20240730$EXP$$CA-PURDUE-USA-2024-0308932$PURDUE$$40$YR$$F$Y$96$KG$20240730$$HP$CA$CA
237334612$23733461$2$F$$20240207$20240411$20240717$PER$$US-PFIZER INC-PV202400047654$PFIZER$$$$$F$Y$$$20240717$$CN$US$US
237334643$23733464$3$F$$20240529$20240411$20240725$PER$$US-LUNDBECK-DKLU3076133$LUNDBECK$$$$$$Y$$$20240725$$CN$US$US
237335408$23733540$8$F$20240101$20240819$20240411$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-003294$UNITED THERAPEUTICS$$$$$F$Y$$$20240827$$$US$US
237335472$23733547$2$F$$20240723$20240411$20240801$PER$$US-SA-2024SA109686$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240801$$MD$US$US
237335903$23733590$3$F$20220201$20240726$20240411$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-054021$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240726$$MD$JP$JP
237336132$23733613$2$F$20240501$20240627$20240411$20240702$EXP$$CA-ABBVIE-5714441$ABBVIE$$$$E$M$Y$$$20240702$$CN$CA$CA
237336155$23733615$5$F$$20240904$20240411$20240906$EXP$$CA-TAKEDA-2023TUS075568$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
237336752$23733675$2$F$$20240628$20240411$20240704$EXP$$JP-ABBVIE-5715000$ABBVIE$$$$$M$Y$$$20240704$$MD$JP$JP
237336815$23733681$5$F$20240324$20240628$20240411$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001082$ACADIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240723$$CN$US$US
237336832$23733683$2$F$$20240701$20240411$20240702$PER$$NVSC2024US077313$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
237336922$23733692$2$F$20240301$20240709$20240411$20240709$EXP$$PK-BRISTOL-MYERS SQUIBB COMPANY-2024-056339$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240709$$PH$PK$PK
237337072$23733707$2$F$20160801$20240917$20240411$20240923$EXP$$BR-BIOGEN-2024BI01259333$BIOGEN$$27$YR$$F$Y$71$KG$20240923$$CN$BR$BR
237337103$23733710$3$F$$20240702$20240411$20240705$EXP$$US-ABBVIE-5713286$ABBVIE$$$$$M$Y$69.399$KG$20240705$$CN$US$US
237337252$23733725$2$F$$20240705$20240411$20240715$PER$$US-SA-2024SA107260$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240715$$MD$US$US
237337262$23733726$2$F$$20240916$20240411$20240924$PER$$US-SA-2024SA107191$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240924$$MD$US$US
237337272$23733727$2$F$20240101$20240827$20240411$20240919$PER$$US-SA-2024SA110495$SANOFI AVENTIS$$56$YR$A$F$Y$67.58$KG$20240919$$MD$US$US
237337492$23733749$2$F$$20240627$20240411$20240701$PER$$US-ALXN-202404USA000428US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
237338102$23733810$2$F$$20240723$20240412$20240725$PER$$US-PFIZER INC-202400083463$PFIZER$$60$YR$$F$Y$$$20240725$$CN$US$US
237338252$23733825$2$F$20240407$20240627$20240412$20240702$PER$$US-AMGEN-USASP2024072339$AMGEN$$81$YR$E$F$Y$$$20240702$$PH$US$US
237338353$23733835$3$F$$20240709$20240412$20240722$EXP$$GB-Accord-417948$ACCORD$Chou M, Lai L, Neveu M, Ritchie A. Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy. BMJ Case Rep. 2024 Mar 27;17(3):e256961.$$$T$M$Y$$$20240719$$HP$GB$GB
237338673$23733867$3$F$20230101$20240919$20240412$20240925$EXP$$US-ABBVIE-5713601$ABBVIE$$59$YR$$F$Y$$$20240925$$CN$US$US
237338683$23733868$3$F$20240406$20240718$20240412$20240722$PER$$US-AMGEN-USASP2024072251$AMGEN$$53$YR$A$M$Y$$$20240722$$CN$US$US
237339042$23733904$2$F$$20240401$20240412$20240712$EXP$$BR-NOVOPROD-1200208$NOVO NORDISK$$$$$F$Y$$$20240712$$MD$BR$BR
237339302$23733930$2$F$20240101$20240731$20240412$20240806$EXP$$US-ABBVIE-5712199$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
237339322$23733932$2$F$20230810$20240802$20240412$20240807$EXP$$US-ABBVIE-5528035$ABBVIE$$55$YR$$F$Y$$$20240807$$CN$US$US
237339392$23733939$2$F$$20240708$20240412$20240711$EXP$PL-EMA-DD-20240401-7482827-170435$NVSC2024PL073336$NOVARTIS$Potocki P. Metronomic chemotherapy in multimodality approach to a patient with breast cancer cutaneous metastases. ONCOLOGY IN CLINICAL PRACTICE-EDUCATION. 2018;4:A16-9$55$YR$$F$Y$$$20240711$$HP$PL$PL
237339486$23733948$6$F$20240408$20240712$20240412$20240716$EXP$$ES-ABBVIE-5713054$ABBVIE$$69$YR$$M$Y$81$KG$20240716$$MD$ES$ES
237339622$23733962$2$F$20240101$20240722$20240412$20240731$PER$$US-SA-2024SA107508$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240731$$MD$US$US
237339742$23733974$2$F$20111028$20240829$20240412$20240903$EXP$$CA-SANDOZ INC.-PHHY2011CA101638$SANDOZ$$12$YR$$M$Y$$$20240903$$HP$CA$CA
237339842$23733984$2$F$$20240402$20240412$20240710$PER$$PH-ROCHE-3537178$ROCHE$$$$$F$Y$$$20240628$$HP$PH$PH
237339903$23733990$3$F$20230101$20240809$20240412$20240817$EXP$$CA-CELLTRION INC.-2023CA020393$CELLTRION$$$$$$Y$$$20240817$$HP$CA$CA
237339924$23733992$4$F$20240601$20240627$20240412$20240702$EXP$$US-SA-2024SA109515$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240702$$CN$US$US
237340082$23734008$2$F$20240315$20240910$20240412$20240930$PER$$CA-TOLMAR, INC.-24CA047762$TOLMAR$$75$YR$$M$Y$$$20240930$$CN$CA$CA
237340113$23734011$3$F$20240315$20240903$20240412$20240926$PER$$CA-TOLMAR, INC.-24CA047806$TOLMAR$$70$YR$$M$Y$$$20240926$$CN$CA$CA
237340202$23734020$2$F$20210101$20240905$20240412$20240917$EXP$$JP-TAKEDA-2024TUS034466$TAKEDA$$$$$M$Y$$$20240917$$MD$JP$JP
237340432$23734043$2$F$$20240626$20240412$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02968$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237340512$23734051$2$F$$20240731$20240412$20240807$EXP$$US-ALXN-202404USA000489US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240807$$CN$US$US
237340802$23734080$2$F$$20240726$20240412$20240801$PER$$US-ALXN-202404USA000491US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
237340912$23734091$2$F$$20240829$20240412$20240912$PER$$US-SA-2024SA108707$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240912$$MD$US$US
237341122$23734112$2$F$$20240723$20240412$20240730$EXP$$GB-TAKEDA-2021TUS025754$TAKEDA$$56$YR$$M$Y$$$20240730$$HP$GB$GB
237341162$23734116$2$F$20240101$20240828$20240412$20240911$PER$$US-SA-2024SA109067$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240911$$MD$US$US
237341192$23734119$2$F$$20240911$20240412$20240916$PER$$US-ALXN-202404USA000508US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240916$$CN$US$US
237341272$23734127$2$F$20240319$20240909$20240412$20240912$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-239499$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$$$20240912$$MD$US$US
237341314$23734131$4$F$$20240721$20240412$20240730$30DAY$$US-GSK-US2024AMR041986$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$CN$US$US
237341584$23734158$4$F$$20240627$20240412$20240815$PER$$US-LUNDBECK-DKLU3076033$LUNDBECK$$$$$$Y$$$20240815$$HP$US$US
237341683$23734168$3$F$20230101$20240627$20240412$20240705$EXP$$CA-CELLTRION INC.-2023CA010536$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
237341782$23734178$2$F$$20240725$20240412$20240802$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000732$BLUEPRINT MEDICINES$$$$$F$Y$$$20240802$$CN$US$US
237341906$23734190$6$F$20240306$20240821$20240412$20240829$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-020428$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$90$KG$20240829$$MD$DE$DE
237342045$23734204$5$F$$20240716$20240412$20240723$PER$$US-ALXN-202404USA000511US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
237342063$23734206$3$F$20220208$20240910$20240412$20240918$EXP$$CA-AMGEN-CANSL2023167890$AMGEN$$35$YR$A$F$Y$$$20240918$$HP$CA$CA
237342103$23734210$3$F$$20240829$20240412$20240905$30DAY$$GR-JNJFOC-20240424115$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$GR$GR
237342132$23734213$2$F$20240101$20240701$20240412$20240722$PER$$US-SA-2024SA106558$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240720$$CN$US$US
237342262$23734226$2$F$20240801$20240910$20240412$20240918$EXP$$BR-TAKEDA-2024TUS034031$TAKEDA$$69$YR$$M$Y$$$20240918$$CN$BR$BR
237342442$23734244$2$F$20240101$20240711$20240412$20240725$EXP$$US-MDD US Operations-MDD202403-000790$MDD OPERATIONS$$78$YR$$M$Y$$$20240725$$CN$US$
237342455$23734245$5$F$20240101$20240820$20240412$20240828$EXP$$CA-CELLTRION INC.-2024CA008078$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
237342473$23734247$3$F$$20240920$20240412$20240924$EXP$$JP-GSK-JP2024JPN046893$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
237342882$23734288$2$F$20240701$20240718$20240412$20240728$PER$$US-SA-2024SA109856$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240728$$MD$US$US
237342962$23734296$2$F$$20240711$20240412$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055279$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240712$$MD$US$US
237343032$23734303$2$F$20230101$20240730$20240412$20240808$PER$$US-SA-2024SA106346$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240808$$MD$US$US
237343212$23734321$2$F$$20240722$20240412$20240731$PER$$US-SA-2024SA110479$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240731$$MD$US$US
237343272$23734327$2$F$$20240717$20240412$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-021482$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240717$$CN$US$US
237343372$23734337$2$F$$20240703$20240412$20240709$EXP$$DE-AMGEN-DEUSP2024069207$AMGEN$$$$$F$Y$$$20240708$$CN$DE$DE
237343435$23734343$5$F$20240222$20240917$20240412$20240927$PER$$US-GSK-US2024041992$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240927$$CN$US$US
237343512$23734351$2$F$$20240912$20240412$20240924$EXP$$CA-Accord-418191$ACCORD$Voisine E, Lemay S, Beaudoin J, Jacob P, Philippon F, Marchand L, et al. Cardiac sarcoidosis with extensive and heterogeneous left ventricular FDG uptake in absence of guidelines indication for an implantable defibrillator: Ventricular tachycardia precipitated by immunosuppressive therapy, should we have done differently? Pacing and clinical electrophysiology. 2024:1-7.$40$YR$A$M$Y$$$20240924$$MD$CA$CA
237343602$23734360$2$F$$20240715$20240412$20240723$PER$$US-BIOGEN-2024BI01258962$BIOGEN$$$$$M$Y$$$20240723$$CN$US$US
237343772$23734377$2$F$$20240626$20240412$20240702$EXP$$NVSC2024IT060022$NOVARTIS$$$$E$M$Y$$$20240702$$MD$IT$IT
237343862$23734386$2$F$20240405$20240724$20240412$20240725$PER$$US-AMGEN-UMISP2024070618$AMGEN$$78$YR$E$F$Y$$$20240725$$CN$US$US
237344164$23734416$4$F$$20240911$20240412$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202404007808$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240912$$CN$US$US
237344183$23734418$3$F$20240101$20240905$20240412$20240914$EXP$$CA-CELLTRION INC.-2024CA008689$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
237344473$23734447$3$F$$20240723$20240412$20240725$PER$$NVSC2024US077174$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
237344872$23734487$2$F$$20240708$20240412$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202404006176$ELI LILLY AND CO$$$$$$Y$$$20240711$$CN$US$US
237345263$23734526$3$F$20240409$20240718$20240412$20240722$PER$$US-AMGEN-USASP2024073095$AMGEN$$75$YR$E$F$Y$$$20240722$$CN$US$US
237345492$23734549$2$F$$20240723$20240412$20240806$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66992$HIKMA$$$$$F$Y$$$20240806$$CN$US$US
237345863$23734586$3$F$20240715$20240821$20240412$20240828$EXP$$CA-JNJFOC-20240412464$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240828$$CN$CA$CA
237346014$23734601$4$F$20240301$20240703$20240412$20240705$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-021498$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240705$$CN$US$US
237346023$23734602$3$F$$20240711$20240412$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057529$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240712$$CN$US$US
237346032$23734603$2$F$$20240702$20240412$20240710$EXP$$CA-CELLTRION INC.-2024CA008141$CELLTRION$$$$$$Y$$$20240710$$HP$CA$CA
237346062$23734606$2$F$20240301$20240715$20240412$20240728$EXP$$US-UCBSA-2024017310$UCB$$37$YR$$F$Y$$$20240728$$HP$US$US
237346606$23734660$6$F$20240401$20240905$20240412$20240910$EXP$$US-GSK-US2024AMR043912$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240910$$CN$US$US
237346752$23734675$2$F$20230101$20240731$20240412$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2023-032555$UNITED THERAPEUTICS$$$$$F$Y$$$20240809$$$US$US
237346882$23734688$2$F$20231201$20240621$20240412$20240710$PER$$CA-TOLMAR, INC.-24CA047420$TOLMAR$$81$YR$$M$Y$$$20240710$$CN$CA$CA
237346952$23734695$2$F$20240318$20240708$20240412$20240729$PER$$CA-TOLMAR, INC.-24CA047789$TOLMAR$$85$YR$$M$Y$$$20240726$$CN$CA$CA
237347028$23734702$8$F$20240101$20240627$20240412$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-010150$UNITED THERAPEUTICS$$$$$F$Y$88.889$KG$20240703$$$US$US
237347115$23734711$5$F$20240229$20240909$20240412$20240913$EXP$$DE-ROCHE-3542006$ROCHE$$$$E$F$Y$$$20240913$$CN$DE$DE
237347412$23734741$2$F$$20240404$20240412$20240701$EXP$$FR-AstraZeneca-2024A085696$ASTRAZENECA$$$$A$F$Y$$$20240701$$MD$FR$
237347434$23734743$4$F$20240101$20240918$20240412$20240928$EXP$$CA-CELLTRION INC.-2024CA008570$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
237347472$23734747$2$F$20240101$20240718$20240412$20240726$EXP$$CA-Vifor (International) Inc.-VIT-2024-03133$VIFOR$$73$YR$$M$Y$$$20240726$$CN$CA$CA
237347522$23734752$2$F$$20240722$20240412$20240727$PER$$US-JNJFOC-20240419870$JOHNSON AND JOHNSON$$$$$F$Y$$$20240727$$HP$US$US
237347868$23734786$8$F$20240117$20240912$20240412$20240918$EXP$$US-ABBVIE-5712909$ABBVIE$$21$YR$$M$Y$86$KG$20240918$$MD$US$US
237347903$23734790$3$F$$20240628$20240412$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02916$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237348244$23734824$4$F$20240101$20240819$20240412$20240826$EXP$$CA-CELLTRION INC.-2024CA008518$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
237348863$23734886$3$F$20240223$20240713$20240412$20240722$EXP$$CA-CELLTRION INC.-2024CA005234$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
237349062$23734906$2$F$20180101$20240701$20240412$20240705$EXP$$US-ABBVIE-5715124$ABBVIE$$18$YR$$M$Y$$$20240705$$CN$US$US
237349364$23734936$4$F$20200101$20240916$20240412$20240927$EXP$$US-ROCHE-3541477$ROCHE$$81$YR$E$F$Y$$$20240927$$CN$US$US
237349802$23734980$2$F$20240403$20240903$20240412$20240909$EXP$$US-AMGEN-USASP2024070001$AMGEN$$69$YR$E$F$Y$$$20240909$$CN$US$US
237349932$23734993$2$F$$20240704$20240412$20240715$EXP$$CA-APOTEX-2024AP004500$APOTEX$$$$E$F$Y$$$20240715$$PH$CA$CA
237349953$23734995$3$F$20240119$20240808$20240412$20240814$EXP$$JP-JNJFOC-20240435770$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240814$$MD$JP$JP
237350035$23735003$5$F$20240101$20240705$20240412$20240708$PER$$US-AMGEN-USASP2024069740$AMGEN$$62$YR$A$M$Y$$$20240708$$HP$US$US
237350212$23735021$2$F$20240301$20240716$20240412$20240717$EXP$$US-JNJFOC-20240417766$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
237350422$23735042$2$F$$20240716$20240412$20240718$EXP$$US-JNJFOC-20240418087$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$HP$US$US
237350563$23735056$3$F$20240503$20240807$20240412$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001641$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240829$$CN$US$US
237351052$23735105$2$F$20230801$20240820$20240412$20240903$EXP$$US-MDD US Operations-MDD202308-003199$MDD OPERATIONS$$66$YR$$F$Y$$$20240903$$HP$US$
237351062$23735106$2$F$$20240820$20240412$20240828$EXP$$CA-TEVA-VS-3180397$TEVA$$74$YR$$F$Y$$$20240828$$MD$CA$CA
237351143$23735114$3$F$20220101$20240717$20240412$20240725$EXP$$CA-CELLTRION INC.-2022CA008700$CELLTRION$$$$$$Y$$$20240725$$MD$CA$CA
237351623$23735162$3$F$20240408$20240816$20240412$20240823$PER$$US-AMGEN-USASP2024073578$AMGEN$$82$YR$E$F$Y$$$20240823$$CN$US$US
237352003$23735200$3$F$20240219$20240625$20240412$20240712$EXP$$US-ASTELLAS-2024US010176$ASTELLAS$$49$YR$$F$Y$$$20240712$$CN$US$US
237352254$23735225$4$F$20240226$20240730$20240412$20240801$EXP$$JP-ASTELLAS-2024JP002352$ASTELLAS$$76$YR$$M$Y$$$20240801$$MD$JP$JP
237352423$23735242$3$F$20240401$20240912$20240412$20240919$EXP$$JP-ASTELLAS-2024JP002436$ASTELLAS$$$$$M$Y$$$20240919$$MD$JP$JP
237352542$23735254$2$F$$20240711$20240412$20240717$EXP$$PE-AMGEN-PERSP2024022549$AMGEN$$60$YR$A$F$Y$$$20240717$$CN$PE$PE
237352552$23735255$2$F$20240407$20240816$20240412$20240821$PER$$US-AMGEN-USASP2024073004$AMGEN$$73$YR$E$M$Y$$$20240821$$CN$US$US
237352914$23735291$4$F$20220603$20240710$20240412$20240722$EXP$$CA-CELLTRION INC.-2024CA003854$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
237352924$23735292$4$F$20240404$20240626$20240412$20240704$EXP$$CA-CELLTRION INC.-2024CA008642$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
237352932$23735293$2$F$20230501$20240708$20240412$20240716$EXP$FR-AFSSAPS-TO2024000441$FR-TEVA-VS-3179701$TEVA$$67$YR$$M$Y$72$KG$20240716$$PH$FR$FR
237353143$23735314$3$F$20240101$20240813$20240412$20240821$EXP$$CA-CELLTRION INC.-2024CA008692$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
237353183$23735318$3$F$20230101$20240924$20240412$20240930$EXP$$JP-009507513-2404JPN000786J$MERCK$$63$YR$$$Y$$$20240928$$HP$JP$JP
237353322$23735332$2$F$$20240628$20240412$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02913$LUPIN$$$$$$Y$$$20240718$$CN$US$US
237353423$23735342$3$F$$20240628$20240412$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02874$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237353483$23735348$3$F$$20240831$20240412$20240906$EXP$$TH-TAKEDA-2022TUS102467$TAKEDA$$26$YR$$M$Y$$$20240906$$CN$TH$TH
237353674$23735367$4$F$20240327$20240815$20240412$20240820$PER$$US-AMGEN-USASP2024073824$AMGEN$$70$YR$E$F$Y$65.8$KG$20240820$$MD$US$US
237353752$23735375$2$F$$20240730$20240412$20240805$EXP$$JP-009507513-2404JPN000741J$MERCK$$$$$F$Y$$$20240805$$MD$JP$JP
237353867$23735386$7$F$20240101$20240723$20240412$20240812$EXP$$US-ORGANON-O2404USA001472$ORGANON$$$$$F$Y$102.2$KG$20240812$$HP$US$US
237353913$23735391$3$F$20240408$20240716$20240412$20240718$EXP$$IN-ROCHE-3540053$ROCHE$$77$YR$E$M$Y$53$KG$20240718$$MD$IN$IN
237353922$23735392$2$F$$20240725$20240412$20240731$EXP$$IN-ROCHE-3514939$ROCHE$$64$YR$A$M$Y$70.3$KG$20240731$$CN$IN$IN
237354024$23735402$4$F$$20240626$20240412$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02918$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237354152$23735415$2$F$$20240628$20240412$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02875$LUPIN$$$$$$Y$$$20240718$$CN$US$US
237354264$23735426$4$F$20240201$20240827$20240412$20240828$EXP$$CA-TAKEDA-2024TUS033997$TAKEDA$$60$YR$$F$Y$$$20240828$$CN$CA$CA
237354294$23735429$4$F$20240426$20240913$20240412$20240918$EXP$$CA-TAKEDA-2024TUS034261$TAKEDA$$52$YR$$F$Y$$$20240918$$CN$CA$CA
237354592$23735459$2$F$$20240626$20240412$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02877$LUPIN$$$$$$Y$$$20240711$$CN$US$US
237354835$23735483$5$F$20240301$20240719$20240412$20240729$EXP$$US-ROCHE-3524696$ROCHE$$79$YR$E$F$Y$$$20240729$$CN$US$US
237354842$23735484$2$F$20240306$20240708$20240412$20240709$EXP$IE-HPRA-2024-111662$IE-JNJFOC-20240386310$JOHNSON AND JOHNSON$$45$YR$A$F$Y$57$KG$20240709$$HP$IE$IE
237354913$23735491$3$F$20240101$20240812$20240412$20240824$EXP$$GB-UCBSA-2024017227$UCB$$$$$M$Y$$$20240824$$CN$GB$GB
237354962$23735496$2$F$$20240628$20240412$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02922$LUPIN$$$$$$Y$$$20240718$$CN$US$US
237355092$23735509$2$F$$20240703$20240412$20240711$EXP$$JP-AMGEN-JPNSP2024071485$AMGEN$$$$E$$Y$$$20240711$$MD$JP$JP
237355112$23735511$2$F$20230505$20240808$20240412$20240816$EXP$$JP-009507513-2305JPN002060J$MERCK$$75$YR$$M$Y$62$KG$20240816$$MD$JP$JP
237355253$23735525$3$F$20230911$20240709$20240412$20240711$EXP$$JP-ABBVIE-5683865$ABBVIE$$72$YR$$M$Y$82$KG$20240711$$MD$JP$JP
237355262$23735526$2$F$$20240626$20240412$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02932$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237355272$23735527$2$F$$20240628$20240412$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02876$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237355352$23735535$2$F$20240301$20240709$20240412$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202404006396$ELI LILLY AND CO$$$$$M$Y$$$20240719$$MD$US$US
237355422$23735542$2$F$20240315$20240912$20240412$20240916$EXP$$NVSC2024US058549$NOVARTIS$$83$YR$$F$Y$$$20240916$$CN$US$US
237355672$23735567$2$F$$20240628$20240412$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02923$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237355903$23735590$3$F$$20240628$20240412$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02930$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237356102$23735610$2$F$$20240701$20240412$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02931$LUPIN$$$$$$Y$$$20240718$$CN$US$US
237356242$23735624$2$F$$20240702$20240412$20240705$EXP$$FR-BAYER-2024A047711$BAYER$$$$$F$Y$$$20240705$$CN$FR$FR
237356522$23735652$2$F$20240201$20240711$20240412$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-043262$BRISTOL MYERS SQUIBB$$17$YR$T$M$Y$$$20240711$$CN$US$US
237356552$23735655$2$F$$20240813$20240412$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057490$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240815$$CN$US$US
237357974$23735797$4$F$$20240712$20240412$20240725$EXP$$JP-UCBSA-2024017230$UCB$$5$YR$$F$Y$11.9$KG$20240725$$MD$JP$JP
237358153$23735815$3$F$20231210$20240801$20240412$20240813$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-02901$HIKMA$$$$$M$Y$92.1$KG$20240813$$HP$US$US
237358163$23735816$3$F$20240301$20240627$20240412$20240701$PER$$US-ALXN-202404USA000438US$ALEXION PHARMACEUTICALS$$95$YR$$F$Y$$$20240701$$CN$US$US
237358702$23735870$2$F$20240410$20240813$20240412$20240814$PER$$US-AMGEN-USASP2024073006$AMGEN$$73$YR$E$M$Y$$$20240814$$CN$US$US
237358722$23735872$2$F$20240401$20240725$20240412$20240730$PER$$US-AMGEN-USASP2024070584$AMGEN$$64$YR$A$F$Y$$$20240730$$CN$US$US
237359092$23735909$2$F$$20240626$20240412$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02917$LUPIN$$$$$$Y$$$20240711$$CN$US$US
237359122$23735912$2$F$20210924$20240911$20240412$20240923$PER$$GR-HELSINN-2021GR023788$HELSINN HEALTHCARE$$84$YR$$M$Y$$$20240923$$CN$GR$GR
237359404$23735940$4$F$20231201$20240802$20240412$20240809$EXP$$US-ALXN-202404USA000496US$ALEXION PHARMACEUTICALS$$72$YR$$F$Y$$$20240809$$CN$US$US
237359752$23735975$2$F$$20240801$20240412$20240806$EXP$$AU-JNJFOC-20240429056$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$HP$AU$AU
237360113$23736011$3$F$$20240709$20240412$20240718$PER$$US-PHARMING-PHAUS2024000299$PHARMING GROUP$$$$$$Y$$$20240718$$CN$US$US
237360813$23736081$3$F$20240330$20240702$20240412$20240702$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-055252$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$55$KG$20240702$$MD$IT$IT
237360833$23736083$3$F$$20240711$20240412$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057715$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240711$$CN$US$US
237360854$23736085$4$F$20240101$20240701$20240412$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057459$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240703$$CN$US$US
237360873$23736087$3$F$$20240906$20240412$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057297$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240910$$HP$US$US
237361833$23736183$3$F$20240303$20240703$20240412$20240713$EXP$$IT-TEVA-VS-3177148$TEVA$$70$YR$$M$Y$76$KG$20240713$$MD$IT$US
237362533$23736253$3$F$20240326$20240625$20240412$20240701$PER$$US-PFIZER INC-202400081035$PFIZER$$27$YR$$F$Y$$$20240701$$CN$US$US
237362815$23736281$5$F$20240528$20240705$20240412$20240713$PER$$US-SA-2024SA107269$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240713$$MD$US$US
237362842$23736284$2$F$20220901$20240725$20240412$20240805$PER$$US-SA-2024SA106996$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240805$$MD$US$US
237363043$23736304$3$F$20240101$20240705$20240412$20240716$PER$$US-SA-2024SA105898$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240716$$MD$US$US
237363132$23736313$2$F$20231201$20240731$20240412$20240810$PER$$US-SA-2024SA104914$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240810$$MD$US$US
237363262$23736326$2$F$20240301$20240723$20240412$20240801$PER$$US-SA-2024SA106083$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240801$$MD$US$US
237363342$23736334$2$F$20240701$20240719$20240412$20240730$PER$$US-SA-2024SA109727$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240730$$MD$US$US
237363402$23736340$2$F$20240101$20240827$20240412$20240905$PER$$US-SA-2024SA109850$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240905$$MD$US$US
237363513$23736351$3$F$20240301$20240624$20240412$20240701$PER$$US-SA-2024SA109729$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240701$$MD$US$US
237363662$23736366$2$F$20240101$20240717$20240412$20240725$PER$$US-SA-2024SA109681$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240725$$MD$US$US
237363692$23736369$2$F$20240101$20240802$20240412$20240813$PER$$US-SA-2024SA110425$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240814$$MD$US$US
237363762$23736376$2$F$20240101$20240718$20240412$20240725$PER$$US-SA-2024SA110158$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240725$$MD$US$US
237363772$23736377$2$F$20240101$20240911$20240412$20240926$PER$$US-SA-2024SA110267$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240926$$MD$US$US
237363812$23736381$2$F$$20240722$20240412$20240730$PER$$US-SA-2024SA109741$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240730$$MD$US$US
237364093$23736409$3$F$20160101$20240924$20240412$20240930$EXP$$CO-SANDOZ INC.-PHHY2016CO148527$SANDOZ$$$$$F$Y$64$KG$20240930$$CN$CO$CO
237364102$23736410$2$F$$20240827$20240412$20240830$EXP$$NVSC2024CN077038$NOVARTIS$$67$YR$$M$Y$$$20240830$$CN$CN$CN
237364243$23736424$3$F$$20240708$20240412$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-055659$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240708$$MD$JP$JP
237364903$23736490$3$F$$20240808$20240412$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024042699$VIIV$$$$$M$Y$107$KG$20240816$$MD$US$US
237365092$23736509$2$F$20240327$20240711$20240412$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057831$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240711$$CN$US$US
237365102$23736510$2$F$$20240711$20240412$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056925$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240712$$CN$US$US
237365212$23736521$2$F$20240101$20240903$20240412$20240912$PER$$US-SA-2024SA110085$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240912$$MD$US$US
237365383$23736538$3$F$$20240829$20240412$20240906$EXP$$CA-AstraZeneca-2024A082055$ASTRAZENECA$$$$$F$Y$$$20240906$$HP$CA$
237365432$23736543$2$F$20240320$20240812$20240412$20240816$PER$$US-AMGEN-USASP2024073508$AMGEN$$83$YR$E$F$Y$$$20240815$$HP$US$US
237365462$23736546$2$F$$20240913$20240412$20240923$EXP$$JP-SA-2024SA107777$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240923$$PH$JP$JP
237365474$23736547$4$F$20240402$20240909$20240412$20240918$EXP$$JP-Eisai-EC-2024-163317$EISAI$$79$YR$E$M$Y$62$KG$20240918$$MD$JP$JP
237365582$23736558$2$F$$20240628$20240412$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02979$LUPIN$$$$$$Y$$$20240716$$PH$US$US
237365753$23736575$3$F$20231201$20240625$20240412$20240701$EXP$$US-BIOGEN-2024BI01258965$BIOGEN$$39$YR$$F$Y$$$20240630$$CN$US$US
237365925$23736592$5$F$$20240802$20240412$20240807$30DAY$$GB-PFIZER INC-PV202400043831$PFIZER$$85$YR$$M$Y$$$20240807$$HP$GB$GB
237365935$23736593$5$F$$20240821$20240412$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02937$LUPIN$$$$$$Y$$$20240909$$CN$US$US
237365954$23736595$4$F$$20240808$20240412$20240813$30DAY$$GB-PFIZER INC-PV202400044579$PFIZER$$85$YR$$M$Y$$$20240813$$CN$GB$GB
237366432$23736643$2$F$$20240903$20240412$20240905$30DAY$$GB-PFIZER INC-202400076135$PFIZER$$$$$M$Y$$$20240905$$CN$GB$GB
237366463$23736646$3$F$20240101$20240830$20240412$20240906$EXP$$JP-009507513-2402JPN000893J$MERCK$$65$YR$$M$Y$$$20240906$$MD$JP$JP
237366755$23736675$5$F$20240402$20240819$20240412$20240826$EXP$$JP-DSJP-DSJ-2024-116513AA$DAIICHI$$54$YR$$F$Y$42$KG$20240826$$MD$JP$JP
237366842$23736684$2$F$$20240710$20240412$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056203$BRISTOL MYERS SQUIBB$$30$YR$A$M$Y$$$20240710$$HP$US$US
237367143$23736714$3$F$20240328$20240913$20240412$20240918$PER$$CA-BRACCO-2024CA01851$BRACCO$$26$YR$$M$Y$$$20240918$$HP$CA$CA
237367192$23736719$2$F$$20240806$20240412$20240809$PER$$US-PFIZER INC-PV202400048201$PFIZER$$56$YR$$F$Y$$$20240809$$HP$US$US
237367242$23736724$2$F$20240612$20240703$20240412$20240708$EXP$$US-PFIZER INC-202400085474$PFIZER$$71$YR$$F$Y$$$20240708$$HP$US$US
237367253$23736725$3$F$20240101$20240718$20240412$20240722$EXP$$US-PFIZER INC-202400085222$PFIZER$$58$YR$$F$Y$$$20240722$$CN$US$US
237367322$23736732$2$F$$20240912$20240412$20240916$PER$$US-PFIZER INC-PV202400048461$PFIZER$$56$YR$$F$Y$$$20240916$$HP$US$US
237367393$23736739$3$F$$20240710$20240412$20240715$PER$$US-PFIZER INC-PV202400047531$PFIZER$$65$YR$$F$Y$$$20240715$$HP$US$US
237367512$23736751$2$F$$20240726$20240412$20240730$PER$$US-PFIZER INC-PV202400048179$PFIZER$$67$YR$$F$Y$$$20240730$$HP$US$US
237367533$23736753$3$F$20240101$20240906$20240412$20240910$PER$$US-PFIZER INC-PV202400046847$PFIZER$$67$YR$$F$Y$$$20240910$$HP$US$US
237367662$23736766$2$F$20240301$20240813$20240412$20240815$PER$$US-PFIZER INC-PV202400047141$PFIZER$$87$YR$$F$Y$$$20240815$$HP$US$US
237367673$23736767$3$F$20240101$20240801$20240412$20240805$PER$$US-PFIZER INC-PV202400019481$PFIZER$$74$YR$$F$Y$$$20240805$$HP$US$US
237368012$23736801$2$F$$20240626$20240412$20240711$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440557$RANBAXY$Chang Y-L, Sae-lim C, Lin S-L, Lai H-W, Huang H-I, Lai Y-C, et al. Scarless totally implantable venous access port (TIVAP) implantation: Surgical technique, preliminary results, learning curve, and patients-reported outcome in 125 breast cancer patients. Surg Oncol. 2024;53 (0):102048(1-9)$$$$F$Y$$$20240711$$HP$TW$TW
237368092$23736809$2$F$$20240729$20240412$20240813$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440619$RANBAXY$Prejbisz A, Kosinski P, Dobrowolski P. Hypertension conditions during pregnancy. Med Prakt. 2024;2:71-76$$$N$$Y$$$20240813$$HP$PL$PL
237368122$23736812$2$F$$20240703$20240412$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440662$RANBAXY$Donahoe LL, Snelgrove JW, de Perrot M, Sermer M, Silversides C, Granton J, et al. Pregnancy and pulmonary hypertension in the pre-lung transplant patient: Successfully saving two lives with extracorporeal lung support. JTCVS Tech. 2023;Aug; 20(c):186-191$37$YR$$F$Y$$$20240718$$MD$CA$CA
237368152$23736815$2$F$$20240729$20240412$20240813$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440618$RANBAXY$Prejbisz A, Kosinski P, Dobrowolski P. Hypertension conditions during pregnancy. Med Prakt. 2024;2:71-76$27$YR$$F$Y$$$20240813$$HP$PL$PL
237368165$23736816$5$F$20230917$20240715$20240412$20240730$EXP$$DE-SUNPHARMA-2024RR-440996AA$RANBAXY$$61$YR$$M$Y$$$20240730$$HP$DE$DE
237368233$23736823$3$F$20240228$20240617$20240412$20240702$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-441801$RANBAXY$$$$E$M$Y$74$KG$20240702$$CN$IT$IT
237368362$23736836$2$F$$20240729$20240412$20240813$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440620$RANBAXY$Prejbisz A, Kosinski P, Dobrowolski P. Hypertension conditions during pregnancy. Med Prakt. 2024;2:71-76$42$YR$$F$Y$$$20240813$$HP$PL$PL
237368683$23736868$3$F$$20240826$20240412$20240909$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440659$RANBAXY$Shacham Y, Goldman AD. Continuous Urine Output Monitoring to Guide De-Escalation of Continuous Renal Replacement Therapy. J Am Soc Nephrol. 2023;34:1059(PUB040)$68$YR$$M$Y$$$20240909$$HP$IL$IL
237368752$23736875$2$F$$20240627$20240412$20240712$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440764$RANBAXY$Laarhuis SRE, Kerskes CHM, Nijziel MR, van Wensen RJA, Touw DJ. Linezolid?Induced Thrombocytopenia in Patients with Renal Impairment: A Case Series, Review and Dose Advice. Drugs RD. 2024;Mar; 24(1):109-115$49$YR$$M$Y$86$KG$20240712$$HP$NL$NL
237368902$23736890$2$F$$20240628$20240412$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02929$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237369142$23736914$2$F$$20240627$20240412$20240712$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440763$RANBAXY$Laarhuis SRE, Kerskes CHM, Nijziel MR, van Wensen RJA, Touw DJ. Linezolid?Induced Thrombocytopenia in Patients with Renal Impairment: A Case Series, Review and Dose Advice. Drugs RD. 2024;Mar; 24(1):109-115$65$YR$$F$Y$98$KG$20240712$$HP$NL$NL
237369362$23736936$2$F$20231026$20240627$20240412$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-442026$RANBAXY$$53$YR$$M$Y$$$20240712$$MD$FR$FR
237369553$23736955$3$F$20240328$20240708$20240412$20240709$EXP$$NVSC2024BR076614$NOVARTIS$$0$YR$$F$Y$$$20240709$$MD$BR$BR
237369803$23736980$3$F$$20240812$20240412$20240820$EXP$$NVSC2024IT073641$NOVARTIS$Collini A, Ongaro A, Evald F, Lazzi S, Micheletti G, Ruggieri G. Tacrolimus-Associated Terminal Ileitis After Kidney Transplantation, Mimicking Crohn Disease: A Case Report.. TRANSPLANTATION PROCEEDINGS. 2024;56(2):459-62$33$YR$$$Y$$$20240820$$HP$IT$IT
237369932$23736993$2$F$$20240627$20240412$20240712$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440760$RANBAXY$Laarhuis SRE, Kerskes CHM, Nijziel MR, van Wensen RJA, Touw DJ. Linezolid?Induced Thrombocytopenia in Patients with Renal Impairment: A Case Series, Review and Dose Advice. Drugs RD. 2024;Mar; 24(1):109-115$59$YR$$F$Y$82$KG$20240712$$HP$NL$NL
237370172$23737017$2$F$$20240329$20240412$20240813$EXP$$CA-TEVA-VS-3180218$TEVA$$40$YR$$F$Y$$$20240813$$HP$CA$CA
237370182$23737018$2$F$20240101$20240708$20240412$20240717$EXP$$US-TEVA-VS-3178273$TEVA$$$$A$F$Y$$$20240717$$MD$US$US
237370302$23737030$2$F$$20240715$20240412$20240724$PER$$US-SA-2024SA105137$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240724$$MD$US$US
237370546$23737054$6$F$20240403$20240821$20240412$20240825$EXP$$US-TAKEDA-2024TUS033774$TAKEDA$$57$YR$$F$Y$$$20240825$$CN$US$US
237370622$23737062$2$F$$20240807$20240412$20240815$PER$$US-SA-2024SA109563$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240815$$CN$US$US
237370722$23737072$2$F$$20240711$20240412$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056875$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240711$$CN$US$US
237370825$23737082$5$F$20240103$20240608$20240412$20240821$EXP$$CA-JNJFOC-20240107511$JOHNSON AND JOHNSON$$5$YR$C$M$Y$15$KG$20240822$$HP$CA$CA
237371193$23737119$3$F$20120101$20240821$20240412$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202404006235$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240826$$HP$US$US
237371384$23737138$4$F$20231217$20240724$20240412$20240726$EXP$$CA-UCBSA-2023060410$UCB$$28$YR$$F$Y$$$20240726$$CN$CA$CA
237371512$23737151$2$F$20221121$20240829$20240412$20240906$EXP$$JP-AKEBIA EUROPE LIMITED-JP-AKEB-22-023127$AKEBIA THERAPEUTICS$$43$YR$$M$Y$133.5$KG$20240906$$MD$JP$JP
237371564$23737156$4$F$20240201$20240921$20240412$20240925$30DAY$$GB-PFIZER INC-PV202400045878$PFIZER$$22$YR$$M$Y$$$20240925$$CN$GB$GB
237371653$23737165$3$F$20211015$20240819$20240412$20240829$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-000517$AKEBIA THERAPEUTICS$$85$YR$$F$Y$30.6$KG$20240829$$MD$JP$JP
237371835$23737183$5$F$20240318$20240904$20240412$20240911$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000738$BLUEPRINT MEDICINES$$79$YR$E$F$Y$$$20240911$$CN$US$US
237371972$23737197$2$F$20240319$20240411$20240412$20240812$EXP$$CN-BAYER-2024A053756$BAYER$$81$YR$E$M$Y$50$KG$20240812$$HP$CN$CN
237372013$23737201$3$F$20240909$20240909$20240412$20240916$EXP$$CA-TAKEDA-2023TUS020541$TAKEDA$$73$YR$$F$Y$$$20240916$$CN$CA$CA
237372022$23737202$2$F$20240404$20240809$20240412$20240820$PER$$US-SA-2024SA111443$SANOFI AVENTIS$$56$YR$A$F$Y$99.79$KG$20240820$$MD$US$US
237372232$23737223$2$F$20240409$20240726$20240412$20240730$PER$$US-AMGEN-USASP2024073796$AMGEN$$84$YR$E$M$Y$$$20240730$$CN$US$US
237372272$23737227$2$F$20240327$20240711$20240412$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057824$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240711$$HP$US$US
237372322$23737232$2$F$$20240730$20240412$20240805$EXP$$CA-TAKEDA-2024TUS032966$TAKEDA$$$$$M$Y$$$20240805$$CN$CA$CA
237372503$23737250$3$F$20240320$20240828$20240412$20240904$EXP$$CN-JNJFOC-20240428195$JOHNSON AND JOHNSON$$73$YR$E$M$Y$60$KG$20240904$$HP$CN$CN
237372803$23737280$3$F$20240321$20240909$20240412$20240910$EXP$$US-BAYER-2024A049865$BAYER$$11$YR$C$M$Y$$$20240910$$CN$US$US
237372922$23737292$2$F$$20240404$20240412$20240701$EXP$$FR-AstraZeneca-2024A085674$ASTRAZENECA$$$$A$M$Y$$$20240701$$MD$FR$
2373729613$23737296$13$F$20240401$20240918$20240412$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010409$UNITED THERAPEUTICS$$83$YR$$F$Y$71.655$KG$20240928$$$US$US
237373504$23737350$4$F$$20240827$20240412$20240906$EXP$$DE-JNJFOC-20240274113$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240906$$MD$DE$DE
237373915$23737391$5$F$$20240805$20240412$20240807$EXP$$US-SANDOZ INC.-NVSC2021US191417$SANDOZ$$$$$F$Y$57.143$KG$20240807$$HP$US$US
237373932$23737393$2$F$$20240702$20240412$20240709$PER$$US-MYLANLABS-2024M1026394$MYLAN$$$$$F$Y$99.79$KG$20240709$$CN$US$US
237374713$23737471$3$F$$20240715$20240412$20240730$EXP$$US-PHARMAAND GMBH-2024PHR00298$pharmaAND$$$$$M$Y$$$20240730$$CN$US$US
237375162$23737516$2$F$20240709$20240719$20240412$20240722$30DAY$$US-SANDOZ INC.-SDZ2024US038774$SANDOZ$$67$YR$$M$Y$$$20240722$$HP$US$US
237375172$23737517$2$F$$20240823$20240412$20240828$EXP$CA-HEALTHCANVIG-001075170$CA-PURDUE-USA-2024-0308971$PURDUE$$61$YR$$M$Y$$$20240828$$HP$CA$CA
237375182$23737518$2$F$$20240917$20240412$20240919$EXP$$CA-PURDUE-USA-2024-0308954$PURDUE$$49$YR$$M$Y$$$20240919$$HP$CA$CA
237375369$23737536$9$F$20231204$20240909$20240412$20240911$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-000149$BOEHRINGER INGELHEIM$$95$YR$E$M$Y$81.193$KG$20240911$$CN$US$US
237375453$23737545$3$F$20220212$20240806$20240412$20240816$EXP$$JP-AKEBIA EUROPE LIMITED-JP-AKEB-22-022678$AKEBIA THERAPEUTICS$$82$YR$$M$Y$57.8$KG$20240816$$MD$JP$JP
237375824$23737582$4$F$20230207$20240821$20240412$20240828$EXP$$CA-JNJFOC-20230239377$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240828$$PH$CA$CA
237376089$23737608$9$F$20240101$20240821$20240412$20240826$EXP$$CA-GSK-CA2023AMR095132$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$CA$CA
237376222$23737622$2$F$$20240729$20240412$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-021609$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240729$$CN$US$US
237376292$23737629$2$F$20200101$20240709$20240412$20240716$EXP$$US-009507513-2404USA006988$MERCK$$$$A$F$Y$$$20240716$$MD$US$US
237376382$23737638$2$F$20230310$20240722$20240412$20240801$EXP$$JP-TEVA-VS-3178727$TEVA$$51$YR$$F$Y$$$20240801$$MD$JP$JP
237376514$23737651$4$F$20240227$20240801$20240412$20240812$EXP$$US-BAXTER-2024BAX016252$BAXTER$$78$YR$$F$Y$69.9$KG$20240812$$HP$US$US
237376753$23737675$3$F$$20240912$20240412$20240926$PER$$US-SA-2024SA107090$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240926$$MD$US$US
237376802$23737680$2$F$$20240913$20240412$20240916$EXP$$GR-SANDOZ INC.-SDZ2024GR038137$SANDOZ$$44$YR$$M$Y$$$20240916$$HP$GR$GR
237376822$23737682$2$F$20240215$20240829$20240412$20240905$EXP$$TH-Ipsen Biopharmaceuticals, Inc.-2024-04749$IPSEN$$65$YR$E$F$Y$$$20240905$$HP$TH$TH
237376996$23737699$6$F$20170801$20240620$20240412$20240718$EXP$$CA-UCBSA-2024017052$UCB$$40$YR$$F$Y$73$KG$20240718$$MD$CA$CA
237377023$23737702$3$F$$20240903$20240412$20240905$EXP$$IT-SANDOZ INC.-SDZ2024IT038552$SANDOZ$$18$YR$$M$Y$$$20240905$$HP$IT$IT
237377045$23737704$5$F$20240419$20240920$20240412$20240926$EXP$$CA-TAKEDA-2024TUS015866$TAKEDA$$57$YR$$M$Y$$$20240926$$CN$CA$CA
237377212$23737721$2$F$$20240404$20240412$20240701$EXP$$FR-AstraZeneca-2024A085623$ASTRAZENECA$$$$E$F$Y$$$20240701$$MD$FR$
237377262$23737726$2$F$20240409$20240724$20240412$20240727$PER$$US-AMGEN-USASP2024074101$AMGEN$$78$YR$E$M$Y$$$20240727$$PH$US$US
237377634$23737763$4$F$20230314$20240725$20240412$20240726$EXP$$CA-PFIZER INC-202300114619$PFIZER$$68$YR$$F$Y$$$20240726$$HP$CA$CA
237377752$23737775$2$F$20240213$20240702$20240412$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050474$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$77.11$KG$20240704$$CN$US$US
237378164$23737816$4$F$20240619$20240626$20240412$20240701$EXP$$US-PFIZER INC-202400083971$PFIZER$$88$YR$$M$Y$68.04$KG$20240701$$CN$US$US
237378472$23737847$2$F$20240327$20240830$20240412$20240911$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404002546$ELI LILLY AND CO$$71$YR$E$F$Y$60$KG$20240911$$CN$JP$JP
237378833$23737883$3$F$20240301$20240912$20240412$20240917$PER$$US-BIOGEN-2024BI01257977$BIOGEN$$47$YR$$F$Y$$$20240917$$CN$US$US
237379073$23737907$3$F$20240102$20240814$20240412$20240824$EXP$FR-AFSSAPS-BX2024000079$FR-TEVA-VS-3163459$TEVA$$66$YR$$M$Y$$$20240824$$HP$FR$FR
237379092$23737909$2$F$20231121$20240828$20240412$20240905$EXP$$JP-AstraZeneca-2024A083552$ASTRAZENECA$$64$YR$$F$Y$$$20240905$$MD$JP$
237379172$23737917$2$F$$20240716$20240412$20240718$PER$$US-JNJFOC-20240422872$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240718$$CN$US$US
237379719$23737971$9$F$$20240913$20240412$20240920$EXP$$NVSC2024CL057762$NOVARTIS$$60$YR$$F$Y$$$20240920$$CN$CL$CL
237379852$23737985$2$F$20220627$20240821$20240412$20240828$EXP$$JP-Eisai-EC-2022-130826$EISAI$$65$YR$E$F$Y$$$20240828$$MD$JP$JP
237380223$23738022$3$F$20240401$20240730$20240412$20240813$EXP$$CO-VER-202400004$VERITY PHARMACEUTICALS$$8$YR$C$F$Y$$$20240813$$HP$CO$CO
237380502$23738050$2$F$20220101$20240805$20240412$20240814$EXP$$JP-Eisai-EC-2022-124457$EISAI$Takeda K. Current Status and Future Prospects of Drug Therapy for Endometrial Cancer.. The 76th Annual Congress of the Japan Society of Obstetrics and Gynecology LS11 Lecture Slides..$55$YR$A$F$Y$50$KG$20240814$$MD$JP$JP
237380794$23738079$4$F$$20240724$20240412$20240725$PER$$NVSC2024US077793$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
237380963$23738096$3$F$$20240628$20240412$20240703$PER$$US-PFIZER INC-PV202400048621$PFIZER$$72$YR$$M$Y$73.469$KG$20240703$$CN$US$US
237381062$23738106$2$F$$20240718$20240412$20240722$PER$$US-PFIZER INC-PV202400047544$PFIZER$$64$YR$$F$Y$$$20240722$$HP$US$US
237381382$23738138$2$F$20240406$20240924$20240412$20240925$PER$$US-AMGEN-USASP2024073763$AMGEN$$70$YR$E$M$Y$$$20240925$$CN$US$US
237381427$23738142$7$F$$20240912$20240412$20240925$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-116468$DAIICHI$$$$$F$Y$$$20240925$$CN$US$US
237381602$23738160$2$F$$20240909$20240412$20240911$PER$$US-PFIZER INC-PV202400047266$PFIZER$$61$YR$$F$Y$$$20240911$$HP$US$US
237381872$23738187$2$F$$20240719$20240412$20240801$PER$$US-SA-2024SA106565$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240801$$MD$US$US
237381898$23738189$8$F$20240322$20240729$20240412$20240731$EXP$$ZA-PFIZER INC-PV202400047566$PFIZER$$20$YR$$M$Y$$$20240731$$MD$ZA$ZA
237382144$23738214$4$F$20230901$20240716$20240412$20240726$EXP$$JP-AKEBIA THERAPEUTICS, INC.-JP-AKEB-24-000538$AKEBIA THERAPEUTICS$$82$YR$$F$Y$60$KG$20240726$$MD$JP$JP
237382452$23738245$2$F$20240101$20240807$20240412$20240814$EXP$$US-BIOMARINAP-US-2024-157192$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
237382592$23738259$2$F$$20240712$20240412$20240718$30DAY$$CA-SANDOZ INC.-SDZ2024CA038861$SANDOZ$$$$$M$Y$$$20240718$$CN$CA$CA
237382683$23738268$3$F$20240301$20240805$20240412$20240814$PER$$US-BAUSCHBL-2024BNL004207$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240815$$CN$US$US
237382732$23738273$2$F$$20240821$20240412$20240823$EXP$$CA-PURDUE-USA-2024-0308972$PURDUE$$48$YR$$M$Y$$$20240823$$HP$CA$CA
237382942$23738294$2$F$$20240711$20240412$20240715$EXP$$US-PFIZER INC-202400085279$PFIZER$$87$YR$$F$Y$$$20240715$$CN$US$US
237383004$23738300$4$F$20240101$20240711$20240412$20240715$EXP$$US-PFIZER INC-202400085417$PFIZER$$41$YR$$F$Y$$$20240715$$MD$US$US
237383232$23738323$2$F$20240329$20240401$20240412$20240731$EXP$$US-SCPHARMACEUTICALS-2024-SCPH-US000152$PAREXEL$$$$$$Y$$$20240731$$HP$US$US
237383243$23738324$3$F$20240323$20240828$20240412$20240903$EXP$$CN-JNJFOC-20240421111$JOHNSON AND JOHNSON$$54$YR$A$F$Y$65$KG$20240903$$HP$CN$CN
237383272$23738327$2$F$20220101$20240404$20240412$20240718$EXP$$NVSC2024CZ039774$NOVARTIS$Cmucharova E. Pacientka s primarne generalizovan?m lobularnim HR+, HER2? karcinomem prsu lecena ribociclibem. [Patient with primary generalized lobular HR+, HER2? breast cancer treated with ribociclib]. ACTA MEDICINAE. 2024;13:14-6$71$YR$$F$Y$$$20240718$$HP$CZ$CZ
237383355$23738335$5$F$20240301$20240809$20240412$20240809$EXP$$NVSC2024PL075304$NOVARTIS$$33$YR$$F$Y$$$20240809$$MD$PL$PL
237383413$23738341$3$F$$20240917$20240412$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057369$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240918$$CN$US$US
237383532$23738353$2$F$$20240702$20240412$20240704$EXP$$GB-SANDOZ INC.-SDZ2024GB032353$SANDOZ$$$$$M$Y$$$20240704$$CN$GB$GB
2373837810$23738378$10$F$20231008$20240723$20240412$20240730$EXP$$FR-MYLANLABS-2024M1031754$MYLAN$$74$YR$$F$Y$73$KG$20240730$$HP$FR$FR
237383913$23738391$3$F$20221201$20240802$20240412$20240807$EXP$$JP-Eisai-EC-2022-129714$EISAI$$56$YR$A$F$Y$41$KG$20240807$$MD$JP$JP
237383972$23738397$2$F$$20240720$20240412$20240729$EXP$$US-BAYER-2024A049177$BAYER$$68$YR$E$M$Y$$$20240729$$CN$US$US
237384066$23738406$6$F$20240408$20240629$20240412$20240703$EXP$$AR-MYLANLABS-2024M1032382$MYLAN$$40$YR$$F$Y$$$20240703$$CN$AR$AR
237384214$23738421$4$F$20230801$20240903$20240412$20240905$EXP$$US-009507513-2403USA005131$MERCK$$76$YR$$M$Y$$$20240905$$PH$US$US
237384483$23738448$3$F$20240717$20240718$20240412$20240801$EXP$$CA-HLS-202400886$HLS THERAPEUTICS$$64$YR$A$F$Y$$$20240801$$PH$CA$CA
237384592$23738459$2$F$$20240731$20240412$20240802$30DAY$$EG-SANDOZ INC.-SDZ2024EG037606$SANDOZ$$$$$F$Y$$$20240802$$CN$EG$EG
237384834$23738483$4$F$20240210$20240709$20240412$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-056650$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240709$$MD$JP$JP
237385282$23738528$2$F$20240401$20240725$20240412$20240806$EXP$$US-MALLINCKRODT-MNK202402347$MALLINCKRODT$$76$YR$$F$Y$$$20240806$$CN$US$US
237385598$23738559$8$F$20240701$20240909$20240412$20240912$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-116470$DAIICHI$$64$YR$$F$Y$$$20240912$$CN$US$US
237385722$23738572$2$F$$20240409$20240412$20240705$EXP$$JP-009507513-2404JPN006166$MERCK$Hashimoto T, Takahashi K, Ito K, Iwade K, Torii A, Sugihara M, et al,.. An autopsy case of lung adenocarcinoma with immune checkpoint inhibitor-induced pneumonia and fulminant myocarditis following pembrolizumab administration: a case report. International Cancer Conference Journal. 2024$67$YR$$M$Y$$$20240705$$HP$JP$JP
237385743$23738574$3$F$$20240628$20240412$20240701$PER$$NVSC2024US078059$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
237385753$23738575$3$F$20240101$20240812$20240412$20240814$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-116148$DAIICHI$$$$$M$Y$$$20240814$$CN$US$US
237385822$23738582$2$F$20231107$20240701$20240412$20240709$EXP$$JP-009507513-2404JPN001153J$MERCK$$38$YR$$F$Y$$$20240709$$MD$JP$JP
237386452$23738645$2$F$$20240718$20240412$20240723$EXP$$US-ABBVIE-5711783$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
237386803$23738680$3$F$20230601$20240624$20240412$20240708$EXP$$US-ABBVIE-5713174$ABBVIE$$65$YR$$M$Y$$$20240708$$CN$US$US
237386924$23738692$4$F$20240101$20240822$20240412$20240830$EXP$$CO-JNJFOC-20240409640$JOHNSON AND JOHNSON$$62$YR$A$M$Y$78$KG$20240830$$HP$CO$CO
237386943$23738694$3$F$$20240730$20240412$20240808$PER$$US-SA-2024SA109520$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240808$$MD$US$US
237386992$23738699$2$F$20240409$20240828$20240412$20240829$PER$$US-AMGEN-USASP2024073948$AMGEN$$66$YR$E$M$Y$$$20240829$$CN$US$US
237387032$23738703$2$F$20240101$20240812$20240412$20240821$PER$$US-SA-2024SA107288$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240821$$MD$US$US
237387072$23738707$2$F$20240301$20240703$20240412$20240708$EXP$$US-ABBVIE-5713932$ABBVIE$$48$YR$$F$Y$$$20240708$$CN$US$US
237387672$23738767$2$F$20231101$20240829$20240413$20240912$PER$$US-SA-2024SA107265$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240912$$MD$US$US
237387752$23738775$2$F$$20240720$20240413$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-016318$AUROBINDO$$23$YR$$M$Y$$$20240731$$PH$FR$FR
237388482$23738848$2$F$20240101$20240910$20240413$20240919$PER$$US-SA-2024SA105349$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240919$$MD$US$US
237388622$23738862$2$F$20221001$20240618$20240413$20240709$EXP$$DE-ROCHE-3542265$ROCHE$$$$A$F$Y$58$KG$20240701$$CN$DE$DE
237388722$23738872$2$F$$20240723$20240413$20240801$PER$$US-SA-2024SA107095$SANOFI AVENTIS$$$$A$F$Y$77.11$KG$20240801$$MD$US$US
237388742$23738874$2$F$20240101$20240626$20240413$20240705$PER$$US-SA-2024SA106992$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240705$$MD$US$US
237388893$23738889$3$F$20240101$20240812$20240413$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009275$UNITED THERAPEUTICS$$$$$M$Y$86.168$KG$20240821$$$US$US
237389233$23738923$3$F$$20240828$20240413$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2023-010511$UNITED THERAPEUTICS$$$$$F$Y$62.585$KG$20240904$$MD$US$US
237389372$23738937$2$F$20231020$20240703$20240413$20240712$EXP$IT-MINISAL02-951060$IT-TEVA-2023-IT-2945408$TEVA$$10$YR$$F$Y$27$KG$20240712$$PH$IT$IT
237389423$23738942$3$F$$20240628$20240413$20240708$EXP$$CA-CELLTRION INC.-2022CA022508$CELLTRION$$$$$$Y$$$20240708$$HP$CA$CA
237389584$23738958$4$F$20240101$20240731$20240413$20240802$EXP$$US-UCBSA-2024017302$UCB$$$$$F$Y$$$20240802$$CN$US$US
237389692$23738969$2$F$$20240719$20240413$20240729$PER$$US-SA-2024SA107743$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240729$$MD$US$US
237390033$23739003$3$F$$20240826$20240413$20240910$EXP$$NL-ABBVIE-5444829$ABBVIE$$$$E$F$Y$$$20240910$$CN$NL$NL
237390042$23739004$2$F$20231001$20240827$20240413$20240830$EXP$$US-ABBVIE-5713291$ABBVIE$$80$YR$$M$Y$79.378$KG$20240830$$CN$US$US
237390112$23739011$2$F$20231018$20240715$20240413$20240730$EXP$FR-AFSSAPS-LM2024000179$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-105482$ZYDUS PHARM$$$$$$Y$$$20240730$$MD$FR$FR
237390132$23739013$2$F$20100503$20240827$20240413$20240909$EXP$FR-EMA-DD-20240326-7482655-061813$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-105483$ZYDUS PHARM$$$$$$Y$$$20240909$$MD$FR$FR
237390512$23739051$2$F$$20240624$20240413$20240708$PER$$US-MSNLABS-2024MSNSPO00761$MSN LABORATORIES$$$$$$Y$$$20240708$$CN$US$US
237390532$23739053$2$F$20240313$20240806$20240413$20240808$EXP$$JP-ABBVIE-5716003$ABBVIE$$50$YR$$F$Y$$$20240808$$MD$JP$JP
237390554$23739055$4$F$20240326$20240904$20240413$20240911$EXP$$US-ABBVIE-5715428$ABBVIE$$64$YR$$F$Y$$$20240911$$CN$US$US
237390562$23739056$2$F$20240301$20240705$20240413$20240712$EXP$$US-SA-2024SA111403$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240712$$MD$US$US
237390573$23739057$3$F$$20240701$20240413$20240710$PER$$US-SA-2024SA108027$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240710$$MD$US$US
237390582$23739058$2$F$20240101$20240726$20240413$20240806$PER$$US-SA-2024SA107528$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240806$$MD$US$US
237390592$23739059$2$F$$20240711$20240413$20240716$EXP$$US-SA-2024SA111188$SANOFI AVENTIS$$$$E$F$Y$$$20240716$$MD$US$US
237391122$23739112$2$F$$20240722$20240413$20240724$EXP$$GB-UCBSA-2024017215$UCB$$$$$F$Y$$$20240724$$CN$GB$GB
237391422$23739142$2$F$20240101$20240919$20240413$20240925$EXP$$US-ABBVIE-5717483$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
237391812$23739181$2$F$20230101$20240702$20240413$20240711$PER$$US-SA-2024SA106855$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240711$$MD$US$US
237391882$23739188$2$F$20240101$20240812$20240413$20240821$PER$$US-SA-2024SA107594$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240821$$MD$US$US
237391893$23739189$3$F$20160101$20240826$20240413$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-017100$AUROBINDO$$34$YR$$M$Y$79$KG$20240904$$CN$FR$FR
237391966$23739196$6$F$20240101$20240806$20240413$20240814$EXP$$CA-CELLTRION INC.-2024CA008772$CELLTRION$$$$$$Y$$$20240814$$HP$CA$CA
237392243$23739224$3$F$20231001$20240716$20240413$20240723$PER$$US-SA-2024SA108042$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240723$$MD$US$US
237392433$23739243$3$F$20240101$20240829$20240413$20240912$PER$$US-SA-2024SA105939$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240912$$MD$US$US
237392452$23739245$2$F$20240101$20240709$20240413$20240717$PER$$US-SA-2024SA107519$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240717$$MD$US$US
237392713$23739271$3$F$$20240812$20240413$20240814$EXP$$CA-JNJFOC-20240415359$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240814$$PH$CA$CA
237392812$23739281$2$F$$20240822$20240413$20240829$EXP$$US-ABBVIE-5716187$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
2373930510$23739305$10$F$20240101$20240820$20240413$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-006343$UNITED THERAPEUTICS$$$$$M$Y$87.528$KG$20240828$$$US$US
237393233$23739323$3$F$20240715$20240919$20240413$20240924$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-116449$DAIICHI$$67$YR$$F$Y$$$20240924$$CN$US$US
237393252$23739325$2$F$20240407$20240724$20240413$20240727$PER$$US-AMGEN-USASP2024073255$AMGEN$$69$YR$E$F$Y$$$20240727$$CN$US$US
237394052$23739405$2$F$20230901$20240802$20240413$20240808$EXP$$BR-TAKEDA-2023TUS092862$TAKEDA$$0$YR$$M$Y$8$KG$20240808$$CN$BR$BR
237394104$23739410$4$F$20240101$20240626$20240413$20240705$PER$$US-SA-2024SA107177$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240705$$MD$US$US
237394262$23739426$2$F$20240201$20240730$20240413$20240801$EXP$$US-UCBSA-2024017224$UCB$$64$YR$$F$Y$$$20240801$$HP$US$US
237394272$23739427$2$F$$20240719$20240413$20240729$EXP$IN-MLMSERVICE-20240327-4911756-1$IN-STRIDES ARCOLAB LIMITED-2024SP004264$STRIDES$Vasantha Shekar Reddy H, S Nagabushana D, Kattamanchi D, Dakappa A.. Nystagmus in a child with nephrotic syndrome.. BMJ Case Reports. 2024;17(2):e259734$$$C$M$Y$$$20240729$$MD$IN$IN
237394552$23739455$2$F$20240331$20240911$20240413$20240919$PER$$US-SA-2024SA107701$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240919$$HP$US$US
237394562$23739456$2$F$20240101$20240627$20240413$20240709$PER$$US-SA-2024SA107726$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240709$$MD$US$US
237394672$23739467$2$F$20230225$20240828$20240413$20240904$EXP$FR-AFSSAPS-AN2024000364$FR-TEVA-VS-3180674$TEVA$$63$YR$$M$Y$69$KG$20240904$$MD$FR$FR
237394743$23739474$3$F$20221229$20240708$20240413$20240711$EXP$$US-TAKEDA-2024TUS034907$TAKEDA$$66$YR$$F$Y$$$20240711$$HP$US$US
2373952110$23739521$10$F$20240101$20240717$20240413$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-010190$UNITED THERAPEUTICS$$$$$M$Y$93.424$KG$20240723$$$US$US
237395314$23739531$4$F$20211101$20240918$20240413$20240925$EXP$$DE-ROCHE-3085508$ROCHE$$54$YR$A$F$Y$$$20240925$$MD$DE$DE
237395323$23739532$3$F$20240101$20240808$20240413$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-010031$UNITED THERAPEUTICS$$$$$F$Y$104.31$KG$20240817$$$US$US
237395333$23739533$3$F$$20240920$20240413$20240925$EXP$$CA-ROCHE-3542700$ROCHE$$$$A$F$Y$$$20240925$$CN$CA$CA
237395422$23739542$2$F$20240323$20240819$20240413$20240821$EXP$$CA-ROCHE-3166323$ROCHE$$26$YR$A$F$Y$$$20240821$$CN$CA$CA
237395482$23739548$2$F$$20240813$20240413$20240819$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-021541$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240819$$HP$CA$CA
237395872$23739587$2$F$20240101$20240703$20240413$20240708$EXP$$US-AMGEN-USASP2024073888$AMGEN$$59$YR$A$M$Y$66.49$KG$20240708$$CN$US$US
237395943$23739594$3$F$20240329$20240919$20240413$20240927$PER$$US-GSK-US2024043421$GLAXOSMITHKLINE$$28$YR$$F$Y$$$20240927$$CN$US$US
237396152$23739615$2$F$20240101$20240702$20240413$20240711$PER$$US-SA-2024SA107303$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240711$$MD$US$US
237396223$23739622$3$F$20240803$20240820$20240413$20240827$PER$$US-SA-2024SA107672$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240827$$MD$US$US
237396402$23739640$2$F$$20240725$20240413$20240805$PER$$US-SA-2024SA106892$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240805$$MD$US$US
237396492$23739649$2$F$20240301$20240702$20240413$20240711$PER$$US-SA-2024SA106924$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240711$$MD$US$US
237397372$23739737$2$F$20240207$20240905$20240414$20240918$EXP$$DE-AUROBINDO-AUR-APL-2024-016522$AUROBINDO$$$$E$F$Y$$$20240918$$MD$DE$DE
237397382$23739738$2$F$$20240812$20240414$20240822$EXP$$FR-AUROBINDO-AUR-APL-2024-016516$AUROBINDO$$71$YR$$F$Y$$$20240822$$MD$FR$FR
237397452$23739745$2$F$20240101$20240904$20240414$20240916$PER$$US-SA-2024SA106782$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240916$$MD$US$US
237397543$23739754$3$F$$20240819$20240414$20240916$PER$$US-AstraZeneca-2024A086899$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
237397642$23739764$2$F$$20240729$20240414$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057524$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240730$$HP$US$US
237397692$23739769$2$F$$20240708$20240414$20240712$EXP$PL-EMA-DD-20240401-7482827-170435$PL-SANDOZ INC.-SDZ2024PL038954$SANDOZ$$55$YR$$F$Y$$$20240712$$HP$PL$PL
237397957$23739795$7$F$20240129$20240822$20240414$20240902$EXP$$DE-AUROBINDO-AUR-APL-2024-009538$AUROBINDO$$62$YR$$M$Y$$$20240902$$MD$DE$DE
237398053$23739805$3$F$20240101$20240710$20240414$20240718$PER$$US-SA-2024SA107649$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240718$$MD$US$US
237398172$23739817$2$F$$20240905$20240414$20240913$PER$$US-SA-2024SA109425$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240913$$HP$US$US
237398212$23739821$2$F$$20240717$20240414$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US037430$SANDOZ$$$$$M$Y$$$20240724$$HP$US$US
237398272$23739827$2$F$$20240722$20240414$20240724$30DAY$$US-SANDOZ INC.-SDZ2023US046811$SANDOZ$$$$$M$Y$$$20240724$$CN$US$US
237398304$23739830$4$F$20240101$20240723$20240414$20240801$PER$$US-SA-2024SA107130$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240801$$MD$US$US
237398464$23739846$4$F$20240101$20240821$20240414$20240917$PER$$US-SA-2024SA111217$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240918$$MD$US$US
237398732$23739873$2$F$$20240722$20240414$20240731$PER$$US-SA-2024SA109896$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240731$$MD$US$US
237398852$23739885$2$F$$20240702$20240414$20240711$PER$$US-SA-2024SA109270$SANOFI AVENTIS$$$$E$F$Y$40.8$KG$20240711$$MD$US$US
237399072$23739907$2$F$20221018$20240808$20240414$20240817$PER$$US-SA-2024SA055791$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240817$$MD$US$US
237399242$23739924$2$F$$20240716$20240414$20240725$PER$$US-SA-2024SA109457$SANOFI AVENTIS$$68$YR$E$M$Y$108$KG$20240725$$MD$US$US
237399422$23739942$2$F$20240601$20240702$20240414$20240711$PER$$US-SA-2024SA106718$SANOFI AVENTIS$$58$YR$A$F$Y$74.84$KG$20240711$$MD$US$US
237399442$23739944$2$F$20240401$20240726$20240414$20240806$PER$$US-SA-2024SA106725$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240806$$MD$US$US
237399782$23739978$2$F$$20240716$20240414$20240718$PER$$US-JNJFOC-20240419709$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240718$$CN$US$US
237399843$23739984$3$F$$20240916$20240414$20240925$EXP$$CA-TEVA-VS-3180652$TEVA$$71$YR$$M$Y$$$20240925$$HP$CA$CA
237399897$23739989$7$F$20240323$20240823$20240414$20240902$EXP$$US-GSK-US2024AMR043082$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240902$$CN$US$US
237400022$23740002$2$F$20240219$20240715$20240414$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057771$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240715$$CN$US$US
237400212$23740021$2$F$$20240722$20240414$20240724$PER$$NVSC2024US078054$NOVARTIS$$$$$F$Y$$$20240724$$HP$US$US
237400343$23740034$3$F$20231101$20240717$20240414$20240726$PER$$US-SA-2024SA106285$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240726$$MD$US$US
237401203$23740120$3$F$$20240906$20240414$20240912$EXP$$NVSC2024US047363$NOVARTIS$$$$$M$Y$$$20240912$$CN$US$US
237401333$23740133$3$F$$20240717$20240414$20240723$30DAY$$US-SANDOZ INC.-SDZ2024US037063$SANDOZ$$$$$M$Y$$$20240723$$CN$US$US
237401632$23740163$2$F$20240101$20240725$20240414$20240730$EXP$$CA-ABBVIE-5714284$ABBVIE$$62$YR$$F$Y$$$20240730$$CN$CA$CA
237401832$23740183$2$F$20240301$20240628$20240414$20240704$EXP$$US-ABBVIE-5715478$ABBVIE$$64$YR$$F$Y$$$20240704$$CN$US$US
237401844$23740184$4$F$$20240822$20240414$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056449$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$92.08$KG$20240827$$CN$US$US
237401872$23740187$2$F$$20240906$20240414$20240906$EXP$$NO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-021585$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240906$$PH$NO$NO
237401934$23740193$4$F$20230101$20240820$20240414$20240828$PER$$US-BAUSCHBL-2024BNL004303$BAUSCH AND LOMB$$69$YR$$F$Y$$$20240828$$CN$US$US
237402266$23740226$6$F$20221201$20240819$20240414$20240821$EXP$$NVSC2024FR077825$NOVARTIS$$74$YR$$F$Y$64.3$KG$20240821$$HP$FR$FR
237402413$23740241$3$F$20230101$20240702$20240414$20240705$EXP$$US-ABBVIE-5717514$ABBVIE$$67$YR$$F$Y$131.08$KG$20240705$$CN$US$US
237402932$23740293$2$F$$20240812$20240414$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053521$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240815$$CN$US$US
237403163$23740316$3$F$20240713$20240717$20240414$20240725$EXP$$US-BEH-2024170525$CSL BEHRING$$39$YR$A$F$Y$$$20240725$$HP$US$US
237403272$23740327$2$F$20240301$20240905$20240415$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057572$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240912$$CN$US$US
237403354$23740335$4$F$$20240627$20240415$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057352$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$88.9$KG$20240701$$CN$US$US
237403523$23740352$3$F$20240318$20240701$20240415$20240722$PER$$FR-TOLMAR, INC.-24FR047833$TOLMAR$$75$YR$$M$Y$$$20240722$$PH$FR$FR
237403582$23740358$2$F$20240409$20240920$20240415$20240927$EXP$$US-JNJFOC-20240426560$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
237403912$23740391$2$F$20240410$20240805$20240415$20240808$PER$$US-AMGEN-USASP2024074299$AMGEN$$64$YR$A$M$Y$$$20240808$$CN$US$US
237404032$23740403$2$F$$20240723$20240415$20240801$PER$$US-SA-2024SA110821$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240801$$MD$US$US
237404052$23740405$2$F$$20240812$20240415$20240820$PER$$US-SA-2024SA110825$SANOFI AVENTIS$$$$E$M$Y$94.8$KG$20240820$$MD$US$US
237404192$23740419$2$F$20240101$20240625$20240415$20240704$PER$$US-SA-2024SA110745$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240704$$MD$US$US
237404322$23740432$2$F$$20240729$20240415$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057483$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240731$$HP$US$US
237404592$23740459$2$F$20240101$20240722$20240415$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-057175$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240730$$MD$JP$JP
237404633$23740463$3$F$20240308$20240816$20240415$20240823$EXP$$CN-BEIGENE-BGN-2024-005416$BEIGENE$$$$$$Y$$$20240823$$MD$CN$CN
237404682$23740468$2$F$20240201$20240726$20240415$20240805$EXP$$CA-BEH-2024168655$CSL BEHRING$$67$YR$E$F$Y$131.5$KG$20240805$$HP$CA$CA
237404723$23740472$3$F$20240415$20240701$20240415$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056352$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$70.67$KG$20240702$$CN$US$US
237404903$23740490$3$F$$20240404$20240415$20240805$EXP$$GB-EMA-DD-20181127-n9c8j7-154206$Haleon PLC$$29$YR$$M$Y$$$20240805$$MD$GB$GB
237404942$23740494$2$F$20240101$20240717$20240415$20240725$PER$$US-SA-2024SA031799$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240725$$MD$US$US
237405003$23740500$3$F$20180820$20240807$20240415$20240812$EXP$$JP-009507513-2404JPN000954J$MERCK$$65$YR$$M$Y$73.2$KG$20240812$$MD$JP$JP
237405073$23740507$3$F$$20240628$20240415$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02910$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237405093$23740509$3$F$20221217$20240729$20240415$20240731$EXP$$JP-GILEAD-2024-0665914$GILEAD$$87$YR$E$M$Y$$$20240731$$MD$JP$JP
237405202$23740520$2$F$$20240628$20240415$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02925$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237405282$23740528$2$F$$20240626$20240415$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02941$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237405596$23740559$6$F$20240715$20240925$20240415$20240927$EXP$$NVSC2024US019379$NOVARTIS$$50$YR$$F$Y$$$20240927$$CN$US$US
237406362$23740636$2$F$20240410$20240711$20240415$20240713$PER$$US-AMGEN-USASP2024074261$AMGEN$$57$YR$A$F$Y$$$20240713$$CN$US$US
237406622$23740662$2$F$$20240408$20240415$20240925$PER$$US-GSK-US2024AMR046403$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
237407163$23740716$3$F$20240411$20240704$20240415$20240705$PER$$US-AMGEN-USASP2024074890$AMGEN$$81$YR$E$F$Y$$$20240705$$CN$US$US
237407392$23740739$2$F$$20240711$20240415$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-057646$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240711$$MD$JP$JP
237407483$23740748$3$F$20240311$20240801$20240415$20240808$EXP$$NVSC2023IT270054$NOVARTIS$$58$YR$$F$Y$$$20240808$$CN$IT$IT
237407742$23740774$2$F$$20240828$20240415$20240904$EXP$$US-ABBVIE-5718615$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
237407755$23740775$5$F$20210616$20240725$20240415$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057716$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$41.28$KG$20240730$$CN$US$US
237407792$23740779$2$F$$20240628$20240415$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02907$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237407812$23740781$2$F$$20240628$20240415$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02908$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237408023$23740802$3$F$$20240711$20240415$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055344$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240711$$CN$US$US
237408042$23740804$2$F$20240501$20240627$20240415$20240815$PER$$US-LUNDBECK-DKLU3076072$LUNDBECK$$$$$$Y$$$20240815$$HP$US$US
237408274$23740827$4$F$20240301$20240621$20240415$20240702$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001655$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240702$$CN$US$US
237408393$23740839$3$F$20240323$20240718$20240415$20240730$30DAY$$CN-JNJFOC-20240373762$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$CN$CN
237408482$23740848$2$F$$20240627$20240415$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02924$LUPIN$$$$$$Y$$$20240715$$CN$US$US
237408542$23740854$2$F$$20240628$20240415$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02926$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237408782$23740878$2$F$20240401$20240821$20240415$20240830$EXP$$JP-009507513-2404JPN001319J$MERCK$$8$DEC$$M$Y$$$20240830$$PH$JP$JP
237408933$23740893$3$F$20240407$20240822$20240415$20240824$PER$$US-AMGEN-USASP2024073965$AMGEN$$65$YR$E$F$Y$$$20240824$$CN$US$US
237409062$23740906$2$F$20230101$20240613$20240415$20240702$PER$$PA-TOLMAR, INC.-24PA047932$TOLMAR$$$$$M$Y$$$20240702$$CN$PA$PA
237409162$23740916$2$F$20240202$20240712$20240415$20240717$EXP$$NVSJ2024JP001744$NOVARTIS$$89$YR$$F$Y$$$20240718$$PH$JP$JP
237409674$23740967$4$F$20240201$20240823$20240415$20240828$EXP$$US-ABBVIE-5714304$ABBVIE$$57$YR$$M$Y$$$20240828$$CN$US$US
237410026$23741002$6$F$20240308$20240731$20240415$20240807$EXP$$US-GSK-US2024044807$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
237410284$23741028$4$F$$20240713$20240415$20240720$EXP$$JP-JNJFOC-20240426541$JOHNSON AND JOHNSON$Ishida T, Ishida T. Treatment Strategies for Multiple Myeloma Up To Date 2024; including CAR-T and bispecific antibodies. DARZQURO WEB Seminar. 2024 MAR 18;.$69$YR$E$F$Y$$$20240719$$MD$JP$JP
237410302$23741030$2$F$20240404$20240723$20240415$20240725$PER$$US-AMGEN-USASP2024069696$AMGEN$$73$YR$E$F$Y$$$20240725$$CN$US$US
237410412$23741041$2$F$$20240716$20240415$20240724$EXP$$GB-ROCHE-3535873$ROCHE$$$$A$F$Y$$$20240724$$CN$GB$GB
237410552$23741055$2$F$20240320$20240701$20240415$20240702$EXP$CZ-CZSUKL-24000985$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-057660$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$72$KG$20240702$$PH$CZ$CZ
237410562$23741056$2$F$$20240829$20240415$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058166$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240909$$HP$US$US
237410783$23741078$3$F$$20240820$20240415$20240829$EXP$$US-INTERCEPT-PM2024000731$INTERCEPT PHARMACEUTICALS$$$$$F$Y$95.238$KG$20240829$$CN$US$US
237411142$23741114$2$F$$20240703$20240415$20240711$EXP$$AU-TAKEDA-2024TUS034011$TAKEDA$$$$$M$Y$$$20240711$$CN$AU$AU
237411152$23741115$2$F$20240131$20240801$20240415$20240810$EXP$FR-AFSSAPS-AN2024000334$FR-TEVA-VS-3181029$TEVA$$82$YR$$M$Y$62.8$KG$20240810$$CN$FR$FR
237411224$23741122$4$F$20240117$20240802$20240415$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-056806$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$50$KG$20240808$$MD$JP$JP
237411392$23741139$2$F$$20240710$20240415$20240714$EXP$$US-JNJFOC-20240426931$JOHNSON AND JOHNSON$$87$YR$E$M$Y$$$20240715$$CN$US$US
237411472$23741147$2$F$$20240829$20240415$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA038461$SANDOZ$$13$YR$$M$Y$$$20240902$$MD$CA$CA
237411632$23741163$2$F$$20240724$20240415$20240726$EXP$$CA-SANDOZ INC.-NVSC2020CA355616$SANDOZ$$57$YR$$M$Y$$$20240726$$HP$CA$CA
237411802$23741180$2$F$20240323$20240814$20240415$20240909$30DAY$$MX-BECTON DICKINSON-MX-BD-24-000197$BECTON DICKINSON$$$$$$Y$$$20240909$$CN$MX$MX
237411933$23741193$3$F$20240326$20240814$20240415$20240909$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000200$BECTON DICKINSON$$$$$$Y$$$20240909$$CN$GB$GB
237411962$23741196$2$F$20240326$20240729$20240415$20240827$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000198$BECTON DICKINSON$$$$$$Y$$$20240827$$CN$GB$GB
237412043$23741204$3$F$20230525$20240729$20240415$20240801$EXP$$CO-TAKEDA-2023TUS063382$TAKEDA$$10$YR$$F$Y$25$KG$20240801$$CN$CO$CO
237412203$23741220$3$F$20240101$20240711$20240415$20240715$EXP$$US-UCBSA-2024017946$UCB$$$$$M$Y$$$20240715$$HP$US$US
237412342$23741234$2$F$$20240818$20240415$20240830$EXP$$US-Accord-418235$ACCORD$Bansal M, Mehta A, Vallabhajosyula S. SEVERE MULTIVESSEL CORONARY VASOSPASM SECONDARY TO 5-FLUOROURACIL MIMICKING ST-SEGMENT-ELEVATION MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. 2024;83(13 Supplement):3329$56$YR$A$M$Y$$$20240830$$MD$US$US
237412454$23741245$4$F$20230907$20240902$20240415$20240910$EXP$$JP-009507513-2309JPN001121J$MERCK$$73$YR$$M$Y$$$20240910$$MD$JP$JP
237412473$23741247$3$F$$20240627$20240415$20240703$EXP$$JP-009507513-2404JPN001067J$MERCK$$76$YR$$F$Y$$$20240703$$MD$JP$JP
237412803$23741280$3$F$$20240806$20240415$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-026239$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240809$$CN$US$US
237413166$23741316$6$F$20240105$20240705$20240415$20240709$EXP$$DE-009507513-2404DEU005476$MERCK$$67$YR$$F$Y$79$KG$20240709$$MD$DE$DE
237413203$23741320$3$F$20240101$20240727$20240415$20240801$EXP$$CA-JNJFOC-20240422517$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240801$$HP$CA$CA
237413542$23741354$2$F$20240216$20240703$20240415$20240713$EXP$IT-MINISAL02-975974$IT-TEVA-VS-3181479$TEVA$$10$YR$$F$Y$27$KG$20240713$$PH$IT$IT
237413572$23741357$2$F$20240321$20240410$20240415$20240909$EXP$GB-MHRA-ADR 28668271$GB-UCBSA-2024017639$UCB$$71$YR$$F$Y$$$20240909$$MD$GB$GB
237413743$23741374$3$F$20240401$20240612$20240415$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001333$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240705$$CN$US$US
237414292$23741429$2$F$$20240722$20240415$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US038924$SANDOZ$$$$$F$Y$$$20240724$$CN$US$US
237414303$23741430$3$F$$20240628$20240415$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03065$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237414449$23741444$9$F$20240208$20240822$20240415$20240905$EXP$$JP-ASTELLAS-2024JP002450$ASTELLAS$$82$YR$E$M$Y$53.4$KG$20240905$$MD$JP$JP
237414482$23741448$2$F$$20240917$20240415$20240921$EXP$$AU-ROCHE-3544336$ROCHE$$59$YR$A$M$Y$$$20240921$$CN$AU$AU
237414583$23741458$3$F$$20240628$20240415$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02942$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237414683$23741468$3$F$20240201$20240712$20240415$20240720$EXP$$US-ABBVIE-5717737$ABBVIE$$75$YR$$M$Y$104.32$KG$20240720$$CN$US$US
237414814$23741481$4$F$$20240821$20240415$20240828$EXP$$AR-GSK-AR2024AMR045792$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$AR$AR
237414824$23741482$4$F$$20240913$20240415$20240921$EXP$$GB-GSK-GB2024EME045854$GLAXOSMITHKLINE$$$$$$Y$$$20240921$$MD$GB$GB
237415184$23741518$4$F$$20240628$20240415$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02943$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237415225$23741522$5$F$20240422$20240605$20240415$20240926$PER$$US-GSK-US2024AMR044202$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240926$$CN$US$US
237415313$23741531$3$F$$20240829$20240415$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057424$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240902$$CN$US$US
237415452$23741545$2$F$$20240902$20240415$20240903$EXP$$CA-SANDOZ INC.-SDZ2024CA031415$SANDOZ$$$$$F$Y$$$20240903$$MD$CA$CA
237415825$23741582$5$F$20231001$20240916$20240415$20240923$EXP$$CO-JNJFOC-20240105768$JOHNSON AND JOHNSON$$45$YR$A$M$Y$69$KG$20240923$$HP$CO$CO
237415923$23741592$3$F$20240401$20240715$20240415$20240724$EXP$$CA-CELLTRION INC.-2024CA008765$CELLTRION$$$$$$Y$$$20240724$$CN$CA$CA
237416063$23741606$3$F$20240409$20240726$20240415$20240729$PER$$US-AMGEN-USASP2024074815$AMGEN$$61$YR$A$M$Y$$$20240729$$CN$US$US
237416072$23741607$2$F$$20240628$20240415$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02963$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237416142$23741614$2$F$$20240628$20240415$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02950$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237416275$23741627$5$F$20240416$20240826$20240415$20240903$EXP$$CA-CELLTRION INC.-2024CA008766$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
237416362$23741636$2$F$$20240627$20240415$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02973$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237417814$23741781$4$F$20100503$20240827$20240415$20240830$EXP$$FR-MYLANLABS-11P-056-0695247-00$MYLAN$$67$YR$$M$Y$74$KG$20240830$$MD$FR$FR
237418002$23741800$2$F$20240101$20240718$20240415$20240723$PER$$JP-Eisai-EC-2024-163605$EISAI$$$$E$M$Y$$$20240723$$MD$JP$JP
237418022$23741802$2$F$20231110$20240719$20240415$20240729$EXP$FR-AFSSAPS-RE2024000278$FR-TEVA-VS-3181707$TEVA$$35$YR$$F$Y$54$KG$20240729$$MD$FR$FR
237418162$23741816$2$F$$20240715$20240415$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057850$BRISTOL MYERS SQUIBB$$40$YR$A$M$Y$$$20240715$$CN$US$US
237418643$23741864$3$F$20231001$20240725$20240415$20240805$EXP$$AU-Accord-417888$ACCORD$$$$$M$Y$$$20240805$$CN$AU$AU
237418795$23741879$5$F$$20240808$20240415$20240816$EXP$$US-GSK-US2024AMR044195$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
237419882$23741988$2$F$20231201$20240712$20240415$20240712$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-012083$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$60$KG$20240712$$CN$FR$FR
237419982$23741998$2$F$$20240626$20240415$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02985$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237420273$23742027$3$F$20240101$20240705$20240415$20240705$EXP$$CA-PFIZER INC-202400079179$PFIZER$$71$YR$$F$Y$$$20240705$$HP$CA$CA
237420362$23742036$2$F$$20240717$20240415$20240722$EXP$$IN-ROCHE-3545655$ROCHE$$78$YR$E$M$Y$$$20240722$$CN$IN$IN
237420483$23742048$3$F$20240223$20240620$20240415$20240701$EXP$PT-INFARMED-E202403-541$PT-Accord-418083$ACCORD$$64$YR$A$F$Y$64$KG$20240701$$PH$PT$PT
237420492$23742049$2$F$20240326$20240822$20240415$20240828$EXP$$DE-AstraZeneca-2024A088917$ASTRAZENECA$$$$$M$Y$100$KG$20240828$$MD$DE$
237420702$23742070$2$F$$20240731$20240415$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057530$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240801$$HP$US$US
237420942$23742094$2$F$$20240628$20240415$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02996$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237421732$23742173$2$F$20240201$20240922$20240415$20240930$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-10707$SAMSUNG BIOEPIS$$45$YR$A$M$Y$65$KG$20241001$$MD$CA$CA
237421814$23742181$4$F$$20240712$20240415$20240723$EXP$$CA-APOTEX-2024AP004507$APOTEX$$$$E$$Y$$$20240723$$HP$CA$CA
237421822$23742182$2$F$$20240715$20240415$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057758$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240715$$CN$US$US
237421862$23742186$2$F$20221003$20240709$20240415$20240716$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-057749$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$55$KG$20240716$$PH$JP$JP
237421892$23742189$2$F$$20240725$20240415$20240731$EXP$$GB-TAKEDA-2024TUS034228$TAKEDA$$$$$M$Y$$$20240731$$CN$GB$GB
237422153$23742215$3$F$20240321$20240722$20240415$20240724$30DAY$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-054197$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$68.04$KG$20240724$$CN$US$US
237422942$23742294$2$F$$20240710$20240415$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-057227$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$MD$JP$JP
237422993$23742299$3$F$20240211$20240909$20240415$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055518$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240919$$HP$US$US
237423194$23742319$4$F$20240326$20240709$20240415$20240712$EXP$$US-GSK-US2024AMR047537$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$MD$US$US
237423203$23742320$3$F$20220101$20240919$20240415$20240924$EXP$$DE-TAKEDA-2024TUS033194$TAKEDA$$$$T$M$Y$54$KG$20240924$$HP$DE$DE
237423253$23742325$3$F$20240407$20240724$20240415$20240730$EXP$$NVSC2024US077487$NOVARTIS$$66$YR$$F$Y$$$20240730$$CN$US$US
237423314$23742331$4$F$$20240725$20240415$20240805$30DAY$$US-PFIZER INC-PV202400047084$PFIZER$$8$YR$$M$Y$$$20240805$$CN$US$US
237423823$23742382$3$F$20240402$20240703$20240415$20240904$EXP$$CA-LUNDBECK-DKLU3076435$LUNDBECK$$$$$$Y$$$20240904$$CN$CA$CA
237424732$23742473$2$F$$20240827$20240415$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058223$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240828$$CN$US$US
237425175$23742517$5$F$20221227$20240826$20240415$20240827$EXP$$JP-PFIZER INC-202400085479$PFIZER$$58$YR$$M$Y$70$KG$20240827$$MD$JP$JP
237425523$23742552$3$F$$20240819$20240415$20240821$EXP$$NVSC2024ZA056754$NOVARTIS$$35$YR$$F$Y$$$20240821$$CN$ZA$ZA
237425882$23742588$2$F$$20240408$20240415$20240808$PER$$US-BAYER-2024A051785$BAYER$$45$YR$A$F$Y$$$20240808$$HP$US$US
237425983$23742598$3$F$$20240801$20240415$20240806$PER$$US-AMGEN-USASP2024074047$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
237426296$23742629$6$F$20240301$20240724$20240415$20240729$EXP$$CA-PFIZER INC-202300435623$PFIZER$$56$YR$$M$Y$83.5$KG$20240729$$MD$CA$CA
237426492$23742649$2$F$20200101$20240913$20240415$20240919$EXP$$US-ABBVIE-5713931$ABBVIE$$53$YR$$F$Y$$$20240919$$CN$US$US
237426687$23742668$7$F$$20240906$20240415$20240910$30DAY$$US-PFIZER INC-202400076023$PFIZER$$14$YR$$M$Y$49.9$KG$20240910$$MD$US$US
237426752$23742675$2$F$20240305$20240705$20240415$20240715$EXP$IT-MINISAL02-975758$IT-TEVA-VS-3181120$TEVA$$16$YR$$F$Y$66$KG$20240715$$PH$IT$IT
237427005$23742700$5$F$20240401$20240430$20240415$20240828$EXP$$US-ABBVIE-5717254$ABBVIE$$68$YR$$F$Y$61$KG$20240828$$CN$US$US
237427472$23742747$2$F$20240409$20240725$20240415$20240727$PER$$US-AMGEN-USASP2024074569$AMGEN$$44$YR$A$M$Y$$$20240727$$CN$US$US
237427712$23742771$2$F$$20240711$20240415$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053075$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240717$$MD$US$US
237427793$23742779$3$F$20240224$20240703$20240415$20240705$EXP$$US-PFIZER INC-PV202400048993$PFIZER$$52$YR$$F$Y$$$20240705$$HP$US$US
237427945$23742794$5$F$$20240910$20240415$20240917$30DAY$$ES-PFIZER INC-PV202400043067$PFIZER$$$$$$Y$$$20240917$$CN$ES$ES
237428062$23742806$2$F$20220227$20240625$20240415$20240701$EXP$$US-MYLANLABS-2024M1018039$MYLAN$$36$YR$$F$Y$101.61$KG$20240701$$CN$US$US
237428085$23742808$5$F$$20240905$20240415$20240906$30DAY$$US-PFIZER INC-202400076894$PFIZER$$9$YR$$M$Y$$$20240906$$CN$US$US
237428116$23742811$6$F$$20240809$20240415$20240813$30DAY$$US-PFIZER INC-202400075746$PFIZER$$16$YR$$M$Y$54.43$KG$20240813$$MD$US$US
237428264$23742826$4$F$20240301$20240726$20240415$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057998$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$83.91$KG$20240729$$PH$US$US
237428272$23742827$2$F$20230410$20240904$20240415$20240909$EXP$$US-MYLANLABS-2024M1033307$MYLAN$$55$YR$$F$Y$$$20240909$$HP$US$US
237428352$23742835$2$F$20230101$20240726$20240415$20240731$EXP$$US-SA-2024SA111911$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240731$$MD$US$US
237428462$23742846$2$F$$20240722$20240415$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US038951$SANDOZ$$$$$M$Y$$$20240724$$CN$US$US
237428692$23742869$2$F$$20240708$20240415$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058174$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240711$$CN$US$US
237428702$23742870$2$F$$20240716$20240415$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058464$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240717$$HP$US$US
237428738$23742873$8$F$20240101$20240925$20240415$20240930$EXP$$US-PFIZER INC-202400079030$PFIZER$$21$YR$$M$Y$$$20240930$$HP$US$US
2374291911$23742919$11$F$$20240723$20240415$20240725$30DAY$$BR-PFIZER INC-202400072609$PFIZER$$24$YR$$M$Y$$$20240725$$PH$BR$BR
237429206$23742920$6$F$20240331$20240807$20240415$20240812$30DAY$$US-PFIZER INC-202400076365$PFIZER$$20$YR$$F$Y$$$20240812$$CN$US$US
237429442$23742944$2$F$$20240829$20240415$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA038619$SANDOZ$$15$YR$$F$Y$$$20240902$$HP$CA$CA
237429586$23742958$6$F$20240329$20240903$20240415$20240905$30DAY$$US-PFIZER INC-202400076436$PFIZER$$15$YR$$M$Y$$$20240905$$CN$US$US
237429662$23742966$2$F$20240130$20240710$20240415$20240716$EXP$FR-AFSSAPS-BX2024000604$FR-MYLANLABS-2024M1032650$MYLAN$$41$YR$$M$Y$92$KG$20240716$$PH$FR$FR
237429903$23742990$3$F$$20240710$20240415$20240712$PER$$US-PFIZER INC-PV202400008021$PFIZER$$63$YR$$F$Y$$$20240712$$HP$US$US
237429932$23742993$2$F$$20240628$20240415$20240705$EXP$$CA-GSK-CA2022AMR116751$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$HP$CA$CA
237430125$23743012$5$F$20240409$20240924$20240415$20240927$EXP$$CA-TAKEDA-2024TUS034739$TAKEDA$$58$YR$$M$Y$$$20240927$$CN$CA$CA
237430142$23743014$2$F$$20240829$20240415$20240903$EXP$$CA-TAKEDA-2022TUS014910$TAKEDA$$$$$F$Y$$$20240903$$CN$CA$CA
237430172$23743017$2$F$20240411$20240812$20240415$20240813$PER$$US-AMGEN-USASP2024074876$AMGEN$$55$YR$A$F$Y$$$20240813$$CN$US$US
237430253$23743025$3$F$20240116$20240923$20240415$20240927$EXP$$NVSC2024CA011544$NOVARTIS$$43$YR$$F$Y$$$20240927$$CN$CA$CA
237430365$23743036$5$F$20240101$20240801$20240415$20240805$PER$$US-PFIZER INC-PV202400048967$PFIZER$$60$YR$$F$Y$$$20240805$$HP$US$US
237430522$23743052$2$F$$20240711$20240415$20240715$EXP$$US-PFIZER INC-202400086560$PFIZER$$56$YR$$F$Y$$$20240715$$CN$US$US
237430563$23743056$3$F$$20240905$20240415$20240910$EXP$$US-PFIZER INC-PV202400048952$PFIZER$$73$YR$$M$Y$$$20240910$$CN$US$US
237430653$23743065$3$F$$20240710$20240415$20240715$EXP$$US-PFIZER INC-202400057950$PFIZER$$20$YR$$F$Y$$$20240715$$CN$US$US
237430887$23743088$7$F$$20240917$20240415$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058287$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240923$$CN$US$US
237431302$23743130$2$F$$20240627$20240415$20240701$EXP$$JP-BAYER-2024A049768$BAYER$$$$$M$Y$$$20240701$$MD$JP$JP
237431415$23743141$5$F$$20240905$20240415$20240909$30DAY$$PA-PFIZER INC-PV202400040586$PFIZER$$12$YR$$M$Y$$$20240909$$CN$PA$PA
237431442$23743144$2$F$$20240716$20240415$20240717$PER$$US-PFIZER INC-PV202200006172$PFIZER$$66$YR$$F$Y$$$20240717$$CN$US$US
237431453$23743145$3$F$$20240730$20240415$20240801$PER$$US-PFIZER INC-PV202400048903$PFIZER$$72$YR$$M$Y$$$20240801$$CN$US$US
237431464$23743146$4$F$$20240903$20240415$20240904$30DAY$$US-PFIZER INC-202400076384$PFIZER$$12$YR$$M$Y$$$20240904$$CN$US$US
237431573$23743157$3$F$$20240607$20240415$20240926$PER$$US-GSK-US2024AMR044159$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
237431584$23743158$4$F$20240710$20240826$20240415$20240902$EXP$$CA-GSK-CA2024044664$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$CA$CA
237431703$23743170$3$F$$20240801$20240415$20240806$30DAY$$US-PFIZER INC-PV202400044209$PFIZER$$$$$$Y$$$20240806$$CN$US$US
237431765$23743176$5$F$20230824$20240702$20240415$20240709$EXP$$JP-PFIZER INC-202400084846$PFIZER$$60$YR$$F$Y$$$20240709$$PH$JP$JP
237431813$23743181$3$F$$20240809$20240415$20240820$30DAY$$US-PFIZER INC-PV202400044194$PFIZER$$$$$$Y$$$20240820$$HP$US$US
237431854$23743185$4$F$$20240909$20240415$20240913$30DAY$$US-PFIZER INC-PV202400044343$PFIZER$$$$$$Y$$$20240913$$HP$US$US
237432173$23743217$3$F$$20240712$20240415$20240716$30DAY$$US-PFIZER INC-PV202400044438$PFIZER$$$$$$Y$$$20240716$$HP$US$US
237432183$23743218$3$F$$20240801$20240415$20240805$30DAY$$US-PFIZER INC-PV202400044619$PFIZER$$$$$M$Y$$$20240805$$HP$US$US
237432215$23743221$5$F$$20240821$20240415$20240826$30DAY$$US-PFIZER INC-PV202400044641$PFIZER$$$$$$Y$$$20240826$$CN$US$US
237432292$23743229$2$F$$20240829$20240415$20240902$EXP$$US-BIOVITRUM-CTI2024US04530$BIOVITRUM$$69$YR$$M$Y$$$20240902$$CN$US$US
237432432$23743243$2$F$20231230$20240628$20240415$20240702$EXP$$FR-PFIZER INC-202400083082$PFIZER$$73$YR$$F$Y$61$KG$20240702$$MD$FR$FR
237432562$23743256$2$F$$20240712$20240415$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057908$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240712$$CN$US$US
237432682$23743268$2$F$$20240706$20240415$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202404007943$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240711$$CN$US$US
237432952$23743295$2$F$$20240816$20240415$20240826$EXP$$US-GSK-US2024AMR044216$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
237432962$23743296$2$F$20240402$20240820$20240415$20240826$EXP$$CA-PUMA BIOTECHNOLOGY, LTD.-2024-PUM-CA000562$PUMA$$$$$$Y$$$20240826$$MD$CA$CA
237433023$23743302$3$F$20230525$20240715$20240415$20240717$30DAY$$US-PFIZER INC-PV202400044523$PFIZER$$$$$$Y$$$20240717$$HP$US$US
237433044$23743304$4$F$$20240909$20240415$20240910$30DAY$$US-PFIZER INC-202400077814$PFIZER$$8$YR$$F$Y$$$20240910$$CN$US$US
237433135$23743313$5$F$20231214$20240911$20240415$20240917$EXP$SE-SEMPA-2024-003094$SE-ABBVIE-5719561$ABBVIE$$34$YR$$M$Y$73$KG$20240917$$MD$SE$SE
237433202$23743320$2$F$20240301$20240912$20240415$20240916$EXP$$DE-ROCHE-3545761$ROCHE$$33$YR$A$F$Y$58$KG$20240916$$MD$DE$DE
237433325$23743332$5$F$20240301$20240909$20240415$20240916$30DAY$$US-PFIZER INC-202400077789$PFIZER$$9$YR$$F$Y$23.13$KG$20240916$$MD$US$US
237433337$23743333$7$F$$20240924$20240415$20240926$30DAY$$US-PFIZER INC-202400077959$PFIZER$$11$YR$$M$Y$$$20240926$$CN$US$US
237433563$23743356$3$F$$20240609$20240415$20240703$PER$$US-AstraZeneca-2024A088106$ASTRAZENECA$$$$$M$Y$$$20240703$$CN$US$
237433692$23743369$2$F$20231001$20240722$20240415$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057644$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240730$$CN$US$US
237434232$23743423$2$F$$20240628$20240415$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02696$LUPIN$$$$$$Y$$$20240716$$PH$US$US
237434262$23743426$2$F$$20240821$20240415$20240826$EXP$CA-HEALTHCANVIG-001075303$CA-PURDUE-USA-2024-0308967$PURDUE$$72$YR$$F$Y$$$20240826$$HP$CA$CA
237434326$23743432$6$F$20240301$20240709$20240415$20240715$EXP$$JP-PFIZER INC-202400082339$PFIZER$$65$YR$$M$Y$$$20240715$$MD$JP$JP
237434904$23743490$4$F$$20240805$20240415$20240812$EXP$$NVSC2024US077479$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
237434942$23743494$2$F$$20240808$20240415$20240812$EXP$$US-BAYER-2024A054478$BAYER$$64$YR$A$M$Y$$$20240812$$CN$US$US
237435222$23743522$2$F$20240410$20240726$20240415$20240730$PER$$US-PFIZER INC-PV202300182197$PFIZER$$64$YR$$F$Y$$$20240730$$HP$US$US
237435252$23743525$2$F$$20240904$20240415$20240906$EXP$$NVSC2024CA078621$NOVARTIS$$5$YR$$F$Y$$$20240906$$HP$CA$CA
237435432$23743543$2$F$$20240830$20240415$20240904$EXP$$CA-JNJFOC-20240436775$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240904$$HP$CA$CA
237435442$23743544$2$F$20231101$20240821$20240415$20240830$EXP$$UA-TEVA-VS-3183079$TEVA$$45$YR$$M$Y$$$20240830$$MD$UA$UA
237436003$23743600$3$F$20230601$20240409$20240415$20240814$EXP$$NVSC2023BR119749$NOVARTIS$$69$YR$$F$Y$$$20240814$$CN$BR$BR
237436074$23743607$4$F$$20240723$20240415$20240726$EXP$$US-TAKEDA-US202027558$TAKEDA$$$$$F$Y$77$KG$20240726$$HP$US$US
237436132$23743613$2$F$$20240703$20240415$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057709$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240704$$CN$US$US
237436602$23743660$2$F$$20240819$20240415$20240822$EXP$$US-SANDOZ INC.-NVSC2020US308113$SANDOZ$$$$$F$Y$81.633$KG$20240822$$CN$US$US
237436652$23743665$2$F$20231201$20240710$20240415$20240719$PER$$US-MYLANLABS-2024M1028171$MYLAN$$55$YR$$$Y$73$KG$20240719$$CN$US$US
237436852$23743685$2$F$20230413$20240708$20240415$20240715$EXP$$US-CHATTEMPRD-2024OHG012753$CHATTEM$$58$YR$A$F$Y$$$20240715$$LW$US$US
237436992$23743699$2$F$20160101$20240731$20240415$20240802$EXP$$US-TAKEDA-2024TUS033088$TAKEDA$$$$$F$Y$85$KG$20240802$$HP$US$US
237437144$23743714$4$F$$20240723$20240415$20240725$PER$$NVSC2024US078906$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
237437762$23743776$2$F$$20240712$20240415$20240718$30DAY$$US-SANDOZ INC.-SDZ2024US039196$SANDOZ$$$$$F$Y$$$20240718$$CN$US$US
237437918$23743791$8$F$20230601$20240904$20240415$20240911$EXP$$CA-SA-2023SA317933$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240911$$CN$CA$CA
237437943$23743794$3$F$$20240725$20240415$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US039163$SANDOZ$$$$$$Y$$$20240729$$HP$US$US
237437992$23743799$2$F$$20240724$20240415$20240728$EXP$$US-SANDOZ INC.-NVSC2023US118917$SANDOZ$$$$$F$Y$$$20240728$$CN$US$US
237438053$23743805$3$F$$20240830$20240415$20240903$EXP$$US-TAKEDA-2023TUS079624$TAKEDA$$$$$F$Y$$$20240903$$CN$US$US
237438142$23743814$2$F$$20240729$20240415$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-055595$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240802$$PH$JP$JP
237438562$23743856$2$F$20240101$20240626$20240415$20240705$PER$$US-SA-2024SA108762$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240705$$MD$US$US
237438592$23743859$2$F$$20240822$20240415$20240917$PER$$US-SA-2024SA107513$SANOFI AVENTIS$$20$YR$A$M$Y$72.57$KG$20240918$$MD$US$US
237438613$23743861$3$F$20240301$20240801$20240415$20240812$PER$$US-SA-2024SA107404$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240812$$MD$US$US
237438813$23743881$3$F$20240101$20240821$20240415$20240902$PER$$US-SA-2024SA109755$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240902$$MD$US$US
237438883$23743888$3$F$20210501$20240803$20240415$20240808$PER$$US-SA-2021SA346344$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240808$$MD$US$US
237438902$23743890$2$F$20240201$20240807$20240415$20240816$PER$$US-SA-2024SA109372$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240816$$MD$US$US
237438972$23743897$2$F$20240301$20240711$20240415$20240723$PER$$US-SA-2024SA109762$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240723$$MD$US$US
237439252$23743925$2$F$20231001$20240627$20240415$20240710$PER$$US-SA-2023SA378887$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240710$$MD$US$US
237439562$23743956$2$F$20240101$20240801$20240415$20240814$PER$$US-SA-2024SA108832$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240814$$MD$US$US
237439622$23743962$2$F$$20240724$20240415$20240802$PER$$US-SA-2024SA109849$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240802$$MD$US$US
237439634$23743963$4$F$20240101$20240715$20240415$20240723$PER$$US-SA-2024SA109846$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240723$$MD$US$US
237439642$23743964$2$F$20240101$20240715$20240415$20240723$PER$$US-SA-2024SA108521$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240723$$MD$US$US
237439662$23743966$2$F$20240601$20240627$20240415$20240708$PER$$US-SA-2024SA109193$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240708$$MD$US$US
237439672$23743967$2$F$$20240906$20240415$20240918$PER$$US-SA-2024SA109352$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240918$$MD$US$US
237439702$23743970$2$F$$20240624$20240415$20240702$PER$$US-SA-2024SA106639$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240702$$MD$US$US
237439767$23743976$7$F$20240101$20240705$20240415$20240713$PER$$US-SA-2024SA108590$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240713$$MD$US$US
237439852$23743985$2$F$$20240806$20240415$20240814$PER$$US-SA-2024SA109141$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240814$$MD$US$US
237439872$23743987$2$F$20240101$20240628$20240415$20240712$PER$$US-SA-2024SA110767$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240712$$MD$US$US
237439882$23743988$2$F$20240301$20240723$20240415$20240801$PER$$US-SA-2024SA109650$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240801$$MD$US$US
237439982$23743998$2$F$$20240722$20240415$20240731$PER$$US-SA-2024SA109489$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240731$$MD$US$US
237440012$23744001$2$F$$20240628$20240415$20240710$PER$$US-SA-2024SA110696$SANOFI AVENTIS$$35$YR$A$F$Y$81.64$KG$20240710$$MD$US$US
237440044$23744004$4$F$20240101$20240812$20240415$20240819$PER$$US-SA-2024SA108570$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240819$$MD$US$US
237440072$23744007$2$F$$20240918$20240415$20240925$PER$$US-SA-2024SA110810$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240925$$MD$US$US
237440283$23744028$3$F$20230101$20240706$20240415$20240715$PER$$US-SA-2024SA111465$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240715$$MD$US$US
237440474$23744047$4$F$20240405$20240805$20240415$20240814$PER$$US-SA-2024SA107706$SANOFI AVENTIS$$64$YR$A$F$Y$106$KG$20240814$$MD$US$US
237440482$23744048$2$F$20240328$20240829$20240415$20240923$PER$$US-SA-2024SA112354$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240923$$MD$US$US
237440544$23744054$4$F$20240101$20240716$20240415$20240722$EXP$$US-SA-2024SA112036$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240722$$MD$US$US
237440652$23744065$2$F$$20240725$20240415$20240802$PER$$US-SA-2024SA112026$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240802$$MD$US$US
237440813$23744081$3$F$20240101$20240712$20240415$20240724$PER$$US-SA-2024SA112389$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240724$$MD$US$US
237441132$23744113$2$F$20230801$20240627$20240415$20240708$PER$$US-SA-2024SA020051$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240708$$MD$US$US
237441142$23744114$2$F$20240428$20240816$20240415$20240822$EXP$$FR-MYLANLABS-2024M1032586$MYLAN$$71$YR$$F$Y$$$20240822$$MD$FR$FR
237441203$23744120$3$F$$20240809$20240415$20240816$EXP$$CA-TAKEDA-2022TUS085105$TAKEDA$$$$$M$Y$$$20240816$$MD$CA$CA
237441302$23744130$2$F$20240727$20240729$20240415$20240805$EXP$$US-SA-2024SA113199$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240805$$MD$US$US
237441382$23744138$2$F$20240329$20240823$20240415$20240916$PER$$US-SA-2024SA109448$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240916$$MD$US$US
237441412$23744141$2$F$20240101$20240724$20240415$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US038278$SANDOZ$$$$$M$Y$$$20240729$$CN$US$US
237441895$23744189$5$F$20230301$20240827$20240415$20240904$EXP$$CA-OTSUKA-2023_007301$OTSUKA$$45$YR$$F$Y$$$20240904$$HP$CA$CA
237441962$23744196$2$F$$20240802$20240415$20240816$EXP$$MX-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440894$RANBAXY$Barrios Ruiz JF, De La Garza F, Mingura Ledezma V, Cantu O, Tejada Vasquez AC,Gomez-Almaguer D, et al. CYP Inhibition and Low-Dose Dasatinib for Chronic Myeloid Leukemia: Preliminary Results of a Promising, Cost-Effective Treatment Option. Blood. 2023;142(Suppl):5744?5745$30$YR$$M$Y$$$20240816$$MD$MX$MX
237442192$23744219$2$F$$20240909$20240415$20240913$EXP$$US-ABBVIE-5719059$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
237442216$23744221$6$F$20240101$20240802$20240415$20240812$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000332$DECIPHERA PHARMACEUTICALS$$91$YR$E$F$Y$$$20240812$$CN$US$US
237442673$23744267$3$F$20240601$20240821$20240415$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058159$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$90.26$KG$20240903$$CN$US$US
237442774$23744277$4$F$$20240905$20240415$20240910$EXP$$GB-MYLANLABS-2024M1033989$MYLAN$$45$YR$$F$Y$$$20240910$$CN$GB$GB
237443364$23744336$4$F$20240301$20240910$20240415$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057731$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$60.33$KG$20240917$$MD$US$US
237443433$23744343$3$F$20240305$20240902$20240415$20240904$EXP$$GB-MYLANLABS-2024M1022244$MYLAN$$65$YR$$F$Y$$$20240904$$MD$GB$GB
237443543$23744354$3$F$20230828$20240909$20240415$20240913$EXP$$JP-Taiho Oncology Inc-2024-003635$TAIHO ONCOLOGY INC$$74$YR$E$M$Y$68.1$KG$20240913$$MD$JP$JP
237443803$23744380$3$F$20240208$20240625$20240415$20240702$EXP$$NL-ABBVIE-5719053$ABBVIE$$72$YR$$F$Y$$$20240702$$HP$NL$NL
237444005$23744400$5$F$20240313$20240808$20240415$20240906$EXP$FR-AFSSAPS-LM2024000181$FR-SA-2024SA110280$SANOFI AVENTIS$$7$MON$I$M$Y$5.48$KG$20240906$$MD$FR$FR
237444063$23744406$3$F$20240321$20240722$20240415$20240730$30DAY$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057877$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$68.04$KG$20240730$$CN$US$US
237444272$23744427$2$F$$20240821$20240415$20240827$EXP$$US-TAKEDA-2023TUS098972$TAKEDA$$$$$M$Y$$$20240827$$CN$US$US
237444372$23744437$2$F$$20240912$20240415$20240917$EXP$$JP-009507513-2404JPN000941J$MERCK$$76$YR$$M$Y$$$20240917$$MD$JP$JP
237444522$23744452$2$F$$20240405$20240415$20240725$PER$$US-009507513-2404USA005268$MERCK$Gonzalez J, Lowenhaar G, Mehta C, Cangemi R, Guidi J. RUPTURED ROOT ABSCESS WITH AORTOPULMONARY FISTULA CAUSED BY VANCOMYCIN-RESISTANT-ENTEROCOCCUS PROSTHETIC VALVE ENDOCARDITIS. Journal of the American College of Cardiology. 2024;83 (13) Suppl A:4281$77$YR$$F$Y$$$20240725$$HP$US$US
237444592$23744459$2$F$$20240906$20240415$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057556$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240910$$HP$US$US
237444626$23744462$6$F$20221201$20240813$20240415$20240816$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-053156$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$64.3$KG$20240816$$MD$FR$FR
237444854$23744485$4$F$$20240827$20240415$20240830$EXP$FR-AFSSAPS-TO2024000648$FR-PFIZER INC-202400084737$PFIZER$$58$YR$$F$Y$$$20240830$$CN$FR$FR
237445093$23744509$3$F$20230101$20240917$20240415$20240920$EXP$$US-ABBVIE-5716253$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
237445113$23744511$3$F$20240409$20240715$20240415$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202307015334$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240718$$CN$US$US
237445254$23744525$4$F$20240412$20240923$20240415$20240926$PER$$NVSC2024US078907$NOVARTIS$$59$YR$$F$Y$$$20240926$$CN$US$US
237445573$23744557$3$F$20231201$20240716$20240415$20240726$PER$$US-SA-2024SA112423$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240726$$MD$US$US
237445713$23744571$3$F$$20240708$20240415$20240716$EXP$NL-LRB-00864729$NL-TEVA-VS-3182226$TEVA$$67$YR$$M$Y$59$KG$20240716$$MD$NL$NL
237446022$23744602$2$F$$20240715$20240415$20240715$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-058389$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240715$$MD$JP$JP
237446623$23744662$3$F$20240301$20240703$20240415$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057396$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240710$$CN$US$US
237447322$23744732$2$F$20240405$20240715$20240415$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058396$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240715$$CN$US$US
237447583$23744758$3$F$$20240827$20240415$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058523$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$$$20240830$$HP$US$US
237447592$23744759$2$F$$20240830$20240415$20240906$EXP$$JP-009507513-2404JPN001108J$MERCK$$55$YR$$F$Y$$$20240906$$MD$JP$JP
237447744$23744774$4$F$20220124$20240717$20240415$20240719$EXP$$JP-GILEAD-2024-0669032$GILEAD$Miyake M, Furukubo T, Yoshida T, Tanaka R, Oda T, Hashimoto K, et al.. ORIGINAL ARTICLE Assessment of standard remdesivir dosage in dialysis patients via monitoring of hypersensitivity reactions and biochemical liver function tests. The Japanese Journal of Nephrology and Pharmacotherapy. 2024;13(1):13-21$66$YR$E$M$Y$36.5$KG$20240719$$PH$JP$JP
237447825$23744782$5$F$20220211$20240726$20240415$20240731$EXP$$JP-GILEAD-2024-0669030$GILEAD$Miyake M, Furukubo T, Yoshida T, Tanaka R, Oda T, Hashimoto K, et al.. ORIGINAL ARTICLE Assessment of standard remdesivir dosage in dialysis patients via monitoring of hypersensitivity reactions and biochemical liver function tests. The Japanese Journal of Nephrology and Pharmacotherapy. 2024;13(1):13-21$91$YR$E$M$Y$48.6$KG$20240731$$PH$JP$JP
237447983$23744798$3$F$20230530$20240923$20240415$20240926$EXP$$DE-TAKEDA-2024TUS033969$TAKEDA$$62$YR$$M$Y$87$KG$20240926$$HP$DE$DE
237448003$23744800$3$F$$20240703$20240415$20240711$EXP$$US-ALXN-202404USA000770US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
237448094$23744809$4$F$20220727$20240717$20240415$20240720$EXP$$JP-GILEAD-2024-0668855$GILEAD$Miyake M, Furukubo T, Yoshida T, Tanaka R, Oda T, Hashimoto K, et al.. ORIGINAL ARTICLE Assessment of standard remdesivir dosage in dialysis patients via monitoring of hypersensitivity reactions and biochemical liver function tests. The Japanese Journal of Nephrology and Pharmacotherapy. 2024;13(1):13-21$63$YR$A$M$Y$59$KG$20240719$$PH$JP$JP
237448102$23744810$2$F$$20240822$20240415$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056269$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240826$$HP$US$US
237448314$23744831$4$F$20240301$20240722$20240415$20240725$EXP$$US-ABBVIE-5634473$ABBVIE$$64$YR$$M$Y$$$20240725$$CN$US$US
237448383$23744838$3$F$20240327$20240718$20240415$20240725$EXP$$JP-MTPC-MTPC2024-0002978$Unknown Manufacturer$$67$YR$$F$Y$$$20240725$$PH$JP$JP
237448593$23744859$3$F$$20240712$20240415$20240718$EXP$$JP-AMGEN-JPNSP2024071390$AMGEN$$$$E$$Y$$$20240718$$MD$JP$JP
237448942$23744894$2$F$$20240717$20240415$20240722$EXP$$NVSJ2024JP004645$NOVARTIS$$75$YR$$$Y$$$20240723$$PH$JP$JP
237448972$23744897$2$F$$20240726$20240415$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-057168$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$MD$JP$JP
237448983$23744898$3$F$20231204$20240628$20240415$20240703$EXP$$NVSJ2024JP004632$NOVARTIS$$69$YR$$F$Y$41$KG$20240704$$MD$JP$JP
237449004$23744900$4$F$20230814$20240820$20240415$20240825$EXP$$NVSJ2024JP003117$NOVARTIS$$72$YR$$F$Y$$$20240826$$MD$JP$JP
237449192$23744919$2$F$20220801$20240711$20240415$20240716$EXP$$US-ABBVIE-5714872$ABBVIE$$67$YR$$F$Y$89$KG$20240716$$HP$US$US
237449322$23744932$2$F$20240419$20240702$20240415$20240709$EXP$$DE-ABBVIE-5720525$ABBVIE$$56$YR$$M$Y$79$KG$20240709$$MD$DE$DE
237449503$23744950$3$F$20240101$20240826$20240415$20240830$EXP$$US-ABBVIE-5713828$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
237449543$23744954$3$F$20240409$20240918$20240415$20240920$EXP$$US-TAKEDA-2022TUS073172$TAKEDA$$32$YR$$M$Y$$$20240920$$CN$US$US
237449662$23744966$2$F$20240409$20240917$20240415$20240924$EXP$$DE-ABBVIE-5715699$ABBVIE$$78$YR$$M$Y$$$20240924$$CN$DE$DE
237449764$23744976$4$F$20240325$20240802$20240415$20240807$EXP$$US-BIOGEN-2024BI01259702$BIOGEN$$76$YR$$M$Y$81.9$KG$20240807$$CN$US$US
237449852$23744985$2$F$$20240415$20240415$20240703$EXP$$CA-SANDOZ INC.-SDZ2024CA039391$SANDOZ$$$$$$Y$$$20240703$$CN$CA$CA
237450144$23745014$4$F$20240314$20240822$20240415$20240828$EXP$$US-ABBVIE-5715496$ABBVIE$$67$YR$$F$Y$$$20240828$$CN$US$US
237450242$23745024$2$F$$20240715$20240415$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057707$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240715$$CN$US$US
237450262$23745026$2$F$20240401$20240627$20240415$20240702$EXP$$JP-009507513-2404JPN001162J$MERCK$$71$YR$$M$Y$$$20240702$$MD$JP$JP
237450483$23745048$3$F$20240201$20240716$20240415$20240718$PER$$US-BAUSCHBL-2024BNL025280$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240719$$CN$US$US
237450492$23745049$2$F$$20240625$20240415$20240701$PER$$US-BAUSCHBL-2024BNL004304$BAUSCH AND LOMB$$$$$F$Y$$$20240701$$CN$US$US
237450572$23745057$2$F$$20240711$20240415$20240715$EXP$$US-TAKEDA-2020TUS046805$TAKEDA$$$$$F$Y$$$20240715$$HP$US$US
237450593$23745059$3$F$$20240717$20240415$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058916$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240717$$CN$US$US
237450664$23745066$4$F$$20240915$20240415$20240916$PER$$US-ALXN-202404USA000549US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
237450683$23745068$3$F$20240412$20240813$20240415$20240817$PER$$US-AMGEN-USASP2024074438$AMGEN$$49$YR$A$M$Y$142.9$KG$20240817$$MD$US$US
237450752$23745075$2$F$20240101$20240625$20240415$20240702$PER$$US-SA-2024SA112828$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240702$$MD$US$US
237450962$23745096$2$F$$20240725$20240416$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057899$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240730$$CN$US$US
237451182$23745118$2$F$20240101$20240708$20240416$20240715$EXP$$US-ABBVIE-5719675$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
237451242$23745124$2$F$20240320$20240725$20240416$20240821$PER$$CA-TOLMAR, INC.-24CA047898$TOLMAR$$86$YR$$M$Y$$$20240821$$CN$CA$CA
237451263$23745126$3$F$20240321$20240905$20240416$20240924$PER$$CA-TOLMAR, INC.-24CA047919$TOLMAR$$91$YR$$M$Y$$$20240924$$CN$CA$CA
237451302$23745130$2$F$20240322$20240712$20240416$20240730$PER$$CA-TOLMAR, INC.-24CA047946$TOLMAR$$67$YR$$M$Y$$$20240730$$CN$CA$CA
237451332$23745133$2$F$20240301$20240712$20240416$20240718$EXP$$US-ABBVIE-5719634$ABBVIE$$36$YR$$F$Y$$$20240718$$CN$US$US
237451832$23745183$2$F$20240405$20240620$20240416$20240702$PER$$US-SA-2024SA110928$SANOFI AVENTIS$$38$YR$A$F$Y$83.914$KG$20240702$$MD$US$US
237452022$23745202$2$F$$20240725$20240416$20240808$EXP$$US-ABBVIE-5719474$ABBVIE$$73$YR$$F$Y$$$20240808$$CN$US$US
237452033$23745203$3$F$20240320$20240624$20240416$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001412$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240718$$CN$US$US
237452092$23745209$2$F$$20240705$20240416$20240708$PER$$US-ALXN-202402USA001198US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
237452152$23745215$2$F$20240407$20240919$20240416$20240920$PER$$US-AMGEN-USASP2024074217$AMGEN$$37$YR$A$M$Y$$$20240920$$CN$US$US
237452173$23745217$3$F$20150101$20240710$20240416$20240710$EXP$$HU-JNJFOC-20240441605$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240711$$MD$HU$HU
237452772$23745277$2$F$$20240807$20240416$20240813$EXP$$US-ABBVIE-5720125$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
237453333$23745333$3$F$$20240808$20240416$20240814$EXP$$JP-AMGEN-JPNSP2024074126$AMGEN$$66$YR$E$$Y$$$20240814$$MD$JP$JP
237453563$23745356$3$F$20240101$20240717$20240416$20240724$EXP$$CA-APOTEX-2024AP004608$APOTEX$$$$E$M$Y$$$20240724$$PH$CA$CA
237453622$23745362$2$F$$20240824$20240416$20240827$PER$$NVSC2024US079592$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
237453805$23745380$5$F$20240405$20240918$20240416$20240927$EXP$$CA-CELLTRION INC.-2024CA008833$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
237453853$23745385$3$F$20240101$20240627$20240416$20240708$PER$$US-SA-2024SA108595$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240708$$CN$US$US
237453972$23745397$2$F$20231001$20240912$20240416$20240921$EXP$$JP-ABBVIE-5720983$ABBVIE$$62$YR$$M$Y$41$KG$20240921$$PH$JP$JP
237454012$23745401$2$F$20240412$20240719$20240416$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202404009042$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240731$$CN$US$US
237454043$23745404$3$F$20231030$20240703$20240416$20240708$EXP$$JP-AMGEN-JPNSP2024071968$AMGEN$$93$YR$E$F$Y$$$20240708$$MD$JP$JP
237454054$23745405$4$F$$20240910$20240416$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056926$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240918$$CN$US$US
237454063$23745406$3$F$20240201$20240917$20240416$20240924$PER$$US-SA-2024SA107749$SANOFI AVENTIS$$9$YR$C$M$Y$32$KG$20240925$$MD$US$US
237454072$23745407$2$F$$20240717$20240416$20240722$PER$$US-TAKEDA-2024TUS034783$TAKEDA$$$$$M$Y$$$20240722$$MD$US$US
237454154$23745415$4$F$$20240722$20240416$20240731$EXP$$US-TAKEDA-2023TUS109680$TAKEDA$$$$$F$Y$$$20240731$$CN$US$US
237454382$23745438$2$F$20240410$20240724$20240416$20240727$PER$$US-AMGEN-USASP2024074464$AMGEN$$68$YR$E$M$Y$$$20240727$$CN$US$US
237454392$23745439$2$F$20240330$20240726$20240416$20240731$PER$$US-AMGEN-USASP2024075278$AMGEN$$69$YR$E$F$Y$$$20240731$$CN$US$US
237454442$23745444$2$F$20220101$20240807$20240416$20240817$EXP$FR-AFSSAPS-PV2024000253$FR-TEVA-VS-3182359$TEVA$$10$YR$$F$Y$39.6$KG$20240817$$MD$FR$FR
237454482$23745448$2$F$$20240729$20240416$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058196$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240802$$CN$US$US
237454493$23745449$3$F$20240401$20240718$20240416$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057767$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$68.2$KG$20240719$$PH$US$US
237454632$23745463$2$F$$20240712$20240416$20240723$PER$$US-SA-2024SA109333$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240723$$MD$US$US
237454656$23745465$6$F$20240101$20240829$20240416$20240918$PER$$US-SA-2024SA109430$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240918$$MD$US$US
237454792$23745479$2$F$20230701$20240710$20240416$20240718$EXP$$US-EMD Serono-2024019660$EMD SERONO INC$$65$YR$E$M$Y$$$20240718$$CN$US$US
237454936$23745493$6$F$20230901$20240719$20240416$20240801$PER$$US-SA-2024SA106990$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240801$$MD$US$US
237454972$23745497$2$F$$20240722$20240416$20240726$PER$$US-AMGEN-USASP2024073295$AMGEN$$$$$F$Y$$$20240726$$HP$US$US
237455133$23745513$3$F$20240320$20240715$20240416$20240807$PER$$US-TOLMAR, INC.-24US047875$TOLMAR$$63$YR$$M$Y$$$20240807$$HP$US$US
237456632$23745663$2$F$$20240715$20240416$20240725$EXP$PT-EMA-DD-20240327-7482691-054958$PT-MSNLABS-2024MSNLIT00831$MSN LABORATORIES$Conde MG,  Encarnacao UJD..Management of hypertension in a patient with orthostatic hypotension - A CASE REPORT.18th Portuguese Congress on Hypertension and Global Cardiovascular Risk.2024$$$$$Y$$$20240725$$HP$PT$PT
237456642$23745664$2$F$$20240718$20240416$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058346$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240719$$HP$US$US
237456744$23745674$4$F$20240403$20240903$20240416$20240912$PER$$US-SA-2024SA107170$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240912$$MD$US$US
237456772$23745677$2$F$$20240828$20240416$20240829$EXP$$CA-SANDOZ INC.-NVSC2022CA015272$SANDOZ$$$$$M$Y$93$KG$20240829$$HP$CA$CA
237456782$23745678$2$F$$20240729$20240416$20240801$EXP$$US-SANDOZ INC.-SDZ2024US038967$SANDOZ$$$$$F$Y$$$20240801$$CN$US$US
237456834$23745683$4$F$20240101$20240628$20240416$20240705$EXP$$JP-009507513-2402JPN003633J$MERCK$$82$YR$$M$Y$$$20240705$$MD$JP$JP
237456925$23745692$5$F$20240405$20240607$20240416$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001675$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240701$$CN$US$US
237456982$23745698$2$F$$20240708$20240416$20240709$EXP$$NVSC2024DE079366$NOVARTIS$$$$$F$Y$$$20240709$$MD$DE$DE
237457223$23745722$3$F$$20240529$20240416$20240808$EXP$$NVSC2021DO279189$NOVARTIS$$$$$F$Y$$$20240808$$CN$DO$DO
237457293$23745729$3$F$20220601$20240719$20240416$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-055677$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240723$$MD$JP$JP
237457363$23745736$3$F$20240101$20240712$20240416$20240722$PER$$US-SA-2024SA113346$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240722$$MD$US$US
237457493$23745749$3$F$20231201$20240729$20240416$20240806$EXP$$CA-SA-2022SA195526$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240806$$MD$CA$CA
237457562$23745756$2$F$$20240412$20240416$20240906$EXP$$NO-BAUSCH-BL-2024-005959$BAUSCH AND LOMB$$$$$M$Y$$$20240906$$MD$NO$NO
237457642$23745764$2$F$$20240816$20240416$20240822$EXP$$US-SA-2024SA112929$SANOFI AVENTIS$$63$YR$A$F$Y$65$KG$20240822$$MD$US$US
237457663$23745766$3$F$20240101$20240903$20240416$20240913$30DAY$$US-GSK-US2024044932$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240913$$CN$US$US
237457672$23745767$2$F$20231201$20240917$20240416$20240930$EXP$$CA-UCBSA-2022064231$UCB$$36$YR$$F$Y$$$20240930$$CN$CA$CA
237457832$23745783$2$F$$20240801$20240416$20240808$EXP$$US-ABBVIE-5717825$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
237457872$23745787$2$F$$20240813$20240416$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001468$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
237458012$23745801$2$F$20240227$20240830$20240416$20240903$EXP$$JP-TAKEDA-2024TJP005411$TAKEDA$$69$YR$$$Y$$$20240903$$MD$JP$JP
237458052$23745805$2$F$20240301$20240805$20240416$20240816$EXP$$US-UCBSA-2024017933$UCB$$48$YR$$F$Y$$$20240816$$HP$US$US
237458172$23745817$2$F$$20240628$20240416$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02990$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237458192$23745819$2$F$$20240628$20240416$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02989$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237458202$23745820$2$F$$20240628$20240416$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02991$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237458223$23745822$3$F$$20240808$20240416$20240820$PER$$US-JNJFOC-20240437656$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240820$$CN$US$US
237458232$23745823$2$F$$20240626$20240416$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02997$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237458282$23745828$2$F$$20240626$20240416$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03003$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237458472$23745847$2$F$$20240628$20240416$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02993$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237458632$23745863$2$F$$20240626$20240416$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02994$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237458772$23745877$2$F$20240326$20240717$20240416$20240722$EXP$$IT-ABBVIE-5719062$ABBVIE$$64$YR$$M$Y$92$KG$20240722$$MD$IT$IT
237458864$23745886$4$F$20240619$20240626$20240416$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001385$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240719$$CN$US$US
237459203$23745920$3$F$$20240813$20240416$20240816$EXP$$NL-SANDOZ INC.-SDZ2024NL038881$SANDOZ$$50$YR$$F$Y$$$20240816$$MD$NL$NL
237459392$23745939$2$F$$20240819$20240416$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-051877$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240823$$CN$US$US
237459402$23745940$2$F$$20240820$20240416$20240827$EXP$$CA-JNJFOC-20240427678$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240827$$PH$CA$CA
237459492$23745949$2$F$20240403$20240711$20240416$20240722$EXP$$AU-BEH-2024170588$CSL BEHRING$$32$YR$A$M$Y$$$20240719$$HP$AU$AU
237459584$23745958$4$F$20230907$20240825$20240416$20240829$EXP$$CA-ROCHE-3428739$ROCHE$$48$YR$A$M$Y$$$20240829$$HP$CA$CA
237459862$23745986$2$F$20240304$20240409$20240416$20240926$EXP$$US-GSK-US2024AMR046999$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
237459874$23745987$4$F$$20240628$20240416$20240925$PER$$US-GSK-US2024AMR047692$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
237459992$23745999$2$F$$20240403$20240416$20240710$PER$$IN-ROCHE-3540176$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
237460572$23746057$2$F$20240101$20240815$20240416$20240820$EXP$$US-ABBVIE-5719615$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
237460762$23746076$2$F$20240412$20240906$20240416$20240909$PER$$US-AMGEN-USASP2024075099$AMGEN$$56$YR$A$F$Y$$$20240909$$CN$US$US
237460787$23746078$7$F$20240405$20240717$20240416$20240725$EXP$$CA-CELLTRION INC.-2024CA008836$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
237461012$23746101$2$F$20240402$20240625$20240416$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010368$UNITED THERAPEUTICS$$74$YR$$F$Y$95.238$KG$20240703$$$US$US
237461092$23746109$2$F$20240408$20240802$20240416$20240806$PER$$US-AMGEN-USASP2024073775$AMGEN$$72$YR$E$M$Y$$$20240806$$CN$US$US
237461142$23746114$2$F$20240412$20240802$20240416$20240806$PER$$US-AMGEN-USASP2024075412$AMGEN$$69$YR$E$M$Y$$$20240806$$CN$US$US
237461242$23746124$2$F$20240401$20240716$20240416$20240718$EXP$$US-JNJFOC-20240430165$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240718$$HP$US$US
237461282$23746128$2$F$$20240626$20240416$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02978$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237461462$23746146$2$F$20240210$20240709$20240416$20240710$EXP$$NL-AMGEN-NLDSL2024075196$AMGEN$$69$YR$E$M$Y$$$20240710$$CN$NL$NL
237461483$23746148$3$F$$20240625$20240416$20240701$EXP$$US-SHIRE-US201733817$TAKEDA$$$$$F$Y$$$20240701$$HP$US$US
237462125$23746212$5$F$20240320$20240826$20240416$20240831$EXP$$US-ABBVIE-5720417$ABBVIE$$74$YR$$F$Y$75$KG$20240831$$CN$US$US
237462182$23746218$2$F$$20240820$20240416$20240831$EXP$$DE-862174955-ML2024-02337$Unknown Manufacturer$Baskal S, Posma RA, Bollenbach A, Dieperink W, Bakker SJL, Nijsten MW, Touw DJ, Tsikas D. GC-MS analysis of 4-hydroxyproline: elevated proline hydroxylation in metformin-associated lactic acidosis and metformin-treated Becker muscular dystrophy patients. Amino Acids. 2024 Mar 10;56(21): doi:10. 1007/ s00726- 024- 03383-9.$70$YR$E$F$Y$84$KG$20240831$$HP$DE$DE
237462272$23746227$2$F$$20240412$20240416$20240925$PER$$US-GSK-US2024AMR047602$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
237462582$23746258$2$F$20240607$20240611$20240416$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001448$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240705$$CN$US$US
237462662$23746266$2$F$20230101$20240725$20240416$20240801$EXP$$JP-009507513-2403JPN002177J$MERCK$$54$YR$$F$Y$$$20240801$$MD$JP$JP
237462724$23746272$4$F$20110714$20240707$20240416$20240715$EXP$$ES-BEH-2024170729$CSL BEHRING$$26$YR$A$F$Y$$$20240715$$MD$ES$ES
237462894$23746289$4$F$$20240906$20240416$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058415$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$112.49$KG$20240910$$CN$US$US
237463132$23746313$2$F$$20240624$20240416$20240711$PER$$US-APOTEX-2024AP004317$APOTEX$$$$$$Y$$$20240711$$CN$US$US
237463232$23746323$2$F$$20240809$20240416$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058195$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240813$$CN$US$US
237463244$23746324$4$F$20240408$20240703$20240416$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058273$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$80.74$KG$20240704$$HP$US$US
237463494$23746349$4$F$$20240722$20240416$20240926$PER$$US-GSK-US2024AMR047605$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
237463574$23746357$4$F$20240201$20240718$20240416$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055841$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240724$$CN$US$US
237463965$23746396$5$F$20240101$20240829$20240416$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058933$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240902$$CN$US$US
237464184$23746418$4$F$20240101$20240904$20240416$20240911$EXP$$US-ABBVIE-5720797$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
237464192$23746419$2$F$$20240628$20240416$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-02992$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237464252$23746425$2$F$20240401$20240906$20240416$20240912$EXP$$US-BIOGEN-2024BI01257974$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
237464472$23746447$2$F$20240301$20240724$20240416$20240729$EXP$$CA-Orion Corporation ORION PHARMA-24_00029315$ORION$$56$YR$A$M$Y$83.5$KG$20240729$$MD$CA$
237464652$23746465$2$F$$20240628$20240416$20240710$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-03274$HIKMA$$$$$F$Y$$$20240710$$MD$US$US
237464753$23746475$3$F$20240201$20240808$20240416$20240809$EXP$$JP-ASTELLAS-2024JP002473$ASTELLAS$$75$YR$$M$Y$$$20240809$$MD$JP$JP
237464905$23746490$5$F$20240210$20240501$20240416$20240902$EXP$$US-VIIV HEALTHCARE LIMITED-US2024045535$VIIV$$$$$$Y$$$20240902$$PH$US$US
237465032$23746503$2$F$20240411$20240730$20240416$20240801$PER$$US-AMGEN-USASP2024075296$AMGEN$$72$YR$E$M$Y$$$20240801$$CN$US$US
237465223$23746522$3$F$20240320$20240729$20240416$20240802$PER$$US-AMGEN-USASP2024074974$AMGEN$$31$YR$A$F$Y$$$20240801$$CN$US$US
237465355$23746535$5$F$$20240813$20240416$20240815$EXP$$CA-TAKEDA-2024TUS035305$TAKEDA$$$$$F$Y$$$20240815$$CN$CA$CA
237465432$23746543$2$F$20240101$20240715$20240416$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057848$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240729$$CN$US$US
237465832$23746583$2$F$$20240716$20240416$20240723$PER$$US-JNJFOC-20240428647$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$PH$US$US
237465863$23746586$3$F$$20240726$20240416$20240726$PER$$NVSC2024US080028$NOVARTIS$$38$YR$$F$Y$$$20240726$$MD$US$US
237465942$23746594$2$F$$20240715$20240416$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059172$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240715$$CN$US$US
237465992$23746599$2$F$20240203$20240908$20240416$20240910$EXP$$NVSC2024GB003135$NOVARTIS$$75$YR$$F$Y$79$KG$20240910$$HP$GB$GB
237466042$23746604$2$F$$20240904$20240416$20240904$PER$$US-ALXN-202404USA000703US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
237466462$23746646$2$F$$20240807$20240416$20240817$EXP$CA-MHPD-E2B_06860350$CA-Accord-418452$ACCORD$$77$YR$E$F$Y$$$20240817$$HP$CA$CA
237466483$23746648$3$F$20211026$20240916$20240416$20240923$EXP$$CA-TAKEDA-2024TUS033843$TAKEDA$$33$YR$$F$Y$$$20240923$$MD$CA$CA
237466512$23746651$2$F$$20240813$20240416$20240816$EXP$$CA-TAKEDA-2024TUS022092$TAKEDA$$$$$F$Y$$$20240816$$CN$CA$CA
237466582$23746658$2$F$20200423$20240830$20240416$20240903$EXP$$US-TAKEDA-US202014511$TAKEDA$$85$YR$$F$Y$$$20240903$$HP$US$US
237467053$23746705$3$F$$20240725$20240416$20240926$PER$$US-GSK-US2024AMR047684$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
237467112$23746711$2$F$20240411$20240730$20240416$20240801$PER$$US-AMGEN-USASP2024075498$AMGEN$$70$YR$E$M$Y$$$20240801$$CN$US$US
237467622$23746762$2$F$$20240718$20240416$20240722$EXP$$CO-BAYER-2024A055045$BAYER$$71$YR$E$F$Y$$$20240722$$CN$CO$CO
237467732$23746773$2$F$20240101$20240716$20240416$20240717$EXP$$US-JNJFOC-20240423851$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240717$$CN$US$US
237467784$23746778$4$F$20221026$20240718$20240416$20240722$EXP$$CA-GSK-CA2022155300$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$HP$CA$CA
237467812$23746781$2$F$20240411$20240731$20240416$20240803$PER$$US-AMGEN-USASP2024074828$AMGEN$$60$YR$A$M$Y$$$20240803$$CN$US$US
237467893$23746789$3$F$$20240621$20240416$20240702$EXP$$DE-Accord-418610$ACCORD$Koschitzki K, Karrer S, Berneburg M, Niebel D, Drexler K. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema). J Dtsch Dermatol Ges. 2024 Apr 3.$53$YR$A$M$Y$$$20240702$$HP$DE$DE
237468132$23746813$2$F$$20240725$20240416$20240730$EXP$$NVSC2024GB078481$NOVARTIS$$23$YR$$F$Y$$$20240730$$CN$GB$GB
237468693$23746869$3$F$$20240701$20240416$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055783$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240702$$CN$US$US
237468832$23746883$2$F$$20240621$20240416$20240705$EXP$$US-BIOCODEX2-2024000545$BIOCODEX$$$$$F$Y$28.5$KG$20240628$$CN$US$US
237468904$23746890$4$F$$20240719$20240416$20240723$30DAY$$CA-PFIZER INC-PV202400041321$PFIZER$$$$$$Y$$$20240723$$MD$CA$CA
237469465$23746946$5$F$$20240913$20240416$20240930$EXP$$US-SA-2024SA113135$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240930$$MD$US$US
237469772$23746977$2$F$20240414$20240826$20240416$20240828$PER$$US-AMGEN-USASP2024076187$AMGEN$$84$YR$E$M$Y$$$20240828$$CN$US$US
237469922$23746992$2$F$20240401$20240411$20240416$20240813$EXP$$CN-BAYER-2024A054146$BAYER$$67$YR$E$F$Y$48$KG$20240813$$HP$CN$CN
237470003$23747000$3$F$$20240731$20240416$20240806$EXP$$CA-TAKEDA-2020TUS058888$TAKEDA$$$$$M$Y$$$20240806$$CN$CA$CA
237470185$23747018$5$F$20240508$20240702$20240416$20240708$EXP$$CA-TAKEDA-2024TUS034699$TAKEDA$$65$YR$$F$Y$$$20240708$$CN$CA$CA
237470553$23747055$3$F$20240315$20240627$20240416$20240717$PER$$BR-TOLMAR, INC.-24BR047903$TOLMAR$$8$YR$$F$Y$$$20240717$$CN$BR$BR
237470592$23747059$2$F$20230901$20240910$20240416$20240930$PER$$CA-TOLMAR, INC.-24CA047563$TOLMAR$$77$YR$$M$Y$$$20240930$$CN$CA$CA
237470752$23747075$2$F$$20240715$20240416$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056757$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240715$$PH$US$US
237470802$23747080$2$F$20240219$20240409$20240416$20240710$EXP$$IT-ROCHE-3543799$ROCHE$$60$YR$A$M$Y$$$20240710$$MD$IT$IT
237471088$23747108$8$F$20240405$20240814$20240416$20240822$EXP$$JP-MYLANLABS-2024M1032242$MYLAN$$4$DEC$$M$Y$$$20240822$$PH$JP$JP
237471392$23747139$2$F$$20240808$20240416$20240812$EXP$$US-MYLANLABS-2024M1034031$MYLAN$$$$$M$Y$$$20240812$$MD$US$US
237471438$23747143$8$F$$20240823$20240416$20240826$PER$$NVSC2024US079624$NOVARTIS$$$$$$Y$$$20240826$$CN$US$US
237471443$23747144$3$F$$20240917$20240416$20240924$PER$$NVSC2024US080155$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
237471483$23747148$3$F$20240308$20240716$20240416$20240722$EXP$$US-ROCHE-3539743$ROCHE$$51$YR$A$M$Y$81.65$KG$20240719$$CN$US$US
237472612$23747261$2$F$20231228$20240731$20240416$20240805$EXP$$FR-EXELIXIS-XL18424073545$EXELIXIS$$$$$$Y$$$20240805$$MD$FR$FR
237473244$23747324$4$F$20240101$20240726$20240416$20240807$EXP$$US-INSMED-2024-00877-USAA$INSMED$$$$$F$Y$$$20240807$$CN$US$US
237473452$23747345$2$F$20231010$20240730$20240416$20240805$EXP$$US-MYLANLABS-2024M1033408$MYLAN$$53$YR$$F$Y$169$KG$20240805$$MD$US$US
237473884$23747388$4$F$$20240627$20240416$20240705$EXP$$GB-PFIZER INC-PV202400049090$PFIZER$Kumaria, A.. Beating a skullduggerous infantile hemispheric high-grade glioma. British Journal of Neurosurgery. 2024;38(2):544-545$5$MON$$M$Y$$$20240705$$HP$GB$GB
237474056$23747405$6$F$$20240709$20240416$20240710$EXP$$NVSC2024US080322$NOVARTIS$$$$$$Y$$$20240710$$HP$US$US
237474414$23747441$4$F$$20240729$20240416$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059209$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240730$$CN$US$US
237474483$23747448$3$F$20231201$20240807$20240416$20240812$EXP$$NL-MYLANLABS-2024M1032274$MYLAN$$54$YR$$F$Y$$$20240812$$HP$NL$NL
237474757$23747475$7$F$20240301$20240905$20240416$20240916$EXP$$US-BEH-2024170529$CSL BEHRING$$36$YR$A$M$Y$80.7$KG$20240916$$HP$US$US
237474883$23747488$3$F$$20240911$20240416$20240911$PER$$US-ALXN-202404USA000697US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
237475142$23747514$2$F$$20240409$20240416$20240820$PER$$US-BAYER-2024A052418$BAYER$$41$YR$A$F$Y$$$20240820$$CN$US$US
237475212$23747521$2$F$$20240715$20240416$20240715$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-058463$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240715$$MD$JP$JP
237475225$23747522$5$F$$20240709$20240416$20240715$EXP$$CA-TAKEDA-2024TUS034584$TAKEDA$$$$$M$Y$$$20240715$$CN$CA$CA
237475353$23747535$3$F$$20240716$20240416$20240723$EXP$$GB-MYLANLABS-2024M1033351$MYLAN$Chou M, Lai L, Neveu M, Ritchie A. Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy.. BMJ-Case-Rep. 2024;17 (3)$$$T$M$Y$$$20240723$$HP$GB$GB
237475612$23747561$2$F$20240112$20240701$20240416$20240710$EXP$$JP-009507513-2404JPN001155J$MERCK$$54$YR$$F$Y$$$20240710$$MD$JP$JP
237475992$23747599$2$F$$20240925$20240416$20240927$EXP$$CA-009507513-2404CAN007638$MERCK$$81$YR$$F$Y$$$20240927$$PH$CA$CA
237476904$23747690$4$F$$20240815$20240416$20240820$30DAY$$US-PFIZER INC-202400078716$PFIZER$$14$YR$$M$Y$$$20240820$$CN$US$US
237476936$23747693$6$F$$20240903$20240416$20240906$30DAY$$US-PFIZER INC-202400079691$PFIZER$$14$YR$$M$Y$$$20240906$$HP$US$US
237476953$23747695$3$F$$20240801$20240416$20240808$30DAY$$US-PFIZER INC-202400079221$PFIZER$$15$YR$$M$Y$$$20240808$$PH$US$US
237476965$23747696$5$F$$20240906$20240416$20240911$30DAY$$US-PFIZER INC-PV202400044828$PFIZER$$15$YR$$F$Y$$$20240911$$CN$US$US
237476986$23747698$6$F$$20240905$20240416$20240909$30DAY$$US-PFIZER INC-202400078808$PFIZER$$15$YR$$M$Y$49.9$KG$20240909$$PH$US$US
237476993$23747699$3$F$$20240903$20240416$20240905$30DAY$$US-PFIZER INC-202400077711$PFIZER$$37$YR$$M$Y$$$20240905$$CN$US$US
237477006$23747700$6$F$20240301$20240917$20240416$20240920$30DAY$$US-PFIZER INC-202400079186$PFIZER$$16$YR$$M$Y$$$20240920$$CN$US$US
237477015$23747701$5$F$$20240815$20240416$20240820$30DAY$$US-PFIZER INC-202400079138$PFIZER$$12$YR$$F$Y$$$20240820$$CN$US$US
237477024$23747702$4$F$$20240905$20240416$20240911$30DAY$$US-PFIZER INC-202400078857$PFIZER$$14$YR$$M$Y$$$20240911$$CN$US$US
237477035$23747703$5$F$20240403$20240826$20240416$20240828$30DAY$$US-PFIZER INC-202400079048$PFIZER$$67$YR$$M$Y$$$20240828$$CN$US$US
237477045$23747704$5$F$$20240806$20240416$20240808$30DAY$$US-PFIZER INC-202400079110$PFIZER$$13$YR$$M$Y$$$20240808$$CN$US$US
237477057$23747705$7$F$$20240923$20240416$20240927$30DAY$$US-PFIZER INC-PV202400044638$PFIZER$$$$$$Y$$$20240927$$HP$US$US
2374770810$23747708$10$F$$20240820$20240416$20240823$30DAY$$US-PFIZER INC-202400079078$PFIZER$$12$YR$$M$Y$$$20240823$$HP$US$US
237477097$23747709$7$F$20240403$20240628$20240416$20240703$30DAY$$US-PFIZER INC-202400079703$PFIZER$$14$YR$$M$Y$47.619$KG$20240703$$CN$US$US
237477773$23747777$3$F$20240403$20240904$20240416$20240909$30DAY$$US-PFIZER INC-202400079018$PFIZER$$14$YR$$F$Y$$$20240909$$CN$US$US
237478142$23747814$2$F$20240123$20240827$20240416$20240917$PER$$DO-TOLMAR, INC.-24DO047240$TOLMAR$$87$YR$$M$Y$$$20240917$$CN$DO$DO
237478462$23747846$2$F$$20240403$20240416$20240807$EXP$$US-RDY-LIT/USA/24/0005684$DR REDDYS$Dubois MM. Treatment of Campylobacter upsaliensis and Helicobacter canis in twin brothers with XLA. Journal of the Pediatric Infectious Diseases Society. 2022 Jul;11: 9-10. doi:10.1093/jpids/piac041.036.$5$YR$C$M$Y$$$20240807$$HP$US$US
237478708$23747870$8$F$20240101$20240711$20240416$20240716$EXP$$CA-TAKEDA-2024TUS031407$TAKEDA$$79$YR$$M$Y$$$20240716$$CN$CA$CA
237478943$23747894$3$F$20240224$20240703$20240416$20240705$EXP$$US-PFIZER INC-PV202400020512$PFIZER$$52$YR$$F$Y$$$20240705$$HP$US$US
237479222$23747922$2$F$20230101$20240625$20240416$20240703$EXP$$US-AstraZeneca-2024A085252$ASTRAZENECA$$70$YR$$F$Y$$$20240703$$CN$US$
237479322$23747932$2$F$$20240403$20240416$20240807$EXP$$US-RDY-LIT/USA/24/0005678$DR REDDYS$Dubois MM. Treatment of Campylobacter upsaliensis and Helicobacter canis in twin brothers with XLA. Journal of the Pediatric Infectious Diseases Society. 2022 Jul;11(1): 9-10. doi:10.1093/jpids/piac041.036.$5$YR$C$M$Y$$$20240807$$HP$US$US
237479482$23747948$2$F$$20240923$20240416$20240927$EXP$$IT-ORGANON-O2404ITA001074$ORGANON$$28$YR$$F$Y$$$20240927$$MD$IT$IT
237479572$23747957$2$F$$20240829$20240416$20240906$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000758$BLUEPRINT MEDICINES$$$$$M$Y$$$20240906$$CN$US$US
237479966$23747996$6$F$20240315$20240905$20240416$20240913$EXP$$GR-EXELIXIS-XL18424076237$EXELIXIS$$$$$$Y$$$20240912$$MD$GR$GR
237479972$23747997$2$F$20240302$20240819$20240416$20240822$EXP$$US-OTSUKA-2024_007713$OTSUKA$$42$YR$$F$Y$77.11$KG$20240822$$MD$US$US
237480392$23748039$2$F$$20240814$20240416$20240821$PER$$US-BIOGEN-2024BI01260372$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
237480433$23748043$3$F$20240408$20240724$20240416$20240731$PER$$NL-Eisai-EC-2024-163761$EISAI$$78$YR$E$F$Y$$$20240731$$MD$NL$NL
237481033$23748103$3$F$$20240807$20240416$20240816$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202404008368$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$IN$IN
237481134$23748113$4$F$$20240816$20240416$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058917$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240823$$CN$US$US
237481312$23748131$2$F$$20240711$20240416$20240715$PER$$US-PFIZER INC-US-GBT-021266$PFIZER$$65$YR$$M$Y$$$20240715$$CN$US$US
237481466$23748146$6$F$$20240718$20240416$20240725$EXP$$NVSC2024CO078318$NOVARTIS$$$$$M$Y$65$KG$20240725$$CN$CO$CO
237481493$23748149$3$F$20240412$20240820$20240416$20240823$PER$$US-AMGEN-USASP2024075450$AMGEN$$83$YR$E$M$Y$79.365$KG$20240823$$HP$US$US
237481713$23748171$3$F$20240401$20240911$20240416$20240918$EXP$$JP-009507513-2404JPN001522J$MERCK$$9$DEC$$M$Y$$$20240918$$MD$JP$JP
237481882$23748188$2$F$20240101$20240726$20240416$20240805$PER$$US-SA-2024SA109020$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240805$$MD$US$US
237481904$23748190$4$F$20240101$20240731$20240416$20240808$PER$$US-SA-2024SA111807$SANOFI AVENTIS$$64$YR$A$F$Y$79.38$KG$20240808$$MD$US$US
237481933$23748193$3$F$20240101$20240716$20240416$20240724$PER$$US-SA-2024SA109702$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240724$$MD$US$US
237482133$23748213$3$F$20240101$20240729$20240416$20240806$PER$$US-SA-2024SA110617$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240806$$MD$US$US
237482142$23748214$2$F$$20240701$20240416$20240710$PER$$US-SA-2024SA109428$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240710$$MD$US$US
237482232$23748223$2$F$$20240724$20240416$20240801$PER$$US-SA-2024SA109185$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240801$$MD$US$US
237482343$23748234$3$F$20240101$20240904$20240416$20240925$PER$$US-SA-2024SA110638$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240925$$CN$US$US
237482355$23748235$5$F$20240101$20240823$20240416$20240918$PER$$US-SA-2024SA110971$SANOFI AVENTIS$$76$YR$E$F$Y$58$KG$20240918$$MD$US$US
237482562$23748256$2$F$20240401$20240719$20240416$20240731$PER$$US-SA-2024SA110572$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240731$$MD$US$US
237482612$23748261$2$F$$20240717$20240416$20240725$PER$$US-SA-2024SA110142$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240725$$MD$US$US
237482672$23748267$2$F$$20240628$20240416$20240710$PER$$US-SA-2024SA070665$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240710$$MD$US$US
237482702$23748270$2$F$20240101$20240701$20240416$20240710$PER$$US-SA-2024SA112585$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240710$$MD$US$US
237482723$23748272$3$F$$20240722$20240416$20240730$PER$$US-SA-2024SA109963$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240730$$MD$US$US
237482732$23748273$2$F$20240101$20240729$20240416$20240806$PER$$US-SA-2024SA112157$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240806$$MD$US$US
237482792$23748279$2$F$20200501$20240725$20240416$20240805$PER$$US-SA-2024SA110614$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240805$$MD$US$US
237482993$23748299$3$F$20231201$20240903$20240416$20240912$PER$$US-SA-2024SA111133$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240912$$MD$US$US
237483082$23748308$2$F$$20240701$20240416$20240710$PER$$US-SA-2024SA112468$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240710$$MD$US$US
237483482$23748348$2$F$20240101$20240904$20240416$20240916$PER$$US-SA-2024SA110313$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240916$$MD$US$US
237483542$23748354$2$F$$20240821$20240416$20240917$PER$$US-SA-2024SA110991$SANOFI AVENTIS$$$$A$F$Y$140$KG$20240918$$MD$US$US
237483602$23748360$2$F$$20240624$20240416$20240703$PER$$US-SA-2024SA112599$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240703$$MD$US$US
237483613$23748361$3$F$20240101$20240918$20240416$20240926$PER$$US-SA-2024SA114300$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240926$$HP$US$US
237483837$23748383$7$F$$20240718$20240416$20240729$PER$$US-SA-2024SA113084$SANOFI AVENTIS$$57$YR$A$F$Y$128.8$KG$20240729$$HP$US$US
237483892$23748389$2$F$20240401$20240916$20240416$20240924$PER$$US-SA-2024SA111409$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240924$$MD$US$US
237484062$23748406$2$F$$20240730$20240416$20240808$PER$$US-SA-2024SA113241$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240808$$MD$US$US
237484105$23748410$5$F$20240409$20240814$20240416$20240821$EXP$$CA-GSK-CA2024046149$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$CA$CA
237484182$23748418$2$F$$20240816$20240416$20240829$PER$$US-SA-2024SA108414$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240829$$MD$US$US
237484264$23748426$4$F$20240105$20240716$20240416$20240723$EXP$$NVSC2024FR035686$NOVARTIS$$$$A$F$Y$61$KG$20240723$$MD$FR$FR
237484312$23748431$2$F$$20240716$20240416$20240724$PER$$US-SA-2024SA112473$SANOFI AVENTIS$$$$E$F$Y$$$20240724$$MD$US$US
237484322$23748432$2$F$20240101$20240718$20240416$20240728$PER$$US-SA-2024SA110394$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240728$$MD$US$US
237484462$23748446$2$F$20240718$20240718$20240416$20240728$PER$$US-SA-2024SA092085$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240728$$PH$US$US
237484965$23748496$5$F$20240801$20240905$20240416$20240909$EXP$$US-PFIZER INC-202400085287$PFIZER$$69$YR$$M$Y$74.84$KG$20240909$$CN$US$US
237485002$23748500$2$F$20230827$20240711$20240416$20240715$EXP$$US-BIOVITRUM-2024-US-005741$BIOVITRUM$$86$YR$$F$Y$$$20240715$$CN$US$US
237485432$23748543$2$F$20240601$20240708$20240416$20240710$EXP$$US-INCYTE CORPORATION-2024IN003720$INCYTE$$$$$$Y$$$20240710$$CN$US$US
237485572$23748557$2$F$$20240628$20240416$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441574$RANBAXY$Cairns J, Feng TL, Ong MC. Continuous ketamine infusion for the management of opioid-induced hyperalgesia following amputation. BMJ Case Rep. 2024;17:no pagination, e255333, 1-4$7$DEC$$F$Y$$$20240712$$HP$CA$CA
237485622$23748562$2$F$20240322$20240826$20240416$20240910$EXP$$DE-SUNPHARMA-2024RR-441611AA$RANBAXY$$65$YR$$M$Y$98$KG$20240910$$HP$DE$DE
237486042$23748604$2$F$$20240722$20240416$20240730$PER$$US-SA-2024SA109424$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240730$$MD$US$US
237486282$23748628$2$F$$20240703$20240416$20240710$PER$$US-BIOGEN-2024BI01259339$BIOGEN$$$$$M$Y$$$20240710$$HP$US$US
237486294$23748629$4$F$20240201$20240828$20240416$20240906$EXP$$US-ROCHE-3545427$ROCHE$$71$YR$E$M$Y$102.51$KG$20240906$$CN$US$US
237486373$23748637$3$F$$20240628$20240416$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059167$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240702$$CN$US$US
237486402$23748640$2$F$20231130$20240628$20240416$20240702$EXP$$FR-SANDOZ INC.-SDZ2024FR039544$SANDOZ$$71$YR$$F$Y$$$20240702$$HP$FR$FR
237486653$23748665$3$F$$20240823$20240416$20240903$EXP$$PT-MYLANLABS-2024M1033615$MYLAN$$$$$$Y$$$20240903$$CN$PT$PT
237486762$23748676$2$F$20240411$20240729$20240416$20240731$PER$$US-AMGEN-USASP2024075263$AMGEN$$59$YR$A$M$Y$$$20240731$$CN$US$US
237486793$23748679$3$F$20240301$20240904$20240416$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059313$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240913$$CN$US$US
237486802$23748680$2$F$$20240725$20240416$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059103$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$77.11$KG$20240726$$CN$US$US
237486832$23748683$2$F$$20240717$20240416$20240724$EXP$$US-AMGEN-USASP2024073112$AMGEN$$$$$F$Y$$$20240724$$HP$US$US
237486853$23748685$3$F$$20240909$20240416$20240914$EXP$$CA-TAKEDA-2023TUS010637$TAKEDA$$$$$F$Y$58.9$KG$20240914$$CN$CA$CA
237486902$23748690$2$F$20140101$20240715$20240416$20240723$EXP$$CA-SANDOZ INC.-PHHY2014CA143301$SANDOZ$$45$YR$$F$Y$$$20240723$$CN$CA$CA
237487102$23748710$2$F$$20240814$20240416$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059069$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$77.56$KG$20240819$$CN$US$US
237487703$23748770$3$F$$20240716$20240416$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058511$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240716$$PH$US$US
237487712$23748771$2$F$$20240710$20240416$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059401$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240712$$CN$US$US
237487873$23748787$3$F$20231001$20240806$20240416$20240811$EXP$$US-ABBVIE-5720514$ABBVIE$$73$YR$$M$Y$84$KG$20240811$$CN$US$US
237488186$23748818$6$F$20240507$20240722$20240416$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059133$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240722$$CN$US$US
237488262$23748826$2$F$20240325$20240819$20240416$20240822$PER$$US-PFIZER INC-202400085541$PFIZER$$77$YR$$F$Y$$$20240822$$HP$US$US
237488483$23748848$3$F$$20240729$20240416$20240731$PER$$US-PFIZER INC-PV202400048912$PFIZER$$85$YR$$F$Y$$$20240731$$HP$US$US
237489663$23748966$3$F$$20240924$20240416$20240927$EXP$$CA-TAKEDA-2024TUS035813$TAKEDA$$$$$M$Y$$$20240927$$CN$CA$CA
237489673$23748967$3$F$20240418$20240904$20240416$20240909$EXP$$CA-TAKEDA-2024TUS035761$TAKEDA$$73$YR$$F$Y$$$20240909$$CN$CA$CA
237489913$23748991$3$F$$20240829$20240416$20240903$EXP$$US-ABBVIE-5720940$ABBVIE$$$$$M$Y$147.41$KG$20240903$$CN$US$US
237490013$23749001$3$F$$20240711$20240416$20240722$EXP$$PT-Integrated Therapeutic Solutions Inc.-2155620$Integrated Therapeutic Solutions$$37$YR$$F$Y$$$20240722$$$PT$PT
237490253$23749025$3$F$20211001$20240726$20240416$20240726$PER$$NVSC2024US080285$NOVARTIS$$35$YR$$F$Y$$$20240726$$MD$US$US
237490432$23749043$2$F$20240410$20240727$20240416$20240801$EXP$$US-AMGEN-USASP2024072525$AMGEN$$48$YR$A$F$Y$$$20240801$$CN$US$US
237490442$23749044$2$F$$20240819$20240416$20240820$EXP$$CA-ORGANON-2102CAN001298$ORGANON$$60$YR$$M$Y$$$20240820$$HP$CA$CA
237490502$23749050$2$F$20240330$20240903$20240416$20240913$PER$$US-SA-2024SA113528$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240913$$MD$US$US
237490642$23749064$2$F$$20240806$20240416$20240814$EXP$$FR-AstraZeneca-2024A045585$ASTRAZENECA$$$$$F$Y$60$KG$20240814$$MD$FR$
237490685$23749068$5$F$20231207$20240701$20240416$20240709$EXP$$US-AstraZeneca-2024A089072$ASTRAZENECA$$70$YR$$M$Y$94.1$KG$20240709$$HP$US$
237490775$23749077$5$F$$20240730$20240416$20240810$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202404009370$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240810$$CN$CA$CA
237490784$23749078$4$F$20240406$20240904$20240416$20240909$EXP$$AT-PFIZER INC-202400088159$PFIZER$$61$YR$$F$Y$$$20240909$$HP$AT$AT
237490805$23749080$5$F$20240423$20240801$20240416$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059158$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240802$$CN$US$US
237491442$23749144$2$F$$20240708$20240416$20240716$EXP$$IN-MYLANLABS-2024M1034264$MYLAN$Indhumathi E, Karthikeyan B, Nair SV. Renal cortical necrosis in transplant patient with Covid infection. Indian-J-Nephrol 2021; 31 (Suppl.) S60.$47$YR$$M$Y$$$20240716$$HP$IN$IN
237491684$23749168$4$F$20231122$20240628$20240416$20240704$EXP$$IT-BAUSCH-BL-2024-005855$BAUSCH AND LOMB$$61$YR$$F$Y$58$KG$20240704$$HP$IT$IT
237492282$23749228$2$F$$20240725$20240416$20240807$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK089962$GLENMARK$$$$$$Y$$$20240807$$HP$CA$CA
237492642$23749264$2$F$$20240812$20240416$20240816$EXP$$GB-MYLANLABS-2024M1033970$MYLAN$$$$$F$Y$$$20240816$$HP$GB$GB
237492706$23749270$6$F$20240701$20240806$20240416$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059345$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240809$$CN$US$US
237492772$23749277$2$F$$20240715$20240416$20240715$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-059185$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240715$$MD$PR$PR
237492902$23749290$2$F$$20240628$20240416$20240701$PER$$NVSC2024US080436$NOVARTIS$$$$$$Y$$$20240701$$MD$US$US
237493233$23749323$3$F$20240320$20240516$20240416$20240806$PER$$US-AstraZeneca-2024A068501$ASTRAZENECA$$26598$DY$$M$Y$$$20240806$$CN$US$
237493282$23749328$2$F$$20240712$20240416$20240725$PER$$US-Calliditas-2024CAL00564$CALLIDITAS THERAPEUTICS$$58$YR$A$F$Y$95.7$KG$20240725$$CN$US$US
237493292$23749329$2$F$$20240711$20240416$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057763$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240711$$CN$US$US
237493314$23749331$4$F$$20240827$20240416$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059254$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$69.85$KG$20240830$$CN$US$US
237493753$23749375$3$F$$20240617$20240416$20240807$PER$$US-LUNDBECK-DKLU3076202$LUNDBECK$$$$$$Y$$$20240807$$CN$US$US
237494354$23749435$4$F$20240101$20240925$20240416$20240930$EXP$$US-KARYOPHARM-2024KPT000855$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240930$$CN$US$US
237494462$23749446$2$F$$20240716$20240416$20240722$EXP$$JP-009507513-2404JPN001882J$MERCK$$30$YR$$M$Y$$$20240719$$MD$JP$JP
237494512$23749451$2$F$20240301$20240719$20240416$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059264$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240722$$HP$US$US
237495004$23749500$4$F$20231201$20240708$20240416$20240904$EXP$$CA-LUNDBECK-DKLU3076800$LUNDBECK$$$$$$Y$$$20240904$$HP$CA$CA
237495167$23749516$7$F$20240324$20240726$20240416$20240803$EXP$$US-TAKEDA-2024TUS028970$TAKEDA$$61$YR$$F$Y$$$20240803$$CN$US$US
237496004$23749600$4$F$$20240814$20240416$20240820$EXP$$CA-JNJFOC-20231065238$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240820$$CN$CA$CA
237496074$23749607$4$F$$20240828$20240416$20240904$EXP$$US-TRAVERE-2024TVT00299$TRAVERE THERAPEUTICS$$35$YR$A$F$Y$$$20240904$$CN$US$US
237496098$23749609$8$F$20230101$20240809$20240416$20240816$EXP$$US-ABBVIE-5693852$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
237496353$23749635$3$F$20240401$20240827$20240416$20240904$PER$$US-BIOGEN-2024BI01259594$BIOGEN$$42$YR$$F$Y$$$20240904$$CN$US$US
237496703$23749670$3$F$20240405$20240626$20240416$20240703$PER$$US-AMGEN-USASP2024070980$AMGEN$$57$YR$A$M$Y$92.5$KG$20240703$$HP$US$US
237496913$23749691$3$F$20240201$20240717$20240416$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059920$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240717$$CN$US$US
237497122$23749712$2$F$$20240731$20240416$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-058592$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240809$$MD$JP$JP
237497394$23749739$4$F$20230621$20240830$20240416$20240905$EXP$$JP-009507513-2404JPN000312J$MERCK$$74$YR$$M$Y$60$KG$20240905$$MD$JP$JP
237497873$23749787$3$F$20240201$20240629$20240417$20240708$PER$$US-SA-2024SA113419$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240708$$MD$US$US
237497935$23749793$5$F$$20240924$20240417$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056573$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240926$$CN$US$US
237498012$23749801$2$F$20240903$20240911$20240417$20240918$EXP$$US-ABBVIE-5720995$ABBVIE$$57$YR$$M$Y$$$20240918$$CN$US$US
237498182$23749818$2$F$$20240816$20240417$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-009251$JAZZ$$$$$F$Y$$$20240822$$CN$US$US
237498222$23749822$2$F$$20240801$20240417$20240808$PER$$US-ALXN-202404USA000681US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
237498402$23749840$2$F$20230901$20240919$20240417$20240925$PER$$US-JAZZ PHARMACEUTICALS-2023-US-006092$JAZZ$$31$YR$$M$Y$$$20240925$$MD$US$US
237498525$23749852$5$F$20240401$20240822$20240417$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056641$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240902$$CN$US$US
237498584$23749858$4$F$20240408$20240708$20240417$20240716$EXP$$CA-CELLTRION INC.-2024CA008953$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
237498792$23749879$2$F$20240301$20240716$20240417$20240808$PER$$CA-TOLMAR, INC.-24CA047942$TOLMAR$$69$YR$$M$Y$$$20240808$$CN$CA$CA
237498845$23749884$5$F$20240301$20240909$20240417$20240927$PER$$CA-TOLMAR, INC.-24CA048022$TOLMAR$$74$YR$$M$Y$$$20240927$$CN$CA$CA
237498973$23749897$3$F$$20240909$20240417$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-024623$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240918$$MD$JP$JP
237498995$23749899$5$F$$20240722$20240417$20240727$EXP$$US-TAKEDA-2024TUS006611$TAKEDA$$$$$F$Y$63$KG$20240727$$CN$US$US
237499052$23749905$2$F$$20240607$20240417$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001474$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
237499062$23749906$2$F$20240409$20240920$20240417$20240923$PER$$US-AMGEN-USASP2024073215$AMGEN$$69$YR$E$F$Y$$$20240923$$CN$US$US
237499242$23749924$2$F$20240701$20240730$20240417$20240812$PER$$US-SA-2024SA014810$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240812$$MD$US$US
237499272$23749927$2$F$20240101$20240709$20240417$20240717$PER$$US-SA-2024SA113549$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240717$$MD$US$US
237499822$23749982$2$F$20240101$20240627$20240417$20240702$PER$$US-UNITED THERAPEUTICS-UNT-2024-006062$UNITED THERAPEUTICS$$79$YR$$M$Y$$$20240702$$$US$US
237500532$23750053$2$F$$20240628$20240417$20240711$EXP$$US-ADVANZ PHARMA-202404003274$ADVANZ PHARMA$$$$$$Y$$$20240711$$CN$US$US
237500593$23750059$3$F$20240304$20240827$20240417$20240903$EXP$$CA-JNJFOC-20240340921$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240903$$HP$CA$CA
237500772$23750077$2$F$$20240812$20240417$20240814$EXP$$CA-TAKEDA-2024TUS033991$TAKEDA$$$$$F$Y$$$20240814$$CN$CA$CA
237500922$23750092$2$F$20231201$20240915$20240417$20240917$PER$$NVSC2024US080441$NOVARTIS$$$$$$Y$$$20240917$$CN$US$US
237500972$23750097$2$F$$20240729$20240417$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059455$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240805$$CN$US$US
237500982$23750098$2$F$20240321$20240917$20240417$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058476$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240918$$HP$US$US
237501012$23750101$2$F$20231226$20240408$20240417$20240717$EXP$$CN-HALEON-2167316$Haleon PLC$$75$YR$$F$Y$$$20240716$$HP$CN$CN
237501155$23750115$5$F$$20240716$20240417$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059619$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240716$$CN$US$US
237501403$23750140$3$F$20240101$20240731$20240417$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-001262$UNITED THERAPEUTICS$$76$YR$$M$Y$$$20240809$$$US$US
237501482$23750148$2$F$$20240725$20240417$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-041038$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240806$$MD$JP$JP
237501642$23750164$2$F$$20240626$20240417$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03023$LUPIN$$$$$$Y$$$20240712$$HP$US$US
237501895$23750189$5$F$20220101$20240625$20240417$20240703$EXP$$CA-CELLTRION INC.-2022CA010157$CELLTRION$$$$$$Y$$$20240703$$HP$CA$CA
237501982$23750198$2$F$$20240628$20240417$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03053$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237502083$23750208$3$F$$20240613$20240417$20240709$PER$$PR-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001446$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$PR$US
237502134$23750213$4$F$$20240909$20240417$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059233$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240916$$CN$US$US
237502162$23750216$2$F$$20240627$20240417$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03081$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237502212$23750221$2$F$20240414$20240814$20240417$20240817$PER$$US-AMGEN-USASP2024075684$AMGEN$$76$YR$E$F$Y$$$20240817$$CN$US$US
237502262$23750226$2$F$$20240729$20240417$20240801$30DAY$$US-SANDOZ INC.-SDZ2024US039522$SANDOZ$$$$$M$Y$$$20240801$$CN$US$US
237502542$23750254$2$F$$20240610$20240417$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001429$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
237502552$23750255$2$F$$20240715$20240417$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059186$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240715$$CN$US$US
237502622$23750262$2$F$$20240618$20240417$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001430$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
237503063$23750306$3$F$20240601$20240801$20240417$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001436$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240827$$CN$US$US
237503189$23750318$9$F$20240404$20240911$20240417$20240913$EXP$$US-GSK-US2024AMR047547$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$US$US
237503212$23750321$2$F$$20240702$20240417$20240711$EXP$$CA-CELLTRION INC.-2024CA008879$CELLTRION$$$$$$Y$$$20240711$$CN$CA$CA
237503232$23750323$2$F$20240401$20240625$20240417$20240702$PER$$US-BIOGEN-2024BI01259980$BIOGEN$$31$YR$$F$Y$$$20240702$$CN$US$US
237503302$23750330$2$F$$20240904$20240417$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202404009476$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240910$$HP$US$US
237503382$23750338$2$F$20210629$20240828$20240417$20240905$EXP$DE-ADRED-04862-03$DE-RDY-SPO/GER/22/0155093$DR REDDYS$$78$YR$E$M$Y$$$20240905$$PH$DE$DE
237503395$23750339$5$F$20240405$20240724$20240417$20240729$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-022442$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$$$20240729$$CN$US$US
237503434$23750343$4$F$20240427$20240703$20240417$20240708$EXP$$CA-TAKEDA-2019TUS039478$TAKEDA$$29$YR$$M$Y$$$20240708$$HP$CA$CA
237503518$23750351$8$F$20240402$20240916$20240417$20240920$EXP$$NVSC2024RU078409$NOVARTIS$$2$YR$$M$Y$13.9$KG$20240920$$CN$RU$RU
237503634$23750363$4$F$$20240709$20240417$20240715$EXP$$CA-ROCHE-3546450$ROCHE$$$$A$F$Y$$$20240715$$CN$CA$CA
237504392$23750439$2$F$$20240628$20240417$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03052$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237504482$23750448$2$F$$20240628$20240417$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03083$LUPIN$$$$$$Y$$$20240714$$PH$US$US
237504752$23750475$2$F$$20240626$20240417$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03084$LUPIN$$$$$$Y$$$20240712$$HP$US$US
237504853$23750485$3$F$$20240719$20240417$20240723$PER$$NVSC2024US081084$NOVARTIS$$$$$M$Y$$$20240723$$HP$US$US
237504902$23750490$2$F$$20240626$20240417$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03026$LUPIN$$$$$$Y$$$20240712$$HP$US$US
237505102$23750510$2$F$20240101$20240716$20240417$20240718$PER$$US-JNJFOC-20240432994$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$HP$US$US
237505552$23750555$2$F$$20240723$20240417$20240725$PER$$US-JNJFOC-20240435648$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$MD$US$US
237505713$23750571$3$F$20240407$20240722$20240417$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202404009489$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240724$$CN$US$US
237506023$23750602$3$F$20240101$20240910$20240417$20240915$EXP$$CA-JNJFOC-20240321881$JOHNSON AND JOHNSON$$$$$F$Y$$$20240915$$HP$CA$CA
237506104$23750610$4$F$20221101$20240902$20240417$20240911$EXP$$JP-ROCHE-3545188$ROCHE$$82$YR$E$M$Y$70$KG$20240911$$MD$JP$JP
237506272$23750627$2$F$$20240710$20240417$20240717$EXP$$US-SA-2024SA114563$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240717$$MD$US$US
237506412$23750641$2$F$20240314$20240726$20240417$20240802$EXP$$JP-AstraZeneca-2024A088001$ASTRAZENECA$$90$YR$$F$Y$$$20240802$$MD$JP$
237506542$23750654$2$F$20240312$20240702$20240417$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003080$ACADIA PHARMACEUTICALS$$63$YR$$M$Y$$$20240726$$HP$US$US
237506722$23750672$2$F$20240101$20240917$20240417$20240923$EXP$$NVSC2023DE118195$NOVARTIS$$$$A$F$Y$$$20240923$$CN$DE$DE
237507034$23750703$4$F$20230201$20240731$20240417$20240806$EXP$$CA-TAKEDA-2023TUS066413$TAKEDA$$48$YR$$F$Y$$$20240806$$HP$CA$CA
237507503$23750750$3$F$20240101$20240808$20240417$20240821$EXP$$CA-APOTEX-2024AP004640$APOTEX$$$$A$M$Y$$$20240821$$PH$CA$CA
237507562$23750756$2$F$20240411$20240731$20240417$20240806$EXP$$US-AMGEN-USASP2024074264$AMGEN$$71$YR$E$F$Y$$$20240806$$CN$US$US
237507903$23750790$3$F$$20240911$20240417$20240918$EXP$$CA-TAKEDA-2024TUS004612$TAKEDA$$$$$M$Y$$$20240918$$HP$CA$CA
2375079211$23750792$11$F$20240101$20240809$20240417$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-006223$UNITED THERAPEUTICS$$$$$F$Y$85.714$KG$20240817$$$US$US
237508102$23750810$2$F$$20240924$20240417$20240925$EXP$$BR-JNJFOC-20240430012$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240925$$HP$BR$BR
237508492$23750849$2$F$20240214$20240724$20240417$20240801$EXP$$JP-ROCHE-3545146$ROCHE$$59$YR$A$M$Y$62$KG$20240801$$MD$JP$JP
237508523$23750852$3$F$20240405$20240826$20240417$20240828$PER$$US-AMGEN-USASP2024074755$AMGEN$$76$YR$E$M$Y$108.84$KG$20240827$$MD$US$US
237508557$23750855$7$F$20240101$20240821$20240417$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-007673$UNITED THERAPEUTICS$$$$$F$Y$100.23$KG$20240828$$$US$US
237508764$23750876$4$F$20240301$20240715$20240417$20240722$EXP$$US-GSK-US2024046122$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
237509002$23750900$2$F$20231201$20240711$20240417$20240730$PER$$CA-TOLMAR, INC.-24CA047832$TOLMAR$$73$YR$$M$Y$$$20240730$$CN$CA$CA
237509013$23750901$3$F$$20240902$20240417$20240919$PER$$CA-TOLMAR, INC.-24CA047850$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
237509032$23750903$2$F$20240319$20240903$20240417$20240926$PER$$CA-TOLMAR, INC.-24CA047851$TOLMAR$$75$YR$$M$Y$$$20240926$$CN$CA$CA
237509073$23750907$3$F$$20240725$20240417$20240730$PER$$CA-TOLMAR, INC.-24CA047869$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
237509083$23750908$3$F$20240201$20240708$20240417$20240729$PER$$CA-TOLMAR, INC.-24CA047885$TOLMAR$$81$YR$$M$Y$$$20240726$$CN$CA$CA
237509092$23750909$2$F$$20240709$20240417$20240730$PER$$CA-TOLMAR, INC.-24CA047890$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
237509273$23750927$3$F$$20240628$20240417$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03067$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237509406$23750940$6$F$$20240716$20240417$20240725$EXP$$GB-AUROBINDO-AUR-APL-2024-017445$AUROBINDO$Ritchie AA, Chou MM, Lai LL, Neveu MM. Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy. BMJ Case Rep. 2024;17:3$$$T$M$Y$$$20240725$$MD$GB$GB
237509462$23750946$2$F$$20240722$20240417$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US038993$SANDOZ$$$$$M$Y$$$20240724$$CN$US$US
237509492$23750949$2$F$$20240819$20240417$20240821$EXP$$DE-SANDOZ INC.-SDZ2024DE039328$SANDOZ$$54$YR$$F$Y$$$20240821$$HP$DE$DE
237509753$23750975$3$F$$20240809$20240417$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-015197$AUROBINDO$$78$YR$$F$Y$67.131$KG$20240821$$CN$US$US
237509795$23750979$5$F$$20240719$20240417$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059578$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240722$$HP$US$US
237509884$23750988$4$F$$20240808$20240417$20240821$EXP$$PL-AUROBINDO-AUR-APL-2024-016904$AUROBINDO$Potocki P. Metronomic chemotherapy in multimodality approach to a patient with breast cancer cutaneous metastases. Oncology In Clinical Practice-Education. 2018;Supl A 4:A16-A19$55$YR$$F$Y$$$20240821$$MD$PL$PL
237509953$23750995$3$F$$20240507$20240417$20240802$EXP$$NVSC2024ZA079009$NOVARTIS$$56$YR$$F$Y$$$20240802$$MD$ZA$ZA
237510022$23751002$2$F$$20240924$20240417$20240930$EXP$$CA-HALEON-2166435$Haleon PLC$$71$YR$$F$Y$69$KG$20240927$$CN$CA$CA
237510108$23751010$8$F$20240322$20240710$20240417$20240715$EXP$$ES-AUROBINDO-AUR-APL-2024-018008$AUROBINDO$$58$YR$$F$Y$63.1$KG$20240715$$MD$ES$ES
237510463$23751046$3$F$$20240813$20240417$20240819$EXP$$NVSC2024CA080572$NOVARTIS$$47$YR$$F$Y$$$20240819$$HP$CA$CA
237510753$23751075$3$F$20200101$20240416$20240417$20240801$EXP$$IT-ASTELLAS-2024EU003455$ASTELLAS$Maggioni G, Fedrigo M, Visentin A, Carturan E, Ruocco V, Trentin L, et a. Severe Fatal Mucormycosis in a Patient with Chronic Lymphocytic Leukaemia Treated with Zanubrutinib: A Case Report and Review of the Literature. Current Oncology. 2023;30(9):8255-65$74$YR$$F$Y$$$20240801$$HP$IT$IT
237510854$23751085$4$F$20231129$20240708$20240417$20240718$EXP$$JP-JNJFOC-20240152063$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240718$$CN$JP$JP
237511314$23751131$4$F$20240101$20240909$20240417$20240923$EXP$$US-INSMED, INC.-2024-01407-US$INSMED$$$$$F$Y$$$20240923$$CN$US$US
237511375$23751137$5$F$20240101$20240628$20240417$20240705$EXP$$CA-CELLTRION INC.-2024CA009021$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
237511422$23751142$2$F$$20240716$20240417$20240725$EXP$$GB-862174955-ML2024-02388$Unknown Manufacturer$Chou M, Lai L, Neveu M, Ritchie A. Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy. BMJ case reports. 2024;17(3):e256961. DOI: 10.1136/bcr-2023-256961.$$$T$M$Y$$$20240725$$MD$GB$GB
237511493$23751149$3$F$20240125$20240704$20240417$20240716$EXP$$DE-ROCHE-3543367$ROCHE$$40$YR$A$F$Y$$$20240716$$MD$DE$DE
237511532$23751153$2$F$$20240717$20240417$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058950$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$88.1$KG$20240717$$PH$US$US
237511554$23751155$4$F$$20240716$20240417$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060204$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240716$$CN$US$US
237511572$23751157$2$F$20240101$20240909$20240417$20240913$EXP$$US-ABBVIE-5718061$ABBVIE$$57$YR$$F$Y$$$20240913$$CN$US$US
237511942$23751194$2$F$$20240726$20240417$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058998$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240730$$CN$US$US
237511993$23751199$3$F$$20240903$20240417$20240903$PER$$US-ALXN-202404USA000808US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
237512012$23751201$2$F$$20240628$20240417$20240703$EXP$$NVSC2021BR318414$NOVARTIS$$$$$$Y$$$20240703$$MD$BR$BR
237512473$23751247$3$F$$20240617$20240417$20240704$30DAY$$US-GSK-US2024AMR045824$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
237513242$23751324$2$F$$20240708$20240417$20240710$EXP$FR-BAYER-2024A054176$FR-SANDOZ INC.-SDZ2024FR039727$SANDOZ$$$$$F$Y$$$20240710$$CN$FR$FR
237513292$23751329$2$F$$20240827$20240417$20240830$EXP$$IE-MYLANLABS-2024M1033576$MYLAN$$$$$F$Y$$$20240830$$PH$IE$IE
237513362$23751336$2$F$$20240808$20240417$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058602$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$115.67$KG$20240816$$CN$US$US
237513753$23751375$3$F$$20240918$20240417$20240926$PER$$NVSC2024US081264$NOVARTIS$$72$YR$$F$Y$54$KG$20240926$$HP$US$US
237514224$23751422$4$F$20240327$20240422$20240417$20240812$EXP$$NVSC2024US080073$NOVARTIS$$53$YR$$F$Y$80.7$KG$20240812$$CN$US$US
237514422$23751442$2$F$20240412$20240729$20240417$20240801$PER$$US-AMGEN-USASP2024075425$AMGEN$$59$YR$A$F$Y$$$20240801$$CN$US$US
237515023$23751502$3$F$$20240708$20240417$20240712$EXP$FR-BAYER-2024A054178$FR-SANDOZ INC.-SDZ2024FR039812$SANDOZ$$$$$F$Y$$$20240712$$CN$FR$FR
237515223$23751522$3$F$$20240828$20240417$20240904$EXP$$US-ABBVIE-5719174$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
237515532$23751553$2$F$$20240812$20240417$20240819$EXP$$CA-GSK-CA2024AMR047615$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$HP$CA$CA
237515574$23751557$4$F$20231116$20240801$20240417$20240807$EXP$$CA-TAKEDA-2023TUS115508$TAKEDA$$70$YR$$M$Y$$$20240807$$HP$CA$CA
237515662$23751566$2$F$$20240910$20240417$20240912$EXP$$CA-PFIZER INC-202400088778$PFIZER$$63$YR$$F$Y$$$20240912$$HP$CA$CA
237515732$23751573$2$F$$20240916$20240417$20240918$EXP$$US-PFIZER INC-PV202400049492$PFIZER$$64$YR$$F$Y$$$20240918$$HP$US$US
237515829$23751582$9$F$20240320$20240910$20240417$20240912$EXP$$US-PFIZER INC-PV202400049685$PFIZER$$55$YR$$F$Y$$$20240912$$MD$US$US
237515863$23751586$3$F$20231201$20240828$20240417$20240902$EXP$$CA-PFIZER INC-202300450532$PFIZER$$82$YR$$M$Y$$$20240902$$HP$CA$CA
237516163$23751616$3$F$$20240821$20240417$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059194$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240830$$CN$US$US
237517282$23751728$2$F$$20240415$20240417$20240919$EXP$$NVSC2024US080163$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
237517905$23751790$5$F$20240401$20240724$20240417$20240731$EXP$$US-GILEAD-2024-0669583$GILEAD$$73$YR$E$F$Y$$$20240731$$HP$US$US
237517953$23751795$3$F$20240329$20240711$20240417$20240715$EXP$$GB-MYLANLABS-2024M1033746$MYLAN$$$$$F$Y$$$20240715$$HP$GB$GB
237518762$23751876$2$F$20230101$20240815$20240417$20240820$EXP$$JP-009507513-2305JPN001419J$MERCK$$$$$F$Y$$$20240820$$MD$JP$JP
237519094$23751909$4$F$20210101$20240719$20240417$20240724$EXP$$US-JAZZ-2022-US-000793$JAZZ$$$$$F$Y$61.088$KG$20240724$$MD$US$US
237519233$23751923$3$F$$20240813$20240417$20240823$EXP$$CA-APOTEX-2024AP004572$APOTEX$$71$YR$$F$Y$69$KG$20240823$$HP$CA$CA
237519242$23751924$2$F$$20240712$20240417$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059328$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$74.84$KG$20240717$$CN$US$US
237519284$23751928$4$F$$20240722$20240417$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059384$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240730$$CN$US$US
237519372$23751937$2$F$$20240802$20240417$20240812$EXP$$DE-TEVA-VS-3183250$TEVA$$$$$M$Y$$$20240812$$CN$DE$DE
237519512$23751951$2$F$20240301$20240902$20240417$20240905$EXP$$UY-ABBVIE-5719154$ABBVIE$$58$YR$$F$Y$$$20240905$$CN$UY$UY
237519853$23751985$3$F$20240101$20240722$20240417$20240725$PER$$US-PFIZER INC-PV202400048671$PFIZER$$58$YR$$F$Y$$$20240725$$HP$US$US
237519878$23751987$8$F$20240401$20240925$20240417$20240927$PER$$US-PFIZER INC-PV202400041800$PFIZER$$27$YR$$F$Y$$$20240927$$HP$US$US
237520012$23752001$2$F$$20240717$20240417$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059056$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240717$$CN$US$US
237520113$23752011$3$F$$20240613$20240417$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001492$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
237520332$23752033$2$F$20240101$20240708$20240417$20240715$PER$$US-SA-2024SA110732$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240715$$MD$US$US
237520412$23752041$2$F$20240101$20240722$20240417$20240730$PER$$US-SA-2024SA109640$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240730$$MD$US$US
237520432$23752043$2$F$20240301$20240805$20240417$20240813$PER$$US-SA-2024SA112080$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240814$$MD$US$US
237520472$23752047$2$F$20240301$20240722$20240417$20240730$PER$$US-SA-2024SA109751$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240730$$MD$US$US
237520542$23752054$2$F$$20240830$20240417$20240923$PER$$US-SA-2024SA112190$SANOFI AVENTIS$$$$T$M$Y$$$20240923$$MD$US$US
237520562$23752056$2$F$$20240809$20240417$20240826$PER$$US-SA-2024SA110831$SANOFI AVENTIS$$$$A$M$Y$82.5$KG$20240826$$MD$US$US
237520582$23752058$2$F$20230801$20240822$20240417$20240906$PER$$US-SA-2024SA111010$SANOFI AVENTIS$$$$E$M$Y$$$20240906$$MD$US$US
237520662$23752066$2$F$20240101$20240812$20240417$20240827$PER$$US-SA-2024SA112580$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
237520763$23752076$3$F$20240101$20240621$20240417$20240702$PER$$US-SA-2024SA113043$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240702$$MD$US$US
237520832$23752083$2$F$$20240719$20240417$20240728$PER$$US-SA-2024SA112471$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240728$$MD$US$US
237520882$23752088$2$F$$20240723$20240417$20240801$PER$$US-SA-2024SA112586$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240801$$MD$US$US
237520902$23752090$2$F$$20240711$20240417$20240801$PER$$US-SA-2024SA114119$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240719$$MD$US$US
237521102$23752110$2$F$20230801$20240701$20240417$20240716$PER$$US-SA-2024SA112612$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240716$$MD$US$US
237521143$23752114$3$F$$20240906$20240417$20240917$PER$$US-SA-2024SA112630$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240918$$MD$US$US
237521303$23752130$3$F$20240703$20240820$20240417$20240904$PER$$US-SA-2024SA086121$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240904$$MD$US$US
237521362$23752136$2$F$$20240625$20240417$20240704$PER$$US-SA-2024SA111454$SANOFI AVENTIS$$$$E$F$Y$$$20240704$$MD$US$US
237521382$23752138$2$F$$20240717$20240417$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058435$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240717$$CN$US$US
237521502$23752150$2$F$$20240722$20240417$20240731$PER$$US-SA-2024SA111947$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240731$$MD$US$US
237521522$23752152$2$F$20240101$20240822$20240417$20240906$PER$$US-SA-2024SA112188$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240906$$MD$US$US
237521592$23752159$2$F$$20240719$20240417$20240731$PER$$US-SA-2024SA111211$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240731$$MD$US$US
237521802$23752180$2$F$20240408$20240809$20240417$20240820$PER$$US-SA-2024SA113775$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240820$$MD$US$US
237521883$23752188$3$F$20240101$20240917$20240417$20240923$PER$$US-SA-2024SA103851$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240923$$MD$US$US
237522072$23752207$2$F$20240101$20240702$20240417$20240711$PER$$US-SA-2024SA112509$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240711$$MD$US$US
237522124$23752212$4$F$20240101$20240909$20240417$20240917$PER$$US-SA-2024SA116482$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240918$$MD$US$US
237522337$23752233$7$F$20240322$20240826$20240417$20240830$EXP$$JP-ABBVIE-5721217$ABBVIE$$22$YR$$M$Y$63$KG$20240828$$MD$JP$JP
237522432$23752243$2$F$20230501$20240816$20240417$20240827$EXP$$JP-TAKEDA-2024TUS035979$TAKEDA$$57$YR$$F$Y$$$20240827$$MD$JP$JP
237522602$23752260$2$F$$20240718$20240417$20240724$EXP$$JP-ABBVIE-5721324$ABBVIE$$$$$$Y$$$20240724$$MD$JP$JP
237523284$23752328$4$F$20240101$20240807$20240417$20240816$PER$$US-SA-2024SA113579$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240816$$MD$US$US
237523385$23752338$5$F$20240401$20240903$20240417$20240906$30DAY$$US-PFIZER INC-202400080043$PFIZER$$11$YR$$F$Y$48.08$KG$20240906$$CN$US$US
237523394$23752339$4$F$$20240904$20240417$20240909$30DAY$$US-PFIZER INC-202400079023$PFIZER$$71$YR$$M$Y$$$20240909$$CN$US$US
237523502$23752350$2$F$20240101$20240728$20240417$20240802$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006110$JAZZ$$$$$M$Y$$$20240802$$CN$US$US
237523832$23752383$2$F$$20240708$20240417$20240714$EXP$FR-BAYER-2024A054181$FR-SANDOZ INC.-SDZ2024FR039802$SANDOZ$$$$$F$Y$$$20240714$$CN$FR$FR
237523852$23752385$2$F$$20240411$20240417$20240919$EXP$$CZ-MYLANLABS-2024M1033873$MYLAN$Kotas R. Erenumab in the successful treatment of migraine can alleviate comorbid depression. Remedia. 2024;34(1):54-56$$$$F$Y$$$20240919$$MD$CZ$CZ
237523882$23752388$2$F$20240410$20240903$20240417$20240916$EXP$$PT-ELI_LILLY_AND_COMPANY-PT202404007697$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$PT$PT
237524012$23752401$2$F$$20240716$20240417$20240717$EXP$$US-INCYTE CORPORATION-2024IN003815$INCYTE$$$$$$Y$$$20240717$$CN$US$US
237524142$23752414$2$F$20240402$20240904$20240417$20240922$PER$$US-SA-2024SA113627$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240922$$MD$US$US
237524192$23752419$2$F$$20240627$20240417$20240702$EXP$$ZA-MYLANLABS-2024M1032341$MYLAN$$41$WK$$F$Y$2.8$KG$20240702$$HP$ZA$ZA
237524382$23752438$2$F$20231201$20240627$20240417$20240705$PER$$US-VERTEX PHARMACEUTICALS-2024-006414$VERTEX$$$$$F$Y$$$20240705$$CN$US$US
237524393$23752439$3$F$$20240815$20240417$20240820$EXP$$US-VERTEX PHARMACEUTICALS-2024-006470$VERTEX$$43$YR$$$Y$$$20240820$$CN$US$US
237524886$23752488$6$F$$20240714$20240417$20240715$30DAY$$US-PFIZER INC-202400080277$PFIZER$$5$YR$$M$Y$$$20240715$$CN$US$US
237524893$23752489$3$F$$20240802$20240417$20240809$30DAY$$US-PFIZER INC-202400080077$PFIZER$$10$YR$$F$Y$$$20240809$$CN$US$US
237524904$23752490$4$F$$20240903$20240417$20240905$30DAY$$US-PFIZER INC-202400080411$PFIZER$$11$YR$$F$Y$$$20240905$$CN$US$US
237525063$23752506$3$F$20240401$20240822$20240417$20240830$EXP$$US-ABBVIE-5722044$ABBVIE$$76$YR$$F$Y$$$20240829$$CN$US$US
237525112$23752511$2$F$$20240716$20240417$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-060034$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240717$$MD$JP$JP
237525122$23752512$2$F$20240101$20240701$20240417$20240708$EXP$$US-SA-2024SA116264$SANOFI AVENTIS$$42$YR$A$M$Y$95.25$KG$20240708$$MD$US$US
237525132$23752513$2$F$20230101$20240905$20240417$20240915$PER$$US-SA-2024SA112655$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240915$$MD$US$US
237525354$23752535$4$F$20240101$20240625$20240417$20240704$PER$$US-SA-2024SA111704$SANOFI AVENTIS$$54$YR$A$F$Y$78$KG$20240704$$MD$US$US
237525453$23752545$3$F$20240101$20240802$20240417$20240808$EXP$$US-OTSUKA-2024_010429$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
237525462$23752546$2$F$20240327$20240722$20240417$20240725$EXP$$GR-JNJFOC-20240434670$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240725$$MD$GR$GR
237525752$23752575$2$F$$20240717$20240417$20240724$EXP$$CA-JNJFOC-20231264348$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240724$$HP$CA$CA
237525944$23752594$4$F$20231101$20240703$20240417$20240708$EXP$$US-BIOGEN-2024BI01245051$BIOGEN$$54$YR$$F$Y$$$20240708$$CN$US$US
237525952$23752595$2$F$20240701$20240722$20240417$20240731$PER$$US-SA-2024SA112412$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240731$$MD$US$US
237525992$23752599$2$F$$20240628$20240417$20240701$PER$$NVSC2024US081313$NOVARTIS$$$$$M$Y$$$20240701$$HP$US$US
237526104$23752610$4$F$$20240905$20240417$20240909$30DAY$$US-PFIZER INC-202400080419$PFIZER$$14$YR$$M$Y$48.526$KG$20240909$$CN$US$US
237526115$23752611$5$F$20240309$20240909$20240417$20240912$30DAY$$US-PFIZER INC-202400080121$PFIZER$$15$YR$$F$Y$$$20240912$$CN$US$US
237526125$23752612$5$F$$20240903$20240417$20240905$30DAY$$US-PFIZER INC-202400080243$PFIZER$$14$YR$$M$Y$45.359$KG$20240905$$CN$US$US
237526144$23752614$4$F$$20240905$20240417$20240909$30DAY$$US-PFIZER INC-202400073106$PFIZER$$37$YR$$F$Y$49.9$KG$20240909$$MD$US$US
237526153$23752615$3$F$$20240903$20240417$20240904$30DAY$$US-PFIZER INC-202400079869$PFIZER$$15$YR$$M$Y$$$20240904$$CN$US$US
237526634$23752663$4$F$20240301$20240708$20240417$20240713$EXP$$US-SA-2024SA114274$SANOFI AVENTIS$$63$YR$A$M$Y$95.25$KG$20240713$$MD$US$US
237526789$23752678$9$F$20240411$20240808$20240417$20240813$PER$$US-PFIZER INC-PV202400049793$PFIZER$$62$YR$$F$Y$$$20240813$$HP$US$US
237527075$23752707$5$F$20240101$20240904$20240417$20240913$PER$$US-SA-2024SA111089$SANOFI AVENTIS$$41$YR$A$M$Y$81.6$KG$20240913$$MD$US$US
237527114$23752711$4$F$$20240708$20240417$20240715$EXP$$BR-JNJFOC-20240428914$JOHNSON AND JOHNSON$$59$YR$A$F$Y$67$KG$20240715$$MD$BR$BR
237527124$23752712$4$F$$20240909$20240417$20240912$EXP$$CA-BAUSCH-BL-2024-005692$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240912$$HP$CA$CA
237527205$23752720$5$F$$20240821$20240417$20240823$PER$$US-BIOVITRUM-CTI2023US04169$BIOVITRUM$$70$YR$$M$Y$$$20240823$$CN$US$US
237527216$23752721$6$F$$20240823$20240417$20240827$EXP$$US-BIOVITRUM-2024-US-005849$BIOVITRUM$$67$YR$$M$Y$$$20240827$$CN$US$US
237527224$23752722$4$F$20240101$20240909$20240417$20240911$PER$$US-BIOVITRUM-2024-US-005846$BIOVITRUM$$77$YR$$M$Y$$$20240911$$CN$US$US
237527285$23752728$5$F$20240101$20240718$20240417$20240731$PER$$US-SA-2024SA112613$SANOFI AVENTIS$$56$YR$A$M$Y$77$KG$20240731$$MD$US$US
237527482$23752748$2$F$$20240708$20240417$20240712$EXP$$FR-SANDOZ INC.-SDZ2024FR039737$SANDOZ$$$$$F$Y$$$20240712$$CN$FR$FR
237527774$23752777$4$F$20240101$20240805$20240417$20240814$EXP$$GB-GALDERMA-GB2024006115$GALDERMA$$$$$$Y$$$20240814$$CN$GB$GB
237527785$23752778$5$F$$20240716$20240417$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059903$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240717$$CN$US$US
237528024$23752802$4$F$20231107$20240826$20240417$20240903$EXP$$US-OTSUKA-2024_005470$OTSUKA$$39$YR$$F$Y$54.42$KG$20240903$$MD$US$US
237528112$23752811$2$F$20240408$20240730$20240417$20240808$PER$$US-SA-2024SA115116$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240808$$MD$US$US
237528133$23752813$3$F$$20240910$20240417$20240911$EXP$$US-TAKEDA-2024TUS035035$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
237528332$23752833$2$F$$20240828$20240417$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA039201$SANDOZ$$57$YR$$M$Y$$$20240829$$HP$CA$CA
237528376$23752837$6$F$$20240903$20240417$20240905$30DAY$$US-PFIZER INC-202400081392$PFIZER$$12$YR$$F$Y$46.27$KG$20240905$$CN$US$US
237528384$23752838$4$F$$20240905$20240417$20240910$30DAY$$US-PFIZER INC-202400081395$PFIZER$$16$YR$$M$Y$$$20240910$$CN$US$US
237528394$23752839$4$F$$20240724$20240417$20240725$30DAY$$US-PFIZER INC-202400081405$PFIZER$$13$YR$$M$Y$$$20240725$$CN$US$US
237528406$23752840$6$F$20240201$20240905$20240417$20240906$30DAY$$US-PFIZER INC-202400081162$PFIZER$$12$YR$$F$Y$47.166$KG$20240906$$CN$US$US
237528413$23752841$3$F$20240403$20240902$20240417$20240904$30DAY$$US-PFIZER INC-202400079800$PFIZER$$14$YR$$M$Y$$$20240904$$CN$US$US
237528426$23752842$6$F$$20240906$20240417$20240911$30DAY$$US-PFIZER INC-202400080020$PFIZER$$10$YR$$F$Y$$$20240911$$CN$US$US
237528435$23752843$5$F$20240401$20240903$20240417$20240905$30DAY$$US-PFIZER INC-202400081180$PFIZER$$16$YR$$M$Y$$$20240905$$CN$US$US
237528862$23752886$2$F$20220213$20240410$20240417$20240930$EXP$$US-TPU-TPU-2024-00141$TEIKOKU$$87$YR$E$M$Y$$$20240930$$CN$US$US
237529153$23752915$3$F$20240101$20240821$20240417$20240823$EXP$$CA-PFIZER INC-202400053050$PFIZER$$88$YR$$F$Y$$$20240823$$CN$CA$CA
237529203$23752920$3$F$$20240828$20240417$20240902$EXP$$CA-PFIZER INC-202400087821$PFIZER$$62$YR$$M$Y$$$20240902$$HP$CA$CA
237529233$23752923$3$F$20230818$20240902$20240417$20240905$EXP$$ES-PFIZER INC-202400085764$PFIZER$$71$YR$$M$Y$81.6$KG$20240905$$MD$ES$ES
237529413$23752941$3$F$20220101$20240801$20240417$20240805$EXP$$US-PFIZER INC-PV202400049915$PFIZER$$72$YR$$M$Y$$$20240805$$HP$US$US
237529592$23752959$2$F$20240101$20240718$20240417$20240725$EXP$$US-ABBVIE-5722470$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
237529822$23752982$2$F$$20240717$20240417$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053802$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240717$$MD$US$US
237530012$23753001$2$F$20230508$20240801$20240417$20240801$EXP$$DE-SANDOZ INC.-SDZ2024DE039610$SANDOZ$$34$YR$$F$Y$$$20240801$$CN$DE$DE
237530172$23753017$2$F$$20240722$20240417$20240727$PER$$US-SA-2024SA114256$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240727$$MD$US$US
237530192$23753019$2$F$20240101$20240724$20240417$20240801$PER$$US-SA-2024SA112560$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240801$$MD$US$US
237530266$23753026$6$F$20240410$20240916$20240417$20240925$EXP$$CA-TAKEDA-2023TUS086210$TAKEDA$$40$YR$$M$Y$$$20240925$$HP$CA$CA
237530432$23753043$2$F$20230514$20240813$20240417$20240816$EXP$$PR-ABBVIE-5722331$ABBVIE$$64$YR$$F$Y$93$KG$20240816$$CN$PR$PR
237530473$23753047$3$F$20240406$20240902$20240417$20240902$EXP$$IT-ALXN-202404EEA000741IT$ALEXION PHARMACEUTICALS$$31$YR$$F$Y$47$KG$20240902$$MD$IT$IT
237530882$23753088$2$F$20240320$20240719$20240417$20240726$PER$$US-BIOVITRUM-2024-US-005792$BIOVITRUM$$6$YR$$M$Y$$$20240726$$HP$US$US
237531023$23753102$3$F$$20240723$20240417$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059902$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240725$$CN$US$US
237531623$23753162$3$F$$20240906$20240417$20240911$EXP$$CA-TAKEDA-2024TUS036130$TAKEDA$$$$$F$Y$$$20240911$$CN$CA$CA
237531727$23753172$7$F$20231114$20240718$20240417$20240723$EXP$$JP-ALXN-202404JPN001087JP$ALEXION PHARMACEUTICALS$$47$YR$$M$Y$44.9$KG$20240723$$MD$JP$JP
237531794$23753179$4$F$$20240621$20240417$20240701$EXP$$CA-TAKEDA-2024TUS035568$TAKEDA$$$$$M$Y$$$20240701$$CN$CA$CA
237532312$23753231$2$F$$20240718$20240417$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202404006801$ELI LILLY AND CO$$30$YR$A$F$Y$60$KG$20240725$$CN$US$US
237532333$23753233$3$F$$20240715$20240417$20240715$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-057609$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240715$$MD$CZ$CZ
237532396$23753239$6$F$20240101$20240828$20240417$20240926$PER$$US-SA-2024SA113546$SANOFI AVENTIS$$47$YR$A$F$Y$113.39$KG$20240926$$MD$US$US
237533282$23753328$2$F$20240326$20240715$20240417$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057822$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240715$$CN$US$US
237534033$23753403$3$F$20220211$20240905$20240417$20240909$EXP$$CA-PFIZER INC-202101721601$PFIZER$$75$YR$$F$Y$$$20240909$$MD$CA$CA
237534192$23753419$2$F$20100101$20240710$20240417$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202404004274$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240719$$MD$US$US
237534374$23753437$4$F$$20240731$20240417$20240806$PER$$NVSC2024US081307$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
237534432$23753443$2$F$$20240711$20240417$20240716$PER$$US-PFIZER INC-202400086565$PFIZER$$54$YR$$F$Y$$$20240716$$HP$US$US
237534508$23753450$8$F$20240410$20240822$20240417$20240828$EXP$$CO-TAKEDA-2023TUS033288$TAKEDA$$45$YR$$F$Y$100$KG$20240828$$CN$CO$CO
237534742$23753474$2$F$20231011$20240406$20240417$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202404004990$ELI LILLY AND CO$$$$T$F$Y$$$20240828$$CN$US$US
237534936$23753493$6$F$20240322$20240708$20240417$20240712$EXP$$ES-PFIZER INC-202400085763$PFIZER$$58$YR$$F$Y$63.1$KG$20240712$$MD$ES$ES
237534942$23753494$2$F$20230306$20240409$20240417$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-139350$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$75.4$KG$20240807$$MD$JP$JP
237534952$23753495$2$F$20240101$20240709$20240417$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060176$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240712$$CN$US$US
237535142$23753514$2$F$20240101$20240624$20240417$20240703$PER$$US-SA-2024SA115089$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240703$$MD$US$US
237535199$23753519$9$F$20230218$20240917$20240417$20240920$EXP$$NVSC2024BR060629$NOVARTIS$$63$YR$$F$Y$62$KG$20240920$$HP$BR$BR
237535242$23753524$2$F$$20240705$20240417$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-056606$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240709$$CN$US$US
237535502$23753550$2$F$$20240726$20240417$20240730$30DAY$$US-SANDOZ INC.-SDZ2024US039690$SANDOZ$$$$$F$Y$$$20240730$$HP$US$US
237535892$23753589$2$F$20240311$20240418$20240417$20240906$EXP$$US-FARMAPROD-202403-0870$DOMPE FARMACEUTICI$$86$YR$E$F$Y$$$20240904$$CN$US$
237536712$23753671$2$F$20240101$20240724$20240417$20240801$PER$$US-SA-2024SA112403$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240801$$MD$US$US
237536754$23753675$4$F$$20240820$20240417$20240823$PER$$NVSC2024US081569$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
237537132$23753713$2$F$$20240718$20240417$20240802$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441673$RANBAXY$Neacsu OI, Ciobanu A, Nanea IT. Unusual etiology of pulmonary hypertension. Pol Arch Med Wewn. 2022;132 (Suppl.):19-20$43$YR$$M$Y$$$20240802$$HP$RO$RO
237537292$23753729$2$F$$20240703$20240417$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441657$RANBAXY$Colijn MA, Carrion P, Poirier-Morency G, Rogic S, Torres I, Menon M, et al. SETD1A variant-associated psychosis: A systematic review of the clinical literature and description of two new cases. Prog Neuropsychopharmacol Biol Psychiatry. 2024;129:110888(1-11)$33$YR$$M$Y$$$20240718$$HP$CA$CA
237537362$23753736$2$F$$20240912$20240417$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441600$RANBAXY$Bahamonde JR. Membranous Nephropathy during treatment of Rheumatoid Arthritis with Adalimumab. Kidney Int Rep. 2024;9 (Suppl.) (4):S148-S149$52$YR$$F$Y$$$20240927$$HP$US$US
237537592$23753759$2$F$$20240403$20240417$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441464$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
237537602$23753760$2$F$$20240729$20240417$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441547$RANBAXY$Amezquita JALA, Becerra-Gonzales VG, Martinez MAV, Iskander M, Quintero-Martinez JA, Rojas IAM, et all. FROM GAINS TO STRAINS: A CASE OF ANABOLIC STEROID INDUCED MYOCARDITIS. J Am Coll Cardiol. 2024;83 (s)(13):4351$29$YR$$M$Y$$$20240813$$HP$US$US
237537732$23753773$2$F$$20240718$20240417$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060343$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$74.39$KG$20240722$$CN$US$US
237538002$23753800$2$F$$20240815$20240417$20240821$PER$$JP-Eisai-EC-2024-163613$EISAI$Tamayama Mito. A case of hypothyroidism and isolated ACTH deficiency after pembrolizumab administration. The 243rd Kinki Regional Meeting of the Japanese Society of Internal Medicine (Abstracts) The 243rd Kinki Regional Meeting of the Japanese Society of Internal Medicine (Hybrid Meeting) Conference Abstracts Case Reports (ICSR included). 2024; -(-): 164-.$70$YR$E$F$Y$$$20240821$$MD$JP$JP
237538172$23753817$2$F$20240301$20240903$20240417$20240911$EXP$$JP-Eisai-EC-2024-163965$EISAI$$81$YR$E$M$Y$$$20240911$$MD$JP$JP
237538534$23753853$4$F$20231218$20240730$20240417$20240813$EXP$$CA-HLS-202401004$HLS THERAPEUTICS$$21$YR$A$M$Y$118$KG$20240813$$MD$CA$CA
237539192$23753919$2$F$$20240722$20240417$20240805$EXP$$CA-HLS-202400961$HLS THERAPEUTICS$$60$YR$A$M$Y$$$20240805$$HP$CA$CA
237539422$23753942$2$F$$20240318$20240417$20240822$30DAY$$US-Amphastar Pharmaceuticals, Inc.-2155702$AMPHASTAR$$$$$$Y$$$20240822$$$US$US
237539683$23753968$3$F$$20240709$20240417$20240710$PER$$US-ALXN-202404USA000856US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
237539712$23753971$2$F$$20240702$20240417$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202404011597$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
237540192$23754019$2$F$$20240708$20240417$20240721$EXP$GR-STADA-01222341$GR-STRIDES ARCOLAB LIMITED-2024SP004268$STRIDES$Lianou I, Mousafeiris V, Ntourantonis D, Baikousis A, Repantis Th.. Pathological fractures of lower extremities in a patient with psoriasis treated with anti-TNF-A factor. Case presentation, clinical assessment and treatment.. 79th Congress of the Hellenic Association of Orthopaedic Surgery and Traumatolog. 2023;04-07$62$YR$$F$Y$$$20240719$$MD$GR$GR
237540223$23754022$3$F$20230330$20240626$20240417$20240702$EXP$$NVSJ2024JP004569$NOVARTIS$$69$YR$$F$Y$$$20240703$$MD$JP$JP
237540544$23754054$4$F$20240101$20240815$20240417$20240822$EXP$$US-SA-2024SA113909$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240822$$MD$US$US
237540594$23754059$4$F$20240301$20240722$20240417$20240729$EXP$$JP-009507513-2404JPN001682J$MERCK$$77$YR$$M$Y$$$20240729$$MD$JP$JP
237540842$23754084$2$F$$20240823$20240417$20240823$PER$$NVSC2024US081309$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
237541422$23754142$2$F$$20240906$20240417$20240909$EXP$$NVSJ2024JP004732$NOVARTIS$$$$$F$Y$$$20240910$$MD$JP$JP
237541692$23754169$2$F$$20240721$20240417$20240729$PER$$US-SA-2024SA112584$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240729$$MD$US$US
237541723$23754172$3$F$$20240718$20240417$20240829$PER$$US-LUNDBECK-DKLU3076249$LUNDBECK$$$$$$Y$$$20240829$$CN$US$US
237541796$23754179$6$F$20230530$20240904$20240417$20240913$EXP$$JP-ASTELLAS-2024JP002557$ASTELLAS$$66$YR$E$M$Y$84$KG$20240913$$MD$JP$JP
237541825$23754182$5$F$20240401$20240705$20240417$20240820$PER$$US-LUNDBECK-DKLU3076282$LUNDBECK$$$$$$Y$$$20240820$$HP$US$US
237541852$23754185$2$F$$20240722$20240417$20240809$PER$$US-TEVA-VS-3178405$TEVA$$$$$F$Y$$$20240809$$HP$US$US
237541964$23754196$4$F$$20240627$20240417$20240705$EXP$$US-TAKEDA-2024TUS029940$TAKEDA$$$$$F$Y$$$20240705$$CN$US$US
237541976$23754197$6$F$20240101$20240726$20240417$20240802$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011068$UNITED THERAPEUTICS$$$$$F$Y$61.224$KG$20240802$$$US$US
237542256$23754225$6$F$20240426$20240701$20240417$20240704$EXP$$US-TAKEDA-2014BAX029315$TAKEDA$$32$YR$$F$Y$41.723$KG$20240704$$HP$US$US
237542309$23754230$9$F$20240201$20240823$20240417$20240827$EXP$$DE-JNJFOC-20240222351$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240827$$HP$DE$DE
237542333$23754233$3$F$20240331$20240912$20240418$20240920$EXP$$KR-ABBVIE-5722019$ABBVIE$$56$YR$$F$Y$49$KG$20240920$$MD$KR$KR
237542474$23754247$4$F$20240401$20240830$20240418$20240909$EXP$$CA-ABBVIE-5722789$ABBVIE$$62$YR$$F$Y$$$20240909$$HP$CA$CA
237542753$23754275$3$F$20231201$20240716$20240418$20240716$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-060153$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240716$$MD$JP$JP
237542762$23754276$2$F$$20240717$20240418$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059765$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240717$$CN$US$US
237542823$23754282$3$F$20240101$20240923$20240418$20240927$PER$$US-SA-2024SA112009$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240927$$MD$US$US
237542962$23754296$2$F$$20240717$20240418$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059059$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240717$$HP$US$US
237542995$23754299$5$F$$20240819$20240418$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057605$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240827$$CN$US$US
237543002$23754300$2$F$$20240724$20240418$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US039668$SANDOZ$$$$$M$Y$$$20240729$$CN$US$US
237543243$23754324$3$F$$20240725$20240418$20240803$PER$$US-SA-2024SA114500$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240803$$HP$US$US
237543342$23754334$2$F$20240323$20240914$20240418$20240916$EXP$$ES-BAUSCH-BL-2024-006069$BAUSCH AND LOMB$$68$YR$$M$Y$74.4$KG$20240916$$MD$ES$ES
237543463$23754346$3$F$20240201$20240704$20240418$20240716$EXP$$CO-JNJFOC-20240229126$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20240716$$HP$CO$CO
237543502$23754350$2$F$$20240823$20240418$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001447$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
237544132$23754413$2$F$$20240812$20240418$20240822$EXP$CA-HEALTHCANVIG-E2B_06917441$CA-NOVOPROD-1204140$NOVO NORDISK$$10$YR$$F$Y$48$KG$20240822$$HP$CA$CA
237544284$23754428$4$F$$20240812$20240418$20240822$EXP$CA-HEALTHCANVIG-E2B_05260683$CA-NOVOPROD-1204368$NOVO NORDISK$$55$YR$$F$Y$107$KG$20240822$$HP$CA$CA
237544466$23754446$6$F$20240501$20240712$20240418$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060492$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240719$$CN$US$US
237544714$23754471$4$F$$20240910$20240418$20240917$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000789$BLUEPRINT MEDICINES$$$$$M$Y$$$20240917$$CN$US$US
237544742$23754474$2$F$$20240913$20240418$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000788$BLUEPRINT MEDICINES$$$$$F$Y$$$20240920$$CN$US$US
237544842$23754484$2$F$20221201$20240903$20240418$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE039880$SANDOZ$$$$A$F$Y$$$20240905$$MD$DE$DE
237544893$23754489$3$F$20240415$20240727$20240418$20240730$PER$$US-AMGEN-USASP2024076339$AMGEN$$65$YR$E$M$Y$$$20240730$$CN$US$US
237544942$23754494$2$F$20240314$20240809$20240418$20240815$EXP$$JP-009507513-2404JPN001518J$MERCK$$6$DEC$$F$Y$$$20240815$$MD$JP$JP
237545103$23754510$3$F$20240412$20240712$20240418$20240717$EXP$$NVSC2024US078776$NOVARTIS$$56$YR$$F$Y$$$20240717$$CN$US$US
237545162$23754516$2$F$$20240408$20240418$20240722$EXP$$IL-Y-MABS THERAPEUTICS, INC.-SPO2024-IL-001541$Y-MABS THERAPEUTICS$$$$$$Y$$$20240722$$MD$IL$IL
237545182$23754518$2$F$$20240830$20240418$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202404010767$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240905$$MD$US$US
237545212$23754521$2$F$20240501$20240628$20240418$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202404011091$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240702$$CN$US$US
237545402$23754540$2$F$20240414$20240731$20240418$20240803$PER$$US-AMGEN-USASP2024076300$AMGEN$$76$YR$E$F$Y$$$20240802$$CN$US$US
237545472$23754547$2$F$20240401$20240708$20240418$20240716$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-059339$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240716$$MD$JP$JP
237545962$23754596$2$F$$20240805$20240418$20240816$EXP$$FR-SANDOZ INC.-PHHY2014FR157878$SANDOZ$$58$YR$$F$Y$$$20240816$$MD$FR$FR
237546172$23754617$2$F$20240105$20240726$20240418$20240809$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-442830$RANBAXY$$67$YR$$M$Y$$$20240809$$MD$DE$DE
237546442$23754644$2$F$$20240708$20240418$20240710$EXP$FR-BAYER-2024A054169$FR-SANDOZ INC.-SDZ2024FR040019$SANDOZ$$$$$F$Y$$$20240710$$CN$FR$FR
237546513$23754651$3$F$20240903$20240903$20240418$20240909$EXP$$US-TAKEDA-2024TUS024299$TAKEDA$$44$YR$$F$Y$$$20240909$$CN$US$US
237546532$23754653$2$F$$20240731$20240418$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-017112$AUROBINDO$Belnavis G, Goyal A, Boudoulas KD, Breckenridge MB. A CASE OF MYOCARDIAL INFARCTION IN A YOUNG BODYBUILDER ON TESTOSTERONE. Journal of the American College of Cardiology. 2024;83(13); supp. A:3294$33$YR$$M$Y$$$20240813$$MD$US$US
237546553$23754655$3$F$$20240813$20240418$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-016886$AUROBINDO$Marof BZ, Saado J, Lee K, Groner A, May TP. A CASE OF USE DEPENDENCE EFFECT AND TOXICITY OF FLECAINIDE DUE TO PACEMAKER TRACKED ATRIAL TACHYCARDIA, RENAL FAILURE, AND HYPONATREMIA. Journal of the American College of Cardiology. 2024;83(13):2892$76$YR$$F$Y$$$20240827$$MD$US$US
237546692$23754669$2$F$$20240805$20240418$20240816$EXP$$US-AUROBINDO-AUR-APL-2024-017125$AUROBINDO$Spitz A, Shi H, Panjawatanan P, Skarda C, Shahsavari S, Welch T, et al. LATE-ONSET AMIODARONE-INDUCED THYROTOXICOSIS (AIT) CAUSING RECURRENT HEART FAILURE WITH REDUCED EJECTION FRACTION. Journal of the American College of Cardiology. 2024;83(13):3182$58$YR$$M$Y$$$20240816$$MD$US$US
237546933$23754693$3$F$20220101$20240708$20240418$20240715$EXP$$CA-TAKEDA-2022TUS017512$TAKEDA$$$$$M$Y$59$KG$20240715$$HP$CA$CA
237547194$23754719$4$F$$20240812$20240418$20240816$PER$$NVSC2024US081691$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
237547383$23754738$3$F$$20240627$20240418$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03088$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237547422$23754742$2$F$20240415$20240730$20240418$20240805$PER$$US-AMGEN-USASP2024076385$AMGEN$$72$YR$E$F$Y$$$20240804$$CN$US$US
237547452$23754745$2$F$$20240723$20240418$20240725$EXP$$US-JNJFOC-20240434970$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$CN$US$US
237547483$23754748$3$F$$20240726$20240418$20240806$EXP$$US-ROCHE-3544192$ROCHE$$82$YR$E$F$Y$$$20240806$$CN$US$US
237547522$23754752$2$F$$20240626$20240418$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03090$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237548082$23754808$2$F$$20240716$20240418$20240718$EXP$$US-JNJFOC-20240434626$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
237548143$23754814$3$F$20220503$20240814$20240418$20240821$EXP$$CA-CELLTRION INC.-2022CA005785$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
237548332$23754833$2$F$20240105$20240716$20240418$20240717$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-043633$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$85$KG$20240717$$MD$DE$DE
237548432$23754843$2$F$20240414$20240806$20240418$20240808$PER$$US-AMGEN-USASP2024076295$AMGEN$$60$YR$A$M$Y$$$20240808$$MD$US$US
237548562$23754856$2$F$20240301$20240806$20240418$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058816$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$55.34$KG$20240809$$CN$US$US
237548595$23754859$5$F$$20240705$20240418$20240710$EXP$$CA-JNJFOC-20240436710$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240710$$HP$CA$CA
237548783$23754878$3$F$20240405$20240630$20240418$20240709$EXP$$CA-CELLTRION INC.-2024CA008997$CELLTRION$$$$$$Y$$$20240709$$HP$CA$CA
237548792$23754879$2$F$20240415$20240717$20240418$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-060359$BRISTOL MYERS SQUIBB$$65$YR$E$$Y$$$20240717$$PH$JP$JP
237548803$23754880$3$F$$20240719$20240418$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-057661$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240723$$MD$JP$JP
237548822$23754882$2$F$$20240820$20240418$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060788$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240826$$HP$US$US
237549262$23754926$2$F$$20240715$20240418$20240717$30DAY$$US-SANDOZ INC.-SDZ2024US040298$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
2375493211$23754932$11$F$20240101$20240917$20240418$20240926$EXP$$CA-UCBSA-2024018772$UCB$$$$$M$Y$$$20240926$$CN$CA$CA
237549382$23754938$2$F$20240101$20240707$20240418$20240712$EXP$$CL-SANDOZ INC.-SDZ2024CL040131$SANDOZ$$34$YR$$M$Y$$$20240712$$CN$CL$CL
237549412$23754941$2$F$20240414$20240816$20240418$20240821$PER$$US-AMGEN-USASP2024076265$AMGEN$$30$YR$A$F$Y$$$20240820$$CN$US$US
237549772$23754977$2$F$20240411$20240718$20240418$20240720$PER$$US-AMGEN-USASP2024076216$AMGEN$$71$YR$E$M$Y$$$20240720$$CN$US$US
237550232$23755023$2$F$20240412$20240822$20240418$20240829$EXP$$IN-GSK-IN2024APC047780$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$IN$IN
237550312$23755031$2$F$$20240716$20240418$20240716$EXP$$IN-BRISTOL-MYERS SQUIBB COMPANY-2024-059955$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240716$$MD$IN$IN
237550516$23755051$6$F$20240101$20240729$20240418$20240731$EXP$$US-UCBSA-2024009152$UCB$$$$$F$Y$$$20240731$$CN$US$US
237550522$23755052$2$F$$20240708$20240418$20240710$EXP$FR-BAYER-2024A054165$FR-SANDOZ INC.-SDZ2024FR040053$SANDOZ$$$$$F$Y$$$20240710$$CN$FR$FR
237550532$23755053$2$F$20240406$20240717$20240418$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060494$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240717$$CN$US$US
237550645$23755064$5$F$$20240801$20240418$20240805$30DAY$$GB-SANDOZ INC.-SDZ2024GB040246$SANDOZ$$$$$M$Y$$$20240805$$CN$GB$GB
237550673$23755067$3$F$$20240801$20240418$20240807$EXP$$US-GSK-US2024AMR046469$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
237550812$23755081$2$F$$20240701$20240418$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03082$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237551042$23755104$2$F$$20240627$20240418$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03089$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237551082$23755108$2$F$20230616$20240828$20240418$20240904$EXP$$JP-ARGENX-2024-ARGX-JP000526AA$ARGENX BVBA$Kawama K, Warabi Y, Bokuda K, Kimura H, Takahashi K. Exacerbation of Thymoma-Associated Myasthenia Gravis Following Efgartigimod Treatment Related to Anti-acetylcholine Receptor Antibody Overshoot: A Report of Two Cases. Cureus. 2023;15(12)$$$$$Y$$$20240904$$MD$JP$JP
237551172$23755117$2$F$$20240924$20240418$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060184$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$93.44$KG$20240926$$CN$US$US
237551652$23755165$2$F$$20240919$20240418$20240923$EXP$$CA-ORGANON-O2404CAN002114$ORGANON$$49$YR$$M$Y$$$20240923$$HP$CA$CA
237551662$23755166$2$F$20240412$20240724$20240418$20240730$PER$$US-AMGEN-USASP2024076177$AMGEN$$79$YR$E$F$Y$$$20240729$$CN$US$US
237551684$23755168$4$F$20240105$20240724$20240418$20240731$EXP$$BR-JNJFOC-20240169495$JOHNSON AND JOHNSON$$40$YR$A$F$Y$63$KG$20240801$$CN$BR$BR
237551906$23755190$6$F$20240416$20240729$20240418$20240807$EXP$$US-AMGEN-USASP2024077355$AMGEN$$63$YR$A$F$Y$$$20240807$$MD$US$US
237551983$23755198$3$F$20220501$20240415$20240418$20240722$EXP$$NVSC2024RU081789$NOVARTIS$$$$T$M$Y$$$20240722$$MD$RU$RU
237552162$23755216$2$F$20240101$20240729$20240418$20240808$EXP$FR-AFSSAPS-LM2024000180$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-105758$ZYDUS PHARM$$$$$$Y$$$20240808$$MD$FR$FR
237552886$23755288$6$F$20240119$20240903$20240418$20240911$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-06345$IPSEN$$5$YR$C$F$Y$15.42$KG$20240911$$CN$US$US
237553062$23755306$2$F$20240410$20240925$20240418$20240926$30DAY$$IT-SANDOZ INC.-SDZ2024IT040245$SANDOZ$$11$YR$$$Y$33$KG$20240926$$CN$IT$IT
237553342$23755334$2$F$20240415$20240731$20240418$20240802$PER$$US-AMGEN-USASP2024076110$AMGEN$$62$YR$A$M$Y$$$20240802$$CN$US$US
237553542$23755354$2$F$20240401$20240408$20240418$20240926$PER$$US-GSK-US2024AMR047536$GLAXOSMITHKLINE$$44$YR$$M$Y$$$20240926$$CN$US$US
237553572$23755357$2$F$$20240628$20240418$20240704$EXP$$JP-009507513-2404JPN001752J$MERCK$$6$DEC$$F$Y$$$20240704$$MD$JP$JP
237553635$23755363$5$F$$20240805$20240418$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060466$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240806$$CN$US$US
237553663$23755366$3$F$20240102$20240626$20240418$20240709$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-00491$SAMSUNG BIOEPIS$$47$YR$A$F$Y$88$KG$20240709$$HP$CA$CA
237553842$23755384$2$F$$20240410$20240418$20240719$EXP$$NL-BAUSCH-BL-2015-030710$BAUSCH AND LOMB$Van Tellingen V, Van Trotsenburg P. Obesity in ROHHADNET Syndrome: Does Cortisol Play a Role. Hormone Research in Paediatrics. 2015;84 (SUPPLEMENT 1):230.$10$YR$$F$Y$$$20240719$$MD$NL$NL
237553972$23755397$2$F$$20240919$20240418$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059227$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240925$$CN$US$US
237553982$23755398$2$F$$20240703$20240418$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060363$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240705$$CN$US$US
237554002$23755400$2$F$$20240717$20240418$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059692$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240717$$CN$US$US
237554152$23755415$2$F$20240331$20240717$20240418$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060868$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240717$$CN$US$US
237554232$23755423$2$F$$20240920$20240418$20240930$EXP$$GB-TAKEDA-2024TUS034728$TAKEDA$$$$$F$Y$$$20240930$$CN$GB$GB
237554392$23755439$2$F$20220801$20240414$20240418$20240805$EXP$$NVSC2024BR075486$NOVARTIS$$86$YR$$F$Y$76$KG$20240805$$CN$BR$BR
237554552$23755455$2$F$$20240716$20240418$20240717$PER$$US-JNJFOC-20240432227$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$PH$US$US
237554573$23755457$3$F$$20240805$20240418$20240809$PER$$US-ALXN-202404USA001046US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
237554615$23755461$5$F$20170101$20240802$20240418$20240822$EXP$$US-BEH-2024170452$CSL BEHRING$$61$YR$A$F$Y$38.095$KG$20240822$$HP$US$US
237554873$23755487$3$F$$20240909$20240418$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059772$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240915$$HP$US$US
237554883$23755488$3$F$$20240627$20240418$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03105$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237555012$23755501$2$F$$20240627$20240418$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03107$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237555113$23755511$3$F$20231101$20240723$20240418$20240805$EXP$$US-ENDO PHARMACEUTICALS INC-2024-001692$ENDO$$9$YR$$F$Y$51$KG$20240805$$MD$US$US
237555403$23755540$3$F$20240412$20240819$20240418$20240829$EXP$$JP-ASTELLAS-2024JP002498$ASTELLAS$$91$YR$E$F$Y$$$20240827$$PH$JP$JP
237555632$23755563$2$F$20231101$20240823$20240418$20240828$EXP$$CZ-JNJFOC-20240441623$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240828$$HP$CZ$CZ
237555665$23755566$5$F$$20240821$20240418$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03145$LUPIN$$$$$$Y$$$20240909$$CN$US$US
237555815$23755581$5$F$20240124$20240806$20240418$20240827$EXP$$CN-ASTELLAS-2024US011118$ASTELLAS$$62$YR$A$M$Y$$$20240821$$CN$CN$CN
237555852$23755585$2$F$20240415$20240728$20240418$20240730$PER$$US-AMGEN-USASP2024076220$AMGEN$$65$YR$E$F$Y$$$20240730$$CN$US$US
237555872$23755587$2$F$$20240627$20240418$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03106$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237555926$23755592$6$F$20230730$20240906$20240418$20240916$EXP$$US-Taiho Oncology Inc-2023-006346$TAIHO ONCOLOGY INC$$76$YR$E$F$Y$60.33$KG$20240916$$CN$US$US
237555996$23755599$6$F$20240701$20240814$20240418$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059530$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240816$$HP$US$US
237556222$23755622$2$F$$20240701$20240418$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03102$LUPIN$$$$$$Y$$$20240719$$CN$US$US
237556363$23755636$3$F$$20240912$20240418$20240922$EXP$$US-ASTELLAS-2024EU003573$ASTELLAS$$$$A$M$Y$$$20240923$$CN$US$US
237556803$23755680$3$F$20240316$20240828$20240418$20240907$EXP$$ZA-AUROBINDO-AUR-APL-2024-017477$AUROBINDO$$27$DY$$F$Y$5$KG$20240907$$MD$ZA$ZA
237556972$23755697$2$F$20240413$20240726$20240418$20240729$PER$$US-AMGEN-USASP2024076044$AMGEN$$61$YR$A$M$Y$$$20240729$$CN$US$US
237557024$23755702$4$F$$20240816$20240418$20240828$EXP$$CA-SANDOZ-SDZ2023CA019951$Haleon PLC$$82$YR$$F$Y$$$20240828$$MD$CA$CA
237557623$23755762$3$F$20240326$20240422$20240418$20240805$EXP$$NVSC2024RU068989$NOVARTIS$$46$YR$$M$Y$$$20240805$$CN$RU$RU
237557663$23755766$3$F$20240415$20240906$20240418$20240909$PER$$US-AMGEN-USASP2024076085$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
237558013$23755801$3$F$20231101$20240702$20240418$20240710$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010994$UNITED THERAPEUTICS$$63$YR$$F$Y$$$20240710$$$US$US
237558202$23755820$2$F$$20240712$20240418$20240717$EXP$$US-ASTELLAS-2024US011129$ASTELLAS$$$$$$Y$$$20240717$$CN$US$US
237558253$23755825$3$F$$20240606$20240418$20240927$EXP$US-ALVOGEN-2024094393$US-ALVOGEN-2024094393$ALVOGEN$$$$$$Y$$$20240927$$CN$US$US
237558545$23755854$5$F$$20240717$20240418$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061039$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240717$$CN$US$US
237558722$23755872$2$F$20240415$20240726$20240418$20240730$PER$$US-AMGEN-USASP2024076169$AMGEN$$45$YR$A$M$Y$$$20240730$$CN$US$US
237558742$23755874$2$F$20240101$20240702$20240418$20240708$EXP$$JP-DSJP-DSJ-2024-104198$DAIICHI$Kaneko N, Numata Y, Nogawa M, Satou K, Aoki S, Koshio J, et al. A-15 A case of interstitial lung disease due to Trastuzumab Deruxtecan (T-DXd) experienced at our hospital, The 92nd Joint Hokuriku Regional Meeting on Respiratory Organs, The 104th Japanese Society for Tuberculosis and Non-tuberculous Mycobacterial Infection, The 93rd Japanese Society for Respiratory Medicine, The 78th Japanese Society for Respiratory Endoscopy, The 63rd Japanese Society for Sarcoidosis and Granulomatous Diseases.$7$DEC$$F$Y$$$20240708$$HP$JP$JP
237559305$23755930$5$F$20240401$20240814$20240418$20240820$EXP$$JP-ABBVIE-5723613$ABBVIE$$64$YR$$F$Y$$$20240820$$MD$JP$JP
237559324$23755932$4$F$20240101$20240707$20240418$20240708$30DAY$$AR-PFIZER INC-202400078879$PFIZER$$9$YR$$F$Y$$$20240708$$CN$AR$AR
237559385$23755938$5$F$20240101$20240910$20240418$20240912$PER$$US-BIOGEN-2024BI01258392$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
237559522$23755952$2$F$$20240718$20240418$20240731$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK090146$GLENMARK$$$$$$Y$$$20240731$$HP$CA$CA
237560054$23756005$4$F$20240201$20240717$20240418$20240727$EXP$$CA-CELLTRION INC.-2024CA003079$CELLTRION$$$$$$Y$$$20240727$$MD$CA$CA
237560142$23756014$2$F$20240415$20240801$20240418$20240803$PER$$US-AMGEN-USASP2024076029$AMGEN$$60$YR$A$M$Y$$$20240803$$CN$US$US
237560192$23756019$2$F$$20240711$20240418$20240716$EXP$$US-ASTELLAS-2024US010992$ASTELLAS$$$$$M$Y$$$20240716$$CN$US$US
237560222$23756022$2$F$$20240821$20240418$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057633$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240904$$CN$US$US
237560485$23756048$5$F$20240501$20240718$20240418$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060867$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240723$$CN$US$US
237560572$23756057$2$F$$20240403$20240418$20240710$PER$$FR-ROCHE-3540572$ROCHE$$$$$F$Y$$$20240628$$MD$FR$FR
237560896$23756089$6$F$$20240916$20240418$20240919$30DAY$$CR-PFIZER INC-PV202400033529$PFIZER$$60$YR$$M$Y$$$20240919$$CN$CR$CR
237561133$23756113$3$F$20240301$20240730$20240418$20240806$EXP$$CA-JNJFOC-20240428197$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240806$$HP$CA$CA
237561292$23756129$2$F$20230101$20240716$20240418$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058995$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240717$$CN$US$US
237561524$23756152$4$F$20240531$20240909$20240418$20240912$EXP$$US-GSK-US2024AMR048347$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$US$US
237561606$23756160$6$F$$20240805$20240418$20240813$EXP$$JP-PFIZER INC-202400088539$PFIZER$Nakayama, R.. Polymorphic lymphoproliferative disorder arising in a rheumatoid arthritis patient, presenting as fibrin-associated large B-cell lymphoma-like lesions in aortic and mitral valves. Pathology international. 2024;1-7$60$YR$$F$Y$47$KG$20240813$$MD$JP$JP
237561982$23756198$2$F$20240101$20240626$20240418$20240701$EXP$$US-ABBVIE-5723882$ABBVIE$$67$YR$$M$Y$$$20240701$$CN$US$US
237562302$23756230$2$F$20240101$20240808$20240418$20240816$PER$$US-SA-2024SA113648$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240816$$MD$US$US
237562452$23756245$2$F$20240409$20240717$20240418$20240726$PER$$US-SA-2024SA111637$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240726$$MD$US$US
237562483$23756248$3$F$20240101$20240726$20240418$20240731$PER$$US-SA-2024SA114029$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240731$$MD$US$US
237562532$23756253$2$F$$20240724$20240418$20240802$PER$$US-SA-2024SA114043$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240802$$MD$US$US
237562572$23756257$2$F$20240101$20240701$20240418$20240710$PER$$US-SA-2024SA112212$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240710$$MD$US$US
237562752$23756275$2$F$20240701$20240806$20240418$20240816$PER$$US-SA-2024SA115219$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240816$$CN$US$US
237562984$23756298$4$F$$20240711$20240418$20240722$PER$$US-SA-2024SA113965$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240722$$MD$US$US
237562992$23756299$2$F$20240627$20240627$20240418$20240709$PER$$US-SA-2024SA112130$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240709$$HP$US$US
237563112$23756311$2$F$$20240722$20240418$20240730$PER$$US-SA-2024SA112404$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240730$$MD$US$US
237563212$23756321$2$F$20240702$20240715$20240418$20240722$PER$$US-SA-2024SA113532$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240723$$MD$US$US
237563403$23756340$3$F$20240101$20240819$20240418$20240828$PER$$US-SA-2024SA115081$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240828$$MD$US$US
237563563$23756356$3$F$20240201$20240827$20240418$20240911$PER$$US-SA-2024SA082655$SANOFI AVENTIS$$54$YR$A$M$Y$73.64$KG$20240911$$MD$US$US
237563662$23756366$2$F$20240401$20240911$20240418$20240928$PER$$US-SA-2024SA112465$SANOFI AVENTIS$$37$YR$A$F$Y$56.2$KG$20240928$$MD$US$US
237563862$23756386$2$F$20240408$20240913$20240418$20240923$PER$$US-SA-2024SA115068$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240923$$MD$US$US
237563882$23756388$2$F$20240701$20240711$20240418$20240722$PER$$US-SA-2024SA115508$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240720$$MD$US$US
237563913$23756391$3$F$$20240729$20240418$20240806$PER$$US-SA-2024SA115751$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240806$$MD$US$US
237564052$23756405$2$F$20240101$20240711$20240418$20240722$PER$$US-SA-2024SA115678$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240722$$MD$US$US
237564062$23756406$2$F$$20240911$20240418$20240923$EXP$$US-BEH-2024170767$CSL BEHRING$$41$YR$A$M$Y$$$20240923$$MD$US$US
237564442$23756444$2$F$$20240730$20240418$20240811$EXP$$US-AUROBINDO-AUR-APL-2024-016883$AUROBINDO$Afriyie F, Gilani N, Fanous M, Mansoor A, Shah K, Waller AH. CHASING THE HIGH TOWARDS DEATH. A CASE OF LOPERAMIDE INDUCED CARDIAC ARREST. Journal of the American College of Cardiology. 2024;83(13):2941$49$YR$$M$Y$$$20240812$$MD$US$US
237564542$23756454$2$F$20240101$20240823$20240418$20240827$PER$$US-AMGEN-USASP2024076279$AMGEN$$77$YR$E$M$Y$$$20240827$$CN$US$US
237564563$23756456$3$F$$20240702$20240418$20240708$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-002146$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$FR$FR
237564672$23756467$2$F$20230710$20240725$20240418$20240801$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2023CUR003152$CURRAX PHARMACEUTICALS$$53$YR$$M$Y$$$20240801$$CN$CA$CA
237564864$23756486$4$F$20240101$20240828$20240418$20240923$PER$$US-SA-2024SA113598$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240923$$MD$US$US
237564912$23756491$2$F$$20240828$20240418$20240923$PER$$US-SA-2024SA115053$SANOFI AVENTIS$$$$E$F$Y$81$KG$20240923$$MD$US$US
237564972$23756497$2$F$20240101$20240621$20240418$20240702$PER$$US-SA-2024SA114137$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240702$$MD$US$US
237565135$23756513$5$F$$20240717$20240418$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061269$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240717$$CN$US$US
237565152$23756515$2$F$20240101$20240802$20240418$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060403$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240806$$CN$US$US
237565672$23756567$2$F$20240317$20240624$20240418$20240704$EXP$$US-BEH-2024170712$CSL BEHRING$$56$YR$A$F$Y$$$20240704$$HP$US$US
237565732$23756573$2$F$20240415$20240731$20240418$20240802$PER$$US-AMGEN-USASP2024076288$AMGEN$$76$YR$E$F$Y$$$20240802$$CN$US$US
237565977$23756597$7$F$20240101$20240923$20240418$20240926$EXP$$US-KARYOPHARM-2024KPT000856$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240926$$CN$US$US
237566083$23756608$3$F$$20240807$20240418$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060913$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$58.97$KG$20240826$$CN$US$US
237566114$23756611$4$F$20240301$20240806$20240418$20240807$30DAY$$PR-PFIZER INC-202400074083$PFIZER$$10$YR$$F$Y$29.478$KG$20240807$$CN$PR$PR
237566162$23756616$2$F$20240101$20240430$20240418$20240909$PER$$US-KARYOPHARM-2024KPT000868$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240909$$CN$US$US
237566174$23756617$4$F$20240401$20240711$20240418$20240717$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400476$MYOVANT SCIENCES$$64$YR$$M$Y$$$20240717$$CN$US$US
237566223$23756622$3$F$20240218$20240625$20240418$20240701$EXP$$US-JNJFOC-20240430610$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$MD$US$US
237566272$23756627$2$F$20240301$20240807$20240418$20240814$PER$$US-SA-2024SA114816$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240814$$MD$US$US
237566694$23756669$4$F$$20240906$20240418$20240912$EXP$$CA-JNJFOC-20240429515$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240912$$HP$CA$CA
237566772$23756677$2$F$$20240708$20240418$20240711$EXP$$FR-SANDOZ INC.-SDZ2024FR040005$SANDOZ$$$$$F$Y$$$20240711$$CN$FR$FR
237566802$23756680$2$F$$20240710$20240418$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058266$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240712$$CN$US$US
237567092$23756709$2$F$$20240909$20240418$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404008857$ELI LILLY AND CO$$$$$M$Y$$$20240920$$CN$JP$JP
237567262$23756726$2$F$$20240701$20240418$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03157$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237567472$23756747$2$F$$20240701$20240418$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03127$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237567492$23756749$2$F$$20240701$20240418$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03128$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237567532$23756753$2$F$20240701$20240730$20240418$20240807$PER$$US-SA-2024SA114467$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240807$$MD$US$US
237567552$23756755$2$F$20240409$20240913$20240418$20240918$PER$$CA-BRACCO-2024CA01994$BRACCO$$71$YR$$F$Y$$$20240918$$HP$CA$CA
237567653$23756765$3$F$$20240919$20240418$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060849$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240920$$CN$US$US
237567663$23756766$3$F$$20240701$20240418$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03129$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237567812$23756781$2$F$20240201$20240828$20240418$20240903$EXP$FR-AFSSAPS-SE2024000273$FR-MYLANLABS-2024M1034295$MYLAN$$34$YR$$M$Y$$$20240903$$MD$FR$FR
237567982$23756798$2$F$$20240625$20240418$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03131$LUPIN$$$$$$Y$$$20240705$$CN$US$US
237568063$23756806$3$F$20240401$20240716$20240418$20240717$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-060014$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240717$$PH$TW$TW
237568085$23756808$5$F$20240101$20240814$20240418$20240821$EXP$$US-SA-2024SA116807$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240821$$CN$US$US
237568235$23756823$5$F$20240305$20240708$20240418$20240711$EXP$$PL-PFIZER INC-202400065353$PFIZER$$74$YR$$M$Y$80$KG$20240711$$MD$PL$PL
237568273$23756827$3$F$20240101$20240708$20240418$20240715$EXP$$US-SA-2023SA197841$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240715$$MD$US$US
237568323$23756832$3$F$20240404$20240902$20240418$20240909$EXP$$ES-FreseniusKabi-FK202406324$FRESENIUS KABI$$$$E$M$Y$81.6$KG$20240909$$MD$ES$ES
237568393$23756839$3$F$20170420$20240805$20240418$20240809$EXP$$PHHY2017CA061381$NOVARTIS$$33$YR$$M$Y$$$20240809$$CN$CA$CA
237568703$23756870$3$F$$20240730$20240418$20240802$PER$$US-ALXN-202404USA000981US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
237568742$23756874$2$F$20201125$20240806$20240418$20240809$EXP$$CA-TAKEDA-2024TUS036949$TAKEDA$$30$YR$$F$Y$$$20240809$$CN$CA$CA
237568753$23756875$3$F$$20240911$20240418$20240918$EXP$$CA-002147023-NVSC2023CA091867$Haleon PLC$$50$YR$$F$Y$68$KG$20240918$$HP$CA$CA
237568953$23756895$3$F$$20240806$20240418$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060971$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240808$$CN$US$US
237569102$23756910$2$F$20240323$20240706$20240418$20240729$PER$$CA-TOLMAR, INC.-24CA047967$TOLMAR$$62$YR$$M$Y$$$20240726$$CN$CA$CA
237569444$23756944$4$F$20240415$20240809$20240418$20240812$PER$$US-AMGEN-USASP2024076314$AMGEN$$56$YR$A$M$Y$99.773$KG$20240811$$MD$US$US
237569472$23756947$2$F$20240101$20240629$20240418$20240704$EXP$$US-SA-2024SA118332$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240704$$MD$US$US
237569512$23756951$2$F$20240101$20240718$20240418$20240728$PER$$US-SA-2024SA110937$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240728$$MD$US$US
237569554$23756955$4$F$20240101$20240722$20240418$20240727$EXP$$US-SA-2024SA117318$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240727$$MD$US$US
237569772$23756977$2$F$$20240728$20240418$20240729$EXP$$CL-PFIZER INC-PV202400050728$PFIZER$$9$YR$$M$Y$$$20240729$$CN$CL$CL
237569802$23756980$2$F$20210101$20240702$20240418$20240704$EXP$$GB-PFIZER INC-202400088799$PFIZER$$59$YR$$M$Y$$$20240704$$MD$GB$GB
237569824$23756982$4$F$$20240916$20240418$20240919$30DAY$$US-PFIZER INC-202400081373$PFIZER$$11$YR$$F$Y$$$20240919$$CN$US$US
237569974$23756997$4$F$$20240812$20240418$20240815$30DAY$$US-PFIZER INC-202400081396$PFIZER$$8$YR$$M$Y$40.82$KG$20240815$$HP$US$US
237569982$23756998$2$F$$20240904$20240418$20240906$PER$$US-PFIZER INC-PV202400050564$PFIZER$$74$YR$$F$Y$$$20240906$$CN$US$US
237569994$23756999$4$F$$20240919$20240418$20240924$30DAY$$US-PFIZER INC-202400081539$PFIZER$$10$YR$$M$Y$$$20240924$$CN$US$US
237570075$23757007$5$F$20240601$20240916$20240418$20240919$PER$$US-PFIZER INC-PV202400050628$PFIZER$$70$YR$$F$Y$99.773$KG$20240919$$CN$US$US
237570093$23757009$3$F$$20240806$20240418$20240808$30DAY$$US-PFIZER INC-202400080990$PFIZER$$14$YR$$F$Y$$$20240808$$CN$US$US
237570114$23757011$4$F$$20240809$20240418$20240816$30DAY$$US-PFIZER INC-202400081150$PFIZER$$14$YR$$M$Y$$$20240816$$CN$US$US
237570162$23757016$2$F$20220818$20240801$20240418$20240814$EXP$$ES-AUROBINDO-AUR-APL-2022-038859$AUROBINDO$$85$YR$$M$Y$61.7$KG$20240814$$MD$ES$ES
237570633$23757063$3$F$$20240813$20240418$20240816$PER$$US-PFIZER INC-202400017413$PFIZER$$17$YR$$F$Y$$$20240816$$CN$US$US
237570643$23757064$3$F$$20240802$20240418$20240807$PER$$US-PFIZER INC-PV202400047115$PFIZER$$73$YR$$$Y$$$20240807$$HP$US$US
237570792$23757079$2$F$$20240627$20240418$20240701$PER$$US-PFIZER INC-202300272017$PFIZER$$62$YR$$M$Y$88.45$KG$20240701$$CN$US$US
237571003$23757100$3$F$$20240911$20240418$20240913$PER$$US-PFIZER INC-PV202400050367$PFIZER$$75$YR$$M$Y$$$20240913$$HP$US$US
237571135$23757113$5$F$$20240812$20240418$20240814$PER$$NVSC2024US080554$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
237571303$23757130$3$F$20240112$20240826$20240418$20240905$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2024FOS000451$RIGEL PHARMACEUTICALS$$69$YR$$M$Y$60.7$KG$20240905$$MD$JP$JP
237571362$23757136$2$F$20240416$20240717$20240418$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060479$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240717$$HP$US$US
237571422$23757142$2$F$$20240724$20240418$20240806$PER$$US-SA-2024SA113863$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240806$$MD$US$US
237571482$23757148$2$F$$20240722$20240418$20240731$PER$$US-SA-2024SA113896$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240731$$MD$US$US
237571595$23757159$5$F$20240216$20240723$20240418$20240726$EXP$$US-JNJFOC-20240302535$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240726$$CN$US$US
237572172$23757217$2$F$20240415$20240711$20240418$20240713$PER$$US-AMGEN-USASP2024076124$AMGEN$$75$YR$E$M$Y$$$20240713$$CN$US$US
237572203$23757220$3$F$20201104$20240827$20240418$20240902$EXP$$CA-TAKEDA-2024TUS036792$TAKEDA$$72$YR$$F$Y$$$20240902$$CN$CA$CA
237572353$23757235$3$F$20240301$20240816$20240418$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058884$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240827$$HP$US$US
237572443$23757244$3$F$20240411$20240802$20240418$20240809$EXP$$CA-TAKEDA-2023TUS098655$TAKEDA$$81$YR$$M$Y$$$20240809$$CN$CA$CA
237572613$23757261$3$F$20231001$20240913$20240418$20240919$EXP$$US-ABBVIE-5719749$ABBVIE$$72$YR$$M$Y$$$20240919$$CN$US$US
237572963$23757296$3$F$$20240712$20240418$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-057536$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$100$KG$20240722$$PH$US$US
237573012$23757301$2$F$20240301$20240404$20240418$20240801$PER$$US-MYLANLABS-2024M1031991$MYLAN$$$$$$Y$$$20240801$$CN$US$US
237573232$23757323$2$F$20240718$20240722$20240418$20240731$PER$$US-SA-2024SA113873$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240731$$MD$US$US
237573294$23757329$4$F$20230801$20240715$20240418$20240722$EXP$$CA-GSK-CA2023106143$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$MD$CA$CA
237573402$23757340$2$F$20240316$20240828$20240418$20240906$EXP$$ZA-AUROBINDO-AUR-APL-2024-017481$AUROBINDO$$6$WK$$M$Y$6$KG$20240906$$MD$ZA$ZA
237573522$23757352$2$F$20240405$20240726$20240418$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST002267$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240731$$CN$US$US
237573942$23757394$2$F$$20240708$20240418$20240711$EXP$$FR-SANDOZ INC.-SDZ2024FR039795$SANDOZ$$$$$F$Y$$$20240711$$CN$FR$FR
237573982$23757398$2$F$20240101$20240724$20240418$20240802$PER$$US-SA-2024SA112123$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240802$$MD$US$US
237574122$23757412$2$F$$20240816$20240418$20240820$EXP$$NVSC2024US082194$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
237574275$23757427$5$F$20240424$20240731$20240418$20240806$EXP$$CA-TAKEDA-2024TUS035495$TAKEDA$$27$YR$$F$Y$$$20240806$$CN$CA$CA
237574543$23757454$3$F$$20240716$20240418$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058546$BRISTOL MYERS SQUIBB$$12$YR$T$F$Y$$$20240717$$HP$US$US
237574883$23757488$3$F$20240313$20240625$20240418$20240703$EXP$PT-INFARMED-E202404-81$PT-009507513-2404PRT007427$MERCK$$61$YR$$F$Y$71$KG$20240703$$PH$PT$PT
237574925$23757492$5$F$20231101$20240710$20240418$20240723$PER$$US-ALKERMES INC.-ALK-2024-000994$ALKERMES$$70$YR$$F$Y$$$20240723$$MD$US$US
237575042$23757504$2$F$20240101$20240807$20240418$20240814$PER$$US-ABBVIE-5718850$ABBVIE$$$$$M$Y$61.234$KG$20240814$$HP$US$US
237575154$23757515$4$F$20240409$20240625$20240418$20240702$EXP$$US-UCBSA-2024018082$UCB$$21$YR$$F$Y$$$20240702$$CN$US$US
237575315$23757531$5$F$20231124$20240815$20240418$20240815$EXP$$CA-PFIZER INC-202400088082$PFIZER$$60$YR$$F$Y$$$20240815$$HP$CA$CA
237575533$23757553$3$F$20230510$20240628$20240418$20240702$EXP$$US-PFIZER INC-202400086655$PFIZER$$75$YR$$M$Y$86.18$KG$20240702$$CN$US$US
237575835$23757583$5$F$$20240807$20240418$20240809$30DAY$$US-PFIZER INC-202400083414$PFIZER$$13$YR$$M$Y$$$20240809$$CN$US$US
237575848$23757584$8$F$$20240917$20240418$20240920$30DAY$$US-PFIZER INC-202400081964$PFIZER$$9$YR$$F$Y$$$20240920$$CN$US$US
237575852$23757585$2$F$20240404$20240808$20240418$20240812$30DAY$$US-PFIZER INC-202400080976$PFIZER$$7$YR$$F$Y$$$20240812$$CN$US$US
237575864$23757586$4$F$$20240906$20240418$20240911$30DAY$$US-PFIZER INC-202400081933$PFIZER$$16$YR$$M$Y$$$20240911$$CN$US$US
237575874$23757587$4$F$$20240920$20240418$20240923$PER$$US-PFIZER INC-202400082346$PFIZER$$13$YR$$M$Y$$$20240923$$CN$US$US
237575887$23757588$7$F$$20240906$20240418$20240911$30DAY$$US-PFIZER INC-202400082817$PFIZER$$10$YR$$F$Y$29.48$KG$20240911$$MD$US$US
237575905$23757590$5$F$$20240903$20240418$20240909$30DAY$$US-PFIZER INC-202400081440$PFIZER$$10$YR$$F$Y$$$20240909$$CN$US$US
237575915$23757591$5$F$$20240806$20240418$20240809$30DAY$$US-PFIZER INC-202400082355$PFIZER$$16$YR$$M$Y$56.689$KG$20240809$$MD$US$US
237575927$23757592$7$F$$20240904$20240418$20240906$30DAY$$US-PFIZER INC-202400081898$PFIZER$$10$YR$$M$Y$$$20240906$$CN$US$US
237576095$23757609$5$F$20240326$20240723$20240418$20240726$30DAY$$US-JNJFOC-20240388892$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240726$$CN$US$US
237576102$23757610$2$F$20230101$20240722$20240418$20240801$EXP$RU-MLMSERVICE-20240404-4901792-1$RU-STRIDES ARCOLAB LIMITED-2024SP004481$STRIDES$Gantsgorn EV, Archakova MA, Manvelyan RM, Malleev IM, Antonyan BG, Dzangiev II, et al.. A CLINICAL CASE OF CARBAMAZEPINE-INDUCED HEPATITIS.. Eksperimental^naya i Klinicheskaya Farmakologiya.. 2024;87(1):21-24$31$YR$$F$Y$$$20240801$$MD$RU$RU
237576152$23757615$2$F$20240101$20240730$20240418$20240731$EXP$$US-UCBSA-2024018312$UCB$$$$$F$Y$$$20240731$$CN$US$US
237576427$23757642$7$F$20240101$20240917$20240418$20240920$30DAY$$US-PFIZER INC-202400082885$PFIZER$$14$YR$$M$Y$$$20240920$$MD$US$US
237576438$23757643$8$F$$20240921$20240418$20240925$30DAY$$US-PFIZER INC-202400082710$PFIZER$$11$YR$$F$Y$$$20240925$$HP$US$US
237576622$23757662$2$F$20240101$20240830$20240418$20240927$PER$$US-SA-2024SA113116$SANOFI AVENTIS$$65$YR$E$F$Y$51$KG$20240927$$MD$US$US
237577142$23757714$2$F$20240416$20240730$20240418$20240801$PER$$US-AMGEN-USASP2024077733$AMGEN$$41$YR$A$F$Y$$$20240801$$CN$US$US
237577255$23757725$5$F$20240101$20240829$20240418$20240902$EXP$$CA-JNJFOC-20240377516$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240902$$CN$CA$CA
237577262$23757726$2$F$20231101$20240830$20240418$20240905$EXP$$CO-JNJFOC-20240153757$JOHNSON AND JOHNSON$$51$YR$A$F$Y$61$KG$20240905$$HP$CO$CO
237577472$23757747$2$F$20240412$20240716$20240418$20240725$EXP$$DE-Ipsen Biopharmaceuticals, Inc.-2024-06200$IPSEN$$45$YR$A$F$Y$$$20240725$$HP$DE$DE
237577573$23757757$3$F$20240415$20240704$20240418$20240709$EXP$$DE-PFIZER INC-PV202400050609$PFIZER$$82$YR$$F$Y$$$20240709$$MD$DE$DE
237577583$23757758$3$F$20240112$20240705$20240418$20240710$EXP$IT-MINISAL02-980290$IT-PFIZER INC-202400087569$PFIZER$$59$YR$$F$Y$54$KG$20240710$$MD$IT$IT
237577645$23757764$5$F$20230503$20240719$20240418$20240729$EXP$$DE-PFIZER INC-202300222589$PFIZER$$62$YR$$M$Y$$$20240729$$MD$DE$DE
237577882$23757788$2$F$20240401$20240722$20240418$20240730$PER$$US-SA-2024SA111993$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240730$$MD$US$US
237577902$23757790$2$F$20240101$20240701$20240418$20240711$PER$$US-SA-2024SA115231$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240711$$CN$US$US
237577922$23757792$2$F$20240413$20240729$20240418$20240731$PER$$US-AMGEN-USASP2024077729$AMGEN$$75$YR$E$M$Y$$$20240731$$CN$US$US
237578363$23757836$3$F$$20240521$20240418$20240814$EXP$$NVSC2024US081453$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
237578462$23757846$2$F$20240101$20240717$20240418$20240726$PER$$US-SA-2024SA115481$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240726$$CN$US$US
237578542$23757854$2$F$$20240717$20240418$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059108$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240717$$CN$US$US
237578792$23757879$2$F$20240411$20240925$20240418$20240930$EXP$GB-MHRA-TPP7617390C9420756YC1712834781694$GB-MYLANLABS-2024M1034304$MYLAN$$64$YR$$F$Y$78$KG$20240930$$MD$GB$GB
237578833$23757883$3$F$$20240814$20240418$20240819$EXP$$GB-MYLANLABS-2024M1034685$MYLAN$$$$$M$Y$$$20240819$$MD$GB$GB
237579023$23757902$3$F$$20240712$20240418$20240725$PER$$US-Calliditas-2024CAL00571$CALLIDITAS THERAPEUTICS$$65$YR$E$M$Y$$$20240725$$CN$US$US
2375790711$23757907$11$F$$20240823$20240418$20240829$PER$$NVSC2024US082284$NOVARTIS$$$$$$Y$$$20240829$$CN$US$US
237579302$23757930$2$F$20240201$20240606$20240418$20240713$PER$$BR-WT-2024-AMR-024231$Waylis$$$$E$F$Y$$$20240713$$CN$BR$BR
237579472$23757947$2$F$20240411$20240716$20240418$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059052$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240716$$HP$US$US
237579493$23757949$3$F$20240401$20240923$20240418$20240925$EXP$$US-SA-2024SA117387$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240925$$MD$US$US
237579512$23757951$2$F$20240414$20240817$20240418$20240821$PER$$US-AMGEN-USASP2024076087$AMGEN$$67$YR$E$F$Y$$$20240821$$CN$US$US
237579574$23757957$4$F$$20240807$20240418$20240814$EXP$$CZ-BIOGEN-2024BI01259922$BIOGEN$$39$YR$$F$Y$$$20240814$$MD$CZ$CZ
237579944$23757994$4$F$$20240801$20240418$20240809$PER$$US-ABBVIE-5720557$ABBVIE$$$$$M$Y$$$20240809$$MD$US$US
237580052$23758005$2$F$$20240415$20240418$20240708$EXP$$NVSC2024CA080705$NOVARTIS$$77$YR$$F$Y$$$20240708$$HP$CA$CA
237580065$23758006$5$F$20240410$20240712$20240418$20240725$PER$$US-Calliditas-2024CAL00574$CALLIDITAS THERAPEUTICS$$35$YR$A$F$Y$$$20240725$$CN$US$US
237580078$23758007$8$F$20240421$20240812$20240418$20240821$EXP$$US-Calliditas-2024CAL00578$CALLIDITAS THERAPEUTICS$$62$YR$A$M$Y$80$KG$20240821$$CN$US$US
237580212$23758021$2$F$20240101$20240803$20240418$20240809$EXP$$US-SA-2024SA117890$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240809$$MD$US$US
237580392$23758039$2$F$20240101$20240719$20240418$20240723$PER$$US-Eisai-EC-2024-164008$EISAI$$74$YR$E$F$Y$$$20240723$$CN$US$US
237580402$23758040$2$F$20240201$20240709$20240418$20240715$EXP$$CA-Eisai-EC-2024-164134$EISAI$$74$YR$E$M$Y$$$20240715$$CN$CA$CA
237580574$23758057$4$F$20240613$20240729$20240418$20240731$EXP$$US-KYOWAKIRIN-2024KK009059$KYOWA$$$$$$Y$$$20240731$$CN$US$US
237580652$23758065$2$F$$20240820$20240418$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060225$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240821$$HP$US$US
237580712$23758071$2$F$$20240410$20240418$20240716$EXP$$BE-AstraZeneca-2024A090283$ASTRAZENECA$$$$A$M$Y$$$20240716$$MD$BE$
237580812$23758081$2$F$$20240716$20240418$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061095$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240719$$CN$US$US
237580972$23758097$2$F$$20240726$20240418$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060984$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240729$$CN$US$US
237581132$23758113$2$F$20240101$20240703$20240418$20240710$PER$$US-Eisai-EC-2024-160906$EISAI$$58$YR$A$M$Y$81.6$KG$20240710$$CN$US$US
237581245$23758124$5$F$$20240523$20240418$20240806$PER$$US-AstraZeneca-2024A085078$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
237581992$23758199$2$F$20240101$20240528$20240418$20240903$PER$$US-KARYOPHARM-2024KPT000876$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
237582023$23758202$3$F$$20240813$20240418$20240816$PER$$NVSC2024US082307$NOVARTIS$$$$$M$Y$$$20240816$$HP$US$US
237582033$23758203$3$F$$20240730$20240418$20240814$PER$$US-Calliditas-2024CAL00582$CALLIDITAS THERAPEUTICS$$70$YR$E$M$Y$$$20240812$$CN$US$US
237582063$23758206$3$F$20230501$20240716$20240418$20240729$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00240$CATALYST PHARMA$$56$YR$$M$Y$110.66$KG$20240729$$CN$US$US
237582084$23758208$4$F$20220907$20240711$20240418$20240721$EXP$$DE-SANDOZ INC.-NVSC2022DE211742$SANDOZ$$$$E$F$Y$76$KG$20240721$$HP$DE$DE
237582193$23758219$3$F$20240101$20240624$20240418$20240709$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00300$CATALYST PHARMA$$$$$F$Y$78.912$KG$20240709$$CN$US$US
237582302$23758230$2$F$$20240719$20240418$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060553$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240719$$MD$US$US
237582362$23758236$2$F$20240408$20240626$20240418$20240703$PER$$JP-Eisai-EC-2024-163715$EISAI$$$$A$F$Y$$$20240703$$MD$JP$JP
237582884$23758288$4$F$20240311$20240708$20240418$20240904$EXP$$CA-LUNDBECK-DKLU3076873$LUNDBECK$$$$$$Y$$$20240904$$HP$CA$CA
237582962$23758296$2$F$$20240711$20240418$20240721$EXP$$CA-TEVA-VS-3181964$TEVA$$62$YR$$F$Y$$$20240721$$HP$CA$CA
237583726$23758372$6$F$20240410$20240913$20240418$20240918$EXP$$JP-009507513-2404JPN001523J$MERCK$$46$YR$$F$Y$$$20240918$$MD$JP$JP
237583762$23758376$2$F$$20240819$20240418$20240823$EXP$$CA-BAUSCH-BL-2024-006095$BAUSCH AND LOMB$$14$YR$$M$Y$41$KG$20240823$$HP$CA$CA
237583792$23758379$2$F$20240101$20240807$20240418$20240817$EXP$$DE-TEVA-VS-3183356$TEVA$$84$YR$$F$Y$$$20240817$$CN$DE$DE
237583912$23758391$2$F$20130501$20240902$20240418$20240909$EXP$$PHHY2014PL151647$NOVARTIS$Kaminska D, Koscielska-Kasprzak K, Myszka M, Banasik M, Chelmonski A, Boratynska M et al.. Significant Infections After Hand Transplantation in a Polish Population. TRANSPLANTATION PROCEEDINGS. 2014;46(8):2887-9$28$YR$$M$Y$$$20240909$$HP$PL$PL
237584034$23758403$4$F$20240712$20240925$20240418$20240927$EXP$$US-TAKEDA-2024TUS036814$TAKEDA$$55$YR$$F$Y$$$20240927$$HP$US$US
237584242$23758424$2$F$$20240408$20240418$20240916$EXP$$CA-BAUSCHBL-2024BNL025638$BAUSCH AND LOMB$$$$$F$Y$$$20240916$$HP$CA$CA
237584296$23758429$6$F$20240401$20240722$20240418$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058246$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240724$$CN$US$US
237585362$23758536$2$F$20240402$20240703$20240418$20240819$PER$$US-LUNDBECK-DKLU3076305$LUNDBECK$$$$$$Y$$$20240819$$HP$US$US
237585442$23758544$2$F$$20240712$20240418$20240722$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000779$BLUEPRINT MEDICINES$$$$$F$Y$$$20240722$$CN$US$US
237585543$23758554$3$F$20240607$20240827$20240418$20240902$EXP$$GB-TAKEDA-2024TUS036412$TAKEDA$$86$YR$$F$Y$$$20240902$$CN$GB$GB
237588372$23758837$2$F$20240722$20240807$20240418$20240815$PER$$US-ROCHE-3456788$ROCHE$$81$YR$E$F$Y$$$20240815$$CN$US$US
237590862$23759086$2$F$$20240730$20240418$20240802$PER$$US-ROCHE-3514870$ROCHE$$$$E$M$Y$$$20240802$$CN$US$US
237592482$23759248$2$F$$20240821$20240418$20240827$EXP$$CA-APOTEX-2024AP004646$APOTEX$$66$YR$$M$Y$$$20240827$$HP$CA$CA
237592853$23759285$3$F$20230617$20240909$20240418$20240912$PER$$US-ROCHE-3389291$ROCHE$$86$YR$E$F$Y$$$20240912$$CN$US$US
237593692$23759369$2$F$20240201$20240819$20240418$20240826$EXP$$JP-009507513-2404JPN002327J$MERCK$$$$$F$Y$$$20240826$$MD$JP$JP
237593892$23759389$2$F$20240319$20240912$20240418$20240920$EXP$$RO-JNJFOC-20240370531$JOHNSON AND JOHNSON$$$$$F$Y$65$KG$20240921$$MD$RO$RO
237593933$23759393$3$F$20240321$20240808$20240418$20240818$EXP$$IT-JNJFOC-20240452784$JOHNSON AND JOHNSON$$58$YR$A$$Y$54$KG$20240818$$HP$IT$IT
237594014$23759401$4$F$20201230$20240902$20240418$20240903$EXP$$CA-SANDOZ INC.-NVSC2020CA347333$SANDOZ$$85$YR$$M$Y$$$20240903$$CN$CA$CA
237594062$23759406$2$F$20240301$20240618$20240418$20240702$EXP$$JP-AMGEN-JPNSP2024077798$AMGEN$$8$DEC$E$F$Y$$$20240702$$MD$JP$JP
237594122$23759412$2$F$20240125$20240829$20240418$20240829$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-005612$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240829$$CN$FR$FR
237594133$23759413$3$F$$20240910$20240418$20240918$EXP$$GB-TAKEDA-2024TUS036926$TAKEDA$$$$$M$Y$$$20240918$$CN$GB$GB
237594154$23759415$4$F$20240416$20240717$20240418$20240720$PER$$US-AMGEN-USASP2024077012$AMGEN$$78$YR$E$M$Y$$$20240720$$CN$US$US
237594183$23759418$3$F$$20240709$20240418$20240711$EXP$$CA-BIOGEN-2024BI01260441$BIOGEN$$$$$F$Y$$$20240711$$CN$CA$CA
237594192$23759419$2$F$$20240718$20240418$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059043$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240718$$CN$US$US
237595562$23759556$2$F$$20240723$20240418$20240801$PER$$US-SA-2024SA113904$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240801$$CN$US$US
237595753$23759575$3$F$20230125$20240926$20240418$20240928$EXP$$GR-ABBVIE-5724907$ABBVIE$$82$YR$$F$Y$68$KG$20240928$$HP$GR$GR
237595764$23759576$4$F$20240404$20240905$20240418$20240911$EXP$$US-ABBVIE-5721502$ABBVIE$$79$YR$$F$Y$60$KG$20240911$$CN$US$US
237595822$23759582$2$F$$20240619$20240418$20240708$PER$$US-BAUSCHBL-2024BNL025454$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240708$$CN$US$US
237596407$23759640$7$F$20240313$20240717$20240419$20240717$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-057426$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$70$KG$20240717$$HP$DE$DE
237596422$23759642$2$F$20150101$20240819$20240419$20240828$EXP$$AU-BAUSCHBL-BL-2018-004242$BAUSCH AND LOMB$Chakradeo K, Paul Y, Liu C, Mudge D, De S. Disseminated cryptococcosis presenting initially as lower limb cellulitis in a renal transplant recipient - A case report. BMC Nephrology. 2018;19(1):. doi:10.1186/s12882-018-0815-7$59$YR$$M$Y$$$20240828$$MD$AU$AU
237596572$23759657$2$F$20240402$20240822$20240419$20240826$EXP$$JP-TAKEDA-2024TJP005594$TAKEDA$$6$DEC$$M$Y$$$20240826$$MD$JP$JP
237596742$23759674$2$F$20240414$20240816$20240419$20240820$PER$$US-AMGEN-USASP2024077491$AMGEN$$61$YR$A$M$Y$$$20240820$$CN$US$US
237596853$23759685$3$F$20230101$20240730$20240419$20240808$EXP$$CO-ABBVIE-5722395$ABBVIE$$$$$F$Y$$$20240808$$MD$CO$CO
237596922$23759692$2$F$20240101$20240712$20240419$20240718$EXP$$US-ABBVIE-5722858$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
237597042$23759704$2$F$$20240711$20240419$20240723$PER$$US-SA-2024SA114530$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240723$$MD$US$US
237597134$23759713$4$F$20240522$20240819$20240419$20240822$EXP$$US-ABBVIE-5723015$ABBVIE$$79$YR$$F$Y$47$KG$20240822$$CN$US$US
237597154$23759715$4$F$20240311$20240704$20240419$20240711$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-020698$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$45$KG$20240711$$CN$JP$JP
237597162$23759716$2$F$20220201$20240801$20240419$20240807$EXP$$UY-ABBVIE-5722185$ABBVIE$$72$YR$$F$Y$$$20240807$$CN$UY$UY
237597272$23759727$2$F$20240401$20240725$20240419$20240807$PER$$US-SA-2024SA115108$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240807$$MD$US$US
237597593$23759759$3$F$20240502$20240813$20240419$20240816$EXP$$CA-TAKEDA-2024TUS029827$TAKEDA$$50$YR$$F$Y$$$20240816$$CN$CA$CA
237597703$23759770$3$F$20240301$20240717$20240419$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-061119$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240719$$MD$JP$JP
237597842$23759784$2$F$$20240616$20240419$20240709$PER$$US-TOLMAR, INC.-23US048354$TOLMAR$$$$$M$Y$$$20240709$$CN$US$US
237597942$23759794$2$F$20240801$20240912$20240419$20240918$EXP$$US-BEH-2024170544$CSL BEHRING$$41$YR$A$M$Y$$$20240918$$HP$US$US
237597972$23759797$2$F$$20240718$20240419$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058077$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$CN$US$US
237597983$23759798$3$F$20240101$20240911$20240419$20240925$PER$$US-SA-2024SA114438$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240925$$MD$US$US
237598002$23759800$2$F$20230101$20240821$20240419$20240904$PER$$US-SA-2024SA113587$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240904$$MD$US$US
237598174$23759817$4$F$20240301$20240830$20240419$20240903$PER$$US-AMGEN-USASP2024076128$AMGEN$$68$YR$E$M$Y$$$20240903$$CN$US$US
237598342$23759834$2$F$20240401$20240722$20240419$20240727$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-013146$JAZZ$$49$YR$$M$Y$$$20240727$$CN$US$US
237598364$23759836$4$F$20240101$20240724$20240419$20240730$EXP$$BR-AMGEN-BRASL2024075143$AMGEN$$55$YR$A$F$Y$$$20240730$$MD$BR$BR
237598442$23759844$2$F$$20240801$20240419$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060356$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$51.71$KG$20240802$$CN$US$US
237598472$23759847$2$F$20240101$20240628$20240419$20240712$PER$$US-SA-2024SA114843$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240712$$MD$US$US
237598933$23759893$3$F$20240601$20240805$20240419$20240813$PER$$US-SA-2024SA114674$SANOFI AVENTIS$$12$YR$T$M$Y$63$KG$20240814$$MD$US$US
237599132$23759913$2$F$20240701$20240807$20240419$20240812$EXP$$US-BEH-2024170641$CSL BEHRING$$40$YR$A$M$Y$$$20240812$$CN$US$US
237599316$23759931$6$F$20240301$20240720$20240419$20240729$EXP$$CA-TAKEDA-2024TUS030857$TAKEDA$$84$YR$$M$Y$$$20240729$$CN$CA$CA
237599543$23759954$3$F$$20240722$20240419$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-051062$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$HP$JP$JP
237599582$23759958$2$F$20240413$20240730$20240419$20240801$PER$$US-AMGEN-USASP2024078189$AMGEN$$69$YR$E$M$Y$$$20240801$$CN$US$US
237599904$23759990$4$F$$20240925$20240419$20240930$EXP$$CA-TAKEDA-2024TUS036368$TAKEDA$$$$$M$Y$$$20240930$$HP$CA$CA
237600012$23760001$2$F$20240201$20240827$20240419$20240903$EXP$FR-AFSSAPS-SE2024000273$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-105753$ZYDUS PHARM$$$$$$Y$$$20240903$$MD$FR$FR
237600072$23760007$2$F$$20240701$20240419$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03142$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237600152$23760015$2$F$$20240716$20240419$20240718$PER$$US-JNJFOC-20240431652$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$US$US
237600282$23760028$2$F$$20240627$20240419$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03158$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237600323$23760032$3$F$20230101$20240702$20240419$20240709$EXP$$CA-CELLTRION INC.-2023CA009859$CELLTRION$$$$$$Y$$$20240709$$MD$CA$CA
237600452$23760045$2$F$20240415$20240718$20240419$20240723$PER$$US-AMGEN-USASP2024076350$AMGEN$$63$YR$A$M$Y$$$20240723$$CN$US$US
237600736$23760073$6$F$$20240917$20240419$20240923$EXP$$NVSC2023US273231$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
237600792$23760079$2$F$$20240909$20240419$20240919$EXP$CA-HEALTHCANVIG-E2B_02780298$CA-NOVOPROD-1204276$NOVO NORDISK$$$$$F$Y$$$20240919$$HP$CA$CA
237600824$23760082$4$F$$20240812$20240419$20240822$EXP$CA-HEALTHCANVIG-E2B_06555241$CA-NOVOPROD-1204158$NOVO NORDISK$$77$YR$$M$Y$$$20240822$$HP$CA$CA
237600833$23760083$3$F$$20240909$20240419$20240919$EXP$CA-HEALTHCANVIG-E2B_05196467$CA-NOVOPROD-1204102$NOVO NORDISK$$63$YR$$F$Y$$$20240919$$CN$CA$CA
237601222$23760122$2$F$20240415$20240727$20240419$20240731$PER$$US-AMGEN-USASP2024076321$AMGEN$$62$YR$A$F$Y$$$20240731$$CN$US$US
237601292$23760129$2$F$20190817$20240423$20240419$20240724$EXP$$KR-HALEON-2167303$Haleon PLC$$51$YR$$M$Y$79$KG$20240724$$MD$KR$KR
237601322$23760132$2$F$$20240701$20240419$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03130$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237601362$23760136$2$F$$20240812$20240419$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA040140$SANDOZ$$66$YR$$M$Y$$$20240819$$HP$CA$CA
237601443$23760144$3$F$20190911$20240828$20240419$20240905$EXP$$CO-SANDOZ INC.-NVSC2019CO022097$SANDOZ$$60$YR$$F$Y$78$KG$20240905$$CN$CO$CO
237601773$23760177$3$F$$20240701$20240419$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03156$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237602012$23760201$2$F$20240401$20240830$20240419$20240906$EXP$$JP-009507513-2404JPN001548J$MERCK$$$$$F$Y$$$20240906$$MD$JP$JP
237602312$23760231$2$F$$20240821$20240419$20240905$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442343$RANBAXY$Caruso MR, Bartoletti R, Malloggi S, Pacini M, Betti P. Xanthine Incrustation in JJ Stents: a Rare Complication of Urate-Lowering Therapy in Lesch-Nyhan Syndrome with Kidney Stones. Kidney Int Rep. 2024;9 (Suppl.)(4):S348-S349/WCN24-2073$30$YR$$M$Y$$$20240905$$HP$IT$IT
237602333$23760233$3$F$$20240730$20240419$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441102$RANBAXY$Harada N, Shibano I, Izuta Y, Kizawa Y, Shiragami H, Tsumura A, Ohji G, Mugitani A. Infectious mononucleosis due to Epstein-Barr virus reactivation in animmunocompromised 60-year-old patient with COVID-19. J Infect Chemother. 2024;02 Apr:1-9$60$YR$$M$Y$$$20240814$$HP$JP$JP
237602562$23760256$2$F$20240416$20240712$20240419$20240713$PER$$US-AMGEN-USASP2024077236$AMGEN$$77$YR$E$F$Y$$$20240713$$CN$US$US
237602603$23760260$3$F$$20240815$20240419$20240820$PER$$US-AMGEN-USASP2024077982$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
237602743$23760274$3$F$20240301$20240618$20240419$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001775$ACADIA PHARMACEUTICALS$$5$YR$$F$Y$$$20240712$$CN$US$US
237602802$23760280$2$F$20240711$20240711$20240419$20240714$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006117$JAZZ$$0$YR$$F$Y$$$20240714$$CN$US$US
237602926$23760292$6$F$20240101$20240701$20240419$20240705$PER$$US-BIOGEN-2023BI01218112$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
237603122$23760312$2$F$20221213$20240716$20240419$20240717$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-058178$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240717$$MD$PL$PL
237603242$23760324$2$F$20240416$20240723$20240419$20240725$PER$$US-AMGEN-USASP2024077455$AMGEN$$69$YR$E$F$Y$$$20240725$$CN$US$US
237603845$23760384$5$F$20230801$20240820$20240419$20240824$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-258778$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240824$$CN$US$US
237603873$23760387$3$F$20240414$20240820$20240419$20240824$PER$$US-AMGEN-USASP2024076176$AMGEN$$68$YR$E$M$Y$$$20240824$$MD$US$US
237603952$23760395$2$F$$20240729$20240419$20240807$EXP$$CA-APOTEX-2024AP004614$APOTEX$$32$YR$$F$Y$$$20240807$$HP$CA$CA
237604142$23760414$2$F$20230901$20240905$20240419$20240911$EXP$$US-ABBVIE-5723418$ABBVIE$$55$YR$$F$Y$$$20240911$$CN$US$US
237604233$23760423$3$F$20240101$20240712$20240419$20240718$EXP$$CA-ABBVIE-5722308$ABBVIE$$62$YR$$F$Y$$$20240718$$CN$CA$CA
237604403$23760440$3$F$$20240912$20240419$20240919$EXP$$US-GSK-US2024045523$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
237604453$23760445$3$F$20240401$20240803$20240419$20240810$EXP$$CA-CELLTRION INC.-2024CA009210$CELLTRION$$$$$$Y$$$20240810$$HP$CA$CA
237604743$23760474$3$F$$20240817$20240419$20240821$PER$$NVSC2024US081856$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
237604755$23760475$5$F$20240106$20240708$20240419$20240711$EXP$$FR-ABBVIE-5724174$ABBVIE$$77$YR$$F$Y$59$KG$20240711$$CN$FR$FR
237604832$23760483$2$F$20230918$20240722$20240419$20240723$EXP$$NVSC2024DE081759$NOVARTIS$$77$YR$$F$Y$66$KG$20240723$$MD$DE$DE
237605642$23760564$2$F$20240325$20240909$20240419$20240927$PER$$CA-TOLMAR, INC.-24CA048006$TOLMAR$$69$YR$$M$Y$$$20240927$$CN$CA$CA
237605663$23760566$3$F$20240325$20240910$20240419$20240930$PER$$CA-TOLMAR, INC.-24CA048010$TOLMAR$$73$YR$$M$Y$$$20240930$$CN$CA$CA
237605683$23760568$3$F$20170620$20240725$20240419$20240923$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK100043$Haleon PLC$$37$YR$$M$Y$$$20240921$$MD$CA$CA
237605723$23760572$3$F$20240325$20240617$20240419$20240709$PER$$US-TOLMAR, INC.-24US047952$TOLMAR$$$$$$Y$$$20240709$$HP$US$US
237605923$23760592$3$F$$20240611$20240419$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001538$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
237606122$23760612$2$F$20231104$20240711$20240419$20240712$EXP$$JP-TAKEDA-2024TJP005706$TAKEDA$$0$YR$$M$Y$2.7$KG$20240712$$MD$JP$JP
237606332$23760633$2$F$$20240627$20240419$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-442996$RANBAXY$$30$YR$$F$Y$$$20240712$$MD$FR$FR
237606514$23760651$4$F$$20240713$20240419$20240722$EXP$$CA-CELLTRION INC.-2024CA009179$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
237606792$23760679$2$F$$20240408$20240419$20240712$PER$$US-LEO Pharma-369414$LEO PHARM$$45$YR$$M$Y$91$KG$20240712$$CN$US$US
237606813$23760681$3$F$20240401$20240410$20240419$20240702$PER$$US-LEO Pharma-369377$LEO PHARM$$45$YR$$M$Y$$$20240702$$HP$US$US
237606883$23760688$3$F$20231208$20240912$20240419$20240918$EXP$$JP-009507513-2312JPN003419J$MERCK$$8$DEC$$M$Y$$$20240918$$MD$JP$JP
237606902$23760690$2$F$$20240827$20240419$20240829$EXP$$JP-TAKEDA-2024TJP005528$TAKEDA$$7$DEC$$F$Y$$$20240829$$PH$JP$JP
237607342$23760734$2$F$20240301$20240625$20240419$20240702$EXP$$US-SA-2024SA117305$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240702$$MD$US$US
237607383$23760738$3$F$$20240909$20240419$20240917$EXP$$CA-APOTEX-2024AP004641$APOTEX$$65$YR$$F$Y$$$20240917$$HP$CA$CA
237607655$23760765$5$F$20240301$20240819$20240419$20240823$PER$$US-AMGEN-USASP2024077945$AMGEN$$76$YR$E$F$Y$72.8$KG$20240823$$PH$US$US
237607672$23760767$2$F$20220122$20240723$20240419$20240731$EXP$$JP-AstraZeneca-2024A090489$ASTRAZENECA$$85$YR$$F$Y$43$KG$20240731$$MD$JP$
237607782$23760778$2$F$20231229$20240619$20240419$20240704$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-443297$RANBAXY$$76$YR$$M$Y$65$KG$20240704$$PH$FR$FR
237607934$23760793$4$F$$20240920$20240419$20240923$EXP$$NVSC2024US079091$NOVARTIS$$$$$M$Y$$$20240923$$CN$US$US
237608242$23760824$2$F$$20240403$20240419$20240720$PER$$US-JNJFOC-20240413274$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$MD$US$US
237608542$23760854$2$F$$20240626$20240419$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03173$LUPIN$$$$$$Y$$$20240713$$CN$US$US
237608613$23760861$3$F$20240131$20240730$20240419$20240730$EXP$$FR-JNJFOC-20240451866$JOHNSON AND JOHNSON$$59$YR$A$M$Y$50$KG$20240731$$MD$FR$FR
237608702$23760870$2$F$$20240701$20240419$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03126$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237608762$23760876$2$F$$20240404$20240419$20240711$PER$$US-LEO Pharma-369311$LEO PHARM$$63$YR$$M$Y$$$20240711$$CN$US$US
237609014$23760901$4$F$20231231$20240903$20240419$20240910$30DAY$$US-GSK-US2024046163$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240910$$CN$US$US
237609193$23760919$3$F$20240701$20240718$20240419$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058210$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240726$$CN$US$US
237609224$23760922$4$F$20231127$20240903$20240419$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-009831$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$42$KG$20240911$$MD$JP$JP
237609344$23760934$4$F$20240406$20240703$20240419$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03169$LUPIN$$$$$$Y$$$20240729$$PH$US$US
237609412$23760941$2$F$20240416$20240730$20240419$20240801$PER$$US-AMGEN-USASP2024077047$AMGEN$$79$YR$E$F$Y$$$20240801$$CN$US$US
237609534$23760953$4$F$20240301$20240913$20240419$20240917$EXP$$US-Taiho Oncology Inc-2023-010481$TAIHO ONCOLOGY INC$$73$YR$E$M$Y$$$20240917$$CN$US$US
237609553$23760955$3$F$20240101$20240910$20240419$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058983$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240913$$HP$US$US
237610112$23761011$2$F$$20240710$20240419$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202404009964$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240716$$HP$US$US
237610129$23761012$9$F$20240316$20240919$20240419$20240923$EXP$$US-JNJFOC-20240356472$JOHNSON AND JOHNSON$$64$YR$A$F$Y$72.3$KG$20240924$$HP$US$US
237610202$23761020$2$F$$20240710$20240419$20240715$EXP$$GB-TAKEDA-2022TUS018034$TAKEDA$$$$$F$Y$$$20240715$$CN$GB$GB
237610452$23761045$2$F$$20240820$20240419$20240830$EXP$$CA-APOTEX-2024AP004621$APOTEX$$14$YR$$M$Y$41$KG$20240830$$HP$CA$CA
237610552$23761055$2$F$20240412$20240728$20240419$20240730$PER$$US-AMGEN-USASP2024077191$AMGEN$$66$YR$E$M$Y$$$20240730$$CN$US$US
237610722$23761072$2$F$20240229$20240807$20240419$20240817$EXP$FR-AFSSAPS-PV2024000241$FR-TEVA-VS-3185313$TEVA$$18$YR$$F$Y$32.6$KG$20240817$$MD$FR$FR
237610823$23761082$3$F$$20240826$20240419$20240826$EXP$SI-EMA-DD-20240403-7483181-123015$SI-ROCHE-3543068$ROCHE$Kojc N, Rigler AA, Mlinsek G, Kovac D, Ferluga D, Arnol M Outcome of polyomavirus nephropathy in renal transplant patients: A single-center experience. Clinical Nephrology. 2017;88:S109-14.$59$YR$A$M$Y$$$20240826$$MD$SI$SI
237611015$23761101$5$F$20231219$20240816$20240419$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060623$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240816$$CN$US$US
237611052$23761105$2$F$20201224$20240819$20240419$20240823$EXP$$CA-JNJFOC-20210237321$JOHNSON AND JOHNSON$$65$YR$E$F$Y$54$KG$20240823$$HP$CA$CA
237611113$23761111$3$F$20240101$20240702$20240419$20240708$EXP$$US-SA-2024SA116859$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240708$$CN$US$US
237611202$23761120$2$F$$20240814$20240419$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03216$LUPIN$$$$$$Y$$$20240901$$CN$US$US
237611269$23761126$9$F$20240101$20240628$20240419$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011146$UNITED THERAPEUTICS$$$$$F$Y$58.73$KG$20240705$$$US$US
237611402$23761140$2$F$20240328$20240709$20240419$20240722$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-05315$IPSEN$$3$YR$C$M$Y$$$20240722$$HP$US$US
237611452$23761145$2$F$20240220$20240715$20240419$20240724$EXP$$DE-TEVA-VS-3184215$TEVA$$86$YR$$M$Y$68$KG$20240724$$MD$DE$DE
237612252$23761225$2$F$$20240717$20240419$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061352$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240717$$CN$US$US
237612573$23761257$3$F$20240417$20240915$20240419$20240920$EXP$$ZA-TAKEDA-2024TUS036980$TAKEDA$$10$YR$$F$Y$$$20240920$$CN$ZA$ZA
237612614$23761261$4$F$20210101$20240918$20240419$20240928$EXP$$CA-CELLTRION INC.-2021CA019491$CELLTRION$$$$$$Y$$$20240928$$CN$CA$CA
237612912$23761291$2$F$$20240415$20240419$20240729$EXP$$NVSC2024CA080588$NOVARTIS$$77$YR$$F$Y$$$20240729$$HP$CA$CA
237613022$23761302$2$F$$20240814$20240419$20240823$EXP$$CA-APOTEX-2023AP016988$APOTEX$$3$YR$$M$Y$$$20240823$$HP$CA$CA
237613042$23761304$2$F$20240101$20240904$20240419$20240920$EXP$$US-SA-2024SA117869$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240920$$MD$US$US
237613205$23761320$5$F$20240419$20240713$20240419$20240716$EXP$$CA-TAKEDA-2023TUS071271$TAKEDA$$21$YR$$F$Y$$$20240716$$MD$CA$CA
237613222$23761322$2$F$$20240719$20240419$20240725$EXP$$GR-MYLANLABS-2024M1035205$MYLAN$Papadokostaki E, Koutrakou P, Mastrogiorgakis D, Emmanouilidou Ev, Papazachariou A, Repa A, Filippatos Th. Autoimmune necrotizing myositis induced by atorvastatin. 22nd Panhellenic diabetological conference. 2024;27-30$68$YR$$M$Y$$$20240725$$HP$GR$GR
237613434$23761343$4$F$20211206$20240821$20240419$20240831$EXP$$US-GSK-US2021240500$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240831$$CN$US$US
237613454$23761345$4$F$20240101$20240819$20240419$20240827$EXP$$CA-CELLTRION INC.-2023CA024338$CELLTRION$$$$$$Y$$$20240827$$MD$CA$CA
237613532$23761353$2$F$20240403$20240723$20240419$20240731$EXP$$JP-AstraZeneca-2024A090488$ASTRAZENECA$$55$YR$$M$Y$$$20240731$$MD$JP$
237613603$23761360$3$F$20240403$20240717$20240419$20240718$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-059427$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240718$$MD$AU$AU
237614143$23761414$3$F$20230215$20240813$20240419$20240816$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-213898$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$$$20240816$$CN$US$US
237614813$23761481$3$F$20240329$20240819$20240419$20240822$EXP$$ES-JNJFOC-20240437234$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240822$$MD$ES$ES
237615093$23761509$3$F$20230901$20240726$20240419$20240805$EXP$$DE-EMD Serono-2024020034$EMD SERONO INC$$39$YR$A$F$Y$75$KG$20240805$$MD$DE$DE
237615192$23761519$2$F$20240416$20240805$20240419$20240808$PER$$US-AMGEN-USASP2024077276$AMGEN$$75$YR$E$M$Y$$$20240808$$CN$US$US
237615502$23761550$2$F$$20240826$20240419$20240905$EXP$$CA-TEVA-2021-CA-1952728$TEVA$$60$YR$$M$Y$$$20240905$$HP$CA$CA
237616453$23761645$3$F$$20240822$20240419$20240902$EXP$$CA-APOTEX-2024AP004713$APOTEX$$64$YR$$F$Y$$$20240902$$HP$CA$CA
237616462$23761646$2$F$20240409$20240820$20240419$20240827$EXP$$DE-JNJFOC-20240435826$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$74$KG$20240827$$MD$DE$DE
237616622$23761662$2$F$$20240514$20240419$20240802$PER$$US-FDC-2024USSPO00309$FDC LIMITED$$72$YR$E$F$Y$74.8$KG$20240802$$CN$US$US
237616672$23761667$2$F$$20240729$20240419$20240807$EXP$$JP-ROCHE-3545777$ROCHE$Koga T, Shirahane K, Toba T, Azama S and Aibe H. Two Cases of Pseudocirrhosis Which Developed during Chemotherapy for Breast Cancer with Multiple Metastases to Liver.. The 59th Annual Meeting of Kyushu Association of Endocrine Surgery. 2024;121:-.$77$YR$E$F$Y$$$20240807$$MD$JP$JP
237616712$23761671$2$F$$20240729$20240419$20240808$EXP$CA-MHPD-E2B_06854077$CA-Accord-419024$ACCORD$$65$YR$E$F$Y$$$20240808$$HP$CA$CA
237616802$23761680$2$F$$20240409$20240419$20240806$EXP$$NVSC2024RU078418$NOVARTIS$$65$YR$$F$Y$$$20240806$$HP$RU$RU
237616832$23761683$2$F$$20240918$20240419$20240925$PER$$US-GSK-US2024046863$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
237616946$23761694$6$F$20240410$20240628$20240419$20240711$EXP$$JP-UCBSA-2024018715$UCB$$76$YR$$F$Y$71$KG$20240711$$MD$JP$JP
237616992$23761699$2$F$20240131$20240201$20240419$20240905$PER$$US-ALIMERA SCIENCES INC.-US-A16013-24-000160$ALIMERA$$$$$$Y$$$20240905$$MD$US$US
237617002$23761700$2$F$$20240403$20240419$20240905$PER$$US-ALIMERA SCIENCES INC.-US-A16013-24-000304$ALIMERA$$$$$$Y$$$20240905$$MD$US$US
237617422$23761742$2$F$20230128$20240821$20240419$20240828$EXP$$SA-GSK-SA2024EME049133$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$SA$SA
237617826$23761782$6$F$20240512$20240912$20240419$20240917$EXP$$US-BAYER-2024A056063$BAYER$$36$YR$A$M$Y$$$20240917$$CN$US$US
237617902$23761790$2$F$$20240816$20240419$20240826$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR006984$AEGERION$$$$$M$Y$$$20240826$$CN$US$US
237618115$23761811$5$F$20240411$20240816$20240419$20240823$EXP$$JP-EXELIXIS-CABO-24076394$EXELIXIS$$68$YR$$M$Y$50$KG$20240823$$MD$JP$JP
237618304$23761830$4$F$20240301$20240813$20240419$20240913$PER$$US-Eisai-EC-2024-163844$EISAI$$56$YR$A$M$Y$90.7$KG$20240913$$CN$US$US
237618313$23761831$3$F$20240301$20240722$20240419$20240731$EXP$$JP-Eisai-EC-2024-162639$EISAI$$$$A$M$Y$70$KG$20240731$$MD$JP$JP
237618493$23761849$3$F$20240627$20240910$20240419$20240917$EXP$$CA-AMGEN-CANSL2022043450$AMGEN$$47$YR$A$F$Y$$$20240916$$HP$CA$CA
237618592$23761859$2$F$$20240802$20240419$20240808$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-03057$HIKMA$$72$YR$$M$Y$$$20240808$$CN$CA$CA
237618603$23761860$3$F$20240101$20240802$20240419$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008777$UNITED THERAPEUTICS$$$$$F$Y$99.773$KG$20240809$$$US$US
237619097$23761909$7$F$20240101$20240906$20240419$20240917$EXP$$US-INSMED, INC.-2024-00593-US$INSMED$$$$$F$Y$$$20240917$$CN$US$US
237619492$23761949$2$F$20231023$20240822$20240419$20240830$PER$$JP-Eisai-EC-2024-163966$EISAI$$65$YR$E$F$Y$32$KG$20240830$$PH$JP$JP
237619742$23761974$2$F$$20240807$20240419$20240807$PER$$US-ALXN-202404USA001066US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
237619782$23761978$2$F$20240402$20240912$20240419$20240913$PER$$NVSC2024US082579$NOVARTIS$$77$YR$$F$Y$$$20240913$$HP$US$US
237620192$23762019$2$F$20230412$20240712$20240419$20240722$EXP$$JP-ABBVIE-5720488$ABBVIE$$29$YR$$M$Y$48$KG$20240719$$MD$JP$JP
237620652$23762065$2$F$20240312$20240417$20240419$20240801$PER$$US-BAYER-2024A058072$BAYER$$31$YR$A$F$Y$$$20240801$$MD$US$US
237621222$23762122$2$F$20240401$20240717$20240419$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058907$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$50.8$KG$20240719$$CN$US$US
237621232$23762123$2$F$$20240717$20240419$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-061078$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240717$$PH$JP$JP
237621436$23762143$6$F$$20240819$20240419$20240821$EXP$$NVSC2024US080340$NOVARTIS$$$$$M$Y$$$20240821$$CN$US$US
237621482$23762148$2$F$20220901$20240722$20240419$20240731$PER$$JP-Eisai-EC-2024-162374$EISAI$Hashiwaki Sayumi et al.. A case of recurrent endometrial cancer successfully treated with oral lenvatinib alone despite discontinuation of pembrolizumab after its single dose only due to immune-related adverse event. The 76th Annual Congress of the Japan Society of Obstetrics and Gynecology : S-411-S-411.$61$YR$A$F$Y$$$20240731$$MD$JP$JP
237621604$23762160$4$F$20240301$20240715$20240419$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061438$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240716$$HP$US$US
237621672$23762167$2$F$$20240622$20240419$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03162$LUPIN$$$$$$Y$$$20240704$$CN$US$US
237621993$23762199$3$F$$20240725$20240419$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058387$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240730$$CN$US$US
237622006$23762200$6$F$20230101$20240903$20240419$20240910$EXP$$US-PFIZER INC-202400086633$PFIZER$$10$YR$$F$Y$18.62$KG$20240910$$CN$US$US
237622054$23762205$4$F$$20240913$20240419$20240918$30DAY$$US-PFIZER INC-PV202400047205$PFIZER$$$$$$Y$$$20240918$$CN$US$US
237622513$23762251$3$F$$20240712$20240419$20240722$EXP$$US-RECORDATI RARE DISEASES-2023000377$RECORDATI$$$$$$Y$$$20240722$$CN$US$US
237622668$23762266$8$F$$20240906$20240419$20240911$30DAY$$US-PFIZER INC-PV202400043602$PFIZER$$10$YR$$F$Y$$$20240911$$CN$US$US
237623084$23762308$4$F$20240321$20240813$20240419$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061692$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240814$$CN$US$US
237623152$23762315$2$F$$20240705$20240419$20240720$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-03132$HIKMA$$31$YR$$F$Y$45$KG$20240719$$PH$CA$CA
237623392$23762339$2$F$$20240709$20240419$20240724$EXP$$GB-LUPIN HEALTHCARE (UK) LIMITED-2024-03215$LUPIN$Chou M, Lai L, Neveu M, Ritchie A. Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy. British Medical Journal Case Reports. 2024;17 (3):1-5$$$T$M$Y$$$20240724$$HP$GB$GB
237623492$23762349$2$F$$20240923$20240419$20240927$EXP$$GB-VERTEX PHARMACEUTICALS-2024-006742$VERTEX$$$$A$M$Y$$$20240927$$CN$GB$GB
237623983$23762398$3$F$20240101$20240806$20240419$20240809$EXP$$US-PFIZER INC-202400087894$PFIZER$$85$YR$$F$Y$80.726$KG$20240809$$CN$US$US
237624253$23762425$3$F$20240417$20240820$20240419$20240827$PER$$US-AMGEN-USASP2024078421$AMGEN$$66$YR$E$F$Y$$$20240826$$CN$US$US
237624322$23762432$2$F$$20240723$20240419$20240728$PER$$US-JNJFOC-20240426447$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240728$$MD$US$US
237624712$23762471$2$F$20230920$20240822$20240419$20240904$EXP$$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2024-019208$VALIDUS$$$$$$Y$$$20240904$$PH$CA$CA
237624722$23762472$2$F$20220920$20240719$20240419$20240729$EXP$$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2024-019209$VALIDUS$$$$$$Y$$$20240729$$PH$CA$CA
237624752$23762475$2$F$$20240723$20240419$20240725$EXP$$US-JNJFOC-20240453942$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240725$$MD$US$US
237624766$23762476$6$F$20240101$20240705$20240419$20240709$EXP$$CA-PFIZER INC-202300392998$PFIZER$$65$YR$$F$Y$$$20240709$$HP$CA$CA
237624843$23762484$3$F$20240416$20240828$20240419$20240830$PER$$US-AMGEN-USASP2024077335$AMGEN$$75$YR$E$M$Y$$$20240830$$CN$US$US
237625094$23762509$4$F$20231103$20240723$20240419$20240726$EXP$$NVSC2024FR075408$NOVARTIS$$$$A$F$Y$$$20240726$$MD$FR$FR
237625206$23762520$6$F$20240101$20240711$20240419$20240717$EXP$$CA-PFIZER INC-202400089350$PFIZER$$77$YR$$F$Y$$$20240717$$HP$CA$CA
237625283$23762528$3$F$$20240814$20240419$20240816$PER$$US-PFIZER INC-202400090081$PFIZER$$67$YR$$F$Y$$$20240816$$CN$US$US
237625292$23762529$2$F$$20240802$20240419$20240808$EXP$$US-ABBVIE-5721804$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
237625322$23762532$2$F$20240301$20240903$20240419$20240913$PER$$JP-Eisai-EC-2024-163876$EISAI$$$$E$M$Y$$$20240913$$MD$JP$JP
237625453$23762545$3$F$$20240820$20240419$20240823$PER$$US-ALXN-202404USA001062US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
237625472$23762547$2$F$$20240726$20240419$20240803$EXP$$CA-TEVA-VS-3182337$TEVA$$$$$M$Y$$$20240803$$HP$CA$CA
237625504$23762550$4$F$20240208$20240704$20240419$20240712$EXP$$CA-TAKEDA-2024TUS035615$TAKEDA$$15$YR$$M$Y$$$20240712$$CN$CA$CA
237625553$23762555$3$F$20240401$20240702$20240419$20240708$PER$$US-PFIZER INC-202400090184$PFIZER$$26$YR$$M$Y$87.075$KG$20240708$$CN$US$US
237625673$23762567$3$F$$20240626$20240419$20240701$PER$$US-PFIZER INC-202400089309$PFIZER$$54$YR$$F$Y$$$20240701$$MD$US$US
237625694$23762569$4$F$$20240916$20240419$20240918$PER$$US-PFIZER INC-202400089048$PFIZER$$17$YR$$M$Y$$$20240918$$CN$US$US
237625842$23762584$2$F$20240701$20240722$20240419$20240724$PER$$US-PFIZER INC-202400089538$PFIZER$$58$YR$$F$Y$$$20240724$$MD$US$US
237626114$23762611$4$F$$20240730$20240419$20240805$EXP$$CA-TAKEDA-2024TUS035738$TAKEDA$$$$$M$Y$$$20240805$$CN$CA$CA
237626152$23762615$2$F$$20240701$20240419$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03178$LUPIN$$$$$$Y$$$20240719$$CN$US$US
237626273$23762627$3$F$$20240701$20240419$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03175$LUPIN$$$$$$Y$$$20240719$$CN$US$US
237626553$23762655$3$F$20240122$20240326$20240419$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00075$Phathom Pharmaceuticals$$54$YR$$M$Y$$$20240717$$CN$US$US
237626562$23762656$2$F$20240117$20240913$20240419$20240919$EXP$$JP-GENMAB-2024-01268$GENMAB$$77$YR$$F$Y$37$KG$20240919$$PH$JP$JP
237626632$23762663$2$F$20240321$20240326$20240419$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00158$Phathom Pharmaceuticals$$74$YR$$M$Y$$$20240717$$CN$US$US
237626923$23762692$3$F$20220101$20240627$20240419$20240702$EXP$$US-UCBSA-2023007108$UCB$$$$$M$Y$134$KG$20240702$$CN$US$US
237627043$23762704$3$F$20240408$20240709$20240419$20240715$30DAY$$GB-PFIZER INC-202400081989$PFIZER$$$$$$Y$$$20240715$$HP$GB$GB
237627254$23762725$4$F$20240410$20240816$20240419$20240821$30DAY$$DE-PFIZER INC-202400084916$PFIZER$$1$YR$$M$Y$10$KG$20240821$$MD$DE$DE
237627574$23762757$4$F$20240329$20240828$20240419$20240831$EXP$$NVSC2024CO083075$NOVARTIS$$60$YR$$F$Y$65$KG$20240831$$CN$CO$CO
237627592$23762759$2$F$20240324$20240729$20240419$20240731$EXP$FR-AFSSAPS-LM2024000199$FR-FreseniusKabi-FK202406332$FRESENIUS KABI$$22$YR$A$F$Y$58.7$KG$20240731$$MD$FR$FR
237627653$23762765$3$F$$20240701$20240419$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03185$LUPIN$$$$$$Y$$$20240719$$CN$US$US
237627962$23762796$2$F$20240323$20240912$20240419$20240917$EXP$$ES-ABBVIE-5720232$ABBVIE$$68$YR$$M$Y$74$KG$20240917$$MD$ES$ES
237627973$23762797$3$F$20240101$20240823$20240419$20240826$EXP$$US-UCBSA-2024009092$UCB$$$$$M$Y$$$20240826$$CN$US$US
237628112$23762811$2$F$20240101$20240711$20240419$20240718$EXP$$US-SA-2024SA117744$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240718$$MD$US$US
237628143$23762814$3$F$20240101$20240702$20240419$20240710$EXP$$US-SA-2024SA119615$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240710$$MD$US$US
237628363$23762836$3$F$$20240712$20240419$20240725$PER$$US-SA-2024SA117105$SANOFI AVENTIS$$71$YR$E$M$Y$64.8$KG$20240725$$MD$US$US
237628372$23762837$2$F$20240301$20240719$20240419$20240730$PER$$US-SA-2024SA118835$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240730$$MD$US$US
237628492$23762849$2$F$$20240805$20240419$20240813$PER$$US-SA-2024SA114323$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240814$$MD$US$US
237628562$23762856$2$F$20180801$20240715$20240419$20240723$PER$$US-SA-2024SA119076$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240723$$MD$US$US
237628574$23762857$4$F$20240101$20240724$20240419$20240801$PER$$US-SA-2024SA114619$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240801$$MD$US$US
237628683$23762868$3$F$$20240711$20240419$20240722$PER$$US-SA-2024SA112060$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
237628694$23762869$4$F$$20240802$20240419$20240814$PER$$US-SA-2024SA115381$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240814$$MD$US$US
237628712$23762871$2$F$20240101$20240703$20240419$20240712$PER$$US-SA-2024SA115562$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240712$$MD$US$US
237628913$23762891$3$F$20240101$20240712$20240419$20240724$PER$$US-SA-2024SA116115$SANOFI AVENTIS$$75$YR$E$F$Y$83.4$KG$20240724$$MD$US$US
237629182$23762918$2$F$20240101$20240719$20240419$20240730$PER$$US-SA-2024SA115937$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240730$$MD$US$US
237629592$23762959$2$F$20240101$20240729$20240419$20240807$PER$$US-SA-2024SA113931$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240807$$HP$US$US
237629682$23762968$2$F$$20240716$20240419$20240724$PER$$US-SA-2024SA114419$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$MD$US$US
237629742$23762974$2$F$$20240710$20240419$20240718$PER$$US-SA-2024SA114571$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240718$$MD$US$US
237629773$23762977$3$F$20240101$20240729$20240419$20240806$PER$$US-SA-2024SA113707$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240806$$MD$US$US
237629852$23762985$2$F$20240101$20240626$20240419$20240703$PER$$US-SA-2024SA115058$SANOFI AVENTIS$$26$YR$A$F$Y$117.93$KG$20240703$$MD$US$US
237629902$23762990$2$F$$20240724$20240419$20240802$PER$$US-SA-2024SA114704$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240802$$MD$US$US
237629984$23762998$4$F$$20240917$20240419$20240919$EXP$$US-SA-2024SA116752$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240919$$MD$US$US
237630024$23763002$4$F$20240101$20240716$20240419$20240723$PER$$US-SA-2024SA115891$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240723$$MD$US$US
237630212$23763021$2$F$20240101$20240718$20240419$20240728$PER$$US-SA-2024SA115955$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240728$$MD$US$US
237630744$23763074$4$F$$20240731$20240419$20240809$PER$$US-SA-2024SA117614$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240809$$HP$US$US
237631023$23763102$3$F$20240327$20240729$20240419$20240730$EXP$$DE-SANDOZ INC.-SDZ2024DE038763$SANDOZ$$83$YR$$M$Y$$$20240730$$MD$DE$DE
237631393$23763139$3$F$20240222$20240819$20240419$20240828$EXP$$US-TEVA-VS-3184266$TEVA$$47$YR$$F$Y$89.6$KG$20240828$$MD$US$US
237631403$23763140$3$F$20231101$20240709$20240419$20240710$EXP$$US-ALXN-202404USA001139US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
237631704$23763170$4$F$20130501$20240902$20240419$20240910$EXP$$PL-SANDOZ INC.-PHHY2014PL151647$SANDOZ$$28$YR$$M$Y$$$20240910$$MD$PL$PL
237631813$23763181$3$F$$20240625$20240419$20240703$EXP$$IL-JNJFOC-20240440518$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$PH$IL$IL
237631863$23763186$3$F$$20240821$20240419$20240827$EXP$$CA-SANDOZ INC.-SDZ2024CA039199$SANDOZ$$12$MON$$M$Y$$$20240827$$MD$CA$CA
237631973$23763197$3$F$$20240614$20240419$20240702$30DAY$$BE-JNJFOC-20240453999$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$BE$BE
237632262$23763226$2$F$20240418$20240627$20240419$20240702$PER$$US-AMGEN-USASP2024078851$AMGEN$$53$YR$A$M$Y$$$20240702$$CN$US$US
237632352$23763235$2$F$20240301$20240411$20240419$20240925$PER$$US-GSK-US2024AMR047546$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$CN$US$US
237632382$23763238$2$F$20240416$20240718$20240419$20240722$PER$$US-AMGEN-USASP2024077644$AMGEN$$81$YR$E$M$Y$$$20240721$$CN$US$US
237632765$23763276$5$F$20240216$20240725$20240419$20240731$EXP$$FR-EXELIXIS-XL18424076452$EXELIXIS$$$$$$Y$$$20240731$$MD$FR$FR
237632936$23763293$6$F$20240320$20240812$20240419$20240816$EXP$$US-BIOVITRUM-2024-US-005909$BIOVITRUM$$78$YR$$M$Y$$$20240816$$CN$US$US
237632942$23763294$2$F$$20240627$20240419$20240716$PER$$US-UniquePharma-US-2024UPLSPO00011$UNIQUE PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
237632982$23763298$2$F$$20240725$20240419$20240802$EXP$$US-BAYER-2024A053090$BAYER$$86$YR$E$M$Y$$$20240802$$CN$US$US
237633003$23763300$3$F$20240120$20240823$20240419$20240829$EXP$$CA-BIOGEN-2024BI01260359$BIOGEN$$40$YR$$F$Y$$$20240829$$PH$CA$CA
237633242$23763324$2$F$20240405$20240716$20240419$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-058529$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240716$$CN$CA$CA
237633444$23763344$4$F$$20240522$20240419$20240925$PER$$US-GSK-US2024AMR047516$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
237633483$23763348$3$F$$20240523$20240419$20240925$PER$$US-GSK-US2023AMR039889$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
237633642$23763364$2$F$20231121$20240905$20240419$20240909$EXP$$US-AstraZeneca-2024A093534$ASTRAZENECA$$79$YR$$M$Y$87$KG$20240909$$HP$US$
237633653$23763365$3$F$20230707$20240809$20240419$20240814$EXP$$JP-AstraZeneca-2024A090487$ASTRAZENECA$$63$YR$$F$Y$52$KG$20240814$$MD$JP$
237633702$23763370$2$F$$20240821$20240419$20240903$EXP$$US-SA-2024SA115209$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240903$$MD$US$US
237633852$23763385$2$F$20240601$20240725$20240419$20240806$PER$$US-SA-2024SA114088$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240806$$MD$US$US
237634002$23763400$2$F$$20240717$20240419$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058827$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240717$$HP$US$US
237634102$23763410$2$F$$20240725$20240419$20240903$PER$$US-LUNDBECK-DKLU3076409$LUNDBECK$$$$$$Y$$$20240903$$CN$US$US
237634142$23763414$2$F$20240328$20240723$20240419$20240731$EXP$$JP-AstraZeneca-2024A090291$ASTRAZENECA$$77$YR$$M$Y$55$KG$20240731$$MD$JP$
237634152$23763415$2$F$20240101$20240723$20240419$20240731$EXP$$JP-AstraZeneca-2024A090313$ASTRAZENECA$$86$YR$$F$Y$43$KG$20240731$$MD$JP$
2376344112$23763441$12$F$20231004$20240710$20240419$20240711$EXP$$NZ-MYLANLABS-2023M1105278$MYLAN$$65$YR$$M$Y$$$20240711$$PH$NZ$NZ
237634493$23763449$3$F$$20240711$20240419$20240715$PER$$NVSC2024US083629$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
237634504$23763450$4$F$20240314$20240731$20240419$20240814$PER$$US-Calliditas-2024CAL00587$CALLIDITAS THERAPEUTICS$$19$YR$A$M$Y$74.8$KG$20240813$$CN$US$US
237634613$23763461$3$F$$20240727$20240419$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-026298$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240805$$MD$JP$JP
237634653$23763465$3$F$20231107$20240625$20240419$20240701$EXP$$US-ABBVIE-5521012$ABBVIE$$67$YR$$M$Y$$$20240701$$CN$US$US
237634675$23763467$5$F$20240404$20240910$20240419$20240916$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-002099$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240916$$MD$JP$JP
237634733$23763473$3$F$$20240819$20240419$20240827$PER$$US-SA-2024SA114033$SANOFI AVENTIS$$60$YR$A$F$Y$79$KG$20240827$$MD$US$US
237634753$23763475$3$F$20240417$20240627$20240419$20240702$PER$$US-AMGEN-USASP2024079061$AMGEN$$64$YR$A$F$Y$$$20240702$$CN$US$US
237635162$23763516$2$F$20240101$20240903$20240419$20240912$EXP$$JP-009507513-2402JPN000030J$MERCK$$81$YR$$M$Y$$$20240912$$MD$JP$JP
237635242$23763524$2$F$$20240625$20240419$20240703$PER$$US-BIOGEN-2024BI01260459$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
237635382$23763538$2$F$20240101$20240718$20240419$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059741$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240718$$CN$US$US
237635502$23763550$2$F$$20240716$20240419$20240722$PER$$US-BIOGEN-2024BI01253956$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
237635573$23763557$3$F$$20240815$20240419$20240819$EXP$$CA-MYLANLABS-2024M1034608$MYLAN$$43$YR$$F$Y$96$KG$20240819$$HP$CA$CA
237635795$23763579$5$F$20240101$20240722$20240419$20240725$EXP$$US-PFIZER INC-202400089481$PFIZER$$60$YR$$F$Y$$$20240725$$HP$US$US
237635864$23763586$4$F$20240327$20240917$20240419$20240925$EXP$$CA-TAKEDA-2024TUS035911$TAKEDA$$44$YR$$F$Y$$$20240925$$CN$CA$CA
237635902$23763590$2$F$20240119$20240416$20240419$20240808$EXP$$NVSC2024US010253$NOVARTIS$$76$YR$$M$Y$90.26$KG$20240808$$CN$US$US
237635952$23763595$2$F$20240408$20240705$20240419$20240712$PER$$US-BIOMARINAP-US-2024-157101$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
237636464$23763646$4$F$$20240614$20240419$20240718$EXP$$NVSC2023KR200165$NOVARTIS$$$$A$M$Y$$$20240718$$MD$KR$KR
237636605$23763660$5$F$20220608$20240718$20240419$20240719$EXP$$JP-Eisai-EC-2022-117355$EISAI$$51$YR$A$F$Y$60$KG$20240719$$MD$JP$JP
237636664$23763666$4$F$20240101$20240809$20240419$20240813$EXP$$JP-Eisai-EC-2024-163714$EISAI$$$$E$$Y$72$KG$20240813$$HP$JP$JP
237636803$23763680$3$F$20230304$20240809$20240419$20240813$PER$$DE-Eisai-EC-2023-135923$EISAI$$64$YR$A$M$Y$67.5$KG$20240813$$MD$DE$DE
237636914$23763691$4$F$$20240628$20240419$20240705$EXP$$US-Taiho Oncology Inc-2023-004122$TAIHO ONCOLOGY INC$$69$YR$E$F$Y$$$20240705$$CN$US$US
237637085$23763708$5$F$20220411$20240830$20240419$20240909$EXP$$JP-PFIZER INC-202200763111$PFIZER$$2$MON$$F$Y$4.845$KG$20240909$$MD$JP$JP
237637213$23763721$3$F$20240213$20240823$20240419$20240829$EXP$$JP-AstraZeneca-2024A090187$ASTRAZENECA$$82$YR$$M$Y$62$KG$20240829$$MD$JP$
237637232$23763723$2$F$20231109$20240723$20240419$20240731$EXP$$JP-AstraZeneca-2024A090655$ASTRAZENECA$$56$YR$$M$Y$$$20240731$$MD$JP$
237637676$23763767$6$F$20240417$20240814$20240419$20240825$PER$$US-JNJFOC-20240457799$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240825$$HP$US$US
237637792$23763779$2$F$$20240729$20240419$20240805$EXP$$CA-BEH-2024170633$CSL BEHRING$$$$$F$Y$$$20240805$$CN$CA$CA
237638167$23763816$7$F$$20240919$20240419$20240923$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-117241$DAIICHI$$$$$M$Y$$$20240923$$MD$US$US
237638243$23763824$3$F$20240403$20240625$20240419$20240704$PER$$US-SA-2024SA116696$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240704$$MD$US$US
237638652$23763865$2$F$20240501$20240605$20240419$20240806$PER$$US-GALDERMA-US2024005172$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
237639202$23763920$2$F$$20240603$20240419$20240806$PER$$US-GALDERMA-US2024005695$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
237639963$23763996$3$F$20240408$20240709$20240419$20240710$EXP$$US-ALXN-202404USA001182US$ALEXION PHARMACEUTICALS$$62$YR$$M$Y$101.8$KG$20240710$$MD$US$US
237640142$23764014$2$F$$20240826$20240419$20240903$EXP$$US-ELI_LILLY_AND_COMPANY-US202404007385$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240903$$CN$US$US
237640692$23764069$2$F$20240101$20240924$20240419$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062218$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$88.45$KG$20240927$$CN$US$US
237640852$23764085$2$F$$20240710$20240419$20240722$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP004600$STRIDES$Watanabe Y, Hirai K, Hirata M, Kitano T, Ito K, Ookawara S, et al.. Steroid-resistant minimal change nephrotic syndrome associated with thymoma treated effectively with rituximab following thymectomy and cyclosporine: a case report.. BMC Nephrology. 2024;25(1):53$71$YR$$M$Y$$$20240722$$HP$JP$JP
237641323$23764132$3$F$20240301$20240918$20240419$20240922$EXP$$US-ABBVIE-5723390$ABBVIE$$60$YR$$M$Y$$$20240922$$CN$US$US
237641363$23764136$3$F$20240101$20240924$20240419$20240927$EXP$$US-ABBVIE-5723871$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
237641482$23764148$2$F$20231214$20240718$20240419$20240725$EXP$$CA-ABBVIE-5607328$ABBVIE$$60$YR$$M$Y$90.718$KG$20240725$$CN$CA$CA
237641782$23764178$2$F$20240101$20240731$20240420$20240807$EXP$$US-ABBVIE-5723880$ABBVIE$$41$YR$$F$Y$$$20240807$$CN$US$US
237641952$23764195$2$F$20231101$20240724$20240420$20240731$EXP$$US-ABBVIE-5721426$ABBVIE$$63$YR$$M$Y$$$20240731$$CN$US$US
237642192$23764219$2$F$$20240909$20240420$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000319$DECIPHERA PHARMACEUTICALS$$76$YR$E$M$Y$$$20240927$$CN$US$US
237642232$23764223$2$F$20240101$20240705$20240420$20240713$PER$$US-SA-2024SA117210$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240714$$MD$US$US
237642285$23764228$5$F$20240101$20240718$20240420$20240801$EXP$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000320$DECIPHERA PHARMACEUTICALS$$68$YR$A$M$Y$$$20240801$$MD$US$US
237642453$23764245$3$F$20240101$20240812$20240420$20240816$PER$$US-SA-2024SA043526$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240817$$MD$US$US
237642604$23764260$4$F$20240408$20240822$20240420$20240912$EXP$$US-SA-2024SA119055$SANOFI AVENTIS$$64$YR$A$M$Y$65.32$KG$20240912$$HP$US$US
237643052$23764305$2$F$$20240710$20240420$20240801$PER$$US-SA-2024SA114103$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240719$$MD$US$US
237643073$23764307$3$F$20240101$20240708$20240420$20240716$PER$$US-SA-2024SA116420$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240716$$MD$US$US
237643092$23764309$2$F$20240415$20240724$20240420$20240726$PER$$US-AMGEN-USASP2024077651$AMGEN$$65$YR$E$F$Y$$$20240726$$CN$US$US
237643113$23764311$3$F$$20240717$20240420$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060401$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$83.91$KG$20240717$$CN$US$US
237643302$23764330$2$F$20240101$20240724$20240420$20240802$PER$$US-SA-2024SA116836$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240802$$MD$US$US
237643725$23764372$5$F$$20240716$20240420$20240725$EXP$$GB-TORRENT-00036216$TORRENT$$$$T$M$Y$$$20240725$$MD$COUNTRY NOT SPECIFIED$GB
237643772$23764377$2$F$$20240410$20240420$20240905$PER$$US-HALEON-USCH2024014725$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
237643782$23764378$2$F$20240101$20240805$20240420$20240813$PER$$US-SA-2024SA115919$SANOFI AVENTIS$$98$YR$E$F$Y$$$20240814$$CN$US$US
237643812$23764381$2$F$$20240624$20240420$20240702$EXP$$US-SA-2024SA118526$SANOFI AVENTIS$$$$E$F$Y$80.74$KG$20240702$$MD$US$US
237644032$23764403$2$F$$20240726$20240420$20240807$PER$$US-SA-2024SA114719$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240807$$MD$US$US
237644073$23764407$3$F$$20240830$20240420$20240909$EXP$$IT-CELLTRION INC.-2024IT008987$CELLTRION$Novielli D.. Upadacitinib in concurrent Crohn^s disease, atopic dermatitis and alopecia areata: A case report. J Eur Acad Dermatol Venereol. 2024;38:e8-e10$$$$$Y$$$20240909$$HP$IT$IT
237644094$23764409$4$F$$20240906$20240420$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061546$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$60.33$KG$20240909$$CN$US$US
237644142$23764414$2$F$20240416$20240924$20240420$20240925$PER$$US-AMGEN-USASP2024078075$AMGEN$$73$YR$E$M$Y$$$20240925$$CN$US$US
237644302$23764430$2$F$20240101$20240808$20240420$20240812$EXP$$US-ABBVIE-5722967$ABBVIE$$60$YR$$M$Y$$$20240812$$CN$US$US
237644582$23764458$2$F$$20240402$20240420$20240905$PER$$US-HALEON-2166860$Haleon PLC$$$$$F$Y$$$20240905$$CN$US$US
237644803$23764480$3$F$20240101$20240719$20240420$20240802$PER$$US-SA-2024SA118978$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240802$$MD$US$US
237644943$23764494$3$F$$20240828$20240420$20240906$EXP$$CA-TEVA-VS-3184589$TEVA$$62$YR$$M$Y$$$20240906$$HP$CA$CA
237645222$23764522$2$F$$20240719$20240420$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061968$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240719$$CN$US$US
237645293$23764529$3$F$20240101$20240808$20240420$20240813$PER$$US-SA-2024SA097093$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240814$$MD$US$US
237645402$23764540$2$F$20240101$20240722$20240420$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000336$DECIPHERA PHARMACEUTICALS$$59$YR$A$M$Y$$$20240806$$CN$US$US
237645494$23764549$4$F$20240101$20240709$20240420$20240717$PER$$US-SA-2024SA116240$SANOFI AVENTIS$$64$YR$A$F$Y$68.03$KG$20240717$$MD$US$US
237645512$23764551$2$F$20240101$20240808$20240420$20240820$PER$$US-SA-2024SA116887$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240820$$MD$US$US
237645552$23764555$2$F$$20240722$20240420$20240730$PER$$US-SA-2024SA117213$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240730$$MD$US$US
237645624$23764562$4$F$20240101$20240917$20240420$20240923$PER$$US-SA-2024SA116801$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240923$$MD$US$US
237645643$23764564$3$F$20240401$20240726$20240420$20240801$PER$$US-SA-2024SA116200$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240801$$MD$US$US
237645812$23764581$2$F$20240416$20240808$20240420$20240809$PER$$US-AMGEN-USASP2024078480$AMGEN$$69$YR$E$F$Y$$$20240809$$CN$US$US
237646352$23764635$2$F$$20240712$20240420$20240801$EXP$$US-SA-2024SA118915$SANOFI AVENTIS$$$$A$F$Y$$$20240719$$MD$US$US
237646622$23764662$2$F$20240101$20240716$20240420$20240725$EXP$$US-ABBVIE-5726556$ABBVIE$$36$YR$$F$Y$61$KG$20240725$$HP$US$US
237646662$23764666$2$F$20210101$20240702$20240420$20240710$EXP$$US-SA-2024SA119598$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240710$$MD$US$US
237646762$23764676$2$F$20240416$20240802$20240420$20240802$PER$$US-AMGEN-USASP2024078560$AMGEN$$63$YR$A$F$Y$$$20240802$$CN$US$US
237647083$23764708$3$F$20240101$20240708$20240420$20240716$PER$$US-SA-2024SA119744$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240716$$MD$US$US
237647273$23764727$3$F$20240101$20240826$20240420$20240910$PER$$US-SA-2024SA116460$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240910$$MD$US$US
237647402$23764740$2$F$20230101$20240805$20240420$20240812$EXP$$CA-CELLTRION INC.-2023CA021803$CELLTRION$$$$$$Y$$$20240812$$CN$CA$CA
237647662$23764766$2$F$$20240820$20240420$20240826$EXP$$US-TAKEDA-2023TUS120930$TAKEDA$$$$$M$Y$$$20240826$$HP$US$US
237647792$23764779$2$F$20240313$20240801$20240420$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-017537$AUROBINDO$$7$MON$$M$Y$5.48$KG$20240812$$MD$FR$FR
237647874$23764787$4$F$20240101$20240711$20240420$20240720$EXP$$CA-CELLTRION INC.-2024CA009142$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
237647974$23764797$4$F$20240101$20240920$20240420$20240930$EXP$$CA-CELLTRION INC.-2024CA009243$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
237648096$23764809$6$F$20230101$20240919$20240420$20240924$EXP$$US-ABBVIE-5724905$ABBVIE$$$$$M$Y$82$KG$20240924$$CN$US$US
237648442$23764844$2$F$$20240919$20240420$20240924$EXP$$JP-ABBVIE-5726481$ABBVIE$$$$$$Y$$$20240924$$PH$JP$JP
237648463$23764846$3$F$20240412$20240722$20240420$20240729$EXP$$US-AMGEN-USASP2024077881$AMGEN$$56$YR$A$F$Y$$$20240729$$MD$US$US
237648533$23764853$3$F$$20240712$20240420$20240801$PER$$US-SA-2024SA119913$SANOFI AVENTIS$$$$E$M$Y$111$KG$20240719$$MD$US$US
237648652$23764865$2$F$20240417$20240827$20240420$20240829$PER$$US-AMGEN-USASP2024078565$AMGEN$$75$YR$E$M$Y$$$20240829$$HP$US$US
237648822$23764882$2$F$$20240716$20240420$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060026$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$72.562$KG$20240717$$CN$US$US
237648833$23764883$3$F$$20240726$20240420$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-017899$AUROBINDO$$64$YR$$M$Y$$$20240807$$HP$CA$CA
237648976$23764897$6$F$20240325$20240925$20240420$20240930$EXP$$US-TAKEDA-2024TUS037358$TAKEDA$$51$YR$$F$Y$$$20240930$$HP$US$US
237649012$23764901$2$F$20240417$20240730$20240420$20240801$PER$$US-AMGEN-USASP2024078698$AMGEN$$82$YR$E$M$Y$$$20240801$$CN$US$US
237649032$23764903$2$F$$20240628$20240420$20240702$PER$$US-AMGEN-USASP2024077930$AMGEN$$$$$M$Y$$$20240702$$MD$US$US
237649182$23764918$2$F$20240417$20240814$20240420$20240816$PER$$US-AMGEN-USASP2024079041$AMGEN$$52$YR$A$M$Y$$$20240816$$CN$US$US
237649192$23764919$2$F$$20240801$20240420$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-018146$AUROBINDO$$$$$F$Y$$$20240814$$HP$CA$CA
237649202$23764920$2$F$$20240906$20240420$20240911$EXP$$FR-AUROBINDO-AUR-APL-2024-006486$AUROBINDO$Strube N, Vigot-Matter L, Chaux AG, Hoornaert.A et al.,. Sinus lift with vestibular approach:  complications and failures.. Clinic. 2024;45(434):39-45$55$YR$$F$Y$$$20240911$$MD$FR$FR
237649382$23764938$2$F$$20240724$20240420$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-017951$AUROBINDO$$60$YR$$F$Y$$$20240806$$HP$CA$CA
237649482$23764948$2$F$$20240610$20240420$20240710$PER$$US-AstraZeneca-2024A090797$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
237649523$23764952$3$F$20240418$20240726$20240420$20240816$EXP$$US-ABBVIE-5726996$ABBVIE$$23$YR$$F$Y$$$20240816$$MD$US$US
237649662$23764966$2$F$20240418$20240703$20240420$20240704$PER$$US-AMGEN-USASP2024079153$AMGEN$$59$YR$A$F$Y$$$20240704$$HP$US$US
237649702$23764970$2$F$20240214$20240415$20240420$20240812$EXP$$NVSC2024AR074571$NOVARTIS$$40$YR$$F$Y$$$20240812$$CN$AR$AR
237649732$23764973$2$F$$20240726$20240420$20240806$PER$$US-SA-2024SA117350$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240806$$MD$US$US
237650052$23765005$2$F$$20240722$20240420$20240730$PER$$US-SA-2024SA116538$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240730$$MD$US$US
237650153$23765015$3$F$20230529$20240711$20240420$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-060023$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240719$$MD$JP$JP
237650417$23765041$7$F$20240101$20240920$20240420$20240930$EXP$$CA-CELLTRION INC.-2024CA009290$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
237650652$23765065$2$F$20240301$20240823$20240420$20240830$EXP$$US-ABBVIE-5725813$ABBVIE$$24$YR$$M$Y$$$20240830$$CN$US$US
237650722$23765072$2$F$$20240805$20240420$20240807$EXP$$US-ABBVIE-5725815$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
237650872$23765087$2$F$$20240726$20240420$20240806$PER$$US-SA-2024SA118078$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240806$$MD$US$US
237651064$23765106$4$F$20240101$20240829$20240420$20240911$PER$$US-SA-2024SA116564$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240911$$MD$US$US
237651293$23765129$3$F$$20240807$20240420$20240820$PER$$US-SA-2024SA115466$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240820$$MD$US$US
237651434$23765143$4$F$20221115$20240911$20240420$20240913$EXP$$US-ABBVIE-4729570$ABBVIE$$75$YR$$M$Y$83.914$KG$20240913$$CN$US$US
237651632$23765163$2$F$20240101$20240731$20240420$20240805$PER$$US-SA-2024SA118091$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
237651832$23765183$2$F$20230901$20240831$20240420$20240912$EXP$FR-AFSSAPS-NT2024000317$FR-Accord-419611$ACCORD$$78$YR$E$M$Y$69$KG$20240912$$MD$FR$FR
237651866$23765186$6$F$20230308$20240717$20240420$20240727$EXP$IE-EMA-2024320-AUTODUP-1710966772825$IE-Accord-419029$ACCORD$$68$YR$E$M$Y$$$20240727$$CN$IE$IE
237651933$23765193$3$F$20231008$20240725$20240420$20240730$EXP$$JP-ABBVIE-5726465$ABBVIE$$81$YR$$F$Y$43$KG$20240730$$MD$JP$JP
237652082$23765208$2$F$20231208$20240814$20240420$20240820$EXP$$CZ-ABBVIE-5727700$ABBVIE$$57$YR$$M$Y$89$KG$20240820$$MD$CZ$CZ
237652242$23765224$2$F$20230901$20240729$20240420$20240806$PER$$US-SA-2024SA115048$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240806$$MD$US$US
237652366$23765236$6$F$20240813$20240911$20240420$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061898$BRISTOL MYERS SQUIBB$$23$YR$A$F$Y$$$20240913$$HP$US$US
237652504$23765250$4$F$20240413$20240719$20240420$20240729$PER$$US-SA-2024SA117446$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240729$$HP$US$US
237652672$23765267$2$F$20240417$20240726$20240420$20240730$PER$$US-AMGEN-USASP2024079192$AMGEN$$74$YR$E$F$Y$$$20240730$$CN$US$US
237652682$23765268$2$F$20240101$20240726$20240420$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-017436$AUROBINDO$$77$YR$$F$Y$$$20240807$$MD$FR$FR
237652743$23765274$3$F$$20240730$20240420$20240806$EXP$$PT-SA-2024SA120348$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240806$$CN$PT$PT
237652842$23765284$2$F$20230101$20240702$20240420$20240712$EXP$$US-UNITED THERAPEUTICS-UNT-2023-037655$UNITED THERAPEUTICS$$$$$M$Y$68.481$KG$20240712$$$US$US
237652963$23765296$3$F$$20240416$20240420$20240731$EXP$$CA-SA-2024SA118238$SANOFI AVENTIS$$43$YR$A$F$Y$70$KG$20240731$$HP$CA$CA
237652984$23765298$4$F$20230101$20240705$20240420$20240710$EXP$$US-UCBSA-2023044843$UCB$$$$$F$Y$19.05$KG$20240710$$MD$US$US
237653092$23765309$2$F$20240405$20240730$20240420$20240809$EXP$$CH-TEVA-VS-3181578$TEVA$$42$YR$$F$Y$$$20240809$$CN$CH$CH
237653102$23765310$2$F$$20240724$20240420$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059536$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$89.09$KG$20240801$$CN$US$US
237653132$23765313$2$F$20240201$20240823$20240420$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-017441$AUROBINDO$$34$YR$$M$Y$$$20240902$$MD$FR$FR
237653153$23765315$3$F$$20240702$20240420$20240708$EXP$$US-SA-2024SA110093$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240708$$MD$US$US
237653444$23765344$4$F$20201101$20240826$20240420$20240909$PER$$US-SA-2024SA115515$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240909$$MD$US$US
237653462$23765346$2$F$20240101$20240813$20240420$20240821$PER$$US-SA-2024SA118760$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240821$$MD$US$US
237653492$23765349$2$F$20240101$20240730$20240420$20240808$PER$$US-SA-2024SA115509$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240808$$MD$US$US
237653543$23765354$3$F$20240301$20240716$20240420$20240718$EXP$$US-UCBSA-2024018408$UCB$$61$YR$$F$Y$$$20240718$$HP$US$US
237653563$23765356$3$F$20240406$20240724$20240420$20240729$PER$$US-AMGEN-USASP2024077633$AMGEN$$58$YR$A$M$Y$$$20240728$$HP$US$US
237653602$23765360$2$F$$20240808$20240420$20240812$EXP$$NVSC2024US082541$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
237653842$23765384$2$F$20230919$20240702$20240420$20240711$PER$$US-SA-2024SA112022$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240711$$MD$US$US
237654084$23765408$4$F$20240101$20240801$20240420$20240810$PER$$US-SA-2024SA118873$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240810$$MD$US$US
237654103$23765410$3$F$20240417$20240813$20240420$20240815$PER$$US-AMGEN-USASP2024079575$AMGEN$$64$YR$A$M$Y$$$20240815$$CN$US$US
237654152$23765415$2$F$20240401$20240724$20240420$20240802$PER$$US-SA-2024SA115308$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240802$$MD$US$US
237654252$23765425$2$F$20240416$20240807$20240420$20240809$PER$$US-AMGEN-USASP2024080051$AMGEN$$67$YR$E$F$Y$$$20240809$$CN$US$US
237654352$23765435$2$F$$20240726$20240420$20240805$PER$$US-SA-2024SA114776$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240805$$MD$US$US
237654412$23765441$2$F$20240308$20240730$20240420$20240802$EXP$$US-JNJFOC-20240433773$JOHNSON AND JOHNSON$$64$YR$A$M$Y$82$KG$20240802$$HP$US$US
237654502$23765450$2$F$20240101$20240810$20240420$20240821$PER$$US-SA-2024SA119229$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240821$$CN$US$US
237654603$23765460$3$F$20230701$20240710$20240420$20240714$EXP$$US-ABBVIE-5582696$ABBVIE$$57$YR$$F$Y$$$20240714$$CN$US$US
237654892$23765489$2$F$20240408$20240830$20240420$20240913$PER$$US-SA-2024SA115356$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240913$$MD$US$US
237655012$23765501$2$F$$20240729$20240420$20240806$PER$$US-SA-2024SA115062$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240806$$MD$US$US
237655032$23765503$2$F$20240408$20240824$20240420$20240830$EXP$$NVSC2024IN082806$NOVARTIS$$65$YR$$M$Y$$$20240830$$CN$IN$IN
237655222$23765522$2$F$$20240628$20240420$20240708$EXP$$US-VIIV HEALTHCARE LIMITED-US2024045617$VIIV$$$$$M$Y$76$KG$20240708$$MD$US$US
237655412$23765541$2$F$20240101$20240712$20240420$20240723$PER$$US-SA-2024SA113692$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240723$$MD$US$US
237655515$23765551$5$F$$20240808$20240420$20240820$PER$$US-SA-2024SA118587$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240820$$MD$US$US
237655602$23765560$2$F$20240408$20240723$20240420$20240730$PER$$US-SA-2024SA115288$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240730$$MD$US$US
237655622$23765562$2$F$20240212$20240712$20240420$20240719$EXP$$CO-GSK-CO2024AMR020379$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$CN$CO$CO
237655652$23765565$2$F$20240101$20240720$20240420$20240729$PER$$US-SA-2024SA115063$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240729$$MD$US$US
237655673$23765567$3$F$$20240906$20240420$20240910$EXP$$US-PAREXEL-2021US002852$TAKEDA$$$$$F$Y$93$KG$20240910$$CN$US$US
237655722$23765572$2$F$$20240730$20240420$20240807$PER$$US-SA-2024SA119910$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240807$$MD$US$US
237655736$23765573$6$F$20240101$20240623$20240420$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011406$UNITED THERAPEUTICS$$$$$F$Y$41.723$KG$20240703$$$US$US
237655892$23765589$2$F$20240101$20240722$20240420$20240731$PER$$US-SA-2024SA115840$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240731$$MD$US$US
237655962$23765596$2$F$$20240823$20240420$20240906$PER$$US-SA-2024SA115131$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240906$$MD$US$US
237656023$23765602$3$F$$20240913$20240420$20240919$30DAY$$GB-JNJFOC-20240403546$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$CN$GB$GB
237656146$23765614$6$F$$20240917$20240421$20240926$EXP$$CA-ROCHE-3548004$ROCHE$$$$A$F$Y$$$20240926$$HP$CA$CA
237656522$23765652$2$F$20240401$20240917$20240421$20240925$PER$$US-SA-2024SA118141$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240925$$MD$US$US
237656572$23765657$2$F$20240401$20240806$20240421$20240813$PER$$US-SA-2024SA115672$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240814$$CN$US$US
237656884$23765688$4$F$$20240725$20240421$20240730$PER$$NVSC2024US083221$NOVARTIS$$$$$M$Y$$$20240730$$CN$US$US
237656982$23765698$2$F$$20240815$20240421$20240829$PER$$US-SA-2024SA118827$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240829$$MD$US$US
237657182$23765718$2$F$20231230$20240626$20240421$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-017407$AUROBINDO$$73$YR$$F$Y$61$KG$20240703$$MD$FR$FR
237657264$23765726$4$F$20240101$20240701$20240421$20240708$EXP$$US-SA-2024SA120336$SANOFI AVENTIS$$81$YR$E$F$Y$72.5$KG$20240708$$MD$US$US
237657342$23765734$2$F$$20240716$20240421$20240725$30DAY$$US-GSK-US2024047421$GLAXOSMITHKLINE$$$$$M$Y$89.35$KG$20240725$$HP$US$US
237657464$23765746$4$F$20160901$20240718$20240421$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-017653$AUROBINDO$$34$YR$$M$Y$$$20240729$$CN$FR$FR
237657582$23765758$2$F$20240324$20240725$20240421$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-017710$AUROBINDO$$22$YR$$F$Y$58.7$KG$20240805$$MD$FR$FR
237657802$23765780$2$F$20230801$20240729$20240421$20240807$PER$$US-SA-2024SA117848$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240807$$MD$US$US
237657923$23765792$3$F$20240101$20240624$20240421$20240703$PER$$US-SA-2024SA116406$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240703$$MD$US$US
237658162$23765816$2$F$20240101$20240702$20240421$20240709$PER$$US-SA-2024SA116757$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240709$$MD$US$US
237658172$23765817$2$F$20240811$20240814$20240421$20240828$PER$$US-SA-2024SA116798$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240828$$MD$US$US
237658202$23765820$2$F$$20240620$20240421$20240703$PER$$US-SA-2024SA116701$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240703$$MD$US$US
237658432$23765843$2$F$$20240819$20240421$20240822$EXP$$CA-GSK-CA2024AMR049648$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$CA$CA
237658723$23765872$3$F$20240101$20240911$20240421$20240916$EXP$$US-ABBVIE-5687513$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
237658982$23765898$2$F$20240301$20240809$20240421$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-050655$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240819$$PH$US$US
237659073$23765907$3$F$20240101$20240711$20240421$20240722$EXP$$US-ABBVIE-5726142$ABBVIE$$52$YR$$F$Y$86$KG$20240719$$CN$US$US
237659254$23765925$4$F$$20240813$20240421$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061649$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240814$$CN$US$US
237659262$23765926$2$F$20240301$20240626$20240421$20240702$EXP$$NVSC2024HU082803$NOVARTIS$$$$A$F$Y$$$20240702$$MD$HU$HU
237659312$23765931$2$F$20240301$20240809$20240421$20240820$PER$$US-SA-2024SA115922$SANOFI AVENTIS$$64$YR$A$F$Y$66.67$KG$20240820$$MD$US$US
237659472$23765947$2$F$20240412$20240818$20240421$20240823$EXP$$NVSJ2024JP004752$NOVARTIS$$6$MON$$F$Y$8.5$KG$20240823$$MD$JP$JP
237659482$23765948$2$F$$20240802$20240421$20240808$PER$$US-ABBVIE-5721663$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
237659625$23765962$5$F$20240201$20240718$20240421$20240725$EXP$$JP-SA-2024SA117263$SANOFI AVENTIS$$77$YR$E$M$Y$45.3$KG$20240725$$MD$JP$JP
237659823$23765982$3$F$$20240718$20240421$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000797$BLUEPRINT MEDICINES$$$$$M$Y$$$20240726$$CN$US$US
237660026$23766002$6$F$20230101$20240821$20240421$20240826$EXP$$US-ABBVIE-5724744$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
237660112$23766011$2$F$20230601$20240716$20240421$20240719$EXP$$CA-BIOGEN-2024BI01260536$BIOGEN$$36$YR$$F$Y$$$20240719$$CN$CA$CA
237660232$23766023$2$F$$20240626$20240421$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061149$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240704$$CN$US$US
237660392$23766039$2$F$20240415$20240722$20240421$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060522$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240722$$CN$US$US
237660522$23766052$2$F$20231002$20240716$20240421$20240723$EXP$$US-ABBVIE-5726630$ABBVIE$$70$YR$$F$Y$81$KG$20240723$$CN$US$US
237661092$23766109$2$F$20240409$20240730$20240421$20240802$EXP$$US-ABBVIE-5723415$ABBVIE$$69$YR$$F$Y$$$20240802$$CN$US$US
237661158$23766115$8$F$20240101$20240905$20240421$20240910$EXP$$IL-ABBVIE-5727179$ABBVIE$$$$$M$Y$$$20240910$$MD$IL$IL
237661287$23766128$7$F$20240411$20240717$20240421$20240725$PER$$US-ALXN-202404USA001081US$ALEXION PHARMACEUTICALS$$77$YR$$F$Y$$$20240725$$CN$US$US
237661292$23766129$2$F$$20240716$20240421$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061603$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240719$$HP$US$US
237661352$23766135$2$F$$20240822$20240422$20240829$EXP$$IL-JNJFOC-20240461013$JOHNSON AND JOHNSON$$53$YR$A$$Y$$$20240829$$MD$IL$IL
237661412$23766141$2$F$20240409$20240829$20240422$20240829$PER$$US-JNJFOC-20240432476$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240829$$HP$US$US
237661816$23766181$6$F$20180101$20240919$20240422$20240925$EXP$$JP-GSK-JP2024JPN048273$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$PH$JP$JP
237661862$23766186$2$F$$20240827$20240422$20240904$EXP$$US-ABBVIE-5725991$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
237662242$23766224$2$F$$20240906$20240422$20240912$EXP$$US-ABBVIE-5727384$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
237662292$23766229$2$F$$20240719$20240422$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062111$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240719$$CN$US$US
237662402$23766240$2$F$20230324$20240627$20240422$20240702$EXP$$US-ABBVIE-4732917$ABBVIE$$75$YR$$M$Y$$$20240702$$CN$US$US
237662412$23766241$2$F$20240101$20240715$20240422$20240719$EXP$$CA-ABBVIE-5723538$ABBVIE$$75$YR$$F$Y$$$20240719$$CN$CA$CA
237662472$23766247$2$F$$20240722$20240422$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062139$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240722$$CN$US$US
237662502$23766250$2$F$20231201$20240625$20240422$20240701$EXP$$US-ABBVIE-5727097$ABBVIE$$66$YR$$F$Y$$$20240701$$CN$US$US
237662682$23766268$2$F$20230101$20240919$20240422$20240926$EXP$$US-ABBVIE-5727326$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
237662953$23766295$3$F$20230505$20240917$20240422$20240924$EXP$$AU-TAKEDA-2020TUS020935$TAKEDA$$60$YR$$F$Y$$$20240924$$HP$AU$AU
237663064$23766306$4$F$$20240709$20240422$20240714$EXP$$CA-ApotexCA-000573$AVEVA$$60$YR$A$F$Y$61$KG$20240715$$MD$CA$CA
237663392$23766339$2$F$20240101$20240710$20240422$20240718$PER$$US-SA-2024SA078649$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240718$$MD$US$US
237663422$23766342$2$F$$20240701$20240422$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03186$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237663552$23766355$2$F$$20240701$20240422$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03197$LUPIN$$$$$$Y$$$20240719$$CN$US$US
237663592$23766359$2$F$$20240628$20240422$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03146$LUPIN$$$$$$Y$$$20240716$$PH$US$US
237663603$23766360$3$F$$20240716$20240422$20240720$EXP$$US-TAKEDA-2024TUS033686$TAKEDA$$$$$F$Y$$$20240720$$CN$US$US
237663652$23766365$2$F$$20240703$20240422$20240711$EXP$$CA-TAKEDA-2024TUS037435$TAKEDA$$$$$M$Y$$$20240711$$CN$CA$CA
237663732$23766373$2$F$20210712$20240912$20240422$20240917$EXP$$DE-SANDOZ INC.-NVSC2021DE174064$SANDOZ$$$$E$F$Y$78$KG$20240917$$HP$DE$DE
237663752$23766375$2$F$20240416$20240808$20240422$20240810$PER$$US-AMGEN-USASP2024078345$AMGEN$$64$YR$A$M$Y$$$20240809$$CN$US$US
237663832$23766383$2$F$$20240807$20240422$20240817$EXP$$CA-BAXTER-2024BAX016925$BAXTER$$35$YR$$F$Y$$$20240817$$HP$CA$CA
237663942$23766394$2$F$$20240821$20240422$20240831$EXP$$CA-BAXTER-2024BAX017079$BAXTER$$36$YR$$M$Y$$$20240831$$HP$CA$CA
237664102$23766410$2$F$20240403$20240815$20240422$20240822$EXP$$CA-TAKEDA-2024TUS035771$TAKEDA$$66$YR$$M$Y$95$KG$20240822$$HP$CA$CA
237664142$23766414$2$F$20240329$20240715$20240422$20240725$EXP$NO-NOMAADVRE-RELISSO-2024-Vak54w$NO-NOVOPROD-1203061$NOVO NORDISK$$49$YR$$M$Y$182$KG$20240725$$MD$NO$NO
237664303$23766430$3$F$20240402$20240815$20240422$20240826$EXP$$CA-TAKEDA-2024TUS036796$TAKEDA$$72$YR$$F$Y$78$KG$20240826$$HP$CA$CA
237664492$23766449$2$F$20240101$20240628$20240422$20240709$EXP$$US-NOVOPROD-1205473$NOVO NORDISK$$$$E$F$Y$$$20240709$$CN$US$US
237664545$23766454$5$F$20240403$20240621$20240422$20240702$30DAY$$BR-NOVOPROD-1205625$NOVO NORDISK$$60$YR$$M$Y$94$KG$20240702$$CN$BR$BR
237664563$23766456$3$F$20170101$20240629$20240422$20240709$EXP$$US-NOVOPROD-1206410$NOVO NORDISK$$70$YR$$F$Y$72.109$KG$20240709$$MD$US$US
237664622$23766462$2$F$$20240622$20240422$20240702$EXP$$US-NOVOPROD-1189263$NOVO NORDISK$$$$$F$Y$$$20240702$$CN$US$US
237664695$23766469$5$F$20230101$20240910$20240422$20240919$EXP$$CA-CELLTRION INC.-2023CA014113$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
237664743$23766474$3$F$20240301$20240722$20240422$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062263$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240722$$CN$US$US
237664922$23766492$2$F$20240418$20240730$20240422$20240801$EXP$$US-TAKEDA-US202005301$TAKEDA$$66$YR$$F$Y$$$20240801$$MD$US$US
237664962$23766496$2$F$20240219$20240905$20240422$20240910$EXP$$CA-TAKEDA-2023TUS093577$TAKEDA$$76$YR$$M$Y$$$20240910$$CN$CA$CA
237665512$23766551$2$F$$20240822$20240422$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061012$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240826$$CN$US$US
237665673$23766567$3$F$20240415$20240702$20240422$20240709$EXP$$CA-TAKEDA-2024TUS034680$TAKEDA$$34$YR$$F$Y$99$KG$20240709$$CN$CA$CA
237665803$23766580$3$F$$20240828$20240422$20240902$EXP$$CA-JNJFOC-20240459612$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240902$$CN$CA$CA
237665823$23766582$3$F$$20240819$20240422$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-018267$AUROBINDO$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al.. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$56$YR$$M$Y$$$20240902$$MD$US$US
237665922$23766592$2$F$$20240718$20240422$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060569$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240719$$CN$US$US
237665932$23766593$2$F$$20240717$20240422$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-018242$AUROBINDO$Al-Toubah T, Pelle E, Hallanger-Johnson J, Haider M, Strosberg J. ACTH-secreting pancreatic neuroendocrine neoplasms: A case-series. J-Neuroendocrinol. 2023;351-8$48$YR$$F$Y$$$20240726$$HP$US$US
237666073$23766607$3$F$20240327$20240916$20240422$20240920$PER$$US-BIOVITRUM-2024-US-006033$BIOVITRUM$$80$YR$$F$Y$$$20240920$$CN$US$US
237666232$23766623$2$F$$20240924$20240422$20240927$EXP$$CA-HALEON-2168438$Haleon PLC$$54$YR$$F$Y$$$20240927$$HP$CA$CA
237666272$23766627$2$F$20240417$20240811$20240422$20240812$PER$$US-AMGEN-USASP2024079374$AMGEN$$72$YR$E$F$Y$$$20240812$$HP$US$US
237666406$23766640$6$F$20230101$20240621$20240422$20240704$EXP$$NVSC2024KR070409$NOVARTIS$$$$A$M$Y$$$20240704$$CN$KR$KR
237666504$23766650$4$F$20240404$20240815$20240422$20240824$EXP$$US-GSK-US2024AMR047691$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240824$$CN$US$US
237666762$23766676$2$F$$20240717$20240422$20240723$EXP$$GB-SANDOZ INC.-SDZ2024GB040660$SANDOZ$$$$$F$Y$$$20240723$$CN$GB$GB
237667072$23766707$2$F$20240414$20240719$20240422$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060780$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240719$$CN$US$US
237667145$23766714$5$F$$20240913$20240422$20240915$EXP$$US-ALXN-202404USA001175US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$HP$US$US
237667153$23766715$3$F$$20240819$20240422$20240831$EXP$$US-AUROBINDO-AUR-APL-2024-018274$AUROBINDO$Jillella AP, Shishkina I, Giddens G, Corley C, K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$63$YR$$M$Y$$$20240831$$MD$US$US
237667223$23766722$3$F$$20240618$20240422$20240703$EXP$$JP-ROCHE-3546052$ROCHE$$54$YR$A$F$Y$$$20240703$$PH$JP$JP
237667303$23766730$3$F$$20240731$20240422$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-062243$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240731$$PH$JP$JP
237667542$23766754$2$F$$20240712$20240422$20240719$EXP$$JP-AMGEN-JPNSP2024077459$AMGEN$$$$$$Y$$$20240719$$HP$JP$JP
237667574$23766757$4$F$20240309$20240722$20240422$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-062292$BRISTOL MYERS SQUIBB$$9$DEC$E$F$Y$$$20240722$$MD$JP$JP
237667773$23766777$3$F$20240626$20240709$20240422$20240710$EXP$$US-TAKEDA-2024TUS035455$TAKEDA$$64$YR$$F$Y$$$20240710$$CN$US$US
237667964$23766796$4$F$20240101$20240916$20240422$20240926$EXP$$US-INSMED, INC.-2024-01522-US$INSMED$$$$$M$Y$$$20240926$$CN$US$US
237668123$23766812$3$F$$20240627$20240422$20240703$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000801$BLUEPRINT MEDICINES$$$$$F$Y$$$20240703$$CN$US$US
237668152$23766815$2$F$20240417$20240727$20240422$20240731$PER$$US-AMGEN-USASP2024078362$AMGEN$$63$YR$A$M$Y$$$20240731$$CN$US$US
237668482$23766848$2$F$$20240819$20240422$20240831$EXP$$US-AUROBINDO-AUR-APL-2024-018271$AUROBINDO$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$64$YR$$F$Y$$$20240831$$MD$US$US
237668513$23766851$3$F$20230901$20240701$20240422$20240703$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-269450$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$$$20240703$$MD$US$US
237668552$23766855$2$F$$20240415$20240422$20240926$PER$$US-GSK-US2024AMR049666$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
237668683$23766868$3$F$$20240710$20240422$20240716$EXP$$US-TAKEDA-2024TUS030310$TAKEDA$$$$$F$Y$$$20240716$$HP$US$US
237669065$23766906$5$F$20240324$20240628$20240422$20240711$EXP$$US-ACORDA-ACO_176876_2024$ACORDA$$73$YR$$M$Y$$$20240711$$CN$US$US
237669162$23766916$2$F$$20240923$20240422$20240926$EXP$$CA-HALEON-2168518$Haleon PLC$$66$YR$$M$Y$$$20240926$$HP$CA$CA
237669402$23766940$2$F$20240408$20240718$20240422$20240727$EXP$$US-GSK-US2024047363$GLAXOSMITHKLINE$$74$YR$$M$Y$$$20240727$$CN$US$US
237669832$23766983$2$F$$20240802$20240422$20240808$EXP$$US-ABBVIE-5729197$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
237670292$23767029$2$F$$20240412$20240422$20240925$PER$$US-GSK-US2024AMR049159$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
237670892$23767089$2$F$$20240819$20240422$20240831$EXP$$US-AUROBINDO-AUR-APL-2024-018273$AUROBINDO$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al.. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$60$YR$$F$Y$$$20240831$$MD$US$US
237670904$23767090$4$F$20240413$20240814$20240422$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005858$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240906$$CN$US$US
237671002$23767100$2$F$$20240723$20240422$20240725$EXP$$US-JNJFOC-20240449894$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$MD$US$US
237671074$23767107$4$F$20240416$20240911$20240422$20240920$PER$$US-AMGEN-USASP2024077685$AMGEN$$24$YR$A$M$Y$52.608$KG$20240920$$PH$US$US
237671252$23767125$2$F$$20240819$20240422$20240830$EXP$$US-AUROBINDO-AUR-APL-2024-018269$AUROBINDO$Jillella AP, Shishkina I, Giddens G, Corley C, K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$62$YR$$M$Y$$$20240830$$MD$US$US
237671425$23767142$5$F$20240401$20240820$20240422$20240827$EXP$$US-GSK-US2024AMR048460$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240827$$CN$US$US
237671433$23767143$3$F$20240229$20240807$20240422$20240809$EXP$FR-AFSSAPS-BX2024000738$FR-GSK-FR2024050916$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$MD$FR$FR
237671522$23767152$2$F$$20240719$20240422$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062359$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$74.39$KG$20240724$$CN$US$US
237672022$23767202$2$F$$20240627$20240422$20240701$EXP$$JP-ASTELLAS-2023JP000185$ASTELLAS$$65$YR$$M$Y$$$20240701$$MD$JP$JP
237672064$23767206$4$F$20240101$20240903$20240422$20240905$EXP$$NVSC2024US016848$NOVARTIS$$58$YR$$F$Y$64.86$KG$20240905$$CN$US$US
237672113$23767211$3$F$20240326$20240819$20240422$20240824$EXP$$JP-AstraZeneca-2024A092452$ASTRAZENECA$$70$YR$$M$Y$66$KG$20240823$$MD$JP$
237672173$23767217$3$F$$20240725$20240422$20240730$EXP$$JP-ASTELLAS-2024JP002629$ASTELLAS$$$$E$M$Y$$$20240730$$MD$JP$JP
237672272$23767227$2$F$$20240722$20240422$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062144$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240722$$CN$US$US
237672552$23767255$2$F$$20240620$20240422$20240701$EXP$$CA-APOTEX-2024AP004754$APOTEX$$52$YR$$F$Y$$$20240701$$HP$CA$CA
237672662$23767266$2$F$$20240819$20240422$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-018275$AUROBINDO$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.):12547-12548$76$YR$$M$Y$$$20240829$$MD$US$US
237672952$23767295$2$F$$20240819$20240422$20240831$EXP$$US-AUROBINDO-AUR-APL-2024-018277$AUROBINDO$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al.. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$74$YR$$M$Y$$$20240831$$MD$US$US
237673543$23767354$3$F$$20240709$20240422$20240712$EXP$$US-GSK-US2024048064$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$US$US
237673674$23767367$4$F$$20240716$20240422$20240720$EXP$$CA-JNJFOC-20240451518$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240719$$HP$CA$CA
237673704$23767370$4$F$$20240904$20240422$20240905$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-023244$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$$$20240905$$CN$US$US
237673832$23767383$2$F$20240401$20240807$20240422$20240807$PER$$US-ALXN-202404USA001107US$ALEXION PHARMACEUTICALS$$70$YR$$M$Y$$$20240807$$CN$US$US
237673983$23767398$3$F$$20240715$20240422$20240723$EXP$$CA-APOTEX-2024AP004702$APOTEX$$44$YR$$M$Y$$$20240723$$HP$CA$CA
237674632$23767463$2$F$$20240712$20240422$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062350$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240715$$CN$US$US
237674712$23767471$2$F$20201101$20240725$20240422$20240801$EXP$$NVSC2024BR083965$NOVARTIS$$76$YR$$F$Y$64$KG$20240801$$CN$BR$BR
237674862$23767486$2$F$$20240716$20240422$20240722$EXP$$CA-BIOGEN-2024BI01260583$BIOGEN$$$$$F$Y$$$20240722$$HP$CA$CA
237675122$23767512$2$F$20240401$20240715$20240422$20240722$EXP$$US-ASTELLAS-2024US011406$ASTELLAS$$$$$M$Y$$$20240719$$CN$US$US
237675232$23767523$2$F$$20240722$20240422$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061327$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240722$$CN$US$US
237675352$23767535$2$F$20190103$20240711$20240422$20240716$PER$$US-BIOVITRUM-2024-US-002912$BIOVITRUM$$43$YR$$F$Y$$$20240716$$CN$US$US
237675953$23767595$3$F$$20240618$20240422$20240704$30DAY$$US-GSK-US2024047353$GLAXOSMITHKLINE$$$$$M$Y$$$20240704$$CN$US$US
237676543$23767654$3$F$20231101$20240805$20240422$20240809$EXP$$NVSC2024CO059947$NOVARTIS$$15$YR$$M$Y$63$KG$20240809$$CN$CO$CO
237676692$23767669$2$F$20231104$20240901$20240422$20240905$EXP$$ES-ROCHE-3543346$ROCHE$$59$YR$A$M$Y$72.5$KG$20240905$$MD$ES$ES
237676884$23767688$4$F$20231212$20240711$20240422$20240723$EXP$$US-BAYER-2024A052453$BAYER$$1$YR$I$F$Y$6.848$KG$20240723$$CN$US$US
237677023$23767702$3$F$$20240701$20240422$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03191$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237677079$23767707$9$F$20231122$20240807$20240422$20240812$EXP$$CA-ROCHE-3472342$ROCHE$$43$YR$A$F$Y$$$20240812$$HP$CA$CA
237677192$23767719$2$F$$20240712$20240422$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062376$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$95.25$KG$20240716$$CN$US$US
237677363$23767736$3$F$$20240828$20240422$20240902$PER$$US-BIOGEN-2022BI01122348$BIOGEN$$$$$F$Y$$$20240902$$CN$US$US
237677403$23767740$3$F$20231015$20240610$20240422$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001576$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240705$$CN$US$US
237677552$23767755$2$F$$20240717$20240422$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-018240$AUROBINDO$Al-Toubah T, Pelle E, Hallanger-Johnson J, Haider M, Strosberg J. ACTH-secreting pancreatic neuroendocrine neoplasms: A case-series. J-Neuroendocrinol. 2023;351-8:e13336$29$YR$$M$Y$$$20240726$$HP$US$US
237677642$23767764$2$F$$20240819$20240422$20240830$EXP$$US-AUROBINDO-AUR-APL-2024-018270$AUROBINDO$Jillella AP, Bradshaw D, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.):12547-12548$69$YR$$M$Y$$$20240830$$MD$US$US
237677655$23767765$5$F$$20240916$20240422$20240925$EXP$$US-INSMED, INC.-2024-00567-US$INSMED$$$$$F$Y$$$20240925$$CN$US$US
237677983$23767798$3$F$$20240821$20240422$20240902$EXP$CA-APOTEX-2024AP004646$CA-Accord-420705$ACCORD$$66$YR$E$M$Y$$$20240902$$HP$CA$CA
237678272$23767827$2$F$$20240819$20240422$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-018279$AUROBINDO$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al.. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$70$YR$$M$Y$$$20240829$$MD$US$US
237678453$23767845$3$F$$20240819$20240422$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-018272$AUROBINDO$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al.. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$59$YR$$M$Y$$$20240902$$MD$US$US
237678688$23767868$8$F$$20240729$20240422$20240809$EXP$$PL-AUROBINDO-AUR-APL-2024-018508$AUROBINDO$Woro? J, Siwek M. Bolesny wytrysk jako konsekwencja niekorzystnych interakcji escitalopramu, mianseryny i fluorochinolon?w u pacjenta cierpi?cego na depresj?.Medycyna Praktyczna Psychiatria(Painful ejaculation as consequence unfavorable interactions escitalopram, mianserins i fluoroquinolones u patient suffering from depression) (Painful ejaculation as a consequence of unfavorable interactions of escitalopram, mianserins and fluoroquinolones in a patient suffering from depression). Medycyna Prak$24$YR$$M$Y$$$20240809$$MD$PL$PL
237678974$23767897$4$F$$20240909$20240422$20240913$EXP$$GR-MYLANLABS-2024M1034922$MYLAN$Theodoridou P, Pastirmatzi E, Samaras K, Stefanidis C, Gouliaros N, Chatzielephateriou C. Cardiac tamponade of left ventricle in a patient with severe Pulmonary Hypertension: an interesting case. Hearts and vessels. 2024;29 (1)$82$YR$$M$Y$$$20240913$$MD$GR$GR
237678984$23767898$4$F$20231201$20240717$20240422$20240722$EXP$$AU-ORGANON-O2404AUS002335$ORGANON$$27$YR$$F$Y$$$20240722$$MD$AU$AU
237679332$23767933$2$F$20240118$20240827$20240422$20240902$EXP$$NVSC2024KZ043832$NOVARTIS$$59$YR$$F$Y$70$KG$20240902$$MD$KZ$KZ
237679455$23767945$5$F$20220101$20240621$20240422$20240701$EXP$$GB-RDY-SPO/GBR/24/0005847$DR REDDYS$$$$$M$Y$$$20240701$$MD$GB$GB
237679793$23767979$3$F$20240309$20240722$20240422$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062290$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240722$$MD$US$US
237679822$23767982$2$F$20240301$20240730$20240422$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061644$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240801$$HP$US$US
237680353$23768035$3$F$$20240701$20240422$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03192$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237680473$23768047$3$F$20240411$20240621$20240422$20240710$30DAY$$US-GSK-US2024047413$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240710$$CN$US$US
237680503$23768050$3$F$$20240805$20240422$20240812$30DAY$$US-GSK-US2024047423$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
237680565$23768056$5$F$$20240913$20240422$20240917$EXP$CA-002147023-NVSC2024CA080925$CA-SANDOZ INC.-SDZ2024CA040928$SANDOZ$$70$YR$$F$Y$$$20240917$$HP$CA$CA
237680872$23768087$2$F$20240201$20240809$20240422$20240815$EXP$$US-ABBVIE-5726539$ABBVIE$$90$YR$$M$Y$$$20240815$$CN$US$US
237681272$23768127$2$F$$20240822$20240422$20240903$EXP$$FR-Accord-419740$ACCORD$Darres A, Del Bello A, Marion O, de Lamballerie X, Malvy D, Izopet J and Kamar N Failure of favipiravir to treat chronic norovirus infection in a kidney transplant patient (Letter to the Editor).$64$YR$A$M$Y$$$20240903$$HP$FR$FR
237681542$23768154$2$F$20240419$20240729$20240422$20240802$PER$$US-AMGEN-USASP2024079999$AMGEN$$72$YR$E$M$Y$$$20240802$$CN$US$US
237682012$23768201$2$F$$20240816$20240422$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061887$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240819$$CN$US$US
237682032$23768203$2$F$$20240722$20240422$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060137$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240722$$CN$US$US
237682054$23768205$4$F$20231115$20240820$20240422$20240902$EXP$$GR-UCBSA-2024019394$UCB$$25$YR$$M$Y$90$KG$20240902$$MD$GR$GR
237682884$23768288$4$F$20240418$20240729$20240422$20240801$PER$$US-AMGEN-USASP2024079221$AMGEN$$59$YR$A$F$Y$$$20240801$$CN$US$US
237683124$23768312$4$F$20240101$20240723$20240422$20240807$EXP$$DE-INSMED, INC.-2024-01202-DE$INSMED$$68$YR$$F$Y$$$20240807$$CN$DE$DE
237683132$23768313$2$F$$20240917$20240422$20240924$EXP$$CA-ROCHE-3545090$ROCHE$$19$YR$A$M$Y$98$KG$20240924$$HP$CA$CA
237683203$23768320$3$F$20231201$20240802$20240422$20240806$30DAY$$CO-PFIZER INC-202400076415$PFIZER$$12$YR$$M$Y$$$20240806$$PH$CO$CO
237683242$23768324$2$F$$20240807$20240422$20240808$30DAY$$GR-PFIZER INC-PV202400043802$PFIZER$$$$$$Y$$$20240808$$CN$GR$GR
237683292$23768329$2$F$20240413$20240726$20240422$20240730$30DAY$$US-SANDOZ INC.-SDZ2024US039908$SANDOZ$$73$YR$$M$Y$$$20240730$$CN$US$US
237683352$23768335$2$F$20240418$20240729$20240422$20240801$PER$$US-AMGEN-USASP2024079378$AMGEN$$62$YR$A$M$Y$$$20240801$$CN$US$US
237684502$23768450$2$F$20240109$20240710$20240422$20240715$EXP$$GB-MYLANLABS-2024M1003516$MYLAN$$33$YR$$M$Y$$$20240715$$MD$GB$GB
237685432$23768543$2$F$$20240909$20240422$20240917$EXP$$CA-APOTEX-2024AP004693$APOTEX$$49$YR$$M$Y$$$20240917$$HP$CA$CA
237685792$23768579$2$F$$20240629$20240422$20240702$EXP$$GB-SANDOZ INC.-SDZ2024GB041035$SANDOZ$$$$$F$Y$$$20240702$$CN$GB$GB
237685802$23768580$2$F$20240122$20240919$20240422$20240923$EXP$$IN-SANDOZ INC.-SDZ2024IN041258$SANDOZ$$30$YR$$M$Y$$$20240923$$CN$IN$IN
237686112$23768611$2$F$$20240626$20240422$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03229$LUPIN$$$$$$Y$$$20240711$$CN$US$US
237686123$23768612$3$F$20230601$20240628$20240422$20240702$EXP$$FR-TAKEDA-2024TUS037892$TAKEDA$$77$YR$$F$Y$$$20240702$$HP$FR$FR
237686193$23768619$3$F$$20240805$20240422$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061972$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240806$$CN$US$US
237686243$23768624$3$F$$20240730$20240422$20240802$EXP$$CA-TAKEDA-2024TUS002495$TAKEDA$$$$$F$Y$$$20240802$$CN$CA$CA
237686272$23768627$2$F$20240312$20240730$20240422$20240731$EXP$$NVSC2024DE082635$NOVARTIS$$$$A$M$Y$97$KG$20240731$$MD$DE$DE
237686302$23768630$2$F$$20240801$20240422$20240806$EXP$$US-SA-2024SA121702$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240806$$MD$US$US
237686395$23768639$5$F$20230824$20240919$20240422$20240923$EXP$$AU-MYLANLABS-2023M1090952$MYLAN$$48$YR$$M$Y$$$20240923$$HP$AU$AU
237686556$23768655$6$F$20240524$20240805$20240422$20240809$EXP$$US-GILEAD-2024-0669172$GILEAD$$4$YR$C$F$Y$$$20240809$$HP$US$US
237686564$23768656$4$F$$20240712$20240422$20240926$PER$$US-GSK-US2024AMR048297$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
237686675$23768667$5$F$20240220$20240711$20240422$20240711$30DAY$$PR-PFIZER INC-PV202400014923$PFIZER$$13$YR$$M$Y$47.619$KG$20240711$$CN$PR$PR
237686717$23768671$7$F$$20240702$20240422$20240705$EXP$$DE-009507513-2404DEU009691$MERCK$$$$$M$Y$$$20240705$$MD$DE$DE
237686722$23768672$2$F$20231108$20240905$20240422$20240913$EXP$$US-OTSUKA-2023_029347$OTSUKA$$$$$F$Y$$$20240913$$HP$US$US
237686773$23768677$3$F$20231129$20240704$20240422$20240807$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2023-21313$IPSEN$$48$YR$A$M$Y$$$20240807$$CN$GB$GB
237686822$23768682$2$F$20240405$20240702$20240422$20240702$PER$$US-JNJFOC-20240432282$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240702$$CN$US$US
237686862$23768686$2$F$20230508$20240418$20240422$20240826$EXP$$US-BAYER-2024A058994$BAYER$$68$YR$E$M$Y$57$KG$20240826$$HP$US$US
237687042$23768704$2$F$20230101$20240624$20240422$20240701$EXP$$DE-MYLANLABS-2024M1035729$MYLAN$$53$YR$$M$Y$67$KG$20240701$$CN$DE$DE
237687172$23768717$2$F$$20240626$20240422$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03227$LUPIN$$$$$$Y$$$20240711$$CN$US$US
237687262$23768726$2$F$$20240910$20240422$20240923$EXP$$CA-APOTEX-2024AP004755$APOTEX$$53$YR$$F$Y$$$20240923$$MD$CA$CA
237687363$23768736$3$F$$20240626$20240422$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03202$LUPIN$$$$$$Y$$$20240711$$CN$US$US
237687513$23768751$3$F$20240101$20240805$20240422$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061743$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$66.68$KG$20240808$$PH$US$US
237687713$23768771$3$F$20240101$20240827$20240422$20240831$EXP$$NVSC2024EG082908$NOVARTIS$$46$YR$$F$Y$$$20240831$$CN$EG$EG
237687792$23768779$2$F$20230808$20240702$20240422$20240709$EXP$$AR-GSK-AR2023AMR095365$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$AR$AR
237687822$23768782$2$F$20240415$20240923$20240422$20240926$EXP$$US-KYOWAKIRIN-2024KK009361$KYOWA$$$$$$Y$$$20240926$$HP$US$US
237687902$23768790$2$F$$20240627$20240422$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03188$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237687933$23768793$3$F$$20240826$20240422$20240829$30DAY$$BR-PFIZER INC-202400076382$PFIZER$$30$YR$$F$Y$$$20240829$$CN$BR$BR
237688233$23768823$3$F$$20240701$20240422$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03203$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237688277$23768827$7$F$20230801$20240904$20240422$20240909$EXP$$GB-MYLANLABS-2023M1092528$MYLAN$$63$YR$$M$Y$$$20240909$$MD$GB$GB
237688492$23768849$2$F$$20240726$20240422$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062494$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240730$$CN$US$US
237688534$23768853$4$F$20240226$20240807$20240422$20240809$EXP$$US-JNJFOC-20240446001$JOHNSON AND JOHNSON$$21$YR$A$M$Y$60.2$KG$20240809$$MD$US$US
237688592$23768859$2$F$20230616$20240716$20240422$20240727$EXP$$DE-UCBSA-2024018961$UCB$$$$A$F$Y$$$20240727$$MD$DE$DE
237688813$23768881$3$F$$20240723$20240422$20240729$EXP$$US-SA-2024SA120040$SANOFI AVENTIS$$71$YR$E$M$Y$79.37$KG$20240729$$MD$US$US
237688935$23768893$5$F$$20240905$20240422$20240910$PER$$US-PFIZER INC-PV202400049737$PFIZER$$63$YR$$F$Y$68.04$KG$20240910$$CN$US$US
237689273$23768927$3$F$20240508$20240814$20240422$20240819$EXP$$CA-TAKEDA-2024TUS036358$TAKEDA$$38$YR$$F$Y$$$20240819$$CN$CA$CA
237689444$23768944$4$F$$20240820$20240422$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060557$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$50.35$KG$20240829$$CN$US$US
237689473$23768947$3$F$20240409$20240718$20240422$20240729$PER$$US-AMGEN-USASP2024073664$AMGEN$$66$YR$E$M$Y$$$20240729$$CN$US$US
237690114$23769011$4$F$20240407$20240902$20240422$20240907$EXP$$JP-SHIONOGI INC.-2024000976$SHIONOGI$$$$$$Y$$$20240907$$MD$JP$JP
237690195$23769019$5$F$$20240905$20240422$20240909$30DAY$$US-PFIZER INC-PV202400045002$PFIZER$$14$YR$$M$Y$$$20240909$$CN$US$US
237690208$23769020$8$F$20240408$20240914$20240422$20240919$30DAY$$US-PFIZER INC-202400083732$PFIZER$$14$YR$$M$Y$$$20240919$$MD$US$US
237690215$23769021$5$F$$20240808$20240422$20240815$30DAY$$US-PFIZER INC-202400076924$PFIZER$$12$YR$$M$Y$$$20240815$$CN$US$US
237690224$23769022$4$F$$20240906$20240422$20240909$30DAY$$US-PFIZER INC-202400083854$PFIZER$$12$YR$$M$Y$33.57$KG$20240909$$CN$US$US
237690233$23769023$3$F$20240408$20240903$20240422$20240906$30DAY$$US-PFIZER INC-202400083204$PFIZER$$9$YR$$M$Y$$$20240906$$CN$US$US
237690254$23769025$4$F$20240328$20240805$20240422$20240813$30DAY$$US-PFIZER INC-202400082851$PFIZER$$12$YR$$M$Y$$$20240813$$CN$US$US
237690363$23769036$3$F$20230801$20240805$20240422$20240808$EXP$$CO-ABBVIE-5727682$ABBVIE$$65$YR$$M$Y$68$KG$20240808$$CN$CO$CO
237690495$23769049$5$F$20240101$20240906$20240422$20240916$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00184$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
237690842$23769084$2$F$20240401$20240806$20240422$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062650$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$79.38$KG$20240807$$CN$US$US
237691113$23769111$3$F$$20240903$20240422$20240906$EXP$$GB-MYLANLABS-2024M1036228$MYLAN$$$$$F$Y$$$20240906$$CN$GB$GB
237691345$23769134$5$F$20240410$20240923$20240422$20240928$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006327$JAZZ$$39$YR$$F$Y$$$20240928$$CN$US$US
237691442$23769144$2$F$20240131$20240722$20240422$20240722$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-062522$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240722$$MD$IT$IT
237691502$23769150$2$F$20210713$20240701$20240422$20240703$EXP$$DE-PFIZER INC-PV202400052412$PFIZER$$69$YR$$F$Y$$$20240703$$MD$DE$DE
237691874$23769187$4$F$$20240701$20240422$20240701$PER$$US-PFIZER INC-PV202400051886$PFIZER$$51$YR$$M$Y$$$20240701$$HP$US$US
237691882$23769188$2$F$$20240925$20240422$20240926$PER$$US-PFIZER INC-PV202400052336$PFIZER$$64$YR$$F$Y$$$20240926$$CN$US$US
237691923$23769192$3$F$$20240722$20240422$20240725$PER$$US-PFIZER INC-PV202400051845$PFIZER$$81$YR$$M$Y$$$20240725$$HP$US$US
237692183$23769218$3$F$20240101$20240801$20240422$20240806$EXP$$CA-PFIZER INC-202400053128$PFIZER$$58$YR$$F$Y$$$20240806$$MD$CA$CA
237692362$23769236$2$F$$20240709$20240422$20240711$PER$$US-PFIZER INC-202400090252$PFIZER$$77$YR$$F$Y$$$20240711$$CN$US$US
237692423$23769242$3$F$$20240819$20240422$20240827$EXP$$CA-PFIZER INC-202400090894$PFIZER$$63$YR$$M$Y$$$20240827$$MD$CA$CA
237692542$23769254$2$F$$20240807$20240422$20240808$PER$$US-PFIZER INC-202400091938$PFIZER$$63$YR$$F$Y$$$20240808$$HP$US$US
237692552$23769255$2$F$$20240624$20240422$20240701$PER$$US-PFIZER INC-PV202300082708$PFIZER$$86$YR$$F$Y$$$20240701$$CN$US$US
237692703$23769270$3$F$$20240627$20240422$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03187$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237692852$23769285$2$F$$20240726$20240422$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA000262$SANDOZ$$61$YR$$M$Y$$$20240729$$CN$CA$CA
237692983$23769298$3$F$20240401$20240729$20240422$20240805$PER$$US-ALXN-202404USA001074US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
237693052$23769305$2$F$20240201$20240722$20240422$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-060671$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$96$KG$20240722$$CN$CA$CA
237693063$23769306$3$F$20240402$20240902$20240422$20240904$30DAY$$AR-PFIZER INC-202400080676$PFIZER$$10$YR$$F$Y$$$20240904$$CN$AR$AR
237693072$23769307$2$F$20240330$20240808$20240422$20240809$30DAY$$AR-PFIZER INC-202400079651$PFIZER$$6$YR$$F$Y$$$20240809$$CN$AR$AR
237693484$23769348$4$F$20240118$20240826$20240422$20240902$EXP$$CO-GSK-CO2024AMR012126$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$CO$CO
237693612$23769361$2$F$20200101$20240823$20240422$20240829$EXP$$CO-BIOGEN-2022BI01148718$BIOGEN$$$$$F$Y$56$KG$20240828$$CN$CO$CO
237693632$23769363$2$F$$20240507$20240422$20240903$PER$$US-KARYOPHARM-2024KPT000916$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
237693646$23769364$6$F$20240101$20240820$20240422$20240826$PER$$US-KARYOPHARM-2024KPT000913$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240826$$CN$US$US
237694054$23769405$4$F$20240414$20240723$20240422$20240726$EXP$$JP-PFIZER INC-PV202400050993$PFIZER$$77$YR$$F$Y$54.7$KG$20240726$$PH$JP$JP
237694353$23769435$3$F$20240611$20240816$20240422$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062716$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240820$$HP$US$US
237694462$23769446$2$F$20210817$20240829$20240422$20240829$EXP$$JP-LUNDBECK-DKLU3037059$LUNDBECK$$$$$$Y$$$20240829$$MD$JP$JP
237694542$23769454$2$F$$20240925$20240422$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA041327$SANDOZ$$53$YR$$F$Y$100$KG$20240927$$CN$CA$CA
237694554$23769455$4$F$20240316$20240706$20240422$20240722$EXP$$ES-UCBSA-2024019130$UCB$$$$$F$Y$$$20240719$$MD$ES$ES
237694992$23769499$2$F$20240301$20240918$20240422$20240927$PER$$NVSC2024US084798$NOVARTIS$$71$YR$$F$Y$$$20240927$$CN$US$US
237695402$23769540$2$F$$20240723$20240422$20240724$EXP$$FR-JNJFOC-20240436677$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240724$$MD$FR$FR
237695443$23769544$3$F$20230702$20240704$20240422$20240705$EXP$$DE-BAUSCH-BL-2024-006283$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240705$$HP$DE$DE
237695512$23769551$2$F$20240109$20240814$20240422$20240819$EXP$FR-AFSSAPS-LM2024000215$FR-ROCHE-3548891$ROCHE$$51$YR$A$F$Y$$$20240819$$PH$FR$FR
237695542$23769554$2$F$20240115$20240728$20240422$20240801$EXP$$IL-JNJFOC-20240456586$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$MD$IL$IL
237695552$23769555$2$F$20220101$20240716$20240422$20240723$EXP$$US-ABBVIE-5725887$ABBVIE$$$$$F$Y$50$KG$20240723$$CN$US$US
237695733$23769573$3$F$20240412$20240814$20240422$20240821$EXP$$DE-BAXTER-2024BAX016978$BAXTER$$34$YR$$M$Y$$$20240821$$HP$DE$DE
237695894$23769589$4$F$$20240920$20240422$20240924$EXP$$JP-PFIZER INC-202400090561$PFIZER$Harada, N.. Infectious mononucleosis due to Epstein-Barr virus reactivation in an immunocompromised 60-year-old patient with COVID-19. Journal of infection and chemotherapy. Official Journal of the Japan Society of Chemotherapy. 2024;10.1016/j.jiac.2024.03.023$60$YR$$M$Y$$$20240924$$MD$JP$JP
237695932$23769593$2$F$20221201$20240903$20240422$20240905$EXP$$DE-PFIZER INC-202400088398$PFIZER$$55$YR$$F$Y$$$20240905$$MD$DE$DE
237696033$23769603$3$F$20240101$20240911$20240422$20240918$EXP$$NVSC2024MX043863$NOVARTIS$$71$YR$$M$Y$56$KG$20240918$$CN$MX$MX
237696493$23769649$3$F$20240401$20240701$20240422$20240710$30DAY$$US-GSK-US2024047427$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240710$$CN$US$US
237696543$23769654$3$F$$20240906$20240422$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062646$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240910$$CN$US$US
237696682$23769668$2$F$20240207$20240807$20240422$20240813$PER$$JP-Eisai-EC-2024-163987$EISAI$$50$YR$A$F$Y$49$KG$20240814$$PH$JP$JP
2376966910$23769669$10$F$20240401$20240902$20240422$20240910$EXP$$NVSC2024CL084022$NOVARTIS$$43$YR$$F$Y$$$20240910$$CN$CL$CL
237696872$23769687$2$F$$20240624$20240422$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202404007916$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240705$$MD$US$US
237696912$23769691$2$F$$20240703$20240422$20240712$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404007316$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240712$$CN$JP$JP
237697062$23769706$2$F$$20240827$20240422$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA041137$SANDOZ$$60$YR$$M$Y$$$20240828$$HP$CA$CA
237697234$23769723$4$F$20220701$20240624$20240422$20240925$EXP$$US-GSK-US2021AMR024443$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
237697283$23769728$3$F$20240319$20240722$20240422$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-048868$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240724$$PH$JP$JP
237697393$23769739$3$F$20231018$20240716$20240422$20240722$EXP$$DE-SANDOZ INC.-SDZ2024DE041158$SANDOZ$$65$YR$$M$Y$76$KG$20240722$$MD$DE$DE
237697642$23769764$2$F$$20240918$20240422$20240925$EXP$$JP-AMGEN-JPNSP2024076566$AMGEN$$$$$$Y$$$20240925$$HP$JP$JP
237697982$23769798$2$F$20240227$20240910$20240422$20240918$EXP$$NVSC2024NL056559$NOVARTIS$$62$YR$$M$Y$$$20240918$$HP$NL$NL
237698754$23769875$4$F$20240401$20240614$20240422$20240701$PER$$US-KARYOPHARM-2024KPT000891$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240701$$CN$US$US
237699142$23769914$2$F$20240329$20240421$20240422$20240918$EXP$FR-AFSSAPS-AM2024000333$FR-BAUSCH-BL-2024-006405$BAUSCH AND LOMB$$29$YR$$F$Y$$$20240918$$MD$FR$FR
237699193$23769919$3$F$$20240909$20240422$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062552$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$95.25$KG$20240910$$CN$US$US
237699412$23769941$2$F$20221201$20240626$20240422$20240702$EXP$$JP-009507513-2212JPN004315J$MERCK$$38$YR$$F$Y$$$20240702$$MD$JP$JP
237699622$23769962$2$F$$20240812$20240422$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062609$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240816$$HP$US$US
237699864$23769986$4$F$$20240917$20240422$20240919$PER$$NVSC2024US082116$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
237700233$23770023$3$F$20240402$20240716$20240422$20240722$EXP$$US-BAYER-2024A053824$BAYER$$13$YR$T$F$Y$$$20240722$$CN$US$US
237700753$23770075$3$F$20240406$20240920$20240422$20240924$EXP$$ES-TAKEDA-2024TUS027942$TAKEDA$$$$$F$Y$$$20240924$$CN$ES$ES
237700792$23770079$2$F$$20240816$20240422$20240819$EXP$$NVSC2023DE113922$NOVARTIS$Hoffmann J, Schliesser G, Neubauer A. Abatacept as salvage therapy for life-threatening refractory autoimmune hemolytic anemia: a case report. HEMATOLOGY. 2023;28(1):1-5:22080$54$YR$$F$Y$$$20240819$$HP$DE$DE
237701004$23770100$4$F$$20240708$20240422$20240710$EXP$$US-INCYTE CORPORATION-2024IN003948$INCYTE$$$$$$Y$$$20240710$$CN$US$US
237701102$23770110$2$F$20240404$20240704$20240422$20240708$EXP$$JP-BAYER-2024A054051$BAYER$$82$YR$E$F$Y$$$20240708$$MD$JP$JP
237701234$23770123$4$F$$20240830$20240422$20240830$PER$$NVSC2024US083216$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
237701242$23770124$2$F$$20240830$20240422$20240906$EXP$$JP-009507513-2404JPN002135J$MERCK$Kawahara T, Sunada Y, Kirishi H, Saito T, Mimura A, Ichiyama N, et al.. PP706 A case of sclerosing cholangitis with intrahepatic beadlike changes as an immune-related adverse event. The 64th Annual Meeting of The Japanese Respiratory Society$78$YR$$M$Y$$$20240906$$HP$JP$JP
237701462$23770146$2$F$$20240722$20240422$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062724$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240722$$CN$US$US
237701703$23770170$3$F$$20240729$20240422$20240730$PER$$NVSC2024US084345$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
237701795$23770179$5$F$20240401$20240724$20240422$20240729$EXP$$GB-MYLANLABS-2024M1036234$MYLAN$$$$$M$Y$$$20240729$$PH$GB$GB
237702302$23770230$2$F$20240101$20240811$20240422$20240820$PER$$US-SA-2024SA119979$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240820$$MD$US$US
237702332$23770233$2$F$$20240718$20240422$20240727$PER$$US-SA-2024SA112611$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240727$$MD$US$US
237702392$23770239$2$F$20240401$20240624$20240422$20240702$PER$$US-SA-2024SA114991$SANOFI AVENTIS$$78$YR$E$F$Y$68$KG$20240702$$MD$US$US
237702412$23770241$2$F$20240701$20240722$20240422$20240803$PER$$US-SA-2024SA116853$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240803$$MD$US$US
237702632$23770263$2$F$20240501$20240703$20240422$20240712$PER$$US-SA-2024SA114984$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240712$$MD$US$US
237702672$23770267$2$F$20240401$20240731$20240422$20240809$PER$$US-SA-2024SA113586$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240809$$MD$US$US
237702722$23770272$2$F$20240101$20240918$20240422$20240926$PER$$US-SA-2024SA116806$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240926$$MD$US$US
237702734$23770273$4$F$20240101$20240813$20240422$20240827$PER$$US-SA-2024SA090641$SANOFI AVENTIS$$$$A$M$Y$$$20240827$$MD$US$US
237702893$23770289$3$F$20240101$20240812$20240422$20240826$PER$$US-SA-2024SA118623$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240826$$MD$US$US
237703015$23770301$5$F$$20240726$20240422$20240730$PER$$US-SA-2024SA118519$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240730$$MD$US$US
237703044$23770304$4$F$20240403$20240628$20240422$20240703$EXP$$JP-AstraZeneca-2024A092453$ASTRAZENECA$$75$YR$$F$Y$66$KG$20240703$$MD$JP$
237703192$23770319$2$F$$20240729$20240422$20240807$PER$$US-SA-2024SA116340$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240807$$MD$US$US
237703222$23770322$2$F$$20240724$20240422$20240801$PER$$US-SA-2024SA116728$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240801$$MD$US$US
237703332$23770333$2$F$20240301$20240726$20240422$20240806$PER$$US-SA-2024SA116657$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240806$$MD$US$US
237703392$23770339$2$F$$20240730$20240422$20240807$PER$$US-SA-2024SA116580$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240807$$MD$US$US
237703462$23770346$2$F$$20240712$20240422$20240723$PER$$US-SA-2024SA118145$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240723$$MD$US$US
237703512$23770351$2$F$20240101$20240703$20240422$20240712$PER$$US-SA-2024SA116796$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240712$$MD$US$US
237703544$23770354$4$F$20240201$20240626$20240422$20240703$PER$$US-SA-2024SA118408$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240703$$MD$US$US
237703662$23770366$2$F$$20240730$20240422$20240808$PER$$US-SA-2024SA118174$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240808$$MD$US$US
237703832$23770383$2$F$20240401$20240702$20240422$20240711$PER$$US-SA-2024SA120036$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240711$$MD$US$US
237703992$23770399$2$F$20240101$20240723$20240422$20240730$PER$$US-SA-2024SA120246$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240730$$MD$US$US
237704023$23770402$3$F$$20240802$20240422$20240814$PER$$US-SA-2024SA121708$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240814$$MD$US$US
237704063$23770406$3$F$20240817$20240819$20240422$20240828$PER$$US-SA-2024SA118676$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240828$$MD$US$US
237704092$23770409$2$F$20240101$20240808$20240422$20240812$PER$$US-SA-2024SA007338$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240812$$CN$US$US
237704112$23770411$2$F$$20240726$20240422$20240801$PER$$US-SA-2024SA120299$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240801$$MD$US$US
237704393$23770439$3$F$20240101$20240708$20240422$20240717$PER$$US-SA-2024SA120324$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240717$$MD$US$US
237704592$23770459$2$F$20240201$20240702$20240422$20240711$PER$$US-SA-2024SA120540$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240711$$MD$US$US
237704632$23770463$2$F$20240101$20240906$20240422$20240917$PER$$US-SA-2024SA120613$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240918$$MD$US$US
237704653$23770465$3$F$20240401$20240819$20240422$20240830$PER$$US-SA-2024SA118152$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240830$$MD$US$US
237705042$23770504$2$F$20240326$20240722$20240422$20240724$EXP$FR-AFSSAPS-LL2024000697$FR-PFIZER INC-202400088525$PFIZER$$2$YR$$F$Y$15$KG$20240724$$PH$FR$FR
237705172$23770517$2$F$20220629$20240725$20240422$20240801$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-006356$JAZZ$$7$YR$$M$Y$24.6$KG$20240801$$MD$JP$JP
237705923$23770592$3$F$20231108$20240715$20240422$20240723$EXP$$CA-BEH-2024167914$CSL BEHRING$$74$YR$E$M$Y$83.9$KG$20240723$$MD$CA$CA
237706405$23770640$5$F$20220701$20240626$20240422$20240710$EXP$$JP-AMGEN-JPNSP2023081694$AMGEN$$75$YR$E$F$Y$$$20240709$$MD$JP$JP
237706504$23770650$4$F$20220701$20240626$20240422$20240709$EXP$$JP-AMGEN-JPNSP2023081893$AMGEN$Ishida T. Examination of the efficacy and safety of avacopan for ANCA-associated vasculitis. The 67th General Assembly and Scientific Meeting of the Japan College of Rheumatology. 2024 APR;.$88$YR$E$F$Y$$$20240709$$MD$JP$JP
237707053$23770705$3$F$$20240701$20240422$20240712$30DAY$$CN-JNJFOC-20240414747$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$MD$CN$CN
237707233$23770723$3$F$20240327$20240723$20240422$20240729$EXP$$NVSJ2024JP004923$NOVARTIS$$67$YR$$M$Y$$$20240730$$MD$JP$JP
237707942$23770794$2$F$$20240412$20240422$20240710$PER$$US-JNJFOC-20240438769$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$PH$US$US
237708032$23770803$2$F$20240101$20240718$20240422$20240728$PER$$US-SA-2024SA121202$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240728$$MD$US$US
237708282$23770828$2$F$$20240701$20240422$20240703$EXP$$US-ABBVIE-5729496$ABBVIE$$62$YR$$M$Y$$$20240703$$HP$US$US
237708762$23770876$2$F$$20240717$20240423$20240723$PER$$NVSC2024US082911$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
237708802$23770880$2$F$20240301$20240711$20240423$20240716$EXP$$US-ABBVIE-5729180$ABBVIE$$50$YR$$M$Y$$$20240716$$CN$US$US
237708815$23770881$5$F$20240417$20240724$20240423$20240805$PER$$KR-JAZZ PHARMACEUTICALS-2024-KR-006363$JAZZ$$70$YR$$M$Y$68$KG$20240805$$MD$KR$KR
237708943$23770894$3$F$20240412$20240911$20240423$20240917$EXP$$US-ABBVIE-5727589$ABBVIE$$40$YR$$M$Y$$$20240917$$CN$US$US
237709433$23770943$3$F$20230302$20240912$20240423$20240923$EXP$$ES-AMNEAL PHARMACEUTICALS-2023-AMRX-04704$AMNEAL$$$$$$Y$$$20240923$$MD$ES$ES
237709524$23770952$4$F$20100101$20240717$20240423$20240722$EXP$$US-ABBVIE-5725973$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
237709942$23770994$2$F$$20240819$20240423$20240830$EXP$$US-AUROBINDO-AUR-APL-2024-018278$AUROBINDO$Jillella AP, Shishkina I, Giddens G, Corley C, Green K, Ashley R, et al.. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2022;140 (Suppl.1):12547-12548$55$YR$$F$Y$$$20240830$$MD$US$US
237709952$23770995$2$F$20240412$20240830$20240423$20240909$EXP$$MX-EMD Serono-2024020306$EMD SERONO INC$$46$YR$A$F$Y$$$20240909$$CN$MX$MX
237709963$23770996$3$F$$20240912$20240423$20240927$EXP$$JP-009507513-2404JPN002152J$MERCK$Sato Y, Iwabuchi N. 5 A case of vesicoileal fistula induced by Pembrolizumab successful treatment for ureteral carcinoma. The 95th Miyazaki Regional Meeting of The Japanese Urological Association [The 4. 14$82$YR$$M$Y$$$20240927$$MD$JP$JP
237710122$23771012$2$F$$20240718$20240423$20240729$EXP$$CA-AUROBINDO-AUR-APL-2023-054116$AUROBINDO$Capua M. Amlicke M, Esposito E, Belfer J, Bellis M, Falkowitz D, et al.. Time of Observation in Xenobiotic lnqestions in Children. Is 6 Hours Too Long?.. Pediatric Emergency Care. 2023;39:E24-E29$$$$$Y$$$20240729$$MD$CA$CA
237710253$23771025$3$F$$20240802$20240423$20240826$PER$$AU-TOLMAR, INC.-24AU048167$TOLMAR$$$$$M$Y$$$20240826$$CN$AU$AU
237710392$23771039$2$F$$20240717$20240423$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-018218$AUROBINDO$Titus A, Anwar K, Jamil MO. Iatrogenic Reversible Hypofibrinogenemia in the Setting of Using a Direct Thrombin Inhibitor for Treatment for Recurrent Deep Vein Thrombosis. Blood. 2022;140 (Suppl. 1):11288$28$YR$$F$Y$$$20240726$$HP$US$US
237710653$23771065$3$F$20240101$20240812$20240423$20240821$PER$$US-SA-2024SA120643$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240821$$MD$US$US
237710712$23771071$2$F$$20240723$20240423$20240729$EXP$$US-SA-2024SA121390$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240729$$MD$US$US
237710735$23771073$5$F$20240626$20240909$20240423$20240912$EXP$$CA-TAKEDA-2018TUS023355$TAKEDA$$68$YR$$M$Y$$$20240912$$CN$CA$CA
237710792$23771079$2$F$20240301$20240411$20240423$20240729$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00165$PRINSTON PHARMACEUTICAL$$70$YR$$M$Y$82.54$KG$20240719$$CN$US$US
237710854$23771085$4$F$$20240702$20240423$20240708$EXP$$JP-009507513-2404JPN002265J$MERCK$Hara M. [Original article] Review of ^toxic eruption^ cases in our dermatology clinic. Possible relations between oral lesions and the development of toxic eruption, and laboratory makers predicting severe cases.. Journal of the Japan Organization of Clinical Dermatologists. 2024;41(1):46-54$61$YR$$F$Y$$$20240708$$MD$JP$JP
237710922$23771092$2$F$20240401$20240627$20240423$20240702$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-004476$AMGEN$$59$YR$A$F$Y$$$20240701$$HP$US$US
237711072$23771107$2$F$$20240627$20240423$20240704$EXP$$US-JNJFOC-20240449803$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240704$$CN$US$US
237711412$23771141$2$F$$20240717$20240423$20240726$EXP$$IN-AUROBINDO-AUR-APL-2024-017665$AUROBINDO$Vairamoorthy N, Gupta D, Mondal S, Agarwal C, Moule P, Langer S, et al. A Second Course of Horse ATG in Patients with Relapsed Severe Aplastic Anaemia: A Series of 3 Cases. Indian-JHematol-Blood-Transfus. 2023;39 (Suppl.):S1?S199$$$E$M$Y$$$20240726$$HP$IN$IN
237711482$23771148$2$F$$20240626$20240423$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03184$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237711562$23771156$2$F$$20240701$20240423$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03205$LUPIN$$$$$$Y$$$20240718$$CN$US$US
237711613$23771161$3$F$$20240701$20240423$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03204$LUPIN$$$$$$Y$$$20240716$$CN$US$US
237711702$23771170$2$F$$20240701$20240423$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03190$LUPIN$$$$$$Y$$$20240717$$CN$US$US
237711802$23771180$2$F$$20240626$20240423$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03219$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237711922$23771192$2$F$20231127$20240814$20240423$20240820$EXP$$CA-SANDOZ INC.-NVSC2022CA220822$SANDOZ$$57$YR$$F$Y$$$20240820$$CN$CA$CA
237711992$23771199$2$F$20240417$20240813$20240423$20240816$PER$$US-AMGEN-USASP2024079347$AMGEN$$48$YR$A$M$Y$$$20240816$$CN$US$US
237712033$23771203$3$F$$20240712$20240423$20240718$PER$$US-LEO Pharma-369626$LEO PHARM$$53$YR$$M$Y$$$20240718$$PH$US$US
237712205$23771220$5$F$20240505$20240711$20240423$20240801$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001521$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240802$$CN$US$US
237712212$23771221$2$F$20240331$20240530$20240423$20240807$PER$$US-AstraZeneca-2024A079131$ASTRAZENECA$$24635$DY$$M$Y$$$20240807$$CN$US$
237712385$23771238$5$F$20240410$20240916$20240423$20240924$EXP$$US-EMD Serono-2024020195$EMD SERONO INC$$67$YR$E$F$Y$$$20240924$$CN$US$US
237712472$23771247$2$F$$20240718$20240423$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-018057$AUROBINDO$Marcelo R, Giamanco N, Hamele M. Burkitt lymphoma presenting with severe acidosis and refractory hypoglycemia. Pediatr-Blood-Cancer. 2023;70(6):no pagination$13$YR$$F$Y$$$20240729$$HP$US$US
237712688$23771268$8$F$$20240725$20240423$20240730$EXP$$CA-JNJFOC-20240186013$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240730$$HP$CA$CA
237712792$23771279$2$F$20240418$20240801$20240423$20240805$PER$$US-AMGEN-USASP2024080380$AMGEN$$68$YR$E$M$Y$$$20240805$$CN$US$US
237712872$23771287$2$F$20240629$20240718$20240423$20240726$EXP$$US-SA-2024SA121799$SANOFI AVENTIS$$75$YR$E$F$Y$47.17$KG$20240726$$MD$US$US
237713002$23771300$2$F$$20240806$20240423$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442486$RANBAXY$Subba H, Riker RR, Dunn S, Gagnon DJ. Vasopressin-Induced Hyponatremia in Patients With Aneurysmal Subarachnoid Hemorrhage: A Case Series and Literature Review. J Pharm Pract. 2023;36 (3):689-694$51$YR$$F$Y$$$20240821$$MD$US$US
237713042$23771304$2$F$$20240806$20240423$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442487$RANBAXY$Subba H, Riker RR, Dunn S, Gagnon DJ. Vasopressin-Induced Hyponatremia in Patients With Aneurysmal Subarachnoid Hemorrhage: A Case Series and Literature Review. J Pharm Pract. 2023;36 (3):689-694$62$YR$$F$Y$$$20240821$$MD$US$US
237713192$23771319$2$F$$20240708$20240423$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202404012163$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240722$$CN$US$US
237713272$23771327$2$F$$20240702$20240423$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202404009254$ELI LILLY AND CO$$43$YR$A$F$Y$74.84$KG$20240704$$CN$US$US
237713503$23771350$3$F$$20240816$20240423$20240819$EXP$$NVSC2024US084175$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
237713716$23771371$6$F$20240101$20240705$20240423$20240712$PER$$US-UNITED THERAPEUTICS-UNT-2024-009965$UNITED THERAPEUTICS$$$$$F$Y$83.9$KG$20240712$$$US$US
237713827$23771382$7$F$20240301$20240716$20240423$20240724$EXP$$CA-AstraZeneca-2024A091927$ASTRAZENECA$$954$MON$$M$Y$$$20240724$$MD$CA$
237713972$23771397$2$F$$20240809$20240423$20240822$EXP$$US-AUROBINDO-AUR-APL-2024-018502$AUROBINDO$Khan S, Khan D, Mustafa A, Nisar A, Spagnola J, Rizvi T. FULMINANT LEUKOCYTOCLASTIC VASCULITIS CAUSED BY RICKETTSIA PRESENTING AS STEMIAND VF ARREST. J-Am-CollCardiol. 2024;83 (no 13)$44$YR$$M$Y$$$20240822$$HP$US$US
237713992$23771399$2$F$$20240809$20240423$20240822$EXP$$US-AUROBINDO-AUR-APL-2024-018248$AUROBINDO$Karan A, Ali K, Garcia GD, Mohanlal A, Chandler Z, Rollini F. CARDIOPHYLAXIS: KOUNIS SYNDROME TYPE II INDUCED BY REGADENOSON IN A PATIENT WITH SYSTEMIC MASTOCYTOSIS. J-Am-Coll-Cardiol. 2024;83:4394$64$YR$$M$Y$$$20240822$$HP$US$US
237714136$23771413$6$F$20240408$20240920$20240423$20240927$EXP$$US-BEH-2024170763$CSL BEHRING$$82$YR$E$F$Y$$$20240927$$MD$US$US
237714365$23771436$5$F$$20240827$20240423$20240909$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000353$DECIPHERA PHARMACEUTICALS$$69$YR$E$M$Y$$$20240909$$CN$US$US
237714452$23771445$2$F$20240326$20240625$20240423$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-443420$RANBAXY$$$$$F$Y$$$20240710$$MD$GB$GB
237714482$23771448$2$F$20231228$20240619$20240423$20240704$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-443460$RANBAXY$$4$YR$$F$Y$15.3$KG$20240704$$PH$FR$FR
237714822$23771482$2$F$$20240717$20240423$20240726$EXP$$CA-AUROBINDO-AUR-APL-2024-017837$AUROBINDO$Gu Y, Zhang Q, Pasternak SH, Ang LC.. Pick^s disease presenting with corticobasal syndrome: A case report and clinicopathological review. Clinical Neuropathology. 2023;42:212-218$70$YR$$F$Y$$$20240726$$HP$CA$CA
237715253$23771525$3$F$20160426$20240709$20240423$20240710$EXP$$CA-TAKEDA-2023TUS048962$TAKEDA$$73$YR$$M$Y$$$20240710$$HP$CA$CA
237715672$23771567$2$F$$20240609$20240423$20240704$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001620$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
237715762$23771576$2$F$$20240625$20240423$20240706$EXP$$ES-ROCHE-3544928$ROCHE$$$$$F$Y$$$20240706$$CN$ES$ES
237715892$23771589$2$F$$20240626$20240423$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03239$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237716212$23771621$2$F$$20240723$20240423$20240725$PER$$US-JNJFOC-20240449329$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240725$$HP$US$US
237716392$23771639$2$F$$20240627$20240423$20240701$EXP$$NVSC2024US083656$NOVARTIS$$21$YR$$M$Y$$$20240701$$CN$US$US
237716636$23771663$6$F$$20240805$20240423$20240814$EXP$$JP-AMGEN-JPNSP2024078799$AMGEN$Nakayama, R.. Polymorphic lymphoproliferative disorder arising in a rheumatoid arthritis patient, presenting as fibrin-associated large B-cell lymphoma-like lesions in aortic and mitral valves. Pathology international. 2024;1-7$60$YR$A$F$Y$47$KG$20240814$$MD$JP$JP
237716674$23771667$4$F$20240101$20240703$20240423$20240705$EXP$$JP-009507513-2404JPN002325J$MERCK$$$$$$Y$$$20240705$$MD$JP$JP
237716783$23771678$3$F$$20240923$20240423$20240924$PER$$NVSC2024US082318$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
237716822$23771682$2$F$$20240809$20240423$20240821$EXP$$GB-AUROBINDO-AUR-APL-2024-018493$AUROBINDO$Basu S, Gupta S, Bass P, Proctor I, Hamour S, Salama AD. A Novel Form of Retroviral Associated Proliferative Glomerulonephritis?. J-Am-Soc-Nephrol. 2016;27635A$41$YR$$M$Y$$$20240821$$HP$GB$GB
237717356$23771735$6$F$20210101$20240828$20240423$20240906$EXP$$FR-ORGANON-O2308FRA001297$ORGANON$$$$$F$Y$49.5$KG$20240906$$CN$FR$FR
237717522$23771752$2$F$$20240704$20240423$20240704$PER$$NVSC2024US085145$NOVARTIS$$8$MON$$$Y$$$20240704$$MD$US$US
237717543$23771754$3$F$20240601$20240805$20240423$20240808$EXP$$US-ABBVIE-5728994$ABBVIE$$79$YR$$F$Y$$$20240808$$CN$US$US
237717652$23771765$2$F$$20240909$20240423$20240919$EXP$$FR-CELLTRION INC.-2024FR008951$CELLTRION$Lequain, H. Immune recovery uveitis in Whipple^s disease: an unusual ocular presentation. Journal of Ophthalmic Inflammation and Infection. 2024;10:1-7$$$$$Y$$$20240919$$HP$FR$FR
237717662$23771766$2$F$20240401$20240627$20240423$20240708$EXP$$JP-009507513-2404JPN002331J$MERCK$$8$DEC$$F$Y$$$20240708$$MD$JP$JP
237717702$23771770$2$F$$20240916$20240423$20240926$EXP$$CA-APOTEX-2023AP007199$APOTEX$$82$YR$$F$Y$$$20240926$$HP$CA$CA
237717745$23771774$5$F$20230901$20240822$20240423$20240904$EXP$$JP-AMGEN-JPNSP2024079163$AMGEN$Mori K, Shirai T, Mutoh T, Narita M, Hoshi Y, Machiyama T. High incidence of drug-induced liver injury in patients with ANCA-associated vasculitis using Avacopan. The 68th General Assembly and Scientific Meeting of the Japan College of Rheumatology. 2024 APR;.$73$YR$E$F$Y$53.3$KG$20240904$$MD$JP$JP
237717773$23771777$3$F$20231201$20240605$20240423$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003471$TG THERAPEUTICS$$49$YR$$F$Y$97.959$KG$20240715$$CN$US$US
237717863$23771786$3$F$20240401$20240718$20240423$20240725$EXP$$US-ABBVIE-5728920$ABBVIE$$63$YR$$F$Y$$$20240725$$CN$US$US
237717913$23771791$3$F$20240405$20240724$20240423$20240730$EXP$$JP-BAUSCH-BL-2024-006426$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240730$$MD$JP$JP
237718026$23771802$6$F$$20240729$20240423$20240730$PER$$NVSC2024US084969$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
237718573$23771857$3$F$20240116$20240625$20240423$20240701$EXP$$FR-JNJFOC-20240432877$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240701$$CN$FR$FR
237718633$23771863$3$F$20240320$20240802$20240423$20240806$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-023600$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240806$$MD$JP$JP
237718664$23771866$4$F$20201201$20240726$20240423$20240911$EXP$$BR-BEH-2024170642$CSL BEHRING$$45$YR$A$F$Y$89$KG$20240911$$CN$BR$BR
237718763$23771876$3$F$$20240831$20240423$20240904$EXP$$NVSC2024GB085083$NOVARTIS$$$$A$F$Y$$$20240904$$CN$GB$GB
237718812$23771881$2$F$20240131$20240427$20240423$20240715$EXP$$JP-ROCHE-3507836$ROCHE$$71$YR$E$F$Y$45.6$KG$20240715$$MD$JP$JP
237719074$23771907$4$F$20240416$20240902$20240423$20240903$PER$$US-AMGEN-USASP2024079457$AMGEN$$66$YR$E$F$Y$$$20240903$$CN$US$US
237719214$23771921$4$F$20240415$20240611$20240423$20240925$PER$$US-GSK-US2024AMR050417$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
237719583$23771958$3$F$$20240626$20240423$20240711$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-03226$LUPIN$$$$$$Y$$$20240711$$CN$US$US
237719852$23771985$2$F$$20240626$20240423$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03236$LUPIN$$$$$$Y$$$20240712$$PH$US$US
237719914$23771991$4$F$20240401$20240809$20240423$20240819$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-06270$IPSEN$$33$YR$A$F$Y$$$20240819$$HP$CA$CA
237719942$23771994$2$F$$20240820$20240423$20240829$EXP$$CA-JNJFOC-20240456058$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240829$$HP$CA$CA
237719952$23771995$2$F$20240413$20240703$20240423$20240710$PER$$US-Vifor (International) Inc.-VIT-2024-03484$VIFOR$$70$YR$$F$Y$82$KG$20240710$$HP$US$US
237720292$23772029$2$F$$20240725$20240423$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001197$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
237720413$23772041$3$F$20240201$20240821$20240423$20240823$EXP$$US-TAKEDA-US202007112$TAKEDA$$74$YR$$F$Y$$$20240823$$MD$US$US
237721156$23772115$6$F$20221220$20240904$20240423$20240909$EXP$$NVSC2024IN084059$NOVARTIS$$68$YR$$F$Y$$$20240909$$CN$IN$IN
237721162$23772116$2$F$$20240626$20240423$20240704$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011440$UNITED THERAPEUTICS$$$$$M$Y$111.11$KG$20240704$$$US$US
237721202$23772120$2$F$20230625$20240726$20240423$20240809$EXP$$KR-SPECTRUM PHARMACEUTICALS, INC.-KR-2024AST000083$SPECTRUM$$72$YR$$F$Y$58$KG$20240809$$MD$KR$KR
237721285$23772128$5$F$$20240925$20240423$20240927$PER$$NVSC2024US084498$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
237721312$23772131$2$F$20240401$20240627$20240423$20240705$EXP$$CA-ABBVIE-5728984$ABBVIE$$$$A$F$Y$$$20240705$$MD$CA$CA
237721455$23772145$5$F$20240101$20240827$20240423$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011353$UNITED THERAPEUTICS$$$$$F$Y$68.6$KG$20240906$$$US$US
237721472$23772147$2$F$$20240718$20240423$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-018216$AUROBINDO$Pabon-Vazquez E, Thomas GN, Anea B, Kosuru V.. Double Insult: Secondary IgA and Anticoagulant-Related Nephropathy. J-Am-Soc-Nephrol. 2023;34:603$62$YR$$M$Y$$$20240729$$HP$US$US
237721573$23772157$3$F$20240403$20240507$20240423$20240802$PER$$US-AstraZeneca-2024A082428$ASTRAZENECA$$27424$DY$$M$Y$$$20240802$$CN$US$
237721602$23772160$2$F$$20240711$20240423$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03238$LUPIN$$$$$$Y$$$20240808$$CN$US$US
237721794$23772179$4$F$20240422$20240725$20240423$20240730$EXP$$JP-EXELIXIS-CABO-24076011$EXELIXIS$$9$DEC$$M$Y$$$20240730$$PH$JP$JP
237721962$23772196$2$F$20231227$20240905$20240423$20240910$EXP$$NVSC2024GT010661$NOVARTIS$$82$YR$$F$Y$$$20240910$$CN$GT$GT
237722276$23772227$6$F$20240417$20240910$20240423$20240912$EXP$$AU-TAKEDA-2024TUS037803$TAKEDA$$79$YR$$F$Y$$$20240912$$CN$AU$AU
237722642$23772264$2$F$$20240717$20240423$20240726$EXP$$CA-AUROBINDO-AUR-APL-2024-017737$AUROBINDO$Baxter CL, Martin EG, Marwa BM, Pacaud D, Cummings EA. Very severe hypertriglyceridemia complicating pediatric acute lymphoblastic leukemia treatment: a call for management guidelines. Pediatr-Endocrinol-Metab. 2023;36:978-982$12$MON$$M$Y$$$20240726$$HP$CA$CA
237722822$23772282$2$F$20240417$20240613$20240423$20240708$PER$$US-AstraZeneca-2024A094092$ASTRAZENECA$$24361$DY$$M$Y$$$20240709$$CN$US$
237722922$23772292$2$F$$20240717$20240423$20240726$EXP$$IT-AUROBINDO-AUR-APL-2024-018059$AUROBINDO$Frioni F, Galli E, Sora F, Zini G, Sica S, Chiusolo P. Spontaneous resolution of ^therapy-related myelodysplasia^ occurred after treatment with CAR-T cells: All that glitters is not gold.. Int-J-LabHaematol. 2023;45(5):810-812$45$YR$$F$Y$$$20240726$$HP$IT$IT
237722943$23772294$3$F$$20240703$20240423$20240711$EXP$$CA-TAKEDA-2024TUS037814$TAKEDA$$$$$F$Y$$$20240711$$MD$CA$CA
237723183$23772318$3$F$$20240913$20240423$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202404014320$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240920$$CN$US$US
2377232210$23772322$10$F$20240325$20240614$20240423$20240717$EXP$$AR-MYLANLABS-2024M1036202$MYLAN$$14$YR$$M$Y$$$20240717$$CN$AR$AR
237723272$23772327$2$F$$20240717$20240423$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-018130$AUROBINDO$Shropshire WC, Endres BT, Borjan J, Aitken SL, Bachman WC, Mcelheny CL, et al.. High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated beta-lactamase CMY-185 variant. J-Antimicrob-Chemother. 2023;78(10):2442-2450$$$$M$Y$$$20240726$$HP$US$US
237723302$23772330$2$F$$20240718$20240423$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-018126$AUROBINDO$Rajagopal A, Goleniak R, Kumbar LM. Point-of-Care Ultrasound (POCUS) in Metastatic Ovarian Carcinoma: Kidney Injury and Inferior Vena Cava (IVC) Compression. J-Am-Soc-Nephrol. 2023;34465$65$YR$$F$Y$$$20240726$$HP$US$US
237723585$23772358$5$F$$20240918$20240423$20240930$EXP$$CO-ROCHE-3547708$ROCHE$$37$YR$A$F$Y$84$KG$20240930$$CN$CO$CO
237723683$23772368$3$F$$20240705$20240423$20240709$PER$$NVSC2024US084803$NOVARTIS$$$$$M$Y$$$20240709$$CN$US$US
237724243$23772424$3$F$$20240822$20240423$20240829$EXP$$CA-Orion Corporation ORION PHARMA-24_00029428$ORION$$63$YR$A$M$Y$$$20240829$$MD$CA$
237724272$23772427$2$F$$20240717$20240423$20240726$EXP$$CA-AUROBINDO-AUR-APL-2024-017736$AUROBINDO$Baxter CL, Martin EG, Marwa BM, Pacaud D, Cummings EA.. Very severe hypertriglyceridemia complicating pediatric acute lymphoblastic leukemia treatment: a call for management guidelines.. JPediatr-Endocrinol-Metab. 2023;36(10):978-982$7$YR$$M$Y$$$20240726$$HP$CA$CA
237724435$23772443$5$F$20230110$20240819$20240423$20240826$EXP$$NVSC2024DE083831$NOVARTIS$$63$YR$$F$Y$80$KG$20240826$$MD$DE$DE
237724922$23772492$2$F$$20240805$20240423$20240810$PER$$US-ALXN-202404USA001318US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240810$$PH$US$US
237724982$23772498$2$F$$20240702$20240423$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03257$LUPIN$$$$$$Y$$$20240719$$CN$US$US
237725074$23772507$4$F$$20240905$20240423$20240909$30DAY$$KR-PFIZER INC-PV202400042963$PFIZER$$13$YR$$M$Y$$$20240909$$CN$KR$KR
237725272$23772527$2$F$$20240717$20240423$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-018109$AUROBINDO$Kshattry S, Parker TL, Huntington SF. Peripheral Blasts in a Patient Receiving Chemotherapy. JAMA. 2023;330(16):1581-1582$80$YR$$M$Y$$$20240725$$MD$US$US
237725292$23772529$2$F$20240415$20240820$20240423$20240823$PER$$US-AMGEN-USASP2024079113$AMGEN$$65$YR$E$M$Y$$$20240823$$CN$US$US
237725435$23772543$5$F$$20240812$20240423$20240815$30DAY$$KR-PFIZER INC-PV202400042852$PFIZER$$9$YR$$M$Y$$$20240815$$CN$KR$KR
237725444$23772544$4$F$20240401$20240821$20240423$20240821$30DAY$$CO-PFIZER INC-PV202400048606$PFIZER$$8$YR$$M$Y$$$20240821$$CN$CO$CO
237725472$23772547$2$F$$20240717$20240423$20240726$EXP$$CA-AUROBINDO-AUR-APL-2024-017734$AUROBINDO$Baxter CL, Martin EG, Marwa BM, Pacaud D, Cummings EA. Very severe hypertriglyceridemia complicating pediatric acute lymphoblastic leukemia treatment: a call for management guidelines. JPediatr-Endocrinol-Metab. 2023;36(10):978?982$11$YR$$F$Y$$$20240726$$HP$CA$CA
237725832$23772583$2$F$20240418$20240731$20240423$20240807$EXP$$US-ASTELLAS-2024US011758$ASTELLAS$$72$YR$$M$Y$$$20240807$$HP$US$US
237725892$23772589$2$F$$20240715$20240423$20240723$EXP$$CA-HALEON-2169030$Haleon PLC$$44$YR$$F$Y$97$KG$20240722$$HP$CA$CA
237725902$23772590$2$F$20220930$20240416$20240423$20240809$EXP$$BR-SANDOZ INC.-NVSC2022BR247474$SANDOZ$$34$YR$$F$Y$$$20240809$$HP$BR$BR
237725956$23772595$6$F$20210901$20240820$20240423$20240824$EXP$$NVSC2024MX034790$NOVARTIS$$51$YR$$F$Y$62$KG$20240824$$CN$MX$MX
237726272$23772627$2$F$20240402$20240918$20240423$20240925$EXP$$JP-GENMAB-2024-01281$GENMAB$$78$YR$$F$Y$$$20240925$$MD$JP$JP
237726303$23772630$3$F$$20240712$20240423$20240723$EXP$$ZA-AUROBINDO-AUR-APL-2024-018521$AUROBINDO$Omar S, Parris P, Gurke CR.. Hemoadsorption Therapy for Calcium Channel Blocker Overdose: A Case Report.. J Emerg Med. 2024;66(4):e463-e466$2$DEC$$M$Y$$$20240723$$HP$ZA$ZA
237726792$23772679$2$F$$20240722$20240423$20240725$PER$$US-BIOVITRUM-2023-US-021532$BIOVITRUM$$64$YR$$F$Y$$$20240725$$CN$US$US
237726902$23772690$2$F$20230823$20240710$20240423$20240710$30DAY$$AT-PFIZER INC-202300284299$PFIZER$$$$A$F$Y$$$20240710$$CN$AT$AT
237727332$23772733$2$F$$20240626$20240423$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03240$LUPIN$$$$$$Y$$$20240713$$CN$US$US
237727346$23772734$6$F$$20240916$20240423$20240920$EXP$$US-PFIZER INC-202400089513$PFIZER$$$$$F$Y$$$20240920$$CN$US$US
237727746$23772774$6$F$20240404$20240628$20240423$20240711$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-060426$REGENERON$$$$$$Y$$$20240711$$HP$CH$CH
237727802$23772780$2$F$$20240626$20240423$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03252$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237728774$23772877$4$F$20240101$20240917$20240423$20240919$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-023517$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240919$$MD$US$US
237728804$23772880$4$F$20240608$20240903$20240423$20240906$EXP$$CA-JNJFOC-20240458656$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240906$$PH$CA$CA
237728933$23772893$3$F$20240322$20240801$20240423$20240806$30DAY$$CO-PFIZER INC-PV202400045279$PFIZER$$14$YR$$M$Y$$$20240806$$CN$CO$CO
237729142$23772914$2$F$$20240802$20240423$20240806$30DAY$$CO-PFIZER INC-PV202400045359$PFIZER$$$$$$Y$$$20240806$$CN$CO$CO
237729464$23772946$4$F$$20240905$20240423$20240912$EXP$$BR-GSK-BR2023AMR139385$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$HP$BR$BR
237729473$23772947$3$F$$20240912$20240423$20240925$PER$$US-SA-2024SA117215$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240925$$MD$US$US
237729642$23772964$2$F$$20240712$20240423$20240722$PER$$US-SA-2024SA116080$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240722$$MD$US$US
237729702$23772970$2$F$$20240730$20240423$20240808$PER$$US-SA-2024SA114612$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240808$$CN$US$US
237729713$23772971$3$F$20240101$20240904$20240423$20240925$PER$$US-SA-2024SA116357$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240925$$MD$US$US
237729793$23772979$3$F$20240601$20240731$20240423$20240809$PER$$US-SA-2024SA116640$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240809$$MD$US$US
237729933$23772993$3$F$$20240910$20240423$20240912$PER$$US-ALXN-202404USA001366US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
237730142$23773014$2$F$20240101$20240628$20240423$20240712$PER$$US-SA-2024SA117666$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240712$$MD$US$US
237730162$23773016$2$F$20240401$20240724$20240423$20240802$PER$$US-SA-2024SA117229$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240802$$MD$US$US
237730224$23773022$4$F$20240101$20240819$20240423$20240828$PER$$US-SA-2024SA119026$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240828$$MD$US$US
237730272$23773027$2$F$$20240715$20240423$20240722$PER$$US-SA-2024SA119570$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240721$$MD$US$US
237730282$23773028$2$F$20240406$20240716$20240423$20240724$PER$$US-SA-2024SA119044$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240724$$MD$US$US
237730312$23773031$2$F$20240101$20240726$20240423$20240806$PER$$US-SA-2024SA121499$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240806$$MD$US$US
237730442$23773044$2$F$$20240730$20240423$20240807$PER$$US-SA-2024SA121672$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240807$$MD$US$US
237730503$23773050$3$F$$20240812$20240423$20240821$PER$$US-SA-2024SA120969$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240821$$MD$US$US
237730512$23773051$2$F$20230101$20240725$20240423$20240805$PER$$US-SA-2024SA119646$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240805$$MD$US$US
237730552$23773055$2$F$20240401$20240802$20240423$20240813$PER$$US-SA-2024SA121096$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240814$$MD$US$US
237730572$23773057$2$F$$20240802$20240423$20240812$PER$$US-SA-2024SA121336$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240812$$MD$US$US
237730602$23773060$2$F$$20240730$20240423$20240807$PER$$US-SA-2024SA121089$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240807$$MD$US$US
237730642$23773064$2$F$$20240806$20240423$20240816$PER$$US-SA-2024SA120900$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240816$$MD$US$US
237730872$23773087$2$F$20240404$20240915$20240423$20240920$PER$$US-SA-2024SA121512$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240920$$MD$US$US
237731052$23773105$2$F$$20240323$20240423$20240923$PER$$RO-ROCHE-3535117$ROCHE$$63$YR$A$F$Y$$$20240923$$MD$RO$RO
237731502$23773150$2$F$20240101$20240702$20240423$20240711$PER$$US-SA-2024SA121112$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240711$$MD$US$US
237731532$23773153$2$F$20240401$20240801$20240423$20240810$PER$$US-SA-2024SA121020$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240810$$MD$US$US
237731563$23773156$3$F$$20240724$20240423$20240802$EXP$$US-BAYER-2024A060176$BAYER$$80$YR$E$M$Y$$$20240802$$CN$US$US
237731604$23773160$4$F$20240101$20240830$20240423$20240919$PER$$US-SA-2024SA121213$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240919$$CN$US$US
237731712$23773171$2$F$20240101$20240808$20240423$20240821$PER$$US-SA-2024SA119761$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240822$$MD$US$US
237731864$23773186$4$F$20240101$20240801$20240423$20240809$PER$$US-SA-2024SA122431$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240809$$MD$US$US
237731922$23773192$2$F$20240101$20240625$20240423$20240704$PER$$US-SA-2024SA120822$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240704$$MD$US$US
237731942$23773194$2$F$$20240731$20240423$20240808$PER$$US-SA-2024SA049876$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240808$$MD$US$US
237731953$23773195$3$F$20240301$20240722$20240423$20240730$PER$$US-SA-2024SA121407$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240730$$MD$US$US
237732005$23773200$5$F$20240101$20240805$20240423$20240810$EXP$$US-SA-2024SA121556$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240810$$MD$US$US
237732023$23773202$3$F$20240402$20240903$20240423$20240904$30DAY$$CO-PFIZER INC-202400079998$PFIZER$$13$YR$$M$Y$$$20240904$$MD$CO$CO
237732085$23773208$5$F$20240318$20240708$20240423$20240720$EXP$FR-AFSSAPS-LY2024000502$FR-JAZZ PHARMACEUTICALS-2024-FR-006355$JAZZ$$$$$$Y$$$20240719$$PH$FR$FR
237732245$23773224$5$F$20240213$20240710$20240423$20240712$EXP$$JP-DSJP-DSJ-2024-117585$DAIICHI$$64$YR$$F$Y$$$20240712$$MD$JP$JP
237732293$23773229$3$F$20240101$20240802$20240423$20240808$30DAY$$CO-PFIZER INC-PV202400045912$PFIZER$$11$YR$$M$Y$$$20240808$$CN$CO$CO
237732313$23773231$3$F$20240408$20240825$20240423$20240829$EXP$$IN-PFIZER INC-PV202300076403$PFIZER$$57$YR$$F$Y$$$20240829$$CN$IN$IN
237732354$23773235$4$F$20240403$20240801$20240423$20240806$30DAY$$CO-PFIZER INC-PV202400045916$PFIZER$$$$$$Y$$$20240806$$CN$CO$CO
237732374$23773237$4$F$20240301$20240903$20240423$20240904$30DAY$$CO-PFIZER INC-202400082035$PFIZER$$14$YR$$M$Y$$$20240904$$CN$CO$CO
237732792$23773279$2$F$20240217$20240902$20240423$20240906$EXP$$AU-TAKEDA-2024TUS016834$TAKEDA$$85$YR$$M$Y$$$20240906$$CN$AU$AU
237732962$23773296$2$F$20240330$20240422$20240423$20240724$EXP$$CN-BAYER-2024A060628$BAYER$$42$YR$A$F$Y$$$20240724$$HP$CN$CN
237733312$23773331$2$F$$20240626$20240423$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03249$LUPIN$$$$$$Y$$$20240711$$CN$US$US
237733462$23773346$2$F$20240101$20240722$20240423$20240724$PER$$US-AMGEN-USASP2024080366$AMGEN$$49$YR$A$F$Y$$$20240724$$HP$US$US
237733506$23773350$6$F$20231129$20240712$20240423$20240724$EXP$$JP-UNITED THERAPEUTICS-UNT-2023-036584$UNITED THERAPEUTICS$$78$YR$$F$Y$$$20240724$$$JP$JP
237733512$23773351$2$F$$20240808$20240423$20240813$PER$$US-BIOGEN-2020BI00958918$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
237733602$23773360$2$F$20150501$20240902$20240423$20240905$EXP$GB-MHRA-MED-202404171040588320-QCKMP$GB-PFIZER INC-202400090758$PFIZER$$79$YR$$F$Y$63$KG$20240905$$PH$GB$GB
237733632$23773363$2$F$$20240708$20240423$20240712$EXP$$GB-PFIZER INC-202400090749$PFIZER$$51$YR$$F$Y$$$20240712$$MD$GB$GB
237733712$23773371$2$F$20231221$20240625$20240423$20240702$EXP$FR-AFSSAPS-BX2024000696$FR-009507513-2404FRA008155$MERCK$$42$YR$$F$Y$52$KG$20240702$$HP$FR$FR
237733764$23773376$4$F$20240408$20240904$20240423$20240904$30DAY$$CO-PFIZER INC-202400084336$PFIZER$$12$YR$$M$Y$$$20240904$$CN$CO$CO
237733913$23773391$3$F$20240711$20240905$20240423$20240912$EXP$$CA-TAKEDA-2019TUS052708$TAKEDA$$56$YR$$M$Y$$$20240912$$CN$CA$CA
237734122$23773412$2$F$20240101$20240812$20240423$20240816$EXP$$US-MYLANLABS-2024M1035942$MYLAN$$$$$F$Y$70.3$KG$20240816$$MD$US$US
237734273$23773427$3$F$$20240802$20240423$20240807$30DAY$$CO-PFIZER INC-202400079756$PFIZER$$14$YR$$M$Y$$$20240807$$CN$CO$CO
237734283$23773428$3$F$$20240710$20240423$20240712$30DAY$$CO-PFIZER INC-PV202400048611$PFIZER$$$$C$M$Y$$$20240712$$CN$CO$CO
237734293$23773429$3$F$$20240711$20240423$20240716$30DAY$$CO-PFIZER INC-202400085148$PFIZER$$6$YR$$M$Y$$$20240716$$CN$CO$CO
237734305$23773430$5$F$20240101$20240902$20240423$20240904$30DAY$$CO-PFIZER INC-PV202400047284$PFIZER$$11$YR$$M$Y$$$20240904$$CN$CO$CO
237734323$23773432$3$F$$20240903$20240423$20240905$30DAY$$CO-PFIZER INC-PV202400047894$PFIZER$$$$$$Y$$$20240905$$MD$CO$CO
237734332$23773433$2$F$20240414$20240903$20240423$20240904$30DAY$$CO-PFIZER INC-202400087994$PFIZER$$13$YR$$M$Y$$$20240904$$CN$CO$CO
237734343$23773434$3$F$$20240903$20240423$20240905$30DAY$$CO-PFIZER INC-PV202400047893$PFIZER$$$$$$Y$$$20240905$$MD$CO$CO
237734353$23773435$3$F$$20240902$20240423$20240905$30DAY$$CO-PFIZER INC-PV202400047293$PFIZER$$6$YR$$F$Y$$$20240905$$CN$CO$CO
237734363$23773436$3$F$$20240903$20240423$20240909$30DAY$$CO-PFIZER INC-PV202400049931$PFIZER$$11$YR$$M$Y$$$20240909$$CN$CO$CO
237734373$23773437$3$F$$20240716$20240423$20240719$30DAY$$CO-PFIZER INC-202400083472$PFIZER$$8$YR$$$Y$$$20240719$$MD$CO$CO
237734545$23773454$5$F$$20240821$20240423$20240827$EXP$$US-INCYTE CORPORATION-2024IN003935$INCYTE$$$$$$Y$$$20240827$$CN$US$US
237734894$23773489$4$F$$20240731$20240423$20240805$PER$$US-PFIZER INC-202400043476$PFIZER$$64$YR$$F$Y$79.38$KG$20240805$$CN$US$US
237735126$23773512$6$F$20240417$20240729$20240423$20240801$EXP$$CA-JNJFOC-20240460286$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240801$$HP$CA$CA
237735486$23773548$6$F$$20240918$20240423$20240927$EXP$$CA-TEVA-VS-3186372$TEVA$$66$YR$$M$Y$$$20240927$$HP$CA$CA
237735592$23773559$2$F$$20240715$20240423$20240723$PER$$US-SA-2024SA117228$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240723$$MD$US$US
237735824$23773582$4$F$$20240903$20240423$20240909$30DAY$$US-PFIZER INC-202400079008$PFIZER$$10$YR$$M$Y$$$20240909$$HP$US$US
237735893$23773589$3$F$20240417$20240517$20240423$20240731$PER$$US-BAYER-2024A060368$BAYER$$46$YR$A$F$Y$$$20240731$$HP$US$US
237735953$23773595$3$F$$20240805$20240423$20240807$30DAY$$US-PFIZER INC-202400079698$PFIZER$$1$YR$$M$Y$$$20240807$$CN$US$US
237735984$23773598$4$F$$20240905$20240423$20240909$30DAY$$US-PFIZER INC-202400079160$PFIZER$$58$YR$$F$Y$$$20240909$$CN$US$US
237736014$23773601$4$F$$20240904$20240423$20240909$30DAY$$US-PFIZER INC-202400080444$PFIZER$$6$YR$$M$Y$$$20240909$$CN$US$US
237736043$23773604$3$F$$20240801$20240423$20240805$30DAY$$US-PFIZER INC-202400079663$PFIZER$$11$YR$$F$Y$20.3$KG$20240805$$HP$US$US
237736223$23773622$3$F$20231001$20240917$20240423$20240923$EXP$$US-AMGEN-USASP2024078752$AMGEN$$84$YR$E$F$Y$$$20240922$$CN$US$US
237736232$23773623$2$F$20230101$20240724$20240423$20240726$EXP$$JP-ABBVIE-5730283$ABBVIE$$70$YR$$M$Y$$$20240726$$MD$JP$JP
237736402$23773640$2$F$20240301$20240717$20240423$20240725$PER$$US-SA-2024SA119400$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240725$$MD$US$US
237736642$23773664$2$F$20240401$20240730$20240423$20240807$PER$$US-SA-2024SA119586$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240807$$MD$US$US
237737217$23773721$7$F$$20240906$20240423$20240910$30DAY$$US-PFIZER INC-202400081115$PFIZER$$14$YR$$F$Y$$$20240910$$CN$US$US
237737225$23773722$5$F$$20240920$20240423$20240924$30DAY$$US-PFIZER INC-202400079759$PFIZER$$74$YR$$M$Y$84.37$KG$20240924$$CN$US$US
237737285$23773728$5$F$$20240906$20240423$20240910$30DAY$$US-PFIZER INC-202400080021$PFIZER$$2$YR$$F$Y$$$20240910$$MD$US$US
237737303$23773730$3$F$20240404$20240823$20240423$20240828$30DAY$$US-PFIZER INC-202400081054$PFIZER$$8$YR$$M$Y$$$20240828$$CN$US$US
237737395$23773739$5$F$20240101$20240725$20240423$20240802$PER$$US-SA-2024SA117626$SANOFI AVENTIS$$52$YR$A$F$Y$84.2$KG$20240802$$HP$US$US
237737402$23773740$2$F$20240101$20240918$20240423$20240926$PER$$US-SA-2024SA116455$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240926$$MD$US$US
237737534$23773753$4$F$20240406$20240903$20240423$20240906$30DAY$$US-PFIZER INC-202400083224$PFIZER$$10$YR$$M$Y$22.676$KG$20240906$$CN$US$US
237737546$23773754$6$F$$20240904$20240423$20240906$30DAY$$US-PFIZER INC-202400082131$PFIZER$$4$YR$$M$Y$16.327$KG$20240906$$HP$US$US
237737554$23773755$4$F$20240301$20240724$20240423$20240730$30DAY$$US-PFIZER INC-202400082786$PFIZER$$10$YR$$F$Y$26.31$KG$20240730$$CN$US$US
237737692$23773769$2$F$20240315$20240709$20240423$20240717$EXP$CZ-CZSUKL-24000807$CZ-TEVA-VS-3185372$TEVA$$42$YR$$F$Y$71$KG$20240717$$MD$CZ$CZ
237737944$23773794$4$F$$20240903$20240423$20240906$30DAY$$US-PFIZER INC-PV202400047233$PFIZER$$$$$F$Y$$$20240906$$CN$US$US
237737954$23773795$4$F$$20240904$20240423$20240909$30DAY$$US-PFIZER INC-202400082920$PFIZER$$13$YR$$M$Y$$$20240909$$HP$US$US
237738022$23773802$2$F$20240405$20240801$20240423$20240805$EXP$$ZA-MYLANLABS-2024M1036421$MYLAN$$34$YR$$F$Y$$$20240805$$HP$ZA$ZA
237738292$23773829$2$F$$20240808$20240423$20240812$30DAY$$US-PFIZER INC-202400076800$PFIZER$$$$$F$Y$$$20240812$$CN$US$US
237738333$23773833$3$F$$20240712$20240423$20240715$30DAY$$US-PFIZER INC-202400082794$PFIZER$$14$YR$$M$Y$$$20240715$$HP$US$US
237738805$23773880$5$F$20240324$20240701$20240423$20240711$EXP$$CH-BAXTER-2024BAX016958$BAXTER$$72$YR$$F$Y$64.3$KG$20240711$$MD$CH$CH
237738842$23773884$2$F$20240409$20240409$20240423$20240731$EXP$$US-SCPHARMACEUTICALS-2024-SCPH-US000174$PAREXEL$$86$YR$$F$Y$$$20240731$$CN$US$US
237738962$23773896$2$F$$20240806$20240423$20240813$PER$$US-SA-2024SA118752$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240814$$MD$US$US
237739403$23773940$3$F$20240617$20240806$20240423$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202404014319$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240812$$CN$US$US
237739582$23773958$2$F$20240412$20240911$20240423$20240919$PER$$US-SA-2024SA119845$SANOFI AVENTIS$$14$YR$T$M$Y$75.29$KG$20240919$$MD$US$US
237739762$23773976$2$F$20201002$20240808$20240423$20240813$PER$$US-BIOGEN-2020BI00911665$BIOGEN$$17$YR$$F$Y$$$20240813$$CN$US$US
237740423$23774042$3$F$$20240705$20240423$20240709$EXP$$NVSC2024US085222$NOVARTIS$$$$I$F$Y$$$20240709$$MD$US$US
237740622$23774062$2$F$$20240708$20240423$20240709$PER$$US-PFIZER INC-202400091173$PFIZER$$61$YR$$F$Y$$$20240709$$CN$US$US
237741112$23774111$2$F$$20240716$20240423$20240717$PER$$US-PFIZER INC-PV202400052118$PFIZER$$64$YR$$M$Y$$$20240717$$HP$US$US
237741432$23774143$2$F$20170601$20240717$20240423$20240725$PER$$US-SA-2024SA115823$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240725$$MD$US$US
237741562$23774156$2$F$20240408$20240708$20240423$20240717$EXP$$FR-KREUSSLER-2024-FR-000002$CHEMISCHE FABRIK KREUSSLER$$67$YR$E$F$Y$90$KG$20240717$$MD$FR$FR
237741765$23774176$5$F$20240418$20240705$20240423$20240710$EXP$$JP-ABBVIE-5729718$ABBVIE$$16$YR$$M$Y$$$20240710$$MD$JP$JP
237742132$23774213$2$F$$20240702$20240423$20240704$EXP$$CH-JNJFOC-20230705595$JOHNSON AND JOHNSON$$8$DEC$E$$Y$$$20240704$$MD$CH$CH
237742174$23774217$4$F$20211004$20240806$20240423$20240814$EXP$$US-CHATTEMPRD-2024OHG013353$CHATTEM$$$$E$M$Y$$$20240814$$LW$US$US
237742213$23774221$3$F$$20240709$20240423$20240710$PER$$US-ALXN-202404USA001246US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
237742522$23774252$2$F$20230901$20240904$20240423$20240913$EXP$FR-AFSSAPS-NT2024000317$FR-TEVA-VS-3185484$TEVA$$78$YR$$M$Y$69$KG$20240913$$MD$FR$FR
237742963$23774296$3$F$$20240820$20240423$20240828$EXP$$CA-TEVA-VS-3186973$TEVA$$64$YR$$M$Y$$$20240828$$HP$CA$CA
237743373$23774337$3$F$20230101$20240730$20240423$20240807$PER$$US-SA-2024SA114940$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240807$$MD$US$US
237743382$23774338$2$F$20240101$20240724$20240423$20240802$PER$$US-SA-2024SA118995$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240802$$MD$US$US
237743482$23774348$2$F$20230916$20240809$20240423$20240814$EXP$$JP-AstraZeneca-2024A089442$ASTRAZENECA$$64$YR$$F$Y$65$KG$20240814$$MD$JP$
237743543$23774354$3$F$20230824$20240722$20240423$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-062760$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$50.8$KG$20240722$$PH$JP$JP
237743578$23774357$8$F$20240307$20240918$20240423$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063160$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$75.3$KG$20240930$$CN$US$US
237743752$23774375$2$F$20240202$20240626$20240423$20240701$PER$$NVSC2024US085739$NOVARTIS$$44$YR$$F$Y$$$20240701$$CN$US$US
237743768$23774376$8$F$20190506$20240809$20240423$20240819$PER$$US-OTSUKA-2024_011315$OTSUKA$$44$YR$$M$Y$101.15$KG$20240819$$MD$US$US
237743792$23774379$2$F$$20240809$20240423$20240814$EXP$$NVSC2024GB085178$NOVARTIS$$$$A$F$Y$$$20240814$$CN$GB$GB
237744202$23774420$2$F$20240422$20240807$20240423$20240809$PER$$US-AMGEN-USASP2024080948$AMGEN$$68$YR$E$F$Y$$$20240809$$CN$US$US
237744244$23774424$4$F$20240401$20240717$20240423$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062915$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240719$$CN$US$US
237744332$23774433$2$F$$20240727$20240423$20240801$EXP$$CA-JNJFOC-20240452403$JOHNSON AND JOHNSON$$65$YR$E$F$Y$72.64$KG$20240801$$HP$CA$CA
237745182$23774518$2$F$20240330$20240722$20240423$20240725$EXP$$US-BAYER-2024A059578$BAYER$$42$YR$A$M$Y$$$20240725$$CN$US$US
237745214$23774521$4$F$$20240903$20240423$20240909$EXP$$CA-JNJFOC-20240423538$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240910$$HP$CA$CA
237745454$23774545$4$F$$20240729$20240423$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063102$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240730$$CN$US$US
237745482$23774548$2$F$$20240722$20240423$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063548$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240723$$HP$US$US
237745502$23774550$2$F$$20240813$20240423$20240817$EXP$$NVSC2024CA085454$NOVARTIS$Watts C, Martin TL. Etizolam blood concentrations in 191 forensic cases in Ontario, Canada (2019?2020).. JOURNAL OF ANALYTICAL TOXICOLOGY. 2022;46(7):719-25$43$YR$$M$Y$$$20240817$$HP$CA$CA
237745572$23774557$2$F$20240417$20240808$20240423$20240811$PER$$US-AMGEN-USASP2024080186$AMGEN$$67$YR$E$M$Y$$$20240810$$CN$US$US
237745813$23774581$3$F$$20240805$20240423$20240808$EXP$$JP-JNJFOC-20240467275$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240809$$MD$JP$JP
237746072$23774607$2$F$20210101$20240807$20240423$20240817$EXP$FR-AFSSAPS-AVBX2024000106$FR-TEVA-VS-3185707$TEVA$$31$YR$$F$Y$$$20240817$$PH$FR$FR
237746103$23774610$3$F$$20240828$20240423$20240906$EXP$$CA-JNJFOC-20240459807$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240906$$HP$CA$CA
237746492$23774649$2$F$$20240722$20240423$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-060823$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240723$$MD$JP$JP
237747142$23774714$2$F$$20240625$20240423$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-436853$RANBAXY$$88$YR$$F$Y$$$20240710$$PH$GB$GB
237747397$23774739$7$F$20240101$20240910$20240423$20240918$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00229$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
237748066$23774806$6$F$20240101$20240725$20240423$20240731$EXP$$US-PFIZER INC-PV202400052935$PFIZER$$58$YR$$F$Y$$$20240731$$HP$US$US
237748192$23774819$2$F$$20240718$20240423$20240722$PER$$US-PFIZER INC-PV202400052588$PFIZER$$66$YR$$F$Y$$$20240722$$HP$US$US
237748202$23774820$2$F$$20240918$20240423$20240920$PER$$US-PFIZER INC-PV202400053085$PFIZER$$66$YR$$F$Y$$$20240920$$HP$US$US
237748262$23774826$2$F$$20240829$20240423$20240911$PER$$US-INCYTE CORPORATION-2024IN003387$INCYTE$$$$$$Y$$$20240911$$CN$US$US
237748532$23774853$2$F$$20240722$20240423$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-062398$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$61.6$KG$20240722$$PH$JP$JP
237748574$23774857$4$F$20240624$20240903$20240423$20240909$EXP$$GB-TAKEDA-2024TUS036990$TAKEDA$$18$YR$$M$Y$$$20240909$$CN$GB$GB
237748592$23774859$2$F$$20240705$20240423$20240705$PER$$NVSC2024US085492$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
237748692$23774869$2$F$$20240827$20240423$20240902$EXP$$GB-TAKEDA-2024TUS034745$TAKEDA$$$$$F$Y$$$20240902$$CN$GB$GB
237748853$23774885$3$F$$20240801$20240423$20240806$PER$$NVSC2024US083670$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
237749113$23774911$3$F$20220101$20240722$20240423$20240812$EXP$$JP-009507513-2307JPN002698J$MERCK$Hoshino K, Hagimoto M, Toyama A, Murakami M, Harada H, Ueda T, et al. p-146 Early treatment experience with lenvatinib mesylate and pembrolizumab combination therapy for recurrent corpus uteri carcinoma in our hospital. The 65th Annual Meeting of The Japan Society of Gynecologic Oncology.. 2023;41(3):343$60$YR$$F$Y$$$20240812$$MD$JP$JP
237749134$23774913$4$F$$20240820$20240423$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063551$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240821$$CN$US$US
237749326$23774932$6$F$20231129$20240717$20240423$20240722$EXP$$HK-PFIZER INC-202400091931$PFIZER$$53$YR$$F$Y$84$KG$20240722$$MD$HK$HK
237749792$23774979$2$F$20240101$20240912$20240423$20240913$EXP$$US-KYOWAKIRIN-2024KK009674$KYOWA$$$$$$Y$$$20240913$$CN$US$US
237750352$23775035$2$F$$20240603$20240423$20240711$PER$$US-MYLANLABS-2024M1036014$MYLAN$$$$$F$Y$53.07$KG$20240711$$CN$US$US
237750392$23775039$2$F$$20240703$20240423$20240704$PER$$NVSC2024US085817$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
237750772$23775077$2$F$$20240722$20240423$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063505$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240723$$HP$US$US
237750833$23775083$3$F$20240319$20240715$20240423$20240717$EXP$$DE-PFIZER INC-PV202400052012$PFIZER$$68$YR$$F$Y$$$20240717$$MD$DE$DE
237750845$23775084$5$F$20240401$20240726$20240423$20240730$EXP$$US-PFIZER INC-202400071097$PFIZER$$85$YR$$F$Y$$$20240730$$HP$US$US
237750994$23775099$4$F$20240514$20240814$20240423$20240816$30DAY$$US-PFIZER INC-PV202400047957$PFIZER$$12$YR$$M$Y$$$20240816$$MD$US$US
237751133$23775113$3$F$20240405$20240801$20240423$20240802$EXP$$ZA-MYLANLABS-2024M1036426$MYLAN$$$$$F$Y$2.5$KG$20240802$$HP$ZA$ZA
237751442$23775144$2$F$$20240415$20240423$20240918$EXP$$GB-BAUSCH-BL-2024-006145$BAUSCH AND LOMB$Gorgun B, Chakrabarti P. 19 A rare case of slowly progressive fatal pneumonia following oral dexamethasone therapy. Clinical Infection in Practice.. 2023;20(1):13. doi:10.1016/j.clinpr.2023.100286.$86$YR$$M$Y$$$20240918$$HP$GB$GB
237751504$23775150$4$F$$20240917$20240423$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063342$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240920$$CN$US$US
237751832$23775183$2$F$$20240723$20240423$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063566$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240723$$CN$US$US
237752182$23775218$2$F$$20240716$20240423$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063402$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240717$$HP$US$US
237752192$23775219$2$F$$20240703$20240423$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063837$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240709$$HP$US$US
237752282$23775228$2$F$$20240701$20240423$20240702$EXP$RO-JNJFOC-20240414512$RO-SANDOZ INC.-SDZ2024RO041861$SANDOZ$$73$YR$$F$Y$90$KG$20240702$$CN$RO$RO
237752612$23775261$2$F$$20240826$20240423$20240828$EXP$$CA-BAUSCH-BL-2024-006416$BAUSCH AND LOMB$$48$YR$$M$Y$$$20240828$$HP$CA$CA
237752622$23775262$2$F$20240419$20240730$20240423$20240731$PER$$US-AMGEN-USASP2024080228$AMGEN$$73$YR$E$F$Y$$$20240731$$CN$US$US
237752973$23775297$3$F$20230101$20240904$20240423$20240912$EXP$$CA-BEH-2023163936$CSL BEHRING$$45$YR$A$F$Y$44$KG$20240912$$CN$CA$CA
237753033$23775303$3$F$$20240627$20240423$20240710$PER$$US-Calliditas-2024CAL00584$CALLIDITAS THERAPEUTICS$$59$YR$A$M$Y$117$KG$20240710$$CN$US$US
237753052$23775305$2$F$20190711$20240802$20240423$20240808$EXP$$IT-MYLANLABS-2024M1035068$MYLAN$$78$YR$$F$Y$$$20240808$$HP$IT$IT
237753693$23775369$3$F$20240707$20240708$20240423$20240711$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006427$JAZZ$$2$YR$$M$Y$$$20240711$$CN$US$US
237753702$23775370$2$F$20230925$20240701$20240423$20240711$EXP$$JP-009507513-2402JPN003817J$MERCK$$60$YR$$F$Y$$$20240711$$MD$JP$JP
237753803$23775380$3$F$$20240628$20240423$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063466$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$72.12$KG$20240701$$CN$US$US
237753922$23775392$2$F$$20240808$20240423$20240813$PER$$JP-Eisai-EC-2024-164168$EISAI$$$$E$M$Y$$$20240814$$MD$JP$JP
237754182$23775418$2$F$$20240723$20240423$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063581$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240723$$CN$US$US
237755632$23775563$2$F$20220101$20240417$20240423$20240727$EXP$$AU-ABBVIE-5728323$ABBVIE$$$$$F$Y$$$20240727$$HP$AU$AU
237755692$23775569$2$F$20240301$20240801$20240423$20240805$EXP$$NL-BIOGEN-2024BI01261004$BIOGEN$$17$YR$$F$Y$$$20240805$$HP$NL$NL
237755893$23775589$3$F$$20240725$20240423$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-054839$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240726$$MD$JP$JP
237755922$23775592$2$F$20240401$20240624$20240423$20240701$PER$$US-BAUSCHBL-2024BNL025742$BAUSCH AND LOMB$$$$$M$Y$$$20240701$$CN$US$US
237756043$23775604$3$F$20240401$20240909$20240423$20240917$EXP$$IL-Blueprint Medicines Corporation-SP-IL-2024-000810$BLUEPRINT MEDICINES$$22$YR$A$M$Y$$$20240917$$HP$IL$IL
237756184$23775618$4$F$$20240809$20240423$20240815$EXP$$US-TAKEDA-2024TUS036426$TAKEDA$$$$$M$Y$$$20240815$$CN$US$US
237756233$23775623$3$F$20240601$20240803$20240423$20240812$PER$$US-SA-2024SA117980$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240812$$MD$US$US
237756552$23775655$2$F$20240409$20240924$20240423$20240930$EXP$$JP-GSK-JP2024JPN050800$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$JP$JP
237756712$23775671$2$F$$20240908$20240423$20240910$EXP$$NVSC2024GB082754$NOVARTIS$$$$$F$Y$$$20240910$$CN$GB$GB
237756764$23775676$4$F$20240513$20240911$20240423$20240916$EXP$$US-ABBVIE-5729025$ABBVIE$$78$YR$$F$Y$74$KG$20240916$$CN$US$US
237757022$23775702$2$F$$20240716$20240423$20240718$EXP$$US-ABBVIE-5731434$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
237757053$23775705$3$F$20231201$20240830$20240423$20240903$EXP$JP-MMM-V4FXEPBZ$JP-GSK-JP2024050277$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$MD$JP$JP
237757232$23775723$2$F$$20240716$20240423$20240724$PER$$US-SA-2024SA121274$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240724$$MD$US$US
237757242$23775724$2$F$20240701$20240708$20240423$20240713$PER$$US-SA-2020SA034459$SANOFI AVENTIS$$79$YR$E$F$Y$77.11$KG$20240713$$MD$US$US
237757302$23775730$2$F$$20240711$20240423$20240722$EXP$$JP-009507513-2403JPN003673J$MERCK$$7$DEC$$M$Y$$$20240719$$MD$JP$JP
237757582$23775758$2$F$20240101$20240913$20240423$20240925$EXP$$BE-ABBVIE-5731504$ABBVIE$$76$YR$$F$Y$55$KG$20240925$$HP$BE$BE
237757736$23775773$6$F$20240101$20240920$20240423$20240926$EXP$$IE-ABBVIE-5709708$ABBVIE$$73$YR$$F$Y$$$20240926$$CN$IE$IE
237757812$23775781$2$F$$20240822$20240424$20240825$EXP$$JP-TAKEDA-2024TJP000693$TAKEDA$$5$DEC$$M$Y$$$20240825$$PH$JP$JP
237757865$23775786$5$F$$20240731$20240424$20240805$EXP$$GR-AMGEN-GRCSP2024079714$AMGEN$$$$$F$Y$$$20240804$$MD$GR$GR
237758122$23775812$2$F$20240101$20240716$20240424$20240723$EXP$$US-ABBVIE-5726057$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
237758414$23775841$4$F$20240415$20240906$20240424$20240921$EXP$$FR-ABBVIE-5730487$ABBVIE$$79$YR$$M$Y$$$20240921$$HP$FR$FR
237758424$23775842$4$F$20240412$20240828$20240424$20240911$PER$$US-SA-2024SA119583$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240911$$MD$US$US
237758472$23775847$2$F$20240101$20240709$20240424$20240717$PER$$US-SA-2024SA121321$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240717$$MD$US$US
237758503$23775850$3$F$20221227$20240924$20240424$20240925$EXP$$PT-SANDOZ INC.-SDZ2024PT042040$SANDOZ$$52$YR$$F$Y$58$KG$20240925$$MD$PT$PT
237758572$23775857$2$F$20240418$20240805$20240424$20240808$PER$$US-AMGEN-USASP2024080269$AMGEN$$77$YR$E$$Y$$$20240808$$PH$US$US
237758673$23775867$3$F$$20240725$20240424$20240728$30DAY$$US-SANDOZ INC.-SDZ2024US042003$SANDOZ$$$$$M$Y$$$20240728$$CN$US$US
237759052$23775905$2$F$$20240724$20240424$20240801$PER$$US-SA-2024SA122617$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240801$$MD$US$US
237759543$23775954$3$F$$20240808$20240424$20240814$EXP$$US-BEIGENE-BGN-2024-005935$BEIGENE$$$$$$Y$$$20240814$$CN$US$US
237759766$23775976$6$F$20240101$20240920$20240424$20240930$EXP$$CA-CELLTRION INC.-2024CA009439$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
237759782$23775978$2$F$20240327$20240814$20240424$20240830$PER$$CA-TOLMAR, INC.-24CA048040$TOLMAR$$86$YR$$M$Y$$$20240829$$CN$CA$CA
237759803$23775980$3$F$$20240904$20240424$20240924$PER$$CA-TOLMAR, INC.-24CA048067$TOLMAR$$$$$M$Y$$$20240924$$CN$CA$CA
237759812$23775981$2$F$20240327$20240619$20240424$20240710$PER$$CA-TOLMAR, INC.-24CA048097$TOLMAR$$67$YR$$M$Y$$$20240710$$CN$CA$CA
237759822$23775982$2$F$20240327$20240717$20240424$20240809$PER$$CA-TOLMAR, INC.-24CA048098$TOLMAR$$61$YR$$M$Y$$$20240809$$CN$CA$CA
237759932$23775993$2$F$$20240711$20240424$20240722$EXP$$US-ABBVIE-5729346$ABBVIE$$$$$F$Y$73$KG$20240722$$CN$US$US
237760043$23776004$3$F$$20240917$20240424$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062391$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240918$$CN$US$US
237760342$23776034$2$F$20240401$20240712$20240424$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202404013749$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240716$$CN$US$US
237760473$23776047$3$F$$20240814$20240424$20240820$EXP$$US-TAKEDA-2024TUS017788$TAKEDA$$$$$M$Y$76$KG$20240820$$HP$US$US
237760733$23776073$3$F$$20240618$20240424$20240925$PER$$US-GSK-US2024AMR049677$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
237760773$23776077$3$F$$20240808$20240424$20240812$EXP$$CA-TAKEDA-2024TUS037970$TAKEDA$$$$$F$Y$$$20240812$$CN$CA$CA
237761013$23776101$3$F$20240421$20240723$20240424$20240726$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-023851$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$$$20240726$$CN$US$US
237761023$23776102$3$F$20240306$20240808$20240424$20240813$EXP$$AU-TAKEDA-2024TUS038490$TAKEDA$$31$YR$$M$Y$$$20240813$$MD$AU$AU
237761482$23776148$2$F$20240408$20240604$20240424$20240731$PER$$US-LUNDBECK-DKLU3076573$LUNDBECK$$$$$$Y$$$20240731$$CN$US$US
237761532$23776153$2$F$$20240730$20240424$20240808$PER$$US-SA-2024SA121741$SANOFI AVENTIS$$$$A$M$Y$88.4$KG$20240808$$MD$US$US
237761663$23776166$3$F$$20240801$20240424$20240809$EXP$$US-BIOGEN-2024BI01261214$BIOGEN$$$$$M$Y$$$20240809$$CN$US$US
237761677$23776167$7$F$20240206$20240626$20240424$20240829$EXP$$CA-BEH-2024168476$CSL BEHRING$$68$YR$E$F$Y$86$KG$20240829$$CN$CA$CA
237761982$23776198$2$F$$20240819$20240424$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063809$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240821$$HP$US$US
237762025$23776202$5$F$20220311$20240923$20240424$20240926$EXP$$CA-ROCHE-3052245$ROCHE$$54$YR$A$F$Y$43.54$KG$20240926$$CN$CA$CA
237762043$23776204$3$F$20240712$20240730$20240424$20240801$EXP$$US-ABBVIE-5618505$ABBVIE$$67$YR$$M$Y$89$KG$20240801$$CN$US$US
237762223$23776222$3$F$$20240722$20240424$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-062519$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240722$$MD$JP$JP
2377630410$23776304$10$F$$20240809$20240424$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202404009646$ELI LILLY AND CO$$73$YR$E$F$Y$86.168$KG$20240815$$CN$US$US
237763232$23776323$2$F$20240419$20240822$20240424$20240824$PER$$US-AMGEN-USASP2024080697$AMGEN$$67$YR$E$M$Y$$$20240824$$CN$US$US
237763563$23776356$3$F$20240222$20240710$20240424$20240714$EXP$$US-ROCHE-3546753$ROCHE$$80$YR$E$F$Y$88.63$KG$20240714$$HP$US$US
237763692$23776369$2$F$20231201$20231230$20240424$20240821$PER$$US-UCBSA-2024000345$UCB$$49$YR$$F$Y$$$20240821$$HP$US$US
237763702$23776370$2$F$$20240110$20240424$20240821$PER$$US-UCBSA-2024001942$UCB$$$$$F$Y$$$20240821$$MD$US$US
237763712$23776371$2$F$$20240110$20240424$20240821$PER$$US-UCBSA-2024002010$UCB$$$$$$Y$$$20240821$$MD$US$US
237763722$23776372$2$F$$20240125$20240424$20240821$PER$$US-UCBSA-2024004459$UCB$$$$$F$Y$$$20240821$$MD$US$US
237763732$23776373$2$F$$20240201$20240424$20240821$PER$$US-UCBSA-2024002982$UCB$$$$$M$Y$$$20240821$$MD$US$US
237763762$23776376$2$F$$20240131$20240424$20240821$PER$$US-UCBSA-2024005814$UCB$$$$$M$Y$$$20240821$$HP$US$US
237763772$23776377$2$F$20240101$20240717$20240424$20240821$PER$$US-UCBSA-2024009128$UCB$$$$$F$Y$78.93$KG$20240821$$HP$US$US
237763782$23776378$2$F$$20240220$20240424$20240821$PER$$US-UCBSA-2024009082$UCB$$$$$$Y$$$20240821$$MD$US$US
237763792$23776379$2$F$$20240221$20240424$20240821$PER$$US-UCBSA-2024009245$UCB$$$$$$Y$$$20240821$$HP$US$US
237763802$23776380$2$F$20240228$20240229$20240424$20240821$PER$$US-UCBSA-2024010568$UCB$$62$YR$$F$Y$$$20240821$$HP$US$US
237763812$23776381$2$F$$20240305$20240424$20240821$PER$$US-UCBSA-2024011546$UCB$$$$$$Y$$$20240821$$HP$US$US
237763822$23776382$2$F$20240101$20240220$20240424$20240821$PER$$US-UCBSA-2024001169$UCB$$30$YR$$F$Y$88.5$KG$20240821$$CN$US$US
237763832$23776383$2$F$$20240226$20240424$20240821$PER$$US-UCBSA-2024003263$UCB$$$$$$Y$$$20240821$$HP$US$US
237763842$23776384$2$F$20240308$20240308$20240424$20240821$PER$$US-UCBSA-2024012148$UCB$$93$YR$$M$Y$$$20240821$$HP$US$US
237763852$23776385$2$F$$20240309$20240424$20240821$PER$$US-UCBSA-2024013664$UCB$$$$$F$Y$$$20240821$$MD$US$US
237763862$23776386$2$F$20240301$20240313$20240424$20240821$PER$$US-UCBSA-2024012065$UCB$$75$YR$$F$Y$$$20240821$$HP$US$US
237763872$23776387$2$F$$20240725$20240424$20240821$PER$$US-UCBSA-2024014396$UCB$$$$$F$Y$$$20240821$$MD$US$US
237763882$23776388$2$F$$20240321$20240424$20240821$PER$$US-UCBSA-2024014392$UCB$$$$$F$Y$$$20240821$$MD$US$US
237763934$23776393$4$F$20240101$20240627$20240424$20240701$EXP$$US-UCBSA-2024012237$UCB$$$$$M$Y$$$20240701$$HP$US$US
237764245$23776424$5$F$20240501$20240910$20240424$20240918$EXP$$GB-JNJFOC-20240467994$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240918$$CN$GB$GB
237765092$23776509$2$F$$20240628$20240424$20240711$EXP$$ES-CIPLA LTD.-2024ES03807$CIPLA$$$$$$Y$$$20240711$$CN$ES$ES
237765253$23776525$3$F$20240101$20240707$20240424$20240715$EXP$$US-SA-2024SA117220$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240715$$MD$US$US
237765352$23776535$2$F$$20240726$20240424$20240806$PER$$US-SA-2024SA086189$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240806$$MD$US$US
237765382$23776538$2$F$$20240731$20240424$20240808$PER$$US-SA-2024SA120384$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240808$$MD$US$US
237765392$23776539$2$F$20240201$20240716$20240424$20240725$PER$$US-SA-2024SA121960$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240725$$MD$US$US
237765432$23776543$2$F$$20240729$20240424$20240807$PER$$US-SA-2024SA118069$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240807$$MD$US$US
237765493$23776549$3$F$20240101$20240826$20240424$20240906$PER$$US-SA-2024SA119903$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240906$$MD$US$US
237765502$23776550$2$F$$20240730$20240424$20240807$PER$$US-SA-2024SA118772$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240807$$MD$US$US
237765752$23776575$2$F$$20240718$20240424$20240729$EXP$$PT-AUROBINDO-AUR-APL-2024-018547$AUROBINDO$Ferreira H, Sousa C, Bras G, Leite L, Vaz CP, Moura MC, et al.. WCN24-559 PROTOCADHERIN FAT1-POSITIVE MEMBRANOUS NEPHROPATHY SECONDARY TO HEMATOPOIETIC STEM CELL TRANSPLANTATION SUCESSFULLY TREATED WITH RITUXIMAB. Kidney-Int-Rep. 2024;9 (Suppl.)(4):S62-S63$67$YR$$M$Y$$$20240729$$HP$PT$PT
237766413$23776641$3$F$$20240708$20240424$20240717$EXP$$US-UCBSA-2024003458$UCB$$$$$F$Y$56.689$KG$20240718$$HP$US$US
237766712$23776671$2$F$$20240827$20240424$20240902$EXP$$US-CIPLA (EU) LIMITED-2024US03893$CIPLA$Woods HB, Bharathidasan K, Yang M, Nichols J, Nugent K.. Delayed onset graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency virus: A case series. The American Journal of the Medical Science. 2024;367 (S1):S9 to S10$$$$$Y$$$20240902$$MD$US$US
237766862$23776686$2$F$20231016$20240719$20240424$20240730$EXP$$DE-ROCHE-3441203$ROCHE$$34$YR$A$F$Y$$$20240730$$MD$DE$DE
237767073$23776707$3$F$20230417$20240902$20240424$20240911$EXP$$CA-CELLTRION INC.-2023CA008352$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
237767164$23776716$4$F$20221201$20240710$20240424$20240717$EXP$$NVSC2024DE083560$NOVARTIS$$$$A$F$Y$70$KG$20240717$$CN$DE$DE
237767493$23776749$3$F$20220801$20240716$20240424$20240723$EXP$$CA-JNJFOC-20220805554$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240722$$CN$CA$CA
237767813$23776781$3$F$20240409$20240520$20240424$20240806$PER$$US-AstraZeneca-2024A092060$ASTRAZENECA$$22528$DY$$F$Y$$$20240806$$CN$US$
237767834$23776783$4$F$$20240507$20240424$20240805$EXP$$US-AstraZeneca-2024A091439$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
237768044$23776804$4$F$20230901$20240717$20240424$20240805$EXP$IT-MINISAL02-978294$IT-AMGEN-ITASP2024079680$AMGEN$$68$YR$E$F$Y$65$KG$20240804$$MD$IT$IT
237768132$23776813$2$F$$20240809$20240424$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-017844$AUROBINDO$Lee M, Amin H, Dasu N, Khalid Y. MANAGEMENT OF RHYTHM CONTROL AND CARDIOGENIC SHOCK IN PATIENT WITH DEXTROTRANSPOSITION OF THE GREAT ARTERIES. J-Am-CollCardiol. 2024;83 (Suppl.)(13):4313$42$YR$$M$Y$$$20240821$$HP$US$US
237768144$23776814$4$F$$20240802$20240424$20240808$PER$$NVSC2024US086294$NOVARTIS$$$$$M$Y$$$20240808$$CN$US$US
237768215$23776821$5$F$$20240920$20240424$20240925$EXP$$JP-GSK-JP2024JPN050796$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$JP$JP
237768472$23776847$2$F$20240315$20240911$20240424$20240917$EXP$FR-AFSSAPS-MA2024000466$FR-GSK-FR2024051574$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$FR$FR
237768572$23776857$2$F$$20240913$20240424$20240927$EXP$$TH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442913$RANBAXY$Chawalitmongkol K, Maneenil K, Thungthong P, Deerochanawong C. Prevalence and Associated Factors for Thyroid Dysfunction Among Patients On Targeted Therapy for Cancers: A Single-Center Study from Thailand. J ASEAN Fed Endocr Soc. 2023;38 (2):78-85$70$YR$$M$Y$$$20240927$$MD$TH$TH
237768593$23776859$3$F$20240409$20240831$20240424$20240913$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-442884$RANBAXY$$74$YR$$M$Y$$$20240913$$MD$DE$DE
237768883$23776888$3$F$20230101$20240806$20240424$20240809$EXP$$AR-JNJFOC-20240145952$JOHNSON AND JOHNSON$$63$YR$A$F$Y$59$KG$20240809$$CN$AR$AR
237768902$23776890$2$F$20200807$20240920$20240424$20240926$EXP$$CA-TAKEDA-2020TUS032468$TAKEDA$$51$YR$$M$Y$$$20240926$$HP$CA$CA
237768922$23776892$2$F$$20240628$20240424$20240709$EXP$DE-BFARM-24002306$DE-Accord-419730$ACCORD$$$$A$F$Y$$$20240709$$MD$DE$DE
237769133$23776913$3$F$20240101$20240813$20240424$20240816$EXP$$CA-ABBVIE-5726939$ABBVIE$$78$YR$$F$Y$$$20240816$$CN$CA$CA
237769152$23776915$2$F$20230124$20240709$20240424$20240710$EXP$$FR-TAKEDA-2024TUS038537$TAKEDA$$$$E$F$Y$$$20240710$$MD$FR$FR
237769263$23776926$3$F$$20240719$20240424$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061113$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240723$$CN$US$US
237769292$23776929$2$F$$20240802$20240424$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063917$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$105.69$KG$20240805$$CN$US$US
237769336$23776933$6$F$$20240821$20240424$20240823$EXP$$US-TAKEDA-US201832379$TAKEDA$$$$$F$Y$66$KG$20240823$$HP$US$US
237769374$23776937$4$F$$20240801$20240424$20240805$PER$$NVSC2024US086420$NOVARTIS$$$$$M$Y$$$20240805$$CN$US$US
237769392$23776939$2$F$20240421$20240704$20240424$20240705$PER$$US-AMGEN-USASP2024081124$AMGEN$$62$YR$A$F$Y$$$20240705$$CN$US$US
237769403$23776940$3$F$$20240819$20240424$20240822$EXP$$CA-AMGEN-CANSP2024080859$AMGEN$$63$YR$A$M$Y$$$20240822$$MD$CA$CA
237769463$23776946$3$F$20240401$20240815$20240424$20240823$EXP$$CA-CELLTRION INC.-2024CA009460$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
237769563$23776956$3$F$$20240716$20240424$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063915$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$68.04$KG$20240718$$CN$US$US
237769603$23776960$3$F$20240101$20240725$20240424$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063965$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$83.91$KG$20240729$$CN$US$US
237769622$23776962$2$F$20240301$20240723$20240424$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064132$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240723$$CN$US$US
237769732$23776973$2$F$$20240812$20240424$20240827$PER$$NVSC2024US086712$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
237769864$23776986$4$F$20240131$20240719$20240424$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-062515$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240719$$MD$JP$JP
237769882$23776988$2$F$$20240808$20240424$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063002$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$48.08$KG$20240810$$CN$US$US
237769904$23776990$4$F$$20240719$20240424$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063972$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240722$$HP$US$US
237769942$23776994$2$F$20240414$20240814$20240424$20240818$PER$$US-AMGEN-USASP2024080780$AMGEN$$59$YR$A$F$Y$$$20240817$$CN$US$US
237770063$23777006$3$F$$20240826$20240424$20240831$PER$$NVSC2024US084922$NOVARTIS$$$$$F$Y$95$KG$20240831$$HP$US$US
237770203$23777020$3$F$20240328$20240605$20240424$20240701$EXP$$US-AstraZeneca-2024A091740$ASTRAZENECA$$60$YR$$F$Y$109$KG$20240701$$HP$US$
237770373$23777037$3$F$20240403$20240724$20240424$20240729$EXP$$CA-JNJFOC-20240459853$JOHNSON AND JOHNSON$$10$YR$C$F$Y$33$KG$20240729$$HP$CA$CA
237770773$23777077$3$F$20231001$20240625$20240424$20240704$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007432$UNITED THERAPEUTICS$$43$YR$$F$Y$114.29$KG$20240704$$PH$US$US
237770818$23777081$8$F$20240308$20240916$20240424$20240919$EXP$$CA-BIOGEN-2024BI01256110$BIOGEN$$40$YR$$F$Y$$$20240919$$HP$CA$CA
237770852$23777085$2$F$20240827$20240916$20240424$20240923$PER$$NVSC2024US085532$NOVARTIS$$$$A$F$Y$$$20240923$$CN$US$US
237770914$23777091$4$F$20240401$20240807$20240424$20240816$EXP$$US-GSK-US2024AMR050253$GLAXOSMITHKLINE$$53$YR$$F$Y$96.054$KG$20240816$$CN$US$US
237770923$23777092$3$F$$20240802$20240424$20240812$EXP$$US-GSK-US2024AMR050117$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
237771142$23777114$2$F$20240421$20240726$20240424$20240730$PER$$US-AMGEN-USASP2024080928$AMGEN$$76$YR$E$M$Y$$$20240729$$CN$US$US
237771182$23777118$2$F$$20240717$20240424$20240724$EXP$$US-BIOGEN-2024BI01261420$BIOGEN$$$$$M$Y$$$20240724$$CN$US$US
237771282$23777128$2$F$$20240717$20240424$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-018145$AUROBINDO$Agrawal A, Kandah F, Mahowald M. ACUTE PANCREATITIS SECONDARYTO LISINOPRIL USE. J-Am-Coll-Cardiol. 2024;83(Suppl.)(13:3179$55$YR$$F$Y$$$20240726$$HP$US$US
237771353$23777135$3$F$20240516$20240808$20240424$20240812$EXP$$CA-TAKEDA-2024TUS038728$TAKEDA$$58$YR$$F$Y$$$20240812$$CN$CA$CA
237771443$23777144$3$F$20180524$20240909$20240424$20240916$EXP$$CO-ROCHE-3257918$ROCHE$$34$YR$A$F$Y$68$KG$20240916$$CN$CO$CO
2377715010$23777150$10$F$20240101$20240906$20240424$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010356$UNITED THERAPEUTICS$$$$$M$Y$65.76$KG$20240914$$$US$US
237771523$23777152$3$F$20240421$20240809$20240424$20240812$PER$$US-AMGEN-USASP2024081484$AMGEN$$37$YR$A$M$Y$$$20240812$$CN$US$US
237771563$23777156$3$F$20240419$20240816$20240424$20240822$PER$$US-AMGEN-USASP2024081001$AMGEN$$79$YR$E$F$Y$$$20240822$$PH$US$US
237771743$23777174$3$F$20240115$20240805$20240424$20240805$EXP$$BE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-023059$BOEHRINGER INGELHEIM$$55$YR$A$M$Y$83$KG$20240805$$MD$BE$BE
237771783$23777178$3$F$20230701$20240517$20240424$20240711$EXP$$UY-ROCHE-3398044$ROCHE$$40$YR$A$F$Y$$$20240708$$MD$UY$UY
237771803$23777180$3$F$20240404$20240919$20240424$20240930$EXP$$US-BAXTER-2024BAX016851$BAXTER$$63$YR$$M$Y$$$20240930$$MD$US$US
237771953$23777195$3$F$$20240724$20240424$20240729$EXP$$NVSJ2024JP005039$NOVARTIS$$$$E$F$Y$$$20240729$$PH$JP$JP
237772152$23777215$2$F$$20240718$20240424$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-017809$AUROBINDO$Schmitz L, Alotaibi M, Kant S. Symptomatic Cytomegalovirus (CMV) Infection and Antibody-Mediated Rejection (ABMR) of Kidney Allograft. J-Am-Soc-Nephrol. 2023;34:617-618$59$YR$$M$Y$$$20240729$$HP$US$US
237772322$23777232$2$F$20240205$20240723$20240424$20240805$EXP$$FR-CIPLA LTD.-2024FR03801$CIPLA$$$$$$Y$$$20240805$$MD$FR$FR
237772602$23777260$2$F$$20240717$20240424$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-018142$AUROBINDO$Raza S, Jafry A, Bilal MI, Belden WA.. TRANSIENT LEFT BUNDLE BRANCH BLOCK AND ORGANIZATION OF ATRIAL FIBRILLATION TO ATRIAL FLUTTER WITH LACOSAMIDE INFUSION. J-Am-Coll-Cardiol. 2024;83(Suppl.13):2960$81$YR$$M$Y$$$20240726$$HP$US$US
237772684$23777268$4$F$20240414$20240830$20240424$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202404013738$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240912$$MD$US$US
237773152$23777315$2$F$$20240708$20240424$20240709$PER$$US-JNJFOC-20240448986$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$HP$US$US
237773492$23777349$2$F$20240409$20240902$20240424$20240904$EXP$$DE-SANDOZ INC.-SDZ2024DE042147$SANDOZ$$8$DEC$$F$Y$74$KG$20240904$$MD$DE$DE
237773772$23777377$2$F$20240311$20240622$20240424$20240703$EXP$FR-AFSSAPS-DJ2024000517$FR-Accord-420341$ACCORD$$72$YR$E$M$Y$60$KG$20240703$$MD$FR$FR
237773785$23777378$5$F$20240319$20240731$20240424$20240809$EXP$$KR-Accord-420322$ACCORD$$56$YR$A$F$Y$$$20240809$$MD$KR$KR
237773892$23777389$2$F$$20240708$20240424$20240717$EXP$$AR-JNJFOC-20240437809$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$AR$AR
237773972$23777397$2$F$20240101$20240819$20240424$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063886$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240824$$HP$US$US
237774082$23777408$2$F$20240420$20240821$20240424$20240823$EXP$$US-SANDOZ INC.-NVSC2023US093773$SANDOZ$$63$YR$$F$Y$71.927$KG$20240823$$CN$US$US
237774112$23777411$2$F$$20240814$20240424$20240822$EXP$$ZA-Vifor (International) Inc.-VIT-2024-03482$VIFOR$$$$E$M$Y$$$20240822$$HP$ZA$ZA
237774122$23777412$2$F$20240301$20240718$20240424$20240726$PER$$US-AMGEN-USASP2024081878$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
237774542$23777454$2$F$$20240816$20240424$20240821$EXP$$US-ABBVIE-5731518$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
237774642$23777464$2$F$20240423$20240919$20240424$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202404015084$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240923$$CN$US$US
237775044$23777504$4$F$$20240620$20240424$20240704$30DAY$$US-GSK-US2024048146$GLAXOSMITHKLINE$$$$$M$Y$$$20240704$$CN$US$US
237775086$23777508$6$F$20240101$20240718$20240424$20240724$PER$$US-AMGEN-USASP2024081559$AMGEN$$67$YR$E$F$Y$$$20240724$$HP$US$US
2377753411$23777534$11$F$20230801$20240619$20240424$20240703$EXP$$CA-BEH-2024169894$CSL BEHRING$$52$YR$A$M$Y$102$KG$20240703$$HP$CA$CA
237775383$23777538$3$F$20240408$20240916$20240424$20240923$EXP$$CA-JNJFOC-20240455777$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240923$$CN$CA$CA
237775892$23777589$2$F$$20240422$20240424$20240710$EXP$$NVSC2024US085961$NOVARTIS$$90$YR$$M$Y$$$20240710$$MD$US$US
237775912$23777591$2$F$$20240717$20240424$20240729$EXP$$MX-AUROBINDO-AUR-APL-2024-018577$AUROBINDO$Gutierrez-Castillo A, Cabrera-Larios H, Segovia-Rivera F, Valdez-Ventura R, Flores-Garcia NC. Passenger lymphocyte syndrome, an unusual cause of anemia after liver transplantation. Ann-Hepatol. 2024$43$YR$$F$Y$$$20240729$$HP$MX$MX
237776045$23777604$5$F$20200601$20240816$20240424$20240819$EXP$$CA-SANDOZ INC.-PHHY2017CA134651$SANDOZ$$51$YR$$F$Y$$$20240819$$CN$CA$CA
237776255$23777625$5$F$$20240808$20240424$20240808$30DAY$$CL-PFIZER INC-PV202400043205$PFIZER$$11$YR$$F$Y$$$20240808$$CN$CL$CL
237776298$23777629$8$F$$20240905$20240424$20240910$EXP$$US-PFIZER INC-202400089227$PFIZER$$15$YR$$M$Y$63.5$KG$20240910$$CN$US$US
237776303$23777630$3$F$20240401$20240625$20240424$20240701$30DAY$$KR-PFIZER INC-PV202400043934$PFIZER$$8$YR$$F$Y$$$20240701$$HP$KR$KR
237776432$23777643$2$F$20240419$20240628$20240424$20240702$EXP$$NVSC2024US085636$NOVARTIS$$52$YR$$F$Y$$$20240702$$HP$US$US
237776646$23777664$6$F$$20240907$20240424$20240910$30DAY$$US-PFIZER INC-202400084101$PFIZER$$7$YR$$F$Y$$$20240910$$CN$US$US
237776654$23777665$4$F$20240408$20240711$20240424$20240715$30DAY$$US-PFIZER INC-202400083944$PFIZER$$6$YR$$F$Y$16.33$KG$20240715$$MD$US$US
237776872$23777687$2$F$20240401$20240704$20240424$20240711$EXP$$US-VIIV HEALTHCARE LIMITED-US2024049412$VIIV$$$$$$Y$$$20240711$$HP$US$US
237777084$23777708$4$F$$20240821$20240424$20240829$EXP$$NVSC2024CA085248$NOVARTIS$$62$YR$$F$Y$$$20240829$$CN$CA$CA
237777092$23777709$2$F$$20240627$20240424$20240701$PER$$NVSC2024US086789$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
237777133$23777713$3$F$$20240703$20240424$20240705$EXP$$NVSC2024US086234$NOVARTIS$$$$$M$Y$$$20240705$$CN$US$US
237777384$23777738$4$F$$20240912$20240424$20240916$30DAY$$US-PFIZER INC-202400083974$PFIZER$$61$YR$$F$Y$$$20240916$$CN$US$US
237777394$23777739$4$F$$20240915$20240424$20240919$30DAY$$US-PFIZER INC-202400083648$PFIZER$$9$YR$$M$Y$$$20240919$$CN$US$US
237777413$23777741$3$F$$20240903$20240424$20240906$30DAY$$US-PFIZER INC-202400083722$PFIZER$$11$YR$$F$Y$$$20240906$$MD$US$US
237777452$23777745$2$F$$20240719$20240424$20240724$EXP$$NL-PFIZER INC-202400090630$PFIZER$Beerepoot, S.. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series. Journal of neurology. 2024;271(7):4028-4038$14$YR$$F$Y$$$20240724$$HP$NL$NL
237777483$23777748$3$F$20240101$20240905$20240424$20240917$30DAY$$US-PFIZER INC-202400083956$PFIZER$$10$YR$$M$Y$$$20240917$$CN$US$US
237777554$23777755$4$F$$20240903$20240424$20240906$30DAY$$US-PFIZER INC-202400083975$PFIZER$$10$YR$$M$Y$$$20240906$$CN$US$US
237777566$23777756$6$F$$20240909$20240424$20240911$30DAY$$US-PFIZER INC-202400084555$PFIZER$$13$YR$$M$Y$$$20240911$$HP$US$US
237777698$23777769$8$F$20240801$20240928$20240424$20240930$30DAY$$US-PFIZER INC-202400084545$PFIZER$$8$YR$$M$Y$37.642$KG$20240930$$MD$US$US
237777716$23777771$6$F$$20240913$20240424$20240918$30DAY$$US-PFIZER INC-PV202400048833$PFIZER$$71$YR$$M$Y$$$20240918$$CN$US$US
237777743$23777774$3$F$$20240903$20240424$20240905$30DAY$$US-PFIZER INC-202400084437$PFIZER$$15$YR$$M$Y$49.9$KG$20240905$$CN$US$US
237777763$23777776$3$F$20240101$20240701$20240424$20240704$EXP$$US-UCBSA-2024018544$UCB$$$$$M$Y$$$20240704$$CN$US$US
237777774$23777777$4$F$$20240725$20240424$20240730$30DAY$$US-PFIZER INC-202400084482$PFIZER$$11$YR$$M$Y$$$20240730$$CN$US$US
237777782$23777778$2$F$$20240809$20240424$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-018691$AUROBINDO$Akhtar M, Bashir H, Patel A, Patel K, Menon SG. TREATMENT OF TYPE A RIGHT ATRIAL THROMBUS WITH ANTICOAGULATION.. J-Am-Coll-Cardio. 2024;83 (Suppl.)(13):4177$48$YR$$M$Y$$$20240821$$HP$US$US
237777882$23777788$2$F$20210826$20240723$20240424$20240731$EXP$$JP-AstraZeneca-2024A090453$ASTRAZENECA$$66$YR$$M$Y$73$KG$20240731$$MD$JP$
237778723$23777872$3$F$$20240915$20240424$20240926$30DAY$$US-PFIZER INC-202400083815$PFIZER$$9$YR$$F$Y$$$20240926$$HP$US$US
237778752$23777875$2$F$$20240911$20240424$20240920$PER$$US-009507513-2404USA000633$MERCK$$$$$M$Y$$$20240920$$MD$US$US
237778972$23777897$2$F$20231128$20240923$20240424$20240927$EXP$$US-OTSUKA-2023_032511$OTSUKA$$$$$F$Y$$$20240927$$CN$US$US
237779013$23777901$3$F$20240411$20240722$20240424$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063433$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$PH$US$US
237779104$23777910$4$F$$20240905$20240424$20240910$30DAY$$US-PFIZER INC-202400078731$PFIZER$$51$YR$$M$Y$$$20240910$$MD$US$US
237779123$23777912$3$F$$20240910$20240424$20240916$EXP$$US-BAYER-2024A059010$BAYER$$$$A$M$Y$79.365$KG$20240916$$CN$US$US
237779187$23777918$7$F$$20240907$20240424$20240910$30DAY$$US-PFIZER INC-202400084370$PFIZER$$11$YR$$F$Y$$$20240910$$MD$US$US
237779192$23777919$2$F$$20240808$20240424$20240812$30DAY$$US-PFIZER INC-202400079279$PFIZER$$14$YR$$M$Y$48.534$KG$20240812$$CN$US$US
237779207$23777920$7$F$$20240909$20240424$20240912$30DAY$$US-PFIZER INC-PV202400047697$PFIZER$$$$$F$Y$$$20240912$$MD$US$US
237779215$23777921$5$F$20240408$20240904$20240424$20240909$30DAY$$US-PFIZER INC-202400083525$PFIZER$$12$YR$$F$Y$$$20240909$$MD$US$US
237779224$23777922$4$F$$20240920$20240424$20240924$30DAY$$US-PFIZER INC-202400084444$PFIZER$$9$YR$$M$Y$$$20240924$$CN$US$US
237779233$23777923$3$F$$20240922$20240424$20240925$30DAY$$US-PFIZER INC-202400083454$PFIZER$$$$$M$Y$$$20240925$$CN$US$US
237779244$23777924$4$F$$20240815$20240424$20240820$30DAY$$US-PFIZER INC-PV202400044566$PFIZER$$$$$M$Y$$$20240820$$CN$US$US
237779253$23777925$3$F$$20240912$20240424$20240918$EXP$$US-PFIZER INC-PV202400052141$PFIZER$$$$$M$Y$$$20240918$$CN$US$US
237779392$23777939$2$F$$20240711$20240424$20240716$EXP$$CA-BIOGEN-2024BI01261430$BIOGEN$$$$$F$Y$$$20240716$$HP$CA$CA
237779482$23777948$2$F$$20240722$20240424$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-063331$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$MD$JP$JP
237780016$23778001$6$F$$20240909$20240424$20240911$30DAY$$US-PFIZER INC-202400083709$PFIZER$$14$YR$$M$Y$39.002$KG$20240911$$CN$US$US
237780036$23778003$6$F$$20240904$20240424$20240911$30DAY$$US-PFIZER INC-202400083803$PFIZER$$15$YR$$M$Y$61.69$KG$20240911$$MD$US$US
237780057$23778005$7$F$20240101$20240907$20240424$20240910$30DAY$$US-PFIZER INC-202400083880$PFIZER$$31$YR$$F$Y$$$20240910$$CN$US$US
237780165$23778016$5$F$$20240915$20240424$20240919$30DAY$$US-PFIZER INC-202400084041$PFIZER$$10$YR$$F$Y$24.95$KG$20240919$$CN$US$US
237780174$23778017$4$F$$20240905$20240424$20240909$30DAY$$US-PFIZER INC-202400083852$PFIZER$$11$YR$$M$Y$$$20240909$$CN$US$US
237780184$23778018$4$F$$20240914$20240424$20240919$30DAY$$US-PFIZER INC-202400083811$PFIZER$$9$YR$$M$Y$$$20240919$$CN$US$US
237780194$23778019$4$F$$20240916$20240424$20240919$30DAY$$US-PFIZER INC-202400083504$PFIZER$$15$YR$$M$Y$$$20240919$$CN$US$US
237780603$23778060$3$F$$20240711$20240424$20240712$30DAY$$US-PFIZER INC-202400083945$PFIZER$$14$YR$$$Y$$$20240712$$HP$US$US
237780634$23778063$4$F$$20240904$20240424$20240906$30DAY$$US-PFIZER INC-202400084278$PFIZER$$9$YR$$M$Y$$$20240906$$HP$US$US
237780685$23778068$5$F$$20240706$20240424$20240709$PER$$US-PFIZER INC-PV202400053583$PFIZER$$$$$F$Y$$$20240709$$CN$US$US
237780716$23778071$6$F$$20240813$20240424$20240816$PER$$US-PFIZER INC-PV202400053660$PFIZER$$78$YR$$F$Y$$$20240816$$HP$US$US
237780882$23778088$2$F$$20240729$20240424$20240801$PER$$US-PFIZER INC-PV202400053658$PFIZER$$48$YR$$F$Y$$$20240801$$HP$US$US
237781063$23778106$3$F$$20240617$20240424$20240709$30DAY$$US-GSK-US2024048192$GLAXOSMITHKLINE$$$$$F$Y$$$20240709$$CN$US$US
237781224$23778122$4$F$20210312$20240918$20240424$20240927$EXP$$US-UCBSA-2022056767$UCB$$19$YR$$F$Y$$$20240927$$CN$US$US
237781335$23778133$5$F$$20240921$20240424$20240925$30DAY$$US-PFIZER INC-202400084553$PFIZER$$$$$M$Y$$$20240925$$CN$US$US
237781346$23778134$6$F$$20240810$20240424$20240814$30DAY$$US-PFIZER INC-202400084801$PFIZER$$13$YR$$M$Y$$$20240814$$CN$US$US
237781622$23778162$2$F$$20240812$20240424$20240814$EXP$$US-SHIRE-US202000036AA$TAKEDA$$$$$M$Y$$$20240814$$HP$US$US
237781714$23778171$4$F$20240301$20240729$20240424$20240805$EXP$$US-Calliditas-2024CAL00580$CALLIDITAS THERAPEUTICS$$71$YR$E$M$Y$88.6$KG$20240805$$CN$US$US
237782292$23778229$2$F$$20240718$20240424$20240723$EXP$$US-PFIZER INC-202400092089$PFIZER$$65$YR$$F$Y$82.55$KG$20240723$$HP$US$US
237782676$23778267$6$F$20240409$20240812$20240424$20240814$30DAY$$US-PFIZER INC-202400084304$PFIZER$$12$YR$$M$Y$38.56$KG$20240814$$CN$US$US
237782685$23778268$5$F$20240328$20240719$20240424$20240719$30DAY$$AR-PFIZER INC-PV202400045954$PFIZER$$6$YR$$M$Y$$$20240719$$CN$AR$AR
237782693$23778269$3$F$20240411$20240903$20240424$20240906$30DAY$$AR-PFIZER INC-202400086320$PFIZER$$72$YR$$F$Y$$$20240906$$CN$AR$AR
237782706$23778270$6$F$20240407$20240903$20240424$20240904$30DAY$$AR-PFIZER INC-202400082009$PFIZER$$7$YR$$M$Y$$$20240904$$HP$AR$AR
237782725$23778272$5$F$$20240725$20240424$20240730$30DAY$$US-PFIZER INC-202400084847$PFIZER$$15$YR$$M$Y$40.9$KG$20240730$$MD$US$US
237782739$23778273$9$F$20240301$20240903$20240424$20240904$30DAY$$AR-PFIZER INC-202400079652$PFIZER$$12$YR$$F$Y$$$20240904$$HP$AR$AR
237782924$23778292$4$F$20240415$20240920$20240424$20240925$PER$$AR-PFIZER INC-202400086337$PFIZER$$10$YR$$F$Y$$$20240925$$CN$AR$AR
237782934$23778293$4$F$$20240909$20240424$20240911$30DAY$$CO-PFIZER INC-PV202400052678$PFIZER$$12$YR$$F$Y$$$20240911$$CN$CO$CO
237782964$23778296$4$F$$20240903$20240424$20240904$30DAY$$CO-PFIZER INC-PV202400049173$PFIZER$$16$YR$$M$Y$$$20240904$$CN$CO$CO
237783004$23778300$4$F$20240201$20240905$20240424$20240909$30DAY$$CO-PFIZER INC-PV202400053305$PFIZER$$10$YR$$M$Y$$$20240909$$CN$CO$CO
237783013$23778301$3$F$$20240905$20240424$20240909$30DAY$$CO-PFIZER INC-PV202400052079$PFIZER$$15$YR$$M$Y$$$20240909$$CN$CO$CO
237783322$23778332$2$F$20230912$20240719$20240424$20240725$EXP$$JP-ROCHE-3549347$ROCHE$$48$YR$A$F$Y$$$20240726$$MD$JP$JP
237783442$23778344$2$F$20231201$20240909$20240424$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202404009790$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240911$$CN$US$US
237784422$23778442$2$F$20240414$20240719$20240424$20240724$EXP$$US-INCYTE CORPORATION-2024IN004134$INCYTE$$$$$$Y$$$20240724$$CN$US$US
237784752$23778475$2$F$$20240627$20240424$20240701$EXP$$ZA-TAKEDA-2023TUS004300$TAKEDA$$$$$F$Y$$$20240701$$CN$ZA$ZA
237784816$23778481$6$F$20230501$20240806$20240424$20240814$EXP$$CA-UCBSA-2023034457$UCB$$28$YR$$F$Y$$$20240814$$CN$CA$CA
237784893$23778489$3$F$20240501$20240917$20240424$20240920$EXP$$CA-TAKEDA-2024TUS038014$TAKEDA$$24$YR$$M$Y$$$20240920$$CN$CA$CA
237784973$23778497$3$F$20240101$20240724$20240424$20240731$EXP$$JP-009507513-2404JPN001381J$MERCK$$92$YR$$M$Y$$$20240731$$MD$JP$JP
237784993$23778499$3$F$$20240708$20240424$20240710$PER$$US-ALXN-202404USA001421US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
237785102$23778510$2$F$20240419$20240625$20240424$20240702$EXP$$CA-AMGEN-CANSL2024080918$AMGEN$$58$YR$A$F$Y$59.5$KG$20240702$$CN$CA$CA
237785202$23778520$2$F$$20240716$20240424$20240722$PER$$NVSC2024US086875$NOVARTIS$$$$$F$Y$$$20240722$$CN$US$US
237785253$23778525$3$F$$20240802$20240424$20240809$EXP$$CA-GSK-CA2021AMR101520$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$CA$CA
237785422$23778542$2$F$20240301$20240630$20240424$20240703$EXP$$SA-GSK-SA2024EME031536$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$SA$SA
237785545$23778554$5$F$20240411$20240723$20240424$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063970$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$80.272$KG$20240723$$CN$US$US
237785604$23778560$4$F$20240410$20240813$20240424$20240822$EXP$$JP-ROCHE-3549247$ROCHE$$74$YR$E$M$Y$52.3$KG$20240822$$MD$JP$JP
237785632$23778563$2$F$$20240820$20240424$20240822$EXP$$NVSC2024US084662$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
237785973$23778597$3$F$20240325$20240718$20240424$20240724$EXP$$JP-009507513-2404JPN002094J$MERCK$$7$DEC$$M$Y$$$20240724$$PH$JP$JP
237786022$23778602$2$F$20211201$20240703$20240424$20240710$EXP$$IT-BAUSCH-BL-2024-006517$BAUSCH AND LOMB$Salvia G, Michelucci A, Dini V, Fidanzi C, Granieri G, Margiotta F, Bevilacqua M, Mazzatenta C, Romanelli M. Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum. Australas J Dermatol. 2024;0:1-3. doi:10.1111/ ajd.14266$43$YR$$F$Y$$$20240710$$MD$IT$IT
237786256$23778625$6$F$20240301$20240913$20240424$20240913$30DAY$$AT-PFIZER INC-PV202400045318$PFIZER$$$$C$$Y$$$20240913$$MD$AT$AT
237786274$23778627$4$F$$20240923$20240424$20240930$30DAY$$CO-PFIZER INC-PV202400044786$PFIZER$$$$$$Y$$$20240930$$HP$CO$CO
237786342$23778634$2$F$20240601$20240709$20240424$20240723$PER$$US-RDY-CLI/USA/24/0005813$DR REDDYS$$10$YR$T$F$Y$35$KG$20240723$$CN$US$US
237786353$23778635$3$F$$20240628$20240424$20240725$PER$$US-RDY-SPO/USA/24/0005913$DR REDDYS$$$$$$Y$$$20240725$$CN$US$US
237786492$23778649$2$F$20240101$20240716$20240424$20240722$EXP$$US-SA-2024SA121608$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240720$$MD$US$US
237787912$23778791$2$F$20240305$20240830$20240424$20240905$EXP$$JP-009507513-2403JPN001834J$MERCK$$74$YR$$F$Y$$$20240905$$MD$JP$JP
237788054$23778805$4$F$20240101$20240905$20240424$20240909$EXP$$US-ABBVIE-5731598$ABBVIE$$$$$M$Y$89$KG$20240909$$CN$US$US
237788082$23778808$2$F$$20240705$20240424$20240705$PER$$NVSC2024US086957$NOVARTIS$$$$$$Y$$$20240705$$HP$US$US
237788102$23778810$2$F$20240329$20240701$20240424$20240705$EXP$$US-ABBVIE-5729689$ABBVIE$$55$YR$$F$Y$73$KG$20240705$$CN$US$US
237788165$23778816$5$F$20240329$20240724$20240424$20240728$EXP$$CO-JNJFOC-20240473744$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240729$$HP$CO$CO
237788602$23778860$2$F$20240410$20240718$20240424$20240726$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404010712AA$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240726$$CN$JP$JP
237788653$23778865$3$F$20211208$20240813$20240424$20240821$EXP$$US-ABBVIE-5731862$ABBVIE$$60$YR$$F$Y$$$20240821$$CN$US$US
237788863$23778886$3$F$20231130$20240620$20240424$20240701$EXP$$CA-TAKEDA-2023TUS115273$TAKEDA$$22$YR$$M$Y$$$20240701$$HP$CA$CA
237789656$23778965$6$F$20240401$20240722$20240424$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063114$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240722$$CN$US$US
237789685$23778968$5$F$20230101$20240809$20240424$20240816$EXP$$CA-GSK-CA2023124352$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$HP$CA$CA
237789702$23778970$2$F$20240419$20240731$20240424$20240802$PER$$US-AMGEN-USASP2024081474$AMGEN$$57$YR$A$M$Y$$$20240802$$CN$US$US
237789742$23778974$2$F$20240408$20240723$20240424$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064371$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240723$$CN$US$US
237789772$23778977$2$F$20240318$20240723$20240424$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-064059$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240723$$MD$JP$JP
237790102$23779010$2$F$$20240904$20240424$20240911$EXP$$NVSC2024JP083664$NOVARTIS$Oiwa K, Lee S, Fujita K, Ueda T, Yamauchi T. Clinical features of clonal cytogenetic abnormalities in philadelphia-negative cells developed during tyrosine kinase inhibitor treatment. INTERNAL MEDICINE. 2024;63:729-32$76$YR$$M$Y$$$20240912$$HP$JP$JP
237790563$23779056$3$F$20240404$20240919$20240424$20240925$EXP$$US-FreseniusKabi-FK202406403$FRESENIUS KABI$$63$YR$A$M$Y$$$20240925$$MD$US$US
237790812$23779081$2$F$$20240909$20240424$20240911$PER$$US-PFIZER INC-PV202400021814$PFIZER$$42$YR$$F$Y$$$20240911$$HP$US$US
237791482$23779148$2$F$$20240904$20240424$20240911$EXP$$NVSC2024JP083662$NOVARTIS$Oiwa K, Lee S, Fujita K, Ueda T, Yamauchi T. Clinical features of clonal cytogenetic abnormalities in philadelphia-negative cells developed during tyrosine kinase inhibitor treatment. INTERN-MED. 2024;63:729-32$80$YR$$M$Y$$$20240912$$HP$JP$JP
237791642$23779164$2$F$$20240711$20240424$20240721$EXP$$CA-BAXTER-2024BAX017172$BAXTER$$52$YR$$F$Y$$$20240719$$HP$CA$CA
237791654$23779165$4$F$$20240717$20240424$20240724$EXP$$CA-BAXTER-2024BAX017087$BAXTER$$61$YR$$F$Y$$$20240724$$CN$CA$CA
237791802$23779180$2$F$$20240811$20240424$20240816$EXP$$US-SA-2024SA121769$SANOFI AVENTIS$$$$$F$Y$$$20240816$$CN$US$US
237791974$23779197$4$F$$20240709$20240424$20240710$EXP$$GR-JNJFOC-20240450853$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240710$$HP$GR$GR
237792003$23779200$3$F$$20240716$20240424$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202404013351$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240726$$CN$US$US
237792272$23779227$2$F$20240417$20240822$20240424$20240828$PER$$JP-Eisai-EC-2024-164169$EISAI$$$$$$Y$$$20240828$$PH$JP$JP
237792364$23779236$4$F$20230101$20240705$20240424$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060892$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240709$$CN$US$US
237792392$23779239$2$F$20201014$20240923$20240424$20240924$EXP$$US-PURDUE PHARMA-USA-2024-0309190$PURDUE$$$$E$M$Y$$$20240924$$CN$US$US
237792912$23779291$2$F$$20240904$20240424$20240912$EXP$$NVSC2024JP083610$NOVARTIS$Oiwa K, Lee S, Fujita K, Ueda T, Yamauchi T. Clinical Features of Clonal Cytogenetic Abnormalities in Philadelphia-negative Cells Developed During Tyrosine Kinase Inhibitor Treatment.. Internal Medicine. 2024;63(5):729-732$77$YR$$F$Y$$$20240913$$HP$JP$JP
237793065$23779306$5$F$$20240819$20240424$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063930$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240827$$CN$US$US
237793175$23779317$5$F$20240401$20240917$20240424$20240924$EXP$$JP-009507513-2404JPN002490J$MERCK$$70$YR$$F$Y$$$20240924$$MD$JP$JP
237793192$23779319$2$F$$20240401$20240424$20240816$PER$$US-MYLANLABS-2024M1030300$MYLAN$$$$$F$Y$72.57$KG$20240816$$CN$US$US
237793343$23779334$3$F$20240404$20240823$20240424$20240903$EXP$$CA-OTSUKA-2024_011576$OTSUKA$$32$YR$$M$Y$$$20240903$$HP$CA$CA
2377934312$23779343$12$F$20200601$20240716$20240424$20240726$EXP$$CA-TAKEDA-2024TUS037780$TAKEDA$$80$YR$$M$Y$69$KG$20240726$$HP$CA$CA
237793512$23779351$2$F$20240101$20240703$20240424$20240715$PER$$US-SA-2024SA118685$SANOFI AVENTIS$$$$A$M$Y$$$20240715$$MD$US$US
237793563$23779356$3$F$20240401$20240718$20240424$20240728$PER$$US-SA-2024SA117926$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240728$$MD$US$US
237793763$23779376$3$F$$20240916$20240424$20240923$PER$$US-SA-2024SA122281$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240923$$MD$US$US
237793783$23779378$3$F$20240101$20240731$20240424$20240809$PER$$US-SA-2024SA120371$SANOFI AVENTIS$$43$YR$A$F$Y$79$KG$20240809$$MD$US$US
237793892$23779389$2$F$$20240715$20240424$20240723$PER$$US-SA-2024SA119866$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240723$$MD$US$US
237794032$23779403$2$F$20211001$20240815$20240424$20240828$PER$$US-SA-2024SA120422$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240828$$MD$US$US
237794124$23779412$4$F$20240101$20240908$20240424$20240909$EXP$$CA-PFIZER INC-202400016724$PFIZER$$4$YR$$F$Y$$$20240909$$PH$CA$CA
237794162$23779416$2$F$20240601$20240703$20240424$20240712$PER$$US-SA-2024SA122516$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240712$$MD$US$US
237794192$23779419$2$F$$20240711$20240424$20240816$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2023-119519$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$97$KG$20240816$$MD$CA$CA
237794312$23779431$2$F$$20240801$20240424$20240809$PER$$US-SA-2024SA119214$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240809$$MD$US$US
237794373$23779437$3$F$20240101$20240913$20240424$20240923$PER$$US-SA-2024SA118834$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240923$$MD$US$US
237794503$23779450$3$F$20240601$20240806$20240424$20240814$PER$$US-SA-2024SA118137$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240814$$MD$US$US
237794782$23779478$2$F$$20240801$20240424$20240809$PER$$US-SA-2024SA121764$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240809$$MD$US$US
237794863$23779486$3$F$20240101$20240626$20240424$20240705$PER$$US-SA-2024SA121986$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240705$$MD$US$US
237795042$23779504$2$F$20240222$20240620$20240424$20240701$PER$$US-SA-2024SA120561$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240701$$MD$US$US
237795102$23779510$2$F$20240101$20240828$20240424$20240910$PER$$US-SA-2024SA118939$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240910$$MD$US$US
237795212$23779521$2$F$20240401$20240724$20240424$20240801$PER$$US-SA-2024SA118329$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240801$$MD$US$US
237795332$23779533$2$F$20240101$20240627$20240424$20240710$PER$$US-SA-2024SA119028$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240710$$MD$US$US
237795412$23779541$2$F$$20240809$20240424$20240820$PER$$US-SA-2024SA123215$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240820$$MD$US$US
237795482$23779548$2$F$$20240715$20240424$20240722$PER$$US-SA-2024SA122388$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240723$$MD$US$US
237795514$23779551$4$F$20240501$20240802$20240424$20240816$PER$$US-SA-2024SA124046$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240816$$MD$US$US
237795703$23779570$3$F$$20240819$20240424$20240830$PER$$US-SA-2024SA122366$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240830$$MD$US$US
237795792$23779579$2$F$20240401$20240819$20240424$20240828$PER$$US-SA-2024SA123561$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240828$$MD$US$US
237795912$23779591$2$F$20240413$20240620$20240424$20240701$PER$$US-SA-2024SA123415$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240701$$HP$US$US
237796162$23779616$2$F$20240403$20240913$20240424$20240923$EXP$$FR-SPRINGWORKS THERAPEUTICS-SW-001566$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240923$$MD$FR$FR
237796273$23779627$3$F$20240119$20240813$20240424$20240814$EXP$$ES-TAKEDA-2024TUS037532$TAKEDA$$11$YR$$F$Y$$$20240814$$HP$ES$ES
237796302$23779630$2$F$$20240727$20240424$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006477$JAZZ$$$$$M$Y$$$20240730$$CN$US$US
237796332$23779633$2$F$20240101$20240709$20240424$20240717$PER$$US-SA-2024SA006010$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240717$$MD$US$US
237796502$23779650$2$F$20240101$20240813$20240424$20240821$PER$$US-SA-2024SA121484$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240821$$MD$US$US
237796553$23779655$3$F$$20240731$20240424$20240808$PER$$US-SA-2024SA123925$SANOFI AVENTIS$$$$A$F$Y$$$20240808$$MD$US$US
237796562$23779656$2$F$$20240723$20240424$20240726$PER$$US-PFIZER INC-202400092870$PFIZER$$33$YR$$M$Y$113.4$KG$20240726$$CN$US$US
237796834$23779683$4$F$20231101$20240815$20240424$20240821$EXP$$US-ABBVIE-5732521$ABBVIE$$67$YR$$M$Y$$$20240821$$CN$US$US
237797205$23779720$5$F$$20240723$20240424$20240726$EXP$$US-PFIZER INC-PV202400053735$PFIZER$$70$YR$$F$Y$$$20240726$$HP$US$US
237797213$23779721$3$F$20240101$20240820$20240424$20240830$PER$$US-MYLANLABS-2024M1032418$MYLAN$$$$$M$Y$$$20240830$$CN$US$US
237797412$23779741$2$F$$20240621$20240424$20240702$EXP$$US-SA-2024SA119731$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240702$$HP$US$US
237797522$23779752$2$F$20240417$20240724$20240424$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202404015464$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240726$$CN$US$US
237797632$23779763$2$F$20130301$20240715$20240424$20240717$EXP$FR-EMA-DD-20240416-7482701-144940$FR-SANDOZ INC.-SDZ2024FR041697$SANDOZ$$35$YR$$F$Y$$$20240717$$MD$FR$FR
237797672$23779767$2$F$20240101$20240821$20240424$20240828$EXP$$JP-Eisai-EC-2024-164164$EISAI$$$$A$$Y$$$20240828$$MD$JP$JP
237798012$23779801$2$F$20240312$20240709$20240424$20240715$EXP$$CH-BIOGEN-2024BI01261443$BIOGEN$$62$YR$$F$Y$$$20240715$$CN$CH$CH
237798372$23779837$2$F$$20240724$20240424$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064302$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240726$$MD$US$US
237798602$23779860$2$F$20230601$20240731$20240424$20240807$EXP$$US-ABBVIE-5731599$ABBVIE$$27$YR$$F$Y$$$20240807$$CN$US$US
237798633$23779863$3$F$20240401$20240702$20240424$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064423$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240703$$CN$US$US
237798992$23779899$2$F$20240301$20240809$20240424$20240813$EXP$$CA-PFIZER INC-202400093549$PFIZER$$83$YR$$M$Y$60.781$KG$20240813$$HP$CA$CA
237799266$23779926$6$F$$20240918$20240424$20240923$EXP$$US-Taiho Oncology Inc-2024-004203$TAIHO ONCOLOGY INC$$63$YR$A$F$Y$$$20240923$$CN$US$US
237799494$23779949$4$F$20240401$20240925$20240424$20240927$EXP$$US-SANDOZ INC.-SDZ2024US042393$SANDOZ$$68$YR$$M$Y$$$20240927$$CN$US$US
237799652$23779965$2$F$20240219$20240909$20240424$20240911$EXP$$IT-PFIZER INC-202400091384$PFIZER$$60$YR$$M$Y$$$20240911$$MD$IT$IT
237799682$23779968$2$F$20240408$20240716$20240424$20240726$EXP$$CN-PFIZER INC-PV202400052926$PFIZER$$67$YR$$M$Y$60$KG$20240726$$HP$CN$CN
237799712$23779971$2$F$$20240724$20240424$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064298$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240724$$CN$US$US
237799736$23779973$6$F$20240501$20240709$20240424$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063888$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$58.7$KG$20240715$$CN$US$US
237799843$23779984$3$F$20240101$20240719$20240424$20240726$EXP$$US-BEH-2024170821$CSL BEHRING$$70$YR$E$F$Y$$$20240726$$CN$US$US
237800012$23780001$2$F$20240401$20240724$20240424$20240731$EXP$$JP-009507513-2404JPN002467J$MERCK$$74$YR$$M$Y$$$20240731$$PH$JP$JP
237800043$23780004$3$F$20221201$20240723$20240424$20240725$EXP$$FR-SANDOZ INC.-SDZ2024FR039580$SANDOZ$$74$YR$$F$Y$64.3$KG$20240725$$HP$FR$FR
237800573$23780057$3$F$$20240909$20240424$20240919$EXP$$FR-Eisai-EC-2024-164225$EISAI$$0$YR$$$Y$$$20240919$$MD$FR$FR
237800632$23780063$2$F$20240401$20240828$20240424$20240904$PER$$US-SA-2024SA123130$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240904$$MD$US$US
237800653$23780065$3$F$20240301$20240708$20240424$20240717$PER$$US-SA-2024SA120698$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240717$$MD$US$US
237800744$23780074$4$F$20230806$20240805$20240424$20240817$EXP$$LT-VER-202400003$VERITY PHARMACEUTICALS$$75$YR$E$M$Y$115$KG$20240817$$HP$LT$LT
237800783$23780078$3$F$$20240830$20240424$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064335$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240904$$CN$US$US
237800962$23780096$2$F$20240101$20240729$20240424$20240802$PER$$JP-Eisai-EC-2024-163989$EISAI$$$$E$M$Y$$$20240802$$MD$JP$JP
237801114$23780111$4$F$$20240819$20240424$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064074$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240821$$CN$US$US
237801245$23780124$5$F$20240101$20240805$20240424$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055197$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$$$20240807$$HP$US$US
237801362$23780136$2$F$20240101$20240709$20240424$20240715$EXP$$JP-009507513-2404JPN002580J$MERCK$$6$DEC$$M$Y$$$20240715$$MD$JP$JP
237801415$23780141$5$F$20240310$20240709$20240424$20240710$PER$$US-ALXN-202404USA001397US$ALEXION PHARMACEUTICALS$$70$YR$$F$Y$$$20240710$$CN$US$US
237801594$23780159$4$F$20240220$20240812$20240424$20240819$EXP$$DE-BIOGEN-2024BI01261448$BIOGEN$$59$YR$$F$Y$55$KG$20240819$$MD$DE$DE
237802754$23780275$4$F$$20240723$20240424$20240730$EXP$$CO-GSK-CO2024AMR050846$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$CO$CO
237802886$23780288$6$F$$20240628$20240424$20240702$PER$$US-JNJFOC-20240462890$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
237802922$23780292$2$F$20240101$20240905$20240424$20240909$EXP$$NVSJ2024JP005062$NOVARTIS$$$$A$F$Y$66$KG$20240910$$MD$JP$JP
237803033$23780303$3$F$20240412$20240916$20240424$20240918$EXP$$US-TAKEDA-2024TUS035690$TAKEDA$$60$YR$$F$Y$75$KG$20240918$$CN$US$US
237803093$23780309$3$F$20220725$20240902$20240424$20240909$EXP$$BE-JNJFOC-20231121587$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$43$KG$20240910$$MD$BE$BE
237803207$23780320$7$F$20240406$20240729$20240424$20240801$EXP$$NVSC2024RU086088$NOVARTIS$$0$YR$$F$Y$5.05$KG$20240802$$CN$RU$RU
237803212$23780321$2$F$20240101$20240722$20240424$20240731$PER$$US-SA-2024SA123802$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240731$$MD$US$US
237803253$23780325$3$F$$20240923$20240424$20240924$PER$$NVSC2024US084802$NOVARTIS$$$$$F$Y$62$KG$20240925$$HP$US$US
237803315$23780331$5$F$20240719$20240725$20240424$20240806$EXP$$US-ABBVIE-5729470$ABBVIE$$57$YR$$M$Y$102$KG$20240806$$CN$US$US
237803352$23780335$2$F$20240419$20240709$20240424$20240713$EXP$$IT-ABBVIE-5730212$ABBVIE$$72$YR$$F$Y$$$20240713$$CN$IT$IT
237803395$23780339$5$F$20240101$20240722$20240424$20240731$PER$$US-SA-2024SA062523$SANOFI AVENTIS$$81$YR$E$M$Y$98.88$KG$20240731$$MD$US$US
237803413$23780341$3$F$$20240807$20240424$20240812$EXP$$JP-SA-2024SA122576$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240813$$MD$JP$JP
237803443$23780344$3$F$20240318$20240605$20240424$20240703$EXP$$GB-AMGEN-GBRNI2024079733$AMGEN$$75$YR$E$M$Y$98.4$KG$20240703$$HP$GB$GB
237803475$23780347$5$F$$20240916$20240424$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064240$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240919$$CN$US$US
237803492$23780349$2$F$20240423$20240715$20240424$20240718$PER$$US-AMGEN-USASP2024081898$AMGEN$$73$YR$E$F$Y$$$20240718$$CN$US$US
237803523$23780352$3$F$20231201$20240816$20240424$20240823$EXP$$US-ABBVIE-5732242$ABBVIE$$63$YR$$F$Y$$$20240823$$CN$US$US
237803692$23780369$2$F$$20240709$20240424$20240710$PER$$US-ALXN-202404USA001343US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
237803772$23780377$2$F$20240401$20240801$20240424$20240813$PER$$US-SA-2024SA122971$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240814$$MD$US$US
237803822$23780382$2$F$$20240722$20240424$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-063320$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240722$$MD$JP$JP
237803883$23780388$3$F$20230101$20240723$20240424$20240727$EXP$$CO-ABBVIE-5732428$ABBVIE$$$$$F$Y$40$KG$20240727$$CN$CO$CO
237804053$23780405$3$F$20240101$20240701$20240424$20240709$PER$$US-SA-2024SA122490$SANOFI AVENTIS$$15$YR$T$F$Y$52.16$KG$20240709$$MD$US$US
237804412$23780441$2$F$$20240813$20240425$20240814$PER$$NVSC2024US087334$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
237804564$23780456$4$F$20240402$20240823$20240425$20240902$EXP$$CA-TOLMAR, INC.-24CA048196$TOLMAR$$48$YR$$M$Y$$$20240902$$CN$CA$CA
237804592$23780459$2$F$$20240723$20240425$20240819$PER$$CA-TOLMAR, INC.-24CA048201$TOLMAR$$$$$M$Y$$$20240814$$CN$CA$CA
237804602$23780460$2$F$$20240717$20240425$20240809$PER$$CA-TOLMAR, INC.-24CA048199$TOLMAR$$$$$M$Y$$$20240809$$MD$CA$CA
237804623$23780462$3$F$$20240919$20240425$20240930$EXP$$NL-ABBVIE-5726293$ABBVIE$$$$E$M$Y$$$20240930$$CN$NL$NL
237804664$23780466$4$F$$20240805$20240425$20240814$PER$$US-ALXN-202404USA001536US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
237804682$23780468$2$F$$20240731$20240425$20240808$PER$$US-SA-2024SA121235$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240808$$MD$US$US
237804752$23780475$2$F$$20240722$20240425$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-063232$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240722$$MD$JP$JP
237804772$23780477$2$F$20240414$20240424$20240425$20240930$EXP$$GB-JNJFOC-20240451947$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$GB$GB
237804823$23780482$3$F$$20240722$20240425$20240726$EXP$$US-ABBVIE-5732449$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
237804863$23780486$3$F$20240401$20240822$20240425$20240823$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-064272$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240823$$HP$PR$PR
237804953$23780495$3$F$$20240715$20240425$20240720$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-002649$JAZZ$$$$$F$Y$$$20240720$$MD$US$US
237805413$23780541$3$F$20231115$20240822$20240425$20240904$EXP$$JP-AMGEN-JPNSP2024080880$AMGEN$Mori K. Consideration of drug-induced liver injury in patients with ANCA-associated vasculitis using Avacopan. The 68th General Assembly and Scientific Meeting of the Japan College of Rheumatology. 2024 APR;.$79$YR$E$F$Y$$$20240904$$MD$JP$JP
237805453$23780545$3$F$20240427$20240607$20240425$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001847$ACADIA PHARMACEUTICALS$$64$YR$$M$Y$$$20240701$$CN$US$US
237805713$23780571$3$F$20230923$20240822$20240425$20240903$EXP$$JP-AMGEN-JPNSP2024080881$AMGEN$Mori K. Consideration of drug-induced liver injury in patients with ANCA-associated vasculitis using Avacopan. The 68th General Assembly and Scientific Meeting of the Japan College of Rheumatology. 2024 APR;.$68$YR$E$M$Y$54$KG$20240902$$MD$JP$JP
237805733$23780573$3$F$20240414$20240918$20240425$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024048810$VIIV$$47$YR$$M$Y$77.11$KG$20240927$$CN$US$US
237806012$23780601$2$F$$20240625$20240425$20240717$PER$$CA-TOLMAR, INC.-24CA048204$TOLMAR$$$$$M$Y$$$20240717$$CN$CA$CA
237806042$23780604$2$F$20240403$20240822$20240425$20240910$PER$$CA-TOLMAR, INC.-24CA048231$TOLMAR$$75$YR$$M$Y$$$20240909$$CN$CA$CA
237806913$23780691$3$F$20231226$20240916$20240425$20240918$EXP$$CA-ROCHE-3551755$ROCHE$$33$YR$A$F$Y$$$20240918$$CN$CA$CA
237807102$23780710$2$F$$20240724$20240425$20240824$PER$$US-AstraZeneca-2024A067441$ASTRAZENECA$$57$YR$$M$Y$$$20240823$$CN$US$
237807132$23780713$2$F$20240423$20240830$20240425$20240903$PER$$US-AMGEN-USASP2024082086$AMGEN$$78$YR$E$M$Y$$$20240903$$CN$US$US
237808683$23780868$3$F$20240411$20240725$20240425$20240731$EXP$$JP-009507513-2404JPN002461J$MERCK$$52$YR$$F$Y$$$20240731$$MD$JP$JP
237809482$23780948$2$F$20240422$20240916$20240425$20240918$PER$$US-AMGEN-USASP2024082179$AMGEN$$56$YR$A$F$Y$$$20240918$$CN$US$US
237809493$23780949$3$F$20240802$20240802$20240425$20240809$EXP$$CA-TAKEDA-2024TUS000974$TAKEDA$$37$YR$$F$Y$$$20240809$$CN$CA$CA
237809513$23780951$3$F$20230301$20240702$20240425$20240711$EXP$$US-UNITED THERAPEUTICS-UNT-2024-001231$UNITED THERAPEUTICS$$82$YR$$F$Y$96.599$KG$20240711$$$US$US
237809563$23780956$3$F$20240403$20240619$20240425$20240711$PER$$FR-TOLMAR, INC.-24FR048174$TOLMAR$$84$YR$$M$Y$$$20240710$$PH$FR$FR
237809772$23780977$2$F$$20240729$20240425$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-057732$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240729$$MD$JP$JP
237810322$23781032$2$F$20240421$20240808$20240425$20240810$PER$$US-AMGEN-USASP2024080966$AMGEN$$67$YR$E$M$Y$$$20240810$$CN$US$US
237810485$23781048$5$F$20210924$20240813$20240425$20240819$EXP$$CA-SANDOZ INC.-NVSC2020CA094040$SANDOZ$$73$YR$$F$Y$$$20240819$$CN$CA$CA
237810543$23781054$3$F$20240320$20240623$20240425$20240702$EXP$$CA-CELLTRION INC.-2024CA009610$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
237810752$23781075$2$F$$20240724$20240425$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-064629$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240724$$MD$JP$JP
237810782$23781078$2$F$20240215$20240723$20240425$20240805$EXP$$IT-CIPLA LTD.-2024IT03809$CIPLA$$$$$$Y$$$20240805$$PH$IT$IT
237811112$23781111$2$F$20240213$20240726$20240425$20240802$PER$$US-ALXN-202404USA001199US$ALEXION PHARMACEUTICALS$$77$YR$$F$Y$$$20240802$$CN$US$US
237811252$23781125$2$F$20240301$20240731$20240425$20240805$EXP$$US-UCBSA-2024019507$UCB$$26$YR$$M$Y$$$20240805$$HP$US$US
237811323$23781132$3$F$$20240420$20240425$20240731$EXP$$CA-SA-2024SA122362$SANOFI AVENTIS$$44$YR$A$F$Y$97$KG$20240731$$HP$CA$CA
237812002$23781200$2$F$20240422$20240730$20240425$20240801$PER$$US-AMGEN-USASP2024082175$AMGEN$$68$YR$E$M$Y$$$20240801$$HP$US$US
237812032$23781203$2$F$20240415$20240415$20240425$20240716$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-11886$SAMSUNG BIOEPIS$$46$YR$A$M$Y$$$20240716$$HP$CA$CA
237812205$23781220$5$F$20211101$20240918$20240425$20240927$EXP$$AU-CELLTRION INC.-2023AU020418$CELLTRION$$$$$$Y$$$20240927$$MD$AU$AU
237812252$23781225$2$F$$20240717$20240425$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-017885$AUROBINDO$Ahmed A, Naeem N, Domench DI, Mohamed MS, Waheed SH, Rao M.. PROPAFENONE INDUCED BRUGADA TYPE IPATTERN AND WIDE COMPLEX TACHYCARDIA. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):2893$69$YR$$M$Y$$$20240726$$HP$US$US
237812373$23781237$3$F$20240330$20240830$20240425$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059984$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$89.81$KG$20240903$$CN$US$US
237812442$23781244$2$F$20240324$20240326$20240425$20240710$PER$$US-ROCHE-3535201$ROCHE$$70$YR$E$M$Y$$$20240628$$CN$US$US
237812603$23781260$3$F$20240313$20240906$20240425$20240917$EXP$$JP-ARDELYX-2024ARDX001979$ARDELYX$$61$YR$$$Y$$$20240917$$MD$JP$JP
237812782$23781278$2$F$20240404$20240814$20240425$20240816$EXP$FR-AFSSAPS-TO2024000715$FR-JNJFOC-20240476552$JOHNSON AND JOHNSON$$49$YR$A$M$Y$77$KG$20240816$$PH$FR$FR
237812795$23781279$5$F$20240422$20240709$20240425$20240711$PER$$US-AMGEN-USASP2024082100$AMGEN$$76$YR$E$M$Y$$$20240711$$CN$US$US
237812802$23781280$2$F$20240222$20240730$20240425$20240801$PER$$US-AMGEN-USASP2024082002$AMGEN$$77$YR$E$M$Y$$$20240801$$CN$US$US
237812942$23781294$2$F$$20240724$20240425$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064413$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240724$$CN$US$US
237812972$23781297$2$F$20240101$20240717$20240425$20240722$EXP$$CA-UCBSA-2023040183$UCB$$$$$M$Y$$$20240722$$CN$CA$CA
237813042$23781304$2$F$$20240809$20240425$20240822$EXP$$US-AUROBINDO-AUR-APL-2024-018172$AUROBINDO$Thakkar A, Kumar D, Namburu L, Patel J. CLOT PLOT TWIST: A RARE CASE OF TRANEXAMIC ACID-INDUCED STEMI. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):3313$80$YR$$F$Y$$$20240822$$HP$US$US
237813244$23781324$4$F$$20240727$20240425$20240731$EXP$$NVSC2024US083761$NOVARTIS$$$$$M$Y$$$20240731$$CN$US$US
237813273$23781327$3$F$20230921$20240829$20240425$20240907$EXP$$JP-Merz Pharmaceuticals GmbH-24-01387$MERZ$$74$YR$$F$Y$$$20240907$$MD$JP$JP
237813343$23781334$3$F$20240422$20240816$20240425$20240821$PER$$US-AMGEN-USASP2024081463$AMGEN$$45$YR$A$M$Y$$$20240820$$CN$US$US
237813582$23781358$2$F$$20240717$20240425$20240719$PER$$US-AMGEN-USASP2024081703$AMGEN$$$$$F$Y$$$20240718$$HP$US$US
237813642$23781364$2$F$$20240419$20240425$20240701$EXP$CH-SM-2024-10854$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-027959$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240701$$PH$CH$CH
237813826$23781382$6$F$20240424$20240821$20240425$20240828$PER$$NVSC2024US087684$NOVARTIS$$54$YR$$M$Y$76.8$KG$20240828$$HP$US$US
237813834$23781383$4$F$20240101$20240920$20240425$20240930$EXP$$CA-CELLTRION INC.-2024CA009452$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
237813883$23781388$3$F$$20240904$20240425$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202404015964$ELI LILLY AND CO$$$$$M$Y$$$20240909$$CN$US$US
237814153$23781415$3$F$20240409$20240807$20240425$20240819$EXP$$US-GSK-US2024AMR049259$GLAXOSMITHKLINE$$52$YR$$F$Y$123$KG$20240819$$CN$US$US
237814225$23781422$5$F$20240101$20240809$20240425$20240817$EXP$$CA-CELLTRION INC.-2024CA008550$CELLTRION$$$$$$Y$$$20240817$$MD$CA$CA
237814254$23781425$4$F$20230101$20240703$20240425$20240717$EXP$$JP-AMGEN-JPNSP2024081231$AMGEN$Kataoka W, Ainai S, Anegawa M, Inoue M, Nakagawa H, Kageyama G. A case of suspected exacerbation of Pseudomonas aeruginosa pneumonia by Avacopan. The 68th General Assembly and Scientific Meeting of the Japan College of Rheumatology. 2024 APR;.$85$YR$E$F$Y$46.4$KG$20240717$$MD$JP$JP
237814262$23781426$2$F$20240422$20240726$20240425$20240730$PER$$US-AMGEN-USASP2024082170$AMGEN$$68$YR$E$M$Y$$$20240730$$CN$US$US
237814383$23781438$3$F$20240417$20240716$20240425$20240718$PER$$US-JNJFOC-20240463609$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240718$$HP$US$US
237814422$23781442$2$F$20240423$20240906$20240425$20240907$PER$$US-AMGEN-USASP2024082589$AMGEN$$77$YR$E$M$Y$$$20240906$$MD$US$US
237815174$23781517$4$F$20231208$20240719$20240425$20240725$EXP$$AU-BEH-2024169967$CSL BEHRING$$74$YR$E$M$Y$78$KG$20240725$$HP$AU$AU
237815373$23781537$3$F$20240320$20240911$20240425$20240917$EXP$$US-BEH-2024170335$CSL BEHRING$$78$YR$E$F$Y$23.855$KG$20240917$$CN$US$US
237815413$23781541$3$F$20230101$20240906$20240425$20240916$EXP$$CA-CELLTRION INC.-2023CA025415$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
237815493$23781549$3$F$20231001$20240624$20240425$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2023-028880$UNITED THERAPEUTICS$$73$YR$$M$Y$70.748$KG$20240703$$$US$US
237815598$23781559$8$F$20240101$20240829$20240425$20240907$EXP$$CA-CELLTRION INC.-2024CA007990$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
237815893$23781589$3$F$20230201$20240908$20240425$20240918$EXP$$JP-JNJFOC-20240475606$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240918$$MD$JP$JP
237815982$23781598$2$F$20240422$20240815$20240425$20240820$PER$$US-AMGEN-USASP2024082205$AMGEN$$55$YR$A$F$Y$$$20240820$$CN$US$US
237816162$23781616$2$F$20240405$20240816$20240425$20240910$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000222$BECTON DICKINSON$$$$$$Y$$$20240910$$HP$GB$GB
237816292$23781629$2$F$20240228$20240416$20240425$20240822$EXP$$AR-BEH-2024171118$CSL BEHRING$$3$YR$C$M$Y$20$KG$20240822$$CN$AR$AR
237816362$23781636$2$F$20240422$20240725$20240425$20240729$PER$$US-AMGEN-USASP2024082577$AMGEN$$54$YR$A$M$Y$$$20240728$$CN$US$US
237816423$23781642$3$F$$20240821$20240425$20240828$EXP$$US-JNJFOC-20240462050$JOHNSON AND JOHNSON$$7$DEC$$M$Y$108.51$KG$20240828$$CN$US$US
237816473$23781647$3$F$20230313$20240919$20240425$20240927$EXP$$CA-TAKEDA-2022TUS095270$TAKEDA$$45$YR$$F$Y$$$20240927$$CN$CA$CA
237816512$23781651$2$F$20240410$20240830$20240425$20240909$EXP$$BR-CELLTRION INC.-2023BR004301$CELLTRION$$$$$$Y$$$20240909$$CN$BR$BR
237816622$23781662$2$F$$20240718$20240425$20240719$EXP$$IN-ROCHE-3550563$ROCHE$$52$YR$A$M$Y$$$20240720$$CN$IN$IN
237816753$23781675$3$F$20240404$20240507$20240425$20240806$PER$$US-AstraZeneca-2024A085687$ASTRAZENECA$$24387$DY$$M$Y$$$20240806$$CN$US$
237816787$23781678$7$F$20240401$20240826$20240425$20240903$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011948$UNITED THERAPEUTICS$$40$YR$$F$Y$102.95$KG$20240903$$$US$US
237817243$23781724$3$F$20240421$20240810$20240425$20240812$PER$$US-AMGEN-USASP2024081833$AMGEN$$68$YR$E$M$Y$$$20240812$$CN$US$US
237817522$23781752$2$F$20230801$20240625$20240425$20240701$EXP$FR-AFSSAPS-SE2024000306$FR-ABBVIE-5732541$ABBVIE$$82$YR$$F$Y$74$KG$20240701$$MD$FR$FR
237817642$23781764$2$F$$20240626$20240425$20240706$EXP$DE-BFARM-24002183$DE-TEVA-VS-3186097$TEVA$$$$$F$Y$$$20240706$$CN$DE$DE
237817884$23781788$4$F$20240321$20240730$20240425$20240807$EXP$PT-INFARMED-F202404-309$PT-ROCHE-3550151$ROCHE$$73$YR$E$F$Y$$$20240807$$PH$PT$PT
237817972$23781797$2$F$20240421$20240731$20240425$20240802$PER$$US-AMGEN-USASP2024082407$AMGEN$$49$YR$A$F$Y$$$20240802$$CN$US$US
237817992$23781799$2$F$20240420$20240730$20240425$20240801$PER$$US-AMGEN-USASP2024081292$AMGEN$$68$YR$E$F$Y$$$20240801$$CN$US$US
237818042$23781804$2$F$20240421$20240819$20240425$20240821$PER$$US-AMGEN-USASP2024082310$AMGEN$$53$YR$A$M$Y$$$20240821$$CN$US$US
237818053$23781805$3$F$20240315$20240730$20240425$20240805$EXP$$US-GSK-US2024AMR051717$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240805$$CN$US$US
237818083$23781808$3$F$20240410$20240722$20240425$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060539$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$HP$US$US
237818123$23781812$3$F$20240226$20240628$20240425$20240703$EXP$$NVSC2024US036728$NOVARTIS$$39$YR$$F$Y$$$20240703$$CN$US$US
237818352$23781835$2$F$$20240708$20240425$20240716$EXP$$CA-BAXTER-2024BAX017310$BAXTER$$28$YR$$M$Y$$$20240716$$CN$CA$CA
237818375$23781837$5$F$$20240711$20240425$20240721$EXP$$CA-BAXTER-2024BAX017089$BAXTER$$78$YR$$F$Y$93$KG$20240721$$CN$CA$CA
237818416$23781841$6$F$$20240730$20240425$20240807$EXP$$CA-BAXTER-2024BAX017161$BAXTER$$77$YR$$F$Y$$$20240807$$HP$CA$CA
237818883$23781888$3$F$$20240820$20240425$20240823$EXP$$US-ABBVIE-5731816$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
237818952$23781895$2$F$20240404$20240801$20240425$20240805$EXP$$FR-ROCHE-3550790$ROCHE$$74$YR$E$M$Y$54$KG$20240805$$MD$FR$FR
237819072$23781907$2$F$$20240719$20240425$20240725$EXP$$DE-AMGEN-DEUSP2024079830$AMGEN$$33$YR$A$F$Y$$$20240725$$MD$DE$DE
237819083$23781908$3$F$20240419$20240728$20240425$20240801$PER$$US-AMGEN-USASP2024079758$AMGEN$$76$YR$E$F$Y$$$20240801$$CN$US$US
237819182$23781918$2$F$$20240802$20240425$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-063237$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$MD$JP$JP
237819452$23781945$2$F$20240423$20240710$20240425$20240711$PER$$US-AMGEN-USASP2024082289$AMGEN$$63$YR$A$M$Y$$$20240711$$CN$US$US
237819485$23781948$5$F$20240101$20240719$20240425$20240727$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011771$UNITED THERAPEUTICS$$$$$F$Y$34.014$KG$20240727$$$US$US
237819622$23781962$2$F$$20240718$20240425$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-018682$AUROBINDO$Tavares MV, Sittol RD, Chang S-M, Otuonye G, Barnes T. A Sweet and Salty Milieu: The Utility of CT in Bilateral Adrenal Hemorrhage. J-Endocr-Soc. 2020;4 (Suppl.):A409$68$YR$$F$Y$$$20240729$$MD$US$US
237819722$23781972$2$F$$20240724$20240425$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064477$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240724$$HP$US$US
237819922$23781992$2$F$20230101$20240919$20240425$20240930$EXP$$JP-UCBSA-2024019348$UCB$$$$$F$Y$$$20240930$$HP$JP$JP
237820172$23782017$2$F$$20240724$20240425$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055010$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$HP$US$US
237820203$23782020$3$F$20240330$20240808$20240425$20240809$EXP$$US-UCBSA-2024020277$UCB$$63$YR$$F$Y$$$20240809$$CN$US$US
237820304$23782030$4$F$20100503$20240829$20240425$20240910$EXP$FR-EMA-DD-20240326-7482655-061813$FR-TEVA-VS-3186124$TEVA$$67$YR$$M$Y$74$KG$20240910$$MD$FR$FR
237820482$23782048$2$F$20240310$20240717$20240425$20240718$EXP$PT-INFARMED-E202404-332$PT-ROCHE-3549044$ROCHE$$66$YR$E$F$Y$$$20240718$$PH$PT$PT
237820682$23782068$2$F$20240411$20240626$20240425$20240702$EXP$$MX-TAKEDA-2022TUS010042$TAKEDA$$64$YR$$F$Y$$$20240702$$CN$MX$MX
237820704$23782070$4$F$$20240911$20240425$20240920$30DAY$$FR-PFIZER INC-PV202400045320$PFIZER$$$$$$Y$$$20240920$$PH$FR$FR
237820713$23782071$3$F$20240402$20240905$20240425$20240910$30DAY$$DO-PFIZER INC-202400078946$PFIZER$$12$YR$$M$Y$$$20240910$$CN$DO$DO
237820724$23782072$4$F$20230101$20240716$20240425$20240723$30DAY$$FR-PFIZER INC-PV202400045744$PFIZER$$6$YR$$F$Y$$$20240723$$MD$FR$FR
237820876$23782087$6$F$$20240725$20240425$20240801$EXP$$IN-ROCHE-3424534$ROCHE$$57$YR$A$F$Y$59$KG$20240801$$MD$IN$IN
237820943$23782094$3$F$20240101$20240718$20240425$20240727$EXP$$CA-CELLTRION INC.-2024CA001016$CELLTRION$$$$$$Y$$$20240727$$HP$CA$CA
237821102$23782110$2$F$$20240718$20240425$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-018827$AUROBINDO$Foster J, Shahlapour M, Horani MH, Diedrich V, Leonard T. The Case of a Rare Anaplastic Thyroid Cancer Variant with Rhabdoid Features. J-Endocr-Soc. 2020;4 (Suppl.):A85 abstr. MON-444$49$YR$$F$Y$$$20240729$$HP$US$US
237821292$23782129$2$F$$20240830$20240425$20240905$PER$$US-ALXN-202404USA001454US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
237821373$23782137$3$F$20240420$20240729$20240425$20240801$PER$$US-AMGEN-USASP2024081363$AMGEN$$72$YR$E$F$Y$$$20240801$$CN$US$US
237821422$23782142$2$F$$20240718$20240425$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-018870$AUROBINDO$Dabbas W, Naik R, Al-Hashemi N, Tang I. WCN24-863 HISTOPLASMA ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN KIDNEYTRANSPLANT RECIPIENT. Kidney-IntRep. 2024;9 (Suppl.)(4):S452$42$YR$$F$Y$$$20240729$$HP$US$US
237822082$23782208$2$F$$20240617$20240425$20240702$EXP$$RU-Unichem Pharmaceuticals (USA) Inc-UCM202404-000436$UNICHEM$$33$YR$A$F$Y$$$20240702$$HP$RU$
237822145$23782214$5$F$20240409$20240711$20240425$20240723$EXP$$US-Accord-420761$ACCORD$$77$YR$E$F$Y$82.1$KG$20240723$$HP$US$US
237822173$23782217$3$F$$20240724$20240425$20240725$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-064590$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240725$$MD$AT$AT
237822182$23782218$2$F$$20240911$20240425$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064709$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240912$$HP$US$US
237822622$23782262$2$F$20240401$20240627$20240425$20240702$EXP$$US-ABBVIE-5733298$ABBVIE$$62$YR$$F$Y$$$20240702$$CN$US$US
237822635$23782263$5$F$20240201$20240815$20240425$20240820$EXP$$CN-Ipsen Biopharmaceuticals, Inc.-2024-06927$IPSEN$$84$YR$E$M$Y$75$KG$20240820$$MD$CN$CN
237823002$23782300$2$F$$20240726$20240425$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US042923$SANDOZ$$$$$F$Y$$$20240729$$CN$US$US
237823032$23782303$2$F$20240422$20240820$20240425$20240823$PER$$US-AMGEN-USASP2024082279$AMGEN$$76$YR$E$F$Y$$$20240822$$CN$US$US
237823273$23782327$3$F$20240829$20240905$20240425$20240912$EXP$$CO-GSK-CO2024AMR035686$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$CO$CO
237823362$23782336$2$F$$20240709$20240425$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064084$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240710$$CN$US$US
237823422$23782342$2$F$$20240911$20240425$20240923$EXP$$CA-APOTEX-2024AP004920$APOTEX$$69$YR$$F$Y$$$20240923$$HP$CA$CA
237824262$23782426$2$F$20210604$20240628$20240425$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-443352$RANBAXY$$30$YR$$F$Y$$$20240712$$MD$FR$FR
237824413$23782441$3$F$20211001$20240705$20240425$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-443886$RANBAXY$$64$YR$$F$Y$$$20240719$$CN$FR$FR
237824943$23782494$3$F$$20240717$20240425$20240801$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-443287$RANBAXY$Theodorakis E, Touloupakis G, Antonini G, Lettera MG, Teli M. Atypical lumbar pedicle fractures. A case report and comparative review of the literature: Bisphosphonate-related? Possible matching with diagnostic criteria of atypical fractures of the femur. Brain Spine. 2024;4(0):5 pages$71$YR$$F$Y$$$20240801$$HP$IT$IT
237824972$23782497$2$F$$20240708$20240425$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA042164$SANDOZ$$58$YR$$F$Y$61$KG$20240709$$CN$CA$CA
237824993$23782499$3$F$$20240820$20240425$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA042537$SANDOZ$$72$YR$$F$Y$$$20240821$$HP$CA$CA
237825154$23782515$4$F$20240409$20240820$20240425$20240903$30DAY$$GB-PFIZER INC-PV202400047798$PFIZER$$35$YR$$F$Y$$$20240903$$CN$GB$GB
237825163$23782516$3$F$20240101$20240904$20240425$20240916$30DAY$$GB-PFIZER INC-PV202400050615$PFIZER$$63$YR$$M$Y$$$20240916$$CN$GB$GB
237825178$23782517$8$F$$20240916$20240425$20240927$30DAY$$GB-PFIZER INC-PV202400052028$PFIZER$$63$YR$$M$Y$$$20240927$$CN$GB$GB
237825184$23782518$4$F$$20240902$20240425$20240916$30DAY$$GB-PFIZER INC-PV202400046610$PFIZER$$69$YR$$M$Y$$$20240916$$CN$GB$GB
237825202$23782520$2$F$$20240904$20240425$20240905$30DAY$$GB-PFIZER INC-PV202400049874$PFIZER$$9$YR$$F$Y$$$20240905$$CN$GB$GB
237825302$23782530$2$F$$20240718$20240425$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-018168$AUROBINDO$Gupta M, Bacha F.. Severe Hyperglycemia in the Setting of Hypernatremic Dehydration. J-EndocrSoc. 2019;13 (Suppl.):SUN-277$10$MON$$M$Y$0.79$KG$20240729$$MD$US$US
237825393$23782539$3$F$20240312$20240818$20240425$20240819$EXP$$US-BAYER-2024A059867$BAYER$$41$YR$A$F$Y$104.7$KG$20240819$$CN$US$US
237825602$23782560$2$F$$20240919$20240425$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202404015268$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240927$$CN$US$US
237825773$23782577$3$F$$20240903$20240425$20240904$30DAY$$CO-PFIZER INC-PV202400047839$PFIZER$$11$YR$$F$Y$$$20240904$$CN$CO$CO
237825792$23782579$2$F$20240412$20240904$20240425$20240906$30DAY$$CO-PFIZER INC-PV202400051422$PFIZER$$$$$F$Y$$$20240906$$CN$CO$CO
237825813$23782581$3$F$$20240626$20240425$20240701$30DAY$$US-PFIZER INC-PV202400045813$PFIZER$$67$YR$$F$Y$55.34$KG$20240701$$HP$US$US
237825843$23782584$3$F$$20240728$20240425$20240730$30DAY$$US-PFIZER INC-PV202400048838$PFIZER$$$$$F$Y$$$20240730$$CN$US$US
237825855$23782585$5$F$$20240903$20240425$20240905$30DAY$$JP-PFIZER INC-PV202400044445$PFIZER$$$$$F$Y$$$20240905$$CN$JP$JP
237825864$23782586$4$F$$20240715$20240425$20240717$30DAY$$US-PFIZER INC-PV202400046245$PFIZER$$49$YR$$F$Y$53.52$KG$20240717$$CN$US$US
237825883$23782588$3$F$$20240724$20240425$20240731$EXP$$CA-APOTEX-2024AP005094$APOTEX$$65$YR$$M$Y$$$20240731$$HP$CA$CA
237825934$23782593$4$F$20240329$20240801$20240425$20240815$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03359$HIKMA$$19$YR$$M$Y$$$20240815$$MD$US$US
237825942$23782594$2$F$$20240610$20240425$20240801$PER$$US-LUNDBECK-DKLU3076599$LUNDBECK$$$$$$Y$$$20240801$$CN$US$US
237825952$23782595$2$F$20240307$20240703$20240425$20240813$PER$$US-LUNDBECK-DKLU3076625$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
237826044$23782604$4$F$$20240723$20240425$20240904$PER$$US-LUNDBECK-DKLU3076626$LUNDBECK$$$$$$Y$$$20240904$$CN$US$US
237826072$23782607$2$F$$20240821$20240425$20240830$30DAY$$US-GSK-US2024048020$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
237826564$23782656$4$F$20240410$20240718$20240425$20240722$30DAY$$US-PFIZER INC-202400085195$PFIZER$$16$YR$$M$Y$$$20240722$$MD$US$US
237826583$23782658$3$F$20240101$20240904$20240425$20240906$30DAY$$US-PFIZER INC-202400084688$PFIZER$$13$YR$$F$Y$49.887$KG$20240906$$CN$US$US
237826605$23782660$5$F$$20240905$20240425$20240909$30DAY$$US-PFIZER INC-202400085138$PFIZER$$12$YR$$M$Y$$$20240909$$CN$US$US
237826622$23782662$2$F$20240422$20240729$20240425$20240801$PER$$US-AMGEN-USASP2024082623$AMGEN$$54$YR$A$F$Y$$$20240801$$CN$US$US
237826692$23782669$2$F$20190101$20240711$20240425$20240717$EXP$$US-ABBVIE-5732231$ABBVIE$$$$$F$Y$61$KG$20240717$$CN$US$US
237826796$23782679$6$F$$20240911$20240425$20240911$30DAY$$US-PFIZER INC-202400084623$PFIZER$$12$YR$$M$Y$$$20240911$$CN$US$US
237826823$23782682$3$F$20240401$20240913$20240425$20240918$30DAY$$US-PFIZER INC-202400085131$PFIZER$$10$YR$$M$Y$40.37$KG$20240918$$CN$US$US
237826867$23782686$7$F$20240415$20240925$20240425$20240927$30DAY$$US-PFIZER INC-202400085173$PFIZER$$16$YR$$M$Y$$$20240927$$CN$US$US
237826878$23782687$8$F$20240401$20240921$20240425$20240925$30DAY$$US-PFIZER INC-202400084821$PFIZER$$13$YR$$M$Y$$$20240925$$CN$US$US
237826912$23782691$2$F$20240101$20240813$20240425$20240815$EXP$$JP-GILEAD-2024-0670776$GILEAD$$$$A$F$Y$$$20240815$$MD$JP$JP
237826964$23782696$4$F$20230904$20240916$20240425$20240923$EXP$$US-JNJFOC-20240449498$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240923$$CN$US$US
237827114$23782711$4$F$20240412$20240618$20240425$20240708$EXP$$AU-ROCHE-3549607$ROCHE$$75$YR$E$F$Y$53$KG$20240708$$MD$AU$AU
237827256$23782725$6$F$20240101$20240726$20240425$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-010642$UNITED THERAPEUTICS$$$$$F$Y$50.794$KG$20240731$$$US$US
237827294$23782729$4$F$$20240910$20240425$20240912$30DAY$$US-PFIZER INC-202400086322$PFIZER$$80$YR$$F$Y$$$20240912$$CN$US$US
237827413$23782741$3$F$20230101$20240624$20240425$20240701$EXP$$US-INTERCEPT-PM2023001489$INTERCEPT PHARMACEUTICALS$$$$$F$Y$67.12$KG$20240701$$CN$US$US
237827452$23782745$2$F$$20240814$20240425$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA042613$SANDOZ$$42$YR$$F$Y$$$20240819$$HP$CA$CA
237827495$23782749$5$F$20240410$20240907$20240425$20240911$30DAY$$US-PFIZER INC-202400085186$PFIZER$$14$YR$$M$Y$50.8$KG$20240911$$CN$US$US
237827515$23782751$5$F$20240301$20240904$20240425$20240910$30DAY$$US-PFIZER INC-202400085294$PFIZER$$11$YR$$M$Y$$$20240910$$HP$US$US
237827527$23782752$7$F$20240301$20240906$20240425$20240910$30DAY$$US-PFIZER INC-202400085820$PFIZER$$14$YR$$M$Y$37.6$KG$20240910$$HP$US$US
237827542$23782754$2$F$$20240725$20240425$20240729$30DAY$$US-PFIZER INC-202400084550$PFIZER$$15$YR$$M$Y$$$20240729$$CN$US$US
237827556$23782755$6$F$20240408$20240920$20240425$20240925$30DAY$$US-PFIZER INC-202400086485$PFIZER$$4$YR$$F$Y$9.53$KG$20240925$$MD$US$US
237827566$23782756$6$F$$20240904$20240425$20240909$30DAY$$US-PFIZER INC-202400013670$PFIZER$$49$YR$$F$Y$$$20240909$$CN$US$US
237827574$23782757$4$F$20240410$20240802$20240425$20240802$30DAY$$US-PFIZER INC-202400086040$PFIZER$$19$YR$$F$Y$104.78$KG$20240802$$CN$US$US
237827802$23782780$2$F$$20240626$20240425$20240701$PER$$US-BAUSCHBL-2024BNL025745$BAUSCH AND LOMB$$$$$F$Y$$$20240701$$CN$US$US
237828159$23782815$9$F$$20240914$20240425$20240919$30DAY$$US-PFIZER INC-202400085871$PFIZER$$11$YR$$F$Y$$$20240919$$CN$US$US
237828164$23782816$4$F$$20240809$20240425$20240813$30DAY$$US-PFIZER INC-202400085618$PFIZER$$11$YR$$M$Y$$$20240813$$CN$US$US
237828213$23782821$3$F$20240412$20240904$20240425$20240909$30DAY$$US-PFIZER INC-202400087568$PFIZER$$6$YR$$M$Y$$$20240909$$CN$US$US
237828227$23782822$7$F$$20240915$20240425$20240919$30DAY$$US-PFIZER INC-202400088561$PFIZER$$11$YR$$F$Y$25.85$KG$20240919$$CN$US$US
237828234$23782823$4$F$$20240905$20240425$20240910$30DAY$$US-PFIZER INC-202400088091$PFIZER$$2$YR$$M$Y$9.977$KG$20240910$$CN$US$US
237828502$23782850$2$F$20240418$20240807$20240425$20240808$PER$$US-AMGEN-USASP2024079553$AMGEN$$61$YR$A$M$Y$$$20240808$$CN$US$US
237829482$23782948$2$F$$20240718$20240425$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-018840$AUROBINDO$Slack D, Brooks D, Levine AC. Chronic Opioid Use as a Cause of Severe Hypothyroidism: A Case Report. Journal of the Endocrine Society. 2020;4 (Suppl.):A1029-A1030$56$YR$$F$Y$$$20240729$$MD$US$US
237829505$23782950$5$F$$20240904$20240425$20240909$30DAY$$US-PFIZER INC-202400085779$PFIZER$$42$YR$$F$Y$91.17$KG$20240909$$HP$US$US
237829535$23782953$5$F$$20240907$20240425$20240910$30DAY$$US-PFIZER INC-202400089211$PFIZER$$13$YR$$F$Y$$$20240910$$CN$US$US
237829544$23782954$4$F$$20240727$20240425$20240802$30DAY$$US-PFIZER INC-202400085449$PFIZER$$13$YR$$M$Y$$$20240802$$CN$US$US
237829553$23782955$3$F$$20240725$20240425$20240729$30DAY$$US-PFIZER INC-202400084908$PFIZER$$9$YR$$M$Y$$$20240729$$CN$US$US
237829562$23782956$2$F$$20240701$20240425$20240708$PER$$US-JNJFOC-20240464585$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$HP$US$US
237829787$23782978$7$F$$20240905$20240425$20240910$30DAY$$US-PFIZER INC-202400089287$PFIZER$$11$YR$$F$Y$$$20240910$$CN$US$US
237829834$23782983$4$F$$20240905$20240425$20240910$30DAY$$US-PFIZER INC-202400087900$PFIZER$$12$YR$$F$Y$$$20240910$$CN$US$US
237829886$23782988$6$F$$20240913$20240425$20240918$30DAY$$US-PFIZER INC-202400089483$PFIZER$$11$YR$$M$Y$$$20240918$$HP$US$US
237830117$23783011$7$F$20240406$20240905$20240425$20240916$30DAY$$US-PFIZER INC-PV202400049489$PFIZER$$11$YR$$F$Y$$$20240916$$CN$US$US
237830125$23783012$5$F$$20240920$20240425$20240925$30DAY$$US-PFIZER INC-202400087457$PFIZER$$54$YR$$F$Y$69.4$KG$20240925$$MD$US$US
237830137$23783013$7$F$$20240906$20240425$20240910$30DAY$$US-PFIZER INC-202400087552$PFIZER$$61$YR$$M$Y$$$20240910$$CN$US$US
237830144$23783014$4$F$20240413$20240911$20240425$20240916$30DAY$$US-PFIZER INC-202400087984$PFIZER$$45$YR$$F$Y$68.04$KG$20240916$$HP$US$US
237830192$23783019$2$F$20240422$20240701$20240425$20240703$PER$$US-AMGEN-USASP2024081303$AMGEN$$64$YR$A$F$Y$$$20240703$$CN$US$US
237830215$23783021$5$F$$20240828$20240425$20240903$EXP$$CA-TAKEDA-2024TUS037221$TAKEDA$$$$$M$Y$$$20240903$$CN$CA$CA
237830234$23783023$4$F$20210712$20240823$20240425$20240827$EXP$$CA-TAKEDA-2023TUS056042$TAKEDA$$73$YR$$F$Y$$$20240827$$HP$CA$CA
237830592$23783059$2$F$$20240821$20240425$20240826$EXP$$TR-ELI_LILLY_AND_COMPANY-TR202404009271$ELI LILLY AND CO$$13$YR$T$F$Y$$$20240826$$CN$NL$TR
237830764$23783076$4$F$20230101$20240728$20240425$20240731$PER$$US-AMGEN-USASP2024078450$AMGEN$$60$YR$A$F$Y$55.782$KG$20240731$$HP$US$US
237830934$23783093$4$F$20240301$20240710$20240425$20240715$EXP$$US-KYOWAKIRIN-2024KK009876$KYOWA$$$$$$Y$$$20240715$$CN$US$US
237830955$23783095$5$F$$20240610$20240425$20240717$EXP$$US-AstraZeneca-2024A093068$ASTRAZENECA$$39$YR$$F$Y$$$20240717$$HP$US$
237831224$23783122$4$F$$20240915$20240425$20240925$30DAY$$US-PFIZER INC-202400087025$PFIZER$$9$YR$$M$Y$26.304$KG$20240925$$CN$US$US
237831232$23783123$2$F$$20240725$20240425$20240729$30DAY$$US-PFIZER INC-202400087828$PFIZER$$51$YR$$M$Y$$$20240729$$CN$US$US
237831243$23783124$3$F$20240101$20240727$20240425$20240802$30DAY$$US-PFIZER INC-202400087582$PFIZER$$9$YR$$F$Y$31.3$KG$20240802$$CN$US$US
237831274$23783127$4$F$$20240906$20240425$20240912$30DAY$$US-PFIZER INC-202400086495$PFIZER$$13$YR$$M$Y$$$20240912$$CN$US$US
237831287$23783128$7$F$$20240917$20240425$20240923$30DAY$$US-PFIZER INC-202400086884$PFIZER$$14$YR$$M$Y$$$20240923$$CN$US$US
237831432$23783143$2$F$$20240711$20240425$20240717$EXP$$FR-MYLANLABS-2024M1036585$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237831552$23783155$2$F$$20240711$20240425$20240716$EXP$$FR-MYLANLABS-2024M1037046$MYLAN$$$$$F$Y$$$20240716$$CN$FR$FR
237831572$23783157$2$F$$20240711$20240425$20240717$EXP$$FR-MYLANLABS-2024M1037049$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237831582$23783158$2$F$$20240711$20240425$20240717$EXP$$FR-MYLANLABS-2024M1036581$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237831592$23783159$2$F$$20240711$20240425$20240717$EXP$$FR-MYLANLABS-2024M1037053$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237831855$23783185$5$F$20230101$20240917$20240425$20240927$EXP$$US-INSMED, INC.-2023-04696-US$INSMED$$$$$F$Y$$$20240927$$CN$US$US
237832152$23783215$2$F$20240326$20240425$20240425$20240801$PER$$US-BAYER-2024A062096$BAYER$$19$YR$A$F$Y$$$20240801$$HP$US$US
237832164$23783216$4$F$20240101$20240712$20240425$20240729$EXP$$NL-AMGEN-NLDNI2024081719$AMGEN$$80$YR$E$F$Y$$$20240729$$HP$NL$NL
237832293$23783229$3$F$20240402$20240808$20240425$20240814$30DAY$$GR-PFIZER INC-PV202400044694$PFIZER$$11$YR$$F$Y$25$KG$20240814$$CN$GR$GR
237832452$23783245$2$F$20240620$20240813$20240425$20240815$EXP$$US-KYOWAKIRIN-2024KK009429$KYOWA$$$$$$Y$$$20240815$$HP$US$US
237832562$23783256$2$F$$20240617$20240425$20240702$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-441959$RANBAXY$$58$YR$$M$Y$$$20240702$$CN$DE$DE
237832824$23783282$4$F$20240403$20240807$20240425$20240814$EXP$$NVSC2024DE083413$NOVARTIS$$58$YR$$F$Y$58$KG$20240814$$MD$DE$DE
237833002$23783300$2$F$20230101$20240627$20240425$20240710$EXP$$NZ-AMICUS THERAPEUTICS, INC.-AMI_3054$AMICUS THERAPEUTICS$$$$$M$Y$$$20240710$$MD$NZ$NZ
237833123$23783312$3$F$20230101$20240724$20240425$20240731$PER$$US-BIOGEN-2022BI01167170$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
237833233$23783323$3$F$$20240905$20240425$20240911$30DAY$$KR-PFIZER INC-PV202400045648$PFIZER$$5$YR$$M$Y$$$20240911$$CN$KR$KR
237833595$23783359$5$F$20240101$20240830$20240425$20240906$EXP$$JP-AMGEN-JPNSP2024073787$AMGEN$$$$E$F$Y$$$20240906$$MD$JP$JP
237833962$23783396$2$F$20240119$20240906$20240425$20240916$EXP$FR-AFSSAPS-PO2024000307$FR-TEVA-VS-3186542$TEVA$$54$YR$$F$Y$62$KG$20240916$$MD$FR$FR
237834074$23783407$4$F$20231125$20240715$20240425$20240716$EXP$$AR-MYLANLABS-2023M1127797$MYLAN$$44$YR$$M$Y$$$20240716$$HP$AR$AR
237834086$23783408$6$F$$20240920$20240425$20240925$EXP$$GB-MYLANLABS-2024M1037337$MYLAN$$$$$F$Y$$$20240925$$MD$GB$GB
237834333$23783433$3$F$$20240807$20240425$20240813$EXP$$CA-TAKEDA-2024TUS012103$TAKEDA$$$$$F$Y$$$20240813$$CN$CA$CA
237834634$23783463$4$F$20230612$20240826$20240425$20240912$EXP$$US-JNJFOC-20230808080$JOHNSON AND JOHNSON$$64$YR$A$F$Y$74$KG$20240912$$HP$US$US
237834776$23783477$6$F$20240409$20240718$20240425$20240722$EXP$$GB-009507513-2404GBR010564$MERCK$$76$YR$$M$Y$60$KG$20240722$$HP$GB$GB
237835232$23783523$2$F$$20240730$20240425$20240805$30DAY$$US-GSK-US2024048153$GLAXOSMITHKLINE$$$$$F$Y$104$KG$20240804$$CN$US$US
237835494$23783549$4$F$20230303$20240917$20240425$20240927$EXP$$JP-TEVA-VS-3178700$TEVA$$45$YR$$M$Y$$$20240927$$MD$JP$JP
237835833$23783583$3$F$$20240917$20240425$20240921$EXP$$GB-TAKEDA-2024TUS038577$TAKEDA$$$$$M$Y$$$20240921$$CN$GB$GB
237835872$23783587$2$F$20201101$20240708$20240425$20240722$EXP$$CZ-NORDICGR-055821$NORDIC PHARMA$Zitko T. Upadacitinib in a patient with TNF inhibitor-induced sarcoidosis. FARMAKOTERAPIE. 2023;19(6):780, 782.$$$A$F$Y$$$20240722$$MD$CZ$CZ
237835962$23783596$2$F$20240401$20240704$20240425$20240712$EXP$$US-JNJFOC-20240473742$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240712$$HP$US$US
237836104$23783610$4$F$20240101$20240715$20240425$20240725$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-000720$SK LIFE SCIENCE$$$$$$Y$$$20240725$$HP$CA$CA
237836243$23783624$3$F$$20240806$20240425$20240813$PER$$US-ALXN-202404USA001503US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
237836274$23783627$4$F$20240412$20240925$20240425$20240930$EXP$$CA-VERTEX PHARMACEUTICALS-2024-006971$VERTEX$$43$YR$$F$Y$64$KG$20240930$$HP$CA$CA
237836382$23783638$2$F$$20240823$20240425$20240829$PER$$US-VERTEX PHARMACEUTICALS-2024-007059$VERTEX$$$$$$Y$$$20240829$$CN$US$US
237836475$23783647$5$F$$20240820$20240425$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA042730$SANDOZ$$65$YR$$F$Y$$$20240821$$HP$CA$CA
237836903$23783690$3$F$$20240815$20240425$20240822$EXP$$CA-GSK-CA2024050003$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$CA$CA
237836923$23783692$3$F$20240417$20240626$20240425$20240701$EXP$$FR-ABBVIE-5727621$ABBVIE$$65$YR$$M$Y$$$20240701$$HP$FR$FR
237836993$23783699$3$F$20240407$20240721$20240425$20240801$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404012675$ELI LILLY AND CO$$43$YR$A$F$Y$57$KG$20240801$$CN$JP$JP
237837436$23783743$6$F$20240101$20240702$20240425$20240704$EXP$$US-PFIZER INC-202400093031$PFIZER$$61$YR$$M$Y$114$KG$20240704$$HP$US$US
237837495$23783749$5$F$20240101$20240925$20240425$20240927$EXP$$CA-PFIZER INC-202400093163$PFIZER$$40$YR$$M$Y$120$KG$20240927$$HP$CA$CA
237837535$23783753$5$F$20240201$20240718$20240425$20240718$EXP$$CA-PFIZER INC-202400094080$PFIZER$$69$YR$$F$Y$$$20240718$$HP$CA$CA
237837582$23783758$2$F$$20240723$20240425$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063638$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240723$$CN$US$US
237837592$23783759$2$F$20240419$20240724$20240425$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063541$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$PH$US$US
237837633$23783763$3$F$$20240906$20240425$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062249$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240910$$MD$US$US
237837685$23783768$5$F$20240801$20240905$20240425$20240910$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-064851$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$69.4$KG$20240910$$CN$PR$PR
237837692$23783769$2$F$20240301$20240724$20240425$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064603$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240724$$CN$US$US
237837735$23783773$5$F$20240407$20240802$20240425$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064428$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240805$$CN$US$US
237837743$23783774$3$F$20230101$20240723$20240425$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062782$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240723$$CN$US$US
237837782$23783778$2$F$$20240724$20240425$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064419$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240724$$CN$US$US
237837884$23783788$4$F$20240407$20240906$20240425$20240910$30DAY$$GR-PFIZER INC-PV202400047152$PFIZER$$10$YR$$M$Y$23$KG$20240910$$CN$GR$GR
237837913$23783791$3$F$20240401$20240808$20240425$20240820$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400129$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
237837974$23783797$4$F$$20240709$20240425$20240710$PER$$US-ALXN-202404USA001353US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
237837985$23783798$5$F$$20240923$20240425$20240926$30DAY$$GR-PFIZER INC-PV202400051348$PFIZER$$13$YR$$F$Y$37$KG$20240926$$CN$GR$GR
237837993$23783799$3$F$20240409$20240924$20240425$20240927$30DAY$$GR-PFIZER INC-PV202400048001$PFIZER$$9$YR$$M$Y$34$KG$20240927$$CN$GR$GR
237838017$23783801$7$F$20240419$20240911$20240425$20240916$30DAY$$GR-PFIZER INC-PV202400053344$PFIZER$$4$YR$$F$Y$14$KG$20240916$$CN$GR$GR
237838026$23783802$6$F$20240419$20240913$20240425$20240919$30DAY$$GR-PFIZER INC-PV202400053342$PFIZER$$4$YR$$F$Y$14$KG$20240919$$CN$GR$GR
237838033$23783803$3$F$$20240829$20240425$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065332$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$79.83$KG$20240902$$CN$US$US
237838042$23783804$2$F$$20240814$20240425$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063316$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240816$$HP$US$US
237838153$23783815$3$F$$20240725$20240425$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064872$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240726$$CN$US$US
237838164$23783816$4$F$$20240705$20240425$20240718$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-061749$BRISTOL MYERS SQUIBB$Rivoli G, Bartalucci G, Laurino M, Coviello E, Beltrami G, Coniglio ML, et al. Poligenic predisposition to late onset severe haemophagocytic lymphohistiocytosis in a patient with MDS. Haematologica. 2021 Oct 01;106(Supplement 3):174.$64$YR$A$M$Y$$$20240718$$HP$IT$IT
237838372$23783837$2$F$20230101$20240628$20240425$20240705$EXP$$NVSC2023BR214865$NOVARTIS$$$$$F$Y$$$20240705$$CN$BR$BR
237838463$23783846$3$F$$20240805$20240425$20240807$PER$$NVSC2024US088121$NOVARTIS$$$$$M$Y$$$20240807$$CN$US$US
237838562$23783856$2$F$20240101$20240903$20240425$20240905$PER$$US-PFIZER INC-202400093083$PFIZER$$43$YR$$F$Y$$$20240905$$HP$US$US
237838652$23783865$2$F$20240301$20240723$20240425$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063963$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240723$$CN$US$US
237838683$23783868$3$F$$20240705$20240425$20240711$EXP$$US-INCYTE CORPORATION-2024IN004292$INCYTE$$$$$$Y$$$20240711$$MD$US$US
237839163$23783916$3$F$$20240716$20240425$20240723$PER$$US-ALXN-202404USA001420US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
237839212$23783921$2$F$20240311$20240917$20240425$20240919$EXP$$JP-Eisai-EC-2024-164520$EISAI$$57$YR$A$F$Y$$$20240919$$MD$JP$JP
237839243$23783924$3$F$20240328$20240701$20240425$20240710$PER$$JP-Eisai-EC-2024-164162$EISAI$$65$YR$E$F$Y$$$20240710$$MD$JP$JP
237839262$23783926$2$F$$20240722$20240425$20240729$EXP$$JP-ABBVIE-5734256$ABBVIE$$42$YR$$F$Y$$$20240729$$PH$JP$JP
237839432$23783943$2$F$20240301$20240423$20240425$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202404016080$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240725$$CN$US$US
237839484$23783948$4$F$20240101$20240624$20240425$20240701$PER$$US-SA-2024SA122799$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240701$$MD$US$US
237839522$23783952$2$F$20231001$20240620$20240425$20240701$PER$$US-SA-2024SA121197$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240701$$MD$US$US
237839672$23783967$2$F$20240701$20240731$20240425$20240809$PER$$US-SA-2024SA120537$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240809$$MD$US$US
237839722$23783972$2$F$20231101$20240712$20240425$20240723$PER$$US-SA-2024SA120107$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240722$$MD$US$US
237839783$23783978$3$F$$20240805$20240425$20240813$PER$$US-SA-2024SA121210$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240814$$MD$US$US
237839862$23783986$2$F$20240101$20240731$20240425$20240808$PER$$US-SA-2024SA121412$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240808$$MD$US$US
237839953$23783995$3$F$20240101$20240917$20240425$20240922$PER$$US-SA-2024SA120374$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240923$$MD$US$US
237839972$23783997$2$F$20240401$20240730$20240425$20240807$PER$$US-SA-2024SA122101$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240807$$MD$US$US
237839992$23783999$2$F$20240301$20240809$20240425$20240820$PER$$US-SA-2024SA120409$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240820$$MD$US$US
237840042$23784004$2$F$20240401$20240730$20240425$20240807$PER$$US-SA-2024SA121100$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240807$$MD$US$US
237840072$23784007$2$F$20240701$20240729$20240425$20240807$PER$$US-SA-2024SA119023$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240807$$MD$US$US
237840102$23784010$2$F$$20240802$20240425$20240813$PER$$US-SA-2024SA121635$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240814$$MD$US$US
237840132$23784013$2$F$20240401$20240717$20240425$20240726$PER$$US-SA-2024SA122466$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240726$$MD$US$US
237840324$23784032$4$F$$20240821$20240425$20240904$PER$$US-SA-2024SA122422$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240904$$MD$US$US
237840462$23784046$2$F$$20240730$20240425$20240807$PER$$US-SA-2024SA121214$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240807$$MD$US$US
237840762$23784076$2$F$20230101$20240730$20240425$20240808$PER$$US-SA-2024SA120895$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240808$$MD$US$US
237840792$23784079$2$F$20240101$20240730$20240425$20240808$PER$$US-SA-2024SA120497$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240808$$MD$US$US
237840923$23784092$3$F$20240101$20240903$20240425$20240913$PER$$US-SA-2024SA123381$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240913$$MD$US$US
237840995$23784099$5$F$20200101$20240829$20240425$20240917$PER$$US-SA-2024SA116468$SANOFI AVENTIS$$69$YR$E$F$Y$93.4$KG$20240918$$CN$US$US
237841002$23784100$2$F$$20240724$20240425$20240802$PER$$US-SA-2024SA124895$SANOFI AVENTIS$$$$E$M$Y$$$20240802$$MD$US$US
237841417$23784141$7$F$$20240812$20240425$20240821$EXP$$US-TORRENT-00013539$TORRENT$$69$YR$E$F$Y$$$20240821$$HP$US$US
237841444$23784144$4$F$$20240731$20240425$20240807$PER$$US-SA-2024SA123709$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240807$$MD$US$US
237841472$23784147$2$F$$20240909$20240425$20240919$PER$$US-SA-2024SA125244$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240919$$MD$US$US
237841502$23784150$2$F$20230801$20240711$20240425$20240801$PER$$US-SA-2024SA123499$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240719$$MD$US$US
237841743$23784174$3$F$20240101$20240808$20240425$20240816$PER$$US-SA-2024SA124486$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240816$$MD$US$US
237841943$23784194$3$F$20240401$20240815$20240425$20240816$PER$$US-AMGEN-USASP2024081872$AMGEN$$24$YR$A$M$Y$$$20240816$$HP$US$US
237842263$23784226$3$F$20240404$20240712$20240425$20240717$PER$$US-PFIZER INC-202400094708$PFIZER$$16$YR$$M$Y$77.11$KG$20240717$$CN$US$US
237842533$23784253$3$F$20240301$20240725$20240425$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064591$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240725$$CN$US$US
237842885$23784288$5$F$20231114$20240701$20240425$20240708$EXP$$IT-ABBVIE-5732965$ABBVIE$$49$YR$$M$Y$112$KG$20240708$$MD$IT$IT
237843252$23784325$2$F$20240101$20240715$20240425$20240722$PER$$US-SA-2024SA121947$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240723$$MD$US$US
237843282$23784328$2$F$$20240801$20240425$20240809$PER$$US-SA-2024SA125245$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240809$$MD$US$US
237843312$23784331$2$F$$20240805$20240425$20240812$PER$$US-SA-2024SA123192$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240812$$MD$US$US
237843885$23784388$5$F$$20240716$20240425$20240724$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-06981$IPSEN$$$$$M$Y$$$20240724$$HP$GB$GB
237843913$23784391$3$F$20240419$20240827$20240425$20240830$EXP$$US-ABBVIE-5733013$ABBVIE$$43$YR$$M$Y$86$KG$20240830$$CN$US$US
237844093$23784409$3$F$20240417$20240716$20240425$20240718$PER$$US-AMGEN-USASP2024082006$AMGEN$$83$YR$E$F$Y$$$20240718$$MD$US$US
237844222$23784422$2$F$20240101$20240703$20240425$20240716$PER$$US-SA-2024SA122155$SANOFI AVENTIS$$52$YR$A$F$Y$102.5$KG$20240716$$MD$US$US
237844292$23784429$2$F$$20240830$20240425$20240904$PER$$US-SA-2024SA121787$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240904$$MD$US$US
237844805$23784480$5$F$20240604$20240912$20240425$20240918$EXP$$US-BIOGEN-2024BI01261220$BIOGEN$$26$YR$$M$Y$$$20240918$$CN$US$US
237845494$23784549$4$F$$20240827$20240425$20240906$EXP$$US-TEVA-VS-3185290$TEVA$Gondal MUR, Lemoine J, Segal J, Kiyani Z, Bilal MI, Ansari F, et al. CARDIOTOXICITY INDUCED BY CAPECITABINE AND OXALIPLATIN IN GASTRIC CANCER TREATMENT: A RARE CASE OF CARDIAC ARREST AND CARDIOGENIC SHOCK. European Journal of Case Reports in Internal Medicine 11: , No. 4, 2024.; Gondal MUR, Segal J, Bilal MI, Baig MW, Qureshi AM, Donato A. CARDIOTOXICITY INDUCED BY CAPECITABINE AND OXALIPLATIN IN GASTRIC CANCER TREATMENT - A RARE CASE OF CARDIAC ARREST AND CARDIOGENIC SHOCK. J-Am-Coll-Cardiol...$45$YR$$F$Y$$$20240906$$HP$US$US
237845553$23784555$3$F$20230613$20240604$20240425$20240731$EXP$$NVSC2024DE086251$NOVARTIS$$25$YR$$M$Y$80$KG$20240731$$MD$DE$DE
237845562$23784556$2$F$20240401$20240918$20240425$20240926$PER$$NVSC2024US087065$NOVARTIS$$$$$F$Y$$$20240926$$HP$US$US
237845942$23784594$2$F$20240101$20240905$20240425$20240915$PER$$US-SA-2024SA121004$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240915$$MD$US$US
237846054$23784605$4$F$20240101$20240809$20240425$20240814$PER$$US-SA-2024SA077022$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240814$$MD$US$US
237846162$23784616$2$F$$20240725$20240425$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065435$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240725$$HP$US$US
237846182$23784618$2$F$$20240628$20240425$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065397$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240702$$CN$US$US
237846442$23784644$2$F$$20240705$20240425$20240705$PER$$NVSC2024US087987$NOVARTIS$$$$$$Y$$$20240705$$MD$US$US
237846558$23784655$8$F$$20240910$20240425$20240919$EXP$$PL-INCYTE CORPORATION-2024IN003972$INCYTE$Szlauer-stefanska A, Kaminska-winciorek G.. Patient with chronic cutaneous and mucosal forms of graft- versus-host disease. DERMATOLOGIA PO DYPLOMIE. 2024;2$$$$$Y$$$20240919$$HP$PL$PL
237846844$23784684$4$F$20240424$20240719$20240425$20240722$EXP$$NVSC2024US088120$NOVARTIS$$76$YR$$F$Y$$$20240722$$CN$US$US
237846862$23784686$2$F$$20240725$20240425$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065456$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240725$$CN$US$US
237846924$23784692$4$F$$20240725$20240425$20240729$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-002306$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240729$$MD$US$US
237846933$23784693$3$F$20240423$20240726$20240425$20240730$PER$$US-AMGEN-USASP2024082746$AMGEN$$55$YR$A$M$Y$$$20240730$$CN$US$US
237847005$23784700$5$F$$20240711$20240425$20240721$EXP$$CA-BAXTER-2024BAX017146$BAXTER$$41$YR$$F$Y$$$20240719$$HP$CA$CA
237847142$23784714$2$F$$20240729$20240425$20240731$PER$$US-PFIZER INC-PV202400042221$PFIZER$$89$YR$$F$Y$$$20240731$$HP$US$US
237847263$23784726$3$F$20240301$20240812$20240425$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065458$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240814$$CN$US$US
237847295$23784729$5$F$$20240820$20240425$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-060004$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240826$$HP$JP$JP
237847472$23784747$2$F$20230127$20240806$20240425$20240816$EXP$$FR-JNJFOC-20240449418$JOHNSON AND JOHNSON$$63$YR$A$F$Y$40$KG$20240816$$MD$FR$FR
237847502$23784750$2$F$$20240709$20240425$20240715$EXP$$FR-MYLANLABS-2024M1036637$MYLAN$$$$$F$Y$$$20240715$$CN$FR$FR
237847542$23784754$2$F$$20240905$20240425$20240911$EXP$$DE-MYLANLABS-2024M1036914$MYLAN$$$$A$F$Y$$$20240911$$MD$DE$DE
237847603$23784760$3$F$20240101$20240910$20240425$20240918$EXP$$JP-GENMAB-2024-01055AA$GENMAB$$8$DEC$$F$Y$$$20240918$$HP$JP$JP
237847673$23784767$3$F$20230101$20240506$20240425$20240814$EXP$$NVSC2023BR273377$NOVARTIS$$$$$F$Y$$$20240814$$CN$BR$BR
237847712$23784771$2$F$20240103$20240724$20240425$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-064790$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240724$$MD$JP$JP
237847772$23784777$2$F$20240405$20240819$20240425$20240822$EXP$FR-AFSSAPS-BR2024000336$FR-009507513-2404FRA008816$MERCK$$41$YR$$M$Y$63$KG$20240822$$MD$FR$FR
237847972$23784797$2$F$20240407$20240801$20240425$20240806$PER$$US-AMGEN-USASP2024072443$AMGEN$$62$YR$A$F$Y$$$20240805$$CN$US$US
237848303$23784830$3$F$20240101$20240905$20240425$20240909$EXP$$US-PFIZER INC-202300204448$PFIZER$$86$YR$$F$Y$$$20240909$$CN$US$US
237848464$23784846$4$F$20240201$20240903$20240425$20240917$EXP$$US-SA-2024SA121674$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240917$$MD$US$US
237848492$23784849$2$F$20240423$20240729$20240425$20240801$PER$$US-AMGEN-USASP2024083423$AMGEN$$70$YR$E$F$Y$$$20240801$$MD$US$US
237848663$23784866$3$F$20240101$20240828$20240425$20240906$PER$$US-SA-2024SA120303$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240906$$MD$US$US
2378486710$23784867$10$F$20240401$20240731$20240425$20240806$EXP$$AR-TAKEDA-2024TUS032268$TAKEDA$$7$YR$$M$Y$$$20240806$$CN$AR$AR
237848752$23784875$2$F$20231101$20240816$20240425$20240821$EXP$$US-TAKEDA-US202034298$TAKEDA$$61$YR$$F$Y$$$20240821$$MD$US$US
237848852$23784885$2$F$$20240809$20240425$20240812$PER$$US-PFIZER INC-PV202400053668$PFIZER$$76$YR$$F$Y$$$20240812$$CN$US$US
237848884$23784888$4$F$$20240903$20240425$20240909$EXP$$US-PFIZER INC-202400092827$PFIZER$$74$YR$$F$Y$$$20240909$$CN$US$US
237848935$23784893$5$F$$20240821$20240425$20240826$PER$$US-PFIZER INC-PV202400053886$PFIZER$$73$YR$$F$Y$$$20240826$$HP$US$US
237849425$23784942$5$F$20240419$20240811$20240425$20240926$EXP$$IL-ABBVIE-5729410$ABBVIE$$77$YR$$F$Y$$$20240926$$CN$IL$IL
237849514$23784951$4$F$$20240814$20240425$20240816$EXP$$US-PFIZER INC-202400085602$PFIZER$$73$YR$$F$Y$$$20240816$$CN$US$US
237849832$23784983$2$F$$20240730$20240425$20240807$PER$$US-SA-2024SA120191$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240807$$MD$US$US
237849842$23784984$2$F$$20240726$20240425$20240805$PER$$US-SA-2024SA120386$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240805$$MD$US$US
237850102$23785010$2$F$$20240725$20240425$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065276$BRISTOL MYERS SQUIBB$$5$DEC$A$M$Y$$$20240725$$MD$US$US
237850534$23785053$4$F$$20240918$20240425$20240923$EXP$$CA-TAKEDA-2024TUS038218$TAKEDA$$$$$M$Y$$$20240923$$MD$CA$CA
237850704$23785070$4$F$20240724$20240807$20240425$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065394$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240809$$CN$US$US
237850783$23785078$3$F$20240201$20240711$20240425$20240716$PER$$US-PURDUE PHARMA-USA-2024-0309189$PURDUE$$71$YR$$F$Y$63.05$KG$20240716$$CN$US$US
237850835$23785083$5$F$20220501$20240701$20240425$20240710$EXP$$US-NOVOPROD-1076740$NOVO NORDISK$$63$YR$$M$Y$$$20240710$$CN$US$US
237851032$23785103$2$F$20240118$20240823$20240425$20240828$EXP$$US-ABBVIE-5733184$ABBVIE$$70$YR$$F$Y$$$20240828$$CN$US$US
237851062$23785106$2$F$$20240701$20240425$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064898$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240702$$CN$US$US
237851172$23785117$2$F$20240131$20240913$20240425$20240920$EXP$$JP-EMD Serono-2024020820$EMD SERONO INC$$88$YR$E$M$Y$60$KG$20240920$$PH$JP$JP
237851412$23785141$2$F$$20240912$20240425$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA042649$SANDOZ$$49$YR$$M$Y$$$20240913$$HP$CA$CA
237851812$23785181$2$F$20240401$20240716$20240425$20240724$PER$$US-SA-2024SA122817$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240724$$MD$US$US
237851837$23785183$7$F$20240412$20240829$20240425$20240904$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000814$BLUEPRINT MEDICINES$$83$YR$E$F$Y$$$20240905$$CN$US$US
237852162$23785216$2$F$$20240627$20240425$20240701$EXP$$JP-AstraZeneca-2024A069459$ASTRAZENECA$$71$YR$$M$Y$$$20240701$$MD$JP$
237852212$23785221$2$F$$20240725$20240425$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065254$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240725$$CN$US$US
237852422$23785242$2$F$$20240729$20240425$20240807$PER$$US-SA-2024SA118397$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240807$$MD$US$US
237852702$23785270$2$F$$20240703$20240425$20240708$EXP$$GB-SANDOZ INC.-SDZ2024GB042788$SANDOZ$$$$$M$Y$$$20240708$$CN$GB$GB
237852712$23785271$2$F$20220707$20240801$20240425$20240808$PER$$JP-Eisai-EC-2024-156752$EISAI$$73$YR$E$F$Y$$$20240808$$MD$JP$JP
237853042$23785304$2$F$$20240725$20240425$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064520$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$HP$US$US
237853102$23785310$2$F$$20240627$20240425$20240705$EXP$$CA-TEVA-VS-3189271$TEVA$$44$YR$$F$Y$97$KG$20240705$$HP$CA$CA
237853142$23785314$2$F$20190901$20240416$20240425$20240822$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003707$AKCEA THERAPEUTICS$$$$$$Y$$$20240822$$PH$US$US
237853152$23785315$2$F$$20240628$20240425$20240708$30DAY$$GB-MYLANLABS-2024M1036189$MYLAN$$$$$$Y$$$20240708$$PH$GB$GB
237853272$23785327$2$F$20240419$20240711$20240425$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064615$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240719$$HP$US$US
237853812$23785381$2$F$20240101$20240712$20240425$20240722$PER$$US-SA-2024SA124863$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240722$$MD$US$US
237854143$23785414$3$F$20230113$20240902$20240425$20240911$PER$$JP-Eisai-EC-2024-164101$EISAI$$48$YR$A$F$Y$66$KG$20240911$$HP$JP$JP
237854152$23785415$2$F$20240210$20240701$20240425$20240702$PER$$GB-Eisai-EC-2024-164130$EISAI$$$$$M$Y$$$20240702$$MD$GB$GB
237854242$23785424$2$F$$20240802$20240425$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065328$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240805$$CN$US$US
237854292$23785429$2$F$20240410$20240725$20240425$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065550$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240725$$CN$US$US
237854632$23785463$2$F$$20240822$20240425$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065311$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240824$$CN$US$US
237854652$23785465$2$F$$20240709$20240425$20240710$PER$$US-ALXN-202404USA001502US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
237854862$23785486$2$F$20240423$20240427$20240425$20240829$EXP$$US-BIOMARINAP-US-2024-157447$BIOMARIN$$$$$$Y$$$20240829$$CN$US$US
237854925$23785492$5$F$20240110$20240920$20240425$20240926$EXP$$CN-VER-202400006$VERITY PHARMACEUTICALS$$71$YR$E$M$Y$64$KG$20240926$$HP$CN$CN
237855052$23785505$2$F$20230101$20240911$20240425$20240923$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202404014730$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240923$$CN$DE$BR
237855172$23785517$2$F$20240101$20240619$20240425$20240712$PER$$US-BEH-2024171247$CSL BEHRING$$$$A$F$Y$$$20240712$$HP$US$US
237855314$23785531$4$F$20240101$20240809$20240425$20240821$EXP$$US-BIOMARINAP-US-2024-157423$BIOMARIN$$$$$$Y$$$20240821$$HP$US$US
237855382$23785538$2$F$$20240709$20240425$20240710$PER$$US-ALXN-202404USA001514US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
237855535$23785553$5$F$20240401$20240827$20240425$20240829$EXP$$JP-SA-2024SA119432$SANOFI AVENTIS$$64$YR$A$M$Y$44$KG$20240830$$MD$JP$JP
237855542$23785554$2$F$20240101$20240711$20240425$20240718$EXP$$US-ABBVIE-5732763$ABBVIE$$$$$F$Y$$$20240718$$MD$US$US
237855566$23785556$6$F$$20240909$20240425$20240911$EXP$$CA-SANDOZ INC.-NVSC2022CA236686$SANDOZ$$65$YR$$F$Y$34$KG$20240911$$CN$CA$CA
237855602$23785560$2$F$$20240424$20240425$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202404016568$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240710$$CN$US$US
237855694$23785569$4$F$20240512$20240710$20240425$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060520$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240715$$CN$US$US
237855824$23785582$4$F$$20240712$20240425$20240722$EXP$$US-ZENPEP LLC-2024AIMT00676$AIMMUNE$$$$$$Y$$$20240722$$HP$US$US
237855913$23785591$3$F$20240322$20240801$20240425$20240805$EXP$$JP-TAKEDA-2024TJP005936$TAKEDA$$6$DEC$$F$Y$$$20240805$$PH$JP$JP
237855983$23785598$3$F$$20240722$20240425$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-062414$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240723$$PH$JP$JP
237856142$23785614$2$F$$20240722$20240425$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061075$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$PH$US$US
237856202$23785620$2$F$20240722$20240722$20240425$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062842$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240724$$CN$US$US
237856342$23785634$2$F$20240403$20240808$20240425$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063207$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240813$$CN$US$US
237856455$23785645$5$F$$20240812$20240425$20240819$EXP$$CA-CELLTRION INC.-2024CA009320$CELLTRION$$$$$$Y$$$20240819$$PH$CA$CA
237856512$23785651$2$F$$20240926$20240425$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062344$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240926$$HP$US$US
237856532$23785653$2$F$20231216$20240917$20240425$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-063028$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$46$KG$20240924$$PH$JP$JP
237856544$23785654$4$F$$20240911$20240425$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061969$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240913$$CN$US$US
237856645$23785664$5$F$$20240816$20240425$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063013$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240819$$CN$US$US
237856743$23785674$3$F$$20240813$20240425$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061254$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$91.17$KG$20240821$$CN$US$US
237856852$23785685$2$F$$20240719$20240425$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062502$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240723$$CN$US$US
237856872$23785687$2$F$$20240722$20240425$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062895$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240723$$CN$US$US
237856993$23785699$3$F$20240101$20240723$20240425$20240731$EXP$$US-ABBVIE-5733102$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
237857182$23785718$2$F$20230401$20240723$20240425$20240726$EXP$FR-AFSSAPS-AN2024000539$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-062686$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240726$$PH$FR$FR
237857282$23785728$2$F$20220927$20240821$20240425$20240826$EXP$$MX-TAKEDA-2022TUS069703$TAKEDA$$2$YR$$M$Y$$$20240826$$CN$MX$MX
237857399$23785739$9$F$$20240718$20240425$20240723$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-039478$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240723$$HP$FR$FR
237857412$23785741$2$F$$20240719$20240425$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063212$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240719$$CN$US$US
237857564$23785756$4$F$20240411$20240814$20240425$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063030$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$111.13$KG$20240816$$CN$US$US
237857583$23785758$3$F$20240730$20240731$20240425$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061877$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$94.8$KG$20240801$$CN$US$US
237857842$23785784$2$F$$20240717$20240425$20240729$EXP$$US-MALLINCKRODT-MNK202402611$MALLINCKRODT$$54$YR$A$F$Y$$$20240729$$HP$US$US
237857972$23785797$2$F$$20240725$20240425$20240725$EXP$$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-062904$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$HP$SE$SE
237858083$23785808$3$F$20230101$20240704$20240425$20240712$EXP$$CA-CELLTRION INC.-2022CA019806$CELLTRION$$$$$$Y$$$20240712$$MD$CA$CA
237858164$23785816$4$F$$20240819$20240425$20240821$EXP$$NVSC2024US088312$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
237858364$23785836$4$F$$20240830$20240425$20240909$30DAY$$IL-JNJFOC-20240412392$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240909$$CN$IL$IL
237858472$23785847$2$F$20240401$20240815$20240425$20240828$PER$$US-SA-2024SA125171$SANOFI AVENTIS$$76$YR$E$M$Y$124$KG$20240828$$MD$US$US
237858564$23785856$4$F$20231201$20240906$20240425$20240916$EXP$$CA-CELLTRION INC.-2023CA024181$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
237858676$23785867$6$F$20240416$20240912$20240425$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-060743$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240919$$MD$JP$JP
237859433$23785943$3$F$$20240722$20240426$20240729$EXP$$JP-AMGEN-JPNSP2024082569$AMGEN$Okazaki, S.. Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis.. Modern rheumatology case reports. 2024;8(2):296-301$48$YR$A$F$Y$58$KG$20240729$$HP$JP$JP
237859456$23785945$6$F$20240101$20240625$20240426$20240702$PER$$US-UNITED THERAPEUTICS-UNT-2024-011112$UNITED THERAPEUTICS$$$$$F$Y$75.737$KG$20240702$$$US$US
237859562$23785956$2$F$$20240719$20240426$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063569$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240719$$HP$US$US
237859965$23785996$5$F$20240101$20240716$20240426$20240722$EXP$$US-ABBVIE-5732923$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
237860032$23786003$2$F$20240101$20240815$20240426$20240828$PER$$US-SA-2024SA059937$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240828$$MD$US$US
237860122$23786012$2$F$20240401$20240806$20240426$20240814$PER$$US-SA-2024SA122432$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240814$$MD$US$US
237860157$23786015$7$F$$20240906$20240426$20240910$EXP$GR-SEATTLE GENETICS-2024SGN04265$GR-ROCHE-3551313$ROCHE$$$$$F$Y$$$20240910$$MD$GR$GR
237860186$23786018$6$F$$20240923$20240426$20240926$EXP$$US-TAKEDA-2024TUS004727$TAKEDA$$$$$F$Y$70.3$KG$20240926$$CN$US$US
237860213$23786021$3$F$20240401$20240724$20240426$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065080$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240724$$CN$US$US
237860274$23786027$4$F$20240408$20240716$20240426$20240720$EXP$$US-TAKEDA-2024TUS038715$TAKEDA$$56$YR$$M$Y$71$KG$20240720$$HP$US$US
237860542$23786054$2$F$20240801$20240828$20240426$20240918$PER$$US-SA-2024SA122701$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240918$$MD$US$US
237860733$23786073$3$F$20240208$20240725$20240426$20240802$EXP$$JP-GENMAB-2024-00488AA$GENMAB$$66$YR$$M$Y$63.5$KG$20240802$$MD$JP$JP
237860802$23786080$2$F$$20240724$20240426$20240725$EXP$$DK-BRISTOL-MYERS SQUIBB COMPANY-2024-064553$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240725$$CN$DK$DK
237860903$23786090$3$F$20231101$20240807$20240426$20240812$EXP$$DE-EMD Serono-2024021434$EMD SERONO INC$$33$YR$A$F$Y$$$20240812$$MD$DE$DE
237860923$23786092$3$F$20240501$20240730$20240426$20240802$EXP$$US-ABBVIE-5725162$ABBVIE$$63$YR$$F$Y$$$20240802$$CN$US$US
237860974$23786097$4$F$20240401$20240730$20240426$20240805$EXP$$JP-GSK-JP2024JPN051429$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$MD$JP$JP
237861143$23786114$3$F$$20240617$20240426$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001612$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
237861393$23786139$3$F$20240215$20240724$20240426$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-065101$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240724$$MD$JP$JP
237861429$23786142$9$F$20240424$20240826$20240426$20240828$EXP$$CA-ROCHE-2366131$ROCHE$$50$YR$A$F$Y$$$20240828$$CN$CA$CA
237861573$23786157$3$F$20240101$20240730$20240426$20240809$EXP$$US-INSMED, INC.-2024-01580-US$INSMED$$$$$F$Y$$$20240809$$CN$US$US
237861592$23786159$2$F$$20240628$20240426$20240703$EXP$$JP-GSK-JP2024053422$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$PH$JP$JP
237861632$23786163$2$F$$20240712$20240426$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065529$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$75.75$KG$20240716$$CN$US$US
237861643$23786164$3$F$20231101$20240808$20240426$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062004$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240819$$HP$US$US
237861672$23786167$2$F$$20240911$20240426$20240920$EXP$$US-INTERCEPT-PM2024000815$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
237861793$23786179$3$F$20240330$20240619$20240426$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001660$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240712$$CN$US$US
237861973$23786197$3$F$20240101$20240826$20240426$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-009129$UNITED THERAPEUTICS$$$$$M$Y$$$20240829$$$US$US
237862022$23786202$2$F$20240301$20240909$20240426$20240912$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006605$JAZZ$$48$YR$$F$Y$$$20240912$$CN$US$US
237862423$23786242$3$F$$20240614$20240426$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001647$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240709$$CN$US$US
237862612$23786261$2$F$$20240730$20240426$20240731$EXP$$US-JNJFOC-20240449327$JOHNSON AND JOHNSON$$2$WK$N$F$Y$$$20240731$$MD$US$US
237862703$23786270$3$F$20240101$20240920$20240426$20240930$EXP$$CA-CELLTRION INC.-2024CA005209$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
237862794$23786279$4$F$20240215$20240730$20240426$20240808$EXP$$US-UNITED THERAPEUTICS-UNT-2024-005109$UNITED THERAPEUTICS$$45$YR$$F$Y$154.2$KG$20240808$$$US$US
237862812$23786281$2$F$$20240711$20240426$20240725$EXP$$DE-AMGEN-DEUSP2024079768$AMGEN$Zimmermann J, Jabs W, Schoenermarck U, Bieringer M, Schneider U, Sonnemann J. Characterizing Treatment Response, Tolerability, and Rationale for Choosing Avacopan Therapy in Patients with ANCA-Associated Vasculitis: A Multicenter Observational Study in a Real-World Setting. 21st International Vasculitis Workshop (Barcelona). 2024 APR;.$$$$$Y$$$20240725$$MD$DE$DE
237862922$23786292$2$F$20240422$20240805$20240426$20240808$PER$$US-AMGEN-USASP2024082239$AMGEN$$66$YR$E$F$Y$$$20240808$$CN$US$US
237863092$23786309$2$F$$20240709$20240426$20240725$EXP$$PH-ROCHE-3552331$ROCHE$$$$$$Y$$$20240726$$MD$PH$PH
237863152$23786315$2$F$$20240722$20240426$20240725$EXP$$JP-GSK-JP2024051065$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$PH$JP$JP
237863432$23786343$2$F$$20240731$20240426$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-019528$AUROBINDO$$26$YR$$F$Y$58$KG$20240813$$HP$CA$CA
237863443$23786344$3$F$20240423$20240805$20240426$20240808$PER$$US-AMGEN-USASP2024082104$AMGEN$$69$YR$E$F$Y$$$20240808$$CN$US$US
237863452$23786345$2$F$20240423$20240905$20240426$20240909$PER$$US-AMGEN-USASP2024082344$AMGEN$$73$YR$E$M$Y$$$20240909$$CN$US$US
237863802$23786380$2$F$$20240822$20240426$20240828$EXP$$JP-EMD Serono-2024021427$EMD SERONO INC$$52$YR$A$F$Y$37$KG$20240828$$MD$JP$JP
237863916$23786391$6$F$20220101$20240914$20240426$20240916$EXP$$CA-PFIZER INC-202400092479$PFIZER$$70$YR$$M$Y$$$20240916$$HP$CA$CA
237864142$23786414$2$F$$20240711$20240426$20240726$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004567$SAREPTA THERAPEUTICS$$6$YR$$M$Y$$$20240726$$CN$US$US
237864412$23786441$2$F$$20240806$20240426$20240808$EXP$$US-SANDOZ INC.-SDZ2024US042412$SANDOZ$$$$$F$Y$$$20240808$$CN$US$US
237864982$23786498$2$F$20240101$20240916$20240426$20240919$EXP$$GB-SANDOZ INC.-SDZ2024GB028620$SANDOZ$$79$YR$$F$Y$$$20240919$$CN$GB$GB
237865202$23786520$2$F$20240101$20240827$20240426$20240919$EXP$$GB-UCBSA-2024019352$UCB$$$$$M$Y$$$20240919$$CN$GB$GB
237865225$23786522$5$F$$20240826$20240426$20240903$EXP$$US-TAKEDA-2024TUS039373$TAKEDA$$$$$M$Y$$$20240903$$MD$US$US
237865322$23786532$2$F$20240420$20240812$20240426$20240813$PER$$US-AMGEN-USASP2024081142$AMGEN$$78$YR$E$F$Y$$$20240813$$CN$US$US
237865382$23786538$2$F$$20240806$20240426$20240812$EXP$$CA-TAKEDA-2023TUS105631$TAKEDA$$$$$M$Y$$$20240812$$CN$CA$CA
237865444$23786544$4$F$20240501$20240814$20240426$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065695$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$111.58$KG$20240822$$CN$US$US
237865454$23786545$4$F$$20240821$20240426$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065563$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$55.79$KG$20240826$$CN$US$US
237865582$23786558$2$F$$20240905$20240426$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03360$LUPIN$$$$$$Y$$$20240921$$CN$US$US
237865733$23786573$3$F$$20240910$20240426$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065766$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240911$$CN$US$US
237866083$23786608$3$F$20231101$20240723$20240426$20240726$EXP$$BR-SANDOZ INC.-SDZ2024BR039774$SANDOZ$$9$YR$$F$Y$$$20240726$$CN$BR$BR
237866132$23786613$2$F$20240101$20240816$20240426$20240822$EXP$$JP-009507513-2401JPN005136J$MERCK$$75$YR$$M$Y$$$20240822$$MD$JP$JP
237866363$23786636$3$F$20240301$20240724$20240426$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065664$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240725$$HP$US$US
237866412$23786641$2$F$$20240919$20240426$20240927$EXP$$JP-ROCHE-3546899$ROCHE$Harada N, Shibano I, Izuta Y, Kizawa Y, Shiragami H, Tsumura A, Ohji G and Mugitani A Infectious mononucleosis due to Epstein-Barr virus reactivation in an immunocompromised 60-year-old patient with COVID-19. Doi: 10.1016/j.jiac.2024.03.023. Journal of Infection and Chemotherapy 2024;30 (11); 1182-1185$60$YR$A$M$Y$$$20240927$$HP$JP$JP
237866533$23786653$3$F$$20240819$20240426$20240829$30DAY$$US-GSK-US2024AMR051090$GLAXOSMITHKLINE$$$$$M$Y$$$20240829$$CN$US$US
237866632$23786663$2$F$$20240820$20240426$20240822$EXP$$CA-TAKEDA-2020TUS028455$TAKEDA$$$$$M$Y$96.4$KG$20240822$$HP$CA$CA
237866773$23786677$3$F$$20240723$20240426$20240728$PER$$US-ALXN-202404USA001658US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240728$$CN$US$US
237866852$23786685$2$F$$20240726$20240426$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064944$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240729$$CN$US$US
237866983$23786698$3$F$$20240702$20240426$20240706$EXP$$SK-ROCHE-3550943$ROCHE$$49$YR$A$F$Y$$$20240706$$MD$SK$SK
237867052$23786705$2$F$20230508$20240729$20240426$20240808$EXP$$DE-AUROBINDO-AUR-APL-2024-018465$AUROBINDO$$34$YR$$F$Y$$$20240808$$CN$DE$DE
237867253$23786725$3$F$$20240707$20240426$20240715$EXP$$AU-CELLTRION INC.-2024AU009519$CELLTRION$$$$$$Y$$$20240716$$MD$AU$AU
237867662$23786766$2$F$$20240920$20240426$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058229$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240924$$CN$US$US
237867742$23786774$2$F$20240101$20240820$20240426$20240827$EXP$$IT-ABBVIE-5733172$ABBVIE$$67$YR$$M$Y$$$20240827$$CN$IT$IT
237868154$23786815$4$F$20240313$20240701$20240426$20240705$EXP$$PH-ALCON LABORATORIES-ALC2024PH002123$ALCON$$75$YR$$M$Y$$$20240705$$MD$PH$PH
237868223$23786822$3$F$$20240826$20240426$20240830$EXP$$CA-TAKEDA-2023TUS110610$TAKEDA$$$$$F$Y$$$20240830$$CN$CA$CA
237868252$23786825$2$F$20240423$20240827$20240426$20240828$PER$$US-AMGEN-USASP2024082635$AMGEN$$70$YR$E$M$Y$$$20240828$$CN$US$US
237868482$23786848$2$F$$20240626$20240426$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03308$LUPIN$$$$$$Y$$$20240712$$CN$US$US
2378686913$23786869$13$F$20240101$20240726$20240426$20240805$EXP$$CA-CELLTRION INC.-2024CA009687$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
237868852$23786885$2$F$$20240701$20240426$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03326$LUPIN$$$$$$Y$$$20240718$$CN$US$US
237868896$23786889$6$F$20240423$20240708$20240426$20240712$EXP$$US-ABBVIE-5697421$ABBVIE$$66$YR$$F$Y$$$20240712$$CN$US$US
237869592$23786959$2$F$20240401$20240814$20240426$20240909$30DAY$$US-BECTON DICKINSON-US-BD-24-000219$BECTON DICKINSON$$$$$$Y$$$20240909$$CN$US$US
237869732$23786973$2$F$$20240702$20240426$20240703$EXP$$US-JNJFOC-20240449239$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240703$$MD$US$US
237869894$23786989$4$F$$20240823$20240426$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064699$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$77.11$KG$20240902$$CN$US$US
237870003$23787000$3$F$20240301$20240813$20240426$20240824$PER$$US-AMGEN-USASP2024081807$AMGEN$$76$YR$E$F$Y$$$20240824$$CN$US$US
237870036$23787003$6$F$20240404$20240821$20240426$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010617$UNITED THERAPEUTICS$$64$YR$$M$Y$98.866$KG$20240829$$$US$US
237870212$23787021$2$F$20240408$20240702$20240426$20240705$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-024328$BOEHRINGER INGELHEIM$$50$YR$A$M$Y$$$20240705$$MD$JP$JP
237870315$23787031$5$F$20240401$20240718$20240426$20240926$PER$$US-GSK-US2024AMR050942$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240926$$HP$US$US
237870334$23787033$4$F$20240401$20240905$20240426$20240909$EXP$$US-GSK-US2024AMR047620$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$CN$US$US
237870552$23787055$2$F$$20240916$20240426$20240918$EXP$$CA-SANDOZ INC.-SDZ2024CA042646$SANDOZ$$66$YR$$M$Y$$$20240918$$HP$CA$CA
237870753$23787075$3$F$20240423$20240801$20240426$20240803$PER$$US-AMGEN-USASP2024083200$AMGEN$$73$YR$E$F$Y$$$20240803$$CN$US$US
237870882$23787088$2$F$$20240624$20240426$20240703$EXP$$CA-BAXTER-2024BAX017286$BAXTER$$$$$$Y$$$20240703$$MD$CA$CA
237871132$23787113$2$F$$20240905$20240426$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065805$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240906$$HP$US$US
237871163$23787116$3$F$$20240805$20240426$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064328$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240805$$CN$US$US
237871247$23787124$7$F$$20240627$20240426$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433831$RANBAXY$$$$A$M$Y$85.261$KG$20240712$$MD$US$US
237871382$23787138$2$F$20240108$20240712$20240426$20240726$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-444297$RANBAXY$$84$YR$$M$Y$74$KG$20240726$$HP$DE$DE
237871623$23787162$3$F$20240419$20240917$20240426$20240920$EXP$$US-ABBVIE-5734432$ABBVIE$$26$YR$$F$Y$$$20240920$$CN$US$US
237872102$23787210$2$F$$20240827$20240426$20240906$30DAY$$US-GSK-US2024049935$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
237872113$23787211$3$F$20240419$20240625$20240426$20240701$30DAY$$US-GSK-US2024049994$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240701$$CN$US$US
237872122$23787212$2$F$$20240701$20240426$20240710$EXP$$US-GSK-US2024AMR053554$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$HP$US$US
237872193$23787219$3$F$20240301$20240627$20240426$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064649$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240701$$HP$US$US
237872236$23787223$6$F$20240416$20240809$20240426$20240819$30DAY$$US-JNJFOC-20240408168$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240819$$CN$US$US
237872272$23787227$2$F$$20240625$20240426$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-443248$RANBAXY$Odenigbo N, Nkemjika S, Atolagbe A, Nwabueze C, Olwit C, Lawrence J, et al. Donepezil induced bradycardia in a schizophrenic patient with comorbid neurocognitive. J Med Case Rep. 2024;18 (1):129$70$YR$$F$Y$$$20240710$$HP$US$US
237872415$23787241$5$F$20240427$20240822$20240426$20240825$EXP$$GR-ABBVIE-5734491$ABBVIE$$73$YR$$M$Y$$$20240825$$CN$GR$GR
237872663$23787266$3$F$20220823$20240813$20240426$20240819$EXP$$FR-AstraZeneca-2024A095519$ASTRAZENECA$$67$YR$$F$Y$61.4$KG$20240819$$MD$FR$
237873312$23787331$2$F$$20240730$20240426$20240809$EXP$FR-AFSSAPS-AVNT2024000208$FR-TEVA-VS-3187074$TEVA$$23$YR$$M$Y$$$20240809$$PH$FR$FR
237873382$23787338$2$F$20231018$20240711$20240426$20240722$EXP$FR-AFSSAPS-LM2024000179$FR-Accord-420227$ACCORD$$84$YR$E$F$Y$48.5$KG$20240722$$MD$FR$FR
237873595$23787359$5$F$20220529$20240909$20240426$20240913$EXP$$US-GSK-US2024AMR051092$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$US$US
237874113$23787411$3$F$20230408$20240723$20240426$20240726$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-022661$BOEHRINGER INGELHEIM$Kuge Y, Kato R, Oishi D, Maejima R, Tanabe S, Hirayama Y. SGLT2 inhibitor-associated euglycemic diabetic ketoacidosis in ICU admitted patients. The 51st Annual Meeting of the Japanese Society of Intensive Care Medicine. 2024 Mar;340.$71$YR$E$M$Y$49.4$KG$20240726$$MD$JP$JP
237874302$23787430$2$F$$20240724$20240426$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064442$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240724$$CN$US$US
237874505$23787450$5$F$20240101$20240905$20240426$20240909$30DAY$$US-PFIZER INC-202400088076$PFIZER$$21$YR$$M$Y$63.5$KG$20240909$$HP$US$US
237874513$23787451$3$F$$20240906$20240426$20240910$30DAY$$US-PFIZER INC-202400088058$PFIZER$$14$YR$$F$Y$$$20240910$$CN$US$US
237874524$23787452$4$F$$20240905$20240426$20240909$30DAY$$US-PFIZER INC-202400088162$PFIZER$$71$YR$$M$Y$$$20240909$$CN$US$US
237874554$23787455$4$F$20240313$20240701$20240426$20240705$EXP$$PH-ALCON LABORATORIES-ALC2024PH002120$ALCON$$63$YR$$M$Y$$$20240705$$MD$PH$PH
237874587$23787458$7$F$20240416$20240909$20240426$20240911$30DAY$$US-PFIZER INC-202400089519$PFIZER$$5$YR$$F$Y$$$20240911$$CN$US$US
237874595$23787459$5$F$$20240921$20240426$20240925$30DAY$$US-PFIZER INC-202400081961$PFIZER$$4$MON$$F$Y$5.466$KG$20240925$$CN$US$US
237874733$23787473$3$F$$20240826$20240426$20240828$EXP$$CA-TAKEDA-2024TUS038903$TAKEDA$$$$$F$Y$$$20240828$$MD$CA$CA
237874837$23787483$7$F$20240416$20240918$20240426$20240920$30DAY$$US-PFIZER INC-202400089598$PFIZER$$5$YR$$F$Y$$$20240920$$CN$US$US
237874845$23787484$5$F$$20240906$20240426$20240911$30DAY$$US-PFIZER INC-202400089533$PFIZER$$9$YR$$M$Y$23.59$KG$20240911$$CN$US$US
237874854$23787485$4$F$$20240910$20240426$20240912$30DAY$$US-PFIZER INC-202400089192$PFIZER$$8$YR$$F$Y$$$20240912$$CN$US$US
237874865$23787486$5$F$$20240913$20240426$20240917$EXP$$US-PFIZER INC-202400089213$PFIZER$$11$YR$$F$Y$$$20240917$$CN$US$US
237874873$23787487$3$F$$20240906$20240426$20240910$30DAY$$US-PFIZER INC-202400087285$PFIZER$$19$YR$$F$Y$$$20240910$$CN$US$US
237874884$23787488$4$F$$20240917$20240426$20240920$30DAY$$US-PFIZER INC-202400086524$PFIZER$$10$YR$$F$Y$23.5$KG$20240920$$CN$US$US
237874908$23787490$8$F$$20240918$20240426$20240923$30DAY$$US-PFIZER INC-202400088589$PFIZER$$15$YR$$M$Y$$$20240923$$HP$US$US
237875105$23787510$5$F$$20240809$20240426$20240813$30DAY$$US-PFIZER INC-PV202400042967$PFIZER$$$$$F$Y$$$20240813$$CN$US$US
237875124$23787512$4$F$$20240910$20240426$20240912$30DAY$$US-PFIZER INC-202400089553$PFIZER$$6$YR$$M$Y$$$20240912$$CN$US$US
237875154$23787515$4$F$$20240913$20240426$20240918$30DAY$$US-PFIZER INC-PV202400050181$PFIZER$$2$YR$$M$Y$$$20240918$$HP$US$US
237875178$23787517$8$F$20240208$20240906$20240426$20240911$30DAY$$US-PFIZER INC-202400090306$PFIZER$$75$YR$$M$Y$72.57$KG$20240911$$HP$US$US
237875194$23787519$4$F$$20240919$20240426$20240924$30DAY$$US-PFIZER INC-PV202400048601$PFIZER$$10$YR$$F$Y$$$20240924$$HP$US$US
2378752011$23787520$11$F$20240512$20240921$20240426$20240927$EXP$$US-PFIZER INC-202400088976$PFIZER$$7$YR$$M$Y$$$20240927$$CN$US$US
237875223$23787522$3$F$20240306$20240906$20240426$20240909$EXP$PT-INFARMED-J202404-352$PT-DSJP-DSE-2024-118481$DAIICHI$$47$YR$$F$Y$$$20240909$$MD$PT$PT
237875273$23787527$3$F$$20240708$20240426$20240716$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-012188$UNITED THERAPEUTICS$$58$YR$$F$Y$$$20240716$$PH$JP$JP
237875378$23787537$8$F$20240401$20240703$20240426$20240711$PER$$US-UNITED THERAPEUTICS-UNT-2024-011151$UNITED THERAPEUTICS$$43$YR$$M$Y$86.168$KG$20240711$$$US$US
237876012$23787601$2$F$$20240909$20240426$20240912$EXP$$JP-GSK-JP2024JPN051468$GLAXOSMITHKLINE$Seta D, Imahori M, Koga Y, Honda K, Boku S, Takebayashi M. 2 A case of bipolar disorder in which obsessive-compulsive symptoms were aggravated due to lamotrigine. 106th Kumamoto Society of Psychiatry and Neurology. 3$$$$$Y$$$20240912$$MD$JP$JP
237876033$23787603$3$F$$20240907$20240426$20240917$30DAY$$US-GSK-US2024AMR050808$GLAXOSMITHKLINE$$$$$F$Y$$$20240917$$CN$US$US
237876056$23787605$6$F$$20240723$20240426$20240730$EXP$$BE-VIIV HEALTHCARE LIMITED-BE2024EME052821$VIIV$$$$$$Y$$$20240730$$MD$BE$BE
237876063$23787606$3$F$20230928$20240806$20240426$20240813$EXP$$CA-GSK-CA2023134405$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$PH$CA$CA
237876502$23787650$2$F$20240101$20240827$20240426$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009782$UNITED THERAPEUTICS$$$$$M$Y$61.678$KG$20240906$$$US$US
237876652$23787665$2$F$20240416$20240808$20240426$20240812$30DAY$$US-GSK-US2024048916$GLAXOSMITHKLINE$$15$YR$$F$Y$$$20240812$$MD$US$US
237876763$23787676$3$F$$20240723$20240426$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064345$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240723$$CN$US$US
237876812$23787681$2$F$$20240709$20240426$20240723$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-03397$HIKMA$$55$YR$$M$Y$$$20240723$$CN$US$US
237876823$23787682$3$F$20230601$20240703$20240426$20240716$PER$$US-ALKERMES INC.-ALK-2024-001015$ALKERMES$$37$YR$$F$Y$$$20240716$$HP$US$US
237877072$23787707$2$F$$20240821$20240426$20240825$EXP$$CA-BAUSCH-BL-2024-006197$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240825$$HP$CA$CA
237877187$23787718$7$F$20200601$20240909$20240426$20240916$EXP$$CA-PFIZER INC-202400094737$PFIZER$$80$YR$$M$Y$69$KG$20240916$$MD$CA$CA
237877193$23787719$3$F$$20240716$20240426$20240723$EXP$$CA-JNJFOC-20240469131$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$HP$CA$CA
237877255$23787725$5$F$20240326$20240916$20240426$20240923$EXP$$US-GSK-US2024049993$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$US$US
237877266$23787726$6$F$$20240729$20240426$20240805$EXP$$BE-VIIV HEALTHCARE LIMITED-BE2024EME053077$VIIV$$$$$$Y$$$20240805$$MD$BE$BE
237877344$23787734$4$F$$20240924$20240426$20240926$30DAY$$US-PFIZER INC-202400087529$PFIZER$$11$YR$$F$Y$$$20240926$$CN$US$US
237877356$23787735$6$F$$20240913$20240426$20240918$30DAY$$US-PFIZER INC-202400086404$PFIZER$$10$YR$$F$Y$$$20240918$$CN$US$US
237877365$23787736$5$F$20240327$20240731$20240426$20240802$30DAY$$US-PFIZER INC-202400070963$PFIZER$$14$YR$$F$Y$44.444$KG$20240802$$CN$US$US
237877375$23787737$5$F$$20240904$20240426$20240909$30DAY$$US-PFIZER INC-202400086541$PFIZER$$13$YR$$F$Y$$$20240909$$HP$US$US
237877488$23787748$8$F$$20240906$20240426$20240910$30DAY$$US-PFIZER INC-202400087447$PFIZER$$15$YR$$M$Y$48.08$KG$20240910$$HP$US$US
237877522$23787752$2$F$20240411$20240627$20240426$20240703$EXP$$DE-SA-2024SA127117$SANOFI AVENTIS$$56$YR$A$M$Y$105$KG$20240703$$MD$DE$DE
237877622$23787762$2$F$$20240627$20240426$20240701$EXP$$BE-UCBSA-2024020081$UCB$$$$$M$Y$$$20240701$$CN$BE$BE
237877645$23787764$5$F$20240417$20240729$20240426$20240802$EXP$$US-PFIZER INC-202400091726$PFIZER$$65$YR$$F$Y$58.97$KG$20240802$$CN$US$US
237877654$23787765$4$F$$20240912$20240426$20240916$30DAY$$US-PFIZER INC-202400087318$PFIZER$$10$YR$$M$Y$$$20240916$$CN$US$US
237877872$23787787$2$F$20240717$20240722$20240426$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000842$BLUEPRINT MEDICINES$$42$YR$A$F$Y$$$20240731$$CN$US$US
237878404$23787840$4$F$$20240919$20240426$20240926$EXP$$CA-TAKEDA-2024TUS039432$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
237878467$23787846$7$F$20240509$20240918$20240426$20240927$EXP$$CA-TAKEDA-2024TUS023867$TAKEDA$$65$YR$$F$Y$$$20240927$$HP$CA$CA
237878512$23787851$2$F$$20240731$20240426$20240811$EXP$$CA-AUROBINDO-AUR-APL-2024-019519$AUROBINDO$$44$YR$$F$Y$112$KG$20240812$$HP$CA$CA
237879494$23787949$4$F$$20240827$20240426$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-061788$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240902$$MD$JP$JP
237879504$23787950$4$F$$20240912$20240426$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062930$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240913$$CN$US$US
237879593$23787959$3$F$$20240815$20240426$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-060847$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240822$$CN$US$US
237879662$23787966$2$F$$20240719$20240426$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062120$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240719$$CN$US$US
237879972$23787997$2$F$$20240711$20240426$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-059563$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$64.41$KG$20240716$$MD$US$US
237879993$23787999$3$F$$20240910$20240426$20240920$EXP$$DE-MSNLABS-2024MSNLIT00883$MSN LABORATORIES$Gallinger A, Osei-Davies R, Hennersdorf F.Reversibility of a critical intraventricular conduction delay under flecainide and lacosamide by sodium bicarbonate.Internal Medicine.2024$$$$$Y$$$20240920$$MD$DE$DE
237880072$23788007$2$F$$20240722$20240426$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062624$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240722$$CN$US$US
237880132$23788013$2$F$20240401$20240719$20240426$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-062455$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240719$$MD$JP$JP
237881133$23788113$3$F$20240417$20240628$20240426$20240702$EXP$$NVSC2024US087491$NOVARTIS$$0$YR$$F$Y$$$20240702$$CN$US$US
237881142$23788114$2$F$20231212$20240628$20240426$20240702$EXP$$NVSC2023US265178$NOVARTIS$$65$YR$$F$Y$$$20240702$$CN$US$US
237881182$23788118$2$F$20240314$20240625$20240426$20240701$EXP$FR-AFSSAPS-TS2024000411$FR-MYLANLABS-2024M1036773$MYLAN$$36$YR$$F$Y$62$KG$20240701$$MD$FR$FR
237881192$23788119$2$F$20220301$20240703$20240426$20240709$EXP$$DE-MYLANLABS-2024M1037330$MYLAN$$72$YR$$F$Y$$$20240709$$HP$DE$DE
237881212$23788121$2$F$$20240711$20240426$20240717$EXP$$FR-MYLANLABS-2024M1036862$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237881222$23788122$2$F$$20240711$20240426$20240717$EXP$$FR-MYLANLABS-2024M1036575$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237881302$23788130$2$F$20230101$20240820$20240426$20240828$EXP$$CA-JNJFOC-20231074627$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240828$$HP$CA$CA
237881412$23788141$2$F$$20240821$20240426$20240830$PER$$US-INCYTE CORPORATION-2024IN004186$INCYTE$$$$$$Y$$$20240830$$MD$US$US
237881502$23788150$2$F$$20240902$20240426$20240912$EXP$$DE-AUROBINDO-AUR-APL-2024-018993$AUROBINDO$Bugia L, Jungbauer F, Zaubitzer L, Horner C, Merx K, Yasser AM. et.al. Nivolumab as a Promising Treatment Option for Metastatic Salivary Duct Carcinoma. Journal of Immunotherapy. 2024;47 (7):2858-259$65$YR$$M$Y$$$20240912$$HP$DE$DE
237881573$23788157$3$F$20240412$20240730$20240426$20240807$EXP$$LV-SA-2024SA124611$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240807$$HP$LV$LV
237881593$23788159$3$F$20240306$20240812$20240426$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-018589$AUROBINDO$$72$YR$$M$Y$65$KG$20240822$$CN$GB$GB
237881783$23788178$3$F$20230101$20240731$20240426$20240808$EXP$$JP-AstraZeneca-2024A096297$ASTRAZENECA$Watanabe K, et al.. 57 A case of congestive cardiac failure in which hyperglycemic hyperosmolar syndrome developed while taking an SGLT2 inhibitor.. The 178th Tohoku Regional Meeting of the Japanese Circulation Society 2024;51.$74$YR$$M$Y$70$KG$20240808$$MD$JP$
237881832$23788183$2$F$20130905$20240719$20240426$20240726$EXP$$JP-AstraZeneca-2023A242011$ASTRAZENECA$$60$YR$$F$Y$42$KG$20240726$$MD$JP$
237881944$23788194$4$F$20240101$20240712$20240426$20240717$EXP$$CA-PFIZER INC-202300301122$PFIZER$$70$YR$$M$Y$$$20240717$$MD$CA$CA
237882103$23788210$3$F$20240730$20240802$20240426$20240808$EXP$$US-KYOWAKIRIN-2024KK010035$KYOWA$$$$$$Y$$$20240808$$CN$US$US
237882493$23788249$3$F$20210812$20240911$20240426$20240918$EXP$$JP-ROCHE-3224567$ROCHE$$51$YR$A$F$Y$46.9$KG$20240918$$MD$JP$JP
237882573$23788257$3$F$20220525$20240913$20240426$20240918$EXP$$IT-PFIZER INC-202400093415$PFIZER$$75$YR$$M$Y$74$KG$20240918$$MD$IT$IT
237882582$23788258$2$F$20240401$20240723$20240426$20240726$EXP$$US-PFIZER INC-202400094740$PFIZER$$76$YR$$F$Y$$$20240726$$HP$US$US
237882602$23788260$2$F$$20240821$20240426$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-064866$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240826$$PH$JP$JP
237882682$23788268$2$F$$20240807$20240426$20240811$EXP$$NVSC2024US088710$NOVARTIS$Alshawa L, Leahy B, Rueckert J, Maskey A, Keshavamurthy S, Anstead M, et al. Hemophagocytic Lymphohistiocytosis: A Rare Diagnosis in the Immediate Aftermath of Lung Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2024;43(4):S484-S5$63$YR$$M$Y$$$20240811$$HP$US$US
237883053$23788305$3$F$20060802$20240701$20240426$20240703$EXP$$GB-MYLANLABS-2024M1037300$MYLAN$$$$$F$Y$75.9$KG$20240703$$MD$GB$GB
237883174$23788317$4$F$20240301$20240731$20240426$20240806$EXP$$US-UCBSA-2024019775$UCB$$56$YR$$F$Y$$$20240806$$CN$US$US
237883362$23788336$2$F$20240424$20240723$20240426$20240725$PER$$US-AMGEN-USASP2024083206$AMGEN$$70$YR$E$$Y$$$20240725$$CN$US$US
237883672$23788367$2$F$20240303$20240716$20240426$20240726$EXP$$CN-PFIZER INC-PV202400054204$PFIZER$$67$YR$$M$Y$72$KG$20240726$$HP$CN$CN
237883812$23788381$2$F$$20240826$20240426$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065659$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240827$$CN$US$US
237883995$23788399$5$F$20220701$20240802$20240426$20240808$EXP$$US-ASTELLAS-2024US012096$ASTELLAS$$66$YR$$M$Y$$$20240808$$CN$US$US
237884013$23788401$3$F$$20240625$20240426$20240702$EXP$$US-TAKEDA-2024TUS038895$TAKEDA$$$$$M$Y$78$KG$20240702$$HP$US$US
237884162$23788416$2$F$$20240711$20240426$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-051249$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$HP$CA$CA
237884218$23788421$8$F$$20240718$20240426$20240725$EXP$$FR-EXELIXIS-CABO-24075025$EXELIXIS$$77$YR$$M$Y$$$20240725$$HP$FR$FR
237884274$23788427$4$F$$20240701$20240426$20240708$30DAY$$BR-JNJFOC-20240468372$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$BR$BR
237884502$23788450$2$F$20240216$20240705$20240426$20240709$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-064794$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240709$$HP$FR$FR
237884512$23788451$2$F$20240405$20240626$20240426$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011148$UNITED THERAPEUTICS$$66$YR$$F$Y$89.342$KG$20240703$$$US$US
237884532$23788453$2$F$20240101$20240808$20240426$20240812$PER$$US-JNJFOC-20240442221$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240812$$CN$US$US
237884562$23788456$2$F$20220820$20240703$20240426$20240709$EXP$$CA-OTSUKA-2021_028273$OTSUKA$$76$YR$$F$Y$$$20240709$$MD$CA$CA
237884692$23788469$2$F$20240624$20240724$20240426$20240729$EXP$$CA-ABBVIE-5734001$ABBVIE$$$$A$F$Y$$$20240729$$CN$CA$CA
237884834$23788483$4$F$20240401$20240822$20240426$20240828$PER$$US-AMGEN-USASP2024084098$AMGEN$$66$YR$E$M$Y$$$20240828$$PH$US$US
237885244$23788524$4$F$20240301$20240820$20240426$20240916$EXP$$NL-ABBVIE-5734477$ABBVIE$$$$A$F$Y$$$20240916$$CN$NL$NL
237885342$23788534$2$F$$20240725$20240426$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066063$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240725$$CN$US$US
237885436$23788543$6$F$20240101$20240624$20240426$20240701$PER$$US-SA-2024SA126252$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240701$$MD$US$US
237885492$23788549$2$F$$20240703$20240426$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03328$LUPIN$$$$$$Y$$$20240728$$CN$US$US
237885794$23788579$4$F$$20240621$20240426$20240701$PER$$JP-PFIZER INC-202400079465$PFIZER$$11$YR$$F$Y$$$20240701$$PH$JP$JP
237885884$23788588$4$F$$20240724$20240426$20240730$EXP$$BR-PFIZER INC-202400079623$PFIZER$$$$$M$Y$$$20240730$$CN$BR$BR
237885902$23788590$2$F$$20240711$20240426$20240716$EXP$$FR-MYLANLABS-2024M1036587$MYLAN$$$$$F$Y$$$20240716$$CN$FR$FR
237886012$23788601$2$F$$20240908$20240426$20240909$EXP$$IT-BAUSCH-BL-2024-006650$BAUSCH AND LOMB$$69$YR$$M$Y$77.174$KG$20240909$$MD$IT$IT
237886073$23788607$3$F$20240404$20240906$20240426$20240912$30DAY$$DO-PFIZER INC-202400079905$PFIZER$$12$YR$$M$Y$$$20240912$$CN$DO$DO
237886087$23788608$7$F$$20240914$20240426$20240918$30DAY$$DO-PFIZER INC-PV202400045933$PFIZER$$15$YR$$M$Y$$$20240918$$CN$DO$DO
237886093$23788609$3$F$$20240726$20240426$20240731$30DAY$$GB-PFIZER INC-PV202400045238$PFIZER$$14$YR$$M$Y$$$20240731$$CN$GB$GB
237886102$23788610$2$F$20240327$20240704$20240426$20240710$30DAY$$KR-PFIZER INC-PV202400046058$PFIZER$$7$YR$$M$Y$$$20240710$$HP$KR$KR
237886236$23788623$6$F$$20240629$20240426$20240701$EXP$$US-PFIZER INC-PV202400054038$PFIZER$$56$YR$$F$Y$52.154$KG$20240701$$CN$US$US
237886323$23788632$3$F$20231019$20240829$20240426$20240906$EXP$$US-ABBVIE-5733460$ABBVIE$$65$YR$$F$Y$102.51$KG$20240906$$CN$US$US
237886502$23788650$2$F$$20240809$20240426$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065440$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240813$$HP$US$US
237886992$23788699$2$F$$20240821$20240426$20240830$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2024FOS000493$RIGEL PHARMACEUTICALS$$81$YR$$M$Y$$$20240830$$MD$JP$JP
237887374$23788737$4$F$20210722$20240911$20240426$20240915$EXP$$CA-PFIZER INC-202201087917$PFIZER$$65$YR$$M$Y$122$KG$20240915$$MD$CA$CA
237887432$23788743$2$F$$20240711$20240426$20240717$EXP$$FR-MYLANLABS-2024M1036638$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237887612$23788761$2$F$$20240711$20240426$20240717$EXP$$FR-MYLANLABS-2024M1036578$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237887712$23788771$2$F$$20240806$20240426$20240821$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-03319$LUPIN$$$$$$Y$$$20240821$$CN$AU$AU
237887752$23788775$2$F$20240412$20240627$20240426$20240701$EXP$$US-PFIZER INC-PV202400055336$PFIZER$$68$YR$$F$Y$$$20240701$$HP$US$US
237888042$23788804$2$F$$20240620$20240426$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202404009798$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240702$$MD$US$US
237888203$23788820$3$F$20240101$20240711$20240426$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202404011389$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240724$$CN$US$US
237888312$23788831$2$F$20240414$20240906$20240426$20240911$EXP$$US-BAYER-2024A062863$BAYER$$27$YR$A$M$Y$$$20240911$$CN$US$US
237888416$23788841$6$F$20240401$20240906$20240426$20240910$30DAY$$US-PFIZER INC-202400090969$PFIZER$$12$YR$$F$Y$$$20240910$$CN$US$US
237888614$23788861$4$F$20240418$20240910$20240426$20240912$30DAY$$US-PFIZER INC-202400091277$PFIZER$$75$YR$$M$Y$120.2$KG$20240912$$CN$US$US
237888627$23788862$7$F$20240315$20240916$20240426$20240919$30DAY$$US-PFIZER INC-202400092487$PFIZER$$9$MON$$M$Y$9.23$KG$20240919$$HP$US$US
237888644$23788864$4$F$$20240905$20240426$20240910$30DAY$$US-PFIZER INC-202400091232$PFIZER$$12$YR$$M$Y$$$20240910$$CN$US$US
237888712$23788871$2$F$$20240813$20240426$20240817$EXP$$CA-SANDOZ INC.-SDZ2024CA043022$SANDOZ$$28$YR$$F$Y$$$20240817$$HP$CA$CA
237888873$23788887$3$F$20220103$20240820$20240426$20240826$EXP$$BE-JNJFOC-20220925412$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$43$KG$20240827$$MD$BE$BE
237889062$23788906$2$F$$20240711$20240426$20240717$EXP$$FR-MYLANLABS-2024M1036720$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237889306$23788930$6$F$20240419$20240915$20240426$20240920$30DAY$$US-PFIZER INC-202400093054$PFIZER$$17$YR$$M$Y$$$20240920$$CN$US$US
237889472$23788947$2$F$20240423$20240819$20240426$20240822$PER$$US-AMGEN-USASP2024083353$AMGEN$$80$YR$E$F$Y$$$20240822$$CN$US$US
237889553$23788955$3$F$20230111$20240905$20240426$20240910$EXP$$JP-009507513-2404JPN002983J$MERCK$Kato M, Kishigami Y, Shibata R, Murai T, Takanashi A, Mori S, et al.. Experience of using combination therapy of Lenvatinib plus Pembrolizumab for recurrent endometrial cancer. The Tokai journal of obstetrics and gynecology. 2024;60:63-71$74$YR$$F$Y$$$20240910$$MD$JP$JP
237889765$23788976$5$F$20240101$20240906$20240426$20240920$PER$$US-KARYOPHARM-2024KPT000890$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240920$$CN$US$US
237889853$23788985$3$F$20240425$20240910$20240426$20240911$PER$$US-AMGEN-USASP2024084003$AMGEN$$60$YR$A$F$Y$$$20240911$$CN$US$US
237890143$23789014$3$F$20240126$20240508$20240426$20240904$EXP$$FR-BAXTER-2024BAX017031$BAXTER$$0$YR$$M$Y$$$20240904$$MD$FR$FR
237890333$23789033$3$F$$20240820$20240426$20240912$EXP$$US-SA-2024SA124940$SANOFI AVENTIS$$$$T$F$Y$70.3$KG$20240912$$MD$US$US
237890872$23789087$2$F$$20240419$20240426$20240801$EXP$$NVSC2023CA278779$NOVARTIS$$44$YR$$F$Y$$$20240801$$HP$CA$CA
237890962$23789096$2$F$20231001$20240819$20240426$20240826$PER$$JP-Eisai-EC-2024-164419$EISAI$$62$YR$A$F$Y$$$20240826$$MD$JP$JP
237891093$23789109$3$F$20240419$20240806$20240426$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-063950$BRISTOL MYERS SQUIBB$$6$DEC$A$F$Y$$$20240807$$MD$JP$JP
237891503$23789150$3$F$$20240918$20240426$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065943$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$69.4$KG$20240924$$CN$US$US
237891802$23789180$2$F$$20240823$20240426$20240826$PER$$JP-Eisai-EC-2024-160358$EISAI$$62$YR$A$F$Y$$$20240826$$MD$JP$JP
237891822$23789182$2$F$$20240828$20240426$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA042548$SANDOZ$$51$YR$$M$Y$$$20240829$$HP$CA$CA
237891884$23789188$4$F$20230101$20240902$20240426$20240913$EXP$$JP-INSMED, INC.-2023-04608-JP$INSMED$$48$YR$$F$Y$$$20240913$$CN$JP$JP
237891903$23789190$3$F$$20240719$20240426$20240729$EXP$$JP-INSMED-2024-01674-JPAA$INSMED$$73$YR$$M$Y$$$20240729$$CN$JP$JP
237892023$23789202$3$F$20240403$20240724$20240426$20240731$EXP$$JP-JNJFOC-20240480814$JOHNSON AND JOHNSON$$12$YR$T$F$Y$$$20240731$$MD$JP$JP
237892392$23789239$2$F$$20240711$20240426$20240716$EXP$$FR-MYLANLABS-2024M1036874$MYLAN$$$$$F$Y$$$20240716$$CN$FR$FR
237892412$23789241$2$F$20240424$20240626$20240426$20240701$EXP$$NVSC2024GB088770$NOVARTIS$$$$A$F$Y$$$20240701$$CN$GB$GB
237892422$23789242$2$F$$20240628$20240426$20240703$EXP$$NVSC2024US088811$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
237892463$23789246$3$F$20240101$20240910$20240426$20240918$EXP$$JP-GENMAB-2024-01259$GENMAB$$80$YR$$M$Y$$$20240918$$MD$JP$JP
237892525$23789252$5$F$20240315$20240701$20240426$20240711$EXP$$PH-ALCON LABORATORIES-ALC2024PH002124$ALCON$$74$YR$$F$Y$$$20240711$$MD$PH$PH
237892544$23789254$4$F$20240317$20240701$20240426$20240708$EXP$$PH-ALCON LABORATORIES-ALC2024PH002122$ALCON$$65$YR$$M$Y$$$20240708$$MD$PH$PH
237892583$23789258$3$F$20231001$20240807$20240426$20240813$EXP$$US-ABBVIE-5732944$ABBVIE$$78$YR$$F$Y$73$KG$20240813$$CN$US$US
237892742$23789274$2$F$20240101$20240729$20240426$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062117$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240730$$HP$US$US
237892752$23789275$2$F$$20240724$20240426$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064435$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240724$$CN$US$US
237893012$23789301$2$F$$20240726$20240426$20240731$PER$$US-PFIZER INC-PV202300201699$PFIZER$$73$YR$$F$Y$$$20240731$$CN$US$US
237893145$23789314$5$F$20240101$20240806$20240426$20240813$EXP$$JP-GENMAB-2024-01358$GENMAB$$42$YR$$F$Y$$$20240813$$MD$JP$JP
237893153$23789315$3$F$$20240823$20240426$20240828$EXP$$US-VERTEX PHARMACEUTICALS-2024-007153$VERTEX$$12$YR$$M$Y$$$20240828$$CN$US$US
237893253$23789325$3$F$20230101$20240618$20240426$20240711$EXP$$CA-SA-2024SA123492$SANOFI AVENTIS$$4$MON$I$M$Y$4$KG$20240711$$PH$CA$CA
237893322$23789332$2$F$20240421$20240731$20240426$20240803$PER$$US-AMGEN-USASP2024081277$AMGEN$$63$YR$A$F$Y$$$20240802$$CN$US$US
237893494$23789349$4$F$$20240812$20240426$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065730$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240814$$CN$US$US
237893565$23789356$5$F$20240109$20240821$20240426$20240824$EXP$$NVSC2024CO008939$NOVARTIS$$46$YR$$F$Y$100$KG$20240824$$CN$CO$CO
237893693$23789369$3$F$$20240711$20240426$20240715$PER$$US-PFIZER INC-PV202300140144$PFIZER$$65$YR$$F$Y$65.76$KG$20240715$$CN$US$US
237893762$23789376$2$F$20240101$20240805$20240426$20240807$PER$$US-PFIZER INC-PV202400054451$PFIZER$$47$YR$$M$Y$$$20240807$$HP$US$US
237893983$23789398$3$F$$20240520$20240426$20240902$EXP$$PL-GENMAB-2024-01402$GENMAB$$59$YR$$M$Y$55$KG$20240903$$MD$PL$PL
237894162$23789416$2$F$$20240730$20240426$20240801$PER$$US-PFIZER INC-202101499914$PFIZER$$87$YR$$F$Y$$$20240801$$CN$US$US
237894175$23789417$5$F$$20240920$20240426$20240924$30DAY$$US-PFIZER INC-202400085578$PFIZER$$14$YR$$F$Y$$$20240924$$CN$US$US
237894214$23789421$4$F$$20240723$20240426$20240725$PER$$US-PFIZER INC-202400095665$PFIZER$$34$YR$$F$Y$$$20240725$$MD$US$US
237894342$23789434$2$F$$20240802$20240426$20240807$PER$$US-PFIZER INC-202400094656$PFIZER$$60$YR$$F$Y$$$20240807$$CN$US$US
237894584$23789458$4$F$20240321$20240827$20240426$20240910$PER$$US-Calliditas-2024CAL00619$CALLIDITAS THERAPEUTICS$$47$YR$A$M$Y$97.49$KG$20240910$$CN$US$US
237894602$23789460$2$F$20240101$20240626$20240426$20240703$EXP$$US-ABBVIE-5733458$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
237894672$23789467$2$F$20240401$20240412$20240426$20240718$EXP$$CN-HALEON-2168360$Haleon PLC$$46$YR$$F$Y$52$KG$20240717$$HP$CN$CN
237894702$23789470$2$F$20131201$20240416$20240426$20240725$EXP$$CA-BAYER-2024A058291$BAYER$$32$YR$A$F$Y$$$20240725$$CN$CA$CA
237894813$23789481$3$F$$20240717$20240426$20240724$PER$$US-ALXN-202404USA001516US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
237895076$23789507$6$F$20240517$20240827$20240426$20240829$EXP$$CA-TAKEDA-2024TUS038896$TAKEDA$$53$YR$$M$Y$$$20240829$$CN$CA$CA
237895353$23789535$3$F$20240105$20240828$20240426$20240904$EXP$$JP-GENMAB-2024-00068AA$GENMAB$$75$YR$$F$Y$56.2$KG$20240904$$MD$JP$JP
237895612$23789561$2$F$20240328$20240712$20240426$20240720$EXP$$US-ABBVIE-5735056$ABBVIE$$23$YR$$M$Y$$$20240720$$CN$US$US
237896713$23789671$3$F$20240424$20240718$20240426$20240723$PER$$US-AMGEN-USASP2024083220$AMGEN$$67$YR$E$M$Y$$$20240723$$MD$US$US
237896913$23789691$3$F$20170601$20240516$20240426$20240718$EXP$$PL-MYLANLABS-2024M1033880$MYLAN$Jartych A, Anna J.W, Konrad R, Weronika K, Micha? K.. A case of concomitant juvenile idiopathic arthritis (JIA) and paediatric-onset multiple sclerosis (POMS) ? treatment  with secukinumab and dimethyl fumarate followed by ofatumumab. JOURNAL OF PRE-CLINICAL AND CLINICAL RESEARCH.. 2024;1:16-20$22$YR$$M$Y$$$20240718$$MD$PL$PL
237897042$23789704$2$F$$20240731$20240426$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064737$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$116.57$KG$20240807$$CN$US$US
237897364$23789736$4$F$$20240904$20240426$20240909$30DAY$$US-PFIZER INC-202400077888$PFIZER$$17$YR$$M$Y$$$20240909$$CN$US$US
237897502$23789750$2$F$$20240717$20240426$20240722$EXP$$US-ABBVIE-5734417$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
237897704$23789770$4$F$20240101$20240723$20240426$20240725$EXP$$US-INCYTE CORPORATION-2024IN004220$INCYTE$$$$$$Y$$$20240725$$MD$US$US
237897792$23789779$2$F$20230601$20240411$20240426$20240715$EXP$$PT-SMPA-2024SUN000284$SUNOVION$$$$$$Y$$$20240715$$MD$DE$DE
237898142$23789814$2$F$20240422$20240724$20240426$20240726$PER$$US-AMGEN-USASP2024081928$AMGEN$$46$YR$A$F$Y$$$20240726$$CN$US$US
237898422$23789842$2$F$$20240725$20240426$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-065690$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$MD$JP$JP
237898464$23789846$4$F$$20240717$20240426$20240724$30DAY$$DE-PFIZER INC-202400081661$PFIZER$$63$YR$$M$Y$$$20240724$$CN$DE$DE
237898482$23789848$2$F$$20240627$20240426$20240710$EXP$$GB-INCYTE CORPORATION-2024IN004206$INCYTE$$$$$$Y$$$20240710$$MD$GB$GB
237898523$23789852$3$F$20240301$20240923$20240426$20240925$30DAY$$KR-PFIZER INC-PV202400046423$PFIZER$$7$YR$$F$Y$$$20240925$$HP$KR$KR
237899003$23789900$3$F$$20240924$20240426$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065017$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240926$$CN$US$US
237899044$23789904$4$F$$20240715$20240426$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA042717$SANDOZ$$44$YR$$M$Y$$$20240717$$HP$CA$CA
237899112$23789911$2$F$$20240708$20240426$20240710$30DAY$$US-PFIZER INC-PV202400023722$PFIZER$$13$YR$$M$Y$$$20240710$$MD$US$US
237899123$23789912$3$F$20240328$20240712$20240426$20240712$30DAY$$CL-PFIZER INC-PV202400049832$PFIZER$$11$YR$$$Y$$$20240712$$CN$CL$CL
237899162$23789916$2$F$$20240405$20240426$20240814$PER$$US-INCYTE CORPORATION-2024IN003676$INCYTE$$$$$$Y$$$20240814$$CN$US$US
237899557$23789955$7$F$20240422$20240918$20240426$20240921$EXP$$FR-ABBVIE-5733003$ABBVIE$$22$YR$$M$Y$72$KG$20240921$$MD$FR$FR
237899657$23789965$7$F$$20240906$20240426$20240911$30DAY$$US-PFIZER INC-202400082046$PFIZER$$12$YR$$M$Y$$$20240911$$CN$US$US
237899685$23789968$5$F$$20240906$20240426$20240910$30DAY$$US-PFIZER INC-202400076333$PFIZER$$16$YR$$M$Y$$$20240910$$CN$US$US
237899694$23789969$4$F$$20240907$20240426$20240910$30DAY$$US-PFIZER INC-202400087933$PFIZER$$12$YR$$F$Y$$$20240910$$CN$US$US
237899704$23789970$4$F$20240410$20240909$20240426$20240911$30DAY$$US-PFIZER INC-202400085558$PFIZER$$59$YR$$M$Y$$$20240911$$CN$US$US
237899723$23789972$3$F$20240401$20240711$20240426$20240722$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-006674$JAZZ$$22$YR$$F$Y$$$20240722$$PH$JP$JP
237900016$23790001$6$F$20240412$20240906$20240426$20240910$30DAY$$CR-PFIZER INC-PV202400047330$PFIZER$$11$YR$$F$Y$$$20240910$$HP$CR$CR
237900172$23790017$2$F$20231201$20240702$20240426$20240705$30DAY$$JP-PFIZER INC-202400081540$PFIZER$$10$YR$$M$Y$$$20240705$$MD$JP$JP
237900214$23790021$4$F$$20240903$20240426$20240909$30DAY$$CA-PFIZER INC-202400080864$PFIZER$$11$YR$$F$Y$$$20240909$$HP$CA$CA
237900242$23790024$2$F$$20240701$20240426$20240705$30DAY$$JP-PFIZER INC-PV202400047124$PFIZER$$$$$$Y$$$20240705$$MD$JP$JP
237900252$23790025$2$F$$20240701$20240426$20240712$EXP$$DE-MAYNE PHARMA-2024MYN000111$MAYNE$Koschitzki K, Karrer S, Berneburg M, Niebel D, Drexler K. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema). Journal of the German Society of Dermatology. 2024;22 (6):833-6$$$$$Y$$$20240712$$HP$DE$DE
237900285$23790028$5$F$20240411$20240807$20240426$20240809$30DAY$$US-PFIZER INC-202400085191$PFIZER$$39$YR$$F$Y$61.678$KG$20240809$$CN$US$US
237900382$23790038$2$F$$20240704$20240426$20240708$30DAY$$GB-PFIZER INC-202400086101$PFIZER$$$$$F$Y$$$20240708$$HP$GB$GB
237900472$23790047$2$F$$20240701$20240426$20240705$30DAY$$JP-PFIZER INC-PV202400047749$PFIZER$$8$YR$$M$Y$$$20240705$$MD$JP$JP
237900553$23790055$3$F$20230516$20240906$20240426$20240909$EXP$$JP-AstraZeneca-2023A217197$ASTRAZENECA$$75$YR$$M$Y$64$KG$20240909$$MD$JP$
237900993$23790099$3$F$$20240805$20240426$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-065749$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240805$$MD$JP$JP
237901023$23790102$3$F$$20240719$20240426$20240729$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000840$BLUEPRINT MEDICINES$$$$$F$Y$$$20240729$$HP$US$US
237901052$23790105$2$F$$20240722$20240426$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000841$BLUEPRINT MEDICINES$$$$$F$Y$$$20240731$$CN$US$US
237901135$23790113$5$F$$20240830$20240426$20240902$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-024451$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240902$$CN$US$US
237901143$23790114$3$F$20240319$20240808$20240426$20240814$EXP$$DE-ABBVIE-5721078$ABBVIE$$61$YR$$M$Y$$$20240814$$HP$DE$DE
237901422$23790142$2$F$$20240625$20240426$20240705$EXP$$AE-009507513-2404ARE009765$MERCK$$34$YR$$M$Y$$$20240705$$MD$AE$AE
237901582$23790158$2$F$20210101$20240807$20240426$20240808$EXP$$US-ALXN-A202111077$ALEXION PHARMACEUTICALS$$$$E$F$Y$$$20240808$$CN$US$US
237901722$23790172$2$F$$20240906$20240426$20240912$EXP$$US-GILEAD-2024-0670199$GILEAD$$65$YR$E$M$Y$$$20240912$$MD$US$US
237901772$23790177$2$F$$20240712$20240426$20240721$PER$$CZ-Blueprint Medicines Corporation-SP-CZ-2024-000846$BLUEPRINT MEDICINES$$$$$M$Y$$$20240719$$MD$CZ$CZ
237901862$23790186$2$F$$20240906$20240426$20240912$EXP$$US-GILEAD-2024-0670206$GILEAD$$61$YR$A$M$Y$$$20240912$$MD$US$US
237902145$23790214$5$F$20240701$20240826$20240426$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000834$BLUEPRINT MEDICINES$$63$YR$A$M$Y$111.23$KG$20240830$$CN$US$US
237902162$23790216$2$F$$20240927$20240426$20240930$EXP$$NVSC2024CA088712$NOVARTIS$$$$A$F$Y$$$20241001$$HP$CA$CA
237902222$23790222$2$F$20240401$20240711$20240426$20240714$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-024468$BOEHRINGER INGELHEIM$$48$YR$A$F$Y$$$20240714$$CN$US$US
237902342$23790234$2$F$20240415$20240725$20240426$20240726$EXP$$IN-ROCHE-3552300$ROCHE$$71$YR$E$M$Y$62.1$KG$20240726$$CN$IN$IN
237902792$23790279$2$F$20240101$20240710$20240427$20240724$EXP$$US-IBSA PHARMA INC.-2024IBS000032$IBSA INSTITUT BIOCHIMIQUE$$$$$$Y$$$20240724$$CN$US$US
237902942$23790294$2$F$20200101$20240829$20240427$20240906$EXP$$US-ROCHE-3548514$ROCHE$$78$YR$E$F$Y$$$20240906$$CN$US$US
237903452$23790345$2$F$$20240806$20240427$20240820$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-03338$LUPIN$$31$YR$$F$Y$$$20240820$$CN$AU$AU
237903522$23790352$2$F$$20240806$20240427$20240819$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-03301$LUPIN$$$$$$Y$$$20240819$$CN$AU$AU
237903602$23790360$2$F$20240425$20240731$20240427$20240802$PER$$US-AMGEN-USASP2024084013$AMGEN$$60$YR$A$F$Y$$$20240802$$CN$US$US
237903678$23790367$8$F$20240101$20240909$20240427$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010690$UNITED THERAPEUTICS$$$$$F$Y$54.875$KG$20240919$$$US$US
237903692$23790369$2$F$$20240628$20240427$20240702$EXP$$NVSC2024BR088344$NOVARTIS$$$$$$Y$$$20240702$$MD$BR$BR
237903802$23790380$2$F$20231020$20240619$20240427$20240704$EXP$FR-AFSSAPS-AVMA2024000123$FR-TEVA-VS-3188153$TEVA$$42$YR$$M$Y$$$20240704$$PH$FR$FR
237903816$23790381$6$F$20240321$20240906$20240427$20240911$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-003571$JAZZ$$56$YR$$M$Y$$$20240911$$MD$US$US
237903872$23790387$2$F$20240422$20240620$20240427$20240715$PER$$US-AstraZeneca-2024A096724$ASTRAZENECA$$22182$DY$$$Y$$$20240715$$CN$US$
237904032$23790403$2$F$20240424$20240828$20240427$20240830$PER$$US-AMGEN-USASP2024083626$AMGEN$$70$YR$E$F$Y$$$20240830$$CN$US$US
237904072$23790407$2$F$$20240620$20240427$20240703$PER$$US-AstraZeneca-2024A098691$ASTRAZENECA$$$$$M$Y$$$20240703$$CN$US$
237904472$23790447$2$F$20230101$20240705$20240427$20240705$PER$$NVSC2024US089166$NOVARTIS$$57$YR$$F$Y$$$20240705$$HP$US$US
237904522$23790452$2$F$$20240702$20240427$20240708$EXP$$GB-TAKEDA-2024TUS038847$TAKEDA$$$$$M$Y$$$20240708$$CN$GB$GB
237904666$23790466$6$F$20240101$20240816$20240427$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-008922$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240823$$$US$US
237905044$23790504$4$F$20240101$20240909$20240427$20240917$EXP$$CA-CELLTRION INC.-2024CA001445$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
237905142$23790514$2$F$$20240422$20240427$20240812$EXP$$NVSC2024US066536$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
237905393$23790539$3$F$20240425$20240801$20240427$20240805$PER$$US-AMGEN-USASP2024083966$AMGEN$$59$YR$A$F$Y$$$20240805$$CN$US$US
237905484$23790548$4$F$$20240816$20240427$20240822$EXP$$NVSC2024US061761$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
237905722$23790572$2$F$$20240626$20240427$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03331$LUPIN$$$$$$Y$$$20240711$$CN$US$US
237906052$23790605$2$F$$20240905$20240427$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03350$LUPIN$$$$$$Y$$$20240921$$CN$US$US
237906064$23790606$4$F$$20240705$20240427$20240708$EXP$$NVSC2024US088160$NOVARTIS$$42$YR$$M$Y$$$20240708$$CN$US$US
237906084$23790608$4$F$$20240806$20240427$20240808$EXP$$NVSC2024US087797$NOVARTIS$$$$$F$Y$$$20240808$$MD$US$US
237906286$23790628$6$F$$20240712$20240427$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011907$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240719$$$US$US
237906372$23790637$2$F$$20240709$20240427$20240715$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-005136$JAZZ$$$$$F$Y$$$20240715$$CN$US$US
237906462$23790646$2$F$$20240812$20240427$20240821$EXP$$CA-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00226$VELOXIS PHARMACEUTICALS$Zhang J, Suarez A.. Envarsus induced thrombotic microangiography in an adult kidney transplant patient. Canadian Journal of Hospital Pharmacy.. 2024;77(2):24$57$YR$$F$Y$$$20240821$$MD$CA$CA
237906502$23790650$2$F$20231218$20240918$20240427$20240925$EXP$$CA-GSK-CA2023167062$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$CA$CA
237906512$23790651$2$F$20231126$20240621$20240427$20240701$EXP$SE-SEMPA-2024-002748$SE-TEVA-VS-3187280$TEVA$$17$YR$$F$Y$$$20240701$$HP$SE$SE
237906523$23790652$3$F$$20240920$20240427$20240926$EXP$$NVSC2024US088854$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
237906812$23790681$2$F$20240320$20240913$20240427$20240915$EXP$SE-SEMPA-2024-002741$SE-ROCHE-3547567$ROCHE$$82$YR$E$F$Y$$$20240915$$MD$SE$SE
237906835$23790683$5$F$20240522$20240812$20240427$20240819$EXP$$CA-TAKEDA-2024TUS016113$TAKEDA$$32$YR$$F$Y$$$20240819$$HP$CA$CA
237906846$23790684$6$F$20240611$20240710$20240427$20240722$EXP$$CA-TAKEDA-2024TUS024230$TAKEDA$$21$YR$$M$Y$$$20240722$$MD$CA$CA
237906922$23790692$2$F$$20240708$20240427$20240716$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024052553$VIIV$$$$$M$Y$$$20240716$$HP$US$US
237907074$23790707$4$F$$20240920$20240427$20240927$EXP$XI-EMA-DD-20240402-7483181-065544$XI-TEVA-VS-3187986$TEVA$$69$YR$$M$Y$$$20240927$$CN$GB$GB
237907274$23790727$4$F$20231101$20240709$20240427$20240711$EXP$$CA-UCBSA-2024014943$UCB$$59$YR$$F$Y$$$20240711$$CN$CA$CA
237907322$23790732$2$F$$20240705$20240427$20240715$EXP$DE-BFARM-24002306$DE-TEVA-VS-3187278$TEVA$$$$A$F$Y$$$20240715$$MD$DE$DE
237907472$23790747$2$F$20230911$20240701$20240427$20240709$EXP$IE-HPRA-2024-111529$IE-TEVA-VS-3187606$TEVA$$$$N$M$Y$$$20240709$$MD$IE$IE
237907752$23790775$2$F$20240301$20240817$20240427$20240827$EXP$$DE-TEVA-VS-3187029$TEVA$$62$YR$$F$Y$$$20240827$$MD$DE$DE
237907852$23790785$2$F$20240404$20240722$20240427$20240801$EXP$$DE-AUROBINDO-AUR-APL-2024-018687$AUROBINDO$$$$E$F$Y$63.9$KG$20240801$$MD$DE$DE
237908442$23790844$2$F$20240402$20240730$20240427$20240802$PER$$US-AMGEN-USASP2024084468$AMGEN$$61$YR$A$M$Y$$$20240802$$CN$US$US
237908605$23790860$5$F$$20240819$20240427$20240828$EXP$$US-GSK-US2024049830$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$CN$US$US
237908673$23790867$3$F$$20240917$20240427$20240927$PER$$US-GSK-US2024049493$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$PH$US$US
237908842$23790884$2$F$20240425$20240727$20240427$20240730$PER$$US-AMGEN-USASP2024084401$AMGEN$$76$YR$E$F$Y$$$20240730$$CN$US$US
237908852$23790885$2$F$$20240705$20240427$20240705$PER$$NVSC2024US089394$NOVARTIS$$$$$F$Y$$$20240705$$MD$US$US
237908993$23790899$3$F$$20240805$20240427$20240812$EXP$$FR-AstraZeneca-2024A095714$ASTRAZENECA$$$$$M$Y$80$KG$20240812$$MD$FR$
237909023$23790902$3$F$20240422$20240730$20240427$20240801$PER$$US-AMGEN-USASP2024084074$AMGEN$$73$YR$E$F$Y$$$20240801$$HP$US$US
237909072$23790907$2$F$20240424$20240812$20240427$20240813$PER$$US-AMGEN-USASP2024084412$AMGEN$$84$YR$E$F$Y$$$20240813$$CN$US$US
237910004$23791000$4$F$20240425$20240711$20240427$20240723$PER$$US-AMGEN-USASP2024084064$AMGEN$$$$$$Y$$$20240723$$PH$US$US
237910492$23791049$2$F$20231001$20240808$20240428$20240819$EXP$FR-AFSSAPS-MP2024000649$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-062741$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$83.5$KG$20240819$$MD$FR$FR
237910733$23791073$3$F$20230411$20240815$20240428$20240823$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2023-09124$IPSEN$$49$YR$A$M$Y$$$20240823$$HP$CA$CA
237911082$23791108$2$F$$20240626$20240428$20240711$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000359$DECIPHERA PHARMACEUTICALS$$48$YR$A$F$Y$$$20240711$$CN$US$US
237911282$23791128$2$F$$20240722$20240428$20240731$30DAY$$US-GSK-US2024050557$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$CN$US$US
237911382$23791138$2$F$20240101$20240709$20240428$20240709$EXP$PT-INFARMED-T202404-468$PT-JNJFOC-20240481431$JOHNSON AND JOHNSON$$37$YR$A$F$Y$68$KG$20240710$$CN$PT$PT
237911422$23791142$2$F$$20240726$20240428$20240730$EXP$$NVSC2024CN089029$NOVARTIS$Jing P, Xiaodan C, Lingyan W, Gang M, Qiuzi J, Ningning G et al.. Retrospective analysis of application and conversion of biologic agents in patients with psoriasis  based on real world data from 2020 to 2021. J CLIN DERMATOL. 2024;53 (94)$49$YR$$F$Y$$$20240730$$HP$CN$CN
237911463$23791146$3$F$$20240711$20240428$20240715$EXP$$US-JNJFOC-20240466573$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240716$$CN$US$US
237911733$23791173$3$F$20240322$20240809$20240428$20240813$EXP$$BE-JNJFOC-20240473592$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240814$$MD$BE$BE
237911892$23791189$2$F$20240101$20240404$20240428$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240757$IRONSHORE PHARMA$$9$YR$C$F$Y$$$20240810$$MD$US$US
237911952$23791195$2$F$$20240906$20240428$20240911$EXP$$JP-AMGEN-JPNSP2024082342$AMGEN$$$$$F$Y$$$20240910$$HP$JP$JP
237912012$23791201$2$F$$20240807$20240428$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR052880$VIIV$$$$$$Y$$$20240816$$HP$US$US
237912084$23791208$4$F$$20240729$20240428$20240801$EXP$$CA-JNJFOC-20240468781$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240801$$HP$CA$CA
237913002$23791300$2$F$$20240725$20240428$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-065723$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240725$$MD$JP$JP
237913053$23791305$3$F$20230317$20240731$20240428$20240802$EXP$$CL-SANDOZ INC.-SDZ2024CL043336$SANDOZ$$12$YR$$M$Y$$$20240802$$CN$CL$CL
237913082$23791308$2$F$$20240723$20240428$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055570$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$US$US
237913172$23791317$2$F$20240421$20240903$20240428$20240903$EXP$IT-MINISAL02-982522$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-024319$BOEHRINGER INGELHEIM$$87$YR$E$F$Y$$$20240903$$MD$IT$IT
237913522$23791352$2$F$20240419$20240823$20240428$20240830$EXP$$JP-009507513-2404JPN003141J$MERCK$$67$YR$$F$Y$$$20240830$$MD$JP$JP
237913547$23791354$7$F$20240405$20240725$20240428$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-065811$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$59$KG$20240725$$MD$JP$JP
237913752$23791375$2$F$$20240625$20240429$20240704$EXP$$BE-NOVOPROD-1210236$NOVO NORDISK$Greet Peeters et al. Severe insulin resistance in a patient with diabetes after treatment with brentuximab vedotin. BMJ Case Rep. 2024;17:1-5$$$$M$Y$$$20240704$$HP$BE$BE
237913833$23791383$3$F$20220101$20240813$20240429$20240816$EXP$$US-ABBVIE-5725382$ABBVIE$$$$$F$Y$77.11$KG$20240816$$CN$US$US
237913892$23791389$2$F$20231023$20240912$20240429$20240920$EXP$$CA-EMD Serono-2023483571$EMD SERONO INC$$39$YR$A$F$Y$$$20240920$$CN$CA$CA
237914093$23791409$3$F$$20240621$20240429$20240701$30DAY$$US-GSK-US2024049484$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
237914223$23791422$3$F$20240419$20240724$20240429$20240725$EXP$$CA-PFIZER INC-202400093895$PFIZER$$70$YR$$M$Y$84.3$KG$20240725$$HP$CA$CA
237914432$23791443$2$F$20240424$20240718$20240429$20240723$PER$$US-AMGEN-USASP2024083141$AMGEN$$84$YR$E$F$Y$$$20240723$$CN$US$US
237914862$23791486$2$F$20100503$20240827$20240429$20240830$EXP$FR-EMA-DD-20240326-7482655-061913$FR-HALEON-2168889$Haleon PLC$$67$YR$$M$Y$74$KG$20240830$$MD$FR$FR
237914952$23791495$2$F$20240101$20240716$20240429$20240721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065599$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$92.08$KG$20240722$$HP$US$US
237915492$23791549$2$F$20240106$20240507$20240429$20240704$EXP$FR-AFSSAPS-NY2024000337$FR-HALEON-2168535$Haleon PLC$$77$YR$$F$Y$59$KG$20240703$$PH$FR$FR
237915552$23791555$2$F$$20240729$20240429$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-062786$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$72.8$KG$20240729$$PH$US$US
237916522$23791652$2$F$$20240716$20240429$20240724$PER$$US-SA-2024SA123996$SANOFI AVENTIS$$$$E$M$Y$99.79$KG$20240724$$MD$US$US
237916582$23791658$2$F$20240101$20240627$20240429$20240710$PER$$US-SA-2024SA122310$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$MD$US$US
237916593$23791659$3$F$20230301$20240624$20240429$20240703$PER$$US-SA-2024SA123408$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240703$$MD$US$US
237916602$23791660$2$F$$20240821$20240429$20240916$PER$$US-SA-2024SA123933$SANOFI AVENTIS$$$$A$F$Y$92.98$KG$20240916$$MD$US$US
237916722$23791672$2$F$20240101$20240906$20240429$20240916$PER$$US-SA-2024SA122072$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240916$$MD$US$US
237916982$23791698$2$F$$20240730$20240429$20240807$PER$$US-SA-2024SA121126$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240807$$MD$US$US
237917072$23791707$2$F$20240101$20240731$20240429$20240808$PER$$US-SA-2024SA120779$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240808$$MD$US$US
237917132$23791713$2$F$$20240810$20240429$20240819$PER$$US-SA-2024SA121327$SANOFI AVENTIS$$$$A$M$Y$$$20240819$$MD$US$US
237917182$23791718$2$F$$20240731$20240429$20240809$PER$$US-SA-2024SA121776$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240809$$MD$US$US
237917192$23791719$2$F$20240501$20240712$20240429$20240724$PER$$US-SA-2024SA122522$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240724$$MD$US$US
237917202$23791720$2$F$$20240801$20240429$20240810$PER$$US-SA-2024SA120925$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$MD$US$US
237917282$23791728$2$F$20240322$20240701$20240429$20240710$PER$$US-SA-2024SA122160$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240710$$MD$US$US
237917435$23791743$5$F$20240101$20240903$20240429$20240912$PER$$US-SA-2024SA123259$SANOFI AVENTIS$$13$YR$T$M$Y$61$KG$20240912$$MD$US$US
237917642$23791764$2$F$$20240629$20240429$20240708$PER$$US-SA-2024SA127100$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240708$$MD$US$US
237917672$23791767$2$F$20240101$20240802$20240429$20240813$PER$$US-SA-2024SA123351$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240814$$MD$US$US
237917682$23791768$2$F$20240401$20240819$20240429$20240828$PER$$US-SA-2024SA120549$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240828$$MD$US$US
237917692$23791769$2$F$20240401$20240729$20240429$20240807$PER$$US-SA-2024SA121426$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240807$$MD$US$US
237917773$23791777$3$F$20240401$20240729$20240429$20240807$PER$$US-SA-2024SA122112$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240807$$MD$US$US
237917955$23791795$5$F$20240101$20240903$20240429$20240912$PER$$US-SA-2024SA121094$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240912$$MD$US$US
237918152$23791815$2$F$20240401$20240729$20240429$20240807$PER$$US-SA-2024SA122228$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240807$$MD$US$US
237918172$23791817$2$F$20240401$20240730$20240429$20240808$PER$$US-SA-2024SA120403$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240808$$MD$US$US
237918194$23791819$4$F$20240318$20240812$20240429$20240820$PER$$US-SA-2024SA120814$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240820$$MD$US$US
237918232$23791823$2$F$20240401$20240726$20240429$20240805$PER$$US-SA-2024SA122347$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240805$$MD$US$US
237918302$23791830$2$F$20240423$20240704$20240429$20240705$EXP$$JP-PFIZER INC-PV202400054608$PFIZER$$86$YR$$M$Y$$$20240705$$MD$JP$JP
2379183110$23791831$10$F$$20240917$20240429$20240923$30DAY$$US-PFIZER INC-202400087942$PFIZER$$11$YR$$F$Y$$$20240923$$CN$US$US
237918343$23791834$3$F$20240101$20240808$20240429$20240820$PER$$US-SA-2024SA121420$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240820$$MD$US$US
237918352$23791835$2$F$20240417$20240906$20240429$20240917$PER$$US-SA-2024SA122149$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240918$$HP$US$US
237918392$23791839$2$F$20240410$20240701$20240429$20240710$PER$$US-SA-2024SA121211$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240710$$MD$US$US
237918403$23791840$3$F$20240401$20240807$20240429$20240816$PER$$US-SA-2024SA121993$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240816$$MD$US$US
237918622$23791862$2$F$$20240807$20240429$20240814$PER$$US-SA-2024SA121990$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240814$$MD$US$US
237918632$23791863$2$F$$20240718$20240429$20240724$PER$$US-SA-2024SA123323$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240724$$MD$US$US
237918642$23791864$2$F$$20240627$20240429$20240709$PER$$US-SA-2024SA092816$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240709$$MD$US$US
237918692$23791869$2$F$20240418$20240621$20240429$20240702$PER$$US-SA-2024SA123443$SANOFI AVENTIS$$2$MON$I$M$Y$$$20240702$$MD$US$US
237918792$23791879$2$F$20240401$20240717$20240429$20240725$PER$$US-SA-2024SA122186$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240725$$MD$US$US
237918882$23791888$2$F$20240701$20240806$20240429$20240814$PER$$US-SA-2024SA123601$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240814$$MD$US$US
237918984$23791898$4$F$20240101$20240726$20240429$20240802$EXP$$US-SA-2024SA122624$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240802$$MD$US$US
237919216$23791921$6$F$20240101$20240913$20240429$20240928$PER$$US-SA-2024SA125183$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240928$$MD$US$US
237919252$23791925$2$F$$20240708$20240429$20240722$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-12105$SAMSUNG BIOEPIS$$57$YR$A$M$Y$$$20240722$$CN$GB$GB
237919316$23791931$6$F$20240101$20240829$20240429$20240918$EXP$$US-SA-2024SA125957$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240918$$CN$US$US
237919322$23791932$2$F$20230101$20240821$20240429$20240915$PER$$US-SA-2024SA125817$SANOFI AVENTIS$$57$YR$A$F$Y$77.73$KG$20240915$$MD$US$US
237919436$23791943$6$F$20240101$20240726$20240429$20240806$PER$$US-SA-2024SA125021$SANOFI AVENTIS$$11$YR$C$M$Y$43$KG$20240806$$MD$US$US
237919534$23791953$4$F$20240101$20240912$20240429$20240920$PER$$US-SA-2024SA125597$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240920$$MD$US$US
237919584$23791958$4$F$20240101$20240715$20240429$20240723$PER$$US-SA-2024SA125588$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240723$$MD$US$US
237919723$23791972$3$F$20240421$20240829$20240429$20240902$PER$$US-SA-2024SA126779$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240902$$HP$US$US
237919883$23791988$3$F$$20240731$20240429$20240809$PER$$US-SA-2024SA125517$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240809$$MD$US$US
237919922$23791992$2$F$20240101$20240807$20240429$20240816$PER$$US-SA-2024SA127025$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240816$$MD$US$US
237920003$23792000$3$F$$20240813$20240429$20240826$PER$$US-SA-2024SA125682$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240826$$MD$US$US
237920082$23792008$2$F$$20240904$20240429$20240916$PER$$US-SA-2024SA125114$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240916$$MD$US$US
237920142$23792014$2$F$$20240409$20240429$20240801$PER$$US-TEVA-VS-3182038$TEVA$$$$A$M$Y$$$20240801$$CN$US$US
237920195$23792019$5$F$20240125$20240722$20240429$20240724$EXP$$US-UCBSA-2024005767$UCB$$40$YR$$F$Y$122.4$KG$20240724$$CN$US$US
237920283$23792028$3$F$20230901$20240803$20240429$20240814$EXP$$US-NOVOPROD-1209160$NOVO NORDISK$$43$YR$$F$Y$$$20240814$$CN$US$US
237920354$23792035$4$F$$20240704$20240429$20240709$EXP$$CA-GSK-CA2023AMR011513$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$HP$CA$CA
237920674$23792067$4$F$20230201$20240819$20240429$20240826$EXP$$CA-GSK-CA2023AMR039562$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$HP$CA$CA
237921113$23792111$3$F$20240202$20240718$20240429$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066175$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$73.94$KG$20240725$$HP$US$US
237921143$23792114$3$F$$20240514$20240429$20240925$PER$$US-GSK-US2024AMR052196$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
237921322$23792132$2$F$20240101$20240716$20240429$20240718$EXP$$ES-JNJFOC-20240345760$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240719$$HP$ES$ES
237921344$23792134$4$F$20231023$20240829$20240429$20240907$EXP$$US-GSK-US2024051771$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240907$$MD$US$US
237921913$23792191$3$F$$20240812$20240429$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065877$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$70.31$KG$20240820$$CN$US$US
237922182$23792218$2$F$$20240918$20240429$20240930$PER$$NVSC2024US084583$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
237922274$23792227$4$F$20240415$20240802$20240429$20240813$EXP$$US-NOVOPROD-1209848$NOVO NORDISK$$87$YR$$F$Y$73.469$KG$20240813$$CN$US$US
237922293$23792229$3$F$$20240725$20240429$20240802$30DAY$$BR-NOVOPROD-1209450$NOVO NORDISK$$$$$F$Y$$$20240802$$CN$BR$BR
237922302$23792230$2$F$20240101$20240826$20240429$20240904$EXP$$US-JNJFOC-20240458439$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240905$$CN$US$US
237922333$23792233$3$F$20240423$20240823$20240429$20240824$PER$$US-AMGEN-USASP2024083363$AMGEN$$64$YR$A$M$Y$$$20240823$$HP$US$US
237922372$23792237$2$F$$20240814$20240429$20240819$EXP$$US-SANDOZ INC.-NVSC2022US205422$SANDOZ$$$$$M$Y$64.399$KG$20240819$$CN$US$US
237922404$23792240$4$F$20240313$20240701$20240429$20240708$EXP$$PH-ALCON LABORATORIES-ALC2024PH002121$ALCON$$79$YR$$M$Y$$$20240708$$MD$PH$PH
237922444$23792244$4$F$20240413$20240612$20240429$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001653$ACADIA PHARMACEUTICALS$$14$YR$$F$Y$$$20240705$$CN$US$US
237922673$23792267$3$F$20231101$20240722$20240429$20240801$EXP$$US-ORGANON-O2404USA003015$ORGANON$$69$YR$$F$Y$41.723$KG$20240801$$HP$US$US
237922692$23792269$2$F$$20240624$20240429$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065719$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240704$$CN$US$US
237922803$23792280$3$F$20240720$20240723$20240429$20240726$EXP$$US-TAKEDA-2024TUS036821$TAKEDA$$12$YR$$F$Y$41.8$KG$20240726$$HP$US$US
237922812$23792281$2$F$20240326$20240630$20240429$20240708$EXP$FR-AFSSAPS-AM2024000345$FR-BAUSCH-BL-2024-006646$BAUSCH AND LOMB$$73$YR$$F$Y$93$KG$20240708$$PH$FR$FR
237923242$23792324$2$F$20240318$20240722$20240429$20240722$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2156183$JIANGSU HANSOH PHARMACEUTICAL$$87$YR$$M$Y$$$20240722$$MD$CN$CN
237923455$23792345$5$F$$20240909$20240429$20240911$30DAY$$US-PFIZER INC-202400074072$PFIZER$$16$YR$$M$Y$$$20240911$$MD$US$US
237923554$23792355$4$F$20240622$20240622$20240429$20240701$EXP$$CA-TAKEDA-2023TUS043719$TAKEDA$$64$YR$$M$Y$$$20240701$$MD$CA$CA
237923562$23792356$2$F$$20240718$20240429$20240724$EXP$$US-ABBVIE-5735443$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
237923582$23792358$2$F$$20240716$20240429$20240727$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-12865$SAMSUNG BIOEPIS$$64$YR$A$F$Y$$$20240727$$MD$CA$CA
237923732$23792373$2$F$20240312$20240821$20240429$20240826$EXP$$US-ABBVIE-5735749$ABBVIE$$43$YR$$F$Y$$$20240826$$CN$US$US
237923882$23792388$2$F$20240301$20240626$20240429$20240705$PER$$US-SA-2024SA124374$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240705$$MD$US$US
237923902$23792390$2$F$$20240919$20240429$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202404017655$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240923$$CN$US$US
237923952$23792395$2$F$$20240627$20240429$20240703$EXP$$US-CHATTEMPRD-2024OHG014066$CHATTEM$$72$YR$E$M$Y$$$20240703$$LW$US$US
237923983$23792398$3$F$$20240716$20240429$20240806$PER$$US-BIOVITRUM-CTI2023US04325$BIOVITRUM$$78$YR$$M$Y$$$20240806$$CN$US$US
237924152$23792415$2$F$20240101$20240722$20240429$20240725$PER$$US-AMGEN-USASP2024084085$AMGEN$$58$YR$A$F$Y$$$20240725$$CN$US$US
237924194$23792419$4$F$20240401$20240520$20240429$20240925$PER$$US-GSK-US2024AMR052806$GLAXOSMITHKLINE$$84$YR$$F$Y$$$20240925$$CN$US$US
237924265$23792426$5$F$$20240905$20240429$20240909$30DAY$$US-PFIZER INC-202400087876$PFIZER$$7$YR$$M$Y$$$20240909$$CN$US$US
237924275$23792427$5$F$$20240914$20240429$20240920$30DAY$$US-PFIZER INC-202400088071$PFIZER$$15$YR$$M$Y$$$20240920$$CN$US$US
237924292$23792429$2$F$$20240905$20240429$20240910$30DAY$$US-PFIZER INC-202400087903$PFIZER$$12$YR$$F$Y$$$20240910$$CN$US$US
237924326$23792432$6$F$$20240919$20240429$20240924$30DAY$$US-PFIZER INC-202400088059$PFIZER$$14$YR$$M$Y$$$20240924$$MD$US$US
237924382$23792438$2$F$20230801$20240726$20240429$20240809$EXP$$US-UCBSA-2023039697$UCB$$15$YR$$M$Y$$$20240809$$CN$US$US
237924468$23792446$8$F$20240301$20240913$20240429$20240918$30DAY$$US-PFIZER INC-202400088089$PFIZER$$10$YR$$F$Y$24.943$KG$20240918$$CN$US$US
237924476$23792447$6$F$$20240913$20240429$20240918$30DAY$$US-PFIZER INC-202400088571$PFIZER$$10$YR$$M$Y$$$20240918$$CN$US$US
237924485$23792448$5$F$20240414$20240909$20240429$20240911$30DAY$$US-PFIZER INC-202400088090$PFIZER$$60$YR$$F$Y$74.84$KG$20240911$$MD$US$US
237924494$23792449$4$F$$20240910$20240429$20240912$30DAY$$US-PFIZER INC-PV202400052410$PFIZER$$$$$$Y$$$20240912$$HP$US$US
237924583$23792458$3$F$$20240611$20240429$20240703$30DAY$$BR-JNJFOC-20240462602$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$BR$BR
237924712$23792471$2$F$$20240422$20240429$20240725$EXP$$RU-ROCHE-3548470$ROCHE$$$$A$F$Y$$$20240725$$MD$RU$RU
237924832$23792483$2$F$20240101$20240820$20240429$20240902$PER$$US-SA-2024SA123367$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240902$$MD$US$US
237924866$23792486$6$F$20240101$20240918$20240429$20240923$30DAY$$US-PFIZER INC-202400088524$PFIZER$$17$YR$$M$Y$$$20240923$$HP$US$US
237924874$23792487$4$F$20240413$20240905$20240429$20240909$30DAY$$US-PFIZER INC-202400088112$PFIZER$$15$YR$$M$Y$$$20240909$$CN$US$US
237924883$23792488$3$F$$20240912$20240429$20240916$30DAY$$US-PFIZER INC-202400088847$PFIZER$$10$YR$$F$Y$$$20240916$$CN$US$US
237924906$23792490$6$F$20240413$20240904$20240429$20240909$30DAY$$US-PFIZER INC-202400089296$PFIZER$$11$YR$$M$Y$22.23$KG$20240909$$CN$US$US
237924917$23792491$7$F$$20240923$20240429$20240927$30DAY$$US-PFIZER INC-202400088103$PFIZER$$12$YR$$M$Y$$$20240927$$HP$US$US
237925152$23792515$2$F$20240101$20240812$20240429$20240821$PER$$US-SA-2024SA127441$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240821$$MD$US$US
237925263$23792526$3$F$20240401$20240701$20240429$20240708$EXP$$GB-JNJFOC-20240466214$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240708$$CN$GB$GB
237925344$23792534$4$F$20240101$20240913$20240429$20240923$EXP$$CA-CELLTRION INC.-2024CA002557$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
237925422$23792542$2$F$20240401$20240710$20240429$20240717$PER$$US-SA-2024SA127520$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240718$$MD$US$US
237925522$23792552$2$F$20240101$20240716$20240429$20240723$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012107$UNITED THERAPEUTICS$$$$$F$Y$$$20240723$$$US$US
237925983$23792598$3$F$$20240807$20240429$20240812$EXP$$CA-ROCHE-3546717$ROCHE$$$$A$F$Y$74$KG$20240812$$CN$CA$CA
237926033$23792603$3$F$$20240223$20240429$20240814$EXP$$US-SPECGX-T202400696$SPECGX$$$$$$Y$$$20240814$$CN$US$US
237926142$23792614$2$F$$20240726$20240429$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066400$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$99.79$KG$20240729$$CN$US$US
237926242$23792624$2$F$20240329$20240731$20240429$20240805$PER$$US-RDY-SPO/USA/24/0006357$DR REDDYS$$76$YR$E$M$Y$$$20240805$$MD$US$US
237926422$23792642$2$F$20240101$20240830$20240429$20240913$PER$$US-SA-2024SA123087$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240913$$MD$US$US
237926453$23792645$3$F$20240101$20240801$20240429$20240806$PER$$US-SA-2024SA121220$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240806$$MD$US$US
237926576$23792657$6$F$20240101$20240917$20240429$20240926$EXP$$CA-CELLTRION INC.-2024CA003987$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
237926802$23792680$2$F$20240101$20240729$20240429$20240801$PER$$US-AMGEN-USASP2024084754$AMGEN$$62$YR$A$M$Y$$$20240801$$CN$US$US
237926992$23792699$2$F$20230101$20240718$20240429$20240722$EXP$$US-UCBSA-2023057444$UCB$$$$$M$Y$$$20240722$$CN$US$US
237927002$23792700$2$F$$20240626$20240429$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03357$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237927052$23792705$2$F$$20240808$20240429$20240817$PER$$US-SA-2024SA123113$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240817$$MD$US$US
237927183$23792718$3$F$20240101$20240808$20240429$20240816$EXP$$CA-CELLTRION INC.-2024CA009804$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
237927224$23792722$4$F$20240407$20240627$20240429$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001679$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240723$$CN$US$US
237927242$23792724$2$F$20240424$20240731$20240429$20240802$PER$$US-AMGEN-USASP2024083750$AMGEN$$$$$F$Y$$$20240802$$CN$US$US
237927427$23792742$7$F$20240101$20240725$20240429$20240730$EXP$$CA-JNJFOC-20240178450$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240730$$HP$CA$CA
237927533$23792753$3$F$20240301$20240815$20240429$20240828$PER$$US-SA-2024SA121895$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240828$$MD$US$US
237927742$23792774$2$F$20231101$20240708$20240429$20240717$PER$$US-SA-2024SA123299$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240717$$MD$US$US
237927774$23792777$4$F$$20240718$20240429$20240727$PER$$US-SA-2024SA126825$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240727$$MD$US$US
237927813$23792781$3$F$20240101$20240711$20240429$20240801$PER$$US-SA-2024SA124964$SANOFI AVENTIS$$35$YR$A$M$Y$106$KG$20240719$$MD$US$US
237928002$23792800$2$F$$20240702$20240429$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03369$LUPIN$$$$$$Y$$$20240719$$PH$US$US
237928144$23792814$4$F$20240412$20240823$20240429$20240830$EXP$$US-GSK-US2024AMR051484$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240830$$CN$US$US
237928182$23792818$2$F$$20240805$20240429$20240807$PER$$US-AMGEN-USASP2024084363$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
237928672$23792867$2$F$20240405$20240627$20240429$20240703$EXP$$DE-SA-2024SA127919$SANOFI AVENTIS$$37$YR$A$M$Y$120$KG$20240703$$MD$DE$DE
237928732$23792873$2$F$$20240620$20240429$20240702$PER$$US-SA-2024SA123941$SANOFI AVENTIS$$53$YR$A$M$Y$88.45$KG$20240702$$MD$US$US
237928902$23792890$2$F$$20240729$20240429$20240731$EXP$$JP-ASTELLAS-2024JP000560$ASTELLAS$$8$DEC$$M$Y$$$20240731$$HP$JP$JP
237929004$23792900$4$F$$20240718$20240429$20240723$PER$$NVSC2024US087852$NOVARTIS$$$$$F$Y$103$KG$20240723$$HP$US$US
237929015$23792901$5$F$$20240710$20240429$20240716$EXP$$JP-ASTELLAS-2024JP002769$ASTELLAS$$8$DEC$$M$Y$$$20240716$$MD$JP$JP
237929143$23792914$3$F$$20240805$20240429$20240808$EXP$$JP-SA-2024SA123345$SANOFI AVENTIS$Ishida H.. 117: Two cases of patients with rheumatoid arthritis (RA) acutely exacerbated after dupilumab (DUP) treatment of eosinophilic sinusitis (ECRS).. The 244th Kinki Regional Meeting of the Japanese Society of Internal Medicine (2. UNK;UNK:UNK$69$YR$E$F$Y$$$20240809$$MD$JP$JP
237929212$23792921$2$F$20240314$20240624$20240429$20240702$EXP$FR-AFSSAPS-TS2024000411$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-106030$ZYDUS PHARM$$$$$$Y$$$20240702$$MD$FR$FR
237929304$23792930$4$F$$20240903$20240429$20240907$EXP$$CA-ASTELLAS-2023US038275$ASTELLAS$No information. No information. No information NA;No information:No information.$57$YR$A$M$Y$$$20240907$$MD$CA$CA
237929318$23792931$8$F$20240101$20240912$20240429$20240920$EXP$$CA-CELLTRION INC.-2024CA006868$CELLTRION$$$$$$Y$$$20240920$$MD$CA$CA
237929343$23792934$3$F$20240401$20240611$20240429$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001738$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240705$$CN$US$US
237929553$23792955$3$F$$20240621$20240429$20240701$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202404-000445$UNICHEM$$$$$F$Y$$$20240701$$CN$US$
237929612$23792961$2$F$$20240807$20240429$20240816$PER$$US-SA-2024SA123149$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240816$$MD$US$US
237929662$23792966$2$F$20240423$20240725$20240429$20240729$PER$$US-AMGEN-USASP2024084746$AMGEN$$62$YR$A$F$Y$$$20240728$$CN$US$US
237929692$23792969$2$F$20220501$20240704$20240429$20240706$EXP$$NVSC2022GB138311$NOVARTIS$$25$YR$$M$Y$$$20240706$$CN$GB$GB
237929774$23792977$4$F$20230501$20240916$20240429$20240920$EXP$$GB-MYLANLABS-2023M1083143$MYLAN$$88$YR$$F$Y$88$KG$20240920$$MD$GB$GB
237930012$23793001$2$F$20240425$20240726$20240429$20240730$PER$$US-AMGEN-USASP2024084865$AMGEN$$51$YR$A$M$Y$$$20240730$$CN$US$US
237930022$23793002$2$F$20240123$20240709$20240429$20240710$EXP$$DE-JNJFOC-20240478441$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240710$$MD$DE$DE
237930084$23793008$4$F$20230101$20240726$20240429$20240801$EXP$$JP-ASTELLAS-2024US011874$ASTELLAS$$69$YR$$M$Y$45$KG$20240801$$HP$GB$JP
237930134$23793013$4$F$20220101$20240625$20240429$20240709$EXP$$JP-AMGEN-JPNSP2024085152$AMGEN$Ishida T. Efficacy and safety of avacopan for treatment of ANCA-associated vasculitis. The 68th General Assembly and Scientific Meeting of the Japan College of Rheumatology. 2024 APR;.$79$YR$E$F$Y$48.1$KG$20240709$$MD$JP$JP
237930152$23793015$2$F$20220317$20240808$20240429$20240812$EXP$$CA-UCBSA-2024020298$UCB$$75$YR$$F$Y$$$20240812$$CN$CA$CA
237930313$23793031$3$F$20240401$20240702$20240429$20240711$EXP$$JP-TERSERA THERAPEUTICS LLC-2024TRS002132$TERSERA THERAPEUTICS$$$$$$Y$$$20240711$$MD$JP$JP
237930613$23793061$3$F$20240423$20240506$20240429$20240812$EXP$$NVSC2024CO085339$NOVARTIS$$76$YR$$F$Y$57$KG$20240812$$CN$CO$CO
237930653$23793065$3$F$20201124$20240711$20240429$20240718$EXP$GB-ROCHE-2729221$GB-RDY-SPO/GBR/24/0006274$DR REDDYS$$72$YR$E$F$Y$60$KG$20240718$$MD$GB$GB
237930705$23793070$5$F$$20240831$20240429$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-065807$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240905$$MD$JP$JP
237931963$23793196$3$F$20240223$20240916$20240429$20240925$EXP$$FR-EXELIXIS-XL18424076728$EXELIXIS$$69$YR$$M$Y$66$KG$20240925$$MD$FR$FR
237932306$23793230$6$F$20240415$20240815$20240429$20240820$EXP$$JP-AMGEN-JPNSP2024083581$AMGEN$$72$YR$E$M$Y$68$KG$20240820$$MD$JP$JP
237932412$23793241$2$F$20240211$20240729$20240429$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066057$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$66.9$KG$20240729$$HP$US$US
237932524$23793252$4$F$20240201$20240826$20240429$20240828$EXP$$JP-SAKK-2024SA097539AA$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240829$$MD$JP$JP
237932602$23793260$2$F$20240201$20240829$20240429$20240910$EXP$FR-AFSSAPS-SE2024000273$FR-Accord-420983$ACCORD$$34$YR$A$M$Y$$$20240910$$MD$FR$FR
237932834$23793283$4$F$$20240902$20240429$20240906$EXP$$JP-DSJP-DSJ-2024-118817$DAIICHI$$82$YR$$M$Y$$$20240906$$PH$JP$JP
237933014$23793301$4$F$$20240924$20240429$20240927$EXP$$NVSC2024CA018220$NOVARTIS$$66$YR$$F$Y$$$20240927$$CN$CA$CA
237933073$23793307$3$F$20240118$20240920$20240429$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-066088$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240926$$MD$JP$JP
237933158$23793315$8$F$20240101$20240807$20240429$20240814$EXP$$US-SA-2024SA126268$SANOFI AVENTIS$$53$YR$A$F$Y$88$KG$20240814$$MD$US$US
237933162$23793316$2$F$$20240813$20240429$20240821$PER$$US-SA-2024SA127762$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240821$$MD$US$US
237933222$23793322$2$F$$20240806$20240429$20240814$PER$$US-SA-2024SA124714$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240814$$MD$US$US
237933312$23793331$2$F$20240101$20240712$20240429$20240725$PER$$US-SA-2024SA094856$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240725$$MD$US$US
237933492$23793349$2$F$$20240626$20240429$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03442$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237933513$23793351$3$F$20210401$20240715$20240429$20240717$EXP$$US-GILEAD-2024-0670937$GILEAD$$78$YR$E$F$Y$54.875$KG$20240717$$HP$US$US
237933692$23793369$2$F$20240101$20240808$20240429$20240816$PER$$US-SA-2024SA124258$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240816$$MD$US$US
237933972$23793397$2$F$$20240618$20240429$20240701$30DAY$$TW-JNJFOC-20240467497$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$TW$TW
237934005$23793400$5$F$$20240909$20240429$20240909$PER$$NVSC2024US089096$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
237934202$23793420$2$F$$20240819$20240429$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066454$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240829$$CN$US$US
237934672$23793467$2$F$20240403$20240416$20240429$20240724$EXP$GB-MHRA-TPP52790573C9863460YC1712314866793$GB-BAYER-2024A056253$BAYER$$4$YR$C$F$Y$14$KG$20240724$$HP$GB$GB
237934833$23793483$3$F$20210224$20240704$20240429$20240710$EXP$$NVSC2024ES086509$NOVARTIS$$8$YR$$M$Y$$$20240710$$MD$ES$ES
237934873$23793487$3$F$$20240708$20240429$20240717$EXP$$TR-AMGEN-TURSP2024081620$AMGEN$Ozen, S.. Drug-induced lupus erythematosus in childhood: Case-based review. Lupus. 2024;1-12:10.1177/09612033241245078$16$YR$T$F$Y$$$20240717$$MD$TR$TR
237935176$23793517$6$F$20240319$20240716$20240429$20240722$EXP$$JP-ROCHE-3550477$ROCHE$$54$YR$A$F$Y$56$KG$20240722$$CN$JP$JP
237935197$23793519$7$F$20240424$20240919$20240429$20240925$PER$$US-JNJFOC-20240475971$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240925$$HP$US$US
237935473$23793547$3$F$$20240719$20240429$20240726$EXP$$PA-ROCHE-3552566$ROCHE$$61$YR$A$F$Y$$$20240726$$MD$PA$PA
237935555$23793555$5$F$20240401$20240626$20240429$20240701$PER$$US-JNJFOC-20240475875$JOHNSON AND JOHNSON$$38$YR$A$F$Y$70.37$KG$20240702$$HP$US$US
237935626$23793562$6$F$20240101$20240919$20240429$20240928$EXP$$CA-CELLTRION INC.-2024CA009363$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
237935732$23793573$2$F$$20240910$20240429$20240918$EXP$$CA-GSK-CA2024051144$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$PH$CA$CA
237935852$23793585$2$F$$20240417$20240429$20240702$PER$$US-LEO Pharma-369820$LEO PHARM$$55$YR$$F$Y$$$20240702$$PH$US$US
237935894$23793589$4$F$$20240902$20240429$20240904$30DAY$$AT-PFIZER INC-PV202400046526$PFIZER$$$$$M$Y$$$20240904$$CN$AT$AT
237935956$23793595$6$F$20210903$20240819$20240429$20240830$EXP$$JP-ABBVIE-5735653$ABBVIE$Iguchi E, Tsujii A, Siripongvutikorn Y, Yamamoto K, Yoshimura M, Nakabayashi A, et al. P3-138: A case of rheumatoid arthritis in which PCP and CMV infection developed simultaneously while using JAK inhibitor. The 68th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology. 2024;867.; Iguchi E, Tsujii A, Siripongvutikorn Y, et al. P3-138: A case of rheumatoid arthritis in which PCP and CMV infection developed simultaneously while using JAK inhibitor. The 68th Annua...$70$YR$$F$Y$39$KG$20240830$$MD$JP$JP
237935978$23793597$8$F$20231208$20240703$20240429$20240705$PER$$CA-PFIZER INC-202300443571$PFIZER$$74$YR$$M$Y$73$KG$20240705$$MD$CA$CA
237936002$23793600$2$F$$20240814$20240429$20240814$EXP$$US-BAYER-2024A056433$BAYER$$21$YR$A$F$Y$$$20240814$$HP$US$US
237936362$23793636$2$F$20240601$20240702$20240429$20240711$PER$$US-SA-2024SA128007$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240711$$MD$US$US
237936432$23793643$2$F$$20240722$20240429$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-066029$BRISTOL MYERS SQUIBB$Fukazawa S, et al. A case of granulomatosis with polyangiitis requiring differentiation from infection due to fistula formation in the posterior part of the auricle. The 68th Annual General Assembly and Scientific Meeting of the Japanese College of Rheumatology.$68$YR$E$F$Y$$$20240730$$HP$JP$JP
237936902$23793690$2$F$20240423$20240625$20240429$20240704$30DAY$$US-GSK-US2024052049$GLAXOSMITHKLINE$$74$YR$$M$Y$$$20240704$$CN$US$US
237937252$23793725$2$F$20240101$20240712$20240429$20240722$PER$$US-SA-2024SA125267$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240722$$MD$US$US
237937262$23793726$2$F$$20240819$20240429$20240828$PER$$US-SA-2024SA125253$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240828$$MD$US$US
237937272$23793727$2$F$20240101$20240702$20240429$20240711$PER$$US-SA-2024SA127251$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240711$$MD$US$US
237938145$23793814$5$F$20230401$20240910$20240429$20240912$EXP$$IN-PFIZER INC-PV202300139702$PFIZER$$59$YR$$M$Y$$$20240912$$CN$IN$IN
237938162$23793816$2$F$20230401$20240923$20240429$20240926$EXP$$CA-PFIZER INC-202300148393$PFIZER$$73$YR$$M$Y$$$20240926$$MD$CA$CA
237938223$23793822$3$F$$20240920$20240429$20240924$PER$$NVSC2024US087716$NOVARTIS$$36$YR$$F$Y$$$20240924$$CN$US$US
237938397$23793839$7$F$$20240905$20240429$20240911$30DAY$$US-PFIZER INC-202400089295$PFIZER$$7$YR$$M$Y$$$20240911$$CN$US$US
237938514$23793851$4$F$$20240830$20240429$20240912$PER$$US-SA-2024SA127487$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240912$$MD$US$US
237938553$23793855$3$F$$20240702$20240429$20240705$30DAY$$IE-PFIZER INC-PV202400048594$PFIZER$$23$YR$$M$Y$$$20240705$$HP$IE$IE
237938834$23793883$4$F$20240415$20240625$20240429$20240701$30DAY$$DE-PFIZER INC-202400087471$PFIZER$$36$YR$$F$Y$$$20240701$$PH$DE$DE
237938845$23793884$5$F$$20240906$20240429$20240910$30DAY$$US-PFIZER INC-202400089423$PFIZER$$16$YR$$M$Y$86.168$KG$20240910$$CN$US$US
237938854$23793885$4$F$20240313$20240821$20240429$20240829$EXP$$AU-BEH-2024171071$CSL BEHRING$$71$YR$E$F$Y$47.6$KG$20240829$$CN$AU$AU
237938992$23793899$2$F$20240314$20240729$20240429$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065990$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240729$$HP$US$US
237939073$23793907$3$F$20240413$20240718$20240429$20240725$PER$$US-BIOVITRUM-2024-US-006175$BIOVITRUM$$10$YR$$F$Y$$$20240725$$CN$US$US
237939186$23793918$6$F$$20240726$20240429$20240826$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-07190$IPSEN$$$$$M$Y$91$KG$20240826$$HP$US$US
237939203$23793920$3$F$$20240709$20240429$20240715$30DAY$$FR-PFIZER INC-PV202400050509$PFIZER$$3$YR$$M$Y$$$20240715$$HP$FR$FR
237939213$23793921$3$F$$20240709$20240429$20240711$30DAY$$FR-PFIZER INC-202400087419$PFIZER$$5$MON$$M$Y$$$20240711$$PH$FR$FR
237939522$23793952$2$F$$20240711$20240429$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03381$LUPIN$$$$$$Y$$$20240808$$CN$US$US
237939572$23793957$2$F$20231130$20240827$20240429$20240902$EXP$$JP-009507513-2404JPN003165J$MERCK$$8$DEC$$M$Y$$$20240902$$MD$JP$JP
237939932$23793993$2$F$$20240703$20240429$20240712$PER$$US-SA-2024SA123850$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240712$$MD$US$US
237940123$23794012$3$F$20240201$20240730$20240429$20240808$PER$$US-SA-2024SA128269$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240808$$MD$US$US
237940212$23794021$2$F$20230101$20240912$20240429$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063301$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240918$$HP$US$US
237940352$23794035$2$F$$20240904$20240429$20240913$EXP$$CA-TEVA-VS-3190640$TEVA$$34$YR$$F$Y$$$20240913$$CN$CA$CA
237940405$23794040$5$F$$20240827$20240429$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066184$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240828$$HP$US$US
237940506$23794050$6$F$$20240905$20240429$20240906$30DAY$$US-PFIZER INC-202400089109$PFIZER$$3$YR$$F$Y$$$20240906$$CN$US$US
237940826$23794082$6$F$$20240917$20240429$20240920$30DAY$$US-PFIZER INC-202400089146$PFIZER$$7$YR$$M$Y$$$20240920$$MD$US$US
237940854$23794085$4$F$$20240906$20240429$20240911$30DAY$$US-PFIZER INC-PV202400046334$PFIZER$$12$YR$$M$Y$$$20240911$$CN$US$US
237941115$23794111$5$F$20240810$20240905$20240429$20240909$EXP$$IN-PFIZER INC-PV202400023690$PFIZER$$53$YR$$F$Y$66$KG$20240909$$CN$IN$IN
237941212$23794121$2$F$$20240903$20240429$20240906$EXP$$JP-AstraZeneca-2024A099633$ASTRAZENECA$$80$YR$$M$Y$$$20240906$$MD$JP$
237941252$23794125$2$F$$20240711$20240429$20240716$EXP$$FR-MYLANLABS-2024M1036589$MYLAN$$$$$F$Y$$$20240716$$CN$FR$FR
237941414$23794141$4$F$20240401$20240910$20240429$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066424$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240912$$CN$US$US
237941422$23794142$2$F$$20240729$20240429$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066138$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240729$$MD$US$US
237941523$23794152$3$F$20240401$20240730$20240429$20240809$EXP$$US-GSK-US2024AMR052350$GLAXOSMITHKLINE$$64$YR$$F$Y$63.039$KG$20240809$$CN$US$US
237941572$23794157$2$F$20210101$20240621$20240429$20240702$EXP$$RU-SA-2024SA123693$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240702$$MD$RU$RU
237941938$23794193$8$F$$20240906$20240429$20240910$30DAY$$US-PFIZER INC-202400091230$PFIZER$$12$YR$$M$Y$$$20240910$$CN$US$US
237942173$23794217$3$F$$20240726$20240429$20240802$EXP$$NL-MYLANLABS-2024M1037012$MYLAN$Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, van der Knaap MS, Bugiani M, Wolf NI.. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series.. J Neurol. 2024;271:4028-4038$27$MON$$M$Y$$$20240802$$HP$NL$NL
237942223$23794222$3$F$$20240910$20240429$20240916$30DAY$$KR-PFIZER INC-PV202400050595$PFIZER$$10$YR$$M$Y$$$20240916$$CN$KR$KR
237942255$23794225$5$F$$20240905$20240429$20240910$30DAY$$US-PFIZER INC-202400089000$PFIZER$$13$YR$$M$Y$$$20240910$$CN$US$US
237942266$23794226$6$F$$20240906$20240429$20240910$30DAY$$US-PFIZER INC-202400090535$PFIZER$$14$YR$$M$Y$49.9$KG$20240910$$MD$US$US
237942274$23794227$4$F$20240422$20240725$20240429$20240801$EXP$$NVSC2024US090333$NOVARTIS$$68$YR$$F$Y$78$KG$20240801$$CN$US$US
237942385$23794238$5$F$$20240913$20240429$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065579$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240919$$CN$US$US
237942447$23794244$7$F$$20240913$20240429$20240918$30DAY$$US-PFIZER INC-202400091113$PFIZER$$10$YR$$M$Y$$$20240918$$CN$US$US
237942473$23794247$3$F$$20240711$20240429$20240715$30DAY$$US-PFIZER INC-PV202400044560$PFIZER$$$$$$Y$$$20240715$$CN$US$US
237942602$23794260$2$F$$20240624$20240429$20240701$30DAY$$US-PFIZER INC-PV202400048906$PFIZER$$52$YR$$M$Y$75.3$KG$20240701$$CN$US$US
237942922$23794292$2$F$20240129$20240625$20240429$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-443333$RANBAXY$$67$YR$$M$Y$80$KG$20240710$$MD$GB$GB
237942976$23794297$6$F$$20240905$20240429$20240911$EXP$$CA-TAKEDA-2024TUS039070$TAKEDA$$$$$F$Y$$$20240911$$CN$CA$CA
237943012$23794301$2$F$$20240706$20240429$20240710$EXP$$US-GSK-US2024AMR053074$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$US$US
237943083$23794308$3$F$20240123$20240925$20240429$20240930$EXP$$PT-ORGANON-O2404PRT003403$ORGANON$$29$YR$$F$Y$$$20240930$$MD$PT$PT
237943245$23794324$5$F$$20240905$20240429$20240913$30DAY$$DO-PFIZER INC-PV202400047937$PFIZER$$12$YR$$M$Y$$$20240913$$HP$DO$DO
237943432$23794343$2$F$$20240509$20240429$20240709$PER$$IT-AVEVA-000634$AVEVA$Basilicata P, Marisei M, Guadagni R, Sibilio M, Niola M, Pieri M. Pediatric poisoning management: How clinical practice can benefit from forensic approach. J Forensic Sci. 2024, doi: 10.1111/1556-4029.15517. PMID: 38558455.$$$$$Y$$$20240606$$HP$IT$IT
237943623$23794362$3$F$$20240918$20240429$20240928$EXP$$US-SA-2024SA126790$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240928$$MD$US$US
237943812$23794381$2$F$$20240711$20240429$20240717$EXP$$FR-MYLANLABS-2024M1036633$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237943832$23794383$2$F$$20240711$20240429$20240717$EXP$$FR-MYLANLABS-2024M1036726$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237943842$23794384$2$F$$20240711$20240429$20240717$EXP$$FR-MYLANLABS-2024M1036631$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237943872$23794387$2$F$$20240711$20240429$20240717$EXP$$FR-MYLANLABS-2024M1036728$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237943922$23794392$2$F$$20240711$20240429$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03411$LUPIN$$$$$$Y$$$20240809$$CN$US$US
237944072$23794407$2$F$20240414$20240829$20240429$20240911$PER$$US-SA-2024SA123769$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240911$$MD$US$US
237944182$23794418$2$F$$20240418$20240429$20240719$EXP$$US-TEVA-VS-3186718$TEVA$$62$YR$$M$Y$$$20240719$$HP$US$US
237944534$23794453$4$F$20220118$20240725$20240429$20240730$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-025321$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$92.6$KG$20240730$$MD$DE$DE
237944568$23794456$8$F$$20240910$20240429$20240917$EXP$$CA-GSK-CA2024051882$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
237944632$23794463$2$F$20230101$20240903$20240429$20240925$PER$$US-SA-2024SA127689$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240925$$MD$US$US
237944853$23794485$3$F$20240408$20240907$20240429$20240910$30DAY$$US-PFIZER INC-202400089942$PFIZER$$12$YR$$M$Y$31.75$KG$20240910$$CN$US$US
237944874$23794487$4$F$$20240918$20240429$20240923$30DAY$$US-PFIZER INC-PV202400052065$PFIZER$$$$$M$Y$$$20240923$$HP$US$US
237944884$23794488$4$F$$20240911$20240429$20240913$30DAY$$US-PFIZER INC-202400090298$PFIZER$$5$YR$$F$Y$$$20240913$$CN$US$US
237944893$23794489$3$F$$20240912$20240429$20240917$30DAY$$US-PFIZER INC-PV202400044289$PFIZER$$$$$$Y$$$20240917$$HP$US$US
237944914$23794491$4$F$$20240913$20240429$20240918$30DAY$$US-PFIZER INC-202400090411$PFIZER$$11$YR$$M$Y$$$20240918$$HP$US$US
237944943$23794494$3$F$$20240903$20240429$20240906$30DAY$$US-PFIZER INC-202400092779$PFIZER$$11$YR$$M$Y$$$20240906$$CN$US$US
237944954$23794495$4$F$$20240814$20240429$20240814$30DAY$$KR-PFIZER INC-202400089260$PFIZER$$$$$$Y$$$20240814$$CN$KR$KR
237944963$23794496$3$F$$20240912$20240429$20240917$30DAY$$US-PFIZER INC-PV202400050994$PFIZER$$$$$$Y$$$20240917$$CN$US$US
237944975$23794497$5$F$20240401$20240924$20240429$20240927$30DAY$$US-PFIZER INC-202400090384$PFIZER$$10$YR$$F$Y$27.22$KG$20240927$$MD$US$US
237944985$23794498$5$F$$20240905$20240429$20240910$30DAY$$US-PFIZER INC-202400089091$PFIZER$$7$YR$$M$Y$$$20240910$$CN$US$US
237944993$23794499$3$F$20240416$20240904$20240429$20240909$30DAY$$US-PFIZER INC-202400090223$PFIZER$$9$YR$$M$Y$25.4$KG$20240909$$CN$US$US
237945003$23794500$3$F$$20240905$20240429$20240912$30DAY$$US-PFIZER INC-202400091011$PFIZER$$11$YR$$M$Y$$$20240912$$CN$US$US
237945012$23794501$2$F$$20240801$20240429$20240812$EXP$$US-ALXN-202404USA001769US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
237945033$23794503$3$F$$20240425$20240429$20240923$EXP$$NVSC2024DE088778$NOVARTIS$$22$YR$$F$Y$85$KG$20240923$$MD$DE$DE
237945042$23794504$2$F$$20240924$20240429$20240925$EXP$$CA-HALEON-2168468$Haleon PLC$$68$YR$$M$Y$$$20240925$$HP$CA$CA
237945062$23794506$2$F$20240415$20240712$20240429$20240715$EXP$$NVSC2024DE084555$NOVARTIS$$82$YR$$F$Y$$$20240716$$MD$DE$DE
237945112$23794511$2$F$20240101$20240725$20240429$20240805$PER$$US-SA-2024SA127878$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240804$$MD$US$US
237945512$23794551$2$F$$20240415$20240429$20240814$EXP$$CA-HALEON-2169784$Haleon PLC$$75$YR$$F$Y$70$KG$20240814$$HP$CA$CA
237945563$23794556$3$F$20230701$20240906$20240429$20240913$EXP$$CA-GSK-CA2023AMR104005$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$CA$CA
237945572$23794557$2$F$$20240711$20240429$20240715$EXP$$CA-PFIZER INC-202400093665$PFIZER$$77$YR$$F$Y$$$20240715$$HP$CA$CA
237945582$23794558$2$F$20240422$20240711$20240429$20240715$EXP$$US-PFIZER INC-PV202400055110$PFIZER$$76$YR$$F$Y$$$20240715$$CN$US$US
237945702$23794570$2$F$$20240814$20240429$20240820$EXP$$HU-MYLANLABS-2024M1036918$MYLAN$$$$A$F$Y$$$20240820$$HP$HU$HU
237945752$23794575$2$F$20240407$20240409$20240429$20240826$EXP$$US-BAXTER-2024BAX017262$BAXTER$$$$$$Y$$$20240826$$PH$US$US
237945854$23794585$4$F$20240101$20240715$20240429$20240722$EXP$$CA-UCBSA-2024015445$UCB$$75$YR$$F$Y$$$20240719$$CN$CA$CA
237945865$23794586$5$F$20210101$20240917$20240429$20240920$30DAY$$US-PFIZER INC-202400091180$PFIZER$$7$YR$$F$Y$22.676$KG$20240920$$CN$US$US
237945883$23794588$3$F$20230301$20240627$20240429$20240702$30DAY$$AR-PFIZER INC-202400091652$PFIZER$$52$YR$$F$Y$$$20240702$$CN$AR$AR
237945894$23794589$4$F$$20240910$20240429$20240912$30DAY$$US-PFIZER INC-PV202400049210$PFIZER$$1$YR$$M$Y$8.745$KG$20240912$$MD$US$US
237945924$23794592$4$F$$20240703$20240429$20240704$PER$$US-PFIZER INC-PV202400054827$PFIZER$$71$YR$$$Y$$$20240704$$MD$US$US
237946192$23794619$2$F$$20240715$20240429$20240723$EXP$$US-BAYER-2024A028179$BAYER$$53$YR$A$F$Y$$$20240723$$CN$US$US
237946202$23794620$2$F$20231004$20240814$20240429$20240819$EXP$$US-UCBSA-2023049031$UCB$$79$YR$$F$Y$$$20240819$$CN$US$US
237946362$23794636$2$F$20240401$20240719$20240429$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066513$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$103.42$KG$20240726$$CN$US$US
237946372$23794637$2$F$$20240628$20240429$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065949$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240701$$CN$US$US
237946533$23794653$3$F$$20240703$20240429$20240703$PER$$NVSC2024US087872$NOVARTIS$$$$A$F$Y$$$20240703$$MD$US$US
237946572$23794657$2$F$20240423$20240807$20240429$20240809$30DAY$$US-SANDOZ INC.-SDZ2024US042837$SANDOZ$$82$YR$$$Y$$$20240809$$HP$US$US
237946582$23794658$2$F$20230817$20240817$20240429$20240823$EXP$$NO-ORGANON-O2404NOR003302$ORGANON$$$$$F$Y$$$20240823$$HP$NO$NO
237946622$23794662$2$F$$20240711$20240429$20240717$EXP$$FR-MYLANLABS-2024M1037047$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237946632$23794663$2$F$$20240711$20240429$20240717$EXP$$FR-MYLANLABS-2024M1037052$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237946652$23794665$2$F$$20240711$20240429$20240717$EXP$$FR-MYLANLABS-2024M1037056$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
237946662$23794666$2$F$$20240805$20240429$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-065706$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$MD$JP$JP
237946727$23794672$7$F$$20240923$20240429$20240927$30DAY$$US-PFIZER INC-202400090237$PFIZER$$14$YR$$M$Y$49.9$KG$20240927$$MD$US$US
237946735$23794673$5$F$$20240915$20240429$20240919$30DAY$$US-PFIZER INC-202400091160$PFIZER$$16$YR$$M$Y$$$20240919$$HP$US$US
237946755$23794675$5$F$$20240912$20240429$20240918$30DAY$$US-PFIZER INC-202400091172$PFIZER$$12$YR$$F$Y$$$20240918$$HP$US$US
237946783$23794678$3$F$$20240907$20240429$20240911$30DAY$$US-PFIZER INC-202400090429$PFIZER$$15$YR$$M$Y$58.97$KG$20240911$$CN$US$US
237946814$23794681$4$F$$20240905$20240429$20240906$30DAY$$US-PFIZER INC-202400089266$PFIZER$$15$YR$$M$Y$43.09$KG$20240906$$CN$US$US
237946824$23794682$4$F$20240401$20240906$20240429$20240910$30DAY$$US-PFIZER INC-202400091178$PFIZER$$14$YR$$M$Y$40.82$KG$20240910$$HP$US$US
237946844$23794684$4$F$$20240906$20240429$20240910$30DAY$$US-PFIZER INC-202400090676$PFIZER$$7$YR$$F$Y$$$20240910$$CN$US$US
237946855$23794685$5$F$$20240910$20240429$20240912$30DAY$$US-PFIZER INC-202400090952$PFIZER$$11$YR$$F$Y$$$20240912$$CN$US$US
237946912$23794691$2$F$$20240703$20240429$20240711$EXP$$JP-AMGEN-JPNSP2024083065$AMGEN$$$$$$Y$$$20240711$$MD$JP$JP
237946922$23794692$2$F$$20240806$20240429$20240816$PER$$US-SA-2024SA128471$SANOFI AVENTIS$$5$YR$C$M$Y$27$KG$20240816$$MD$US$US
237947073$23794707$3$F$$20240904$20240429$20240912$EXP$$GR-BRISTOL-MYERS SQUIBB COMPANY-2024-065697$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240912$$MD$GR$GR
237947184$23794718$4$F$20230831$20240917$20240429$20240927$EXP$$CA-TAKEDA-2023TUS121551$TAKEDA$$40$YR$$F$Y$$$20240927$$CN$CA$CA
237947193$23794719$3$F$$20240809$20240429$20240813$EXP$$US-BIOVITRUM-2024-US-005870$BIOVITRUM$$70$YR$$M$Y$$$20240813$$CN$US$US
237947223$23794722$3$F$20230601$20240718$20240429$20240723$EXP$$US-ROCHE-3553017$ROCHE$$72$YR$E$F$Y$$$20240723$$MD$US$US
237947242$23794724$2$F$20221115$20240724$20240429$20240801$PER$$US-BAYER-2024A059143$BAYER$$79$YR$E$M$Y$$$20240801$$CN$US$US
237947822$23794782$2$F$$20240719$20240429$20240730$PER$$US-SA-2024SA127821$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240730$$MD$US$US
237947932$23794793$2$F$$20240910$20240429$20240916$EXP$$GB-SANDOZ INC.-SDZ2024GB043483$SANDOZ$$$$$F$Y$$$20240916$$CN$GB$GB
237948162$23794816$2$F$20240324$20240628$20240429$20240701$EXP$$NVSC2024US090209$NOVARTIS$$74$YR$$M$Y$$$20240701$$CN$US$US
237948186$23794818$6$F$20240529$20240913$20240429$20240920$EXP$$CA-GSK-CA2024006270$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$MD$CA$CA
237948382$23794838$2$F$$20240814$20240429$20240828$PER$$US-SA-2024SA127858$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240828$$MD$US$US
237948402$23794840$2$F$20240101$20240729$20240429$20240806$EXP$$JP-009507513-2404JPN003346J$MERCK$$$$$F$Y$$$20240806$$PH$JP$JP
237948434$23794843$4$F$20240419$20240625$20240429$20240702$EXP$$US-TRAVERE-2024TVT00394$TRAVERE THERAPEUTICS$$48$YR$A$M$Y$$$20240702$$CN$US$US
237948503$23794850$3$F$$20240819$20240429$20240821$EXP$$NVSC2024US087676$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
237948662$23794866$2$F$$20240628$20240429$20240702$EXP$$NVSC2024BR089760$NOVARTIS$$$$$F$Y$$$20240702$$MD$BR$BR
237948755$23794875$5$F$$20240917$20240429$20240920$30DAY$$US-PFIZER INC-202400093077$PFIZER$$12$YR$$F$Y$$$20240920$$CN$US$US
237948795$23794879$5$F$$20240913$20240429$20240918$30DAY$$US-PFIZER INC-202400092176$PFIZER$$15$YR$$F$Y$$$20240918$$CN$US$US
237948809$23794880$9$F$$20240917$20240429$20240920$30DAY$$US-PFIZER INC-202400091928$PFIZER$$14$YR$$M$Y$$$20240920$$CN$US$US
237948814$23794881$4$F$20240418$20240905$20240429$20240909$30DAY$$US-PFIZER INC-202400091801$PFIZER$$15$YR$$M$Y$49.9$KG$20240909$$HP$US$US
237948834$23794883$4$F$20240401$20240709$20240429$20240723$PER$$US-BEH-2024171490$CSL BEHRING$$22$YR$A$M$Y$$$20240723$$CN$US$US
237948875$23794887$5$F$$20240912$20240429$20240916$30DAY$$US-PFIZER INC-202400092941$PFIZER$$13$YR$$M$Y$$$20240916$$CN$US$US
237948902$23794890$2$F$20230921$20240815$20240429$20240820$EXP$$CA-TAKEDA-2023TUS093324$TAKEDA$$71$YR$$F$Y$$$20240820$$CN$CA$CA
237949302$23794930$2$F$20240415$20240902$20240429$20240912$EXP$GB-MHRA-MED-202404171040588320-QCKMP$GB-TEVA-VS-3187396$TEVA$$79$YR$$F$Y$63$KG$20240912$$PH$GB$GB
237949485$23794948$5$F$20240421$20240909$20240429$20240911$30DAY$$US-PFIZER INC-202400092871$PFIZER$$15$YR$$M$Y$68.49$KG$20240911$$CN$US$US
237949496$23794949$6$F$$20240915$20240429$20240919$30DAY$$US-PFIZER INC-202400093072$PFIZER$$8$YR$$M$Y$$$20240919$$CN$US$US
237949506$23794950$6$F$20240421$20240906$20240429$20240910$30DAY$$US-PFIZER INC-202400092958$PFIZER$$11$YR$$M$Y$29.48$KG$20240910$$HP$US$US
237949707$23794970$7$F$$20240911$20240429$20240913$EXP$$CA-HLS-202401067$HLS THERAPEUTICS$$$$A$M$Y$$$20240913$$MD$CA$CA
237949813$23794981$3$F$$20240711$20240429$20240711$EXP$$GB-JNJFOC-20240465024$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240711$$HP$GB$GB
237949842$23794984$2$F$$20240719$20240429$20240727$PER$$US-SA-2024SA128776$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240727$$MD$US$US
237949982$23794998$2$F$$20240729$20240429$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064358$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240729$$CN$US$US
237950102$23795010$2$F$20200101$20240628$20240429$20240701$EXP$$DE-PFIZER INC-202101060605$PFIZER$$77$YR$$F$Y$$$20240701$$MD$DE$DE
237950393$23795039$3$F$$20240618$20240429$20240703$30DAY$$TR-JNJFOC-20240482109$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$TR$TR
237950785$23795078$5$F$20240301$20240627$20240429$20240815$30DAY$$AR-PFIZER INC-PV202400047991$PFIZER$$66$YR$$F$Y$$$20240815$$HP$AR$AR
237950952$23795095$2$F$20230101$20240403$20240429$20240813$PER$$US-SPECGX-T202301788$SPECGX$$$$$M$Y$$$20240813$$CN$US$US
237951054$23795105$4$F$20220222$20240710$20240429$20240712$EXP$$JP-DSJP-DSJ-2024-118635$DAIICHI$$54$YR$$F$Y$$$20240712$$MD$JP$JP
237951068$23795106$8$F$$20240914$20240429$20240920$30DAY$$PA-PFIZER INC-PV202400048564$PFIZER$$14$YR$$M$Y$$$20240920$$HP$PA$PA
237951143$23795114$3$F$$20240705$20240429$20240705$PER$$NVSC2024US090338$NOVARTIS$$$$$M$Y$$$20240705$$MD$US$US
237951252$23795125$2$F$20240425$20240729$20240429$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066648$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240729$$CN$US$US
237951272$23795127$2$F$$20240805$20240429$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-065883$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$MD$JP$JP
237951304$23795130$4$F$$20240605$20240429$20240925$EXP$$JP-ABBVIE-5735574$ABBVIE$Tsushima T, Sato N, Guo Y, Nakamura H, Kunisada K, Chi S, et al. Richter transformation acquiring PLCG2 mutation during Bruton tyrosine kinase inhibitors treatment. eJHaem. 2024;jha2.891.$72$YR$$M$Y$$$20240925$$MD$JP$JP
237951352$23795135$2$F$$20240906$20240429$20240913$EXP$$US-GILEAD-2024-0670807$GILEAD$$71$YR$E$M$Y$$$20240913$$MD$US$US
237951552$23795155$2$F$$20240731$20240429$20240809$PER$$US-SA-2024SA123863$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240809$$MD$US$US
237951612$23795161$2$F$20230205$20240807$20240429$20240812$30DAY$$US-SANDOZ INC.-NVSC2023US029180$SANDOZ$$16$YR$$M$Y$$$20240812$$CN$US$US
237952283$23795228$3$F$20230830$20240624$20240429$20240703$EXP$DE-EMA-DD-20240417-7482679-083717$DE-RDY-SPO/DEU/24/0006130$DR REDDYS$$91$YR$E$M$Y$94$KG$20240703$$HP$DE$DE
237952324$23795232$4$F$20240417$20240828$20240429$20240904$EXP$$CN-BEH-2024171130$CSL BEHRING$$70$YR$E$M$Y$61$KG$20240904$$HP$CN$CN
237952493$23795249$3$F$$20240723$20240429$20240729$EXP$$JP-AMGEN-JPNSP2024083332$AMGEN$$84$YR$E$F$Y$$$20240729$$MD$JP$JP
237952712$23795271$2$F$$20240813$20240429$20240816$EXP$$JP-PFIZER INC-PV202400053607$PFIZER$Tokui, H.. A case of Palindromic rheumatism in which drug-induced serositis occurred during treatment with salazosulfapyridine. The 68th Annual General Assembly and Scientific Meeting of the Japan College of. 2024;68th:935$7$DEC$$M$Y$$$20240816$$MD$JP$JP
237952852$23795285$2$F$20240419$20240621$20240429$20240703$PER$$US-SA-2024SA124160$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240703$$MD$US$US
237952912$23795291$2$F$20240101$20240805$20240429$20240813$EXP$FR-AFSSAPS-LM2024000180$FR-TEVA-VS-3188483$TEVA$$77$YR$$F$Y$$$20240813$$MD$FR$FR
237953057$23795305$7$F$20240201$20240813$20240429$20240816$30DAY$$NO-PFIZER INC-PV202400049046$PFIZER$$$$$F$Y$$$20240816$$CN$NO$NO
237953093$23795309$3$F$20240320$20240918$20240429$20240925$EXP$$FR-TAKEDA-2024TUS038918$TAKEDA$$42$YR$$M$Y$$$20240925$$HP$FR$FR
237953213$23795321$3$F$$20240729$20240429$20240801$PER$$US-PFIZER INC-PV202400054904$PFIZER$$73$YR$$F$Y$$$20240801$$HP$US$US
237953252$23795325$2$F$20230101$20240404$20240429$20240927$PER$$US-TPU-TPU-2024-00139$TEIKOKU$$73$YR$E$F$Y$58.97$KG$20240927$$CN$US$US
237953465$23795346$5$F$20160801$20240708$20240429$20240712$EXP$$FR-MYLANLABS-2024M1034101$MYLAN$$34$YR$$M$Y$$$20240712$$CN$FR$FR
237953555$23795355$5$F$20240501$20240705$20240429$20240709$PER$$US-PFIZER INC-PV202400054914$PFIZER$$74$YR$$F$Y$$$20240709$$HP$US$US
237953568$23795356$8$F$20210721$20240815$20240429$20240819$EXP$$CA-TAKEDA-2021TUS037378$TAKEDA$$24$YR$$M$Y$$$20240819$$HP$CA$CA
237953577$23795357$7$F$20240101$20240801$20240429$20240806$EXP$$CA-PFIZER INC-202400070355$PFIZER$$58$YR$$M$Y$$$20240806$$HP$CA$CA
237953605$23795360$5$F$$20240909$20240429$20240911$30DAY$$US-PFIZER INC-202400093619$PFIZER$$22$YR$$F$Y$$$20240911$$CN$US$US
237953619$23795361$9$F$$20240921$20240429$20240925$30DAY$$US-PFIZER INC-202400093037$PFIZER$$15$YR$$F$Y$58.97$KG$20240925$$CN$US$US
237953682$23795368$2$F$20240423$20240626$20240429$20240701$EXP$$US-KYOWAKIRIN-2024KK010022$KYOWA$$$$$$Y$$$20240701$$CN$US$US
237953745$23795374$5$F$$20240915$20240429$20240919$30DAY$$US-PFIZER INC-202400093433$PFIZER$$15$YR$$M$Y$$$20240919$$CN$US$US
237953842$23795384$2$F$$20240814$20240429$20240820$EXP$$CA-TAKEDA-2024TUS038990$TAKEDA$$$$$M$Y$$$20240820$$MD$CA$CA
237953902$23795390$2$F$$20240808$20240429$20240817$PER$$US-SA-2024SA124344$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240817$$MD$US$US
237954093$23795409$3$F$20240402$20240718$20240429$20240724$EXP$$CA-BEH-2024171226$CSL BEHRING$$58$YR$A$M$Y$111$KG$20240724$$MD$CA$CA
237954133$23795413$3$F$$20240726$20240429$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066951$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240729$$CN$US$US
237954164$23795416$4$F$20230101$20240828$20240429$20240902$EXP$$NVSC2024DE088103$NOVARTIS$$$$A$F$Y$$$20240902$$MD$DE$DE
237954214$23795421$4$F$20240420$20240918$20240429$20240923$30DAY$$US-PFIZER INC-202400093165$PFIZER$$13$YR$$F$Y$$$20240923$$CN$US$US
237954224$23795422$4$F$20240419$20240909$20240429$20240911$30DAY$$US-PFIZER INC-202400092917$PFIZER$$15$YR$$M$Y$$$20240911$$CN$US$US
237954262$23795426$2$F$$20240722$20240429$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000363$DECIPHERA PHARMACEUTICALS$$80$YR$E$F$Y$$$20240806$$HP$US$US
237954273$23795427$3$F$$20240718$20240429$20240725$EXP$$US-TAKEDA-2024TUS040242$TAKEDA$$$$$M$Y$$$20240725$$CN$US$US
237954284$23795428$4$F$20221115$20240915$20240429$20240927$EXP$$CN-GILEAD-2023-0639600$GILEAD$$68$YR$E$M$Y$$$20240927$$MD$CN$CN
237954322$23795432$2$F$$20240812$20240429$20240820$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000361$DECIPHERA PHARMACEUTICALS$$67$YR$A$F$Y$$$20240820$$CN$US$US
237954364$23795436$4$F$$20240905$20240429$20240910$30DAY$$US-PFIZER INC-202400091017$PFIZER$$13$YR$$M$Y$$$20240910$$CN$US$US
237954375$23795437$5$F$$20240907$20240429$20240912$30DAY$$US-PFIZER INC-202400091913$PFIZER$$7$YR$$F$Y$$$20240912$$CN$US$US
237954452$23795445$2$F$$20240708$20240429$20240715$EXP$$CA-OTSUKA-2024_010889$OTSUKA$$$$$F$Y$$$20240715$$MD$CA$CA
237954765$23795476$5$F$20240101$20240802$20240429$20240807$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000343$DECIPHERA PHARMACEUTICALS$$77$YR$E$F$Y$$$20240807$$CN$US$US
237954782$23795478$2$F$20240201$20240830$20240429$20240909$EXP$FR-AFSSAPS-SE2024000273$FR-TEVA-VS-3188716$TEVA$$34$YR$$M$Y$$$20240909$$MD$FR$FR
237954995$23795499$5$F$$20240909$20240429$20240911$30DAY$$US-PFIZER INC-202400093080$PFIZER$$8$YR$$M$Y$25.4$KG$20240911$$HP$US$US
237955122$23795512$2$F$$20240913$20240429$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066932$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240913$$CN$US$US
237955133$23795513$3$F$20240308$20240716$20240429$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066765$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$65.77$KG$20240724$$CN$US$US
237955172$23795517$2$F$$20240904$20240429$20240919$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000364$DECIPHERA PHARMACEUTICALS$$53$YR$A$F$Y$83.7$KG$20240919$$CN$US$US
237955492$23795549$2$F$$20240715$20240429$20240724$PER$$NVSC2024US090193$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
237955504$23795550$4$F$$20240906$20240429$20240910$30DAY$$US-PFIZER INC-202400092964$PFIZER$$17$YR$$F$Y$$$20240910$$CN$US$US
237955555$23795555$5$F$20240723$20240822$20240429$20240827$EXP$$US-PFIZER INC-PV202400054993$PFIZER$$65$YR$$F$Y$81.633$KG$20240827$$CN$US$US
237955593$23795559$3$F$$20240911$20240429$20240913$30DAY$$US-PFIZER INC-202400091731$PFIZER$$4$YR$$M$Y$$$20240913$$CN$US$US
237955604$23795560$4$F$20240101$20240913$20240429$20240918$30DAY$$US-PFIZER INC-202400092859$PFIZER$$10$YR$$M$Y$34.93$KG$20240918$$CN$US$US
237955615$23795561$5$F$$20240914$20240429$20240919$30DAY$$US-PFIZER INC-202400092974$PFIZER$$5$YR$$F$Y$13.77$KG$20240919$$CN$US$US
237955904$23795590$4$F$$20240917$20240429$20240920$30DAY$$US-PFIZER INC-202400093343$PFIZER$$70$YR$$F$Y$$$20240920$$CN$US$US
237955914$23795591$4$F$$20240913$20240429$20240918$30DAY$$US-PFIZER INC-202400093247$PFIZER$$5$YR$$F$Y$$$20240918$$CN$US$US
237955938$23795593$8$F$$20240918$20240429$20240920$30DAY$$US-PFIZER INC-202400093051$PFIZER$$9$YR$$F$Y$18.14$KG$20240920$$MD$US$US
237955942$23795594$2$F$$20240711$20240429$20240711$PER$$NVSC2024US088949$NOVARTIS$$$$$$Y$$$20240711$$MD$US$US
237956172$23795617$2$F$20240401$20240809$20240429$20240903$PER$$US-KARYOPHARM-2024KPT000914$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
237956232$23795623$2$F$20240414$20240722$20240429$20240731$PER$$US-SA-2024SA124411$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240731$$MD$US$US
237956492$23795649$2$F$20240401$20240624$20240429$20240703$PER$$US-VERTEX PHARMACEUTICALS-2024-006886$VERTEX$$7$YR$$F$Y$$$20240703$$MD$US$US
237956672$23795667$2$F$$20240816$20240429$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066595$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$98.88$KG$20240823$$CN$US$US
237956693$23795669$3$F$20231201$20240724$20240429$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066431$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240725$$CN$US$US
237956993$23795699$3$F$20240305$20240711$20240429$20240715$EXP$$GB-009507513-2404GBR011105$MERCK$$52$YR$$M$Y$88$KG$20240715$$CN$GB$GB
237957244$23795724$4$F$20240101$20240719$20240429$20240727$PER$$US-SA-2024SA127688$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240727$$MD$US$US
237957682$23795768$2$F$20240418$20240428$20240429$20240918$EXP$FR-AFSSAPS-TS2024000489$FR-BAUSCH-BL-2024-006744$BAUSCH AND LOMB$$71$YR$$F$Y$82$KG$20240918$$MD$FR$FR
237957722$23795772$2$F$20240411$20240708$20240429$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066790$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$64.1$KG$20240710$$PH$US$US
237957732$23795773$2$F$20240426$20240830$20240429$20240903$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-066631$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$66.22$KG$20240903$$CN$PR$PR
237957832$23795783$2$F$$20240719$20240429$20240722$PER$$US-PFIZER INC-PV202400056150$PFIZER$$59$YR$$M$Y$$$20240722$$HP$US$US
237957972$23795797$2$F$20240401$20240816$20240429$20240822$EXP$$JP-009507513-2404JPN002946J$MERCK$$64$YR$$M$Y$$$20240822$$MD$JP$JP
237958162$23795816$2$F$20240402$20240729$20240429$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066731$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240729$$CN$US$US
237958182$23795818$2$F$$20240710$20240429$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066569$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240712$$HP$US$US
237958282$23795828$2$F$20240401$20240729$20240429$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066630$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240729$$CN$US$US
237958302$23795830$2$F$20240401$20240626$20240429$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012017$UNITED THERAPEUTICS$$57$YR$$F$Y$54.422$KG$20240705$$$US$US
237958352$23795835$2$F$20231101$20240712$20240429$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202404018238$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240715$$CN$US$US
237958385$23795838$5$F$$20240816$20240429$20240822$PER$$US-BIOGEN-2024BI01261793$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
237958402$23795840$2$F$20240329$20240709$20240429$20240821$PER$$US-LUNDBECK-DKLU3076780$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
237958432$23795843$2$F$$20240920$20240429$20240925$EXP$$JP-009507513-2404JPN002977J$MERCK$Hirose K, Ofuchi T, Kawata K, Ebata Y, Yoshizumi T. A Case of Small Bowel Obstruction Due to Stent Migration from the Site of an Esophageal Cancer During Immune Checkpoint Inhibitor Therapy. Journal of Abdominal Emergency Medicine. 2024;44(3):551-4$77$YR$$M$Y$54.4$KG$20240925$$MD$JP$JP
237958472$23795847$2$F$$20240625$20240429$20240702$PER$$US-BIOGEN-2024BI01261221$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
237958482$23795848$2$F$20240422$20240723$20240429$20240730$PER$$US-BIOGEN-2024BI01261896$BIOGEN$$38$YR$$M$Y$$$20240730$$CN$US$US
237958722$23795872$2$F$$20240723$20240429$20240801$PER$$US-SA-2024SA127210$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240801$$MD$US$US
237958823$23795882$3$F$20240314$20240625$20240429$20240701$EXP$$US-BIOGEN-2024BI01256205$BIOGEN$$67$YR$$F$Y$$$20240630$$CN$US$US
237958983$23795898$3$F$20240417$20240624$20240429$20240702$PER$$US-BIOGEN-2024BI01261024$BIOGEN$$29$YR$$M$Y$$$20240702$$CN$US$US
237959003$23795900$3$F$$20240913$20240429$20240918$EXP$$CA-BIOGEN-2024BI01262132$BIOGEN$$$$$F$Y$$$20240918$$CN$CA$CA
237959072$23795907$2$F$$20240702$20240429$20240704$EXP$$IE-BIOGEN-2024BI01261930$BIOGEN$$51$YR$$F$Y$$$20240704$$HP$IE$IE
237959402$23795940$2$F$20240101$20240916$20240429$20240918$PER$$US-BIOGEN-2024BI01257412$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
237959452$23795945$2$F$$20240626$20240429$20240703$PER$$US-BIOGEN-2024BI01261471$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
237959472$23795947$2$F$20130101$20240624$20240429$20240701$PER$$US-BIOGEN-2024BI01262292$BIOGEN$$$$$M$Y$$$20240701$$CN$US$US
237959642$23795964$2$F$$20240422$20240429$20240930$EXP$$US-TPU-TPU-2024-00165$TEIKOKU$$$$$$Y$$$20240930$$CN$US$US
237959904$23795990$4$F$20240410$20240724$20240429$20240801$30DAY$$MX-JNJFOC-20240443647$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240801$$CN$MX$MX
237960054$23796005$4$F$20230208$20240628$20240429$20240702$EXP$$NVSJ2023JP016719$NOVARTIS$$46$YR$$F$Y$38.4$KG$20240702$$MD$JP$JP
237960092$23796009$2$F$$20240702$20240429$20240709$EXP$$CH-TAKEDA-2023TUS067258$TAKEDA$$8$DEC$$$Y$$$20240709$$MD$CH$CH
237960123$23796012$3$F$$20240805$20240429$20240808$EXP$$JP-SA-2024SA123373$SANOFI AVENTIS$Ishida H.. 117: Two cases of patients with rheumatoid arthritis (RA) acutely exacerbated after dupilumab (DUP) treatment of eosinophilic sinusitis (ECRS).. The 244th Kinki Regional Meeting of the Japanese Society of Internal Medicine (2. UNK;UNK:UNK$70$YR$E$M$Y$$$20240809$$MD$JP$JP
237960373$23796037$3$F$$20240704$20240429$20240708$EXP$$NVSJ2024JP005182$NOVARTIS$$73$YR$$M$Y$$$20240709$$MD$JP$JP
237960422$23796042$2$F$20240222$20240801$20240429$20240808$EXP$$US-ABBVIE-5735194$ABBVIE$$80$YR$$F$Y$68$KG$20240808$$CN$US$US
237960527$23796052$7$F$20230101$20240904$20240429$20240910$EXP$$CO-ABBVIE-5737287$ABBVIE$$$$$F$Y$63$KG$20240910$$CN$CO$CO
237960642$23796064$2$F$$20240823$20240429$20240829$EXP$$CA-ABBVIE-5735274$ABBVIE$$$$A$F$Y$$$20240829$$CN$CA$CA
237960986$23796098$6$F$20231208$20240801$20240429$20240807$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202401010056$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240807$$CN$DE$DE
237961002$23796100$2$F$$20240729$20240429$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063187$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240730$$CN$US$US
237961063$23796106$3$F$20240417$20240820$20240429$20240826$PER$$US-JNJFOC-20240460826$JOHNSON AND JOHNSON$$35$YR$A$$Y$$$20240826$$CN$US$US
237961142$23796114$2$F$$20240829$20240429$20240905$EXP$$US-ABBVIE-5735974$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
237961153$23796115$3$F$20240403$20240909$20240429$20240912$EXP$$US-ABBVIE-5734500$ABBVIE$$65$YR$$M$Y$$$20240912$$CN$US$US
237961242$23796124$2$F$20240415$20240809$20240429$20240814$EXP$$US-ABBVIE-5736111$ABBVIE$$70$YR$$M$Y$$$20240814$$CN$US$US
237961302$23796130$2$F$$20240628$20240429$20240703$EXP$$NVSC2024US088157$NOVARTIS$$40$YR$$F$Y$$$20240703$$MD$US$US
237961394$23796139$4$F$20240411$20240711$20240429$20240718$EXP$$CA-JNJFOC-20240446317$JOHNSON AND JOHNSON$$68$YR$E$M$Y$73$KG$20240718$$PH$CA$CA
237961742$23796174$2$F$$20240729$20240430$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065995$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240729$$HP$US$US
237961903$23796190$3$F$20230101$20240826$20240430$20240903$EXP$$AR-JNJFOC-20231146191$JOHNSON AND JOHNSON$$68$YR$E$F$Y$78$KG$20240903$$CN$AR$AR
237962303$23796230$3$F$20240305$20240711$20240430$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-020792$AUROBINDO$$52$YR$$M$Y$88$KG$20240719$$MD$GB$GB
237962543$23796254$3$F$$20240729$20240430$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066846$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240729$$CN$US$US
237962603$23796260$3$F$20221101$20240911$20240430$20240918$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR042881$VIIV$$32$YR$$M$Y$54.4$KG$20240918$$HP$US$US
237962742$23796274$2$F$20230101$20240628$20240430$20240703$PER$$US-BIOGEN-2024BI01248575$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
237962775$23796277$5$F$20240419$20240905$20240430$20240911$EXP$$CO-TAKEDA-2024TUS039745$TAKEDA$$60$YR$$F$Y$80$KG$20240911$$CN$CO$CO
237962782$23796278$2$F$$20240715$20240430$20240722$PER$$US-ALXN-202404USA001747US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
237962943$23796294$3$F$20240101$20240812$20240430$20240814$EXP$$US-ABBVIE-5735780$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
237962962$23796296$2$F$$20240730$20240430$20240801$PER$$NVSC2024US090749$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
237962972$23796297$2$F$$20240417$20240430$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-020211$AUROBINDO$Pradeep P, Alcaraz R. To B, or Not to B. JEndocr-Soc. 2019$49$YR$$F$Y$$$20240724$$HP$US$US
237963047$23796304$7$F$20240101$20240902$20240430$20240910$EXP$$CA-CELLTRION INC.-2024CA006319$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
237963184$23796318$4$F$$20240819$20240430$20240902$EXP$$CA-002147023-NVSC2023CA096330$Haleon PLC$$44$YR$$F$Y$97$KG$20240830$$MD$CA$CA
237963214$23796321$4$F$20231201$20240628$20240430$20240703$EXP$$US-ABBVIE-5736009$ABBVIE$$65$YR$$M$Y$$$20240703$$CN$US$US
237963224$23796322$4$F$$20240815$20240430$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US043800$SANDOZ$$$$$M$Y$$$20240821$$CN$US$US
237963273$23796327$3$F$$20240729$20240430$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066898$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240729$$CN$US$US
237963292$23796329$2$F$20230927$20240716$20240430$20240723$EXP$$SA-GSK-SA2023EME140945$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$SA$SA
237963342$23796334$2$F$20240424$20240828$20240430$20240903$EXP$$JP-AMGEN-JPNSP2024084439$AMGEN$$$$$$Y$$$20240903$$PH$JP$JP
237963402$23796340$2$F$$20240628$20240430$20240704$EXP$$CA-TAKEDA-2019TUS069785$TAKEDA$$$$$M$Y$$$20240704$$CN$CA$CA
237963572$23796357$2$F$20220101$20240912$20240430$20240917$EXP$$US-JAZZ-2022-US-027363$JAZZ$$$$$F$Y$59$KG$20240917$$MD$US$US
237963653$23796365$3$F$20240113$20240725$20240430$20240803$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012232$UNITED THERAPEUTICS$$87$YR$$M$Y$89.796$KG$20240803$$$US$US
237963834$23796383$4$F$20230925$20240911$20240430$20240925$EXP$$JP-AMGEN-JPNNI2023234227$AMGEN$Sugawara M, Baba D, Ninagawa K, Shimizu Y. Short-term utility of avacopan after remission induction therapy with rituximab in elderly patients with ANCA-associated vasculitis. The 68th General Assembly and Scientific Meeting of the Japan College of Rheumatology. 2024 APR;.$70$YR$E$M$Y$59.2$KG$20240925$$MD$JP$JP
237963924$23796392$4$F$20231001$20240909$20240430$20240911$EXP$$IN-GSK-IN2023APC085910$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$IN$IN
237964053$23796405$3$F$20231209$20240913$20240430$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-024754$JAZZ$$64$YR$$F$Y$$$20240918$$CN$US$US
237964252$23796425$2$F$20240328$20240703$20240430$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001725$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240726$$CN$US$US
237964582$23796458$2$F$20240325$20240716$20240430$20240729$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI03901$NEUROCRINE BIOSCIENCES$$74$YR$$F$Y$$$20240729$$HP$US$US
237964678$23796467$8$F$20240101$20240906$20240430$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012292$UNITED THERAPEUTICS$$$$$F$Y$66.213$KG$20240913$$$US$US
237964813$23796481$3$F$20231108$20240620$20240430$20240701$EXP$$SE-BEH-2024168118$CSL BEHRING$$$$A$M$Y$$$20240701$$MD$SE$SE
237964862$23796486$2$F$$20240807$20240430$20240809$30DAY$$US-SANDOZ INC.-SDZ2024US043718$SANDOZ$$$$$M$Y$$$20240809$$CN$US$US
237964912$23796491$2$F$20230307$20230313$20240430$20240909$EXP$$US-HALEON-2169092$Haleon PLC$$$$I$M$Y$2.26$KG$20240909$$HP$US$US
237964975$23796497$5$F$20240101$20240705$20240430$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-012419$UNITED THERAPEUTICS$$$$$F$Y$83.9$KG$20240709$$$US$US
237964994$23796499$4$F$20240101$20240628$20240430$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012428$UNITED THERAPEUTICS$$$$$F$Y$108.84$KG$20240706$$$US$US
237965362$23796536$2$F$20240401$20240628$20240430$20240702$PER$$US-UNITED THERAPEUTICS-UNT-2024-011437$UNITED THERAPEUTICS$$53$YR$$F$Y$52.154$KG$20240702$$$US$US
237965422$23796542$2$F$$20240314$20240430$20240801$PER$$US-TEVA-VS-3180210$TEVA$$$$$$Y$$$20240801$$CN$US$US
237965702$23796570$2$F$$20240731$20240430$20240807$EXP$ES-GERMAN-LIT/ESP/24/0006397$ES-RDY-LIT/ESP/24/0006397$DR REDDYS$Taibo A, Estevez AS, Campayo NM, Mayo MR, Bermudez Md, Fonseca E. Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain. Mycoses. 2023 Oct 01;66(10): 891-897. doi:10.1111/myc.13628.$50$YR$A$M$Y$$$20240807$$MD$ES$ES
237965863$23796586$3$F$20240424$20240925$20240430$20240930$PER$$US-BIOGEN-2024BI01262251$BIOGEN$$34$YR$$F$Y$$$20240930$$CN$US$US
237966022$23796602$2$F$$20240625$20240430$20240708$EXP$$US-NOVOPROD-1210458$NOVO NORDISK$$$$$F$Y$$$20240708$$CN$US$US
237966033$23796603$3$F$20230116$20240820$20240430$20240829$EXP$$US-NOVOPROD-1210359$NOVO NORDISK$$71$YR$$F$Y$$$20240829$$CN$US$US
237966213$23796621$3$F$$20240902$20240430$20240903$EXP$$CA-BAUSCH-BL-2024-006499$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240903$$HP$CA$CA
237966542$23796654$2$F$$20240829$20240430$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-006852$AUROBINDO$Jiang SX, Duncan J, Ko HH.. Acquired Fanconi Syndrome from Tenofovir Treatment in a Patient with Hepatitis B.. Case Reports in Hepatology. 2023;6158407$62$YR$$F$Y$$$20240910$$MD$CA$CA
237966672$23796667$2$F$$20240724$20240430$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-020685$AUROBINDO$Kachmar J, El-Haffaf Z, Bollee G. Atypical ADPKD Due to a DNAJB11 Pathogenic Variant: An Educational Case Report. Canadian journal of kidney health and disease. 2023;10:1-7$55$YR$$F$Y$$$20240805$$HP$CA$CA
237966802$23796680$2$F$$20240705$20240430$20240710$EXP$$CA-UCBSA-2024020635$UCB$$$$$F$Y$45.351$KG$20240710$$CN$CA$CA
237966852$23796685$2$F$20210907$20240627$20240430$20240704$EXP$$FR-CELLTRION INC.-2024FR009632$CELLTRION$$$$$$Y$$$20240704$$MD$FR$FR
237966882$23796688$2$F$20220501$20240628$20240430$20240703$EXP$$US-EMD Serono-2024022615$EMD SERONO INC$$52$YR$A$F$Y$$$20240703$$CN$US$US
237966934$23796693$4$F$$20240829$20240430$20240903$EXP$$US-TAKEDA-2024TUS040920$TAKEDA$$$$$F$Y$$$20240903$$CN$US$US
237966993$23796699$3$F$20240415$20240709$20240430$20240712$EXP$$JP-009507513-2404JPN003392J$MERCK$$6$DEC$$F$Y$$$20240712$$MD$JP$JP
237967193$23796719$3$F$$20240826$20240430$20240902$EXP$$CA-CHEPLA-1500137081$CHEPLAPHARM$$23$YR$$F$Y$$$20240902$$HP$COUNTRY NOT SPECIFIED$CA
237967405$23796740$5$F$20240401$20240904$20240430$20240906$PER$$US-AMGEN-USASP2024085154$AMGEN$$74$YR$E$M$Y$$$20240906$$CN$US$US
237967512$23796751$2$F$$20240718$20240430$20240722$EXP$$US-UCBSA-2024020474$UCB$$$$$M$Y$$$20240722$$HP$US$US
237967562$23796756$2$F$20240201$20240918$20240430$20240925$EXP$$US-GSK-US2020AMR237455$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
237968723$23796872$3$F$20231124$20240830$20240430$20240913$EXP$$US-UCBSA-2023056662$UCB$$76$YR$$F$Y$82.54$KG$20240913$$HP$US$US
237968862$23796886$2$F$20231001$20240824$20240430$20240830$EXP$$JP-009507513-2404JPN003365J$MERCK$$69$YR$$M$Y$$$20240830$$MD$JP$JP
237968895$23796889$5$F$20240423$20240717$20240430$20240724$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-024777$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$86.6$KG$20240725$$CN$US$US
237968952$23796895$2$F$20230306$20240701$20240430$20240702$EXP$$US-UCBSA-2023011792$UCB$$64$YR$$M$Y$$$20240702$$CN$US$US
237968962$23796896$2$F$20240315$20240622$20240430$20240701$EXP$$MX-BIOVITRUM-2024-MX-004919$BIOVITRUM$$79$DY$$F$Y$5.2$KG$20240701$$CN$MX$MX
237968982$23796898$2$F$$20240811$20240430$20240813$PER$$US-AMGEN-USASP2024085039$AMGEN$$$$A$F$Y$$$20240812$$CN$US$US
237969262$23796926$2$F$$20240702$20240430$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03435$LUPIN$$$$$$Y$$$20240723$$CN$US$US
237969272$23796927$2$F$$20240704$20240430$20240705$EXP$$NVSC2024US090634$NOVARTIS$$$$$$Y$$$20240706$$CN$US$US
237969313$23796931$3$F$20240402$20240625$20240430$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001717$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240719$$CN$US$US
237969652$23796965$2$F$$20240722$20240430$20240727$EXP$$JP-AMGEN-JPNSP2024085098$AMGEN$Okazaki, S.. Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis. Modern rheumatology case reports. 2024;1-6$61$YR$A$F$Y$$$20240727$$HP$JP$JP
237969782$23796978$2$F$20231201$20240920$20240430$20240930$EXP$$US-BEH-2024171097$CSL BEHRING$$81$YR$E$F$Y$$$20240930$$HP$US$US
237970172$23797017$2$F$$20240621$20240430$20240708$PER$$US-APOTEX-2024AP004592$APOTEX$$$$$M$Y$$$20240708$$CN$US$US
237970423$23797042$3$F$20240321$20240717$20240430$20240725$EXP$$PT-AUROBINDO-AUR-APL-2024-019628$AUROBINDO$$73$YR$$F$Y$$$20240725$$PH$PT$PT
237970444$23797044$4$F$20230701$20240622$20240430$20240701$EXP$$US-GILEAD-2024-0671025$GILEAD$$50$YR$A$F$Y$$$20240701$$CN$US$US
237971062$23797106$2$F$$20240702$20240430$20240706$EXP$$NVSC2024GB090647$NOVARTIS$$$$A$M$Y$$$20240706$$CN$GB$GB
237971582$23797158$2$F$$20240923$20240430$20240930$EXP$$US-GSK-US2024051959$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
237971642$23797164$2$F$20240429$20240729$20240430$20240731$PER$$US-AMGEN-USASP2024085810$AMGEN$$69$YR$E$F$Y$$$20240730$$CN$US$US
237971745$23797174$5$F$20240101$20240629$20240430$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011929$UNITED THERAPEUTICS$$$$$F$Y$$$20240705$$$US$US
237971785$23797178$5$F$20240416$20240701$20240430$20240723$PER$$US-TRAVERE-2024TVT00310$TRAVERE THERAPEUTICS$$31$YR$A$M$Y$$$20240719$$CN$US$US
237972032$23797203$2$F$20240325$20240416$20240430$20240729$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00171$Unknown Manufacturer$$21$YR$$M$Y$$$20240729$$CN$US$US
237972146$23797214$6$F$20240301$20240812$20240430$20240822$PER$$US-TRAVERE-2024TVT00315$TRAVERE THERAPEUTICS$$58$YR$A$F$Y$$$20240822$$CN$US$US
237972153$23797215$3$F$$20240819$20240430$20240917$PER$$US-TRAVERE-2024TVT00318$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
237972174$23797217$4$F$20240301$20240604$20240430$20240817$PER$$US-TRAVERE-2024TVT00314$TRAVERE THERAPEUTICS$$43$YR$A$F$Y$138.35$KG$20240817$$CN$US$US
237972254$23797225$4$F$20240508$20240729$20240430$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066895$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240729$$HP$US$US
237972543$23797254$3$F$$20240820$20240430$20240917$PER$$US-TRAVERE-2024TVT00404$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240917$$CN$US$US
237972582$23797258$2$F$$20240729$20240430$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064458$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240729$$CN$US$US
237972623$23797262$3$F$$20240830$20240430$20240903$EXP$$NVSC2024US089789$NOVARTIS$$$$$F$Y$$$20240903$$HP$US$US
237972638$23797263$8$F$$20240921$20240430$20240927$EXP$$NVSC2024US087966$NOVARTIS$$34$YR$$F$Y$$$20240927$$CN$US$US
237972872$23797287$2$F$20240313$20240717$20240430$20240722$EXP$$JP-TAKEDA-2024TJP006091$TAKEDA$$8$DEC$$F$Y$$$20240722$$MD$JP$JP
237973234$23797323$4$F$20230815$20240704$20240430$20240709$EXP$$DE-SA-2023SA307746$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240709$$MD$DE$DE
237973414$23797341$4$F$20240428$20240820$20240430$20240823$PER$$US-AMGEN-USASP2024085648$AMGEN$$79$YR$E$F$Y$$$20240823$$MD$US$US
237973442$23797344$2$F$$20240703$20240430$20240704$EXP$$NVSC2024BR087589$NOVARTIS$$$$$F$Y$$$20240704$$MD$BR$BR
237973664$23797366$4$F$20240203$20240708$20240430$20240712$EXP$$CA-ABBVIE-5735801$ABBVIE$$59$YR$$M$Y$81.5$KG$20240712$$MD$CA$CA
237973682$23797368$2$F$$20240703$20240430$20240705$EXP$$NVSC2024US089860$NOVARTIS$$28$YR$$$Y$$$20240705$$MD$US$US
237973885$23797388$5$F$20240401$20240424$20240430$20240805$EXP$$GB-AUROBINDO-AUR-APL-2024-021423$AUROBINDO$$37$YR$$M$Y$$$20240805$$PH$GB$GB
237974063$23797406$3$F$$20240503$20240430$20240820$EXP$$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-02899$HIKMA$Mancianti N, Tripodi SA, Pascucci A, Calatroni M, La Porta E, Guarnieri A, Garosi G.. Mancianti N, Tripodi SA, Pascucci A, Calatroni M, La Porta E, Guarnieri A, Garosi G. Immunohistochemical Evaluation of Renal Biopsy with Anti-PD1 and p53 to Solve the Dilemma between Platinum- and Pembrolizumab-Induced AKI: Case Report and Review. J Clin Med. 2024;13(7):1828$77$YR$$F$Y$78$KG$20240820$$MD$IT$IT
237974112$23797411$2$F$20240224$20240625$20240430$20240701$EXP$$JP-GSK-JP2024JPN052780$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$PH$JP$JP
237974123$23797412$3$F$$20240729$20240430$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066896$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240729$$CN$US$US
237974143$23797414$3$F$$20240627$20240430$20240703$EXP$$JP-AMGEN-JPNSP2024083509$AMGEN$$32$YR$A$F$Y$$$20240703$$PH$JP$JP
237974303$23797430$3$F$20231021$20240926$20240430$20240930$EXP$$US-BIOGEN-2024BI01261819$BIOGEN$$52$YR$$F$Y$$$20240930$$CN$US$US
237974612$23797461$2$F$20240418$20240801$20240430$20240805$30DAY$$US-SANDOZ INC.-SDZ2024US043715$SANDOZ$$12$YR$$M$Y$$$20240805$$CN$US$US
237974642$23797464$2$F$$20240627$20240430$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03450$LUPIN$$$$$$Y$$$20240714$$CN$US$US
237974682$23797468$2$F$20231101$20240808$20240430$20240814$EXP$$JP-009507513-2401JPN006724J$MERCK$$8$DEC$$F$Y$$$20240814$$MD$JP$JP
237975072$23797507$2$F$20240404$20240426$20240430$20240906$PER$$NVSC2024US090425$NOVARTIS$$30$YR$$M$Y$$$20240906$$HP$US$US
237975544$23797554$4$F$20240216$20240808$20240430$20240813$30DAY$$US-SANDOZ INC.-SDZ2024US043866$SANDOZ$$12$YR$$$Y$$$20240813$$CN$US$US
237975573$23797557$3$F$$20240909$20240430$20240911$EXP$$GR-SANDOZ INC.-SDZ2024GR043418$SANDOZ$$82$YR$$M$Y$$$20240911$$MD$GR$GR
237975715$23797571$5$F$20240307$20240628$20240430$20240701$EXP$$IE-MYLANLABS-2024M1031252$MYLAN$$$$$F$Y$$$20240701$$HP$IE$IE
237975802$23797580$2$F$$20240711$20240430$20240711$PER$$NVSC2024US091077$NOVARTIS$$$$$M$Y$$$20240711$$CN$US$US
237975892$23797589$2$F$$20240620$20240430$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001726$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
237976072$23797607$2$F$20240424$20240628$20240430$20240701$EXP$$NVSC2024US090615$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
237976103$23797610$3$F$20240421$20240716$20240430$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202404017530$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240722$$HP$US$US
237976222$23797622$2$F$20070101$20240621$20240430$20240701$EXP$$US-JNJFOC-20240476393$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$LW$US$US
237976253$23797625$3$F$$20240708$20240430$20240710$EXP$$NVSC2024ZA089743$NOVARTIS$$$$$M$Y$$$20240710$$HP$ZA$ZA
237976482$23797648$2$F$20080101$20240621$20240430$20240701$EXP$$US-JNJFOC-20240472344$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$LW$US$US
237976572$23797657$2$F$20240405$20240717$20240430$20240807$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000225$BECTON DICKINSON$$$$$$Y$$$20240807$$CN$GB$GB
237976592$23797659$2$F$20240405$20240717$20240430$20240807$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000224$BECTON DICKINSON$$$$$$Y$$$20240807$$CN$GB$GB
237976646$23797664$6$F$20230920$20240911$20240430$20240919$EXP$$CA-CELLTRION INC.-2023CA021362$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
237976733$23797673$3$F$$20240708$20240430$20240711$EXP$$NVSC2024ZA089740$NOVARTIS$$$$$M$Y$$$20240711$$HP$ZA$ZA
237977122$23797712$2$F$20130513$20240621$20240430$20240701$EXP$$US-JNJFOC-20240471539$JOHNSON AND JOHNSON$$12$YR$$M$Y$$$20240701$$LW$US$US
237977172$23797717$2$F$$20240702$20240430$20240711$EXP$$ES-LEO Pharma-367928$LEO PHARM$$69$YR$$F$Y$$$20240711$$MD$ES$ES
237977313$23797731$3$F$20240315$20240626$20240430$20240701$EXP$$FR-ASTELLAS-2024EU003988$ASTELLAS$$74$YR$$M$Y$$$20240701$$CN$FR$FR
237977512$23797751$2$F$$20240716$20240430$20240722$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01409$AMNEAL$$$$$F$Y$$$20240722$$CN$US$US
237977524$23797752$4$F$20240101$20240627$20240430$20240703$EXP$$JP-ASTELLAS-2024JP002739$ASTELLAS$$8$DEC$$F$Y$$$20240703$$MD$JP$JP
237977683$23797768$3$F$20220301$20240718$20240430$20240724$EXP$$NVSC2024ES086203$NOVARTIS$$5$YR$$F$Y$$$20240724$$MD$ES$ES
237977693$23797769$3$F$$20240723$20240430$20240730$EXP$$JP-AMGEN-JPNSP2024084171$AMGEN$$70$YR$E$F$Y$$$20240730$$MD$JP$JP
237977862$23797786$2$F$$20240711$20240430$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03510$LUPIN$$$$$$Y$$$20240809$$CN$US$US
237977922$23797792$2$F$$20240704$20240430$20240705$EXP$$NVSC2024US090041$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
237979163$23797916$3$F$$20240702$20240430$20240711$EXP$$GB-Accord-421078$ACCORD$$78$YR$E$M$Y$$$20240711$$CN$GB$GB
237979283$23797928$3$F$20240428$20240808$20240430$20240812$PER$$US-AMGEN-USASP2024085668$AMGEN$$66$YR$E$M$Y$$$20240812$$CN$US$US
237979362$23797936$2$F$$20240729$20240430$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-067287$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240729$$MD$JP$JP
237979582$23797958$2$F$20240426$20240704$20240430$20240707$PER$$US-AMGEN-USASP2024084869$AMGEN$$50$YR$A$M$Y$$$20240707$$CN$US$US
237979702$23797970$2$F$$20240704$20240430$20240708$EXP$$GB-MYLANLABS-2024M1038191$MYLAN$$$$$M$Y$$$20240708$$HP$GB$GB
237980122$23798012$2$F$$20240730$20240430$20240731$PER$$US-JNJFOC-20240471296$JOHNSON AND JOHNSON$$$$$F$Y$43.13$KG$20240731$$CN$US$US
237980132$23798013$2$F$$20240418$20240430$20240711$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-12583$SAMSUNG BIOEPIS$$$$$M$Y$$$20240711$$PH$AU$AU
237980192$23798019$2$F$20230101$20240628$20240430$20240703$EXP$$NVSC2024BR089666$NOVARTIS$$$$$M$Y$$$20240703$$MD$BR$BR
237980223$23798022$3$F$20240417$20240710$20240430$20240712$EXP$$JP-GSK-JP2024055031$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$MD$JP$JP
237980362$23798036$2$F$$20240911$20240430$20240919$EXP$$PT-AUROBINDO-AUR-APL-2024-019936$AUROBINDO$Mariana Trindade,Ana Simoes. REPETITION  SYNCOPES: WHAT ARE THEY DUE TO?. Portuguese Journal of General and Family Medicine (Rev Port Med Geral Fam). 2024;40 (Supple) 12$93$YR$$F$Y$$$20240919$$HP$PT$PT
237980646$23798064$6$F$20240416$20240809$20240430$20240813$EXP$$US-JNJFOC-20240469328$JOHNSON AND JOHNSON$$$$C$F$Y$$$20240813$$CN$US$US
237980782$23798078$2$F$$20240701$20240430$20240703$EXP$$US-TAKEDA-2024TUS041046$TAKEDA$$$$$M$Y$$$20240703$$CN$US$US
237980893$23798089$3$F$$20240614$20240430$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002021$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
237980902$23798090$2$F$20240428$20240731$20240430$20240802$PER$$US-AMGEN-USASP2024086129$AMGEN$$61$YR$A$M$Y$$$20240802$$CN$US$US
237980954$23798095$4$F$20240420$20240718$20240430$20240723$PER$$US-AMGEN-USASP2024085721$AMGEN$$59$YR$A$F$Y$$$20240723$$CN$US$US
237981335$23798133$5$F$$20240911$20240430$20240912$30DAY$$US-PFIZER INC-202400094040$PFIZER$$15$YR$$M$Y$63.5$KG$20240912$$HP$US$US
237981353$23798135$3$F$20240417$20240909$20240430$20240911$30DAY$$US-PFIZER INC-202400094105$PFIZER$$16$YR$$M$Y$68.036$KG$20240911$$CN$US$US
237981376$23798137$6$F$$20240913$20240430$20240919$30DAY$$US-PFIZER INC-202400093698$PFIZER$$12$YR$$M$Y$$$20240919$$CN$US$US
237981424$23798142$4$F$$20240914$20240430$20240916$30DAY$$US-PFIZER INC-202400095019$PFIZER$$14$YR$$M$Y$$$20240916$$CN$US$US
237981583$23798158$3$F$20210101$20240716$20240430$20240722$EXP$$JP-JNJFOC-20240487994$JOHNSON AND JOHNSON$$76$YR$E$F$Y$44$KG$20240722$$MD$JP$JP
237981705$23798170$5$F$20230129$20240904$20240430$20240909$EXP$$JP-AstraZeneca-2024A088422$ASTRAZENECA$Nobusawa T, et al. 46 Two cases of unresectable hepatocellular carcinoma successfully treated with durvalumab and tremelimumab despite of occurrences of serious immune-related adverse events during the therapeutic course.. The 380th Annual Meeting of the Kanto Branch of the Japanese Society of Gastroenterology 2024;35.$73$YR$$M$Y$157$KG$20240909$$MD$JP$
237981825$23798182$5$F$20240401$20240729$20240430$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066802$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240729$$CN$US$US
237981874$23798187$4$F$$20240917$20240430$20240920$30DAY$$US-PFIZER INC-202400094326$PFIZER$$12$YR$$M$Y$$$20240920$$CN$US$US
237981974$23798197$4$F$$20240913$20240430$20240918$30DAY$$US-PFIZER INC-202400094352$PFIZER$$14$YR$$M$Y$$$20240918$$CN$US$US
237981997$23798199$7$F$20240101$20240913$20240430$20240913$EXP$$CA-PFIZER INC-202400093730$PFIZER$$63$YR$$F$Y$$$20240913$$MD$CA$CA
237982014$23798201$4$F$20230701$20240911$20240430$20240913$30DAY$$US-PFIZER INC-202400094017$PFIZER$$12$YR$$M$Y$54.43$KG$20240913$$CN$US$US
237982023$23798202$3$F$20210627$20240727$20240430$20240805$EXP$$US-SA-2021SA222202$SANOFI AVENTIS$$63$YR$A$F$Y$122.4$KG$20240805$$MD$US$US
237982038$23798203$8$F$20240401$20240920$20240430$20240924$30DAY$$US-PFIZER INC-202400094259$PFIZER$$16$YR$$M$Y$$$20240924$$CN$US$US
237982304$23798230$4$F$20240320$20240709$20240430$20240813$EXP$$HU-RECORDATI RARE DISEASE INC.-2024002945$RECORDATI$$$$$$Y$$$20240813$$MD$HU$HU
237982365$23798236$5$F$$20240915$20240430$20240919$30DAY$$US-PFIZER INC-202400093751$PFIZER$$14$YR$$F$Y$$$20240919$$MD$US$US
237982372$23798237$2$F$20230911$20240622$20240430$20240702$EXP$IE-HPRA-2024-111529$IE-Accord-421137$ACCORD$$$$N$M$Y$$$20240702$$MD$IE$IE
237982852$23798285$2$F$$20240903$20240430$20240903$PER$$US-ALXN-202404USA001729US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
237982953$23798295$3$F$$20240722$20240430$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-000742$UNITED THERAPEUTICS$$$$$F$Y$109.75$KG$20240731$$$US$US
237983043$23798304$3$F$$20240711$20240430$20240712$EXP$$CA-PFIZER INC-202400093662$PFIZER$$70$YR$$F$Y$$$20240712$$HP$CA$CA
237983053$23798305$3$F$20220623$20240618$20240430$20240703$EXP$$DE-PFIZER INC-202400095239$PFIZER$$60$YR$$F$Y$$$20240703$$HP$DE$DE
237983166$23798316$6$F$20230101$20240801$20240430$20240809$EXP$$HU-MIRUM PHARMACEUTICALS, INC.-HU-MIR-24-00134$MIRUM PHARMACEUTICALS$$$$$$Y$$$20240809$$MD$HU$HU
237983443$23798344$3$F$$20240918$20240430$20240923$EXP$$GB-ROCHE-3553092$ROCHE$$$$T$F$Y$$$20240923$$CN$GB$GB
237983522$23798352$2$F$$20240702$20240430$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067116$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240703$$CN$US$US
237983602$23798360$2$F$$20240905$20240430$20240909$30DAY$$US-PFIZER INC-202400095671$PFIZER$$16$YR$$M$Y$78.6$KG$20240909$$PH$US$US
237983822$23798382$2$F$$20240729$20240430$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067416$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240729$$CN$US$US
237984074$23798407$4$F$$20240911$20240430$20240916$30DAY$$GB-PFIZER INC-PV202400051835$PFIZER$$33$YR$$F$Y$$$20240916$$CN$GB$GB
237984083$23798408$3$F$20240422$20240710$20240430$20240717$PER$$AR-PFIZER INC-202400093781$PFIZER$$8$YR$$F$Y$$$20240717$$CN$AR$AR
237984102$23798410$2$F$$20240801$20240430$20240802$EXP$$GB-SANDOZ INC.-NVSC2022GB076876$SANDOZ$$$$$F$Y$$$20240802$$CN$GB$GB
237984212$23798421$2$F$20240101$20240925$20240430$20240930$EXP$$US-SANDOZ INC.-SDZ2024US018908$SANDOZ$$$$$M$Y$$$20240930$$CN$US$US
237984222$23798422$2$F$$20240729$20240430$20240805$EXP$$BE-SANDOZ INC.-SDZ2024BE043969$SANDOZ$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-induced anaphylaxis uncommon in mastocytosis: findings from two large cohorts. THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2024$39$YR$$$Y$$$20240805$$HP$BE$BE
237984582$23798458$2$F$$20240725$20240430$20240729$EXP$$US-PFIZER INC-PV202400054305$PFIZER$$69$YR$$F$Y$$$20240729$$HP$US$US
237984794$23798479$4$F$20230101$20240906$20240430$20240911$30DAY$$US-PFIZER INC-202400093787$PFIZER$$42$YR$$F$Y$$$20240911$$CN$US$US
237984833$23798483$3$F$$20240910$20240430$20240916$30DAY$$DO-PFIZER INC-PV202400054027$PFIZER$$11$YR$$F$Y$$$20240916$$CN$DO$DO
237984843$23798484$3$F$20240411$20240909$20240430$20240910$30DAY$$CL-PFIZER INC-PV202400053328$PFIZER$$$$A$M$Y$$$20240910$$CN$CL$CL
237984863$23798486$3$F$$20240905$20240430$20240909$30DAY$$CO-PFIZER INC-PV202400053280$PFIZER$$6$YR$$M$Y$$$20240909$$CN$CO$CO
237985007$23798500$7$F$$20240909$20240430$20240913$EXP$$CA-009507513-2404CAN011389$MERCK$$44$YR$$F$Y$97$KG$20240913$$HP$CA$CA
237985014$23798501$4$F$$20240920$20240430$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067170$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240923$$CN$US$US
237985022$23798502$2$F$20240424$20240719$20240430$20240725$EXP$$US-OTSUKA-2024_012167$OTSUKA$$68$YR$$M$Y$122.9$KG$20240725$$CN$US$US
237985252$23798525$2$F$$20240712$20240430$20240716$30DAY$$US-PFIZER INC-202400093629$PFIZER$$10$YR$$M$Y$$$20240716$$CN$US$US
237985264$23798526$4$F$$20240915$20240430$20240920$30DAY$$US-PFIZER INC-202400094157$PFIZER$$12$YR$$M$Y$$$20240920$$CN$US$US
237985293$23798529$3$F$20240421$20240914$20240430$20240918$30DAY$$KR-PFIZER INC-PV202400053040$PFIZER$$11$YR$$F$Y$$$20240918$$HP$KR$KR
237985325$23798532$5$F$20240418$20240913$20240430$20240918$30DAY$$US-PFIZER INC-202400093770$PFIZER$$8$YR$$F$Y$17.24$KG$20240918$$CN$US$US
237985373$23798537$3$F$20230101$20240724$20240430$20240729$EXP$$CA-PFIZER INC-202400096824$PFIZER$$18$YR$$F$Y$90.703$KG$20240729$$HP$CA$CA
237985392$23798539$2$F$20240424$20240717$20240430$20240722$EXP$$JP-PFIZER INC-202400095400$PFIZER$$81$YR$$F$Y$48.7$KG$20240722$$PH$JP$JP
237985472$23798547$2$F$$20240801$20240430$20240805$EXP$$US-PFIZER INC-202400096481$PFIZER$$57$YR$$F$Y$$$20240805$$MD$US$US
237985494$23798549$4$F$20180831$20240909$20240430$20240910$30DAY$$AR-PFIZER INC-202400092931$PFIZER$$11$YR$$M$Y$$$20240910$$CN$AR$AR
237985723$23798572$3$F$$20240621$20240430$20240701$EXP$$BR-SANDOZ INC.-SDZ2024BR043987$SANDOZ$$$$$M$Y$$$20240701$$CN$BR$BR
237985796$23798579$6$F$$20240913$20240430$20240920$30DAY$$US-PFIZER INC-202400094169$PFIZER$$70$YR$$F$Y$$$20240920$$CN$US$US
237985815$23798581$5$F$$20240704$20240430$20240710$30DAY$$TR-PFIZER INC-PV202400051085$PFIZER$$10$YR$$$Y$$$20240710$$CN$TR$TR
237985834$23798583$4$F$$20240529$20240430$20240705$30DAY$$AU-PFIZER INC-202400095325$PFIZER$$$$$F$Y$$$20240705$$PH$AU$AU
237985934$23798593$4$F$20240701$20240917$20240430$20240925$EXP$$CA-JNJFOC-20240482682$JOHNSON AND JOHNSON$$63$YR$A$M$Y$77$KG$20240925$$HP$CA$CA
237985992$23798599$2$F$$20240702$20240430$20240708$EXP$$GB-MYLANLABS-2024M1038211$MYLAN$$$$$M$Y$$$20240708$$MD$GB$GB
237986082$23798608$2$F$$20240729$20240430$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067252$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240729$$CN$US$US
237986193$23798619$3$F$$20240703$20240430$20240705$30DAY$$AU-PFIZER INC-202400093305$PFIZER$$$$$F$Y$$$20240705$$PH$AU$AU
237986202$23798620$2$F$20240417$20240905$20240430$20240910$30DAY$$AR-PFIZER INC-202400090859$PFIZER$$13$YR$$M$Y$$$20240910$$CN$AR$AR
237986392$23798639$2$F$$20240911$20240430$20240917$EXP$$US-CHATTEMPRD-2024OHG013888$CHATTEM$$77$YR$E$M$Y$$$20240917$$LW$US$US
237986563$23798656$3$F$$20240716$20240430$20240807$EXP$$JP-009507513-2310JPN003990J$MERCK$Oi Y, Dofutsu M, Kondo H, Yamaguchi S, Nakagawa S, Shimura M, et al.. P-048 A case of recurrent corpus uteri carcinoma leading to mass forming pancreatitis as an immune-related adverse reaction. The journal of the Japan Society of Gynecologic Oncology / The 66th Annual Meeti. 2024;42(3):366$71$YR$$F$Y$$$20240807$$MD$JP$JP
237986743$23798674$3$F$20240426$20240731$20240430$20240803$PER$$US-AMGEN-USASP2024085158$AMGEN$$80$YR$E$F$Y$$$20240803$$CN$US$US
237986902$23798690$2$F$20240501$20240730$20240430$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202404017514$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240802$$HP$US$US
237987074$23798707$4$F$$20240917$20240430$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066506$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240918$$CN$US$US
237987184$23798718$4$F$$20240918$20240430$20240926$30DAY$$CO-PFIZER INC-PV202400053971$PFIZER$$10$YR$$M$Y$$$20240926$$CN$CO$CO
237987463$23798746$3$F$20240417$20240904$20240430$20240909$EXP$$CA-TAKEDA-2024TUS037481$TAKEDA$$79$YR$$M$Y$$$20240909$$CN$CA$CA
237987586$23798758$6$F$20240301$20240911$20240430$20240917$EXP$$US-PFIZER INC-202400095916$PFIZER$$67$YR$$F$Y$83.91$KG$20240917$$MD$US$US
237987616$23798761$6$F$20240420$20240910$20240430$20240913$30DAY$$JP-PFIZER INC-PV202400053551$PFIZER$$8$YR$$$Y$$$20240913$$CN$JP$JP
237988423$23798842$3$F$$20240916$20240430$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067247$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240920$$CN$US$US
237988533$23798853$3$F$20240428$20240711$20240430$20240809$EXP$$CN-BAYER-2024A064390$BAYER$$62$YR$A$$Y$$$20240809$$MD$CN$CN
237988612$23798861$2$F$20240418$20240729$20240430$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067375$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240729$$CN$US$US
237988643$23798864$3$F$$20240816$20240430$20240821$EXP$$CN-JNJFOC-20240468190$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$MD$CN$CN
237988837$23798883$7$F$20240418$20240911$20240430$20240917$30DAY$$US-PFIZER INC-202400095441$PFIZER$$39$YR$$F$Y$85.73$KG$20240917$$CN$US$US
237988858$23798885$8$F$$20240904$20240430$20240904$30DAY$$AT-PFIZER INC-PV202400054445$PFIZER$$10$YR$$F$Y$$$20240904$$CN$AT$AT
237988903$23798890$3$F$20240419$20240917$20240430$20240920$30DAY$$GR-PFIZER INC-PV202400053939$PFIZER$$15$YR$$M$Y$60$KG$20240920$$CN$GR$GR
237988964$23798896$4$F$$20240802$20240430$20240806$30DAY$$US-PFIZER INC-202400095648$PFIZER$$$$$F$Y$$$20240806$$CN$US$US
237988972$23798897$2$F$$20240905$20240430$20240910$30DAY$$AR-PFIZER INC-PV202400054575$PFIZER$$$$$$Y$$$20240910$$CN$AR$AR
237989242$23798924$2$F$20240417$20240813$20240430$20240816$EXP$$US-MYLANLABS-2024M1038222$MYLAN$$59$YR$$M$Y$$$20240816$$CN$US$US
237989486$23798948$6$F$$20240925$20240430$20240930$30DAY$$PA-PFIZER INC-PV202400053381$PFIZER$$11$YR$$F$Y$$$20240930$$HP$PA$PA
237990363$23799036$3$F$$20240729$20240430$20240802$EXP$$JP-PFIZER INC-202400094874$PFIZER$Okazaki, S.. Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis. Modern Rheumatology Case Reports. 2024;1-6$48$YR$$F$Y$58$KG$20240802$$HP$JP$JP
237990383$23799038$3$F$20230301$20240909$20240430$20240911$EXP$$DE-PFIZER INC-202400055824$PFIZER$$52$YR$$M$Y$$$20240911$$MD$DE$DE
237990505$23799050$5$F$20240414$20240726$20240430$20240730$30DAY$$PE-PFIZER INC-PV202400053261$PFIZER$$$$$F$Y$$$20240730$$CN$PE$PE
237990513$23799051$3$F$$20240713$20240430$20240715$30DAY$$CL-PFIZER INC-PV202400054480$PFIZER$$10$YR$$F$Y$$$20240715$$CN$CL$CL
237990523$23799052$3$F$$20240910$20240430$20240911$30DAY$$CO-PFIZER INC-202400092767$PFIZER$$12$YR$$F$Y$$$20240911$$CN$CO$CO
237990723$23799072$3$F$20160101$20240514$20240430$20240828$EXP$$FR-TEVA-VS-3187931$TEVA$$47$YR$$F$Y$$$20240828$$CN$FR$FR
237990772$23799077$2$F$20240301$20240923$20240430$20240930$EXP$$IL-ABBVIE-5692320$ABBVIE$$77$YR$$F$Y$$$20240930$$CN$IL$IL
237990792$23799079$2$F$$20240729$20240430$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067326$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240729$$CN$US$US
237990853$23799085$3$F$20240401$20240912$20240430$20240916$30DAY$$AR-PFIZER INC-202400092742$PFIZER$$6$YR$$M$Y$$$20240916$$CN$AR$AR
237990872$23799087$2$F$20240318$20240715$20240430$20240718$PER$$US-PFIZER INC-PV202400055349$PFIZER$$47$YR$$F$Y$$$20240718$$HP$US$US
237990933$23799093$3$F$20240415$20240910$20240430$20240912$30DAY$$UY-PFIZER INC-202400096377$PFIZER$$9$YR$$F$Y$$$20240912$$CN$UY$UY
237991102$23799110$2$F$$20240805$20240430$20240807$PER$$NVSC2024US091417$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
237991212$23799121$2$F$20210101$20240812$20240430$20240816$EXP$$CA-SANDOZ INC.-NVSC2021CA058194$SANDOZ$$$$$F$Y$$$20240816$$CN$CA$CA
237991242$23799124$2$F$20240428$20240711$20240430$20240712$EXP$$CN-BAYER-2024A064424$BAYER$$58$YR$A$$Y$$$20240712$$MD$CN$CN
237991274$23799127$4$F$$20240802$20240430$20240806$30DAY$$US-PFIZER INC-PV202400044362$PFIZER$$$$$$Y$$$20240806$$HP$US$US
237991453$23799145$3$F$20230201$20240705$20240430$20240715$EXP$$US-ROCHE-3544718$ROCHE$$77$YR$E$F$Y$$$20240715$$CN$US$US
237991982$23799198$2$F$$20240708$20240430$20240709$PER$$US-PFIZER INC-202400097560$PFIZER$$51$YR$$F$Y$$$20240709$$CN$US$US
237992152$23799215$2$F$$20240814$20240430$20240816$PER$$US-PFIZER INC-202400095771$PFIZER$$54$YR$$F$Y$$$20240816$$CN$US$US
237992274$23799227$4$F$$20240815$20240430$20240819$PER$$US-PFIZER INC-202400097931$PFIZER$$68$YR$$M$Y$86.168$KG$20240819$$CN$US$US
237992294$23799229$4$F$20220101$20240820$20240430$20240822$EXP$$US-PFIZER INC-PV202400055198$PFIZER$$52$YR$$F$Y$$$20240822$$HP$US$US
237992783$23799278$3$F$$20240705$20240430$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066557$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240705$$HP$US$US
237992896$23799289$6$F$$20240915$20240430$20240919$30DAY$$US-PFIZER INC-202400095914$PFIZER$$9$YR$$F$Y$$$20240919$$CN$US$US
237992914$23799291$4$F$$20240913$20240430$20240917$30DAY$$US-PFIZER INC-PV202400044173$PFIZER$$$$$$Y$$$20240917$$HP$US$US
237993305$23799330$5$F$20240425$20240902$20240430$20240904$30DAY$$US-PFIZER INC-202400095825$PFIZER$$75$YR$$M$Y$124.74$KG$20240904$$CN$US$US
237993543$23799354$3$F$20240426$20240926$20240430$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066930$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240928$$CN$US$US
237993614$23799361$4$F$20240101$20240720$20240430$20240731$PER$$JP-PFIZER INC-PV202400052475$PFIZER$$11$YR$$M$Y$$$20240731$$MD$JP$JP
237993703$23799370$3$F$$20240925$20240430$20240930$EXP$$US-PFIZER INC-PV202400055765$PFIZER$$71$YR$$F$Y$97.506$KG$20240930$$CN$US$US
237993854$23799385$4$F$20240723$20240918$20240430$20240920$EXP$$US-PFIZER INC-PV202400056283$PFIZER$$59$YR$$M$Y$$$20240920$$HP$US$US
237993912$23799391$2$F$20240101$20240826$20240430$20240828$PER$$US-PFIZER INC-PV202400056320$PFIZER$$62$YR$$F$Y$$$20240828$$HP$US$US
237993982$23799398$2$F$$20240626$20240430$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03433$LUPIN$$$$$$Y$$$20240712$$CN$US$US
237994182$23799418$2$F$20240429$20240729$20240430$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067265$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240729$$CN$US$US
237994224$23799422$4$F$$20240902$20240430$20240904$30DAY$$US-PFIZER INC-PV202400044172$PFIZER$$$$$$Y$$$20240904$$HP$US$US
237994314$23799431$4$F$$20240802$20240430$20240807$30DAY$$US-PFIZER INC-PV202400044239$PFIZER$$$$$$Y$$$20240807$$HP$US$US
237994393$23799439$3$F$$20240805$20240430$20240808$30DAY$$US-PFIZER INC-PV202400044203$PFIZER$$$$$$Y$$$20240808$$HP$US$US
237994667$23799466$7$F$20240103$20240906$20240430$20240913$EXP$$CA-GSK-CA2024000941$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$CA$CA
237994714$23799471$4$F$$20240802$20240430$20240807$EXP$$GB-MYLANLABS-2024M1038946$MYLAN$$$$$M$Y$$$20240807$$HP$GB$GB
237994742$23799474$2$F$20240329$20240814$20240430$20240819$EXP$FR-AFSSAPS-AM2024000333$FR-MYLANLABS-2024M1038327$MYLAN$$29$YR$$F$Y$102$KG$20240819$$MD$FR$FR
237995062$23799506$2$F$20240429$20240820$20240430$20240823$PER$$US-AMGEN-USASP2024086174$AMGEN$$78$YR$E$F$Y$$$20240823$$CN$US$US
237995142$23799514$2$F$20240101$20240710$20240430$20240716$EXP$$CA-GSK-CA2023107488$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$HP$CA$CA
237995632$23799563$2$F$20240401$20240624$20240430$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-012055$UNITED THERAPEUTICS$$61$YR$$F$Y$101.13$KG$20240703$$$US$US
237996093$23799609$3$F$20240301$20240718$20240430$20240730$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-000708$SK LIFE SCIENCE$$$$$$Y$$$20240730$$HP$CA$CA
237996342$23799634$2$F$20240322$20240509$20240430$20240823$EXP$$FR-HALEON-2171348$Haleon PLC$$86$YR$$M$Y$$$20240823$$MD$FR$FR
237996482$23799648$2$F$20230127$20240920$20240430$20240926$EXP$$CA-TAKEDA-2023TUS009404$TAKEDA$$87$YR$$M$Y$$$20240926$$HP$CA$CA
2379966110$23799661$10$F$$20240806$20240430$20240807$EXP$$BE-JNJFOC-20240481881$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240807$$HP$BE$BE
237996822$23799682$2$F$$20240807$20240430$20240807$PER$$US-ALXN-202404USA001778US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
237997305$23799730$5$F$$20240709$20240430$20240723$EXP$$CA-LUPIN HEALTHCARE (UK) LIMITED-2024-03379$LUPIN$$65$YR$$M$Y$96$KG$20240723$$HP$CA$CA
2379976111$23799761$11$F$20240105$20240823$20240430$20240830$EXP$$US-Calliditas-2024CAL00640$CALLIDITAS THERAPEUTICS$$78$YR$E$M$Y$$$20240830$$CN$US$US
237997933$23799793$3$F$20240409$20240913$20240430$20240917$EXP$$NVSC2024US091149$NOVARTIS$$45$YR$$F$Y$$$20240917$$CN$US$US
237997982$23799798$2$F$20240301$20240411$20240430$20240710$PER$$FR-ROCHE-3547125$ROCHE$$79$YR$E$F$Y$$$20240628$$MD$FR$FR
237998134$23799813$4$F$20230308$20240822$20240430$20240827$PER$$US-BIOVITRUM-2024-US-006473$BIOVITRUM$$73$YR$$M$Y$$$20240827$$CN$US$US
237998262$23799826$2$F$20240101$20240802$20240430$20240811$EXP$$US-JNJFOC-20240472002$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240811$$CN$US$US
237999012$23799901$2$F$20240412$20240625$20240430$20240710$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI04025$NEUROCRINE BIOSCIENCES$$36$YR$$F$Y$$$20240711$$HP$US$US
237999502$23799950$2$F$20240101$20240702$20240430$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202404015025$ELI LILLY AND CO$$37$YR$A$F$Y$57.143$KG$20240711$$CN$US$US
237999512$23799951$2$F$20240406$20240705$20240430$20240717$EXP$FR-AFSSAPS-BX2024000766$FR-ELI_LILLY_AND_COMPANY-FR202404016570$ELI LILLY AND CO$$9$YR$C$F$Y$$$20240717$$CN$FR$FR
237999542$23799954$2$F$20240301$20240722$20240430$20240729$EXP$$US-TAKEDA-2024TUS028719$TAKEDA$$59$YR$$M$Y$124$KG$20240729$$HP$US$US
237999574$23799957$4$F$$20240718$20240430$20240731$PER$$US-Calliditas-2024CAL00646$CALLIDITAS THERAPEUTICS$$63$YR$A$F$Y$61.2$KG$20240731$$CN$US$US
237999652$23799965$2$F$20240215$20240814$20240430$20240821$EXP$$JP-GENMAB-2024-00506AA$GENMAB$$7$DEC$$M$Y$50$KG$20240821$$MD$JP$JP
237999693$23799969$3$F$20240318$20240520$20240430$20240819$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI03994$NEUROCRINE BIOSCIENCES$$6$DEC$$F$Y$$$20240819$$MD$US$US
237999702$23799970$2$F$20240425$20240816$20240430$20240821$PER$$US-AMGEN-USASP2024085111$AMGEN$$86$YR$E$M$Y$$$20240821$$CN$US$US
237999887$23799988$7$F$20240101$20240909$20240430$20240913$EXP$$US-ABBVIE-5734553$ABBVIE$$$$$F$Y$74$KG$20240913$$CN$US$US
238000322$23800032$2$F$$20240811$20240430$20240822$EXP$$CN-JNJFOC-20240458272$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240822$$HP$CN$CN
238000512$23800051$2$F$20240101$20240704$20240430$20240711$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-063780$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240711$$MD$AU$AU
238000583$23800058$3$F$20240301$20240819$20240430$20240822$EXP$$US-BIOVITRUM-2024-US-004392$BIOVITRUM$$52$YR$$F$Y$$$20240822$$PH$US$US
238000743$23800074$3$F$20240619$20240918$20240430$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202404016709$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240923$$CN$US$US
2380007612$23800076$12$F$$20240805$20240430$20240805$EXP$$BE-JNJFOC-20240481842$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240806$$HP$BE$BE
238000854$23800085$4$F$$20240813$20240430$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US032103$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
238001004$23800100$4$F$20240401$20240716$20240430$20240801$EXP$$US-SA-2024SA118919$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240719$$MD$US$US
238001283$23800128$3$F$$20240917$20240430$20240923$EXP$$GB-TAKEDA-2024TUS032299$TAKEDA$$$$$M$Y$$$20240923$$HP$GB$GB
238001513$23800151$3$F$$20240711$20240430$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064816$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240715$$CN$US$US
238001882$23800188$2$F$20230313$20240701$20240430$20240704$EXP$$AT-ABBVIE-5733596$ABBVIE$$30$YR$$F$Y$51$KG$20240704$$MD$AT$AT
238002892$23800289$2$F$$20240729$20240430$20240806$EXP$$BE-SANDOZ INC.-SDZ2024BE043996$SANDOZ$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-induced anaphylaxis uncommon in mastocytosis: findings from two large cohorts. THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024;12(7):1850-62$38$YR$$$Y$$$20240806$$HP$BE$BE
238002902$23800290$2$F$$20240701$20240430$20240709$PER$$US-INCYTE CORPORATION-2024IN004396$INCYTE$$$$$$Y$$$20240709$$CN$US$US
238003073$23800307$3$F$$20240708$20240430$20240710$EXP$$NVSC2021GB197913$NOVARTIS$$$$E$F$Y$$$20240710$$CN$GB$GB
238003212$23800321$2$F$20230101$20240831$20240430$20240905$EXP$$FR-KYOWAKIRIN-2024KK010252$KYOWA$$$$$$Y$$$20240905$$HP$FR$FR
238003343$23800334$3$F$20240315$20240913$20240430$20240918$EXP$FR-AFSSAPS-MA2024000466$FR-MYLANLABS-2024M1038148$MYLAN$$36$YR$$M$Y$$$20240918$$MD$FR$FR
238003472$23800347$2$F$20060101$20240621$20240430$20240701$EXP$$US-JNJFOC-20240472559$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$LW$US$US
238003902$23800390$2$F$20240411$20240827$20240430$20240831$PER$$US-ABBVIE-5738896$ABBVIE$$32$YR$$F$Y$$$20240831$$MD$US$US
238003962$23800396$2$F$20240401$20240715$20240430$20240722$EXP$$US-SA-2024SA128476$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240720$$MD$US$US
238004134$23800413$4$F$20240423$20240827$20240430$20240903$EXP$$IN-GSK-IN2024APC038319$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$IN$IN
238004205$23800420$5$F$20230101$20240902$20240430$20240910$EXP$$PE-SA-2024SA095058$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240910$$MD$PE$PE
238004333$23800433$3$F$20240320$20240626$20240430$20240701$EXP$$TW-BIOGEN-2024BI01261948$BIOGEN$$37$YR$$M$Y$75$KG$20240630$$HP$TW$TW
238005004$23800500$4$F$20240101$20240802$20240430$20240807$EXP$$CA-UCBSA-2024016867$UCB$$$$$M$Y$$$20240807$$CN$CA$CA
238005164$23800516$4$F$20240422$20240807$20240430$20240812$EXP$$DE-JNJFOC-20240476067$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240812$$HP$DE$DE
238005485$23800548$5$F$$20240729$20240430$20240805$EXP$$CA-TAKEDA-2024TUS032801$TAKEDA$$$$$F$Y$$$20240805$$CN$CA$CA
238005602$23800560$2$F$$20240709$20240430$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-007060$VERTEX$$$$$$Y$$$20240715$$CN$US$US
238006003$23800600$3$F$20240101$20240807$20240430$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067598$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$85.73$KG$20240808$$CN$US$US
238006022$23800602$2$F$$20240910$20240430$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064186$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240912$$CN$US$US
238006593$23800659$3$F$20240409$20240730$20240430$20240806$EXP$$US-ABBVIE-5738339$ABBVIE$$71$YR$$F$Y$$$20240806$$CN$US$US
238006804$23800680$4$F$20231101$20240818$20240430$20240820$EXP$$DE-ROCHE-3476350$ROCHE$$27$YR$A$M$Y$67$KG$20240820$$MD$DE$DE
238006912$23800691$2$F$$20240918$20240430$20240923$PER$$US-PFIZER INC-PV202300008372$PFIZER$$62$YR$$F$Y$$$20240923$$CN$US$US
238007393$23800739$3$F$20240424$20240904$20240430$20240909$30DAY$$US-AMGEN-USASP2024083860$AMGEN$$30$YR$A$F$Y$79.9$KG$20240909$$PH$US$US
238007733$23800773$3$F$20240320$20240806$20240430$20240806$EXP$$US-JNJFOC-20240482081$JOHNSON AND JOHNSON$$73$YR$E$M$Y$77.7$KG$20240806$$HP$US$US
238008323$23800832$3$F$20240101$20240725$20240430$20240731$EXP$$JP-009507513-2404JPN002938J$MERCK$$8$DEC$$M$Y$$$20240731$$MD$JP$JP
238009034$23800903$4$F$$20240708$20240430$20240716$EXP$$DE-AstraZeneca-2024A100422$ASTRAZENECA$$$$$$Y$$$20240716$$MD$DE$
238009052$23800905$2$F$20240401$20240711$20240430$20240715$EXP$$US-INCYTE CORPORATION-2024IN004489$INCYTE$$$$$$Y$$$20240715$$CN$US$US
238009136$23800913$6$F$20240418$20240729$20240430$20240814$PER$$US-Calliditas-2024CAL00662$CALLIDITAS THERAPEUTICS$$43$YR$A$M$Y$82$KG$20240812$$CN$US$US
238009372$23800937$2$F$$20240902$20240430$20240916$EXP$$NL-TEVA-VS-3191421$TEVA$$75$YR$$F$Y$$$20240916$$CN$NL$NL
238009623$23800962$3$F$$20240814$20240430$20240823$EXP$$US-ALXN-202404USA001715US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$HP$US$US
238009797$23800979$7$F$20240101$20240918$20240430$20240924$EXP$$CA-BAUSCH-BL-2024-005368$BAUSCH AND LOMB$$69$YR$$F$Y$$$20240924$$CN$CA$CA
238009863$23800986$3$F$20240322$20240702$20240430$20240716$PER$$US-Calliditas-2024CAL00660$CALLIDITAS THERAPEUTICS$$29$YR$A$F$Y$50$KG$20240716$$CN$US$US
238010432$23801043$2$F$$20240809$20240430$20240815$EXP$$JP-009507513-2404JPN002961J$MERCK$$6$DEC$$F$Y$$$20240815$$HP$JP$JP
238010575$23801057$5$F$$20240807$20240430$20240814$PER$$NVSC2024US089964$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
238010582$23801058$2$F$$20240709$20240430$20240711$EXP$$CA-ABBVIE-5736764$ABBVIE$$55$YR$$M$Y$$$20240711$$CN$CA$CA
238010792$23801079$2$F$$20240723$20240430$20240725$PER$$NVSC2024US090394$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
238010873$23801087$3$F$20220101$20240905$20240430$20240912$EXP$$JP-009507513-2301JPN004100J$MERCK$Murai T, Shibata R, Kato M, Kotori Y, Mori S, Inamura T, et al.. P-143 Experience with Lenvatinib/Pembrolizumab Combination Therapy for Recurrent Corpus Uteri. The 65th Annual Meeting of  Japan Society of Gynecologic Oncology.. 2023;41(3):342$63$YR$$F$Y$$$20240912$$MD$JP$JP
238010893$23801089$3$F$$20240628$20240430$20240704$PER$$NVSC2024US088542$NOVARTIS$$22$YR$$F$Y$$$20240704$$CN$US$US
238010932$23801093$2$F$20231227$20240823$20240430$20240902$EXP$$JP-009507513-2404JPN003009J$MERCK$$76$YR$$F$Y$$$20240902$$MD$JP$JP
238010965$23801096$5$F$$20240624$20240430$20240701$EXP$$US-TAKEDA-2024TUS039350$TAKEDA$$$$$M$Y$$$20240701$$CN$US$US
238011202$23801120$2$F$20240301$20240709$20240430$20240710$PER$$US-ALXN-202404USA001748US$ALEXION PHARMACEUTICALS$$57$YR$$F$Y$$$20240710$$CN$US$US
238011303$23801130$3$F$20240417$20240709$20240430$20240710$PER$$US-ALXN-202404USA001649US$ALEXION PHARMACEUTICALS$$73$YR$$F$Y$58$KG$20240710$$CN$US$US
238011562$23801156$2$F$$20240826$20240430$20240909$PER$$US-SA-2024SA120432$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240909$$MD$US$US
238011623$23801162$3$F$20240101$20240819$20240430$20240829$PER$$US-SA-2024SA122902$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240829$$MD$US$US
238011632$23801163$2$F$20240401$20240730$20240430$20240807$PER$$US-SA-2024SA121922$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240807$$MD$US$US
238011822$23801182$2$F$$20240830$20240430$20240925$PER$$US-SA-2024SA124929$SANOFI AVENTIS$$$$A$F$Y$46.82$KG$20240925$$MD$US$US
238011922$23801192$2$F$$20240627$20240430$20240708$PER$$US-SA-2024SA124542$SANOFI AVENTIS$$22$YR$A$F$Y$72.57$KG$20240708$$MD$US$US
238011932$23801193$2$F$$20240709$20240430$20240718$PER$$US-SA-2024SA123228$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240718$$MD$US$US
238012315$23801231$5$F$20240101$20240709$20240430$20240717$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011861$UNITED THERAPEUTICS$$$$$F$Y$67.12$KG$20240717$$$US$US
238012332$23801233$2$F$20240801$20240829$20240430$20240923$PER$$US-SA-2024SA125735$SANOFI AVENTIS$$35$YR$A$M$Y$97.52$KG$20240923$$MD$US$US
238012583$23801258$3$F$20240101$20240913$20240430$20240920$PER$$US-SA-2024SA125925$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240920$$MD$US$US
238012612$23801261$2$F$$20240715$20240430$20240722$PER$$US-SA-2024SA126360$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240722$$MD$US$US
238012822$23801282$2$F$20240801$20240827$20240430$20240919$PER$$US-SA-2024SA125767$SANOFI AVENTIS$$51$YR$A$F$Y$63.5$KG$20240919$$MD$US$US
238012852$23801285$2$F$20240417$20240816$20240430$20240829$PER$$US-SA-2024SA126836$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240829$$MD$US$US
238013323$23801332$3$F$20240708$20240813$20240430$20240826$PER$$US-SA-2024SA126644$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240826$$MD$US$US
238013442$23801344$2$F$$20240730$20240430$20240807$PER$$US-SA-2024SA129580$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240807$$MD$US$US
238013573$23801357$3$F$20240101$20240702$20240430$20240711$PER$$US-SA-2024SA126932$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240711$$MD$US$US
238013625$23801362$5$F$20240404$20240906$20240430$20240926$PER$$US-SA-2024SA130082$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240926$$MD$US$US
238013773$23801377$3$F$$20240806$20240430$20240814$PER$$US-SA-2024SA126909$SANOFI AVENTIS$$52$YR$A$F$Y$110.5$KG$20240814$$MD$US$US
238014084$23801408$4$F$20240501$20240905$20240430$20240914$PER$$US-SA-2024SA130121$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240914$$MD$US$US
238014092$23801409$2$F$20240401$20240830$20240430$20240917$PER$$US-SA-2024SA049877$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240918$$MD$US$US
238014153$23801415$3$F$20240301$20240722$20240430$20240731$PER$$US-SA-2024SA130473$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240731$$MD$US$US
238014483$23801448$3$F$20240101$20240626$20240430$20240705$PER$$US-SA-2024SA129010$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240705$$MD$US$US
238014552$23801455$2$F$20240410$20240703$20240430$20240710$PER$$US-SA-2024SA125587$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240710$$MD$US$US
238014592$23801459$2$F$20240401$20240621$20240430$20240703$PER$$US-SA-2024SA128886$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240703$$MD$US$US
238014858$23801485$8$F$20240101$20240923$20240430$20240925$EXP$$US-SA-2024SA127731$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240925$$MD$US$US
238014942$23801494$2$F$$20240823$20240430$20240911$PER$$US-SA-2024SA128703$SANOFI AVENTIS$$31$YR$A$F$Y$53.18$KG$20240911$$MD$US$US
238015034$23801503$4$F$20230101$20240816$20240430$20240829$PER$$US-SA-2024SA128805$SANOFI AVENTIS$$61$YR$A$F$Y$98.4$KG$20240829$$MD$US$US
238015132$23801513$2$F$$20240620$20240430$20240701$PER$$US-SA-2024SA129365$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240701$$CN$US$US
238015142$23801514$2$F$20230101$20240730$20240430$20240808$PER$$US-SA-2024SA129999$SANOFI AVENTIS$$65$YR$E$M$Y$65.306$KG$20240808$$MD$US$US
238015152$23801515$2$F$$20240619$20240430$20240701$PER$$US-SA-2024SA125143$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240701$$MD$US$US
238015162$23801516$2$F$20240101$20240828$20240430$20240917$PER$$US-SA-2024SA128385$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240918$$MD$US$US
238015202$23801520$2$F$20240101$20240802$20240430$20240813$PER$$US-SA-2024SA128930$SANOFI AVENTIS$$92$YR$E$F$Y$$$20240814$$MD$US$US
238015332$23801533$2$F$$20240712$20240430$20240724$PER$$US-SA-2024SA129906$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240724$$CN$US$US
238015482$23801548$2$F$20240101$20240820$20240430$20240824$EXP$$US-ABBVIE-5735940$ABBVIE$$$$$M$Y$$$20240824$$CN$US$US
238015552$23801555$2$F$20240424$20240821$20240430$20240829$EXP$$BR-ABBVIE-5736799$ABBVIE$$60$YR$$M$Y$108$KG$20240829$$CN$BR$BR
238015593$23801559$3$F$20240301$20240808$20240430$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067606$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$38.56$KG$20240812$$CN$US$US
238015783$23801578$3$F$20240419$20240701$20240430$20240703$PER$$US-AMGEN-USASP2024086409$AMGEN$$75$YR$E$F$Y$$$20240703$$CN$US$US
238015833$23801583$3$F$$20240722$20240430$20240726$EXP$$CA-ABBVIE-5588790$ABBVIE$$$$$M$Y$$$20240726$$HP$CA$CA
238015842$23801584$2$F$20240201$20240808$20240430$20240811$EXP$$US-ABBVIE-5738421$ABBVIE$$65$YR$$F$Y$$$20240811$$CN$US$US
238015893$23801589$3$F$20240101$20240627$20240430$20240702$EXP$$NL-ABBVIE-5722087$ABBVIE$$$$E$M$Y$66$KG$20240702$$CN$NL$NL
238015972$23801597$2$F$20240425$20240626$20240430$20240701$PER$$US-AMGEN-USASP2024086320$AMGEN$$77$YR$E$M$Y$$$20240701$$CN$US$US
238016002$23801600$2$F$$20240729$20240430$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064007$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240730$$CN$US$US
238016463$23801646$3$F$20240419$20240725$20240501$20240730$EXP$$US-ABBVIE-5738288$ABBVIE$$73$YR$$M$Y$$$20240730$$CN$US$US
238016825$23801682$5$F$20240101$20240904$20240501$20240926$EXP$$US-SA-2024SA127175$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240926$$MD$US$US
238016842$23801684$2$F$20240101$20240625$20240501$20240704$PER$$US-SA-2024SA131058$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240704$$MD$US$US
238016892$23801689$2$F$$20240919$20240501$20240927$EXP$$US-ABBVIE-5738622$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
238017034$23801703$4$F$20231201$20240717$20240501$20240725$EXP$$US-ABBVIE-5738752$ABBVIE$$58$YR$$F$Y$86$KG$20240725$$CN$US$US
238017058$23801705$8$F$20240101$20240827$20240501$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008799$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240905$$$US$US
238017123$23801712$3$F$20240101$20240829$20240501$20240905$EXP$$NL-ABBVIE-5736568$ABBVIE$$63$YR$$M$Y$$$20240905$$CN$NL$NL
238017175$23801717$5$F$20240101$20240627$20240501$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012576$UNITED THERAPEUTICS$$$$$F$Y$44.444$KG$20240706$$$US$US
238017214$23801721$4$F$20240405$20240418$20240501$20240710$PER$$US-ROCHE-3548831$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
238017952$23801795$2$F$$20240813$20240501$20240814$30DAY$$IN-ABBVIE-5737574$ABBVIE$$$$$$Y$$$20240814$$CN$IN$IN
238018633$23801863$3$F$20240101$20240702$20240501$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001707$ACADIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240726$$CN$US$US
238018992$23801899$2$F$$20240708$20240501$20240711$EXP$$GR-AMGEN-GRCSP2024084432$AMGEN$Krikelis:M. New-Onset, Treatment-Resistant Inflammatory Bowel Disease after Administration of Secukinumab for Plaque Psoriasis: A Case Report and Review of the Existing Literature. Mediterranean Journal of Rheumatology (online). 2024;35 (1):150-155$65$YR$E$M$Y$$$20240711$$MD$GR$GR
238019282$23801928$2$F$20240428$20240808$20240501$20240810$PER$$US-AMGEN-USASP2024086273$AMGEN$$75$YR$E$F$Y$$$20240810$$CN$US$US
238019364$23801936$4$F$$20240725$20240501$20240731$EXP$$CA-TAKEDA-2024TUS039293$TAKEDA$$$$$F$Y$$$20240731$$CN$CA$CA
238019372$23801937$2$F$20240413$20240716$20240501$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001722$ACADIA PHARMACEUTICALS$$90$YR$$M$Y$$$20240809$$CN$US$US
238020464$23802046$4$F$20240411$20240731$20240501$20240808$EXP$$AR-TAKEDA-2024TUS040153$TAKEDA$$4$YR$$F$Y$$$20240808$$CN$AR$AR
238020765$23802076$5$F$20240201$20240814$20240501$20240821$EXP$$US-SA-2024SA130149$SANOFI AVENTIS$$76$YR$E$F$Y$48.526$KG$20240821$$MD$US$US
238020853$23802085$3$F$20230701$20240918$20240501$20240926$EXP$$US-ROCHE-3515715$ROCHE$$47$YR$A$F$Y$80.29$KG$20240926$$CN$US$US
238021122$23802112$2$F$20240426$20240807$20240501$20240809$PER$$US-AMGEN-USASP2024085136$AMGEN$$80$YR$E$M$Y$$$20240809$$CN$US$US
238021262$23802126$2$F$20240310$20240627$20240501$20240703$EXP$$US-ABBVIE-5736068$ABBVIE$$73$YR$$M$Y$$$20240703$$CN$US$US
238021465$23802146$5$F$$20240828$20240501$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067789$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$69.85$KG$20240829$$CN$US$US
238021532$23802153$2$F$$20240712$20240501$20240716$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-07327$IPSEN$$$$$F$Y$$$20240716$$HP$US$US
238021572$23802157$2$F$20240428$20240812$20240501$20240813$PER$$US-AMGEN-USASP2024086081$AMGEN$$48$YR$A$F$Y$$$20240813$$CN$US$US
238021922$23802192$2$F$$20240918$20240501$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202404017588$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240923$$MD$US$US
238022014$23802201$4$F$20190101$20240919$20240501$20240925$EXP$$US-ABBVIE-5284387$ABBVIE$$$$$F$Y$70$KG$20240925$$CN$US$US
238022023$23802202$3$F$$20240724$20240501$20240802$EXP$$US-ABBVIE-5739441$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
238022195$23802219$5$F$20240101$20240904$20240501$20240916$EXP$$JP-UCBSA-2024019539$UCB$$$$$F$Y$$$20240916$$CN$JP$JP
238022452$23802245$2$F$$20240906$20240501$20240914$EXP$$US-ABBVIE-5738471$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
238022662$23802266$2$F$20240401$20240808$20240501$20240812$EXP$$CA-UCBSA-2024021077$UCB$$44$YR$$F$Y$$$20240812$$CN$CA$CA
238022694$23802269$4$F$$20240731$20240501$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065653$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240807$$CN$US$US
238022722$23802272$2$F$$20240425$20240501$20240814$EXP$$NVSC2024US077541$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
238022993$23802299$3$F$$20240911$20240501$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-067353$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$MD$JP$JP
238023174$23802317$4$F$20231101$20240710$20240501$20240719$EXP$$DE-ABBVIE-5733737$ABBVIE$$1$DY$$M$Y$2.7$KG$20240719$$MD$DE$DE
238023422$23802342$2$F$$20240702$20240501$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067858$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240703$$CN$US$US
238023512$23802351$2$F$20240216$20240626$20240501$20240701$EXP$$US-SA-2024SA127403$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240701$$HP$US$US
238023582$23802358$2$F$20220901$20240425$20240501$20240925$EXP$$US-GSK-US2022AMR033947$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
238023753$23802375$3$F$20240101$20240710$20240501$20240716$EXP$$US-ABBVIE-5738985$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
238024143$23802414$3$F$20240418$20240826$20240501$20240831$EXP$$US-RDY-CLI/USA/24/0006476$DR REDDYS$$22$YR$A$F$Y$$$20240831$$MD$US$US
238024256$23802425$6$F$20240406$20240909$20240501$20240916$EXP$$US-RDY-CLI/USA/24/0006473$DR REDDYS$$28$YR$A$F$Y$$$20240916$$MD$US$US
238024317$23802431$7$F$20240101$20240917$20240501$20240927$EXP$$US-UCBSA-2024017340$UCB$$$$$F$Y$$$20240927$$MD$US$US
238024353$23802435$3$F$20231005$20240814$20240501$20240821$EXP$$CA-TAKEDA-2023TUS096449$TAKEDA$$53$YR$$F$Y$$$20240821$$HP$CA$CA
238024393$23802439$3$F$$20240617$20240501$20240704$30DAY$$US-GSK-US2024054183$GLAXOSMITHKLINE$$$$$M$Y$$$20240704$$MD$US$US
238025113$23802511$3$F$20240328$20240814$20240501$20240820$EXP$$CA-TAKEDA-2024TUS035560$TAKEDA$$39$YR$$M$Y$$$20240820$$CN$CA$CA
238025132$23802513$2$F$$20240812$20240501$20240819$EXP$$US-GILEAD-2024-0671135$GILEAD$$18$YR$A$M$Y$$$20240819$$CN$US$US
238025163$23802516$3$F$20240422$20240827$20240501$20240905$EXP$$JP-ROCHE-3555686$ROCHE$$76$YR$E$F$Y$46.6$KG$20240905$$MD$JP$JP
238025717$23802571$7$F$20190522$20240808$20240501$20240813$EXP$$CA-TAKEDA-2024TUS039461$TAKEDA$$40$YR$$F$Y$$$20240813$$CN$CA$CA
238025745$23802574$5$F$20220407$20240909$20240501$20240911$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2024-066721$REGENERON$$$$$M$Y$$$20240911$$CN$CO$CO
238025772$23802577$2$F$$20240703$20240501$20240708$EXP$$ZA-ABBVIE-5739543$ABBVIE$$79$YR$$F$Y$$$20240708$$MD$ZA$ZA
238025812$23802581$2$F$$20240520$20240501$20240814$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01422$AMNEAL$$$$$$Y$$$20240814$$PH$US$US
238025822$23802582$2$F$$20240520$20240501$20240814$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01299$AMNEAL$$$$$$Y$$$20240814$$PH$US$US
238025945$23802594$5$F$20201207$20240719$20240501$20240730$EXP$$CA-TAKEDA-2024TUS040596$TAKEDA$$40$YR$$F$Y$$$20240730$$MD$CA$CA
238026312$23802631$2$F$20231126$20240802$20240501$20240809$EXP$$BR-AMGEN-BRASL2023216844$AMGEN$$27$YR$A$M$Y$$$20240809$$CN$BR$BR
238026582$23802658$2$F$$20240909$20240501$20240911$PER$$US-ALXN-202404USA001822US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
238026786$23802678$6$F$20240429$20240809$20240501$20240813$EXP$$NVSC2024US090751$NOVARTIS$$39$YR$$F$Y$180$KG$20240813$$CN$US$US
238027233$23802723$3$F$$20240821$20240501$20240831$EXP$$ES-AUROBINDO-AUR-APL-2023-057630$AUROBINDO$Valenzuela EF,Carbajo  A.Y.,  Fern?ndez-Prada S.J, Rubiales BM, Jimenez NC,. Beyond Crohn?s disease: Deferasiroxas possible agent for drug-induced ileocolitis. Gastroenterolog?a y Hepatolog?a. 2023;GASTRO-2101:1-2$72$YR$$F$Y$$$20240831$$HP$ES$ES
238027423$23802742$3$F$20240101$20240805$20240501$20240807$EXP$$CA-UCBSA-2024020509$UCB$$$$$F$Y$$$20240807$$CN$CA$CA
238027622$23802762$2$F$20240427$20240708$20240501$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202404018703$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240711$$CN$US$US
238027793$23802779$3$F$20240429$20240805$20240501$20240809$EXP$$FR-SA-2024SA032204$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240809$$CN$FR$FR
238028105$23802810$5$F$20240424$20240628$20240501$20240710$30DAY$$US-ROCHE-3553860$ROCHE$$$$$$Y$$$20240710$$CN$US$US
238028332$23802833$2$F$20230601$20240716$20240501$20240722$EXP$$US-ABBVIE-5738624$ABBVIE$$72$YR$$F$Y$130$KG$20240722$$CN$US$US
238028364$23802836$4$F$20240201$20240814$20240501$20240822$EXP$$BG-AMGEN-BGRSP2024084434$AMGEN$$78$YR$E$F$Y$$$20240822$$MD$BG$BG
238028422$23802842$2$F$20231101$20240802$20240501$20240806$EXP$$IE-MYLANLABS-2023M1117044$MYLAN$$55$YR$$M$Y$$$20240806$$CN$IE$IE
238028635$23802863$5$F$20231001$20240909$20240501$20240913$EXP$$NO-ROCHE-3555128$ROCHE$$59$YR$A$M$Y$$$20240913$$MD$NO$NO
238028712$23802871$2$F$20240701$20240715$20240501$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202404018771$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240717$$CN$US$US
238028812$23802881$2$F$20240429$20240712$20240501$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067790$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$54.88$KG$20240716$$HP$US$US
238028822$23802882$2$F$20240401$20240723$20240501$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068073$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240725$$HP$US$US
238029032$23802903$2$F$20240401$20240703$20240501$20240705$EXP$$NVSC2024US091288$NOVARTIS$$40$YR$$F$Y$$$20240705$$CN$US$US
238029352$23802935$2$F$20240419$20240730$20240501$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067891$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240730$$CN$US$US
238029434$23802943$4$F$20221014$20240626$20240501$20240701$EXP$$CA-TAKEDA-2023TUS009370$TAKEDA$$7$YR$$F$Y$$$20240701$$CN$CA$CA
238029692$23802969$2$F$$20240708$20240501$20240717$EXP$$US-TAKEDA-2024TUS018790$TAKEDA$$$$$F$Y$$$20240717$$CN$US$US
238029732$23802973$2$F$20240301$20240828$20240501$20240905$EXP$$JP-AstraZeneca-2024A098257$ASTRAZENECA$$80$YR$$F$Y$$$20240905$$MD$JP$
238029744$23802974$4$F$20220101$20240924$20240501$20240927$EXP$$GB-MYLANLABS-2024M1038709$MYLAN$$63$YR$$M$Y$$$20240927$$CN$GB$GB
238030252$23803025$2$F$$20240423$20240501$20240925$PER$$US-GSK-US2024AMR054783$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
238031683$23803168$3$F$$20240805$20240501$20240817$EXP$$NL-AUROBINDO-AUR-APL-2024-020027$AUROBINDO$Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, van der Knaap MS, Bugiani M, Wolf NI.. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series.. Journal of Neurology. 2024;271:4028?4038$25$MON$$F$Y$$$20240817$$HP$NL$NL
238032113$23803211$3$F$$20240805$20240501$20240817$EXP$$NL-AUROBINDO-AUR-APL-2024-019605$AUROBINDO$Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, et al. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series. Journal of Neurology. 2024;271:4028?4038$27$MON$$M$Y$$$20240817$$HP$NL$NL
238032194$23803219$4$F$$20240830$20240501$20240903$30DAY$$US-PFIZER INC-202400096898$PFIZER$$14$YR$$M$Y$$$20240903$$CN$US$US
238032215$23803221$5$F$$20240812$20240501$20240815$30DAY$$US-PFIZER INC-202400096012$PFIZER$$8$YR$$M$Y$$$20240815$$CN$US$US
238032245$23803224$5$F$$20240914$20240501$20240919$30DAY$$US-PFIZER INC-PV202400056755$PFIZER$$13$YR$$M$Y$$$20240919$$CN$US$US
238032253$23803225$3$F$$20240828$20240501$20240903$30DAY$$US-PFIZER INC-202400094825$PFIZER$$13$YR$$F$Y$$$20240903$$CN$US$US
238032284$23803228$4$F$$20240812$20240501$20240816$30DAY$$US-PFIZER INC-PV202200089661$PFIZER$$72$YR$$F$Y$$$20240816$$HP$US$US
238032294$23803229$4$F$$20240918$20240501$20240920$30DAY$$US-PFIZER INC-202400094959$PFIZER$$13$YR$$M$Y$$$20240920$$CN$US$US
238032302$23803230$2$F$20240422$20240807$20240501$20240809$30DAY$$CA-PFIZER INC-PV202400055096$PFIZER$$23$YR$$F$Y$$$20240809$$CN$CA$CA
238032315$23803231$5$F$20231101$20240911$20240501$20240916$30DAY$$US-PFIZER INC-202400096754$PFIZER$$15$YR$$M$Y$42.18$KG$20240916$$CN$US$US
238032374$23803237$4$F$$20240918$20240501$20240923$30DAY$$US-PFIZER INC-202400094847$PFIZER$$15$YR$$F$Y$44.45$KG$20240923$$MD$US$US
238032395$23803239$5$F$20240423$20240701$20240501$20240701$30DAY$$US-PFIZER INC-202400095214$PFIZER$$40$YR$$F$Y$$$20240701$$HP$US$US
238032403$23803240$3$F$$20240829$20240501$20240904$EXP$$IN-PFIZER INC-PV202400056123$PFIZER$$42$YR$$M$Y$$$20240904$$CN$IN$IN
238032417$23803241$7$F$20240425$20240920$20240501$20240925$30DAY$$US-PFIZER INC-202400096910$PFIZER$$9$YR$$M$Y$21.23$KG$20240925$$CN$US$US
238032425$23803242$5$F$$20240826$20240501$20240903$30DAY$$US-PFIZER INC-202400094666$PFIZER$$13$YR$$F$Y$$$20240903$$CN$US$US
238032433$23803243$3$F$$20240726$20240501$20240801$EXP$$US-PFIZER INC-PV202400055519$PFIZER$$78$YR$$F$Y$$$20240801$$CN$US$US
238033642$23803364$2$F$20240419$20240823$20240501$20240827$PER$$JP-Eisai-EC-2024-164517$EISAI$$67$YR$E$F$Y$$$20240827$$MD$JP$JP
238033753$23803375$3$F$20240305$20240711$20240501$20240715$EXP$$GB-OTSUKA-2024_012027$OTSUKA$$52$YR$$M$Y$88$KG$20240715$$MD$GB$GB
238033762$23803376$2$F$20240415$20240709$20240501$20240717$EXP$$JP-Eisai-EC-2024-164617$EISAI$$$$A$F$Y$$$20240717$$MD$JP$JP
238033802$23803380$2$F$$20240619$20240501$20240709$EXP$$GB-ROCHE-3484342$ROCHE$$58$YR$A$F$Y$$$20240701$$CN$GB$GB
238033944$23803394$4$F$$20240821$20240501$20240826$EXP$$CA-PFIZER INC-2020127412$PFIZER$$60$YR$$F$Y$81$KG$20240826$$HP$CA$CA
238034543$23803454$3$F$$20240910$20240501$20240912$30DAY$$KR-PFIZER INC-PV202400054345$PFIZER$$13$YR$$F$Y$$$20240912$$CN$KR$KR
238035112$23803511$2$F$$20240806$20240501$20240812$EXP$$US-MYLANLABS-2024M1037748$MYLAN$$$$$F$Y$$$20240812$$PH$US$US
238035132$23803513$2$F$$20240719$20240501$20240724$EXP$$DE-ROCHE-3550220$ROCHE$$33$YR$A$F$Y$$$20240724$$MD$DE$DE
238035145$23803514$5$F$20240702$20240726$20240501$20240730$EXP$$CA-TAKEDA-2024TUS039082$TAKEDA$$72$YR$$M$Y$$$20240730$$CN$CA$CA
238035153$23803515$3$F$$20240729$20240501$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202404018871$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240731$$CN$US$US
238035322$23803532$2$F$$20240701$20240501$20240704$EXP$$NVSC2024TH091231$NOVARTIS$$$$$F$Y$$$20240704$$CN$TH$TH
238035392$23803539$2$F$20240101$20240829$20240501$20240910$EXP$$US-UCBSA-2024021020$UCB$$$$$F$Y$$$20240910$$HP$US$US
238035422$23803542$2$F$20240422$20240807$20240501$20240807$PER$$US-ALXN-202404USA001955US$ALEXION PHARMACEUTICALS$$58$YR$$F$Y$$$20240807$$CN$US$US
238035433$23803543$3$F$$20240709$20240501$20240710$EXP$$US-ALXN-202404USA001806US$ALEXION PHARMACEUTICALS$$8$YR$$M$Y$19$KG$20240710$$MD$US$US
238035452$23803545$2$F$$20240715$20240501$20240716$PER$$US-ALXN-202404USA001883US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
238035645$23803564$5$F$20230814$20240904$20240501$20240916$EXP$$CA-UCBSA-2023042018$UCB$$30$YR$$F$Y$$$20240916$$CN$CA$CA
238036292$23803629$2$F$$20240712$20240501$20240712$PER$$NVSC2024US092342$NOVARTIS$$$$$M$Y$$$20240712$$CN$US$US
238036467$23803646$7$F$20240101$20240910$20240501$20240917$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR001024$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$CA$CA
238036513$23803651$3$F$20230420$20240702$20240501$20240711$EXP$$CO-EXELIXIS-CABO-23065830$EXELIXIS$$67$YR$$M$Y$85$KG$20240711$$CN$CO$CO
238036813$23803681$3$F$20240401$20240719$20240501$20240726$EXP$$US-SA-2024SA130312$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240726$$MD$US$US
238036876$23803687$6$F$20240501$20240924$20240501$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067989$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240925$$PH$US$US
238036882$23803688$2$F$$20240826$20240501$20240829$PER$$US-ALXN-202404USA001887US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
238037242$23803724$2$F$$20240830$20240501$20240902$EXP$$NVSC2024US090942$NOVARTIS$$$$$F$Y$$$20240902$$MD$US$US
238037692$23803769$2$F$$20240703$20240501$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067470$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240705$$HP$US$US
238037762$23803776$2$F$20240429$20240726$20240501$20240730$PER$$US-AMGEN-USASP2024086470$AMGEN$$81$YR$E$M$Y$$$20240729$$HP$US$US
238038012$23803801$2$F$20240101$20240919$20240501$20240930$EXP$$GB-UCBSA-2024011220$UCB$$74$YR$$F$Y$90.4$KG$20240930$$HP$GB$GB
238038322$23803832$2$F$20240404$20240808$20240501$20240813$EXP$$FR-PFIZER INC-202400097273$PFIZER$$74$YR$$M$Y$54$KG$20240813$$MD$FR$FR
238038572$23803857$2$F$$20240822$20240501$20240828$EXP$$US-TAKEDA-2024TUS003129$TAKEDA$$$$$F$Y$$$20240828$$HP$US$US
238038857$23803885$7$F$20240601$20240916$20240501$20240923$EXP$$CA-TAKEDA-2024TUS039328$TAKEDA$$67$YR$$F$Y$$$20240923$$HP$CA$CA
238039353$23803935$3$F$$20240903$20240501$20240905$PER$$US-ALXN-202404USA001876US$ALEXION PHARMACEUTICALS$$$$$M$Y$58.957$KG$20240905$$PH$US$US
238039512$23803951$2$F$$20240725$20240501$20240801$EXP$$US-TAKEDA-2024TUS019885$TAKEDA$$$$$M$Y$$$20240801$$CN$US$US
238039724$23803972$4$F$20240404$20240805$20240501$20240812$30DAY$$US-ALKERMES INC.-ALK-2024-000972$ALKERMES$$$$$$Y$$$20240812$$HP$US$US
238039902$23803990$2$F$20240201$20240724$20240501$20240801$EXP$FR-AFSSAPS-DJ2024000522$FR-TEVA-VS-3189689$TEVA$$81$YR$$M$Y$92$KG$20240801$$MD$FR$FR
238039922$23803992$2$F$20230601$20240731$20240501$20240806$EXP$$US-TAKEDA-2024TUS040264$TAKEDA$$29$YR$$F$Y$$$20240806$$MD$US$US
238040032$23804003$2$F$20231001$20240715$20240501$20240718$EXP$$US-JNJFOC-20240477996$JOHNSON AND JOHNSON$$34$YR$A$M$Y$97.837$KG$20240718$$HP$US$US
238040422$23804042$2$F$$20240628$20240501$20240703$EXP$$NVSC2024US088070$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
238040446$23804044$6$F$20240409$20240718$20240501$20240727$EXP$$GB-TEVA-VS-3189767$TEVA$$76$YR$$M$Y$60$KG$20240727$$HP$GB$GB
238040463$23804046$3$F$$20240819$20240501$20240903$EXP$$US-ASTELLAS-2024US012362$ASTELLAS$$59$YR$A$F$Y$$$20240903$$MD$US$US
238041112$23804111$2$F$$20240726$20240501$20240812$PER$$US-AstraZeneca-2024A100852$ASTRAZENECA$$72$YR$$F$Y$$$20240812$$HP$US$
238041233$23804123$3$F$$20240821$20240501$20240829$EXP$$GB-INCYTE CORPORATION-2024IN004384$INCYTE$$$$$$Y$$$20240829$$MD$GB$GB
238041254$23804125$4$F$$20240722$20240501$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066117$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240724$$CN$US$US
238041572$23804157$2$F$20231215$20240827$20240501$20240903$EXP$FR-AFSSAPS-PA2024000966$FR-TEVA-VS-3188751$TEVA$$56$YR$$M$Y$55.2$KG$20240903$$MD$FR$FR
238041633$23804163$3$F$$20240710$20240501$20240716$EXP$$CA-PFIZER INC-202400094478$PFIZER$$70$YR$$F$Y$$$20240716$$HP$CA$CA
238041665$23804166$5$F$$20240805$20240501$20240809$EXP$$US-Taiho Oncology Inc-2024-002588$TAIHO ONCOLOGY INC$$$$A$F$Y$95.35$KG$20240809$$CN$US$US
238041683$23804168$3$F$20240428$20240806$20240501$20240807$PER$$US-AMGEN-USASP2024085852$AMGEN$$72$YR$E$F$Y$$$20240807$$CN$US$US
238041793$23804179$3$F$$20240711$20240501$20240715$PER$$NVSC2024US092317$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
238042003$23804200$3$F$20240105$20240711$20240501$20240719$EXP$$JP-AstraZeneca-2024A096553$ASTRAZENECA$$77$YR$$M$Y$59$KG$20240719$$MD$JP$
238042142$23804214$2$F$$20240724$20240501$20240729$EXP$$US-MYLANLABS-2024M1039378$MYLAN$$$$$F$Y$$$20240729$$PH$US$US
238042528$23804252$8$F$$20240723$20240501$20240730$30DAY$$DE-PFIZER INC-202400092749$PFIZER$$72$YR$$M$Y$$$20240730$$PH$DE$DE
238042604$23804260$4$F$20230918$20240912$20240501$20240924$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202404014808$ELI LILLY AND CO$$22$YR$A$F$Y$63$KG$20240924$$CN$DE$DE
238042893$23804289$3$F$$20240710$20240501$20240715$PER$$NVSC2024US091591$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
238043162$23804316$2$F$20240401$20240827$20240501$20240904$EXP$$JP-Eisai-EC-2024-164480$EISAI$$54$YR$A$F$Y$$$20240904$$MD$JP$JP
238043348$23804334$8$F$$20240628$20240501$20240703$EXP$$CA-PFIZER INC-202300229541$PFIZER$$23$YR$$M$Y$$$20240703$$HP$CA$CA
238043466$23804346$6$F$20240101$20240710$20240501$20240717$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-000429$SK LIFE SCIENCE$$$$$$Y$$$20240717$$HP$CA$CA
238043632$23804363$2$F$20240210$20240725$20240501$20240730$EXP$$US-OTSUKA-2024_012037$OTSUKA$$71$YR$$F$Y$$$20240730$$CN$US$US
238044155$23804415$5$F$$20240923$20240501$20240926$EXP$$US-PFIZER INC-202400096715$PFIZER$$62$YR$$F$Y$86.1$KG$20240926$$HP$US$US
238044302$23804430$2$F$20230714$20240819$20240501$20240829$EXP$FR-AFSSAPS-AM2024000347$FR-FERRINGPH-2024FE02075$FERRING$$$$$$Y$$$20240829$$MD$FR$FR
238044353$23804435$3$F$$20240726$20240501$20240730$EXP$$JP-Eisai-EC-2024-164809$EISAI$$$$E$M$Y$$$20240730$$MD$JP$JP
238044377$23804437$7$F$$20240911$20240501$20240916$30DAY$$US-PFIZER INC-PV202400044590$PFIZER$$12$YR$$M$Y$49.887$KG$20240916$$MD$US$US
238044472$23804447$2$F$$20240429$20240501$20240719$EXP$NL-LRB-00968653$NL-BAUSCH-BL-2024-006869$BAUSCH AND LOMB$$77$YR$$F$Y$70$KG$20240719$$CN$NL$NL
238044492$23804449$2$F$20240101$20240703$20240501$20240705$EXP$$US-BAUSCH-BL-2024-006344$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240705$$CN$US$US
238044944$23804494$4$F$$20240709$20240501$20240710$PER$$US-ALXN-202404USA001981US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
238045143$23804514$3$F$20240401$20240401$20240501$20240919$PER$$JP-ROCHE-3553624$ROCHE$$$$$F$Y$$$20240919$$PH$JP$JP
238045372$23804537$2$F$$20240715$20240501$20240717$EXP$$CA-PFIZER INC-202400098403$PFIZER$$77$YR$$F$Y$$$20240717$$HP$CA$CA
238045623$23804562$3$F$20240313$20240801$20240501$20240807$EXP$IT-MINISAL02-981432$IT-MYLANLABS-2024M1037880$MYLAN$$58$YR$$M$Y$$$20240807$$MD$IT$IT
238045943$23804594$3$F$$20240628$20240501$20240704$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000854$BLUEPRINT MEDICINES$$$$$F$Y$$$20240704$$CN$US$US
238045983$23804598$3$F$20200501$20240628$20240501$20240705$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-021212$JAZZ$$6$YR$$F$Y$26.4$KG$20240705$$CN$US$US
238046122$23804612$2$F$20240201$20240730$20240501$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404015863$ELI LILLY AND CO$$85$YR$E$$Y$$$20240809$$CN$JP$JP
238046424$23804642$4$F$20240423$20240916$20240501$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006848$JAZZ$$25$YR$$M$Y$$$20240920$$CN$US$US
238046574$23804657$4$F$20230901$20240730$20240501$20240802$EXP$$AR-VERTEX PHARMACEUTICALS-2024-006131$VERTEX$$31$YR$$F$Y$$$20240802$$HP$US$US
238046593$23804659$3$F$20240306$20240911$20240501$20240917$EXP$$GR-INCYTE CORPORATION-2024IN004479$INCYTE$$$$$$Y$$$20240917$$MD$GR$GR
238046652$23804665$2$F$$20240709$20240501$20240710$PER$$US-ALXN-202404USA002007US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
238046713$23804671$3$F$20240101$20240912$20240501$20240917$EXP$$US-PFIZER INC-PV202400057026$PFIZER$$54$YR$$F$Y$$$20240917$$HP$US$US
238047202$23804720$2$F$$20240807$20240501$20240809$EXP$$FR-JNJFOC-20240480293$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240809$$MD$FR$FR
238047262$23804726$2$F$$20240709$20240501$20240710$PER$$US-ALXN-202404USA001942US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
238047815$23804781$5$F$20240411$20240822$20240501$20240828$30DAY$$MX-JNJFOC-20240438407$JOHNSON AND JOHNSON$$61$YR$A$F$Y$58$KG$20240828$$CN$MX$MX
238047922$23804792$2$F$20240419$20240729$20240501$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066640$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240729$$HP$US$US
238047932$23804793$2$F$$20240904$20240501$20240911$EXP$$JP-Eisai-EC-2024-164432$EISAI$$61$YR$A$F$Y$$$20240911$$MD$JP$JP
238048252$23804825$2$F$20240415$20240729$20240501$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-065340$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240730$$CN$US$US
238048284$23804828$4$F$20231001$20240705$20240501$20240726$EXP$$US-ABBVIE-5738879$ABBVIE$$55$YR$$F$Y$76$KG$20240726$$CN$US$US
238048492$23804849$2$F$$20240715$20240501$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063690$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$55.79$KG$20240718$$CN$US$US
238048673$23804867$3$F$20231226$20240828$20240501$20240903$EXP$$CA-TAKEDA-2024TUS002607$TAKEDA$$36$YR$$F$Y$$$20240903$$MD$CA$CA
238048713$23804871$3$F$20240101$20240705$20240501$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-012556$UNITED THERAPEUTICS$$$$$F$Y$$$20240713$$$US$US
238048773$23804877$3$F$$20240906$20240501$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066955$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240916$$HP$US$US
238048902$23804890$2$F$$20240709$20240501$20240710$PER$$US-JNJFOC-20240471605$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$CN$US$US
238049084$23804908$4$F$$20240829$20240501$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-005264$UNITED THERAPEUTICS$$$$$F$Y$53.061$KG$20240904$$$US$US
238049252$23804925$2$F$20240419$20240807$20240501$20240807$PER$$US-ALXN-202404USA001952US$ALEXION PHARMACEUTICALS$$72$YR$$F$Y$$$20240807$$CN$US$US
238049353$23804935$3$F$20240101$20240919$20240501$20240925$EXP$$US-BIOGEN-2024BI01262353$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
238049392$23804939$2$F$20240327$20240819$20240501$20240828$EXP$$DE-BIOGEN-2024BI01262695$BIOGEN$$33$YR$$F$Y$67$KG$20240828$$MD$DE$DE
238049414$23804941$4$F$20240101$20240718$20240501$20240801$EXP$$US-ABBVIE-5739522$ABBVIE$$64$YR$$F$Y$$$20240801$$CN$US$US
238049464$23804946$4$F$20240401$20240731$20240501$20240806$EXP$$JP-JNJFOC-20240482142$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240806$$PH$JP$JP
238049554$23804955$4$F$$20240702$20240501$20240712$EXP$$PL-DENTSPLY-2024SCDP000122$DENTSPLY$$24$YR$$M$Y$$$20240712$$MD$PL$PL
238049652$23804965$2$F$20230201$20240919$20240501$20240925$EXP$$US-ABBVIE-5629288$ABBVIE$$61$YR$$M$Y$108.86$KG$20240925$$CN$US$US
238049672$23804967$2$F$$20240822$20240501$20240828$EXP$$US-ABBVIE-5739302$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
238049793$23804979$3$F$20210101$20240709$20240501$20240710$PER$$US-ALXN-202404USA001919US$ALEXION PHARMACEUTICALS$$$$$F$Y$61.678$KG$20240710$$CN$US$US
238050164$23805016$4$F$20240101$20240702$20240502$20240706$EXP$$US-ABBVIE-5739484$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
238050483$23805048$3$F$20231001$20240730$20240502$20240806$EXP$$US-BIOGEN-2024BI01262334$BIOGEN$$67$YR$$F$Y$$$20240806$$CN$US$US
238050893$23805089$3$F$20240401$20240716$20240502$20240731$EXP$$AU-AMGEN-AUSNI2024074769$AMGEN$$82$YR$E$M$Y$73$KG$20240731$$PH$AU$AU
238050963$23805096$3$F$$20240916$20240502$20240924$EXP$$CA-TEVA-VS-3191918$TEVA$$52$YR$$F$Y$$$20240924$$MD$CA$CA
238051453$23805145$3$F$20240416$20240621$20240502$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002000$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240716$$CN$US$US
238052542$23805254$2$F$$20240911$20240502$20240920$EXP$$US-NOVOPROD-1211612$NOVO NORDISK$$64$YR$$F$Y$$$20240920$$CN$US$US
238052572$23805257$2$F$20230201$20240418$20240502$20240712$EXP$$US-NOVOPROD-1208310$NOVO NORDISK$$64$YR$$F$Y$$$20240712$$CN$US$US
238052743$23805274$3$F$$20240806$20240502$20240807$PER$$US-JNJFOC-20240470710$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
238052912$23805291$2$F$$20240822$20240502$20240827$EXP$$US-TAKEDA-2024TUS041120$TAKEDA$$$$$F$Y$97$KG$20240827$$HP$US$US
238053083$23805308$3$F$20240410$20240918$20240502$20240925$EXP$$CA-JNJFOC-20240207278$JOHNSON AND JOHNSON$$38$YR$A$M$Y$104$KG$20240925$$HP$CA$CA
238053343$23805334$3$F$20190823$20240716$20240502$20240722$EXP$$CA-TAKEDA-2024TUS041393$TAKEDA$$18$YR$$F$Y$$$20240722$$CN$CA$CA
238053392$23805339$2$F$20240117$20240731$20240502$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-004189$UNITED THERAPEUTICS$$82$YR$$M$Y$92.2$KG$20240810$$$US$US
238053633$23805363$3$F$$20240709$20240502$20240710$PER$$US-ALXN-202404USA001935US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
238053663$23805366$3$F$$20240830$20240502$20240902$PER$$NVSC2024US092679$NOVARTIS$$$$$$Y$$$20240903$$HP$US$US
238054032$23805403$2$F$20240101$20240701$20240502$20240709$EXP$$JP-AstraZeneca-2024A099227$ASTRAZENECA$$$$$$Y$$$20240709$$MD$JP$
238054358$23805435$8$F$20240420$20240920$20240502$20240926$EXP$$CA-GSK-CA2023AMR065843$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$CA$CA
238054423$23805442$3$F$20240426$20240812$20240502$20240813$PER$$US-AMGEN-USASP2024085585$AMGEN$$73$YR$E$F$Y$$$20240813$$CN$US$US
238054752$23805475$2$F$20240328$20240909$20240502$20240918$EXP$FR-AFSSAPS-MA2024000498$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-106382$ZYDUS PHARM$$$$$$Y$$$20240918$$MD$FR$FR
238054802$23805480$2$F$20240321$20240712$20240502$20240722$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-106416$ZYDUS PHARM$$$$$$Y$$$20240722$$CN$US$US
238054922$23805492$2$F$20240102$20240709$20240502$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067189$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240718$$CN$US$US
238054932$23805493$2$F$$20240621$20240502$20240701$EXP$$JP-AMGEN-JPNSP2024086285$AMGEN$$8$DEC$E$M$Y$$$20240630$$MD$JP$JP
238055025$23805502$5$F$20191122$20240716$20240502$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-114622$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$49.6$KG$20240719$$MD$JP$JP
238055182$23805518$2$F$$20240701$20240502$20240710$EXP$$GB-CELLTRION INC.-2023GB012703$CELLTRION$$$$$$Y$$$20240710$$CN$GB$GB
238055492$23805549$2$F$20240430$20240628$20240502$20240702$PER$$US-AMGEN-USASP2024086913$AMGEN$$61$YR$A$F$Y$$$20240702$$CN$US$US
238055702$23805570$2$F$20240404$20240808$20240502$20240821$EXP$$FR-CIPLA LTD.-2024FR04019$CIPLA$$$$$$Y$$$20240821$$PH$FR$FR
238055872$23805587$2$F$20240101$20240802$20240502$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-064523$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$75.8$KG$20240805$$PH$US$US
238056034$23805603$4$F$$20240926$20240502$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068144$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240927$$CN$US$US
238056103$23805610$3$F$20231205$20240627$20240502$20240705$EXP$$CA-BEH-2024171422$CSL BEHRING$$72$YR$E$M$Y$$$20240705$$HP$CA$CA
238056123$23805612$3$F$20240123$20240911$20240502$20240924$EXP$$US-UCBSA-2024004416$UCB$$26$YR$$F$Y$$$20240925$$CN$US$US
238056132$23805613$2$F$$20240719$20240502$20240729$EXP$$TH-ROCHE-3554098$ROCHE$$72$YR$E$F$Y$$$20240729$$CN$TH$TH
238056404$23805640$4$F$20180929$20240723$20240502$20240726$EXP$$AU-AMGEN-AUSSP2024066769$AMGEN$$78$YR$E$F$Y$$$20240726$$CN$AU$AU
238056623$23805662$3$F$20230421$20240820$20240502$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068482$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240820$$CN$US$US
238057132$23805713$2$F$$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068270$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240731$$CN$US$US
238057412$23805741$2$F$20080101$20240918$20240502$20240930$EXP$GB-SHIRE-CA201925146$GB-RDY-SPO/GBR/24/0006439$DR REDDYS$$53$YR$A$M$Y$$$20240930$$HP$GB$GB
238057502$23805750$2$F$20231201$20240906$20240502$20240913$EXP$$CA-GSK-CA2023168881$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$PH$CA$CA
238057652$23805765$2$F$$20240425$20240502$20240812$EXP$$NVSC2024PA092252$NOVARTIS$$$$$F$Y$$$20240812$$CN$PA$PA
238057902$23805790$2$F$$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068235$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240731$$CN$US$US
238059012$23805901$2$F$$20240702$20240502$20240708$EXP$$US-UCBSA-2023020612$UCB$$$$$F$Y$$$20240708$$HP$US$US
238059652$23805965$2$F$$20240627$20240502$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-020417$AUROBINDO$$19$YR$$F$Y$$$20240705$$PH$US$US
238059772$23805977$2$F$20221208$20240712$20240502$20240715$EXP$$US-UCBSA-2023024013$UCB$$31$YR$$F$Y$$$20240715$$HP$US$US
238059832$23805983$2$F$20240427$20240819$20240502$20240821$PER$$US-AMGEN-USASP2024086932$AMGEN$$81$YR$E$F$Y$$$20240821$$CN$US$US
238060133$23806013$3$F$20231217$20240702$20240502$20240710$EXP$$US-UNITED THERAPEUTICS-UNT-2023-036476$UNITED THERAPEUTICS$$73$YR$$F$Y$78.912$KG$20240710$$$US$US
238061232$23806123$2$F$20240430$20240805$20240502$20240807$PER$$US-AMGEN-USASP2024087087$AMGEN$$62$YR$A$M$Y$$$20240807$$HP$US$US
238062432$23806243$2$F$$20240830$20240502$20240912$EXP$$US-UCBSA-2023036844$UCB$$$$$F$Y$$$20240912$$HP$US$US
238062552$23806255$2$F$$20240703$20240502$20240705$EXP$$NVSC2024US081710$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
238062912$23806291$2$F$20240429$20240809$20240502$20240812$PER$$US-AMGEN-USASP2024087046$AMGEN$$62$YR$A$F$Y$$$20240812$$CN$US$US
238063192$23806319$2$F$$20240426$20240502$20240813$EXP$$NVSC2024TW092077$NOVARTIS$$$$$$Y$$$20240813$$MD$TW$TW
238063314$23806331$4$F$20240101$20240709$20240502$20240715$EXP$$US-ABBVIE-5739792$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
238063462$23806346$2$F$$20240717$20240502$20240726$EXP$$TH-AMGEN-THASP2024081661$AMGEN$$$$$$Y$$$20240726$$HP$TH$TH
238063533$23806353$3$F$20230926$20240802$20240502$20240814$EXP$$US-UCBSA-2023047556$UCB$$11$YR$$F$Y$$$20240814$$CN$US$US
238063574$23806357$4$F$$20240730$20240502$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-065797$BRISTOL MYERS SQUIBB$$9$DEC$E$F$Y$$$20240808$$MD$JP$JP
238063664$23806366$4$F$20240325$20240904$20240502$20240911$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-024858$BOEHRINGER INGELHEIM$$86$YR$E$M$Y$116$KG$20240911$$CN$DE$DE
238064013$23806401$3$F$20240422$20240716$20240502$20240718$EXP$$CA-TAKEDA-2023TUS115079$TAKEDA$$34$YR$$F$Y$$$20240718$$CN$CA$CA
238064023$23806402$3$F$20231202$20240716$20240502$20240723$EXP$$CA-TAKEDA-2023TUS088170$TAKEDA$$60$YR$$M$Y$$$20240723$$MD$CA$CA
238064072$23806407$2$F$20210426$20240802$20240502$20240805$EXP$$US-TAKEDA-2021TUS023133$TAKEDA$$40$YR$$M$Y$$$20240805$$HP$US$US
238064112$23806411$2$F$20231031$20240830$20240502$20240903$EXP$$US-TAKEDA-2023TUS087584$TAKEDA$$62$YR$$F$Y$$$20240903$$HP$US$US
238064134$23806413$4$F$20231219$20240628$20240502$20240704$EXP$$FR-ABBVIE-5737277$ABBVIE$$51$YR$$M$Y$84$KG$20240704$$MD$FR$FR
238064493$23806449$3$F$20240101$20240705$20240502$20240709$EXP$$US-ABBVIE-5697359$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
238064713$23806471$3$F$20240201$20240807$20240502$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-067883$BRISTOL MYERS SQUIBB$$6$DEC$A$$Y$$$20240819$$MD$JP$JP
238065063$23806506$3$F$$20240702$20240502$20240709$EXP$$AT-JNJFOC-20240474603$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240709$$HP$AT$AT
238065232$23806523$2$F$20240501$20240822$20240502$20240824$PER$$US-AMGEN-USASP2024087708$AMGEN$$77$YR$E$M$Y$$$20240824$$CN$US$US
238065303$23806530$3$F$$20240712$20240502$20240716$PER$$NVSC2024US092471$NOVARTIS$$$$$F$Y$$$20240716$$MD$US$US
238065502$23806550$2$F$$20240626$20240502$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03484$LUPIN$$$$$$Y$$$20240712$$CN$US$US
238065512$23806551$2$F$$20240626$20240502$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03476$LUPIN$$$$$$Y$$$20240711$$CN$US$US
238065523$23806552$3$F$20240101$20240625$20240502$20240702$EXP$$US-TEVA-VS-3186831$TEVA$$17$YR$$F$Y$$$20240702$$HP$US$US
238065712$23806571$2$F$$20240904$20240502$20240905$EXP$$CA-BAUSCH-BL-2024-006909$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240905$$HP$CA$CA
238065877$23806587$7$F$20240425$20240731$20240502$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-067091$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240809$$HP$JP$JP
238065994$23806599$4$F$$20240711$20240502$20240719$EXP$$CA-TEVA-VS-3191473$TEVA$$44$YR$$M$Y$$$20240719$$HP$CA$CA
238066162$23806616$2$F$20160101$20240730$20240502$20240731$EXP$$US-JNJFOC-20240471352$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240731$$CN$US$US
238066315$23806631$5$F$20240428$20240730$20240502$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-068018$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240730$$PH$JP$JP
238066475$23806647$5$F$$20240821$20240502$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03477$LUPIN$$$$$$Y$$$20240912$$CN$US$US
238066503$23806650$3$F$$20240823$20240502$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03536$LUPIN$Sadeghi S, Anderson A, Van DA, Holmes D, Sanne S, Montgomery D. Bilateral trismus in the setting of a unilateral stroke of the internal capsule. The American Journal of the Medical Sciences. 2024;367 (1):S73$53$YR$$F$Y$$$20240905$$HP$US$US
238066542$23806654$2$F$$20240715$20240502$20240718$EXP$$CA-Orion Corporation ORION PHARMA-24_00029636$ORION$$77$YR$E$F$Y$$$20240718$$HP$CA$
238066572$23806657$2$F$20240401$20240704$20240502$20240705$EXP$$NVSC2024GB090048$NOVARTIS$$25$YR$$M$Y$$$20240705$$CN$GB$GB
238066622$23806662$2$F$$20240627$20240502$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03483$LUPIN$$$$$$Y$$$20240714$$CN$US$US
238066772$23806677$2$F$20240101$20240911$20240502$20240914$EXP$$US-ABBVIE-5740342$ABBVIE$$$$$F$Y$58$KG$20240914$$CN$US$US
238066793$23806679$3$F$20240401$20240910$20240502$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-068415$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$MD$JP$JP
238066863$23806686$3$F$$20240809$20240502$20240813$EXP$$CA-ROCHE-3556835$ROCHE$$$$A$F$Y$$$20240813$$CN$CA$CA
238066904$23806690$4$F$20240101$20240801$20240502$20240806$EXP$$ES-ABBVIE-5740045$ABBVIE$$$$$M$Y$$$20240806$$HP$ES$ES
238066912$23806691$2$F$$20240626$20240502$20240701$EXP$$US-TAKEDA-2022TUS037853$TAKEDA$$$$$F$Y$77$KG$20240701$$HP$US$US
238067004$23806700$4$F$20230905$20240903$20240502$20240904$EXP$$US-TAKEDA-2023TUS093398$TAKEDA$$66$YR$$F$Y$$$20240904$$MD$US$US
238067032$23806703$2$F$20240417$20240711$20240502$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03474$LUPIN$$$$$$Y$$$20240809$$CN$US$US
238067243$23806724$3$F$$20240705$20240502$20240710$EXP$$NVSC2024AR092582$NOVARTIS$$$$$F$Y$$$20240710$$CN$AR$AR
238067683$23806768$3$F$$20240428$20240502$20240717$PER$$US-ABBVIE-5741352$ABBVIE$$$$E$F$Y$$$20240717$$HP$US$US
238071502$23807150$2$F$20240615$20240816$20240502$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068172$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240819$$CN$US$US
238071943$23807194$3$F$$20240428$20240502$20240722$PER$$US-ABBVIE-5741331$ABBVIE$$35$YR$$F$Y$$$20240719$$HP$US$US
238072303$23807230$3$F$20240201$20240918$20240502$20240925$EXP$$AR-GSK-AR2024AMR027738$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$AR$AR
238072326$23807232$6$F$$20240715$20240502$20240926$PER$$US-GSK-US2024AMR050356$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$HP$US$US
238072335$23807233$5$F$20240422$20240604$20240502$20240925$PER$$US-GSK-US2024AMR053258$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240925$$CN$US$US
238072962$23807296$2$F$20240101$20240710$20240502$20240715$EXP$$US-ABBVIE-5739520$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
238073006$23807300$6$F$$20240922$20240502$20240930$EXP$$PT-JNJFOC-20240478787$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20241001$$CN$PT$PT
238073255$23807325$5$F$$20240808$20240502$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068383$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240813$$CN$US$US
238074093$23807409$3$F$20240227$20240816$20240502$20240822$EXP$$US-ABBVIE-5737993$ABBVIE$$75$YR$$M$Y$89$KG$20240822$$HP$US$US
238074492$23807449$2$F$20240320$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068537$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240731$$HP$US$US
238074532$23807453$2$F$$20240704$20240502$20240705$EXP$$NVSC2024BR090919$NOVARTIS$$$$$$Y$$$20240705$$MD$BR$BR
238074712$23807471$2$F$$20240626$20240502$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03529$LUPIN$$$$$$Y$$$20240712$$CN$US$US
238075162$23807516$2$F$20240426$20240802$20240502$20240806$PER$$US-AMGEN-USASP2024086041$AMGEN$$45$YR$A$M$Y$$$20240806$$CN$US$US
238075517$23807551$7$F$20240101$20240903$20240502$20240910$EXP$$NVSC2024MX078364$NOVARTIS$$76$YR$$F$Y$64$KG$20240910$$CN$MX$MX
238075992$23807599$2$F$$20240719$20240502$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-444007$RANBAXY$Rousset L, Caux F, Matcasu I, Khalifa B, Brechignac S, Assier H, et al. Variability of viral reactivations during recurrence of DRESS. Australas J Dermatol. 2024;65:88-90$68$YR$$M$Y$$$20240802$$MD$FR$FR
238076274$23807627$4$F$20240228$20240905$20240502$20240910$EXP$$US-ABBVIE-5740034$ABBVIE$$67$YR$$F$Y$98$KG$20240910$$CN$US$US
238076285$23807628$5$F$20240522$20240905$20240502$20240910$EXP$$CA-TAKEDA-2024TUS022631$TAKEDA$$54$YR$$F$Y$$$20240910$$CN$CA$CA
238076312$23807631$2$F$$20240701$20240502$20240708$EXP$$US-TAKEDA-2023TUS119091$TAKEDA$$$$$F$Y$$$20240708$$CN$US$US
238076325$23807632$5$F$20230913$20240722$20240502$20240730$EXP$$CA-CELLTRION INC.-2023CA018348$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
238076412$23807641$2$F$$20240912$20240502$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-443890$RANBAXY$Reddy SB, Botros M, Mahapatra S, Corral J. What caused the pancytopenia?. Am J Med Sci. 2024;367 (Suppl.):S165-S166 (282)$74$YR$$F$Y$$$20240927$$HP$US$US
238076422$23807642$2$F$$20240819$20240502$20240830$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-443808$RANBAXY$Ratner S, Sloan S, Brewster K. COVID-19 OR CLOZAPINE? A CASE OF LIKELY CLOZAPINE-INDUCED SYSTEMIC INFLAMMATORY RESPONSE SYNDROME. Am J Geriatr Psychiatry. 2024;APR; 32: 4S:S75-S76-S77$6$DEC$$F$Y$$$20240830$$MD$US$US
238076634$23807663$4$F$20201009$20240617$20240502$20240702$EXP$$IT-ROCHE-2870741$ROCHE$$55$YR$A$M$Y$$$20240702$$MD$IT$IT
238076732$23807673$2$F$$20240920$20240502$20240930$PER$$US-GSK-US2024051314$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
238077222$23807722$2$F$$20240815$20240502$20240822$EXP$GR-EMA-DD-20220122-veeravajhul_p-164132$GR-ROCHE-3552474$ROCHE$Eleftheriotis G, Kalagiakou E K. Hemophagocytic Syndrome relted to Leismania Donovani Infection with Complication Rhombencephalitis caused by Listeria Monocytogenes and CMV.. In: The 20th Panhellenic Congress on infections. 2020-Sep;17-20.$43$YR$A$M$Y$$$20240822$$MD$GR$GR
238077266$23807726$6$F$20240715$20240903$20240502$20240906$EXP$$US-TAKEDA-2024TUS040679$TAKEDA$$34$YR$$F$Y$79$KG$20240906$$CN$US$US
238077652$23807765$2$F$$20240712$20240502$20240717$EXP$$JP-ASTELLAS-2024JP002829$ASTELLAS$$$$E$M$Y$$$20240717$$MD$JP$JP
238077682$23807768$2$F$$20240722$20240502$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068155$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240724$$CN$US$US
238077692$23807769$2$F$20240401$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068455$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240731$$HP$US$US
238077892$23807789$2$F$20240417$20240621$20240502$20240704$EXP$$CA-BEH-2024171419$CSL BEHRING$$18$YR$A$F$Y$103$KG$20240704$$CN$CA$CA
238078366$23807836$6$F$20240808$20240906$20240502$20240912$EXP$$US-TAKEDA-2024TUS041254$TAKEDA$$47$YR$$M$Y$65$KG$20240912$$HP$US$US
238078432$23807843$2$F$20230101$20240625$20240502$20240704$EXP$$US-UNITED THERAPEUTICS-UNT-2023-027452$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240704$$$US$US
238078592$23807859$2$F$20240301$20240703$20240502$20240710$EXP$$JP-009507513-2404JPN003179J$MERCK$$79$YR$$F$Y$$$20240710$$MD$JP$JP
238078793$23807879$3$F$20240401$20240810$20240502$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068300$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240820$$PH$US$US
238078862$23807886$2$F$20230330$20240623$20240502$20240701$EXP$$CA-CELLTRION INC.-2022CA008141$CELLTRION$$$$$$Y$$$20240701$$MD$CA$CA
238079163$23807916$3$F$20240221$20240820$20240502$20240827$EXP$FR-AFSSAPS-LL2024000787$FR-009507513-2404FRA012070$MERCK$$48$YR$$F$Y$60$KG$20240827$$MD$FR$FR
238079343$23807934$3$F$$20240710$20240502$20240710$EXP$$AE-PFIZER INC-PV202400056406$PFIZER$$57$YR$$F$Y$$$20240710$$CN$AE$AE
238079435$23807943$5$F$$20240917$20240502$20240919$EXP$$GR-PFIZER INC-202400098030$PFIZER$$82$YR$$M$Y$$$20240919$$MD$GR$GR
238079502$23807950$2$F$$20240708$20240502$20240710$EXP$$CA-PFIZER INC-202400094796$PFIZER$$78$YR$$F$Y$$$20240710$$CN$CA$CA
238079524$23807952$4$F$20240215$20240701$20240502$20240708$EXP$$FR-PFIZER INC-202400097293$PFIZER$$64$YR$$F$Y$48$KG$20240708$$HP$FR$FR
238079535$23807953$5$F$20190829$20240913$20240502$20240913$EXP$$CA-PFIZER INC-2019257911$PFIZER$$49$YR$$F$Y$75$KG$20240913$$MD$CA$CA
238079573$23807957$3$F$$20240626$20240502$20240708$EXP$$GB-PFIZER INC-202400096514$PFIZER$$37$YR$$F$Y$$$20240708$$MD$GB$GB
238079842$23807984$2$F$20240424$20240722$20240502$20240724$30DAY$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066346$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240724$$HP$US$US
238079852$23807985$2$F$$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068442$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240731$$HP$US$US
238079953$23807995$3$F$$20240501$20240502$20240807$EXP$$NVSC2024RU090933$NOVARTIS$Sultanbaev AV, Kolyadina IV, Menshikov KV, Musin ShI, Nasretdinov AF,  Sultanbaeva NI et al. Efficacy and safety  of alpelisib in patients with HR+ HER2-negative metastatic breast cancer in real clinical practice: Results of a single-center observational retrospective study. JOURNAL OF MODERN ONCOLOGY. 2024;26(1):65?72$$$A$F$Y$$$20240807$$HP$RU$RU
238080033$23808003$3$F$20210421$20240620$20240502$20240726$EXP$$NVSC2024ES087466$NOVARTIS$$3$YR$$F$Y$$$20240726$$MD$ES$ES
238080123$23808012$3$F$$20240703$20240502$20240704$EXP$$NVSC2024GB089316$NOVARTIS$$$$$F$Y$$$20240704$$HP$GB$GB
238080222$23808022$2$F$20240430$20240828$20240502$20240830$PER$$US-AMGEN-USASP2024087730$AMGEN$$67$YR$E$M$Y$$$20240830$$CN$US$US
238080702$23808070$2$F$$20240717$20240502$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-020096$AUROBINDO$Trinh S, Joseph F.. Refractory Pediatric Ocular Myasthenia Gravis. J-Child-Neurol. 2023;38568:8-9$2$YR$$M$Y$$$20240726$$MD$US$US
238080803$23808080$3$F$20240301$20240823$20240502$20240901$EXP$$CA-TAKEDA-2024TUS013632$TAKEDA$$68$YR$$M$Y$$$20240901$$CN$CA$CA
238081203$23808120$3$F$20230701$20240922$20240502$20240925$EXP$$US-SANDOZ INC.-SDZ2024US043814$SANDOZ$$27$YR$$F$Y$230$KG$20240925$$CN$US$US
238081282$23808128$2$F$$20240710$20240502$20240712$EXP$$US-PFIZER INC-202400098845$PFIZER$$68$YR$$F$Y$$$20240712$$CN$US$US
238081333$23808133$3$F$20240401$20240703$20240502$20240708$EXP$$US-PFIZER INC-202400097654$PFIZER$$76$YR$$F$Y$$$20240708$$CN$US$US
238081384$23808138$4$F$$20240812$20240502$20240815$EXP$$GB-PFIZER INC-PV202400055613$PFIZER$$8$YR$$$Y$$$20240815$$CN$GB$GB
238081562$23808156$2$F$$20240726$20240502$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202405000056$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240730$$CN$US$US
238081632$23808163$2$F$$20240808$20240502$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-020251$AUROBINDO$$35$YR$$M$Y$$$20240820$$HP$CA$CA
238081807$23808180$7$F$20240426$20240828$20240502$20240830$EXP$$NVSC2024US090691$NOVARTIS$$60$YR$$F$Y$$$20240830$$CN$US$US
238081913$23808191$3$F$20240305$20240711$20240502$20240720$EXP$$GB-TEVA-VS-3190687$TEVA$$52$YR$$M$Y$88$KG$20240720$$CN$GB$GB
238082294$23808229$4$F$20240423$20240712$20240502$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-012336$UNITED THERAPEUTICS$$44$YR$$F$Y$77.098$KG$20240719$$$US$US
238082583$23808258$3$F$20240102$20240628$20240502$20240706$EXP$$DE-AUROBINDO-AUR-APL-2024-019848$AUROBINDO$$$$E$F$Y$$$20240706$$MD$DE$DE
238083027$23808302$7$F$20240101$20240912$20240502$20240925$EXP$$CA-UCBSA-2024019641$UCB$$$$$F$Y$$$20240925$$CN$CA$CA
238083183$23808318$3$F$20240301$20240711$20240502$20240718$EXP$$CA-APOTEX-2024AP005142$APOTEX$$80$YR$E$M$Y$69$KG$20240718$$MD$CA$CA
238083263$23808326$3$F$$20240701$20240502$20240711$30DAY$$US-GSK-US2024051396$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
238083392$23808339$2$F$20231128$20231207$20240502$20240925$PER$$US-TEVA-VS-3139161$TEVA$$53$YR$$F$Y$80.74$KG$20240925$$CN$US$US
238083605$23808360$5$F$20240414$20240624$20240502$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-020437$AUROBINDO$$59$YR$$M$Y$99.6$KG$20240703$$MD$US$US
238083614$23808361$4$F$20240101$20240801$20240502$20240808$EXP$$CA-CELLTRION INC.-2024CA002411$CELLTRION$$$$$$Y$$$20240809$$PH$CA$CA
238083704$23808370$4$F$$20240912$20240502$20240916$30DAY$$US-PFIZER INC-202400095953$PFIZER$$9$YR$$F$Y$$$20240916$$HP$US$US
238083762$23808376$2$F$20240304$20240701$20240502$20240704$EXP$$NVSC2024FR091670$NOVARTIS$$$$C$$Y$$$20240704$$MD$FR$FR
238084162$23808416$2$F$$20240417$20240502$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-020290$AUROBINDO$Dauterive E, Subauste J.. A Hidden Thirst: Unmasking of Central Diabetes Insipidus. J-Endocr-Soc. 2020;4:A714-A715$50$YR$$M$Y$$$20240723$$MD$US$US
238084243$23808424$3$F$$20240828$20240502$20240903$EXP$$CA-SANDOZ INC.-SDZ2024CA044211$SANDOZ$$40$YR$$F$Y$73$KG$20240903$$HP$CA$CA
238084466$23808446$6$F$20240422$20240910$20240502$20240918$30DAY$$US-PFIZER INC-202300336309$PFIZER$$8$YR$$M$Y$22.449$KG$20240918$$CN$US$US
238084473$23808447$3$F$$20240916$20240502$20240919$30DAY$$US-PFIZER INC-202400094926$PFIZER$$11$YR$$F$Y$$$20240919$$CN$US$US
238084506$23808450$6$F$20240424$20240911$20240502$20240916$30DAY$$US-PFIZER INC-202300187881$PFIZER$$12$YR$$M$Y$32.66$KG$20240916$$MD$US$US
238084535$23808453$5$F$20240414$20240925$20240502$20240930$30DAY$$US-PFIZER INC-202400095636$PFIZER$$2$YR$$M$Y$$$20240930$$HP$US$US
238084564$23808456$4$F$$20240911$20240502$20240912$30DAY$$US-PFIZER INC-202400095830$PFIZER$$5$YR$$M$Y$$$20240912$$CN$US$US
238084582$23808458$2$F$$20240710$20240502$20240712$EXP$$US-PFIZER INC-202400097638$PFIZER$$72$YR$$F$Y$$$20240712$$CN$US$US
238084616$23808461$6$F$$20240816$20240502$20240821$30DAY$$US-PFIZER INC-202400096420$PFIZER$$15$YR$$M$Y$79.7$KG$20240821$$MD$US$US
238085043$23808504$3$F$20240408$20240711$20240502$20240718$EXP$$CA-TAKEDA-2024TUS041385$TAKEDA$$15$YR$$F$Y$$$20240718$$CN$CA$CA
238085552$23808555$2$F$20240401$20240426$20240502$20240923$EXP$$US-BAUSCH-BL-2024-006707$BAUSCH AND LOMB$$$$$F$Y$$$20240923$$MD$US$US
238085602$23808560$2$F$$20240829$20240502$20240904$PER$$US-PFIZER INC-PV202400056838$PFIZER$$38$YR$$F$Y$$$20240904$$HP$US$US
238086344$23808634$4$F$$20240813$20240502$20240814$PER$$NVSC2024US092787$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
238086362$23808636$2$F$20230517$20240704$20240502$20240705$EXP$$NVSC2024US092549$NOVARTIS$$45$YR$$M$Y$$$20240706$$CN$US$US
238086373$23808637$3$F$$20240629$20240502$20240704$PER$$NVSC2024US092785$NOVARTIS$$39$YR$$F$Y$$$20240704$$CN$US$US
238086643$23808664$3$F$$20240719$20240502$20240726$PER$$US-BIOVITRUM-2024-US-006571$BIOVITRUM$$65$YR$$M$Y$$$20240726$$CN$US$US
238086653$23808665$3$F$20240218$20240830$20240502$20240906$EXP$$PT-AstraZeneca-2024A100811$ASTRAZENECA$$81$YR$$F$Y$$$20240906$$MD$PT$
238086822$23808682$2$F$$20240426$20240502$20240718$PER$$NVSC2024US090434$NOVARTIS$$$$A$F$Y$$$20240718$$CN$US$US
238086864$23808686$4$F$20220310$20240709$20240502$20240712$EXP$$NVSC2024ZA092820$NOVARTIS$$44$YR$$F$Y$$$20240712$$CN$ZA$ZA
238086882$23808688$2$F$$20240717$20240502$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067647$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240719$$MD$US$US
238087018$23808701$8$F$20240101$20240812$20240502$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012674$UNITED THERAPEUTICS$$$$$F$Y$89.796$KG$20240821$$$US$US
238087042$23808704$2$F$20240429$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067561$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$62.14$KG$20240731$$HP$US$US
238087072$23808707$2$F$$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068752$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240731$$CN$US$US
238087192$23808719$2$F$$20240628$20240502$20240705$PER$$US-BIOGEN-2024BI01262649$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
238087283$23808728$3$F$$20240812$20240502$20240819$EXP$$CA-GSK-CA2023167889$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$MD$CA$CA
238087462$23808746$2$F$20230901$20240820$20240502$20240822$EXP$$US-ROCHE-3549530$ROCHE$$36$YR$A$F$Y$68.04$KG$20240822$$CN$US$US
238087652$23808765$2$F$$20240704$20240502$20240706$EXP$$NVSC2024GB092703$NOVARTIS$$$$A$M$Y$$$20240706$$CN$GB$GB
238088052$23808805$2$F$$20240712$20240502$20240715$PER$$US-PFIZER INC-202400097925$PFIZER$$49$YR$$F$Y$$$20240715$$CN$US$US
238088095$23808809$5$F$20240101$20240912$20240502$20240921$EXP$$CA-CELLTRION INC.-2024CA010073$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
238088132$23808813$2$F$20240101$20240710$20240502$20240722$EXP$$US-UCBSA-2024021346$UCB$$$$$M$Y$$$20240722$$HP$US$US
238088372$23808837$2$F$20240417$20240912$20240502$20240916$EXP$$UY-PFIZER INC-202400096379$PFIZER$$15$YR$$M$Y$$$20240916$$HP$UY$UY
238088383$23808838$3$F$20230901$20240718$20240502$20240718$EXP$$CA-PFIZER INC-202400097648$PFIZER$$62$YR$$M$Y$$$20240718$$HP$CA$CA
238088492$23808849$2$F$$20240906$20240502$20240911$30DAY$$DE-PFIZER INC-PV202400051850$PFIZER$$5$YR$$M$Y$$$20240911$$PH$DE$DE
238088602$23808860$2$F$$20240704$20240502$20240718$PER$$CA-IGSA-BIG0028791$GRIFOLS$Jennifer A. McCombe, Bryan T. Klassen, Eoin P. Flanagan, James W. Teener, Anastasia Zekeridou, Sean J. Pittock, Andrew McKeon. Eculizumab for the treatment of glycine receptor antibody associated. Journal of Neurology. 2023;270:4555?4557$20$YR$$M$Y$$$20240718$$HP$CA$CA
238088722$23808872$2$F$20240327$20240628$20240502$20240703$PER$$US-AMGEN-USASP2024087986$AMGEN$$59$YR$A$M$Y$$$20240703$$CN$US$US
238088774$23808877$4$F$$20240913$20240502$20240918$30DAY$$US-PFIZER INC-202400094160$PFIZER$$15$YR$$F$Y$$$20240918$$CN$US$US
238088804$23808880$4$F$$20240917$20240502$20240920$30DAY$$US-PFIZER INC-202400091713$PFIZER$$14$YR$$M$Y$$$20240920$$CN$US$US
238088813$23808881$3$F$20240101$20240724$20240502$20240726$EXP$$US-ABBVIE-5739838$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
238088992$23808899$2$F$20240101$20240627$20240502$20240705$EXP$$CA-CELLTRION INC.-2024CA010052$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
238089095$23808909$5$F$$20240911$20240502$20240913$30DAY$$US-PFIZER INC-202400095096$PFIZER$$12$YR$$M$Y$$$20240913$$CN$US$US
238089182$23808918$2$F$20240416$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068721$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240731$$CN$US$US
238089192$23808919$2$F$20240415$20240923$20240502$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068723$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240924$$CN$US$US
238089403$23808940$3$F$20240414$20240702$20240502$20240710$EXP$$IL-AstraZeneca-2024A099231$ASTRAZENECA$$15309$DY$$F$Y$$$20240710$$MD$IL$
238089452$23808945$2$F$$20240725$20240502$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068733$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240726$$CN$US$US
238089622$23808962$2$F$$20240729$20240502$20240802$EXP$$BR-GSK-BR2024AMR054761$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$BR$BR
238089904$23808990$4$F$$20240918$20240502$20240920$EXP$$GB-MYLANLABS-2024M1039520$MYLAN$$$$$F$Y$$$20240920$$PH$GB$GB
238089932$23808993$2$F$20240321$20240808$20240502$20240814$EXP$PT-INFARMED-F202404-483$PT-MYLANLABS-2024M1038550$MYLAN$$73$YR$$F$Y$$$20240814$$MD$PT$PT
238090143$23809014$3$F$20240417$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068711$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240731$$CN$US$US
238090164$23809016$4$F$$20240730$20240502$20240807$EXP$$JP-Taiho Oncology Inc-2024-004001$TAIHO ONCOLOGY INC$$70$YR$E$M$Y$$$20240807$$MD$JP$JP
238090242$23809024$2$F$20240421$20240801$20240502$20240805$EXP$$PH-OTSUKA-2024_012063$OTSUKA$$83$YR$$M$Y$$$20240805$$HP$PH$PH
238090592$23809059$2$F$$20240702$20240502$20240708$EXP$$GB-MYLANLABS-2024M1039258$MYLAN$$$$$M$Y$$$20240708$$PH$GB$GB
238090752$23809075$2$F$20220808$20240718$20240502$20240724$PER$$US-BIOVITRUM-2024-US-006565$BIOVITRUM$$72$YR$$M$Y$$$20240724$$CN$US$US
238090764$23809076$4$F$20240401$20240829$20240502$20240905$EXP$$CA-JNJFOC-20240503935$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240906$$HP$CA$CA
238090805$23809080$5$F$20240409$20240923$20240502$20240927$EXP$$US-BIOVITRUM-2024-US-006566$BIOVITRUM$$84$YR$$M$Y$$$20240927$$CN$US$US
238091703$23809170$3$F$20240123$20240903$20240502$20240905$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-001010$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240905$$CN$CA$CA
238091943$23809194$3$F$20230826$20240917$20240502$20240923$EXP$$JP-TAKEDA-2024TUS039647$TAKEDA$$83$YR$$M$Y$55.6$KG$20240923$$MD$JP$JP
238092502$23809250$2$F$$20240711$20240502$20240723$EXP$$US-TEVA-VS-3191508$TEVA$Price MZ, Price RL. Treating Schizophrenia and Bipolar I Disorder in the Real-World Setting: Effectiveness and Safety of Olanzapine/Samidorphan Combination. Prim-Care-Companion-CNS-Disord 2024; 26 (2):.; Price MZ, Price RL. Treating Schizophrenia and Bipolar I Disorder in the Real-World Setting: Effectiveness and Safety of Olanzapine/Samidorphan Combination. Prim-Care-Companion-CNS-Disord 2024; 26 (2):.$45$YR$$F$Y$$$20240723$$HP$US$US
238092986$23809298$6$F$20240416$20240917$20240502$20240920$30DAY$$US-PFIZER INC-202400089935$PFIZER$$11$YR$$F$Y$$$20240920$$CN$US$US
238093173$23809317$3$F$$20240801$20240502$20240807$EXP$$OM-MYLANLABS-2024M1039713$MYLAN$$13$YR$$M$Y$$$20240807$$HP$OM$OM
238093182$23809318$2$F$20240101$20240821$20240502$20240828$EXP$$JP-GENMAB-2024-01435$GENMAB$$6$DEC$$M$Y$$$20240828$$MD$JP$JP
238093312$23809331$2$F$$20240705$20240502$20240705$EXP$$NVSC2024US092851$NOVARTIS$$$$$F$Y$$$20240706$$MD$US$US
238094012$23809401$2$F$20230504$20240916$20240502$20240925$EXP$$US-UCBSA-2023017406$UCB$$29$YR$$F$Y$$$20240925$$HP$US$US
238094793$23809479$3$F$$20240809$20240502$20240828$PER$$US-PHARMING-PHAUS2024000346$PHARMING GROUP$$$$$$Y$$$20240819$$CN$US$US
238094952$23809495$2$F$$20240819$20240502$20240823$PER$$US-PHARMING-PHAUS2024000340$PHARMING GROUP$$$$$$Y$$$20240823$$CN$US$US
238095042$23809504$2$F$$20240702$20240502$20240708$EXP$$US-TAKEDA-2024TUS040656$TAKEDA$$$$$F$Y$$$20240708$$CN$US$US
238095244$23809524$4$F$20240428$20240717$20240502$20240725$EXP$$US-Calliditas-2024CAL00677$CALLIDITAS THERAPEUTICS$$57$YR$A$M$Y$$$20240725$$CN$US$US
238095537$23809553$7$F$$20240917$20240502$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068687$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240919$$CN$US$US
238095682$23809568$2$F$$20240725$20240502$20240802$EXP$$NL-TEVA-VS-3191678$TEVA$De Vries ACH, Lankester AC, Niemeyer C, Van Den Heuvel-Eibrink MM. THE CLINICAL PHENOTYPE OF 2 SIBLINGS WITH JMML WITH HETEROGENEOUS c-CBL MUTATIONS. Haematologica 2015; 100 15 abstr. P19.; De Vries ACH, Lankester AC, Niemeyer C, Van Den Heuvel-Eibrink MM. THE CLINICAL PHENOTYPE OF 2 SIBLINGS WITH JMML WITH HETEROGENEOUS c-CBL MUTATIONS. Haematologica 2015; 100 15 abstr. P19.$$$I$F$Y$$$20240802$$HP$NL$NL
238095783$23809578$3$F$20240409$20240909$20240502$20240911$EXP$DE-BFARM-24002957$DE-ORGANON-O2405DEU000016$ORGANON$$27$YR$$F$Y$$$20240911$$MD$DE$DE
238096843$23809684$3$F$$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068712$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240731$$HP$US$US
238097394$23809739$4$F$20240403$20240715$20240502$20240718$EXP$$NVSC2024FR092494$NOVARTIS$$$$E$F$Y$65$KG$20240718$$MD$FR$FR
238098322$23809832$2$F$$20240904$20240502$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068630$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240905$$HP$US$US
238098403$23809840$3$F$20240412$20240820$20240502$20240827$PER$$US-VERTEX PHARMACEUTICALS-2024-007410$VERTEX$$14$YR$$M$Y$$$20240827$$PH$US$US
238098442$23809844$2$F$20230428$20240917$20240502$20240926$EXP$$US-UCBSA-2023022535$UCB$$51$YR$$F$Y$104.31$KG$20240926$$HP$US$US
238098583$23809858$3$F$$20240711$20240502$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006834$JAZZ$$$$$M$Y$16.508$KG$20240717$$CN$US$US
238098622$23809862$2$F$$20240722$20240502$20240724$EXP$$US-UCBSA-2023024144$UCB$$$$$M$Y$68$KG$20240724$$HP$US$US
238098802$23809880$2$F$20240427$20240814$20240502$20240819$PER$$US-AMGEN-USASP2024085942$AMGEN$$86$YR$E$M$Y$$$20240819$$CN$US$US
238098942$23809894$2$F$20240401$20240827$20240502$20240903$EXP$$CO-GSK-CO2024AMR055002$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$CO$CO
238098952$23809895$2$F$20240409$20240722$20240502$20240727$EXP$$US-ABBVIE-5741905$ABBVIE$$64$YR$$M$Y$$$20240727$$CN$US$US
238098983$23809898$3$F$20231006$20240815$20240502$20240822$EXP$$NZ-OTSUKA-2024_010768$OTSUKA$$45$YR$$M$Y$$$20240822$$MD$NZ$NZ
238099133$23809913$3$F$$20240814$20240502$20240819$EXP$$JP-PFIZER INC-202400098253$PFIZER$Nagata, Y.. A case of methotrexate-related lymphoproliferative disease showing multiple liver lesions in a patient with rheumatoid arthritis. Clinical Journal of Gastroenterology. 2024;17(4):705-710$66$YR$$F$Y$$$20240819$$MD$JP$JP
238099522$23809952$2$F$$20240724$20240502$20240801$PER$$US-RDY-SPO/USA/24/0006151$DR REDDYS$$87$YR$E$F$Y$$$20240802$$CN$US$US
238099822$23809982$2$F$$20240924$20240502$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066717$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$74.39$KG$20240927$$HP$US$US
238100194$23810019$4$F$20240124$20240702$20240502$20240704$EXP$$US-TAKEDA-2024TUS040223$TAKEDA$$0$YR$$M$Y$$$20240704$$MD$US$US
238100273$23810027$3$F$$20240918$20240502$20240925$EXP$$CA-TAKEDA-2024TUS039289$TAKEDA$$$$$M$Y$$$20240925$$CN$CA$CA
238100322$23810032$2$F$$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068815$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240731$$HP$US$US
238100572$23810057$2$F$$20240730$20240502$20240731$EXP$$US-JNJFOC-20240471120$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
238100622$23810062$2$F$$20240629$20240502$20240701$EXP$$PK-PFIZER INC-PV202300142936$PFIZER$$47$YR$$F$Y$$$20240701$$CN$PK$PK
238100653$23810065$3$F$$20240910$20240502$20240912$30DAY$$US-PFIZER INC-PV202400056935$PFIZER$$72$YR$$F$Y$$$20240912$$CN$US$US
238100665$23810066$5$F$$20240915$20240502$20240919$30DAY$$US-PFIZER INC-PV202400046239$PFIZER$$11$YR$$M$Y$28.8$KG$20240919$$MD$US$US
238100966$23810096$6$F$$20240919$20240502$20240919$30DAY$$GB-PFIZER INC-PV202400051892$PFIZER$$47$YR$$M$Y$$$20240919$$CN$GB$GB
238100985$23810098$5$F$$20240812$20240502$20240816$30DAY$$US-PFIZER INC-PV202400057319$PFIZER$$$$$$Y$$$20240816$$CN$US$US
238101477$23810147$7$F$20240403$20240923$20240502$20240930$EXP$$CN-TEVA-VS-3188480$TEVA$$67$YR$$F$Y$48.2$KG$20240930$$MD$CN$CN
238101482$23810148$2$F$$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068673$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240731$$HP$US$US
238101492$23810149$2$F$20240401$20240723$20240502$20240727$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012880$UNITED THERAPEUTICS$$70$YR$$F$Y$59.864$KG$20240727$$PH$US$US
238101662$23810166$2$F$20240323$20240620$20240502$20240703$EXP$$US-TEVA-VS-3189431$TEVA$$27$YR$$F$Y$$$20240703$$HP$US$US
238102432$23810243$2$F$$20240812$20240502$20240817$30DAY$$US-SANDOZ INC.-SDZ2024US044146$SANDOZ$$$$$F$Y$$$20240817$$CN$US$US
238102682$23810268$2$F$20240214$20240805$20240502$20240815$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404018666$ELI LILLY AND CO$$32$YR$A$F$Y$64.6$KG$20240815$$CN$JP$JP
238102792$23810279$2$F$$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068727$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240731$$CN$US$US
238102849$23810284$9$F$20240424$20240918$20240502$20240920$EXP$$DE-TAKEDA-2024TUS040420$TAKEDA$$61$YR$$F$Y$$$20240920$$HP$DE$DE
238102926$23810292$6$F$20240228$20240819$20240502$20240822$EXP$$US-PFIZER INC-PV202400028160$PFIZER$$80$YR$$F$Y$82.993$KG$20240822$$HP$US$US
238103276$23810327$6$F$20240124$20240922$20240502$20240926$EXP$$ES-BAUSCH-BL-2024-003200$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240926$$HP$ES$ES
238103293$23810329$3$F$$20240913$20240502$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US043700$SANDOZ$$$$$F$Y$$$20240919$$CN$US$US
238103302$23810330$2$F$$20240702$20240502$20240703$EXP$$US-SANDOZ INC.-SDZ2024US044755$SANDOZ$$71$YR$$F$Y$$$20240703$$CN$US$US
238103442$23810344$2$F$$20240701$20240502$20240702$PER$$US-JNJFOC-20240487624$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
238103792$23810379$2$F$$20240703$20240502$20240710$EXP$$IT-MYLANLABS-2024M1039215$MYLAN$Arcadi T, Storer S, Bona F, Zanatta P, Gallo M. Lenalidomide-induced myocarditis:a Rare Case of Cardiotoxicity. J-Cardiovasc-Magn-Resonance 2024; 26 (Suppl. 1) 592-593.$55$YR$$F$Y$$$20240710$$MD$IT$IT
238104352$23810435$2$F$20240301$20240612$20240502$20240806$PER$$US-GALDERMA-US2024006010$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
238104972$23810497$2$F$$20240806$20240502$20240826$PER$$US-GALDERMA-US2024006722$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
238105052$23810505$2$F$20240401$20240723$20240502$20240826$PER$$US-GALDERMA-US2024007015$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
238105153$23810515$3$F$20240301$20240919$20240502$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066570$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240920$$HP$US$US
238105234$23810523$4$F$20240401$20240701$20240502$20240708$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-002408$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240708$$MD$US$US
238105272$23810527$2$F$20240401$20240711$20240502$20240730$PER$$US-KARYOPHARM-2024KPT000910$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240730$$CN$US$US
238105303$23810530$3$F$$20240709$20240502$20240719$30DAY$$US-GSK-US2024AMR051474$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
238105592$23810559$2$F$20240401$20240624$20240502$20240703$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-004861$AMGEN$$20$YR$A$F$Y$$$20240703$$CN$US$US
238105822$23810582$2$F$20240304$20240827$20240502$20240904$EXP$FR-AFSSAPS-BX2024000752$FR-EMD Serono-2024022742$EMD SERONO INC$$67$YR$E$M$Y$65$KG$20240904$$MD$FR$FR
238105982$23810598$2$F$$20240729$20240502$20240802$EXP$$US-TAKEDA-2024TUS041230$TAKEDA$$$$$F$Y$83$KG$20240802$$HP$US$US
238106004$23810600$4$F$$20240820$20240502$20240828$PER$$US-BIOMARINAP-US-2024-156720$BIOMARIN$$$$$$Y$$$20240828$$HP$US$US
238106098$23810609$8$F$20240328$20240704$20240502$20240708$EXP$$AU-PFIZER INC-PV202400046237$PFIZER$$80$YR$$F$Y$76.6$KG$20240708$$MD$AU$AU
238106262$23810626$2$F$20231101$20240715$20240502$20240717$EXP$$DE-SANDOZ INC.-SDZ2024DE044370$SANDOZ$$1$DY$$M$Y$2.69$KG$20240717$$MD$DE$DE
2381062813$23810628$13$F$$20240802$20240502$20240808$EXP$PL-SYNOPTIS-034a-L-0005$PL-MYLANLABS-2024M1036279$MYLAN$Woron J, Siwek M.. Painful ejaculation as a consequence of adverse interactions of escitalopram, mianserin and fluoroquinolones in a patient suffering from depression.. Practical medicine - psychiatry.. 2024;97(2):72-74$24$YR$$M$Y$$$20240808$$MD$PL$PL
238106344$23810634$4$F$20240416$20240702$20240502$20240715$EXP$$AR-HORIZON THERAPEUTICS-HZN-2024-004918$AMGEN$$6$YR$C$M$Y$$$20240715$$CN$AR$AR
238106393$23810639$3$F$$20240729$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068781$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240731$$CN$US$US
238106402$23810640$2$F$20240220$20240731$20240502$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-028801$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240731$$PH$US$US
238106412$23810641$2$F$20240229$20240724$20240502$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-064902$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240724$$MD$JP$JP
238106762$23810676$2$F$20240401$20240801$20240502$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068902$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240801$$CN$US$US
238106792$23810679$2$F$$20240816$20240502$20240823$EXP$$CA-TAKEDA-2024TUS041139$TAKEDA$$$$$M$Y$$$20240823$$MD$CA$CA
238107039$23810703$9$F$20240613$20240826$20240502$20240829$EXP$$CA-TAKEDA-2024TUS041161$TAKEDA$$52$YR$$F$Y$$$20240829$$MD$CA$CA
238107082$23810708$2$F$$20240703$20240502$20240708$EXP$$AU-MYLANLABS-2024M1036558$MYLAN$$$$A$$Y$$$20240708$$PH$AU$AU
238107642$23810764$2$F$20240501$20240626$20240502$20240704$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000867$BLUEPRINT MEDICINES$$16$YR$T$F$Y$$$20240704$$MD$US$US
238107872$23810787$2$F$20240401$20240912$20240502$20240916$PER$$US-AMGEN-USASP2024068680$AMGEN$$73$YR$E$M$Y$$$20240916$$CN$US$US
238108043$23810804$3$F$20240501$20240711$20240502$20240718$PER$$US-ABBVIE-5743071$ABBVIE$$49$YR$$F$Y$105$KG$20240718$$MD$US$US
238108082$23810808$2$F$20240101$20240905$20240502$20240910$EXP$$US-OTSUKA-2024_012156$OTSUKA$$50$YR$$M$Y$$$20240910$$HP$US$US
238108412$23810841$2$F$20240501$20240731$20240502$20240802$PER$$US-AMGEN-USASP2024087918$AMGEN$$60$YR$A$F$Y$$$20240802$$CN$US$US
238109122$23810912$2$F$20240101$20240425$20240502$20240715$PER$$US-TRAVERE-2024TVT00415$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240715$$HP$US$US
238109192$23810919$2$F$$20240731$20240502$20240802$30DAY$$US-SANDOZ INC.-SDZ2024US044137$SANDOZ$$$$$M$Y$$$20240802$$CN$US$US
238109307$23810930$7$F$20240418$20240913$20240502$20240923$PER$$JP-Eisai-EC-2024-164812$EISAI$$$$E$M$Y$$$20240923$$MD$JP$JP
238109492$23810949$2$F$$20240804$20240502$20240813$EXP$$US-NOVOPROD-1209795$NOVO NORDISK$$$$$F$Y$$$20240813$$CN$US$US
238109763$23810976$3$F$$20240803$20240502$20240808$PER$$US-JNJFOC-20240467340$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240808$$CN$US$US
238109792$23810979$2$F$$20240801$20240502$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068760$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240801$$CN$US$US
238109912$23810991$2$F$$20240801$20240502$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068620$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240801$$CN$US$US
238109942$23810994$2$F$20231201$20240703$20240502$20240711$PER$$US-INCYTE CORPORATION-2024IN004508$INCYTE$$$$$$Y$$$20240711$$CN$US$US
238110012$23811001$2$F$20240401$20240906$20240502$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069020$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240911$$CN$US$US
238110152$23811015$2$F$$20240801$20240502$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068227$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240801$$CN$US$US
238110493$23811049$3$F$20231121$20240805$20240502$20240812$EXP$$JP-009507513-2403JPN003749J$MERCK$$51$YR$$F$Y$$$20240812$$MD$JP$JP
238110514$23811051$4$F$$20240725$20240502$20240729$EXP$$CA-LUNDBECK-DKLU3077437$LUNDBECK$$$$$$Y$$$20240729$$CN$CA$CA
238110613$23811061$3$F$$20240716$20240502$20240725$EXP$$US-BEH-2024171325$CSL BEHRING$$47$YR$A$F$Y$$$20240725$$HP$US$US
238110643$23811064$3$F$$20240827$20240502$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068662$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240902$$CN$US$US
238110664$23811066$4$F$20240409$20240730$20240502$20240911$PER$$US-LUNDBECK-DKLU3076846$LUNDBECK$$$$$$Y$$$20240911$$HP$US$US
238110832$23811083$2$F$$20240830$20240502$20240905$EXP$$JP-009507513-2404JPN003472J$MERCK$$7$DEC$$M$Y$$$20240905$$MD$JP$JP
238110952$23811095$2$F$20240401$20240719$20240502$20240724$PER$$US-BEH-2024171457$CSL BEHRING$$68$YR$E$F$Y$$$20240724$$HP$US$US
238111013$23811101$3$F$20240423$20240626$20240502$20240703$EXP$$US-BIOGEN-2024BI01262556$BIOGEN$$87$YR$$M$Y$$$20240703$$HP$US$US
238111103$23811110$3$F$$20240621$20240502$20240703$EXP$$US-MALLINCKRODT-MNK202402084$MALLINCKRODT$$50$YR$A$F$Y$$$20240703$$HP$US$US
238111182$23811118$2$F$20180319$20240730$20240502$20240808$EXP$$GB-BEH-2024171505$CSL BEHRING$$57$YR$A$F$Y$$$20240808$$HP$GB$GB
238111332$23811133$2$F$$20240701$20240502$20240705$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-025182$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240705$$CN$US$US
238111992$23811199$2$F$$20240805$20240502$20240805$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-066287$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$PH$GB$PK
238112206$23811220$6$F$20231201$20240912$20240502$20240921$EXP$$ES-ABBVIE-5564718$ABBVIE$$73$YR$$F$Y$$$20240921$$CN$ES$ES
238112382$23811238$2$F$20240317$20240820$20240502$20240826$EXP$$JP-009507513-2404JPN003375J$MERCK$$50$YR$$F$Y$$$20240826$$MD$JP$JP
238112402$23811240$2$F$$20240924$20240502$20240930$EXP$$JP-AMGEN-JPNSP2024084408$AMGEN$$$$$$Y$$$20240930$$MD$JP$JP
238112412$23811241$2$F$20240301$20240813$20240502$20240814$PER$$US-AMGEN-USASP2024082698$AMGEN$$70$YR$E$M$Y$$$20240814$$CN$US$US
238112604$23811260$4$F$$20240710$20240502$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002136$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
238112612$23811261$2$F$20240101$20240626$20240502$20240704$EXP$$CA-APOTEX-2024AP005008$APOTEX$$$$A$M$Y$$$20240704$$HP$CA$CA
238112675$23811267$5$F$20240101$20240813$20240502$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-005421$UNITED THERAPEUTICS$$$$$M$Y$68.027$KG$20240817$$$US$US
238112793$23811279$3$F$20240101$20240909$20240502$20240912$EXP$$CA-PFIZER INC-202300353070$PFIZER$$64$YR$$F$Y$$$20240912$$HP$CA$CA
238112892$23811289$2$F$$20240621$20240502$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001757$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238113034$23811303$4$F$20240101$20240821$20240502$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068656$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240827$$CN$US$US
238113283$23811328$3$F$20240201$20240626$20240502$20240701$EXP$$US-ABBVIE-5741992$ABBVIE$$44$YR$$F$Y$$$20240701$$CN$US$US
238113452$23811345$2$F$$20240808$20240503$20240815$EXP$$GB-TAKEDA-GB201811079$TAKEDA$$$$$F$Y$$$20240815$$CN$GB$GB
238113556$23811355$6$F$20220126$20240730$20240503$20240805$EXP$$CO-TAKEDA-2021TUS057296$TAKEDA$$9$YR$$M$Y$34$KG$20240805$$CN$CO$CO
238113774$23811377$4$F$20240305$20240817$20240503$20240819$EXP$$AR-ABBVIE-5742092$ABBVIE$$74$YR$$M$Y$75$KG$20240819$$MD$AR$AR
238113832$23811383$2$F$20240401$20240710$20240503$20240712$EXP$$JP-TAKEDA-2024TJP006291$TAKEDA$$8$DEC$$F$Y$$$20240712$$MD$JP$JP
238114012$23811401$2$F$20240327$20240709$20240503$20240715$EXP$$US-ABBVIE-5742061$ABBVIE$$50$YR$$M$Y$$$20240715$$CN$US$US
238114215$23811421$5$F$20240408$20240508$20240503$20240708$EXP$$US-RDY-CLI/USA/24/0006470$DR REDDYS$$25$YR$A$F$Y$$$20240708$$MD$US$US
238114284$23811428$4$F$$20240801$20240503$20240808$PER$$US-ALXN-202404USA002174US$ALEXION PHARMACEUTICALS$$$$$M$Y$123.4$KG$20240808$$MD$US$US
238114303$23811430$3$F$20240326$20240708$20240503$20240709$PER$$US-AMGEN-USASP2024087449$AMGEN$$78$YR$E$F$Y$$$20240709$$CN$US$US
238114485$23811448$5$F$20230830$20240708$20240503$20240722$EXP$DE-EMA-DD-20240417-7482679-083717$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-11087$ALKEM$$91$YR$$M$Y$94$KG$20240722$$HP$DE$DE
238114493$23811449$3$F$$20240709$20240503$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067717$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240709$$HP$US$US
238114552$23811455$2$F$20240421$20240620$20240503$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001473$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240712$$CN$US$US
238114603$23811460$3$F$$20240702$20240503$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001720$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
238114734$23811473$4$F$20240429$20240711$20240503$20240801$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002137$ACADIA PHARMACEUTICALS$$88$YR$$F$Y$$$20240802$$CN$US$US
238114763$23811476$3$F$20231201$20240710$20240503$20240716$EXP$$DO-ABBVIE-5742948$ABBVIE$$62$YR$$M$Y$$$20240716$$CN$DO$DO
238115034$23811503$4$F$20240101$20240909$20240503$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010643$UNITED THERAPEUTICS$$$$$F$Y$58.957$KG$20240919$$$US$US
238115352$23811535$2$F$20211021$20240501$20240503$20240726$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-208972$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$70$KG$20240726$$CN$ES$ES
238115372$23811537$2$F$20240427$20240730$20240503$20240801$PER$$US-AMGEN-USASP2024087908$AMGEN$$83$YR$E$F$Y$$$20240801$$CN$US$US
238115592$23811559$2$F$$20240618$20240503$20240701$EXP$$RU-NOVOPROD-1209448$NOVO NORDISK$$$$$M$Y$$$20240701$$MD$RU$RU
238115842$23811584$2$F$$20240627$20240503$20240703$EXP$$US-AstraZeneca-2024A103021$ASTRAZENECA$$59$YR$$M$Y$$$20240703$$MD$US$
238115873$23811587$3$F$20240307$20240620$20240503$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001729$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240712$$CN$US$US
238115923$23811592$3$F$$20240618$20240503$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001807$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
238116022$23811602$2$F$20210501$20240419$20240503$20240812$EXP$$PA-SANDOZ INC.-NVSC2021PA140953$SANDOZ$$54$YR$$F$Y$68$KG$20240812$$CN$PA$PA
238116082$23811608$2$F$$20240829$20240503$20240904$EXP$$US-ALXN-202404USA002038US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
238116102$23811610$2$F$20240429$20240610$20240503$20240710$PER$$US-AstraZeneca-2024A102270$ASTRAZENECA$$27767$DY$$F$Y$$$20240710$$CN$US$
238116232$23811623$2$F$$20240701$20240503$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-012629$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240704$$$US$US
238116302$23811630$2$F$$20240715$20240503$20240729$EXP$$US-ROCHE-3552203$ROCHE$$79$YR$E$F$Y$$$20240729$$CN$US$US
238116613$23811661$3$F$20240401$20240816$20240503$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-068954$BRISTOL MYERS SQUIBB$$9$DEC$E$$Y$$$20240816$$PH$JP$JP
238116632$23811663$2$F$$20240815$20240503$20240822$EXP$$US-INTERCEPT-PM2024000855$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240822$$HP$US$US
238116663$23811666$3$F$20240428$20240801$20240503$20240805$EXP$$GB-TAKEDA-2024TUS034408$TAKEDA$$25$YR$$M$Y$$$20240805$$CN$GB$GB
238116714$23811671$4$F$20240401$20240712$20240503$20240716$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-025121$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240716$$CN$US$US
238116906$23811690$6$F$20231226$20240809$20240503$20240814$EXP$$CA-CELLTRION INC.-2023CA025345$CELLTRION$$$$$$Y$$$20240814$$HP$CA$CA
238117202$23811720$2$F$20240101$20240723$20240503$20240730$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-005009$AMGEN$$55$YR$A$F$Y$$$20240730$$CN$US$US
238117342$23811734$2$F$$20240826$20240503$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202405000840$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240828$$PH$US$US
238117603$23811760$3$F$20240702$20240723$20240503$20240726$EXP$$US-TAKEDA-2024TUS040035$TAKEDA$$47$YR$$F$Y$$$20240726$$CN$US$US
238118533$23811853$3$F$20240501$20240827$20240503$20240828$PER$$US-AMGEN-USASP2024088034$AMGEN$$68$YR$E$M$Y$$$20240828$$CN$US$US
238118923$23811892$3$F$$20240921$20240503$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069109$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$97.52$KG$20240923$$CN$US$US
238118932$23811893$2$F$$20240816$20240503$20240816$EXP$$IS-BRISTOL-MYERS SQUIBB COMPANY-2024-063568$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240816$$MD$IS$IS
238119293$23811929$3$F$20220516$20240814$20240503$20240816$EXP$$US-UCBSA-2023028061$UCB$$46$YR$$F$Y$$$20240816$$HP$US$US
238119755$23811975$5$F$$20240830$20240503$20240911$30DAY$$AR-JNJFOC-20240437005$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240911$$CN$AR$AR
238119792$23811979$2$F$20230101$20240801$20240503$20240815$EXP$$US-UCBSA-2023027061$UCB$$$$$F$Y$$$20240815$$HP$US$US
238120284$23812028$4$F$20240418$20240806$20240503$20240820$EXP$$RU-ROCHE-3555175$ROCHE$$47$YR$A$F$Y$$$20240820$$HP$RU$RU
238120322$23812032$2$F$$20240612$20240503$20240709$PER$$US-AstraZeneca-2024A090222$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
238120872$23812087$2$F$20240201$20240709$20240503$20240719$30DAY$$US-GSK-US2024051921$GLAXOSMITHKLINE$$65$YR$$M$Y$$$20240719$$HP$US$US
238121065$23812106$5$F$20240101$20240626$20240503$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012383$UNITED THERAPEUTICS$$$$$F$Y$73.469$KG$20240703$$$US$US
238121302$23812130$2$F$$20240816$20240503$20240816$EXP$$TH-BRISTOL-MYERS SQUIBB COMPANY-2024-069213$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240816$$CN$TH$TH
238121773$23812177$3$F$20240425$20240801$20240503$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067028$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$71$KG$20240804$$CN$US$US
2381218310$23812183$10$F$$20240827$20240503$20240902$EXP$$US-JNJFOC-20240473034$JOHNSON AND JOHNSON$$$$$F$Y$52.3$KG$20240902$$HP$US$US
238121842$23812184$2$F$$20240730$20240503$20240731$PER$$US-JNJFOC-20240480252$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$HP$US$US
238122332$23812233$2$F$$20240725$20240503$20240801$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000878$BLUEPRINT MEDICINES$$$$$M$Y$$$20240801$$CN$US$US
238122572$23812257$2$F$$20240801$20240503$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066211$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240801$$HP$US$US
238122582$23812258$2$F$20231201$20240730$20240503$20240731$EXP$$US-JNJFOC-20240481046$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20240731$$MD$US$US
238122613$23812261$3$F$$20240624$20240503$20240702$PER$$US-ALXN-202404USA002079US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
238122952$23812295$2$F$20230101$20240829$20240503$20240911$EXP$$US-UCBSA-2023034980$UCB$$$$$M$Y$125.17$KG$20240911$$HP$US$US
238123695$23812369$5$F$20231205$20240819$20240503$20240822$EXP$$CA-JNJFOC-20231231099$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240823$$CN$CA$CA
238123772$23812377$2$F$20240328$20240717$20240503$20240726$EXP$$CA-CELLTRION INC.-2024CA008484$CELLTRION$$$$$$Y$$$20240726$$CN$CA$CA
2381238810$23812388$10$F$$20240628$20240503$20240710$EXP$$CA-ROCHE-3550823$ROCHE$$$$E$F$Y$$$20240710$$CN$CA$CA
238123904$23812390$4$F$20240415$20240727$20240503$20240803$EXP$$CA-CELLTRION INC.-2024CA009838$CELLTRION$$$$$$Y$$$20240803$$CN$CA$CA
238123913$23812391$3$F$20240111$20240731$20240503$20240805$EXP$$CA-JNJFOC-20240481503$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240805$$PH$CA$CA
238123982$23812398$2$F$20240301$20240709$20240503$20240722$EXP$$JP-UCBSA-2024020852$UCB$$57$YR$$M$Y$65$KG$20240720$$PH$JP$JP
238124022$23812402$2$F$20240430$20240731$20240503$20240802$PER$$US-AMGEN-USASP2024087192$AMGEN$$71$YR$E$M$Y$$$20240802$$CN$US$US
238124035$23812403$5$F$20200529$20240627$20240503$20240701$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-027392$JAZZ$$32$YR$$M$Y$$$20240701$$CN$US$US
238124082$23812408$2$F$$20240702$20240503$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03519$LUPIN$$$$$$Y$$$20240722$$CN$US$US
238124202$23812420$2$F$20240811$20240813$20240503$20240819$30DAY$$US-GSK-US2024051919$GLAXOSMITHKLINE$$72$YR$$M$Y$$$20240819$$MD$US$US
238124232$23812423$2$F$20240427$20240829$20240503$20240902$PER$$US-AMGEN-USASP2024088059$AMGEN$$79$YR$E$F$Y$$$20240901$$CN$US$US
238124292$23812429$2$F$20240314$20240814$20240503$20240822$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004589$SAREPTA THERAPEUTICS$$16$YR$$M$Y$126.98$KG$20240822$$HP$US$US
238124355$23812435$5$F$20230802$20240910$20240503$20240915$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-255662$BOEHRINGER INGELHEIM$$88$YR$E$F$Y$$$20240915$$CN$US$US
238124413$23812441$3$F$$20240628$20240503$20240704$EXP$$CA-JNJFOC-20240481778$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240704$$HP$CA$CA
238124552$23812455$2$F$$20240703$20240503$20240715$EXP$$US-ROCHE-3551382$ROCHE$$77$YR$E$F$Y$$$20240715$$CN$US$US
238124623$23812462$3$F$20240401$20240627$20240503$20240702$EXP$$US-TAKEDA-2024TUS032450$TAKEDA$$27$YR$$F$Y$$$20240702$$MD$US$US
238124644$23812464$4$F$20240501$20240820$20240503$20240822$PER$$US-AMGEN-USASP2024088374$AMGEN$$73$YR$E$F$Y$$$20240822$$CN$US$US
238124672$23812467$2$F$$20240626$20240503$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03497$LUPIN$$$$$$Y$$$20240714$$CN$US$US
238124742$23812474$2$F$$20240626$20240503$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03518$LUPIN$$$$$$Y$$$20240712$$CN$US$US
238124752$23812475$2$F$20240401$20240623$20240503$20240701$EXP$$CA-CELLTRION INC.-2024CA010069$CELLTRION$$$$$$Y$$$20240701$$HP$CA$CA
238124822$23812482$2$F$$20240626$20240503$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03517$LUPIN$$$$$$Y$$$20240711$$CN$US$US
238125113$23812511$3$F$20240501$20240802$20240503$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-068851$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$53$KG$20240809$$PH$JP$JP
238125192$23812519$2$F$20230601$20240710$20240503$20240718$EXP$$US-EMD Serono-2023473050$EMD SERONO INC$$59$YR$A$F$Y$$$20240718$$CN$US$US
238125253$23812525$3$F$20240522$20240911$20240503$20240918$EXP$$CA-TAKEDA-2024TUS040943$TAKEDA$$68$YR$$M$Y$$$20240918$$CN$CA$CA
238125292$23812529$2$F$$20240917$20240503$20240927$EXP$001075170$CA-Accord-421881$ACCORD$$61$YR$A$M$Y$$$20240927$$HP$CA$CA
238125352$23812535$2$F$20240412$20240703$20240503$20240709$EXP$$CA-TAKEDA-2024TUS035760$TAKEDA$$16$YR$$M$Y$$$20240709$$CN$CA$CA
238125524$23812552$4$F$20240401$20240912$20240503$20240920$EXP$$CA-CELLTRION INC.-2024CA010079$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
238125682$23812568$2$F$$20240918$20240503$20240930$EXP$$CA-CELLTRION INC.-2023CA016126$CELLTRION$$$$$$Y$$$20240930$$CN$CA$CA
238125762$23812576$2$F$20240215$20240624$20240503$20240704$EXP$$JP-EMD Serono-2024023099$EMD SERONO INC$$8$DEC$E$M$Y$$$20240704$$MD$JP$JP
238125893$23812589$3$F$20240814$20240828$20240503$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202405000761$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240903$$HP$US$US
238125973$23812597$3$F$20231101$20240812$20240503$20240815$EXP$$DE-ROCHE-3551329$ROCHE$$62$YR$A$M$Y$94$KG$20240815$$MD$DE$DE
238126032$23812603$2$F$$20240626$20240503$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03508$LUPIN$$$$$$Y$$$20240711$$CN$US$US
238126074$23812607$4$F$20240101$20240918$20240503$20240923$EXP$$US-ABBVIE-5742112$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
238126112$23812611$2$F$$20240626$20240503$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03524$LUPIN$$$$$$Y$$$20240713$$CN$US$US
238126203$23812620$3$F$20230201$20240705$20240503$20240712$EXP$$US-ROCHE-3555480$ROCHE$$87$YR$E$M$Y$$$20240712$$MD$US$US
238126253$23812625$3$F$20240417$20240703$20240503$20240706$EXP$$GB-ABBVIE-5662193$ABBVIE$$81$YR$$M$Y$$$20240706$$CN$GB$GB
238126772$23812677$2$F$$20240712$20240503$20240712$EXP$NL-LRB-00963519$NL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-025570$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$65$KG$20240712$$CN$NL$NL
238126842$23812684$2$F$$20240618$20240503$20240703$EXP$$US-GILEAD-2024-0670354$GILEAD$$$$E$F$Y$$$20240703$$MD$US$US
238126873$23812687$3$F$$20240626$20240503$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03516$LUPIN$$$$$$Y$$$20240712$$CN$US$US
238127062$23812706$2$F$20240501$20240820$20240503$20240823$PER$$US-AMGEN-USASP2024087931$AMGEN$$73$YR$E$M$Y$$$20240823$$CN$US$US
238127082$23812708$2$F$20240416$20240828$20240503$20240902$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-067251$REGENERON$$$$$F$Y$$$20240902$$CN$US$US
238127152$23812715$2$F$20240724$20240801$20240503$20240808$EXP$$US-CHIESI-2024CHF02441$CHIESI$$45$YR$$M$Y$85$KG$20240808$$HP$US$US
238127182$23812718$2$F$20240401$20240626$20240503$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03520$LUPIN$$$$$$Y$$$20240711$$CN$US$US
238127252$23812725$2$F$20231117$20240701$20240503$20240702$EXP$$DE-SANDOZ INC.-SDZ2024DE044077$SANDOZ$$70$YR$$M$Y$$$20240702$$MD$DE$DE
238127322$23812732$2$F$$20240626$20240503$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03525$LUPIN$$$$$$Y$$$20240712$$CN$US$US
238127442$23812744$2$F$$20240626$20240503$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03514$LUPIN$$$$$$Y$$$20240712$$PH$US$US
238127533$23812753$3$F$20240430$20240724$20240503$20240727$PER$$US-AMGEN-USASP2024087277$AMGEN$$80$YR$E$M$Y$$$20240727$$CN$US$US
238127577$23812757$7$F$20230101$20240903$20240503$20240909$EXP$$GB-ABBVIE-5545308$ABBVIE$$66$YR$$M$Y$$$20240909$$PH$GB$GB
238127602$23812760$2$F$$20240626$20240503$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03511$LUPIN$$$$$$Y$$$20240712$$CN$US$US
238128002$23812800$2$F$$20240626$20240503$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03512$LUPIN$$$$$$Y$$$20240712$$CN$US$US
238128074$23812807$4$F$20240101$20240728$20240503$20240805$EXP$$CA-CELLTRION INC.-2024CA010152$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
238128243$23812824$3$F$$20240626$20240503$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03522$LUPIN$$$$$$Y$$$20240712$$CN$US$US
238128422$23812842$2$F$20240329$20240711$20240503$20240720$EXP$$JP-AMGEN-JPNSP2024086324$AMGEN$$88$YR$E$F$Y$$$20240719$$PH$JP$JP
238128462$23812846$2$F$20240201$20240418$20240503$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-020087$AUROBINDO$$40$YR$$F$Y$$$20240703$$CN$FR$FR
238128492$23812849$2$F$$20240626$20240503$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03526$LUPIN$$$$$$Y$$$20240712$$CN$US$US
238128602$23812860$2$F$$20240802$20240503$20240808$EXP$$GB-TAKEDA-2024TUS040671$TAKEDA$$$$$F$Y$$$20240808$$CN$GB$GB
238128652$23812865$2$F$$20240802$20240503$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068887$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240802$$CN$US$US
238128664$23812866$4$F$20240403$20240805$20240503$20240816$EXP$$DE-AUROBINDO-AUR-APL-2024-019825$AUROBINDO$$58$YR$$F$Y$58$KG$20240816$$MD$DE$DE
238128723$23812872$3$F$$20240722$20240503$20240725$EXP$$US-TAKEDA-2024TUS007987$TAKEDA$$$$$F$Y$48$KG$20240725$$HP$US$US
238129042$23812904$2$F$20240420$20240722$20240503$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063303$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$58.97$KG$20240730$$CN$US$US
238129062$23812906$2$F$20240401$20240626$20240503$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03515$LUPIN$$$$$$Y$$$20240713$$CN$US$US
238129193$23812919$3$F$20230501$20240909$20240503$20240917$EXP$$AT-JNJFOC-20240455416$JOHNSON AND JOHNSON$$56$YR$A$$Y$$$20240918$$MD$AT$AT
238129262$23812926$2$F$$20240626$20240503$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03523$LUPIN$$$$$$Y$$$20240712$$PH$US$US
238129452$23812945$2$F$$20240626$20240503$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03521$LUPIN$$$$$$Y$$$20240713$$CN$US$US
238129482$23812948$2$F$20200101$20240731$20240503$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-068480$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240731$$MD$JP$JP
238129593$23812959$3$F$20240315$20240909$20240503$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-019774$AUROBINDO$$36$YR$$M$Y$$$20240920$$MD$FR$FR
238129602$23812960$2$F$$20240816$20240503$20240821$EXP$$CA-TAKEDA-2021TUS056676$TAKEDA$$$$$M$Y$$$20240821$$CN$CA$CA
238129652$23812965$2$F$$20240626$20240503$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03531$LUPIN$$$$$$Y$$$20240711$$CN$US$US
238129692$23812969$2$F$$20240426$20240503$20240910$EXP$$US-ROCHE-3553844$ROCHE$$$$$$Y$$$20240910$$CN$US$US
238129802$23812980$2$F$$20240723$20240503$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068854$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240802$$CN$US$US
238129972$23812997$2$F$20240415$20240702$20240503$20240705$EXP$$FR-EXELIXIS-XL18424076854$EXELIXIS$$$$$$Y$$$20240705$$MD$FR$FR
238130033$23813003$3$F$$20240917$20240503$20240923$EXP$IT-GERMAN-LIT/ITA/24/0006604$IT-RDY-LIT/ITA/24/0006604$DR REDDYS$Arcadi T, Storer S, Bona F, Zanatta P, Gallo M. Lenalidomide-induced myocarditis:a Rare Case of Cardiotoxicity. Journal of Cardiovascular Magnetic Resonance. 2024;26: 592-593. doi:10.1016/j.jocmr.2024.100869.$55$YR$A$F$Y$$$20240923$$MD$IT$IT
238130082$23813008$2$F$$20240418$20240503$20240702$EXP$$CA-AUROBINDO-AUR-APL-2024-020167$AUROBINDO$$31$YR$$F$Y$$$20240702$$CN$CA$CA
238130095$23813009$5$F$20240419$20240805$20240503$20240809$EXP$$US-GSK-US2024AMR053443$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240809$$HP$US$US
238130202$23813020$2$F$$20240730$20240503$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202405000788$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240731$$CN$US$US
238130223$23813022$3$F$$20240326$20240503$20240704$EXP$$CA-SANDOZ INC.-SDZ2024CA044217$SANDOZ$$40$YR$$F$Y$96$KG$20240704$$HP$CA$CA
238130282$23813028$2$F$20240430$20240801$20240503$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068741$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240801$$CN$US$US
238131362$23813136$2$F$20220101$20240725$20240503$20240806$EXP$US-MLMSERVICE-20240418-PI032813-00034-1$US-RDY-SPO/USA/24/0006567$DR REDDYS$Shacker M, Braat JP, Arjuna A. Acute Hepatitis After Lung Transplant in a Recipient from Hep C Donor: The Chicken or the Egg Phenomenon? The Journal of Heart and Lung Transplantation. 2024;43(4) SUPPLEMENT: S480. DOI: 10.1016/j.healun.2024.02.646.$70$YR$E$F$Y$$$20240806$$MD$US$US
238131422$23813142$2$F$19660101$20240708$20240503$20240723$EXP$$US-CHATTEMPRD-2024OHG015489$CHATTEM$$13$YR$A$M$Y$$$20240723$$LW$US$US
238131432$23813143$2$F$20240430$20240726$20240503$20240730$PER$$US-AMGEN-USASP2024088529$AMGEN$$57$YR$A$F$Y$$$20240729$$CN$US$US
238131592$23813159$2$F$$20240710$20240503$20240717$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00327$AMNEAL$$$$$M$Y$14.512$KG$20240717$$HP$US$US
238131642$23813164$2$F$20240801$20240802$20240503$20240807$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00080$AMNEAL$$19$YR$$F$Y$49.977$KG$20240807$$CN$US$US
238131655$23813165$5$F$$20240905$20240503$20240911$EXP$$GB-TAKEDA-2024TUS041427$TAKEDA$$$$$M$Y$$$20240911$$CN$GB$GB
238131912$23813191$2$F$$20240906$20240503$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202405000986$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240910$$CN$US$US
238132004$23813200$4$F$$20240725$20240503$20240729$EXP$$CA-ROCHE-3552516$ROCHE$$$$A$F$Y$$$20240729$$CN$CA$CA
238132142$23813214$2$F$20240326$20240809$20240503$20240812$EXP$$FR-AMGEN-FRASP2024087293$AMGEN$$74$YR$E$M$Y$54$KG$20240811$$MD$FR$FR
238132244$23813224$4$F$20231005$20240812$20240503$20240817$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-267711$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240817$$CN$US$US
238132352$23813235$2$F$$20240812$20240503$20240816$EXP$$TR-IPCA LABORATORIES LIMITED-IPC-2024-TR-001066$IPCA$Gul Pamukcu Gunaydn, Hatice Duygu Ciftci Sivri,  Serkan Sivri, et.al. Concurrent Spontaneous Sublingual and Intramural Small Bowel Hematoma due to Warfarin Use. Case Reports in Emergency Medicine. 2015;1-3$$$$$Y$$$20240816$$HP$TR$TR
238132582$23813258$2$F$20230401$20240729$20240503$20240809$EXP$FR-AFSSAPS-AN2024000539$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-106492$ZYDUS PHARM$$$$$$Y$$$20240809$$PH$FR$FR
238133392$23813339$2$F$20240101$20240623$20240503$20240701$EXP$$CA-CELLTRION INC.-2024CA010003$CELLTRION$$$$$$Y$$$20240701$$CN$CA$CA
238133462$23813346$2$F$$20240801$20240503$20240809$EXP$JP-MLMSERVICE-20240416-PI021520-00233-1$JP-STRIDES ARCOLAB LIMITED-2024SP005103$STRIDES$Shimomura M, Okura Y, Takahashi Y, Kobayashi I.. Successful treatment of erythema nodosum with salazosulfapyridine in a 9-year-old patient with chronic non-bacterial osteomyelitis.. Modern rheumatology case reports. 2024;8 (2):394-397$9$YR$$F$Y$$$20240809$$MD$JP$JP
238133733$23813373$3$F$20240903$20240903$20240503$20240906$EXP$$AU-TAKEDA-2024TUS029922$TAKEDA$$38$YR$$F$Y$$$20240906$$CN$AU$AU
238133772$23813377$2$F$$20240731$20240503$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068510$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240731$$CN$US$US
238133992$23813399$2$F$20240418$20240624$20240503$20240701$EXP$$US-Eisai-EC-2024-164587$EISAI$$77$YR$E$F$Y$$$20240701$$CN$US$US
238134255$23813425$5$F$20240325$20240813$20240503$20240821$EXP$$CA-CELLTRION INC.-2024CA010173$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
238134502$23813450$2$F$20240501$20240722$20240503$20240724$PER$$US-AMGEN-USASP2024088127$AMGEN$$78$YR$E$F$Y$$$20240724$$CN$US$US
238134516$23813451$6$F$$20240902$20240503$20240909$EXP$$GB-TAKEDA-2024TUS041740$TAKEDA$$$$$F$Y$$$20240909$$MD$GB$GB
238134862$23813486$2$F$$20240801$20240503$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068278$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240805$$HP$US$US
238134972$23813497$2$F$$20240809$20240503$20240815$EXP$$JP-BAUSCH-BL-2024-003796$BAUSCH AND LOMB$$9$DEC$$M$Y$$$20240815$$MD$JP$JP
238135152$23813515$2$F$$20240425$20240503$20240712$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-02383$SAMSUNG BIOEPIS$$32$YR$A$F$Y$61$KG$20240712$$HP$CA$CA
238135262$23813526$2$F$20220411$20240628$20240503$20240705$EXP$$JP-009507513-2404JPN003769J$MERCK$$$$$F$Y$$$20240705$$MD$JP$JP
238135513$23813551$3$F$$20240911$20240503$20240917$EXP$$CA-TEVA-VS-3192495$TEVA$$21$YR$$F$Y$$$20240917$$MD$CA$CA
238135613$23813561$3$F$20230412$20240830$20240503$20240913$EXP$$PL-ASTELLAS-2024EU004239$ASTELLAS$$65$YR$E$M$Y$$$20240913$$MD$PL$PL
238135652$23813565$2$F$$20240822$20240503$20240904$EXP$CA-MHPD-E2B_06938467$CA-Accord-421249$ACCORD$$65$YR$E$F$Y$$$20240903$$HP$CA$CA
238135803$23813580$3$F$20240301$20240703$20240503$20240715$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-13237$SAMSUNG BIOEPIS$$69$YR$E$F$Y$$$20240715$$CN$CA$CA
238135865$23813586$5$F$20240401$20240910$20240503$20240912$30DAY$$US-PFIZER INC-202400098735$PFIZER$$14$YR$$M$Y$$$20240912$$CN$US$US
2381358911$23813589$11$F$$20240915$20240503$20240919$30DAY$$US-PFIZER INC-202400097312$PFIZER$$15$YR$$M$Y$$$20240919$$MD$US$US
238135913$23813591$3$F$$20240910$20240503$20240913$30DAY$$US-PFIZER INC-202400097128$PFIZER$$3$YR$$M$Y$$$20240913$$CN$US$US
238135925$23813592$5$F$$20240920$20240503$20240924$30DAY$$US-PFIZER INC-202400096748$PFIZER$$11$YR$$F$Y$$$20240924$$CN$US$US
238135945$23813594$5$F$20240419$20240918$20240503$20240925$30DAY$$US-PFIZER INC-202400092845$PFIZER$$15$YR$$M$Y$$$20240925$$CN$US$US
238135954$23813595$4$F$$20240711$20240503$20240717$30DAY$$US-PFIZER INC-202400085124$PFIZER$$15$YR$$F$Y$$$20240717$$CN$US$US
238135974$23813597$4$F$$20240910$20240503$20240912$30DAY$$US-PFIZER INC-202400099471$PFIZER$$7$YR$$M$Y$$$20240912$$CN$US$US
238136025$23813602$5$F$20240428$20240911$20240503$20240913$30DAY$$US-PFIZER INC-202400098803$PFIZER$$13$YR$$F$Y$37.642$KG$20240913$$CN$US$US
238136064$23813606$4$F$$20240912$20240503$20240916$30DAY$$US-PFIZER INC-202400096735$PFIZER$$12$YR$$F$Y$$$20240916$$CN$US$US
238136073$23813607$3$F$20240425$20240710$20240503$20240725$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-11822$SAMSUNG BIOEPIS$$47$YR$A$F$Y$$$20240725$$CN$CA$CA
238136142$23813614$2$F$20240501$20240702$20240503$20240704$PER$$US-AMGEN-USASP2024087892$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
238136602$23813660$2$F$20240301$20240703$20240503$20240709$EXP$$US-ABBVIE-5742271$ABBVIE$$69$YR$$M$Y$$$20240709$$CN$US$US
238136732$23813673$2$F$20240227$20240717$20240503$20240720$PER$$US-JNJFOC-20240505789$JOHNSON AND JOHNSON$$$$$$Y$$$20240720$$HP$US$US
238136995$23813699$5$F$20240401$20240712$20240503$20240715$PER$$US-AMGEN-USASP2024088326$AMGEN$$75$YR$E$M$Y$$$20240715$$CN$US$US
2381372614$23813726$14$F$20240503$20240902$20240503$20240903$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-119297$DAIICHI$$61$YR$$F$Y$$$20240903$$CN$US$US
238137273$23813727$3$F$$20240708$20240503$20240722$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-13176$SAMSUNG BIOEPIS$$95$YR$E$F$Y$$$20240722$$CN$CA$CA
238137533$23813753$3$F$$20240709$20240503$20240715$EXP$$CA-JNJFOC-20240490024$JOHNSON AND JOHNSON$$10$YR$C$F$Y$39$KG$20240715$$CN$CA$CA
238137742$23813774$2$F$20240113$20240529$20240503$20240711$EXP$$FR-GSK-FR2024EME055089$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$FR$FR
238137917$23813791$7$F$20240101$20240916$20240503$20240924$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-119331$DAIICHI$$$$$F$Y$$$20240925$$CN$US$US
238138342$23813834$2$F$20221004$20240807$20240503$20240813$PER$$JP-Eisai-EC-2024-164660$EISAI$$59$YR$A$F$Y$83$KG$20240813$$MD$JP$JP
238138552$23813855$2$F$$20240711$20240503$20240712$EXP$$US-TAKEDA-2024TUS008704$TAKEDA$$$$$M$Y$$$20240712$$CN$US$US
238138702$23813870$2$F$20240429$20240813$20240503$20240817$PER$$US-AMGEN-USASP2024088441$AMGEN$$60$YR$A$F$Y$$$20240817$$CN$US$US
238139043$23813904$3$F$20240325$20240627$20240503$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-020548$AUROBINDO$$60$YR$$M$Y$93$KG$20240706$$MD$FR$FR
238139175$23813917$5$F$20240502$20240815$20240503$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066464$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240826$$CN$US$US
238139262$23813926$2$F$$20240819$20240503$20240822$EXP$$US-BAYER-2024A065742$BAYER$$82$YR$E$F$Y$$$20240822$$CN$US$US
238140362$23814036$2$F$$20240705$20240503$20240806$PER$$US-GALDERMA-US2024001404$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
238140494$23814049$4$F$$20240702$20240503$20240709$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000861$BLUEPRINT MEDICINES$$$$$M$Y$$$20240709$$CN$US$US
238141133$23814113$3$F$$20240802$20240503$20240812$30DAY$$US-GSK-US2024052022$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
238141182$23814118$2$F$20240322$20240709$20240503$20240717$EXP$$JP-009507513-2404JPN001532J$MERCK$$80$YR$$M$Y$$$20240717$$MD$JP$JP
238141212$23814121$2$F$20220512$20240705$20240503$20240708$EXP$$DE-SANDOZ INC.-SDZ2024DE044254$SANDOZ$$31$YR$$F$Y$$$20240708$$MD$DE$DE
238141234$23814123$4$F$20240323$20240731$20240503$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068419$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240731$$CN$US$US
238141294$23814129$4$F$$20240723$20240503$20240725$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-119334$DAIICHI$$$$$F$Y$$$20240725$$CN$US$US
238141402$23814140$2$F$20230901$20240903$20240503$20240916$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-13322$SAMSUNG BIOEPIS$$21$YR$A$M$Y$$$20240916$$CN$CA$CA
238141412$23814141$2$F$20240323$20240708$20240503$20240716$EXP$DE-CADRBFARM-2024327420$DE-BAUSCH-BL-2024-006935$BAUSCH AND LOMB$$17$YR$$M$Y$58$KG$20240716$$CN$DE$DE
238141622$23814162$2$F$$20240711$20240503$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03513$LUPIN$$$$$$Y$$$20240809$$CN$US$US
238141884$23814188$4$F$$20240905$20240503$20240909$30DAY$$CO-PFIZER INC-PV202400053918$PFIZER$$$$$$Y$$$20240909$$CN$CO$CO
2381419215$23814192$15$F$$20240904$20240503$20240909$EXP$$GB-LEO Pharma-364790$LEO PHARM$$$$$M$Y$$$20240909$$HP$GB$GB
238142402$23814240$2$F$$20240729$20240503$20240805$EXP$$US-BAYER-2024A065734$BAYER$$51$YR$A$F$Y$$$20240805$$CN$US$US
238142462$23814246$2$F$$20240826$20240503$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069288$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240829$$CN$US$US
238142652$23814265$2$F$$20240819$20240503$20240822$30DAY$$US-SANDOZ INC.-SDZ2024US044961$SANDOZ$$$$$F$Y$$$20240822$$HP$US$US
238142834$23814283$4$F$$20240708$20240503$20240710$PER$$US-ALXN-202404USA002173US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
238142882$23814288$2$F$$20240809$20240503$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-444356$RANBAXY$Pang S, Tilton A, Angelle KL. A rare case of eastern equine encephalitis in a 3-yearold male in Lousiana. Am J Med Sci. 2024;367(S1):S448-S449 (719)$3$YR$$M$Y$$$20240823$$HP$US$US
238143533$23814353$3$F$$20240911$20240503$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069523$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240913$$CN$US$US
238144042$23814404$2$F$20240305$20240621$20240503$20240702$EXP$GB-MYLANLABS-2024M1021509$GB-TORRENT-00036448$TORRENT$$52$YR$A$M$Y$88$KG$20240702$$MD$GB$GB
238144134$23814413$4$F$20240101$20240704$20240503$20240710$EXP$$JP-DSJP-DSJ-2024-118751$DAIICHI$$70$YR$$F$Y$55$KG$20240710$$MD$JP$JP
238144163$23814416$3$F$$20240904$20240503$20240913$EXP$$GR-EMD Serono-2024022049$EMD SERONO INC$Theodoridou P, Pastirmatzi E, Samaras K, Stefanidis C, Gouliaros N, et al. Cardiac tamponade of left ventricle in a patient with severe Pulmonary Hypertension: an interesting case. Kardia kai Angeia. 2024;29(1):$82$YR$E$M$Y$$$20240913$$MD$GR$GR
238144484$23814448$4$F$$20240812$20240503$20240815$30DAY$$IE-PFIZER INC-PV202400055632$PFIZER$$10$YR$$M$Y$$$20240815$$CN$IE$IE
238144552$23814455$2$F$20240101$20240716$20240503$20240722$EXP$$GB-UCBSA-2023004961$UCB$$$$$F$Y$$$20240719$$CN$GB$GB
238144642$23814464$2$F$20230101$20240628$20240503$20240703$PER$$US-AMGEN-USASP2024088592$AMGEN$$77$YR$E$M$Y$$$20240703$$CN$US$US
238144863$23814486$3$F$20230101$20240729$20240503$20240730$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-277739$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$69.3$KG$20240730$$CN$ES$ES
238144892$23814489$2$F$20210101$20240502$20240503$20240808$EXP$$AD-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-165969$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$77$KG$20240808$$CN$AD$AD
238145513$23814551$3$F$20220201$20240613$20240503$20240808$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-155276$BOEHRINGER INGELHEIM$$56$YR$A$M$Y$124$KG$20240808$$CN$ES$ES
238145522$23814552$2$F$20210801$20240429$20240503$20240726$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-123388$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$74$KG$20240726$$CN$ES$ES
238145574$23814557$4$F$$20240909$20240503$20240919$EXP$$US-UCBSA-2024021503$UCB$$$$$M$Y$$$20240919$$CN$US$US
238145696$23814569$6$F$20240404$20240919$20240503$20240923$EXP$$CA-TAKEDA-2024TUS041893$TAKEDA$$26$YR$$F$Y$$$20240923$$CN$CA$CA
238145732$23814573$2$F$20230101$20240425$20240503$20240827$EXP$$KR-TAKEDA-2024TUS041079$TAKEDA$$$$E$F$Y$$$20240827$$MD$KR$KR
238145842$23814584$2$F$20240429$20240726$20240503$20240729$PER$$US-BAYER-2024A064168$BAYER$$$$$F$Y$$$20240729$$CN$US$US
238145863$23814586$3$F$$20240731$20240503$20240805$PER$$US-BIOGEN-2024BI01260625$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
238146422$23814642$2$F$$20240801$20240503$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069540$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$HP$US$US
238146593$23814659$3$F$$20240613$20240503$20240703$EXP$$US-ROCHE-3554879$ROCHE$$67$YR$E$M$Y$$$20240703$$CN$US$US
238146982$23814698$2$F$20240404$20240501$20240503$20240705$PER$$US-Eisai-EC-2024-163355$EISAI$$83$YR$$M$Y$$$20240705$$HP$US$US
238146992$23814699$2$F$20220302$20240725$20240503$20240809$PER$$US-BAYER-2024A064169$BAYER$$48$YR$A$F$Y$99.5$KG$20240809$$MD$US$US
238147122$23814712$2$F$20240404$20240626$20240503$20240703$EXP$$IT-AUROBINDO-AUR-APL-2024-019842$AUROBINDO$$65$YR$$F$Y$80$KG$20240703$$MD$IT$IT
238147302$23814730$2$F$20240201$20240731$20240503$20240805$EXP$$US-BIOGEN-2024BI01262576$BIOGEN$$67$YR$$F$Y$$$20240805$$CN$US$US
238147373$23814737$3$F$$20240830$20240503$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069319$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240904$$CN$US$US
238147435$23814743$5$F$20230726$20240724$20240503$20240731$EXP$FR-AFSSAPS-GR2024000503$FR-ROCHE-3555932$ROCHE$$64$YR$A$F$Y$57.2$KG$20240731$$PH$FR$FR
238147463$23814746$3$F$20240301$20240708$20240503$20240715$EXP$FR-AFSSAPS-BX2024000789$FR-OTSUKA-2024_012365$OTSUKA$$20$YR$$F$Y$$$20240715$$PH$FR$FR
238147492$23814749$2$F$20200101$20240903$20240503$20240905$EXP$$US-ABBVIE-5743437$ABBVIE$$$$$F$Y$43$KG$20240905$$CN$US$US
238147723$23814772$3$F$$20240703$20240503$20240712$30DAY$$US-GSK-US2024052025$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$PH$US$US
238147932$23814793$2$F$20240328$20240909$20240503$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-020508$AUROBINDO$$87$YR$$M$Y$$$20240919$$MD$FR$FR
238148012$23814801$2$F$20231101$20240909$20240503$20240927$PER$$CA-TOLMAR, INC.-24CA048007$TOLMAR$$71$YR$$M$Y$$$20240927$$CN$CA$CA
238148052$23814805$2$F$20240407$20240726$20240503$20240821$PER$$CA-TOLMAR, INC.-24CA048313$TOLMAR$$65$YR$$M$Y$$$20240821$$CN$CA$CA
238148182$23814818$2$F$20240430$20240911$20240503$20240912$PER$$US-AMGEN-USASP2024087759$AMGEN$$63$YR$A$F$Y$$$20240911$$CN$US$US
238148523$23814852$3$F$$20240704$20240503$20240709$EXP$$US-TAKEDA-2024TUS040668$TAKEDA$$$$$M$Y$$$20240709$$CN$US$US
238148613$23814861$3$F$20240412$20240910$20240503$20240918$EXP$$JP-ARGENX-2024-ARGX-JP002837$ARGENX BVBA$$$$$$Y$$$20240918$$MD$JP$JP
238148682$23814868$2$F$20240415$20240710$20240503$20240718$EXP$$DE-AUROBINDO-AUR-APL-2024-020439$AUROBINDO$$82$YR$$F$Y$$$20240718$$MD$DE$DE
238148792$23814879$2$F$20240516$20240905$20240503$20240910$EXP$$PH-OTSUKA-2024_012085$OTSUKA$$63$YR$$M$Y$$$20240910$$CN$PH$PH
238149012$23814901$2$F$20240204$20240828$20240503$20240903$EXP$$IN-SANDOZ INC.-SDZ2024IN044091$SANDOZ$$34$YR$$M$Y$$$20240903$$CN$IN$IN
238149233$23814923$3$F$$20240704$20240503$20240710$EXP$$JP-AMGEN-JPNSP2024086461$AMGEN$$$$E$F$Y$$$20240710$$MD$JP$JP
238149252$23814925$2$F$20240501$20240729$20240503$20240731$PER$$US-AMGEN-USASP2024087754$AMGEN$$75$YR$E$F$Y$$$20240731$$CN$US$US
238149263$23814926$3$F$$20240712$20240503$20240801$PER$$US-TEVA-VS-3186059$TEVA$$73$YR$$M$Y$$$20240801$$PH$US$US
238149733$23814973$3$F$20240301$20240816$20240503$20240823$EXP$$CA-TAKEDA-2024TUS041640$TAKEDA$$70$YR$$M$Y$$$20240823$$MD$CA$CA
238149862$23814986$2$F$20230728$20240722$20240503$20240801$EXP$$DE-NORDICGR-055888$NORDIC PHARMA$$72$YR$$F$Y$$$20240730$$MD$DE$DE
238150182$23815018$2$F$$20240719$20240503$20240723$EXP$$BR-PFIZER INC-202400098629$PFIZER$$81$YR$$F$Y$$$20240723$$CN$BR$BR
238150244$23815024$4$F$20180101$20240819$20240503$20240821$EXP$$US-PFIZER INC-PV202400057291$PFIZER$$36$YR$$M$Y$$$20240821$$HP$US$US
238150292$23815029$2$F$$20240807$20240503$20240810$EXP$$US-TAKEDA-2024TUS029166$TAKEDA$$$$$F$Y$$$20240810$$CN$US$US
238150354$23815035$4$F$20240427$20240829$20240503$20240830$PER$$JP-Eisai-EC-2024-165066$EISAI$$68$YR$E$F$Y$52$KG$20240830$$MD$JP$JP
238150764$23815076$4$F$$20240628$20240503$20240705$EXP$$CA-TAKEDA-2024TUS041787$TAKEDA$$$$$M$Y$$$20240705$$MD$CA$CA
238150853$23815085$3$F$20240320$20240710$20240503$20240719$EXP$$CO-EXELIXIS-CABO-24076933$EXELIXIS$$49$YR$$M$Y$87$KG$20240719$$MD$CO$CO
238151013$23815101$3$F$20240101$20240724$20240503$20240729$EXP$$CA-PFIZER INC-202400098773$PFIZER$$54$YR$$F$Y$60.4$KG$20240729$$HP$CA$CA
238151044$23815104$4$F$$20240926$20240503$20240927$30DAY$$CO-PFIZER INC-PV202400056465$PFIZER$$35$YR$$F$Y$$$20240927$$CN$CO$CO
238151173$23815117$3$F$20240402$20240913$20240503$20240916$EXP$$IT-SANDOZ INC.-SDZ2024IT044543$SANDOZ$$81$YR$$F$Y$57$KG$20240916$$HP$IT$IT
238151272$23815127$2$F$$20240731$20240503$20240810$30DAY$$US-GSK-US2024051920$GLAXOSMITHKLINE$$$$$M$Y$$$20240810$$HP$US$US
238151313$23815131$3$F$$20240722$20240503$20240731$30DAY$$US-GSK-US2024052729$GLAXOSMITHKLINE$$$$$M$Y$$$20240731$$CN$US$US
238151372$23815137$2$F$$20240828$20240503$20240902$EXP$$CA-PFIZER INC-202400100081$PFIZER$$41$YR$$F$Y$$$20240902$$HP$CA$CA
238151385$23815138$5$F$$20240906$20240503$20240910$EXP$$US-PFIZER INC-PV202400055783$PFIZER$$76$YR$$M$Y$$$20240910$$CN$US$US
238151433$23815143$3$F$20240428$20240905$20240503$20240910$30DAY$$AR-PFIZER INC-202400097646$PFIZER$$8$YR$$F$Y$$$20240910$$HP$AR$AR
238151502$23815150$2$F$$20240904$20240503$20240905$EXP$$CA-BAUSCH-BL-2024-006910$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240905$$HP$CA$CA
238151533$23815153$3$F$20240101$20240709$20240503$20240711$EXP$$CA-PFIZER INC-202400098730$PFIZER$$43$YR$$F$Y$$$20240711$$HP$CA$CA
238151572$23815157$2$F$$20240708$20240503$20240709$EXP$$GR-PFIZER INC-PV202400056988$PFIZER$$82$YR$$M$Y$$$20240709$$CN$GR$GR
238151592$23815159$2$F$20210907$20240627$20240503$20240701$EXP$$CA-PFIZER INC-202201025868$PFIZER$$41$YR$$M$Y$116$KG$20240701$$HP$CA$CA
238151613$23815161$3$F$20200512$20240909$20240503$20240912$EXP$PT-INFARMED-B202404-459$PT-ABBVIE-5742865$ABBVIE$$32$YR$$F$Y$67$KG$20240912$$CN$PT$PT
238151773$23815177$3$F$$20240910$20240503$20240912$30DAY$$US-PFIZER INC-202400094022$PFIZER$$66$YR$$F$Y$81.65$KG$20240912$$MD$US$US
238151824$23815182$4$F$$20240914$20240503$20240919$30DAY$$GT-PFIZER INC-PV202400055654$PFIZER$$11$YR$$M$Y$$$20240919$$CN$GT$GT
238152252$23815225$2$F$$20240709$20240503$20240710$PER$$US-ALXN-202404USA002124US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
238152282$23815228$2$F$$20240627$20240503$20240705$EXP$$US-BAYER-2024A064185$BAYER$$75$YR$E$M$Y$$$20240705$$CN$US$US
238152313$23815231$3$F$20240101$20240806$20240503$20240809$PER$$US-PFIZER INC-202400098916$PFIZER$$71$YR$$M$Y$$$20240809$$MD$US$US
238152422$23815242$2$F$$20240703$20240503$20240708$PER$$US-PFIZER INC-202400098647$PFIZER$$19$YR$$M$Y$$$20240708$$MD$US$US
238152912$23815291$2$F$$20240615$20240503$20240708$EXP$$US-SANDOZ INC.-SDZ2023US014413$SANDOZ$$$$$F$Y$53.968$KG$20240708$$CN$US$US
238153272$23815327$2$F$$20240703$20240503$20240708$PER$$US-PFIZER INC-202400099326$PFIZER$$82$YR$$F$Y$$$20240708$$HP$US$US
238153613$23815361$3$F$$20240717$20240503$20240723$EXP$$US-KYOWAKIRIN-2024KK010509$KYOWA$$$$$$Y$$$20240723$$HP$US$US
238153673$23815367$3$F$$20240725$20240503$20240801$EXP$$CA-GSK-CA2023174570$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$CA$CA
238153872$23815387$2$F$$20240805$20240503$20240814$EXP$$US-MYLANLABS-2024M1039448$MYLAN$Singh H, Patel P, Mawari SK, Menon P. Cyclosporine Induced Organizing Pneumonia: When the Immunosuppressant Causes Inflammation. Am-J-Respir-Crit-Care-Med 2023; 207 (plus Poster) abstr. A3169.$30$YR$$F$Y$$$20240814$$HP$US$US
238153952$23815395$2$F$20240201$20240625$20240503$20240701$EXP$$US-ABBVIE-5742737$ABBVIE$$51$YR$$F$Y$$$20240701$$CN$US$US
238154174$23815417$4$F$20240201$20240829$20240503$20240906$EXP$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-003195$PHARMAESSENTIA$$$$$F$Y$$$20240906$$CN$US$US
238154513$23815451$3$F$$20240814$20240503$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US044714$SANDOZ$$$$$M$Y$$$20240820$$CN$US$US
238155246$23815524$6$F$20240401$20240828$20240503$20240830$30DAY$$US-PFIZER INC-202400098577$PFIZER$$65$YR$$F$Y$52.16$KG$20240830$$HP$US$US
238155282$23815528$2$F$20240321$20240803$20240503$20240816$EXP$$PT-AUROBINDO-AUR-APL-2024-020492$AUROBINDO$$73$YR$$F$Y$$$20240816$$MD$PT$PT
238155312$23815531$2$F$$20240808$20240503$20240819$EXP$$JP-ROCHE-3554530$ROCHE$Aizawa Y, Arai S, Sato R, Yoshida Y, Hasegawa A, Hiyama C et al.. P3-249 A case of secondary alveolar proteinosis which developed during treatment for refractory adult Still^s disease.. The 68th Annual General Assembly and Scientific Meeting of the Japan College of 2024;:895-.$63$YR$A$F$Y$59$KG$20240819$$MD$JP$JP
238155332$23815533$2$F$20220101$20240628$20240503$20240705$EXP$$JP-009507513-2404JPN003765J$MERCK$$$$$F$Y$$$20240705$$MD$JP$JP
238155572$23815557$2$F$20240718$20240719$20240503$20240720$EXP$$US-TAKEDA-2024TUS042087$TAKEDA$$77$YR$$M$Y$$$20240720$$CN$US$US
238155732$23815573$2$F$$20240709$20240503$20240710$PER$$US-ALXN-202404USA002123US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
238156533$23815653$3$F$$20240813$20240503$20240815$PER$$US-PFIZER INC-202300447873$PFIZER$$26$YR$$F$Y$$$20240815$$HP$US$US
238156572$23815657$2$F$20240101$20240912$20240503$20240916$PER$$US-PFIZER INC-PV202400057173$PFIZER$$27$YR$$F$Y$$$20240916$$HP$US$US
238156586$23815658$6$F$$20240909$20240503$20240910$PER$$US-PFIZER INC-PV202400056701$PFIZER$$71$YR$$F$Y$$$20240910$$HP$US$US
238156682$23815668$2$F$20240101$20240918$20240503$20240920$EXP$$US-PFIZER INC-202400099312$PFIZER$$72$YR$$F$Y$$$20240920$$HP$US$US
238157162$23815716$2$F$$20240904$20240503$20240912$EXP$$JP-AstraZeneca-2024A067567$ASTRAZENECA$Motoyoshi Y, et al.. Durvalumab plus Tremelimumab treatment in patients with unresectable HCC; an early experience.. 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL) 2024;$72$YR$$M$Y$$$20240912$$MD$JP$
238157262$23815726$2$F$20130501$20240830$20240503$20240910$EXP$$PL-AUROBINDO-AUR-APL-2019-083591$AUROBINDO$Kaminska D, Koscielska-Kasprzak K, Myszka M, Banasik M, Chelmonski A, Boratynska M, et al. Significant infections after hand transplantation in a Polish population. Transplantation Proceedings. 2014;46(8):2887-9$28$YR$$M$Y$$$20240910$$HP$PL$PL
238157613$23815761$3$F$$20240813$20240503$20240905$PER$$US-INCYTE CORPORATION-2024IN003917$INCYTE$$$$$$Y$$$20240905$$CN$US$US
238157662$23815766$2$F$20240501$20240916$20240503$20240918$PER$$US-AMGEN-USASP2024088118$AMGEN$$76$YR$E$F$Y$$$20240918$$CN$US$US
238157862$23815786$2$F$20230101$20240628$20240503$20240704$EXP$$JP-009507513-2404JPN003770J$MERCK$$$$$F$Y$$$20240704$$MD$JP$JP
238157874$23815787$4$F$$20240821$20240503$20240828$EXP$$JP-009507513-2404JPN003753J$MERCK$$52$YR$$F$Y$$$20240828$$MD$JP$JP
238158083$23815808$3$F$20240401$20240715$20240503$20240722$EXP$$NL-ABBVIE-5743147$ABBVIE$$$$E$M$Y$$$20240722$$CN$NL$NL
238158142$23815814$2$F$$20240906$20240503$20240910$PER$$US-ALXN-202404USA002138US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
238158153$23815815$3$F$20240410$20240709$20240503$20240710$PER$$US-ALXN-202404USA002183US$ALEXION PHARMACEUTICALS$$77$YR$$M$Y$$$20240710$$CN$US$US
238158242$23815824$2$F$$20240801$20240503$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069391$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240801$$CN$US$US
238158252$23815825$2$F$$20240909$20240503$20240920$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000049$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
238158263$23815826$3$F$20240301$20240715$20240503$20240717$EXP$$US-JNJFOC-20240488106$JOHNSON AND JOHNSON$$30$YR$A$F$Y$89.892$KG$20240717$$HP$US$US
238158284$23815828$4$F$20240303$20240725$20240503$20240726$EXP$$FR-BIOVITRUM-2024-FR-005843$BIOVITRUM$$65$YR$$F$Y$77$KG$20240726$$CN$FR$FR
238158394$23815839$4$F$20240425$20240829$20240503$20240903$EXP$$JP-TAIWAN SHIONOGI + CO., LTD.-2024001036$SHIONOGI$$$$$$Y$$$20240903$$MD$JP$JP
238158673$23815867$3$F$20240613$20240715$20240503$20240722$EXP$$CA-GSK-CA2024049455$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$HP$CA$CA
238158772$23815877$2$F$20240401$20240426$20240503$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003536$TG THERAPEUTICS$$46$YR$$M$Y$$$20240715$$CN$US$US
238158872$23815887$2$F$20240726$20240731$20240503$20240801$EXP$$US-KYOWAKIRIN-2024KK010481$KYOWA$$$$$$Y$$$20240801$$HP$US$US
238159023$23815902$3$F$$20240709$20240503$20240710$PER$$US-ALXN-202404USA002022US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
238159092$23815909$2$F$$20240711$20240503$20240724$EXP$$AU-TEVA-VS-3193009$TEVA$JACK LIU. Unusual Response of HDL-Chol Level and Body Weight to Atorvastatin: A Case Report. Current Health Sciences Journal. 2024 January-March; Vol. 50, No. 1: 155-157$58$YR$$M$Y$$$20240724$$HP$AU$AU
238159284$23815928$4$F$$20240924$20240503$20240926$EXP$$US-SANDOZ INC.-SDZ2024US044114$SANDOZ$$$$$$Y$$$20240926$$CN$US$US
238159312$23815931$2$F$20240101$20240814$20240503$20240826$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00357$CATALYST PHARMA$$$$$F$Y$63.492$KG$20240826$$CN$US$US
238159335$23815933$5$F$20230301$20240806$20240503$20240813$EXP$$ES-ABBVIE-5740209$ABBVIE$$72$YR$$M$Y$$$20240813$$CN$ES$ES
238159576$23815957$6$F$20240101$20240918$20240503$20240923$EXP$$US-PFIZER INC-PV202400057244$PFIZER$$59$YR$$F$Y$$$20240923$$CN$US$US
238159685$23815968$5$F$$20240821$20240503$20240827$EXP$$US-PFIZER INC-202400098780$PFIZER$$64$YR$$M$Y$$$20240827$$CN$US$US
238159773$23815977$3$F$20240206$20240701$20240503$20240703$EXP$$GB-DSJP-DSE-2024-113795$DAIICHI$$51$YR$$F$Y$103.8$KG$20240703$$HP$GB$GB
238160002$23816000$2$F$$20240808$20240503$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US044849$SANDOZ$$$$$M$Y$$$20240812$$CN$US$US
238161314$23816131$4$F$20240201$20240624$20240503$20240702$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000890$BLUEPRINT MEDICINES$$70$YR$E$M$Y$$$20240702$$CN$US$US
238161525$23816152$5$F$$20240725$20240503$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA044570$SANDOZ$$$$$M$Y$$$20240729$$MD$CA$CA
238162182$23816218$2$F$$20240709$20240503$20240719$PER$$US-INCYTE CORPORATION-2024IN003865$INCYTE$$$$$$Y$$$20240719$$CN$US$US
238162233$23816223$3$F$20240201$20240805$20240503$20240808$EXP$$US-ABBVIE-5742624$ABBVIE$$27$YR$$M$Y$24.493$KG$20240808$$HP$US$US
238162414$23816241$4$F$$20240731$20240503$20240801$EXP$$US-PFIZER INC-202400098775$PFIZER$$87$YR$$F$Y$70.31$KG$20240801$$CN$US$US
238162512$23816251$2$F$20240212$20240808$20240503$20240816$EXP$$ZA-MYLANLABS-2024M1040021$MYLAN$$$$$F$Y$3.45$KG$20240816$$HP$ZA$ZA
238162822$23816282$2$F$20231127$20240705$20240503$20240712$EXP$$DE-PFIZER INC-202400099829$PFIZER$$41$YR$$F$Y$58$KG$20240712$$HP$DE$DE
238162874$23816287$4$F$20240319$20240517$20240503$20240813$EXP$$BR-SANDOZ INC.-SDZ2024BR045026$SANDOZ$$54$YR$$F$Y$$$20240813$$CN$BR$BR
238163002$23816300$2$F$20240402$20240722$20240503$20240723$EXP$$IN-ROCHE-3502076$ROCHE$$66$YR$E$M$Y$70$KG$20240723$$CN$IN$IN
238163034$23816303$4$F$$20240808$20240503$20240809$30DAY$$US-SANDOZ INC.-SDZ2024US044840$SANDOZ$$$$$M$Y$$$20240809$$CN$US$US
238163042$23816304$2$F$$20240802$20240503$20240806$30DAY$$US-SANDOZ INC.-SDZ2024US043748$SANDOZ$$$$$M$Y$$$20240806$$CN$US$US
238163062$23816306$2$F$$20240708$20240503$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069290$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$75.75$KG$20240710$$CN$US$US
238163133$23816313$3$F$20240101$20240711$20240503$20240718$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00222$CATALYST PHARMA$$$$$F$Y$81.633$KG$20240718$$CN$US$US
238163322$23816332$2$F$20240328$20240913$20240503$20240918$EXP$FR-AFSSAPS-MA2024000498$FR-MYLANLABS-2024M1039533$MYLAN$$87$YR$$M$Y$$$20240918$$MD$FR$FR
238163383$23816338$3$F$20240401$20240815$20240503$20240824$EXP$$TR-AstraZeneca-2024A101611$ASTRAZENECA$$53$YR$$F$Y$$$20240823$$PH$TR$
238163402$23816340$2$F$20240317$20240628$20240503$20240703$EXP$$CN-ABBVIE-5743123$ABBVIE$$43$YR$$M$Y$90$KG$20240703$$MD$CN$CN
238163512$23816351$2$F$20240421$20240815$20240503$20240819$EXP$$CN-AstraZeneca-2024A099851$ASTRAZENECA$$208$MON$$M$Y$$$20240819$$MD$CN$
238163582$23816358$2$F$20181023$20240911$20240503$20240913$EXP$$CA-SANDOZ INC.-NVSC2021CA235074$SANDOZ$$75$YR$$F$Y$$$20240913$$MD$CA$CA
238164152$23816415$2$F$20220701$20240628$20240503$20240702$PER$$JP-Eisai-EC-2024-165100$EISAI$$75$YR$E$F$Y$$$20240702$$MD$JP$JP
238164282$23816428$2$F$$20240820$20240503$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069496$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240821$$CN$US$US
238164503$23816450$3$F$20240419$20240709$20240503$20240710$EXP$$US-ALXN-202404USA002017US$ALEXION PHARMACEUTICALS$$18$YR$$M$Y$$$20240710$$CN$US$US
238164822$23816482$2$F$20240502$20240802$20240503$20240805$30DAY$$US-SANDOZ INC.-SDZ2024US045109$SANDOZ$$34$YR$$F$Y$$$20240805$$HP$US$US
238164922$23816492$2$F$$20240814$20240503$20240820$30DAY$$EG-SANDOZ INC.-SDZ2024EG036876$SANDOZ$$$$$F$Y$$$20240820$$HP$EG$EG
238165383$23816538$3$F$$20240903$20240503$20240903$PER$$US-ALXN-202404USA002133US$ALEXION PHARMACEUTICALS$$$$$F$Y$63.492$KG$20240903$$CN$US$US
238165464$23816546$4$F$$20240812$20240503$20240816$30DAY$$US-PFIZER INC-PV202400057716$PFIZER$$$$$F$Y$$$20240816$$CN$US$US
238165623$23816562$3$F$$20240813$20240503$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006958$JAZZ$$$$$M$Y$$$20240821$$CN$US$US
238165642$23816564$2$F$20240418$20240806$20240503$20240814$PER$$JP-Eisai-EC-2024-164632$EISAI$$$$E$M$Y$$$20240814$$MD$JP$JP
238165893$23816589$3$F$20240402$20240626$20240503$20240705$EXP$$US-BIOGEN-2024BI01262317$BIOGEN$$76$YR$$F$Y$$$20240705$$HP$US$US
238165934$23816593$4$F$$20240708$20240503$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067297$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240710$$CN$US$US
238165982$23816598$2$F$20220101$20240705$20240503$20240711$EXP$$GR-BRISTOL-MYERS SQUIBB COMPANY-2024-066066$BRISTOL MYERS SQUIBB$Dedes N, Tatoulis I, Tsoukalas K, Bozikas A, Ntanasis I, Liatsou E, et al. Necrotic laryngitis caused by acinetobacter baumannii in a 37-year-old patient with hemophagocytic syndrome and multiple myeloma. 23rd Panhellenic Congress on Infections. 2024 Mar;163.$37$YR$A$M$Y$$$20240711$$HP$GR$GR
2381663911$23816639$11$F$20240101$20240625$20240503$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012729$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240705$$$US$US
238166516$23816651$6$F$20240101$20240812$20240503$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007710$UNITED THERAPEUTICS$$$$$M$Y$107.94$KG$20240821$$$US$US
2381665313$23816653$13$F$20240101$20240828$20240504$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011787$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240906$$PH$US$US
238166583$23816658$3$F$20230330$20240724$20240504$20240731$EXP$$CA-CELLTRION INC.-2023CA002933$CELLTRION$$$$$$Y$$$20240731$$MD$CA$CA
238166682$23816668$2$F$20240101$20240626$20240504$20240703$EXP$$CA-CELLTRION INC.-2024CA009377$CELLTRION$$$$$$Y$$$20240703$$HP$CA$CA
238166773$23816677$3$F$20240508$20240623$20240504$20240701$EXP$$CA-CELLTRION INC.-2024CA010078$CELLTRION$$$$$$Y$$$20240701$$CN$CA$CA
238166846$23816684$6$F$20240101$20240830$20240504$20240909$EXP$$CA-CELLTRION INC.-2024CA007505$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
238166852$23816685$2$F$20240101$20240623$20240504$20240701$EXP$$CA-CELLTRION INC.-2024CA004320$CELLTRION$$$$$$Y$$$20240701$$HP$CA$CA
238166862$23816686$2$F$$20240918$20240504$20240930$EXP$CA-MHPD-E2B_06906193$CA-Accord-421880$ACCORD$$14$YR$T$M$Y$41$KG$20240930$$HP$CA$CA
238166874$23816687$4$F$20191003$20240726$20240504$20240805$EXP$$CA-CELLTRION INC.-2024CA010106$CELLTRION$$$$$$Y$$$20240805$$CN$CA$CA
238167032$23816703$2$F$20230831$20240802$20240504$20240812$EXP$FR-AFSSAPS-TO2024000667$FR-TEVA-VS-3190543$TEVA$$78$YR$$M$Y$$$20240812$$MD$FR$FR
238167084$23816708$4$F$20240101$20240624$20240504$20240801$EXP$$CA-CELLTRION INC.-2024CA010075$CELLTRION$$$$$$Y$$$20240801$$HP$CA$CA
238167584$23816758$4$F$20240401$20240731$20240504$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012654$UNITED THERAPEUTICS$$68$YR$$M$Y$77.098$KG$20240807$$$US$US
238167594$23816759$4$F$20240310$20240903$20240504$20240910$EXP$PT-INFARMED-E202404-424$PT-TEVA-VS-3191205$TEVA$$75$YR$$F$Y$$$20240910$$MD$PT$PT
238167803$23816780$3$F$$20240812$20240504$20240814$PER$$NVSC2024US092254$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
238167823$23816782$3$F$20240430$20240812$20240504$20240814$PER$$NVSC2024US092454$NOVARTIS$$40$YR$$F$Y$$$20240814$$CN$US$US
238167902$23816790$2$F$$20240805$20240504$20240812$EXP$$NVSC2024US091202$NOVARTIS$Singh H, Patel P, Mawari S, Caliman N. Cyclosporine-associated organizing pneumonia. AMERICAN JOURNAL OF THERAPEUTICS. 2023;0(0):1-3$30$YR$$F$Y$$$20240812$$HP$US$US
238167994$23816799$4$F$20240209$20240802$20240504$20240809$EXP$$NVSC2024US091452$NOVARTIS$$61$YR$$F$Y$81.65$KG$20240809$$CN$US$US
238168023$23816802$3$F$$20240506$20240504$20240812$EXP$$NVSC2024GB087181$NOVARTIS$$$$$F$Y$$$20240812$$PH$GB$GB
238168074$23816807$4$F$20240311$20240919$20240504$20240925$EXP$$NVSC2024CO090619$NOVARTIS$$77$YR$$M$Y$64$KG$20240925$$CN$CO$CO
238168082$23816808$2$F$$20240701$20240504$20240704$EXP$$NVSC2024FR091664$NOVARTIS$$$$$$Y$$$20240704$$MD$FR$FR
238168412$23816841$2$F$20230901$20240703$20240504$20240704$EXP$$NVSC2024US090339$NOVARTIS$$7$YR$$M$Y$$$20240704$$MD$US$US
238168423$23816842$3$F$20240221$20240905$20240504$20240906$EXP$$NVSC2024US088890$NOVARTIS$$62$YR$$F$Y$$$20240906$$CN$US$US
238168462$23816846$2$F$$20240717$20240504$20240724$EXP$$NVSC2024GB093430$NOVARTIS$$$$E$M$Y$$$20240724$$CN$GB$GB
238168472$23816847$2$F$20240301$20240704$20240504$20240705$EXP$$NVSC2024GB092572$NOVARTIS$$50$YR$$F$Y$$$20240705$$CN$GB$GB
238168622$23816862$2$F$20220601$20240812$20240504$20240819$EXP$$NVSC2023ZA258044$NOVARTIS$$54$YR$$F$Y$$$20240819$$HP$ZA$ZA
238168662$23816866$2$F$$20240712$20240504$20240715$PER$$NVSC2024US093830$NOVARTIS$$$$$M$Y$$$20240715$$MD$US$US
238168792$23816879$2$F$$20240708$20240504$20240711$EXP$$NVSC2024AU093729$NOVARTIS$$$$$F$Y$$$20240711$$HP$AU$AU
238168843$23816884$3$F$20240125$20240904$20240504$20240909$EXP$$NVSC2024BR041326$NOVARTIS$$69$YR$$F$Y$$$20240909$$CN$BR$BR
238168875$23816887$5$F$$20240819$20240504$20240820$PER$$NVSC2024US093520$NOVARTIS$$$$$F$Y$$$20240820$$HP$US$US
238168882$23816888$2$F$$20240705$20240504$20240705$EXP$$NVSC2024US092784$NOVARTIS$$$$$$Y$$$20240705$$CN$US$US
238168962$23816896$2$F$$20240430$20240504$20240819$EXP$$NVSC2024US093726$NOVARTIS$$$$$M$Y$$$20240819$$CN$US$US
238168972$23816897$2$F$20240420$20240705$20240504$20240708$EXP$$NVSC2024US090666$NOVARTIS$$44$YR$$M$Y$95.238$KG$20240708$$PH$US$US
238168992$23816899$2$F$$20240717$20240504$20240718$PER$$NVSC2024US093384$NOVARTIS$$$$$$Y$$$20240718$$MD$US$US
238169015$23816901$5$F$$20240520$20240504$20240924$EXP$$NVSC2024US094104$NOVARTIS$$$$$M$Y$$$20240924$$HP$US$US
238169043$23816904$3$F$$20240813$20240504$20240814$PER$$NVSC2024US093988$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
238169075$23816907$5$F$$20240813$20240504$20240820$PER$$NVSC2024US093383$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
238169092$23816909$2$F$$20240705$20240504$20240708$EXP$$NVSC2024US092712$NOVARTIS$$$$$F$Y$$$20240708$$MD$US$US
238169104$23816910$4$F$$20240807$20240504$20240809$PER$$NVSC2024US093834$NOVARTIS$$$$$F$Y$$$20240809$$HP$US$US
238169143$23816914$3$F$$20240705$20240504$20240705$PER$$NVSC2024US092453$NOVARTIS$$16$MON$$F$Y$$$20240705$$MD$US$US
238169152$23816915$2$F$$20240628$20240504$20240702$PER$$NVSC2024US092391$NOVARTIS$$$$$$Y$$$20240702$$MD$US$US
238169203$23816920$3$F$$20240807$20240504$20240808$PER$$NVSC2024US093457$NOVARTIS$$$$$M$Y$$$20240808$$HP$US$US
238169303$23816930$3$F$$20240627$20240504$20240704$PER$$NVSC2024US093067$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
238169313$23816931$3$F$$20240815$20240504$20240819$PER$$NVSC2024US093968$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
238169334$23816933$4$F$$20240807$20240504$20240808$PER$$NVSC2024US093044$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
238169433$23816943$3$F$$20240731$20240504$20240802$PER$$NVSC2024US093310$NOVARTIS$$$$$M$Y$$$20240802$$HP$US$US
238169443$23816944$3$F$$20240712$20240504$20240712$PER$$NVSC2024US093052$NOVARTIS$$$$$F$Y$$$20240712$$CN$US$US
238169454$23816945$4$F$$20240805$20240504$20240808$PER$$NVSC2024US093525$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
238169468$23816946$8$F$20230313$20240904$20240504$20240909$EXP$$NVSC2024BR093554$NOVARTIS$$40$YR$$M$Y$95$KG$20240909$$MD$BR$BR
238169516$23816951$6$F$$20240806$20240504$20240807$PER$$NVSC2024US093224$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
238169524$23816952$4$F$20240331$20240805$20240504$20240806$PER$$NVSC2024US091376$NOVARTIS$$48$YR$$F$Y$$$20240806$$CN$US$US
238169543$23816954$3$F$$20240813$20240504$20240814$PER$$NVSC2024US093504$NOVARTIS$$$$$M$Y$$$20240814$$HP$US$US
238169553$23816955$3$F$$20240729$20240504$20240730$PER$$NVSC2024US092334$NOVARTIS$$$$$M$Y$108$KG$20240730$$CN$US$US
238169584$23816958$4$F$$20240813$20240504$20240816$PER$$NVSC2024US093789$NOVARTIS$$$$$F$Y$$$20240816$$HP$US$US
238169604$23816960$4$F$$20240809$20240504$20240812$PER$$NVSC2024US093314$NOVARTIS$$$$$F$Y$$$20240812$$HP$US$US
238169654$23816965$4$F$20240512$20240701$20240504$20240704$EXP$$NVSC2024US088587$NOVARTIS$$83$YR$$M$Y$$$20240704$$CN$US$US
238169663$23816966$3$F$20231219$20240813$20240504$20240814$PER$$NVSC2024US093370$NOVARTIS$$$$$M$Y$$$20240815$$HP$US$US
238169703$23816970$3$F$$20240813$20240504$20240814$PER$$NVSC2024US093318$NOVARTIS$$$$$F$Y$$$20240814$$HP$US$US
238169712$23816971$2$F$20240401$20240830$20240504$20240903$EXP$$NVSC2024GB093090$NOVARTIS$$$$$F$Y$$$20240903$$CN$GB$GB
238169774$23816977$4$F$$20240809$20240504$20240812$EXP$$NVSC2024US093548$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
238169795$23816979$5$F$$20240812$20240504$20240813$PER$$NVSC2024US094074$NOVARTIS$$$$$F$Y$$$20240813$$HP$US$US
238169833$23816983$3$F$20240401$20240902$20240504$20240905$EXP$$NVSC2024GB091357$NOVARTIS$$$$$M$Y$$$20240905$$CN$GB$GB
238170103$23817010$3$F$20200512$20240822$20240504$20240904$EXP$PT-INFARMED-B202404-459$PT-MACLEODS PHARMA-MAC2024047076$MACLEODS$$$$$$Y$$$20240904$$CN$PT$PT
238170122$23817012$2$F$20240305$20240621$20240504$20240703$EXP$$GB-MACLEODS PHARMA-MAC2024047079$MACLEODS$$$$$$Y$$$20240703$$CN$GB$GB
238170653$23817065$3$F$20230101$20240711$20240504$20240722$EXP$DE-BFARM-23007236$DE-Accord-391825$ACCORD$$90$YR$E$F$Y$62$KG$20240722$$MD$DE$DE
238171117$23817111$7$F$20240101$20240807$20240504$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012053$UNITED THERAPEUTICS$$$$$M$Y$88.481$KG$20240817$$$US$US
238171265$23817126$5$F$20240101$20240820$20240504$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-008102$UNITED THERAPEUTICS$$$$$M$Y$$$20240828$$$US$US
238171973$23817197$3$F$20240415$20240724$20240505$20240802$30DAY$$US-GSK-US2024053334$GLAXOSMITHKLINE$$45$YR$$F$Y$88$KG$20240802$$MD$US$US
238172144$23817214$4$F$$20240725$20240505$20240803$30DAY$$US-GSK-US2024053381$GLAXOSMITHKLINE$$$$$F$Y$$$20240803$$HP$US$US
238172352$23817235$2$F$20230101$20240626$20240505$20240701$PER$$US-AMGEN-USASP2024088267$AMGEN$$52$YR$A$M$Y$$$20240701$$CN$US$US
238172392$23817239$2$F$$20240709$20240505$20240710$PER$$US-ALXN-202404USA002241US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
238172483$23817248$3$F$20240301$20240906$20240505$20240915$EXP$$JP-ARDELYX-2024ARDX001980$ARDELYX$$60$YR$$M$Y$$$20240916$$MD$JP$JP
238172582$23817258$2$F$$20240801$20240505$20240807$PER$$US-009507513-2404USA010719$MERCK$$$$$F$Y$$$20240807$$CN$US$US
238172612$23817261$2$F$20240401$20240703$20240505$20240711$EXP$$JP-009507513-2404JPN003574J$MERCK$$8$DEC$$M$Y$$$20240711$$MD$JP$JP
238172653$23817265$3$F$20240501$20240728$20240505$20240730$PER$$US-AMGEN-USASP2024088301$AMGEN$$56$YR$A$M$Y$$$20240730$$CN$US$US
238172662$23817266$2$F$20220801$20240809$20240505$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-187147$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240813$$CN$US$US
238172952$23817295$2$F$$20240719$20240505$20240729$PER$$US-SA-2024SA126872$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240729$$MD$US$US
238172992$23817299$2$F$20240101$20240620$20240505$20240701$PER$$US-SA-2024SA126480$SANOFI AVENTIS$$13$YR$T$F$Y$50.6$KG$20240701$$MD$US$US
238173142$23817314$2$F$$20240918$20240505$20240926$PER$$US-SA-2024SA127782$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240926$$MD$US$US
238173214$23817321$4$F$20221014$20240703$20240505$20240712$PER$$US-SA-2024SA126659$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240712$$MD$US$US
238173292$23817329$2$F$20240101$20240724$20240505$20240802$PER$$US-SA-2024SA130212$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240802$$MD$US$US
238173314$23817331$4$F$20240301$20240806$20240505$20240814$PER$$US-SA-2024SA130667$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240814$$MD$US$US
238173352$23817335$2$F$20240101$20240720$20240505$20240729$PER$$US-SA-2024SA130588$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240729$$MD$US$US
238173402$23817340$2$F$20231101$20240621$20240505$20240705$PER$$US-SA-2024SA127914$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240705$$MD$US$US
238173572$23817357$2$F$$20240722$20240505$20240731$PER$$US-SA-2024SA126796$SANOFI AVENTIS$$$$A$M$Y$$$20240731$$MD$US$US
238173592$23817359$2$F$20240401$20240903$20240505$20240912$PER$$US-SA-2024SA127814$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240912$$MD$US$US
238173682$23817368$2$F$20240422$20240909$20240505$20240925$PER$$US-SA-2024SA126442$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240925$$HP$US$US
238173703$23817370$3$F$20240101$20240918$20240505$20240927$PER$$US-SA-2024SA127948$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240927$$MD$US$US
238173774$23817377$4$F$20240101$20240830$20240505$20240913$PER$$US-SA-2024SA126883$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240914$$MD$US$US
238173883$23817388$3$F$20240401$20240827$20240505$20240904$PER$$US-SA-2024SA131212$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240904$$MD$US$US
238173952$23817395$2$F$20240101$20240724$20240505$20240802$PER$$US-SA-2024SA127743$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240802$$MD$US$US
238174002$23817400$2$F$$20240807$20240505$20240816$PER$$US-SA-2024SA130516$SANOFI AVENTIS$$$$C$F$Y$$$20240816$$CN$US$US
238174013$23817401$3$F$20231101$20240809$20240505$20240820$PER$$US-SA-2024SA127775$SANOFI AVENTIS$$97$YR$E$F$Y$$$20240820$$MD$US$US
238174212$23817421$2$F$20240101$20240624$20240505$20240703$PER$$US-SA-2024SA127043$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240703$$MD$US$US
238174223$23817422$3$F$20240101$20240708$20240505$20240713$EXP$$US-SA-2024SA098256$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240713$$CN$US$US
238174332$23817433$2$F$$20240726$20240505$20240806$PER$$US-SA-2024SA130726$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240806$$MD$US$US
238174343$23817434$3$F$20240101$20240723$20240505$20240729$PER$$US-SA-2024SA126228$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240729$$MD$US$US
238174603$23817460$3$F$20240101$20240725$20240505$20240805$PER$$US-SA-2024SA128055$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240805$$MD$US$US
238174622$23817462$2$F$20240101$20240626$20240505$20240705$PER$$US-SA-2024SA131335$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240705$$MD$US$US
238174682$23817468$2$F$20240101$20240812$20240505$20240827$PER$$US-SA-2024SA126570$SANOFI AVENTIS$$13$YR$T$F$Y$50.8$KG$20240827$$MD$US$US
238174713$23817471$3$F$$20240802$20240505$20240813$PER$$US-SA-2024SA127661$SANOFI AVENTIS$$$$A$F$Y$69.85$KG$20240814$$MD$US$US
238174744$23817474$4$F$20240101$20240703$20240505$20240712$PER$$US-SA-2024SA128638$SANOFI AVENTIS$$12$YR$T$F$Y$58.2$KG$20240712$$MD$US$US
238174954$23817495$4$F$20240101$20240723$20240505$20240729$EXP$$US-SA-2024SA131418$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240729$$CN$US$US
238175093$23817509$3$F$20240101$20240820$20240505$20240913$PER$$US-SA-2024SA131205$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240913$$MD$US$US
238175132$23817513$2$F$20240101$20240725$20240505$20240805$PER$$US-SA-2024SA131578$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240805$$CN$US$US
238175302$23817530$2$F$20240101$20240821$20240505$20240902$PER$$US-SA-2024SA063107$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240902$$MD$US$US
238175362$23817536$2$F$20240209$20240723$20240505$20240729$PER$$US-SA-2024SA130880$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240729$$MD$US$US
238175492$23817549$2$F$20240401$20240723$20240505$20240802$EXP$$US-ZENPEP LLC-2024AIMT00723$AIMMUNE$$$$$$Y$$$20240802$$CN$US$US
238176072$23817607$2$F$20221101$20240722$20240505$20240722$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-057072$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$90$KG$20240722$$MD$NL$NL
238176102$23817610$2$F$$20240917$20240505$20240924$PER$$US-TAKEDA-2024TUS042217$TAKEDA$$$$$F$Y$$$20240924$$PH$US$US
238176125$23817612$5$F$20240304$20240723$20240505$20240725$EXP$$IT-SANDOZ INC.-SDZ2024IT045024$SANDOZ$$66$YR$$F$Y$48$KG$20240725$$HP$IT$IT
238176172$23817617$2$F$$20240920$20240505$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069385$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$79.83$KG$20240923$$HP$US$US
238176522$23817652$2$F$20240430$20240805$20240506$20240808$PER$$US-AMGEN-USASP2024088177$AMGEN$$72$YR$E$F$Y$$$20240808$$CN$US$US
238176672$23817667$2$F$20200601$20240919$20240506$20240920$EXP$$DE-SANDOZ INC.-NVSC2021DE315854$SANDOZ$$80$YR$$M$Y$69$KG$20240920$$HP$DE$DE
238177444$23817744$4$F$20130101$20240711$20240506$20240722$EXP$$AR-NOVOPROD-1212186$NOVO NORDISK$$71$YR$$F$Y$72.8$KG$20240719$$CN$AR$AR
238177612$23817761$2$F$$20240704$20240506$20240725$PER$$CA-TOLMAR, INC.-24CA048405$TOLMAR$$$$$M$Y$$$20240725$$CN$CA$CA
238177723$23817772$3$F$20190602$20240830$20240506$20240909$EXP$$CA-HALEON-2171583$Haleon PLC$$72$YR$$M$Y$$$20240909$$MD$CA$CA
238177822$23817782$2$F$$20240808$20240506$20240812$PER$$US-AMGEN-USASP2024087914$AMGEN$$$$$F$Y$$$20240811$$MD$US$US
238177903$23817790$3$F$$20240725$20240506$20240730$EXP$$IN-ROCHE-3556592$ROCHE$$78$YR$E$M$Y$$$20240730$$CN$IN$IN
238177965$23817796$5$F$20230328$20240816$20240506$20240826$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-000568$Alvotech$$53$YR$$F$Y$65.3$KG$20240826$$CN$CA$CA
238178002$23817800$2$F$20240319$20240716$20240506$20240718$EXP$FR-AFSSAPS-RE2024000449$FR-JNJFOC-20240512317$JOHNSON AND JOHNSON$$85$YR$E$M$Y$64$KG$20240718$$MD$FR$FR
238178196$23817819$6$F$20230101$20240915$20240506$20240924$EXP$$CA-CELLTRION INC.-2023CA025283$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
238178403$23817840$3$F$20240501$20240822$20240506$20240829$PER$$US-AMGEN-USASP2024088691$AMGEN$$68$YR$E$$Y$$$20240829$$CN$US$US
238178462$23817846$2$F$$20240805$20240506$20240814$EXP$$NO-NOVOPROD-1211657$NOVO NORDISK$$41$YR$$F$Y$60$KG$20240814$$MD$NO$NO
238178502$23817850$2$F$20240501$20240719$20240506$20240722$PER$$NVSC2024US093274$NOVARTIS$$$$A$F$Y$$$20240722$$CN$US$US
238178573$23817857$3$F$20190101$20240627$20240506$20240701$EXP$$US-UCBSA-2024021299$UCB$$30$YR$$M$Y$$$20240701$$CN$US$US
238178653$23817865$3$F$$20240628$20240506$20240705$EXP$$CO-SANDOZ INC.-NVSC2022CO028780$SANDOZ$$$$$F$Y$78$KG$20240705$$CN$CO$CO
238178754$23817875$4$F$$20240830$20240506$20240909$EXP$$GB-CELLTRION INC.-2024GB008938$CELLTRION$$$$$$Y$$$20240909$$CN$GB$GB
238178922$23817892$2$F$20190326$20240731$20240506$20240813$EXP$$US-NOVOPROD-1212899$NOVO NORDISK$$72$YR$$M$Y$$$20240813$$HP$US$US
238179062$23817906$2$F$20240210$20240625$20240506$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-000725$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240719$$CN$US$US
238179433$23817943$3$F$20240420$20240725$20240506$20240726$PER$$US-AMGEN-USASP2024087224$AMGEN$$61$YR$A$F$Y$$$20240726$$CN$US$US
238179532$23817953$2$F$$20240722$20240506$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069718$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240724$$HP$US$US
238179762$23817976$2$F$$20240805$20240506$20240812$EXP$$US-APOTEX-2024AP005393$APOTEX$Singh H, Patel P, Mawari SK, Menon P.. Cyclosporine Induced Organizing Pneumonia: When the Immunosuppressant Causes Inflammation. American Journal of Respiratory and Critical Care Medicine. 2023;207(1):1-4$30$YR$$F$Y$$$20240812$$MD$US$US
238179852$23817985$2$F$20240430$20240725$20240506$20240726$PER$$US-AMGEN-USASP2024087339$AMGEN$$74$YR$E$F$Y$$$20240726$$CN$US$US
238179982$23817998$2$F$$20240626$20240506$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03546$LUPIN$$$$$$Y$$$20240712$$CN$US$US
238179993$23817999$3$F$20191101$20240904$20240506$20240911$EXP$$US-ROCHE-3268130$ROCHE$$59$YR$A$M$Y$124.74$KG$20240911$$CN$US$US
238180042$23818004$2$F$$20240709$20240506$20240710$PER$$US-ALXN-202404USA002258US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
238180052$23818005$2$F$$20240702$20240506$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03549$LUPIN$$$$$$Y$$$20240717$$CN$US$US
238180092$23818009$2$F$20240502$20240805$20240506$20240808$PER$$US-AMGEN-USASP2024088694$AMGEN$$73$YR$E$F$Y$$$20240808$$CN$US$US
238180163$23818016$3$F$$20240626$20240506$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03563$LUPIN$$$$$$Y$$$20240713$$CN$US$US
238180223$23818022$3$F$20240501$20240812$20240506$20240814$PER$$US-AMGEN-USASP2024088456$AMGEN$$62$YR$A$F$Y$$$20240813$$CN$US$US
238180232$23818023$2$F$$20240912$20240506$20240917$EXP$$US-TAKEDA-2021TUS076281$TAKEDA$$$$$F$Y$$$20240917$$CN$US$US
238180382$23818038$2$F$$20240701$20240506$20240708$PER$$US-SA-2024SA129559$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240708$$CN$US$US
238180412$23818041$2$F$20240301$20240829$20240506$20240911$PER$$US-SA-2024SA127767$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240911$$MD$US$US
238180562$23818056$2$F$$20240626$20240506$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03547$LUPIN$$$$$$Y$$$20240711$$CN$US$US
238180722$23818072$2$F$$20240712$20240506$20240722$EXP$$US-CELLTRION INC.-2024US009940$CELLTRION$$$$$$Y$$$20240722$$CN$US$US
238180903$23818090$3$F$$20240702$20240506$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03552$LUPIN$$$$$$Y$$$20240722$$CN$US$US
238181012$23818101$2$F$$20240626$20240506$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03553$LUPIN$$$$$$Y$$$20240713$$CN$US$US
238181063$23818106$3$F$20240609$20240611$20240506$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001778$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240705$$CN$US$US
238181092$23818109$2$F$$20240610$20240506$20240701$PER$$US-AstraZeneca-2024A087837$ASTRAZENECA$$$$$F$Y$$$20240701$$CN$US$
238181102$23818110$2$F$20240101$20240717$20240506$20240726$PER$$US-SA-2024SA128406$SANOFI AVENTIS$$42$YR$A$M$Y$92.98$KG$20240727$$MD$US$US
238181703$23818170$3$F$$20240719$20240506$20240729$EXP$$US-GSK-US2024AMR054590$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
238182623$23818262$3$F$20240401$20240723$20240506$20240801$PER$$US-SA-2024SA128752$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240801$$MD$US$US
238183883$23818388$3$F$20240212$20240729$20240506$20240806$EXP$$CA-CELLTRION INC.-2024CA004272$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
238184582$23818458$2$F$$20240725$20240506$20240802$EXP$$TH-ROCHE-3552315$ROCHE$$$$$$Y$$$20240803$$CN$TH$TH
238184847$23818484$7$F$$20240822$20240506$20240829$EXP$$BR-JNJFOC-20240483521$JOHNSON AND JOHNSON$$27$YR$A$M$Y$89$KG$20240829$$CN$BR$BR
238185882$23818588$2$F$20230721$20240716$20240506$20240722$PER$$US-SA-2024SA127059$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240722$$MD$US$US
238186622$23818662$2$F$$20240627$20240506$20240714$PER$$US-AstraZeneca-2024A103087$ASTRAZENECA$$$$$F$Y$$$20240714$$CN$US$
238186852$23818685$2$F$$20240702$20240506$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03312$LUPIN$$$$$$Y$$$20240718$$CN$US$US
238187276$23818727$6$F$20240424$20240723$20240506$20240803$EXP$$US-JNJFOC-20240480164$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240803$$HP$US$US
238187503$23818750$3$F$$20240626$20240506$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03548$LUPIN$$$$$$Y$$$20240712$$CN$US$US
238187972$23818797$2$F$20240101$20240816$20240506$20240823$EXP$$US-BIOGEN-2024BI01262946$BIOGEN$$75$YR$$F$Y$$$20240823$$CN$US$US
238188024$23818802$4$F$20240401$20240807$20240506$20240810$EXP$$US-SA-2024SA127655$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240810$$CN$US$US
238188154$23818815$4$F$$20240626$20240506$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03562$LUPIN$$$$$$Y$$$20240711$$CN$US$US
238188263$23818826$3$F$$20240909$20240506$20240916$EXP$$CA-GSK-CA2023043746$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$CA$CA
238188415$23818841$5$F$20230101$20240705$20240506$20240713$EXP$$CA-CELLTRION INC.-2023CA019552$CELLTRION$$$$$$Y$$$20240713$$MD$CA$CA
238188553$23818855$3$F$20240101$20240814$20240506$20240827$PER$$US-SA-2024SA127674$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240827$$MD$US$US
238188592$23818859$2$F$20240405$20240617$20240506$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001808$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240712$$CN$US$US
238188632$23818863$2$F$20240404$20240805$20240506$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069377$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240806$$HP$US$US
238188942$23818894$2$F$$20240626$20240506$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03557$LUPIN$$$$$$Y$$$20240712$$CN$US$US
238189172$23818917$2$F$20240401$20240822$20240506$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069287$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$64.86$KG$20240826$$CN$US$US
238189243$23818924$3$F$$20240626$20240506$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03555$LUPIN$$$$$$Y$$$20240712$$PH$US$US
238189443$23818944$3$F$$20240702$20240506$20240716$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-03558$LUPIN$$$$$$Y$$$20240716$$CN$US$US
238189512$23818951$2$F$20240405$20240705$20240506$20240713$EXP$$CA-CELLTRION INC.-2024CA010204$CELLTRION$$$$$$Y$$$20240713$$HP$CA$CA
238189672$23818967$2$F$$20240708$20240506$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068701$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240712$$CN$US$US
238189845$23818984$5$F$20240401$20240829$20240506$20240907$EXP$$CA-CELLTRION INC.-2024CA010223$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
238189903$23818990$3$F$20240409$20240708$20240506$20240717$PER$$US-SA-2024SA129475$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240717$$MD$US$US
238190072$23819007$2$F$$20240711$20240506$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03569$LUPIN$$$$$$Y$$$20240809$$CN$US$US
238190203$23819020$3$F$20240408$20240626$20240506$20240724$PER$$FR-TOLMAR, INC.-24FR048333$TOLMAR$$67$YR$$M$Y$$$20240724$$PH$FR$FR
238190762$23819076$2$F$$20240802$20240506$20240806$PER$$NVSC2024US087270$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
238191043$23819104$3$F$20210101$20240621$20240506$20240809$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-212601$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$49.5$KG$20240809$$CN$ES$ES
238191262$23819126$2$F$$20240805$20240506$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069465$BRISTOL MYERS SQUIBB$$37$YR$A$M$Y$$$20240805$$MD$US$US
238191323$23819132$3$F$20230101$20240725$20240506$20240805$PER$$US-SA-2024SA131806$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240805$$MD$US$US
238191364$23819136$4$F$$20240802$20240506$20240806$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-013293$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240806$$CN$CA$CA
238191372$23819137$2$F$$20240701$20240506$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069151$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240702$$CN$US$US
238191532$23819153$2$F$$20240710$20240506$20240722$EXP$$RS-ROCHE-3556776$ROCHE$$$$A$M$Y$$$20240722$$MD$RS$RS
238191823$23819182$3$F$20211230$20240903$20240506$20240906$EXP$$CA-TAKEDA-2022TUS000229$TAKEDA$$54$YR$$F$Y$$$20240906$$MD$CA$CA
238191862$23819186$2$F$$20240812$20240506$20240822$EXP$$NL-BIOCON BIOLOGICS LIMITED-BBL2024001883$BIOCON$Kreuger A.L, Jolink H, Halkes C.J.M, von dem Borne P.A, Veelken H, Lankester A.C, et al.,. Allogene stamceltransplantatie bij volwassen pati?nten met een primaire immuundefici?ntie (Allogeneic stem cell transplantation in adult patients with primary immune deficiency). Nederlands tijdschrift voor hematologie. 2024;21(2):73-79/83-94$$$$$Y$$$20240822$$MD$NL$NL
238191903$23819190$3$F$20240503$20240906$20240506$20240908$PER$$US-AMGEN-USASP2024088830$AMGEN$$65$YR$E$F$Y$$$20240908$$CN$US$US
238191962$23819196$2$F$$20240613$20240506$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001792$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
238192342$23819234$2$F$$20240712$20240506$20240716$EXP$$IN-ROCHE-3555069$ROCHE$$68$YR$E$F$Y$45$KG$20240716$$CN$IN$IN
238192412$23819241$2$F$20240502$20240819$20240506$20240822$PER$$US-AMGEN-USASP2024088840$AMGEN$$55$YR$A$F$Y$$$20240821$$CN$US$US
238192472$23819247$2$F$$20240802$20240506$20240802$EXP$$MX-BRISTOL-MYERS SQUIBB COMPANY-2024-069909$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240802$$MD$MX$MX
238192483$23819248$3$F$$20240805$20240506$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069577$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240805$$CN$US$US
238192544$23819254$4$F$$20240827$20240506$20240830$30DAY$$US-SANDOZ INC.-SDZ2024US043646$SANDOZ$$$$$M$Y$$$20240830$$CN$US$US
238192712$23819271$2$F$$20240619$20240506$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001833$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
238192732$23819273$2$F$$20240802$20240506$20240812$EXP$$US-GSK-US2024AMR056448$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$HP$US$US
238192826$23819282$6$F$20230401$20240602$20240506$20240814$EXP$$BR-SANDOZ INC.-SDZ2024BR045344$SANDOZ$$71$YR$$F$Y$65$KG$20240814$$CN$BR$BR
238192912$23819291$2$F$20240428$20240830$20240506$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068891$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240903$$CN$US$US
238193273$23819327$3$F$20240101$20240725$20240506$20240730$PER$$US-SA-2024SA128745$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240730$$MD$US$US
238193323$23819332$3$F$$20240709$20240506$20240712$EXP$$US-SANDOZ INC.-NVSC2022US079247$SANDOZ$$$$$F$Y$195.01$KG$20240712$$CN$US$US
238193382$23819338$2$F$$20240702$20240506$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03596$LUPIN$$$$$M$Y$$$20240724$$CN$US$US
238193754$23819375$4$F$20240401$20240805$20240506$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069720$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240805$$CN$US$US
238193785$23819378$5$F$20240101$20240916$20240506$20240927$EXP$$CA-UCBSA-2024010085$UCB$$$$$M$Y$$$20240927$$CN$CA$CA
238193812$23819381$2$F$$20240709$20240506$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03556$LUPIN$$$$$$Y$$$20240806$$CN$US$US
238194052$23819405$2$F$20240414$20240820$20240506$20240903$PER$$US-AstraZeneca-2024A091469$ASTRAZENECA$$20256$DY$$F$Y$$$20240903$$CN$US$
238194142$23819414$2$F$20240701$20240828$20240506$20240918$PER$$US-SA-2024SA128841$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240918$$MD$US$US
238194193$23819419$3$F$20240501$20240807$20240506$20240808$PER$$NVSC2024US092961$NOVARTIS$$60$YR$$F$Y$$$20240808$$HP$US$US
238194263$23819426$3$F$20230427$20240617$20240506$20240701$EXP$$JP-AMGEN-JPNSP2024085233$AMGEN$$72$YR$E$F$Y$63.8$KG$20240701$$MD$JP$JP
238194272$23819427$2$F$$20240701$20240506$20240710$PER$$US-SA-2024SA128870$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240710$$MD$US$US
238194333$23819433$3$F$$20240723$20240506$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069486$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240724$$HP$US$US
238194452$23819445$2$F$$20240702$20240506$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03551$LUPIN$$$$$$Y$$$20240722$$CN$US$US
238194472$23819447$2$F$20240501$20240725$20240506$20240727$PER$$US-AMGEN-USASP2024088738$AMGEN$$68$YR$E$M$Y$$$20240727$$CN$US$US
238194498$23819449$8$F$20240101$20240904$20240506$20240912$EXP$$CA-CELLTRION INC.-2024CA010219$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
238194722$23819472$2$F$$20240906$20240506$20240919$EXP$$US-AUROBINDO-AUR-APL-2024-020524$AUROBINDO$Patel S, Dalton S, Taecharvongphairoj V, Kumar A, Ashraf J, Kaur P, et al.. Acute Hypoxic Respiratory Failure and Septic Shock Secondary to Mycetoma.. Am-J-Respir-Crit-Care-Med. 2023;207:A5186$71$YR$$M$Y$$$20240919$$HP$US$US
238194932$23819493$2$F$$20240626$20240506$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03559$LUPIN$$$$$$Y$$$20240713$$CN$US$US
238195112$23819511$2$F$$20240916$20240506$20240918$EXP$$AU-MYLANLABS-2024M1040049$MYLAN$$$$$M$Y$$$20240918$$HP$AU$AU
238195323$23819532$3$F$$20240820$20240506$20240830$PER$$US-SA-2024SA131830$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240830$$MD$US$US
238195492$23819549$2$F$20240101$20240827$20240506$20240910$PER$$US-SA-2024SA132488$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240910$$MD$US$US
238195532$23819553$2$F$$20240830$20240506$20240904$EXP$$GB-MYLANLABS-2024M1040123$MYLAN$$$$$M$Y$$$20240904$$PH$GB$GB
238195542$23819554$2$F$$20240805$20240506$20240813$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP005187$STRIDES$Singh H, Patel P, Mawari SK, Menon P.. Cyclosporine Induced Organizing Pneumonia: When the Immunosuppressant Causes Inflammation.. American Journal of Respiratory and Critical Care Medicine. 2023;207(plusPoster):abstr. A3169.$30$YR$$F$Y$$$20240813$$MD$US$US
238195585$23819558$5$F$20240429$20240709$20240506$20240714$30DAY$$US-AMGEN-USASL2024086729$AMGEN$$72$YR$E$F$Y$$$20240714$$PH$US$US
238195602$23819560$2$F$$20240621$20240506$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001805$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238195612$23819561$2$F$20240628$20240628$20240506$20240705$EXP$$CA-CELLTRION INC.-2024CA010200$CELLTRION$$$$$$Y$$$20240705$$CN$CA$CA
238195655$23819565$5$F$20240401$20240802$20240506$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070088$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240802$$CN$US$US
238195682$23819568$2$F$$20240308$20240506$20240923$PER$$JP-ROCHE-3538492$ROCHE$$$$$F$Y$$$20240923$$MD$JP$JP
238195782$23819578$2$F$20240429$20240807$20240506$20240807$PER$$US-ALXN-202404USA002216US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
238196025$23819602$5$F$20240101$20240909$20240506$20240926$EXP$$US-SA-2024SA131834$SANOFI AVENTIS$$67$YR$E$M$Y$88.45$KG$20240926$$MD$US$US
238196384$23819638$4$F$$20240903$20240506$20240918$EXP$$US-GRAVITIPHARMA-GRA-2404-US-SPO-0124$GRAVITI PHARMACEUTICALS$$42$YR$A$F$Y$64$KG$20240918$$CN$US$US
238196402$23819640$2$F$20240502$20240815$20240506$20240820$PER$$US-AMGEN-USASP2024088935$AMGEN$$71$YR$E$M$Y$$$20240820$$CN$US$US
238196454$23819645$4$F$20240101$20240830$20240506$20240909$EXP$$CA-CELLTRION INC.-2024CA010207$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
238196594$23819659$4$F$$20240813$20240506$20240814$PER$$NVSC2024US094480$NOVARTIS$$$$$F$Y$$$20240814$$HP$US$US
238196735$23819673$5$F$20240405$20240829$20240506$20240910$PER$$US-Umedica-000023$UMEDICA LABS$$69$YR$$F$Y$$$20240908$$CN$US$
238197022$23819702$2$F$20240501$20240808$20240506$20240810$PER$$US-AMGEN-USASP2024088364$AMGEN$$78$YR$E$F$Y$$$20240810$$CN$US$US
238197042$23819704$2$F$$20240809$20240506$20240820$PER$$US-SA-2024SA133735$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240820$$MD$US$US
238197502$23819750$2$F$20240402$20240718$20240506$20240722$EXP$$IN-ROCHE-3556738$ROCHE$$63$YR$A$F$Y$$$20240722$$CN$IN$IN
238197593$23819759$3$F$20240426$20240814$20240506$20240827$EXP$$US-UCBSA-2024012061$UCB$$50$YR$$F$Y$54.422$KG$20240827$$HP$US$US
238197865$23819786$5$F$20240201$20240802$20240506$20240807$EXP$BG-SEATTLE GENETICS-2024SGN04664$BG-ROCHE-3555954$ROCHE$$78$YR$E$F$Y$$$20240807$$MD$BG$BG
238198046$23819804$6$F$20221201$20240702$20240506$20240726$30DAY$$US-UCBSA-2024021145$UCB$$77$YR$$F$Y$145$KG$20240726$$CN$US$US
238198202$23819820$2$F$20230101$20240625$20240506$20240701$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-008058$JAZZ$$45$YR$$M$Y$$$20240701$$MD$US$US
238198262$23819826$2$F$20231212$20240829$20240506$20240909$EXP$$US-ROCHE-3504427$ROCHE$$52$YR$A$M$Y$149.69$KG$20240909$$CN$US$US
238198342$23819834$2$F$20231101$20240715$20240506$20240722$EXP$$DE-AMGEN-DEUSP2024085766$AMGEN$$1$DY$N$M$Y$2.69$KG$20240722$$MD$DE$DE
238198882$23819888$2$F$$20240416$20240506$20240723$EXP$$US-TEVA-VS-3187724$TEVA$$$$A$F$Y$$$20240723$$MD$US$US
238198892$23819889$2$F$$20240624$20240506$20240705$EXP$$US-ROCHE-3556660$ROCHE$$75$YR$E$M$Y$$$20240706$$CN$US$US
238199182$23819918$2$F$20230101$20240723$20240506$20240731$EXP$$JP-009507513-2404JPN003781J$MERCK$$9$DEC$$M$Y$$$20240731$$MD$JP$JP
238199252$23819925$2$F$20240101$20240711$20240506$20240801$PER$$US-SA-2024SA128230$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240719$$MD$US$US
238199382$23819938$2$F$20240101$20240625$20240506$20240701$EXP$$NVSC2024DE094209$NOVARTIS$$18$YR$$M$Y$$$20240701$$MD$DE$DE
238199953$23819995$3$F$$20240709$20240506$20240710$PER$$US-ALXN-202404USA002273US$ALEXION PHARMACEUTICALS$$$$$M$Y$25.67$KG$20240710$$CN$US$US
238200143$23820014$3$F$20240703$20240711$20240506$20240802$PER$$US-Vifor (International) Inc.-VIT-2024-03500$VIFOR$$$$A$M$Y$126.1$KG$20240802$$HP$US$US
238200333$23820033$3$F$$20240815$20240506$20240820$PER$$NVSC2024US094103$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
238200364$23820036$4$F$$20240707$20240506$20240717$EXP$$GB-AMGEN-GBRNI2024089441$AMGEN$$$$$M$Y$$$20240716$$CN$GB$GB
238200792$23820079$2$F$$20240823$20240506$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069752$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$77.11$KG$20240827$$CN$US$US
238200852$23820085$2$F$20240101$20240726$20240506$20240807$PER$$US-SA-2024SA129766$SANOFI AVENTIS$$63$YR$A$M$Y$50.8$KG$20240807$$MD$US$US
238201192$23820119$2$F$20240424$20240704$20240506$20240708$EXP$$US-PFIZER INC-202400100455$PFIZER$$95$YR$$M$Y$$$20240708$$CN$US$US
238201202$23820120$2$F$20240425$20240701$20240506$20240704$EXP$$DE-UCBSA-2024021693$UCB$$38$YR$$M$Y$80$KG$20240704$$MD$DE$DE
238201443$23820144$3$F$20240426$20240709$20240506$20240710$PER$$US-ALXN-202404USA002275US$ALEXION PHARMACEUTICALS$$75$YR$$F$Y$$$20240710$$CN$US$US
238201492$23820149$2$F$20240502$20240809$20240506$20240812$PER$$US-AMGEN-USASP2024089148$AMGEN$$67$YR$E$M$Y$$$20240812$$CN$US$US
238201544$23820154$4$F$20240414$20240521$20240506$20240708$PER$$US-AstraZeneca-2024A090611$ASTRAZENECA$$25320$DY$$F$Y$$$20240708$$CN$US$
238201625$23820162$5$F$20230828$20240723$20240506$20240729$EXP$$CA-PFIZER INC-PV202300087496$PFIZER$$49$YR$$F$Y$69.5$KG$20240729$$MD$CA$CA
238201656$23820165$6$F$20240322$20240711$20240506$20240723$EXP$$CA-PFIZER INC-202400099630$PFIZER$$71$YR$$M$Y$$$20240723$$MD$CA$CA
238202042$23820204$2$F$$20240722$20240506$20240801$EXP$$US-GSK-US2024054204$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
238202252$23820225$2$F$20240601$20240715$20240506$20240722$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-025800$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240722$$HP$DE$DE
238202564$23820256$4$F$$20240919$20240506$20240923$30DAY$$US-PFIZER INC-202400097854$PFIZER$$57$YR$$M$Y$79.379$KG$20240923$$MD$US$US
238202583$23820258$3$F$$20240920$20240506$20240925$30DAY$$US-PFIZER INC-PV202400056137$PFIZER$$$$$$Y$$$20240925$$HP$US$US
238202604$23820260$4$F$$20240826$20240506$20240830$EXP$$IN-PFIZER INC-PV202400057859$PFIZER$$69$YR$$M$Y$86.6$KG$20240830$$CN$IN$IN
238202652$23820265$2$F$20240316$20240920$20240506$20240925$EXP$$GB-PFIZER INC-PV202400057929$PFIZER$$77$YR$$F$Y$$$20240925$$CN$GB$GB
238202693$23820269$3$F$20240327$20240812$20240506$20240815$EXP$FR-AFSSAPS-AN2024000565$FR-PFIZER INC-202400098200$PFIZER$$33$YR$$M$Y$84$KG$20240815$$MD$FR$FR
238202704$23820270$4$F$$20240921$20240506$20240926$30DAY$$US-PFIZER INC-202400099349$PFIZER$$12$YR$$M$Y$$$20240926$$CN$US$US
238202872$23820287$2$F$$20240630$20240506$20240701$EXP$$GB-PFIZER INC-PV202400057382$PFIZER$$$$$$Y$$$20240701$$HP$GB$GB
238202912$23820291$2$F$20240428$20240628$20240506$20240701$EXP$$CA-PFIZER INC-202400099396$PFIZER$$79$YR$$M$Y$$$20240701$$HP$CA$CA
238203047$23820304$7$F$$20240812$20240506$20240815$30DAY$$US-PFIZER INC-202400098008$PFIZER$$$$$M$Y$$$20240815$$CN$US$US
238203073$23820307$3$F$20240413$20240909$20240506$20240910$30DAY$$AR-PFIZER INC-202400099136$PFIZER$$18$YR$$M$Y$$$20240910$$HP$AR$AR
238203084$23820308$4$F$20240401$20240920$20240506$20240925$30DAY$$US-PFIZER INC-202400099373$PFIZER$$9$YR$$M$Y$$$20240925$$CN$US$US
238203097$23820309$7$F$$20240923$20240506$20240926$30DAY$$US-PFIZER INC-202400098887$PFIZER$$14$YR$$M$Y$$$20240926$$HP$US$US
238203123$23820312$3$F$$20240915$20240506$20240919$30DAY$$US-PFIZER INC-202400098799$PFIZER$$20$YR$$F$Y$68.49$KG$20240919$$CN$US$US
238203135$23820313$5$F$$20240911$20240506$20240913$30DAY$$US-PFIZER INC-202400098046$PFIZER$$11$YR$$M$Y$$$20240913$$CN$US$US
238203143$23820314$3$F$$20240830$20240506$20240903$30DAY$$US-PFIZER INC-202400097603$PFIZER$$11$YR$$F$Y$$$20240903$$HP$US$US
238203154$23820315$4$F$$20240916$20240506$20240920$30DAY$$US-PFIZER INC-202400098979$PFIZER$$10$YR$$M$Y$27.22$KG$20240920$$CN$US$US
238203165$23820316$5$F$20240426$20240919$20240506$20240924$30DAY$$US-PFIZER INC-202400097811$PFIZER$$11$YR$$F$Y$$$20240924$$CN$US$US
238203335$23820333$5$F$20240428$20240919$20240506$20240924$30DAY$$US-PFIZER INC-202400097886$PFIZER$$36$YR$$M$Y$49.9$KG$20240924$$MD$US$US
238203354$23820335$4$F$$20240919$20240506$20240924$30DAY$$GR-PFIZER INC-PV202400056989$PFIZER$$7$YR$$M$Y$16$KG$20240924$$CN$GR$GR
238203394$23820339$4$F$$20240910$20240506$20240912$30DAY$$US-PFIZER INC-202400098074$PFIZER$$12$YR$$M$Y$$$20240912$$HP$US$US
238203434$23820343$4$F$$20240712$20240506$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03560$LUPIN$$$$$$Y$$$20240808$$CN$US$US
238203552$23820355$2$F$$20240426$20240506$20240720$EXP$$DE-TEVA-VS-3192564$TEVA$$83$YR$$M$Y$$$20240720$$MD$DE$DE
238203673$23820367$3$F$20240305$20240711$20240506$20240717$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202404015713$ELI LILLY AND CO$$52$YR$A$M$Y$88$KG$20240717$$HP$GB$GB
238203783$23820378$3$F$20240409$20240715$20240506$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069958$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240722$$HP$US$US
238203982$23820398$2$F$20240101$20240813$20240506$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067166$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$76.2$KG$20240816$$CN$US$US
238204213$23820421$3$F$$20240702$20240506$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068273$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240703$$HP$US$US
238204563$23820456$3$F$20240501$20240625$20240506$20240701$PER$$US-AMGEN-USASP2024088205$AMGEN$$72$YR$E$F$Y$$$20240701$$CN$US$US
238204703$23820470$3$F$20240201$20240731$20240506$20240809$EXP$$CO-EXELIXIS-CABO-24075209$EXELIXIS$$74$YR$$M$Y$76$KG$20240809$$CN$CO$CO
238204795$23820479$5$F$20240301$20240807$20240506$20240813$EXP$$NVSC2024DE094981$NOVARTIS$$51$YR$$F$Y$$$20240813$$MD$DE$DE
238204822$23820482$2$F$$20240729$20240506$20240806$EXP$$NL-Bion-012991$BIONPHARMA$$90$YR$E$F$Y$$$20240805$$HP$NL$NL
238205193$23820519$3$F$$20240925$20240506$20240926$EXP$$ES-SANDOZ INC.-SDZ2024ES045011$SANDOZ$$60$YR$$M$Y$59$KG$20240926$$MD$ES$ES
238205332$23820533$2$F$$20240827$20240506$20240905$EXP$$DK-AUROBINDO-AUR-APL-2024-020841$AUROBINDO$Loft JA, Riis PT, Schultz NA, Bjerrum S, Schonning K, Pedersen CR, et,al. Maribavir for the treatment of cytomegalovirus infection in a liver transplant patient.. Ugeskr Laeger.. 2024;186:V11230726.$49$YR$$M$Y$$$20240905$$MD$DK$DK
238205423$23820542$3$F$20240101$20240724$20240506$20240802$PER$$US-SA-2024SA129437$SANOFI AVENTIS$$30$YR$A$M$Y$85.72$KG$20240802$$MD$US$US
238205436$23820543$6$F$20230101$20240723$20240506$20240812$EXP$$CA-UCBSA-2023057984$UCB$$$$$F$Y$$$20240812$$CN$CA$CA
238205732$23820573$2$F$20240503$20240912$20240506$20240915$PER$$US-AMGEN-USASP2024089570$AMGEN$$38$YR$A$M$Y$$$20240915$$CN$US$US
238205774$23820577$4$F$20240502$20240808$20240506$20240810$PER$$US-AMGEN-USASP2024088792$AMGEN$$68$YR$E$F$Y$$$20240810$$CN$US$US
238205802$23820580$2$F$20240401$20240702$20240506$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03333$LUPIN$$$$$$Y$$$20240719$$CN$US$US
238206152$23820615$2$F$20210901$20240711$20240506$20240718$EXP$$US-GSK-US2024054885$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$US$US
238206172$23820617$2$F$$20240812$20240506$20240816$30DAY$$US-SANDOZ INC.-SDZ2024US045006$SANDOZ$$$$$F$Y$$$20240816$$CN$US$US
238206253$23820625$3$F$20230826$20240917$20240506$20240930$EXP$$JP-ABBVIE-5743452$ABBVIE$$83$YR$$M$Y$56$KG$20240929$$MD$JP$JP
238206602$23820660$2$F$$20240916$20240506$20240919$EXP$$US-PFIZER INC-202400099860$PFIZER$$61$YR$$M$Y$$$20240919$$CN$US$US
238206693$23820669$3$F$20240401$20240731$20240506$20240805$EXP$$CA-PFIZER INC-202400101043$PFIZER$$79$YR$$F$Y$$$20240804$$HP$CA$CA
238206706$23820670$6$F$20240101$20240830$20240506$20240903$EXP$$CA-PFIZER INC-PV202400051309$PFIZER$$80$YR$$M$Y$71.8$KG$20240903$$MD$CA$CA
238206734$23820673$4$F$20240323$20240711$20240506$20240712$EXP$$US-PFIZER INC-PV202400058161$PFIZER$$83$YR$$M$Y$75.1$KG$20240712$$CN$US$US
238206755$23820675$5$F$20240101$20240725$20240506$20240730$EXP$$CA-PFIZER INC-202300287000$PFIZER$$77$YR$$M$Y$$$20240730$$MD$CA$CA
238206833$23820683$3$F$20240430$20240719$20240506$20240723$PER$$US-AMGEN-USASP2024089487$AMGEN$$77$YR$E$F$Y$$$20240723$$CN$US$US
238207182$23820718$2$F$20221201$20240625$20240506$20240702$EXP$$JP-ABBVIE-5743721$ABBVIE$$64$YR$$M$Y$67$KG$20240702$$MD$JP$JP
238207215$23820721$5$F$20210101$20240627$20240506$20240708$EXP$$JP-ABBVIE-21K-087-3903388-00$ABBVIE$$51$YR$$M$Y$74$KG$20240708$$MD$JP$JP
238207233$23820723$3$F$$20240501$20240506$20240717$PER$$US-ABBVIE-5746180$ABBVIE$$$$$M$Y$$$20240717$$MD$US$US
238207342$23820734$2$F$$20240805$20240506$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070217$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240805$$HP$US$US
238207522$23820752$2$F$20210101$20240715$20240506$20240722$EXP$$US-ABBVIE-5743434$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
238207563$23820756$3$F$20240430$20240717$20240506$20240722$PER$$US-AMGEN-USASP2024087748$AMGEN$$66$YR$E$M$Y$$$20240721$$CN$US$US
238207742$23820774$2$F$20240301$20240904$20240506$20240912$PER$$JP-Eisai-EC-2024-165067$EISAI$$$$E$M$Y$$$20240912$$MD$JP$JP
238207772$23820777$2$F$20240401$20240709$20240506$20240710$PER$$US-ALXN-202404USA002229US$ALEXION PHARMACEUTICALS$$63$YR$$F$Y$$$20240710$$CN$US$US
238208002$23820800$2$F$$20240626$20240506$20240806$PER$$US-GALDERMA-US2024006208$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
238208092$23820809$2$F$20240101$20240605$20240506$20240806$PER$$US-GALDERMA-US2024006646$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
238208762$23820876$2$F$20240430$20240710$20240506$20240710$PER$$US-BAYER-2024A065474$BAYER$$24$YR$A$F$Y$$$20240710$$HP$US$US
238208783$23820878$3$F$$20240819$20240506$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069743$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240820$$CN$US$US
238208926$23820892$6$F$20240101$20240916$20240506$20240925$EXP$$US-INSMED, INC.-2024-01768-US$INSMED$$$$$M$Y$$$20240925$$CN$US$US
238209014$23820901$4$F$$20240807$20240506$20240809$PER$$NVSC2024US094061$NOVARTIS$$$$$F$Y$$$20240809$$HP$US$US
238209083$23820908$3$F$20240426$20240718$20240506$20240726$EXP$$US-ALXN-202404USA002361US$ALEXION PHARMACEUTICALS$$59$YR$$F$Y$65.5$KG$20240726$$MD$US$US
238209253$23820925$3$F$20240101$20240805$20240506$20240813$PER$$US-SA-2024SA126950$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240814$$MD$US$US
238209442$23820944$2$F$$20240709$20240506$20240710$PER$$US-ALXN-202404USA002362US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
238209502$23820950$2$F$20230209$20240624$20240506$20240701$EXP$$CA-GSK-CA2023AMR025761$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$CA$CA
238209563$23820956$3$F$20240502$20240730$20240506$20240802$PER$$US-AMGEN-USASP2024089549$AMGEN$$69$YR$E$F$Y$$$20240802$$CN$US$US
238209903$23820990$3$F$20240209$20240708$20240506$20240715$EXP$FR-AFSSAPS-BX2024000763$FR-OTSUKA-2024_012368$OTSUKA$$33$YR$$M$Y$$$20240715$$PH$FR$FR
238209915$23820991$5$F$20221225$20240827$20240506$20240902$EXP$$US-TAKEDA-2021TUS053234$TAKEDA$$25$YR$$F$Y$68$KG$20240902$$MD$US$US
238210012$23821001$2$F$20240101$20240725$20240506$20240802$PER$$US-SA-2024SA073497$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240802$$MD$US$US
238210072$23821007$2$F$20240409$20240911$20240506$20240919$EXP$$JP-RADIUS HEALTH INC.-2024JP003018$RADIUS PHARM$$76$YR$$F$Y$$$20240919$$MD$JP$JP
238210112$23821011$2$F$20240805$20240805$20240506$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202405001697$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240807$$CN$US$US
238210152$23821015$2$F$20240415$20240822$20240506$20240827$EXP$$US-ABBVIE-5742111$ABBVIE$$36$YR$$F$Y$$$20240827$$CN$US$US
238210222$23821022$2$F$20201206$20240830$20240506$20240909$EXP$FR-AFSSAPS-RE2024000440$FR-BAYER-2024A065518$BAYER$$35$YR$A$F$Y$85$KG$20240909$$CN$FR$FR
238210503$23821050$3$F$20230714$20240819$20240506$20240828$EXP$FR-AFSSAPS-AM2024000347$FR-EMD Serono-2024023073$EMD SERONO INC$$35$YR$A$F$Y$$$20240828$$MD$FR$FR
238210612$23821061$2$F$20240501$20240627$20240506$20240701$EXP$$IE-PFIZER INC-PV202400057824$PFIZER$$$$$F$Y$$$20240701$$HP$IE$IE
238210626$23821062$6$F$20240429$20240922$20240506$20240925$30DAY$$US-PFIZER INC-202400099322$PFIZER$$16$YR$$M$Y$73.48$KG$20240925$$HP$US$US
238210647$23821064$7$F$20240422$20240619$20240506$20240705$30DAY$$US-JNJFOC-20240475303$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240705$$HP$US$US
238210703$23821070$3$F$20240430$20240925$20240506$20240926$PER$$US-AMGEN-USASP2024089569$AMGEN$$53$YR$A$F$Y$$$20240926$$CN$US$US
238210784$23821078$4$F$$20240812$20240506$20240816$30DAY$$CL-PFIZER INC-PV202400057024$PFIZER$$9$YR$$F$Y$$$20240816$$CN$CL$CL
238210797$23821079$7$F$20240401$20240916$20240506$20240919$30DAY$$KR-PFIZER INC-PV202400056809$PFIZER$$10$YR$$M$Y$$$20240919$$CN$KR$KR
238210802$23821080$2$F$$20240912$20240506$20240919$EXP$$PR-PFIZER INC-202400098479$PFIZER$$13$YR$$M$Y$$$20240919$$MD$PR$PR
238210882$23821088$2$F$20230101$20240812$20240506$20240814$EXP$$CA-UCBSA-2023009603$UCB$$$$$F$Y$$$20240814$$CN$CA$CA
238210942$23821094$2$F$20240401$20240903$20240506$20240926$PER$$US-SA-2024SA129303$SANOFI AVENTIS$$$$E$M$Y$107.95$KG$20240926$$MD$US$US
238210982$23821098$2$F$20240412$20240903$20240506$20240904$30DAY$$UY-PFIZER INC-202400087974$PFIZER$$12$YR$$F$Y$$$20240904$$CN$UY$UY
238211002$23821100$2$F$$20240909$20240506$20240911$30DAY$$US-PFIZER INC-202400099174$PFIZER$$9$YR$$F$Y$$$20240911$$CN$US$US
238211014$23821101$4$F$$20240920$20240506$20240926$30DAY$$US-PFIZER INC-202400099383$PFIZER$$8$YR$$M$Y$$$20240926$$CN$US$US
238211039$23821103$9$F$20240101$20240924$20240506$20240930$30DAY$$US-PFIZER INC-PV202400050281$PFIZER$$17$YR$$M$Y$$$20240930$$MD$US$US
238211234$23821123$4$F$$20240918$20240506$20240923$30DAY$$US-PFIZER INC-202400048350$PFIZER$$11$YR$$F$Y$$$20240923$$CN$US$US
238211249$23821124$9$F$$20240813$20240506$20240819$30DAY$$US-PFIZER INC-202400099485$PFIZER$$12$YR$$F$Y$39.909$KG$20240819$$CN$US$US
238211254$23821125$4$F$$20240911$20240506$20240918$30DAY$$US-PFIZER INC-202400099388$PFIZER$$15$YR$$M$Y$$$20240918$$CN$US$US
238211265$23821126$5$F$$20240915$20240506$20240918$30DAY$$US-PFIZER INC-202400099498$PFIZER$$11$YR$$F$Y$$$20240918$$HP$US$US
238211283$23821128$3$F$$20240910$20240506$20240913$30DAY$$US-PFIZER INC-202400098842$PFIZER$$12$YR$$F$Y$35.38$KG$20240913$$CN$US$US
238211382$23821138$2$F$$20240704$20240506$20240710$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-119506$DAIICHI$$$$$M$Y$$$20240710$$CN$US$US
238211583$23821158$3$F$20231215$20240702$20240506$20240707$EXP$$US-ABBVIE-5743141$ABBVIE$$33$YR$$F$Y$55$KG$20240707$$CN$US$US
238211652$23821165$2$F$20240411$20240510$20240506$20240731$PER$$US-BAYER-2024A065404$BAYER$$33$YR$A$F$Y$$$20240731$$HP$US$US
238211735$23821173$5$F$20240101$20240919$20240506$20240926$EXP$$US-ABBVIE-5743226$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
238211773$23821177$3$F$20240417$20240523$20240506$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067353$REGENERON$$$$$M$Y$$$20240911$$MD$US$US
238211862$23821186$2$F$20240301$20240808$20240506$20240810$EXP$$US-ABBVIE-5743474$ABBVIE$$68$YR$$F$Y$$$20240810$$CN$US$US
238212114$23821211$4$F$$20240921$20240506$20240925$30DAY$$US-PFIZER INC-202400097966$PFIZER$$10$YR$$M$Y$$$20240925$$CN$US$US
238212124$23821212$4$F$$20240915$20240506$20240919$30DAY$$US-PFIZER INC-PV202400045027$PFIZER$$12$YR$$F$Y$$$20240919$$MD$US$US
238212164$23821216$4$F$$20240915$20240506$20240916$30DAY$$US-PFIZER INC-202400099401$PFIZER$$14$YR$$M$Y$$$20240916$$CN$US$US
238212342$23821234$2$F$$20240430$20240506$20240905$PER$$US-HALEON-2172385$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
238212442$23821244$2$F$$20240827$20240506$20240830$PER$$US-PFIZER INC-202400100671$PFIZER$$64$YR$$M$Y$$$20240830$$HP$US$US
238212453$23821245$3$F$$20240911$20240506$20240913$30DAY$$US-PFIZER INC-202400098752$PFIZER$$$$$M$Y$$$20240913$$CN$US$US
238212463$23821246$3$F$$20240625$20240506$20240701$30DAY$$US-PFIZER INC-202400098756$PFIZER$$67$YR$$F$Y$$$20240701$$CN$US$US
238212554$23821255$4$F$$20240920$20240506$20240925$30DAY$$US-PFIZER INC-202400099323$PFIZER$$15$YR$$M$Y$$$20240925$$PH$US$US
238212892$23821289$2$F$$20240827$20240506$20240829$PER$$US-PFIZER INC-PV202400044856$PFIZER$$69$YR$$F$Y$$$20240829$$CN$US$US
238212902$23821290$2$F$20240101$20240715$20240506$20240717$PER$$US-PFIZER INC-PV202400057890$PFIZER$$76$YR$$F$Y$$$20240717$$HP$US$US
238212942$23821294$2$F$20231201$20240731$20240506$20240806$PER$$US-PFIZER INC-202400100168$PFIZER$$49$YR$$F$Y$$$20240806$$HP$US$US
238212992$23821299$2$F$20200101$20240925$20240506$20240926$PER$$US-PFIZER INC-PV202300165740$PFIZER$$65$YR$$F$Y$$$20240926$$HP$US$US
238213112$23821311$2$F$$20240730$20240506$20240801$PER$$US-PFIZER INC-PV202400057814$PFIZER$$53$YR$$F$Y$119.37$KG$20240801$$MD$US$US
238213164$23821316$4$F$$20240808$20240506$20240813$PER$$US-PFIZER INC-202400100195$PFIZER$$63$YR$$F$Y$$$20240813$$HP$US$US
238213182$23821318$2$F$$20240819$20240506$20240822$PER$$US-PFIZER INC-PV202400057691$PFIZER$$96$YR$$F$Y$$$20240822$$HP$US$US
238213287$23821328$7$F$20220101$20240826$20240506$20240829$EXP$$US-PFIZER INC-PV202400051401$PFIZER$$66$YR$$F$Y$$$20240829$$MD$US$US
238213372$23821337$2$F$20230101$20240724$20240506$20240725$EXP$$JP-BAYER-2024A062010$BAYER$$60$YR$A$M$Y$$$20240725$$PH$JP$JP
238213492$23821349$2$F$20240101$20240823$20240506$20240828$EXP$$DE-AMGEN-DEUSP2024086404$AMGEN$$64$YR$A$$Y$$$20240828$$PH$DE$DE
238213543$23821354$3$F$20240430$20240628$20240506$20240702$EXP$$CA-PFIZER INC-202400099266$PFIZER$$81$YR$$M$Y$$$20240702$$PH$CA$CA
238213594$23821359$4$F$20240428$20240814$20240506$20240821$PER$$NVSC2024US094925$NOVARTIS$$32$YR$$F$Y$$$20240821$$CN$US$US
238214002$23821400$2$F$20240401$20240807$20240506$20240812$EXP$$US-PFIZER INC-202400100222$PFIZER$$74$YR$$F$Y$$$20240812$$CN$US$US
238214013$23821401$3$F$$20240807$20240506$20240808$PER$$NVSC2024US094234$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
238214633$23821463$3$F$20230105$20240709$20240506$20240723$EXP$$GB-TEVA-VS-3192429$TEVA$$68$YR$$F$Y$51$KG$20240723$$HP$GB$GB
238214692$23821469$2$F$20240401$20240903$20240506$20240927$PER$$US-SA-2024SA129291$SANOFI AVENTIS$$2$YR$C$M$Y$11.52$KG$20240927$$MD$US$US
238214853$23821485$3$F$20240101$20240624$20240506$20240709$PER$$US-SA-2024SA129310$SANOFI AVENTIS$$51$YR$A$F$Y$111.57$KG$20240709$$MD$US$US
238214975$23821497$5$F$20231101$20240821$20240506$20240828$EXP$$CO-TAKEDA-2023TUS117033$TAKEDA$$61$YR$$M$Y$94$KG$20240828$$CN$CO$CO
238215313$23821531$3$F$20240101$20240708$20240506$20240717$PER$$US-SA-2024SA130558$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240717$$MD$US$US
238215502$23821550$2$F$20210407$20240701$20240506$20240704$EXP$$US-SA-2023SA320320$SANOFI AVENTIS$$55$YR$A$M$Y$85.6$KG$20240704$$HP$US$US
238215733$23821573$3$F$$20240702$20240506$20240710$EXP$$JP-009507513-2404JPN003772J$MERCK$Kadoma N, Atsumi K, Shinbu K, Nishima S, Hisakane K, Nagata K, et al.. 6. A Case of Allergic Bronchopulmonary Mycosis During Pembrolizumab Treatment. The 259th Kanto Regional Meeting of The Japanese Respiratory Society. 2024;8$85$YR$$F$Y$$$20240710$$MD$JP$JP
238216133$23821613$3$F$20240427$20240722$20240506$20240729$EXP$$JP-009507513-2404JPN003744J$MERCK$$74$YR$$F$Y$$$20240729$$MD$JP$JP
238216222$23821622$2$F$$20240426$20240506$20240730$EXP$$US-GSK-US2024AMR055136$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$HP$US$US
238216343$23821634$3$F$$20240821$20240506$20240826$EXP$$CA-PFIZER INC-202400100322$PFIZER$$56$YR$$F$Y$$$20240826$$HP$CA$CA
238216533$23821653$3$F$20240221$20240820$20240506$20240827$EXP$$NVSC2023CL161416$NOVARTIS$$58$YR$$F$Y$$$20240827$$CN$CL$CL
238216543$23821654$3$F$$20240701$20240506$20240705$30DAY$$US-PFIZER INC-PV202400056245$PFIZER$$$$$F$Y$$$20240705$$CN$US$US
238216675$23821667$5$F$$20240807$20240506$20240809$PER$$NVSC2024US094057$NOVARTIS$$$$$F$Y$$$20240809$$HP$US$US
238216804$23821680$4$F$20240420$20240820$20240506$20240821$30DAY$$CO-PFIZER INC-PV202400056945$PFIZER$$10$YR$$M$Y$$$20240821$$CN$CO$CO
238216844$23821684$4$F$20240425$20240910$20240506$20240913$30DAY$$BE-PFIZER INC-PV202400055069$PFIZER$$66$YR$$F$Y$$$20240913$$PH$BE$BE
238216933$23821693$3$F$20240502$20240723$20240506$20240726$PER$$US-AMGEN-USASP2024089195$AMGEN$$86$YR$E$F$Y$$$20240726$$CN$US$US
238217352$23821735$2$F$20230903$20240828$20240506$20240903$PER$$JP-Eisai-EC-2024-164991$EISAI$$75$YR$E$F$Y$40$KG$20240903$$MD$JP$JP
238217452$23821745$2$F$$20240701$20240506$20240703$EXP$$NVSC2024FR093953$NOVARTIS$$33$YR$$M$Y$$$20240704$$HP$FR$FR
238217632$23821763$2$F$20240426$20240625$20240506$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202404018201$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240705$$CN$US$US
238217662$23821766$2$F$$20240702$20240506$20240710$EXP$$US-ELI_LILLY_AND_COMPANY-US202404016256$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240710$$CN$US$US
238217704$23821770$4$F$20231201$20240723$20240506$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202405000094$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240802$$CN$US$US
238217732$23821773$2$F$20240420$20240724$20240506$20240805$EXP$$PL-ELI_LILLY_AND_COMPANY-PL202404016474$ELI LILLY AND CO$$38$YR$A$M$Y$130$KG$20240805$$HP$PL$PL
238217882$23821788$2$F$20240201$20240308$20240506$20240830$EXP$$GR-Accord-412318$SUNOVION$$$$$$Y$$$20240830$$HP$GR$GR
238217983$23821798$3$F$$20240909$20240506$20240912$30DAY$$CO-PFIZER INC-PV202400054554$PFIZER$$8$YR$$F$Y$$$20240912$$CN$CO$CO
238218093$23821809$3$F$$20240806$20240506$20240808$PER$$NVSC2024US094063$NOVARTIS$$$$$F$Y$$$20240808$$HP$US$US
238218112$23821811$2$F$$20240729$20240506$20240805$EXP$$US-ABBVIE-5742347$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
238218155$23821815$5$F$20240426$20240723$20240506$20240730$EXP$$US-GSK-US2024AMR055921$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240730$$CN$US$US
238218164$23821816$4$F$$20240819$20240506$20240826$EXP$$US-GSK-US2024AMR055649$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
238218323$23821832$3$F$$20240905$20240506$20240912$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-066928$BRISTOL MYERS SQUIBB$Pizzini AM, Fantoni C, Zaccaroni S, Silingardi M. Acute severe renal failure in a patient receiving apixaban: a case report. Italian Journal of Medicine. 2024;18(2):doi:10.4081/itjm.2024.1718.$74$YR$E$M$Y$$$20240912$$HP$IT$IT
2382184312$23821843$12$F$$20240918$20240506$20240928$EXP$GB-MHRA-ADR 28304985$GB-TEVA-VS-3192935$TEVA$$$$$M$Y$$$20240928$$CN$GB$GB
238218744$23821874$4$F$20240401$20240902$20240506$20240909$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202405002680$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240909$$CN$DE$MX
238218872$23821887$2$F$$20240729$20240506$20240801$EXP$$US-ABBVIE-5743324$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
238219005$23821900$5$F$$20240905$20240506$20240910$EXP$$CA-AMGEN-CANSP2024087579$AMGEN$$39$YR$A$F$Y$74$KG$20240910$$MD$CA$CA
238219062$23821906$2$F$$20240418$20240506$20240729$EXP$$CA-TEVA-2022-CA-2827235$TEVA$$83$YR$$M$Y$$$20240729$$HP$CA$CA
238219612$23821961$2$F$$20240806$20240506$20240813$EXP$$US-JNJFOC-20240479734$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240813$$MD$US$US
238219692$23821969$2$F$$20240708$20240506$20240716$PER$$US-SA-2024SA127271$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240716$$CN$US$US
238219822$23821982$2$F$20240101$20240730$20240506$20240801$PER$$US-AMGEN-USASP2024088807$AMGEN$$90$YR$E$M$Y$$$20240801$$CN$US$US
238219893$23821989$3$F$20231113$20240821$20240506$20240905$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-423711$RANBAXY$$74$YR$E$M$Y$59$KG$20240905$$MD$CN$CN
238220042$23822004$2$F$$20240718$20240506$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069894$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$67$KG$20240723$$HP$US$US
238220052$23822005$2$F$$20240805$20240506$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069415$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240805$$HP$US$US
238220143$23822014$3$F$$20240627$20240506$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST002239$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240628$$CN$US$US
238220162$23822016$2$F$20240314$20240804$20240506$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-444989$RANBAXY$$72$YR$E$M$Y$56.8$KG$20240816$$MD$CN$CN
238220282$23822028$2$F$$20240729$20240506$20240813$EXP$$SK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-444812$RANBAXY$Sedlak M, Brusikova K, Sobolova V, Kralik M. Rare presentation of BRASH syndrome with hypoglycemia and altered mental status. Int J Emerg Med. 2023;16(1):1-5$74$YR$$F$Y$$$20240813$$HP$SK$SK
238220342$23822034$2$F$20240205$20240804$20240506$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445030$RANBAXY$$75$YR$E$M$Y$60$KG$20240816$$MD$CN$CN
238220403$23822040$3$F$20240223$20240804$20240506$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-444978$RANBAXY$$78$YR$E$F$Y$50$KG$20240816$$HP$CN$CN
238221202$23822120$2$F$$20240722$20240506$20240813$PER$$US-INCYTE CORPORATION-2024IN003835$INCYTE$$$$$$Y$$$20240813$$HP$US$US
238221493$23822149$3$F$$20240624$20240506$20240701$EXP$$CA-BIOGEN-2024BI01262763$BIOGEN$$$$$F$Y$$$20240630$$HP$CA$CA
238221664$23822166$4$F$$20240813$20240506$20240816$PER$$NVSC2024US093359$NOVARTIS$$$$$F$Y$$$20240816$$HP$US$US
238221773$23822177$3$F$$20240905$20240506$20240913$30DAY$$IL-JNJFOC-20240445165$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$IL$IL
238221922$23822192$2$F$20221104$20240812$20240506$20240819$PER$$US-SA-2024SA130112$SANOFI AVENTIS$$62$YR$A$F$Y$62.5$KG$20240820$$CN$US$US
238221942$23822194$2$F$20240325$20240708$20240506$20240711$EXP$$BR-BIOGEN-2024BI01262975$BIOGEN$$58$YR$$F$Y$55$KG$20240711$$HP$BR$BR
238221972$23822197$2$F$20231201$20240910$20240506$20240916$EXP$$US-OTSUKA-2024_012566$OTSUKA$$55$YR$$M$Y$$$20240916$$HP$US$US
238222093$23822209$3$F$20240313$20240802$20240506$20240812$EXP$IT-MINISAL02-981432$IT-TEVA-VS-3192574$TEVA$$58$YR$$M$Y$$$20240812$$MD$IT$IT
238222432$23822243$2$F$20240429$20240925$20240506$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069639$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240926$$CN$US$US
238222615$23822261$5$F$20240301$20240721$20240506$20240722$PER$$US-PFIZER INC-202400098615$PFIZER$$$$$F$Y$$$20240722$$CN$US$US
238222623$23822262$3$F$$20240912$20240506$20240916$PER$$PR-PFIZER INC-202400098787$PFIZER$$9$YR$$F$Y$$$20240916$$CN$PR$PR
238222692$23822269$2$F$$20240801$20240506$20240810$EXP$$CA-TEVA-VS-3192870$TEVA$$46$YR$$F$Y$$$20240810$$PH$CA$CA
238222986$23822298$6$F$20240501$20240819$20240506$20240822$PER$$US-PFIZER INC-PV202400057465$PFIZER$$45$YR$$F$Y$$$20240822$$HP$US$US
238223102$23822310$2$F$20240502$20240729$20240506$20240731$PER$$US-AMGEN-USASP2024088706$AMGEN$$71$YR$E$M$Y$$$20240730$$HP$US$US
238223205$23822320$5$F$$20240808$20240506$20240809$30DAY$$US-PFIZER INC-202400099712$PFIZER$$$$$F$Y$$$20240809$$CN$US$US
238223242$23822324$2$F$$20240812$20240506$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068149$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240819$$CN$US$US
238223365$23822336$5$F$$20240911$20240506$20240913$30DAY$$US-PFIZER INC-202400099400$PFIZER$$61$YR$$F$Y$$$20240913$$CN$US$US
238223702$23822370$2$F$$20240827$20240506$20240828$EXP$$CA-SANDOZ INC.-SDZ2023CA065790$SANDOZ$$3$YR$$M$Y$$$20240828$$CN$CA$CA
238223722$23822372$2$F$20240401$20240716$20240506$20240719$EXP$$US-OTSUKA-2024_012300$OTSUKA$$52$YR$$F$Y$$$20240719$$CN$US$US
238223852$23822385$2$F$20240429$20240813$20240506$20240814$30DAY$$US-SANDOZ INC.-SDZ2024US045591$SANDOZ$$59$YR$$F$Y$$$20240814$$HP$US$US
238223869$23822386$9$F$20240101$20240905$20240506$20240910$EXP$$US-SANDOZ INC.-SDZ2024US045097$SANDOZ$$$$$F$Y$61.224$KG$20240910$$CN$US$US
238223982$23822398$2$F$20220201$20240506$20240506$20240812$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-157215$BOEHRINGER INGELHEIM$$92$YR$E$M$Y$$$20240812$$CN$ES$ES
238223992$23822399$2$F$20220701$20240506$20240506$20240812$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-184429$BOEHRINGER INGELHEIM$$66$YR$E$F$Y$$$20240812$$CN$ES$ES
238224046$23822404$6$F$20240101$20240722$20240506$20240729$PER$$US-PFIZER INC-202400098832$PFIZER$$74$YR$$M$Y$68.481$KG$20240729$$CN$US$US
238224076$23822407$6$F$$20240917$20240506$20240923$30DAY$$US-PFIZER INC-202400099504$PFIZER$$15$YR$$M$Y$52.16$KG$20240923$$CN$US$US
238224113$23822411$3$F$20230101$20240620$20240506$20240812$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-272793$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$78$KG$20240812$$CN$ES$ES
238224153$23822415$3$F$20230422$20240813$20240506$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US043689$SANDOZ$$60$YR$$F$Y$$$20240820$$CN$US$US
238224242$23822424$2$F$$20240807$20240506$20240810$EXP$$JP-ABBVIE-5742655$ABBVIE$$$$$$Y$$$20240810$$MD$JP$JP
238224302$23822430$2$F$$20240813$20240506$20240814$EXP$$US-SANDOZ INC.-SDZ2024US045167$SANDOZ$$$$$$Y$$$20240814$$CN$US$US
238224502$23822450$2$F$$20240805$20240506$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068858$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240805$$HP$US$US
238224802$23822480$2$F$20240306$20240306$20240506$20240722$EXP$$US-SCPHARMACEUTICALS-2024-SCPH-US000089$PAREXEL$$46$YR$$M$Y$159.67$KG$20240722$$CN$US$US
238225223$23822522$3$F$20231201$20240716$20240506$20240722$EXP$$US-JAZZ-2022-US-023659$JAZZ$$47$YR$$F$Y$$$20240722$$HP$US$US
238225402$23822540$2$F$$20240426$20240506$20240716$PER$$US-ABBVIE-5742397$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
238225465$23822546$5$F$20231001$20240905$20240506$20240905$EXP$$NVSC2024NO095190$NOVARTIS$$59$YR$$M$Y$$$20240905$$MD$NO$NO
238225804$23822580$4$F$$20240827$20240506$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068694$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240905$$CN$US$US
238225855$23822585$5$F$20240210$20240625$20240506$20240703$PER$$US-INCYTE CORPORATION-2024IN004620$INCYTE$$$$$$Y$$$20240703$$MD$US$US
238225895$23822589$5$F$$20240925$20240506$20240930$EXP$$US-SANDOZ INC.-SDZ2024US044789$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
238226562$23822656$2$F$20240315$20240916$20240506$20240920$EXP$FR-AFSSAPS-MA2024000466$FR-TEVA-VS-3192315$TEVA$$36$YR$$M$Y$$$20240920$$MD$FR$FR
238227202$23822720$2$F$20240401$20240624$20240506$20240703$EXP$$AU-CARA THERAPEUTICS, INC.-2024-00252-AU$CARA THERAPEUTICS$$69$YR$$M$Y$59$KG$20240703$$MD$AU$AU
238227222$23822722$2$F$$20240722$20240506$20240726$EXP$$US-GILEAD-2024-0671642$GILEAD$$$$A$M$Y$$$20240726$$CN$US$US
238227503$23822750$3$F$$20240701$20240506$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070302$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240702$$CN$US$US
238227565$23822756$5$F$$20240813$20240506$20240814$PER$$NVSC2024US094064$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
238227705$23822770$5$F$$20240708$20240506$20240712$EXP$$CA-AstraZeneca-2024A103220$ASTRAZENECA$$$$$F$Y$$$20240712$$HP$CA$
238228183$23822818$3$F$20231101$20240829$20240506$20240903$EXP$$US-ABBVIE-5742411$ABBVIE$$74$YR$$M$Y$83$KG$20240903$$CN$US$US
238228302$23822830$2$F$20240402$20240906$20240506$20240913$EXP$$US-ABBVIE-5743040$ABBVIE$$84$YR$$F$Y$$$20240913$$CN$US$US
238228842$23822884$2$F$20240101$20240823$20240506$20240909$EXP$$NL-ABBVIE-5745921$ABBVIE$$$$E$F$Y$$$20240909$$CN$NL$NL
238229183$23822918$3$F$$20240830$20240506$20240905$EXP$$NVSC2024US092042$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
238229522$23822952$2$F$20240101$20240716$20240506$20240722$EXP$$US-BIOGEN-2024BI01263255$BIOGEN$$$$$M$Y$$$20240722$$CN$US$US
238229753$23822975$3$F$20120101$20240906$20240506$20240914$EXP$$US-ABBVIE-5740233$ABBVIE$$51$YR$$M$Y$$$20240914$$CN$US$US
238229822$23822982$2$F$$20240801$20240506$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068525$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240801$$CN$US$US
238229852$23822985$2$F$$20240709$20240506$20240710$PER$$US-ALXN-202404USA002240US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
238229953$23822995$3$F$20191025$20240628$20240506$20240701$EXP$HR-HALMED-300085075$NVSC2024HR095192$NOVARTIS$$49$YR$$F$Y$$$20240701$$MD$HR$HR
238230073$23823007$3$F$20190917$20240711$20240506$20240718$EXP$$JP-GSK-JP2024JPN055584$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$JP$JP
238230093$23823009$3$F$$20240630$20240506$20240705$EXP$$IL-TAKEDA-2024TUS042975$TAKEDA$$$$$F$Y$$$20240705$$CN$IL$IL
238230622$23823062$2$F$20240304$20240426$20240507$20240707$PER$$US-JNJFOC-20240483798$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240708$$HP$US$US
238230772$23823077$2$F$$20240706$20240507$20240716$30DAY$$US-ABBVIE-5746451$ABBVIE$$$$$$Y$$$20240716$$CN$US$US
238231037$23823103$7$F$20240101$20240704$20240507$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-013429$UNITED THERAPEUTICS$$$$$F$Y$60.771$KG$20240710$$$US$US
238231062$23823106$2$F$$20240622$20240507$20240705$EXP$$CA-ROCHE-3553328$ROCHE$$$$A$F$Y$$$20240705$$CN$CA$CA
2382310910$23823109$10$F$20240101$20240923$20240507$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-013062$UNITED THERAPEUTICS$$$$$F$Y$108.84$KG$20240928$$$US$US
238231113$23823111$3$F$20240402$20240628$20240507$20240704$EXP$$JP-GSK-JP2024JPN055897$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$MD$JP$JP
238231123$23823112$3$F$20240101$20240812$20240507$20240814$EXP$$CA-PFIZER INC-202400038471$PFIZER$$74$YR$$M$Y$$$20240814$$HP$CA$CA
238231243$23823124$3$F$20240422$20240705$20240507$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002052$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240712$$CN$US$US
238231372$23823137$2$F$$20240807$20240507$20240807$PER$$US-ALXN-202404USA002405US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
238231422$23823142$2$F$$20240626$20240507$20240704$EXP$$CA-AMGEN-CANSP2024089445$AMGEN$$70$YR$E$F$Y$$$20240703$$CN$CA$CA
238231584$23823158$4$F$20240101$20240805$20240507$20240814$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011716$UNITED THERAPEUTICS$$$$$M$Y$83.9$KG$20240814$$$US$US
238231673$23823167$3$F$$20240705$20240507$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068395$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240711$$CN$US$US
238231682$23823168$2$F$20230601$20240920$20240507$20240926$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-248898$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240926$$CN$US$US
238231967$23823196$7$F$20230203$20240724$20240507$20240923$EXP$$US-BEH-2024171612$CSL BEHRING$$66$YR$E$F$Y$68.027$KG$20240923$$HP$US$US
238232042$23823204$2$F$20240305$20240623$20240507$20240807$EXP$GB-MYLANLABS-2024M1021509$GB-DEXPHARM-2024-1143$DEXCEL$$52$YR$A$M$Y$88$KG$20240807$$CN$GB$GB
238232202$23823220$2$F$20230801$20240626$20240507$20240708$EXP$$AR-NOVOPROD-1213215$NOVO NORDISK$$29$YR$$F$Y$70$KG$20240708$$CN$AR$AR
238232272$23823227$2$F$20240318$20240625$20240507$20240704$EXP$$US-NOVOPROD-1213550$NOVO NORDISK$$71$YR$$M$Y$$$20240704$$CN$US$US
238232372$23823237$2$F$20240301$20240813$20240507$20240823$EXP$$JP-NOVOPROD-1205181$NOVO NORDISK$$20$YR$$F$Y$116.5$KG$20240823$$MD$JP$JP
238232473$23823247$3$F$$20240717$20240507$20240828$PER$$US-LUNDBECK-DKLU3077032$LUNDBECK$$$$$$Y$$$20240828$$CN$US$US
238232693$23823269$3$F$20240101$20240626$20240507$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-011161$UNITED THERAPEUTICS$$$$$F$Y$$$20240704$$$US$US
238232723$23823272$3$F$$20240806$20240507$20240808$PER$$NVSC2024US094073$NOVARTIS$$$$$F$Y$$$20240808$$HP$US$US
238232902$23823290$2$F$$20240909$20240507$20240920$EXP$$CA-SANDOZ-SDZ2023CA055173$Haleon PLC$$82$YR$$F$Y$$$20240920$$MD$CA$CA
238232922$23823292$2$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03591$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238232973$23823297$3$F$20240502$20240815$20240507$20240820$PER$$US-AMGEN-USASP2024089780$AMGEN$$79$YR$E$F$Y$$$20240819$$CN$US$US
238232982$23823298$2$F$$20240819$20240507$20240820$PER$$NVSC2024US095776$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
238233027$23823302$7$F$20240414$20240911$20240507$20240914$EXP$$US-ABBVIE-5743438$ABBVIE$$66$YR$$F$Y$82$KG$20240914$$HP$US$US
238233082$23823308$2$F$20240401$20240609$20240507$20240702$PER$$US-AstraZeneca-2024A087582$ASTRAZENECA$$22029$DY$$M$Y$$$20240702$$CN$US$
238233152$23823315$2$F$$20240802$20240507$20240808$PER$$US-ABBVIE-5742432$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
238233213$23823321$3$F$20231101$20240705$20240507$20240708$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-276849$BOEHRINGER INGELHEIM$$57$YR$A$F$Y$$$20240708$$CN$US$US
238233382$23823338$2$F$20230128$20240906$20240507$20240910$EXP$$DE-ROCHE-3553248$ROCHE$$75$YR$E$F$Y$$$20240910$$MD$DE$DE
238233554$23823355$4$F$$20240806$20240507$20240814$PER$$NVSC2024US094054$NOVARTIS$$$$$F$Y$$$20240814$$HP$US$US
238233652$23823365$2$F$$20240702$20240507$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03593$LUPIN$$$$$$Y$$$20240722$$CN$US$US
238233742$23823374$2$F$$20240812$20240507$20240816$EXP$$CN-IPCA LABORATORIES LIMITED-IPC-2024-CN-001064$IPCA$Zihao Wanga, Tianxiang Jianga, Mingchun Mu, et.al. Small bowel intramural hematoma caused by warfarin: case report and  literature review. Scandinavian Journal of Gastroenterology. 2024;1-7$$$$$Y$$$20240816$$HP$CN$CN
238233752$23823375$2$F$$20240702$20240507$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03595$LUPIN$$$$$$Y$$$20240722$$CN$US$US
238233814$23823381$4$F$20240502$20240801$20240507$20240805$PER$$US-AMGEN-USASP2024089457$AMGEN$$79$YR$E$F$Y$$$20240805$$CN$US$US
238233862$23823386$2$F$$20240702$20240507$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03587$LUPIN$$$$$$Y$$$20240718$$CN$US$US
238234113$23823411$3$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03589$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238234134$23823413$4$F$20240502$20240905$20240507$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069464$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240911$$CN$US$US
238234144$23823414$4$F$$20240813$20240507$20240819$PER$$NVSC2024US094066$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
238234183$23823418$3$F$20240201$20240723$20240507$20240724$EXP$$BG-ROCHE-3557358$ROCHE$$78$YR$E$F$Y$$$20240724$$MD$BG$BG
238234303$23823430$3$F$$20240702$20240507$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001859$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
238234373$23823437$3$F$20240401$20240626$20240507$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001842$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240719$$CN$US$US
238234392$23823439$2$F$20240424$20240729$20240507$20240801$EXP$$GB-EMD Serono-2024023299$EMD SERONO INC$$58$YR$A$F$Y$$$20240801$$CN$GB$GB
238234532$23823453$2$F$20201015$20240809$20240507$20240815$EXP$$US-TAKEDA-US202034372$TAKEDA$$34$YR$$F$Y$$$20240815$$CN$US$US
238234553$23823455$3$F$20240225$20240809$20240507$20240812$PER$$NVSC2024US093797$NOVARTIS$$$$$F$Y$$$20240812$$HP$US$US
238234562$23823456$2$F$$20240715$20240507$20240717$PER$$NVSC2024US095846$NOVARTIS$$$$$F$Y$117$KG$20240717$$CN$US$US
238234572$23823457$2$F$$20240813$20240507$20240814$PER$$NVSC2024US093307$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
238234695$23823469$5$F$20240419$20240729$20240507$20240806$EXP$$IE-BEH-2024171875$CSL BEHRING$$52$YR$A$F$Y$90$KG$20240806$$HP$IE$IE
238234783$23823478$3$F$$20240613$20240507$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001835$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
238235015$23823501$5$F$20240101$20240806$20240507$20240811$PER$$US-AMGEN-USASP2024089472$AMGEN$$69$YR$E$F$Y$170$KG$20240811$$MD$US$US
238235192$23823519$2$F$$20240813$20240507$20240814$PER$$NVSC2024US093838$NOVARTIS$$$$$M$Y$$$20240814$$HP$US$US
238235392$23823539$2$F$$20240814$20240507$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001873$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
238235734$23823573$4$F$$20240806$20240507$20240808$PER$$NVSC2024US093385$NOVARTIS$$$$$F$Y$$$20240808$$HP$US$US
238236555$23823655$5$F$20240610$20240828$20240507$20240906$EXP$$US-ROCHE-3558775$ROCHE$$49$YR$A$F$Y$112.94$KG$20240906$$CN$US$US
238236872$23823687$2$F$20231201$20240708$20240507$20240710$EXP$$US-UCBSA-2023056635$UCB$$35$YR$$M$Y$59.41$KG$20240710$$HP$US$US
238237302$23823730$2$F$20240601$20240705$20240507$20240709$EXP$$US-UCBSA-2023057534$UCB$$74$YR$$F$Y$$$20240709$$HP$US$US
238237452$23823745$2$F$$20240705$20240507$20240705$EXP$$NVSC2024US094681$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
238238533$23823853$3$F$$20240805$20240507$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070080$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240805$$CN$US$US
238238732$23823873$2$F$20230101$20240719$20240507$20240723$EXP$$US-UCBSA-2023058705$UCB$$$$$F$Y$$$20240723$$HP$US$US
238239143$23823914$3$F$20230820$20240617$20240507$20240715$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001860$ACADIA PHARMACEUTICALS$$1$YR$$F$Y$$$20240715$$PH$US$US
238239152$23823915$2$F$$20240722$20240507$20240725$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-07567$IPSEN$$82$YR$E$F$Y$70$KG$20240725$$CN$US$US
238239304$23823930$4$F$$20240904$20240507$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-068299$BRISTOL MYERS SQUIBB$Nakamura Y. Comparison of IO-IO combination therapy and IO-TKI combination therapy in poor risk renal cell carcinoma. Urological Society. 2024.$68$YR$E$M$Y$$$20240913$$MD$JP$JP
238239813$23823981$3$F$20230101$20240809$20240507$20240823$EXP$$US-UCBSA-2023049608$UCB$$$$$F$Y$79.819$KG$20240823$$HP$US$US
238239824$23823982$4$F$20230101$20240911$20240507$20240920$EXP$$US-UCBSA-2023049533$UCB$$$$$F$Y$$$20240920$$HP$US$US
238240034$23824003$4$F$$20240806$20240507$20240808$PER$$NVSC2024US093833$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
238240042$23824004$2$F$$20240820$20240507$20240827$EXP$$US-ABBVIE-5742663$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
238240772$23824077$2$F$20170501$20240708$20240507$20240715$EXP$$BR-BIOGEN-2018BI00626393$BIOGEN$$52$YR$$F$Y$55$KG$20240715$$HP$BR$BR
238240822$23824082$2$F$$20240711$20240507$20240726$PER$$US-RISINGPHARMA-US-2024RISSPO00122$RISING PHARMACEUTICALS$$$$$M$Y$17$KG$20240726$$CN$US$US
238241355$23824135$5$F$20240128$20240826$20240507$20240902$EXP$$CA-JNJFOC-20240211053$JOHNSON AND JOHNSON$$68$YR$E$M$Y$65.77$KG$20240902$$CN$CA$CA
238241862$23824186$2$F$20240416$20240923$20240507$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070017$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240924$$HP$US$US
238241882$23824188$2$F$$20240711$20240507$20240717$EXP$$JP-ROCHE-3557244$ROCHE$Ohno S, Nakakita J, Hasumi T, et al. Clinical features and actual conditions of treatment for seven cases of TAFRO syndrome treated in our department.. The 68th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology 2024 Apr;2024:519-.$$$$$Y$$$20240717$$MD$JP$JP
238242012$23824201$2$F$20240415$20240703$20240507$20240708$EXP$$US-ABBVIE-5741991$ABBVIE$$66$YR$$F$Y$$$20240708$$CN$US$US
238242052$23824205$2$F$20240415$20240801$20240507$20240805$EXP$$US-UCBSA-2024022242$UCB$$60$YR$$M$Y$90.703$KG$20240805$$HP$US$US
238242255$23824225$5$F$20240502$20240918$20240507$20240923$PER$$US-JNJFOC-20240508219$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240923$$HP$US$US
238242372$23824237$2$F$20240222$20240725$20240507$20240807$EXP$$FR-CIPLA LTD.-2024FR04244$CIPLA$$$$$$Y$$$20240807$$MD$FR$FR
238242393$23824239$3$F$$20240812$20240507$20240819$EXP$$NVSC2024US091171$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
238242532$23824253$2$F$20240416$20240816$20240507$20240824$EXP$$PK-ROCHE-3440082$ROCHE$$54$YR$A$F$Y$$$20240824$$CN$PK$PK
238242562$23824256$2$F$20240101$20240821$20240507$20240826$EXP$$US-ABBVIE-5743024$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
238242622$23824262$2$F$20240401$20240822$20240507$20240829$PER$$US-AMGEN-USASP2024087776$AMGEN$$81$YR$E$M$Y$$$20240829$$CN$US$US
238242655$23824265$5$F$20230415$20240815$20240507$20240828$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-23-00347$MIRUM PHARMACEUTICALS$$10$YR$$M$Y$$$20240828$$MD$US$US
238242833$23824283$3$F$20240101$20240710$20240507$20240722$EXP$$CA-CELLTRION INC.-2024CA010235$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
238242934$23824293$4$F$20240501$20240716$20240507$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-013439$UNITED THERAPEUTICS$$76$YR$$M$Y$68.481$KG$20240720$$$US$US
238243014$23824301$4$F$$20240917$20240507$20240919$EXP$$CA-TAKEDA-2024TUS022263$TAKEDA$$$$$F$Y$$$20240919$$CN$CA$CA
238243063$23824306$3$F$20210101$20240918$20240507$20240927$EXP$$CA-CELLTRION INC.-2021CA013589$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
238243075$23824307$5$F$20240328$20240717$20240507$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-245802$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240719$$CN$US$US
238243272$23824327$2$F$$20240701$20240507$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070642$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240702$$HP$US$US
238243294$23824329$4$F$$20240814$20240507$20240820$EXP$$CA-TAKEDA-2024TUS040346$TAKEDA$$$$$F$Y$$$20240820$$CN$CA$CA
238243313$23824331$3$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03588$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238243412$23824341$2$F$20240419$20240905$20240507$20240909$EXP$$JP-GILEAD-2024-0670541$GILEAD$$80$YR$E$F$Y$44$KG$20240909$$PH$JP$JP
238243442$23824344$2$F$20240401$20240702$20240507$20240705$PER$$US-AMGEN-USASP2024089840$AMGEN$$71$YR$E$F$Y$$$20240704$$PH$US$US
238243462$23824346$2$F$20240502$20240807$20240507$20240809$PER$$US-AMGEN-USASP2024088901$AMGEN$$69$YR$E$M$Y$$$20240809$$CN$US$US
238243512$23824351$2$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03586$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238243594$23824359$4$F$20240102$20240812$20240507$20240819$PER$$NVSC2024US093419$NOVARTIS$$$$$M$Y$$$20240819$$HP$US$US
238243623$23824362$3$F$$20240702$20240507$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03592$LUPIN$$$$$$Y$$$20240722$$CN$US$US
238243663$23824366$3$F$$20240820$20240507$20240902$EXP$$US-UCBSA-2024021979$UCB$$$$$F$Y$$$20240902$$HP$US$US
238243793$23824379$3$F$20240502$20240724$20240507$20240730$PER$$US-AMGEN-USASP2024089537$AMGEN$$78$YR$E$M$Y$$$20240729$$CN$US$US
238243822$23824382$2$F$20240327$20240628$20240507$20240709$EXP$$JP-AMGEN-JPNSP2024088186$AMGEN$$6$DEC$A$F$Y$$$20240709$$MD$JP$JP
238243852$23824385$2$F$$20240718$20240507$20240720$PER$$NVSC2024US095835$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
238244322$23824432$2$F$$20240815$20240507$20240819$30DAY$$US-SANDOZ INC.-SDZ2024US044554$SANDOZ$$$$$$Y$$$20240819$$CN$US$US
238244342$23824434$2$F$20240429$20240816$20240507$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US045285$SANDOZ$$11$YR$$F$Y$$$20240821$$CN$US$US
238244454$23824445$4$F$20240429$20240815$20240507$20240822$EXP$$CA-CELLTRION INC.-2024CA010264$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
238244654$23824465$4$F$$20240828$20240507$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070003$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240830$$CN$US$US
238244683$23824468$3$F$20240101$20240905$20240507$20240919$EXP$$CA-UCBSA-2024005738$UCB$$$$$F$Y$$$20240919$$HP$CA$CA
238244842$23824484$2$F$20240301$20240424$20240507$20240702$PER$$US-LEO Pharma-369993$LEO PHARM$$61$YR$$F$Y$$$20240702$$PH$US$US
238245472$23824547$2$F$$20240719$20240507$20240726$EXP$$US-TAKEDA-2024TUS032836$TAKEDA$$$$$F$Y$$$20240726$$CN$US$US
238245635$23824563$5$F$20240610$20240627$20240507$20240703$EXP$$CA-TAKEDA-2024TUS041363$TAKEDA$$52$YR$$F$Y$$$20240703$$CN$CA$CA
238245736$23824573$6$F$20240101$20240718$20240507$20240724$EXP$$US-AMGEN-USASP2024086864$AMGEN$$79$YR$E$M$Y$$$20240724$$CN$US$US
238245842$23824584$2$F$20231201$20240724$20240507$20240731$EXP$$CA-GSK-CA2023169560$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$CA$CA
238246125$23824612$5$F$20200206$20240814$20240507$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070389$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$78.5$KG$20240828$$CN$US$US
238246202$23824620$2$F$20240502$20240807$20240507$20240809$PER$$US-AMGEN-USASP2024089916$AMGEN$$62$YR$A$F$Y$$$20240809$$HP$US$US
238246304$23824630$4$F$20240101$20240717$20240507$20240729$EXP$$US-INSMED, INC.-2024-01792-US$INSMED$$$$$M$Y$$$20240729$$HP$US$US
238246353$23824635$3$F$$20240805$20240507$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070463$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240805$$CN$US$US
238246392$23824639$2$F$$20240919$20240507$20240923$EXP$$JP-ASTELLAS-2024JP002839$ASTELLAS$$82$YR$E$F$Y$$$20240923$$MD$JP$JP
238246503$23824650$3$F$20240408$20240718$20240507$20240723$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-067986$REGENERON$$81$YR$$M$Y$$$20240723$$MD$JP$JP
238246582$23824658$2$F$20240101$20240625$20240507$20240702$EXP$$CA-CELLTRION INC.-2024CA006391$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
238246593$23824659$3$F$20240502$20240619$20240507$20240709$EXP$$IT-GSK-IT2024056904$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$IT$IT
238246612$23824661$2$F$20231009$20240805$20240507$20240812$EXP$$DE-VIIV HEALTHCARE LIMITED-DE2023EME167263$VIIV$$$$$$Y$$$20240812$$MD$DE$DE
238246672$23824667$2$F$20240501$20240701$20240507$20240703$PER$$US-AMGEN-USASP2024089906$AMGEN$$70$YR$E$F$Y$$$20240702$$CN$US$US
238246912$23824691$2$F$20240101$20240628$20240507$20240706$EXP$$CA-CELLTRION INC.-2024CA010390$CELLTRION$$$$$$Y$$$20240706$$CN$CA$CA
238246933$23824693$3$F$$20240710$20240507$20240720$EXP$$CA-CELLTRION INC.-2024CA010343$CELLTRION$$$$$$Y$$$20240720$$CN$CA$CA
238246943$23824694$3$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03645$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238246982$23824698$2$F$$20240730$20240507$20240806$EXP$$US-GSK-US2024AMR057016$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$US$US
238246992$23824699$2$F$20240501$20240729$20240507$20240731$PER$$US-AMGEN-USASP2024089894$AMGEN$$57$YR$A$M$Y$$$20240731$$CN$US$US
238247083$23824708$3$F$$20240822$20240507$20240828$EXP$$CA-Orion Corporation ORION PHARMA-24_00029710$ORION$$56$YR$A$F$Y$$$20240828$$HP$CA$
238247522$23824752$2$F$20240329$20240617$20240507$20240703$EXP$$US-Vifor (International) Inc.-VIT-2024-03520$VIFOR$$55$YR$$M$Y$103.5$KG$20240703$$HP$US$US
238247542$23824754$2$F$20231118$20240716$20240507$20240802$PER$$US-Vifor (International) Inc.-VIT-2024-03511$VIFOR$$25$YR$$F$Y$82.9$KG$20240802$$HP$US$US
238247686$23824768$6$F$20230901$20240822$20240507$20240829$EXP$$DE-ROCHE-3553120$ROCHE$$66$YR$E$M$Y$$$20240829$$MD$DE$DE
238247743$23824774$3$F$20240501$20240729$20240507$20240731$PER$$US-AMGEN-USASP2024087900$AMGEN$$70$YR$E$M$Y$$$20240730$$CN$US$US
238247802$23824780$2$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03620$LUPIN$$$$$$Y$$$20240724$$PH$US$US
238247904$23824790$4$F$20240422$20240905$20240507$20240910$EXP$$AR-PFIZER INC-202400092942$PFIZER$$7$YR$$F$Y$$$20240910$$CN$AR$AR
238247962$23824796$2$F$$20240828$20240507$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202405002659$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240903$$CN$US$US
238248072$23824807$2$F$$20240805$20240507$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069534$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240805$$CN$US$US
238248143$23824814$3$F$$20240628$20240507$20240708$EXP$$DE-MYLANLABS-2024M1039661$MYLAN$$46$YR$$M$Y$77$KG$20240708$$PH$DE$DE
238248212$23824821$2$F$$20240627$20240507$20240704$EXP$$FR-REGENERON PHARMACEUTICALS, INC.-2024-066485$REGENERON$$$$$$Y$$$20240704$$MD$FR$FR
238248254$23824825$4$F$$20240913$20240507$20240923$EXP$$CA-CELLTRION INC.-2024CA010344$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
238248292$23824829$2$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03643$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238248323$23824832$3$F$20240409$20240712$20240507$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-020584$AUROBINDO$$76$YR$$M$Y$60$KG$20240723$$MD$GB$GB
238248363$23824836$3$F$20240101$20240705$20240507$20240712$EXP$$US-JNJFOC-20240483891$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240712$$CN$US$US
238248463$23824846$3$F$20240516$20240718$20240507$20240725$EXP$$CA-TAKEDA-2024TUS042316$TAKEDA$$36$YR$$F$Y$$$20240725$$CN$CA$CA
238248682$23824868$2$F$20240402$20240808$20240507$20240814$EXP$CZ-CZSUKL-24001109$CZ-AMGEN-CZESP2024088330$AMGEN$$37$YR$A$F$Y$68$KG$20240813$$MD$CZ$CZ
238248972$23824897$2$F$20230929$20240621$20240507$20240705$EXP$$EU-OCTA-GAM09824$OCTAPHARMA$$76$YR$E$M$Y$79$KG$20240704$$MD$EU$EU
238249112$23824911$2$F$$20240627$20240507$20240702$EXP$$GB-AMGEN-GBRSP2024087503$AMGEN$$55$YR$A$F$Y$$$20240701$$CN$GB$GB
238249324$23824932$4$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03662$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238249385$23824938$5$F$20231001$20240918$20240507$20240920$EXP$$NO-BAUSCH-BL-2024-007153$BAUSCH AND LOMB$$59$YR$$M$Y$$$20240920$$MD$NO$NO
238249592$23824959$2$F$20240503$20240806$20240507$20240809$PER$$US-AMGEN-USASP2024089883$AMGEN$$59$YR$A$F$Y$$$20240809$$CN$US$US
238249642$23824964$2$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03646$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238249692$23824969$2$F$$20240815$20240507$20240821$EXP$$ZA-Vifor (International) Inc.-VIT-2024-03887$VIFOR$$80$YR$$F$Y$$$20240821$$HP$ZA$ZA
238249764$23824976$4$F$20240201$20240807$20240507$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069498$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240814$$CN$US$US
238249832$23824983$2$F$20230127$20240731$20240507$20240808$EXP$$DE-BAYER-2024A065625$BAYER$Fetzer K.; Forchhammer S.; Silber T.; Volc S.. A rare case of acute generalized exanthematous pustulosis induced by gadobutrol. Contact dermatitis. 2024;1-3$50$YR$A$M$Y$$$20240808$$HP$DE$DE
238249912$23824991$2$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03626$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238249984$23824998$4$F$20240401$20240613$20240507$20240712$PER$$US-AstraZeneca-2024A093230$ASTRAZENECA$$804$MON$$F$Y$$$20240712$$CN$US$
238250002$23825000$2$F$$20240703$20240507$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03622$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238250043$23825004$3$F$$20240624$20240507$20240709$EXP$$CA-GSK-CA2024AMR056631$GLAXOSMITHKLINE$$5$DEC$$F$Y$76$KG$20240709$$HP$CA$CA
238250084$23825008$4$F$$20240912$20240507$20240927$EXP$$US-TEVA-VS-3193946$TEVA$$$$$M$Y$$$20240927$$LW$US$US
238250112$23825011$2$F$$20240918$20240507$20240924$EXP$$US-009507513-2405USA001109$MERCK$Fang Y, Clarke LG, Smith BJ, Shah S. Incidence of serotonin syndrome in patients receiving tedizolid and concomitant serotonergic agents. Antimicrobial agents and chemotherapy. 2024$61$YR$$F$Y$$$20240924$$HP$US$US
238250122$23825012$2$F$$20240918$20240507$20240925$EXP$$US-009507513-2405USA001112$MERCK$Fang Y, Clarke LG, Smith BJ, Shah S. Incidence of serotonin syndrome in patients receiving tedizolid and concomitant serotonergic agents. Antimicrobial agents and chemotherapy. 2024$65$YR$$F$Y$$$20240925$$HP$US$US
238250162$23825016$2$F$$20240830$20240507$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070605$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240904$$CN$US$US
238250212$23825021$2$F$20240502$20240819$20240507$20240822$PER$$US-AMGEN-USASP2024088557$AMGEN$$65$YR$E$F$Y$$$20240822$$CN$US$US
238250224$23825022$4$F$20240501$20240812$20240507$20240815$EXP$$US-AMGEN-USASP2024088707$AMGEN$$69$YR$E$F$Y$$$20240814$$CN$US$US
238250352$23825035$2$F$$20240716$20240507$20240722$PER$$NVSC2024US095826$NOVARTIS$$72$YR$$M$Y$$$20240722$$HP$US$US
238250362$23825036$2$F$$20240501$20240507$20240807$EXP$$NVSC2024RU091498$NOVARTIS$Sultanbaev AV, Kolyadina IV, Menshikov KV, Musin ShI, Nasretdinov AF, Sultanbaeva NI et al.. Efficacy and safety of alpelisib in patients with HR+  HER2-negative metastatic breast cancer in real clinical  practice: Results of a single-center observational  retrospective study. JOURNAL OF MODERN ONCOLOGY [??????????? ?????????]. 2024;26 (1):65-72$70$YR$$F$Y$$$20240807$$HP$RU$RU
238250642$23825064$2$F$$20240729$20240507$20240806$30DAY$$US-GSK-US2024055268$GLAXOSMITHKLINE$$$$$M$Y$$$20240806$$CN$US$US
238250732$23825073$2$F$20231002$20240625$20240507$20240717$PER$$BR-TOLMAR, INC.-24BR048434$TOLMAR$$9$YR$$F$Y$$$20240717$$CN$BR$BR
238250746$23825074$6$F$$20240920$20240507$20240926$30DAY$$US-PFIZER INC-202400098877$PFIZER$$7$YR$$F$Y$21.769$KG$20240926$$CN$US$US
238250922$23825092$2$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03625$LUPIN$$$$$$Y$$$20240724$$HP$US$US
238250932$23825093$2$F$20240101$20240805$20240507$20240808$EXP$$CA-ABBVIE-5745816$ABBVIE$$70$YR$$F$Y$$$20240808$$CN$CA$CA
238251245$23825124$5$F$20231204$20240919$20240507$20240925$EXP$$SI-BAYER-2024A009773$BAYER$$76$YR$E$M$Y$$$20240925$$MD$SI$SI
238251524$23825152$4$F$20240401$20240909$20240507$20240910$30DAY$$UY-PFIZER INC-202400100075$PFIZER$$9$YR$$M$Y$$$20240910$$CN$UY$UY
238251535$23825153$5$F$$20240910$20240507$20240912$30DAY$$US-PFIZER INC-202400100477$PFIZER$$$$$M$Y$$$20240912$$CN$US$US
238251545$23825154$5$F$20240301$20240921$20240507$20240925$30DAY$$US-PFIZER INC-202400100843$PFIZER$$11$YR$$F$Y$40$KG$20240925$$HP$US$US
238251595$23825159$5$F$$20240501$20240507$20240919$EXP$$JP-PFIZER INC-PV202400058066$PFIZER$$$$$F$Y$$$20240919$$CN$JP$JP
238251615$23825161$5$F$20240501$20240913$20240507$20240918$30DAY$$GR-PFIZER INC-PV202400058421$PFIZER$$7$YR$$F$Y$20$KG$20240918$$CN$GR$GR
238251633$23825163$3$F$20240429$20240910$20240507$20240911$30DAY$$CO-PFIZER INC-PV202400058314$PFIZER$$$$$M$Y$$$20240911$$CN$CO$CO
238251664$23825166$4$F$20240501$20240828$20240507$20240830$30DAY$$US-PFIZER INC-202400099957$PFIZER$$76$YR$$F$Y$$$20240830$$CN$US$US
238251675$23825167$5$F$$20240812$20240507$20240816$30DAY$$NL-PFIZER INC-PV202400057313$PFIZER$$$$$F$Y$66$KG$20240816$$PH$NL$NL
238251812$23825181$2$F$$20240718$20240507$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070444$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$48.53$KG$20240722$$CN$US$US
238251872$23825187$2$F$$20240606$20240507$20240708$PER$$US-LUNDBECK-DKLU3076898$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
238252003$23825200$3$F$20240301$20240605$20240507$20240731$PER$$US-LUNDBECK-DKLU3076907$LUNDBECK$$$$$$Y$$$20240731$$CN$US$US
238252037$23825203$7$F$$20240923$20240507$20240926$30DAY$$PR-PFIZER INC-202400099309$PFIZER$$10$YR$$M$Y$$$20240926$$CN$PR$PR
238252074$23825207$4$F$$20240911$20240507$20240913$30DAY$$US-PFIZER INC-202400100519$PFIZER$$60$YR$$F$Y$79.38$KG$20240913$$CN$US$US
238252085$23825208$5$F$$20240912$20240507$20240920$30DAY$$US-PFIZER INC-202400100450$PFIZER$$7$YR$$M$Y$$$20240920$$CN$US$US
238252096$23825209$6$F$$20240910$20240507$20240913$30DAY$$US-PFIZER INC-202400098503$PFIZER$$61$YR$$M$Y$$$20240913$$PH$US$US
238252106$23825210$6$F$$20240920$20240507$20240925$30DAY$$US-PFIZER INC-202400100527$PFIZER$$10$YR$$M$Y$$$20240925$$MD$US$US
238252113$23825211$3$F$$20240712$20240507$20240718$EXP$$US-LUNDBECK-DKLU3076921$LUNDBECK$$$$$$Y$$$20240718$$CN$US$US
238252273$23825227$3$F$$20240708$20240507$20240717$EXP$$BE-ROCHE-3549940$ROCHE$$62$YR$A$F$Y$$$20240717$$MD$BE$BE
238252302$23825230$2$F$20240430$20240630$20240507$20240705$EXP$$RU-SA-2024SA133713$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240705$$MD$RU$RU
238252343$23825234$3$F$$20240704$20240507$20240731$EXP$$NVSC2024IE008014$NOVARTIS$$$$$F$Y$$$20240731$$PH$IE$IE
238252362$23825236$2$F$20240417$20240724$20240507$20240903$PER$$US-LUNDBECK-DKLU3076998$LUNDBECK$$$$$$Y$$$20240903$$CN$US$US
238252382$23825238$2$F$20231220$20240710$20240507$20240718$EXP$FR-AFSSAPS-PC2024000277$FR-SA-2024SA133612$SANOFI AVENTIS$$53$YR$A$F$Y$67$KG$20240718$$MD$FR$FR
238252713$23825271$3$F$$20240903$20240507$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-444909$RANBAXY$Chmieliauskaite M, Grosh MD, Syed A, Pinto A. The Patient Faints in the Waiting Area with a Suspected Hypoglycemic Event. [Review]. Dent Clin North Am. 2023;67 (4):605-607$80$YR$$F$Y$$$20240918$$HP$US$US
238253152$23825315$2$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03642$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238253412$23825341$2$F$20240409$20240702$20240507$20240723$PER$$CA-TOLMAR, INC.-24CA048362$TOLMAR$$65$YR$$M$Y$$$20240723$$CN$CA$CA
238253422$23825342$2$F$$20240829$20240507$20240918$PER$$CA-TOLMAR, INC.-24CA048364$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
238253452$23825345$2$F$20240812$20240812$20240507$20240903$PER$$CA-TOLMAR, INC.-24CA048367$TOLMAR$$75$YR$$M$Y$$$20240903$$CN$CA$CA
238253772$23825377$2$F$20231225$20240618$20240507$20240703$EXP$IT-MINISAL02-980637$IT-TEVA-VS-3191115$TEVA$$81$YR$$F$Y$$$20240703$$HP$IT$IT
238253802$23825380$2$F$20240301$20240806$20240507$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067447$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$5.41$KG$20240806$$CN$US$US
238254512$23825451$2$F$$20240717$20240507$20240718$EXP$$US-PFIZER INC-202400100241$PFIZER$$46$YR$$F$Y$$$20240718$$CN$US$US
238254652$23825465$2$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03624$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238254803$23825480$3$F$$20240629$20240507$20240701$EXP$$CA-PFIZER INC-202400099311$PFIZER$$78$YR$$F$Y$$$20240701$$HP$CA$CA
238254812$23825481$2$F$20240101$20240629$20240507$20240701$EXP$$CA-PFIZER INC-202300359026$PFIZER$$76$YR$$M$Y$79$KG$20240701$$MD$CA$CA
238255013$23825501$3$F$$20240905$20240507$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03685$LUPIN$$$$$$Y$$$20240920$$CN$US$US
238255053$23825505$3$F$$20240912$20240507$20240924$PER$$US-PFIZER INC-202400100269$PFIZER$$13$YR$$M$Y$$$20240924$$CN$US$US
238255103$23825510$3$F$20240501$20240912$20240507$20240916$PER$$US-PFIZER INC-202400099729$PFIZER$$15$YR$$M$Y$$$20240916$$CN$US$US
238255126$23825512$6$F$20240401$20240722$20240507$20240724$PER$$US-PFIZER INC-202400100925$PFIZER$$23$YR$$F$Y$61.69$KG$20240724$$CN$US$US
238255182$23825518$2$F$20240101$20240903$20240507$20240904$PER$$US-PFIZER INC-PV202400058717$PFIZER$$60$YR$$F$Y$$$20240904$$HP$US$US
238255192$23825519$2$F$$20240829$20240507$20240904$PER$$US-PFIZER INC-202400079007$PFIZER$$29$YR$$F$Y$$$20240904$$MD$US$US
238255203$23825520$3$F$$20240913$20240507$20240919$PER$$US-PFIZER INC-202400101117$PFIZER$$12$YR$$M$Y$$$20240919$$CN$US$US
238255284$23825528$4$F$$20240923$20240507$20240924$PER$$US-PFIZER INC-202400101174$PFIZER$$16$YR$$M$Y$$$20240924$$CN$US$US
238255414$23825541$4$F$20240328$20240705$20240507$20240710$EXP$$US-UNITED THERAPEUTICS-UNT-2024-003337$UNITED THERAPEUTICS$$75$YR$$M$Y$86.168$KG$20240710$$$US$US
238255775$23825577$5$F$$20240917$20240507$20240926$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-064307$BRISTOL MYERS SQUIBB$Arcadi T, Storer S, Bona F, Zanatta P, Gallo M. Lenalidomide-induced myocarditis: a rare case of cardiotoxicity. Journal of Cardiovascular Magnetic Resonance. 2024;26(Suppl 1):592-3. doi:10.1016/j.jocmr.2024.100869.$55$YR$A$F$Y$$$20240926$$MD$IT$IT
238256023$23825602$3$F$20220623$20240809$20240507$20240822$EXP$$US-UCBSA-2024020240$UCB$$35$YR$$F$Y$$$20240822$$HP$US$US
238256312$23825631$2$F$$20240724$20240507$20240726$EXP$$CA-PFIZER INC-202400047608$PFIZER$$66$YR$$F$Y$$$20240726$$HP$CA$CA
238256513$23825651$3$F$20240427$20240705$20240507$20240710$EXP$$NVSC2024US086705$NOVARTIS$$77$YR$$F$Y$$$20240710$$CN$US$US
238256532$23825653$2$F$$20240627$20240507$20240702$EXP$$CA-TAKEDA-2024TUS043310$TAKEDA$$$$$F$Y$$$20240702$$CN$CA$CA
238256605$23825660$5$F$20240101$20240918$20240507$20240923$30DAY$$US-PFIZER INC-202400100410$PFIZER$$15$YR$$M$Y$$$20240923$$CN$US$US
238256634$23825663$4$F$$20240919$20240507$20240924$30DAY$$US-PFIZER INC-202400100347$PFIZER$$14$YR$$M$Y$$$20240924$$CN$US$US
238256645$23825664$5$F$$20240921$20240507$20240923$30DAY$$US-PFIZER INC-202400099342$PFIZER$$16$YR$$M$Y$$$20240923$$CN$US$US
238256674$23825667$4$F$$20240909$20240507$20240911$30DAY$$US-PFIZER INC-202400100550$PFIZER$$15$YR$$M$Y$68.04$KG$20240911$$MD$US$US
238256762$23825676$2$F$$20240905$20240507$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070445$BRISTOL MYERS SQUIBB$$22$YR$A$M$Y$$$20240911$$HP$US$US
238256772$23825677$2$F$$20240709$20240507$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070327$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240718$$CN$US$US
238256823$23825682$3$F$20220212$20240821$20240507$20240826$EXP$$US-TAKEDA-2021TUS031317$TAKEDA$$46$YR$$F$Y$75$KG$20240826$$HP$US$US
238256902$23825690$2$F$$20240927$20240507$20240930$EXP$$CA-HALEON-2168802$Haleon PLC$$$$$F$Y$$$20240927$$HP$CA$CA
238256986$23825698$6$F$$20240812$20240507$20240815$30DAY$$US-PFIZER INC-202400097559$PFIZER$$14$YR$$F$Y$$$20240815$$CN$US$US
238257113$23825711$3$F$$20240729$20240507$20240731$EXP$$US-PFIZER INC-PV202400058758$PFIZER$$47$YR$$F$Y$$$20240731$$HP$US$US
238257144$23825714$4$F$$20240921$20240507$20240925$30DAY$$US-PFIZER INC-202400099399$PFIZER$$9$YR$$F$Y$$$20240925$$CN$US$US
238257184$23825718$4$F$19770101$20240707$20240507$20240708$EXP$$US-PFIZER INC-2021152573$PFIZER$$84$YR$$F$Y$63.946$KG$20240708$$HP$US$US
238257214$23825721$4$F$20230323$20240913$20240507$20240918$EXP$$CA-PFIZER INC-202300130654$PFIZER$$46$YR$$F$Y$$$20240918$$HP$CA$CA
238257222$23825722$2$F$20240724$20240801$20240507$20240805$EXP$$US-PFIZER INC-202400102126$PFIZER$$76$YR$$F$Y$$$20240805$$CN$US$US
238257265$23825726$5$F$$20240911$20240507$20240913$30DAY$$US-PFIZER INC-202400099590$PFIZER$$12$YR$$F$Y$$$20240913$$CN$US$US
238257286$23825728$6$F$20240416$20240802$20240507$20240806$EXP$$DK-PFIZER INC-202400101338$PFIZER$$62$YR$$M$Y$73$KG$20240806$$MD$DK$DK
238257494$23825749$4$F$20240519$20240718$20240507$20240723$EXP$$GR-VIATRISJAPAN-2024M1040515AA$MYLAN$$92$YR$$F$Y$$$20240723$$CN$GR$GR
238257623$23825762$3$F$20240101$20240722$20240507$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069234$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$68.49$KG$20240726$$CN$US$US
238257892$23825789$2$F$$20240722$20240507$20240724$EXP$$IN-ROCHE-3525426$ROCHE$$47$YR$A$M$Y$$$20240724$$MD$IN$IN
238258093$23825809$3$F$20240201$20240807$20240507$20240814$EXP$$JP-009507513-2405JPN000068J$MERCK$$71$YR$$M$Y$$$20240814$$MD$JP$JP
238258102$23825810$2$F$$20240923$20240507$20240930$PER$$US-009507513-2405USA001271$MERCK$$58$YR$$F$Y$$$20240930$$CN$US$US
238258212$23825821$2$F$$20240703$20240507$20240711$PER$$US-INCYTE CORPORATION-2024IN004606$INCYTE$$$$$$Y$$$20240711$$CN$US$US
238258313$23825831$3$F$$20240711$20240507$20240721$EXP$$GB-TEVA-VS-3193681$TEVA$$37$YR$$F$Y$$$20240721$$MD$GB$GB
238258342$23825834$2$F$20240426$20240911$20240507$20240920$EXP$$CA-JNJFOC-20240201368$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240920$$HP$CA$CA
238258542$23825854$2$F$$20240627$20240507$20240701$PER$$US-PFIZER INC-PV202400058113$PFIZER$$78$YR$$F$Y$87.1$KG$20240701$$MD$US$US
238258609$23825860$9$F$20231201$20240822$20240507$20240827$EXP$$US-PFIZER INC-202400100916$PFIZER$$23$YR$$F$Y$61.69$KG$20240827$$MD$US$US
238258663$23825866$3$F$$20240705$20240507$20240705$EXP$$BR-PFIZER INC-202400100812$PFIZER$$$$$M$Y$$$20240705$$CN$BR$BR
238258812$23825881$2$F$$20240719$20240507$20240723$PER$$US-PFIZER INC-PV202400035403$PFIZER$$35$YR$$M$Y$$$20240723$$CN$US$US
238258854$23825885$4$F$$20240916$20240507$20240920$30DAY$$US-PFIZER INC-202400100509$PFIZER$$10$YR$$F$Y$$$20240920$$CN$US$US
238258953$23825895$3$F$20240305$20240711$20240507$20240724$EXP$$GB-LABORATORIOS LICONSA S.A.-2404GB03511$INSUD PHARMA$$52$YR$$M$Y$88$KG$20240724$$CN$GB$GB
238259172$23825917$2$F$$20240730$20240507$20240801$PER$$US-PFIZER INC-PV202400058101$PFIZER$$81$YR$$F$Y$$$20240801$$HP$US$US
238259213$23825921$3$F$$20240731$20240507$20240805$PER$$US-PFIZER INC-202400100767$PFIZER$$78$YR$$M$Y$$$20240805$$CN$US$US
238259255$23825925$5$F$$20240630$20240507$20240704$PER$$US-PFIZER INC-PV202400058557$PFIZER$$80$YR$$M$Y$97.506$KG$20240704$$CN$US$US
238259293$23825929$3$F$$20240730$20240507$20240807$EXP$$CA-OTSUKA-2023_032822$OTSUKA$$$$$F$Y$$$20240807$$MD$CA$CA
238259372$23825937$2$F$20240401$20240624$20240507$20240701$EXP$$US-SA-2024SA135804$SANOFI AVENTIS$$73$YR$E$F$Y$81.64$KG$20240701$$MD$US$US
238259543$23825954$3$F$20240301$20240704$20240507$20240708$EXP$$NVSC2024DE096028$NOVARTIS$$45$YR$$F$Y$$$20240708$$MD$DE$DE
238260064$23826006$4$F$20230101$20240919$20240507$20240930$EXP$$US-UCBSA-2023060196$UCB$$$$$F$Y$88.435$KG$20240930$$HP$US$US
238260554$23826055$4$F$$20240914$20240507$20240919$30DAY$$US-PFIZER INC-202400098150$PFIZER$$12$YR$$$Y$$$20240919$$CN$US$US
238260563$23826056$3$F$$20240812$20240507$20240819$30DAY$$AT-PFIZER INC-202400100499$PFIZER$$$$$$Y$$$20240819$$CN$AT$AT
238260605$23826060$5$F$20230825$20240628$20240507$20240702$EXP$$US-PFIZER INC-202400100729$PFIZER$$22$YR$$F$Y$61.69$KG$20240702$$CN$US$US
238260672$23826067$2$F$20240411$20240725$20240507$20240802$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-06676$IPSEN$$51$YR$A$F$Y$$$20240802$$CN$US$US
238261553$23826155$3$F$20240402$20240722$20240507$20240724$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-060394$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$HP$TW$TW
238261782$23826178$2$F$20220801$20240506$20240507$20240812$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-205989$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$78$KG$20240812$$CN$ES$ES
238261862$23826186$2$F$20230601$20240718$20240507$20240801$EXP$$US-UCBSA-2024000487$UCB$$39$YR$$F$Y$55.329$KG$20240801$$HP$US$US
238261936$23826193$6$F$20240101$20240820$20240507$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03687$LUPIN$$$$$$Y$$$20240905$$CN$US$US
238262084$23826208$4$F$20240428$20240722$20240507$20240724$PER$$US-AMGEN-USASP2024088129$AMGEN$$73$YR$E$M$Y$$$20240723$$CN$US$US
238262212$23826221$2$F$20221207$20240820$20240507$20240821$EXP$$US-UCBSA-2024000744$UCB$$55$YR$$F$Y$$$20240821$$HP$US$US
238262552$23826255$2$F$20240101$20240508$20240507$20240903$PER$$US-KARYOPHARM-2024KPT000975$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
238262853$23826285$3$F$20230802$20240820$20240507$20240826$PER$$JP-Eisai-EC-2023-153985$EISAI$$54$YR$A$F$Y$60$KG$20240826$$MD$JP$JP
238263762$23826376$2$F$20240101$20240906$20240507$20240917$EXP$$US-UCBSA-2024001746$UCB$$38$YR$$F$Y$91.61$KG$20240917$$HP$US$US
238263912$23826391$2$F$20230523$20240726$20240507$20240730$EXP$$US-UCBSA-2024002826$UCB$$44$YR$$F$Y$99.501$KG$20240730$$HP$US$US
238264143$23826414$3$F$20170101$20240704$20240507$20240711$EXP$$CA-BIOMARINAP-CA-2024-157737$BIOMARIN$$$$$$Y$$$20240711$$HP$CA$CA
238264684$23826468$4$F$20240427$20240628$20240507$20240705$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404018306$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240705$$CN$JP$JP
238265433$23826543$3$F$20200304$20240913$20240507$20240923$EXP$$CA-TAKEDA-2024TUS043976$TAKEDA$$64$YR$$M$Y$$$20240923$$MD$CA$CA
238266082$23826608$2$F$20230601$20240507$20240507$20240812$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-275680$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$85$KG$20240812$$CN$ES$ES
238266113$23826611$3$F$20240401$20240829$20240507$20240911$EXP$$US-UCBSA-2024005699$UCB$$42$YR$$F$Y$$$20240911$$HP$US$US
238266482$23826648$2$F$$20240708$20240507$20240713$EXP$$US-ABBVIE-5743845$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
238266947$23826694$7$F$$20240814$20240507$20240819$EXP$$US-PFIZER INC-PV202400057909$PFIZER$$$$$$Y$$$20240819$$MD$US$US
238267043$23826704$3$F$$20240703$20240507$20240712$EXP$$US-NOVOPROD-1207297$NOVO NORDISK$$$$$F$Y$$$20240712$$CN$US$US
238267062$23826706$2$F$$20240701$20240507$20240710$EXP$$US-NOVOPROD-1188895$NOVO NORDISK$$55$YR$$F$Y$$$20240710$$CN$US$US
238267074$23826707$4$F$20230419$20240715$20240507$20240724$EXP$$NZ-NOVOPROD-1212307$NOVO NORDISK$$59$YR$$F$Y$105.2$KG$20240724$$HP$NZ$NZ
238267253$23826725$3$F$20240502$20240916$20240507$20240918$PER$$US-AMGEN-USASP2024089166$AMGEN$$72$YR$E$M$Y$$$20240918$$CN$US$US
238267262$23826726$2$F$20240117$20240808$20240507$20240821$EXP$$US-UCBSA-2024007156$UCB$$33$YR$$F$Y$52.2$KG$20240821$$HP$US$US
238267274$23826727$4$F$20231201$20240909$20240507$20240914$EXP$$JP-TAKEDA-2024TUS042593$TAKEDA$Katayama Y.. AL amyloidosis in the era of Dara-CyBorD therapy$60$YR$$M$Y$53.4$KG$20240914$$MD$JP$JP
238267362$23826736$2$F$20240821$20240821$20240507$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070847$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240904$$CN$US$US
238267742$23826774$2$F$$20240823$20240507$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070893$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240826$$HP$US$US
238267772$23826777$2$F$$20240711$20240507$20240711$PER$$US-ALXN-202405USA000060US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
238267893$23826789$3$F$20240410$20240730$20240507$20240802$PER$$US-AMGEN-USASP2024089671$AMGEN$$76$YR$E$M$Y$$$20240801$$CN$US$US
238268202$23826820$2$F$20240422$20240627$20240507$20240701$PER$$US-ALXN-202405USA000140US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240701$$MD$US$US
238268212$23826821$2$F$$20240807$20240507$20240807$PER$$US-ALXN-202404USA002383US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
238268263$23826826$3$F$20240419$20240625$20240507$20240703$EXP$$JP-TAKEDA-2024TUS043187$TAKEDA$$64$YR$$M$Y$$$20240703$$PH$JP$JP
238268375$23826837$5$F$20240401$20240715$20240507$20240717$EXP$$AR-BIOMARINAP-AR-2024-157660$BIOMARIN$$$$$$Y$$$20240717$$CN$AR$AR
238268405$23826840$5$F$$20240926$20240507$20240927$PER$$US-PFIZER INC-202400100936$PFIZER$$64$YR$$F$Y$$$20240927$$HP$US$US
238268452$23826845$2$F$20230502$20240629$20240507$20240701$EXP$$CA-PFIZER INC-202300097523$PFIZER$$20$YR$$M$Y$$$20240701$$MD$CA$CA
238268502$23826850$2$F$$20240607$20240507$20240718$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405001043$ELI LILLY AND CO$Murayama Y, et al..A case of CHD-PH Treprostinil inhalation was introduced as perinatal management.The 25th Annual Meeting of Japanese Society for Adult Congenital Heart Diseases 2024;:.$40$YR$A$F$Y$42.8$KG$20240718$$MD$JP$JP
238268533$23826853$3$F$$20240813$20240507$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070606$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240815$$HP$US$US
238268542$23826854$2$F$20240101$20240805$20240507$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069395$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240805$$HP$US$US
238268672$23826867$2$F$$20240725$20240507$20240730$PER$$US-PFIZER INC-202400101755$PFIZER$$6$YR$$F$Y$$$20240730$$CN$US$US
238268682$23826868$2$F$20240101$20240726$20240507$20240730$PER$$US-PFIZER INC-202400100411$PFIZER$$77$YR$$F$Y$$$20240730$$MD$US$US
238269144$23826914$4$F$20231229$20240717$20240507$20240723$EXP$$JP-GENMAB-2024-00989$GENMAB$$80$YR$$M$Y$48$KG$20240723$$MD$JP$JP
238269193$23826919$3$F$$20240814$20240507$20240822$EXP$$CA-JNJFOC-20240513320$JOHNSON AND JOHNSON$$71$YR$E$F$Y$69$KG$20240822$$HP$CA$CA
238269233$23826923$3$F$20200604$20240703$20240507$20240709$EXP$$DE-MYLANLABS-2021M1040823$MYLAN$$$$A$F$Y$71$KG$20240709$$HP$DE$DE
238269842$23826984$2$F$$20240805$20240507$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-070610$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$MD$JP$JP
238269883$23826988$3$F$$20240702$20240507$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03667$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238269893$23826989$3$F$20240424$20240824$20240507$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070764$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240829$$PH$US$US
238269942$23826994$2$F$20190101$20240910$20240507$20240920$PER$$US-ALKERMES INC.-ALK-2024-001190$ALKERMES$$$$$M$Y$$$20240920$$CN$US$US
238270012$23827001$2$F$20240502$20240730$20240507$20240801$PER$$US-AMGEN-USASP2024088927$AMGEN$$83$YR$E$M$Y$$$20240801$$MD$US$US
238270052$23827005$2$F$20231201$20240710$20240507$20240722$EXP$$DE-Merck Healthcare KGaA-2024023334$MERCK KGAA$$81$YR$E$F$Y$$$20240719$$CN$DE$DE
238270303$23827030$3$F$20231101$20240417$20240507$20240724$EXP$$US-APELLIS-APL-2024-003510$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240724$$MD$US$US
238270432$23827043$2$F$$20240628$20240507$20240708$EXP$$PT-SA-2024SA136202$SANOFI AVENTIS$$$$E$$Y$$$20240708$$HP$PT$PT
238271022$23827102$2$F$$20240515$20240507$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089007$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
238271072$23827107$2$F$$20240525$20240507$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089845$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
238271132$23827113$2$F$$20240503$20240507$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089934$GLENMARK$$$$$$Y$$$20240807$$HP$US$US
238271412$23827141$2$F$$20240522$20240507$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089889$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
238271822$23827182$2$F$$20240730$20240507$20240805$EXP$$US-ABBVIE-5745824$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
238271843$23827184$3$F$20240409$20240627$20240507$20240808$PER$$CA-TOLMAR, INC.-24CA048373$TOLMAR$$68$YR$$M$Y$$$20240808$$CN$CA$CA
238271923$23827192$3$F$20231101$20240801$20240507$20240806$EXP$$US-ABBVIE-5742418$ABBVIE$$70$YR$$F$Y$100$KG$20240806$$CN$US$US
238272202$23827220$2$F$$20240828$20240507$20240917$PER$$US-TEVA-VS-3186741$TEVA$$67$YR$$F$Y$$$20240917$$CN$US$US
238272538$23827253$8$F$20240301$20240812$20240507$20240815$30DAY$$US-PFIZER INC-202400099892$PFIZER$$5$YR$$M$Y$15.3$KG$20240815$$CN$US$US
238272554$23827255$4$F$$20240914$20240507$20240919$30DAY$$US-PFIZER INC-202400099510$PFIZER$$75$YR$$F$Y$$$20240919$$CN$US$US
238272572$23827257$2$F$$20240717$20240507$20240718$PER$$NVSC2024US096195$NOVARTIS$$$$$$Y$$$20240719$$MD$US$US
238272612$23827261$2$F$$20240702$20240507$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03672$LUPIN$$$$$$Y$$$20240718$$CN$US$US
238272725$23827272$5$F$$20240910$20240507$20240912$30DAY$$US-PFIZER INC-202400100800$PFIZER$$11$YR$$M$Y$$$20240912$$CN$US$US
238272832$23827283$2$F$$20240702$20240507$20240726$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03678$LUPIN$$$$$$Y$$$20240726$$CN$US$US
238272934$23827293$4$F$$20240918$20240507$20240927$EXP$$ZA-ROCHE-3552069$ROCHE$$$$A$F$Y$$$20240927$$CN$ZA$ZA
238272985$23827298$5$F$$20240922$20240507$20240925$30DAY$$US-PFIZER INC-202400101120$PFIZER$$10$YR$$M$Y$27.664$KG$20240925$$CN$US$US
238273093$23827309$3$F$20231221$20240716$20240507$20240723$EXP$$US-ABBVIE-5742637$ABBVIE$$82$YR$$F$Y$$$20240723$$CN$US$US
238273302$23827330$2$F$20240401$20240805$20240507$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071010$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240805$$CN$US$US
238273564$23827356$4$F$20240506$20240812$20240507$20240813$PER$$US-AMGEN-USASP2024090677$AMGEN$$77$YR$E$F$Y$$$20240812$$CN$US$US
238273673$23827367$3$F$20240506$20240701$20240507$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US045923$SANDOZ$$47$YR$$F$Y$$$20240703$$HP$US$US
238273834$23827383$4$F$20240422$20240805$20240507$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-070534$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$63$KG$20240805$$MD$JP$JP
238273912$23827391$2$F$$20240906$20240507$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068680$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240910$$CN$US$US
238274025$23827402$5$F$$20240808$20240507$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070692$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240810$$CN$US$US
238274163$23827416$3$F$20240201$20240729$20240507$20240802$EXP$$AR-ELI_LILLY_AND_COMPANY-AR202405003478$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240802$$CN$DE$AR
238274212$23827421$2$F$$20240628$20240507$20240701$EXP$$GB-009507513-2405GBR001444$MERCK$$$$$M$Y$$$20240701$$HP$GB$GB
238274363$23827436$3$F$20240506$20240905$20240507$20240909$PER$$US-AMGEN-USASP2024090532$AMGEN$$67$YR$E$M$Y$$$20240908$$CN$US$US
238274593$23827459$3$F$$20240620$20240507$20240716$EXP$$FR-ROCHE-3556046$ROCHE$$84$YR$E$F$Y$$$20240716$$PH$FR$FR
238274644$23827464$4$F$$20240816$20240507$20240819$PER$$NVSC2024US095827$NOVARTIS$$$$$M$Y$$$20240819$$CN$US$US
238274714$23827471$4$F$$20240627$20240507$20240701$PER$$NVSC2024US096243$NOVARTIS$$$$$M$Y$92$KG$20240701$$CN$US$US
238274815$23827481$5$F$20240420$20240628$20240507$20240710$EXP$$US-APELLIS-2024-APL-0000019$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
238274883$23827488$3$F$$20240819$20240507$20240823$EXP$$US-VERTEX PHARMACEUTICALS-2024-007495$VERTEX$$27$YR$$F$Y$$$20240823$$CN$US$US
238275232$23827523$2$F$20240505$20240731$20240507$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070926$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240802$$CN$US$US
238275492$23827549$2$F$20240504$20240815$20240507$20240820$PER$$US-AMGEN-USASP2024090145$AMGEN$$72$YR$E$F$Y$$$20240820$$CN$US$US
238275594$23827559$4$F$$20240821$20240507$20240829$EXP$$US-TAKEDA-2024TUS040598$TAKEDA$$$$$F$Y$$$20240829$$CN$US$US
238275623$23827562$3$F$$20240923$20240507$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070305$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240924$$HP$US$US
238275702$23827570$2$F$20240101$20240806$20240507$20240807$EXP$$US-TAKEDA-2024TUS042085$TAKEDA$$55$YR$$F$Y$$$20240807$$CN$US$US
238275932$23827593$2$F$20240101$20240730$20240507$20240806$EXP$$US-SA-2024SA135950$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240806$$MD$US$US
238275984$23827598$4$F$20240423$20240903$20240507$20240913$EXP$$GB-TAKEDA-2024TUS042811$TAKEDA$$61$YR$$M$Y$107$KG$20240913$$MD$GB$GB
238276152$23827615$2$F$$20240719$20240507$20240720$PER$$NVSC2024US094734$NOVARTIS$$$$$M$Y$$$20240719$$CN$US$US
238276305$23827630$5$F$$20240731$20240507$20240812$EXP$$US-APELLIS-APL-2024-004366$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240809$$MD$US$US
238276343$23827634$3$F$20240501$20240805$20240507$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-070545$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240805$$MD$JP$JP
238276483$23827648$3$F$$20240812$20240507$20240814$EXP$$CA-BAUSCH-BL-2024-007176$BAUSCH AND LOMB$$44$YR$$M$Y$$$20240814$$CN$CA$CA
238276692$23827669$2$F$20240405$20240426$20240507$20240705$EXP$$US-JNJFOC-20240483879$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240705$$HP$US$US
238276713$23827671$3$F$20230101$20240603$20240507$20240702$EXP$$US-AstraZeneca-2024A106462$ASTRAZENECA$$38$YR$$M$Y$$$20240702$$CN$US$
238276752$23827675$2$F$$20240815$20240507$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US045961$SANDOZ$$$$$M$Y$$$20240820$$CN$US$US
238276955$23827695$5$F$20240321$20240725$20240507$20240730$EXP$$GB-MYLANLABS-2024M1036395$MYLAN$$49$YR$$M$Y$$$20240730$$PH$GB$GB
238277012$23827701$2$F$$20240703$20240507$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071105$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240704$$CN$US$US
238278092$23827809$2$F$$20240903$20240507$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202405003661$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240904$$CN$US$US
238278163$23827816$3$F$20240502$20240812$20240507$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069583$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240814$$CN$US$US
238278212$23827821$2$F$20240401$20240610$20240507$20240716$PER$$US-INCYTE CORPORATION-2024IN003562$INCYTE$$$$$$Y$$$20240716$$CN$US$US
238278342$23827834$2$F$$20240808$20240507$20240813$EXP$$GB-VERTEX PHARMACEUTICALS-2024-007759$VERTEX$$$$$F$Y$$$20240813$$CN$GB$GB
238278432$23827843$2$F$20240101$20240626$20240507$20240813$PER$$US-LUNDBECK-DKLU3077271$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
238279255$23827925$5$F$$20240924$20240507$20240927$EXP$$US-TAKEDA-2024TUS035371$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
238279293$23827929$3$F$$20240813$20240507$20240819$EXP$$IT-JNJFOC-20240518900$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20240819$$MD$IT$IT
238279302$23827930$2$F$$20240709$20240507$20240710$PER$$US-ALXN-202404USA002371US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
238279312$23827931$2$F$20240430$20240807$20240507$20240807$PER$$US-ALXN-202404USA002393US$ALEXION PHARMACEUTICALS$$58$YR$$F$Y$$$20240807$$CN$US$US
238279633$23827963$3$F$20230413$20240905$20240507$20240911$EXP$$US-ABBVIE-4729875$ABBVIE$$73$YR$$M$Y$$$20240911$$HP$US$US
238279732$23827973$2$F$20240101$20240713$20240507$20240720$EXP$$GB-ABBVIE-5664105$ABBVIE$$28$YR$$F$Y$$$20240720$$CN$GB$GB
238280182$23828018$2$F$$20240826$20240507$20240829$EXP$$US-TAKEDA-2023TUS074725$TAKEDA$$$$$F$Y$90$KG$20240829$$CN$US$US
238280343$23828034$3$F$20240101$20240718$20240507$20240731$PER$$US-APOTEX-2024AP004976$APOTEX$$$$$F$Y$$$20240731$$CN$US$US
238280397$23828039$7$F$$20240912$20240507$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069281$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240916$$CN$US$US
238280512$23828051$2$F$20240420$20240827$20240507$20240829$PER$$US-JNJFOC-20240466477$JOHNSON AND JOHNSON$$51$YR$A$M$Y$104.42$KG$20240829$$CN$US$US
238280572$23828057$2$F$20230101$20240708$20240507$20240713$EXP$$US-ABBVIE-5604299$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
238280664$23828066$4$F$20230101$20240708$20240507$20240715$EXP$$US-ABBVIE-5747283$ABBVIE$$$$$F$Y$63$KG$20240715$$CN$US$US
238280735$23828073$5$F$20230226$20240917$20240507$20240920$EXP$$NVSJ2023JP003889$NOVARTIS$$$$A$M$Y$$$20240920$$CN$JP$JP
238280814$23828081$4$F$20240401$20240805$20240507$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070740$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240805$$CN$US$US
238280872$23828087$2$F$20240401$20240729$20240507$20240801$EXP$$US-ABBVIE-5747600$ABBVIE$$58$YR$$F$Y$$$20240801$$CN$US$US
238280885$23828088$5$F$20240422$20240724$20240507$20240801$EXP$$KR-ABBVIE-5742317$ABBVIE$$75$YR$$M$Y$74$KG$20240801$$MD$KR$KR
238281054$23828105$4$F$20240501$20240828$20240507$20240902$PER$$US-AMGEN-USASP2024088858$AMGEN$$59$YR$A$F$Y$$$20240902$$CN$US$US
238281163$23828116$3$F$$20240725$20240507$20240730$EXP$$US-ABBVIE-5708160$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
238281395$23828139$5$F$20240503$20240718$20240507$20240722$EXP$$FR-ABBVIE-5748963$ABBVIE$$60$YR$$M$Y$88$KG$20240722$$MD$FR$FR
238281424$23828142$4$F$20240418$20240814$20240507$20240820$EXP$$MX-TAKEDA-2023TUS017574$TAKEDA$$9$YR$$M$Y$$$20240820$$CN$MX$MX
238281444$23828144$4$F$20240101$20240723$20240507$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069956$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240730$$CN$US$US
238281462$23828146$2$F$$20240806$20240507$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071059$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240806$$HP$US$US
238281513$23828151$3$F$$20240904$20240507$20240906$EXP$$US-TAKEDA-2024TUS025293$TAKEDA$$$$$M$Y$$$20240906$$CN$US$US
238281863$23828186$3$F$$20240813$20240508$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US045361$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
238281983$23828198$3$F$$20240703$20240508$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069539$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$93.44$KG$20240704$$CN$US$US
238282012$23828201$2$F$20240101$20240815$20240508$20240820$EXP$$US-ABBVIE-5747120$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
238282054$23828205$4$F$$20240627$20240508$20240701$EXP$$CA-ABBVIE-5747058$ABBVIE$$72$YR$$F$Y$$$20240701$$HP$CA$CA
238282522$23828252$2$F$$20240814$20240508$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US045957$SANDOZ$$$$$M$Y$$$20240820$$CN$US$US
238282592$23828259$2$F$20240403$20240729$20240508$20240806$EXP$$JP-GENMAB-2024-01469$GENMAB$$78$YR$$F$Y$48.8$KG$20240806$$MD$JP$JP
238282605$23828260$5$F$20240429$20240624$20240508$20240702$EXP$$US-JNJFOC-20240503260$JOHNSON AND JOHNSON$$73$YR$E$M$Y$99.426$KG$20240703$$CN$US$US
238282652$23828265$2$F$$20240910$20240508$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068948$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240912$$CN$US$US
238282702$23828270$2$F$20240424$20240708$20240508$20240710$PER$$US-AMGEN-USASP2024090502$AMGEN$$67$YR$E$M$Y$$$20240709$$CN$US$US
238282712$23828271$2$F$$20240719$20240508$20240722$PER$$NVSC2024US094494$NOVARTIS$$$$$F$Y$$$20240722$$MD$US$US
238282852$23828285$2$F$20240101$20240801$20240508$20240805$EXP$$US-ABBVIE-5734414$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
238283232$23828323$2$F$$20240803$20240508$20240807$PER$$NVSC2024US096543$NOVARTIS$$$$$$Y$$$20240807$$CN$US$US
238283242$23828324$2$F$$20240719$20240508$20240726$EXP$$US-GSK-US2024056392$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
238283354$23828335$4$F$20240418$20240627$20240508$20240703$EXP$$US-JNJFOC-20240470058$JOHNSON AND JOHNSON$$71$YR$E$F$Y$56.568$KG$20240704$$PH$US$US
238283372$23828337$2$F$20240101$20240702$20240508$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070490$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240709$$CN$US$US
238283574$23828357$4$F$$20240708$20240508$20240717$EXP$$CA-CELLTRION INC.-2024CA010104$CELLTRION$$$$$$Y$$$20240717$$CN$CA$CA
238283912$23828391$2$F$20240501$20240730$20240508$20240809$EXP$$US-NOVOPROD-1214755$NOVO NORDISK$$75$YR$$F$Y$$$20240809$$CN$US$US
238283942$23828394$2$F$20210906$20240907$20240508$20240918$EXP$$JP-NOVOPROD-1213997$NOVO NORDISK$$53$YR$$F$Y$114$KG$20240918$$MD$JP$JP
238284243$23828424$3$F$20240426$20240718$20240508$20240725$EXP$$US-GSK-US2024055814$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$US$US
238284312$23828431$2$F$$20240806$20240508$20240806$PER$$US-JNJFOC-20240488170$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$CN$US$US
238284703$23828470$3$F$20210128$20240726$20240508$20240802$EXP$$US-GSK-US2024055811$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$US$US
238284734$23828473$4$F$20240115$20240813$20240508$20240814$PER$$NVSC2024US093387$NOVARTIS$$$$$F$Y$$$20240814$$HP$US$US
238284766$23828476$6$F$20240503$20240705$20240508$20240708$PER$$US-AMGEN-USASP2024090690$AMGEN$$69$YR$E$F$Y$$$20240707$$CN$US$US
238284882$23828488$2$F$20240412$20240731$20240508$20240826$PER$$CA-TOLMAR, INC.-24CA048486$TOLMAR$$72$YR$$M$Y$$$20240826$$CN$CA$CA
238285113$23828511$3$F$$20240726$20240508$20240801$PER$$US-ABBVIE-5749751$ABBVIE$$$$$$Y$$$20240801$$MD$US$US
238285252$23828525$2$F$$20240715$20240508$20240716$EXP$$IN-ROCHE-3558782$ROCHE$$51$YR$A$F$Y$$$20240716$$MD$IN$IN
238285672$23828567$2$F$20240915$20240916$20240508$20240923$EXP$$CO-GSK-CO2023AMR125220$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$CO$CO
238285752$23828575$2$F$20240409$20240522$20240508$20240802$PER$$US-MankindUS-000162$MANKIND PHARMA$$80$YR$E$M$Y$65.77$KG$20240802$$CN$US$US
238285774$23828577$4$F$20230801$20240712$20240508$20240719$EXP$$CO-GSK-CO2023AMR140545$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$PH$CO$CO
238285882$23828588$2$F$$20230508$20240508$20240821$PER$$US-JNJFOC-20240516670$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$CN$US$US
238285903$23828590$3$F$$20240702$20240508$20240726$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03679$LUPIN$$$$$$Y$$$20240726$$CN$US$US
238286125$23828612$5$F$$20240910$20240508$20240916$EXP$$CA-JNJFOC-20240508278$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240916$$HP$CA$CA
238286173$23828617$3$F$$20240805$20240508$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069426$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240805$$CN$US$US
238286242$23828624$2$F$20240506$20240720$20240508$20240723$PER$$US-AMGEN-USASP2024090428$AMGEN$$59$YR$A$F$Y$$$20240723$$CN$US$US
238286272$23828627$2$F$20240501$20240725$20240508$20240729$PER$$US-AMGEN-USASP2024091039$AMGEN$$57$YR$A$F$Y$$$20240728$$CN$US$US
238286393$23828639$3$F$$20240708$20240508$20240925$PER$$US-GSK-US2024AMR056966$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
238286626$23828662$6$F$20240101$20240827$20240508$20240905$EXP$$CA-CELLTRION INC.-2024CA006449$CELLTRION$$$$$$Y$$$20240905$$CN$CA$CA
238286742$23828674$2$F$$20240715$20240508$20240724$EXP$$CA-HALEON-2171152$Haleon PLC$$43$YR$$F$Y$68$KG$20240724$$HP$CA$CA
238286873$23828687$3$F$$20240808$20240508$20240819$EXP$$CA-ORGANON-O2405CAN000130$ORGANON$$$$$F$Y$$$20240819$$HP$CA$CA
238286883$23828688$3$F$$20240524$20240508$20240712$EXP$$CA-SA-2019SA096117$Haleon PLC$$61$YR$$F$Y$70$KG$20240711$$CN$CA$CA
238286903$23828690$3$F$20240401$20240903$20240508$20240911$EXP$$CA-CELLTRION INC.-2024CA003262$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
238286943$23828694$3$F$$20240827$20240508$20240829$EXP$$US-TAKEDA-2024TUS044049$TAKEDA$$$$$M$Y$$$20240829$$HP$US$US
238287182$23828718$2$F$$20240807$20240508$20240814$PER$$US-RDY-SPO/USA/24/0006461$DR REDDYS$$24$YR$A$F$Y$$$20240814$$CN$US$US
238287212$23828721$2$F$20240401$20240709$20240508$20240718$PER$$US-RDY-SPO/USA/24/0006645$DR REDDYS$$75$YR$A$F$Y$$$20240718$$CN$US$US
238287273$23828727$3$F$20230731$20240628$20240508$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202404011311$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$US$US
238287933$23828793$3$F$20240420$20240620$20240508$20240807$PER$$US-AstraZeneca-2024A095902$ASTRAZENECA$$26067$DY$$F$Y$$$20240807$$CN$US$
238289572$23828957$2$F$$20240701$20240508$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-052689$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240703$$CN$US$US
238290133$23829013$3$F$20240325$20240619$20240508$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-067879$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$$$20240702$$PH$JP$JP
238291014$23829101$4$F$20240101$20240819$20240508$20240826$EXP$$CA-CELLTRION INC.-2024CA007439$CELLTRION$$$$$$Y$$$20240826$$MD$CA$CA
238291232$23829123$2$F$$20240805$20240508$20240809$PER$$NVSC2024US092271$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
238291332$23829133$2$F$20221001$20240729$20240508$20240801$EXP$$DE-ROCHE-3555278$ROCHE$$53$YR$A$F$Y$55$KG$20240801$$MD$DE$DE
238291532$23829153$2$F$20240101$20240917$20240508$20240927$PER$$US-GSK-US2024054697$GLAXOSMITHKLINE$$91$YR$$F$Y$$$20240927$$CN$US$US
238292003$23829200$3$F$$20240809$20240508$20240827$PER$$US-APOTEX-2024AP005114$APOTEX$$$$$M$Y$$$20240827$$CN$US$US
238292012$23829201$2$F$20240505$20240802$20240508$20240806$PER$$US-AMGEN-USASP2024090952$AMGEN$$84$YR$E$F$Y$$$20240806$$CN$US$US
238292062$23829206$2$F$20240429$20240722$20240508$20240724$EXP$$US-ABBVIE-5747777$ABBVIE$$78$YR$$F$Y$68$KG$20240724$$CN$US$US
238292504$23829250$4$F$$20240826$20240508$20240828$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-071131$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$58.06$KG$20240828$$CN$PR$PR
238292612$23829261$2$F$20240101$20240911$20240508$20240923$EXP$$US-UCBSA-2024010563$UCB$$$$$F$Y$81.646$KG$20240923$$HP$US$US
238292772$23829277$2$F$$20240801$20240508$20240805$EXP$$US-UCBSA-2024011125$UCB$$$$$F$Y$$$20240805$$HP$US$US
238292852$23829285$2$F$$20240813$20240508$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-021208$AUROBINDO$$27$YR$$M$Y$$$20240826$$HP$CA$CA
238292973$23829297$3$F$20240101$20240919$20240508$20240927$EXP$$US-UCBSA-2024011019$UCB$$$$$F$Y$$$20240927$$CN$US$US
238293412$23829341$2$F$20240501$20240726$20240508$20240730$PER$$US-AMGEN-USASP2024088534$AMGEN$$65$YR$E$F$Y$$$20240729$$CN$US$US
238293623$23829362$3$F$$20240708$20240508$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069709$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240712$$HP$US$US
238293783$23829378$3$F$20231201$20240607$20240508$20240701$PER$$US-JNJFOC-20240441876$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240701$$CN$US$US
238293984$23829398$4$F$$20240820$20240508$20240822$EXP$$NVSC2024US095749$NOVARTIS$$$$$$Y$$$20240822$$MD$US$US
238294092$23829409$2$F$$20240711$20240508$20240711$EXP$$US-ALXN-202405USA000032US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240711$$MD$US$US
238294153$23829415$3$F$20240418$20240805$20240508$20240819$EXP$$BE-JNJFOC-20240512194$JOHNSON AND JOHNSON$$$$E$F$Y$45$KG$20240819$$HP$BE$BE
238294212$23829421$2$F$20230811$20240710$20240508$20240717$EXP$$US-TAKEDA-2023TUS071652$TAKEDA$$15$YR$$M$Y$95.71$KG$20240717$$CN$US$US
238294224$23829422$4$F$20240101$20240924$20240508$20240924$EXP$$US-UCBSA-2024020269$UCB$$$$$F$Y$214$KG$20240924$$HP$US$US
238294232$23829423$2$F$20240506$20240725$20240508$20240727$PER$$US-AMGEN-USASP2024090430$AMGEN$$79$YR$E$$Y$$$20240727$$CN$US$US
238294243$23829424$3$F$20210101$20240805$20240508$20240811$EXP$$PL-AMGEN-POLSP2024087047$AMGEN$$16$YR$T$M$Y$$$20240811$$MD$PL$PL
238294392$23829439$2$F$$20240823$20240508$20240827$PER$$US-AMGEN-USASP2024089697$AMGEN$$$$$F$Y$$$20240827$$PH$US$US
238294433$23829443$3$F$20240501$20240729$20240508$20240801$EXP$$US-ABBVIE-5744898$ABBVIE$$63$YR$$F$Y$$$20240801$$CN$US$US
238294852$23829485$2$F$20210101$20240627$20240508$20240702$EXP$$CA-CELLTRION INC.-2020CA030680$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
238294944$23829494$4$F$20240101$20240625$20240508$20240701$PER$$US-ABBVIE-5749376$ABBVIE$$$$$M$Y$52$KG$20240701$$CN$US$US
238294962$23829496$2$F$20230726$20240709$20240508$20240723$EXP$$FR-CIPLA LTD.-2024FR04239$CIPLA$$$$$$Y$$$20240723$$PH$FR$FR
238294992$23829499$2$F$$20240711$20240508$20240711$PER$$US-ALXN-202405USA000144US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$US$US
238295232$23829523$2$F$$20240910$20240508$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-020928$AUROBINDO$Mei JY, Xu L, Nguyen TA.. Smartwatch detection of new-onset monomorphic ventricular tachycardia in pregnancy. BMJ-Case-Rep. 2024;17No. 2:e258807$4$DEC$$F$Y$$$20240923$$MD$US$US
238295372$23829537$2$F$$20240903$20240508$20240904$EXP$$US-TAKEDA-2023TUS006907$TAKEDA$$$$$F$Y$75$KG$20240904$$CN$US$US
238295383$23829538$3$F$20240405$20240507$20240508$20240802$PER$$US-AstraZeneca-2024A084370$ASTRAZENECA$$22887$DY$$F$Y$$$20240802$$CN$US$
238295548$23829554$8$F$20240101$20240903$20240508$20240911$EXP$$CA-CELLTRION INC.-2024CA003328$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
238295662$23829566$2$F$$20240712$20240508$20240715$EXP$$NVSC2024CH094517$NOVARTIS$$55$YR$$M$Y$$$20240715$$MD$CH$CH
238295732$23829573$2$F$$20240806$20240508$20240806$PER$$US-JNJFOC-20240501997$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240807$$CN$US$US
238295752$23829575$2$F$$20240702$20240508$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03680$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238295872$23829587$2$F$$20240702$20240508$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03677$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238295902$23829590$2$F$20240429$20240627$20240508$20240701$EXP$$CA-TAKEDA-2023TUS054641$TAKEDA$$42$YR$$F$Y$$$20240701$$CN$CA$CA
238295964$23829596$4$F$20240504$20240925$20240508$20240930$EXP$$CA-TAKEDA-2024TUS032253$TAKEDA$$53$YR$$M$Y$$$20240930$$CN$CA$CA
238296032$23829603$2$F$$20240501$20240508$20240925$PER$$US-GSK-US2024AMR056044$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
238296065$23829606$5$F$20230531$20240920$20240508$20240927$EXP$$CA-GSK-CA2023AMR077645$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$HP$CA$CA
238296092$23829609$2$F$$20240708$20240508$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071124$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240709$$CN$US$US
238296133$23829613$3$F$20240301$20240815$20240508$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070353$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240823$$HP$US$US
238296213$23829621$3$F$20240401$20240702$20240508$20240705$EXP$$US-JNJFOC-20240507654$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240705$$HP$US$US
238296226$23829622$6$F$20240401$20240614$20240508$20240701$30DAY$$US-JNJFOC-20240500952$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
238296323$23829632$3$F$$20240823$20240508$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071339$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240826$$CN$US$US
238296332$23829633$2$F$20240401$20240429$20240508$20240821$EXP$$US-BIOGEN-2024BI01263002$BIOGEN$$37$YR$$F$Y$$$20240821$$HP$US$US
238296392$23829639$2$F$20230907$20240716$20240508$20240729$EXP$$CN-EMD Serono-2024024160$EMD SERONO INC$$37$YR$A$F$Y$$$20240729$$MD$CN$CN
238296493$23829649$3$F$$20240605$20240508$20240829$PER$$US-JNJFOC-20240486647$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$HP$US$US
238296634$23829663$4$F$20230801$20240722$20240508$20240725$EXP$$NVSC2023AR243572$NOVARTIS$$62$YR$$M$Y$$$20240725$$CN$AR$AR
238296742$23829674$2$F$$20240819$20240508$20240821$EXP$$US-SANDOZ INC.-SDZ2024US046132$SANDOZ$$$$$$Y$$$20240821$$CN$US$US
238296752$23829675$2$F$$20240710$20240508$20240715$EXP$$CA-SANDOZ INC.-SDZ2024CA046207$SANDOZ$$68$YR$$F$Y$$$20240715$$MD$CA$CA
238297123$23829712$3$F$$20240905$20240508$20240912$EXP$$CA-GSK-CA2024AMR056579$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$HP$CA$CA
238297163$23829716$3$F$20240406$20240917$20240508$20240924$EXP$$CA-GSK-CA2024028415$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$CA$CA
238297322$23829732$2$F$$20240711$20240508$20240711$PER$$US-ALXN-202405USA000080US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
238297483$23829748$3$F$20240324$20240710$20240508$20240711$EXP$$ES-SANDOZ INC.-SDZ2024ES046243$SANDOZ$$82$YR$$F$Y$64.2$KG$20240711$$MD$ES$ES
238297712$23829771$2$F$20240505$20240806$20240508$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071055$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240806$$CN$US$US
238297732$23829773$2$F$$20240502$20240508$20240814$EXP$$NVSC2024US069372$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
238297752$23829775$2$F$20240430$20240820$20240508$20240823$PER$$US-AMGEN-USASP2024090927$AMGEN$$62$YR$A$F$Y$$$20240823$$CN$US$US
238297852$23829785$2$F$$20240716$20240508$20240723$EXP$$US-ABBVIE-5743863$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
238297883$23829788$3$F$20240510$20240805$20240508$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070263$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240805$$CN$US$US
238297973$23829797$3$F$20240301$20240730$20240508$20240801$PER$$US-AMGEN-USASP2024088585$AMGEN$$65$YR$E$F$Y$$$20240801$$CN$US$US
238298364$23829836$4$F$$20240827$20240508$20240829$EXP$$CA-TAKEDA-2024TUS042716$TAKEDA$$$$$F$Y$$$20240829$$CN$CA$CA
238298505$23829850$5$F$$20240904$20240508$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03675$LUPIN$$$$$$Y$$$20240920$$CN$US$US
238298532$23829853$2$F$$20240812$20240508$20240813$EXP$$CA-BAUSCH-BL-2024-007210$BAUSCH AND LOMB$$62$WK$$F$Y$$$20240813$$HP$CA$CA
238298653$23829865$3$F$20240828$20240828$20240508$20240904$PER$$US-BEH-2024171616$CSL BEHRING$$66$YR$E$F$Y$$$20240904$$CN$US$US
238298722$23829872$2$F$$20240814$20240508$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US045960$SANDOZ$$$$$M$Y$$$20240820$$CN$US$US
238298732$23829873$2$F$$20240702$20240508$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03669$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238298813$23829881$3$F$20240406$20240723$20240508$20240819$PER$$FR-TOLMAR, INC.-24FR048335$TOLMAR$$84$YR$$M$Y$$$20240819$$PH$FR$FR
238298852$23829885$2$F$20240119$20240719$20240508$20240812$PER$$NL-TOLMAR, INC.-24NL048377$TOLMAR$$80$YR$$M$Y$$$20240812$$HP$NL$NL
238299482$23829948$2$F$$20240702$20240508$20240704$EXP$$JP-ASTELLAS-2024JP002267$ASTELLAS$$$$E$$Y$$$20240704$$MD$JP$JP
238299757$23829975$7$F$20240419$20240819$20240508$20240821$EXP$$US-Leiters-2156683$LEITERS COMPOUNDING PHARMACY$$52$YR$$F$Y$$$20240821$$$US$US
238299777$23829977$7$F$20240420$20240819$20240508$20240821$EXP$$US-Leiters-2156682$LEITERS COMPOUNDING PHARMACY$$77$YR$$M$Y$$$20240821$$$US$US
238300073$23830007$3$F$20240702$20240703$20240508$20240708$EXP$$GB-MYLANLABS-2024M1041071$MYLAN$$$$$M$Y$$$20240708$$MD$GB$GB
238300232$23830023$2$F$20240108$20240710$20240508$20240717$EXP$$HN-MYLANLABS-2024M1041247$MYLAN$$78$YR$$M$Y$65.77$KG$20240717$$CN$HN$HN
238300402$23830040$2$F$20230525$20240918$20240508$20240925$EXP$$CA-GSK-CA2023AMR076041$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$CA$CA
238300542$23830054$2$F$$20240711$20240508$20240711$EXP$$US-ALXN-202405USA000311US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240711$$HP$US$US
238300713$23830071$3$F$$20240702$20240508$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03668$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238300862$23830086$2$F$20240503$20240822$20240508$20240826$PER$$US-AMGEN-USASP2024090755$AMGEN$$62$YR$A$M$Y$$$20240826$$CN$US$US
238301093$23830109$3$F$20240103$20240705$20240508$20240717$EXP$$US-UCBSA-2024021956$UCB$$27$YR$$F$Y$$$20240717$$CN$US$US
238301154$23830115$4$F$$20240707$20240508$20240710$EXP$$NVSC2024IL080814$NOVARTIS$$50$YR$$F$Y$$$20240710$$HP$IL$IL
238301353$23830135$3$F$20230101$20240807$20240508$20240817$EXP$$DE-TEVA-VS-3194482$TEVA$$79$YR$$M$Y$$$20240817$$CN$DE$DE
238301702$23830170$2$F$20240305$20240622$20240508$20240702$EXP$$GB-MSNLABS-2024MSNSPO00993$MSN LABORATORIES$$$$$$Y$$$20240702$$MD$GB$GB
238301833$23830183$3$F$20240502$20240809$20240508$20240814$EXP$$AR-MYLANLABS-2024M1041445$MYLAN$$17$YR$$F$Y$$$20240814$$HP$AR$AR
238301872$23830187$2$F$20240412$20240919$20240508$20240927$EXP$$US-BEH-2024170489$CSL BEHRING$$3$YR$C$M$Y$$$20240927$$HP$US$US
238301912$23830191$2$F$$20240813$20240508$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-021205$AUROBINDO$$34$YR$$F$Y$$$20240827$$HP$CA$CA
238301922$23830192$2$F$20240505$20240811$20240508$20240812$PER$$US-AMGEN-USASP2024090834$AMGEN$$65$YR$E$F$Y$$$20240812$$CN$US$US
238301982$23830198$2$F$$20240806$20240508$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071322$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240808$$HP$US$US
238302052$23830205$2$F$$20240807$20240508$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071174$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240808$$HP$US$US
238302063$23830206$3$F$20240401$20240625$20240508$20240704$EXP$$US-SA-2024SA131758$SANOFI AVENTIS$$79$YR$E$M$Y$78.02$KG$20240704$$CN$US$US
238302112$23830211$2$F$20240506$20240725$20240508$20240729$PER$$US-AMGEN-USASP2024090390$AMGEN$$65$YR$E$M$Y$$$20240728$$CN$US$US
238302285$23830228$5$F$20240221$20240808$20240508$20240813$EXP$$NVSC2024ID090101$NOVARTIS$$82$YR$$F$Y$49$KG$20240813$$PH$ID$ID
238302312$23830231$2$F$20240701$20240718$20240508$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069495$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240723$$PH$US$US
238302552$23830255$2$F$20240418$20240821$20240508$20240827$EXP$$US-SA-2024SA131509$SANOFI AVENTIS$$56$YR$A$$Y$82$KG$20240827$$HP$US$US
238302562$23830256$2$F$20240329$20240711$20240508$20240716$EXP$FR-AFSSAPS-BX2024000786$FR-CHEPLA-2024005663$CHEPLAPHARM$$44$YR$$M$Y$$$20240716$$PH$COUNTRY NOT SPECIFIED$FR
238302616$23830261$6$F$20231216$20240716$20240508$20240725$EXP$$CA-CELLTRION INC.-2023CA025103$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
238302882$23830288$2$F$$20240813$20240508$20240827$EXP$$CA-AUROBINDO-AUR-APL-2022-024929$AUROBINDO$$71$YR$$F$Y$$$20240827$$HP$CA$CA
238303413$23830341$3$F$$20240919$20240508$20240925$EXP$$GB-MYLANLABS-2024M1040854$MYLAN$$$$$M$Y$$$20240925$$PH$GB$GB
238303492$23830349$2$F$$20240805$20240508$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070583$BRISTOL MYERS SQUIBB$$70$YR$E$$Y$$$20240805$$HP$US$US
238303612$23830361$2$F$20240423$20240626$20240508$20240703$30DAY$$US-AMGEN-USASP2024086956$AMGEN$$56$YR$A$F$Y$65.76$KG$20240703$$PH$US$US
238303643$23830364$3$F$$20240712$20240508$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071294$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240717$$HP$US$US
238303695$23830369$5$F$20240429$20240805$20240508$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070732$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240805$$CN$US$US
238303852$23830385$2$F$20240319$20240903$20240508$20240913$30DAY$$US-GSK-US2024AMR056451$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240913$$CN$US$US
238303862$23830386$2$F$20240629$20240703$20240508$20240710$EXP$$CO-GSK-CO2023AMR173143$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$CO$CO
238303992$23830399$2$F$20240125$20240917$20240508$20240920$EXP$$CA-AMERICAN REGENT INC-2024001731$AMERICAN REGENT$$44$YR$$F$Y$$$20240920$$HP$CA$CA
238304082$23830408$2$F$20240427$20240702$20240508$20240711$EXP$$IN-FERRINGPH-2024FE02187$FERRING$$$$$$Y$$$20240711$$MD$IN$IN
238304332$23830433$2$F$$20240922$20240508$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202405003794$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240926$$CN$US$US
238304475$23830447$5$F$$20240925$20240508$20240930$30DAY$$CL-PFIZER INC-PV202400023365$PFIZER$$11$YR$$F$Y$$$20240930$$CN$CL$CL
238304493$23830449$3$F$$20240910$20240508$20240913$30DAY$$CO-PFIZER INC-PV202400058839$PFIZER$$8$YR$$M$Y$$$20240913$$CN$CO$CO
238304503$23830450$3$F$20240401$20240910$20240508$20240911$30DAY$$AR-PFIZER INC-202400096439$PFIZER$$9$YR$$F$Y$$$20240911$$CN$AR$AR
238304525$23830452$5$F$20240101$20240926$20240508$20240930$EXP$$CO-PFIZER INC-PV202400058827$PFIZER$$6$YR$$F$Y$$$20240930$$CN$CO$CO
238304603$23830460$3$F$$20240626$20240508$20240709$EXP$$TN-MACLEODS PHARMA-MAC2024047142$MACLEODS$$$$$$Y$$$20240709$$MD$TN$TN
238304782$23830478$2$F$$20240731$20240508$20240806$EXP$$ES-AUROBINDO-AUR-APL-2024-022172$AUROBINDO$Taibo A, SeoaneEstevez A, MartinezCampayo N, RodriguezMayo M, ArevaloBermudez MDP, Fonseca E.. Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain. Mycoses. 2023;66 (10):891-897$50$YR$$M$Y$$$20240806$$MD$ES$ES
238305032$23830503$2$F$$20240725$20240508$20240726$PER$$US-BIOVITRUM-2024-US-006821$BIOVITRUM$$77$YR$$F$Y$$$20240726$$CN$US$US
238305362$23830536$2$F$20240410$20240626$20240508$20240701$EXP$FR-AFSSAPS-DJ2024000676$FR-REGENERON PHARMACEUTICALS, INC.-2024-068452$REGENERON$$81$YR$$F$Y$$$20240701$$MD$FR$FR
238305452$23830545$2$F$20240624$20240718$20240508$20240724$EXP$$US-ABBVIE-5745995$ABBVIE$$37$YR$$F$Y$$$20240724$$CN$US$US
238305465$23830546$5$F$$20240710$20240508$20240724$EXP$GB-MLMSERVICE-20240422-PI034858-00270-1$GB-STRIDES ARCOLAB LIMITED-2024SP005288$STRIDES$Needleman A, Sheaff M, Pepper RJ, Evans RDR.. Immunoglobulin G4-related disease presenting with nephrotic syndrome due to minimal change disease: a case report.. Journal of medical case reports.. 2024;18(1):192 (1-5)$$$$$Y$$$20240724$$MD$GB$GB
238305672$23830567$2$F$$20240709$20240508$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071162$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240715$$CN$US$US
238305683$23830568$3$F$20240401$20240508$20240508$20240813$EXP$$NVSC2024BR080488$NOVARTIS$$58$YR$$F$Y$$$20240813$$CN$BR$BR
238305982$23830598$2$F$$20240819$20240508$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US046091$SANDOZ$$$$$F$Y$$$20240821$$CN$US$US
238305994$23830599$4$F$20240417$20240702$20240508$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03600$HIKMA$$75$YR$$F$Y$78$KG$20240716$$MD$US$US
238306152$23830615$2$F$20240505$20240505$20240508$20240812$EXP$$NVSC2024IL089864$NOVARTIS$$56$YR$$F$Y$$$20240812$$HP$IL$IL
238306393$23830639$3$F$20240501$20240701$20240508$20240711$EXP$$US-INSMED, INC.-2024-00481-US$INSMED$$76$YR$$F$Y$$$20240711$$CN$US$US
238306432$23830643$2$F$$20240808$20240508$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US045354$SANDOZ$$$$$M$Y$$$20240812$$CN$US$US
238306473$23830647$3$F$$20240719$20240508$20240726$30DAY$$US-GSK-US2024AMR056623$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$MD$US$US
238306552$23830655$2$F$20180101$20240812$20240508$20240814$EXP$$US-MYLANLABS-2024M1041444$MYLAN$$$$$F$Y$106.96$KG$20240814$$HP$US$US
238306596$23830659$6$F$20190101$20240705$20240508$20240709$EXP$$NL-AMGEN-NLDNI2024089170$AMGEN$$$$A$M$Y$$$20240708$$MD$NL$NL
238306662$23830666$2$F$$20240429$20240508$20240717$EXP$$US-TEVA-VS-3193724$TEVA$Vierra M, Bansal VV, Morgan RB, Witmer HDD, Reddy B, Dhiman A, et al. Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery. Ann-Surg-Oncol 2024; 31 645-654.; Vierra M, Bansal VV, Morgan RB, Witmer HDD, Reddy B, Dhiman A, et al. Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery. Ann-Surg-Oncol 2024; 31 645-654.$50$YR$$F$Y$$$20240717$$HP$US$US
238306772$23830677$2$F$20240422$20240628$20240508$20240708$EXP$$FR-PFIZER INC-202400102930$PFIZER$$53$YR$$F$Y$71$KG$20240708$$MD$FR$FR
238307213$23830721$3$F$$20240607$20240508$20240801$PER$$US-LUNDBECK-DKLU3077719$LUNDBECK$$$$$$Y$$$20240801$$CN$US$US
238307342$23830734$2$F$$20240626$20240508$20240701$PER$$US-BAYER-2024A061145$BAYER$$27$YR$A$F$Y$$$20240701$$CN$US$US
238307553$23830755$3$F$20230701$20240620$20240508$20240710$PER$$BR-TOLMAR, INC.-24BR048421$TOLMAR$$9$YR$$F$Y$$$20240709$$CN$BR$BR
238307933$23830793$3$F$$20240815$20240508$20240816$30DAY$$DE-TAKEDA-2024TUS041502$TAKEDA$$$$$F$Y$$$20240816$$PH$DE$DE
238308214$23830821$4$F$$20240721$20240508$20240724$PER$$NVSC2024US095325$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
238308224$23830822$4$F$$20240826$20240508$20240902$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-012715$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240902$$CN$US$US
238308373$23830837$3$F$20240505$20240715$20240508$20240716$PER$$US-AMGEN-USASP2024091242$AMGEN$$57$YR$A$M$Y$$$20240716$$CN$US$US
238308412$23830841$2$F$20240503$20240806$20240508$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071320$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240806$$CN$US$US
238308542$23830854$2$F$20240426$20240509$20240508$20240731$PER$$US-BAYER-2024A067370$BAYER$$31$YR$A$F$Y$$$20240731$$MD$US$US
238308644$23830864$4$F$$20240819$20240508$20240822$EXP$$GB-SANDOZ INC.-SDZ2024GB046316$SANDOZ$$$$$F$Y$$$20240822$$CN$GB$GB
238308824$23830882$4$F$$20240812$20240508$20240816$30DAY$$US-PFIZER INC-202400097169$PFIZER$$$$$$Y$$$20240816$$PH$US$US
238308834$23830883$4$F$20240422$20240812$20240508$20240815$30DAY$$JP-PFIZER INC-PV202400056763$PFIZER$$$$$$Y$$$20240815$$PH$JP$JP
238309434$23830943$4$F$20240424$20240905$20240508$20240909$30DAY$$CL-PFIZER INC-PV202400052039$PFIZER$$3$YR$$M$Y$16$KG$20240909$$CN$CL$CL
238309672$23830967$2$F$$20240708$20240508$20240715$EXP$$US-SA-2024SA137615$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240715$$CN$US$US
238309694$23830969$4$F$20240401$20240620$20240508$20240701$PER$$US-SA-2024SA137555$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240702$$HP$US$US
238309993$23830999$3$F$20240419$20240806$20240508$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071548$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240806$$CN$US$US
238310162$23831016$2$F$20240101$20240709$20240508$20240711$EXP$$US-UCBSA-2024022098$UCB$$$$$M$Y$118.84$KG$20240711$$HP$US$US
238310172$23831017$2$F$$20240712$20240508$20240715$EXP$$NVSC2024US096245$NOVARTIS$$31$YR$$F$Y$$$20240715$$CN$US$US
238310313$23831031$3$F$20230101$20240827$20240508$20240829$EXP$$CA-PFIZER INC-202300355738$PFIZER$$91$YR$$F$Y$$$20240829$$HP$CA$CA
238310334$23831033$4$F$20240101$20240729$20240508$20240802$EXP$$IN-PFIZER INC-PV202400032413$PFIZER$$40$YR$$M$Y$$$20240802$$CN$IN$IN
238310347$23831034$7$F$20240301$20240904$20240508$20240909$EXP$$IN-PFIZER INC-PV202400058573$PFIZER$$41$YR$$F$Y$$$20240909$$CN$IN$IN
238310352$23831035$2$F$$20240630$20240508$20240701$EXP$$CA-PFIZER INC-202400102665$PFIZER$$68$YR$$M$Y$$$20240701$$MD$CA$CA
238310394$23831039$4$F$$20240729$20240508$20240731$EXP$$US-PFIZER INC-PV202400059810$PFIZER$$59$YR$$F$Y$$$20240731$$HP$US$US
238310453$23831045$3$F$20240821$20240829$20240508$20240903$EXP$$IN-PFIZER INC-PV202400059133$PFIZER$$38$YR$$F$Y$$$20240903$$CN$IN$IN
238310493$23831049$3$F$20231125$20240820$20240508$20240827$EXP$$IN-PFIZER INC-PV202300209977$PFIZER$$65$YR$$F$Y$52$KG$20240827$$CN$IN$IN
238310885$23831088$5$F$20240424$20240830$20240508$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-444683$RANBAXY$$19$YR$A$F$Y$$$20240913$$MD$US$US
238311443$23831144$3$F$$20240826$20240508$20240907$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK090514$GLENMARK$$$$$$Y$$$20240907$$CN$CA$CA
238311493$23831149$3$F$$20240726$20240508$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445052$RANBAXY$Patel EJ,Ahmad M,Schwartz BS,Zante AV,Kersten R,Loftus P. Invasive Fungal Sinusitis in an Immunocompetent Patient After Sinus Surgery for Chronic Rhinosinusitis with Nasal Polyps and a Mycetoma. Laryngoscope. 2024;Apr 23:PMID: 38651570,11-12$38$YR$$F$Y$$$20240809$$MD$US$US
238311562$23831156$2$F$$20240729$20240508$20240812$EXP$$US-UCBSA-2024021973$UCB$$$$$F$Y$111.13$KG$20240812$$HP$US$US
238311632$23831163$2$F$20240301$20240916$20240508$20240923$EXP$FR-AFSSAPS-BX2024000821$FR-PFIZER INC-202400101283$PFIZER$$39$YR$$F$Y$$$20240923$$PH$FR$FR
238312012$23831201$2$F$20230906$20240704$20240508$20240704$EXP$$CA-PFIZER INC-202300283579$PFIZER$$59$YR$$M$Y$$$20240704$$MD$CA$CA
238312032$23831203$2$F$$20240629$20240508$20240701$EXP$$CA-PFIZER INC-202400101626$PFIZER$$7$YR$$F$Y$$$20240701$$HP$CA$CA
238312074$23831207$4$F$20240101$20240629$20240508$20240701$EXP$$CA-PFIZER INC-202400062561$PFIZER$$23$YR$$F$Y$$$20240701$$MD$CA$CA
238312196$23831219$6$F$20240414$20240712$20240508$20240717$EXP$$ES-PFIZER INC-202400102308$PFIZER$$47$YR$$F$Y$62.2$KG$20240717$$MD$ES$ES
238312253$23831225$3$F$$20240711$20240508$20240711$PER$$US-ALXN-202405USA000109US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
238312322$23831232$2$F$$20240806$20240508$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071357$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240806$$HP$US$US
238312343$23831234$3$F$$20240625$20240508$20240705$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK090516$GLENMARK$$$$$$Y$$$20240705$$MD$CA$CA
238312463$23831246$3$F$$20240830$20240508$20240904$EXP$$CA-PFIZER INC-202400102684$PFIZER$$87$YR$$M$Y$77$KG$20240904$$HP$CA$CA
238312532$23831253$2$F$$20240730$20240508$20240805$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-002336$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
238312653$23831265$3$F$$20240627$20240508$20240701$PER$$US-ALXN-202405USA000135US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
238312815$23831281$5$F$20240425$20240916$20240508$20240925$30DAY$$US-PFIZER INC-202400100957$PFIZER$$14$YR$$M$Y$38.2$KG$20240925$$MD$US$US
238312822$23831282$2$F$$20240827$20240508$20240904$EXP$$CA-PFIZER INC-202400102807$PFIZER$$46$YR$$F$Y$122$KG$20240904$$HP$CA$CA
238312845$23831284$5$F$$20240923$20240508$20240926$30DAY$$US-PFIZER INC-202400101285$PFIZER$$9$YR$$F$Y$$$20240926$$CN$US$US
238312893$23831289$3$F$$20240630$20240508$20240701$EXP$$US-PFIZER INC-202400100759$PFIZER$$66$YR$$F$Y$$$20240701$$CN$US$US
238312913$23831291$3$F$20240401$20240912$20240508$20240917$30DAY$$US-PFIZER INC-PV202400057337$PFIZER$$12$YR$$F$Y$47.173$KG$20240917$$HP$US$US
238313005$23831300$5$F$20240410$20240828$20240508$20240906$EXP$$ZA-TAKEDA-2024TUS032205$TAKEDA$$46$YR$$F$Y$$$20240906$$CN$ZA$ZA
238313124$23831312$4$F$$20240828$20240508$20240903$30DAY$$US-PFIZER INC-202400100329$PFIZER$$19$YR$$M$Y$$$20240903$$CN$US$US
238313132$23831313$2$F$20220501$20240716$20240508$20240718$PER$$US-PFIZER INC-202400102717$PFIZER$$54$YR$$F$Y$62.14$KG$20240718$$HP$US$US
238313223$23831322$3$F$20240201$20240820$20240508$20240826$PER$$US-PFIZER INC-PV202400029307$PFIZER$$67$YR$$F$Y$$$20240826$$HP$US$US
238313244$23831324$4$F$$20240917$20240508$20240920$PER$$US-PFIZER INC-PV202400054627$PFIZER$$89$YR$$F$Y$$$20240920$$CN$US$US
238313293$23831329$3$F$$20240916$20240508$20240919$PER$$US-PFIZER INC-202300435542$PFIZER$$71$YR$$F$Y$$$20240919$$CN$US$US
238313565$23831356$5$F$$20240806$20240508$20240809$30DAY$$US-PFIZER INC-202400101029$PFIZER$$12$YR$$M$Y$$$20240809$$CN$US$US
238313608$23831360$8$F$20240504$20240922$20240508$20240926$30DAY$$US-PFIZER INC-202400101662$PFIZER$$15$YR$$M$Y$84.37$KG$20240926$$CN$US$US
238313624$23831362$4$F$20240119$20240920$20240508$20240926$30DAY$$US-PFIZER INC-202400100852$PFIZER$$16$YR$$M$Y$$$20240926$$CN$US$US
238313633$23831363$3$F$$20240925$20240508$20240927$30DAY$$US-PFIZER INC-202400102332$PFIZER$$18$YR$$F$Y$$$20240927$$CN$US$US
238313645$23831364$5$F$$20240911$20240508$20240913$PER$$US-PFIZER INC-202400101064$PFIZER$$1$YR$$M$Y$$$20240913$$CN$US$US
238313712$23831371$2$F$20240314$20240712$20240508$20240717$PER$$US-INCYTE CORPORATION-2024IN004550$INCYTE$$$$$$Y$$$20240717$$CN$US$US
238313733$23831373$3$F$20240401$20240716$20240508$20240719$PER$$US-AMGEN-USASP2024091294$AMGEN$$82$YR$E$F$Y$$$20240719$$CN$US$US
238314253$23831425$3$F$$20240801$20240508$20240810$EXP$$DE-TEVA-VS-3194953$TEVA$$49$YR$$F$Y$$$20240810$$CN$DE$DE
238314572$23831457$2$F$$20240816$20240508$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202404017899$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240829$$CN$US$US
238314733$23831473$3$F$$20240809$20240508$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA045612$SANDOZ$$$$$F$Y$$$20240814$$MD$CA$CA
238314842$23831484$2$F$20210713$20240709$20240508$20240712$EXP$$DE-MYLANLABS-2024M1039607$MYLAN$$69$YR$$F$Y$$$20240712$$MD$DE$DE
238314954$23831495$4$F$20240427$20240704$20240508$20240705$EXP$$NVSC2024US059969$NOVARTIS$$65$YR$$F$Y$$$20240705$$CN$US$US
238315182$23831518$2$F$20240120$20240708$20240508$20240711$EXP$$US-OTSUKA-2024_003006$OTSUKA$$$$$F$Y$$$20240711$$CN$US$US
238315272$23831527$2$F$20240101$20240619$20240508$20240806$PER$$US-GALDERMA-US2024006511$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
238315462$23831546$2$F$$20240613$20240508$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000006$VERRICA PHARMACEUTICALS$$78$YR$$M$Y$$$20240731$$HP$US$US
238315482$23831548$2$F$$20240613$20240508$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000009$VERRICA PHARMACEUTICALS$$$$$M$Y$$$20240731$$MD$US$US
238315492$23831549$2$F$20240101$20240613$20240508$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000015$VERRICA PHARMACEUTICALS$$$$$$Y$$$20240731$$MD$US$US
238315612$23831561$2$F$$20240909$20240508$20240911$EXP$$CA-BAUSCH-BL-2024-007218$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240911$$HP$CA$CA
238315632$23831563$2$F$$20240909$20240508$20240911$EXP$$CA-BAUSCH-BL-2024-007240$BAUSCH AND LOMB$$74$YR$$F$Y$54$KG$20240911$$HP$CA$CA
238315702$23831570$2$F$$20240906$20240508$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-007631$VERTEX$$8$YR$$F$Y$$$20240912$$CN$US$US
238315793$23831579$3$F$$20240711$20240508$20240711$PER$$US-ALXN-202405USA000072US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
238315902$23831590$2$F$20220101$20240724$20240508$20240731$EXP$$CA-PFIZER INC-202201188447$PFIZER$$69$YR$$M$Y$95$KG$20240731$$MD$CA$CA
238315914$23831591$4$F$$20240627$20240508$20240701$PER$$US-PFIZER INC-PV202400059167$PFIZER$$77$YR$$M$Y$$$20240701$$CN$US$US
238315965$23831596$5$F$$20240911$20240508$20240913$30DAY$$GB-PFIZER INC-202400102716$PFIZER$$3$YR$$M$Y$$$20240913$$CN$GB$GB
238315973$23831597$3$F$$20240911$20240508$20240913$30DAY$$GB-PFIZER INC-202400099728$PFIZER$$55$YR$$F$Y$$$20240913$$CN$GB$GB
238316005$23831600$5$F$$20240913$20240508$20240918$30DAY$$US-PFIZER INC-202400100968$PFIZER$$6$YR$$M$Y$$$20240918$$HP$US$US
238316043$23831604$3$F$$20240701$20240508$20240704$EXP$$NVSC2024US097434$NOVARTIS$$$$$F$Y$$$20240704$$HP$US$US
238316144$23831614$4$F$20240418$20240612$20240508$20240712$PER$$US-AstraZeneca-2024A094614$ASTRAZENECA$$19952$DY$$M$Y$$$20240712$$HP$US$
238316208$23831620$8$F$20240401$20240918$20240508$20240925$30DAY$$US-PFIZER INC-202400102394$PFIZER$$5$YR$$F$Y$15.42$KG$20240925$$CN$US$US
238316273$23831627$3$F$$20240708$20240508$20240712$EXP$$US-AMGEN-USASP2024087921$AMGEN$$71$YR$E$F$Y$$$20240712$$CN$US$US
238316324$23831632$4$F$20240426$20240918$20240508$20240926$EXP$$AU-TAKEDA-2024TUS043901$TAKEDA$$36$YR$$F$Y$$$20240926$$CN$AU$AU
238316632$23831663$2$F$$20240906$20240508$20240910$30DAY$$KR-PFIZER INC-PV202400056903$PFIZER$$13$YR$$M$Y$$$20240910$$CN$KR$KR
238316703$23831670$3$F$$20240919$20240508$20240924$30DAY$$CH-PFIZER INC-202400102320$PFIZER$$$$$$Y$$$20240924$$PH$CH$CH
238316714$23831671$4$F$20240501$20240922$20240508$20240925$30DAY$$US-PFIZER INC-202400098863$PFIZER$$12$YR$$M$Y$$$20240925$$CN$US$US
238316952$23831695$2$F$$20240704$20240508$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-067071$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240704$$HP$US$US
238316992$23831699$2$F$$20240806$20240508$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071510$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240806$$CN$US$US
238317012$23831701$2$F$$20240625$20240508$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069564$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240701$$CN$US$US
238317795$23831779$5$F$$20240921$20240508$20240924$PER$$NVSC2024US093020$NOVARTIS$$$$$F$Y$57$KG$20240924$$CN$US$US
238318143$23831814$3$F$20240325$20240705$20240508$20240715$EXP$$JP-Vifor (International) Inc.-VIT-2024-04088$VIFOR$$72$YR$$M$Y$$$20240715$$HP$JP$JP
238319072$23831907$2$F$$20240711$20240508$20240713$EXP$$IN-ROCHE-3557956$ROCHE$$56$YR$A$M$Y$41.8$KG$20240713$$MD$IN$IN
238319192$23831919$2$F$20240313$20240702$20240508$20240704$EXP$IT-MINISAL02-982610$IT-TAKEDA-2024TUS041746$TAKEDA$$68$YR$$M$Y$$$20240704$$HP$IT$IT
238319345$23831934$5$F$20231127$20240710$20240508$20240716$EXP$$US-OTSUKA-2024_012797$OTSUKA$$6$DEC$$F$Y$$$20240716$$HP$US$US
238319373$23831937$3$F$20240424$20240925$20240508$20240927$EXP$$US-BAYER-2024A066031$BAYER$$40$YR$A$M$Y$$$20240927$$CN$US$US
238319522$23831952$2$F$$20240628$20240508$20240724$PER$$US-AstraZeneca-2024A105374$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
238319652$23831965$2$F$20200201$20240423$20240508$20240927$EXP$$CA-AKCEA THERAPEUTICS, INC.-2024IS004109$AKCEA THERAPEUTICS$$$$$$Y$$$20240926$$MD$CA$CA
238319683$23831968$3$F$20240101$20240627$20240508$20240704$EXP$$US-ABBVIE-5744022$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
238319973$23831997$3$F$$20240813$20240508$20240819$EXP$$CA-Taiho Oncology Inc-2024-002535$TAIHO ONCOLOGY INC$$60$YR$A$M$Y$$$20240819$$HP$CA$CA
238320026$23832002$6$F$20240401$20240716$20240508$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009360$UNITED THERAPEUTICS$$73$YR$$F$Y$78.005$KG$20240720$$$US$US
238320112$23832011$2$F$20230101$20240702$20240508$20240704$PER$$US-PFIZER INC-PV202400059262$PFIZER$$41$YR$$F$Y$$$20240704$$HP$US$US
238320153$23832015$3$F$20240101$20240509$20240508$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071432$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240702$$CN$US$US
238320465$23832046$5$F$20240427$20240812$20240508$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069492$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$81.65$KG$20240816$$CN$US$US
238320694$23832069$4$F$20240429$20240821$20240508$20240830$EXP$$JP-009507513-2405JPN000095J$MERCK$$78$YR$$F$Y$$$20240830$$MD$JP$JP
238320913$23832091$3$F$$20240916$20240508$20240918$30DAY$$CO-PFIZER INC-PV202400058345$PFIZER$$$$$F$Y$$$20240918$$MD$CO$CO
238320925$23832092$5$F$20240416$20240906$20240508$20240910$EXP$$DE-PFIZER INC-PV202400058815$PFIZER$$85$YR$$F$Y$68$KG$20240910$$MD$DE$DE
238320972$23832097$2$F$$20240806$20240508$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069481$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240806$$MD$US$US
238321028$23832102$8$F$20240101$20240919$20240508$20240924$30DAY$$US-PFIZER INC-202400102091$PFIZER$$14$YR$$M$Y$40.3$KG$20240924$$HP$US$US
238321045$23832104$5$F$$20240912$20240508$20240916$30DAY$$US-PFIZER INC-202400102791$PFIZER$$9$YR$$M$Y$$$20240916$$CN$US$US
238321248$23832124$8$F$20220101$20240723$20240508$20240730$EXP$$NVSC2024MX094750$NOVARTIS$$$$$F$Y$83$KG$20240730$$CN$MX$MX
238321273$23832127$3$F$20240401$20240806$20240508$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-071431$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240806$$MD$JP$JP
238321424$23832142$4$F$20230413$20240903$20240508$20240906$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405001037$ELI LILLY AND CO$$77$YR$E$F$Y$42$KG$20240906$$CN$JP$JP
238321533$23832153$3$F$20240301$20240731$20240508$20240808$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404019007$ELI LILLY AND CO$$45$YR$A$F$Y$63$KG$20240808$$CN$JP$JP
238321862$23832186$2$F$$20240429$20240508$20240702$EXP$$US-AMGEN-USASP2024088152$AMGEN$Kapoian:T.. Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin. Journal of the American Society of Nephrology. 2008;19 (2):372-379$$$$$Y$$$20240702$$MD$US$US
238321943$23832194$3$F$$20240816$20240508$20240822$EXP$$GB-TAKEDA-2024TUS043674$TAKEDA$$$$$M$Y$$$20240822$$HP$GB$GB
238322184$23832218$4$F$$20240815$20240508$20240820$EXP$$US-SANDOZ INC.-SDZ2024US044916$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
238322492$23832249$2$F$20240504$20240806$20240508$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070809$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240806$$CN$US$US
238322504$23832250$4$F$20240701$20240807$20240508$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071687$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240809$$CN$US$US
238322942$23832294$2$F$20240413$20240827$20240508$20240830$EXP$PT-INFARMED-B202404-651$PT-FreseniusKabi-FK202407394$FRESENIUS KABI$$78$YR$E$M$Y$$$20240830$$MD$PT$PT
238323073$23832307$3$F$20240401$20240924$20240508$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071703$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240927$$CN$US$US
238323102$23832310$2$F$$20240705$20240508$20240709$EXP$$DE-PFIZER INC-PV202400057787$PFIZER$$$$$F$Y$$$20240709$$MD$DE$DE
238323382$23832338$2$F$$20240905$20240508$20240909$EXP$$CA-JNJFOC-20240485918$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240909$$HP$CA$CA
238323422$23832342$2$F$$20240806$20240508$20240806$EXP$$US-JNJFOC-20240479091$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240806$$CN$US$US
238323462$23832346$2$F$20240401$20240619$20240508$20240702$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI04310$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240702$$MD$US$US
238323643$23832364$3$F$20240101$20240903$20240508$20240913$PER$$US-SA-2024SA130532$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240913$$MD$US$US
238323732$23832373$2$F$$20240822$20240508$20240906$PER$$US-SA-2024SA129982$SANOFI AVENTIS$$$$A$M$Y$$$20240906$$MD$US$US
238323762$23832376$2$F$$20240806$20240508$20240813$PER$$US-SA-2024SA130387$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240814$$MD$US$US
238323803$23832380$3$F$$20240917$20240508$20240924$PER$$US-SA-2024SA128820$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240924$$CN$US$US
238323903$23832390$3$F$$20240807$20240508$20240815$PER$$US-SA-2024SA129505$SANOFI AVENTIS$$$$E$F$Y$$$20240815$$MD$US$US
238324123$23832412$3$F$20240101$20240708$20240508$20240717$PER$$US-SA-2024SA131349$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240717$$MD$US$US
238324132$23832413$2$F$$20240731$20240508$20240808$PER$$US-SA-2024SA131196$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240808$$MD$US$US
238324262$23832426$2$F$20240301$20240805$20240508$20240813$PER$$US-SA-2024SA131599$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240814$$CN$US$US
238324354$23832435$4$F$20230101$20240819$20240508$20240829$PER$$US-SA-2024SA134595$SANOFI AVENTIS$$52$YR$A$F$Y$82.54$KG$20240829$$MD$US$US
238324482$23832448$2$F$20240101$20240718$20240508$20240730$PER$$US-SA-2024SA130430$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240730$$MD$US$US
238324512$23832451$2$F$20240101$20240628$20240508$20240709$PER$$US-SA-2024SA130861$SANOFI AVENTIS$$$$E$M$Y$68$KG$20240709$$MD$US$US
238324546$23832454$6$F$20240101$20240913$20240508$20240922$PER$$US-SA-2024SA132696$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240923$$MD$US$US
238324732$23832473$2$F$20240101$20240702$20240508$20240711$PER$$US-SA-2024SA131281$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240711$$MD$US$US
238324752$23832475$2$F$20240101$20240703$20240508$20240715$PER$$US-SA-2024SA131000$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240715$$MD$US$US
238324873$23832487$3$F$20240525$20240917$20240508$20240923$PER$$US-SA-2024SA129567$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240923$$MD$US$US
238325113$23832511$3$F$$20240731$20240508$20240809$PER$$US-SA-2024SA131579$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
238325132$23832513$2$F$20240101$20240705$20240508$20240717$PER$$US-SA-2024SA134866$SANOFI AVENTIS$$57$YR$A$F$Y$63.5$KG$20240717$$MD$US$US
238325292$23832529$2$F$20240101$20240705$20240508$20240717$PER$$US-SA-2024SA131292$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240717$$MD$US$US
238325492$23832549$2$F$$20240627$20240508$20240706$PER$$US-SA-2024SA131333$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240706$$MD$US$US
238325652$23832565$2$F$$20240626$20240508$20240705$PER$$US-SA-2024SA131326$SANOFI AVENTIS$$$$E$F$Y$$$20240705$$MD$US$US
238325742$23832574$2$F$20240101$20240719$20240508$20240731$PER$$US-SA-2024SA129875$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240731$$MD$US$US
238325783$23832578$3$F$$20240702$20240508$20240715$PER$$US-SA-2024SA129725$SANOFI AVENTIS$$$$C$M$Y$32.6$KG$20240715$$MD$US$US
238325792$23832579$2$F$$20240926$20240508$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071288$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240928$$HP$US$US
238325803$23832580$3$F$20240401$20240805$20240508$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-070818$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240805$$PH$JP$JP
238325953$23832595$3$F$$20240703$20240508$20240712$PER$$US-SA-2024SA129879$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
238326163$23832616$3$F$20240101$20240625$20240508$20240708$PER$$US-SA-2024SA130605$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240708$$MD$US$US
238326202$23832620$2$F$20240601$20240709$20240508$20240718$PER$$US-SA-2024SA132316$SANOFI AVENTIS$$84$YR$E$M$Y$131$KG$20240718$$MD$US$US
238326212$23832621$2$F$20240101$20240815$20240508$20240828$PER$$US-SA-2024SA131122$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240828$$MD$US$US
238326282$23832628$2$F$20240101$20240708$20240508$20240717$PER$$US-SA-2024SA130738$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240717$$MD$US$US
238326564$23832656$4$F$20240101$20240827$20240508$20240909$PER$$US-SA-2024SA130617$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240909$$MD$US$US
238326622$23832662$2$F$20240708$20240723$20240508$20240801$PER$$US-SA-2024SA046772$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240801$$MD$US$US
238326704$23832670$4$F$20190101$20240902$20240508$20240909$EXP$$FI-SANDOZ INC.-SDZ2024FI046179$SANDOZ$$26$YR$$F$Y$$$20240909$$MD$FI$FI
238326713$23832671$3$F$20240429$20240902$20240508$20240904$EXP$$AR-SANDOZ INC.-SDZ2024AR046355$SANDOZ$$2$YR$$M$Y$10.9$KG$20240904$$CN$AR$AR
238326775$23832677$5$F$$20240712$20240508$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA045876$SANDOZ$$65$YR$$F$Y$34$KG$20240717$$HP$CA$CA
238326792$23832679$2$F$20240404$20240725$20240508$20240801$PER$$US-SA-2024SA134137$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240801$$MD$US$US
238326852$23832685$2$F$$20240830$20240508$20240912$PER$$US-SA-2024SA137207$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240912$$CN$US$US
238326972$23832697$2$F$20240328$20240826$20240508$20240909$PER$$US-SA-2024SA134386$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240909$$MD$US$US
238327033$23832703$3$F$$20240822$20240508$20240904$PER$$US-SA-2024SA133825$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240904$$MD$US$US
238327383$23832738$3$F$20240101$20240906$20240508$20240917$PER$$US-SA-2024SA137195$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240918$$MD$US$US
238327404$23832740$4$F$20240101$20240905$20240508$20240914$PER$$US-SA-2024SA131405$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240914$$MD$US$US
238327432$23832743$2$F$$20240624$20240508$20240703$PER$$US-SA-2024SA134117$SANOFI AVENTIS$$65$YR$E$M$Y$159.21$KG$20240703$$CN$US$US
238327482$23832748$2$F$20240101$20240621$20240508$20240703$PER$$US-SA-2024SA134414$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240703$$MD$US$US
238327612$23832761$2$F$$20240620$20240508$20240702$PER$$US-SA-2024SA135935$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240702$$CN$US$US
238327633$23832763$3$F$20240101$20240813$20240508$20240821$PER$$US-SA-2024SA134567$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240821$$MD$US$US
238327712$23832771$2$F$20240101$20240822$20240508$20240915$PER$$US-SA-2024SA136419$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240915$$CN$US$US
238327992$23832799$2$F$20240101$20240822$20240508$20240912$PER$$US-SA-2024SA136712$SANOFI AVENTIS$$$$A$M$Y$113.38$KG$20240912$$MD$US$US
238328092$23832809$2$F$$20240620$20240508$20240705$PER$$US-SA-2024SA130327$SANOFI AVENTIS$$57$YR$A$F$Y$70.3$KG$20240705$$MD$US$US
238328302$23832830$2$F$20240416$20240917$20240508$20240924$PER$$US-SA-2024SA136720$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240924$$MD$US$US
238328422$23832842$2$F$20240101$20240909$20240508$20240926$PER$$US-SA-2024SA134371$SANOFI AVENTIS$$73$YR$E$F$Y$99$KG$20240926$$MD$US$US
238328452$23832845$2$F$20240101$20240703$20240508$20240712$PER$$US-SA-2024SA136562$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240712$$MD$US$US
238328522$23832852$2$F$20230915$20240826$20240508$20240902$EXP$$CA-TAKEDA-2024TUS044866$TAKEDA$$76$YR$$F$Y$44$KG$20240902$$HP$CA$CA
238328532$23832853$2$F$20240101$20240806$20240508$20240919$PER$$US-SA-2024SA135649$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240919$$MD$US$US
238328582$23832858$2$F$20240401$20240711$20240508$20240801$PER$$US-SA-2024SA137419$SANOFI AVENTIS$$9$MON$I$M$Y$$$20240719$$MD$US$US
238328753$23832875$3$F$20210422$20240912$20240508$20240920$EXP$$CA-AKCEA THERAPEUTICS, INC.-2024IS004223$AKCEA THERAPEUTICS$$$$$$Y$$$20240919$$MD$CA$CA
238328762$23832876$2$F$20240701$20240814$20240508$20240829$PER$$US-SA-2024SA136444$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240829$$MD$US$US
238328822$23832882$2$F$20231201$20240625$20240508$20240708$PER$$US-SA-2024SA136998$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240708$$MD$US$US
238329122$23832912$2$F$20230101$20240702$20240508$20240715$PER$$US-SA-2024SA134456$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240715$$MD$US$US
238329252$23832925$2$F$20230101$20240903$20240508$20240912$PER$$US-SA-2024SA137093$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240912$$CN$US$US
238329425$23832942$5$F$20231201$20240911$20240508$20240927$PER$$US-SA-2024SA133371$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240927$$MD$US$US
238329773$23832977$3$F$20240405$20240814$20240508$20240820$PER$$US-SA-2024SA133916$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240820$$MD$US$US
238330142$23833014$2$F$$20240620$20240508$20240701$EXP$$US-SA-2024SA132036$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240701$$MD$US$US
238330182$23833018$2$F$20240216$20240710$20240508$20240711$EXP$$DE-SANDOZ INC.-SDZ2024DE046231$SANDOZ$$78$YR$$F$Y$$$20240711$$MD$DE$DE
238330263$23833026$3$F$20240415$20240702$20240508$20240708$EXP$$CA-MYLANLABS-2024M1040376$MYLAN$$69$YR$$F$Y$76.19$KG$20240708$$PH$CA$CA
238330306$23833030$6$F$20240316$20240624$20240508$20240701$EXP$$DE-SANDOZ INC.-SDZ2024DE046244$SANDOZ$$53$YR$$M$Y$$$20240701$$MD$DE$DE
238330412$23833041$2$F$$20240805$20240508$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068714$BRISTOL MYERS SQUIBB$$5$DEC$A$F$Y$$$20240805$$HP$US$US
238330452$23833045$2$F$$20240815$20240508$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071169$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240820$$CN$US$US
238330583$23833058$3$F$20230101$20240910$20240508$20240912$PER$$US-ALXN-202404USA002419US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
238330792$23833079$2$F$$20240913$20240508$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070330$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240916$$HP$US$US
238330972$23833097$2$F$$20240717$20240508$20240726$EXP$$IT-MYLANLABS-2024M1040399$MYLAN$Basilicata P, Marisei M, Guadagni R, Sibilio M, Niola M, Pieri M.,. Pediatric poisoning management: How clinical practice can benefit from forensic approach. Journal of Forensic Sciences. 2024;69 (4):1501-1507$4$YR$$M$Y$$$20240726$$MD$IT$IT
238331014$23833101$4$F$$20240711$20240508$20240716$EXP$$AU-MYLANLABS-2024M1040202$MYLAN$$$$$F$Y$68$KG$20240716$$HP$AU$AU
238331023$23833102$3$F$$20240718$20240508$20240724$EXP$$DE-MYLANLABS-2024M1040347$MYLAN$$$$I$M$Y$2.9$KG$20240724$$HP$DE$DE
238331162$23833116$2$F$20170601$20240708$20240508$20240712$EXP$PT-INFARMED-T202404-460$PT-MYLANLABS-2024M1040162$MYLAN$$28$YR$$F$Y$50$KG$20240712$$CN$PT$PT
238331292$23833129$2$F$$20240725$20240508$20240729$PER$$NVSC2024US097527$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
238331305$23833130$5$F$20230214$20240819$20240508$20240829$EXP$$JP-009507513-2404JPN003155J$MERCK$Muroi H, Nakajima M, Inoue N, Kubo R, Takise S, Nakagawa M. et al.. PS-131-2  Treatment outcome of unresectable advanced/recurrent esophageal cancer. The 124th Annual Congress of Japan Surgical Society$91$YR$$M$Y$$$20240829$$MD$JP$JP
238331494$23833149$4$F$$20240821$20240508$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070698$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240826$$CN$US$US
238331782$23833178$2$F$$20240806$20240508$20240806$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-069611$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240806$$MD$AT$AT
238332053$23833205$3$F$$20240806$20240508$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071688$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240806$$MD$US$US
238332192$23833219$2$F$$20240718$20240508$20240718$PER$$NVSC2024US097238$NOVARTIS$$$$$$Y$$$20240718$$MD$US$US
238332232$23833223$2$F$20240405$20240805$20240508$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068998$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240805$$PH$US$US
238332483$23833248$3$F$$20240910$20240508$20240911$30DAY$$CL-PFIZER INC-202400102846$PFIZER$$$$$$Y$$$20240911$$CN$CL$CL
238332502$23833250$2$F$$20240606$20240508$20240718$PER$$US-JNJFOC-20240485298$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
238332562$23833256$2$F$$20240807$20240508$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068831$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$PH$US$US
238332613$23833261$3$F$20231207$20240701$20240508$20240709$EXP$$US-AstraZeneca-2024A106401$ASTRAZENECA$$70$YR$$M$Y$92.1$KG$20240709$$HP$US$
238332672$23833267$2$F$$20240815$20240508$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US046393$SANDOZ$$$$$M$Y$$$20240821$$CN$US$US
238332822$23833282$2$F$$20240802$20240508$20240809$EXP$$AU-AstraZeneca-2024A107957$ASTRAZENECA$unknown. unknown. unknown$38$YR$$M$Y$$$20240809$$MD$AU$
238332942$23833294$2$F$$20240416$20240508$20240701$EXP$$FR-AstraZeneca-2024A108068$ASTRAZENECA$$$$E$F$Y$$$20240701$$MD$FR$
238332962$23833296$2$F$$20240802$20240508$20240803$PER$$US-AstraZeneca-2024A105721$ASTRAZENECA$$$$$M$Y$$$20240803$$MD$US$
238332973$23833297$3$F$$20240819$20240508$20240824$30DAY$$GB-SANDOZ INC.-SDZ2024GB046323$SANDOZ$$$$$M$Y$$$20240824$$CN$GB$GB
238332983$23833298$3$F$$20240827$20240508$20240830$EXP$$US-SANDOZ INC.-SDZ2024US046071$SANDOZ$$$$$$Y$$$20240830$$CN$US$US
238333443$23833344$3$F$20230401$20240717$20240508$20240724$EXP$$JP-009507513-2405JPN000018J$MERCK$$6$DEC$$M$Y$$$20240724$$PH$JP$JP
238333504$23833350$4$F$20240320$20240808$20240508$20240905$EXP$$CA-BEH-2024170366$CSL BEHRING$$70$YR$E$M$Y$77.098$KG$20240905$$HP$CA$CA
238333672$23833367$2$F$20240101$20240820$20240508$20240827$EXP$FR-AFSSAPS-MA2024000719$FR-VERTEX PHARMACEUTICALS-2024-007708$VERTEX$$5$YR$$F$Y$19$KG$20240827$$MD$FR$FR
238333702$23833370$2$F$20240426$20240905$20240508$20240910$PER$$JP-Eisai-EC-2024-165334$EISAI$$$$E$F$Y$$$20240910$$MD$JP$JP
238333712$23833371$2$F$20230908$20240829$20240508$20240905$EXP$$JP-Eisai-EC-2024-165335$EISAI$$78$YR$E$F$Y$$$20240905$$MD$JP$JP
238333872$23833387$2$F$$20240712$20240508$20240722$PER$$US-BAUSCHBL-2024BNL026517$BAUSCH AND LOMB$$$$$F$Y$$$20240722$$CN$US$US
238333983$23833398$3$F$20240508$20240823$20240508$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-026534$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240826$$CN$US$US
238334102$23833410$2$F$$20240920$20240508$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-020776$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240923$$CN$US$US
238334215$23833421$5$F$20240424$20240913$20240508$20240923$PER$$US-SA-2024SA130828$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240923$$MD$US$US
238334244$23833424$4$F$20240101$20240726$20240508$20240806$PER$$US-SA-2024SA130922$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240806$$MD$US$US
238334332$23833433$2$F$20240101$20240720$20240508$20240729$PER$$US-SA-2024SA130901$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240729$$MD$US$US
238334392$23833439$2$F$$20240719$20240508$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070897$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240723$$CN$US$US
238334494$23833449$4$F$$20240821$20240508$20240828$PER$$US-ALXN-202405USA000063US$ALEXION PHARMACEUTICALS$$$$$M$Y$111.11$KG$20240828$$CN$US$US
238334512$23833451$2$F$$20240710$20240508$20240717$PER$$US-BIOGEN-2024BI01259349$BIOGEN$$$$$M$Y$$$20240717$$HP$US$US
238334713$23833471$3$F$20220101$20240621$20240508$20240702$EXP$$CA-ALVOTECHPMS-2022-ALVOTECHPMS-000073$Alvotech$$34$YR$$F$Y$$$20240702$$CN$CA$CA
238334822$23833482$2$F$$20240707$20240508$20240709$EXP$$DE-BIOGEN-2024BI01263847$BIOGEN$$$$$F$Y$$$20240709$$MD$DE$DE
238334872$23833487$2$F$20240101$20240725$20240508$20240731$EXP$$US-ABBVIE-5326530$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
238334894$23833489$4$F$20240501$20240627$20240508$20240703$30DAY$$US-AMGEN-USASP2024090388$AMGEN$$69$YR$E$F$Y$113$KG$20240703$$PH$US$US
238335672$23833567$2$F$$20240628$20240508$20240816$PER$$US-LUNDBECK-DKLU3077098$LUNDBECK$$$$$$Y$$$20240816$$MD$US$US
238335984$23833598$4$F$$20240628$20240508$20240709$EXP$$US-SA-2024SA131846$SANOFI AVENTIS$$83$YR$E$F$Y$74$KG$20240709$$CN$US$US
238336072$23833607$2$F$$20240702$20240508$20240705$EXP$$US-ABBVIE-5750022$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
238336292$23833629$2$F$20200101$20240621$20240508$20240702$PER$$US-SA-2024SA136484$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240702$$MD$US$US
238336324$23833632$4$F$$20240829$20240508$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069970$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240902$$CN$US$US
238336655$23833665$5$F$20240101$20240817$20240508$20240827$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013587$UNITED THERAPEUTICS$$$$$M$Y$75.737$KG$20240827$$$US$US
238336664$23833666$4$F$20240421$20240726$20240508$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070053$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$92.14$KG$20240801$$PH$US$US
238336774$23833677$4$F$20240101$20240709$20240508$20240716$PER$$US-UNITED THERAPEUTICS-UNT-2024-013715$UNITED THERAPEUTICS$$$$$F$Y$53.061$KG$20240716$$$US$US
238336795$23833679$5$F$20240401$20240723$20240508$20240806$EXP$$JP-SAKK-2024SA130150AA$SANOFI AVENTIS$$76$YR$E$$Y$$$20240807$$MD$JP$JP
238336922$23833692$2$F$20240501$20240726$20240508$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069901$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$72.12$KG$20240802$$HP$US$US
238337052$23833705$2$F$20240310$20240629$20240509$20240706$EXP$IT-MINISAL02-982390$IT-AUROBINDO-AUR-APL-2024-021112$AUROBINDO$$88$YR$$F$Y$55$KG$20240706$$MD$IT$IT
238337132$23833713$2$F$20240501$20240627$20240509$20240701$PER$$US-ALXN-202405USA000101US$ALEXION PHARMACEUTICALS$$61$YR$$M$Y$$$20240701$$CN$US$US
238337376$23833737$6$F$20240505$20240828$20240509$20240903$EXP$$CA-TAKEDA-2024TUS044109$TAKEDA$$69$YR$$M$Y$$$20240903$$CN$CA$CA
238337493$23833749$3$F$20231205$20240806$20240509$20240813$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-271260$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240813$$CN$CA$CA
238337602$23833760$2$F$$20240708$20240509$20240710$PER$$NVSC2024US097775$NOVARTIS$$$$$$Y$$$20240710$$HP$US$US
238337763$23833776$3$F$$20240704$20240509$20240710$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-020844$BOEHRINGER INGELHEIM$$86$YR$E$F$Y$$$20240710$$CN$CA$CA
238337783$23833778$3$F$$20240814$20240509$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071090$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240819$$CN$US$US
238337852$23833785$2$F$20240501$20240801$20240509$20240805$PER$$US-AMGEN-USASP2024089814$AMGEN$$74$YR$E$F$Y$$$20240805$$CN$US$US
238337932$23833793$2$F$$20240703$20240509$20240708$EXP$$US-ABBVIE-5714409$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
238338483$23833848$3$F$$20240805$20240509$20240828$EXP$$JP-JNJFOC-20240509472$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$65.1$KG$20240828$$HP$JP$JP
238338492$23833849$2$F$$20240807$20240509$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071905$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240807$$HP$US$US
238338523$23833852$3$F$$20240814$20240509$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US045334$SANDOZ$$$$$F$Y$$$20240820$$PH$US$US
238338633$23833863$3$F$$20240809$20240509$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070431$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240813$$CN$US$US
238338652$23833865$2$F$$20240613$20240509$20240709$PER$$US-AstraZeneca-2024A091641$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
238338874$23833887$4$F$$20240911$20240509$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070332$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240913$$HP$US$US
238339023$23833902$3$F$20240201$20240913$20240509$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-003143$JAZZ$$35$YR$$M$Y$$$20240924$$CN$US$US
238339442$23833944$2$F$$20240815$20240509$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070056$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240821$$CN$US$US
238339602$23833960$2$F$20240505$20240814$20240509$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US045128$SANDOZ$$13$YR$$F$Y$$$20240820$$CN$US$US
238339653$23833965$3$F$20240505$20240819$20240509$20240822$PER$$US-AMGEN-USASP2024090255$AMGEN$$61$YR$A$M$Y$$$20240821$$CN$US$US
238339893$23833989$3$F$20230101$20240702$20240509$20240710$EXP$$US-UNITED THERAPEUTICS-UNT-2024-006017$UNITED THERAPEUTICS$$$$$M$Y$$$20240710$$$US$US
238340113$23834011$3$F$20220101$20240917$20240509$20240925$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-005238$AMGEN$$58$YR$A$M$Y$$$20240925$$LW$US$US
238340124$23834012$4$F$20240503$20240823$20240509$20240923$PER$$US-CHATTEMPRD-2024OHG015872$CHATTEM$$$$$F$Y$$$20240923$$CN$US$US
238340182$23834018$2$F$$20240715$20240509$20240722$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-005241$AMGEN$$$$$F$Y$$$20240722$$LW$US$US
238340483$23834048$3$F$20240504$20240802$20240509$20240806$PER$$US-AMGEN-USASP2024091773$AMGEN$$73$YR$E$F$Y$$$20240806$$HP$US$US
238340522$23834052$2$F$$20240710$20240509$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071263$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240712$$CN$US$US
238340532$23834053$2$F$20240425$20240627$20240509$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070688$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$108.41$KG$20240701$$CN$US$US
238340633$23834063$3$F$20240429$20240829$20240509$20240904$EXP$$US-ABBVIE-5746457$ABBVIE$$71$YR$$F$Y$66.7$KG$20240904$$CN$US$US
238340662$23834066$2$F$20240423$20240821$20240509$20240829$EXP$$BE-JNJFOC-20240507858$JOHNSON AND JOHNSON$$$$A$F$Y$60$KG$20240829$$MD$BE$BE
238340782$23834078$2$F$$20240924$20240509$20240926$EXP$$CA-002147023-NVSC2021CA234688$Haleon PLC$$53$YR$$M$Y$$$20240926$$HP$CA$CA
238340862$23834086$2$F$20231225$20240716$20240509$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013089$UNITED THERAPEUTICS$$75$YR$$M$Y$126.98$KG$20240726$$$US$US
238340972$23834097$2$F$$20240708$20240509$20240716$EXP$$CA-TOLMAR, INC.-24CA048038$TOLMAR$$$$$M$Y$$$20240716$$MD$CA$CA
238341273$23834127$3$F$$20240708$20240509$20240716$30DAY$$US-GSK-US2024054908$GLAXOSMITHKLINE$$$$$M$Y$$$20240716$$CN$US$US
238341293$23834129$3$F$20200407$20240701$20240509$20240709$EXP$$US-SA-2024SA131975$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240709$$CN$US$US
238341612$23834161$2$F$$20240702$20240509$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03710$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238341675$23834167$5$F$20231207$20240717$20240509$20240725$EXP$$JP-ABBVIE-5675108$ABBVIE$$74$YR$$M$Y$69$KG$20240725$$MD$JP$JP
238341982$23834198$2$F$$20240702$20240509$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03718$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238341993$23834199$3$F$$20240909$20240509$20240917$EXP$$US-SANDOZ INC.-SDZ2024US045659$SANDOZ$$$$$$Y$$$20240917$$CN$US$US
238342152$23834215$2$F$$20240806$20240509$20240807$PER$$US-JNJFOC-20240489802$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240807$$CN$US$US
238343682$23834368$2$F$20220601$20240627$20240509$20240822$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR056642$VIIV$$73$YR$$F$Y$$$20240822$$MD$US$US
238343773$23834377$3$F$20240504$20240703$20240509$20240711$EXP$$US-AstraZeneca-2024A107690$ASTRAZENECA$$24641$DY$$F$Y$$$20240711$$HP$US$
238344893$23834489$3$F$$20240806$20240509$20240815$30DAY$$US-GSK-US2024055838$GLAXOSMITHKLINE$$$$$M$Y$$$20240815$$CN$US$US
238345812$23834581$2$F$$20240730$20240509$20240809$EXP$$US-VIIV HEALTHCARE LIMITED-US2024054852$VIIV$$$$$M$Y$$$20240809$$CN$US$US
238346322$23834632$2$F$20240415$20240806$20240509$20240806$PER$$US-JNJFOC-20240487062$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$CN$US$US
238347062$23834706$2$F$$20240912$20240509$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071731$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$HP$US$US
238347122$23834712$2$F$$20240702$20240509$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03720$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238347282$23834728$2$F$20240401$20240919$20240509$20240928$EXP$$US-BEH-2024171600$CSL BEHRING$$71$YR$E$F$Y$$$20240928$$HP$US$US
238347513$23834751$3$F$20240101$20240506$20240509$20240705$EXP$$US-ABBVIE-5751633$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
238347532$23834753$2$F$$20240702$20240509$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03717$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238347602$23834760$2$F$$20240830$20240509$20240919$PER$$US-TEVA-VS-3182153$TEVA$$57$YR$$F$Y$$$20240919$$CN$US$US
238348012$23834801$2$F$20240415$20240606$20240509$20240805$PER$$US-CIPLA LTD.-2024US04010$CIPLA$$$$$$Y$$$20240805$$CN$US$US
238348022$23834802$2$F$$20240916$20240509$20240923$EXP$$US-GSK-US2024056295$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$US$US
238348252$23834825$2$F$20240429$20240709$20240509$20240717$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013020$UNITED THERAPEUTICS$$67$YR$$F$Y$49.887$KG$20240717$$$US$US
238348282$23834828$2$F$20231130$20240708$20240509$20240711$EXP$DE-BFARM-24003109$DE-GSK-DE2024057774$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$DE$DE
238348503$23834850$3$F$20240305$20240712$20240509$20240725$EXP$GB-MHRA-ADR 28600648$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-09104$ALKEM$$52$YR$$M$Y$88$KG$20240725$$CN$GB$GB
238348682$23834868$2$F$20240505$20240629$20240509$20240707$EXP$$CA-AMGEN-CANSP2024091126$AMGEN$$76$YR$E$F$Y$$$20240707$$HP$CA$CA
238348764$23834876$4$F$20240318$20240702$20240509$20240904$EXP$$FR-ROCHE-3556771$ROCHE$$75$YR$E$F$Y$$$20240904$$MD$FR$FR
238348843$23834884$3$F$$20240711$20240509$20240711$PER$$US-ALXN-202405USA000263US$ALEXION PHARMACEUTICALS$$$$A$M$Y$$$20240711$$HP$US$US
238348963$23834896$3$F$$20240830$20240509$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071906$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240903$$HP$US$US
238349106$23834910$6$F$$20240919$20240509$20240930$EXP$$GB-TAKEDA-2024TUS036765$TAKEDA$$$$$F$Y$$$20240930$$CN$GB$GB
238349115$23834911$5$F$20240101$20240704$20240509$20240711$EXP$$CA-CELLTRION INC.-2024CA010487$CELLTRION$$$$$$Y$$$20240711$$CN$CA$CA
238349462$23834946$2$F$$20240807$20240509$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070985$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240807$$CN$US$US
238349472$23834947$2$F$20240501$20240807$20240509$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072141$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240807$$CN$US$US
238349562$23834956$2$F$20240505$20240731$20240509$20240806$PER$$US-AMGEN-USASP2024090377$AMGEN$$74$YR$E$M$Y$$$20240805$$CN$US$US
238349604$23834960$4$F$$20240909$20240509$20240912$EXP$$US-ROCHE-3554898$ROCHE$$71$YR$E$F$Y$$$20240912$$CN$US$US
238349673$23834967$3$F$20240101$20240629$20240509$20240708$EXP$$CA-CELLTRION INC.-2024CA006351$CELLTRION$$$$$$Y$$$20240708$$CN$CA$CA
238349683$23834968$3$F$20240528$20240924$20240509$20240927$EXP$$CA-TAKEDA-2018TUS017280$TAKEDA$$65$YR$$M$Y$$$20240927$$CN$CA$CA
238349722$23834972$2$F$$20240822$20240509$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024055861$VIIV$$$$$M$Y$$$20240830$$HP$US$US
238349733$23834973$3$F$20240402$20240913$20240509$20240917$EXP$$US-GSK-US2024056325$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$US$US
238349962$23834996$2$F$$20240624$20240509$20240708$EXP$$IE-ROCHE-3546288$ROCHE$$$$$F$Y$$$20240708$$CN$IE$IE
238350072$23835007$2$F$20240415$20240730$20240509$20240826$PER$$US-TOLMAR, INC.-24US048482$TOLMAR$$74$YR$$M$Y$$$20240826$$PH$US$US
238350182$23835018$2$F$20210501$20240925$20240509$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071121$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240926$$CN$US$US
238350252$23835025$2$F$20240101$20240727$20240509$20240805$EXP$$CA-CELLTRION INC.-2024CA010524$CELLTRION$$$$$$Y$$$20240805$$PH$CA$CA
238350514$23835051$4$F$20240101$20240913$20240509$20240919$PER$$US-BIOGEN-2024BI01262935$BIOGEN$$$$$F$Y$$$20240919$$CN$US$US
238350532$23835053$2$F$$20240629$20240509$20240708$EXP$$CA-CELLTRION INC.-2024CA010585$CELLTRION$$$$$$Y$$$20240708$$HP$CA$CA
238350632$23835063$2$F$$20240501$20240509$20240808$PER$$US-LEO Pharma-370139$LEO PHARM$$75$YR$$M$Y$$$20240808$$CN$US$US
238350772$23835077$2$F$$20240719$20240509$20240731$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03717$HIKMA$$$$$F$Y$$$20240731$$CN$US$US
238350793$23835079$3$F$$20240711$20240509$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03881$LUPIN$$$$$$Y$$$20240809$$CN$US$US
238350864$23835086$4$F$$20240816$20240509$20240823$EXP$$CA-TAKEDA-2023TUS081846$TAKEDA$$$$$F$Y$$$20240823$$CN$CA$CA
238350932$23835093$2$F$$20240827$20240509$20240830$EXP$$US-TAKEDA-2024TUS044694$TAKEDA$$$$$F$Y$$$20240830$$HP$US$US
238350963$23835096$3$F$20230101$20240905$20240509$20240911$EXP$$DE-JNJFOC-20240513718$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240911$$MD$DE$DE
238351033$23835103$3$F$20240101$20240723$20240509$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-013168$JAZZ$$$$$F$Y$$$20240730$$MD$US$US
238351123$23835112$3$F$$20240909$20240509$20240912$EXP$$NVSC2024US095240$NOVARTIS$$$$$$Y$$$20240912$$CN$US$US
238351154$23835115$4$F$$20240911$20240509$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071874$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240916$$HP$US$US
238351182$23835118$2$F$$20240702$20240509$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03721$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238351192$23835119$2$F$$20240606$20240509$20240718$PER$$US-JNJFOC-20240485133$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$US$US
238351292$23835129$2$F$$20240711$20240509$20240722$EXP$$CA-SPECGX-T202401073$SPECGX$$59$YR$$F$Y$$$20240722$$HP$CA$CA
238351312$23835131$2$F$$20240711$20240509$20240722$EXP$$CA-SPECGX-T202401074$SPECGX$$34$YR$$M$Y$$$20240722$$MD$CA$CA
238351333$23835133$3$F$$20240701$20240509$20240708$PER$$US-ALXN-202405USA000141US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
238351342$23835134$2$F$$20240807$20240509$20240807$PER$$US-ALXN-202405USA000108US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
238351482$23835148$2$F$20240401$20240809$20240509$20240815$EXP$$US-BEH-2024171856$CSL BEHRING$$31$YR$A$M$Y$$$20240815$$HP$US$US
238351623$23835162$3$F$$20240802$20240509$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072002$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240807$$CN$US$US
238351792$23835179$2$F$20240508$20240716$20240509$20240719$EXP$$NVSC2024GB097754$NOVARTIS$$62$YR$$F$Y$$$20240719$$CN$GB$GB
238351812$23835181$2$F$20240101$20240507$20240509$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000141$Tarsus Pharmaceuticals$$$$$$Y$$$20240806$$MD$US$US
238351863$23835186$3$F$20230101$20240815$20240509$20240827$EXP$$CA-UCBSA-2024022603$UCB$$$$$M$Y$$$20240827$$CN$CA$CA
238351912$23835191$2$F$20240405$20240626$20240509$20240703$EXP$$CA-JNJFOC-20240509801$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240703$$HP$CA$CA
238351962$23835196$2$F$$20240702$20240509$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03716$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238351972$23835197$2$F$$20240705$20240509$20240708$EXP$$NVSC2024US097767$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
238352493$23835249$3$F$$20240724$20240509$20240728$EXP$$NVSC2024GB097897$NOVARTIS$$$$A$F$Y$$$20240728$$CN$GB$GB
238352564$23835256$4$F$20181004$20240813$20240509$20240815$EXP$$NVSC2024PT097577$NOVARTIS$$36$YR$$M$Y$$$20240815$$MD$PT$PT
238352582$23835258$2$F$$20240626$20240509$20240705$30DAY$$US-GSK-US2024AMR056974$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$US$US
238352602$23835260$2$F$20240501$20240703$20240509$20240708$EXP$$US-ABBVIE-5751558$ABBVIE$$55$YR$$M$Y$$$20240708$$CN$US$US
238352754$23835275$4$F$$20240627$20240509$20240703$EXP$$JP-JNJFOC-20240420441$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240703$$MD$JP$JP
238352884$23835288$4$F$20231019$20240826$20240509$20240905$EXP$$US-UCBSA-2024022667$UCB$$69$YR$$M$Y$87.982$KG$20240905$$HP$US$US
238352914$23835291$4$F$20240101$20240730$20240509$20240807$EXP$$CA-CELLTRION INC.-2024CA010525$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
238352974$23835297$4$F$20240415$20240617$20240509$20240704$30DAY$$US-GSK-US2024054836$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240704$$CN$US$US
238353042$23835304$2$F$$20240709$20240509$20240710$PER$$US-ALXN-202404USA001758US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
238353062$23835306$2$F$$20240813$20240509$20240814$EXP$$US-JNJFOC-20240508637$JOHNSON AND JOHNSON$$$$$F$Y$$$20240815$$HP$US$US
238353194$23835319$4$F$20221230$20240701$20240509$20240709$EXP$$IT-ABBVIE-4725059$ABBVIE$$71$YR$$F$Y$55$KG$20240709$$CN$IT$IT
238353242$23835324$2$F$20240425$20240806$20240509$20240809$PER$$US-AMGEN-USASP2024090546$AMGEN$$86$YR$E$M$Y$$$20240809$$CN$US$US
238353312$23835331$2$F$$20240628$20240509$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-444573$RANBAXY$$73$YR$$M$Y$101$KG$20240712$$MD$GB$GB
2383534010$23835340$10$F$20240502$20240628$20240509$20240703$EXP$$US-MYLANLABS-2024M1041152$MYLAN$$22$YR$$F$Y$$$20240703$$HP$US$US
238353692$23835369$2$F$$20240712$20240509$20240726$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-445132$RANBAXY$Stuben BO, Hoyer DP, Radunz S, Saner F, Schmidt H, Baba HA, et al. Idiosyncratic Drug-Induced Liver Injury in a Healthy Patient following PCSK9-Inhibitor Injection. Case Reports Hepatol. 2024;2024:4 pages$66$YR$$M$Y$$$20240726$$HP$DE$DE
238353954$23835395$4$F$20240502$20240702$20240509$20240717$EXP$$AR-MYLANLABS-2024M1041118$MYLAN$$63$YR$$F$Y$$$20240717$$CN$AR$AR
238354094$23835409$4$F$20240401$20240801$20240509$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-026624$BOEHRINGER INGELHEIM$$54$YR$A$F$Y$$$20240801$$CN$US$US
238354222$23835422$2$F$20240401$20240905$20240509$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069373$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240905$$CN$US$US
238354252$23835425$2$F$20240508$20240807$20240509$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072063$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$72.57$KG$20240813$$CN$US$US
238354262$23835426$2$F$$20240807$20240509$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072058$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240807$$HP$US$US
238355065$23835506$5$F$20240101$20240903$20240509$20240911$EXP$$US-UNITED THERAPEUTICS-UNT-2024-005544$UNITED THERAPEUTICS$$$$$F$Y$47.166$KG$20240911$$$US$US
238355103$23835510$3$F$$20240904$20240509$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072156$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$93.89$KG$20240906$$CN$US$US
238355432$23835543$2$F$20240503$20240711$20240509$20240717$PER$$US-ABBVIE-5751243$ABBVIE$$44$YR$$F$Y$80$KG$20240717$$MD$US$US
238355592$23835559$2$F$20240101$20240626$20240509$20240703$EXP$$US-AMGEN-USASP2024088737$AMGEN$$39$YR$A$F$Y$$$20240703$$MD$US$US
238355692$23835569$2$F$20240101$20240625$20240509$20240710$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00255$Phathom Pharmaceuticals$$$$A$F$Y$$$20240710$$MD$JP$JP
238355782$23835578$2$F$$20240526$20240509$20240807$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01385$AMNEAL$$$$$$Y$$$20240807$$CN$US$US
238355895$23835589$5$F$20240413$20240805$20240509$20240808$EXP$$US-JNJFOC-20240444516$JOHNSON AND JOHNSON$$88$YR$E$M$Y$$$20240808$$CN$US$US
238356112$23835611$2$F$$20240619$20240509$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071289$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240701$$CN$US$US
238356252$23835625$2$F$$20240709$20240509$20240709$EXP$$NVSC2024GB097682$NOVARTIS$$$$$F$Y$$$20240709$$CN$GB$GB
238356272$23835627$2$F$$20240923$20240509$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202405004583$ELI LILLY AND CO$$$$$F$Y$$$20240924$$CN$US$US
238356578$23835657$8$F$20230818$20240807$20240509$20240812$PER$$US-ROCHE-3528902$ROCHE$$22$YR$A$F$Y$49.44$KG$20240812$$CN$US$US
238356624$23835662$4$F$$20240711$20240509$20240716$EXP$$US-GSK-US2024056391$GLAXOSMITHKLINE$$$$$F$Y$$$20240716$$PH$US$US
238356652$23835665$2$F$20240501$20240711$20240509$20240713$EXP$$GB-ABBVIE-5751647$ABBVIE$$80$YR$$M$Y$$$20240713$$CN$GB$GB
238356862$23835686$2$F$20240115$20240822$20240509$20240903$EXP$$PT-AUROBINDO-AUR-APL-2024-020713$AUROBINDO$$53$YR$$M$Y$80$KG$20240903$$CN$PT$PT
238356905$23835690$5$F$$20240909$20240509$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-021117$AUROBINDO$$50$YR$$F$Y$49.5$KG$20240920$$MD$FR$FR
238356954$23835695$4$F$20240101$20240816$20240509$20240824$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013534$UNITED THERAPEUTICS$$$$$M$Y$94.785$KG$20240824$$PH$US$US
238356992$23835699$2$F$$20240624$20240509$20240705$EXP$$CA-ROCHE-3560718$ROCHE$$$$A$F$Y$$$20240705$$CN$CA$CA
238357062$23835706$2$F$20240428$20240709$20240509$20240716$EXP$$US-GSK-US2024056218$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$US$US
238357222$23835722$2$F$20240101$20240715$20240509$20240723$EXP$$US-SA-2024SA139871$SANOFI AVENTIS$$60$YR$A$F$Y$94$KG$20240723$$MD$US$US
238357365$23835736$5$F$$20240806$20240509$20240814$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000385$DECIPHERA PHARMACEUTICALS$$71$YR$E$M$Y$$$20240814$$CN$US$US
238357433$23835743$3$F$20240227$20240725$20240509$20240803$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01575$AMNEAL$$29$YR$$F$Y$$$20240803$$MD$US$US
238357545$23835754$5$F$$20240618$20240509$20240702$EXP$$CA-ROCHE-3560200$ROCHE$$$$A$F$Y$$$20240702$$CN$CA$CA
238357703$23835770$3$F$20240220$20240709$20240509$20240717$EXP$$CH-DECIPHERA PHARMACEUTICALS LLC-2024CH000403$DECIPHERA PHARMACEUTICALS$$79$YR$E$M$Y$$$20240717$$CN$CH$CH
238357792$23835779$2$F$$20240910$20240509$20240921$EXP$CA-MHPD-001075300$CA-Accord-422835$ACCORD$$62$YR$A$M$Y$$$20240921$$HP$CA$CA
238358053$23835805$3$F$$20240702$20240509$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03756$LUPIN$$$$$$Y$$$20240723$$CN$US$US
238358103$23835810$3$F$20240401$20240813$20240509$20240820$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013475$UNITED THERAPEUTICS$$75$YR$$F$Y$73.469$KG$20240820$$$US$US
238358193$23835819$3$F$$20240819$20240509$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072018$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240827$$MD$JP$JP
238358242$23835824$2$F$20240401$20240807$20240509$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072443$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240807$$HP$US$US
238358502$23835850$2$F$$20240701$20240509$20240708$PER$$US-ALXN-202405USA000113US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
238358593$23835859$3$F$$20240906$20240509$20240911$PER$$NVSC2024US098255$NOVARTIS$$92$YR$$M$Y$$$20240911$$CN$US$US
238358842$23835884$2$F$$20240702$20240509$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072062$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240703$$CN$US$US
238359112$23835911$2$F$20240401$20240702$20240509$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03765$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238359293$23835929$3$F$20240401$20240626$20240509$20240709$EXP$$CA-ROCHE-3557438$ROCHE$$69$YR$E$F$Y$$$20240709$$CN$CA$CA
238359332$23835933$2$F$$20240819$20240509$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072015$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240830$$CN$US$US
238359382$23835938$2$F$$20240725$20240509$20240730$EXP$$FR-VIIV HEALTHCARE LIMITED-FR2024055441$VIIV$$$$$$Y$$$20240730$$PH$FR$FR
238359442$23835944$2$F$$20240502$20240509$20240809$EXP$$BR-SANDOZ INC.-SDZ2024BR046842$SANDOZ$$$$$F$Y$99$KG$20240809$$CN$BR$BR
238359452$23835945$2$F$$20240704$20240509$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03803$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238359534$23835953$4$F$20240101$20240807$20240509$20240819$EXP$$US-INSMED, INC.-2024-01714-US$INSMED$$$$$F$Y$$$20240819$$HP$US$US
238359594$23835959$4$F$20230508$20240910$20240509$20240919$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000377$DECIPHERA PHARMACEUTICALS$$58$YR$A$M$Y$$$20240919$$MD$US$US
238359603$23835960$3$F$20240421$20240709$20240509$20240717$EXP$$US-Stemline Therapeutics, Inc.-2024ST002695$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240716$$CN$US$US
238359762$23835976$2$F$20220108$20240621$20240509$20240704$EXP$FR-AFSSAPS-AM2024000358$FR-Merck Healthcare KGaA-2024023739$MERCK KGAA$$33$YR$A$F$Y$70$KG$20240701$$CN$FR$FR
238359803$23835980$3$F$20240424$20240507$20240509$20240805$PER$$US-AstraZeneca-2024A099770$ASTRAZENECA$$27329$DY$$M$Y$$$20240805$$CN$US$
238359942$23835994$2$F$20240228$20240822$20240509$20240903$EXP$$PT-AUROBINDO-AUR-APL-2024-020711$AUROBINDO$$43$YR$$M$Y$90$KG$20240903$$CN$PT$PT
238359972$23835997$2$F$$20240425$20240509$20240801$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004171$AKCEA THERAPEUTICS$$$$$$Y$$$20240801$$CN$US$US
238360033$23836003$3$F$$20240912$20240509$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072295$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240918$$HP$US$US
238360052$23836005$2$F$20231201$20240809$20240509$20240812$EXP$$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-070370$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240812$$MD$SE$SE
238360282$23836028$2$F$$20240815$20240509$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-021665$AUROBINDO$$38$YR$$F$Y$102$KG$20240828$$HP$CA$CA
238360342$23836034$2$F$20240507$20240726$20240509$20240730$PER$$US-AMGEN-USASP2024092312$AMGEN$$70$YR$E$M$Y$$$20240729$$CN$US$US
238360352$23836035$2$F$20240508$20240718$20240509$20240722$PER$$US-AMGEN-USASP2024092009$AMGEN$$78$YR$E$M$Y$$$20240722$$CN$US$US
238360442$23836044$2$F$$20240805$20240509$20240809$EXP$$JP-JNJFOC-20240524943$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240809$$MD$JP$JP
238360502$23836050$2$F$20240506$20240802$20240509$20240806$PER$$US-AMGEN-USASP2024092219$AMGEN$$60$YR$A$F$Y$$$20240805$$CN$US$US
238360532$23836053$2$F$20231201$20240730$20240509$20240731$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-002555$BOEHRINGER INGELHEIM$$84$YR$E$M$Y$65$KG$20240731$$CN$ES$ES
238360612$23836061$2$F$$20240731$20240509$20240810$EXP$$CA-TEVA-VS-3196202$TEVA$$$$$$Y$$$20240810$$HP$CA$CA
238360902$23836090$2$F$20240412$20240731$20240509$20240811$EXP$$FR-AUROBINDO-AUR-APL-2024-020708$AUROBINDO$$75$YR$$M$Y$138$KG$20240812$$MD$FR$FR
238360962$23836096$2$F$$20240906$20240509$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071952$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$78.02$KG$20240909$$CN$US$US
238361072$23836107$2$F$20240401$20240805$20240509$20240816$EXP$$US-UCBSA-2024022183$UCB$$27$YR$$F$Y$$$20240816$$HP$US$US
238361166$23836116$6$F$20240101$20240627$20240509$20240710$EXP$$CA-ROCHE-3558150$ROCHE$$45$YR$A$F$Y$120$KG$20240710$$MD$CA$CA
238361392$23836139$2$F$20200221$20240720$20240509$20240730$EXP$$DE-AUROBINDO-AUR-APL-2024-021031$AUROBINDO$$26$YR$$M$Y$85$KG$20240730$$MD$DE$DE
238361492$23836149$2$F$20211129$20240724$20240509$20240803$EXP$$DE-AUROBINDO-AUR-APL-2024-021353$AUROBINDO$$82$YR$$F$Y$$$20240803$$MD$DE$DE
238361542$23836154$2$F$$20240815$20240509$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072147$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240815$$MD$JP$JP
238361853$23836185$3$F$20240401$20240718$20240509$20240724$EXP$$FI-MYLANLABS-2024M1041336$MYLAN$$58$YR$$M$Y$$$20240724$$MD$FI$FI
238361954$23836195$4$F$$20240909$20240509$20240912$30DAY$$IT-PFIZER INC-PV202400053909$PFIZER$$$$$M$Y$$$20240912$$CN$IT$IT
238362044$23836204$4$F$$20240913$20240509$20240918$30DAY$$US-PFIZER INC-202400102747$PFIZER$$14$YR$$M$Y$$$20240918$$CN$US$US
238362062$23836206$2$F$20240101$20240703$20240509$20240703$EXP$$CA-PFIZER INC-202400102133$PFIZER$$66$YR$$F$Y$$$20240703$$HP$CA$CA
2383620913$23836209$13$F$20230901$20240712$20240509$20240718$EXP$$DE-PFIZER INC-202400098460$PFIZER$$79$YR$$M$Y$67$KG$20240718$$HP$DE$DE
238362132$23836213$2$F$$20240703$20240509$20240703$EXP$$CA-PFIZER INC-202400102124$PFIZER$$40$YR$$F$Y$$$20240703$$HP$CA$CA
238362232$23836223$2$F$$20240906$20240509$20240911$EXP$$CA-PFIZER INC-202400102055$PFIZER$$35$YR$$F$Y$$$20240911$$MD$CA$CA
238362313$23836231$3$F$20240904$20240904$20240509$20240913$EXP$$CA-CELLTRION INC.-2024CA010601$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
238362382$23836238$2$F$$20240919$20240509$20240924$EXP$$GB-ABBVIE-5749857$ABBVIE$$$$A$F$Y$$$20240924$$CN$GB$GB
238362472$23836247$2$F$20240429$20240806$20240509$20240812$PER$$US-JNJFOC-20240488066$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$MD$US$US
238362579$23836257$9$F$20190101$20240712$20240509$20240716$EXP$$US-PFIZER INC-202400103020$PFIZER$$59$YR$$F$Y$67.59$KG$20240716$$CN$US$US
238362782$23836278$2$F$20240201$20240924$20240509$20240926$PER$$US-PFIZER INC-PV202400059407$PFIZER$$53$YR$$F$Y$$$20240926$$HP$US$US
238363182$23836318$2$F$$20240912$20240509$20240915$PER$$US-ALXN-202405USA000081US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
238363202$23836320$2$F$$20240805$20240509$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202405002330$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240814$$CN$US$US
238363312$23836331$2$F$20221201$20240708$20240509$20240715$EXP$$US-OTSUKA-2024_012926$OTSUKA$$66$YR$$M$Y$112.8$KG$20240715$$MD$US$US
238363413$23836341$3$F$20240507$20240814$20240509$20240818$PER$$US-AMGEN-USASP2024092237$AMGEN$$63$YR$A$M$Y$$$20240817$$CN$US$US
238363503$23836350$3$F$20240301$20240708$20240509$20240712$EXP$$US-PFIZER INC-PV202400038177$PFIZER$$58$YR$$F$Y$$$20240712$$HP$US$US
238363582$23836358$2$F$20220906$20240704$20240509$20240704$EXP$$CA-PFIZER INC-202200951400$PFIZER$$56$YR$$F$Y$76$KG$20240704$$MD$CA$CA
238363763$23836376$3$F$$20240905$20240509$20240905$EXP$$CA-PFIZER INC-202400015690$PFIZER$$72$YR$$M$Y$$$20240905$$HP$CA$CA
238363805$23836380$5$F$20240101$20240822$20240509$20240826$EXP$$CA-PFIZER INC-202400103456$PFIZER$$74$YR$$M$Y$$$20240826$$HP$CA$CA
238363815$23836381$5$F$20230404$20240723$20240509$20240726$EXP$$CA-PFIZER INC-202300116902$PFIZER$$67$YR$$M$Y$131$KG$20240726$$MD$CA$CA
238364342$23836434$2$F$$20240719$20240509$20240720$PER$$NVSC2024US098091$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
238364413$23836441$3$F$20240502$20240708$20240509$20240709$EXP$$US-UCBSA-2024022158$UCB$$7$YR$$F$Y$$$20240709$$CN$US$US
238364487$23836448$7$F$$20240812$20240509$20240815$30DAY$$CA-PFIZER INC-202400094760$PFIZER$$39$YR$$F$Y$$$20240815$$CN$CA$CA
238364493$23836449$3$F$$20240921$20240509$20240925$30DAY$$KR-PFIZER INC-PV202400058123$PFIZER$$8$YR$$$Y$$$20240925$$CN$KR$KR
238364504$23836450$4$F$$20240921$20240509$20240924$30DAY$$GT-PFIZER INC-PV202400058363$PFIZER$$4$YR$$F$Y$$$20240924$$HP$GT$GT
238364513$23836451$3$F$20240508$20240807$20240509$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071821$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240809$$CN$US$US
238364525$23836452$5$F$$20240807$20240509$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072168$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240807$$CN$US$US
238364693$23836469$3$F$$20240730$20240509$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202405004015$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240805$$CN$US$US
238364932$23836493$2$F$20230801$20240715$20240509$20240720$EXP$$CO-JNJFOC-20230914337$JOHNSON AND JOHNSON$$42$YR$A$M$Y$60$KG$20240719$$HP$CO$CO
238364993$23836499$3$F$$20240912$20240509$20240916$30DAY$$US-PFIZER INC-202400100814$PFIZER$$25$YR$$F$Y$$$20240916$$CN$US$US
238365004$23836500$4$F$20240101$20240920$20240509$20240925$30DAY$$US-PFIZER INC-202400103185$PFIZER$$14$YR$$M$Y$36.281$KG$20240925$$CN$US$US
238365163$23836516$3$F$20240505$20240718$20240509$20240722$PER$$US-AMGEN-USASP2024091737$AMGEN$$83$YR$E$F$Y$$$20240722$$CN$US$US
238365392$23836539$2$F$20240331$20240711$20240509$20240712$EXP$FR-AFSSAPS-NT2024000508$FR-PFIZER INC-202400102233$PFIZER$$69$YR$$M$Y$99$KG$20240712$$HP$FR$FR
238365915$23836591$5$F$$20240904$20240509$20240911$EXP$$CA-ROCHE-3559738$ROCHE$$$$A$M$Y$$$20240911$$CN$CA$CA
238365953$23836595$3$F$$20240703$20240509$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072248$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$104.33$KG$20240705$$CN$US$US
238366098$23836609$8$F$20240501$20240921$20240509$20240925$30DAY$$US-PFIZER INC-202400091104$PFIZER$$12$YR$$M$Y$36.74$KG$20240925$$MD$US$US
238366112$23836611$2$F$20240129$20240725$20240509$20240731$EXP$$US-OTSUKA-2024_002907$OTSUKA$$67$YR$$F$Y$$$20240731$$CN$US$US
238366352$23836635$2$F$20211129$20240730$20240509$20240805$EXP$$DE-MYLANLABS-2024M1040904$MYLAN$$82$YR$$F$Y$$$20240805$$HP$DE$DE
238366382$23836638$2$F$$20240823$20240509$20240827$EXP$$US-INCYTE CORPORATION-2024IN004884$INCYTE$$$$$$Y$$$20240827$$HP$US$US
238366422$23836642$2$F$20240429$20240711$20240509$20240711$EXP$$US-ALXN-202405USA000094US$ALEXION PHARMACEUTICALS$$12$YR$$F$Y$$$20240711$$CN$US$US
238366464$23836646$4$F$$20240913$20240509$20240918$30DAY$$PR-PFIZER INC-202400103120$PFIZER$$13$YR$$M$Y$$$20240918$$CN$PR$PR
238366475$23836647$5$F$20240502$20240906$20240509$20240912$30DAY$$US-PFIZER INC-202400100801$PFIZER$$11$YR$$M$Y$28.12$KG$20240912$$CN$US$US
238366522$23836652$2$F$$20240807$20240509$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072432$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240807$$CN$US$US
238366546$23836654$6$F$20240317$20240621$20240509$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007125$JAZZ$$38$YR$$M$Y$$$20240703$$MD$US$US
238366713$23836671$3$F$20231001$20240917$20240509$20240919$EXP$$NO-PFIZER INC-202400103349$PFIZER$$59$YR$$M$Y$$$20240919$$MD$NO$NO
238366894$23836689$4$F$20240208$20240912$20240509$20240917$EXP$$US-PFIZER INC-202400103171$PFIZER$$8$YR$$F$Y$$$20240917$$CN$US$US
238366914$23836691$4$F$20240504$20240918$20240509$20240923$30DAY$$US-PFIZER INC-202400101656$PFIZER$$6$YR$$M$Y$21.32$KG$20240923$$CN$US$US
238366982$23836698$2$F$$20240725$20240509$20240730$PER$$US-ABBVIE-5747468$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
238367092$23836709$2$F$20240214$20240813$20240509$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-069711$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$90.26$KG$20240821$$PH$US$US
238367242$23836724$2$F$20230101$20240624$20240509$20240701$EXP$$BR-BIOGEN-2024BI01262532$BIOGEN$$$$$M$Y$62$KG$20240701$$MD$BR$BR
238367312$23836731$2$F$20230912$20240912$20240509$20240920$EXP$$US-BEH-2024171911$CSL BEHRING$$64$YR$A$F$Y$83.63$KG$20240920$$CN$US$US
238367452$23836745$2$F$20230901$20240715$20240509$20240722$EXP$$US-BEH-2024171760$CSL BEHRING$$52$YR$A$M$Y$$$20240719$$HP$US$US
238367463$23836746$3$F$$20240722$20240509$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000979$DECIPHERA PHARMACEUTICALS$$70$YR$E$M$Y$$$20240806$$HP$US$US
238367533$23836753$3$F$$20240801$20240509$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072044$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240802$$CN$US$US
238367542$23836754$2$F$$20240806$20240509$20240807$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-069687$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240808$$MD$AT$AT
238367812$23836781$2$F$$20240819$20240509$20240823$EXP$$CA-TAKEDA-2023TUS121579$TAKEDA$$$$$F$Y$$$20240823$$MD$CA$CA
238367832$23836783$2$F$20240323$20240708$20240509$20240716$EXP$$CA-TAKEDA-2024TUS029763$TAKEDA$$56$YR$$M$Y$$$20240716$$MD$CA$CA
238368152$23836815$2$F$20110701$20240628$20240509$20240708$EXP$$FR-TEVA-VS-3177483$TEVA$$38$YR$$F$Y$$$20240708$$LW$FR$FR
238368342$23836834$2$F$20240309$20240710$20240509$20240716$EXP$FR-AFSSAPS-BX2024000816$FR-MYLANLABS-2024M1040907$MYLAN$$82$YR$$F$Y$$$20240716$$PH$FR$FR
238368444$23836844$4$F$20240503$20240606$20240509$20240902$PER$$US-ASTELLAS-2024US013315$ASTELLAS$$45$YR$A$F$Y$$$20240830$$MD$US$US
238368593$23836859$3$F$20240401$20240702$20240509$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03771$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238368602$23836860$2$F$$20240701$20240509$20240709$EXP$$US-OTSUKA-2024_012899$OTSUKA$$$$$$Y$$$20240709$$HP$US$US
238368612$23836861$2$F$$20240827$20240509$20240905$EXP$$US-SA-2024SA139646$SANOFI AVENTIS$$$$A$M$Y$$$20240905$$MD$US$US
238368852$23836885$2$F$20240401$20240726$20240509$20240801$EXP$$US-ABBVIE-5747227$ABBVIE$$52$YR$$F$Y$$$20240801$$CN$US$US
238369022$23836902$2$F$20240430$20240813$20240509$20240821$PER$$US-JNJFOC-20240500927$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240821$$MD$US$US
238369132$23836913$2$F$20230301$20240626$20240509$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071615$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$92.08$KG$20240701$$CN$US$US
238369142$23836914$2$F$20221230$20240827$20240509$20240906$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-000651$AKEBIA THERAPEUTICS$$92$YR$$F$Y$42$KG$20240906$$CN$JP$JP
238369262$23836926$2$F$$20240702$20240509$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03760$LUPIN$$$$$$Y$$$20240718$$CN$US$US
238369348$23836934$8$F$20240606$20240916$20240509$20240919$EXP$$US-BIOVITRUM-2024-US-006291$BIOVITRUM$$76$YR$$M$Y$$$20240919$$CN$US$US
238369555$23836955$5$F$$20240617$20240509$20240809$EXP$$PT-ABBVIE-5748821$SANDOZ$$$$E$$Y$$$20240809$$HP$PT$PT
2383699110$23836991$10$F$$20240905$20240509$20240910$EXP$$US-VERTEX PHARMACEUTICALS-2024-007685$VERTEX$$55$YR$$F$Y$$$20240910$$CN$US$US
238370062$23837006$2$F$$20240729$20240509$20240730$EXP$$US-GILEAD-2024-0672180$GILEAD$$71$YR$E$F$Y$$$20240730$$MD$US$US
238370123$23837012$3$F$$20240702$20240509$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03804$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238370213$23837021$3$F$$20240708$20240509$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202405000401$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240719$$MD$US$US
238370382$23837038$2$F$20240503$20240625$20240509$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202405003140$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240701$$CN$US$US
238370452$23837045$2$F$$20240626$20240509$20240701$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405001075$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$JP$JP
238370612$23837061$2$F$20240308$20240426$20240509$20240909$EXP$$US-TEVA-VS-3196017$TEVA$$21$YR$$M$Y$$$20240909$$CN$US$US
238370662$23837066$2$F$$20240808$20240509$20240820$EXP$$ES-AUROBINDO-AUR-APL-2024-023003$AUROBINDO$Moreno-alonso D, Llorens-torrom? S, Febrer BCD, Garc?a MA, Serrano-berm?dez G, Trelis-navarro J et al. Adhesive capsaicin 8% patch for improved control of pain caused by chemotherapy induced peripheral neuropathy in patients with multiple myeloma: A single-centre, seven-case series. Journal of Oncology Pharmacy Practice. 2024;30 (4):752-758$$$$F$Y$$$20240820$$HP$ES$ES
238371093$23837109$3$F$$20240704$20240509$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03761$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238371173$23837117$3$F$20240101$20240716$20240509$20240722$EXP$$US-ABBVIE-5728555$ABBVIE$$$$$M$Y$90$KG$20240722$$CN$US$US
238371203$23837120$3$F$$20240718$20240509$20240813$PER$$US-INCYTE CORPORATION-2024IN004147$INCYTE$$$$$$Y$$$20240813$$CN$US$US
238371617$23837161$7$F$20240418$20240916$20240509$20240924$EXP$$US-ROCHE-3559817$ROCHE$$23$YR$A$M$Y$113.4$KG$20240924$$CN$US$US
238371742$23837174$2$F$20181001$20240629$20240509$20240701$EXP$$US-PFIZER INC-PV202400058915$PFIZER$$8$YR$$M$Y$23.2$KG$20240701$$MD$US$US
238372142$23837214$2$F$$20240809$20240509$20240823$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-445691$RANBAXY$Horn S, Danyel M, Erdmann N, Boschann F, Gunnarsson C, Biskup S. Case report: KPTN generelated syndrome associated with a spectrum of neurodevelopmental anomalies including severe epilepsy. Front Neurol. 2023;13:no pagination$6$YR$$M$Y$$$20240823$$HP$DE$DE
238372154$23837215$4$F$20240620$20240626$20240509$20240703$EXP$$CA-GSK-CA2024057233$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CA$CA
238372363$23837236$3$F$$20240719$20240509$20240802$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445398$RANBAXY$Andre RT, Romao JP, Rebelo MS, Pais FC, Fernandes AM, Baronet PM, et al. Hepatotoxicity to Risperidone. Prim Care Companion CNS Disord. 2024;26 (2):23cr03658/e1-e2$44$YR$$F$Y$$$20240802$$MD$PT$PT
238372372$23837237$2$F$$20240829$20240509$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445376$RANBAXY$Tan JQE, Dawson JL, Bastiampillai T. Can lithium be used in the setting of clozapine commencement in patients with COVID- 19 associated neutropenia: A case report. Clin Case Rep. 2024;12 (4):e8758(1-6)$19$YR$$M$Y$$$20240913$$HP$AU$AU
238372612$23837261$2$F$$20240729$20240509$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-445412$RANBAXY$Arcadi T, Storer S, Bona F, Zanatta P, Gallo M. Lenalidomide-induced myocarditis:a Rare Case of Cardiotoxicity. J Cardiovasc Magn Resonance. 2024;26 (Suppl.):100229$55$YR$$M$Y$$$20240813$$MD$IT$IT
238372632$23837263$2$F$$20240715$20240509$20240717$PER$$NVSC2024US098525$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
238372844$23837284$4$F$20240425$20240617$20240509$20240701$EXP$$CH-ORGANON-O2405CHE000665$ORGANON$$$$A$F$Y$80$KG$20240701$$MD$CH$CH
238373022$23837302$2$F$$20240715$20240509$20240716$EXP$$NVSC2024CO097760$NOVARTIS$$$$$F$Y$$$20240716$$MD$CO$CO
238373054$23837305$4$F$20240229$20240904$20240509$20240911$EXP$$CA-GSK-CA2024027657$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$MD$CA$CA
238373252$23837325$2$F$$20240730$20240509$20240822$PER$$CA-TOLMAR, INC.-24CA048450$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
238373272$23837327$2$F$20240412$20240705$20240509$20240731$PER$$CA-TOLMAR, INC.-24CA048476$TOLMAR$$77$YR$$M$Y$$$20240731$$CN$CA$CA
238373402$23837340$2$F$$20240703$20240509$20240722$PER$$US-INCYTE CORPORATION-2024IN004143$INCYTE$$$$$$Y$$$20240719$$MD$US$US
238373553$23837355$3$F$20240505$20240729$20240509$20240731$PER$$US-AMGEN-USASP2024090809$AMGEN$$71$YR$E$F$Y$$$20240731$$CN$US$US
238373576$23837357$6$F$20240414$20240826$20240509$20240901$EXP$$ES-AUROBINDO-AUR-APL-2024-022187$AUROBINDO$$47$YR$$F$Y$59.1$KG$20240901$$MD$ES$ES
238373832$23837383$2$F$$20240805$20240509$20240808$EXP$$BE-AUROBINDO-AUR-APL-2024-022479$AUROBINDO$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T.. Drug-induced anaphylaxis uncommon in mastocytosis: findings from two large cohorts. THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE.. 2024;12(7):1850- 62$39$YR$$$Y$$$20240808$$MD$SE$BE
238373852$23837385$2$F$$20240904$20240509$20240910$EXP$$JP-009507513-2405JPN000108J$MERCK$$69$YR$$F$Y$$$20240910$$MD$JP$JP
238373902$23837390$2$F$$20240730$20240509$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070479$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240731$$CN$US$US
238373972$23837397$2$F$20240328$20240916$20240509$20240924$EXP$FR-AFSSAPS-MA2024000498$FR-TEVA-VS-3193355$TEVA$$87$YR$$M$Y$$$20240924$$MD$FR$FR
238375084$23837508$4$F$20240501$20240905$20240509$20240906$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-071117$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$78.47$KG$20240906$$CN$PR$PR
238375092$23837509$2$F$$20240807$20240509$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072546$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240807$$CN$US$US
238375157$23837515$7$F$20240502$20240911$20240509$20240913$30DAY$$US-PFIZER INC-202400102834$PFIZER$$13$YR$$F$Y$30.84$KG$20240913$$CN$US$US
238375263$23837526$3$F$$20240802$20240509$20240807$EXP$$NVSC2024US096962$NOVARTIS$$$$$F$Y$$$20240807$$HP$US$US
238375642$23837564$2$F$20240101$20240819$20240509$20240829$EXP$FR-RIGEL PHARMACEUTICALS, INC.-2024FOS000555$FR-RIGEL PHARMACEUTICALS, INC.-2024FOS000555$RIGEL PHARMACEUTICALS$$82$YR$$M$Y$57$KG$20240829$$PH$FR$FR
238375972$23837597$2$F$20240101$20240726$20240509$20240806$PER$$US-SA-2024SA134335$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240806$$MD$US$US
238376042$23837604$2$F$20240401$20240610$20240509$20240703$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-07756$IPSEN$$8$YR$C$M$Y$$$20240703$$HP$US$US
238376264$23837626$4$F$20240101$20240702$20240509$20240709$EXP$$US-SA-2024SA136450$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240709$$CN$US$US
238376283$23837628$3$F$$20240731$20240509$20240809$PER$$US-SA-2024SA136184$SANOFI AVENTIS$$30$YR$A$M$Y$104.3$KG$20240809$$MD$US$US
238376684$23837668$4$F$20240101$20240723$20240509$20240731$PER$$US-SA-2024SA132673$SANOFI AVENTIS$$52$YR$A$M$Y$84.4$KG$20240731$$MD$US$US
238376702$23837670$2$F$$20240816$20240509$20240829$PER$$US-SA-2024SA134287$SANOFI AVENTIS$$$$E$F$Y$113$KG$20240829$$MD$US$US
238376942$23837694$2$F$20240101$20240719$20240509$20240729$PER$$US-SA-2024SA132234$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240729$$MD$US$US
238377052$23837705$2$F$20240101$20240726$20240509$20240806$PER$$US-SA-2024SA132685$SANOFI AVENTIS$$86$YR$E$F$Y$64.399$KG$20240806$$MD$US$US
238377142$23837714$2$F$20240101$20240806$20240509$20240814$PER$$US-SA-2024SA134352$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240814$$MD$US$US
238377193$23837719$3$F$20240101$20240801$20240509$20240810$PER$$US-SA-2024SA136059$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240810$$MD$US$US
238377216$23837721$6$F$20240101$20240917$20240509$20240925$PER$$US-SA-2024SA134368$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240925$$MD$US$US
238377482$23837748$2$F$20240101$20240820$20240509$20240830$PER$$US-SA-2024SA138232$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240830$$MD$US$US
238377622$23837762$2$F$20240417$20240806$20240509$20240806$EXP$$US-JNJFOC-20240503781$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240807$$CN$US$US
238377972$23837797$2$F$20240401$20240709$20240509$20240717$PER$$US-SA-2024SA102134$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240717$$MD$US$US
238378032$23837803$2$F$20240101$20240701$20240509$20240710$PER$$US-SA-2024SA137906$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240710$$MD$US$US
238378122$23837812$2$F$20240425$20240710$20240509$20240718$PER$$US-SA-2024SA136632$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240719$$MD$US$US
238378172$23837817$2$F$20240101$20240923$20240509$20240930$PER$$US-SA-2024SA137893$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240929$$MD$US$US
238378312$23837831$2$F$20240301$20240710$20240509$20240718$PER$$US-SA-2024SA131546$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240718$$MD$US$US
238378402$23837840$2$F$20240101$20240805$20240509$20240813$PER$$US-SA-2024SA137279$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240814$$MD$US$US
238378432$23837843$2$F$20240101$20240717$20240509$20240725$PER$$US-SA-2024SA137262$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240725$$CN$US$US
238378492$23837849$2$F$20240101$20240715$20240509$20240724$PER$$US-SA-2024SA135791$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240724$$MD$US$US
238378582$23837858$2$F$20240101$20240625$20240509$20240704$PER$$US-SA-2024SA138382$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240704$$MD$US$US
238378602$23837860$2$F$20230101$20240621$20240509$20240701$PER$$US-SA-2024SA085763$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240701$$MD$US$US
238378642$23837864$2$F$20240401$20240624$20240509$20240703$PER$$US-SA-2024SA137222$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240703$$MD$US$US
238378762$23837876$2$F$$20240730$20240509$20240808$PER$$US-SA-2024SA136467$SANOFI AVENTIS$$15$YR$T$M$Y$45.17$KG$20240808$$MD$US$US
238378772$23837877$2$F$20240101$20240625$20240509$20240704$PER$$US-SA-2024SA137024$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240704$$MD$US$US
238378882$23837888$2$F$$20240620$20240509$20240701$PER$$US-SA-2024SA139126$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240701$$CN$US$US
238378952$23837895$2$F$20240417$20240723$20240509$20240731$EXP$$DE-009507513-2405DEU001704$MERCK$$3$MON$$M$Y$5.2$KG$20240731$$MD$DE$DE
238378962$23837896$2$F$$20240807$20240509$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071385$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240807$$CN$US$US
238378983$23837898$3$F$$20240814$20240509$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071492$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240814$$CN$US$US
238379422$23837942$2$F$20240501$20240904$20240509$20240906$EXP$$GB-SANDOZ INC.-SDZ2024GB001090$SANDOZ$$61$YR$$F$Y$$$20240906$$CN$GB$GB
238379583$23837958$3$F$20240403$20240702$20240509$20240705$EXP$$US-SA-2024SA138072$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240705$$MD$US$US
238379652$23837965$2$F$20240101$20240625$20240509$20240704$PER$$US-SA-2024SA139184$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240704$$MD$US$US
238379952$23837995$2$F$$20240723$20240509$20240725$EXP$$US-JNJFOC-20240430789$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$HP$US$US
238380203$23838020$3$F$20240302$20240626$20240509$20240709$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-IBA-000038$Unknown Manufacturer$$$$$$Y$$$20240709$$CN$US$US
238380532$23838053$2$F$$20240712$20240509$20240715$EXP$$NVSC2024US097642$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
238380582$23838058$2$F$$20240807$20240509$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072389$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240807$$CN$US$US
238380594$23838059$4$F$20240601$20240717$20240509$20240725$PER$$US-SA-2024SA138531$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
238380612$23838061$2$F$$20240716$20240509$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072622$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240718$$CN$US$US
238380742$23838074$2$F$$20240727$20240509$20240805$PER$$US-SA-2024SA053680$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240805$$CN$US$US
238380792$23838079$2$F$$20240807$20240509$20240807$PER$$US-ALXN-202405USA000066US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
238380894$23838089$4$F$20111116$20240715$20240509$20240716$EXP$US-EMA-20150624-AUTODUP-440363$US-PFIZER INC-PV202400058260$PFIZER$$54$YR$$F$Y$56.236$KG$20240716$$HP$US$US
238381112$23838111$2$F$20240101$20240625$20240509$20240701$EXP$$CA-ABBVIE-5752299$ABBVIE$$72$YR$$F$Y$$$20240701$$CN$CA$CA
238381132$23838113$2$F$$20240827$20240509$20240912$EXP$$US-SA-2024SA138580$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240912$$MD$US$US
238381332$23838133$2$F$$20240812$20240509$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071693$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240814$$CN$US$US
238381512$23838151$2$F$20240101$20240726$20240509$20240731$EXP$$BR-AMERICAN REGENT INC-2024001714$AMERICAN REGENT$$$$$F$Y$56$KG$20240731$$CN$BR$BR
238381622$23838162$2$F$$20240814$20240509$20240825$EXP$$CA-JNJFOC-20240508947$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240825$$HP$CA$CA
238381722$23838172$2$F$20240101$20240628$20240509$20240702$PER$$US-PFIZER INC-202400103358$PFIZER$$65$YR$$F$Y$68.04$KG$20240702$$CN$US$US
238381782$23838178$2$F$$20240624$20240509$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202404007433$ELI LILLY AND CO$$56$YR$A$F$Y$73.469$KG$20240701$$CN$US$US
238381792$23838179$2$F$$20240830$20240509$20240904$PER$$US-JNJFOC-20240464900$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
238381883$23838188$3$F$20220118$20240910$20240509$20240919$EXP$$NVSC2022FR092533$NOVARTIS$$70$YR$$M$Y$89$KG$20240919$$MD$FR$FR
238384233$23838423$3$F$$20240806$20240509$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071460$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240806$$CN$US$US
238384293$23838429$3$F$$20240819$20240509$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072580$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240822$$CN$US$US
238384672$23838467$2$F$$20240807$20240509$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072591$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240807$$CN$US$US
238384772$23838477$2$F$$20240709$20240509$20240713$EXP$$US-SA-2024SA138551$SANOFI AVENTIS$$18$YR$A$M$Y$59.874$KG$20240713$$MD$US$US
238384812$23838481$2$F$$20240702$20240509$20240711$PER$$US-SA-2024SA135108$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240711$$MD$US$US
238384883$23838488$3$F$20210101$20240816$20240509$20240822$EXP$$CA-TAKEDA-2024TUS045700$TAKEDA$$45$YR$$M$Y$$$20240822$$HP$CA$CA
238384902$23838490$2$F$20240101$20240910$20240509$20240912$EXP$$US-PFIZER INC-PV202400059814$PFIZER$$85$YR$$M$Y$$$20240912$$HP$US$US
238384943$23838494$3$F$$20240710$20240509$20240715$EXP$$US-PFIZER INC-202400103915$PFIZER$$82$YR$$F$Y$$$20240715$$CN$US$US
238385224$23838522$4$F$$20240913$20240509$20240923$EXP$$NL-TEVA-VS-3195662$TEVA$Sampaio-Pinto V,Kelters IR,Van Der Geest JSA,Zwetsloot PP,Teske AJ,De Boer TP,Van Der Kaaij NP,Sluijter JPG,Van Laake LW. Modelling chemotherapy-induced cardiotoxicity with live myocardial slices: from bedside to bench and back again. Cardiovascular Research. 2024-05, 120 (Suppl.): i55.; Kelters IR, van der GeestJS, Sampaio-Pinto V, Zwetsloot PM, Teske AJ, De Boer TP, et al. Ex Vivo Myocardial Slices Unveil Reversibility in Chemotherapy-Induced Cardiotoxicity. J-Heart-Lung-Transplant 2024; 43...$48$YR$$F$Y$$$20240923$$HP$NL$NL
238385853$23838585$3$F$$20240805$20240509$20240808$EXP$$GB-MYLANLABS-2024M1041489$MYLAN$Abiodun A, Crake T, Ghosh AK, Westwood M, Herrey AS, Manisty CH., et al. A Mirror to the Multiple Faces of Cardiotoxicity. Journal of Cardiovascular Magnetic Resonance. 2024;26$81$YR$$F$Y$$$20240808$$HP$GB$GB
238386145$23838614$5$F$20240430$20240710$20240509$20240712$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-070394$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240712$$MD$DE$DE
238386312$23838631$2$F$20240507$20240816$20240509$20240820$PER$$US-AMGEN-USASP2024092360$AMGEN$$62$YR$A$F$Y$$$20240820$$CN$US$US
238386422$23838642$2$F$$20240911$20240509$20240918$EXP$$CA-TEVA-VS-3196648$TEVA$$37$YR$$F$Y$$$20240918$$MD$CA$CA
238386774$23838677$4$F$$20240730$20240509$20240807$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000934$BLUEPRINT MEDICINES$$$$$M$Y$$$20240807$$HP$US$US
238387162$23838716$2$F$$20240829$20240509$20240906$PER$$US-VERTEX PHARMACEUTICALS-2024-007913$VERTEX$$$$A$$Y$$$20240906$$HP$US$US
238387183$23838718$3$F$$20240711$20240509$20240711$PER$$US-ALXN-202405USA000156US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
238387323$23838732$3$F$$20240523$20240509$20240719$EXP$FR-AFSSAPS-RS2024000404$FR-BAUSCH-BL-2024-007043$BAUSCH AND LOMB$$11$YR$$M$Y$$$20240719$$MD$FR$FR
238387574$23838757$4$F$20240101$20240903$20240509$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072510$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$76.2$KG$20240905$$CN$US$US
238387704$23838770$4$F$$20240711$20240509$20240720$EXP$$CA-TEVA-VS-3196772$TEVA$$70$YR$$M$Y$$$20240720$$HP$CA$CA
238388143$23838814$3$F$20240419$20240506$20240509$20240731$EXP$$US-ARGENX-2024-ARGX-US002734$ARGENX BVBA$$$$$$Y$$$20240731$$CN$US$US
238388515$23838851$5$F$20240401$20240730$20240509$20240807$EXP$$US-ARGENX-2024-ARGX-US002917$ARGENX BVBA$$$$$$Y$$$20240807$$HP$US$US
238388932$23838893$2$F$20240425$20240913$20240509$20240917$EXP$$US-KYOWAKIRIN-2024KK010618$KYOWA$$$$$$Y$$$20240917$$HP$US$US
238389012$23838901$2$F$$20240717$20240509$20240722$EXP$$US-KYOWAKIRIN-2024KK010812$KYOWA$$$$$$Y$$$20240722$$CN$US$US
238389042$23838904$2$F$$20240506$20240509$20240806$EXP$$US-KYOWAKIRIN-2024KK010693$KYOWA$$$$$$Y$$$20240806$$MD$US$US
238389053$23838905$3$F$20240501$20240705$20240509$20240712$EXP$$US-KYOWAKIRIN-2024KK010813$KYOWA$$$$$$Y$$$20240712$$HP$US$US
238389062$23838906$2$F$20240401$20240710$20240509$20240715$EXP$$US-KYOWAKIRIN-2024KK010818$KYOWA$$$$$$Y$$$20240715$$HP$US$US
238389142$23838914$2$F$20230602$20240711$20240509$20240725$EXP$$AR-AKCEA THERAPEUTICS, INC.-2023IS001564$AKCEA THERAPEUTICS$$$$$$Y$$$20240724$$MD$AR$AR
238389202$23838920$2$F$20240325$20240903$20240509$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202405004620$ELI LILLY AND CO$$$$A$F$Y$$$20240905$$CN$US$US
238389272$23838927$2$F$20240507$20240823$20240509$20240828$PER$$US-AMGEN-USASP2024092469$AMGEN$$81$YR$E$F$Y$$$20240827$$CN$US$US
238389403$23838940$3$F$$20240628$20240509$20240702$EXP$$CA-SANDOZ INC.-SDZ2024CA045747$SANDOZ$$$$$F$Y$$$20240702$$CN$CA$CA
238389542$23838954$2$F$$20240703$20240509$20240705$EXP$$US-SANDOZ INC.-SDZ2024US045609$SANDOZ$$$$$$Y$$$20240705$$CN$US$US
238389692$23838969$2$F$20240101$20240715$20240509$20240720$EXP$$US-009507513-2405USA002106$MERCK$$$$$M$Y$$$20240720$$CN$US$US
238389885$23838988$5$F$20240305$20240527$20240509$20240718$EXP$$CA-Taiho Oncology Inc-2024-002585$TAIHO ONCOLOGY INC$$58$YR$A$M$Y$$$20240718$$CN$CA$CA
238390052$23839005$2$F$$20240711$20240509$20240711$EXP$$US-ALXN-202405USA000272US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$MD$US$US
238390103$23839010$3$F$20210722$20240628$20240509$20240709$PER$$JP-Eisai-EC-2024-165130$EISAI$$35$YR$A$F$Y$$$20240709$$MD$JP$JP
238390132$23839013$2$F$$20240807$20240509$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070906$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240807$$HP$US$US
238390223$23839022$3$F$20240425$20240711$20240509$20240711$PER$$US-ALXN-202405USA000219US$ALEXION PHARMACEUTICALS$$60$YR$$$Y$$$20240711$$CN$US$US
238390313$23839031$3$F$20230823$20240906$20240509$20240917$PER$$US-SA-2024SA136302$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240918$$MD$US$US
238390622$23839062$2$F$20230101$20240508$20240509$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-273870$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$49$KG$20240813$$CN$ES$ES
238390642$23839064$2$F$$20240705$20240509$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202405004096$ELI LILLY AND CO$$31$YR$A$M$Y$$$20240709$$CN$US$US
238390743$23839074$3$F$$20240911$20240509$20240915$PER$$US-ALXN-202405USA000186US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
238390872$23839087$2$F$$20240711$20240509$20240711$EXP$$US-ALXN-202405USA000198US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$MD$US$US
238390912$23839091$2$F$$20240625$20240509$20240703$PER$$US-ALXN-202405USA000228US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240703$$CN$US$US
238390932$23839093$2$F$20240327$20240503$20240509$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00587$AIMMUNE$$$$$$Y$$$20240801$$HP$US$US
238390992$23839099$2$F$20240307$20240514$20240509$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00609$AIMMUNE$$$$$$Y$$$20240801$$HP$US$US
238391107$23839110$7$F$20240430$20240903$20240509$20240916$EXP$$ZA-TAKEDA-2024TUS036945$TAKEDA$$66$YR$$F$Y$$$20240916$$HP$ZA$ZA
238391173$23839117$3$F$20230510$20240626$20240509$20240710$PER$$US-RADIUS HEALTH INC.-2024US002915$RADIUS PHARM$$81$YR$$F$Y$$$20240710$$MD$US$US
238391232$23839123$2$F$20240101$20240506$20240509$20240925$EXP$FR-AFSSAPS-ST2024000811$FR-ROCHE-3558741$ROCHE$$59$YR$A$M$Y$$$20240925$$MD$FR$FR
238391263$23839126$3$F$20130409$20240819$20240509$20240821$EXP$$NVSJ2024JP005058$NOVARTIS$$40$YR$$M$Y$69$KG$20240822$$MD$JP$JP
238391363$23839136$3$F$20230101$20240710$20240509$20240713$EXP$$PL-BIOGEN-2024BI01263994$BIOGEN$$$$$F$Y$$$20240713$$MD$PL$PL
238391693$23839169$3$F$20230714$20240822$20240509$20240830$EXP$$BE-JNJFOC-20240510776$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$80$KG$20240830$$MD$BE$BE
238391722$23839172$2$F$$20240712$20240509$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068968$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240716$$HP$US$US
238391893$23839189$3$F$20240101$20240729$20240509$20240805$PER$$US-BAUSCHBL-2024BNL026635$BAUSCH AND LOMB$$$$$F$Y$$$20240806$$CN$US$US
238392222$23839222$2$F$20240411$20240501$20240509$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00681$AIMMUNE$$$$$$Y$$$20240801$$MD$US$US
238392386$23839238$6$F$20240329$20240704$20240509$20240706$EXP$$CA-ABBVIE-5750838$ABBVIE$$39$YR$$M$Y$63.5$KG$20240706$$MD$CA$CA
238392468$23839246$8$F$20240101$20240913$20240509$20240918$EXP$$CA-ABBVIE-5630098$ABBVIE$$86$YR$$M$Y$77$KG$20240918$$MD$CA$CA
238392582$23839258$2$F$$20240909$20240509$20240925$PER$$US-BEIGENE-BGN-2024-006125$BEIGENE$$$$$$Y$$$20240925$$MD$US$US
238392663$23839266$3$F$$20240905$20240509$20240910$EXP$$AU-SANDOZ INC.-SDZ2024AU046628$SANDOZ$$26$YR$$M$Y$$$20240910$$MD$AU$AU
238392745$23839274$5$F$$20240815$20240509$20240822$EXP$$GB-TAKEDA-2024TUS035783$TAKEDA$$$$$F$Y$$$20240822$$CN$GB$GB
238392762$23839276$2$F$$20240625$20240509$20240702$PER$$NVSC2024US091048$NOVARTIS$$67$YR$$M$Y$$$20240702$$CN$US$US
238392976$23839297$6$F$20240430$20240806$20240509$20240808$EXP$$NVSC2024US092496$NOVARTIS$$65$YR$$M$Y$98$KG$20240808$$HP$US$US
238393182$23839318$2$F$20240101$20240701$20240509$20240706$EXP$$US-ABBVIE-5751270$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
238393217$23839321$7$F$20211101$20240905$20240509$20240912$EXP$$US-ABBVIE-5746860$ABBVIE$$69$YR$$F$Y$64.41$KG$20240912$$CN$US$US
238393232$23839323$2$F$20231204$20240617$20240509$20240701$EXP$$JP-AMGEN-JPNSP2024092066$AMGEN$$78$YR$E$M$Y$$$20240630$$MD$JP$JP
238393304$23839330$4$F$20240301$20240722$20240509$20240726$30DAY$$US-JNJFOC-20240461869$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240726$$CN$US$US
238393493$23839349$3$F$$20240626$20240509$20240701$EXP$$BE-JNJFOC-20240512173$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$HP$BE$BE
238394122$23839412$2$F$20240507$20240508$20240510$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202405004513$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240709$$CN$US$US
238394173$23839417$3$F$20240101$20240630$20240510$20240709$EXP$$CA-CELLTRION INC.-2024CA010551$CELLTRION$$$$$$Y$$$20240709$$HP$CA$CA
238394302$23839430$2$F$$20240719$20240510$20240720$PER$$NVSC2024US098393$NOVARTIS$$$$$F$Y$$$20240719$$MD$US$US
238394312$23839431$2$F$20240101$20240716$20240510$20240720$EXP$$US-ABBVIE-5751999$ABBVIE$$$$$F$Y$$$20240720$$MD$US$US
238394496$23839449$6$F$20240507$20240912$20240510$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-013616$UNITED THERAPEUTICS$$39$YR$$F$Y$70.295$KG$20240919$$$US$US
238394542$23839454$2$F$20231123$20240621$20240510$20240702$EXP$$MX-JAZZ PHARMACEUTICALS-2024-MX-007242$JAZZ$$72$YR$$M$Y$70$KG$20240702$$MD$MX$MX
238395062$23839506$2$F$20240723$20240801$20240510$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072130$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240802$$CN$US$US
238395153$23839515$3$F$$20240802$20240510$20240813$PER$$US-SA-2024SA131801$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240814$$MD$US$US
238395195$23839519$5$F$20240101$20240815$20240510$20240824$EXP$$CA-CELLTRION INC.-2023CA021968$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
238395365$23839536$5$F$20231101$20240829$20240510$20240912$EXP$$CA-CELLTRION INC.-2023CA021638$CELLTRION$$$$$$Y$$$20240912$$MD$CA$CA
238395472$23839547$2$F$$20240912$20240510$20240916$EXP$$CA-JNJFOC-20240517057$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240916$$HP$CA$CA
238395803$23839580$3$F$20240401$20240916$20240510$20240920$PER$$US-SA-2024SA141347$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240920$$MD$US$US
238395822$23839582$2$F$$20240705$20240510$20240728$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001927$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
238395833$23839583$3$F$$20240628$20240510$20240708$EXP$$CA-AUROBINDO-AUR-APL-2024-021661$AUROBINDO$$78$YR$$$Y$38$KG$20240708$$PH$CA$CA
238395912$23839591$2$F$20240428$20240703$20240510$20240712$EXP$$US-NOVOPROD-1214438$NOVO NORDISK$$75$YR$$F$Y$$$20240712$$CN$US$US
238395986$23839598$6$F$$20240724$20240510$20240805$EXP$$GB-NOVOPROD-1214863$NOVO NORDISK$$$$$M$Y$$$20240805$$CN$GB$GB
238396003$23839600$3$F$20160101$20240913$20240510$20240924$EXP$$US-NOVOPROD-1215317$NOVO NORDISK$$56$YR$$F$Y$$$20240924$$CN$US$US
238396012$23839601$2$F$20231101$20240805$20240510$20240816$EXP$$US-NOVOPROD-1216066$NOVO NORDISK$$74$YR$$F$Y$113.83$KG$20240816$$MD$US$US
238396052$23839605$2$F$20240705$20240708$20240510$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001907$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240730$$CN$US$US
238396223$23839622$3$F$20221220$20240710$20240510$20240716$EXP$$JP-GSK-JP2024057371$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$MD$JP$JP
238396232$23839623$2$F$$20240617$20240510$20240704$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024055866$VIIV$$$$$M$Y$$$20240704$$HP$US$US
238396462$23839646$2$F$20240101$20240905$20240510$20240911$EXP$$US-ABBVIE-5749711$ABBVIE$$$$$F$Y$115$KG$20240911$$CN$US$US
238396542$23839654$2$F$20240501$20240918$20240510$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072355$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240920$$HP$US$US
238396973$23839697$3$F$$20240805$20240510$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001964$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
238396984$23839698$4$F$$20240702$20240510$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001941$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
238397012$23839701$2$F$$20240906$20240510$20240910$EXP$$CA-JNJFOC-20240510001$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240910$$HP$CA$CA
238397162$23839716$2$F$$20240828$20240510$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071848$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240902$$CN$US$US
238397242$23839724$2$F$20240101$20240702$20240510$20240705$PER$$US-AMGEN-USASP2024091612$AMGEN$$23$YR$A$F$Y$$$20240705$$HP$US$US
238397505$23839750$5$F$20200811$20240827$20240510$20240904$EXP$$CA-JNJFOC-20240429045$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240904$$HP$CA$CA
238397535$23839753$5$F$20240425$20240716$20240510$20240718$30DAY$$US-JNJFOC-20240479643$JOHNSON AND JOHNSON$$32$YR$A$F$Y$81.72$KG$20240718$$PH$US$US
238397573$23839757$3$F$$20240626$20240510$20240705$30DAY$$US-GSK-US2024AMR056567$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$HP$US$US
238397586$23839758$6$F$$20240722$20240510$20240926$EXP$$US-GSK-US2024AMR056445$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
238397782$23839778$2$F$20240414$20240801$20240510$20240826$PER$$CA-TOLMAR, INC.-24CA048492$TOLMAR$$75$YR$$M$Y$$$20240826$$CN$CA$CA
238397792$23839779$2$F$20240414$20240801$20240510$20240826$PER$$CA-TOLMAR, INC.-24CA048481$TOLMAR$$69$YR$$M$Y$$$20240826$$CN$CA$CA
238397814$23839781$4$F$$20240703$20240510$20240715$PER$$US-AstraZeneca-2024A107811$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$US$
238397824$23839782$4$F$$20240521$20240510$20240808$PER$$US-LEO Pharma-370186$LEO PHARM$$54$YR$$M$Y$$$20240808$$PH$US$US
238397896$23839789$6$F$$20240802$20240510$20240812$EXP$$US-GSK-US2024AMR056967$GLAXOSMITHKLINE$$$$$F$Y$35.465$KG$20240812$$CN$US$US
238397993$23839799$3$F$$20240808$20240510$20240819$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-03773$LUPIN$Madgula AS, Pappan N, Tuli A, Ranganathan K, Raina A. Cardiogenic shock from Bupriopion toxicity successfully managed by VA-ECMO. Journal of the American College of Cardiology. 2024;83(13)Suppl A:4323$$$$$Y$$$20240819$$HP$US$US
238398072$23839807$2$F$$20240820$20240510$20240902$EXP$$CA-UCBSA-2023001888$UCB$$$$$F$Y$$$20240902$$CN$CA$CA
238398293$23839829$3$F$$20240722$20240510$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03766$LUPIN$$$$$$Y$$$20240731$$CN$US$US
238398423$23839842$3$F$$20240702$20240510$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03786$LUPIN$$$$$$Y$$$20240724$$PH$US$US
238398503$23839850$3$F$$20240801$20240510$20240810$EXP$$US-SA-2024SA132784$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240810$$MD$US$US
238398702$23839870$2$F$$20240815$20240510$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072267$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240819$$MD$JP$JP
238398933$23839893$3$F$20240401$20240809$20240510$20240816$EXP$$US-INTERCEPT-PM2024000870$INTERCEPT PHARMACEUTICALS$$72$YR$$F$Y$74.376$KG$20240816$$CN$US$US
238398963$23839896$3$F$20240101$20240815$20240510$20240822$EXP$$US-INTERCEPT-PM2024000912$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
238398972$23839897$2$F$$20240614$20240510$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001939$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
238398982$23839898$2$F$$20240823$20240510$20240827$EXP$$CA-JNJFOC-20240512313$JOHNSON AND JOHNSON$$63$YR$A$M$Y$80$KG$20240827$$CN$CA$CA
238399178$23839917$8$F$20230101$20240725$20240510$20240803$EXP$$CA-CELLTRION INC.-2023CA019853$CELLTRION$$$$$$Y$$$20240803$$HP$CA$CA
238399245$23839924$5$F$20240423$20240730$20240510$20240925$PER$$US-GSK-US2024AMR056025$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240925$$CN$US$US
238399302$23839930$2$F$$20240808$20240510$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070225$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$73.4$KG$20240808$$HP$US$US
238399493$23839949$3$F$$20240815$20240510$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072825$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240821$$MD$JP$JP
238399912$23839991$2$F$$20240802$20240510$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-021856$AUROBINDO$Jay Reaume. Chronic pain: A case application of a novel framework to guide interprofessional assessment and intervention in primary care. Canadian Journal of Pain. 2023$61$YR$$M$Y$$$20240815$$HP$CA$CA
238400032$23840003$2$F$20240506$20240808$20240510$20240809$PER$$US-AMGEN-USASP2024091011$AMGEN$$69$YR$E$M$Y$$$20240809$$CN$US$US
238400042$23840004$2$F$20231217$20240626$20240510$20240704$EXP$$DE-AUROBINDO-AUR-APL-2024-021360$AUROBINDO$$70$YR$$M$Y$$$20240704$$MD$DE$DE
238400263$23840026$3$F$$20240823$20240510$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202405004684$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240827$$CN$US$US
238401852$23840185$2$F$20240601$20240701$20240510$20240704$EXP$$US-UCBSA-2023054642$UCB$$74$YR$$F$Y$127.44$KG$20240704$$HP$US$US
238401923$23840192$3$F$20240306$20240610$20240510$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001918$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240705$$CN$US$US
238401933$23840193$3$F$20240430$20240617$20240510$20240711$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001863$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240711$$CN$US$US
238402282$23840228$2$F$20240601$20240711$20240510$20240715$EXP$$US-UCBSA-2023057832$UCB$$58$YR$$F$Y$$$20240715$$HP$US$US
238402353$23840235$3$F$$20240802$20240510$20240809$PER$$US-ALXN-202405USA000194US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
238403682$23840368$2$F$$20240614$20240510$20240702$30DAY$$CA-JNJFOC-20240522508$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$CA$CA
238403694$23840369$4$F$20240502$20240610$20240510$20240703$30DAY$$US-JNJFOC-20240511801$JOHNSON AND JOHNSON$$58$YR$A$$Y$$$20240703$$HP$US$US
238403712$23840371$2$F$$20240830$20240510$20240903$EXP$$US-GSK-US2024057351$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
238404532$23840453$2$F$20240506$20240718$20240510$20240724$PER$$US-AMGEN-USASP2024092513$AMGEN$$48$YR$A$M$Y$$$20240724$$CN$US$US
238404843$23840484$3$F$$20240717$20240510$20240725$EXP$$CA-CELLTRION INC.-2023CA004213$CELLTRION$$$$$$Y$$$20240726$$HP$CA$CA
238405562$23840556$2$F$$20240719$20240510$20240720$PER$$NVSC2024US099174$NOVARTIS$$$$$F$Y$$$20240719$$HP$US$US
238405572$23840557$2$F$$20240701$20240510$20240704$PER$$US-BIOGEN-2024BI01259405$BIOGEN$$$$$F$Y$63.56$KG$20240704$$CN$US$US
238406054$23840605$4$F$20240101$20240830$20240510$20240909$30DAY$$FR-JNJFOC-20240520926$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240909$$CN$FR$FR
238406102$23840610$2$F$20240202$20240716$20240510$20240722$EXP$$US-ABBVIE-5752179$ABBVIE$$72$YR$$M$Y$79$KG$20240722$$CN$US$US
238406113$23840611$3$F$20240401$20240610$20240510$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001871$ACADIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240707$$CN$US$US
238406304$23840630$4$F$20240317$20240906$20240510$20240909$EXP$$NVSC2024US061806$NOVARTIS$$41$YR$$M$Y$$$20240909$$CN$US$US
238406412$23840641$2$F$$20240806$20240510$20240820$EXP$$US-UCBSA-2024006083$UCB$$$$$F$Y$$$20240820$$HP$US$US
238406553$23840655$3$F$$20240621$20240510$20240702$EXP$$JP-UCBSA-2024022941$UCB$$67$YR$$F$Y$$$20240702$$MD$JP$JP
238406612$23840661$2$F$$20240816$20240510$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072957$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240819$$MD$JP$JP
238406714$23840671$4$F$$20240807$20240510$20240814$EXP$$GB-TAKEDA-2024TUS044031$TAKEDA$$$$$M$Y$$$20240814$$CN$GB$GB
238407062$23840706$2$F$20240311$20240705$20240510$20240711$EXP$$CA-JNJFOC-20240364596$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240711$$HP$CA$CA
238407262$23840726$2$F$20240418$20240808$20240510$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072953$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240808$$CN$US$US
238407322$23840732$2$F$20240424$20240911$20240510$20240917$EXP$$NVSC2024CO098825$NOVARTIS$$54$YR$$F$Y$57$KG$20240917$$CN$CO$CO
238407342$23840734$2$F$20240406$20240705$20240510$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-021177$AUROBINDO$$9$YR$$F$Y$$$20240712$$PH$FR$FR
238407622$23840762$2$F$20200512$20240829$20240510$20240904$EXP$PT-INFARMED-B202404-459$PT-TEVA-VS-3194226$TEVA$$32$YR$$F$Y$67$KG$20240904$$CN$PT$PT
238407682$23840768$2$F$$20240628$20240510$20240705$EXP$$PT-AUROBINDO-AUR-APL-2024-007145$AUROBINDO$Alexandre. I., Carvalho J., Anselmo M., Freitas P., Coelho S.. IS IT POSSIBLE TO SURVIVE 1.9 BICARBONATE? ? A CASE OF LACTIC ACIDOSIS ASSOCIATED WITH METFORMIN (SER? POSS?VEL SOBREVIVER A BICARBONATO DE 1.9? ? UM CASO DE ACIDOSE L?CTICA ASSOCIADA ? METFORMINA). Portuguese Kidney Journal. 2023;(SUPPL. 1):189-190$80$YR$$M$Y$$$20240705$$MD$PT$PT
238407788$23840778$8$F$20240101$20240821$20240510$20240829$EXP$$CA-CELLTRION INC.-2024CA010600$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
238407932$23840793$2$F$$20240628$20240510$20240705$EXP$$US-AstraZeneca-2024A105057$ASTRAZENECA$$$$$$Y$$$20240705$$CN$US$
238408042$23840804$2$F$$20240712$20240510$20240718$EXP$$DE-AMGEN-DEUSP2024092018$AMGEN$$$$$F$Y$$$20240718$$MD$DE$DE
238408192$23840819$2$F$20240506$20240809$20240510$20240810$EXP$$RO-ABBVIE-5750690$ABBVIE$$70$YR$$M$Y$$$20240810$$CN$RO$RO
238408252$23840825$2$F$20231028$20240730$20240510$20240802$EXP$$JP-ABBVIE-5750774$ABBVIE$$37$YR$$M$Y$62$KG$20240802$$MD$JP$JP
238408267$23840826$7$F$20240425$20240912$20240510$20240917$EXP$$US-TAKEDA-2024TUS045647$TAKEDA$$46$YR$$F$Y$95.23$KG$20240917$$CN$US$US
238408432$23840843$2$F$20240505$20240821$20240510$20240823$PER$$US-AMGEN-USASP2024091048$AMGEN$$59$YR$A$M$Y$$$20240823$$CN$US$US
238408453$23840845$3$F$20240124$20240730$20240510$20240805$EXP$$DE-SANDOZ INC.-SDZ2024DE047256$SANDOZ$$57$YR$$F$Y$60.6$KG$20240805$$MD$DE$DE
238408513$23840851$3$F$$20240617$20240510$20240709$EXP$$US-ROCHE-3558643$ROCHE$$77$YR$E$M$Y$$$20240702$$CN$US$US
238408542$23840854$2$F$20240101$20240709$20240510$20240711$EXP$$CA-UCBSA-2024022677$UCB$$$$$M$Y$$$20240711$$CN$CA$CA
238408982$23840898$2$F$$20240716$20240510$20240720$EXP$$US-ABBVIE-5750659$ABBVIE$$$$$M$Y$102$KG$20240720$$CN$US$US
238408992$23840899$2$F$20240508$20240712$20240510$20240717$EXP$$NVSC2024US098906$NOVARTIS$$59$YR$$F$Y$$$20240717$$CN$US$US
238409104$23840910$4$F$20240417$20240710$20240510$20240925$PER$$US-GSK-US2024AMR056529$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240925$$CN$US$US
238409143$23840914$3$F$20240101$20240824$20240510$20240903$EXP$$CA-CELLTRION INC.-2023CA023484$CELLTRION$$$$$$Y$$$20240903$$MD$CA$CA
238409243$23840924$3$F$20240221$20240821$20240510$20240829$EXP$$CA-JNJFOC-20240452012$JOHNSON AND JOHNSON$$45$YR$A$F$Y$130$KG$20240829$$HP$CA$CA
238409253$23840925$3$F$$20240826$20240510$20240903$EXP$$US-ROCHE-3558931$ROCHE$$75$YR$E$F$Y$$$20240903$$CN$US$US
238409393$23840939$3$F$20240401$20240628$20240510$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001974$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240723$$CN$US$US
238409405$23840940$5$F$20240101$20240919$20240510$20240930$EXP$$US-INSMED, INC.-2024-01311-US$INSMED$$$$$F$Y$$$20240930$$HP$US$US
238409473$23840947$3$F$20200101$20240626$20240510$20240706$EXP$DE-EMA-DD-20210218-agrahari_P-114512$DE-Pharmaxis-001222$Pharmaxis Europe limited$$80$YR$E$M$Y$69$KG$20240502$$MD$DE$CA
238409555$23840955$5$F$$20240805$20240510$20240809$EXP$$NVSC2024CO098784$NOVARTIS$$$$$M$Y$83$KG$20240810$$CN$CO$CO
238409714$23840971$4$F$20240125$20240707$20240510$20240716$EXP$$CA-CELLTRION INC.-2024CA009972$CELLTRION$$$$$$Y$$$20240716$$MD$CA$CA
238409952$23840995$2$F$$20240823$20240510$20240823$PER$$NVSC2024US098598$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
238409963$23840996$3$F$20180101$20240813$20240510$20240815$EXP$$NVSC2024PT098642$NOVARTIS$$46$YR$$F$Y$$$20240815$$MD$PT$PT
238410062$23841006$2$F$20240101$20240702$20240510$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03789$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238410092$23841009$2$F$$20240724$20240510$20240730$EXP$$CA-NOVITIUMPHARMA-2024CANVP00723$NOVITIUM PHARMA$R. Lalli.End-Stage Heart Failure After Hydroxychloroquine Exposure in a Teenager.The Journal of Heart and Lung Transplantation.APR-2024;43:1-1$16$YR$T$F$Y$$$20240730$$HP$CA$CA
238410163$23841016$3$F$$20240815$20240510$20240820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072102$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240821$$MD$JP$JP
238410312$23841031$2$F$20240301$20240730$20240510$20240731$PER$$US-AMGEN-USASP2024089993$AMGEN$$79$YR$E$F$Y$$$20240731$$CN$US$US
238410412$23841041$2$F$$20231222$20240510$20240923$PER$$CN-ROCHE-3481514$ROCHE$Li Y, Zhang J, Cai Z, Gao, X, Zhang L, Lu Z, Wang X, Yu P, Li J and Fang F. Disitamab Vedotin (RC48) for HER2-positive advanced breast cancer: a case report and literature review. DOI:10.3389/fonc.2023.1286392. Frontiers in Oncology 2023;13:1-8.$54$YR$A$F$Y$$$20240923$$HP$CN$CN
238410502$23841050$2$F$20240504$20240724$20240510$20240729$PER$$US-AMGEN-USASP2024090375$AMGEN$$66$YR$E$M$Y$$$20240729$$CN$US$US
238410534$23841053$4$F$$20240726$20240510$20240807$EXP$$US-INSMED, INC.-2024-01819-US$INSMED$$$$$M$Y$$$20240807$$CN$US$US
238410552$23841055$2$F$$20240702$20240510$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03790$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238410623$23841062$3$F$$20240824$20240510$20240919$EXP$$US-862174955-ML2024-02855$Unknown Manufacturer$$70$YR$E$F$Y$$$20240919$$CN$US$US
2384107410$23841074$10$F$20240330$20240823$20240510$20240827$EXP$$US-TAKEDA-2024TUS033338$TAKEDA$$35$YR$$F$Y$$$20240827$$HP$US$US
238410802$23841080$2$F$20210918$20240626$20240510$20240711$EXP$$JP-RECORDATI RARE DISEASE INC.-2023007682$RECORDATI$$$$$$Y$$$20240711$$MD$JP$JP
238410873$23841087$3$F$20240425$20240716$20240510$20240725$EXP$$FR-SA-2024SA134344$SANOFI AVENTIS$$40$YR$A$M$Y$65$KG$20240725$$HP$FR$FR
238410903$23841090$3$F$$20240925$20240510$20240927$EXP$$CA-TAKEDA-2024TUS046338$TAKEDA$$$$$F$Y$$$20240927$$MD$CA$CA
238410933$23841093$3$F$20240506$20240624$20240510$20240702$EXP$$NVSC2024CO098741$NOVARTIS$$50$YR$$F$Y$68$KG$20240702$$CN$CO$CO
238410963$23841096$3$F$20240215$20240625$20240510$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-021536$AUROBINDO$$63$YR$$F$Y$$$20240703$$MD$FR$FR
238411245$23841124$5$F$20240101$20240916$20240510$20240925$EXP$$US-INSMED, INC.-2024-00630-US$INSMED$$$$$F$Y$$$20240925$$CN$US$US
238411273$23841127$3$F$$20240718$20240510$20240722$EXP$$CH-TAKEDA-2024TUS046107$TAKEDA$$$$$F$Y$$$20240722$$HP$GB$CH
238411452$23841145$2$F$20190101$20240509$20240510$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-275374$BOEHRINGER INGELHEIM$$60$YR$A$M$Y$81$KG$20240813$$CN$ES$ES
238411532$23841153$2$F$$20240711$20240510$20240722$30DAY$$US-GSK-US2024055841$GLAXOSMITHKLINE$$$$$M$Y$$$20240722$$PH$US$US
238411554$23841155$4$F$$20240625$20240510$20240702$30DAY$$US-GSK-US2024055468$GLAXOSMITHKLINE$$$$$M$Y$$$20240702$$CN$US$US
238411582$23841158$2$F$$20240724$20240510$20240724$PER$$NVSC2024US098946$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
238411804$23841180$4$F$20191101$20240705$20240510$20240715$EXP$$IT-AUROBINDO-AUR-APL-2024-021942$AUROBINDO$Rivoli G, Bartalucci G, Laurino M, Coviello E, Beltrami G, Coniglio ML, et al.. Poligenic predisposition to late onset severe haemophagocytic lymphohistiocytosis in a patient with MDS.. Haematologica. 2021;106(s3):174$64$YR$$M$Y$$$20240715$$MD$IT$IT
238411832$23841183$2$F$$20240816$20240510$20240910$30DAY$$US-BECTON DICKINSON-US-BD-24-000237$BECTON DICKINSON$$$$$$Y$$$20240910$$CN$US$US
238411842$23841184$2$F$$20240816$20240510$20240910$30DAY$$US-BECTON DICKINSON-US-BD-24-000238$BECTON DICKINSON$$$$$$Y$$$20240910$$CN$US$US
238411852$23841185$2$F$$20240816$20240510$20240910$30DAY$$US-BECTON DICKINSON-US-BD-24-000240$BECTON DICKINSON$$$$$$Y$$$20240910$$CN$US$US
238411862$23841186$2$F$$20240814$20240510$20240909$30DAY$$US-BECTON DICKINSON-US-BD-24-000239$BECTON DICKINSON$$$$$$Y$$$20240909$$CN$US$US
238411913$23841191$3$F$20240201$20240718$20240510$20240722$PER$$US-AMGEN-USASP2024092578$AMGEN$$78$YR$E$F$Y$82.993$KG$20240722$$MD$US$US
238411962$23841196$2$F$$20240816$20240510$20240823$EXP$$NVSC2024IN026021$NOVARTIS$$$$$F$Y$$$20240823$$CN$IN$IN
238412164$23841216$4$F$20230401$20240802$20240510$20240805$EXP$$US-BAUSCH-BL-2023-005586$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240805$$CN$US$US
238412203$23841220$3$F$20240401$20240911$20240510$20240916$EXP$$CA-PFIZER INC-202400102431$PFIZER$$39$YR$$F$Y$$$20240916$$HP$CA$CA
238412532$23841253$2$F$$20240702$20240510$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03754$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238412904$23841290$4$F$20231205$20240814$20240510$20240829$PER$$US-ASTELLAS-2024US011328$ASTELLAS$$85$YR$E$F$Y$$$20240828$$CN$US$US
238413013$23841301$3$F$20240501$20240701$20240510$20240704$PER$$US-BIOVITRUM-2024-US-006923$BIOVITRUM$$74$YR$$F$Y$$$20240704$$CN$US$US
238413102$23841310$2$F$$20240625$20240510$20240704$30DAY$$US-GSK-US2024AMR056067$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
238413123$23841312$3$F$$20240806$20240510$20240814$30DAY$$US-GSK-US2024AMR056024$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
238413153$23841315$3$F$$20240709$20240510$20240715$EXP$$GB-TAKEDA-2024TUS040816$TAKEDA$$$$$M$Y$$$20240715$$CN$GB$GB
238413194$23841319$4$F$20240507$20240808$20240510$20240810$PER$$US-AMGEN-USASP2024092528$AMGEN$$95$YR$E$F$Y$$$20240810$$HP$US$US
238413322$23841332$2$F$20230401$20240902$20240510$20240909$EXP$FR-AFSSAPS-ST2024000753$FR-ROCHE-3554953$ROCHE$$43$YR$A$F$Y$70$KG$20240909$$MD$FR$FR
238413362$23841336$2$F$$20240704$20240510$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03811$LUPIN$$$$$$Y$$$20240725$$CN$US$US
238413432$23841343$2$F$$20240703$20240510$20240712$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013594$UNITED THERAPEUTICS$$$$$M$Y$54.875$KG$20240712$$$US$US
238413612$23841361$2$F$$20240710$20240510$20240718$EXP$$US-CELLTRION INC.-2024US010564$CELLTRION$$$$$$Y$$$20240718$$MD$US$US
238413652$23841365$2$F$20240301$20240711$20240510$20240721$EXP$$US-BAYER-2024A065005$BAYER$$73$YR$E$M$Y$$$20240719$$CN$US$US
238413713$23841371$3$F$20240409$20240606$20240510$20240823$EXP$$RO-BAUSCH-BL-2024-007242$BAUSCH AND LOMB$$80$YR$$M$Y$100$KG$20240823$$PH$RO$RO
238413883$23841388$3$F$20220505$20240827$20240510$20240904$EXP$$CA-CELLTRION INC.-2022CA007432$CELLTRION$$$$$$Y$$$20240904$$MD$CA$CA
238414062$23841406$2$F$$20240805$20240510$20240808$EXP$$US-ABBVIE-5752121$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
238414272$23841427$2$F$20240101$20240704$20240510$20240711$EXP$$CA-JNJFOC-20240356884$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240711$$HP$CA$CA
238414392$23841439$2$F$$20240815$20240510$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072778$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240816$$MD$JP$JP
238414782$23841478$2$F$$20240429$20240510$20240925$EXP$$AU-JUBILANT CADISTA PHARMACEUTICALS-2024AU000597$JUBILANT$Tan R, Abasszade J. H, Dhillon H, Kuan C. C, Worland T, Tabatabai S. Severe hepatitis Complicating olmesartan enteropathy: A case report. Case Rep Gastroenterol. 2024;18:238-243$43$YR$$F$Y$$$20240925$$HP$AU$AU
238414832$23841483$2$F$20210101$20240629$20240510$20240708$EXP$$CA-CELLTRION INC.-2024CA010683$CELLTRION$$$$$$Y$$$20240708$$HP$CA$CA
238415162$23841516$2$F$$20240819$20240510$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072083$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240823$$CN$US$US
238415212$23841521$2$F$20240215$20240723$20240510$20240801$30DAY$$US-GSK-US2024055758$GLAXOSMITHKLINE$$69$YR$$M$Y$$$20240801$$CN$US$US
238415234$23841523$4$F$20240427$20240913$20240510$20240918$EXP$$UZ-AMERICAN REGENT INC-2024001774$AMERICAN REGENT$$27$YR$$F$Y$80$KG$20240918$$MD$UZ$UZ
238415283$23841528$3$F$20220101$20240924$20240510$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-021711$AUROBINDO$$63$YR$$M$Y$$$20240927$$MD$GB$GB
238415493$23841549$3$F$$20240621$20240510$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-022259$AUROBINDO$$$$$M$Y$$$20240703$$CN$US$US
238415572$23841557$2$F$$20240808$20240510$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072981$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240808$$HP$US$US
238415772$23841577$2$F$$20240712$20240510$20240715$EXP$$NVSC2024US098891$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
238416502$23841650$2$F$20240101$20240807$20240510$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070194$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$93.9$KG$20240807$$PH$US$US
238416603$23841660$3$F$$20240830$20240510$20240906$PER$$US-ALXN-202405USA000146US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
238416832$23841683$2$F$$20240701$20240510$20240709$EXP$ES-MLMSERVICE-20240430-PI038758-00153-1$ES-STRIDES ARCOLAB LIMITED-2024SP005428$STRIDES$Fernandez-Gordon Sanchez FM, Labrador CG, Becerra LW, Paz Fern?ndez BA, Mart?nez Aguilar AP, Castano-Milla C.. Active microscopic colitis precipitated by fluoxetine.. Revista espanola de enfermedades digestivas. 2024$41$YR$$F$Y$$$20240709$$MD$ES$ES
238417852$23841785$2$F$20240506$20240731$20240510$20240802$PER$$US-AMGEN-USASP2024091421$AMGEN$$65$YR$E$F$Y$$$20240802$$CN$US$US
238418002$23841800$2$F$20230327$20240626$20240510$20240711$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-23-01358$HIKMA$$18$YR$$F$Y$151.1$KG$20240711$$HP$US$US
238418175$23841817$5$F$20190101$20240814$20240510$20240822$EXP$$US-INSMED, INC.-2022-00392-US$INSMED$$$$$M$Y$$$20240822$$HP$US$US
238418182$23841818$2$F$20240427$20240820$20240510$20240826$EXP$$US-TAKEDA-2020TUS018602$TAKEDA$$48$YR$$F$Y$$$20240826$$CN$US$US
238418245$23841824$5$F$20240410$20240729$20240510$20240805$EXP$$CO-AMGEN-COLSP2024088928$AMGEN$$56$YR$A$F$Y$$$20240804$$CN$CO$CO
238418262$23841826$2$F$$20240715$20240510$20240719$EXP$$NVSC2024US098651$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
238418282$23841828$2$F$$20240808$20240510$20240816$PER$$US-ALXN-202405USA000391US$ALEXION PHARMACEUTICALS$$$$$F$Y$56.689$KG$20240816$$CN$US$US
238418292$23841829$2$F$20240206$20240704$20240510$20240711$EXP$$NVSC2024DE096082$NOVARTIS$$4$MON$$M$Y$3.3$KG$20240711$$PH$DE$DE
238418456$23841845$6$F$20240101$20240910$20240510$20240912$PER$$US-BIOGEN-2024BI01259726$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
238418482$23841848$2$F$$20240227$20240510$20240821$PER$$US-UCBSA-2024010159$UCB$$$$$M$Y$$$20240821$$HP$US$US
238418522$23841852$2$F$20240101$20240710$20240510$20240821$PER$$US-UCBSA-2024012916$UCB$$$$$F$Y$44.45$KG$20240821$$CN$US$US
238418742$23841874$2$F$$20240808$20240510$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070975$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240808$$CN$US$US
238419002$23841900$2$F$20240907$20240909$20240510$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072317$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240912$$CN$US$US
238419276$23841927$6$F$20231001$20240918$20240510$20240919$EXP$$NO-JNJFOC-20240522422$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240919$$MD$NO$NO
238419283$23841928$3$F$20240101$20240723$20240510$20240726$EXP$$US-JNJFOC-20240508141$JOHNSON AND JOHNSON$$65$YR$E$M$Y$101.5$KG$20240726$$PH$US$US
238419292$23841929$2$F$20240401$20240829$20240510$20240905$EXP$$US-OTSUKA-2023_021369$OTSUKA$$54$YR$$M$Y$$$20240905$$CN$US$US
238419332$23841933$2$F$$20240814$20240510$20240822$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004944$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
238419412$23841941$2$F$$20240702$20240510$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03775$LUPIN$$$$$$Y$$$20240725$$CN$US$US
238419652$23841965$2$F$$20240704$20240510$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03836$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238419712$23841971$2$F$20240330$20240710$20240510$20240716$EXP$FR-AFSSAPS-BX2024000786$FR-MYLANLABS-2024M1040637$MYLAN$$44$YR$$M$Y$$$20240716$$PH$FR$FR
238419743$23841974$3$F$$20240626$20240510$20240705$30DAY$$US-GSK-US2024AMR056438$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
238419802$23841980$2$F$20240601$20240625$20240510$20240705$EXP$$AU-ROCHE-3561447$ROCHE$$39$YR$A$M$Y$$$20240705$$CN$AU$AU
238419983$23841998$3$F$20240401$20240705$20240510$20240708$EXP$$US-UCBSA-2024022250$UCB$$54$YR$$F$Y$$$20240708$$CN$US$US
238420193$23842019$3$F$20230309$20240718$20240510$20240722$EXP$$US-PFIZER INC-202300223881$PFIZER$$12$YR$$F$Y$58.2$KG$20240722$$CN$US$US
238420315$23842031$5$F$$20240827$20240510$20240902$EXP$$CA-PFIZER INC-202400096535$PFIZER$$53$YR$$M$Y$$$20240902$$CN$CA$CA
238420524$23842052$4$F$20240427$20240917$20240510$20240923$EXP$$IN-PFIZER INC-PV202400056542$PFIZER$$67$YR$$F$Y$78.3$KG$20240923$$CN$IN$IN
238420575$23842057$5$F$20240101$20240904$20240510$20240909$EXP$$CA-PFIZER INC-202400099258$PFIZER$$51$YR$$F$Y$99$KG$20240909$$MD$CA$CA
238420623$23842062$3$F$20231201$20240717$20240510$20240729$EXP$$SG-ROCHE-3560135$ROCHE$$72$YR$E$F$Y$40$KG$20240729$$CN$SG$SG
238420652$23842065$2$F$$20240808$20240510$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070879$BRISTOL MYERS SQUIBB$$$$$F$Y$61.6$KG$20240808$$MD$US$US
238420662$23842066$2$F$20240506$20240730$20240510$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071408$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240806$$PH$US$US
238420885$23842088$5$F$20240427$20240910$20240510$20240916$30DAY$$AR-PFIZER INC-202400097546$PFIZER$$10$YR$$F$Y$$$20240916$$CN$AR$AR
238420896$23842089$6$F$20231101$20240809$20240510$20240814$EXP$$CA-PFIZER INC-202400025005$PFIZER$$28$YR$$F$Y$$$20240814$$MD$CA$CA
238420904$23842090$4$F$20240101$20240918$20240510$20240920$30DAY$$GB-PFIZER INC-PV202400059278$PFIZER$$1$YR$$F$Y$$$20240920$$CN$GB$GB
238420992$23842099$2$F$$20240912$20240510$20240916$EXP$$CA-JNJFOC-20240516935$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240916$$HP$CA$CA
238421123$23842112$3$F$20231117$20240705$20240510$20240705$EXP$$CA-PFIZER INC-202300385769$PFIZER$$41$YR$$F$Y$75$KG$20240705$$HP$CA$CA
238421413$23842141$3$F$20240506$20240813$20240510$20240819$EXP$$US-MYLANLABS-2024M1042182$MYLAN$$21$YR$$M$Y$279$KG$20240819$$MD$US$US
238421432$23842143$2$F$$20240709$20240510$20240717$EXP$$NVSC2024GB098801$NOVARTIS$$54$YR$$M$Y$$$20240717$$CN$GB$GB
238421533$23842153$3$F$$20240913$20240510$20240927$EXP$$NVSC2024IN099231$NOVARTIS$$$$$F$Y$$$20240927$$CN$IN$IN
238421612$23842161$2$F$20240618$20240830$20240510$20240909$EXP$$CA-CELLTRION INC.-2023CA019787$CELLTRION$$$$$$Y$$$20240909$$CN$CA$CA
238421742$23842174$2$F$20240310$20240704$20240510$20240709$EXP$IT-MINISAL02-982390$IT-MYLANLABS-2024M1040015$MYLAN$$88$YR$$F$Y$55$KG$20240709$$MD$IT$IT
238421982$23842198$2$F$$20240909$20240510$20240916$30DAY$$CO-PFIZER INC-PV202400056432$PFIZER$$$$$$Y$$$20240916$$MD$CO$CO
238422014$23842201$4$F$20240401$20240624$20240510$20240701$EXP$$US-SA-2024SA134188$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240701$$HP$US$US
238422872$23842287$2$F$20240101$20240719$20240510$20240726$EXP$$JP-GENMAB-2024-01553$GENMAB$$64$YR$$M$Y$$$20240726$$MD$JP$JP
238422943$23842294$3$F$20240119$20240709$20240510$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-001369$JAZZ$$52$YR$$F$Y$$$20240717$$HP$US$US
238423353$23842335$3$F$20240418$20240731$20240510$20240802$PER$$US-PFIZER INC-PV202400060265$PFIZER$$78$YR$$F$Y$104.8$KG$20240802$$PH$US$US
238423482$23842348$2$F$20231201$20240813$20240510$20240815$PER$$US-PFIZER INC-202400104902$PFIZER$$64$YR$$M$Y$$$20240815$$HP$US$US
238423493$23842349$3$F$20160209$20240715$20240510$20240722$EXP$$CA-PFIZER INC-202200167580$PFIZER$$57$YR$$M$Y$86$KG$20240722$$MD$CA$CA
238423592$23842359$2$F$$20240904$20240510$20240906$PER$$US-PFIZER INC-202400103743$PFIZER$$77$YR$$F$Y$$$20240906$$CN$US$US
238423684$23842368$4$F$$20240703$20240510$20240704$PER$$US-PFIZER INC-PV202400053081$PFIZER$$70$YR$$F$Y$$$20240704$$CN$US$US
238423782$23842378$2$F$20210101$20240715$20240510$20240717$PER$$US-PFIZER INC-PV202400007625$PFIZER$$24$YR$$M$Y$$$20240717$$HP$US$US
238423793$23842379$3$F$$20240711$20240510$20240718$EXP$$CA-HALEON-2166594$Haleon PLC$$44$YR$$F$Y$97$KG$20240717$$CN$CA$CA
238423906$23842390$6$F$20240503$20240814$20240510$20240821$EXP$$CA-CELLTRION INC.-2024CA010568$CELLTRION$$$$$$Y$$$20240821$$CN$CA$CA
238424443$23842444$3$F$20240101$20240726$20240510$20240731$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-002601$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
238424863$23842486$3$F$$20240708$20240510$20240711$EXP$$NVSC2024GB098748$NOVARTIS$$$$A$F$Y$$$20240711$$CN$GB$GB
238425012$23842501$2$F$20240520$20240822$20240510$20240903$EXP$$US-BEH-2024171750$CSL BEHRING$$77$YR$E$F$Y$192.56$KG$20240903$$CN$US$US
238425072$23842507$2$F$20240101$20240709$20240510$20240712$EXP$$CA-PFIZER INC-202400091786$PFIZER$$73$YR$$F$Y$$$20240712$$CN$CA$CA
238425082$23842508$2$F$$20240704$20240510$20240704$EXP$$CA-PFIZER INC-202400103832$PFIZER$$63$YR$$F$Y$$$20240704$$MD$CA$CA
238425098$23842509$8$F$20231201$20240912$20240510$20240912$EXP$$CA-PFIZER INC-PV202400060565$PFIZER$$32$YR$$F$Y$$$20240912$$HP$CA$CA
238425144$23842514$4$F$20240506$20240730$20240510$20240806$EXP$$US-BEH-2024171755$CSL BEHRING$$48$YR$A$F$Y$68$KG$20240806$$HP$US$US
238425542$23842554$2$F$20240402$20240708$20240510$20240717$EXP$$DE-TEVA-VS-3193797$TEVA$$80$YR$$M$Y$90$KG$20240717$$MD$DE$DE
238425632$23842563$2$F$$20240725$20240510$20240730$PER$$US-PFIZER INC-PV202400060939$PFIZER$$58$YR$$F$Y$$$20240730$$HP$US$US
238425692$23842569$2$F$20240401$20240715$20240510$20240716$EXP$$IT-BIOGEN-2024BI01263875$BIOGEN$$28$YR$$M$Y$$$20240716$$MD$IT$IT
238425723$23842572$3$F$$20240711$20240510$20240711$PER$$US-ALXN-202405USA000129US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
238425833$23842583$3$F$20240430$20240816$20240510$20240823$EXP$$CO-TAKEDA-2024TUS045681$TAKEDA$$35$YR$$M$Y$65$KG$20240823$$CN$CO$CO
238426084$23842608$4$F$$20240923$20240510$20240926$EXP$$CA-TAKEDA-2024TUS045702$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
238426184$23842618$4$F$20240503$20240704$20240510$20240716$EXP$$AU-ROCHE-3558734$ROCHE$$34$YR$A$M$Y$$$20240716$$HP$AU$AU
238426232$23842623$2$F$20240508$20240702$20240510$20240705$PER$$US-AMGEN-USASP2024092831$AMGEN$$36$YR$A$F$Y$$$20240705$$PH$US$US
238426272$23842627$2$F$$20240712$20240510$20240715$EXP$$NVSC2024US098704$NOVARTIS$$61$YR$$F$Y$$$20240715$$HP$US$US
238426562$23842656$2$F$$20240702$20240510$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202404019085$ELI LILLY AND CO$$$$I$$Y$$$20240703$$CN$US$US
238426662$23842666$2$F$20240314$20240705$20240510$20240710$EXP$FR-AFSSAPS-TS2024000411$FR-HALEON-2172944$Haleon PLC$$36$YR$$F$Y$62$KG$20240709$$MD$FR$FR
238426754$23842675$4$F$$20240806$20240510$20240808$PER$$US-PFIZER INC-PV202400060483$PFIZER$$86$YR$$F$Y$56.7$KG$20240808$$CN$US$US
238426762$23842676$2$F$$20240718$20240510$20240722$PER$$US-PFIZER INC-202400104463$PFIZER$$79$YR$$M$Y$$$20240722$$CN$US$US
238426882$23842688$2$F$20240428$20240820$20240510$20240828$EXP$$CA-JNJFOC-20240508708$JOHNSON AND JOHNSON$$57$YR$A$M$Y$79$KG$20240828$$HP$CA$CA
238427102$23842710$2$F$$20240624$20240510$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000132$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
238427533$23842753$3$F$$20240703$20240510$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2021-US-025605$JAZZ$$$$$M$Y$$$20240710$$HP$US$US
238427573$23842757$3$F$$20240514$20240510$20240808$PER$$US-LEO Pharma-370155$LEO PHARM$$63$YR$$M$Y$$$20240808$$CN$US$US
238427642$23842764$2$F$$20240711$20240510$20240711$PER$$US-ALXN-202405USA000296US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
238427702$23842770$2$F$$20240704$20240510$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03872$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238427772$23842777$2$F$20240407$20240808$20240510$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073140$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240812$$CN$US$US
238427832$23842783$2$F$20240507$20240702$20240510$20240807$PER$$US-AstraZeneca-2024A108468$ASTRAZENECA$$25760$DY$$F$Y$$$20240807$$CN$US$
238427902$23842790$2$F$$20240812$20240510$20240822$EXP$$CA-BAXTER-2024BAX017962$BAXTER$$14$YR$$M$Y$$$20240822$$HP$CA$CA
238428343$23842834$3$F$20240502$20240813$20240510$20240814$PER$$US-AMGEN-USASP2024090006$AMGEN$$63$YR$A$M$Y$$$20240814$$CN$US$US
238428462$23842846$2$F$$20240624$20240510$20240704$EXP$$US-GSK-US2024AMR056184$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
238428622$23842862$2$F$$20240711$20240510$20240715$EXP$$US-TAKEDA-2024TUS045562$TAKEDA$$$$$F$Y$$$20240715$$HP$US$US
238428784$23842878$4$F$$20240922$20240510$20240925$30DAY$$US-PFIZER INC-202400102371$PFIZER$$9$YR$$F$Y$$$20240925$$CN$US$US
238428794$23842879$4$F$$20240925$20240510$20240927$30DAY$$US-PFIZER INC-202400103066$PFIZER$$8$YR$$M$Y$$$20240927$$CN$US$US
238428805$23842880$5$F$$20240913$20240510$20240918$30DAY$$US-PFIZER INC-202400100543$PFIZER$$$$$M$Y$$$20240918$$CN$US$US
238428815$23842881$5$F$20240422$20240724$20240510$20240726$EXP$$CH-MYLANLABS-2024M1041707$MYLAN$$$$C$F$Y$$$20240726$$PH$CH$CH
238428972$23842897$2$F$$20240725$20240510$20240731$EXP$$US-SA-2024SA141334$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240731$$MD$US$US
238429086$23842908$6$F$$20240911$20240510$20240913$30DAY$$US-PFIZER INC-202400103161$PFIZER$$11$YR$$F$Y$$$20240913$$CN$US$US
238429113$23842911$3$F$$20240711$20240510$20240711$PER$$US-ALXN-202405USA000301US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
238429254$23842925$4$F$20240101$20240712$20240510$20240719$EXP$$US-AMGEN-USASP2024091162$AMGEN$$77$YR$E$F$Y$$$20240719$$CN$US$US
238429274$23842927$4$F$$20240627$20240510$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071631$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240701$$CN$US$US
238429294$23842929$4$F$$20240909$20240510$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071126$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240911$$CN$US$US
238429592$23842959$2$F$20240401$20240807$20240510$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072180$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240807$$CN$US$US
238429612$23842961$2$F$$20240716$20240510$20240722$EXP$$US-JNJFOC-20240506827$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$HP$US$US
238429712$23842971$2$F$$20240507$20240510$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202405004270$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240828$$CN$US$US
238430002$23843000$2$F$$20240808$20240510$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072923$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$MD$JP$JP
238430437$23843043$7$F$20230601$20240717$20240510$20240724$EXP$$US-MYLANLABS-2024M1041596$MYLAN$$22$YR$$F$Y$61.69$KG$20240724$$CN$US$US
238430462$23843046$2$F$$20240830$20240510$20240906$EXP$$DK-MYLANLABS-2024M1041188$MYLAN$Loft J, Riis P, Schultz N, Bjerrum S, Schonning K, Pedersen C,. Maribavir for the treatment of cytomegalovirus infection in a liver transplant patient.. Ugeskr Laeger.. 2024;186:1457-1548$49$YR$$M$Y$$$20240906$$HP$DK$DK
238430542$23843054$2$F$$20240813$20240510$20240816$EXP$$US-LUNDBECK-DKLU3077809$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
238430723$23843072$3$F$20230605$20240724$20240510$20240731$EXP$$US-OTSUKA-2023_015017$OTSUKA$$$$$F$Y$$$20240731$$CN$US$US
238430804$23843080$4$F$$20240829$20240510$20240903$EXP$$AU-PFIZER INC-202400104140$PFIZER$Yeoh, K.. Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual. Transplant infectious disease. 2024;26(4):10.1111/tid.14273$53$YR$$F$Y$$$20240903$$HP$AU$AU
238431212$23843121$2$F$20240101$20240626$20240510$20240703$EXP$$US-SA-2024SA135116$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240703$$MD$US$US
2384312914$23843129$14$F$$20240913$20240510$20240919$EXP$$US-JNJFOC-20240484563$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$CN$US$US
238431373$23843137$3$F$$20240625$20240510$20240701$30DAY$$US-PFIZER INC-202400103142$PFIZER$$13$YR$$F$Y$$$20240701$$MD$US$US
238431403$23843140$3$F$20240429$20240922$20240510$20240925$30DAY$$US-PFIZER INC-202400102967$PFIZER$$7$YR$$M$Y$$$20240925$$CN$US$US
238431563$23843156$3$F$$20240913$20240510$20240918$30DAY$$US-PFIZER INC-202400103952$PFIZER$$8$YR$$F$Y$$$20240918$$HP$US$US
238431575$23843157$5$F$$20240922$20240510$20240925$30DAY$$US-PFIZER INC-202400103033$PFIZER$$12$YR$$F$Y$$$20240925$$HP$US$US
238432032$23843203$2$F$20240318$20240627$20240510$20240701$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-048057$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240701$$MD$AU$AU
238432052$23843205$2$F$$20240711$20240510$20240711$PER$$US-ALXN-202405USA000193US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
238432313$23843231$3$F$$20240924$20240510$20240926$EXP$$BR-PFIZER INC-PV202300040921$PFIZER$$$$$M$Y$68$KG$20240926$$MD$BR$BR
238432414$23843241$4$F$$20240913$20240510$20240918$30DAY$$US-PFIZER INC-202400102803$PFIZER$$9$YR$$M$Y$$$20240918$$CN$US$US
238432963$23843296$3$F$$20240703$20240510$20240709$PER$$US-BIOGEN-2024BI01264046$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
238433023$23843302$3$F$20240426$20240619$20240510$20240702$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01527$AMNEAL$$61$YR$$M$Y$111.11$KG$20240702$$HP$US$US
238433094$23843309$4$F$$20240809$20240510$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072750$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$83.46$KG$20240814$$CN$US$US
238433122$23843312$2$F$20231001$20240813$20240510$20240819$EXP$$NO-BRISTOL-MYERS SQUIBB COMPANY-2024-071064$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240819$$MD$NO$NO
238433272$23843327$2$F$20230501$20240819$20240510$20240828$EXP$$US-NOVOPROD-1206647$NOVO NORDISK$$$$$M$Y$$$20240828$$CN$US$US
238433504$23843350$4$F$20240419$20240719$20240510$20240729$EXP$$US-JNJFOC-20240505717$JOHNSON AND JOHNSON$$71$YR$E$M$Y$75$KG$20240729$$HP$US$US
238433553$23843355$3$F$$20240801$20240510$20240805$PER$$NVSC2024US097889$NOVARTIS$$$$$M$Y$$$20240806$$HP$US$US
238433632$23843363$2$F$20231222$20240703$20240510$20240712$EXP$$US-NOVOPROD-1214880$NOVO NORDISK$$63$YR$$F$Y$130.27$KG$20240712$$MD$US$US
238433754$23843375$4$F$20231013$20240823$20240510$20240830$EXP$$CA-GSK-CA2023141331$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$HP$CA$CA
238433763$23843376$3$F$20231001$20240718$20240510$20240724$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-005295$AMGEN$$48$YR$A$F$Y$$$20240724$$CN$US$US
238433822$23843382$2$F$$20240712$20240510$20240717$EXP$$NVSC2024US035937$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
238433973$23843397$3$F$$20240704$20240510$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03824$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238434072$23843407$2$F$$20240704$20240510$20240711$PER$$US-JNJFOC-20240507395$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$HP$US$US
238434402$23843440$2$F$$20240712$20240510$20240715$EXP$$NVSC2024US097427$NOVARTIS$$$$$F$Y$$$20240715$$MD$US$US
238434473$23843447$3$F$20240506$20240922$20240510$20240925$30DAY$$US-PFIZER INC-202400103114$PFIZER$$13$YR$$M$Y$$$20240925$$HP$US$US
238434545$23843454$5$F$20240508$20240917$20240510$20240924$30DAY$$US-PFIZER INC-PV202400045824$PFIZER$$15$YR$$M$Y$$$20240924$$CN$US$US
238434553$23843455$3$F$20240507$20240922$20240510$20240925$30DAY$$US-PFIZER INC-202400103091$PFIZER$$12$YR$$M$Y$27.22$KG$20240925$$CN$US$US
238434562$23843456$2$F$$20240724$20240510$20240725$PER$$NVSC2024US095956$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
238434964$23843496$4$F$20240501$20240911$20240510$20240923$EXP$$US-SA-2024SA141815$SANOFI AVENTIS$$61$YR$A$F$Y$56.7$KG$20240923$$MD$US$US
238435114$23843511$4$F$20240206$20240814$20240510$20240820$EXP$$DE-SA-2024SA054173$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240820$$HP$DE$DE
238435192$23843519$2$F$$20240731$20240510$20240801$EXP$$GB-MYLANLABS-2024M1042320$MYLAN$$$$$F$Y$$$20240801$$CN$GB$GB
238435204$23843520$4$F$$20240715$20240510$20240925$PER$$US-GSK-US2024AMR056920$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
238435272$23843527$2$F$20230801$20240719$20240510$20240726$EXP$$US-JNJFOC-20230822715$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240726$$CN$US$US
238435532$23843553$2$F$$20240723$20240510$20240729$EXP$$US-JNJFOC-20240503733$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$CN$US$US
238435582$23843558$2$F$$20240909$20240510$20240912$EXP$CA-HEALTHCANVIG-E2B_06948654$CA-PURDUE-USA-2024-0309499$PURDUE$$44$YR$$F$Y$97$KG$20240912$$HP$CA$CA
238436045$23843604$5$F$$20240808$20240510$20240814$EXP$$US-GSK-US2024AMR056041$GLAXOSMITHKLINE$$$$$F$Y$53.96$KG$20240814$$HP$US$US
238436212$23843621$2$F$$20240825$20240510$20240827$PER$$NVSC2024US099171$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
238436312$23843631$2$F$20210201$20240430$20240510$20240926$EXP$$CA-AKCEA THERAPEUTICS, INC.-2024IS004332$AKCEA THERAPEUTICS$$$$$$Y$$$20240926$$MD$CA$CA
238436542$23843654$2$F$20221101$20240503$20240510$20240730$EXP$$CA-AKCEA THERAPEUTICS, INC.-2024IS004434$AKCEA THERAPEUTICS$$$$$$Y$$$20240729$$CN$CA$CA
238436602$23843660$2$F$$20240627$20240510$20240701$PER$$US-PFIZER INC-202400095670$PFIZER$$70$YR$$F$Y$$$20240701$$CN$US$US
238436752$23843675$2$F$$20240711$20240510$20240711$PER$$US-ALXN-202405USA000212US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
238436945$23843694$5$F$20240730$20240909$20240510$20240918$EXP$$US-Calliditas-2024CAL00683$CALLIDITAS THERAPEUTICS$$59$YR$A$F$Y$$$20240918$$CN$US$US
238436952$23843695$2$F$20240507$20240703$20240510$20240705$PER$$US-AMGEN-USASP2024092216$AMGEN$$67$YR$E$M$Y$$$20240705$$CN$US$US
238436963$23843696$3$F$$20240912$20240510$20240920$EXP$$CA-TEVA-VS-3196638$TEVA$$$$N$M$Y$1$KG$20240920$$MD$CA$CA
238437164$23843716$4$F$$20240819$20240510$20240909$PER$$US-INCYTE CORPORATION-2024IN004294$INCYTE$$$$$$Y$$$20240909$$HP$US$US
238437236$23843723$6$F$20240503$20240923$20240510$20240930$EXP$$TW-PFIZER INC-202400102178$PFIZER$$$$A$F$Y$$$20240930$$HP$TW$TW
238437273$23843727$3$F$$20240708$20240510$20240710$EXP$$DE-ALXN-202405EEA000433DE$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240710$$PH$DE$DE
238437372$23843737$2$F$$20240630$20240510$20240701$EXP$$US-PFIZER INC-202400104176$PFIZER$$79$YR$$F$Y$$$20240701$$CN$US$US
238437603$23843760$3$F$20240215$20240628$20240510$20240708$EXP$$FR-MYLANLABS-2024M1040905$MYLAN$$63$YR$$F$Y$$$20240708$$MD$FR$FR
238437802$23843780$2$F$$20240711$20240510$20240715$EXP$$US-BIOGEN-2024BI01263997$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
238437973$23843797$3$F$$20240923$20240510$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073059$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$87.54$KG$20240924$$CN$US$US
238438424$23843842$4$F$20240101$20240912$20240510$20240916$EXP$$US-PFIZER INC-202400104901$PFIZER$$65$YR$$F$Y$41.27$KG$20240916$$HP$US$US
238438442$23843844$2$F$20240503$20240905$20240510$20240911$EXP$$CA-JNJFOC-20240512234$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240911$$HP$CA$CA
238438543$23843854$3$F$20240401$20240711$20240510$20240711$PER$$US-ALXN-202405USA000252US$ALEXION PHARMACEUTICALS$$67$YR$$M$Y$$$20240711$$CN$US$US
238438744$23843874$4$F$20240101$20240906$20240510$20240917$PER$$US-SA-2024SA135012$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240918$$MD$US$US
238438773$23843877$3$F$20240417$20240813$20240510$20240815$EXP$$US-JNJFOC-20240506752$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240816$$HP$US$US
238438872$23843887$2$F$$20240919$20240510$20240930$PER$$US-SA-2024SA136103$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240930$$MD$US$US
238438992$23843899$2$F$20240331$20240717$20240510$20240726$PER$$US-SA-2024SA135748$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240726$$MD$US$US
238439133$23843913$3$F$20240101$20240628$20240510$20240712$PER$$US-SA-2024SA135117$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240712$$MD$US$US
238439272$23843927$2$F$20240401$20240830$20240510$20240913$PER$$US-SA-2024SA135427$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240913$$MD$US$US
238439322$23843932$2$F$$20240801$20240510$20240809$PER$$US-SA-2024SA134999$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240809$$MD$US$US
238439332$23843933$2$F$$20240711$20240510$20240801$PER$$US-SA-2024SA134996$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240719$$MD$US$US
238439423$23843942$3$F$20240101$20240809$20240510$20240826$PER$$US-SA-2024SA134861$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240826$$MD$US$US
238439492$23843949$2$F$20240101$20240801$20240510$20240810$PER$$US-SA-2024SA136579$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240810$$MD$US$US
238439602$23843960$2$F$$20240904$20240510$20240913$PER$$US-SA-2024SA134512$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240913$$MD$US$US
238439775$23843977$5$F$20240101$20240816$20240510$20240821$EXP$$US-SA-2024SA115662$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240821$$CN$US$US
238439933$23843993$3$F$$20240621$20240510$20240702$PER$$US-SA-2024SA025284$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240702$$MD$US$US
238440072$23844007$2$F$20240101$20240819$20240510$20240829$PER$$US-SA-2024SA138537$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240829$$MD$US$US
238440532$23844053$2$F$20240101$20240722$20240510$20240731$PER$$US-SA-2024SA138656$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240731$$MD$US$US
238440742$23844074$2$F$$20240808$20240510$20240815$EXP$$PL-BAUSCH-BL-2024-007400$BAUSCH AND LOMB$Jagura A, Wawerska J, Sobolewska-Wlodarczyk A, Gasiorowska A. Dolegliwosci bolowe w klatce piersiowej u mlodej pacjentki z choroba lesniowskiego-crohna. Gastroenterologia praktyczna. 2023;3:87-93.$22$YR$$F$Y$$$20240815$$HP$PL$PL
238440762$23844076$2$F$20240101$20240802$20240510$20240813$PER$$US-SA-2024SA138979$SANOFI AVENTIS$$62$YR$A$M$Y$85.275$KG$20240814$$MD$US$US
238440864$23844086$4$F$20240101$20240719$20240510$20240728$PER$$US-SA-2024SA138699$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240728$$MD$US$US
238441113$23844111$3$F$20240101$20240808$20240510$20240816$PER$$US-SA-2024SA139666$SANOFI AVENTIS$$79$YR$E$F$Y$38$KG$20240816$$MD$US$US
238441213$23844121$3$F$20240503$20240719$20240510$20240726$PER$$US-ALXN-202405USA000331US$ALEXION PHARMACEUTICALS$$61$YR$$F$Y$$$20240726$$CN$US$US
238441472$23844147$2$F$20240101$20240826$20240510$20240904$EXP$$JP-009507513-2405JPN000079J$MERCK$$7$DEC$$M$Y$$$20240904$$MD$JP$JP
238441512$23844151$2$F$20231201$20240918$20240510$20240918$EXP$$MX-AstraZeneca-2024A110033$ASTRAZENECA$$65$YR$$M$Y$$$20240918$$MD$MX$
238441632$23844163$2$F$$20240711$20240510$20240716$PER$$US-ABBVIE-5749102$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
238441822$23844182$2$F$20240403$20240624$20240510$20240703$EXP$IT-MINISAL02-982187$IT-TEVA-VS-3193977$TEVA$$14$YR$$F$Y$53$KG$20240703$$PH$IT$IT
238441972$23844197$2$F$20240403$20240708$20240510$20240717$EXP$$DE-TEVA-VS-3194335$TEVA$$68$YR$$M$Y$$$20240717$$MD$DE$DE
238442092$23844209$2$F$$20240729$20240510$20240826$PER$$US-GALDERMA-US2024006590$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
238442112$23844211$2$F$20240301$20240716$20240510$20240826$PER$$US-GALDERMA-US2024006624$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
238442313$23844231$3$F$20230320$20240813$20240510$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072802$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$68.8$KG$20240816$$PH$JP$JP
238442383$23844238$3$F$$20240807$20240510$20240808$EXP$$US-PFIZER INC-202400103815$PFIZER$Kuczmarski, T.. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma. British journal of haematology. 2024;1-9$49$YR$$F$Y$$$20240808$$HP$US$US
238442492$23844249$2$F$$20240702$20240510$20240710$EXP$$US-AstraZeneca-2024A104915$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
238442632$23844263$2$F$$20240812$20240510$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-007255$JAZZ$$$$$M$Y$$$20240819$$CN$US$US
238442703$23844270$3$F$20240424$20240719$20240510$20240724$PER$$US-JNJFOC-20240475877$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240724$$HP$US$US
238442773$23844277$3$F$20230415$20240729$20240510$20240806$EXP$$SA-SANDOZ INC.-SDZ2024SA046849$SANDOZ$$29$YR$$F$Y$$$20240806$$CN$SA$SA
238442812$23844281$2$F$$20240904$20240510$20240905$EXP$$CA-SANDOZ INC.-SDZ2024CA047252$SANDOZ$$30$YR$$F$Y$$$20240905$$CN$CA$CA
238442842$23844284$2$F$20240901$20240910$20240510$20240916$EXP$$GB-SANDOZ INC.-SDZ2024GB046893$SANDOZ$$$$E$M$Y$$$20240916$$CN$GB$GB
238442852$23844285$2$F$20240424$20240704$20240510$20240709$30DAY$$US-SANDOZ INC.-SDZ2024US046957$SANDOZ$$15$YR$$M$Y$$$20240709$$CN$US$US
238443112$23844311$2$F$$20240830$20240510$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073258$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240905$$HP$US$US
238443192$23844319$2$F$20240201$20240628$20240510$20240711$EXP$$HU-ELI_LILLY_AND_COMPANY-HU202405002567$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240710$$CN$HU$HU
238443262$23844326$2$F$$20240704$20240510$20240706$EXP$$JP-ABBVIE-5754834$ABBVIE$UENO M, Sando Y, Kondo A, Matsuda M, Yoshioka T, Sunami K. A case of serious infection that repeatedly occurred in association with IgG decreased during the treatment for chronic GVHD. Proceedings of the 63rd Chugoku-Shikoku Regional Meeting of the Japanese Society of Hematology;Okayama-shi Okayama. 2024;22-22.; Masaya UENO, et al.: Department of Hematology, National Hospital Organization Okayama Medical Center. A case of serious infection that repeatedly occurred in association with IgG decr...$23$YR$$M$Y$$$20240706$$MD$JP$JP
238443282$23844328$2$F$$20240801$20240510$20240808$PER$$US-VERTEX PHARMACEUTICALS-2024-007910$VERTEX$$$$$$Y$93$KG$20240808$$CN$US$US
238443312$23844331$2$F$20231101$20240716$20240510$20240723$EXP$$US-009507513-2405USA000418$MERCK$$70$YR$$F$Y$$$20240723$$CN$US$US
238443422$23844342$2$F$$20240628$20240510$20240705$PER$$US-ALXN-202405USA000371US$ALEXION PHARMACEUTICALS$$$$$M$Y$144.22$KG$20240705$$CN$US$US
238443564$23844356$4$F$20240101$20240626$20240510$20240703$EXP$$JP-APELLIS-APL-2024-003843$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240703$$CN$JP$JP
238443665$23844366$5$F$20240502$20240722$20240510$20240726$PER$$US-ROCHE-3558957$ROCHE$$49$YR$A$$Y$85.7$KG$20240726$$HP$US$US
238443962$23844396$2$F$20220509$20240510$20240510$20240729$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-183184$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$62.3$KG$20240729$$CN$ES$ES
238444103$23844410$3$F$20240201$20240731$20240510$20240806$EXP$$US-ABBVIE-5751581$ABBVIE$$67$YR$$M$Y$8.164$KG$20240806$$CN$US$US
238444132$23844413$2$F$20220601$20240510$20240510$20240812$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-221696$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$110$KG$20240813$$CN$ES$ES
238444162$23844416$2$F$20230201$20240510$20240510$20240716$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242733$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$55$KG$20240716$$CN$ES$ES
238444214$23844421$4$F$$20240806$20240510$20240809$EXP$$US-GILEAD-2024-0672233$GILEAD$$65$YR$E$F$Y$$$20240809$$HP$US$US
238444323$23844432$3$F$20240401$20240823$20240510$20240829$EXP$$US-TAKEDA-2024TUS041957$TAKEDA$$77$YR$$M$Y$110$KG$20240829$$CN$US$US
238444334$23844433$4$F$20240312$20240709$20240510$20240809$PER$$US-AstraZeneca-2024A092534$ASTRAZENECA$$24347$DY$$M$Y$$$20240809$$CN$US$
238444484$23844448$4$F$20240415$20240729$20240510$20240801$EXP$$CA-LUNDBECK-DKLU3077576$LUNDBECK$$$$$$Y$$$20240801$$CN$CA$CA
238444512$23844451$2$F$$20240827$20240510$20240909$PER$$US-SA-2024SA141296$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240909$$MD$US$US
238444645$23844464$5$F$20240625$20240809$20240510$20240814$EXP$$US-TAKEDA-2024TUS031937$TAKEDA$$77$YR$$F$Y$$$20240814$$CN$US$US
238444843$23844484$3$F$$20240701$20240510$20240801$PER$$US-BIOMARINAP-US-2023-154826$BIOMARIN$$$$$$Y$$$20240801$$CN$US$US
238444874$23844487$4$F$$20240810$20240510$20240820$EXP$$US-BIOMARINAP-US-2024-157816$BIOMARIN$$$$$$Y$$$20240820$$MD$US$US
238444934$23844493$4$F$$20240710$20240510$20240719$PER$$JP-RADIUS HEALTH INC.-2024JP003209$RADIUS PHARM$$74$YR$$F$Y$$$20240719$$MD$JP$JP
238444948$23844494$8$F$20240414$20240719$20240510$20240726$EXP$$GB-AMGEN-GBRNI2024085100$AMGEN$$79$YR$E$M$Y$$$20240726$$MD$GB$GB
238445114$23844511$4$F$$20240731$20240510$20240802$EXP$$DE-ROCHE-3560982$ROCHE$$$$$F$Y$$$20240802$$MD$DE$DE
238445133$23844513$3$F$20240101$20240509$20240510$20240815$EXP$$HN-BIOGEN-2024BI01264463$BIOGEN$$33$YR$$F$Y$$$20240815$$CN$HN$HN
238445165$23844516$5$F$$20240702$20240510$20240705$PER$$US-AstraZeneca-2024A101731$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
238445922$23844592$2$F$$20240807$20240511$20240816$PER$$US-SA-2024SA132550$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240816$$MD$US$US
238446333$23844633$3$F$20240421$20240715$20240511$20240801$EXP$$US-SA-2024SA136925$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240719$$MD$US$US
238446378$23844637$8$F$$20240712$20240511$20240717$EXP$$CA-JNJFOC-20240523337$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240717$$HP$CA$CA
238446672$23844667$2$F$20231219$20240619$20240511$20240704$EXP$IT-MINISAL02-982807$IT-TEVA-VS-3195129$TEVA$$72$YR$$F$Y$70$KG$20240704$$MD$IT$IT
238446742$23844674$2$F$$20240423$20240511$20240801$PER$$US-TEVA-VS-3188449$TEVA$$$$$F$Y$$$20240801$$CN$US$US
238446932$23844693$2$F$20240501$20240719$20240511$20240723$PER$$US-AMGEN-USASP2024092670$AMGEN$$88$YR$E$F$Y$$$20240723$$CN$US$US
238446942$23844694$2$F$20240101$20240723$20240511$20240801$PER$$US-SA-2024SA141432$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240801$$MD$US$US
238447033$23844703$3$F$20240101$20240702$20240511$20240708$EXP$$CA-ABBVIE-5752718$ABBVIE$$71$YR$$M$Y$$$20240708$$CN$CA$CA
238447132$23844713$2$F$20240507$20240710$20240511$20240712$PER$$US-AMGEN-USASP2024091640$AMGEN$$75$YR$E$F$Y$$$20240712$$MD$US$US
238447142$23844714$2$F$$20240627$20240511$20240702$PER$$US-AMGEN-USASP2024093559$AMGEN$$$$$M$Y$$$20240702$$MD$US$US
238447367$23844736$7$F$20240101$20240903$20240511$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-012287$UNITED THERAPEUTICS$$$$$F$Y$62.132$KG$20240910$$$US$US
238447382$23844738$2$F$20240422$20240629$20240511$20240708$EXP$$CA-CELLTRION INC.-2024CA010780$CELLTRION$$$$$$Y$$$20240708$$HP$CA$CA
238447396$23844739$6$F$20240101$20240730$20240511$20240807$EXP$$CA-CELLTRION INC.-2024CA001367$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
238447432$23844743$2$F$$20240705$20240511$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-014065$UNITED THERAPEUTICS$$$$$F$Y$57.143$KG$20240713$$$US$US
238447622$23844762$2$F$20231101$20240717$20240511$20240726$EXP$$DE-TEVA-VS-3195185$TEVA$$1$DY$$M$Y$2.69$KG$20240726$$MD$DE$DE
238447642$23844764$2$F$20240101$20240718$20240511$20240722$PER$$US-AMGEN-USASP2024091573$AMGEN$$64$YR$A$M$Y$$$20240722$$CN$US$US
238447764$23844776$4$F$20240424$20240702$20240511$20240716$EXP$$JP-ABBVIE-5750920$ABBVIE$$58$YR$$F$Y$30$KG$20240716$$MD$JP$JP
238447773$23844777$3$F$$20240826$20240511$20240903$EXP$$CA-APOTEX-2024AP005561$APOTEX$$74$YR$$F$Y$60$KG$20240903$$HP$CA$CA
238447843$23844784$3$F$$20240815$20240511$20240827$PER$$US-SA-2024SA136505$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240827$$HP$US$US
238447884$23844788$4$F$20231101$20240813$20240511$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-021365$JAZZ$$44$YR$$F$Y$$$20240819$$MD$US$US
238447933$23844793$3$F$20240326$20240801$20240511$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010999$UNITED THERAPEUTICS$$35$YR$$F$Y$47.392$KG$20240809$$$US$US
238448112$23844811$2$F$20240320$20240806$20240511$20240808$EXP$$US-ABBVIE-5751783$ABBVIE$$65$YR$$F$Y$$$20240808$$CN$US$US
238448492$23844849$2$F$20231105$20240722$20240511$20240729$EXP$$NVSC2023IN274916$NOVARTIS$$82$YR$$M$Y$$$20240729$$CN$IN$IN
238448892$23844889$2$F$20240501$20240814$20240511$20240819$PER$$US-AMGEN-USASP2024092241$AMGEN$$62$YR$A$F$Y$$$20240819$$CN$US$US
238448952$23844895$2$F$20240321$20240716$20240511$20240724$PER$$US-SA-2024SA135645$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240724$$MD$US$US
238449193$23844919$3$F$20240101$20240822$20240511$20240914$PER$$US-SA-2024SA135182$SANOFI AVENTIS$$63$YR$A$M$Y$104.3$KG$20240914$$MD$US$US
238449472$23844947$2$F$20240101$20240815$20240511$20240828$PER$$US-SA-2024SA139376$SANOFI AVENTIS$$42$YR$A$F$Y$108$KG$20240828$$MD$US$US
238449592$23844959$2$F$$20240422$20240511$20240801$PER$$US-TEVA-VS-3187580$TEVA$$$$$M$Y$$$20240801$$CN$US$US
238449683$23844968$3$F$20240606$20240702$20240511$20240709$EXP$$CA-CELLTRION INC.-2024CA010723$CELLTRION$$$$$$Y$$$20240709$$HP$CA$CA
238449772$23844977$2$F$$20240909$20240511$20240913$EXP$$US-ABBVIE-5751717$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
238449953$23844995$3$F$20240420$20240805$20240511$20240815$EXP$$DE-UCBSA-2024022847$UCB$$40$YR$$M$Y$69$KG$20240815$$MD$DE$DE
238449982$23844998$2$F$$20240819$20240511$20240821$EXP$$US-ABBVIE-5753381$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
238450156$23845015$6$F$20240502$20240913$20240511$20240923$EXP$$CA-CELLTRION INC.-2024CA010669$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
238450172$23845017$2$F$20240507$20240730$20240511$20240802$PER$$US-AMGEN-USASP2024092798$AMGEN$$70$YR$E$F$Y$$$20240802$$CN$US$US
238450222$23845022$2$F$20240506$20240806$20240511$20240808$PER$$US-AMGEN-USASP2024093500$AMGEN$$78$YR$E$F$Y$$$20240808$$CN$US$US
238450242$23845024$2$F$20240330$20240712$20240511$20240723$EXP$FR-AFSSAPS-BX2024000786$FR-TEVA-VS-3195132$TEVA$$44$YR$$M$Y$$$20240723$$PH$FR$FR
238450253$23845025$3$F$20240101$20240828$20240511$20240919$PER$$US-SA-2024SA139668$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240919$$MD$US$US
238450642$23845064$2$F$$20240813$20240511$20240814$PER$$US-JNJFOC-20240500493$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240814$$CN$US$US
238450882$23845088$2$F$20240201$20240918$20240511$20240925$EXP$$CA-ABBVIE-5751313$ABBVIE$$$$A$F$Y$$$20240925$$CN$CA$CA
238451126$23845112$6$F$20240404$20240826$20240511$20240903$EXP$$CA-CELLTRION INC.-2024CA010757$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
238451493$23845149$3$F$20240115$20240820$20240511$20240822$EXP$$JP-ABBVIE-5752535$ABBVIE$$61$YR$$M$Y$53$KG$20240822$$MD$JP$JP
238451569$23845156$9$F$20240101$20240919$20240511$20240928$EXP$$CA-CELLTRION INC.-2024CA010782$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
238451702$23845170$2$F$20240507$20240726$20240511$20240730$PER$$US-AMGEN-USASP2024092333$AMGEN$$71$YR$E$F$Y$$$20240730$$CN$US$US
238451963$23845196$3$F$20240101$20240709$20240511$20240716$EXP$$CA-ABBVIE-5752275$ABBVIE$$58$YR$$F$Y$$$20240716$$HP$CA$CA
238452253$23845225$3$F$20240524$20240725$20240511$20240802$EXP$$US-GSK-US2024AMR057462$GLAXOSMITHKLINE$$67$YR$$F$Y$60$KG$20240802$$CN$US$US
238452306$23845230$6$F$20240401$20240911$20240511$20240916$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-005429$JAZZ$$46$YR$$F$Y$$$20240916$$CN$US$US
238452363$23845236$3$F$20240501$20240730$20240511$20240802$PER$$US-AMGEN-USASP2024092075$AMGEN$$65$YR$E$M$Y$$$20240801$$CN$US$US
238452417$23845241$7$F$20240207$20240807$20240511$20240814$EXP$$CA-AMGEN-CANSL2024048115$AMGEN$$59$YR$A$F$Y$63.4$KG$20240814$$MD$CA$CA
238452472$23845247$2$F$$20240819$20240511$20240828$PER$$US-SA-2024SA141791$SANOFI AVENTIS$$$$A$F$Y$190.5$KG$20240828$$MD$US$US
238452562$23845256$2$F$$20240710$20240511$20240718$EXP$$DE-AMAROX PHARMA-AMR2024DE01269$HETERO$$$$$M$Y$2.9$KG$20240718$$HP$DE$DE
238452692$23845269$2$F$20240101$20240626$20240511$20240705$PER$$US-SA-2024SA141790$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240705$$MD$US$US
238452802$23845280$2$F$$20240805$20240511$20240808$EXP$$BE-AUROBINDO-AUR-APL-2024-022160$AUROBINDO$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-induced anaphylaxis uncommon in mastocytosis: findings from two large cohorts. THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024;12(7):1850-62$38$YR$$$Y$$$20240808$$MD$BE$BE
238452982$23845298$2$F$20240321$20240730$20240511$20240801$EXP$$US-TAKEDA-2024TUS027624$TAKEDA$$71$YR$$M$Y$$$20240801$$CN$US$US
238453114$23845311$4$F$$20240705$20240511$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-004738$UNITED THERAPEUTICS$$$$$M$Y$$$20240710$$$US$US
238453164$23845316$4$F$20240410$20240607$20240511$20240701$30DAY$$US-JNJFOC-20240511229$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240701$$HP$US$US
238453332$23845333$2$F$$20240730$20240511$20240807$PER$$US-SA-2024SA140669$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240807$$MD$US$US
238453484$23845348$4$F$$20240812$20240511$20240822$PER$$US-TRAVERE-2024TVT00341$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
238453562$23845356$2$F$20240507$20240821$20240511$20240824$PER$$US-AMGEN-USASP2024092729$AMGEN$$55$YR$A$F$Y$$$20240824$$CN$US$US
238453663$23845366$3$F$20240323$20240801$20240511$20240822$PER$$US-TRAVERE-2024TVT00346$TRAVERE THERAPEUTICS$$59$YR$A$M$Y$74.84$KG$20240822$$CN$US$US
238453678$23845367$8$F$20240709$20240813$20240511$20240820$EXP$$US-TRAVERE-2024TVT00338$TRAVERE THERAPEUTICS$$52$YR$A$F$Y$$$20240820$$CN$US$US
238453685$23845368$5$F$20240401$20240813$20240511$20240820$EXP$$US-TRAVERE-2024TVT00344$TRAVERE THERAPEUTICS$$44$YR$A$F$Y$$$20240820$$CN$US$US
238453862$23845386$2$F$$20240715$20240511$20240815$PER$$US-TRAVERE-2024TVT00356$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240815$$HP$US$US
238453892$23845389$2$F$$20240809$20240511$20240822$PER$$US-TRAVERE-2024TVT00373$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
238453962$23845396$2$F$$20240617$20240511$20240716$PER$$US-JNJFOC-20240481604$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$CN$US$US
238454012$23845401$2$F$20240507$20240821$20240511$20240824$PER$$US-AMGEN-USASP2024092794$AMGEN$$79$YR$E$M$Y$$$20240824$$CN$US$US
238454022$23845402$2$F$20220901$20240717$20240511$20240724$EXP$$NVSC2024IT096384$NOVARTIS$Ferraioli M, Fiannacca L, Greco E, Cela E, Fatica M, Bergamini A et al.. Risankizumab efficacy in synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) remission: a case report on rheumatologic and dermatologic disease manifestations with literature review. CASE REPORTS IN IMMUNOLOGY. 2024;1-5$63$YR$$F$Y$$$20240724$$HP$IT$IT
238454203$23845420$3$F$20231011$20240626$20240511$20240709$PER$$US-MYLANLABS-2024M1040169$MYLAN$$19$YR$$F$Y$74.84$KG$20240709$$CN$US$US
238454404$23845440$4$F$$20240812$20240511$20240822$PER$$US-TRAVERE-2024TVT00408$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
238454423$23845442$3$F$20240421$20240710$20240511$20240815$PER$$US-TRAVERE-2024TVT00395$TRAVERE THERAPEUTICS$$40$YR$A$F$Y$$$20240815$$CN$US$US
238454512$23845451$2$F$20240508$20240926$20240511$20240927$PER$$US-AMGEN-USASP2024093174$AMGEN$$80$YR$E$F$Y$$$20240927$$CN$US$US
238454543$23845454$3$F$20240826$20240830$20240511$20240917$PER$$US-TRAVERE-2024TVT00431$TRAVERE THERAPEUTICS$$42$YR$A$M$Y$$$20240917$$CN$US$US
238454562$23845456$2$F$$20240904$20240511$20240930$PER$$US-TRAVERE-2024TVT00425$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
238454692$23845469$2$F$20240301$20240827$20240511$20240911$PER$$US-SA-2024SA136341$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240911$$MD$US$US
238454752$23845475$2$F$$20240812$20240511$20240826$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024055863$VIIV$$$$$F$Y$$$20240826$$HP$US$US
238455033$23845503$3$F$20240502$20240815$20240511$20240829$PER$$US-SA-2024SA139753$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240829$$MD$US$US
238455104$23845510$4$F$20231130$20240628$20240511$20240704$EXP$$US-ABBVIE-5754726$ABBVIE$$55$YR$$F$Y$77$KG$20240704$$HP$US$US
238455623$23845562$3$F$$20240712$20240511$20240727$EXP$$US-TEVA-VS-3196310$TEVA$$67$YR$$M$Y$$$20240727$$CN$US$US
238455632$23845563$2$F$$20240626$20240511$20240712$PER$$US-AstraZeneca-2024A100748$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
238455702$23845570$2$F$20240801$20240828$20240511$20240909$PER$$US-SA-2024SA138054$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240909$$CN$US$US
238455863$23845586$3$F$$20240706$20240511$20240808$PER$$US-AstraZeneca-2024A109642$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
238455872$23845587$2$F$$20240701$20240511$20240709$EXP$AU-STRIDES ARCOLAB LIMITED-2024SP005425$AU-STRIDES ARCOLAB LIMITED-2024SP005425$STRIDES$Madike R, Rana K, Patel S, Selva D.. A case of disseminated nocardiosis with orbital apex involvement and endophthalmitis.. Orbit (Amsterdam, Netherlands).. 2024;1-4$7$DEC$$M$Y$$$20240709$$MD$AU$AU
238455913$23845591$3$F$20240420$20240709$20240511$20240715$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013632$UNITED THERAPEUTICS$$60$YR$$F$Y$83.9$KG$20240715$$$US$US
238456333$23845633$3$F$$20240820$20240511$20240827$EXP$$CA-JNJFOC-20240509883$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240827$$HP$CA$CA
238456342$23845634$2$F$20240101$20240808$20240511$20240817$PER$$US-SA-2024SA141059$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240817$$MD$US$US
238456483$23845648$3$F$20240509$20240808$20240511$20240809$PER$$US-AMGEN-USASP2024093137$AMGEN$$73$YR$E$F$Y$$$20240809$$HP$US$US
238456782$23845678$2$F$$20240813$20240511$20240815$EXP$$US-JNJFOC-20240507397$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$HP$US$US
238456952$23845695$2$F$$20240716$20240511$20240724$EXP$$CA-AstraZeneca-2024A108012$ASTRAZENECA$$65$YR$$F$Y$34$KG$20240724$$MD$CA$
238456973$23845697$3$F$20240401$20240812$20240511$20240817$EXP$$TR-JNJFOC-20240504685$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240817$$MD$TR$TR
238457082$23845708$2$F$20240510$20240816$20240511$20240821$PER$$US-AMGEN-USASP2024094254$AMGEN$$89$YR$E$M$Y$$$20240820$$HP$US$US
238457283$23845728$3$F$$20240626$20240511$20240722$PER$$US-AstraZeneca-2024A109386$ASTRAZENECA$$79$YR$$F$Y$$$20240722$$CN$US$
238457352$23845735$2$F$20230818$20240813$20240511$20240814$PER$$US-JNJFOC-20240505733$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240814$$CN$US$US
238457462$23845746$2$F$20240101$20240724$20240511$20240802$PER$$US-SA-2024SA139526$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240802$$MD$US$US
238457492$23845749$2$F$20240416$20240423$20240511$20240806$PER$$US-AstraZeneca-2024A106712$ASTRAZENECA$$25224$DY$$F$Y$59$KG$20240806$$CN$US$
238457522$23845752$2$F$20240701$20240725$20240511$20240807$PER$$US-SA-2024SA135631$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240807$$MD$US$US
238457562$23845756$2$F$$20240610$20240512$20240703$PER$$US-AstraZeneca-2024A101953$ASTRAZENECA$$$$$M$Y$$$20240703$$CN$US$
238457572$23845757$2$F$$20240624$20240512$20240711$PER$$US-AstraZeneca-2024A101966$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
238457793$23845779$3$F$$20240626$20240512$20240705$EXP$$US-SA-2024SA132959$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240705$$MD$US$US
238457924$23845792$4$F$$20240625$20240512$20240704$PER$$US-SA-2024SA135385$SANOFI AVENTIS$$$$E$M$Y$58.9$KG$20240704$$MD$US$US
238458005$23845800$5$F$20240101$20240814$20240512$20240828$PER$$US-SA-2024SA139747$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240828$$MD$US$US
238458112$23845811$2$F$20240510$20240814$20240512$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-027061$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240814$$CN$US$US
238458182$23845818$2$F$20240426$20240722$20240512$20240807$PER$$US-AstraZeneca-2024A100349$ASTRAZENECA$$16347$DY$$F$Y$$$20240807$$CN$US$
238458203$23845820$3$F$20240422$20240620$20240512$20240702$PER$$US-SA-2024SA137048$SANOFI AVENTIS$$2$YR$C$F$Y$11.8$KG$20240702$$MD$US$US
238458273$23845827$3$F$20221210$20240916$20240512$20240920$EXP$$NVSC2022IN295037$NOVARTIS$$66$YR$$F$Y$$$20240920$$CN$IN$IN
238458383$23845838$3$F$20240505$20240916$20240512$20240924$PER$$US-SA-2024SA142861$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240924$$MD$US$US
238458405$23845840$5$F$$20240725$20240512$20240729$EXP$$US-SANDOZ INC.-SDZ2024US046084$SANDOZ$$$$$$Y$$$20240729$$CN$US$US
238458442$23845844$2$F$20240425$20240705$20240512$20240716$EXP$$CA-JNJFOC-20240510633$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240716$$HP$CA$CA
238458473$23845847$3$F$20240101$20240625$20240512$20240704$PER$$US-SA-2024SA137299$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240704$$MD$US$US
238458494$23845849$4$F$20231109$20240812$20240512$20240819$EXP$$NVSC2023GB240310$NOVARTIS$$35$YR$$F$Y$$$20240819$$CN$GB$GB
238459804$23845980$4$F$20240509$20240801$20240512$20240805$EXP$$US-JNJFOC-20240534139$JOHNSON AND JOHNSON$$36$YR$A$F$Y$83$KG$20240805$$HP$US$US
238459832$23845983$2$F$20240101$20240822$20240512$20240905$PER$$US-SA-2024SA136030$SANOFI AVENTIS$$58$YR$A$M$Y$104$KG$20240905$$MD$US$US
238459855$23845985$5$F$20230427$20240826$20240512$20240902$EXP$$PHHY2018IN008516$NOVARTIS$$15$YR$$F$Y$$$20240902$$CN$IN$IN
238459942$23845994$2$F$20240101$20240905$20240512$20240920$PER$$US-SA-2024SA140888$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240920$$MD$US$US
238460012$23846001$2$F$$20240826$20240512$20240905$PER$$US-SA-2024SA140958$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240905$$MD$US$US
238460092$23846009$2$F$$20240730$20240512$20240808$PER$$US-SA-2024SA137183$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240808$$MD$US$US
238460123$23846012$3$F$20240101$20240806$20240512$20240820$PER$$US-SA-2024SA137177$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240820$$MD$US$US
238460162$23846016$2$F$$20240703$20240512$20240708$EXP$$GB-AMGEN-GBRSP2024091146$AMGEN$$64$YR$A$F$Y$$$20240707$$CN$GB$GB
238460233$23846023$3$F$20240801$20240814$20240512$20240827$PER$$US-SA-2024SA139769$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240827$$MD$US$US
238460402$23846040$2$F$20220913$20240703$20240512$20240709$EXP$$PK-AMGEN-PAKSP2020191216$AMGEN$$37$YR$A$M$Y$118$KG$20240709$$CN$PK$PK
238460412$23846041$2$F$$20240706$20240512$20240710$EXP$$PK-AMGEN-PAKSP2023229805$AMGEN$$53$YR$A$F$Y$74$KG$20240709$$CN$PK$PK
238460485$23846048$5$F$20240521$20240821$20240512$20240829$EXP$$CA-JNJFOC-20240515463$JOHNSON AND JOHNSON$$58$YR$A$M$Y$77$KG$20240829$$HP$CA$CA
238460512$23846051$2$F$$20240913$20240512$20240930$PER$$US-TRAVERE-2024TVT00337$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
238460625$23846062$5$F$20240404$20240814$20240512$20240822$PER$$US-TRAVERE-2024TVT00351$TRAVERE THERAPEUTICS$$65$YR$E$M$Y$$$20240822$$CN$US$US
238460692$23846069$2$F$$20240819$20240512$20240917$PER$$US-TRAVERE-2024TVT00372$TRAVERE THERAPEUTICS$$55$YR$A$F$Y$$$20240917$$CN$US$US
238460772$23846077$2$F$$20240710$20240512$20240815$PER$$US-TRAVERE-2024TVT00390$TRAVERE THERAPEUTICS$$54$YR$A$F$Y$$$20240815$$CN$US$US
238460804$23846080$4$F$20240421$20240911$20240512$20240930$PER$$US-TRAVERE-2024TVT00388$TRAVERE THERAPEUTICS$$62$YR$A$M$Y$$$20240930$$CN$US$US
238460823$23846082$3$F$$20240606$20240512$20240718$PER$$US-TRAVERE-2024TVT00399$TRAVERE THERAPEUTICS$$45$YR$A$M$Y$$$20240718$$CN$US$US
238460833$23846083$3$F$$20240701$20240512$20240815$PER$$US-TRAVERE-2024TVT00405$TRAVERE THERAPEUTICS$$24$YR$A$M$Y$$$20240815$$CN$US$US
238460842$23846084$2$F$20240422$20240919$20240512$20240930$PER$$US-TRAVERE-2024TVT00403$TRAVERE THERAPEUTICS$$39$YR$A$F$Y$$$20240930$$CN$US$US
238460914$23846091$4$F$20240422$20240820$20240512$20240917$PER$$US-TRAVERE-2024TVT00412$TRAVERE THERAPEUTICS$$30$YR$A$F$Y$$$20240917$$CN$US$US
238460964$23846096$4$F$$20240911$20240512$20240930$PER$$US-TRAVERE-2024TVT00432$TRAVERE THERAPEUTICS$$69$YR$E$M$Y$$$20240930$$CN$US$US
238461032$23846103$2$F$$20240701$20240512$20240815$PER$$US-TRAVERE-2024TVT00434$TRAVERE THERAPEUTICS$$51$YR$A$M$Y$$$20240815$$CN$US$US
238461053$23846105$3$F$$20240731$20240512$20240815$PER$$US-TRAVERE-2024TVT00437$TRAVERE THERAPEUTICS$$39$YR$A$F$Y$$$20240815$$CN$US$US
238461232$23846123$2$F$$20240628$20240512$20240715$PER$$US-AstraZeneca-2024A108494$ASTRAZENECA$$$$$M$Y$$$20240715$$MD$US$
238461282$23846128$2$F$20240101$20240711$20240512$20240722$PER$$US-SA-2024SA140391$SANOFI AVENTIS$$80$YR$E$F$Y$90$KG$20240721$$MD$US$US
238461303$23846130$3$F$20240101$20240826$20240512$20240909$PER$$US-SA-2024SA141141$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240909$$MD$US$US
238461452$23846145$2$F$$20240812$20240512$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072499$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240812$$HP$US$US
238461592$23846159$2$F$20240429$20240621$20240512$20240715$PER$$US-AstraZeneca-2024A103508$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
238462065$23846206$5$F$20240503$20240625$20240512$20240709$EXP$$US-ABBVIE-5752623$ABBVIE$$0$YR$$M$Y$$$20240709$$HP$US$US
238462114$23846211$4$F$20240418$20240813$20240512$20240819$PER$$US-JNJFOC-20240513459$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240819$$HP$US$US
238462142$23846214$2$F$$20240715$20240512$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071957$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240716$$HP$US$US
238462252$23846225$2$F$20240105$20240827$20240512$20240829$EXP$$US-ABBVIE-5757213$ABBVIE$$81$YR$$M$Y$$$20240829$$CN$US$US
238462353$23846235$3$F$20240401$20240809$20240512$20240822$30DAY$$US-JNJFOC-20240444519$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240822$$CN$US$US
238462492$23846249$2$F$$20240721$20240512$20240725$30DAY$$EG-SANDOZ INC.-SDZ2024EG047563$SANDOZ$$$$$M$Y$$$20240724$$CN$EG$EG
238462512$23846251$2$F$$20240814$20240512$20240821$EXP$$US-SANDOZ INC.-SDZ2024US046116$SANDOZ$$$$$M$Y$$$20240821$$CN$US$US
238462553$23846255$3$F$$20240719$20240512$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070670$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240723$$CN$US$US
238462562$23846256$2$F$$20240827$20240512$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072103$BRISTOL MYERS SQUIBB$$32$YR$A$M$Y$$$20240830$$CN$US$US
238462692$23846269$2$F$$20240701$20240512$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072371$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240703$$CN$US$US
238462804$23846280$4$F$$20240927$20240512$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072201$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20241001$$CN$US$US
238462862$23846286$2$F$$20240716$20240512$20240720$EXP$$US-JNJFOC-20240508629$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240719$$CN$US$US
238463003$23846300$3$F$20220812$20240705$20240512$20240710$EXP$$CH-ABBVIE-4258752$ABBVIE$$81$YR$$M$Y$68$KG$20240710$$MD$CH$CH
238463192$23846319$2$F$$20240702$20240512$20240703$PER$$NVSC2024US100040$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
238463223$23846322$3$F$$20240802$20240512$20240805$EXP$$US-TAKEDA-2024TUS014487$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
238463293$23846329$3$F$20240410$20240701$20240512$20240702$EXP$PT-INFARMED-E202404-992$PT-JNJFOC-20240533208$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240703$$PH$PT$PT
238463442$23846344$2$F$20240507$20240830$20240512$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072988$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240903$$HP$US$US
238463712$23846371$2$F$20240506$20240813$20240512$20240816$EXP$$US-JNJFOC-20240521191$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240816$$CN$US$US
238463853$23846385$3$F$$20240722$20240513$20240730$EXP$$GB-PFIZER INC-202400105634$PFIZER$$$$$M$Y$$$20240730$$CN$GB$GB
238464002$23846400$2$F$20240101$20240711$20240513$20240722$PER$$US-SA-2024SA134293$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240722$$MD$US$US
238464493$23846449$3$F$20240501$20240626$20240513$20240701$EXP$$GB-EMD Serono-2024025066$EMD SERONO INC$$76$YR$E$F$Y$$$20240701$$CN$GB$GB
238464732$23846473$2$F$20231201$20240719$20240513$20240809$PER$$CA-TOLMAR, INC.-24CA048037$TOLMAR$$72$YR$$M$Y$$$20240809$$CN$CA$CA
238464832$23846483$2$F$$20240706$20240513$20240715$EXP$$PK-AMGEN-PAKSP2024093232$AMGEN$$57$YR$A$M$Y$$$20240715$$CN$PK$PK
238464903$23846490$3$F$$20240815$20240513$20240820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072300$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240820$$MD$JP$JP
238465103$23846510$3$F$20240401$20240702$20240513$20240709$EXP$$US-GSK-US2024057253$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$US$US
238465204$23846520$4$F$$20240812$20240513$20240815$EXP$$CA-TAKEDA-2024TUS040972$TAKEDA$$$$$F$Y$$$20240815$$CN$CA$CA
238465212$23846521$2$F$20170726$20240822$20240513$20240827$EXP$$CA-TAKEDA-2024TUS043827$TAKEDA$$41$YR$$F$Y$$$20240827$$CN$CA$CA
238465362$23846536$2$F$20240425$20240708$20240513$20240711$EXP$$CA-TAKEDA-2024TUS043164$TAKEDA$$60$YR$$F$Y$77$KG$20240711$$MD$CA$CA
238465623$23846562$3$F$20231225$20240919$20240513$20240930$EXP$IE-EMA-DD-20240501-7482831-131856$IE-NOVOPROD-1215980$NOVO NORDISK$$37$YR$$F$Y$103$KG$20240930$$MD$IE$IE
238465712$23846571$2$F$20240229$20240620$20240513$20240701$EXP$$US-NOVOPROD-1216507$NOVO NORDISK$$77$YR$$F$Y$$$20240701$$CN$US$US
238465752$23846575$2$F$20240401$20240802$20240513$20240809$EXP$$US-SA-2024SA142242$SANOFI AVENTIS$$51$YR$A$F$Y$117$KG$20240809$$MD$US$US
238465824$23846582$4$F$20240301$20240808$20240513$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073203$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240808$$CN$US$US
238465863$23846586$3$F$20240509$20240729$20240513$20240731$PER$$US-AMGEN-USASP2024093197$AMGEN$$67$YR$E$F$Y$$$20240731$$CN$US$US
238465932$23846593$2$F$$20240807$20240513$20240808$EXP$$US-UCBSA-2024022670$UCB$$$$$F$Y$$$20240808$$CN$US$US
238465994$23846599$4$F$20240401$20240726$20240513$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202405004886$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240731$$CN$US$US
238466142$23846614$2$F$20240101$20240719$20240513$20240726$EXP$$US-SA-2024SA142801$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240726$$CN$US$US
238466156$23846615$6$F$20240101$20240628$20240513$20240708$EXP$$CA-CELLTRION INC.-2024CA010870$CELLTRION$$$$$$Y$$$20240708$$HP$CA$CA
238466683$23846668$3$F$20240329$20240802$20240513$20240802$EXP$$JP-ABBVIE-5754822$ABBVIE$$63$YR$$F$Y$$$20240802$$MD$JP$JP
238466812$23846681$2$F$$20240820$20240513$20240828$EXP$$CA-JNJFOC-20240517063$JOHNSON AND JOHNSON$$67$YR$E$F$Y$78$KG$20240828$$PH$CA$CA
238466982$23846698$2$F$$20240827$20240513$20240830$30DAY$$IT-JNJFOC-20240482595$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$HP$IT$IT
238467203$23846720$3$F$$20240904$20240513$20240914$30DAY$$US-GSK-US2024056826$GLAXOSMITHKLINE$$$$$M$Y$78.005$KG$20240914$$HP$US$US
238467453$23846745$3$F$20230928$20240621$20240513$20240701$EXP$$US-HALEON-USCH2024AMR011017$Haleon PLC$$27$YR$$F$Y$68.027$KG$20240701$$CN$US$US
238467563$23846756$3$F$$20240715$20240513$20240728$30DAY$$US-JNJFOC-20240513487$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
238467662$23846766$2$F$20240508$20240912$20240513$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202405005634$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240916$$CN$US$US
238467844$23846784$4$F$20240101$20240620$20240513$20240704$PER$$US-SA-2024SA142010$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240704$$MD$US$US
238468022$23846802$2$F$20240101$20240715$20240513$20240723$PER$$US-SA-2024SA143110$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240723$$MD$US$US
238468042$23846804$2$F$20240101$20240701$20240513$20240710$PER$$US-SA-2024SA142413$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240710$$MD$US$US
238468063$23846806$3$F$20240101$20240628$20240513$20240712$PER$$US-SA-2024SA142687$SANOFI AVENTIS$$88$YR$E$F$Y$70.57$KG$20240712$$MD$US$US
238468093$23846809$3$F$$20240902$20240513$20240906$30DAY$$IL-JNJFOC-20240474243$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$IL$IL
238468292$23846829$2$F$$20240708$20240513$20240712$EXP$$CA-JNJFOC-20240517124$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$HP$CA$CA
238468314$23846831$4$F$20240101$20240729$20240513$20240806$EXP$$CA-CELLTRION INC.-2024CA009667$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
238468354$23846835$4$F$20240101$20240913$20240513$20240923$EXP$$CA-CELLTRION INC.-2024CA010849$CELLTRION$$$$$$Y$$$20240923$$CN$CA$CA
238468372$23846837$2$F$20240501$20240626$20240513$20240702$EXP$$JP-AMGEN-JPNSP2024092812$AMGEN$$82$YR$E$F$Y$$$20240702$$PH$JP$JP
238469422$23846942$2$F$20240418$20240809$20240513$20240828$PER$$CA-TOLMAR, INC.-24CA048635$TOLMAR$$89$YR$$M$Y$$$20240828$$CN$CA$CA
238469432$23846943$2$F$20240416$20240626$20240513$20240722$PER$$CA-TOLMAR, INC.-24CA048637$TOLMAR$$68$YR$$M$Y$$$20240719$$CN$CA$CA
238469524$23846952$4$F$$20240920$20240513$20240923$EXP$$NVSC2024US037819$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
238469612$23846961$2$F$20240401$20240722$20240513$20240725$EXP$$NVSC2024GB100142$NOVARTIS$$$$$M$Y$$$20240725$$CN$GB$GB
238469632$23846963$2$F$$20240624$20240513$20240704$EXP$$PT-ABBVIE-5756962$ABBVIE$$$$E$$Y$$$20240704$$CN$PT$PT
238469662$23846966$2$F$$20240723$20240513$20240726$EXP$$US-JNJFOC-20240523389$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$US$US
238469764$23846976$4$F$$20240917$20240513$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073369$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240924$$CN$US$US
238469892$23846989$2$F$20240801$20240829$20240513$20240910$PER$$US-RDY-CLI/USA/24/0006868$DR REDDYS$$7$YR$C$M$Y$28.3$KG$20240910$$MD$US$US
238470183$23847018$3$F$$20240619$20240513$20240704$30DAY$$US-JNJFOC-20240525412$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
238470582$23847058$2$F$20240228$20240813$20240513$20240819$EXP$$US-JNJFOC-20240507898$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240820$$MD$US$US
238471223$23847122$3$F$20240501$20240715$20240513$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073511$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240717$$CN$US$US
238471375$23847137$5$F$20240201$20240603$20240513$20240729$EXP$$US-ROCHE-3551362$ROCHE$$39$YR$A$F$Y$74.84$KG$20240729$$CN$US$US
238471522$23847152$2$F$20240501$20240808$20240513$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073160$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240809$$HP$US$US
238471752$23847175$2$F$20240101$20240830$20240513$20240912$EXP$$US-UCBSA-2024022912$UCB$$$$$F$Y$$$20240912$$HP$US$US
238472122$23847212$2$F$$20240731$20240513$20240806$EXP$$US-TAKEDA-2024TUS044610$TAKEDA$$$$$F$Y$$$20240806$$CN$US$US
238472142$23847214$2$F$$20240709$20240513$20240710$PER$$US-ALXN-202404USA002028US$ALEXION PHARMACEUTICALS$$$$$F$Y$53.5$KG$20240710$$MD$US$US
238472702$23847270$2$F$20240430$20240625$20240513$20240704$EXP$$CO-ORPHANEU-2024003325$RECORDATI$$$$$$Y$$$20240704$$CN$CO$CO
238472932$23847293$2$F$20220502$20240904$20240513$20240906$EXP$$AU-TAKEDA-2022TUS029663$TAKEDA$$40$YR$$F$Y$$$20240906$$HP$AU$AU
238472983$23847298$3$F$$20240625$20240513$20240731$PER$$US-AstraZeneca-2024A105927$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
238473002$23847300$2$F$$20240806$20240513$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071242$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240807$$CN$US$US
238473274$23847327$4$F$20240509$20240625$20240513$20240702$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-027047$BOEHRINGER INGELHEIM$$50$YR$A$M$Y$$$20240702$$MD$CN$CN
238473532$23847353$2$F$20240430$20240827$20240513$20240904$EXP$$US-CHEPLA-2024005811$CHEPLAPHARM$$$$$F$Y$$$20240903$$HP$COUNTRY NOT SPECIFIED$US
238473613$23847361$3$F$$20240704$20240513$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03932$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238473674$23847367$4$F$$20240820$20240513$20240827$EXP$$CA-ROCHE-3557491$ROCHE$$66$YR$E$M$Y$70$KG$20240827$$HP$CA$CA
238473792$23847379$2$F$20240101$20240709$20240513$20240712$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-068581$REGENERON$$$$$$Y$$$20240712$$HP$US$US
238473893$23847389$3$F$20240428$20240823$20240513$20240829$EXP$$CA-TAKEDA-2024TUS032990$TAKEDA$$80$YR$$F$Y$$$20240829$$CN$CA$CA
238474462$23847446$2$F$$20240719$20240513$20240725$PER$$US-AMGEN-USASP2024092853$AMGEN$El Meedani H.; El Meedani H.; Alsamarraie H.. A case of Primary Hyperparathyroidism presenting with Urosepsis in Pregnancy. Endocrine Practice. 2024;30 (5):S94$$$$$Y$$$20240725$$HP$US$US
238474502$23847450$2$F$$20240624$20240513$20240712$PER$$US-AstraZeneca-2024A100281$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$US$
238474554$23847455$4$F$20240223$20240823$20240513$20240828$EXP$$US-RDY-CLI/USA/24/0006977$DR REDDYS$$23$YR$A$F$Y$$$20240828$$HP$US$US
238474672$23847467$2$F$$20240704$20240513$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03812$LUPIN$$$$$$Y$$$20240725$$CN$US$US
238474705$23847470$5$F$$20240903$20240513$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072298$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240904$$CN$US$US
238474894$23847489$4$F$$20240824$20240513$20240828$PER$$US-JNJFOC-20240519291$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240828$$CN$US$US
238474912$23847491$2$F$20221201$20240510$20240513$20240812$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-275128$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$81$KG$20240812$$CN$ES$ES
238474943$23847494$3$F$20240315$20240712$20240513$20240715$EXP$FR-AFSSAPS-ST2024000788$FR-ROCHE-3557150$ROCHE$$30$YR$A$F$Y$57$KG$20240715$$PH$FR$FR
238474995$23847499$5$F$$20240809$20240513$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073603$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240813$$CN$US$US
238475193$23847519$3$F$$20240830$20240513$20240909$EXP$FR-AFSSAPS-DJ2024000673$FR-ROCHE-3559387$ROCHE$$89$YR$E$F$Y$$$20240909$$MD$FR$FR
238475253$23847525$3$F$20240401$20240807$20240513$20240812$EXP$$CA-JNJFOC-20240530617$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240812$$HP$CA$CA
238475283$23847528$3$F$20240419$20240826$20240513$20240829$PER$$US-JNJFOC-20240487622$JOHNSON AND JOHNSON$$62$YR$A$M$Y$106.24$KG$20240829$$PH$US$US
238475452$23847545$2$F$20240509$20240911$20240513$20240916$EXP$$JP-ASTELLAS-2024JP003017$ASTELLAS$$7$DEC$E$M$Y$$$20240916$$PH$JP$JP
238475694$23847569$4$F$20240419$20240830$20240513$20240909$EXP$FR-AFSSAPS-DJ2024000670$FR-ROCHE-3558531$ROCHE$$76$YR$E$F$Y$$$20240909$$MD$FR$FR
238475733$23847573$3$F$20240501$20240806$20240513$20240808$EXP$$JP-ASTELLAS-2024JP003031$ASTELLAS$$$$E$F$Y$$$20240808$$PH$JP$JP
238475762$23847576$2$F$20220925$20240717$20240513$20240720$EXP$$NVSC2024US100349$NOVARTIS$$46$YR$$M$Y$$$20240719$$CN$US$US
238475832$23847583$2$F$$20240802$20240513$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073345$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240805$$CN$US$US
238475922$23847592$2$F$20150101$20240702$20240513$20240708$EXP$$US-CHEPLA-3000003932$CHEPLAPHARM$$$$$M$Y$89.438$KG$20240707$$CN$COUNTRY NOT SPECIFIED$US
238475953$23847595$3$F$$20240916$20240513$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202405006140$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240923$$MD$US$US
238476012$23847601$2$F$$20240708$20240513$20240716$EXP$$US-AstraZeneca-2024A108999$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
238476082$23847608$2$F$$20240708$20240513$20240710$EXP$$DE-ASTELLAS-2024US013578$ASTELLAS$$72$YR$$M$Y$$$20240710$$MD$DE$DE
238476142$23847614$2$F$$20240722$20240513$20240725$EXP$$NVSJ2024JP005324$NOVARTIS$$45$YR$$F$Y$$$20240725$$MD$JP$JP
238476202$23847620$2$F$$20240809$20240513$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073520$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240812$$HP$US$US
238476242$23847624$2$F$20130501$20240919$20240513$20240925$EXP$PL-EMA-DD-20240407-7482647-172406$PL-MYLANLABS-2024M1035325$MYLAN$KAMINSKA D, KOSCIELSKA-KASPRZAK K, MYSZKA M, BANASIK M, CHE?MONSKI A, BORATYNSKA M, JAB?ECKI J, KLINGER M.. Significant infections after hand transplantation in a polish population. Transplantation proceedings. 2014;46(8):2887-9$28$YR$$M$Y$$$20240925$$HP$PL$PL
238476284$23847628$4$F$$20240812$20240513$20240816$30DAY$$CA-PFIZER INC-202400105576$PFIZER$$$$$$Y$$$20240816$$HP$CA$CA
238476292$23847629$2$F$20240101$20240909$20240513$20240912$EXP$$CA-PFIZER INC-202400091780$PFIZER$$61$YR$$M$Y$$$20240912$$HP$CA$CA
238476312$23847631$2$F$20240101$20240707$20240513$20240708$EXP$$CA-PFIZER INC-202400101347$PFIZER$$86$YR$$F$Y$$$20240708$$HP$CA$CA
238476322$23847632$2$F$20240101$20240704$20240513$20240704$EXP$$CA-PFIZER INC-202400104020$PFIZER$$51$YR$$F$Y$$$20240704$$CN$CA$CA
238476703$23847670$3$F$20240429$20240716$20240513$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024056896$VIIV$$37$YR$$M$Y$$$20240726$$MD$US$US
238476932$23847693$2$F$20240501$20240717$20240513$20240720$PER$$US-JNJFOC-20240503129$JOHNSON AND JOHNSON$$$$$F$Y$$$20240720$$CN$US$US
238477242$23847724$2$F$$20240729$20240513$20240805$EXP$$US-GSK-US2022071340$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$MD$US$US
238477253$23847725$3$F$$20240722$20240513$20240801$30DAY$$US-GSK-US2024056876$GLAXOSMITHKLINE$$$$$M$Y$$$20240801$$CN$US$US
238477263$23847726$3$F$$20240925$20240513$20240930$EXP$$US-GSK-US2024AMR057013$GLAXOSMITHKLINE$$$$$$Y$$$20240929$$MD$US$US
238477332$23847733$2$F$$20240822$20240513$20240826$30DAY$$US-SANDOZ INC.-SDZ2024US047579$SANDOZ$$$$$F$Y$$$20240826$$HP$US$US
238477573$23847757$3$F$20240418$20240711$20240513$20240722$EXP$$GR-TAKEDA-2024TUS046059$TAKEDA$$69$YR$$M$Y$74.3$KG$20240722$$HP$GR$GR
238477612$23847761$2$F$$20240822$20240513$20240830$EXP$$CA-APOTEX-2024AP005612$APOTEX$$44$YR$$M$Y$$$20240830$$HP$CA$CA
238477803$23847780$3$F$20230731$20240708$20240513$20240715$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-130447$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240715$$MD$JP$JP
238478082$23847808$2$F$$20231218$20240513$20240712$PER$$US-ENDO USA, INC.-2024-000008$ENDO$$$$$M$Y$$$20240712$$CN$US$US
238478103$23847810$3$F$$20240312$20240513$20240916$PER$$US-ENDO USA, INC.-2024-001393$ENDO$$$$$M$Y$$$20240916$$CN$US$US
238478113$23847811$3$F$$20231219$20240513$20240916$PER$$US-ENDO USA, INC.-2024-000170$ENDO$$$$$M$Y$$$20240916$$CN$US$US
238478123$23847812$3$F$$20231226$20240513$20240916$PER$$US-ENDO USA, INC.-2024-000220$ENDO$$$$$M$Y$$$20240916$$CN$US$US
238478134$23847813$4$F$$20231205$20240513$20240916$PER$$US-ENDO USA, INC.-2023-006104$ENDO$$$$$F$Y$$$20240916$$CN$US$US
238478142$23847814$2$F$20240313$20240813$20240513$20240913$PER$$US-Eisai-EC-2024-164486$EISAI$$58$YR$A$F$Y$$$20240913$$CN$US$US
238478154$23847815$4$F$$20240227$20240513$20240916$PER$$US-ENDO USA, INC.-2024-001221$ENDO$$$$$F$Y$$$20240916$$CN$US$US
238478256$23847825$6$F$20240731$20240903$20240513$20240905$EXP$$IE-MYLANLABS-2024M1041349$MYLAN$$$$$F$Y$$$20240905$$MD$IE$IE
238478543$23847854$3$F$20240509$20240812$20240513$20240813$PER$$US-AMGEN-USASP2024093924$AMGEN$$74$YR$E$F$Y$$$20240812$$CN$US$US
238478692$23847869$2$F$$20240702$20240513$20240712$EXP$$JP-ROCHE-3561443$ROCHE$Onishi S, Iwasaki S, Nakagawa S, Tanaka S and Taniguchi K An autopsy case of systemic amyloidosis after immune-checkpoint inhibitor therapy for carcinosarcoma. Journal of Pathology International 2024;113:463-4.$7$DEC$E$M$Y$$$20240712$$MD$JP$JP
238478752$23847875$2$F$20220510$20240705$20240513$20240705$EXP$$CA-PFIZER INC-202400043997$PFIZER$$57$YR$$M$Y$$$20240705$$HP$CA$CA
238478962$23847896$2$F$$20240821$20240513$20240823$PER$$NVSC2024US100170$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
238478973$23847897$3$F$20231201$20240910$20240513$20240917$EXP$$CO-GSK-CO2023AMR171050$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$CO$CO
238479062$23847906$2$F$$20240707$20240513$20240708$EXP$$CA-PFIZER INC-202400105292$PFIZER$$77$YR$$F$Y$$$20240708$$HP$CA$CA
238479083$23847908$3$F$20231001$20240925$20240513$20240927$EXP$$US-PFIZER INC-PV202400061241$PFIZER$$50$YR$$F$Y$$$20240927$$HP$US$US
238479393$23847939$3$F$$20240711$20240513$20240717$EXP$$US-PFIZER INC-PV202200095642$PFIZER$$89$YR$$F$Y$$$20240717$$CN$US$US
238479415$23847941$5$F$20230928$20240705$20240513$20240712$EXP$ES-UCBSA-2023054512$ES-RDY-SPO/ESP/24/0006818$DR REDDYS$$44$YR$A$M$Y$74$KG$20240712$$MD$ES$ES
238479424$23847942$4$F$20231127$20240725$20240513$20240726$EXP$$CN-TAKEDA-2024TUS017686$TAKEDA$$31$YR$$M$Y$49$KG$20240726$$MD$CN$CN
238479563$23847956$3$F$20230101$20240711$20240513$20240717$PER$$US-JNJFOC-20240503682$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240717$$CN$US$US
238479593$23847959$3$F$$20240917$20240513$20240923$EXP$$CH-JNJFOC-20240514799$JOHNSON AND JOHNSON$$69$YR$E$M$Y$79$KG$20240923$$MD$CH$CH
238480012$23848001$2$F$20240501$20240814$20240513$20240816$PER$$US-AMGEN-USASP2024093262$AMGEN$$88$YR$E$F$Y$$$20240816$$CN$US$US
238480068$23848006$8$F$20240401$20240918$20240513$20240927$EXP$$CO-EXELIXIS-CABO-24077228$EXELIXIS$$46$YR$$F$Y$105$KG$20240927$$CN$CO$CO
238480302$23848030$2$F$20230719$20240710$20240513$20240715$EXP$$JP-PFIZER INC-202400082070$PFIZER$$6$DEC$$M$Y$$$20240715$$MD$JP$JP
238480323$23848032$3$F$$20240624$20240513$20240702$PER$$US-ALXN-202405USA000167US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
238480492$23848049$2$F$$20240726$20240513$20240726$EXP$$TR-PFIZER INC-PV202400061117$PFIZER$$40$YR$$M$Y$$$20240726$$MD$TR$TR
238480772$23848077$2$F$$20240630$20240513$20240701$EXP$$TR-PFIZER INC-202400105460$PFIZER$$38$YR$$M$Y$$$20240701$$MD$TR$TR
238480904$23848090$4$F$$20240723$20240513$20240730$PER$$US-PFIZER INC-PV202400060668$PFIZER$$82$YR$$F$Y$53.061$KG$20240730$$CN$US$US
238480932$23848093$2$F$20190801$20240719$20240513$20240724$EXP$$US-MYLANLABS-2024M1042043$MYLAN$$40$YR$$F$Y$65.77$KG$20240724$$HP$US$US
238481262$23848126$2$F$$20240627$20240513$20240704$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000892$BLUEPRINT MEDICINES$$$$$M$Y$$$20240704$$HP$US$US
238481543$23848154$3$F$20240101$20240913$20240513$20240926$EXP$$CA-UCBSA-2024023182$UCB$$$$$F$Y$$$20240926$$CN$CA$CA
238481672$23848167$2$F$$20240706$20240513$20240708$30DAY$$CO-PFIZER INC-202400104637$PFIZER$$$$$M$Y$$$20240708$$CN$CO$CO
238481684$23848168$4$F$$20240912$20240513$20240917$30DAY$$US-PFIZER INC-202400103941$PFIZER$$$$$F$Y$$$20240917$$CN$US$US
238481695$23848169$5$F$$20240925$20240513$20240927$30DAY$$CA-PFIZER INC-202400018353$PFIZER$$12$YR$$F$Y$$$20240927$$CN$CA$CA
238481725$23848172$5$F$20220101$20240715$20240513$20240718$EXP$$NL-TAKEDA-2024TUS042271$TAKEDA$$$$A$M$Y$$$20240718$$HP$NL$NL
238482533$23848253$3$F$$20240802$20240513$20240807$EXP$$US-PFIZER INC-202400103814$PFIZER$Kuczmarski, T.. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma. British Journal of Haematology. 2024;205(1):100-108$58$YR$$M$Y$$$20240807$$HP$US$US
238482654$23848265$4$F$$20240913$20240513$20240916$30DAY$$CL-PFIZER INC-PV202400059983$PFIZER$$9$YR$$F$Y$$$20240916$$CN$CL$CL
238482665$23848266$5$F$$20240912$20240513$20240917$30DAY$$US-PFIZER INC-202400104190$PFIZER$$14$YR$$M$Y$$$20240917$$CN$US$US
238482704$23848270$4$F$$20240917$20240513$20240920$30DAY$$US-PFIZER INC-202400103067$PFIZER$$13$YR$$M$Y$$$20240920$$CN$US$US
238482725$23848272$5$F$20240508$20240917$20240513$20240923$30DAY$$US-PFIZER INC-202400104690$PFIZER$$13$YR$$M$Y$$$20240923$$CN$US$US
238482745$23848274$5$F$20240502$20240919$20240513$20240924$30DAY$$US-PFIZER INC-202400103034$PFIZER$$14$YR$$M$Y$$$20240924$$MD$US$US
238482773$23848277$3$F$$20240916$20240513$20240919$30DAY$$CL-PFIZER INC-PV202400059392$PFIZER$$4$YR$$M$Y$$$20240919$$CN$CL$CL
238483012$23848301$2$F$20240301$20240904$20240513$20240909$PER$$US-ALXN-202405USA000333US$ALEXION PHARMACEUTICALS$$68$YR$$M$Y$$$20240909$$CN$US$US
238483074$23848307$4$F$$20240911$20240513$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073801$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240913$$HP$US$US
238483213$23848321$3$F$20240418$20240809$20240513$20240819$EXP$$US-ORPHANEU-2024003212$RECORDATI$$$$$$Y$$$20240819$$CN$US$US
238483243$23848324$3$F$20220410$20240512$20240513$20240730$EXP$$US-APELLIS-APL-2024-004394$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240730$$CN$US$US
238483433$23848343$3$F$20240715$20240810$20240513$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073805$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$67.59$KG$20240814$$CN$US$US
238483442$23848344$2$F$20240417$20240821$20240513$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073755$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240823$$CN$US$US
238483452$23848345$2$F$20240301$20240712$20240513$20240715$PER$$US-ALXN-202405USA000377US$ALEXION PHARMACEUTICALS$$73$YR$$M$Y$$$20240715$$CN$US$US
238483605$23848360$5$F$20230101$20240911$20240513$20240916$EXP$$CA-PFIZER INC-202400104685$PFIZER$$53$YR$$F$Y$49$KG$20240916$$HP$CA$CA
238483712$23848371$2$F$20240509$20240726$20240513$20240730$PER$$US-AMGEN-USASP2024093339$AMGEN$$69$YR$E$F$Y$$$20240730$$CN$US$US
238483826$23848382$6$F$$20240925$20240513$20240930$30DAY$$PA-PFIZER INC-PV202400058855$PFIZER$$12$YR$$F$Y$$$20240930$$HP$PA$PA
238483834$23848383$4$F$20240501$20240925$20240513$20240927$30DAY$$US-PFIZER INC-202400103836$PFIZER$$4$YR$$M$Y$14.1$KG$20240927$$CN$US$US
238484102$23848410$2$F$20240214$20240708$20240513$20240711$EXP$FR-AFSSAPS-GR2024000556$FR-PFIZER INC-202400105256$PFIZER$$81$YR$$M$Y$78$KG$20240711$$PH$FR$FR
238484133$23848413$3$F$20240401$20240819$20240513$20240826$EXP$$IT-LEO Pharma-370269$LEO PHARM$$23$YR$$F$Y$60$KG$20240826$$MD$IT$IT
238484152$23848415$2$F$20240412$20240628$20240513$20240703$EXP$$CA-TAKEDA-2024TUS044627$TAKEDA$$63$YR$$M$Y$$$20240703$$HP$CA$CA
238484233$23848423$3$F$$20240711$20240513$20240715$PER$$US-PFIZER INC-PV202400061013$PFIZER$$59$YR$$F$Y$$$20240715$$HP$US$US
238484383$23848438$3$F$$20240709$20240513$20240711$PER$$US-PFIZER INC-202400105124$PFIZER$$63$YR$$F$Y$$$20240711$$HP$US$US
238484455$23848445$5$F$20240101$20240715$20240513$20240722$EXP$$US-UCBSA-2024016211$UCB$$$$$M$Y$131.51$KG$20240719$$CN$US$US
238484473$23848447$3$F$20230809$20240626$20240513$20240701$EXP$$JP-AstraZeneca-2024A110416$ASTRAZENECA$$90$YR$$M$Y$61$KG$20240701$$MD$JP$
238484513$23848451$3$F$20240504$20240717$20240513$20240720$EXP$$NVSC2024US100661$NOVARTIS$$34$YR$$F$Y$$$20240720$$CN$US$US
238484553$23848455$3$F$20240414$20240808$20240513$20240815$30DAY$$US-Kaleo, Inc.-2024KL000008$KALEO$$20$YR$A$M$Y$$$20240813$$CN$US$US
238484737$23848473$7$F$20240101$20240819$20240513$20240823$EXP$$US-UCBSA-2024020009$UCB$$$$$F$Y$$$20240823$$CN$US$US
238484812$23848481$2$F$$20240819$20240513$20240826$30DAY$$BR-SANDOZ INC.-NVSC2021BR283916$SANDOZ$$$$$F$Y$$$20240826$$CN$BR$BR
238485652$23848565$2$F$20240503$20240826$20240513$20240903$EXP$$US-MYLANLABS-2024M1042462$MYLAN$$61$YR$$M$Y$115.67$KG$20240903$$HP$US$US
238485703$23848570$3$F$20231207$20240704$20240513$20240709$EXP$$CA-TAKEDA-2019TUS042323$TAKEDA$$76$YR$$F$Y$$$20240709$$CN$CA$CA
238486253$23848625$3$F$20240416$20240710$20240513$20240712$EXP$$US-PFIZER INC-202400105348$PFIZER$$77$YR$$M$Y$90.72$KG$20240712$$CN$US$US
238486542$23848654$2$F$20240427$20240828$20240513$20240903$EXP$$US-OTSUKA-2024_013015$OTSUKA$$$$$F$Y$$$20240903$$CN$US$US
238486593$23848659$3$F$$20240916$20240513$20240927$EXP$$CA-APOTEX-2022AP003192$APOTEX$$66$YR$$F$Y$105$KG$20240927$$HP$CA$CA
238486652$23848665$2$F$20240326$20240806$20240513$20240812$EXP$$CA-GSK-CA2024032262$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$HP$CA$CA
238486682$23848668$2$F$20240301$20240701$20240513$20240705$EXP$$US-OTSUKA-2024_007877$OTSUKA$$$$$M$Y$$$20240705$$MD$US$US
238486945$23848694$5$F$20240131$20240916$20240513$20240923$EXP$$US-TAKEDA-2015BLT000043$TAKEDA$$72$YR$$F$Y$78$KG$20240923$$CN$US$US
238486972$23848697$2$F$$20240712$20240513$20240715$PER$$US-ALXN-202405USA000338US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
238486994$23848699$4$F$20240403$20240619$20240513$20240712$EXP$$CZ-ROCHE-3549975$ROCHE$$10$YR$C$F$Y$30$KG$20240712$$MD$CZ$CZ
238487112$23848711$2$F$$20240620$20240513$20240703$PER$$US-BEH-2024171893$CSL BEHRING$$28$YR$A$F$Y$70.295$KG$20240703$$HP$US$US
238487212$23848721$2$F$$20240827$20240513$20240903$EXP$$US-INCYTE CORPORATION-2024IN005006$INCYTE$$$$$$Y$$$20240903$$CN$US$US
238487232$23848723$2$F$$20240910$20240513$20240911$PER$$US-PFIZER INC-PV202400060678$PFIZER$$82$YR$$F$Y$$$20240911$$CN$US$US
238487242$23848724$2$F$$20240801$20240513$20240806$PER$$US-PFIZER INC-PV202400031440$PFIZER$$86$YR$$M$Y$$$20240806$$CN$US$US
238487333$23848733$3$F$20240101$20240703$20240513$20240708$PER$$US-PFIZER INC-202400105321$PFIZER$$84$YR$$M$Y$102.06$KG$20240708$$CN$US$US
238487642$23848764$2$F$$20240906$20240513$20240910$PER$$US-PFIZER INC-202400104758$PFIZER$$92$YR$$M$Y$$$20240910$$HP$US$US
238487665$23848766$5$F$20240410$20240812$20240513$20240816$PER$$PR-PFIZER INC-202400103742$PFIZER$$50$YR$$F$Y$79.83$KG$20240816$$PH$PR$PR
238487722$23848772$2$F$20240501$20240724$20240513$20240729$PER$$US-PFIZER INC-PV202400061229$PFIZER$$78$YR$$M$Y$92.971$KG$20240729$$HP$US$US
238487892$23848789$2$F$$20240722$20240513$20240726$EXP$$US-TAKEDA-2021TUS050813$TAKEDA$$$$$F$Y$29$KG$20240726$$HP$US$US
238488043$23848804$3$F$$20240509$20240513$20240717$EXP$$US-INCYTE CORPORATION-2024IN004957$INCYTE$$$$$$Y$$$20240717$$CN$US$US
238488462$23848846$2$F$20240428$20240510$20240513$20240702$EXP$$US-VANTIVE-2024VAN016776$Vantive US Healthcare$$62$YR$$M$Y$111$KG$20240702$$HP$US$US
238488535$23848853$5$F$$20240626$20240513$20240705$EXP$$CA-OTSUKA-2024_007101$OTSUKA$$$$$M$Y$$$20240705$$CN$CA$CA
238488592$23848859$2$F$20230101$20240724$20240513$20240731$EXP$$CO-JNJFOC-20240511247$JOHNSON AND JOHNSON$$50$YR$A$F$Y$70$KG$20240731$$HP$CO$CO
238488612$23848861$2$F$$20240916$20240513$20240923$EXP$$JP-009507513-2405JPN000117J$MERCK$$8$DEC$$M$Y$$$20240923$$MD$JP$JP
238488652$23848865$2$F$20220101$20240710$20240513$20240720$EXP$$DE-TEVA-VS-3195741$TEVA$$49$YR$$M$Y$$$20240720$$MD$DE$DE
238488762$23848876$2$F$$20240717$20240513$20240724$EXP$$CA-MYLANLABS-2024M1043184$MYLAN$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. J-Anal-Toxicol 2023; 47 (4): 385-392.$28$YR$$F$Y$$$20240724$$HP$CA$CA
238489242$23848924$2$F$$20240815$20240513$20240825$EXP$$CA-BAXTER-2024BAX018005$BAXTER$$$$$M$Y$38$KG$20240825$$HP$CA$CA
238489302$23848930$2$F$$20240812$20240513$20240816$EXP$$CZ-MYLANLABS-2024M1041465$MYLAN$Pisova B, Stefan M, Kotowski T, Dutkova A, Havlin J, Fila L et al.. Cryptococcal Meningitis in a Patient After LuTx: A Happy Ending After All.. THE JOURNAL OF HEART AND LUNG TRANSPLANTATION.. 2024;43(4):S463$61$YR$$M$Y$$$20240816$$HP$CZ$CZ
238489512$23848951$2$F$20240710$20240725$20240513$20240802$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-070276$REGENERON$$62$YR$$M$Y$$$20240802$$HP$CO$CO
238489563$23848956$3$F$$20240725$20240513$20240730$EXP$$CA-PFIZER INC-202300356375$PFIZER$$56$YR$$M$Y$$$20240730$$MD$CA$CA
238489663$23848966$3$F$20240321$20240806$20240513$20240807$PER$$US-JNJFOC-20240500959$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
238489792$23848979$2$F$20240101$20240830$20240513$20240923$PER$$US-SA-2024SA134817$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240923$$MD$US$US
238490022$23849002$2$F$$20240711$20240513$20240711$EXP$$US-ALXN-202405USA000318US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
238490046$23849004$6$F$20240101$20240620$20240513$20240705$PER$$US-SA-2024SA138094$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240705$$MD$US$US
238490152$23849015$2$F$$20240620$20240513$20240701$PER$$US-SA-2024SA136758$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240701$$CN$US$US
238490192$23849019$2$F$$20240701$20240513$20240710$PER$$US-SA-2024SA136977$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240710$$MD$US$US
238490213$23849021$3$F$$20240814$20240513$20240827$PER$$US-SA-2024SA139928$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240827$$MD$US$US
238490392$23849039$2$F$$20240814$20240513$20240828$PER$$US-SA-2024SA138577$SANOFI AVENTIS$$$$A$M$Y$81.64$KG$20240828$$MD$US$US
238490572$23849057$2$F$20190101$20240620$20240513$20240703$PER$$US-SA-2024SA138548$SANOFI AVENTIS$$79$YR$E$F$Y$58.9$KG$20240703$$MD$US$US
238490632$23849063$2$F$$20240715$20240513$20240724$PER$$US-SA-2024SA137082$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240724$$MD$US$US
238490652$23849065$2$F$20211201$20240716$20240513$20240724$PER$$US-SA-2024SA135602$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240724$$MD$US$US
238490702$23849070$2$F$20240101$20240725$20240513$20240805$PER$$US-SA-2024SA139085$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240805$$MD$US$US
238490782$23849078$2$F$$20240918$20240513$20240925$PER$$US-SA-2024SA136121$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240925$$MD$US$US
238490842$23849084$2$F$$20240805$20240513$20240813$PER$$US-SA-2024SA134871$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240814$$MD$US$US
238490942$23849094$2$F$20240101$20240813$20240513$20240827$PER$$US-SA-2024SA137587$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240827$$MD$US$US
238491224$23849122$4$F$20240101$20240821$20240513$20240826$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-069150$REGENERON$$$$$F$Y$$$20240826$$CN$US$US
238491262$23849126$2$F$20240101$20240823$20240513$20240906$PER$$US-SA-2024SA142788$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240906$$MD$US$US
238491342$23849134$2$F$20240301$20240819$20240513$20240828$PER$$US-SA-2024SA143498$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240828$$MD$US$US
238491452$23849145$2$F$$20240731$20240513$20240808$PER$$US-SA-2024SA142596$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240808$$MD$US$US
238491472$23849147$2$F$20240101$20240815$20240513$20240827$PER$$US-SA-2024SA143569$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240828$$CN$US$US
238491562$23849156$2$F$20240601$20240729$20240513$20240807$PER$$US-SA-2024SA143560$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240807$$MD$US$US
238491572$23849157$2$F$$20240625$20240513$20240704$PER$$US-SA-2024SA143521$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240704$$CN$US$US
238491583$23849158$3$F$20240101$20240810$20240513$20240819$PER$$US-SA-2024SA142686$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240819$$CN$US$US
238491612$23849161$2$F$20240101$20240725$20240513$20240802$PER$$US-SA-2024SA143068$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240802$$MD$US$US
238491642$23849164$2$F$$20240703$20240513$20240712$PER$$US-SA-2024SA143556$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240712$$MD$US$US
238491732$23849173$2$F$20240101$20240909$20240513$20240916$PER$$US-SA-2024SA142550$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240916$$MD$US$US
238491842$23849184$2$F$$20240827$20240513$20240904$PER$$US-SA-2024SA142704$SANOFI AVENTIS$$$$A$F$Y$$$20240904$$MD$US$US
238491862$23849186$2$F$$20240826$20240513$20240829$EXP$$GB-AstraZeneca-2024A111265$ASTRAZENECA$$$$$$Y$$$20240829$$MD$GB$
238491912$23849191$2$F$20240101$20240712$20240513$20240724$PER$$US-SA-2024SA142529$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240724$$MD$US$US
238491933$23849193$3$F$20240101$20240826$20240513$20240914$PER$$US-SA-2024SA141600$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240914$$MD$US$US
238492132$23849213$2$F$20240101$20240702$20240513$20240711$PER$$US-SA-2024SA141621$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240711$$MD$US$US
238492222$23849222$2$F$$20240711$20240513$20240716$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-069153$REGENERON$$$$$F$Y$$$20240716$$CN$US$US
238492412$23849241$2$F$$20240806$20240513$20240808$EXP$$US-ASTELLAS-2024US012488$ASTELLAS$$77$YR$$M$Y$$$20240808$$HP$US$US
238492472$23849247$2$F$$20240718$20240513$20240723$EXP$$NVSC2024US099118$NOVARTIS$$$$$M$Y$$$20240723$$CN$US$US
238492602$23849260$2$F$$20240809$20240513$20240814$EXP$$JP-SA-2024SA139687$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240815$$HP$JP$JP
238492792$23849279$2$F$$20240712$20240513$20240715$PER$$US-ALXN-202405USA000381US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
238493002$23849300$2$F$20230807$20240704$20240513$20240709$EXP$$IN-PFIZER INC-PV202200024557$PFIZER$$71$YR$$F$Y$$$20240709$$CN$IN$IN
238493093$23849309$3$F$$20240919$20240513$20240925$EXP$$US-ABBVIE-5757174$ABBVIE$$$$$F$Y$59$KG$20240925$$CN$US$US
238494302$23849430$2$F$20240427$20240807$20240513$20240816$EXP$FR-AFSSAPS-BR2024000402$FR-BAYER-2024A070222$BAYER$$15$YR$T$M$Y$65.5$KG$20240816$$MD$FR$FR
238494348$23849434$8$F$20240421$20240829$20240513$20240905$EXP$$US-GSK-US2024AMR057499$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$US$US
238494453$23849445$3$F$20240417$20240710$20240513$20240715$PER$$US-JNJFOC-20240514124$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$US$US
238494463$23849446$3$F$20240503$20240725$20240513$20240730$EXP$$NVSC2024FR100020$NOVARTIS$$$$E$F$Y$71$KG$20240730$$MD$FR$FR
238494652$23849465$2$F$20231201$20240702$20240513$20240708$EXP$$CO-TAKEDA-2024TUS032487$TAKEDA$$48$YR$$M$Y$70$KG$20240708$$CN$CO$CO
238495052$23849505$2$F$$20240708$20240513$20240717$PER$$US-SA-2024SA142023$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240717$$MD$US$US
238495272$23849527$2$F$$20240704$20240513$20240715$30DAY$$US-NOVOPROD-1210351$NOVO NORDISK$$$$$$Y$$$20240715$$CN$US$US
238495284$23849528$4$F$$20240912$20240513$20240920$EXP$$CA-TAKEDA-2024TUS044785$TAKEDA$$$$$M$Y$$$20240920$$CN$CA$CA
238495602$23849560$2$F$$20240703$20240513$20240712$EXP$$US-NOVOPROD-1209693$NOVO NORDISK$$$$$F$Y$$$20240712$$CN$US$US
238495642$23849564$2$F$$20240916$20240513$20240925$EXP$$US-NOVOPROD-1209103$NOVO NORDISK$$$$$F$Y$$$20240925$$CN$US$US
238495662$23849566$2$F$20240507$20240725$20240513$20240727$PER$$US-AMGEN-USASP2024094157$AMGEN$$47$YR$A$M$Y$$$20240727$$CN$US$US
238495843$23849584$3$F$$20240923$20240513$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073878$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240924$$CN$US$US
238496232$23849623$2$F$$20240726$20240513$20240730$PER$$US-PFIZER INC-PV202400061617$PFIZER$$60$YR$$M$Y$$$20240730$$HP$US$US
238496592$23849659$2$F$20240503$20240906$20240513$20240910$30DAY$$AR-PFIZER INC-202400102884$PFIZER$$10$YR$$F$Y$$$20240910$$CN$AR$AR
238496613$23849661$3$F$$20240812$20240513$20240816$30DAY$$GB-PFIZER INC-PV202400060452$PFIZER$$8$YR$$F$Y$$$20240816$$CN$GB$GB
238496663$23849666$3$F$20240426$20240808$20240513$20240815$EXP$$US-MYLANLABS-2024M1043123$MYLAN$$64$YR$$F$Y$$$20240815$$HP$US$US
238496672$23849667$2$F$20240508$20240812$20240513$20240814$EXP$$US-MYLANLABS-2024M1042566$MYLAN$$13$YR$$M$Y$71.21$KG$20240814$$HP$US$US
238496994$23849699$4$F$$20240712$20240513$20240717$PER$$US-JNJFOC-20240517531$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
238497133$23849713$3$F$20240419$20240723$20240513$20240815$PER$$US-TRAVERE-2024TVT00264$TRAVERE THERAPEUTICS$$64$YR$A$M$Y$$$20240815$$CN$US$US
238497252$23849725$2$F$$20240712$20240513$20240715$PER$$US-ALXN-202405USA000358US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240715$$CN$US$US
238497615$23849761$5$F$$20240925$20240513$20240930$EXP$$SK-MYLANLABS-2024M1042019$MYLAN$Bellova B.. DIFFUSE LARGE CELL LYMPHOMA (DLBCL) IN AN ^OLD BACHELOR^. Zborn?k. 2024$67$YR$$M$Y$$$20240930$$HP$SK$SK
238497833$23849783$3$F$$20240626$20240513$20240711$PER$$US-AstraZeneca-2024A103181$ASTRAZENECA$$$$$M$Y$$$20240711$$HP$US$
238497854$23849785$4$F$$20240711$20240513$20240722$EXP$$FR-AstraZeneca-2024A110834$ASTRAZENECA$$34$YR$$F$Y$86$KG$20240722$$MD$FR$
238497862$23849786$2$F$20230301$20240820$20240513$20240824$EXP$$JP-AstraZeneca-2024A034650$ASTRAZENECA$$$$A$M$Y$$$20240823$$MD$JP$
238497962$23849796$2$F$20231001$20240826$20240513$20240830$EXP$$NO-MYLANLABS-2024M1042361$MYLAN$$59$YR$$M$Y$$$20240830$$MD$NO$NO
238498302$23849830$2$F$20240423$20240507$20240513$20240718$PER$$NVSC2024US097128$NOVARTIS$$$$$F$Y$$$20240718$$CN$US$US
238498363$23849836$3$F$20240507$20240923$20240513$20240926$EXP$$US-OTSUKA-2024_013227$OTSUKA$$$$$F$Y$$$20240926$$CN$US$US
238498462$23849846$2$F$$20240905$20240513$20240909$30DAY$$US-PFIZER INC-PV202400056173$PFIZER$$$$$$Y$$$20240909$$HP$US$US
238498493$23849849$3$F$$20240710$20240513$20240718$PER$$US-SA-2024SA137147$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240718$$MD$US$US
238498504$23849850$4$F$20230301$20240827$20240513$20240904$EXP$$NVSC2024PT097572$NOVARTIS$$21$YR$$F$Y$$$20240904$$MD$PT$PT
238498523$23849852$3$F$20240301$20240919$20240513$20240930$PER$$US-TRAVERE-2024TVT00266$TRAVERE THERAPEUTICS$$72$YR$E$M$Y$$$20240930$$CN$US$US
238498542$23849854$2$F$20240301$20240812$20240513$20240822$PER$$US-TRAVERE-2024TVT00259$TRAVERE THERAPEUTICS$$65$YR$E$M$Y$$$20240822$$CN$US$US
238498583$23849858$3$F$20240305$20240705$20240513$20240711$PER$$US-TRAVERE-2024TVT00268$TRAVERE THERAPEUTICS$$49$YR$A$F$Y$181.4$KG$20240711$$CN$US$US
238498952$23849895$2$F$20240418$20240826$20240513$20240830$EXP$$IN-PFIZER INC-PV202300111220$PFIZER$$63$YR$$F$Y$$$20240830$$CN$IN$IN
238499102$23849910$2$F$20240101$20240722$20240513$20240723$EXP$$US-KARYOPHARM-2024KPT001043$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240723$$CN$US$US
238499114$23849911$4$F$20240101$20240903$20240513$20240905$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-008106$BOEHRINGER INGELHEIM$$55$YR$A$F$Y$$$20240905$$CN$US$US
238499203$23849920$3$F$20240101$20240718$20240513$20240723$EXP$$US-ABBVIE-5757145$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
238499462$23849946$2$F$$20240819$20240513$20240821$EXP$$US-ABBVIE-5757304$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
238499474$23849947$4$F$20240509$20240812$20240513$20240814$PER$$US-AMGEN-USASP2024093377$AMGEN$$71$YR$E$F$Y$$$20240813$$MD$US$US
238499533$23849953$3$F$$20240905$20240513$20240911$EXP$$CA-PURDUE-USA-2024-0309532$PURDUE$$$$$F$Y$97$KG$20240911$$HP$CA$CA
238499552$23849955$2$F$$20240812$20240513$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA047646$SANDOZ$$34$YR$$F$Y$$$20240814$$CN$CA$CA
238499593$23849959$3$F$20240414$20240705$20240513$20240715$EXP$$ES-TEVA-VS-3195904$TEVA$$47$YR$$F$Y$62.2$KG$20240715$$HP$ES$ES
238499822$23849982$2$F$$20240429$20240513$20240701$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000093$ASSERTIO THERAPEUTICS$$44$YR$$F$Y$$$20240701$$HP$CA$CA
238500102$23850010$2$F$20240401$20240628$20240513$20240705$EXP$$US-BAYER-2024A068372$BAYER$$21$YR$A$M$Y$$$20240705$$CN$US$US
238500202$23850020$2$F$20240401$20240730$20240513$20240808$PER$$US-SA-2024SA136876$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240808$$MD$US$US
238501085$23850108$5$F$20240508$20240925$20240513$20240927$30DAY$$US-PFIZER INC-202400104164$PFIZER$$4$YR$$M$Y$$$20240927$$CN$US$US
238501542$23850154$2$F$$20240719$20240513$20240724$PER$$US-AMGEN-USASP2024092240$AMGEN$Gummalla S.; Balasubramaniapandian C.; Alshami S. et al.. Hyperparathyroidism in Pregnancy Resistant to Cinacalcet. Endocrine Practice. 2024;30 (5):S82-S83$21$YR$A$F$Y$$$20240724$$HP$US$US
238501693$23850169$3$F$$20240702$20240513$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073098$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240703$$CN$US$US
238502003$23850200$3$F$$20240626$20240513$20240701$30DAY$$FI-PFIZER INC-202400101576$PFIZER$$$$A$$Y$$$20240701$$PH$FI$FI
238502102$23850210$2$F$$20240722$20240513$20240725$EXP$$CA-MYLANLABS-202101565371$MYLAN$$54$YR$$F$Y$$$20240725$$HP$CA$CA
238502374$23850237$4$F$20220311$20240913$20240513$20240917$EXP$$ES-BAUSCH-BL-2024-007413$BAUSCH AND LOMB$$75$YR$$F$Y$61.5$KG$20240917$$HP$ES$ES
238502412$23850241$2$F$20231202$20240816$20240513$20240826$EXP$$CA-TAKEDA-2024TUS046310$TAKEDA$$$$$F$Y$$$20240826$$HP$CA$CA
238502432$23850243$2$F$20240309$20240712$20240513$20240722$EXP$FR-AFSSAPS-BX2024000816$FR-TEVA-VS-3195638$TEVA$$82$YR$$F$Y$$$20240722$$PH$FR$FR
238502482$23850248$2$F$$20240719$20240513$20240724$EXP$$US-AMGEN-USASP2024092843$AMGEN$El Meedani H.; El Meedani H.; Alsamarraie H.. A case of Primary Hyperparathyroidism presenting with Urosepsis in Pregnancy. Endocrine Practice. 2024;30 (5):S94$30$YR$A$F$Y$$$20240724$$HP$US$US
238502633$23850263$3$F$$20240916$20240513$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073862$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240918$$CN$US$US
238502692$23850269$2$F$$20240712$20240513$20240712$EXP$$NVSC2024US099162$NOVARTIS$$$$$$Y$$$20240712$$MD$US$US
238502742$23850274$2$F$$20231219$20240513$20240916$PER$$US-ENDO USA, INC.-2024-000175$ENDO$$$$$M$Y$$$20240916$$CN$US$US
238502753$23850275$3$F$$20240326$20240513$20240806$PER$$US-ENDO USA, INC.-2024-001565$ENDO$$$$$M$Y$$$20240806$$CN$US$US
238502763$23850276$3$F$$20231218$20240513$20240916$PER$$US-ENDO USA, INC.-2024-000067$ENDO$$$$$M$Y$$$20240916$$CN$US$US
238502814$23850281$4$F$$20240227$20240513$20240918$PER$$US-ENDO USA, INC.-2024-001229$ENDO$$$$$F$Y$$$20240918$$CN$US$US
238502822$23850282$2$F$$20240812$20240513$20240827$PER$$US-JNJFOC-20240533925$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$HP$US$US
238502894$23850289$4$F$20180101$20240730$20240513$20240802$EXP$$IT-MYLANLABS-2024M1041183$MYLAN$Rosati G, Annunziata L, Scarano E, Dapoto F, Bilancia D.. Clinical outcomes of intermittent panitumumab based-therapy for previously treated older patient with metastatic colorectal cancer: a case report and review of literature.. Frontiers in oncology. 2024;14:1369952$83$YR$$M$Y$78$KG$20240802$$HP$IT$IT
238503002$23850300$2$F$$20240729$20240513$20240802$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-027246$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240802$$HP$US$US
238503152$23850315$2$F$$20240801$20240513$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072257$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240805$$CN$US$US
238503252$23850325$2$F$20210101$20240513$20240513$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-083517$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$93$KG$20240813$$CN$ES$ES
238503273$23850327$3$F$$20240725$20240513$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073943$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240726$$CN$US$US
238503462$23850346$2$F$20230401$20240510$20240513$20240812$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-276253$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$52$KG$20240813$$CN$ES$ES
238503472$23850347$2$F$20190101$20240513$20240513$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-114117$BOEHRINGER INGELHEIM$$53$YR$A$F$Y$55.5$KG$20240813$$CN$ES$ES
238503493$23850349$3$F$$20240831$20240513$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073911$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$93.44$KG$20240903$$CN$US$US
238503692$23850369$2$F$$20240909$20240513$20240913$EXP$$CA-BAUSCH-BL-2024-007239$BAUSCH AND LOMB$$$$$F$Y$$$20240913$$HP$CA$CA
238503902$23850390$2$F$$20240220$20240513$20240916$PER$$US-ENDO USA, INC.-2024-001132$ENDO$$$$$M$Y$$$20240916$$CN$US$US
238503912$23850391$2$F$$20240130$20240513$20240916$PER$$US-ENDO USA, INC.-2024-002131$ENDO$$$$$M$Y$$$20240916$$CN$US$US
238503934$23850393$4$F$$20240305$20240513$20240916$PER$$US-ENDO USA, INC.-2024-001301$ENDO$$$$$F$Y$$$20240916$$CN$US$US
238503972$23850397$2$F$$20240819$20240513$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073792$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240821$$HP$US$US
238503982$23850398$2$F$20210401$20240510$20240513$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098750$BOEHRINGER INGELHEIM$$58$YR$A$M$Y$70.5$KG$20240813$$CN$ES$ES
238504142$23850414$2$F$$20240718$20240513$20240725$EXP$$JP-009507513-2405JPN000556J$MERCK$$63$YR$$F$Y$$$20240725$$MD$JP$JP
238504172$23850417$2$F$20230701$20240918$20240513$20240924$EXP$$BR-LUNDBECK-DKLU3077922$LUNDBECK$$$$$$Y$$$20240924$$LW$BR$BR
238504275$23850427$5$F$20240101$20240822$20240513$20240829$PER$$US-009507513-2404USA008308$MERCK$$$$$M$Y$$$20240829$$CN$US$US
238504322$23850432$2$F$$20240711$20240513$20240711$PER$$US-ALXN-202405USA000315US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
238504522$23850452$2$F$20240401$20240610$20240513$20240703$PER$$US-JNJFOC-20240514268$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240703$$CN$US$US
238504562$23850456$2$F$20240411$20240809$20240513$20240809$EXP$FR-AFSSAPS-PV2024000393$FR-ROCHE-3560912$ROCHE$$13$YR$T$M$Y$44.3$KG$20240809$$MD$FR$FR
238504603$23850460$3$F$$20240702$20240513$20240904$EXP$$CA-LUNDBECK-DKLU3077928$LUNDBECK$$$$$$Y$$$20240904$$CN$CA$CA
238504813$23850481$3$F$$20240902$20240513$20240911$EXP$$JP-009507513-2405JPN000551J$MERCK$$63$YR$$F$Y$$$20240911$$MD$JP$JP
238504823$23850482$3$F$$20240906$20240513$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202405006064$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240924$$CN$US$US
238505403$23850540$3$F$20240308$20240710$20240513$20240716$PER$$US-AMGEN-USASP2024091785$AMGEN$$38$YR$A$F$Y$$$20240716$$HP$US$US
238505612$23850561$2$F$$20240813$20240513$20240814$PER$$US-JNJFOC-20240511362$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240814$$HP$US$US
238505653$23850565$3$F$20220101$20240716$20240513$20240716$EXP$$CH-JNJFOC-20240530823$JOHNSON AND JOHNSON$$$$E$$Y$$$20240717$$MD$CH$CH
238505712$23850571$2$F$$20240802$20240513$20240808$EXP$$US-ABBVIE-5751242$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
238505762$23850576$2$F$$20240625$20240513$20240704$EXP$$PL-JNJFOC-20240523145$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240704$$MD$PL$PL
238505853$23850585$3$F$$20240709$20240513$20240716$EXP$$NVSJ2024JP005681$NOVARTIS$$80$YR$$F$Y$$$20240716$$MD$JP$JP
238505982$23850598$2$F$20221001$20240702$20240513$20240708$EXP$$US-ABBVIE-5469080$ABBVIE$$77$YR$$M$Y$74.842$KG$20240708$$CN$US$US
238506132$23850613$2$F$20240430$20240820$20240513$20240825$30DAY$$IT-SANDOZ INC.-SDZ2024IT046882$SANDOZ$$14$YR$$F$Y$46$KG$20240825$$CN$IT$IT
238506162$23850616$2$F$$20240705$20240513$20240716$PER$$US-SA-2024SA141595$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240716$$MD$US$US
238506293$23850629$3$F$$20240925$20240513$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US047806$SANDOZ$$$$$M$Y$$$20240930$$CN$US$US
238506303$23850630$3$F$$20240814$20240513$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073749$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240822$$CN$US$US
238506322$23850632$2$F$$20240812$20240513$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-073461$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240814$$MD$JP$JP
238506442$23850644$2$F$$20240708$20240513$20240719$EXP$$JP-AMGEN-JPNSP2024093967$AMGEN$$$$$$Y$$$20240719$$MD$JP$JP
238506462$23850646$2$F$$20240423$20240513$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-160928$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240916$$CN$US$US
238506494$23850649$4$F$20240425$20240710$20240513$20240715$EXP$$US-ABBVIE-5753679$ABBVIE$$56$YR$$M$Y$70$KG$20240715$$CN$US$US
238506573$23850657$3$F$$20240705$20240513$20240710$PER$$NVSC2024US095278$NOVARTIS$$28$YR$$$Y$$$20240710$$CN$US$US
238506624$23850662$4$F$20240503$20240923$20240513$20240925$EXP$$US-TAKEDA-2024TUS045583$TAKEDA$$60$YR$$F$Y$$$20240925$$MD$US$US
238506643$23850664$3$F$20240322$20240701$20240513$20240708$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-026362$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240708$$MD$US$US
238506707$23850670$7$F$$20240726$20240513$20240813$EXP$$NVSC2024US095472$NOVARTIS$$35$YR$$M$Y$$$20240813$$CN$US$US
238506833$23850683$3$F$20240101$20240722$20240513$20240731$PER$$US-SA-2024SA142812$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240731$$MD$US$US
238506964$23850696$4$F$$20240918$20240513$20240926$EXP$$US-MALLINCKRODT-MNK202401695$MALLINCKRODT$$76$YR$E$M$Y$160$KG$20240926$$HP$US$US
238507233$23850723$3$F$20240401$20240909$20240514$20240924$PER$$US-SA-2024SA143140$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240924$$MD$US$US
238507322$23850732$2$F$20240101$20240726$20240514$20240805$PER$$US-SA-2024SA142825$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240805$$MD$US$US
238507382$23850738$2$F$20240101$20240726$20240514$20240807$PER$$US-SA-2024SA142869$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240807$$MD$US$US
238508005$23850800$5$F$20240425$20240729$20240514$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012602$UNITED THERAPEUTICS$$69$YR$$F$Y$46.712$KG$20240807$$$US$US
238508102$23850810$2$F$20211104$20240507$20240514$20240703$EXP$$LT-CELLTRION INC.-2024LT010651$CELLTRION$$$$$$Y$$$20240703$$MD$LT$LT
238508373$23850837$3$F$20230301$20240913$20240514$20240918$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-026797$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240918$$CN$US$US
238508382$23850838$2$F$$20240827$20240514$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001968$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$CN$US$US
238508413$23850841$3$F$20231101$20240823$20240514$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-031594$JAZZ$$24$YR$$F$Y$$$20240827$$MD$US$US
238509002$23850900$2$F$$20240506$20240514$20240819$PER$$NVSC2024US096963$NOVARTIS$$$$$F$Y$$$20240819$$MD$US$US
238509064$23850906$4$F$$20240708$20240514$20240715$EXP$$SK-ABBVIE-5756430$ABBVIE$$$$$M$Y$114$KG$20240715$$MD$SK$SK
238509152$23850915$2$F$$20240509$20240514$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000127$Tarsus Pharmaceuticals$$$$$M$Y$$$20240806$$MD$US$US
238509243$23850924$3$F$$20240705$20240514$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001982$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
238509394$23850939$4$F$$20240816$20240514$20240822$PER$$NVSC2024US098227$NOVARTIS$$$$$M$Y$$$20240822$$CN$US$US
238509573$23850957$3$F$$20240828$20240514$20240902$EXP$$US-ALXN-202404USA000817US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240902$$CN$US$US
238509643$23850964$3$F$$20240815$20240514$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-073058$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240815$$MD$JP$JP
238509662$23850966$2$F$$20240506$20240514$20240808$PER$$US-LEO Pharma-370230$LEO PHARM$$33$YR$$F$Y$$$20240808$$CN$US$US
238509712$23850971$2$F$$20240704$20240514$20240707$PER$$NVSC2024US095781$NOVARTIS$$$$$$Y$$$20240708$$CN$US$US
238509832$23850983$2$F$20240416$20240709$20240514$20240730$PER$$CA-TOLMAR, INC.-24CA048548$TOLMAR$$65$YR$$M$Y$$$20240730$$CN$CA$CA
238509874$23850987$4$F$20240416$20240723$20240514$20240819$PER$$FR-TOLMAR, INC.-24FR048526$TOLMAR$$79$YR$$M$Y$$$20240819$$PH$FR$FR
238509924$23850992$4$F$$20240813$20240514$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074051$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240813$$CN$US$US
238510092$23851009$2$F$20240509$20240731$20240514$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073979$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240807$$CN$US$US
238510104$23851010$4$F$20240501$20240916$20240514$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073833$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$61.69$KG$20240924$$PH$US$US
238510183$23851018$3$F$20240417$20240717$20240514$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002006$ACADIA PHARMACEUTICALS$$19$YR$$F$Y$$$20240809$$CN$US$US
238510214$23851021$4$F$20240601$20240716$20240514$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001975$ACADIA PHARMACEUTICALS$$31$YR$$F$Y$$$20240809$$CN$US$US
238510243$23851024$3$F$$20240618$20240514$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001991$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
238510263$23851026$3$F$20240307$20240625$20240514$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001374$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240719$$CN$US$US
238510374$23851037$4$F$$20240712$20240514$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001993$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
238510443$23851044$3$F$$20240610$20240514$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002001$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
238510564$23851056$4$F$$20240918$20240514$20240930$PER$$NVSC2024US098092$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
238510702$23851070$2$F$20240101$20240802$20240514$20240813$PER$$US-SA-2024SA143491$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240814$$MD$US$US
238510802$23851080$2$F$20240101$20240625$20240514$20240701$EXP$$HR-JNJFOC-20240535806$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240701$$MD$HR$HR
238510842$23851084$2$F$20240509$20240801$20240514$20240803$PER$$US-AMGEN-USASP2024093348$AMGEN$$68$YR$E$F$Y$$$20240803$$CN$US$US
238510852$23851085$2$F$20240223$20240502$20240514$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000145$Tarsus Pharmaceuticals$$19$YR$$M$Y$$$20240806$$CN$US$US
238510882$23851088$2$F$20240212$20240517$20240514$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000153$Tarsus Pharmaceuticals$$77$YR$$F$Y$$$20240806$$PH$US$US
238510902$23851090$2$F$$20240624$20240514$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071225$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240717$$CN$US$US
238511072$23851107$2$F$$20240819$20240514$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074017$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240826$$CN$US$US
238511152$23851115$2$F$$20240924$20240514$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202405006097$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240927$$CN$US$US
238511172$23851117$2$F$$20240628$20240514$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002010$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
238511233$23851123$3$F$20220101$20240705$20240514$20240710$EXP$$JP-SA-2024SA141289$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240710$$MD$JP$JP
238511314$23851131$4$F$20230402$20240909$20240514$20240915$EXP$$CA-JNJFOC-20230457543$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240915$$HP$CA$CA
238511352$23851135$2$F$$20240814$20240514$20240820$EXP$$CA-SA-2024SA144134$SANOFI AVENTIS$$71$YR$E$M$Y$174$KG$20240820$$HP$CA$CA
238511362$23851136$2$F$$20240430$20240514$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066986$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240826$$CN$US$US
238511403$23851140$3$F$20240509$20240725$20240514$20240727$PER$$US-AMGEN-USASP2024093448$AMGEN$$38$YR$A$M$Y$$$20240727$$CN$US$US
238511422$23851142$2$F$20240101$20240726$20240514$20240801$EXP$$DE-AMGEN-DEUSL2024091995$AMGEN$$59$YR$A$F$Y$$$20240731$$CN$DE$DE
238511534$23851153$4$F$20210101$20240702$20240514$20240709$EXP$$US-UCBSA-2024002839$UCB$$$$$F$Y$$$20240709$$HP$US$US
238511803$23851180$3$F$20230522$20240716$20240514$20240718$EXP$$FR-JNJFOC-20240514393$JOHNSON AND JOHNSON$$57$YR$A$F$Y$66$KG$20240718$$MD$FR$FR
238511852$23851185$2$F$$20240815$20240514$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072176$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240819$$MD$JP$JP
238511874$23851187$4$F$$20240916$20240514$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074025$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240918$$CN$US$US
238512152$23851215$2$F$$20240705$20240514$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-106735$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240708$$CN$US$US
238512352$23851235$2$F$$20240710$20240514$20240711$PER$$NVSC2024US100423$NOVARTIS$$$$$$Y$$$20240711$$CN$US$US
238512482$23851248$2$F$$20240624$20240514$20240708$PER$$US-AstraZeneca-2024A101137$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$US$
238512602$23851260$2$F$$20240806$20240514$20240806$EXP$$SI-JNJFOC-20240519132$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$MD$SI$SI
238512653$23851265$3$F$$20240701$20240514$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073896$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$67.13$KG$20240705$$CN$US$US
238512662$23851266$2$F$20240402$20240910$20240514$20240920$EXP$$IT-AUROBINDO-AUR-APL-2024-021889$AUROBINDO$$81$YR$$F$Y$57$KG$20240920$$HP$IT$IT
238513142$23851314$2$F$20240410$20240729$20240514$20240805$EXP$$AR-AMGEN-ARGSP2024094471$AMGEN$$77$YR$E$F$Y$$$20240805$$CN$AR$AR
238513314$23851331$4$F$20240511$20240812$20240514$20240814$PER$$US-AMGEN-USASP2024094606$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
238513722$23851372$2$F$$20240718$20240514$20240723$EXP$$JP-JNJFOC-20240537889$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240723$$PH$JP$JP
238513764$23851376$4$F$20240507$20240828$20240514$20240829$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-027402$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$51.1$KG$20240829$$MD$JP$JP
238513902$23851390$2$F$20240709$20240709$20240514$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002038$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240731$$CN$US$US
238513982$23851398$2$F$$20240709$20240514$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-070691$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240717$$CN$US$US
238514005$23851400$5$F$$20240823$20240514$20240903$PER$$US-SA-2024SA140101$SANOFI AVENTIS$$$$A$$Y$$$20240903$$HP$US$US
238514112$23851411$2$F$$20240715$20240514$20240720$EXP$$CL-JNJFOC-20240522186$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240719$$CN$CL$CL
238514912$23851491$2$F$20180920$20240701$20240514$20240704$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-073076$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240704$$CN$TR$TR
2385149210$23851492$10$F$20240101$20240722$20240514$20240730$PER$$US-UNITED THERAPEUTICS-UNT-2024-005328$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240730$$$US$US
238515193$23851519$3$F$20240509$20240701$20240514$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074036$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$93.44$KG$20240705$$CN$US$US
238515562$23851556$2$F$$20240909$20240514$20240918$EXP$$CA-APOTEX-2024AP005696$APOTEX$$43$YR$$F$Y$$$20240918$$MD$CA$CA
238515683$23851568$3$F$$20240830$20240514$20240906$EXP$$CA-HALEON-2166471$Haleon PLC$$44$YR$$F$Y$97$KG$20240906$$HP$CA$CA
238515882$23851588$2$F$20240101$20240829$20240514$20240903$EXP$$CA-JNJFOC-20240514063$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240903$$CN$CA$CA
238515902$23851590$2$F$20240101$20240917$20240514$20240925$EXP$$US-TEVA-VS-3190942$TEVA$$14$YR$$M$Y$$$20240925$$HP$US$US
238515932$23851593$2$F$$20240816$20240514$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-074154$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240826$$MD$JP$JP
238515953$23851595$3$F$$20240823$20240514$20240829$EXP$$JP-GSK-JP2024JPN059149$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$MD$JP$JP
238515993$23851599$3$F$$20240611$20240514$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002033$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240707$$CN$US$US
238516182$23851618$2$F$20180607$20240416$20240514$20240812$EXP$$FR-GRUNENTHAL-2018-22979$Haleon PLC$$69$YR$$M$Y$66$KG$20240809$$PH$FR$FR
238516202$23851620$2$F$$20240702$20240514$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03532$LUPIN$$$$$$Y$$$20240722$$CN$US$US
238516422$23851642$2$F$20230929$20240827$20240514$20240902$EXP$$AU-TAKEDA-2023TUS094855$TAKEDA$$54$YR$$M$Y$$$20240902$$CN$AU$AU
238516442$23851644$2$F$$20240720$20240514$20240726$PER$$US-UNITED THERAPEUTICS-UNT-2024-013633$UNITED THERAPEUTICS$$$$$$Y$$$20240726$$$US$US
238516492$23851649$2$F$$20240628$20240514$20240709$PER$$US-AstraZeneca-2024A103407$ASTRAZENECA$$$$$$Y$$$20240709$$CN$US$
238516592$23851659$2$F$$20240820$20240514$20240820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072128$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240820$$MD$JP$JP
238516602$23851660$2$F$20240401$20240813$20240514$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074126$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240813$$CN$US$US
238516612$23851661$2$F$$20240912$20240514$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074159$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240912$$CN$US$US
238516632$23851663$2$F$$20240812$20240514$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074206$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240812$$PH$US$US
238516673$23851667$3$F$20240507$20240628$20240514$20240702$PER$$US-BIOVITRUM-2024-US-007043$BIOVITRUM$$87$YR$$F$Y$$$20240702$$CN$US$US
238517093$23851709$3$F$20240401$20240823$20240514$20240827$EXP$$NVSC2024GR099915$NOVARTIS$$60$YR$$F$Y$$$20240827$$MD$GR$GR
238517143$23851714$3$F$20240322$20240624$20240514$20240701$PER$$US-AMGEN-USASP2024093093$AMGEN$$49$YR$A$F$Y$101.13$KG$20240630$$PH$US$US
238517162$23851716$2$F$20240507$20240628$20240514$20240704$PER$$US-AMGEN-USASP2024093060$AMGEN$$72$YR$E$F$Y$79.3$KG$20240704$$PH$US$US
238517254$23851725$4$F$$20240911$20240514$20240917$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-08095$IPSEN$$84$YR$E$M$Y$54.4$KG$20240917$$CN$US$US
238517343$23851734$3$F$20240201$20240827$20240514$20240831$PER$$US-ABBVIE-5757847$ABBVIE$$73$YR$$F$Y$59$KG$20240831$$CN$US$US
238517466$23851746$6$F$20240301$20240813$20240514$20240822$EXP$$CO-EXELIXIS-CABO-24077219$EXELIXIS$$70$YR$$M$Y$71$KG$20240822$$CN$CO$CO
238517583$23851758$3$F$$20240822$20240514$20240823$PER$$NVSC2024US100172$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
238517652$23851765$2$F$$20240701$20240514$20240707$PER$$US-AstraZeneca-2024A099028$ASTRAZENECA$$$$$F$Y$$$20240707$$MD$US$
238517733$23851773$3$F$$20240710$20240514$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073939$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240712$$CN$US$US
238517882$23851788$2$F$$20240712$20240514$20240712$PER$$US-ALXN-202405USA000445US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
238517892$23851789$2$F$$20240712$20240514$20240715$PER$$US-ALXN-202405USA000332US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
238517963$23851796$3$F$$20240702$20240514$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001944$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
238518012$23851801$2$F$20240413$20240822$20240514$20240903$EXP$$PT-AUROBINDO-AUR-APL-2024-021987$AUROBINDO$$78$YR$$M$Y$$$20240903$$MD$PT$PT
238518253$23851825$3$F$$20240914$20240514$20240919$EXP$$US-862174955-ML2024-02859$Unknown Manufacturer$$76$YR$E$F$Y$$$20240919$$CN$US$US
238518363$23851836$3$F$$20240815$20240514$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-074256$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240819$$MD$JP$JP
238518426$23851842$6$F$$20240910$20240514$20240917$EXP$$CA-GSK-CA2024021897$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
238518523$23851852$3$F$20231201$20240725$20240514$20240729$EXP$$US-UCBSA-2024001541$UCB$$25$YR$$F$Y$$$20240729$$CN$US$US
238518626$23851862$6$F$20240101$20240918$20240514$20240925$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000369$DECIPHERA PHARMACEUTICALS$$40$YR$A$M$Y$$$20240925$$CN$US$US
238518692$23851869$2$F$20240424$20240612$20240514$20240712$PER$$US-AstraZeneca-2024A100599$ASTRAZENECA$$25067$DY$$F$Y$$$20240712$$CN$US$
238518763$23851876$3$F$$20240618$20240514$20240703$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000368$DECIPHERA PHARMACEUTICALS$$71$YR$E$F$Y$$$20240703$$MD$US$US
238518854$23851885$4$F$20240405$20240826$20240514$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000375$DECIPHERA PHARMACEUTICALS$$62$YR$A$F$Y$$$20240905$$CN$US$US
238518983$23851898$3$F$20240508$20240802$20240514$20240806$PER$$US-AMGEN-USASP2024093872$AMGEN$$79$YR$E$F$Y$$$20240805$$CN$US$US
238519093$23851909$3$F$20240101$20240815$20240514$20240909$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000427$DECIPHERA PHARMACEUTICALS$$65$YR$A$F$Y$60.9$KG$20240909$$CN$US$US
238519273$23851927$3$F$20240516$20240709$20240514$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001963$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240731$$CN$US$US
238519372$23851937$2$F$20240507$20240712$20240514$20240712$PER$$US-ALXN-202405USA000498US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240712$$MD$US$US
238519712$23851971$2$F$20240101$20240702$20240514$20240710$EXP$$US-AMGEN-USASP2024092912$AMGEN$$73$YR$E$F$Y$$$20240709$$MD$US$US
238519776$23851977$6$F$20230731$20240920$20240514$20240930$EXP$$DE-AUROBINDO-AUR-APL-2024-021883$AUROBINDO$Osei-Davies R, Gallinger A, Hennersdorf F. P10-03 Korrektur einer lebensbedrohlichen Verbreiterung des QRS Komplexes unter einer Kombinationstherapie aus Flecainid und Lacosamid durch Natriumbicarbonat (p.73); Die Innere Medizin: onlinefirst 10.04.2024 - Abstracts: 130. Kongress der Deutschen Gesellschaft f?r Innere Medizin e.V. 2024;1-7:13-16$72$YR$$F$Y$$$20240930$$MD$DE$DE
238519864$23851986$4$F$20240314$20240719$20240514$20240730$EXP$$US-MACLEODS PHARMA-MAC2024047201$MACLEODS$$$$$$Y$$$20240730$$HP$US$US
238519943$23851994$3$F$20240512$20240822$20240514$20240826$PER$$US-AMGEN-USASP2024094980$AMGEN$$74$YR$E$M$Y$$$20240826$$CN$US$US
238520004$23852000$4$F$20240506$20240624$20240514$20240701$30DAY$$US-GSK-US2024057945$GLAXOSMITHKLINE$$88$YR$$F$Y$$$20240701$$CN$US$US
238520233$23852023$3$F$20240329$20240823$20240514$20240828$EXP$$NVSC2024GR099921$NOVARTIS$$65$YR$$F$Y$$$20240828$$MD$GR$GR
238520453$23852045$3$F$20200101$20240822$20240514$20240827$EXP$$NVSC2024MX100598$NOVARTIS$$$$$F$Y$60$KG$20240827$$CN$MX$MX
238520502$23852050$2$F$$20240813$20240514$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074280$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240813$$CN$US$US
238520586$23852058$6$F$20231108$20240912$20240514$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-073418$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$47.1$KG$20240917$$PH$JP$JP
238520612$23852061$2$F$$20240917$20240514$20240927$EXP$$CA-APOTEX-2024AP005673$APOTEX$$74$YR$$F$Y$54$KG$20240927$$HP$CA$CA
238520715$23852071$5$F$20240301$20240815$20240514$20240822$EXP$$NVSC2024MX081705$NOVARTIS$$18$YR$$F$Y$61$KG$20240822$$CN$MX$MX
238520796$23852079$6$F$20240304$20240910$20240514$20240921$EXP$$IT-AUROBINDO-AUR-APL-2024-021898$AUROBINDO$$66$YR$$F$Y$48$KG$20240921$$HP$IT$IT
238520885$23852088$5$F$20240501$20240729$20240514$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074110$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240805$$CN$US$US
238520943$23852094$3$F$$20240716$20240514$20240723$EXP$$AR-GSK-AR2023AMR108834$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$AR$AR
238520992$23852099$2$F$20240101$20240731$20240514$20240807$EXP$$GB-ABBVIE-5755970$ABBVIE$$75$YR$$M$Y$$$20240807$$CN$GB$GB
238521073$23852107$3$F$20240820$20240822$20240514$20240827$EXP$$US-TAKEDA-2022TUS002200$TAKEDA$$81$YR$$M$Y$73$KG$20240827$$MD$US$US
238521382$23852138$2$F$$20240716$20240514$20240805$PER$$AU-TOLMAR, INC.-24AU048499$TOLMAR$$$$$M$Y$$$20240805$$HP$AU$AU
238521523$23852152$3$F$$20240618$20240514$20240702$EXP$$CA-ROCHE-3558106$ROCHE$$$$A$M$Y$$$20240702$$CN$CA$CA
238521623$23852162$3$F$$20240814$20240514$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000371$DECIPHERA PHARMACEUTICALS$$68$YR$A$M$Y$$$20240905$$CN$US$US
238521802$23852180$2$F$$20240820$20240514$20240912$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000235$BECTON DICKINSON$$$$$$Y$$$20240912$$CN$GB$GB
238521853$23852185$3$F$20240215$20240830$20240514$20240902$EXP$$US-TAKEDA-2024TUS042734$TAKEDA$$80$YR$$F$Y$$$20240902$$CN$US$US
238522064$23852206$4$F$20240601$20240716$20240514$20240720$EXP$$CA-JNJFOC-20240518550$JOHNSON AND JOHNSON$$66$YR$E$F$Y$76$KG$20240719$$HP$CA$CA
238522123$23852212$3$F$$20240909$20240514$20240916$EXP$$US-TAKEDA-2024TUS034174$TAKEDA$$$$$F$Y$91$KG$20240916$$MD$US$US
238522162$23852216$2$F$20240418$20240828$20240514$20240903$EXP$FR-AFSSAPS-PA2024001010$FR-BAYER-2024A065539$BAYER$$37$YR$A$M$Y$104$KG$20240903$$CN$FR$FR
238522392$23852239$2$F$20240511$20240718$20240514$20240722$EXP$$NVSC2024US101323$NOVARTIS$$43$YR$$F$Y$$$20240722$$CN$US$US
238522422$23852242$2$F$20240401$20240718$20240514$20240722$EXP$$US-UCBSA-2024023763$UCB$$28$YR$$F$Y$$$20240719$$HP$US$US
238522654$23852265$4$F$20240827$20240827$20240514$20240830$EXP$$CA-TAKEDA-2024TUS030900$TAKEDA$$73$YR$$M$Y$$$20240830$$MD$CA$CA
238522992$23852299$2$F$20240412$20240808$20240514$20240820$EXP$FR-AFSSAPS-2024034162$FR-Accord-423710$ACCORD$$75$YR$E$M$Y$138$KG$20240820$$MD$FR$FR
238523002$23852300$2$F$20230101$20240620$20240514$20240702$EXP$$SA-Accord-423381$ACCORD$Alharbi FH, Almutairi FA, Aljutayli ZA, Albuhayji SA, Alharbi HD, Almutairi AA. Severe Renal Impairment in a Patient with Recent Rheumatoid Arthritis Diagnosis following Methotrexate Initiation: A Case Report. Journal of Pharmacy and Bioallied Sciences. 2024;16(Suppl 2):S1878-82.$50$YR$A$M$Y$$$20240701$$MD$SA$SA
238523152$23852315$2$F$20231222$20240703$20240514$20240710$EXP$$US-GSK-US2024AMR059309$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$US$US
238523242$23852324$2$F$20231003$20240808$20240514$20240813$EXP$$GB-MYLANLABS-2023M1104842$MYLAN$$25$YR$$F$Y$$$20240813$$MD$GB$GB
238523292$23852329$2$F$20230202$20240701$20240514$20240705$EXP$$US-OTSUKA-2024_013219$OTSUKA$$69$YR$$F$Y$90.72$KG$20240705$$CN$US$US
238523322$23852332$2$F$20240201$20240705$20240514$20240717$EXP$$US-ELI_LILLY_AND_COMPANY-US202405001972$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
238523412$23852341$2$F$$20240719$20240514$20240722$EXP$$NVSC2024US100282$NOVARTIS$$49$YR$$F$Y$$$20240722$$MD$US$US
238523543$23852354$3$F$20240401$20240912$20240514$20240918$EXP$$CA-Orion Corporation ORION PHARMA-24_00029849$ORION$$39$YR$A$F$Y$$$20240918$$MD$CA$
238523592$23852359$2$F$20240101$20240723$20240514$20240727$EXP$$US-AMGEN-USASL2024068452$AMGEN$$65$YR$E$F$Y$$$20240727$$HP$US$US
238523644$23852364$4$F$20240509$20240912$20240514$20240913$EXP$$KR-ABBVIE-5759240$ABBVIE$$62$YR$$M$Y$69$KG$20240913$$MD$KR$KR
238523674$23852367$4$F$$20240816$20240514$20240822$EXP$$US-TAKEDA-2024TUS044166$TAKEDA$$$$$F$Y$$$20240822$$CN$US$US
238524023$23852402$3$F$20231117$20240704$20240514$20240709$EXP$$PE-UCBSA-2023055984$UCB$$34$YR$$F$Y$68$KG$20240709$$CN$PE$PE
238524064$23852406$4$F$20240417$20240906$20240514$20240913$EXP$$US-SANDOZ INC.-SDZ2023US022163$SANDOZ$$44$YR$$F$Y$71.655$KG$20240913$$CN$US$US
238524074$23852407$4$F$20240430$20240823$20240514$20240827$EXP$$NVSC2024US101370$NOVARTIS$$68$YR$$M$Y$$$20240827$$CN$US$US
238524102$23852410$2$F$$20240717$20240514$20240721$EXP$$CA-MYLANLABS-2024M1043221$MYLAN$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. J-Anal-Toxicol 2023; 47 (4): 385-392.$21$YR$$M$Y$$$20240719$$HP$CA$CA
238524122$23852412$2$F$$20240717$20240514$20240725$EXP$$CA-MYLANLABS-2024M1043232$MYLAN$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. J-Anal-Toxicol 2023; 47 (4): 385-392.$43$YR$$M$Y$$$20240725$$HP$CA$CA
238524212$23852421$2$F$20240513$20240815$20240514$20240816$PER$$US-AMGEN-USASP2024095118$AMGEN$$77$YR$E$F$Y$$$20240816$$CN$US$US
238524386$23852438$6$F$20240119$20240830$20240514$20240909$EXP$$JP-ROCHE-3560947$ROCHE$$82$YR$E$F$Y$41.1$KG$20240909$$MD$JP$JP
238524433$23852443$3$F$$20240918$20240514$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074311$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240919$$CN$US$US
238524813$23852481$3$F$$20240711$20240514$20240711$EXP$$US-PFIZER INC-PV202400061372$PFIZER$$66$YR$$F$Y$$$20240711$$CN$US$US
238524943$23852494$3$F$$20240723$20240514$20240729$EXP$$US-GILEAD-2024-0672373$GILEAD$$$$A$F$Y$$$20240729$$CN$US$US
238525192$23852519$2$F$20240513$20240906$20240514$20240907$PER$$US-AMGEN-USASP2024094879$AMGEN$$66$YR$E$M$Y$$$20240907$$CN$US$US
238525724$23852572$4$F$20240418$20240917$20240514$20240920$30DAY$$CL-PFIZER INC-202400106580$PFIZER$$$$A$M$Y$$$20240920$$CN$CL$CL
238525755$23852575$5$F$$20240928$20240514$20240930$30DAY$$FR-PFIZER INC-202400092857$PFIZER$$$$$F$Y$$$20240930$$CN$FR$FR
238525882$23852588$2$F$$20240827$20240514$20240905$EXP$$US-VIVUS, Inc.-2024V1000541$VIVUS$$$$A$F$Y$$$20240902$$CN$US$US
238526083$23852608$3$F$$20240529$20240514$20240905$PER$$US-ALIMERA SCIENCES INC.-US-A16013-24-000354$ALIMERA$$$$$F$Y$$$20240905$$MD$US$US
238526122$23852612$2$F$$20240905$20240514$20240910$EXP$$US-ABBVIE-5755919$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
238526312$23852631$2$F$$20240708$20240514$20240717$EXP$$AR-TAKEDA-2024TUS046728$TAKEDA$$$$$M$Y$43$KG$20240717$$CN$AR$AR
238526702$23852670$2$F$20240506$20240709$20240514$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071350$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$92.2$KG$20240712$$CN$US$US
238526963$23852696$3$F$$20240906$20240514$20240919$EXP$$CA-PFIZER INC-202400106531$PFIZER$$71$YR$$F$Y$89$KG$20240919$$HP$CA$CA
238526982$23852698$2$F$20230101$20240904$20240514$20240906$EXP$$ZA-PFIZER INC-PV202400061792$PFIZER$$64$YR$$F$Y$65$KG$20240906$$MD$ZA$ZA
238527402$23852740$2$F$$20240812$20240514$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074003$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240814$$CN$US$US
238527452$23852745$2$F$20240101$20240809$20240514$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073626$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$59.87$KG$20240814$$PH$US$US
238527536$23852753$6$F$20240101$20240828$20240514$20240830$EXP$$CA-PFIZER INC-202400104821$PFIZER$$57$YR$$M$Y$$$20240830$$HP$CA$CA
238527593$23852759$3$F$$20240624$20240514$20240701$EXP$$CA-VIATRISJAPAN-2024M1043088AA$MYLAN$$17$YR$$F$Y$73$KG$20240701$$CN$CA$CA
238527694$23852769$4$F$$20240717$20240514$20240725$EXP$$NVSC2024BG100096$NOVARTIS$Gerasimov A. Toxicity in treatment of malignant skin melanoma with braf/mek inhibitors - a clinical case. 1(2):85-90$58$YR$$M$Y$$$20240725$$HP$BG$BG
238527713$23852771$3$F$20240423$20240820$20240514$20240823$PER$$US-AMGEN-USASP2024095337$AMGEN$$74$YR$E$F$Y$$$20240823$$CN$US$US
238527853$23852785$3$F$$20240909$20240514$20240916$EXP$$CA-SANDOZ INC.-NVSC2022CA251075$SANDOZ$$75$YR$$F$Y$70$KG$20240916$$HP$CA$CA
238527962$23852796$2$F$$20240711$20240514$20240711$PER$$US-ALXN-202405USA000136US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$US$US
238528742$23852874$2$F$20231101$20240705$20240514$20240718$EXP$$DE-ROCHE-3558062$ROCHE$$31$YR$A$F$Y$75$KG$20240718$$MD$DE$DE
238528824$23852882$4$F$20240610$20240807$20240514$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072447$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240814$$CN$US$US
238529012$23852901$2$F$$20240712$20240514$20240726$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-01587$AMNEAL$Hirayama I, Kamijo Y, Abe H, Nonaka M, Yano T, et al.. Guanfacine poisoning resulting in transient ST-segment elevation: a case report. Int J Emerg Med. 2024;17:1$15$YR$$M$Y$48$KG$20240726$$HP$JP$JP
238529233$23852923$3$F$20231130$20240708$20240514$20240717$EXP$DE-BFARM-24003109$DE-TORRENT-00026686$TORRENT$$35$YR$A$F$Y$$$20240717$$MD$DE$DE
238529312$23852931$2$F$20240418$20240707$20240514$20240708$EXP$$CA-PFIZER INC-202400106424$PFIZER$$78$YR$$F$Y$$$20240708$$HP$CA$CA
238529372$23852937$2$F$$20240726$20240514$20240801$EXP$$NVSC2024US099542$NOVARTIS$$$$$F$Y$$$20240801$$HP$US$US
238529382$23852938$2$F$20240505$20240719$20240514$20240722$EXP$$NVSC2024DK099990$NOVARTIS$$$$$F$Y$$$20240723$$HP$DK$DK
238529482$23852948$2$F$$20240701$20240514$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074291$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240701$$HP$US$US
238529605$23852960$5$F$$20240925$20240514$20240927$30DAY$$US-PFIZER INC-202400105281$PFIZER$$7$YR$$F$Y$$$20240927$$CN$US$US
238529643$23852964$3$F$$20240910$20240514$20240912$30DAY$$CO-PFIZER INC-202400103860$PFIZER$$15$YR$$M$Y$$$20240912$$CN$CO$CO
238529662$23852966$2$F$20230116$20240807$20240514$20240809$EXP$$GB-PFIZER INC-202400106043$PFIZER$$48$YR$$F$Y$$$20240809$$MD$GB$GB
238529685$23852968$5$F$$20240921$20240514$20240926$30DAY$$US-PFIZER INC-202400104972$PFIZER$$7$YR$$F$Y$$$20240926$$CN$US$US
238529893$23852989$3$F$$20240925$20240514$20240930$30DAY$$US-PFIZER INC-202400104701$PFIZER$$14$YR$$M$Y$55$KG$20240930$$MD$US$US
238529903$23852990$3$F$20240502$20240820$20240514$20240827$30DAY$$US-PFIZER INC-202400104966$PFIZER$$12$YR$$F$Y$26.76$KG$20240827$$CN$US$US
238529914$23852991$4$F$20240506$20240914$20240514$20240919$30DAY$$US-PFIZER INC-202400104959$PFIZER$$11$YR$$M$Y$41.28$KG$20240919$$CN$US$US
238530634$23853063$4$F$20240508$20240924$20240514$20240926$30DAY$$US-PFIZER INC-202400104935$PFIZER$$14$YR$$M$Y$$$20240926$$MD$US$US
238530645$23853064$5$F$20230623$20240711$20240514$20240711$30DAY$$JP-PFIZER INC-PV202400060081$PFIZER$$$$T$M$Y$$$20240711$$MD$JP$JP
238530654$23853065$4$F$20240501$20240917$20240514$20240919$30DAY$$US-PFIZER INC-202400104485$PFIZER$$3$YR$$M$Y$12.25$KG$20240919$$CN$US$US
238530733$23853073$3$F$20240508$20240815$20240514$20240823$30DAY$$US-PFIZER INC-202400104809$PFIZER$$10$YR$$M$Y$$$20240823$$CN$US$US
238530865$23853086$5$F$$20240918$20240514$20240926$PER$$NVSC2024US100242$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
238531002$23853100$2$F$$20240812$20240514$20240813$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-074194$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240814$$PH$JP$JP
238531043$23853104$3$F$20240512$20240802$20240514$20240805$PER$$US-AMGEN-USASP2024094897$AMGEN$$78$YR$E$F$Y$$$20240805$$CN$US$US
238531355$23853135$5$F$20240101$20240722$20240514$20240724$EXP$$CA-PFIZER INC-202400104681$PFIZER$$65$YR$$M$Y$$$20240724$$MD$CA$CA
238531412$23853141$2$F$$20240807$20240514$20240814$EXP$$EG-SANDOZ INC.-SDZ2024EG047865$SANDOZ$$$$$F$Y$$$20240814$$CN$EG$EG
238531613$23853161$3$F$20240101$20240731$20240514$20240807$EXP$$JP-GENMAB-2024-01555$GENMAB$$51$YR$$F$Y$68$KG$20240807$$MD$JP$JP
238531632$23853163$2$F$20220101$20240715$20240514$20240723$EXP$FR-AFSSAPS-MA2024000583$FR-SA-2024SA141466$SANOFI AVENTIS$$77$YR$E$F$Y$59$KG$20240723$$CN$FR$FR
238531703$23853170$3$F$$20240704$20240514$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03814$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238531713$23853171$3$F$$20240913$20240514$20240919$30DAY$$US-PFIZER INC-202400103855$PFIZER$$5$YR$$M$Y$14.51$KG$20240919$$CN$US$US
238531865$23853186$5$F$20231001$20240702$20240514$20240906$EXP$$SG-BRISTOL-MYERS SQUIBB COMPANY-2024-073588$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240906$$MD$SG$SG
238531982$23853198$2$F$$20240704$20240514$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03849$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238532046$23853204$6$F$20240101$20240827$20240514$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-012418$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240903$$$US$US
238532123$23853212$3$F$$20240722$20240514$20240801$EXP$$CA-JNJFOC-20240527128$JOHNSON AND JOHNSON$$15$WK$I$M$Y$$$20240801$$HP$CA$CA
238532312$23853231$2$F$$20240826$20240514$20240830$EXP$$JP-AstraZeneca-2024A110234$ASTRAZENECA$$$$$F$Y$$$20240830$$MD$JP$
238532364$23853236$4$F$$20240822$20240514$20240827$EXP$$CA-TAKEDA-2023TUS104642$TAKEDA$$$$$M$Y$$$20240827$$CN$CA$CA
238532413$23853241$3$F$20240101$20240924$20240514$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074458$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240925$$CN$US$US
238532422$23853242$2$F$$20240816$20240514$20240820$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-002599$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240820$$MD$CA$CA
238532502$23853250$2$F$$20240510$20240514$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202405006908$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240820$$CN$US$US
238532583$23853258$3$F$20240101$20240803$20240514$20240808$EXP$$CA-ABBVIE-5758172$ABBVIE$$$$A$M$Y$$$20240808$$CN$CA$CA
238532652$23853265$2$F$$20240819$20240514$20240903$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-446165$RANBAXY$Martins Mendes T, Fonseca T, Pereira Anjos D. Recurrent Bacteremia after Cyanoacrylate Sclerotherapy of Ectopic Duodenal Varices. Acta Med Port. 2024;37 (2):136-141$47$YR$$F$Y$$$20240903$$HP$PT$PT
238532672$23853267$2$F$$20240710$20240514$20240725$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445504$RANBAXY$Andre E, Lemaitre F, Verdier M-C, Haufroid V, Pereira JP, Hantson P. Transient Lactic Acidosis and Elevation of Transaminases after the Introduction of Remdesivir in a Patient with Acute Kidney Injury. Case Rep Crit Care. 2024;2024 (0):1-5$56$YR$$F$Y$$$20240725$$HP$BE$BE
238532702$23853270$2$F$$20240812$20240514$20240827$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445130$RANBAXY$Yamamoto H, Kuroda H, Hiramoto N, Hasuike T, Doi A, Nishioka H. Successful maintenance treatment of disseminated nocardiosis with cerebral abscess in a severely immunocompromised patient allergic totrimethoprim-sulfamethoxazole using moxifloxacin and high-dose minocycline: A case report. J Infect Chemother. 2024;Apr 24:Online ahead of print(21)$60$YR$$M$Y$$$20240827$$HP$JP$JP
238532963$23853296$3$F$$20240806$20240514$20240809$PER$$US-PFIZER INC-202400104934$PFIZER$$74$YR$$F$Y$$$20240809$$HP$US$US
238533012$23853301$2$F$20240401$20240829$20240514$20240906$EXP$$JP-009507513-2405JPN000634J$MERCK$$8$DEC$$$Y$$$20240906$$MD$JP$JP
238533192$23853319$2$F$20240401$20240905$20240514$20240909$EXP$$US-PFIZER INC-202400105889$PFIZER$$61$YR$$F$Y$$$20240909$$HP$US$US
238533209$23853320$9$F$20240606$20240801$20240514$20240808$EXP$$CA-BEH-2024172050$CSL BEHRING$$86$YR$E$F$Y$63.492$KG$20240808$$CN$CA$CA
238533242$23853324$2$F$20190101$20240624$20240514$20240701$EXP$$CA-TAKEDA-2019TUS011768$TAKEDA$$$$$M$Y$$$20240701$$HP$CA$CA
238533434$23853343$4$F$20240425$20240819$20240514$20240903$EXP$$AR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446015$RANBAXY$-. A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination with Chemotherapy with or without Tislelizumab in Subjects with HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA). -. -;-:-$80$YR$$M$Y$70$KG$20240903$$HP$AR$AR
238533452$23853345$2$F$$20240829$20240514$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-445942$RANBAXY$Haider S, Chua W, Balakrishnar B, Della-Fiorentina S, Roberts TL, Keat K. Novel treatments for novel side effects: A case report and review of baricitinib use in the treatment of chronic inflammatory demyelinating polyneuropathy caused by immune checkpoint inhibitor use. J Immunother Cancer. 2023;11:1-4$6$DEC$$$Y$$$20240913$$MD$AU$AU
238533552$23853355$2$F$$20240425$20240514$20240923$PER$$NL-ROCHE-3549264$ROCHE$Kelters I, Van der Geest J, Sampaio-Pinto V,  Zwetsloot P, Teske A, De Boer T, van der Kaaij N, Sluijter J and Van Laake L. Ex Vivo Myocardial Slices Unveil Reversibility in Chemotherapy-Induced Cardiotoxicity.[Abstract number;1152] Doi;10.1016/j.healun.2024.02.769. Journal of Heart and Lung Transplantation 2024 Apr;43 (3 SUPPL):-.$48$YR$A$F$Y$$$20240923$$HP$NL$NL
238534133$23853413$3$F$20240503$20240703$20240514$20240712$EXP$$IN-INCYTE CORPORATION-2024IN005046$INCYTE$$$$$$Y$$$20240712$$CN$IN$IN
238534172$23853417$2$F$20240505$20240707$20240514$20240708$EXP$$CA-PFIZER INC-202400106686$PFIZER$$41$YR$$F$Y$$$20240708$$CN$CA$CA
238534212$23853421$2$F$20240301$20240707$20240514$20240708$EXP$$CA-PFIZER INC-202400106443$PFIZER$$46$YR$$F$Y$$$20240708$$HP$CA$CA
238534662$23853466$2$F$$20240809$20240514$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445766$RANBAXY$Kaur S, Egal S, Jabbal IS, Abanilla FM. SGLT2 Inhibitors in Membranous Nephropathy: Worthy of Consideration?. J Am Soc Nephrol. 2023;34:1151(PUB364)$68$YR$$M$Y$$$20240823$$HP$US$US
238534712$23853471$2$F$$20240701$20240514$20240705$30DAY$$GB-SANDOZ INC.-SDZ2023GB019762$SANDOZ$$$$$F$Y$$$20240705$$CN$GB$GB
238534754$23853475$4$F$$20240729$20240514$20240731$30DAY$$GB-PFIZER INC-PV202400061185$PFIZER$$9$YR$$M$Y$$$20240731$$CN$GB$GB
238534922$23853492$2$F$20220901$20240813$20240514$20240813$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-072523$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240813$$MD$PL$PL
238534935$23853493$5$F$$20240712$20240514$20240723$PER$$NVSC2024US100799$NOVARTIS$$47$YR$$F$Y$$$20240723$$CN$US$US
238534973$23853497$3$F$20240416$20240711$20240514$20240711$EXP$$NVSC2024DE101039$NOVARTIS$$85$YR$$F$Y$68$KG$20240711$$MD$DE$DE
238535063$23853506$3$F$20240501$20240905$20240514$20240909$PER$$US-PFIZER INC-PV202400062022$PFIZER$$77$YR$$F$Y$$$20240909$$CN$US$US
238535583$23853558$3$F$$20240829$20240514$20240906$PER$$US-PHARMING-PHAUS2024000371$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
238535628$23853562$8$F$20240710$20240909$20240514$20240916$EXP$$US-PHARMING-PHAUS2024000364$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
238535654$23853565$4$F$$20240814$20240514$20240828$PER$$US-PHARMING-PHAUS2024000374$PHARMING GROUP$$$$$$Y$$$20240822$$CN$US$US
238535853$23853585$3$F$$20240813$20240514$20240821$EXP$$US-MYLANLABS-2024M1043073$MYLAN$$$$$M$Y$$$20240821$$PH$US$US
238535894$23853589$4$F$20180101$20240720$20240514$20240731$EXP$$IT-AUROBINDO-AUR-APL-2024-021849$AUROBINDO$Rosati G, Annunziata L, Scarano E, Dapoto F, Bilancia D.. Clinical outcomes of intermittent panitumumab based-therapy for previously treated older patient with metastatic colorectal cancer: a case report and review of literature.. Frontiers in oncology. 2024;14:1369952$83$YR$$M$Y$78$KG$20240731$$MD$IT$IT
238536342$23853634$2$F$$20240710$20240514$20240711$EXP$$IT-ALXN-202405EEA000322IT$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240711$$MD$IT$IT
238536422$23853642$2$F$20240413$20240717$20240514$20240720$EXP$$NVSC2024US092547$NOVARTIS$$69$YR$$F$Y$$$20240720$$HP$US$US
238536453$23853645$3$F$$20240719$20240514$20240725$EXP$$CA-TAKEDA-2024TUS045415$TAKEDA$$$$$F$Y$$$20240725$$MD$CA$CA
238536682$23853668$2$F$20240425$20240509$20240514$20240925$EXP$$NVSC2024RU100934$NOVARTIS$$17$YR$$M$Y$$$20240925$$HP$RU$RU
238536802$23853680$2$F$20240501$20240712$20240514$20240722$EXP$$FR-Stemline Therapeutics, Inc.-2024ST002841$STEMLINE THERAPEUTICS$$$$$F$Y$$$20240717$$PH$FR$FR
238536862$23853686$2$F$$20240702$20240514$20240705$EXP$$JP-SANDOZ INC.-SDZ2024JP047849$SANDOZ$$93$YR$$F$Y$$$20240705$$PH$JP$JP
238537012$23853701$2$F$$20240708$20240514$20240710$EXP$$BR-ROCHE-3559831$ROCHE$$$$$F$Y$$$20240710$$MD$BR$BR
238537084$23853708$4$F$20240426$20240917$20240514$20240926$EXP$$US-AUROBINDO-AUR-APL-2024-022378$AUROBINDO$$72$YR$$F$Y$54.1$KG$20240926$$MD$US$US
238537254$23853725$4$F$20240505$20240807$20240514$20240812$EXP$$JP-009507513-2405JPN000434J$MERCK$$$$E$M$Y$$$20240812$$MD$JP$JP
238537272$23853727$2$F$$20240711$20240514$20240711$PER$$US-ALXN-202405USA000321US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
238537352$23853735$2$F$$20240703$20240514$20240708$EXP$$US-UCBSA-2024023312$UCB$$$$$F$Y$103$KG$20240708$$HP$US$US
238537402$23853740$2$F$$20240819$20240514$20240822$EXP$$GB-MYLANLABS-2024M1043074$MYLAN$$$$$F$Y$$$20240822$$HP$GB$GB
238537602$23853760$2$F$$20240422$20240514$20240806$PER$$US-AstraZeneca-2024A096147$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
238537642$23853764$2$F$20240101$20240704$20240514$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03941$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238537953$23853795$3$F$$20240719$20240514$20240723$PER$$US-PFIZER INC-202400106736$PFIZER$$50$YR$$M$Y$$$20240723$$HP$US$US
238538093$23853809$3$F$$20240709$20240514$20240717$PER$$US-VERTEX PHARMACEUTICALS-2024-008055$VERTEX$$13$YR$$F$Y$$$20240717$$CN$US$US
238538142$23853814$2$F$20240301$20240628$20240514$20240704$EXP$$JP-009507513-2405JPN000713J$MERCK$$68$YR$$M$Y$$$20240704$$MD$JP$JP
238538194$23853819$4$F$20240101$20240719$20240514$20240724$PER$$CA-Eisai-EC-2024-165468$EISAI$$70$YR$E$M$Y$$$20240724$$CN$CA$CA
238538304$23853830$4$F$$20240916$20240514$20240918$30DAY$$CO-PFIZER INC-PV202400058918$PFIZER$$15$YR$$M$Y$$$20240918$$CN$CO$CO
238538316$23853831$6$F$$20240922$20240514$20240925$30DAY$$US-PFIZER INC-202400101128$PFIZER$$15$YR$$F$Y$$$20240925$$CN$US$US
238538353$23853835$3$F$$20240730$20240514$20240807$EXP$$CA-AstraZeneca-2024A108607$ASTRAZENECA$$$$$M$Y$$$20240807$$MD$CA$
238538383$23853838$3$F$20240510$20240808$20240514$20240812$PER$$US-AMGEN-USASP2024095208$AMGEN$$56$YR$A$M$Y$$$20240812$$CN$US$US
238538402$23853840$2$F$$20240717$20240514$20240718$PER$$NVSC2024US099670$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
238538482$23853848$2$F$$20240726$20240514$20240730$PER$$US-BIOGEN-2024BI01264315$BIOGEN$$$$$M$Y$$$20240730$$CN$US$US
238538492$23853849$2$F$$20240712$20240514$20240717$PER$$NVSC2024US101628$NOVARTIS$$$$$F$Y$$$20240717$$HP$US$US
238538603$23853860$3$F$20240301$20240703$20240514$20240708$EXP$$CA-JNJFOC-20240520835$JOHNSON AND JOHNSON$$52$YR$A$M$Y$96$KG$20240708$$HP$CA$CA
238538772$23853877$2$F$$20240815$20240514$20240820$EXP$$US-MYLANLABS-2024M1042618$MYLAN$$$$$F$Y$$$20240820$$HP$US$US
238539052$23853905$2$F$20231010$20240710$20240514$20240710$EXP$$KR-ACERUSPHRM-2024-KR-000002$ACERUS PHARMACEUTICALS$$66$YR$E$M$Y$$$20240710$$HP$KR$KR
238539142$23853914$2$F$$20240925$20240514$20240930$30DAY$$CO-PFIZER INC-PV202400059974$PFIZER$$15$YR$$M$Y$$$20240930$$CN$CO$CO
238539353$23853935$3$F$20240417$20240711$20240514$20240718$EXP$$US-GSK-US2024059681$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$US$US
238539513$23853951$3$F$20230516$20240626$20240514$20240702$EXP$$DE-UCBSA-2024023714$UCB$$$$A$F$Y$$$20240702$$MD$DE$DE
238539532$23853953$2$F$$20240806$20240514$20240807$EXP$$US-ASTELLAS-2024US013651$ASTELLAS$$80$YR$$M$Y$$$20240807$$CN$US$US
238539542$23853954$2$F$20240506$20240712$20240514$20240717$EXP$$IN-ROCHE-3562815$ROCHE$$75$YR$E$M$Y$$$20240717$$CN$IN$IN
238539562$23853956$2$F$20240422$20240628$20240514$20240705$EXP$$US-Vifor (International) Inc.-VIT-2024-04236$VIFOR$$45$YR$$F$Y$83.4$KG$20240705$$HP$US$US
238539602$23853960$2$F$$20240704$20240514$20240722$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-03834$LUPIN$$$$$$Y$$$20240719$$CN$US$US
238539622$23853962$2$F$20231221$20240709$20240514$20240718$EXP$$JP-BAXTER-2024BAX018141$BAXTER$$63$YR$$M$Y$86$KG$20240718$$PH$JP$JP
238539773$23853977$3$F$20240403$20240521$20240514$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00703$AVADEL CNS PHARMA$$19$YR$$F$Y$43.084$KG$20240822$$CN$US$US
238539874$23853987$4$F$20240101$20240906$20240514$20240911$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000413$DECIPHERA PHARMACEUTICALS$$79$YR$E$M$Y$$$20240911$$HP$US$US
238539922$23853992$2$F$20190201$20240514$20240514$20240812$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-276545$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$69$KG$20240813$$CN$ES$ES
238539932$23853993$2$F$$20240705$20240514$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074001$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240709$$CN$US$US
238540032$23854003$2$F$$20240419$20240514$20240710$PER$$US-ROCHE-3550374$ROCHE$$$$A$F$Y$49.9$KG$20240701$$CN$US$US
238540242$23854024$2$F$$20240814$20240514$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202405006248$ELI LILLY AND CO$$53$YR$A$F$Y$140.6$KG$20240829$$HP$US$US
238540334$23854033$4$F$$20240906$20240514$20240910$EXP$$NVSC2024US100122$NOVARTIS$$$$$M$Y$$$20240910$$HP$US$US
238540613$23854061$3$F$20240320$20240613$20240514$20240806$PER$$US-LUNDBECK-DKLU3077908$LUNDBECK$$$$$$Y$$$20240806$$CN$US$US
238540902$23854090$2$F$20240430$20240712$20240514$20240726$EXP$$CN-PFIZER INC-PV202400061474$PFIZER$$64$YR$$F$Y$54$KG$20240726$$HP$CN$CN
238541023$23854102$3$F$20240510$20240808$20240514$20240809$PER$$NVSC2024US101750$NOVARTIS$$79$YR$$M$Y$$$20240809$$HP$US$US
238541032$23854103$2$F$$20240822$20240514$20240823$PER$$NVSC2024US101241$NOVARTIS$$$$$$Y$$$20240823$$CN$US$US
238541102$23854110$2$F$$20240813$20240514$20240819$PER$$US-JNJFOC-20240526797$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$US$US
238541482$23854148$2$F$$20240830$20240514$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074258$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240902$$CN$US$US
238541824$23854182$4$F$20240325$20240816$20240514$20240821$EXP$$US-Eisai-EC-2024-163027$EISAI$$81$YR$E$M$Y$80.739$KG$20240821$$CN$US$US
238541832$23854183$2$F$20240101$20240909$20240514$20240930$PER$$US-Eisai-EC-2024-163448$EISAI$$61$YR$A$F$Y$$$20240930$$CN$US$US
238541992$23854199$2$F$$20240712$20240514$20240717$EXP$$NVSC2024US101447$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
238542002$23854200$2$F$$20240429$20240514$20240701$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000092$ASSERTIO THERAPEUTICS$$44$YR$$F$Y$$$20240701$$HP$CA$CA
238542012$23854201$2$F$20240101$20240628$20240514$20240704$EXP$$US-SA-2024SA143809$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240704$$CN$US$US
238542122$23854212$2$F$$20240820$20240514$20240823$EXP$$US-ABBVIE-5755488$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
238542473$23854247$3$F$20240101$20240726$20240514$20240731$EXP$$CA-GENMAB-2024-01656$GENMAB$$74$YR$$M$Y$$$20240731$$HP$CA$CA
238542512$23854251$2$F$$20240903$20240514$20240910$EXP$$CA-SA-2024SA144564$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240910$$HP$CA$CA
238542522$23854252$2$F$$20240704$20240514$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03869$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238542843$23854284$3$F$20240513$20240708$20240514$20240709$EXP$$GB-PFIZER INC-202400107446$PFIZER$$67$YR$$F$Y$$$20240709$$MD$GB$GB
238542872$23854287$2$F$$20240508$20240514$20240703$PER$$US-009507513-2405USA002935$MERCK$$$$$M$Y$$$20240703$$PH$US$US
238542952$23854295$2$F$20221201$20240820$20240514$20240821$EXP$$US-JNJFOC-20240537565$JOHNSON AND JOHNSON$$$$E$F$Y$71$KG$20240822$$HP$US$US
238543164$23854316$4$F$$20240813$20240514$20240816$PER$$US-JNJFOC-20240537649$JOHNSON AND JOHNSON$$$$E$F$Y$71$KG$20240817$$HP$US$US
238543372$23854337$2$F$$20240712$20240514$20240726$PER$$US-ALKERMES INC.-ALK-2024-001207$ALKERMES$$$$$M$Y$$$20240726$$HP$US$US
238543682$23854368$2$F$$20240701$20240514$20240704$PER$$NVSC2024US095432$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
238544014$23854401$4$F$20240501$20240715$20240514$20240717$EXP$$US-JNJFOC-20240538745$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240717$$CN$US$US
238544043$23854404$3$F$20231001$20240627$20240514$20240704$PER$$US-BIOGEN-2024BI01260264$BIOGEN$$69$YR$$F$Y$$$20240704$$CN$US$US
238544052$23854405$2$F$$20240708$20240514$20240722$PER$$US-INCYTE CORPORATION-2024IN004358$INCYTE$$$$$$Y$$$20240719$$CN$US$US
238544062$23854406$2$F$20240301$20240618$20240514$20240705$PER$$US-Eisai-EC-2024-163358$EISAI$$66$YR$E$F$Y$$$20240705$$CN$US$US
238544074$23854407$4$F$$20240826$20240514$20240828$PER$$NVSC2024US101481$NOVARTIS$$$$$F$Y$$$20240828$$MD$US$US
238544082$23854408$2$F$$20240628$20240514$20240702$EXP$$IN-PFIZER INC-PV202400062340$PFIZER$$54$YR$$F$Y$$$20240702$$CN$IN$IN
238544092$23854409$2$F$$20240503$20240514$20240910$EXP$EG-SA-SAC20240508000142$EG-SA-2024SA139862$SANOFI AVENTIS$$61$YR$A$F$Y$75$KG$20240910$$PH$EG$EG
238544173$23854417$3$F$$20240722$20240514$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074218$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240725$$CN$US$US
238544222$23854422$2$F$$20240424$20240514$20240724$PER$$US-INCYTE CORPORATION-2024IN004356$INCYTE$$$$$$Y$$$20240724$$CN$US$US
238544263$23854426$3$F$20240101$20240730$20240514$20240802$PER$$US-PFIZER INC-PV202400061721$PFIZER$$65$YR$$F$Y$$$20240802$$CN$US$US
238544313$23854431$3$F$$20240910$20240514$20240919$PER$$US-INCYTE CORPORATION-2024IN004348$INCYTE$$$$$$Y$$$20240919$$HP$US$US
238544323$23854432$3$F$20240422$20240827$20240514$20240902$PER$$HN-REGENERON PHARMACEUTICALS, INC.-2024-071328$REGENERON$$$$$F$Y$$$20240902$$CN$HN$HN
238544344$23854434$4$F$20240423$20240521$20240514$20240902$EXP$$PL-GENMAB-2024-01658$GENMAB$$60$YR$$M$Y$86$KG$20240903$$MD$PL$PL
238544504$23854450$4$F$$20240917$20240514$20240920$30DAY$$CA-PFIZER INC-202400100769$PFIZER$$38$YR$$F$Y$$$20240920$$HP$CA$CA
238544552$23854455$2$F$20220101$20240514$20240514$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-153947$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$65.5$KG$20240813$$CN$ES$ES
238544662$23854466$2$F$$20240828$20240514$20240830$EXP$CA-HEALTHCANVIG-E2B_07012981$CA-PURDUE-USA-2024-0309556$PURDUE$Trollip E, Hawkins K, Kwek I, Dewart K, Qureshi M, Senaratne JM. Bupivacaine and morphine epidural use for refractory neuropathic pain relief in a Guillain-Barre syndrome patient. Clin Case Rep. 2023;11(4)$$$$M$Y$$$20240830$$HP$CA$CA
238544812$23854481$2$F$$20240718$20240514$20240724$EXP$$US-ABBVIE-5757818$ABBVIE$$$$$M$Y$84$KG$20240724$$CN$US$US
238544932$23854493$2$F$$20240612$20240514$20240702$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-07866$IPSEN$$$$$F$Y$70$KG$20240702$$CN$US$US
238544942$23854494$2$F$$20240712$20240514$20240715$PER$$US-ALXN-202405USA000372US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
238544973$23854497$3$F$20240328$20240909$20240514$20240917$PER$$US-Calliditas-2024CAL00694$CALLIDITAS THERAPEUTICS$$42$YR$A$M$Y$79.4$KG$20240918$$CN$US$US
238545084$23854508$4$F$20240627$20240830$20240514$20240904$EXP$$US-DSJP-DSU-2024-120356$DAIICHI$$60$YR$$F$Y$$$20240904$$CN$US$US
238545752$23854575$2$F$20240325$20240813$20240514$20240816$EXP$$US-JNJFOC-20240511380$JOHNSON AND JOHNSON$$62$YR$A$M$Y$69.916$KG$20240817$$CN$US$US
238545885$23854588$5$F$$20240819$20240514$20240826$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000976$BLUEPRINT MEDICINES$$$$$F$Y$$$20240827$$CN$US$US
238546092$23854609$2$F$20240513$20240723$20240514$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US048155$SANDOZ$$70$YR$$F$Y$$$20240724$$HP$US$US
238546222$23854622$2$F$$20240717$20240514$20240723$EXP$$NVSC2024CL100087$NOVARTIS$$64$YR$$F$Y$$$20240723$$MD$CL$CL
238546273$23854627$3$F$20240501$20240701$20240514$20240709$PER$$US-INCYTE CORPORATION-2024IN004681$INCYTE$$$$$$Y$$$20240709$$MD$US$US
238546392$23854639$2$F$$20240911$20240514$20240914$EXP$$CA-SANDOZ INC.-SDZ2024CA047901$SANDOZ$$32$YR$$F$Y$111$KG$20240914$$MD$CA$CA
238546463$23854646$3$F$20220601$20240529$20240514$20240814$EXP$$NVSC2024MX100603$NOVARTIS$$60$YR$$F$Y$100$KG$20240814$$CN$MX$MX
238546643$23854664$3$F$$20240822$20240514$20240823$30DAY$$US-SANDOZ INC.-SDZ2024US048260$SANDOZ$$6$YR$$$Y$$$20240823$$HP$US$US
238546654$23854665$4$F$20240101$20240624$20240514$20240701$PER$$US-AMGEN-USASP2024095075$AMGEN$$74$YR$E$M$Y$$$20240701$$CN$US$US
238546672$23854667$2$F$$20240828$20240514$20240905$EXP$$CA-AstraZeneca-2024A107169$ASTRAZENECA$$56$YR$$F$Y$$$20240905$$MD$CA$
238546832$23854683$2$F$20240401$20240913$20240514$20240923$PER$$US-INCYTE CORPORATION-2024IN004752$INCYTE$$$$$$Y$$$20240923$$CN$US$US
238546845$23854684$5$F$20240301$20240730$20240514$20240806$PER$$US-INCYTE CORPORATION-2024IN004754$INCYTE$$$$$$Y$$$20240806$$CN$US$US
238546943$23854694$3$F$20240426$20240702$20240514$20240708$EXP$$US-SA-2024SA145827$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240708$$MD$US$US
238546993$23854699$3$F$20231130$20240710$20240514$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-014923$JAZZ$$30$YR$$M$Y$$$20240717$$MD$US$US
238547033$23854703$3$F$20230101$20240802$20240514$20240809$EXP$$BR-PURDUE-USA-2024-0308432$PURDUE$$29$YR$$F$Y$68$KG$20240809$$CN$BR$BR
238547043$23854704$3$F$$20240826$20240514$20240828$PER$$NVSC2024US101698$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
238547093$23854709$3$F$20230116$20240808$20240514$20240819$EXP$$GB-SANDOZ INC.-SDZ2024GB048165$SANDOZ$$48$YR$$F$Y$$$20240819$$MD$GB$GB
238547212$23854721$2$F$20211101$20240513$20240514$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-136590$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$85.5$KG$20240813$$CN$ES$ES
238547242$23854724$2$F$20231114$20240516$20240514$20240703$PER$$US-Eisai-EC-2024-163785$EISAI$$67$YR$E$F$Y$$$20240703$$MD$US$US
238547303$23854730$3$F$$20240927$20240514$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074626$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240930$$CN$US$US
238547334$23854733$4$F$20240421$20240527$20240514$20240705$EXP$AT-BASGAGES-2024-003025$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-072967$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240705$$MD$AT$AT
238547572$23854757$2$F$20231230$20240710$20240514$20240715$EXP$$US-ABBVIE-5758011$ABBVIE$$76$YR$$F$Y$$$20240715$$CN$US$US
238547732$23854773$2$F$20240501$20240711$20240514$20240716$EXP$$US-ABBVIE-5757728$ABBVIE$$77$YR$$F$Y$$$20240716$$CN$US$US
238547823$23854782$3$F$20240511$20240727$20240514$20240731$PER$$US-AMGEN-USASP2024095148$AMGEN$$72$YR$E$M$Y$$$20240731$$CN$US$US
238547844$23854784$4$F$20240506$20240806$20240514$20240813$PER$$US-PFIZER INC-202400105020$PFIZER$$71$YR$$F$Y$51.7$KG$20240813$$HP$US$US
238547885$23854788$5$F$$20240826$20240514$20240829$PER$$NVSC2024US101562$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
238548012$23854801$2$F$$20240701$20240514$20240709$EXP$$US-Calliditas-2024CAL00712$CALLIDITAS THERAPEUTICS$$41$YR$A$M$Y$81.4$KG$20240709$$CN$US$US
238548232$23854823$2$F$20240512$20240802$20240514$20240805$PER$$US-AMGEN-USASP2024094736$AMGEN$$73$YR$E$M$Y$$$20240805$$CN$US$US
238548262$23854826$2$F$$20240709$20240514$20240715$EXP$$US-SA-2024SA138630$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240715$$CN$US$US
238548292$23854829$2$F$20150715$20240709$20240514$20240712$EXP$$FR-MYLANLABS-2024M1042832$MYLAN$$72$YR$$M$Y$$$20240712$$LW$FR$FR
238548302$23854830$2$F$20181101$20240709$20240514$20240712$EXP$$FR-MYLANLABS-2024M1042694$MYLAN$$84$YR$$M$Y$$$20240712$$CN$FR$FR
238548492$23854849$2$F$$20240719$20240514$20240723$EXP$$US-BAUSCH-BL-2024-007525$BAUSCH AND LOMB$$88$YR$$M$Y$$$20240723$$CN$US$US
238548662$23854866$2$F$$20240620$20240514$20240812$PER$$US-ANIPHARMA-2024-US-005947$ANI$$$$$M$Y$$$20240812$$HP$US$US
238548752$23854875$2$F$$20240801$20240514$20240808$EXP$$US-ANIPHARMA-2024-US-010990$ANI$$58$YR$$F$Y$$$20240808$$CN$US$US
238548812$23854881$2$F$$20240508$20240514$20240812$PER$$US-ANIPHARMA-2024-US-007050$ANI$$57$YR$$M$Y$$$20240812$$HP$US$US
238548822$23854882$2$F$20230601$20240521$20240514$20240812$PER$$US-ANIPHARMA-2024-US-018599$ANI$$51$YR$$F$Y$$$20240812$$HP$US$US
238548892$23854889$2$F$20231201$20240430$20240514$20240812$PER$$US-ANIPHARMA-2024-US-019234$ANI$$73$YR$$F$Y$$$20240812$$HP$US$US
238548912$23854891$2$F$$20240520$20240514$20240812$PER$$US-ANIPHARMA-2024-US-008649$ANI$$$$$F$Y$$$20240812$$HP$US$US
238549052$23854905$2$F$20240419$20240506$20240514$20240812$PER$$US-ANIPHARMA-2024-US-024409$ANI$$54$YR$$F$Y$154.22$KG$20240812$$HP$US$US
238549112$23854911$2$F$$20240712$20240514$20240715$EXP$$NVSC2024US099429$NOVARTIS$$$$$M$Y$$$20240715$$CN$US$US
238549162$23854916$2$F$20240319$20240506$20240514$20240812$PER$$US-ANIPHARMA-2024-US-021031$ANI$$78$YR$$F$Y$$$20240812$$HP$US$US
238549232$23854923$2$F$20240322$20240718$20240514$20240812$PER$$US-ANIPHARMA-2024-US-019795$ANI$$65$YR$$M$Y$$$20240812$$HP$US$US
238549252$23854925$2$F$$20240530$20240514$20240812$PER$$US-ANIPHARMA-2024-US-024556$ANI$$$$$M$Y$$$20240812$$HP$US$US
238549272$23854927$2$F$20240201$20240620$20240514$20240705$PER$$US-SA-2024SA139031$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240705$$MD$US$US
238549302$23854930$2$F$$20240910$20240514$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074545$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$83.91$KG$20240911$$CN$US$US
238549312$23854931$2$F$$20240605$20240514$20240812$PER$$US-ANIPHARMA-2024-US-023923$ANI$$68$YR$$F$Y$$$20240812$$HP$US$US
238549422$23854942$2$F$20240101$20240703$20240514$20240716$PER$$US-SA-2024SA136896$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240716$$MD$US$US
238549453$23854945$3$F$$20240712$20240514$20240722$PER$$US-SA-2024SA139565$SANOFI AVENTIS$$$$E$M$Y$78.92$KG$20240722$$MD$US$US
238549473$23854947$3$F$20240101$20240911$20240514$20240918$PER$$US-SA-2024SA138538$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240918$$MD$US$US
238549693$23854969$3$F$20240101$20240816$20240514$20240830$PER$$US-SA-2024SA137144$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240830$$MD$US$US
238549714$23854971$4$F$$20240716$20240514$20240731$EXP$$IL-PFIZER INC-PV202400059928$PFIZER$$7$DEC$$F$Y$$$20240731$$CN$IL$IL
238549782$23854978$2$F$20240501$20240717$20240514$20240724$PER$$US-SA-2024SA135989$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240725$$MD$US$US
238549822$23854982$2$F$20240101$20240919$20240514$20240930$PER$$US-SA-2024SA138731$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240930$$MD$US$US
238549972$23854997$2$F$20231201$20240626$20240514$20240705$PER$$US-SA-2024SA139039$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240705$$MD$US$US
238550074$23855007$4$F$20240301$20240803$20240514$20240808$EXP$$US-SA-2024SA139346$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240808$$MD$US$US
238550172$23855017$2$F$20240401$20240709$20240514$20240717$PER$$US-SA-2024SA137341$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240717$$MD$US$US
238550192$23855019$2$F$20240213$20240924$20240514$20240930$EXP$$JP-009507513-2402JPN003190J$MERCK$$73$YR$$F$Y$41$KG$20240930$$MD$JP$JP
238550282$23855028$2$F$20220101$20240712$20240514$20240724$PER$$US-SA-2024SA137372$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240724$$MD$US$US
238550404$23855040$4$F$20240101$20240724$20240514$20240802$PER$$US-SA-2024SA137264$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240802$$MD$US$US
238550492$23855049$2$F$$20240628$20240514$20240708$PER$$US-SA-2024SA137777$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240708$$MD$US$US
238550522$23855052$2$F$20240101$20240905$20240514$20240917$PER$$US-SA-2024SA140294$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240918$$MD$US$US
238550635$23855063$5$F$20240101$20240806$20240514$20240813$EXP$$US-SA-2024SA139049$SANOFI AVENTIS$$51$YR$A$F$Y$127$KG$20240813$$MD$US$US
238550653$23855065$3$F$$20240725$20240514$20240730$PER$$US-SA-2024SA138754$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
238550682$23855068$2$F$20240101$20240801$20240514$20240810$PER$$US-SA-2024SA140060$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240810$$MD$US$US
238550723$23855072$3$F$20240101$20240725$20240514$20240805$PER$$US-SA-2024SA139046$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240805$$MD$US$US
238550782$23855078$2$F$$20240709$20240514$20240717$PER$$US-SA-2024SA136846$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240717$$MD$US$US
238550822$23855082$2$F$$20240813$20240514$20240827$PER$$US-SA-2024SA136152$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240827$$MD$US$US
238550872$23855087$2$F$$20240904$20240514$20240917$PER$$US-SA-2024SA139748$SANOFI AVENTIS$$$$T$M$Y$$$20240918$$MD$US$US
238550882$23855088$2$F$$20240724$20240514$20240805$PER$$US-SA-2024SA138857$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240805$$MD$US$US
238550934$23855093$4$F$20240101$20240725$20240514$20240801$PER$$US-SA-2024SA139540$SANOFI AVENTIS$$53$YR$A$F$Y$83.9$KG$20240801$$MD$US$US
238551063$23855106$3$F$$20240826$20240514$20240905$PER$$US-SA-2024SA139385$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240905$$MD$US$US
238551142$23855114$2$F$$20240710$20240514$20240723$PER$$US-SA-2024SA139661$SANOFI AVENTIS$$$$A$M$Y$$$20240723$$MD$US$US
238551163$23855116$3$F$20240101$20240716$20240514$20240724$PER$$US-SA-2024SA067823$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240724$$MD$US$US
238551354$23855135$4$F$20240101$20240718$20240514$20240728$PER$$US-SA-2024SA139472$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240728$$MD$US$US
238551366$23855136$6$F$20240101$20240712$20240514$20240801$EXP$$US-SA-2024SA141656$SANOFI AVENTIS$$66$YR$E$F$Y$54.4$KG$20240719$$MD$US$US
238551482$23855148$2$F$20240601$20240726$20240514$20240806$PER$$US-SA-2024SA138355$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240806$$MD$US$US
238551523$23855152$3$F$20240101$20240627$20240514$20240702$PER$$US-SA-2024SA141381$SANOFI AVENTIS$$95$YR$E$F$Y$$$20240702$$MD$US$US
238551672$23855167$2$F$20240916$20240916$20240514$20240922$PER$$US-SA-2024SA139444$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240923$$MD$US$US
238552133$23855213$3$F$$20240919$20240514$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073893$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240923$$HP$US$US
238552142$23855214$2$F$20240311$20240802$20240514$20240813$PER$$US-SA-2024SA141794$SANOFI AVENTIS$$24$YR$A$F$Y$78.01$KG$20240814$$MD$US$US
238552222$23855222$2$F$$20240706$20240514$20240715$PER$$US-SA-2024SA138597$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240715$$MD$US$US
238552252$23855225$2$F$20240101$20240626$20240514$20240705$PER$$US-SA-2024SA140486$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240705$$MD$US$US
238552333$23855233$3$F$20240101$20240813$20240514$20240820$PER$$US-SA-2024SA141712$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240820$$MD$US$US
238552342$23855234$2$F$$20240827$20240514$20240917$PER$$US-SA-2024SA140292$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$MD$US$US
238552432$23855243$2$F$20240101$20240724$20240514$20240801$PER$$US-SA-2024SA140855$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240801$$MD$US$US
238552513$23855251$3$F$20240101$20240717$20240514$20240725$PER$$US-SA-2024SA141638$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240725$$MD$US$US
238552563$23855256$3$F$$20240806$20240514$20240816$PER$$US-SA-2024SA140942$SANOFI AVENTIS$$2$YR$C$M$Y$13.6$KG$20240816$$CN$US$US
238552662$23855266$2$F$20240502$20240708$20240514$20240717$PER$$US-SA-2024SA133780$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240717$$MD$US$US
238552752$23855275$2$F$20240101$20240702$20240514$20240711$PER$$US-SA-2024SA139653$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240711$$MD$US$US
238552882$23855288$2$F$$20240731$20240514$20240809$PER$$US-SA-2024SA140013$SANOFI AVENTIS$$$$A$F$Y$96.145$KG$20240809$$MD$US$US
238552972$23855297$2$F$20240101$20240722$20240514$20240731$PER$$US-SA-2024SA141838$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240731$$MD$US$US
238553113$23855311$3$F$20240701$20240812$20240514$20240819$PER$$US-SA-2024SA141830$SANOFI AVENTIS$$35$YR$A$F$Y$56.69$KG$20240819$$MD$US$US
238553262$23855326$2$F$20240910$20240912$20240514$20240926$PER$$US-SA-2024SA142727$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240926$$MD$US$US
238553282$23855328$2$F$$20240715$20240514$20240723$PER$$US-SA-2024SA140547$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240723$$MD$US$US
238553342$23855334$2$F$$20240723$20240514$20240801$PER$$US-SA-2024SA144518$SANOFI AVENTIS$$64$YR$A$M$Y$98$KG$20240801$$MD$US$US
238553442$23855344$2$F$$20240801$20240514$20240808$PER$$US-SA-2024SA143343$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240808$$MD$US$US
238553732$23855373$2$F$20240101$20240726$20240514$20240806$PER$$US-SA-2024SA114186$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240806$$CN$US$US
238553802$23855380$2$F$$20240724$20240514$20240801$PER$$US-SA-2024SA144716$SANOFI AVENTIS$$59$YR$A$F$Y$136$KG$20240801$$MD$US$US
238554002$23855400$2$F$20240101$20240830$20240514$20240913$PER$$US-SA-2024SA143468$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240913$$MD$US$US
238554032$23855403$2$F$20240101$20240717$20240514$20240725$PER$$US-SA-2024SA143482$SANOFI AVENTIS$$$$$F$Y$$$20240725$$MD$US$US
238554043$23855404$3$F$20240101$20240805$20240514$20240813$PER$$US-SA-2024SA143529$SANOFI AVENTIS$$74$YR$E$F$Y$62.59$KG$20240814$$MD$US$US
238554073$23855407$3$F$20240101$20240705$20240514$20240716$PER$$US-SA-2024SA139677$SANOFI AVENTIS$$64$YR$A$M$Y$113.4$KG$20240716$$MD$US$US
238554412$23855441$2$F$20240101$20240903$20240514$20240927$PER$$US-SA-2024SA145577$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240927$$CN$US$US
238554603$23855460$3$F$$20240701$20240514$20240708$PER$$US-SA-2024SA084058$SANOFI AVENTIS$$86$YR$E$M$Y$137$KG$20240708$$MD$US$US
238554712$23855471$2$F$20240101$20240727$20240514$20240805$PER$$US-SA-2024SA136816$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240805$$MD$US$US
238554843$23855484$3$F$$20240710$20240514$20240711$EXP$$DE-ALXN-202405EEA000712DE$ALEXION PHARMACEUTICALS$$$$$F$Y$52.5$KG$20240711$$MD$DE$DE
238554964$23855496$4$F$20230612$20240909$20240514$20240916$EXP$$NVSC2024KR099607$NOVARTIS$$81$YR$$F$Y$$$20240916$$MD$KR$KR
238555022$23855502$2$F$$20240617$20240514$20240809$EXP$$MY-ROCHE-3562257$ROCHE$$$$$$Y$$$20240809$$MD$MY$MY
238555372$23855537$2$F$20240508$20240710$20240514$20240717$PER$$US-JAZZ PHARMACEUTICALS-2024-US-000831$JAZZ$$49$YR$$F$Y$$$20240717$$HP$US$US
238555505$23855550$5$F$$20240827$20240514$20240902$EXP$$GR-ABBVIE-5589832$ABBVIE$$73$YR$$F$Y$82$KG$20240902$$HP$GR$GR
238555635$23855563$5$F$20240404$20240806$20240514$20240817$EXP$$FR-VER-202400008$VERITY PHARMACEUTICALS$$70$YR$E$M$Y$80$KG$20240817$$HP$FR$FR
238555764$23855576$4$F$20240409$20240806$20240514$20240817$EXP$$CZ-VER-202400005$VERITY PHARMACEUTICALS$$53$YR$A$M$Y$80$KG$20240817$$HP$CZ$CZ
238555932$23855593$2$F$$20240723$20240514$20240801$PER$$US-SA-2024SA141707$SANOFI AVENTIS$$15$YR$T$M$Y$64$KG$20240801$$CN$US$US
238555962$23855596$2$F$$20240712$20240514$20240715$PER$$US-ALXN-202405USA000426US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238556122$23855612$2$F$$20240712$20240514$20240715$PER$$US-ALXN-202405USA000444US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238556162$23855616$2$F$$20240712$20240514$20240715$PER$$US-ALXN-202405USA000422US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
238556194$23855619$4$F$20240428$20240827$20240514$20240902$PER$$US-JNJFOC-20240504554$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240902$$CN$US$US
238556332$23855633$2$F$20240501$20240822$20240514$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202405003291$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240904$$HP$US$US
238556354$23855635$4$F$$20240909$20240514$20240923$EXP$$NVSJ2024JP005675$NOVARTIS$$$$$$Y$$$20240924$$MD$JP$JP
238556362$23855636$2$F$$20240819$20240514$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-071476$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240822$$MD$JP$JP
238556403$23855640$3$F$$20240710$20240514$20240722$EXP$JP-MLMSERVICE-20240429-PI042721-00270-1$JP-STRIDES ARCOLAB LIMITED-2024SP005536$STRIDES$Kiuchi Z, Tanaka E, Nunokawa S, Yoshida S, Hosaki A, Kogure T, et al.. Pediatric frequent relapsing nephrotic syndrome with multiple cerebral infarctions accompanied by patent foramen ovale and cerebral venous sinus thrombosis: a case report.. BMC nephrology. 2024;25(1):146$14$YR$$F$Y$42$KG$20240722$$MD$JP$JP
238556625$23855662$5$F$20230316$20240807$20240514$20240914$EXP$$US-ABBVIE-5757354$ABBVIE$$67$YR$$M$Y$115$KG$20240914$$HP$US$US
238556673$23855667$3$F$20240325$20240813$20240514$20240816$EXP$$US-JNJFOC-20240530093$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240816$$HP$US$US
238556702$23855670$2$F$20240401$20240701$20240514$20240704$EXP$JP-MMM-OF3TEV9Q$JP-GSK-JP2024059255$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$PH$JP$JP
238557003$23855700$3$F$20230920$20240628$20240514$20240703$EXP$$JP-GSK-JP2024JPN059201$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$JP$JP
238557132$23855713$2$F$$20240923$20240514$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073917$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240924$$CN$US$US
238557162$23855716$2$F$$20240624$20240514$20240710$30DAY$$US-GSK-US2024057962$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
238557224$23855722$4$F$20240101$20240820$20240514$20240826$EXP$$NVSJ2024JP005589$NOVARTIS$$52$YR$$F$Y$42$KG$20240826$$MD$JP$JP
238557272$23855727$2$F$$20240705$20240514$20240708$EXP$$NVSC2024GB086136$NOVARTIS$$$$A$F$Y$$$20240708$$CN$GB$GB
238557362$23855736$2$F$20240101$20240703$20240514$20240709$EXP$$DE-AMGEN-DEUSP2024094959$AMGEN$$$$$F$Y$$$20240709$$CN$DE$DE
238557404$23855740$4$F$20240419$20240904$20240514$20240911$EXP$$CA-BIOGEN-2024BI01264476$BIOGEN$$61$YR$$F$Y$$$20240911$$CN$CA$CA
238557483$23855748$3$F$20240415$20240629$20240514$20240704$EXP$$NVSC2024CL080118$NOVARTIS$$67$YR$$F$Y$$$20240704$$CN$CL$CL
238557652$23855765$2$F$$20240712$20240514$20240715$PER$$US-ALXN-202405USA000434US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238557682$23855768$2$F$$20240703$20240514$20240711$EXP$$PT-JNJFOC-20240524792$JOHNSON AND JOHNSON$$64$YR$A$$Y$$$20240711$$MD$PT$PT
238557812$23855781$2$F$20240401$20240911$20240514$20240917$EXP$$US-ABBVIE-5757395$ABBVIE$$57$YR$$M$Y$$$20240917$$CN$US$US
238558046$23855804$6$F$$20240913$20240515$20240918$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000973$BLUEPRINT MEDICINES$$$$$F$Y$$$20240918$$CN$US$US
238558124$23855812$4$F$20240701$20240807$20240515$20240813$EXP$$US-ABBVIE-5757375$ABBVIE$$85$YR$$M$Y$$$20240813$$CN$US$US
238558284$23855828$4$F$20240101$20240722$20240515$20240731$PER$$US-SA-2024SA144919$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240731$$MD$US$US
238558423$23855842$3$F$20240506$20240614$20240515$20240702$30DAY$$AE-JNJFOC-20240525854$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240702$$CN$AE$AE
238558592$23855859$2$F$20230101$20240905$20240515$20240913$EXP$$JP-009507513-2405JPN000401J$MERCK$$49$YR$$F$Y$$$20240913$$MD$JP$JP
238558612$23855861$2$F$$20240921$20240515$20240925$PER$$NVSC2024US098386$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
238558672$23855867$2$F$$20240905$20240515$20240918$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-071033$BRISTOL MYERS SQUIBB$Cattaneo D, Pagano S, Beltrami M, Micheli V, Gervasoni C. Potential association between chia seeds use and low atazanavir trough concentrations in an HIV-infected patient. European Journal of Clinical Pharmacology. 2023 Jun 19;79(8):1145-6. doi:10.1007/s00228-023-03524-1.$60$YR$A$M$Y$$$20240918$$HP$IT$IT
238558812$23855881$2$F$20240801$20240819$20240515$20240828$PER$$US-SA-2024SA144972$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240828$$MD$US$US
238559043$23855904$3$F$$20240907$20240515$20240911$PER$$NVSC2024US097708$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
238559172$23855917$2$F$20240304$20240809$20240515$20240823$EXP$$US-NOVOPROD-1219963$NOVO NORDISK$$71$YR$$M$Y$$$20240823$$CN$US$US
238559552$23855955$2$F$$20240718$20240515$20240720$EXP$$NVSC2024US098248$NOVARTIS$$$$A$$Y$$$20240719$$MD$US$US
2385596513$23855965$13$F$20240101$20240923$20240515$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014025$UNITED THERAPEUTICS$$$$$F$Y$66.213$KG$20240927$$$US$US
238559882$23855988$2$F$20240406$20240916$20240515$20240922$EXP$$US-BIOGEN-2024BI01264474$BIOGEN$$75$YR$$F$Y$$$20240922$$CN$US$US
238560072$23856007$2$F$$20240802$20240515$20240806$EXP$$US-ABBVIE-5757705$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
238560133$23856013$3$F$$20240707$20240515$20240709$EXP$$AU-ALXN-202404OCE002071AU$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$MD$AU$AU
238560155$23856015$5$F$20240701$20240801$20240515$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-004648$UNITED THERAPEUTICS$$78$YR$$F$Y$$$20240810$$$US$US
238560205$23856020$5$F$20240509$20240702$20240515$20240705$PER$$US-UNITED THERAPEUTICS-UNT-2024-007812$UNITED THERAPEUTICS$$71$YR$$F$Y$63.946$KG$20240705$$$US$US
238560235$23856023$5$F$20231101$20240913$20240515$20240917$EXP$$US-GSK-US2024059791$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$US$US
238560282$23856028$2$F$$20240731$20240515$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-014058$UNITED THERAPEUTICS$$$$$F$Y$$$20240806$$$US$US
238560402$23856040$2$F$$20240625$20240515$20240702$30DAY$$US-GSK-US2024057394$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
238560462$23856046$2$F$20230101$20240814$20240515$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071694$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240814$$CN$US$US
238560756$23856075$6$F$20240507$20240715$20240515$20240726$PER$$US-AMGEN-USASP2024091355$AMGEN$$70$YR$E$F$Y$$$20240726$$PH$US$US
238560994$23856099$4$F$20231101$20240705$20240515$20240711$EXP$$GB-EMD Serono-2024023539$EMD SERONO INC$$57$YR$A$F$Y$$$20240711$$CN$GB$GB
238561233$23856123$3$F$$20240905$20240515$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074095$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$81.19$KG$20240912$$HP$US$US
238561373$23856137$3$F$$20240819$20240515$20240820$EXP$$US-ROCHE-3559097$ROCHE$$$$E$F$Y$53.52$KG$20240820$$CN$US$US
238561482$23856148$2$F$20240426$20240625$20240515$20240702$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-107116$ZYDUS PHARM$$$$$$Y$$$20240702$$HP$US$US
238561502$23856150$2$F$$20240703$20240515$20240708$EXP$$CA-TAKEDA-2024TUS046517$TAKEDA$$$$$M$Y$$$20240708$$CN$CA$CA
238562054$23856205$4$F$$20240826$20240515$20240828$EXP$$CA-SANDOZ INC.-NVSC2022CA053513$SANDOZ$$$$$F$Y$$$20240828$$CN$CA$CA
238562173$23856217$3$F$20240101$20240426$20240515$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000069$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$CN$US$US
238562236$23856223$6$F$$20240815$20240515$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-073690$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$52.7$KG$20240826$$MD$JP$JP
238562412$23856241$2$F$20240303$20240430$20240515$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000083$Tarsus Pharmaceuticals$$61$YR$$M$Y$$$20240806$$MD$US$US
238562542$23856254$2$F$20240301$20240425$20240515$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000088$Tarsus Pharmaceuticals$$88$YR$$M$Y$$$20240806$$PH$US$US
238562652$23856265$2$F$20240201$20240625$20240515$20240702$EXP$$AR-AMGEN-ARGSP2024094640$AMGEN$$52$YR$A$F$Y$$$20240702$$CN$AR$AR
238562972$23856297$2$F$$20240721$20240515$20240725$EXP$$NVSC2024HU100155$NOVARTIS$$$$$$Y$$$20240725$$MD$HU$HU
238563073$23856307$3$F$$20240802$20240515$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074481$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240808$$CN$US$US
238563104$23856310$4$F$20240426$20240711$20240515$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202405007085$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240716$$CN$US$US
238563154$23856315$4$F$20240507$20240818$20240515$20240822$30DAY$$US-SANDOZ INC.-SDZ2024US046516$SANDOZ$$63$YR$$F$Y$$$20240822$$CN$US$US
238563242$23856324$2$F$20240101$20240711$20240515$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03873$LUPIN$$$$$$Y$$$20240809$$CN$US$US
238563292$23856329$2$F$20240101$20240813$20240515$20240814$EXP$$US-JNJFOC-20240524645$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240814$$MD$US$US
238563524$23856352$4$F$20240101$20240925$20240515$20240930$PER$$US-BIOGEN-2024BI01263035$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
238563602$23856360$2$F$$20240614$20240515$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002011$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
238563632$23856363$2$F$$20240715$20240515$20240715$PER$$US-ALXN-202405USA000584US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240715$$CN$US$US
238563682$23856368$2$F$$20240708$20240515$20240712$PER$$US-BEH-2024171700$CSL BEHRING$$$$$$Y$$$20240712$$MD$US$US
238563823$23856382$3$F$20240501$20240911$20240515$20240925$PER$$US-GSK-US2024058416$GLAXOSMITHKLINE$$44$YR$$M$Y$$$20240925$$CN$US$US
238563852$23856385$2$F$$20240709$20240515$20240718$30DAY$$US-GSK-US2024059013$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
238563892$23856389$2$F$$20240715$20240515$20240725$PER$$US-RDY-SPO/USA/24/0006987$DR REDDYS$$24$YR$A$F$Y$$$20240725$$MD$US$US
238563902$23856390$2$F$$20240627$20240515$20240708$PER$$US-RDY-SPO/USA/24/0006948$DR REDDYS$$86$YR$E$M$Y$$$20240708$$CN$US$US
238563942$23856394$2$F$20240408$20240812$20240515$20240821$EXP$$CA-ABBVIE-5760524$ABBVIE$$85$YR$$F$Y$$$20240821$$HP$CA$CA
238564022$23856402$2$F$20221201$20240705$20240515$20240713$EXP$$HR-CELLTRION INC.-2024HR011108$CELLTRION$$$$$$Y$$$20240713$$MD$HR$HR
238564073$23856407$3$F$$20240802$20240515$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074486$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$94.35$KG$20240805$$CN$US$US
238564223$23856422$3$F$$20240621$20240515$20240702$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01591$AMNEAL$$$$$M$Y$2.02$KG$20240702$$HP$US$US
238564517$23856451$7$F$20240507$20240913$20240515$20240923$EXP$$CA-CELLTRION INC.-2024CA011211$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
238564534$23856453$4$F$$20240621$20240515$20240702$EXP$$US-QILU PHARMACEUTICAL CO.LTD.-QLU-000049-2024$QILU PHARMACEUTICAL$$$$I$M$Y$2.02$KG$20240702$$HP$US$US
238564723$23856472$3$F$$20240620$20240515$20240709$PER$$US-AstraZeneca-2024A104723$ASTRAZENECA$$$$$M$Y$$$20240709$$CN$US$
238564752$23856475$2$F$20240416$20240830$20240515$20240919$30DAY$$US-BECTON DICKINSON-US-BD-24-000261$BECTON DICKINSON$$$$$$Y$$$20240919$$HP$US$US
238564822$23856482$2$F$$20240725$20240515$20240726$PER$$NVSC2024US100194$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
238564843$23856484$3$F$$20240712$20240515$20240717$PER$$US-ROCHE-3562707$ROCHE$$$$E$F$Y$40.82$KG$20240717$$CN$US$US
238564854$23856485$4$F$20240503$20240723$20240515$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-013947$UNITED THERAPEUTICS$$42$YR$$M$Y$86.168$KG$20240727$$$US$US
238565036$23856503$6$F$20240720$20240920$20240515$20240927$EXP$$CA-GSK-CA2024059645$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$CA$CA
238565062$23856506$2$F$$20240709$20240515$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA048266$SANDOZ$$40$YR$$F$Y$96$KG$20240710$$HP$CA$CA
238565133$23856513$3$F$$20240816$20240515$20240821$PER$$NVSC2024US102117$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
238565142$23856514$2$F$$20240712$20240515$20240719$EXP$$BR-ABBVIE-5760281$ABBVIE$$9$YR$$M$Y$36$KG$20240719$$CN$BR$BR
238565254$23856525$4$F$20240101$20240822$20240515$20240830$EXP$$CA-CELLTRION INC.-2024CA011057$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
238565404$23856540$4$F$20231001$20240830$20240515$20240906$EXP$$JP-009507513-2310JPN003795J$MERCK$$7$DEC$$M$Y$$$20240906$$MD$JP$JP
238565513$23856551$3$F$20240327$20240628$20240515$20240701$EXP$$JP-GSK-JP2024060834$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$JP$JP
238565545$23856554$5$F$20240101$20240716$20240515$20240724$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013548$UNITED THERAPEUTICS$$$$$F$Y$174.15$KG$20240724$$$US$US
238565583$23856558$3$F$20240301$20240826$20240515$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202405006902$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240828$$CN$US$US
238565642$23856564$2$F$20220101$20240813$20240515$20240821$EXP$$CA-CELLTRION INC.-2022CA012804$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
238565653$23856565$3$F$$20240715$20240515$20240729$EXP$$US-CIPLA LTD.-2024US04635$CIPLA$Zardoost P, Buckman Z, Weaver J, Elston S, Prouty A, Stuart R et al. Continuous renal replacement therapy for Lithium toxicity: A worthy treatment to avoid intradialytic hypotension and vasopressors.. Clinical Case Reports. 2024;12(4):e8775:1 to 4$$$$$Y$$$20240729$$MD$US$US
238565712$23856571$2$F$$20240726$20240515$20240726$PER$$NVSC2024US102197$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
238565837$23856583$7$F$20240416$20240920$20240515$20240924$EXP$$JP-GSK-JP2024JPN059905$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
238565924$23856592$4$F$20240114$20240710$20240515$20240717$30DAY$$US-AMGEN-USASL2024094669$AMGEN$$71$YR$E$F$Y$$$20240717$$HP$US$US
238565993$23856599$3$F$20230320$20240813$20240515$20240820$EXP$$JP-EXELIXIS-CABO-24077241$EXELIXIS$$70$YR$$M$Y$68.8$KG$20240820$$PH$JP$JP
238566002$23856600$2$F$20240430$20240716$20240515$20240723$EXP$$JP-EXELIXIS-CABO-24077238$EXELIXIS$$$$$M$Y$$$20240723$$MD$JP$JP
238566083$23856608$3$F$$20240812$20240515$20240813$EXP$$US-TAKEDA-2024TUS044821$TAKEDA$$$$$F$Y$$$20240813$$CN$US$US
238566292$23856629$2$F$20240401$20240722$20240515$20240723$EXP$$NVSC2024SI100764$NOVARTIS$$$$A$F$Y$$$20240723$$MD$SI$SI
238566326$23856632$6$F$20230125$20240912$20240515$20240920$EXP$$CA-CELLTRION INC.-2024CA003721$CELLTRION$$$$$$Y$$$20240920$$CN$CA$CA
238566402$23856640$2$F$$20240712$20240515$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074672$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240716$$CN$US$US
238566513$23856651$3$F$20240524$20240723$20240515$20240730$EXP$$CA-TAKEDA-2024TUS047307$TAKEDA$$58$YR$$F$Y$$$20240730$$CN$CA$CA
238566543$23856654$3$F$20240101$20240716$20240515$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-014112$UNITED THERAPEUTICS$$$$$F$Y$79.365$KG$20240723$$$US$US
238566572$23856657$2$F$$20240912$20240515$20240916$EXP$$PH-TAKEDA-2024TUS046588$TAKEDA$$$$$F$Y$$$20240916$$MD$PH$PH
238566658$23856665$8$F$20240501$20240726$20240515$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-014234$UNITED THERAPEUTICS$$48$YR$$F$Y$65.76$KG$20240731$$$US$US
238566663$23856666$3$F$$20240830$20240515$20240909$EXP$FR-AFSSAPS-DJ2024000671$FR-ROCHE-3559262$ROCHE$$78$YR$E$M$Y$$$20240909$$MD$FR$FR
238566684$23856668$4$F$20240507$20240723$20240515$20240730$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014267$UNITED THERAPEUTICS$$49$YR$$F$Y$92.971$KG$20240730$$$US$US
238566733$23856673$3$F$$20240906$20240515$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074198$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$82.55$KG$20240910$$CN$US$US
238566823$23856682$3$F$$20240918$20240515$20240925$EXP$$CA-TAKEDA-2024TUS045764$TAKEDA$$$$$M$Y$$$20240925$$MD$CA$CA
238567062$23856706$2$F$20210325$20240821$20240515$20240828$EXP$$US-CHIESI-2024CHF02690$CHIESI$$70$YR$$M$Y$68.4$KG$20240828$$CN$US$US
238567142$23856714$2$F$$20240516$20240515$20240812$EXP$$US-GRAVITIPHARMA-GRA-2402-US-SPO-0016$GRAVITI PHARMACEUTICALS$$74$YR$E$F$Y$62.14$KG$20240812$$PH$US$US
238567192$23856719$2$F$20240426$20240625$20240515$20240710$PER$$US-AstraZeneca-2024A100933$ASTRAZENECA$$28229$DY$$F$Y$$$20240710$$CN$US$
238567272$23856727$2$F$20240709$20240812$20240515$20240815$PER$$CN-REGENERON PHARMACEUTICALS, INC.-2024-071739$REGENERON$$71$YR$$M$Y$$$20240815$$HP$CN$CN
238567305$23856730$5$F$$20240916$20240515$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074788$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240918$$CN$US$US
238567344$23856734$4$F$$20240909$20240515$20240924$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-446411$RANBAXY$Pinci C, Bianciardi E, Sferra I, Castellani G, Santini R, Siracusano A, et al. Switching from paliperidone palmitate 3-monthly long-acting injection to oral aripiprazole in a pregnant woman with schizophrenia: a case report and short review. Riv Psichiatr. 2024;59 (2):75-79$30$YR$$F$Y$$$20240924$$HP$IT$IT
238567392$23856739$2$F$$20240913$20240515$20240927$EXP$$MA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-446376$RANBAXY$Lakhal I, Ait Oussous S, Kherbach H, Boutaggount F, Mokfi R, Ait El Hadj F, et al. Capecitabine induced Steven-Johnson syndrome: A case report with literature review. Rev Fr Allergol. 2024;64 (3)$49$YR$$M$Y$$$20240927$$HP$MA$MA
238567722$23856772$2$F$$20240829$20240515$20240902$EXP$$CA-TAKEDA-2022TUS046404$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
238567812$23856781$2$F$20240101$20240712$20240515$20240717$EXP$$US-SA-2024SA144740$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240717$$MD$US$US
238567872$23856787$2$F$$20240917$20240515$20240927$PER$$US-GSK-US2024058433$GLAXOSMITHKLINE$$$$$M$Y$$$20240927$$CN$US$US
238567902$23856790$2$F$$20240523$20240515$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090698$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
238567923$23856792$3$F$20240101$20240827$20240515$20240911$EXP$$US-SA-2024SA145708$SANOFI AVENTIS$$70$YR$E$M$Y$70.3$KG$20240911$$MD$US$US
238567962$23856796$2$F$20230101$20240708$20240515$20240713$EXP$$AU-SA-2024SA145429$SANOFI AVENTIS$$41$YR$A$F$Y$126$KG$20240713$$MD$AU$AU
238567972$23856797$2$F$20240308$20240712$20240515$20240716$EXP$$NVSC2024US102131$NOVARTIS$$45$YR$$F$Y$$$20240716$$CN$US$US
238568072$23856807$2$F$20240301$20240704$20240515$20240712$EXP$$CA-CELLTRION INC.-2023CA025106$CELLTRION$$$$$$Y$$$20240712$$MD$CA$CA
238568345$23856834$5$F$20240101$20240722$20240515$20240806$EXP$$US-INSMED, INC.-2024-01034-US$INSMED$$$$$F$Y$$$20240806$$CN$US$US
238568393$23856839$3$F$$20240822$20240515$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074079$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240826$$CN$US$US
238568633$23856863$3$F$$20240813$20240515$20240813$EXP$$US-JNJFOC-20240524835$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240813$$HP$US$US
238568682$23856868$2$F$20240101$20240607$20240515$20240822$PER$$US-CHIESI-2024CHF01523$CHIESI$$48$YR$$M$Y$$$20240822$$CN$US$US
238568712$23856871$2$F$20240301$20240515$20240515$20240822$PER$$US-CHIESI-2024CHF02349$CHIESI$$42$YR$$F$Y$$$20240822$$CN$US$US
238568774$23856877$4$F$20230101$20240903$20240515$20240918$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-09545$ALKEM$$$$A$F$Y$$$20240918$$MD$DE$DE
238568993$23856899$3$F$$20240909$20240515$20240917$EXP$$CA-APOTEX-2024AP005675$APOTEX$$58$YR$$M$Y$$$20240917$$HP$CA$CA
238569015$23856901$5$F$20240401$20240923$20240515$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074869$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240925$$CN$US$US
238569032$23856903$2$F$20231001$20240706$20240515$20240715$EXP$$JP-009507513-2405JPN000576J$MERCK$$79$YR$$F$Y$47.8$KG$20240715$$MD$JP$JP
238569272$23856927$2$F$$20240711$20240515$20240722$EXP$$CA-SPECGX-T202401076$SPECGX$$35$YR$$F$Y$$$20240722$$MD$CA$CA
238569342$23856934$2$F$$20240718$20240515$20240720$EXP$$NVSC2024US098426$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
238569353$23856935$3$F$20240507$20240521$20240515$20240717$PER$$NVSC2024US102081$NOVARTIS$$64$YR$$F$Y$83.91$KG$20240717$$CN$US$US
238569412$23856941$2$F$20231220$20240626$20240515$20240823$PER$$US-CHIESI-2024CHF02420$CHIESI$$41$YR$$M$Y$$$20240823$$CN$US$US
238569442$23856944$2$F$20240612$20240621$20240515$20240822$PER$$US-CHIESI-2024CHF02741$CHIESI$$18$YR$$F$Y$$$20240822$$MD$US$US
238569522$23856952$2$F$20240411$20240708$20240515$20240717$EXP$ES-AEMPS-1517055$ES-ASTELLAS-2024EU004564$ASTELLAS$$2$YR$$F$Y$$$20240717$$MD$ES$ES
238569563$23856956$3$F$20230101$20240708$20240515$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202405007397$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240710$$CN$US$US
238569703$23856970$3$F$20210420$20240806$20240515$20240810$EXP$$MX-TAKEDA-2021TUS026943$TAKEDA$$5$YR$$M$Y$$$20240810$$CN$MX$MX
238569712$23856971$2$F$20240504$20240626$20240515$20240701$EXP$$JP-ASTELLAS-2024JP003054$ASTELLAS$$95$YR$$F$Y$$$20240701$$PH$JP$JP
238569752$23856975$2$F$20240101$20240705$20240515$20240715$EXP$$CA-CELLTRION INC.-2024CA011098$CELLTRION$$$$$$Y$$$20240715$$HP$CA$CA
238569867$23856986$7$F$20240507$20240807$20240515$20240813$EXP$$US-TAKEDA-2024TUS045741$TAKEDA$$76$YR$$F$Y$64$KG$20240813$$HP$US$US
238569932$23856993$2$F$$20240710$20240515$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074858$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240712$$CN$US$US
238569962$23856996$2$F$$20240803$20240515$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074836$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$98.43$KG$20240806$$CN$US$US
238569983$23856998$3$F$$20240820$20240515$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074865$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240823$$CN$US$US
238570072$23857007$2$F$20240101$20240911$20240515$20240925$EXP$$CA-AMGEN-CANSP2024094798$AMGEN$$$$$$Y$$$20240924$$MD$CA$CA
238570214$23857021$4$F$$20240715$20240515$20240718$EXP$$NVSC2024CA101313$NOVARTIS$$59$YR$$M$Y$$$20240718$$HP$CA$CA
238570232$23857023$2$F$$20240918$20240515$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074933$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240918$$CN$US$US
238570574$23857057$4$F$20240328$20240715$20240515$20240730$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-07210$ALKEM$$70$YR$$F$Y$$$20240730$$CN$US$US
238570624$23857062$4$F$20240501$20240829$20240515$20240903$EXP$$CA-ABBVIE-5760162$ABBVIE$$62$YR$$F$Y$$$20240903$$CN$CA$CA
238570642$23857064$2$F$20240410$20240503$20240515$20240731$PER$$US-BAYER-2024A066473$BAYER$$34$YR$A$F$Y$$$20240731$$HP$US$US
238570732$23857073$2$F$$20240916$20240515$20240916$PER$$US-ALXN-202405USA000459US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
238571023$23857102$3$F$20240301$20240701$20240515$20240708$EXP$$JP-009507513-2403JPN002394J$MERCK$$61$YR$$F$Y$$$20240708$$MD$JP$JP
238571035$23857103$5$F$20240101$20240911$20240515$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011083$UNITED THERAPEUTICS$$$$$F$Y$82.54$KG$20240921$$$US$US
238571102$23857110$2$F$20111116$20240715$20240515$20240722$EXP$US-EMA-20150624-AUTODUP-440363$US-TAKEDA-2024TUS046638$TAKEDA$$54$YR$$F$Y$56$KG$20240722$$HP$US$US
238571412$23857141$2$F$20240512$20240718$20240515$20240726$30DAY$$US-GSK-US2024060301$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240726$$MD$US$US
238571453$23857145$3$F$20240101$20240731$20240515$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075197$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240801$$HP$US$US
238571563$23857156$3$F$20240401$20240725$20240515$20240812$EXP$$US-BEH-2024171865$CSL BEHRING$$65$YR$E$M$Y$$$20240811$$HP$US$US
238571742$23857174$2$F$$20240719$20240515$20240724$PER$$NVSC2024US100137$NOVARTIS$$65$YR$$M$Y$$$20240724$$HP$US$US
238571824$23857182$4$F$$20240709$20240515$20240717$EXP$$JP-ABBVIE-5754453$ABBVIE$$80$YR$$M$Y$$$20240717$$CN$JP$JP
238571852$23857185$2$F$$20240813$20240515$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074844$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240813$$CN$US$US
238572182$23857218$2$F$$20240620$20240515$20240704$30DAY$$US-GSK-US2024057423$GLAXOSMITHKLINE$$$$$M$Y$$$20240704$$CN$US$US
238572232$23857223$2$F$$20240708$20240515$20240717$EXP$JP-MLMSERVICE-20240429-PI042726-00270-1$JP-STRIDES ARCOLAB LIMITED-2024SP005537$STRIDES$Nakanoh H, Takeuchi H, Shiho M, Terajima Y, Okamoto S, Onishi Y, et al.. Successful treatment for life threatening recurrent non-traumatic rectus sheath hematoma in a case with microscopic polyangiitis with rapidly progressive glomerulonephritis.. Internal medicine (Tokyo, Japan). 2024;3239-23$68$YR$$F$Y$$$20240717$$MD$JP$JP
238572392$23857239$2$F$20240401$20240708$20240515$20240709$EXP$$NVSC2024PL100807$NOVARTIS$$54$YR$$M$Y$$$20240709$$MD$PL$PL
238572422$23857242$2$F$$20240626$20240515$20240705$EXP$$US-SA-2024SA104660$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240705$$PH$US$US
238572472$23857247$2$F$20240319$20240712$20240515$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-022035$AUROBINDO$$85$YR$$M$Y$64$KG$20240722$$MD$FR$FR
238572706$23857270$6$F$20240101$20240719$20240515$20240724$EXP$$JP-JNJFOC-20240372701$JOHNSON AND JOHNSON$$79$YR$E$M$Y$79$KG$20240724$$$COUNTRY NOT SPECIFIED$JP
238573312$23857331$2$F$20240101$20240814$20240515$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074918$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240814$$HP$US$US
238573433$23857343$3$F$$20240627$20240515$20240912$EXP$$US-AUROBINDO-AUR-APL-2024-023261$AUROBINDO$Hartog N, Duffner U, Holsworth A, Stingl C, Fogg G, Rossetti L, et al. 182 Inherited POMP-Related Autoinflammation and Immune Dysregulation Disease Treated with Baricitinib Prior to Hematopoietic Stem Cell Transplant. Clin-Immunol. 2024;262S:110124$6$MON$$F$Y$$$20240912$$MD$US$US
238573453$23857345$3$F$$20240719$20240515$20240722$EXP$$NVSC2024CH100070$NOVARTIS$$$$$$Y$$$20240722$$MD$CH$CH
238573513$23857351$3$F$20220922$20240729$20240515$20240805$EXP$$US-AMGEN-USASP2024093170$AMGEN$$75$YR$E$M$Y$$$20240805$$MD$US$US
238573547$23857354$7$F$$20240920$20240515$20240924$EXP$$GB-PFIZER INC-PV202400061916$PFIZER$$48$YR$$F$Y$$$20240924$$CN$GB$GB
238573553$23857355$3$F$20240427$20240814$20240515$20240814$EXP$$CA-PFIZER INC-202400097756$PFIZER$$68$YR$$M$Y$$$20240814$$HP$CA$CA
238573683$23857368$3$F$20240101$20240815$20240515$20240906$PER$$NI-TOLMAR, INC.-24NI047976$TOLMAR$$9$YR$$F$Y$$$20240905$$HP$NI$NI
238573822$23857382$2$F$20240416$20240702$20240515$20240813$PER$$TR-TOLMAR, INC.-24TR048598$TOLMAR$$75$YR$$M$Y$$$20240813$$MD$TR$TR
238573902$23857390$2$F$20231226$20240904$20240515$20240911$EXP$$CA-AMERICAN REGENT INC-2024001726$AMERICAN REGENT$$24$YR$$M$Y$$$20240911$$HP$CA$CA
238574263$23857426$3$F$20240101$20240910$20240515$20240913$EXP$$CA-PFIZER INC-202300357935$PFIZER$$89$YR$$F$Y$$$20240913$$MD$CA$CA
238574322$23857432$2$F$20240310$20240629$20240515$20240711$EXP$IT-MINISAL02-982390$IT-Accord-423982$ACCORD$$88$YR$E$F$Y$55$KG$20240711$$MD$IT$IT
238574402$23857440$2$F$$20240709$20240515$20240730$PER$$AU-TOLMAR, INC.-24AU048557$TOLMAR$$$$$M$Y$$$20240730$$CN$AU$AU
238574503$23857450$3$F$20240201$20240711$20240515$20240717$EXP$$CA-AMGEN-CANSL2024006352$AMGEN$$74$YR$E$M$Y$$$20240717$$HP$CA$CA
238574522$23857452$2$F$$20240704$20240515$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03899$LUPIN$$$$$$Y$$$20240728$$PH$US$US
238574532$23857453$2$F$$20240704$20240515$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03879$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238574623$23857462$3$F$$20240814$20240515$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074852$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240814$$CN$US$US
238574722$23857472$2$F$20240204$20240515$20240515$20240802$PER$$US-FDC-2024USSPO00366$FDC LIMITED$$78$YR$E$F$Y$120$KG$20240802$$CN$US$US
238574734$23857473$4$F$20240401$20240628$20240515$20240708$30DAY$$US-GSK-US2024057885$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240708$$CN$US$US
238574932$23857493$2$F$20240110$20240904$20240515$20240912$EXP$$CA-AMERICAN REGENT INC-2024001728$AMERICAN REGENT$$36$YR$$F$Y$$$20240912$$HP$CA$CA
238575386$23857538$6$F$$20240729$20240515$20240806$30DAY$$US-GSK-US2024059043$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$CN$US$US
238575412$23857541$2$F$$20240624$20240515$20240704$30DAY$$US-GSK-US2024058565$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
238575665$23857566$5$F$$20240924$20240515$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202405007059$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240926$$MD$US$US
238575852$23857585$2$F$$20240807$20240515$20240822$PER$$US-LEADINGPHARMA-US-2024LEASPO00141$LEADING PHARMA$$$$$$Y$$$20240822$$CN$US$US
238576405$23857640$5$F$$20240712$20240515$20240716$EXP$$CL-JNJFOC-20240526315$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240716$$CN$CL$CL
238576782$23857678$2$F$$20240821$20240515$20240823$PER$$NVSC2024US100039$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
238577013$23857701$3$F$20230901$20240903$20240515$20240916$PER$$US-Kiniksa Pharmaceuticals Ltd.-2023KPU000862$KINIKSA PHARMACEUTICALS$$71$YR$E$F$Y$$$20240912$$CN$US$US
238577322$23857732$2$F$20240401$20240711$20240515$20240715$EXP$$US-UCBSA-2024023679$UCB$$62$YR$$F$Y$$$20240715$$HP$US$US
238577402$23857740$2$F$20240601$20240708$20240515$20240718$EXP$$US-ELI_LILLY_AND_COMPANY-US202405006367$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240718$$CN$US$US
238577742$23857774$2$F$$20240910$20240515$20240925$EXP$$CA-HLS-202401207$HLS THERAPEUTICS$$64$YR$A$M$Y$$$20240925$$MD$CA$CA
238578112$23857811$2$F$20230928$20240715$20240515$20240730$EXP$$CH-BEH-2023166651$CSL BEHRING$$66$YR$E$M$Y$88$KG$20240730$$MD$CH$CH
238578125$23857812$5$F$20231124$20240830$20240515$20240909$EXP$$CA-CELLTRION INC.-2023CA024327$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
238579023$23857902$3$F$$20240704$20240515$20240711$EXP$$CA-JNJFOC-20240519201$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240711$$CN$CA$CA
238579032$23857903$2$F$$20240610$20240515$20240703$30DAY$$IL-JNJFOC-20240532408$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$IL$IL
238579292$23857929$2$F$20240514$20240514$20240515$20240717$PER$$US-HALEON-2175206$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
238579442$23857944$2$F$$20240620$20240515$20240702$30DAY$$CL-JNJFOC-20240531145$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$CL$CL
238579613$23857961$3$F$$20240704$20240515$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03877$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238579764$23857976$4$F$$20240624$20240515$20240701$PER$$US-PFIZER INC-PV202300159426$PFIZER$$73$YR$$F$Y$72.57$KG$20240701$$CN$US$US
238579825$23857982$5$F$20240506$20240809$20240515$20240809$PER$$US-PFIZER INC-202400104775$PFIZER$$52$YR$$M$Y$92$KG$20240809$$HP$US$US
238580103$23858010$3$F$20240504$20240704$20240515$20240710$EXP$$JP-AMGEN-JPNSP2024093675$AMGEN$$59$YR$A$F$Y$$$20240710$$MD$JP$JP
238580185$23858018$5$F$20240918$20240919$20240515$20240927$EXP$$IN-VANTIVE-2024VAN016935$Vantive US Healthcare$$72$YR$$M$Y$$$20240927$$CN$IN$IN
238580386$23858038$6$F$$20240809$20240515$20240816$EXP$$CA-GSK-CA2024043370$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$CA$CA
238580495$23858049$5$F$$20240624$20240515$20240702$EXP$$CA-TAKEDA-2024TUS045493$TAKEDA$$$$$F$Y$$$20240702$$HP$CA$CA
238581152$23858115$2$F$20240513$20240802$20240515$20240812$PER$$US-AMGEN-USASP2024095038$AMGEN$$76$YR$E$F$Y$$$20240812$$CN$US$US
238581232$23858123$2$F$$20240801$20240515$20240808$EXP$$FR-MYLANLABS-2024M1042040$MYLAN$Martin M, Hill C, Bewley S, MacLennan AH, Braillon A. Transgenerational adverse effects of valproate? A patient report from 90 affected families.. Birth Defects Research. 2022;114(1):13?6$$$C$M$Y$$$20240808$$HP$FR$FR
238581322$23858132$2$F$$20240827$20240515$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-022225$AUROBINDO$$87$YR$$M$Y$$$20240906$$HP$CA$CA
238581453$23858145$3$F$20240907$20240919$20240515$20240923$EXP$$US-SA-2024SA145928$SANOFI AVENTIS$$91$YR$E$M$Y$$$20240923$$MD$US$US
238581565$23858156$5$F$20240511$20240817$20240515$20240821$PER$$US-AMGEN-USASP2024095905$AMGEN$$73$YR$E$M$Y$$$20240821$$CN$US$US
238581596$23858159$6$F$20240101$20240911$20240515$20240913$30DAY$$US-PFIZER INC-202400106760$PFIZER$$12$YR$$F$Y$30.84$KG$20240913$$CN$US$US
238581626$23858162$6$F$$20240812$20240515$20240816$30DAY$$US-PFIZER INC-PV202400060959$PFIZER$$$$$$Y$$$20240816$$HP$US$US
238581874$23858187$4$F$20240101$20240702$20240515$20240705$30DAY$$GR-PFIZER INC-202400105427$PFIZER$$$$A$F$Y$$$20240705$$CN$GR$GR
238581972$23858197$2$F$$20240704$20240515$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03878$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238582002$23858200$2$F$20231127$20240709$20240515$20240718$EXP$$DE-MYLANLABS-2024M1042257$MYLAN$$35$YR$$F$Y$$$20240718$$MD$DE$DE
238582122$23858212$2$F$$20240813$20240515$20240813$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-074454$BRISTOL MYERS SQUIBB$$4$DEC$A$$Y$$$20240813$$MD$JP$JP
238582132$23858213$2$F$$20240712$20240515$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074605$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240715$$CN$US$US
2385822310$23858223$10$F$20240423$20240823$20240515$20240827$EXP$$JP-DSJP-DSJ-2024-120208$DAIICHI$$74$YR$$F$Y$46$KG$20240827$$MD$JP$JP
238582252$23858225$2$F$$20240702$20240515$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03880$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238582494$23858249$4$F$20240324$20240710$20240515$20240716$EXP$$ES-AUROBINDO-AUR-APL-2024-022726$AUROBINDO$$82$YR$$F$Y$64.2$KG$20240716$$MD$ES$ES
238582612$23858261$2$F$$20240814$20240515$20240819$PER$$US-PFIZER INC-202400106639$PFIZER$$34$YR$$M$Y$72.57$KG$20240819$$CN$US$US
238582853$23858285$3$F$20240501$20240722$20240515$20240724$PER$$US-PFIZER INC-202400107833$PFIZER$$60$YR$$M$Y$$$20240724$$HP$US$US
238583283$23858328$3$F$$20240701$20240515$20240709$EXP$$ES-MYLANLABS-2024M1042502$MYLAN$Sanchez FM, Labrador CG, Becerra LW, Fernandez BA, Aguilar AP, Castano-Milla C.. Active microscopic colitis precipitated by fluoxetine.. Revista espanola de enfermedades digestivas.. 2024;1$41$YR$$F$Y$$$20240709$$HP$ES$ES
238583323$23858332$3$F$$20240812$20240515$20240827$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446186$RANBAXY$Ota T, Yoshida K, Suzuki Y,Kuroda K, Kimura T. A case of lithium intoxication with reversible parkinsonism. Rinsho Shinkeigaku. 2023;63 (6):382 -385$73$YR$$M$Y$58$KG$20240827$$MD$JP$JP
238583472$23858347$2$F$$20240627$20240515$20240701$EXP$$DE-PFIZER INC-202400108034$PFIZER$$89$YR$$$Y$50$KG$20240701$$MD$DE$DE
238583943$23858394$3$F$$20240827$20240515$20240831$EXP$$NVSC2024AU102327$NOVARTIS$$$$$M$Y$$$20240831$$HP$AU$AU
238584072$23858407$2$F$20230101$20240816$20240515$20240820$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-004753$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240820$$MD$CA$CA
238584093$23858409$3$F$20240401$20240912$20240515$20240917$EXP$$AR-PFIZER INC-202400100106$PFIZER$$41$YR$$F$Y$$$20240917$$CN$AR$AR
238584103$23858410$3$F$$20240710$20240515$20240710$EXP$$CA-PFIZER INC-202400106799$PFIZER$$63$YR$$M$Y$$$20240710$$MD$CA$CA
238584163$23858416$3$F$$20240730$20240515$20240808$EXP$$AU-GENERIC HEALTH PTY. LTD.-2024-03896$LUPIN$$$$$$Y$$$20240808$$PH$AU$AU
238584362$23858436$2$F$20240101$20240708$20240515$20240711$EXP$$US-ABBVIE-5755877$ABBVIE$$39$YR$$F$Y$$$20240711$$CN$US$US
238584493$23858449$3$F$20240508$20240910$20240515$20240912$30DAY$$US-PFIZER INC-202400105094$PFIZER$$15$YR$$M$Y$$$20240912$$CN$US$US
238584502$23858450$2$F$$20240823$20240515$20240829$EXP$$JP-GENMAB-2024-00722AA$GENMAB$$64$YR$$F$Y$$$20240829$$MD$JP$JP
238584579$23858457$9$F$20240508$20240926$20240515$20240930$EXP$$CA-TAKEDA-2024TUS043424$TAKEDA$$73$YR$$F$Y$41$KG$20240930$$HP$CA$CA
238584702$23858470$2$F$$20240710$20240515$20240712$EXP$$CA-PFIZER INC-202400107631$PFIZER$$70$YR$$M$Y$$$20240712$$HP$CA$CA
238584762$23858476$2$F$$20240916$20240515$20240919$EXP$$CA-PFIZER INC-202400107604$PFIZER$$22$YR$$F$Y$$$20240919$$HP$CA$CA
238584833$23858483$3$F$$20240812$20240515$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073292$BRISTOL MYERS SQUIBB$$64$YR$E$F$Y$$$20240812$$HP$US$US
238584943$23858494$3$F$$20240815$20240515$20240820$PER$$US-PFIZER INC-202400052530$PFIZER$$14$YR$$M$Y$$$20240820$$CN$US$US
238584962$23858496$2$F$20240401$20240923$20240515$20240926$PER$$US-PFIZER INC-202400107492$PFIZER$$67$YR$$F$Y$$$20240926$$CN$US$US
238585012$23858501$2$F$20240510$20240718$20240515$20240723$PER$$US-AMGEN-USASP2024094213$AMGEN$$58$YR$A$F$Y$$$20240723$$CN$US$US
238585233$23858523$3$F$20240506$20240814$20240515$20240821$PER$$US-BAYER-2024A068072$BAYER$$27$YR$A$F$Y$$$20240821$$MD$US$US
238585574$23858557$4$F$$20240916$20240515$20240924$30DAY$$US-PFIZER INC-PV202400060807$PFIZER$$13$YR$$M$Y$$$20240924$$CN$US$US
238585756$23858575$6$F$$20240812$20240515$20240816$30DAY$$US-PFIZER INC-202400105832$PFIZER$$2$YR$$M$Y$$$20240816$$CN$US$US
238585775$23858577$5$F$$20240813$20240515$20240816$30DAY$$US-PFIZER INC-202400106583$PFIZER$$13$YR$$M$Y$$$20240816$$CN$US$US
238585804$23858580$4$F$20240508$20240917$20240515$20240920$30DAY$$US-PFIZER INC-202400106073$PFIZER$$11$YR$$M$Y$36.1$KG$20240920$$CN$US$US
238585817$23858581$7$F$20240508$20240813$20240515$20240819$30DAY$$US-PFIZER INC-202400105839$PFIZER$$14$YR$$F$Y$29.48$KG$20240819$$MD$US$US
238585862$23858586$2$F$$20240806$20240515$20240807$PER$$NVSC2024US102889$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
238585913$23858591$3$F$20240508$20240724$20240515$20240731$EXP$$AU-SEPTODONT-2024018629$SEPTODONT$$22$YR$A$F$Y$60$KG$20240731$$HP$AU$AU
238586355$23858635$5$F$20240501$20240913$20240515$20240917$EXP$$US-BAYER-2024A067558$BAYER$$59$YR$A$M$Y$$$20240917$$CN$US$US
238586413$23858641$3$F$$20240903$20240515$20240906$EXP$$CA-SA-2024SA144792$SANOFI AVENTIS$$40$YR$A$F$Y$73$KG$20240906$$MD$CA$CA
238586582$23858658$2$F$20230213$20240805$20240515$20240810$EXP$$BR-ROCHE-3560498$ROCHE$$77$YR$E$M$Y$$$20240810$$MD$BR$BR
238586743$23858674$3$F$20240503$20240920$20240515$20240925$30DAY$$CA-PFIZER INC-202400101856$PFIZER$$62$YR$$F$Y$$$20240925$$HP$CA$CA
238586882$23858688$2$F$$20240821$20240515$20240821$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-073692$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240821$$MD$GB$GB
238586973$23858697$3$F$20230209$20240627$20240515$20240702$EXP$$CA-JNJFOC-20230106447$JOHNSON AND JOHNSON$$55$YR$A$F$Y$90$KG$20240702$$PH$CA$CA
238587212$23858721$2$F$$20240715$20240515$20240720$EXP$$CA-JNJFOC-20240456102$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240719$$HP$CA$CA
238587506$23858750$6$F$$20240816$20240515$20240819$30DAY$$CA-JNJFOC-20240522070$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240819$$PH$CA$CA
238587756$23858775$6$F$20230101$20240806$20240515$20240814$EXP$$BR-SANDOZ INC.-SDZ2024BR048597$SANDOZ$$$$$F$Y$$$20240814$$CN$BR$BR
238587923$23858792$3$F$20231206$20240911$20240515$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404016732$ELI LILLY AND CO$$62$YR$A$M$Y$67$KG$20240920$$CN$JP$JP
238587953$23858795$3$F$20240325$20240821$20240515$20240902$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202405003196$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$MX$MX
238588042$23858804$2$F$$20240911$20240515$20240916$EXP$$GB-MYLANLABS-2024M1043396$MYLAN$$$$$F$Y$$$20240916$$CN$GB$GB
238588072$23858807$2$F$$20240626$20240515$20240702$EXP$$GB-MYLANLABS-2024M1041205$MYLAN$$$$$F$Y$$$20240702$$HP$GB$GB
238588282$23858828$2$F$$20240626$20240515$20240701$EXP$$US-ASTELLAS-2024US013623$ASTELLAS$$$$$M$Y$$$20240701$$CN$US$US
238588372$23858837$2$F$$20240729$20240515$20240802$EXP$$CN-PFIZER INC-PV202400061091$PFIZER$Zhang, C.. Pharmaceutical Practice of Acute Renal Injury Induced by Interaction Between Voriconazole and Nifedipine: A Case Report. Herald of Medicine. 2024;43(4):636-638$69$YR$$F$Y$64$KG$20240802$$PH$CN$CN
238588452$23858845$2$F$$20240703$20240515$20240709$EXP$$FR-MYLANLABS-2024M1041796$MYLAN$$38$YR$$F$Y$$$20240709$$LW$FR$FR
238588593$23858859$3$F$$20240808$20240515$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074623$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240812$$CN$US$US
238588682$23858868$2$F$$20240613$20240515$20240702$30DAY$$FR-JNJFOC-20240521508$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$FR$FR
238588932$23858893$2$F$20240514$20240802$20240515$20240805$PER$$US-AMGEN-USASP2024095824$AMGEN$$63$YR$A$F$Y$$$20240805$$CN$US$US
238588963$23858896$3$F$20240402$20240725$20240515$20240802$EXP$$BE-TAKEDA-2024TUS046774$TAKEDA$$$$$M$Y$$$20240802$$CN$BE$BE
238589052$23858905$2$F$$20240701$20240515$20240705$30DAY$$US-GSK-US2024059166$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$CN$US$US
238589072$23858907$2$F$20240423$20240710$20240515$20240715$EXP$FR-AFSSAPS-GR2024000556$FR-SA-2024SA146060$SANOFI AVENTIS$$81$YR$E$M$Y$78$KG$20240715$$PH$FR$FR
238589082$23858908$2$F$$20240705$20240515$20240710$PER$$US-BIOGEN-2024BI01264614$BIOGEN$$$$$F$Y$$$20240710$$MD$US$US
238589502$23858950$2$F$$20240627$20240515$20240702$30DAY$$US-GSK-US2024059175$GLAXOSMITHKLINE$$$$$M$Y$$$20240702$$CN$US$US
238589554$23858955$4$F$20240607$20240726$20240515$20240731$EXP$$CO-JNJFOC-20240531191$JOHNSON AND JOHNSON$$69$YR$E$F$Y$77$KG$20240731$$HP$CO$CO
238589572$23858957$2$F$$20240820$20240515$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA048581$SANDOZ$$44$YR$$M$Y$$$20240821$$CN$CA$CA
238589792$23858979$2$F$$20240820$20240515$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA048632$SANDOZ$$14$YR$$M$Y$$$20240821$$CN$CA$CA
238589852$23858985$2$F$20240501$20240820$20240515$20240902$EXP$$US-ASTELLAS-2024EU004646$ASTELLAS$$64$YR$A$M$Y$$$20240902$$CN$US$US
238590022$23859002$2$F$20230609$20240708$20240515$20240709$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-003615$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240709$$MD$JP$JP
238590172$23859017$2$F$$20240807$20240515$20240808$PER$$US-ALXN-A202209479$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
238590192$23859019$2$F$$20240514$20240515$20240814$PER$$NVSC2024US102703$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
238590592$23859059$2$F$20210227$20240708$20240515$20240709$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2021-000525$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240709$$MD$JP$JP
238590602$23859060$2$F$$20240807$20240515$20240812$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-002640$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
238590633$23859063$3$F$20231101$20240801$20240515$20240806$EXP$$CA-JNJFOC-20240485922$JOHNSON AND JOHNSON$$31$YR$A$F$Y$54$KG$20240806$$CN$CA$CA
238590733$23859073$3$F$20240101$20240717$20240515$20240723$PER$$US-AMGEN-USASL2024093995$AMGEN$$71$YR$E$M$Y$$$20240723$$HP$US$US
238591062$23859106$2$F$$20240821$20240515$20240826$30DAY$$GB-SANDOZ INC.-SDZ2024GB005916$SANDOZ$$$$$M$Y$$$20240826$$CN$GB$GB
238591123$23859112$3$F$$20240724$20240515$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072960$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240726$$CN$US$US
238591162$23859116$2$F$$20240814$20240515$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074742$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240814$$PH$US$US
238591182$23859118$2$F$$20240813$20240515$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074321$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240814$$CN$US$US
238591453$23859145$3$F$20240513$20240719$20240515$20240816$EXP$$NVSC2024US102591$NOVARTIS$$49$YR$$M$Y$$$20240816$$CN$US$US
238591472$23859147$2$F$$20240910$20240515$20240912$30DAY$$CO-PFIZER INC-PV202400058833$PFIZER$$$$$$Y$$$20240912$$CN$CO$CO
238591482$23859148$2$F$20240502$20240912$20240515$20240916$30DAY$$AR-PFIZER INC-202400100100$PFIZER$$$$$F$Y$$$20240916$$CN$AR$AR
238591494$23859149$4$F$$20240730$20240515$20240801$EXP$$CA-TAKEDA-2024TUS048057$TAKEDA$$$$$F$Y$$$20240801$$CN$CA$CA
238592212$23859221$2$F$$20240709$20240515$20240712$EXP$$GB-BIOGEN-2024BI01264581$BIOGEN$$$$A$F$Y$$$20240712$$CN$GB$GB
238592495$23859249$5$F$20240501$20240913$20240515$20240920$30DAY$$US-PFIZER INC-202400105791$PFIZER$$18$YR$$M$Y$72.57$KG$20240920$$CN$US$US
238592534$23859253$4$F$20240301$20240915$20240515$20240919$30DAY$$US-PFIZER INC-202400103663$PFIZER$$14$YR$$M$Y$$$20240919$$CN$US$US
238592544$23859254$4$F$$20240925$20240515$20240930$30DAY$$US-PFIZER INC-202400105653$PFIZER$$11$YR$$F$Y$$$20240930$$CN$US$US
238592555$23859255$5$F$$20240925$20240515$20240930$30DAY$$CR-PFIZER INC-PV202400060615$PFIZER$$9$YR$$F$Y$$$20240930$$HP$CR$CR
238592783$23859278$3$F$$20240814$20240515$20240820$EXP$$DE-PFIZER INC-202400106303$PFIZER$$49$YR$$F$Y$$$20240820$$CN$DE$DE
238593062$23859306$2$F$$20240628$20240515$20240701$PER$$US-JNJFOC-20240539238$JOHNSON AND JOHNSON$$34$YR$A$F$Y$112$KG$20240701$$PH$US$US
238593112$23859311$2$F$$20240801$20240515$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075402$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$72.12$KG$20240806$$CN$US$US
238593292$23859329$2$F$$20240701$20240515$20240708$EXP$$US-Taiho Oncology Inc-2024-004802$TAIHO ONCOLOGY INC$$$$A$F$Y$$$20240708$$CN$US$US
238593362$23859336$2$F$20240415$20240703$20240515$20240710$PER$$CN-Eisai-EC-2024-165433$EISAI$$54$YR$A$F$Y$56.5$KG$20240710$$HP$CN$CN
238593422$23859342$2$F$20230912$20240717$20240515$20240719$EXP$$CA-GSK-CA2023125223$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$HP$CA$CA
238593623$23859362$3$F$20240509$20240813$20240515$20240815$30DAY$$CA-PFIZER INC-202400104843$PFIZER$$29$YR$$F$Y$$$20240815$$PH$CA$CA
238593798$23859379$8$F$20230425$20240718$20240515$20240724$PER$$US-BIOGEN-2023BI01219216$BIOGEN$$70$YR$$M$Y$$$20240724$$CN$US$US
238593862$23859386$2$F$20240430$20240822$20240515$20240826$EXP$$US-MYLANLABS-2024M1041458$MYLAN$$37$YR$$M$Y$$$20240826$$HP$US$US
238594202$23859420$2$F$$20240709$20240515$20240718$PER$$US-VERTEX PHARMACEUTICALS-2024-008245$VERTEX$$34$YR$$$Y$$$20240718$$CN$US$US
238594292$23859429$2$F$$20240718$20240515$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202405007918$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240723$$CN$US$US
238594312$23859431$2$F$20240101$20240703$20240515$20240710$EXP$$US-JNJFOC-20240513446$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240711$$CN$US$US
238594343$23859434$3$F$20240101$20240912$20240515$20240916$EXP$$US-KYOWAKIRIN-2024KK011218$KYOWA$$$$$$Y$$$20240916$$HP$US$US
238594473$23859447$3$F$$20240719$20240515$20240727$EXP$$US-RDY-CLI/USA/24/0007036$DR REDDYS$$34$WK$I$M$Y$2.02$KG$20240727$$MD$US$US
238594512$23859451$2$F$$20240622$20240515$20240702$EXP$$JP-JNJFOC-20240524907$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$MD$JP$JP
238594712$23859471$2$F$20240101$20240802$20240515$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075304$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240805$$HP$US$US
238594722$23859472$2$F$20240513$20240822$20240515$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075248$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$58.97$KG$20240824$$CN$US$US
238594732$23859473$2$F$$20240628$20240515$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074797$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240702$$CN$US$US
238594822$23859482$2$F$20240506$20240702$20240515$20240708$30DAY$$US-MYLANLABS-2024M1042370$MYLAN$$$$$$Y$$$20240708$$PH$US$US
238594832$23859483$2$F$$20240725$20240515$20240726$PER$$NVSC2024US102739$NOVARTIS$$$$$F$Y$$$20240726$$MD$US$US
238595084$23859508$4$F$$20240918$20240515$20240923$30DAY$$US-PFIZER INC-202400106066$PFIZER$$13$YR$$M$Y$$$20240923$$CN$US$US
238595122$23859512$2$F$$20240805$20240515$20240809$EXP$$NVSC2024GB099856$NOVARTIS$$$$$F$Y$$$20240809$$CN$GB$GB
238595273$23859527$3$F$20240131$20240624$20240515$20240701$EXP$$DE-FreseniusKabi-FK202407640$FRESENIUS KABI$$48$YR$A$M$Y$$$20240701$$HP$DE$DE
238595322$23859532$2$F$$20240712$20240515$20240715$PER$$US-ALXN-202405USA000441US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240715$$CN$US$US
238595353$23859535$3$F$20201201$20240607$20240515$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-107066$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$75$KG$20240813$$CN$ES$ES
238595572$23859557$2$F$20240514$20240801$20240515$20240805$PER$$US-AMGEN-USASP2024096049$AMGEN$$67$YR$E$M$Y$$$20240805$$CN$US$US
238595608$23859560$8$F$20240510$20240920$20240515$20240925$30DAY$$GR-PFIZER INC-PV202400061868$PFIZER$$7$YR$$F$Y$21$KG$20240925$$HP$GR$GR
238595622$23859562$2$F$$20240826$20240515$20240828$EXP$$US-SANDOZ INC.-SDZ2024US048688$SANDOZ$$$$$F$Y$$$20240828$$HP$US$US
238595702$23859570$2$F$20230101$20240705$20240515$20240708$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-274257$BOEHRINGER INGELHEIM$$56$YR$A$M$Y$109$KG$20240708$$CN$ES$ES
238595812$23859581$2$F$20240506$20240813$20240515$20240816$EXP$$US-MYLANLABS-2024M1042996$MYLAN$$63$YR$$M$Y$103$KG$20240816$$HP$US$US
238595922$23859592$2$F$$20240724$20240515$20240805$EXP$$CA-MYLANLABS-2024M1043082$MYLAN$$58$YR$$F$Y$$$20240805$$HP$CA$CA
238595974$23859597$4$F$20240401$20240908$20240515$20240911$EXP$$US-KYOWAKIRIN-2024KK011317$KYOWA$$$$$$Y$$$20240911$$HP$US$US
238596442$23859644$2$F$$20240628$20240515$20240703$EXP$$NVSC2024CA056356$NOVARTIS$$$$A$F$Y$$$20240703$$CN$CA$CA
238596522$23859652$2$F$20210101$20240923$20240515$20240923$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-180415$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$80$KG$20240923$$CN$ES$ES
238596545$23859654$5$F$$20240925$20240515$20240926$EXP$$CA-SANDOZ INC.-SDZ2024CA048623$SANDOZ$$$$$M$Y$$$20240926$$CN$CA$CA
238596642$23859664$2$F$20240101$20240909$20240515$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075029$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240910$$HP$US$US
238596833$23859683$3$F$$20240902$20240515$20240905$EXP$$FI-MYLANLABS-2024M1042616$MYLAN$Wilenius M, Jernman J, Hietaharju A, Salonen T, Helasjoki T, Martikainen I, et al.. Swollen eyelids caused by polyvinylpyrrolidone histiocytosis with intravenous methylphenidate.. LANCET. 2024;403:1574-5$26$YR$$F$Y$$$20240905$$MD$FI$FI
238596962$23859696$2$F$20231124$20240710$20240515$20240718$EXP$$JP-AstraZeneca-2024A051803$ASTRAZENECA$$52$YR$$M$Y$55$KG$20240718$$MD$JP$
238597035$23859703$5$F$20240418$20240723$20240515$20240726$EXP$$GR-SANDOZ INC.-SDZ2024GR048334$SANDOZ$$68$YR$$M$Y$74.3$KG$20240726$$MD$GR$GR
238597052$23859705$2$F$$20240814$20240515$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA048338$SANDOZ$$22$YR$$F$Y$$$20240820$$CN$CA$CA
238597094$23859709$4$F$$20240906$20240515$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074807$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240910$$CN$US$US
238597246$23859724$6$F$20240501$20240822$20240515$20240830$EXP$$CO-AMRYT PHARMACEUTICALS DAC-AEGR007117$AEGERION$$$$$$Y$$$20240830$$CN$CO$CO
238597302$23859730$2$F$20240513$20240814$20240515$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074900$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$76.8$KG$20240814$$HP$US$US
238597512$23859751$2$F$$20240814$20240515$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA048339$SANDOZ$$3$DEC$$M$Y$$$20240822$$HP$CA$CA
238597522$23859752$2$F$$20240712$20240515$20240722$EXP$$CA-APELLIS-2024-APL-0000036$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$CA$CA
238597532$23859753$2$F$20240409$20240716$20240515$20240726$EXP$$JP-APELLIS-APL-2023-003434$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$JP$JP
238598002$23859800$2$F$$20240617$20240515$20240701$EXP$$US-JNJFOC-20240538228$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240701$$HP$US$US
238598103$23859810$3$F$$20240715$20240515$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075344$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$92.99$KG$20240718$$CN$US$US
238598194$23859819$4$F$20240425$20240718$20240515$20240726$EXP$$US-Calliditas-2024CAL00717$CALLIDITAS THERAPEUTICS$$57$YR$A$M$Y$102.3$KG$20240726$$CN$US$US
238598293$23859829$3$F$20240101$20240626$20240515$20240701$EXP$$US-PFIZER INC-202400107557$PFIZER$$56$YR$$M$Y$$$20240701$$HP$US$US
238598372$23859837$2$F$20221124$20240902$20240515$20240910$EXP$$DE-ROCHE-3238913$ROCHE$$32$YR$A$F$Y$$$20240910$$CN$DE$DE
238598424$23859842$4$F$20230701$20240812$20240515$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-007421$JAZZ$$55$YR$$F$Y$$$20240819$$CN$US$US
238598622$23859862$2$F$20240401$20240912$20240515$20240920$EXP$$US-RADIUS HEALTH INC.-2024US003121$RADIUS PHARM$$78$YR$$F$Y$$$20240920$$CN$US$US
238598652$23859865$2$F$20240201$20240709$20240515$20240715$EXP$$US-ROCHE-3555503$ROCHE$$59$YR$A$F$Y$53.98$KG$20240715$$CN$US$US
238598697$23859869$7$F$20141009$20240830$20240515$20240909$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-22244$IPSEN$$54$YR$A$F$Y$$$20240909$$HP$CA$CA
238598722$23859872$2$F$20240401$20240725$20240515$20240801$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-08267$IPSEN$$69$YR$E$F$Y$71.66$KG$20240801$$CN$US$US
238598732$23859873$2$F$$20240728$20240515$20240810$EXP$$CA-HLS-202401248$HLS THERAPEUTICS$$64$YR$A$M$Y$$$20240810$$PH$CA$CA
238598745$23859874$5$F$20240507$20240708$20240515$20240718$PER$$JP-Eisai-EC-2024-165792$EISAI$$67$YR$E$F$Y$$$20240718$$MD$JP$JP
238599102$23859910$2$F$20240101$20240719$20240515$20240730$PER$$US-SA-2024SA141634$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240730$$MD$US$US
238599112$23859911$2$F$20240101$20240828$20240515$20240910$PER$$US-SA-2024SA140620$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240910$$MD$US$US
238599163$23859916$3$F$20240101$20240719$20240515$20240802$PER$$US-SA-2024SA141639$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240802$$MD$US$US
238599265$23859926$5$F$20240401$20240819$20240515$20240822$EXP$$US-SA-2024SA141577$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240822$$MD$US$US
238599302$23859930$2$F$$20240820$20240515$20240912$PER$$US-SA-2024SA141126$SANOFI AVENTIS$$36$YR$A$F$Y$77.27$KG$20240912$$MD$US$US
238599362$23859936$2$F$20240401$20240723$20240515$20240801$PER$$US-SA-2024SA142229$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240801$$MD$US$US
238599472$23859947$2$F$20240101$20240722$20240515$20240731$PER$$US-SA-2024SA141673$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240731$$MD$US$US
238599522$23859952$2$F$20240101$20240715$20240515$20240724$PER$$US-SA-2024SA143386$SANOFI AVENTIS$$22$YR$A$F$Y$95.7$KG$20240724$$MD$US$US
238599652$23859965$2$F$20240701$20240730$20240515$20240808$PER$$US-SA-2024SA141285$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240808$$MD$US$US
238599673$23859967$3$F$20230101$20240704$20240515$20240712$PER$$US-SA-2024SA142631$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240712$$MD$US$US
238599723$23859972$3$F$20240101$20240918$20240515$20240930$PER$$US-SA-2024SA141122$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240930$$MD$US$US
238599892$23859989$2$F$20240101$20240906$20240515$20240917$PER$$US-SA-2024SA143156$SANOFI AVENTIS$$2$YR$C$M$Y$21$KG$20240918$$CN$US$US
238599904$23859990$4$F$20240507$20240716$20240515$20240724$PER$$US-SA-2024SA143172$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240724$$MD$US$US
238600224$23860022$4$F$20240101$20240819$20240515$20240829$PER$$US-SA-2024SA141146$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240829$$MD$US$US
238600232$23860023$2$F$20240401$20240619$20240515$20240702$PER$$US-SA-2024SA141610$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240702$$MD$US$US
238600322$23860032$2$F$$20240827$20240515$20240919$PER$$US-SA-2024SA143175$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240919$$MD$US$US
238600342$23860034$2$F$20240301$20240702$20240515$20240711$PER$$US-SA-2024SA142248$SANOFI AVENTIS$$56$YR$A$F$Y$104.32$KG$20240711$$MD$US$US
238600483$23860048$3$F$20240701$20240703$20240515$20240712$PER$$US-SA-2024SA143264$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240712$$MD$US$US
238600702$23860070$2$F$20240101$20240909$20240515$20240917$PER$$US-SA-2024SA140730$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240918$$MD$US$US
238600742$23860074$2$F$20240101$20240726$20240515$20240806$PER$$US-SA-2024SA145540$SANOFI AVENTIS$$61$YR$A$F$Y$108$KG$20240806$$MD$US$US
238600802$23860080$2$F$20240101$20240726$20240515$20240807$PER$$US-SA-2024SA145133$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240807$$MD$US$US
238600843$23860084$3$F$$20240715$20240515$20240724$PER$$US-SA-2024SA145772$SANOFI AVENTIS$$$$A$M$Y$111$KG$20240724$$MD$US$US
238600854$23860085$4$F$20240714$20240826$20240515$20240912$PER$$US-SA-2024SA146167$SANOFI AVENTIS$$65$YR$E$F$Y$74.84$KG$20240912$$MD$US$US
238600982$23860098$2$F$20240101$20240909$20240515$20240918$PER$$US-SA-2024SA146253$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240918$$MD$US$US
238601023$23860102$3$F$$20240913$20240515$20240920$PER$$US-SA-2024SA145337$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240920$$MD$US$US
238601042$23860104$2$F$$20240827$20240515$20240905$PER$$US-SA-2024SA145795$SANOFI AVENTIS$$8$YR$C$M$Y$20.6$KG$20240905$$CN$US$US
238601072$23860107$2$F$20240408$20240822$20240515$20240902$PER$$US-SA-2024SA146277$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240902$$MD$US$US
238601102$23860110$2$F$$20240701$20240515$20240710$PER$$US-SA-2024SA146065$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240710$$MD$US$US
238601172$23860117$2$F$20240101$20240711$20240515$20240801$PER$$US-SA-2024SA145985$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240719$$HP$US$US
238601182$23860118$2$F$20240101$20240702$20240515$20240711$PER$$US-SA-2024SA147745$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240711$$MD$US$US
238601233$23860123$3$F$$20240821$20240515$20240904$PER$$US-SA-2024SA145406$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240904$$MD$US$US
238601282$23860128$2$F$20240101$20240716$20240515$20240725$PER$$US-SA-2024SA147658$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240725$$MD$US$US
238601642$23860164$2$F$$20240828$20240515$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075117$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$92.53$KG$20240906$$HP$US$US
238601662$23860166$2$F$$20240715$20240515$20240715$PER$$US-ALXN-202405USA000501US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
238601704$23860170$4$F$20240503$20240805$20240515$20240812$EXP$$CZ-VER-202400006$VERITY PHARMACEUTICALS$$66$YR$E$M$Y$85$KG$20240812$$HP$CZ$CZ
238601712$23860171$2$F$$20240715$20240515$20240715$PER$$US-ALXN-202405USA000506US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238601892$23860189$2$F$20240508$20240708$20240515$20240711$PER$$US-ALXN-202405USA000478US$ALEXION PHARMACEUTICALS$$58$YR$$F$Y$$$20240711$$CN$US$US
238602033$23860203$3$F$$20240913$20240515$20240919$EXP$$JP-009507513-2401JPN000761J$MERCK$Teramoto Y, Fujii T, Hanamoto M, Takamura K, Nakada T. 5 A Case of Urothelial Carcinoma with Iris Metastasis. The 337th Okayama Regional Meeting of the Japanese Urological Association$66$YR$$F$Y$$$20240919$$MD$JP$JP
238602302$23860230$2$F$$20240717$20240515$20240722$PER$$US-BAUSCHBL-2024BNL026759$BAUSCH AND LOMB$$$$$M$Y$$$20240722$$CN$US$US
238602324$23860232$4$F$$20240729$20240515$20240805$EXP$$US-ABBVIE-5308228$ABBVIE$$$$$M$Y$$$20240805$$MD$US$US
238602382$23860238$2$F$$20240723$20240515$20240725$PER$$NVSC2024US103034$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
238602433$23860243$3$F$$20240718$20240515$20240726$EXP$$CA-TAKEDA-2024TUS046574$TAKEDA$$$$$F$Y$$$20240726$$CN$CA$CA
238602483$23860248$3$F$$20240816$20240515$20240826$PER$$US-BAUSCHBL-2024BNL026790$BAUSCH AND LOMB$$$$$M$Y$$$20240826$$CN$US$US
238602633$23860263$3$F$$20240727$20240515$20240801$EXP$$CA-ABBVIE-5760591$ABBVIE$$$$$M$Y$$$20240801$$HP$CA$CA
238603013$23860301$3$F$20240101$20240912$20240515$20240923$PER$$US-SA-2024SA142356$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240923$$MD$US$US
238603162$23860316$2$F$20240101$20240709$20240515$20240717$PER$$US-SA-2024SA142660$SANOFI AVENTIS$$44$YR$A$F$Y$71.21$KG$20240717$$MD$US$US
238603242$23860324$2$F$$20240826$20240515$20240828$PER$$US-AMGEN-USASP2024094206$AMGEN$$$$$$Y$$$20240828$$CN$US$US
238603332$23860333$2$F$$20240710$20240515$20240710$EXP$$CA-PFIZER INC-202300312816$PFIZER$$75$YR$$M$Y$$$20240710$$MD$CA$CA
238603412$23860341$2$F$$20240813$20240515$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074314$BRISTOL MYERS SQUIBB$$62$YR$E$F$Y$$$20240813$$CN$US$US
238603475$23860347$5$F$20240501$20240909$20240515$20240914$EXP$$IL-ABBVIE-5759216$ABBVIE$$80$YR$$F$Y$$$20240914$$CN$IL$IL
238603552$23860355$2$F$20240503$20240712$20240515$20240715$PER$$US-ALXN-202405USA000495US$ALEXION PHARMACEUTICALS$$64$YR$$M$Y$$$20240715$$CN$US$US
238603623$23860362$3$F$20240101$20240711$20240515$20240716$EXP$$DE-ABBVIE-5760670$ABBVIE$$$$$F$Y$$$20240716$$MD$DE$DE
238603702$23860370$2$F$20240101$20240807$20240515$20240816$PER$$US-SA-2024SA144823$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240816$$MD$US$US
238603712$23860371$2$F$$20240820$20240515$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075140$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240820$$CN$US$US
238603763$23860376$3$F$$20240712$20240515$20240716$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202405003582$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240716$$CN$ES$ES
238603823$23860382$3$F$$20240813$20240515$20240820$EXP$$US-SANDOZ INC.-SDZ2024US048762$SANDOZ$$$$$$Y$$$20240820$$HP$US$US
238603862$23860386$2$F$20240101$20240717$20240515$20240731$PER$$US-APOTEX-2024AP005334$APOTEX$$$$$M$Y$$$20240731$$CN$US$US
238603872$23860387$2$F$$20240903$20240515$20240906$EXP$$CA-SA-2024SA144483$SANOFI AVENTIS$$$$$F$Y$97$KG$20240906$$MD$CA$CA
238603944$23860394$4$F$20240429$20240801$20240515$20240802$EXP$$CA-ABBVIE-5752977$ABBVIE$$53$YR$$F$Y$129$KG$20240802$$MD$CA$CA
238604222$23860422$2$F$$20240813$20240516$20240813$EXP$$US-JNJFOC-20240519536$JOHNSON AND JOHNSON$$76$YR$E$F$Y$72.64$KG$20240813$$CN$US$US
238604243$23860424$3$F$$20240627$20240516$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075478$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240710$$CN$US$US
238604352$23860435$2$F$20231115$20240904$20240516$20240913$EXP$$NL-ABBVIE-5761921$ABBVIE$$78$YR$$M$Y$83$KG$20240913$$MD$NL$NL
238604363$23860436$3$F$$20240917$20240516$20240925$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000438$DECIPHERA PHARMACEUTICALS$$52$YR$A$F$Y$$$20240925$$HP$US$US
238604462$23860446$2$F$20240507$20240715$20240516$20240715$PER$$US-ALXN-202405USA000509US$ALEXION PHARMACEUTICALS$$83$YR$$M$Y$$$20240715$$CN$US$US
238604482$23860448$2$F$20240301$20240701$20240516$20240704$EXP$$US-ABBVIE-5755762$ABBVIE$$51$YR$$M$Y$108.86$KG$20240704$$CN$US$US
238604513$23860451$3$F$20231001$20240730$20240516$20240801$EXP$$JP-ABBVIE-5755843$ABBVIE$$60$YR$$F$Y$60$KG$20240801$$MD$JP$JP
238604684$23860468$4$F$20240313$20240807$20240516$20240815$EXP$$CA-CELLTRION INC.-2024CA001829$CELLTRION$$$$$$Y$$$20240815$$MD$CA$CA
238604713$23860471$3$F$$20240830$20240516$20240909$EXP$FR-AFSSAPS-DJ2024000675$FR-ROCHE-3558692$ROCHE$$81$YR$E$F$Y$53$KG$20240909$$MD$FR$FR
238604762$23860476$2$F$$20240725$20240516$20240730$EXP$$MY-AstraZeneca-2024A110677$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$MY$
238605084$23860508$4$F$20200501$20240905$20240516$20240911$EXP$$NVSC2020MX349830$NOVARTIS$$33$YR$$M$Y$100$KG$20240911$$HP$MX$MX
238605216$23860521$6$F$20240901$20240909$20240516$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074877$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240916$$CN$US$US
238605342$23860534$2$F$$20240621$20240516$20240702$PER$$US-AstraZeneca-2024A098423$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
238605492$23860549$2$F$20240101$20240910$20240516$20240917$EXP$$JP-009507513-2405JPN000544J$MERCK$$85$YR$$M$Y$$$20240917$$MD$JP$JP
238605502$23860550$2$F$$20240918$20240516$20240927$PER$$NVSC2024US103303$NOVARTIS$$$$$F$Y$$$20240927$$HP$US$US
238605672$23860567$2$F$$20240705$20240516$20240710$EXP$$US-SA-2024SA144836$SANOFI AVENTIS$$61$YR$A$F$Y$88.45$KG$20240710$$MD$US$US
238605762$23860576$2$F$$20240807$20240516$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074928$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240809$$CN$US$US
238605774$23860577$4$F$$20240820$20240516$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074874$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240823$$CN$US$US
238605782$23860578$2$F$20240101$20240801$20240516$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073899$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240806$$CN$US$US
238605792$23860579$2$F$$20240711$20240516$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075365$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240719$$CN$US$US
238605852$23860585$2$F$$20240702$20240516$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202405008405$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240703$$CN$US$US
238606005$23860600$5$F$20230101$20240829$20240516$20240910$EXP$$US-SA-2024SA146947$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240910$$MD$US$US
238606152$23860615$2$F$$20240726$20240516$20240726$PER$$NVSC2024US103283$NOVARTIS$$$$$F$Y$$$20240726$$HP$US$US
238606233$23860623$3$F$20240420$20240624$20240516$20240711$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000383$DECIPHERA PHARMACEUTICALS$$54$YR$A$F$Y$$$20240711$$CN$US$US
238606383$23860638$3$F$$20240815$20240516$20240822$PER$$NVSC2024US097075$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
2386065018$23860650$18$F$20230101$20240918$20240516$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011978$UNITED THERAPEUTICS$$$$$F$Y$53.515$KG$20240926$$$US$US
238606753$23860675$3$F$$20240815$20240516$20240821$PER$$NVSC2024US095079$NOVARTIS$$$$$M$Y$$$20240821$$CN$US$US
238606873$23860687$3$F$$20240627$20240516$20240702$EXP$$CA-SANDOZ INC.-SDZ2024CA048637$SANDOZ$$$$$F$Y$$$20240702$$CN$CA$CA
238607122$23860712$2$F$20240301$20240724$20240516$20240731$EXP$$DE-AMGEN-DEUSP2024075678$AMGEN$$$$A$F$Y$$$20240730$$PH$DE$DE
238607182$23860718$2$F$$20240709$20240516$20240711$PER$$US-HALEON-2175216$Haleon PLC$$$$$$Y$$$20240711$$CN$US$US
238607213$23860721$3$F$20191209$20240829$20240516$20240902$EXP$$CA-TAKEDA-2024TUS046410$TAKEDA$$35$YR$$F$Y$$$20240902$$CN$CA$CA
238607292$23860729$2$F$20240502$20240816$20240516$20240820$PER$$NVSC2024US097463$NOVARTIS$$41$YR$$F$Y$$$20240820$$CN$US$US
238607382$23860738$2$F$$20240909$20240516$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075250$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$68.04$KG$20240912$$CN$US$US
238607433$23860743$3$F$$20240624$20240516$20240702$PER$$US-HETERO-HET2024US01351$HETERO$$$$I$M$Y$2.02$KG$20240702$$HP$US$US
238607443$23860744$3$F$20240511$20240730$20240516$20240802$PER$$US-AMGEN-USASP2024095207$AMGEN$$71$YR$E$F$Y$$$20240802$$CN$US$US
238607622$23860762$2$F$20231201$20240624$20240516$20240708$EXP$$CO-NOVOPROD-1218477$NOVO NORDISK$$76$YR$$F$Y$54$KG$20240708$$CN$CO$CO
238607765$23860776$5$F$$20240715$20240516$20240726$EXP$GB-MLMSERVICE-20240430-PI045133-00030-1$GB-STRIDES ARCOLAB LIMITED-2024SP005627$STRIDES$Manti M, Kamperidis N, Toskas A, Martin H, Misra R.. Acute severe ulcerative colitis flare complicated by myopericarditis and infliximab-induced hepatitis.. European Journal of Case Reports in Internal Medicine.. 2024;11(4).$$$$$Y$$$20240726$$MD$GB$GB
238607773$23860777$3$F$$20240621$20240516$20240701$EXP$$JP-BEH-2024172002$CSL BEHRING$$40$YR$A$F$Y$$$20240701$$MD$JP$JP
238607787$23860778$7$F$20240418$20240718$20240516$20240720$EXP$$GR-JNJFOC-20240506685$JOHNSON AND JOHNSON$$68$YR$E$M$Y$74.3$KG$20240719$$MD$GR$GR
238607944$23860794$4$F$$20240909$20240516$20240919$EXP$CA-HEALTHCANVIG-E2B_06886600$CA-NOVOPROD-1219238$NOVO NORDISK$$34$YR$$F$Y$$$20240919$$CN$CA$CA
238608093$23860809$3$F$20240227$20240628$20240516$20240702$EXP$FR-AFSSAPS-NY2024000327$FR-HALEON-2174234$Haleon PLC$$43$YR$$F$Y$63$KG$20240702$$MD$FR$FR
238608172$23860817$2$F$$20240708$20240516$20240710$EXP$$BR-ROCHE-3559288$ROCHE$$$$A$F$Y$$$20240710$$HP$BR$BR
238608212$23860821$2$F$$20240719$20240516$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075361$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240723$$CN$US$US
238608342$23860834$2$F$20240324$20240809$20240516$20240813$EXP$FR-AFSSAPS-LM2024000199$FR-HALEON-2174200$Haleon PLC$$22$YR$$F$Y$58.7$KG$20240812$$MD$FR$FR
238608512$23860851$2$F$20240422$20240725$20240516$20240731$EXP$IT-MINISAL02-983977$IT-CHEPLA-2024005988$CHEPLAPHARM$$26$YR$$F$Y$$$20240731$$MD$COUNTRY NOT SPECIFIED$IT
238608742$23860874$2$F$$20240509$20240516$20240910$EXP$$US-ROCHE-3561248$ROCHE$$$$$$Y$$$20240910$$CN$US$US
238608923$23860892$3$F$$20240909$20240516$20240919$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK084405$GLENMARK$$$$$$Y$$$20240919$$HP$CA$CA
238608973$23860897$3$F$20240502$20240820$20240516$20240829$EXP$$IT-JNJFOC-20240529231$JOHNSON AND JOHNSON$$66$YR$E$M$Y$95$KG$20240829$$MD$IT$IT
238609062$23860906$2$F$20211123$20240909$20240516$20240910$EXP$$DE-SANDOZ INC.-SDZ2024DE048298$SANDOZ$$55$YR$$F$Y$$$20240910$$CN$DE$DE
238609114$23860911$4$F$20240606$20240826$20240516$20240903$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000420$DECIPHERA PHARMACEUTICALS$$68$YR$A$M$Y$$$20240903$$CN$US$US
238609142$23860914$2$F$20240101$20240625$20240516$20240701$PER$$US-AMGEN-USASP2024094773$AMGEN$$54$YR$A$M$Y$$$20240630$$CN$US$US
238609192$23860919$2$F$20240401$20240814$20240516$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075088$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240814$$CN$US$US
238609423$23860942$3$F$$20240814$20240516$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075387$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240814$$CN$US$US
238609762$23860976$2$F$$20240827$20240516$20240909$EXP$$AR-PADAGIS-2024PAD00825$PADAGIS$Vicentin D.M., Juarez C.P., Luna C., Luna J.D.. Orbital compartment syndrome due to periorbital angioedema. Orbit (London). 2024;43(2):265-269$$$$$Y$$$20240909$$HP$AR$AR
238609794$23860979$4$F$20240603$20240815$20240516$20240829$EXP$$US-UCBSA-2024007223$UCB$$74$YR$$M$Y$115.65$KG$20240829$$HP$US$US
238609902$23860990$2$F$20231001$20240808$20240516$20240821$EXP$$US-UCBSA-2023039585$UCB$$87$YR$$M$Y$77.11$KG$20240821$$HP$US$US
238610043$23861004$3$F$20240507$20240703$20240516$20240712$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004634$SAREPTA THERAPEUTICS$$13$YR$$M$Y$44.9$KG$20240712$$MD$US$US
238610053$23861005$3$F$$20240703$20240516$20240715$EXP$$US-ROCHE-3561622$ROCHE$$62$YR$A$F$Y$$$20240715$$CN$US$US
238610062$23861006$2$F$$20240626$20240516$20240705$EXP$$US-ROCHE-3560645$ROCHE$$45$YR$A$F$Y$$$20240706$$CN$US$US
238610103$23861010$3$F$20240702$20240702$20240516$20240716$EXP$$US-INSMED, INC.-2024-01862-US$INSMED$$77$YR$$M$Y$$$20240716$$CN$US$US
238610402$23861040$2$F$$20240913$20240516$20240919$EXP$$JP-009507513-2405JPN001050J$MERCK$$$$E$$Y$$$20240919$$MD$JP$JP
238610544$23861054$4$F$20240709$20240916$20240516$20240919$EXP$$US-TAKEDA-2024TUS048178$TAKEDA$$47$YR$$F$Y$102$KG$20240919$$HP$US$US
238610572$23861057$2$F$$20240912$20240516$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075226$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240916$$CN$US$US
238610612$23861061$2$F$$20240911$20240516$20240916$EXP$$US-SANDOZ INC.-SDZ2023US007862$SANDOZ$$$$$M$Y$97.052$KG$20240916$$CN$US$US
238610622$23861062$2$F$$20240925$20240516$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA037659$SANDOZ$$$$$M$Y$$$20240927$$MD$CA$CA
238611283$23861128$3$F$20240101$20240709$20240516$20240718$EXP$$US-ELI_LILLY_AND_COMPANY-US202405008703$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240718$$CN$US$US
238611422$23861142$2$F$$20240829$20240516$20240918$PER$$US-TEVA-VS-3193306$TEVA$$$$$$Y$$$20240918$$HP$US$US
238611522$23861152$2$F$20240510$20240807$20240516$20240813$EXP$$US-ABBVIE-5761228$ABBVIE$$57$YR$$F$Y$$$20240813$$CN$US$US
238611634$23861163$4$F$20240424$20240628$20240516$20240807$PER$$US-AstraZeneca-2024A102107$ASTRAZENECA$$21524$DY$$M$Y$$$20240807$$CN$US$
238611762$23861176$2$F$20180101$20240515$20240516$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-188158$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$74.5$KG$20240813$$CN$ES$ES
238611772$23861177$2$F$20230301$20240515$20240516$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-250675$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$72$KG$20240813$$CN$ES$ES
238611792$23861179$2$F$20240421$20240814$20240516$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075710$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240814$$HP$US$US
238611842$23861184$2$F$20240322$20240827$20240516$20240830$EXP$$US-ABBVIE-5761514$ABBVIE$$77$YR$$F$Y$59$KG$20240830$$CN$US$US
238612012$23861201$2$F$$20240510$20240516$20240807$EXP$$NVSC2024US100222$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
238612072$23861207$2$F$20240417$20240624$20240516$20240710$30DAY$$US-GSK-US2024057427$GLAXOSMITHKLINE$$39$YR$$F$Y$$$20240710$$CN$US$US
238612194$23861219$4$F$20240501$20240926$20240516$20240930$EXP$$JP-TAKEDA-2024TJP006907$TAKEDA$$0$YR$$M$Y$7.4$KG$20240930$$MD$JP$JP
238612232$23861223$2$F$$20240730$20240516$20240808$EXP$$GB-CELLTRION INC.-2024GB011347$CELLTRION$$$$$$Y$$$20240808$$CN$GB$GB
238612313$23861231$3$F$$20240918$20240516$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075443$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240918$$CN$US$US
238612352$23861235$2$F$$20240711$20240516$20240724$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-073682$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240724$$HP$CA$CA
238612473$23861247$3$F$20240510$20240731$20240516$20240802$PER$$US-AMGEN-USASP2024095246$AMGEN$$81$YR$E$M$Y$$$20240802$$CN$US$US
238612565$23861256$5$F$20240101$20240807$20240516$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014184$UNITED THERAPEUTICS$$$$$F$Y$79.819$KG$20240816$$$US$US
238612682$23861268$2$F$20240508$20240712$20240516$20240715$PER$$US-ALXN-202405USA000471US$ALEXION PHARMACEUTICALS$$52$YR$$F$Y$$$20240715$$CN$US$US
238612722$23861272$2$F$20240101$20240731$20240516$20240805$EXP$$US-ABBVIE-5759609$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
238612803$23861280$3$F$20230101$20240903$20240516$20240913$EXP$$DE-AUROBINDO-AUR-APL-2024-022249$AUROBINDO$$$$A$F$Y$$$20240913$$MD$DE$DE
238612883$23861288$3$F$20231025$20240709$20240516$20240713$EXP$$JP-ABBVIE-5761187$ABBVIE$$58$YR$$F$Y$102$KG$20240713$$MD$JP$JP
238612913$23861291$3$F$20240101$20240821$20240516$20240828$EXP$$US-ABBVIE-5760741$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
238613004$23861300$4$F$$20240828$20240516$20240906$EXP$$US-TEVA-VS-3197072$TEVA$Singh H, Patel P, Mawari S, Caliman N Cyclosporine-Associated Organizing Pneumonia. American Journal of Therapeutics 31: e450-e453, No. 4, Jul-Aug 2024  .; Singh H, Patel P, Mawari SK, Menon P. Cyclosporine Induced Organizing Pneumonia: When the Immunosuppressant Causes Inflammation. Am-J-Respir-Crit-Care-Med 2023; 207 (plus Poster) abstr. A3169.; Singh H, Patel P, Mawari SK, Menon P. Cyclosporine Induced Organizing Pneumonia: When the Immunosuppressant Causes Inflammation. Am-J-Respir-Crit-C...$30$YR$$F$Y$$$20240906$$MD$US$US
238613034$23861303$4$F$$20240816$20240516$20240822$EXP$$IT-ROCHE-3558843$ROCHE$$6$MON$I$F$Y$3.28$KG$20240822$$MD$IT$IT
238613152$23861315$2$F$$20240709$20240516$20240712$EXP$$NVSC2024BR101163$NOVARTIS$$$$$F$Y$$$20240712$$CN$BR$BR
238613212$23861321$2$F$$20240827$20240516$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073827$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240828$$CN$US$US
238613334$23861333$4$F$20240430$20240716$20240516$20240717$EXP$$DE-SANDOZ INC.-SDZ2024DE048797$SANDOZ$$57$YR$$F$Y$$$20240717$$MD$DE$DE
238613373$23861337$3$F$$20240830$20240516$20240904$EXP$$US-SA-2024SA143420$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240904$$HP$US$US
238613382$23861338$2$F$20240512$20240729$20240516$20240801$PER$$US-AMGEN-USASP2024095539$AMGEN$$66$YR$E$M$Y$$$20240731$$CN$US$US
238613402$23861340$2$F$20240101$20240712$20240516$20240718$EXP$$US-ABBVIE-5760154$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
238613454$23861345$4$F$20220226$20240830$20240516$20240908$EXP$$FR-CELLTRION INC.-2024FR011088$CELLTRION$$$$$$Y$$$20240909$$HP$FR$FR
238613604$23861360$4$F$20231213$20240819$20240516$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-072827$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$55$KG$20240826$$MD$JP$JP
238613848$23861384$8$F$20220729$20240925$20240516$20240930$EXP$$US-TAKEDA-2022TUS052590$TAKEDA$$45$YR$$F$Y$$$20240930$$CN$US$US
238613932$23861393$2$F$20220325$20240919$20240516$20240924$EXP$$US-TAKEDA-2022TUS020308$TAKEDA$$46$YR$$F$Y$$$20240924$$CN$US$US
238613943$23861394$3$F$$20240719$20240516$20240726$EXP$$CA-TAKEDA-2023TUS108013$TAKEDA$$$$$M$Y$$$20240726$$CN$CA$CA
238614082$23861408$2$F$$20240514$20240516$20240701$PER$$US-HALEON-2175158$Haleon PLC$$65$YR$$F$Y$$$20240701$$CN$US$US
238614194$23861419$4$F$20240516$20240711$20240516$20240716$EXP$$CA-TAKEDA-2023TUS121522$TAKEDA$$28$YR$$F$Y$$$20240716$$CN$CA$CA
238614204$23861420$4$F$20240208$20240918$20240516$20240925$EXP$$CO-GSK-CO2024AMR048443$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$CO$CO
238614518$23861451$8$F$20240101$20240906$20240516$20240916$EXP$$CA-CELLTRION INC.-2024CA011358$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
238614592$23861459$2$F$$20240624$20240516$20240702$30DAY$$US-GSK-US2024057457$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
238614732$23861473$2$F$$20240913$20240516$20240917$EXP$$CA-TAKEDA-2024TUS026149$TAKEDA$$$$$F$Y$$$20240917$$MD$CA$CA
238614853$23861485$3$F$20240312$20240515$20240516$20240723$PER$$US-HALEON-2172024$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
238614872$23861487$2$F$20240101$20240731$20240516$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075714$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$56.4$KG$20240806$$PH$US$US
238614894$23861489$4$F$20240605$20240801$20240516$20240805$EXP$$CA-TAKEDA-2024TUS035963$TAKEDA$$74$YR$$F$Y$$$20240805$$CN$CA$CA
238615282$23861528$2$F$$20240624$20240516$20240703$30DAY$$US-GSK-US2024057442$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
238615302$23861530$2$F$20230101$20240715$20240516$20240718$EXP$$US-ABBVIE-5759620$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
238615352$23861535$2$F$$20240715$20240516$20240715$PER$$US-ALXN-202405USA000503US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238615473$23861547$3$F$$20240912$20240516$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075549$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240913$$CN$US$US
238615503$23861550$3$F$20240401$20240913$20240516$20240916$EXP$IT-MINISAL02-985275$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-075775$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$61$KG$20240916$$PH$IT$IT
238615515$23861551$5$F$$20240716$20240516$20240722$EXP$$GB-ROCHE-3561349$ROCHE$$11$YR$C$F$Y$$$20240719$$MD$GB$GB
238615562$23861556$2$F$20231213$20240713$20240516$20240717$EXP$$AU-TAKEDA-2023TUS121406$TAKEDA$$29$YR$$F$Y$$$20240717$$HP$AU$AU
238615672$23861567$2$F$$20240515$20240516$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075922$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$HP$US$US
238615742$23861574$2$F$20240501$20240717$20240516$20240720$EXP$$NVSC2024GB103277$NOVARTIS$$$$A$F$Y$$$20240720$$CN$GB$GB
238615792$23861579$2$F$$20240828$20240516$20240905$EXP$$CA-TAKEDA-2023TUS013805$TAKEDA$$47$YR$$F$Y$76$KG$20240905$$HP$CA$CA
238615812$23861581$2$F$20240101$20240718$20240516$20240725$EXP$$US-ABBVIE-5759634$ABBVIE$$$$$F$Y$77$KG$20240725$$CN$US$US
238615822$23861582$2$F$$20240715$20240516$20240715$PER$$US-ALXN-202405USA000790US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240715$$CN$US$US
238615993$23861599$3$F$20240430$20240718$20240516$20240723$EXP$$JP-GSK-JP2024061552$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$JP$JP
238616022$23861602$2$F$$20240718$20240516$20240720$EXP$$NVSC2024BR101206$NOVARTIS$$$$$F$Y$$$20240719$$MD$BR$BR
238616033$23861603$3$F$20240503$20240809$20240516$20240812$PER$$US-AMGEN-USASP2024096547$AMGEN$$63$YR$A$F$Y$$$20240812$$CN$US$US
238616042$23861604$2$F$$20240819$20240516$20240827$EXP$$CA-APOTEX-2024AP005678$APOTEX$$34$YR$$F$Y$$$20240827$$PH$CA$CA
238616152$23861615$2$F$$20240910$20240516$20240917$PER$$US-AMGEN-USASP2024094359$AMGEN$$$$$F$Y$$$20240917$$CN$US$US
238616322$23861632$2$F$20231001$20240919$20240516$20240930$EXP$$US-ROCHE-3561839$ROCHE$$79$YR$E$F$Y$$$20240930$$CN$US$US
238616412$23861641$2$F$$20240903$20240516$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202405008072$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240905$$CN$US$US
238616562$23861656$2$F$$20240709$20240516$20240710$EXP$GB-002147023-NVSC2024GB097682$GB-ROCHE-3561682$ROCHE$$$$$F$Y$$$20240710$$CN$GB$GB
238617062$23861706$2$F$20240308$20240806$20240516$20240808$EXP$$CO-JNJFOC-20240338248$JOHNSON AND JOHNSON$$86$YR$E$F$Y$78$KG$20240808$$HP$CO$CO
238617145$23861714$5$F$$20240905$20240516$20240912$EXP$$CA-ROCHE-3563064$ROCHE$$57$YR$A$F$Y$$$20240912$$CN$CA$CA
238617152$23861715$2$F$20240301$20240726$20240516$20240803$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009738$UNITED THERAPEUTICS$$58$YR$$F$Y$95.238$KG$20240803$$$US$US
238617192$23861719$2$F$$20240705$20240516$20240715$EXP$$JP-AMGEN-JPNSP2024094998$AMGEN$$53$YR$A$F$Y$$$20240715$$MD$JP$JP
238617242$23861724$2$F$20231130$20240814$20240516$20240821$EXP$$CA-SA-2024SA143899$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240821$$HP$CA$CA
238617552$23861755$2$F$20240204$20240515$20240516$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000148$Tarsus Pharmaceuticals$$52$YR$$F$Y$$$20240806$$MD$US$US
238617634$23861763$4$F$20240404$20240529$20240516$20240710$PER$$US-AMGEN-USASP2024092654$AMGEN$$59$YR$A$F$Y$64$KG$20240710$$PH$US$US
238617872$23861787$2$F$$20240813$20240516$20240815$EXP$$US-JNJFOC-20240524123$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
238617914$23861791$4$F$20240513$20240822$20240516$20240827$PER$$US-AMGEN-USASP2024095777$AMGEN$$71$YR$E$F$Y$$$20240827$$CN$US$US
238618062$23861806$2$F$20240426$20240814$20240516$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075736$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240814$$HP$US$US
238618254$23861825$4$F$$20240702$20240516$20240704$PER$$NVSC2024US103297$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
238618262$23861826$2$F$$20240712$20240516$20240716$EXP$$IN-ROCHE-3562886$ROCHE$$51$YR$A$M$Y$$$20240716$$CN$IN$IN
238618275$23861827$5$F$20240321$20240828$20240516$20240911$30DAY$$US-AMGEN-USASL2024095180$AMGEN$$35$YR$A$F$Y$$$20240910$$HP$US$US
238618302$23861830$2$F$$20240723$20240516$20240723$EXP$$IN-ROCHE-3493836$ROCHE$$51$YR$A$F$Y$63.3$KG$20240723$$CN$IN$IN
238618422$23861842$2$F$$20240813$20240516$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074824$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$81.633$KG$20240815$$CN$US$US
238618782$23861878$2$F$$20240624$20240516$20240703$30DAY$$US-GSK-US2024057446$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
238619022$23861902$2$F$20240515$20240816$20240516$20240820$PER$$US-AMGEN-USASP2024096820$AMGEN$$63$YR$A$F$Y$$$20240820$$CN$US$US
238619732$23861973$2$F$$20240729$20240516$20240808$EXP$$CA-HALEON-2172486$Haleon PLC$$43$YR$$F$Y$96$KG$20240808$$HP$CA$CA
238620024$23862002$4$F$20240420$20240911$20240516$20240919$EXP$$CA-JNJFOC-20240533506$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240919$$HP$CA$CA
238620172$23862017$2$F$$20240719$20240516$20240722$PER$$NVSC2024US100481$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
238620332$23862033$2$F$$20240813$20240516$20240819$EXP$$US-TAKEDA-2024TUS045808$TAKEDA$$$$$M$Y$98.413$KG$20240819$$MD$US$US
238620472$23862047$2$F$20240301$20240625$20240516$20240702$EXP$$JP-AMGEN-JPNSP2024095505$AMGEN$$$$$F$Y$$$20240702$$MD$JP$JP
238620512$23862051$2$F$$20240904$20240516$20240918$EXP$$JP-ALVOGEN-2024094619$ALVOGEN$Ueda Y, Sakai T, Yamada K, Arita K, Ishige Y, Hoshi D, Yanagisawa H, Iwao-Kawanami H, Kawanami T, Mizuta S, Fukushima T, Yamada S, Yachie A, Masaki Y. Fatal hemophagocytic lymphohistiocytosis with intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case. Immunological Medicine. 2024 Apr 15;47 (3):192-199. doi:doi.org/10.1080/25785826.2024.2338594$61$YR$$F$Y$$$20240918$$HP$JP$JP
238620612$23862061$2$F$$20240702$20240516$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-075742$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$MD$JP$JP
238620712$23862071$2$F$20230622$20240801$20240516$20240807$EXP$$CA-GSK-CA2023087891$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$HP$CA$CA
238620962$23862096$2$F$20240512$20240912$20240516$20240919$EXP$FR-AFSSAPS-AVMA2024000198$FR-CHEPLA-2024006016$CHEPLAPHARM$$35$YR$$M$Y$$$20240919$$PH$COUNTRY NOT SPECIFIED$FR
238620972$23862097$2$F$20240418$20240828$20240516$20240902$EXP$$CA-JNJFOC-20240533533$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240902$$HP$CA$CA
238620983$23862098$3$F$20231101$20240702$20240516$20240708$EXP$$US-JNJFOC-20240423015$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240709$$HP$US$US
238621012$23862101$2$F$$20240722$20240516$20240801$EXP$$JP-009507513-2405JPN000110J$MERCK$$9$DEC$$M$Y$$$20240801$$MD$JP$JP
238621094$23862109$4$F$20240101$20240723$20240516$20240802$EXP$$US-INSMED, INC.-2024-01543-US$INSMED$$$$$M$Y$$$20240802$$CN$US$US
238621274$23862127$4$F$$20240705$20240516$20240828$EXP$$CA-HALEON-2173535$Haleon PLC$$44$YR$$F$Y$68$KG$20240828$$HP$CA$CA
238621472$23862147$2$F$20240505$20240621$20240516$20240702$30DAY$$US-GSK-US2024057389$GLAXOSMITHKLINE$$41$YR$$F$Y$$$20240702$$CN$US$US
238621502$23862150$2$F$20240506$20240628$20240516$20240703$EXP$$US-MYLANLABS-2024M1043265$MYLAN$$72$YR$$F$Y$$$20240703$$HP$US$US
238621532$23862153$2$F$20240509$20240822$20240516$20240827$EXP$$US-MYLANLABS-2024M1043828$MYLAN$$49$YR$$F$Y$$$20240827$$PH$US$US
238621673$23862167$3$F$20240101$20240823$20240516$20240830$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-005487$AMGEN$$81$YR$E$F$Y$$$20240829$$CN$US$US
238621782$23862178$2$F$20240410$20240710$20240516$20240722$EXP$$NL-Accord-424193$ACCORD$$70$YR$E$M$Y$79.2$KG$20240722$$HP$NL$NL
238621882$23862188$2$F$$20240709$20240516$20240716$EXP$$TR-ROCHE-3561975$ROCHE$$23$YR$A$F$Y$$$20240717$$MD$TR$TR
238622006$23862200$6$F$$20240906$20240516$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429657$RANBAXY$$$$A$F$Y$65.306$KG$20240920$$CN$US$US
238622013$23862201$3$F$20240401$20240510$20240516$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446632$RANBAXY$$37$YR$A$M$Y$$$20240702$$CN$US$US
238622312$23862231$2$F$$20240628$20240516$20240705$30DAY$$US-GSK-US2024057432$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$PH$US$US
238622572$23862257$2$F$$20240819$20240516$20240826$EXP$$NVSC2024BR060153$NOVARTIS$$$$$M$Y$$$20240826$$CN$BR$BR
238622612$23862261$2$F$$20240821$20240516$20240826$EXP$$GB-MYLANLABS-2024M1043278$MYLAN$$$$$F$Y$$$20240826$$CN$GB$GB
238622952$23862295$2$F$20240429$20240715$20240516$20240717$PER$$US-PFIZER INC-202400108385$PFIZER$$57$YR$$M$Y$$$20240717$$PH$US$US
238623023$23862302$3$F$$20240904$20240516$20240911$EXP$$US-PFIZER INC-PV202400063920$PFIZER$$65$YR$$F$Y$62.5$KG$20240911$$CN$US$US
238623535$23862353$5$F$20240909$20240910$20240516$20240913$EXP$$NVSC2024AR073418$NOVARTIS$$60$YR$$F$Y$$$20240913$$CN$AR$AR
238623572$23862357$2$F$20240213$20240701$20240516$20240703$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-120860$DAIICHI$$66$YR$$F$Y$$$20240703$$MD$US$US
238623843$23862384$3$F$20240401$20240620$20240516$20240701$PER$$US-AMGEN-USASP2024094599$AMGEN$$75$YR$E$M$Y$$$20240701$$CN$US$US
238623995$23862399$5$F$20240101$20240905$20240516$20240914$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-009300$UNITED THERAPEUTICS$$$$$M$Y$84.3$KG$20240914$$$JP$JP
238624022$23862402$2$F$20240506$20240913$20240516$20240921$EXP$$CA-CELLTRION INC.-2024CA011230$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
238624072$23862407$2$F$20230101$20240514$20240516$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-247147$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$70$KG$20240813$$CN$ES$ES
238624192$23862419$2$F$$20240624$20240516$20240704$30DAY$$US-GSK-US2024057441$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
238624224$23862422$4$F$20240101$20240716$20240516$20240720$EXP$$US-JNJFOC-20240521237$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240720$$CN$US$US
238624262$23862426$2$F$$20240514$20240516$20240722$EXP$$NVSC2024CA102603$NOVARTIS$$69$YR$$M$Y$$$20240722$$HP$CA$CA
238624372$23862437$2$F$$20240628$20240516$20240704$EXP$$NVSJ2024JP005788$NOVARTIS$$$$A$F$Y$$$20240704$$PH$JP$JP
238624402$23862440$2$F$$20240620$20240516$20240701$EXP$$NVSJ2024JP005600$NOVARTIS$Aizawa Y, Arai S, Sato R, Yoshida Y, Hasegawa A, Hiyama C et al.. A Patient who Developed Secondary Alveolar Proteinosis during Treatment for Refractory Adult onset Still^s Disease. Program and Abstracts for The 68th Annual General Assembly and Scientific Meetin. 2024;P3-249$63$YR$$F$Y$$$20240701$$HP$JP$JP
238624492$23862449$2$F$$20240711$20240516$20240721$EXP$$GB-TEVA-VS-3156979$TEVA$$$$E$M$Y$$$20240721$$CN$GB$GB
238624592$23862459$2$F$$20240627$20240516$20240703$EXP$$TZ-AUROBINDO-AUR-APL-2024-023583$AUROBINDO$Pallangyo P, Bhalia SV, Komba M, Mkojera ZS, Mayala HA, Kifai E, et al.. A nightmare of clopidogrel resistance in a resource-limited setting: case report of subacute stent thrombosis.. The Egyptian Heart Journal. 2023;75(1):1-8$60$YR$$M$Y$$$20240703$$HP$TZ$TZ
238624782$23862478$2$F$20231111$20240906$20240516$20240919$EXP$$ES-AUROBINDO-AUR-APL-2024-022903$AUROBINDO$$69$YR$$M$Y$79$KG$20240919$$MD$ES$ES
238624872$23862487$2$F$$20240923$20240516$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202405007930$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240925$$CN$US$US
238625003$23862500$3$F$$20240627$20240516$20240705$EXP$$JP-OTSUKA-2024_002458$OTSUKA$$7$DEC$$M$Y$$$20240705$$MD$JP$JP
238625032$23862503$2$F$$20240704$20240516$20240710$EXP$$US-MYLANLABS-2024M1043090$MYLAN$$$$$F$Y$$$20240710$$CN$US$US
238625054$23862505$4$F$20240407$20240806$20240516$20240814$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014440$UNITED THERAPEUTICS$$77$YR$$M$Y$71.202$KG$20240814$$$US$US
238625162$23862516$2$F$20240514$20240716$20240516$20240718$PER$$US-AMGEN-USASP2024096595$AMGEN$$69$YR$E$M$Y$97.959$KG$20240718$$CN$US$US
238625233$23862523$3$F$$20240917$20240516$20240919$PER$$US-PFIZER INC-PV202400063298$PFIZER$$63$YR$$F$Y$$$20240919$$HP$US$US
238625296$23862529$6$F$20200101$20240911$20240516$20240917$EXP$$CA-TAKEDA-CA202027986$TAKEDA$$$$$F$Y$99$KG$20240917$$CN$CA$CA
238625333$23862533$3$F$$20240823$20240516$20240829$PER$$US-PFIZER INC-PV202400059702$PFIZER$$76$YR$$F$Y$81.65$KG$20240829$$MD$US$US
238625452$23862545$2$F$$20240814$20240516$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075804$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240820$$HP$US$US
238625532$23862553$2$F$$20240801$20240516$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075506$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240802$$CN$US$US
238626403$23862640$3$F$20240512$20240712$20240516$20240712$EXP$$US-BAYER-2024A071265$BAYER$$79$YR$E$F$Y$53.061$KG$20240712$$PH$US$US
238626534$23862653$4$F$$20240830$20240516$20240904$EXP$$US-BEH-2024172254$CSL BEHRING$$62$YR$A$F$Y$78.49$KG$20240904$$HP$US$US
238626734$23862673$4$F$20240427$20240805$20240516$20240815$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004610$SAREPTA THERAPEUTICS$$7$YR$$M$Y$24.036$KG$20240815$$HP$US$US
238627062$23862706$2$F$$20240710$20240516$20240710$EXP$$CA-PFIZER INC-202400106557$PFIZER$$53$YR$$F$Y$$$20240710$$HP$CA$CA
238627103$23862710$3$F$$20240915$20240516$20240919$30DAY$$US-PFIZER INC-202400107244$PFIZER$$13$YR$$M$Y$31.746$KG$20240919$$CN$US$US
238627213$23862721$3$F$20240101$20240715$20240516$20240718$EXP$$US-PFIZER INC-202400107683$PFIZER$$73$YR$$F$Y$$$20240718$$HP$US$US
238627233$23862723$3$F$$20240905$20240516$20240909$30DAY$$CO-PFIZER INC-PV202400060548$PFIZER$$15$YR$$M$Y$$$20240909$$CN$CO$CO
238627248$23862724$8$F$$20240818$20240516$20240821$30DAY$$US-PFIZER INC-202400105851$PFIZER$$12$YR$$M$Y$41.7$KG$20240821$$MD$US$US
238627253$23862725$3$F$20240514$20240711$20240516$20240712$30DAY$$TW-PFIZER INC-PV202400062344$PFIZER$$$$E$F$Y$$$20240712$$HP$TW$TW
238627295$23862729$5$F$20240101$20240821$20240516$20240828$30DAY$$US-PFIZER INC-202400107223$PFIZER$$19$MON$$F$Y$8.62$KG$20240828$$CN$US$US
238627304$23862730$4$F$20240513$20240812$20240516$20240816$30DAY$$JP-PFIZER INC-PV202400061809$PFIZER$$$$$$Y$$$20240816$$HP$JP$JP
238627373$23862737$3$F$20240511$20240913$20240516$20240918$30DAY$$US-PFIZER INC-202400107506$PFIZER$$13$YR$$M$Y$$$20240918$$CN$US$US
238627392$23862739$2$F$20231130$20240711$20240516$20240717$EXP$DE-BFARM-24003109$DE-MYLANLABS-2024M1042671$MYLAN$$35$YR$$F$Y$$$20240717$$MD$DE$DE
238627464$23862746$4$F$$20240829$20240516$20240903$30DAY$$US-PFIZER INC-202400107581$PFIZER$$12$YR$$F$Y$$$20240903$$MD$US$US
238627505$23862750$5$F$20240101$20240917$20240516$20240924$EXP$$TN-SA-2024SA141389$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240924$$MD$TN$TN
238627525$23862752$5$F$$20240619$20240516$20240702$EXP$$CA-ROCHE-3564742$ROCHE$$$$A$F$Y$$$20240703$$MD$CA$CA
238627635$23862763$5$F$$20240910$20240516$20240920$EXP$$CA-SANDOZ INC.-SDZ2024CA047814$SANDOZ$$65$YR$$F$Y$34$KG$20240920$$CN$CA$CA
238627716$23862771$6$F$$20240915$20240516$20240919$30DAY$$US-PFIZER INC-202400106856$PFIZER$$32$YR$$F$Y$$$20240919$$CN$US$US
238627733$23862773$3$F$$20231229$20240516$20240905$EXP$$CN-PFIZER INC-PV202400063053$PFIZER$$34$YR$$M$Y$85$KG$20240905$$CN$CN$CN
238627752$23862775$2$F$20240101$20240906$20240516$20240910$30DAY$$KR-PFIZER INC-PV202400061894$PFIZER$$5$YR$$M$Y$$$20240910$$CN$KR$KR
238627762$23862776$2$F$20240509$20240925$20240516$20240930$30DAY$$AR-PFIZER INC-202400106460$PFIZER$$11$YR$$M$Y$$$20240930$$CN$AR$AR
238627772$23862777$2$F$20240509$20240913$20240516$20240917$30DAY$$AR-PFIZER INC-202400106470$PFIZER$$13$YR$$M$Y$$$20240917$$CN$AR$AR
238627812$23862781$2$F$$20240813$20240516$20240814$EXP$$US-JNJFOC-20240545377$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$US$US
238627862$23862786$2$F$20240101$20240626$20240516$20240703$EXP$$JP-GENMAB-2024-01595$GENMAB$$8$DEC$$F$Y$$$20240703$$MD$JP$JP
238627872$23862787$2$F$20240704$20240710$20240516$20240724$EXP$$US-SA-2024SA143758$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240724$$MD$US$US
238627883$23862788$3$F$20230803$20240822$20240516$20240831$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-014569$UNITED THERAPEUTICS$$78$YR$$M$Y$$$20240831$$$JP$JP
238627972$23862797$2$F$$20240701$20240516$20240704$PER$$US-MYLANLABS-2024M1037462$MYLAN$$$$$F$Y$65.77$KG$20240704$$CN$US$US
238627982$23862798$2$F$$20240704$20240516$20240716$30DAY$$TR-JNJFOC-20240538145$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$TR$TR
238628242$23862824$2$F$$20240710$20240516$20240718$EXP$$US-SANDOZ INC.-SDZ2023US022408$SANDOZ$$$$$F$Y$$$20240718$$CN$US$US
238628252$23862825$2$F$20240508$20240715$20240516$20240715$PER$$US-ALXN-202405USA000538US$ALEXION PHARMACEUTICALS$$40$YR$$F$Y$$$20240715$$CN$US$US
238628472$23862847$2$F$20240804$20240804$20240516$20240808$EXP$$AE-TAKEDA-2024TUS048502$TAKEDA$$$$$$Y$$$20240808$$CN$AE$AE
238628593$23862859$3$F$20230407$20240731$20240516$20240824$EXP$$JP-AstraZeneca-2023A087046$ASTRAZENECA$$5$YR$C$F$Y$24$KG$20240823$$MD$JP$
238628622$23862862$2$F$20240401$20240705$20240516$20240712$EXP$$US-AstraZeneca-2024A109229$ASTRAZENECA$$61$YR$$F$Y$$$20240712$$CN$US$
238628655$23862865$5$F$20240505$20240716$20240516$20240729$EXP$$BR-PFIZER INC-202400107392$PFIZER$$44$YR$$M$Y$63$KG$20240729$$CN$BR$BR
238628882$23862888$2$F$$20240715$20240516$20240715$PER$$US-ALXN-202405USA000574US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$MD$US$US
238628892$23862889$2$F$20190701$20240715$20240516$20240715$PER$$US-ALXN-202405USA000547US$ALEXION PHARMACEUTICALS$$78$YR$$F$Y$$$20240715$$CN$US$US
238628933$23862893$3$F$20240501$20240918$20240516$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-007505$JAZZ$$7$YR$$F$Y$$$20240922$$CN$US$US
238628952$23862895$2$F$$20240729$20240516$20240802$EXP$$GB-ROCHE-3560269$ROCHE$$$$$$Y$$$20240802$$MD$GB$GB
238628962$23862896$2$F$$20240702$20240516$20240703$PER$$NVSC2024US103901$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
238629162$23862916$2$F$$20240620$20240516$20240702$30DAY$$SA-JNJFOC-20240535732$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$SA$SA
238629283$23862928$3$F$$20240705$20240516$20240716$EXP$$AT-TEVA-VS-3197935$TEVA$$$$A$M$Y$$$20240716$$MD$AT$AT
238629343$23862934$3$F$20240501$20240724$20240516$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-009914$JAZZ$$47$YR$$F$Y$$$20240730$$HP$US$US
238629403$23862940$3$F$20230428$20240811$20240516$20240816$EXP$$CA-GSK-CA2023063260$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$HP$CA$CA
238629414$23862941$4$F$$20240708$20240516$20240711$EXP$$CA-GSK-CA2024060190$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$CA$CA
238629533$23862953$3$F$$20240719$20240516$20240724$EXP$$NVSC2024US102242$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
238629553$23862955$3$F$20230101$20240718$20240516$20240730$EXP$$BR-TEVA-VS-3197586$TEVA$$33$YR$$F$Y$$$20240730$$CN$BR$BR
238629604$23862960$4$F$20240206$20240830$20240516$20240905$EXP$$JP-AstraZeneca-2024A110147$ASTRAZENECA$$60$YR$$F$Y$53$KG$20240905$$MD$JP$
238629612$23862961$2$F$$20240726$20240516$20240726$PER$$NVSC2024US103112$NOVARTIS$$$$$$Y$$$20240726$$MD$US$US
238629655$23862965$5$F$20240502$20240806$20240516$20240828$PER$$JP-Eisai-EC-2024-165735$EISAI$$73$YR$E$M$Y$$$20240828$$MD$JP$JP
238629732$23862973$2$F$$20240814$20240516$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075669$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240912$$CN$US$US
238629783$23862978$3$F$20240501$20240731$20240516$20240805$30DAY$$US-GSK-US2024058417$GLAXOSMITHKLINE$$69$YR$$M$Y$$$20240804$$HP$US$US
238629902$23862990$2$F$$20240807$20240516$20240822$PER$$US-LEADINGPHARMA-US-2024LEASPO00145$LEADING PHARMA$$$$$$Y$$$20240822$$CN$US$US
238629922$23862992$2$F$20240101$20240805$20240516$20240812$PER$$US-BAYER-2024A071853$BAYER$$32$YR$A$F$Y$$$20240812$$CN$US$US
238630002$23863000$2$F$20240101$20240823$20240516$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000424$DECIPHERA PHARMACEUTICALS$$55$YR$A$M$Y$$$20240905$$CN$US$US
238630032$23863003$2$F$20211101$20240515$20240516$20240802$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-146645$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$70$KG$20240802$$CN$ES$ES
238630072$23863007$2$F$$20240729$20240516$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074796$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240730$$CN$US$US
238630143$23863014$3$F$20240101$20240816$20240516$20240826$EXP$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000436$DECIPHERA PHARMACEUTICALS$$59$YR$A$F$Y$72.562$KG$20240826$$CN$US$US
238630162$23863016$2$F$$20240624$20240516$20240702$EXP$$US-AstraZeneca-2024A109299$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
238630332$23863033$2$F$$20240514$20240516$20240708$PER$$US-PFIZER INC-202400108355$PFIZER$$63$YR$$F$Y$$$20240708$$HP$US$US
238630442$23863044$2$F$$20240904$20240516$20240906$PER$$US-PFIZER INC-PV202400063768$PFIZER$$74$YR$$F$Y$$$20240906$$CN$US$US
238630612$23863061$2$F$$20240803$20240516$20240805$EXP$$CA-PFIZER INC-202400107775$PFIZER$$75$YR$$M$Y$$$20240805$$HP$CA$CA
238630642$23863064$2$F$20210501$20240712$20240516$20240715$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098187$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$62.6$KG$20240715$$CN$ES$ES
238630678$23863067$8$F$20240201$20240716$20240516$20240723$EXP$$CA-JNJFOC-20240385170$JOHNSON AND JOHNSON$$55$YR$A$F$Y$117$KG$20240723$$HP$CA$CA
238630753$23863075$3$F$$20240904$20240516$20240913$EXP$$US-GSK-US2024AMR059871$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
238630862$23863086$2$F$20230101$20240709$20240516$20240715$EXP$$BR-TAKEDA-2023TUS085296$TAKEDA$$$$$F$Y$11$KG$20240715$$CN$BR$BR
238630952$23863095$2$F$20220704$20240820$20240516$20240827$EXP$$NVSC2024RU103127$NOVARTIS$$$$A$M$Y$$$20240827$$MD$RU$RU
238631062$23863106$2$F$20240505$20240826$20240516$20240904$PER$$US-AstraZeneca-2024A107066$ASTRAZENECA$$21573$DY$$F$Y$$$20240904$$CN$US$
238631092$23863109$2$F$$20240808$20240516$20240809$PER$$US-ABBVIE-5760862$ABBVIE$$$$$F$Y$$$20240809$$HP$US$US
238631102$23863110$2$F$$20240725$20240516$20240730$EXP$$CA-SA-2024SA142944$SANOFI AVENTIS$Unknown. Unknown. Unknown. Unkn;Unknown:Unknown$$$A$$Y$$$20240730$$MD$CA$CA
238631312$23863131$2$F$$20240617$20240516$20240711$EXP$$CA-002147023-NVSC2024CA031685$Haleon PLC$$44$YR$$F$Y$$$20240711$$HP$CA$CA
238631352$23863135$2$F$$20240710$20240516$20240710$EXP$$CA-PFIZER INC-202400107847$PFIZER$$47$YR$$M$Y$$$20240710$$HP$CA$CA
238631363$23863136$3$F$20240420$20240710$20240516$20240717$EXP$$DE-PFIZER INC-202400108837$PFIZER$$$$A$M$Y$56$KG$20240717$$HP$DE$DE
238631385$23863138$5$F$20230101$20240924$20240516$20240926$EXP$$US-PFIZER INC-PV202400063833$PFIZER$$71$YR$$F$Y$$$20240926$$HP$US$US
238631572$23863157$2$F$$20240909$20240516$20240918$30DAY$$US-GSK-US2024060097$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
238631583$23863158$3$F$20240515$20240715$20240516$20240716$PER$$US-AMGEN-USASP2024097214$AMGEN$$78$YR$E$F$Y$$$20240716$$CN$US$US
238631642$23863164$2$F$$20240826$20240516$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US049141$SANDOZ$$$$$M$Y$$$20240827$$CN$US$US
238631662$23863166$2$F$$20240909$20240516$20240913$EXP$$US-SANDOZ INC.-SDZ2024US048420$SANDOZ$Li Y, Ang H S, Fatehi P.. The Roller Coaster of Lamotrigine Levels: Successful Treatment of Massive Lamotrigine Overdose With Continuous Veno-Venous Hemodiafiltration and Rifampin. Cureus. 2024;16(7):e65637$66$YR$$M$Y$86$KG$20240913$$MD$US$US
238632244$23863224$4$F$$20240913$20240516$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA049117$SANDOZ$$84$YR$$M$Y$$$20240916$$HP$CA$CA
238632423$23863242$3$F$20211101$20240712$20240516$20240715$EXP$$US-ALXN-202405USA000493US$ALEXION PHARMACEUTICALS$$46$YR$$F$Y$$$20240715$$MD$US$US
238632705$23863270$5$F$$20240812$20240516$20240816$PER$$US-PFIZER INC-PV202300155816$PFIZER$$77$YR$$F$Y$63.4$KG$20240816$$CN$US$US
238632717$23863271$7$F$$20240920$20240516$20240923$30DAY$$US-PFIZER INC-202400099316$PFIZER$$$$$$Y$$$20240923$$PH$US$US
238632793$23863279$3$F$20230802$20240513$20240516$20240927$EXP$$NVSC2024CA103696$NOVARTIS$$69$YR$$M$Y$$$20240927$$CN$CA$CA
238632805$23863280$5$F$20240114$20240901$20240516$20240903$EXP$$IT-BAUSCH-BL-2024-007526$BAUSCH AND LOMB$$63$YR$$M$Y$82$KG$20240903$$HP$IT$IT
238632834$23863283$4$F$20240506$20240607$20240516$20240926$EXP$$US-GSK-US2024AMR059215$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
238633133$23863313$3$F$20240301$20240916$20240516$20240923$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-13455$SAMSUNG BIOEPIS$$40$YR$A$F$Y$$$20240923$$PH$CA$CA
238633172$23863317$2$F$20240401$20240726$20240516$20240809$EXP$$US-UCBSA-2024023602$UCB$$56$YR$$F$Y$$$20240809$$HP$US$US
238633192$23863319$2$F$20230731$20240816$20240516$20240819$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-000477$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$43$KG$20240820$$MD$DE$DE
238633222$23863322$2$F$$20240801$20240516$20240805$EXP$$US-TAKEDA-2024TUS048439$TAKEDA$$$$$$Y$$$20240805$$MD$US$US
238633235$23863323$5$F$20240515$20240830$20240516$20240913$EXP$$US-UCBSA-2024022247$UCB$$10$YR$$F$Y$42$KG$20240913$$CN$US$US
238633242$23863324$2$F$20231113$20240917$20240516$20240925$EXP$$JP-JNJFOC-20240545902$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240926$$MD$JP$JP
238633312$23863331$2$F$$20240726$20240516$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074982$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240729$$CN$US$US
238633323$23863332$3$F$$20240816$20240516$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076029$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240816$$MD$US$US
238633452$23863345$2$F$20240304$20240527$20240516$20240910$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-055962$REGENERON$$63$YR$$F$Y$$$20240910$$CN$CA$CA
238633472$23863347$2$F$$20240808$20240516$20240812$EXP$$US-PFIZER INC-202400108906$PFIZER$$78$YR$$F$Y$$$20240812$$CN$US$US
238633715$23863371$5$F$20240503$20240626$20240516$20240709$EXP$$GB-BEH-2024172198$CSL BEHRING$$79$YR$E$M$Y$$$20240709$$CN$GB$GB
238633792$23863379$2$F$$20240826$20240516$20240830$EXP$$JP-TAKEDA-2024TUS046545$TAKEDA$Fukuda M. Multiple myeloma with central nervous invasion presenting hydrocephalus. Proceedings of the 63rd Chugoku-Shikoku Regional Meeting of the Japanese Society. 2024;3 (16):40$81$YR$$M$Y$$$20240830$$MD$JP$JP
238633812$23863381$2$F$20240418$20240710$20240516$20240910$EXP$$ES-TEVA-VS-3197075$TEVA$$72$YR$$M$Y$$$20240910$$CN$ES$ES
238633912$23863391$2$F$20240408$20240912$20240516$20240920$EXP$$CA-TOLMAR, INC.-24CA048296$TOLMAR$$94$YR$$M$Y$$$20240920$$CN$CA$CA
238634104$23863410$4$F$$20240924$20240516$20240927$EXP$$US-TAKEDA-2023TUS082445$TAKEDA$$$$$M$Y$$$20240927$$CN$US$US
238634182$23863418$2$F$$20240807$20240516$20240813$EXP$$US-SA-2024SA054002$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240813$$CN$US$US
238634193$23863419$3$F$20230101$20240820$20240516$20240902$EXP$$US-UCBSA-2023035294$UCB$$$$$F$Y$80.091$KG$20240902$$HP$US$US
238634222$23863422$2$F$20240101$20240830$20240516$20240917$EXP$$US-SA-2024SA147992$SANOFI AVENTIS$$63$YR$A$F$Y$60.781$KG$20240917$$MD$US$US
238634252$23863425$2$F$$20240911$20240516$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075882$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$$$20240912$$HP$US$US
238634692$23863469$2$F$$20240513$20240516$20240716$EXP$$BG-AMGEN-BGRSP2024095378$AMGEN$$63$YR$A$M$Y$$$20240716$$MD$BG$BG
238634773$23863477$3$F$20240501$20240701$20240516$20240709$EXP$$JP-ARGENX-2024-ARGX-JP003087AA$ARGENX BVBA$$$$$$Y$$$20240709$$MD$JP$JP
238634812$23863481$2$F$$20240802$20240516$20240808$EXP$$JP-009507513-2401JPN000249J$MERCK$$8$DEC$$M$Y$$$20240808$$MD$JP$JP
238634894$23863489$4$F$20240412$20240627$20240516$20240709$EXP$$AU-GUERBET / LLC-AU-20240030$GUERBET$$18$YR$A$M$Y$67$KG$20240709$$HP$AU$AU
238635212$23863521$2$F$$20240829$20240516$20240904$EXP$$CA-PFIZER INC-202300312064$PFIZER$$62$YR$$F$Y$$$20240904$$HP$CA$CA
238635242$23863524$2$F$20231206$20240809$20240516$20240813$EXP$$NVSC2023GB260765$NOVARTIS$$$$$M$Y$$$20240813$$CN$GB$GB
238635252$23863525$2$F$$20240717$20240516$20240719$EXP$$NVSC2024US103560$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
238635272$23863527$2$F$$20240708$20240516$20240715$EXP$$IN-ROCHE-3560103$ROCHE$$68$YR$E$M$Y$$$20240715$$CN$IN$IN
238635472$23863547$2$F$$20240627$20240516$20240709$PER$$US-INCYTE CORPORATION-2024IN004233$INCYTE$$$$$$Y$$$20240709$$CN$US$US
238635532$23863553$2$F$$20240628$20240516$20240723$EXP$$US-Vifor (International) Inc.-VIT-2024-03783$VIFOR$$$$$$Y$$$20240723$$HP$US$US
238635613$23863561$3$F$20240411$20240813$20240516$20240820$EXP$$CZ-009507513-2405CZE002853$MERCK$$26$YR$$F$Y$95$KG$20240820$$CN$CZ$CZ
238635622$23863562$2$F$$20240815$20240516$20240823$PER$$US-Eisai-EC-2024-163769$EISAI$$$$E$F$Y$$$20240823$$MD$US$US
238635772$23863577$2$F$20240507$20240715$20240516$20240715$PER$$US-ALXN-202405USA000764US$ALEXION PHARMACEUTICALS$$39$YR$$F$Y$$$20240715$$CN$US$US
238635802$23863580$2$F$20240401$20240430$20240516$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000132$ARCUTIS$$$$$$Y$$$20240819$$CN$US$US
238635812$23863581$2$F$$20240516$20240516$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000134$ARCUTIS$$$$$$Y$$$20240819$$MD$US$US
238636024$23863602$4$F$20240301$20240820$20240516$20240821$EXP$$US-INCYTE CORPORATION-2024IN005150$INCYTE$$$$$$Y$$$20240821$$CN$US$US
238636094$23863609$4$F$20240221$20240718$20240516$20240724$30DAY$$US-AMGEN-USASL2024094369$AMGEN$$63$YR$A$F$Y$$$20240724$$HP$US$US
238636283$23863628$3$F$20240502$20240716$20240516$20240727$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-13814$SAMSUNG BIOEPIS$$75$YR$E$F$Y$$$20240727$$CN$CA$CA
238636373$23863637$3$F$20240508$20240910$20240516$20240912$30DAY$$IT-SANDOZ INC.-SDZ2024IT048125$SANDOZ$$77$YR$$F$Y$78$KG$20240912$$CN$IT$IT
238636422$23863642$2$F$20240415$20240821$20240516$20240831$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-13418$SAMSUNG BIOEPIS$$63$YR$A$M$Y$88$KG$20240831$$CN$CA$CA
238636582$23863658$2$F$20210923$20240628$20240516$20240712$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-13473$SAMSUNG BIOEPIS$$65$YR$E$F$Y$127$KG$20240712$$CN$CA$CA
238636612$23863661$2$F$20240425$20240803$20240516$20240816$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-13350$SAMSUNG BIOEPIS$$20$YR$A$M$Y$$$20240814$$CN$CA$CA
238636882$23863688$2$F$$20240731$20240516$20240805$EXP$CZ-CZSUKL-24001241$CZ-009507513-2405CZE002848$MERCK$$$$$$Y$$$20240805$$CN$CZ$CZ
238636992$23863699$2$F$$20240509$20240516$20240723$EXP$$NVSC2024GB099733$NOVARTIS$Fernando F, Innes AJ, Claudiani S, Pryce A, Hayden C, Byrne J et al.. The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia. BONE MARROW TRANSPLANTATION. 2023;58 (7):1-3$27$YR$$M$Y$$$20240723$$HP$GB$GB
238637263$23863726$3$F$20240304$20240701$20240516$20240705$EXP$$US-OTSUKA-2024_006780$OTSUKA$$45$YR$$M$Y$$$20240705$$MD$US$US
238637392$23863739$2$F$20240427$20240701$20240516$20240705$PER$$US-BAYER-2024A068030$BAYER$$51$YR$A$F$Y$$$20240705$$CN$US$US
238637442$23863744$2$F$$20240708$20240516$20240711$EXP$$NVSC2024US102480$NOVARTIS$$$$$F$Y$$$20240711$$CN$US$US
238637473$23863747$3$F$20240101$20240627$20240516$20240709$EXP$$US-INSMED, INC.-2024-01815-US$INSMED$$$$$M$Y$$$20240709$$CN$US$US
238637524$23863752$4$F$20240101$20240809$20240516$20240814$EXP$$US-PFIZER INC-PV202400063271$PFIZER$$74$YR$$F$Y$57.596$KG$20240814$$CN$US$US
238637644$23863764$4$F$20231109$20240909$20240516$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075947$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$69.76$KG$20240911$$CN$US$US
238637916$23863791$6$F$20240401$20240812$20240516$20240820$30DAY$$JP-PFIZER INC-PV202400059294$PFIZER$$8$DEC$$F$Y$$$20240820$$PH$JP$JP
238637923$23863792$3$F$$20240703$20240516$20240717$PER$$US-Calliditas-2024CAL00707$CALLIDITAS THERAPEUTICS$$43$YR$A$M$Y$91.6$KG$20240717$$CN$US$US
238638003$23863800$3$F$$20240715$20240516$20240715$PER$$US-ALXN-202405USA000546US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238638243$23863824$3$F$$20240919$20240516$20240924$EXP$$CA-SANDOZ INC.-SDZ2024CA049047$SANDOZ$$$$$F$Y$$$20240924$$MD$CA$CA
238638282$23863828$2$F$20240117$20240717$20240516$20240720$EXP$$NVSC2024GB103495$NOVARTIS$$51$YR$$F$Y$79$KG$20240720$$CN$GB$GB
238638524$23863852$4$F$$20240821$20240516$20240826$30DAY$$US-PFIZER INC-202400106971$PFIZER$$10$YR$$M$Y$$$20240826$$HP$US$US
238638614$23863861$4$F$20240531$20240704$20240516$20240708$EXP$$CA-TAKEDA-2024TUS048365$TAKEDA$$43$YR$$M$Y$$$20240708$$CN$CA$CA
238638622$23863862$2$F$20240301$20240910$20240516$20240917$EXP$$US-ABBVIE-5761771$ABBVIE$$72$YR$$M$Y$$$20240917$$CN$US$US
238638644$23863864$4$F$$20240812$20240516$20240816$30DAY$$US-PFIZER INC-202400104967$PFIZER$$72$YR$$F$Y$58.06$KG$20240816$$CN$US$US
238638656$23863865$6$F$$20240812$20240516$20240816$30DAY$$US-PFIZER INC-202400105665$PFIZER$$$$$$Y$$$20240816$$PH$US$US
238638673$23863867$3$F$20240101$20240917$20240516$20240919$30DAY$$CA-PFIZER INC-202400104754$PFIZER$$15$YR$$F$Y$$$20240919$$CN$CA$CA
238638702$23863870$2$F$20240101$20240805$20240516$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075855$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240806$$CN$US$US
238638713$23863871$3$F$20240508$20240709$20240516$20240713$EXP$$US-ABBVIE-5760406$ABBVIE$$63$YR$$M$Y$$$20240713$$CN$US$US
238638772$23863877$2$F$$20240731$20240516$20240807$EXP$$US-TAKEDA-2024TUS046550$TAKEDA$$23$YR$$F$Y$$$20240807$$CN$US$US
238639052$23863905$2$F$20240512$20240826$20240516$20240828$30DAY$$US-SANDOZ INC.-SDZ2024US049070$SANDOZ$$60$YR$$M$Y$$$20240828$$HP$US$US
238639132$23863913$2$F$20230926$20240702$20240516$20240711$EXP$$IE-SA-2023SA314577$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240711$$CN$IE$IE
238639182$23863918$2$F$20240101$20240718$20240516$20240723$EXP$$US-SA-2024SA118213$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240723$$MD$US$US
238639314$23863931$4$F$20240101$20240919$20240516$20240924$EXP$$US-SA-2024SA148015$SANOFI AVENTIS$$80$YR$E$M$Y$108.4$KG$20240924$$MD$US$US
238639624$23863962$4$F$20200101$20240814$20240516$20240821$PER$$US-BIOGEN-2020BI00913806$BIOGEN$$$$$M$Y$$$20240821$$CN$US$US
238639694$23863969$4$F$$20240906$20240516$20240917$EXP$$NVSC2024GB100855$NOVARTIS$$$$A$M$Y$$$20240917$$HP$GB$GB
238639833$23863983$3$F$20231101$20240715$20240516$20240722$EXP$$US-JNJFOC-20240537614$JOHNSON AND JOHNSON$$46$YR$A$F$Y$49.486$KG$20240722$$HP$US$US
238639853$23863985$3$F$$20240912$20240516$20240923$PER$$US-INCYTE CORPORATION-2024IN005040$INCYTE$$$$$$Y$$$20240923$$CN$US$US
238639862$23863986$2$F$$20240816$20240516$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075219$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240816$$CN$US$US
238639872$23863987$2$F$$20240912$20240516$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072350$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240917$$CN$US$US
238639902$23863990$2$F$20230820$20240628$20240516$20240711$PER$$US-MYLANLABS-2024M1040310$MYLAN$$$$$$Y$$$20240711$$CN$US$US
238639933$23863993$3$F$$20240724$20240516$20240731$EXP$$NVSC2024CL101212$NOVARTIS$$$$$F$Y$$$20240731$$CN$CL$CL
238639982$23863998$2$F$20240409$20240712$20240516$20240717$EXP$$NVSC2024US100535$NOVARTIS$$59$YR$$F$Y$$$20240717$$CN$US$US
238640273$23864027$3$F$$20240830$20240516$20240904$EXP$$NVSC2024US102836$NOVARTIS$$$$$$Y$$$20240904$$CN$US$US
238640294$23864029$4$F$20220922$20240904$20240516$20240909$EXP$$US-OTSUKA-2024_001141$OTSUKA$$54$YR$$M$Y$74.83$KG$20240909$$MD$US$US
238640422$23864042$2$F$20240430$20240806$20240516$20240812$EXP$$US-INCYTE CORPORATION-2024IN004787$INCYTE$$$$$$Y$$$20240812$$CN$US$US
238640462$23864046$2$F$20240514$20240726$20240516$20240726$PER$$NVSC2024US103178$NOVARTIS$$51$YR$$$Y$$$20240726$$CN$US$US
238640583$23864058$3$F$20240409$20240628$20240516$20240705$EXP$$CH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-027756$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$56$KG$20240705$$MD$CH$CH
238640702$23864070$2$F$20220501$20240829$20240516$20240905$EXP$$JP-009507513-2405JPN001076J$MERCK$$8$DEC$$M$Y$$$20240905$$MD$JP$JP
238640742$23864074$2$F$$20240726$20240516$20240726$PER$$NVSC2024US103308$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
238640814$23864081$4$F$20240130$20240819$20240516$20240829$PER$$US-INCYTE CORPORATION-2024IN005015$INCYTE$$$$$$Y$$$20240829$$CN$US$US
238640832$23864083$2$F$20240301$20240729$20240516$20240802$EXP$$US-BIOGEN-2024BI01258150$BIOGEN$$66$YR$$F$Y$$$20240802$$CN$US$US
238640962$23864096$2$F$$20240628$20240516$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074876$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240701$$CN$US$US
238640983$23864098$3$F$$20240509$20240516$20240705$EXP$$NVSC2024TW099466$NOVARTIS$$$$A$M$Y$$$20240705$$MD$TW$TW
238641254$23864125$4$F$$20240726$20240516$20240806$EXP$$GR-ELI_LILLY_AND_COMPANY-GR202405005092$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240806$$CN$GR$GR
238641302$23864130$2$F$$20240820$20240516$20240904$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00741$AVADEL CNS PHARMA$$$$$F$Y$$$20240904$$CN$US$US
238641323$23864132$3$F$20240401$20240813$20240516$20240828$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00725$AVADEL CNS PHARMA$$42$YR$$F$Y$83.5$KG$20240828$$CN$US$US
238641492$23864149$2$F$$20240906$20240516$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075824$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240910$$HP$US$US
238641535$23864153$5$F$20240901$20240919$20240516$20240925$PER$$US-Blueprint Medicines Corporation-SP-US-2024-000993$BLUEPRINT MEDICINES$$57$YR$A$F$Y$$$20240925$$CN$US$US
238641563$23864156$3$F$$20240717$20240516$20240719$EXP$$US-ABBVIE-5761983$ABBVIE$$$$$M$Y$$$20240719$$CN$US$US
238641592$23864159$2$F$20240422$20240726$20240516$20240801$EXP$IT-MINISAL02-983977$IT-MYLANLABS-2024M1043048$MYLAN$$26$YR$$F$Y$$$20240801$$MD$IT$IT
238641712$23864171$2$F$$20240709$20240516$20240719$EXP$$PT-TEVA-VS-3197615$TEVA$Gomes DA, Paiva MS, Ranchordas S, Santos RR, Ferreira J, Trabulo M. Acute Coronary Syndrome in a Young Male with Long-Term Use of Anabolic-Androgenic Steroids. Arq-Bras-Cardiol 2023; 120 (2):.; Gomes DA, Paiva MS, Ranchordas S, Santos RR, Ferreira J, Trabulo M. Acute Coronary Syndrome in a Young Male with Long-Term Use of Anabolic-Androgenic Steroids. Arq-Bras-Cardiol 2023; 120 (2):.$43$YR$$M$Y$$$20240719$$HP$PT$PT
238641723$23864172$3$F$$20240808$20240516$20240815$EXP$$US-SA-2024SA147721$SANOFI AVENTIS$$84$YR$E$M$Y$63.5$KG$20240815$$MD$US$US
238641793$23864179$3$F$20240328$20240625$20240516$20240705$PER$$US-Eisai-EC-2024-164183$EISAI$$54$YR$A$M$Y$$$20240705$$HP$US$US
238641802$23864180$2$F$20240508$20240701$20240516$20240709$EXP$$US-AstraZeneca-2024A109998$ASTRAZENECA$$30643$DY$$M$Y$$$20240709$$CN$US$
238641865$23864186$5$F$$20240926$20240516$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075550$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$65.77$KG$20240930$$CN$US$US
238641992$23864199$2$F$$20240712$20240516$20240722$EXP$$US-APELLIS-2024-APL-0000057$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240722$$MD$US$US
238642212$23864221$2$F$$20240709$20240516$20240718$PER$$US-AstraZeneca-2024A113027$ASTRAZENECA$$$$$$Y$$$20240718$$CN$US$
238642532$23864253$2$F$$20240716$20240516$20240725$PER$$US-APELLIS-APL-2024-003706$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
238642713$23864271$3$F$20240724$20240727$20240516$20240907$PER$$US-LUNDBECK-DKLU3077926$LUNDBECK$$$$$$Y$$$20240908$$CN$US$US
238643002$23864300$2$F$$20240827$20240516$20240830$30DAY$$US-SANDOZ INC.-SDZ2024US048674$SANDOZ$$$$$F$Y$$$20240830$$CN$US$US
238643318$23864331$8$F$20240329$20240725$20240516$20240803$PER$$US-SA-2024SA144275$SANOFI AVENTIS$$76$YR$E$F$Y$96.9$KG$20240803$$CN$US$US
238643922$23864392$2$F$20220101$20240807$20240516$20240808$PER$$US-ALXN-A202305167$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240808$$CN$US$US
238643932$23864393$2$F$20240415$20240722$20240516$20240802$EXP$$EG-PFIZER INC-PV202400063399$PFIZER$$44$YR$$M$Y$$$20240802$$PH$EG$EG
238643942$23864394$2$F$20240313$20240722$20240516$20240802$EXP$$EG-PFIZER INC-PV202400063401$PFIZER$$36$YR$$M$Y$$$20240802$$PH$EG$EG
238644032$23864403$2$F$$20240808$20240516$20240813$EXP$$US-MYLANLABS-2024M1044264$MYLAN$$$$$F$Y$$$20240813$$HP$US$US
238644122$23864412$2$F$$20240625$20240516$20240705$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202405003551$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$BR$BR
238644133$23864413$3$F$$20240716$20240516$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202405005571$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240726$$CN$US$US
238644412$23864441$2$F$20220812$20240911$20240516$20240918$PER$$US-SA-2024SA148812$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240918$$MD$US$US
238644453$23864445$3$F$20240101$20240717$20240516$20240726$PER$$US-SA-2024SA143582$SANOFI AVENTIS$$54$YR$A$F$Y$93.197$KG$20240726$$MD$US$US
238644522$23864452$2$F$20240101$20240722$20240516$20240730$PER$$US-SA-2024SA142317$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240730$$MD$US$US
238644532$23864453$2$F$$20240624$20240516$20240703$PER$$US-SA-2024SA143531$SANOFI AVENTIS$$42$YR$A$F$Y$77.1$KG$20240703$$CN$US$US
238644743$23864474$3$F$20240101$20240820$20240516$20240829$PER$$US-SA-2024SA142838$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240829$$MD$US$US
238644773$23864477$3$F$20240101$20240715$20240516$20240724$PER$$US-SA-2024SA144866$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240724$$MD$US$US
238644852$23864485$2$F$20240101$20240806$20240516$20240813$PER$$US-SA-2024SA141889$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240814$$MD$US$US
238645162$23864516$2$F$$20240806$20240516$20240814$PER$$US-SA-2024SA081970$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240814$$MD$US$US
238645173$23864517$3$F$20240415$20240817$20240516$20240830$PER$$US-SA-2024SA143215$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240830$$MD$TW$US
238645404$23864540$4$F$20240501$20240624$20240516$20240701$EXP$$US-SA-2024SA141822$SANOFI AVENTIS$$93$YR$E$F$Y$$$20240701$$MD$US$US
238645454$23864545$4$F$20240101$20240724$20240516$20240801$EXP$$US-SA-2024SA142926$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240801$$MD$US$US
238645462$23864546$2$F$$20240903$20240516$20240913$PER$$US-INCYTE CORPORATION-2024IN005055$INCYTE$$$$$$Y$$$20240913$$CN$US$US
238645513$23864551$3$F$$20240814$20240516$20240827$PER$$US-SA-2024SA144860$SANOFI AVENTIS$$49$YR$A$F$Y$58.967$KG$20240828$$MD$US$US
238645612$23864561$2$F$20240101$20240703$20240516$20240712$PER$$US-SA-2024SA144921$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240712$$MD$US$US
238645743$23864574$3$F$20240101$20240711$20240516$20240722$PER$$US-SA-2024SA144984$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240722$$MD$US$US
238645792$23864579$2$F$20231001$20240912$20240516$20240926$PER$$US-SA-2024SA142982$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240926$$MD$US$US
238646202$23864620$2$F$20240509$20240726$20240516$20240806$PER$$US-SA-2024SA144906$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240806$$MD$US$US
238646352$23864635$2$F$20240101$20240711$20240516$20240722$PER$$US-SA-2024SA144801$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240720$$MD$US$US
238646392$23864639$2$F$20240101$20240703$20240516$20240714$PER$$US-SA-2024SA146468$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240714$$MD$US$US
238646432$23864643$2$F$$20240626$20240516$20240705$PER$$US-SA-2024SA146929$SANOFI AVENTIS$$$$A$M$Y$$$20240705$$MD$US$US
238646452$23864645$2$F$20240401$20240718$20240516$20240727$PER$$US-SA-2024SA146005$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240727$$MD$US$US
238646482$23864648$2$F$20240801$20240815$20240516$20240828$PER$$US-SA-2024SA145050$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240828$$MD$US$US
238646552$23864655$2$F$20240101$20240626$20240516$20240705$PER$$US-SA-2024SA144495$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240705$$MD$US$US
238646642$23864664$2$F$$20240625$20240516$20240708$PER$$US-SA-2024SA146913$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240708$$MD$US$US
238646812$23864681$2$F$20231001$20240701$20240516$20240710$PER$$US-SA-2024SA147335$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240710$$MD$US$US
238646863$23864686$3$F$$20240624$20240516$20240702$PER$$US-SA-2024SA147324$SANOFI AVENTIS$$27$YR$A$F$Y$93$KG$20240702$$MD$US$US
238646943$23864694$3$F$20240101$20240701$20240516$20240710$PER$$US-SA-2024SA147584$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240710$$MD$US$US
238647643$23864764$3$F$20240401$20240827$20240516$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076131$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$50.8$KG$20240830$$PH$US$US
238647752$23864775$2$F$20191010$20240628$20240516$20240705$EXP$$BR-TAKEDA-2020TUS002613$TAKEDA$$64$YR$$F$Y$$$20240705$$CN$BR$BR
238647783$23864778$3$F$$20240826$20240516$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076121$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$80.29$KG$20240827$$CN$US$US
238647832$23864783$2$F$20240201$20240819$20240516$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076205$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240819$$CN$US$US
238648063$23864806$3$F$20240509$20240708$20240516$20240904$EXP$$CA-LUNDBECK-DKLU3078098$LUNDBECK$$$$$$Y$$$20240904$$CN$CA$CA
238648182$23864818$2$F$$20240725$20240516$20240727$PER$$US-AMGEN-USASP2024095331$AMGEN$$$$$F$Y$$$20240727$$CN$US$US
238648312$23864831$2$F$$20240714$20240516$20240718$EXP$$US-BIOMARINAP-US-2024-157920$BIOMARIN$$$$$$Y$$$20240718$$CN$US$US
238648512$23864851$2$F$20240512$20240627$20240516$20240704$PER$$US-AMGEN-USASP2024096236$AMGEN$$58$YR$A$F$Y$$$20240704$$PH$US$US
238648582$23864858$2$F$$20240715$20240516$20240715$PER$$US-ALXN-202405USA000591US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238648672$23864867$2$F$$20240715$20240516$20240715$PER$$US-ALXN-202405USA000601US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238648702$23864870$2$F$$20240715$20240516$20240715$PER$$US-ALXN-202405USA000607US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
238648786$23864878$6$F$20230921$20240917$20240516$20240925$30DAY$$CA-JNJFOC-20230957059$JOHNSON AND JOHNSON$$80$YR$E$F$Y$56$KG$20240925$$PH$CA$CA
238648816$23864881$6$F$20240505$20240626$20240516$20240704$EXP$$AE-JNJFOC-20240526835$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240704$$CN$AE$AE
238648982$23864898$2$F$$20240827$20240516$20240830$30DAY$$US-SANDOZ INC.-SDZ2024US048692$SANDOZ$$$$$M$Y$$$20240830$$CN$US$US
238649104$23864910$4$F$20240120$20240816$20240516$20240822$30DAY$$US-AMGEN-USASL2024094475$AMGEN$$48$YR$A$F$Y$$$20240822$$HP$US$US
238649233$23864923$3$F$20240418$20240603$20240516$20240925$PER$$US-GSK-US2024AMR058613$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240925$$CN$US$US
238649282$23864928$2$F$$20240815$20240516$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071360$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240823$$CN$US$US
238649383$23864938$3$F$20240501$20240708$20240516$20240716$EXP$$NVSC2024US085253$NOVARTIS$$74$YR$$F$Y$81$KG$20240716$$CN$US$US
238649594$23864959$4$F$$20240711$20240516$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002044$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
238649642$23864964$2$F$$20240814$20240516$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-075869$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240814$$MD$JP$JP
238649682$23864968$2$F$$20240514$20240516$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202405009348$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240820$$CN$US$US
238649762$23864976$2$F$20231201$20240829$20240516$20240903$EXP$$US-ABBVIE-5646465$ABBVIE$$60$YR$$M$Y$$$20240903$$CN$US$US
238650152$23865015$2$F$20240101$20240807$20240516$20240812$EXP$$JP-009507513-2405JPN000869J$MERCK$$71$YR$$F$Y$$$20240812$$MD$JP$JP
238650193$23865019$3$F$20240101$20240807$20240516$20240813$EXP$$US-ABBVIE-5761832$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
238650252$23865025$2$F$20230628$20240813$20240516$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-071353$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$50.1$KG$20240821$$PH$JP$JP
238650282$23865028$2$F$20240317$20240801$20240516$20240806$EXP$$CA-ABBVIE-5761837$ABBVIE$$26$YR$$F$Y$65$KG$20240806$$CN$CA$CA
238650363$23865036$3$F$$20240820$20240516$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-075579$BRISTOL MYERS SQUIBB$$8$DEC$E$$Y$$$20240821$$MD$JP$JP
238650632$23865063$2$F$20240509$20240627$20240516$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075943$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240703$$PH$US$US
238650684$23865068$4$F$20240418$20240821$20240516$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002020$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240913$$CN$US$US
238650773$23865077$3$F$20230101$20240903$20240516$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074597$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240913$$CN$US$US
238650832$23865083$2$F$20240408$20240701$20240516$20240710$EXP$$US-RADIUS HEALTH INC.-2024US003204$RADIUS PHARM$$69$YR$$F$Y$$$20240710$$CN$US$US
238651045$23865104$5$F$20240430$20240822$20240517$20240826$EXP$$DE-JNJFOC-20240522607$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240826$$HP$DE$DE
238651152$23865115$2$F$20240505$20240711$20240517$20240722$PER$$US-SA-2024SA145837$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240722$$MD$US$US
238651422$23865142$2$F$$20240808$20240517$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076207$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240813$$CN$US$US
238651562$23865156$2$F$$20240814$20240517$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075193$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240814$$CN$US$US
238651863$23865186$3$F$20240513$20240722$20240517$20240724$PER$$US-AMGEN-USASP2024097191$AMGEN$$68$YR$E$F$Y$$$20240723$$PH$US$US
238652002$23865200$2$F$$20240628$20240517$20240708$30DAY$$US-GSK-US2024059125$GLAXOSMITHKLINE$$$$$M$Y$$$20240708$$CN$US$US
238652113$23865211$3$F$20240301$20240705$20240517$20240710$EXP$$US-ABBVIE-5762008$ABBVIE$$46$YR$$F$Y$54$KG$20240710$$CN$US$US
238652452$23865245$2$F$20240101$20240704$20240517$20240711$EXP$$CA-CELLTRION INC.-2024CA011304$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
238652472$23865247$2$F$$20240715$20240517$20240715$PER$$US-ALXN-202405USA000648US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238652742$23865274$2$F$20240409$20240422$20240517$20240808$PER$$CA-TOLMAR, INC.-24CA048343$TOLMAR$$71$YR$$M$Y$$$20240808$$HP$CA$CA
238653182$23865318$2$F$$20240701$20240517$20240704$EXP$$GB-TAKEDA-2020TUS057112$TAKEDA$$$$$M$Y$$$20240704$$CN$GB$GB
238653332$23865333$2$F$20240430$20240823$20240517$20240830$EXP$$CA-TAKEDA-2024TUS044497$TAKEDA$$55$YR$$F$Y$$$20240830$$MD$CA$CA
238653423$23865342$3$F$20220609$20240625$20240517$20240702$EXP$$CA-TAKEDA-2022TUS039397$TAKEDA$$72$YR$$F$Y$$$20240702$$CN$CA$CA
238653492$23865349$2$F$20240407$20240725$20240517$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002050$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240816$$CN$US$US
238653572$23865357$2$F$$20240917$20240517$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075661$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240924$$HP$US$US
238653692$23865369$2$F$20240511$20240808$20240517$20240812$PER$$US-AMGEN-USASP2024095611$AMGEN$$65$YR$E$F$Y$$$20240812$$CN$US$US
238653743$23865374$3$F$20240315$20240728$20240517$20240730$PER$$US-AMGEN-USASP2024097223$AMGEN$$58$YR$A$M$Y$$$20240730$$CN$US$US
238653862$23865386$2$F$$20240716$20240517$20240722$EXP$$TR-TOLMAR, INC.-24TR049269$TOLMAR$Mente?o?lu D., Elkiran L., Kurmu? G.I., Kartal S.P.. A pediatric case of two Nicolau syndrome lesions following leuprolide injection in the upper extremity. Indian Journal of Pharmacology. 2024;56:2:141-143$9$YR$$F$Y$$$20240722$$MD$TR$TR
238654252$23865425$2$F$$20240426$20240517$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000098$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$CN$US$US
238654442$23865444$2$F$$20240703$20240517$20240716$PER$$US-AstraZeneca-2024A104455$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
238654622$23865462$2$F$$20240715$20240517$20240715$EXP$$US-ALXN-202405USA000590US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
238654662$23865466$2$F$$20240819$20240517$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-014567$UNITED THERAPEUTICS$$$$$F$Y$55.329$KG$20240822$$$US$US
238654703$23865470$3$F$20240222$20240821$20240517$20240826$EXP$$CA-JNJFOC-20240336837$JOHNSON AND JOHNSON$$58$YR$A$M$Y$98$KG$20240826$$HP$CA$CA
238654772$23865477$2$F$20240507$20240704$20240517$20240711$EXP$$CA-CELLTRION INC.-2024CA011360$CELLTRION$$$$$$Y$$$20240711$$CN$CA$CA
238654783$23865478$3$F$20240515$20240828$20240517$20240830$PER$$US-AMGEN-USASP2024097604$AMGEN$$73$YR$E$F$Y$$$20240830$$CN$US$US
238654792$23865479$2$F$20240512$20240709$20240517$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-013959$UNITED THERAPEUTICS$$62$YR$$F$Y$70.295$KG$20240713$$$US$US
238654822$23865482$2$F$$20240807$20240517$20240807$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-022931$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240807$$CN$JP$JP
238654935$23865493$5$F$20190101$20240710$20240517$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-022213$AUROBINDO$$$$A$M$Y$$$20240719$$MD$NL$NL
238655144$23865514$4$F$$20240709$20240517$20240724$EXP$$US-LUPIN EUROPE GMBH-2024-04058$LUPIN$$$$$$Y$$$20240724$$HP$US$US
238655393$23865539$3$F$$20240628$20240517$20240715$PER$$US-AstraZeneca-2024A106055$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
238655462$23865546$2$F$$20240920$20240517$20240930$PER$$US-GSK-US2024061335$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$CN$US$US
238655503$23865550$3$F$20240101$20240830$20240517$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-011341$UNITED THERAPEUTICS$$$$$M$Y$107.94$KG$20240905$$$US$US
238655652$23865565$2$F$$20240410$20240517$20240807$PER$$US-IMP-2024000172$Harrow Health$$$$E$F$Y$$$20240807$$CN$US$US
238655723$23865572$3$F$20240303$20240628$20240517$20240703$EXP$$US-TAKEDA-2023TUS023650$TAKEDA$$50$YR$$F$Y$112$KG$20240703$$CN$US$US
238655792$23865579$2$F$20240509$20240916$20240517$20240918$PER$$US-AMGEN-USASP2024094273$AMGEN$$64$YR$A$M$Y$$$20240918$$CN$US$US
238655872$23865587$2$F$20230101$20240818$20240517$20240824$EXP$$SA-GSK-SA2023EME155655$GLAXOSMITHKLINE$$$$$$Y$$$20240824$$CN$SA$SA
238655903$23865590$3$F$$20240910$20240517$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA049206$SANDOZ$$40$YR$$F$Y$$$20240917$$HP$CA$CA
238655913$23865591$3$F$$20240726$20240517$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA049328$SANDOZ$$34$YR$$M$Y$$$20240730$$CN$CA$CA
238655922$23865592$2$F$$20240705$20240517$20240710$EXP$$CA-TAKEDA-2024TUS002599$TAKEDA$$$$$F$Y$$$20240710$$CN$CA$CA
238655943$23865594$3$F$20220110$20240718$20240517$20240725$EXP$$CA-TAKEDA-2022TUS036015$TAKEDA$$68$YR$$M$Y$$$20240725$$CN$CA$CA
238656162$23865616$2$F$$20240911$20240517$20240913$PER$$US-AMGEN-USASP2024095661$AMGEN$$$$A$F$Y$$$20240912$$HP$US$US
238656183$23865618$3$F$20240101$20240911$20240517$20240920$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00180$CATALYST PHARMA$$$$$F$Y$69.841$KG$20240920$$CN$US$US
238656313$23865631$3$F$$20240807$20240517$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002090$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
238656754$23865675$4$F$20240730$20240910$20240517$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076316$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240917$$HP$US$US
238656813$23865681$3$F$$20240717$20240517$20240725$EXP$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000432$DECIPHERA PHARMACEUTICALS$$77$YR$E$F$Y$$$20240725$$CN$US$US
238656844$23865684$4$F$$20240709$20240517$20240724$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-03927$LUPIN$$27$YR$$F$Y$$$20240724$$HP$US$US
238656865$23865686$5$F$20240401$20240723$20240517$20240726$30DAY$$US-JNJFOC-20240523330$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$141$KG$20240726$$CN$US$US
238656972$23865697$2$F$20240421$20240712$20240517$20240801$PER$$CA-TOLMAR, INC.-24CA048675$TOLMAR$$63$YR$$M$Y$$$20240801$$CN$CA$CA
238657142$23865714$2$F$$20240909$20240517$20240912$EXP$$US-TAKEDA-2021TUS067689$TAKEDA$$$$$M$Y$45$KG$20240912$$MD$US$US
238657483$23865748$3$F$20240807$20240822$20240517$20240828$EXP$$CA-CELLTRION INC.-2024CA010290$CELLTRION$$$$$$Y$$$20240828$$CN$CA$CA
238657493$23865749$3$F$20240101$20240830$20240517$20240909$EXP$$CA-CELLTRION INC.-2024CA004507$CELLTRION$$$$$$Y$$$20240909$$MD$CA$CA
238657514$23865751$4$F$20240830$20240830$20240517$20240905$EXP$$CA-TAKEDA-2024TUS047231$TAKEDA$$28$YR$$M$Y$$$20240905$$CN$CA$CA
238657652$23865765$2$F$20240101$20240722$20240517$20240729$EXP$$JP-GENMAB-2024-01558$GENMAB$$72$YR$$$Y$$$20240729$$MD$JP$JP
238658855$23865885$5$F$20240423$20240815$20240517$20240819$EXP$$NL-JNJFOC-20240524861$JOHNSON AND JOHNSON$$68$YR$E$M$Y$83$KG$20240819$$MD$NL$NL
238659002$23865900$2$F$$20240618$20240517$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002097$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
238659034$23865903$4$F$20231230$20240909$20240517$20240911$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006296$JAZZ$$54$YR$$F$Y$$$20240911$$CN$US$US
238659274$23865927$4$F$20240101$20240729$20240517$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012993$UNITED THERAPEUTICS$$$$$M$Y$86.168$KG$20240807$$$US$US
238659298$23865929$8$F$20231001$20240904$20240517$20240911$EXP$$CA-CELLTRION INC.-2024CA011513$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
238659323$23865932$3$F$20240815$20240820$20240517$20240828$EXP$$CA-CELLTRION INC.-2024CA011502$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
2386594310$23865943$10$F$20240101$20240702$20240517$20240716$EXP$$US-BEH-2024171987$CSL BEHRING$$35$YR$A$F$Y$102.49$KG$20240716$$HP$US$US
238659452$23865945$2$F$$20240621$20240517$20240708$PER$$US-LP Pharmaceuticals Inc -2157122$LP PHARMACEUTICALS$$$$$M$Y$$$20240708$$$US$US
238659582$23865958$2$F$20240514$20240813$20240517$20240814$PER$$US-AMGEN-USASP2024096306$AMGEN$$77$YR$E$F$Y$$$20240814$$CN$US$US
238659593$23865959$3$F$20240419$20240628$20240517$20240702$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-072956$REGENERON$$$$$F$Y$$$20240702$$HP$US$US
238659604$23865960$4$F$20240207$20240707$20240517$20240713$EXP$$CA-CELLTRION INC.-2023CA024613$CELLTRION$$$$$$Y$$$20240713$$MD$CA$CA
238659612$23865961$2$F$20240402$20240624$20240517$20240709$EXP$IT-MINISAL02-983260$IT-SERVIER-S24005454$SERVIER$$$$$$Y$$$20240709$$PH$IT$IT
238659724$23865972$4$F$$20240906$20240517$20240909$EXP$$NVSC2023US268093$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
238659773$23865977$3$F$20240506$20240905$20240517$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-014359$UNITED THERAPEUTICS$$46$YR$$F$Y$69.841$KG$20240914$$$US$US
238659784$23865978$4$F$20240509$20240826$20240517$20240903$30DAY$$US-GSK-US2024059120$GLAXOSMITHKLINE$$42$YR$$F$Y$$$20240903$$CN$US$US
238659812$23865981$2$F$$20240701$20240517$20240703$PER$$NVSC2024US104341$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
238659963$23865996$3$F$20221130$20240705$20240517$20240715$EXP$$CA-CELLTRION INC.-2022CA021116$CELLTRION$$$$$$Y$$$20240715$$HP$CA$CA
238660042$23866004$2$F$$20240719$20240517$20240731$EXP$$US-ROCHE-3564366$ROCHE$$74$YR$E$F$Y$$$20240731$$CN$US$US
238660152$23866015$2$F$$20240613$20240517$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002109$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
238660182$23866018$2$F$$20240625$20240517$20240704$30DAY$$US-GSK-US2024AMR058063$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
238660416$23866041$6$F$$20240716$20240517$20240720$30DAY$$US-AMGEN-USASL2024093820$AMGEN$$$$$F$Y$$$20240719$$HP$US$US
238660432$23866043$2$F$20240419$20240702$20240517$20240704$PER$$US-AMGEN-USASP2024095149$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
238660463$23866046$3$F$20170101$20240718$20240517$20240722$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-071537$REGENERON$$$$$F$Y$$$20240722$$HP$US$US
238660522$23866052$2$F$$20240814$20240517$20240826$EXP$$CA-SA-2024SA143994$SANOFI AVENTIS$$$$$F$Y$$$20240826$$HP$CA$CA
238660542$23866054$2$F$20240710$20240710$20240517$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073456$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240715$$CN$US$US
238660604$23866060$4$F$20240507$20240805$20240517$20240809$30DAY$$US-AMGEN-USASP2024095109$AMGEN$$$$$$Y$$$20240809$$PH$US$US
238660692$23866069$2$F$$20240712$20240517$20240726$EXP$$SI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445512$RANBAXY$Prebil K,Palandacic AK,Prelog PS. Complex visual hallucinations associated with ranolazine treatment: a casereport. Can J Cardiol. 2024;Apr 29,S0828:282X(24)00339-8$$$E$$Y$$$20240726$$HP$SI$SI
238661072$23866107$2$F$20240416$20240417$20240517$20240807$PER$$US-IMP-2024000175$Harrow Health$$72$YR$E$F$Y$$$20240807$$CN$US$US
238661082$23866108$2$F$$20240701$20240517$20240705$EXP$$US-ABBVIE-5761786$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
238661432$23866143$2$F$20240417$20240712$20240517$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014680$UNITED THERAPEUTICS$$64$YR$$M$Y$102.95$KG$20240719$$$US$US
238661492$23866149$2$F$20240401$20240725$20240517$20240729$EXP$$SI-UCBSA-2024020154$UCB$$$$A$F$Y$$$20240729$$MD$SI$SI
238661552$23866155$2$F$20240508$20240722$20240517$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-073046$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240724$$CN$JP$JP
238661603$23866160$3$F$20240501$20240718$20240517$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-014442$UNITED THERAPEUTICS$$27$YR$$M$Y$59.41$KG$20240723$$$US$US
238661693$23866169$3$F$20240119$20240807$20240517$20240809$EXP$$US-JNJFOC-20240517234$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240809$$HP$US$US
238661714$23866171$4$F$20240101$20240807$20240517$20240815$EXP$$CA-CELLTRION INC.-2024CA008260$CELLTRION$$$$$$Y$$$20240815$$MD$CA$CA
238661732$23866173$2$F$20240515$20240708$20240517$20240709$PER$$US-AMGEN-USASP2024096700$AMGEN$$63$YR$A$F$Y$$$20240709$$PH$US$US
238661926$23866192$6$F$$20240702$20240517$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073384$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$104.33$KG$20240715$$CN$US$US
238661952$23866195$2$F$$20240705$20240517$20240712$30DAY$$US-GSK-US2024059157$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$CN$US$US
238661973$23866197$3$F$20240509$20240709$20240517$20240718$30DAY$$US-GSK-US2024058974$GLAXOSMITHKLINE$$84$YR$$M$Y$$$20240718$$HP$US$US
238662014$23866201$4$F$20240101$20240825$20240517$20240903$EXP$$CA-CELLTRION INC.-2023CA023835$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
238662033$23866203$3$F$$20240718$20240517$20240726$30DAY$$US-ABBVIE-5762182$ABBVIE$$$$$$Y$$$20240726$$CN$US$US
238662132$23866213$2$F$$20240724$20240517$20240729$PER$$NVSC2024US104701$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
238662212$23866221$2$F$$20240729$20240517$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075412$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$65.77$KG$20240801$$CN$US$US
238662253$23866225$3$F$$20240626$20240517$20240705$30DAY$$US-GSK-US2024059160$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
238662303$23866230$3$F$20221011$20240828$20240517$20240902$EXP$$AU-TAKEDA-2022TUS073976$TAKEDA$$31$YR$$F$Y$$$20240902$$CN$AU$AU
238662333$23866233$3$F$20240227$20240903$20240517$20240909$EXP$$US-JNJFOC-20240312911$JOHNSON AND JOHNSON$$85$YR$E$M$Y$74.91$KG$20240909$$HP$US$US
238662342$23866234$2$F$$20240625$20240517$20240716$PER$$US-JNJFOC-20240481666$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240716$$CN$US$US
238662372$23866237$2$F$20240801$20240801$20240517$20240807$EXP$$US-TAKEDA-2023TUS014363$TAKEDA$$68$YR$$F$Y$$$20240807$$HP$US$US
238662433$23866243$3$F$20240515$20240821$20240517$20240824$PER$$US-AMGEN-USASP2024097190$AMGEN$$72$YR$E$F$Y$$$20240824$$MD$US$US
238662463$23866246$3$F$$20240912$20240517$20240916$EXP$$US-TAKEDA-2024TUS004771$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
238662612$23866261$2$F$$20240706$20240517$20240713$EXP$$CA-CELLTRION INC.-2024CA011241$CELLTRION$$$$$$Y$$$20240713$$CN$CA$CA
238662692$23866269$2$F$$20240820$20240517$20240823$EXP$$US-JNJFOC-20240515732$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$MD$US$US
238662782$23866278$2$F$20240530$20240620$20240517$20240703$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000446$DECIPHERA PHARMACEUTICALS$$74$YR$E$M$Y$$$20240703$$CN$US$US
238662892$23866289$2$F$20221228$20240827$20240517$20240904$EXP$$CA-JNJFOC-20230117560$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240904$$CN$CA$CA
238663025$23866302$5$F$$20240724$20240517$20240727$EXP$$US-ROCHE-3563768$ROCHE$$$$E$F$Y$$$20240727$$MD$US$US
238663072$23866307$2$F$$20240909$20240517$20240918$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-076646$BRISTOL MYERS SQUIBB$Yeoh K, Lass-Florl C, Lamoth F, Slavin MA, Williams E, Neofytos D. Clinicopathologic conference: bloodstream infection in an allogeneic hamatopoietic cell transplant: thinking beyond the usual. Transplant Infectious Disease. 2024 May 02;26:1-6. doi:10.1111/tid.14273.$53$YR$A$F$Y$$$20240918$$HP$AU$AU
238663082$23866308$2$F$20240514$20240816$20240517$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076073$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$72.57$KG$20240816$$CN$US$US
238663245$23866324$5$F$$20240715$20240517$20240722$EXP$$DE-ABBVIE-5761760$ABBVIE$$$$$F$Y$$$20240722$$CN$DE$DE
238663282$23866328$2$F$20230427$20240708$20240517$20240711$EXP$$JP-EXELIXIS-CABO-24077333$EXELIXIS$$75$YR$$M$Y$45$KG$20240711$$MD$JP$JP
238663482$23866348$2$F$20240101$20240918$20240517$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202405008921$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240925$$CN$US$US
238663564$23866356$4$F$20240111$20240625$20240517$20240706$EXP$$CA-ROCHE-3565600$ROCHE$$34$YR$A$F$Y$$$20240706$$CN$CA$CA
238663572$23866357$2$F$20240313$20240611$20240517$20240701$EXP$$AU-ROCHE-3564344$ROCHE$$27$YR$A$F$Y$56$KG$20240701$$MD$AU$AU
238663592$23866359$2$F$20240319$20240620$20240517$20240702$EXP$FR-AFSSAPS-TO2024000758$FR-Accord-424472$ACCORD$$65$YR$E$M$Y$98$KG$20240702$$PH$FR$FR
238663672$23866367$2$F$20240303$20240702$20240517$20240705$EXP$$US-AstraZeneca-2024A114483$ASTRAZENECA$$28888$DY$$F$Y$$$20240705$$MD$US$
238663682$23866368$2$F$$20240625$20240517$20240703$EXP$$RO-AstraZeneca-2024A113531$ASTRAZENECA$$41$YR$$F$Y$$$20240703$$MD$RO$
238663832$23866383$2$F$$20240704$20240517$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03906$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238663862$23866386$2$F$$20240718$20240517$20240722$EXP$$NVSC2024BR104215$NOVARTIS$$$$$M$Y$$$20240722$$CN$BR$BR
238663912$23866391$2$F$20220601$20240926$20240517$20240930$EXP$$CA-ROCHE-3565218$ROCHE$$56$YR$A$F$Y$$$20240930$$MD$CA$CA
238663962$23866396$2$F$$20240704$20240517$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03937$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238664003$23866400$3$F$$20240916$20240517$20240923$EXP$$CL-JNJFOC-20240511390$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240923$$CN$CL$CL
238664014$23866401$4$F$20230401$20240815$20240517$20240830$EXP$$US-ASTELLAS-2024EU004758$ASTELLAS$$72$YR$E$M$Y$$$20240830$$CN$US$US
238664072$23866407$2$F$$20240704$20240517$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03907$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238664212$23866421$2$F$$20240924$20240517$20240926$EXP$$NVSC2024CA101297$NOVARTIS$$44$YR$$F$Y$$$20240926$$HP$CA$CA
238664222$23866422$2$F$$20240704$20240517$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03908$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238664232$23866423$2$F$$20240704$20240517$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03905$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238664372$23866437$2$F$20240422$20240603$20240517$20240927$30DAY$$US-JNJFOC-20240467852$JOHNSON AND JOHNSON$$36$YR$A$$Y$$$20240927$$CN$US$US
238664392$23866439$2$F$$20240912$20240517$20240912$PER$$US-ALXN-202405USA000694US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
238664493$23866449$3$F$20240209$20240628$20240517$20240712$EXP$$DE-ROCHE-3559022$ROCHE$$56$YR$A$M$Y$79$KG$20240712$$MD$DE$DE
238664565$23866456$5$F$20240617$20240819$20240517$20240820$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-251340$BOEHRINGER INGELHEIM$$63$YR$A$F$Y$$$20240821$$CN$CA$CA
238664673$23866467$3$F$$20240621$20240517$20240701$30DAY$$US-GSK-US2024058552$GLAXOSMITHKLINE$$$$$M$Y$$$20240701$$MD$US$US
238664683$23866468$3$F$$20240903$20240517$20240906$EXP$$CA-TAKEDA-2024TUS047852$TAKEDA$$$$$F$Y$$$20240906$$MD$CA$CA
238664712$23866471$2$F$20240101$20240708$20240517$20240716$EXP$$CA-CELLTRION INC.-2024CA011527$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
238664722$23866472$2$F$$20240704$20240517$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03929$LUPIN$$$$$$Y$$$20240725$$CN$US$US
238664973$23866497$3$F$20240101$20240816$20240517$20240821$EXP$$US-SA-2024SA148285$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240821$$MD$US$US
238665042$23866504$2$F$$20240730$20240517$20240802$EXP$$JP-JNJFOC-20240545096$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240802$$PH$JP$JP
238665365$23866536$5$F$$20240720$20240517$20240725$EXP$$PA-ROCHE-3563900$ROCHE$$10$MON$I$$Y$7$KG$20240725$$MD$PA$PA
238665392$23866539$2$F$20240502$20240820$20240517$20240823$PER$$US-JNJFOC-20240522413$JOHNSON AND JOHNSON$$15$YR$T$$Y$$$20240823$$MD$US$US
238665472$23866547$2$F$20240501$20240912$20240517$20240912$PER$$US-ALXN-202405USA000721US$ALEXION PHARMACEUTICALS$$71$YR$$F$Y$$$20240912$$CN$US$US
238665522$23866552$2$F$$20240701$20240517$20240809$PER$$US-AUROBINDO-AUR-APL-2024-016970$AUROBINDO$$$$$$Y$$$20240809$$HP$US$US
238665604$23866560$4$F$20240401$20240708$20240517$20240715$PER$$US-BIOGEN-2024BI01265163$BIOGEN$$66$YR$$F$Y$$$20240715$$CN$US$US
238665682$23866568$2$F$$20240624$20240517$20240703$30DAY$$US-GSK-US2024059140$GLAXOSMITHKLINE$$$$$M$Y$$$20240703$$CN$US$US
238665993$23866599$3$F$$20240808$20240517$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04024$LUPIN$$$$$$Y$$$20240822$$CN$US$US
238666092$23866609$2$F$$20240703$20240517$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076585$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$89$YR$E$F$Y$76$KG$20240705$$HP$US$US
238666253$23866625$3$F$$20240722$20240517$20240730$30DAY$$US-GSK-US2024061318$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$CN$US$US
238666263$23866626$3$F$$20240802$20240517$20240813$EXP$$US-GSK-US2024AMR061996$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
238666382$23866638$2$F$$20240905$20240517$20240906$EXP$$US-GILEAD-2024-0672915$GILEAD$$11$YR$C$M$Y$35.4$KG$20240906$$HP$US$US
238666652$23866665$2$F$$20240702$20240517$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03901$LUPIN$$$$$$Y$$$20240725$$CN$US$US
238666692$23866669$2$F$20240415$20240815$20240517$20240820$EXP$$US-ABBVIE-5763328$ABBVIE$$69$YR$$M$Y$$$20240820$$CN$US$US
238666852$23866685$2$F$$20240723$20240517$20240801$EXP$$US-SPECGX-T202401132$SPECGX$Khan A, Lahmar A, Asif H, Haseeb M, Rai K. Serotonin syndrome precipitated by the use of cocaine and fentanyl. Cureus. 2022;14(3):1-4$37$YR$$F$Y$$$20240801$$HP$US$US
238666872$23866687$2$F$20231019$20240708$20240517$20240723$EXP$$IT-RIGEL PHARMACEUTICALS, INC.-2024FOS000578$RIGEL PHARMACEUTICALS$$64$YR$$$Y$$$20240723$$HP$IT$IT
238666912$23866691$2$F$20240418$20240625$20240517$20240705$EXP$$US-RIGEL PHARMACEUTICALS, INC.-2024FOS000561$RIGEL PHARMACEUTICALS$$$$$$Y$$$20240705$$CN$US$US
238666922$23866692$2$F$$20240910$20240517$20240918$EXP$$NVSC2024CA103610$NOVARTIS$Cros G, Chapdelaine H, Teira P, Fernandez I, Pastore Y, Haddad E et al.. A novel variant in caspase recruitment domain family member 11 highlights the variability of clinical manifestations and management in a three generation family. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 3265-8$8$YR$$F$Y$$$20240918$$HP$CA$CA
238667183$23866718$3$F$20240422$20240722$20240517$20240729$PER$$US-AMGEN-USASP2024095197$AMGEN$$58$YR$A$M$Y$$$20240729$$HP$US$US
238667192$23866719$2$F$20220601$20240516$20240517$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-183928$BOEHRINGER INGELHEIM$$54$YR$A$F$Y$75$KG$20240813$$CN$ES$ES
238667272$23866727$2$F$$20240703$20240517$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076584$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$77$YR$E$M$Y$88.4$KG$20240705$$HP$US$US
238667282$23866728$2$F$20240509$20240628$20240517$20240701$PER$$US-AMGEN-USASP2024097185$AMGEN$$66$YR$E$F$Y$$$20240701$$CN$US$US
238667503$23866750$3$F$$20240702$20240517$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03904$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238667672$23866767$2$F$$20240704$20240517$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03958$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238667803$23866780$3$F$20180101$20240613$20240517$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-210267$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$50$KG$20240813$$CN$ES$ES
238667952$23866795$2$F$$20240703$20240517$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076575$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$81$YR$E$F$Y$56.2$KG$20240705$$HP$US$US
238668012$23866801$2$F$$20240705$20240517$20240712$EXP$$JP-AMGEN-JPNSP2024095438$AMGEN$$87$YR$E$M$Y$$$20240712$$HP$JP$JP
238668163$23866816$3$F$$20240704$20240517$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03940$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238668282$23866828$2$F$$20240828$20240517$20240912$PER$$US-IMP-2024000241$Harrow Health$$65$YR$E$F$Y$$$20240912$$CN$US$US
238668322$23866832$2$F$20231202$20240717$20240517$20240801$EXP$$CN-ROCHE-3514998$ROCHE$$67$YR$E$F$Y$$$20240801$$MD$CN$CN
238668412$23866841$2$F$$20240729$20240517$20240731$EXP$$US-TAKEDA-2024TUS048619$TAKEDA$$$$$M$Y$$$20240731$$CN$US$US
238668604$23866860$4$F$$20240820$20240517$20240822$PER$$NVSC2024US099527$NOVARTIS$$$$$M$Y$$$20240822$$CN$US$US
238668622$23866862$2$F$20240101$20240913$20240517$20240923$PER$$US-Kiniksa Pharmaceuticals Ltd.-2024KPU000122$KINIKSA PHARMACEUTICALS$$79$YR$E$M$Y$$$20240923$$HP$US$US
238668733$23866873$3$F$20240502$20240712$20240517$20240717$EXP$$US-JNJFOC-20240523058$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240717$$MD$US$US
238668773$23866877$3$F$20240420$20240924$20240517$20240927$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-076640$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240927$$PH$PR$PR
238668782$23866878$2$F$20240226$20240821$20240517$20240829$EXP$$BE-JNJFOC-20240526018$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$43$KG$20240829$$MD$BE$BE
238668993$23866899$3$F$$20240730$20240517$20240802$PER$$NVSC2024US104289$NOVARTIS$$$$$F$Y$$$20240802$$HP$US$US
238669026$23866902$6$F$$20240911$20240517$20240913$EXP$$FR-MYLANLABS-2024M1044638$MYLAN$$71$YR$$M$Y$$$20240913$$HP$FR$FR
238669142$23866914$2$F$$20240621$20240517$20240717$PER$$US-IMP-2024000244$Harrow Health$$$$E$F$Y$$$20240717$$CN$US$US
238669582$23866958$2$F$$20240721$20240517$20240725$PER$$US-HORIZON THERAPEUTICS-HZN-2024-001470$AMGEN$$$$A$F$Y$$$20240724$$CN$US$US
238669822$23866982$2$F$$20240625$20240517$20240709$EXP$$CA-ROCHE-3564738$ROCHE$$$$A$M$Y$$$20240709$$CN$CA$CA
238669836$23866983$6$F$20240509$20240712$20240517$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000433$DECIPHERA PHARMACEUTICALS$$74$YR$E$F$Y$$$20240731$$CN$US$US
238669842$23866984$2$F$$20240202$20240517$20240906$PER$$US-HORIZON THERAPEUTICS-HZN-2024-001563$AMGEN$$$$$F$Y$$$20240906$$MD$US$US
238669852$23866985$2$F$20240101$20240905$20240517$20240913$EXP$$JP-009507513-2405JPN001300J$MERCK$$5$DEC$$F$Y$$$20240913$$MD$JP$JP
238669953$23866995$3$F$$20240708$20240517$20240717$EXP$CN-MLMSERVICE-20240506-PI048979-00218-1$CN-STRIDES ARCOLAB LIMITED-2024SP005712$STRIDES$Yu D, Luo Y, Sun L.. Nontyphoidal salmonella septic arthritis in A patient with systemic lupus erythematosus: A case report.. Diagnostic Microbiology and Infectious Disease. 2024;109(3):116332$43$YR$$F$Y$$$20240717$$MD$CN$CN
238670042$23867004$2$F$$20240702$20240517$20240711$PER$$US-RDY-SPO/USA/24/0007065$DR REDDYS$$$$$M$Y$$$20240712$$MD$US$US
238670115$23867011$5$F$$20240826$20240517$20240905$EXP$$CA-TEVA-VS-3185599$TEVA$$78$YR$$F$Y$93$KG$20240905$$HP$CA$CA
238670234$23867023$4$F$$20240724$20240517$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072777$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$76$YR$E$M$Y$80$KG$20240730$$HP$US$US
238670257$23867025$7$F$20240101$20240812$20240517$20240819$EXP$$CA-PUMA BIOTECHNOLOGY, INC.-2024-PUM-CA000702$PUMA$$$$$$Y$$$20240819$$HP$CA$CA
238670262$23867026$2$F$$20240703$20240517$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076580$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$62$YR$A$F$Y$49.4$KG$20240704$$HP$US$US
238670603$23867060$3$F$20240515$20240809$20240517$20240812$PER$$US-AMGEN-USASP2024097786$AMGEN$$76$YR$E$M$Y$$$20240812$$CN$US$US
238670762$23867076$2$F$$20240726$20240517$20240726$PER$$NVSC2024US104042$NOVARTIS$$$$$F$Y$$$20240726$$MD$US$US
238670792$23867079$2$F$20240513$20240718$20240517$20240722$EXP$$NVSC2024US104380$NOVARTIS$$64$YR$$M$Y$$$20240722$$CN$US$US
238670832$23867083$2$F$20230901$20240820$20240517$20240823$EXP$$US-JNJFOC-20240526257$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240823$$CN$US$US
238670922$23867092$2$F$$20240509$20240517$20240805$EXP$$BR-BAYER-2024A071467$BAYER$$23$YR$A$F$Y$$$20240805$$CN$BR$BR
238671014$23867101$4$F$20240505$20240909$20240517$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014105$UNITED THERAPEUTICS$$61$YR$$F$Y$83.447$KG$20240919$$$US$US
238671112$23867111$2$F$20240514$20240820$20240517$20240823$PER$$US-AMGEN-USASP2024096847$AMGEN$$50$YR$A$M$Y$$$20240823$$CN$US$US
238671242$23867124$2$F$$20240703$20240517$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076574$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$84$YR$E$M$Y$83$KG$20240709$$HP$US$US
238671253$23867125$3$F$$20240909$20240517$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076665$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$103.42$KG$20240911$$CN$US$US
238671262$23867126$2$F$$20240816$20240517$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-076267$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240816$$MD$JP$JP
238671333$23867133$3$F$$20240910$20240517$20240915$EXP$$ES-JNJFOC-20240536106$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240916$$MD$ES$ES
238671522$23867152$2$F$20240513$20240811$20240517$20240812$PER$$US-AMGEN-USASP2024096337$AMGEN$$69$YR$E$F$Y$$$20240812$$CN$US$US
238671702$23867170$2$F$$20240711$20240517$20240719$30DAY$$US-GSK-US2024AMR058342$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
238671714$23867171$4$F$20230527$20240914$20240517$20240919$EXP$$CA-GSK-CA2023075141$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$HP$CA$CA
238671744$23867174$4$F$$20240703$20240517$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076586$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$77$YR$E$M$Y$99.3$KG$20240712$$HP$US$US
238671752$23867175$2$F$$20240703$20240517$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076576$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$81$YR$E$M$Y$112.5$KG$20240705$$HP$US$US
238671763$23867176$3$F$$20240819$20240517$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076808$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240819$$CN$US$US
238671834$23867183$4$F$$20240912$20240517$20240917$PER$$GB-PFIZER INC-PV202400059965$PFIZER$$55$YR$$F$Y$$$20240917$$HP$GB$GB
238671843$23867184$3$F$20240510$20240814$20240517$20240819$30DAY$$US-PFIZER INC-202400106842$PFIZER$$8$YR$$F$Y$17.24$KG$20240819$$CN$US$US
238671885$23867188$5$F$20240506$20240925$20240517$20240927$30DAY$$US-PFIZER INC-202400103664$PFIZER$$11$YR$$F$Y$$$20240927$$CN$US$US
238671892$23867189$2$F$20230901$20240813$20240517$20240815$30DAY$$US-PFIZER INC-202400106549$PFIZER$$6$YR$$F$Y$15.42$KG$20240815$$CN$US$US
238671905$23867190$5$F$$20240906$20240517$20240911$30DAY$$CO-PFIZER INC-202400096499$PFIZER$$10$YR$$M$Y$$$20240911$$CN$CO$CO
238671916$23867191$6$F$20240514$20240918$20240517$20240923$30DAY$$US-PFIZER INC-202400109049$PFIZER$$15$YR$$M$Y$46.72$KG$20240923$$CN$US$US
238671936$23867193$6$F$20240510$20240918$20240517$20240923$30DAY$$US-PFIZER INC-202400108140$PFIZER$$15$YR$$M$Y$$$20240923$$CN$US$US
238671942$23867194$2$F$20240513$20240706$20240517$20240708$EXP$$US-PFIZER INC-202400107598$PFIZER$$5$YR$$F$Y$16.78$KG$20240708$$CN$US$US
238671953$23867195$3$F$$20240820$20240517$20240822$30DAY$$US-PFIZER INC-202400106808$PFIZER$$17$YR$$M$Y$$$20240822$$HP$US$US
238672013$23867201$3$F$20240822$20240823$20240517$20240828$EXP$$NVSC2024CA103692$NOVARTIS$$52$YR$$F$Y$$$20240828$$CN$CA$CA
238672062$23867206$2$F$$20240925$20240517$20240930$EXP$$CA-HALEON-2166596$Haleon PLC$$$$$F$Y$$$20240930$$HP$CA$CA
238672215$23867221$5$F$$20240906$20240517$20240911$30DAY$$CO-PFIZER INC-202400097510$PFIZER$$12$YR$$F$Y$$$20240911$$CN$CO$CO
238672222$23867222$2$F$20240514$20240812$20240517$20240814$30DAY$$US-PFIZER INC-202400107497$PFIZER$$13$YR$$M$Y$65.77$KG$20240814$$CN$US$US
238672235$23867223$5$F$20240513$20240915$20240517$20240916$30DAY$$US-PFIZER INC-202400107845$PFIZER$$16$YR$$F$Y$55.79$KG$20240916$$MD$US$US
238672244$23867224$4$F$20240503$20240918$20240517$20240923$30DAY$$GR-PFIZER INC-PV202400062630$PFIZER$$11$YR$$M$Y$30$KG$20240923$$CN$GR$GR
238672332$23867233$2$F$20200101$20240916$20240517$20240920$EXP$$US-SA-2024SA144660$SANOFI AVENTIS$$80$YR$E$F$Y$56.69$KG$20240920$$HP$US$US
238672932$23867293$2$F$$20240806$20240517$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076168$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240809$$CN$US$US
238673052$23867305$2$F$20240101$20240823$20240517$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000439$DECIPHERA PHARMACEUTICALS$$52$YR$A$F$Y$48.5$KG$20240905$$CN$US$US
238673214$23867321$4$F$$20240906$20240517$20240916$EXP$$GB-TAKEDA-2024TUS046500$TAKEDA$$$$$F$Y$$$20240916$$CN$GB$GB
238673332$23867333$2$F$20240507$20240730$20240517$20240731$EXP$$US-JNJFOC-20240519696$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
238673792$23867379$2$F$20240424$20240704$20240517$20240711$PER$$JP-Eisai-EC-2024-165604$EISAI$$$$E$F$Y$$$20240711$$MD$JP$JP
238673822$23867382$2$F$$20240703$20240517$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076583$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$78$YR$E$M$Y$119.3$KG$20240705$$HP$US$US
238673892$23867389$2$F$$20240625$20240517$20240705$30DAY$$US-GSK-US2024058547$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$PH$US$US
238674052$23867405$2$F$20230917$20240801$20240517$20240807$EXP$$CA-TAKEDA-2024TUS048887$TAKEDA$$43$YR$$M$Y$79$KG$20240807$$HP$CA$CA
238674162$23867416$2$F$$20240720$20240517$20240731$EXP$$PL-AUROBINDO-AUR-APL-2024-023559$AUROBINDO$Wach A, Kosa?ka-W?giel J, Korkosz M. Double trouble: a case of DRESS syndrome induced by lamotrigine and subsequent skin reaction to levetiracetam.. POLISH ARCHIVES OF INTERNAL MEDICINE.. 2024;134 (6):16729$21$YR$$F$Y$$$20240731$$MD$PL$PL
238674404$23867440$4$F$20230821$20240729$20240517$20240808$EXP$$JP-Merz Pharmaceuticals GmbH-24-01645$MERZ$$53$YR$$F$Y$60.5$KG$20240808$$MD$JP$JP
238674762$23867476$2$F$$20240703$20240517$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076571$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$75$YR$E$F$Y$77.8$KG$20240704$$HP$US$US
238674902$23867490$2$F$$20240724$20240517$20240731$PER$$US-ALXN-202405USA000602US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
238674922$23867492$2$F$$20240715$20240517$20240715$PER$$US-ALXN-202405USA000543US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238674972$23867497$2$F$$20240719$20240517$20240723$PER$$US-PFIZER INC-202400103934$PFIZER$$$$$F$Y$$$20240723$$HP$US$US
238675013$23867501$3$F$20240101$20240903$20240517$20240905$PER$$US-PFIZER INC-202400107733$PFIZER$$71$YR$$M$Y$79.38$KG$20240905$$CN$US$US
238675092$23867509$2$F$20240101$20240711$20240517$20240716$PER$$US-PFIZER INC-202400108662$PFIZER$$84$YR$$F$Y$$$20240716$$HP$US$US
238675204$23867520$4$F$$20240826$20240517$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US048629$SANDOZ$$$$$F$Y$$$20240829$$CN$US$US
238675362$23867536$2$F$20240904$20240909$20240517$20240920$PER$$US-FARMAPROD-202405-1756$DOMPE FARMACEUTICI$$61$YR$A$F$Y$$$20240920$$CN$US$US
238675463$23867546$3$F$$20240912$20240517$20240917$PER$$US-PFIZER INC-202400108703$PFIZER$$14$YR$$M$Y$$$20240917$$CN$US$US
238675762$23867576$2$F$$20240715$20240517$20240716$PER$$US-ALXN-202405USA000719US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
238675772$23867577$2$F$$20240715$20240517$20240716$PER$$US-ALXN-202405USA000707US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238676142$23867614$2$F$$20240703$20240517$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076570$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$70$YR$E$M$Y$95.7$KG$20240705$$HP$US$US
238676172$23867617$2$F$$20240703$20240517$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076582$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$76$YR$E$F$Y$52.3$KG$20240704$$HP$US$US
238676193$23867619$3$F$$20240729$20240517$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068441$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240805$$CN$US$US
238676322$23867632$2$F$$20240507$20240517$20240726$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03891$HIKMA$Zardoost P, Buckman Z, Weaver J, Elston S, Prouty A, Stuart R, Wehrum HL.. Zardoost P, Buckman Z, Weaver J, Elston S, Prouty A, Stuart R, Wehrum HL. Continuous renal replacement therapy for lithium toxicity: A worthy treatment to avoid intradialytic hypotension and vasopressors.. Clinical Case Reports. 2024;12(4):e8775$54$YR$$F$Y$$$20240726$$MD$US$US
238676353$23867635$3$F$$20240722$20240517$20240809$30DAY$$JP-PFIZER INC-PV202400062086$PFIZER$$$$$$Y$$$20240809$$MD$JP$JP
238676392$23867639$2$F$$20240916$20240517$20240919$30DAY$$KR-PFIZER INC-202400107741$PFIZER$$$$$$Y$$$20240919$$CN$KR$KR
238676522$23867652$2$F$$20240807$20240517$20240822$PER$$US-LEADINGPHARMA-US-2024LEASPO00148$LEADING PHARMA$$$$$$Y$$$20240822$$CN$US$US
238676665$23867666$5$F$20240202$20240918$20240517$20240925$EXP$$US-JNJFOC-20240538900$JOHNSON AND JOHNSON$$80$YR$E$M$Y$74.8$KG$20240925$$HP$US$US
238676772$23867677$2$F$$20240624$20240517$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076578$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$76$YR$E$M$Y$89.4$KG$20240704$$HP$US$US
238676782$23867678$2$F$20240708$20240708$20240517$20240712$EXP$$US-OTSUKA-2024_013470$OTSUKA$$$$$F$Y$$$20240712$$HP$US$US
238676802$23867680$2$F$$20240715$20240517$20240716$PER$$US-ALXN-202405USA000705US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
238676902$23867690$2$F$$20240718$20240517$20240718$EXP$$NVSC2024US104151$NOVARTIS$$37$YR$$M$Y$$$20240718$$CN$US$US
238677022$23867702$2$F$$20240726$20240517$20240729$PER$$NVSC2024US102457$NOVARTIS$$$$$F$Y$$$20240729$$CN$US$US
238677262$23867726$2$F$20240101$20240820$20240517$20240822$EXP$$US-JNJFOC-20240533341$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240822$$MD$US$US
238677422$23867742$2$F$$20240813$20240517$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-071611$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240813$$MD$US$US
238677442$23867744$2$F$$20240724$20240517$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076787$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240729$$HP$US$US
238677452$23867745$2$F$$20240715$20240517$20240715$EXP$$US-ALXN-202405USA000666US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$MD$US$US
238677552$23867755$2$F$20230901$20240711$20240517$20240715$EXP$$US-ELI_LILLY_AND_COMPANY-US202405003868$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240715$$CN$US$US
238677775$23867777$5$F$20240101$20240826$20240517$20240827$EXP$$CA-PFIZER INC-PV202400062763$PFIZER$$72$YR$$M$Y$46.82$KG$20240827$$MD$CA$CA
238677782$23867778$2$F$20220513$20240711$20240517$20240711$EXP$$CA-PFIZER INC-202400107502$PFIZER$$49$YR$$M$Y$$$20240711$$CN$CA$CA
238677832$23867783$2$F$$20240715$20240517$20240715$PER$$US-ALXN-202405USA000679US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
238677897$23867789$7$F$$20240816$20240517$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076244$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240820$$HP$US$US
238678035$23867803$5$F$$20240909$20240517$20240912$EXP$$US-GILEAD-2024-0673045$GILEAD$$58$YR$A$F$Y$$$20240912$$HP$US$US
238678112$23867811$2$F$20240508$20240722$20240517$20240725$EXP$$GB-MYLANLABS-2024M1043302$MYLAN$$$$$M$Y$$$20240725$$CN$GB$GB
238678435$23867843$5$F$$20240917$20240517$20240920$30DAY$$CA-PFIZER INC-PV202400064293$PFIZER$$38$YR$$F$Y$$$20240920$$HP$CA$CA
238678452$23867845$2$F$20240101$20240906$20240517$20240913$EXP$$JP-AstraZeneca-2024A112379$ASTRAZENECA$$$$E$M$Y$$$20240913$$MD$JP$
238678662$23867866$2$F$$20240830$20240517$20240908$EXP$$JP-009507513-2405JPN001080J$MERCK$$8$DEC$$M$Y$$$20240908$$MD$JP$JP
238678682$23867868$2$F$$20240717$20240517$20240719$EXP$$NVSC2024GB104446$NOVARTIS$$$$A$F$Y$$$20240719$$CN$GB$GB
238679003$23867900$3$F$$20240725$20240517$20240730$PER$$US-PFIZER INC-202400110590$PFIZER$$16$YR$$F$Y$$$20240730$$CN$US$US
238679132$23867913$2$F$20240101$20240802$20240517$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202405008960$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240807$$HP$US$US
238679172$23867917$2$F$20231122$20240724$20240517$20240805$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405004955$ELI LILLY AND CO$$76$YR$E$F$Y$42.7$KG$20240805$$CN$JP$JP
238679372$23867937$2$F$20220518$20240701$20240517$20240712$EXP$$JP-AKEBIA THERAPEUTICS, INC.-JP-AKEB-22-021509$AKEBIA THERAPEUTICS$$$$$$Y$$$20240712$$MD$JP$JP
238679483$23867948$3$F$20240501$20240705$20240517$20240709$EXP$$ES-ABBVIE-5756596$ABBVIE$$77$YR$$F$Y$$$20240709$$CN$ES$ES
238679522$23867952$2$F$$20240906$20240517$20240919$EXP$$US-MYLANLABS-2024M1041481$MYLAN$$$$$M$Y$$$20240919$$MD$US$US
238679682$23867968$2$F$$20240515$20240517$20240708$EXP$$IL-BIOVITRUM-2024-IL-007254$BIOVITRUM$$$$$F$Y$$$20240708$$MD$IL$IL
238679903$23867990$3$F$20230901$20240819$20240517$20240822$PER$$NVSC2024US104735$NOVARTIS$$45$YR$$M$Y$$$20240822$$HP$US$US
238679963$23867996$3$F$$20240705$20240517$20240821$PER$$US-RDY-SPO/USA/23/0175288$DR REDDYS$$6$YR$C$F$Y$29.21$KG$20240821$$CN$US$US
238680282$23868028$2$F$$20240715$20240517$20240716$PER$$US-ALXN-202405USA000733US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238680774$23868077$4$F$20240311$20240812$20240517$20240814$EXP$$DE-PFIZER INC-PV202400064219$PFIZER$$72$YR$$F$Y$$$20240814$$MD$DE$DE
238680943$23868094$3$F$$20240628$20240517$20240704$EXP$$SE-AstraZeneca-2024A113219$ASTRAZENECA$$76$YR$$M$Y$$$20240704$$HP$SE$
238681153$23868115$3$F$20240411$20240718$20240517$20240725$EXP$FR-AFSSAPS-SE2024000353$FR-LUNDBECK-DKLU3077687$LUNDBECK$$$$$$Y$$$20240725$$MD$FR$FR
238681193$23868119$3$F$$20240704$20240517$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03954$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238681472$23868147$2$F$20240501$20240704$20240517$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03903$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238681832$23868183$2$F$$20240704$20240517$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03931$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238682062$23868206$2$F$20240507$20240703$20240517$20240708$EXP$$AR-MYLANLABS-2024M1042881$MYLAN$$15$YR$$M$Y$$$20240708$$HP$AR$AR
238682092$23868209$2$F$$20240703$20240517$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076581$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$53$YR$A$M$Y$86$KG$20240705$$HP$US$US
238682102$23868210$2$F$$20240703$20240517$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076577$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$76$YR$E$M$Y$80.3$KG$20240704$$HP$US$US
238682192$23868219$2$F$$20240722$20240517$20240729$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202405005896$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240729$$CN$BR$BR
238682212$23868221$2$F$$20240702$20240517$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03957$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238682512$23868251$2$F$$20240520$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001509$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
238682662$23868266$2$F$$20240509$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001511$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$51.302$KG$20240722$$CN$US$US
238682762$23868276$2$F$$20240515$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001596$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
238683012$23868301$2$F$$20240909$20240517$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075898$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240912$$HP$US$US
238683302$23868330$2$F$$20240516$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001628$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240722$$CN$US$US
238683452$23868345$2$F$$20240508$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001693$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240722$$CN$US$US
238683862$23868386$2$F$$20240610$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001629$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240722$$CN$US$US
238683972$23868397$2$F$$20240703$20240517$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076573$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$74$YR$E$F$Y$77.6$KG$20240705$$HP$US$US
238683983$23868398$3$F$20240425$20240806$20240517$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076902$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240810$$CN$US$US
238684032$23868403$2$F$20060101$20240820$20240517$20240822$EXP$$US-JNJFOC-20240528267$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240822$$CN$US$US
238684622$23868462$2$F$$20240430$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001803$STEMLINE THERAPEUTICS$$48$YR$A$F$Y$$$20240722$$CN$US$US
238684743$23868474$3$F$$20240903$20240517$20240905$EXP$$GB-MYLANLABS-2024M1044331$MYLAN$$$$$F$Y$$$20240905$$CN$GB$GB
238684782$23868478$2$F$$20240517$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001789$STEMLINE THERAPEUTICS$$84$YR$E$F$Y$$$20240722$$CN$US$US
238684962$23868496$2$F$$20240914$20240517$20240919$EXP$$CN-PFIZER INC-PV202400063930$PFIZER$$48$YR$$F$Y$$$20240919$$CN$CN$CN
238684992$23868499$2$F$$20240813$20240517$20240828$EXP$$CA-HLS-202401193$HLS THERAPEUTICS$$66$YR$E$F$Y$64$KG$20240828$$MD$CA$CA
238685032$23868503$2$F$20240101$20240918$20240517$20240922$EXP$$US-ABBVIE-5763598$ABBVIE$$$$$M$Y$$$20240922$$CN$US$US
238685072$23868507$2$F$20211218$20240724$20240517$20240730$PER$$US-BIOGEN-2022BI01128896$BIOGEN$$56$YR$$F$Y$$$20240730$$CN$US$US
238685242$23868524$2$F$$20240926$20240517$20240930$EXP$$CA-HALEON-2167445$Haleon PLC$Trollip E, Hawkins K, Kwek I, Dewart K, Qureshi M, Senaratne JM: Bupivacaine and morphine epidural use for refractory neuropathic pain relief in a Guillain-Barre syndrome patient. CLINICAL CASE REPORTS. Volume: 11(4) Year: 2023 Pages: 1-6.$3$DEC$$M$Y$$$20240928$$HP$CA$CA
238685392$23868539$2$F$$20240513$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001911$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
238685412$23868541$2$F$20240101$20240605$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001921$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240722$$CN$US$US
238685482$23868548$2$F$$20240611$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001925$STEMLINE THERAPEUTICS$$65$YR$A$F$Y$$$20240722$$CN$US$US
238685512$23868551$2$F$$20240612$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001932$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240722$$CN$US$US
238685532$23868553$2$F$$20240503$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001943$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
238685692$23868569$2$F$20240516$20240523$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001962$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240722$$CN$US$US
238685722$23868572$2$F$$20240515$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001948$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240722$$CN$US$US
238685742$23868574$2$F$$20240502$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001957$STEMLINE THERAPEUTICS$$87$YR$E$F$Y$$$20240722$$CN$US$US
238685842$23868584$2$F$$20240712$20240517$20240715$EXP$$CA-PFIZER INC-PV202300104987$PFIZER$$63$YR$$F$Y$$$20240715$$HP$CA$CA
238686032$23868603$2$F$$20240703$20240517$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076579$BRISTOL MYERS SQUIBB$McClain C, Buckallew AR, Armbruster AL. Evaluation of apixaban use in patients with advanced kidney disease. Journal of Pharmacy Technology. 2024 Jan 01;1-7. doi:10.1177/87551225241247691.$76$YR$E$F$Y$80.7$KG$20240704$$HP$US$US
238686282$23868628$2$F$20100101$20240722$20240517$20240725$EXP$$US-ORGANON-O2405USA001312$ORGANON$$$$$M$Y$$$20240725$$LW$US$US
238686382$23868638$2$F$$20240531$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001967$STEMLINE THERAPEUTICS$$84$YR$E$F$Y$$$20240722$$CN$US$US
238686392$23868639$2$F$$20240502$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001968$STEMLINE THERAPEUTICS$$85$YR$E$F$Y$$$20240722$$HP$US$US
238686822$23868682$2$F$$20240429$20240517$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST002021$STEMLINE THERAPEUTICS$$78$YR$E$F$Y$$$20240718$$CN$US$US
238687033$23868703$3$F$$20240719$20240517$20240724$EXP$$CA-JNJFOC-20240534087$JOHNSON AND JOHNSON$$46$YR$A$M$Y$68$KG$20240724$$CN$CA$CA
238687352$23868735$2$F$20240602$20240604$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002157$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240722$$CN$US$US
238687392$23868739$2$F$20240322$20240602$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002070$STEMLINE THERAPEUTICS$$52$YR$A$F$Y$$$20240722$$CN$US$US
238687432$23868743$2$F$$20240507$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002136$STEMLINE THERAPEUTICS$$85$YR$E$F$Y$$$20240722$$CN$US$US
238687522$23868752$2$F$$20240523$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002181$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240722$$CN$US$US
238687562$23868756$2$F$$20240529$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002170$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
238687632$23868763$2$F$$20240625$20240517$20240702$EXP$$US-SA-2024SA143864$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240702$$MD$US$US
238687642$23868764$2$F$20231024$20240731$20240517$20240808$EXP$FR-AFSSAPS-CF2024000204$FR-SA-2024SA144228$SANOFI AVENTIS$$75$YR$E$M$Y$122$KG$20240808$$MD$FR$FR
238687854$23868785$4$F$20240502$20240906$20240517$20240910$30DAY$$JP-PFIZER INC-PV202400059189$PFIZER$$$$$$Y$$$20240910$$HP$JP$JP
238687903$23868790$3$F$20240419$20240911$20240517$20240913$EXP$$US-PFIZER INC-202400109844$PFIZER$$56$YR$$F$Y$102.04$KG$20240913$$HP$US$US
238688162$23868816$2$F$$20240815$20240517$20240821$EXP$$NL-ROCHE-3563129$ROCHE$van Kuilenburg A, Pleunis-van Empel MCH, Brouwer RB, Sijben AEJ, Knapen DG, Oude Munnink TH, et al. Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants. DOI:10.1200/PO.23.00599.. JCO Precision Oncology. 2024;8:E2300599-.$55$YR$A$M$Y$$$20240821$$HP$NL$NL
238688192$23868819$2$F$$20240712$20240517$20240715$PER$$US-ALXN-202405USA000492US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
238688212$23868821$2$F$20240420$20240802$20240517$20240805$EXP$FR-AFSSAPS-PV2024000388$FR-PFIZER INC-202400109091$PFIZER$$78$YR$$F$Y$42$KG$20240805$$MD$FR$FR
238688542$23868854$2$F$$20240531$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002254$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240722$$CN$US$US
238688582$23868858$2$F$$20240502$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002271$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240722$$CN$US$US
238688622$23868862$2$F$$20240607$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002272$STEMLINE THERAPEUTICS$$39$YR$A$F$Y$$$20240722$$CN$US$US
238688702$23868870$2$F$$20240529$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002310$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240722$$CN$US$US
238688742$23868874$2$F$20240329$20240611$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002231$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240722$$CN$US$US
238688752$23868875$2$F$$20240516$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002302$STEMLINE THERAPEUTICS$$78$YR$E$F$Y$$$20240722$$CN$US$US
238688773$23868877$3$F$20240719$20240723$20240517$20240731$EXP$$US-Stemline Therapeutics, Inc.-2024ST002283$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240726$$CN$US$US
238689042$23868904$2$F$20240506$20240625$20240517$20240703$EXP$$CO-AstraZeneca-2024A111894$ASTRAZENECA$$3743$WK$$M$Y$74$KG$20240703$$CN$CO$
238689102$23868910$2$F$$20240715$20240517$20240715$EXP$$US-ALXN-202405USA000570US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
238689113$23868911$3$F$$20240715$20240517$20240716$PER$$US-ALXN-202405USA000700US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238689132$23868913$2$F$20240227$20240716$20240517$20240722$EXP$$US-ABBVIE-5757718$ABBVIE$$56$YR$$F$Y$$$20240719$$CN$US$US
238689152$23868915$2$F$20190708$20240512$20240517$20240812$EXP$$NVSC2022IN217339$NOVARTIS$$48$YR$$F$Y$$$20240812$$CN$IN$IN
238689292$23868929$2$F$$20230816$20240517$20240715$EXP$$US-NOVOPROD-1201197$NOVO NORDISK$$$$$$Y$$$20240715$$CN$US$US
238689352$23868935$2$F$$20240507$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002324$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240722$$CN$US$US
238689412$23868941$2$F$$20240516$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002347$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240722$$CN$US$US
238689452$23868945$2$F$$20240514$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002325$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240722$$CN$US$US
238689522$23868952$2$F$20240101$20240612$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002374$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240718$$CN$US$US
238689532$23868953$2$F$$20240605$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002348$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240722$$CN$US$US
238689552$23868955$2$F$$20240506$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002357$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240718$$CN$US$US
238689602$23868960$2$F$$20240524$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002388$STEMLINE THERAPEUTICS$$50$YR$A$F$Y$$$20240718$$CN$US$US
238689712$23868971$2$F$20240408$20240708$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002361$STEMLINE THERAPEUTICS$$83$YR$E$F$Y$$$20240718$$CN$US$US
238689782$23868978$2$F$$20240624$20240517$20240708$EXP$$US-NOVOPROD-1212662$NOVO NORDISK$$$$$M$Y$$$20240708$$CN$US$US
238689872$23868987$2$F$$20240709$20240517$20240717$EXP$$PE-JNJFOC-20240523405$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240717$$HP$PE$PE
238689882$23868988$2$F$20240514$20240708$20240517$20240711$PER$$US-JNJFOC-20240540734$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240711$$PH$US$US
238689892$23868989$2$F$20240405$20240430$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002379$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
238689922$23868992$2$F$$20240507$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002382$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240718$$CN$US$US
238690022$23869002$2$F$$20240909$20240517$20240920$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-074856$BRISTOL MYERS SQUIBB$Yeoh K, Lass-Florl C, Lamoth F, Slavin MA, Williams E, Neofytos D. Clinicopathologic conference: bloodstream infection in an allogeneic hamatopoietic cell transplant: thinking beyond the usual. Transplant Infectious Disease. 2024 May 02;26:1-6. doi:10.1111/tid.14273.$53$YR$A$F$Y$$$20240920$$HP$AU$AU
238690093$23869009$3$F$20240113$20240612$20240517$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003571$TG THERAPEUTICS$$59$YR$$F$Y$62.132$KG$20240715$$CN$US$US
238690152$23869015$2$F$20240508$20240715$20240517$20240715$PER$$US-ALXN-202405USA000651US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238690172$23869017$2$F$$20240708$20240517$20240711$PER$$US-ALXN-202405USA000682US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
238690243$23869024$3$F$20240515$20240822$20240517$20240824$PER$$US-AMGEN-USASP2024097490$AMGEN$$64$YR$A$M$Y$$$20240824$$MD$US$US
238690572$23869057$2$F$20240101$20240703$20240517$20240710$EXP$$CA-JNJFOC-20240530180$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20240710$$HP$CA$CA
238690584$23869058$4$F$20240101$20240910$20240517$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011108$UNITED THERAPEUTICS$$52$YR$$F$Y$$$20240920$$$US$US
238690653$23869065$3$F$$20240715$20240517$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076819$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240717$$CN$US$US
238690662$23869066$2$F$20240722$20240722$20240517$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076828$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240723$$HP$US$US
238690732$23869073$2$F$$20240503$20240517$20240723$EXP$$US-Covis Pharma GmbH-2024COV00572$COVIS PHARMA$$$$$F$Y$$$20240716$$CN$US$US
238690842$23869084$2$F$20210601$20240715$20240517$20240715$PER$$US-ALXN-202405USA000658US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238690892$23869089$2$F$20230901$20240723$20240517$20240728$EXP$$US-ABBVIE-5759885$ABBVIE$$71$YR$$F$Y$$$20240728$$CN$US$US
238691003$23869100$3$F$$20240808$20240517$20240809$EXP$$NVSC2023AU273725$NOVARTIS$$$$$F$Y$$$20240809$$HP$AU$AU
238691102$23869110$2$F$20240510$20240705$20240517$20240715$EXP$$JP-AstraZeneca-2024A112380$ASTRAZENECA$$60$YR$$F$Y$$$20240715$$MD$JP$
238691195$23869119$5$F$$20240829$20240517$20240908$EXP$$US-GSK-US2023049987$GLAXOSMITHKLINE$$$$$F$Y$$$20240908$$CN$US$US
238691432$23869143$2$F$$20240607$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000801$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240722$$CN$US$US
238691512$23869151$2$F$20240202$20240508$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000828$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240722$$CN$US$US
238691562$23869156$2$F$$20240513$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000770$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
238691742$23869174$2$F$$20240608$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000872$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240722$$CN$US$US
238691782$23869178$2$F$$20240509$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000901$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240722$$CN$US$US
238691842$23869184$2$F$20240101$20240603$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000682$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
238691862$23869186$2$F$$20240528$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000671$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
238691972$23869197$2$F$$20240530$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000857$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240722$$CN$US$US
238692002$23869200$2$F$$20240514$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000720$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240722$$CN$US$US
238692042$23869204$2$F$$20240510$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000725$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240722$$CN$US$US
238692282$23869228$2$F$$20240807$20240517$20240814$EXP$$US-TAKEDA-2024TUS047023$TAKEDA$$$$$F$Y$$$20240814$$CN$US$US
238692402$23869240$2$F$20240101$20240528$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000723$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240722$$CN$US$US
238692482$23869248$2$F$$20240709$20240517$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076028$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240712$$CN$US$US
238692492$23869249$2$F$$20240809$20240517$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076923$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240813$$CN$US$US
238692502$23869250$2$F$20240101$20240522$20240517$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST000760$STEMLINE THERAPEUTICS$$62$YR$A$F$Y$$$20240718$$CN$US$US
238692603$23869260$3$F$$20240904$20240517$20240906$PER$$US-PFIZER INC-PV202300056423$PFIZER$$70$YR$$F$Y$$$20240906$$CN$US$US
238692713$23869271$3$F$20240430$20240912$20240517$20240916$EXP$$JP-WT-2024-01432$Waylis$$$$$$Y$$$20240916$$PH$JP$JP
238692722$23869272$2$F$20240422$20240815$20240517$20240819$EXP$$JP-AstraZeneca-2024A112449$ASTRAZENECA$$68$YR$$M$Y$65$KG$20240819$$MD$JP$
238692752$23869275$2$F$$20240716$20240517$20240719$EXP$$SI-AstraZeneca-2024A114204$ASTRAZENECA$Mlinsek, G; Blagus, T; Malgaj V, M; Ales R, A; Dolzan,V. Genetic variability in rosuvastatin metabolism explains rhabdomyolysis and consequent acute renal failure. Nephrology Dialysis Transplantation 2024;39(Supplement 1):i2823-i2824.$79$YR$$F$Y$$$20240719$$HP$SI$
238692982$23869298$2$F$$20240820$20240517$20240823$EXP$$US-JNJFOC-20240523661$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$CN$US$US
238693002$23869300$2$F$$20240719$20240517$20240801$PER$$US-Calliditas-2024CAL00716$CALLIDITAS THERAPEUTICS$$42$YR$A$M$Y$140.7$KG$20240801$$CN$US$US
238693403$23869340$3$F$20220401$20240823$20240517$20240830$PER$$US-BIOGEN-2024BI01264742$BIOGEN$$47$YR$$F$Y$$$20240830$$CN$US$US
238693422$23869342$2$F$$20240715$20240517$20240715$PER$$US-ALXN-202405USA000672US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
238693442$23869344$2$F$$20240807$20240517$20240808$PER$$US-ALXN-A202102282$ALEXION PHARMACEUTICALS$$$$E$F$Y$$$20240808$$CN$US$US
238693462$23869346$2$F$$20240708$20240517$20240715$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-073067$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240715$$MD$JP$JP
238693624$23869362$4$F$20240509$20240919$20240517$20240926$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-005480$AMGEN$$46$YR$A$M$Y$$$20240926$$HP$US$US
238693734$23869373$4$F$$20240802$20240517$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074891$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240806$$CN$US$US
238693762$23869376$2$F$$20240715$20240517$20240715$PER$$US-ALXN-202405USA000674US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240715$$CN$US$US
238693982$23869398$2$F$20240507$20240703$20240517$20240705$EXP$$IL-BAYER-2024A068463$BAYER$$82$YR$E$M$Y$$$20240705$$CN$IL$IL
238694412$23869441$2$F$$20240614$20240517$20240702$30DAY$$TR-JNJFOC-20240548404$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$TR$TR
238694575$23869457$5$F$$20240924$20240517$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076613$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240927$$CN$US$US
238694582$23869458$2$F$$20240816$20240517$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076978$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240816$$CN$US$US
238694592$23869459$2$F$$20240819$20240517$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077233$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240819$$CN$US$US
238694664$23869466$4$F$$20240808$20240517$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001006$BLUEPRINT MEDICINES$$$$$M$Y$$$20240814$$CN$US$US
238694822$23869482$2$F$$20240715$20240517$20240716$PER$$US-ALXN-202405USA000684US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
238694842$23869484$2$F$$20240628$20240517$20240717$30DAY$$IL-JNJFOC-20240544328$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$IL$IL
238694865$23869486$5$F$$20240703$20240517$20240715$EXP$$IN-ROCHE-3562860$ROCHE$$44$YR$A$M$Y$$$20240715$$CN$IN$IN
238694872$23869487$2$F$$20240629$20240517$20240701$EXP$$US-TAKEDA-2023TUS056280$TAKEDA$$$$$M$Y$$$20240701$$CN$US$US
238694943$23869494$3$F$$20240708$20240517$20240710$EXP$$JP-ABBVIE-5764571$ABBVIE$Murata M, Taisuke K, Ikezawa S, Urakami H, Tachibana K, Morizane S. A case of skin squamous cell carcinoma developed while using biologic preparation for psoriasis vulgaris. The 40th Annual Meeting of the Japanese Skin Cancer Society. 2024;144-144.; Murata M, Kanno T, Ikezawa S, Urakami H, Tachibana K, Morizane S. D-4-5: A case of skin squamous cell carcinoma developed while using biologic preparation for psoriasis vulgaris. The 40th Annual Meeting of the Japanese Skin Cancer Society. 2024;14...$67$YR$$M$Y$$$20240710$$HP$JP$JP
238695063$23869506$3$F$$20240724$20240517$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-076868$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240801$$PH$JP$JP
238695143$23869514$3$F$$20240806$20240517$20240812$EXP$$US-TAKEDA-2024TUS040983$TAKEDA$$$$$M$Y$$$20240812$$HP$US$US
238695183$23869518$3$F$20240513$20240723$20240517$20240730$PER$$US-PHARMING-PHAUS2024000390$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
238695402$23869540$2$F$20240404$20240723$20240517$20240724$EXP$$US-ORGANON-O2405USA001334$ORGANON$$20$YR$$F$Y$58.96$KG$20240724$$MD$US$US
238695412$23869541$2$F$$20240715$20240517$20240722$EXP$$US-SA-2024SA145521$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240722$$MD$US$US
238695453$23869545$3$F$20240101$20240724$20240517$20240729$EXP$$JP-ABBVIE-5762879$ABBVIE$$60$YR$$M$Y$$$20240729$$PH$JP$JP
238695562$23869556$2$F$$20240429$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002561$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
238695582$23869558$2$F$$20240502$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002562$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240718$$CN$US$US
238695642$23869564$2$F$$20240506$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002580$STEMLINE THERAPEUTICS$$42$YR$A$F$Y$$$20240718$$CN$US$US
238695672$23869567$2$F$20240519$20240606$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002598$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
238695682$23869568$2$F$$20240509$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002601$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240718$$CN$US$US
238695732$23869573$2$F$$20240530$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002608$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
238695772$23869577$2$F$$20240515$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002615$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
238695782$23869578$2$F$20240415$20240523$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002547$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240718$$CN$US$US
238695792$23869579$2$F$$20240611$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002617$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
238695802$23869580$2$F$20240422$20240524$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002622$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240718$$CN$US$US
238695812$23869581$2$F$$20240502$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002625$STEMLINE THERAPEUTICS$$51$YR$A$F$Y$$$20240718$$CN$US$US
238695852$23869585$2$F$$20240530$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002635$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
238695862$23869586$2$F$20240421$20240520$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002637$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
238695902$23869590$2$F$$20240522$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002636$STEMLINE THERAPEUTICS$$51$YR$A$F$Y$$$20240718$$CN$US$US
238695932$23869593$2$F$20240401$20240514$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002600$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240718$$CN$US$US
238695962$23869596$2$F$$20240709$20240517$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076822$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240709$$CN$US$US
238696012$23869601$2$F$20240422$20240510$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002607$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
238696052$23869605$2$F$20240501$20240611$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002544$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$CN$US$US
238696122$23869612$2$F$$20240514$20240517$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002616$STEMLINE THERAPEUTICS$$49$YR$A$F$Y$$$20240718$$CN$US$US
238696203$23869620$3$F$20240507$20240806$20240517$20240809$EXP$$CN-Eisai-EC-2024-165596$EISAI$$42$YR$A$F$Y$44.6$KG$20240809$$MD$CN$CN
238696222$23869622$2$F$$20240621$20240517$20240704$30DAY$$JP-JNJFOC-20240538271$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$PH$JP$JP
238696242$23869624$2$F$20240406$20240816$20240517$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077137$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$80.726$KG$20240816$$CN$US$US
238696272$23869627$2$F$$20240711$20240517$20240715$EXP$$GB-AMGEN-GBRSP2024097079$AMGEN$$42$YR$A$F$Y$$$20240715$$CN$GB$GB
238696292$23869629$2$F$$20240828$20240517$20240903$EXP$$CA-TAKEDA-2024TUS048423$TAKEDA$$$$$M$Y$$$20240903$$HP$CA$CA
238696346$23869634$6$F$20240418$20240913$20240517$20240921$EXP$$JP-009507513-2404JPN002484J$MERCK$$7$DEC$$M$Y$$$20240921$$MD$JP$JP
238696402$23869640$2$F$20240425$20240517$20240517$20240703$PER$$US-Eisai-EC-2024-164695$EISAI$$57$YR$A$M$Y$108$KG$20240703$$HP$US$US
238696422$23869642$2$F$20240422$20240517$20240517$20240703$PER$$US-Eisai-EC-2024-164690$EISAI$$74$YR$E$F$Y$$$20240703$$CN$US$US
238696502$23869650$2$F$$20240722$20240517$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-074834$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240725$$CN$JP$JP
238696542$23869654$2$F$20240425$20240802$20240517$20240809$EXP$$JP-009507513-2405JPN001213J$MERCK$$77$YR$$M$Y$$$20240809$$MD$JP$JP
238696605$23869660$5$F$20230801$20240912$20240517$20240920$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000447$DECIPHERA PHARMACEUTICALS$$67$YR$A$M$Y$$$20240920$$CN$US$US
238696692$23869669$2$F$$20240701$20240517$20240708$EXP$$JP-OTSUKA-2024_014030$OTSUKA$$6$DEC$$M$Y$$$20240708$$MD$JP$JP
238696754$23869675$4$F$20240501$20240830$20240517$20240903$EXP$$AU-MYLANLABS-2024M1043603$MYLAN$$22$YR$$M$Y$$$20240903$$HP$AU$AU
238696762$23869676$2$F$$20240719$20240517$20240801$PER$$US-Calliditas-2024CAL00719$CALLIDITAS THERAPEUTICS$$48$YR$A$F$Y$$$20240801$$CN$US$US
238696822$23869682$2$F$$20240710$20240517$20240715$PER$$US-AMGEN-USASP2024098353$AMGEN$$$$$$Y$$$20240715$$CN$US$US
238696832$23869683$2$F$20240101$20240821$20240517$20240827$EXP$$JP-009507513-2405JPN001053J$MERCK$$8$DEC$$M$Y$$$20240827$$MD$JP$JP
238696862$23869686$2$F$20240513$20240702$20240517$20240704$EXP$$RO-ABBVIE-5760636$ABBVIE$$58$YR$$M$Y$$$20240704$$CN$RO$RO
238696913$23869691$3$F$$20240919$20240517$20240930$30DAY$$GR-JNJFOC-20240537900$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$GR$GR
238697063$23869706$3$F$20220129$20240718$20240517$20240723$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-151750$BOEHRINGER INGELHEIM$$55$YR$A$F$Y$51.2$KG$20240719$$CN$ES$ES
238697072$23869707$2$F$20240501$20240822$20240517$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US049552$SANDOZ$$13$YR$$F$Y$$$20240827$$CN$US$US
238697162$23869716$2$F$$20240617$20240517$20240701$30DAY$$JP-JNJFOC-20240537507$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$JP$JP
238697263$23869726$3$F$20240413$20240712$20240517$20240807$EXP$$NVSC2024US102552$NOVARTIS$$61$YR$$F$Y$$$20240807$$CN$US$US
238697283$23869728$3$F$$20240729$20240517$20240809$30DAY$$PH-JNJFOC-20240537487$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$CN$PH$PH
238697312$23869731$2$F$$20240717$20240517$20240724$EXP$$US-ASTELLAS-2024EU004756$ASTELLAS$$$$$M$Y$$$20240724$$CN$US$US
238697333$23869733$3$F$20240101$20240816$20240517$20240822$EXP$$US-ABBVIE-5762735$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
238697364$23869736$4$F$20240111$20240702$20240517$20240708$EXP$$BR-AKCEA THERAPEUTICS, INC.-2024IS001344$AKCEA THERAPEUTICS$$$$$$Y$$$20240705$$MD$BR$BR
238697382$23869738$2$F$$20240715$20240517$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076641$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240716$$CN$US$US
238697572$23869757$2$F$$20240617$20240517$20240701$30DAY$$DE-JNJFOC-20240537434$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$DE$BG
238697604$23869760$4$F$20240405$20240709$20240517$20240716$EXP$$JP-TEVA-VS-3182094$TEVA$$52$YR$$F$Y$$$20240716$$HP$JP$JP
238697722$23869772$2$F$$20240715$20240517$20240715$PER$$US-ALXN-202405USA000606US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
238698163$23869816$3$F$20240501$20240823$20240517$20240823$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-076557$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$50$KG$20240823$$PH$TW$TW
238698593$23869859$3$F$20240801$20240822$20240517$20240909$EXP$$US-SA-2024SA142647$SANOFI AVENTIS$$65$YR$E$M$Y$61$KG$20240909$$MD$US$US
238698662$23869866$2$F$$20240906$20240517$20240918$PER$$US-SA-2024SA143129$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240918$$MD$US$US
238698672$23869867$2$F$$20240808$20240517$20240826$PER$$US-SA-2024SA142592$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240826$$MD$US$US
238698712$23869871$2$F$20240301$20240712$20240517$20240722$PER$$US-SA-2024SA142564$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240722$$MD$US$US
238698873$23869887$3$F$20240101$20240702$20240517$20240711$PER$$US-SA-2024SA145698$SANOFI AVENTIS$$74$YR$E$F$Y$81.6$KG$20240711$$MD$US$US
238698892$23869889$2$F$20240101$20240717$20240517$20240726$PER$$US-SA-2024SA144983$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240726$$MD$US$US
238698923$23869892$3$F$20240101$20240808$20240517$20240816$PER$$US-SA-2024SA144797$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240816$$MD$US$US
238698952$23869895$2$F$$20240820$20240517$20240902$PER$$US-SA-2024SA143360$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240902$$MD$US$US
238698983$23869898$3$F$20240101$20240809$20240517$20240819$PER$$US-SA-2024SA091593$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240819$$MD$US$US
238699122$23869912$2$F$20240101$20240704$20240517$20240715$PER$$US-SA-2024SA138864$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240715$$MD$US$US
238699302$23869930$2$F$20240101$20240729$20240517$20240807$PER$$US-SA-2024SA143341$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240807$$MD$US$US
238699503$23869950$3$F$20240101$20240823$20240517$20240913$PER$$US-SA-2024SA143205$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240913$$MD$US$US
238699683$23869968$3$F$20240101$20240620$20240517$20240701$PER$$US-SA-2024SA143837$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240701$$PH$US$US
238699832$23869983$2$F$20240301$20240726$20240517$20240807$PER$$US-SA-2024SA145022$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240807$$MD$US$US
238699852$23869985$2$F$20240501$20240819$20240517$20240828$PER$$US-SA-2024SA145793$SANOFI AVENTIS$$35$YR$A$M$Y$104.3$KG$20240828$$MD$US$US
238699892$23869989$2$F$$20240816$20240517$20240829$PER$$US-SA-2024SA143214$SANOFI AVENTIS$$$$A$F$Y$$$20240829$$MD$US$US
238699902$23869990$2$F$20240701$20240729$20240517$20240806$PER$$US-SA-2024SA143122$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240806$$MD$US$US
238699922$23869992$2$F$20240401$20240731$20240517$20240809$PER$$US-SA-2024SA143334$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240809$$MD$US$US
238700262$23870026$2$F$20240101$20240725$20240517$20240807$PER$$US-SA-2024SA144390$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240807$$MD$US$US
238700282$23870028$2$F$20240101$20240814$20240517$20240827$PER$$US-SA-2024SA144670$SANOFI AVENTIS$$83$YR$E$F$Y$55.7$KG$20240827$$MD$US$US
238700462$23870046$2$F$20240101$20240826$20240517$20240910$PER$$US-SA-2024SA145667$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240910$$MD$US$US
238700492$23870049$2$F$20240101$20240626$20240517$20240705$PER$$US-SA-2024SA144386$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240705$$MD$US$US
238700573$23870057$3$F$$20240718$20240517$20240731$PER$$US-SA-2024SA145783$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240731$$MD$US$US
238700603$23870060$3$F$20240101$20240724$20240517$20240802$PER$$US-SA-2024SA146012$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240802$$MD$US$US
238700632$23870063$2$F$20240911$20240911$20240517$20240919$PER$$US-SA-2024SA144850$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240919$$MD$US$US
238700643$23870064$3$F$20240101$20240620$20240517$20240701$PER$$US-SA-2024SA146073$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240701$$MD$US$US
238700654$23870065$4$F$20240101$20240823$20240517$20240918$PER$$US-SA-2024SA147134$SANOFI AVENTIS$$26$YR$A$M$Y$83.9$KG$20240918$$MD$US$US
238700723$23870072$3$F$20240101$20240808$20240517$20240817$PER$$US-SA-2024SA148158$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240817$$MD$US$US
238700743$23870074$3$F$20240101$20240719$20240517$20240730$PER$$US-SA-2024SA145633$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240730$$MD$US$US
238700772$23870077$2$F$$20240716$20240517$20240725$PER$$US-SA-2024SA147515$SANOFI AVENTIS$$74$YR$E$F$Y$77.11$KG$20240725$$MD$US$US
238700793$23870079$3$F$20240101$20240815$20240517$20240828$PER$$US-SA-2024SA148149$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240828$$MD$US$US
238700854$23870085$4$F$20240401$20240823$20240517$20240905$PER$$US-SA-2024SA147003$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240905$$MD$US$US
238700863$23870086$3$F$$20240630$20240517$20240703$PER$$US-SA-2024SA146048$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240703$$MD$US$US
238700882$23870088$2$F$20240101$20240819$20240517$20240828$PER$$US-SA-2024SA148232$SANOFI AVENTIS$$40$YR$A$M$Y$97$KG$20240828$$MD$US$US
238700923$23870092$3$F$20240426$20240709$20240517$20240717$PER$$US-SA-2024SA147951$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240717$$MD$US$US
238700932$23870093$2$F$$20240916$20240517$20240923$PER$$US-SA-2021SA257575$SANOFI AVENTIS$$61$YR$A$M$Y$82.5$KG$20240923$$MD$US$US
238700942$23870094$2$F$$20240730$20240517$20240807$PER$$US-SA-2024SA148176$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240807$$MD$US$US
238700982$23870098$2$F$$20240624$20240517$20240703$PER$$US-SA-2024SA146851$SANOFI AVENTIS$$$$A$M$Y$58$KG$20240703$$MD$US$US
238701062$23870106$2$F$20240309$20240701$20240517$20240708$PER$$US-SA-2024SA126284$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240708$$MD$US$US
238701103$23870110$3$F$20240101$20240815$20240517$20240827$PER$$US-SA-2024SA147491$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240827$$CN$US$US
238701112$23870111$2$F$20240101$20240805$20240517$20240813$PER$$US-SA-2024SA148183$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240814$$MD$US$US
238701172$23870117$2$F$20240101$20240918$20240517$20240926$PER$$US-SA-2024SA148236$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240926$$MD$US$US
238701322$23870132$2$F$20240101$20240701$20240517$20240710$PER$$US-SA-2024SA148447$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240710$$MD$US$US
238701662$23870166$2$F$$20240718$20240517$20240724$EXP$$NVSC2024US104458$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
238701762$23870176$2$F$20230501$20240703$20240517$20240715$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202404011235$ELI LILLY AND CO$$47$YR$A$M$Y$143.5$KG$20240715$$CN$DE$DE
238701962$23870196$2$F$$20240712$20240517$20240715$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-077223$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240715$$MD$JP$JP
238702072$23870207$2$F$$20240723$20240517$20240730$EXP$DE-BFARM-24003193$NVSC2024DE099196$NOVARTIS$$$$A$M$Y$78$KG$20240730$$MD$DE$DE
238702162$23870216$2$F$$20240702$20240517$20240708$EXP$$US-AstraZeneca-2024A114291$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$US$
238702303$23870230$3$F$$20240529$20240517$20240712$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-14558$SAMSUNG BIOEPIS$$$$$$Y$$$20240712$$HP$CA$CA
238702364$23870236$4$F$20240501$20240802$20240517$20240809$PER$$US-BAUSCHBL-2024BNL026917$BAUSCH AND LOMB$$81$YR$$M$Y$76$KG$20240809$$MD$US$US
238702874$23870287$4$F$20240101$20240828$20240517$20240910$EXP$$US-MALLINCKRODT-MNK202401608$MALLINCKRODT$$$$$F$Y$$$20240910$$CN$US$US
238702932$23870293$2$F$$20240814$20240517$20240822$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024003341$BIOCON$$$$$$Y$$$20240822$$HP$CA$CA
238702972$23870297$2$F$$20240703$20240517$20240704$PER$$NVSC2024US101955$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
238703003$23870300$3$F$20240513$20240716$20240517$20240718$PER$$NVSC2024US105064$NOVARTIS$$74$YR$$M$Y$$$20240718$$HP$US$US
238703303$23870330$3$F$$20240902$20240517$20240930$PER$$US-TRAVERE-2024TVT00454$TRAVERE THERAPEUTICS$$57$YR$A$M$Y$$$20240930$$CN$US$US
238703313$23870331$3$F$$20240807$20240517$20240819$EXP$$US-TRAVERE-2024TVT00453$TRAVERE THERAPEUTICS$$54$YR$A$M$Y$127.91$KG$20240819$$CN$US$US
238703514$23870351$4$F$20230802$20240920$20240517$20240927$EXP$$CN-ABBVIE-5497755$ABBVIE$$49$YR$$M$Y$80$KG$20240927$$MD$CN$CN
238703683$23870368$3$F$$20240709$20240517$20240723$EXP$$ES-AUROBINDO-AUR-APL-2024-022624$AUROBINDO$Sanchez FM, Labrador CG, Becerra LW, Fernandez BA, Aguilar AP, Castano-Milla C. Active microscopic colitis precipitated by  fluoxetine.. Revista espanola de enfermedades digestivas. 2024;1$41$YR$$F$Y$$$20240719$$HP$ES$ES
238703692$23870369$2$F$20240101$20240702$20240517$20240708$EXP$$DE-ABBVIE-5749394$ABBVIE$$$$$F$Y$$$20240708$$CN$DE$DE
238703724$23870372$4$F$20240101$20240708$20240517$20240716$EXP$$US-ABBVIE-5763534$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
238703853$23870385$3$F$20240701$20240703$20240517$20240815$PER$$US-TRAVERE-2024TVT00458$TRAVERE THERAPEUTICS$$48$YR$A$F$Y$$$20240815$$CN$US$US
238703892$23870389$2$F$$20240620$20240518$20240731$PER$$US-TRAVERE-2024TVT00467$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240731$$CN$US$US
238703923$23870392$3$F$20240821$20240909$20240518$20240917$PER$$US-TRAVERE-2024TVT00465$TRAVERE THERAPEUTICS$$47$YR$A$F$Y$$$20240917$$CN$US$US
238704012$23870401$2$F$20240401$20240801$20240518$20240809$PER$$US-SA-2024SA146922$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240809$$MD$US$US
238704073$23870407$3$F$20200101$20240808$20240518$20240814$EXP$$US-ABBVIE-5755497$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
238704252$23870425$2$F$20240503$20240709$20240518$20240715$EXP$$CA-JNJFOC-20240317408$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240715$$CN$CA$CA
238704304$23870430$4$F$20240501$20240826$20240518$20240905$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-014898$UNITED THERAPEUTICS$$72$YR$$M$Y$62.4$KG$20240905$$PH$JP$JP
238704442$23870444$2$F$20231115$20240713$20240518$20240724$EXP$JP-MMM-1X3SNRG0$JP-ABBVIE-5702588$ABBVIE$$83$YR$$F$Y$$$20240724$$MD$JP$JP
238704565$23870456$5$F$20240516$20240729$20240518$20240731$PER$$US-AMGEN-USASP2024098485$AMGEN$$70$YR$E$F$Y$$$20240731$$CN$US$US
238704672$23870467$2$F$20240101$20240808$20240518$20240813$EXP$$US-SA-2024SA147634$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240813$$MD$US$US
238704833$23870483$3$F$20240101$20240711$20240518$20240722$PER$$US-SA-2024SA148593$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240722$$MD$US$US
238704903$23870490$3$F$$20240808$20240518$20240820$PER$$US-SA-2024SA143545$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240820$$MD$US$US
238705192$23870519$2$F$$20240802$20240518$20240808$EXP$$US-ABBVIE-5760444$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
238705213$23870521$3$F$20240515$20240728$20240518$20240730$PER$$US-AMGEN-USASP2024098565$AMGEN$$80$YR$E$M$Y$$$20240730$$CN$US$US
238705393$23870539$3$F$20240514$20240730$20240518$20240802$PER$$US-AMGEN-USASP2024097105$AMGEN$$60$YR$A$M$Y$$$20240801$$CN$US$US
238705512$23870551$2$F$20231101$20240627$20240518$20240708$PER$$US-SA-2024SA146942$SANOFI AVENTIS$$64$YR$A$F$Y$111$KG$20240708$$MD$US$US
238705522$23870552$2$F$20240101$20240626$20240518$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-013943$UNITED THERAPEUTICS$$$$$M$Y$104.31$KG$20240703$$$US$US
238705535$23870553$5$F$20240101$20240722$20240518$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-014783$UNITED THERAPEUTICS$$$$$F$Y$102.04$KG$20240727$$$US$US
238705632$23870563$2$F$$20240430$20240518$20240717$PER$$US-TEVA-VS-3194925$TEVA$$$$$F$Y$$$20240717$$PH$US$US
238705694$23870569$4$F$20240101$20240814$20240518$20240819$EXP$$US-SA-2024SA145053$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240819$$MD$US$US
238705753$23870575$3$F$20240513$20240627$20240518$20240701$EXP$$US-ABBVIE-5763727$ABBVIE$$60$YR$$F$Y$113$KG$20240701$$CN$US$US
238705824$23870582$4$F$20240513$20240820$20240518$20240827$EXP$$US-AMGEN-USASP2024095894$AMGEN$$62$YR$A$F$Y$$$20240826$$CN$US$US
238705862$23870586$2$F$$20240910$20240518$20240917$PER$$US-SA-2024SA143537$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240918$$MD$US$US
238705922$23870592$2$F$20240101$20240806$20240518$20240818$PER$$US-SA-2024SA143152$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240819$$MD$US$US
238705972$23870597$2$F$20240101$20240815$20240518$20240829$PER$$US-SA-2024SA141672$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240829$$CN$US$US
238706102$23870610$2$F$20240601$20240702$20240518$20240711$PER$$US-SA-2024SA145362$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240711$$MD$US$US
238706194$23870619$4$F$20240101$20240911$20240518$20240920$PER$$US-SA-2024SA145238$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240920$$MD$US$US
238706325$23870632$5$F$20240515$20240711$20240518$20240815$PER$$US-TRAVERE-2024TVT00487$TRAVERE THERAPEUTICS$$44$YR$A$M$Y$$$20240815$$CN$US$US
238706372$23870637$2$F$20240201$20240703$20240518$20240712$PER$$US-SA-2024SA145266$SANOFI AVENTIS$$50$YR$A$F$Y$84$KG$20240712$$MD$US$US
238706444$23870644$4$F$20240101$20240819$20240518$20240828$PER$$US-SA-2024SA149649$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240828$$MD$US$US
238706665$23870666$5$F$20240101$20240802$20240518$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010880$UNITED THERAPEUTICS$$$$$F$Y$$$20240810$$$US$US
238706822$23870682$2$F$$20240709$20240518$20240717$PER$$US-SA-2024SA148678$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240717$$MD$US$US
238707104$23870710$4$F$20240101$20240710$20240518$20240722$EXP$$CA-CELLTRION INC.-2024CA011593$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
238707162$23870716$2$F$20240501$20240819$20240518$20240822$PER$$US-AMGEN-USASP2024098131$AMGEN$$85$YR$E$F$Y$$$20240822$$CN$US$US
238707212$23870721$2$F$$20240802$20240518$20240808$PER$$US-ABBVIE-5759949$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
238707263$23870726$3$F$20240101$20240702$20240518$20240709$EXP$$US-SA-2024SA148700$SANOFI AVENTIS$$94$YR$E$M$Y$$$20240709$$CN$US$US
238707512$23870751$2$F$$20240822$20240518$20240917$PER$$US-SA-2024SA112192$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240918$$CN$US$US
238707842$23870784$2$F$20230501$20240504$20240518$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-022717$AUROBINDO$$59$YR$$M$Y$$$20240702$$MD$FR$FR
238708013$23870801$3$F$20240512$20240828$20240518$20240910$PER$$US-SA-2024SA146160$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240910$$MD$US$US
238708072$23870807$2$F$$20240805$20240518$20240812$EXP$$PT-AUROBINDO-AUR-APL-2024-023255$AUROBINDO$S? B, Lopes M, Robalo J.. Voluntary drug intoxication in adolescents: impact of COVID-19 pandemic.. Portuguese Journal of Pediatrics. 2024;55(1):20-26$17$YR$$F$Y$$$20240812$$HP$PT$PT
238708504$23870850$4$F$20240508$20240711$20240518$20240724$EXP$$FR-TEVA-VS-3198996$TEVA$$37$YR$$F$Y$63$KG$20240724$$CN$FR$FR
238708864$23870886$4$F$20240101$20240903$20240518$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-011607$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240912$$$US$US
238709612$23870961$2$F$$20240909$20240518$20240911$30DAY$$KR-ABBVIE-5493144$ABBVIE$$$$$$Y$$$20240911$$HP$KR$US
238709693$23870969$3$F$20240507$20240715$20240518$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-013743$UNITED THERAPEUTICS$$70$YR$$F$Y$90.703$KG$20240720$$$US$US
238709712$23870971$2$F$20240401$20240715$20240518$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-022730$AUROBINDO$$33$YR$$F$Y$$$20240718$$HP$GB$GB
238709742$23870974$2$F$$20240802$20240518$20240813$PER$$US-SA-2024SA146844$SANOFI AVENTIS$$69$YR$E$M$Y$131$KG$20240814$$MD$US$US
238709752$23870975$2$F$$20240812$20240518$20240822$EXP$$SK-TEVA-VS-3198071$TEVA$Bellova B. DIFFUSE LARGE CELL LYMPHOMA (DLBCL) IN AN ^OLD BACHELOR^. Interna med. 2024; 24 (S1): 7, ISSN: 1335-8359.; Bellova B. DIFFUSE LARGE CELL LYMPHOMA (DLBCL) IN AN ^OLD BACHELOR^. Interna med. 2024; 24 (S1): 7, ISSN: 1335-8359; Bellova B. DIFFUSE LARGE CELL LYMPHOMA (DLBCL) IN AN ^OLD BACHELOR^. Interna med. 2024; 24 (S1): 7, ISSN: 1335-8359; Bellova B. DIFFUSE LARGE CELL LYMPHOMA (DLBCL) IN AN ^OLD BACHELOR^. Interna med. 2024; 24 (S1): 7, ISSN: 1335-8359$67$YR$$M$Y$$$20240822$$MD$SK$SK
238709773$23870977$3$F$$20240912$20240518$20240922$PER$$US-SA-2024SA149919$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240922$$MD$US$US
238709833$23870983$3$F$$20240715$20240518$20240723$EXP$$IT-AUROBINDO-AUR-APL-2024-021893$AUROBINDO$Arcadi T, Storer S, Bona F, Zanatta P, Gallo M.. Kiosk 8Q-TA-07 - Lenalidomide-induced myocarditis: a Rare Case of Cardiotoxicity.. Journal of Cardiovascular Magnetic Resonance. 2024;26 (Suppl. 1):592-593$55$YR$$F$Y$$$20240723$$MD$IT$IT
238709902$23870990$2$F$$20240723$20240518$20240729$EXP$$US-JNJFOC-20240533940$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$CN$US$US
238709942$23870994$2$F$20181101$20240704$20240518$20240714$EXP$$FR-AUROBINDO-AUR-APL-2024-022922$AUROBINDO$$84$YR$$M$Y$$$20240714$$CN$FR$FR
238710042$23871004$2$F$20240422$20240719$20240518$20240730$EXP$$IT-AUROBINDO-AUR-APL-2024-022811$AUROBINDO$$26$YR$$F$Y$$$20240730$$MD$IT$IT
238710062$23871006$2$F$$20240820$20240518$20240823$EXP$$US-JNJFOC-20240528043$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$HP$US$US
238710133$23871013$3$F$20240101$20240703$20240518$20240712$PER$$US-SA-2024SA149658$SANOFI AVENTIS$$$$A$M$Y$$$20240712$$MD$US$US
238710209$23871020$9$F$20230216$20240918$20240518$20240925$EXP$$GB-JNJFOC-20240520801$JOHNSON AND JOHNSON$$74$YR$E$M$Y$66.5$KG$20240925$$MD$GB$GB
238710252$23871025$2$F$$20240820$20240518$20240827$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014486$UNITED THERAPEUTICS$$$$$F$Y$80.726$KG$20240827$$$US$US
238710262$23871026$2$F$20240501$20240722$20240518$20240726$EXP$$FI-AMGEN-FINSP2024094860$AMGEN$$60$YR$A$M$Y$$$20240726$$PH$FI$FI
238710304$23871030$4$F$20240408$20240820$20240518$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011126$UNITED THERAPEUTICS$$68$YR$$M$Y$92.063$KG$20240828$$$US$US
238710313$23871031$3$F$20240508$20240624$20240518$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015001$UNITED THERAPEUTICS$$70$YR$$F$Y$54.422$KG$20240703$$$US$US
238710372$23871037$2$F$20240101$20240823$20240518$20240902$PER$$US-SA-2024SA150171$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240902$$MD$US$US
238710592$23871059$2$F$20240509$20240808$20240518$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014597$UNITED THERAPEUTICS$$67$YR$$F$Y$64.399$KG$20240816$$$US$US
238710613$23871061$3$F$20240420$20240820$20240518$20240826$EXP$$AU-TAKEDA-2024TUS047211$TAKEDA$$60$YR$$M$Y$$$20240826$$CN$AU$AU
238710652$23871065$2$F$$20240731$20240518$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202405007224$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240813$$MD$US$US
238710792$23871079$2$F$$20240709$20240518$20240717$PER$$US-SA-2024SA149924$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240717$$MD$US$US
238710823$23871082$3$F$20240101$20240801$20240518$20240810$PER$$US-SA-2024SA149922$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240810$$MD$US$US
238710922$23871092$2$F$20240101$20240826$20240518$20240830$EXP$$JP-AMGEN-JPNSP2024095111$AMGEN$$$$$$Y$$$20240830$$MD$JP$JP
238710963$23871096$3$F$20240101$20240913$20240518$20240920$PER$$US-SA-2024SA148747$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240920$$CN$US$US
238711052$23871105$2$F$$20240425$20240518$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000115$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$CN$US$US
238711163$23871116$3$F$20240101$20240806$20240518$20240814$PER$$US-SA-2024SA149926$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240814$$MD$US$US
238711302$23871130$2$F$20240101$20240522$20240518$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000129$Tarsus Pharmaceuticals$$72$YR$$M$Y$$$20240806$$MD$US$US
238711345$23871134$5$F$20210101$20240705$20240518$20240712$PER$$US-SA-2024SA146237$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240712$$MD$US$US
238711372$23871137$2$F$20240101$20240424$20240518$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000133$Tarsus Pharmaceuticals$$73$YR$$F$Y$$$20240806$$PH$US$US
238711482$23871148$2$F$20240101$20240823$20240518$20240904$PER$$US-SA-2024SA143145$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240904$$MD$US$US
238711523$23871152$3$F$$20240613$20240518$20240925$PER$$US-GSK-US2024AMR060498$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
238711714$23871171$4$F$20240101$20240716$20240518$20240725$PER$$US-SA-2024SA147280$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240725$$MD$US$US
238711842$23871184$2$F$20240918$20240920$20240518$20240927$EXP$$CA-GSK-CA2024016719$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$CA$CA
238712102$23871210$2$F$$20240828$20240519$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR058741$VIIV$$$$$M$Y$86$KG$20240906$$HP$US$US
238712242$23871224$2$F$$20240820$20240519$20240829$PER$$US-SA-2024SA149290$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240829$$MD$US$US
238712592$23871259$2$F$20240509$20240625$20240519$20240704$30DAY$$US-GSK-US2024059135$GLAXOSMITHKLINE$$64$YR$$M$Y$$$20240704$$CN$US$US
238712722$23871272$2$F$20240416$20240823$20240519$20240902$EXP$$US-VIIV HEALTHCARE LIMITED-US2024059092$VIIV$$53$YR$$M$Y$$$20240902$$CN$US$US
238712732$23871273$2$F$20240801$20240828$20240519$20240923$PER$$US-SA-2024SA146446$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240923$$MD$US$US
238713083$23871308$3$F$$20240806$20240519$20240813$30DAY$$US-GSK-US2024061881$GLAXOSMITHKLINE$$$$$M$Y$52.1$KG$20240813$$MD$US$US
238713242$23871324$2$F$$20240627$20240519$20240706$EXP$$CN-AUROBINDO-AUR-APL-2024-023440$AUROBINDO$He L, Shen X, Liu Y, Gao L, Wu J, Yu C, et al. The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review. Transl-Cancer- Res. 2022;11(11):4206-4217$52$YR$$F$Y$$$20240706$$HP$CN$CN
238713422$23871342$2$F$$20240913$20240519$20240923$PER$$US-GSK-US2024059121$GLAXOSMITHKLINE$$81$YR$$F$Y$$$20240923$$CN$US$US
238713452$23871345$2$F$20240508$20240607$20240519$20240703$30DAY$$US-GSK-US2024059114$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240703$$CN$US$US
238713582$23871358$2$F$$20240627$20240519$20240706$EXP$$US-AUROBINDO-AUR-APL-2024-023198$AUROBINDO$Blohm JE, Panthula M, Aggarwal A, Swazo R, Ashoka A, Ainapurapu B. Fatal Disseminated Coccidioidomycosis in Cirrhosis: A Case Series. [Review]. The American journal of medicine. 2023;136(7):707-709$56$YR$$M$Y$$$20240706$$MD$US$US
238713592$23871359$2$F$$20240627$20240519$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-023201$AUROBINDO$Blohm JE, Panthula M, Aggarwal A, Swazo R, Ashoka A, Ainapurapu B. Fatal Disseminated Coccidioidomycosis in Cirrhosis: A Case Series. [Review]. The American journal of medicine. 2023;136(7):707-709$62$YR$$F$Y$$$20240705$$MD$US$US
238713762$23871376$2$F$$20240627$20240519$20240705$30DAY$$US-GSK-US2024AMR059239$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
238713865$23871386$5$F$20240517$20240903$20240519$20240913$EXP$$US-GSK-US2024AMR061049$GLAXOSMITHKLINE$$65$YR$$F$Y$75.73$KG$20240913$$CN$US$US
238714002$23871400$2$F$$20240627$20240519$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-022859$AUROBINDO$Thakolwiboon S, Linnoila J, Pittock SJ, Dubey D, Zekeridou A. Cerebellar leptomeningeal enhancement: An imaging finding of rapidly progressive Purkinje cell cytoplasmic autoantibody type 1 paraneoplastic cerebellar syndrome. J-Neuroimmunol. 2024;3871-3873$7$DEC$$F$Y$$$20240705$$HP$US$US
238714082$23871408$2$F$$20240912$20240519$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA048783$SANDOZ$$74$YR$$F$Y$54$KG$20240913$$HP$CA$CA
238714183$23871418$3$F$20240507$20240708$20240519$20240716$PER$$US-SA-2024SA145650$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240716$$MD$US$US
238714315$23871431$5$F$20240607$20240823$20240519$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076449$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240823$$CN$US$US
238714484$23871448$4$F$$20240716$20240519$20240726$EXP$$PL-AUROBINDO-AUR-APL-2024-022195$AUROBINDO$Wach A, Kosa?ka-W?giel J, Korkosz M. Double trouble: a case of DRESS syndrome induced by lamotrigine and subsequent skin reaction to levetiracetam. Polish archives of internal medicine. 2024;134 (6):16729$21$YR$$F$Y$$$20240726$$MD$PL$PL
238714582$23871458$2$F$20240101$20240717$20240519$20240726$PER$$US-SA-2024SA145144$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240726$$CN$US$US
238714694$23871469$4$F$20240501$20240625$20240519$20240708$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK090713$GLENMARK$$$$$$Y$$$20240708$$HP$GB$GB
238714783$23871478$3$F$$20240827$20240519$20240902$PER$$US-SA-2024SA149648$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240902$$MD$US$US
238714792$23871479$2$F$20240501$20240823$20240519$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076878$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240823$$CN$US$US
238714883$23871488$3$F$$20240909$20240519$20240923$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK090857$GLENMARK$$$$$$Y$$$20240923$$HP$CA$CA
238714914$23871491$4$F$$20240801$20240519$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076776$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240802$$CN$US$US
238714923$23871492$3$F$$20240819$20240519$20240826$EXP$$CA-GSK-CA2024061837$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$CA$CA
238715193$23871519$3$F$$20240714$20240519$20240723$30DAY$$US-GSK-US2024AMR061390$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$CN$US$US
238715262$23871526$2$F$$20240718$20240519$20240723$EXP$$NVSC2024GB100105$NOVARTIS$$25$YR$$F$Y$$$20240723$$HP$GB$GB
238715302$23871530$2$F$20240201$20240628$20240519$20240702$PER$$US-AMGEN-USASP2024097447$AMGEN$$74$YR$E$F$Y$$$20240702$$CN$US$US
238715392$23871539$2$F$$20240912$20240519$20240916$EXP$$JP-TAKEDA-2024TJP006958$TAKEDA$$$$$F$Y$$$20240916$$MD$JP$JP
238715402$23871540$2$F$$20240704$20240519$20240708$EXP$$NVSJ2024JP005905$NOVARTIS$$$$E$M$Y$$$20240709$$MD$JP$JP
238715533$23871553$3$F$20240101$20240905$20240519$20240911$EXP$$US-ABBVIE-5763813$ABBVIE$$$$$M$Y$80$KG$20240911$$CN$US$US
238715562$23871556$2$F$$20240802$20240519$20240808$EXP$$US-ABBVIE-5759854$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
238715672$23871567$2$F$20170101$20240626$20240519$20240701$EXP$$BR-BIOGEN-2024BI01265326$BIOGEN$$46$YR$$F$Y$86$KG$20240701$$CN$BR$BR
238715695$23871569$5$F$20240101$20240809$20240519$20240816$EXP$$ES-ABBVIE-5764130$ABBVIE$$$$$M$Y$$$20240816$$CN$ES$ES
238715802$23871580$2$F$20240505$20240826$20240519$20240830$30DAY$$US-SANDOZ INC.-SDZ2024US049369$SANDOZ$$3$YR$$M$Y$$$20240829$$CN$US$US
238715814$23871581$4$F$$20240828$20240519$20240904$30DAY$$CN-JNJFOC-20240489158$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$CN$CN$CN
238715823$23871582$3$F$20240401$20240702$20240519$20240706$EXP$$US-ABBVIE-5764064$ABBVIE$$60$YR$$F$Y$$$20240706$$CN$US$US
238715832$23871583$2$F$20240401$20240716$20240519$20240724$EXP$$US-ABBVIE-5764019$ABBVIE$$57$YR$$M$Y$$$20240724$$CN$US$US
238716032$23871603$2$F$20240816$20240919$20240519$20240926$EXP$$US-ABBVIE-5764262$ABBVIE$$62$YR$$F$Y$$$20240926$$CN$US$US
238716172$23871617$2$F$$20240918$20240519$20240919$PER$$NVSC2024US104197$NOVARTIS$$$$$M$Y$$$20240919$$HP$US$US
238716243$23871624$3$F$20240510$20240621$20240519$20240702$EXP$$JP-SAKK-2024SA142167AA$SANOFI AVENTIS$$79$YR$E$M$Y$50$KG$20240703$$PH$JP$JP
238716413$23871641$3$F$20240507$20240813$20240519$20240821$EXP$$US-AstraZeneca-2024A112804$ASTRAZENECA$$66$YR$$F$Y$112.9$KG$20240821$$MD$US$
238716582$23871658$2$F$20240401$20240701$20240519$20240705$EXP$$US-ABBVIE-5759648$ABBVIE$$40$YR$$M$Y$90.718$KG$20240705$$CN$US$US
238716612$23871661$2$F$20240301$20240424$20240519$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000135$Tarsus Pharmaceuticals$$77$YR$$F$Y$$$20240806$$MD$US$US
238716622$23871662$2$F$20240101$20240530$20240519$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000136$Tarsus Pharmaceuticals$$$$$$Y$$$20240806$$CN$US$US
238716652$23871665$2$F$$20240425$20240519$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000146$Tarsus Pharmaceuticals$$$$$M$Y$$$20240806$$CN$US$US
238716682$23871668$2$F$$20240417$20240519$20240802$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000147$Tarsus Pharmaceuticals$$17$YR$$F$Y$$$20240802$$CN$US$US
238716702$23871670$2$F$20240401$20240430$20240519$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000150$Tarsus Pharmaceuticals$$72$YR$$F$Y$$$20240806$$CN$US$US
238716712$23871671$2$F$$20240425$20240519$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000151$Tarsus Pharmaceuticals$$57$YR$$M$Y$$$20240806$$CN$US$US
238716732$23871673$2$F$$20240517$20240519$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000152$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$CN$US$US
238716772$23871677$2$F$$20240909$20240519$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074687$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240917$$CN$US$US
238716802$23871680$2$F$20230701$20240716$20240519$20240719$EXP$$US-ABBVIE-5761494$ABBVIE$$67$YR$$F$Y$$$20240719$$CN$US$US
238716852$23871685$2$F$20240321$20240619$20240519$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000155$Tarsus Pharmaceuticals$$80$YR$$F$Y$$$20240806$$CN$US$US
238717212$23871721$2$F$$20240802$20240520$20240808$EXP$$US-ABBVIE-5760346$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
238717622$23871762$2$F$20240501$20240725$20240520$20240726$PER$$US-AMGEN-USASP2024099107$AMGEN$$73$YR$E$F$Y$$$20240726$$CN$US$US
238717653$23871765$3$F$20240603$20240822$20240520$20240920$PER$$US-SA-2024SA146902$SANOFI AVENTIS$$74$YR$E$F$Y$60.7$KG$20240920$$MD$US$US
238717733$23871773$3$F$20240514$20240617$20240520$20240711$PER$$US-BEIGENE-BGN-2024-007100$BEIGENE$$$$$$Y$$$20240711$$CN$US$US
238717772$23871777$2$F$20240509$20240626$20240520$20240705$30DAY$$US-GSK-US2024059778$GLAXOSMITHKLINE$$61$YR$$M$Y$$$20240705$$CN$US$US
238717855$23871785$5$F$20240401$20240813$20240520$20240827$PER$$US-SA-2024SA146607$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240827$$HP$US$US
238717902$23871790$2$F$20240513$20240816$20240520$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076468$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240816$$CN$US$US
238717922$23871792$2$F$20240514$20240514$20240520$20240717$PER$$NVSC2024US105219$NOVARTIS$$$$$$Y$$$20240718$$CN$US$US
238717965$23871796$5$F$20240508$20240905$20240520$20240910$EXP$$CA-TAKEDA-2024TUS047315$TAKEDA$$15$YR$$M$Y$$$20240910$$CN$CA$CA
238718002$23871800$2$F$$20240624$20240520$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002134$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
238718042$23871804$2$F$20240701$20240722$20240520$20240807$PER$$AU-TOLMAR, INC.-24AU048651$TOLMAR$$98$YR$$M$Y$$$20240806$$CN$COUNTRY NOT SPECIFIED$AU
238718222$23871822$2$F$20240406$20240903$20240520$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202405004889$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240913$$CN$US$US
238718263$23871826$3$F$20240101$20240711$20240520$20240724$PER$$US-SA-2024SA146759$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240724$$MD$US$US
238718313$23871831$3$F$$20240909$20240520$20240920$EXP$$JP-AMGEN-JPNSP2024096631$AMGEN$$82$YR$E$M$Y$$$20240920$$MD$JP$JP
238718342$23871834$2$F$$20240912$20240520$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA049839$SANDOZ$$2$MON$$$Y$$$20240916$$HP$CA$CA
238718392$23871839$2$F$20240515$20240705$20240520$20240711$30DAY$$US-GSK-US2024061878$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
238718722$23871872$2$F$20240514$20240805$20240520$20240808$PER$$US-AMGEN-USASP2024097157$AMGEN$$62$YR$A$M$Y$$$20240808$$CN$US$US
238718882$23871888$2$F$$20240509$20240520$20240724$PER$$US-SA-2024SA143978$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240724$$CN$US$US
238718902$23871890$2$F$20240509$20240806$20240520$20240814$PER$$US-SA-2024SA146255$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240814$$MD$US$US
238718933$23871893$3$F$20130901$20240812$20240520$20240813$EXP$$US-GILEAD-2024-0673330$GILEAD$$53$YR$A$M$Y$$$20240813$$LW$US$US
238719062$23871906$2$F$$20240701$20240520$20240704$30DAY$$US-GSK-US2024061883$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
238719082$23871908$2$F$20240506$20240822$20240520$20240825$EXP$$JP-TAKEDA-2024TJP006989$TAKEDA$$8$DEC$$M$Y$$$20240825$$MD$JP$JP
238719212$23871921$2$F$20240401$20240725$20240520$20240802$PER$$US-SA-2024SA147002$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240802$$CN$US$US
238719243$23871924$3$F$20201230$20240729$20240520$20240730$EXP$$US-GILEAD-2024-0673333$GILEAD$$58$YR$A$M$Y$$$20240730$$LW$US$US
238719303$23871930$3$F$20240301$20240801$20240520$20240805$EXP$$JP-SA-2024SA149073$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240805$$MD$JP$JP
238719323$23871932$3$F$$20240923$20240520$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076731$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240925$$CN$US$US
238719633$23871963$3$F$20181030$20240726$20240520$20240729$PER$$US-GILEAD-2024-0673334$GILEAD$$48$YR$A$F$Y$$$20240729$$LW$US$US
238719842$23871984$2$F$$20240718$20240520$20240722$EXP$$JP-TAKEDA-2024TJP007116$TAKEDA$$6$DEC$$M$Y$$$20240722$$MD$JP$JP
238719853$23871985$3$F$20200125$20240729$20240520$20240731$EXP$$US-GILEAD-2024-0673335$GILEAD$$48$YR$A$M$Y$$$20240731$$LW$US$US
238719874$23871987$4$F$20240426$20240614$20240520$20240702$30DAY$$US-JNJFOC-20240512372$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240702$$CN$US$US
238719922$23871992$2$F$20240516$20240812$20240520$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076446$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240819$$PH$US$US
238719962$23871996$2$F$$20240710$20240520$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076794$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240719$$HP$US$US
238719972$23871997$2$F$20231201$20240702$20240520$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-076632$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240704$$MD$JP$JP
238719982$23871998$2$F$20210301$20240820$20240520$20240821$PER$$US-JNJFOC-20240545626$JOHNSON AND JOHNSON$$$$A$M$Y$100.3$KG$20240822$$MD$US$US
238719992$23871999$2$F$20160628$20240726$20240520$20240729$PER$$US-GILEAD-2024-0673336$GILEAD$$30$YR$A$M$Y$$$20240729$$LW$US$US
238720002$23872000$2$F$20230101$20240621$20240520$20240704$EXP$$JP-AMGEN-JPNSP2024098074$AMGEN$$84$YR$E$F$Y$42.6$KG$20240703$$MD$JP$JP
238720243$23872024$3$F$$20240521$20240520$20240807$PER$$US-AstraZeneca-2024A100755$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
238720272$23872027$2$F$$20240712$20240520$20240718$EXP$$GB-ROCHE-3562449$ROCHE$$$$$F$Y$$$20240718$$CN$GB$GB
238720314$23872031$4$F$$20240607$20240520$20240926$PER$$US-GSK-US2024AMR062593$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
238720442$23872044$2$F$$20240715$20240520$20240716$PER$$US-ALXN-202405USA000826US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238720483$23872048$3$F$$20240819$20240520$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077132$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240820$$CN$US$US
238720523$23872052$3$F$20240501$20240722$20240520$20240726$EXP$$DE-BIOGEN-2024BI01265336$BIOGEN$$$$$F$Y$$$20240726$$MD$DE$DE
238720572$23872057$2$F$$20240627$20240520$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-022971$AUROBINDO$Suresh MG, Sekar A, Arun Kumar P, Dasari M, Mohamed N, Beck M.. NSIP/OP Overlap: An Unknown in Modern Era.. Am-J-Respir-Crit-Care-Med. 2023;2071$63$YR$$M$Y$$$20240705$$HP$US$US
238720682$23872068$2$F$20240101$20240906$20240520$20240916$EXP$$CA-CELLTRION INC.-2024CA003028$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
238720932$23872093$2$F$20240314$20240507$20240520$20240715$EXP$IT-MINISAL02-983449$IT-MELINTA THERAPEUTICS, LLC-IT-MLNT-24-00255$Unknown Manufacturer$$$$$$Y$$$20240715$$MD$IT$IT
238720982$23872098$2$F$20220901$20240722$20240520$20240725$EXP$$AT-AMGEN-AUTSP2024094693$AMGEN$$43$YR$A$M$Y$$$20240725$$MD$AT$AT
238721052$23872105$2$F$$20240909$20240520$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-074267$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$MD$JP$JP
238721242$23872124$2$F$20240413$20240628$20240520$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002105$ACADIA PHARMACEUTICALS$$43$YR$$F$Y$$$20240723$$CN$US$US
238721282$23872128$2$F$$20240828$20240520$20240906$PER$$US-JNJFOC-20240554556$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$CN$US$US
238721562$23872156$2$F$$20240711$20240520$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04144$LUPIN$$$$$$Y$$$20240729$$PH$US$US
238721674$23872167$4$F$20240410$20240610$20240520$20240702$30DAY$$US-JNJFOC-20240511905$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240703$$HP$US$US
238721703$23872170$3$F$20230801$20240830$20240520$20240910$PER$$US-ABBVIE-5760253$ABBVIE$$17$YR$$M$Y$66$KG$20240910$$CN$US$US
238721824$23872182$4$F$$20240719$20240520$20240725$PER$$US-HORIZON THERAPEUTICS-HZN-2024-001472$AMGEN$$$$A$F$Y$$$20240725$$CN$US$US
238721902$23872190$2$F$$20240715$20240520$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077395$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240719$$CN$US$US
238722163$23872216$3$F$20190705$20240909$20240520$20240912$PER$$US-GILEAD-2024-0673364$GILEAD$$58$YR$A$M$Y$$$20240912$$LW$US$US
238722182$23872218$2$F$20240423$20240716$20240520$20240808$PER$$CA-TOLMAR, INC.-24CA048704$TOLMAR$$71$YR$$M$Y$$$20240808$$CN$CA$CA
238722202$23872220$2$F$20240423$20240717$20240520$20240809$PER$$CA-TOLMAR, INC.-24CA048719$TOLMAR$$71$YR$$M$Y$$$20240809$$CN$CA$CA
238722562$23872256$2$F$$20240627$20240520$20240706$EXP$$US-AUROBINDO-AUR-APL-2024-022974$AUROBINDO$Mahmood SK, Al Asadi L.. A Rare Case of Pulmonary Mucormycosis in an Immunocompetent Patient.. Am-J-RespirCrit-Care-Med. 2023;207:A5588$66$YR$$F$Y$$$20240706$$HP$US$US
238722722$23872272$2$F$$20240715$20240520$20240717$EXP$$US-ORGANON-O2405USA001315$ORGANON$$$$$F$Y$$$20240717$$CN$US$US
238722783$23872278$3$F$20210207$20240822$20240520$20240826$PER$$US-GILEAD-2024-0673325$GILEAD$$53$YR$A$F$Y$$$20240826$$LW$US$US
238722832$23872283$2$F$$20240811$20240520$20240816$EXP$$IN-SANDOZ INC.-SDZ2024IN049430$SANDOZ$$$$$M$Y$$$20240816$$CN$IN$IN
238722903$23872290$3$F$$20240813$20240520$20240819$EXP$$DE-ORGANON-O2405DEU001488$ORGANON$$49$YR$$F$Y$$$20240819$$CN$DE$DE
238722963$23872296$3$F$$20240826$20240520$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US049208$SANDOZ$$$$$M$Y$$$20240829$$CN$US$US
238723152$23872315$2$F$$20240624$20240520$20240702$EXP$$DE-AUROBINDO-AUR-APL-2024-023325$AUROBINDO$$89$YR$$F$Y$50$KG$20240702$$MD$DE$DE
238723172$23872317$2$F$20240307$20240718$20240520$20240726$EXP$$JP-ROCHE-3559342$ROCHE$$9$DEC$E$M$Y$59.8$KG$20240726$$MD$JP$JP
238723212$23872321$2$F$$20240710$20240520$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077398$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$107.5$KG$20240718$$HP$US$US
238723272$23872327$2$F$20240201$20240717$20240520$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002128$JAZZ$$28$YR$$F$Y$$$20240724$$CN$US$US
238723474$23872347$4$F$20240216$20240912$20240520$20240918$30DAY$$US-AMGEN-USASL2024095065$AMGEN$$77$YR$E$F$Y$$$20240918$$HP$US$US
238723704$23872370$4$F$20240513$20240627$20240520$20240704$EXP$$JP-GSK-JP2024JPN060994$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$MD$JP$JP
238723732$23872373$2$F$20230901$20240715$20240520$20240716$EXP$$US-GILEAD-2024-0673084$GILEAD$$59$YR$A$M$Y$68$KG$20240716$$CN$US$US
238723752$23872375$2$F$$20240916$20240520$20240916$PER$$US-ALXN-202405USA000798US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
238723782$23872378$2$F$20140310$20240703$20240520$20240705$PER$$US-GILEAD-2024-0673361$GILEAD$$60$YR$A$M$Y$$$20240705$$LW$US$US
238723792$23872379$2$F$$20240904$20240520$20240907$EXP$$NVSC2024CA103086$NOVARTIS$$70$YR$$F$Y$$$20240907$$CN$CA$CA
238723992$23872399$2$F$20240301$20240723$20240520$20240731$30DAY$$US-GSK-US2024061216$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240731$$CN$US$US
238724022$23872402$2$F$$20240627$20240520$20240706$EXP$$CH-AUROBINDO-AUR-APL-2024-023586$AUROBINDO$Heini AD, Beck P, Bacher U, Seipel K, Zander T, Pabst T, et al. BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom^s Macroglobulinemia. J-Clin-Med. 2023;12:6$44$YR$$M$Y$$$20240706$$HP$CH$CH
238724153$23872415$3$F$20240402$20240917$20240520$20240920$EXP$$JP-TAKEDA-2024TJP007174$TAKEDA$$74$YR$$M$Y$71.6$KG$20240920$$MD$JP$JP
238724242$23872424$2$F$$20240513$20240520$20240812$EXP$$NVSC2024GB101650$NOVARTIS$$$$$F$Y$$$20240812$$CN$GB$GB
238724295$23872429$5$F$20240429$20240727$20240520$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002093$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240805$$CN$US$US
238724542$23872454$2$F$$20240912$20240520$20240912$PER$$US-ALXN-202405USA000804US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
238724593$23872459$3$F$20160511$20240816$20240520$20240819$PER$$US-GILEAD-2024-0673426$GILEAD$$33$YR$A$M$Y$$$20240819$$LW$US$US
238724627$23872462$7$F$20240626$20240916$20240520$20240923$EXP$$CA-TAKEDA-2024TUS047303$TAKEDA$$28$YR$$F$Y$$$20240923$$CN$CA$CA
238724633$23872463$3$F$20240301$20240912$20240520$20240919$EXP$$CA-TAKEDA-2024TUS047256$TAKEDA$$12$YR$$F$Y$$$20240919$$CN$CA$CA
238724653$23872465$3$F$20231101$20240719$20240520$20240726$EXP$$CA-GSK-CA2024024839$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$CA$CA
238724692$23872469$2$F$20240511$20240809$20240520$20240813$PER$$US-AMGEN-USASP2024096106$AMGEN$$74$YR$E$F$Y$$$20240812$$CN$US$US
238724852$23872485$2$F$$20240624$20240520$20240708$EXP$$PK-ROCHE-3562760$ROCHE$$48$YR$A$M$Y$$$20240708$$CN$PK$PK
238725073$23872507$3$F$20191226$20240823$20240520$20240827$PER$$US-GILEAD-2024-0673307$GILEAD$$53$YR$A$F$Y$$$20240827$$LW$US$US
238725152$23872515$2$F$20240429$20240701$20240520$20240710$EXP$$BR-BAXTER-2024BAX017905$BAXTER$$20$YR$$F$Y$$$20240710$$PH$BR$BR
238725562$23872556$2$F$$20240430$20240520$20240729$PER$$US-TEVA-VS-3194167$TEVA$$$$$$Y$$$20240729$$HP$US$US
238725572$23872557$2$F$20240502$20240815$20240520$20240820$PER$$US-AMGEN-USASP2024099113$AMGEN$$44$YR$A$M$Y$$$20240820$$CN$US$US
238725612$23872561$2$F$$20240729$20240520$20240805$EXP$$JP-009507513-2405JPN001349J$MERCK$$70$YR$$F$Y$$$20240804$$MD$JP$JP
238725654$23872565$4$F$20240416$20240815$20240520$20240823$EXP$$US-TAKEDA-2024TUS038628$TAKEDA$$80$YR$$M$Y$$$20240823$$MD$US$US
238725802$23872580$2$F$$20240701$20240520$20240724$PER$$US-AstraZeneca-2024A110744$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
238725872$23872587$2$F$20230901$20240515$20240520$20240726$PER$$US-ABBVIE-5763311$ABBVIE$$55$YR$$F$Y$49.441$KG$20240726$$CN$US$US
238726153$23872615$3$F$$20240720$20240520$20240731$EXP$$GB-AUROBINDO-AUR-APL-2024-022932$AUROBINDO$Ali UA.. 43 Invasive fungal infection as an Infective complication of anti-diabetic drugs.. Clinical Infection in Practice. 2023;20(Suppl 1)$51$YR$$F$Y$$$20240731$$MD$GB$GB
238726342$23872634$2$F$20211122$20240713$20240520$20240718$EXP$$CA-GSK-CA2021240302$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$CA$CA
238726513$23872651$3$F$20240411$20240911$20240520$20240919$EXP$$US-TAKEDA-2024TUS032318$TAKEDA$$59$YR$$F$Y$$$20240919$$MD$US$US
238726543$23872654$3$F$20240101$20240712$20240520$20240722$EXP$$US-009507513-2405USA002779$MERCK$$$$$F$Y$$$20240719$$PH$US$US
238726552$23872655$2$F$20240821$20240904$20240520$20240910$EXP$$US-TAKEDA-2024TUS045658$TAKEDA$$73$YR$$F$Y$45$KG$20240910$$MD$US$US
238726732$23872673$2$F$$20240729$20240520$20240802$EXP$$US-TAKEDA-2024TUS047185$TAKEDA$$$$$F$Y$$$20240802$$MD$US$US
238726852$23872685$2$F$20201204$20240827$20240520$20240902$PER$$US-GILEAD-2024-0673312$GILEAD$$50$YR$A$M$Y$$$20240902$$LW$US$US
238726932$23872693$2$F$20240510$20240829$20240520$20240905$EXP$$CA-TAKEDA-2024TUS047371$TAKEDA$$39$YR$$F$Y$$$20240905$$CN$CA$CA
238727092$23872709$2$F$20240516$20240714$20240520$20240716$PER$$US-AMGEN-USASP2024098197$AMGEN$$76$YR$E$F$Y$$$20240716$$CN$US$US
238727162$23872716$2$F$$20240731$20240520$20240805$EXP$$NVSC2024US104846$NOVARTIS$$$$$F$Y$$$20240803$$HP$US$US
238727182$23872718$2$F$$20240916$20240520$20240923$EXP$$US-MYLANLABS-2024M1045550$MYLAN$$$$$M$Y$$$20240923$$HP$US$US
238727373$23872737$3$F$$20240819$20240520$20240829$EXP$$NVSC2024CA101285$NOVARTIS$$43$YR$$F$Y$96$KG$20240829$$HP$CA$CA
238727403$23872740$3$F$$20240629$20240520$20240711$EXP$$NL-Accord-425028$ACCORD$van Kuilenburg ABP, Pleunis-van Empel MCH, Brouwer RB, Sijben AEJ, Knapen DG, Oude Munnink TH, et al. Lethal capecitabine toxicity in patients with complete dihydropyrimidine dehydrogenase deficiency due to ultra-rare DPYD variants. JCO precision oncology. 2024;8:e2300599. DOI: 10.1200/PO.23.00599.$65$YR$E$F$Y$$$20240711$$HP$NL$NL
238727473$23872747$3$F$20160901$20240823$20240520$20240827$EXP$$US-GILEAD-2024-0673311$GILEAD$$56$YR$A$M$Y$$$20240827$$LW$US$US
238727523$23872752$3$F$20240515$20240808$20240520$20240813$EXP$$JP-GILEAD-2024-0672979$GILEAD$$86$YR$E$F$Y$36.5$KG$20240813$$MD$JP$JP
238727642$23872764$2$F$$20240709$20240520$20240815$PER$$US-TRAVERE-2024TVT00471$TRAVERE THERAPEUTICS$$$$$F$Y$113.99$KG$20240815$$CN$US$US
238727693$23872769$3$F$$20240923$20240520$20240930$PER$$US-TRAVERE-2024TVT00469$TRAVERE THERAPEUTICS$$70$YR$E$M$Y$$$20240930$$CN$US$US
238727746$23872774$6$F$20240513$20240923$20240520$20240927$EXP$$CO-AMGEN-COLSL2024096341$AMGEN$$20$YR$A$M$Y$$$20240927$$CN$CO$CO
238727803$23872780$3$F$20150112$20240823$20240520$20240826$PER$$US-GILEAD-2024-0673328$GILEAD$$60$YR$A$M$Y$$$20240826$$LW$US$US
238727852$23872785$2$F$20240101$20240731$20240520$20240802$EXP$$US-UCBSA-2024006679$UCB$$$$$F$Y$$$20240802$$CN$US$US
238728013$23872801$3$F$20170906$20240731$20240520$20240801$EXP$$US-GILEAD-2024-0673338$GILEAD$$54$YR$A$M$Y$$$20240801$$LW$US$US
238728225$23872822$5$F$20240424$20240816$20240520$20240913$PER$$US-TOLMAR, INC.-24US048831$TOLMAR$$10$YR$$F$Y$$$20240913$$HP$US$US
238728254$23872825$4$F$$20240829$20240520$20240902$PER$$US-ALXN-202405USA000777US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$HP$US$US
238728282$23872828$2$F$$20240611$20240520$20240730$PER$$US-TRAVERE-2024TVT00484$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240730$$CN$US$US
238728362$23872836$2$F$$20240911$20240520$20240930$PER$$US-TRAVERE-2024TVT00495$TRAVERE THERAPEUTICS$$8$YR$C$M$Y$$$20240930$$CN$US$US
238728482$23872848$2$F$20240120$20240814$20240520$20240828$EXP$$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2024-019254$VALIDUS$$$$$$Y$$$20240828$$PH$CA$CA
238728592$23872859$2$F$$20240701$20240520$20240705$PER$$US-AstraZeneca-2024A110014$ASTRAZENECA$$$$$F$Y$103$KG$20240705$$HP$US$
238728602$23872860$2$F$$20240802$20240520$20240808$PER$$US-ABBVIE-5760030$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
238728743$23872874$3$F$$20240819$20240520$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-077102$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240819$$MD$JP$JP
238729062$23872906$2$F$$20240823$20240520$20240827$EXP$$NVSC2024CN104615$NOVARTIS$$$$$$Y$$$20240827$$MD$CN$CN
238729193$23872919$3$F$20160201$20240805$20240520$20240808$EXP$$PL-TAKEDA-2024TUS048511$TAKEDA$Instytut medycyny wsi.im.witolda chodzki (lublin). Journal Of Pre-Clinical And Clinical Research. 2024;2:28-134$9$YR$$M$Y$$$20240808$$HP$PL$PL
238729222$23872922$2$F$20240401$20240910$20240520$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074959$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240911$$PH$US$US
238729412$23872941$2$F$20240101$20240814$20240520$20240820$EXP$$AT-ABBVIE-5763563$ABBVIE$$26$YR$$F$Y$$$20240820$$CN$AT$AT
238729492$23872949$2$F$$20240814$20240520$20240828$EXP$$CA-CHATTEMPRD-2024OHG017419$CHATTEM$$$$$F$Y$$$20240828$$HP$CA$CA
238729632$23872963$2$F$$20240731$20240520$20240731$PER$$NVSC2024US105657$NOVARTIS$$$$$F$Y$$$20240731$$MD$US$US
238729703$23872970$3$F$20231226$20240917$20240520$20240927$EXP$$RU-EMD Serono-2024026062$EMD SERONO INC$$33$YR$A$F$Y$$$20240927$$CN$RU$RU
238729783$23872978$3$F$$20240613$20240520$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002094$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
238729802$23872980$2$F$$20240823$20240520$20240826$EXP$$NVSC2024CN104903$NOVARTIS$$$$$M$Y$$$20240826$$MD$CN$CN
238729872$23872987$2$F$$20240828$20240520$20240903$EXP$$CA-JNJFOC-20240549049$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240903$$HP$CA$CA
238729882$23872988$2$F$$20240611$20240520$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002092$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
238730123$23873012$3$F$$20240712$20240520$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002103$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
238730152$23873015$2$F$20200311$20240729$20240520$20240805$EXP$$CA-TAKEDA-2020TUS016280$TAKEDA$$52$YR$$F$Y$$$20240804$$PH$CA$CA
238730212$23873021$2$F$20231130$20240711$20240520$20240718$EXP$DE-BFARM-24003109$DE-TEVA-VS-3197877$TEVA$$35$YR$$F$Y$$$20240718$$MD$DE$DE
238730342$23873034$2$F$$20240716$20240520$20240716$PER$$US-ALXN-202405USA001079US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$HP$US$US
238730423$23873042$3$F$20240510$20240710$20240520$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202405009326$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240715$$CN$US$US
238730862$23873086$2$F$$20240921$20240520$20240926$EXP$$AT-TAKEDA-2024TUS035691$TAKEDA$$$$$M$Y$$$20240926$$CN$GB$AT
238731063$23873106$3$F$$20240628$20240520$20240706$EXP$$PT-AUROBINDO-AUR-APL-2024-023584$AUROBINDO$Martins Mendes T, Fonseca T, Pereira Anjos D. Recurrent Bacteremia after Cyanoacrylate Sclerotherapy of Ectopic Duodenal Varices (Recurrent Bacteremia after Cyanoacrylate Sclerotherapy of Ectopic Duodenal Varices). Acta-Med-Port. 2024;37(2):136-141$47$YR$$F$Y$$$20240706$$HP$PT$PT
238731112$23873111$2$F$$20240625$20240520$20240704$EXP$CA-MHPD-E2B_06928849$CA-Accord-425294$ACCORD$$65$YR$E$F$Y$$$20240704$$HP$CA$CA
238731183$23873118$3$F$20231214$20240702$20240520$20240705$EXP$FR-AFSSAPS-TO2024000808$FR-ASTELLAS-2024EU004812$ASTELLAS$$88$YR$$M$Y$$$20240705$$CN$NL$FR
238731973$23873197$3$F$$20240704$20240520$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03944$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238732002$23873200$2$F$20240401$20240715$20240520$20240716$PER$$US-ALXN-202405USA000841US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238732013$23873201$3$F$20240416$20240716$20240520$20240716$PER$$US-ALXN-202405USA001043US$ALEXION PHARMACEUTICALS$$4$YR$$M$Y$$$20240716$$MD$US$US
238732053$23873205$3$F$20240415$20240905$20240520$20240909$30DAY$$CL-PFIZER INC-202400089030$PFIZER$$16$YR$$M$Y$$$20240909$$CN$CL$CL
238732142$23873214$2$F$20240401$20240909$20240520$20240916$EXP$$JP-AMGEN-JPNSP2024096358$AMGEN$$$$E$F$Y$$$20240916$$MD$JP$JP
238732293$23873229$3$F$$20240702$20240520$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03949$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238732473$23873247$3$F$$20240704$20240520$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03950$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238732512$23873251$2$F$20240419$20240913$20240520$20240918$EXP$$NVSJ2024JP005695$NOVARTIS$$83$YR$$F$Y$54.1$KG$20240918$$PH$JP$JP
238732632$23873263$2$F$20170609$20240823$20240520$20240826$PER$$US-GILEAD-2024-0673313$GILEAD$$24$YR$A$M$Y$$$20240826$$LW$US$US
238732712$23873271$2$F$$20240704$20240520$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03945$LUPIN$$$$$$Y$$$20240725$$CN$US$US
238732803$23873280$3$F$20240331$20240718$20240520$20240729$EXP$$US-BEH-2024172159$CSL BEHRING$$50$YR$A$F$Y$$$20240729$$HP$US$US
238733452$23873345$2$F$20240422$20240814$20240520$20240909$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000263$BECTON DICKINSON$$$$$$Y$$$20240909$$CN$GB$GB
238733462$23873346$2$F$20240422$20240814$20240520$20240909$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000264$BECTON DICKINSON$$$$$$Y$$$20240909$$CN$GB$GB
238733473$23873347$3$F$20240201$20240725$20240520$20240802$EXP$$IE-EXELIXIS-CABO-24077449$EXELIXIS$$71$YR$$M$Y$$$20240802$$HP$IE$IE
238733492$23873349$2$F$$20240704$20240520$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03934$LUPIN$$$$$F$Y$$$20240728$$PH$US$US
238733502$23873350$2$F$20240422$20240910$20240520$20240925$30DAY$$US-BECTON DICKINSON-US-BD-24-000265$BECTON DICKINSON$$$$$$Y$$$20240925$$HP$US$US
238733683$23873368$3$F$20240101$20240912$20240520$20240918$EXP$$CA-ABBVIE-5763838$ABBVIE$$70$YR$$F$Y$$$20240918$$MD$CA$CA
238733822$23873382$2$F$$20240627$20240520$20240701$EXP$$GB-MYLANLABS-2024M1045313$MYLAN$$$$$F$Y$$$20240701$$MD$GB$GB
238734114$23873411$4$F$$20240820$20240520$20240823$30DAY$$US-PFIZER INC-202400106918$PFIZER$$5$YR$$M$Y$12.925$KG$20240823$$CN$US$US
238734143$23873414$3$F$$20240815$20240520$20240815$EXP$$US-PFIZER INC-PV202400063543$PFIZER$$12$YR$$F$Y$37.1$KG$20240815$$MD$US$US
238734173$23873417$3$F$$20240903$20240520$20240918$30DAY$$US-PFIZER INC-202400108050$PFIZER$$$$$M$Y$$$20240918$$CN$US$US
2387341810$23873418$10$F$20240501$20240915$20240520$20240924$30DAY$$US-PFIZER INC-202400108842$PFIZER$$73$YR$$M$Y$102.51$KG$20240924$$MD$US$US
238734194$23873419$4$F$$20240814$20240520$20240820$30DAY$$US-PFIZER INC-202400106991$PFIZER$$15$YR$$M$Y$$$20240820$$CN$US$US
238734223$23873422$3$F$$20240916$20240520$20240920$30DAY$$US-PFIZER INC-202400098549$PFIZER$$12$YR$$M$Y$$$20240920$$CN$US$US
238734322$23873432$2$F$$20240828$20240520$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US049544$SANDOZ$$$$$M$Y$$$20240902$$CN$US$US
238734512$23873451$2$F$20231201$20240723$20240520$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-024222$AUROBINDO$$74$YR$$F$Y$$$20240802$$CN$ES$ES
238734543$23873454$3$F$$20240807$20240520$20240902$EXP$$CZ-ASTELLAS-2024US014071$ASTELLAS$$72$YR$E$M$Y$78$KG$20240902$$CN$CZ$CZ
238734652$23873465$2$F$$20240911$20240520$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA048127$SANDOZ$$56$YR$$F$Y$$$20240913$$HP$CA$CA
238734683$23873468$3$F$$20240704$20240520$20240711$EXP$$PT-TAKEDA-2024TUS049246$TAKEDA$Marques CI, Silva C, Fernandes C, Costa CL, Ogando A. Stevens-Johnson syndrome - an uncommon presentation. European Journal of Case Reports in Internal Medicine. 2021;8(1):129$94$YR$$M$Y$$$20240711$$HP$PT$PT
238735162$23873516$2$F$20240401$20240712$20240520$20240717$EXP$$US-UCBSA-2024024166$UCB$$64$YR$$F$Y$$$20240717$$HP$US$US
238735194$23873519$4$F$20240101$20240829$20240520$20240904$EXP$$US-ABBVIE-5765306$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
238735242$23873524$2$F$20240430$20240715$20240520$20240716$PER$$US-ALXN-202405USA000801US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
238735354$23873535$4$F$$20240710$20240520$20240717$EXP$$IN-VANTIVE-2024VAN017086$Vantive US Healthcare$$5$YR$$M$Y$$$20240717$$CN$IN$IN
238735372$23873537$2$F$$20240812$20240520$20240821$EXP$$AU-DAIICHI SANKYO, INC.-DSJ-2024-121284$DAIICHI$$$$E$F$Y$$$20240821$$MD$AU$AU
238735462$23873546$2$F$20120331$20240815$20240520$20240816$PER$$US-GILEAD-2024-0673461$GILEAD$$47$YR$A$M$Y$$$20240816$$LW$US$US
238736132$23873613$2$F$$20240613$20240520$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001450$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240722$$CN$US$US
238736192$23873619$2$F$$20240603$20240520$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001474$STEMLINE THERAPEUTICS$$52$YR$A$F$Y$$$20240722$$CN$US$US
238736272$23873627$2$F$$20240521$20240520$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001480$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240722$$CN$US$US
238736292$23873629$2$F$$20240610$20240520$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST000994$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240722$$CN$US$US
238736562$23873656$2$F$$20240515$20240520$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001461$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240722$$CN$US$US
238736602$23873660$2$F$$20240429$20240520$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001058$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240718$$CN$US$US
238736842$23873684$2$F$$20240516$20240520$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001094$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240722$$CN$US$US
238737142$23873714$2$F$$20240712$20240520$20240715$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-077082$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240715$$MD$JP$JP
238737224$23873722$4$F$20220610$20240920$20240520$20240924$EXP$$AR-MYLANLABS-2024M1045427$MYLAN$$15$YR$$F$Y$$$20240924$$CN$AR$AR
238737402$23873740$2$F$20240329$20240708$20240520$20240711$PER$$US-ABBVIE-5767014$ABBVIE$$19$YR$$F$Y$81.646$KG$20240711$$MD$US$US
238737572$23873757$2$F$20200101$20240712$20240520$20240715$EXP$$US-GILEAD-2024-0673354$GILEAD$$45$YR$A$M$Y$$$20240715$$LW$US$US
238737592$23873759$2$F$20240501$20240906$20240520$20240909$EXP$$US-ROCHE-3565758$ROCHE$$28$YR$A$F$Y$$$20240909$$CN$US$US
238737602$23873760$2$F$$20240702$20240520$20240715$EXP$$GB-ROCHE-3565777$ROCHE$Kafagi A, Li A, Jayne D and Brix S Anti-GBM disease in pregnancy. Doi: 10.1136/bcr-2023-257767.. BMJ case reports 2024 Apr 30;17 (4):1-4.$$$$F$Y$$$20240715$$HP$GB$GB
238737788$23873778$8$F$$20240913$20240520$20240925$30DAY$$AR-JNJFOC-20240475111$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$AR$AR
238737793$23873779$3$F$20181129$20240812$20240520$20240814$PER$$US-GILEAD-2024-0673504$GILEAD$$44$YR$A$M$Y$$$20240814$$LW$US$US
238737814$23873781$4$F$20240601$20240731$20240520$20240805$PER$$US-ALXN-202405USA000845US$ALEXION PHARMACEUTICALS$$56$YR$$F$Y$$$20240805$$PH$US$US
238737992$23873799$2$F$$20240701$20240520$20240703$PER$$NVSC2024US105785$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
238738004$23873800$4$F$20240101$20240628$20240520$20240701$EXP$$US-KARYOPHARM-2024KPT000949$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240701$$CN$US$US
238738063$23873806$3$F$20240512$20240713$20240520$20240715$EXP$$CA-PFIZER INC-202400125185$PFIZER$$76$YR$$F$Y$$$20240715$$HP$CA$CA
238738072$23873807$2$F$$20240710$20240520$20240710$EXP$$US-PFIZER INC-PV202400064554$PFIZER$$74$YR$$M$Y$$$20240710$$CN$US$US
238738112$23873811$2$F$20240229$20240704$20240520$20240705$EXP$$NVSC2024GB105435$NOVARTIS$$34$YR$$M$Y$75$KG$20240705$$MD$GB$GB
238738142$23873814$2$F$20130724$20240715$20240520$20240717$PER$$US-GILEAD-2024-0673320$GILEAD$$53$YR$A$M$Y$$$20240717$$LW$US$US
238738152$23873815$2$F$$20240627$20240520$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-023200$AUROBINDO$Blohm JE, Panthula M, Aggarwal A, Swazo R, Ashoka A, Ainapurapu B. Fatal Disseminated Coccidioidomycosis in Cirrhosis: A Case Series. [Review]. The American journal of medicine. 2023;136(7):707-709$43$YR$$M$Y$$$20240705$$MD$US$US
238738243$23873824$3$F$20240108$20240702$20240520$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-04375$VIFOR$$66$YR$$M$Y$99.2$KG$20240709$$HP$US$US
238738372$23873837$2$F$$20240827$20240520$20240917$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000278$BECTON DICKINSON$$$$$$Y$$$20240917$$CN$GB$GB
238738383$23873838$3$F$$20240911$20240520$20240927$30DAY$$US-BECTON DICKINSON-US-BD-24-000273$BECTON DICKINSON$$$$$$Y$$$20240927$$CN$US$US
238738392$23873839$2$F$$20240827$20240520$20240917$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000271$BECTON DICKINSON$$$$$$Y$$$20240917$$CN$GB$GB
238738402$23873840$2$F$$20240827$20240520$20240917$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000270$BECTON DICKINSON$$$$$$Y$$$20240917$$CN$GB$GB
238738412$23873841$2$F$$20240827$20240520$20240917$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000269$BECTON DICKINSON$$$$$$Y$$$20240917$$CN$GB$GB
238738422$23873842$2$F$20240423$20240814$20240520$20240909$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000267$BECTON DICKINSON$$$$$$Y$$$20240909$$CN$GB$GB
238738442$23873844$2$F$20240423$20240729$20240520$20240827$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000268$BECTON DICKINSON$$$$$$Y$$$20240827$$CN$GB$GB
238738562$23873856$2$F$20231022$20240625$20240520$20240709$EXP$$JP-ROCHE-3446844$ROCHE$$82$YR$E$M$Y$58.5$KG$20240708$$MD$JP$JP
238738623$23873862$3$F$20190101$20240912$20240520$20240916$EXP$$US-GILEAD-2024-0673363$GILEAD$$66$YR$E$M$Y$$$20240916$$LW$US$US
238738972$23873897$2$F$$20240507$20240520$20240808$PER$$US-LEO Pharma-370354$LEO PHARM$$62$YR$$F$Y$$$20240808$$CN$US$US
238738984$23873898$4$F$20240712$20240819$20240520$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077248$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240822$$CN$US$US
238739033$23873903$3$F$$20240805$20240520$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077266$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240807$$CN$US$US
238739272$23873927$2$F$$20240711$20240520$20240718$EXP$$PK-AMGEN-INDSP2021003431$AMGEN$$13$YR$T$M$Y$40$KG$20240718$$CN$PK$PK
238739432$23873943$2$F$20201011$20240806$20240520$20240807$EXP$$US-GILEAD-2024-0673343$GILEAD$$38$YR$A$M$Y$$$20240807$$LW$US$US
238739596$23873959$6$F$$20240806$20240520$20240813$EXP$$US-VERTEX PHARMACEUTICALS-2024-008435$VERTEX$$$$$$Y$$$20240813$$CN$US$US
238739602$23873960$2$F$$20240705$20240520$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03948$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238739882$23873988$2$F$20230101$20240819$20240520$20240821$EXP$$GB-SA-2023SA236163$SANOFI AVENTIS$$27$YR$A$F$Y$71$KG$20240821$$MD$GB$GB
238739953$23873995$3$F$$20240712$20240520$20240718$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR060931$VIIV$$$$$M$Y$70.748$KG$20240718$$CN$US$US
238740053$23874005$3$F$$20240704$20240520$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03946$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238740112$23874011$2$F$$20240710$20240520$20240718$EXP$$BR-ROCHE-3563086$ROCHE$$$$$F$Y$$$20240718$$MD$BR$BR
238740123$23874012$3$F$$20240515$20240520$20240701$EXP$$US-APELLIS-2024-APL-0000031$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240628$$MD$US$US
238740253$23874025$3$F$20221201$20240921$20240520$20240925$EXP$$IN-PFIZER INC-PV202300137282$PFIZER$$62$YR$$F$Y$60$KG$20240925$$CN$IN$IN
238740308$23874030$8$F$20240101$20240904$20240520$20240904$EXP$$CA-PFIZER INC-202400122739$PFIZER$$77$YR$$F$Y$$$20240904$$MD$CA$CA
238740362$23874036$2$F$$20240705$20240520$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03962$LUPIN$$$$$$Y$$$20240804$$CN$US$US
238740372$23874037$2$F$$20240705$20240520$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03955$LUPIN$$$$$$Y$$$20240729$$PH$US$US
238740392$23874039$2$F$20240514$20240815$20240520$20240820$EXP$$US-MYLANLABS-2024M1044674$MYLAN$$62$YR$$F$Y$80.272$KG$20240820$$HP$US$US
238740502$23874050$2$F$$20240705$20240520$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03979$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238740612$23874061$2$F$20240220$20240912$20240520$20240925$EXP$$JP-SHIONOGI INC.-2024001101$SHIONOGI$$5$DEC$A$M$Y$59.3$KG$20240925$$MD$JP$JP
238740622$23874062$2$F$20240217$20240912$20240520$20240925$EXP$$JP-SHIONOGI INC.-2024001106$SHIONOGI$$7$DEC$E$M$Y$78.4$KG$20240925$$MD$JP$JP
238740652$23874065$2$F$$20240705$20240520$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03943$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238740662$23874066$2$F$$20240705$20240520$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03953$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238740722$23874072$2$F$20240101$20240722$20240520$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-014878$UNITED THERAPEUTICS$$$$$F$Y$63.039$KG$20240731$$$US$US
238741182$23874118$2$F$$20240703$20240520$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-014909$UNITED THERAPEUTICS$$$$$F$Y$71.655$KG$20240710$$$US$US
238741212$23874121$2$F$$20240705$20240520$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03990$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238741222$23874122$2$F$20240510$20240711$20240520$20240717$EXP$$US-GSK-US2024062457$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$US$US
238741294$23874129$4$F$20020101$20240918$20240520$20240925$EXP$$NVSC2024DE101859$NOVARTIS$$74$YR$$F$Y$$$20240925$$CN$DE$DE
238741455$23874145$5$F$20240425$20240627$20240520$20240709$30DAY$$AR-JNJFOC-20240486607$JOHNSON AND JOHNSON$$70$YR$E$F$Y$55$KG$20240709$$CN$AR$AR
238741462$23874146$2$F$$20240710$20240520$20240712$EXP$$US-PFIZER INC-PV202400061279$PFIZER$$79$YR$$M$Y$$$20240712$$MD$US$US
238741512$23874151$2$F$20180101$20240815$20240520$20240819$PER$$US-GILEAD-2024-0673476$GILEAD$$50$YR$A$F$Y$$$20240819$$LW$US$US
238741692$23874169$2$F$20240501$20240906$20240520$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076429$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240911$$CN$US$US
238741872$23874187$2$F$20170601$20240822$20240520$20240827$PER$$US-GILEAD-2024-0673309$GILEAD$$48$YR$A$F$Y$$$20240827$$LW$US$US
238741972$23874197$2$F$20190112$20240806$20240520$20240807$PER$$US-GILEAD-2024-0673437$GILEAD$$56$YR$A$M$Y$$$20240807$$LW$US$US
238742272$23874227$2$F$20240513$20240924$20240520$20240930$EXP$$US-MYLANLABS-2024M1045344$MYLAN$$50$YR$$M$Y$$$20240930$$HP$US$US
238742343$23874234$3$F$$20240722$20240520$20240726$EXP$$NVSC2024US047775$NOVARTIS$$$$$M$Y$$$20240726$$CN$US$US
238742422$23874242$2$F$20240126$20240702$20240520$20240709$EXP$$FR-MYLANLABS-2024M1043571$MYLAN$$$$A$F$Y$$$20240709$$MD$FR$FR
238742594$23874259$4$F$20240426$20240819$20240520$20240820$EXP$$DE-SANDOZ INC.-SDZ2024DE049683$SANDOZ$$74$YR$$M$Y$70$KG$20240820$$HP$DE$DE
238742672$23874267$2$F$20131029$20240813$20240520$20240819$PER$$US-GILEAD-2024-0673498$GILEAD$$25$YR$A$M$Y$$$20240819$$LW$US$US
238742752$23874275$2$F$$20240916$20240520$20240919$EXP$$US-SANDOZ INC.-SDZ2023US004232$SANDOZ$$$$$F$Y$83.9$KG$20240919$$CN$US$US
238742762$23874276$2$F$20230101$20240627$20240520$20240703$EXP$$US-SANDOZ INC.-SDZ2024US049665$SANDOZ$$$$$F$Y$$$20240703$$CN$US$US
238743112$23874311$2$F$$20240806$20240520$20240812$EXP$$JP-PFIZER INC-202400171905$PFIZER$$$$$$Y$$$20240812$$MD$JP$JP
238743132$23874313$2$F$20231222$20240802$20240520$20240807$EXP$FR-AFSSAPS-PV2024000363$FR-PFIZER INC-202400109093$PFIZER$$72$YR$$F$Y$58$KG$20240807$$MD$FR$FR
238743242$23874324$2$F$20240301$20240703$20240520$20240704$EXP$$CA-PFIZER INC-202400125083$PFIZER$$87$YR$$M$Y$62.132$KG$20240704$$HP$CA$CA
238743392$23874339$2$F$20230216$20240705$20240520$20240709$EXP$$CA-TAKEDA-2023TUS057625$TAKEDA$$53$YR$$F$Y$70$KG$20240709$$CN$CA$CA
238743502$23874350$2$F$$20240718$20240520$20240722$EXP$$US-SANDOZ INC.-SDZ2024US049820$SANDOZ$$$$$F$Y$$$20240722$$CN$US$US
238743643$23874364$3$F$$20240725$20240520$20240801$EXP$$CA-SA-2024SA149007$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240801$$HP$CA$CA
238743672$23874367$2$F$20240401$20240808$20240520$20240821$EXP$$US-UCBSA-2024024281$UCB$$43$YR$$F$Y$$$20240821$$HP$US$US
238743803$23874380$3$F$$20240701$20240520$20240703$EXP$$US-PFIZER INC-202400108448$PFIZER$$81$YR$$F$Y$$$20240703$$CN$US$US
238743894$23874389$4$F$$20240711$20240520$20240715$PER$$US-PFIZER INC-202400108650$PFIZER$$$$$$Y$$$20240715$$PH$US$US
238744092$23874409$2$F$$20240513$20240520$20240729$EXP$$GB-AKCEA THERAPEUTICS, INC.-2024IS004795$AKCEA THERAPEUTICS$$$$$$Y$$$20240729$$CN$GB$GB
238744152$23874415$2$F$$20240814$20240520$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075758$BRISTOL MYERS SQUIBB$$80$YR$E$$Y$$$20240814$$MD$US$US
238744254$23874425$4$F$20240501$20240703$20240520$20240704$PER$$US-PFIZER INC-202400171536$PFIZER$$70$YR$$M$Y$79.365$KG$20240704$$CN$US$US
238744333$23874433$3$F$20240518$20240715$20240520$20240717$PER$$US-PFIZER INC-202400147822$PFIZER$$72$YR$$F$Y$65.76$KG$20240717$$CN$US$US
238744342$23874434$2$F$$20240701$20240520$20240709$30DAY$$US-GSK-US2024060284$GLAXOSMITHKLINE$$$$$F$Y$$$20240709$$CN$US$US
238744537$23874453$7$F$20240301$20240823$20240520$20240823$PER$$US-PFIZER INC-202400130433$PFIZER$$73$YR$$F$Y$83.46$KG$20240823$$CN$US$US
238744622$23874462$2$F$20240425$20240903$20240520$20240912$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-014819$UNITED THERAPEUTICS$$62$YR$$M$Y$$$20240912$$$JP$JP
238744793$23874479$3$F$20240601$20240725$20240520$20240801$EXP$$CA-GSK-CA2024061258$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$CA$CA
238744822$23874482$2$F$20161020$20240823$20240520$20240827$PER$$US-GILEAD-2024-0673485$GILEAD$$47$YR$A$F$Y$$$20240827$$LW$US$US
238744933$23874493$3$F$$20240519$20240520$20240906$PER$$NVSC2024US106125$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
238745112$23874511$2$F$20231221$20240618$20240520$20240701$EXP$JP-MHLW-i2410000821$JP-NOVOPROD-1220200$NOVO NORDISK$$74$YR$$M$Y$40.9$KG$20240701$$PH$JP$JP
238745182$23874518$2$F$20240505$20240716$20240520$20240716$PER$$US-ALXN-202405USA000873US$ALEXION PHARMACEUTICALS$$76$YR$$M$Y$$$20240716$$CN$US$US
238745502$23874550$2$F$20240101$20240905$20240520$20240917$EXP$SE-SEMPA-2024-003852$SE-NOVOPROD-1220055$NOVO NORDISK$$18$YR$$F$Y$76$KG$20240917$$HP$SE$SE
238745732$23874573$2$F$$20240627$20240520$20240703$PER$$US-HORIZON THERAPEUTICS-HZN-2024-003524$AMGEN$$$$$F$Y$$$20240703$$MD$US$US
238745793$23874579$3$F$20240514$20240904$20240520$20240909$EXP$$JP-009507513-2405JPN001534J$MERCK$$73$YR$$F$Y$54.8$KG$20240909$$MD$JP$JP
238745842$23874584$2$F$20111231$20240916$20240520$20240918$PER$$US-GILEAD-2024-0673539$GILEAD$$49$YR$A$M$Y$$$20240918$$LW$US$US
238745943$23874594$3$F$$20240712$20240520$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077622$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240717$$HP$US$US
238746022$23874602$2$F$$20240709$20240520$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075618$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240711$$CN$US$US
238746243$23874624$3$F$20240101$20240723$20240520$20240726$EXP$$NVSC2024US105371$NOVARTIS$$17$YR$$F$Y$$$20240726$$CN$US$US
238746272$23874627$2$F$20240328$20240711$20240520$20240711$EXP$$CA-PFIZER INC-202400108587$PFIZER$$77$YR$$$Y$$$20240711$$HP$CA$CA
238746393$23874639$3$F$$20240910$20240520$20240919$EXP$$CA-ROCHE-3565630$ROCHE$$65$YR$E$F$Y$$$20240919$$MD$CA$CA
238746603$23874660$3$F$20240508$20240625$20240520$20240704$EXP$$US-GSK-US2024AMR060634$GLAXOSMITHKLINE$$69$YR$$F$Y$64.399$KG$20240704$$CN$US$US
238746693$23874669$3$F$20240511$20240814$20240520$20240820$30DAY$$GR-PFIZER INC-PV202400062670$PFIZER$$14$YR$$M$Y$45$KG$20240820$$CN$GR$GR
238746724$23874672$4$F$$20240826$20240520$20240829$30DAY$$CA-PFIZER INC-202400108524$PFIZER$$$$$$Y$$$20240829$$HP$CA$CA
2387467410$23874674$10$F$$20240917$20240520$20240924$30DAY$$KR-PFIZER INC-PV202400064327$PFIZER$$7$YR$$M$Y$$$20240924$$CN$KR$KR
238746755$23874675$5$F$$20240812$20240520$20240816$30DAY$$IT-PFIZER INC-PV202400059958$PFIZER$$$$$$Y$$$20240816$$PH$IT$IT
238746762$23874676$2$F$20240101$20240626$20240520$20240701$30DAY$$GR-PFIZER INC-PV202400062702$PFIZER$$11$YR$$F$Y$38$KG$20240701$$MD$GR$GR
238746893$23874689$3$F$20240419$20240905$20240520$20240910$EXP$$US-OTSUKA-2024_013968$OTSUKA$$73$YR$$M$Y$72.1$KG$20240910$$CN$US$US
238746922$23874692$2$F$$20240503$20240520$20240729$EXP$$PT-GILEAD-2024-0672971$GILEAD$$$$A$$Y$$$20240729$$HP$PT$PT
238746943$23874694$3$F$20240512$20240813$20240520$20240819$30DAY$$GR-PFIZER INC-PV202400062624$PFIZER$$12$YR$$F$Y$31$KG$20240819$$CN$GR$GR
238747113$23874711$3$F$20230926$20240701$20240520$20240708$EXP$$IE-MYLANLABS-2023M1104375$MYLAN$$76$YR$$F$Y$67$KG$20240708$$MD$IE$IE
238747143$23874714$3$F$20240517$20240827$20240520$20240830$30DAY$$US-SANDOZ INC.-SDZ2024US049978$SANDOZ$$$$$F$Y$$$20240830$$HP$US$US
238747232$23874723$2$F$$20240625$20240520$20240704$EXP$$CA-SANDOZ INC.-SDZ2024CA049571$SANDOZ$$44$YR$$F$Y$$$20240704$$HP$CA$CA
238747343$23874734$3$F$20150712$20240906$20240520$20240909$EXP$$US-GILEAD-2024-0673562$GILEAD$$42$YR$A$M$Y$$$20240909$$LW$US$US
238747462$23874746$2$F$20240101$20240805$20240520$20240808$EXP$$US-UCBSA-2024016111$UCB$$$$$F$Y$$$20240808$$CN$US$US
238747475$23874747$5$F$$20240924$20240520$20240927$30DAY$$US-PFIZER INC-202400104169$PFIZER$$12$YR$$F$Y$42.3$KG$20240927$$HP$US$US
238747486$23874748$6$F$$20240823$20240520$20240827$30DAY$$JO-PFIZER INC-202400106365$PFIZER$$$$$$Y$$$20240827$$CN$JO$JO
238747523$23874752$3$F$$20240717$20240520$20240717$PER$$US-ALXN-202405USA000823US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
238747604$23874760$4$F$$20240815$20240520$20240820$30DAY$$US-PFIZER INC-202400107753$PFIZER$$14$YR$$M$Y$39.92$KG$20240820$$CN$US$US
238747702$23874770$2$F$20240516$20240728$20240520$20240730$PER$$US-AMGEN-USASP2024099120$AMGEN$$74$YR$E$F$Y$$$20240730$$CN$US$US
238747752$23874775$2$F$$20240207$20240520$20240808$PER$$US-OTSUKA-2024_003322$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
238747772$23874777$2$F$$20240206$20240520$20240808$PER$$US-OTSUKA-2024_003318$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
238747792$23874779$2$F$$20240201$20240520$20240808$EXP$$US-OTSUKA-2024_002894$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
238747833$23874783$3$F$20240503$20240701$20240520$20240807$PER$$US-AstraZeneca-2024A105656$ASTRAZENECA$$29919$DY$$$Y$$$20240807$$HP$US$
238747862$23874786$2$F$$20240628$20240520$20240703$EXP$$US-AstraZeneca-2024A114506$ASTRAZENECA$$$$$F$Y$$$20240703$$MD$US$
238747892$23874789$2$F$$20240402$20240520$20240808$PER$$US-OTSUKA-2024_009148$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
238747902$23874790$2$F$$20240412$20240520$20240808$PER$$US-OTSUKA-2024_010942$OTSUKA$$$$T$F$Y$$$20240808$$PH$US$US
238747912$23874791$2$F$$20240418$20240520$20240808$PER$$US-OTSUKA-2024_004706$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
238747922$23874792$2$F$$20240327$20240520$20240808$PER$$US-OTSUKA-2024_002142$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
238747942$23874794$2$F$$20240515$20240520$20240807$PER$$US-OTSUKA-2024_006899$OTSUKA$$$$$$Y$$$20240807$$HP$US$US
238747952$23874795$2$F$$20240404$20240520$20240808$PER$$US-OTSUKA-2024_009367$OTSUKA$$4$DEC$$F$Y$$$20240808$$HP$US$US
238747962$23874796$2$F$20240301$20240328$20240520$20240808$PER$$US-OTSUKA-2024_008668$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
238747992$23874799$2$F$$20240515$20240520$20240807$PER$$US-OTSUKA-2024_006910$OTSUKA$$$$$$Y$$$20240807$$HP$US$US
238748002$23874800$2$F$$20240416$20240520$20240808$PER$$US-OTSUKA-2024_004136$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
238748032$23874803$2$F$20240208$20240209$20240520$20240808$PER$$US-OTSUKA-2024_003657$OTSUKA$$37$YR$$M$Y$$$20240808$$PH$US$US
238748053$23874805$3$F$20240201$20240531$20240520$20240808$EXP$$US-OTSUKA-2024_008660$OTSUKA$$46$YR$$M$Y$$$20240808$$HP$US$US
238748082$23874808$2$F$$20240327$20240520$20240808$PER$$US-OTSUKA-2024_002147$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
238748092$23874809$2$F$$20240227$20240520$20240808$PER$$US-OTSUKA-2024_005363$OTSUKA$$$$$M$Y$81.65$KG$20240808$$CN$US$US
238748132$23874813$2$F$$20240513$20240520$20240812$EXP$$NVSC2023CL033195$NOVARTIS$$60$YR$$F$Y$$$20240812$$CN$CL$CL
238748142$23874814$2$F$$20240719$20240520$20240724$EXP$$NVSC2024US105921$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
238748222$23874822$2$F$$20240205$20240520$20240808$PER$$US-OTSUKA-2023_031437$OTSUKA$$27$YR$$M$Y$$$20240808$$HP$US$US
238748242$23874824$2$F$$20240209$20240520$20240808$EXP$$US-OTSUKA-2024_003721$OTSUKA$$21$YR$$F$Y$$$20240808$$HP$US$US
238748253$23874825$3$F$$20240620$20240520$20240808$PER$$US-OTSUKA-2024_010950$OTSUKA$$6$DEC$$F$Y$$$20240808$$PH$US$US
238748262$23874826$2$F$$20240418$20240520$20240808$PER$$US-OTSUKA-2024_011406$OTSUKA$$54$YR$$F$Y$$$20240808$$MD$US$US
238748282$23874828$2$F$20231023$20240419$20240520$20240808$PER$$US-OTSUKA-2024_011519$OTSUKA$$27$YR$$F$Y$$$20240808$$HP$US$US
238748292$23874829$2$F$$20240403$20240520$20240808$PER$$US-OTSUKA-2024_009178$OTSUKA$$4$DEC$$M$Y$$$20240808$$HP$US$US
238748303$23874830$3$F$$20240603$20240520$20240808$PER$$US-OTSUKA-2024_008670$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
238748312$23874831$2$F$$20240304$20240520$20240808$PER$$US-OTSUKA-2024_006111$OTSUKA$$30$YR$$F$Y$$$20240808$$HP$US$US
238748322$23874832$2$F$20240130$20240508$20240520$20240807$PER$$US-OTSUKA-2024_010569$OTSUKA$$46$YR$$M$Y$107.48$KG$20240807$$HP$US$US
238748343$23874834$3$F$20240304$20240510$20240520$20240808$PER$$US-OTSUKA-2024_006441$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
238748372$23874837$2$F$$20240220$20240520$20240808$EXP$$US-OTSUKA-2024_004658$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
238748402$23874840$2$F$$20240301$20240520$20240808$EXP$$US-OTSUKA-2024_005751$OTSUKA$$$$$M$Y$$$20240808$$MD$US$US
238748423$23874842$3$F$$20240531$20240520$20240808$PER$$US-OTSUKA-2024_008664$OTSUKA$$33$YR$$M$Y$$$20240808$$HP$US$US
238748483$23874848$3$F$20240405$20240712$20240520$20240719$EXP$$JP-GENMAB-2024-01220AA$GENMAB$$8$DEC$$F$Y$$$20240719$$MD$JP$JP
238748542$23874854$2$F$$20240820$20240520$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077856$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240820$$HP$US$US
238748614$23874861$4$F$$20240907$20240520$20240910$PER$$NVSC2024US106034$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
238748654$23874865$4$F$$20240924$20240520$20240930$EXP$$US-BIOVITRUM-2024-US-007267$BIOVITRUM$$77$YR$$F$Y$$$20240930$$CN$US$US
238748672$23874867$2$F$20240125$20240820$20240520$20240821$PER$$US-JNJFOC-20240541424$JOHNSON AND JOHNSON$$$$A$M$Y$100$KG$20240822$$MD$US$US
238748696$23874869$6$F$$20240727$20240520$20240731$EXP$$CA-TAKEDA-2024TUS049746$TAKEDA$$$$$F$Y$$$20240731$$CN$CA$CA
238748822$23874882$2$F$$20240906$20240520$20240916$EXP$$FR-MYLANLABS-2024M1044302$MYLAN$Desbuissons G,Ngango L,Baudeau C,Fournier P. Successful twin pregnancy in a woman undergoing alternate diurnal and nocturnal hemodialysis. Hemodial. Int.. 2024;28(2):233-235$$$N$M$Y$0.76$KG$20240916$$HP$FR$FR
238748874$23874887$4$F$$20240911$20240520$20240916$EXP$$IT-MYLANLABS-2024M1044305$MYLAN$Pizzini AM, Fantoni C, Zaccaroni S, Silingardi M. Acute severe renal failure in a patient receiving apixaban: a case report. Italian Journal of Medicine. 2024;18(2)$74$YR$$M$Y$$$20240916$$HP$IT$IT
238749033$23874903$3$F$$20240722$20240520$20240802$PER$$US-Calliditas-2024CAL00725$CALLIDITAS THERAPEUTICS$$28$YR$A$F$Y$58.2$KG$20240802$$CN$US$US
238749053$23874905$3$F$20160101$20240820$20240520$20240821$PER$$US-GILEAD-2024-0673549$GILEAD$$23$YR$A$M$Y$$$20240821$$LW$US$US
238749062$23874906$2$F$$20240715$20240520$20240716$PER$$US-ALXN-202405USA000812US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
238749112$23874911$2$F$$20240830$20240520$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US049774$SANDOZ$$$$$M$Y$$$20240903$$CN$US$US
238749193$23874919$3$F$$20240718$20240520$20240724$EXP$$NVSC2024CZ105310$NOVARTIS$$$$$F$Y$$$20240724$$MD$CZ$CZ
238749442$23874944$2$F$20230101$20240716$20240520$20240718$EXP$$US-PFIZER INC-202400124069$PFIZER$$60$YR$$F$Y$$$20240718$$CN$US$US
238749662$23874966$2$F$20240501$20240801$20240520$20240805$PER$$US-PFIZER INC-202400130404$PFIZER$$55$YR$$F$Y$$$20240805$$CN$US$US
238749824$23874982$4$F$20231001$20240829$20240520$20240904$EXP$$US-ABBVIE-5654074$ABBVIE$$63$YR$$M$Y$77$KG$20240904$$CN$US$US
238749883$23874988$3$F$20240514$20240708$20240520$20240716$30DAY$$US-AMGEN-USASP2024096705$AMGEN$$65$YR$E$F$Y$108.84$KG$20240716$$HP$US$US
238749892$23874989$2$F$20170101$20240826$20240520$20240830$PER$$US-GILEAD-2024-0673435$GILEAD$$38$YR$A$M$Y$$$20240830$$LW$US$US
238750022$23875002$2$F$$20240705$20240520$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077648$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$84.37$KG$20240709$$CN$US$US
238750043$23875004$3$F$$20240916$20240520$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077176$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240916$$CN$US$US
238750132$23875013$2$F$20200101$20240628$20240520$20240701$PER$$US-GILEAD-2024-0673577$GILEAD$$57$YR$A$F$Y$$$20240701$$LW$US$US
238750402$23875040$2$F$$20240816$20240520$20240820$PER$$NVSC2024US098488$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
238750544$23875054$4$F$20240101$20240815$20240520$20240821$EXP$$CA-UCBSA-2024018773$UCB$$$$$F$Y$$$20240821$$HP$CA$CA
238750992$23875099$2$F$20240516$20240820$20240520$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077924$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240820$$PH$US$US
238751112$23875111$2$F$20240101$20240709$20240520$20240716$EXP$$US-ABBVIE-5728970$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
238751182$23875118$2$F$20240509$20240716$20240520$20240716$PER$$US-ALXN-202405USA000872US$ALEXION PHARMACEUTICALS$$74$YR$$F$Y$$$20240716$$CN$US$US
238751192$23875119$2$F$$20240715$20240520$20240716$PER$$US-ALXN-202405USA000799US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238751235$23875123$5$F$20240101$20240903$20240520$20240914$EXP$$US-UCBSA-2024019415$UCB$$$$$M$Y$$$20240914$$MD$US$US
238751253$23875125$3$F$20240411$20240909$20240520$20240911$EXP$$BR-BAYER-2024A071475$BAYER$$40$YR$A$F$Y$$$20240911$$CN$BR$BR
238751273$23875127$3$F$$20240809$20240520$20240823$PER$$US-Calliditas-2024CAL00729$CALLIDITAS THERAPEUTICS$$77$YR$E$F$Y$$$20240823$$CN$US$US
238751392$23875139$2$F$$20240715$20240520$20240729$EXP$$IN-CIPLA LTD.-2024IN04685$CIPLA$$$$$$Y$$$20240729$$CN$IN$IN
238751713$23875171$3$F$20200715$20240802$20240520$20240805$PER$$US-GILEAD-2024-0673337$GILEAD$$32$YR$A$M$Y$$$20240805$$LW$US$US
238751874$23875187$4$F$$20240722$20240520$20240805$PER$$US-Calliditas-2024CAL00730$CALLIDITAS THERAPEUTICS$$58$YR$A$M$Y$$$20240805$$CN$US$US
238751902$23875190$2$F$$20240710$20240520$20240711$EXP$$DE-ALXN-202405EEA001071DE$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$MD$DE$DE
238752402$23875240$2$F$20240507$20240711$20240520$20240712$EXP$$IN-ROCHE-3567079$ROCHE$$61$YR$A$M$Y$70$KG$20240712$$CN$IN$IN
238752494$23875249$4$F$$20240830$20240520$20240904$EXP$$US-PFIZER INC-202400108027$PFIZER$$50$YR$$F$Y$$$20240904$$CN$US$US
238752503$23875250$3$F$20171126$20240718$20240520$20240722$EXP$$US-GILEAD-2024-0673321$GILEAD$$55$YR$A$M$Y$$$20240719$$LW$US$US
238752662$23875266$2$F$20240517$20240801$20240520$20240803$PER$$US-AMGEN-USASP2024099327$AMGEN$$57$YR$A$F$Y$$$20240803$$CN$US$US
238752714$23875271$4$F$20240508$20240703$20240520$20240708$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-002781$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$US$US
238752755$23875275$5$F$$20240726$20240520$20240731$EXP$$NVSC2024US101120$NOVARTIS$$$$$$Y$$$20240731$$CN$US$US
238753224$23875322$4$F$20240618$20240708$20240520$20240717$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001022$BLUEPRINT MEDICINES$$52$YR$A$M$Y$$$20240717$$CN$US$US
238753275$23875327$5$F$20240101$20240918$20240520$20240919$30DAY$$FR-PFIZER INC-202400107441$PFIZER$$11$YR$$F$Y$$$20240919$$MD$FR$FR
238753282$23875328$2$F$$20240807$20240520$20240808$30DAY$$BR-PFIZER INC-202400102863$PFIZER$$$$$F$Y$$$20240808$$PH$BR$BR
238753442$23875344$2$F$20240101$20240806$20240520$20240810$EXP$$US-SA-2024SA151196$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240810$$MD$US$US
238753592$23875359$2$F$20240401$20240827$20240520$20240911$EXP$$US-SA-2024SA150573$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240911$$MD$US$US
238753602$23875360$2$F$$20240814$20240520$20240815$PER$$NVSC2024US105548$NOVARTIS$$$$$M$Y$104.78$KG$20240815$$CN$US$US
238753732$23875373$2$F$20240101$20240807$20240520$20240812$PER$$US-BIOGEN-2024BI01262108$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
238753753$23875375$3$F$20240401$20240822$20240520$20240917$PER$$US-TRAVERE-2024TVT00490$TRAVERE THERAPEUTICS$$44$YR$A$F$Y$$$20240917$$CN$US$US
238753815$23875381$5$F$20190601$20240725$20240520$20240808$PER$$US-GILEAD-2024-0673316$GILEAD$$22$YR$A$M$Y$$$20240807$$LW$US$US
238753822$23875382$2$F$$20240910$20240520$20240918$EXP$$NVSC2024CA101505$NOVARTIS$$36$YR$$F$Y$$$20240918$$HP$CA$CA
238753892$23875389$2$F$$20240826$20240520$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076661$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240828$$CN$US$US
238754043$23875404$3$F$$20240710$20240520$20240711$EXP$$JP-TAKEDA-2024TUS049136$TAKEDA$$5$DEC$$M$Y$$$20240711$$MD$JP$JP
238754343$23875434$3$F$20240701$20240802$20240520$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077634$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240808$$CN$US$US
238754362$23875436$2$F$$20240910$20240520$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077662$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240913$$CN$US$US
238754483$23875448$3$F$20240513$20240831$20240520$20240910$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405008715$ELI LILLY AND CO$$73$YR$E$M$Y$54$KG$20240910$$CN$JP$JP
238754572$23875457$2$F$20240509$20240814$20240520$20240819$EXP$$MN-AstraZeneca-2024A116820$ASTRAZENECA$$14840$DY$$F$Y$85$KG$20240819$$HP$MN$
238754633$23875463$3$F$$20240708$20240520$20240715$PER$$US-AstraZeneca-2024A109662$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$US$
238754712$23875471$2$F$$20240627$20240520$20240710$PER$$US-FARMAPROD-202405-1801$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240710$$CN$US$US
238754723$23875472$3$F$20240507$20240912$20240520$20240918$EXP$$JP-Eisai-EC-2024-165869$EISAI$$69$YR$E$M$Y$90$KG$20240918$$MD$JP$JP
238754744$23875474$4$F$$20240722$20240520$20240729$EXP$$CA-OTSUKA-2024_013681$OTSUKA$$$$$M$Y$$$20240729$$HP$CA$CA
238755072$23875507$2$F$20170501$20240716$20240520$20240717$EXP$$US-GILEAD-2024-0673319$GILEAD$$42$YR$A$M$Y$$$20240717$$LW$US$US
238755142$23875514$2$F$20240503$20240703$20240520$20240712$PER$$US-AstraZeneca-2024A111661$ASTRAZENECA$$54$YR$$F$Y$$$20240712$$CN$US$
238755443$23875544$3$F$$20240619$20240520$20240703$30DAY$$GB-JNJFOC-20240548050$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$CN$GB$GB
238755462$23875546$2$F$$20240621$20240520$20240705$30DAY$$PH-JNJFOC-20240548135$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$PH$PH
238755473$23875547$3$F$20111221$20240823$20240520$20240828$PER$$US-GILEAD-2024-0673323$GILEAD$$45$YR$A$M$Y$$$20240828$$LW$US$US
238755543$23875554$3$F$20240229$20240819$20240520$20240822$EXP$$US-OTSUKA-2024_005872$OTSUKA$$65$YR$$F$Y$$$20240822$$MD$US$US
238755942$23875594$2$F$20200727$20240513$20240520$20240812$EXP$$NVSC2022IN132494$NOVARTIS$$71$YR$$F$Y$$$20240812$$CN$IN$IN
238755982$23875598$2$F$20240401$20240701$20240520$20240704$PER$$US-PFIZER INC-PV202400065037$PFIZER$$52$YR$$F$Y$$$20240704$$HP$US$US
238756172$23875617$2$F$$20240703$20240520$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077603$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$74.84$KG$20240705$$CN$US$US
238756212$23875621$2$F$$20240827$20240520$20240830$EXP$$US-TAKEDA-2024TUS032480$TAKEDA$$$$$M$Y$$$20240830$$CN$US$US
238756332$23875633$2$F$$20240823$20240520$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075325$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240823$$CN$US$US
238756352$23875635$2$F$$20240628$20240520$20240701$30DAY$$AU-MYLANLABS-2024M1042238$MYLAN$$$$$$Y$$$20240701$$CN$AU$AU
238756572$23875657$2$F$$20240910$20240520$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076563$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240911$$CN$US$US
238756652$23875665$2$F$20240501$20240822$20240520$20240830$EXP$$JP-009507513-2405JPN001342J$MERCK$$54$YR$$F$Y$$$20240830$$MD$JP$JP
238756792$23875679$2$F$$20240828$20240520$20240910$EXP$$CA-PFIZER INC-202400172003$PFIZER$$$$$$Y$$$20240910$$HP$CA$CA
238756872$23875687$2$F$$20240718$20240520$20240718$EXP$$US-ALXN-202405USA001262US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$MD$US$US
238756932$23875693$2$F$$20240627$20240520$20240701$PER$$NVSC2024US100442$NOVARTIS$$$$$$Y$$$20240701$$CN$US$US
238756954$23875695$4$F$20240504$20240617$20240520$20240702$30DAY$$US-JNJFOC-20240520108$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$US$US
238757033$23875703$3$F$$20240912$20240520$20240912$PER$$US-ALXN-202405USA000800US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
238757292$23875729$2$F$20240426$20240916$20240520$20240918$PER$$US-AMGEN-USASP2024098613$AMGEN$$51$YR$A$F$Y$$$20240918$$PH$US$US
238757452$23875745$2$F$20240401$20240701$20240520$20240708$PER$$US-SA-2024SA135676$SANOFI AVENTIS$$39$YR$A$F$Y$136$KG$20240708$$MD$US$US
238757522$23875752$2$F$20230101$20240702$20240520$20240711$PER$$US-SA-2024SA146635$SANOFI AVENTIS$$37$YR$A$F$Y$61.6$KG$20240711$$MD$US$US
238757632$23875763$2$F$20231101$20240802$20240520$20240812$PER$$US-SA-2024SA055675$SANOFI AVENTIS$$33$YR$A$M$Y$80.28$KG$20240812$$MD$US$US
238757682$23875768$2$F$20240101$20240723$20240520$20240805$PER$$US-SA-2024SA145685$SANOFI AVENTIS$$55$YR$A$F$Y$61.23$KG$20240805$$MD$US$US
238757702$23875770$2$F$20240101$20240705$20240520$20240801$PER$$US-SA-2024SA145422$SANOFI AVENTIS$$65$YR$E$F$Y$73$KG$20240719$$MD$US$US
238757752$23875775$2$F$20240101$20240913$20240520$20240924$PER$$US-SA-2024SA146876$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240924$$MD$US$US
238757872$23875787$2$F$$20240716$20240520$20240724$PER$$US-SA-2024SA144461$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$MD$US$US
238757923$23875792$3$F$20240101$20240817$20240520$20240829$PER$$US-SA-2024SA146912$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240829$$MD$US$US
238757942$23875794$2$F$20240425$20240729$20240520$20240807$PER$$US-SA-2024SA146974$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240807$$MD$US$US
238757982$23875798$2$F$20240101$20240715$20240520$20240722$PER$$US-SA-2024SA146547$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240723$$MD$US$US
238758002$23875800$2$F$20240401$20240709$20240520$20240718$PER$$US-SA-2024SA145664$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240718$$MD$US$US
238758012$23875801$2$F$20240601$20240701$20240520$20240708$PER$$US-SA-2024SA146214$SANOFI AVENTIS$$46$YR$A$F$Y$88.435$KG$20240708$$MD$US$US
238758043$23875804$3$F$20240506$20240910$20240520$20240916$PER$$US-SA-2024SA146118$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240916$$HP$US$US
238758062$23875806$2$F$20240101$20240623$20240520$20240702$PER$$US-SA-2024SA145769$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240702$$MD$US$US
238758173$23875817$3$F$20240508$20240624$20240520$20240703$PER$$US-SA-2024SA145355$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240703$$HP$US$US
238758362$23875836$2$F$20240101$20240717$20240520$20240724$PER$$US-SA-2024SA146303$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240724$$MD$US$US
238758422$23875842$2$F$$20240826$20240520$20240918$PER$$US-SA-2024SA147163$SANOFI AVENTIS$$77$YR$E$F$Y$90.7$KG$20240918$$MD$US$US
238758433$23875843$3$F$20240101$20240625$20240520$20240704$PER$$US-SA-2024SA146433$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240704$$MD$US$US
238758512$23875851$2$F$$20240625$20240520$20240708$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202404000529$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240708$$CN$ES$ES
238758634$23875863$4$F$20240101$20240728$20240520$20240802$PER$$US-SA-2024SA148552$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240802$$MD$US$US
238758713$23875871$3$F$20240101$20240625$20240520$20240705$PER$$US-SA-2024SA146892$SANOFI AVENTIS$$16$YR$T$M$Y$49.44$KG$20240705$$MD$US$US
238758733$23875873$3$F$20240101$20240829$20240520$20240911$PER$$US-SA-2024SA146744$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240911$$MD$US$US
238758862$23875886$2$F$20240101$20240625$20240520$20240704$PER$$US-SA-2024SA147389$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240704$$MD$US$US
238758882$23875888$2$F$20240101$20240702$20240520$20240711$PER$$US-SA-2024SA148241$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240711$$MD$US$US
238758892$23875889$2$F$20240509$20240822$20240520$20240904$PER$$US-SA-2024SA146829$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240904$$MD$US$US
238758962$23875896$2$F$20240425$20240709$20240520$20240718$PER$$US-SA-2024SA147759$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240718$$MD$US$US
238759072$23875907$2$F$20240101$20240708$20240520$20240716$PER$$US-SA-2024SA147090$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240716$$MD$US$US
238759123$23875912$3$F$20240101$20240828$20240520$20240918$PER$$US-SA-2024SA151533$SANOFI AVENTIS$$57$YR$A$M$Y$122$KG$20240918$$MD$US$US
238759222$23875922$2$F$$20240802$20240520$20240813$PER$$US-SA-2024SA146765$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240814$$MD$US$US
238759312$23875931$2$F$20240401$20240830$20240520$20240919$PER$$US-SA-2024SA150954$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240919$$MD$US$US
238759414$23875941$4$F$$20240725$20240520$20240806$PER$$US-SA-2024SA151259$SANOFI AVENTIS$$$$A$F$Y$81.64$KG$20240806$$MD$US$US
238759452$23875945$2$F$20240101$20240730$20240520$20240808$PER$$US-SA-2024SA148305$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240808$$MD$US$US
238759482$23875948$2$F$20240101$20240629$20240520$20240708$PER$$US-SA-2024SA150850$SANOFI AVENTIS$$92$YR$E$F$Y$$$20240708$$CN$US$US
238759513$23875951$3$F$20240101$20240812$20240520$20240821$PER$$US-SA-2024SA080164$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240821$$CN$US$US
238759532$23875953$2$F$$20240624$20240520$20240703$PER$$US-SA-2024SA149954$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
238759542$23875954$2$F$$20240705$20240520$20240717$PER$$US-SA-2024SA147521$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240717$$MD$US$US
238759702$23875970$2$F$$20240904$20240520$20240914$PER$$US-SA-2024SA151015$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240914$$MD$US$US
238759755$23875975$5$F$20240101$20240820$20240520$20240827$EXP$$US-SA-2024SA150669$SANOFI AVENTIS$$92$YR$E$M$Y$60.78$KG$20240827$$MD$US$US
238759982$23875998$2$F$20240512$20240628$20240520$20240712$PER$$US-SA-2024SA150445$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240712$$MD$US$US
238760063$23876006$3$F$20240501$20240717$20240520$20240725$PER$$US-SA-2024SA149961$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240725$$MD$US$US
238760072$23876007$2$F$20240101$20240821$20240520$20240903$PER$$US-SA-2024SA150283$SANOFI AVENTIS$$14$YR$T$F$Y$38$KG$20240903$$MD$US$US
238760252$23876025$2$F$20220101$20240822$20240520$20240830$PER$$US-BIOGEN-2024BI01264846$BIOGEN$$$$$M$Y$$$20240830$$CN$US$US
238760362$23876036$2$F$20240101$20240709$20240520$20240717$PER$$US-SA-2024SA151152$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240717$$MD$US$US
238760382$23876038$2$F$$20240702$20240520$20240711$PER$$US-SA-2024SA134810$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240711$$MD$US$US
238760392$23876039$2$F$20240101$20240809$20240520$20240816$PER$$US-SA-2024SA148304$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240816$$MD$US$US
238760422$23876042$2$F$20240301$20240731$20240520$20240808$PER$$US-SA-2024SA147484$SANOFI AVENTIS$$10$MON$I$F$Y$$$20240808$$MD$US$US
238761062$23876106$2$F$20231001$20240815$20240520$20240925$PER$$US-IMP-2023000338$Harrow Health$$$$E$F$Y$$$20240925$$CN$US$US
238761094$23876109$4$F$20240101$20240913$20240520$20240925$PER$$US-SA-2024SA148224$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240925$$MD$US$US
238761132$23876113$2$F$$20240710$20240520$20240718$PER$$US-SA-2024SA147955$SANOFI AVENTIS$$$$E$F$Y$$$20240718$$MD$US$US
238761153$23876115$3$F$$20240704$20240520$20240709$EXP$$IN-PFIZER INC-2021245723$PFIZER$$71$YR$$F$Y$$$20240709$$CN$IN$IN
238761362$23876136$2$F$$20240822$20240520$20240917$PER$$US-SA-2024SA147355$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240918$$MD$US$US
238761402$23876140$2$F$20240229$20240701$20240520$20240703$PER$$US-BIOMARINAP-US-2024-157832$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
238761433$23876143$3$F$20240327$20240913$20240520$20240925$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405005322$ELI LILLY AND CO$$68$YR$E$M$Y$72$KG$20240925$$CN$JP$JP
238761473$23876147$3$F$$20240621$20240520$20240702$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405006992$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240702$$CN$JP$JP
238761542$23876154$2$F$20240109$20240710$20240520$20240722$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405005312$ELI LILLY AND CO$$55$YR$A$F$Y$72$KG$20240722$$CN$JP$JP
238761912$23876191$2$F$20240331$20240812$20240520$20240820$EXP$$CA-LUNDBECK-DKLU3078160$LUNDBECK$$$$$$Y$$$20240820$$HP$CA$CA
238762192$23876219$2$F$20240501$20240816$20240520$20240829$EXP$$IN-INCYTE CORPORATION-2024IN005289$INCYTE$$$$$$Y$$$20240829$$CN$IN$IN
238762212$23876221$2$F$20180509$20240910$20240520$20240912$PER$$US-GILEAD-2024-0673342$GILEAD$$31$YR$A$M$Y$$$20240912$$LW$US$US
238762232$23876223$2$F$20200501$20240701$20240520$20240702$PER$$US-GILEAD-2024-0673346$GILEAD$$20$YR$A$M$Y$$$20240702$$LW$US$US
238762242$23876224$2$F$20211031$20240712$20240520$20240715$EXP$$US-GILEAD-2024-0673350$GILEAD$$48$YR$A$F$Y$$$20240715$$LW$US$US
238762332$23876233$2$F$20180223$20240715$20240520$20240716$EXP$$US-GILEAD-2024-0673355$GILEAD$$41$YR$A$F$Y$$$20240716$$LW$US$US
238762412$23876241$2$F$20140101$20240710$20240520$20240711$EXP$$US-GILEAD-2024-0673359$GILEAD$$42$YR$A$M$Y$$$20240711$$LW$US$US
238762462$23876246$2$F$20160101$20240823$20240520$20240828$EXP$$US-GILEAD-2024-0673368$GILEAD$$57$YR$A$M$Y$$$20240828$$LW$US$US
238762472$23876247$2$F$20230429$20240626$20240520$20240702$EXP$$GB-ABBVIE-5735136$ABBVIE$$59$YR$$F$Y$64$KG$20240702$$HP$GB$GB
238762572$23876257$2$F$20200101$20240719$20240520$20240728$PER$$US-SA-2024SA149823$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240728$$HP$US$US
238762622$23876262$2$F$20240101$20240906$20240520$20240912$PER$$US-BAUSCHBL-2024BNL026962$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240912$$CN$US$US
238762742$23876274$2$F$20220901$20240712$20240520$20240726$EXP$$US-ABBVIE-5766722$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
238762953$23876295$3$F$$20240718$20240520$20240723$EXP$$CN-JNJFOC-20240534990$JOHNSON AND JOHNSON$$31$YR$A$M$Y$69$KG$20240723$$MD$CN$CN
238762973$23876297$3$F$20201114$20240826$20240520$20240830$EXP$$US-GILEAD-2024-0673428$GILEAD$$67$YR$E$F$Y$$$20240830$$LW$US$US
238763052$23876305$2$F$20190802$20240910$20240520$20240912$PER$$US-GILEAD-2024-0673432$GILEAD$$37$YR$A$F$Y$$$20240912$$LW$US$US
238763082$23876308$2$F$$20240826$20240520$20240828$EXP$$JP-TAKEDA-2024TJP007184$TAKEDA$$$$$M$Y$$$20240828$$MD$JP$JP
238763143$23876314$3$F$20150715$20240819$20240520$20240820$PER$$US-GILEAD-2024-0673436$GILEAD$$42$YR$A$F$Y$$$20240820$$LW$US$US
238763484$23876348$4$F$20240516$20240624$20240520$20240701$30DAY$$US-AMGEN-USASP2024098384$AMGEN$$66$YR$E$F$Y$105.22$KG$20240701$$HP$US$US
238763742$23876374$2$F$$20240807$20240520$20240808$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-076773$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240808$$CN$TW$TW
238763752$23876375$2$F$20130101$20240815$20240520$20240819$PER$$US-GILEAD-2024-0673469$GILEAD$$44$YR$A$M$Y$$$20240819$$LW$US$US
238763812$23876381$2$F$20240101$20240905$20240520$20240917$PER$$US-SA-2024SA147060$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240918$$MD$US$US
238763892$23876389$2$F$20240501$20240719$20240520$20240729$PER$$US-SA-2024SA148190$SANOFI AVENTIS$$63$YR$A$F$Y$92$KG$20240729$$CN$US$US
238763992$23876399$2$F$20240301$20240719$20240520$20240725$EXP$$JP-GENMAB-2024-01666$GENMAB$$75$YR$$M$Y$$$20240725$$MD$JP$JP
238764162$23876416$2$F$$20240701$20240520$20240703$PER$$NVSC2024US106313$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
238764192$23876419$2$F$$20240710$20240520$20240718$PER$$US-SA-2024SA150758$SANOFI AVENTIS$$60$YR$A$M$Y$72.5$KG$20240718$$MD$US$US
238764264$23876426$4$F$20240524$20240722$20240520$20240727$EXP$$US-ABBVIE-5623993$ABBVIE$$87$YR$$M$Y$$$20240727$$CN$US$US
238764322$23876432$2$F$$20240906$20240521$20240916$EXP$$JP-009507513-2405JPN001513J$MERCK$Yoshida Y, Mori T, Asakura Y, Koyama H. P73-3 Two cases of endometrial cancer with perforation early after initiation of pembrolizumab plus lenvatinib. 2024 the Japanese Society of Medical Oncology Annual Meeting$70$YR$$F$Y$$$20240916$$MD$JP$JP
238764343$23876434$3$F$20160610$20240823$20240521$20240828$PER$$US-GILEAD-2024-0673481$GILEAD$$43$YR$A$M$Y$$$20240828$$LW$US$US
238764354$23876435$4$F$$20240827$20240521$20240910$EXP$$US-MALLINCKRODT-MNK202403196$MALLINCKRODT$$$$$M$Y$$$20240910$$CN$US$US
238764442$23876444$2$F$$20240625$20240521$20240703$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000168$EMCURE$$$$$$Y$$$20240703$$PH$US$US
238764472$23876447$2$F$20121230$20240827$20240521$20240830$PER$$US-GILEAD-2024-0673488$GILEAD$$29$YR$A$M$Y$$$20240830$$LW$US$US
238764712$23876471$2$F$20080512$20240920$20240521$20240924$PER$$US-GILEAD-2024-0673518$GILEAD$$48$YR$A$M$Y$$$20240924$$LW$US$US
238764744$23876474$4$F$$20240628$20240521$20240703$PER$$US-TAKEDA-2024TUS049079$TAKEDA$$$$$F$Y$$$20240703$$CN$US$US
238764812$23876481$2$F$20240801$20240827$20240521$20240904$PER$$US-SA-2024SA151140$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240904$$MD$US$US
238764912$23876491$2$F$20240512$20240715$20240521$20240722$PER$$US-SA-2024SA152301$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240723$$MD$US$US
238764925$23876492$5$F$20240101$20240801$20240521$20240809$PER$$US-SA-2024SA150919$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240809$$MD$US$US
238764977$23876497$7$F$$20240923$20240521$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076444$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$90.26$KG$20240924$$CN$US$US
238764982$23876498$2$F$$20240709$20240521$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077439$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240711$$CN$US$US
238765024$23876502$4$F$20230101$20240819$20240521$20240822$EXP$$US-ABBVIE-4743304$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
238765066$23876506$6$F$20240401$20240917$20240521$20240925$EXP$$US-ABBVIE-5764791$ABBVIE$$77$YR$$F$Y$78.925$KG$20240925$$CN$US$US
238765083$23876508$3$F$20230301$20240730$20240521$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002096$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$65$KG$20240822$$CN$US$US
238765292$23876529$2$F$20240701$20240722$20240521$20240731$PER$$US-SA-2024SA147817$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240731$$MD$US$US
238765352$23876535$2$F$$20240816$20240521$20240821$EXP$$US-ABBVIE-5725189$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
238765392$23876539$2$F$$20240730$20240521$20240731$PER$$NVSC2024US100692$NOVARTIS$$30$YR$$M$Y$$$20240731$$CN$US$US
238765522$23876552$2$F$20240101$20240807$20240521$20240816$PER$$US-SA-2024SA148134$SANOFI AVENTIS$$60$YR$A$M$Y$107.5$KG$20240816$$MD$US$US
238765654$23876565$4$F$20230919$20240802$20240521$20240815$EXP$$AT-ROCHE-3563024$ROCHE$$65$YR$E$M$Y$80$KG$20240815$$MD$AT$AT
238765713$23876571$3$F$20240101$20240826$20240521$20240909$EXP$$NL-ABBVIE-5765865$ABBVIE$$77$YR$$F$Y$$$20240909$$CN$NL$NL
238765923$23876592$3$F$20240401$20240730$20240521$20240731$PER$$US-JNJFOC-20240550390$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
238765982$23876598$2$F$20240401$20240716$20240521$20240808$PER$$CA-TOLMAR, INC.-24CA048787$TOLMAR$$66$YR$$M$Y$$$20240808$$CN$CA$CA
238765992$23876599$2$F$20240424$20240716$20240521$20240808$PER$$CA-TOLMAR, INC.-24CA048789$TOLMAR$$65$YR$$M$Y$$$20240808$$CN$CA$CA
238766072$23876607$2$F$20240425$20240729$20240521$20240821$PER$$CA-TOLMAR, INC.-24CA048832$TOLMAR$$78$YR$$M$Y$$$20240821$$CN$CA$CA
238766082$23876608$2$F$20240426$20240719$20240521$20240806$PER$$CA-TOLMAR, INC.-24CA048833$TOLMAR$$67$YR$$M$Y$$$20240806$$CN$CA$CA
238766252$23876625$2$F$20240424$20240819$20240521$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077499$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240820$$HP$US$US
238766263$23876626$3$F$$20240912$20240521$20240920$EXP$$CA-TAKEDA-2024TUS032278$TAKEDA$$$$$F$Y$$$20240920$$HP$CA$CA
238766412$23876641$2$F$20240428$20240725$20240521$20240807$EXP$$IT-CIPLA LTD.-2024IT04666$CIPLA$$$$$$Y$$$20240807$$MD$IT$IT
238766513$23876651$3$F$20231101$20240711$20240521$20240717$EXP$$CA-CELLTRION INC.-2023CA024229$CELLTRION$$$$$$Y$$$20240717$$HP$CA$CA
238766593$23876659$3$F$20230822$20240711$20240521$20240722$EXP$$US-NOVOPROD-1222387$NOVO NORDISK$$63$YR$$F$Y$256$KG$20240722$$HP$US$US
238766643$23876664$3$F$20240227$20240711$20240521$20240722$EXP$$US-NOVOPROD-1197261$NOVO NORDISK$$66$YR$$F$Y$$$20240722$$CN$US$US
238766682$23876668$2$F$20240507$20240729$20240521$20240807$30DAY$$BE-NOVOPROD-1221745$NOVO NORDISK$$68$YR$$M$Y$$$20240807$$CN$BE$BE
238766822$23876682$2$F$20240101$20240815$20240521$20240828$PER$$US-SA-2024SA151797$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240828$$MD$US$US
238766882$23876688$2$F$20240405$20240702$20240521$20240704$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-077311$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$94.35$KG$20240704$$HP$CA$CA
238766992$23876699$2$F$20240501$20240726$20240521$20240806$PER$$US-SA-2024SA146715$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240806$$MD$US$US
238767142$23876714$2$F$20240413$20240617$20240521$20240701$EXP$FR-AFSSAPS-LY2024000610$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-107330$ZYDUS PHARM$$$$$$Y$$$20240701$$PH$FR$FR
238767204$23876720$4$F$20240302$20240731$20240521$20240809$EXP$$KR-JAZZ PHARMACEUTICALS-2024-KR-007790$JAZZ$$64$YR$$M$Y$68.3$KG$20240808$$MD$KR$KR
238767222$23876722$2$F$$20240729$20240521$20240731$EXP$$NVSC2024CL105059$NOVARTIS$$$$$$Y$$$20240731$$MD$CL$CL
238767235$23876723$5$F$20220101$20240914$20240521$20240919$EXP$$NVSC2023MX186904$NOVARTIS$$$$$M$Y$72$KG$20240919$$CN$MX$MX
238767383$23876738$3$F$$20240718$20240521$20240726$30DAY$$US-GSK-US2024061930$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$PH$US$US
238767472$23876747$2$F$$20240730$20240521$20240808$PER$$US-SA-2024SA150444$SANOFI AVENTIS$$$$A$F$Y$$$20240808$$MD$US$US
238767504$23876750$4$F$20240101$20240719$20240521$20240730$PER$$US-SA-2024SA146986$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240730$$CN$US$US
238767523$23876752$3$F$20240306$20240704$20240521$20240710$EXP$$BR-SA-2024SA082223$SANOFI AVENTIS$$3$YR$C$F$Y$11.6$KG$20240710$$HP$BR$BR
238767662$23876766$2$F$$20240705$20240521$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03951$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238767672$23876767$2$F$$20240702$20240521$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03952$LUPIN$$$$$$Y$$$20240725$$CN$US$US
238767762$23876776$2$F$$20240704$20240521$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03972$LUPIN$$$$$$Y$$$20240725$$CN$US$US
238767783$23876778$3$F$$20240717$20240521$20240731$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-09965$ALKEM$Shin HJ, Na JH, Lee YM.. A case of exacerbated encephalopathy with stroke-like episodes and lactic acidosis triggered by metformin in a patient with MELAS. Neurol Sci. 2024;45(5):2337-2339$32$YR$$F$Y$$$20240731$$HP$KR$KR
238767813$23876781$3$F$20240420$20240627$20240521$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002125$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240723$$CN$US$US
238767833$23876783$3$F$$20240702$20240521$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03980$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238767892$23876789$2$F$20240510$20240705$20240521$20240715$30DAY$$US-GSK-US2024061925$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240715$$CN$US$US
238767923$23876792$3$F$20240407$20240717$20240521$20240717$PER$$US-ALXN-202405USA000871US$ALEXION PHARMACEUTICALS$$80$YR$$M$Y$$$20240717$$CN$US$US
238767963$23876796$3$F$20240506$20240730$20240521$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077624$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$54.3$KG$20240731$$PH$US$US
238767972$23876797$2$F$$20240705$20240521$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03970$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238767982$23876798$2$F$$20240725$20240521$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03956$LUPIN$$$$$$Y$$$20240817$$CN$US$US
238768002$23876800$2$F$20240511$20240516$20240521$20240925$PER$$US-AMGEN-USASP2024097582$AMGEN$$70$YR$E$M$Y$$$20240925$$CN$US$US
238768072$23876807$2$F$20240201$20240702$20240521$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03981$LUPIN$$2$YR$$M$Y$15.42$KG$20240725$$CN$US$US
238768083$23876808$3$F$$20240705$20240521$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03984$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238768182$23876818$2$F$$20240705$20240521$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03968$LUPIN$$$$$$Y$$$20240804$$CN$US$US
238768202$23876820$2$F$20240101$20240708$20240521$20240716$EXP$$CA-CELLTRION INC.-2024CA004573$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
238768292$23876829$2$F$$20240708$20240521$20240711$PER$$US-ALXN-202405USA000914US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
238768303$23876830$3$F$$20240705$20240521$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03947$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238768382$23876838$2$F$20240401$20240808$20240521$20240820$EXP$$US-SPECGX-T202401106$SPECGX$$76$YR$$F$Y$82$KG$20240820$$CN$US$US
238768392$23876839$2$F$20240301$20240627$20240521$20240705$EXP$$US-BIOGEN-2024BI01265115$BIOGEN$$50$YR$$F$Y$107.5$KG$20240705$$CN$US$US
238768402$23876840$2$F$20240328$20240529$20240521$20240708$EXP$FR-AFSSAPS-TS2024000457$FR-HALEON-2175664$Haleon PLC$$61$YR$$M$Y$61$KG$20240705$$MD$FR$FR
238768433$23876843$3$F$$20240705$20240521$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04067$LUPIN$$$$$$Y$$$20240731$$CN$US$US
238768612$23876861$2$F$$20240712$20240521$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078189$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240715$$CN$US$US
238768792$23876879$2$F$$20240816$20240521$20240826$30DAY$$IL-JNJFOC-20240504691$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$IL$IL
238768992$23876899$2$F$20231201$20240813$20240521$20240814$PER$$NVSC2024US095043$NOVARTIS$$$$$M$Y$$$20240814$$HP$US$US
238769238$23876923$8$F$20240101$20240823$20240521$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014721$UNITED THERAPEUTICS$$$$$F$Y$101.13$KG$20240831$$$US$US
238769343$23876934$3$F$20240509$20240820$20240521$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-077806$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240821$$MD$JP$JP
238769353$23876935$3$F$20180920$20240716$20240521$20240717$PER$$US-GILEAD-2024-0673317$GILEAD$$61$YR$A$F$Y$$$20240717$$LW$US$US
238769362$23876936$2$F$20240517$20240813$20240521$20240814$PER$$US-AMGEN-USASP2024099114$AMGEN$$66$YR$E$F$Y$$$20240814$$CN$US$US
238769394$23876939$4$F$$20240820$20240521$20240829$PER$$NVSC2024US100240$NOVARTIS$$$$$F$Y$$$20240829$$HP$US$US
238769433$23876943$3$F$$20240905$20240521$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03982$LUPIN$$$$$$Y$$$20240921$$PH$US$US
238769453$23876945$3$F$20190505$20240823$20240521$20240828$PER$$US-GILEAD-2024-0673324$GILEAD$$45$YR$A$F$Y$$$20240828$$LW$US$US
238769464$23876946$4$F$20240408$20240702$20240521$20240712$EXP$CZ-CZSUKL-24001251$CZ-BEH-2024171954$CSL BEHRING$$65$YR$E$M$Y$105$KG$20240712$$MD$CZ$CZ
238769494$23876949$4$F$20240405$20240627$20240521$20240710$EXP$$NL-GSK-NL2024EME062863$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$PH$NL$NL
238769622$23876962$2$F$20240101$20240712$20240521$20240723$EXP$$US-ARDELYX-2024ARDX003104$ARDELYX$$66$YR$$M$Y$$$20240723$$HP$US$US
238769692$23876969$2$F$$20240820$20240521$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077976$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240820$$CN$US$US
238769742$23876974$2$F$20150612$20240806$20240521$20240807$PER$$US-GILEAD-2024-0673339$GILEAD$$47$YR$A$M$Y$$$20240807$$LW$US$US
238769784$23876978$4$F$20240716$20240813$20240521$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002170$ACADIA PHARMACEUTICALS$$67$YR$$F$Y$51$KG$20240906$$CN$US$US
238769793$23876979$3$F$$20240710$20240521$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002173$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
238769922$23876992$2$F$$20240802$20240521$20240813$EXP$$CA-INTERCEPT-PM2024001027$INTERCEPT PHARMACEUTICALS$$55$YR$$F$Y$$$20240813$$CN$CA$CA
238769942$23876994$2$F$$20240820$20240521$20240823$PER$$US-JNJFOC-20240536174$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240823$$CN$US$US
238769983$23876998$3$F$20230501$20240814$20240521$20240814$EXP$$NVSC2024DE104682$NOVARTIS$$$$A$F$Y$54$KG$20240814$$MD$DE$DE
238770132$23877013$2$F$$20240716$20240521$20240716$PER$$US-ALXN-202405USA000982US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238770243$23877024$3$F$20240519$20240826$20240521$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-028800$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240827$$PH$US$US
238770252$23877025$2$F$20240415$20240625$20240521$20240705$EXP$$US-BEH-2024172319$CSL BEHRING$$46$YR$A$F$Y$$$20240705$$HP$US$US
238770262$23877026$2$F$20240301$20240815$20240521$20240822$PER$$PR-BIOGEN-2024BI01256939$BIOGEN$$60$YR$$F$Y$69.462$KG$20240822$$CN$PR$PR
238770352$23877035$2$F$20240125$20240801$20240521$20240805$EXP$$CA-TAKEDA-2024TUS049189$TAKEDA$$76$YR$$F$Y$73$KG$20240805$$HP$CA$CA
238770483$23877048$3$F$$20240709$20240521$20240715$PER$$US-BIOGEN-2023BI01196837$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
238770573$23877057$3$F$$20240912$20240521$20240927$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-15166$SAMSUNG BIOEPIS$$67$YR$E$M$Y$$$20240927$$CN$AU$AU
238770583$23877058$3$F$20240101$20240716$20240521$20240722$EXP$$US-UCBSA-2024024471$UCB$$$$$F$Y$$$20240722$$CN$US$US
238770603$23877060$3$F$20240506$20240814$20240521$20240816$PER$$US-AMGEN-USASP2024099293$AMGEN$$59$YR$A$M$Y$$$20240816$$CN$US$US
238770672$23877067$2$F$$20240718$20240521$20240726$30DAY$$US-GSK-US2024062279$GLAXOSMITHKLINE$$$$$M$Y$122$KG$20240726$$MD$US$US
238770722$23877072$2$F$$20240816$20240521$20240819$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-073544$REGENERON$$$$$M$Y$$$20240819$$HP$CA$CA
238770842$23877084$2$F$$20240902$20240521$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077503$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$88.9$KG$20240904$$CN$US$US
238771042$23877104$2$F$$20240627$20240521$20240706$EXP$$US-AUROBINDO-AUR-APL-2024-023525$AUROBINDO$Taha Y, Mathavan A, Belaunzaran M, Ross SJ, Miles WM, Ruzieh M. BEYOND THE BEAT: A CASE OF WIDE COMPLEX TACHYCARDIA. J-Am-Coll-Cardio. 2024;83 (Suppl.)(13):3688$76$YR$$F$Y$$$20240706$$HP$US$US
238771052$23877105$2$F$20201101$20240703$20240521$20240705$PER$$US-GILEAD-2024-0673351$GILEAD$$47$YR$A$M$Y$$$20240705$$LW$US$US
238771143$23877114$3$F$20240409$20240624$20240521$20240705$EXP$$JP-ROCHE-3563959$ROCHE$$57$YR$A$M$Y$$$20240705$$MD$JP$JP
238771173$23877117$3$F$$20240627$20240521$20240706$EXP$$CA-AUROBINDO-AUR-APL-2024-023291$AUROBINDO$Sassine S, Remy A, Demaret T, Ovetchkine P, Kakkar F, Tran TH, et al.. From pancytopenia to hyperleukocytosis, an unexpected presentation of immune reconstitution inflammatory syndrome in an infant with methylmalonic acidemia. Clinical Immunology. 2024;262(Supplement):110092$2$MON$$$Y$$$20240706$$MD$CA$CA
238771333$23877133$3$F$$20240705$20240521$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03974$LUPIN$$$$$$Y$$$20240804$$CN$US$US
238771442$23877144$2$F$20240326$20240517$20240521$20240918$EXP$FR-AFSSAPS-PP2024000460$FR-BAUSCH-BL-2024-007838$BAUSCH AND LOMB$$71$YR$$M$Y$85$KG$20240918$$MD$FR$FR
238771532$23877153$2$F$$20240708$20240521$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076705$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240715$$HP$US$US
238771612$23877161$2$F$20240516$20240819$20240521$20240822$PER$$US-AMGEN-USASP2024098980$AMGEN$$75$YR$E$M$Y$$$20240822$$CN$US$US
238771632$23877163$2$F$20210101$20240712$20240521$20240715$EXP$$US-GILEAD-2024-0673356$GILEAD$$57$YR$A$F$Y$$$20240715$$LW$US$US
238771642$23877164$2$F$20190611$20240710$20240521$20240711$EXP$$US-GILEAD-2024-0673360$GILEAD$$61$YR$A$M$Y$$$20240711$$LW$US$US
238771682$23877168$2$F$$20240706$20240521$20240713$EXP$$CA-CELLTRION INC.-2024CA011626$CELLTRION$$$$$$Y$$$20240713$$HP$CA$CA
238771712$23877171$2$F$$20240515$20240521$20240726$EXP$$US-ARGENX-2024-ARGX-US003350$ARGENX BVBA$$$$$$Y$$$20240726$$CN$US$US
238771783$23877178$3$F$20240501$20240702$20240521$20240708$EXP$$GB-ABBVIE-5765881$ABBVIE$$56$YR$$M$Y$99$KG$20240708$$CN$GB$GB
238771793$23877179$3$F$$20240618$20240521$20240806$EXP$$SG-ROCHE-3564659$ROCHE$$$$$$Y$$$20240806$$CN$SG$SG
238771852$23877185$2$F$$20240828$20240521$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202405006149$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240909$$CN$US$US
238772062$23877206$2$F$$20240621$20240521$20240702$PER$$US-TRAVERE-2024TVT00492$TRAVERE THERAPEUTICS$$35$YR$A$F$Y$$$20240702$$MD$US$US
238772222$23877222$2$F$$20240819$20240521$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076354$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240820$$MD$US$US
238772323$23877232$3$F$$20240822$20240521$20240827$EXP$$ES-TAKEDA-2024TUS049177$TAKEDA$$64$YR$$F$Y$$$20240827$$HP$ES$ES
238772333$23877233$3$F$20240501$20240522$20240521$20240701$30DAY$$US-AMGEN-USASL2024095277$AMGEN$$71$YR$E$$Y$$$20240701$$CN$US$US
238772392$23877239$2$F$$20240709$20240521$20240716$EXP$$JP-SA-2024SA151868$SANOFI AVENTIS$$$$A$M$Y$$$20240716$$PH$JP$JP
238772442$23877244$2$F$$20240909$20240521$20240924$EXP$$CA-APOTEX-2024AP005901$APOTEX$$36$YR$$F$Y$$$20240924$$HP$CA$CA
238772742$23877274$2$F$$20240628$20240521$20240704$PER$$US-APOTEX-2024AP005453$APOTEX$$$$$F$Y$$$20240704$$CN$US$US
238772782$23877278$2$F$20240503$20240717$20240521$20240723$EXP$$AU-BEH-2024172355$CSL BEHRING$$57$YR$A$F$Y$82$KG$20240723$$HP$AU$AU
238772954$23877295$4$F$$20240920$20240521$20240923$PER$$US-GILEAD-2024-0673395$GILEAD$$$$A$M$Y$$$20240923$$LW$US$US
238772972$23877297$2$F$$20240705$20240521$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03976$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238773022$23877302$2$F$20240501$20240823$20240521$20240831$EXP$$AU-TAKEDA-2021TUS024895$TAKEDA$$16$YR$$F$Y$56$KG$20240831$$CN$AU$AU
238773082$23877308$2$F$$20240903$20240521$20240909$EXP$$GB-TAKEDA-2024TUS048966$TAKEDA$$$$$M$Y$$$20240909$$CN$GB$GB
238773143$23877314$3$F$20240501$20240917$20240521$20240927$PER$$US-GSK-US2024AMR062599$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240927$$CN$US$US
238773195$23877319$5$F$$20240819$20240521$20240823$EXP$$CA-TAKEDA-2024TUS047486$TAKEDA$$$$$F$Y$$$20240823$$CN$CA$CA
238773273$23877327$3$F$$20240705$20240521$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03975$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238773292$23877329$2$F$$20240917$20240521$20240920$EXP$$US-TAKEDA-2023TUS085966$TAKEDA$$$$$F$Y$$$20240920$$CN$US$US
238773442$23877344$2$F$$20240704$20240521$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03983$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238773464$23877346$4$F$$20240806$20240521$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077565$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240808$$CN$US$US
238773472$23877347$2$F$$20240910$20240521$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078547$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240911$$HP$US$US
238773512$23877351$2$F$20240501$20240711$20240521$20240717$EXP$$JP-AMGEN-JPNSP2024096789$AMGEN$$$$$$Y$$$20240717$$PH$JP$JP
238773543$23877354$3$F$$20240705$20240521$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03978$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238773603$23877360$3$F$20240523$20240730$20240521$20240805$EXP$$CA-TAKEDA-2024TUS025602$TAKEDA$$47$YR$$M$Y$$$20240805$$CN$CA$CA
238773613$23877361$3$F$20240225$20240819$20240521$20240826$EXP$$US-BEH-2024172396$CSL BEHRING$$21$YR$A$F$Y$$$20240826$$HP$US$US
238773662$23877366$2$F$$20240705$20240521$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03977$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238773703$23877370$3$F$20240428$20240520$20240521$20240805$PER$$US-AstraZeneca-2024A103815$ASTRAZENECA$$24453$DY$$$Y$$$20240805$$CN$US$
238773733$23877373$3$F$20240402$20240730$20240521$20240802$EXP$$JP-AstraZeneca-2024A116189$ASTRAZENECA$$79$YR$$F$Y$61$KG$20240802$$MD$JP$
238773785$23877378$5$F$20240101$20240828$20240521$20240906$EXP$$CA-CELLTRION INC.-2023CA022207$CELLTRION$$$$$$Y$$$20240906$$MD$CA$CA
238773862$23877386$2$F$$20240702$20240521$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03998$LUPIN$$$$$$Y$$$20240725$$CN$US$US
238773885$23877388$5$F$20240101$20240802$20240521$20240812$EXP$$JP-JNJFOC-20231168598$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240812$$CN$JP$JP
238773892$23877389$2$F$20240424$20240722$20240521$20240815$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000274$BECTON DICKINSON$$$$$$Y$$$20240814$$CN$GB$GB
238773912$23877391$2$F$$20240821$20240521$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078398$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240822$$CN$US$US
238773924$23877392$4$F$20240101$20240704$20240521$20240709$EXP$$CA-ABBVIE-5765387$ABBVIE$$83$YR$$F$Y$$$20240709$$HP$CA$CA
238773952$23877395$2$F$$20240805$20240521$20240829$30DAY$$US-BECTON DICKINSON-US-BD-24-000277$BECTON DICKINSON$$$$$$Y$$$20240829$$CN$US$US
238773972$23877397$2$F$20240425$20240722$20240521$20240815$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000285$BECTON DICKINSON$$$$$$Y$$$20240814$$CN$GB$GB
238774043$23877404$3$F$$20240710$20240521$20240716$EXP$$IN-VANTIVE-2024VAN017113$Vantive US Healthcare$$64$YR$$M$Y$$$20240716$$CN$IN$IN
238774052$23877405$2$F$20240424$20240826$20240521$20240916$30DAY$$CA-BECTON DICKINSON-CA-BD-24-000287$BECTON DICKINSON$$$$$$Y$$$20240916$$CN$CA$CA
238774122$23877412$2$F$$20240821$20240521$20240913$30DAY$$US-BECTON DICKINSON-US-BD-24-000289$BECTON DICKINSON$$$$$$Y$$$20240913$$CN$US$US
238774432$23877443$2$F$$20240819$20240521$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077097$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240819$$HP$US$US
238774582$23877458$2$F$20240429$20240819$20240521$20240909$PER$$CA-TOLMAR, INC.-24CA048867$TOLMAR$$86$YR$$M$Y$$$20240909$$CN$CA$CA
238774602$23877460$2$F$20230915$20240821$20240521$20240917$PER$$CA-TOLMAR, INC.-24CA048926$TOLMAR$$75$YR$$M$Y$$$20240917$$CN$CA$CA
238774672$23877467$2$F$20240301$20240627$20240521$20240724$PER$$CO-TOLMAR, INC.-24CO048893$TOLMAR$$69$YR$$M$Y$$$20240724$$CN$CO$CO
238774702$23877470$2$F$$20240705$20240521$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03973$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238774733$23877473$3$F$20100629$20240822$20240521$20240823$PER$$US-GILEAD-2024-0673554$GILEAD$$49$YR$A$M$Y$$$20240823$$LW$US$US
238774802$23877480$2$F$$20240705$20240521$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04023$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238774864$23877486$4$F$20240517$20240617$20240521$20240704$30DAY$$US-JNJFOC-20240551734$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240704$$PH$US$US
238774892$23877489$2$F$20240401$20240701$20240521$20240704$EXP$$NVSC2024DE104635$NOVARTIS$$85$YR$$F$Y$$$20240704$$CN$DE$DE
238774923$23877492$3$F$20240301$20240726$20240521$20240730$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-077812$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$78.02$KG$20240730$$CN$PR$PR
238775013$23877501$3$F$20210101$20240822$20240521$20240826$PER$$US-AMGEN-USASP2024098053$AMGEN$$67$YR$E$M$Y$$$20240825$$CN$US$US
238775132$23877513$2$F$20240515$20240823$20240521$20240827$PER$$US-AMGEN-USASP2024098106$AMGEN$$72$YR$E$F$Y$$$20240827$$CN$US$US
238775254$23877525$4$F$$20240718$20240521$20240723$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-076507$BRISTOL MYERS SQUIBB$Vischini G, Speciale S, Przygocka A, Martano L, Manna GL, Baraldi O. Lessons for the clinical nephrologist: acute kidney injury during therapy with apixaban. Journal of Nephrology. 2024;37(2):511-3. doi:10.1007/s40620-023-01781-y.$81$YR$E$M$Y$$$20240723$$HP$IT$IT
238775272$23877527$2$F$20240513$20240711$20240521$20240717$EXP$$CA-CELLTRION INC.-2024CA009443$CELLTRION$$$$$$Y$$$20240717$$PH$CA$CA
238775302$23877530$2$F$20240330$20240802$20240521$20240806$EXP$FR-AFSSAPS-PV2024000363$FR-AMGEN-FRASP2024097579$AMGEN$$72$YR$E$F$Y$58$KG$20240806$$MD$FR$FR
238775393$23877539$3$F$20240516$20240626$20240521$20240709$30DAY$$PR-JNJFOC-20240551487$JOHNSON AND JOHNSON$$40$YR$A$F$Y$65.83$KG$20240709$$CN$PR$PR
238775482$23877548$2$F$$20240820$20240521$20240823$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-078717$BRISTOL MYERS SQUIBB$$$$E$M$Y$52$KG$20240823$$MD$JP$JP
238775542$23877554$2$F$20240508$20240806$20240521$20240807$PER$$US-JNJFOC-20240527508$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240807$$HP$US$US
238775815$23877581$5$F$20240507$20240911$20240521$20240926$30DAY$$US-LUPIN PHARMACEUTICALS INC.-2024-03997$LUPIN$$$$$$Y$$$20240926$$CN$US$US
238775962$23877596$2$F$$20240517$20240521$20240925$PER$$US-GSK-US2024AMR062529$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
238775992$23877599$2$F$20230224$20240708$20240521$20240711$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2024JPN061468$VIIV$$$$$$Y$$$20240711$$MD$JP$JP
238776052$23877605$2$F$20220504$20240715$20240521$20240717$EXP$$US-GILEAD-2024-0673348$GILEAD$$$$$F$Y$$$20240717$$LW$US$US
238776092$23877609$2$F$20240125$20240718$20240521$20240725$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2157237$JIANGSU HANSOH PHARMACEUTICAL$$$$$F$Y$$$20240725$$$CN$CN
238776185$23877618$5$F$20240504$20240628$20240521$20240806$PER$$US-AstraZeneca-2024A107103$ASTRAZENECA$$29615$DY$$F$Y$$$20240806$$CN$US$
238776193$23877619$3$F$20160101$20240827$20240521$20240902$PER$$US-GILEAD-2024-0673637$GILEAD$$59$YR$A$M$Y$$$20240902$$LW$US$US
238776203$23877620$3$F$$20240827$20240521$20240904$PER$$US-TRAVERE-2024TVT00485$TRAVERE THERAPEUTICS$$$$$F$Y$78.38$KG$20240904$$HP$US$US
238776252$23877625$2$F$$20240801$20240521$20240801$PER$$NVSC2024US101624$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
238776309$23877630$9$F$20240101$20240731$20240521$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-000954$UNITED THERAPEUTICS$$$$$F$Y$68.934$KG$20240809$$$US$US
238776413$23877641$3$F$20150929$20240820$20240521$20240823$PER$$US-GILEAD-2024-0673327$GILEAD$$43$YR$A$M$Y$$$20240823$$LW$US$US
238776463$23877646$3$F$20240101$20240704$20240521$20240705$EXP$$US-KYOWAKIRIN-2024KK012040$KYOWA$$$$$$Y$$$20240705$$CN$US$US
238776502$23877650$2$F$20150101$20240910$20240521$20240912$PER$$US-GILEAD-2024-0673353$GILEAD$$32$YR$A$M$Y$$$20240912$$LW$US$US
238776552$23877655$2$F$20190101$20240620$20240521$20240701$EXP$$NVSC2020CO198534$NOVARTIS$$$$$F$Y$34$KG$20240701$$CN$CO$CO
238776692$23877669$2$F$20240101$20240724$20240521$20240725$EXP$$US-UCBSA-2024024548$UCB$$$$$F$Y$$$20240725$$HP$US$US
238776833$23877683$3$F$$20240711$20240521$20240723$PER$$US-RDY-SPO/USA/24/0007212$DR REDDYS$$21$YR$A$$Y$$$20240723$$MD$US$US
238776932$23877693$2$F$$20240725$20240521$20240731$EXP$$NVSC2024RU102937$NOVARTIS$$$$$F$Y$$$20240731$$MD$RU$RU
238777292$23877729$2$F$$20240814$20240521$20240822$EXP$$US-BIOGEN-2024BI01264649$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
238777312$23877731$2$F$20170201$20240708$20240521$20240709$EXP$$US-GILEAD-2024-0673357$GILEAD$$47$YR$A$M$Y$$$20240709$$LW$US$US
238777392$23877739$2$F$$20240820$20240521$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076480$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240820$$HP$US$US
238777412$23877741$2$F$$20240827$20240521$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-076475$BRISTOL MYERS SQUIBB$$9$DEC$E$$Y$$$20240905$$MD$JP$JP
238777432$23877743$2$F$20240401$20240909$20240521$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078456$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240911$$HP$US$US
238777534$23877753$4$F$$20240712$20240521$20240723$EXP$$IN-ROCHE-3515262$ROCHE$$52$YR$A$M$Y$$$20240723$$MD$IN$IN
238777712$23877771$2$F$$20240701$20240521$20240708$PER$$US-AstraZeneca-2024A109271$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$US$
238777792$23877779$2$F$20160830$20240802$20240521$20240805$PER$$US-GILEAD-2024-0673341$GILEAD$$42$YR$A$M$Y$$$20240805$$LW$US$US
238777886$23877788$6$F$20240101$20240827$20240521$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009899$UNITED THERAPEUTICS$$$$$F$Y$110.66$KG$20240905$$$US$US
238777992$23877799$2$F$20240508$20240509$20240521$20240808$PER$$US-LEO Pharma-370372$LEO PHARM$$23$YR$$F$Y$$$20240808$$HP$US$US
238778197$23877819$7$F$20240411$20240618$20240521$20240702$30DAY$$US-AMGEN-USASP2024096831$AMGEN$$$$$$Y$$$20240702$$PH$US$US
238778243$23877824$3$F$20180101$20240823$20240521$20240826$EXP$$US-GILEAD-2024-0673362$GILEAD$$40$YR$A$M$Y$$$20240826$$LW$US$US
238778384$23877838$4$F$20240201$20240807$20240521$20240814$EXP$$US-GSK-US2024062957$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$US$US
238778482$23877848$2$F$20230906$20240815$20240521$20240830$EXP$$CA-ASTELLAS-2024US014125$ASTELLAS$$64$YR$A$F$Y$82$KG$20240830$$HP$CA$CA
238778793$23877879$3$F$20240507$20240819$20240521$20240826$EXP$$JP-GENMAB-2024-01647$GENMAB$$7$DEC$$M$Y$$$20240826$$MD$JP$JP
238778853$23877885$3$F$20240426$20240613$20240521$20240701$30DAY$$US-JNJFOC-20240486389$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240701$$CN$US$US
238778882$23877888$2$F$20161103$20240820$20240521$20240822$EXP$$US-GILEAD-2024-0673366$GILEAD$$53$YR$A$M$Y$$$20240822$$LW$US$US
238779084$23877908$4$F$20240226$20240625$20240521$20240710$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-01744$AMNEAL$$$$$$Y$$$20240710$$PH$JP$JP
238779154$23877915$4$F$20211013$20240917$20240521$20240919$EXP$$NVSJ2024JP005913$NOVARTIS$$37$YR$$F$Y$49.2$KG$20240919$$MD$JP$JP
238779203$23877920$3$F$$20240710$20240521$20240717$PER$$US-AMGEN-USASP2024099591$AMGEN$$69$YR$E$F$Y$$$20240716$$MD$US$US
238779402$23877940$2$F$20230701$20240813$20240521$20240822$EXP$$JP-JNJFOC-20230842549$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240823$$CN$JP$JP
238779432$23877943$2$F$20240507$20240626$20240521$20240822$PER$$US-CHIESI-2024CHF02832$CHIESI$$$$A$M$Y$$$20240822$$MD$US$US
238779532$23877953$2$F$$20240906$20240521$20240911$EXP$$VN-AMGEN-VNMSP2024098977$AMGEN$Giang N. T.; Trong N. M.; Hung N. K. et al.. Tumor Thrombectomy via Surgically Reopened Umbilical Vein as a Palliative Treatment for Patient with Advanced Hepatocellular Carcinoma. Liver Cancer. 2023;12 (SUPPL_1):S70-S71$$$$M$Y$$$20240911$$HP$VN$VN
238779552$23877955$2$F$20231101$20240819$20240521$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-078397$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$47$KG$20240819$$PH$JP$JP
238779632$23877963$2$F$$20240708$20240521$20240711$PER$$US-ALXN-202405USA000910US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
238779692$23877969$2$F$20240507$20240621$20240521$20240821$PER$$US-CHIESI-2024CHF02686$CHIESI$$8$YR$$M$Y$34$KG$20240821$$MD$US$US
238779953$23877995$3$F$20230301$20240703$20240521$20240708$EXP$$IT-TAKEDA-2024TUS031719$TAKEDA$$47$YR$$M$Y$$$20240708$$CN$IT$IT
238780032$23878003$2$F$20231201$20240815$20240521$20240829$EXP$$US-UCBSA-2023059471$UCB$$55$YR$$F$Y$$$20240829$$CN$US$US
238780072$23878007$2$F$20240429$20240731$20240521$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078540$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$74.12$KG$20240802$$CN$US$US
238780142$23878014$2$F$20170301$20240813$20240521$20240814$PER$$US-GILEAD-2024-0673349$GILEAD$$$$$F$Y$$$20240814$$LW$US$US
238780162$23878016$2$F$20231210$20240628$20240521$20240702$PER$$US-AstraZeneca-2024A112821$ASTRAZENECA$$25627$DY$$M$Y$$$20240702$$CN$US$
238780242$23878024$2$F$$20240715$20240521$20240717$PER$$US-ALXN-202405USA000925US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
238780315$23878031$5$F$20240322$20240711$20240521$20240715$EXP$$CN-AMGEN-CHNNI2024096761$AMGEN$$71$YR$E$F$Y$50$KG$20240715$$MD$CN$CN
238780582$23878058$2$F$$20240614$20240521$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002167$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
238780632$23878063$2$F$$20240830$20240521$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077890$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240903$$HP$US$US
238780732$23878073$2$F$$20240708$20240521$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202405010741$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240715$$HP$US$US
238780752$23878075$2$F$20150101$20240821$20240521$20240827$PER$$US-GILEAD-2024-0673532$GILEAD$$55$YR$A$M$Y$$$20240826$$LW$US$US
238780772$23878077$2$F$20240518$20240829$20240521$20240830$PER$$US-AMGEN-USASP2024099737$AMGEN$$64$YR$A$F$Y$$$20240830$$CN$US$US
238780783$23878078$3$F$20160101$20240724$20240521$20240725$PER$$US-GILEAD-2024-0673358$GILEAD$$53$YR$A$M$Y$$$20240725$$LW$US$US
238780964$23878096$4$F$20240506$20240917$20240521$20240928$EXP$$TW-Accord-424687$ACCORD$$53$YR$A$M$Y$47.8$KG$20240928$$HP$TW$TW
238781133$23878113$3$F$20180328$20240819$20240521$20240823$PER$$US-GILEAD-2024-0673538$GILEAD$$58$YR$A$M$Y$$$20240823$$LW$US$US
238781164$23878116$4$F$20240203$20240628$20240521$20240704$EXP$$JP-JNJFOC-20240558206$JOHNSON AND JOHNSON$$58$YR$A$F$Y$68.9$KG$20240704$$MD$JP$JP
238781343$23878134$3$F$20181117$20240820$20240521$20240823$PER$$US-GILEAD-2024-0673367$GILEAD$$56$YR$A$M$Y$$$20240823$$LW$US$US
238781524$23878152$4$F$20240226$20240625$20240521$20240705$EXP$$US-VIIV HEALTHCARE LIMITED-US2024060869$VIIV$$59$YR$$M$Y$96.6$KG$20240705$$MD$US$US
238781592$23878159$2$F$20181004$20240822$20240521$20240828$EXP$$PT-MYLANLABS-2024M1044717$MYLAN$$36$YR$$M$Y$$$20240828$$MD$PT$PT
238781652$23878165$2$F$$20240812$20240521$20240827$EXP$$US-ASTELLAS-2024US013977$ASTELLAS$$$$$F$Y$$$20240820$$PH$US$US
238781742$23878174$2$F$$20240625$20240521$20240705$EXP$$FR-AMGEN-FRASP2024095218$AMGEN$$$$$F$Y$$$20240705$$MD$FR$FR
238781762$23878176$2$F$20240422$20240613$20240521$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002075$ACADIA PHARMACEUTICALS$$55$YR$$F$Y$$$20240708$$CN$US$US
238781872$23878187$2$F$20180726$20240813$20240521$20240815$EXP$$US-GILEAD-2024-0673378$GILEAD$$45$YR$A$M$Y$$$20240815$$LW$US$US
238781933$23878193$3$F$20240501$20240605$20240521$20240925$PER$$US-GSK-US2024AMR061519$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240925$$CN$US$US
238781952$23878195$2$F$$20240520$20240521$20240925$PER$$US-GSK-US2024AMR063105$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
238782002$23878200$2$F$$20240712$20240521$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-078697$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240719$$MD$JP$JP
238782822$23878282$2$F$$20240811$20240521$20240813$EXP$$US-SANDOZ INC.-SDZ2024US044691$SANDOZ$$$$$$Y$$$20240813$$CN$US$US
238782944$23878294$4$F$20230918$20240917$20240521$20240922$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-168336$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240922$$MD$JP$JP
238783262$23878326$2$F$$20240820$20240521$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078817$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240820$$HP$US$US
238783452$23878345$2$F$$20240917$20240521$20240919$EXP$$AU-SANDOZ INC.-SDZ2024AU050096$SANDOZ$$59$YR$$M$Y$$$20240919$$CN$AU$AU
238783473$23878347$3$F$20240401$20240819$20240521$20240826$EXP$$NVSC2024BR088824$NOVARTIS$$67$YR$$F$Y$60$KG$20240826$$CN$BR$BR
238783782$23878378$2$F$$20240819$20240521$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078776$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240819$$CN$US$US
238783842$23878384$2$F$$20230705$20240521$20240903$EXP$$US-JNJFOC-20230711861$JOHNSON AND JOHNSON$$$$$M$Y$73.4$KG$20240903$$MD$US$US
238783953$23878395$3$F$$20240713$20240521$20240716$EXP$$GB-AMGEN-GBRSP2024098972$AMGEN$$84$YR$E$M$Y$$$20240716$$CN$GB$GB
238784003$23878400$3$F$$20240805$20240521$20240815$EXP$$JP-ABBVIE-5762733$ABBVIE$$67$YR$$F$Y$63$KG$20240815$$MD$JP$JP
238784232$23878423$2$F$$20240816$20240521$20240820$EXP$$CA-PFIZER INC-202400171758$PFIZER$$81$YR$$F$Y$$$20240820$$PH$CA$CA
238784322$23878432$2$F$20230307$20240722$20240521$20240725$EXP$$JP-PFIZER INC-202400094158$PFIZER$$77$YR$$F$Y$$$20240725$$MD$JP$JP
238784346$23878434$6$F$20240101$20240709$20240521$20240715$EXP$$CA-PFIZER INC-202400072945$PFIZER$$51$YR$$F$Y$$$20240715$$MD$CA$CA
238784412$23878441$2$F$20240101$20240729$20240521$20240806$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014635$UNITED THERAPEUTICS$$$$$F$Y$77.551$KG$20240806$$$US$US
238784533$23878453$3$F$20240502$20240701$20240521$20240706$EXP$$AU-ROCHE-3561637$ROCHE$$40$YR$A$F$Y$$$20240706$$MD$AU$AU
238784782$23878478$2$F$$20240715$20240521$20240716$PER$$US-ALXN-202405USA000949US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238785054$23878505$4$F$$20240918$20240521$20240923$30DAY$$US-PFIZER INC-202400107896$PFIZER$$10$YR$$M$Y$$$20240923$$CN$US$US
238785064$23878506$4$F$$20240917$20240521$20240923$30DAY$$US-PFIZER INC-202400108500$PFIZER$$9$YR$$M$Y$$$20240923$$CN$US$US
238785332$23878533$2$F$$20240807$20240521$20240822$PER$$US-LEADINGPHARMA-US-2024LEASPO00147$LEADING PHARMA$$$$$$Y$$$20240822$$CN$US$US
238785414$23878541$4$F$$20240920$20240521$20240924$30DAY$$US-PFIZER INC-202400108478$PFIZER$$13$YR$$M$Y$$$20240924$$CN$US$US
238785425$23878542$5$F$$20240826$20240521$20240828$30DAY$$US-PFIZER INC-202400121470$PFIZER$$13$YR$$M$Y$$$20240828$$CN$US$US
238785493$23878549$3$F$$20240806$20240521$20240809$30DAY$$US-PFIZER INC-PV202400044712$PFIZER$$$$$$Y$$$20240809$$CN$US$US
238785502$23878550$2$F$$20240729$20240521$20240731$EXP$$US-PFIZER INC-202400131218$PFIZER$$73$YR$$M$Y$$$20240731$$CN$US$US
238785555$23878555$5$F$$20240912$20240521$20240917$30DAY$$US-PFIZER INC-202400110978$PFIZER$$2$YR$$F$Y$$$20240917$$CN$US$US
238785592$23878559$2$F$$20240714$20240521$20240715$30DAY$$CO-PFIZER INC-PV202400064183$PFIZER$$$$$$Y$$$20240715$$CN$CO$CO
238785682$23878568$2$F$20240520$20240814$20240521$20240819$PER$$US-AMGEN-USASP2024100025$AMGEN$$83$YR$E$F$Y$$$20240819$$CN$US$US
238786062$23878606$2$F$$20240917$20240521$20240919$EXP$$US-PFIZER INC-PV202400066017$PFIZER$$59$YR$$F$Y$$$20240919$$HP$US$US
238786082$23878608$2$F$20240101$20240704$20240521$20240709$EXP$$BR-PFIZER INC-PV202400065517$PFIZER$$78$YR$$F$Y$80$KG$20240709$$CN$BR$BR
238786142$23878614$2$F$20240505$20240709$20240521$20240710$EXP$$JP-PFIZER INC-PV202400065201$PFIZER$$50$YR$$F$Y$53$KG$20240710$$PH$JP$JP
238786232$23878623$2$F$$20240820$20240521$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078981$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240820$$CN$US$US
238786242$23878624$2$F$$20240820$20240521$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078637$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240820$$CN$US$US
238786392$23878639$2$F$20240513$20240813$20240521$20240819$EXP$$US-MYLANLABS-2024M1045721$MYLAN$$33$YR$$M$Y$235$KG$20240819$$HP$US$US
238786403$23878640$3$F$20240514$20240812$20240521$20240819$EXP$$US-MYLANLABS-2024M1045429$MYLAN$$21$YR$$F$Y$79.8$KG$20240819$$HP$US$US
238786442$23878644$2$F$$20240503$20240521$20240729$EXP$$PT-GILEAD-2024-0672972$GILEAD$$$$A$$Y$$$20240729$$HP$PT$PT
238786492$23878649$2$F$20240504$20240511$20240521$20240717$EXP$$CN-G1 THERAPEUTICS-2024G1CN0000056$G1 THERAPEUTICS$$$$$$Y$$$20240717$$MD$CN$CN
238786533$23878653$3$F$20230131$20240729$20240521$20240805$EXP$$JP-EXELIXIS-CABO-24077455$EXELIXIS$$69$YR$$M$Y$60.7$KG$20240805$$MD$JP$JP
238787043$23878704$3$F$$20240627$20240521$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-023507$AUROBINDO$Smith D, Tsui BCH, Khoo C.. Local Anesthetic Systemic Toxicity in Cardiac Surgery Patient with Erector Spinae Plane Catheter: A Case Report.. A-APract. 2024;18No:4$38$YR$$F$Y$$$20240705$$MD$US$US
238787223$23878722$3$F$$20240715$20240521$20240719$PER$$US-AstraZeneca-2024A117552$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
238787233$23878723$3$F$20180108$20240827$20240521$20240830$EXP$$US-GILEAD-2024-0673423$GILEAD$$63$YR$A$M$Y$$$20240830$$LW$US$US
238787277$23878727$7$F$20240620$20240913$20240521$20240918$30DAY$$US-PFIZER INC-202400107590$PFIZER$$15$YR$$M$Y$79.38$KG$20240918$$CN$US$US
238787362$23878736$2$F$20240516$20240801$20240521$20240805$PER$$US-AMGEN-USASP2024098355$AMGEN$$79$YR$E$M$Y$$$20240805$$CN$US$US
238787463$23878746$3$F$$20240819$20240521$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-078145$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240819$$PH$JP$JP
238787507$23878750$7$F$20240524$20240904$20240521$20240909$EXP$$CA-TAKEDA-2024TUS017017$TAKEDA$$70$YR$$F$Y$$$20240909$$CN$CA$CA
238787722$23878772$2$F$20240421$20240711$20240521$20240723$EXP$FR-AFSSAPS-LY2024000676$FR-TEVA-VS-3198820$TEVA$$28$YR$$F$Y$64$KG$20240723$$CN$FR$FR
238787985$23878798$5$F$20240514$20240925$20240521$20240930$30DAY$$JO-PFIZER INC-202400109111$PFIZER$$15$YR$$M$Y$$$20240930$$HP$JO$JO
238787997$23878799$7$F$20240514$20240829$20240521$20240904$30DAY$$GR-PFIZER INC-PV202400064135$PFIZER$$1$YR$$M$Y$6.3$KG$20240904$$CN$GR$GR
238788054$23878805$4$F$20240518$20240722$20240521$20240724$EXP$$US-SANDOZ INC.-SDZ2024US050528$SANDOZ$$69$YR$$F$Y$$$20240724$$HP$US$US
238788123$23878812$3$F$$20240625$20240521$20240704$EXP$GB-MHRA-ADR 28721894$GB-TEVA-VS-3199111$TEVA$$59$YR$$F$Y$47$KG$20240704$$CN$GB$GB
238788162$23878816$2$F$$20240501$20240521$20240801$PER$$US-TEVA-VS-3196703$TEVA$$$$$$Y$$$20240801$$HP$US$US
238788466$23878846$6$F$20190101$20240821$20240521$20240827$EXP$$US-009507513-2402USA008515$MERCK$$$$$M$Y$52.707$KG$20240827$$MD$US$US
238788477$23878847$7$F$20240501$20240812$20240521$20240818$EXP$$NVSC2024CA106523$NOVARTIS$$51$YR$$F$Y$$$20240818$$CN$CA$CA
238788493$23878849$3$F$20181031$20240814$20240521$20240815$EXP$$US-GILEAD-2024-0673449$GILEAD$$57$YR$A$M$Y$$$20240815$$LW$US$US
238788542$23878854$2$F$20240501$20240627$20240521$20240705$EXP$$US-ARGENX-2024-ARGX-US003226$ARGENX BVBA$$$$$$Y$$$20240705$$CN$US$US
238788554$23878855$4$F$$20240926$20240521$20240930$30DAY$$US-PFIZER INC-202400130367$PFIZER$$5$YR$$M$Y$$$20240930$$CN$US$US
238788922$23878892$2$F$$20240704$20240521$20240710$EXP$$JP-Eisai-EC-2024-165972$EISAI$$$$$F$Y$$$20240710$$MD$JP$JP
238789002$23878900$2$F$$20240510$20240521$20240812$PER$$US-LEO Pharma-370398$LEO PHARM$$76$YR$$M$Y$$$20240812$$CN$US$US
238789032$23878903$2$F$20240407$20240625$20240521$20240703$EXP$IT-MINISAL02-984051$IT-TEVA-VS-3199082$TEVA$$57$YR$$F$Y$$$20240703$$MD$IT$IT
238789092$23878909$2$F$20230715$20230908$20240521$20240903$EXP$$US-JNJFOC-20230923859$JOHNSON AND JOHNSON$$72$YR$E$M$Y$103$KG$20240903$$MD$US$US
238789127$23878912$7$F$20240423$20240912$20240521$20240919$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405007037$ELI LILLY AND CO$$65$YR$E$M$Y$55$KG$20240919$$CN$JP$JP
238789172$23878917$2$F$$20240913$20240521$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202405006837$ELI LILLY AND CO$$$$$F$Y$$$20240924$$CN$US$US
238789212$23878921$2$F$$20240815$20240521$20240827$PER$$US-INCYTE CORPORATION-2024IN005188$INCYTE$$$$$$Y$$$20240827$$CN$US$US
238789292$23878929$2$F$$20240715$20240521$20240716$PER$$US-ALXN-202405USA000784US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238789373$23878937$3$F$20240401$20240710$20240521$20240714$EXP$$US-ABBVIE-5766693$ABBVIE$$65$YR$$F$Y$$$20240714$$CN$US$US
238789422$23878942$2$F$20240501$20240904$20240521$20240912$EXP$$JP-AstraZeneca-2024A115862$ASTRAZENECA$$89$YR$$F$Y$36$KG$20240912$$MD$JP$
238789716$23878971$6$F$20240311$20240909$20240521$20240923$EXP$$JP-UROVANT SCIENCES GMBH-202405-URV-000707$SUNOVION$$$$$$Y$$$20240923$$MD$JP$JP
238789795$23878979$5$F$20240502$20240820$20240521$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072850$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240820$$CN$US$US
238790132$23879013$2$F$20240214$20240625$20240521$20240701$EXP$$FR-DSJP-DSE-2024-118283$DAIICHI$$63$YR$$F$Y$56$KG$20240701$$MD$FR$FR
238790303$23879030$3$F$$20240913$20240521$20240921$EXP$$JP-009507513-2405JPN001510J$MERCK$Tsukuda H, Tsuya A, Okabe T, Oota Y, Sakaguchi H, Fukuoka M. P73-8 CUP successfully treated with lenvatinib and pembrolizumab based on IHC and multi -gene panel testing: a case report. 2024 the Japanese Society of Medical Oncology Annual Meeting$54$YR$$F$Y$$$20240921$$MD$JP$JP
238790322$23879032$2$F$20210801$20240812$20240521$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-188156$BOEHRINGER INGELHEIM$$59$YR$A$M$Y$75$KG$20240813$$CN$ES$ES
238790332$23879033$2$F$20240101$20240712$20240521$20240717$EXP$$US-Eisai-EC-2024-166035$EISAI$$63$YR$A$F$Y$$$20240717$$CN$US$US
238792812$23879281$2$F$20240501$20240913$20240521$20240917$30DAY$$AR-PFIZER INC-202400100704$PFIZER$$10$YR$$F$Y$$$20240917$$HP$AR$AR
238792842$23879284$2$F$$20240812$20240521$20240814$30DAY$$CL-PFIZER INC-PV202400060546$PFIZER$$$$$F$Y$$$20240814$$CN$CL$CL
238792853$23879285$3$F$$20240812$20240521$20240816$30DAY$$AU-PFIZER INC-PV202400058429$PFIZER$$$$$$Y$$$20240816$$PH$AU$AU
238793202$23879320$2$F$20231201$20240729$20240521$20240731$EXP$$AU-UCBSA-2024023867$UCB$$79$YR$$F$Y$$$20240731$$CN$AU$AU
238793982$23879398$2$F$20240101$20240618$20240521$20240702$EXP$$CA-RIGEL PHARMACEUTICALS, INC.-2022FOS000633$RIGEL PHARMACEUTICALS$$60$YR$$F$Y$$$20240702$$PH$CA$CA
238794153$23879415$3$F$$20240717$20240521$20240719$PER$$US-PFIZER INC-PV202400064862$PFIZER$$70$YR$$M$Y$$$20240719$$CN$US$US
238794572$23879457$2$F$$20240912$20240521$20240913$30DAY$$CL-PFIZER INC-202400172404$PFIZER$$$$$$Y$$$20240913$$CN$CL$CL
238794666$23879466$6$F$20240510$20240917$20240521$20240924$30DAY$$US-PFIZER INC-202400125109$PFIZER$$14$YR$$M$Y$56.47$KG$20240924$$CN$US$US
238794676$23879467$6$F$$20240904$20240521$20240910$EXP$$CA-TAKEDA-2024TUS029470$TAKEDA$$$$$M$Y$$$20240910$$CN$CA$CA
238794772$23879477$2$F$20240526$20240626$20240521$20240702$EXP$$CH-MYLANLABS-2024M1044850$MYLAN$$$$A$M$Y$$$20240702$$PH$CH$CH
238794802$23879480$2$F$$20240626$20240521$20240703$EXP$$US-SA-2024SA151033$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
238794882$23879488$2$F$20220930$20240705$20240521$20240716$EXP$$JP-ROCHE-3565842$ROCHE$$61$YR$A$M$Y$72$KG$20240716$$MD$JP$JP
238795162$23879516$2$F$20240506$20240711$20240521$20240715$PER$$US-PFIZER INC-202400171678$PFIZER$$44$YR$$F$Y$$$20240715$$HP$US$US
238795202$23879520$2$F$$20240718$20240521$20240722$PER$$US-PFIZER INC-PV202400065385$PFIZER$$54$YR$$F$Y$$$20240722$$CN$US$US
238795245$23879524$5$F$20240513$20240909$20240521$20240911$30DAY$$JO-PFIZER INC-202400108212$PFIZER$$$$$$Y$$$20240911$$CN$JO$JO
238795262$23879526$2$F$$20240627$20240521$20240701$PER$$US-PFIZER INC-PV202400066029$PFIZER$$96$YR$$F$Y$$$20240701$$HP$US$US
238795272$23879527$2$F$20240501$20240628$20240521$20240703$PER$$US-PFIZER INC-202400172327$PFIZER$$69$YR$$F$Y$71.67$KG$20240703$$HP$US$US
238795372$23879537$2$F$$20240807$20240521$20240809$PER$$US-PFIZER INC-PV202400066050$PFIZER$$85$YR$$F$Y$$$20240809$$HP$US$US
238795623$23879562$3$F$20230215$20240715$20240521$20240722$EXP$$ES-ORGANON-O2405ESP001456$ORGANON$$30$YR$$F$Y$$$20240722$$MD$ES$ES
238795662$23879566$2$F$$20240719$20240521$20240722$EXP$$NVSC2024PR106461$NOVARTIS$$69$YR$$F$Y$$$20240722$$CN$PR$PR
238795753$23879575$3$F$20240101$20240702$20240521$20240705$EXP$$US-SA-2024SA150854$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240705$$CN$US$US
238795983$23879598$3$F$20240430$20240716$20240521$20240716$PER$$US-ALXN-202405USA000877US$ALEXION PHARMACEUTICALS$$66$YR$$F$Y$$$20240716$$CN$US$US
238795992$23879599$2$F$$20240705$20240521$20240725$PER$$US-TEVA-VS-3195571$TEVA$$84$YR$$F$Y$$$20240725$$CN$US$US
238796572$23879657$2$F$20230825$20240711$20240521$20240711$EXP$$DK-Integrated Therapeutic Solutions Inc.-2157259$Integrated Therapeutic Solutions$$30$YR$$M$Y$$$20240711$$$DE$DE
238796702$23879670$2$F$$20240709$20240521$20240710$EXP$$US-JNJFOC-20240379987$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240710$$CN$US$US
238796713$23879671$3$F$$20240712$20240521$20240718$PER$$US-JNJFOC-20240556032$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$CN$US$US
238796772$23879677$2$F$$20240705$20240521$20240712$EXP$$IE-TAKEDA-2024TUS048784$TAKEDA$$3$DEC$$F$Y$$$20240712$$CN$IE$IE
238796783$23879678$3$F$20090512$20240816$20240521$20240819$PER$$US-GILEAD-2024-0673475$GILEAD$$41$YR$A$M$Y$$$20240819$$LW$US$US
238796822$23879682$2$F$20240101$20240809$20240521$20240813$EXP$$US-ABBVIE-5766749$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
238796844$23879684$4$F$$20240703$20240521$20240712$30DAY$$US-ROCHE-3332889$ROCHE$$17$YR$T$M$Y$$$20240712$$MD$US$US
238796874$23879687$4$F$20240101$20240830$20240521$20240905$PER$$US-VERTEX PHARMACEUTICALS-2024-008279$VERTEX$$$$$F$Y$$$20240905$$CN$US$US
238796944$23879694$4$F$20240512$20240708$20240521$20240710$EXP$$DE-MYLANLABS-2024M1045534$MYLAN$$$$$F$Y$$$20240710$$CN$DE$DE
238797154$23879715$4$F$20231001$20240911$20240521$20240916$EXP$$US-ASTELLAS-2024US005423$ASTELLAS$$62$YR$A$F$Y$$$20240916$$HP$US$US
238797263$23879726$3$F$20230901$20240718$20240521$20240902$PER$$US-ASTELLAS-2024US005420$ASTELLAS$$59$YR$A$F$Y$$$20240830$$HP$US$US
238797453$23879745$3$F$20240409$20240620$20240521$20240902$PER$$US-ASTELLAS-2024US010903$ASTELLAS$$47$YR$A$F$Y$$$20240830$$MD$US$US
238797463$23879746$3$F$20240301$20240522$20240521$20240902$PER$$US-ASTELLAS-2024US011238$ASTELLAS$$54$YR$A$F$Y$$$20240830$$MD$US$US
238797473$23879747$3$F$20240130$20240513$20240521$20240902$PER$$US-ASTELLAS-2024US010247$ASTELLAS$$5$DEC$A$F$Y$$$20240830$$MD$US$US
238797503$23879750$3$F$20240301$20240517$20240521$20240902$PER$$US-ASTELLAS-2024US013736$ASTELLAS$$79$YR$E$F$Y$$$20240830$$HP$US$US
238797603$23879760$3$F$$20240625$20240521$20240902$PER$$US-ASTELLAS-2024US009068$ASTELLAS$$55$YR$A$F$Y$$$20240830$$CN$US$US
238797643$23879764$3$F$20240401$20240513$20240521$20240902$PER$$US-ASTELLAS-2024US010654$ASTELLAS$$66$YR$E$F$Y$$$20240830$$CN$US$US
238797793$23879779$3$F$20240301$20240516$20240521$20240902$PER$$US-ASTELLAS-2024US008606$ASTELLAS$$61$YR$A$F$Y$$$20240830$$CN$US$US
238798035$23879803$5$F$$20240816$20240521$20240822$EXP$$DE-MYLANLABS-2024M1044660$MYLAN$$49$YR$$F$Y$61$KG$20240822$$CN$DE$DE
238798153$23879815$3$F$20240401$20240723$20240521$20240902$PER$$US-ASTELLAS-2024US012723$ASTELLAS$$55$YR$A$F$Y$$$20240830$$CN$US$US
238798293$23879829$3$F$20240210$20240524$20240521$20240902$PER$$US-ASTELLAS-2024US012942$ASTELLAS$$$$$F$Y$$$20240830$$CN$US$US
238798383$23879838$3$F$20240201$20240530$20240521$20240902$PER$$US-ASTELLAS-2024US012621$ASTELLAS$$78$YR$E$F$Y$$$20240830$$CN$US$US
238798413$23879841$3$F$20240402$20240718$20240521$20240902$PER$$US-ASTELLAS-2024US012828$ASTELLAS$$65$YR$E$F$Y$$$20240830$$CN$US$US
238798473$23879847$3$F$20231001$20240729$20240521$20240902$PER$$US-ASTELLAS-2024US011442$ASTELLAS$$77$YR$E$F$Y$$$20240830$$HP$US$US
238798513$23879851$3$F$20240625$20240828$20240521$20240906$EXP$$PK-AMRYT PHARMACEUTICALS DAC-AEGR007133$AEGERION$$$$$$Y$$$20240906$$MD$PK$PK
238798584$23879858$4$F$20240313$20240813$20240521$20240815$EXP$$US-PFIZER INC-202400125066$PFIZER$$76$YR$$F$Y$42.63$KG$20240815$$MD$US$US
238798683$23879868$3$F$20240518$20240702$20240521$20240704$PER$$US-PFIZER INC-202400172437$PFIZER$$67$YR$$F$Y$68.707$KG$20240704$$CN$US$US
238798813$23879881$3$F$20240101$20240830$20240521$20240904$EXP$$CA-JNJFOC-20240349755$JOHNSON AND JOHNSON$$50$YR$A$F$Y$41$KG$20240904$$HP$CA$CA
238798853$23879885$3$F$20240429$20240626$20240521$20240821$EXP$IT-MINISAL02-984912$IT-BAYER-2024A074009$BAYER$$45$YR$A$M$Y$74$KG$20240821$$PH$IT$IT
238798914$23879891$4$F$20240520$20240917$20240521$20240920$PER$$US-AMGEN-USASP2024099929$AMGEN$$88$YR$E$F$Y$$$20240919$$PH$US$US
238799062$23879906$2$F$20240101$20240820$20240521$20240820$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-077636$BRISTOL MYERS SQUIBB$$52$YR$A$$Y$$$20240820$$MD$CH$CH
238799102$23879910$2$F$$20240912$20240521$20240916$EXP$$NVSC2024AU106584$NOVARTIS$$$$$F$Y$$$20240916$$HP$AU$AU
238799183$23879918$3$F$20240501$20240719$20240521$20240724$PER$$US-PFIZER INC-PV202400064981$PFIZER$$2$YR$$M$Y$12.245$KG$20240724$$CN$US$US
238799202$23879920$2$F$$20240701$20240521$20240703$30DAY$$AU-PFIZER INC-202400108863$PFIZER$$8$DEC$$F$Y$$$20240703$$CN$AU$AU
238799212$23879921$2$F$$20240711$20240521$20240716$30DAY$$JP-PFIZER INC-202400171784$PFIZER$$$$$$Y$$$20240716$$MD$JP$JP
238799227$23879922$7$F$20240501$20240815$20240521$20240819$30DAY$$CA-PFIZER INC-202400120865$PFIZER$$80$YR$$F$Y$66.213$KG$20240819$$MD$CA$CA
238799303$23879930$3$F$20240101$20240917$20240521$20240927$EXP$$US-INSMED, INC.-2024-01949-US$INSMED$$$$$F$Y$$$20240927$$CN$US$US
238799323$23879932$3$F$20240129$20240711$20240521$20240716$EXP$$GB-MYLANLABS-2024M1009493$MYLAN$$68$YR$$F$Y$$$20240716$$MD$GB$GB
238799332$23879933$2$F$$20240711$20240521$20240722$EXP$$JP-ROCHE-3567237$ROCHE$$8$DEC$E$$Y$$$20240722$$MD$JP$JP
238799342$23879934$2$F$$20240624$20240521$20240701$EXP$$GB-MYLANLABS-2024M1045067$MYLAN$$$$$F$Y$63.8$KG$20240701$$CN$GB$GB
238799382$23879938$2$F$20190703$20240821$20240521$20240827$PER$$US-GILEAD-2024-0673548$GILEAD$$54$YR$A$M$Y$$$20240827$$LW$US$US
238799524$23879952$4$F$$20240614$20240521$20240701$30DAY$$JP-JNJFOC-20240517408$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$MD$JP$JP
238799552$23879955$2$F$20240520$20240702$20240521$20240703$PER$$US-JNJFOC-20240557757$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240703$$PH$US$US
238799702$23879970$2$F$$20240808$20240521$20240812$EXP$$US-ABBVIE-5764978$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
238799712$23879971$2$F$$20240710$20240521$20240715$EXP$$CA-TAKEDA-2022TUS045307$TAKEDA$$$$$F$Y$$$20240715$$MD$CA$CA
238799872$23879987$2$F$20240101$20240828$20240521$20240904$EXP$$JP-009507513-2405JPN001235J$MERCK$$63$YR$$F$Y$$$20240904$$MD$JP$JP
238800172$23880017$2$F$20230710$20240719$20240521$20240724$EXP$$NVSC2024US105917$NOVARTIS$$48$YR$$F$Y$$$20240724$$MD$US$US
238800302$23880030$2$F$$20240730$20240521$20240731$EXP$FI-EMA-DD-20201125-kumarvn_p-104556$FI-SANDOZ INC.-NVSC2020FI309314$SANDOZ$$23$YR$$F$Y$$$20240731$$MD$FI$FI
238800343$23880034$3$F$20171103$20240731$20240521$20240801$PER$$US-GILEAD-2024-0673631$GILEAD$$55$YR$A$M$Y$$$20240801$$LW$US$US
238800513$23880051$3$F$$20240916$20240521$20240923$EXP$$IT-ROCHE-3564760$ROCHE$Elice F, Sommaggio R, Cappuzzello E, Riva M, Tisi M, Bernardi M, Bozza A, Catanzaro D, Chieregato K, Merlo A, Giaretta I, Pieta A, Krampera M, Visco C, Trentin L, Visentin A, Tosetto A, Astori G and Rosato A. A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report. DOI: 10.3324/haematol.2023.284881. Haematologica 2024 May 09;:1-6.$59$YR$A$F$Y$$$20240923$$HP$IT$IT
238800592$23880059$2$F$20240409$20240725$20240521$20240730$EXP$$JP-AstraZeneca-2024A115379$ASTRAZENECA$$68$YR$$F$Y$$$20240730$$MD$JP$
238800632$23880063$2$F$$20240710$20240521$20240710$30DAY$$FR-PFIZER INC-202400108155$PFIZER$$3$YR$$F$Y$$$20240710$$CN$FR$FR
238800722$23880072$2$F$$20240516$20240521$20240723$EXP$$US-APELLIS-APL-2023-002800$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
238801122$23880112$2$F$20231101$20240717$20240521$20240826$PER$$US-GALDERMA-US2024007085$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
238801132$23880113$2$F$$20240707$20240521$20240806$PER$$US-GALDERMA-US2024007722$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
238801632$23880163$2$F$$20240604$20240521$20240806$PER$$US-GALDERMA-US2024007381$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
238802002$23880200$2$F$$20240709$20240521$20240715$EXP$$JP-009507513-2405JPN001092J$MERCK$$65$YR$$M$Y$$$20240715$$MD$JP$JP
238802052$23880205$2$F$$20240806$20240521$20240817$EXP$$AU-ROCHE-3566938$ROCHE$$$$A$F$Y$$$20240817$$CN$AU$AU
238802154$23880215$4$F$20240101$20240905$20240521$20240906$PER$$US-AMGEN-USASP2024099530$AMGEN$$45$YR$A$F$Y$$$20240906$$HP$US$US
238802204$23880220$4$F$20240228$20240730$20240521$20240802$EXP$$FI-MYLANLABS-2024M1045928$MYLAN$$16$YR$$F$Y$$$20240802$$MD$FI$FI
238802653$23880265$3$F$$20240629$20240521$20240704$EXP$$NVSC2024US103973$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
238802933$23880293$3$F$20240507$20240716$20240521$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202405007528$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240726$$MD$US$US
238803213$23880321$3$F$20240301$20240815$20240521$20240820$EXP$$TR-ABBVIE-5765432$ABBVIE$$74$YR$$F$Y$$$20240820$$CN$TR$TR
238803392$23880339$2$F$$20240910$20240521$20240912$PER$$US-BIOGEN-2024BI01265479$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
238803454$23880345$4$F$20240101$20240629$20240521$20240702$PER$$US-Eisai-EC-2024-163398$EISAI$$63$YR$A$F$Y$$$20240702$$CN$US$US
238803462$23880346$2$F$$20240711$20240521$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074607$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240718$$CN$US$US
238803504$23880350$4$F$$20240709$20240521$20240905$EXP$$NVSC2024FR105933$NOVARTIS$$46$YR$$F$Y$$$20240905$$MD$FR$FR
238803552$23880355$2$F$$20240731$20240521$20240806$EXP$$CA-PURDUE-USA-2024-0309686$PURDUE$$44$YR$$F$Y$$$20240806$$HP$CA$CA
238803603$23880360$3$F$20240101$20240826$20240521$20240906$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000080$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240906$$CN$US$US
238803962$23880396$2$F$20240101$20240731$20240521$20240807$EXP$$US-SA-2024SA152183$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240807$$MD$US$US
238804242$23880424$2$F$20220101$20240731$20240521$20240807$EXP$$JP-009507513-2404JPN000430J$MERCK$$80$YR$$M$Y$39$KG$20240807$$MD$JP$JP
238804523$23880452$3$F$20240516$20240828$20240521$20240830$PER$$US-AMGEN-USASP2024099288$AMGEN$$72$YR$E$F$Y$$$20240829$$CN$US$US
238804624$23880462$4$F$20230316$20240624$20240521$20240702$EXP$$JP-AstraZeneca-2024A116243$ASTRAZENECA$$61$YR$$F$Y$$$20240702$$MD$JP$
238804832$23880483$2$F$20240513$20240731$20240521$20240805$EXP$$JP-009507513-2405JPN001878J$MERCK$$8$DEC$$M$Y$$$20240805$$MD$JP$JP
238804852$23880485$2$F$20220711$20240723$20240521$20240802$EXP$$BR-BIOCON-BCN-2022-000916$BIOCON$$$$$$Y$$$20240802$$HP$BR$BR
238805263$23880526$3$F$20240502$20240603$20240521$20240703$PER$$US-AstraZeneca-2024A106993$ASTRAZENECA$$87$YR$$M$Y$84.4$KG$20240703$$CN$US$
238805752$23880575$2$F$20240507$20240621$20240521$20240704$PER$$US-JNJFOC-20240523418$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240705$$CN$US$US
238805812$23880581$2$F$$20240717$20240521$20240718$PER$$US-PFIZER INC-PV202400065721$PFIZER$$56$YR$$F$Y$$$20240718$$PH$US$US
238805852$23880585$2$F$$20240708$20240521$20240711$PER$$US-PFIZER INC-202400172483$PFIZER$$60$YR$$M$Y$$$20240711$$HP$US$US
238805953$23880595$3$F$20240101$20240913$20240521$20240917$PER$$US-PFIZER INC-202400130399$PFIZER$$43$YR$$F$Y$$$20240917$$MD$US$US
238806112$23880611$2$F$20240529$20240821$20240521$20240829$EXP$$US-GSK-US2024AMR061972$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$HP$US$US
238806294$23880629$4$F$20240513$20240911$20240521$20240913$30DAY$$US-PFIZER INC-202400125163$PFIZER$$12$YR$$M$Y$$$20240913$$CN$US$US
2388063210$23880632$10$F$20240509$20240925$20240521$20240930$EXP$$IT-PFIZER INC-PV202400064689$PFIZER$$46$YR$$M$Y$74$KG$20240930$$HP$IT$IT
238806463$23880646$3$F$20240401$20240709$20240521$20240711$EXP$$US-PFIZER INC-202400132114$PFIZER$$34$YR$$F$Y$84.717$KG$20240711$$HP$US$US
238806523$23880652$3$F$20240401$20240718$20240521$20240723$30DAY$$JP-PFIZER INC-PV202400063664$PFIZER$$$$$F$Y$$$20240723$$CN$JP$JP
238806612$23880661$2$F$20231207$20240713$20240521$20240715$EXP$$CA-PFIZER INC-202300310871$PFIZER$$64$YR$$F$Y$$$20240715$$MD$CA$CA
238806703$23880670$3$F$20240501$20240521$20240521$20240708$PER$$US-AMGEN-USASP2024100000$AMGEN$$77$YR$E$F$Y$$$20240707$$CN$US$US
238807112$23880711$2$F$$20240714$20240521$20240724$EXP$$US-JNJFOC-20240239406$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$MD$US$US
238807392$23880739$2$F$20240507$20240820$20240521$20240830$EXP$$US-BAYER-2024A071888$BAYER$$21$YR$A$M$Y$$$20240830$$CN$US$US
238807503$23880750$3$F$$20240729$20240521$20240805$30DAY$$US-GSK-US2024061330$GLAXOSMITHKLINE$$$$$M$Y$$$20240805$$CN$US$US
238807552$23880755$2$F$$20240711$20240521$20240716$30DAY$$US-GSK-US2024062466$GLAXOSMITHKLINE$$$$$F$Y$$$20240716$$CN$US$US
238807592$23880759$2$F$20210623$20240827$20240521$20240902$PER$$US-GILEAD-2024-0673611$GILEAD$$39$YR$A$F$Y$$$20240902$$LW$US$US
238807662$23880766$2$F$$20240916$20240521$20240918$PER$$US-PFIZER INC-202400172484$PFIZER$$16$YR$$M$Y$$$20240918$$CN$US$US
238807703$23880770$3$F$$20240712$20240521$20240716$PER$$US-PFIZER INC-PV202400065457$PFIZER$$75$YR$$M$Y$$$20240716$$HP$US$US
238807782$23880778$2$F$$20240912$20240521$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202405011146$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240917$$CN$US$US
238807834$23880783$4$F$20240418$20240805$20240521$20240808$EXP$$BE-ABBVIE-5762982$ABBVIE$$79$YR$$M$Y$80$KG$20240808$$MD$BE$BE
238807914$23880791$4$F$$20240827$20240521$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-076541$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240828$$MD$JP$JP
238807982$23880798$2$F$$20240708$20240521$20240711$30DAY$$US-GSK-US2024AMR062322$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
238807994$23880799$4$F$20240613$20240614$20240521$20240925$PER$$US-GSK-US2024AMR062067$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$CN$US$US
238808312$23880831$2$F$20240518$20240731$20240521$20240802$PER$$US-AMGEN-USASP2024099948$AMGEN$$53$YR$A$M$Y$$$20240802$$CN$US$US
238808362$23880836$2$F$20240101$20240627$20240521$20240702$EXP$$FR-ORGANON-O2405FRA001535$ORGANON$$16$YR$$F$Y$$$20240702$$CN$FR$FR
238808383$23880838$3$F$$20240828$20240521$20240904$EXP$$US-GSK-US2024AMR062577$GLAXOSMITHKLINE$$$$$F$Y$54.43$KG$20240904$$CN$US$US
238808602$23880860$2$F$20240512$20240715$20240521$20240716$PER$$US-ALXN-202405USA000810US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
238808622$23880862$2$F$20240101$20240805$20240521$20240807$EXP$$US-ABBVIE-5765892$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
238808942$23880894$2$F$$20230802$20240521$20240701$EXP$$US-NOVOPROD-1202925$NOVO NORDISK$$$$$F$Y$$$20240701$$CN$US$US
238809072$23880907$2$F$$20240705$20240521$20240705$PER$$NVSC2024US106955$NOVARTIS$$$$$$Y$$$20240705$$MD$US$US
238809153$23880915$3$F$20240507$20240702$20240521$20240709$EXP$$TR-JNJFOC-20240524452$JOHNSON AND JOHNSON$$$$$F$Y$60$KG$20240709$$MD$TR$TR
238809342$23880934$2$F$$20240805$20240521$20240811$EXP$$JP-009507513-2405JPN001914J$MERCK$$64$YR$$$Y$$$20240811$$MD$JP$JP
238809513$23880951$3$F$$20240705$20240521$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078378$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$71.21$KG$20240705$$CN$US$US
238809552$23880955$2$F$20240503$20240820$20240521$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074710$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$71.12$KG$20240820$$HP$US$US
238809822$23880982$2$F$$20240731$20240521$20240731$PER$$NVSC2024US106998$NOVARTIS$$$$$M$Y$$$20240731$$CN$US$US
238809944$23880994$4$F$20230101$20240711$20240521$20240716$EXP$$US-ABBVIE-5767828$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
238809952$23880995$2$F$$20240626$20240521$20240701$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-09807$IPSEN$$$$$M$Y$$$20240701$$MD$CA$CA
238810232$23881023$2$F$$20240712$20240521$20240719$EXP$$NVSC2024VN105081$NOVARTIS$$43$YR$$F$Y$$$20240719$$MD$VN$VN
238810502$23881050$2$F$$20240704$20240521$20240704$PER$$NVSC2024US107064$NOVARTIS$$$$$M$Y$$$20240704$$HP$US$US
238810832$23881083$2$F$$20240621$20240521$20240703$30DAY$$US-JNJFOC-20240545410$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$US$US
238811253$23881125$3$F$$20240809$20240521$20240823$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-447321$RANBAXY$Rusu C, Cernat MC, Ionescu DM, Berghea EC. NERD diagnosis ? a challenge in the pediatric population. Alergologia. 2024;VIII, No. 1:51$11$YR$$F$Y$$$20240823$$HP$RO$RO
238811302$23881130$2$F$$20240829$20240521$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446996$RANBAXY$$84$YR$$M$Y$$$20240913$$HP$AU$AU
238811504$23881150$4$F$$20240704$20240521$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447112$RANBAXY$Bussan E, Can A. A Small Price to Pay to Avoid the Intensive Care Unit for Methimazole Induced Agranulocytosis. Endocr Pract. 2024;30 (Suppl.) (5):S156, 1705897$36$YR$$F$Y$$$20240719$$HP$US$US
238811602$23881160$2$F$20240109$20240829$20240521$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447176$RANBAXY$$62$YR$$M$Y$$$20240913$$HP$AU$AU
238811772$23881177$2$F$20240101$20240624$20240521$20240703$PER$$US-Eisai-EC-2024-164321$EISAI$$59$YR$A$M$Y$$$20240703$$CN$US$US
238811802$23881180$2$F$$20240719$20240521$20240723$EXP$$US-TAKEDA-2022TUS060850$TAKEDA$$$$$F$Y$$$20240723$$MD$US$US
238811822$23881182$2$F$20240101$20240801$20240521$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076877$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240802$$CN$US$US
238812162$23881216$2$F$$20240618$20240521$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446864$RANBAXY$-. -. -. -;-:-$79$YR$$M$Y$72.608$KG$20240703$$MD$US$US
238812702$23881270$2$F$$20240729$20240521$20240730$EXP$$IE-PFIZER INC-202400011248$PFIZER$$$$E$$Y$71.2$KG$20240730$$MD$IE$IE
238812812$23881281$2$F$20240110$20240716$20240521$20240719$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-121427$DAIICHI$$50$YR$$M$Y$$$20240719$$MD$US$US
238812822$23881282$2$F$$20240704$20240521$20240704$PER$$NVSC2024US106235$NOVARTIS$$$$$$Y$$$20240705$$PH$US$US
238813012$23881301$2$F$20240501$20240814$20240521$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079154$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240820$$CN$US$US
238813103$23881310$3$F$$20240912$20240521$20240918$EXP$$CA-TAKEDA-2024TUS049589$TAKEDA$$$$$M$Y$$$20240918$$CN$CA$CA
238813193$23881319$3$F$$20240813$20240521$20240828$EXP$$CA-HLS-202401199$HLS THERAPEUTICS$$56$YR$A$F$Y$$$20240828$$MD$CA$CA
238813202$23881320$2$F$$20240711$20240521$20240716$PER$$US-Taiho Oncology Inc-2024-004983$TAIHO ONCOLOGY INC$$85$YR$E$M$Y$79.38$KG$20240716$$CN$US$US
238813372$23881337$2$F$$20240626$20240521$20240702$EXP$$FR-MYLANLABS-2024M1044715$MYLAN$Lagreula M, Waultier-Rascalou A, Coget E, Delannoy V, Chiriac A.M, Demoly P et.al... Hypersensitivityand drug-induced allergy session. French Journal of Allergology. 2024;64 (S):13$65$YR$$F$Y$$$20240702$$MD$FR$FR
238813475$23881347$5$F$20231101$20240619$20240521$20240704$EXP$$DE-ROCHE-3563074$ROCHE$$37$YR$A$F$Y$62$KG$20240704$$MD$DE$DE
238813863$23881386$3$F$$20240820$20240521$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078718$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240824$$CN$US$US
238814493$23881449$3$F$20240601$20240829$20240521$20240904$EXP$$US-PFIZER INC-202400172576$PFIZER$$80$YR$$M$Y$74.84$KG$20240904$$CN$US$US
238814522$23881452$2$F$$20240621$20240521$20240702$PER$$US-ALKERMES INC.-ALK-2024-001354$ALKERMES$$$$$M$Y$$$20240702$$PH$US$US
238814582$23881458$2$F$20240101$20240701$20240521$20240703$PER$$US-Eisai-EC-2024-165944$EISAI$$54$YR$A$F$Y$$$20240703$$CN$US$US
238814683$23881468$3$F$20220101$20240722$20240521$20240821$EXP$$JP-AstraZeneca-2024A115408$ASTRAZENECA$$$$$F$Y$$$20240821$$MD$JP$
238814692$23881469$2$F$$20240610$20240521$20240705$PER$$US-AstraZeneca-2024A097883$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
238814754$23881475$4$F$20231201$20240722$20240521$20240722$EXP$IT-MINISAL02-985397$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-028838$BOEHRINGER INGELHEIM$$85$YR$E$F$Y$54$KG$20240722$$CN$IT$IT
238814817$23881481$7$F$20240101$20240917$20240521$20240924$EXP$$US-KARYOPHARM-2024KPT000966$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240924$$CN$US$US
238814822$23881482$2$F$$20240702$20240521$20240711$EXP$$JP-009507513-2405JPN001681J$MERCK$$74$YR$$M$Y$$$20240711$$MD$JP$JP
238815142$23881514$2$F$$20240607$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001377$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240722$$CN$US$US
238815152$23881515$2$F$$20240515$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001381$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240722$$CN$US$US
238815182$23881518$2$F$$20240503$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001386$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240722$$CN$US$US
238815272$23881527$2$F$$20240703$20240521$20240704$PER$$NVSC2024US106260$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
238815313$23881531$3$F$20240101$20240729$20240521$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078361$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240730$$HP$US$US
238815592$23881559$2$F$20240401$20240701$20240521$20240710$PER$$US-SA-2024SA146776$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240710$$MD$US$US
238815622$23881562$2$F$20240101$20240816$20240521$20240829$PER$$US-SA-2024SA146461$SANOFI AVENTIS$$32$YR$A$M$Y$69$KG$20240829$$MD$US$US
238815662$23881566$2$F$$20240722$20240521$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202405008657$ELI LILLY AND CO$$35$YR$A$F$Y$113.38$KG$20240726$$CN$US$US
238815762$23881576$2$F$20240101$20240729$20240521$20240807$PER$$US-SA-2024SA146318$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240807$$MD$US$US
238815773$23881577$3$F$$20240709$20240521$20240718$PER$$US-SA-2023SA163908$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240718$$MD$US$US
238815802$23881580$2$F$20191101$20240911$20240521$20240919$PER$$US-SA-2021SA289383$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240919$$MD$US$US
238816093$23881609$3$F$20231101$20240703$20240521$20240712$PER$$US-SA-2024SA045509$SANOFI AVENTIS$$13$YR$T$M$Y$67$KG$20240712$$CN$US$US
238816142$23881614$2$F$20240101$20240814$20240521$20240828$PER$$US-SA-2024SA148281$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240828$$MD$US$US
238816282$23881628$2$F$$20240814$20240521$20240828$PER$$US-SA-2024SA149574$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240828$$CN$US$US
238816352$23881635$2$F$$20240911$20240521$20240923$PER$$US-SA-2024SA147376$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240923$$MD$US$US
238816392$23881639$2$F$20240101$20240716$20240521$20240724$PER$$US-SA-2024SA149080$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240724$$MD$US$US
238816463$23881646$3$F$$20240715$20240521$20240718$PER$$US-SA-2024SA149537$SANOFI AVENTIS$$$$A$M$Y$$$20240718$$MD$US$US
238816582$23881658$2$F$20230101$20240806$20240521$20240816$PER$$US-SA-2024SA150734$SANOFI AVENTIS$$44$YR$A$M$Y$90.71$KG$20240816$$MD$US$US
238816633$23881663$3$F$20240101$20240828$20240521$20240904$PER$$US-SA-2024SA149202$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240904$$MD$US$US
238816662$23881666$2$F$$20240801$20240521$20240813$PER$$US-SA-2024SA150960$SANOFI AVENTIS$$$$E$F$Y$76.19$KG$20240814$$MD$US$US
238816692$23881669$2$F$$20240814$20240521$20240828$PER$$US-SA-2024SA149468$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240828$$MD$US$US
238816782$23881678$2$F$20240701$20240731$20240521$20240808$PER$$US-SA-2024SA151730$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240808$$MD$US$US
238816792$23881679$2$F$$20240514$20240521$20240909$PER$$US-SA-2024SA149412$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240909$$MD$US$US
238816822$23881682$2$F$$20240820$20240521$20240910$PER$$US-SA-2024SA019379$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240910$$MD$US$US
238816985$23881698$5$F$20240101$20240716$20240521$20240722$EXP$$US-SA-2024SA151766$SANOFI AVENTIS$$31$YR$A$F$Y$83.46$KG$20240722$$MD$US$US
238817042$23881704$2$F$20240101$20240712$20240521$20240722$PER$$US-SA-2024SA151773$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240722$$MD$US$US
238817142$23881714$2$F$20240101$20240628$20240521$20240703$PER$$US-SA-2024SA149557$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240703$$MD$US$US
238817363$23881736$3$F$20240501$20240624$20240521$20240703$PER$$US-SA-2024SA149129$SANOFI AVENTIS$$45$YR$A$F$Y$83.91$KG$20240703$$MD$US$US
238817382$23881738$2$F$20240701$20240826$20240521$20240918$PER$$US-SA-2024SA151891$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240918$$MD$US$US
238817604$23881760$4$F$20240507$20240905$20240521$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075032$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240909$$CN$US$US
238817623$23881762$3$F$20240101$20240712$20240521$20240717$PER$$US-SA-2024SA150228$SANOFI AVENTIS$$40$YR$A$M$Y$115$KG$20240717$$MD$US$US
238817922$23881792$2$F$$20240723$20240521$20240801$PER$$US-SA-2024SA152017$SANOFI AVENTIS$$$$A$M$Y$$$20240801$$MD$US$US
238817954$23881795$4$F$20240101$20240802$20240521$20240816$PER$$US-SA-2024SA151525$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240816$$MD$US$US
238818213$23881821$3$F$$20240710$20240521$20240711$EXP$$ES-ALXN-202405EEA000908ES$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240711$$MD$ES$ES
238818233$23881823$3$F$20240513$20240724$20240521$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078322$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240805$$CN$US$US
238818303$23881830$3$F$20240501$20240921$20240521$20240925$EXP$$IN-PFIZER INC-PV202400065733$PFIZER$$64$YR$$M$Y$$$20240925$$CN$IN$IN
238818332$23881833$2$F$20240101$20240730$20240521$20240802$EXP$$US-PFIZER INC-202400131471$PFIZER$$50$YR$$F$Y$132$KG$20240802$$PH$US$US
238818432$23881843$2$F$20240307$20240819$20240521$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078525$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240820$$HP$US$US
238818463$23881846$3$F$$20240808$20240521$20240924$PER$$US-LUNDBECK-DKLU3078086$LUNDBECK$$$$$$Y$$$20240924$$CN$US$US
238818512$23881851$2$F$$20240730$20240521$20240830$PER$$US-SIGA Technologies, Inc.-2157273$SIGA TECHNOLOGIES$$30$YR$$M$Y$$$20240830$$MD$US$US
238818702$23881870$2$F$$20240611$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002664$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
238818712$23881871$2$F$20240101$20240528$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002682$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240718$$CN$US$US
238818742$23881874$2$F$20240101$20240611$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002684$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240718$$CN$US$US
238818752$23881875$2$F$20240331$20240516$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002232$STEMLINE THERAPEUTICS$$53$YR$E$F$Y$$$20240722$$CN$US$US
238818782$23881878$2$F$20240612$20240613$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002699$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240718$$CN$US$US
238818792$23881879$2$F$20240101$20240511$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002691$STEMLINE THERAPEUTICS$$52$YR$A$F$Y$$$20240718$$CN$US$US
238818813$23881881$3$F$20240318$20240622$20240521$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST002709$STEMLINE THERAPEUTICS$$40$YR$A$F$Y$101.7$KG$20240627$$CN$US$US
238818922$23881892$2$F$20240421$20240522$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002667$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
238818972$23881897$2$F$20240407$20240503$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002418$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
238818982$23881898$2$F$$20240508$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002432$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240718$$HP$US$US
238819032$23881903$2$F$20240401$20240521$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002665$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$CN$US$US
238819082$23881908$2$F$20240401$20240610$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002717$STEMLINE THERAPEUTICS$$48$YR$A$F$Y$$$20240718$$CN$US$US
238819152$23881915$2$F$20240413$20240507$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002447$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$CN$US$US
238819162$23881916$2$F$20240101$20240522$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002474$STEMLINE THERAPEUTICS$$45$YR$A$F$Y$$$20240718$$CN$US$US
238819232$23881923$2$F$20240512$20240612$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002497$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240718$$CN$US$US
238819332$23881933$2$F$$20240506$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002528$STEMLINE THERAPEUTICS$$78$YR$E$F$Y$$$20240718$$CN$US$US
238819342$23881934$2$F$$20240521$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002535$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
238819372$23881937$2$F$$20240514$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002454$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
238819392$23881939$2$F$20240414$20240528$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002467$STEMLINE THERAPEUTICS$$86$YR$E$F$Y$$$20240718$$CN$US$US
238819402$23881940$2$F$$20240516$20240521$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002493$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
238819704$23881970$4$F$$20240821$20240521$20240830$EXP$$CA-HLS-202401287$HLS THERAPEUTICS$$$$A$F$Y$$$20240830$$MD$CA$CA
238819783$23881978$3$F$20230409$20240531$20240521$20240711$EXP$$BR-LUNDBECK-DKLU3070338$LUNDBECK$$$$$$Y$$$20240711$$CN$BR$BR
238819912$23881991$2$F$$20240702$20240521$20240703$PER$$NVSC2024US107289$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
238819963$23881996$3$F$20230101$20240916$20240521$20240917$PER$$US-ALXN-A202311743$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
238820032$23882003$2$F$20240517$20240801$20240521$20240805$PER$$US-AMGEN-USASP2024099271$AMGEN$$67$YR$E$M$Y$$$20240805$$CN$US$US
238820042$23882004$2$F$$20240711$20240521$20240711$PER$$NVSC2024US103877$NOVARTIS$$$$$$Y$$$20240711$$CN$US$US
238820282$23882028$2$F$20240415$20240821$20240521$20240827$PER$$US-AMGEN-USASP2024098304$AMGEN$$40$YR$A$F$Y$$$20240827$$HP$US$US
238820334$23882033$4$F$20190101$20240913$20240521$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-076470$BRISTOL MYERS SQUIBB$$4$DEC$A$F$Y$$$20240927$$MD$JP$JP
238820362$23882036$2$F$20240401$20240708$20240521$20240712$EXP$$DE-ABBVIE-5767861$ABBVIE$$68$YR$$M$Y$85$KG$20240712$$MD$DE$DE
238820492$23882049$2$F$$20240701$20240521$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202405011100$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240703$$CN$US$US
238820632$23882063$2$F$$20240718$20240521$20240724$EXP$$JP-009507513-2405JPN001678J$MERCK$$68$YR$$F$Y$$$20240724$$MD$JP$JP
238820643$23882064$3$F$20160510$20240827$20240521$20240902$PER$$US-GILEAD-2024-0673636$GILEAD$$27$YR$A$M$Y$$$20240902$$LW$US$US
238820773$23882077$3$F$20240417$20240816$20240521$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-076635$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240816$$MD$JP$JP
238820792$23882079$2$F$$20240830$20240521$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078505$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240909$$HP$US$US
238820882$23882088$2$F$20240101$20240918$20240521$20240925$EXP$$JP-009507513-2402JPN002480J$MERCK$$9$DEC$$M$Y$$$20240925$$MD$JP$JP
238821044$23882104$4$F$20240301$20240904$20240521$20240911$EXP$$US-ABBVIE-5765465$ABBVIE$$71$YR$$F$Y$$$20240911$$CN$US$US
238821092$23882109$2$F$20180101$20240817$20240521$20240819$PER$$US-GILEAD-2024-0673522$GILEAD$$31$YR$A$M$Y$$$20240819$$LW$US$US
238821102$23882110$2$F$$20240926$20240521$20240927$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-075846$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240927$$MD$CA$CA
238821332$23882133$2$F$20240507$20240712$20240521$20240726$EXP$$CN-PFIZER INC-PV202400065183$PFIZER$$92$YR$$F$Y$55$KG$20240726$$HP$CN$CN
238821532$23882153$2$F$20240401$20240627$20240521$20240705$EXP$$JP-009507513-2405JPN001722J$MERCK$$7$DEC$$F$Y$$$20240705$$MD$JP$JP
238821804$23882180$4$F$$20240801$20240521$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-009912$UNITED THERAPEUTICS$$$$$F$Y$71.655$KG$20240807$$$US$US
238821852$23882185$2$F$$20240709$20240521$20240711$EXP$$US-BIOGEN-2024BI01265648$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
238821902$23882190$2$F$20240101$20240806$20240521$20240816$PER$$US-SA-2024SA152417$SANOFI AVENTIS$$75$YR$E$F$Y$60.3$KG$20240816$$MD$US$US
238822113$23882211$3$F$20210325$20240905$20240521$20240911$EXP$$US-ABBVIE-5761251$ABBVIE$$63$YR$$F$Y$108$KG$20240911$$CN$US$US
238822142$23882214$2$F$$20240808$20240521$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077683$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240812$$CN$US$US
238822182$23882218$2$F$20240101$20240702$20240522$20240704$EXP$$GB-ABBVIE-5765411$ABBVIE$$48$YR$$M$Y$76$KG$20240704$$MD$GB$GB
238822292$23882229$2$F$20240501$20240625$20240522$20240701$PER$$US-AMGEN-USASP2024098354$AMGEN$$63$YR$A$F$Y$$$20240630$$CN$US$US
238822304$23882230$4$F$$20240713$20240522$20240722$EXP$$NVSC2024BR107099$NOVARTIS$$$$$M$Y$$$20240722$$CN$BR$BR
238822312$23882231$2$F$20190101$20240903$20240522$20240909$EXP$$US-ABBVIE-4707209$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
238822423$23882242$3$F$20240501$20240920$20240522$20240924$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-077791$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$65.77$KG$20240924$$CN$PR$PR
238822512$23882251$2$F$20240101$20240721$20240522$20240724$EXP$$CA-UCBSA-2024024663$UCB$$$$$F$Y$$$20240724$$CN$CA$CA
238822542$23882254$2$F$$20240716$20240522$20240722$EXP$$CA-UCBSA-2024024658$UCB$$$$$M$Y$$$20240719$$MD$CA$CA
238822682$23882268$2$F$20210101$20240805$20240522$20240808$EXP$$US-ABBVIE-5761067$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
238822713$23882271$3$F$20240101$20240628$20240522$20240705$EXP$$PT-ABBVIE-5618710$ABBVIE$$77$YR$$M$Y$$$20240705$$CN$PT$PT
238822752$23882275$2$F$20240101$20240628$20240522$20240712$PER$$US-APOTEX-2024AP005540$APOTEX$$$$$M$Y$$$20240712$$CN$US$US
238822973$23882297$3$F$20240208$20240912$20240522$20240921$EXP$$AR-JNJFOC-20240264893$JOHNSON AND JOHNSON$$72$YR$E$F$Y$68$KG$20240921$$CN$AR$AR
238822983$23882298$3$F$20240510$20240627$20240522$20240702$PER$$US-JNJFOC-20240536224$JOHNSON AND JOHNSON$$68$YR$E$F$Y$91.708$KG$20240702$$PH$US$US
238823222$23882322$2$F$$20240801$20240522$20240808$EXP$$CA-TAKEDA-2024TUS049164$TAKEDA$$45$YR$$F$Y$84$KG$20240808$$HP$CA$CA
238823253$23882325$3$F$20240101$20240628$20240522$20240704$EXP$$US-JNJFOC-20240544469$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240704$$HP$US$US
238823532$23882353$2$F$$20240710$20240522$20240718$PER$$US-SA-2024SA151804$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240718$$MD$US$US
238823702$23882370$2$F$$20240715$20240522$20240717$PER$$US-ALXN-202405USA000916US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
238823722$23882372$2$F$$20240625$20240522$20240702$EXP$GB-MHRA-ADR 28721894$GB-ADVANZ PHARMA-202405004139$ADVANZ PHARMA$$$$$$Y$$$20240702$$CN$GB$GB
238823824$23882382$4$F$20240509$20240613$20240522$20240702$30DAY$$US-JNJFOC-20240527494$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240702$$CN$US$US
238823862$23882386$2$F$$20240710$20240522$20240711$EXP$$IT-ALXN-202405EEA000806IT$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$MD$IT$IT
238823872$23882387$2$F$$20240701$20240522$20240710$PER$$US-SA-2024SA150049$SANOFI AVENTIS$$51$YR$A$F$Y$77.098$KG$20240710$$MD$US$US
238823924$23882392$4$F$$20240819$20240522$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078661$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240819$$CN$US$US
238823956$23882395$6$F$20240101$20240806$20240522$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013215$UNITED THERAPEUTICS$$$$$F$Y$87.982$KG$20240816$$$US$US
238824072$23882407$2$F$$20240624$20240522$20240701$30DAY$$US-GSK-US2024061884$GLAXOSMITHKLINE$$$$$M$Y$$$20240701$$CN$US$US
238824092$23882409$2$F$20240513$20240731$20240522$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076936$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$67.13$KG$20240801$$HP$US$US
238824263$23882426$3$F$20210101$20240628$20240522$20240709$EXP$$EG-NOVOPROD-1221870$NOVO NORDISK$$854$MON$$M$Y$$$20240709$$CN$EG$EG
238824332$23882433$2$F$$20240610$20240522$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004684$STRIDES$$$$$M$Y$$$20240816$$CN$US$US
238824342$23882434$2$F$$20240826$20240522$20240827$PER$$NVSC2024US107212$NOVARTIS$$$$$M$Y$$$20240828$$HP$US$US
238824412$23882441$2$F$$20240821$20240522$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079099$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240821$$CN$US$US
238824432$23882443$2$F$$20240702$20240522$20240708$EXP$$US-GSK-US2024061891$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$CN$US$US
238824502$23882450$2$F$20240401$20240814$20240522$20240827$EXP$$US-NOVOPROD-1223059$NOVO NORDISK$$67$YR$$M$Y$$$20240827$$CN$US$US
238824522$23882452$2$F$20240510$20240718$20240522$20240729$EXP$$US-NOVOPROD-1223076$NOVO NORDISK$$69$YR$$F$Y$181.41$KG$20240729$$MD$US$US
238824672$23882467$2$F$20240229$20240710$20240522$20240717$EXP$FR-AFSSAPS-SE2024000394$FR-SA-2024SA152088$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240717$$MD$FR$FR
238824684$23882468$4$F$20240401$20240710$20240522$20240716$PER$$US-SA-2024SA150173$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240716$$MD$US$US
238824802$23882480$2$F$$20240812$20240522$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA049776$SANDOZ$$44$YR$$F$Y$97$KG$20240814$$HP$CA$CA
238824855$23882485$5$F$20240515$20240807$20240522$20240815$PER$$US-ALXN-202405USA000935US$ALEXION PHARMACEUTICALS$$81$YR$$M$Y$$$20240815$$CN$US$US
238824874$23882487$4$F$20230601$20240715$20240522$20240718$EXP$$US-UCBSA-2024024377$UCB$$0$YR$$F$Y$3.12$KG$20240718$$CN$US$US
238824883$23882488$3$F$20240101$20240814$20240522$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076203$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240821$$CN$US$US
238825324$23882532$4$F$20240504$20240614$20240522$20240709$30DAY$$GB-JNJFOC-20240427657$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240709$$PH$GB$GB
238825342$23882534$2$F$20240520$20240725$20240522$20240729$PER$$US-AMGEN-USASP2024100224$AMGEN$$66$YR$E$F$Y$$$20240729$$MD$US$US
238825372$23882537$2$F$$20240702$20240522$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04019$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238825463$23882546$3$F$20190519$20240911$20240522$20240920$EXP$$BR-GSK-BR2019GSK052969$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$BR$BR
238825532$23882553$2$F$20240401$20240828$20240522$20240909$EXP$$JP-ROCHE-3565825$ROCHE$$8$DEC$E$F$Y$40$KG$20240909$$MD$JP$JP
238825553$23882555$3$F$20240501$20240702$20240522$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04021$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238825633$23882563$3$F$20170512$20240912$20240522$20240917$PER$$US-GILEAD-2024-0673857$GILEAD$$62$YR$A$M$Y$$$20240917$$LW$US$US
238825713$23882571$3$F$$20240722$20240522$20240729$EXP$$CA-TAKEDA-2024TUS049659$TAKEDA$$$$$M$Y$$$20240729$$MD$CA$CA
238825753$23882575$3$F$20220501$20240904$20240522$20240906$PER$$US-GILEAD-2024-0673858$GILEAD$$61$YR$A$M$Y$$$20240906$$LW$US$US
238825812$23882581$2$F$$20240705$20240522$20240713$EXP$$JP-ROCHE-3565837$ROCHE$$8$DEC$E$$Y$$$20240713$$MD$JP$JP
238825862$23882586$2$F$$20240816$20240522$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079236$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240829$$HP$US$US
238825983$23882598$3$F$$20240702$20240522$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04018$LUPIN$$$$$$Y$$$20240724$$PH$US$US
238826003$23882600$3$F$20200212$20240909$20240522$20240913$PER$$US-GILEAD-2024-0673859$GILEAD$$50$YR$A$F$Y$$$20240913$$LW$US$US
238826042$23882604$2$F$$20240801$20240522$20240813$EXP$$CA-TAKEDA-2024TUS049176$TAKEDA$$56$YR$$F$Y$81$KG$20240813$$CN$CA$CA
238826072$23882607$2$F$$20240923$20240522$20240924$EXP$$CA-HALEON-2175311$Haleon PLC$$$$$M$Y$$$20240924$$MD$CA$CA
238826083$23882608$3$F$20220101$20240816$20240522$20240819$PER$$US-GILEAD-2024-0673487$GILEAD$$58$YR$A$M$Y$$$20240819$$LW$US$US
238826092$23882609$2$F$$20240708$20240522$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075780$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240715$$MD$US$US
238826182$23882618$2$F$20201007$20240910$20240522$20240912$PER$$US-GILEAD-2024-0673860$GILEAD$$69$YR$E$F$Y$$$20240912$$LW$US$US
238826273$23882627$3$F$$20240912$20240522$20240923$EXP$$CA-002147023-NVSC2023CA023064$Haleon PLC$$$$A$F$Y$$$20240920$$HP$CA$CA
238826282$23882628$2$F$20190312$20240904$20240522$20240906$PER$$US-GILEAD-2024-0673861$GILEAD$$40$YR$A$M$Y$$$20240906$$LW$US$US
238826312$23882631$2$F$$20240614$20240522$20240704$30DAY$$US-GSK-US2024060289$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
238826384$23882638$4$F$20230101$20240715$20240522$20240717$EXP$$US-UCBSA-2024006008$UCB$$$$$F$Y$$$20240717$$CN$US$US
238826403$23882640$3$F$20160101$20240905$20240522$20240911$PER$$US-GILEAD-2024-0673862$GILEAD$$69$YR$E$F$Y$$$20240911$$LW$US$US
238826502$23882650$2$F$20200310$20240911$20240522$20240916$PER$$US-GILEAD-2024-0673863$GILEAD$$54$YR$A$M$Y$$$20240916$$LW$US$US
238826572$23882657$2$F$$20240820$20240522$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077317$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240820$$CN$US$US
238826613$23882661$3$F$$20240726$20240522$20240807$EXP$$DE-AUROBINDO-AUR-APL-2024-023286$AUROBINDO$$$$I$M$Y$2.9$KG$20240807$$HP$DE$DE
238826904$23882690$4$F$20240221$20240904$20240522$20240911$EXP$$JP-GENMAB-2024-00643AA$GENMAB$$72$YR$$F$Y$$$20240911$$MD$JP$JP
238827005$23882700$5$F$20240201$20240904$20240522$20240917$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-08979$SAMSUNG BIOEPIS$$46$YR$A$F$Y$$$20240917$$CN$CA$CA
238827052$23882705$2$F$20240101$20240626$20240522$20240703$EXP$$JP-JNJFOC-20240549312$JOHNSON AND JOHNSON$$8$DEC$E$$Y$$$20240704$$MD$JP$JP
238827112$23882711$2$F$$20240627$20240522$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-023618$AUROBINDO$Murray M, McBrine M.. Purpura Fulminans Due to Streptococcus Gallolyticus Subspecies Pasteurianus Bacteremia in an Immunocompromised Host. Am-J-Respir-Crit-Care-Med. 2023;207:A5369$67$YR$$F$Y$$$20240705$$HP$US$US
238827122$23882712$2$F$$20240703$20240522$20240709$PER$$US-AstraZeneca-2024A107022$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
238827263$23882726$3$F$$20240726$20240522$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202405011736$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240730$$CN$US$US
238827333$23882733$3$F$20210114$20240909$20240522$20240912$EXP$$US-GILEAD-2024-0673882$GILEAD$$63$YR$A$M$Y$$$20240912$$LW$US$US
238827372$23882737$2$F$$20240704$20240522$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04072$LUPIN$$$$$$Y$$$20240729$$PH$US$US
238827523$23882752$3$F$20210810$20240918$20240522$20240920$PER$$US-GILEAD-2024-0673510$GILEAD$$40$YR$A$F$Y$$$20240920$$LW$US$US
238827603$23882760$3$F$$20240702$20240522$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04044$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238827685$23882768$5$F$20240403$20240916$20240522$20240919$EXP$$US-TAKEDA-2024TUS036934$TAKEDA$$64$YR$$F$Y$90.7$KG$20240919$$CN$US$US
238827703$23882770$3$F$20130730$20240905$20240522$20240910$EXP$$US-GILEAD-2024-0673893$GILEAD$$36$YR$A$F$Y$$$20240910$$LW$US$US
238827892$23882789$2$F$20240501$20240802$20240522$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014970$UNITED THERAPEUTICS$$57$YR$$M$Y$$$20240810$$$US$US
238828072$23882807$2$F$20240520$20240821$20240522$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079511$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240821$$CN$US$US
238828094$23882809$4$F$20240101$20240802$20240522$20240810$EXP$$CA-CELLTRION INC.-2024CA011879$CELLTRION$$$$$$Y$$$20240810$$HP$CA$CA
238828132$23882813$2$F$20191127$20240909$20240522$20240912$PER$$US-GILEAD-2024-0673895$GILEAD$$67$YR$E$M$Y$$$20240912$$LW$US$US
238828143$23882814$3$F$20240101$20240715$20240522$20240724$EXP$$CA-CELLTRION INC.-2024CA011840$CELLTRION$$$$$$Y$$$20240724$$HP$CA$CA
238828273$23882827$3$F$20220825$20240912$20240522$20240916$EXP$$US-GILEAD-2024-0673896$GILEAD$$50$YR$A$M$Y$$$20240916$$LW$US$US
238828283$23882828$3$F$20190506$20240912$20240522$20240916$PER$$US-GILEAD-2024-0673884$GILEAD$$56$YR$A$M$Y$$$20240916$$LW$US$US
238828332$23882833$2$F$$20240725$20240522$20240729$EXP$$NVSC2024GB107483$NOVARTIS$$$$A$F$Y$$$20240729$$CN$GB$GB
238828382$23882838$2$F$20240101$20240705$20240522$20240713$EXP$$CA-CELLTRION INC.-2024CA011842$CELLTRION$$$$$$Y$$$20240713$$CN$CA$CA
238828493$23882849$3$F$20240520$20240815$20240522$20240819$PER$$US-AMGEN-USASP2024100268$AMGEN$$76$YR$E$M$Y$$$20240819$$CN$US$US
238828603$23882860$3$F$20240101$20240711$20240522$20240720$EXP$$CA-CELLTRION INC.-2024CA011897$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
238828782$23882878$2$F$20211223$20240912$20240522$20240916$PER$$US-GILEAD-2024-0673898$GILEAD$$54$YR$A$M$Y$$$20240916$$LW$US$US
238828832$23882883$2$F$20240517$20240815$20240522$20240820$PER$$US-AMGEN-USASP2024100511$AMGEN$$73$YR$E$F$Y$$$20240820$$HP$US$US
238828873$23882887$3$F$$20240612$20240522$20240701$EXP$$CA-ROCHE-3565333$ROCHE$$$$E$M$Y$$$20240701$$CN$CA$CA
238828962$23882896$2$F$20231212$20240628$20240522$20240705$EXP$$US-JNJFOC-20240549145$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240705$$CN$US$US
238828973$23882897$3$F$$20240730$20240522$20240731$PER$$US-JNJFOC-20240548929$JOHNSON AND JOHNSON$$47$YR$A$M$Y$74.91$KG$20240731$$CN$US$US
238829042$23882904$2$F$$20240621$20240522$20240701$30DAY$$US-GSK-US2024061321$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
238829078$23882907$8$F$20190904$20240814$20240522$20240823$EXP$$CA-CELLTRION INC.-2024CA011943$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
238829102$23882910$2$F$$20240728$20240522$20240729$EXP$$NVSC2024SA103979$NOVARTIS$$36$YR$$M$Y$$$20240729$$MD$SA$SA
238829112$23882911$2$F$$20240816$20240522$20240820$EXP$$NVSC2024US107472$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
238829124$23882912$4$F$20240512$20240626$20240522$20240703$30DAY$$CO-AMGEN-COLSP2024097748$AMGEN$$$$$$Y$$$20240703$$HP$CO$CO
238829224$23882922$4$F$$20240830$20240522$20240902$EXP$$NVSC2024GB105392$NOVARTIS$$$$A$F$Y$$$20240902$$CN$GB$GB
238829233$23882923$3$F$20211201$20240904$20240522$20240906$EXP$$US-GILEAD-2024-0673887$GILEAD$$56$YR$A$M$Y$$$20240906$$LW$US$US
238829243$23882924$3$F$20161222$20240822$20240522$20240823$EXP$$US-GILEAD-2024-0673525$GILEAD$$45$YR$A$F$Y$$$20240823$$LW$US$US
238829352$23882935$2$F$$20240711$20240522$20240717$EXP$$IL-ABBVIE-5769156$ABBVIE$$49$YR$$F$Y$74$KG$20240717$$MD$IL$IL
238829402$23882940$2$F$20220420$20240910$20240522$20240913$PER$$US-GILEAD-2024-0673888$GILEAD$$56$YR$A$M$Y$$$20240913$$LW$US$US
238829476$23882947$6$F$20240101$20240809$20240522$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014906$UNITED THERAPEUTICS$$$$$M$Y$66.213$KG$20240817$$$US$US
238829502$23882950$2$F$20240101$20240707$20240522$20240715$EXP$$CA-CELLTRION INC.-2024CA011834$CELLTRION$$$$$$Y$$$20240715$$HP$CA$CA
238829582$23882958$2$F$20240401$20240724$20240522$20240805$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-15367$SAMSUNG BIOEPIS$$76$YR$$M$Y$77$KG$20240805$$HP$CA$CA
238829602$23882960$2$F$$20240806$20240522$20240809$EXP$$JP-EXELIXIS-CABO-24077506$EXELIXIS$$77$YR$$M$Y$$$20240809$$PH$JP$JP
238829743$23882974$3$F$20190101$20240909$20240522$20240917$PER$$US-GILEAD-2024-0673891$GILEAD$$45$YR$A$M$Y$$$20240916$$LW$US$US
238829822$23882982$2$F$$20240904$20240522$20240905$PER$$US-ALXN-202405USA000938US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
238829832$23882983$2$F$$20240923$20240522$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079173$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$86.18$KG$20240924$$CN$US$US
238829984$23882998$4$F$20240413$20240822$20240522$20240902$EXP$$US-BEH-2024172299$CSL BEHRING$$44$YR$A$F$Y$$$20240902$$HP$US$US
238830322$23883032$2$F$20230101$20240729$20240522$20240805$EXP$$SG-ROCHE-3566154$ROCHE$$49$YR$A$F$Y$$$20240805$$CN$SG$SG
238830373$23883037$3$F$20240425$20240716$20240522$20240724$EXP$$JP-AstraZeneca-2024A115428$ASTRAZENECA$$87$YR$$F$Y$86$KG$20240724$$MD$JP$
238830394$23883039$4$F$20240101$20240729$20240522$20240806$EXP$$CA-CELLTRION INC.-2023CA025657$CELLTRION$$$$$$Y$$$20240806$$MD$CA$CA
238830483$23883048$3$F$20140502$20240912$20240522$20240916$EXP$$US-GILEAD-2024-0673899$GILEAD$$47$YR$A$M$Y$$$20240916$$LW$US$US
238830933$23883093$3$F$$20240716$20240522$20240730$EXP$GB-MLMSERVICE-20240430-PI045133-00030-1$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-09910$ALKEM$Manti M, Kamperidis N, Toskas A, Martin H, Misra R.. Acute Severe Ulcerative Colitis Flare Complicated by Myopericarditis and Infliximab-Induced Hepatitis. European Journal of Case Reports in Internal Medicine. 2024;11(4):unk$25$YR$$M$Y$$$20240730$$MD$GB$GB
238830973$23883097$3$F$20240101$20240706$20240522$20240711$EXP$$US-SA-2024SA152664$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240711$$MD$US$US
238830994$23883099$4$F$20240206$20240827$20240522$20240830$EXP$$DE-AMGEN-DEUNI2024097585$AMGEN$$84$YR$E$F$Y$$$20240829$$HP$DE$DE
238831173$23883117$3$F$$20240923$20240522$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078980$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240925$$CN$US$US
238831232$23883123$2$F$$20240823$20240522$20240902$EXP$IT-EMA-DD-20230215-7207890-115156$IT-BIOCON BIOLOGICS LIMITED-BBL2024003410$BIOCON$Bernardini N, Skroza N, Mambrin A, Tolino E, Anzalone A, Balduzzi V et al. A tailored therapeutic approach for patients affected by multi-drug resistant psoriasis. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. 2020;155(4):511-2$$$$$Y$$$20240902$$HP$IT$IT
238831292$23883129$2$F$$20240704$20240522$20240711$EXP$$CO-GSK-CO2024AMR063096$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$CO$CO
238831342$23883134$2$F$$20240801$20240522$20240806$EXP$$CA-TAKEDA-2024TUS049148$TAKEDA$$39$YR$$F$Y$62$KG$20240806$$CN$CA$CA
238831354$23883135$4$F$20160601$20240916$20240522$20240918$PER$$US-GILEAD-2024-0673404$GILEAD$$44$YR$A$M$Y$$$20240918$$LW$US$US
238831362$23883136$2$F$$20240816$20240522$20240830$EXP$$US-UCBSA-2024013659$UCB$$$$$M$Y$$$20240830$$CN$US$US
238831372$23883137$2$F$$20240822$20240522$20240905$EXP$$US-TAKEDA-2024TUS047548$TAKEDA$$$$$M$Y$$$20240905$$CN$US$US
238831503$23883150$3$F$20240515$20240617$20240522$20240703$30DAY$$US-JNJFOC-20240547804$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240703$$HP$US$US
238831552$23883155$2$F$$20240705$20240522$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079188$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240708$$HP$US$US
238831612$23883161$2$F$20160401$20240909$20240522$20240911$PER$$US-GILEAD-2024-0673915$GILEAD$$50$YR$A$M$Y$$$20240911$$LW$US$US
238831633$23883163$3$F$$20240917$20240522$20240923$EXP$$GB-SANDOZ INC.-SDZ2024GB049863$SANDOZ$$$$$M$Y$$$20240923$$CN$GB$GB
238831792$23883179$2$F$20240510$20240626$20240522$20240705$30DAY$$US-GSK-US2024061334$GLAXOSMITHKLINE$$81$YR$$F$Y$79.456$KG$20240705$$MD$US$US
238831823$23883182$3$F$20240101$20240628$20240522$20240703$EXP$$CA-ABBVIE-5767534$ABBVIE$$64$YR$$F$Y$$$20240703$$CN$CA$CA
238832065$23883206$5$F$20240430$20240921$20240522$20240925$EXP$$DE-TAKEDA-2024TUS049742$TAKEDA$$72$YR$$F$Y$$$20240925$$HP$DE$DE
238832222$23883222$2$F$20171118$20240906$20240522$20240909$PER$$US-GILEAD-2024-0673613$GILEAD$$30$YR$A$M$Y$$$20240909$$LW$US$US
238832793$23883279$3$F$$20240712$20240522$20240807$30DAY$$US-GSK-US2024063130$GLAXOSMITHKLINE$$$$$M$Y$$$20240807$$CN$US$US
238832812$23883281$2$F$$20240813$20240522$20240826$EXP$$US-ROCHE-3563191$ROCHE$$85$YR$E$M$Y$$$20240826$$CN$US$US
238832923$23883292$3$F$$20240711$20240522$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04162$LUPIN$$$$$$Y$$$20240809$$CN$US$US
238832952$23883295$2$F$$20240514$20240522$20240808$PER$$US-LEO Pharma-370497$LEO PHARM$$51$YR$$F$Y$$$20240808$$CN$US$US
238833042$23883304$2$F$$20240719$20240522$20240723$EXP$$NVSC2024BE106449$NOVARTIS$$71$YR$$F$Y$$$20240723$$MD$BE$BE
238833142$23883314$2$F$$20240807$20240522$20240813$PER$$US-LEO Pharma-370464$LEO PHARM$$76$YR$$F$Y$$$20240813$$PH$US$US
238833175$23883317$5$F$20240808$20240808$20240522$20240813$EXP$$CA-TAKEDA-2024TUS048989$TAKEDA$$63$YR$$F$Y$$$20240813$$CN$CA$CA
238833226$23883322$6$F$20221027$20240815$20240522$20240828$EXP$$US-UCBSA-2022062912$UCB$$2$YR$$F$Y$22.4$KG$20240828$$MD$US$US
238833283$23883328$3$F$$20240726$20240522$20240802$EXP$$IN-VANTIVE-2024VAN017143$Vantive US Healthcare$$50$YR$$M$Y$$$20240802$$CN$IN$IN
238833292$23883329$2$F$$20240628$20240522$20240705$EXP$$US-VANTIVE-2024VAN017005$Vantive US Healthcare$$$$$$Y$$$20240705$$CN$US$US
238833303$23883330$3$F$$20240820$20240522$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079575$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240820$$HP$US$US
238833352$23883335$2$F$20240209$20240902$20240522$20240904$EXP$$DE-ROCHE-3521768$ROCHE$$45$YR$A$F$Y$56.5$KG$20240904$$CN$DE$DE
238833363$23883336$3$F$$20240801$20240522$20240806$EXP$$NVSC2024US105822$NOVARTIS$$$$$$Y$$$20240806$$CN$US$US
238833372$23883337$2$F$20240401$20240731$20240522$20240801$PER$$NVSC2024US103695$NOVARTIS$$$$$M$Y$$$20240801$$MD$US$US
238833432$23883343$2$F$20230112$20240829$20240522$20240911$EXP$$JP-INSMED-2024-02034-JPAA$INSMED$$79$YR$$F$Y$34.4$KG$20240911$$MD$JP$JP
238833502$23883350$2$F$20240426$20240717$20240522$20240807$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000286$BECTON DICKINSON$$$$$$Y$$$20240807$$CN$GB$GB
238833512$23883351$2$F$20240426$20240717$20240522$20240808$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000284$BECTON DICKINSON$$$$$$Y$$$20240808$$CN$GB$GB
238833542$23883354$2$F$$20240715$20240522$20240718$EXP$$AU-ROCHE-3563417$ROCHE$$$$A$F$Y$$$20240718$$MD$AU$AU
238833652$23883365$2$F$$20240821$20240522$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078008$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240821$$MD$US$US
238833714$23883371$4$F$$20240702$20240522$20240726$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04020$LUPIN$$$$$$Y$$$20240726$$CN$US$US
238833833$23883383$3$F$$20240522$20240522$20240808$PER$$US-LEO Pharma-370549$LEO PHARM$$21$YR$$M$Y$$$20240808$$CN$US$US
238833883$23883388$3$F$20170101$20240910$20240522$20240912$EXP$$US-GILEAD-2024-0673616$GILEAD$$30$YR$A$M$Y$$$20240912$$LW$US$US
238834024$23883402$4$F$20240301$20240917$20240522$20240923$EXP$$US-ABBVIE-5766489$ABBVIE$$77$YR$$F$Y$72$KG$20240923$$CN$US$US
238834062$23883406$2$F$$20240716$20240522$20240724$EXP$DK-MLMSERVICE-20240507-PI051932-00330-1$DK-STRIDES ARCOLAB LIMITED-2024SP005860$STRIDES$Lundby C, Farrell B, Wilson A.. Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects.. British Journal of Clinical Pharmacology.. 2024;90 (7):1-4$76$YR$$F$Y$$$20240724$$MD$CA$CA
238834092$23883409$2$F$$20240705$20240522$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04016$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238834142$23883414$2$F$20240509$20240814$20240522$20240828$PER$$US-SA-2024SA121650$SANOFI AVENTIS$$83$YR$E$M$Y$117$KG$20240828$$MD$US$US
238834223$23883422$3$F$20240101$20240623$20240522$20240702$PER$$US-SA-2024SA149714$SANOFI AVENTIS$$66$YR$E$M$Y$81.64$KG$20240702$$MD$US$US
238834262$23883426$2$F$20240101$20240731$20240522$20240809$PER$$US-SA-2024SA149561$SANOFI AVENTIS$$15$YR$T$M$Y$90.71$KG$20240809$$MD$US$US
238834292$23883429$2$F$20220301$20240903$20240522$20240912$PER$$US-SA-2024SA149647$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240912$$MD$US$US
238834343$23883434$3$F$20240412$20240531$20240522$20240708$EXP$$JP-ASTELLAS-2024US014531$ASTELLAS$$80$YR$$F$Y$$$20240708$$CN$JP$JP
238834462$23883446$2$F$20240101$20240718$20240522$20240724$PER$$US-SA-2024SA152058$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240725$$CN$US$US
238834472$23883447$2$F$$20240731$20240522$20240801$PER$$NVSC2024US106680$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
238834522$23883452$2$F$20240101$20240823$20240522$20240906$PER$$US-SA-2024SA152744$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240906$$MD$US$US
238834833$23883483$3$F$20240502$20240717$20240522$20240720$EXP$$NVSC2024US094183$NOVARTIS$$37$YR$$M$Y$$$20240720$$CN$US$US
238834872$23883487$2$F$$20240802$20240522$20240809$EXP$$PL-AMGEN-POLSP2024095134$AMGEN$$32$YR$A$F$Y$$$20240809$$MD$PL$PL
238834962$23883496$2$F$$20240811$20240522$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-007216$JAZZ$Ontko J, McDaniel M, Huailin Z, Garg G et al. A Case of Psychosis Associated with Mixed Oxybate Salts (Xywav) in Idiopathic Hypersomnia. American Psychiatric Association Annual Meeting. 2024$30$YR$$F$Y$$$20240819$$HP$US$US
238834983$23883498$3$F$20240507$20240710$20240522$20240716$PER$$US-AMGEN-USASP2024099505$AMGEN$$$$$$Y$$$20240716$$PH$US$US
238834993$23883499$3$F$20240518$20240821$20240522$20240826$PER$$US-AMGEN-USASP2024099991$AMGEN$$$$$M$Y$$$20240825$$CN$US$US
238835094$23883509$4$F$$20240702$20240522$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04055$LUPIN$$$$$$Y$$$20240718$$CN$US$US
238835183$23883518$3$F$$20240712$20240522$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-023903$AUROBINDO$$74$YR$$F$Y$$$20240723$$CN$US$US
238835343$23883534$3$F$20120911$20240910$20240522$20240912$PER$$US-GILEAD-2024-0673848$GILEAD$$53$YR$A$F$Y$$$20240912$$LW$US$US
238835372$23883537$2$F$$20240705$20240522$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04051$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238835553$23883555$3$F$$20240702$20240522$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04052$LUPIN$$$$$$Y$$$20240724$$PH$US$US
238835562$23883556$2$F$$20240706$20240522$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04054$LUPIN$$$$$$Y$$$20240731$$CN$US$US
238835722$23883572$2$F$20240101$20240712$20240522$20240722$PER$$US-SA-2024SA147681$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240722$$MD$US$US
238835743$23883574$3$F$20240101$20240819$20240522$20240828$PER$$US-SA-2024SA151995$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240828$$MD$US$US
238836012$23883601$2$F$20240427$20240724$20240522$20240731$PER$$US-RDY-SPO/USA/24/0007262$DR REDDYS$$88$YR$E$M$Y$$$20240731$$CN$US$US
238836042$23883604$2$F$20220101$20240628$20240522$20240701$PER$$US-GILEAD-2024-0673574$GILEAD$$33$YR$A$F$Y$$$20240701$$LW$US$US
238836062$23883606$2$F$$20240716$20240522$20240720$EXP$$DE-AMGEN-DEUSL2024099023$AMGEN$$63$YR$A$F$Y$$$20240720$$CN$DE$DE
238836132$23883613$2$F$$20240625$20240522$20240703$EXP$$BR-AstraZeneca-2024A116984$ASTRAZENECA$$60$YR$$F$Y$$$20240703$$MD$BR$
238836142$23883614$2$F$20240508$20240627$20240522$20240701$EXP$$JP-AstraZeneca-2024A115387$ASTRAZENECA$$21864$DY$$M$Y$75$KG$20240701$$MD$JP$
238836162$23883616$2$F$20190222$20240923$20240522$20240925$PER$$US-GILEAD-2024-0673851$GILEAD$$56$YR$A$M$Y$$$20240925$$LW$US$US
238836272$23883627$2$F$$20240704$20240522$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04048$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238836942$23883694$2$F$20231130$20240704$20240522$20240716$EXP$DE-BFARM-24003109$DE-Accord-425256$ACCORD$$35$YR$A$F$Y$$$20240716$$MD$DE$DE
238837172$23883717$2$F$$20240710$20240522$20240720$EXP$$CA-CELLTRION INC.-2024CA011923$CELLTRION$$$$$$Y$$$20240720$$CN$CA$CA
238837392$23883739$2$F$20230101$20240702$20240522$20240703$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-005826$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$63$KG$20240703$$CN$ES$ES
238837542$23883754$2$F$$20240619$20240522$20240701$30DAY$$US-GSK-US2024AMR062416$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
238837562$23883756$2$F$$20240709$20240522$20240723$30DAY$$US-GSK-US2024060803$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$PH$US$US
238837572$23883757$2$F$$20240709$20240522$20240718$30DAY$$US-GSK-US2024063107$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
238837712$23883771$2$F$$20240522$20240522$20240802$PER$$US-HALEON-2176966$Haleon PLC$$20$YR$$M$Y$$$20240802$$CN$US$US
238837762$23883776$2$F$20240515$20240821$20240522$20240826$PER$$US-AMGEN-USASP2024097843$AMGEN$$48$YR$A$F$Y$$$20240825$$CN$US$US
238837832$23883783$2$F$20240501$20240624$20240522$20240704$EXP$$US-BEH-2024172385$CSL BEHRING$$$$A$M$Y$163$KG$20240704$$MD$US$US
238837913$23883791$3$F$20150101$20240910$20240522$20240912$EXP$$US-GILEAD-2024-0673852$GILEAD$$60$YR$A$M$Y$$$20240912$$LW$US$US
238838002$23883800$2$F$20230726$20240709$20240522$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-024133$AUROBINDO$$64$YR$$F$Y$57.2$KG$20240719$$PH$FR$FR
238838012$23883801$2$F$$20240730$20240522$20240802$PER$$US-AMGEN-USASP2024100279$AMGEN$$$$$F$Y$$$20240802$$CN$US$US
238838402$23883840$2$F$20240313$20240626$20240522$20240702$EXP$$JP-EXELIXIS-CABO-24076035$EXELIXIS$$6$DEC$$F$Y$$$20240702$$MD$JP$JP
238838602$23883860$2$F$$20240711$20240522$20240722$EXP$NL-LRB-00971301$NL-Accord-425324$ACCORD$$38$MON$C$M$Y$17.5$KG$20240722$$MD$NL$NL
238838652$23883865$2$F$$20240916$20240522$20240919$30DAY$$US-PFIZER INC-202400172021$PFIZER$$10$YR$$M$Y$25.85$KG$20240919$$CN$US$US
238838667$23883866$7$F$20240521$20240911$20240522$20240913$30DAY$$US-PFIZER INC-202400172496$PFIZER$$70$YR$$M$Y$105.67$KG$20240913$$HP$US$US
238838674$23883867$4$F$$20240920$20240522$20240926$30DAY$$US-PFIZER INC-202400108416$PFIZER$$$$$$Y$$$20240926$$CN$US$US
238838685$23883868$5$F$$20240918$20240522$20240923$30DAY$$US-PFIZER INC-202400172426$PFIZER$$69$YR$$F$Y$$$20240923$$CN$US$US
238838692$23883869$2$F$$20240627$20240522$20240705$EXP$$JP-009507513-2405JPN001135J$MERCK$$70$YR$$F$Y$$$20240705$$HP$JP$JP
238838862$23883886$2$F$20240501$20240830$20240522$20240903$EXP$$US-BEH-2024172398$CSL BEHRING$$2$YR$C$M$Y$$$20240903$$HP$US$US
238838913$23883891$3$F$$20240813$20240522$20240816$30DAY$$US-PFIZER INC-202400135727$PFIZER$$14$YR$$M$Y$$$20240816$$CN$US$US
238838925$23883892$5$F$$20240815$20240522$20240820$30DAY$$US-PFIZER INC-202400171584$PFIZER$$14$YR$$F$Y$35.38$KG$20240820$$CN$US$US
238838953$23883895$3$F$$20240925$20240522$20240927$30DAY$$US-PFIZER INC-202400104178$PFIZER$$16$YR$$M$Y$$$20240927$$CN$US$US
238839103$23883910$3$F$$20240912$20240522$20240917$30DAY$$US-PFIZER INC-202400108354$PFIZER$$11$YR$$M$Y$90.72$KG$20240917$$CN$US$US
2388392110$23883921$10$F$20240101$20240822$20240522$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014108$UNITED THERAPEUTICS$$$$$M$Y$82.812$KG$20240829$$$US$US
238839255$23883925$5$F$$20240916$20240522$20240919$30DAY$$US-PFIZER INC-202400125092$PFIZER$$2$YR$$F$Y$11.2$KG$20240919$$CN$US$US
238839292$23883929$2$F$20240509$20240701$20240522$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US049746$SANDOZ$$42$YR$$F$Y$$$20240703$$CN$US$US
238839372$23883937$2$F$$20240830$20240522$20240909$EXP$$JP-009507513-2405JPN001885J$MERCK$$69$YR$$F$Y$$$20240909$$MD$JP$JP
238839512$23883951$2$F$$20240624$20240522$20240701$EXP$$GB-VERTEX PHARMACEUTICALS-2024-008643$VERTEX$$$$$F$Y$$$20240701$$CN$GB$GB
238839682$23883968$2$F$20190605$20240724$20240522$20240729$EXP$$CA-TAKEDA-2024TUS049182$TAKEDA$$98$YR$$F$Y$$$20240729$$CN$CA$CA
238839753$23883975$3$F$20240517$20240628$20240522$20240702$PER$$US-AMGEN-USASP2024098574$AMGEN$$66$YR$E$M$Y$$$20240702$$CN$US$US
238839802$23883980$2$F$20140716$20240627$20240522$20240701$EXP$$US-GILEAD-2024-0673508$GILEAD$$51$YR$A$F$Y$$$20240701$$LW$US$US
238839984$23883998$4$F$$20240628$20240522$20240723$30DAY$$TR-JNJFOC-20240552665$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$TR$TR
238840024$23884002$4$F$$20240730$20240522$20240809$EXP$$US-GSK-US2024AMR063686$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
238840073$23884007$3$F$20220601$20240709$20240522$20240717$30DAY$$US-GSK-US2024061879$GLAXOSMITHKLINE$$76$YR$$F$Y$59.9$KG$20240717$$HP$US$US
238840113$23884011$3$F$$20240822$20240522$20240822$30DAY$$CZ-PFIZER INC-202400173761$PFIZER$$$$$$Y$$$20240822$$CN$CZ$CZ
238840135$23884013$5$F$$20240703$20240522$20240709$30DAY$$BR-PFIZER INC-202400132463$PFIZER$$24$YR$$M$Y$$$20240709$$PH$BR$BR
238840302$23884030$2$F$20200415$20240823$20240522$20240826$PER$$US-GILEAD-2024-0673483$GILEAD$$46$YR$A$M$Y$$$20240826$$LW$US$US
238840404$23884040$4$F$20190326$20240703$20240522$20240704$EXP$$NVSC2024IL104913$NOVARTIS$Haviv R, Zeitlin L, Moshe V, Ziv A, Rabinowicz N, Benedetti FD et al. Long term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva. RHEUMATOLOGY. 2024;1-30$16$YR$$M$Y$$$20240704$$HP$IL$IL
238840433$23884043$3$F$$20240715$20240522$20240805$30DAY$$JP-PFIZER INC-PV202400064975$PFIZER$$$$$$Y$$$20240805$$MD$JP$JP
238840453$23884045$3$F$$20240724$20240522$20240802$30DAY$$US-GSK-US2024063125$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
238840572$23884057$2$F$$20240624$20240522$20240707$EXP$$JP-AMGEN-JPNSP2024098520$AMGEN$$$$$$Y$$$20240707$$PH$JP$JP
238840674$23884067$4$F$$20240905$20240522$20240918$EXP$$IT-AUROBINDO-AUR-APL-2024-023327$AUROBINDO$Pizzini AM, Fantoni C, Zaccaroni S, Silingardi M.. Acute severe renal failure in a patient receiving apixaban: a case report.. Italian Journal of Medicine.. 2024;18(2):1718$74$YR$$M$Y$$$20240918$$HP$IT$IT
238840692$23884069$2$F$20240501$20240628$20240522$20240704$EXP$$JP-009507513-2405JPN002131J$MERCK$$7$DEC$$F$Y$$$20240704$$MD$JP$JP
238840712$23884071$2$F$$20240724$20240522$20240805$EXP$$CZ-AUROBINDO-AUR-APL-2024-023391$AUROBINDO$Bundarova L, et al. What little is known about pregabalin. Psychiatry for practice. 2024;25(1):40-42$$$$F$Y$$$20240805$$MD$CZ$CZ
238840722$23884072$2$F$$20240702$20240522$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04037$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238840753$23884075$3$F$$20240706$20240522$20240708$30DAY$$AR-PFIZER INC-202400023701$PFIZER$$12$YR$$F$Y$$$20240708$$CN$AR$AR
238840763$23884076$3$F$20240517$20240916$20240522$20240919$30DAY$$CL-PFIZER INC-PV202400065589$PFIZER$$13$YR$$F$Y$$$20240919$$CN$CL$CL
238840793$23884079$3$F$$20240820$20240522$20240822$30DAY$$GR-PFIZER INC-PV202400064806$PFIZER$$11$YR$$F$Y$$$20240822$$CN$GR$GR
238840813$23884081$3$F$$20240815$20240522$20240819$30DAY$$NL-PFIZER INC-202400173030$PFIZER$$$$$$Y$$$20240819$$CN$NL$NL
238840852$23884085$2$F$20240401$20240715$20240522$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-023073$AUROBINDO$$33$YR$$F$Y$$$20240718$$HP$GB$GB
238840922$23884092$2$F$20200203$20240905$20240522$20240906$PER$$US-GILEAD-2024-0673865$GILEAD$$56$YR$A$M$Y$$$20240906$$LW$US$US
238840934$23884093$4$F$$20240828$20240522$20240903$30DAY$$JO-PFIZER INC-202400172188$PFIZER$$$$$$Y$$$20240903$$CN$JO$JO
238840972$23884097$2$F$$20240702$20240522$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04049$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238841022$23884102$2$F$$20240712$20240522$20240718$EXP$$PT-MYLANLABS-2024M1046340$MYLAN$Marques CM, Pereira AF, Fernandes C, Ferreira JM, Ogando A, Oliveira C. Weil^s disease - a severe form of leptospirosis. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl. 1) 443 abstr. 738.$40$YR$$M$Y$$$20240718$$HP$PT$PT
238841112$23884111$2$F$20170101$20240718$20240522$20240722$PER$$US-GILEAD-2024-0673318$GILEAD$$30$YR$A$M$Y$$$20240722$$LW$US$US
238841122$23884112$2$F$20210721$20240627$20240522$20240701$PER$$US-GILEAD-2024-0673505$GILEAD$$56$YR$A$M$Y$$$20240701$$LW$US$US
238841173$23884117$3$F$20240101$20240827$20240522$20240917$EXP$$US-SA-2024SA152155$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240917$$CN$US$US
238841273$23884127$3$F$$20240815$20240522$20240821$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04531$VIFOR$$$$A$M$Y$$$20240821$$HP$ZA$ZA
238841392$23884139$2$F$$20240815$20240522$20240821$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04395$VIFOR$$$$E$F$Y$$$20240821$$HP$ZA$ZA
238841413$23884141$3$F$$20240910$20240522$20240924$EXP$$CA-002147023-NVSC2021CA213420$Haleon PLC$$40$YR$$F$Y$73$KG$20240923$$CN$CA$CA
238841452$23884145$2$F$$20240730$20240522$20240731$PER$$US-JNJFOC-20240543133$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240731$$HP$US$US
238841582$23884158$2$F$20161003$20240822$20240522$20240826$PER$$US-GILEAD-2024-0673326$GILEAD$$50$YR$A$F$Y$$$20240826$$LW$US$US
238841783$23884178$3$F$20240517$20240730$20240522$20240802$PER$$US-AMGEN-USASP2024099562$AMGEN$$68$YR$E$F$Y$$$20240802$$HP$US$US
238841813$23884181$3$F$$20240812$20240522$20240822$EXP$$DE-AUROBINDO-AUR-APL-2024-023717$AUROBINDO$$49$YR$$F$Y$$$20240822$$CN$DE$DE
238841832$23884183$2$F$20240423$20240712$20240522$20240722$EXP$FR-AFSSAPS-GR2024000556$FR-TEVA-VS-3199514$TEVA$$81$YR$$M$Y$78$KG$20240722$$PH$FR$FR
238841842$23884184$2$F$20140101$20240910$20240522$20240913$PER$$US-GILEAD-2024-0673623$GILEAD$$44$YR$A$F$Y$$$20240913$$LW$US$US
238842162$23884216$2$F$$20240719$20240522$20240727$EXP$$US-ABBVIE-5769036$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
238842302$23884230$2$F$$20240820$20240522$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079642$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240820$$CN$US$US
238842333$23884233$3$F$20201105$20240712$20240522$20240716$EXP$$US-UCBSA-2024024639$UCB$$4$YR$$F$Y$$$20240716$$CN$US$US
238842492$23884249$2$F$20240513$20240710$20240522$20240718$EXP$$CA-CELLTRION INC.-2024CA011878$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
238842513$23884251$3$F$20190304$20240926$20240522$20240930$PER$$US-GILEAD-2024-0673625$GILEAD$$50$YR$A$M$Y$$$20240930$$LW$US$US
238842562$23884256$2$F$20231201$20240729$20240522$20240731$EXP$$US-ABBVIE-5769164$ABBVIE$$62$YR$$F$Y$$$20240731$$CN$US$US
238842792$23884279$2$F$$20240722$20240522$20240724$EXP$$US-INCYTE CORPORATION-2024IN005239$INCYTE$$$$$$Y$$$20240724$$MD$US$US
238842822$23884282$2$F$20230601$20240709$20240522$20240719$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202405008555$ELI LILLY AND CO$$63$YR$A$F$Y$76$KG$20240719$$CN$DE$DE
238842932$23884293$2$F$$20240715$20240522$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075958$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240717$$CN$US$US
238842942$23884294$2$F$$20240809$20240522$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079656$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240813$$CN$US$US
238843152$23884315$2$F$20240415$20240731$20240522$20240802$EXP$$NZ-MYLANLABS-2024M1042856$MYLAN$$31$YR$$M$Y$$$20240802$$HP$NZ$NZ
238843173$23884317$3$F$$20240726$20240522$20240801$EXP$$GB-MYLANLABS-2024M1046406$MYLAN$$$$$M$Y$$$20240801$$MD$GB$GB
238843272$23884327$2$F$$20240819$20240522$20240819$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-078964$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240819$$CN$CH$CH
238843282$23884328$2$F$20240520$20240813$20240522$20240814$PER$$US-AMGEN-USASP2024100749$AMGEN$$62$YR$A$M$Y$$$20240814$$CN$US$US
238843402$23884340$2$F$20240101$20240816$20240522$20240829$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00284$CATALYST PHARMA$$$$$M$Y$30.839$KG$20240829$$CN$US$US
238843802$23884380$2$F$20240101$20240705$20240522$20240712$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00347$CATALYST PHARMA$$$$$M$Y$37.642$KG$20240712$$CN$US$US
238843932$23884393$2$F$20170101$20240805$20240522$20240807$EXP$$US-GILEAD-2024-0673340$GILEAD$$30$YR$A$M$Y$$$20240807$$LW$US$US
238844022$23884402$2$F$$20240730$20240522$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079674$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240731$$CN$US$US
238844222$23884422$2$F$20240410$20240726$20240522$20240730$EXP$$NVSC2024US107822$NOVARTIS$$56$YR$$F$Y$$$20240730$$CN$US$US
238844434$23884443$4$F$$20240730$20240522$20240731$EXP$$US-JNJFOC-20240539396$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240731$$CN$US$US
238844493$23884449$3$F$20240208$20240627$20240522$20240702$EXP$$JP-EXELIXIS-CABO-24077520$EXELIXIS$$88$YR$$M$Y$$$20240702$$MD$JP$JP
238844536$23884453$6$F$20240501$20240813$20240522$20240815$30DAY$$US-PFIZER INC-202400106840$PFIZER$$13$YR$$F$Y$$$20240815$$CN$US$US
238844573$23884457$3$F$20240501$20240814$20240522$20240816$EXP$$AR-PFIZER INC-202400173369$PFIZER$$80$YR$$M$Y$$$20240816$$CN$AR$AR
238844662$23884466$2$F$$20240702$20240522$20240703$EXP$$US-PFIZER INC-PV202400066831$PFIZER$$69$YR$$F$Y$$$20240703$$CN$US$US
238844773$23884477$3$F$20200311$20240806$20240522$20240807$PER$$US-GILEAD-2024-0673344$GILEAD$$34$YR$A$M$Y$$$20240807$$LW$US$US
238844853$23884485$3$F$20130916$20240905$20240522$20240910$PER$$US-GILEAD-2024-0673969$GILEAD$$67$YR$E$M$Y$$$20240910$$LW$US$US
238844903$23884490$3$F$20240401$20240815$20240522$20240820$PER$$US-AMGEN-USASP2024100818$AMGEN$$50$YR$A$F$Y$$$20240820$$HP$US$US
238844997$23884499$7$F$$20240801$20240522$20240805$PER$$US-PFIZER INC-PV202400066446$PFIZER$$52$YR$$F$Y$$$20240805$$HP$US$US
238845422$23884542$2$F$20190405$20240823$20240522$20240828$PER$$US-GILEAD-2024-0673479$GILEAD$$38$YR$A$M$Y$$$20240828$$LW$US$US
238845462$23884546$2$F$20230605$20240627$20240522$20240701$EXP$$AR-PFIZER INC-202400173346$PFIZER$$55$YR$$F$Y$$$20240701$$CN$AR$AR
238845832$23884583$2$F$$20240626$20240522$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076439$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$111.13$KG$20240716$$CN$US$US
238845872$23884587$2$F$20240101$20240723$20240522$20240730$EXP$$US-ABBVIE-5769147$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
238845944$23884594$4$F$20240101$20240619$20240522$20240703$30DAY$$US-JNJFOC-20240552004$JOHNSON AND JOHNSON$$63$YR$A$F$Y$58.566$KG$20240704$$CN$US$US
238846033$23884603$3$F$20240513$20240627$20240522$20240703$PER$$US-Eisai-EC-2024-166019$EISAI$$76$YR$E$M$Y$72.6$KG$20240703$$MD$US$US
238846063$23884606$3$F$20171024$20240912$20240522$20240917$PER$$US-GILEAD-2024-0673960$GILEAD$$67$YR$E$M$Y$$$20240917$$LW$US$US
238846092$23884609$2$F$20240418$20240809$20240522$20240809$EXP$$CN-PFIZER INC-PV202400065085$PFIZER$$41$YR$$M$Y$65$KG$20240809$$HP$CN$CN
238846162$23884616$2$F$20240219$20240702$20240522$20240705$EXP$FR-AFSSAPS-AM2024000404$FR-PFIZER INC-202400172037$PFIZER$$57$YR$$M$Y$69$KG$20240705$$PH$FR$FR
238846222$23884622$2$F$$20240712$20240522$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078349$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$56.7$KG$20240717$$CN$US$US
238846342$23884634$2$F$20240101$20240711$20240522$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075753$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240719$$HP$US$US
238846363$23884636$3$F$20180223$20240909$20240522$20240911$PER$$US-GILEAD-2024-0673971$GILEAD$$54$YR$A$F$Y$$$20240911$$LW$US$US
238846453$23884645$3$F$$20240807$20240522$20240812$EXP$$IN-PFIZER INC-2021859465$PFIZER$$53$YR$$M$Y$$$20240812$$CN$IN$IN
238846502$23884650$2$F$20240116$20240626$20240522$20240701$EXP$$FR-PFIZER INC-202400172989$PFIZER$$55$YR$$F$Y$76.5$KG$20240701$$HP$FR$FR
238846522$23884652$2$F$$20240713$20240522$20240715$EXP$$US-PFIZER INC-202400172897$PFIZER$$31$YR$$F$Y$$$20240715$$CN$US$US
238846702$23884670$2$F$$20240723$20240522$20240819$PER$$GT-TOLMAR, INC.-24GT048786$TOLMAR$$$$$M$Y$$$20240819$$CN$GT$GT
238846722$23884672$2$F$20240417$20240711$20240522$20240802$PER$$NI-TOLMAR, INC.-24NI048796$TOLMAR$$8$YR$$F$Y$$$20240802$$CN$NI$NI
238847013$23884701$3$F$20240101$20240905$20240522$20240916$EXP$$US-ORPHANEU-2024003657$RECORDATI$$$$$$Y$$$20240916$$CN$US$US
238847032$23884703$2$F$20240101$20240627$20240522$20240707$PER$$US-SA-2024SA147097$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240707$$MD$US$US
238847042$23884704$2$F$20240421$20240712$20240522$20240717$EXP$$CN-PFIZER INC-PV202400066697$PFIZER$$85$YR$$M$Y$$$20240717$$HP$CN$CN
238847072$23884707$2$F$$20240717$20240522$20240722$EXP$$US-PFIZER INC-202400172778$PFIZER$$94$YR$$M$Y$$$20240722$$HP$US$US
238847162$23884716$2$F$$20240821$20240522$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079527$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240821$$CN$US$US
238847183$23884718$3$F$20180101$20240905$20240522$20240910$PER$$US-GILEAD-2024-0673983$GILEAD$$59$YR$A$F$Y$$$20240910$$LW$US$US
238847232$23884723$2$F$20120806$20240904$20240522$20240906$PER$$US-GILEAD-2024-0673976$GILEAD$$45$YR$A$M$Y$$$20240906$$LW$US$US
238847696$23884769$6$F$$20240916$20240522$20240924$EXP$$BR-JNJFOC-20240138121$JOHNSON AND JOHNSON$$32$YR$A$M$Y$45$KG$20240924$$CN$BR$BR
238847792$23884779$2$F$$20240821$20240522$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079508$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240821$$CN$US$US
238847804$23884780$4$F$20240926$20240926$20240522$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079864$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240930$$CN$US$US
238847812$23884781$2$F$20240520$20240821$20240522$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078807$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240821$$HP$US$US
238847872$23884787$2$F$20240508$20240725$20240522$20240729$EXP$$NVSC2024US107903$NOVARTIS$$24$YR$$F$Y$$$20240729$$CN$US$US
238847932$23884793$2$F$20240518$20240828$20240522$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US050415$SANDOZ$$69$YR$$F$Y$$$20240829$$HP$US$US
238848163$23884816$3$F$20240516$20240711$20240522$20240718$EXP$$US-GSK-US2024062961$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$US$US
238848183$23884818$3$F$20240101$20240701$20240522$20240704$PER$$US-AMGEN-USASP2024099959$AMGEN$$50$YR$A$M$Y$$$20240704$$CN$US$US
238848232$23884823$2$F$20240101$20240704$20240522$20240723$PER$$US-APOTEX-2024AP005521$APOTEX$$$$$$Y$$$20240723$$CN$US$US
238848502$23884850$2$F$20230101$20240802$20240522$20240808$EXP$$CA-UCBSA-2023044900$UCB$$$$$F$Y$$$20240808$$CN$CA$CA
238848612$23884861$2$F$$20240819$20240522$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078821$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240819$$CN$US$US
238848643$23884864$3$F$20240501$20240925$20240522$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080010$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240925$$CN$US$US
238848752$23884875$2$F$$20240711$20240522$20240718$PER$$US-BIOGEN-2024BI01265295$BIOGEN$$$$$F$Y$$$20240718$$CN$US$US
238848842$23884884$2$F$$20240819$20240522$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077754$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240819$$CN$US$US
238848852$23884885$2$F$$20240819$20240522$20240819$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-079013$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240819$$MD$IT$IT
238848872$23884887$2$F$20231125$20240801$20240522$20240806$EXP$$CA-TAKEDA-2024TUS048878$TAKEDA$$53$YR$$F$Y$92$KG$20240806$$HP$CA$CA
238848962$23884896$2$F$20240501$20240704$20240522$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-03999$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238849073$23884907$3$F$20240424$20240711$20240522$20240722$EXP$$JP-ROCHE-3567592$ROCHE$$61$YR$A$F$Y$77.4$KG$20240719$$CN$JP$JP
238849142$23884914$2$F$20220101$20240624$20240522$20240703$EXP$$PT-SA-2024SA148615$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240703$$HP$PT$PT
238849212$23884921$2$F$$20240628$20240522$20240703$EXP$$JP-JNJFOC-20240557845$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240703$$PH$JP$JP
238849502$23884950$2$F$$20240702$20240522$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04025$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238849542$23884954$2$F$20240510$20240917$20240522$20240925$EXP$$CA-JNJFOC-20240543244$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240925$$HP$CA$CA
238849552$23884955$2$F$$20240905$20240522$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079330$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240911$$HP$US$US
238849562$23884956$2$F$$20240705$20240522$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04015$LUPIN$$$$$$Y$$$20240728$$CN$US$US
238849642$23884964$2$F$20240417$20240625$20240522$20240701$EXP$$BE-Ipsen Biopharmaceuticals, Inc.-2024-08485$IPSEN$$31$YR$A$F$Y$$$20240701$$CN$BE$BE
238849652$23884965$2$F$$20240822$20240522$20240827$PER$$US-GILEAD-2024-0673567$GILEAD$$$$$$Y$$$20240826$$LW$US$US
238849694$23884969$4$F$20240504$20240820$20240522$20240822$PER$$US-AMGEN-USASP2024101107$AMGEN$$56$YR$A$M$Y$$$20240822$$CN$US$US
238849733$23884973$3$F$20140717$20240906$20240522$20240912$PER$$US-GILEAD-2024-0673886$GILEAD$$57$YR$A$M$Y$$$20240912$$LW$US$US
238849763$23884976$3$F$20160511$20240904$20240522$20240906$PER$$US-GILEAD-2024-0673897$GILEAD$$52$YR$A$M$Y$$$20240906$$LW$US$US
238849832$23884983$2$F$20240321$20240821$20240522$20240828$PER$$US-SCIEGENP-2024SCSPO00258$SCIEGEN$$$$$$Y$$$20240828$$CN$US$US
238849862$23884986$2$F$$20240726$20240522$20240805$PER$$US-SA-2024SA144488$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240805$$MD$US$US
238849933$23884993$3$F$20100127$20240910$20240522$20240916$PER$$US-GILEAD-2024-0673872$GILEAD$$53$YR$A$F$Y$$$20240916$$LW$US$US
238849942$23884994$2$F$20240513$20240704$20240522$20240710$EXP$$CA-OTSUKA-2024_014101$OTSUKA$$82$YR$$M$Y$$$20240710$$MD$CA$CA
238849952$23884995$2$F$$20240628$20240522$20240703$EXP$$NVSC2024MX106616$NOVARTIS$$$$$F$Y$69$KG$20240703$$CN$MX$MX
238850102$23885010$2$F$20190620$20240909$20240522$20240911$EXP$$US-GILEAD-2024-0673894$GILEAD$$59$YR$A$F$Y$$$20240911$$LW$US$US
238850203$23885020$3$F$$20240702$20240522$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04038$LUPIN$$$$$$Y$$$20240724$$PH$US$US
238850212$23885021$2$F$20240425$20240627$20240522$20240701$PER$$US-JNJFOC-20240561777$JOHNSON AND JOHNSON$$82$YR$E$F$Y$72.186$KG$20240701$$MD$US$US
238850325$23885032$5$F$20240101$20240729$20240522$20240805$EXP$$US-SA-2024SA148460$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240805$$MD$US$US
238850472$23885047$2$F$20240430$20240828$20240522$20240904$PER$$US-BEH-2024172051$CSL BEHRING$$41$YR$A$M$Y$$$20240904$$CN$US$US
238850572$23885057$2$F$20240116$20240909$20240522$20240917$PER$$US-BAYER-2024A070856$BAYER$$42$YR$A$F$Y$70.748$KG$20240917$$CN$US$US
238850583$23885058$3$F$20240101$20240728$20240522$20240729$EXP$$CA-PFIZER INC-202400171931$PFIZER$$53$YR$$M$Y$$$20240729$$MD$CA$CA
238850622$23885062$2$F$20240429$20240614$20240522$20240702$30DAY$$US-GSK-US2024062481$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240702$$CN$US$US
238850762$23885076$2$F$$20240702$20240522$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04046$LUPIN$$$$$$Y$$$20240724$$CN$US$US
238850783$23885078$3$F$$20240827$20240522$20240828$PER$$NVSC2024US102702$NOVARTIS$$$$$M$Y$$$20240828$$CN$US$US
238850833$23885083$3$F$$20240704$20240522$20240710$EXP$$JP-009507513-2405JPN001897J$MERCK$$$$$F$Y$$$20240710$$MD$JP$JP
238850843$23885084$3$F$20231218$20240704$20240522$20240710$EXP$PT-INFARMED-E202405-138$PT-MYLANLABS-2024M1045059$MYLAN$$88$YR$$M$Y$64$KG$20240710$$PH$PT$PT
238850852$23885085$2$F$$20240623$20240522$20240701$EXP$$RO-CELLTRION INC.-2024RO011917$CELLTRION$$$$$$Y$$$20240701$$MD$RO$RO
238850866$23885086$6$F$20240430$20240913$20240522$20240918$EXP$$GR-PFIZER INC-PV202400065558$PFIZER$$2$YR$$F$Y$12$KG$20240918$$CN$GR$GR
238850873$23885087$3$F$$20240920$20240522$20240924$30DAY$$US-PFIZER INC-202400125020$PFIZER$$$$$M$Y$$$20240924$$CN$US$US
238850912$23885091$2$F$20150629$20240912$20240522$20240916$PER$$US-GILEAD-2024-0673864$GILEAD$$57$YR$A$M$Y$$$20240916$$LW$US$US
238850922$23885092$2$F$$20240716$20240522$20240716$PER$$US-ALXN-202405USA000979US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238850954$23885095$4$F$20240516$20240905$20240522$20240910$30DAY$$GR-PFIZER INC-PV202400064804$PFIZER$$6$YR$$M$Y$13$KG$20240910$$CN$GR$GR
238851432$23885143$2$F$20240222$20240829$20240522$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447180$RANBAXY$$74$YR$$F$Y$90.2$KG$20240913$$MD$AU$AU
238851542$23885154$2$F$$20240829$20240522$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447212$RANBAXY$$40$YR$$F$Y$$$20240913$$HP$AU$AU
238851672$23885167$2$F$$20240711$20240522$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04026$LUPIN$$$$$$Y$$$20240809$$CN$US$US
238851762$23885176$2$F$20230307$20240829$20240522$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447234$RANBAXY$$73$YR$$F$Y$61$KG$20240913$$HP$AU$AU
238851792$23885179$2$F$20230301$20240711$20240522$20240716$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-052726$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240716$$MD$JP$JP
238851803$23885180$3$F$$20240708$20240522$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079406$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240711$$CN$US$US
238851832$23885183$2$F$20240507$20240626$20240522$20240705$PER$$US-SA-2024SA152458$SANOFI AVENTIS$$59$YR$A$M$Y$74.84$KG$20240705$$CN$US$US
238851943$23885194$3$F$20190101$20240926$20240522$20240927$PER$$US-GILEAD-2024-0673473$GILEAD$$48$YR$A$F$Y$$$20240927$$LW$US$US
238851982$23885198$2$F$$20240815$20240522$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079235$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240816$$CN$US$US
238851994$23885199$4$F$$20240917$20240522$20240920$30DAY$$US-PFIZER INC-202400106022$PFIZER$$40$YR$$M$Y$$$20240920$$CN$US$US
238852005$23885200$5$F$$20240814$20240522$20240819$30DAY$$US-PFIZER INC-202400171683$PFIZER$$14$YR$$M$Y$37.4$KG$20240819$$MD$US$US
238852173$23885217$3$F$$20240907$20240522$20240916$EXP$$US-TAKEDA-2024TUS007535$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
238852262$23885226$2$F$20180101$20240826$20240522$20240830$PER$$US-GILEAD-2024-0673614$GILEAD$$40$YR$A$M$Y$$$20240830$$LW$US$US
238852303$23885230$3$F$20240201$20240730$20240522$20240802$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405011761$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240802$$CN$JP$JP
238852423$23885242$3$F$$20240814$20240522$20240814$EXP$$US-PFIZER INC-202400172992$PFIZER$$65$YR$$M$Y$$$20240814$$CN$US$US
238852482$23885248$2$F$$20240819$20240522$20240823$EXP$$NVSC2024CA101358$NOVARTIS$$72$YR$$M$Y$$$20240823$$HP$CA$CA
238852543$23885254$3$F$20240426$20240717$20240522$20240725$EXP$$JP-ALXN-202405JPN001022JP$ALEXION PHARMACEUTICALS$$41$YR$$M$Y$$$20240725$$MD$JP$JP
238852553$23885255$3$F$20190513$20240820$20240522$20240823$EXP$$US-GILEAD-2024-0673433$GILEAD$$38$YR$A$M$Y$$$20240823$$LW$US$US
238852932$23885293$2$F$20240501$20240712$20240522$20240724$PER$$US-SA-2024SA153523$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240724$$MD$US$US
238853063$23885306$3$F$$20240922$20240522$20240924$PER$$US-PFIZER INC-PV202400066535$PFIZER$$54$YR$$F$Y$$$20240924$$HP$US$US
238853145$23885314$5$F$$20240722$20240522$20240725$PER$$US-PFIZER INC-PV202400066003$PFIZER$$62$YR$$F$Y$100.9$KG$20240725$$CN$US$US
238853152$23885315$2$F$20240101$20240708$20240522$20240710$PER$$US-PFIZER INC-PV202400066322$PFIZER$$35$YR$$M$Y$$$20240710$$HP$US$US
238853252$23885325$2$F$20240401$20240625$20240522$20240703$EXP$$US-AstraZeneca-2024A113688$ASTRAZENECA$$865$MON$$M$Y$$$20240703$$CN$US$
238853262$23885326$2$F$20240509$20240802$20240522$20240806$EXP$$US-ABBVIE-5768994$ABBVIE$$57$YR$$M$Y$$$20240806$$CN$US$US
238853412$23885341$2$F$$20240823$20240522$20240904$PER$$US-SA-2024SA150891$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240904$$MD$US$US
238853433$23885343$3$F$$20240626$20240522$20240701$EXP$$US-PFIZER INC-PV202400065453$PFIZER$Elangovan, C.. Reversible Cerebral Vasoconstriction Syndrome Precipitated by IV and Oral Steroids in a Patient with New Diagnosis of Multiple Sclerosis. Annals of Neurology. 2019;86 (suppl 24):S140$28$YR$$F$Y$$$20240701$$MD$US$US
238853552$23885355$2$F$$20240828$20240522$20240910$PER$$US-SA-2024SA153721$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240910$$MD$US$US
238853592$23885359$2$F$20220329$20240910$20240522$20240913$PER$$US-GILEAD-2024-0673982$GILEAD$$64$YR$A$F$Y$$$20240913$$LW$US$US
238853633$23885363$3$F$20231117$20240730$20240522$20240801$EXP$$JP-ABBVIE-5769713$ABBVIE$$85$YR$$F$Y$$$20240801$$MD$JP$JP
238853674$23885367$4$F$$20240813$20240522$20240814$EXP$$US-PFIZER INC-202400173375$PFIZER$$52$YR$$M$Y$87.8$KG$20240814$$CN$US$US
238853722$23885372$2$F$20240101$20240708$20240522$20240717$PER$$US-SA-2024SA148533$SANOFI AVENTIS$$74$YR$E$F$Y$54.43$KG$20240717$$MD$US$US
238853752$23885375$2$F$$20240621$20240522$20240701$EXP$$IT-TAKEDA-2024TUS050604$TAKEDA$$$$$$Y$$$20240701$$CN$IT$RO
238853773$23885377$3$F$20240513$20240716$20240522$20240717$PER$$US-ALXN-202405USA000967US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
238853863$23885386$3$F$20240125$20240709$20240522$20240713$EXP$$CA-TAKEDA-2024TUS048962$TAKEDA$$79$YR$$F$Y$$$20240713$$CN$CA$CA
238853932$23885393$2$F$20240101$20240802$20240522$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076745$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240808$$HP$US$US
238853942$23885394$2$F$$20240821$20240522$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079992$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240821$$CN$US$US
238853972$23885397$2$F$$20240712$20240522$20240712$EXP$$US-PFIZER INC-202400172743$PFIZER$$58$YR$$M$Y$$$20240712$$HP$US$US
238854064$23885406$4$F$$20240812$20240522$20240816$30DAY$$US-PFIZER INC-202400171591$PFIZER$$$$$$Y$$$20240816$$PH$US$US
238854262$23885426$2$F$20240520$20240730$20240522$20240802$PER$$US-AMGEN-USASP2024101101$AMGEN$$69$YR$E$M$Y$$$20240802$$CN$US$US
238854433$23885443$3$F$20240506$20240704$20240522$20240714$EXP$$ES-BAXTER-2024BAX018311$BAXTER$$67$YR$$F$Y$69.1$KG$20240714$$HP$ES$ES
238854512$23885451$2$F$20240517$20240917$20240522$20240924$EXP$$US-SANDOZ INC.-NVSC2022US235092$SANDOZ$$30$YR$$F$Y$77.098$KG$20240924$$CN$US$US
238854546$23885454$6$F$20240516$20240905$20240522$20240911$EXP$$US-TAKEDA-2024TUS047610$TAKEDA$$67$YR$$F$Y$$$20240911$$MD$US$US
238854582$23885458$2$F$$20240917$20240522$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA050843$SANDOZ$$3$YR$$M$Y$$$20240919$$HP$CA$CA
238854652$23885465$2$F$$20240628$20240522$20240709$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024056866$VIIV$$$$$$Y$$$20240709$$HP$US$US
238855324$23885532$4$F$20240101$20240730$20240522$20240802$EXP$$US-ABBVIE-5596425$ABBVIE$$$$$F$Y$92$KG$20240802$$CN$US$US
238855363$23885536$3$F$20240501$20240626$20240522$20240709$PER$$US-Calliditas-2024CAL00740$CALLIDITAS THERAPEUTICS$$49$YR$A$F$Y$$$20240709$$CN$US$US
238855442$23885544$2$F$20240101$20240724$20240522$20240731$EXP$$US-SA-2024SA152821$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240731$$CN$US$US
238855723$23885572$3$F$$20240828$20240522$20240911$PER$$US-SA-2024SA150069$SANOFI AVENTIS$$10$YR$C$M$Y$37.9$KG$20240911$$MD$US$US
238855853$23885585$3$F$20240412$20240708$20240522$20240716$EXP$$US-Calliditas-2024CAL00742$CALLIDITAS THERAPEUTICS$$72$YR$E$M$Y$$$20240716$$CN$US$US
238856152$23885615$2$F$$20240724$20240522$20240729$EXP$$JP-OTSUKA-2024_014160$OTSUKA$$$$$$Y$$$20240729$$PH$JP$JP
238856195$23885619$5$F$$20240628$20240522$20240703$5DAY$$US-ASTELLAS-2024US014441$ASTELLAS$$$$$M$Y$$$20240703$$CN$US$US
238856432$23885643$2$F$20240101$20240708$20240522$20240713$EXP$$JP-AMGEN-JPNSP2024035701$AMGEN$$90$YR$E$F$Y$$$20240713$$PH$JP$JP
238856752$23885675$2$F$20240501$20240912$20240522$20240916$PER$$US-PFIZER INC-PV202300190599$PFIZER$$67$YR$$F$Y$92.99$KG$20240916$$CN$US$US
238856872$23885687$2$F$20240501$20240718$20240522$20240723$PER$$US-PFIZER INC-PV202400066611$PFIZER$$55$YR$$F$Y$$$20240723$$HP$US$US
238856892$23885689$2$F$$20240816$20240522$20240820$PER$$US-PFIZER INC-PV202400066744$PFIZER$$28$YR$$F$Y$$$20240820$$HP$US$US
238856942$23885694$2$F$$20240717$20240522$20240722$PER$$US-PFIZER INC-202300422437$PFIZER$$64$YR$$F$Y$$$20240722$$CN$US$US
238856964$23885696$4$F$$20240702$20240522$20240703$PER$$US-PFIZER INC-PV202400066890$PFIZER$$54$YR$$F$Y$$$20240703$$HP$US$US
238856972$23885697$2$F$$20240730$20240522$20240731$PER$$US-PFIZER INC-202400173456$PFIZER$$77$YR$$F$Y$$$20240731$$HP$US$US
238856982$23885698$2$F$$20240913$20240522$20240917$EXP$$US-PFIZER INC-PV202400066329$PFIZER$$80$YR$$F$Y$$$20240917$$CN$US$US
238857054$23885705$4$F$20240101$20240903$20240522$20240923$EXP$$US-SA-2024SA152991$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240923$$CN$US$US
238857122$23885712$2$F$$20240722$20240522$20240723$EXP$$NVSC2024FR106293$NOVARTIS$$$$$$Y$$$20240723$$MD$FR$FR
238857298$23885729$8$F$$20240829$20240522$20240830$PER$$NVSC2024US108129$NOVARTIS$$$$$$Y$$$20240830$$CN$US$US
238857312$23885731$2$F$$20240805$20240522$20240808$EXP$$NVSC2024CA101407$NOVARTIS$$40$YR$$F$Y$$$20240808$$MD$CA$CA
238857532$23885753$2$F$20220101$20240828$20240522$20240903$EXP$$US-ABBVIE-5768995$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
238857553$23885755$3$F$$20240708$20240522$20240716$EXP$$US-Calliditas-2024CAL00744$CALLIDITAS THERAPEUTICS$$34$YR$A$M$Y$77.1$KG$20240716$$CN$US$US
238857563$23885756$3$F$20240515$20240703$20240522$20240717$PER$$US-Calliditas-2024CAL00743$CALLIDITAS THERAPEUTICS$$28$YR$A$M$Y$53.07$KG$20240717$$CN$US$US
238857853$23885785$3$F$$20240829$20240522$20240904$EXP$$GB-TAKEDA-2024TUS050078$TAKEDA$$$$$M$Y$$$20240904$$CN$GB$GB
238858153$23885815$3$F$$20240712$20240522$20240805$EXP$$US-AstraZeneca-2024A113465$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
238858193$23885819$3$F$$20240704$20240522$20240712$EXP$$CA-AstraZeneca-2024A114619$ASTRAZENECA$$$$$M$Y$$$20240712$$HP$CA$
238858492$23885849$2$F$20240301$20240722$20240522$20240724$PER$$US-PFIZER INC-PV202400066636$PFIZER$$48$YR$$F$Y$$$20240724$$HP$US$US
238858682$23885868$2$F$$20240701$20240522$20240705$EXP$$DE-ASTELLAS-2024US014100$ASTELLAS$$71$YR$$F$Y$$$20240705$$CN$DE$DE
238858692$23885869$2$F$$20240515$20240522$20240902$PER$$US-ASTELLAS-2024US014148$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
238858892$23885889$2$F$$20240627$20240522$20240718$PER$$US-INCYTE CORPORATION-2024IN004588$INCYTE$$$$$$Y$$$20240718$$HP$US$US
238858942$23885894$2$F$20240520$20240703$20240522$20240717$PER$$US-AMGEN-USASP2024100968$AMGEN$$84$YR$E$M$Y$$$20240717$$CN$US$US
238859142$23885914$2$F$20240517$20240807$20240522$20240808$PER$$US-AMGEN-USASP2024101236$AMGEN$$66$YR$E$F$Y$$$20240807$$CN$US$US
238859172$23885917$2$F$20230101$20240820$20240522$20240828$EXP$RU-RZN-2360991$RU-VERTEX PHARMACEUTICALS-2024-008370$VERTEX$$$$$M$Y$12.6$KG$20240828$$CN$RU$RU
238859255$23885925$5$F$20240401$20240829$20240522$20240905$EXP$$US-GSK-US2024AMR063964$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240905$$MD$US$US
238859382$23885938$2$F$$20240813$20240522$20240826$PER$$US-SA-2024SA150762$SANOFI AVENTIS$$$$A$F$Y$46.26$KG$20240826$$MD$US$US
238859404$23885940$4$F$20240101$20240719$20240522$20240725$EXP$$US-SA-2024SA154201$SANOFI AVENTIS$$13$YR$T$F$Y$68.5$KG$20240725$$MD$US$US
238859503$23885950$3$F$20230101$20240819$20240522$20240823$EXP$$US-AMGEN-USASP2024099166$AMGEN$$67$YR$E$F$Y$$$20240823$$CN$US$US
238859622$23885962$2$F$$20240716$20240522$20240806$PER$$US-AstraZeneca-2024A117488$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
238859642$23885964$2$F$20240510$20240715$20240522$20240723$EXP$$US-AstraZeneca-2024A112617$ASTRAZENECA$$19280$DY$$F$Y$$$20240723$$CN$US$
238859672$23885967$2$F$$20240626$20240522$20240702$EXP$$GB-009507513-2405GBR006346$MERCK$$78$YR$$M$Y$77$KG$20240702$$MD$GB$GB
238859732$23885973$2$F$$20240821$20240522$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080094$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240821$$CN$US$US
238859863$23885986$3$F$20240101$20240814$20240522$20240828$PER$$US-SA-2024SA148674$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240828$$MD$US$US
238859933$23885993$3$F$20240513$20240911$20240522$20240913$EXP$$US-TAKEDA-2024TUS050531$TAKEDA$$33$YR$$M$Y$$$20240913$$PH$US$US
238860343$23886034$3$F$20240508$20240614$20240522$20240702$30DAY$$US-JNJFOC-20240527900$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240702$$HP$US$US
238860422$23886042$2$F$20230201$20240730$20240522$20240806$EXP$$CA-GSK-CA2023GSK132647$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$CA$CA
238860542$23886054$2$F$20240101$20240801$20240522$20240808$PER$$US-SA-2024SA145798$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240808$$CN$US$US
238860723$23886072$3$F$20240101$20240706$20240522$20240710$EXP$$IN-PFIZER INC-PV202200079974$PFIZER$$60$YR$$F$Y$$$20240710$$CN$IN$IN
238860773$23886077$3$F$20240508$20240618$20240522$20240702$30DAY$$US-JNJFOC-20240531855$JOHNSON AND JOHNSON$$39$YR$A$M$Y$171.61$KG$20240703$$CN$US$US
238860822$23886082$2$F$$20240906$20240522$20240911$EXP$$US-GILEAD-2024-0673925$GILEAD$$64$YR$A$M$Y$$$20240911$$MD$US$US
238860832$23886083$2$F$20240521$20240730$20240522$20240801$PER$$US-AMGEN-USASP2024101196$AMGEN$$75$YR$E$F$Y$$$20240801$$CN$US$US
238860892$23886089$2$F$$20240827$20240522$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079677$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240829$$CN$US$US
238860932$23886093$2$F$20240508$20240730$20240522$20240802$EXP$$NVSC2024IT105517$NOVARTIS$$$$A$F$Y$$$20240802$$MD$IT$IT
238860994$23886099$4$F$20240419$20240903$20240522$20240913$PER$$US-Calliditas-2024CAL00748$CALLIDITAS THERAPEUTICS$$48$YR$A$F$Y$66.3$KG$20240913$$CN$US$US
238861002$23886100$2$F$$20240906$20240522$20240909$PER$$NVSC2024US108027$NOVARTIS$$$$$F$Y$$$20240909$$HP$US$US
238861053$23886105$3$F$$20240705$20240522$20240710$EXP$$US-PFIZER INC-PV202400066266$PFIZER$$64$YR$$M$Y$$$20240710$$HP$US$US
238861062$23886106$2$F$20190711$20240618$20240522$20240703$EXP$$DE-ROCHE-3183797$ROCHE$$37$YR$A$F$Y$$$20240703$$MD$DE$DE
238861072$23886107$2$F$20240514$20240910$20240522$20240911$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-079731$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$68.04$KG$20240911$$CN$PR$PR
238861092$23886109$2$F$20240101$20240813$20240522$20240820$EXP$$JP-009507513-2405JPN001638J$MERCK$$6$DEC$$M$Y$$$20240820$$MD$JP$JP
238861142$23886114$2$F$20240401$20240830$20240522$20240925$PER$$US-SA-2024SA150821$SANOFI AVENTIS$$83$YR$E$F$Y$52.27$KG$20240925$$MD$US$US
238861342$23886134$2$F$20240101$20240906$20240522$20240912$EXP$$US-ABBVIE-5766254$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
238861355$23886135$5$F$20220518$20240905$20240522$20240909$EXP$$SA-SA-2023SA252718$SANOFI AVENTIS$$25$YR$A$F$Y$77.9$KG$20240910$$MD$SA$SA
238861384$23886138$4$F$20240501$20240830$20240522$20240904$EXP$$TW-JNJFOC-20240549665$JOHNSON AND JOHNSON$$65$YR$E$F$Y$40$KG$20240904$$CN$TW$TW
238861412$23886141$2$F$$20240705$20240522$20240718$PER$$US-Calliditas-2024CAL00749$CALLIDITAS THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
238861442$23886144$2$F$$20240820$20240522$20240826$EXP$$GB-TAKEDA-2022TUS067839$TAKEDA$$$$$M$Y$$$20240826$$CN$GB$GB
238861572$23886157$2$F$$20240808$20240522$20240814$EXP$$JP-009507513-2405JPN002060J$MERCK$$$$$F$Y$$$20240814$$MD$JP$JP
238861713$23886171$3$F$$20240702$20240522$20240708$EXP$$NVSC2024US100752$NOVARTIS$Whyte MP, McAlister WH, Dhiman V, Gopinathan NR, Bhadada SK. Drug-induced osteopetrosis. BONE. 2023;173:1-9$7$YR$$F$Y$$$20240708$$HP$US$US
238861872$23886187$2$F$$20240710$20240522$20240801$PER$$US-SA-2024SA150650$SANOFI AVENTIS$$$$T$M$Y$38$KG$20240719$$CN$US$US
238862042$23886204$2$F$$20240619$20240522$20240701$PER$$US-Calliditas-2024CAL00751$CALLIDITAS THERAPEUTICS$$35$YR$A$F$Y$76.2$KG$20240701$$CN$US$US
238862052$23886205$2$F$$20240715$20240522$20240726$PER$$US-Calliditas-2024CAL00753$CALLIDITAS THERAPEUTICS$$35$YR$A$F$Y$89.6$KG$20240726$$CN$US$US
238862233$23886223$3$F$20240509$20240701$20240522$20240709$EXP$$US-ASTELLAS-2024US014544$ASTELLAS$$87$YR$$F$Y$$$20240709$$HP$US$US
238862263$23886226$3$F$$20240625$20240522$20240902$PER$$US-ASTELLAS-2024US014174$ASTELLAS$$57$YR$A$F$Y$$$20240830$$MD$US$US
238862282$23886228$2$F$20240101$20240517$20240522$20240703$PER$$US-Eisai-EC-2024-165143$EISAI$$82$YR$E$F$Y$71$KG$20240703$$MD$US$US
238862379$23886237$9$F$20240101$20240918$20240522$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013887$UNITED THERAPEUTICS$$$$$M$Y$74.83$KG$20240926$$$US$US
238862534$23886253$4$F$20240501$20240802$20240522$20240809$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004617$SAREPTA THERAPEUTICS$$6$YR$$M$Y$22.3$KG$20240809$$CN$US$US
238862553$23886255$3$F$20240408$20240717$20240522$20240722$EXP$$NVSC2024FR081823$NOVARTIS$$44$YR$$F$Y$$$20240722$$PH$FR$FR
238862613$23886261$3$F$20240615$20240717$20240522$20240729$PER$$US-Calliditas-2024CAL00752$CALLIDITAS THERAPEUTICS$$48$YR$A$F$Y$93.89$KG$20240729$$CN$US$US
238862622$23886262$2$F$$20240830$20240522$20240912$PER$$US-Calliditas-2024CAL00755$CALLIDITAS THERAPEUTICS$$42$YR$A$F$Y$$$20240912$$CN$US$US
238862633$23886263$3$F$$20240918$20240522$20240925$PER$$US-Calliditas-2024CAL00754$CALLIDITAS THERAPEUTICS$$49$YR$A$F$Y$80.3$KG$20240925$$MD$US$US
238862642$23886264$2$F$20240501$20240522$20240522$20240705$PER$$US-Eisai-EC-2024-165402$EISAI$$83$YR$E$F$Y$$$20240705$$CN$US$US
238862703$23886270$3$F$$20240604$20240522$20240731$PER$$US-LUNDBECK-DKLU3078295$LUNDBECK$$$$$$Y$$$20240731$$CN$US$US
238862782$23886278$2$F$20240510$20240528$20240522$20240723$PER$$US-LUNDBECK-DKLU3077992$LUNDBECK$$$$$$Y$$$20240723$$CN$US$US
238862882$23886288$2$F$20240301$20240705$20240522$20240705$PER$$NVSC2024US106102$NOVARTIS$$$$$F$Y$$$20240705$$MD$US$US
238862906$23886290$6$F$$20240923$20240522$20240930$PER$$US-ALXN-202405USA000980US$ALEXION PHARMACEUTICALS$$$$A$$Y$$$20240930$$$US$US
238863042$23886304$2$F$$20240520$20240522$20240710$PER$$US-LUNDBECK-DKLU3077713$LUNDBECK$$$$$$Y$$$20240711$$CN$US$US
238863162$23886316$2$F$20240501$20240521$20240522$20240826$PER$$US-Aprecia Pharmaceuticals-APRE20240930$APRECIA PHARMACEUTICALS$$91$YR$E$F$Y$$$20240826$$CN$US$US
238863203$23886320$3$F$20200101$20240822$20240522$20240828$EXP$$US-PFIZER INC-202400105546$PFIZER$$66$YR$$F$Y$$$20240828$$HP$US$US
238863223$23886322$3$F$$20240814$20240522$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079643$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$83.91$KG$20240819$$CN$US$US
238863342$23886334$2$F$$20240802$20240522$20240807$EXP$$US-TAKEDA-2024TUS041292$TAKEDA$$$$$M$Y$$$20240807$$MD$US$US
238863393$23886339$3$F$20240118$20240711$20240522$20240718$EXP$$US-ROCHE-3563673$ROCHE$$$$$$Y$$$20240718$$HP$US$US
238863403$23886340$3$F$$20240625$20240522$20240708$PER$$US-Calliditas-2024CAL00760$CALLIDITAS THERAPEUTICS$$38$YR$A$M$Y$$$20240708$$CN$US$US
238863444$23886344$4$F$$20240821$20240522$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079322$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240823$$HP$US$US
238863472$23886347$2$F$$20240910$20240522$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079750$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240911$$CN$US$US
238863592$23886359$2$F$20240514$20240815$20240522$20240822$EXP$$US-MYLANLABS-2024M1046786$MYLAN$$20$YR$$M$Y$$$20240822$$PH$US$US
238863692$23886369$2$F$$20240801$20240522$20240805$PER$$JP-Eisai-EC-2024-166051$EISAI$$$$E$M$Y$$$20240804$$MD$JP$JP
238863713$23886371$3$F$$20240904$20240522$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080216$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240905$$CN$US$US
238863722$23886372$2$F$$20240806$20240522$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080221$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240808$$CN$US$US
238863742$23886374$2$F$20240501$20240822$20240522$20240904$PER$$US-SA-2024SA149123$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240904$$MD$US$US
238863812$23886381$2$F$20240423$20240826$20240522$20240827$EXP$$US-KARYOPHARM-2024KPT000954$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240827$$CN$US$US
238863902$23886390$2$F$20240513$20240628$20240522$20240703$PER$$US-BAUSCH-BL-2024-007636$BAUSCH AND LOMB$$71$YR$$F$Y$54.48$KG$20240703$$CN$US$US
238863944$23886394$4$F$20240518$20240730$20240522$20240802$PER$$US-AMGEN-USASP2024100947$AMGEN$$52$YR$A$F$Y$$$20240801$$CN$US$US
238864203$23886420$3$F$20240510$20240806$20240522$20240809$EXP$$JP-Eisai-EC-2024-165989$EISAI$$85$YR$E$F$Y$40$KG$20240809$$HP$JP$JP
238864392$23886439$2$F$20240501$20240701$20240522$20240711$EXP$$US-SMPA-2024SUN000371$SUNOVION$$$$$$Y$$$20240711$$CN$US$US
238864442$23886444$2$F$20231208$20240814$20240522$20240820$EXP$$US-MYLANLABS-2024M1046096$MYLAN$$73$YR$$M$Y$64.399$KG$20240820$$CN$US$US
238864652$23886465$2$F$$20240515$20240522$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001227$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240722$$CN$US$US
238864842$23886484$2$F$20240220$20240530$20240522$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST001265$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240722$$CN$US$US
238865512$23886551$2$F$20240401$20240912$20240522$20240919$EXP$$JP-Eisai-EC-2024-165967$EISAI$$$$A$F$Y$$$20240919$$MD$JP$JP
238865523$23886552$3$F$20231031$20240708$20240522$20240718$EXP$$JP-Eisai-EC-2024-166074$EISAI$$67$YR$E$F$Y$$$20240718$$MD$JP$JP
238865532$23886553$2$F$$20240723$20240522$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080172$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$79.38$KG$20240724$$PH$US$US
238865613$23886561$3$F$20240521$20240904$20240522$20240911$30DAY$$TR-SANDOZ INC.-SDZ2024TR050999$SANDOZ$$7$YR$$F$Y$18$KG$20240911$$CN$TR$TR
238865694$23886569$4$F$20240223$20240806$20240522$20240911$EXP$$CA-BEH-2024172564$CSL BEHRING$$71$YR$E$M$Y$73$KG$20240911$$CN$CA$CA
238865702$23886570$2$F$$20240918$20240522$20240925$EXP$$BR-LUNDBECK-DKLU3071143$LUNDBECK$$$$$$Y$$$20240925$$CN$BR$BR
238865782$23886578$2$F$20220101$20240830$20240522$20240906$EXP$$JP-Eisai-EC-2024-165857$EISAI$$$$E$M$Y$$$20240906$$MD$JP$JP
238865942$23886594$2$F$$20240701$20240522$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079293$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240710$$HP$US$US
238865952$23886595$2$F$20240325$20240830$20240522$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077918$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$58.97$KG$20240903$$CN$US$US
238866152$23886615$2$F$$20240906$20240522$20240911$EXP$$US-GILEAD-2024-0673903$GILEAD$$64$YR$A$M$Y$$$20240911$$MD$US$US
238866492$23886649$2$F$$20240716$20240522$20240716$PER$$US-ALXN-202405USA001068US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
238866552$23886655$2$F$20240515$20240716$20240522$20240716$PER$$US-ALXN-202405USA001072US$ALEXION PHARMACEUTICALS$$78$YR$$F$Y$$$20240716$$CN$US$US
238866562$23886656$2$F$$20240708$20240522$20240711$EXP$$GB-SANDOZ INC.-SDZ2024GB050337$SANDOZ$$$$$F$Y$$$20240711$$CN$GB$GB
238866692$23886669$2$F$20240519$20240821$20240522$20240824$PER$$US-AMGEN-USASP2024100063$AMGEN$$52$YR$A$M$Y$$$20240824$$CN$US$US
238866822$23886682$2$F$$20240904$20240522$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-079414$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240912$$MD$JP$JP
238866852$23886685$2$F$$20240627$20240522$20240703$EXP$GB-MHRA-ADR 28721894$GB-STRIDES ARCOLAB LIMITED-2024SP005787$STRIDES$$59$YR$$F$Y$47$KG$20240703$$MD$GB$GB
238866892$23886689$2$F$$20240907$20240522$20240909$EXP$$CN-ABBVIE-5765811$ABBVIE$$$$$$Y$$$20240909$$HP$CN$CN
238867032$23886703$2$F$20240519$20240730$20240522$20240802$PER$$US-AMGEN-USASP2024100061$AMGEN$$55$YR$A$M$Y$$$20240802$$CN$US$US
238867182$23886718$2$F$20240101$20240703$20240522$20240709$PER$$US-AstraZeneca-2024A107257$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
238867192$23886719$2$F$20130206$20240910$20240522$20240912$PER$$US-GILEAD-2024-0674024$GILEAD$$23$YR$A$M$Y$$$20240912$$LW$US$US
238867262$23886726$2$F$20120423$20240910$20240522$20240913$PER$$US-GILEAD-2024-0674034$GILEAD$$58$YR$A$M$Y$$$20240913$$LW$US$US
238867322$23886732$2$F$$20240627$20240522$20240702$EXP$$NVSJ2024JP005956$NOVARTIS$$$$$M$Y$$$20240702$$MD$JP$JP
238867353$23886735$3$F$20240101$20240827$20240522$20240830$EXP$$US-ABBVIE-5665008$ABBVIE$$$$$M$Y$74.843$KG$20240830$$CN$US$US
238867363$23886736$3$F$20240510$20240625$20240522$20240703$EXP$$DE-JNJFOC-20240541928$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240703$$MD$DE$DE
238867372$23886737$2$F$20190115$20240909$20240522$20240911$PER$$US-GILEAD-2024-0674038$GILEAD$$62$YR$A$F$Y$$$20240911$$LW$US$US
238867422$23886742$2$F$20210730$20240904$20240522$20240906$PER$$US-GILEAD-2024-0674042$GILEAD$$48$YR$A$M$Y$$$20240906$$LW$US$US
238867512$23886751$2$F$$20240517$20240522$20240703$EXP$$NVSC2024US035031$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
238867672$23886767$2$F$20240508$20240711$20240522$20240716$EXP$$US-JNJFOC-20240542201$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240716$$HP$US$US
238867802$23886780$2$F$20070711$20240906$20240522$20240911$EXP$$US-GILEAD-2024-0674052$GILEAD$$51$YR$A$M$Y$$$20240911$$LW$US$US
238867873$23886787$3$F$20161003$20240904$20240522$20240906$PER$$US-GILEAD-2024-0674053$GILEAD$$61$YR$A$M$Y$$$20240906$$LW$US$US
238867932$23886793$2$F$20131106$20240909$20240522$20240911$EXP$$US-GILEAD-2024-0674054$GILEAD$$49$YR$A$F$Y$$$20240911$$LW$US$US
238868052$23886805$2$F$20150101$20240910$20240522$20240912$EXP$$US-GILEAD-2024-0674057$GILEAD$$29$YR$A$M$Y$$$20240912$$LW$US$US
238868123$23886812$3$F$20240101$20240712$20240522$20240723$PER$$US-BAUSCHBL-2024BNL027197$BAUSCH AND LOMB$$$$$F$Y$$$20240722$$CN$US$US
238868292$23886829$2$F$20240101$20240815$20240522$20240821$EXP$$US-ABBVIE-5768687$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
238868513$23886851$3$F$20210101$20240911$20240522$20240913$EXP$$US-GILEAD-2024-0674063$GILEAD$$67$YR$E$M$Y$$$20240913$$LW$US$US
238868563$23886856$3$F$$20240827$20240522$20240906$EXP$$GB-TEVA-VS-3200410$TEVA$Gabarin M, Arnson Y, Neuman Y, Arow Z, Assali A, Pereg D. Cardiac Tamponade in Patients Treated with Direct Oral Anticoagulants. Isr-Med-Assoc-J 2023; 25 (6): 430-433.; Abiodun A, Crake T, Ghosh AK, Westwood M, Herrey AS, Manisty CH. CMR: A Mirror to the Multiple Faces of Cardiotoxicity. J-Cardiovasc-Magn-Resonance 2024; 26 (Suppl.) abstr. Kiosk 8Q-FA-01.$81$YR$$F$Y$$$20240906$$HP$GB$GB
238868612$23886861$2$F$20240401$20240719$20240522$20240724$EXP$$NVSC2024US091985$NOVARTIS$$51$YR$$F$Y$$$20240724$$CN$US$US
238868652$23886865$2$F$20190309$20240912$20240522$20240918$EXP$$US-GILEAD-2024-0674064$GILEAD$$29$YR$A$M$Y$$$20240918$$LW$US$US
238868752$23886875$2$F$$20240625$20240522$20240703$EXP$$US-ALXN-202405USA001019US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$HP$US$US
238868885$23886888$5$F$$20240628$20240522$20240706$EXP$$US-ALXN-202405USA001033US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240706$$CN$US$US
238868962$23886896$2$F$$20240619$20240522$20240705$PER$$US-APOTEX-2024AP005582$APOTEX$$$$$$Y$$$20240705$$CN$US$US
238868983$23886898$3$F$$20240806$20240522$20240816$EXP$$GB-TEVA-VS-3200389$TEVA$Needleman A, Sheaff M, Pepper RJ, Evans RDR. Immunoglobulin G4-related disease presenting with nephrotic syndrome due to minimal change disease: a case report. Journal of medical case reports 2024; 18(1): 192 (1-5).; Needleman A, Sheaff M, Pepper RJ, Evans RDR. Immunoglobulin G4-related disease presenting with nephrotic syndrome due to minimal change disease: a case report. J-Med-Case-Rep 2024; 18 (1): 1-5.; Needleman A, Sheaff M, Pepper RJ, Evans RDR. Immunoglobulin G4-related disease presen...$67$YR$$M$Y$$$20240816$$HP$GB$GB
238869082$23886908$2$F$20240101$20240814$20240522$20240820$EXP$$US-SA-2024SA153071$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240820$$CN$US$US
238869092$23886909$2$F$20240301$20240704$20240522$20240710$EXP$$BR-TAKEDA-2024TUS049897$TAKEDA$$27$YR$$F$Y$$$20240710$$CN$BR$BR
238869152$23886915$2$F$$20240716$20240523$20240723$EXP$$US-ABBVIE-5766917$ABBVIE$$$$$M$Y$136$KG$20240723$$CN$US$US
238869172$23886917$2$F$$20240704$20240523$20240709$EXP$$US-PFIZER INC-202400173401$PFIZER$$47$YR$$F$Y$$$20240709$$CN$US$US
238869193$23886919$3$F$20240101$20240722$20240523$20240729$EXP$$US-ABBVIE-5768578$ABBVIE$$$$$M$Y$68$KG$20240729$$HP$US$US
238869202$23886920$2$F$20240822$20240917$20240523$20240919$EXP$$NL-PFIZER INC-202400172006$PFIZER$$78$YR$$M$Y$84$KG$20240919$$MD$NL$NL
238869322$23886932$2$F$20240430$20240613$20240523$20240705$PER$$US-TOLMAR, INC.-24US048940$TOLMAR$$85$YR$$M$Y$$$20240705$$HP$US$US
238869393$23886939$3$F$20200101$20240806$20240523$20240809$EXP$$US-ABBVIE-5768852$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
238869433$23886943$3$F$$20240917$20240523$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078634$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$95.16$KG$20240923$$CN$US$US
238869622$23886962$2$F$$20240716$20240523$20240717$PER$$US-ALXN-202405USA001088US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
238869702$23886970$2$F$$20240504$20240523$20240822$PER$$US-MankindUS-000159$MANKIND PHARMA$$$$$F$Y$$$20240822$$CN$US$US
238869712$23886971$2$F$$20240716$20240523$20240717$PER$$US-ALXN-202405USA000990US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
238869783$23886978$3$F$20240516$20240806$20240523$20240813$PER$$US-AMGEN-USASP2024098395$AMGEN$$61$YR$A$M$Y$111.9$KG$20240813$$PH$US$US
238869802$23886980$2$F$$20240708$20240523$20240712$EXP$$US-SANDOZ INC.-SDZ2024US050886$SANDOZ$$$$$M$Y$$$20240712$$CN$US$US
238870012$23887001$2$F$$20240705$20240523$20240715$30DAY$$US-NOVOPROD-1222971$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
238870064$23887006$4$F$20190101$20240617$20240523$20240717$EXP$$US-ROCHE-3564074$ROCHE$$62$YR$A$M$Y$$$20240717$$CN$US$US
238870152$23887015$2$F$20240514$20240709$20240523$20240711$PER$$US-HALEON-2175521$Haleon PLC$$$$$F$Y$$$20240711$$CN$US$US
238870243$23887024$3$F$20240418$20240916$20240523$20240921$EXP$$US-ABBVIE-5732480$ABBVIE$$57$YR$$M$Y$120.65$KG$20240921$$CN$US$US
238870262$23887026$2$F$20240510$20240628$20240523$20240712$PER$$US-AMGEN-USASP2024096907$AMGEN$$73$YR$E$F$Y$$$20240712$$PH$US$US
238870352$23887035$2$F$$20240718$20240523$20240718$PER$$US-ALXN-202405USA001142US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
238870723$23887072$3$F$20230101$20240806$20240523$20240828$PER$$US-TOLMAR, INC.-24US049184$TOLMAR$$$$$M$Y$$$20240827$$MD$US$US
238870763$23887076$3$F$20240108$20240813$20240523$20240823$PER$$US-BIOCON-BCN-2024-000060$BIOCON$$$$$M$Y$$$20240823$$HP$US$US
238870872$23887087$2$F$20240317$20240603$20240523$20240701$PER$$US-AstraZeneca-2024A107303$ASTRAZENECA$$25944$DY$$F$Y$$$20240701$$CN$US$
238870894$23887089$4$F$20220613$20240726$20240523$20240728$EXP$$JP-TAKEDA-2022TJP076333$TAKEDA$$5$YR$$F$Y$16.3$KG$20240728$$MD$JP$JP
238871152$23887115$2$F$20240518$20240912$20240523$20240912$PER$$US-AMGEN-USASP2024099747$AMGEN$$55$YR$A$M$Y$$$20240912$$CN$US$US
238871242$23887124$2$F$20240519$20240731$20240523$20240803$PER$$US-AMGEN-USASP2024099955$AMGEN$$53$YR$A$M$Y$$$20240803$$CN$US$US
238871252$23887125$2$F$20220108$20240903$20240523$20240910$EXP$$CA-CELLTRION INC.-2022CA001515$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
238871472$23887147$2$F$20240101$20240806$20240523$20240812$EXP$$US-SA-2024SA153684$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240812$$MD$US$US
238871493$23887149$3$F$$20240917$20240523$20240920$EXP$$CA-ABBVIE-5769083$ABBVIE$$48$YR$$F$Y$68$KG$20240920$$HP$CA$CA
238871612$23887161$2$F$$20240806$20240523$20240807$EXP$$US-JNJFOC-20240545204$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$HP$US$US
238871752$23887175$2$F$$20240704$20240523$20240705$EXP$$NVSC2024GB083782$NOVARTIS$$$$$F$Y$$$20240705$$CN$GB$GB
238871823$23887182$3$F$$20240803$20240523$20240909$EXP$$CA-002147023-NVSC2024CA010313$Haleon PLC$$44$YR$$F$Y$97$KG$20240909$$HP$CA$CA
238871962$23887196$2$F$$20240820$20240523$20240823$EXP$$US-JNJFOC-20240546178$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240823$$CN$US$US
238872042$23887204$2$F$20240514$20240521$20240523$20240709$PER$$US-HALEON-2177046$Haleon PLC$$50$YR$$M$Y$$$20240709$$CN$US$US
238872133$23887213$3$F$20240512$20240912$20240523$20240913$EXP$$IL-ROCHE-3565446$ROCHE$$71$YR$E$F$Y$$$20240913$$CN$IL$IL
238872184$23887218$4$F$$20240628$20240523$20240701$EXP$$RO-JNJFOC-20240564133$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$MD$RO$RO
238872464$23887246$4$F$$20240823$20240523$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080364$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$64.86$KG$20240827$$CN$US$US
238872722$23887272$2$F$$20240716$20240523$20240724$PER$$US-SA-2024SA150301$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240724$$MD$US$US
238872762$23887276$2$F$$20240703$20240523$20240712$PER$$US-SA-2024SA149576$SANOFI AVENTIS$$13$YR$T$F$Y$53.8$KG$20240712$$CN$US$US
238872833$23887283$3$F$20240101$20240828$20240523$20240910$PER$$US-SA-2024SA150766$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240910$$MD$US$US
238872892$23887289$2$F$$20240711$20240523$20240801$PER$$US-SA-2024SA150654$SANOFI AVENTIS$$$$A$F$Y$$$20240719$$MD$US$US
238873082$23887308$2$F$20240101$20240722$20240523$20240731$PER$$US-SA-2024SA153549$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240731$$MD$US$US
238873243$23887324$3$F$$20240917$20240523$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009123$UNITED THERAPEUTICS$$$$$F$Y$57.143$KG$20240925$$$US$US
238873393$23887339$3$F$$20240821$20240523$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079475$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240821$$CN$US$US
238873453$23887345$3$F$20240101$20240815$20240523$20240821$EXP$$US-SA-2024SA154241$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240821$$MD$US$US
238873482$23887348$2$F$$20240718$20240523$20240718$PER$$US-ALXN-202405USA001266US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
238873582$23887358$2$F$20240501$20240820$20240523$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079274$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240820$$CN$US$US
238873684$23887368$4$F$20240508$20240814$20240523$20240816$PER$$US-ROCHE-3564841$ROCHE$$49$YR$A$F$Y$$$20240817$$HP$US$US
238873712$23887371$2$F$20240101$20240906$20240523$20240909$PER$$US-AMGEN-USASP2024100863$AMGEN$$79$YR$E$F$Y$$$20240909$$CN$US$US
238873792$23887379$2$F$20240101$20240808$20240523$20240827$PER$$US-APOTEX-2024AP005511$APOTEX$$$$$F$Y$$$20240827$$CN$US$US
238873963$23887396$3$F$20240416$20240817$20240523$20240829$EXP$$DE-AUROBINDO-AUR-APL-2024-023568$AUROBINDO$$85$YR$$F$Y$68$KG$20240829$$MD$DE$DE
238874223$23887422$3$F$20240401$20240719$20240523$20240724$EXP$$NVSC2024US106685$NOVARTIS$$48$YR$$F$Y$$$20240724$$CN$US$US
238874242$23887424$2$F$$20240927$20240523$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080514$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240930$$HP$US$US
238874262$23887426$2$F$20240101$20240628$20240523$20240705$PER$$US-APOTEX-2024AP005570$APOTEX$$$$$M$Y$$$20240705$$CN$US$US
238874272$23887427$2$F$$20240513$20240523$20240730$EXP$$US-SAMSUNG BIOEPIS-SB-2024-15489$SAMSUNG BIOEPIS$Deshpande N, Belkin M. New-Onset Neurosarcoidosis Following Heart Transplant for Cardiac Sarcoidosis. JACC: Case Reports.. doi:https://dx.doi.org/10.1016/j.jaccas.2024.102358$63$YR$A$F$Y$$$20240730$$MD$US$US
238874284$23887428$4$F$$20240920$20240523$20240924$EXP$$US-ROCHE-3563654$ROCHE$$44$YR$A$F$Y$$$20240924$$CN$US$US
238874402$23887440$2$F$$20240705$20240523$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04161$LUPIN$$$$$$Y$$$20240731$$CN$US$US
238874413$23887441$3$F$20230216$20240830$20240523$20240903$PER$$US-BIOVITRUM-CTI2024US04514$BIOVITRUM$$81$YR$$M$Y$$$20240903$$CN$US$US
238874503$23887450$3$F$20240603$20240920$20240523$20240925$EXP$$CA-TAKEDA-2024TUS049153$TAKEDA$$49$YR$$M$Y$$$20240925$$CN$CA$CA
238874652$23887465$2$F$20230402$20240829$20240523$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012765$UNITED THERAPEUTICS$$73$YR$$F$Y$51.701$KG$20240906$$$US$US
238874763$23887476$3$F$$20240723$20240523$20240725$EXP$$EG-JNJFOC-20240553034$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240725$$MD$EG$EG
238874962$23887496$2$F$$20240711$20240523$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202405012735$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240715$$CN$US$US
238875022$23887502$2$F$$20240717$20240523$20240723$EXP$$GB-AMGEN-GBRSP2024092017$AMGEN$$52$YR$A$M$Y$$$20240723$$CN$GB$GB
238875092$23887509$2$F$$20240917$20240523$20240921$EXP$$CA-ABBVIE-5769048$ABBVIE$$44$YR$$F$Y$97$KG$20240921$$HP$CA$CA
238875122$23887512$2$F$$20240716$20240523$20240716$PER$$US-ALXN-202405USA001020US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
238875193$23887519$3$F$$20240712$20240523$20240824$PER$$US-AstraZeneca-2024A115026$ASTRAZENECA$$$$$F$Y$$$20240824$$CN$US$
238875252$23887525$2$F$20240424$20240626$20240523$20240701$EXP$$US-ABBVIE-5768938$ABBVIE$$86$YR$$M$Y$70.306$KG$20240701$$CN$US$US
238875359$23887535$9$F$20240516$20240906$20240523$20240912$EXP$$CA-BIOGEN-2024BI01265904$BIOGEN$$60$YR$$F$Y$$$20240912$$CN$CA$CA
238875463$23887546$3$F$20240518$20240813$20240523$20240816$EXP$$NVSC2024US108458$NOVARTIS$$44$YR$$F$Y$$$20240816$$CN$US$US
238875582$23887558$2$F$20240701$20240722$20240523$20240729$EXP$$US-BIOGEN-2024BI01247435$BIOGEN$$33$YR$$M$Y$$$20240729$$CN$US$US
238875802$23887580$2$F$$20240808$20240523$20240813$EXP$$JP-TAKEDA-2024TJP007325$TAKEDA$$6$DEC$$M$Y$$$20240813$$PH$JP$JP
238875814$23887581$4$F$$20240717$20240523$20240722$EXP$$GB-JNJFOC-20240555292$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240722$$CN$GB$GB
238875822$23887582$2$F$$20240705$20240523$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04043$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238875842$23887584$2$F$$20240903$20240523$20240906$30DAY$$US-SANDOZ INC.-SDZ2024US050454$SANDOZ$$$$$F$Y$$$20240906$$CN$US$US
238876012$23887601$2$F$$20240726$20240523$20240731$EXP$$NVSC2024US108387$NOVARTIS$$$$$F$Y$$$20240731$$CN$US$US
238876033$23887603$3$F$20240423$20240628$20240523$20240710$EXP$$US-Accord-424763$ACCORD$$76$YR$E$F$Y$50.4$KG$20240710$$HP$US$US
238876127$23887612$7$F$20240601$20240909$20240523$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202405012435$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240912$$CN$US$US
238876143$23887614$3$F$20240501$20240718$20240523$20240729$EXP$$US-Accord-425349$ACCORD$$50$YR$A$F$Y$$$20240729$$MD$US$US
238876242$23887624$2$F$20240517$20240723$20240523$20240725$PER$$US-AMGEN-USASP2024100741$AMGEN$$49$YR$A$M$Y$$$20240725$$CN$US$US
238876304$23887630$4$F$$20240830$20240523$20240903$EXP$$IN-TAKEDA-2024TUS048518$TAKEDA$$$$$M$Y$$$20240903$$MD$IN$IN
238876373$23887637$3$F$20240424$20240827$20240523$20240828$EXP$$NL-JNJFOC-20240554904$JOHNSON AND JOHNSON$$$$A$M$Y$90$KG$20240828$$HP$NL$NL
238876382$23887638$2$F$20240301$20240726$20240523$20240730$EXP$$NVSC2024US108050$NOVARTIS$$41$YR$$F$Y$$$20240730$$CN$US$US
238876412$23887641$2$F$20140101$20240905$20240523$20240909$PER$$US-GILEAD-2024-0673885$GILEAD$$49$YR$A$M$Y$$$20240909$$LW$US$US
238876572$23887657$2$F$20240401$20240730$20240523$20240802$EXP$$US-ABBVIE-5770808$ABBVIE$$66$YR$$M$Y$$$20240802$$CN$US$US
238876592$23887659$2$F$20230622$20240808$20240523$20240814$EXP$$US-TAKEDA-2023TUS043685$TAKEDA$$26$YR$$F$Y$109$KG$20240814$$CN$US$US
238876602$23887660$2$F$$20240814$20240523$20240823$EXP$$TR-TEVA-VS-3200594$TEVA$Y ld r m BG, Aykutlu HC. The Dark Side of Combination Therapy: Tardive Dyskinesia in an Autistic Patient Using Fluoxetine and Dual Antipsychotics. Turk-J-Child-Adolesc-Ment-Health 2024; 31 (1): 99-102.; Y ld r m BG, Aykutlu HC. The Dark Side of Combination Therapy: Tardive Dyskinesia in an Autistic Patient Using Fluoxetine and Dual Antipsychotics. Turk-J-Child-Adolesc-Ment-Health 2024; 31 (1): 99-102.; Y ld r m BG, Aykutlu HC. The Dark Side of Combination Therapy: Tardive Dyskinesia in an Aut...$13$YR$$F$Y$$$20240823$$HP$TR$TR
238876632$23887663$2$F$$20240718$20240523$20240718$PER$$US-ALXN-202405USA001209US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$MD$US$US
238876663$23887666$3$F$20240510$20240821$20240523$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079439$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240821$$CN$US$US
238876686$23887668$6$F$$20240813$20240523$20240819$EXP$$CA-GILEAD-2024-0673216$GILEAD$$21$YR$A$F$Y$$$20240819$$CN$CA$CA
238876763$23887676$3$F$20190101$20240919$20240523$20240920$PER$$US-GILEAD-2024-0673892$GILEAD$$58$YR$A$M$Y$$$20240920$$LW$US$US
238876772$23887677$2$F$$20240815$20240523$20240823$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04439$VIFOR$$$$$M$Y$$$20240823$$HP$ZA$ZA
238876792$23887679$2$F$20240513$20240625$20240523$20240702$EXP$$CA-CELLTRION INC.-2024CA011978$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
238876802$23887680$2$F$20240520$20240726$20240523$20240730$PER$$US-AMGEN-USASP2024100090$AMGEN$$81$YR$E$F$Y$99$KG$20240730$$CN$US$US
238876903$23887690$3$F$20240515$20240725$20240523$20240729$EXP$$US-UCBSA-2024024848$UCB$$77$YR$$F$Y$$$20240729$$CN$US$US
238876952$23887695$2$F$20240513$20240820$20240523$20240823$PER$$US-JNJFOC-20240537439$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240823$$CN$US$US
238877062$23887706$2$F$20221003$20240708$20240523$20240711$EXP$$JP-GILEAD-2024-0673032$GILEAD$$6$DEC$A$M$Y$$$20240711$$MD$JP$JP
238877232$23887723$2$F$$20240718$20240523$20240718$PER$$US-ALXN-202405USA001156US$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240718$$CN$US$US
238877262$23887726$2$F$20150120$20240825$20240523$20240828$PER$$US-GILEAD-2024-0673513$GILEAD$$56$YR$A$M$Y$$$20240828$$LW$US$US
238877312$23887731$2$F$$20240711$20240523$20240717$EXP$$US-ROCHE-3565819$ROCHE$$83$YR$E$M$Y$$$20240717$$CN$US$US
238877393$23887739$3$F$20240516$20240722$20240523$20240723$EXP$$NVSC2024FR107475$NOVARTIS$$60$YR$$F$Y$53$KG$20240723$$CN$FR$FR
238877413$23887741$3$F$20240501$20240710$20240523$20240720$EXP$$CA-CELLTRION INC.-2024CA011968$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
238877566$23887756$6$F$20240501$20240909$20240523$20240916$EXP$$CA-CELLTRION INC.-2024CA011975$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
238877632$23887763$2$F$$20240705$20240523$20240711$PER$$US-AstraZeneca-2024A110981$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
238877774$23887777$4$F$20230519$20240723$20240523$20240726$EXP$$US-ABBVIE-5770569$ABBVIE$$74$YR$$M$Y$$$20240726$$CN$US$US
238877823$23887782$3$F$$20240617$20240523$20240709$PER$$US-ALXN-202405USA001210US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
238878053$23887805$3$F$20150830$20240905$20240523$20240909$PER$$US-GILEAD-2024-0673853$GILEAD$$42$YR$A$M$Y$$$20240909$$LW$US$US
238878072$23887807$2$F$$20240723$20240523$20240728$PER$$NVSC2024US103592$NOVARTIS$$$$$$Y$$$20240729$$CN$US$US
238878084$23887808$4$F$20240413$20240509$20240523$20240730$EXP$$US-APELLIS-APL-2024-004426$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240729$$MD$US$US
238878122$23887812$2$F$$20240716$20240523$20240716$EXP$$US-ALXN-202405USA001036US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$MD$US$US
238878262$23887826$2$F$$20240821$20240523$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079847$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240821$$MD$US$US
238878342$23887834$2$F$$20240503$20240523$20240801$PER$$US-TEVA-VS-3196379$TEVA$$$$$$Y$$$20240801$$CN$US$US
238878412$23887841$2$F$20240515$20240715$20240523$20240722$EXP$$CA-TAKEDA-2023TUS102743$TAKEDA$$53$YR$$F$Y$$$20240722$$CN$CA$CA
238878596$23887859$6$F$20230101$20240909$20240523$20240916$EXP$$DE-ROCHE-3567183$ROCHE$$63$YR$A$M$Y$$$20240916$$CN$DE$DE
238878603$23887860$3$F$20240508$20240722$20240523$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-075734$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$HP$JP$JP
238878792$23887879$2$F$20211123$20240906$20240523$20240919$EXP$$DE-AUROBINDO-AUR-APL-2024-023571$AUROBINDO$$55$YR$$F$Y$$$20240919$$CN$DE$DE
238879023$23887902$3$F$20160902$20240711$20240523$20240924$EXP$$FR-TEVA-VS-3198414$TEVA$$34$YR$$M$Y$$$20240924$$CN$FR$FR
238879064$23887906$4$F$20240101$20240808$20240523$20240809$EXP$$US-UCBSA-2024024581$UCB$$$$$F$Y$$$20240809$$CN$US$US
238879183$23887918$3$F$20200101$20240904$20240523$20240905$EXP$$US-GILEAD-2024-0674009$GILEAD$$38$YR$A$M$Y$$$20240905$$LW$US$US
238879262$23887926$2$F$$20240821$20240523$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080354$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240821$$HP$US$US
238879282$23887928$2$F$$20240822$20240523$20240826$30DAY$$US-SANDOZ INC.-SDZ2024US050012$SANDOZ$$$$$$Y$$$20240826$$CN$US$US
238879302$23887930$2$F$$20240726$20240523$20240726$EXP$$NVSC2024FR108268$NOVARTIS$$40$YR$$F$Y$$$20240726$$MD$FR$FR
238879622$23887962$2$F$20201027$20240910$20240523$20240912$PER$$US-GILEAD-2024-0673855$GILEAD$$28$YR$A$F$Y$$$20240912$$LW$US$US
238879632$23887963$2$F$20240401$20240701$20240523$20240702$PER$$US-JNJFOC-20240488404$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
238879762$23887976$2$F$20240430$20240628$20240523$20240703$EXP$$US-EMD Serono-2024027194$EMD SERONO INC$$64$YR$A$M$Y$$$20240703$$CN$US$US
238879803$23887980$3$F$20121017$20240816$20240523$20240819$PER$$US-GILEAD-2024-0673543$GILEAD$$62$YR$A$M$Y$$$20240819$$LW$US$US
238879974$23887997$4$F$20240507$20240620$20240523$20240701$EXP$$JP-UCBSA-2024024696$UCB$$49$YR$$M$Y$$$20240701$$MD$JP$JP
238880022$23888002$2$F$20120614$20240911$20240523$20240916$PER$$US-GILEAD-2024-0673980$GILEAD$$30$YR$A$M$Y$$$20240916$$LW$US$US
238880033$23888003$3$F$$20240830$20240523$20240904$PER$$NVSC2024US108130$NOVARTIS$$$$$F$Y$$$20240904$$MD$US$US
238880045$23888004$5$F$20240520$20240628$20240523$20240704$EXP$$NVSC2024CA108409$NOVARTIS$$56$YR$$M$Y$$$20240704$$CN$CA$CA
238880102$23888010$2$F$$20240910$20240523$20240916$PER$$US-GILEAD-2024-0674036$GILEAD$$$$A$M$Y$$$20240916$$LW$US$US
238880132$23888013$2$F$20161020$20240701$20240523$20240702$EXP$$US-GILEAD-2024-0673576$GILEAD$$31$YR$A$M$Y$$$20240702$$LW$US$US
238880142$23888014$2$F$20210101$20240821$20240523$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-080374$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240822$$MD$JP$JP
238880313$23888031$3$F$20200720$20240907$20240523$20240911$EXP$$US-GILEAD-2024-0673984$GILEAD$$57$YR$A$M$Y$$$20240911$$LW$US$US
238880322$23888032$2$F$$20240718$20240523$20240718$PER$$US-ALXN-202405USA001268US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$MD$US$US
238880345$23888034$5$F$$20240627$20240523$20240702$PER$$US-LEO Pharma-370503$LEO PHARM$$58$YR$$M$Y$$$20240702$$CN$US$US
238880563$23888056$3$F$20240515$20240628$20240523$20240706$PER$$US-AMGEN-USASP2024099003$AMGEN$$59$YR$A$M$Y$$$20240706$$PH$US$US
238880612$23888061$2$F$$20240920$20240523$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-024870$AUROBINDO$Candeloro M, Eikelboom JW, Chan N, Bhagirath V, Douketis JD, Schulman S.. Carbamazepine, phenytoin, and oral anticoagulants: Drug-drug interaction and clinical  events in a retrospective cohort.. Research and Practice in Thrombosis and  Haemostasis.. 2022;6 (2):e12650$71$YR$$F$Y$$$20240928$$HP$CA$CA
238880623$23888062$3$F$$20240730$20240523$20240806$EXP$$US-ROCHE-3566300$ROCHE$$$$E$M$Y$$$20240806$$CN$US$US
238880652$23888065$2$F$$20240821$20240523$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080387$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240821$$CN$US$US
238880972$23888097$2$F$20090101$20240911$20240523$20240916$EXP$$US-GILEAD-2024-0673985$GILEAD$$39$YR$A$M$Y$$$20240916$$LW$US$US
238881042$23888104$2$F$$20240518$20240523$20240808$PER$$US-LEO Pharma-370581$LEO PHARM$$60$YR$$F$Y$$$20240808$$CN$US$US
238881054$23888105$4$F$$20240801$20240523$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080415$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240808$$CN$US$US
238881104$23888110$4$F$20231101$20240910$20240523$20240917$EXP$$CA-GSK-CA2024025642$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
238881142$23888114$2$F$$20240712$20240523$20240722$EXP$$VN-SANDOZ INC.-SDZ2024VN051009$SANDOZ$$43$YR$$F$Y$$$20240722$$MD$VN$VN
238881172$23888117$2$F$20231201$20240713$20240523$20240722$EXP$$CA-CELLTRION INC.-2024CA010251$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
238881255$23888125$5$F$20230101$20240906$20240523$20240916$EXP$$CA-CELLTRION INC.-2023CA016463$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
238881272$23888127$2$F$20170101$20240904$20240523$20240906$EXP$$US-GILEAD-2024-0673871$GILEAD$$55$YR$A$M$Y$$$20240906$$LW$US$US
238881442$23888144$2$F$$20240802$20240523$20240812$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-075473$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240812$$MD$PL$PL
238881782$23888178$2$F$$20240513$20240523$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003043$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238881793$23888179$3$F$20180111$20240909$20240523$20240912$PER$$US-GILEAD-2024-0674026$GILEAD$$44$YR$A$F$Y$$$20240912$$LW$US$US
238881803$23888180$3$F$$20240805$20240523$20240807$EXP$$CA-ORGANON-O2405CAN001717$ORGANON$$65$YR$$F$Y$34$KG$20240807$$HP$CA$CA
238881903$23888190$3$F$20240101$20240709$20240523$20240710$EXP$$US-UCBSA-2024013196$UCB$$$$$F$Y$$$20240710$$CN$US$US
238882032$23888203$2$F$$20240820$20240523$20240823$EXP$$US-JNJFOC-20240558657$JOHNSON AND JOHNSON$$$$A$F$Y$115$KG$20240823$$MD$US$US
238882193$23888219$3$F$$20240904$20240523$20240904$PER$$US-ALXN-202405USA000948US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
238882227$23888222$7$F$20230420$20240918$20240523$20240924$EXP$$AU-TAKEDA-2023TUS044415$TAKEDA$$49$YR$$F$Y$$$20240924$$CN$AU$AU
238882283$23888228$3$F$20151224$20240912$20240523$20240916$PER$$US-GILEAD-2024-0673873$GILEAD$$55$YR$A$M$Y$$$20240916$$LW$US$US
238882413$23888241$3$F$20240512$20240919$20240523$20240928$EXP$$CA-CELLTRION INC.-2024CA012047$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
238882672$23888267$2$F$20240521$20240823$20240523$20240827$PER$$US-AMGEN-USASP2024101001$AMGEN$$69$YR$E$F$Y$$$20240826$$CN$US$US
238882682$23888268$2$F$$20240723$20240523$20240726$EXP$$JP-ASTELLAS-2024JP003361$ASTELLAS$$8$DEC$$M$Y$$$20240726$$MD$JP$JP
238882852$23888285$2$F$$20240821$20240523$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080558$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240821$$HP$US$US
238882994$23888299$4$F$20240510$20240806$20240523$20240813$EXP$$JP-AMGEN-JPNSP2024098001$AMGEN$$71$YR$E$M$Y$$$20240813$$PH$JP$JP
238883002$23888300$2$F$20240401$20240913$20240523$20240927$EXP$$US-UCBSA-2024024862$UCB$$51$YR$$F$Y$$$20240927$$HP$US$US
238883022$23888302$2$F$$20240515$20240523$20240723$EXP$$NVSC2024US106287$NOVARTIS$Gwinn M, Bonilla M. Unmasking true acute kidney injury: a case report on CDK 4/6 inhibitor-induced renal toxicity. AMERICAN JOURNAL OF KIDNEY DISEASES. 2024;83 (Supl 2)(4):S20$66$YR$$F$Y$$$20240723$$HP$US$US
238883063$23888306$3$F$20211207$20240905$20240523$20240910$PER$$US-GILEAD-2024-0673988$GILEAD$$64$YR$A$M$Y$$$20240910$$LW$US$US
238883102$23888310$2$F$$20240627$20240523$20240703$EXP$$DE-MYLANLABS-2024M1045091$MYLAN$$89$YR$$F$Y$50$KG$20240703$$MD$DE$DE
238883173$23888317$3$F$20240401$20240808$20240523$20240814$EXP$$IN-GSK-IN2024APC063862$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$IN$IN
238883184$23888318$4$F$20240307$20240719$20240523$20240724$EXP$$NVSC2024DE060375$NOVARTIS$$38$YR$$F$Y$61$KG$20240724$$MD$DE$DE
238883302$23888330$2$F$20240630$20240705$20240523$20240710$EXP$$US-ASTELLAS-2024US014402$ASTELLAS$$88$YR$$M$Y$$$20240710$$CN$US$US
238883313$23888331$3$F$20160101$20240914$20240523$20240917$PER$$US-GILEAD-2024-0673874$GILEAD$$50$YR$A$M$Y$$$20240917$$LW$US$US
238883322$23888332$2$F$$20240628$20240523$20240709$PER$$US-JNJFOC-20240564152$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$HP$US$US
238883753$23888375$3$F$20240209$20240709$20240523$20240722$EXP$$CA-BAYER-2024A070854$BAYER$$54$YR$A$F$Y$$$20240722$$CN$CA$CA
238883822$23888382$2$F$20240521$20240628$20240523$20240702$PER$$US-AMGEN-USASP2024101232$AMGEN$$67$YR$E$F$Y$$$20240702$$CN$US$US
238883852$23888385$2$F$20240507$20240715$20240523$20240716$PER$$US-ALXN-202405USA000947US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
238883902$23888390$2$F$$20240715$20240523$20240716$EXP$$US-ALXN-202405USA000950US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$PH$US$US
238883923$23888392$3$F$20130709$20240910$20240523$20240916$EXP$$US-GILEAD-2024-0673992$GILEAD$$43$YR$A$M$Y$$$20240916$$LW$US$US
238883932$23888393$2$F$20230317$20240801$20240523$20240807$EXP$$PT-MYLANLABS-2024M1046339$MYLAN$Duarte AM, Leiria N, Pires R, Cortez M. Arising from the bottom - a rare complication of a thoracic epidural catheter. Region-Anesth-Pain-Med 2023; 48 (Suppl. 1) A185 abstr. 36246.$44$YR$$M$Y$73.8$KG$20240807$$HP$PT$PT
238884002$23888400$2$F$20240301$20240924$20240523$20240930$EXP$$JP-009507513-2405JPN001242J$MERCK$$$$$F$Y$$$20240930$$MD$JP$JP
238884052$23888405$2$F$20130812$20240905$20240523$20240906$PER$$US-GILEAD-2024-0673989$GILEAD$$39$YR$A$M$Y$$$20240906$$LW$US$US
238884124$23888412$4$F$20240101$20240725$20240523$20240802$EXP$$JP-GENMAB-2024-01135AA$GENMAB$$76$YR$$F$Y$37$KG$20240802$$MD$JP$JP
238884272$23888427$2$F$$20240625$20240523$20240701$EXP$$JP-JNJFOC-20240566231$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$PH$JP$JP
238884543$23888454$3$F$20240501$20240724$20240523$20240730$PER$$US-AMGEN-USASP2024101975$AMGEN$$$$$$Y$$$20240729$$PH$US$US
238884632$23888463$2$F$20230601$20240522$20240523$20240729$EXP$$NVSC2024RO107945$NOVARTIS$$63$YR$$F$Y$$$20240729$$MD$RO$RO
238884772$23888477$2$F$20230302$20240805$20240523$20240812$EXP$PT-INFARMED-A202405-43$PT-MYLANLABS-2024M1045454$MYLAN$$53$YR$$F$Y$$$20240812$$PH$PT$PT
238884832$23888483$2$F$$20240517$20240523$20240723$EXP$$NVSC2024FR104709$NOVARTIS$Flippot R, Telli T, Velev, M., Flechon, A, De Vries-Brilland, M, Turpin L et al. Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study.. EUROPEAN UROLOGY ONCOLOGY. 2024;S2588-9311$$$$M$Y$$$20240723$$HP$FR$FR
238884842$23888484$2$F$20110418$20240909$20240523$20240912$EXP$$US-GILEAD-2024-0673875$GILEAD$$33$YR$A$F$Y$$$20240912$$LW$US$US
238884872$23888487$2$F$20240101$20240714$20240523$20240715$EXP$$CA-PFIZER INC-202400173352$PFIZER$$62$YR$$M$Y$$$20240715$$HP$CA$CA
238884882$23888488$2$F$20240517$20240714$20240523$20240715$EXP$$CA-PFIZER INC-202300358177$PFIZER$$83$YR$$M$Y$$$20240715$$HP$CA$CA
238884893$23888489$3$F$20230101$20240718$20240523$20240723$EXP$$CA-PFIZER INC-202300283406$PFIZER$$66$YR$$F$Y$$$20240723$$HP$CA$CA
238884902$23888490$2$F$20240101$20240710$20240523$20240710$EXP$$CA-PFIZER INC-202400095532$PFIZER$$67$YR$$F$Y$$$20240710$$CN$CA$CA
238884942$23888494$2$F$$20240722$20240523$20240725$EXP$$JO-JNJFOC-20240553329$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240725$$MD$JO$JO
238885233$23888523$3$F$$20240627$20240523$20240708$EXP$$US-AUROBINDO-AUR-APL-2024-024674$AUROBINDO$Khandait H, Musleh G, Abruzzo A, Noori MAM, Joshi MB.. Idiosyncratic Amiodarone-Induced Torsades de Pointes: A Case Report. SN Comprehensive Clinical Medicine.. 2024;6(1):40$70$YR$$F$Y$$$20240708$$HP$US$US
238885423$23888542$3$F$20181023$20240911$20240523$20240916$EXP$$US-GILEAD-2024-0673994$GILEAD$$43$YR$A$M$Y$$$20240916$$LW$US$US
238885502$23888550$2$F$20180717$20240909$20240523$20240913$PER$$US-GILEAD-2024-0674010$GILEAD$$48$YR$A$M$Y$$$20240913$$LW$US$US
238885552$23888555$2$F$$20240821$20240523$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080463$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240821$$CN$US$US
238885893$23888589$3$F$20240417$20240708$20240523$20240711$EXP$$NVSC2024GB108313$NOVARTIS$$$$E$F$Y$$$20240711$$CN$GB$GB
238885913$23888591$3$F$$20240917$20240523$20240923$EXP$$NVSC2024AU107180$NOVARTIS$$59$YR$$M$Y$$$20240923$$CN$AU$AU
238885942$23888594$2$F$$20240624$20240523$20240701$PER$$US-JNJFOC-20240559830$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$HP$US$US
238885972$23888597$2$F$20230901$20240823$20240523$20240828$EXP$$NVSJ2023JP017604$NOVARTIS$$60$YR$$F$Y$$$20240828$$MD$JP$JP
238886002$23888600$2$F$20240430$20240703$20240523$20240704$EXP$$US-INCYTE CORPORATION-2024IN005459$INCYTE$$$$$$Y$$$20240704$$MD$US$US
238886022$23888602$2$F$20230307$20240806$20240523$20240812$EXP$PT-INFARMED-A202405-48$PT-MYLANLABS-2024M1045552$MYLAN$$52$YR$$F$Y$$$20240812$$PH$PT$PT
238886093$23888609$3$F$$20240913$20240523$20240918$30DAY$$US-PFIZER INC-202400105794$PFIZER$$$$$$Y$$$20240918$$CN$US$US
238886124$23888612$4$F$$20240822$20240523$20240822$EXP$$GB-PFIZER INC-PV202400067025$PFIZER$$60$YR$$F$Y$$$20240822$$CN$GB$GB
238886133$23888613$3$F$20220829$20240907$20240523$20240910$PER$$US-GILEAD-2024-0673880$GILEAD$$41$YR$A$M$Y$$$20240910$$LW$US$US
238886192$23888619$2$F$20240429$20240821$20240523$20240903$30DAY$$GB-PFIZER INC-202400105414$PFIZER$$$$$$Y$$$20240903$$CN$GB$GB
238886202$23888620$2$F$20161010$20240912$20240523$20240916$PER$$US-GILEAD-2024-0673997$GILEAD$$52$YR$A$M$Y$$$20240916$$LW$US$US
238886944$23888694$4$F$20240515$20240726$20240523$20240727$PER$$US-AMGEN-USASP2024100560$AMGEN$$60$YR$A$F$Y$$$20240727$$CN$US$US
238887073$23888707$3$F$20130101$20240909$20240523$20240912$EXP$$US-GILEAD-2024-0673881$GILEAD$$57$YR$A$F$Y$$$20240912$$LW$US$US
238887083$23888708$3$F$20221101$20240909$20240523$20240911$PER$$US-GILEAD-2024-0674000$GILEAD$$50$YR$A$M$Y$$$20240911$$LW$US$US
238887142$23888714$2$F$20240513$20240820$20240523$20240823$PER$$US-JNJFOC-20240551962$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240823$$CN$US$US
238887502$23888750$2$F$$20240709$20240523$20240713$EXP$$US-ABBVIE-5769889$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
238887542$23888754$2$F$20240425$20240722$20240523$20240815$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000282$BECTON DICKINSON$$$$$$Y$$$20240814$$CN$GB$GB
238887553$23888755$3$F$20191121$20240910$20240523$20240912$PER$$US-GILEAD-2024-0673998$GILEAD$$54$YR$A$M$Y$$$20240912$$LW$US$US
238887602$23888760$2$F$20240424$20240722$20240523$20240815$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000283$BECTON DICKINSON$$$$$$Y$$$20240814$$CN$GB$GB
238887655$23888765$5$F$20231201$20240816$20240523$20240819$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-280035$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240819$$CN$US$US
238887743$23888774$3$F$20180623$20240905$20240523$20240912$EXP$$US-GILEAD-2024-0674002$GILEAD$$43$YR$A$M$Y$$$20240912$$LW$US$US
238887762$23888776$2$F$$20240716$20240523$20240716$PER$$US-ALXN-202405USA001061US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
238887953$23888795$3$F$$20240812$20240523$20240816$30DAY$$JO-PFIZER INC-202400106396$PFIZER$$$$$$Y$$$20240816$$CN$JO$JO
238887964$23888796$4$F$$20240921$20240523$20240925$30DAY$$US-PFIZER INC-202400171700$PFIZER$$11$YR$$M$Y$$$20240925$$CN$US$US
238888004$23888800$4$F$$20240921$20240523$20240925$30DAY$$US-PFIZER INC-202400171799$PFIZER$$14$YR$$M$Y$$$20240925$$CN$US$US
238888023$23888802$3$F$$20240821$20240523$20240826$30DAY$$US-PFIZER INC-202400125082$PFIZER$$13$YR$$M$Y$$$20240826$$CN$US$US
238888062$23888806$2$F$20240501$20240704$20240523$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04073$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238888082$23888808$2$F$$20240710$20240523$20240723$EXP$$US-JNJFOC-20240540896$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240719$$HP$US$US
238888132$23888813$2$F$20240201$20240613$20240523$20240704$PER$$US-009507513-2405USA001933$MERCK$$35$YR$$F$Y$$$20240704$$CN$US$US
238888143$23888814$3$F$$20240704$20240523$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04106$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238888173$23888817$3$F$$20240829$20240523$20240904$30DAY$$CO-PFIZER INC-202400172328$PFIZER$$13$YR$$F$Y$$$20240904$$CN$CO$CO
238888183$23888818$3$F$$20240910$20240523$20240912$30DAY$$GB-PFIZER INC-PV202400066327$PFIZER$$64$YR$$F$Y$$$20240912$$CN$GB$GB
238888363$23888836$3$F$$20240718$20240523$20240718$PER$$US-ALXN-202405USA001222US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
238888377$23888837$7$F$20240101$20240826$20240523$20240904$EXP$$US-UCBSA-2024023920$UCB$$$$$F$Y$63$KG$20240904$$CN$US$US
238888413$23888841$3$F$20211214$20240910$20240523$20240913$PER$$US-GILEAD-2024-0674037$GILEAD$$63$YR$A$M$Y$$$20240913$$LW$US$US
238888423$23888842$3$F$20240501$20240816$20240523$20240821$PER$$US-Eisai-EC-2024-166220$EISAI$$60$YR$A$F$Y$$$20240821$$CN$US$US
238888433$23888843$3$F$$20240704$20240523$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04154$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238888502$23888850$2$F$20240520$20240906$20240523$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079858$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240909$$CN$US$US
238888562$23888856$2$F$20200701$20240906$20240523$20240911$PER$$US-GILEAD-2024-0673966$GILEAD$$32$YR$A$M$Y$$$20240911$$LW$US$US
238888662$23888866$2$F$$20240626$20240523$20240708$EXP$$JP-AMGEN-JPNSP2024099020$AMGEN$Nobuhiro Hashimoto, Terumasa Hayashi, Tatsuo Kagimura, Ichiei Narita. Erythropoiesis-stimulating agents (ESA) hyporesponsiveness is associated with malignancy development - Subanalysis of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis stimulating agents, darbepoetiN alfa (BRIGHTEN)$$$$$Y$$$20240708$$MD$JP$JP
238888673$23888867$3$F$20160818$20240906$20240523$20240916$PER$$US-GILEAD-2024-0674069$GILEAD$$43$YR$A$F$Y$$$20240916$$LW$US$US
238888686$23888868$6$F$20240101$20240815$20240523$20240822$30DAY$$US-PFIZER INC-202400130343$PFIZER$$7$YR$$F$Y$$$20240822$$CN$US$US
238888732$23888873$2$F$$20240704$20240523$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04075$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238888896$23888889$6$F$20240401$20240911$20240523$20240916$30DAY$$US-UCBSA-2024022465$UCB$$54$YR$$F$Y$85.7$KG$20240916$$CN$US$US
238889073$23888907$3$F$20240514$20240703$20240523$20240710$EXP$$US-VERTEX PHARMACEUTICALS-2024-008682$VERTEX$$31$YR$$M$Y$$$20240710$$MD$US$US
238889102$23888910$2$F$20240501$20240911$20240523$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080680$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240913$$CN$US$US
238889112$23888911$2$F$20230901$20240724$20240523$20240730$EXP$$FR-VERTEX PHARMACEUTICALS-2024-002743$VERTEX$$6$YR$$M$Y$$$20240730$$MD$FR$FR
238889152$23888915$2$F$$20240708$20240523$20240717$PER$$US-VERTEX PHARMACEUTICALS-2024-008352$VERTEX$$2$YR$$M$Y$$$20240717$$CN$US$US
238889162$23888916$2$F$$20240826$20240523$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079455$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240829$$CN$US$US
238889205$23888920$5$F$$20240628$20240523$20240708$5DAY$$US-ASTELLAS-2024US014446$ASTELLAS$$$$$$Y$$$20240708$$CN$US$US
238889243$23888924$3$F$20240401$20240704$20240523$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04112$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238889255$23888925$5$F$20160218$20240904$20240523$20240909$PER$$US-GILEAD-2024-0674027$GILEAD$$51$YR$A$M$Y$$$20240909$$LW$US$US
238889393$23888939$3$F$$20240916$20240523$20240919$30DAY$$US-PFIZER INC-202400173053$PFIZER$$13$YR$$M$Y$$$20240919$$CN$US$US
238889423$23888942$3$F$20170901$20240911$20240523$20240913$PER$$US-GILEAD-2024-0674031$GILEAD$$68$YR$E$M$Y$$$20240913$$LW$US$US
238889512$23888951$2$F$20170510$20240906$20240523$20240912$PER$$US-GILEAD-2024-0674006$GILEAD$$49$YR$A$M$Y$$$20240912$$LW$US$US
238889524$23888952$4$F$$20240906$20240523$20240910$EXP$$NVSC2024AU108885$NOVARTIS$$$$$F$Y$$$20240910$$HP$AU$AU
238889563$23888956$3$F$20240501$20240821$20240523$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080613$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240821$$CN$US$US
238889572$23888957$2$F$$20240821$20240523$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080508$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240822$$CN$US$US
238889612$23888961$2$F$$20240705$20240523$20240708$PER$$US-AstraZeneca-2024A119183$ASTRAZENECA$$$$$M$Y$$$20240708$$MD$US$
238889663$23888966$3$F$$20240717$20240523$20240805$30DAY$$JP-PFIZER INC-PV202400064963$PFIZER$$$$$$Y$$$20240805$$MD$JP$JP
238889674$23888967$4$F$$20240712$20240523$20240712$30DAY$$US-PFIZER INC-202400172803$PFIZER$$6$YR$$M$Y$$$20240712$$CN$US$US
238889772$23888977$2$F$$20240618$20240523$20240702$30DAY$$GB-JNJFOC-20240558723$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$GB$GB
238889792$23888979$2$F$$20240704$20240523$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04118$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238889802$23888980$2$F$20210529$20240910$20240523$20240912$EXP$$US-GILEAD-2024-0673979$GILEAD$$47$YR$A$M$Y$$$20240912$$LW$US$US
238889912$23888991$2$F$20240228$20240702$20240523$20240704$PER$$NVSC2024US109054$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
238889963$23888996$3$F$20231206$20240708$20240523$20240716$EXP$$KR-TAKEDA-2024TUS050098$TAKEDA$$$$A$F$Y$$$20240716$$MD$KR$KR
238889983$23888998$3$F$$20240510$20240523$20240722$EXP$$US-APELLIS-2024-APL-0000011$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240722$$HP$US$US
238890013$23889001$3$F$20240501$20240701$20240523$20240709$EXP$$JP-009507513-2405JPN001634J$MERCK$$61$YR$$M$Y$$$20240709$$MD$JP$JP
238890082$23889008$2$F$20240516$20240701$20240523$20240709$PER$$US-JNJFOC-20240551778$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
238890122$23889012$2$F$$20240627$20240523$20240703$EXP$$JP-JNJFOC-20240565591$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240703$$MD$JP$JP
238890142$23889014$2$F$20240428$20240814$20240523$20240820$EXP$$IT-AMGEN-ITASP2024097620$AMGEN$$53$YR$A$F$Y$61$KG$20240820$$CN$IT$IT
238890173$23889017$3$F$20150423$20240911$20240523$20240916$EXP$$US-GILEAD-2024-0674067$GILEAD$$58$YR$A$M$Y$$$20240916$$LW$US$US
2388902712$23889027$12$F$$20240809$20240523$20240816$EXP$$US-SANDOZ INC.-SDZ2024US050169$SANDOZ$$$$$F$Y$93.424$KG$20240816$$CN$US$US
238890362$23889036$2$F$$20240923$20240523$20240926$EXP$$GB-MYLANLABS-2024M1046640$MYLAN$$53$YR$$F$Y$$$20240926$$MD$GB$GB
238890403$23889040$3$F$$20240715$20240523$20240723$EXP$$US-APELLIS-2024-APL-0000074$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
238890453$23889045$3$F$$20240703$20240523$20240708$EXP$$US-INCYTE CORPORATION-2024IN005305$INCYTE$$$$$$Y$$$20240708$$MD$US$US
238890503$23889050$3$F$20210201$20240904$20240523$20240906$EXP$$US-GILEAD-2024-0674013$GILEAD$$57$YR$A$M$Y$$$20240906$$LW$US$US
238890515$23889051$5$F$20180502$20240830$20240523$20240905$EXP$$CA-TAKEDA-2018TUS009230$TAKEDA$$76$YR$$M$Y$$$20240905$$CN$CA$CA
238890552$23889055$2$F$$20240624$20240523$20240703$30DAY$$JP-JNJFOC-20240557549$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$JP$JP
238890573$23889057$3$F$20210503$20240911$20240523$20240913$PER$$US-GILEAD-2024-0673968$GILEAD$$55$YR$A$M$Y$$$20240913$$LW$US$US
238890662$23889066$2$F$20240207$20240829$20240523$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447342$RANBAXY$$75$YR$$F$Y$$$20240913$$MD$AU$AU
238890842$23889084$2$F$20240516$20240731$20240523$20240803$PER$$US-AMGEN-USASP2024101884$AMGEN$$67$YR$E$F$Y$$$20240803$$CN$US$US
238891032$23889103$2$F$$20240910$20240523$20240912$PER$$US-GILEAD-2024-0674016$GILEAD$$56$YR$A$M$Y$$$20240912$$LW$US$US
238891103$23889110$3$F$$20240821$20240523$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080915$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240821$$CN$US$US
238891323$23889132$3$F$20240430$20240716$20240523$20240729$EXP$$US-JNJFOC-20240509404$JOHNSON AND JOHNSON$$62$YR$A$F$Y$64$KG$20240729$$MD$US$US
238891332$23889133$2$F$$20240510$20240523$20240906$PER$$US-FARMAPROD-202404-1335$DOMPE FARMACEUTICI$$$$E$F$Y$63.32$KG$20240904$$CN$US$
238891352$23889135$2$F$20240507$20240712$20240523$20240724$EXP$$JP-AMGEN-JPNSP2024100630$AMGEN$$8$DEC$E$F$Y$$$20240723$$MD$JP$JP
238891462$23889146$2$F$20191230$20240905$20240523$20240906$EXP$$US-GILEAD-2024-0674019$GILEAD$$57$YR$A$M$Y$$$20240906$$LW$US$US
238891553$23889155$3$F$20160502$20240906$20240523$20240910$PER$$US-GILEAD-2024-0674004$GILEAD$$41$YR$A$M$Y$$$20240910$$LW$US$US
238891614$23889161$4$F$20240608$20240803$20240523$20240807$EXP$$AU-TAKEDA-2024TUS012594$TAKEDA$$76$YR$$M$Y$$$20240807$$HP$AU$AU
238891625$23889162$5$F$20240110$20240802$20240523$20240807$EXP$$CA-TAKEDA-2024TUS018045$TAKEDA$$13$YR$$M$Y$$$20240807$$HP$CA$CA
238891842$23889184$2$F$$20240704$20240523$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04137$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238891944$23889194$4$F$20240501$20240701$20240523$20240704$EXP$$ZA-AMGEN-ZAFSP2024100802$AMGEN$$63$YR$A$F$Y$$$20240704$$HP$ZA$ZA
238891952$23889195$2$F$$20240731$20240523$20240807$PER$$US-INCYTE CORPORATION-2024IN005148$INCYTE$$$$$$Y$$$20240807$$CN$US$US
238892022$23889202$2$F$20240101$20240910$20240523$20240913$PER$$US-009507513-2404USA011174$MERCK$$$$$M$Y$$$20240913$$CN$US$US
238892392$23889239$2$F$$20240620$20240523$20240702$PER$$US-TRAVERE-2024TVT00508$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240702$$CN$US$US
238892422$23889242$2$F$20240401$20240725$20240523$20240730$EXP$$US-UCBSA-2024025056$UCB$$41$YR$$F$Y$$$20240730$$HP$US$US
238892453$23889245$3$F$20240516$20240709$20240523$20240712$PER$$JP-Eisai-EC-2024-165976$EISAI$$74$YR$E$F$Y$$$20240712$$MD$JP$JP
238892472$23889247$2$F$20200523$20240919$20240523$20240920$PER$$US-GILEAD-2024-0673959$GILEAD$$40$YR$A$M$Y$$$20240920$$LW$US$US
238892483$23889248$3$F$20210101$20240910$20240523$20240916$PER$$US-GILEAD-2024-0674022$GILEAD$$54$YR$A$M$Y$$$20240916$$LW$US$US
238892562$23889256$2$F$$20240711$20240523$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-015224$UNITED THERAPEUTICS$$$$$F$Y$82.086$KG$20240719$$$US$US
238892862$23889286$2$F$20240426$20240702$20240523$20240813$PER$$TR-TOLMAR, INC.-24TR048912$TOLMAR$$72$YR$$M$Y$$$20240813$$PH$TR$TR
238892872$23889287$2$F$20240426$20240702$20240523$20240813$PER$$TR-TOLMAR, INC.-24TR048919$TOLMAR$$$$E$M$Y$$$20240813$$MD$TR$TR
238892892$23889289$2$F$$20240702$20240523$20240709$EXP$$JP-009507513-2405JPN001685J$MERCK$$67$YR$$M$Y$$$20240709$$MD$JP$JP
238892934$23889293$4$F$20240502$20240805$20240523$20240815$EXP$$JP-EMD Serono-2024026175$EMD SERONO INC$$74$YR$E$F$Y$40$KG$20240815$$MD$JP$JP
238893022$23889302$2$F$20240116$20240821$20240523$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076423$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240821$$HP$US$US
238893322$23889332$2$F$20130619$20240905$20240523$20240906$PER$$US-GILEAD-2024-0674033$GILEAD$$47$YR$A$M$Y$$$20240906$$LW$US$US
238893563$23889356$3$F$20220506$20240904$20240523$20240905$PER$$US-GILEAD-2024-0673964$GILEAD$$64$YR$A$M$Y$$$20240905$$LW$US$US
238893703$23889370$3$F$20231201$20240715$20240523$20240719$EXP$$CA-ABBVIE-5770302$ABBVIE$$56$YR$$M$Y$80$KG$20240719$$PH$CA$CA
238893752$23889375$2$F$20240501$20240925$20240523$20240930$EXP$$CA-PFIZER INC-202300452790$PFIZER$$43$YR$$F$Y$$$20240930$$HP$CA$CA
238893876$23889387$6$F$$20240725$20240523$20240725$EXP$$US-PFIZER INC-202200699389$PFIZER$$65$YR$$F$Y$58.5$KG$20240725$$CN$US$US
238893942$23889394$2$F$$20240906$20240523$20240909$EXP$$US-PFIZER INC-202400174141$PFIZER$$65$YR$$F$Y$$$20240909$$HP$US$US
238894045$23889404$5$F$20240507$20240812$20240523$20240815$EXP$$FR-PFIZER INC-202400171936$PFIZER$$61$YR$$M$Y$133$KG$20240815$$MD$FR$FR
238894303$23889430$3$F$20200301$20240814$20240523$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080958$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$53.1$KG$20240820$$PH$US$US
238894523$23889452$3$F$20150101$20240909$20240523$20240911$PER$$US-GILEAD-2024-0674040$GILEAD$$65$YR$E$M$Y$$$20240911$$LW$US$US
238894572$23889457$2$F$$20240415$20240523$20240705$PER$$US-APELLIS-2024-APL-0000018$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240705$$CN$US$US
238894773$23889477$3$F$$20240826$20240523$20240903$30DAY$$US-PFIZER INC-202400173257$PFIZER$$43$YR$$F$Y$$$20240903$$CN$US$US
238895032$23889503$2$F$$20240625$20240523$20240708$EXP$$FR-TAKEDA-2024TUS050628$TAKEDA$$$$$M$Y$$$20240708$$CN$FR$FR
238895103$23889510$3$F$20240624$20240819$20240523$20240821$PER$$US-PFIZER INC-202400106850$PFIZER$$55$YR$$F$Y$$$20240821$$HP$US$US
238895203$23889520$3$F$20210101$20240820$20240523$20240822$PER$$US-PFIZER INC-PV202400066899$PFIZER$$63$YR$$F$Y$$$20240822$$HP$US$US
238895352$23889535$2$F$$20240705$20240523$20240705$PER$$NVSC2024US104826$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
238895545$23889554$5$F$$20240924$20240523$20240927$EXP$$US-TAKEDA-2024TUS049892$TAKEDA$$$$$M$Y$$$20240927$$MD$US$US
238895752$23889575$2$F$20240321$20240821$20240523$20240826$EXP$$US-OTSUKA-2024_007706$OTSUKA$$$$$M$Y$$$20240826$$CN$US$US
238895952$23889595$2$F$20230201$20240730$20240523$20240805$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2023CUR003956$CURRAX PHARMACEUTICALS$$42$YR$$F$Y$$$20240805$$CN$CA$CA
238896084$23889608$4$F$20240424$20240904$20240523$20240912$EXP$$CA-TAKEDA-2024TUS037206$TAKEDA$$67$YR$$F$Y$$$20240912$$CN$CA$CA
238896123$23889612$3$F$$20240624$20240523$20240701$PER$$US-PFIZER INC-PV202400066187$PFIZER$$63$YR$$M$Y$$$20240701$$HP$US$US
238896192$23889619$2$F$$20240726$20240523$20240729$EXP$$NVSC2024US108841$NOVARTIS$$$$$M$Y$$$20240729$$CN$US$US
238896203$23889620$3$F$20210701$20240726$20240523$20240730$EXP$$CA-TAKEDA-2024TUS051299$TAKEDA$$20$YR$$F$Y$$$20240730$$HP$CA$CA
238896224$23889622$4$F$20230101$20240820$20240523$20240823$EXP$$US-BIOGEN-2024BI01265137$BIOGEN$$$$$F$Y$$$20240823$$MD$US$US
238896262$23889626$2$F$20240118$20240715$20240523$20240718$EXP$$ES-PFIZER INC-202400083952$PFIZER$$$$E$M$Y$104.5$KG$20240718$$MD$ES$ES
238896344$23889634$4$F$20240101$20240815$20240523$20240820$PER$$US-PFIZER INC-PV202400054830$PFIZER$$76$YR$$F$Y$$$20240820$$CN$US$US
238896352$23889635$2$F$$20240829$20240523$20240903$EXP$$BE-PFIZER INC-202400172950$PFIZER$Mustafovski M.. WORKSHOP VAN DE BELGIAN CLUB OF DERMATOPATHOLOGY - The importance of Clinicopathological Correlation in Dermatology.. SKIN. 2024;27(2):14-17$72$YR$$M$Y$$$20240903$$HP$BE$BE
238896532$23889653$2$F$20240521$20240821$20240523$20240824$PER$$US-AMGEN-USASP2024101344$AMGEN$$84$YR$E$F$Y$$$20240824$$HP$US$US
238896543$23889654$3$F$20210603$20240917$20240523$20240919$EXP$$ES-PFIZER INC-202400173725$PFIZER$$59$YR$$M$Y$93.1$KG$20240919$$MD$ES$ES
238896604$23889660$4$F$20230601$20240820$20240523$20240826$EXP$$BR-AstraZeneca-2024A059946$ASTRAZENECA$$14202$DY$$F$Y$73$KG$20240826$$MD$BR$
238896653$23889665$3$F$$20240813$20240523$20240816$PER$$US-PFIZER INC-202400174456$PFIZER$$30$YR$$F$Y$$$20240816$$HP$US$US
238896692$23889669$2$F$$20240718$20240523$20240725$EXP$$NVSC2024GB037152$NOVARTIS$$27$YR$$F$Y$$$20240725$$HP$GB$GB
238896743$23889674$3$F$20240322$20240710$20240523$20240711$EXP$$GR-SANDOZ INC.-SDZ2024GR050409$SANDOZ$$63$YR$$F$Y$58$KG$20240711$$MD$GR$GR
238896773$23889677$3$F$$20240718$20240523$20240718$PER$$US-ALXN-202405USA001166US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
238896793$23889679$3$F$20240101$20240703$20240523$20240705$EXP$$US-UCBSA-2024025264$UCB$$$$$M$Y$84.4$KG$20240705$$HP$US$US
238896874$23889687$4$F$20240107$20240806$20240523$20240820$EXP$$US-UCBSA-2024002007$UCB$$4$YR$$F$Y$$$20240820$$CN$US$US
238896882$23889688$2$F$20240501$20240704$20240523$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04108$LUPIN$$$$$$Y$$$20240725$$CN$US$US
238896913$23889691$3$F$$20240708$20240523$20240712$EXP$$US-Taiho Oncology Inc-2024-005096$TAIHO ONCOLOGY INC$$68$YR$E$M$Y$93.89$KG$20240712$$CN$US$US
238896975$23889697$5$F$20240506$20240920$20240523$20240926$EXP$$US-TAKEDA-2024TUS041686$TAKEDA$$15$YR$$M$Y$42$KG$20240926$$HP$US$US
238897074$23889707$4$F$20240513$20240708$20240523$20240711$EXP$$DE-ALXN-202405EEA000942DE$ALEXION PHARMACEUTICALS$$36$YR$$F$Y$83$KG$20240711$$MD$DE$DE
238897153$23889715$3$F$$20240710$20240523$20240711$EXP$$US-TAKEDA-2024TUS051264$TAKEDA$$$$$M$Y$$$20240711$$CN$US$US
238897162$23889716$2$F$$20240709$20240523$20240711$PER$$NVSC2024US106647$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
238897222$23889722$2$F$$20240704$20240523$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04107$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238897283$23889728$3$F$$20240704$20240523$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04117$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238897382$23889738$2$F$20240513$20240716$20240523$20240725$EXP$$JP-RADIUS HEALTH, INC.-2024JP003545$RADIUS PHARM$$81$YR$$F$Y$$$20240725$$MD$JP$JP
238897513$23889751$3$F$20240105$20240627$20240523$20240703$EXP$$US-ASTELLAS-2024US014315$ASTELLAS$$72$YR$$F$Y$$$20240703$$CN$US$US
238897722$23889772$2$F$20240101$20240827$20240523$20240911$PER$$US-009507513-2405USA001418$MERCK$$$$$F$Y$$$20240911$$CN$US$US
238897762$23889776$2$F$20221001$20240628$20240523$20240705$EXP$$US-AstraZeneca-2024A114481$ASTRAZENECA$$41$YR$$F$Y$$$20240705$$MD$US$
238897814$23889781$4$F$20240304$20240729$20240523$20240807$EXP$$CA-TEVA-VS-3177080$TEVA$$48$YR$$F$Y$$$20240807$$MD$CA$CA
238898003$23889800$3$F$20240624$20240821$20240523$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080877$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$68.49$KG$20240821$$HP$US$US
238898192$23889819$2$F$$20240702$20240523$20240710$EXP$$US-AstraZeneca-2024A114683$ASTRAZENECA$$$$$F$Y$$$20240710$$MD$US$
238898252$23889825$2$F$$20240507$20240523$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1054356$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238898362$23889836$2$F$$20240709$20240523$20240709$PER$$US-BAYER-2024A073542$BAYER$$$$$F$Y$$$20240709$$CN$US$US
238898672$23889867$2$F$$20240902$20240523$20240903$PER$$NVSC2024US107103$NOVARTIS$$$$$M$Y$$$20240903$$HP$US$US
238898773$23889877$3$F$20240508$20240802$20240523$20240807$EXP$$JP-AstraZeneca-2024A116112$ASTRAZENECA$$66$YR$$F$Y$$$20240807$$MD$JP$
238898892$23889889$2$F$20240101$20240903$20240523$20240926$PER$$US-SA-2024SA150709$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240926$$MD$US$US
238898952$23889895$2$F$20240513$20240819$20240523$20240828$PER$$US-SA-2024SA150742$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240828$$MD$US$US
238899192$23889919$2$F$20240101$20240719$20240523$20240725$EXP$$GB-VERTEX PHARMACEUTICALS-2024-008841$VERTEX$$$$$F$Y$$$20240725$$CN$GB$GB
238899274$23889927$4$F$$20240819$20240523$20240828$PER$$US-VERTEX PHARMACEUTICALS-2024-008685$VERTEX$$$$$F$Y$$$20240828$$CN$US$US
238899543$23889954$3$F$20240101$20240815$20240523$20240828$PER$$US-SA-2024SA151996$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240828$$MD$US$US
238899582$23889958$2$F$20240101$20240819$20240523$20240829$PER$$US-SA-2024SA153176$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240829$$MD$US$US
238899622$23889962$2$F$$20240627$20240523$20240708$PER$$US-SA-2024SA151883$SANOFI AVENTIS$$19$YR$A$F$Y$83$KG$20240708$$MD$US$US
238899702$23889970$2$F$20240101$20240716$20240523$20240826$PER$$US-GALDERMA-US2024007764$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
238899752$23889975$2$F$20240424$20240612$20240523$20240703$EXP$$NZ-ROCHE-3568456$ROCHE$$28$YR$A$F$Y$$$20240703$$MD$NZ$NZ
238899822$23889982$2$F$20240501$20240912$20240523$20240923$PER$$US-SA-2024SA150967$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240923$$MD$US$US
238899883$23889988$3$F$20240101$20240814$20240523$20240828$PER$$US-SA-2024SA151049$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240828$$MD$US$US
238899969$23889996$9$F$20230401$20240916$20240523$20240919$EXP$$US-SA-2024SA150605$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240919$$MD$US$US
238900172$23890017$2$F$20220101$20240708$20240523$20240717$PER$$US-SA-2021SA319613$SANOFI AVENTIS$$60$YR$A$M$Y$58.957$KG$20240717$$MD$US$US
238900232$23890023$2$F$20240101$20240911$20240523$20240926$PER$$US-SA-2024SA152225$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240926$$MD$US$US
238900252$23890025$2$F$20240501$20240822$20240523$20240904$PER$$US-SA-2024SA150713$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240904$$MD$US$US
238900275$23890027$5$F$20240101$20240906$20240523$20240916$PER$$US-SA-2024SA151262$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240916$$MD$US$US
238900322$23890032$2$F$20210715$20240802$20240523$20240815$EXP$$US-UCBSA-2022046564$UCB$$16$YR$$M$Y$42.5$KG$20240815$$CN$US$US
238900372$23890037$2$F$20240418$20240822$20240523$20240904$PER$$US-SA-2024SA150597$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240904$$MD$US$US
238900493$23890049$3$F$20240508$20240613$20240523$20240702$30DAY$$JP-JNJFOC-20240534616$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$JP$JP
238900582$23890058$2$F$20240501$20240910$20240523$20240918$PER$$US-SA-2024SA153452$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$MD$US$US
238900803$23890080$3$F$20240307$20240828$20240523$20240903$EXP$$CA-MYLANLABS-2024M1022796$MYLAN$$48$YR$$F$Y$$$20240903$$CN$CA$CA
238900852$23890085$2$F$$20240722$20240523$20240731$PER$$US-SA-2024SA153545$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240731$$CN$US$US
238901012$23890101$2$F$20230901$20240709$20240523$20240717$PER$$US-SA-2024SA155155$SANOFI AVENTIS$$2$YR$C$F$Y$19.955$KG$20240717$$MD$US$US
238901043$23890104$3$F$20240101$20240620$20240523$20240701$PER$$US-SA-2024SA154456$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240701$$MD$US$US
238901052$23890105$2$F$20240101$20240728$20240523$20240806$PER$$US-SA-2024SA154995$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240806$$MD$US$US
238901362$23890136$2$F$$20240716$20240523$20240724$PER$$US-SA-2024SA154908$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240724$$MD$US$US
238901435$23890143$5$F$20240101$20240717$20240523$20240722$EXP$$US-SA-2024SA154228$SANOFI AVENTIS$$8$YR$C$F$Y$56$KG$20240722$$CN$US$US
238901475$23890147$5$F$20240101$20240705$20240523$20240718$PER$$US-SA-2024SA155379$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240718$$MD$US$US
238901802$23890180$2$F$$20240830$20240523$20240911$PER$$US-SA-2024SA154623$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240911$$MD$US$US
238901962$23890196$2$F$$20240730$20240523$20240808$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005884$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
238902046$23890204$6$F$$20240921$20240523$20240925$30DAY$$US-PFIZER INC-202400132095$PFIZER$$9$YR$$F$Y$$$20240925$$HP$US$US
238902062$23890206$2$F$$20240713$20240523$20240715$EXP$$CA-PFIZER INC-202400173327$PFIZER$$81$YR$$M$Y$$$20240715$$CN$CA$CA
238902152$23890215$2$F$20221101$20240917$20240523$20240925$EXP$$NVSC2024IN061107$NOVARTIS$$27$YR$$M$Y$$$20240925$$CN$IN$IN
238902743$23890274$3$F$20240519$20240813$20240523$20240814$PER$$US-AMGEN-USASP2024101980$AMGEN$$71$YR$E$F$Y$$$20240814$$CN$US$US
238902902$23890290$2$F$20240201$20240711$20240523$20240712$EXP$$NVSC2024RO104910$NOVARTIS$$51$YR$$F$Y$$$20240712$$MD$RO$RO
238903043$23890304$3$F$20240501$20240712$20240523$20240718$PER$$US-BIOGEN-2024BI01265867$BIOGEN$$27$YR$$F$Y$$$20240718$$CN$US$US
238903123$23890312$3$F$20240509$20240627$20240523$20240708$30DAY$$CA-MYLANLABS-2024M1044811$MYLAN$$77$YR$$F$Y$47.62$KG$20240708$$PH$CA$CA
238903483$23890348$3$F$20210101$20240909$20240523$20240919$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-080639$BRISTOL MYERS SQUIBB$Lopez-Nunez M, Ropero-Luis G, Prolo-Acosta A, Ruiz-Cantero A. Systemic inflammatory response and polyserositis secondary to treatment with dasatinib. European Journal of Case Reports in Internal Medicine. 2022;9(Suppl 1):612-3. doi:10.12890/2022_V9Sup1.$55$YR$A$F$Y$$$20240919$$HP$ES$ES
238903662$23890366$2$F$$20240722$20240523$20240726$EXP$$RO-BIOGEN-2024BI01266064$BIOGEN$$39$YR$$F$Y$$$20240726$$MD$RO$RO
238903723$23890372$3$F$$20240716$20240523$20240717$PER$$US-ALXN-202405USA001028US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
238903742$23890374$2$F$20240401$20240716$20240523$20240716$PER$$US-ALXN-202405USA001080US$ALEXION PHARMACEUTICALS$$68$YR$$M$Y$$$20240716$$CN$US$US
238903818$23890381$8$F$$20240916$20240523$20240920$EXP$$US-GILEAD-2024-0672837$GILEAD$$$$A$F$Y$$$20240920$$CN$US$US
238903893$23890389$3$F$$20240628$20240523$20240702$PER$$NVSC2024US101945$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
238903982$23890398$2$F$$20240702$20240523$20240710$EXP$$US-AstraZeneca-2024A114333$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
238904102$23890410$2$F$20240105$20240820$20240523$20240821$PER$$US-JNJFOC-20240565445$JOHNSON AND JOHNSON$$$$A$M$Y$77$KG$20240822$$MD$US$US
238904124$23890412$4$F$20240101$20240802$20240523$20240807$PER$$US-SA-2024SA154516$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240807$$MD$US$US
238904412$23890441$2$F$20240101$20240910$20240523$20240913$PER$$US-PFIZER INC-PV202400067416$PFIZER$$25$YR$$F$Y$$$20240913$$HP$US$US
238904553$23890455$3$F$20240428$20240820$20240523$20240829$EXP$$JP-BAUSCH-BL-2024-008015$BAUSCH AND LOMB$$11$YR$$M$Y$38$KG$20240829$$MD$JP$JP
238904612$23890461$2$F$$20240710$20240523$20240711$EXP$$FR-ALXN-202405EEA001001FR$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240711$$MD$FR$FR
238904653$23890465$3$F$20230607$20240726$20240523$20240729$EXP$$JP-AstraZeneca-2023A133182$ASTRAZENECA$$84$YR$$M$Y$66$KG$20240729$$MD$JP$
238904684$23890468$4$F$$20240812$20240523$20240815$30DAY$$ES-PFIZER INC-202400172337$PFIZER$$$$$$Y$$$20240815$$HP$ES$ES
238904733$23890473$3$F$20240101$20240729$20240523$20240810$EXP$$JP-UCBSA-2024024438$UCB$$58$YR$$F$Y$$$20240810$$CN$JP$JP
238904822$23890482$2$F$$20240705$20240523$20240705$PER$$NVSC2024US105629$NOVARTIS$$$$$M$Y$$$20240705$$HP$US$US
238904873$23890487$3$F$20240328$20240911$20240523$20240920$EXP$$JP-JNJFOC-20240567803$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20240920$$MD$JP$JP
238905002$23890500$2$F$20240413$20240619$20240523$20240704$EXP$FR-AFSSAPS-LY2024000610$FR-TEVA-VS-3198998$TEVA$$89$YR$$M$Y$59$KG$20240704$$PH$FR$FR
238905014$23890501$4$F$$20240715$20240523$20240717$EXP$$DE-TAKEDA-2024TUS024545$TAKEDA$$$$$F$Y$$$20240717$$CN$DE$DE
238905173$23890517$3$F$$20240629$20240523$20240704$PER$$US-AMGEN-USASP2024101606$AMGEN$$72$YR$E$F$Y$$$20240704$$MD$US$US
238905182$23890518$2$F$$20240702$20240523$20240709$EXP$$FI-BAYER-2024A072790$BAYER$$$$$M$Y$68$KG$20240709$$HP$FI$FI
238905235$23890523$5$F$$20240710$20240523$20240715$EXP$$GB-PFIZER INC-202400173808$PFIZER$Brix, S.. Anti-GBM disease in pregnancy.. BMJ Case Reports. 2024;17(4):10.1136/bcr-2023-257767$$$N$F$Y$0.806$KG$20240715$$MD$GB$GB
238905243$23890524$3$F$$20240822$20240523$20240827$EXP$$CA-TAKEDA-2023TUS093597$TAKEDA$$$$$M$Y$$$20240827$$HP$CA$CA
238905413$23890541$3$F$$20240923$20240523$20240930$EXP$$NVSC2024US103882$NOVARTIS$$36$YR$$F$Y$$$20240930$$CN$US$US
238905422$23890542$2$F$20240117$20240618$20240523$20240701$EXP$$NVSC2024IT011770$NOVARTIS$$55$YR$$F$Y$70$KG$20240701$$MD$IT$IT
238905432$23890543$2$F$$20240918$20240523$20240919$EXP$$CA-ABBVIE-5769081$ABBVIE$$51$YR$$M$Y$$$20240919$$MD$CA$CA
238905444$23890544$4$F$20240424$20240708$20240523$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072060$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240711$$CN$US$US
238905586$23890558$6$F$20240410$20240911$20240523$20240919$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202404008048$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240919$$HP$CA$CA
238905602$23890560$2$F$$20240723$20240523$20240729$EXP$$GR-INCYTE CORPORATION-2024IN005444$INCYTE$$$$$$Y$$$20240729$$MD$GR$GR
238905732$23890573$2$F$$20240712$20240523$20240723$EXP$$VN-INCYTE CORPORATION-2024IN005402$INCYTE$$$$$$Y$$$20240723$$MD$VN$VN
238905822$23890582$2$F$20240513$20240731$20240523$20240808$PER$$US-SA-2024SA149618$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240808$$MD$US$US
238905892$23890589$2$F$20220518$20240627$20240523$20240704$EXP$$NVSC2023IN051704$NOVARTIS$$50$YR$$F$Y$$$20240704$$CN$IN$IN
238905922$23890592$2$F$20240101$20240821$20240523$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080873$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$103$KG$20240821$$HP$US$US
238905965$23890596$5$F$$20240901$20240523$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US051470$SANDOZ$$$$$F$Y$$$20240904$$CN$US$US
238906014$23890601$4$F$$20240924$20240523$20240926$PER$$NVSC2024US109179$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
238906452$23890645$2$F$$20240926$20240523$20240928$EXP$$CA-ROCHE-3562904$ROCHE$$33$YR$A$F$Y$104$KG$20240928$$HP$CA$CA
238906613$23890661$3$F$$20240628$20240523$20240708$30DAY$$US-MYLANLABS-2024M1044749$MYLAN$$$$$F$Y$$$20240708$$CN$US$US
238906645$23890664$5$F$20240529$20240715$20240523$20240717$EXP$$GB-MYLANLABS-2024M1045873$MYLAN$$$$$M$Y$$$20240717$$PH$GB$GB
238906722$23890672$2$F$$20240627$20240523$20240704$PER$$US-BIOGEN-2024BI01265906$BIOGEN$$$$$F$Y$$$20240704$$CN$US$US
238906752$23890675$2$F$20240101$20240917$20240523$20240926$PER$$JP-Eisai-EC-2024-166052$EISAI$$88$YR$E$M$Y$$$20240926$$MD$JP$JP
238906862$23890686$2$F$20240517$20240701$20240523$20240702$EXP$$GB-KYOWAKIRIN-2024KK012335$KYOWA$$$$$$Y$$$20240702$$HP$GB$GB
238906874$23890687$4$F$20231116$20240614$20240523$20240704$EXP$FR-AFSSAPS-PA2024001090$FR-TEVA-VS-3199683$TEVA$$66$YR$$F$Y$71.8$KG$20240704$$MD$FR$FR
238906953$23890695$3$F$$20240705$20240523$20240709$PER$$NVSC2024US109009$NOVARTIS$$$$$M$Y$142.88$KG$20240709$$HP$US$US
238906983$23890698$3$F$$20240628$20240523$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080511$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240704$$HP$US$US
238906993$23890699$3$F$20240101$20240726$20240523$20240731$EXP$$US-KYOWAKIRIN-2024KK012409$KYOWA$$$$$$Y$$$20240731$$HP$US$US
238907072$23890707$2$F$20231201$20240829$20240523$20240918$PER$$CA-TOLMAR, INC.-24CA047906$TOLMAR$$82$YR$$M$Y$$$20240918$$HP$CA$CA
238907125$23890712$5$F$$20240828$20240523$20240903$PER$$NVSC2024US108300$NOVARTIS$$$$$F$Y$$$20240903$$CN$US$US
238907185$23890718$5$F$20240720$20240725$20240523$20240730$EXP$$GB-TAKEDA-2024TUS048971$TAKEDA$$29$YR$$F$Y$$$20240730$$CN$GB$GB
238907292$23890729$2$F$20240511$20240820$20240523$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079811$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240820$$CN$US$US
238907322$23890732$2$F$$20240910$20240523$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080865$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240913$$HP$US$US
238907653$23890765$3$F$20240519$20240829$20240523$20240903$PER$$US-AMGEN-USASP2024099523$AMGEN$$77$YR$E$F$Y$$$20240903$$CN$US$US
238907703$23890770$3$F$$20240906$20240523$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080545$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$46.72$KG$20240912$$CN$US$US
238907732$23890773$2$F$$20240730$20240523$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080716$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240731$$CN$US$US
238907792$23890779$2$F$20240519$20240723$20240523$20240725$PER$$US-AMGEN-USASP2024100929$AMGEN$$61$YR$A$M$Y$$$20240725$$CN$US$US
238907802$23890780$2$F$20240501$20240705$20240523$20240705$PER$$NVSC2024US105473$NOVARTIS$$$$$F$Y$$$20240705$$MD$US$US
238908042$23890804$2$F$$20240807$20240523$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080337$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240812$$CN$US$US
238908064$23890806$4$F$$20240828$20240523$20240901$30DAY$$US-SANDOZ INC.-SDZ2024US050473$SANDOZ$$$$$F$Y$$$20240901$$CN$US$US
238908124$23890812$4$F$20240530$20240702$20240523$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-025637$JAZZ$$8$YR$$M$Y$$$20240918$$CN$US$US
238908392$23890839$2$F$$20240821$20240523$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079959$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240821$$MD$US$US
238908573$23890857$3$F$20200701$20240731$20240523$20240801$EXP$$NVSC2024GB108280$NOVARTIS$$8$YR$$M$Y$$$20240801$$MD$GB$GB
238908704$23890870$4$F$$20240729$20240523$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080764$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240730$$CN$US$US
238908783$23890878$3$F$$20240821$20240523$20240828$PER$$US-ABBVIE-5771325$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
238908933$23890893$3$F$20240427$20240625$20240523$20240701$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-007707$JAZZ$$19$YR$$M$Y$$$20240701$$CN$US$US
238908972$23890897$2$F$$20240702$20240523$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202405011452$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240708$$MD$US$US
238909032$23890903$2$F$$20240726$20240523$20240729$PER$$NVSC2024US107160$NOVARTIS$$$$A$M$Y$$$20240729$$CN$US$US
238909134$23890913$4$F$20240503$20240923$20240523$20240927$EXP$$US-BAYER-2024A073889$BAYER$$69$YR$E$F$Y$88.889$KG$20240927$$CN$US$US
238909165$23890916$5$F$20230926$20240806$20240523$20240819$PER$$US-SA-2024SA155329$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240819$$MD$US$US
238909572$23890957$2$F$$20240911$20240523$20240916$EXP$$CA-PURDUE-USA-2024-0309741$PURDUE$Kleinman R, Thakrar A.. Using short-acting opioids to relieve opioid withdrawal in hospital. CMAJ. 2023;195(49):E1718-20$35$YR$$F$Y$$$20240916$$HP$CA$CA
238909802$23890980$2$F$$20240812$20240523$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080574$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240814$$CN$US$US
238909842$23890984$2$F$20240415$20240709$20240523$20240716$EXP$FR-AFSSAPS-PB2024000516$FR-SA-2024SA154278$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240716$$MD$FR$FR
238909864$23890986$4$F$20240418$20240731$20240523$20240807$EXP$$JP-ABBVIE-5771168$ABBVIE$$65$YR$$M$Y$65.4$KG$20240807$$MD$JP$JP
238909972$23890997$2$F$$20240718$20240523$20240718$PER$$US-ALXN-202405USA001214US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
238910195$23891019$5$F$$20240731$20240523$20240808$PER$$US-ALXN-202405USA001212US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$HP$US$US
238910236$23891023$6$F$20240101$20240826$20240523$20240903$EXP$$US-SA-2024SA149883$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240903$$MD$US$US
238910332$23891033$2$F$20240516$20240718$20240523$20240718$PER$$US-ALXN-202405USA001184US$ALEXION PHARMACEUTICALS$$22$YR$$F$Y$$$20240718$$CN$US$US
238910362$23891036$2$F$$20240702$20240523$20240704$PER$$US-AMGEN-USASP2024102082$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
238910393$23891039$3$F$20240501$20240701$20240523$20240707$EXP$$US-BIOGEN-2024BI01266151$BIOGEN$$74$YR$$F$Y$$$20240707$$CN$US$US
2389104613$23891046$13$F$20240514$20240923$20240523$20240924$EXP$$DE-BIOMARINAP-DE-2024-158079$BIOMARIN$$$$$$Y$$$20240924$$HP$DE$DE
238910482$23891048$2$F$20231017$20240920$20240523$20240925$EXP$$JP-BIOMARINAP-JP-2024-156955$BIOMARIN$$$$$$Y$$$20240925$$MD$JP$JP
238910573$23891057$3$F$20240510$20240812$20240523$20240821$PER$$US-SA-2024SA150151$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240821$$MD$US$US
238910693$23891069$3$F$20210301$20240705$20240523$20240708$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-111289$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$73$KG$20240708$$CN$ES$ES
238910722$23891072$2$F$20240101$20240708$20240523$20240717$EXP$$JP-Eisai-EC-2024-166237$EISAI$$77$YR$E$M$Y$$$20240717$$MD$JP$JP
238910733$23891073$3$F$20230831$20240731$20240523$20240809$PER$$GB-Eisai-EC-2024-165828$EISAI$$69$YR$E$F$Y$72.3$KG$20240809$$MD$GB$GB
238910745$23891074$5$F$20240101$20240923$20240523$20240926$EXP$$US-BIOVITRUM-CTI2024US04492$BIOVITRUM$$74$YR$$M$Y$$$20240926$$CN$US$US
238910752$23891075$2$F$$20240703$20240523$20240711$EXP$$US-AstraZeneca-2024A114400$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
238910954$23891095$4$F$20240126$20240826$20240523$20240903$EXP$$FR-AstraZeneca-2024A114154$ASTRAZENECA$$$$A$F$Y$$$20240903$$MD$FR$
238911012$23891101$2$F$$20240916$20240523$20240924$EXP$$JP-009507513-2405JPN001737J$MERCK$$9$DEC$$F$Y$$$20240924$$MD$JP$JP
238911143$23891114$3$F$20240601$20240812$20240523$20240815$PER$$US-ALXN-202405USA001107US$ALEXION PHARMACEUTICALS$$11$YR$$M$Y$31.746$KG$20240815$$CN$US$US
238911253$23891125$3$F$20240401$20240714$20240523$20240715$EXP$$US-PFIZER INC-202400173397$PFIZER$$73$YR$$F$Y$48.99$KG$20240715$$CN$US$US
238911492$23891149$2$F$$20240722$20240523$20240806$EXP$$CA-HLS-202401220$HLS THERAPEUTICS$$50$YR$A$F$Y$$$20240806$$MD$CA$CA
238911533$23891153$3$F$20231127$20240710$20240523$20240715$EXP$$JP-BIOMARINAP-JP-2024-158082$BIOMARIN$$$$$$Y$$$20240715$$CN$JP$JP
238911772$23891177$2$F$20240422$20240725$20240523$20240807$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202405009509$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240807$$CN$IT$IT
238911862$23891186$2$F$20240502$20240820$20240523$20240904$PER$$US-AstraZeneca-2024A105539$ASTRAZENECA$$6754$DY$$F$Y$$$20240904$$CN$US$
238912032$23891203$2$F$$20240925$20240523$20240930$EXP$$CA-SANDOZ INC.-SDZ2024CA051030$SANDOZ$$$$$M$Y$$$20240930$$MD$CA$CA
238912212$23891221$2$F$$20240628$20240523$20240705$EXP$GR-STRIDES ARCOLAB LIMITED-2024SP005955$GR-STRIDES ARCOLAB LIMITED-2024SP005955$STRIDES$Koliaki C, Siafarikas C, Tsakanikas A, Georgopoulou A, Mylona M.. A young neutropenic patient with glycogen storage disease and diarrhea: An underlying infection or her pre-existing Crohn^s like disease?. European Journal of Case Reports in Internal Medicine. 2019;6 (Suppl. 1):411$30$YR$$F$Y$$$20240705$$MD$GR$GR
238912432$23891243$2$F$$20240626$20240523$20240701$EXP$$JP-TAKEDA-2024TJP007277$TAKEDA$$$$$M$Y$$$20240701$$MD$JP$JP
238912532$23891253$2$F$$20240910$20240523$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA050698$SANDOZ$$35$YR$$F$Y$$$20240912$$MD$CA$CA
238912573$23891257$3$F$$20240718$20240523$20240724$PER$$US-BIOGEN-2023BI01240280$BIOGEN$$$$$F$Y$$$20240724$$CN$US$US
238912602$23891260$2$F$$20240815$20240523$20240822$EXP$$CA-BIOGEN-2023BI01219300$BIOGEN$$$$$M$Y$$$20240822$$CN$CA$CA
238912633$23891263$3$F$20240516$20240716$20240523$20240722$EXP$$NVSJ2024JP005909$NOVARTIS$$28$YR$$F$Y$$$20240723$$MD$JP$JP
238912673$23891267$3$F$20240531$20240819$20240523$20240827$PER$$US-BIOGEN-2024BI01265791$BIOGEN$$59$YR$$F$Y$$$20240827$$CN$US$US
238912953$23891295$3$F$20240401$20240825$20240523$20240902$PER$$US-JNJFOC-20240543131$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240903$$CN$US$US
238913023$23891302$3$F$20231013$20240718$20240523$20240722$EXP$$NVSJ2024JP006091$NOVARTIS$$64$YR$$M$Y$95.3$KG$20240722$$MD$JP$JP
238913344$23891334$4$F$20240307$20240716$20240523$20240724$EXP$$BR-TAKEDA-2024TUS031507$TAKEDA$$10$YR$$M$Y$$$20240724$$CN$BR$BR
238913372$23891337$2$F$$20240910$20240523$20240917$EXP$$NVSC2024CA107102$NOVARTIS$$50$YR$$F$Y$$$20240917$$HP$CA$CA
238913433$23891343$3$F$20240515$20240620$20240523$20240702$30DAY$$US-JNJFOC-20240544957$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240703$$CN$US$US
238913472$23891347$2$F$20240418$20240905$20240523$20240912$EXP$$US-ABBVIE-5769238$ABBVIE$$65$YR$$F$Y$73$KG$20240912$$CN$US$US
238913534$23891353$4$F$20240101$20240813$20240523$20240821$EXP$$US-ABBVIE-5768960$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
238913553$23891355$3$F$20240307$20240822$20240523$20240916$EXP$$US-ABBVIE-5770371$ABBVIE$$73$YR$$M$Y$103$KG$20240916$$HP$US$US
238913562$23891356$2$F$20240517$20240821$20240523$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-080386$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240822$$MD$JP$JP
238913712$23891371$2$F$$20240725$20240523$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001423$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238913822$23891382$2$F$$20240528$20240523$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001745$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238913902$23891390$2$F$$20240719$20240523$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001811$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238914162$23891416$2$F$20240523$20240911$20240523$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081210$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240913$$CN$US$US
238914182$23891418$2$F$$20240820$20240523$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079851$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240820$$CN$US$US
238914352$23891435$2$F$20240401$20240711$20240523$20240718$EXP$$JP-AMGEN-JPNSP2024100372$AMGEN$$7$DEC$E$$Y$$$20240718$$MD$JP$JP
238914416$23891441$6$F$$20240701$20240523$20240705$EXP$$DE-ABBVIE-5644818$ABBVIE$$$$$M$Y$$$20240705$$CN$DE$DE
238914542$23891454$2$F$$20240710$20240523$20240715$EXP$$US-ABBVIE-5770215$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
238914552$23891455$2$F$20231101$20240919$20240523$20240925$EXP$$US-ABBVIE-5771001$ABBVIE$$75$YR$$M$Y$$$20240925$$CN$US$US
238914582$23891458$2$F$20240401$20240701$20240523$20240702$EXP$IT-MINISAL02-985876$IT-JNJFOC-20240566676$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240703$$MD$IT$IT
238914774$23891477$4$F$20240101$20240718$20240523$20240724$EXP$$US-ABBVIE-5771164$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
238914813$23891481$3$F$20230101$20240725$20240523$20240731$EXP$$US-ABBVIE-5771232$ABBVIE$$49$YR$$F$Y$52$KG$20240731$$CN$US$US
238914864$23891486$4$F$20240101$20240620$20240523$20240805$EXP$$CA-ABBVIE-5769829$ABBVIE$$75$YR$$F$Y$$$20240805$$HP$CA$CA
238915032$23891503$2$F$$20240717$20240523$20240723$PER$$US-ALXN-202405USA001223US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
238915193$23891519$3$F$20240508$20240730$20240524$20240731$EXP$$NVSJ2024JP005969$NOVARTIS$$55$YR$$F$Y$61$KG$20240801$$MD$JP$JP
238915242$23891524$2$F$20230601$20240703$20240524$20240712$PER$$US-SA-2023SA292667$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240712$$CN$US$US
238915302$23891530$2$F$$20240701$20240524$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002184$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
238915542$23891554$2$F$$20240627$20240524$20240701$PER$$US-AstraZeneca-2024A119114$ASTRAZENECA$$$$$F$Y$$$20240701$$HP$US$
238915762$23891576$2$F$20240101$20240911$20240524$20240917$EXP$$US-ABBVIE-5771187$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
238916003$23891600$3$F$$20240614$20240524$20240704$EXP$$US-ROCHE-3531499$ROCHE$$83$YR$E$F$Y$$$20240704$$CN$US$US
238916064$23891606$4$F$20240519$20240724$20240524$20240727$EXP$$US-AMGEN-USASP2024100100$AMGEN$$76$YR$E$F$Y$$$20240727$$CN$US$US
238916082$23891608$2$F$20240513$20240624$20240524$20240702$PER$$US-SA-2024SA150772$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240702$$MD$US$US
238916182$23891618$2$F$20240501$20240718$20240524$20240718$EXP$$US-ALXN-202405USA001181US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
238916232$23891623$2$F$20240101$20240715$20240524$20240722$EXP$$US-ABBVIE-5766708$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
238916252$23891625$2$F$20240101$20240716$20240524$20240724$PER$$US-SA-2024SA156293$SANOFI AVENTIS$$6$YR$C$M$Y$18$KG$20240724$$MD$US$US
238916272$23891627$2$F$20240801$20240903$20240524$20240913$PER$$US-SA-2024SA154821$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240913$$MD$US$US
238916822$23891682$2$F$$20240717$20240524$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078167$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240718$$CN$US$US
238916842$23891684$2$F$20230110$20240802$20240524$20240806$PER$$NVSC2024US104310$NOVARTIS$$47$YR$$F$Y$$$20240806$$CN$US$US
238916892$23891689$2$F$$20240621$20240524$20240702$EXP$$JP-UCBSA-2024024962$UCB$$$$A$$Y$$$20240702$$PH$JP$JP
238916962$23891696$2$F$20240101$20240712$20240524$20240717$PER$$US-AMGEN-USASP2024101623$AMGEN$$65$YR$E$M$Y$$$20240717$$HP$US$US
238917013$23891701$3$F$$20240829$20240524$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US047805$SANDOZ$$$$$M$Y$$$20240902$$HP$US$US
238917092$23891709$2$F$20240101$20240806$20240524$20240814$PER$$US-SA-2024SA152341$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240814$$MD$US$US
238917112$23891711$2$F$20231201$20240821$20240524$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078077$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240821$$CN$US$US
238917192$23891719$2$F$20240101$20240911$20240524$20240920$PER$$US-SA-2024SA155376$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240920$$MD$US$US
238917222$23891722$2$F$$20240516$20240524$20240817$PER$$US-AUROBINDO-AUR-APL-2024-012868$AUROBINDO$$66$YR$$F$Y$62.1$KG$20240817$$PH$US$US
238917233$23891723$3$F$$20240906$20240524$20240913$EXP$$CA-TAKEDA-2024TUS048364$TAKEDA$$71$YR$$F$Y$89$KG$20240913$$HP$CA$CA
238917403$23891740$3$F$20240506$20240621$20240524$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002174$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240716$$CN$US$US
238917543$23891754$3$F$$20240622$20240524$20240701$EXP$$EG-NOVOPROD-1224719$NOVO NORDISK$$45$YR$$F$Y$88$KG$20240701$$MD$EG$EG
238917572$23891757$2$F$20230601$20240704$20240524$20240715$EXP$$US-NOVOPROD-1175051$NOVO NORDISK$$$$A$M$Y$$$20240715$$CN$US$US
238917612$23891761$2$F$20240426$20240717$20240524$20240729$EXP$$US-NOVOPROD-1224398$NOVO NORDISK$$58$YR$$M$Y$$$20240729$$HP$US$US
238917903$23891790$3$F$20240719$20240812$20240524$20240813$EXP$$US-TAKEDA-US201914861$TAKEDA$$65$YR$$F$Y$95$KG$20240813$$HP$US$US
238918102$23891810$2$F$20240501$20240912$20240524$20240918$PER$$US-SA-2024SA150611$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240918$$MD$US$US
238918113$23891811$3$F$20240501$20240809$20240524$20240820$PER$$US-SA-2024SA153162$SANOFI AVENTIS$$73$YR$E$M$Y$108.86$KG$20240820$$MD$US$US
238918282$23891828$2$F$20240401$20240620$20240524$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002171$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240712$$CN$US$US
238918294$23891829$4$F$20230101$20240731$20240524$20240805$EXP$$JP-SA-2024SA152550$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240805$$MD$JP$JP
238918323$23891832$3$F$20240101$20240708$20240524$20240717$PER$$US-SA-2024SA152363$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240717$$MD$US$US
238918332$23891833$2$F$20240401$20240828$20240524$20240906$PER$$US-SA-2024SA155937$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240906$$MD$US$US
238918592$23891859$2$F$20240518$20240702$20240524$20240705$EXP$$US-AstraZeneca-2024A117998$ASTRAZENECA$$26841$DY$$F$Y$$$20240705$$CN$US$
238918682$23891868$2$F$$20240501$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002021$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238918722$23891872$2$F$$20240509$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002083$BIOCON$$$$$$Y$$$20240819$$HP$US$US
238918802$23891880$2$F$$20240719$20240524$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002277$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238918822$23891882$2$F$20220101$20240805$20240524$20240810$EXP$$US-SA-2023SA037050$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240810$$MD$US$US
238918882$23891888$2$F$$20240506$20240524$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002450$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238918952$23891895$2$F$$20240430$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002536$BIOCON$$$$$$Y$$$20240819$$HP$US$US
238919042$23891904$2$F$$20240715$20240524$20240717$PER$$US-TAKEDA-2024TUS051530$TAKEDA$$$$$F$Y$57$KG$20240717$$MD$US$US
238919092$23891909$2$F$$20240429$20240524$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002872$BIOCON$$$$$$Y$$$20240816$$HP$US$US
238919243$23891924$3$F$$20240718$20240524$20240725$EXP$$US-EXELIXIS-CABO-24077049$EXELIXIS$$$$$F$Y$$$20240725$$CN$US$US
238919542$23891954$2$F$$20240729$20240524$20240803$PER$$US-ROCHE-3447347$ROCHE$$$$$$Y$$$20240803$$CN$US$US
238920552$23892055$2$F$20231103$20240621$20240524$20240703$EXP$$CA-INTERCEPT-PM2023001101$INTERCEPT PHARMACEUTICALS$$75$YR$$F$Y$$$20240703$$PH$CA$CA
238920572$23892057$2$F$$20240703$20240524$20240712$EXP$$US-INTERCEPT-PM2024000937$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
238921002$23892100$2$F$$20240627$20240524$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-024469$AUROBINDO$Amarnani AD, Free MF, Baweja R. Psilocybin and the Development of Serotonin Toxicity. PrimCare-Comp-CNS-Disorders. 2024;26(1):23cr03648$35$YR$$F$Y$$$20240705$$MD$US$US
238921042$23892104$2$F$20240517$20240821$20240524$20240821$EXP$$IE-BRISTOL-MYERS SQUIBB COMPANY-2024-080479$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240821$$PH$IE$IE
238921917$23892191$7$F$$20240926$20240524$20240930$EXP$$CA-JNJFOC-20240550326$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240930$$HP$CA$CA
238921934$23892193$4$F$20240503$20240927$20240524$20240930$EXP$$NVSC2024US106049$NOVARTIS$$52$YR$$F$Y$$$20240930$$CN$US$US
238921964$23892196$4$F$20240522$20240702$20240524$20240704$PER$$US-AMGEN-USASP2024102438$AMGEN$$75$YR$E$F$Y$$$20240704$$CN$US$US
238923252$23892325$2$F$20240504$20240515$20240524$20240906$EXP$$CN-CHATTEMPRD-2024OHG018245$CHATTEM$$81$YR$E$F$Y$40$KG$20240906$$HP$CN$CN
238923282$23892328$2$F$20240101$20240918$20240524$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080521$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240919$$CN$US$US
238923383$23892338$3$F$$20240719$20240524$20240727$EXP$$BR-CELLTRION INC.-2023BR000893$CELLTRION$$$$$$Y$$$20240727$$CN$BR$BR
238923492$23892349$2$F$20240502$20240711$20240524$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002223$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240802$$CN$US$US
238924132$23892413$2$F$$20240523$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002197$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238924192$23892419$2$F$20240706$20240801$20240524$20240812$EXP$$US-BIOCON BIOLOGICS LIMITED-BBL2024002534$BIOCON$$$$$$Y$$$20240812$$CN$US$US
238924232$23892423$2$F$$20240604$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002756$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238924292$23892429$2$F$$20240513$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002814$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238924312$23892431$2$F$$20240523$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002411$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238924372$23892437$2$F$$20240508$20240524$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002798$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238924502$23892450$2$F$$20240716$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002874$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238924573$23892457$3$F$20240101$20240626$20240524$20240702$PER$$US-UNITED THERAPEUTICS-UNT-2024-013202$UNITED THERAPEUTICS$$$$$F$Y$107.03$KG$20240702$$$US$US
238924672$23892467$2$F$20240101$20240726$20240524$20240806$PER$$US-SA-2024SA155858$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240806$$MD$US$US
238924722$23892472$2$F$20231101$20240723$20240524$20240801$PER$$US-SA-2024SA152373$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240801$$MD$US$US
238924792$23892479$2$F$$20240911$20240524$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA051603$SANDOZ$$3$DEC$$M$Y$$$20240919$$HP$CA$CA
238925063$23892506$3$F$20240301$20240822$20240524$20240830$EXP$$CL-EMD Serono-2024027608$EMD SERONO INC$$71$YR$E$F$Y$$$20240830$$CN$CL$CL
238926043$23892604$3$F$20240401$20240702$20240524$20240704$PER$$NVSC2024US102047$NOVARTIS$$51$YR$$M$Y$$$20240704$$CN$US$US
238926053$23892605$3$F$20240521$20240705$20240524$20240709$EXP$$NVSC2024US109678$NOVARTIS$$85$YR$$M$Y$$$20240709$$HP$US$US
238926112$23892611$2$F$$20231121$20240524$20240930$PER$$US-ROCHE-3443017$ROCHE$$37$YR$A$F$Y$58.7$KG$20240930$$PH$US$US
238926182$23892618$2$F$20231127$20240712$20240524$20240723$EXP$ES-AEMPS-1523602$ES-JNJFOC-20240566570$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240722$$MD$ES$ES
238926202$23892620$2$F$20240517$20240628$20240524$20240702$PER$$US-JNJFOC-20240552265$JOHNSON AND JOHNSON$$54$YR$A$F$Y$54.48$KG$20240702$$CN$US$US
238926332$23892633$2$F$$20240704$20240524$20240716$PER$$US-AstraZeneca-2024A107154$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
238926594$23892659$4$F$20240701$20240829$20240524$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002193$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240923$$CN$US$US
238926824$23892682$4$F$20240101$20240702$20240524$20240705$EXP$$US-UCBSA-2024024766$UCB$$$$$F$Y$286$KG$20240705$$CN$US$US
238927162$23892716$2$F$20240516$20240718$20240524$20240718$PER$$US-ALXN-202405USA001305US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240718$$CN$US$US
238927194$23892719$4$F$$20240822$20240524$20240823$EXP$$US-TAKEDA-2024TUS051609$TAKEDA$$$$$F$Y$$$20240823$$MD$US$US
238927222$23892722$2$F$20240510$20240712$20240524$20240722$EXP$$DE-TEVA-VS-3200424$TEVA$$70$YR$$M$Y$$$20240722$$MD$DE$DE
238927243$23892724$3$F$20240101$20240906$20240524$20240916$EXP$$CA-CELLTRION INC.-2024CA012051$CELLTRION$$$$$$Y$$$20240916$$CN$CA$CA
238927282$23892728$2$F$20240417$20240716$20240524$20240726$EXP$$CH-TEVA-VS-3201093$TEVA$$$$A$F$Y$$$20240726$$MD$CH$CH
238927533$23892753$3$F$$20240715$20240524$20240723$PER$$NVSC2024US105088$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
238927552$23892755$2$F$20240101$20240702$20240524$20240708$EXP$$CA-BIOGEN-2024BI01264348$BIOGEN$$$$$F$Y$$$20240708$$PH$CA$CA
238927622$23892762$2$F$20240227$20240508$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001416$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238927762$23892776$2$F$$20240430$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001680$BIOCON$$$$$$Y$$$20240819$$PH$US$US
238927812$23892781$2$F$$20240508$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001667$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238927862$23892786$2$F$$20240620$20240524$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002197$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
238928002$23892800$2$F$$20240613$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001986$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238928052$23892805$2$F$$20240701$20240524$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002020$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238928082$23892808$2$F$$20240704$20240524$20240705$PER$$NVSC2024US105421$NOVARTIS$$$$$$Y$$$20240705$$MD$US$US
238928094$23892809$4$F$$20240704$20240524$20240712$EXP$$CA-TAKEDA-2024TUS039286$TAKEDA$$$$$M$Y$$$20240712$$CN$CA$CA
238928135$23892813$5$F$$20240904$20240524$20240907$EXP$$CA-JNJFOC-20240463546$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240907$$CN$CA$CA
238928262$23892826$2$F$$20240802$20240524$20240802$PER$$NVSC2024US109357$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
238928272$23892827$2$F$20240501$20240830$20240524$20240913$PER$$US-SA-2024SA151807$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240913$$MD$US$US
238928322$23892832$2$F$$20240723$20240524$20240729$EXP$$AU-AMGEN-AUSSP2024101345$AMGEN$$$$$$Y$$$20240729$$MD$AU$AU
238928362$23892836$2$F$$20240830$20240524$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002203$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
238928402$23892840$2$F$$20240620$20240524$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002205$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
238928462$23892846$2$F$$20240725$20240524$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080712$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$82.1$KG$20240729$$CN$US$US
238928552$23892855$2$F$$20240723$20240524$20240729$EXP$$AU-AMGEN-AUSSP2024101342$AMGEN$$$$$$Y$$$20240729$$MD$AU$AU
238928614$23892861$4$F$20240101$20240905$20240524$20240914$EXP$$CA-CELLTRION INC.-2024CA012061$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
238928624$23892862$4$F$$20240920$20240524$20240920$EXP$$NVSC2024US108046$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
238928706$23892870$6$F$20240521$20240626$20240524$20240704$30DAY$$US-JNJFOC-20240560630$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240704$$CN$US$US
238928762$23892876$2$F$$20240605$20240524$20240801$PER$$US-LUNDBECK-DKLU3077249$LUNDBECK$$$$$$Y$$$20240801$$CN$US$US
238928802$23892880$2$F$20231201$20240723$20240524$20240903$PER$$US-LUNDBECK-DKLU3077263$LUNDBECK$$$$$$Y$$$20240903$$HP$US$US
238928852$23892885$2$F$$20240723$20240524$20240724$EXP$$DE-JNJFOC-20240545884$JOHNSON AND JOHNSON$$88$YR$E$$Y$$$20240724$$MD$DE$DE
238928872$23892887$2$F$$20240724$20240524$20240813$PER$$US-LUNDBECK-DKLU3077272$LUNDBECK$$$$$$Y$$$20240813$$HP$US$US
238928922$23892892$2$F$$20240718$20240524$20240723$EXP$$US-SANDOZ INC.-SDZ2024US051032$SANDOZ$$$$$F$Y$$$20240723$$CN$US$US
238929013$23892901$3$F$20240515$20240910$20240524$20240918$PER$$US-JNJFOC-20240567678$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$HP$US$US
238929074$23892907$4$F$$20240913$20240524$20240923$EXP$$JP-ARDELYX-2024ARDX002735$ARDELYX$$$$$M$Y$$$20240923$$MD$JP$JP
238929212$23892921$2$F$20240220$20240320$20240524$20240826$PER$$US-ROCHE-3516833$ROCHE$$82$YR$E$F$Y$94.35$KG$20240826$$CN$US$US
238929262$23892926$2$F$20240201$20240405$20240524$20240830$PER$$US-ROCHE-3515851$ROCHE$$76$YR$E$F$Y$69$KG$20240830$$PH$US$US
238929273$23892927$3$F$$20240619$20240524$20240708$PER$$US-ROCHE-3510881$ROCHE$$45$YR$A$F$Y$$$20240708$$CN$US$US
238929534$23892953$4$F$$20240823$20240524$20240828$EXP$$GB-TAKEDA-2024TUS034882$TAKEDA$$$$$F$Y$$$20240828$$CN$GB$GB
238929712$23892971$2$F$$20240808$20240524$20240809$EXP$$US-ROCHE-3569012$ROCHE$$75$YR$E$M$Y$$$20240810$$CN$US$US
238929773$23892977$3$F$20230824$20240626$20240524$20240709$PER$$US-ROCHE-3419288$ROCHE$$79$YR$E$F$Y$71.21$KG$20240705$$CN$US$US
238930002$23893000$2$F$$20240823$20240524$20240902$PER$$US-ROCHE-3532970$ROCHE$$55$YR$A$F$Y$$$20240902$$CN$US$US
238930312$23893031$2$F$20240208$20240817$20240524$20240822$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000912$BIOCON$$$$$$Y$$$20240822$$PH$US$US
238930342$23893034$2$F$$20240621$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000716$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238930362$23893036$2$F$20240202$20240710$20240524$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000762$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238930382$23893038$2$F$$20240713$20240524$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001001$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238930765$23893076$5$F$20230416$20240819$20240524$20240823$EXP$$US-ABBVIE-5729608$ABBVIE$$75$YR$$F$Y$90$KG$20240823$$CN$US$US
238930833$23893083$3$F$20240420$20240716$20240524$20240723$EXP$$CA-TAKEDA-2024TUS049800$TAKEDA$$72$YR$$M$Y$60$KG$20240723$$PH$CA$CA
238931494$23893149$4$F$20240604$20240723$20240524$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002200$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240816$$CN$US$US
238931932$23893193$2$F$$20240705$20240524$20240710$PER$$NVSC2024US106299$NOVARTIS$$$$$$Y$$$20240710$$CN$US$US
238932002$23893200$2$F$$20240830$20240524$20240904$EXP$$US-ABBVIE-5614463$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
238932222$23893222$2$F$20240101$20240705$20240524$20240705$PER$$NVSC2024US109241$NOVARTIS$$$$$$Y$$$20240705$$HP$US$US
238932292$23893229$2$F$$20240725$20240524$20240727$PER$$US-ROCHE-3388144$ROCHE$$20$YR$A$F$Y$$$20240727$$CN$US$US
238932488$23893248$8$F$$20240702$20240524$20240710$EXP$$US-ROCHE-3529839$ROCHE$$42$YR$A$F$Y$125$KG$20240710$$CN$US$US
238932692$23893269$2$F$$20240801$20240524$20240807$EXP$$US-ARGENX-2024-ARGX-US003516$ARGENX BVBA$$$$$$Y$$$20240807$$CN$US$US
238932733$23893273$3$F$20240409$20240627$20240524$20240702$EXP$$JP-EXELIXIS-CABO-24076439$EXELIXIS$$61$YR$$M$Y$100$KG$20240702$$MD$JP$JP
238933392$23893339$2$F$$20240730$20240524$20240731$EXP$$US-JNJFOC-20240555525$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240731$$CN$US$US
238933463$23893346$3$F$20230802$20240703$20240524$20240705$EXP$$DE-SANDOZ INC.-SDZ2024DE051485$SANDOZ$$$$E$F$Y$$$20240705$$CN$DE$DE
238933663$23893366$3$F$$20240916$20240524$20240924$EXP$$PL-SANDOZ INC.-NVSC2022PL095380$SANDOZ$$31$YR$$M$Y$$$20240924$$MD$PL$PL
238933962$23893396$2$F$$20240730$20240524$20240822$PER$$AU-TOLMAR, INC.-24AU048895$TOLMAR$$$$$M$Y$$$20240822$$CN$AU$AU
238935092$23893509$2$F$20240522$20240821$20240524$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081235$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240823$$CN$US$US
238935163$23893516$3$F$$20240723$20240524$20240725$EXP$$EG-JNJFOC-20240553515$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240725$$MD$EG$EG
238935832$23893583$2$F$$20240823$20240524$20240828$EXP$$US-TAKEDA-2024TUS021546$TAKEDA$$$$$M$Y$$$20240828$$HP$US$US
238935902$23893590$2$F$20220313$20240708$20240524$20240712$EXP$$NVSC2024CO090320$NOVARTIS$$50$YR$$F$Y$65$KG$20240712$$CN$CO$CO
238936192$23893619$2$F$$20240720$20240524$20240724$PER$$US-ROCHE-3457100$ROCHE$$$$E$F$Y$$$20240724$$CN$US$US
238937433$23893743$3$F$20230518$20240813$20240524$20240816$PER$$US-ROCHE-3353456$ROCHE$$77$YR$E$F$Y$79.38$KG$20240816$$CN$US$US
238938373$23893837$3$F$20240101$20240708$20240524$20240718$EXP$$US-AMGEN-USASP2024099751$AMGEN$$55$YR$A$F$Y$69.841$KG$20240718$$PH$US$US
238938502$23893850$2$F$$20240806$20240524$20240806$EXP$$US-JNJFOC-20240546553$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$MD$US$US
238938772$23893877$2$F$20230921$20240708$20240524$20240718$EXP$$ES-BEH-2024172642$CSL BEHRING$$23$YR$A$M$Y$75$KG$20240718$$MD$ES$ES
238938913$23893891$3$F$20240101$20240813$20240524$20240820$EXP$$US-SA-2024SA156018$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240820$$CN$US$US
238939093$23893909$3$F$$20240701$20240524$20240708$EXP$$NVSC2019CL007311$NOVARTIS$$63$YR$$M$Y$$$20240708$$CN$CL$CL
238939202$23893920$2$F$20240509$20240624$20240524$20240702$PER$$US-AMGEN-USASP2024100654$AMGEN$$81$YR$E$M$Y$66$KG$20240702$$PH$US$US
238939374$23893937$4$F$$20240703$20240524$20240711$EXP$$CN-AstraZeneca-2024A120138$ASTRAZENECA$$$$E$F$Y$49$KG$20240711$$MD$CN$
238939533$23893953$3$F$$20240923$20240524$20240924$EXP$$CA-ORGANON-O2405CAN001752$ORGANON$$40$YR$$F$Y$96$KG$20240924$$HP$CA$CA
238939642$23893964$2$F$$20240805$20240524$20240808$EXP$$JP-TAKEDA-2024TJP007495$TAKEDA$$9$YR$$M$Y$$$20240808$$MD$JP$JP
238939762$23893976$2$F$$20240718$20240524$20240718$PER$$US-ALXN-202405USA001283US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
238940293$23894029$3$F$$20240626$20240524$20240702$EXP$$US-TAKEDA-2024TUS038331$TAKEDA$$$$$F$Y$$$20240702$$CN$US$US
238940492$23894049$2$F$$20240706$20240524$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04159$LUPIN$$$$$$Y$$$20240731$$CN$US$US
238940532$23894053$2$F$$20240912$20240524$20240924$EXP$$CA-APOTEX-2020AP008861$APOTEX$$36$YR$$F$Y$$$20240924$$HP$CA$CA
238941232$23894123$2$F$$20240705$20240524$20240705$PER$$NVSC2024US109057$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
238941543$23894154$3$F$20240223$20240624$20240524$20240702$30DAY$$US-AMGEN-USASP2024099886$AMGEN$$41$YR$A$F$Y$$$20240702$$PH$US$US
238941572$23894157$2$F$$20240709$20240524$20240717$EXP$$US-SERVIER-S24005608$SERVIER$$$$$$Y$$$20240717$$HP$US$US
238941922$23894192$2$F$$20240704$20240524$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04138$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238942102$23894210$2$F$$20240704$20240524$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04136$LUPIN$$$$$$Y$$$20240730$$CN$US$US
238942562$23894256$2$F$$20240924$20240524$20240926$PER$$US-ROCHE-3402797$ROCHE$$$$A$F$Y$$$20240926$$HP$US$US
238942973$23894297$3$F$20240401$20240711$20240524$20240717$PER$$US-AMGEN-USASP2024100161$AMGEN$$67$YR$E$M$Y$$$20240717$$CN$US$US
238943042$23894304$2$F$20240425$20240709$20240524$20240712$EXP$$NVSC2024SK105744$NOVARTIS$$53$YR$$M$Y$$$20240712$$MD$SK$SK
238943333$23894333$3$F$20240401$20240626$20240524$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002163$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$12$KG$20240719$$CN$US$US
238943892$23894389$2$F$$20240826$20240524$20240905$EXP$$US-AUROBINDO-AUR-APL-2024-024353$AUROBINDO$Aiello M, Roy S, Chitty L, Johnson B, Warrick M.. Prolonged administration of intrathecal baclofen in a patient with generalized grade 4 tetanus. Reg Anesth Pain Med. 2024;49(7):540-542$62$YR$$F$Y$$$20240905$$HP$US$US
238944622$23894462$2$F$20240510$20240711$20240524$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04182$LUPIN$$$$$$Y$$$20240809$$CN$US$US
238944933$23894493$3$F$20240515$20240919$20240524$20240928$EXP$$CA-CELLTRION INC.-2024CA012022$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
238944993$23894499$3$F$$20240712$20240524$20240715$EXP$$SE-ROCHE-3567133$ROCHE$$$$A$F$Y$$$20240715$$MD$SE$SE
238945263$23894526$3$F$20240101$20240714$20240524$20240723$EXP$$CA-CELLTRION INC.-2024CA012079$CELLTRION$$$$$$Y$$$20240723$$HP$CA$CA
238945343$23894534$3$F$$20240628$20240524$20240702$30DAY$$GB-JNJFOC-20240544050$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$GB$GB
238945382$23894538$2$F$20240521$20240701$20240524$20240704$PER$$US-AMGEN-USASP2024102734$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
238946562$23894656$2$F$$20240904$20240524$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04183$LUPIN$$$$$$Y$$$20240920$$PH$US$US
238946982$23894698$2$F$$20240706$20240524$20240711$EXP$$DE-TAKEDA-2024TUS050479$TAKEDA$$23$YR$$M$Y$$$20240711$$CN$DE$DE
238947282$23894728$2$F$$20240611$20240524$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002226$ACADIA PHARMACEUTICALS$$$$$F$Y$43.537$KG$20240705$$CN$US$US
238947855$23894785$5$F$$20240924$20240524$20240930$EXP$$CA-HALEON-2167456$Haleon PLC$$50$YR$$F$Y$68$KG$20240930$$HP$CA$CA
238947873$23894787$3$F$20230116$20240807$20240524$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-023750$AUROBINDO$$48$YR$$F$Y$$$20240820$$MD$GB$GB
238948062$23894806$2$F$$20240624$20240524$20240704$PER$$US-ROCHE-3524769$ROCHE$$$$A$F$Y$$$20240704$$CN$US$US
238948183$23894818$3$F$20230424$20240611$20240524$20240718$EXP$$NVSC2024TR094197$NOVARTIS$$60$YR$$F$Y$77.9$KG$20240718$$MD$TR$TR
238948193$23894819$3$F$20240523$20240628$20240524$20240703$PER$$US-AMGEN-USASP2024102648$AMGEN$$56$YR$A$F$Y$$$20240703$$CN$US$US
238948692$23894869$2$F$$20240627$20240524$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-024481$AUROBINDO$Van Gompel JJ, Mahajan A, Shinya Y, Laack NN, Link MJ, O^Brien EK, et al. Longitudinal treatment outcomes of recurrent clival chordomas: a single-center retrospective study. J-Neurosurg. 2023;140(4):920-928$73$YR$$F$Y$$$20240705$$MD$US$US
238948924$23894892$4$F$$20240801$20240524$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081435$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240802$$CN$US$US
238948942$23894894$2$F$$20240808$20240524$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081135$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240813$$CN$US$US
238949002$23894900$2$F$20240521$20240725$20240524$20240727$PER$$US-JNJFOC-20240562804$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240727$$CN$US$US
238949092$23894909$2$F$$20240627$20240524$20240708$EXP$$US-AUROBINDO-AUR-APL-2024-024667$AUROBINDO$Valaparla VL, Banerjee P, Elnaeem A, Sharma T, Bhatt S, J.M. Rodr?guez-Fernandez, et al.. Cerebral vasospasm due to Fusarium solani meningitis: A complication from medical tourism. Case report and literature review. J-Stroke-Cerebrovasc-Dis. 2024;33:331-5$29$YR$$F$Y$$$20240708$$MD$US$US
238949462$23894946$2$F$20231001$20240715$20240524$20240717$PER$$US-ROCHE-3521748$ROCHE$$54$YR$A$F$Y$$$20240717$$CN$US$US
238949502$23894950$2$F$$20240716$20240524$20240722$PER$$US-ROCHE-3521440$ROCHE$$72$YR$E$F$Y$$$20240722$$CN$US$US
238949572$23894957$2$F$$20240710$20240524$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1054905$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238949752$23894975$2$F$20240601$20240705$20240524$20240708$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-029743$BOEHRINGER INGELHEIM$$8$DEC$E$M$Y$$$20240708$$MD$JP$JP
238949772$23894977$2$F$20240227$20240626$20240524$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002196$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240719$$CN$US$US
238949902$23894990$2$F$$20240628$20240524$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081267$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$84.37$KG$20240701$$CN$US$US
238949932$23894993$2$F$$20240813$20240524$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081565$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$103.42$KG$20240814$$CN$US$US
238950113$23895011$3$F$$20240807$20240524$20240813$EXP$$DE-MYLANLABS-2024M1045449$MYLAN$$49$YR$$F$Y$61$KG$20240813$$CN$DE$DE
238950522$23895052$2$F$$20240813$20240524$20240819$PER$$US-ROCHE-3525686$ROCHE$$74$YR$E$F$Y$$$20240819$$CN$US$US
238950894$23895089$4$F$$20240822$20240524$20240827$EXP$$CA-Orion Corporation ORION PHARMA-24_00030074$ORION$$69$YR$E$F$Y$88$KG$20240827$$HP$CA$
238951114$23895111$4$F$$20240830$20240524$20240903$EXP$$US-SANDOZ INC.-SDZ2024US051152$SANDOZ$$$$$M$Y$$$20240903$$HP$US$US
238952433$23895243$3$F$$20240712$20240524$20240717$EXP$$CA-TAKEDA-2023TUS077716$TAKEDA$$$$$F$Y$73.5$KG$20240717$$MD$CA$CA
238952583$23895258$3$F$20240510$20240912$20240524$20240926$EXP$$AU-CIPLA (EU) LIMITED-2024AU04944$CIPLA$Yeoh K, Lass-Florl C, Lamoth F, Slavin MA, Williams E, Neofytos D.. Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual. Transplant Infectious Disease. 2024;e14273.:1 to 6$$$$$Y$$$20240926$$MD$AU$AU
238952744$23895274$4$F$20240101$20240806$20240524$20240813$EXP$$US-ABBVIE-5772149$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
238952762$23895276$2$F$$20240812$20240524$20240819$EXP$$SK-MYLANLABS-2024M1030368$MYLAN$Part M.. Treatment of a patient with psoriasis of childbearing age - case report. DERMA. 2024;24(1):14-15$41$YR$$F$Y$$$20240819$$MD$SK$SK
238952943$23895294$3$F$20221101$20240828$20240524$20240910$EXP$$JP-INSMED-2022-03311-JPAA$INSMED$$73$YR$$F$Y$42.5$KG$20240910$$CN$JP$JP
238953132$23895313$2$F$20240101$20240814$20240524$20240822$EXP$$US-SA-2024SA155533$SANOFI AVENTIS$$$$A$M$Y$$$20240822$$MD$US$US
238953395$23895339$5$F$20230713$20240813$20240524$20240820$EXP$$NVSC2024US068404$NOVARTIS$$33$YR$$F$Y$$$20240820$$CN$US$US
238953403$23895340$3$F$20231023$20240809$20240524$20240813$EXP$$NVSC2024GB096840$NOVARTIS$$57$YR$$F$Y$$$20240813$$CN$GB$GB
238953432$23895343$2$F$20240401$20240521$20240524$20240911$EXP$$EG-SA-2024SA157129$SANOFI AVENTIS$$43$YR$A$M$Y$81$KG$20240911$$HP$EG$EG
238954323$23895432$3$F$20240507$20240722$20240524$20240731$EXP$$NL-TEVA-VS-3200393$TEVA$$59$YR$$M$Y$$$20240731$$CN$NL$NL
238954502$23895450$2$F$20230101$20240816$20240524$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081269$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240820$$CN$US$US
238954773$23895477$3$F$20240205$20240804$20240524$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447476$RANBAXY$$76$YR$E$F$Y$63$KG$20240816$$HP$CN$CN
238954972$23895497$2$F$$20240729$20240524$20240813$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-447847$RANBAXY$Naesgaard AR, Gjerstad L, Heuser K, et al. Biological rhythms and epilepsy treatment. Neurologia Praktyczna. 2023;(4):7-14$20$YR$$M$Y$$$20240813$$HP$NO$NO
238955395$23895539$5$F$20240501$20240830$20240524$20240910$EXP$$US-INSMED, INC.-2024-02023-US$INSMED$$55$YR$$M$Y$$$20240910$$CN$US$US
238955682$23895568$2$F$20240331$20240804$20240524$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447477$RANBAXY$$83$YR$E$F$Y$39$KG$20240816$$MD$CN$CN
238955753$23895575$3$F$20230501$20240917$20240524$20240926$EXP$$JP-ARGENX-2023-ARGX-JP001836$ARGENX BVBA$$$$$$Y$$$20240926$$MD$JP$JP
238955802$23895580$2$F$$20240808$20240524$20240813$EXP$$JP-GILEAD-2024-0673833$GILEAD$Tamaki S, Yamada E, Nishiki J, Minami H, Fujieda A, Nakamura Y, et al.. P-3 Experience of administration of emicizumab to 2 patients with refractory acquired haemophilia A. Japanese Journal of Transfusion and Cell Therapy. 2024;70(2):362$62$YR$A$M$Y$$$20240813$$MD$JP$JP
238955922$23895592$2$F$$20240718$20240524$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079494$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240723$$CN$US$US
238955952$23895595$2$F$20240425$20240715$20240524$20240722$EXP$$LB-ROCHE-3563672$ROCHE$$46$YR$A$F$Y$$$20240722$$CN$LB$LB
238955963$23895596$3$F$$20240813$20240524$20240816$EXP$$CA-ABBVIE-5769764$ABBVIE$$65$YR$$F$Y$69$KG$20240816$$HP$CA$CA
238956013$23895601$3$F$20240521$20240702$20240524$20240704$PER$$US-AMGEN-USASP2024102514$AMGEN$$59$YR$A$F$Y$$$20240704$$CN$US$US
238956037$23895603$7$F$$20240827$20240524$20240910$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-08665$IPSEN$$86$YR$E$M$Y$78.92$KG$20240910$$CN$US$US
238956182$23895618$2$F$20240430$20240629$20240524$20240703$PER$$US-BIOVITRUM-2024-US-007465$BIOVITRUM$$78$YR$$M$Y$$$20240703$$CN$US$US
2389562811$23895628$11$F$$20240711$20240524$20240722$PER$$US-ROCHE-3566830$ROCHE$$$$$$Y$$$20240722$$MD$US$US
238956412$23895641$2$F$$20240702$20240524$20240710$EXP$$US-AstraZeneca-2024A115325$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
238956662$23895666$2$F$$20240423$20240524$20240710$EXP$$CA-002147023-NVSC2022CA114820$Haleon PLC$$59$YR$$F$Y$68$KG$20240710$$HP$CA$CA
238956702$23895670$2$F$$20240909$20240524$20240921$EXP$$GR-Accord-425674$ACCORD$Theodoridou P, Pastirmatzi E, Samaras K, Stefanidis C, Gouliaros N,Chatzielephateriou C. Cardiac tamponade of left ventricle in a patient with severe Pulmonary Hypertension: an interesting case. Kardia kai Angeia.2024;29 (1)$82$YR$E$M$Y$$$20240921$$MD$GR$GR
238956842$23895684$2$F$20240423$20240705$20240524$20240717$EXP$FR-AFSSAPS-2024039462$FR-Accord-425604$ACCORD$$81$YR$E$M$Y$78$KG$20240717$$PH$FR$FR
238956913$23895691$3$F$$20240710$20240524$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080763$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240712$$CN$US$US
238957182$23895718$2$F$$20240711$20240524$20240720$EXP$$GB-BAXTER-2024BAX017563$BAXTER$$37$YR$$F$Y$$$20240720$$CN$IE$GB
238957214$23895721$4$F$$20240906$20240524$20240913$EXP$$CA-TAKEDA-2024TUS051261$TAKEDA$$$$$F$Y$$$20240913$$CN$CA$CA
238957412$23895741$2$F$$20240906$20240524$20240910$30DAY$$US-PFIZER INC-202400105997$PFIZER$$12$YR$$F$Y$$$20240910$$CN$US$US
238957433$23895743$3$F$$20240814$20240524$20240820$30DAY$$US-PFIZER INC-202400172756$PFIZER$$9$YR$$M$Y$23.59$KG$20240820$$CN$US$US
238957474$23895747$4$F$$20240820$20240524$20240822$30DAY$$US-PFIZER INC-202400172896$PFIZER$$65$YR$$F$Y$59.87$KG$20240822$$CN$US$US
238957493$23895749$3$F$20240715$20240809$20240524$20240813$EXP$$GB-MYLANLABS-2024M1046624$MYLAN$$$$$M$Y$$$20240813$$MD$GB$GB
238957514$23895751$4$F$$20240813$20240524$20240819$EXP$$GB-MYLANLABS-2024M1046394$MYLAN$$$$$M$Y$$$20240819$$HP$GB$GB
238957522$23895752$2$F$$20240802$20240524$20240802$PER$$NVSC2024US109495$NOVARTIS$$$$$F$Y$$$20240802$$HP$US$US
238957632$23895763$2$F$20240101$20240829$20240524$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015268$UNITED THERAPEUTICS$$$$$F$Y$61.224$KG$20240906$$$US$US
238957712$23895771$2$F$20240625$20240625$20240524$20240702$PER$$US-AMGEN-USASP2024102421$AMGEN$$63$YR$A$F$Y$$$20240702$$CN$US$US
238957732$23895773$2$F$20240201$20240724$20240524$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081462$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$84.8$KG$20240726$$PH$US$US
238957762$23895776$2$F$20240513$20240815$20240524$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078399$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240819$$HP$US$US
238958066$23895806$6$F$20240501$20240822$20240524$20240827$30DAY$$US-PFIZER INC-202400173463$PFIZER$$4$MON$$M$Y$5.58$KG$20240827$$CN$US$US
238958075$23895807$5$F$$20240905$20240524$20240911$30DAY$$US-PFIZER INC-202400174090$PFIZER$$9$YR$$F$Y$$$20240911$$CN$US$US
238958083$23895808$3$F$$20240815$20240524$20240820$30DAY$$US-PFIZER INC-202400173623$PFIZER$$11$YR$$M$Y$$$20240820$$CN$US$US
238958142$23895814$2$F$$20240808$20240524$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202405013379$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240813$$CN$US$US
2389584110$23895841$10$F$20240414$20240828$20240524$20240911$EXP$$US-AUROBINDO-AUR-APL-2024-025259$AUROBINDO$$59$YR$$M$Y$99.2$KG$20240911$$MD$US$US
238958603$23895860$3$F$$20240626$20240524$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077741$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240701$$CN$US$US
238958776$23895877$6$F$20240501$20240916$20240524$20240919$30DAY$$US-PFIZER INC-202400171649$PFIZER$$13$YR$$M$Y$37.19$KG$20240919$$HP$US$US
238958795$23895879$5$F$$20240730$20240524$20240806$PER$$US-PFIZER INC-PV202400066297$PFIZER$$$$$$Y$$$20240806$$PH$US$US
238958823$23895882$3$F$20240101$20240925$20240524$20240930$30DAY$$US-PFIZER INC-202400171725$PFIZER$$6$YR$$M$Y$$$20240930$$CN$US$US
238958912$23895891$2$F$$20240630$20240524$20240705$EXP$$ES-ABBVIE-5772771$ABBVIE$$43$YR$$F$Y$100$KG$20240705$$MD$ES$ES
238958924$23895892$4$F$20240101$20240723$20240524$20240729$EXP$$NL-ABBVIE-5772159$ABBVIE$$88$YR$$F$Y$$$20240729$$HP$NL$NL
238958932$23895893$2$F$$20240716$20240524$20240720$PER$$NVSC2024US109745$NOVARTIS$$$$$$Y$$$20240719$$CN$US$US
238958946$23895894$6$F$$20240731$20240524$20240806$PER$$NVSC2024US107161$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
238958962$23895896$2$F$20240519$20240730$20240524$20240802$PER$$US-AMGEN-USASP2024102006$AMGEN$$63$YR$A$M$Y$$$20240802$$CN$US$US
238959112$23895911$2$F$$20240702$20240524$20240710$EXP$$US-AstraZeneca-2024A118080$ASTRAZENECA$$19756$DY$$F$Y$$$20240710$$CN$US$
238959196$23895919$6$F$$20240915$20240524$20240919$30DAY$$US-PFIZER INC-202400173613$PFIZER$$15$YR$$M$Y$53.52$KG$20240919$$CN$US$US
238959215$23895921$5$F$$20240828$20240524$20240903$30DAY$$US-PFIZER INC-202400105895$PFIZER$$17$YR$$M$Y$$$20240903$$PH$US$US
238959224$23895922$4$F$$20240920$20240524$20240924$30DAY$$US-PFIZER INC-202400172083$PFIZER$$$$$$Y$$$20240924$$CN$US$US
238959243$23895924$3$F$20240519$20240815$20240524$20240820$30DAY$$US-PFIZER INC-202400173183$PFIZER$$10$MON$$F$Y$7.71$KG$20240820$$CN$US$US
238959258$23895925$8$F$$20240918$20240524$20240923$30DAY$$US-PFIZER INC-202400173592$PFIZER$$11$YR$$F$Y$$$20240923$$CN$US$US
238959362$23895936$2$F$20240506$20240523$20240524$20240705$PER$$US-Eisai-EC-2024-165829$EISAI$$66$YR$E$F$Y$66$KG$20240705$$CN$US$US
238959412$23895941$2$F$20240326$20240705$20240524$20240715$EXP$$ES-AUROBINDO-AUR-APL-2024-024016$AUROBINDO$$67$YR$$F$Y$$$20240715$$MD$ES$ES
238959492$23895949$2$F$20240319$20240822$20240524$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081365$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$92.99$KG$20240822$$HP$US$US
238959513$23895951$3$F$$20240903$20240524$20240904$PER$$NVSC2024US109143$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
238959612$23895961$2$F$$20240715$20240524$20240718$EXP$$CA-SANDOZ INC.-SDZ2024CA051804$SANDOZ$$$$$M$Y$$$20240718$$CN$CA$CA
238959652$23895965$2$F$$20240717$20240524$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002218$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
238959822$23895982$2$F$20240501$20240726$20240524$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076658$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240805$$PH$US$US
238959853$23895985$3$F$20231018$20240916$20240524$20240925$EXP$$CA-CELLTRION INC.-2023CA017301$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
238959993$23895999$3$F$20230601$20240913$20240524$20240917$30DAY$$KR-PFIZER INC-202400174416$PFIZER$$8$YR$$$Y$$$20240917$$CN$KR$KR
238960025$23896002$5$F$$20240823$20240524$20240829$30DAY$$KR-PFIZER INC-202400174300$PFIZER$$11$YR$$M$Y$$$20240829$$CN$KR$KR
238960042$23896004$2$F$$20240911$20240524$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-024718$AUROBINDO$Baumert LS, Shih AR, Chung RT. HBV reactivation and clinical resolution in an isolated anti-HBc-positive patient during immune checkpoint inhibition. Med-(NY). 2024;5 (2):126-131$68$YR$$M$Y$$$20240925$$HP$US$US
238960254$23896025$4$F$$20240913$20240524$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081569$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240913$$HP$US$US
238960332$23896033$2$F$$20240815$20240524$20240820$EXP$$US-ABBVIE-5772627$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
238960402$23896040$2$F$$20240621$20240524$20240703$PER$$US-ALKERMES INC.-ALK-2024-001431$ALKERMES$$$$$F$Y$$$20240703$$PH$US$US
238960515$23896051$5$F$20240101$20240823$20240524$20240823$EXP$$CA-PFIZER INC-PV202400048556$PFIZER$$42$YR$$M$Y$83.6$KG$20240823$$HP$CA$CA
238960613$23896061$3$F$20240101$20240819$20240524$20240821$EXP$$US-PFIZER INC-202400106558$PFIZER$$49$YR$$F$Y$$$20240821$$HP$US$US
238960653$23896065$3$F$$20240628$20240524$20240703$EXP$$JP-PFIZER INC-PV202400066929$PFIZER$$78$YR$$M$Y$$$20240703$$MD$JP$JP
238960682$23896068$2$F$$20240814$20240524$20240819$30DAY$$CO-PFIZER INC-PV202400066467$PFIZER$$11$YR$$F$Y$$$20240819$$CN$CO$CO
238960752$23896075$2$F$20230101$20240827$20240524$20240829$EXP$$ZA-PFIZER INC-202400173786$PFIZER$$41$YR$$F$Y$$$20240829$$MD$ZA$ZA
238960792$23896079$2$F$20230101$20240703$20240524$20240709$EXP$$CA-UCBSA-2023036090$UCB$$$$$M$Y$$$20240709$$CN$CA$CA
238960822$23896082$2$F$20240520$20240717$20240524$20240717$30DAY$$CO-PFIZER INC-202400173328$PFIZER$$13$YR$$M$Y$$$20240717$$MD$CO$CO
238960832$23896083$2$F$$20240913$20240524$20240917$30DAY$$CL-PFIZER INC-PV202400061991$PFIZER$$10$YR$$F$Y$$$20240917$$CN$CL$CL
238961004$23896100$4$F$20240517$20240821$20240524$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015271$UNITED THERAPEUTICS$$62$YR$$F$Y$90.703$KG$20240829$$PH$US$US
238961173$23896117$3$F$20240518$20240626$20240524$20240701$PER$$US-PFIZER INC-202400173342$PFIZER$$79$YR$$F$Y$62.132$KG$20240701$$CN$US$US
238961213$23896121$3$F$$20240729$20240524$20240801$PER$$US-PFIZER INC-PV202400067371$PFIZER$$59$YR$$F$Y$$$20240801$$HP$US$US
238961323$23896132$3$F$$20240701$20240524$20240705$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-029787$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240705$$CN$US$US
238961332$23896133$2$F$$20240613$20240524$20240707$EXP$$GB-JNJFOC-20240517884$JOHNSON AND JOHNSON$$$$$M$Y$$$20240707$$CN$GB$GB
238961374$23896137$4$F$$20240817$20240524$20240821$PER$$NVSC2024US106316$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
238961544$23896154$4$F$20240426$20240902$20240524$20240909$EXP$$IE-JNJFOC-20240529324$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240909$$CN$IE$IE
238961572$23896157$2$F$$20240716$20240524$20240723$EXP$$GB-JNJFOC-20240555227$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240724$$HP$GB$GB
238961643$23896164$3$F$20240420$20240726$20240524$20240731$EXP$$US-OTSUKA-2024_014639$OTSUKA$$$$$M$Y$$$20240731$$CN$US$US
238961712$23896171$2$F$20210603$20240905$20240524$20240911$EXP$$ES-AUROBINDO-AUR-APL-2024-025112$AUROBINDO$$59$YR$$M$Y$93.1$KG$20240911$$MD$ES$ES
238961872$23896187$2$F$20240101$20240714$20240524$20240715$EXP$$CA-PFIZER INC-202400174884$PFIZER$$82$YR$$F$Y$$$20240715$$HP$CA$CA
238961882$23896188$2$F$$20240714$20240524$20240715$EXP$$CA-PFIZER INC-202300318189$PFIZER$$28$YR$$F$Y$$$20240715$$MD$CA$CA
238961892$23896189$2$F$20240401$20240630$20240524$20240701$30DAY$$TR-PFIZER INC-PV202400061033$PFIZER$$8$YR$$F$Y$30$KG$20240701$$MD$TR$TR
238961906$23896190$6$F$$20240913$20240524$20240916$30DAY$$CA-PFIZER INC-202400174921$PFIZER$$$$$$Y$$$20240916$$HP$CA$CA
238961964$23896196$4$F$$20240715$20240524$20240722$30DAY$$US-PFIZER INC-202400107448$PFIZER$$$$$$Y$$$20240722$$PH$US$US
238961977$23896197$7$F$20240101$20240903$20240524$20240905$30DAY$$US-PFIZER INC-202400172557$PFIZER$$15$YR$$M$Y$$$20240905$$CN$US$US
238962273$23896227$3$F$$20240725$20240524$20240729$EXP$$NVSC2024US103330$NOVARTIS$$$$$F$Y$55.329$KG$20240729$$CN$US$US
238962444$23896244$4$F$$20240827$20240524$20240830$PER$$US-JNJFOC-20240547476$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240830$$HP$US$US
238962572$23896257$2$F$$20240726$20240524$20240801$30DAY$$TR-PFIZER INC-202400108118$PFIZER$$$$$$Y$$$20240801$$PH$TR$TR
238962583$23896258$3$F$$20240706$20240524$20240708$30DAY$$DO-PFIZER INC-PV202400066466$PFIZER$$17$YR$$M$Y$$$20240708$$HP$DO$DO
238962592$23896259$2$F$20240401$20240806$20240524$20240812$EXP$$CN-PFIZER INC-PV202400067599$PFIZER$$41$YR$$M$Y$$$20240812$$CN$CN$CN
238962694$23896269$4$F$20240101$20240823$20240524$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-015599$UNITED THERAPEUTICS$$$$$F$Y$58.957$KG$20240830$$$US$US
238962812$23896281$2$F$$20240916$20240524$20240924$EXP$$US-TAKEDA-2024TUS040356$TAKEDA$$$$$M$Y$$$20240924$$CN$US$US
238962842$23896284$2$F$$20240613$20240524$20240709$EXP$$SG-ROCHE-3567874$ROCHE$$71$YR$E$F$Y$$$20240704$$MD$SG$SG
238962862$23896286$2$F$$20240711$20240524$20240715$PER$$US-AMGEN-USASP2024102484$AMGEN$$72$YR$E$F$Y$$$20240715$$MD$US$US
238962902$23896290$2$F$20181230$20240812$20240524$20240827$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-196529$RANBAXY$$$$$F$Y$$$20240827$$CN$RO$RO
238963012$23896301$2$F$$20240705$20240524$20240712$EXP$$DK-TAKEDA-2024TUS051789$TAKEDA$$84$YR$$F$Y$$$20240712$$HP$DK$DK
238963063$23896306$3$F$20240519$20240829$20240524$20240902$PER$$NVSC2024US109137$NOVARTIS$$57$YR$$F$Y$$$20240902$$CN$US$US
238963252$23896325$2$F$$20240701$20240524$20240704$EXP$$JP-AMGEN-JPNSP2024076497$AMGEN$$$$E$F$Y$$$20240704$$PH$JP$JP
238963342$23896334$2$F$$20240913$20240524$20240924$EXP$$FR-JNJFOC-20240554723$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240924$$MD$FR$FR
238963374$23896337$4$F$$20240718$20240524$20240726$EXP$$US-TAKEDA-2024TUS002167$TAKEDA$$$$$F$Y$62$KG$20240726$$MD$US$US
238963522$23896352$2$F$20240515$20240807$20240524$20240809$PER$$US-AMGEN-USASP2024102894$AMGEN$$66$YR$E$F$Y$$$20240809$$CN$US$US
238963782$23896378$2$F$$20240624$20240524$20240703$30DAY$$AT-JNJFOC-20240567932$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$AT$AT
238964137$23896413$7$F$20240101$20240628$20240524$20240704$EXP$$US-UCBSA-2024025162$UCB$$$$$F$Y$$$20240704$$CN$US$US
238964152$23896415$2$F$20240416$20240621$20240524$20240701$EXP$$JP-AMGEN-JPNSP2024101428$AMGEN$$8$DEC$E$M$Y$$$20240630$$MD$JP$JP
238964232$23896423$2$F$$20240723$20240524$20240725$EXP$$DE-JNJFOC-20240560227$JOHNSON AND JOHNSON$$$$N$F$Y$$$20240725$$MD$DE$DE
238964522$23896452$2$F$$20240807$20240524$20240812$EXP$$GB-SANDOZ INC.-SDZ2024GB042792$SANDOZ$$$$$F$Y$$$20240812$$CN$GB$GB
238964732$23896473$2$F$20240523$20240702$20240524$20240705$PER$$US-AMGEN-USASP2024102801$AMGEN$$73$YR$E$F$Y$$$20240704$$CN$US$US
238964822$23896482$2$F$20240419$20240517$20240524$20240717$EXP$IT-MINISAL02-984427$IT-TEVA-VS-3200351$TEVA$$63$YR$$M$Y$$$20240717$$MD$IT$IT
238964843$23896484$3$F$$20240823$20240524$20240829$PER$$NVSC2024US104424$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
238965022$23896502$2$F$$20240719$20240524$20240725$EXP$$AU-AMERICAN REGENT INC-2024001940$AMERICAN REGENT$$46$YR$$F$Y$70$KG$20240725$$HP$AU$AU
238965073$23896507$3$F$$20240705$20240524$20240705$PER$$NVSC2024US109140$NOVARTIS$$$$$M$Y$$$20240705$$CN$US$US
238965112$23896511$2$F$$20240822$20240524$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081915$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240822$$HP$US$US
238965213$23896521$3$F$$20240726$20240524$20240801$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015541$UNITED THERAPEUTICS$$$$$F$Y$45.351$KG$20240801$$$US$US
238965302$23896530$2$F$20240501$20240819$20240524$20240909$PER$$CA-TOLMAR, INC.-24CA049012$TOLMAR$$81$YR$$M$Y$$$20240909$$CN$CA$CA
238965342$23896534$2$F$20240501$20240819$20240524$20240909$PER$$CA-TOLMAR, INC.-24CA049021$TOLMAR$$79$YR$$M$Y$$$20240909$$CN$CA$CA
238965372$23896537$2$F$$20240726$20240524$20240729$EXP$$NVSC2024AU108785$NOVARTIS$$72$YR$$$Y$$$20240729$$MD$AU$AU
238965702$23896570$2$F$20240208$20240716$20240524$20240726$EXP$$CH-TEVA-VS-3201087$TEVA$$49$YR$$F$Y$$$20240726$$MD$CH$CH
238965742$23896574$2$F$20240722$20240809$20240524$20240814$EXP$$US-TAKEDA-2024TUS050495$TAKEDA$$79$YR$$F$Y$$$20240814$$CN$US$US
238965762$23896576$2$F$20240506$20240731$20240524$20240801$EXP$$US-TAKEDA-2024TUS034641$TAKEDA$$72$YR$$M$Y$$$20240801$$CN$US$US
238965782$23896578$2$F$20240101$20240822$20240524$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081660$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240823$$HP$US$US
238965859$23896585$9$F$20240101$20240815$20240524$20240822$PER$$US-BIOGEN-2024BI01265870$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
238965952$23896595$2$F$20220708$20240904$20240524$20240905$EXP$$AU-TAKEDA-2022TUS005204$TAKEDA$$38$YR$$F$Y$$$20240905$$HP$AU$AU
238965985$23896598$5$F$20240129$20240711$20240524$20240717$EXP$$AR-TAKEDA-2024TUS050710$TAKEDA$$8$YR$$M$Y$$$20240717$$CN$AR$AR
238965993$23896599$3$F$20240524$20240816$20240524$20240821$EXP$$CA-TAKEDA-2024TUS050830$TAKEDA$$75$YR$$M$Y$$$20240821$$CN$CA$CA
238966073$23896607$3$F$$20240703$20240524$20240712$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001057$BLUEPRINT MEDICINES$$$$$F$Y$$$20240709$$CN$US$US
238966132$23896613$2$F$20240425$20240703$20240524$20240711$EXP$$US-JNJFOC-20240555117$JOHNSON AND JOHNSON$$65$YR$E$F$Y$68.8$KG$20240711$$MD$US$US
238966173$23896617$3$F$$20240718$20240524$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001058$BLUEPRINT MEDICINES$$$$$F$Y$$$20240726$$CN$US$US
238966343$23896634$3$F$$20240725$20240524$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081603$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240726$$CN$US$US
238966482$23896648$2$F$$20240905$20240524$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-008688$VERTEX$$$$$$Y$$$20240912$$CN$US$US
238966783$23896678$3$F$$20240621$20240524$20240702$PER$$US-ROCHE-3565474$ROCHE$$$$$F$Y$$$20240702$$CN$US$US
238967082$23896708$2$F$$20240621$20240524$20240702$EXP$$US-OTSUKA-2024_014300$OTSUKA$$$$$M$Y$101.15$KG$20240702$$CN$US$US
238967152$23896715$2$F$$20240716$20240524$20240724$EXP$$US-Calliditas-2024CAL00763$CALLIDITAS THERAPEUTICS$$30$YR$A$F$Y$98.9$KG$20240724$$CN$US$US
238967162$23896716$2$F$$20240702$20240524$20240703$PER$$US-JNJFOC-20240568326$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240703$$CN$US$US
238967292$23896729$2$F$$20240909$20240524$20240909$PER$$US-ALXN-202405USA001256US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
238967363$23896736$3$F$20240201$20240802$20240524$20240809$EXP$$JP-AMGEN-JPNSP2024070683$AMGEN$$97$YR$E$F$Y$$$20240809$$MD$JP$JP
238967392$23896739$2$F$20240115$20240808$20240524$20240813$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-002871$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240813$$CN$US$US
238967432$23896743$2$F$20150925$20240701$20240524$20240705$EXP$$JP-GILEAD-2018-0382000$GILEAD$$40$YR$A$M$Y$$$20240705$$MD$JP$JP
238967645$23896764$5$F$20240401$20240621$20240524$20240703$EXP$$BR-JNJFOC-20240551092$JOHNSON AND JOHNSON$$22$YR$A$F$Y$56$KG$20240703$$CN$BR$BR
238967735$23896773$5$F$20230928$20240822$20240524$20240830$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-000833$AKEBIA THERAPEUTICS$$84$YR$$M$Y$71$KG$20240830$$MD$JP$JP
238967863$23896786$3$F$20230501$20240910$20240524$20240920$EXP$$US-TORRENT-00013573$TORRENT$$66$YR$E$M$Y$86$KG$20240920$$MD$US$US
238967962$23896796$2$F$$20240718$20240524$20240718$PER$$US-ALXN-202405USA001351US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
238967972$23896797$2$F$$20240909$20240524$20240909$PER$$US-ALXN-202405USA001242US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
238968134$23896813$4$F$20240401$20240815$20240524$20240823$EXP$$US-Calliditas-2024CAL00765$CALLIDITAS THERAPEUTICS$$45$YR$A$F$Y$$$20240823$$CN$US$US
238968203$23896820$3$F$$20240703$20240524$20240714$30DAY$$DE-JNJFOC-20240562611$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$PH$DE$DE
238968492$23896849$2$F$$20240619$20240524$20240703$30DAY$$GB-JNJFOC-20240562445$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$GB$GB
238968523$23896852$3$F$$20240718$20240524$20240718$PER$$US-ALXN-202405USA001358US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
238968582$23896858$2$F$20240516$20240902$20240524$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US050997$SANDOZ$$14$YR$$M$Y$$$20240904$$HP$US$US
238968732$23896873$2$F$20240401$20240905$20240524$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081560$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240906$$HP$US$US
238968953$23896895$3$F$$20240718$20240524$20240718$PER$$US-ALXN-202405USA001296US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
238969032$23896903$2$F$20240428$20240705$20240524$20240715$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001029$SK LIFE SCIENCE$$$$$$Y$$$20240715$$CN$US$US
238969142$23896914$2$F$20240501$20240627$20240524$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081835$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240703$$HP$US$US
238969432$23896943$2$F$$20240722$20240524$20240726$PER$$US-BIOGEN-2024BI01266045$BIOGEN$$$$$M$Y$$$20240726$$CN$US$US
238969442$23896944$2$F$$20240722$20240524$20240727$PER$$US-JNJFOC-20240504261$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240727$$CN$US$US
238969462$23896946$2$F$20231101$20240520$20240524$20240919$PER$$US-GILEAD-2024-0673924$GILEAD$$64$YR$A$M$Y$$$20240919$$CN$US$US
238969912$23896991$2$F$$20240625$20240524$20240701$PER$$US-PFIZER INC-PV202300189925$PFIZER$$82$YR$$F$Y$$$20240701$$MD$US$US
238970302$23897030$2$F$20240501$20240712$20240524$20240724$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405014078$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240723$$CN$JP$JP
238970333$23897033$3$F$20240601$20240710$20240524$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202405008776$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240722$$CN$US$US
238970392$23897039$2$F$20240415$20240726$20240524$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405000799$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240809$$CN$JP$JP
238970462$23897046$2$F$$20240916$20240524$20240924$EXP$$CA-PFIZER INC-202400174790$PFIZER$$59$YR$$F$Y$$$20240924$$MD$CA$CA
238970593$23897059$3$F$$20240718$20240524$20240718$PER$$US-ALXN-202405USA001285US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
238970662$23897066$2$F$20240516$20240827$20240524$20240828$EXP$$US-JNJFOC-20240547633$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240828$$CN$US$US
238970892$23897089$2$F$$20240704$20240524$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04203$LUPIN$$$$$$Y$$$20240729$$CN$US$US
238970963$23897096$3$F$20190101$20240807$20240524$20240812$EXP$$CA-JNJFOC-20240550381$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240812$$HP$CA$CA
238971376$23897137$6$F$$20240918$20240524$20240923$30DAY$$US-PFIZER INC-202400173602$PFIZER$$14$YR$$M$Y$$$20240923$$CN$US$US
238971396$23897139$6$F$20240518$20240925$20240524$20240925$30DAY$$AR-PFIZER INC-202400173170$PFIZER$$9$YR$$F$Y$$$20240925$$CN$AR$AR
238971573$23897157$3$F$$20240716$20240524$20240723$EXP$$US-JNJFOC-20240490038$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
238971862$23897186$2$F$20240401$20240624$20240524$20240711$EXP$$US-Calliditas-2024CAL00806$CALLIDITAS THERAPEUTICS$$63$YR$A$F$Y$88$KG$20240711$$CN$US$US
238972063$23897206$3$F$20230801$20240917$20240524$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-080131$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$76.9$KG$20240924$$MD$JP$JP
238972122$23897212$2$F$20231201$20240912$20240524$20240919$EXP$$US-SA-2024SA156143$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240919$$MD$US$US
238972157$23897215$7$F$20230101$20240725$20240524$20240730$EXP$$US-SANOFI-AVENTIS R+D-2024SA153436$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240730$$MD$US$US
238972432$23897243$2$F$20240401$20240919$20240524$20240924$EXP$IT-MINISAL02-985275$IT-MYLANLABS-2024M1046116$MYLAN$$78$YR$$M$Y$61$KG$20240924$$PH$IT$IT
238972502$23897250$2$F$$20240916$20240524$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA051829$SANDOZ$$$$$F$Y$$$20240917$$CN$CA$CA
238972513$23897251$3$F$20240516$20240831$20240524$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US050589$SANDOZ$$77$YR$$M$Y$$$20240904$$CN$US$US
238972542$23897254$2$F$20240510$20240731$20240524$20240813$EXP$$US-UCBSA-2024025882$UCB$$67$YR$$M$Y$106.59$KG$20240813$$CN$US$US
238972682$23897268$2$F$$20240718$20240524$20240718$PER$$US-ALXN-202405USA001356US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
238972722$23897272$2$F$20230101$20240624$20240524$20240701$EXP$$CA-JNJFOC-20231062052$JOHNSON AND JOHNSON$$$$T$F$Y$$$20240701$$HP$CA$CA
238972802$23897280$2$F$$20240819$20240524$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081539$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240822$$CN$US$US
238973002$23897300$2$F$20240507$20240627$20240524$20240702$EXP$IT-MINISAL02-985419$IT-SA-2024SA156652$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240702$$MD$IT$IT
238973084$23897308$4$F$20240101$20240716$20240524$20240722$EXP$$US-SA-2024SA157081$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240720$$MD$US$US
238973124$23897312$4$F$20240408$20240712$20240524$20240718$EXP$$AR-TAKEDA-2024TUS051997$TAKEDA$$31$YR$$F$Y$90$KG$20240718$$CN$AR$AR
238973162$23897316$2$F$20240101$20240712$20240524$20240913$PER$$US-KARYOPHARM-2024KPT001028$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240913$$CN$US$US
238973302$23897330$2$F$$20240910$20240524$20240913$PER$$US-ALXN-202405USA001368US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
238973332$23897333$2$F$$20240718$20240524$20240718$PER$$US-ALXN-202405USA001341US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
238973463$23897346$3$F$$20240628$20240524$20240705$30DAY$$AU-JNJFOC-20240561372$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$PH$AU$AU
238973492$23897349$2$F$20240101$20240814$20240524$20240819$PER$$US-PFIZER INC-202400174933$PFIZER$$60$YR$$F$Y$$$20240819$$HP$US$US
238973642$23897364$2$F$$20240716$20240524$20240717$PER$$US-ALXN-202405USA001444US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
238973652$23897365$2$F$$20240718$20240524$20240725$EXP$$US-ALXN-202405USA001372US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
238973712$23897371$2$F$20240408$20240628$20240524$20240705$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-007788$JAZZ$$28$YR$$M$Y$$$20240705$$CN$US$US
238973762$23897376$2$F$20240401$20240723$20240524$20240726$EXP$$US-BIOVITRUM-2024-US-007402$BIOVITRUM$$88$YR$$M$Y$$$20240726$$CN$US$US
238973783$23897378$3$F$$20240910$20240524$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA051842$SANDOZ$$72$YR$$F$Y$$$20240919$$CN$CA$CA
238973852$23897385$2$F$$20240521$20240524$20240723$PER$$US-INCYTE CORPORATION-2024IN005399$INCYTE$$$$$$Y$$$20240723$$CN$US$US
238973933$23897393$3$F$20220616$20240705$20240524$20240708$EXP$$DE-BIOVITRUM-2024-DE-007511$BIOVITRUM$$55$YR$$F$Y$$$20240708$$MD$DE$DE
238973942$23897394$2$F$20230901$20240702$20240524$20240709$EXP$$SI-JNJFOC-20240571449$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240709$$MD$SI$SI
238973984$23897398$4$F$$20240924$20240524$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078934$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240924$$CN$US$US
238974012$23897401$2$F$20240501$20240718$20240524$20240718$PER$$US-ALXN-202405USA001279US$ALEXION PHARMACEUTICALS$$54$YR$$M$Y$$$20240718$$CN$US$US
238974043$23897404$3$F$$20240909$20240524$20240916$EXP$$CA-ABBVIE-5772292$ABBVIE$$$$$M$Y$$$20240916$$HP$CA$CA
238974112$23897411$2$F$$20240816$20240524$20240819$PER$$US-BIOVITRUM-2024-US-007547$BIOVITRUM$$72$YR$$M$Y$$$20240819$$CN$US$US
238974132$23897413$2$F$20240508$20240628$20240524$20240705$EXP$$CO-VANTIVE-2024VAN017069$Vantive US Healthcare$$49$YR$$F$Y$$$20240705$$CN$CO$CO
238974163$23897416$3$F$$20240627$20240524$20240703$30DAY$$TR-JNJFOC-20240561146$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$TR$TR
238974202$23897420$2$F$20240202$20240731$20240524$20240802$30DAY$$US-SANDOZ INC.-SDZ2024US012052$SANDOZ$$9$YR$$F$Y$$$20240802$$CN$US$US
238974242$23897424$2$F$20240101$20240626$20240524$20240701$EXP$$DE-ABBVIE-5772706$ABBVIE$$32$YR$$M$Y$72$KG$20240701$$HP$DE$DE
238974276$23897427$6$F$$20240806$20240524$20240807$PER$$US-HALEON-2176897$Haleon PLC$$$$$$Y$$$20240807$$CN$US$US
238974282$23897428$2$F$20240426$20240712$20240524$20240725$EXP$$IE-Orchard Therapeutics-2157402$ORCHARD THERAPEUTICS EUROPE$$8$YR$$M$Y$$$20240725$$MD$IT$IE
238974342$23897434$2$F$$20240704$20240524$20240709$EXP$$JP-JNJFOC-20240565056$JOHNSON AND JOHNSON$Megumi FUJIMOTO et al.; Department of Dermatology, National Hospital Organization Osaka National Hospital. A case of toxic epidermal necrolysis due to APALUTAMIDE with various immune reconstitution syndromes. The Japanese Journal of Dermatology. Proceedings of the 123rd Annual Meeting of the Japanese Dermatological Association;2024.6.6,7,8,9;Kyoto-shi Kyoto:2024;134(5)1518$83$YR$E$M$Y$$$20240709$$$COUNTRY NOT SPECIFIED$JP
238974382$23897438$2$F$$20240715$20240524$20240717$EXP$$NVSC2024US109138$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
238974392$23897439$2$F$20230801$20240829$20240524$20240906$EXP$$NZ-TAKEDA-2024TUS039993$TAKEDA$$62$YR$$M$Y$$$20240906$$MD$NZ$NZ
238974527$23897452$7$F$$20240918$20240524$20240920$PER$$US-BIOGEN-2024BI01265978$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
238974543$23897454$3$F$20240101$20240704$20240524$20240710$EXP$$CA-JNJFOC-20221138270$JOHNSON AND JOHNSON$$20$YR$A$M$Y$53$KG$20240710$$HP$CA$CA
238974593$23897459$3$F$$20240626$20240524$20240702$EXP$$US-TG THERAPEUTICS INC.-TGT003608$TG THERAPEUTICS$$$$$$Y$$$20240702$$MD$US$US
238974602$23897460$2$F$$20240907$20240524$20240913$EXP$$NVSC2024US103183$NOVARTIS$$38$YR$$M$Y$140$KG$20240913$$CN$US$US
238974694$23897469$4$F$20240101$20240715$20240524$20240719$EXP$$CA-ABBVIE-5771964$ABBVIE$$61$YR$$M$Y$$$20240719$$CN$CA$CA
238974752$23897475$2$F$$20240624$20240524$20240703$30DAY$$JP-JNJFOC-20240557659$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$JP$JP
238974976$23897497$6$F$20240421$20240809$20240524$20240816$EXP$$US-Calliditas-2024CAL00836$CALLIDITAS THERAPEUTICS$$82$YR$E$M$Y$$$20240816$$CN$US$US
238975012$23897501$2$F$20230930$20240814$20240524$20240820$EXP$$JP-ABBVIE-5583696$ABBVIE$$59$YR$$F$Y$60$KG$20240820$$MD$JP$JP
238975183$23897518$3$F$20220101$20240821$20240524$20240825$EXP$$US-ABBVIE-5737623$ABBVIE$$$$$F$Y$$$20240825$$CN$US$US
238975303$23897530$3$F$20240516$20240814$20240524$20240815$30DAY$$CO-PFIZER INC-PV202400066501$PFIZER$$13$YR$$M$Y$54$KG$20240815$$CN$CO$CO
238975333$23897533$3$F$$20240718$20240524$20240723$30DAY$$US-SANDOZ INC.-SDZ2024US051399$SANDOZ$$$$$F$Y$$$20240723$$CN$US$US
238975582$23897558$2$F$$20240717$20240524$20240722$PER$$US-AMGEN-USASP2024102352$AMGEN$$35$YR$A$M$Y$$$20240722$$HP$US$US
238975613$23897561$3$F$20240101$20240805$20240524$20240807$EXP$$CO-ABBVIE-5771539$ABBVIE$$$$$M$Y$70$KG$20240807$$CN$CO$CO
238975773$23897577$3$F$$20240627$20240524$20240705$EXP$$US-Calliditas-2024CAL00842$CALLIDITAS THERAPEUTICS$$45$YR$A$F$Y$145.15$KG$20240705$$CN$US$US
238975792$23897579$2$F$$20240911$20240524$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA051273$SANDOZ$$58$YR$$F$Y$$$20240923$$CN$CA$CA
238976013$23897601$3$F$20240413$20240625$20240524$20240725$EXP$$IT-BAXTER-2024BAX018612$BAXTER$$72$YR$$M$Y$56.5$KG$20240725$$MD$IT$IT
238976092$23897609$2$F$$20240712$20240524$20240717$EXP$$GB-MYLANLABS-2024M1019507$MYLAN$$$$$F$Y$$$20240717$$PH$GB$GB
238976112$23897611$2$F$$20240625$20240524$20240701$30DAY$$AR-PFIZER INC-202400134958$PFIZER$$68$YR$$F$Y$$$20240701$$CN$AR$AR
238976303$23897630$3$F$20240415$20240621$20240524$20240701$EXP$IT-MINISAL02-984510$IT-TEVA-VS-3199929$TEVA$$65$YR$$F$Y$46$KG$20240701$$MD$IT$IT
238976382$23897638$2$F$$20240718$20240524$20240718$PER$$US-ALXN-202405USA001165US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
238976392$23897639$2$F$20240321$20240703$20240524$20240712$EXP$FR-AFSSAPS-LL2024000899$FR-009507513-2405FRA006891$MERCK$$70$YR$$F$Y$54$KG$20240712$$MD$FR$FR
238976402$23897640$2$F$$20240703$20240524$20240704$PER$$NVSC2024US110199$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
238976542$23897654$2$F$$20240715$20240524$20240729$EXP$$CA-HLS-202401331$HLS THERAPEUTICS$$$$E$M$Y$$$20240729$$HP$CA$CA
238976674$23897667$4$F$20240401$20240702$20240524$20240710$EXP$$JP-GENMAB-2024-01290AA$GENMAB$$91$YR$$F$Y$42.3$KG$20240710$$MD$JP$JP
238976707$23897670$7$F$20240501$20240917$20240524$20240923$EXP$$JP-AMGEN-JPNSP2024093336$AMGEN$$75$YR$E$F$Y$56.3$KG$20240923$$MD$JP$JP
238976772$23897677$2$F$20240515$20240718$20240524$20240718$PER$$US-ALXN-202405USA001238US$ALEXION PHARMACEUTICALS$$73$YR$$F$Y$$$20240718$$CN$US$US
238977072$23897707$2$F$20240212$20240710$20240524$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000969$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238977282$23897728$2$F$$20240722$20240524$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080266$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240724$$CN$US$US
238977342$23897734$2$F$20240522$20240629$20240524$20240703$EXP$$US-KYOWAKIRIN-2024KK012445$KYOWA$$$$$$Y$$$20240703$$HP$US$US
238977665$23897766$5$F$$20240917$20240524$20240926$PER$$US-Calliditas-2024CAL00771$CALLIDITAS THERAPEUTICS$$39$YR$A$F$Y$74.8$KG$20240926$$CN$US$US
238977722$23897772$2$F$20180101$20240716$20240524$20240724$EXP$$JP-JNJFOC-A-CH2018-178239$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240724$$MD$JP$JP
238977832$23897783$2$F$$20240910$20240524$20240912$EXP$$NVSC2024CA108727$NOVARTIS$$44$YR$$F$Y$$$20240912$$HP$CA$CA
238977882$23897788$2$F$20240101$20240912$20240524$20240917$EXP$$GB-VERTEX PHARMACEUTICALS-2024-008799$VERTEX$$$$$F$Y$$$20240917$$CN$GB$GB
238978222$23897822$2$F$$20240718$20240524$20240725$EXP$$JP-009507513-2405JPN002359J$MERCK$$55$YR$$F$Y$$$20240725$$MD$JP$JP
238978262$23897826$2$F$20240509$20240715$20240524$20240722$PER$$US-ALXN-202403USA000054US$ALEXION PHARMACEUTICALS$$31$YR$$F$Y$111$KG$20240722$$MD$US$US
238978273$23897827$3$F$20230101$20240807$20240524$20240808$PER$$US-ALXN-A202308147$ALEXION PHARMACEUTICALS$$63$YR$$M$Y$$$20240808$$CN$US$US
238978432$23897843$2$F$$20240610$20240524$20240702$PER$$NVSC2024US110215$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
238978532$23897853$2$F$$20240717$20240524$20240722$EXP$$US-AstraZeneca-2024A117889$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
238978683$23897868$3$F$20240101$20240703$20240524$20240717$PER$$US-Calliditas-2024CAL00773$CALLIDITAS THERAPEUTICS$$33$YR$A$M$Y$$$20240717$$CN$US$US
238979144$23897914$4$F$$20240626$20240524$20240704$EXP$$US-APELLIS-APL-2024-004392$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240704$$CN$US$US
238979172$23897917$2$F$$20240621$20240524$20240702$PER$$US-ALKERMES INC.-ALK-2024-001435$ALKERMES$$$$$M$Y$$$20240702$$PH$US$US
238979212$23897921$2$F$20240501$20240625$20240524$20240708$PER$$US-ALKERMES INC.-ALK-2024-001420$ALKERMES$$45$YR$$F$Y$105.22$KG$20240708$$HP$US$US
238979302$23897930$2$F$$20240718$20240524$20240718$PER$$US-ALXN-202405USA001233US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
238979343$23897934$3$F$$20240625$20240524$20240701$EXP$$SK-MYLANLABS-2024M1038176$MYLAN$Satnik V. Day of the Clinical Pharmacist in the Central Slovak Constitution of Heart and Vascular Diseases. Pharmacist. 2024;29(4):14-15$82$YR$$M$Y$85$KG$20240701$$PH$SK$SK
238979362$23897936$2$F$$20240702$20240524$20240710$EXP$$US-AstraZeneca-2024A116141$ASTRAZENECA$$$$$$Y$$$20240710$$HP$US$
238979462$23897946$2$F$20231213$20240425$20240524$20240717$EXP$$US-APELLIS-APL-2023-003430$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
238979484$23897948$4$F$20240202$20240828$20240524$20240904$PER$$US-APELLIS-APL-2024-003915$APELLIS PHARMACEUTICALS$$$$$$Y$91.626$KG$20240904$$CN$US$US
238979543$23897954$3$F$20240101$20240918$20240524$20240927$PER$$US-INCYTE CORPORATION-2024IN005450$INCYTE$$$$$$Y$$$20240927$$CN$US$US
238979782$23897978$2$F$20240101$20240719$20240524$20240730$PER$$US-SA-2024SA153235$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240730$$MD$US$US
238979824$23897982$4$F$20240101$20240903$20240524$20240928$PER$$US-SA-2024SA151799$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240928$$MD$US$US
238979914$23897991$4$F$20240101$20240819$20240524$20240826$PER$$US-SA-2024SA152070$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240826$$CN$US$US
238980193$23898019$3$F$20240501$20240724$20240524$20240806$PER$$US-SA-2024SA152371$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240806$$MD$US$US
238980372$23898037$2$F$20240501$20240826$20240524$20240909$PER$$US-SA-2024SA152359$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240909$$MD$US$US
238980382$23898038$2$F$$20240730$20240524$20240808$PER$$US-SA-2024SA151507$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240808$$HP$US$US
238980434$23898043$4$F$20240517$20240814$20240524$20240828$PER$$US-SA-2024SA155534$SANOFI AVENTIS$$36$YR$A$F$Y$61.2$KG$20240828$$MD$US$US
238980722$23898072$2$F$20240101$20240812$20240524$20240820$PER$$US-SA-2024SA155862$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240820$$MD$US$US
238980782$23898078$2$F$$20240918$20240524$20240927$PER$$US-SA-2024SA156281$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240927$$MD$US$US
238980832$23898083$2$F$20240101$20240708$20240524$20240717$PER$$US-SA-2024SA026373$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240717$$CN$US$US
238980944$23898094$4$F$20240101$20240719$20240524$20240725$EXP$$US-SA-2024SA157043$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240725$$MD$US$US
238981082$23898108$2$F$20240201$20240717$20240524$20240726$PER$$US-SA-2024SA156087$SANOFI AVENTIS$$68$YR$E$F$Y$63.14$KG$20240726$$MD$US$US
238981183$23898118$3$F$20240601$20240725$20240524$20240805$PER$$US-SA-2024SA156378$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240805$$MD$US$US
238981222$23898122$2$F$$20240626$20240524$20240705$PER$$US-SA-2024SA155909$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$HP$US$US
238981242$23898124$2$F$$20240717$20240524$20240726$PER$$US-SA-2024SA156039$SANOFI AVENTIS$$$$$F$Y$$$20240726$$HP$US$US
238981372$23898137$2$F$$20240730$20240524$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081873$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240731$$CN$US$US
238981392$23898139$2$F$20240701$20240712$20240524$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081791$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$94.8$KG$20240717$$HP$US$US
238981462$23898146$2$F$$20240702$20240524$20240710$EXP$$US-AstraZeneca-2024A115357$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
238981473$23898147$3$F$$20240619$20240524$20240812$EXP$$FR-AstraZeneca-2024A119118$ASTRAZENECA$$$$$M$Y$91$KG$20240812$$MD$FR$
238981552$23898155$2$F$20150701$20240816$20240524$20240828$PER$$US-INCYTE CORPORATION-2024IN005448$INCYTE$$$$$$Y$$$20240828$$CN$US$US
238981682$23898168$2$F$$20240822$20240524$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-082158$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240822$$CN$US$US
238981732$23898173$2$F$$20240708$20240524$20240716$EXP$$JP-TAKEDA-2024TUS051673$TAKEDA$$22$YR$$M$Y$60.1$KG$20240716$$MD$JP$JP
238981872$23898187$2$F$$20240703$20240524$20240709$EXP$$CZ-BAUSCH-BL-2024-007990$BAUSCH AND LOMB$Volsakova E. Eosinophilic asthma without peripheral eosinophilia. Farmakoterapie. 2024;20 (2):114-118.$$$$M$Y$$$20240709$$MD$CZ$CZ
238981893$23898189$3$F$$20240708$20240524$20240711$EXP$$US-BAUSCH-BL-2024-007854$BAUSCH AND LOMB$$$$$$Y$$$20240711$$PH$US$US
238981922$23898192$2$F$$20240705$20240524$20240705$PER$$NVSC2024US110150$NOVARTIS$$25$YR$$M$Y$$$20240705$$HP$US$US
238981932$23898193$2$F$$20240827$20240524$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-082076$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240830$$CN$US$US
238982033$23898203$3$F$$20240718$20240524$20240731$PER$$US-Calliditas-2024CAL00776$CALLIDITAS THERAPEUTICS$$75$YR$E$M$Y$64.4$KG$20240731$$CN$US$US
238982053$23898205$3$F$20240520$20240720$20240524$20240723$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-029737$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$75$KG$20240723$$MD$IT$IT
238982092$23898209$2$F$$20240827$20240524$20240827$PER$$US-PURDUE PHARMA-USA-2024-0309764$PURDUE$$$$$F$Y$$$20240827$$HP$US$US
238982172$23898217$2$F$$20240910$20240524$20240920$PER$$US-ALKERMES INC.-ALK-2024-001460$ALKERMES$$$$$M$Y$$$20240920$$PH$US$US
238982253$23898225$3$F$20231201$20240702$20240524$20240709$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-077892$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$76.2$KG$20240709$$CN$PR$PR
238982336$23898233$6$F$$20240812$20240524$20240819$30DAY$$IL-PFIZER INC-202400172588$PFIZER$$$$$M$Y$$$20240819$$CN$IL$IL
238982342$23898234$2$F$$20240909$20240524$20240909$PER$$US-ALXN-202405USA001263US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
238982362$23898236$2$F$$20240718$20240524$20240718$PER$$US-ALXN-202405USA001255US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
238982472$23898247$2$F$$20240911$20240524$20240911$PER$$US-ALXN-202405USA001261US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240911$$CN$US$US
238982712$23898271$2$F$$20240625$20240524$20240701$EXP$$GR-PFIZER INC-202400173715$PFIZER$$65$YR$$M$Y$$$20240701$$MD$GR$GR
238982842$23898284$2$F$20240501$20240718$20240524$20240718$PER$$US-ALXN-202405USA001367US$ALEXION PHARMACEUTICALS$$36$YR$$F$Y$$$20240718$$CN$US$US
238982862$23898286$2$F$$20240909$20240524$20240921$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-122905$DAIICHI$$$$$F$Y$$$20240921$$CN$US$US
238982872$23898287$2$F$$20240716$20240524$20240731$EXP$$CA-HLS-202401341$HLS THERAPEUTICS$$$$A$M$Y$$$20240731$$PH$CA$CA
238982883$23898288$3$F$20240519$20240716$20240524$20240718$30DAY$$US-SANDOZ INC.-SDZ2024US051897$SANDOZ$$40$YR$$F$Y$$$20240718$$HP$US$US
238982977$23898297$7$F$20240101$20240812$20240524$20240826$EXP$$US-MALLINCKRODT-MNK202403269$MALLINCKRODT$$63$YR$A$F$Y$$$20240827$$CN$US$US
238983323$23898332$3$F$$20240926$20240524$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081708$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240930$$CN$US$US
238983352$23898335$2$F$$20240826$20240524$20240829$PER$$US-009507513-2405USA005876$MERCK$$$$$F$Y$$$20240829$$CN$US$US
238983372$23898337$2$F$20200101$20240515$20240524$20240723$EXP$$FR-JAZZ PHARMACEUTICALS-2024-FR-007591$JAZZ$$$$$$Y$$$20240723$$CN$FR$FR
238983394$23898339$4$F$20240507$20240716$20240524$20240723$EXP$$CH-TAKEDA-2024TUS049868$TAKEDA$$66$YR$$F$Y$71$KG$20240723$$CN$CH$CH
238983422$23898342$2$F$$20240719$20240524$20240801$PER$$US-JNJFOC-20240508856$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240801$$CN$US$US
238983532$23898353$2$F$20240501$20240717$20240524$20240722$PER$$US-009507513-2405USA006624$MERCK$$79$YR$$M$Y$81.859$KG$20240722$$HP$US$US
238983593$23898359$3$F$$20240726$20240524$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-007877$JAZZ$$$$$F$Y$$$20240729$$CN$US$US
238983622$23898362$2$F$$20240906$20240524$20240912$EXP$$JP-009507513-2405JPN001514J$MERCK$Yoshida Y, Mori T, Asakura Y, Koyama H. P73-3 Two cases of endometrial cancer with perforation early after initiation of pembrolizumab plus lenvatinib. 2024 the Japanese Society of Medical Oncology Annual Meeting$67$YR$$F$Y$$$20240912$$MD$JP$JP
238983672$23898367$2$F$$20240627$20240524$20240702$EXP$$JP-009507513-2405JPN001636J$MERCK$$$$$F$Y$$$20240702$$MD$JP$JP
238983732$23898373$2$F$20240201$20240919$20240524$20240924$EXP$$US-ABBVIE-5731860$ABBVIE$$76$YR$$M$Y$$$20240924$$CN$US$US
238983833$23898383$3$F$20240512$20240722$20240524$20240730$EXP$$US-ROCHE-3569185$ROCHE$$73$YR$E$F$Y$$$20240730$$CN$US$US
238983844$23898384$4$F$20231016$20240705$20240524$20240708$EXP$$CA-ABBVIE-5771341$ABBVIE$$66$YR$$F$Y$$$20240708$$MD$CA$CA
238983872$23898387$2$F$20230925$20240820$20240524$20240824$EXP$$JP-ABBVIE-5771894$ABBVIE$$80$YR$$M$Y$$$20240824$$MD$JP$JP
238983892$23898389$2$F$20240314$20240820$20240524$20240824$EXP$$JP-ABBVIE-5771888$ABBVIE$$65$YR$$F$Y$$$20240824$$MD$JP$JP
238983922$23898392$2$F$20240311$20240822$20240524$20240903$EXP$$KR-JAZZ PHARMACEUTICALS-2024-KR-008022$JAZZ$$67$YR$$M$Y$58.1$KG$20240903$$MD$KR$KR
238983993$23898399$3$F$20240201$20240814$20240524$20240822$EXP$$US-ABBVIE-5732319$ABBVIE$$71$YR$$F$Y$116$KG$20240822$$CN$US$US
238984252$23898425$2$F$$20240711$20240525$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001179$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238984262$23898426$2$F$$20240708$20240525$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001194$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238984454$23898445$4$F$20240101$20240715$20240525$20240720$EXP$$US-ABBVIE-5768980$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
238984472$23898447$2$F$20240304$20240605$20240525$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001625$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238984542$23898454$2$F$$20240617$20240525$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001679$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238984692$23898469$2$F$$20240508$20240525$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001911$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238984722$23898472$2$F$$20240506$20240525$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001876$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238984792$23898479$2$F$$20240430$20240525$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001797$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238984902$23898490$2$F$$20240802$20240525$20240808$PER$$US-ABBVIE-5767422$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
238984922$23898492$2$F$20240501$20240919$20240525$20240926$EXP$$DE-ABBVIE-5772864$ABBVIE$$73$YR$$M$Y$$$20240926$$CN$DE$DE
238985003$23898500$3$F$$20240710$20240525$20240724$EXP$$FR-ROCHE-3564121$ROCHE$Bartak H, Fareh T, Ben Othman N, Viard D, Cohen M, Rocher F Dental Adverse Effects of Anti-CD20 Therapies. doi:10.1007/s40120-024-00616-7. Neurol Ther. 2024;13:917-30.$79$YR$E$F$Y$$$20240724$$HP$FR$FR
238985042$23898504$2$F$20240422$20240711$20240525$20240726$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI04808$NEUROCRINE BIOSCIENCES$$45$YR$$F$Y$$$20240726$$HP$US$US
238985103$23898510$3$F$$20240905$20240525$20240910$EXP$$US-ABBVIE-5767002$ABBVIE$$$$$M$Y$113$KG$20240910$$CN$US$US
238985142$23898514$2$F$20200101$20240719$20240525$20240725$EXP$$US-ABBVIE-5770824$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
238985163$23898516$3$F$20240101$20240815$20240525$20240822$EXP$$CA-ABBVIE-5772653$ABBVIE$$24$YR$$M$Y$$$20240822$$CN$CA$CA
238985332$23898533$2$F$$20240608$20240525$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002270$BIOCON$$$$$$Y$$$20240819$$PH$US$US
238985642$23898564$2$F$$20240430$20240525$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002863$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238985652$23898565$2$F$$20240729$20240525$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003045$BIOCON$$$$$$Y$$$20240816$$PH$US$US
238985752$23898575$2$F$$20240520$20240525$20240715$EXP$$AU-HALEON-2176506$Haleon PLC$Dong M, Pearce F, Singh, N. Lin M. A case of Lomentospora prolifians endophthalmitis treated with the novel antifungal agent Olorofim. Journal of Ophthalmic Inflammation and Infetion. Volume: 14 (1) Year: 2024; Dong M, Pearce F, Singh, N. Lin M. A case of Lomentospora prolifians endophthalmitis treated with the novel antifungal agent Olorofim. Journal of Ophthalmic Inflammation and Infetion. Volume: 14 (1) Year: 2024; Dong M, Pearce F, Singh, N. Lin M, A case of Lomentospora prolifians endoph...$57$YR$$M$Y$$$20240712$$HP$AU$AU
238985762$23898576$2$F$$20240508$20240525$20240806$PER$$US-TEVA-VS-3197564$TEVA$$67$YR$$M$Y$$$20240806$$CN$US$US
238985813$23898581$3$F$20240521$20240905$20240525$20240919$EXP$$US-UCBSA-2024026090$UCB$$40$YR$$F$Y$$$20240919$$CN$US$US
238986062$23898606$2$F$20240101$20240806$20240525$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015037$UNITED THERAPEUTICS$$$$$M$Y$$$20240816$$$US$US
238986215$23898621$5$F$20240101$20240626$20240525$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-015430$UNITED THERAPEUTICS$$$$$M$Y$80.726$KG$20240703$$$US$US
238986295$23898629$5$F$20240101$20240813$20240525$20240822$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015486$UNITED THERAPEUTICS$$$$$F$Y$117.01$KG$20240822$$$US$US
238986422$23898642$2$F$20211101$20240807$20240525$20240812$EXP$$NVSC2021MX268782$NOVARTIS$$44$YR$$F$Y$60$KG$20240812$$CN$MX$MX
238986442$23898644$2$F$$20240702$20240525$20240708$PER$$US-AstraZeneca-2024A108518$ASTRAZENECA$$$$$F$Y$$$20240708$$MD$US$
238986652$23898665$2$F$$20240625$20240525$20240709$PER$$US-RDY-SPO/USA/24/0007222$DR REDDYS$$74$YR$E$M$Y$$$20240709$$CN$US$US
238986713$23898671$3$F$$20240625$20240525$20240708$PER$$US-RDY-SPO/USA/24/0007257$DR REDDYS$$$$$F$Y$$$20240709$$HP$US$US
238986752$23898675$2$F$20231221$20240904$20240525$20240916$EXP$$CA-UCBSA-2024003635$UCB$$68$YR$$M$Y$$$20240916$$MD$CA$CA
238987052$23898705$2$F$$20240708$20240525$20240719$PER$$US-AstraZeneca-2024A111857$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
238987147$23898714$7$F$20240101$20240816$20240525$20240824$EXP$$CA-CELLTRION INC.-2024CA012021$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
238987372$23898737$2$F$20231029$20240708$20240525$20240723$EXP$$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-107234$ZYDUS PHARM$$$$$$Y$$$20240723$$MD$ES$ES
238987432$23898743$2$F$20240401$20240820$20240525$20240823$EXP$$JP-ABBVIE-5771194$ABBVIE$$80$YR$$F$Y$$$20240823$$MD$JP$JP
238987472$23898747$2$F$20230810$20240823$20240525$20240906$EXP$$US-UCBSA-2023040640$UCB$$5$YR$$M$Y$$$20240906$$CN$US$US
238987632$23898763$2$F$20240101$20240725$20240525$20240731$EXP$$GB-ABBVIE-5772639$ABBVIE$$61$YR$$F$Y$$$20240731$$HP$GB$GB
238987655$23898765$5$F$20220222$20240627$20240525$20240709$EXP$$ES-ABBVIE-5773612$ABBVIE$$81$YR$$F$Y$81$KG$20240709$$MD$ES$ES
238987883$23898788$3$F$$20240625$20240525$20240712$EXP$$CA-002147023-NVSC2024CA031625$Haleon PLC$$62$YR$$F$Y$$$20240712$$HP$CA$CA
238987945$23898794$5$F$20240101$20240905$20240525$20240911$EXP$$US-ABBVIE-5773369$ABBVIE$$$$$F$Y$$$20240911$$HP$US$US
238987992$23898799$2$F$20240504$20240723$20240525$20240726$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-10241$IPSEN$$49$YR$A$F$Y$$$20240726$$CN$GB$GB
238988133$23898813$3$F$20231001$20240801$20240525$20240806$EXP$$US-ABBVIE-5736211$ABBVIE$$55$YR$$F$Y$$$20240806$$CN$US$US
238988163$23898816$3$F$$20240925$20240525$20240927$EXP$$CA-HALEON-2176233$Haleon PLC$$44$YR$$F$Y$$$20240927$$HP$CA$CA
238988182$23898818$2$F$20240405$20240820$20240525$20240902$EXP$$JP-UCBSA-2024023244$UCB$$$$$$Y$60$KG$20240902$$MD$JP$JP
238988273$23898827$3$F$$20240903$20240525$20240909$EXP$$CA-ROCHE-3568623$ROCHE$$52$YR$A$M$Y$$$20240909$$HP$CA$CA
238988283$23898828$3$F$20240501$20240718$20240525$20240727$PER$$US-AstraZeneca-2024A119442$ASTRAZENECA$$86$YR$$F$Y$$$20240728$$CN$US$
238988293$23898829$3$F$$20240906$20240525$20240913$EXP$$US-ABBVIE-5772985$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
238988314$23898831$4$F$$20240715$20240525$20240725$EXP$$CA-HEALTHCANVIG-05151808$Haleon PLC$$43$YR$$F$Y$97$KG$20240725$$HP$CA$CA
238988362$23898836$2$F$$20240626$20240525$20240705$PER$$US-SA-2024SA153894$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240705$$MD$US$US
238988472$23898847$2$F$$20240625$20240525$20240709$EXP$$CA-HALEON-2176679$Haleon PLC$$44$YR$$F$Y$97$KG$20240709$$MD$CA$CA
238988562$23898856$2$F$20240101$20240703$20240525$20240715$PER$$US-SA-2024SA153888$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240715$$MD$US$US
238988652$23898865$2$F$20240101$20240726$20240525$20240806$PER$$US-SA-2024SA153886$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240806$$MD$US$US
238988772$23898877$2$F$$20240705$20240525$20240706$PER$$US-AstraZeneca-2024A120439$ASTRAZENECA$$$$$M$Y$$$20240706$$HP$US$
238989012$23898901$2$F$$20240514$20240525$20240704$EXP$$CA-HALEON-2176822$Haleon PLC$$$$$F$Y$$$20240703$$HP$CA$CA
238989073$23898907$3$F$20240514$20240626$20240525$20240708$EXP$$US-862174955-ML2024-03178$Unknown Manufacturer$$79$YR$E$M$Y$$$20240708$$CN$US$US
238989092$23898909$2$F$$20240514$20240525$20240723$EXP$$CA-002147023-NVSC2022CA095089$Haleon PLC$$44$YR$$F$Y$68$KG$20240723$$HP$CA$CA
238989288$23898928$8$F$20240101$20240826$20240525$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012913$UNITED THERAPEUTICS$$$$$F$Y$48.526$KG$20240904$$$US$US
238989363$23898936$3$F$$20240925$20240525$20240927$EXP$$CA-HALEON-2175268$Haleon PLC$$44$YR$$F$Y$$$20240926$$HP$CA$CA
238989412$23898941$2$F$$20240829$20240525$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-014958$UNITED THERAPEUTICS$$$$$M$Y$50.794$KG$20240906$$$US$US
238989482$23898948$2$F$20230601$20240820$20240525$20240823$EXP$$JP-ABBVIE-5771902$ABBVIE$$65$YR$$F$Y$$$20240823$$MD$JP$JP
238989524$23898952$4$F$$20240827$20240525$20240903$PER$$US-SA-2024SA153027$SANOFI AVENTIS$$$$E$F$Y$$$20240903$$MD$US$US
238989702$23898970$2$F$20240508$20240627$20240525$20240707$PER$$US-SA-2024SA156885$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240708$$MD$US$US
238989733$23898973$3$F$20240101$20240723$20240525$20240801$PER$$US-SA-2024SA153219$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240801$$CN$US$US
238990195$23899019$5$F$20240318$20240823$20240525$20240829$EXP$$CA-JNJFOC-20240365967$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240829$$CN$CA$CA
238990232$23899023$2$F$$20240705$20240525$20240708$PER$$US-AstraZeneca-2024A120039$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$US$
238990277$23899027$7$F$20240401$20240806$20240525$20240809$EXP$$CA-BIOMARINAP-CA-2024-157493$BIOMARIN$$$$$$Y$$$20240809$$HP$CA$CA
238990282$23899028$2$F$$20240719$20240525$20240814$PER$$US-AstraZeneca-2024A118460$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
238990292$23899029$2$F$20240101$20240829$20240525$20240910$PER$$US-SA-2024SA156901$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240910$$CN$US$US
238990322$23899032$2$F$20240516$20240628$20240525$20240710$PER$$US-SA-2024SA156494$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240710$$MD$US$US
238990412$23899041$2$F$20240130$20240717$20240525$20240726$PER$$US-SA-2024SA156314$SANOFI AVENTIS$$3$YR$C$F$Y$13.6$KG$20240726$$MD$US$US
238990452$23899045$2$F$$20240828$20240525$20240911$PER$$US-SA-2024SA153530$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240911$$MD$US$US
238990702$23899070$2$F$20240101$20240718$20240525$20240806$PER$$US-009507513-2405USA002585$MERCK$$53$YR$$M$Y$$$20240806$$CN$US$US
238990737$23899073$7$F$$20240716$20240526$20240912$EXP$$HR-002147023-NVSC2021HR042645$Haleon PLC$$56$YR$$F$Y$$$20240912$$MD$HR$HR
238990882$23899088$2$F$$20240513$20240526$20240711$EXP$$CA-002147023-NVSC2023CA088007$Haleon PLC$$50$YR$$F$Y$68$KG$20240711$$CN$CA$CA
238990943$23899094$3$F$20240508$20240614$20240526$20240711$PER$$US-AstraZeneca-2024A109305$ASTRAZENECA$$21930$DY$$M$Y$97.5$KG$20240711$$MD$US$
238990972$23899097$2$F$$20240628$20240526$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080543$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240705$$CN$US$US
238991053$23899105$3$F$20240513$20240613$20240526$20240705$PER$$US-AstraZeneca-2024A112487$ASTRAZENECA$$26673$DY$$F$Y$$$20240705$$CN$US$
238991066$23899106$6$F$20231123$20240815$20240526$20240819$EXP$$JP-AstraZeneca-2024A119436$ASTRAZENECA$$80$YR$$M$Y$54$KG$20240819$$MD$JP$
238991132$23899113$2$F$$20240515$20240526$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002759$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238991202$23899120$2$F$$20240522$20240526$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002474$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238991212$23899121$2$F$20231201$20240515$20240526$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000656$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238991222$23899122$2$F$$20240518$20240526$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002189$BIOCON$$$$$$Y$$$20240816$$PH$US$US
238991232$23899123$2$F$$20240521$20240526$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002733$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238991252$23899125$2$F$20240513$20240604$20240526$20240701$PER$$US-AstraZeneca-2024A112611$ASTRAZENECA$$23041$DY$$F$Y$$$20240701$$CN$US$
238991272$23899127$2$F$20240314$20240617$20240526$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001743$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238991342$23899134$2$F$20230101$20240822$20240526$20240904$PER$$US-SA-2024SA152931$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240904$$MD$US$US
238991412$23899141$2$F$$20240719$20240526$20240730$PER$$US-SA-2022SA030422$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240730$$MD$US$US
238991592$23899159$2$F$20240101$20240704$20240526$20240712$PER$$US-AstraZeneca-2024A113569$ASTRAZENECA$$22070$DY$$$Y$$$20240712$$CN$US$
238991732$23899173$2$F$20240516$20240823$20240526$20240828$EXP$$US-RDY-CLI/USA/24/0007545$DR REDDYS$$16$YR$T$F$Y$$$20240828$$MD$US$US
238991784$23899178$4$F$20240126$20240822$20240526$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-024504$AUROBINDO$$$$A$F$Y$$$20240903$$MD$FR$FR
238991823$23899182$3$F$20240427$20240718$20240526$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-029809$BOEHRINGER INGELHEIM$$50$YR$A$M$Y$$$20240719$$CN$US$US
238991882$23899188$2$F$$20240813$20240526$20240827$PER$$US-SA-2024SA156577$SANOFI AVENTIS$$$$T$F$Y$$$20240827$$MD$US$US
238992062$23899206$2$F$$20240715$20240526$20240723$PER$$US-SA-2024SA156581$SANOFI AVENTIS$$$$C$M$Y$$$20240723$$MD$US$US
238992092$23899209$2$F$$20240524$20240526$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000771$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238992112$23899211$2$F$20240221$20240624$20240526$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-023804$AUROBINDO$$85$YR$$M$Y$80.8$KG$20240702$$PH$FR$FR
238992332$23899233$2$F$$20240627$20240526$20240706$EXP$$US-AUROBINDO-AUR-APL-2024-024189$AUROBINDO$Catahay J, Okedele O, Calderon I, Bhatt H, Lahoti L.. 25 Unveiling a Hiccup^s Mishap: A Rare Case of Neuromyelitis Optica. Clin-Immunol. 2024;262S:109967$27$YR$$F$Y$$$20240706$$HP$US$US
238992412$23899241$2$F$$20240627$20240526$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-024493$AUROBINDO$Louka C, Chiao S.. Intravenous Ketamine Exacerbating Symptoms of Acute Stress Disorder: A Case Report and Systematized Review of Existing Literature. J-Acad-Consult-Liaison- Psychiatry. 2024;65(2):204-213$26$YR$$M$Y$$$20240705$$MD$US$US
238992452$23899245$2$F$$20240703$20240526$20240708$PER$$US-AstraZeneca-2024A112523$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$US$
238992502$23899250$2$F$$20240627$20240526$20240705$EXP$$IT-AUROBINDO-AUR-APL-2024-024215$AUROBINDO$Massafra UG, Giovannangeli F, Migliore A.. Psoriatic arthropathy in patients with previous neoplasia: a case series of four patients treated with secukinumab and literature review. Eur-RevMed-Pharmacol-Sci. 2024;28(7):2878-2893$48$YR$$F$Y$$$20240705$$MD$IT$IT
238992532$23899253$2$F$$20240617$20240526$20240820$EXP$$CA-002147023-NVSC2024CA060162$Haleon PLC$$43$YR$$F$Y$96$KG$20240819$$HP$CA$CA
238992622$23899262$2$F$$20240627$20240526$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-024422$AUROBINDO$Kataria V, Agha T, Ryman K, Iyer N.. Strategic Utilization of Dantrolene in a Case of Severe Acute Generalized Tetanus.. J-Pharm-Pract. 2023;37(3):766-769$32$YR$$M$Y$$$20240705$$HP$US$US
238992752$23899275$2$F$$20240627$20240526$20240706$EXP$$US-AUROBINDO-AUR-APL-2024-024190$AUROBINDO$Solomon CG, Alsaigh T, Dhaliwal G, Fukaya E, Leeper NJ, Sayed N. An Alternate Explanation. NEngl-J-Med. 2023;388 (14):1318-1324$48$YR$$M$Y$$$20240706$$MD$US$US
238992792$23899279$2$F$20240502$20240827$20240526$20240828$EXP$$US-JNJFOC-20240553261$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$PH$US$US
238992872$23899287$2$F$$20240827$20240526$20240828$EXP$$US-JNJFOC-20240553276$JOHNSON AND JOHNSON$$18$YR$A$$Y$$$20240828$$MD$US$US
238993072$23899307$2$F$$20240806$20240526$20240808$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001054$BLUEPRINT MEDICINES$$$$$F$Y$$$20240808$$CN$US$US
238993252$23899325$2$F$20240501$20240624$20240526$20240712$EXP$$KW-JNJFOC-20240518531$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240712$$CN$KW$KW
238993262$23899326$2$F$$20240822$20240526$20240904$PER$$US-AstraZeneca-2024A113683$ASTRAZENECA$$$$$M$Y$$$20240904$$MD$US$
238993282$23899328$2$F$$20240624$20240526$20240703$PER$$US-AstraZeneca-2024A117866$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
238993313$23899331$3$F$$20240703$20240526$20240802$PER$$US-AstraZeneca-2024A113710$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
238993322$23899332$2$F$$20240808$20240526$20240816$PER$$US-SA-2024SA152217$SANOFI AVENTIS$$$$E$M$Y$$$20240817$$MD$US$US
238993392$23899339$2$F$20240411$20240503$20240526$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002419$BIOCON$$$$$$Y$$$20240819$$CN$US$US
238993402$23899340$2$F$20240101$20240702$20240526$20240711$PER$$US-SA-2024SA152420$SANOFI AVENTIS$$10$MON$I$M$Y$$$20240711$$MD$US$US
238993432$23899343$2$F$20240111$20240703$20240526$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001644$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238993442$23899344$2$F$20240207$20240719$20240526$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000868$BIOCON$$$$$$Y$$$20240816$$CN$US$US
238993454$23899345$4$F$$20240911$20240526$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-082202$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240911$$CN$US$US
238993472$23899347$2$F$$20240611$20240526$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000676$BIOCON$$$$$$Y$$$20240818$$CN$US$US
238993554$23899355$4$F$20240101$20240917$20240526$20240926$PER$$US-SA-2024SA151563$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240926$$MD$US$US
238993563$23899356$3$F$20240101$20240806$20240526$20240812$PER$$US-SA-2024SA151570$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240813$$MD$US$US
238993584$23899358$4$F$20240518$20240718$20240526$20240718$PER$$US-ALXN-202405USA001362US$ALEXION PHARMACEUTICALS$$61$YR$$F$Y$$$20240718$$CN$US$US
238993592$23899359$2$F$$20240820$20240526$20240830$PER$$US-SA-2024SA151615$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240830$$MD$US$US
238993782$23899378$2$F$$20240719$20240526$20240724$EXP$$NVSC2024US108861$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
238994125$23899412$5$F$20240404$20240831$20240526$20240906$EXP$$TR-SANDOZ INC.-SDZ2024TR051937$SANDOZ$$79$YR$$M$Y$77.5$KG$20240906$$CN$TR$TR
238995232$23899523$2$F$$20240621$20240526$20240709$PER$$US-ROCHE-3380718$ROCHE$$62$YR$A$F$Y$$$20240702$$CN$US$US
238995362$23899536$2$F$$20240626$20240526$20240704$PER$$US-ROCHE-3489277$ROCHE$$20$YR$A$F$Y$$$20240704$$MD$US$US
238997624$23899762$4$F$$20240708$20240526$20240709$PER$$NVSC2024US110421$NOVARTIS$$77$YR$$M$Y$$$20240709$$HP$US$US
238998092$23899809$2$F$$20240925$20240526$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA051113$SANDOZ$$46$YR$$F$Y$$$20240927$$HP$CA$CA
239000663$23900066$3$F$20240205$20240702$20240526$20240704$EXP$$NVSJ2024JP001814$NOVARTIS$$51$YR$$M$Y$$$20240705$$MD$JP$JP
239000692$23900069$2$F$20240501$20240829$20240526$20240905$EXP$$CA-ABBVIE-5763988$ABBVIE$$$$A$F$Y$$$20240905$$CN$CA$CA
239001602$23900160$2$F$$20240702$20240526$20240705$EXP$$NVSJ2024JP006119$NOVARTIS$$74$YR$$F$Y$$$20240705$$MD$JP$JP
239001634$23900163$4$F$20240430$20240718$20240526$20240725$EXP$$US-ABBVIE-5772944$ABBVIE$$46$YR$$M$Y$68$KG$20240725$$HP$US$US
239002394$23900239$4$F$$20240820$20240526$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-082180$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240822$$HP$US$US
239002742$23900274$2$F$$20240813$20240526$20240814$PER$$US-ROCHE-3378590$ROCHE$$$$A$F$Y$$$20240814$$CN$US$US
239003442$23900344$2$F$$20240925$20240526$20240926$PER$$US-ROCHE-3385548$ROCHE$$$$A$F$Y$$$20240926$$MD$US$US
239003932$23900393$2$F$20240101$20240916$20240526$20240926$EXP$$US-JNJFOC-20240558559$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240927$$HP$US$US
239010552$23901055$2$F$$20240719$20240526$20240723$PER$$US-ROCHE-3503531$ROCHE$$44$YR$A$F$Y$$$20240723$$CN$US$US
239010612$23901061$2$F$$20240702$20240526$20240705$EXP$$NVSJ2024JP006123$NOVARTIS$$56$YR$$F$Y$$$20240705$$MD$JP$JP
239011372$23901137$2$F$$20240924$20240526$20240927$PER$$US-ROCHE-3399891$ROCHE$$$$$F$Y$$$20240927$$HP$US$US
239013097$23901309$7$F$20240520$20240920$20240526$20240924$EXP$$US-TAKEDA-2023TUS014187$TAKEDA$$50$YR$$F$Y$$$20240923$$MD$US$US
239015023$23901502$3$F$20240101$20240812$20240526$20240821$EXP$$CA-ABBVIE-5773153$ABBVIE$$78$YR$$F$Y$$$20240821$$CN$CA$CA
239015545$23901554$5$F$20240601$20240702$20240526$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079771$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240710$$CN$US$US
239018662$23901866$2$F$$20240919$20240526$20240923$PER$$US-ROCHE-3409789$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
239019533$23901953$3$F$20240429$20240620$20240526$20240702$30DAY$$TR-JNJFOC-20240524627$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$TR$TR
239020263$23902026$3$F$$20240814$20240526$20240828$PER$$US-SA-2024SA156375$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240828$$HP$US$US
239022542$23902254$2$F$$20240806$20240527$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079521$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240808$$CN$US$US
239022852$23902285$2$F$20240101$20240719$20240527$20240729$PER$$US-SA-2024SA156860$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240729$$MD$US$US
239022863$23902286$3$F$20240501$20240819$20240527$20240828$PER$$US-SA-2024SA156852$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240828$$MD$US$US
239022872$23902287$2$F$$20240808$20240527$20240820$PER$$US-SA-2024SA157074$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240820$$MD$US$US
239023503$23902350$3$F$20240227$20240906$20240527$20240913$PER$$US-ROCHE-3518768$ROCHE$$76$YR$E$F$Y$92.53$KG$20240913$$CN$US$US
239025134$23902513$4$F$20240522$20240905$20240527$20240913$EXP$$CA-TAKEDA-2024TUS039784$TAKEDA$$86$YR$$F$Y$$$20240913$$HP$CA$CA
239025272$23902527$2$F$$20240821$20240527$20240821$EXP$$IE-BRISTOL-MYERS SQUIBB COMPANY-2024-080084$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240821$$HP$IE$IE
239025303$23902530$3$F$$20240709$20240527$20240712$EXP$$NVSC2024US107036$NOVARTIS$$$$$M$Y$$$20240712$$HP$US$US
239025372$23902537$2$F$$20240627$20240527$20240708$PER$$US-SA-2024SA157058$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240708$$MD$US$US
239025602$23902560$2$F$20230702$20240717$20240527$20240729$EXP$$US-NOVOPROD-1224173$NOVO NORDISK$$51$YR$$M$Y$$$20240729$$CN$US$US
239025702$23902570$2$F$20190101$20240726$20240527$20240806$EXP$$ES-NOVOPROD-1226257$NOVO NORDISK$$55$YR$$F$Y$$$20240806$$PH$ES$ES
239025962$23902596$2$F$20240425$20240620$20240527$20240702$PER$$US-AstraZeneca-2024A117545$ASTRAZENECA$$27497$DY$$F$Y$$$20240702$$CN$US$
239025994$23902599$4$F$20240502$20240708$20240527$20240711$30DAY$$AR-JNJFOC-20240515777$JOHNSON AND JOHNSON$$62$YR$A$M$Y$99$KG$20240711$$CN$AR$AR
239026052$23902605$2$F$20240503$20240604$20240527$20240708$PER$$FR-TOLMAR, INC.-24FR049112$TOLMAR$$$$E$M$Y$$$20240708$$PH$FR$FR
239026063$23902606$3$F$20240503$20240814$20240527$20240910$PER$$FR-TOLMAR, INC.-24FR049121$TOLMAR$$89$YR$$M$Y$$$20240910$$PH$FR$FR
239026072$23902607$2$F$$20240613$20240527$20240702$PER$$NL-TOLMAR, INC.-24NL049033$TOLMAR$$$$$M$Y$$$20240702$$CN$NL$NL
239026082$23902608$2$F$20240503$20240604$20240527$20240708$PER$$FR-TOLMAR, INC.-24FR049119$TOLMAR$$$$E$M$Y$$$20240708$$PH$FR$FR
239026305$23902630$5$F$20230101$20240711$20240527$20240718$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-028927$BOEHRINGER INGELHEIM$$93$YR$E$F$Y$60$KG$20240719$$CN$BR$BR
239026362$23902636$2$F$20240517$20240820$20240527$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079479$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240820$$CN$US$US
239026492$23902649$2$F$$20240624$20240527$20240805$PER$$US-AstraZeneca-2024A101661$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
239026562$23902656$2$F$20240404$20240702$20240527$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202405008702$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240710$$CN$US$US
239026722$23902672$2$F$$20240620$20240527$20240703$EXP$$US-GRAVITIPHARMA-GRA-2405-US-LIT-0150$GRAVITI PHARMACEUTICALS$$35$YR$A$F$Y$$$20240703$$MD$US$US
239026913$23902691$3$F$20240523$20240829$20240527$20240901$EXP$$JP-TAKEDA-2024TJP007459$TAKEDA$$8$DEC$$M$Y$$$20240901$$MD$JP$JP
239026962$23902696$2$F$$20240620$20240527$20240703$EXP$$US-GRAVITIPHARMA-GRA-2405-US-LIT-0148$GRAVITI PHARMACEUTICALS$$62$YR$A$F$Y$$$20240703$$MD$US$US
239027102$23902710$2$F$20240101$20240912$20240527$20240922$PER$$US-SA-2024SA117589$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240923$$MD$US$US
239027122$23902712$2$F$$20240910$20240527$20240918$PER$$US-SA-2024SA155716$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240918$$MD$US$US
239027352$23902735$2$F$20240509$20240618$20240527$20240703$30DAY$$US-JNJFOC-20240527420$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240703$$HP$US$US
239027532$23902753$2$F$$20240806$20240527$20240811$PER$$US-BIOGEN-2024BI01266322$BIOGEN$$$$$F$Y$$$20240811$$CN$US$US
239027663$23902766$3$F$20200220$20240626$20240527$20240704$EXP$$CA-CELLTRION INC.-2023CA024959$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
239027674$23902767$4$F$20240131$20240923$20240527$20240930$EXP$$AU-TAKEDA-2023TUS110322$TAKEDA$$55$YR$$F$Y$$$20240930$$HP$AU$AU
239027753$23902775$3$F$20240516$20240805$20240527$20240813$PER$$US-SA-2024SA152776$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240814$$MD$US$US
239027892$23902789$2$F$$20240807$20240527$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-082289$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240814$$HP$US$US
239027912$23902791$2$F$$20240614$20240527$20240702$PER$$MY-TOLMAR, INC.-24MY048914$TOLMAR$$$$$$Y$$$20240702$$PH$MY$MY
239027942$23902794$2$F$20231115$20240719$20240527$20240812$PER$$NL-TOLMAR, INC.-24NL048991$TOLMAR$$77$YR$$M$Y$$$20240812$$CN$NL$NL
239028133$23902813$3$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04164$LUPIN$$$$$$Y$$$20240731$$HP$US$US
239028292$23902829$2$F$$20240625$20240527$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081531$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$77.11$KG$20240704$$CN$US$US
239028452$23902845$2$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04179$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239028466$23902846$6$F$20240501$20240927$20240527$20240927$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-021475$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$$$20240927$$CN$JP$JP
239028552$23902855$2$F$$20240726$20240527$20240729$EXP$$NVSC2024US110048$NOVARTIS$$$$$M$Y$$$20240729$$CN$US$US
239028572$23902857$2$F$20240513$20240705$20240527$20240708$EXP$$RO-AstraZeneca-2024A118793$ASTRAZENECA$$$$$M$Y$$$20240708$$MD$RO$
239028592$23902859$2$F$20190901$20240714$20240527$20240716$EXP$$PK-AMGEN-PAKSP2021210955$AMGEN$$32$YR$A$M$Y$$$20240716$$CN$PK$PK
239028825$23902882$5$F$20230101$20240722$20240527$20240730$EXP$$CA-CELLTRION INC.-2024CA000609$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
239029322$23902932$2$F$20240401$20240709$20240527$20240730$PER$$CA-TOLMAR, INC.-24CA048510$TOLMAR$$79$YR$$M$Y$$$20240730$$CN$CA$CA
239029372$23902937$2$F$20240425$20240606$20240527$20240702$PER$$CA-TOLMAR, INC.-24CA048794$TOLMAR$$62$YR$$M$Y$$$20240702$$HP$CA$CA
239029412$23902941$2$F$20240301$20240715$20240527$20240723$EXP$$BE-BEH-2023166625$CSL BEHRING$$85$YR$E$F$Y$$$20240723$$HP$BE$BE
239029472$23902947$2$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04167$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239029583$23902958$3$F$20240507$20240716$20240527$20240723$PER$$NVSC2024US110785$NOVARTIS$$66$YR$$M$Y$122.45$KG$20240723$$MD$US$US
239029592$23902959$2$F$$20240624$20240527$20240703$PER$$US-AstraZeneca-2024A119376$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
239029682$23902968$2$F$20240501$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04168$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239029722$23902972$2$F$20240522$20240815$20240527$20240820$PER$$US-AMGEN-USASP2024102591$AMGEN$$60$YR$A$F$Y$$$20240819$$CN$US$US
239029773$23902977$3$F$$20240709$20240527$20240712$PER$$US-BIOGEN-2024BI01266058$BIOGEN$$$$$F$Y$$$20240712$$CN$US$US
239029892$23902989$2$F$20220301$20240820$20240527$20240830$EXP$$US-ROCHE-3510314$ROCHE$$76$YR$E$F$Y$$$20240830$$CN$US$US
239029952$23902995$2$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04169$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239030085$23903008$5$F$$20240912$20240527$20240923$EXP$$US-JNJFOC-20240554800$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240923$$CN$US$US
239030192$23903019$2$F$20240424$20240703$20240527$20240820$PER$$US-LUNDBECK-DKLU3077279$LUNDBECK$$$$$$Y$$$20240820$$CN$US$US
239030234$23903023$4$F$20230201$20240730$20240527$20240801$EXP$$US-UCBSA-2024025267$UCB$$51$YR$$F$Y$$$20240801$$CN$US$US
239030242$23903024$2$F$$20240724$20240527$20240905$PER$$US-LUNDBECK-DKLU3077261$LUNDBECK$$$$$$Y$$$20240905$$HP$US$US
239030395$23903039$5$F$20200907$20240618$20240527$20240702$EXP$$JP-BEH-2024172388$CSL BEHRING$$65$YR$E$F$Y$55.8$KG$20240702$$HP$JP$JP
239030443$23903044$3$F$$20240713$20240527$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04155$LUPIN$$$$$$Y$$$20240809$$CN$US$US
239030462$23903046$2$F$$20240711$20240527$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04160$LUPIN$$$$$$Y$$$20240809$$CN$US$US
239030492$23903049$2$F$$20240625$20240527$20240701$30DAY$$US-GSK-US2024063718$GLAXOSMITHKLINE$$$$$M$Y$$$20240701$$CN$US$US
239030582$23903058$2$F$$20240628$20240527$20240703$30DAY$$US-GSK-US2024AMR063535$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$US$US
239030595$23903059$5$F$20240515$20240627$20240527$20240925$EXP$$US-GSK-US2024AMR063754$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$US$US
239030763$23903076$3$F$20240517$20240530$20240527$20240925$PER$$US-GSK-US2024AMR063483$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240925$$CN$US$US
239030928$23903092$8$F$20240517$20240909$20240527$20240913$EXP$$US-GSK-US2024AMR063928$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240913$$CN$US$US
239030942$23903094$2$F$20210101$20240828$20240527$20240829$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-083821$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$75$KG$20240829$$CN$ES$ES
239030973$23903097$3$F$20231128$20240905$20240527$20240915$EXP$$BE-ESPERIONTHERAPEUTICS-2024BEL00752$ESPERION THERAPEUTICS$$64$YR$$M$Y$110$KG$20240916$$MD$BE$BE
239031053$23903105$3$F$20240508$20240724$20240527$20240727$PER$$US-AMGEN-USASP2024103439$AMGEN$$86$YR$E$F$Y$$$20240727$$CN$US$US
239031082$23903108$2$F$20240101$20240924$20240527$20240930$EXP$$JP-009507513-2405JPN001933J$MERCK$$70$YR$$M$Y$$$20240930$$MD$JP$JP
239031182$23903118$2$F$20240517$20240719$20240527$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081967$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240723$$HP$US$US
239031195$23903119$5$F$20211119$20240618$20240527$20240702$EXP$$JP-BEH-2024172389$CSL BEHRING$$71$YR$E$F$Y$42.1$KG$20240702$$HP$JP$JP
239031282$23903128$2$F$20180101$20240715$20240527$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202405014391$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240726$$CN$US$US
239031385$23903138$5$F$20211019$20240618$20240527$20240702$EXP$$JP-BEH-2024172390$CSL BEHRING$$68$YR$E$M$Y$46.9$KG$20240702$$HP$JP$JP
239031562$23903156$2$F$20240219$20240904$20240527$20240919$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00331$Phathom Pharmaceuticals$$58$YR$$M$Y$75$KG$20240919$$MD$JP$JP
239031585$23903158$5$F$20191007$20240618$20240527$20240702$EXP$$JP-BEH-2024172391$CSL BEHRING$$73$YR$E$F$Y$47.2$KG$20240702$$HP$JP$JP
239031605$23903160$5$F$20191021$20240618$20240527$20240702$EXP$$JP-BEH-2024172392$CSL BEHRING$$73$YR$E$M$Y$50.8$KG$20240702$$HP$JP$JP
239031992$23903199$2$F$20240607$20240625$20240527$20240705$EXP$$US-BEH-2024172682$CSL BEHRING$$16$YR$T$M$Y$$$20240705$$CN$US$US
239032024$23903202$4$F$20240507$20240808$20240527$20240821$EXP$$US-ELI_LILLY_AND_COMPANY-US202405006756$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240821$$CN$US$US
239032182$23903218$2$F$20240501$20240703$20240527$20240709$EXP$$IL-ABBVIE-5774647$ABBVIE$$73$YR$$M$Y$$$20240709$$MD$IL$IL
239032283$23903228$3$F$$20240628$20240527$20240709$30DAY$$IT-JNJFOC-20240510057$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240709$$PH$IT$IT
239032343$23903234$3$F$20240209$20240919$20240527$20240930$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2157431$JIANGSU HANSOH PHARMACEUTICAL$$$$$F$Y$$$20240930$$MD$CN$CN
239032412$23903241$2$F$$20240626$20240527$20240708$EXP$$CA-APOTEX-2024AP006104$APOTEX$$31$YR$$F$Y$$$20240708$$MD$CA$CA
239032526$23903252$6$F$20240514$20240828$20240527$20240903$EXP$$FR-ROCHE-3566278$ROCHE$$51$YR$A$F$Y$73$KG$20240903$$MD$FR$FR
239032532$23903253$2$F$20240202$20240905$20240527$20240911$EXP$$CA-ROCHE-3568009$ROCHE$$57$YR$A$M$Y$$$20240911$$CN$CA$CA
239032543$23903254$3$F$20230101$20240702$20240527$20240711$EXP$$BE-ESPERIONTHERAPEUTICS-2024BEL00739$ESPERION THERAPEUTICS$$58$YR$$F$Y$$$20240711$$MD$BE$BE
239032852$23903285$2$F$20240501$20240718$20240527$20240718$PER$$US-ALXN-202405USA001382US$ALEXION PHARMACEUTICALS$$54$YR$$F$Y$$$20240718$$CN$US$US
239032872$23903287$2$F$20240410$20240723$20240527$20240727$EXP$$NL-KOANAAP-SML-NL-2024-00474$UNKNOWN$$70$YR$E$M$Y$79.2$KG$20240727$$HP$NL$NL
239032922$23903292$2$F$20240201$20240719$20240527$20240724$EXP$$US-ABBVIE-5773524$ABBVIE$$67$YR$$F$Y$$$20240724$$CN$US$US
239032983$23903298$3$F$$20240630$20240527$20240705$PER$$IL-Blueprint Medicines Corporation-SP-IL-2024-001053$BLUEPRINT MEDICINES$$44$YR$A$M$Y$84$KG$20240705$$MD$IL$IL
239033022$23903302$2$F$$20240718$20240527$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083064$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240807$$CN$US$US
239033042$23903304$2$F$$20240801$20240527$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-081280$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$MD$JP$JP
239033053$23903305$3$F$$20240705$20240527$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081542$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240711$$HP$US$US
239033182$23903318$2$F$$20240718$20240527$20240718$PER$$US-ALXN-202405USA001413US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239033192$23903319$2$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04171$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239033242$23903324$2$F$20240501$20240726$20240527$20240801$EXP$$JP-009507513-2405JPN002084J$MERCK$$$$$F$Y$$$20240801$$MD$JP$JP
239033532$23903353$2$F$$20240628$20240527$20240703$PER$$US-JNJFOC-20240567107$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
239033652$23903365$2$F$$20240704$20240527$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04175$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239033724$23903372$4$F$$20240724$20240527$20240729$EXP$$GB-SANDOZ INC.-SDZ2024GB052076$SANDOZ$$$$$F$Y$$$20240729$$CN$GB$GB
239034012$23903401$2$F$20240522$20240704$20240527$20240710$EXP$$CA-AMGEN-CANSL2024102553$AMGEN$$43$YR$A$F$Y$102.3$KG$20240710$$CN$CA$CA
239034042$23903404$2$F$$20240703$20240527$20240704$PER$$NVSC2024US110971$NOVARTIS$$$$$$Y$$$20240705$$HP$US$US
239034092$23903409$2$F$20240501$20240718$20240527$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-030026$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240719$$CN$US$US
239034182$23903418$2$F$$20240724$20240527$20240726$EXP$$CA-BAUSCH-BL-2024-008109$BAUSCH AND LOMB$$58$YR$$M$Y$$$20240726$$HP$CA$CA
239034235$23903423$5$F$20240604$20240723$20240527$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080555$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240802$$CN$US$US
239034502$23903450$2$F$20240430$20240723$20240527$20240819$PER$$CA-TOLMAR, INC.-24CA048983$TOLMAR$$69$YR$$M$Y$$$20240814$$CN$CA$CA
239034672$23903467$2$F$$20240705$20240527$20240716$EXP$$IN-ROCHE-3567086$ROCHE$$69$YR$E$M$Y$$$20240716$$MD$IN$IN
239034762$23903476$2$F$20231101$20240807$20240527$20240909$EXP$$JP-ARGENX-2024-ARGX-JP002737AA$ARGENX BVBA$$$$$$Y$$$20240909$$HP$JP$JP
239034954$23903495$4$F$$20240819$20240527$20240826$EXP$$US-AMGEN-USASL2024082771$AMGEN$$44$YR$A$F$Y$73.4$KG$20240826$$MD$US$US
239034972$23903497$2$F$$20240716$20240527$20240719$EXP$$SE-AMGEN-SWESP2024099402$AMGEN$$$$$F$Y$$$20240719$$CN$SE$SE
239034982$23903498$2$F$20240520$20240730$20240527$20240801$PER$$US-AMGEN-USASP2024103220$AMGEN$$58$YR$A$F$Y$$$20240801$$CN$US$US
239035373$23903537$3$F$20240510$20240910$20240527$20240918$EXP$$JP-GENMAB-2024-01804$GENMAB$$86$YR$$F$Y$$$20240918$$PH$JP$JP
239035554$23903555$4$F$20240201$20240702$20240527$20240712$EXP$$JP-ROCHE-3566876$ROCHE$$9$DEC$E$M$Y$46.4$KG$20240712$$MD$JP$JP
239035593$23903559$3$F$20240101$20240911$20240527$20240921$EXP$$US-UCBSA-2024019508$UCB$$$$$F$Y$43.003$KG$20240921$$MD$US$US
239035792$23903579$2$F$20240522$20240909$20240527$20240910$PER$$US-AMGEN-USASP2024102585$AMGEN$$82$YR$E$F$Y$$$20240910$$CN$US$US
239035803$23903580$3$F$$20240614$20240527$20240718$PER$$US-AstraZeneca-2024A114658$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
239035812$23903581$2$F$$20240718$20240527$20240729$PER$$US-AstraZeneca-2024A119095$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
239035844$23903584$4$F$20230914$20240805$20240527$20240815$PER$$US-APELLIS-APL-2023-003004$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240815$$HP$US$US
239036063$23903606$3$F$$20240520$20240527$20240807$EXP$$US-SAMSUNG BIOEPIS-SB-2024-15509$SAMSUNG BIOEPIS$Pan Q, Suzette G. From 60% to 5% in 12 Weeks: A Trastuzumab-Induced Left Ventricular Ejection Fraction Drop. Cureus. doi:https://dx.doi.org/10.7759/cureus.59172$54$YR$A$F$Y$$$20240807$$HP$US$US
239036095$23903609$5$F$20220625$20240806$20240527$20240812$EXP$$JP-ASTELLAS-2022JP012375$ASTELLAS$$33$YR$$F$Y$$$20240812$$MD$JP$JP
239036193$23903619$3$F$20230807$20240624$20240527$20240702$EXP$$US-APELLIS-APL-2023-002893$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240702$$HP$US$US
239036713$23903671$3$F$20230801$20240703$20240527$20240708$EXP$$NVSC2024MX094868$NOVARTIS$$25$YR$$F$Y$65$KG$20240708$$CN$MX$MX
239036803$23903680$3$F$20240501$20240905$20240527$20240912$EXP$$JP-ASTELLAS-2024JP003433$ASTELLAS$$8$DEC$E$M$Y$$$20240912$$MD$JP$JP
239036902$23903690$2$F$20240427$20240628$20240527$20240705$EXP$$FR-AstraZeneca-2024A121804$ASTRAZENECA$$76$YR$$M$Y$90$KG$20240705$$MD$FR$
239037032$23903703$2$F$20240101$20240808$20240527$20240814$EXP$$JP-009507513-2402JPN002010J$MERCK$$37$YR$$M$Y$$$20240814$$MD$JP$JP
239037142$23903714$2$F$20240427$20240626$20240527$20240705$EXP$$NL-BAXTER-2024BAX018616$BAXTER$$72$YR$$M$Y$81.1$KG$20240705$$MD$NL$NL
239037574$23903757$4$F$20240701$20240722$20240527$20240926$PER$$US-GSK-US2024AMR064184$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240926$$CN$US$US
239037916$23903791$6$F$20240101$20240906$20240527$20240920$EXP$$US-UCBSA-2024024173$UCB$$$$$M$Y$161.03$KG$20240920$$HP$US$US
239037922$23903792$2$F$20140605$20240820$20240527$20240827$EXP$$CO-UCBSA-2024026403$UCB$$52$YR$$F$Y$52$KG$20240827$$CN$CO$CO
239038312$23903831$2$F$$20240713$20240527$20240722$EXP$$CA-CELLTRION INC.-2024CA012120$CELLTRION$$$$$$Y$$$20240722$$CN$CA$CA
239038352$23903835$2$F$$20240802$20240527$20240808$PER$$US-ABBVIE-5771389$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
239038512$23903851$2$F$$20240829$20240527$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA051865$SANDOZ$$80$YR$$F$Y$$$20240902$$HP$CA$CA
239038733$23903873$3$F$20240501$20240816$20240527$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002191$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240830$$CN$US$US
239038972$23903897$2$F$20240510$20240801$20240527$20240816$PER$$US-GRANULES-US-2024GRASPO00174$GRANULES INDIA$$17$YR$T$F$Y$$$20240816$$CN$US$US
239039214$23903921$4$F$$20240722$20240527$20240729$EXP$$NVSC2024US088743$NOVARTIS$$$$$F$Y$$$20240729$$CN$US$US
239039332$23903933$2$F$20230801$20240801$20240527$20240807$EXP$$AR-GSK-AR2023AMR120371$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$AR$AR
239039343$23903934$3$F$$20240626$20240527$20240708$EXP$$CA-HALEON-2176988$Haleon PLC$$44$YR$$F$Y$70$KG$20240705$$HP$CA$CA
239039402$23903940$2$F$$20240730$20240527$20240806$EXP$$CA-ASTELLAS-2024US014848$ASTELLAS$$28$YR$$F$Y$$$20240806$$CN$CA$CA
239039452$23903945$2$F$20240522$20240730$20240527$20240803$PER$$US-AMGEN-USASP2024102704$AMGEN$$82$YR$E$M$Y$$$20240803$$CN$US$US
239039502$23903950$2$F$$20240821$20240527$20240826$EXP$$CA-Orion Corporation ORION PHARMA-24_00030075$ORION$$58$YR$A$M$Y$$$20240826$$HP$CA$
239039542$23903954$2$F$$20240910$20240527$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US051984$SANDOZ$$$$$$Y$25$KG$20240912$$CN$US$US
239039572$23903957$2$F$$20240726$20240527$20240730$EXP$$NVSC2024US109671$NOVARTIS$$$$$M$Y$$$20240730$$CN$US$US
239039683$23903968$3$F$$20240916$20240527$20240918$EXP$$NVSC2024CA110340$NOVARTIS$$$$$F$Y$$$20240918$$CN$CA$CA
239039783$23903978$3$F$$20240917$20240527$20240927$EXP$$US-862174955-ML2024-03080$MICRO LABS$$80$YR$E$F$Y$$$20240927$$CN$US$US
239039802$23903980$2$F$20240520$20240701$20240527$20240704$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-10274$IPSEN$$76$YR$E$F$Y$$$20240704$$CN$GB$GB
239039872$23903987$2$F$$20240828$20240527$20240905$PER$$US-JNJFOC-20240506353$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$HP$US$US
239039882$23903988$2$F$20220422$20240911$20240527$20240920$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-076445$BRISTOL MYERS SQUIBB$Tsaktanis T, Stritzelberger J, To VTD, Uhl M, Schwab S, Heuss D, et al. Case report: cerebrospinal fluid neutrophilic pleocytosis upon intrathecal triamcinolone injection. Frontiers in Neurology. 2024 Apr 23;15:1-5. doi:10.3389/fneur.2024.1372266.$76$YR$E$F$Y$$$20240920$$HP$DE$DE
239039932$23903993$2$F$$20240708$20240527$20240717$30DAY$$US-GSK-US2024062476$GLAXOSMITHKLINE$$$$$F$Y$$$20240717$$CN$US$US
239040013$23904001$3$F$20240101$20240716$20240527$20240722$EXP$$US-SA-2024SA158241$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240722$$MD$US$US
239040194$23904019$4$F$$20240829$20240527$20240910$EXP$$GB-AMGEN-GBRSP2024099349$AMGEN$$79$YR$E$F$Y$$$20240909$$CN$GB$GB
239040212$23904021$2$F$$20240725$20240527$20240729$EXP$$US-ROCHE-3567787$ROCHE$$12$YR$T$M$Y$$$20240729$$CN$US$US
239040292$23904029$2$F$20230207$20240703$20240527$20240708$EXP$$JP-JNJFOC-20240569715$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240708$$MD$JP$JP
239040392$23904039$2$F$20240118$20240624$20240527$20240711$30DAY$$US-AMGEN-USASP2024100930$AMGEN$$$$$$Y$$$20240710$$HP$US$US
239040473$23904047$3$F$20240312$20240701$20240527$20240710$EXP$IT-MINISAL02-986559$IT-INCYTE CORPORATION-2024IN005541$INCYTE$$$$$$Y$$$20240710$$MD$IT$IT
239040524$23904052$4$F$20240101$20240918$20240527$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083321$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240919$$HP$US$US
239040572$23904057$2$F$20201004$20240907$20240527$20240909$EXP$$US-TAKEDA-2024TUS050950$TAKEDA$$68$YR$$M$Y$$$20240909$$MD$US$US
239040592$23904059$2$F$20240520$20240705$20240527$20240707$PER$$US-JNJFOC-20240561142$JOHNSON AND JOHNSON$$$$$M$Y$$$20240707$$CN$US$US
239040972$23904097$2$F$20240405$20240517$20240527$20240710$EXP$IT-MINISAL02-980238$IT-TEVA-VS-3190034$TEVA$$50$YR$$F$Y$$$20240710$$MD$IT$IT
239041012$23904101$2$F$20240502$20240627$20240527$20240702$EXP$$KR-CELLTRION INC.-2024KR011951$CELLTRION$$$$$$Y$$$20240702$$CN$KR$KR
239041142$23904114$2$F$$20240904$20240527$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202405014583$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240911$$CN$US$US
239041252$23904125$2$F$20240301$20240620$20240527$20240704$EXP$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000168$ARCUTIS$$$$$$Y$$$20240703$$CN$US$US
239041352$23904135$2$F$$20240515$20240527$20240802$PER$$US-AstraZeneca-2024A115028$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
239041662$23904166$2$F$20240514$20240701$20240527$20240708$EXP$$US-INCYTE CORPORATION-2024IN005416$INCYTE$$$$$$Y$$$20240708$$MD$US$US
239041693$23904169$3$F$$20240913$20240527$20240918$30DAY$$US-PFIZER INC-202400108000$PFIZER$$12$YR$$F$Y$$$20240918$$CN$US$US
239041704$23904170$4$F$20240501$20240921$20240527$20240926$30DAY$$US-PFIZER INC-202400173568$PFIZER$$14$YR$$M$Y$56.7$KG$20240926$$CN$US$US
239041742$23904174$2$F$20240501$20240912$20240527$20240917$30DAY$$US-PFIZER INC-202400107523$PFIZER$$15$YR$$F$Y$$$20240917$$HP$US$US
239041756$23904175$6$F$20240519$20240920$20240527$20240924$30DAY$$US-PFIZER INC-202400172775$PFIZER$$16$YR$$M$Y$48.81$KG$20240924$$MD$US$US
239041762$23904176$2$F$$20240807$20240527$20240809$PER$$US-AMGEN-USASP2024103194$AMGEN$$$$$M$Y$$$20240809$$CN$US$US
239041782$23904178$2$F$$20240619$20240527$20240701$30DAY$$AR-JNJFOC-20240570046$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$AR$AR
239041792$23904179$2$F$$20240709$20240527$20240717$EXP$$PE-JNJFOC-20240556252$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$MD$PE$PE
239041802$23904180$2$F$$20240719$20240527$20240730$EXP$$DE-AUROBINDO-AUR-APL-2024-024272$AUROBINDO$$19$DY$$M$Y$2.9$KG$20240730$$HP$DE$DE
239041902$23904190$2$F$20240101$20240709$20240527$20240715$EXP$$US-BAUSCH-BL-2024-007809$BAUSCH AND LOMB$$1$YR$$$Y$$$20240715$$PH$US$US
239041912$23904191$2$F$20231023$20240815$20240527$20240829$EXP$$CA-ASTELLAS-2024US014679$ASTELLAS$$7$YR$C$M$Y$23.6$KG$20240829$$HP$CA$CA
239041962$23904196$2$F$$20240724$20240527$20240801$EXP$$JP-009507513-2405JPN007021$MERCK$$58$YR$$M$Y$$$20240801$$MD$JP$JP
239042024$23904202$4$F$$20240921$20240527$20240925$30DAY$$US-PFIZER INC-202400173905$PFIZER$$13$YR$$M$Y$$$20240925$$CN$US$US
239042048$23904204$8$F$$20240915$20240527$20240919$30DAY$$US-PFIZER INC-202300283678$PFIZER$$10$YR$$M$Y$$$20240919$$CN$US$US
239042104$23904210$4$F$$20240925$20240527$20240926$30DAY$$US-PFIZER INC-202400173274$PFIZER$$18$YR$$F$Y$$$20240926$$CN$US$US
239042152$23904215$2$F$20240101$20240826$20240527$20240903$EXP$$CA-CELLTRION INC.-2024CA012403$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
239042242$23904224$2$F$20231214$20240517$20240527$20240829$EXP$$DE-JNJFOC-20240554932$JOHNSON AND JOHNSON$$59$YR$A$F$Y$67$KG$20240829$$MD$DE$DE
239042432$23904243$2$F$$20240625$20240527$20240707$30DAY$$FR-JNJFOC-20240569044$JOHNSON AND JOHNSON$$13$YR$T$$Y$$$20240708$$PH$FR$FR
239042452$23904245$2$F$20240515$20240828$20240527$20240904$EXP$FR-AFSSAPS-RN2024000576$FR-KOANAAP-SML-FR-2024-00475$Unknown Manufacturer$$58$YR$A$M$Y$$$20240904$$PH$FR$FR
239042502$23904250$2$F$$20240905$20240527$20240917$EXP$$GR-KOANAAP-SML-GR-2024-00479$SHILPA MEDICARE$Mamalis, S. PATIENT RESPONSE WITH MIXED METASTATIC CHOLANGIOCARCINOMA, HEPATOCELLULAR CARCINOMA AND END-STAGE RENAL FAILURE TO LOW DOSES OF REGORAFENIB. 22nd PANHELLENIC CONGRESS ON HEPATOLOGY, abstract. 2024;116$63$YR$A$M$Y$$$20240917$$MD$GR$GR
239042572$23904257$2$F$20240517$20240708$20240527$20240716$30DAY$$US-GSK-US2024062469$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240716$$CN$US$US
239042823$23904282$3$F$20150101$20240925$20240527$20240927$EXP$$US-GILEAD-2024-0674505$GILEAD$$$$A$M$Y$$$20240927$$LW$US$US
239042843$23904284$3$F$20240501$20240911$20240527$20240918$EXP$$CA-JNJFOC-20240563021$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20240918$$HP$CA$CA
239042852$23904285$2$F$20240422$20240709$20240527$20240709$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-030036$BOEHRINGER INGELHEIM$$40$YR$A$F$Y$81$KG$20240709$$MD$DE$DE
239043113$23904311$3$F$20240401$20240715$20240527$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002229$ACADIA PHARMACEUTICALS$$21$YR$$F$Y$$$20240809$$CN$US$US
239043142$23904314$2$F$$20240807$20240527$20240807$PER$$US-ALXN-202405USA001419US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
239043283$23904328$3$F$$20240704$20240527$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04174$LUPIN$$$$$$Y$$$20240729$$CN$US$US
239043322$23904332$2$F$$20240730$20240527$20240807$EXP$$CA-ASTELLAS-2024US014834$ASTELLAS$$24$YR$$M$Y$$$20240807$$CN$CA$CA
239043632$23904363$2$F$20201017$20240807$20240527$20240814$EXP$$BR-TAKEDA-2020TUS045598$TAKEDA$$44$YR$$F$Y$$$20240814$$CN$BR$BR
239043662$23904366$2$F$$20240702$20240527$20240709$PER$$US-AstraZeneca-2024A114894$ASTRAZENECA$$70$YR$$F$Y$$$20240709$$HP$US$
239043694$23904369$4$F$20240319$20240903$20240527$20240911$EXP$$JP-AstraZeneca-2024A119429$ASTRAZENECA$$72$YR$$M$Y$66$KG$20240911$$MD$JP$
239043712$23904371$2$F$$20240718$20240527$20240718$PER$$US-ALXN-202405USA001410US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239043752$23904375$2$F$$20240903$20240527$20240906$EXP$$CA-JNJFOC-20240561674$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240906$$PH$CA$CA
239044022$23904402$2$F$$20240718$20240527$20240718$PER$$US-ALXN-202405USA001380US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239044263$23904426$3$F$20240419$20240725$20240527$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002231$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240821$$CN$US$US
239044302$23904430$2$F$20240522$20240821$20240527$20240824$PER$$US-AMGEN-USASP2024102626$AMGEN$$82$YR$E$M$Y$$$20240824$$CN$US$US
239044312$23904431$2$F$20240522$20240626$20240527$20240703$PER$$US-AMGEN-USASP2024103389$AMGEN$$76$YR$E$M$Y$$$20240703$$CN$US$US
239044343$23904434$3$F$20240512$20240812$20240527$20240816$EXP$$DE-ROCHE-3566590$ROCHE$$$$A$F$Y$$$20240816$$CN$DE$DE
239044462$23904446$2$F$$20240903$20240527$20240906$EXP$$CA-JNJFOC-20240558845$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240906$$HP$CA$CA
239044523$23904452$3$F$$20240813$20240527$20240820$EXP$$US-ABBVIE-5770560$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
239044612$23904461$2$F$20240809$20240815$20240527$20240820$PER$$NVSC2024US110737$NOVARTIS$$48$YR$$F$Y$$$20240820$$HP$US$US
239044652$23904465$2$F$$20240826$20240527$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083514$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240826$$CN$US$US
239044732$23904473$2$F$$20240920$20240527$20240925$EXP$$NVSC2024GB109456$NOVARTIS$$$$$M$Y$$$20240925$$CN$GB$GB
239044792$23904479$2$F$$20240628$20240527$20240702$30DAY$$KR-JNJFOC-20240565491$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$KR$KR
239044802$23904480$2$F$$20240624$20240527$20240703$30DAY$$ES-JNJFOC-20240565278$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$ES$ES
239044832$23904483$2$F$20181003$20240626$20240527$20240701$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-10145$IPSEN$$52$YR$A$M$Y$$$20240701$$HP$US$US
239044843$23904484$3$F$20240514$20240701$20240527$20240704$EXP$$GB-SANDOZ INC.-SDZ2024GB051315$SANDOZ$$35$YR$$M$Y$$$20240704$$CN$GB$GB
239044862$23904486$2$F$$20240711$20240527$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04215$LUPIN$$$$$$Y$$$20240809$$CN$US$US
239044872$23904487$2$F$$20240829$20240527$20240830$EXP$$CA-SANDOZ INC.-NVSC2023CA059653$SANDOZ$$55$YR$$F$Y$$$20240830$$HP$CA$CA
239045052$23904505$2$F$20240517$20240904$20240527$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080409$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240904$$CN$US$US
239045092$23904509$2$F$$20240708$20240527$20240715$30DAY$$US-GSK-US2024063140$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
239045153$23904515$3$F$$20240730$20240527$20240807$EXP$$CA-ASTELLAS-2024US014812$ASTELLAS$$51$YR$$M$Y$$$20240807$$CN$CA$CA
239045224$23904522$4$F$$20240814$20240527$20240819$EXP$$NVSC2024GB103123$NOVARTIS$$$$A$F$Y$$$20240819$$CN$GB$GB
239045305$23904530$5$F$20240101$20240920$20240527$20240925$EXP$$US-ABBVIE-5773805$ABBVIE$$$$$M$Y$97$KG$20240925$$CN$US$US
239045395$23904539$5$F$20240516$20240902$20240527$20240923$EXP$$AR-SA-2024SA157568$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240923$$MD$AR$AR
239045594$23904559$4$F$$20240913$20240527$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA051769$SANDOZ$$36$YR$$F$Y$$$20240923$$HP$CA$CA
239045679$23904567$9$F$20230901$20240712$20240527$20240716$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-081976$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$67$KG$20240716$$HP$DE$DE
239045742$23904574$2$F$$20240716$20240527$20240717$PER$$US-ALXN-202405USA001436US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
239045912$23904591$2$F$$20240830$20240527$20240903$30DAY$$GB-PFIZER INC-202400173219$PFIZER$$41$YR$$F$Y$$$20240903$$HP$GB$GB
239045924$23904592$4$F$20240519$20240918$20240527$20240923$30DAY$$US-PFIZER INC-PV202400046228$PFIZER$$10$MON$$F$Y$$$20240923$$HP$US$US
239045932$23904593$2$F$20240228$20240627$20240527$20240702$30DAY$$CO-PFIZER INC-PV202400067762$PFIZER$$12$YR$$F$Y$30$KG$20240702$$CN$CO$CO
239045943$23904594$3$F$$20240819$20240527$20240822$30DAY$$KR-PFIZER INC-202400178490$PFIZER$$11$YR$$$Y$$$20240822$$CN$KR$KR
239045975$23904597$5$F$$20240821$20240527$20240822$30DAY$$US-PFIZER INC-202400105894$PFIZER$$17$YR$$M$Y$$$20240822$$PH$US$US
239045985$23904598$5$F$20240228$20240917$20240527$20240920$30DAY$$CO-PFIZER INC-PV202400067763$PFIZER$$12$YR$$F$Y$30$KG$20240920$$CN$CO$CO
239046105$23904610$5$F$$20240915$20240527$20240919$30DAY$$US-PFIZER INC-202400174030$PFIZER$$13$YR$$F$Y$$$20240919$$CN$US$US
239046122$23904612$2$F$20240514$20240829$20240527$20240903$30DAY$$JO-PFIZER INC-202400108149$PFIZER$$$$C$M$Y$$$20240903$$CN$JO$JO
239046223$23904622$3$F$20240101$20240702$20240527$20240704$PER$$US-AMGEN-USASP2024101862$AMGEN$$44$YR$A$F$Y$$$20240704$$HP$US$US
239046292$23904629$2$F$20240510$20240709$20240527$20240712$EXP$$US-AstraZeneca-2024A122188$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$US$
239046313$23904631$3$F$20230101$20240912$20240527$20240913$EXP$$US-ABBVIE-5775638$ABBVIE$$$$$M$Y$90.9$KG$20240913$$CN$US$US
239046322$23904632$2$F$20240101$20240717$20240527$20240717$EXP$$CA-PFIZER INC-202400175243$PFIZER$$34$YR$$F$Y$$$20240717$$HP$CA$CA
239046382$23904638$2$F$$20240827$20240527$20240906$EXP$$CA-TEVA-VS-3202428$TEVA$Hrubesz G, Dwyer K, McIsaac DI, Sood MM, Clark E, Douketis J, et al. Perioperative management of apixaban in patients with advanced CKD undergoing a planned invasive procedure. Blood-Adv 2024; 8 (3): 732-735.; Hrubesz G, Dwyer K, McIsaac DI, Sood MM, Clark E, Douketis J, et al. Perioperative management of apixaban in patients with advanced CKD undergoing a planned invasive procedure. Blood-Adv 2024; 8 (3): 732-735.; Hrubesz G, Dwyer K, McIsaac DI, Sood MM, Clark E, Douketis J, et al. Perioper...$76$YR$$M$Y$$$20240906$$HP$CA$CA
239046412$23904641$2$F$$20240820$20240527$20240822$PER$$NVSC2024US111219$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
239046472$23904647$2$F$$20240905$20240527$20240906$EXP$$US-EXELIXIS-CABO-24077576$EXELIXIS$$$$$M$Y$90.975$KG$20240906$$CN$US$US
239046673$23904667$3$F$20240101$20240805$20240527$20240808$PER$$US-BIOGEN-2019BI00701076$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
239046913$23904691$3$F$20240101$20240724$20240527$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083653$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240725$$HP$US$US
239046933$23904693$3$F$$20240702$20240527$20240709$30DAY$$US-MYLANLABS-2024M1047228$MYLAN$$$$$F$Y$$$20240709$$CN$US$US
239046992$23904699$2$F$$20240807$20240527$20240816$EXP$$US-VANTIVE-2024VAN017149$Vantive US Healthcare$$$$$M$Y$$$20240816$$HP$US$US
239047033$23904703$3$F$$20240715$20240527$20240717$EXP$$DE-MYLANLABS-2024M1047432$MYLAN$$$$C$$Y$9$KG$20240717$$CN$DE$DE
239047114$23904711$4$F$20240401$20240719$20240527$20240727$EXP$$CA-CELLTRION INC.-2024CA012167$CELLTRION$$$$$$Y$$$20240727$$HP$CA$CA
239047163$23904716$3$F$$20240704$20240527$20240716$EXP$$IN-ROCHE-3566944$ROCHE$$45$YR$A$F$Y$$$20240716$$MD$IN$IN
239047263$23904726$3$F$20240109$20240806$20240527$20240809$EXP$$JP-GENMAB-2024-01789$GENMAB$$65$YR$$M$Y$54.1$KG$20240809$$MD$JP$JP
239047282$23904728$2$F$$20240719$20240527$20240727$EXP$$US-ROCHE-3568676$ROCHE$$77$YR$E$M$Y$$$20240727$$CN$US$US
239047372$23904737$2$F$20200619$20240627$20240527$20240702$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-083106$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$57.2$KG$20240702$$MD$KR$KR
239047483$23904748$3$F$20200221$20200305$20240527$20240724$EXP$$BE-ABBVIE-5775670$ABBVIE$$69$YR$$M$Y$$$20240724$$HP$BE$BE
239047563$23904756$3$F$20240520$20240731$20240527$20240808$EXP$$JP-AMGEN-JPNSP2024101191$AMGEN$$87$YR$E$F$Y$$$20240807$$MD$JP$JP
239047582$23904758$2$F$20240510$20240826$20240527$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083723$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240826$$CN$US$US
239047652$23904765$2$F$$20240910$20240527$20240912$EXP$$NVSC2024CA110643$NOVARTIS$$50$YR$$F$Y$$$20240912$$HP$CA$CA
239047683$23904768$3$F$20240520$20240827$20240527$20240902$PER$$US-AMGEN-USASP2024100409$AMGEN$$61$YR$A$F$Y$$$20240902$$CN$US$US
239047792$23904779$2$F$20240527$20240619$20240527$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002234$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240712$$CN$US$US
239048083$23904808$3$F$$20240801$20240527$20240807$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-080629$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240807$$MD$GB$GB
239048182$23904818$2$F$20240524$20240830$20240527$20240902$PER$$US-AMGEN-USASP2024103709$AMGEN$$78$YR$E$M$Y$$$20240902$$CN$US$US
239048257$23904825$7$F$20240101$20240906$20240527$20240918$EXP$$US-INSMED, INC.-2024-01618-US$INSMED$$$$$F$Y$$$20240918$$CN$US$US
239048282$23904828$2$F$$20240924$20240527$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083414$BRISTOL MYERS SQUIBB$$25$YR$A$F$Y$$$20240925$$HP$US$US
239048582$23904858$2$F$$20240812$20240527$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083209$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$58.06$KG$20240815$$CN$US$US
239048595$23904859$5$F$20240816$20240826$20240527$20240829$EXP$$CA-HLS-202401325$HLS THERAPEUTICS$$66$YR$E$M$Y$$$20240829$$PH$CA$CA
239048683$23904868$3$F$$20240725$20240527$20240803$30DAY$$US-GSK-US2024063683$GLAXOSMITHKLINE$$$$$F$Y$$$20240803$$PH$US$US
239048764$23904876$4$F$20240101$20240821$20240527$20240830$EXP$$US-INSMED, INC.-2024-00944-US$INSMED$$$$$F$Y$$$20240830$$CN$US$US
239048772$23904877$2$F$$20240820$20240527$20240827$EXP$$CA-SA-2024SA153911$SANOFI AVENTIS$Unknown. Unknown. Unknown. Unkn;Unknown:Unknown$30$YR$A$F$Y$$$20240827$$MD$CA$CA
239048844$23904884$4$F$$20240820$20240527$20240827$EXP$$CA-SA-2024SA153793$SANOFI AVENTIS$unknown. unknown. unknown. unk;unk:unk$51$YR$A$M$Y$$$20240827$$MD$CA$CA
239048852$23904885$2$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04204$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239049062$23904906$2$F$$20240711$20240527$20240711$PER$$NVSC2024US111104$NOVARTIS$$$$$M$Y$$$20240711$$CN$US$US
239049082$23904908$2$F$$20240624$20240527$20240711$PER$$US-Calliditas-2024CAL00786$CALLIDITAS THERAPEUTICS$$33$YR$A$M$Y$82$KG$20240711$$CN$US$US
239049096$23904909$6$F$$20240809$20240527$20240821$EXP$$US-Calliditas-2024CAL00784$CALLIDITAS THERAPEUTICS$$46$YR$A$M$Y$101$KG$20240821$$CN$US$US
239049122$23904912$2$F$20240430$20240516$20240527$20240802$EXP$GB-MHRA-TPP49201322C6625450YC1715692820169$GB-TORRENT-00036557$TORRENT$$5$YR$C$F$Y$18$KG$20240802$$HP$GB$GB
239049142$23904914$2$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04205$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239049192$23904919$2$F$20231201$20240716$20240527$20240716$PER$$US-ALXN-202405USA001584US$ALEXION PHARMACEUTICALS$$19$YR$$F$Y$$$20240716$$CN$US$US
239049322$23904932$2$F$$20240621$20240527$20240702$EXP$GB-MYLANLABS-2024M1024342$GB-TORRENT-00036571$TORRENT$$$$$M$Y$$$20240702$$MD$GB$GB
239049482$23904948$2$F$$20240730$20240527$20240801$EXP$$NVSC2024DE110059$NOVARTIS$$$$$F$Y$$$20240801$$MD$DE$DE
239049523$23904952$3$F$20240428$20240613$20240527$20240708$30DAY$$DE-JNJFOC-20240500369$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240708$$HP$DE$DE
239049562$23904956$2$F$$20240924$20240527$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083647$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$102.06$KG$20240925$$CN$US$US
239049722$23904972$2$F$20240521$20240702$20240527$20240705$PER$$US-AMGEN-USASP2024102535$AMGEN$$56$YR$A$$Y$$$20240705$$CN$US$US
239049913$23904991$3$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04208$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239050012$23905001$2$F$20240515$20240830$20240527$20240902$EXP$FR-AFSSAPS-RN2024000576$NVSC2024FR105838$NOVARTIS$$58$YR$$M$Y$$$20240902$$PH$FR$FR
239050103$23905010$3$F$$20240920$20240527$20240926$EXP$$JP-009507513-2405JPN002524J$MERCK$Kawabata K, Muraoka K, Kunimoto K, Yamamoto Y, Jinnin M. P15-6 A case of linear IgA bullous dermatosis developed after administration of pembrolizumab. The Japanese Journal of Dermatology, The 123rd Annual Meeting of the Japanese De. 2024;134(5):1526-7$8$DEC$$M$Y$$$20240926$$HP$JP$JP
239050213$23905021$3$F$20240429$20240729$20240527$20240731$EXP$$CA-JNJFOC-20240568013$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240731$$HP$CA$CA
239050443$23905044$3$F$20230901$20240730$20240527$20240805$EXP$$CN-009507513-2310CHN007808$MERCK$$67$YR$$M$Y$66$KG$20240805$$MD$CN$CN
239050483$23905048$3$F$20240501$20240626$20240527$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04213$LUPIN$$$$$$Y$$$20240711$$CN$US$US
239050522$23905052$2$F$$20240729$20240527$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083687$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240730$$HP$US$US
239050552$23905055$2$F$$20240831$20240527$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US050869$SANDOZ$$$$$M$Y$$$20240903$$CN$US$US
239050592$23905059$2$F$$20240626$20240527$20240702$EXP$$CA-JNJFOC-20230319990$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240702$$CN$CA$CA
239050702$23905070$2$F$$20240807$20240527$20240815$EXP$$CA-ROCHE-3570325$ROCHE$$$$A$M$Y$$$20240815$$CN$CA$CA
239050772$23905077$2$F$20240601$20240712$20240527$20240717$EXP$$BR-JNJFOC-20240547780$JOHNSON AND JOHNSON$$45$YR$A$F$Y$68$KG$20240717$$MD$BR$BR
239050792$23905079$2$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04214$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239050812$23905081$2$F$$20240625$20240527$20240703$EXP$$US-AstraZeneca-2024A118896$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
239050883$23905088$3$F$20230101$20240625$20240527$20240701$EXP$$DE-ORGANON-O2405DEU002218$ORGANON$$$$$F$Y$$$20240701$$CN$DE$DE
239050943$23905094$3$F$$20240910$20240527$20240924$PER$$US-SA-2024SA158010$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240924$$HP$US$US
239051172$23905117$2$F$20240501$20240802$20240527$20240813$PER$$US-SA-2024SA153476$SANOFI AVENTIS$$14$YR$T$M$Y$47$KG$20240814$$MD$US$US
239051276$23905127$6$F$$20240830$20240527$20240905$PER$$NVSC2024US106211$NOVARTIS$$$$$M$Y$$$20240905$$CN$US$US
239051322$23905132$2$F$20240101$20240712$20240527$20240724$PER$$US-SA-2024SA150433$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240724$$MD$US$US
239051333$23905133$3$F$20240501$20240703$20240527$20240715$PER$$US-SA-2024SA154571$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240715$$MD$US$US
239051514$23905151$4$F$20240101$20240904$20240527$20240925$EXP$$US-SA-2024SA154696$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240925$$CN$US$US
239051572$23905157$2$F$20240101$20240904$20240527$20240914$PER$$US-SA-2024SA154531$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240914$$MD$US$US
239051603$23905160$3$F$$20240701$20240527$20240709$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001062$BLUEPRINT MEDICINES$$$$$F$Y$$$20240709$$HP$US$US
239051614$23905161$4$F$$20240729$20240527$20240805$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001061$BLUEPRINT MEDICINES$$$$$F$Y$$$20240805$$CN$US$US
239051643$23905164$3$F$20240101$20240705$20240527$20240717$PER$$US-SA-2024SA153501$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240717$$MD$US$US
239051892$23905189$2$F$20240401$20240716$20240527$20240717$PER$$US-ALXN-202405USA001426US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
239051903$23905190$3$F$$20240829$20240527$20240910$PER$$US-SA-2024SA155997$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240910$$MD$US$US
239052083$23905208$3$F$$20240702$20240527$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04216$LUPIN$$$$$$Y$$$20240724$$CN$US$US
239052102$23905210$2$F$$20240710$20240527$20240710$PER$$NVSC2024US111210$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
239052112$23905211$2$F$20240507$20240723$20240527$20240801$PER$$US-SA-2024SA157079$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240801$$MD$US$US
239052133$23905213$3$F$$20240830$20240527$20240904$PER$$US-SA-2024SA154946$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240904$$HP$US$US
239052182$23905218$2$F$20240521$20240624$20240527$20240703$PER$$US-SA-2024SA156402$SANOFI AVENTIS$$74$YR$E$F$Y$23$KG$20240703$$HP$US$US
239052193$23905219$3$F$$20240904$20240527$20240924$PER$$US-SA-2024SA157683$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240924$$CN$US$US
239052372$23905237$2$F$20240614$20240625$20240527$20240708$PER$$US-SA-2024SA157517$SANOFI AVENTIS$$39$YR$A$M$Y$106.5$KG$20240708$$MD$US$US
239052452$23905245$2$F$20240517$20240812$20240527$20240822$EXP$$DE-TEVA-VS-3201828$TEVA$$50$YR$$F$Y$$$20240822$$CN$DE$DE
239052632$23905263$2$F$20240101$20240816$20240527$20240828$PER$$US-SA-2024SA157411$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240828$$MD$US$US
239052703$23905270$3$F$20240521$20240809$20240527$20240820$PER$$US-SA-2024SA157748$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240820$$MD$US$US
239052812$23905281$2$F$20240101$20240708$20240527$20240716$PER$$US-SA-2024SA155391$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240716$$MD$US$US
239052922$23905292$2$F$$20240823$20240527$20240906$PER$$US-SA-2024SA155028$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240906$$MD$US$US
239053073$23905307$3$F$20240518$20240717$20240527$20240725$PER$$US-SA-2024SA156819$SANOFI AVENTIS$$74$YR$E$M$Y$76.65$KG$20240725$$MD$US$US
239053312$23905331$2$F$20240523$20240814$20240527$20240819$PER$$US-AMGEN-USASP2024103803$AMGEN$$63$YR$A$M$Y$$$20240819$$CN$US$US
239053412$23905341$2$F$$20240827$20240527$20240829$PER$$US-JNJFOC-20240570655$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240829$$CN$US$US
239053512$23905351$2$F$20240401$20240625$20240527$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202405014809$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240701$$MD$US$US
239053582$23905358$2$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04210$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239053622$23905362$2$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04217$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239053703$23905370$3$F$20240101$20240710$20240527$20240718$PER$$US-SA-2024SA154747$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240718$$MD$US$US
239053713$23905371$3$F$$20240706$20240527$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04241$LUPIN$$$$$$Y$$$20240729$$CN$US$US
239053752$23905375$2$F$20240423$20240711$20240527$20240712$EXP$FR-AFSSAPS-NT2024000542$NVSC2024FR106075$NOVARTIS$$37$YR$$F$Y$97$KG$20240712$$MD$FR$FR
239053882$23905388$2$F$20220101$20240722$20240527$20240723$30DAY$$AR-PFIZER INC-PV202400063459$PFIZER$$$$$F$Y$$$20240723$$CN$AR$AR
239053892$23905389$2$F$$20240812$20240527$20240813$30DAY$$AR-PFIZER INC-PV202400063452$PFIZER$$$$$F$Y$$$20240813$$CN$AR$AR
239053915$23905391$5$F$$20240821$20240527$20240828$30DAY$$US-PFIZER INC-202400105789$PFIZER$$17$YR$$M$Y$$$20240828$$PH$US$US
239053954$23905395$4$F$20240612$20240918$20240527$20240926$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001068$BLUEPRINT MEDICINES$$75$YR$E$F$Y$$$20240926$$CN$US$US
239054045$23905404$5$F$20231208$20240708$20240527$20240710$EXP$$CA-ABBVIE-5773202$ABBVIE$$66$YR$$M$Y$$$20240710$$MD$CA$CA
239054133$23905413$3$F$$20240729$20240527$20240801$PER$$US-PFIZER INC-202400175834$PFIZER$$56$YR$$F$Y$$$20240801$$CN$US$US
239054164$23905416$4$F$$20240702$20240527$20240704$PER$$US-PFIZER INC-202400178491$PFIZER$$$$A$M$Y$$$20240704$$MD$US$US
239054483$23905448$3$F$20240523$20240923$20240527$20240924$PER$$US-PFIZER INC-202400175955$PFIZER$$70$YR$$M$Y$81.633$KG$20240924$$CN$US$US
239054594$23905459$4$F$20230101$20240724$20240527$20240726$PER$$US-PFIZER INC-PV202400032955$PFIZER$$75$YR$$M$Y$$$20240726$$CN$US$US
239054642$23905464$2$F$20240101$20240626$20240527$20240701$PER$$US-PFIZER INC-PV202400068008$PFIZER$$65$YR$$F$Y$$$20240701$$HP$US$US
239054675$23905467$5$F$20240520$20240812$20240527$20240820$EXP$$IL-UNITED THERAPEUTICS-UNT-2024-015907$UNITED THERAPEUTICS$$45$YR$$F$Y$$$20240820$$$IL$IL
239054762$23905476$2$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04222$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239054863$23905486$3$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04224$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239054882$23905488$2$F$$20240725$20240527$20240726$EXP$$NVSC2024GB110454$NOVARTIS$$$$A$F$Y$$$20240726$$MD$GB$GB
239054914$23905491$4$F$20220101$20240717$20240527$20240723$EXP$$FI-JNJFOC-20240576206$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240722$$CN$FI$FI
239054932$23905493$2$F$20240519$20240913$20240527$20240919$EXP$$JP-009507513-2405JPN002506J$MERCK$$9$DEC$$M$Y$$$20240919$$MD$JP$JP
239055112$23905511$2$F$20240514$20240702$20240527$20240705$EXP$$NVSC2024DE109070$NOVARTIS$$$$A$F$Y$108$KG$20240705$$CN$DE$DE
239055163$23905516$3$F$20240506$20240725$20240527$20240729$EXP$$JP-ALXN-202405JPN001640JP$ALEXION PHARMACEUTICALS$$74$YR$$M$Y$$$20240729$$MD$JP$JP
239055172$23905517$2$F$$20240706$20240527$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04238$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239055262$23905526$2$F$20240523$20240722$20240527$20240724$PER$$US-AMGEN-USASP2024102877$AMGEN$$62$YR$A$M$Y$$$20240724$$CN$US$US
239055442$23905544$2$F$$20240801$20240527$20240805$PER$$US-JNJFOC-20240559788$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$US$US
239055463$23905546$3$F$$20240716$20240527$20240723$PER$$US-JNJFOC-20240559035$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
239055482$23905548$2$F$$20240807$20240527$20240807$PER$$NVSC2024US111079$NOVARTIS$$$$$F$Y$$$20240807$$PH$US$US
239055522$23905552$2$F$20240514$20240820$20240527$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079604$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240820$$CN$US$US
239055542$23905554$2$F$20240516$20240718$20240527$20240718$PER$$US-ALXN-202405USA001247US$ALEXION PHARMACEUTICALS$$41$YR$$F$Y$$$20240718$$CN$US$US
239055562$23905556$2$F$20220101$20240714$20240527$20240716$PER$$NVSC2024US110543$NOVARTIS$$34$YR$$$Y$$$20240716$$CN$US$US
239055583$23905558$3$F$$20240829$20240527$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US051844$SANDOZ$$$$$F$Y$$$20240904$$CN$US$US
239055722$23905572$2$F$$20240828$20240527$20240902$EXP$$US-PFIZER INC-PV202400069044$PFIZER$$87$YR$$F$Y$$$20240902$$CN$US$US
239055744$23905574$4$F$20240501$20240830$20240527$20240905$EXP$$JP-PFIZER INC-202400173781$PFIZER$$8$DEC$$M$Y$$$20240905$$MD$JP$JP
239055805$23905580$5$F$20230101$20240702$20240527$20240703$EXP$$CA-PFIZER INC-202300118968$PFIZER$$52$YR$$F$Y$$$20240703$$HP$CA$CA
239056012$23905601$2$F$$20240729$20240527$20240802$EXP$$GB-JNJFOC-20240558346$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240802$$CN$GB$GB
239056095$23905609$5$F$20240101$20240905$20240527$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078921$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240911$$CN$US$US
239056153$23905615$3$F$$20240724$20240527$20240725$PER$$US-JNJFOC-20240568043$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$HP$US$US
239056293$23905629$3$F$$20240821$20240527$20240827$EXP$$IN-PFIZER INC-PV202400063355$PFIZER$$47$YR$$F$Y$$$20240827$$CN$IN$IN
239056522$23905652$2$F$20240501$20240823$20240527$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083177$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240827$$CN$US$US
239056692$23905669$2$F$20240521$20240731$20240527$20240802$EXP$$NVSC2024TR110585$NOVARTIS$$26$YR$$M$Y$90$KG$20240802$$MD$TR$TR
239056772$23905677$2$F$20240519$20240826$20240527$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083128$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240827$$CN$US$US
239056794$23905679$4$F$20240401$20240918$20240527$20240920$EXP$$JP-PFIZER INC-PV202400068136$PFIZER$$77$YR$$M$Y$60$KG$20240920$$PH$JP$JP
239056803$23905680$3$F$$20240710$20240527$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076524$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$51.26$KG$20240716$$CN$US$US
239056812$23905681$2$F$$20240814$20240527$20240816$EXP$$US-PFIZER INC-202400175829$PFIZER$$75$YR$$F$Y$$$20240816$$CN$US$US
239056822$23905682$2$F$20230101$20240726$20240527$20240731$EXP$$US-PFIZER INC-202400175079$PFIZER$$70$YR$$F$Y$$$20240731$$HP$US$US
239056862$23905686$2$F$$20240717$20240527$20240717$EXP$$CA-PFIZER INC-202400175274$PFIZER$$79$YR$$M$Y$$$20240717$$CN$CA$CA
239056883$23905688$3$F$20240501$20240702$20240527$20240712$EXP$$CA-PFIZER INC-202400175540$PFIZER$$72$YR$$F$Y$$$20240712$$HP$CA$CA
239056892$23905689$2$F$$20240730$20240527$20240802$EXP$$US-PFIZER INC-PV202400068086$PFIZER$$60$YR$$F$Y$$$20240802$$HP$US$US
239056903$23905690$3$F$$20240628$20240527$20240702$EXP$$JP-PFIZER INC-PV202400066909$PFIZER$$79$YR$$M$Y$$$20240702$$MD$JP$JP
239056935$23905693$5$F$20220101$20240322$20240527$20240926$EXP$$CA-PFIZER INC-202200274687$PFIZER$$70$YR$$F$Y$114$KG$20240926$$HP$CA$CA
239056944$23905694$4$F$20240301$20240717$20240527$20240717$EXP$$CA-PFIZER INC-202300203969$PFIZER$$19$YR$$F$Y$$$20240717$$MD$CA$CA
2390570510$23905705$10$F$$20240922$20240527$20240925$PER$$NVSC2024US110160$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
239057182$23905718$2$F$20231106$20240826$20240527$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-083575$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240826$$MD$JP$JP
239057282$23905728$2$F$$20240621$20240527$20240705$PER$$US-SA-2024SA152900$SANOFI AVENTIS$$9$YR$C$M$Y$31$KG$20240705$$MD$US$US
239057372$23905737$2$F$$20240628$20240527$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078922$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240702$$CN$US$US
239057453$23905745$3$F$$20240911$20240527$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083773$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240916$$HP$US$US
239057532$23905753$2$F$$20240812$20240527$20240816$EXP$$NVSC2024US109135$NOVARTIS$$85$YR$$F$Y$$$20240816$$CN$US$US
239057584$23905758$4$F$20240101$20240716$20240527$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083350$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240723$$CN$US$US
239057613$23905761$3$F$20240521$20240724$20240527$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083638$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240726$$CN$US$US
239057732$23905773$2$F$$20240816$20240527$20240830$PER$$US-SA-2024SA156559$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240830$$CN$US$US
239057745$23905774$5$F$20240621$20240823$20240527$20240829$EXP$$AU-TAKEDA-2024TUS051425$TAKEDA$$24$YR$$M$Y$$$20240829$$HP$AU$AU
239057763$23905776$3$F$20240401$20240812$20240527$20240827$EXP$$US-BEH-2024172184$CSL BEHRING$$52$YR$$F$Y$$$20240827$$CN$US$US
239057803$23905780$3$F$20240226$20240819$20240527$20240822$EXP$$NVSC2024US108780$NOVARTIS$$39$YR$$F$Y$$$20240822$$CN$US$US
239057822$23905782$2$F$$20240701$20240527$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084007$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240703$$CN$US$US
239057832$23905783$2$F$$20240716$20240527$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083542$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240718$$CN$US$US
239057912$23905791$2$F$20240510$20240524$20240527$20240918$EXP$FR-AFSSAPS-TS2024000572$FR-BAUSCH-BL-2024-008238$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240918$$MD$FR$FR
239057922$23905792$2$F$20231001$20240702$20240527$20240705$EXP$$NVSC2024US109083$NOVARTIS$$$$$$Y$$$20240705$$CN$US$US
239058055$23905805$5$F$$20240725$20240527$20240730$PER$$US-PFIZER INC-2021215357$PFIZER$$70$YR$$F$Y$$$20240730$$HP$US$US
239058082$23905808$2$F$20230401$20240828$20240527$20240904$PER$$US-PFIZER INC-PV202400068433$PFIZER$$61$YR$$M$Y$$$20240904$$CN$US$US
239058202$23905820$2$F$20240419$20240826$20240527$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083169$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240827$$CN$US$US
239058252$23905825$2$F$$20240724$20240527$20240725$EXP$$NVSC2024AU109247$NOVARTIS$$$$$$Y$$$20240725$$MD$AU$AU
239058322$23905832$2$F$20240101$20240708$20240527$20240716$EXP$$JP-009507513-2405JPN002246J$MERCK$$77$YR$$M$Y$$$20240716$$MD$JP$JP
239058352$23905835$2$F$$20240729$20240527$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083333$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240802$$CN$US$US
239058423$23905842$3$F$20240701$20240806$20240527$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083701$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$43.54$KG$20240810$$MD$US$US
239058433$23905843$3$F$$20240904$20240527$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083900$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240906$$CN$US$US
239058443$23905844$3$F$$20240913$20240527$20240919$EXP$$JP-009507513-2405JPN002345J$MERCK$$61$YR$$F$Y$$$20240919$$MD$JP$JP
239058462$23905846$2$F$20240501$20240909$20240527$20240916$EXP$$JP-009507513-2405JPN002228J$MERCK$$7$DEC$$F$Y$$$20240916$$MD$JP$JP
239058622$23905862$2$F$20240506$20240705$20240527$20240711$EXP$$JP-009507513-2405JPN002517J$MERCK$$6$DEC$$F$Y$$$20240711$$MD$JP$JP
239058642$23905864$2$F$$20240716$20240527$20240717$PER$$US-ALXN-202405USA001464US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
239058813$23905881$3$F$20240224$20240704$20240527$20240706$EXP$$GB-ABBVIE-5774410$ABBVIE$$44$YR$$F$Y$$$20240706$$HP$GB$GB
239058916$23905891$6$F$$20240807$20240527$20240812$EXP$$US-TAKEDA-2024TUS051831$TAKEDA$$$$$F$Y$$$20240812$$CN$US$US
239058972$23905897$2$F$20240101$20240701$20240527$20240704$PER$$US-JNJFOC-20240549207$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
239059103$23905910$3$F$20240506$20240806$20240527$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405013267$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240809$$CN$JP$JP
239059192$23905919$2$F$20240216$20240704$20240527$20240717$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202402015981$ELI LILLY AND CO$$51$YR$A$F$Y$98.5$KG$20240717$$CN$ES$ES
239059265$23905926$5$F$$20240913$20240527$20240920$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202405006955$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240920$$CN$CA$CA
239059292$23905929$2$F$$20240808$20240527$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202405010660$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240819$$CN$US$US
239059363$23905936$3$F$$20240624$20240527$20240701$EXP$$US-MTPC-MTDA2024-0011037$Unknown Manufacturer$$$$E$F$Y$$$20240701$$CN$US$US
239059412$23905941$2$F$20240513$20240812$20240527$20240822$PER$$US-TPU-TPU-2024-00204$TEIKOKU$$89$YR$E$M$Y$$$20240822$$CN$US$US
239059452$23905945$2$F$$20240822$20240527$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081897$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240823$$HP$US$US
239059472$23905947$2$F$20240516$20240626$20240527$20240705$PER$$US-AMGEN-USASP2024099436$AMGEN$$65$YR$E$$Y$52.7$KG$20240705$$PH$US$US
239059535$23905953$5$F$$20240726$20240527$20240806$30DAY$$SG-JNJFOC-20240542668$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$PH$SG$SG
239059542$23905954$2$F$20230101$20240916$20240527$20240925$PER$$US-BIOGEN-2023BI01242107$BIOGEN$$$$$M$Y$$$20240925$$CN$US$US
239059573$23905957$3$F$$20240702$20240527$20240709$EXP$$NVSJ2023JP011607$NOVARTIS$Iijima N, Serisawa M, Ishii Y, Tatsukawa Y, Nakamura S, Ikemoto J et al.. Short-term Results of Peptide Receptor Radionuclide Therapy (PRRT) for  Unresectable Neuroendocrine Neoplasm in Our Hospital. Journal of Japanese Society of Gastroenterology/The 110th General Meeting of the. 2024;121:MO-168$61$YR$$F$Y$$$20240709$$MD$JP$JP
239059702$23905970$2$F$20240501$20240716$20240527$20240725$PER$$US-SA-2024SA155739$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240725$$MD$US$US
239059762$23905976$2$F$$20240722$20240527$20240728$EXP$$US-ABBVIE-5769948$ABBVIE$$$$$F$Y$$$20240728$$CN$US$US
239060042$23906004$2$F$20240423$20240711$20240527$20240718$EXP$$JP-GSK-JP2024JPN063038$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$PH$JP$JP
239060282$23906028$2$F$$20240826$20240527$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-081705$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240827$$MD$JP$JP
239060355$23906035$5$F$20240520$20240703$20240527$20240706$30DAY$$US-JNJFOC-20240561287$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240706$$CN$US$US
239060453$23906045$3$F$20240101$20240711$20240527$20240718$EXP$$US-ABBVIE-5730971$ABBVIE$$80$YR$$F$Y$69.4$KG$20240718$$CN$US$US
239060552$23906055$2$F$20240518$20240711$20240527$20240716$EXP$$US-JNJFOC-20240559755$JOHNSON AND JOHNSON$$94$YR$E$F$Y$$$20240716$$CN$US$US
239060564$23906056$4$F$$20240829$20240527$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US052183$SANDOZ$$$$$F$Y$$$20240902$$PH$US$US
239060573$23906057$3$F$$20240716$20240527$20240722$EXP$$CA-Orion Corporation ORION PHARMA-24_00030083$ORION$$59$YR$A$F$Y$$$20240719$$CN$CA$
239060685$23906068$5$F$20220101$20240906$20240527$20240911$EXP$$JP-AstraZeneca-2024A120986$ASTRAZENECA$$82$YR$$F$Y$49$KG$20240911$$PH$JP$
239060754$23906075$4$F$20240101$20240829$20240527$20240903$EXP$$JP-009507513-2405JPN000864J$MERCK$$7$DEC$$F$Y$$$20240903$$MD$JP$JP
239060782$23906078$2$F$20240505$20240820$20240527$20240827$EXP$$CO-JNJFOC-20240568225$JOHNSON AND JOHNSON$$54$YR$A$M$Y$73$KG$20240827$$HP$CO$CO
239060813$23906081$3$F$20231221$20240802$20240527$20240808$EXP$$NVSJ2024JP004738$NOVARTIS$$78$YR$$F$Y$46$KG$20240808$$MD$JP$JP
239060866$23906086$6$F$20240101$20240903$20240527$20240917$EXP$$US-UCBSA-2024026268$UCB$$$$$M$Y$68.401$KG$20240917$$CN$US$US
239060875$23906087$5$F$20240522$20240625$20240527$20240701$30DAY$$US-AMGEN-USASP2024102920$AMGEN$$67$YR$E$F$Y$119.1$KG$20240701$$PH$US$US
239060883$23906088$3$F$$20240717$20240527$20240718$EXP$$US-ALXN-202405USA001784US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$MD$US$US
239060913$23906091$3$F$20240522$20240705$20240527$20240708$PER$$US-JNJFOC-20240568975$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240708$$CN$US$US
239061134$23906113$4$F$20240130$20240903$20240527$20240905$EXP$$JP-TAKEDA-2024TJP007550$TAKEDA$$5$YR$$F$Y$$$20240905$$HP$JP$JP
239061212$23906121$2$F$20240101$20240819$20240528$20240828$PER$$US-SA-2024SA158358$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240828$$MD$US$US
239061312$23906131$2$F$20240201$20240906$20240528$20240912$EXP$$US-ABBVIE-5774501$ABBVIE$$65$YR$$M$Y$96$KG$20240912$$HP$US$US
239061332$23906133$2$F$20240330$20240809$20240528$20240810$EXP$FR-AFSSAPS-PV2024000363$FR-ROCHE-3565981$ROCHE$$72$YR$E$F$Y$58$KG$20240810$$MD$FR$FR
239061372$23906137$2$F$$20240912$20240528$20240918$EXP$$US-ABBVIE-5773550$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
239061452$23906145$2$F$20240501$20240625$20240528$20240701$EXP$$NVSJ2024JP006060$NOVARTIS$$$$E$F$Y$$$20240701$$PH$JP$JP
239061532$23906153$2$F$20240521$20240711$20240528$20240722$30DAY$$US-GSK-US2024063677$GLAXOSMITHKLINE$$80$YR$$M$Y$$$20240722$$CN$US$US
239061652$23906165$2$F$$20240904$20240528$20240911$EXP$$US-ABBVIE-5772912$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
239061832$23906183$2$F$$20240722$20240528$20240731$EXP$$US-NOVOPROD-1226135$NOVO NORDISK$$$$A$M$Y$$$20240731$$CN$US$US
239061862$23906186$2$F$20240222$20240713$20240528$20240724$EXP$$US-NOVOPROD-1225902$NOVO NORDISK$$69$YR$$F$Y$$$20240724$$CN$US$US
239061904$23906190$4$F$20240509$20240805$20240528$20240814$EXP$$US-NOVOPROD-1226499$NOVO NORDISK$$67$YR$$F$Y$$$20240814$$CN$US$US
239062162$23906216$2$F$20240502$20240529$20240528$20240708$PER$$FR-TOLMAR, INC.-24FR049007$TOLMAR$$76$YR$$M$Y$$$20240708$$PH$FR$FR
239062172$23906217$2$F$20240503$20240529$20240528$20240708$PER$$FR-TOLMAR, INC.-24FR049058$TOLMAR$$78$YR$$M$Y$$$20240708$$PH$FR$FR
239062183$23906218$3$F$20240503$20240528$20240528$20240708$PER$$FR-TOLMAR, INC.-24FR049060$TOLMAR$$88$YR$$M$Y$$$20240708$$PH$FR$FR
239062192$23906219$2$F$20240430$20240529$20240528$20240708$PER$$FR-TOLMAR, INC.-24FR049087$TOLMAR$$71$YR$$M$Y$$$20240708$$PH$FR$FR
239062202$23906220$2$F$20240502$20240528$20240528$20240708$PER$$FR-TOLMAR, INC.-24FR049097$TOLMAR$$82$YR$$M$Y$$$20240708$$PH$FR$FR
239062213$23906221$3$F$20240101$20240722$20240528$20240819$PER$$FR-TOLMAR, INC.-24FR049101$TOLMAR$$80$YR$$M$Y$$$20240814$$PH$FR$FR
239062362$23906236$2$F$$20240820$20240528$20240829$EXP$$CA-SA-2024SA153715$SANOFI AVENTIS$unknown. unknown. unknown. unk;unk:unk$64$MON$C$F$Y$$$20240829$$HP$CA$CA
239062454$23906245$4$F$20240322$20240920$20240528$20240930$EXP$$CA-CELLTRION INC.-2024CA008083$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
239062473$23906247$3$F$20231030$20240626$20240528$20240702$EXP$$US-ABBVIE-5774230$ABBVIE$$73$YR$$M$Y$$$20240702$$CN$US$US
239062542$23906254$2$F$$20240526$20240528$20240717$PER$$US-HALEON-2178169$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239062562$23906256$2$F$20240425$20240812$20240528$20240821$PER$$US-SA-2024SA154499$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240821$$HP$US$US
239062804$23906280$4$F$$20240925$20240528$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083608$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240930$$CN$US$US
239062812$23906281$2$F$20230808$20240822$20240528$20240828$EXP$$JP-ABBVIE-5772011$ABBVIE$$77$YR$$F$Y$$$20240828$$MD$JP$JP
239062873$23906287$3$F$$20240621$20240528$20240701$EXP$$JP-BEH-2024172722$CSL BEHRING$$15$YR$T$M$Y$$$20240701$$MD$JP$JP
239062922$23906292$2$F$$20240816$20240528$20240830$PER$$US-SA-2024SA157331$SANOFI AVENTIS$$$$A$M$Y$$$20240830$$MD$US$US
239062953$23906295$3$F$20231201$20240816$20240528$20240822$EXP$$CA-TAKEDA-2024TUS050687$TAKEDA$$47$YR$$M$Y$$$20240822$$HP$CA$CA
239063005$23906300$5$F$20240401$20240826$20240528$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080912$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240827$$CN$US$US
239063063$23906306$3$F$20240523$20240722$20240528$20240725$PER$$US-AMGEN-USASP2024103391$AMGEN$$77$YR$E$M$Y$$$20240725$$CN$US$US
239063072$23906307$2$F$20240101$20240628$20240528$20240704$EXP$$US-AMGEN-USASP2024100492$AMGEN$$79$YR$E$F$Y$$$20240704$$CN$US$US
239063112$23906311$2$F$$20240905$20240528$20240917$EXP$$US-PADAGIS-2024PAD00892$PADAGIS$Korzec J., Strausbaugh R., Mikolay J.J., Churchwell M.D.. Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A missed opportunity for pharmacist involvement. Journal of the American Pharmacists Association. 2024;64(3):102016$$$$$Y$$$20240917$$PH$US$US
239063313$23906331$3$F$$20240910$20240528$20240917$EXP$$CA-HALEON-2176871$Haleon PLC$$50$YR$$F$Y$68$KG$20240917$$HP$CA$CA
239063622$23906362$2$F$20240520$20240620$20240528$20240704$PER$$US-AstraZeneca-2024A119991$ASTRAZENECA$$93$YR$$F$Y$$$20240704$$CN$US$
239063658$23906365$8$F$$20240906$20240528$20240912$EXP$$PL-SA-2024SA132780$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240912$$MD$PL$PL
239063992$23906399$2$F$20240520$20240711$20240528$20240717$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-083711$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240717$$HP$PR$PR
239064193$23906419$3$F$$20240729$20240528$20240828$PER$$US-AstraZeneca-2024A117978$ASTRAZENECA$$$$$F$Y$$$20240828$$MD$US$
239064272$23906427$2$F$$20240902$20240528$20240902$EXP$$IL-ALXN-202405EEA001264IL$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240902$$MD$IL$IL
239064423$23906442$3$F$20240509$20240806$20240528$20240807$30DAY$$US-SANDOZ INC.-SDZ2024US052317$SANDOZ$$8$YR$$$Y$$$20240807$$CN$US$US
239064442$23906444$2$F$20240101$20240903$20240528$20240911$EXP$$US-SA-2024SA158513$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240911$$MD$US$US
239064612$23906461$2$F$20240523$20240702$20240528$20240705$PER$$US-AMGEN-USASP2024103648$AMGEN$$60$YR$A$F$Y$$$20240705$$HP$US$US
239064853$23906485$3$F$20240501$20240610$20240528$20240702$30DAY$$GB-JNJFOC-20240504712$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240702$$CN$GB$GB
239064912$23906491$2$F$$20240909$20240528$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-080631$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$MD$JP$JP
239065413$23906541$3$F$$20240716$20240528$20240718$PER$$US-AMGEN-USASP2024103079$AMGEN$$88$YR$E$F$Y$$$20240718$$CN$US$US
239065552$23906555$2$F$$20240722$20240528$20240731$EXP$$FR-ROCHE-3566293$ROCHE$$73$YR$E$F$Y$59$KG$20240731$$MD$FR$FR
239065602$23906560$2$F$$20240527$20240528$20240718$PER$$US-HALEON-2178256$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239065713$23906571$3$F$20240101$20240813$20240528$20240819$EXP$$US-ABBVIE-5761893$ABBVIE$$$$$F$Y$83$KG$20240819$$CN$US$US
239065852$23906585$2$F$$20240826$20240528$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083302$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240826$$CN$US$US
239065892$23906589$2$F$20230918$20240624$20240528$20240704$EXP$$CA-BEH-2024172585$CSL BEHRING$$35$YR$A$F$Y$88$KG$20240704$$HP$CA$CA
239065972$23906597$2$F$$20240722$20240528$20240903$PER$$US-LUNDBECK-DKLU3077423$LUNDBECK$$$$$$Y$$$20240903$$HP$US$US
239066126$23906612$6$F$20240101$20240813$20240528$20240819$EXP$$ES-ABBVIE-5771511$ABBVIE$$$$$M$Y$$$20240819$$CN$ES$ES
239066222$23906622$2$F$20201012$20240924$20240528$20240930$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-081884$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240930$$HP$KR$KR
239066273$23906627$3$F$20240501$20240822$20240528$20240829$EXP$$BE-BEH-2024172661$CSL BEHRING$$79$YR$E$F$Y$$$20240829$$HP$BE$BE
239066303$23906630$3$F$20210901$20240624$20240528$20240701$PER$$US-BIOGEN-2022BI01084870$BIOGEN$$57$YR$$F$Y$$$20240701$$CN$US$US
239066363$23906636$3$F$$20240714$20240528$20240722$30DAY$$US-GSK-US2024AMR065669$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$HP$US$US
239066542$23906654$2$F$20230422$20240712$20240528$20240716$PER$$US-ABBVIE-5776820$ABBVIE$$62$YR$$M$Y$$$20240716$$CN$CA$CA
239066762$23906676$2$F$20240401$20240821$20240528$20240827$EXP$$TN-ABBVIE-5775182$ABBVIE$$70$YR$$M$Y$$$20240827$$CN$TN$TN
239066782$23906678$2$F$$20240621$20240528$20240705$EXP$$JP-AMGEN-JPNSP2024103348$AMGEN$$$$$$Y$$$20240705$$PH$JP$JP
239066832$23906683$2$F$20240501$20240522$20240528$20240814$EXP$$NVSC2024US109550$NOVARTIS$$42$YR$$F$Y$88$KG$20240814$$CN$US$US
239067155$23906715$5$F$20240101$20240827$20240528$20240903$EXP$$US-ABBVIE-5773780$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
239067313$23906731$3$F$20240612$20240723$20240528$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083519$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240729$$CN$US$US
239067392$23906739$2$F$20240101$20240708$20240528$20240711$EXP$$US-AMGEN-USASP2024099672$AMGEN$$69$YR$E$F$Y$$$20240711$$MD$US$US
239067652$23906765$2$F$20240501$20240714$20240528$20240723$30DAY$$US-GSK-US2024063682$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$PH$US$US
239067853$23906785$3$F$20240301$20240820$20240528$20240823$EXP$$JP-GSK-JP2024JPN044153$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$JP$JP
239067912$23906791$2$F$20231101$20240729$20240528$20240730$EXP$$US-UCBSA-2024026168$UCB$$55$YR$$F$Y$$$20240730$$HP$US$US
239067943$23906794$3$F$$20240812$20240528$20240813$PER$$US-JNJFOC-20240568059$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
239068042$23906804$2$F$20240507$20240903$20240528$20240908$EXP$$CA-JNJFOC-20240562142$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240909$$CN$CA$CA
239068062$23906806$2$F$20240501$20240711$20240528$20240722$EXP$$JP-ROCHE-3569638$ROCHE$$69$YR$E$F$Y$53.8$KG$20240722$$MD$JP$JP
239068172$23906817$2$F$$20240612$20240528$20240701$30DAY$$GB-JNJFOC-20240518629$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240701$$HP$GB$GB
239068622$23906862$2$F$$20240823$20240528$20240828$EXP$$JP-009507513-2308JPN002880J$MERCK$Iwata N, Takao W, Nishide K, Nozue A. P-098 A case of microsatellite instability-high (MSI-H) positive corpus uteri serous carcinoma (stage 4B) successfully treated by pembrolizumab. Japanese Journal of Gynecological Oncology, The 65th Annual Meeting of Japan Soc. 2023;41(3):331$54$YR$$F$Y$$$20240828$$MD$JP$JP
239068682$23906868$2$F$20180101$20240520$20240528$20240723$EXP$$PT-009507513-2405PRT006484$MERCK$$73$YR$$M$Y$$$20240723$$MD$PT$PT
239068734$23906873$4$F$20240521$20240710$20240528$20240720$30DAY$$US-JNJFOC-20240564538$JOHNSON AND JOHNSON$$47$YR$A$M$Y$103$KG$20240719$$PH$US$US
239068803$23906880$3$F$$20240717$20240528$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084203$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240722$$CN$US$US
239068875$23906887$5$F$20240501$20240917$20240528$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084358$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240925$$CN$US$US
239068934$23906893$4$F$$20240706$20240528$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04206$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239068982$23906898$2$F$20240503$20240624$20240528$20240704$EXP$$JP-ROCHE-3568366$ROCHE$$55$YR$A$M$Y$55.9$KG$20240704$$MD$JP$JP
239069043$23906904$3$F$20240710$20240710$20240528$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002254$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240731$$CN$US$US
239069092$23906909$2$F$$20240705$20240528$20240717$EXP$$DE-ABBVIE-5772948$ABBVIE$$31$YR$$F$Y$$$20240717$$CN$DE$DE
239069123$23906912$3$F$$20240903$20240528$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002259$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
239069183$23906918$3$F$20240501$20240624$20240528$20240704$30DAY$$US-GSK-US2024064015$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240704$$CN$US$US
239069294$23906929$4$F$$20240823$20240528$20240902$EXP$$CA-APOTEX-2024AP006109$APOTEX$$47$YR$$F$Y$71$KG$20240902$$HP$CA$CA
239069382$23906938$2$F$20230501$20240910$20240528$20240924$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04252$LUPIN$Li Y, Htet N. The roller coaster levels: a successful treatment of massive Lamotrigine overdose. Critical Care Medicine. 2024;52 (S1):S438$66$YR$$M$Y$86$KG$20240924$$HP$US$US
239069402$23906940$2$F$$20240716$20240528$20240717$PER$$US-ALXN-202405USA001494US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
239069513$23906951$3$F$$20240909$20240528$20240916$EXP$$JP-009507513-2405JPN002288J$MERCK$$73$YR$$M$Y$$$20240916$$MD$JP$JP
239069672$23906967$2$F$$20240708$20240528$20240712$EXP$$US-AstraZeneca-2024A121211$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
239069732$23906973$2$F$$20240826$20240528$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084299$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240826$$CN$US$US
239069782$23906978$2$F$$20240905$20240528$20240906$PER$$NVSC2024US111438$NOVARTIS$$$$$$Y$$$20240906$$CN$US$US
239069842$23906984$2$F$20240507$20240624$20240528$20240701$EXP$$IT-AUROBINDO-AUR-APL-2024-024549$AUROBINDO$$58$YR$$F$Y$$$20240701$$MD$IT$IT
239069852$23906985$2$F$$20240819$20240528$20240827$EXP$NL-LRB-00972280$NL-TAKEDA-2024TUS052233$TAKEDA$$22$YR$$M$Y$96$KG$20240827$$HP$NL$NL
239069862$23906986$2$F$20240522$20240716$20240528$20240716$PER$$US-TAKEDA-2024TUS052382$TAKEDA$$49$YR$$F$Y$$$20240716$$CN$US$US
239069882$23906988$2$F$$20240730$20240528$20240731$EXP$$US-JNJFOC-20240551762$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240731$$CN$US$US
239070023$23907002$3$F$20231201$20240816$20240528$20240819$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-012322$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$73$KG$20240819$$CN$CA$CA
239070042$23907004$2$F$20240202$20240809$20240528$20240815$EXP$$JP-009507513-2404JPN002318J$MERCK$$8$DEC$$F$Y$$$20240815$$MD$JP$JP
239070072$23907007$2$F$$20240823$20240528$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083275$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240826$$CN$US$US
239070142$23907014$2$F$$20240523$20240528$20240808$EXP$$NVSC2023GB273411$NOVARTIS$$$$$F$Y$$$20240808$$CN$GB$GB
239070244$23907024$4$F$20240606$20240903$20240528$20240906$EXP$$CA-TAKEDA-2022TUS078292$TAKEDA$$19$YR$$F$Y$$$20240906$$CN$CA$CA
239070272$23907027$2$F$$20240627$20240528$20240703$EXP$$BR-TAKEDA-2024TUS051539$TAKEDA$$$$$$Y$$$20240703$$CN$BR$BR
239070402$23907040$2$F$$20240910$20240528$20240916$EXP$$US-TAKEDA-2024TUS037931$TAKEDA$$$$$M$Y$$$20240916$$CN$US$US
239070462$23907046$2$F$$20240711$20240528$20240711$PER$$NVSC2024US111349$NOVARTIS$$$$$$Y$$$20240711$$MD$US$US
239070512$23907051$2$F$$20240607$20240528$20240701$30DAY$$CA-JNJFOC-20240513685$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$CA$CA
239070804$23907080$4$F$$20240814$20240528$20240819$EXP$$CA-TAKEDA-2023TUS075157$TAKEDA$$$$$F$Y$$$20240819$$CN$CA$CA
239070952$23907095$2$F$20240507$20240724$20240528$20240805$EXP$$JP-ROCHE-3569586$ROCHE$$89$YR$E$M$Y$$$20240805$$MD$JP$JP
239070992$23907099$2$F$$20240724$20240528$20240729$EXP$$US-AstraZeneca-2024A121256$ASTRAZENECA$$85$YR$$M$Y$65.8$KG$20240729$$CN$US$
239071082$23907108$2$F$$20240826$20240528$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081483$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240827$$HP$US$US
239071102$23907110$2$F$20240101$20240714$20240528$20240723$EXP$$CA-CELLTRION INC.-2024CA012448$CELLTRION$$$$$$Y$$$20240723$$MD$CA$CA
239071112$23907111$2$F$20230101$20240905$20240528$20240911$EXP$$KR-TAKEDA-2024TUS052585$TAKEDA$$66$YR$$F$Y$62$KG$20240911$$MD$KR$KR
239071583$23907158$3$F$$20240908$20240528$20240910$PER$$NVSC2024US111225$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
239071616$23907161$6$F$20240526$20240730$20240528$20240731$EXP$$CN-SANDOZ INC.-SDZ2024CN052175$SANDOZ$$66$YR$$F$Y$$$20240731$$HP$CN$CN
239071623$23907162$3$F$$20240813$20240528$20240826$EXP$$US-SANDOZ INC.-SDZ2024US052152$SANDOZ$$$$$$Y$$$20240826$$CN$US$US
239071752$23907175$2$F$20240507$20240508$20240528$20240717$PER$$US-HALEON-2174074$Haleon PLC$$75$YR$$M$Y$$$20240717$$MD$US$US
239071794$23907179$4$F$$20240706$20240528$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04223$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239071862$23907186$2$F$20240501$20240718$20240528$20240725$EXP$$CA-ABBVIE-5773531$ABBVIE$$81$YR$$F$Y$$$20240725$$HP$CA$CA
239071872$23907187$2$F$$20240711$20240528$20240715$EXP$$JP-009507513-2405JPN002702J$MERCK$$75$YR$$F$Y$$$20240715$$MD$JP$JP
239071962$23907196$2$F$$20240925$20240528$20240927$PER$$US-TAKEDA-2024TUS052646$TAKEDA$$$$$F$Y$$$20240927$$HP$US$US
239071986$23907198$6$F$$20240709$20240528$20240717$EXP$$GB-ADVANZ PHARMA-202405004268$ADVANZ PHARMA$$$$$$Y$$$20240717$$HP$GB$GB
239072002$23907200$2$F$$20240812$20240528$20240820$EXP$$JP-TEVA-VS-3201117$TEVA$Kimura N, Urabe K, Furue M. Recurrent varicella in a patient with systemic lupus erythematosus treated with immunosuppressants. [Japanese]. Nishinihon-J-Dermatol 2018; 80 (4): 354-357.; Kimura N, Urabe K, Furue M. Recurrent varicella in a patient with systemic lupus erythematosus treated with immunosuppressants. [Japanese]. Nishinihon-J-Dermatol 2018; 80 (4): 354-357.$33$YR$$F$Y$$$20240820$$HP$JP$JP
239072013$23907201$3$F$$20240705$20240528$20240709$EXP$$NVSC2024CN111176$NOVARTIS$$$$$M$Y$$$20240709$$CN$CN$CN
239072102$23907210$2$F$$20240525$20240528$20240718$PER$$US-HALEON-2178244$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239072113$23907211$3$F$$20240917$20240528$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084429$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240917$$CN$US$US
239072182$23907218$2$F$20230901$20240725$20240528$20240807$EXP$$FR-CIPLA LTD.-2024FR05007$CIPLA$$$$$$Y$$$20240807$$CN$FR$FR
239072234$23907223$4$F$$20240701$20240528$20240709$30DAY$$US-JNJFOC-20240566616$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$PH$US$US
239072252$23907225$2$F$20240417$20240813$20240528$20240816$PER$$US-AMGEN-USASP2024103733$AMGEN$$54$YR$A$M$Y$$$20240816$$CN$US$US
239072262$23907226$2$F$20240522$20240812$20240528$20240814$PER$$US-AMGEN-USASP2024103146$AMGEN$$56$YR$A$F$Y$$$20240814$$CN$US$US
239072272$23907227$2$F$20240524$20240816$20240528$20240821$PER$$US-AMGEN-USASP2024103610$AMGEN$$73$YR$E$F$Y$$$20240821$$CN$US$US
239072302$23907230$2$F$$20240527$20240528$20240717$PER$$US-HALEON-2178279$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239072332$23907233$2$F$20230723$20240711$20240528$20240715$EXP$$JP-AstraZeneca-2024A121739$ASTRAZENECA$$72$YR$$M$Y$69$KG$20240715$$MD$JP$
239072342$23907234$2$F$$20240726$20240528$20240729$EXP$$NVSC2024US106767$NOVARTIS$$$$$F$Y$$$20240729$$CN$US$US
239072384$23907238$4$F$20240428$20240801$20240528$20240807$EXP$$TR-ASTELLAS-2024US014920$ASTELLAS$$64$YR$$F$Y$$$20240807$$CN$TR$TR
239072404$23907240$4$F$20201001$20240717$20240528$20240717$PER$$US-ALXN-202405USA001581US$ALEXION PHARMACEUTICALS$$65$YR$$F$Y$$$20240717$$MD$US$US
239072572$23907257$2$F$20240430$20240813$20240528$20240909$30DAY$$US-BECTON DICKINSON-US-BD-24-000294$BECTON DICKINSON$$$$$$Y$$$20240909$$CN$US$US
239072642$23907264$2$F$$20240525$20240528$20240717$PER$$US-HALEON-2178317$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239072682$23907268$2$F$$20240625$20240528$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002262$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239072712$23907271$2$F$$20240726$20240528$20240730$PER$$US-JNJFOC-20240560017$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$HP$US$US
239072752$23907275$2$F$$20240705$20240528$20240710$EXP$$CO-ASTELLAS-2024US014810$ASTELLAS$$55$YR$$F$Y$58$KG$20240710$$CN$CO$CO
239072832$23907283$2$F$20240524$20240730$20240528$20240802$PER$$US-AMGEN-USASP2024104410$AMGEN$$73$YR$E$M$Y$$$20240802$$CN$US$US
239072872$23907287$2$F$$20240827$20240528$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-084152$BRISTOL MYERS SQUIBB$$9$DEC$E$$Y$$$20240827$$MD$JP$JP
239072974$23907297$4$F$20240506$20240917$20240528$20240924$EXP$$JP-ASTELLAS-2024JP002922$ASTELLAS$$8$DEC$E$M$Y$$$20240924$$MD$JP$JP
239073083$23907308$3$F$$20240801$20240528$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202405012566$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240805$$CN$US$US
239073143$23907314$3$F$20240512$20240711$20240528$20240717$PER$$US-BIOGEN-2024BI01265290$BIOGEN$$51$YR$$F$Y$$$20240717$$CN$US$US
239073182$23907318$2$F$20240401$20240711$20240528$20240717$EXP$$US-ASTELLAS-2024US014910$ASTELLAS$$68$YR$$M$Y$$$20240717$$CN$US$US
239073195$23907319$5$F$20240522$20240821$20240528$20240828$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001072$BLUEPRINT MEDICINES$$75$YR$E$M$Y$56.75$KG$20240828$$MD$US$US
239073203$23907320$3$F$20230701$20240627$20240528$20240716$EXP$$SG-ROCHE-3570372$ROCHE$$77$YR$E$F$Y$$$20240716$$CN$SG$SG
239073282$23907328$2$F$20240523$20240730$20240528$20240802$PER$$US-AMGEN-USASP2024103715$AMGEN$$57$YR$A$F$Y$$$20240802$$CN$US$US
239073342$23907334$2$F$20240601$20240624$20240528$20240702$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001073$BLUEPRINT MEDICINES$$55$YR$A$M$Y$$$20240702$$CN$US$US
239073362$23907336$2$F$$20240726$20240528$20240731$EXP$$US-TAKEDA-2024TUS036226$TAKEDA$$$$$F$Y$$$20240731$$CN$US$US
239073373$23907337$3$F$$20240920$20240528$20240930$EXP$$CA-TAKEDA-2024TUS052116$TAKEDA$$$$$M$Y$$$20240930$$CN$CA$CA
239073432$23907343$2$F$20240522$20240730$20240528$20240731$PER$$US-JNJFOC-20240568851$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240731$$PH$US$US
239073462$23907346$2$F$20240124$20240610$20240528$20240701$EXP$$AR-SA-2024SA035933$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240701$$MD$AR$AR
239073503$23907350$3$F$$20240706$20240528$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04250$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239073654$23907365$4$F$20240422$20240828$20240528$20240903$EXP$$JP-JNJFOC-20240576594$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240904$$MD$JP$JP
239073753$23907375$3$F$20240828$20240830$20240528$20240910$EXP$$PK-ROCHE-3566887$ROCHE$$57$YR$A$F$Y$68$KG$20240910$$CN$PK$PK
239073772$23907377$2$F$20240519$20240701$20240528$20240716$30DAY$$US-ROCHE-3568469$ROCHE$$$$$$Y$$$20240716$$CN$US$US
239073832$23907383$2$F$$20240825$20240528$20240902$EXP$$US-AMGEN-USASP2024103217$AMGEN$Aamer S.; Rajan A.; Arora S. et. al.. VASCULAR THREADS AND NEPHRON NESTS: EXPLORING THE ASSOCIATION BETWEEN TAKAYASU ARTERITIS AND MEMBRANOUS NEPHROPATHY. American Journal of Kidney Diseases. 2024;83 (4) SUPPL_2:S108$22$YR$A$F$Y$$$20240901$$HP$US$US
239074232$23907423$2$F$20240401$20240626$20240528$20240705$EXP$$JP-ROCHE-3570137$ROCHE$$7$DEC$E$M$Y$$$20240705$$MD$JP$JP
239074522$23907452$2$F$$20240821$20240528$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079892$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240821$$CN$US$US
239074842$23907484$2$F$$20240620$20240528$20240702$PER$$US-AstraZeneca-2024A118958$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
239074952$23907495$2$F$20240520$20240702$20240528$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079919$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240704$$HP$US$US
239075152$23907515$2$F$$20240702$20240528$20240705$EXP$$CA-SANDOZ INC.-NVSC2022CA133692$SANDOZ$$$$$M$Y$$$20240705$$CN$CA$CA
239075203$23907520$3$F$$20240716$20240528$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002244$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
239075553$23907555$3$F$20240401$20240715$20240528$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002243$ACADIA PHARMACEUTICALS$$11$YR$$F$Y$$$20240809$$CN$US$US
239075892$23907589$2$F$$20240625$20240528$20240703$EXP$$AM-STRIDES ARCOLAB LIMITED-2024SP006082$STRIDES$Kalikyan Z, Hakobyan A.. A rare case of phenobarbital-induced leukocytoclastic vasculitis.. DARU. 2024;32(1):449-454$53$YR$$F$Y$$$20240703$$HP$AM$AM
239076163$23907616$3$F$$20240522$20240528$20240724$EXP$$US-HALEON-2178296$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239076172$23907617$2$F$$20240723$20240528$20240729$EXP$$US-TAKEDA-2024TUS051809$TAKEDA$$$$$M$Y$$$20240729$$CN$US$US
239076238$23907623$8$F$20240508$20240801$20240528$20240812$EXP$$US-BAXTER-2024BAX018576$BAXTER$$68$YR$$M$Y$64.9$KG$20240812$$MD$US$US
239076312$23907631$2$F$$20240526$20240528$20240717$PER$$US-HALEON-2178307$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239076352$23907635$2$F$20240503$20240613$20240528$20240703$PER$$US-TOLMAR, INC.-24US049066$TOLMAR$$$$$F$Y$$$20240703$$HP$US$US
239076362$23907636$2$F$$20240614$20240528$20240703$PER$$US-TOLMAR, INC.-24US049075$TOLMAR$$$$$M$Y$$$20240703$$HP$US$US
239076372$23907637$2$F$20240501$20240614$20240528$20240703$PER$$US-TOLMAR, INC.-24US049084$TOLMAR$$91$YR$$M$Y$$$20240703$$HP$US$US
239076452$23907645$2$F$$20240625$20240528$20240702$PER$$US-BIOGEN-2024BI01266483$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
239076502$23907650$2$F$20240426$20240613$20240528$20240705$PER$$US-TOLMAR, INC.-24US048864$TOLMAR$$73$YR$$M$Y$$$20240705$$HP$US$US
239076522$23907652$2$F$20240426$20240614$20240528$20240702$PER$$US-TOLMAR, INC.-24US048943$TOLMAR$$82$YR$$M$Y$$$20240702$$PH$US$US
239076542$23907654$2$F$20240430$20240612$20240528$20240702$PER$$US-TOLMAR, INC.-24US048960$TOLMAR$$64$YR$$M$Y$$$20240702$$HP$US$US
239076592$23907659$2$F$20240502$20240614$20240528$20240703$PER$$US-TOLMAR, INC.-24US049016$TOLMAR$$77$YR$$M$Y$$$20240703$$PH$US$US
239076602$23907660$2$F$20240501$20240614$20240528$20240703$PER$$US-TOLMAR, INC.-24US049023$TOLMAR$$87$YR$$M$Y$$$20240703$$PH$US$US
239076622$23907662$2$F$20240502$20240612$20240528$20240703$PER$$US-TOLMAR, INC.-24US049051$TOLMAR$$85$YR$$M$Y$$$20240703$$PH$US$US
239076632$23907663$2$F$20240424$20240613$20240528$20240703$PER$$US-TOLMAR, INC.-24US049056$TOLMAR$$78$YR$$M$Y$$$20240703$$HP$US$US
239076642$23907664$2$F$20240506$20240614$20240528$20240703$PER$$US-TOLMAR, INC.-24US049065$TOLMAR$$77$YR$$M$Y$$$20240703$$HP$US$US
239076702$23907670$2$F$$20240527$20240528$20240717$PER$$US-HALEON-2178281$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239076733$23907673$3$F$$20240617$20240528$20240806$PER$$US-AstraZeneca-2024A118506$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
239076742$23907674$2$F$20240408$20240710$20240528$20240717$EXP$$AR-TAKEDA-2024TUS052631$TAKEDA$$31$YR$$F$Y$96$KG$20240717$$CN$AR$AR
239076793$23907679$3$F$20230401$20240808$20240528$20240821$EXP$$US-MACLEODS PHARMA-MAC2024047348$MACLEODS$$$$$$Y$$$20240820$$CN$US$US
239076922$23907692$2$F$20200701$20240807$20240528$20240815$EXP$$GB-TAKEDA-2024TUS051047$TAKEDA$$47$YR$$M$Y$$$20240815$$MD$GB$GB
239076952$23907695$2$F$$20240526$20240528$20240718$PER$$US-HALEON-2178138$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239077236$23907723$6$F$$20240710$20240528$20240723$EXP$$GB-ADVANZ PHARMA-202405004269$ADVANZ PHARMA$$$$$$Y$$$20240723$$HP$GB$GB
239077382$23907738$2$F$$20240527$20240528$20240718$PER$$US-HALEON-2178376$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239077492$23907749$2$F$$20240525$20240528$20240717$PER$$US-HALEON-2178324$Haleon PLC$$10$YR$$M$Y$$$20240717$$CN$US$US
239077502$23907750$2$F$$20240826$20240528$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081908$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$45.81$KG$20240828$$CN$US$US
239077802$23907780$2$F$20220901$20240724$20240528$20240805$EXP$$US-Accord-426859$ACCORD$$$$$F$Y$$$20240805$$CN$US$US
239078074$23907807$4$F$20240507$20240801$20240528$20240807$EXP$$JP-AMGEN-JPNSP2024101860$AMGEN$$74$YR$E$F$Y$$$20240807$$MD$JP$JP
239078313$23907831$3$F$$20240706$20240528$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04260$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239078512$23907851$2$F$20240417$20240601$20240528$20240827$PER$$US-AUROBINDO-AUR-APL-2024-020489$AUROBINDO$$$$$F$Y$$$20240827$$CN$US$US
239078552$23907855$2$F$20240101$20240719$20240528$20240725$PER$$US-AstraZeneca-2024A117854$ASTRAZENECA$$56$YR$$M$Y$$$20240725$$CN$US$
239078572$23907857$2$F$20240327$20240507$20240528$20240827$PER$$US-AUROBINDO-AUR-APL-2024-021086$AUROBINDO$$$$$F$Y$$$20240827$$PH$US$US
239078582$23907858$2$F$20240424$20240506$20240528$20240827$PER$$US-AUROBINDO-AUR-APL-2024-021100$AUROBINDO$$69$YR$$F$Y$68.038$KG$20240827$$CN$US$US
239078722$23907872$2$F$20240401$20240723$20240528$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-079640$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$48.08$KG$20240731$$CN$US$US
239079023$23907902$3$F$$20240708$20240528$20240710$PER$$US-JNJFOC-20240570579$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
239079104$23907910$4$F$20240518$20240809$20240528$20240816$PER$$US-ALXN-202405USA001360US$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240816$$MD$US$US
239079122$23907912$2$F$$20240706$20240528$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04259$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239079172$23907917$2$F$20240101$20240719$20240528$20240719$EXP$$CA-PFIZER INC-202400178711$PFIZER$$68$YR$$F$Y$$$20240719$$HP$CA$CA
239079183$23907918$3$F$$20240716$20240528$20240718$30DAY$$FR-PFIZER INC-202400172181$PFIZER$$$$$$Y$$$20240718$$HP$FR$FR
239079192$23907919$2$F$$20240526$20240528$20240717$PER$$US-HALEON-2178135$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239079332$23907933$2$F$$20240826$20240528$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083839$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$130.7$KG$20240826$$MD$US$US
239079362$23907936$2$F$$20240816$20240528$20240826$EXP$$CN-ROCHE-3567998$ROCHE$Abuduxukuer Z, Cai H, Wang J, Chen Y, Chen K. Efficacy and safety of omalizumab in the treatment of allergic bronchopulmonary aspergillosis: a real-world study.. Chinese Journal of Clinical Medicine. 2024;31:161-8. doi:10.12025/j.issn.1008-6358.2024.20240197.$$$$$Y$$$20240826$$HP$CN$CN
239079383$23907938$3$F$20240204$20240802$20240528$20240809$EXP$$US-AstraZeneca-2024A087543$ASTRAZENECA$$77$YR$$F$Y$$$20240809$$HP$US$
239079422$23907942$2$F$$20240702$20240528$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202405015071$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240709$$CN$US$US
239079473$23907947$3$F$$20240923$20240528$20240930$EXP$$CA-HALEON-2176354$Haleon PLC$$50$YR$$F$Y$$$20240930$$HP$CA$CA
239079592$23907959$2$F$$20240703$20240528$20240709$EXP$$JP-009507513-2405JPN002287J$MERCK$$53$YR$$F$Y$$$20240709$$MD$JP$JP
239079652$23907965$2$F$$20240525$20240528$20240718$PER$$US-HALEON-2178388$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239079793$23907979$3$F$20240101$20240709$20240528$20240715$EXP$$CA-Orion Corporation ORION PHARMA-24_00029412$ORION$$65$YR$E$M$Y$80$KG$20240715$$MD$CA$
239079862$23907986$2$F$$20240717$20240528$20240726$PER$$NVSC2024US111617$NOVARTIS$$$$$$Y$$$20240727$$CN$US$US
239079893$23907989$3$F$20240321$20240701$20240528$20240709$EXP$$US-BAYER-2024A072799$BAYER$$40$YR$A$F$Y$$$20240709$$CN$US$US
239080064$23908006$4$F$$20240611$20240528$20240926$PER$$US-GSK-US2024AMR065312$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
239080084$23908008$4$F$20240520$20240809$20240528$20240816$EXP$$US-GSK-US2024AMR065814$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$US$US
239080132$23908013$2$F$$20240808$20240528$20240817$EXP$$IT-TEVA-VS-3198304$TEVA$$$$$M$Y$$$20240817$$CN$IT$IT
239080202$23908020$2$F$$20240706$20240528$20240708$EXP$$BR-PFIZER INC-PV202400067774$PFIZER$$$$$M$Y$$$20240708$$MD$BR$BR
239080232$23908023$2$F$20100506$20240704$20240528$20240712$EXP$$AU-PFIZER INC-2010SE44774$PFIZER$$48$YR$$M$Y$95$KG$20240712$$MD$AU$AU
239080256$23908025$6$F$20240101$20240626$20240528$20240701$EXP$$CA-PFIZER INC-202400175323$PFIZER$$64$YR$$M$Y$$$20240701$$CN$CA$CA
239080282$23908028$2$F$$20240527$20240528$20240717$PER$$US-HALEON-2178336$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239080503$23908050$3$F$$20240725$20240528$20240731$EXP$$JP-ASTELLAS-2024JP003467$ASTELLAS$$8$DEC$$M$Y$$$20240731$$MD$JP$JP
239080832$23908083$2$F$20231227$20240724$20240528$20240730$EXP$$IN-PFIZER INC-PV202400000669$PFIZER$$57$YR$$F$Y$$$20240730$$CN$IN$IN
239080942$23908094$2$F$$20240723$20240528$20240801$EXP$$US-SA-2024SA155478$SANOFI AVENTIS$$$$E$M$Y$$$20240801$$CN$US$US
239081093$23908109$3$F$20220420$20240924$20240528$20240927$EXP$$CA-TAKEDA-2024TUS052653$TAKEDA$$9$YR$$F$Y$$$20240927$$CN$CA$CA
239081252$23908125$2$F$20231220$20240620$20240528$20240705$EXP$$AU-IMP-2024000230$Harrow Health$$53$YR$A$M$Y$$$20240705$$CN$AU$AU
239081262$23908126$2$F$$20240701$20240528$20240701$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-030252$BOEHRINGER INGELHEIM$$82$YR$E$M$Y$$$20240701$$PH$DE$DE
239081532$23908153$2$F$$20240523$20240528$20240718$PER$$US-LUNDBECK-DKLU3077610$LUNDBECK$$$$$$Y$$$20240718$$CN$US$US
239081582$23908158$2$F$$20240613$20240528$20240708$PER$$US-AstraZeneca-2024A112515$ASTRAZENECA$$$$$M$Y$$$20240709$$CN$US$
239081882$23908188$2$F$20240406$20240913$20240528$20240916$EXP$FR-AFSSAPS-TO2024000783$FR-PFIZER INC-202400103320$PFIZER$$63$YR$$F$Y$66$KG$20240916$$PH$FR$FR
239081964$23908196$4$F$20240101$20240821$20240528$20240827$EXP$$US-PFIZER INC-202400178544$PFIZER$$50$YR$$M$Y$$$20240827$$CN$US$US
239082432$23908243$2$F$20231101$20240619$20240528$20240806$PER$$US-GALDERMA-US2024007692$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
239082793$23908279$3$F$20240412$20240729$20240528$20240822$EXP$IT-MINISAL02-984619$IT-009507513-2405ITA007872$MERCK$$74$YR$$M$Y$90$KG$20240822$$MD$IT$IT
239082812$23908281$2$F$$20240902$20240528$20240904$PER$$US-ALXN-202405USA001456US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
239082912$23908291$2$F$$20240909$20240528$20240916$PER$$NVSC2024US109821$NOVARTIS$$$$$$Y$$$20240916$$CN$US$US
239083183$23908318$3$F$20240513$20240701$20240528$20240705$EXP$IT-MINISAL02-986655$IT-ELI_LILLY_AND_COMPANY-IT202405013069$ELI LILLY AND CO$$49$YR$A$M$Y$88$KG$20240705$$CN$IT$IT
239083252$23908325$2$F$20240301$20240624$20240528$20240701$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404000333$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240701$$CN$JP$JP
239083314$23908331$4$F$20240515$20240805$20240528$20240813$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405009658$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240813$$CN$JP$JP
239083412$23908341$2$F$20230501$20240910$20240528$20240916$EXP$US-MLMSERVICE-20240513-PI059072-00190-1$US-RDY-SPO/USA/24/0007559$DR REDDYS$Li YI, Htet N. THE ROLLER COASTER LEVELS: A SUCCESSFUL TREATMENT OF MASSIVE LAMOTRIGINE OVERDOSE. Critical Care Medicine. 2024;52(1):S438. DOI: 10.1097/01.ccm.0001001892.20378.cd.$66$YR$E$M$Y$86$KG$20240916$$MD$US$US
239083624$23908362$4$F$$20240805$20240528$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081535$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240814$$CN$US$US
239083782$23908378$2$F$20240425$20240625$20240528$20240703$EXP$$DE-AUROBINDO-AUR-APL-2024-024403$AUROBINDO$$$$$M$Y$90$KG$20240703$$MD$DE$DE
239083902$23908390$2$F$20240501$20240808$20240528$20240813$PER$$US-BIOGEN-2024BI01266471$BIOGEN$$58$YR$$M$Y$$$20240813$$CN$US$US
239083973$23908397$3$F$$20240913$20240528$20240916$PER$$NVSC2024US111267$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
239084204$23908420$4$F$20240516$20240801$20240528$20240805$30DAY$$US-JNJFOC-20240547726$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240805$$PH$US$US
239084283$23908428$3$F$20230101$20240802$20240528$20240805$EXP$$NVSC2024US111150$NOVARTIS$$$$$F$Y$$$20240803$$CN$US$US
239084393$23908439$3$F$$20240902$20240528$20240903$EXP$$CA-SANDOZ INC.-SDZ2024CA052384$SANDOZ$$75$YR$$F$Y$$$20240903$$CN$CA$CA
239084425$23908442$5$F$20240510$20240704$20240528$20240709$EXP$$AU-AstraZeneca-2024A120588$ASTRAZENECA$$28783$DY$$F$Y$80$KG$20240709$$MD$AU$
239084552$23908455$2$F$$20240706$20240528$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04246$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239084813$23908481$3$F$$20240920$20240528$20240924$EXP$$CA-SANDOZ INC.-SDZ2024CA052100$SANDOZ$$50$YR$$F$Y$$$20240924$$HP$CA$CA
239085072$23908507$2$F$$20240626$20240528$20240702$PER$$US-INCYTE CORPORATION-2024IN005322$INCYTE$$$$$$Y$$$20240702$$CN$US$US
239085252$23908525$2$F$$20240819$20240528$20240820$PER$$US-BAYER-2024A077172$BAYER$$$$A$F$Y$$$20240820$$CN$US$US
239085393$23908539$3$F$20231115$20240712$20240528$20240718$EXP$$NVSC2023AR270881$NOVARTIS$$28$YR$$F$Y$$$20240718$$CN$AR$AR
239085522$23908552$2$F$$20240706$20240528$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04249$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239085873$23908587$3$F$$20240827$20240528$20240905$30DAY$$US-GSK-US2024063150$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
239086662$23908666$2$F$$20240711$20240528$20240812$EXP$$ZA-ROCHE-3560424$ROCHE$$$$$$Y$$$20240812$$MD$ZA$ZA
239087582$23908758$2$F$20240401$20240730$20240528$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002237$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240822$$CN$US$US
239088152$23908815$2$F$20240101$20240628$20240528$20240704$EXP$$ZA-ABBVIE-5776634$ABBVIE$$55$YR$$F$Y$$$20240704$$CN$ZA$ZA
239088556$23908855$6$F$$20240919$20240528$20240924$EXP$$US-GILEAD-2024-0673034$GILEAD$$$$A$F$Y$$$20240924$$CN$US$US
239088652$23908865$2$F$20240430$20240709$20240528$20240715$EXP$$JP-JNJFOC-20240577150$JOHNSON AND JOHNSON$$26$YR$A$M$Y$58.2$KG$20240715$$PH$JP$JP
239088873$23908887$3$F$20230523$20240807$20240528$20240809$PER$$US-AMGEN-USASP2024103581$AMGEN$$78$YR$E$F$Y$$$20240809$$CN$US$US
239088903$23908890$3$F$20240506$20240708$20240528$20240710$EXP$DE-DCGMA-24203384$NVSC2024DE111237$NOVARTIS$$45$YR$$F$Y$$$20240710$$MD$DE$DE
239088933$23908893$3$F$$20240706$20240528$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04262$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239089453$23908945$3$F$20231029$20240712$20240528$20240722$EXP$$ES-TEVA-VS-3201268$TEVA$$44$YR$$M$Y$74$KG$20240722$$MD$ES$ES
239089492$23908949$2$F$20240703$20240703$20240528$20240708$EXP$$CA-TAKEDA-2024TUS052718$TAKEDA$$35$YR$$M$Y$$$20240708$$CN$CA$CA
239089522$23908952$2$F$$20240526$20240528$20240718$PER$$US-HALEON-2178302$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239089594$23908959$4$F$20240502$20240729$20240528$20240805$EXP$$CA-TAKEDA-2024TUS052280$TAKEDA$$68$YR$$M$Y$$$20240804$$CN$CA$CA
239089624$23908962$4$F$20240201$20240924$20240528$20240927$EXP$$NVSC2024CA029335$NOVARTIS$$75$YR$$F$Y$65$KG$20240927$$CN$CA$CA
239089702$23908970$2$F$20240219$20240704$20240528$20240708$EXP$FR-AFSSAPS-AM2024000404$FR-AMGEN-FRASP2024099590$AMGEN$$57$YR$A$M$Y$69$KG$20240708$$PH$FR$FR
239089873$23908987$3$F$$20240725$20240528$20240808$EXP$$JP-UCBSA-2024026393$UCB$Nakada R, Terasawa Y, Sato T, Takatsu H, Kaito N, Iguchi Y.. A case of cryptogenic new-onset refractory status epilepticus (NORSE) in which cerebrospinal fluid IL-6 was elevated with increased seizure frequency early in the disease : a case report / A case of cryptogenic new-onset refractory status epilepticus (NORSE) with elevated CSF IL-6 and increased seizure frequency in the early stages of the disease. Clinical Neurology. 2023;63(12):843-6$25$YR$$M$Y$79.7$KG$20240808$$MD$JP$JP
239089932$23908993$2$F$$20240706$20240528$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04247$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239090073$23909007$3$F$$20240626$20240528$20240702$PER$$US-AMGEN-USASP2024104187$AMGEN$$$$A$M$Y$$$20240702$$MD$US$US
239090112$23909011$2$F$20240411$20240701$20240528$20240703$EXP$DE-DCGMA-24203385$NVSC2024DE110923$NOVARTIS$$25$YR$$M$Y$$$20240704$$MD$DE$DE
239090224$23909022$4$F$20240425$20240624$20240528$20240705$EXP$IT-MINISAL02-984331$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-04441$HIKMA$$50$YR$$F$Y$85$KG$20240705$$MD$IT$IT
239090233$23909023$3$F$$20240821$20240528$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04264$LUPIN$$$$$$Y$$$20240909$$PH$US$US
239090372$23909037$2$F$20240401$20240730$20240528$20240731$EXP$$DE-JNJFOC-20240561424$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240731$$MD$DE$DE
239090444$23909044$4$F$$20240706$20240528$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04253$LUPIN$$$$$$Y$$$20240725$$CN$US$US
239091272$23909127$2$F$$20240709$20240528$20240711$EXP$$GB-GSK-GB2024064791$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$PH$GB$GB
239091592$23909159$2$F$$20240726$20240528$20240801$EXP$$DE-MYLANLABS-2024M1046417$MYLAN$$19$DY$$M$Y$2.9$KG$20240801$$HP$DE$DE
239092013$23909201$3$F$20240518$20240712$20240528$20240717$EXP$$JP-BAYER-2024A076588$BAYER$$44$YR$A$F$Y$$$20240717$$MD$JP$JP
239092022$23909202$2$F$20240429$20240627$20240528$20240702$PER$$US-ABBVIE-5771284$ABBVIE$$59$YR$$F$Y$88$KG$20240702$$CN$US$US
239092232$23909223$2$F$$20240525$20240528$20240717$PER$$US-HALEON-2178154$Haleon PLC$$8$YR$$M$Y$$$20240717$$CN$US$US
239092472$23909247$2$F$20240513$20240712$20240528$20240714$PER$$NVSC2024US111369$NOVARTIS$$63$YR$$F$Y$$$20240714$$CN$US$US
239092722$23909272$2$F$$20240706$20240528$20240722$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04257$LUPIN$$$$$$Y$$$20240719$$CN$US$US
239092853$23909285$3$F$20200101$20240731$20240528$20240801$EXP$$US-UCBSA-2024024582$UCB$$42$YR$$F$Y$$$20240801$$CN$US$US
239093482$23909348$2$F$20240520$20240708$20240528$20240712$EXP$$US-OTSUKA-2024_014963$OTSUKA$$37$YR$$F$Y$$$20240712$$PH$US$US
239093592$23909359$2$F$20240101$20240903$20240528$20240914$EXP$$CA-SA-2024SA156058$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240914$$HP$CA$CA
239093722$23909372$2$F$$20240807$20240528$20240808$PER$$US-ALXN-A202308112$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
239093782$23909378$2$F$20240821$20240821$20240528$20240904$EXP$$US-SA-2024SA160003$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240904$$CN$US$US
239093842$23909384$2$F$20240501$20240704$20240528$20240709$EXP$$ZA-ELI_LILLY_AND_COMPANY-ZA202405015567$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240709$$HP$ZA$ZA
239093922$23909392$2$F$20240601$20240829$20240528$20240903$EXP$$BE-SA-2024SA158263$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240903$$HP$BE$BE
239094642$23909464$2$F$20231110$20240723$20240528$20240806$EXP$$US-Millicent Holdings Ltd.-MILL20240913$MILLICENT HOLDINGS$$61$YR$A$F$Y$$$20240806$$CN$US$US
239094912$23909491$2$F$20240301$20240731$20240528$20240802$EXP$$CA-TAKEDA-2024TUS050657$TAKEDA$$11$YR$$F$Y$$$20240802$$CN$CA$CA
239094992$23909499$2$F$$20240713$20240528$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04261$LUPIN$$$$$$Y$$$20240816$$CN$US$US
239095003$23909500$3$F$20240521$20240628$20240528$20240701$EXP$$GB-MYLANLABS-2024M1047915$MYLAN$$51$YR$$M$Y$$$20240701$$CN$GB$GB
239095024$23909502$4$F$$20240718$20240528$20240723$EXP$$NZ-MYLANLABS-2024M1047239$MYLAN$$$$$M$Y$$$20240723$$HP$NZ$NZ
239095292$23909529$2$F$20240501$20240821$20240528$20240910$PER$$CA-TOLMAR, INC.-24CA049028$TOLMAR$$80$YR$$M$Y$$$20240909$$CN$CA$CA
239095332$23909533$2$F$$20240724$20240528$20240821$PER$$CA-TOLMAR, INC.-24CA049045$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
239095442$23909544$2$F$20240503$20240726$20240528$20240821$PER$$CA-TOLMAR, INC.-24CA049078$TOLMAR$$87$YR$$M$Y$$$20240821$$CN$CA$CA
239096072$23909607$2$F$$20240706$20240528$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04248$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239096612$23909661$2$F$$20240527$20240528$20240718$PER$$US-HALEON-2178416$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239096642$23909664$2$F$$20240717$20240528$20240717$PER$$US-ALXN-202405USA001648US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$MD$US$US
239097594$23909759$4$F$20231101$20240605$20240528$20240705$EXP$$NVSC2024ES110773$NOVARTIS$$56$YR$$F$Y$$$20240705$$HP$ES$ES
239097833$23909783$3$F$20240401$20240624$20240528$20240703$PER$$US-Calliditas-2024CAL00793$CALLIDITAS THERAPEUTICS$$62$YR$A$F$Y$82$KG$20240703$$CN$US$US
239097842$23909784$2$F$$20240719$20240528$20240802$EXP$$JP-UCBSA-2024026100$UCB$$77$YR$$M$Y$$$20240802$$PH$JP$JP
239097852$23909785$2$F$$20240625$20240528$20240708$PER$$US-Calliditas-2024CAL00790$CALLIDITAS THERAPEUTICS$$37$YR$A$M$Y$69$KG$20240708$$CN$US$US
239097884$23909788$4$F$$20240909$20240528$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084820$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240912$$CN$US$US
239097932$23909793$2$F$$20240701$20240528$20240705$EXP$$PL-AMGEN-POLSP2024102416$AMGEN$Gasior T.; Zaborska B.; Stachowiak P. et al.. Echocardiographic Assessment of Left Ventricular Function in Three Oncologic Therapeutic Modalities in Women with Breast Cancer: The ONCO-ECHO Multicenter Study. Journal of Clinical Medicine. 2024;13 (9):1-13$$$$$Y$$$20240705$$HP$PL$PL
239097992$23909799$2$F$20240501$20240723$20240528$20240729$EXP$$US-VERTEX PHARMACEUTICALS-2024-008950$VERTEX$$38$YR$$M$Y$$$20240729$$CN$US$US
239098172$23909817$2$F$$20240715$20240528$20240722$EXP$$GB-MYLANLABS-2024M1048423$MYLAN$$$$$F$Y$$$20240722$$PH$GB$GB
239098204$23909820$4$F$$20240910$20240528$20240923$EXP$$CA-HALEON-2175675$Haleon PLC$$40$YR$$F$Y$$$20240921$$HP$CA$CA
239098212$23909821$2$F$20240101$20240805$20240528$20240813$EXP$$JP-GENMAB-2024-01353AA$GENMAB$$67$YR$$F$Y$$$20240813$$MD$JP$JP
239098423$23909842$3$F$$20240916$20240528$20240919$EXP$$CA-ORGANON-O2405CAN002337$ORGANON$Unknown. Unknown. Unknown$18$YR$$F$Y$$$20240919$$HP$CA$CA
239098632$23909863$2$F$$20240701$20240528$20240702$EXP$$AU-MYLANLABS-2023M1118906$MYLAN$$$$$M$Y$$$20240702$$HP$AU$AU
239098742$23909874$2$F$20240201$20240704$20240528$20240709$EXP$$NVSC2024AT111288$NOVARTIS$$30$YR$$M$Y$$$20240709$$MD$AT$AT
239098883$23909888$3$F$$20240703$20240528$20240709$PER$$NVSC2024US111612$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
239099128$23909912$8$F$20240101$20240913$20240528$20240913$30DAY$$CA-PFIZER INC-202400174809$PFIZER$$64$YR$$F$Y$$$20240913$$MD$CA$CA
239099463$23909946$3$F$20240801$20240820$20240528$20240823$EXP$$GB-SANDOZ INC.-SDZ2024GB052463$SANDOZ$$23$YR$$F$Y$$$20240823$$CN$GB$GB
239099483$23909948$3$F$20240501$20240709$20240528$20240717$EXP$$US-SANDOZ INC.-SDZ2024US052667$SANDOZ$$52$YR$$F$Y$$$20240717$$CN$US$US
239099492$23909949$2$F$20230101$20240818$20240528$20240823$30DAY$$MX-SANDOZ INC.-SDZ2023MX011418$SANDOZ$$$$$F$Y$$$20240823$$CN$MX$MX
239099592$23909959$2$F$20240422$20240822$20240528$20240827$EXP$$US-ABBVIE-5734992$ABBVIE$$78$YR$$M$Y$$$20240827$$CN$PR$PR
239099633$23909963$3$F$20240601$20240621$20240528$20240705$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-083904$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$74.84$KG$20240705$$CN$PR$PR
239099642$23909964$2$F$20240301$20240715$20240528$20240720$EXP$$NVSC2024CA061195$NOVARTIS$$40$YR$$F$Y$$$20240720$$MD$CA$CA
239099723$23909972$3$F$$20240815$20240528$20240821$EXP$$US-OTSUKA-2024_005127$OTSUKA$$$$$M$Y$$$20240821$$MD$US$US
239099742$23909974$2$F$$20240903$20240528$20240909$EXP$$CA-JNJFOC-20240565692$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240909$$HP$CA$CA
239099812$23909981$2$F$20231001$20240624$20240528$20240710$PER$$US-Calliditas-2024CAL00791$CALLIDITAS THERAPEUTICS$$23$YR$A$M$Y$118.5$KG$20240710$$CN$US$US
239099895$23909989$5$F$20240223$20240902$20240528$20240925$EXP$$CL-BIOMARINAP-CL-2024-158135$BIOMARIN$$$$$$Y$$$20240925$$CN$CL$CL
239099993$23909999$3$F$$20240916$20240528$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009900$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240923$$CN$US$US
239100033$23910003$3$F$$20240912$20240528$20240919$30DAY$$US-PFIZER INC-202400172940$PFIZER$$12$YR$$F$Y$$$20240919$$CN$US$US
239100103$23910010$3$F$20231022$20240702$20240528$20240708$EXP$$CA-GSK-CA2023146582$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$HP$CA$CA
239100332$23910033$2$F$$20240605$20240528$20240708$PER$$BE-TOLMAR, INC.-24BE049114$TOLMAR$$$$$$Y$$$20240708$$PH$BE$BE
239100472$23910047$2$F$$20240815$20240528$20240823$EXP$$US-Calliditas-2024CAL00792$CALLIDITAS THERAPEUTICS$$23$YR$A$M$Y$$$20240823$$CN$US$US
239100482$23910048$2$F$$20240717$20240528$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083150$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240719$$CN$US$US
239100554$23910055$4$F$20240712$20240807$20240528$20240816$EXP$$IN-VANTIVE-2024VAN017095$Vantive US Healthcare$$70$YR$$M$Y$$$20240816$$CN$IN$IN
239100754$23910075$4$F$20240515$20240829$20240528$20240906$PER$$US-PHARMING-PHAUS2024000399$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
239100792$23910079$2$F$$20240822$20240528$20240827$EXP$$GB-MYLANLABS-2024M1047775$MYLAN$$$$$M$Y$$$20240827$$CN$GB$GB
239100892$23910089$2$F$$20240702$20240528$20240708$EXP$$PL-MYLANLABS-2024M1047262$MYLAN$$25$YR$$M$Y$$$20240708$$MD$PL$PL
239100922$23910092$2$F$20240429$20240521$20240528$20240703$EXP$FR-AFSSAPS-AVCF2024000331$FR-TEVA-VS-3201352$TEVA$$41$YR$$F$Y$$$20240703$$HP$FR$FR
239100982$23910098$2$F$20240521$20240905$20240528$20240911$EXP$$JP-009507513-2405JPN002889J$MERCK$$8$DEC$$M$Y$$$20240911$$MD$JP$JP
239101092$23910109$2$F$20240101$20240819$20240528$20240821$PER$$US-PFIZER INC-PV202400068750$PFIZER$$58$YR$$F$Y$$$20240821$$HP$US$US
239101195$23910119$5$F$20230207$20240712$20240528$20240717$EXP$$JP-JNJFOC-20240570172$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240717$$MD$JP$JP
239101312$23910131$2$F$$20240527$20240528$20240724$PER$$US-HALEON-2178303$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
239101474$23910147$4$F$$20240924$20240528$20240926$PER$$NVSC2024US111858$NOVARTIS$$24$YR$$F$Y$$$20240926$$CN$US$US
239102122$23910212$2$F$$20240528$20240528$20240718$PER$$US-HALEON-2178399$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239102396$23910239$6$F$20240101$20240911$20240528$20240918$EXP$$CO-Eisai-EC-2024-166583$EISAI$$54$YR$A$F$Y$75$KG$20240918$$MD$CO$CO
239102622$23910262$2$F$20240521$20240826$20240528$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084249$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240826$$CN$US$US
239103152$23910315$2$F$20240519$20240712$20240528$20240712$PER$$US-ALXN-202405USA001416US$ALEXION PHARMACEUTICALS$$62$YR$$$Y$$$20240712$$CN$US$US
239103173$23910317$3$F$20240319$20240716$20240528$20240717$PER$$US-ALXN-202405USA001477US$ALEXION PHARMACEUTICALS$$54$YR$$F$Y$$$20240717$$CN$US$US
239103732$23910373$2$F$20240101$20240508$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00618$AVADEL CNS PHARMA$$$$$F$Y$$$20240820$$CN$US$US
239103742$23910374$2$F$20240101$20240501$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00634$AVADEL CNS PHARMA$$$$$F$Y$54.422$KG$20240822$$CN$US$US
239103752$23910375$2$F$20240420$20240507$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00645$AVADEL CNS PHARMA$$19$YR$$F$Y$$$20240822$$CN$US$US
239103762$23910376$2$F$20240330$20240502$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00697$AVADEL CNS PHARMA$$59$YR$$M$Y$$$20240822$$CN$US$US
239103772$23910377$2$F$20240101$20240506$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00707$AVADEL CNS PHARMA$$$$$M$Y$80.726$KG$20240822$$CN$US$US
239103782$23910378$2$F$20240401$20240501$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00702$AVADEL CNS PHARMA$$41$YR$$F$Y$$$20240822$$CN$US$US
239103792$23910379$2$F$20240421$20240501$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00700$AVADEL CNS PHARMA$$50$YR$$F$Y$97.506$KG$20240822$$CN$US$US
239103812$23910381$2$F$20240101$20240501$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00626$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239103822$23910382$2$F$20230101$20240507$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00238$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239103832$23910383$2$F$20240101$20240502$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00303$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$HP$US$US
239103842$23910384$2$F$20220101$20240501$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00237$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239103852$23910385$2$F$20240101$20240507$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00516$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239103862$23910386$2$F$20240101$20240503$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00438$AVADEL CNS PHARMA$$$$$M$Y$83.9$KG$20240822$$CN$US$US
239103872$23910387$2$F$20240201$20240507$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00388$AVADEL CNS PHARMA$$31$YR$$F$Y$$$20240822$$CN$US$US
239103882$23910388$2$F$20240101$20240503$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00485$AVADEL CNS PHARMA$$$$$F$Y$$$20240820$$CN$US$US
239103892$23910389$2$F$20240101$20240501$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00568$AVADEL CNS PHARMA$$$$$M$Y$$$20240815$$CN$US$US
239103902$23910390$2$F$20240101$20240503$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00576$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239103922$23910392$2$F$20240101$20240502$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00386$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239103932$23910393$2$F$20240101$20240502$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00546$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239103942$23910394$2$F$20240101$20240501$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00095$AVADEL CNS PHARMA$$$$$F$Y$78.005$KG$20240821$$CN$US$US
239103952$23910395$2$F$20240101$20240503$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00493$AVADEL CNS PHARMA$$$$$F$Y$63.991$KG$20240820$$CN$US$US
239103962$23910396$2$F$20240101$20240503$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00566$AVADEL CNS PHARMA$$$$$F$Y$$$20240819$$CN$US$US
239103972$23910397$2$F$20240101$20240501$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00572$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239103982$23910398$2$F$20240101$20240503$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00597$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239103992$23910399$2$F$20240410$20240507$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00603$AVADEL CNS PHARMA$$61$YR$$F$Y$$$20240822$$CN$US$US
239104042$23910404$2$F$20240101$20240501$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00376$AVADEL CNS PHARMA$$$$$F$Y$56.689$KG$20240822$$CN$US$US
239104052$23910405$2$F$20240101$20240506$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00504$AVADEL CNS PHARMA$$$$$F$Y$56.689$KG$20240822$$CN$US$US
239104062$23910406$2$F$20240401$20240502$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00582$AVADEL CNS PHARMA$$44$YR$$F$Y$$$20240822$$CN$US$US
239104072$23910407$2$F$20240101$20240506$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00605$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239104102$23910410$2$F$20240101$20240501$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00548$AVADEL CNS PHARMA$$$$$M$Y$104.26$KG$20240822$$CN$US$US
239104433$23910443$3$F$$20240918$20240528$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-068762$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240920$$CN$US$US
239104712$23910471$2$F$20240101$20240517$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00620$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239104722$23910472$2$F$20240401$20240524$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00713$AVADEL CNS PHARMA$$35$YR$$F$Y$$$20240820$$CN$US$US
239104732$23910473$2$F$20240301$20240516$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00458$AVADEL CNS PHARMA$$30$YR$$F$Y$$$20240822$$CN$US$US
239104752$23910475$2$F$20240101$20240522$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00589$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239104762$23910476$2$F$20240101$20240516$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00666$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239104772$23910477$2$F$20240101$20240515$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00708$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239104782$23910478$2$F$20240301$20240516$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00459$AVADEL CNS PHARMA$$25$YR$$F$Y$$$20240822$$CN$US$US
239104792$23910479$2$F$20240101$20240514$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00610$AVADEL CNS PHARMA$$$$$F$Y$55.782$KG$20240822$$CN$US$US
239104802$23910480$2$F$20240101$20240501$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00563$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239104812$23910481$2$F$20240101$20240508$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00571$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239104822$23910482$2$F$20240101$20240509$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00579$AVADEL CNS PHARMA$$$$$F$Y$$$20240815$$CN$US$US
239104832$23910483$2$F$20240101$20240509$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00581$AVADEL CNS PHARMA$$$$$F$Y$58.957$KG$20240822$$CN$US$US
239104842$23910484$2$F$20240101$20240513$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00190$AVADEL CNS PHARMA$$53$YR$$F$Y$$$20240822$$CN$US$US
239104852$23910485$2$F$20240101$20240514$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00657$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239104862$23910486$2$F$20240101$20240514$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00565$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239104872$23910487$2$F$$20240508$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00636$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$HP$US$US
239104882$23910488$2$F$20240401$20240513$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00662$AVADEL CNS PHARMA$$34$YR$$F$Y$53.469$KG$20240822$$CN$US$US
239104902$23910490$2$F$20240101$20240513$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00632$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239104912$23910491$2$F$20240101$20240513$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00621$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239104922$23910492$2$F$20240101$20240507$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00641$AVADEL CNS PHARMA$$$$$M$Y$82.585$KG$20240822$$CN$US$US
239104932$23910493$2$F$20240101$20240514$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00705$AVADEL CNS PHARMA$$$$$F$Y$95.692$KG$20240822$$CN$US$US
239104952$23910495$2$F$20240101$20240521$20240528$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00439$AVADEL CNS PHARMA$$$$$F$Y$62.585$KG$20240822$$CN$US$US
239104963$23910496$3$F$20240401$20240514$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00643$AVADEL CNS PHARMA$$68$YR$$F$Y$$$20240822$$CN$US$US
239104972$23910497$2$F$20240226$20240514$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00282$AVADEL CNS PHARMA$$47$YR$$F$Y$$$20240822$$CN$US$US
239104982$23910498$2$F$20230101$20240507$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00369$AVADEL CNS PHARMA$$$$$M$Y$86.576$KG$20240822$$CN$US$US
239104992$23910499$2$F$20240301$20240510$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00435$AVADEL CNS PHARMA$$25$YR$$F$Y$$$20240820$$CN$US$US
239105002$23910500$2$F$20240101$20240507$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00445$AVADEL CNS PHARMA$$$$$M$Y$72.562$KG$20240822$$CN$US$US
239105012$23910501$2$F$20240101$20240510$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00434$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239105022$23910502$2$F$20240101$20240510$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00443$AVADEL CNS PHARMA$$$$$F$Y$67.12$KG$20240822$$CN$US$US
239105032$23910503$2$F$20240101$20240506$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00228$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239105042$23910504$2$F$20240101$20240507$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00500$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239105052$23910505$2$F$20240101$20240508$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00525$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239105062$23910506$2$F$20240101$20240508$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00487$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$HP$US$US
239105112$23910511$2$F$20240101$20240515$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00450$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239105122$23910512$2$F$20240101$20240510$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00513$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239105134$23910513$4$F$$20240826$20240528$20240827$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-084387$BRISTOL MYERS SQUIBB$$78$YR$E$$Y$$$20240827$$CN$TW$TW
239105324$23910532$4$F$$20240904$20240528$20240905$PER$$US-PFIZER INC-202400179086$PFIZER$$40$YR$$F$Y$$$20240905$$CN$US$US
239105343$23910534$3$F$20240101$20240829$20240528$20240902$EXP$$US-PFIZER INC-202400175870$PFIZER$$65$YR$$F$Y$$$20240902$$MD$US$US
239105492$23910549$2$F$20240101$20240920$20240528$20240920$PER$$US-PFIZER INC-PV202400053287$PFIZER$$64$YR$$F$Y$$$20240920$$MD$US$US
239105513$23910551$3$F$20240525$20240708$20240528$20240710$PER$$US-PFIZER INC-202400178428$PFIZER$$67$YR$$F$Y$53.515$KG$20240710$$MD$US$US
239105534$23910553$4$F$$20240911$20240528$20240913$PER$$US-PFIZER INC-PV202400014796$PFIZER$$73$YR$$F$Y$$$20240913$$CN$US$US
239105882$23910588$2$F$$20240527$20240528$20240718$PER$$US-HALEON-2178366$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239105942$23910594$2$F$20240101$20240620$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00250$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239105982$23910598$2$F$20240101$20240709$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00255$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$HP$US$US
239106012$23910601$2$F$20240101$20240702$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00261$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239106082$23910608$2$F$20230101$20240524$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00225$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239106152$23910615$2$F$20240101$20240717$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00214$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239106182$23910618$2$F$20240211$20240723$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00217$AVADEL CNS PHARMA$$27$YR$$F$Y$61.224$KG$20240822$$CN$US$US
239106252$23910625$2$F$20240101$20240614$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00229$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239106302$23910630$2$F$20240101$20240708$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00240$AVADEL CNS PHARMA$$$$$M$Y$83.9$KG$20240822$$CN$US$US
239106353$23910635$3$F$20240101$20240809$20240528$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00211$AVADEL CNS PHARMA$$$$$F$Y$97.098$KG$20240822$$CN$US$US
239106392$23910639$2$F$20240101$20240718$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00202$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239106522$23910652$2$F$$20240726$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00196$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239106532$23910653$2$F$20240201$20240521$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00197$AVADEL CNS PHARMA$$45$YR$$F$Y$$$20240822$$CN$US$US
239106542$23910654$2$F$20231201$20240712$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00199$AVADEL CNS PHARMA$$32$YR$$M$Y$$$20240822$$CN$US$US
239106572$23910657$2$F$20240101$20240730$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00180$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239106592$23910659$2$F$$20240628$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00182$AVADEL CNS PHARMA$$$$$F$Y$54.376$KG$20240822$$CN$US$US
239106622$23910662$2$F$20240101$20240717$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00191$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239106732$23910673$2$F$20240101$20240626$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00159$AVADEL CNS PHARMA$$28$YR$$M$Y$$$20240822$$CN$US$US
239107012$23910701$2$F$20240101$20240606$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00184$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239107062$23910706$2$F$20240601$20240905$20240528$20240911$EXP$$US-Calliditas-2024CAL00795$CALLIDITAS THERAPEUTICS$$70$YR$E$F$Y$67.13$KG$20240911$$CN$US$US
239107073$23910707$3$F$20240515$20240801$20240528$20240814$PER$$US-Calliditas-2024CAL00794$CALLIDITAS THERAPEUTICS$$26$YR$A$F$Y$$$20240814$$CN$US$US
239107242$23910724$2$F$20240101$20240618$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00267$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239107332$23910733$2$F$20240101$20240621$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00277$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239107402$23910740$2$F$20240101$20240628$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00287$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239107432$23910743$2$F$20240101$20240607$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00299$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239107482$23910748$2$F$20240101$20240717$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00306$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239107492$23910749$2$F$20231021$20240513$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00350$AVADEL CNS PHARMA$$19$YR$$F$Y$$$20240819$$CN$US$US
239107642$23910764$2$F$20240101$20240528$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00359$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239107672$23910767$2$F$20240101$20240628$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00366$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239107682$23910768$2$F$20240101$20240613$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00367$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239107752$23910775$2$F$20240101$20240709$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00370$AVADEL CNS PHARMA$$$$$F$Y$61.406$KG$20240822$$CN$US$US
239107772$23910777$2$F$20240101$20240628$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00365$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239107782$23910778$2$F$20240101$20240705$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00348$AVADEL CNS PHARMA$$$$$F$Y$102.04$KG$20240822$$CN$US$US
239107842$23910784$2$F$20240101$20240605$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00381$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239107852$23910785$2$F$20240101$20240730$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00390$AVADEL CNS PHARMA$$$$$F$Y$62.132$KG$20240822$$CN$US$US
239107882$23910788$2$F$20240101$20240710$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00397$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239107972$23910797$2$F$20240101$20240621$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00406$AVADEL CNS PHARMA$$$$$F$Y$$$20240819$$CN$US$US
239108052$23910805$2$F$20240101$20240611$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00391$AVADEL CNS PHARMA$$$$$F$Y$96.145$KG$20240822$$CN$US$US
239108072$23910807$2$F$20240101$20240722$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00449$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239108102$23910810$2$F$20240101$20240614$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00404$AVADEL CNS PHARMA$$$$$F$Y$92.063$KG$20240822$$CN$US$US
239108122$23910812$2$F$20240101$20240624$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00455$AVADEL CNS PHARMA$$$$$F$Y$86.168$KG$20240822$$CN$US$US
239108142$23910814$2$F$20240101$20240729$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00454$AVADEL CNS PHARMA$$$$$F$Y$$$20240815$$CN$US$US
239108182$23910818$2$F$20240101$20240626$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00465$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239108222$23910822$2$F$20240101$20240621$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00412$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239108232$23910823$2$F$20240101$20240606$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00387$AVADEL CNS PHARMA$$$$$M$Y$117.69$KG$20240822$$CN$US$US
239108272$23910827$2$F$20240101$20240625$20240528$20240710$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00417$AVADEL CNS PHARMA$$$$$M$Y$$$20240710$$CN$US$US
239108323$23910832$3$F$20240715$20240805$20240528$20240820$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00415$AVADEL CNS PHARMA$$22$YR$$F$Y$49.887$KG$20240820$$CN$US$US
239108332$23910833$2$F$20240101$20240604$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00424$AVADEL CNS PHARMA$$$$$M$Y$179.96$KG$20240822$$CN$US$US
239108362$23910836$2$F$20240101$20240710$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00428$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239108382$23910838$2$F$20240101$20240523$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00427$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239108462$23910846$2$F$20240101$20240726$20240528$20240809$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00512$AVADEL CNS PHARMA$$$$$M$Y$$$20240809$$CN$US$US
239108492$23910849$2$F$20240101$20240603$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00518$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239108532$23910853$2$F$20240101$20240530$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00489$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239108592$23910859$2$F$20240101$20240530$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00470$AVADEL CNS PHARMA$$$$$F$Y$$$20240821$$HP$US$US
239108642$23910864$2$F$20240101$20240621$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00515$AVADEL CNS PHARMA$$$$$F$Y$63.492$KG$20240822$$CN$US$US
239108732$23910873$2$F$20240101$20240715$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00484$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239108842$23910884$2$F$20240101$20240705$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00539$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$MD$US$US
239108922$23910892$2$F$20240101$20240719$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00558$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239108932$23910893$2$F$20240101$20240628$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00538$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239108942$23910894$2$F$20240101$20240608$20240528$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00549$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239108962$23910896$2$F$20240101$20240531$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00562$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239109072$23910907$2$F$20240101$20240701$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00478$AVADEL CNS PHARMA$$$$$M$Y$62.132$KG$20240822$$CN$US$US
239109112$23910911$2$F$$20240613$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00524$AVADEL CNS PHARMA$$$$$F$Y$$$20240819$$HP$US$US
239109163$23910916$3$F$20240522$20240626$20240528$20240712$30DAY$$US-JNJFOC-20240569003$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240712$$CN$US$US
239109172$23910917$2$F$$20240621$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00479$AVADEL CNS PHARMA$$$$$F$Y$63.492$KG$20240822$$CN$US$US
239109192$23910919$2$F$20240101$20240529$20240528$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00550$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239109212$23910921$2$F$20240101$20240530$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00559$AVADEL CNS PHARMA$$$$$M$Y$79.365$KG$20240820$$CN$US$US
239109394$23910939$4$F$20240514$20240716$20240528$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-074929$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240719$$PH$JP$JP
239109502$23910950$2$F$20240401$20240611$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00650$AVADEL CNS PHARMA$$64$YR$$M$Y$83.9$KG$20240822$$CN$US$US
239109534$23910953$4$F$20240101$20240911$20240528$20240926$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00656$AVADEL CNS PHARMA$$$$$F$Y$$$20240926$$CN$US$US
239109563$23910956$3$F$20240101$20240830$20240528$20240912$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00633$AVADEL CNS PHARMA$$$$$M$Y$$$20240912$$CN$US$US
239109582$23910958$2$F$20240101$20240724$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00604$AVADEL CNS PHARMA$$$$$F$Y$$$20240819$$CN$US$US
239109622$23910962$2$F$20240101$20240725$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00617$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239109642$23910964$2$F$20240101$20240724$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00627$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239109652$23910965$2$F$20240101$20240530$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00613$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239109702$23910970$2$F$20240401$20240529$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00586$AVADEL CNS PHARMA$$44$YR$$F$Y$$$20240822$$CN$US$US
239109762$23910976$2$F$20240101$20240607$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00640$AVADEL CNS PHARMA$$$$$M$Y$$$20240815$$CN$US$US
239109782$23910978$2$F$20240101$20240725$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00659$AVADEL CNS PHARMA$$$$$F$Y$$$20240821$$CN$US$US
239109812$23910981$2$F$20240101$20240712$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00623$AVADEL CNS PHARMA$$$$$F$Y$89.796$KG$20240822$$CN$US$US
239109864$23910986$4$F$20240420$20240723$20240528$20240729$PER$$US-ALXN-202405USA001489US$ALEXION PHARMACEUTICALS$$77$YR$$F$Y$$$20240730$$CN$US$US
239109992$23910999$2$F$20240327$20240529$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00687$AVADEL CNS PHARMA$$47$YR$$F$Y$53.515$KG$20240822$$CN$US$US
239110032$23911003$2$F$20240401$20240615$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00661$AVADEL CNS PHARMA$$31$YR$$F$Y$91.565$KG$20240822$$CN$US$US
239110062$23911006$2$F$20240101$20240912$20240528$20240926$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00667$AVADEL CNS PHARMA$$$$$F$Y$113.38$KG$20240926$$CN$US$US
239110122$23911012$2$F$20240101$20240607$20240528$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00712$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
239110275$23911027$5$F$20220724$20240919$20240528$20240924$EXP$$IT-JNJFOC-20240550106$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240924$$MD$IT$IT
239110405$23911040$5$F$20230724$20240828$20240528$20240902$EXP$$CA-PFIZER INC-202300215322$PFIZER$$43$YR$$F$Y$$$20240902$$MD$CA$CA
239110412$23911041$2$F$$20240730$20240528$20240801$EXP$$IT-PFIZER INC-202300255029$PFIZER$$71$YR$$M$Y$70$KG$20240801$$MD$IT$IT
239110442$23911044$2$F$20230201$20240628$20240528$20240701$EXP$$DE-PFIZER INC-202400178973$PFIZER$$61$YR$$F$Y$57$KG$20240701$$MD$DE$DE
239110492$23911049$2$F$$20240722$20240528$20240726$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-10480$IPSEN$$75$YR$E$F$Y$$$20240726$$MD$JP$JP
239110543$23911054$3$F$$20240903$20240528$20240916$PER$$US-Calliditas-2024CAL00797$CALLIDITAS THERAPEUTICS$$44$YR$A$F$Y$$$20240916$$CN$US$US
239110665$23911066$5$F$$20240903$20240528$20240908$30DAY$$US-SANDOZ INC.-SDZ2024US051848$SANDOZ$$$$$F$Y$$$20240908$$CN$US$US
239110802$23911080$2$F$20240514$20240527$20240528$20240918$EXP$FR-AFSSAPS-PV2024000451$FR-BAUSCH-BL-2024-008334$BAUSCH AND LOMB$$22$YR$$F$Y$83$KG$20240918$$MD$FR$FR
239110942$23911094$2$F$$20240708$20240528$20240711$PER$$US-BAUSCH-BL-2024-007936$BAUSCH AND LOMB$$$$$M$Y$$$20240711$$CN$US$US
239111033$23911103$3$F$20240401$20240729$20240528$20240802$EXP$$US-PFIZER INC-202400178527$PFIZER$$76$YR$$M$Y$146.96$KG$20240802$$CN$US$US
239111122$23911112$2$F$$20240718$20240528$20240718$PER$$US-ALXN-202405USA001385US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239111212$23911121$2$F$20240501$20240718$20240528$20240722$PER$$US-PFIZER INC-PV202400069120$PFIZER$$62$YR$$F$Y$$$20240722$$HP$US$US
239111223$23911122$3$F$$20240828$20240528$20240830$PER$$US-PFIZER INC-202400179402$PFIZER$$61$YR$$F$Y$$$20240830$$MD$US$US
239111353$23911135$3$F$20240131$20240717$20240528$20240723$EXP$$GB-MYLANLABS-2024M1010703$MYLAN$$50$YR$$F$Y$$$20240723$$MD$GB$GB
239111743$23911174$3$F$20240717$20240717$20240528$20240723$EXP$$CA-TAKEDA-2024TUS051818$TAKEDA$$75$YR$$F$Y$$$20240723$$CN$CA$CA
239111793$23911179$3$F$20240516$20240726$20240528$20240801$EXP$$CA-PFIZER INC-202400175880$PFIZER$$64$YR$$F$Y$71$KG$20240801$$HP$CA$CA
239111814$23911181$4$F$20240514$20240803$20240528$20240805$EXP$$CA-PFIZER INC-PV202400069207$PFIZER$$63$YR$$F$Y$$$20240805$$HP$CA$CA
239111872$23911187$2$F$20230904$20240715$20240528$20240718$EXP$FR-AFSSAPS-LL2024000904$FR-009507513-2405FRA006927$MERCK$$40$YR$$F$Y$69$KG$20240718$$MD$FR$FR
239111972$23911197$2$F$$20240529$20240528$20240827$EXP$$AU-TEVA-VS-3201104$TEVA$$75$YR$$M$Y$$$20240827$$HP$AU$AU
239111984$23911198$4$F$20240505$20240708$20240528$20240710$EXP$$CN-AMGEN-CHNNI2024103346$AMGEN$$68$YR$E$M$Y$56$KG$20240710$$MD$CN$CN
239112103$23911210$3$F$20231223$20240823$20240528$20240827$EXP$$DE-TAKEDA-2024TUS052334$TAKEDA$$57$YR$$M$Y$78$KG$20240827$$HP$DE$DE
239112133$23911213$3$F$20240101$20240805$20240528$20240809$EXP$$US-ABBVIE-5773385$ABBVIE$$64$YR$$F$Y$92.986$KG$20240809$$CN$PR$PR
239112372$23911237$2$F$20240410$20240710$20240528$20240716$EXP$FR-AFSSAPS-BX2024001015$FR-MYLANLABS-2024M1046464$MYLAN$$39$YR$$F$Y$$$20240716$$PH$FR$FR
239112495$23911249$5$F$20240501$20240826$20240528$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-084477$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240827$$MD$JP$JP
239112712$23911271$2$F$$20240712$20240528$20240720$EXP$$AE-TAKEDA-2024TUS050493$TAKEDA$$$$$$Y$$$20240720$$CN$AE$AE
239113053$23911305$3$F$20240519$20240730$20240528$20240802$PER$$US-AMGEN-USASP2024101998$AMGEN$$66$YR$E$M$Y$$$20240802$$CN$US$US
239113072$23911307$2$F$$20240709$20240528$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-077585$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240716$$CN$US$US
239113092$23911309$2$F$$20240816$20240528$20240819$PER$$NVSC2024US112269$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
239113234$23911323$4$F$20190101$20240712$20240528$20240715$PER$$US-PFIZER INC-PV202400069139$PFIZER$$70$YR$$M$Y$$$20240715$$CN$US$US
239113312$23911331$2$F$$20240716$20240528$20240717$EXP$$US-ALXN-202405USA001446US$ALEXION PHARMACEUTICALS$$$$$F$Y$40.816$KG$20240717$$CN$US$US
239113412$23911341$2$F$$20240906$20240528$20240916$PER$$NVSC2024US111189$NOVARTIS$$$$$$Y$$$20240916$$CN$US$US
239113492$23911349$2$F$20240513$20240830$20240528$20240904$EXP$$GB-MYLANLABS-2024M1044553$MYLAN$$$$$M$Y$$$20240904$$CN$GB$GB
239113662$23911366$2$F$$20240710$20240528$20240717$EXP$$US-TAKEDA-2024TUS000631$TAKEDA$$$$$F$Y$$$20240717$$CN$US$US
239113694$23911369$4$F$20240101$20240819$20240528$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084819$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240821$$CN$US$US
239113742$23911374$2$F$20231201$20240702$20240528$20240702$PER$$US-BAYER-2024A073453$BAYER$$57$YR$A$F$Y$88$KG$20240702$$CN$US$US
239114112$23911411$2$F$20240429$20240701$20240528$20240702$EXP$$DE-SANDOZ INC.-SDZ2024DE052574$SANDOZ$$61$YR$$F$Y$57$KG$20240702$$MD$DE$DE
239114363$23911436$3$F$20240101$20240821$20240528$20240905$PER$$US-SA-2024SA158328$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240905$$MD$US$US
239114403$23911440$3$F$$20240828$20240528$20240911$PER$$US-SA-2024SA155865$SANOFI AVENTIS$$$$A$F$Y$75$KG$20240911$$MD$US$US
239114432$23911443$2$F$$20240805$20240528$20240813$PER$$US-SA-2024SA156095$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
239114452$23911445$2$F$20231001$20240905$20240528$20240914$PER$$US-SA-2024SA155751$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240914$$MD$US$US
239114542$23911454$2$F$20240501$20240718$20240528$20240728$PER$$US-SA-2024SA154349$SANOFI AVENTIS$$83$YR$E$M$Y$72.57$KG$20240728$$MD$US$US
239114725$23911472$5$F$20231201$20240701$20240528$20240710$PER$$US-SA-2024SA155272$SANOFI AVENTIS$$32$YR$A$M$Y$123.37$KG$20240710$$MD$US$US
239114743$23911474$3$F$$20240830$20240528$20240909$PER$$US-SA-2024SA152941$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240909$$MD$US$US
239115123$23911512$3$F$20240101$20240917$20240528$20240919$PER$$US-BIOMARINAP-US-2024-157970$BIOMARIN$$$$$$Y$$$20240919$$CN$US$US
239115494$23911549$4$F$$20240730$20240528$20240807$PER$$US-SA-2024SA110873$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240807$$MD$US$US
239115532$23911553$2$F$20240101$20240829$20240528$20240923$PER$$US-SA-2024SA156583$SANOFI AVENTIS$$27$YR$A$F$Y$72$KG$20240923$$MD$US$US
239115542$23911554$2$F$20240514$20240521$20240528$20240712$PER$$US-SA-2024SA156405$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240712$$CN$US$US
239115662$23911566$2$F$20240501$20240807$20240528$20240816$PER$$US-SA-2024SA109586$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240816$$MD$US$US
239115672$23911567$2$F$20240101$20240812$20240528$20240820$PER$$US-SA-2024SA158961$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240820$$MD$US$US
239115852$23911585$2$F$$20240702$20240528$20240710$PER$$US-SA-2024SA156353$SANOFI AVENTIS$$$$C$M$Y$$$20240710$$MD$US$US
239115883$23911588$3$F$20240101$20240917$20240528$20240925$PER$$US-SA-2024SA158694$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240925$$MD$US$US
239116132$23911613$2$F$$20240625$20240528$20240703$PER$$US-SA-2024SA156892$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240704$$MD$US$US
239116192$23911619$2$F$$20240705$20240528$20240717$PER$$US-SA-2024SA155839$SANOFI AVENTIS$$$$A$F$Y$58.96$KG$20240717$$MD$US$US
239116262$23911626$2$F$20240101$20240731$20240528$20240813$PER$$US-SA-2024SA156310$SANOFI AVENTIS$$13$YR$T$F$Y$72.57$KG$20240814$$MD$US$US
239116282$23911628$2$F$20240101$20240719$20240528$20240730$PER$$US-SA-2024SA155901$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240730$$MD$US$US
239116302$23911630$2$F$20240502$20240716$20240528$20240723$PER$$US-SA-2024SA157540$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240723$$MD$US$US
239116342$23911634$2$F$$20240827$20240528$20240924$PER$$US-SA-2024SA156605$SANOFI AVENTIS$$$$E$F$Y$$$20240924$$MD$US$US
239116402$23911640$2$F$20240101$20240904$20240528$20240917$PER$$US-SA-2024SA154990$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240918$$MD$US$US
239116464$23911646$4$F$20240101$20240703$20240528$20240717$PER$$US-SA-2024SA157313$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240717$$MD$US$US
239116522$23911652$2$F$20240101$20240823$20240528$20240905$PER$$US-SA-2024SA154806$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240905$$MD$US$US
239116582$23911658$2$F$20240301$20240912$20240528$20240920$PER$$US-SA-2024SA159102$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240920$$MD$US$US
239116672$23911667$2$F$$20240724$20240528$20240802$PER$$US-SA-2024SA158519$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240802$$MD$US$US
239116722$23911672$2$F$20240101$20240910$20240528$20240917$PER$$US-SA-2024SA156904$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240918$$MD$US$US
239116752$23911675$2$F$20240101$20240721$20240528$20240731$PER$$US-SA-2024SA155719$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240731$$MD$US$US
239116772$23911677$2$F$$20240729$20240528$20240807$PER$$US-SA-2024SA155827$SANOFI AVENTIS$$$$A$F$Y$58.9$KG$20240807$$MD$US$US
239116883$23911688$3$F$20240901$20240906$20240528$20240920$PER$$US-SA-2024SA155615$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240920$$MD$US$US
239117032$23911703$2$F$20240101$20240828$20240528$20240910$PER$$US-SA-2024SA155876$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240910$$MD$US$US
239117042$23911704$2$F$20240101$20240805$20240528$20240813$PER$$US-SA-2024SA156910$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240814$$MD$US$US
239117062$23911706$2$F$$20240822$20240528$20240905$PER$$US-SA-2024SA158979$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240905$$MD$US$US
239117072$23911707$2$F$$20240717$20240528$20240725$PER$$US-SA-2024SA157526$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240725$$MD$US$US
239117113$23911711$3$F$$20240826$20240528$20240919$PER$$US-SA-2024SA158333$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240919$$MD$US$US
239117122$23911712$2$F$20240101$20240717$20240528$20240726$PER$$US-SA-2024SA157997$SANOFI AVENTIS$$$$T$M$Y$74.5$KG$20240726$$MD$US$US
239117132$23911713$2$F$$20240717$20240528$20240725$PER$$US-SA-2024SA155753$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240725$$MD$US$US
239117292$23911729$2$F$$20240909$20240528$20240923$PER$$US-SA-2024SA159631$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240923$$CN$US$US
239117364$23911736$4$F$20240101$20240816$20240528$20240829$PER$$US-SA-2024SA158792$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240829$$MD$US$US
239117433$23911743$3$F$20210101$20240812$20240528$20240817$PER$$US-SA-2024SA158846$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240817$$HP$US$US
239117442$23911744$2$F$$20240825$20240528$20240903$PER$$US-SA-2024SA159389$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240903$$MD$US$US
239117705$23911770$5$F$$20240906$20240528$20240911$PER$$NVSC2024US111461$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
239117763$23911776$3$F$20191222$20240722$20240528$20240727$EXP$$US-TAKEDA-US201944893$TAKEDA$$70$YR$$F$Y$$$20240727$$MD$US$US
239117793$23911779$3$F$20240501$20240821$20240528$20240827$EXP$$US-BAYER-2024A074598$BAYER$$37$YR$A$M$Y$$$20240827$$CN$US$US
239117803$23911780$3$F$$20240913$20240528$20240918$30DAY$$CO-PFIZER INC-202400174838$PFIZER$$$$$F$Y$$$20240918$$CN$CO$CO
239117813$23911781$3$F$20240418$20240919$20240528$20240925$EXP$$US-MYLANLABS-2024M1047362$MYLAN$$71$YR$$M$Y$152.7$KG$20240925$$HP$US$US
239117912$23911791$2$F$$20240903$20240528$20240910$EXP$$CA-JNJFOC-20240561659$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240910$$HP$CA$CA
239118152$23911815$2$F$20240522$20240806$20240528$20240814$PER$$US-SA-2024SA159045$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240814$$MD$US$US
239118182$23911818$2$F$$20240822$20240528$20240828$PER$$US-ALXN-202405USA001386US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
239118222$23911822$2$F$$20240628$20240528$20240702$EXP$$JP-OTSUKA-2024_014620$OTSUKA$$$$$$Y$$$20240702$$PH$JP$JP
239118262$23911826$2$F$$20240826$20240528$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084056$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240826$$CN$US$US
239118272$23911827$2$F$20240406$20240725$20240528$20240802$EXP$$US-BAYER-2024A072666$BAYER$$67$YR$E$M$Y$$$20240802$$CN$US$US
239118572$23911857$2$F$20240506$20240716$20240528$20240717$PER$$US-ALXN-202405USA001484US$ALEXION PHARMACEUTICALS$$72$YR$$M$Y$58.957$KG$20240717$$CN$US$US
239118742$23911874$2$F$$20240624$20240528$20240701$EXP$$CA-DSJP-DSJ-2024-123238$DAIICHI$$$$$F$Y$$$20240701$$PH$CA$CA
239118763$23911876$3$F$20240101$20240604$20240528$20240613$PER$$US-SA-2024SA156444$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240613$$MD$US$US
239119782$23911978$2$F$20240501$20240731$20240528$20240805$EXP$$US-PFIZER INC-PV202400069255$PFIZER$$69$YR$$M$Y$96.145$KG$20240805$$CN$US$US
239120283$23912028$3$F$20120101$20240715$20240528$20240718$EXP$FR-AFSSAPS-PA2024001133$NVSC2024FR111291$NOVARTIS$$49$YR$$F$Y$$$20240718$$MD$FR$FR
239120522$23912052$2$F$$20240626$20240528$20240703$PER$$US-INCYTE CORPORATION-2024IN005460$INCYTE$$$$$$Y$$$20240703$$CN$US$US
239120824$23912082$4$F$20240518$20240909$20240528$20240924$PER$$US-SA-2024SA156624$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240924$$MD$US$US
239121222$23912122$2$F$$20240911$20240528$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA052191$SANDOZ$$$$$F$Y$71.8$KG$20240917$$MD$CA$CA
239121272$23912127$2$F$20230810$20240723$20240528$20240725$EXP$FR-AFSSAPS-LM2024000282$FR-SANDOZ INC.-SDZ2024FR052432$SANDOZ$$$$$F$Y$2$KG$20240725$$MD$FR$FR
239121954$23912195$4$F$20240516$20240906$20240528$20240906$PER$$US-ALXN-202405USA001379US$ALEXION PHARMACEUTICALS$$12$YR$$F$Y$$$20240906$$CN$US$US
239121972$23912197$2$F$$20240801$20240528$20240806$EXP$$US-JNJFOC-20240559846$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$CN$US$US
239121992$23912199$2$F$$20240909$20240528$20240917$EXP$$US-MYLANLABS-2024M1047576$MYLAN$$$$$F$Y$$$20240917$$MD$US$US
239122222$23912222$2$F$$20240626$20240528$20240701$EXP$$US-BAUSCHBL-2024BNL027687$BAUSCH AND LOMB$$81$YR$$F$Y$$$20240701$$CN$US$US
239122494$23912249$4$F$20240425$20240826$20240528$20240830$EXP$$JP-AstraZeneca-2024A121044$ASTRAZENECA$$83$YR$$M$Y$45$KG$20240830$$MD$JP$
239122543$23912254$3$F$20230101$20240701$20240528$20240702$EXP$$TR-BIOMARINAP-TR-2024-158134$BIOMARIN$$$$$$Y$$$20240702$$CN$TR$TR
239122612$23912261$2$F$$20240827$20240528$20240904$PER$$US-AstraZeneca-2024A114770$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
239122745$23912274$5$F$20240101$20240724$20240528$20240805$EXP$$CA-DSJP-DSJ-2024-114657$DAIICHI$$$$$F$Y$$$20240805$$CN$CA$CA
239122867$23912286$7$F$20240503$20240619$20240528$20240704$EXP$$CA-HLS-202401351$HLS THERAPEUTICS$$34$YR$A$M$Y$$$20240704$$PH$CA$CA
239123052$23912305$2$F$20230726$20240627$20240528$20240701$EXP$$JP-AstraZeneca-2024A122813$ASTRAZENECA$$81$YR$$M$Y$60$KG$20240701$$MD$JP$
239123263$23912326$3$F$20240520$20240812$20240528$20240819$PER$$US-ALXN-202405USA001462US$ALEXION PHARMACEUTICALS$$67$YR$$M$Y$$$20240819$$CN$US$US
239123642$23912364$2$F$20230801$20240813$20240528$20240909$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000327$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
239123665$23912366$5$F$20240101$20240911$20240528$20240924$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000026$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
239123703$23912370$3$F$$20240724$20240528$20240816$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000428$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
239123932$23912393$2$F$20240515$20240725$20240528$20240726$EXP$$IN-ROCHE-3557196$ROCHE$$75$YR$E$M$Y$55.1$KG$20240726$$CN$IN$IN
239123962$23912396$2$F$20240305$20240717$20240528$20240726$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI02267$NEUROCRINE BIOSCIENCES$$63$YR$$F$Y$$$20240726$$HP$US$US
239124014$23912401$4$F$20240227$20240621$20240528$20240705$EXP$$CA-HLS-202400860$HLS THERAPEUTICS$$60$YR$A$M$Y$$$20240705$$CN$CA$CA
239124262$23912426$2$F$20240302$20240628$20240528$20240705$EXP$$FR-JAZZ PHARMACEUTICALS-2024-FR-003660$JAZZ$$$$$$Y$$$20240705$$MD$FR$FR
239124273$23912427$3$F$$20240716$20240528$20240717$PER$$US-ALXN-202405USA001532US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
239124353$23912435$3$F$20240401$20240920$20240528$20240927$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008179$JAZZ$$46$YR$$F$Y$113.33$KG$20240927$$CN$US$US
239124362$23912436$2$F$$20240823$20240528$20240902$PER$$US-PHARMING-PHAUS2024000407$PHARMING GROUP$$$$$$Y$$$20240902$$CN$US$US
239124383$23912438$3$F$$20240906$20240528$20240913$PER$$US-PHARMING-PHAUS2024000408$PHARMING GROUP$$$$$$Y$$$20240913$$CN$US$US
239124513$23912451$3$F$20190101$20240729$20240528$20240802$EXP$$US-ABBVIE-5715855$ABBVIE$$$$$F$Y$60$KG$20240802$$CN$US$US
239124713$23912471$3$F$20240511$20240909$20240528$20240920$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202405010093$ELI LILLY AND CO$$79$YR$E$F$Y$58.8$KG$20240920$$CN$DE$DE
239124762$23912476$2$F$20240101$20240808$20240528$20240814$EXP$$US-ABBVIE-5773203$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
239124772$23912477$2$F$20190101$20240724$20240528$20240729$EXP$$CA-ABBVIE-5774110$ABBVIE$$$$E$F$Y$98$KG$20240729$$CN$CA$CA
239124853$23912485$3$F$$20240909$20240528$20240918$EXP$$JP-009507513-2405JPN002277J$MERCK$$74$YR$$F$Y$$$20240918$$MD$JP$JP
239125054$23912505$4$F$$20240730$20240528$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081399$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240801$$CN$US$US
239125222$23912522$2$F$$20240614$20240528$20240702$30DAY$$US-JNJFOC-20240544441$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$US$US
239125282$23912528$2$F$20230101$20240718$20240528$20240725$PER$$US-ABBVIE-5772816$ABBVIE$$$$$F$Y$89$KG$20240725$$CN$US$US
239125312$23912531$2$F$$20240712$20240528$20240717$EXP$$NVSJ2024JP006279$NOVARTIS$$$$A$M$Y$$$20240717$$MD$JP$JP
239125392$23912539$2$F$$20240712$20240528$20240712$PER$$NVSC2024US112328$NOVARTIS$$$$$$Y$$$20240712$$HP$US$US
239125402$23912540$2$F$20240501$20240725$20240528$20240730$EXP$$JP-SAKK-2024SA156997AA$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240731$$MD$JP$JP
239125422$23912542$2$F$20240522$20240724$20240528$20240729$PER$$US-AMGEN-USASP2024103398$AMGEN$$55$YR$A$F$Y$$$20240729$$CN$US$US
239125493$23912549$3$F$20240101$20240820$20240528$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008123$JAZZ$$20$YR$$F$Y$$$20240821$$CN$US$US
239125514$23912551$4$F$20240101$20240711$20240528$20240717$EXP$$CA-ABBVIE-5775671$ABBVIE$$56$YR$$M$Y$$$20240717$$CN$CA$CA
239125832$23912583$2$F$$20240717$20240528$20240718$PER$$US-ALXN-202405USA001514US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239125842$23912584$2$F$20240501$20240716$20240528$20240717$PER$$US-ALXN-202405USA001499US$ALEXION PHARMACEUTICALS$$23$YR$$M$Y$$$20240717$$CN$US$US
239125994$23912599$4$F$20240518$20240626$20240528$20240712$30DAY$$US-JNJFOC-20240556167$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240712$$PH$US$US
239126122$23912612$2$F$$20240716$20240529$20240717$PER$$US-ALXN-202405USA001498US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
239126272$23912627$2$F$20240501$20240701$20240529$20240704$EXP$$NVSJ2024JP006242$NOVARTIS$$60$YR$$F$Y$$$20240705$$MD$JP$JP
239126342$23912634$2$F$$20240528$20240529$20240718$PER$$US-HALEON-2178486$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239126352$23912635$2$F$$20240715$20240529$20240724$PER$$US-AstraZeneca-2024A117101$ASTRAZENECA$$$$$$Y$$$20240724$$CN$US$
239126384$23912638$4$F$20240410$20240624$20240529$20240702$PER$$US-AMGEN-USASP2024103384$AMGEN$$68$YR$E$M$Y$$$20240702$$CN$US$US
239126462$23912646$2$F$20231211$20240826$20240529$20240830$EXP$$US-AMGEN-USASP2024102441$AMGEN$$78$YR$E$F$Y$$$20240829$$CN$US$US
239126512$23912651$2$F$$20240522$20240529$20240926$PER$$US-GSK-US2024AMR064276$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
239126545$23912654$5$F$$20240909$20240529$20240912$EXP$$US-ABBVIE-5722454$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
239126743$23912674$3$F$20240501$20240819$20240529$20240823$EXP$$PT-JNJFOC-20240518957$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240823$$HP$PT$PT
239126752$23912675$2$F$20231201$20240827$20240529$20240831$EXP$$US-ABBVIE-5677443$ABBVIE$$73$YR$$M$Y$$$20240831$$CN$US$US
239126762$23912676$2$F$20240501$20240724$20240529$20240727$EXP$$US-ABBVIE-5775697$ABBVIE$$82$YR$$F$Y$$$20240727$$CN$US$US
239126792$23912679$2$F$$20240716$20240529$20240717$PER$$US-TAKEDA-2024TUS053031$TAKEDA$$$$$F$Y$$$20240717$$CN$US$US
239126922$23912692$2$F$$20240919$20240529$20240927$EXP$GB-SANDOZ-SDZ2023GB050268$GB-BIOCON BIOLOGICS LIMITED-BBL2024003641$BIOCON$$$$$$Y$$$20240927$$HP$GB$GB
239127112$23912711$2$F$$20240714$20240529$20240724$30DAY$$US-GSK-US2024063670$GLAXOSMITHKLINE$$$$$F$Y$$$20240724$$CN$US$US
239127122$23912712$2$F$20240519$20240731$20240529$20240802$PER$$US-AMGEN-USASP2024103834$AMGEN$$73$YR$E$M$Y$$$20240802$$CN$US$US
239127193$23912719$3$F$$20240710$20240529$20240721$EXP$GB-MLMSERVICE-20240517-PI059713-00270-2$GB-STRIDES ARCOLAB LIMITED-2024SP006152$STRIDES$Kafagi AH, Li AS, Jayne D, Brix SR.. Anti-GBM disease in pregnancy.. BMJ Case Reports. 2024;17(4):e257767$$$$$Y$$$20240719$$MD$GB$GB
239127222$23912722$2$F$$20240617$20240529$20240717$EXP$$CA-HALEON-CACH2023HLN046973$Haleon PLC$$40$YR$$F$Y$97$KG$20240716$$MD$CA$CA
239127262$23912726$2$F$20240501$20240705$20240529$20240708$EXP$$EC-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-030390$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240708$$MD$EC$EC
239127363$23912736$3$F$$20240701$20240529$20240709$EXP$$US-TOLMAR, INC.-24US049589$TOLMAR$$$$$F$Y$$$20240709$$MD$US$US
239127473$23912747$3$F$20240801$20240829$20240529$20240907$30DAY$$US-GSK-US2024063553$GLAXOSMITHKLINE$$34$YR$$F$Y$$$20240907$$CN$US$US
239127572$23912757$2$F$20240503$20240724$20240529$20240821$PER$$CA-TOLMAR, INC.-24CA049111$TOLMAR$$77$YR$$M$Y$$$20240821$$CN$CA$CA
239127633$23912763$3$F$$20240710$20240529$20240806$PER$$DE-TOLMAR, INC.-24DE049317$TOLMAR$$$$$M$Y$$$20240805$$MD$DE$DE
239127763$23912776$3$F$20200101$20240719$20240529$20240729$PER$$NVSC2024US108278$NOVARTIS$$$$$M$Y$$$20240729$$CN$US$US
239127822$23912782$2$F$$20240717$20240529$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085042$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240718$$CN$US$US
239127932$23912793$2$F$$20240725$20240529$20240801$EXP$$US-NOVOPROD-1224976$NOVO NORDISK$$$$$F$Y$$$20240801$$CN$US$US
239127962$23912796$2$F$20240325$20240801$20240529$20240807$EXP$$BR-TAKEDA-2023TUS092698$TAKEDA$$51$YR$$M$Y$$$20240807$$CN$BR$BR
239128023$23912802$3$F$20240501$20240816$20240529$20240827$EXP$$BR-NOVOPROD-1225379$NOVO NORDISK$$95$YR$$F$Y$60$KG$20240827$$CN$BR$BR
239128032$23912803$2$F$20240521$20240715$20240529$20240722$EXP$$CN-NOVOPROD-1226948$NOVO NORDISK$$$$$F$Y$$$20240719$$CN$CN$CN
239128115$23912811$5$F$$20240329$20240529$20240710$PER$$US-ROCHE-3536498$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
239128226$23912822$6$F$20240101$20240905$20240529$20240910$EXP$$CO-AMGEN-COLSL2024037357$AMGEN$$61$YR$A$F$Y$$$20240910$$CN$CO$CO
239128242$23912824$2$F$20240516$20240910$20240529$20240924$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01893$AMNEAL$$71$YR$$F$Y$$$20240924$$CN$US$US
239128302$23912830$2$F$20230701$20240816$20240529$20240821$EXP$$GR-TAKEDA-2023TUS074933$TAKEDA$$33$YR$$F$Y$$$20240821$$CN$GR$GR
239128503$23912850$3$F$$20240925$20240529$20240927$EXP$$US-TAKEDA-2024TUS052436$TAKEDA$$$$$M$Y$102$KG$20240927$$HP$US$US
239128542$23912854$2$F$$20240527$20240529$20240718$PER$$US-HALEON-2178446$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239128602$23912860$2$F$20240101$20240708$20240529$20240712$EXP$$US-JNJFOC-20240563556$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240712$$CN$US$US
239128623$23912862$3$F$20240321$20240715$20240529$20240718$EXP$$US-JNJFOC-20240562478$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240718$$HP$US$US
239128672$23912867$2$F$20240509$20240829$20240529$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015796$UNITED THERAPEUTICS$$81$YR$$F$Y$90.703$KG$20240906$$$US$US
239128772$23912877$2$F$$20240625$20240529$20240710$EXP$US-JUBILANT CADISTA PHARMACEUTICALS-2024US000630$US-JUBILANT CADISTA PHARMACEUTICALS-2024US000630$JUBILANT$$$$$F$Y$43.084$KG$20240710$$CN$US$US
239128813$23912881$3$F$20240101$20240827$20240529$20240829$PER$$US-JNJFOC-20240558075$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240829$$HP$US$US
239128975$23912897$5$F$$20240806$20240529$20240809$EXP$$CA-ROCHE-3568688$ROCHE$$$$A$F$Y$$$20240809$$CN$CA$CA
239128983$23912898$3$F$20240101$20240808$20240529$20240816$EXP$$US-ROCHE-3569698$ROCHE$$38$YR$A$F$Y$$$20240816$$CN$US$US
239128992$23912899$2$F$20240522$20240625$20240529$20240709$PER$$US-AstraZeneca-2024A119914$ASTRAZENECA$$25117$DY$$M$Y$$$20240709$$CN$US$
239129052$23912905$2$F$$20240520$20240529$20240717$PER$$US-HALEON-2177366$Haleon PLC$$69$YR$$F$Y$$$20240717$$HP$US$US
239129072$23912907$2$F$20240506$20240613$20240529$20240704$PER$$CA-TOLMAR, INC.-24CA049069$TOLMAR$$77$YR$$M$Y$$$20240704$$HP$CA$CA
239129382$23912938$2$F$$20240620$20240529$20240712$PER$$US-AstraZeneca-2024A117828$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
239129472$23912947$2$F$$20240705$20240529$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04310$LUPIN$$$$$$Y$$$20240729$$CN$US$US
239129563$23912956$3$F$$20240705$20240529$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04286$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239129632$23912963$2$F$$20240705$20240529$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04290$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239129644$23912964$4$F$20230101$20240723$20240529$20240805$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-029540$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240805$$CN$US$US
239129682$23912968$2$F$$20240702$20240529$20240708$PER$$NVSC2024US108041$NOVARTIS$$$$$$Y$$$20240708$$CN$US$US
239129713$23912971$3$F$$20240705$20240529$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04320$LUPIN$$$$$$Y$$$20240729$$PH$US$US
239129722$23912972$2$F$$20240528$20240529$20240718$PER$$US-HALEON-2178485$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239129742$23912974$2$F$$20240705$20240529$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04292$LUPIN$$$$$$Y$$$20240729$$CN$US$US
239129753$23912975$3$F$$20240910$20240529$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA052339$SANDOZ$$44$YR$$F$Y$$$20240916$$HP$CA$CA
239129792$23912979$2$F$20240415$20240709$20240529$20240711$EXP$$JP-TAKEDA-2024TJP007741$TAKEDA$$5$DEC$$M$Y$$$20240711$$MD$JP$JP
239129842$23912984$2$F$$20240705$20240529$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04309$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239130023$23913002$3$F$20240330$20240620$20240529$20240703$EXP$$JP-AMGEN-JPNSP2024081874$AMGEN$$82$YR$E$F$Y$42.9$KG$20240703$$MD$JP$JP
239130162$23913016$2$F$$20240625$20240529$20240705$30DAY$$JP-JNJFOC-20240565420$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$MD$JP$JP
239130287$23913028$7$F$$20240911$20240529$20240919$EXP$$CO-AMGEN-COLSP2024104164$AMGEN$$72$YR$E$F$Y$$$20240918$$CN$CO$CO
239130444$23913044$4$F$$20240705$20240529$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04308$LUPIN$$$$$$Y$$$20240729$$CN$US$US
239130492$23913049$2$F$$20240716$20240529$20240717$PER$$US-ALXN-202405USA001507US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
239130562$23913056$2$F$20240523$20240821$20240529$20240824$PER$$US-AMGEN-USASP2024103942$AMGEN$$48$YR$A$F$Y$$$20240824$$CN$US$US
239130572$23913057$2$F$$20240528$20240529$20240718$PER$$US-HALEON-2178569$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239130672$23913067$2$F$$20240526$20240529$20240717$PER$$US-HALEON-2178314$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239130943$23913094$3$F$20240513$20240619$20240529$20240710$EXP$$DE-ROCHE-3567479$ROCHE$$43$YR$A$M$Y$76$KG$20240710$$MD$DE$DE
239130952$23913095$2$F$$20240809$20240529$20240809$PER$$NVSC2024US112332$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
239131012$23913101$2$F$$20240716$20240529$20240717$PER$$US-ALXN-202405USA001506US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
239131042$23913104$2$F$20240420$20240627$20240529$20240711$PER$$US-GRANULES-US-2024GRASPO00176$GRANULES INDIA$$48$YR$A$F$Y$80$KG$20240711$$PH$US$US
239131053$23913105$3$F$$20240705$20240529$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04291$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239131062$23913106$2$F$$20240701$20240529$20240710$EXP$$BE-CELLTRION INC.-2024BE012309$CELLTRION$$$$$$Y$$$20240710$$MD$BE$BE
239131092$23913109$2$F$$20240809$20240529$20240813$PER$$US-BIOGEN-2024BI01266565$BIOGEN$$$$$F$Y$$$20240813$$MD$US$US
239131133$23913113$3$F$$20240628$20240529$20240712$PER$$US-APOTEX-2024AP005577$APOTEX$$$$$F$Y$$$20240712$$CN$US$US
239131152$23913115$2$F$$20240528$20240529$20240718$PER$$US-HALEON-2178554$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239131193$23913119$3$F$20240522$20240628$20240529$20240705$PER$$US-AMGEN-USASP2024103285$AMGEN$$76$YR$E$F$Y$$$20240705$$PH$US$US
239131462$23913146$2$F$20151101$20240902$20240529$20240910$EXP$$JP-AMGEN-JPNSP2024104224$AMGEN$Murahashi M, Hosea Ntege E, Ide K, Maruyama N, Shirakawa J, Koyama H et al.. Metastatic gallbladder cancer presenting as numb chin syndrome: A case report and literature review. Biomedical Reports. 2024;20$69$YR$E$F$Y$$$20240910$$MD$JP$JP
239131543$23913154$3$F$20240724$20240920$20240529$20240926$EXP$$AU-TAKEDA-2018TUS031129$TAKEDA$$44$YR$$F$Y$$$20240926$$PH$AU$AU
239131612$23913161$2$F$$20240814$20240529$20240820$EXP$$GB-TAKEDA-2024TUS052024$TAKEDA$$$$$F$Y$$$20240820$$CN$GB$GB
239131672$23913167$2$F$$20240722$20240529$20240903$PER$$US-LUNDBECK-DKLU3077385$LUNDBECK$$$$$$Y$$$20240903$$HP$US$US
239131742$23913174$2$F$20240401$20240816$20240529$20240830$EXP$$US-UCBSA-2024013359$UCB$$42$YR$$M$Y$$$20240830$$HP$US$US
239131902$23913190$2$F$$20240705$20240529$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085141$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$57.61$KG$20240709$$HP$US$US
239132005$23913200$5$F$$20240718$20240529$20240806$PER$$US-AstraZeneca-2024A121066$ASTRAZENECA$$74$YR$$M$Y$$$20240806$$CN$US$
239132122$23913212$2$F$$20240628$20240529$20240704$30DAY$$CH-JNJFOC-20240562636$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$CH$CH
239132344$23913234$4$F$20240522$20240820$20240529$20240823$EXP$$NVSC2024BR112465$NOVARTIS$$48$YR$$M$Y$$$20240823$$CN$BR$BR
239132364$23913236$4$F$20240101$20240709$20240529$20240712$PER$$US-UNITED THERAPEUTICS-UNT-2024-015113$UNITED THERAPEUTICS$$$$$M$Y$56.689$KG$20240712$$$US$US
239132443$23913244$3$F$20240101$20240712$20240529$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-015154$UNITED THERAPEUTICS$$$$$F$Y$$$20240719$$$US$US
239132455$23913245$5$F$20240508$20240902$20240529$20240926$EXP$$JP-009507513-2405JPN002242J$MERCK$Mase J, Ou B, Kokiso A, Nagao I. O1-2 Two cases of pancytopenia developed after preoperative pharmacotherapy for triple-negative breast cancer. The 21st Chubu Regional Meeting of Japanese Breast Cancer Society. 65$69$YR$$F$Y$$$20240926$$MD$JP$JP
239132613$23913261$3$F$$20240822$20240529$20240823$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-082025$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240823$$HP$IL$IL
239132623$23913262$3$F$20220101$20240720$20240529$20240731$EXP$$NL-AUROBINDO-AUR-APL-2024-024726$AUROBINDO$Amini M, Canales SP, Dhindsa S. A Rare Case of Spontaneous Atypical Tibial and Fibular Fragility Fractures after Bisphosphonate Therapy. Endocrine Practice. 2024;30(5):S92$83$YR$$F$Y$$$20240731$$MD$US$NL
239132692$23913269$2$F$$20240524$20240529$20240912$EXP$$NVSC2024CA097218$NOVARTIS$$60$YR$$F$Y$$$20240912$$CN$CA$CA
239132852$23913285$2$F$20240326$20240712$20240529$20240722$EXP$ES-AEMPS-1521335$ES-TEVA-VS-3200817$TEVA$$67$YR$$F$Y$$$20240722$$MD$ES$ES
239132905$23913290$5$F$20240522$20240823$20240529$20240830$EXP$$CO-CELLTRION INC.-2024CO012330$CELLTRION$$$$$$Y$$$20240830$$HP$CO$CO
239132992$23913299$2$F$20240101$20240917$20240529$20240925$EXP$$US-TEVA-VS-3201498$TEVA$$39$YR$$F$Y$$$20240925$$CN$US$US
239133512$23913351$2$F$$20240718$20240529$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080787$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$81.9$KG$20240723$$CN$US$US
239133532$23913353$2$F$20240401$20240719$20240529$20240809$PER$$US-AstraZeneca-2024A118961$ASTRAZENECA$$73$YR$$M$Y$$$20240809$$CN$US$
239133702$23913370$2$F$$20240906$20240529$20240909$EXP$$NVSC2024CA112051$NOVARTIS$$39$YR$$F$Y$$$20240909$$CN$CA$CA
239133723$23913372$3$F$20240101$20240524$20240529$20240715$PER$$US-AMGEN-USASP2024103638$AMGEN$$48$YR$A$F$Y$$$20240715$$HP$US$US
239133782$23913378$2$F$$20240705$20240529$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04313$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239133842$23913384$2$F$$20240527$20240529$20240718$PER$$US-HALEON-2178559$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239134012$23913401$2$F$$20240916$20240529$20240923$EXP$$GB-TAKEDA-2024TUS052739$TAKEDA$$$$$F$Y$$$20240923$$CN$GB$GB
239134023$23913402$3$F$$20240723$20240529$20240724$EXP$$US-TAKEDA-2024TUS052637$TAKEDA$$$$$M$Y$$$20240724$$CN$US$US
239134063$23913406$3$F$20231031$20240830$20240529$20240904$EXP$$CA-TAKEDA-2023TUS108474$TAKEDA$$31$YR$$M$Y$$$20240904$$MD$CA$CA
239134204$23913420$4$F$20240528$20240705$20240529$20240708$PER$$US-AMGEN-USASP2024105247$AMGEN$$77$YR$E$F$Y$$$20240707$$CN$US$US
239134234$23913423$4$F$$20240723$20240529$20240911$EXP$$JP-CELLTRION INC.-2024JP012450$CELLTRION$Ikegami R, Nishinakagawa S, Nakajima K, Hiraizumi T, Orihara S, Watanabe K, et al. A case in which refractory pneumothorax developed after a long-term (7 years and 6 months) chemotherapy in a patient with rectal cancer with multiple lung metastases. The 379th Meeting of the Kanto Branch of the Japanese Society of Gastroenterolog. 2024$$$$$Y$$$20240911$$MD$JP$JP
239134292$23913429$2$F$20240324$20240621$20240529$20240708$PER$$US-AstraZeneca-2024A113677$ASTRAZENECA$$23927$DY$$F$Y$$$20240708$$CN$US$
239134364$23913436$4$F$$20240910$20240529$20240912$PER$$NVSC2024US112597$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
239134382$23913438$2$F$$20240814$20240529$20240819$EXP$$CA-JNJFOC-20240209821$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240819$$HP$CA$CA
239134422$23913442$2$F$$20240627$20240529$20240702$PER$$US-AMGEN-USASP2024104372$AMGEN$$58$YR$A$F$Y$$$20240702$$HP$US$US
239134442$23913444$2$F$20240417$20240619$20240529$20240704$EXP$FR-AFSSAPS-AM2024000390$FR-TEVA-VS-3201302$TEVA$$70$YR$$M$Y$97.5$KG$20240704$$MD$FR$FR
239134595$23913459$5$F$20240101$20240706$20240529$20240713$EXP$$CA-CELLTRION INC.-2024CA011397$CELLTRION$$$$$$Y$$$20240713$$HP$CA$CA
239134682$23913468$2$F$$20240903$20240529$20240924$30DAY$$US-BECTON DICKINSON-US-BD-24-000307$BECTON DICKINSON$$$$$$Y$$$20240924$$CN$US$US
239134812$23913481$2$F$$20240903$20240529$20240924$30DAY$$US-BECTON DICKINSON-US-BD-24-000308$BECTON DICKINSON$$$$$$Y$$$20240924$$CN$US$US
239134832$23913483$2$F$$20240903$20240529$20240924$30DAY$$US-BECTON DICKINSON-US-BD-24-000309$BECTON DICKINSON$$$$$$Y$$$20240924$$CN$US$US
239134882$23913488$2$F$20240510$20240724$20240529$20240816$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000314$BECTON DICKINSON$$$$$$Y$$$20240816$$CN$GB$GB
239134972$23913497$2$F$$20240528$20240529$20240718$PER$$US-HALEON-2178612$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239135022$23913502$2$F$$20240528$20240529$20240718$PER$$US-HALEON-2178573$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239135122$23913512$2$F$$20240527$20240529$20240717$PER$$US-HALEON-2178150$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239135142$23913514$2$F$$20240528$20240529$20240718$PER$$US-HALEON-2178598$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239135332$23913533$2$F$20240328$20240713$20240529$20240722$EXP$$CA-CELLTRION INC.-2024CA012452$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
239135392$23913539$2$F$20191101$20240910$20240529$20240912$PER$$US-BIOGEN-2019BI00813131$BIOGEN$$24$YR$$F$Y$83.99$KG$20240912$$CN$US$US
239135414$23913541$4$F$$20240705$20240529$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04311$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239135563$23913556$3$F$20240101$20240626$20240529$20240706$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-010293$UNITED THERAPEUTICS$$$$$F$Y$60$KG$20240706$$$JP$JP
239135592$23913559$2$F$$20240724$20240529$20240731$EXP$$CA-GSK-CA2024GSK065298$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$CA$CA
239135653$23913565$3$F$$20240705$20240529$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04285$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239135723$23913572$3$F$20240101$20240820$20240529$20240824$EXP$$NVSC2024AU112482$NOVARTIS$$$$$F$Y$$$20240824$$HP$AU$AU
239135842$23913584$2$F$20240703$20240717$20240529$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084059$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$73.8$KG$20240719$$PH$US$US
239135873$23913587$3$F$$20240705$20240529$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04314$LUPIN$$$$$$Y$$$20240730$$CN$US$US
239135902$23913590$2$F$$20240718$20240529$20240718$PER$$US-ALXN-202405USA001816US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$HP$US$US
239135983$23913598$3$F$20240101$20240801$20240529$20240805$EXP$$NVSC2024US023309$NOVARTIS$$64$YR$$F$Y$$$20240804$$CN$US$US
239136162$23913616$2$F$20240517$20240708$20240529$20240709$PER$$US-AMGEN-USASP2024103917$AMGEN$$52$YR$A$F$Y$$$20240709$$CN$US$US
239136175$23913617$5$F$20240523$20240924$20240529$20240930$PER$$US-AMGEN-USASP2024103719$AMGEN$$76$YR$E$M$Y$$$20240930$$CN$US$US
239136422$23913642$2$F$$20240314$20240529$20240827$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000291$AZURITY PHARMACEUTICALS$$67$YR$E$F$Y$$$20240615$$MD$US$US
239136463$23913646$3$F$20240521$20240917$20240529$20240924$EXP$$JP-ROCHE-3570731$ROCHE$$6$DEC$A$M$Y$57$KG$20240924$$MD$JP$JP
239136642$23913664$2$F$$20240828$20240529$20240829$PER$$US-AMGEN-USASP2024105257$AMGEN$$$$$F$Y$$$20240829$$PH$US$US
239136803$23913680$3$F$20240524$20240806$20240529$20240808$PER$$US-AMGEN-USASP2024105013$AMGEN$$72$YR$E$F$Y$$$20240807$$CN$US$US
239137033$23913703$3$F$20240913$20240916$20240529$20240924$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001891$Alvotech$$77$YR$$F$Y$$$20240924$$CN$CA$CA
239137152$23913715$2$F$$20240728$20240529$20240805$EXP$$DE-AMGEN-DEUSP2024103000$AMGEN$Hildebrandt M. Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma: CE plus G-CSF versus G-CSF only: A single-center retrospective analysis. Transfusion. 2024;64(5):871-880$$$$$Y$$$20240805$$HP$DE$DE
239137163$23913716$3$F$$20240629$20240529$20240703$PER$$US-AMGEN-USASP2024104917$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
239137192$23913719$2$F$20240510$20240726$20240529$20240820$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000321$BECTON DICKINSON$$$$$$Y$$$20240820$$CN$GB$GB
239137222$23913722$2$F$20240510$20240726$20240529$20240820$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000322$BECTON DICKINSON$$$$$$Y$$$20240820$$CN$GB$GB
239137252$23913725$2$F$20240513$20240724$20240529$20240816$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000319$BECTON DICKINSON$$$$$$Y$$$20240816$$CN$GB$GB
239137272$23913727$2$F$20240513$20240724$20240529$20240816$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000323$BECTON DICKINSON$$$$$$Y$$$20240816$$CN$GB$GB
239137402$23913740$2$F$$20240920$20240529$20240926$EXP$$CA-Orion Corporation ORION PHARMA-24_00030092$ORION$$59$YR$A$F$Y$$$20240926$$MD$CA$
239137422$23913742$2$F$20240514$20240820$20240529$20240912$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000325$BECTON DICKINSON$$$$$$Y$$$20240912$$CN$GB$GB
239137644$23913764$4$F$20240521$20240718$20240529$20240729$EXP$$JP-ROCHE-3571631$ROCHE$$85$YR$E$F$Y$45.1$KG$20240729$$MD$JP$JP
239137792$23913779$2$F$20240119$20240611$20240529$20240708$PER$$FR-TOLMAR, INC.-24FR048819$TOLMAR$$$$$M$Y$$$20240708$$PH$FR$FR
239137832$23913783$2$F$20240413$20240613$20240529$20240703$PER$$US-TOLMAR, INC.-24US049105$TOLMAR$$$$$M$Y$$$20240703$$HP$US$US
239137843$23913784$3$F$$20240907$20240529$20240912$EXP$$NVSC2024US111812$NOVARTIS$$$$$M$Y$$$20240912$$CN$US$US
239137852$23913785$2$F$20240131$20240614$20240529$20240703$PER$$US-TOLMAR, INC.-24US049104$TOLMAR$$$$$M$Y$$$20240703$$HP$US$US
239137862$23913786$2$F$$20240613$20240529$20240704$PER$$US-TOLMAR, INC.-24US049117$TOLMAR$$$$$M$Y$$$20240703$$HP$US$US
239137872$23913787$2$F$$20240613$20240529$20240708$PER$$US-TOLMAR, INC.-24US049446$TOLMAR$$$$$$Y$$$20240708$$MD$US$US
239137882$23913788$2$F$$20240613$20240529$20240708$PER$$US-TOLMAR, INC.-24US049447$TOLMAR$$$$$$Y$$$20240708$$MD$US$US
239137912$23913791$2$F$$20240613$20240529$20240708$PER$$US-TOLMAR, INC.-24US049448$TOLMAR$$$$$$Y$$$20240708$$MD$US$US
239138012$23913801$2$F$20230302$20240807$20240529$20240815$EXP$PT-INFARMED-A202405-325$PT-TEVA-VS-3201184$TEVA$$53$YR$$F$Y$$$20240815$$PH$PT$PT
239138094$23913809$4$F$20240422$20240724$20240529$20240801$EXP$$US-CELLTRION INC.-2024US012420$CELLTRION$$$$$$Y$$$20240801$$HP$US$US
239138212$23913821$2$F$$20240702$20240529$20240710$EXP$$BR-AstraZeneca-2024A122265$ASTRAZENECA$$66$YR$$M$Y$$$20240710$$MD$BR$
239138272$23913827$2$F$20230925$20240906$20240529$20240909$EXP$$AU-TAKEDA-2023TUS002779$TAKEDA$$63$YR$$M$Y$$$20240909$$CN$AU$AU
239138773$23913877$3$F$20240519$20240701$20240529$20240715$PER$$US-ROCHE-3568482$ROCHE$$24$YR$A$M$Y$95.25$KG$20240715$$CN$US$US
239138792$23913879$2$F$$20240624$20240529$20240902$PER$$US-CIPLA LTD.-2024US04721$CIPLA$$$$$$Y$$$20240902$$HP$US$US
239138802$23913880$2$F$20230101$20240624$20240529$20240902$PER$$US-CIPLA LTD.-2024US04696$CIPLA$$$$$$Y$$$20240902$$HP$US$US
239138833$23913883$3$F$$20240813$20240529$20240820$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-15846$SAMSUNG BIOEPIS$$84$YR$E$F$Y$$$20240820$$CN$GB$GB
239138852$23913885$2$F$$20240706$20240529$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04379$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239138905$23913890$5$F$20240403$20240830$20240529$20240906$EXP$$FR-ASTELLAS-2024US014285$ASTELLAS$$67$YR$E$M$Y$65$KG$20240906$$MD$FR$FR
239138992$23913899$2$F$20220318$20240801$20240529$20240808$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-084370$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$$$20240808$$MD$DE$DE
239139042$23913904$2$F$20240517$20240709$20240529$20240712$EXP$$US-AstraZeneca-2024A122192$ASTRAZENECA$$82$YR$$M$Y$$$20240712$$CN$US$
239139052$23913905$2$F$$20240625$20240529$20240703$EXP$$US-AstraZeneca-2024A122950$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
239139093$23913909$3$F$$20240815$20240529$20240821$EXP$$NVSC2024US111142$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
239139102$23913910$2$F$20231014$20240910$20240529$20240918$EXP$$JP-AstraZeneca-2023A261461$ASTRAZENECA$$82$YR$$M$Y$59$KG$20240918$$MD$JP$
239139152$23913915$2$F$20240428$20240611$20240529$20240701$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000305$BECTON DICKINSON$$$$$$Y$$$20240701$$HP$GB$GB
239139182$23913918$2$F$20240328$20240807$20240529$20240812$EXP$$US-ASTELLAS-2024US014987$ASTELLAS$$87$YR$$M$Y$$$20240812$$CN$US$US
239139203$23913920$3$F$20240527$20240703$20240529$20240705$PER$$US-AMGEN-USASP2024105059$AMGEN$$73$YR$E$F$Y$$$20240704$$CN$US$US
239139232$23913923$2$F$$20240910$20240529$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085379$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240911$$HP$US$US
239139323$23913932$3$F$20240101$20240626$20240529$20240704$PER$$US-AMGEN-USASP2024105187$AMGEN$$70$YR$E$F$Y$$$20240703$$CN$US$US
239139469$23913946$9$F$20231224$20240816$20240529$20240823$EXP$$CA-ROCHE-3483330$ROCHE$$71$YR$E$F$Y$$$20240823$$CN$CA$CA
239139532$23913953$2$F$20240426$20240620$20240529$20240806$PER$$US-AstraZeneca-2024A100525$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
239139613$23913961$3$F$20220215$20240626$20240529$20240701$EXP$$JP-ASTELLAS-2022JP003813$ASTELLAS$$73$YR$$F$Y$58.4$KG$20240701$$PH$JP$JP
239139656$23913965$6$F$20240823$20240920$20240529$20240926$EXP$$CA-TAKEDA-2024TUS053120$TAKEDA$$47$YR$$F$Y$$$20240926$$MD$CA$CA
239139733$23913973$3$F$20240523$20240806$20240529$20240816$30DAY$$US-GSK-US2024064971$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$PH$US$US
239140012$23914001$2$F$$20240716$20240529$20240716$PER$$US-ALXN-202405USA001608US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
239140222$23914022$2$F$$20240718$20240529$20240718$EXP$$US-PFIZER INC-2021536214$PFIZER$$59$YR$$M$Y$104.33$KG$20240718$$CN$US$US
239140292$23914029$2$F$20220101$20240731$20240529$20240812$EXP$$CZ-MACLEODS PHARMA-MAC2024047364$MACLEODS$Matlova K, Sakarova B, Loffelmannova M, Pikner R..Two Cases of Rare Bisphosphonates Treatment Side Effects : Atypical Femoral Fracture and Inflammatory Eye Reaction.JBMR Plus.2023;7(Supplement 3):e10738$$$$$Y$$$20240812$$MD$CZ$CZ
239140403$23914040$3$F$20240419$20240626$20240529$20240701$EXP$$US-GILEAD-2024-0674267$GILEAD$$75$YR$E$M$Y$$$20240701$$CN$US$US
239140432$23914043$2$F$$20240731$20240529$20240801$EXP$$NVSC2024AE112295$NOVARTIS$$36$YR$$F$Y$$$20240801$$MD$AE$AE
239140445$23914044$5$F$$20240925$20240529$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085073$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240926$$CN$US$US
239140686$23914068$6$F$$20240711$20240529$20240724$PER$$US-ROCHE-3566836$ROCHE$$$$$$Y$$$20240724$$MD$US$US
239140732$23914073$2$F$$20240716$20240529$20240717$EXP$$US-ALXN-202405USA001513US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
239140743$23914074$3$F$20240528$20240912$20240529$20240913$PER$$US-AMGEN-USASP2024105517$AMGEN$$63$YR$A$F$Y$$$20240913$$CN$US$US
239140753$23914075$3$F$20240101$20240724$20240529$20240729$EXP$$CA-ABBVIE-5779093$ABBVIE$$67$YR$$F$Y$$$20240729$$CN$CA$CA
239141034$23914103$4$F$20240506$20240826$20240529$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084566$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$90.703$KG$20240827$$CN$US$US
239141112$23914111$2$F$$20240726$20240529$20240729$PER$$US-JNJFOC-20240576016$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240729$$CN$US$US
239141282$23914128$2$F$20231103$20240705$20240529$20240711$EXP$$JP-PHARMAESSENTIA CORPORATION-JP-2024-PEC-003853$PHARMAESSENTIA$$$$$F$Y$$$20240711$$HP$JP$JP
239141363$23914136$3$F$20240519$20240708$20240529$20240715$EXP$$GB-AMGEN-GBRSP2024104132$AMGEN$$58$YR$A$F$Y$$$20240714$$CN$GB$GB
239141402$23914140$2$F$20231101$20240718$20240529$20240724$EXP$$PE-AMGEN-PERSP2024079588$AMGEN$$55$YR$A$F$Y$$$20240724$$CN$PE$PE
239141633$23914163$3$F$$20240808$20240529$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083870$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$83.46$KG$20240809$$CN$US$US
239141762$23914176$2$F$$20240808$20240529$20240814$EXP$$US-GSK-US2024064936$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$US$US
239141772$23914177$2$F$20240522$20240625$20240529$20240702$EXP$$TR-GSK-TR2024TRK064352$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$TR$TR
239141972$23914197$2$F$$20240920$20240529$20240926$EXP$$GB-MYLANLABS-2024M1047534$MYLAN$$$$$M$Y$$$20240926$$PH$GB$GB
2391420316$23914203$16$F$$20240711$20240529$20240724$EXP$$US-ROCHE-3566812$ROCHE$$$$$$Y$$$20240724$$MD$US$US
239142252$23914225$2$F$$20240527$20240529$20240717$PER$$US-HALEON-2178249$Haleon PLC$$$$$F$Y$$$20240717$$CN$US$US
239142272$23914227$2$F$$20240522$20240529$20240717$PER$$US-HALEON-2178109$Haleon PLC$$45$YR$$F$Y$$$20240717$$HP$US$US
239142283$23914228$3$F$20240223$20240826$20240529$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-082190$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240826$$MD$US$US
239142452$23914245$2$F$20240421$20240718$20240529$20240718$EXP$$CA-PFIZER INC-202300170427$PFIZER$$77$YR$$M$Y$$$20240718$$CN$CA$CA
239142473$23914247$3$F$20231101$20240720$20240529$20240722$EXP$$CA-PFIZER INC-202300288093$PFIZER$$66$YR$$M$Y$$$20240722$$MD$CA$CA
239142523$23914252$3$F$20240216$20240702$20240529$20240704$EXP$$CA-PFIZER INC-202400179473$PFIZER$$71$YR$$F$Y$$$20240704$$HP$CA$CA
239142592$23914259$2$F$20240524$20240629$20240529$20240703$PER$$US-AMGEN-USASP2024103877$AMGEN$$73$YR$E$M$Y$$$20240703$$CN$US$US
239142632$23914263$2$F$20240525$20240812$20240529$20240813$PER$$US-AMGEN-USASP2024105110$AMGEN$$73$YR$E$F$Y$$$20240813$$CN$US$US
239142692$23914269$2$F$$20240715$20240529$20240722$EXP$$US-GILEAD-2024-0674444$GILEAD$$$$E$F$Y$$$20240719$$CN$US$US
239142702$23914270$2$F$20240515$20240919$20240529$20240924$EXP$$NVSC2024DE112165$NOVARTIS$$$$A$F$Y$$$20240924$$MD$DE$DE
239142782$23914278$2$F$20231206$20240628$20240529$20240704$EXP$$US-PFIZER INC-202400179483$PFIZER$$60$YR$$F$Y$64.2$KG$20240704$$HP$US$US
239142872$23914287$2$F$$20240704$20240529$20240709$EXP$$MA-PFIZER INC-PV202400067768$PFIZER$Klevor, R.. Metronidazole-Induced Encephalopathy With Probable Crohn Encephalitis: A Case Report. Clinical Neuropharmacology. 2024;47(3):104-107$24$YR$$F$Y$$$20240709$$MD$MA$MA
239142902$23914290$2$F$20240331$20240815$20240529$20240821$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04633$VIFOR$$67$YR$$F$Y$$$20240821$$CN$ZA$ZA
239142922$23914292$2$F$$20240815$20240529$20240821$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04634$VIFOR$$$$E$M$Y$$$20240821$$CN$ZA$ZA
239142932$23914293$2$F$20240418$20240815$20240529$20240821$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04632$VIFOR$$51$YR$$M$Y$$$20240821$$CN$ZA$ZA
239143232$23914323$2$F$20240501$20240730$20240529$20240802$EXP$$CA-PFIZER INC-202400179643$PFIZER$$65$YR$$M$Y$$$20240802$$HP$CA$CA
239143242$23914324$2$F$20240522$20240702$20240529$20240708$EXP$$IT-ABBVIE-5751461$ABBVIE$$60$YR$$M$Y$$$20240708$$MD$IT$IT
239143302$23914330$2$F$20240521$20240715$20240529$20240722$EXP$$US-RDY-CLI/USA/24/0007704$DR REDDYS$$24$YR$A$F$Y$$$20240722$$MD$US$US
239143324$23914332$4$F$$20240809$20240529$20240816$EXP$$JP-JNJFOC-20240580513$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240816$$HP$JP$JP
239143414$23914341$4$F$20240524$20240715$20240529$20240718$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-077543$REGENERON$$$$$M$Y$$$20240718$$HP$US$US
239143495$23914349$5$F$20240518$20240909$20240529$20240911$30DAY$$US-PFIZER INC-202400174342$PFIZER$$56$YR$$F$Y$73.94$KG$20240911$$CN$US$US
239143514$23914351$4$F$20240501$20240819$20240529$20240821$30DAY$$US-PFIZER INC-202400174771$PFIZER$$14$YR$$F$Y$$$20240821$$CN$US$US
239143524$23914352$4$F$$20240820$20240529$20240822$30DAY$$US-PFIZER INC-202400175623$PFIZER$$7$YR$$M$Y$23.13$KG$20240822$$CN$US$US
239143544$23914354$4$F$$20240921$20240529$20240925$30DAY$$US-PFIZER INC-202400174898$PFIZER$$9$YR$$F$Y$$$20240925$$CN$US$US
239143554$23914355$4$F$20240513$20240821$20240529$20240826$30DAY$$US-PFIZER INC-202400173319$PFIZER$$8$YR$$F$Y$$$20240826$$CN$US$US
239143582$23914358$2$F$$20240717$20240529$20240725$EXP$$GB-TAKEDA-2024TUS039983$TAKEDA$$$$$F$Y$$$20240725$$CN$GB$GB
239143613$23914361$3$F$20240401$20240705$20240529$20240712$EXP$$CO-TAKEDA-2024TUS032644$TAKEDA$$68$YR$$F$Y$65$KG$20240712$$CN$CO$CO
239143623$23914362$3$F$$20240625$20240529$20240702$EXP$$PL-MYLANLABS-2024M1047319$MYLAN$Ja?owska M, Dmochowska B M, Spa?ek M, Falkowski B.Dmochowski M.. Pemphigus foliaceus in an elderly woman: advantages and limitations of histopathology in pemphigus.. Dermatology Review/Przegl?d Dermatologiczny. 2023;110(6):689?693$91$YR$$F$Y$$$20240702$$MD$PL$PL
239143792$23914379$2$F$$20240706$20240529$20240710$30DAY$$US-GSK-US2024AMR066537$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
239143823$23914382$3$F$20220802$20240624$20240529$20240702$EXP$ES-AEMPS-1523457$ES-BAXTER-2024BAX018701$BAXTER$$53$YR$$F$Y$$$20240702$$PH$ES$ES
239143942$23914394$2$F$20240525$20240627$20240529$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202405016384$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
239144124$23914412$4$F$20240509$20240705$20240529$20240712$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-005857$AURINIA PHARMACEUTICALS$$39$YR$$F$Y$$$20240712$$CN$US$US
239144203$23914420$3$F$20240911$20240911$20240529$20240918$EXP$$CA-GSK-CA2023140580$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$CA$CA
239144452$23914445$2$F$$20240725$20240529$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448054$RANBAXY$Shacker M, Braat JP, Arjuna A. Acute Hepatitis After Lung Transplant in a Recipient from Hep C Donor: The Chicken or the Egg Phenomenon?. J Heart Lung Transplant. 2024;43 (Suppl.) (4):S480$70$YR$$F$Y$$$20240809$$HP$US$US
239144972$23914497$2$F$$20240620$20240529$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448490$RANBAXY$Phekoo A, Turk M, Torain J, Cate J, Java A, Sparks MA. USE OF ECULIZUMAB DURING PREGNANCY IN A PATIENT WITH C3GN. Am J Kidney Dis. 2024;APR; 83 (4)(S2):S44/147$$$N$$Y$$$20240705$$HP$US$US
239145022$23914502$2$F$$20240904$20240529$20240906$EXP$$AU-HALEON-2177876$Haleon PLC$$3$YR$$M$Y$$$20240906$$CN$AU$AU
239145082$23914508$2$F$$20240802$20240529$20240816$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448360$RANBAXY$Martin Gutierrez R, Medina Blanco R, Suarez Pinilla P, Landera Rodriguez R, Juncal Ruiz M, Madrazo Del Rio HortegaI, et al. Neuroleptic malignant syndrome: Case report and literature review. Eur Psychiatry. 2017;41 (Suppl.):S564 (EV0492)$32$YR$$M$Y$$$20240816$$HP$ES$ES
239145152$23914515$2$F$$20240731$20240529$20240814$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448467$RANBAXY$Ziaka M. DRUG-ASSOCIATED REACTION WITH SYSTEMIC SYMPTOMS (DARSS). Eur J Case Rep Intern Med. 2023;10 (Suppl.):565(1231)$53$YR$$M$Y$$$20240814$$HP$CH$CH
239145172$23914517$2$F$20240509$20240813$20240529$20240828$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448503$RANBAXY$$75$YR$E$F$Y$37$KG$20240828$$MD$CN$CN
239145283$23914528$3$F$$20240618$20240529$20240730$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447218$RANBAXY$$$$$M$Y$$$20240730$$CN$CA$CA
239145822$23914582$2$F$$20240524$20240529$20240830$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448116$RANBAXY$Marques CI, Silva C, Fernandes C, Costa CL, Ogando A. Stevens Johnson syndrome- An uncommon presentation. Eur J Case Rep Intern Med. 2021;8 (Suppl.):PV300/ 1321(129)$94$YR$$M$Y$$$20240831$$HP$PT$PT
239145853$23914585$3$F$20240523$20240709$20240529$20240716$EXP$$CA-JNJFOC-20240574809$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240716$$PH$CA$CA
239145905$23914590$5$F$20230904$20240821$20240529$20240905$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-418427$RANBAXY$$74$YR$E$F$Y$43.7$KG$20240905$$MD$CN$CN
239145972$23914597$2$F$$20240722$20240529$20240806$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448287$RANBAXY$Tavares JA,Carvalho J,Carneiro P,EmIdio C,Palma C,Pereira R et al. Distributive shock is not always a septic shock- A clinical case. Eur J Case Rep Intern Med. 2019;6 (Suppl.):219.#1745$47$YR$$F$Y$$$20240806$$HP$PT$PT
239145982$23914598$2$F$$20240722$20240529$20240806$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448286$RANBAXY$Venugopal A, Achappa B. A BIZARRE CASE OF REVERSIBLE HEART BLOCK - THEVETIA PERUVIANA INDUCED CARDIOTOXICITY. Eur J Case Rep Intern Med. 2019;6 (Suppl.):219#1747$57$YR$$M$Y$$$20240806$$HP$IN$IN
239146082$23914608$2$F$20240501$20240708$20240529$20240723$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-448324$RANBAXY$$41$YR$$F$Y$$$20240723$$MD$DE$DE
239146242$23914624$2$F$$20240711$20240529$20240717$30DAY$$US-GSK-US2024064155$GLAXOSMITHKLINE$$$$$M$Y$$$20240717$$CN$US$US
239146372$23914637$2$F$20240501$20240704$20240529$20240716$PER$$US-APOTEX-2024AP005720$APOTEX$$$$$F$Y$$$20240716$$CN$US$US
239146443$23914644$3$F$20240101$20240625$20240529$20240712$30DAY$$DE-JNJFOC-20240550187$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$PH$DE$DE
239146492$23914649$2$F$$20240806$20240529$20240809$PER$$US-AMGEN-USASP2024105506$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
239146672$23914667$2$F$$20240624$20240529$20240703$30DAY$$CN-JNJFOC-20240571113$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$CN$CN
239146736$23914673$6$F$20240517$20240925$20240529$20240925$PER$$NVSC2024US112721$NOVARTIS$$43$YR$$F$Y$$$20240925$$CN$US$US
239146802$23914680$2$F$20240401$20240716$20240529$20240717$PER$$US-ALXN-202405USA001586US$ALEXION PHARMACEUTICALS$$83$YR$$M$Y$$$20240717$$CN$US$US
239146892$23914689$2$F$$20240617$20240529$20240702$30DAY$$CA-JNJFOC-20240569066$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$CA$CA
239147074$23914707$4$F$20240401$20240625$20240529$20240701$EXP$$US-EXELIXIS-CABO-24076627$EXELIXIS$$73$YR$$M$Y$$$20240701$$CN$US$US
239147082$23914708$2$F$$20240528$20240529$20240718$PER$$US-HALEON-2178684$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239147313$23914731$3$F$$20240719$20240529$20240722$EXP$$RO-SANDOZ INC.-SDZ2024RO052330$SANDOZ$$54$YR$$F$Y$$$20240722$$HP$RO$RO
239147333$23914733$3$F$20240331$20240819$20240529$20240823$EXP$$JP-ABBVIE-5777974$ABBVIE$$37$YR$$M$Y$45$KG$20240823$$MD$JP$JP
239147382$23914738$2$F$20240801$20240801$20240529$20240806$EXP$$CA-PFIZER INC-202400179479$PFIZER$$21$YR$$M$Y$$$20240806$$HP$CA$CA
239147402$23914740$2$F$$20240528$20240529$20240718$PER$$US-HALEON-2178700$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239147543$23914754$3$F$20230106$20240826$20240529$20240829$EXP$$KR-MYLANLABS-2023M1125625$MYLAN$$55$YR$$M$Y$$$20240829$$MD$KR$KR
239147553$23914755$3$F$20211207$20240528$20240529$20240716$EXP$$GB-AUROBINDO-AUR-APL-2024-024768$AUROBINDO$$80$YR$$M$Y$66$KG$20240716$$CN$GB$GB
239147812$23914781$2$F$$20240628$20240529$20240704$30DAY$$BR-JNJFOC-20240569034$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$HP$BR$BR
239147842$23914784$2$F$20240527$20240720$20240529$20240722$EXP$$US-PFIZER INC-202400179478$PFIZER$$66$YR$$M$Y$72.562$KG$20240722$$CN$US$US
239147892$23914789$2$F$$20240720$20240529$20240722$EXP$$US-PFIZER INC-202400179470$PFIZER$$$$$M$Y$$$20240722$$CN$US$US
239147902$23914790$2$F$$20240529$20240529$20240722$PER$$US-HALEON-2178724$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
239147923$23914792$3$F$$20240725$20240529$20240725$EXP$$CA-PFIZER INC-202400179824$PFIZER$$63$YR$$F$Y$$$20240725$$HP$CA$CA
239147963$23914796$3$F$$20240804$20240529$20240807$EXP$$NVSC2024IL109245$NOVARTIS$$20$YR$$F$Y$$$20240807$$MD$IL$IL
239148012$23914801$2$F$$20240529$20240529$20240718$PER$$US-HALEON-2178722$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239148142$23914814$2$F$20240405$20240703$20240529$20240710$EXP$$NVSC2024MX095951$NOVARTIS$$0$YR$$F$Y$2.17$KG$20240710$$CN$MX$MX
239148472$23914847$2$F$$20240625$20240529$20240705$30DAY$$JP-JNJFOC-20240569025$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$PH$JP$JP
239148792$23914879$2$F$20240101$20240701$20240529$20240708$EXP$$JP-009507513-2404JPN000620J$MERCK$$6$DEC$$F$Y$$$20240708$$MD$JP$JP
239149152$23914915$2$F$$20240626$20240529$20240705$30DAY$$TH-JNJFOC-20240568300$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$TH$TH
239149382$23914938$2$F$$20240527$20240529$20240718$PER$$US-HALEON-2178490$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239149875$23914987$5$F$20240524$20240729$20240529$20240803$EXP$$US-AMGEN-USASP2024105346$AMGEN$$80$YR$E$F$Y$$$20240803$$CN$US$US
239149903$23914990$3$F$20240520$20240729$20240529$20240806$PER$$NVSC2024US112300$NOVARTIS$$0$YR$$F$Y$6.29$KG$20240806$$MD$US$US
239150422$23915042$2$F$$20240528$20240529$20240718$PER$$US-HALEON-2178680$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239151152$23915115$2$F$20240516$20240709$20240529$20240721$30DAY$$US-GSK-US2024063674$GLAXOSMITHKLINE$$79$YR$$M$Y$$$20240721$$CN$US$US
239151312$23915131$2$F$20240515$20240902$20240529$20240905$EXP$FR-AFSSAPS-RN2024000576$FR-MYLANLABS-2024M1047179$MYLAN$$58$YR$$M$Y$$$20240905$$PH$FR$FR
239151962$23915196$2$F$20240201$20240726$20240529$20240729$EXP$$NVSC2024US110277$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
239152062$23915206$2$F$$20240529$20240529$20240718$PER$$US-HALEON-2178715$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239152072$23915207$2$F$$20240718$20240529$20240801$EXP$$US-INSMED, INC.-2024-02045-US$INSMED$$$$$M$Y$$$20240801$$CN$US$US
239152092$23915209$2$F$20211101$20240708$20240529$20240711$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-014988$JAZZ$$34$YR$$M$Y$$$20240711$$CN$US$US
239152224$23915222$4$F$20230913$20240730$20240529$20240802$EXP$$JP-BAYER-2024A078127$BAYER$Nakanishi Y, Mochizuki M, Kasai Y, Takahashi Y, Takeda M. 18. Early experience of triplet therapy in hormone-sensitive prostate cancer with metastases. The Japanese Urological Association Koushinetsu joint regional meeting. 2024;11$74$YR$E$M$Y$$$20240802$$HP$JP$JP
239152394$23915239$4$F$$20240921$20240529$20240925$30DAY$$CA-PFIZER INC-202400174176$PFIZER$$27$YR$$F$Y$$$20240925$$PH$CA$CA
239152404$23915240$4$F$$20240629$20240529$20240701$30DAY$$US-PFIZER INC-202400174644$PFIZER$$3$YR$$M$Y$$$20240701$$CN$US$US
239152432$23915243$2$F$$20240723$20240529$20240729$EXP$$CA-PFIZER INC-202400180028$PFIZER$$12$YR$$F$Y$$$20240729$$CN$CA$CA
239152443$23915244$3$F$20240517$20240910$20240529$20240911$30DAY$$AR-PFIZER INC-202400172243$PFIZER$$58$YR$$M$Y$$$20240911$$CN$AR$AR
239152552$23915255$2$F$20240301$20240720$20240529$20240722$EXP$$CA-PFIZER INC-202400179729$PFIZER$$32$YR$$F$Y$$$20240722$$HP$CA$CA
239152622$23915262$2$F$20240504$20240626$20240529$20240702$EXP$$CO-JNJFOC-20240576410$JOHNSON AND JOHNSON$$58$YR$A$F$Y$80$KG$20240702$$HP$CO$CO
239152642$23915264$2$F$$20240711$20240529$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04317$LUPIN$$$$$$Y$$$20240809$$CN$US$US
239152672$23915267$2$F$20240504$20240604$20240529$20240708$PER$$FR-TOLMAR, INC.-24FR049148$TOLMAR$$70$YR$$M$Y$$$20240708$$PH$FR$FR
239152682$23915268$2$F$20240101$20240605$20240529$20240708$PER$$FR-TOLMAR, INC.-24FR049153$TOLMAR$$75$YR$$M$Y$$$20240708$$PH$FR$FR
239152712$23915271$2$F$20240506$20240605$20240529$20240708$PER$$FR-TOLMAR, INC.-24FR049185$TOLMAR$$$$E$M$Y$$$20240708$$HP$FR$FR
239152732$23915273$2$F$20240503$20240702$20240529$20240813$PER$$TR-TOLMAR, INC.-24TR049192$TOLMAR$$83$YR$$M$Y$$$20240813$$PH$TR$TR
239152762$23915276$2$F$20240506$20240612$20240529$20240704$PER$$US-TOLMAR, INC.-24US049159$TOLMAR$$50$YR$$M$Y$$$20240703$$PH$US$US
239152874$23915287$4$F$20240101$20240808$20240529$20240813$EXP$$CA-PFIZER INC-202400179494$PFIZER$$34$YR$$M$Y$$$20240813$$HP$CA$CA
239152895$23915289$5$F$20240522$20240824$20240529$20240828$30DAY$$GR-PFIZER INC-PV202400067638$PFIZER$$10$YR$$M$Y$45$KG$20240828$$HP$GR$GR
239152904$23915290$4$F$$20240916$20240529$20240919$30DAY$$US-PFIZER INC-PV202400066904$PFIZER$$$$$M$Y$$$20240919$$CN$US$US
239152923$23915292$3$F$20240520$20240629$20240529$20240701$30DAY$$US-PFIZER INC-202400174923$PFIZER$$14$YR$$M$Y$$$20240701$$CN$US$US
239152932$23915293$2$F$20240329$20240720$20240529$20240722$EXP$$CA-PFIZER INC-PV202400032874$PFIZER$$58$YR$$M$Y$73.8$KG$20240722$$MD$CA$CA
239152966$23915296$6$F$$20240827$20240529$20240827$30DAY$$US-PFIZER INC-202400174996$PFIZER$$12$YR$$M$Y$$$20240827$$CN$US$US
239152974$23915297$4$F$$20240921$20240529$20240925$30DAY$$US-PFIZER INC-202400175185$PFIZER$$15$YR$$F$Y$$$20240925$$CN$US$US
239152985$23915298$5$F$20230401$20240918$20240529$20240920$30DAY$$US-PFIZER INC-202400175462$PFIZER$$13$YR$$M$Y$53.07$KG$20240920$$CN$US$US
239152992$23915299$2$F$20240520$20240728$20240529$20240730$30DAY$$CO-PFIZER INC-202400174813$PFIZER$$9$YR$$F$Y$$$20240730$$CN$CO$CO
239153003$23915300$3$F$$20240925$20240529$20240930$30DAY$$US-PFIZER INC-202400174621$PFIZER$$44$YR$$M$Y$$$20240930$$CN$US$US
239153012$23915301$2$F$20240501$20240704$20240529$20240705$30DAY$$CL-PFIZER INC-PV202400067780$PFIZER$$16$YR$$M$Y$$$20240705$$CN$CL$CL
239153082$23915308$2$F$$20240704$20240529$20240710$EXP$$SI-OTSUKA-2024_014906$OTSUKA$$30$YR$$M$Y$$$20240710$$MD$SI$SI
239153125$23915312$5$F$20201118$20240910$20240529$20240913$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-077764$REGENERON$$$$$F$Y$$$20240913$$CN$US$US
239153212$23915321$2$F$$20240528$20240529$20240718$PER$$US-HALEON-2178720$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239153313$23915331$3$F$20240101$20240701$20240529$20240703$EXP$$US-AMGEN-HZN-2024-005805$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
239153372$23915337$2$F$20240527$20240826$20240529$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-030608$BOEHRINGER INGELHEIM$$57$YR$A$F$Y$$$20240827$$CN$US$US
239153444$23915344$4$F$20240701$20240920$20240529$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085506$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240930$$CN$US$US
239153553$23915355$3$F$20240401$20240714$20240529$20240726$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405011490$ELI LILLY AND CO$$13$YR$T$F$Y$$$20240726$$CN$JP$JP
239153622$23915362$2$F$$20240703$20240529$20240705$PER$$US-HALEON-2178570$Haleon PLC$$$$$M$Y$$$20240705$$CN$US$US
239153765$23915376$5$F$$20240826$20240529$20240829$30DAY$$US-PFIZER INC-PV202400044197$PFIZER$$$$$$Y$$$20240829$$HP$US$US
239153772$23915377$2$F$$20240721$20240529$20240722$EXP$$CA-PFIZER INC-202400179496$PFIZER$$76$YR$$M$Y$$$20240722$$HP$CA$CA
239153783$23915378$3$F$$20240822$20240529$20240827$30DAY$$CA-PFIZER INC-202400174831$PFIZER$$40$YR$$F$Y$$$20240827$$PH$CA$CA
239153795$23915379$5$F$20240513$20240923$20240529$20240926$30DAY$$JP-PFIZER INC-PV202400066596$PFIZER$$$$C$$Y$$$20240926$$HP$JP$JP
239153805$23915380$5$F$20240101$20240829$20240529$20240904$EXP$$CN-PFIZER INC-PV202400068846$PFIZER$$60$YR$$F$Y$53$KG$20240904$$CN$CN$CN
239153813$23915381$3$F$$20240813$20240529$20240822$30DAY$$FR-PFIZER INC-202400173799$PFIZER$$15$YR$$F$Y$$$20240822$$PH$FR$FR
239153852$23915385$2$F$$20240628$20240529$20240711$EXP$$US-INSMED, INC.-2024-02066-US$INSMED$$$$$F$Y$$$20240711$$CN$US$US
239153872$23915387$2$F$20240520$20240709$20240529$20240716$EXP$$US-ABBVIE-5770300$ABBVIE$$$$$F$Y$$$20240716$$MD$US$US
239153975$23915397$5$F$20230605$20240808$20240529$20240823$EXP$$JP-Merz Pharmaceuticals GmbH-24-01837$MERZ$$72$YR$$F$Y$44.3$KG$20240823$$MD$JP$JP
239154004$23915400$4$F$20240424$20240822$20240529$20240827$PER$$US-AMGEN-USASP2024105195$AMGEN$$77$YR$E$F$Y$$$20240827$$HP$US$US
239154062$23915406$2$F$20240520$20240717$20240529$20240723$EXP$$GB-TAKEDA-2024TUS052842$TAKEDA$$58$YR$$M$Y$$$20240723$$CN$GB$GB
239154193$23915419$3$F$$20240719$20240529$20240720$PER$$NVSC2024US111884$NOVARTIS$$$$$M$Y$$$20240719$$MD$US$US
239154342$23915434$2$F$$20240701$20240529$20240703$PER$$US-PFIZER INC-PV202400069284$PFIZER$$38$YR$$M$Y$$$20240703$$CN$US$US
239154472$23915447$2$F$$20240822$20240529$20240828$EXP$$CA-TAKEDA-2023TUS095499$TAKEDA$$$$$F$Y$$$20240828$$CN$CA$CA
239154572$23915457$2$F$$20240704$20240529$20240708$30DAY$$EE-JNJFOC-20240567532$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$EE$EE
239154593$23915459$3$F$20240501$20240702$20240529$20240705$EXP$$CA-JNJFOC-20240350565$JOHNSON AND JOHNSON$$57$YR$A$M$Y$146$KG$20240705$$HP$CA$CA
239154642$23915464$2$F$$20240711$20240529$20240717$30DAY$$US-GSK-US2024063111$GLAXOSMITHKLINE$$$$$F$Y$$$20240717$$CN$US$US
239154662$23915466$2$F$20240504$20240709$20240529$20240716$EXP$$US-SA-2024SA160882$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240716$$MD$US$US
239154672$23915467$2$F$20240515$20240520$20240529$20240725$EXP$$US-UCBSA-2024025656$UCB$$27$YR$$F$Y$51$KG$20240725$$MD$US$US
239154702$23915470$2$F$$20240801$20240529$20240802$EXP$$NVSC2024US111419$NOVARTIS$$$$$M$Y$$$20240802$$CN$US$US
239154824$23915482$4$F$20240501$20240709$20240529$20240710$EXP$$US-AMGEN-USASP2024104978$AMGEN$$76$YR$E$F$Y$$$20240710$$CN$US$US
239154833$23915483$3$F$20240520$20240717$20240529$20240722$EXP$$GB-MYLANLABS-2024M1047640$MYLAN$$66$YR$$F$Y$62.9$KG$20240722$$MD$GB$GB
239154852$23915485$2$F$20240512$20240711$20240529$20240724$PER$$US-FARMAPROD-202405-1943$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240724$$MD$US$US
239154923$23915492$3$F$$20240904$20240529$20240905$EXP$$NVSC2024GB104203$NOVARTIS$$$$$F$Y$$$20240905$$CN$GB$GB
239155082$23915508$2$F$$20240529$20240529$20240718$PER$$US-HALEON-2178736$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239155122$23915512$2$F$$20240628$20240529$20240705$30DAY$$IT-JNJFOC-20240564267$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$IT$IT
239155232$23915523$2$F$20231116$20240719$20240529$20240726$PER$$US-AMGEN-USASP2024102675$AMGEN$$74$YR$E$F$Y$$$20240726$$PH$US$US
239155252$23915525$2$F$20240409$20240815$20240529$20240822$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04636$VIFOR$$54$YR$$M$Y$$$20240822$$CN$ZA$ZA
239155292$23915529$2$F$$20240716$20240529$20240717$PER$$US-ALXN-202405USA001566US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
239155302$23915530$2$F$20240423$20240815$20240529$20240821$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04635$VIFOR$$70$YR$$M$Y$$$20240821$$CN$ZA$ZA
239155312$23915531$2$F$$20240806$20240529$20240814$PER$$CA-PFM-2024-03112$PIERRE FABRE MEDICAMENT$Wong K, Ali M, Stalder M, Bonin B, El-Chaar D. Expectant Management of a Triploid Partial Molar Pregnancy at 26 Weeks^ Gestation: A Case Report. American Journal of Perinatology Reports. 2024;14(2):124-28$$$$$Y$$$20240814$$MD$CA$CA
239155332$23915533$2$F$20240401$20240627$20240529$20240705$EXP$$US-Calliditas-2024CAL00807$CALLIDITAS THERAPEUTICS$$49$YR$A$M$Y$98.9$KG$20240705$$CN$US$US
239155353$23915535$3$F$$20240703$20240529$20240717$PER$$US-Calliditas-2024CAL00815$CALLIDITAS THERAPEUTICS$$60$YR$A$F$Y$$$20240717$$CN$US$US
239155363$23915536$3$F$$20240718$20240529$20240725$EXP$$US-Calliditas-2024CAL00812$CALLIDITAS THERAPEUTICS$$49$YR$A$M$Y$79$KG$20240725$$CN$US$US
239155524$23915552$4$F$20240101$20240916$20240529$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081948$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240918$$CN$US$US
239155592$23915559$2$F$$20240517$20240529$20240731$EXP$$CA-AKCEA THERAPEUTICS, INC.-2024IS004990$AKCEA THERAPEUTICS$$$$$$Y$$$20240731$$CN$CA$CA
239155612$23915561$2$F$$20240711$20240529$20240723$EXP$$US-TORRENT-00013582$TORRENT$$43$YR$A$$Y$99$KG$20240723$$PH$US$US
239155632$23915563$2$F$20240528$20240731$20240529$20240803$PER$$US-AMGEN-USASP2024105687$AMGEN$$80$YR$E$F$Y$$$20240803$$CN$US$US
239155642$23915564$2$F$$20240805$20240529$20240809$EXP$$NVSC2024PL112115$NOVARTIS$Milewska J, Chmielinska P, Czuwara J, Kryst A, Jasinska M, Rakowska A, et al. Diagnostic and therapeutic challenges in erythema elevatum diutinum. DERMATOL REV/PRZEGL DERMATOL. 2023;110:711-5$65$YR$$F$Y$$$20240809$$HP$PL$PL
239155652$23915565$2$F$20240523$20240718$20240529$20240724$PER$$US-AMGEN-USASP2024102768$AMGEN$$83$YR$E$F$Y$$$20240724$$CN$US$US
239155672$23915567$2$F$$20240528$20240529$20240722$PER$$US-HALEON-2178594$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
239155772$23915577$2$F$20230222$20240516$20240529$20240904$EXP$$US-BAYER-2024A072984$BAYER$$43$YR$A$F$Y$$$20240904$$MD$US$US
239155786$23915578$6$F$20240507$20240904$20240529$20240911$EXP$$CN-VER-202400009$VERITY PHARMACEUTICALS$$80$YR$E$M$Y$63$KG$20240911$$HP$CN$CN
239155792$23915579$2$F$$20240519$20240529$20240903$EXP$GB-MHRA-ADR 28750925$GB-TORRENT-00036592$TORRENT$$$$A$M$Y$$$20240903$$CN$GB$GB
239155803$23915580$3$F$20211201$20240701$20240529$20240704$EXP$$CZ-ABBVIE-5773703$ABBVIE$$15$YR$$M$Y$52$KG$20240704$$MD$CZ$CZ
239155902$23915590$2$F$20200601$20240725$20240529$20240808$EXP$$CA-MYLANLABS-2024M1047036$MYLAN$$80$YR$$M$Y$69$KG$20240808$$HP$CA$CA
239156012$23915601$2$F$$20240903$20240529$20240924$30DAY$$CO-BECTON DICKINSON-CO-BD-24-000311$BECTON DICKINSON$$$$$$Y$$$20240924$$CN$CO$CO
239156132$23915613$2$F$$20240718$20240529$20240722$PER$$US-PFIZER INC-202400180172$PFIZER$$73$YR$$F$Y$$$20240722$$CN$US$US
239156185$23915618$5$F$20240501$20240916$20240529$20240919$30DAY$$US-PFIZER INC-202400175053$PFIZER$$12$YR$$M$Y$$$20240919$$CN$US$US
239156203$23915620$3$F$$20240920$20240529$20240924$PER$$US-PFIZER INC-202400180330$PFIZER$$37$YR$$M$Y$$$20240924$$CN$US$US
239156253$23915625$3$F$$20240807$20240529$20240809$PER$$US-PFIZER INC-2021123354$PFIZER$$64$YR$$F$Y$$$20240809$$CN$US$US
239156572$23915657$2$F$20230815$20240819$20240529$20240823$EXP$$US-MYLANLABS-2024M1048107$MYLAN$$38$YR$$F$Y$90.975$KG$20240823$$HP$US$US
239156692$23915669$2$F$$20240716$20240529$20240717$PER$$US-ALXN-202405USA001573US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
239156852$23915685$2$F$20230401$20240815$20240529$20240830$EXP$$CA-ASTELLAS-2024US014690$ASTELLAS$$49$YR$A$M$Y$$$20240830$$CN$CA$CA
239157272$23915727$2$F$20240413$20240815$20240529$20240821$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04621$VIFOR$$66$YR$$M$Y$$$20240821$$CN$ZA$ZA
239157322$23915732$2$F$20240401$20240815$20240529$20240821$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04665$VIFOR$$63$YR$$F$Y$$$20240821$$CN$ZA$ZA
239157332$23915733$2$F$20240223$20240815$20240529$20240823$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04626$VIFOR$$66$YR$$F$Y$$$20240823$$CN$ZA$ZA
239157573$23915757$3$F$20230801$20240719$20240529$20240725$EXP$$CA-GSK-CA2023AMR118025$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$PH$CA$CA
239157612$23915761$2$F$20230601$20240724$20240529$20240730$EXP$$DE-MYLANLABS-2024M1048330$MYLAN$$47$YR$$M$Y$143.5$KG$20240730$$CN$DE$DE
239157832$23915783$2$F$$20240703$20240529$20240704$PER$$NVSC2024US113097$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
239157972$23915797$2$F$20230101$20240716$20240529$20240724$PER$$US-VERTEX PHARMACEUTICALS-2024-008856$VERTEX$$5$YR$$F$Y$$$20240724$$CN$US$US
239158154$23915815$4$F$20240523$20240820$20240529$20240824$PER$$US-AMGEN-USASP2024103691$AMGEN$$90$YR$E$M$Y$$$20240824$$CN$US$US
239158224$23915822$4$F$20240826$20240911$20240529$20240919$EXP$$US-Calliditas-2024CAL00824$CALLIDITAS THERAPEUTICS$$72$YR$E$F$Y$$$20240919$$CN$US$US
239158252$23915825$2$F$20240201$20240629$20240529$20240701$30DAY$$UY-PFIZER INC-202400172275$PFIZER$$9$YR$$F$Y$$$20240701$$CN$UY$UY
239158282$23915828$2$F$20240501$20240705$20240529$20240705$30DAY$$CL-PFIZER INC-PV202400067803$PFIZER$$11$YR$$M$Y$$$20240705$$CN$CL$CL
239158292$23915829$2$F$$20240809$20240529$20240816$30DAY$$IT-PFIZER INC-202400180888$PFIZER$$$$$$Y$$$20240816$$MD$IT$IT
239158343$23915834$3$F$$20240806$20240529$20240814$PER$$US-INCYTE CORPORATION-2024IN005504$INCYTE$$$$$$Y$$$20240814$$CN$US$US
239158525$23915852$5$F$20240426$20240903$20240529$20240912$PER$$US-SA-2024SA158235$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240912$$MD$US$US
239158543$23915854$3$F$20231228$20240701$20240529$20240705$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405014948$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240705$$CN$JP$JP
239158644$23915864$4$F$$20240812$20240529$20240820$30DAY$$IT-PFIZER INC-PV202400068203$PFIZER$$$$$$Y$$$20240820$$MD$IT$IT
239158704$23915870$4$F$$20240710$20240529$20240718$PER$$US-SA-2024SA156941$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240718$$MD$US$US
239158753$23915875$3$F$20240101$20240816$20240529$20240829$PER$$US-SA-2024SA156690$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240829$$MD$US$US
239158872$23915887$2$F$20240501$20240906$20240529$20240917$PER$$US-SA-2024SA156546$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240918$$MD$US$US
239158922$23915892$2$F$20230101$20240801$20240529$20240809$PER$$US-SA-2024SA156357$SANOFI AVENTIS$$58$YR$A$F$Y$70.3$KG$20240809$$MD$US$US
239158973$23915897$3$F$20240501$20240910$20240529$20240917$PER$$US-SA-2024SA155622$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240918$$MD$US$US
239158983$23915898$3$F$20240101$20240807$20240529$20240817$PER$$US-SA-2024SA157716$SANOFI AVENTIS$$43$YR$A$M$Y$86$KG$20240817$$MD$US$US
239159032$23915903$2$F$20240501$20240815$20240529$20240827$PER$$US-SA-2024SA157230$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240827$$MD$US$US
239159202$23915920$2$F$$20240705$20240529$20240716$PER$$US-SA-2024SA157384$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240716$$CN$US$US
239159272$23915927$2$F$20240901$20240909$20240529$20240918$PER$$US-SA-2024SA156477$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240918$$MD$US$US
239159553$23915955$3$F$$20240807$20240529$20240930$PER$$US-SA-2024SA157694$SANOFI AVENTIS$$$$A$F$Y$76.6$KG$20240930$$MD$US$US
239159573$23915957$3$F$$20240705$20240529$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04324$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239159602$23915960$2$F$$20240904$20240529$20240926$PER$$US-SA-2024SA157826$SANOFI AVENTIS$$$$T$F$Y$43.265$KG$20240926$$MD$US$US
239159612$23915961$2$F$$20240808$20240529$20240816$PER$$US-SA-2024SA158827$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$MD$US$US
239159653$23915965$3$F$$20240625$20240529$20240704$PER$$US-SA-2024SA158570$SANOFI AVENTIS$$$$A$F$Y$74.38$KG$20240704$$MD$US$US
239159702$23915970$2$F$$20240903$20240529$20240924$PER$$US-SA-2024SA156988$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240924$$MD$US$US
239159752$23915975$2$F$20231115$20240820$20240529$20240902$PER$$US-SA-2024SA157899$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240902$$MD$US$US
239159822$23915982$2$F$$20240814$20240529$20240828$PER$$US-SA-2023SA072592$SANOFI AVENTIS$$$$A$M$Y$$$20240828$$MD$US$US
239159885$23915988$5$F$20240509$20240626$20240529$20240704$EXP$$US-APELLIS-2024-APL-0000049$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240704$$CN$US$US
239159893$23915989$3$F$$20240620$20240529$20240701$PER$$US-SA-2024SA157312$SANOFI AVENTIS$$$$T$M$Y$$$20240701$$MD$US$US
239159954$23915995$4$F$20240401$20240814$20240529$20240819$EXP$$US-SA-2024SA157754$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240819$$MD$US$US
239160032$23916003$2$F$20240521$20240626$20240529$20240702$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-002925$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240702$$CN$CA$CA
239160133$23916013$3$F$20240101$20240708$20240529$20240717$PER$$US-SA-2024SA159403$SANOFI AVENTIS$$66$YR$E$F$Y$49.89$KG$20240717$$MD$US$US
239160172$23916017$2$F$20240101$20240807$20240529$20240816$PER$$US-SA-2024SA159330$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240816$$MD$US$US
239160514$23916051$4$F$20240101$20240904$20240529$20240911$EXP$$CA-KARYOPHARM-2024KPT000729$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240911$$CN$CA$CA
239160602$23916060$2$F$20240520$20240822$20240529$20240915$PER$$US-SA-2024SA160654$SANOFI AVENTIS$$59$YR$A$F$Y$103$KG$20240915$$MD$US$US
239160623$23916062$3$F$20240101$20240903$20240529$20240913$PER$$US-SA-2024SA159912$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240913$$MD$US$US
239160722$23916072$2$F$20240401$20240828$20240529$20240910$PER$$US-SA-2024SA052864$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240910$$MD$US$US
239160732$23916073$2$F$20240101$20240730$20240529$20240808$PER$$US-SA-2024SA157996$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240808$$MD$US$US
239160763$23916076$3$F$20240401$20240828$20240529$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084931$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240828$$HP$US$US
239160772$23916077$2$F$$20240719$20240529$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085445$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240723$$HP$US$US
239160792$23916079$2$F$$20240918$20240529$20240927$PER$$US-SA-2024SA160466$SANOFI AVENTIS$$$$A$F$Y$85.261$KG$20240927$$MD$US$US
239161042$23916104$2$F$$20240801$20240529$20240810$PER$$US-SA-2024SA160380$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240810$$MD$US$US
239161432$23916143$2$F$20240510$20240814$20240529$20240827$PER$$US-SA-2024SA160393$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240827$$MD$US$US
239161482$23916148$2$F$20240501$20240823$20240529$20240906$PER$$US-SA-2024SA160446$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240906$$MD$US$US
239161574$23916157$4$F$20240524$20240826$20240529$20240828$PER$$US-AMGEN-USASP2024105266$AMGEN$$51$YR$A$$Y$$$20240828$$CN$US$US
239161602$23916160$2$F$$20240624$20240529$20240703$PER$$US-SA-2024SA160301$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240703$$MD$US$US
239161802$23916180$2$F$$20240725$20240529$20240902$PER$$US-ASTELLAS-2024US015125$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
239161812$23916181$2$F$$20240701$20240529$20240902$PER$$US-ASTELLAS-2024US015095$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
239161872$23916187$2$F$20210816$20240808$20240529$20240820$EXP$$US-BIOMARINAP-US-2024-158179$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
239161925$23916192$5$F$20230101$20240716$20240529$20240723$EXP$$US-SA-2024SA158999$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240723$$MD$US$US
239161952$23916195$2$F$$20240701$20240529$20240710$PER$$US-SA-2024SA158500$SANOFI AVENTIS$$27$YR$A$F$Y$61$KG$20240710$$MD$US$US
239162062$23916206$2$F$20210401$20240823$20240529$20240830$EXP$$BR-GSK-BR2019GSK104166$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$BR$BR
239162084$23916208$4$F$$20240626$20240529$20240703$EXP$$US-JNJFOC-20240564038$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240704$$CN$US$US
239162094$23916209$4$F$20240401$20240709$20240529$20240731$EXP$$US-ALXN-202405USA000894US$ALEXION PHARMACEUTICALS$$66$YR$$F$Y$53.515$KG$20240801$$CN$US$US
239162232$23916223$2$F$20230901$20240910$20240529$20240917$EXP$$JP-AMGEN-JPNSP2023124051$AMGEN$$50$YR$A$F$Y$$$20240917$$MD$JP$JP
239162264$23916226$4$F$20231114$20240726$20240529$20240731$EXP$$CA-TAKEDA-2024TUS023498$TAKEDA$$16$YR$$F$Y$$$20240731$$HP$CA$CA
239162283$23916228$3$F$$20240917$20240529$20240919$EXP$$US-TAKEDA-2024TUS051642$TAKEDA$$$$$M$Y$$$20240919$$CN$US$US
239162352$23916235$2$F$$20240617$20240529$20240702$30DAY$$DE-JNJFOC-20240564193$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$DE$DE
239162422$23916242$2$F$20240101$20240819$20240529$20240821$EXP$$US-UCBSA-2024025334$UCB$$$$$F$Y$$$20240821$$CN$US$US
239162483$23916248$3$F$20240510$20240723$20240529$20240730$EXP$$CA-OTSUKA-2024_012315$OTSUKA$$53$YR$$F$Y$$$20240730$$CN$CA$CA
239162492$23916249$2$F$20240101$20240827$20240529$20240909$PER$$US-SA-2024SA157652$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240909$$MD$US$US
239162512$23916251$2$F$$20240621$20240529$20240703$PER$$US-SA-2024SA157255$SANOFI AVENTIS$$66$YR$E$F$Y$96.145$KG$20240703$$MD$US$US
239162552$23916255$2$F$$20240619$20240529$20240703$30DAY$$BR-JNJFOC-20240561209$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$PH$BR$BR
239162592$23916259$2$F$20230801$20240624$20240529$20240701$EXP$$BR-GSK-BR2023AMR148963$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$BR$BR
239162632$23916263$2$F$20240517$20240913$20240529$20240917$30DAY$$AR-PFIZER INC-202400173991$PFIZER$$9$YR$$M$Y$$$20240917$$CN$AR$AR
239163092$23916309$2$F$$20240813$20240529$20240815$PER$$US-PFIZER INC-PV202400069195$PFIZER$$84$YR$$M$Y$$$20240815$$CN$US$US
239163102$23916310$2$F$$20240628$20240529$20240701$PER$$US-PFIZER INC-PV202400070219$PFIZER$$87$YR$$F$Y$57.6$KG$20240701$$CN$US$US
239163152$23916315$2$F$20240501$20240722$20240529$20240725$PER$$US-PFIZER INC-202400180402$PFIZER$$59$YR$$F$Y$$$20240725$$HP$US$US
239163362$23916336$2$F$$20240814$20240529$20240819$30DAY$$AR-PFIZER INC-202400175761$PFIZER$$10$YR$$F$Y$$$20240819$$CN$AR$AR
239163372$23916337$2$F$$20240709$20240529$20240712$EXP$$JP-PFIZER INC-202400179637$PFIZER$$$$$$Y$$$20240712$$MD$JP$JP
239163605$23916360$5$F$20240523$20240823$20240529$20240827$PER$$US-AMGEN-USASP2024105616$AMGEN$$78$YR$E$F$Y$$$20240827$$CN$US$US
239163612$23916361$2$F$20240710$20240703$20240529$20240717$PER$$US-Calliditas-2024CAL00802$CALLIDITAS THERAPEUTICS$$39$YR$A$F$Y$54.8$KG$20240717$$CN$US$US
239163712$23916371$2$F$20231204$20240629$20240529$20240701$PER$$US-PFIZER INC-PV202400069165$PFIZER$$12$YR$$M$Y$$$20240701$$MD$US$US
239163727$23916372$7$F$20240501$20240914$20240529$20240918$EXP$$US-BIOVITRUM-2024-US-007799$BIOVITRUM$$55$YR$$F$Y$$$20240918$$CN$US$US
239163734$23916373$4$F$20240610$20240627$20240529$20240702$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-123856$DAIICHI$$31$YR$$F$Y$$$20240702$$CN$US$US
239163752$23916375$2$F$$20240618$20240529$20240703$30DAY$$NL-JNJFOC-20240553793$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$NL$NL
239163912$23916391$2$F$$20240808$20240529$20240817$PER$$US-SA-2024SA157692$SANOFI AVENTIS$$7$YR$C$F$Y$20.411$KG$20240817$$MD$US$US
239164024$23916402$4$F$20240424$20240916$20240529$20240918$EXP$$DE-TAKEDA-2024TUS053131$TAKEDA$$66$YR$$F$Y$$$20240918$$HP$DE$DE
239164043$23916404$3$F$20240514$20240828$20240529$20240902$EXP$$DE-SANDOZ INC.-SDZ2024DE052624$SANDOZ$$$$A$F$Y$108$KG$20240902$$CN$DE$DE
239164203$23916420$3$F$20230101$20240718$20240529$20240725$PER$$US-BIOGEN-2024BI01266709$BIOGEN$$$$$M$Y$$$20240725$$CN$US$US
239164342$23916434$2$F$$20240816$20240529$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA052806$SANDOZ$$43$YR$$F$Y$70$KG$20240819$$HP$CA$CA
239164385$23916438$5$F$20240101$20240708$20240529$20240802$30DAY$$US-AMGEN-USASP2024099819$AMGEN$$55$YR$A$F$Y$70.295$KG$20240802$$PH$US$US
239164413$23916441$3$F$$20240904$20240529$20240909$EXP$$CA-TAKEDA-2024TUS030083$TAKEDA$$$$$M$Y$$$20240909$$CN$CA$CA
239164622$23916462$2$F$$20240718$20240529$20240724$EXP$$JP-009507513-2405JPN002928J$MERCK$$43$YR$$F$Y$$$20240724$$MD$JP$JP
239164702$23916470$2$F$20240501$20240828$20240529$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085557$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240828$$HP$US$US
239164795$23916479$5$F$$20240911$20240529$20240919$EXP$$US-Calliditas-2024CAL00827$CALLIDITAS THERAPEUTICS$$62$YR$A$F$Y$85.2$KG$20240919$$CN$US$US
239164893$23916489$3$F$$20240804$20240529$20240810$PER$$NVSC2024US111440$NOVARTIS$$$$$$Y$$$20240811$$CN$US$US
239165022$23916502$2$F$$20240701$20240529$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085232$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240702$$CN$US$US
239165242$23916524$2$F$$20240529$20240529$20240720$PER$$US-HALEON-2178737$Haleon PLC$$$$$$Y$$$20240720$$CN$US$US
239165253$23916525$3$F$$20240902$20240529$20240905$EXP$$JP-AMGEN-JPNSP2024103020$AMGEN$$$$$M$Y$$$20240905$$MD$JP$JP
239165334$23916533$4$F$20240812$20240826$20240529$20240909$PER$$US-Calliditas-2024CAL00810$CALLIDITAS THERAPEUTICS$$62$YR$A$F$Y$103$KG$20240909$$CN$US$US
239165502$23916550$2$F$20240301$20240806$20240529$20240813$EXP$$US-TAKEDA-2024TUS030392$TAKEDA$$58$YR$$F$Y$78.3$KG$20240813$$HP$US$US
239165512$23916551$2$F$20230101$20240919$20240529$20240926$EXP$$NVSC2024SI076385$NOVARTIS$$47$YR$$M$Y$$$20240926$$MD$SI$SI
239165562$23916556$2$F$20240101$20240815$20240529$20240821$EXP$$CN-PFIZER INC-PV202400069480$PFIZER$$57$YR$$M$Y$$$20240821$$CN$CN$CN
239165593$23916559$3$F$20240501$20240828$20240529$20240904$EXP$$JP-PFIZER INC-202400180471$PFIZER$$8$DEC$$M$Y$$$20240904$$MD$JP$JP
239165854$23916585$4$F$$20240910$20240529$20240912$PER$$NVSC2024US112725$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
239165982$23916598$2$F$$20240806$20240529$20240808$PER$$NVSC2024US113045$NOVARTIS$$$$$F$Y$$$20240808$$HP$US$US
239166023$23916602$3$F$$20240628$20240529$20240708$EXP$$GB-TAKEDA-2024TUS042002$TAKEDA$$$$$M$Y$$$20240708$$CN$GB$GB
239166072$23916607$2$F$20240501$20240620$20240529$20240705$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00811$AVADEL CNS PHARMA$$73$YR$$F$Y$$$20240705$$CN$US$US
239166756$23916675$6$F$20240522$20240820$20240529$20240827$EXP$$GB-APELLIS-APL-2024-003567$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240827$$HP$GB$GB
239166953$23916695$3$F$$20240618$20240529$20240704$30DAY$$DE-JNJFOC-20240550869$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$PH$DE$DE
239167003$23916700$3$F$$20240712$20240529$20240717$30DAY$$FR-PFIZER INC-202400130664$PFIZER$$14$YR$$M$Y$$$20240717$$PH$FR$FR
239167106$23916710$6$F$20230511$20240712$20240529$20240918$EXP$$AT-SANDOZ INC.-SDZ2024AT026958$SANDOZ$$35$YR$$F$Y$62$KG$20240918$$MD$AT$AT
239167273$23916727$3$F$20240708$20240903$20240529$20240913$EXP$$JP-APELLIS-APL-2024-003967$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240913$$CN$JP$JP
239167292$23916729$2$F$20240101$20240708$20240529$20240717$PER$$US-SA-2024SA156850$SANOFI AVENTIS$$52$YR$A$F$Y$62.14$KG$20240717$$MD$US$US
239167383$23916738$3$F$$20240717$20240529$20240718$PER$$US-ALXN-202405USA001512US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239167433$23916743$3$F$20240306$20240711$20240529$20240716$EXP$$ZA-JNJFOC-20240571824$JOHNSON AND JOHNSON$$70$YR$E$M$Y$95$KG$20240716$$MD$ZA$ZA
239167442$23916744$2$F$20230126$20240723$20240529$20240726$EXP$$JP-Eisai-EC-2024-166448$EISAI$$67$YR$E$F$Y$43$KG$20240726$$MD$JP$JP
239167485$23916748$5$F$$20240925$20240529$20240930$30DAY$$US-PFIZER INC-202400174173$PFIZER$$12$YR$$M$Y$$$20240930$$CN$US$US
239167494$23916749$4$F$$20240814$20240529$20240820$30DAY$$US-PFIZER INC-202400175282$PFIZER$$13$YR$$M$Y$33.57$KG$20240820$$CN$US$US
239167636$23916763$6$F$20240523$20240704$20240529$20240716$30DAY$$US-JNJFOC-20240571710$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240716$$CN$US$US
239167642$23916764$2$F$$20240702$20240529$20240712$PER$$US-JNJFOC-20240572518$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
239167674$23916767$4$F$20240430$20240701$20240529$20240706$EXP$$US-TAKEDA-2024TUS052130$TAKEDA$$34$YR$$F$Y$$$20240706$$CN$US$US
239167713$23916771$3$F$20240613$20240801$20240529$20240807$EXP$$CA-TAKEDA-2024TUS048868$TAKEDA$$44$YR$$M$Y$$$20240807$$HP$CA$CA
239167722$23916772$2$F$20230919$20240630$20240529$20240703$EXP$$CN-ABBVIE-5772961$ABBVIE$$36$YR$$F$Y$82$KG$20240703$$MD$CN$CN
239167773$23916777$3$F$$20240718$20240529$20240724$PER$$NVSC2024US111415$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
239168222$23916822$2$F$$20240522$20240529$20240813$PER$$US-BAYER-2024A075675$BAYER$$40$YR$A$F$Y$$$20240813$$HP$US$US
239168243$23916824$3$F$20240519$20240702$20240529$20240722$30DAY$$US-MYLANLABS-2024M1047385$MYLAN$$6$YR$$M$Y$38.5$KG$20240722$$CN$US$US
239168264$23916826$4$F$20240512$20240703$20240529$20240704$EXP$$NVSC2024IR111356$NOVARTIS$$40$YR$$M$Y$$$20240704$$CN$IR$IR
239168392$23916839$2$F$20240419$20240723$20240529$20240731$EXP$$AU-ABBVIE-5779281$ABBVIE$$79$YR$$M$Y$$$20240731$$CN$AU$AU
239168903$23916890$3$F$$20240814$20240529$20240826$EXP$$CA-AMRYT PHARMACEUTICALS DAC-AEGR006981$AEGERION$$$$$$Y$$$20240826$$CN$CA$CA
239168932$23916893$2$F$$20240925$20240529$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085558$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$77.56$KG$20240926$$CN$US$US
239169123$23916912$3$F$20190901$20240830$20240529$20240906$EXP$$DE-SANDOZ INC.-NVSC2020DE220483$SANDOZ$$$$E$F$Y$99$KG$20240906$$HP$DE$DE
239169132$23916913$2$F$$20240902$20240529$20240903$EXP$$US-SANDOZ INC.-SDZ2024US052632$SANDOZ$$$$$$Y$$$20240903$$CN$US$US
239169197$23916919$7$F$20240513$20240816$20240529$20240819$EXP$$DE-SANDOZ INC.-SDZ2024DE052702$SANDOZ$$83$YR$$M$Y$71.2$KG$20240819$$MD$DE$DE
239169362$23916936$2$F$$20240716$20240529$20240717$EXP$$US-ALXN-202405USA001602US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240717$$MD$US$US
239169442$23916944$2$F$$20240827$20240529$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-085354$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240830$$MD$JP$JP
239170002$23917000$2$F$20240222$20240625$20240529$20240701$EXP$$JP-BAYER-2024A077500$BAYER$$72$YR$E$M$Y$$$20240701$$MD$JP$JP
239170392$23917039$2$F$$20240813$20240529$20240819$PER$$NVSC2024US113118$NOVARTIS$$$$$$Y$$$20240819$$CN$US$US
239170434$23917043$4$F$20230807$20240805$20240529$20240807$EXP$$JP-DSJP-DSJ-2024-118769$DAIICHI$$6$DEC$$F$Y$46$KG$20240807$$MD$JP$JP
239171032$23917103$2$F$$20240911$20240529$20240918$PER$$US-Calliditas-2024CAL00821$CALLIDITAS THERAPEUTICS$$55$YR$A$F$Y$54.8$KG$20240918$$CN$US$US
239171222$23917122$2$F$20240201$20240703$20240529$20240708$EXP$$US-SA-2024SA160379$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240708$$MD$US$US
239171282$23917128$2$F$$20240703$20240529$20240712$PER$$US-SA-2024SA160823$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
239171372$23917137$2$F$$20240816$20240529$20240819$PER$$NVSC2024US113146$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
239171382$23917138$2$F$20240501$20240520$20240529$20240703$EXP$$US-VIIV HEALTHCARE LIMITED-US2024064669$VIIV$$$$$$Y$$$20240703$$HP$US$US
239171432$23917143$2$F$$20240703$20240529$20240710$PER$$US-INCYTE CORPORATION-2024IN005549$INCYTE$$$$$$Y$$$20240710$$CN$US$US
239171493$23917149$3$F$20240301$20240724$20240529$20240729$EXP$$CA-LUNDBECK-DKLU3078560$LUNDBECK$$$$$$Y$$$20240729$$CN$CA$CA
239171523$23917152$3$F$20240223$20240722$20240529$20240725$EXP$$US-INCYTE CORPORATION-2024IN004809$INCYTE$$$$$$Y$$$20240725$$HP$US$US
239171552$23917155$2$F$$20240523$20240529$20240718$EXP$$US-Taiho Oncology Inc-2024-005309$TAIHO ONCOLOGY INC$$$$A$F$Y$$$20240718$$CN$US$US
239171562$23917156$2$F$20240506$20240826$20240529$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084415$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240826$$CN$US$US
239171602$23917160$2$F$$20240702$20240529$20240709$PER$$US-BIOMARINAP-US-2024-157879$BIOMARIN$$$$$$Y$$$20240709$$CN$US$US
239171612$23917161$2$F$$20240708$20240529$20240712$PER$$US-BIOMARINAP-US-2024-157903$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
239171684$23917168$4$F$$20240703$20240529$20240711$PER$$US-BIOMARINAP-US-2024-158123$BIOMARIN$$$$$$Y$$$20240711$$CN$US$US
239171743$23917174$3$F$$20240626$20240529$20240710$PER$$US-Calliditas-2024CAL00782$CALLIDITAS THERAPEUTICS$$59$YR$A$M$Y$$$20240710$$CN$US$US
239172043$23917204$3$F$20240512$20240809$20240529$20240819$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-15776$SAMSUNG BIOEPIS$$77$YR$E$F$Y$58$KG$20240819$$MD$DE$DE
239172202$23917220$2$F$$20240711$20240529$20240716$PER$$US-BIOMARINAP-US-2024-157988$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
239172232$23917223$2$F$20240401$20240528$20240529$20240723$PER$$US-LUNDBECK-DKLU3077796$LUNDBECK$$$$$$Y$$$20240723$$CN$US$US
239172292$23917229$2$F$20231115$20240904$20240529$20240923$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000466$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
239172306$23917230$6$F$20240301$20240812$20240529$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000097$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
239172314$23917231$4$F$20240401$20240903$20240529$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000125$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
239172343$23917234$3$F$20240101$20240814$20240529$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000140$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
239172362$23917236$2$F$20240504$20240722$20240529$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000142$UNKNOWN$$$$$$Y$$$20240805$$CN$US$US
239172382$23917238$2$F$20240401$20240820$20240529$20240923$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000510$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
239172412$23917241$2$F$20240101$20240808$20240529$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000067$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
239172432$23917243$2$F$20240101$20240829$20240529$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000079$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
239172583$23917258$3$F$$20240916$20240529$20240924$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001080$BLUEPRINT MEDICINES$$$$$F$Y$$$20240924$$CN$US$US
239172722$23917272$2$F$$20240709$20240529$20240710$PER$$NVSC2024US113158$NOVARTIS$$$$$$Y$$$20240710$$HP$US$US
239172742$23917274$2$F$$20240529$20240529$20240724$PER$$US-HALEON-2178734$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
239172802$23917280$2$F$20240528$20240729$20240529$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085470$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240807$$HP$US$US
239172862$23917286$2$F$$20240718$20240529$20240726$PER$$US-ALXN-202405USA001645US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
239172883$23917288$3$F$$20240709$20240529$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085534$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240711$$HP$US$US
239172943$23917294$3$F$20240430$20240819$20240529$20240823$PER$FR-AFSSAPS-NY2024000549$FR-Eisai-EC-2024-166251$EISAI$$76$YR$E$F$Y$80$KG$20240823$$HP$FR$FR
239172962$23917296$2$F$20240202$20240809$20240529$20240814$PER$$JP-Eisai-EC-2024-164337$EISAI$$$$E$F$Y$$$20240814$$MD$JP$JP
239173192$23917319$2$F$$20240710$20240529$20240716$PER$$US-ALXN-202405USA001593US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
239173252$23917325$2$F$20231115$20240702$20240529$20240709$EXP$$JP-BIOMARINAP-JP-2023-154103$BIOMARIN$$$$$$Y$$$20240709$$CN$JP$JP
239173272$23917327$2$F$$20240827$20240529$20240829$PER$$US-ALXN-202405USA001583US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
239173293$23917329$3$F$20240101$20240812$20240529$20240819$PER$$US-ALXN-202405USA001582US$ALEXION PHARMACEUTICALS$$80$YR$$M$Y$$$20240819$$CN$US$US
239173373$23917337$3$F$20240621$20240716$20240529$20240724$EXP$$US-BIOMARINAP-US-2024-158005$BIOMARIN$$$$$$Y$$$20240724$$CN$US$US
239173403$23917340$3$F$20240523$20240619$20240529$20240708$PER$$US-AstraZeneca-2024A122124$ASTRAZENECA$$27016$DY$$F$Y$$$20240708$$HP$US$
239173412$23917341$2$F$$20240524$20240529$20240708$EXP$$JP-MTPC-MTPC2024-0011163$Unknown Manufacturer$$9$DEC$$M$Y$$$20240708$$PH$JP$JP
239173472$23917347$2$F$20240426$20240709$20240529$20240711$EXP$$NVSJ2024JP006299$NOVARTIS$$49$YR$$M$Y$59$KG$20240712$$PH$JP$JP
239173572$23917357$2$F$$20240705$20240529$20240710$PER$$US-BIOGEN-2024BI01266684$BIOGEN$$$$$M$Y$$$20240710$$CN$US$US
239173872$23917387$2$F$20240509$20240723$20240529$20240730$EXP$$JP-BIOMARINAP-JP-2024-158094$BIOMARIN$$$$$$Y$$$20240730$$CN$JP$JP
239174143$23917414$3$F$20240524$20240830$20240529$20240906$EXP$$NL-ABBVIE-5779492$ABBVIE$$$$E$F$Y$$$20240906$$CN$NL$NL
239174385$23917438$5$F$20240101$20240708$20240529$20240802$30DAY$$US-AMGEN-USASP2024098815$AMGEN$$55$YR$A$F$Y$69.841$KG$20240802$$PH$US$US
239174453$23917445$3$F$20240401$20240816$20240529$20240822$EXP$$US-ABBVIE-5779590$ABBVIE$$72$YR$$F$Y$58.966$KG$20240822$$CN$US$US
239174573$23917457$3$F$$20240816$20240529$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061974$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$90.26$KG$20240816$$CN$US$US
239174662$23917466$2$F$$20240812$20240529$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-074106$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$93.878$KG$20240812$$CN$US$US
239174754$23917475$4$F$20240517$20240625$20240529$20240708$PER$$US-JNJFOC-20240561085$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240709$$CN$US$US
239174832$23917483$2$F$$20240720$20240529$20240729$PER$$US-SA-2024SA159093$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240729$$MD$US$US
239174873$23917487$3$F$$20240711$20240529$20240718$EXP$$NVSJ2024JP006335$NOVARTIS$$$$E$M$Y$$$20240718$$MD$JP$JP
239174923$23917492$3$F$20240520$20240913$20240529$20240920$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001092$BLUEPRINT MEDICINES$$45$YR$A$F$Y$$$20240920$$CN$US$US
239174946$23917494$6$F$20240222$20240806$20240529$20240809$EXP$$ES-JNJFOC-20240488910$JOHNSON AND JOHNSON$$67$YR$E$M$Y$64$KG$20240809$$HP$ES$ES
239174982$23917498$2$F$$20240524$20240529$20240718$PER$$US-HALEON-2178617$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239175194$23917519$4$F$20240101$20240910$20240529$20240917$EXP$$CA-CELLTRION INC.-2024CA012514$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
239175363$23917536$3$F$20240101$20240717$20240529$20240725$EXP$$CA-CELLTRION INC.-2024CA012534$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
239175413$23917541$3$F$20160414$20240829$20240529$20240905$EXP$$BE-ABBVIE-17K-013-3081891-00$ABBVIE$$68$YR$$M$Y$$$20240905$$HP$BE$BE
239175522$23917552$2$F$$20240627$20240530$20240701$30DAY$$US-GSK-US2024063694$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
239175533$23917553$3$F$20240519$20240806$20240530$20240827$30DAY$$US-GSK-US2024063722$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240827$$CN$US$US
239175602$23917560$2$F$20240501$20240703$20240530$20240716$EXP$$PL-ELI_LILLY_AND_COMPANY-PL202405011076$ELI LILLY AND CO$$63$YR$A$F$Y$93$KG$20240716$$CN$PL$PL
239175612$23917561$2$F$$20240704$20240530$20240712$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202405011813$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240712$$CN$DE$DE
239175832$23917583$2$F$$20240703$20240530$20240712$EXP$$JP-SMPA-2024SMP007155$SUNOVION$$$$$$Y$$$20240712$$CN$JP$JP
239175842$23917584$2$F$$20240702$20240530$20240710$EXP$$US-SANDOZ INC.-SDZ2024US053091$SANDOZ$$44$YR$$F$Y$$$20240710$$CN$US$US
239176002$23917600$2$F$20231201$20240625$20240530$20240704$EXP$$MX-NOVOPROD-1225523$NOVO NORDISK$$86$YR$$M$Y$70$KG$20240704$$CN$MX$MX
239176012$23917601$2$F$20240508$20240716$20240530$20240724$EXP$$US-NOVOPROD-1227273$NOVO NORDISK$$53$YR$$M$Y$$$20240724$$CN$US$US
239176042$23917604$2$F$20240101$20240715$20240530$20240723$PER$$US-SA-2024SA159802$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240723$$CN$US$US
239176113$23917611$3$F$20240526$20240826$20240530$20240828$PER$$US-AMGEN-USASP2024105827$AMGEN$$85$YR$E$F$Y$$$20240828$$CN$US$US
239176172$23917617$2$F$$20240528$20240530$20240724$PER$$US-HALEON-2178753$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
239176252$23917625$2$F$$20240712$20240530$20240719$EXP$$US-TAKEDA-2024TUS053395$TAKEDA$$$$$M$Y$$$20240719$$CN$US$US
239176472$23917647$2$F$20230101$20240715$20240530$20240724$EXP$$GR-NOVOPROD-1226405$NOVO NORDISK$$57$YR$$M$Y$135$KG$20240724$$CN$GR$GR
239176563$23917656$3$F$$20240911$20240530$20240926$EXP$$CA-HALEON-2170297$Haleon PLC$$43$YR$$F$Y$96$KG$20240926$$HP$CA$CA
239176702$23917670$2$F$20240516$20240716$20240530$20240717$EXP$$US-ALXN-202405USA001626US$ALEXION PHARMACEUTICALS$$66$YR$$M$Y$$$20240717$$CN$US$US
239176774$23917677$4$F$20231124$20240705$20240530$20240710$30DAY$$US-GSK-US2024064849$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240710$$CN$US$US
239176923$23917692$3$F$20240515$20240717$20240530$20240726$EXP$$CA-CELLTRION INC.-2024CA012573$CELLTRION$$$$$$Y$$$20240726$$HP$CA$CA
239177254$23917725$4$F$20240101$20240919$20240530$20240930$EXP$$PL-GENMAB-2024-01882$GENMAB$$43$YR$$F$Y$60$KG$20240930$$MD$PL$PL
239177293$23917729$3$F$20240426$20240628$20240530$20240702$PER$$US-AMGEN-USASP2024104921$AMGEN$$71$YR$E$F$Y$$$20240702$$CN$US$US
239177312$23917731$2$F$$20240814$20240530$20240902$PER$$AU-TOLMAR, INC.-24AU049080$TOLMAR$$$$$M$Y$$$20240902$$CN$AU$AU
239177454$23917745$4$F$20240101$20240813$20240530$20240826$PER$$US-SA-2024SA160365$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240826$$MD$US$US
239177463$23917746$3$F$20240501$20240624$20240530$20240703$PER$$US-SA-2024SA160875$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240703$$MD$US$US
239177492$23917749$2$F$$20240812$20240530$20240822$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000474$DECIPHERA PHARMACEUTICALS$$73$YR$E$M$Y$$$20240822$$CN$US$US
239177512$23917751$2$F$$20240624$20240530$20240701$PER$$US-JNJFOC-20240561036$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$HP$US$US
239177532$23917753$2$F$20240101$20240911$20240530$20240926$PER$$US-SA-2024SA160516$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240926$$MD$US$US
239177566$23917756$6$F$$20240730$20240530$20240801$EXP$$US-JNJFOC-20240564811$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$HP$US$US
239177592$23917759$2$F$20230101$20240717$20240530$20240725$EXP$$CA-CELLTRION INC.-2023CA021193$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
239177623$23917762$3$F$20240420$20240607$20240530$20240813$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448552$RANBAXY$$90$YR$E$F$Y$$$20240813$$CN$US$US
239177782$23917778$2$F$20240501$20240826$20240530$20240902$EXP$$JP-AMGEN-JPNSP2024105061$AMGEN$$75$YR$E$$Y$$$20240902$$MD$JP$JP
239177913$23917791$3$F$20240101$20240829$20240530$20240906$EXP$$CA-CELLTRION INC.-2024CA006388$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
239177944$23917794$4$F$$20240828$20240530$20240830$PER$$US-AMGEN-USASP2024103704$AMGEN$$$$$F$Y$$$20240830$$PH$US$US
239178003$23917800$3$F$20240601$20240807$20240530$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085877$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240809$$CN$US$US
239178202$23917820$2$F$20240528$20240820$20240530$20240824$EXP$$JP-ABBVIE-5779547$ABBVIE$$70$YR$$F$Y$$$20240824$$MD$JP$JP
239178232$23917823$2$F$20240526$20240708$20240530$20240709$PER$$US-AMGEN-USASP2024105281$AMGEN$$74$YR$E$F$Y$$$20240708$$CN$US$US
239178282$23917828$2$F$20240109$20240708$20240530$20240718$EXP$$CA-ROCHE-3490538$ROCHE$$46$YR$A$F$Y$$$20240718$$CN$CA$CA
239178294$23917829$4$F$$20240909$20240530$20240918$EXP$$GB-ROCHE-3568698$ROCHE$$$$E$F$Y$$$20240918$$CN$GB$GB
239178413$23917841$3$F$$20240527$20240530$20240805$EXP$$NVSC2024US110528$NOVARTIS$$$$$F$Y$$$20240805$$CN$US$US
239178512$23917851$2$F$20240527$20240821$20240530$20240824$PER$$US-AMGEN-USASP2024104951$AMGEN$$63$YR$A$M$Y$$$20240824$$CN$US$US
239178567$23917856$7$F$$20240730$20240530$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-024431$AUROBINDO$$31$YR$$F$Y$$$20240809$$HP$GB$GB
239178587$23917858$7$F$20240101$20240807$20240530$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014831$UNITED THERAPEUTICS$$$$$F$Y$107.94$KG$20240816$$$US$US
239178622$23917862$2$F$20240512$20240704$20240530$20240708$PER$$US-JNJFOC-20240564452$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$US$US
239178682$23917868$2$F$$20240923$20240530$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086047$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240924$$CN$US$US
239178692$23917869$2$F$$20240624$20240530$20240702$EXP$$US-AMGEN-USASP2024103296$AMGEN$Hoch V.; Burke P.; Hans A.. A REFRACTORY CASE OF RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS DUE TO MICROSCOPIC POLYANGIITIS. American Journal of Kidney Diseases. 2024;83 (4):S24$75$YR$E$F$Y$$$20240702$$HP$US$US
239178732$23917873$2$F$20240101$20240725$20240530$20240729$PER$$US-AMGEN-USASP2024105907$AMGEN$$60$YR$A$M$Y$$$20240728$$CN$US$US
239178902$23917890$2$F$20240501$20240523$20240530$20240926$PER$$US-GSK-US2024AMR065174$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240926$$CN$US$US
239178962$23917896$2$F$20240101$20240725$20240530$20240730$EXP$$IT-GENMAB-2024-01885$GENMAB$$52$YR$$M$Y$90$KG$20240730$$MD$IT$IT
239179056$23917905$6$F$20240408$20240719$20240530$20240725$EXP$$DE-JNJFOC-20240575717$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$CN$DE$DE
239179203$23917920$3$F$$20240914$20240530$20240923$EXP$$CA-TAKEDA-2024TUS052710$TAKEDA$$$$$F$Y$$$20240923$$MD$CA$CA
239179346$23917934$6$F$20231212$20240805$20240530$20240817$EXP$$DE-AUROBINDO-AUR-APL-2024-025109$AUROBINDO$$$$E$F$Y$82.4$KG$20240817$$MD$DE$DE
239179352$23917935$2$F$$20240522$20240530$20240807$PER$$US-AstraZeneca-2024A120644$ASTRAZENECA$$$$$$Y$$$20240807$$CN$US$
239179382$23917938$2$F$$20240529$20240530$20240718$PER$$US-HALEON-2178706$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239179416$23917941$6$F$20220926$20240813$20240530$20240821$EXP$$CA-CELLTRION INC.-2022CA012548$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
239179422$23917942$2$F$20240518$20240917$20240530$20240918$EXP$$US-TAKEDA-2024TUS021891$TAKEDA$$74$YR$$F$Y$$$20240918$$CN$US$US
239179555$23917955$5$F$20240101$20240819$20240530$20240826$EXP$$CA-CELLTRION INC.-2024CA012541$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
239179693$23917969$3$F$20240526$20240710$20240530$20240712$PER$$US-AMGEN-USASP2024105586$AMGEN$$63$YR$A$F$Y$$$20240712$$CN$US$US
239179843$23917984$3$F$$20240706$20240530$20240708$EXP$$US-SANDOZ INC.-SDZ2024US052028$SANDOZ$$$$$F$Y$$$20240708$$MD$US$US
239179902$23917990$2$F$$20240529$20240530$20240720$PER$$US-HALEON-2178846$Haleon PLC$$$$$F$Y$$$20240720$$CN$US$US
239179913$23917991$3$F$20240531$20240920$20240530$20240927$EXP$$CA-TAKEDA-2024TUS052369$TAKEDA$$38$YR$$F$Y$$$20240927$$CN$CA$CA
239180123$23918012$3$F$20231115$20240724$20240530$20240729$EXP$$US-TAKEDA-2024TUS051768$TAKEDA$$3$YR$$F$Y$$$20240729$$HP$US$US
239180272$23918027$2$F$$20240724$20240530$20240808$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448875$RANBAXY$Gaspar CF, Greenfield H, Carneiro L. Donepezil as a cause of cardiogenic syncope- elderly heaven or hell. Eur J Case Rep Intern Med. 2019;6 (Suppl.):116(1967)$80$YR$$F$Y$$$20240808$$HP$PT$PT
239180373$23918037$3$F$$20240904$20240530$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085922$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240905$$CN$US$US
239180433$23918043$3$F$20240501$20240701$20240530$20240708$EXP$$US-SA-2024SA160319$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240708$$MD$US$US
239180445$23918044$5$F$20240201$20240821$20240530$20240905$PER$$US-SA-2024SA157728$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240905$$MD$US$US
239180682$23918068$2$F$20240101$20240624$20240530$20240703$PER$$US-SA-2024SA158387$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240703$$MD$US$US
239180713$23918071$3$F$$20240814$20240530$20240829$EXP$CZ-CZSUKL-24001373$CZ-MELINTA THERAPEUTICS, LLC-CZ-MLNT-24-00277$MELINTA THERAPEUTICS$$$$$$Y$$$20240829$$MD$CZ$CZ
239180735$23918073$5$F$20240530$20240808$20240530$20240816$EXP$$CA-TAKEDA-2024TUS053105$TAKEDA$$60$YR$$F$Y$$$20240816$$CN$CA$CA
239180752$23918075$2$F$20240525$20240730$20240530$20240803$PER$$US-AMGEN-USASP2024105632$AMGEN$$67$YR$E$M$Y$$$20240803$$CN$US$US
239180814$23918081$4$F$20240607$20240628$20240530$20240708$EXP$$US-GSK-US2024AMR066879$GLAXOSMITHKLINE$$70$YR$$F$Y$54$KG$20240708$$CN$US$US
239180822$23918082$2$F$$20240625$20240530$20240703$30DAY$$US-GSK-US2024065030$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
239181032$23918103$2$F$$20240706$20240530$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04438$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239181092$23918109$2$F$20240401$20240909$20240530$20240918$EXP$$PK-ROCHE-3567607$ROCHE$$60$YR$A$F$Y$70$KG$20240918$$CN$PK$PK
239181202$23918120$2$F$20240522$20240621$20240530$20240704$30DAY$$US-GSK-US2024AMR065995$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240704$$CN$US$US
239181442$23918144$2$F$20240101$20240707$20240530$20240715$PER$$US-SA-2024SA159019$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240715$$MD$US$US
239181472$23918147$2$F$$20240709$20240530$20240715$EXP$$ES-AMGEN-ESPSP2024102706$AMGEN$Rimola J.; Fernandez-clotet A.; Ordas I. et al.. Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long-term adverse outcomes in Crohn^s disease. Alimentary Pharmacology + Therapeutics. 2024;59 (11):1435-1445$$$$$Y$$$20240715$$HP$ES$ES
239181482$23918148$2$F$20240424$20240628$20240530$20240704$EXP$$US-009507513-2405USA006932$MERCK$$$$$F$Y$$$20240704$$CN$US$US
239181532$23918153$2$F$20230101$20240924$20240530$20240930$EXP$$JP-JNJFOC-20240204359$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240930$$MD$JP$JP
239181592$23918159$2$F$$20240705$20240530$20240716$PER$$US-SA-2024SA157793$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240716$$MD$US$US
239181642$23918164$2$F$20240624$20240705$20240530$20240709$EXP$$US-UCBSA-2024024830$UCB$$56$YR$$F$Y$$$20240709$$CN$US$US
239181712$23918171$2$F$$20240817$20240530$20240822$PER$$NVSC2024US113134$NOVARTIS$$$$$$Y$$$20240822$$CN$US$US
239181722$23918172$2$F$$20240726$20240530$20240730$EXP$$NVSC2024US112591$NOVARTIS$$$$$F$Y$58.957$KG$20240730$$CN$US$US
239181782$23918178$2$F$20210310$20240919$20240530$20240924$EXP$$JP-GSK-JP2020JPN202525$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
239181802$23918180$2$F$$20240909$20240530$20240915$30DAY$$US-SANDOZ INC.-SDZ2024US052916$SANDOZ$$$$$M$Y$$$20240915$$MD$US$US
239181872$23918187$2$F$20240501$20240626$20240530$20240704$EXP$$CA-CELLTRION INC.-2024CA012671$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
239181934$23918193$4$F$20240601$20240719$20240530$20240723$EXP$$CA-JNJFOC-20240573434$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20240723$$HP$CA$CA
239181953$23918195$3$F$$20240814$20240530$20240823$30DAY$$US-GSK-US2024063139$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
239182084$23918208$4$F$20240522$20240827$20240530$20240902$PER$$US-AMGEN-USASP2024103875$AMGEN$$64$YR$A$M$Y$85.261$KG$20240902$$HP$US$US
239182162$23918216$2$F$20240501$20240624$20240530$20240703$PER$$US-SA-2024SA158890$SANOFI AVENTIS$$49$YR$A$F$Y$81.6$KG$20240703$$MD$US$US
239182192$23918219$2$F$20240101$20240815$20240530$20240821$EXP$$CA-ABBVIE-5779169$ABBVIE$$54$YR$$F$Y$$$20240821$$CN$CA$CA
239182202$23918220$2$F$$20240525$20240530$20240717$PER$$US-HALEON-2178120$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239182432$23918243$2$F$$20240711$20240530$20240731$PER$$BR-TOLMAR, INC.-24BR049150$TOLMAR$$$$$M$Y$$$20240731$$PH$BR$BR
239182492$23918249$2$F$20240425$20240614$20240530$20240704$PER$$CA-TOLMAR, INC.-24CA048935$TOLMAR$$62$YR$$M$Y$$$20240704$$HP$CA$CA
239182562$23918256$2$F$20240101$20240528$20240530$20240715$PER$$US-SA-2024SA162273$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240715$$CN$US$US
239182692$23918269$2$F$$20240730$20240530$20240805$EXP$$JP-GSK-JP2024JPN065092$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$PH$JP$JP
239182892$23918289$2$F$$20240717$20240530$20240723$PER$$US-HALEON-2178711$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239183133$23918313$3$F$$20240630$20240530$20240703$EXP$$AU-AstraZeneca-2024A120110$ASTRAZENECA$$78$YR$$M$Y$$$20240703$$MD$AU$
239183283$23918328$3$F$20240526$20240701$20240530$20240705$PER$$US-AMGEN-USASP2024104838$AMGEN$$73$YR$E$F$Y$$$20240704$$CN$US$US
239183553$23918355$3$F$20240519$20240717$20240530$20240725$EXP$$CA-CELLTRION INC.-2024CA012536$CELLTRION$$$$$$Y$$$20240725$$CN$CA$CA
239183573$23918357$3$F$$20240720$20240530$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04344$LUPIN$$$$$$Y$$$20240813$$CN$US$US
239183612$23918361$2$F$$20240805$20240530$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083906$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240808$$CN$US$US
239183646$23918364$6$F$20240515$20240916$20240530$20240926$PER$$US-GSK-US2024AMR066042$GLAXOSMITHKLINE$$52$YR$$F$Y$61.224$KG$20240926$$CN$US$US
239183652$23918365$2$F$20240528$20240816$20240530$20240820$PER$$US-AMGEN-USASP2024105761$AMGEN$$58$YR$A$F$Y$$$20240820$$CN$US$US
239183792$23918379$2$F$$20240711$20240530$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04378$LUPIN$$$$$$Y$$$20240809$$CN$US$US
239183842$23918384$2$F$$20240911$20240530$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA052882$SANDOZ$$44$YR$$F$Y$$$20240913$$HP$CA$CA
239183862$23918386$2$F$20240509$20240621$20240530$20240703$30DAY$$US-JNJFOC-20240532032$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240703$$HP$US$US
239184342$23918434$2$F$$20240805$20240530$20240820$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448603$RANBAXY$Silva A, De Sousa C, Madaleno J, Canha C, Simao A, Carvalho A. NON-ALCOHOLIC STEATOHEPATITIS AFTER LONG-TERM CORTICOSTEROID THERAPY. Eur J Case Rep Intern Med. 2019;6 (Suppl.):351-352/1432$56$YR$$M$Y$$$20240820$$HP$PT$PT
239184392$23918439$2$F$$20240723$20240530$20240723$EXP$$FR-JNJFOC-20240563059$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240723$$PH$FR$FR
239184402$23918440$2$F$20240529$20240529$20240530$20240724$PER$$US-HALEON-2178882$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
239184413$23918441$3$F$20240513$20240621$20240530$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04343$LUPIN$$$$$$Y$$$20240703$$CN$US$US
239184422$23918442$2$F$20160101$20240703$20240530$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-449079$RANBAXY$$34$YR$$M$Y$79$KG$20240718$$CN$FR$FR
239184492$23918449$2$F$$20240529$20240530$20240722$PER$$US-HALEON-2178843$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
239185004$23918500$4$F$20240506$20240918$20240530$20240925$EXP$$CA-TAKEDA-2024TUS053096$TAKEDA$$57$YR$$F$Y$$$20240925$$CN$CA$CA
239185017$23918501$7$F$20240704$20240917$20240530$20240924$EXP$$CA-TAKEDA-2024TUS053594$TAKEDA$$76$YR$$M$Y$$$20240924$$HP$CA$CA
239185073$23918507$3$F$$20240729$20240530$20240808$30DAY$$US-GSK-US2024AMR063377$GLAXOSMITHKLINE$$$$$M$Y$$$20240808$$MD$US$US
239185082$23918508$2$F$20240506$20240705$20240530$20240708$EXP$$DE-SANDOZ INC.-SDZ2024DE052843$SANDOZ$$33$YR$$F$Y$71$KG$20240708$$MD$DE$DE
239185132$23918513$2$F$$20240809$20240530$20240814$EXP$$CA-JNJFOC-20240486679$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20240814$$HP$CA$CA
239185232$23918523$2$F$20240524$20240808$20240530$20240812$PER$$US-ABBVIE-5779971$ABBVIE$$33$YR$$F$Y$$$20240812$$MD$US$US
239185297$23918529$7$F$20230808$20240920$20240530$20240927$EXP$$CA-TAKEDA-2023TUS078547$TAKEDA$$67$YR$$F$Y$$$20240927$$HP$CA$CA
239185512$23918551$2$F$20240523$20240709$20240530$20240717$EXP$$JP-ROCHE-3572217$ROCHE$$6$DEC$A$F$Y$$$20240717$$MD$JP$JP
239185542$23918554$2$F$$20240529$20240530$20240722$PER$$US-HALEON-2178885$Haleon PLC$$$$$M$Y$$$20240722$$CN$US$US
239185622$23918562$2$F$20240507$20240702$20240530$20240710$EXP$IT-MINISAL02-985419$IT-TEVA-VS-3202087$TEVA$$58$YR$$F$Y$$$20240710$$MD$IT$IT
239185702$23918570$2$F$20240501$20240626$20240530$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085279$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240701$$CN$US$US
239185712$23918571$2$F$$20240629$20240530$20240711$EXP$$IN-ROCHE-3571740$ROCHE$$80$YR$E$F$Y$$$20240711$$MD$IN$IN
239185732$23918573$2$F$$20240808$20240530$20240809$EXP$$KR-ROCHE-3571780$ROCHE$Lee S, Kim H J. Genetic predisposition in chemotherapy-induced cardiomyopathy in a 65-year-old female with metastatic breast cancer. DOI: 10.1002/ehf2.14803. ESC Heart Failure. 2024-Aug;11 (4):2410-4. doi:10.1002/ehf2.14803.$65$YR$E$F$Y$$$20240809$$HP$KR$KR
239185742$23918574$2$F$$20240722$20240530$20240731$30DAY$$US-GSK-US2024065000$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$CN$US$US
239185802$23918580$2$F$20240528$20240708$20240530$20240710$PER$$US-AMGEN-USASP2024105554$AMGEN$$70$YR$E$M$Y$$$20240709$$PH$US$US
239185933$23918593$3$F$20240401$20240726$20240530$20240805$EXP$$US-SA-2024SA160357$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240804$$MD$US$US
239185952$23918595$2$F$$20240705$20240530$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04323$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239185963$23918596$3$F$20230801$20240703$20240530$20240706$EXP$$SE-ABBVIE-5780332$ABBVIE$$36$YR$$M$Y$$$20240706$$MD$SE$SE
239185972$23918597$2$F$$20240521$20240530$20240809$EXP$$NVSC2024US109022$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
239186136$23918613$6$F$20230301$20240820$20240530$20240827$EXP$$NVSC2023MX074361$NOVARTIS$$39$YR$$F$Y$74$KG$20240827$$CN$MX$MX
239186184$23918618$4$F$$20240705$20240530$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04325$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239186263$23918626$3$F$$20240705$20240530$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04333$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239186352$23918635$2$F$20210716$20240828$20240530$20240828$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-083056$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240828$$HP$RU$RU
239186395$23918639$5$F$$20240917$20240530$20240925$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001075$BLUEPRINT MEDICINES$$$$$F$Y$$$20240925$$CN$US$US
239186422$23918642$2$F$$20240628$20240530$20240702$PER$$US-AstraZeneca-2024A122968$ASTRAZENECA$$$$$F$Y$$$20240702$$MD$US$
239186472$23918647$2$F$20240501$20240924$20240530$20240930$EXP$$US-AMGEN-USASP2024102954$AMGEN$$57$YR$A$M$Y$$$20240930$$HP$US$US
239186482$23918648$2$F$$20240705$20240530$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04336$LUPIN$$$$$$Y$$$20240729$$CN$US$US
239186546$23918654$6$F$20240101$20240905$20240530$20240910$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015117$UNITED THERAPEUTICS$$$$$F$Y$73.016$KG$20240910$$$US$US
239186593$23918659$3$F$$20240705$20240530$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04326$LUPIN$$$$$$Y$$$20240729$$CN$US$US
239186633$23918663$3$F$20240520$20240808$20240530$20240810$EXP$$NVSC2024GB107489$NOVARTIS$$$$$F$Y$$$20240810$$CN$GB$GB
239186643$23918664$3$F$20240509$20240717$20240530$20240717$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-030727$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240717$$CN$US$US
239186703$23918670$3$F$20240510$20240905$20240530$20240913$EXP$$JP-ARGENX-2024-ARGX-JP003389AA$ARGENX BVBA$$$$$$Y$$$20240913$$MD$JP$JP
239186733$23918673$3$F$$20240706$20240530$20240722$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04335$LUPIN$$$$$$Y$$$20240719$$CN$US$US
239186932$23918693$2$F$20240509$20240812$20240530$20240903$PER$$CA-TOLMAR, INC.-24CA049302$TOLMAR$$72$YR$$M$Y$$$20240903$$CN$CA$CA
239186942$23918694$2$F$20240509$20240801$20240530$20240808$PER$$CA-TOLMAR, INC.-24CA049310$TOLMAR$$66$YR$$M$Y$$$20240808$$CN$CA$CA
239186982$23918698$2$F$20240101$20240731$20240530$20240826$PER$$CA-TOLMAR, INC.-24CA049325$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
239187053$23918705$3$F$$20240705$20240530$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04331$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239187213$23918721$3$F$20240110$20240708$20240530$20240718$EXP$$DE-ROCHE-3568090$ROCHE$$57$YR$A$M$Y$60$KG$20240718$$MD$DE$DE
239187243$23918724$3$F$$20240819$20240530$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085997$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$56.25$KG$20240820$$CN$US$US
239187253$23918725$3$F$$20240627$20240530$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086063$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$68.95$KG$20240703$$CN$US$US
239187272$23918727$2$F$20230802$20240703$20240530$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-053545$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$22$KG$20240703$$MD$JP$JP
239187292$23918729$2$F$20221117$20240802$20240530$20240807$EXP$$NVSC2024US111590$NOVARTIS$$1$YR$$F$Y$11.7$KG$20240807$$MD$US$US
239187372$23918737$2$F$20240101$20240731$20240530$20240809$EXP$$NL-TEVA-VS-3202090$TEVA$$72$YR$$F$Y$$$20240809$$HP$NL$NL
239187392$23918739$2$F$$20240705$20240530$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04340$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239187442$23918744$2$F$$20240718$20240530$20240718$PER$$US-ALXN-202405USA001711US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239187532$23918753$2$F$$20240529$20240530$20240724$PER$$US-HALEON-2178927$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
239187562$23918756$2$F$$20240916$20240530$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086084$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240919$$CN$US$US
239187742$23918774$2$F$$20240526$20240530$20240717$PER$$US-HALEON-2178172$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239187752$23918775$2$F$20240522$20240809$20240530$20240812$PER$$US-AMGEN-USASP2024105782$AMGEN$$72$YR$E$M$Y$$$20240812$$CN$US$US
239187774$23918777$4$F$$20240618$20240530$20240701$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04339$LUPIN$$$$$$Y$$$20240701$$PH$US$US
239187782$23918778$2$F$$20240705$20240530$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04321$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239187863$23918786$3$F$20240801$20240827$20240530$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083522$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$79.83$KG$20240903$$CN$US$US
239187904$23918790$4$F$$20240701$20240530$20240702$EXP$GB-MHRA-ADR 28748881$GB-SANDOZ INC.-SDZ2024GB052510$SANDOZ$$31$YR$$F$Y$$$20240702$$CN$GB$GB
239188042$23918804$2$F$$20240828$20240530$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085678$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240828$$CN$US$US
239188312$23918831$2$F$$20240701$20240530$20240702$PER$$US-JNJFOC-20240579561$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
239188362$23918836$2$F$20240908$20240908$20240530$20240914$PER$$US-ELI_LILLY_AND_COMPANY-US202405016935$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240914$$CN$US$US
239188452$23918845$2$F$$20240701$20240530$20240704$EXP$$CA-BAUSCH-BL-2024-008308$BAUSCH AND LOMB$$82$YR$$M$Y$$$20240704$$HP$CA$CA
239188655$23918865$5$F$20240315$20240910$20240530$20240916$30DAY$$US-SANDOZ INC.-SDZ2024US030819$SANDOZ$$13$YR$$M$Y$$$20240916$$CN$US$US
239188772$23918877$2$F$$20240705$20240530$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04342$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239188923$23918892$3$F$20240528$20240904$20240530$20240905$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-085931$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$105.23$KG$20240905$$CN$PR$PR
239188932$23918893$2$F$$20240627$20240530$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086167$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240702$$CN$US$US
239189202$23918920$2$F$$20240626$20240530$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-015735$UNITED THERAPEUTICS$$$$$F$Y$$$20240703$$$US$US
239189274$23918927$4$F$20240101$20240805$20240530$20240813$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015765$UNITED THERAPEUTICS$$$$$F$Y$$$20240813$$$US$US
239189282$23918928$2$F$20220301$20240701$20240530$20240706$EXP$$ES-AUROBINDO-AUR-APL-2024-026056$AUROBINDO$Diaz Planellas S, Melero Martin MR, Diaz Crespo FJ, Pervan Gonzalez E, Garc?a Prieto AM, Rodr?guez Ben?tez P et al. PEMBROLIZUMAB IMMUNE-MEDIATED NEPHROPATHY.. European Journal of Case Reports in Internal Medicine.. 2023;10 (Supp 1):358-9.$72$YR$$M$Y$$$20240706$$HP$ES$ES
239189483$23918948$3$F$20240226$20240702$20240530$20240712$EXP$$CN-ROCHE-3571756$ROCHE$$56$YR$A$F$Y$$$20240712$$MD$CN$CN
239189592$23918959$2$F$$20240529$20240530$20240723$PER$$US-HALEON-2178967$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239189634$23918963$4$F$$20240702$20240530$20240717$EXP$$US-ASTELLAS-2024EU005226$ASTELLAS$$$$$M$Y$$$20240717$$CN$US$US
239189743$23918974$3$F$$20240627$20240530$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-078135$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240702$$HP$US$US
239189753$23918975$3$F$$20240712$20240530$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086105$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240719$$CN$US$US
239189764$23918976$4$F$20240501$20240705$20240530$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04345$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239189822$23918982$2$F$20240503$20240806$20240530$20240812$EXP$$US-GSK-US2024066424$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
239190102$23919010$2$F$$20240723$20240530$20240725$EXP$$CA-TAKEDA-2024TUS053648$TAKEDA$$$$$F$Y$$$20240725$$CN$CA$CA
239190134$23919013$4$F$$20240705$20240530$20240722$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04372$LUPIN$$$$$$Y$$$20240719$$CN$US$US
239190164$23919016$4$F$20240525$20240625$20240530$20240703$PER$$US-AMGEN-USASP2024104963$AMGEN$$58$YR$A$F$Y$$$20240702$$CN$US$US
239190193$23919019$3$F$$20240909$20240530$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-084522$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240911$$MD$JP$JP
239190242$23919024$2$F$$20240729$20240530$20240731$EXP$$NVSC2024BR113203$NOVARTIS$$$$$M$Y$$$20240731$$CN$BR$BR
239190372$23919037$2$F$$20240529$20240530$20240722$PER$$US-HALEON-2178998$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
239190662$23919066$2$F$$20240528$20240530$20240926$PER$$US-GSK-US2024AMR066569$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
239190762$23919076$2$F$$20240708$20240530$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04357$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239190782$23919078$2$F$$20240604$20240530$20240717$EXP$$US-TEVA-VS-3202241$TEVA$Laws J, Bridges B, Bruccoleri R, Vandevoorde R, King J. THERAPEUTIC PLASMA EXCHANGE FOR REFRACTORY VERAPAMIL POISONING. Crit-Care-Med 2024; 52 (Suppl.) (1): S68.; Laws J, Bridges B, Bruccoleri R, Vandevoorde R, King J. THERAPEUTIC PLASMA EXCHANGE FOR REFRACTORY VERAPAMIL POISONING. Crit-Care-Med 2024; 52 (Suppl.) (1): S68.$14$YR$$F$Y$$$20240717$$HP$US$US
239191067$23919106$7$F$20230809$20240809$20240530$20240812$EXP$$NZ-MYLANLABS-2024M1047758$MYLAN$$41$YR$$M$Y$$$20240812$$PH$NZ$NZ
239191103$23919110$3$F$$20240711$20240530$20240723$EXP$$US-GSK-US2024AMR067367$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
239191183$23919118$3$F$$20240705$20240530$20240718$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04327$LUPIN$$$$$$Y$$$20240718$$HP$US$US
239191272$23919127$2$F$$20240721$20240530$20240729$EXP$$US-CELLTRION INC.-2024US012618$CELLTRION$$$$$$Y$$$20240729$$MD$US$US
239191334$23919133$4$F$20240419$20240522$20240530$20240725$EXP$$FR-ROCHE-3552444$ROCHE$$92$YR$E$M$Y$$$20240725$$MD$FR$FR
239191532$23919153$2$F$$20240712$20240530$20240717$PER$$NVSC2024US113546$NOVARTIS$$$$$M$Y$78.93$KG$20240717$$PH$US$US
239191542$23919154$2$F$20240326$20240725$20240530$20240729$EXP$$US-UCBSA-2024016429$UCB$$70$YR$$M$Y$$$20240729$$CN$US$US
239191692$23919169$2$F$$20240529$20240530$20240722$PER$$US-HALEON-2178929$Haleon PLC$$59$YR$$F$Y$$$20240722$$CN$US$US
239191702$23919170$2$F$$20240802$20240530$20240806$EXP$$NVSC2024AT112511$NOVARTIS$$44$YR$$F$Y$$$20240806$$HP$AT$AT
239191772$23919177$2$F$20240101$20240621$20240530$20240701$EXP$DE-BFARM-24003276$DE-UCBSA-2024025570$UCB$$63$YR$$M$Y$76$KG$20240701$$CN$DE$DE
239191884$23919188$4$F$20240522$20240718$20240530$20240725$EXP$$FR-GSK-FR2024EME066189$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$PH$FR$FR
239191893$23919189$3$F$20230101$20240730$20240530$20240807$EXP$$US-GSK-US2023007440$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
239191922$23919192$2$F$20240401$20240718$20240530$20240725$EXP$$US-BAYER-2024A074941$BAYER$$48$YR$A$M$Y$$$20240725$$CN$US$US
239192334$23919233$4$F$20240507$20240716$20240530$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-024632$AUROBINDO$$61$YR$$M$Y$133$KG$20240725$$MD$FR$FR
239192482$23919248$2$F$$20240724$20240530$20240803$EXP$$CZ-AUROBINDO-AUR-APL-2024-024445$AUROBINDO$Bundarova L.. Co se o pregabalinu malo vi.. Psychiatrie pro praxi.. 2024;25(1):40-2$39$YR$$M$Y$$$20240803$$MD$CZ$CZ
239192573$23919257$3$F$20240520$20240712$20240530$20240715$EXP$$IN-ROCHE-3558085$ROCHE$$61$YR$A$M$Y$73$KG$20240715$$CN$IN$IN
239192602$23919260$2$F$20240522$20240717$20240530$20240725$EXP$$CA-CELLTRION INC.-2024CA012685$CELLTRION$$$$$$Y$$$20240725$$MD$CA$CA
239192623$23919262$3$F$20240425$20240816$20240530$20240830$EXP$$US-BEH-2024173032$CSL BEHRING$$48$YR$A$F$Y$$$20240830$$HP$US$US
239192672$23919267$2$F$$20240802$20240530$20240805$EXP$$JP-OTSUKA-2024_015258$OTSUKA$Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, et al.. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024;44:126$3$YR$$$Y$$$20240805$$MD$JP$JP
239192742$23919274$2$F$$20240614$20240530$20240709$EXP$$US-Vifor (International) Inc.-VIT-2024-04529$VIFOR$$$$$$Y$$$20240709$$HP$US$US
239192752$23919275$2$F$20240101$20240724$20240530$20240727$EXP$SE-SEMPA-2024-004369$SE-ABBVIE-5777432$ABBVIE$$78$YR$$M$Y$$$20240727$$MD$SE$SE
239192834$23919283$4$F$$20240926$20240530$20240926$EXP$$NVSC2024US113715$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
239192942$23919294$2$F$20240101$20240912$20240530$20240918$EXP$$JP-009507513-2405JPN002902J$MERCK$$58$YR$$F$Y$$$20240918$$MD$JP$JP
239192963$23919296$3$F$$20240709$20240530$20240712$EXP$$US-AstraZeneca-2024A124340$ASTRAZENECA$$50$YR$$M$Y$$$20240712$$MD$US$
239193192$23919319$2$F$20240311$20240802$20240530$20240805$EXP$$DE-MYLANLABS-2024M1047711$MYLAN$$$$$F$Y$$$20240805$$CN$DE$DE
239193765$23919376$5$F$20240501$20240828$20240530$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086381$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240828$$CN$US$US
239193792$23919379$2$F$20240402$20240712$20240530$20240722$EXP$$ES-AUROBINDO-AUR-APL-2024-017933$AUROBINDO$$$$E$M$Y$104.5$KG$20240722$$MD$ES$ES
239194112$23919411$2$F$20240201$20240711$20240530$20240715$EXP$$ES-ROCHE-3568552$ROCHE$$$$$$Y$$$20240715$$MD$ES$ES
239194134$23919413$4$F$20221201$20240821$20240530$20240828$EXP$$CA-GSK-CA2023AMR076021$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$CA$CA
239194142$23919414$2$F$$20240527$20240530$20240724$PER$$US-HALEON-2178401$Haleon PLC$$$$$F$Y$$$20240719$$CN$US$US
239194324$23919432$4$F$$20240924$20240530$20240927$EXP$$PT-AUROBINDO-AUR-APL-2024-024616$AUROBINDO$Da Costa FC, Silva AA, Rodrigues CC, Martins MD, Pombo F, Silva B, et al. Olmesartan-induced Enteropathy. European Journal of Case Reports in Internal Medicine. 2021;8(Supplement 1):185-186 (PV447/1715).$70$YR$$M$Y$$$20240927$$HP$PT$PT
239194332$23919433$2$F$$20240526$20240530$20240717$PER$$US-HALEON-2178098$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239194352$23919435$2$F$20240401$20240716$20240530$20240729$EXP$$FR-ASTELLAS-2024US012926$ASTELLAS$$81$YR$$M$Y$$$20240729$$CN$FR$FR
239194372$23919437$2$F$20240513$20240711$20240530$20240717$EXP$$CA-EMD Serono-2024029106$EMD SERONO INC$$52$YR$A$F$Y$$$20240717$$CN$CA$CA
239194385$23919438$5$F$20240101$20240703$20240530$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-012479$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240709$$$US$US
239194463$23919446$3$F$$20240705$20240530$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04319$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239194504$23919450$4$F$20240601$20240808$20240530$20240809$EXP$$CA-TAKEDA-2024TUS052111$TAKEDA$$45$YR$$M$Y$$$20240809$$CN$CA$CA
239194552$23919455$2$F$$20240708$20240530$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04360$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239194692$23919469$2$F$20240527$20240704$20240530$20240708$EXP$$IN-PFIZER INC-PV202400054835$PFIZER$$48$YR$$M$Y$83$KG$20240708$$CN$IN$IN
239194713$23919471$3$F$$20240925$20240530$20240930$EXP$$IN-PFIZER INC-PV202400070671$PFIZER$$41$YR$$M$Y$$$20240930$$CN$IN$IN
239194902$23919490$2$F$20240519$20240913$20240530$20240923$PER$$JP-Eisai-EC-2024-166352$EISAI$$$$E$M$Y$$$20240923$$MD$JP$JP
239194923$23919492$3$F$$20240711$20240530$20240718$PER$$JP-Eisai-EC-2024-166717$EISAI$$75$YR$E$F$Y$$$20240718$$MD$JP$JP
239195093$23919509$3$F$$20240705$20240530$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04332$LUPIN$$$$$$Y$$$20240729$$CN$US$US
239195203$23919520$3$F$20240305$20240625$20240530$20240701$EXP$$JP-PFIZER INC-PV202400070456$PFIZER$$79$YR$$F$Y$67.5$KG$20240701$$MD$JP$JP
239195402$23919540$2$F$$20240625$20240530$20240705$EXP$$US-INSMED, INC.-2024-02134-US$INSMED$$$$$F$Y$$$20240705$$CN$US$US
239195413$23919541$3$F$20240528$20240626$20240530$20240701$EXP$$TW-ABBVIE-5780182$ABBVIE$$58$YR$$M$Y$$$20240701$$CN$TW$TW
239195452$23919545$2$F$20230101$20240627$20240530$20240708$EXP$$NL-RECORDATI-2024001382$RECORDATI$$$$$$Y$$$20240708$$CN$NL$NL
239195472$23919547$2$F$$20240916$20240530$20240926$EXP$$TR-TEVA-VS-3202985$TEVA$Bener FY. A Case of Paradoxical Acneiform Eruption Triggered by Ixekizumab. Turk-Klinik-Case-Rep 2024; 32 (2): 32-5; Bener FY. A Case of Paradoxical Acneiform Eruption Triggered by Ixekizumab. Turk-Klinik-Case-Rep 2024; 32 (2): 32-5.$$$A$M$Y$$$20240926$$HP$TR$TR
239195532$23919553$2$F$$20240528$20240530$20240718$PER$$US-HALEON-2178854$Haleon PLC$$$$$M$Y$$$20240718$$CN$US$US
239195572$23919557$2$F$$20240708$20240530$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04376$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239195612$23919561$2$F$$20240624$20240530$20240702$EXP$$AT-BAYER-2024A075562$BAYER$$73$YR$E$M$Y$$$20240702$$MD$AT$AT
239195672$23919567$2$F$$20240806$20240530$20240808$EXP$$US-PFIZER INC-202400181093$PFIZER$$54$YR$$F$Y$$$20240808$$CN$US$US
239195732$23919573$2$F$20240501$20240624$20240530$20240715$PER$$US-JNJFOC-20240563443$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240715$$CN$US$US
239195762$23919576$2$F$$20240708$20240530$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04359$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239195923$23919592$3$F$20240501$20240717$20240530$20240726$EXP$$CA-CELLTRION INC.-2024CA012660$CELLTRION$$$$$$Y$$$20240726$$HP$CA$CA
239195953$23919595$3$F$$20240708$20240530$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04363$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239195972$23919597$2$F$20240501$20240626$20240530$20240701$PER$$US-AMGEN-USASP2024106466$AMGEN$$78$YR$E$F$Y$$$20240701$$CN$US$US
239196072$23919607$2$F$20230401$20240712$20240530$20240716$PER$$US-AMGEN-USASP2024105550$AMGEN$$57$YR$A$F$Y$$$20240716$$CN$US$US
239196242$23919624$2$F$$20240524$20240530$20240802$EXP$$GB-JNJFOC-20240582256$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240802$$CN$GB$GB
239196273$23919627$3$F$20240709$20240709$20240530$20240716$EXP$$US-GSK-US2024064879$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$US$US
239196464$23919646$4$F$20240101$20240904$20240530$20240909$EXP$$CA-PFIZER INC-202400180485$PFIZER$$57$YR$$M$Y$$$20240909$$MD$CA$CA
239196482$23919648$2$F$$20240822$20240530$20240830$30DAY$$CA-PFIZER INC-PV202400069973$PFIZER$$55$YR$$F$Y$$$20240830$$PH$CA$CA
239196732$23919673$2$F$$20240627$20240530$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-025185$AUROBINDO$$18$YR$$M$Y$$$20240705$$MD$US$US
239196823$23919682$3$F$20240101$20240812$20240530$20240815$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003007$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240815$$MD$US$US
239196833$23919683$3$F$20240101$20240719$20240530$20240727$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002286$JAZZ$$29$YR$$F$Y$$$20240727$$MD$US$US
239196933$23919693$3$F$20230801$20240708$20240530$20240716$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024062976$VIIV$$31$YR$$M$Y$$$20240716$$MD$US$US
239196944$23919694$4$F$20240501$20240729$20240530$20240808$PER$$US-JNJFOC-20240563116$JOHNSON AND JOHNSON$$64$YR$A$F$Y$63.106$KG$20240809$$HP$US$US
239196992$23919699$2$F$20200615$20240708$20240530$20240723$EXP$$JP-RECORDATI RARE DISEASE INC.-2024001687$RECORDATI$$$$$$Y$$$20240723$$MD$JP$JP
239197342$23919734$2$F$20240705$20240829$20240530$20240904$PER$$US-PFIZER INC-202400181146$PFIZER$$49$YR$$M$Y$$$20240904$$CN$US$US
239197352$23919735$2$F$$20240716$20240530$20240718$PER$$US-PFIZER INC-PV202400070865$PFIZER$$$$$$Y$$$20240718$$CN$US$US
239197564$23919756$4$F$20240701$20240820$20240530$20240822$PER$$US-PFIZER INC-202400180923$PFIZER$$54$YR$$M$Y$$$20240822$$CN$US$US
239197615$23919761$5$F$20240101$20240913$20240530$20240919$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR002588$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$CA$CA
239197632$23919763$2$F$20240711$20240711$20240530$20240715$EXP$$CA-TAKEDA-2020TUS039960$TAKEDA$$43$YR$$F$Y$$$20240715$$CN$CA$CA
239197732$23919773$2$F$$20240722$20240530$20240801$30DAY$$US-GSK-US2024064600$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$MD$US$US
239197942$23919794$2$F$20240529$20240626$20240530$20240701$PER$$US-AMGEN-USASP2024106199$AMGEN$$59$YR$A$$Y$$$20240701$$CN$US$US
239198124$23919812$4$F$$20240915$20240530$20240919$30DAY$$US-PFIZER INC-202400178695$PFIZER$$$$$M$Y$$$20240919$$CN$US$US
239198147$23919814$7$F$20240523$20240820$20240530$20240826$30DAY$$US-PFIZER INC-202400178588$PFIZER$$59$YR$$M$Y$95.25$KG$20240826$$CN$US$US
239198202$23919820$2$F$$20240821$20240530$20240828$EXP$$GB-TAKEDA-2024TUS053109$TAKEDA$$$$$M$Y$$$20240828$$CN$GB$GB
239198242$23919824$2$F$20240521$20240701$20240530$20240703$PER$$US-Eisai-EC-2024-166654$EISAI$$66$YR$E$F$Y$67.6$KG$20240703$$CN$US$US
239198293$23919829$3$F$$20240708$20240530$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04368$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239198313$23919831$3$F$20240307$20240726$20240530$20240802$EXP$$CA-GSK-CA2024013001$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$CA$CA
239198792$23919879$2$F$20240521$20240711$20240530$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04381$LUPIN$$$$$$Y$$$20240809$$CN$US$US
239198802$23919880$2$F$$20240826$20240530$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202405017248$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240830$$CN$US$US
239199042$23919904$2$F$$20240701$20240530$20240703$EXP$$US-INCYTE CORPORATION-2024IN005680$INCYTE$$$$$$Y$$$20240703$$CN$US$US
239199202$23919920$2$F$$20240702$20240530$20240708$EXP$$GB-TAKEDA-2024TUS022462$TAKEDA$$$$$M$Y$$$20240708$$CN$GB$GB
239199242$23919924$2$F$$20240828$20240530$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085811$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240828$$CN$US$US
239199373$23919937$3$F$20240522$20240708$20240530$20240709$EXP$$US-MYLANLABS-2024M1047960$MYLAN$$43$YR$$F$Y$98.9$KG$20240709$$PH$US$US
239199383$23919938$3$F$20240521$20240705$20240530$20240711$30DAY$$US-JNJFOC-20240564203$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240711$$CN$US$US
239199402$23919940$2$F$$20240723$20240530$20240725$PER$$US-PFIZER INC-PV202400070838$PFIZER$$76$YR$$F$Y$$$20240725$$CN$US$US
239199412$23919941$2$F$$20240718$20240530$20240722$PER$$US-PFIZER INC-202400181260$PFIZER$$31$YR$$F$Y$$$20240722$$CN$US$US
239199542$23919954$2$F$$20240806$20240530$20240814$EXP$$US-009507513-2405USA008557$MERCK$$77$YR$$M$Y$$$20240814$$HP$US$US
239199813$23919981$3$F$$20240704$20240530$20240704$30DAY$$US-PFIZER INC-202400173934$PFIZER$$14$YR$$M$Y$$$20240704$$CN$US$US
239199823$23919982$3$F$20240101$20240721$20240530$20240722$EXP$$CA-PFIZER INC-202400179606$PFIZER$$77$YR$$F$Y$60$KG$20240722$$MD$CA$CA
239199833$23919983$3$F$$20240913$20240530$20240919$30DAY$$US-PFIZER INC-202400178673$PFIZER$$13$YR$$M$Y$$$20240919$$CN$US$US
239199853$23919985$3$F$$20240821$20240530$20240823$30DAY$$US-PFIZER INC-202400173485$PFIZER$$14$YR$$F$Y$45.36$KG$20240823$$CN$US$US
239199864$23919986$4$F$20240522$20240820$20240530$20240822$30DAY$$US-PFIZER INC-202400175090$PFIZER$$13$YR$$M$Y$$$20240822$$MD$US$US
239199962$23919996$2$F$$20240630$20240530$20240701$30DAY$$US-PFIZER INC-202400179222$PFIZER$$15$YR$$M$Y$$$20240701$$CN$US$US
239200024$23920002$4$F$$20240916$20240530$20240919$30DAY$$US-PFIZER INC-PV202400058099$PFIZER$$12$YR$$M$Y$$$20240919$$CN$US$US
239200095$23920009$5$F$20240502$20240821$20240530$20240821$EXP$$CN-PFIZER INC-PV202400068751$PFIZER$$20$YR$$M$Y$$$20240821$$CN$CN$CN
239200103$23920010$3$F$20230801$20240729$20240530$20240805$EXP$$JP-PFIZER INC-PV202400068936$PFIZER$Moriuchi, K.. O4-3: Clinical experience with benzylpenicillin benzathine intramuscular preparation for syphilis complicating pregnancy. The 40th Annual Meeting of the Japan Society for Infectious Diseases in Obstetri. 2024;40:102$24$YR$$F$Y$55$KG$20240805$$MD$JP$JP
239200113$23920011$3$F$$20240816$20240530$20240821$30DAY$$US-PFIZER INC-202400179406$PFIZER$$15$YR$$M$Y$$$20240821$$CN$US$US
239200133$23920013$3$F$$20240913$20240530$20240918$30DAY$$US-PFIZER INC-202400179298$PFIZER$$6$YR$$F$Y$$$20240918$$HP$US$US
239200142$23920014$2$F$$20240629$20240530$20240701$30DAY$$US-PFIZER INC-202400179372$PFIZER$$14$YR$$M$Y$$$20240701$$CN$US$US
239200172$23920017$2$F$$20240717$20240530$20240722$PER$$US-LEO Pharma-370753$LEO PHARM$$65$YR$$M$Y$$$20240722$$CN$US$US
239200192$23920019$2$F$$20240626$20240530$20240703$EXP$$US-RDY-CLI/USA/24/0007540$DR REDDYS$$34$YR$A$F$Y$63.5$KG$20240703$$CN$US$US
239200203$23920020$3$F$20240525$20240805$20240530$20240806$EXP$$MY-ROCHE-3572072$ROCHE$$58$YR$A$M$Y$78$KG$20240806$$MD$MY$MY
239200342$23920034$2$F$$20240729$20240530$20240730$EXP$$NVSC2024PL113141$NOVARTIS$$26$YR$$F$Y$$$20240730$$MD$PL$PL
239200412$23920041$2$F$20240526$20240716$20240530$20240717$PER$$US-AMGEN-USASP2024106751$AMGEN$$84$YR$E$M$Y$$$20240717$$CN$US$US
239200473$23920047$3$F$20240427$20240712$20240530$20240722$EXP$ES-AEMPS-1521148$ES-TEVA-VS-3201636$TEVA$$49$YR$$F$Y$$$20240722$$PH$ES$ES
239200613$23920061$3$F$20231114$20240716$20240530$20240723$EXP$$CA-GSK-CA2024008745$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$CA$CA
239200822$23920082$2$F$20240101$20240714$20240530$20240723$EXP$$CA-CELLTRION INC.-2024CA012658$CELLTRION$$$$$$Y$$$20240723$$HP$CA$CA
239201002$23920100$2$F$$20240625$20240530$20240709$EXP$$JP-AMGEN-JPNSP2024105092$AMGEN$$7$DEC$E$M$Y$$$20240708$$MD$JP$JP
239201023$23920102$3$F$20240528$20240821$20240530$20240823$PER$$US-AMGEN-USASP2024106105$AMGEN$$65$YR$E$F$Y$$$20240823$$CN$US$US
239201192$23920119$2$F$$20240821$20240530$20240826$EXP$$CA-SANDOZ INC.-SDZ2024CA041330$SANDOZ$$$$$F$Y$$$20240826$$MD$CA$CA
239201212$23920121$2$F$$20240826$20240530$20240830$30DAY$$GR-PFIZER INC-PV202400067525$PFIZER$$9$YR$$F$Y$32$KG$20240830$$CN$GR$GR
239201223$23920122$3$F$$20240815$20240530$20240820$30DAY$$KR-PFIZER INC-202400181254$PFIZER$$10$YR$$$Y$$$20240820$$CN$KR$KR
239201244$23920124$4$F$20220509$20240919$20240530$20240919$30DAY$$AR-PFIZER INC-202400179358$PFIZER$$9$YR$$F$Y$$$20240919$$HP$AR$AR
239201375$23920137$5$F$$20240812$20240530$20240816$EXP$$LU-PFIZER INC-202400175716$PFIZER$$$$$F$Y$$$20240816$$PH$LU$LU
239201384$23920138$4$F$$20240922$20240530$20240925$30DAY$$JP-PFIZER INC-PV202400068455$PFIZER$$4$YR$$$Y$$$20240925$$CN$JP$JP
239201432$23920143$2$F$20240517$20240701$20240530$20240704$PER$$US-AMGEN-USASP2024106673$AMGEN$$66$YR$E$F$Y$$$20240704$$CN$US$US
239201472$23920147$2$F$$20240627$20240530$20240703$30DAY$$TR-JNJFOC-20240577918$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$TR$TR
239201563$23920156$3$F$20240923$20240923$20240530$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086632$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240926$$CN$US$US
239201633$23920163$3$F$$20240711$20240530$20240717$PER$$US-BIOGEN-2024BI01266898$BIOGEN$$$$$M$Y$$$20240717$$CN$US$US
239201715$23920171$5$F$20240514$20240816$20240530$20240830$EXP$$US-GILEAD-2024-0673962$GILEAD$$86$YR$E$F$Y$$$20240830$$CN$US$US
239201762$23920176$2$F$20231121$20240729$20240530$20240805$EXP$$NVSC2023FR256144$NOVARTIS$$$$A$F$Y$78$KG$20240805$$MD$FR$FR
239201952$23920195$2$F$20240519$20240716$20240530$20240716$PER$$US-ALXN-202405USA001429US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
239202052$23920205$2$F$20240301$20240906$20240530$20240917$PER$$JP-Eisai-EC-2024-166441$EISAI$$74$YR$E$F$Y$$$20240917$$MD$JP$JP
239202395$23920239$5$F$20220917$20240919$20240530$20240925$EXP$$IN-PFIZER INC-PV202200038502$PFIZER$$42$YR$$F$Y$57.15$KG$20240925$$CN$IN$IN
239202454$23920245$4$F$20240409$20240610$20240530$20240702$EXP$$AR-APELLIS-2024-APL-0000161$APELLIS PHARMACEUTICALS$$$$$$Y$90$KG$20240702$$MD$AR$AR
239202532$23920253$2$F$20240527$20240813$20240530$20240815$EXP$$US-KYOWAKIRIN-2024KK012877$KYOWA$$$$$$Y$$$20240815$$HP$US$US
239202542$23920254$2$F$$20240815$20240530$20240820$EXP$$CA-GSK-CA2024022492$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$CA$CA
239202552$23920255$2$F$$20240828$20240530$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085361$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240828$$HP$US$US
239202563$23920256$3$F$20240409$20240829$20240530$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086354$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240829$$HP$US$US
239202802$23920280$2$F$$20240517$20240530$20240904$EXP$$ES-BRAEBURN-ES-BRA-24-000422$BRAEBURN PHARMACEUTICALS$$48$YR$$M$Y$$$20240904$$MD$ES$ES
239202932$23920293$2$F$$20240801$20240530$20240802$EXP$$NVSC2024US109231$NOVARTIS$$$$$M$Y$$$20240802$$CN$US$US
239203023$23920302$3$F$$20240621$20240530$20240705$30DAY$$CA-JNJFOC-20240561932$JOHNSON AND JOHNSON$$62$YR$A$M$Y$104$KG$20240705$$HP$CA$CA
239203032$23920303$2$F$20240301$20240624$20240530$20240701$EXP$$CA-JNJFOC-20240570124$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240701$$CN$CA$CA
239203363$23920336$3$F$20240101$20240905$20240530$20240912$EXP$$US-ABBVIE-5780508$ABBVIE$$$$$M$Y$99$KG$20240912$$HP$US$US
239203432$23920343$2$F$20230220$20240905$20240530$20240911$EXP$$IL-TAKEDA-2023TUS104405$TAKEDA$$77$YR$$F$Y$$$20240911$$CN$IL$IL
239203502$23920350$2$F$20240325$20240814$20240530$20240828$EXP$DE-CADRBFARM-2024328098$DE-TEVA-VS-3203211$TEVA$$41$YR$$F$Y$75$KG$20240828$$MD$DE$DE
239203924$23920392$4$F$20220101$20240611$20240530$20240708$EXP$$US-GILEAD-2024-0672612$GILEAD$$56$YR$A$M$Y$$$20240708$$CN$US$US
239204034$23920403$4$F$$20240809$20240530$20240819$30DAY$$CA-JNJFOC-20240553356$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$HP$CA$CA
239204062$23920406$2$F$$20240828$20240530$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086664$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240828$$CN$US$US
239204214$23920421$4$F$20190101$20240819$20240530$20240822$EXP$$SA-SANDOZ INC.-SDZ2024SA044833$SANDOZ$$35$YR$$F$Y$$$20240822$$CN$SA$SA
239204232$23920423$2$F$$20240529$20240530$20240723$PER$$US-HALEON-2178924$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239204265$23920426$5$F$20240524$20240805$20240530$20240813$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001105$BLUEPRINT MEDICINES$$68$YR$E$M$Y$$$20240814$$CN$US$US
239204282$23920428$2$F$20230506$20240701$20240530$20240708$EXP$$FR-AMGEN-FRASP2024101759$AMGEN$$$$$F$Y$$$20240708$$MD$FR$FR
239204324$23920432$4$F$$20240815$20240530$20240821$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001095$BLUEPRINT MEDICINES$$$$$F$Y$$$20240821$$CN$US$US
239204576$23920457$6$F$$20240818$20240530$20240821$30DAY$$US-PFIZER INC-202400180620$PFIZER$$12$YR$$M$Y$42$KG$20240821$$CN$US$US
239204596$23920459$6$F$20240524$20240921$20240530$20240925$30DAY$$US-PFIZER INC-202400180416$PFIZER$$13$YR$$M$Y$$$20240925$$HP$US$US
239204614$23920461$4$F$$20240826$20240530$20240903$30DAY$$DE-PFIZER INC-202400109328$PFIZER$$$$A$F$Y$$$20240903$$MD$DE$DE
239204762$23920476$2$F$20240427$20240614$20240530$20240707$30DAY$$AU-JNJFOC-20240582043$JOHNSON AND JOHNSON$$$$$F$Y$$$20240707$$PH$AU$AU
239204892$23920489$2$F$20231215$20240802$20240530$20240807$EXP$$US-OTSUKA-2024_001721$OTSUKA$$38$YR$$F$Y$$$20240807$$MD$US$US
239205082$23920508$2$F$$20240718$20240530$20240725$EXP$$US-GSK-US2024AMR066527$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
239205192$23920519$2$F$20240516$20240726$20240530$20240802$EXP$$US-JNJFOC-20240575186$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$PH$US$US
239205222$23920522$2$F$$20240529$20240530$20240722$PER$$US-HALEON-2178900$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
239205254$23920525$4$F$20240522$20240829$20240530$20240904$PER$$PR-PFIZER INC-202400180990$PFIZER$$71$YR$$M$Y$$$20240904$$HP$PR$PR
239205332$23920533$2$F$$20240805$20240530$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086750$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240808$$CN$US$US
239205523$23920552$3$F$20240501$20240814$20240530$20240823$EXP$$US-ALXN-202405USA001622US$ALEXION PHARMACEUTICALS$$34$YR$$F$Y$$$20240823$$CN$US$US
239205583$23920558$3$F$20240401$20240709$20240530$20240710$PER$$US-AMGEN-USASP2024105681$AMGEN$$85$YR$E$F$Y$$$20240709$$CN$US$US
239205602$23920560$2$F$20240521$20240711$20240530$20240717$EXP$$DE-BAYER-2024A077115$BAYER$$68$YR$E$F$Y$$$20240717$$CN$DE$DE
239205612$23920561$2$F$$20240520$20240530$20240731$EXP$$FR-AKCEA THERAPEUTICS, INC.-2024IS005299$AKCEA THERAPEUTICS$$$$$$Y$$$20240729$$MD$FR$FR
239205652$23920565$2$F$20240501$20240709$20240530$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085540$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240711$$HP$US$US
239205722$23920572$2$F$20240210$20240705$20240530$20240715$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-000263$SK LIFE SCIENCE$$$$$$Y$$$20240715$$CN$US$US
239205792$23920579$2$F$$20240910$20240530$20240912$PER$$US-BIOGEN-2024BI01259328$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
239205822$23920582$2$F$20240523$20240703$20240530$20240706$EXP$$CA-ABBVIE-5780286$ABBVIE$$74$YR$$M$Y$$$20240706$$MD$CA$CA
239205837$23920583$7$F$20240507$20240715$20240530$20240723$PER$$US-BIOGEN-2024BI01266964$BIOGEN$$38$YR$$F$Y$$$20240723$$CN$US$US
239205862$23920586$2$F$20240430$20240513$20240530$20240704$EXP$$IN-VANTIVE-2024VAN016965$Vantive US Healthcare$$54$YR$$M$Y$$$20240704$$CN$IN$IN
239205892$23920589$2$F$20220501$20240624$20240530$20240702$EXP$$BR-TAKEDA-2024TUS053014$TAKEDA$$43$YR$$F$Y$$$20240702$$CN$BR$BR
239206212$23920621$2$F$20240514$20240826$20240530$20240830$EXP$FR-AFSSAPS-BX2024001042$FR-MYLANLABS-2024M1048599$MYLAN$$63$YR$$M$Y$75$KG$20240830$$MD$FR$FR
239206292$23920629$2$F$$20240627$20240530$20240702$EXP$$CO-ASTELLAS-2024US015273$ASTELLAS$$86$YR$$M$Y$56$KG$20240702$$CN$CO$CO
239206374$23920637$4$F$20240101$20240815$20240530$20240821$PER$$US-SA-2024SA158093$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240821$$MD$US$US
239206462$23920646$2$F$$20240730$20240530$20240808$PER$$US-SA-2024SA158691$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240808$$MD$US$US
239206542$23920654$2$F$20240101$20240802$20240530$20240812$PER$$US-SA-2024SA159206$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240812$$MD$US$US
239206733$23920673$3$F$20240501$20240710$20240530$20240715$PER$$US-SA-2024SA157732$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240715$$MD$US$US
239206793$23920679$3$F$20240601$20240701$20240530$20240710$PER$$US-SA-2024SA159000$SANOFI AVENTIS$$62$YR$A$F$Y$104.32$KG$20240710$$MD$US$US
239206872$23920687$2$F$20240501$20240905$20240530$20240913$PER$$US-SA-2024SA158970$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240913$$MD$US$US
239206912$23920691$2$F$20210101$20240904$20240530$20240913$PER$$US-SA-2024SA158380$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240913$$MD$US$US
239206952$23920695$2$F$20240516$20240806$20240530$20240813$PER$$US-SA-2024SA158915$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240814$$MD$US$US
239206982$23920698$2$F$$20240713$20240530$20240722$PER$$US-SA-2024SA158974$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240722$$MD$US$US
239207102$23920710$2$F$$20240828$20240530$20240923$PER$$US-SA-2024SA158810$SANOFI AVENTIS$$$$E$F$Y$53.07$KG$20240923$$MD$US$US
239207133$23920713$3$F$20240101$20240722$20240530$20240731$PER$$US-SA-2024SA157896$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240731$$MD$US$US
239207162$23920716$2$F$20240101$20240801$20240530$20240810$PER$$US-SA-2024SA157519$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240810$$MD$US$US
239207532$23920753$2$F$20240101$20240624$20240530$20240703$PER$$US-SA-2024SA131701$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240703$$MD$US$US
239207592$23920759$2$F$20240101$20240905$20240530$20240915$PER$$US-SA-2024SA161714$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240915$$MD$US$US
239207612$23920761$2$F$$20240918$20240530$20240925$PER$$US-SA-2024SA161379$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240925$$MD$US$US
239207632$23920763$2$F$20240101$20240809$20240530$20240820$PER$$US-SA-2024SA160878$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240820$$MD$US$US
239207683$23920768$3$F$20240101$20240814$20240530$20240827$PER$$US-SA-2024SA161975$SANOFI AVENTIS$$65$YR$E$M$Y$105$KG$20240827$$MD$US$US
239207743$23920774$3$F$20240101$20240802$20240530$20240812$PER$$US-SA-2024SA160835$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240812$$MD$US$US
239207752$23920775$2$F$20240510$20240701$20240530$20240710$PER$$US-SA-2024SA161017$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240710$$MD$US$US
239207802$23920780$2$F$20240501$20240628$20240530$20240709$PER$$US-SA-2024SA160839$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240709$$HP$US$US
239207912$23920791$2$F$20240101$20240916$20240530$20240923$PER$$US-SA-2024SA162190$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240923$$MD$US$US
239207952$23920795$2$F$20240527$20240903$20240530$20240917$PER$$US-SA-2024SA160964$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240918$$MD$US$US
239207984$23920798$4$F$20240101$20240711$20240530$20240716$PER$$US-SA-2024SA096378$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240716$$MD$US$US
239208274$23920827$4$F$$20240702$20240530$20240704$PER$$NVSC2024US113196$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
239208362$23920836$2$F$$20240524$20240530$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003642$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
239208382$23920838$2$F$$20240529$20240530$20240724$PER$$US-HALEON-2179027$Haleon PLC$$$$$M$Y$$$20240719$$CN$US$US
239208412$23920841$2$F$$20240812$20240530$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-080366$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240816$$HP$US$US
239208422$23920842$2$F$20240101$20240627$20240530$20240701$EXP$$US-KARYOPHARM-2024KPT001118$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240701$$CN$US$US
239208444$23920844$4$F$20240101$20240805$20240530$20240910$PER$$US-KARYOPHARM-2024KPT001119$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240910$$CN$US$US
239208492$23920849$2$F$20240416$20240702$20240530$20240716$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000092$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240716$$MD$US$US
239208663$23920866$3$F$$20240611$20240530$20240812$EXP$$CN-BAYER-2024A063705$BAYER$Tang M.; Wu Z.E.; Li F.. Integrating network pharmacology and drug side-effect data to explore mechanism of liver injury-induced by tyrosine kinase inhibitors. Computers in Biology and Medicine. 2024;170:108040$$$A$F$Y$$$20240812$$MD$CN$US
239208724$23920872$4$F$$20240926$20240530$20240930$30DAY$$US-PFIZER INC-202400180138$PFIZER$$5$YR$$M$Y$$$20240930$$CN$US$US
239208762$23920876$2$F$20240101$20240627$20240530$20240711$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000096$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$US$US
239208802$23920880$2$F$$20240726$20240530$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086597$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240730$$PH$US$US
239208862$23920886$2$F$$20240920$20240530$20240924$PER$$US-PURDUE PHARMA-USA-2024-0309881$PURDUE$$$$$F$Y$$$20240924$$CN$US$US
239209032$23920903$2$F$20230321$20240708$20240530$20240711$EXP$$NVSC2024EG113010$NOVARTIS$$54$YR$$F$Y$67$KG$20240711$$CN$EG$EG
239209072$23920907$2$F$$20240723$20240530$20240801$PER$$US-SA-2024SA157632$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240801$$MD$US$US
239209243$23920924$3$F$20240516$20240626$20240530$20240702$EXP$$JP-BIOMARINAP-JP-2024-158146$BIOMARIN$$$$$$Y$$$20240702$$MD$JP$JP
239209275$23920927$5$F$$20240912$20240530$20240916$PER$$US-BIOVITRUM-2024-US-007806$BIOVITRUM$$79$YR$$F$Y$$$20240916$$CN$US$US
239209285$23920928$5$F$$20240916$20240530$20240917$PER$$US-BIOVITRUM-2024-US-007820$BIOVITRUM$$82$YR$$M$Y$$$20240917$$CN$US$US
239209364$23920936$4$F$$20240815$20240530$20240820$30DAY$$US-PFIZER INC-202400174373$PFIZER$$12$YR$$M$Y$$$20240820$$CN$US$US
239209373$23920937$3$F$$20240828$20240530$20240903$30DAY$$DE-PFIZER INC-202400125199$PFIZER$$36$YR$$F$Y$$$20240903$$PH$DE$DE
239209573$23920957$3$F$20240522$20240802$20240530$20240808$30DAY$$US-GSK-US2024064983$GLAXOSMITHKLINE$$83$YR$$M$Y$$$20240808$$MD$US$US
239209593$23920959$3$F$20240101$20240904$20240530$20240910$EXP$$US-KYOWAKIRIN-2024KK012939$KYOWA$$$$$$Y$$$20240910$$CN$US$US
239209602$23920960$2$F$20200301$20240627$20240530$20240705$EXP$$US-BIOGEN-2024BI01261447$BIOGEN$$52$YR$$M$Y$$$20240705$$CN$US$US
239209742$23920974$2$F$20240101$20240624$20240530$20240708$EXP$$JP-FERRINGPH-2024FE02746$FERRING$$$$$$Y$$$20240708$$PH$JP$JP
239209942$23920994$2$F$20240101$20240820$20240530$20240828$EXP$$US-ABBVIE-5713102$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
239210224$23921022$4$F$20240101$20240626$20240530$20240703$EXP$$US-BAUSCH-BL-2024-007942$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240703$$CN$US$US
2392107210$23921072$10$F$$20240717$20240530$20240801$EXP$GB-TEVA-VS-3203025$GB-TEVA-VS-3203025$TEVA$$38$YR$$M$Y$104$KG$20240801$$HP$GB$GB
239210734$23921073$4$F$20100101$20240902$20240530$20240910$EXP$$GB-BIOGEN-2024BI01266866$BIOGEN$$$$$F$Y$$$20240910$$CN$GB$GB
239210782$23921078$2$F$$20240605$20240530$20240731$PER$$US-LUNDBECK-DKLU3077465$LUNDBECK$$$$$$Y$$$20240731$$CN$US$US
239210863$23921086$3$F$$20240925$20240530$20240927$PER$$US-PFIZER INC-PV202400071038$PFIZER$$87$YR$$F$Y$$$20240927$$CN$US$US
239210922$23921092$2$F$$20240728$20240530$20240802$EXP$$DE-AMGEN-DEUSP2024102932$AMGEN$Hildebrandt M. Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma: CE plus G-CSF versus G-CSF only: A single-center retrospective analysis^. Transfusion. 2024;64(5):871-880$$$$$Y$$$20240802$$MD$DE$DE
239210942$23921094$2$F$$20240718$20240530$20240806$PER$$US-ALXN-202405USA001809US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239211182$23921118$2$F$20240529$20240817$20240530$20240821$PER$$US-AMGEN-USASP2024106843$AMGEN$$84$YR$E$M$Y$$$20240820$$CN$US$US
239211228$23921122$8$F$20230101$20240923$20240530$20240930$EXP$$CA-MYLANLABS-2024M1047785$MYLAN$$36$YR$$F$Y$$$20240930$$PH$CA$CA
239211253$23921125$3$F$$20240726$20240530$20240726$EXP$$CA-PFIZER INC-PV202400070585$PFIZER$$51$YR$$M$Y$$$20240726$$PH$CA$CA
239211274$23921127$4$F$20240501$20240920$20240530$20240927$EXP$$CA-GSK-CA2024064917$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$CA$CA
239211312$23921131$2$F$$20240827$20240530$20240828$30DAY$$US-ELI_LILLY_AND_COMPANY-US202405018084$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240828$$CN$US$US
239211322$23921132$2$F$20240510$20240718$20240530$20240724$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202405015576$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240724$$CN$DE$DE
239211492$23921149$2$F$20240401$20240718$20240530$20240725$EXP$$NVSC2024SI113052$NOVARTIS$$61$YR$$F$Y$$$20240725$$CN$SI$SI
239211613$23921161$3$F$$20240705$20240530$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086882$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240710$$HP$US$US
239211703$23921170$3$F$20240514$20240923$20240530$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086671$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240926$$CN$US$US
239211752$23921175$2$F$$20240715$20240530$20240718$EXP$$US-BIOGEN-2024BI01255181$BIOGEN$$$$$M$Y$$$20240718$$CN$US$US
239211812$23921181$2$F$$20240703$20240530$20240712$PER$$US-SA-2024SA157775$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
239211872$23921187$2$F$20240514$20240828$20240530$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086791$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240828$$CN$US$US
239211886$23921188$6$F$$20240828$20240530$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085802$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240828$$CN$US$US
239211933$23921193$3$F$20240508$20240913$20240530$20240917$EXP$$JP-EMD Serono-2024029154$EMD SERONO INC$$81$YR$E$F$Y$$$20240917$$MD$JP$JP
239212002$23921200$2$F$$20240913$20240530$20240918$PER$$US-ALXN-A202307981$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
239212212$23921221$2$F$20230421$20240724$20240530$20240730$EXP$$TW-PFIZER INC-PV202400069267$PFIZER$$71$YR$$M$Y$68$KG$20240730$$MD$TW$TW
239212352$23921235$2$F$20240527$20240828$20240530$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086732$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240828$$CN$US$US
239212432$23921243$2$F$20240401$20240901$20240530$20240905$EXP$$AU-TAKEDA-2021TUS060256$TAKEDA$$10$YR$$F$Y$30.1$KG$20240905$$MD$AU$AU
239212474$23921247$4$F$$20240701$20240530$20240708$EXP$$CZ-MYLANLABS-2024M1048314$MYLAN$Dolezalova B.. GLP-1 receptor analogues: a palette from which the doctor and the patient can choose. AKTUALNI MEDICINA (CURRENT MEDICINE). 2024;8(1):4-6$64$YR$$M$Y$95$KG$20240708$$MD$CZ$CZ
239212502$23921250$2$F$20240101$20240627$20240530$20240705$PER$$US-ALXN-202405USA001647US$ALEXION PHARMACEUTICALS$$67$YR$$F$Y$$$20240705$$CN$US$US
239212522$23921252$2$F$$20240731$20240530$20240809$PER$$US-SA-2024SA157492$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240809$$MD$US$US
239212755$23921275$5$F$20240506$20240926$20240530$20240930$EXP$$US-BAYER-2024A078260$BAYER$$18$YR$A$M$Y$52.154$KG$20240930$$CN$US$US
239212972$23921297$2$F$20230526$20240625$20240530$20240703$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-081743$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$48$KG$20240703$$MD$KR$KR
239213032$23921303$2$F$$20240718$20240530$20240718$PER$$US-ALXN-202405USA001706US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239213053$23921305$3$F$20240517$20240625$20240530$20240702$EXP$$US-LUNDBECK-DKLU3078668$LUNDBECK$$$$$$Y$$$20240702$$HP$US$US
239213062$23921306$2$F$20210101$20240701$20240530$20240704$EXP$$JP-KYOWAKIRIN-2024KK012729$KYOWA$$$$$$Y$$$20240704$$HP$JP$JP
239213264$23921326$4$F$20240401$20240716$20240530$20240723$EXP$$FR-ABBVIE-5737160$ABBVIE$$77$YR$$F$Y$$$20240723$$HP$FR$FR
239213322$23921332$2$F$$20240828$20240530$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086701$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240828$$CN$US$US
239213422$23921342$2$F$$20240723$20240530$20240730$EXP$$JP-DSJP-DSJ-2024-120005$DAIICHI$$$$$F$Y$$$20240730$$PH$JP$JP
239213562$23921356$2$F$20240401$20240806$20240530$20240906$PER$$US-LUNDBECK-DKLU3077507$LUNDBECK$$$$$$Y$$$20240906$$CN$US$US
239213632$23921363$2$F$$20240727$20240530$20240905$PER$$US-LUNDBECK-DKLU3077461$LUNDBECK$$$$$$Y$$$20240905$$HP$US$US
239213863$23921386$3$F$20240101$20240827$20240530$20240902$EXP$$US-ABBVIE-5779490$ABBVIE$$73$YR$$F$Y$$$20240902$$CN$US$US
239213942$23921394$2$F$20240411$20240806$20240530$20240809$EXP$$JP-AstraZeneca-2024A124762$ASTRAZENECA$Watanabe T, et al.. OS3-6 Two cases of unresectable hepatocellular carcinoma with hyperCKaemia during durvalumab and tremelimumab combination therapy. The 30th Japan Association of Systemic Therapy for HCC 2024;97-. .$77$YR$$M$Y$69$KG$20240809$$PH$JP$
239213962$23921396$2$F$20240201$20240709$20240530$20240717$EXP$$CA-AstraZeneca-2024A121468$ASTRAZENECA$$591$MON$$F$Y$$$20240717$$CN$CA$
239213972$23921397$2$F$$20240624$20240530$20240703$EXP$$BR-AstraZeneca-2024A122299$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$BR$
239214184$23921418$4$F$20240101$20240718$20240530$20240727$PER$$US-SA-2024SA159395$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240727$$MD$US$US
239214242$23921424$2$F$$20240528$20240530$20240718$PER$$US-HALEON-2178683$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239214272$23921427$2$F$$20240711$20240530$20240725$EXP$$CA-HLS-202401349$HLS THERAPEUTICS$$$$A$M$Y$$$20240725$$HP$CA$CA
239214372$23921437$2$F$$20240705$20240530$20240712$EXP$$US-AstraZeneca-2024A120106$ASTRAZENECA$$$$$$Y$$$20240712$$CN$US$
239214447$23921444$7$F$$20240919$20240530$20240924$PER$$NVSC2024US114075$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
239214472$23921447$2$F$$20240528$20240530$20240718$PER$$US-HALEON-2178658$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239214543$23921454$3$F$$20240726$20240530$20240810$EXP$$CA-HLS-202401350$HLS THERAPEUTICS$$$$E$F$Y$$$20240810$$PH$CA$CA
239214652$23921465$2$F$20231101$20240711$20240530$20240805$PER$$US-JNJFOC-20240513607$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240805$$CN$US$US
239214662$23921466$2$F$$20240621$20240530$20240701$PER$$US-Calliditas-2024CAL00831$CALLIDITAS THERAPEUTICS$$60$DY$A$M$Y$$$20240701$$CN$US$US
239214792$23921479$2$F$$20240701$20240530$20240710$EXP$$US-TEVA-VS-3202024$TEVA$Annunzio K, Cackovic M, Bond D, Sawalha Y, Voorhees TJ, Hanel W, et al. Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy. Blood-Adv 2023; 7 (10): 2241-2244.; Annunzio K, Cackovic M, Bond D, Sawalha Y, Voorhees TJ, Hanel W, et al. Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy. Blood-Adv 2023; 7 (10): 2241-2244.; Annunzio K, Cackovic M, Bond D, Sawalha Y, Voorhees TJ, Hanel W, et al. Treatment of primary me...$36$YR$$F$Y$$$20240710$$HP$US$US
239214854$23921485$4$F$20240510$20240816$20240530$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-027222$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240821$$CN$US$US
239214892$23921489$2$F$$20240527$20240530$20240828$EXP$$US-GSK-US2024GSK066682$GLAXOSMITHKLINE$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clinical toxicology. 2024$$$$$Y$$$20240828$$HP$US$US
239214914$23921491$4$F$$20240911$20240530$20240917$EXP$PL-EMA-2024522-AUTODUP-1716406627304$PL-GSK-PL2024066611$GLAXOSMITHKLINE$Szlauer-Stefanska A, Kaminska-Winciorek G. Patient with chronic cutaneous and mucosal form of graft versus host disease. Postgraduate Dermatology [DERMATOLOGY AFTER DIPLOMA]. 2024;2$$$$$Y$$$20240917$$MD$PL$PL
239214922$23921492$2$F$20231222$20240919$20240530$20240926$EXP$$JP-GSK-JP2024JPN051494$GLAXOSMITHKLINE$Ogura M, Nishi K, Ito S. P1?272  Experience in 2 cases of  child systemic lupus erythematosus in which disease activity was inhibited after being infected with novel coronavirus infection (COVID-19). The 68th Annual General Assembly and Scientific Meeting of the Japan College of. 762$$$$$Y$$$20240926$$MD$JP$JP
239215002$23921500$2$F$20240430$20240612$20240530$20240705$PER$$US-TOLMAR, INC.-24US048923$TOLMAR$$85$YR$$M$Y$$$20240705$$HP$US$US
239215012$23921501$2$F$20240501$20240614$20240530$20240702$PER$$US-TOLMAR, INC.-24US048949$TOLMAR$$65$YR$$M$Y$$$20240702$$HP$US$US
239215032$23921503$2$F$20240506$20240614$20240530$20240704$PER$$US-TOLMAR, INC.-24US049174$TOLMAR$$$$$M$Y$$$20240703$$HP$US$US
239215042$23921504$2$F$20240507$20240611$20240530$20240704$PER$$US-TOLMAR, INC.-24US049207$TOLMAR$$82$YR$$M$Y$$$20240704$$HP$US$US
239215293$23921529$3$F$$20240717$20240530$20240718$PER$$US-ALXN-202405USA001905US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239215425$23921542$5$F$20240505$20240626$20240530$20240710$30DAY$$CA-JNJFOC-20240518771$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240710$$PH$CA$CA
239215675$23921567$5$F$20240301$20240918$20240530$20240927$PER$$US-Calliditas-2024CAL00829$CALLIDITAS THERAPEUTICS$$43$YR$A$F$Y$$$20240927$$CN$US$US
239215803$23921580$3$F$20240105$20240722$20240530$20240726$EXP$$US-APELLIS-APL-2024-003531$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$US$US
239215862$23921586$2$F$$20240716$20240530$20240717$PER$$US-ALXN-202405USA001618US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
239215933$23921593$3$F$$20240716$20240530$20240725$EXP$$US-APELLIS-APL-2024-004270$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
239215983$23921598$3$F$20230101$20240719$20240530$20240802$EXP$$US-009507513-2405USA008224$MERCK$$$$$M$Y$$$20240802$$HP$US$US
239215992$23921599$2$F$$20240829$20240530$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084525$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240829$$CN$US$US
239216222$23921622$2$F$20240508$20240626$20240530$20240704$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-077261$REGENERON$$$$$F$Y$$$20240704$$CN$US$US
239216362$23921636$2$F$$20240819$20240530$20240823$EXP$$CA-AMGEN-CANSP2024099629$AMGEN$$43$YR$A$F$Y$96$KG$20240823$$HP$CA$CA
239216392$23921639$2$F$20240527$20240711$20240530$20240718$EXP$$JP-009507513-2405JPN003617J$MERCK$$59$YR$$F$Y$$$20240718$$PH$JP$JP
239216432$23921643$2$F$20211017$20240729$20240530$20240806$EXP$$FR-AstraZeneca-2022A139204$ASTRAZENECA$$932$MON$$F$Y$70$KG$20240806$$MD$FR$
239216773$23921677$3$F$$20240717$20240530$20240718$PER$$US-ALXN-202405USA001654US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239216892$23921689$2$F$20240523$20240718$20240530$20240718$PER$$US-ALXN-202405USA001690US$ALEXION PHARMACEUTICALS$$48$YR$$F$Y$$$20240718$$CN$US$US
239216942$23921694$2$F$20240507$20240812$20240530$20240819$PER$$US-BEH-2024172499$CSL BEHRING$$73$YR$E$F$Y$$$20240819$$HP$US$US
239216972$23921697$2$F$20230801$20240711$20240530$20240718$EXP$$NVSC2023MX178115$NOVARTIS$$35$YR$$F$Y$61$KG$20240718$$CN$MX$MX
239216992$23921699$2$F$$20240709$20240530$20240821$PER$$US-LUNDBECK-DKLU3077506$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
239217042$23921704$2$F$$20240828$20240530$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086692$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240828$$CN$US$US
239217094$23921709$4$F$20240501$20240823$20240530$20240830$EXP$$JP-009507513-2405JPN002975J$MERCK$$83$YR$$M$Y$$$20240830$$MD$JP$JP
239217162$23921716$2$F$$20240711$20240530$20240716$EXP$$JP-009507513-2405JPN002700J$MERCK$$69$YR$$F$Y$$$20240716$$MD$JP$JP
239217235$23921723$5$F$$20240911$20240530$20240919$EXP$$CA-CELLTRION INC.-2022CA022536$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
239217263$23921726$3$F$$20240625$20240530$20240904$EXP$$CA-LUNDBECK-DKLU3078565$LUNDBECK$$$$$$Y$$$20240904$$HP$CA$CA
239217272$23921727$2$F$$20240710$20240530$20240723$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP006293$STRIDES$Al-Hussainy A, Adams J, Simmons J, Kennedy J.. Immune checkpoint inhibitor associated diarrhoea.. BMJ-Case-Rep. 2024;17 (5):e259057$9$DEC$$M$Y$$$20240723$$MD$GB$GB
239217282$23921728$2$F$20240101$20240708$20240530$20240712$PER$$US-AMGEN-USASP2024105464$AMGEN$$42$YR$A$F$Y$$$20240712$$CN$US$US
239217483$23921748$3$F$20240501$20240621$20240530$20240701$PER$$US-BAUSCHBL-2024BNL019755$BAUSCH AND LOMB$$$$$M$Y$$$20240701$$CN$US$US
239217502$23921750$2$F$20230419$20240729$20240530$20240731$EXP$$JP-ABBVIE-5780105$ABBVIE$$70$YR$$M$Y$$$20240731$$MD$JP$JP
239217522$23921752$2$F$20240523$20240712$20240530$20240718$EXP$$NVSJ2024JP006217$NOVARTIS$$$$E$M$Y$$$20240719$$PH$JP$JP
239217612$23921761$2$F$$20240806$20240530$20240809$EXP$$JP-ORGANON-O2405JPN002498$ORGANON$Mori Y. O-0235 Good and bad in an antidepressant mirtazapine. Journal of Japanese Society for Dialysis Therapy (The 69th Annual Meeting of the. 2024;57(S1):478$5$DEC$$M$Y$$$20240809$$MD$JP$JP
239217622$23921762$2$F$20231001$20240827$20240530$20240903$EXP$$NVSC2024EG101872$NOVARTIS$$77$YR$$F$Y$60$KG$20240903$$CN$EG$EG
239217702$23921770$2$F$20240501$20240711$20240530$20240717$EXP$$DE-ABBVIE-5779205$ABBVIE$$56$YR$$F$Y$$$20240717$$MD$DE$DE
239217822$23921782$2$F$$20240905$20240530$20240908$30DAY$$US-SANDOZ INC.-SDZ2024US053319$SANDOZ$$$$$M$Y$$$20240908$$CN$US$US
239217932$23921793$2$F$20240520$20240702$20240530$20240710$PER$$US-JNJFOC-20240560326$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240710$$PH$US$US
239218094$23921809$4$F$$20240920$20240530$20240926$EXP$$US-TAKEDA-2024TUS053372$TAKEDA$$$$$F$Y$99.8$KG$20240926$$HP$US$US
239218162$23921816$2$F$20240101$20240808$20240530$20240814$EXP$$CA-ABBVIE-5779728$ABBVIE$$71$YR$$F$Y$$$20240814$$CN$CA$CA
239218253$23921825$3$F$$20240709$20240530$20240712$EXP$$PL-TAKEDA-2024TUS053550$TAKEDA$$28$YR$$M$Y$$$20240712$$MD$PL$PL
239218303$23921830$3$F$20210616$20240807$20240530$20240809$EXP$$JP-TAKEDA-SH202300968$TAKEDA$$8$YR$$M$Y$$$20240809$$MD$JP$JP
239218342$23921834$2$F$20240201$20240709$20240530$20240712$EXP$$JP-ABBVIE-5780162$ABBVIE$$15$YR$$F$Y$45$KG$20240712$$PH$JP$JP
239218402$23921840$2$F$20240815$20240816$20240530$20240823$EXP$$CA-ABBVIE-5780689$ABBVIE$$78$YR$$M$Y$$$20240823$$CN$CA$CA
239218422$23921842$2$F$20240529$20240820$20240530$20240823$PER$$US-AMGEN-USASP2024106989$AMGEN$$61$YR$A$F$Y$$$20240823$$CN$US$US
239218433$23921843$3$F$20240101$20240724$20240530$20240724$EXP$$CA-PFIZER INC-202400179943$PFIZER$$60$YR$$F$Y$$$20240724$$HP$CA$CA
239218442$23921844$2$F$20240514$20240823$20240530$20240827$EXP$FR-AFSSAPS-BX2024001042$FR-PFIZER INC-202400178968$PFIZER$$63$YR$$M$Y$75$KG$20240827$$MD$FR$FR
239218532$23921853$2$F$$20240828$20240530$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083858$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240828$$CN$US$US
239218733$23921873$3$F$20230701$20240709$20240530$20240716$EXP$$JP-GSK-JP2024JPN065093$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$MD$JP$JP
239218802$23921880$2$F$20240507$20240628$20240530$20240706$EXP$$IT-AUROBINDO-AUR-APL-2024-024729$AUROBINDO$$59$YR$$M$Y$$$20240706$$PH$IT$IT
239218852$23921885$2$F$$20240829$20240530$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-086330$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240829$$MD$JP$JP
239218863$23921886$3$F$20220426$20240628$20240530$20240708$EXP$$FR-CELLTRION INC.-2024FR012507$CELLTRION$$$$$$Y$$$20240708$$PH$FR$FR
239218933$23921893$3$F$20240501$20240715$20240530$20240716$EXP$$CA-ALXN-202405CAN001940CA$ALEXION PHARMACEUTICALS$$18$YR$$M$Y$$$20240716$$MD$CA$CA
239218962$23921896$2$F$20240508$20240702$20240530$20240704$EXP$$US-UCBSA-2024025862$UCB$$84$YR$$F$Y$$$20240704$$CN$US$US
239218972$23921897$2$F$$20240725$20240530$20240801$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001108$BLUEPRINT MEDICINES$$$$$M$Y$$$20240801$$CN$US$US
239219062$23921906$2$F$$20240809$20240530$20240816$EXP$$JP-ARDELYX-2024ARDX003631$ARDELYX$$9$DEC$$M$Y$$$20240816$$MD$JP$JP
239219092$23921909$2$F$20240417$20240705$20240530$20240713$EXP$$JP-ARDELYX-2024ARDX003668$ARDELYX$$74$YR$$M$Y$$$20240713$$PH$JP$JP
239219182$23921918$2$F$$20240719$20240530$20240727$EXP$$CA-CELLTRION INC.-2024CA012789$CELLTRION$$$$$$Y$$$20240727$$HP$CA$CA
239219272$23921927$2$F$$20240709$20240530$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086136$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240711$$CN$US$US
239219292$23921929$2$F$20240507$20240710$20240530$20240712$EXP$$US-ABBVIE-5780877$ABBVIE$$48$YR$$M$Y$$$20240712$$CN$US$US
239219312$23921931$2$F$20240522$20240628$20240530$20240704$30DAY$$MX-AMGEN-MEXSP2024103882$AMGEN$$27$YR$A$F$Y$$$20240704$$MD$MX$MX
239219383$23921938$3$F$20210304$20240918$20240530$20240920$EXP$$JP-ABBVIE-22K-087-4521677-00$ABBVIE$$79$YR$$M$Y$63$KG$20240920$$MD$JP$JP
239219554$23921955$4$F$20240301$20240723$20240531$20240727$EXP$$US-ABBVIE-5779701$ABBVIE$$71$YR$$F$Y$97$KG$20240727$$CN$US$US
239219592$23921959$2$F$$20240902$20240531$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085912$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$132$KG$20240904$$HP$US$US
239219602$23921960$2$F$20240404$20240829$20240531$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-086440$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240829$$MD$JP$JP
239219652$23921965$2$F$20240521$20240626$20240531$20240702$EXP$$US-GSK-US2024066477$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$MD$US$US
239219702$23921970$2$F$$20240731$20240531$20240801$EXP$$NVSC2024TR114123$NOVARTIS$$$$$$Y$$$20240801$$CN$TR$TR
239219752$23921975$2$F$$20240712$20240531$20240715$EXP$$JP-SAKK-2024SA161170AA$SANOFI AVENTIS$$75$YR$E$M$Y$70.7$KG$20240716$$MD$JP$JP
239219772$23921977$2$F$$20240530$20240531$20240724$PER$$US-HALEON-2179018$Haleon PLC$$$$$M$Y$$$20240719$$CN$US$US
239219862$23921986$2$F$20240523$20240710$20240531$20240716$PER$$US-AMGEN-USASP2024104255$AMGEN$$59$YR$A$F$Y$120$KG$20240716$$PH$US$US
239219912$23921991$2$F$$20240621$20240531$20240716$30DAY$$US-GSK-US2024064994$GLAXOSMITHKLINE$$$$$F$Y$$$20240716$$CN$US$US
239220102$23922010$2$F$20240525$20240718$20240531$20240726$30DAY$$US-GSK-US2024066469$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240726$$CN$US$US
239220142$23922014$2$F$20051201$20240701$20240531$20240704$PER$$US-JNJFOC-20240584095$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240705$$HP$US$US
239220214$23922021$4$F$20240505$20240711$20240531$20240724$30DAY$$FR-JNJFOC-20240521934$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240724$$PH$FR$FR
239220284$23922028$4$F$$20240701$20240531$20240708$PER$$US-AstraZeneca-2024A125144$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$US$
239220312$23922031$2$F$20240406$20240610$20240531$20240702$30DAY$$CL-JNJFOC-20240551694$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240702$$CN$CL$CL
239220352$23922035$2$F$20240415$20240724$20240531$20240731$EXP$$CA-JNJFOC-20240566393$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240731$$HP$CA$CA
239220382$23922038$2$F$$20240729$20240531$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085253$BRISTOL MYERS SQUIBB$$29$YR$A$M$Y$$$20240730$$CN$US$US
239220394$23922039$4$F$$20240822$20240531$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086186$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240824$$CN$US$US
239220513$23922051$3$F$20240514$20240730$20240531$20240805$EXP$$DZ-EMD Serono-2024029289$EMD SERONO INC$$45$YR$A$F$Y$$$20240805$$CN$DZ$DZ
239220582$23922058$2$F$$20240711$20240531$20240711$PER$$NVSC2024US114499$NOVARTIS$$$$$F$Y$$$20240711$$CN$US$US
239220592$23922059$2$F$$20240529$20240531$20240724$PER$$US-HALEON-2178955$Haleon PLC$$$$$F$Y$$$20240719$$CN$US$US
239220783$23922078$3$F$$20240606$20240531$20240712$EXP$$JP-NOVOPROD-1230284$NOVO NORDISK$N.Shiozaki et.al... A case of paralytic ileus induced by Ozempic prescribed as part of outpatient weight loss program. The 61st Japan Diabetes Society Kanto Koshinetsu Regional Association. 2024;0-82$48$YR$$F$Y$$$20240712$$MD$JP$JP
239221042$23922104$2$F$$20240619$20240531$20240701$EXP$$LB-NOVOPROD-1156855$NOVO NORDISK$$$$$F$Y$$$20240701$$CN$LB$LB
239221062$23922106$2$F$$20240904$20240531$20240906$EXP$$JP-JNJFOC-20240583768$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$MD$JP$JP
239221123$23922112$3$F$20240401$20240805$20240531$20240827$PER$$CO-TOLMAR, INC.-24CO049288$TOLMAR$$8$YR$$F$Y$$$20240823$$CN$CO$CO
239221152$23922115$2$F$20240507$20240613$20240531$20240704$PER$$US-TOLMAR, INC.-24US049228$TOLMAR$$76$YR$$M$Y$$$20240703$$HP$US$US
239221172$23922117$2$F$$20240614$20240531$20240704$PER$$US-TOLMAR, INC.-24US049256$TOLMAR$$$$$$Y$$$20240703$$HP$US$US
239221182$23922118$2$F$20240502$20240614$20240531$20240704$PER$$US-TOLMAR, INC.-24US049252$TOLMAR$$73$YR$$M$Y$$$20240703$$HP$US$US
239221192$23922119$2$F$20240401$20240620$20240531$20240712$PER$$US-TOLMAR, INC.-24US049244$TOLMAR$$$$$M$Y$$$20240712$$HP$US$US
239221202$23922120$2$F$$20240620$20240531$20240712$PER$$US-TOLMAR, INC.-24US049264$TOLMAR$$$$$$Y$$$20240712$$HP$US$US
239221212$23922121$2$F$20240509$20240620$20240531$20240712$PER$$US-TOLMAR, INC.-24US049260$TOLMAR$$87$YR$$M$Y$$$20240712$$PH$US$US
239221223$23922122$3$F$20240510$20240723$20240531$20240820$PER$$US-TOLMAR, INC.-24US049261$TOLMAR$$63$YR$$M$Y$$$20240813$$MD$US$US
239221232$23922123$2$F$20240509$20240614$20240531$20240708$PER$$US-TOLMAR, INC.-24US049271$TOLMAR$$64$YR$$M$Y$$$20240708$$HP$US$US
239221353$23922135$3$F$20240101$20240816$20240531$20240829$PER$$US-SA-2024SA161327$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240829$$MD$US$US
239221432$23922143$2$F$20240523$20240725$20240531$20240801$PER$$US-BIOGEN-2024BI01266748$BIOGEN$$11$YR$$F$Y$$$20240801$$CN$US$US
239221442$23922144$2$F$$20240627$20240531$20240703$30DAY$$US-ABBVIE-5782129$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
239221622$23922162$2$F$20240520$20240821$20240531$20240913$PER$$US-SA-2024SA161384$SANOFI AVENTIS$$58$YR$A$F$Y$84.3$KG$20240913$$MD$US$US
239221632$23922163$2$F$20240501$20240905$20240531$20240914$PER$$US-SA-2024SA159004$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240914$$MD$US$US
239221642$23922164$2$F$$20240823$20240531$20240905$PER$$US-SA-2024SA162154$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240905$$MD$US$US
239221693$23922169$3$F$$20240808$20240531$20240812$EXP$$CA-JNJFOC-20240280424$JOHNSON AND JOHNSON$$12$YR$T$M$Y$28$KG$20240812$$HP$CA$CA
239221742$23922174$2$F$20240103$20240628$20240531$20240703$EXP$$PE-JNJFOC-20240568901$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240703$$CN$PE$PE
239221762$23922176$2$F$$20240628$20240531$20240705$PER$$US-AstraZeneca-2024A123212$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$US$
239221943$23922194$3$F$20240510$20240703$20240531$20240716$EXP$$JP-UCBSA-2024026323$UCB$$26$YR$$F$Y$$$20240716$$MD$JP$JP
239222143$23922214$3$F$20240816$20240917$20240531$20240923$PER$$US-SA-2024SA159023$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240923$$MD$US$US
239222182$23922218$2$F$$20240725$20240531$20240802$30DAY$$US-GSK-US2024063606$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$CN$US$US
239222192$23922219$2$F$$20240711$20240531$20240720$EXP$$DE-CELLTRION INC.-2024DE012699$CELLTRION$Weber R.G., Basenach E, Forster A, et al.. Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type 2 carrying the N F2:c.784C}Tp.(Arg262) variant.. Clinical neuropathology. 2022;1-5$$$$$Y$$$20240720$$MD$DE$DE
239222232$23922223$2$F$20231201$20240624$20240531$20240703$EXP$$DE-NOVOPROD-1227017$NOVO NORDISK$$$$$M$Y$62.5$KG$20240703$$CN$DE$DE
239222532$23922253$2$F$$20240711$20240531$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202405014915$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240716$$PH$US$US
239223042$23922304$2$F$$20240705$20240531$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002288$ACADIA PHARMACEUTICALS$$$$$M$Y$61$KG$20240729$$CN$US$US
239223092$23922309$2$F$20240401$20240602$20240531$20240829$PER$$US-ENDO PHARMACEUTICALS INC-2024-001860$ENDO$$$$$$Y$$$20240829$$PH$US$US
239223102$23922310$2$F$20240401$20240602$20240531$20240829$PER$$US-ENDO PHARMACEUTICALS INC-2024-001859$ENDO$$$$$$Y$$$20240829$$PH$US$US
239223112$23922311$2$F$20240401$20240602$20240531$20240829$PER$$US-ENDO PHARMACEUTICALS INC-2024-001861$ENDO$$$$$$Y$$$20240829$$PH$US$US
239223122$23922312$2$F$20240401$20240602$20240531$20240829$PER$$US-ENDO PHARMACEUTICALS INC-2024-001852$ENDO$$$$$$Y$$$20240829$$PH$US$US
239223132$23922313$2$F$20240401$20240602$20240531$20240829$PER$$US-ENDO PHARMACEUTICALS INC-2024-001863$ENDO$$$$$$Y$$$20240829$$PH$US$US
239223182$23922318$2$F$20231001$20240611$20240531$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002298$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240705$$CN$US$US
239223232$23922323$2$F$20240401$20240602$20240531$20240829$PER$$US-ENDO PHARMACEUTICALS INC-2024-001862$ENDO$$$$$$Y$$$20240829$$PH$US$US
239223245$23922324$5$F$20240607$20240918$20240531$20240927$EXP$$CA-CELLTRION INC.-2024CA012784$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
239223333$23922333$3$F$$20240708$20240531$20240716$EXP$$GB-CELLTRION INC.-2024GB012492$CELLTRION$$$$$$Y$$$20240716$$CN$GB$GB
239223502$23922350$2$F$$20240731$20240531$20240826$PER$$CA-TOLMAR, INC.-24CA049157$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
239223522$23922352$2$F$20240507$20240801$20240531$20240826$PER$$CA-TOLMAR, INC.-24CA049193$TOLMAR$$87$YR$$M$Y$$$20240826$$CN$CA$CA
239223542$23922354$2$F$$20240730$20240531$20240822$PER$$CA-TOLMAR, INC.-24CA049262$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
239223583$23922358$3$F$$20240605$20240531$20240708$PER$$NL-TOLMAR, INC.-24NL049216$TOLMAR$$$$$$Y$$$20240708$$MD$NL$NL
239223622$23922362$2$F$$20240713$20240531$20240720$EXP$$GB-AMGEN-GBRSP2024104606$AMGEN$$72$YR$E$F$Y$$$20240720$$CN$GB$GB
239223782$23922378$2$F$20240101$20240727$20240531$20240805$PER$$US-SA-2024SA158756$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240805$$MD$US$US
239223795$23922379$5$F$$20240823$20240531$20240903$EXP$$PL-AUROBINDO-AUR-APL-2024-025440$AUROBINDO$Ja?owska M, Bowszyc-Dmochowska M, Spa?ek M, Falkowski B, Dmochowski M.. Pemphigus foliaceus in an elderly woman: advantages and limitations of histopathology in pemphigus. PRZEGL?D DERMATOLOGICZNY(DERMATOLOGICAL REVIEW). 2023;110(6):689-693$91$YR$$F$Y$$$20240903$$MD$PL$PL
239223812$23922381$2$F$$20240528$20240531$20240718$PER$$US-HALEON-2178487$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239223914$23922391$4$F$20240422$20240816$20240531$20240823$EXP$$US-ROCHE-3571231$ROCHE$$74$YR$E$M$Y$$$20240823$$CN$US$US
239223985$23922398$5$F$20231203$20240903$20240531$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002104$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240926$$CN$US$US
239224272$23922427$2$F$$20240723$20240531$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086253$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240725$$CN$US$US
239224342$23922434$2$F$20240205$20240531$20240531$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000547$AXSOME THERAPEUTICS$$38$YR$A$F$Y$$$20240829$$$US$
239224522$23922452$2$F$20240511$20240627$20240531$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000662$AXSOME THERAPEUTICS$$37$YR$A$M$Y$127.4$KG$20240830$$$US$
239224822$23922482$2$F$20240101$20240716$20240531$20240725$EXP$$US-INTERCEPT-PM2024001092$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
239224892$23922489$2$F$20240430$20240703$20240531$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-025102$AUROBINDO$$10$YR$$F$Y$$$20240710$$PH$FR$FR
239224902$23922490$2$F$$20240703$20240531$20240704$EXP$$US-TAKEDA-2024TUS053442$TAKEDA$$$$$F$Y$49.887$KG$20240704$$CN$US$US
239224912$23922491$2$F$$20240730$20240531$20240807$EXP$$PL-TEVA-VS-3202527$TEVA$$41$YR$$F$Y$$$20240807$$CN$PL$PL
239224953$23922495$3$F$$20240704$20240531$20240712$EXP$$CA-ROCHE-3572082$ROCHE$$$$A$F$Y$$$20240712$$HP$CA$CA
239224985$23922498$5$F$20230914$20240820$20240531$20240827$EXP$$CA-GSK-CA2023140558$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$CA$CA
239225083$23922508$3$F$20220119$20240822$20240531$20240830$EXP$$JP-AKEBIA THERAPEUTICS, INC.-JP-AKEB-22-022617$AKEBIA THERAPEUTICS$$80$YR$$F$Y$62.2$KG$20240830$$MD$JP$JP
239225142$23922514$2$F$$20240722$20240531$20240724$EXP$$CA-SANDOZ INC.-NVSC2022CA177843$SANDOZ$$$$$F$Y$$$20240724$$CN$CA$CA
239225213$23922521$3$F$20240401$20240916$20240531$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002301$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240926$$CN$US$US
239225552$23922555$2$F$$20240718$20240531$20240718$PER$$US-ALXN-202405USA001746US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239225562$23922556$2$F$$20240807$20240531$20240807$PER$$US-ALXN-202405USA001682US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
239225753$23922575$3$F$$20240801$20240531$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002304$ACADIA PHARMACEUTICALS$$$$$M$Y$86$KG$20240827$$CN$US$US
239225962$23922596$2$F$20240506$20240613$20240531$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002305$ACADIA PHARMACEUTICALS$$68$YR$$F$Y$$$20240708$$CN$US$US
239226032$23922603$2$F$20240525$20240809$20240531$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086519$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240819$$CN$US$US
239226042$23922604$2$F$$20240909$20240531$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-083380$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240911$$MD$JP$JP
239226063$23922606$3$F$$20240625$20240531$20240701$EXP$$CA-TAKEDA-2019TUS064985$TAKEDA$$$$$M$Y$$$20240701$$CN$CA$CA
239226152$23922615$2$F$$20240530$20240531$20240723$PER$$US-HALEON-2179149$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239226223$23922622$3$F$$20240806$20240531$20240808$EXP$$CA-JNJFOC-20240585988$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240808$$HP$CA$CA
239226272$23922627$2$F$$20240718$20240531$20240718$PER$$US-ALXN-202405USA001744US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239226583$23922658$3$F$20240101$20240703$20240531$20240710$EXP$$US-SA-2024SA161980$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240710$$MD$US$US
239226593$23922659$3$F$20240101$20240704$20240531$20240710$EXP$$CA-BAUSCH-BL-2024-008343$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240710$$PH$CA$CA
239226682$23922668$2$F$20240522$20240524$20240531$20240821$EXP$$US-ABBVIE-5780507$ABBVIE$$40$YR$$F$Y$$$20240821$$MD$US$US
239226712$23922671$2$F$$20240627$20240531$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002276$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
239226822$23922682$2$F$20240608$20240619$20240531$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002275$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240712$$CN$US$US
239226984$23922698$4$F$$20240806$20240531$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202405002206$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240821$$CN$US$US
239227032$23922703$2$F$$20240723$20240531$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002353$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
239227042$23922704$2$F$$20240621$20240531$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002292$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
239227083$23922708$3$F$$20240705$20240531$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04330$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239227294$23922729$4$F$$20240715$20240531$20240725$30DAY$$US-GSK-US2024066482$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
239227382$23922738$2$F$$20240705$20240531$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04334$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239227502$23922750$2$F$$20240708$20240531$20240718$30DAY$$US-GSK-US2024066499$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
239227513$23922751$3$F$$20240708$20240531$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04356$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239227602$23922760$2$F$20240528$20240618$20240531$20240708$EXP$$SG-ROCHE-3572642$ROCHE$$72$YR$E$F$Y$60$KG$20240708$$CN$SG$SG
239227632$23922763$2$F$20240329$20240709$20240531$20240717$EXP$$JP-TEVA-VS-3203613$TEVA$$17$YR$$M$Y$$$20240717$$MD$JP$JP
239227644$23922764$4$F$$20240708$20240531$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04373$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239227842$23922784$2$F$20240601$20240701$20240531$20240705$EXP$$US-GSK-US2024067069$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$US$US
239227865$23922786$5$F$$20240705$20240531$20240711$EXP$$US-GSK-US2024067026$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$US$US
239227873$23922787$3$F$20240506$20240701$20240531$20240717$PER$$US-AstraZeneca-2024A113582$ASTRAZENECA$$68$YR$$M$Y$$$20240717$$CN$US$
239227973$23922797$3$F$20240517$20240707$20240531$20240716$EXP$$FR-DECIPHERA PHARMACEUTICALS LLC-2023FR000370$DECIPHERA PHARMACEUTICALS$$$$E$M$Y$61$KG$20240716$$MD$FR$FR
239228012$23922801$2$F$$20240708$20240531$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04362$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239228122$23922812$2$F$20240401$20240531$20240531$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000668$AXSOME THERAPEUTICS$$$$A$M$Y$95.2$KG$20240829$$MD$US$
239228392$23922839$2$F$20240201$20240524$20240531$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000613$AXSOME THERAPEUTICS$$38$YR$A$F$Y$63$KG$20240830$$$US$
239228452$23922845$2$F$20240101$20240528$20240531$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000629$AXSOME THERAPEUTICS$$73$YR$E$M$Y$$$20240829$$CN$US$
239228532$23922853$2$F$$20240620$20240531$20240716$30DAY$$US-GSK-US2024066465$GLAXOSMITHKLINE$$$$$M$Y$$$20240716$$CN$US$US
239228612$23922861$2$F$$20240716$20240531$20240720$EXP$$NVSC2024AU114460$NOVARTIS$$$$A$F$Y$$$20240719$$HP$AU$AU
239228662$23922866$2$F$$20240717$20240531$20240717$PER$$US-ALXN-202405USA001685US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
239228735$23922873$5$F$20240101$20240710$20240531$20240721$EXP$$CA-CELLTRION INC.-2024CA012800$CELLTRION$$$$$$Y$$$20240722$$CN$CA$CA
239228772$23922877$2$F$20240523$20240703$20240531$20240710$PER$$US-AMGEN-USASP2024105611$AMGEN$$36$YR$A$F$Y$66.4$KG$20240709$$PH$US$US
239228822$23922882$2$F$20240101$20240712$20240531$20240724$PER$$US-TAKEDA-2024TUS053833$TAKEDA$$$$$F$Y$$$20240724$$MD$US$US
239228923$23922892$3$F$$20240717$20240531$20240718$PER$$US-ALXN-202405USA001766US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239228983$23922898$3$F$20240101$20240719$20240531$20240801$EXP$$US-CIPLA LTD.-2024US02587$CIPLA$$$$$$Y$$$20240801$$HP$US$US
239229092$23922909$2$F$$20240712$20240531$20240712$PER$$NVSC2024US114699$NOVARTIS$$$$$F$Y$$$20240712$$PH$US$US
239229224$23922922$4$F$$20240717$20240531$20240725$EXP$$CA-CELLTRION INC.-2024CA012698$CELLTRION$$$$$$Y$$$20240725$$CN$CA$CA
239229302$23922930$2$F$20240527$20240912$20240531$20240917$EXP$$NVSC2024CA112769$NOVARTIS$$49$YR$$M$Y$$$20240917$$MD$CA$CA
239229343$23922934$3$F$20240501$20240820$20240531$20240822$EXP$$JP-GSK-JP2024JPN065106$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$MD$JP$JP
239229426$23922942$6$F$$20240710$20240531$20240712$EXP$$NVSC2024US114416$NOVARTIS$$$$$F$Y$$$20240712$$CN$US$US
239229442$23922944$2$F$20240510$20240717$20240531$20240809$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000316$BECTON DICKINSON$$$$$$Y$$$20240809$$CN$GB$GB
239229462$23922946$2$F$20240510$20240717$20240531$20240808$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000315$BECTON DICKINSON$$$$$$Y$$$20240808$$CN$GB$GB
239229482$23922948$2$F$20230501$20240903$20240531$20240906$EXP$$US-JNJFOC-20240568870$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$CN$US$US
239229502$23922950$2$F$20240510$20240717$20240531$20240808$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000317$BECTON DICKINSON$$$$$$Y$$$20240808$$CN$GB$GB
239229552$23922955$2$F$20240510$20240726$20240531$20240820$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000313$BECTON DICKINSON$$$$$$Y$$$20240820$$CN$GB$GB
239229632$23922963$2$F$$20240718$20240531$20240718$PER$$US-ALXN-202405USA001712US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239229642$23922964$2$F$$20240711$20240531$20240722$30DAY$$US-GSK-US2024AMR063543$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
239230023$23923002$3$F$$20240708$20240531$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04361$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239230082$23923008$2$F$20190801$20240826$20240531$20240829$EXP$$CA-TOLMAR, INC.-24CA049617$TOLMAR$$66$YR$$M$Y$$$20240829$$CN$CA$CA
239230232$23923023$2$F$$20240702$20240531$20240710$30DAY$$US-JNJFOC-20240583106$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$PH$US$US
239230243$23923024$3$F$20240501$20240820$20240531$20240822$EXP$$JP-GSK-JP2024JPN065109$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$MD$JP$JP
239230254$23923025$4$F$20240101$20240805$20240531$20240812$EXP$$CO-JNJFOC-20240430559$JOHNSON AND JOHNSON$$71$YR$E$F$Y$54$KG$20240812$$HP$CO$CO
239230265$23923026$5$F$20230901$20240918$20240531$20240927$EXP$$JP-009507513-2310JPN000786J$MERCK$$7$DEC$$F$Y$$$20240927$$MD$JP$JP
239230353$23923035$3$F$$20240718$20240531$20240725$EXP$$CA-TAKEDA-2024TUS054338$TAKEDA$$$$$M$Y$$$20240725$$CN$CA$CA
239230387$23923038$7$F$20240101$20240918$20240531$20240927$EXP$$CA-CELLTRION INC.-2024CA010393$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
239230442$23923044$2$F$$20240711$20240531$20240716$PER$$NVSC2024US114680$NOVARTIS$$$$$$Y$$$20240716$$MD$US$US
239230482$23923048$2$F$$20240529$20240531$20240724$PER$$US-HALEON-2179028$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
239230502$23923050$2$F$$20240621$20240531$20240917$PER$$US-CELLTRION INC.-2024US010187$CELLTRION$$$$$$Y$$$20240918$$CN$US$US
239230532$23923053$2$F$20181227$20240701$20240531$20240708$EXP$$AR-GSK-AR2024AMR059040$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$AR$AR
239230572$23923057$2$F$20221231$20240703$20240531$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-025098$AUROBINDO$$61$YR$$M$Y$$$20240710$$MD$FR$FR
239230603$23923060$3$F$$20240717$20240531$20240718$PER$$US-ALXN-202405USA001724US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239230642$23923064$2$F$20230101$20240719$20240531$20240729$EXP$$CA-CELLTRION INC.-2023CA013803$CELLTRION$$$$$$Y$$$20240729$$HP$CA$CA
239231062$23923106$2$F$20240306$20240806$20240531$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202403-000280$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
239231242$23923124$2$F$20240101$20240802$20240531$20240810$EXP$$CA-CELLTRION INC.-2024CA012816$CELLTRION$$$$$$Y$$$20240810$$CN$CA$CA
239231262$23923126$2$F$$20240530$20240531$20240723$PER$$US-HALEON-2179173$Haleon PLC$$71$YR$$M$Y$$$20240723$$CN$US$US
239231273$23923127$3$F$$20240708$20240531$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04397$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239231284$23923128$4$F$20240522$20240708$20240531$20240710$EXP$$JP-ROCHE-3572384$ROCHE$$$$$F$Y$58$KG$20240710$$PH$JP$JP
239231432$23923143$2$F$$20240530$20240531$20240723$PER$$US-HALEON-2179221$Haleon PLC$$$$$F$Y$$$20240723$$CN$US$US
239231544$23923154$4$F$20240101$20240905$20240531$20240913$EXP$$CA-CELLTRION INC.-2024CA002485$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
239231562$23923156$2$F$20240429$20240612$20240531$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002335$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240705$$CN$US$US
239231633$23923163$3$F$20240101$20240823$20240531$20240828$EXP$$US-ABBVIE-5780420$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
239231752$23923175$2$F$20240101$20240827$20240531$20240901$EXP$$GB-ABBVIE-5780407$ABBVIE$$57$YR$$M$Y$$$20240901$$HP$GB$GB
239231822$23923182$2$F$$20240619$20240531$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002319$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
239231852$23923185$2$F$$20240708$20240531$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04391$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239231872$23923187$2$F$20240430$20240723$20240531$20240725$EXP$$CA-TAKEDA-2024TUS031821$TAKEDA$$74$YR$$M$Y$$$20240725$$MD$CA$CA
239231882$23923188$2$F$$20240607$20240531$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002309$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240701$$HP$US$US
239231902$23923190$2$F$20240510$20240726$20240531$20240918$PER$$US-CELLTRION INC.-2024US011514$CELLTRION$$$$$$Y$$$20240918$$HP$US$US
239231912$23923191$2$F$20240201$20240703$20240531$20240708$EXP$IT-MINISAL02-986688$IT-SA-2024SA162945$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240708$$PH$IT$IT
239231993$23923199$3$F$20240523$20240827$20240531$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016183$UNITED THERAPEUTICS$$79$YR$$F$Y$81.633$KG$20240904$$$US$US
239232023$23923202$3$F$$20240813$20240531$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002313$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
239232032$23923203$2$F$$20240906$20240531$20240912$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000473$DECIPHERA PHARMACEUTICALS$$76$YR$E$M$Y$96.6$KG$20240912$$CN$US$US
239232082$23923208$2$F$20240426$20240715$20240531$20240725$EXP$$NL-TEVA-VS-3202551$TEVA$$53$YR$$M$Y$$$20240725$$CN$NL$NL
239232113$23923211$3$F$$20240717$20240531$20240718$PER$$US-ALXN-202405USA001677US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239232184$23923218$4$F$$20240905$20240531$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002363$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
239232283$23923228$3$F$20200101$20240719$20240531$20240729$30DAY$$US-GSK-US2024AMR064186$GLAXOSMITHKLINE$$$$$M$Y$$$20240729$$HP$US$US
239232304$23923230$4$F$20230712$20240926$20240531$20240930$EXP$$JP-GILEAD-2024-0674787$GILEAD$Iwasaki H, Egami Y, Nomoto T. P-2-088 A case of infectious pseudoaneurysm rupture of an internal shunt after bacterial pneumonia triggered by COVID-19. Journal of Japanese Society for Dialysis Therapy. 2024;57(S1):776$45$YR$A$F$Y$79$KG$20240930$$MD$JP$JP
239232473$23923247$3$F$$20240826$20240531$20240830$EXP$$JP-AMGEN-JPNSP2024103351$AMGEN$$$$$$Y$$$20240830$$MD$JP$JP
239232612$23923261$2$F$20231213$20240801$20240531$20240802$EXP$$KR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-030631$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$73.1$KG$20240802$$MD$KR$KR
239232722$23923272$2$F$20240328$20240709$20240531$20240712$EXP$$US-AstraZeneca-2024A124178$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$US$
239232782$23923278$2$F$20240508$20240625$20240531$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002100$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240719$$CN$US$US
239232852$23923285$2$F$$20240710$20240531$20240720$EXP$$JP-TEVA-VS-3203659$TEVA$$9$DEC$$F$Y$$$20240720$$MD$JP$JP
239232872$23923287$2$F$20240515$20240806$20240531$20240813$EXP$$DE-ROCHE-3568595$ROCHE$$85$YR$E$F$Y$74.5$KG$20240813$$MD$DE$DE
239232963$23923296$3$F$$20240727$20240531$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002338$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
239232982$23923298$2$F$$20240708$20240531$20240718$30DAY$$US-GSK-US2024066486$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
239233092$23923309$2$F$$20240530$20240531$20240723$PER$$US-HALEON-2179171$Haleon PLC$$68$YR$$M$Y$$$20240723$$CN$US$US
239233103$23923310$3$F$$20240829$20240531$20240906$EXP$$IN-ROCHE-3533886$ROCHE$$39$YR$A$F$Y$$$20240906$$MD$IN$IN
239233236$23923323$6$F$$20240709$20240531$20240722$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007860$JAZZ$$$$$M$Y$$$20240722$$HP$US$US
239233252$23923325$2$F$20220828$20240711$20240531$20240730$PER$$US-JNJFOC-20240538587$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240730$$CN$US$US
239233282$23923328$2$F$$20240625$20240531$20240701$EXP$$US-GSK-US2024066487$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$US$US
239233292$23923329$2$F$20240315$20240827$20240531$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087397$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$66.68$KG$20240829$$PH$US$US
239233442$23923344$2$F$$20240722$20240531$20240724$EXP$$US-GILEAD-2024-0674556$GILEAD$$44$YR$A$F$Y$$$20240724$$MD$US$US
239233622$23923362$2$F$20240328$20240712$20240531$20240717$EXP$$US-AstraZeneca-2024A125792$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
239233632$23923363$2$F$$20240524$20240531$20240917$EXP$$MY-AstraZeneca-2024A124087$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$MY$
239233652$23923365$2$F$$20240717$20240531$20240718$EXP$$US-ALXN-202405USA001722US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239233723$23923372$3$F$20240527$20240809$20240531$20240812$PER$$US-AMGEN-USASP2024107172$AMGEN$$65$YR$E$M$Y$$$20240812$$CN$US$US
239233983$23923398$3$F$20240503$20240624$20240531$20240708$EXP$DE-CADRBFARM-2024327901$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-04671$HIKMA$$28$YR$$F$Y$108$KG$20240708$$CN$DE$DE
239234022$23923402$2$F$20240520$20240730$20240531$20240808$EXP$$JP-ROCHE-3570677$ROCHE$$8$DEC$E$F$Y$$$20240808$$MD$JP$JP
239234082$23923408$2$F$$20240910$20240531$20240916$EXP$$CA-TAKEDA-2024TUS053931$TAKEDA$$$$$M$Y$$$20240916$$CN$CA$CA
239234116$23923411$6$F$20240208$20240911$20240531$20240923$EXP$$CA-TAKEDA-2024TUS054280$TAKEDA$$70$YR$$M$Y$$$20240923$$CN$CA$CA
239234182$23923418$2$F$$20240530$20240531$20240723$PER$$US-HALEON-2179197$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239234272$23923427$2$F$20240519$20240718$20240531$20240816$PER$$US-AstraZeneca-2024A120241$ASTRAZENECA$$26490$DY$$F$Y$$$20240816$$CN$US$
239234413$23923441$3$F$$20240716$20240531$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002333$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
239234433$23923443$3$F$$20240802$20240531$20240806$30DAY$$US-GSK-US2024066498$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$CN$US$US
239234802$23923480$2$F$$20240708$20240531$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04394$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239234942$23923494$2$F$$20240527$20240531$20240701$EXP$$KE-AstraZeneca-2024A122556$ASTRAZENECA$$$$A$F$Y$$$20240701$$MD$KE$
239235163$23923516$3$F$20240515$20240625$20240531$20240705$EXP$$CN-Y-MABS THERAPEUTICS, INC.-SPO2024-CN-001583$Y-MABS THERAPEUTICS$$$$$$Y$$$20240705$$MD$CN$CN
239235252$23923525$2$F$20230101$20240624$20240531$20240702$EXP$$CO-ASTELLAS-2024US013145$ASTELLAS$$51$YR$$F$Y$53$KG$20240702$$CN$CO$CO
239235352$23923535$2$F$$20240717$20240531$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087304$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240731$$HP$US$US
239235733$23923573$3$F$20230101$20240711$20240531$20240712$EXP$$US-ORGANON-O2405USA002514$ORGANON$$$$$F$Y$$$20240712$$MD$US$US
239235923$23923592$3$F$20240430$20240702$20240531$20240705$EXP$$FR-ASTELLAS-2024US014706$ASTELLAS$$68$YR$$F$Y$$$20240705$$CN$FR$FR
239235932$23923593$2$F$20240408$20240709$20240531$20240717$EXP$$US-AstraZeneca-2024A122599$ASTRAZENECA$$22196$DY$$F$Y$$$20240717$$CN$US$
239236162$23923616$2$F$20240401$20240910$20240531$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087402$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240911$$HP$US$US
239236324$23923632$4$F$$20240624$20240531$20240701$EXP$$CN-JNJFOC-20240577236$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240701$$CN$CN$CN
239236483$23923648$3$F$20240513$20240807$20240531$20240816$EXP$$JP-AMGEN-JPNNI2024105654$AMGEN$$50$YR$A$F$Y$75$KG$20240816$$HP$JP$JP
239236662$23923666$2$F$$20240719$20240531$20240802$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-449101$RANBAXY$$42$YR$$F$Y$$$20240802$$MD$PL$PL
239236852$23923685$2$F$20221223$20240722$20240531$20240806$EXP$$DE-SUNPHARMA-2023RR-385816AA$RANBAXY$$69$YR$$M$Y$$$20240806$$MD$DE$DE
239237402$23923740$2$F$20200101$20240731$20240531$20240806$EXP$$NVSC2024US109240$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
239237424$23923742$4$F$$20240712$20240531$20240717$EXP$$US-Vifor (International) Inc.-VIT-2024-04784$VIFOR$$55$YR$$M$Y$94.5$KG$20240717$$HP$US$US
239237462$23923746$2$F$$20240829$20240531$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086936$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240902$$HP$US$US
239237503$23923750$3$F$$20240909$20240531$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-086238$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240917$$MD$JP$JP
239237582$23923758$2$F$$20240725$20240531$20240809$PER$$US-AstraZeneca-2024A124318$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
239237622$23923762$2$F$$20240913$20240531$20240927$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448899$RANBAXY$Martins Andre Pauperio MDM, Pires L, Garces Soares S, Ferreira I, Mesquita M. Bilateral pneumothorax and pazopanib. Eur J Case Rep Intern Med. 2019;6 (Suppl. 1):201-202 (abstr. 929)$77$YR$$M$Y$$$20240927$$HP$PT$PT
239237692$23923769$2$F$$20240729$20240531$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448694$RANBAXY$Lane J. Perforating calcific elastosis: an interesting case. Am J Kidney Dis. 2024;Apr;83 (S2);4:S31 abstr.102$52$YR$$M$Y$$$20240813$$HP$US$US
239238012$23923801$2$F$20240101$20240903$20240531$20240928$PER$$US-SA-2024SA158782$SANOFI AVENTIS$$59$YR$A$F$Y$113.3$KG$20240928$$MD$US$US
239238042$23923804$2$F$20240221$20240904$20240531$20240919$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-449289$RANBAXY$$78$YR$$F$Y$63$KG$20240919$$PH$FR$FR
239238062$23923806$2$F$20240229$20240621$20240531$20240705$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-449281$RANBAXY$$75$YR$$F$Y$73$KG$20240705$$PH$IT$IT
239238195$23923819$5$F$20240101$20240806$20240531$20240811$EXP$$US-SA-2024SA161073$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240811$$MD$US$US
239238232$23923823$2$F$20240101$20240724$20240531$20240802$PER$$US-SA-2024SA160255$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240802$$MD$US$US
239238662$23923866$2$F$$20240620$20240531$20240712$PER$$US-TOLMAR, INC.-24US049171$TOLMAR$$$$$M$Y$$$20240712$$HP$US$US
239238722$23923872$2$F$$20240523$20240531$20240701$EXP$$RU-SA-2024SA159955$SANOFI AVENTIS$$44$YR$A$F$Y$97$KG$20240701$$HP$RU$CA
239238772$23923877$2$F$$20240823$20240531$20240826$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031144$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240826$$CN$JP$JP
239238783$23923878$3$F$$20240820$20240531$20240823$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031034$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240823$$CN$US$US
239238803$23923880$3$F$$20240906$20240531$20240906$PER$$US-ALXN-202405USA001709US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240906$$CN$US$US
239238822$23923882$2$F$20240516$20240722$20240531$20240729$PER$$US-SERVIER-S24005945$SERVIER$$$$$$Y$$$20240729$$HP$US$US
239238883$23923888$3$F$$20240813$20240531$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086274$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$59.29$KG$20240819$$CN$US$US
239238912$23923891$2$F$20240216$20240829$20240531$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-086417$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$72.3$KG$20240829$$PH$JP$JP
239238962$23923896$2$F$$20240828$20240531$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086031$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$104.31$KG$20240828$$CN$US$US
239239012$23923901$2$F$20240528$20240628$20240531$20240704$PER$$US-AMGEN-USASP2024105635$AMGEN$$40$YR$A$F$Y$$$20240703$$CN$US$US
239239092$23923909$2$F$$20231204$20240531$20240923$PER$$JP-ROCHE-3472297$ROCHE$$$$$$Y$$$20240923$$MD$JP$JP
239239182$23923918$2$F$20231130$20240528$20240531$20240723$EXP$IT-MINISAL02-958885$IT-HALEON-2178663$Haleon PLC$$25$YR$$M$Y$$$20240722$$MD$IT$IT
239239432$23923943$2$F$20240101$20240901$20240531$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086481$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240903$$HP$US$US
239239445$23923944$5$F$20230101$20240725$20240531$20240808$EXP$$US-ADVANZ PHARMA-202405004388$ADVANZ PHARMA$$$$$$Y$$$20240808$$MD$US$US
239239524$23923952$4$F$$20240826$20240531$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086082$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240827$$CN$US$US
239239573$23923957$3$F$$20240711$20240531$20240716$EXP$$AU-HALEON-2178565$Haleon PLC$$1$MON$$F$Y$$$20240715$$CN$AU$AU
239239602$23923960$2$F$20240507$20240705$20240531$20240715$EXP$IT-MINISAL02-985321$IT-TEVA-VS-3202579$TEVA$$59$YR$$M$Y$$$20240715$$PH$IT$IT
239239902$23923990$2$F$20240201$20240723$20240531$20240731$EXP$$CO-ASTELLAS-2024US015358$ASTELLAS$$80$YR$$M$Y$$$20240731$$CN$CO$CO
239239982$23923998$2$F$$20240710$20240531$20240715$EXP$$GB-AMGEN-GBRSP2024106044$AMGEN$$$$$M$Y$$$20240714$$HP$GB$GB
239240022$23924002$2$F$20240425$20240709$20240531$20240712$EXP$$JP-MYLANLABS-2024M1047470$MYLAN$$85$YR$$F$Y$40$KG$20240712$$PH$JP$JP
239240233$23924023$3$F$$20240704$20240531$20240712$EXP$$NVSC2024CR114544$NOVARTIS$$$$$M$Y$83$KG$20240712$$CN$CR$CR
239240333$23924033$3$F$$20240712$20240531$20240724$PER$$US-SA-2024SA160676$SANOFI AVENTIS$$$$A$F$Y$63.5$KG$20240724$$MD$US$US
239240452$23924045$2$F$20240501$20240724$20240531$20240802$PER$$US-SA-2024SA163186$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240802$$MD$US$US
239240512$23924051$2$F$20240330$20240628$20240531$20240708$EXP$$US-BIOCODEX2-2024000505$BIOCODEX$$20$YR$$F$Y$43$KG$20240704$$MD$US$US
239240622$23924062$2$F$$20240725$20240531$20240726$EXP$NL-LRB-00974055$NL-ROCHE-3573241$ROCHE$$49$YR$A$F$Y$$$20240726$$HP$NL$NL
239241152$23924115$2$F$$20240529$20240531$20240718$PER$$US-HALEON-2178644$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239241182$23924118$2$F$$20240706$20240531$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04475$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239241212$23924121$2$F$20240413$20240815$20240531$20240821$EXP$FR-AFSSAPS-BX2024001019$FR-MYLANLABS-2024M1048153$MYLAN$$15$YR$$F$Y$$$20240821$$PH$FR$FR
239241242$23924124$2$F$$20240805$20240531$20240807$EXP$$GB-SANDOZ INC.-NVSC2022GB172952$SANDOZ$$$$$M$Y$$$20240807$$CN$GB$GB
239241332$23924133$2$F$20240301$20240717$20240531$20240718$EXP$$US-ALXN-202405USA002027US$ALEXION PHARMACEUTICALS$$52$YR$$F$Y$$$20240718$$CN$US$US
239241442$23924144$2$F$$20240706$20240531$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04503$LUPIN$$$$$$Y$$$20240801$$PH$US$US
239241612$23924161$2$F$$20240819$20240531$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087225$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$79.38$KG$20240827$$CN$US$US
239242032$23924203$2$F$20240501$20240802$20240531$20240805$EXP$$NVSC2024BE114277$NOVARTIS$$$$$M$Y$$$20240805$$MD$BE$BE
239242124$23924212$4$F$$20240907$20240531$20240913$EXP$$NVSC2024BR112596$NOVARTIS$$$$$F$Y$$$20240913$$CN$BR$BR
239242133$23924213$3$F$$20240820$20240531$20240823$EXP$$NVSC2024AU113217$NOVARTIS$$$$$M$Y$$$20240823$$HP$AU$AU
239242212$23924221$2$F$20240328$20240731$20240531$20240809$EXP$FR-AFSSAPS-PV2024000424$FR-TEVA-VS-3202253$TEVA$$20$YR$$M$Y$68$KG$20240809$$MD$FR$FR
239242512$23924251$2$F$20240221$20240702$20240531$20240709$30DAY$$US-AMGEN-USASP2024102798$AMGEN$$71$YR$E$F$Y$69.4$KG$20240709$$PH$US$US
239242652$23924265$2$F$20230301$20240624$20240531$20240702$EXP$$SK-AstraZeneca-2024A125229$ASTRAZENECA$$78$YR$$M$Y$$$20240702$$MD$SK$
239242922$23924292$2$F$$20240802$20240531$20240802$EXP$$NVSC2024US113772$NOVARTIS$$$$$M$Y$86.6$KG$20240802$$CN$US$US
239243103$23924310$3$F$20240504$20240626$20240531$20240709$PER$$US-Calliditas-2024CAL00826$CALLIDITAS THERAPEUTICS$$75$YR$E$F$Y$71.2$KG$20240709$$CN$US$US
239243188$23924318$8$F$20240528$20240821$20240531$20240823$EXP$$CA-ROCHE-3574091$ROCHE$$29$YR$A$F$Y$$$20240823$$CN$CA$CA
239243243$23924324$3$F$$20240716$20240531$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086813$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240719$$CN$US$US
239243263$23924326$3$F$$20240724$20240531$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-084318$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$MD$JP$JP
239243303$23924330$3$F$20240523$20240701$20240531$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-084118$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240709$$PH$JP$JP
239243352$23924335$2$F$$20240831$20240531$20240912$EXP$$RO-Accord-426651$ACCORD$Mustafa A, Danciu AI, Ionescu M. Acute coronary syndrome and cancer in a?young patient. Medical Life. 2024;10:13$32$YR$A$M$Y$$$20240912$$MD$RO$RO
239243542$23924354$2$F$$20240624$20240531$20240703$EXP$$CA-APOTEX-2024AP006303$APOTEX$$52$YR$$F$Y$$$20240703$$HP$CA$CA
239243662$23924366$2$F$$20240712$20240531$20240715$PER$$NVSC2024US114495$NOVARTIS$$$$$M$Y$$$20240715$$HP$US$US
239243792$23924379$2$F$20240101$20240627$20240531$20240703$EXP$$CA-ABBVIE-5781529$ABBVIE$$67$YR$$M$Y$$$20240703$$CN$CA$CA
239244052$23924405$2$F$$20240910$20240531$20240913$EXP$$CA-TAKEDA-2024TUS051367$TAKEDA$$$$$M$Y$$$20240913$$CN$CA$CA
2392444310$23924443$10$F$20240506$20240906$20240531$20240916$EXP$$ES-AUROBINDO-AUR-APL-2024-025114$AUROBINDO$$67$YR$$F$Y$69.1$KG$20240916$$MD$ES$ES
239244473$23924447$3$F$$20240812$20240531$20240815$EXP$$US-PFIZER INC-PV202400071057$PFIZER$$75$YR$$F$Y$$$20240815$$CN$US$US
239244492$23924449$2$F$20240201$20240730$20240531$20240731$EXP$$CN-PFIZER INC-PV202400070754$PFIZER$$16$YR$$F$Y$44$KG$20240731$$HP$CN$CN
239244532$23924453$2$F$$20240720$20240531$20240722$EXP$$US-PFIZER INC-PV202400070977$PFIZER$$67$YR$$F$Y$$$20240722$$CN$US$US
239244582$23924458$2$F$$20240912$20240531$20240919$EXP$$CA-TAKEDA-2024TUS053462$TAKEDA$$$$N$$Y$$$20240919$$CN$CA$CA
239244652$23924465$2$F$20240524$20240630$20240531$20240708$EXP$$US-BAYER-2024A079421$BAYER$$70$YR$E$F$Y$91.61$KG$20240708$$CN$US$US
239244674$23924467$4$F$20240517$20240724$20240531$20240806$EXP$$US-ALEMBIC-2024SCAL000686$ALEMBIC$$$$$$Y$$$20240806$$PH$US$US
239244732$23924473$2$F$$20240610$20240531$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002349$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$HP$US$US
239244862$23924486$2$F$$20240726$20240531$20240726$EXP$$PK-PFIZER INC-PV202400070867$PFIZER$$29$YR$$F$Y$$$20240726$$CN$PK$PK
239244982$23924498$2$F$$20240708$20240531$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04411$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239244992$23924499$2$F$20240520$20240702$20240531$20240710$EXP$$JP-ROCHE-3570256$ROCHE$$77$YR$E$F$Y$$$20240710$$PH$JP$JP
239245142$23924514$2$F$$20240802$20240531$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087363$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240805$$CN$US$US
239245252$23924525$2$F$$20240708$20240531$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04399$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239245303$23924530$3$F$$20240723$20240531$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002315$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
239245372$23924537$2$F$20230101$20240731$20240531$20240805$PER$$US-AMGEN-USASP2024103238$AMGEN$$69$YR$E$F$Y$$$20240805$$CN$US$US
239245412$23924541$2$F$$20240531$20240531$20240722$PER$$US-HALEON-2179257$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
239245462$23924546$2$F$$20240809$20240531$20240820$PER$$US-SA-2024SA161374$SANOFI AVENTIS$$$$E$F$Y$61.6$KG$20240820$$MD$US$US
239245512$23924551$2$F$20240522$20240731$20240531$20240803$PER$$US-AMGEN-USASP2024107548$AMGEN$$64$YR$A$F$Y$$$20240803$$CN$US$US
239245524$23924552$4$F$$20240922$20240531$20240925$30DAY$$US-PFIZER INC-202400178533$PFIZER$$18$MON$$M$Y$7.256$KG$20240925$$CN$US$US
239245532$23924553$2$F$$20240708$20240531$20240710$EXP$$US-PFIZER INC-PV202400059459$PFIZER$$38$YR$$F$Y$$$20240710$$HP$US$US
239245543$23924554$3$F$20240328$20240807$20240531$20240813$30DAY$$US-PFIZER INC-202400180502$PFIZER$$4$MON$$F$Y$$$20240813$$CN$US$US
239245555$23924555$5$F$$20240912$20240531$20240917$30DAY$$US-PFIZER INC-202400180344$PFIZER$$13$YR$$F$Y$33.11$KG$20240917$$CN$US$US
239245562$23924556$2$F$20240101$20240828$20240531$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04402$LUPIN$$$$$$Y$$$20240919$$CN$US$US
239245625$23924562$5$F$20191101$20240917$20240531$20240924$30DAY$$US-PFIZER INC-202400104052$PFIZER$$62$YR$$F$Y$58.97$KG$20240924$$CN$US$US
239245635$23924563$5$F$20240101$20240921$20240531$20240925$30DAY$$US-PFIZER INC-202400180244$PFIZER$$11$YR$$M$Y$$$20240925$$CN$US$US
239245649$23924564$9$F$20240101$20240922$20240531$20240925$30DAY$$US-PFIZER INC-202400180442$PFIZER$$52$YR$$F$Y$91.63$KG$20240925$$HP$US$US
239245657$23924565$7$F$20240522$20240921$20240531$20240925$30DAY$$US-PFIZER INC-202400180571$PFIZER$$13$YR$$F$Y$$$20240925$$CN$US$US
239245663$23924566$3$F$$20240710$20240531$20240712$30DAY$$FR-PFIZER INC-202400172196$PFIZER$$$$$F$Y$$$20240712$$PH$FR$FR
239245672$23924567$2$F$20240525$20240915$20240531$20240919$30DAY$$US-PFIZER INC-202400180474$PFIZER$$10$YR$$M$Y$20.5$KG$20240919$$HP$US$US
239245682$23924568$2$F$$20240802$20240531$20240805$EXP$$NVSC2024US113973$NOVARTIS$$$$$F$Y$$$20240803$$CN$US$US
239245693$23924569$3$F$20231201$20240606$20240531$20240807$EXP$$NVSC2024BR100724$NOVARTIS$$52$YR$$F$Y$59$KG$20240807$$CN$BR$BR
239245702$23924570$2$F$$20240702$20240531$20240709$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-030781$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240709$$CN$US$US
239245732$23924573$2$F$20240501$20240612$20240531$20240705$PER$$US-Eisai-EC-2024-165764$EISAI$$82$YR$E$F$Y$$$20240705$$CN$US$US
239245744$23924574$4$F$20240515$20240830$20240531$20240925$PER$$US-Eisai-EC-2024-166217$EISAI$$73$YR$E$F$Y$$$20240925$$CN$US$US
239245772$23924577$2$F$20230501$20240910$20240531$20240922$EXP$US-MLMSERVICE-20240513-PI059072-00190-1$US-JUBILANT CADISTA PHARMACEUTICALS-2024US000672$JUBILANT$Li YI, Htet N. THE ROLLER COASTER LEVELS: A SUCCESSFUL TREATMENT OF MASSIVE  LAMOTRIGINE OVERDOSE. Critical Care Medicine.. 2024;52(1):S438$66$YR$$M$Y$86$KG$20240922$$MD$US$US
239245902$23924590$2$F$$20240703$20240531$20240703$30DAY$$US-PFIZER INC-202400180339$PFIZER$$13$YR$$M$Y$$$20240703$$CN$US$US
239245917$23924591$7$F$$20240925$20240531$20240930$30DAY$$US-PFIZER INC-202400178560$PFIZER$$14$YR$$M$Y$$$20240930$$CN$US$US
239246012$23924601$2$F$20231127$20240628$20240531$20240704$PER$$US-BAUSCH-BL-2024-008192$BAUSCH AND LOMB$$$$$$Y$$$20240704$$CN$US$US
239246095$23924609$5$F$20240101$20240916$20240531$20240925$EXP$$US-INSMED, INC.-2024-01753-US$INSMED$$$$$F$Y$$$20240925$$CN$US$US
239246152$23924615$2$F$20240423$20240618$20240531$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002028$ACADIA PHARMACEUTICALS$$91$YR$$F$Y$$$20240712$$CN$US$US
239246192$23924619$2$F$$20240703$20240531$20240712$PER$$US-SA-2024SA160829$SANOFI AVENTIS$$28$YR$A$F$Y$108$KG$20240712$$MD$US$US
239246202$23924620$2$F$20240509$20240625$20240531$20240704$PER$$US-SA-2024SA160243$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240704$$MD$US$US
239246275$23924627$5$F$20240517$20240718$20240531$20240726$EXP$$CO-ORG100014127-2024000143$HRA PHARMA$$80$YR$$F$Y$64$KG$20240726$$HP$CO$CO
239246292$23924629$2$F$$20240802$20240531$20240812$EXP$$CA-BAXTER-2024BAX019178$BAXTER$$52$YR$$M$Y$$$20240812$$CN$CA$CA
239246463$23924646$3$F$$20240612$20240531$20240905$EXP$$AT-ROCHE-3555900$ROCHE$$$$E$M$Y$$$20240905$$MD$AT$AT
239246652$23924665$2$F$$20240706$20240531$20240715$PER$$US-SA-2023SA392476$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240715$$MD$US$US
239246932$23924693$2$F$20240101$20240808$20240531$20240815$EXP$$JP-Eisai-EC-2024-166748$EISAI$$37$YR$A$M$Y$$$20240815$$MD$JP$JP
239246993$23924699$3$F$$20240702$20240531$20240708$PER$$US-ALXN-202405USA001686US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$HP$US$US
239247412$23924741$2$F$20240501$20240710$20240531$20240715$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031119$BOEHRINGER INGELHEIM$$58$YR$A$F$Y$$$20240715$$MD$SK$SK
239247463$23924746$3$F$$20240518$20240531$20240807$EXP$$ES-AUROBINDO-AUR-APL-2024-027016$AUROBINDO$Taibo A, SeoaneEstevez A, MartinezCampayo N, RodriguezMayo M, ArevaloBermudez MDP, Fonseca E. Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain. Mycoses. 2023;66(10):891-897$50$YR$$M$Y$$$20240807$$MD$ES$ES
239247482$23924748$2$F$20240904$20240913$20240531$20240919$EXP$$US-ROCHE-3568856$ROCHE$$4$YR$C$M$Y$13.02$KG$20240919$$CN$US$US
239247622$23924762$2$F$20240522$20240715$20240531$20240720$EXP$$US-ABBVIE-5781313$ABBVIE$$69$YR$$F$Y$$$20240720$$CN$US$US
239247772$23924777$2$F$$20240924$20240531$20240927$EXP$$RU-JNJFOC-20240576611$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$HP$RU$RU
239247952$23924795$2$F$$20240529$20240531$20240812$EXP$$NVSC2024US113970$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
239247972$23924797$2$F$20240401$20240702$20240531$20240709$PER$$US-SA-2024SA160439$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240709$$CN$US$US
239247985$23924798$5$F$20240510$20240918$20240531$20240925$EXP$$JP-Eisai-EC-2024-166764$EISAI$$$$E$F$Y$$$20240925$$MD$JP$JP
239247994$23924799$4$F$20230109$20240823$20240531$20240828$EXP$$US-Eisai-EC-2023-133412$EISAI$$72$YR$E$M$Y$80.65$KG$20240828$$MD$US$US
239248052$23924805$2$F$20211122$20240701$20240531$20240708$EXP$IE-HPRA-2024-113115$IE-MYLANLABS-2024M1049536$MYLAN$$$$N$F$Y$1.535$KG$20240708$$MD$IE$IE
239248133$23924813$3$F$20230531$20240827$20240531$20240905$EXP$$JP-HORIZON THERAPEUTICS-HZN-2023-008335$AMGEN$$75$YR$E$F$Y$43$KG$20240904$$HP$JP$JP
239248242$23924824$2$F$20240101$20240805$20240531$20240809$PER$$US-PFIZER INC-PV202400071002$PFIZER$$54$YR$$F$Y$$$20240809$$HP$US$US
239248313$23924831$3$F$$20240703$20240531$20240703$PER$$US-PFIZER INC-PV202400071215$PFIZER$$31$YR$$F$Y$94.785$KG$20240703$$MD$US$US
239248382$23924838$2$F$20240522$20240625$20240531$20240701$PER$$US-PFIZER INC-202400181172$PFIZER$$37$YR$$F$Y$52.154$KG$20240701$$CN$US$US
239248414$23924841$4$F$20240501$20240724$20240531$20240730$PER$$US-PFIZER INC-PV202400071274$PFIZER$$67$YR$$F$Y$96.2$KG$20240730$$MD$US$US
239248422$23924842$2$F$$20240731$20240531$20240805$PER$$US-PFIZER INC-PV202300126370$PFIZER$$37$YR$$F$Y$$$20240805$$HP$US$US
239248533$23924853$3$F$$20240807$20240531$20240812$PER$$US-PFIZER INC-202400174211$PFIZER$$62$YR$$M$Y$68.04$KG$20240812$$CN$US$US
239248552$23924855$2$F$$20240625$20240531$20240701$PER$$US-PFIZER INC-PV202400070784$PFIZER$$63$YR$$F$Y$$$20240701$$HP$US$US
239248603$23924860$3$F$$20240829$20240531$20240904$PER$$US-PFIZER INC-PV202400071690$PFIZER$$78$YR$$F$Y$$$20240904$$HP$US$US
239248612$23924861$2$F$$20240720$20240531$20240722$PER$$US-PFIZER INC-202400181757$PFIZER$$17$YR$$M$Y$$$20240722$$MD$US$US
239248702$23924870$2$F$20240101$20240913$20240531$20240923$PER$$US-SA-2024SA163225$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240923$$MD$US$US
239248712$23924871$2$F$20240101$20240723$20240531$20240801$PER$$US-SA-2024SA159819$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240801$$MD$US$US
239248722$23924872$2$F$20240401$20240806$20240531$20240818$PER$$US-SA-2024SA160130$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240819$$MD$US$US
239248782$23924878$2$F$$20240419$20240531$20240710$PER$$CA-ROCHE-3550311$ROCHE$$56$YR$A$M$Y$$$20240628$$CN$CA$CA
239248872$23924887$2$F$$20240823$20240531$20240902$PER$$US-BEH-2024172441$CSL BEHRING$$$$E$F$Y$$$20240902$$MD$US$US
239249002$23924900$2$F$20240101$20240726$20240531$20240730$EXP$$US-PFIZER INC-PV202400060398$PFIZER$$65$YR$$F$Y$$$20240730$$HP$US$US
239249272$23924927$2$F$20211112$20240912$20240531$20240916$EXP$$ES-AMGEN-ESPNI2024104536$AMGEN$$63$YR$A$F$Y$50$KG$20240916$$MD$ES$ES
239249362$23924936$2$F$20240523$20240723$20240531$20240731$EXP$$US-AstraZeneca-2024A122183$ASTRAZENECA$$9646$DY$$F$Y$$$20240731$$CN$US$
239249382$23924938$2$F$20240409$20240828$20240531$20240901$EXP$$US-ABBVIE-5781085$ABBVIE$$66$YR$$F$Y$106$KG$20240901$$HP$US$US
239249475$23924947$5$F$$20240730$20240531$20240801$PER$$US-PFIZER INC-PV202400071593$PFIZER$$61$YR$$F$Y$$$20240801$$CN$US$US
239249544$23924954$4$F$20240101$20240722$20240531$20240725$EXP$$CA-PFIZER INC-202400180304$PFIZER$$76$YR$$M$Y$$$20240725$$HP$CA$CA
239249592$23924959$2$F$$20240806$20240531$20240808$PER$$US-PFIZER INC-PV202400071004$PFIZER$$65$YR$$F$Y$$$20240808$$HP$US$US
239249622$23924962$2$F$$20240730$20240531$20240801$PER$$US-PFIZER INC-202400181928$PFIZER$$62$YR$$F$Y$$$20240801$$HP$US$US
239249842$23924984$2$F$$20240607$20240531$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002343$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
239249872$23924987$2$F$20240521$20240708$20240531$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04410$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239250042$23925004$2$F$$20240805$20240531$20240808$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-10697$IPSEN$$$$$M$Y$$$20240808$$HP$GB$GB
239250052$23925005$2$F$$20240710$20240531$20240716$PER$$US-ALXN-202405USA001681US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
239250132$23925013$2$F$$20240829$20240531$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-087135$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240829$$MD$JP$JP
239250433$23925043$3$F$20240101$20240703$20240531$20240711$EXP$$CA-JNJFOC-20240310389$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240712$$HP$CA$CA
239250484$23925048$4$F$20240401$20240729$20240531$20240801$EXP$$AU-AMGEN-AUSSP2024104373$AMGEN$$$$$F$Y$$$20240801$$HP$AU$AU
239250642$23925064$2$F$20240501$20240723$20240531$20240725$EXP$$US-INCYTE CORPORATION-2024IN005741$INCYTE$$$$$$Y$$$20240725$$CN$US$US
239250652$23925065$2$F$20240701$20240802$20240531$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002345$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240827$$CN$US$US
239251013$23925101$3$F$20240426$20240710$20240531$20240722$EXP$$KR-SA-2024SA160300$SANOFI AVENTIS$$46$YR$A$F$Y$77$KG$20240722$$HP$KR$KR
239251022$23925102$2$F$$20240726$20240531$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002346$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
239251032$23925103$2$F$20240408$20240627$20240531$20240703$EXP$$US-OTSUKA-2024_015410$OTSUKA$$59$YR$$F$Y$87.98$KG$20240703$$HP$US$US
239251043$23925104$3$F$$20240913$20240531$20240918$30DAY$$US-PFIZER INC-PV202400068358$PFIZER$$13$YR$$M$Y$$$20240918$$HP$US$US
239251054$23925105$4$F$20240423$20240819$20240531$20240822$30DAY$$GB-PFIZER INC-PV202400054418$PFIZER$$6$YR$$F$Y$$$20240822$$CN$GB$GB
239251062$23925106$2$F$$20240815$20240531$20240820$EXP$$US-MYLANLABS-2024M1049183$MYLAN$$$$$F$Y$$$20240820$$HP$US$US
239251492$23925149$2$F$20240510$20240710$20240531$20240715$EXP$$US-OTSUKA-2024_013582$OTSUKA$$$$$F$Y$$$20240715$$CN$US$US
239251502$23925150$2$F$20220601$20240725$20240531$20240802$EXP$CN-MLMSERVICE-20240510-PI057501-00077-1$CN-ROCHE-3572222$ROCHE$Qu F, Kong Y, Yan X and Wang H. Elderly patients with advanced HER2-positive breast cancer with liver metastases benefit from low dose disitamab vedotin (RC48):case series and literature review. Doi;10.1097/CAD.0000000000001613.. Anti-cancer drugs 2024;:-.$79$YR$E$F$Y$$$20240802$$HP$CN$CN
239251982$23925198$2$F$$20240916$20240531$20240925$PER$$US-JNJFOC-20240579627$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
239252002$23925200$2$F$$20240809$20240531$20240809$PER$$NVSC2024US114730$NOVARTIS$$$$$$Y$$$20240809$$MD$US$US
239252022$23925202$2$F$20240426$20240813$20240531$20240819$EXP$$US-MYLANLABS-2024M1049185$MYLAN$$48$YR$$M$Y$$$20240819$$PH$US$US
239252185$23925218$5$F$20240711$20240923$20240531$20240930$EXP$$CA-TAKEDA-2023TUS099424$TAKEDA$$34$YR$$F$Y$$$20240930$$MD$CA$CA
239252552$23925255$2$F$20240101$20240725$20240531$20240731$EXP$$CN-REGENERON PHARMACEUTICALS, INC.-2024-079193$REGENERON$$$$$M$Y$$$20240731$$CN$CN$CN
239252592$23925259$2$F$20240522$20240619$20240531$20240710$PER$$US-AstraZeneca-2024A120103$ASTRAZENECA$$27073$DY$$F$Y$$$20240710$$CN$US$
239252692$23925269$2$F$20230501$20240829$20240531$20240830$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-275197$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$70$KG$20240830$$CN$ES$ES
239252734$23925273$4$F$20240101$20240709$20240531$20240718$EXP$$DE-INSMED, INC.-2024-02130-DE$INSMED$$71$YR$$M$Y$$$20240718$$CN$DE$DE
239252742$23925274$2$F$$20240529$20240531$20240722$PER$$US-HALEON-2178951$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
239252753$23925275$3$F$20240518$20240905$20240531$20240910$30DAY$$US-SANDOZ INC.-SDZ2024US051398$SANDOZ$$15$YR$$M$Y$$$20240910$$HP$US$US
239252812$23925281$2$F$20240501$20240613$20240531$20240704$EXP$JP-ONO-2024JP010435$JP-AMGEN-JPNSP2024107268$AMGEN$$$$E$F$Y$$$20240703$$MD$JP$JP
239253232$23925323$2$F$20240101$20240726$20240531$20240802$EXP$$US-RDY-CLI/USA/24/0007877$DR REDDYS$$18$YR$A$F$Y$$$20240802$$MD$US$US
239253282$23925328$2$F$$20240820$20240531$20240827$PER$$US-SA-2024SA159431$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240827$$MD$US$US
239253332$23925333$2$F$$20240705$20240531$20240711$EXP$$IN-TAKEDA-2023TUS083879$TAKEDA$$$$$M$Y$$$20240711$$CN$IN$IN
239253352$23925335$2$F$$20240712$20240531$20240714$PER$$NVSC2024US114740$NOVARTIS$$$$$$Y$$$20240714$$HP$US$US
239253373$23925337$3$F$20240509$20240710$20240531$20240722$EXP$$US-GSK-US2024AMR067422$GLAXOSMITHKLINE$$59$YR$$F$Y$70.748$KG$20240722$$CN$US$US
239253393$23925339$3$F$$20240925$20240531$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087669$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240926$$CN$US$US
239253444$23925344$4$F$$20240913$20240531$20240919$30DAY$$US-PFIZER INC-202400180535$PFIZER$$15$YR$$M$Y$$$20240919$$CN$US$US
239253494$23925349$4$F$$20240913$20240531$20240918$30DAY$$US-PFIZER INC-202400179407$PFIZER$$10$YR$$M$Y$$$20240918$$CN$US$US
239253515$23925351$5$F$$20240820$20240531$20240822$30DAY$$US-PFIZER INC-202400180658$PFIZER$$26$YR$$F$Y$148.78$KG$20240822$$CN$US$US
239253773$23925377$3$F$20240405$20240926$20240531$20240926$EXP$FR-AFSSAPS-CN2024000476$NVSC2024FR113691$NOVARTIS$$71$YR$$F$Y$$$20240926$$CN$FR$FR
239253942$23925394$2$F$20240321$20240703$20240531$20240709$EXP$$DE-AMGEN-DEUSP2024104217$AMGEN$$53$YR$A$F$Y$57$KG$20240709$$MD$DE$DE
239254174$23925417$4$F$$20240729$20240531$20240805$PER$$US-SA-2024SA158903$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240805$$MD$US$US
239254202$23925420$2$F$$20240703$20240531$20240722$EXP$$CL-EMD Serono-2024029334$EMD SERONO INC$Avila EJ, Roessler EB. BAD: Lactic acidosis associated with the use of metformin, a review of clinical cases. Rev Med Chile. 2023 May 01;151(5): 618-627.$81$YR$E$F$Y$$$20240722$$MD$CL$CL
239254225$23925422$5$F$20240620$20240813$20240531$20240819$30DAY$$US-PFIZER INC-202400108888$PFIZER$$15$YR$$M$Y$79.38$KG$20240819$$CN$US$US
239254284$23925428$4$F$$20240819$20240531$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087644$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240828$$CN$US$US
239254412$23925441$2$F$$20240530$20240531$20240722$PER$$US-HALEON-2179202$Haleon PLC$$$$$F$Y$$$20240722$$CN$US$US
239254482$23925448$2$F$$20240624$20240531$20240702$EXP$$IL-AMGEN-ISRSP2024103386$AMGEN$Turgeman I. Too Much of a Good Thing: The Association of Elevated Vitamin B12 Levels and Outcomes in Patients with Cancer Treated with Immunotherapy. Journal of immunotherapy. 2024;47 (4):117-122$$$$$Y$$$20240701$$MD$IL$IL
239254493$23925449$3$F$20240401$20240723$20240531$20240725$EXP$$US-INCYTE CORPORATION-2024IN005684$INCYTE$$$$$$Y$$$20240725$$HP$US$US
239254532$23925453$2$F$20230829$20240801$20240531$20240805$EXP$$JP-BAYER-2024A079053$BAYER$$59$YR$A$M$Y$$$20240805$$MD$JP$JP
239254602$23925460$2$F$20050701$20240720$20240531$20240801$PER$$US-SA-2024SA158557$SANOFI AVENTIS$$50$YR$A$M$Y$64.4$KG$20240801$$MD$US$US
239254613$23925461$3$F$20240101$20240626$20240531$20240701$EXP$$US-ORGANON-O2405USA002674$ORGANON$$$$$F$Y$$$20240701$$MD$US$US
239254702$23925470$2$F$20240415$20240801$20240531$20240802$EXP$$JP-BAYER-2024A079070$BAYER$$67$YR$E$M$Y$$$20240802$$MD$JP$JP
239254832$23925483$2$F$$20240619$20240531$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002198$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
239254952$23925495$2$F$20240326$20240823$20240531$20240903$EXP$$CA-PFIZER INC-202201309139$PFIZER$$58$YR$$F$Y$$$20240903$$CN$CA$CA
239255023$23925502$3$F$20240101$20240620$20240531$20240702$PER$$US-SA-2024SA160967$SANOFI AVENTIS$$12$YR$T$M$Y$42.18$KG$20240702$$MD$US$US
239255062$23925506$2$F$20240301$20240705$20240531$20240716$EXP$$MX-DSJP-DSJ-2024-119525$DAIICHI$$51$YR$$F$Y$54$KG$20240716$$CN$MX$MX
239255123$23925512$3$F$20230601$20240711$20240531$20240718$EXP$$JP-AMGEN-JPNSP2024103322$AMGEN$$81$YR$E$F$Y$$$20240718$$HP$JP$JP
239255312$23925531$2$F$20240101$20240820$20240531$20240826$PER$$US-PFIZER INC-PV202400071700$PFIZER$$60$YR$$F$Y$$$20240826$$HP$US$US
239255322$23925532$2$F$20240301$20240823$20240531$20240828$PER$$US-PFIZER INC-202400182014$PFIZER$$62$YR$$F$Y$$$20240828$$HP$US$US
239255332$23925533$2$F$20240301$20240830$20240531$20240904$PER$$US-PFIZER INC-PV202400071688$PFIZER$$61$YR$$F$Y$$$20240904$$HP$US$US
239255382$23925538$2$F$20240508$20240829$20240531$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087752$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240829$$CN$US$US
239255464$23925546$4$F$$20240723$20240531$20240726$EXP$$US-GILEAD-2024-0674844$GILEAD$$30$YR$A$F$Y$$$20240726$$CN$US$US
239255492$23925549$2$F$20240501$20240917$20240531$20240924$EXP$$CA-GSK-CA2024067000$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$CA$CA
239255632$23925563$2$F$$20240801$20240531$20240802$EXP$$NVSC2024TR114128$NOVARTIS$$23$YR$$F$Y$$$20240802$$CN$TR$TR
239255643$23925564$3$F$$20240731$20240531$20240802$EXP$$US-BAYER-2024A078247$BAYER$$26$YR$A$M$Y$131.52$KG$20240802$$CN$US$US
239255783$23925578$3$F$20240425$20240912$20240531$20240924$EXP$$US-TAKEDA-2024TUS013184$TAKEDA$$44$YR$$M$Y$104$KG$20240924$$CN$US$US
239256162$23925616$2$F$$20240704$20240531$20240710$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202405016985$ELI LILLY AND CO$$75$YR$E$M$Y$111.3$KG$20240710$$HP$GB$GB
239256182$23925618$2$F$20240428$20240802$20240531$20240806$PER$$US-AMGEN-USASP2024106694$AMGEN$$75$YR$E$M$Y$$$20240806$$MD$US$US
239256732$23925673$2$F$20240401$20240827$20240531$20240905$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003071$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240905$$CN$US$US
239256773$23925677$3$F$20240508$20240803$20240531$20240809$EXP$$NVSC2024IN114336$NOVARTIS$$35$YR$$M$Y$$$20240809$$CN$IN$IN
239256962$23925696$2$F$$20240711$20240531$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04413$LUPIN$$$$$$Y$$$20240809$$CN$US$US
239256972$23925697$2$F$$20240912$20240531$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04364$LUPIN$$$$$$Y$$$20240927$$CN$US$US
239257484$23925748$4$F$20240528$20240709$20240531$20240716$30DAY$$US-JNJFOC-20240582265$JOHNSON AND JOHNSON$$14$YR$T$$Y$$$20240716$$CN$US$US
239257493$23925749$3$F$$20240826$20240531$20240830$EXP$$JP-JNJFOC-20230122126$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$MD$JP$JP
239257512$23925751$2$F$$20240729$20240531$20240801$PER$$US-Taiho Oncology Inc-2024-005327$TAIHO ONCOLOGY INC$$56$YR$A$F$Y$83.73$KG$20240801$$CN$US$US
239257863$23925786$3$F$20240523$20240702$20240531$20240708$30DAY$$US-MYLANLABS-2024M1047792$MYLAN$$65$YR$$F$Y$55.79$KG$20240708$$CN$US$US
239258195$23925819$5$F$20240401$20240911$20240531$20240916$PER$$NVSC2024US114799$NOVARTIS$$$$$F$Y$$$20240916$$HP$US$US
239258562$23925856$2$F$$20240705$20240531$20240726$PER$$AU-TOLMAR, INC.-24AU049221$TOLMAR$$$$$M$Y$$$20240726$$CN$AU$AU
239258593$23925859$3$F$$20240620$20240531$20240710$PER$$AU-TOLMAR, INC.-24AU049258$TOLMAR$$$$$$Y$$$20240709$$MD$AU$AU
239258672$23925867$2$F$20240529$20240829$20240531$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087779$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240829$$PH$US$US
239258733$23925873$3$F$20230127$20240704$20240531$20240708$EXP$$JP-EMD Serono-2024029482$EMD SERONO INC$$87$YR$E$M$Y$$$20240708$$MD$JP$JP
239258844$23925884$4$F$20240513$20240909$20240531$20240920$EXP$$CA-HLS-202401343$HLS THERAPEUTICS$$78$YR$E$F$Y$$$20240920$$HP$CA$CA
239258882$23925888$2$F$20230101$20240726$20240531$20240805$PER$$US-VERTEX PHARMACEUTICALS-2024-004044$VERTEX$$$$$M$Y$$$20240805$$MD$US$US
239258892$23925889$2$F$$20240523$20240531$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-009007$VERTEX$$$$$$Y$$$20240715$$CN$US$US
239258922$23925892$2$F$$20240801$20240531$20240805$PER$$US-VERTEX PHARMACEUTICALS-2024-008062$VERTEX$$$$$F$Y$$$20240805$$CN$US$US
239259202$23925920$2$F$20240423$20240704$20240531$20240708$EXP$$JP-Eisai-EC-2024-166805$EISAI$$8$DEC$E$M$Y$$$20240708$$MD$JP$JP
239259322$23925932$2$F$$20240711$20240531$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04403$LUPIN$$$$$$Y$$$20240809$$CN$US$US
239259352$23925935$2$F$20240506$20240628$20240531$20240704$EXP$$NVSC2024FI110151$NOVARTIS$$39$YR$$M$Y$$$20240704$$MD$FI$FI
239259462$23925946$2$F$$20240823$20240531$20240913$EXP$$US-RADIUS HEALTH INC.-2023US002557$RADIUS PHARM$$$$$F$Y$$$20240913$$CN$US$US
239259632$23925963$2$F$$20240711$20240531$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04404$LUPIN$$$$$$Y$$$20240809$$CN$US$US
239259642$23925964$2$F$20240513$20240706$20240531$20240708$30DAY$$CO-PFIZER INC-PV202400070514$PFIZER$$$$$M$Y$$$20240708$$MD$CO$CO
239259663$23925966$3$F$20240527$20240819$20240531$20240821$30DAY$$AR-PFIZER INC-202400180881$PFIZER$$8$YR$$M$Y$$$20240821$$CN$AR$AR
239259694$23925969$4$F$20240525$20240716$20240531$20240718$30DAY$$GB-PFIZER INC-PV202400069837$PFIZER$$81$YR$$M$Y$$$20240718$$CN$GB$GB
239259712$23925971$2$F$$20240808$20240531$20240808$PER$$NVSC2024US114222$NOVARTIS$$21$YR$$F$Y$$$20240808$$CN$US$US
239259902$23925990$2$F$20230101$20240628$20240531$20240710$EXP$$US-Calliditas-2024CAL00878$CALLIDITAS THERAPEUTICS$$29$YR$A$F$Y$98$KG$20240710$$CN$US$US
239260014$23926001$4$F$20240602$20240827$20240531$20240830$30DAY$$NL-PFIZER INC-202400175783$PFIZER$$38$YR$$F$Y$68$KG$20240830$$PH$NL$NL
239260042$23926004$2$F$20240101$20240717$20240531$20240725$EXP$$IL-SA-2024SA079241$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240725$$MD$IL$IL
239260072$23926007$2$F$20240201$20240627$20240531$20240710$PER$$US-INSUD PHARMA-2405US04003$INSUD PHARMA$$$$$$Y$$$20240710$$HP$US$US
239260095$23926009$5$F$20240101$20240904$20240531$20240911$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016079$UNITED THERAPEUTICS$$$$$F$Y$58.957$KG$20240911$$$US$US
239260412$23926041$2$F$$20240829$20240531$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087727$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240829$$CN$US$US
239260442$23926044$2$F$$20240919$20240531$20240930$EXP$$CA-TAKEDA-2024TUS043427$TAKEDA$$$$$M$Y$$$20240930$$MD$CA$CA
239260572$23926057$2$F$20240507$20240624$20240531$20240703$EXP$$JP-EMD Serono-2024028176$EMD SERONO INC$$7$DEC$E$M$Y$$$20240703$$MD$JP$JP
239260665$23926066$5$F$$20240820$20240531$20240822$30DAY$$US-PFIZER INC-202400180727$PFIZER$$13$YR$$F$Y$$$20240822$$CN$US$US
239261222$23926122$2$F$$20240718$20240531$20240726$EXP$$US-Calliditas-2024CAL00867$CALLIDITAS THERAPEUTICS$$30$YR$A$M$Y$101.6$KG$20240726$$CN$US$US
239261353$23926135$3$F$20240524$20240920$20240531$20240925$30DAY$$KR-PFIZER INC-PV202400068967$PFIZER$$8$YR$$M$Y$$$20240925$$CN$KR$KR
239261422$23926142$2$F$$20240711$20240531$20240711$PER$$NVSC2024US114806$NOVARTIS$$$$$M$Y$$$20240711$$CN$US$US
239261533$23926153$3$F$20240525$20240531$20240531$20240910$PER$$NVSC2024US113453$NOVARTIS$$39$YR$$F$Y$$$20240910$$CN$US$US
239262052$23926205$2$F$$20240708$20240531$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087582$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240712$$CN$US$US
239262153$23926215$3$F$20240529$20240712$20240531$20240812$PER$$AU-OTSUKA-2024_015383$OTSUKA$$32$YR$$F$Y$$$20240812$$HP$AU$AU
239262172$23926217$2$F$$20240709$20240531$20240717$EXP$$US-AstraZeneca-2024A122184$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
239262744$23926274$4$F$20240501$20240815$20240531$20240819$EXP$$JP-ALXN-202405JPN001989JP$ALEXION PHARMACEUTICALS$$71$YR$$M$Y$$$20240819$$MD$JP$JP
239262892$23926289$2$F$20240527$20240528$20240531$20240807$PER$$US-009507513-2405USA009104$MERCK$$$$$F$Y$$$20240807$$HP$US$US
239262943$23926294$3$F$20240521$20240829$20240531$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-087103$BRISTOL MYERS SQUIBB$$9$DEC$E$$Y$$$20240829$$MD$JP$JP
239263162$23926316$2$F$20220926$20240811$20240531$20240823$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202405014747$ELI LILLY AND CO$Shi X..Significant elevation of serum CA19-9 and CA242 levels induced by dulaglutide..BMJ Case Reports. 2024;17(5):.DOI:10.1136/bcr-2023-257657$65$YR$E$F$Y$$$20240823$$MD$CN$CN
239263363$23926336$3$F$20211201$20240715$20240531$20240722$EXP$$NVSC2024RO112258$NOVARTIS$$32$YR$$F$Y$$$20240722$$MD$RO$RO
239263543$23926354$3$F$20240101$20240711$20240531$20240722$EXP$$JP-009507513-2405JPN003119J$MERCK$$74$YR$$$Y$$$20240719$$MD$JP$JP
239263622$23926362$2$F$20220401$20240712$20240531$20240717$EXP$$US-SA-2024SA163004$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240717$$MD$US$US
239263682$23926368$2$F$$20240807$20240531$20240807$PER$$US-ALXN-202405USA001493US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
239263692$23926369$2$F$$20240718$20240531$20240718$PER$$US-ALXN-202405USA001118US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239263772$23926377$2$F$20240417$20240828$20240531$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086122$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240828$$HP$US$US
239264494$23926449$4$F$$20240825$20240531$20240828$30DAY$$US-SANDOZ INC.-SDZ2024US052917$SANDOZ$$$$$$Y$$$20240828$$CN$US$US
239264542$23926454$2$F$20240525$20240718$20240531$20240806$PER$$US-ALXN-202405USA001782US$ALEXION PHARMACEUTICALS$$70$YR$$F$Y$$$20240719$$CN$US$US
239265414$23926541$4$F$$20240715$20240531$20240718$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003047$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240718$$MD$US$US
239265435$23926543$5$F$20240707$20240909$20240531$20240917$EXP$$CA-GSK-CA2023AMR020904$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
239265463$23926546$3$F$$20240531$20240531$20240910$PER$$NVSC2024US114021$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
239265472$23926547$2$F$$20240826$20240531$20240829$PER$$US-PFIZER INC-202400180378$PFIZER$$74$YR$$F$Y$63.5$KG$20240829$$CN$US$US
239265602$23926560$2$F$20240501$20240924$20240531$20240930$EXP$$JP-009507513-2405JPN003100J$MERCK$$$$$F$Y$$$20240930$$MD$JP$JP
239265822$23926582$2$F$$20240528$20240531$20240702$EXP$$DE-AstraZeneca-2024A124398$ASTRAZENECA$$$$$F$Y$$$20240702$$MD$DE$
239265832$23926583$2$F$$20240716$20240531$20240723$EXP$$US-AstraZeneca-2024A125680$ASTRAZENECA$$65$YR$$M$Y$$$20240723$$CN$US$
239265876$23926587$6$F$20240501$20240920$20240531$20240924$30DAY$$US-PFIZER INC-202400178625$PFIZER$$26$YR$$F$Y$63.5$KG$20240924$$CN$US$US
239266142$23926614$2$F$$20240830$20240531$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086544$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240903$$CN$US$US
239266232$23926623$2$F$20240527$20240624$20240531$20240701$EXP$$CA-GSK-CA2024002964$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$HP$CA$CA
239267082$23926708$2$F$$20240822$20240531$20240827$EXP$$US-PFIZER INC-PV202400070347$PFIZER$$85$YR$$F$Y$$$20240827$$CN$US$US
239267492$23926749$2$F$$20240823$20240531$20240829$PER$$US-BIOGEN-2024BI01266946$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
239267642$23926764$2$F$20240429$20240701$20240531$20240708$EXP$$DE-MYLANLABS-2024M1049157$MYLAN$$61$YR$$F$Y$57$KG$20240708$$MD$DE$DE
239267782$23926778$2$F$20240101$20240805$20240531$20240807$PER$$US-AMGEN-USASP2024105660$AMGEN$$$$$$Y$$$20240807$$CN$US$US
239267813$23926781$3$F$20240304$20240718$20240531$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086160$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240723$$HP$US$US
239267822$23926782$2$F$20240515$20240828$20240531$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084011$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240828$$CN$US$US
239268793$23926879$3$F$$20240913$20240531$20240918$30DAY$$US-SANDOZ INC.-SDZ2024US053485$SANDOZ$$$$$M$Y$$$20240918$$CN$US$US
239268832$23926883$2$F$20240522$20240703$20240531$20240708$PER$$US-JNJFOC-20240568557$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240708$$PH$US$US
239268962$23926896$2$F$$20240711$20240531$20240715$PER$$NVSC2024US115200$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
239268982$23926898$2$F$$20240731$20240531$20240802$EXP$$NVSC2024TR114135$NOVARTIS$$28$YR$$F$Y$$$20240802$$CN$TR$TR
239268992$23926899$2$F$$20240712$20240531$20240714$PER$$NVSC2024US114842$NOVARTIS$$$$$F$Y$$$20240714$$CN$US$US
239269462$23926946$2$F$20240528$20240828$20240531$20240828$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-085120$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240828$$HP$IL$IL
239269742$23926974$2$F$$20240723$20240531$20240731$EXP$$IE-AstraZeneca-2024A123665$ASTRAZENECA$$$$$F$Y$$$20240731$$HP$IE$
239270073$23927007$3$F$$20240623$20240531$20240701$EXP$$IL-TAKEDA-2023TUS123708$TAKEDA$$$$$F$Y$$$20240701$$CN$IL$IL
239270252$23927025$2$F$20240101$20240712$20240531$20240717$EXP$$FR-SA-2024SA163155$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240717$$MD$FR$FR
239270532$23927053$2$F$20240401$20240626$20240531$20240702$EXP$$NVSC2024BR108790$NOVARTIS$$7$YR$$F$Y$20$KG$20240702$$MD$BR$BR
239270862$23927086$2$F$$20240627$20240531$20240701$EXP$$JP-AstraZeneca-2024A124724$ASTRAZENECA$$$$$F$Y$$$20240701$$MD$JP$
239271065$23927106$5$F$20240404$20240819$20240531$20240826$EXP$$US-BIOGEN-2024BI01266338$BIOGEN$$67$YR$$M$Y$76.726$KG$20240826$$HP$US$US
239271222$23927122$2$F$$20240829$20240531$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087682$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240829$$CN$US$US
239271243$23927124$3$F$20240101$20240812$20240531$20240814$EXP$$US-PFIZER INC-202400100475$PFIZER$$78$YR$$F$Y$$$20240814$$HP$US$US
239271255$23927125$5$F$20240101$20240715$20240531$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-001630$UNITED THERAPEUTICS$$$$$F$Y$64.399$KG$20240725$$$US$US
239271915$23927191$5$F$$20240829$20240531$20240906$EXP$$CA-TEVA-VS-3203114$TEVA$$35$YR$$F$Y$$$20240906$$HP$CA$CA
239272112$23927211$2$F$$20240528$20240531$20240722$PER$$US-HALEON-2178578$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
239272342$23927234$2$F$$20240726$20240531$20240803$EXP$$CA-TEVA-VS-3204091$TEVA$$65$YR$$F$Y$34$KG$20240803$$HP$CA$CA
239272502$23927250$2$F$$20240621$20240531$20240704$EXP$$CA-TEVA-VS-3204090$TEVA$$65$YR$$F$Y$34$KG$20240704$$HP$CA$CA
239272593$23927259$3$F$20240311$20240729$20240531$20240801$EXP$$NVSC2024DE114641$NOVARTIS$$$$$F$Y$$$20240801$$CN$DE$DE
239272882$23927288$2$F$$20240916$20240531$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086646$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240916$$CN$US$US
239272902$23927290$2$F$$20240724$20240531$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008244$JAZZ$$$$$F$Y$$$20240730$$CN$US$US
239273082$23927308$2$F$20240101$20240628$20240531$20240710$PER$$US-SA-2024SA159278$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240710$$MD$US$US
239273174$23927317$4$F$20240521$20240729$20240531$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085695$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$99.79$KG$20240730$$CN$US$US
239273192$23927319$2$F$$20240726$20240531$20240729$EXP$$CO-PFIZER INC-202400179296$PFIZER$$9$YR$$F$Y$$$20240729$$CN$CO$CO
239273522$23927352$2$F$$20240718$20240531$20240806$PER$$US-ALXN-202405USA001797US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239273652$23927365$2$F$20240524$20240906$20240531$20240911$EXP$$CA-JNJFOC-20240575817$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240911$$HP$CA$CA
239273822$23927382$2$F$$20240828$20240531$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086129$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240828$$CN$US$US
239273853$23927385$3$F$$20240816$20240531$20240830$PER$$US-SA-2024SA158446$SANOFI AVENTIS$$33$YR$A$M$Y$90.703$KG$20240830$$MD$US$US
239274502$23927450$2$F$$20240828$20240531$20240828$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-062640$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$100$KG$20240828$$MD$NL$NL
239274614$23927461$4$F$20240604$20240726$20240531$20240731$EXP$$US-INCYTE CORPORATION-2024IN005502$INCYTE$$$$$$Y$$$20240731$$MD$US$US
239275022$23927502$2$F$$20240718$20240531$20240718$PER$$US-ALXN-202405USA001716US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239275582$23927558$2$F$$20240718$20240531$20240806$PER$$US-ALXN-202405USA001898US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239275592$23927559$2$F$$20240718$20240531$20240806$PER$$US-ALXN-202405USA001790US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239275784$23927578$4$F$20240101$20240723$20240531$20240730$EXP$$US-ALKERMES INC.-ALK-2024-001437$ALKERMES$$$$$M$Y$$$20240730$$MD$US$US
239275822$23927582$2$F$20240910$20240910$20240531$20240917$EXP$$CA-GILEAD-2023-0633077$GILEAD$$77$YR$E$F$Y$$$20240917$$HP$CA$CA
239275912$23927591$2$F$20240515$20240626$20240531$20240703$EXP$$US-RADIUS HEALTH INC.-2024US003575$RADIUS PHARM$$82$YR$$F$Y$$$20240703$$CN$US$US
239275922$23927592$2$F$20240517$20240712$20240531$20240712$EXP$$AU-ALXN-202405OCE001667AU$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240712$$MD$AU$AU
239275932$23927593$2$F$20240501$20240718$20240531$20240806$PER$$US-ALXN-202405USA001779US$ALEXION PHARMACEUTICALS$$74$YR$$M$Y$$$20240719$$CN$US$US
239275965$23927596$5$F$20240101$20240628$20240531$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-013547$UNITED THERAPEUTICS$$$$$F$Y$68.934$KG$20240704$$$US$US
239276036$23927603$6$F$20240101$20240730$20240531$20240808$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016012$UNITED THERAPEUTICS$$$$$F$Y$86.168$KG$20240808$$$US$US
239276045$23927604$5$F$20240101$20240709$20240531$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016066$UNITED THERAPEUTICS$$$$$F$Y$95.238$KG$20240719$$$US$US
239276164$23927616$4$F$20240401$20240730$20240531$20240802$EXP$$US-ABBVIE-5781428$ABBVIE$$80$YR$$M$Y$86$KG$20240802$$CN$US$US
239276172$23927617$2$F$20240912$20240923$20240531$20240927$EXP$$US-KYOWAKIRIN-2024KK013124$KYOWA$$$$$$Y$$$20240927$$HP$US$US
239276213$23927621$3$F$20230104$20240724$20240531$20240726$EXP$$JP-GSK-JP2024JPN065916$GLAXOSMITHKLINE$Suzuki D, Ichie T, Takashima Y, Miura T, Yamashita S, Hayashi H. Note - Drug-Drug Interaction between Daprodustat and Clopidogrel in Patients with Chronic Kidney Disease: A Case Series Study. Japanese Journal of Pharmaceutical Health Care and Sciences. 2024;50:258-263$$$$$Y$$$20240726$$PH$JP$JP
239276322$23927632$2$F$$20240703$20240531$20240722$PER$$US-INCYTE CORPORATION-2024IN005027$INCYTE$$$$$$Y$$$20240719$$MD$US$US
239276334$23927633$4$F$20240502$20240612$20240531$20240708$EXP$$US-APELLIS-2024-APL-0000164$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240708$$MD$US$US
239276375$23927637$5$F$20240101$20240730$20240531$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-016217$UNITED THERAPEUTICS$$$$$M$Y$98.413$KG$20240807$$$US$US
2392763810$23927638$10$F$20240101$20240923$20240531$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-009158$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240927$$$US$US
239276413$23927641$3$F$$20240805$20240531$20240904$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000078$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240904$$CN$US$US
239276652$23927665$2$F$$20240702$20240531$20240710$EXP$$JP-MALLINCKRODT-MNK202403567$MALLINCKRODT$$$$A$$Y$$$20240710$$HP$JP$JP
239276903$23927690$3$F$20240522$20240710$20240531$20240712$EXP$$US-PFIZER INC-PV202400071343$PFIZER$$69$YR$$F$Y$74$KG$20240712$$HP$US$US
239276925$23927692$5$F$20240501$20240625$20240531$20240704$EXP$$CA-BEH-2024173130$CSL BEHRING$$84$YR$E$F$Y$$$20240704$$HP$CA$CA
239276984$23927698$4$F$$20240527$20240531$20240705$EXP$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000617$PAREXEL$Khan Y., Revana A.. When the options run out less is more a case of pediatric narcolepsy with limited treatment options. Sleep. 2024;47:A514$16$YR$$F$Y$$$20240705$$MD$US$US
239277038$23927703$8$F$20240101$20240724$20240531$20240802$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011409$UNITED THERAPEUTICS$$$$$M$Y$68.934$KG$20240802$$$US$US
239277182$23927718$2$F$20240508$20240715$20240531$20240715$EXP$$US-ALXN-202405USA000612US$ALEXION PHARMACEUTICALS$$75$YR$$F$Y$$$20240715$$HP$US$US
239277272$23927727$2$F$$20240708$20240531$20240717$PER$$US-APELLIS-2024-APL-0000073$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
239277412$23927741$2$F$20240502$20240919$20240531$20240923$EXP$$JP-ABBVIE-5779693$ABBVIE$$55$YR$$M$Y$55$KG$20240923$$MD$JP$JP
239277422$23927742$2$F$20220101$20240716$20240531$20240720$EXP$$CH-TAKEDA-2024TUS054153$TAKEDA$$$$E$$Y$$$20240720$$MD$CH$CH
239277453$23927745$3$F$20240506$20240719$20240531$20240725$EXP$$US-APELLIS-2024-APL-0000104$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
239277565$23927756$5$F$20240515$20240721$20240531$20240725$EXP$$US-APELLIS-APL-2023-002587$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
239277572$23927757$2$F$$20240423$20240531$20240705$PER$$US-APELLIS-APL-2023-002735$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240705$$CN$US$US
239277592$23927759$2$F$$20240628$20240531$20240705$EXP$$US-JAZZ PHARMACEUTICALS-202203USGW01684$JAZZ$$$$$F$Y$$$20240705$$CN$US$US
239277723$23927772$3$F$$20240711$20240531$20240712$PER$$US-JNJFOC-20240513789$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240712$$CN$US$US
239277852$23927785$2$F$20240518$20240730$20240531$20240813$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0190$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240812$$MD$US$US
239277892$23927789$2$F$$20240530$20240531$20240722$PER$$US-HALEON-2179167$Haleon PLC$$$$$F$Y$$$20240722$$CN$US$US
239277902$23927790$2$F$$20240612$20240531$20240702$EXP$$TH-ROCHE-3571227$ROCHE$$80$YR$E$F$Y$$$20240702$$CN$TH$TH
239280382$23928038$2$F$$20240530$20240531$20240722$PER$$US-HALEON-2179255$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
239281842$23928184$2$F$20240501$20240626$20240531$20240709$PER$$US-AstraZeneca-2024A123033$ASTRAZENECA$$803$MON$$F$Y$$$20240709$$CN$US$
239282882$23928288$2$F$20240226$20240722$20240531$20240729$EXP$$JP-AMGEN-JPNSP2024104407$AMGEN$$$$$$Y$$$20240729$$PH$JP$JP
239282892$23928289$2$F$$20240731$20240531$20240801$EXP$$NVSC2024US114801$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
239283902$23928390$2$F$20200212$20240704$20240531$20240710$EXP$$BE-ABBVIE-21K-013-3876729-00$ABBVIE$$76$YR$$F$Y$$$20240710$$HP$BE$BE
239284092$23928409$2$F$20240527$20240723$20240531$20240726$EXP$$US-ABBVIE-5781038$ABBVIE$$19$YR$$M$Y$$$20240726$$CN$US$US
239285603$23928560$3$F$$20240701$20240531$20240729$EXP$$US-ABBVIE-5783258$ABBVIE$$62$YR$$M$Y$$$20240729$$HP$US$US
239290363$23929036$3$F$20240101$20240729$20240601$20240802$EXP$$AR-ABBVIE-5779253$ABBVIE$$$$$F$Y$$$20240802$$CN$AR$AR
239290378$23929037$8$F$20240606$20240705$20240601$20240712$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016359$UNITED THERAPEUTICS$$76$YR$$F$Y$$$20240712$$$US$US
239290492$23929049$2$F$$20240723$20240601$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-016386$UNITED THERAPEUTICS$$$$$F$Y$53.968$KG$20240725$$$US$US
239290527$23929052$7$F$20240529$20240813$20240601$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-016044$UNITED THERAPEUTICS$$12$YR$$F$Y$36.281$KG$20240820$$$US$US
239290554$23929055$4$F$20240501$20240703$20240601$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-016040$UNITED THERAPEUTICS$$81$YR$$F$Y$82.54$KG$20240710$$$US$US
239290573$23929057$3$F$$20240731$20240601$20240807$EXP$$US-ABBVIE-5783189$ABBVIE$$69$YR$$M$Y$$$20240807$$HP$US$US
239290862$23929086$2$F$$20240709$20240601$20240716$PER$$US-AstraZeneca-2024A123163$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
239290875$23929087$5$F$20240101$20240708$20240601$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-016284$UNITED THERAPEUTICS$$$$$F$Y$$$20240713$$$US$US
239290995$23929099$5$F$20240527$20240820$20240601$20240822$PER$$US-AMGEN-USASP2024105943$AMGEN$$61$YR$A$F$Y$$$20240821$$CN$US$US
239291012$23929101$2$F$20230101$20240708$20240601$20240716$PER$$US-SA-2024SA163476$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240716$$MD$US$US
239291052$23929105$2$F$20240526$20240816$20240601$20240821$PER$$US-AMGEN-USASP2024105444$AMGEN$$67$YR$E$M$Y$$$20240821$$CN$US$US
239291072$23929107$2$F$$20240528$20240601$20240724$PER$$US-HALEON-2179295$Haleon PLC$$$$$$Y$$$20240724$$CN$US$US
239291342$23929134$2$F$20240411$20240906$20240601$20240918$EXP$$JP-ROCHE-3573187$ROCHE$$71$YR$E$M$Y$55$KG$20240918$$MD$JP$JP
239291403$23929140$3$F$20240501$20240823$20240601$20240902$PER$$US-KOANAAP-SML-US-2024-00489$Unknown Manufacturer$$$$$F$Y$44.4$KG$20240902$$CN$US$US
239291504$23929150$4$F$20240101$20240919$20240601$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014106$UNITED THERAPEUTICS$$61$YR$$M$Y$104.31$KG$20240928$$$US$US
239291512$23929151$2$F$20240611$20240709$20240601$20240718$PER$$US-SA-2024SA164018$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240718$$MD$US$US
239291532$23929153$2$F$$20240916$20240601$20240924$PER$$US-SA-2024SA164051$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240924$$MD$US$US
239291574$23929157$4$F$20240101$20240729$20240601$20240805$EXP$$TW-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-030947$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$52$KG$20240805$$CN$TW$TW
239291622$23929162$2$F$20240521$20240806$20240601$20240807$EXP$$US-JNJFOC-20240568564$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$HP$US$US
239291683$23929168$3$F$20240101$20240910$20240601$20240917$EXP$$CA-CELLTRION INC.-2024CA012890$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
239291692$23929169$2$F$20240101$20240722$20240601$20240731$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012052$UNITED THERAPEUTICS$$$$$F$Y$58.05$KG$20240731$$$US$US
239291703$23929170$3$F$20240501$20240711$20240601$20240716$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015622$UNITED THERAPEUTICS$$64$YR$$M$Y$89.342$KG$20240716$$$US$US
239291733$23929173$3$F$$20240719$20240601$20240828$PER$$US-AstraZeneca-2024A120247$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
239292434$23929243$4$F$20240101$20240827$20240601$20240909$EXP$$JP-UCBSA-2024013590$UCB$$35$YR$$F$Y$$$20240909$$CN$JP$JP
239293583$23929358$3$F$20240529$20240627$20240601$20240708$PER$$US-SA-2024SA163445$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240708$$MD$US$US
239293944$23929394$4$F$20240101$20240725$20240601$20240809$EXP$$CA-UCBSA-2024008105$UCB$$$$$F$Y$$$20240809$$CN$CA$CA
239294832$23929483$2$F$20240515$20240701$20240601$20240705$PER$$US-AstraZeneca-2024A115419$ASTRAZENECA$$18005$DY$$F$Y$$$20240705$$CN$US$
239295122$23929512$2$F$$20240701$20240601$20240708$EXP$$PT-AUROBINDO-AUR-APL-2024-025690$AUROBINDO$Mestre A., Oliveira A., Damiao F., Carvalhana S. ACUTE HEPATITIS IN DRESS SYNDROME. European Journal. 2019;V6Sup1:6$45$YR$$F$Y$$$20240708$$HP$PT$PT
239295362$23929536$2$F$$20240719$20240601$20240802$EXP$$JP-UCBSA-2024027738$UCB$Tsukishima J et al. Preparing a Monitoring Sheet in Managing Adverse Drug Reactions of Tisagenlecleucel. Program/Abstract of the 45th Kinki Regional Meeting of Japanese Society of Hospi. 2024;1-077$9$YR$$M$Y$$$20240802$$PH$JP$JP
239295633$23929563$3$F$20240313$20240717$20240601$20240724$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012753$UNITED THERAPEUTICS$$69$YR$$M$Y$66.213$KG$20240724$$PH$US$US
239297052$23929705$2$F$20240401$20240904$20240601$20240917$EXP$$US-UCBSA-2024027169$UCB$$59$YR$$F$Y$$$20240917$$HP$US$US
239297712$23929771$2$F$20240125$20240705$20240601$20240706$PER$$US-AstraZeneca-2024A127154$ASTRAZENECA$$41$YR$$F$Y$81.6$KG$20240706$$CN$US$
239297852$23929785$2$F$20230913$20240707$20240601$20240709$EXP$$GR-ABBVIE-5781003$ABBVIE$$81$YR$$M$Y$$$20240709$$MD$GR$GR
239298142$23929814$2$F$20240527$20240629$20240601$20240703$PER$$US-AMGEN-USASP2024105422$AMGEN$$76$YR$E$M$Y$$$20240703$$CN$US$US
239299053$23929905$3$F$20240221$20240720$20240601$20240729$EXP$$CA-CELLTRION INC.-2023CA024512$CELLTRION$$$$$$Y$$$20240729$$MD$CA$CA
239299162$23929916$2$F$20240101$20240628$20240601$20240702$EXP$$US-ABBVIE-5782000$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
239299183$23929918$3$F$20240201$20240806$20240601$20240807$PER$$US-JNJFOC-20240583291$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$HP$US$US
239299552$23929955$2$F$20240529$20240625$20240601$20240704$PER$$US-AMGEN-USASP2024107844$AMGEN$$82$YR$E$M$Y$$$20240704$$CN$US$US
239299632$23929963$2$F$20240525$20240705$20240601$20240711$EXP$$CN-JNJFOC-20240576636$JOHNSON AND JOHNSON$$$$$$Y$50$KG$20240711$$MD$CN$CN
239299832$23929983$2$F$20240101$20240819$20240601$20240822$EXP$$JP-ABBVIE-5782439$ABBVIE$$$$$M$Y$$$20240822$$MD$JP$JP
239300112$23930011$2$F$20240101$20240710$20240601$20240801$PER$$US-SA-2024SA164036$SANOFI AVENTIS$$68$YR$E$F$Y$72$KG$20240719$$MD$US$US
239300232$23930023$2$F$$20240530$20240601$20240925$EXP$$CA-ABBVIE-5784124$ABBVIE$$$$A$F$Y$$$20240925$$HP$CA$CA
239300262$23930026$2$F$20240524$20240628$20240601$20240701$PER$$US-AstraZeneca-2024A124884$ASTRAZENECA$$$$$F$Y$$$20240701$$MD$US$
239300283$23930028$3$F$20230101$20240726$20240601$20240807$EXP$$IT-AUROBINDO-AUR-APL-2024-025659$AUROBINDO$Lorenzon L, Campisi A, Di Paolo A, Giuliante F, Buttitta F, D?Ugo D. Case Report: The molecular fingerprint and the clinical implication of an exceptional response to neoadjuvant therapy in a metastatic cardia adenocarcinoma. Frontiers in Surgery. 2024;11:1-8$49$YR$$M$Y$$$20240807$$MD$IT$IT
239300362$23930036$2$F$$20240709$20240601$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031283$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240710$$CN$US$US
239300389$23930038$9$F$20240101$20240805$20240601$20240813$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015072$UNITED THERAPEUTICS$$$$$F$Y$60.317$KG$20240813$$$US$US
239300443$23930044$3$F$$20240725$20240601$20240729$PER$$US-JNJFOC-20240586205$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240729$$PH$US$US
239300522$23930052$2$F$20240501$20240701$20240601$20240703$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-124120$DAIICHI$$72$YR$$M$Y$$$20240703$$MD$US$US
239300643$23930064$3$F$$20240618$20240601$20240718$PER$$US-AstraZeneca-2024A124927$ASTRAZENECA$$$$$$Y$$$20240718$$HP$US$
239300722$23930072$2$F$$20240625$20240601$20240705$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK091069$GLENMARK$$$$$$Y$$$20240705$$CN$CA$CA
239300793$23930079$3$F$20240529$20240802$20240601$20240806$PER$$US-AMGEN-USASP2024107380$AMGEN$$77$YR$E$M$Y$$$20240806$$CN$US$US
239300892$23930089$2$F$20240530$20240830$20240601$20240902$PER$$US-AMGEN-USASP2024107906$AMGEN$$78$YR$E$F$Y$$$20240902$$CN$US$US
239300902$23930090$2$F$20230908$20240710$20240601$20240717$EXP$IT-MINISAL02-986450$IT-AMGEN-ITASP2024102478$AMGEN$$57$YR$A$F$Y$46$KG$20240717$$CN$IT$IT
239301002$23930100$2$F$20240527$20240626$20240601$20240702$PER$$US-AMGEN-USASP2024107956$AMGEN$$70$YR$E$F$Y$$$20240701$$CN$US$US
239301012$23930101$2$F$$20240712$20240601$20240720$EXP$$JP-AMGEN-JPNSP2024101831$AMGEN$$73$YR$E$F$Y$$$20240719$$MD$JP$JP
239301196$23930119$6$F$20240101$20240628$20240601$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015990$UNITED THERAPEUTICS$$$$$F$Y$86.168$KG$20240706$$$US$US
239301232$23930123$2$F$20240523$20240627$20240601$20240702$PER$$US-AMGEN-USASP2024107919$AMGEN$$62$YR$A$F$Y$$$20240702$$CN$US$US
239301303$23930130$3$F$$20240625$20240601$20240702$EXP$$JP-JNJFOC-20240573242$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$MD$JP$JP
239301343$23930134$3$F$20240527$20240708$20240601$20240711$PER$$US-AMGEN-USASP2024106126$AMGEN$$68$YR$E$F$Y$$$20240711$$CN$US$US
239301372$23930137$2$F$20240505$20240704$20240601$20240711$PER$$US-AstraZeneca-2024A107164$ASTRAZENECA$$21314$DY$$F$Y$46.7$KG$20240711$$CN$US$
239301522$23930152$2$F$20230929$20240827$20240601$20240903$EXP$$CA-JNJFOC-20230972472$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240903$$HP$CA$CA
239301542$23930154$2$F$20240501$20240823$20240601$20240904$EXP$$US-RADIUS HEALTH INC.-2024US003420$RADIUS PHARM$$60$YR$$F$Y$$$20240904$$CN$US$US
239301562$23930156$2$F$20240522$20240629$20240601$20240709$EXP$$US-RADIUS HEALTH INC.-2024US003640$RADIUS PHARM$$63$YR$$F$Y$$$20240709$$CN$US$US
239301683$23930168$3$F$$20240718$20240602$20240723$PER$$US-AstraZeneca-2024A121533$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
239301912$23930191$2$F$$20240708$20240602$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04406$LUPIN$$$$$$Y$$$20240801$$PH$US$US
239302043$23930204$3$F$20230501$20240910$20240602$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-026599$AUROBINDO$Li Y, Htet N. SUCCESSFUL TREATMENT OF MASSIVE LAMOTRIGINE OVERDOSE. Crit-Care-Med. 2024;52 (Suppl.)(1):S438 abstr. 932$66$YR$$M$Y$86$KG$20240923$$MD$US$US
239302052$23930205$2$F$20230510$20240701$20240602$20240711$EXP$$BR-SANDOZ INC.-SDZ2024BR053789$SANDOZ$$57$YR$$F$Y$52$KG$20240711$$CN$BR$BR
239302073$23930207$3$F$$20240713$20240602$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04416$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239302132$23930213$2$F$$20240531$20240602$20240722$EXP$$US-SANDOZ INC.-SDZ2024US046690$SANDOZ$Haghparast P, Nadybal M, Yuan C. Treatment-Resistant Priapism in a 61-Year-Old Male After Combined Use of Trazodone, Quetiapine, and Fluoxetine. Journal of Clinical Psychopharmacology. 2024;44:2$61$YR$$M$Y$105$KG$20240722$$HP$US$US
239302602$23930260$2$F$20240101$20240805$20240602$20240811$PER$$US-SA-2024SA160824$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240811$$MD$US$US
239302612$23930261$2$F$$20240712$20240602$20240723$PER$$US-SA-2024SA161291$SANOFI AVENTIS$$15$YR$T$M$Y$68$KG$20240723$$MD$US$US
239302622$23930262$2$F$20240101$20240819$20240602$20240829$PER$$US-SA-2024SA163263$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240829$$MD$US$US
239302794$23930279$4$F$20240101$20240619$20240602$20240701$PER$$US-SA-2024SA160798$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240701$$HP$US$US
239303272$23930327$2$F$20240601$20240803$20240602$20240810$PER$$US-SA-2024SA164138$SANOFI AVENTIS$$96$YR$E$F$Y$$$20240810$$MD$US$US
239303282$23930328$2$F$$20240715$20240602$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087467$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240718$$CN$US$US
239303472$23930347$2$F$$20240724$20240602$20240822$PER$$US-AstraZeneca-2024A126189$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
239303482$23930348$2$F$20240524$20240701$20240602$20240709$PER$$US-JNJFOC-20240578553$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240709$$PH$US$US
239303514$23930351$4$F$20240101$20240719$20240602$20240729$PER$$US-SA-2024SA159846$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240729$$MD$US$US
239303632$23930363$2$F$20240801$20240820$20240602$20240829$PER$$US-SA-2024SA163297$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240829$$MD$US$US
239303744$23930374$4$F$$20240719$20240602$20240724$PER$$US-AstraZeneca-2024A119127$ASTRAZENECA$$66$YR$$M$Y$91.6$KG$20240724$$MD$US$
239303842$23930384$2$F$$20240909$20240602$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-087099$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240911$$MD$JP$JP
239303893$23930389$3$F$20240301$20240828$20240602$20240831$EXP$$US-ABBVIE-5782110$ABBVIE$$51$YR$$F$Y$$$20240831$$CN$US$US
239303934$23930393$4$F$$20240823$20240602$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-085436$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240902$$MD$JP$JP
239303942$23930394$2$F$$20240807$20240602$20240813$EXP$$JP-JNJFOC-20240587864$JOHNSON AND JOHNSON$Watanabe T. Efforts in the joint outpatient department for psoriatic arthritis and psoriasis.$7$DEC$E$M$Y$130$KG$20240813$$MD$JP$JP
239303962$23930396$2$F$$20240701$20240602$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-086175$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240708$$PH$JP$JP
239304212$23930421$2$F$$20240828$20240602$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086124$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240828$$CN$US$US
239304222$23930422$2$F$20240820$20240909$20240602$20240913$EXP$$US-ABBVIE-5781519$ABBVIE$$84$YR$$F$Y$$$20240913$$CN$US$US
239304232$23930423$2$F$20240101$20240805$20240602$20240813$EXP$$US-ABBVIE-5782106$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
239304342$23930434$2$F$20230101$20240529$20240602$20240716$PER$$US-AMGEN-USASP2024107623$AMGEN$$$$A$F$Y$$$20240716$$CN$US$US
239304385$23930438$5$F$$20240715$20240602$20240723$EXP$$NL-ABBVIE-5782579$ABBVIE$$$$E$M$Y$$$20240723$$CN$NL$NL
239304422$23930442$2$F$20240328$20240627$20240602$20240701$EXP$$NVSJ2024JP006444$NOVARTIS$$$$A$M$Y$$$20240701$$MD$JP$JP
239304523$23930452$3$F$20240101$20240723$20240602$20240726$PER$$US-AMGEN-USASP2024106870$AMGEN$$35$YR$A$F$Y$$$20240726$$HP$US$US
239304542$23930454$2$F$$20240529$20240602$20240724$PER$$US-HALEON-2179014$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
239304582$23930458$2$F$$20240828$20240602$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086052$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240828$$CN$US$US
239304904$23930490$4$F$20240407$20240729$20240602$20240801$EXP$$MY-JNJFOC-20240574480$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240801$$MD$MY$MY
239305082$23930508$2$F$20240401$20240625$20240602$20240703$EXP$$JP-009507513-2405JPN003420J$MERCK$$6$DEC$$M$Y$$$20240703$$MD$JP$JP
239305182$23930518$2$F$20240401$20240802$20240602$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008302$JAZZ$$3$YR$$M$Y$$$20240807$$CN$US$US
239305242$23930524$2$F$20240301$20240912$20240602$20240919$EXP$$CA-BIOGEN-2024BI01267209$BIOGEN$$63$YR$$F$Y$$$20240919$$CN$CA$CA
239305452$23930545$2$F$$20240531$20240603$20240723$PER$$US-HALEON-2179261$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239305472$23930547$2$F$20240510$20240703$20240603$20240709$EXP$FR-AFSSAPS-TO2024000903$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-084006$BRISTOL MYERS SQUIBB$$56$YR$E$M$Y$64$KG$20240709$$MD$FR$FR
239305492$23930549$2$F$$20240530$20240603$20240722$PER$$US-HALEON-2179170$Haleon PLC$$$$$F$Y$$$20240722$$CN$US$US
239305512$23930551$2$F$$20240227$20240603$20240712$PER$$US-ENDO USA, INC.-2024-001223$ENDO$$$$$M$Y$$$20240712$$CN$US$US
239305542$23930554$2$F$20240101$20240815$20240603$20240820$EXP$$US-ABBVIE-5781976$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
239305552$23930555$2$F$20240101$20240628$20240603$20240703$EXP$$FR-ABBVIE-5782062$ABBVIE$$$$$M$Y$$$20240703$$HP$FR$FR
239305672$23930567$2$F$$20240531$20240603$20240723$PER$$US-HALEON-2179243$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239305683$23930568$3$F$20240312$20240709$20240603$20240714$30DAY$$US-AMGEN-USASL2024102328$AMGEN$$$$$$Y$$$20240714$$PH$US$US
239305744$23930574$4$F$20240529$20240628$20240603$20240708$PER$$US-SA-2024SA164352$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240708$$MD$US$US
239305782$23930578$2$F$$20240530$20240603$20240725$PER$$US-HALEON-2179026$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
239305993$23930599$3$F$$20240809$20240603$20240811$PER$$NVSC2024US115217$NOVARTIS$$$$$F$Y$$$20240811$$MD$US$US
239306073$23930607$3$F$20240523$20240703$20240603$20240705$PER$$US-JNJFOC-20240571384$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240705$$PH$US$US
239306162$23930616$2$F$20240501$20240724$20240603$20240729$EXP$$US-JNJFOC-20240582960$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240729$$HP$US$US
239306173$23930617$3$F$20240421$20240813$20240603$20240827$EXP$$FR-JNJFOC-20240585589$JOHNSON AND JOHNSON$$51$YR$A$M$Y$87$KG$20240827$$MD$FR$FR
239306246$23930624$6$F$20240101$20240814$20240603$20240823$EXP$$CA-CELLTRION INC.-2024CA011277$CELLTRION$$$$$$Y$$$20240823$$MD$CA$CA
239306272$23930627$2$F$20240513$20240612$20240603$20240708$PER$$FR-TOLMAR, INC.-24FR049433$TOLMAR$$69$YR$$M$Y$$$20240708$$HP$FR$FR
239306282$23930628$2$F$20240101$20240627$20240603$20240722$PER$$IL-TOLMAR, INC.-24IL049311$TOLMAR$$$$$M$Y$$$20240718$$PH$IL$IL
239306302$23930630$2$F$20240202$20240613$20240603$20240702$PER$$NI-TOLMAR, INC.-24NI048829$TOLMAR$$7$YR$$F$Y$$$20240702$$CN$NI$NI
239306312$23930631$2$F$$20240613$20240603$20240705$PER$$US-TOLMAR, INC.-24US048915$TOLMAR$$$$$M$Y$$$20240705$$HP$US$US
239306322$23930632$2$F$$20240612$20240603$20240703$PER$$US-TOLMAR, INC.-24US048965$TOLMAR$$$$$M$Y$$$20240703$$HP$US$US
239306332$23930633$2$F$$20240620$20240603$20240712$PER$$US-TOLMAR, INC.-24US049067$TOLMAR$$$$$$Y$$$20240712$$HP$US$US
239306342$23930634$2$F$20240501$20240614$20240603$20240703$PER$$US-TOLMAR, INC.-24US049094$TOLMAR$$$$$M$Y$$$20240703$$PH$US$US
239306352$23930635$2$F$20240430$20240614$20240603$20240704$PER$$US-TOLMAR, INC.-24US049130$TOLMAR$$76$YR$$M$Y$$$20240703$$HP$US$US
239306362$23930636$2$F$20240507$20240613$20240603$20240704$PER$$US-TOLMAR, INC.-24US049162$TOLMAR$$$$$M$Y$$$20240703$$HP$US$US
239306372$23930637$2$F$20240513$20240620$20240603$20240712$PER$$US-TOLMAR, INC.-24US049318$TOLMAR$$66$YR$$M$Y$$$20240712$$HP$US$US
239306383$23930638$3$F$20240513$20240625$20240603$20240724$PER$$US-TOLMAR, INC.-24US049333$TOLMAR$$78$YR$$M$Y$$$20240724$$HP$US$US
239306402$23930640$2$F$20220701$20240804$20240603$20240827$PER$$US-TOLMAR, INC.-24US049570$TOLMAR$$72$YR$$M$Y$$$20240827$$CN$US$US
239306612$23930661$2$F$$20240623$20240603$20240702$PER$$US-SA-2024SA163683$SANOFI AVENTIS$$$$A$M$Y$$$20240702$$MD$US$US
239306722$23930672$2$F$20240423$20240924$20240603$20240927$EXP$$US-PCCINC-2024-PPL-000413$PIRAMAL$$$$$$Y$$$20240927$$HP$US$US
239306802$23930680$2$F$$20240726$20240603$20240801$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000483$DECIPHERA PHARMACEUTICALS$$67$YR$A$M$Y$$$20240801$$CN$US$US
239307052$23930705$2$F$$20240530$20240603$20240717$PER$$US-HALEON-2179280$Haleon PLC$$$$$F$Y$$$20240717$$CN$US$US
239307253$23930725$3$F$20240501$20240731$20240603$20240809$PER$$US-SA-2024SA164714$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240809$$MD$US$US
239307362$23930736$2$F$$20240624$20240603$20240704$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000459$DECIPHERA PHARMACEUTICALS$$66$YR$A$F$Y$$$20240704$$CN$US$US
239307464$23930746$4$F$20240520$20240723$20240603$20240726$PER$$US-JNJFOC-20240564132$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240726$$CN$US$US
239307483$23930748$3$F$20221128$20240819$20240603$20240827$EXP$$IL-BIOGEN-2023BI01204487$BIOGEN$$0$YR$$M$Y$$$20240827$$CN$IL$IL
239307512$23930751$2$F$20240401$20240712$20240603$20240722$PER$$US-AstraZeneca-2024A112358$ASTRAZENECA$$982$MON$$F$Y$$$20240722$$CN$US$
239307602$23930760$2$F$$20240806$20240603$20240814$EXP$$JP-GSK-JP2024JPN065914$GLAXOSMITHKLINE$Kawano T, Nakai T, Sato T, Kosato H, Takahashi H, Onishi T. P-1-069 - A Case of Life-Saving Haemodialysis in a Patient with Aciclovir Encephalopathy and Acute Kidney Injury. Journal of Japanese Society for Dialysis Therapy. 2024;57:708$$$$$Y$$$20240814$$MD$JP$JP
239307842$23930784$2$F$20240101$20240829$20240603$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087494$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$130.63$KG$20240829$$CN$US$US
239307952$23930795$2$F$20240527$20240805$20240603$20240807$PER$$US-AMGEN-USASP2024108211$AMGEN$$72$YR$E$F$Y$$$20240807$$CN$US$US
239307972$23930797$2$F$20240506$20240708$20240603$20240715$30DAY$$CO-AMGEN-COLSP2024105105$AMGEN$$$$$M$Y$$$20240715$$HP$CO$CO
239308023$23930802$3$F$20140401$20240719$20240603$20240726$EXP$$US-BIOGEN-2023BI01204424$BIOGEN$$56$YR$$F$Y$$$20240726$$CN$US$US
239308042$23930804$2$F$20240101$20240829$20240603$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087192$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240829$$CN$US$US
239308193$23930819$3$F$20240101$20240708$20240603$20240716$EXP$$CA-CELLTRION INC.-2024CA012854$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
239308362$23930836$2$F$$20240527$20240603$20240718$PER$$US-HALEON-2178288$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239308382$23930838$2$F$$20240718$20240603$20240723$EXP$$JP-009507513-2405JPN002927J$MERCK$$24$YR$$F$Y$$$20240723$$MD$JP$JP
239308417$23930841$7$F$20240416$20240919$20240603$20240928$EXP$$CA-CELLTRION INC.-2024CA012856$CELLTRION$$$$$$Y$$$20240928$$CN$CA$CA
239308472$23930847$2$F$$20240823$20240603$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04417$LUPIN$$$$$$Y$$$20240909$$CN$US$US
239308484$23930848$4$F$20240101$20240915$20240603$20240923$EXP$$CA-CELLTRION INC.-2024CA012839$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
239308492$23930849$2$F$$20240704$20240603$20240710$EXP$$SK-ROCHE-3571968$ROCHE$$$$$M$Y$$$20240710$$MD$SK$SK
239308536$23930853$6$F$20240401$20240828$20240603$20240909$EXP$$CA-GSK-CA2023168853$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$HP$CA$CA
239308622$23930862$2$F$20240301$20240718$20240603$20240723$EXP$$JP-JNJFOC-20240602281$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240722$$MD$JP$JP
239308696$23930869$6$F$20240402$20240917$20240603$20240926$EXP$$CA-CELLTRION INC.-2024CA009395$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
239308833$23930883$3$F$$20240829$20240603$20240831$PER$$US-AMGEN-USASP2024108402$AMGEN$$$$$M$Y$$$20240831$$CN$US$US
239308942$23930894$2$F$20240101$20240718$20240603$20240726$EXP$$CA-CELLTRION INC.-2024CA012531$CELLTRION$$$$$$Y$$$20240726$$HP$CA$CA
239308962$23930896$2$F$$20240718$20240603$20240725$EXP$$JP-009507513-2405JPN002929J$MERCK$$18$YR$$M$Y$$$20240725$$MD$JP$JP
239309034$23930903$4$F$20240101$20240812$20240603$20240820$EXP$$CA-CELLTRION INC.-2024CA012877$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
239309042$23930904$2$F$20240801$20240827$20240603$20240910$PER$$US-SA-2024SA164423$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240910$$MD$US$US
239309052$23930905$2$F$20240801$20240821$20240603$20240902$EXP$$US-SA-2024SA104399$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240902$$MD$US$US
239309093$23930909$3$F$20240101$20240827$20240603$20240905$EXP$$US-SA-2024SA161381$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240905$$MD$US$US
239309153$23930915$3$F$$20240814$20240603$20240815$PER$$NVSC2024US115726$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
2393091610$23930916$10$F$20240101$20240816$20240603$20240826$EXP$$CA-CELLTRION INC.-2024CA012865$CELLTRION$$$$$$Y$$$20240826$$CN$CA$CA
239309193$23930919$3$F$20240523$20240918$20240603$20240927$EXP$$CA-CELLTRION INC.-2024CA012893$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
239309222$23930922$2$F$20240101$20240701$20240603$20240709$PER$$US-SA-2024SA161096$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240709$$MD$US$US
239309372$23930937$2$F$$20240712$20240603$20240712$PER$$NVSC2024US114938$NOVARTIS$$$$$F$Y$$$20240712$$CN$US$US
239309602$23930960$2$F$20240507$20240725$20240603$20240729$EXP$$DE-TAKEDA-2024TUS051886$TAKEDA$$12$YR$$F$Y$$$20240729$$HP$DE$DE
239309712$23930971$2$F$20240523$20240817$20240603$20240821$PER$$US-AMGEN-USASP2024108055$AMGEN$$68$YR$E$M$Y$$$20240821$$CN$US$US
239309732$23930973$2$F$20240514$20240702$20240603$20240704$PER$$US-AMGEN-USASP2024108667$AMGEN$$78$YR$E$M$Y$$$20240704$$CN$US$US
239309742$23930974$2$F$$20240620$20240603$20240703$EXP$$US-GRAVITIPHARMA-GRA-2405-US-LIT-0153$GRAVITI PHARMACEUTICALS$Kataria V, Agha T, Ryman K, Iyer N..Strategic Utilization of Dantrolene in a Case of Severe Acute Generalized Tetanus..Journal of Pharmacy Practice.2023;37(3):766-769$32$YR$A$M$Y$$$20240703$$HP$US$US
239309752$23930975$2$F$$20240617$20240603$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002354$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
239309803$23930980$3$F$20210201$20240717$20240603$20240720$EXP$$CA-TAKEDA-2020TUS060750$TAKEDA$$61$YR$$M$Y$$$20240720$$HP$CA$CA
239309833$23930983$3$F$20220427$20240912$20240603$20240918$EXP$$CA-TAKEDA-2021TUS051746$TAKEDA$$74$YR$$F$Y$$$20240918$$HP$CA$CA
239309842$23930984$2$F$$20240620$20240603$20240703$EXP$$US-GRAVITIPHARMA-GRA-2405-US-LIT-0155$GRAVITI PHARMACEUTICALS$Marissa Saber , Albert Zichichi, Mahmoud Amma.SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY.Critical Care Medicine.2024;52 (1):S642$28$YR$A$M$Y$$$20240703$$HP$US$US
239309882$23930988$2$F$20240410$20240701$20240603$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001869$ACADIA PHARMACEUTICALS$$36$YR$$F$Y$$$20240725$$CN$US$US
239310062$23931006$2$F$$20240620$20240603$20240703$EXP$$US-GRAVITIPHARMA-GRA-2405-US-LIT-0154$GRAVITI PHARMACEUTICALS$Schurk H, Patterson J, Zhou Y.CHEATING ^DEATH^: FROM BRAIN DEATH MIMICRYTO VA ECMO AFTER INTENTIONAL DRUG OVERDOSE.Crit-Care-Med.01-JAN-2024;52 (1):S39$57$YR$A$F$Y$$$20240703$$HP$US$US
239310124$23931012$4$F$20240722$20240904$20240603$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087895$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240913$$CN$US$US
239310144$23931014$4$F$20240401$20240731$20240603$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002366$ACADIA PHARMACEUTICALS$$9$YR$$F$Y$$$20240823$$CN$US$US
239310262$23931026$2$F$20240530$20240801$20240603$20240805$PER$$US-AMGEN-USASP2024107946$AMGEN$$55$YR$A$M$Y$$$20240805$$CN$US$US
239310282$23931028$2$F$20240220$20240828$20240603$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-085554$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$59$KG$20240828$$PH$JP$JP
239310493$23931049$3$F$$20240521$20240603$20240916$EXP$$US-NOVOPROD-1227060$NOVO NORDISK$$$$A$M$Y$$$20240916$$CN$US$US
239310534$23931053$4$F$20230301$20240715$20240603$20240725$EXP$$BR-NOVOPROD-1227885$NOVO NORDISK$$$$E$F$Y$82$KG$20240725$$CN$BR$BR
239310604$23931060$4$F$20240201$20240806$20240603$20240808$30DAY$$US-JNJFOC-20240568867$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240808$$CN$US$US
239310663$23931066$3$F$20240508$20240802$20240603$20240813$EXP$$CN-NOVOPROD-1173981$NOVO NORDISK$$13$YR$$M$Y$$$20240813$$CN$CN$CN
239310742$23931074$2$F$20240101$20240917$20240603$20240924$EXP$$JP-009507513-2401JPN005326J$MERCK$$7$DEC$$F$Y$$$20240924$$MD$JP$JP
239310762$23931076$2$F$20240501$20240805$20240603$20240812$EXP$$JP-009507513-2405JPN003184J$MERCK$$5$DEC$$F$Y$$$20240812$$MD$JP$JP
239310802$23931080$2$F$$20240620$20240603$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002359$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
239311002$23931100$2$F$20240430$20240624$20240603$20240705$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00740$AIMMUNE$$$$$$Y$$$20240705$$HP$US$US
239311062$23931106$2$F$$20240902$20240603$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087675$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240902$$HP$US$US
239311083$23931108$3$F$$20240725$20240603$20240808$EXP$$JP-UCBSA-2024027605$UCB$Jin K. Treatment of non-convulsive status epilepticus in elderly patients at the age of 80 or older. Program/Abstract of the 65th Annual Meeting of the Japanese Society of Neurology. 2024;-:469$$$E$$Y$$$20240808$$MD$JP$JP
239311182$23931118$2$F$$20240514$20240603$20240710$PER$$FI-ROCHE-3565534$ROCHE$$76$YR$E$M$Y$$$20240628$$MD$FI$FI
239311192$23931119$2$F$20240501$20240522$20240603$20240702$EXP$$CN-SA-2024SA148880$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240702$$MD$CN$CN
239311203$23931120$3$F$$20240710$20240603$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002384$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
239311222$23931122$2$F$$20240719$20240603$20240730$PER$$US-SA-2023SA350364$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240731$$MD$US$US
239311232$23931123$2$F$20240101$20240824$20240603$20240909$PER$$US-SA-2024SA163356$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240909$$MD$US$US
239311242$23931124$2$F$$20240626$20240603$20240705$PER$$US-SA-2024SA162254$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240705$$MD$US$US
239311292$23931129$2$F$20240530$20240805$20240603$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086947$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240807$$CN$US$US
239311382$23931138$2$F$$20240531$20240603$20240723$PER$$US-HALEON-2179417$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239311642$23931164$2$F$20240101$20240723$20240603$20240725$EXP$FR-AFSSAPS-TS2024000618$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-087748$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$45$KG$20240725$$MD$FR$FR
239311712$23931171$2$F$20240523$20240903$20240603$20240905$EXP$$US-JNJFOC-20240572269$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20240905$$CN$US$US
239311782$23931178$2$F$$20240626$20240603$20240708$EXP$$JP-AMGEN-JPNSP2024106970$AMGEN$Hirokawa, M., Lee, M., Motegi, M.,  amp; Miura, A.. Reversible renal impairment during leukocytosis induced by G-CSF in non-Hodgkin s lymphoma. American Journal of Hematology. 1996;51:328-329.$18$YR$A$M$Y$$$20240707$$PH$JP$JP
239311792$23931179$2$F$20240401$20240828$20240603$20240830$EXP$$JP-TAKEDA-2024TJP007901$TAKEDA$$7$DEC$$M$Y$$$20240830$$MD$JP$JP
239311833$23931183$3$F$20240515$20240801$20240603$20240829$PER$$US-AstraZeneca-2024A119252$ASTRAZENECA$$24232$DY$$M$Y$51.7$KG$20240829$$HP$US$
239311932$23931193$2$F$20240101$20240808$20240603$20240813$EXP$$US-ABBVIE-5780469$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
239311982$23931198$2$F$20240115$20240628$20240603$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087544$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240702$$CN$US$US
239311992$23931199$2$F$20240523$20240705$20240603$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088551$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240708$$CN$US$US
239312012$23931201$2$F$$20240730$20240603$20240801$PER$$US-BIOVITRUM-2024-US-007951$BIOVITRUM$$71$YR$$M$Y$$$20240801$$CN$US$US
239312222$23931222$2$F$20240101$20240730$20240603$20240806$EXP$$US-ABBVIE-5781854$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
239312282$23931228$2$F$20240417$20240703$20240603$20240712$EXP$$US-NOVOPROD-1228570$NOVO NORDISK$$$$$M$Y$$$20240712$$CN$US$US
239312322$23931232$2$F$$20240712$20240603$20240723$EXP$$US-NOVOPROD-1229009$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
239312612$23931261$2$F$20240508$20240805$20240603$20240807$EXP$$NVSC2024SA113923$NOVARTIS$$29$YR$$F$Y$$$20240807$$MD$SA$SA
239312672$23931267$2$F$20240101$20240802$20240603$20240808$PER$$US-ABBVIE-5779816$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
239312692$23931269$2$F$20230223$20240614$20240603$20240709$PER$$US-ROCHE-3569456$ROCHE$$50$YR$A$F$Y$81.65$KG$20240705$$CN$US$US
239312752$23931275$2$F$$20240624$20240603$20240702$EXP$$ES-JNJFOC-20240581556$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$MD$ES$ES
239312854$23931285$4$F$$20240823$20240603$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088588$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240826$$CN$US$US
239312872$23931287$2$F$20230723$20240708$20240603$20240711$EXP$$DE-TAKEDA-2024TUS053075$TAKEDA$$4$YR$$M$Y$$$20240711$$HP$DE$DE
239313042$23931304$2$F$20240501$20240628$20240603$20240705$EXP$$CA-APOTEX-2024AP006367$APOTEX$$87$YR$E$M$Y$$$20240705$$HP$CA$CA
239313063$23931306$3$F$20230928$20240725$20240603$20240730$EXP$$US-AMGEN-USASP2024103926$AMGEN$$52$YR$A$F$Y$$$20240730$$MD$US$US
239313182$23931318$2$F$$20240910$20240603$20240912$EXP$$JP-TAKEDA-2024TJP008031$TAKEDA$$9$MON$$M$Y$$$20240912$$MD$JP$JP
239313262$23931326$2$F$$20240708$20240603$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04421$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239313393$23931339$3$F$$20240708$20240603$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04430$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239313432$23931343$2$F$20240325$20240918$20240603$20240930$EXP$DE-CADRBFARM-2024328098$DE-MSNLABS-2024MSNSPO01186$MSN LABORATORIES$$$$$$Y$$$20240930$$MD$DE$DE
239313492$23931349$2$F$20240523$20240708$20240603$20240711$30DAY$$US-GSK-US2024066470$GLAXOSMITHKLINE$$81$YR$$F$Y$$$20240711$$CN$US$US
239313642$23931364$2$F$$20240530$20240603$20240723$PER$$US-HALEON-2179138$Haleon PLC$$88$YR$$M$Y$$$20240723$$CN$US$US
239313742$23931374$2$F$20240529$20240925$20240603$20240930$30DAY$$IT-SANDOZ INC.-SDZ2024IT054035$SANDOZ$$19$YR$$M$Y$78$KG$20240930$$CN$IT$IT
239313754$23931375$4$F$20240518$20240610$20240603$20240716$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-16666$SAMSUNG BIOEPIS$$46$YR$A$F$Y$$$20240716$$CN$CA$CA
239313782$23931378$2$F$20230201$20240626$20240603$20240708$EXP$$JP-TAKEDA-2024TUS053964$TAKEDA$$66$YR$$M$Y$62$KG$20240708$$MD$JP$JP
239314033$23931403$3$F$20240604$20240822$20240603$20240826$EXP$$CA-TAKEDA-2024TUS054969$TAKEDA$$19$YR$$M$Y$$$20240826$$CN$CA$CA
239314063$23931406$3$F$$20240911$20240603$20240917$EXP$$US-ABBVIE-5783833$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
239314083$23931408$3$F$20240501$20240805$20240603$20240810$EXP$$GB-ABBVIE-5783829$ABBVIE$$37$YR$$F$Y$$$20240810$$CN$GB$GB
239314272$23931427$2$F$$20240531$20240603$20240724$PER$$US-HALEON-2179447$Haleon PLC$$$$$$Y$$$20240724$$CN$US$US
239314362$23931436$2$F$20240529$20240801$20240603$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202405018521$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240807$$CN$US$US
239314412$23931441$2$F$$20240708$20240603$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04418$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239314423$23931442$3$F$$20240813$20240603$20240820$EXP$$CA-ROCHE-3568775$ROCHE$$$$A$F$Y$$$20240820$$CN$CA$CA
239314442$23931444$2$F$$20240524$20240603$20240718$PER$$US-HALEON-2178276$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239314542$23931454$2$F$20240201$20240719$20240603$20240725$EXP$$CA-JNJFOC-20240573957$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240725$$HP$CA$CA
239314552$23931455$2$F$$20240627$20240603$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088037$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$62.8$KG$20240702$$CN$US$US
239314702$23931470$2$F$20240201$20240617$20240603$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002082$ACADIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240712$$CN$US$US
239314762$23931476$2$F$$20240708$20240603$20240723$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04422$LUPIN$$$$$$Y$$$20240723$$CN$US$US
239314792$23931479$2$F$20240427$20240716$20240603$20240717$EXP$$JP-ABBVIE-5754841$ABBVIE$$90$YR$$F$Y$$$20240717$$MD$JP$JP
239314852$23931485$2$F$20230601$20240711$20240603$20240716$EXP$$JP-TAKEDA-2024TJP008085$TAKEDA$Takumi Aoki, Ryota Sakai, Taiji Kosaka, Shoichi Yoshinaga, Akiko Shibata, Takahiko Kurasawa, et al.. Two cases of large vessel vasculitis following administration of vedolizumab for ulcerative colitis. The 68th Annu Gen Assembly and Sci Mtg of Japan College of Rheumatology. 925$17$YR$$M$Y$$$20240716$$MD$JP$JP
239315063$23931506$3$F$$20240708$20240603$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04427$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239315092$23931509$2$F$$20240705$20240603$20240710$PER$$US-BIOGEN-2024BI01267350$BIOGEN$$$$$F$Y$$$20240710$$CN$US$US
239315103$23931510$3$F$20231001$20240701$20240603$20240716$PER$$US-AstraZeneca-2024A067394$ASTRAZENECA$$1012$MON$$F$Y$56.2$KG$20240716$$HP$US$
239315152$23931515$2$F$20240328$20240701$20240603$20240709$EXP$$JP-009507513-2404JPN002633J$MERCK$$68$YR$$F$Y$$$20240709$$MD$JP$JP
239315172$23931517$2$F$20240501$20240905$20240603$20240911$EXP$$JP-009507513-2405JPN003573J$MERCK$$63$YR$$F$Y$$$20240911$$MD$JP$JP
239315232$23931523$2$F$20230101$20240711$20240603$20240716$EXP$$JP-TAKEDA-2024TJP008032$TAKEDA$Takumi Aoki, Ryota Sakai, Taiji Kosaka, Shoichi Yoshinaga, Akiko Shibata, Takahiko Kurasawa, et al.. Two cases of large vessel vasculitis following administration of vedolizumab for ulcerative colitis. The 68th Annu Gen Assembly and Sci Mtg of Japan College of Rheumatology. 925$72$YR$$M$Y$$$20240716$$MD$JP$JP
239315242$23931524$2$F$20240527$20240806$20240603$20240808$PER$$US-AMGEN-USASP2024108421$AMGEN$$60$YR$A$M$Y$$$20240808$$CN$US$US
239315263$23931526$3$F$20240529$20240628$20240603$20240710$30DAY$$US-JNJFOC-20240583742$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240710$$PH$US$US
239315292$23931529$2$F$$20240704$20240603$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088715$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$72.57$KG$20240705$$CN$US$US
239315352$23931535$2$F$20240520$20240722$20240603$20240808$PER$$US-GLANDPHARMA-US-2024GLNSPO00305$GLAND PHARMA$$46$YR$A$F$Y$$$20240808$$PH$US$US
239315375$23931537$5$F$20240520$20240820$20240603$20240827$EXP$$US-GSK-US2024AMR067151$GLAXOSMITHKLINE$$69$YR$$F$Y$63.492$KG$20240827$$CN$US$US
239315442$23931544$2$F$20240530$20240531$20240603$20240723$PER$$US-HALEON-2179462$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239315482$23931548$2$F$20120101$20240805$20240603$20240814$EXP$$PL-TEVA-VS-3197816$TEVA$$42$YR$$F$Y$$$20240814$$MD$PL$PL
239315512$23931551$2$F$$20240708$20240603$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04429$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239315612$23931561$2$F$$20240731$20240603$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088764$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$92.99$KG$20240802$$CN$US$US
239315622$23931562$2$F$20240301$20240729$20240603$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086260$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240807$$CN$US$US
239316052$23931605$2$F$$20240705$20240603$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04431$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239316126$23931612$6$F$$20240918$20240603$20240925$EXP$$US-TAKEDA-2022TUS073610$TAKEDA$$$$$F$Y$81$KG$20240925$$HP$US$US
239316183$23931618$3$F$$20240709$20240603$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086512$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$83.91$KG$20240718$$CN$US$US
239316192$23931619$2$F$$20240711$20240603$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088497$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240716$$CN$US$US
239316212$23931621$2$F$$20240829$20240603$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-087333$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240829$$MD$JP$JP
239316242$23931624$2$F$20240422$20240619$20240603$20240702$EXP$PT-INFARMED-B202405-51$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-04677$HIKMA$$84$YR$$M$Y$$$20240702$$MD$PT$PT
239316422$23931642$2$F$$20240528$20240603$20240718$PER$$US-HALEON-2178407$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
239316522$23931652$2$F$$20240709$20240603$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04460$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239316572$23931657$2$F$$20240902$20240603$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087979$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$78.47$KG$20240902$$HP$US$US
239316593$23931659$3$F$20240501$20240720$20240603$20240801$EXP$$US-CIPLA (EU) LIMITED-2024US05370$CIPLA$$$$$$Y$$$20240801$$CN$US$US
239316672$23931667$2$F$20240527$20240702$20240603$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202405018748$ELI LILLY AND CO$$74$YR$E$$Y$$$20240705$$MD$US$US
239316752$23931675$2$F$$20240716$20240603$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002368$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
239316764$23931676$4$F$20240201$20240806$20240603$20240814$EXP$$CA-CELLTRION INC.-2024CA012675$CELLTRION$$$$$$Y$$$20240814$$MD$CA$CA
239316944$23931694$4$F$20240501$20240716$20240603$20240718$PER$$US-AMGEN-USASP2024107027$AMGEN$$68$YR$E$M$Y$$$20240718$$HP$US$US
239317153$23931715$3$F$20240501$20240718$20240603$20240725$EXP$$US-GSK-US2024066991$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
239317162$23931716$2$F$20240101$20240626$20240603$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085757$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240701$$CN$US$US
239317182$23931718$2$F$$20240723$20240603$20240802$EXP$$JP-009507513-2405JPN003330J$MERCK$$57$YR$$F$Y$$$20240802$$MD$JP$JP
239317284$23931728$4$F$20240508$20240723$20240603$20240803$EXP$$JP-ROCHE-3571525$ROCHE$$65$YR$E$M$Y$50.2$KG$20240803$$MD$JP$JP
239317402$23931740$2$F$$20240731$20240603$20240802$EXP$$JP-ASTELLAS-2024JP003613$ASTELLAS$$8$DEC$$F$Y$$$20240802$$MD$JP$JP
239317592$23931759$2$F$$20240703$20240603$20240709$EXP$$JP-AMGEN-JPNSP2024104512$AMGEN$$74$YR$E$M$Y$$$20240709$$PH$JP$JP
239317612$23931761$2$F$20240416$20240530$20240603$20240723$EXP$DK-DKMA-30730028$DK-HALEON-2179275$Haleon PLC$$84$YR$$F$Y$65$KG$20240723$$MD$DK$DK
239318023$23931802$3$F$$20240821$20240603$20240826$EXP$$US-BIOVITRUM-2024-US-007229$BIOVITRUM$$70$YR$$F$Y$$$20240826$$CN$US$US
239318212$23931821$2$F$$20240621$20240603$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01468$AMNEAL$$$$$$Y$$$20240906$$HP$US$US
239318232$23931823$2$F$$20240708$20240603$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04419$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239318322$23931832$2$F$$20240911$20240603$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-087098$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240917$$MD$JP$JP
239318373$23931837$3$F$$20240703$20240603$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04426$LUPIN$$$$$$Y$$$20240725$$CN$US$US
239318502$23931850$2$F$20201107$20240913$20240603$20240920$EXP$$US-TAKEDA-2024TUS053155$TAKEDA$$20$YR$$F$Y$$$20240920$$MD$US$US
239318543$23931854$3$F$$20240708$20240603$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04424$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239318562$23931856$2$F$20240529$20240925$20240603$20240926$30DAY$$IT-SANDOZ INC.-SDZ2024IT054037$SANDOZ$$18$YR$$M$Y$57$KG$20240926$$CN$IT$IT
239318634$23931863$4$F$$20240712$20240603$20240722$30DAY$$DE-TAKEDA-2024TUS053768$TAKEDA$$84$YR$$F$Y$$$20240722$$CN$DE$DE
239318682$23931868$2$F$$20240530$20240603$20240724$PER$$US-HALEON-2179011$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
239318716$23931871$6$F$20240618$20240912$20240603$20240920$EXP$$US-TAKEDA-2024TUS046953$TAKEDA$$74$YR$$F$Y$$$20240920$$HP$US$US
239318837$23931883$7$F$20240502$20240917$20240603$20240924$EXP$$CA-GSK-CA2024061784$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$CA$CA
239318862$23931886$2$F$$20240730$20240603$20240802$EXP$$JP-ORGANON-O2405JPN002846$ORGANON$Nishio T, Toukairin Y, Hoshi T, Arai T, Nogami M.. A case of lacosamide and mirtazapine self-poisoning.. Legal Medicine.. 2024;69:102457$$$A$F$Y$41$KG$20240802$$MD$JP$JP
239318922$23931892$2$F$$20240729$20240603$20240801$EXP$$IT-ROCHE-3572797$ROCHE$$61$YR$A$M$Y$$$20240801$$MD$IT$IT
239319013$23931901$3$F$20240101$20240805$20240603$20240811$EXP$$US-ABBVIE-5780425$ABBVIE$$$$$F$Y$$$20240811$$CN$US$US
239319063$23931906$3$F$$20240726$20240603$20240801$EXP$$JP-009507513-2405JPN003355J$MERCK$Chibana K, Kaneku K, Higa M, Kuda T, Nakayama Y, Fujita K, et al.. PP571 Immune-related adverse events (irAE) with lung cancer treated with immune checkpoint inhibitors (ICI) in first line therapy. The 64th Annual Meeting of The Japanese Respiratory Society$75$YR$$M$Y$$$20240801$$MD$JP$JP
239319094$23931909$4$F$20240430$20240625$20240603$20240823$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-079420$REGENERON$$$$$F$Y$$$20240823$$HP$DE$DE
239319224$23931922$4$F$$20240909$20240603$20240912$EXP$$US-GSK-US2024AMR066883$GLAXOSMITHKLINE$$$$$F$Y$$$20240912$$CN$US$US
239319412$23931941$2$F$20240101$20240528$20240603$20240701$PER$$US-BAUSCHBL-2024BNL027718$BAUSCH AND LOMB$$74$YR$$F$Y$56$KG$20240701$$CN$US$US
239319602$23931960$2$F$$20240729$20240603$20240802$PER$$US-BIOGEN-2024BI01267414$BIOGEN$$$$$F$Y$$$20240802$$CN$US$US
239319622$23931962$2$F$20240228$20240517$20240603$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00754$AMNEAL$$$$$F$Y$$$20240904$$CN$US$US
239319662$23931966$2$F$$20240607$20240603$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01508$AMNEAL$$$$$F$Y$$$20240904$$PH$US$US
239319702$23931970$2$F$20240417$20240524$20240603$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01539$AMNEAL$$$$$$Y$$$20240904$$PH$US$US
239319814$23931981$4$F$$20240708$20240603$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04425$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239319842$23931984$2$F$$20240605$20240603$20240702$PER$$CA-TOLMAR, INC.-24CA048853$TOLMAR$$$$$$Y$$$20240702$$MD$CA$CA
239319912$23931991$2$F$20240502$20240611$20240603$20240703$PER$$CA-TOLMAR, INC.-24CA049103$TOLMAR$$78$YR$$M$Y$$$20240703$$PH$CA$CA
239319942$23931994$2$F$20240504$20240611$20240603$20240703$PER$$CA-TOLMAR, INC.-24CA049129$TOLMAR$$90$YR$$M$Y$$$20240703$$PH$CA$CA
239319992$23931999$2$F$$20240620$20240603$20240712$PER$$US-TOLMAR, INC.-24US049275$TOLMAR$$$$$M$Y$$$20240712$$CN$US$US
239320033$23932003$3$F$$20240822$20240603$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088474$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240826$$CN$US$US
239320092$23932009$2$F$$20240708$20240603$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04428$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239320243$23932024$3$F$$20240823$20240603$20240829$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-04461$LUPIN$Kanitkar S, Borle AS. Statin-induced necrotizing myopathy: A case report of severe muscle weakness and recovery. Pravara Medical Review. 2024;16(1):79-82$50$YR$$F$Y$$$20240829$$HP$IN$IN
239320297$23932029$7$F$20240101$20240822$20240603$20240830$EXP$$CA-AMGEN-CANSL2024104980$AMGEN$$32$YR$A$M$Y$$$20240830$$MD$CA$CA
239320322$23932032$2$F$20240101$20240729$20240603$20240812$EXP$$FR-UCBSA-2024026699$UCB$$$$$F$Y$$$20240812$$MD$FR$FR
239320443$23932044$3$F$20230825$20240812$20240603$20240826$EXP$$CN-ROCHE-3486477$ROCHE$$60$YR$A$F$Y$$$20240826$$MD$CN$CN
239320462$23932046$2$F$$20240626$20240603$20240705$30DAY$$US-GSK-US2024066467$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$CN$US$US
239320722$23932072$2$F$$20240516$20240603$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01218$AMNEAL$$$$$M$Y$$$20240904$$PH$US$US
239321162$23932116$2$F$$20240710$20240603$20240717$EXP$$CA-AMGEN-CANSP2024104544$AMGEN$$$$$F$Y$$$20240717$$CN$CA$CA
239321202$23932120$2$F$$20240708$20240603$20240711$EXP$$FR-PFIZER INC-202400181570$PFIZER$Donze, C.. Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide. Pediatric Blood and Cancer. 2024;71(8):10.1002/pbc.31076$14$YR$$M$Y$$$20240711$$HP$FR$FR
239321632$23932163$2$F$$20240525$20240603$20240731$EXP$$HR-BAYER-2024A078341$BAYER$$59$YR$A$M$Y$$$20240731$$HP$HR$HR
239321662$23932166$2$F$$20240806$20240603$20240812$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-087852$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240812$$PH$CA$CA
239321753$23932175$3$F$$20240627$20240603$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202405018496$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240704$$MD$US$US
239321782$23932178$2$F$20240515$20240708$20240603$20240710$30DAY$$CO-AMGEN-COLSP2024105423$AMGEN$$$$$$Y$$$20240710$$HP$CO$CO
239321994$23932199$4$F$20240425$20240913$20240603$20240923$EXP$$CA-CELLTRION INC.-2024CA013132$CELLTRION$$$$$$Y$$$20240923$$CN$CA$CA
239322002$23932200$2$F$$20240816$20240603$20240823$EXP$$GB-TAKEDA-2024TUS054462$TAKEDA$$$$$F$Y$$$20240823$$CN$GB$GB
239322082$23932208$2$F$20200101$20240702$20240603$20240704$EXP$$SA-CHIESI-2024CHF03065$CHIESI$$$$$M$Y$$$20240704$$MD$SA$SA
239322122$23932212$2$F$$20240916$20240603$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088651$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240918$$CN$US$US
239322162$23932216$2$F$$20240701$20240603$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088916$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240702$$CN$US$US
239322193$23932219$3$F$20240101$20240919$20240603$20240925$EXP$$JP-009507513-2405JPN002706J$MERCK$$59$YR$$F$Y$$$20240925$$MD$JP$JP
239322202$23932220$2$F$$20240530$20240603$20240724$PER$$US-HALEON-2179016$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
239322284$23932228$4$F$20240101$20240725$20240603$20240806$EXP$$US-INSMED, INC.-2024-02112-US$INSMED$$$$$M$Y$$$20240806$$CN$US$US
239322472$23932247$2$F$$20240626$20240603$20240708$EXP$$JP-TAKEDA-2024TUS053225$TAKEDA$Itagaki M. How to see multiple myeloma for everyone to know$97$YR$$F$Y$$$20240708$$MD$JP$JP
239322552$23932255$2$F$20230622$20240628$20240603$20240703$EXP$$CZ-BAYER-2024A078709$BAYER$$26$YR$A$F$Y$$$20240703$$CN$CZ$CZ
239322933$23932293$3$F$20240501$20240802$20240603$20240813$PER$$US-Kiniksa Pharmaceuticals Ltd.-2024KPU000859$KINIKSA PHARMACEUTICALS$$33$YR$A$F$Y$$$20240812$$MD$US$US
239323192$23932319$2$F$$20240809$20240603$20240811$PER$$NVSC2024US115633$NOVARTIS$$$$$F$Y$$$20240811$$MD$US$US
239323332$23932333$2$F$20240513$20240718$20240603$20240722$EXP$$ES-AUROBINDO-AUR-APL-2024-026058$AUROBINDO$$72$YR$$F$Y$$$20240722$$CN$ES$ES
239323374$23932337$4$F$20230912$20240825$20240603$20240826$EXP$$FR-PFIZER INC-PV202400071752$PFIZER$$49$YR$$M$Y$87$KG$20240826$$MD$FR$FR
239323412$23932341$2$F$20240529$20240822$20240603$20240826$EXP$$US-PFIZER INC-PV202400009186$PFIZER$$71$YR$$F$Y$$$20240826$$MD$US$US
239323472$23932347$2$F$20230101$20240725$20240603$20240730$EXP$$CA-PFIZER INC-202300251610$PFIZER$$57$YR$$M$Y$$$20240730$$CN$CA$CA
239323482$23932348$2$F$$20240801$20240603$20240806$EXP$$US-PFIZER INC-202400092868$PFIZER$$43$YR$$M$Y$$$20240806$$CN$US$US
239323522$23932352$2$F$$20240822$20240603$20240827$EXP$$CA-PFIZER INC-202400181725$PFIZER$$64$YR$$F$Y$$$20240827$$CN$CA$CA
239323592$23932359$2$F$20240723$20240730$20240603$20240801$EXP$$US-PFIZER INC-PV202400071829$PFIZER$$85$YR$$M$Y$$$20240801$$CN$US$US
239323614$23932361$4$F$20220922$20240909$20240603$20240913$EXP$$IN-PFIZER INC-PV202200010828$PFIZER$$39$YR$$F$Y$69.8$KG$20240913$$CN$IN$IN
239323652$23932365$2$F$$20240725$20240603$20240725$EXP$$US-PFIZER INC-PV202400070548$PFIZER$$61$YR$$M$Y$$$20240725$$MD$US$US
239323723$23932372$3$F$20240501$20240828$20240603$20240902$EXP$$US-PFIZER INC-202400181771$PFIZER$$73$YR$$F$Y$68.04$KG$20240902$$HP$US$US
239323743$23932374$3$F$$20240712$20240603$20240716$30DAY$$TW-PFIZER INC-202400173558$PFIZER$$$$$$Y$$$20240716$$PH$TW$TW
239323793$23932379$3$F$20181028$20240821$20240603$20240823$EXP$$US-GILEAD-2024-0675256$GILEAD$$55$YR$A$F$Y$$$20240823$$LW$US$US
239323842$23932384$2$F$$20240526$20240603$20240808$PER$$US-ABBVIE-5778978$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
239323973$23932397$3$F$20230101$20240801$20240603$20240801$EXP$$CA-PFIZER INC-202300102471$PFIZER$$66$YR$$F$Y$$$20240801$$MD$CA$CA
239323985$23932398$5$F$$20240812$20240603$20240816$30DAY$$TW-PFIZER INC-PV202400066313$PFIZER$$$$$$Y$$$20240816$$CN$TW$TW
239323992$23932399$2$F$$20240724$20240603$20240724$EXP$$CA-PFIZER INC-202400050872$PFIZER$$10$YR$$F$Y$$$20240724$$MD$CA$CA
239324002$23932400$2$F$20230929$20240716$20240603$20240726$EXP$$IT-TEVA-VS-3202361$TEVA$$$$A$F$Y$$$20240726$$MD$IT$IT
239324604$23932460$4$F$20240401$20240902$20240603$20240909$EXP$$NVSJ2024JP006408$NOVARTIS$$72$YR$$F$Y$$$20240909$$MD$JP$JP
239324752$23932475$2$F$20240526$20240816$20240603$20240820$PER$$US-AMGEN-USASP2024105568$AMGEN$$65$YR$E$F$Y$$$20240820$$CN$US$US
239324782$23932478$2$F$$20240601$20240603$20240722$PER$$US-HALEON-2179549$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
239324902$23932490$2$F$20240530$20240709$20240603$20240710$PER$$US-JNJFOC-20240587642$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240710$$CN$US$US
239324913$23932491$3$F$20240501$20240724$20240603$20240726$EXP$$US-OTSUKA-2024_011432$OTSUKA$$68$YR$$M$Y$$$20240726$$MD$US$US
239325072$23932507$2$F$20240101$20240625$20240603$20240701$EXP$$BR-UCBSA-2024008737$UCB$$$$$F$Y$54$KG$20240701$$CN$BR$BR
239325172$23932517$2$F$$20240717$20240603$20240723$EXP$$JP-AMGEN-JPNSP2024107384$AMGEN$$$$E$F$Y$$$20240722$$MD$JP$JP
239325332$23932533$2$F$$20240708$20240603$20240711$EXP$$FR-PFIZER INC-PV202400071053$PFIZER$Donze, C.. Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide. Pediatric Blood and Cancer. 2024;71(8):10.1002/pbc.31076$14$YR$$F$Y$$$20240711$$HP$FR$FR
239325382$23932538$2$F$$20240910$20240603$20240918$EXP$$MY-MYLANLABS-2024M1049990$MYLAN$Anuar MA, Alsagoff SASA, Mohamed AR, Murugesu S. Epilepsy of Infancy with Migrating Focal Seizures in a Patient with Nonketotic Hyperglycinemia. Ann-Child-Neurol 2023; 31 (2): 144-147.$3$MON$$F$Y$$$20240918$$HP$MY$MY
239325485$23932548$5$F$$20240911$20240603$20240913$EXP$$NVSC2024US108742$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
239325812$23932581$2$F$20240528$20240821$20240603$20240823$PER$$US-AMGEN-USASP2024108415$AMGEN$$76$YR$E$F$Y$$$20240823$$CN$US$US
239325822$23932582$2$F$$20240602$20240603$20240723$PER$$US-HALEON-2179527$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239325972$23932597$2$F$20220201$20240716$20240603$20240722$EXP$$RU-PERRIGO-24RU004984$PERRIGO$$31$YR$$M$Y$$$20240722$$MD$RU$RU
239325992$23932599$2$F$20240523$20240829$20240603$20240906$EXP$$US-BAYER-2024A080179$BAYER$$40$YR$A$M$Y$$$20240906$$HP$US$US
239326016$23932601$6$F$20240101$20240905$20240603$20240909$EXP$$JP-009507513-2405JPN003174J$MERCK$$$$$M$Y$67$KG$20240909$$MD$JP$JP
239326062$23932606$2$F$$20240601$20240603$20240723$PER$$US-HALEON-2179559$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239326072$23932607$2$F$$20240802$20240603$20240806$EXP$$JP-OTSUKA-2024_015288$OTSUKA$Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, et al.. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024;44:126$3$YR$$$Y$$$20240806$$MD$JP$JP
239326092$23932609$2$F$$20240902$20240603$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-086206$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240910$$CN$JP$JP
239326142$23932614$2$F$20240521$20240727$20240603$20240729$EXP$GB-MHRA-MED-202405311106380720-SRNGH$GB-SANDOZ INC.-SDZ2024GB053965$SANDOZ$$$$$M$Y$$$20240729$$HP$GB$GB
239326172$23932617$2$F$$20240801$20240603$20240820$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR065220$VIIV$$$$$M$Y$106.5$KG$20240820$$CN$US$US
239326292$23932629$2$F$20240501$20240627$20240603$20240701$30DAY$$US-AMGEN-USASP2024105019$AMGEN$$36$YR$A$F$Y$$$20240701$$CN$US$US
239326332$23932633$2$F$20240523$20240705$20240603$20240710$30DAY$$US-AMGEN-USASP2024104707$AMGEN$$63$YR$A$M$Y$82.8$KG$20240710$$PH$US$US
239326342$23932634$2$F$$20240802$20240603$20240806$EXP$$JP-OTSUKA-2024_015285$OTSUKA$Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, et al. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024;44:126$7$YR$$$Y$$$20240806$$MD$JP$JP
239326382$23932638$2$F$20221231$20240710$20240603$20240720$EXP$FR-AFSSAPS-AN2024000699$FR-TEVA-VS-3203233$TEVA$$61$YR$$M$Y$$$20240720$$MD$FR$FR
239326493$23932649$3$F$$20240916$20240603$20240919$EXP$$US-ABBVIE-5348512$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
239326515$23932651$5$F$$20240718$20240603$20240729$EXP$$IT-AUROBINDO-AUR-APL-2024-025986$AUROBINDO$Vischini G, Speciale S, Przygocka A, Martano L, Manna GL, Baraldi O. Lessons for the clinical nephrologist: acute kidney injury during therapy with apixaban. Journal of Nephrology. 2024;37(2):511-513$81$YR$$M$Y$$$20240729$$HP$IT$IT
239326662$23932666$2$F$20240101$20240708$20240603$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087731$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240712$$CN$US$US
239326804$23932680$4$F$$20240919$20240603$20240926$30DAY$$US-PFIZER INC-202400174097$PFIZER$$13$YR$$M$Y$$$20240926$$CN$US$US
239326853$23932685$3$F$$20240909$20240603$20240912$30DAY$$US-PFIZER INC-PV202400070605$PFIZER$$$$$F$Y$$$20240912$$CN$US$US
239326952$23932695$2$F$20220301$20240701$20240603$20240703$EXP$GB-MHRA-MED-202405291424443490-MPNTB$GB-MYLANLABS-2024M1049586$MYLAN$$52$YR$$F$Y$$$20240703$$MD$GB$GB
239327022$23932702$2$F$$20240528$20240603$20240720$PER$$US-HALEON-2178887$Haleon PLC$$$$$$Y$$$20240720$$CN$US$US
239327042$23932704$2$F$20240413$20240708$20240603$20240715$EXP$$FR-AFSSAPS-BX2024001033$ALCON$$$$$$Y$$$20240715$$HP$FR$FR
239327064$23932706$4$F$20240527$20240913$20240603$20240919$30DAY$$US-PFIZER INC-202400180494$PFIZER$$10$YR$$M$Y$$$20240919$$CN$US$US
239327083$23932708$3$F$20240520$20240814$20240603$20240819$30DAY$$CO-PFIZER INC-202400179286$PFIZER$$14$YR$$F$Y$$$20240819$$CN$CO$CO
239327092$23932709$2$F$$20240917$20240603$20240920$30DAY$$CO-PFIZER INC-PV202400067130$PFIZER$$$$$$Y$$$20240920$$CN$CO$CO
239327104$23932710$4$F$$20240708$20240603$20240711$30DAY$$US-PFIZER INC-202400175458$PFIZER$$7$YR$$M$Y$$$20240711$$CN$US$US
239327135$23932713$5$F$20240523$20240923$20240603$20240927$30DAY$$US-PFIZER INC-202400180804$PFIZER$$4$YR$$F$Y$15.9$KG$20240927$$HP$US$US
239327542$23932754$2$F$$20240802$20240603$20240805$EXP$$JP-OTSUKA-2024_015282$OTSUKA$Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, et al.. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024;44:126$12$YR$$$Y$$$20240805$$MD$JP$JP
239327723$23932772$3$F$20240301$20240626$20240603$20240708$30DAY$$US-JNJFOC-20240423932$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
239327772$23932777$2$F$$20240602$20240603$20240722$PER$$US-HALEON-2179534$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
239328042$23932804$2$F$$20240830$20240603$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-088643$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240830$$MD$JP$JP
239328052$23932805$2$F$20240501$20240701$20240603$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088052$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$84.37$KG$20240705$$CN$US$US
239328512$23932851$2$F$$20240802$20240603$20240806$EXP$$JP-OTSUKA-2024_015277$OTSUKA$Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, et al.. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024;44:126$15$YR$$$Y$$$20240806$$MD$JP$JP
239328552$23932855$2$F$$20240802$20240603$20240805$EXP$$JP-OTSUKA-2024_015273AA$OTSUKA$Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, et al.. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity.. Journal of clinical immunology. 2024;44:126$4$MON$$$Y$$$20240805$$MD$JP$JP
239328562$23932856$2$F$$20240802$20240603$20240806$EXP$$JP-OTSUKA-2024_015266$OTSUKA$Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, et al.. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024;44:126$6$YR$$$Y$$$20240806$$MD$JP$JP
239328662$23932866$2$F$$20240802$20240603$20240805$EXP$$JP-OTSUKA-2024_015264$OTSUKA$Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, et al.. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024;44:126$21$YR$$$Y$$$20240805$$MD$JP$JP
239328692$23932869$2$F$$20240718$20240603$20240809$EXP$$CA-OTSUKA-2024_015293$OTSUKA$$$$$F$Y$$$20240809$$MD$CA$CA
239328814$23932881$4$F$20180501$20240823$20240603$20240826$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031426$BOEHRINGER INGELHEIM$$7$DEC$E$M$Y$$$20240826$$MD$JP$JP
239328833$23932883$3$F$20240305$20240806$20240603$20240814$EXP$$ES-OTSUKA-2024_015249$OTSUKA$$59$YR$$F$Y$$$20240814$$MD$ES$ES
239328843$23932884$3$F$$20240801$20240603$20240808$PER$$NVSC2024US115241$NOVARTIS$$43$YR$$M$Y$$$20240808$$CN$US$US
239329032$23932903$2$F$$20240531$20240603$20240717$PER$$US-HALEON-2179562$Haleon PLC$$$$$F$Y$$$20240717$$CN$US$US
239329072$23932907$2$F$$20240602$20240603$20240723$PER$$US-HALEON-2179519$Haleon PLC$$$$$M$Y$$$20240723$$CN$US$US
2393292111$23932921$11$F$$20240924$20240603$20240927$30DAY$$US-PFIZER INC-202400180782$PFIZER$$5$YR$$F$Y$13.61$KG$20240927$$CN$US$US
239329232$23932923$2$F$$20240704$20240603$20240704$30DAY$$US-PFIZER INC-202400180426$PFIZER$$12$YR$$F$Y$$$20240704$$CN$US$US
239329245$23932924$5$F$$20240920$20240603$20240924$30DAY$$US-PFIZER INC-202400178721$PFIZER$$8$YR$$M$Y$$$20240924$$MD$US$US
239329322$23932932$2$F$20240402$20240715$20240603$20240722$EXP$$ES-FreseniusKabi-FK202406326$FRESENIUS KABI$$$$E$M$Y$104.5$KG$20240722$$MD$ES$ES
239329333$23932933$3$F$20240612$20240815$20240603$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087845$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240816$$CN$US$US
239329442$23932944$2$F$$20240709$20240603$20240715$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202405018515$ELI LILLY AND CO$$76$YR$E$M$Y$70$KG$20240715$$CN$CN$CN
239329483$23932948$3$F$$20240829$20240603$20240903$30DAY$$US-PFIZER INC-202400181267$PFIZER$$7$YR$$F$Y$$$20240903$$CN$US$US
239329493$23932949$3$F$$20240909$20240603$20240911$30DAY$$US-PFIZER INC-202400181895$PFIZER$$13$YR$$M$Y$$$20240911$$CN$US$US
239329562$23932956$2$F$20190718$20240815$20240603$20240819$EXP$$CA-TAKEDA-2019TUS059394$TAKEDA$$12$YR$$M$Y$$$20240819$$CN$CA$CA
239329603$23932960$3$F$20240526$20240626$20240603$20240703$PER$$US-AMGEN-USASP2024108206$AMGEN$$51$YR$A$F$Y$$$20240703$$CN$US$US
239329753$23932975$3$F$$20240805$20240603$20240808$PER$$NVSC2024US115243$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
239329772$23932977$2$F$$20240711$20240603$20240715$EXP$$US-TAKEDA-2024TUS055170$TAKEDA$$$$$F$Y$83.447$KG$20240715$$CN$US$US
239329825$23932982$5$F$20240521$20240902$20240603$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088498$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240903$$CN$US$US
239329833$23932983$3$F$$20240829$20240603$20240906$EXP$$CA-TEVA-VS-3203124$TEVA$$7$DEC$$F$Y$$$20240906$$HP$CA$CA
239330043$23933004$3$F$20240101$20240715$20240603$20240805$PER$$US-KARYOPHARM-2024KPT001081$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240805$$CN$US$US
239330202$23933020$2$F$$20240716$20240603$20240720$EXP$AU-TGA-0000786050$AU-SANDOZ INC.-SDZ2024AU053697$SANDOZ$$25$YR$$F$Y$$$20240720$$MD$AU$AU
239330434$23933043$4$F$$20240715$20240603$20240722$EXP$$US-BAYER-2024A076678$BAYER$$81$YR$E$M$Y$$$20240722$$CN$US$US
239330522$23933052$2$F$$20240728$20240603$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088823$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$43.54$KG$20240729$$CN$US$US
239330533$23933053$3$F$20240205$20240814$20240603$20240820$EXP$$CA-GSK-CA2024016097$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$HP$CA$CA
239330553$23933055$3$F$20240101$20240824$20240603$20240826$EXP$$US-KARYOPHARM-2024KPT001105$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240826$$CN$US$US
239330594$23933059$4$F$$20240905$20240603$20240909$EXP$$US-SANDOZ INC.-SDZ2024US053783$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
239330643$23933064$3$F$$20240731$20240603$20240801$EXP$$CA-ALXN-202405CAN002197CA$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$PH$CA$CA
239330652$23933065$2$F$20230901$20240628$20240603$20240703$EXP$$US-INCYTE CORPORATION-2024IN005749$INCYTE$$$$$$Y$$$20240703$$CN$US$US
239330726$23933072$6$F$20240101$20240823$20240603$20240904$EXP$$DE-UCBSA-2024018140$UCB$$$$$F$Y$73$KG$20240904$$HP$DE$DE
239330783$23933078$3$F$20240101$20240724$20240603$20240730$EXP$$US-JNJFOC-20240571032$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240730$$CN$US$US
239331233$23933123$3$F$20180507$20240910$20240603$20240924$EXP$$CA-SANDOZ INC.-NVSC2021CA159043$SANDOZ$$65$YR$$F$Y$$$20240924$$HP$CA$CA
239331252$23933125$2$F$$20240808$20240603$20240812$EXP$$GB-MYLANLABS-2024M1048983$MYLAN$$$$$F$Y$$$20240812$$MD$GB$GB
239331324$23933132$4$F$20240101$20240905$20240603$20240913$EXP$$US-SA-2024SA160460$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240913$$MD$US$US
239331342$23933134$2$F$$20240905$20240603$20240914$PER$$US-SA-2024SA159153$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240914$$MD$US$US
239331382$23933138$2$F$$20240627$20240603$20240709$PER$$US-SA-2024SA160983$SANOFI AVENTIS$$33$YR$A$M$Y$68.027$KG$20240709$$MD$US$US
239331522$23933152$2$F$20240101$20240917$20240603$20240925$PER$$US-SA-2024SA161872$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240925$$MD$US$US
239331532$23933153$2$F$$20240712$20240603$20240725$30DAY$$US-JNJFOC-20240523132$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240725$$CN$US$US
239331592$23933159$2$F$20240610$20240619$20240603$20240701$PER$$US-SA-2024SA126024$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240701$$CN$US$US
239331612$23933161$2$F$$20240621$20240603$20240702$PER$$US-SA-2024SA160331$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240702$$HP$US$US
239331642$23933164$2$F$20240101$20240702$20240603$20240711$PER$$US-SA-2024SA160998$SANOFI AVENTIS$$51$YR$A$M$Y$72.62$KG$20240711$$MD$US$US
239331712$23933171$2$F$$20240701$20240603$20240710$PER$$US-SA-2024SA162725$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240710$$MD$US$US
239331803$23933180$3$F$20240501$20240712$20240603$20240724$PER$$US-SA-2024SA160502$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240724$$MD$US$US
239331982$23933198$2$F$20240424$20240831$20240603$20240924$PER$$US-SA-2024SA163077$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240924$$MD$US$US
239332363$23933236$3$F$$20240826$20240603$20240829$PER$$US-PFIZER INC-202400181294$PFIZER$$24$YR$$M$Y$$$20240829$$CN$US$US
239332452$23933245$2$F$20240501$20240808$20240603$20240813$PER$$US-PFIZER INC-202400181786$PFIZER$$54$YR$$F$Y$$$20240813$$HP$US$US
239332525$23933252$5$F$20230517$20240913$20240603$20240920$PER$$US-PFIZER INC-202300196307$PFIZER$$76$YR$$F$Y$$$20240920$$CN$US$US
239332552$23933255$2$F$$20240725$20240603$20240725$PER$$US-PFIZER INC-202400180331$PFIZER$$54$YR$$F$Y$$$20240725$$HP$US$US
239332604$23933260$4$F$20240101$20240917$20240603$20240919$PER$$US-PFIZER INC-PV202400071518$PFIZER$$70$YR$$F$Y$64.41$KG$20240919$$HP$US$US
239332832$23933283$2$F$$20240730$20240603$20240801$PER$$US-PFIZER INC-PV202400071712$PFIZER$$33$YR$$F$Y$$$20240801$$HP$US$US
239333014$23933301$4$F$$20240731$20240603$20240801$PER$$US-PFIZER INC-PV202400072232$PFIZER$$46$YR$$F$Y$73.923$KG$20240801$$HP$US$US
239333072$23933307$2$F$$20240725$20240603$20240725$PER$$US-PFIZER INC-PV202400070542$PFIZER$$20$YR$$F$Y$$$20240725$$MD$US$US
239333132$23933313$2$F$20220923$20240825$20240603$20240909$EXP$$BE-SA-2024SA162721$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240909$$CN$BE$BE
239333202$23933320$2$F$$20240809$20240603$20240809$PER$$NVSC2024US115646$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
239333212$23933321$2$F$$20240712$20240603$20240712$PER$$NVSC2024US115242$NOVARTIS$$$$$M$Y$$$20240712$$CN$US$US
239333452$23933345$2$F$20240705$20240705$20240603$20240715$PER$$US-SA-2022SA329680$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240715$$MD$US$US
239333663$23933366$3$F$$20240926$20240603$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088770$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$44$KG$20240930$$CN$US$US
239333832$23933383$2$F$$20240729$20240603$20240805$EXP$$NVSC2024FR114792$NOVARTIS$$$$$M$Y$$$20240805$$MD$FR$FR
239333942$23933394$2$F$20240516$20240904$20240603$20240909$EXP$$US-MYLANLABS-2024M1048869$MYLAN$$23$YR$$M$Y$$$20240909$$CN$US$US
239334002$23933400$2$F$20240401$20240619$20240603$20240701$PER$$US-SA-2024SA164997$SANOFI AVENTIS$$77$YR$E$F$Y$49.89$KG$20240701$$MD$US$US
239334243$23933424$3$F$20240315$20240815$20240603$20240823$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04816$VIFOR$$67$YR$$M$Y$$$20240823$$HP$ZA$ZA
239334582$23933458$2$F$$20240627$20240603$20240705$EXP$$JP-OTSUKA-2024_015393$OTSUKA$$$$$F$Y$$$20240705$$MD$JP$JP
239334632$23933463$2$F$$20240715$20240603$20240723$PER$$US-GILEAD-2024-0674100$GILEAD$$22$YR$A$F$Y$$$20240723$$MD$US$US
239334722$23933472$2$F$$20240704$20240603$20240704$PER$$US-PFIZER INC-202400181885$PFIZER$$69$YR$$F$Y$89.81$KG$20240704$$CN$US$US
239334732$23933473$2$F$20240101$20240704$20240603$20240704$PER$$US-PFIZER INC-202400181621$PFIZER$$3$YR$$F$Y$$$20240704$$CN$US$US
239334742$23933474$2$F$20240510$20240624$20240603$20240702$30DAY$$US-PFIZER INC-202400181794$PFIZER$$41$YR$$F$Y$$$20240702$$MD$US$US
239334764$23933476$4$F$$20240703$20240603$20240708$PER$$US-PFIZER INC-PV202400071916$PFIZER$$60$YR$$F$Y$70.295$KG$20240708$$HP$US$US
239334782$23933478$2$F$$20240602$20240603$20240722$PER$$US-HALEON-2179536$Haleon PLC$$$$$F$Y$$$20240722$$CN$US$US
239334952$23933495$2$F$$20240603$20240603$20240723$PER$$US-HALEON-2179528$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239334992$23933499$2$F$20240501$20240707$20240603$20240709$EXP$$US-ARGENX-2024-ARGX-US003933$ARGENX BVBA$$$$$$Y$$$20240709$$CN$US$US
239335322$23933532$2$F$$20240602$20240603$20240723$PER$$US-HALEON-2179583$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239335432$23933543$2$F$$20240531$20240603$20240724$PER$$US-HALEON-2179531$Haleon PLC$$$$$F$Y$$$20240724$$CN$US$US
239335443$23933544$3$F$20240507$20240819$20240603$20240826$EXP$$FR-DSJP-DSE-2024-124090$DAIICHI$$62$YR$$F$Y$$$20240826$$MD$FR$FR
239335462$23933546$2$F$$20240618$20240603$20240702$30DAY$$ES-JNJFOC-20240587317$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$ES$ES
239335632$23933563$2$F$$20240530$20240603$20240723$PER$$US-HALEON-2179162$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239335792$23933579$2$F$$20240509$20240603$20240814$PER$$US-INCYTE CORPORATION-2024IN004979$INCYTE$$$$$$Y$$$20240814$$CN$US$US
239335803$23933580$3$F$$20240816$20240603$20240906$PER$$US-INCYTE CORPORATION-2024IN004978$INCYTE$$$$$$Y$$$20240906$$CN$US$US
239335833$23933583$3$F$$20240715$20240603$20240723$EXP$$DE-AstraZeneca-2024A125492$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$DE$
239335842$23933584$2$F$$20240712$20240603$20240715$PER$$NVSC2024US116019$NOVARTIS$$$$$F$Y$$$20240715$$HP$US$US
239335862$23933586$2$F$$20240603$20240603$20240723$PER$$US-HALEON-2179558$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239335893$23933589$3$F$20240523$20240822$20240603$20240827$PER$$US-AMGEN-USASP2024106268$AMGEN$$57$YR$A$M$Y$$$20240827$$CN$US$US
239335922$23933592$2$F$$20240527$20240603$20240715$EXP$$KR-AMGEN-KORSP2024104493$AMGEN$$$$$$Y$$$20240715$$MD$KR$KR
239335942$23933594$2$F$20220401$20240827$20240603$20240829$EXP$$US-JNJFOC-20240568956$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240829$$CN$US$US
239336132$23933613$2$F$20240514$20240621$20240603$20240702$PER$$US-SA-2024SA160842$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240702$$HP$US$US
239336152$23933615$2$F$20230501$20240529$20240603$20240717$EXP$$US-SA-2024SA165524$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240717$$MD$US$US
239336184$23933618$4$F$$20240909$20240603$20240911$PER$$NVSC2024US115843$NOVARTIS$$$$$M$Y$$$20240911$$CN$US$US
239336222$23933622$2$F$20240502$20240815$20240603$20240822$EXP$$ZA-Vifor (International) Inc.-VIT-2024-04841$VIFOR$$48$YR$$F$Y$$$20240822$$MD$ZA$ZA
239336233$23933623$3$F$$20240919$20240603$20240926$30DAY$$GR-JNJFOC-20240580938$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$GR$GR
239336294$23933629$4$F$20240620$20240816$20240603$20240826$EXP$$US-BAYER-2024A080145$BAYER$$13$YR$T$M$Y$125$KG$20240826$$HP$US$US
239336353$23933635$3$F$$20240920$20240603$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089035$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240925$$CN$US$US
239336472$23933647$2$F$$20240913$20240603$20240918$30DAY$$US-PFIZER INC-202400184882$PFIZER$$$$$$Y$$$20240918$$CN$US$US
239336482$23933648$2$F$$20240727$20240603$20240729$EXP$$CA-PFIZER INC-202400012655$PFIZER$$65$YR$$F$Y$$$20240729$$HP$CA$CA
239336492$23933649$2$F$$20240823$20240603$20240828$30DAY$$DE-PFIZER INC-202400179227$PFIZER$$$$$F$Y$$$20240828$$HP$DE$DE
239336522$23933652$2$F$$20240702$20240603$20240705$30DAY$$US-PFIZER INC-202400174275$PFIZER$$$$$$Y$$$20240705$$PH$US$US
239336702$23933670$2$F$$20240626$20240603$20240724$PER$$US-INCYTE CORPORATION-2024IN004903$INCYTE$$$$$$Y$$$20240724$$MD$US$US
239336723$23933672$3$F$20240426$20240902$20240603$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-088562$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240903$$MD$JP$JP
239336773$23933677$3$F$20230730$20240708$20240603$20240714$EXP$$JP-ABBVIE-5785582$ABBVIE$$58$YR$$M$Y$$$20240714$$MD$JP$JP
239336824$23933682$4$F$20240501$20240802$20240603$20240808$EXP$$JP-OTSUKA-2024_015505$OTSUKA$$45$YR$$F$Y$$$20240808$$MD$JP$JP
239336923$23933692$3$F$20240901$20240917$20240603$20240925$EXP$$US-BAYER-2024A080668$BAYER$$52$YR$A$F$Y$70.295$KG$20240925$$CN$US$US
239337063$23933706$3$F$$20240628$20240603$20240704$30DAY$$KR-JNJFOC-20240579490$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$KR$KR
239337074$23933707$4$F$20231201$20240710$20240603$20240716$EXP$$JP-DSJP-DSJ-2024-124276$DAIICHI$$88$YR$$M$Y$$$20240716$$MD$JP$JP
239337183$23933718$3$F$20240517$20240717$20240603$20240719$EXP$$JP-AstraZeneca-2024A127346$ASTRAZENECA$$77$YR$$M$Y$76$KG$20240719$$MD$JP$
239337262$23933726$2$F$20240101$20240627$20240603$20240705$PER$$US-Eisai-EC-2024-164543$EISAI$$66$YR$E$F$Y$$$20240705$$CN$US$US
239337282$23933728$2$F$$20240802$20240603$20240805$EXP$$JP-OTSUKA-2024_015274$OTSUKA$Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, et al.. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024;44:126$12$MON$$$Y$$$20240805$$MD$JP$JP
239337303$23933730$3$F$$20240801$20240603$20240806$EXP$$AT-MYLANLABS-2024M1049567$MYLAN$Mair L. Talquetamab (Talvey) in multiple myeloma Significant remission in heavily pretreated patient.. Spectrum Oncology Issue. 2024$55$YR$$M$Y$$$20240806$$MD$AT$AT
239337322$23933732$2$F$$20240602$20240603$20240723$PER$$US-HALEON-2179591$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239337352$23933735$2$F$$20240829$20240603$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-086298$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240829$$MD$JP$JP
239337412$23933741$2$F$20210101$20240812$20240603$20240819$EXP$$NL-MYLANLABS-2024M1049813$MYLAN$van Dijk LMM, van Zwol A, Buizer AI, van de PolLA, Slot KM, de Wildt SN, et al. Potentially Life-Threatening Interaction between Opioids and Intrathecal Baclofen in Individuals with a Childhood-Onset Neurological Disorder: A Case Series and Review of the Literature. Neuropediatrics 2024.$14$YR$$M$Y$60$KG$20240819$$MD$NL$NL
239337433$23933743$3$F$$20240909$20240603$20240909$PER$$NVSC2024US115616$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
239337472$23933747$2$F$20240508$20240730$20240603$20240802$EXP$$US-PFIZER INC-202400181801$PFIZER$$68$YR$$M$Y$85.95$KG$20240802$$HP$US$US
239337482$23933748$2$F$$20240729$20240603$20240731$EXP$$CA-PFIZER INC-202400181867$PFIZER$$41$YR$$F$Y$$$20240731$$HP$CA$CA
239337624$23933762$4$F$$20240904$20240603$20240904$EXP$$FR-JNJFOC-20240590134$JOHNSON AND JOHNSON$$77$YR$E$F$Y$43$KG$20240905$$MD$FR$FR
239337633$23933763$3$F$$20240619$20240603$20240710$30DAY$$AE-JNJFOC-20240562633$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$HP$AE$AE
239337642$23933764$2$F$$20240628$20240603$20240703$EXP$$FR-JNJFOC-20240589511$JOHNSON AND JOHNSON$$48$YR$A$F$Y$67$KG$20240703$$MD$FR$FR
239337682$23933768$2$F$$20240601$20240603$20240723$PER$$US-HALEON-2179567$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239337803$23933780$3$F$$20240704$20240603$20240715$EXP$MA-STRIDES ARCOLAB LIMITED-2024SP006392$MA-STRIDES ARCOLAB LIMITED-2024SP006392$STRIDES$Klevor R, Jarti M, Chraa M, Louhab N, Krati K, Kissani N.. Metronidazole-Induced Encephalopathy With Probable Crohn Encephalitis: A Case Report.. Clinical Neuropharmacology. 2024;47(3):104-7$3$DEC$$F$Y$$$20240715$$MD$MA$MA
239337926$23933792$6$F$20240101$20240903$20240603$20240905$EXP$$CA-PFIZER INC-202400047586$PFIZER$$81$YR$$F$Y$$$20240905$$HP$CA$CA
239337982$23933798$2$F$$20240601$20240603$20240723$PER$$US-HALEON-2179535$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239338025$23933802$5$F$20240801$20240910$20240603$20240920$EXP$$CA-GILEAD-2024-0669423$GILEAD$$58$YR$A$F$Y$$$20240920$$HP$CA$CA
239338183$23933818$3$F$$20240910$20240603$20240913$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003063$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240913$$CN$US$US
239338212$23933821$2$F$$20240820$20240603$20240826$EXP$$JP-009507513-2405JPN003407J$MERCK$$$$$F$Y$$$20240826$$MD$JP$JP
239338283$23933828$3$F$$20240704$20240603$20240711$30DAY$$FR-JNJFOC-20240559918$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$FR$FR
239338354$23933835$4$F$20240324$20240904$20240603$20240906$EXP$$CZ-ABBVIE-5780422$ABBVIE$$71$YR$$M$Y$92$KG$20240906$$MD$CZ$CZ
239338362$23933836$2$F$20240527$20240629$20240603$20240705$EXP$$NVSC2024BR114540$NOVARTIS$$5$MON$$$Y$$$20240705$$MD$BR$BR
239338393$23933839$3$F$$20240716$20240603$20240723$PER$$US-BIOGEN-2024BI01257949$BIOGEN$$$$$F$Y$$$20240723$$CN$US$US
239338632$23933863$2$F$20240501$20240801$20240603$20240810$EXP$$BR-TEVA-VS-3203786$TEVA$$42$YR$$F$Y$$$20240810$$CN$BR$BR
239338643$23933864$3$F$20240501$20240702$20240603$20240704$EXP$$JP-DSJP-DSJ-2024-124602$DAIICHI$$65$YR$$M$Y$62.5$KG$20240704$$MD$JP$JP
239338762$23933876$2$F$20240531$20240801$20240603$20240806$PER$$US-AMGEN-USASP2024108799$AMGEN$$58$YR$A$M$Y$$$20240806$$CN$US$US
239338784$23933878$4$F$$20240913$20240603$20240916$PER$$NVSC2024US116086$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
239338813$23933881$3$F$20240430$20240925$20240603$20240926$30DAY$$IT-SANDOZ INC.-SDZ2024IT054029$SANDOZ$$12$YR$$M$Y$42$KG$20240926$$CN$IT$IT
239339002$23933900$2$F$$20240913$20240603$20240919$EXP$$US-SA-2024SA165511$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240919$$MD$US$US
239339063$23933906$3$F$$20240727$20240603$20240730$PER$$US-PFIZER INC-PV202400072371$PFIZER$$81$YR$$M$Y$$$20240730$$CN$US$US
239339135$23933913$5$F$$20240712$20240603$20240716$PER$$US-PFIZER INC-PV202400072217$PFIZER$$83$YR$$F$Y$$$20240716$$HP$US$US
239339182$23933918$2$F$20240101$20240624$20240603$20240705$PER$$US-Eisai-EC-2024-164586$EISAI$$72$YR$E$M$Y$$$20240705$$CN$US$US
239339273$23933927$3$F$$20240708$20240603$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088447$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240711$$HP$US$US
239339292$23933929$2$F$$20240702$20240603$20240708$EXP$$JP-GSK-JP2024JPN065956$GLAXOSMITHKLINE$Kobayashi S, Saito S, Yamada T, Matsumura N, Monma N, Nemoto N, et al. Case report - A case of severe drug eruption with delayed diagnosis due to COVID-19. Journal of Japanese Association for Acute Medicine. 2024;35:160-165$$$$$Y$$$20240708$$MD$JP$JP
239339914$23933991$4$F$20240101$20240625$20240603$20240702$EXP$$US-ALKERMES INC.-ALK-2024-001424$ALKERMES$$33$YR$$F$Y$$$20240702$$HP$US$US
239339962$23933996$2$F$$20240531$20240603$20240723$PER$$US-HALEON-2179568$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239339982$23933998$2$F$20240506$20240911$20240603$20240921$EXP$$JP-ROCHE-3573999$ROCHE$$82$YR$E$F$Y$36$KG$20240921$$MD$JP$JP
239340202$23934020$2$F$$20240531$20240603$20240723$PER$$US-HALEON-2179598$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239340282$23934028$2$F$20240524$20240828$20240603$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086039$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240828$$CN$US$US
239340315$23934031$5$F$$20240719$20240603$20240726$EXP$$US-GSK-US2024AMR068013$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$HP$US$US
239340472$23934047$2$F$$20240626$20240603$20240705$PER$$US-SA-2024SA162974$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240705$$MD$US$US
239340502$23934050$2$F$$20240603$20240603$20240723$PER$$US-HALEON-2179594$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
239340602$23934060$2$F$20240501$20240524$20240603$20240705$PER$$US-Eisai-EC-2024-165385$EISAI$$67$YR$E$M$Y$$$20240705$$CN$US$US
239340612$23934061$2$F$20230101$20240812$20240603$20240813$PER$$US-AMGEN-USASP2024107392$AMGEN$$67$YR$E$F$Y$$$20240813$$CN$US$US
239340642$23934064$2$F$20240501$20240906$20240603$20240917$PER$$US-SA-2024SA160557$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240918$$MD$US$US
239340673$23934067$3$F$$20240812$20240603$20240822$30DAY$$US-GSK-US2024067774$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
239340732$23934073$2$F$$20240802$20240603$20240805$EXP$$JP-OTSUKA-2024_015270$OTSUKA$Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, et al.. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024;44:126$13$YR$$$Y$$$20240805$$MD$JP$JP
239340842$23934084$2$F$20240501$20240902$20240603$20240913$EXP$$JP-FERRINGPH-2024FE02857$FERRING$$$$$$Y$$$20240913$$PH$JP$JP
239340962$23934096$2$F$$20240702$20240603$20240710$PER$$US-PHARMING-PHAUS2024000428$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
239340972$23934097$2$F$20240518$20240701$20240603$20240710$PER$$US-PHARMING-PHAUS2024000435$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
239341042$23934104$2$F$20240501$20240917$20240603$20240925$PER$$US-SA-2024SA161473$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240925$$MD$US$US
239341084$23934108$4$F$20240101$20240730$20240603$20240805$30DAY$$CO-PFIZER INC-PV202400049889$PFIZER$$11$YR$$F$Y$$$20240805$$CN$CO$CO
239341132$23934113$2$F$20240501$20240730$20240603$20240731$EXP$$US-PFIZER INC-PV202400072228$PFIZER$$64$YR$$F$Y$$$20240731$$HP$US$US
239341294$23934129$4$F$20240101$20240819$20240603$20240822$EXP$$US-SA-2024SA080006$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240822$$CN$US$US
239341383$23934138$3$F$20240101$20240911$20240603$20240918$PER$$US-SA-2024SA161114$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240918$$MD$US$US
239341454$23934145$4$F$$20240719$20240603$20240725$EXP$$US-Calliditas-2024CAL00861$CALLIDITAS THERAPEUTICS$$49$YR$A$M$Y$144$KG$20240725$$CN$US$US
239341472$23934147$2$F$$20240802$20240603$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087345$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240806$$HP$US$US
239341542$23934154$2$F$20240529$20240925$20240603$20240926$30DAY$$IT-SANDOZ INC.-SDZ2024IT054043$SANDOZ$$46$YR$$F$Y$47$KG$20240926$$CN$IT$IT
239341702$23934170$2$F$20240101$20240708$20240603$20240710$EXP$DE-PEI-CADR2024328116$DE-DSJP-DSE-2024-123822$DAIICHI$$51$YR$$F$Y$72$KG$20240710$$PH$DE$DE
239341752$23934175$2$F$20190101$20230705$20240603$20240916$EXP$$NVSC2023TR280672$NOVARTIS$$$$$F$Y$70$KG$20240916$$MD$TR$TR
239341772$23934177$2$F$$20240913$20240603$20240923$EXP$$CA-TEVA-VS-3203668$TEVA$$$$A$M$Y$$$20240923$$HP$CA$CA
239341782$23934178$2$F$$20240812$20240603$20240821$EXP$$CA-TEVA-VS-3203621$TEVA$$69$YR$$M$Y$$$20240821$$HP$CA$CA
239341813$23934181$3$F$$20240807$20240603$20240809$EXP$$GB-MYLANLABS-2024M1049554$MYLAN$$$$$M$Y$$$20240809$$CN$GB$GB
239341874$23934187$4$F$20240509$20240711$20240603$20240719$EXP$$JP-DSJP-DSJ-2024-123914$DAIICHI$$85$YR$$F$Y$56.9$KG$20240719$$PH$JP$JP
239341882$23934188$2$F$20240101$20240625$20240603$20240705$PER$$US-RIGEL PHARMACEUTICALS, INC.-2024FOS000622$RIGEL PHARMACEUTICALS$$$$$$Y$$$20240705$$CN$US$US
239341892$23934189$2$F$$20240802$20240603$20240806$EXP$$JP-OTSUKA-2024_015284$OTSUKA$Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, et al.. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024;44:126$6$YR$$$Y$$$20240806$$MD$JP$JP
239341945$23934194$5$F$$20240805$20240603$20240808$EXP$$ES-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003010$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240808$$HP$ES$ES
239341983$23934198$3$F$$20240626$20240603$20240703$EXP$$CA-TAKEDA-2024TUS052115$TAKEDA$$$$$F$Y$$$20240703$$CN$CA$CA
239341992$23934199$2$F$$20240725$20240603$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089198$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$$$20240726$$CN$US$US
239342022$23934202$2$F$$20240627$20240603$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-009240$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240701$$HP$US$US
239342042$23934204$2$F$20210903$20240626$20240603$20240701$EXP$$CA-TAKEDA-2020TUS037684$TAKEDA$$73$YR$$M$Y$$$20240701$$CN$CA$CA
239342112$23934211$2$F$20240401$20240911$20240603$20240915$30DAY$$US-SANDOZ INC.-SDZ2024US054224$SANDOZ$$9$YR$$M$Y$$$20240915$$CN$US$US
239342322$23934232$2$F$$20230609$20240603$20240715$EXP$$US-NOVOPROD-1207771$NOVO NORDISK$$$$$F$Y$$$20240715$$HP$US$US
239342412$23934241$2$F$$20240601$20240603$20240724$PER$$US-HALEON-2179551$Haleon PLC$$$$$$Y$$$20240724$$CN$US$US
239342533$23934253$3$F$20230726$20240607$20240603$20240715$EXP$$US-NOVOPROD-1229574$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
239342612$23934261$2$F$20240313$20240910$20240603$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008365$JAZZ$$21$YR$$F$Y$$$20240913$$CN$US$US
239342792$23934279$2$F$$20240723$20240603$20240724$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008446$JAZZ$$$$$M$Y$$$20240724$$HP$US$US
239342822$23934282$2$F$20240512$20240710$20240603$20240715$EXP$FR-AFSSAPS-TO2024000893$FR-SA-2024SA161782$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240715$$HP$FR$FR
239342923$23934292$3$F$20240525$20240822$20240603$20240905$EXP$$US-ARDELYX-2024ARDX003678$ARDELYX$$68$YR$$F$Y$65.624$KG$20240905$$HP$US$US
239342942$23934294$2$F$20240101$20240729$20240603$20240806$PER$$US-KARYOPHARM-2024KPT001102$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240806$$CN$US$US
239342982$23934298$2$F$$20240708$20240603$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088890$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240709$$CN$US$US
239343052$23934305$2$F$$20240725$20240603$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202405013570$ELI LILLY AND CO$$36$YR$A$M$Y$86.6$KG$20240806$$CN$US$US
239343113$23934311$3$F$$20240911$20240603$20240912$PER$$NVSC2024US116235$NOVARTIS$$$$$M$Y$$$20240912$$CN$US$US
239343132$23934313$2$F$20240101$20240823$20240603$20240902$EXP$$JP-009507513-2403JPN003878J$MERCK$$55$YR$$M$Y$$$20240902$$MD$JP$JP
239343212$23934321$2$F$$20240725$20240603$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088934$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240726$$CN$US$US
239343233$23934323$3$F$$20240822$20240603$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088992$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240824$$CN$US$US
239343252$23934325$2$F$$20240916$20240603$20240919$EXP$$US-MYLANLABS-2024M1049507$MYLAN$$$$$M$Y$$$20240919$$HP$US$US
239343362$23934336$2$F$$20240820$20240603$20240821$PER$$NVSC2024US116310$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
239343412$23934341$2$F$20240401$20240802$20240603$20240807$EXP$$PH-OTSUKA-2024_015435$OTSUKA$$86$YR$$M$Y$$$20240807$$CN$PH$PH
239343432$23934343$2$F$20230801$20240712$20240603$20240717$PER$$AU-Eisai-EC-2024-166722$EISAI$$64$YR$A$F$Y$$$20240717$$HP$AU$AU
239343453$23934345$3$F$20240101$20240719$20240603$20240813$PER$$US-JNJFOC-20240548886$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240813$$CN$US$US
239343482$23934348$2$F$$20240820$20240603$20240829$EXP$$US-NOVOPROD-1230539$NOVO NORDISK$$$$$F$Y$$$20240829$$CN$US$US
239343582$23934358$2$F$$20240701$20240603$20240705$EXP$$JP-KYOWAKIRIN-2024KK012873$KYOWA$$$$$$Y$$$20240705$$HP$JP$JP
239343623$23934362$3$F$$20240705$20240603$20240718$PER$$US-Calliditas-2024CAL00848$CALLIDITAS THERAPEUTICS$$53$YR$A$M$Y$85.27$KG$20240718$$CN$US$US
239343632$23934363$2$F$20240101$20240626$20240603$20240703$PER$$US-KARYOPHARM-2024KPT001095$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240703$$CN$US$US
239343704$23934370$4$F$20210101$20240710$20240603$20240716$EXP$$FI-MYLANLABS-2024M1049461$MYLAN$$$$E$F$Y$$$20240716$$CN$FI$FI
239343803$23934380$3$F$$20240917$20240603$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088598$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$70.31$KG$20240919$$CN$US$US
239343822$23934382$2$F$$20240910$20240603$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088505$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240917$$HP$US$US
239343882$23934388$2$F$$20240703$20240603$20240709$PER$$US-PFIZER INC-PV202400013396$PFIZER$$41$YR$$F$Y$86.2$KG$20240709$$MD$US$US
239343892$23934389$2$F$20240416$20240723$20240603$20240806$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI05088$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240806$$HP$US$US
239343934$23934393$4$F$20240101$20240913$20240603$20240925$PER$$US-KARYOPHARM-2024KPT000972$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240925$$CN$US$US
239343972$23934397$2$F$$20240718$20240603$20240806$PER$$US-ALXN-202405USA001945US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239344045$23934404$5$F$20240529$20240827$20240603$20240830$30DAY$$US-PFIZER INC-202400181853$PFIZER$$9$YR$$F$Y$$$20240830$$CN$US$US
239344182$23934418$2$F$$20240909$20240603$20240915$EXP$$US-SA-2024SA165342$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240915$$MD$US$US
239344292$23934429$2$F$$20240915$20240603$20240919$30DAY$$GB-PFIZER INC-PV202400069018$PFIZER$$14$YR$$F$Y$$$20240919$$CN$GB$GB
239344362$23934436$2$F$$20240829$20240603$20240912$PER$$US-Calliditas-2024CAL00862$CALLIDITAS THERAPEUTICS$$37$YR$A$M$Y$$$20240912$$CN$US$US
239344483$23934448$3$F$20230901$20240528$20240603$20240705$EXP$$BR-AstraZeneca-2024A045274$ASTRAZENECA$$19541$DY$$F$Y$88$KG$20240705$$CN$BR$
239344523$23934452$3$F$20240401$20240613$20240603$20240702$EXP$$CO-JNJFOC-20240527673$JOHNSON AND JOHNSON$$53$YR$A$M$Y$82$KG$20240702$$HP$CO$CO
239344543$23934454$3$F$20240101$20240725$20240603$20240731$EXP$$JP-009507513-2405JPN003565J$MERCK$$$$$F$Y$$$20240731$$MD$JP$JP
239344592$23934459$2$F$$20240731$20240603$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087997$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240805$$HP$US$US
239344622$23934462$2$F$20240730$20240731$20240603$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202405018693$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240805$$CN$US$US
239344892$23934489$2$F$20240523$20240716$20240603$20240718$EXP$$US-PFIZER INC-202400180241$PFIZER$$64$YR$$F$Y$93.44$KG$20240718$$HP$US$US
239345024$23934502$4$F$20240327$20240705$20240603$20240712$EXP$$US-GENMAB-2024-01601$GENMAB$$81$YR$$M$Y$92$KG$20240712$$PH$US$US
239345112$23934511$2$F$$20240627$20240603$20240709$EXP$$US-APELLIS-2024-APL-0000121$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
239345163$23934516$3$F$20240401$20240821$20240603$20240905$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-16387$SAMSUNG BIOEPIS$$67$YR$E$F$Y$89$KG$20240905$$CN$CA$CA
239345172$23934517$2$F$20240101$20240812$20240603$20240820$PER$$US-SA-2024SA160939$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240820$$MD$US$US
239345262$23934526$2$F$$20240716$20240603$20240729$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI05087$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240729$$HP$US$US
239345273$23934527$3$F$20240416$20240625$20240603$20240704$EXP$$US-APELLIS-2024-APL-0000102$APELLIS PHARMACEUTICALS$$$$$$Y$17$KG$20240703$$HP$US$US
239345292$23934529$2$F$20240101$20240827$20240603$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088071$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240829$$HP$US$US
239345353$23934535$3$F$$20240705$20240603$20240716$EXP$$IN-ROCHE-3571763$ROCHE$$76$YR$E$F$Y$$$20240716$$CN$IN$IN
239345383$23934538$3$F$20240528$20240709$20240603$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088800$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$77.56$KG$20240711$$CN$US$US
239345433$23934543$3$F$20240412$20240709$20240603$20240717$EXP$$US-APELLIS-APL-2024-004192$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
239345532$23934553$2$F$20240101$20240617$20240603$20240715$PER$$US-JNJFOC-20240522388$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240715$$CN$US$US
239345642$23934564$2$F$20240401$20240624$20240603$20240709$EXP$$US-MALLINCKRODT-MNK202403540$MALLINCKRODT$$45$YR$A$F$Y$197$KG$20240709$$HP$US$US
239345702$23934570$2$F$$20240718$20240603$20240806$PER$$US-ALXN-202405USA001956US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239345742$23934574$2$F$$20240717$20240603$20240718$PER$$US-ALXN-202405USA001961US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239345764$23934576$4$F$20240112$20240628$20240603$20240710$PER$$US-APELLIS-APL-2024-003595$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
239345792$23934579$2$F$20240529$20240830$20240603$20240902$PER$$US-AMGEN-USASP2024108714$AMGEN$$73$YR$E$F$Y$$$20240902$$CN$US$US
239346112$23934611$2$F$$20240702$20240603$20240712$EXP$$JP-MALLINCKRODT-MNK202403568$MALLINCKRODT$$45$YR$A$M$Y$$$20240712$$HP$JP$JP
239346252$23934625$2$F$$20240701$20240603$20240710$PER$$US-SA-2024SA164759$SANOFI AVENTIS$$63$YR$A$M$Y$68$KG$20240710$$MD$US$US
239346343$23934634$3$F$$20240919$20240603$20240924$EXP$$NVSC2024US114780$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
239346402$23934640$2$F$20240101$20240624$20240603$20240703$PER$$US-SA-2024SA162834$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240703$$HP$US$US
239346445$23934644$5$F$20240415$20240730$20240603$20240805$EXP$$CO-AMGEN-COLSP2024096976$AMGEN$$60$YR$A$F$Y$$$20240805$$CN$CO$CO
239346563$23934656$3$F$$20240715$20240603$20240724$PER$$NVSC2024US116256$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
239346593$23934659$3$F$$20240830$20240603$20240910$30DAY$$US-JNJFOC-20240519210$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
239346602$23934660$2$F$20240301$20240724$20240603$20240731$EXP$$US-ABBVIE-5706985$ABBVIE$$72$YR$$F$Y$$$20240731$$CN$US$US
239346653$23934665$3$F$20240101$20240809$20240603$20240814$EXP$$US-ABBVIE-5780435$ABBVIE$$$$$M$Y$88$KG$20240814$$CN$US$US
239346705$23934670$5$F$20240501$20240902$20240603$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089050$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240902$$CN$US$US
239346712$23934671$2$F$$20240626$20240603$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088526$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240701$$HP$US$US
239346793$23934679$3$F$$20240827$20240603$20240903$EXP$$US-ABBVIE-5780862$ABBVIE$$$$$F$Y$40$KG$20240903$$CN$US$US
239346813$23934681$3$F$$20240725$20240603$20240730$PER$$NVSC2024US116282$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
239346894$23934689$4$F$20231125$20240830$20240603$20240904$EXP$$JP-ABBVIE-5783051$ABBVIE$$82$YR$$M$Y$$$20240904$$MD$JP$JP
239347072$23934707$2$F$20240101$20240829$20240603$20240829$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-087020$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240829$$HP$RU$RU
239347102$23934710$2$F$20240415$20240724$20240603$20240805$EXP$$CA-ABBVIE-5784512$ABBVIE$$74$YR$$M$Y$$$20240804$$HP$CA$CA
239347113$23934711$3$F$20240529$20240626$20240603$20240701$PER$$US-AMGEN-USASP2024108249$AMGEN$$81$YR$E$F$Y$180$KG$20240701$$CN$US$US
239347133$23934713$3$F$20240524$20240913$20240603$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086555$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240920$$CN$US$US
239347184$23934718$4$F$20240501$20240716$20240603$20240718$EXP$$JP-009507513-2405JPN003777J$MERCK$$80$YR$$M$Y$$$20240718$$MD$JP$JP
239347193$23934719$3$F$20230101$20240826$20240603$20240903$EXP$$CA-JNJFOC-20231224918$JOHNSON AND JOHNSON$$26$YR$A$M$Y$69$KG$20240903$$HP$CA$CA
239347372$23934737$2$F$20240525$20240827$20240603$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088512$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$122.47$KG$20240904$$CN$US$US
239347432$23934743$2$F$20240501$20240826$20240603$20240903$EXP$$JP-009507513-2405JPN003337J$MERCK$$$$$F$Y$$$20240903$$MD$JP$JP
239347542$23934754$2$F$20240111$20240705$20240604$20240712$EXP$$NO-SA-2024SA163009$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240712$$MD$NO$NO
239347562$23934756$2$F$$20240726$20240604$20240809$PER$$US-AstraZeneca-2024A125151$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
239347572$23934757$2$F$$20240714$20240604$20240722$PER$$NVSC2024US116290$NOVARTIS$$$$$$Y$$$20240722$$CN$US$US
239347782$23934778$2$F$20240524$20240805$20240604$20240812$30DAY$$US-AMGEN-USASL2024104342$AMGEN$$79$YR$E$M$Y$$$20240812$$CN$US$US
239347992$23934799$2$F$20231102$20240705$20240604$20240711$30DAY$$US-AMGEN-USASP2024105204$AMGEN$$47$YR$A$M$Y$130$KG$20240711$$PH$US$US
239348062$23934806$2$F$20231201$20240627$20240604$20240702$EXP$$US-ABBVIE-5784066$ABBVIE$$58$YR$$F$Y$$$20240702$$CN$US$US
239348115$23934811$5$F$20231024$20240610$20240604$20240731$EXP$$US-ABBVIE-5783007$ABBVIE$$58$YR$$F$Y$72$KG$20240731$$HP$US$US
239348122$23934812$2$F$20240401$20240702$20240604$20240705$EXP$$CA-ABBVIE-5784158$ABBVIE$$$$A$F$Y$$$20240705$$CN$CA$CA
239348223$23934822$3$F$$20240807$20240604$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031642$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240808$$CN$US$US
239348393$23934839$3$F$20240513$20240918$20240604$20240928$EXP$$GB-CELLTRION INC.-2024GB012909$CELLTRION$$$$$$Y$$$20240928$$HP$GB$GB
239348412$23934841$2$F$$20240625$20240604$20240702$30DAY$$US-JNJFOC-20240603078$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$PH$US$US
239348432$23934843$2$F$$20240726$20240604$20240801$EXP$$US-JNJFOC-20240579792$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240802$$HP$US$US
239348472$23934847$2$F$20240101$20240626$20240604$20240702$PER$$US-UNITED THERAPEUTICS-UNT-2024-016515$UNITED THERAPEUTICS$$$$$M$Y$70.295$KG$20240702$$$US$US
239348502$23934850$2$F$$20240815$20240604$20240822$EXP$$PT-HALEON-2176837$Haleon PLC$$$$E$$Y$$$20240822$$HP$PT$PT
239348832$23934883$2$F$20240513$20240709$20240604$20240716$PER$$US-AstraZeneca-2024A113352$ASTRAZENECA$$25788$DY$$M$Y$$$20240716$$CN$US$
239349092$23934909$2$F$20240415$20240718$20240604$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087111$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240726$$CN$US$US
239349242$23934924$2$F$$20240730$20240604$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202405009895$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240801$$MD$US$US
239349282$23934928$2$F$$20240716$20240604$20240726$EXP$$RO-BIOCON BIOLOGICS LIMITED-BBL2024003874$BIOCON$Rosu S, Tiba D, Ichim A, Balteanu M. Combination with reserved prognosis: TB- rheumatoid arthritis. Pneumologia. 2022;71(4):150-3$$$$$Y$$$20240726$$HP$RO$RO
239349332$23934933$2$F$20240315$20240827$20240604$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089391$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$75.3$KG$20240828$$PH$US$US
239349403$23934940$3$F$$20240910$20240604$20240912$30DAY$$IT-SANDOZ INC.-SDZ2024IT054336$SANDOZ$$46$YR$$F$Y$$$20240912$$CN$IT$IT
239349422$23934942$2$F$20240528$20240719$20240604$20240725$EXP$$US-AMGEN-USASP2024106871$AMGEN$$69$YR$E$F$Y$$$20240725$$CN$US$US
239349522$23934952$2$F$$20240815$20240604$20240815$PER$$NVSC2024US116386$NOVARTIS$$$$$F$Y$$$20240815$$CN$US$US
239349582$23934958$2$F$$20240412$20240604$20240916$PER$$US-ENDO USA, INC.-2024-001836$ENDO$$$$$M$Y$$$20240916$$CN$US$US
239349602$23934960$2$F$$20240213$20240604$20240916$PER$$US-ENDO USA, INC.-2024-001042$ENDO$$$$$M$Y$$$20240916$$CN$US$US
239349612$23934961$2$F$$20240720$20240604$20240724$EXP$$US-AMGEN-USASP2024107863$AMGEN$$67$YR$E$F$Y$$$20240723$$CN$US$US
239349622$23934962$2$F$20240501$20240627$20240604$20240702$EXP$$US-ABBVIE-5783874$ABBVIE$$63$YR$$F$Y$$$20240702$$CN$US$US
239349762$23934976$2$F$20240101$20240814$20240604$20240820$EXP$$US-ABBVIE-5784095$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
239349773$23934977$3$F$20231101$20240809$20240604$20240812$EXP$$CA-JNJFOC-20240577176$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240812$$PH$CA$CA
239349834$23934983$4$F$20240101$20240709$20240604$20240711$EXP$$US-JNJFOC-20240587747$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240711$$HP$US$US
239350056$23935005$6$F$20240426$20240809$20240604$20240815$EXP$$AR-TAKEDA-2024TUS047387$TAKEDA$$12$YR$$M$Y$30$KG$20240815$$CN$AR$AR
239350073$23935007$3$F$$20240902$20240604$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089341$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240902$$CN$US$US
239350087$23935008$7$F$20211005$20240816$20240604$20240823$EXP$$CA-CELLTRION INC.-2021CA017343$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
239350213$23935021$3$F$$20240822$20240604$20240827$EXP$$CA-ROCHE-3571908$ROCHE$$65$YR$E$F$Y$$$20240827$$HP$CA$CA
239350272$23935027$2$F$20200115$20240916$20240604$20240924$EXP$$BE-ABBVIE-20K-013-3509077-00$ABBVIE$$68$YR$$M$Y$$$20240924$$HP$BE$BE
239350482$23935048$2$F$20240101$20240621$20240604$20240702$EXP$$JP-NOVOPROD-1228117$NOVO NORDISK$$74$YR$$F$Y$56.6$KG$20240702$$PH$JP$JP
239350603$23935060$3$F$20240507$20240731$20240604$20240809$EXP$$IT-BAXTER-2024BAX019176$BAXTER$$70$YR$$M$Y$57$KG$20240809$$MD$IT$IT
239350792$23935079$2$F$20240101$20240902$20240604$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088678$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240902$$CN$US$US
239350805$23935080$5$F$$20240906$20240604$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089400$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$73.94$KG$20240910$$CN$US$US
239351392$23935139$2$F$20240424$20240711$20240604$20240722$EXP$$US-NOVOPROD-1229808$NOVO NORDISK$$74$YR$$F$Y$$$20240722$$CN$US$US
239351402$23935140$2$F$20231001$20240701$20240604$20240712$EXP$$US-NOVOPROD-1229750$NOVO NORDISK$$69$YR$$F$Y$89$KG$20240712$$MD$US$US
239351502$23935150$2$F$20240501$20240706$20240604$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04449$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239351582$23935158$2$F$20230301$20240702$20240604$20240711$EXP$$HU-BRISTOL-MYERS SQUIBB COMPANY-2024-043216$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240711$$MD$HU$HU
239351645$23935164$5$F$$20240805$20240604$20240812$EXP$GB-NOVOPROD-1229844$GB-NOVOPROD-1229844$NOVO NORDISK$$$$$M$Y$$$20240812$$HP$GB$GB
239351653$23935165$3$F$20240513$20240805$20240604$20240814$EXP$$US-NOVOPROD-1229604$NOVO NORDISK$$73$YR$$M$Y$$$20240814$$CN$US$US
239351784$23935178$4$F$20240530$20240716$20240604$20240717$PER$$US-AMGEN-USASP2024108123$AMGEN$$14$YR$T$M$Y$$$20240717$$CN$US$US
239351803$23935180$3$F$20240529$20240701$20240604$20240709$PER$$US-SA-2024SA164384$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240709$$MD$US$US
239351812$23935181$2$F$20240101$20240619$20240604$20240701$PER$$US-SA-2024SA160893$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$MD$US$US
239351962$23935196$2$F$20240321$20240830$20240604$20240909$EXP$$PL-AUROBINDO-AUR-APL-2024-026325$AUROBINDO$$60$YR$$M$Y$93$KG$20240909$$MD$PL$PL
239352073$23935207$3$F$20240311$20240719$20240604$20240730$EXP$$DE-AUROBINDO-AUR-APL-2024-025449$AUROBINDO$$$$$F$Y$$$20240730$$HP$DE$DE
239352126$23935212$6$F$20240425$20240912$20240604$20240920$EXP$$CA-CELLTRION INC.-2024CA012968$CELLTRION$$$$$$Y$$$20240920$$CN$CA$CA
239352142$23935214$2$F$$20240902$20240604$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089337$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$PH$US$US
239352252$23935225$2$F$$20240530$20240604$20240722$PER$$US-HALEON-2179190$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
239352392$23935239$2$F$$20240808$20240604$20240816$EXP$$US-ROCHE-3573390$ROCHE$$70$YR$E$M$Y$122.47$KG$20240816$$CN$US$US
239352464$23935246$4$F$$20240909$20240604$20240911$PER$$US-BIOGEN-2024BI01267400$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
239352503$23935250$3$F$20240522$20240628$20240604$20240706$EXP$$BR-CELLTRION INC.-2024BR012766$CELLTRION$$$$$$Y$$$20240706$$CN$BR$BR
239352543$23935254$3$F$20240520$20240724$20240604$20240801$EXP$$JP-CELLTRION INC.-2024JP013096$CELLTRION$$$$$$Y$$$20240801$$HP$JP$JP
239352762$23935276$2$F$$20240718$20240604$20240806$PER$$US-ALXN-202405USA001971US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239352822$23935282$2$F$20240508$20240817$20240604$20240822$EXP$$ES-JNJFOC-20240580684$JOHNSON AND JOHNSON$$31$YR$A$F$Y$50$KG$20240822$$HP$ES$ES
239352892$23935289$2$F$20240101$20240723$20240604$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-027269$AUROBINDO$$70$YR$$F$Y$45$KG$20240726$$MD$FR$FR
239352903$23935290$3$F$$20240821$20240604$20240822$PER$$NVSC2024US116688$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
239352942$23935294$2$F$20240101$20240803$20240604$20240810$EXP$$CA-CELLTRION INC.-2023CA024543$CELLTRION$$$$$$Y$$$20240810$$MD$CA$CA
239352952$23935295$2$F$$20240617$20240604$20240715$PER$$US-AstraZeneca-2024A124095$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
239353002$23935300$2$F$20240420$20240730$20240604$20240827$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000330$BECTON DICKINSON$$$$$$Y$$$20240827$$CN$GB$GB
239353012$23935301$2$F$$20240823$20240604$20240916$30DAY$$US-BECTON DICKINSON-US-BD-24-000331$BECTON DICKINSON$$$$$$Y$$$20240916$$HP$US$US
239353062$23935306$2$F$$20240621$20240604$20240704$EXP$$US-GRAVITIPHARMA-GRA-2405-US-LIT-0158$GRAVITI PHARMACEUTICALS$Rana SJ, Patel D.ANAPHYLACTIC TRANSFUSION REACTION TO WASHED PACKED RED BLOOD CELLS.Crit-Care-Med.2024;52:S195$87$YR$E$F$Y$$$20240704$$HP$US$US
239353162$23935316$2$F$$20240726$20240604$20240730$EXP$$US-SANDOZ INC.-SDZ2024US054545$SANDOZ$$$$$M$Y$$$20240730$$HP$US$US
239353263$23935326$3$F$20240402$20240627$20240604$20240704$EXP$$JP-GENMAB-2024-01131AA$GENMAB$$73$YR$$F$Y$$$20240704$$PH$JP$JP
239353335$23935333$5$F$20240530$20240923$20240604$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089233$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240926$$CN$US$US
239353432$23935343$2$F$20230101$20240710$20240604$20240715$EXP$$CN-UCBSA-2023036280$UCB$$33$YR$$F$Y$43$KG$20240715$$CN$CN$CN
239353442$23935344$2$F$20240322$20240816$20240604$20240821$EXP$FR-AFSSAPS-BX2024001036$FR-CHEPLA-2024006772$CHEPLAPHARM$$70$YR$$F$Y$55$KG$20240821$$PH$COUNTRY NOT SPECIFIED$FR
239353672$23935367$2$F$$20240718$20240604$20240806$PER$$US-ALXN-202405USA001970US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239353733$23935373$3$F$20240501$20240905$20240604$20240911$PER$$US-AMGEN-USASP2024108424$AMGEN$$64$YR$A$M$Y$$$20240910$$CN$US$US
239353823$23935382$3$F$$20240711$20240604$20240712$EXP$$CN-ROCHE-3573423$ROCHE$$$$$F$Y$$$20240713$$CN$CN$CN
239353872$23935387$2$F$20230323$20240808$20240604$20240814$EXP$$AR-GSK-AR2023AMR116890$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$AR$AR
239354012$23935401$2$F$$20240624$20240604$20240701$EXP$$CN-ROCHE-3575238$ROCHE$Liu X, Wang Z, Wu W and Zheng S. Sepsis and Pneumonia Caused by Enterococcus faecium following Liver Transplantation Treated with Contezolid as the First-line Therapy, DOI: 10.1016/j.jgar.2024.05.005. Journal of global antimicrobial resistance 2024 May 20;:1-19.$66$YR$E$M$Y$$$20240701$$HP$CN$CN
239354216$23935421$6$F$$20240823$20240604$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085181$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240827$$CN$US$US
239354325$23935432$5$F$$20240921$20240604$20240926$EXP$$US-AMGEN-USASP2024109299$AMGEN$$63$YR$A$F$Y$68.04$KG$20240926$$CN$US$US
239354393$23935439$3$F$20240101$20240703$20240604$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010015$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240706$$PH$US$US
239354492$23935449$2$F$$20240617$20240604$20240904$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-02081$HIKMA$$$$$F$Y$$$20240904$$CN$US$US
239354512$23935451$2$F$$20240516$20240604$20240904$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03272$HIKMA$$$$$F$Y$$$20240904$$CN$US$US
239354652$23935465$2$F$$20240719$20240604$20240730$EXP$$PT-AUROBINDO-AUR-APL-2024-025651$AUROBINDO$Sa A, Almeida J, Coimbra L, Rodrigues F.. LAST BUT NOT LEAST: DIFFERENTIAL DIAGNOSIS OF SEIZURES AFTER SPINE SURGERY. Region-Anesth-Pain-Med. 2022;47(Supl.1) A207:B261$71$YR$$F$Y$65$KG$20240730$$HP$PT$PT
239354842$23935484$2$F$20240101$20240628$20240604$20240704$EXP$$CA-ABBVIE-5655444$ABBVIE$$64$YR$$M$Y$$$20240704$$CN$CA$CA
239354865$23935486$5$F$20240501$20240819$20240604$20240826$EXP$$CA-CELLTRION INC.-2024CA012714$CELLTRION$$$$$$Y$$$20240826$$CN$CA$CA
239354893$23935489$3$F$20240801$20240903$20240604$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086713$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240904$$CN$US$US
239355306$23935530$6$F$$20240910$20240604$20240920$EXP$$CA-HALEON-2171216$Haleon PLC$$40$YR$$F$Y$96$KG$20240920$$CN$CA$CA
239355403$23935540$3$F$$20240718$20240604$20240722$EXP$$SK-ROCHE-3573757$ROCHE$Kazimirova A. Treatment of acquired haemophilia A with aPPC concentrate in a polymorbid patient. Acta medicinae 2024;13 (4):11-2.$91$YR$E$F$Y$$$20240723$$MD$SK$SK
239355424$23935542$4$F$$20240908$20240604$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US053361$SANDOZ$$$$$F$Y$$$20240912$$CN$US$US
239355502$23935550$2$F$20240530$20240711$20240604$20240712$PER$$US-JNJFOC-20240586975$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$HP$US$US
239355574$23935557$4$F$20240521$20240918$20240604$20240926$EXP$$CA-JNJFOC-20240571749$JOHNSON AND JOHNSON$$3$YR$C$F$Y$$$20240926$$HP$CA$CA
239355643$23935564$3$F$$20240903$20240604$20240903$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-089771$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240904$$MD$DE$DE
239355663$23935566$3$F$20180828$20240626$20240604$20240708$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-ITA-20180809669$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240708$$HP$IT$IT
239355682$23935568$2$F$$20240708$20240604$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04451$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239355742$23935574$2$F$20240501$20240627$20240604$20240701$PER$$US-BAUSCHBL-2024BNL027828$BAUSCH AND LOMB$$65$YR$$F$Y$63$KG$20240701$$CN$US$US
239355762$23935576$2$F$$20240805$20240604$20240813$PER$$US-BAUSCHBL-2024BNL027834$BAUSCH AND LOMB$$$$$F$Y$$$20240814$$CN$US$US
239355833$23935583$3$F$20181127$20240701$20240604$20240704$EXP$$HU-ABBVIE-5782613$ABBVIE$$74$YR$$F$Y$$$20240704$$CN$HU$HU
239355912$23935591$2$F$$20240708$20240604$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04455$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239356073$23935607$3$F$20240509$20240807$20240604$20240828$PER$$CA-TOLMAR, INC.-24CA049183$TOLMAR$$62$YR$$M$Y$$$20240828$$CN$CA$CA
239356102$23935610$2$F$20240201$20240814$20240604$20240821$EXP$$US-GSK-US2024066444$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$US$US
239356186$23935618$6$F$20180627$20240918$20240604$20240928$EXP$$CA-TAKEDA-2018TUS022456$TAKEDA$$59$YR$$F$Y$$$20240928$$CN$CA$CA
239356462$23935646$2$F$$20240730$20240604$20240812$EXP$$ES-AUROBINDO-AUR-APL-2024-027791$AUROBINDO$Trigo LL, Del Rocio Fernandez Ojeda M, Azcona MD, Delgado CM, Ruiz FR, De La Luz Calero Bernal M, et al. INTERNAL MEDICINE AND DRUGS, A RELATIONSHIP TO BE TAKEN INTO ACCOUNT?. European Journal of Case Reports in Internal Medicine. 2023;10(Supplement 1:539$63$YR$$M$Y$$$20240812$$MD$ES$ES
239356502$23935650$2$F$$20240701$20240604$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-027809$AUROBINDO$Sircy A, Ibeh B, Boutros N, Bolyard J.. Otitis media to meningitis: a rare group A streptococcus meningitis case.. Critical Care Medicine.. 2024;52(1):S705$43$YR$$M$Y$$$20240709$$MD$US$US
239356765$23935676$5$F$20211205$20240802$20240604$20240807$EXP$$CA-ROCHE-2974537$ROCHE$$49$YR$A$F$Y$$$20240807$$HP$CA$CA
239356783$23935678$3$F$$20240909$20240604$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089588$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240912$$CN$US$US
239356882$23935688$2$F$20220101$20240627$20240604$20240702$EXP$$US-ABBVIE-5767823$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
239356954$23935695$4$F$20240301$20240807$20240604$20240814$EXP$$US-TAKEDA-2024TUS039510$TAKEDA$$77$YR$$F$Y$$$20240814$$CN$US$US
239357073$23935707$3$F$20240101$20240729$20240604$20240801$EXP$$CA-ABBVIE-5784143$ABBVIE$$29$YR$$M$Y$$$20240801$$CN$CA$CA
239357082$23935708$2$F$$20240703$20240604$20240709$EXP$$BE-JNJFOC-20240578396$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$BE$BE
239357172$23935717$2$F$$20240902$20240604$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088801$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$HP$US$US
239357205$23935720$5$F$20230802$20240813$20240604$20240822$EXP$$CH-MIRUM PHARMACEUTICALS, INC.-CH-MIR-24-00133$MIRUM PHARMACEUTICALS$$$$$$Y$$$20240822$$MD$CH$CH
239357214$23935721$4$F$20240527$20240726$20240604$20240811$PER$$US-AstraZeneca-2024A124357$ASTRAZENECA$$18920$DY$$M$Y$$$20240811$$HP$US$
239357283$23935728$3$F$20240507$20240617$20240604$20240710$30DAY$$US-JNJFOC-20240578113$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240711$$CN$US$US
239357333$23935733$3$F$$20240625$20240604$20240703$EXP$$JP-AMGEN-JPNSP2024107910$AMGEN$$$$$$Y$$$20240703$$MD$JP$JP
239357452$23935745$2$F$$20240627$20240604$20240711$EXP$$US-APOTEX-2024AP006363$APOTEX$Sacco A, Danley S, Sen A.. Effect of hyperbilirubinemia and plasma exchange on anticoagulation with unfractionated heparin. Critical Care Medicine. 2024;52(1)(Suppl.1):S201$67$YR$$F$Y$$$20240711$$PH$US$US
239357463$23935746$3$F$20240408$20240717$20240604$20240725$EXP$DE-SANDOZ-SDZ2024DE048074$DE-RDY-SPO/DEU/24/0007671$DR REDDYS$$$$$F$Y$$$20240725$$CN$DE$DE
239357643$23935764$3$F$20240101$20240626$20240604$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009250$UNITED THERAPEUTICS$$$$$F$Y$67.12$KG$20240705$$$US$US
239357782$23935778$2$F$20240529$20240701$20240604$20240703$PER$$US-AMGEN-USASP2024107859$AMGEN$$71$YR$E$F$Y$$$20240703$$CN$US$US
239357793$23935779$3$F$20240101$20240916$20240604$20240925$EXP$$CA-CELLTRION INC.-2024CA010156$CELLTRION$$$$$$Y$$$20240925$$MD$CA$CA
239357932$23935793$2$F$20240514$20240821$20240604$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-026069$AUROBINDO$$63$YR$$M$Y$75$KG$20240831$$MD$FR$FR
239357943$23935794$3$F$$20240823$20240604$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04470$LUPIN$$$$$$Y$$$20240906$$CN$US$US
239357992$23935799$2$F$$20240711$20240604$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04432$LUPIN$$$$$$Y$$$20240809$$CN$US$US
239358112$23935811$2$F$20240101$20240909$20240604$20240910$EXP$$NVSC2024US113400$NOVARTIS$$43$YR$$F$Y$$$20240910$$CN$US$US
239358162$23935816$2$F$20220101$20240625$20240604$20240708$EXP$$JP-ROCHE-3574240$ROCHE$$56$YR$A$F$Y$44.4$KG$20240708$$PH$JP$JP
239358172$23935817$2$F$20240101$20240628$20240604$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089703$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240703$$HP$US$US
239358182$23935818$2$F$$20240709$20240604$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089474$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$49.9$KG$20240711$$CN$US$US
239358224$23935822$4$F$20240307$20240709$20240604$20240711$EXP$$US-UCBSA-2024012632$UCB$$71$YR$$F$Y$$$20240711$$CN$US$US
239358233$23935823$3$F$$20240709$20240604$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04487$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239358282$23935828$2$F$20230101$20240724$20240604$20240801$EXP$$US-AstraZeneca-2024A124299$ASTRAZENECA$$65$YR$$F$Y$$$20240801$$CN$US$
239358413$23935841$3$F$$20240709$20240604$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04480$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239358464$23935846$4$F$$20240709$20240604$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04484$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239358484$23935848$4$F$$20240723$20240604$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089418$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240725$$CN$US$US
239358512$23935851$2$F$$20240902$20240604$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089205$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$CN$US$US
239358534$23935853$4$F$20221208$20240712$20240604$20240719$EXP$$CA-GSK-CA2022184972$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$HP$CA$CA
239358582$23935858$2$F$20240101$20240906$20240604$20240913$EXP$$JP-009507513-2405JPN003238J$MERCK$$8$DEC$$F$Y$$$20240913$$MD$JP$JP
239358605$23935860$5$F$20240807$20240903$20240604$20240909$EXP$$CA-TAKEDA-2023TUS081477$TAKEDA$$78$YR$$F$Y$$$20240909$$CN$CA$CA
239358612$23935861$2$F$20240219$20240629$20240604$20240710$EXP$FR-AFSSAPS-AM2024000404$FR-Accord-427310$ACCORD$$57$YR$A$M$Y$69$KG$20240710$$PH$FR$FR
239358853$23935885$3$F$$20240710$20240604$20240717$EXP$$IN-VANTIVE-2024VAN017409$Vantive US Healthcare$$41$YR$$F$Y$$$20240717$$CN$IN$IN
239358873$23935887$3$F$20240602$20240709$20240604$20240710$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031727$BOEHRINGER INGELHEIM$$97$YR$E$F$Y$$$20240710$$MD$JP$JP
239358882$23935888$2$F$20240527$20240605$20240604$20240704$PER$$US-AMGEN-USASP2024109171$AMGEN$$68$YR$E$F$Y$$$20240704$$CN$US$US
239358982$23935898$2$F$20240529$20240626$20240604$20240701$EXP$$ZA-SA-2024SA164678$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240701$$MD$ZA$ZA
239359042$23935904$2$F$20240501$20240704$20240604$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089393$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240705$$CN$US$US
239359104$23935910$4$F$$20240628$20240604$20240703$PER$$US-AMGEN-USASP2024109352$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
239359112$23935911$2$F$$20240717$20240604$20240720$PER$$NVSC2024US116267$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
239359232$23935923$2$F$$20240727$20240604$20240801$EXP$$CA-JNJFOC-20240580864$JOHNSON AND JOHNSON$$16$YR$T$F$Y$51$KG$20240801$$HP$CA$CA
239359272$23935927$2$F$$20240717$20240604$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089571$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240719$$HP$US$US
239359302$23935930$2$F$20240325$20240717$20240604$20240725$EXP$$FR-AstraZeneca-2024A123047$ASTRAZENECA$$70$YR$$F$Y$$$20240725$$MD$FR$
239359386$23935938$6$F$20240405$20240830$20240604$20240902$EXP$$NVSC2024US092004$NOVARTIS$$72$YR$$F$Y$$$20240902$$CN$US$US
239359425$23935942$5$F$20240405$20240919$20240604$20240923$EXP$$KR-ROCHE-3545263$ROCHE$$70$YR$E$F$Y$61$KG$20240923$$HP$KR$KR
239359652$23935965$2$F$20240501$20240531$20240604$20240703$EXP$ES-AEMPS-1523100$ES-JNJFOC-20240602738$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240703$$MD$ES$ES
239360112$23936011$2$F$$20240819$20240604$20240823$EXP$$US-ROCHE-3572836$ROCHE$Jakubecz C, Maynard M, Sangha K, Serra A, Woodson S, Abboud H, et al. Predictors of serious infection among patients receiving ocrelizumab or ofatumumab for the treatment of multiple sclerosis: a sub analysis of replace MS [Abstract number: DMT17].. International Journal of MS Case. 2024-Jun;26 (Sup 1):31.$$$$$Y$$$20240823$$PH$US$US
239360164$23936016$4$F$20240518$20240828$20240604$20240904$EXP$$CA-JNJFOC-20240580501$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240904$$CN$CA$CA
239360193$23936019$3$F$20240523$20240709$20240604$20240711$PER$$US-AMGEN-USASP2024106529$AMGEN$$36$YR$A$F$Y$68.998$KG$20240711$$PH$US$US
239360362$23936036$2$F$$20240626$20240604$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024059145$VIIV$$$$$M$Y$128$KG$20240705$$HP$US$US
239360382$23936038$2$F$20240501$20240724$20240604$20240730$EXP$$CA-JNJFOC-20240581174$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240730$$HP$CA$CA
239360442$23936044$2$F$20240101$20240722$20240604$20240731$EXP$$FI-AUROBINDO-AUR-APL-2024-026283$AUROBINDO$$16$YR$$F$Y$$$20240731$$MD$FI$FI
239360456$23936045$6$F$20240519$20240715$20240604$20240720$EXP$$NVSC2024DE116229$NOVARTIS$$51$YR$$F$Y$78$KG$20240719$$CN$DE$DE
239360534$23936053$4$F$20230626$20240819$20240604$20240823$EXP$$JP-EXELIXIS-CABO-24077920$EXELIXIS$$86$YR$$M$Y$68$KG$20240823$$MD$JP$JP
239360573$23936057$3$F$$20240801$20240604$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-063553$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240806$$CN$US$US
239360605$23936060$5$F$20240101$20240704$20240604$20240715$30DAY$$TR-JNJFOC-20240521737$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$PH$TR$TR
239360682$23936068$2$F$$20240807$20240604$20240807$PER$$US-ALXN-202405USA001996US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
239360813$23936081$3$F$20240426$20240906$20240604$20240913$EXP$$CO-TAKEDA-2023TUS063847$TAKEDA$$47$YR$$M$Y$83$KG$20240913$$CN$CO$CO
239360922$23936092$2$F$$20240807$20240604$20240810$EXP$$US-TAKEDA-2024TUS054574$TAKEDA$$$$$M$Y$$$20240810$$CN$US$US
239361012$23936101$2$F$$20240701$20240604$20240716$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449333$RANBAXY$Tungaraza TE. Use of Pseudoephedrine in the Management of Severe Clozapine Induced Urinary Urgency and Frequency. BJPsych Open. 2022;8 (Suppl.):S125$33$YR$$F$Y$$$20240716$$HP$GB$GB
239361252$23936125$2$F$$20240808$20240604$20240810$EXP$$CA-TAKEDA-2024TUS055854$TAKEDA$$$$$F$Y$$$20240810$$MD$CA$CA
239361263$23936126$3$F$20240601$20240711$20240604$20240716$EXP$$CA-TAKEDA-2024TUS054363$TAKEDA$$20$YR$$M$Y$$$20240716$$MD$CA$CA
239361273$23936127$3$F$$20240911$20240604$20240918$EXP$$CA-TAKEDA-2024TUS053305$TAKEDA$$$$$F$Y$$$20240918$$CN$CA$CA
239361402$23936140$2$F$$20240906$20240604$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449660$RANBAXY$Crooker KG, Stedman ER, Hitt JR, Tompkins BJ, Repp AB. Causes and outcomes of non-chemotherapy induced neutropenic fever in hospitalized adults: An observational study. Medicine. 2024;103 (18):e38060$$$A$$Y$$$20240920$$MD$US$US
239361512$23936151$2$F$$20240627$20240604$20240712$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449448$RANBAXY$Mora Herrera C, Palomeque Alonso A. Maxillofacial mucormycosis: about a case. O F I L. 2024;34(1):92-94$40$YR$$M$Y$$$20240712$$HP$ES$ES
239361543$23936154$3$F$20240516$20240717$20240604$20240801$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-449178$RANBAXY$$$$E$F$Y$$$20240801$$CN$IT$IT
239361562$23936156$2$F$20240209$20240722$20240604$20240806$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-449836$RANBAXY$$51$YR$$F$Y$$$20240806$$PH$IT$IT
239361962$23936196$2$F$$20240717$20240604$20240805$PER$$US-AstraZeneca-2024A118262$ASTRAZENECA$$$$$F$Y$$$20240803$$CN$US$
239362002$23936200$2$F$20240407$20240816$20240604$20240823$EXP$$DE-TAKEDA-2024TUS053080$TAKEDA$$35$YR$$F$Y$$$20240823$$HP$DE$DE
239362063$23936206$3$F$$20240708$20240604$20240722$EXP$$JP-ROCHE-3575129$ROCHE$Ando T, Yamaguchi N, Todaka M, Fujinami H, Shin T. O-0263 A case of pancreatitis acute which occurred in the perioperative period of living donor renal transplant. Journal of Japanese Society for Dialysis Therapy / The 69th Annual Meeting of th. 2024;57 (S1):482-.$35$YR$A$F$Y$$$20240719$$MD$JP$JP
239362243$23936224$3$F$$20240704$20240604$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086220$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240709$$HP$US$US
239362322$23936232$2$F$$20240701$20240604$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-027763$AUROBINDO$Schwarz J, Robinson J, Rusk A, Heilman R, Cartin-Ceba R.. FOSPHENYTOIN TO POTENTIALLY INDUCE CLEARANCE OF TACROLIMUS LEVEL SECONDARY TO NIRMATRELVIR/RITONAVIR.. Critical Care Medicine. 2024;52(1):S442$73$YR$$M$Y$$$20240709$$MD$US$US
239362362$23936236$2$F$$20240705$20240604$20240709$PER$$US-HALEON-2179765$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
239362702$23936270$2$F$$20240911$20240604$20240917$EXP$$CA-ROCHE-3575814$ROCHE$$$$A$F$Y$$$20240917$$MD$CA$CA
239362942$23936294$2$F$20240507$20240624$20240604$20240703$EXP$IT-MINISAL02-985419$IT-Accord-427311$ACCORD$$58$YR$A$F$Y$$$20240703$$MD$IT$IT
239362953$23936295$3$F$$20240703$20240604$20240807$EXP$$CA-CELLTRION INC.-2024CA013130$CELLTRION$$$$$$Y$$$20240807$$CN$CA$CA
239363212$23936321$2$F$20240401$20240716$20240604$20240720$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-064837$REGENERON$$$$$M$Y$$$20240719$$MD$US$US
239363393$23936339$3$F$20240515$20240624$20240604$20240725$EXP$$NVSC2024CZ116517$NOVARTIS$$$$A$M$Y$$$20240725$$MD$CZ$CZ
239363543$23936354$3$F$20240513$20240706$20240604$20240720$PER$$US-CorePharma LLC-2157740$COREPHARMA$$69$YR$$F$Y$109.09$KG$20240720$$$US$US
239363583$23936358$3$F$20221220$20240716$20240604$20240729$EXP$$PT-ASTELLAS-2024US015874$ASTELLAS$$67$YR$$M$Y$$$20240729$$CN$PT$PT
239363622$23936362$2$F$$20240727$20240604$20240801$EXP$$FR-MYLANLABS-2024M1048420$MYLAN$$69$YR$$M$Y$$$20240801$$CN$FR$FR
239363633$23936363$3$F$20240315$20240814$20240604$20240819$EXP$$IE-MYLANLABS-2024M1025720$MYLAN$$54$YR$$M$Y$$$20240819$$CN$IE$IE
239363663$23936366$3$F$20240501$20240715$20240604$20240718$PER$$US-AMGEN-USASP2024109346$AMGEN$$77$YR$E$F$Y$$$20240718$$PH$US$US
239363723$23936372$3$F$$20240701$20240604$20240708$EXP$$US-AUROBINDO-AUR-APL-2024-027786$AUROBINDO$Slamowitz A, Nickerson T. PROLONGED ECMO REQUIREMENT FOR AN ADOLESCENT WITH AMLODIPINE OVERDOSE. Critical Care Medicine. 2024;52(1):S719$17$YR$$F$Y$$$20240708$$MD$US$US
239363832$23936383$2$F$20240507$20240620$20240604$20240712$PER$$US-TOLMAR, INC.-24US049063$TOLMAR$$78$YR$$M$Y$$$20240712$$PH$US$US
239363852$23936385$2$F$20240429$20240613$20240604$20240703$PER$$US-TOLMAR, INC.-24US049088$TOLMAR$$66$YR$$M$Y$$$20240703$$HP$US$US
239363862$23936386$2$F$20240502$20240613$20240604$20240704$PER$$US-TOLMAR, INC.-24US049113$TOLMAR$$$$$M$Y$$$20240703$$HP$US$US
239363872$23936387$2$F$$20240905$20240604$20240911$EXP$$US-TAKEDA-2023TUS055345$TAKEDA$$$$$M$Y$$$20240911$$CN$US$US
239364002$23936400$2$F$20230101$20240701$20240604$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-027802$AUROBINDO$Razia D, Moin A, Arjuna A, Evans S. VASCULOPATHY AND DEMYELINATING COMPLICATIONS OF VARICELLA IN AN IMMUNOCOMPROMISED PATIENT. Critical Care Medicine. 2024;52(1):S228 abstr. 508$42$YR$$F$Y$$$20240710$$MD$US$US
239364042$23936404$2$F$20240527$20240722$20240604$20240729$PER$$US-AstraZeneca-2024A124367$ASTRAZENECA$$25495$DY$$F$Y$$$20240729$$CN$US$
239364052$23936405$2$F$20210601$20240710$20240604$20240715$EXP$$CZ-BAYER-2024A077632$BAYER$$48$YR$A$F$Y$$$20240715$$MD$CZ$CZ
239364286$23936428$6$F$20240101$20240918$20240604$20240924$EXP$$BR-009507513-2405BRA009837$MERCK$$33$YR$$F$Y$49$KG$20240924$$HP$BR$BR
239364422$23936442$2$F$20240101$20240621$20240604$20240718$PER$$US-JNJFOC-20240559116$JOHNSON AND JOHNSON$$93$YR$E$F$Y$$$20240718$$CN$US$US
239364563$23936456$3$F$$20240701$20240604$20240704$PER$$US-AMGEN-USASP2024109791$AMGEN$$$$$$Y$$$20240703$$CN$US$US
239364872$23936487$2$F$20240501$20240802$20240604$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089636$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240807$$CN$US$US
239365122$23936512$2$F$20240401$20240704$20240604$20240711$EXP$$JP-009507513-2405JPN003380J$MERCK$$8$DEC$$M$Y$$$20240711$$MD$JP$JP
239365362$23936536$2$F$20240101$20240524$20240604$20240723$PER$$US-SA-2024SA163224$SANOFI AVENTIS$$25$YR$A$M$Y$104.3$KG$20240723$$MD$US$US
239365522$23936552$2$F$$20240624$20240604$20240703$PER$$US-SA-2024SA161548$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240703$$MD$US$US
239365583$23936558$3$F$20240101$20240801$20240604$20240812$PER$$US-SA-2024SA163817$SANOFI AVENTIS$$75$YR$E$F$Y$68$KG$20240813$$MD$US$US
239365652$23936565$2$F$$20240812$20240604$20240821$PER$$US-SA-2024SA163201$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240821$$HP$US$US
239365783$23936578$3$F$20240514$20240627$20240604$20240704$PER$$US-SA-2024SA165772$SANOFI AVENTIS$$59$YR$A$F$Y$131.08$KG$20240704$$MD$US$US
239365883$23936588$3$F$20240101$20240903$20240604$20240915$PER$$US-SA-2024SA157715$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240915$$MD$US$US
239365923$23936592$3$F$20240801$20240826$20240604$20240902$PER$$US-SA-2024SA163557$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240902$$MD$US$US
239365932$23936593$2$F$20240101$20240701$20240604$20240710$PER$$US-SA-2024SA162740$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240710$$MD$US$US
239366002$23936600$2$F$20240101$20240718$20240604$20240728$PER$$US-SA-2024SA163586$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240728$$CN$US$US
239366012$23936601$2$F$20240101$20240808$20240604$20240816$PER$$US-SA-2024SA162665$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240816$$MD$US$US
239366152$23936615$2$F$$20240822$20240604$20240905$PER$$US-SA-2024SA164800$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240905$$MD$US$US
239366172$23936617$2$F$$20240528$20240604$20240710$PER$$US-SA-2024SA162116$SANOFI AVENTIS$$$$E$M$Y$$$20240710$$CN$US$US
239366372$23936637$2$F$20240101$20240909$20240604$20240917$PER$$US-SA-2024SA166079$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240918$$MD$US$US
239366722$23936672$2$F$$20240820$20240604$20240826$EXP$$US-TAKEDA-2024TUS053736$TAKEDA$$$$$F$Y$$$20240826$$CN$US$US
239366774$23936677$4$F$20230101$20240827$20240604$20240905$EXP$$US-INSMED, INC.-2023-04807-US$INSMED$$$$$F$Y$$$20240905$$CN$US$US
239366902$23936690$2$F$20240422$20240809$20240604$20240820$EXP$IT-MINISAL02-987416$IT-ROCHE-3573263$ROCHE$$81$YR$E$M$Y$$$20240820$$MD$IT$IT
239367023$23936702$3$F$20211005$20240702$20240604$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-026124$AUROBINDO$$52$YR$$M$Y$73.028$KG$20240711$$CN$US$US
239367214$23936721$4$F$$20240626$20240604$20240702$EXP$$US-GILEAD-2024-0674869$GILEAD$$$$A$F$Y$$$20240702$$CN$US$US
239367263$23936726$3$F$20240517$20240812$20240604$20240816$EXP$$US-SA-2023SA246212$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240816$$MD$US$US
239367272$23936727$2$F$$20240919$20240604$20240926$EXP$$US-BAYER-2024A080106$BAYER$$83$YR$E$F$Y$66.667$KG$20240926$$CN$US$US
239367582$23936758$2$F$20240528$20240625$20240604$20240704$PER$$US-SA-2024SA167351$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240704$$HP$US$US
239367593$23936759$3$F$$20240624$20240604$20240703$PER$$US-SA-2024SA162569$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240703$$HP$US$US
239367672$23936767$2$F$$20240820$20240604$20240831$EXP$$SK-Accord-427393$ACCORD$Penesova A, Minarik P, Huckova M, Vlcek M, Szantova M, Krizanova O. 5-Fluorouracil Induced Hypertriglyceridemia During the Colorectal Cancer Treatment in a Patient With Multifactorial Chylomicronemia Syndrome: A Case Report. Clin Ther. 2024 May 18:S0149-2918(24)00108-5. doi: 10.1016/j.clinthera.2024.05.001. Epub ahead of print. PMID: 38763818.$47$YR$A$F$Y$80$KG$20240831$$MD$SK$SK
239367735$23936773$5$F$20230101$20240711$20240604$20240823$EXP$$CA-BAUSCH-BL-2024-008445$BAUSCH AND LOMB$$46$YR$$F$Y$56$KG$20240823$$CN$CA$CA
239367863$23936786$3$F$$20240729$20240604$20240814$PER$$US-AstraZeneca-2024A128556$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
239367893$23936789$3$F$20240531$20240802$20240604$20240807$PER$$US-AMGEN-USASP2024109217$AMGEN$$55$YR$A$M$Y$$$20240807$$CN$US$US
239367983$23936798$3$F$20240101$20240626$20240604$20240705$PER$$US-SA-2024SA165678$SANOFI AVENTIS$$75$YR$E$F$Y$61.6$KG$20240705$$HP$US$US
239368032$23936803$2$F$20240102$20240711$20240604$20240717$EXP$$GB-MYLANLABS-2024M1001050$MYLAN$$69$YR$$M$Y$$$20240717$$MD$GB$GB
239368092$23936809$2$F$$20240812$20240604$20240812$EXP$$NVSC2024FR116522$NOVARTIS$$57$YR$$M$Y$$$20240812$$MD$FR$FR
239368152$23936815$2$F$$20240701$20240604$20240709$EXP$$PT-AUROBINDO-AUR-APL-2024-027807$AUROBINDO$Reis C, Dias F, Grijo C, Ribeiro A, Almeida J. PSEUDOMEMBRANOUS COLITIS FOLLOWING HELICOBACTER PILORY ERADICATION WITH THE BISMUTH-BASED QUADRUPLE THERAPY. European Journal of Case Reports in Internal Medicine. 2023;10(Suppl 1):237$84$YR$$F$Y$$$20240709$$MD$PT$PT
239368322$23936832$2$F$20240419$20240903$20240604$20240904$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-086598$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240904$$HP$RU$RU
239368344$23936834$4$F$20240501$20240927$20240604$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089742$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$96.16$KG$20240930$$PH$US$US
239368545$23936854$5$F$20240101$20240815$20240604$20240820$EXP$$CA-PFIZER INC-202400079848$PFIZER$$69$YR$$M$Y$$$20240820$$HP$CA$CA
239368782$23936878$2$F$20240521$20240625$20240604$20240708$PER$$US-ALKERMES INC.-ALK-2024-001428$ALKERMES$$38$YR$$M$Y$63.492$KG$20240708$$HP$US$US
239368792$23936879$2$F$$20240729$20240604$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-027787$AUROBINDO$Robertson IJ, Robbins QC, Li PC. Case of metastatic clear cell odontogenic carcinoma with response to chemoimmunotherapy. BMJ Case Reports. 2024;17 (4):e259568$8$DEC$$F$Y$$$20240808$$MD$US$US
239368862$23936886$2$F$$20240706$20240604$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-026816$AUROBINDO$Hanson E, Kakkera K. UNPREDICTABLE PHARMACOKINETICS AND TARGETING TREATMENT OF CALCIUM CHANNEL BLOCKER OVERDOSE. Critical Care Medicine. 2024;52(1)(Supplemen:S85$74$YR$$F$Y$$$20240717$$MD$US$US
239368935$23936893$5$F$20240501$20240903$20240604$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089739$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240904$$PH$US$US
2393689611$23936896$11$F$20200313$20240812$20240604$20240816$EXP$$AR-MYLANLABS-2024M1015450$MYLAN$$11$YR$$M$Y$$$20240816$$CN$AR$AR
239369452$23936945$2$F$$20240706$20240604$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-026673$AUROBINDO$Dulli M, Tasneem Z. RAPID-ONSET AMIODARONE-INDUCED EOSINOPHILIC PNEUMONIA: A RARE ASSOCIATION. Critical Care Medicine. 2024;52(1):S538$63$YR$$M$Y$$$20240717$$MD$US$US
239369522$23936952$2$F$$20240805$20240604$20240813$EXP$$DE-MYLANLABS-2024M1050320$MYLAN$Juche A, Warnecke K, Krause A. Lower leg fractures under anti-rheumatic therapy with methotrexate. Intern-Praxis 2023; 67 (1): 150-155.$84$YR$$F$Y$$$20240813$$MD$DE$DE
239369612$23936961$2$F$20240306$20240927$20240604$20240930$EXP$FR-AFSSAPS-LL2024001025$NVSC2024FR115778$NOVARTIS$$50$YR$$M$Y$$$20240930$$MD$FR$FR
239369663$23936966$3$F$$20240709$20240604$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04489$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239369723$23936972$3$F$20240528$20240718$20240604$20240723$30DAY$$JP-MYLANLABS-2024M1048691$MYLAN$$$$C$F$Y$$$20240723$$MD$JP$JP
239369973$23936997$3$F$20240601$20240913$20240604$20240916$PER$$US-AMGEN-USASP2024109502$AMGEN$$76$YR$E$F$Y$$$20240916$$CN$US$US
239369992$23936999$2$F$20230403$20240819$20240604$20240828$EXP$$JP-EXELIXIS-CABO-24077896$EXELIXIS$$74$YR$$M$Y$72.5$KG$20240828$$MD$JP$JP
239370013$23937001$3$F$20240101$20240722$20240604$20240731$PER$$US-SA-2024SA165876$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240731$$MD$US$US
239370024$23937002$4$F$20240101$20240723$20240604$20240731$PER$$US-SA-2024SA164096$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240731$$MD$US$US
239370204$23937020$4$F$20240418$20240618$20240604$20240703$EXP$FR-AFSSAPS-RS2024000462$FR-TEVA-VS-3204421$TEVA$$82$YR$$M$Y$112.5$KG$20240703$$MD$FR$FR
239370214$23937021$4$F$20240101$20240807$20240604$20240815$EXP$$CA-CELLTRION INC.-2024CA005959$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
239370362$23937036$2$F$20240501$20240703$20240604$20240709$EXP$$US-OTSUKA-2024_015545$OTSUKA$$69$YR$$M$Y$98.2$KG$20240709$$CN$US$US
239370533$23937053$3$F$20240527$20240724$20240604$20240731$EXP$$CA-CELLTRION INC.-2024CA012965$CELLTRION$$$$$$Y$$$20240731$$MD$CA$CA
239370542$23937054$2$F$20220902$20240805$20240604$20240806$EXP$$NVSC2024TR116225$NOVARTIS$$37$YR$$M$Y$75$KG$20240807$$MD$TR$TR
239370592$23937059$2$F$$20240716$20240604$20240720$EXP$$US-AMGEN-USASP2024106670$AMGEN$$$$$F$Y$$$20240720$$CN$US$US
239370925$23937092$5$F$20240605$20240831$20240604$20240910$EXP$$CA-CELLTRION INC.-2024CA012966$CELLTRION$$$$$$Y$$$20240910$$CN$CA$CA
239370963$23937096$3$F$20240401$20240710$20240604$20240715$EXP$$US-PFIZER INC-202400101607$PFIZER$$80$YR$$M$Y$$$20240715$$CN$US$US
239371022$23937102$2$F$20230518$20240728$20240604$20240729$EXP$$CA-PFIZER INC-202300107364$PFIZER$$51$YR$$F$Y$$$20240729$$MD$CA$CA
239371043$23937104$3$F$20240312$20240529$20240604$20240808$EXP$$NVSC2024CA018458$NOVARTIS$$43$YR$$F$Y$$$20240808$$MD$CA$CA
239371092$23937109$2$F$20240222$20240902$20240604$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-088528$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$57.7$KG$20240902$$PH$JP$JP
239371282$23937128$2$F$$20240819$20240604$20240821$30DAY$$US-PFIZER INC-202400181131$PFIZER$$3$YR$$F$Y$$$20240821$$CN$US$US
239371302$23937130$2$F$$20240909$20240604$20240911$30DAY$$CO-PFIZER INC-PV202400067035$PFIZER$$$$$F$Y$$$20240911$$CN$CO$CO
239371323$23937132$3$F$$20240705$20240604$20240705$30DAY$$US-PFIZER INC-202400106966$PFIZER$$14$YR$$M$Y$$$20240705$$CN$US$US
239371334$23937133$4$F$20240517$20240829$20240604$20240904$30DAY$$US-PFIZER INC-202400181963$PFIZER$$3$YR$$M$Y$$$20240904$$CN$US$US
239371343$23937134$3$F$$20240717$20240604$20240717$30DAY$$JO-PFIZER INC-202400109171$PFIZER$$15$YR$$M$Y$$$20240717$$CN$JO$JO
239371354$23937135$4$F$$20240923$20240604$20240925$30DAY$$CL-PFIZER INC-PV202400071828$PFIZER$$10$YR$$M$Y$$$20240925$$CN$CL$CL
239371384$23937138$4$F$$20240702$20240604$20240710$30DAY$$CO-PFIZER INC-202400181703$PFIZER$$11$YR$$M$Y$$$20240710$$CN$CO$CO
239371452$23937145$2$F$$20240802$20240604$20240807$EXP$$DE-MYLANLABS-2024M1050507$MYLAN$Juche A, Warnecke K, Krause A. Lower leg fractures under anti-rheumatic therapy with methotrexate. Intern-Praxis 2023; 67 (1): 150-155.$65$YR$$F$Y$$$20240807$$MD$DE$DE
239371544$23937154$4$F$$20240921$20240604$20240923$30DAY$$US-PFIZER INC-202400181529$PFIZER$$10$YR$$M$Y$$$20240923$$CN$US$US
239371553$23937155$3$F$20240501$20240910$20240604$20240912$30DAY$$CO-PFIZER INC-PV202400071809$PFIZER$$$$$F$Y$$$20240912$$MD$CO$CO
239371565$23937156$5$F$$20240812$20240604$20240816$EXP$$CO-PFIZER INC-PV202400071811$PFIZER$$$$C$M$Y$$$20240816$$CN$CO$CO
239371614$23937161$4$F$$20240913$20240604$20240919$30DAY$$US-PFIZER INC-202400181896$PFIZER$$2$YR$$M$Y$$$20240919$$CN$US$US
239371622$23937162$2$F$20240523$20240911$20240604$20240916$30DAY$$GR-PFIZER INC-PV202400071072$PFIZER$$11$YR$$M$Y$35$KG$20240916$$CN$GR$GR
239371673$23937167$3$F$20240516$20240625$20240604$20240704$30DAY$$CA-JNJFOC-20240449236$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240704$$CN$CA$CA
239371752$23937175$2$F$$20240528$20240604$20240701$EXP$$PT-Ipsen Biopharmaceuticals, Inc.-2024-10616$IPSEN$Martins, A.L., Martins, R.M., Oliveira, R. Caetano, et al. ^Hypoglycemia due to metastatic insulinoma^, HPB, 01-Jan-2024, Vol. 26, Iss. nan, Pp. S161-S162. doi: 10.1016/j.hpb.2024.03.297$56$YR$A$F$Y$$$20240701$$MD$PT$PT
239371862$23937186$2$F$20210101$20240715$20240604$20240716$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-138284$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$56$KG$20240716$$CN$ES$ES
239372055$23937205$5$F$20231209$20240710$20240604$20240718$EXP$$CA-SANDOZ INC.-SDZ2024CA025454$SANDOZ$$74$YR$$M$Y$$$20240718$$MD$CA$CA
239372092$23937209$2$F$$20240904$20240604$20240906$EXP$$US-MYLANLABS-2024M1049664$MYLAN$$$$$F$Y$$$20240906$$CN$US$US
239372143$23937214$3$F$20240524$20240626$20240604$20240703$PER$$US-HETERO-HET2024US01564$HETERO$$76$YR$$F$Y$65.77$KG$20240703$$HP$US$US
239372173$23937217$3$F$20230101$20240815$20240604$20240822$EXP$$US-AMGEN-USASP2024108655$AMGEN$$79$YR$E$F$Y$$$20240822$$CN$US$US
239372182$23937218$2$F$$20240902$20240604$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088555$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240902$$CN$US$US
239372223$23937222$3$F$$20240913$20240604$20240918$30DAY$$US-SANDOZ INC.-SDZ2024US054627$SANDOZ$$$$$M$Y$$$20240918$$HP$US$US
239372244$23937224$4$F$20240206$20240809$20240604$20240819$EXP$$NVSC2024MX078421$NOVARTIS$$56$YR$$F$Y$85$KG$20240819$$CN$MX$MX
239372282$23937228$2$F$$20240807$20240604$20240807$PER$$US-ALXN-202405USA002048US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
239372314$23937231$4$F$$20240709$20240604$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04479$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239372413$23937241$3$F$$20240709$20240604$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04485$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239372462$23937246$2$F$20240101$20240916$20240604$20240924$PER$$US-SA-2024SA160289$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240924$$HP$US$US
239372602$23937260$2$F$$20240719$20240604$20240725$EXP$$JP-009507513-2405JPN003825J$MERCK$$53$YR$$M$Y$$$20240725$$MD$JP$JP
239372642$23937264$2$F$$20240711$20240604$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086445$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240717$$HP$US$US
239372722$23937272$2$F$$20240709$20240604$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04481$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239372794$23937279$4$F$$20240911$20240604$20240913$30DAY$$US-PFIZER INC-202400180168$PFIZER$$15$YR$$F$Y$49.895$KG$20240913$$CN$US$US
239372876$23937287$6$F$$20240828$20240604$20240903$30DAY$$US-PFIZER INC-202400180109$PFIZER$$15$YR$$M$Y$53.07$KG$20240903$$CN$US$US
239372902$23937290$2$F$$20240705$20240604$20240705$30DAY$$US-PFIZER INC-202400103062$PFIZER$$14$YR$$M$Y$$$20240705$$CN$US$US
239372914$23937291$4$F$20240527$20240829$20240604$20240903$30DAY$$US-PFIZER INC-202400181929$PFIZER$$10$YR$$M$Y$31.75$KG$20240903$$CN$US$US
239372924$23937292$4$F$$20240921$20240604$20240923$30DAY$$US-PFIZER INC-202400181471$PFIZER$$13$YR$$F$Y$$$20240923$$CN$US$US
239372982$23937298$2$F$$20240807$20240604$20240810$EXP$$NVSC2024GB115708$NOVARTIS$$$$$F$Y$$$20240810$$CN$GB$GB
239372992$23937299$2$F$$20240627$20240604$20240702$EXP$$US-ABBVIE-5783693$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
239373053$23937305$3$F$$20240709$20240604$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04486$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239373313$23937331$3$F$20240519$20240730$20240604$20240806$EXP$$US-GSK-US2024066446$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$US$US
239373363$23937336$3$F$$20240709$20240604$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04488$LUPIN$$$$$$Y$$$20240804$$PH$US$US
239373403$23937340$3$F$20240101$20240829$20240604$20240906$EXP$$JP-009507513-2404JPN002570J$MERCK$$8$DEC$$F$Y$$$20240906$$MD$JP$JP
239373483$23937348$3$F$$20240705$20240604$20240710$EXP$$NVSC2024US116159$NOVARTIS$$$$$$Y$$$20240710$$CN$US$US
239373586$23937358$6$F$$20240812$20240604$20240816$30DAY$$US-PFIZER INC-202400173637$PFIZER$$$$$$Y$$$20240816$$HP$US$US
239373642$23937364$2$F$20240506$20240701$20240604$20240703$PER$$US-PFIZER INC-202400180445$PFIZER$$$$$M$Y$67.4$KG$20240703$$HP$US$US
239373752$23937375$2$F$20240101$20240726$20240604$20240730$EXP$$US-ABBVIE-5785680$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
239373762$23937376$2$F$20240517$20240705$20240604$20240716$PER$$US-AstraZeneca-2024A120120$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
239373853$23937385$3$F$$20240917$20240604$20240922$PER$$US-SA-2024SA163118$SANOFI AVENTIS$$12$YR$T$M$Y$43.9$KG$20240923$$CN$US$US
239374072$23937407$2$F$20240523$20240712$20240604$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202405014725$ELI LILLY AND CO$$$$$$Y$$$20240718$$CN$US$US
239374214$23937421$4$F$20230701$20240913$20240604$20240924$EXP$$US-TAKEDA-2024TUS038059$TAKEDA$$53$YR$$F$Y$$$20240924$$CN$US$US
239374222$23937422$2$F$$20240709$20240604$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04569$LUPIN$$$$$$Y$$$20240801$$PH$US$US
239374422$23937442$2$F$$20240709$20240604$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04527$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239374564$23937456$4$F$$20240913$20240604$20240927$EXP$$SK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448998$RANBAXY$Penesova A, Minarik P, Huckova  M, Vlcek M, Szantova M, Krizanova O. 5-Fluorouracil Induced Hypertriglyceridemia During the Colorectal Cancer Treatment in a Patient With Multifactorial Chylomicronemia Syndrome: A Case Report. Clin Ther. 2024;May 18;0 (0):1-4$47$YR$$F$Y$80$KG$20240927$$MD$SK$SK
239374856$23937485$6$F$20240513$20240809$20240604$20240816$EXP$$JP-ARGENX-2024-ARGX-JP003811AA$ARGENX BVBA$$$$$$Y$$$20240816$$CN$JP$JP
239374862$23937486$2$F$$20240709$20240604$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04529$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239375063$23937506$3$F$20240101$20240909$20240604$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016184$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240918$$$US$US
239375232$23937523$2$F$$20240823$20240604$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04492$LUPIN$$$$$$Y$$$20240905$$CN$US$US
239375274$23937527$4$F$20221115$20240904$20240604$20240912$EXP$$CA-AMGEN-CANSL2024094319$AMGEN$$57$YR$A$F$Y$108$KG$20240912$$HP$CA$CA
239375293$23937529$3$F$20240603$20240605$20240604$20240710$PER$$US-AMGEN-USASP2024109246$AMGEN$$79$YR$$F$Y$$$20240709$$CN$US$US
239375302$23937530$2$F$20240524$20240916$20240604$20240923$EXP$$US-MYLANLABS-2024M1050147$MYLAN$$41$YR$$F$Y$101.6$KG$20240923$$HP$US$US
2393754511$23937545$11$F$20240101$20240919$20240604$20240930$EXP$$US-BEH-2024173097$CSL BEHRING$$42$YR$A$F$Y$$$20240930$$HP$US$US
239375462$23937546$2$F$20230601$20240816$20240604$20240823$EXP$$CN-TAKEDA-2023TUS067225$TAKEDA$$56$YR$$M$Y$70$KG$20240823$$MD$CN$CN
239375494$23937549$4$F$$20240709$20240604$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04491$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239375563$23937556$3$F$20240426$20240524$20240604$20240705$EXP$$BR-BIOVITRUM-2024-BR-008020$BIOVITRUM$$319$DY$$M$Y$9$KG$20240705$$CN$BR$BR
239375672$23937567$2$F$$20240902$20240604$20240903$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-080975$REGENERON$$82$YR$$M$Y$$$20240903$$MD$DE$DE
239375683$23937568$3$F$20240422$20240711$20240604$20240726$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-124614$DAIICHI$$7$DEC$$$Y$$$20240726$$MD$JP$JP
239375972$23937597$2$F$20240601$20240701$20240604$20240702$PER$$US-BAYER-2024A081032$BAYER$$48$YR$A$F$Y$$$20240702$$CN$US$US
239376024$23937602$4$F$20240403$20240823$20240604$20240828$EXP$$GB-MYLANLABS-2024M1050066$MYLAN$$$$$F$Y$$$20240828$$CN$GB$GB
239376252$23937625$2$F$20240530$20240724$20240604$20240726$PER$$US-PFIZER INC-202400185207$PFIZER$$68$YR$$M$Y$79.38$KG$20240726$$CN$US$US
239376294$23937629$4$F$$20240813$20240604$20240815$PER$$US-PFIZER INC-202400184856$PFIZER$$27$YR$$F$Y$$$20240815$$HP$US$US
239376382$23937638$2$F$20240401$20240725$20240604$20240807$EXP$$IT-CIPLA LTD.-2024IT04829$CIPLA$$$$$$Y$$$20240807$$CN$IT$IT
239376493$23937649$3$F$20240603$20240729$20240604$20240731$PER$$US-AMGEN-USASP2024109812$AMGEN$$72$YR$E$M$Y$$$20240731$$CN$US$US
239376572$23937657$2$F$$20240704$20240604$20240709$EXP$$JP-AstraZeneca-2024A127317$ASTRAZENECA$$90$YR$$M$Y$$$20240709$$MD$JP$
239376646$23937664$6$F$20240714$20240913$20240604$20240920$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001121$BLUEPRINT MEDICINES$$55$YR$A$F$Y$$$20240920$$CN$US$US
239376883$23937688$3$F$20220429$20240723$20240604$20240729$EXP$$CA-TAKEDA-2024TUS053338$TAKEDA$$72$YR$$F$Y$$$20240729$$HP$CA$CA
239377462$23937746$2$F$20240507$20240827$20240604$20240829$EXP$$US-MYLANLABS-2024M1049834$MYLAN$$38$YR$$M$Y$59.41$KG$20240829$$HP$US$US
239377482$23937748$2$F$$20240802$20240604$20240809$EXP$$US-MYLANLABS-2024M1049892$MYLAN$$$$$M$Y$$$20240809$$CN$US$US
239377552$23937755$2$F$20231223$20240716$20240604$20240723$EXP$FR-AFSSAPS-BX2024001030$FR-009507513-2405FRA009318$MERCK$$49$YR$$F$Y$$$20240723$$HP$FR$FR
239377573$23937757$3$F$$20240729$20240604$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088051$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$64.86$KG$20240731$$CN$US$US
239377582$23937758$2$F$$20240903$20240604$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089779$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$76.2$KG$20240904$$CN$US$US
239377793$23937779$3$F$$20240709$20240604$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04494$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239378182$23937818$2$F$$20240912$20240604$20240923$PER$$US-SA-2024SA164025$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240923$$HP$US$US
239378212$23937821$2$F$$20240709$20240604$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04537$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239378232$23937823$2$F$$20240704$20240604$20240710$EXP$$JP-PFIZER INC-PV202400072649$PFIZER$Matsumoto, N.. A case of theophylline toxicity during treatment of pulmonary mycosis after COVID-19. The Japanese Journal of Clinical Toxicology. 2023;36:419-425$83$YR$$M$Y$$$20240710$$HP$JP$JP
239378475$23937847$5$F$$20240830$20240604$20240905$30DAY$$ES-PFIZER INC-202400180101$PFIZER$$$$$$Y$$$20240905$$HP$ES$ES
239378484$23937848$4$F$$20240828$20240604$20240903$30DAY$$US-PFIZER INC-202400180514$PFIZER$$11$WK$$F$Y$$$20240903$$CN$US$US
239378495$23937849$5$F$20240101$20240828$20240604$20240903$30DAY$$US-PFIZER INC-202400180515$PFIZER$$4$MON$$F$Y$$$20240903$$CN$US$US
239378502$23937850$2$F$$20240827$20240604$20240830$30DAY$$NL-PFIZER INC-202400182507$PFIZER$$$$$F$Y$$$20240830$$PH$NL$NL
239378516$23937851$6$F$20240109$20240919$20240604$20240919$30DAY$$JP-PFIZER INC-PV202400059823$PFIZER$$6$YR$$M$Y$21.3$KG$20240919$$MD$JP$JP
239378543$23937854$3$F$20240501$20240922$20240604$20240924$30DAY$$CA-PFIZER INC-202400175897$PFIZER$$61$YR$$F$Y$$$20240924$$HP$CA$CA
239378582$23937858$2$F$$20240801$20240604$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089897$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240805$$HP$US$US
239378592$23937859$2$F$20240101$20240830$20240604$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088783$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240903$$CN$US$US
239378632$23937863$2$F$$20240712$20240604$20240725$PER$$US-Calliditas-2024CAL00857$CALLIDITAS THERAPEUTICS$$76$YR$E$M$Y$84.3$KG$20240725$$CN$US$US
239378744$23937874$4$F$20240409$20240712$20240604$20240718$EXP$$CA-GSK-CA2023137593$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$HP$CA$CA
239378825$23937882$5$F$$20240708$20240604$20240709$PER$$US-AMGEN-USASP2024109777$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
239378962$23937896$2$F$$20240718$20240604$20240806$PER$$US-ALXN-202405USA001906US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239379122$23937912$2$F$20240403$20240625$20240604$20240701$EXP$$US-TAKEDA-2024TUS046431$TAKEDA$$62$YR$$F$Y$$$20240701$$CN$US$US
239379133$23937913$3$F$20240401$20240712$20240604$20240722$EXP$$US-GSK-US2024AMR068085$GLAXOSMITHKLINE$$57$YR$$M$Y$95$KG$20240722$$CN$US$US
239379153$23937915$3$F$20240531$20240822$20240604$20240826$PER$$US-JNJFOC-20240600622$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240827$$HP$US$US
239379425$23937942$5$F$$20240711$20240604$20240725$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-04463$LUPIN$$$$$$Y$$$20240725$$CN$AU$AU
239379484$23937948$4$F$$20240709$20240604$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04586$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239379552$23937955$2$F$$20240528$20240604$20240902$PER$$US-ASTELLAS-2024US015512$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
239379683$23937968$3$F$$20240709$20240604$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04534$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239379884$23937988$4$F$$20240807$20240604$20240809$EXP$$NVSC2024US117214$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
239379943$23937994$3$F$$20240709$20240604$20240802$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04532$LUPIN$$$$$$Y$$$20240802$$CN$US$US
239380092$23938009$2$F$$20240725$20240604$20240729$EXP$$JP-BAYER-2024A080379$BAYER$$81$YR$E$M$Y$$$20240729$$MD$JP$JP
239380133$23938013$3$F$20240501$20240809$20240604$20240815$EXP$$CA-GSK-CA2024065689$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$CN$CA$CA
239380162$23938016$2$F$$20240709$20240604$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04530$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239380242$23938024$2$F$$20240709$20240604$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04540$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239380312$23938031$2$F$20240528$20240904$20240604$20240913$PER$$US-SA-2024SA165278$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240913$$MD$US$US
239380343$23938034$3$F$$20240709$20240604$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04528$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239380353$23938035$3$F$20240101$20240822$20240604$20240828$EXP$$JP-009507513-2405JPN003633J$MERCK$$68$YR$$M$Y$78$KG$20240828$$MD$JP$JP
239380373$23938037$3$F$20240301$20240917$20240604$20240919$EXP$$NVSC2024US115991$NOVARTIS$$57$YR$$M$Y$$$20240920$$CN$US$US
239380402$23938040$2$F$20211201$20240627$20240604$20240703$EXP$$HU-MYLANLABS-2024M1050133$MYLAN$Alexandra, B, Bela, B.. Myth or reality about the broken female heart? MINOCA - Takotsubo cardiomyopathy - a case report. LAM. 2024;34(4):205-211$40$YR$$F$Y$$$20240703$$MD$HU$HU
239380443$23938044$3$F$$20240709$20240604$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04535$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239380462$23938046$2$F$$20240705$20240604$20240705$PER$$US-AstraZeneca-2024A128549$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
239380522$23938052$2$F$20240410$20240624$20240604$20240709$EXP$$JP-ROCHE-3574153$ROCHE$$8$DEC$E$F$Y$$$20240704$$MD$JP$JP
239380622$23938062$2$F$20240426$20240823$20240604$20240919$EXP$$US-Vifor (International) Inc.-VIT-2024-04394$VIFOR$$80$YR$$M$Y$65$KG$20240919$$HP$US$US
239380643$23938064$3$F$20240101$20240624$20240604$20240702$PER$$US-Vifor (International) Inc.-VIT-2024-04387$VIFOR$$55$YR$$M$Y$76$KG$20240702$$HP$US$US
239380712$23938071$2$F$$20240715$20240604$20240730$EXP$NL-LRB-00979075$NL-BAXTER-2024BAX019044$BAXTER$$57$YR$$M$Y$80$KG$20240730$$MD$NL$NL
239380772$23938077$2$F$20240101$20240628$20240604$20240704$PER$$US-JNJFOC-20240584094$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240704$$PH$US$US
239380802$23938080$2$F$$20240711$20240604$20240723$EXP$$JP-Vifor (International) Inc.-VIT-2024-04950$VIFOR$$$$$$Y$$$20240723$$PH$JP$JP
239381133$23938113$3$F$$20240723$20240604$20240725$EXP$$US-PFIZER INC-2024SGN05373$PFIZER$$64$YR$$F$Y$$$20240725$$CN$US$US
239381162$23938116$2$F$$20240903$20240604$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090046$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240903$$CN$US$US
239381212$23938121$2$F$$20240903$20240604$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089953$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240903$$HP$US$US
239381244$23938124$4$F$20240401$20240812$20240604$20240816$EXP$$US-MYLANLABS-2024M1049524$MYLAN$$30$YR$$F$Y$$$20240816$$HP$US$US
239381292$23938129$2$F$$20240805$20240604$20240813$EXP$$DE-MYLANLABS-2024M1050379$MYLAN$Juche A, Warnecke K, Krause A. Lower leg fractures under anti-rheumatic therapy with methotrexate. Intern-Praxis 2023; 67 (1): 150-155.$56$YR$$F$Y$$$20240813$$MD$DE$DE
239381445$23938144$5$F$$20240920$20240604$20240925$EXP$$US-TAKEDA-2024TUS016542$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
239381484$23938148$4$F$20240701$20240830$20240604$20240905$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001125$BLUEPRINT MEDICINES$$25$YR$A$F$Y$$$20240906$$CN$US$US
239381543$23938154$3$F$20231224$20240815$20240604$20240821$EXP$$US-SA-2024SA164979$SANOFI AVENTIS$$62$YR$A$M$Y$106$KG$20240821$$MD$US$US
239381622$23938162$2$F$$20240830$20240604$20240909$EXP$$AR-AMRYT PHARMACEUTICALS DAC-AEGR007160$AEGERION$$$$$$Y$$$20240909$$CN$AR$AR
239381764$23938176$4$F$$20240822$20240604$20240830$EXP$$CA-AstraZeneca-2024A129251$ASTRAZENECA$$$$$F$Y$$$20240830$$MD$CA$
239381833$23938183$3$F$20240206$20240814$20240604$20240819$EXP$$DE-PFIZER INC-2024SGN01848$PFIZER$$79$YR$$F$Y$57.2$KG$20240819$$MD$DE$DE
239381982$23938198$2$F$20220615$20240701$20240604$20240704$EXP$$TW-ABBVIE-5783641$ABBVIE$$59$YR$$$Y$$$20240704$$HP$TW$TW
239382022$23938202$2$F$$20240830$20240604$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-088644$BRISTOL MYERS SQUIBB$$5$DEC$A$M$Y$$$20240830$$MD$JP$JP
239382592$23938259$2$F$$20240530$20240604$20240711$EXP$$ZA-AstraZeneca-2024A127653$ASTRAZENECA$$68$YR$$F$Y$$$20240711$$CN$ZA$
239382822$23938282$2$F$20240101$20240815$20240604$20240821$EXP$$US-SA-2024SA116741$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240821$$CN$US$US
239382862$23938286$2$F$$20240701$20240604$20240710$30DAY$$JP-JNJFOC-20240600209$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$HP$JP$JP
239382902$23938290$2$F$$20240701$20240604$20240710$30DAY$$JP-JNJFOC-20240602332$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$PH$JP$JP
239382922$23938292$2$F$$20240717$20240604$20240717$PER$$NVSC2024US117231$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
239382953$23938295$3$F$$20240626$20240604$20240711$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007164$AEGERION$$$$$F$Y$83.9$KG$20240711$$CN$US$US
239383112$23938311$2$F$20230810$20240722$20240604$20240731$EXP$FR-AFSSAPS-LM2024000282$FR-FreseniusKabi-FK202408518$FRESENIUS KABI$$0$DY$N$F$Y$2$KG$20240731$$MD$FR$FR
239383152$23938315$2$F$$20240719$20240604$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090236$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$73.03$KG$20240726$$HP$US$US
239383164$23938316$4$F$20240101$20240806$20240604$20240917$EXP$$US-SA-2024SA166625$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240917$$HP$US$US
239383434$23938343$4$F$20240530$20240808$20240604$20240819$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2024FOS000654$RIGEL PHARMACEUTICALS$$78$YR$$F$Y$$$20240819$$MD$JP$JP
239383442$23938344$2$F$20240131$20240823$20240604$20240904$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2024FOS000651$RIGEL PHARMACEUTICALS$$79$YR$$F$Y$$$20240904$$MD$JP$JP
239383452$23938345$2$F$$20240624$20240604$20240704$PER$$US-SA-2024SA163381$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240704$$HP$US$US
239383552$23938355$2$F$20240103$20240805$20240604$20240816$PER$$US-MYLANLABS-2024M1043036$MYLAN$$73$YR$$F$Y$58$KG$20240816$$MD$US$US
239383612$23938361$2$F$$20240705$20240604$20240710$30DAY$$JP-JNJFOC-20240582870$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$PH$JP$JP
239383625$23938362$5$F$20240502$20240902$20240604$20240906$PER$$CA-PFIZER INC-PV202400071245$PFIZER$$16$YR$$F$Y$$$20240906$$CN$CA$CA
239383896$23938389$6$F$20240701$20240909$20240604$20240911$PER$$US-PFIZER INC-202400184813$PFIZER$$50$YR$$M$Y$78.93$KG$20240911$$CN$US$US
239383963$23938396$3$F$20231222$20240712$20240604$20240716$PER$$US-PFIZER INC-202400185794$PFIZER$$64$YR$$F$Y$$$20240716$$PH$US$US
239383982$23938398$2$F$$20240706$20240604$20240709$PER$$US-PFIZER INC-PV202400072480$PFIZER$$$$$$Y$$$20240709$$CN$US$US
239384052$23938405$2$F$$20240702$20240604$20240709$30DAY$$JP-JNJFOC-20240581642$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$HP$JP$JP
239384213$23938421$3$F$20240101$20240705$20240604$20240708$PER$$US-PFIZER INC-202400185484$PFIZER$$$$A$M$Y$$$20240708$$MD$US$US
239384232$23938423$2$F$20240528$20240705$20240604$20240708$PER$$US-PFIZER INC-202400181871$PFIZER$$81$YR$$F$Y$$$20240708$$CN$US$US
239384262$23938426$2$F$$20240710$20240604$20240713$EXP$$US-TAKEDA-2024TUS055915$TAKEDA$$$$$M$Y$$$20240713$$HP$US$US
239384284$23938428$4$F$$20240717$20240604$20240718$PER$$US-ALXN-202405USA002012US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239384482$23938448$2$F$$20240726$20240604$20240807$EXP$$US-ELI_LILLY_AND_COMPANY-US202405014178$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240807$$CN$US$US
239384582$23938458$2$F$20240526$20240628$20240604$20240708$EXP$$TH-TEVA-VS-3204144$TEVA$$$$$F$Y$$$20240708$$HP$TH$TH
239384612$23938461$2$F$$20240703$20240604$20240704$EXP$$CA-BAUSCH-BL-2024-008491$BAUSCH AND LOMB$$54$YR$$M$Y$$$20240704$$CN$CA$CA
239384632$23938463$2$F$$20240628$20240604$20240703$EXP$$NL-BAUSCH-BL-2024-008639$BAUSCH AND LOMB$$$$E$M$Y$$$20240703$$MD$NL$NL
239384803$23938480$3$F$$20240903$20240604$20240904$EXP$$US-TAKEDA-2024TUS031408$TAKEDA$$$$$F$Y$$$20240904$$CN$US$US
239384943$23938494$3$F$20240531$20240705$20240604$20240723$30DAY$$US-JNJFOC-20240600007$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240722$$CN$US$US
239384954$23938495$4$F$20240519$20240628$20240604$20240710$EXP$$CA-TEVA-VS-3201464$TEVA$$70$YR$$F$Y$$$20240710$$MD$CA$CA
239384962$23938496$2$F$20240322$20240923$20240604$20240926$EXP$$US-SANDOZ INC.-SDZ2024US052997$SANDOZ$$$$A$F$Y$$$20240926$$CN$US$US
239385052$23938505$2$F$20240501$20240724$20240604$20240801$PER$$US-SA-2024SA163718$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240801$$MD$US$US
239385092$23938509$2$F$20240530$20240820$20240604$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088841$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$103.4$KG$20240828$$PH$US$US
239385313$23938531$3$F$20221101$20240710$20240604$20240723$EXP$$JP-NOVOPROD-1230359$NOVO NORDISK$T.Yamazaki et.al.. A case of a patient who experienced recurrent diabetic chorea at low glucose levels due to decreased injection adherence and after treatment intensification. The 61st Japan Diabetes Society Kanto Koshinetsu Regional Association. 2024;pO-169$81$YR$$F$Y$$$20240723$$MD$JP$JP
239385462$23938546$2$F$20240531$20240712$20240604$20240716$PER$$US-JNJFOC-20240590058$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240716$$CN$US$US
239385612$23938561$2$F$$20240726$20240604$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089870$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240731$$CN$US$US
239385742$23938574$2$F$20230228$20240729$20240604$20240805$EXP$$JP-009507513-2306JPN003326J$MERCK$$74$YR$$M$Y$$$20240805$$MD$JP$JP
239385755$23938575$5$F$$20240912$20240604$20240919$PER$$NVSC2024US117222$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
239385892$23938589$2$F$$20240716$20240604$20240724$EXP$$FR-AstraZeneca-2024A126777$ASTRAZENECA$$$$E$$Y$$$20240724$$MD$FR$
239386022$23938602$2$F$20220830$20240712$20240604$20240718$EXP$$PL-GILEAD-2024-0675520$GILEAD$$62$YR$A$M$Y$69$KG$20240718$$MD$PL$PL
239386042$23938604$2$F$20240419$20240827$20240604$20240924$PER$$US-Eisai-EC-2024-164825$EISAI$$$$$F$Y$$$20240924$$MD$US$US
239386392$23938639$2$F$20240602$20240814$20240604$20240818$PER$$US-AMGEN-USASP2024109598$AMGEN$$68$YR$E$F$Y$$$20240817$$CN$US$US
239386412$23938641$2$F$20201015$20240719$20240604$20240729$EXP$$BA-009507513-2405BIH008746$MERCK$$59$YR$$M$Y$$$20240729$$MD$BA$BA
239386462$23938646$2$F$20231001$20240703$20240604$20240711$EXP$$BR-AstraZeneca-2024A128111$ASTRAZENECA$$19754$DY$$M$Y$101$KG$20240711$$CN$BR$
239386602$23938660$2$F$20240601$20240814$20240604$20240816$PER$$US-AMGEN-USASP2024109477$AMGEN$$79$YR$E$F$Y$$$20240816$$CN$US$US
239386843$23938684$3$F$20240101$20240719$20240604$20240730$PER$$US-SA-2024SA166722$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240730$$MD$US$US
239386874$23938687$4$F$$20240808$20240604$20240814$EXP$$US-AMGEN-USASP2024109578$AMGEN$$64$YR$A$F$Y$$$20240814$$CN$US$US
239386922$23938692$2$F$20230218$20240715$20240604$20240723$EXP$$DE-009507513-2405DEU009454$MERCK$$43$YR$$F$Y$$$20240723$$MD$DE$DE
239387213$23938721$3$F$$20240717$20240604$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090099$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240722$$CN$US$US
239387372$23938737$2$F$20240602$20240730$20240604$20240803$PER$$US-AMGEN-USASP2024109871$AMGEN$$53$YR$A$F$Y$$$20240803$$CN$US$US
239387563$23938756$3$F$20240514$20240908$20240604$20240916$EXP$$SA-SANDOZ INC.-SDZ2024SA020243$SANDOZ$$48$YR$$F$Y$$$20240916$$CN$SA$SA
239387624$23938762$4$F$$20240923$20240604$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA053112$SANDOZ$$$$$F$Y$$$20240925$$MD$CA$CA
239387892$23938789$2$F$$20240729$20240604$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089767$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240731$$HP$US$US
239387912$23938791$2$F$20240603$20240725$20240604$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202406000894$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240731$$CN$US$US
239388212$23938821$2$F$$20240731$20240604$20240805$PER$$US-ALXN-202405USA002058US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
239388247$23938824$7$F$20240517$20240917$20240604$20240928$EXP$$JP-ABBVIE-5785585$ABBVIE$$64$YR$$M$Y$73$KG$20240928$$MD$JP$JP
239388262$23938826$2$F$20240530$20240627$20240604$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089316$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$85.28$KG$20240703$$HP$US$US
239388302$23938830$2$F$$20240903$20240604$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089145$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240904$$HP$US$US
239388456$23938845$6$F$20240527$20240729$20240604$20240808$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406001019$ELI LILLY AND CO$$75$YR$E$M$Y$75$KG$20240808$$CN$JP$JP
239388482$23938848$2$F$20240422$20240910$20240604$20240918$EXP$$JP-ROCHE-3574096$ROCHE$$66$YR$E$M$Y$80.1$KG$20240918$$PH$JP$JP
239388702$23938870$2$F$20240301$20240715$20240604$20240721$EXP$$DE-009507513-2405DEU009373$MERCK$$81$YR$$M$Y$75$KG$20240721$$MD$DE$DE
239388732$23938873$2$F$$20240719$20240604$20240806$PER$$US-ALXN-202405USA002091US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239388773$23938877$3$F$20240814$20240911$20240604$20240916$EXP$$CA-BAUSCH-BL-2024-008525$BAUSCH AND LOMB$$63$YR$$F$Y$109$KG$20240916$$CN$CA$CA
239388863$23938886$3$F$20240101$20240821$20240604$20240829$PER$$US-BAUSCHBL-2024BNL027735$BAUSCH AND LOMB$$69$YR$$F$Y$$$20240829$$CN$US$US
239388892$23938889$2$F$$20240701$20240604$20240710$PER$$US-INCYTE CORPORATION-2024IN005715$INCYTE$$$$$$Y$$$20240710$$CN$US$US
239388903$23938890$3$F$20240101$20240705$20240604$20240712$EXP$$JP-AstraZeneca-2024A127284$ASTRAZENECA$$64$YR$$M$Y$$$20240712$$MD$JP$
239388994$23938899$4$F$$20240707$20240604$20240709$EXP$$GB-SANDOZ INC.-SDZ2024GB044978$SANDOZ$$$$$F$Y$$$20240709$$CN$GB$GB
239389044$23938904$4$F$20240512$20240823$20240604$20240919$EXP$$DE-SANDOZ INC.-SDZ2024DE054216$SANDOZ$$77$YR$$F$Y$58$KG$20240919$$MD$DE$DE
239389202$23938920$2$F$20240401$20240709$20240604$20240715$EXP$IT-MINISAL02-987336$IT-BIOGEN-2024BI01267235$BIOGEN$$33$YR$$F$Y$$$20240715$$MD$IT$IT
239389303$23938930$3$F$20240401$20240707$20240604$20240716$EXP$$HK-INCYTE CORPORATION-2024IN005666$INCYTE$$$$$$Y$$$20240716$$MD$HK$HK
239389596$23938959$6$F$20240101$20240806$20240604$20240822$PER$$US-009507513-2405USA010091$MERCK$$$$$M$Y$101.6$KG$20240822$$CN$US$US
239389643$23938964$3$F$$20240709$20240604$20240712$EXP$$US-PFIZER INC-PV202400071550$PFIZER$$82$YR$$M$Y$$$20240712$$MD$US$US
239389712$23938971$2$F$20240531$20240701$20240604$20240701$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031866$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240702$$CN$US$US
239389732$23938973$2$F$20240501$20240727$20240604$20240806$PER$$US-KARYOPHARM-2024KPT001083$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240806$$CN$US$US
239389743$23938974$3$F$$20240627$20240604$20240712$EXP$$JP-009507513-2405JPN003379J$MERCK$Ogasawara Y, Sasaki T, Nakayama T, Imafuku I. Pj-075-3 Study of 6 cases of nervous system immune-related adverse event (N-irAE) caused by immune checkpoint inhibitors. 65th Annual Meeting of the Japanese Society of Neurology and 19th Asian Oceanian. 504$$$E$M$Y$$$20240712$$MD$JP$JP
239389922$23938992$2$F$$20240712$20240604$20240719$EXP$$US-GSK-US2024GSK069001$GLAXOSMITHKLINE$Olives TD, Sweat CN, Dorsey-Spitz L, Bahadori-Esfahani F, Arens AM, Cole JB, et al. Extracorporeal Membrane Oxygenation: Rescue Therapy in Pediatric Bupropion Cardiotoxicity. Journal of Pediatric Intensive Care. 2023$$$$$Y$$$20240719$$MD$US$US
239389953$23938995$3$F$20240401$20240916$20240604$20240924$EXP$$DK-BEH-2024173090$CSL BEHRING$$62$YR$A$F$Y$48$KG$20240924$$MD$DK$DK
239389982$23938998$2$F$$20240902$20240604$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-089411$BRISTOL MYERS SQUIBB$$5$DEC$A$F$Y$$$20240902$$MD$JP$JP
239390193$23939019$3$F$20240101$20240605$20240604$20240717$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-16471$SAMSUNG BIOEPIS$$87$YR$E$M$Y$62$KG$20240717$$CN$CA$CA
239390212$23939021$2$F$$20240619$20240604$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202405017050$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240701$$CN$US$US
239390223$23939022$3$F$20240101$20240626$20240604$20240702$EXP$$BR-009507513-2405BRA009463$MERCK$$37$YR$$M$Y$$$20240702$$HP$BR$BR
239390263$23939026$3$F$$20240605$20240604$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00843$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
239390512$23939051$2$F$$20240712$20240604$20240712$PER$$US-ALXN-202405USA002087US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
239390523$23939052$3$F$20240501$20240718$20240604$20240806$PER$$US-ALXN-202405USA002017US$ALEXION PHARMACEUTICALS$$83$YR$$M$Y$$$20240719$$CN$US$US
239390552$23939055$2$F$20240401$20240711$20240604$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-026415$JAZZ$$9$YR$$M$Y$$$20240716$$CN$US$US
239390563$23939056$3$F$20230101$20240910$20240604$20240913$EXP$$JP-009507513-2405JPN003381J$MERCK$Baba C, Hirata H, Matsumoto H, Matsuyama H, Oono T, Hidaka I, et al.. Acute Liver injury arising from combination therapy for advanced renal-cell-carcinoma that was caused by immune-related adverse effects and/or was drug induced. The Nishinihon journal of urology. 2024;86(4):237-44$70$YR$$M$Y$41$KG$20240913$$MD$JP$JP
239390582$23939058$2$F$20240415$20240623$20240604$20240701$EXP$$RO-SANDOZ INC.-SDZ2024RO053473$SANDOZ$$$$$M$Y$60$KG$20240701$$MD$RO$RO
239390592$23939059$2$F$$20240708$20240604$20240709$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031906$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240710$$CN$US$US
239390603$23939060$3$F$20220304$20240826$20240604$20240828$EXP$$NVSJ2024JP006544$NOVARTIS$$50$YR$$M$Y$$$20240828$$MD$JP$JP
239390673$23939067$3$F$$20240920$20240604$20240927$30DAY$$CH-JNJFOC-20240582858$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$CH$CH
239390883$23939088$3$F$20240306$20240912$20240604$20240917$30DAY$$US-SANDOZ INC.-SDZ2024US054104$SANDOZ$$12$YR$$M$Y$$$20240917$$CN$US$US
239391032$23939103$2$F$$20240530$20240604$20240924$PER$$US-ABBVIE-5786600$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
239391066$23939106$6$F$20240101$20240919$20240604$20240926$EXP$$ES-ABBVIE-5783921$ABBVIE$$$$$M$Y$$$20240926$$CN$ES$ES
239391113$23939111$3$F$$20240625$20240604$20240717$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-16500$SAMSUNG BIOEPIS$$63$YR$A$F$Y$$$20240717$$PH$DE$DE
239391142$23939114$2$F$20240101$20240702$20240604$20240709$EXP$$US-009507513-2405USA009263$MERCK$$$$$M$Y$$$20240709$$CN$US$US
239391155$23939115$5$F$20240401$20240912$20240604$20240913$EXP$$JP-009507513-2405JPN003207J$MERCK$Tomooka K, Yamada H, Yokoyama S, Sakai Y, Sogou Y, Yoshida E, et al.. U-40-13 A Case of Immune Checkpoint Inhibitor-Related Myocarditis in a Patient with Chronic Active Cardiomyopathy Which was Successfully Treated with Steroid Therapy. The 163rd Tokai Regional Meeting of the Japanese Circulation Society. 51$56$YR$$F$Y$$$20240913$$MD$JP$JP
239391172$23939117$2$F$20220101$20240806$20240604$20240811$EXP$$US-ABBVIE-5783016$ABBVIE$$$$$F$Y$$$20240811$$CN$US$US
239391248$23939124$8$F$20240525$20240705$20240604$20240712$30DAY$$US-JNJFOC-20240577952$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240712$$CN$US$US
239391282$23939128$2$F$20240101$20240729$20240604$20240807$PER$$US-SA-2024SA165335$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240807$$MD$US$US
239391292$23939129$2$F$20240115$20240626$20240604$20240703$EXP$$JP-GSK-JP2024JPN045767$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$JP$JP
239391322$23939132$2$F$20240101$20240710$20240604$20240716$EXP$$US-ABBVIE-5783897$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
239391334$23939133$4$F$20220916$20240703$20240604$20240708$EXP$$US-ABBVIE-5783659$ABBVIE$$65$YR$$F$Y$58$KG$20240708$$CN$US$US
239391392$23939139$2$F$$20240628$20240604$20240705$30DAY$$ZA-JNJFOC-20240571599$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$ZA$ZA
239391402$23939140$2$F$$20240624$20240604$20240709$30DAY$$TW-JNJFOC-20240578302$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$HP$TW$TW
239391472$23939147$2$F$20240101$20240711$20240604$20240722$PER$$US-SA-2024SA165369$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240722$$MD$US$US
239391563$23939156$3$F$20240531$20240807$20240604$20240808$EXP$$NVSJ2024JP006484$NOVARTIS$$41$YR$$M$Y$92$KG$20240809$$PH$JP$JP
239391613$23939161$3$F$$20240910$20240604$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-086242$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240912$$MD$JP$JP
239391693$23939169$3$F$$20240814$20240604$20240822$EXP$$US-ABBVIE-5785191$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
239391904$23939190$4$F$20240517$20240628$20240604$20240712$30DAY$$GB-JNJFOC-20240571231$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$CN$GB$GB
239391942$23939194$2$F$$20240705$20240604$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088665$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240710$$HP$US$US
239391962$23939196$2$F$20240501$20240902$20240604$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089087$BRISTOL MYERS SQUIBB$$23$YR$A$M$Y$$$20240902$$HP$US$US
239392013$23939201$3$F$20240501$20240625$20240604$20240701$EXP$$JP-SA-2024SA164140$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240702$$MD$JP$JP
239392102$23939210$2$F$$20240703$20240604$20240708$30DAY$$IL-JNJFOC-20240581632$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$PH$IL$IL
239392282$23939228$2$F$$20240703$20240605$20240711$EXP$$JP-AMGEN-JPNSP2024104503$AMGEN$$$$$$Y$$$20240710$$PH$JP$JP
239392302$23939230$2$F$$20240701$20240605$20240710$PER$$US-SA-2024SA166736$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$MD$US$US
239392363$23939236$3$F$$20240702$20240605$20240706$EXP$$US-ABBVIE-5783764$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
239392453$23939245$3$F$$20240703$20240605$20240706$EXP$$CA-ABBVIE-5775367$ABBVIE$$$$E$M$Y$$$20240706$$CN$CA$CA
239392462$23939246$2$F$20240513$20240627$20240605$20240703$30DAY$$US-AMGEN-USASL2024107251$AMGEN$$$$$$Y$$$20240703$$CN$US$US
239392492$23939249$2$F$20240501$20240918$20240605$20240923$EXP$$ZA-ABBVIE-5786457$ABBVIE$$44$YR$$M$Y$$$20240923$$CN$ZA$ZA
239392562$23939256$2$F$$20240806$20240605$20240817$PER$$US-SA-2024SA165508$SANOFI AVENTIS$$57$YR$A$F$Y$57.1$KG$20240817$$MD$US$US
239392592$23939259$2$F$$20240916$20240605$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US054665$SANDOZ$$$$$$Y$$$20240919$$HP$US$US
239392782$23939278$2$F$20240410$20240807$20240605$20240808$PER$$US-ALXN-A202308469$ALEXION PHARMACEUTICALS$$59$YR$$F$Y$$$20240808$$MD$US$US
239392803$23939280$3$F$20090101$20240626$20240605$20240812$EXP$$US-AstraZeneca-2024A125766$ASTRAZENECA$$69$YR$$F$Y$73$KG$20240812$$MD$US$
239392852$23939285$2$F$20240513$20240930$20240605$20240930$EXP$$GB-JNJFOC-20240606835$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$GB$GB
239393005$23939300$5$F$20240501$20240627$20240605$20240703$EXP$$ES-ABBVIE-5775875$ABBVIE$$57$YR$$M$Y$$$20240703$$CN$ES$ES
239393062$23939306$2$F$20240103$20240705$20240605$20240716$EXP$$US-NOVOPROD-1230563$NOVO NORDISK$$82$YR$$F$Y$62.585$KG$20240716$$MD$US$US
239393193$23939319$3$F$$20240716$20240605$20240723$EXP$$US-ABBVIE-5779823$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
239393263$23939326$3$F$$20240620$20240605$20240708$PER$$US-AstraZeneca-2024A121237$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$US$
239393392$23939339$2$F$20160101$20240702$20240605$20240715$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108066$ZYDUS PHARM$$$$$$Y$$$20240715$$HP$US$US
239393522$23939352$2$F$$20240912$20240605$20240917$30DAY$$US-SANDOZ INC.-SDZ2024US054621$SANDOZ$$$$$M$Y$$$20240917$$CN$US$US
239393583$23939358$3$F$20240423$20240816$20240605$20240826$EXP$$CA-CELLTRION INC.-2024CA011872$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
239393602$23939360$2$F$20240101$20240802$20240605$20240826$PER$$CA-TOLMAR, INC.-24CA049437$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
239393682$23939368$2$F$$20240802$20240605$20240826$PER$$CA-TOLMAR, INC.-24CA049457$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
239393692$23939369$2$F$$20240905$20240605$20240924$PER$$CA-TOLMAR, INC.-24CA049456$TOLMAR$$$$$M$Y$$$20240924$$CN$CA$CA
239393712$23939371$2$F$20240517$20240624$20240605$20240715$PER$$CA-TOLMAR, INC.-24CA049466$TOLMAR$$75$YR$$M$Y$$$20240715$$HP$CA$CA
239393722$23939372$2$F$$20240903$20240605$20240905$EXP$$US-JNJFOC-20240578738$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240905$$CN$US$US
239393793$23939379$3$F$20240101$20240831$20240605$20240910$EXP$$CA-CELLTRION INC.-2024CA012130$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
239393812$23939381$2$F$20230101$20240820$20240605$20240827$PER$$US-AMGEN-USASP2024109040$AMGEN$$52$YR$A$F$Y$$$20240827$$CN$US$US
239393844$23939384$4$F$$20240912$20240605$20240916$PER$$NVSC2024US117295$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
239393882$23939388$2$F$20240806$20240809$20240605$20240813$EXP$$US-AMGEN-USASP2024106450$AMGEN$$61$YR$A$M$Y$68.027$KG$20240813$$CN$US$US
239393942$23939394$2$F$$20240529$20240605$20240920$EXP$$US-CHATTEMPRD-2024OHG019558$CHATTEM$Swatek JL, Marco SM, Midthun KM. Over-the-Counter Medications Encountered in the Postmortem Pediatric Population from 2010-2020. J Anal Toxicol. 2024 May 21;bkae042. doi:10.1093/jat/bkae042/7678880.$4$MON$I$M$Y$$$20240920$$HP$US$US
239393973$23939397$3$F$$20240802$20240605$20240805$EXP$$NVSJ2024JP006537$NOVARTIS$$$$A$M$Y$$$20240806$$MD$JP$JP
239393983$23939398$3$F$20231201$20240718$20240605$20240729$EXP$$CA-CELLTRION INC.-2023CA024600$CELLTRION$$$$$$Y$$$20240729$$HP$CA$CA
239394082$23939408$2$F$20240301$20240613$20240605$20240712$PER$$US-AstraZeneca-2024A110849$ASTRAZENECA$$23341$DY$$M$Y$$$20240712$$CN$US$
239394242$23939424$2$F$$20240719$20240605$20240719$PER$$NVSC2024US117206$NOVARTIS$$$$$M$Y$$$20240719$$CN$US$US
239394542$23939454$2$F$$20240804$20240605$20240827$PER$$CA-TOLMAR, INC.-24CA049211$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
239394552$23939455$2$F$$20240813$20240605$20240904$PER$$CA-TOLMAR, INC.-24CA049231$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
239394572$23939457$2$F$20240425$20240722$20240605$20240727$PER$$US-ABBVIE-5785295$ABBVIE$$61$YR$$M$Y$$$20240727$$CN$US$US
239394594$23939459$4$F$20240101$20240712$20240605$20240725$EXP$$JP-AMGEN-JPNSP2024103425$AMGEN$$77$YR$E$M$Y$$$20240725$$HP$JP$JP
239394702$23939470$2$F$20240530$20240627$20240605$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090396$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240702$$CN$US$US
239394723$23939472$3$F$20240101$20240829$20240605$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-016491$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240904$$$US$US
239394852$23939485$2$F$20240105$20240627$20240605$20240702$EXP$$BG-ABBVIE-5780765$ABBVIE$$30$YR$$F$Y$$$20240702$$MD$BG$BG
239394922$23939492$2$F$20220718$20240911$20240605$20240913$EXP$$CA-SANDOZ INC.-NVSC2022CA133065$SANDOZ$$72$YR$$M$Y$$$20240913$$CN$CA$CA
239394992$23939499$2$F$$20240618$20240605$20240701$EXP$$JP-AMGEN-JPNSP2024108650$AMGEN$$$$$$Y$$$20240630$$PH$JP$JP
239395015$23939501$5$F$20240829$20240829$20240605$20240904$EXP$$CA-TAKEDA-2024TUS031454$TAKEDA$$73$YR$$M$Y$$$20240904$$CN$CA$CA
239395033$23939503$3$F$$20240731$20240605$20240807$30DAY$$TR-JNJFOC-20240577749$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$TR$TR
239395052$23939505$2$F$$20240710$20240605$20240715$PER$$NVSC2024US117415$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
239395173$23939517$3$F$$20240821$20240605$20240904$PER$$US-SA-2024SA163396$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240904$$MD$US$US
239395192$23939519$2$F$20240101$20240702$20240605$20240711$PER$$US-SA-2024SA163014$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240711$$MD$US$US
239395202$23939520$2$F$20240801$20240826$20240605$20240906$PER$$US-SA-2024SA167452$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240906$$MD$US$US
239395242$23939524$2$F$20231201$20240825$20240605$20240902$EXP$$AU-CELLTRION INC.-2024AU013133$CELLTRION$$$$$$Y$$$20240902$$MD$AU$AU
239395252$23939525$2$F$20240527$20240903$20240605$20240905$EXP$$US-JNJFOC-20240585597$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$PH$US$US
239395262$23939526$2$F$20240129$20240903$20240605$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-089048$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$53.4$KG$20240903$$PH$JP$JP
239395312$23939531$2$F$$20240909$20240605$20240917$EXP$$JP-AMGEN-JPNSP2024109550$AMGEN$$$$$$Y$$$20240917$$MD$JP$JP
239395355$23939535$5$F$20240917$20240918$20240605$20240925$EXP$$US-GSK-US2024067701$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
239395422$23939542$2$F$$20240726$20240605$20240805$30DAY$$US-GSK-US2024067154$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
239395462$23939546$2$F$20191220$20240628$20240605$20240710$EXP$$JP-GSK-JP2020JPN208488$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$JP$JP
239395522$23939552$2$F$$20240624$20240605$20240702$EXP$$IT-AUROBINDO-AUR-APL-2024-027102$AUROBINDO$Ferrante L. Maria e Ivo. due storie, lo stesso sospetto diagnostico. Focus Farmacovigilanza Anno XXVI - n.. 2023;117$77$YR$$F$Y$$$20240702$$MD$IT$IT
239395674$23939567$4$F$20240101$20240709$20240605$20240805$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000460$DECIPHERA PHARMACEUTICALS$$61$YR$A$F$Y$$$20240805$$CN$US$US
239395732$23939573$2$F$$20240808$20240605$20240811$PER$$US-AMGEN-USASP2024107475$AMGEN$$$$A$F$Y$$$20240811$$CN$US$US
239395752$23939575$2$F$$20240902$20240605$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089715$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240902$$CN$US$US
239395774$23939577$4$F$20200101$20240801$20240605$20240808$EXP$$US-SA-2024SA166187$SANOFI AVENTIS$$49$YR$A$M$Y$67.13$KG$20240808$$MD$US$US
239395814$23939581$4$F$20240501$20240708$20240605$20240716$PER$$US-SA-2024SA164112$SANOFI AVENTIS$$27$YR$A$F$Y$90.9$KG$20240716$$MD$US$US
239395842$23939584$2$F$20240501$20240708$20240605$20240717$PER$$US-SA-2024SA163694$SANOFI AVENTIS$$14$YR$T$F$Y$43$KG$20240717$$MD$US$US
239395873$23939587$3$F$20240525$20240729$20240605$20240731$PER$$US-AMGEN-USASP2024109345$AMGEN$$83$YR$E$M$Y$$$20240731$$CN$US$US
239395882$23939588$2$F$20220101$20240625$20240605$20240703$EXP$$HR-CELLTRION INC.-2024HR009936$CELLTRION$$$$$$Y$$$20240703$$MD$HR$HR
239395942$23939594$2$F$20240523$20240819$20240605$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202406000781$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240821$$CN$US$US
239396352$23939635$2$F$20220930$20240720$20240605$20240728$EXP$$CA-CELLTRION INC.-2022CA017143$CELLTRION$$$$$$Y$$$20240729$$HP$CA$CA
239396402$23939640$2$F$$20240903$20240605$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090058$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240904$$CN$US$US
239396453$23939645$3$F$$20240910$20240605$20240918$EXP$$JP-ROCHE-3574080$ROCHE$Hamada T, Inoue K, Kirishi H, Muneishi S A. A case of small cell lung cancer extensive stage where aggravation of paraneoplastic neurological syndrome due to an immune checkpoint inhibitor was noted. [Abstract number: K-12]. The 70th Chugoku-Shikoku Regional Meeting of the Japanese Respiratory Society. 2024;63.$73$YR$E$F$Y$$$20240918$$MD$JP$JP
239396513$23939651$3$F$20240101$20240823$20240605$20240917$PER$$US-SA-2024SA162756$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240918$$CN$US$US
239396532$23939653$2$F$20231004$20240730$20240605$20240808$EXP$$JP-009507513-2311JPN000199J$MERCK$$41$YR$$F$Y$$$20240808$$MD$JP$JP
239396674$23939667$4$F$20240101$20240731$20240605$20240806$EXP$$IE-ABBVIE-5783639$ABBVIE$$66$YR$$F$Y$$$20240806$$HP$IE$IE
239396684$23939668$4$F$$20240709$20240605$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04526$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239396772$23939677$2$F$20240401$20240828$20240605$20240902$EXP$$US-ABBVIE-5785685$ABBVIE$$42$YR$$F$Y$$$20240902$$CN$US$US
239396813$23939681$3$F$$20240709$20240605$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04533$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239396924$23939692$4$F$20240522$20240708$20240605$20240710$PER$$US-JNJFOC-20240568311$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240710$$PH$US$US
239396953$23939695$3$F$$20240709$20240605$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04536$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239397022$23939702$2$F$20240501$20240725$20240605$20240805$PER$$US-SA-2024SA164089$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240804$$MD$US$US
239397032$23939703$2$F$$20240628$20240605$20240708$30DAY$$SG-SA-2024SA162883$SANOFI AVENTIS$$$$$$Y$$$20240708$$HP$SG$SG
239397053$23939705$3$F$20240401$20240722$20240605$20240729$PER$$US-SA-2024SA167553$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240729$$MD$US$US
239397093$23939709$3$F$20240501$20240806$20240605$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04541$LUPIN$$$$$$Y$$$20240813$$CN$US$US
239397372$23939737$2$F$$20240627$20240605$20240704$EXP$$US-JNJFOC-20240585491$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240704$$HP$US$US
239397423$23939742$3$F$$20240729$20240605$20240806$30DAY$$PL-JNJFOC-20240583031$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$PL$PL
239397472$23939747$2$F$$20240702$20240605$20240708$PER$$US-BIOGEN-2024BI01267349$BIOGEN$$$$$F$Y$$$20240708$$MD$US$US
239397483$23939748$3$F$20240101$20240729$20240605$20240805$EXP$$US-ABBVIE-5783849$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
239397502$23939750$2$F$$20240706$20240605$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-026476$AUROBINDO$Kelly E, Adel F, McKie PM, Barsness GW.. FIBROSING MEDIASTINITIS AS A CAUSE OF FATAL PULMONARYARTERIAL HYPERTENSION. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):3803$61$YR$$F$Y$$$20240717$$HP$US$US
239397543$23939754$3$F$$20240701$20240605$20240716$30DAY$$DE-JNJFOC-20240584574$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$DE$DE
239397802$23939780$2$F$$20240729$20240605$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202406001973$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240731$$CN$US$US
239397824$23939782$4$F$$20240913$20240605$20240918$PER$$NVSC2024US117597$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
239397903$23939790$3$F$20240319$20240723$20240605$20240724$EXP$$GR-SANDOZ INC.-SDZ2024GR038940$SANDOZ$$75$YR$$M$Y$65.5$KG$20240724$$MD$GR$GR
239397915$23939791$5$F$20240716$20240823$20240605$20240829$EXP$$NVSC2024US117246$NOVARTIS$$48$YR$$F$Y$77.5$KG$20240829$$CN$US$US
239397933$23939793$3$F$$20240706$20240605$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002370$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
239397943$23939794$3$F$20240101$20240724$20240605$20240731$EXP$$CA-CELLTRION INC.-2024CA013225$CELLTRION$$$$$$Y$$$20240731$$MD$CA$CA
239397974$23939797$4$F$20240530$20240705$20240605$20240722$30DAY$$US-JNJFOC-20240586370$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240721$$PH$US$US
239398033$23939803$3$F$$20240625$20240605$20240711$30DAY$$US-GSK-US2024067163$GLAXOSMITHKLINE$$$$$M$Y$$$20240711$$CN$US$US
239398093$23939809$3$F$$20240709$20240605$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04566$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239398222$23939822$2$F$20211122$20240628$20240605$20240705$EXP$IE-HPRA-2024-113115$IE-TERSERA THERAPEUTICS LLC-2024TRS002820$TERSERA THERAPEUTICS$$$$$$Y$$$20240705$$MD$IE$IE
239398242$23939824$2$F$20151001$20240627$20240605$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-026359$AUROBINDO$N. Amel , M. Hadjadj  and W. Maoudh.. Risperidone induce recurrence ofsevere acute respiratory distress ina patient with psychotic disorders.. European Psychiatr. PY41(suppl1):S674$61$YR$$F$Y$$$20240706$$HP$FR$FR
239398253$23939825$3$F$20240527$20240724$20240605$20240731$EXP$$CN-GSK-CN2024APC067395$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$CN$CN
239398383$23939838$3$F$20240501$20240823$20240605$20240829$EXP$$US-RECORDATI-2024003363$RECORDATI$$$$$$Y$$$20240829$$CN$US$US
239398493$23939849$3$F$$20240702$20240605$20240704$EXP$$JP-GSK-JP2024JPN068410$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$MD$JP$JP
239398512$23939851$2$F$$20240625$20240605$20240703$30DAY$$US-GSK-US2024AMR067576$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$PH$US$US
239398583$23939858$3$F$$20240701$20240605$20240706$PER$$US-AMGEN-USASP2024109829$AMGEN$$$$$M$Y$$$20240706$$CN$US$US
239398852$23939885$2$F$$20240902$20240605$20240905$EXP$$SK-JNJFOC-20240584891$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$MD$SK$SK
239398903$23939890$3$F$$20240709$20240605$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04462$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239399073$23939907$3$F$$20240703$20240605$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-089447$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$MD$JP$JP
239399262$23939926$2$F$$20240402$20240605$20240726$PER$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00098$Unknown Manufacturer$$$$$$Y$$$20240726$$HP$US$US
239399404$23939940$4$F$20240501$20240712$20240605$20240716$PER$$US-AMGEN-USASP2024110170$AMGEN$$92$YR$E$F$Y$$$20240716$$CN$US$US
239399452$23939945$2$F$20240321$20240719$20240605$20240806$PER$$US-ALXN-202405USA002123US$ALEXION PHARMACEUTICALS$$55$YR$$M$Y$$$20240719$$CN$US$US
239399472$23939947$2$F$20240525$20240722$20240605$20240730$EXP$$JP-MTPC-MTPC2024-0011364$MITSUBISHI TANABE PHARMA$$63$YR$$M$Y$$$20240730$$MD$JP$JP
239399612$23939961$2$F$$20240715$20240605$20240716$PER$$NVSC2024US117413$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
239399623$23939962$3$F$$20240710$20240605$20240711$EXP$$NVSC2024US117438$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
239399642$23939964$2$F$20240501$20240822$20240605$20240909$PER$$US-RISINGPHARMA-US-2024RISSPO00160$RISING PHARMACEUTICALS$$$$$F$Y$44.4$KG$20240909$$CN$US$US
239399723$23939972$3$F$$20240719$20240605$20240806$PER$$US-ALXN-202405USA002075US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239399773$23939977$3$F$20240523$20240618$20240605$20240701$EXP$$US-BEH-2024173050$CSL BEHRING$$35$YR$A$F$Y$76.644$KG$20240701$$HP$US$US
239400022$23940002$2$F$20240313$20240816$20240605$20240820$EXP$$TN-ABBVIE-5786523$ABBVIE$$37$YR$$M$Y$$$20240820$$CN$TN$TN
239400263$23940026$3$F$20231211$20240612$20240605$20240702$EXP$$JP-009507513-2312JPN003729J$MERCK$Hirose R, Ota S, Shinkai M, Kamiya Y, Yamamoto S, Sekine T, et al.. 53 A case of immune-related adverse event type 1 diabetes mellitus (irAE-T1DM) in which treatment was started before the onset of ketosis as a result of routine examination during administration of pembrolizumab. The 695th Kanto Regional Meeting of The Japanese Society of Internal Medicine$50$YR$$F$Y$$$20240702$$MD$JP$JP
239400273$23940027$3$F$20240515$20240704$20240605$20240709$EXP$$IN-ROCHE-3575585$ROCHE$$58$YR$A$M$Y$$$20240705$$CN$IN$IN
239400306$23940030$6$F$20240515$20240816$20240605$20240828$EXP$$HK-SA-2024SA166185$SANOFI AVENTIS$$69$YR$E$M$Y$83$KG$20240828$$HP$HK$HK
239400362$23940036$2$F$$20240802$20240605$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090108$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240805$$CN$US$US
239400392$23940039$2$F$20240124$20240729$20240605$20240806$PER$$US-JNJFOC-20240583914$JOHNSON AND JOHNSON$$90$YR$E$M$Y$70.37$KG$20240806$$MD$US$US
239400573$23940057$3$F$20240401$20240731$20240605$20240803$EXP$$US-ABBVIE-5773046$ABBVIE$$52$YR$$M$Y$$$20240803$$CN$US$US
239400662$23940066$2$F$$20240906$20240605$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089800$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240919$$CN$US$US
239400723$23940072$3$F$$20240704$20240605$20240711$EXP$$CA-GSK-CA2023152977$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$CA$CA
239400842$23940084$2$F$$20240626$20240605$20240702$EXP$$US-ABBVIE-5785579$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
239401023$23940102$3$F$20240521$20240827$20240605$20240902$EXP$$US-ABBVIE-5785572$ABBVIE$$73$YR$$F$Y$54$KG$20240902$$CN$US$US
239401054$23940105$4$F$20240101$20240808$20240605$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012528$UNITED THERAPEUTICS$$$$$F$Y$$$20240817$$$US$US
239401093$23940109$3$F$$20240722$20240605$20240726$EXP$$US-ABBVIE-5783999$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
239401173$23940117$3$F$$20240813$20240605$20240823$EXP$$IT-AUROBINDO-AUR-APL-2024-026374$AUROBINDO$Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G, et al. Stevens-Johnson Syndrome Associated with Drugs and Vaccines in Children: A Case-Control Study. PLOS ONE. 2013;8(7):1-8$45$MON$$F$Y$$$20240823$$HP$IT$IT
239401274$23940127$4$F$$20240815$20240605$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089826$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240823$$CN$US$US
239401333$23940133$3$F$$20240801$20240605$20240808$EXP$$NVSC2024US116432$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
239401732$23940173$2$F$20240530$20240725$20240605$20240731$EXP$$US-TAKEDA-2024TUS055921$TAKEDA$$68$YR$$M$Y$$$20240731$$MD$US$US
239401802$23940180$2$F$20240529$20240826$20240605$20240828$PER$$US-AMGEN-USASP2024107797$AMGEN$$38$YR$A$F$Y$$$20240828$$HP$US$US
239401832$23940183$2$F$20240101$20240829$20240605$20240905$EXP$$JP-009507513-2405JPN003944J$MERCK$$$$$F$Y$$$20240905$$PH$JP$JP
239401902$23940190$2$F$$20240701$20240605$20240707$EXP$$JP-GSK-JP2024JPN066522$GLAXOSMITHKLINE$$$$$$Y$$$20240707$$MD$JP$JP
239401912$23940191$2$F$20210601$20240903$20240605$20240909$EXP$$CA-TAKEDA-CA202020803$TAKEDA$$59$YR$$F$Y$$$20240909$$CN$CA$CA
239401953$23940195$3$F$20240529$20240724$20240605$20240806$PER$$US-ALXN-202405USA002152US$ALEXION PHARMACEUTICALS$$82$YR$$F$Y$$$20240806$$CN$US$US
239401982$23940198$2$F$$20240502$20240605$20240710$PER$$FR-ROCHE-3558149$ROCHE$$$$$F$Y$$$20240628$$MD$FR$FR
239402012$23940201$2$F$$20240706$20240605$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-027388$AUROBINDO$Hall J, McMillan D, Leonardi N, Mullane R.. WHEN ZEBRA BODIES ARE NOT JUST BLACK AND WHITE.. Am-J-Kidney-Dis. 2024;83 (Suppl.)(4):S21-S22$21$YR$$F$Y$$$20240718$$MD$US$US
239402043$23940204$3$F$20240401$20240828$20240605$20240916$PER$$BR-TOLMAR, INC.-24BR049368$TOLMAR$$11$YR$$M$Y$$$20240916$$CN$BR$BR
239402074$23940207$4$F$20240529$20240723$20240605$20240725$EXP$$AT-TAKEDA-2024TUS055790$TAKEDA$$83$YR$$M$Y$$$20240725$$HP$AT$AT
239402112$23940211$2$F$$20240711$20240605$20240719$EXP$$CA-AstraZeneca-2024A126106$ASTRAZENECA$$$$$M$Y$$$20240719$$MD$CA$
239402152$23940215$2$F$20240101$20240627$20240605$20240704$PER$$US-009507513-2406USA000019$MERCK$$$$$M$Y$$$20240704$$CN$US$US
239402212$23940221$2$F$$20240710$20240605$20240716$EXP$$IE-TAKEDA-2024TUS056087$TAKEDA$$$$$F$Y$$$20240716$$MD$IE$IE
239402243$23940224$3$F$20240603$20240718$20240605$20240722$EXP$$JP-ABBVIE-5787465$ABBVIE$$60$YR$$F$Y$$$20240722$$MD$JP$JP
239402302$23940230$2$F$20230701$20240711$20240605$20240714$EXP$$NVSC2024FR116206$NOVARTIS$Vija Racaru L, Krim M, Rivet V, Mourey L, Courbon, PF. Myelodysplastic Syndrome Related to Successful Treatment With177Lu-PSMA for Metastatic Castration-Refractory Prostate Cancer. CLINICAL NUCLEAR MEDICINE. 2024$77$YR$$M$Y$$$20240714$$HP$FR$FR
239402332$23940233$2$F$$20240826$20240605$20240916$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000340$BECTON DICKINSON$$$$$$Y$$$20240916$$CN$GB$GB
239402352$23940235$2$F$$20240624$20240605$20240708$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00282$Unknown Manufacturer$$$$$$Y$$$20240708$$CN$BR$BR
239402393$23940239$3$F$20240403$20240712$20240605$20240717$EXP$$US-BIOGEN-2024BI01267291$BIOGEN$$57$YR$$F$Y$$$20240717$$CN$US$US
239402412$23940241$2$F$$20240819$20240605$20240826$EXP$$CA-TAKEDA-2024TUS017824$TAKEDA$$$$$F$Y$$$20240826$$HP$CA$CA
239402443$23940244$3$F$$20240624$20240605$20240701$EXP$$DE-AUROBINDO-AUR-APL-2024-026330$AUROBINDO$Khanafer A, Henkes H, Cohen J, Albina-Palmarola P, Gomori JM, Forsting M, et al.. Endovascular treatment of distal anterior cerebral artery aneurysms using flow modulation devices: mid- and long-term results from a two-center study.. Frontiers in Neurology.. 2024;(15)$$$$F$Y$$$20240701$$MD$DE$DE
239402512$23940251$2$F$20240527$20240709$20240605$20240724$EXP$$CA-TEVA-VS-3204892$TEVA$$38$YR$$F$Y$$$20240724$$CN$CA$CA
239402553$23940255$3$F$20240603$20240924$20240605$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090051$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240925$$CN$US$US
239402672$23940267$2$F$$20240701$20240605$20240709$EXP$$PT-TEVA-VS-3205516$TEVA$Pimenta JL, Liu PC, Marques PV, Morais SA. ANABOLIC STEROID-INDUCED HEPATITIS - A HIDDEN DANGER AT THE GYM. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl.) 308 abstr. 177; Pimenta JL, Liu PC, Marques PV, Morais SA. ANABOLIC STEROID-INDUCED HEPATITIS - A HIDDEN DANGER AT THE GYM. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl.) 308 abstr. 177.$32$YR$$M$Y$$$20240709$$HP$PT$PT
239402695$23940269$5$F$20240101$20240917$20240605$20240920$EXP$$JP-JNJFOC-20240400277$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240920$$HP$JP$JP
239402853$23940285$3$F$$20240621$20240605$20240709$EXP$$IN-ROCHE-3573670$ROCHE$$52$YR$A$F$Y$$$20240701$$CN$IN$IN
239402873$23940287$3$F$$20240806$20240605$20240812$EXP$$US-862174955-ML2024-03294$MICRO LABS$$51$YR$A$M$Y$77$KG$20240812$$CN$US$US
239402902$23940290$2$F$$20240712$20240605$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090426$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240715$$CN$US$US
239402954$23940295$4$F$20240101$20240918$20240605$20240927$EXP$$CA-CELLTRION INC.-2024CA012441$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
239403042$23940304$2$F$$20240911$20240605$20240926$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000342$BECTON DICKINSON$$$$$$Y$$$20240926$$CN$GB$GB
239403055$23940305$5$F$20240528$20240910$20240605$20240912$EXP$$CA-JNJFOC-20240433152$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240912$$HP$CA$CA
239403213$23940321$3$F$$20240724$20240605$20240727$EXP$$US-AstraZeneca-2024A128397$ASTRAZENECA$$$$$M$Y$$$20240727$$CN$US$
239403312$23940331$2$F$20230331$20240626$20240605$20240703$EXP$$CA-GSK-CA2023AMR050238$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$CA$CA
239403332$23940333$2$F$20240101$20240626$20240605$20240710$PER$$US-ABBVIE-5783447$ABBVIE$$$$$M$Y$49.895$KG$20240710$$CN$US$US
239403432$23940343$2$F$$20240709$20240605$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04538$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239403453$23940345$3$F$$20240717$20240605$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-016535$UNITED THERAPEUTICS$$$$$F$Y$56.009$KG$20240725$$MD$US$US
239403482$23940348$2$F$20210928$20240821$20240605$20240830$EXP$$JP-ROCHE-3048967$ROCHE$$56$YR$A$M$Y$74.8$KG$20240830$$MD$JP$JP
239403533$23940353$3$F$20240101$20240828$20240605$20240903$EXP$$US-ABBVIE-5783887$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
239403572$23940357$2$F$$20240719$20240605$20240806$PER$$US-ALXN-202405USA002162US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240719$$CN$US$US
239403582$23940358$2$F$20231201$20240917$20240605$20240927$EXP$$CA-UCBSA-2024026871$UCB$$54$YR$$M$Y$$$20240927$$CN$CA$CA
239403602$23940360$2$F$$20240705$20240605$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090410$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240711$$CN$US$US
239403692$23940369$2$F$20200625$20240710$20240605$20240717$EXP$$CA-TAKEDA-CA202021099$TAKEDA$$28$YR$$M$Y$98$KG$20240717$$HP$CA$CA
239403724$23940372$4$F$20240301$20240917$20240605$20240920$EXP$$US-ABBVIE-5785263$ABBVIE$$48$YR$$F$Y$68$KG$20240920$$CN$US$US
239403732$23940373$2$F$20240101$20240829$20240605$20240903$EXP$$US-ABBVIE-5785640$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
239403842$23940384$2$F$$20240911$20240605$20240927$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000338$BECTON DICKINSON$$$$$$Y$$$20240927$$CN$GB$GB
239403852$23940385$2$F$$20240826$20240605$20240916$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000343$BECTON DICKINSON$$$$$$Y$$$20240916$$CN$GB$GB
239403862$23940386$2$F$$20240911$20240605$20240927$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000337$BECTON DICKINSON$$$$$$Y$$$20240927$$CN$GB$GB
239403872$23940387$2$F$$20240819$20240605$20240912$30DAY$$US-BECTON DICKINSON-US-BD-24-000333$BECTON DICKINSON$$$$$$Y$$$20240912$$CN$US$US
239403883$23940388$3$F$20240520$20240910$20240605$20240926$30DAY$$ES-BECTON DICKINSON-ES-BD-24-000332$BECTON DICKINSON$$$$$$Y$$$20240926$$CN$ES$ES
239403892$23940389$2$F$$20240729$20240605$20240827$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000334$BECTON DICKINSON$$$$$$Y$$$20240827$$CN$GB$GB
239403902$23940390$2$F$20240520$20240730$20240605$20240827$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000329$BECTON DICKINSON$$$$$$Y$$$20240827$$CN$GB$GB
239403912$23940391$2$F$$20240822$20240605$20240916$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000339$BECTON DICKINSON$$$$$$Y$$$20240916$$CN$GB$GB
239403982$23940398$2$F$20240301$20240723$20240605$20240731$EXP$$CA-TAKEDA-2024TUS041871$TAKEDA$$71$YR$$F$Y$$$20240731$$CN$CA$CA
239403997$23940399$7$F$20210101$20240910$20240605$20240916$EXP$$US-UCBSA-2024022141$UCB$$$$$F$Y$$$20240916$$CN$US$US
239404013$23940401$3$F$$20240828$20240605$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US050460$SANDOZ$$$$$M$Y$$$20240902$$CN$US$US
239404132$23940413$2$F$$20240718$20240605$20240806$PER$$US-ALXN-202405USA001948US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239404142$23940414$2$F$$20240706$20240605$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-026314$AUROBINDO$Khan F, Naccour S, Khan S, Patel V, Shaik Z. UNMASKING PROLIFERATIVE  GLOMERULONEPHRITIS WITH MONOCLONAL  IMMUNOGLOBULIN DEPOSITION DISEASE: A  DIAGNOSTIC + MANAGEMENT CHALLENGE. NKF Spring Clinical Meetings. 2024;83 (Suppl.2)(4):S29 abstr. 96$33$YR$$M$Y$$$20240717$$MD$US$US
239404212$23940421$2$F$$20240815$20240605$20240820$EXP$$ZA-TAKEDA-2023TUS084534$TAKEDA$$$$$M$Y$$$20240820$$CN$ZA$ZA
239404262$23940426$2$F$20240429$20240626$20240605$20240704$EXP$$DE-AUROBINDO-AUR-APL-2024-026459$AUROBINDO$$61$YR$$F$Y$57$KG$20240704$$MD$DE$DE
239404304$23940430$4$F$20230101$20240828$20240605$20240902$EXP$$US-TAKEDA-2024TUS051822$TAKEDA$$$$$F$Y$51.3$KG$20240902$$CN$US$US
239404332$23940433$2$F$20240513$20240701$20240605$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016678$UNITED THERAPEUTICS$$29$YR$$F$Y$65.76$KG$20240705$$$US$US
239404343$23940434$3$F$20240604$20240725$20240605$20240729$EXP$$JP-ASTELLAS-2024JP003820$ASTELLAS$$7$DEC$$M$Y$$$20240729$$MD$JP$JP
239404352$23940435$2$F$$20240724$20240605$20240728$PER$$US-AstraZeneca-2024A128068$ASTRAZENECA$$$$$M$Y$$$20240728$$CN$US$
239404465$23940446$5$F$20240606$20240822$20240605$20240829$EXP$$CA-TAKEDA-2024TUS017779$TAKEDA$$29$YR$$M$Y$$$20240829$$CN$CA$CA
239404475$23940447$5$F$20210609$20240829$20240605$20240902$EXP$$CA-TAKEDA-2021TUS035067$TAKEDA$$39$YR$$F$Y$$$20240902$$CN$CA$CA
239404502$23940450$2$F$20240322$20240702$20240605$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01862$AMNEAL$$$$$$Y$$$20240904$$CN$US$US
239404512$23940451$2$F$$20240522$20240605$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01262$AMNEAL$$$$$F$Y$$$20240904$$CN$US$US
239404522$23940452$2$F$$20240729$20240605$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01793$AMNEAL$$$$$F$Y$$$20240904$$CN$US$US
239404552$23940455$2$F$$20240905$20240605$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090897$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240905$$HP$US$US
239404592$23940459$2$F$$20240911$20240605$20240927$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000344$BECTON DICKINSON$$$$$$Y$$$20240927$$CN$GB$GB
239404814$23940481$4$F$20231001$20240919$20240605$20240926$EXP$$GB-TAKEDA-2024TUS052319$TAKEDA$$32$YR$$F$Y$$$20240926$$CN$GB$GB
239404872$23940487$2$F$$20240827$20240605$20240902$PER$$US-TAKEDA-2024TUS056336$TAKEDA$$$$$$Y$$$20240902$$MD$US$US
239405033$23940503$3$F$20240604$20240718$20240605$20240722$EXP$$BE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032027$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$72.6$KG$20240722$$HP$BE$BE
239405046$23940504$6$F$20240528$20240903$20240605$20240910$EXP$$US-RDY-CLI/USA/24/0007934$DR REDDYS$$15$YR$T$F$Y$$$20240910$$MD$US$US
239405092$23940509$2$F$20221228$20240625$20240605$20240702$EXP$$PT-ASTELLAS-2024US015865$ASTELLAS$$49$YR$$F$Y$$$20240702$$CN$PT$PT
239405122$23940512$2$F$20240425$20240708$20240605$20240712$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016231$UNITED THERAPEUTICS$$71$YR$$M$Y$87.528$KG$20240712$$$US$US
239405322$23940532$2$F$20221101$20240722$20240605$20240726$EXP$$CA-JNJFOC-20221135353$JOHNSON AND JOHNSON$$79$YR$E$F$Y$60$KG$20240726$$CN$CA$CA
239405393$23940539$3$F$$20240709$20240605$20240716$PER$$US-Vifor (International) Inc.-VIT-2024-04889$VIFOR$$$$$M$Y$$$20240716$$HP$US$US
239405422$23940542$2$F$$20240618$20240605$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01609$AMNEAL$$$$$M$Y$$$20240906$$CN$US$US
239405472$23940547$2$F$$20240715$20240605$20240718$PER$$US-TAKEDA-2024TUS056222$TAKEDA$$$$$F$Y$$$20240718$$CN$US$US
239405512$23940551$2$F$20190101$20240828$20240605$20240829$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-248375$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$54.6$KG$20240829$$CN$ES$ES
239405543$23940554$3$F$20240101$20240715$20240605$20240717$EXP$$BG-ABBVIE-5784386$ABBVIE$$76$YR$$F$Y$$$20240717$$CN$BG$BG
239405572$23940557$2$F$$20240730$20240605$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090562$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$53.07$KG$20240810$$CN$US$US
239405652$23940565$2$F$$20240711$20240605$20240716$EXP$$ES-ROCHE-3568542$ROCHE$$$$$$Y$$$20240716$$MD$ES$ES
239405683$23940568$3$F$20240101$20240719$20240605$20240725$PER$$US-AMGEN-USASP2024108700$AMGEN$$36$YR$A$F$Y$$$20240725$$HP$US$US
239405722$23940572$2$F$$20240711$20240605$20240715$EXP$$NVSC2024GR117282$NOVARTIS$$$$A$F$Y$$$20240715$$MD$GR$GR
239405844$23940584$4$F$$20240708$20240605$20240718$EXP$$US-ROCHE-3532581$ROCHE$$67$YR$E$F$Y$$$20240718$$CN$US$US
239405952$23940595$2$F$20240101$20240717$20240605$20240722$EXP$$US-ABBVIE-5785909$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
239406102$23940610$2$F$20240601$20240805$20240605$20240807$PER$$US-AMGEN-USASP2024110394$AMGEN$$62$YR$A$M$Y$$$20240807$$CN$US$US
239406702$23940670$2$F$$20240909$20240605$20240920$EXP$FI-EMA-DD-20210322-jain_h1-103937$FI-STERISCIENCE B.V.-2024-ST-000732$Steriscience PTE$Kivivuori SM, Karikoski R, Koukila-Kahkola P, Anttila VJ, Saarinen-Pihkala UM. Zygomycosis Presenting a Major Clinical Challenge: Case Report on Rhizomucor pusillus Infection in a Stem-Cell-Transplant Recipient.. Mycopathologia. 2011;172 (3):241-245$14$YR$$F$Y$$$20240920$$MD$FI$FI
239406812$23940681$2$F$20240401$20240807$20240605$20240807$PER$$US-ALXN-202405USA002107US$ALEXION PHARMACEUTICALS$$64$YR$$F$Y$$$20240807$$CN$US$US
239406822$23940682$2$F$$20240718$20240605$20240806$PER$$US-ALXN-202405USA001995US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239406842$23940684$2$F$$20240911$20240605$20240926$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000335$BECTON DICKINSON$$$$$$Y$$$20240926$$CN$GB$GB
239406883$23940688$3$F$$20240826$20240605$20240829$EXP$$NVSC2024CO106466$NOVARTIS$$$$$M$Y$98$KG$20240829$$CN$CO$CO
239407012$23940701$2$F$20240525$20240530$20240605$20240801$EXP$$IL-REGENERON PHARMACEUTICALS, INC.-2024-080545$REGENERON$$76$YR$$M$Y$$$20240801$$MD$IL$IL
239407133$23940713$3$F$$20240702$20240605$20240705$EXP$$FR-TAKEDA-2024TUS055176$TAKEDA$$$$E$M$Y$$$20240705$$CN$FR$FR
239407152$23940715$2$F$20240101$20240716$20240605$20240724$PER$$US-JNJFOC-20240576969$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240724$$CN$US$US
239407332$23940733$2$F$$20240916$20240605$20240923$EXP$$US-TAKEDA-2022TUS007042$TAKEDA$$$$$M$Y$95$KG$20240923$$CN$US$US
239407593$23940759$3$F$20231211$20240712$20240605$20240719$EXP$$US-AstraZeneca-2024A126285$ASTRAZENECA$$20568$DY$$F$Y$$$20240719$$MD$US$
239407813$23940781$3$F$$20240708$20240605$20240718$EXP$$LT-ROCHE-3572700$ROCHE$Kobeckis K. Perforated ileum in the background of large B-cell lymphoma treatment. DOI: 10.35988/sm-hs.2024.088. Health Sciences 2024;3:38-9.$88$YR$E$F$Y$$$20240718$$MD$LT$LT
239407953$23940795$3$F$20240101$20240704$20240605$20240710$EXP$$CO-GSK-CO2023AMR131994$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$CO$CO
239407975$23940797$5$F$20240502$20240702$20240605$20240709$EXP$$NVSC2024CO103349$NOVARTIS$$61$YR$$M$Y$82$KG$20240709$$CN$CO$CO
239408172$23940817$2$F$$20240709$20240605$20240710$PER$$US-JNJFOC-20240590104$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$PH$US$US
239408782$23940878$2$F$$20240802$20240605$20240805$EXP$$NVSC2024US116828$NOVARTIS$$$$$F$Y$$$20240804$$HP$US$US
239408802$23940880$2$F$$20240910$20240605$20240917$EXP$$US-AMGEN-USASP2024106236$AMGEN$$$$$F$Y$$$20240917$$CN$US$US
239408822$23940882$2$F$20240101$20240808$20240605$20240813$EXP$$US-UCBSA-2024022241$UCB$$$$$M$Y$$$20240813$$CN$US$US
239408882$23940888$2$F$$20240620$20240605$20240704$30DAY$$FR-JNJFOC-20240603244$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$PH$FR$FR
239408972$23940897$2$F$$20240725$20240605$20240805$30DAY$$US-GSK-US2024067760$GLAXOSMITHKLINE$$$$$M$Y$$$20240804$$CN$US$US
239409082$23940908$2$F$20240101$20240826$20240605$20240902$EXP$$US-ABBVIE-5785583$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
239409192$23940919$2$F$$20240628$20240605$20240709$EXP$$JP-ROCHE-3577005$ROCHE$Kadonosono K, Vicente A, Jaycock P, Quezada-Ruiz C, Singh N, Hillier R. Optimisation of the PDS:Key Steps and Impact on Patient Outcomes.. The 128 Annual Meeting of the Japanese Ophthalmological Society (Hybrid Open) 2024;128:O3-003.$$$$$Y$$$20240705$$HP$JP$IQ
239409212$23940921$2$F$$20240812$20240605$20240814$EXP$$FR-ROCHE-3575859$ROCHE$$80$YR$E$F$Y$$$20240814$$MD$FR$FR
239409222$23940922$2$F$20240101$20240711$20240605$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-016200$UNITED THERAPEUTICS$$$$$F$Y$71.202$KG$20240713$$$US$US
239409262$23940926$2$F$20240501$20240628$20240605$20240705$EXP$$US-AstraZeneca-2024A125294$ASTRAZENECA$$875$MON$$M$Y$$$20240705$$MD$US$
239409354$23940935$4$F$$20240916$20240605$20240924$PER$$US-ROCHE-3576349$ROCHE$$61$YR$A$F$Y$$$20240924$$CN$US$US
239409422$23940942$2$F$$20240809$20240605$20240813$EXP$$NVSC2024IT117326$NOVARTIS$$$$$M$Y$$$20240813$$MD$IT$IT
239409433$23940943$3$F$$20240708$20240605$20240724$30DAY$$TR-JNJFOC-20240589476$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$TR$TR
239409452$23940945$2$F$$20240704$20240605$20240716$30DAY$$AU-JNJFOC-20240582297$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$AU$AU
239409552$23940955$2$F$$20240625$20240605$20240709$30DAY$$CL-JNJFOC-20240589354$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$CL$CL
239409852$23940985$2$F$20220101$20240904$20240605$20240904$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-090504$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240904$$MD$CA$CA
239409932$23940993$2$F$20231101$20240627$20240605$20240704$EXP$$CH-VIIV HEALTHCARE LIMITED-CH2024EME068788$VIIV$$$$$$Y$$$20240704$$MD$CH$CH
239410013$23941001$3$F$20240428$20240621$20240605$20240704$PER$$US-AstraZeneca-2024A117831$ASTRAZENECA$$20862$DY$$F$Y$$$20240704$$HP$US$
239410282$23941028$2$F$$20240705$20240605$20240710$30DAY$$BR-JNJFOC-20240585123$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$BR$BR
239410344$23941034$4$F$$20240916$20240605$20240918$EXP$$US-PFIZER INC-PV202400073312$PFIZER$Mills, L.. Adverse Events in Patients Aged 90 Days or Younger Receiving Ketamine in the Emergency Department. Pediatric emergency care. 2024;40(9):665-667$29$YR$$M$Y$$$20240918$$MD$US$US
239410563$23941056$3$F$$20240626$20240605$20240709$30DAY$$AR-JNJFOC-20240588362$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$AR$AR
239410782$23941078$2$F$20240101$20240823$20240605$20240828$EXP$$US-ABBVIE-5785633$ABBVIE$$58$YR$$F$Y$$$20240828$$CN$US$US
239411234$23941123$4$F$20230820$20240923$20240605$20240926$PER$$CA-PFIZER INC-202400172061$PFIZER$$37$YR$$F$Y$$$20240926$$HP$CA$CA
239411262$23941126$2$F$$20240731$20240605$20240731$EXP$$CA-PFIZER INC-202400185197$PFIZER$$61$YR$$M$Y$$$20240731$$HP$CA$CA
239411322$23941132$2$F$20240501$20240702$20240605$20240704$EXP$$FR-PFIZER INC-202400182406$PFIZER$$57$YR$$M$Y$74.5$KG$20240704$$MD$FR$FR
239411372$23941137$2$F$$20240708$20240605$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090997$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240710$$CN$US$US
239411422$23941142$2$F$$20240904$20240605$20240911$EXP$$JP-009507513-2405JPN003187J$MERCK$$$$$F$Y$$$20240911$$MD$JP$JP
239411442$23941144$2$F$$20240628$20240605$20240722$30DAY$$CA-JNJFOC-20240587414$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$PH$CA$CA
239411465$23941146$5$F$20240101$20240816$20240605$20240823$EXP$$US-UCBSA-2024024368$UCB$$$$$M$Y$61.224$KG$20240823$$CN$US$US
239411634$23941163$4$F$20240529$20240922$20240605$20240925$30DAY$$CA-PFIZER INC-202400182496$PFIZER$$63$YR$$M$Y$$$20240925$$PH$CA$CA
239411644$23941164$4$F$$20240920$20240605$20240925$30DAY$$US-PFIZER INC-PV202400050447$PFIZER$$13$YR$$M$Y$$$20240925$$MD$US$US
239411667$23941166$7$F$20240602$20240913$20240605$20240919$30DAY$$US-PFIZER INC-202400185433$PFIZER$$14$YR$$F$Y$$$20240919$$CN$US$US
239411704$23941170$4$F$20240527$20240822$20240605$20240827$30DAY$$US-PFIZER INC-202400180501$PFIZER$$25$MON$$F$Y$$$20240827$$CN$US$US
239411797$23941179$7$F$$20240926$20240605$20240926$30DAY$$US-PFIZER INC-202400184875$PFIZER$$12$YR$$F$Y$$$20240926$$CN$US$US
239411813$23941181$3$F$$20240909$20240605$20240911$30DAY$$US-PFIZER INC-202400180221$PFIZER$$9$YR$$F$Y$$$20240911$$CN$US$US
239411842$23941184$2$F$20240101$20240728$20240605$20240729$EXP$$CA-PFIZER INC-202400186308$PFIZER$$48$YR$$M$Y$$$20240729$$HP$CA$CA
239411853$23941185$3$F$20240521$20240731$20240605$20240805$EXP$$US-TAKEDA-2024TUS053601$TAKEDA$$52$YR$$F$Y$68.03$KG$20240805$$MD$US$US
239411874$23941187$4$F$$20240911$20240605$20240913$30DAY$$US-PFIZER INC-202400181846$PFIZER$$13$YR$$F$Y$$$20240913$$CN$US$US
239412114$23941211$4$F$20240530$20240926$20240605$20240930$30DAY$$US-PFIZER INC-202400184663$PFIZER$$13$YR$$M$Y$$$20240930$$CN$US$US
239412162$23941216$2$F$$20240805$20240605$20240806$PER$$NVSC2024US116359$NOVARTIS$$$$$$Y$$$20240806$$HP$US$US
239412212$23941221$2$F$$20240717$20240605$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090593$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$69.85$KG$20240722$$CN$US$US
239412222$23941222$2$F$$20240708$20240605$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090281$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240709$$HP$US$US
239412262$23941226$2$F$$20240708$20240605$20240716$30DAY$$AU-JNJFOC-20240587309$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$PH$AU$AU
239412283$23941228$3$F$$20240802$20240605$20240808$30DAY$$US-GSK-US2024068942$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
239412412$23941241$2$F$20240531$20240806$20240605$20240808$PER$$US-AMGEN-USASP2024110136$AMGEN$$74$YR$E$M$Y$$$20240808$$CN$US$US
239412523$23941252$3$F$$20240709$20240605$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04564$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239412613$23941261$3$F$20240602$20240806$20240605$20240808$PER$$US-AMGEN-USASP2024109861$AMGEN$$67$YR$E$F$Y$$$20240808$$CN$US$US
239412652$23941265$2$F$$20240703$20240605$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090567$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240704$$CN$US$US
239412682$23941268$2$F$20240529$20240709$20240605$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090377$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$78.47$KG$20240716$$CN$US$US
239412723$23941272$3$F$$20240625$20240605$20240704$EXP$$DE-AUROBINDO-AUR-APL-2024-026786$AUROBINDO$Brettner F, Brettner F, Appelt W, Berlinger A, Perras J, Steindl D et.al.. Cardiovascular arrest afterintoxication with an extremelyhigh dose of Venlafaxine. ?Bridgeto recovery? using ExtracorporealLife Support. Die Anaesthesiologie [Anesthesiology]. 2024;1-4$20$YR$$F$Y$50$KG$20240704$$MD$DE$DE
239412752$23941275$2$F$$20240723$20240605$20240726$EXP$$JP-OTSUKA-2024_015601$OTSUKA$$$$$F$Y$$$20240726$$MD$JP$JP
239412822$23941282$2$F$$20240716$20240605$20240729$EXP$$RO-AUROBINDO-AUR-APL-2024-026313$AUROBINDO$Rosu S, Tiba D, Ichim A, Balteanu M.. Combination with reserved prognosis: TB- rheumatoid arthritis.. .. Pneumologia. 2022;71(4):150-3.$54$YR$$F$Y$$$20240729$$HP$RO$RO
239412854$23941285$4$F$$20240920$20240605$20240925$30DAY$$DE-PFIZER INC-202400174749$PFIZER$$$$$$Y$$$20240925$$PH$DE$DE
239412896$23941289$6$F$$20240906$20240605$20240912$30DAY$$US-PFIZER INC-202400184179$PFIZER$$71$YR$$F$Y$$$20240912$$CN$US$US
239412933$23941293$3$F$$20240828$20240605$20240830$30DAY$$US-PFIZER INC-202400181148$PFIZER$$$$$F$Y$$$20240830$$CN$US$US
239412942$23941294$2$F$$20240712$20240605$20240712$EXP$$MY-PFIZER INC-PV202400073495$PFIZER$$81$YR$$F$Y$$$20240712$$CN$MY$MY
239412952$23941295$2$F$$20240702$20240605$20240703$EXP$$GB-PFIZER INC-PV202400073337$PFIZER$$69$YR$$F$Y$$$20240703$$CN$GB$GB
239412983$23941298$3$F$$20240912$20240605$20240919$30DAY$$GR-PFIZER INC-PV202400072479$PFIZER$$5$YR$$M$Y$41$KG$20240919$$CN$GR$GR
239412993$23941299$3$F$20240529$20240816$20240605$20240822$30DAY$$KR-PFIZER INC-PV202400071650$PFIZER$$$$$$Y$$$20240822$$CN$KR$KR
239413002$23941300$2$F$20240519$20240910$20240605$20240912$30DAY$$JO-PFIZER INC-202400182583$PFIZER$$$$C$$Y$$$20240912$$HP$JO$JO
239413043$23941304$3$F$$20240819$20240605$20240822$30DAY$$CO-PFIZER INC-202400185367$PFIZER$$6$YR$$F$Y$$$20240822$$CN$CO$CO
239413053$23941305$3$F$$20240914$20240605$20240920$30DAY$$JP-PFIZER INC-202400184691$PFIZER$$$$A$$Y$$$20240920$$MD$JP$JP
239413095$23941309$5$F$20181018$20240808$20240605$20240812$EXP$$US-PFIZER INC-202400186050$PFIZER$$80$YR$$F$Y$65.77$KG$20240812$$MD$US$US
239413212$23941321$2$F$$20240701$20240605$20240709$30DAY$$CA-JNJFOC-20240587236$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$CA$CA
239413263$23941326$3$F$20220301$20240711$20240605$20240720$EXP$$DE-AUROBINDO-AUR-APL-2024-026677$AUROBINDO$Prechal D, Arntzen D, Klaas L, Paulmann M, Mockenhaupt M, Thimme R, et al. DRESS as a rare differential diagnosis in eosinophilia, skin rash and acute hepatitis.. Zeitschrift fur Gastroenterologie. 2024;0044-2771$21$YR$$F$Y$55$KG$20240720$$MD$DE$DE
239413272$23941327$2$F$20230101$20240722$20240605$20240729$PER$$US-BIOGEN-2023BI01219707$BIOGEN$$$$$F$Y$$$20240729$$CN$US$US
239413353$23941335$3$F$20240529$20240723$20240605$20240725$EXP$$NZ-MYLANLABS-2024M1049336$MYLAN$$45$YR$$M$Y$94.9$KG$20240725$$HP$NZ$NZ
239413495$23941349$5$F$$20240916$20240605$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090465$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240918$$CN$US$US
239413759$23941375$9$F$$20240925$20240605$20240930$30DAY$$US-PFIZER INC-202400180580$PFIZER$$15$YR$$M$Y$$$20240930$$CN$US$US
239413772$23941377$2$F$$20240728$20240605$20240729$EXP$$CA-PFIZER INC-202400185457$PFIZER$$43$YR$$F$Y$$$20240729$$HP$CA$CA
239413802$23941380$2$F$$20240725$20240605$20240731$EXP$$GB-MYLANLABS-2024M1049914$MYLAN$$$$$M$Y$$$20240731$$HP$GB$GB
239413902$23941390$2$F$$20240729$20240605$20240731$PER$$US-AstraZeneca-2024A128021$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
239414022$23941402$2$F$$20240712$20240605$20240716$PER$$US-PFIZER INC-202400186089$PFIZER$$21$YR$$F$Y$$$20240716$$HP$US$US
239414033$23941403$3$F$20240604$20240820$20240605$20240822$PER$$US-PFIZER INC-PV202300079458$PFIZER$$65$YR$$F$Y$$$20240822$$CN$US$US
239414122$23941412$2$F$20240527$20240726$20240605$20240805$EXP$$CA-CELLTRION INC.-2024CA013172$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
239414326$23941432$6$F$20231103$20240827$20240605$20240904$EXP$$CA-CELLTRION INC.-2024CA013275$CELLTRION$$$$$$Y$$$20240904$$CN$CA$CA
239414362$23941436$2$F$20240531$20240812$20240605$20240813$PER$$US-AMGEN-USASP2024110733$AMGEN$$78$YR$E$F$Y$$$20240813$$CN$US$US
239414394$23941439$4$F$$20240621$20240605$20240808$EXP$$US-THEA-2024001125$Thea Pharma$$$$$F$Y$$$20240808$$CN$US$US
239414472$23941447$2$F$$20240802$20240605$20240810$EXP$$BR-CELLTRION INC.-2024BR013124$CELLTRION$$$$$$Y$$$20240810$$CN$BR$BR
239414562$23941456$2$F$20231110$20240723$20240605$20240730$PER$$CN-REGENERON PHARMACEUTICALS, INC.-2024-081617$REGENERON$$67$YR$$M$Y$$$20240730$$HP$CN$CN
239414592$23941459$2$F$$20240707$20240605$20240708$PER$$US-PFIZER INC-PV202400073410$PFIZER$$65$YR$$F$Y$$$20240708$$HP$US$US
239414672$23941467$2$F$$20240918$20240605$20240923$PER$$US-PFIZER INC-202400186249$PFIZER$$78$YR$$F$Y$64.86$KG$20240923$$HP$US$US
239414862$23941486$2$F$20240511$20240722$20240605$20240728$EXP$$US-SA-2024SA165729$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240728$$MD$US$US
239414882$23941488$2$F$20231001$20240805$20240605$20240813$EXP$$JP-009507513-2401JPN005336J$MERCK$$9$DEC$$M$Y$$$20240813$$MD$JP$JP
239415085$23941508$5$F$20240407$20240809$20240605$20240813$PER$$US-PFIZER INC-PV202400072227$PFIZER$$72$YR$$F$Y$69.388$KG$20240813$$CN$US$US
239415112$23941511$2$F$$20240528$20240605$20240916$PER$$US-HALEON-2179169$Haleon PLC$$78$YR$$F$Y$$$20240916$$CN$US$US
239415122$23941512$2$F$20240101$20240715$20240605$20240718$EXP$$CA-PFIZER INC-202400179534$PFIZER$$64$YR$$M$Y$$$20240718$$MD$CA$CA
239415192$23941519$2$F$$20240905$20240605$20240919$EXP$$JP-AMGEN-JPNSP2024108560$AMGEN$$1$MON$I$F$Y$$$20240919$$PH$JP$JP
239415383$23941538$3$F$$20240711$20240605$20240723$EXP$$GB-VERTEX PHARMACEUTICALS-2023-010048$VERTEX$$$$$M$Y$$$20240723$$CN$GB$GB
239415552$23941555$2$F$$20240604$20240605$20240718$EXP$$NVSC2024US117386$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
239415572$23941557$2$F$$20240614$20240605$20240709$PER$$US-BEH-2024172805$CSL BEHRING$$$$A$F$Y$$$20240709$$CN$US$US
239415963$23941596$3$F$20240501$20240529$20240605$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST002978$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
239416044$23941604$4$F$20230810$20240726$20240605$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-026496$AUROBINDO$$$DY$$F$Y$2$KG$20240807$$MD$FR$FR
239416052$23941605$2$F$20240301$20240717$20240605$20240726$EXP$$VE-ROCHE-3574610$ROCHE$$52$YR$A$M$Y$$$20240726$$MD$VE$VE
239416103$23941610$3$F$20231101$20240830$20240605$20240904$EXP$$NVSC2024FR117454$NOVARTIS$$$$A$F$Y$77$KG$20240904$$MD$FR$FR
239416114$23941611$4$F$$20240912$20240605$20240913$PER$$NVSC2024US118111$NOVARTIS$$$$$F$Y$$$20240913$$MD$US$US
239416142$23941614$2$F$20240403$20240808$20240605$20240815$EXP$$JP-AMGEN-JPNSP2024109365$AMGEN$$8$DEC$E$M$Y$$$20240815$$MD$JP$JP
239416165$23941616$5$F$20240501$20240816$20240605$20240822$PER$$US-BIOGEN-2024BI01267591$BIOGEN$$75$YR$$F$Y$$$20240822$$CN$US$US
239416204$23941620$4$F$$20240726$20240605$20240726$PER$$US-PFIZER INC-202400186388$PFIZER$$$$A$$Y$$$20240726$$MD$US$US
239416262$23941626$2$F$$20240709$20240605$20240721$EXP$GB-MLMSERVICE-20240402-PI004734-00190-1$GB-JUBILANT CADISTA PHARMACEUTICALS-2024GB000699$JUBILANT$Chou M, Lai L, Neveu M, Ritchie A. Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy. BMJ case reports. 2024;17(3):e256961$$$T$M$Y$$$20240719$$MD$GB$GB
239416482$23941648$2$F$20240513$20240805$20240605$20240826$PER$$CA-TOLMAR, INC.-24CA049209$TOLMAR$$77$YR$$M$Y$$$20240826$$CN$CA$CA
239416502$23941650$2$F$20240301$20240801$20240605$20240826$PER$$CA-TOLMAR, INC.-24CA049295$TOLMAR$$84$YR$$M$Y$$$20240826$$CN$CA$CA
239416583$23941658$3$F$$20240709$20240605$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090136$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240717$$CN$US$US
239416693$23941669$3$F$$20240621$20240605$20240802$EXP$GB-009507513-2405GBR005942$GB-MYLANLABS-2024M1050601$MYLAN$$$$$M$Y$$$20240802$$CN$GB$GB
239416783$23941678$3$F$20240603$20240701$20240605$20240706$PER$$US-AMGEN-USASP2024109392$AMGEN$$$$$F$Y$$$20240706$$HP$US$US
239416802$23941680$2$F$20240522$20240710$20240605$20240721$EXP$$US-BAYER-2024A080763$BAYER$$31$YR$A$M$Y$$$20240719$$HP$US$US
239416893$23941689$3$F$20240520$20240704$20240605$20240709$EXP$IT-MINISAL02-988045$IT-RDY-SPO/ITA/24/0008010$DR REDDYS$$65$YR$E$M$Y$51$KG$20240709$$MD$IT$IT
239417242$23941724$2$F$20240501$20240710$20240605$20240715$EXP$$US-AMGEN-USASP2024103659$AMGEN$$32$YR$A$M$Y$68.934$KG$20240715$$HP$US$US
239417372$23941737$2$F$20230707$20240809$20240605$20240819$EXP$CA-MMM-XWOMTJ32$CA-GSK-CA2023112008$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$HP$CA$CA
239417393$23941739$3$F$$20240701$20240605$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088849$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240709$$CN$US$US
239417502$23941750$2$F$20240501$20240711$20240605$20240711$30DAY$$AR-PFIZER INC-202400181750$PFIZER$$43$YR$$F$Y$$$20240711$$CN$AR$AR
239417562$23941756$2$F$$20240902$20240605$20240906$EXP$$IL-JNJFOC-20240600413$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$MD$IL$IL
239417584$23941758$4$F$$20240827$20240605$20240829$30DAY$$US-PFIZER INC-202400185726$PFIZER$$28$YR$$F$Y$$$20240829$$PH$US$US
239417643$23941764$3$F$20240401$20240701$20240605$20240709$EXP$$JP-009507513-2405JPN003764J$MERCK$$9$DEC$$F$Y$$$20240709$$MD$JP$JP
239417665$23941766$5$F$$20240619$20240605$20240702$EXP$$IN-ROCHE-3506335$ROCHE$$61$YR$A$F$Y$$$20240702$$CN$IN$IN
239417782$23941778$2$F$$20240806$20240605$20240808$EXP$$CA-PFIZER INC-PV202300182490$PFIZER$$63$YR$$F$Y$82.7$KG$20240808$$CN$CA$CA
239417822$23941782$2$F$$20240730$20240605$20240805$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024003992$BIOCON$$$$$$Y$$$20240805$$HP$CA$CA
239417852$23941785$2$F$$20240709$20240605$20240710$EXP$$US-BIOVITRUM-2024-US-008051$BIOVITRUM$$86$YR$$M$Y$$$20240710$$MD$US$US
239418052$23941805$2$F$20240101$20240723$20240605$20240731$EXP$$US-SA-2024SA165912$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240731$$MD$US$US
239418132$23941813$2$F$20240101$20240703$20240605$20240711$EXP$$US-SA-2024SA165919$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240711$$MD$US$US
239418182$23941818$2$F$$20240314$20240605$20240710$PER$$US-ROCHE-3527385$ROCHE$$48$YR$A$F$Y$$$20240628$$CN$US$US
239418303$23941830$3$F$20240505$20240701$20240605$20240711$EXP$$US-BIOGEN-2024BI01267443$BIOGEN$$78$YR$$F$Y$$$20240711$$CN$US$US
239418363$23941836$3$F$20240529$20240904$20240605$20240905$PER$$NVSC2024US117081$NOVARTIS$$55$YR$$F$Y$109$KG$20240905$$CN$US$US
239418386$23941838$6$F$20240416$20240726$20240605$20240730$EXP$$GB-MYLANLABS-2024M1047544$MYLAN$$$$$F$Y$$$20240730$$CN$GB$GB
239418392$23941839$2$F$20240603$20240827$20240605$20240828$PER$$US-AMGEN-USASP2024110776$AMGEN$$80$YR$E$F$Y$$$20240828$$CN$US$US
239418572$23941857$2$F$$20240524$20240605$20240906$PER$$US-FARMAPROD-202405-1949$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
239418842$23941884$2$F$20240101$20240620$20240605$20240703$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00423$UPSHER-SMITH$$$$$F$Y$65.76$KG$20240703$$HP$US$US
239418922$23941892$2$F$20220701$20240708$20240605$20240711$EXP$$DE-BAYER-2024A077612$BAYER$Jakob VL; Kraft K; Anthuber C. Toxisches Schocksyndrom durch S. Pyogenes bei einliegendem Levonorgestrel-IUP und Rheumatoider Arthritis - ein seltener Fall im gynaekologischen Dienst. 2023. Gemeinsamer Kongress der Bayerischen Gesellschaft fur Gynaekologie. 2023$42$YR$A$F$Y$$$20240711$$HP$DE$DE
239419023$23941902$3$F$20240501$20240827$20240605$20240902$EXP$$US-TAKEDA-2024TUS055116$TAKEDA$$1$YR$$F$Y$10.8$KG$20240902$$HP$US$US
239419042$23941904$2$F$20240501$20240819$20240605$20240828$PER$$US-SA-2024SA166164$SANOFI AVENTIS$$20$YR$A$M$Y$88$KG$20240828$$MD$US$US
239419093$23941909$3$F$20240528$20240720$20240605$20240726$EXP$$US-SA-2024SA166257$SANOFI AVENTIS$$56$YR$A$M$Y$94.34$KG$20240726$$MD$US$US
239419123$23941912$3$F$$20240806$20240605$20240814$PER$$US-SA-2024SA163528$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240814$$MD$US$US
239419243$23941924$3$F$20240604$20240705$20240605$20240715$PER$$US-SA-2024SA160636$SANOFI AVENTIS$$24$YR$A$F$Y$104$KG$20240715$$MD$US$US
239419292$23941929$2$F$20240501$20240906$20240605$20240914$PER$$US-SA-2024SA164045$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240914$$MD$US$US
239419342$23941934$2$F$$20240701$20240605$20240710$PER$$US-SA-2024SA166875$SANOFI AVENTIS$$38$YR$A$F$Y$63.95$KG$20240710$$MD$US$US
239419563$23941956$3$F$20240701$20240716$20240605$20240725$PER$$US-SA-2024SA163327$SANOFI AVENTIS$$42$YR$A$M$Y$151$KG$20240725$$MD$US$US
239419593$23941959$3$F$20240101$20240731$20240605$20240808$PER$$US-SA-2024SA166143$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240808$$MD$US$US
239419603$23941960$3$F$20240101$20240819$20240605$20240903$PER$$US-SA-2024SA164428$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240903$$MD$US$US
239419623$23941962$3$F$$20240724$20240605$20240802$PER$$US-SA-2024SA166112$SANOFI AVENTIS$$$$C$M$Y$$$20240802$$CN$US$US
239419752$23941975$2$F$$20240628$20240605$20240709$PER$$US-SA-2024SA165252$SANOFI AVENTIS$$$$E$F$Y$$$20240709$$MD$US$US
239419782$23941978$2$F$$20240803$20240605$20240811$PER$$US-SA-2024SA167138$SANOFI AVENTIS$$35$YR$A$F$Y$50.9$KG$20240811$$CN$US$US
239419982$23941998$2$F$20240101$20240801$20240605$20240809$PER$$US-SA-2024SA134347$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240809$$CN$US$US
239420052$23942005$2$F$$20240701$20240605$20240715$PER$$US-Calliditas-2024CAL00866$CALLIDITAS THERAPEUTICS$$20$YR$A$M$Y$40.8$KG$20240715$$CN$US$US
239420142$23942014$2$F$20240101$20240701$20240605$20240710$PER$$US-SA-2024SA139835$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240710$$CN$US$US
239420213$23942021$3$F$20240101$20240724$20240605$20240805$PER$$US-SA-2024SA166956$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240805$$MD$US$US
239420233$23942023$3$F$20240101$20240730$20240605$20240806$PER$$US-SA-2024SA094039$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240806$$CN$US$US
239420263$23942026$3$F$20240101$20240722$20240605$20240731$PER$$US-SA-2024SA166963$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240731$$MD$US$US
239420322$23942032$2$F$$20240627$20240605$20240708$PER$$US-SA-2024SA167923$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
239420342$23942034$2$F$20240531$20240628$20240605$20240709$PER$$US-SA-2024SA167673$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240709$$CN$US$US
239420382$23942038$2$F$20240101$20240704$20240605$20240717$PER$$US-SA-2024SA166301$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
239420412$23942041$2$F$20240101$20240812$20240605$20240821$PER$$US-SA-2024SA167956$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240821$$MD$US$US
239420632$23942063$2$F$$20240823$20240605$20240906$PER$$US-SA-2024SA162889$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240906$$MD$US$US
239420684$23942068$4$F$20231001$20240731$20240605$20240805$PER$$US-SA-2024SA160820$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240805$$MD$US$US
239420852$23942085$2$F$$20240704$20240605$20240708$EXP$$NVSC2024DE118105$NOVARTIS$$71$YR$$M$Y$$$20240708$$MD$DE$DE
239420944$23942094$4$F$20240527$20240906$20240605$20240910$EXP$$US-BAYER-2024A081525$BAYER$$31$YR$A$M$Y$$$20240910$$CN$US$US
239421124$23942112$4$F$20240522$20240628$20240605$20240705$30DAY$$US-GSK-US2024067641$GLAXOSMITHKLINE$$76$YR$$M$Y$59.864$KG$20240705$$MD$US$US
239421163$23942116$3$F$$20240805$20240605$20240807$EXP$$NVSC2019AR033331$NOVARTIS$$$$$F$Y$90$KG$20240807$$CN$AR$AR
239421232$23942123$2$F$$20240709$20240605$20240717$EXP$$DK-MYLANLABS-2024M1049612$MYLAN$Fage S, Johansen C.. Severe and therapeutic challenging oral erosive lichen planus treated with oral roflumilast.. Clin-Exp-Dermatol. 2023;48 (5):556-557$24$YR$$F$Y$$$20240717$$HP$DK$DK
239421292$23942129$2$F$20231206$20240626$20240605$20240702$PER$$NVSC2024US117952$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
239421553$23942155$3$F$$20240827$20240605$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090478$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240830$$HP$US$US
239421632$23942163$2$F$20230810$20240726$20240605$20240731$EXP$FR-AFSSAPS-LM2024000282$FR-MYLANLABS-2024M1049596$MYLAN$$$$N$$Y$2$KG$20240731$$MD$FR$FR
239421662$23942166$2$F$$20240619$20240605$20240701$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202405015585$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240701$$PH$FR$FR
239421742$23942174$2$F$$20240625$20240605$20240701$EXP$$GR-PFIZER INC-202400185060$PFIZER$$60$YR$$M$Y$$$20240701$$MD$GR$GR
239421754$23942175$4$F$20220513$20240716$20240605$20240718$EXP$$BA-PFIZER INC-PV202400073243$PFIZER$$69$YR$$F$Y$68$KG$20240718$$MD$BA$BA
239421962$23942196$2$F$20240422$20240524$20240605$20240906$EXP$$US-FARMAPROD-202405-1668$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240904$$CN$US$US
239421973$23942197$3$F$$20240711$20240605$20240715$EXP$$GB-ORGANON-O2406GBR000112$ORGANON$$$$$F$Y$$$20240715$$HP$GB$GB
239421983$23942198$3$F$$20240715$20240605$20240722$EXP$$US-TAKEDA-2024TUS051281$TAKEDA$$$$$M$Y$$$20240722$$CN$US$US
239422033$23942203$3$F$$20240708$20240605$20240715$EXP$$US-ABBVIE-5784569$ABBVIE$$$$$F$Y$43.998$KG$20240715$$CN$US$US
239422242$23942224$2$F$20240416$20240725$20240605$20240801$EXP$$CN-TAKEDA-2024TUS055926$TAKEDA$$61$YR$$M$Y$53$KG$20240801$$HP$CN$CN
239422313$23942231$3$F$$20240710$20240605$20240717$EXP$$PK-ROCHE-3495976$ROCHE$$66$YR$E$M$Y$$$20240717$$CN$PK$PK
239422364$23942236$4$F$20240501$20240808$20240605$20240821$PER$$US-Calliditas-2024CAL00874$CALLIDITAS THERAPEUTICS$$44$YR$A$M$Y$50.3$KG$20240821$$CN$US$US
239422375$23942237$5$F$20240501$20240920$20240605$20240926$EXP$$US-Calliditas-2024CAL00886$CALLIDITAS THERAPEUTICS$$50$YR$A$F$Y$94.3$KG$20240926$$CN$US$US
239422464$23942246$4$F$20240514$20240710$20240605$20240716$EXP$$US-ALKERMES INC.-ALK-2024-001519$ALKERMES$$57$YR$$F$Y$59.864$KG$20240716$$HP$US$US
239422472$23942247$2$F$20221208$20240715$20240605$20240723$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-34442$IPSEN$$92$YR$E$F$Y$$$20240723$$MD$CA$CA
239422522$23942252$2$F$$20240729$20240605$20240807$PER$$US-SA-2024SA166119$SANOFI AVENTIS$$74$YR$E$F$Y$60$KG$20240807$$MD$US$US
239422663$23942266$3$F$20240512$20240822$20240605$20240826$EXP$$DE-PFIZER INC-202400185058$PFIZER$$77$YR$$F$Y$58$KG$20240826$$MD$DE$DE
239422704$23942270$4$F$$20240730$20240605$20240801$EXP$$NZ-MYLANLABS-2024M1050448$MYLAN$$$$$M$Y$84.7$KG$20240801$$CN$NZ$NZ
239422822$23942282$2$F$20230924$20240625$20240605$20240702$EXP$$US-ALKERMES INC.-ALK-2024-001482$ALKERMES$$37$YR$$M$Y$121.27$KG$20240702$$HP$US$US
239422862$23942286$2$F$20240401$20240730$20240605$20240807$PER$$US-INCYTE CORPORATION-2024IN005574$INCYTE$$$$$$Y$$$20240807$$CN$US$US
239422892$23942289$2$F$$20240809$20240605$20240812$EXP$$NVSC2024AU117314$NOVARTIS$$$$$M$Y$$$20240812$$CN$AU$AU
239423093$23942309$3$F$20240501$20240814$20240605$20240821$EXP$$CA-JNJFOC-20240478988$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240821$$CN$CA$CA
239423202$23942320$2$F$$20240723$20240605$20240730$PER$$US-ALXN-202405USA002224US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
239423243$23942324$3$F$$20240909$20240605$20240911$30DAY$$GB-PFIZER INC-202400185405$PFIZER$$$$$$Y$$$20240911$$CN$GB$GB
239423332$23942333$2$F$$20240726$20240605$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088040$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240730$$CN$US$US
239423412$23942341$2$F$20240512$20240627$20240605$20240708$PER$$US-SA-2024SA162642$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240708$$MD$US$US
239423452$23942345$2$F$20240304$20240607$20240605$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-042117$REGENERON$$$$$$Y$$$20240911$$HP$US$US
239423852$23942385$2$F$20240101$20240606$20240605$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-062378$REGENERON$$$$$M$Y$$$20240911$$MD$US$US
239423872$23942387$2$F$$20240523$20240605$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-063660$REGENERON$$$$$$Y$$$20240911$$HP$US$US
239423922$23942392$2$F$20230101$20240610$20240605$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-068674$REGENERON$$$$$M$Y$$$20240911$$HP$US$US
239423942$23942394$2$F$20231201$20240613$20240605$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-064183$REGENERON$$$$$F$Y$$$20240911$$HP$US$US
239423972$23942397$2$F$20240424$20240703$20240605$20240708$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-069119$REGENERON$$$$$M$Y$$$20240708$$MD$US$US
239424112$23942411$2$F$$20240823$20240605$20240829$EXP$$NVSC2024US115865$NOVARTIS$$$$$F$Y$$$20240829$$HP$US$US
239424222$23942422$2$F$$20240718$20240605$20240725$EXP$$US-ALXN-202405USA001960US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$MD$US$US
239424274$23942427$4$F$20240601$20240829$20240605$20240904$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001136$BLUEPRINT MEDICINES$$74$YR$E$F$Y$$$20240905$$CN$US$US
239424282$23942428$2$F$$20240814$20240605$20240820$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001133$BLUEPRINT MEDICINES$$$$$F$Y$$$20240820$$CN$US$US
239424303$23942430$3$F$$20240819$20240605$20240828$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001135$BLUEPRINT MEDICINES$$$$$M$Y$$$20240828$$CN$US$US
239424332$23942433$2$F$$20240711$20240605$20240721$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001141$BLUEPRINT MEDICINES$$$$$F$Y$$$20240719$$CN$US$US
239424603$23942460$3$F$20100506$20240715$20240605$20240723$EXP$$US-BIOMARINAP-GB-2024-158369$BIOMARIN$$$$$$Y$$$20240723$$CN$US$US
239424812$23942481$2$F$20230101$20240822$20240605$20240828$PER$$US-BIOGEN-2023BI01236681$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
239424824$23942482$4$F$20240604$20240913$20240605$20240917$EXP$$AU-TAKEDA-2024TUS056479$TAKEDA$$44$YR$$F$Y$$$20240917$$CN$AU$AU
239424882$23942488$2$F$20240103$20240729$20240605$20240806$EXP$$ES-ABBVIE-5787155$ABBVIE$$73$YR$$M$Y$71$KG$20240806$$MD$ES$ES
239425013$23942501$3$F$20240517$20240913$20240605$20240918$EXP$$US-ROCHE-3574953$ROCHE$$70$YR$E$F$Y$55.33$KG$20240918$$CN$US$US
239425263$23942526$3$F$20240519$20240825$20240605$20240909$PER$$US-009507513-2405USA006302$MERCK$$57$YR$$F$Y$$$20240909$$PH$US$US
239425462$23942546$2$F$20240101$20240626$20240605$20240702$EXP$$GB-AMGEN-GBRSL2024095012$AMGEN$$75$YR$E$F$Y$$$20240701$$CN$GB$GB
239425612$23942561$2$F$20240518$20240703$20240605$20240705$EXP$$US-ABBVIE-5787776$ABBVIE$$71$YR$$M$Y$$$20240705$$CN$US$US
239425733$23942573$3$F$$20240905$20240605$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090755$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240905$$PH$US$US
239425742$23942574$2$F$20240531$20240904$20240605$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090743$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240904$$HP$US$US
239425902$23942590$2$F$20240415$20240628$20240605$20240703$EXP$$KR-OTSUKA-2024_015783$OTSUKA$$56$YR$$F$Y$$$20240703$$HP$KR$KR
239425962$23942596$2$F$20240501$20240716$20240605$20240719$EXP$$US-AstraZeneca-2024A127811$ASTRAZENECA$$32903$DY$$M$Y$$$20240719$$CN$US$
239426073$23942607$3$F$$20240718$20240605$20240720$PER$$NVSC2024US117938$NOVARTIS$$$$$F$Y$$$20240720$$CN$US$US
239426122$23942612$2$F$$20240806$20240605$20240809$EXP$$US-Taiho Oncology Inc-2024-005380$TAIHO ONCOLOGY INC$$63$YR$A$F$Y$60.33$KG$20240809$$CN$US$US
239426183$23942618$3$F$20240602$20240715$20240605$20240717$PER$$US-JNJFOC-20240603438$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240717$$CN$US$US
239426192$23942619$2$F$20190611$20240524$20240605$20240727$EXP$$BE-ABBVIE-20K-013-3509113-00$ABBVIE$$70$YR$$M$Y$$$20240727$$HP$BE$BE
239426202$23942620$2$F$20240518$20240709$20240605$20240715$EXP$$CO-ABBVIE-5787209$ABBVIE$$63$YR$$M$Y$72$KG$20240715$$HP$CO$CO
239426234$23942623$4$F$$20240918$20240605$20240920$PER$$US-PFIZER INC-202400186110$PFIZER$$49$YR$$F$Y$$$20240920$$CN$US$US
239426322$23942632$2$F$20240101$20240916$20240605$20240919$EXP$$US-SA-2024SA168100$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240919$$MD$US$US
239426352$23942635$2$F$$20240705$20240605$20240712$EXP$$US-AMGEN-USASP2024107732$AMGEN$Larson C.; Berinstein J.; Romain D. et al.. INTRAOPERATIVE AND POSTOPERATIVE OUTCOMES IN TOFACITINIBTREATED ACUTE SEVERE ULCERATIVE COLITIS PATIENTS UNDERGOING TOTAL ABDOMINAL COLECTOMY. Gastroenterology. 2024;166 (5):S-502-S-503$$$$$Y$$$20240712$$HP$US$US
239426362$23942636$2$F$$20240527$20240605$20240712$EXP$$US-AMGEN-USASP2024107778$AMGEN$Leelaviwat N; Parkash S; Prabhakar S.. A case of acquired thrombotic thrombocytopenic purpura following near-drowning. Clinical nephrology - Case nephrology - Case studies. 2024;12 (1):36-41$19$YR$A$F$Y$$$20240712$$MD$US$US
239426423$23942642$3$F$$20240925$20240605$20240930$EXP$$GB-PFIZER INC-2024SGN06285$PFIZER$$42$YR$$F$Y$$$20240930$$MD$GB$GB
239426472$23942647$2$F$20240101$20240705$20240605$20240715$PER$$US-SA-2024SA164128$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240715$$MD$US$US
239426542$23942654$2$F$$20240628$20240605$20240709$30DAY$$CH-JNJFOC-20240571949$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$CH$CH
239426552$23942655$2$F$20240101$20240701$20240605$20240709$EXP$$MX-AstraZeneca-2024A021519$ASTRAZENECA$$24588$DY$$F$Y$51$KG$20240709$$CN$MX$
239426773$23942677$3$F$20240101$20240912$20240605$20240919$PER$$JP-Eisai-EC-2024-166685$EISAI$$56$YR$A$F$Y$$$20240919$$MD$JP$JP
239426814$23942681$4$F$$20240926$20240605$20240930$30DAY$$US-PFIZER INC-202400175296$PFIZER$$13$YR$$M$Y$$$20240930$$CN$US$US
239426862$23942686$2$F$20240525$20240808$20240605$20240810$PER$$US-AMGEN-USASP2024110749$AMGEN$$70$YR$E$M$Y$$$20240810$$CN$US$US
239426932$23942693$2$F$$20240716$20240605$20240723$EXP$$SK-ROCHE-3577109$ROCHE$$$$$$Y$$$20240723$$MD$SK$SK
239426972$23942697$2$F$$20240712$20240605$20240715$EXP$$AT-TAKEDA-2024TUS042738$TAKEDA$Finsterer J. Exacerbating guillain barre syndrome eight days after vector based covid 19 vaccination. Case Reports In Infectious Diseases. 2021$32$YR$$M$Y$$$20240715$$MD$NP$AT
239427062$23942706$2$F$$20240908$20240605$20240910$EXP$$NL-BAUSCH-BL-2024-008640$BAUSCH AND LOMB$$$$E$M$Y$$$20240910$$MD$NL$NL
239427362$23942736$2$F$$20240815$20240605$20240815$PER$$NVSC2024US117914$NOVARTIS$$$$$$Y$$$20240815$$MD$US$US
239427662$23942766$2$F$20240401$20240711$20240605$20240722$EXP$$JP-009507513-2405JPN003932J$MERCK$$70$YR$$F$Y$$$20240719$$MD$JP$JP
239427782$23942778$2$F$20240503$20240626$20240605$20240705$EXP$$US-GENMAB-2024-01915$GENMAB$$56$YR$$F$Y$$$20240705$$PH$US$US
239427842$23942784$2$F$20240501$20240823$20240605$20240902$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-090771$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$83.91$KG$20240902$$CN$PR$PR
239427994$23942799$4$F$20240101$20240904$20240605$20240919$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00820$AVADEL CNS PHARMA$$$$$F$Y$69.841$KG$20240919$$CN$US$US
239428102$23942810$2$F$20230201$20240701$20240605$20240709$EXP$$DE-SA-2024SA165544$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240709$$MD$DE$DE
239428173$23942817$3$F$20240529$20240704$20240605$20240710$PER$$JP-Eisai-EC-2024-166899$EISAI$$$$E$F$Y$$$20240710$$MD$JP$JP
239428344$23942834$4$F$$20240912$20240605$20240917$EXP$$BE-PFIZER INC-PV202400073277$PFIZER$$80$YR$$$Y$$$20240917$$PH$BE$BE
239428533$23942853$3$F$$20240705$20240605$20240712$EXP$$JP-AstraZeneca-2024A127306$ASTRAZENECA$$81$YR$$F$Y$$$20240712$$MD$JP$
239428592$23942859$2$F$20240531$20240905$20240605$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090947$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240905$$CN$US$US
239428612$23942861$2$F$20240527$20240712$20240605$20240717$EXP$$US-RIGEL PHARMACEUTICALS, INC.-2024FOS000637$RIGEL PHARMACEUTICALS$$64$YR$$F$Y$$$20240717$$HP$US$US
239428714$23942871$4$F$20240101$20240724$20240605$20240801$EXP$$US-RIGEL PHARMACEUTICALS, INC.-2024FOS000639$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240801$$HP$US$US
239428823$23942882$3$F$$20240717$20240605$20240719$PER$$NVSC2024US118268$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
239428962$23942896$2$F$$20240625$20240605$20240704$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001147$BLUEPRINT MEDICINES$$$$$F$Y$$$20240704$$CN$US$US
239429083$23942908$3$F$$20240805$20240605$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087112$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240809$$CN$US$US
239429153$23942915$3$F$20240101$20240718$20240605$20240725$EXP$$US-SA-2024SA168063$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240725$$MD$US$US
239429232$23942923$2$F$$20240814$20240605$20240821$EXP$$CA-TAKEDA-2024TUS053599$TAKEDA$$$$$M$Y$$$20240821$$CN$CA$CA
239429332$23942933$2$F$$20240523$20240605$20240801$PER$$US-TEVA-VS-3202179$TEVA$$$$$$Y$$$20240801$$HP$US$US
239429362$23942936$2$F$20240101$20240903$20240605$20240925$PER$$US-SA-2024SA162417$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240925$$CN$US$US
239429372$23942937$2$F$$20240916$20240605$20240924$PER$$US-SA-2024SA164227$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240924$$MD$US$US
239429408$23942940$8$F$20240509$20240916$20240605$20240924$EXP$$FR-PFIZER INC-PV202400072417$PFIZER$$51$YR$$F$Y$44$KG$20240924$$MD$FR$FR
239429424$23942942$4$F$20230126$20240925$20240605$20240926$EXP$$JP-PFIZER INC-202400184880$PFIZER$$71$YR$$F$Y$67.3$KG$20240926$$HP$JP$JP
239429444$23942944$4$F$20240519$20240626$20240605$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003403$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240627$$CN$US$US
239429462$23942946$2$F$20240501$20240627$20240605$20240702$EXP$$US-PFIZER INC-202400185682$PFIZER$$67$YR$$F$Y$$$20240702$$HP$US$US
239429563$23942956$3$F$20240519$20240628$20240605$20240708$EXP$$KW-TAKEDA-2024TUS056097$TAKEDA$$55$YR$$M$Y$$$20240708$$CN$KW$KW
239429582$23942958$2$F$$20240802$20240605$20240805$EXP$$NVSC2024US117849$NOVARTIS$$64$YR$$F$Y$$$20240805$$HP$US$US
239429602$23942960$2$F$$20240701$20240605$20240708$EXP$$JP-TAKEDA-2024TUS056282$TAKEDA$$8$DEC$$M$Y$$$20240708$$HP$JP$JP
239429662$23942966$2$F$20240311$20240701$20240605$20240703$EXP$$RO-AstraZeneca-2024A128976$ASTRAZENECA$$$$E$M$Y$76$KG$20240703$$MD$RO$
239429702$23942970$2$F$$20240715$20240605$20240723$PER$$US-SA-2024SA161368$SANOFI AVENTIS$$54$YR$A$F$Y$72.12$KG$20240723$$MD$US$US
239429752$23942975$2$F$$20240810$20240605$20240812$PER$$NVSC2024US118280$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
239429892$23942989$2$F$20230201$20240725$20240605$20240731$EXP$IT-MINISAL02-987684$IT-MYLANLABS-2024M1050489$MYLAN$$85$YR$$F$Y$$$20240731$$MD$IT$IT
239429995$23942999$5$F$$20240722$20240605$20240726$EXP$$IT-MYLANLABS-2024M1050736$MYLAN$Ferrante L. Maria e Ivo. Maria and Ivo: two stories, the same diagnostic suspicion. Focus Farmacovigilanza Anno XXVI - n. 2024;117$77$YR$$F$Y$$$20240726$$MD$IT$IT
239430023$23943002$3$F$20240501$20240708$20240605$20240711$EXP$$US-PFIZER INC-202400185981$PFIZER$$93$YR$$F$Y$65.76$KG$20240711$$CN$US$US
239430112$23943011$2$F$20211001$20240723$20240605$20240730$EXP$$US-BIOGEN-2024BI01267310$BIOGEN$$53$YR$$F$Y$$$20240730$$CN$US$US
239430252$23943025$2$F$20240518$20240724$20240605$20240730$EXP$IT-MINISAL02-987740$IT-MYLANLABS-2024M1050462$MYLAN$$17$YR$$M$Y$$$20240730$$PH$IT$IT
239430322$23943032$2$F$$20240729$20240605$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-022864$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240730$$CN$US$US
239430442$23943044$2$F$20240511$20240621$20240605$20240701$EXP$FR-AFSSAPS-SE2024000423$FR-TEVA-VS-3204516$TEVA$$72$YR$$F$Y$57$KG$20240701$$MD$FR$FR
239430563$23943056$3$F$20240419$20240807$20240605$20240808$EXP$$AU-WOODWARD-2024-AU-000261$WOODWARD PHARMA SERVICES$$79$YR$$M$Y$$$20240808$$HP$AU$AU
239430683$23943068$3$F$20240610$20240913$20240605$20240923$EXP$$NZ-MYLANLABS-2024M1050440$MYLAN$$52$YR$$F$Y$$$20240923$$HP$NZ$NZ
239430702$23943070$2$F$20210601$20240701$20240605$20240710$EXP$IT-MINISAL02-987617$IT-INCYTE CORPORATION-2024IN005838$INCYTE$$$$$$Y$$$20240710$$MD$IT$IT
239430714$23943071$4$F$20240602$20240805$20240605$20240808$PER$$US-AMGEN-USASP2024109745$AMGEN$$56$YR$A$F$Y$$$20240807$$CN$US$US
239430784$23943078$4$F$20240601$20240813$20240605$20240818$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-026780$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240818$$CN$US$US
239430824$23943082$4$F$20240101$20240716$20240605$20240718$PER$$US-AMGEN-USASP2024110871$AMGEN$$66$YR$E$F$Y$$$20240718$$PH$US$US
239430972$23943097$2$F$$20240717$20240605$20240718$PER$$US-ALXN-202405USA001972US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239431162$23943116$2$F$$20240712$20240605$20240718$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405015755$ELI LILLY AND CO$$65$YR$E$$Y$$$20240718$$CN$JP$JP
239431203$23943120$3$F$20240417$20240624$20240605$20240705$EXP$$AT-ELI_LILLY_AND_COMPANY-AT202404013152$ELI LILLY AND CO$$58$YR$A$F$Y$80$KG$20240705$$CN$AT$AT
239431252$23943125$2$F$20240523$20240627$20240605$20240705$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405016946$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240705$$CN$JP$JP
239431263$23943126$3$F$$20240703$20240605$20240716$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202405018796$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240716$$CN$CN$CN
239431372$23943137$2$F$$20240904$20240605$20240925$PER$$US-SA-2024SA166261$SANOFI AVENTIS$$$$A$F$Y$70.295$KG$20240925$$MD$US$US
239431423$23943142$3$F$$20240830$20240605$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090456$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$62.6$KG$20240911$$CN$US$US
239431683$23943168$3$F$$20240917$20240605$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091015$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240918$$CN$US$US
239431902$23943190$2$F$$20240905$20240605$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090916$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240905$$HP$US$US
239431963$23943196$3$F$20230919$20240913$20240605$20240923$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-10941$IPSEN$$39$YR$A$F$Y$$$20240923$$MD$JP$JP
239431983$23943198$3$F$$20240913$20240605$20240918$30DAY$$US-PFIZER INC-PV202400068188$PFIZER$$13$YR$$M$Y$$$20240918$$MD$US$US
239431994$23943199$4$F$20240529$20240904$20240605$20240904$30DAY$$GR-PFIZER INC-PV202400071127$PFIZER$$8$YR$$M$Y$21$KG$20240904$$CN$GR$GR
239432004$23943200$4$F$$20240909$20240605$20240911$30DAY$$US-PFIZER INC-202400181948$PFIZER$$66$YR$$F$Y$$$20240911$$CN$US$US
239432083$23943208$3$F$20240521$20240913$20240605$20240925$EXP$PT-INFARMED-E202405-652$PT-ELI_LILLY_AND_COMPANY-PT202405016096$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240925$$CN$PT$PT
239432138$23943213$8$F$20240101$20240913$20240605$20240918$EXP$$US-KARYOPHARM-2024KPT001039$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240918$$CN$US$US
239432152$23943215$2$F$$20240719$20240605$20240806$PER$$US-ALXN-202405USA002064US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239432166$23943216$6$F$20240403$20240917$20240605$20240926$EXP$$JP-Eisai-EC-2024-166893$EISAI$$72$YR$E$F$Y$82.3$KG$20240926$$PH$JP$JP
239432252$23943225$2$F$20240415$20240627$20240605$20240705$EXP$$US-BAYER-2024A060616$BAYER$$64$YR$A$M$Y$92.063$KG$20240705$$CN$US$US
239432292$23943229$2$F$$20240912$20240605$20240921$EXP$$JP-ROCHE-3576079$ROCHE$$75$YR$E$M$Y$$$20240921$$MD$JP$JP
239432302$23943230$2$F$20240501$20240712$20240605$20240717$EXP$FR-AFSSAPS-PB2024000576$FR-009507513-2405FRA010024$MERCK$$65$YR$$F$Y$$$20240717$$MD$FR$FR
239432312$23943231$2$F$$20240719$20240605$20240806$PER$$US-ALXN-202405USA002050US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239432473$23943247$3$F$$20240703$20240605$20240708$EXP$$US-PFIZER INC-2024SGN05752$PFIZER$$44$YR$$F$Y$$$20240708$$CN$US$US
239432652$23943265$2$F$$20240903$20240605$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089908$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$88$KG$20240903$$HP$US$US
239432783$23943278$3$F$$20240717$20240605$20240718$PER$$US-ALXN-202405USA001942US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239432813$23943281$3$F$$20240620$20240605$20240824$PER$$US-AstraZeneca-2024A117804$ASTRAZENECA$$$$$M$Y$$$20240823$$MD$US$
239432822$23943282$2$F$$20240718$20240605$20240718$PER$$NVSC2024US118199$NOVARTIS$$$$$$Y$$$20240718$$MD$US$US
239432836$23943283$6$F$20240201$20240918$20240605$20240925$EXP$$GT-BIOGEN-2024BI01267974$BIOGEN$$38$YR$$M$Y$42.63$KG$20240925$$CN$GT$GT
239433112$23943311$2$F$20240521$20240702$20240605$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406001954$ELI LILLY AND CO$$$$$F$Y$79.365$KG$20240705$$HP$US$US
239433193$23943319$3$F$20240325$20240618$20240605$20240709$PER$$US-009507513-2405USA009076$MERCK$$17$YR$$M$Y$$$20240709$$HP$US$US
239433232$23943323$2$F$20240529$20240718$20240605$20240722$PER$$NVSC2024US118322$NOVARTIS$$72$YR$$M$Y$66.8$KG$20240722$$HP$US$US
239433242$23943324$2$F$20240423$20240718$20240605$20240725$PER$$US-ALXN-202405USA002046US$ALEXION PHARMACEUTICALS$$30$YR$$F$Y$$$20240725$$CN$US$US
239433463$23943346$3$F$$20240704$20240605$20240708$EXP$$JP-ABBVIE-5787481$ABBVIE$$$$$M$Y$$$20240708$$PH$JP$JP
239433483$23943348$3$F$$20240914$20240605$20240915$EXP$$US-ALXN-202405USA002114US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
239433492$23943349$2$F$$20240719$20240605$20240806$PER$$US-ALXN-202405USA002132US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239433552$23943355$2$F$$20240730$20240605$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-089465$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240809$$MD$JP$JP
239433576$23943357$6$F$20240410$20240911$20240605$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-089516$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240919$$MD$JP$JP
239433623$23943362$3$F$20240521$20240619$20240605$20240703$EXP$$JP-AMGEN-JPNSP2024108331$AMGEN$$7$DEC$E$M$Y$$$20240703$$PH$JP$JP
239433632$23943363$2$F$$20240904$20240605$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-088718$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$MD$JP$JP
239433663$23943366$3$F$20240325$20240923$20240605$20240925$EXP$$AU-009507513-2405USA009349$MERCK$$72$YR$$F$Y$98.4$KG$20240925$$MD$AU$AU
239433762$23943376$2$F$20240325$20240626$20240605$20240713$PER$$US-ABBVIE-5784449$ABBVIE$$57$YR$$F$Y$$$20240713$$CN$US$US
239433853$23943385$3$F$20240501$20240924$20240605$20240930$EXP$$NVSJ2024JP006625$NOVARTIS$$76$YR$$F$Y$$$20241001$$MD$JP$JP
239433893$23943389$3$F$$20240702$20240605$20240704$PER$$US-AMGEN-USASP2024111026$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
239433922$23943392$2$F$20240529$20240916$20240605$20240925$PER$$US-ABBVIE-5784294$ABBVIE$$37$YR$$F$Y$$$20240925$$CN$US$US
239433932$23943393$2$F$$20240627$20240605$20240702$EXP$$US-ABBVIE-5710304$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
239433954$23943395$4$F$20240101$20240920$20240605$20240925$PER$$US-SA-2024SA166277$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240925$$MD$US$US
239434012$23943401$2$F$$20240711$20240605$20240717$30DAY$$US-JNJFOC-20240608631$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$PH$US$US
239434092$23943409$2$F$$20240710$20240605$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-088630$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240717$$CN$JP$JP
239434174$23943417$4$F$20240523$20240710$20240605$20240715$EXP$$US-BIOGEN-2024BI01267928$BIOGEN$$63$YR$$M$Y$$$20240715$$HP$US$US
239434192$23943419$2$F$$20240628$20240605$20240701$EXP$$JP-TAKEDA-2024TJP008268$TAKEDA$$31$YR$$M$Y$$$20240701$$MD$JP$JP
239434252$23943425$2$F$20240101$20240705$20240605$20240708$EXP$$JP-TAKEDA-2024TJP008180$TAKEDA$$6$DEC$$F$Y$$$20240708$$MD$JP$JP
239434282$23943428$2$F$$20240722$20240605$20240730$PER$$US-ABBVIE-5786209$ABBVIE$$$$$F$Y$$$20240730$$HP$US$US
239434293$23943429$3$F$$20240617$20240605$20240703$30DAY$$US-JNJFOC-20240539998$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240703$$CN$US$US
239434333$23943433$3$F$$20240801$20240605$20240806$EXP$$LB-AMGEN-LBNSP2024110432$AMGEN$$50$YR$A$F$Y$$$20240805$$MD$LB$LB
239434403$23943440$3$F$20240101$20240708$20240605$20240711$EXP$$GB-ABBVIE-5783823$ABBVIE$$61$YR$$F$Y$$$20240711$$MD$GB$GB
239434523$23943452$3$F$20220625$20240802$20240605$20240803$EXP$$JP-ABBVIE-5388926$ABBVIE$$56$YR$$F$Y$$$20240803$$MD$JP$JP
239434532$23943453$2$F$20240806$20240906$20240605$20240912$EXP$$US-ABBVIE-5785964$ABBVIE$$74$YR$$F$Y$64.9$KG$20240912$$CN$US$US
239434622$23943462$2$F$20240101$20240917$20240605$20240924$PER$$US-SA-2024SA166213$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240924$$MD$US$US
239435023$23943502$3$F$20240501$20240704$20240605$20240711$EXP$$JP-009507513-2405JPN003957J$MERCK$$7$DEC$$F$Y$$$20240711$$MD$JP$JP
239435032$23943503$2$F$20240212$20240905$20240605$20240911$EXP$$US-ABBVIE-5691720$ABBVIE$$74$YR$$F$Y$81$KG$20240911$$CN$US$US
239435072$23943507$2$F$20240530$20240624$20240605$20240701$EXP$$JP-009507513-2406JPN000151J$MERCK$$76$YR$$F$Y$$$20240701$$MD$JP$JP
239435194$23943519$4$F$20240617$20240819$20240606$20240826$PER$$US-AMGEN-USASP2024110234$AMGEN$$$$E$F$Y$$$20240826$$CN$US$US
239435452$23943545$2$F$20240513$20240627$20240606$20240702$EXP$$US-ABBVIE-5785827$ABBVIE$$46$YR$$M$Y$86$KG$20240702$$CN$US$US
239435472$23943547$2$F$$20240716$20240606$20240724$EXP$$JP-GSK-JP2024JPN065917$GLAXOSMITHKLINE$Kinugasa M, Tani M, Mori T, Hoshino T, Tsuji Y. Original article  Management of pregnant women affected with COVID- 19 and infection control in a primary care hospital. Journal of Japan Society of Perinatal and Neonatal Medicine. 2024;60:13-19$$$$$Y$$$20240724$$MD$JP$JP
239435482$23943548$2$F$$20240716$20240606$20240724$EXP$$JP-GSK-JP2024JPN067967$GLAXOSMITHKLINE$Kinugasa M, Tani M, Mori T, Hoshino T, Tsuji Y. Original article  Management of pregnant women affected with COVID- 19 and infection control in a primary care hospital. Journal of Japan Society of Perinatal and Neonatal Medicine. 2024;60:13-19$$$$$Y$$$20240724$$MD$JP$JP
239435793$23943579$3$F$$20240701$20240606$20240710$PER$$US-SA-2024SA163299$SANOFI AVENTIS$$$$T$F$Y$77$KG$20240710$$CN$US$US
239435802$23943580$2$F$$20240903$20240606$20240920$PER$$US-SA-2024SA167967$SANOFI AVENTIS$$$$E$M$Y$68$KG$20240920$$MD$US$US
239435883$23943588$3$F$$20240524$20240606$20240710$EXP$$ES-UCBSA-2024027155$UCB$$$$C$M$Y$$$20240710$$MD$ES$ES
239435895$23943589$5$F$20240101$20240911$20240606$20240918$EXP$$US-AMGEN-USASL2024108729$AMGEN$$64$YR$A$M$Y$69.6$KG$20240918$$MD$US$US
239436072$23943607$2$F$$20240520$20240606$20240830$EXP$$ZA-AMGEN-ZAFSP2024108507$AMGEN$$77$YR$E$F$Y$$$20240830$$CN$ZA$ZA
239436152$23943615$2$F$$20240602$20240606$20240725$PER$$US-AMGEN-USASP2024110064$AMGEN$$91$YR$E$M$Y$$$20240725$$CN$US$US
239436252$23943625$2$F$$20240802$20240606$20240813$EXP$$EG-NOVOPROD-1229095$NOVO NORDISK$$70$YR$$M$Y$94$KG$20240813$$CN$EG$EG
239436273$23943627$3$F$20240321$20240814$20240606$20240822$EXP$$CA-CELLTRION INC.-2024CA010883$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
239436324$23943632$4$F$20240101$20240912$20240606$20240923$EXP$$CA-NOVOPROD-1229855$NOVO NORDISK$$67$YR$$F$Y$66.678$KG$20240923$$HP$CA$CA
239436542$23943654$2$F$20230501$20240805$20240606$20240816$EXP$$US-NOVOPROD-1231356$NOVO NORDISK$$73$YR$$F$Y$$$20240816$$MD$US$US
239436712$23943671$2$F$20230801$20240705$20240606$20240709$PER$$US-AMGEN-USASP2024109928$AMGEN$$74$YR$E$F$Y$$$20240708$$CN$US$US
239436723$23943672$3$F$20240501$20240726$20240606$20240802$EXP$$US-ABBVIE-5785614$ABBVIE$$76$YR$$M$Y$69$KG$20240802$$CN$US$US
239436772$23943677$2$F$20240516$20240905$20240606$20240924$PER$$CA-TOLMAR, INC.-24CA049499$TOLMAR$$76$YR$$M$Y$$$20240924$$CN$CA$CA
239436842$23943684$2$F$20240517$20240808$20240606$20240902$PER$$CA-TOLMAR, INC.-24CA049552$TOLMAR$$68$YR$$M$Y$$$20240902$$CN$CA$CA
239436852$23943685$2$F$20240517$20240906$20240606$20240924$PER$$CA-TOLMAR, INC.-24CA049554$TOLMAR$$77$YR$$M$Y$$$20240924$$CN$CA$CA
239437025$23943702$5$F$20240612$20240904$20240606$20240911$PER$$US-BIOGEN-2024BI01261323$BIOGEN$$49$YR$$M$Y$$$20240911$$CN$US$US
239437052$23943705$2$F$$20240702$20240606$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090479$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240704$$CN$US$US
239437172$23943717$2$F$$20240625$20240606$20240701$EXP$$JP-AMGEN-JPNSP2024108512$AMGEN$$$$$M$Y$$$20240701$$MD$JP$JP
239437272$23943727$2$F$$20240703$20240606$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090268$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$53.07$KG$20240710$$CN$US$US
239437415$23943741$5$F$20240528$20240722$20240606$20240726$PER$$US-AMGEN-USASP2024106612$AMGEN$$74$YR$E$F$Y$63.5$KG$20240726$$HP$US$US
239437514$23943751$4$F$$20240716$20240606$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032226$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240716$$CN$US$US
239437562$23943756$2$F$$20240605$20240606$20240916$PER$$NVSC2024US118506$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
239437593$23943759$3$F$20240529$20240709$20240606$20240716$30DAY$$US-AMGEN-USASP2024108480$AMGEN$$68$YR$E$F$Y$93$KG$20240716$$PH$US$US
239437632$23943763$2$F$$20240715$20240606$20240723$EXP$$NL-AstraZeneca-2024A124770$ASTRAZENECA$$60$YR$$M$Y$88$KG$20240723$$MD$NL$
239437682$23943768$2$F$$20240605$20240606$20240916$PER$$NVSC2024US118468$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
239437802$23943780$2$F$$20240530$20240606$20240701$PER$$US-CHATTEMPRD-2024OHG019370$CHATTEM$$$$$F$Y$$$20240701$$CN$US$US
239437882$23943788$2$F$$20240801$20240606$20240805$PER$$NVSC2024US118476$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
239438023$23943802$3$F$20240101$20240903$20240606$20240905$PER$$US-AMGEN-USASP2024111205$AMGEN$$54$YR$A$F$Y$$$20240905$$CN$US$US
239438054$23943805$4$F$20240101$20240708$20240606$20240717$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015841$UNITED THERAPEUTICS$$$$$F$Y$75.737$KG$20240717$$$US$US
239438222$23943822$2$F$20240603$20240821$20240606$20240824$PER$$US-AMGEN-USASP2024111228$AMGEN$$64$YR$A$F$Y$$$20240824$$CN$US$US
239438312$23943831$2$F$20240501$20240823$20240606$20240830$EXP$$US-ABBVIE-5787464$ABBVIE$$74$YR$$M$Y$$$20240829$$CN$US$US
239438404$23943840$4$F$20240101$20240920$20240606$20240930$EXP$$CA-CELLTRION INC.-2024CA003764$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
239438452$23943845$2$F$20240101$20240624$20240606$20240703$EXP$$GB-ROCHE-3360284$ROCHE$$73$YR$E$F$Y$60$KG$20240703$$MD$GB$GB
239438504$23943850$4$F$$20240716$20240606$20240718$PER$$US-AMGEN-USASP2024110973$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
239438747$23943874$7$F$20240602$20240924$20240606$20240926$PER$$NVSC2024US118369$NOVARTIS$$41$YR$$F$Y$$$20240926$$CN$US$US
239438752$23943875$2$F$$20240711$20240606$20240716$PER$$NVSC2024US118378$NOVARTIS$$$$$M$Y$$$20240716$$CN$US$US
239438822$23943882$2$F$$20240701$20240606$20240705$EXP$$NVSC2024US115979$NOVARTIS$$$$$M$Y$$$20240706$$CN$US$US
239438882$23943888$2$F$$20240703$20240606$20240705$EXP$$US-EXELIXIS-CABO-24077897$EXELIXIS$$$$$M$Y$$$20240705$$CN$US$US
239438892$23943889$2$F$20230101$20240626$20240606$20240703$EXP$$JP-JNJFOC-20240612890$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$JP$JP
239438953$23943895$3$F$$20240705$20240606$20240716$PER$$US-AstraZeneca-2024A122873$ASTRAZENECA$$84$YR$$M$Y$$$20240716$$CN$US$
239439006$23943900$6$F$$20240615$20240606$20240712$EXP$$US-ROCHE-3575029$ROCHE$$$$$$Y$$$20240712$$CN$US$US
239439012$23943901$2$F$20240523$20240920$20240606$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024068822$VIIV$$24$YR$$M$Y$$$20240927$$CN$US$US
239439042$23943904$2$F$20240501$20240808$20240606$20240814$30DAY$$US-GSK-US2024068865$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240814$$HP$US$US
239439132$23943913$2$F$20190101$20240628$20240606$20240706$EXP$$FR-ABBVIE-5786833$ABBVIE$$81$YR$$M$Y$$$20240706$$CN$FR$FR
239439162$23943916$2$F$$20240715$20240606$20240717$EXP$$GR-ROCHE-3576112$ROCHE$$60$YR$A$M$Y$$$20240717$$MD$GR$GR
239439232$23943923$2$F$20190516$20240715$20240606$20240722$EXP$DE-002147023-PHHY2019DE116556$DE-RDY-SPO/DEU/24/0008049$DR REDDYS$$$$A$F$Y$68$KG$20240719$$MD$DE$DE
239439394$23943939$4$F$20240604$20240725$20240606$20240731$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016833$UNITED THERAPEUTICS$$53$YR$$M$Y$136.05$KG$20240731$$$US$US
239439434$23943943$4$F$$20240706$20240606$20240717$EXP$$PT-AUROBINDO-AUR-APL-2024-026583$AUROBINDO$Orfao A, Madeira D, Matos C, Corte-Real A, Vilas-Boas S, Almeida R, et al. CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY - WHEN MUSCLES GO ON A DIET. European Journal of Case Reports in Internal Medicine. 2021;8(147 Supp 1):147 abstr. PV346/1043.$48$YR$$M$Y$$$20240717$$HP$PT$PT
239439602$23943960$2$F$$20240904$20240606$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-089755$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$MD$JP$JP
239439612$23943961$2$F$$20240904$20240606$20240916$PER$$US-SA-2024SA164292$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240916$$MD$US$US
239439622$23943962$2$F$$20240906$20240606$20240914$EXP$$DE-ABBVIE-5764139$ABBVIE$$$$$M$Y$99$KG$20240914$$CN$DE$DE
239439634$23943963$4$F$20240613$20240905$20240606$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090852$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240905$$CN$US$US
239439855$23943985$5$F$20240506$20240725$20240606$20240806$PER$$NVSC2024US118647$NOVARTIS$$81$YR$$M$Y$88.364$KG$20240806$$HP$US$US
239439883$23943988$3$F$20240102$20240909$20240606$20240912$EXP$$AT-SANDOZ INC.-SDZ2024AT054806$SANDOZ$$69$YR$$M$Y$$$20240912$$MD$AT$AT
239439952$23943995$2$F$20240520$20240911$20240606$20240916$30DAY$$US-SANDOZ INC.-SDZ2024US054143$SANDOZ$$11$YR$$M$Y$$$20240916$$HP$US$US
239440014$23944001$4$F$20201201$20240824$20240606$20240827$EXP$$EG-SANDOZ INC.-NVSC2022EG281033$SANDOZ$$11$YR$$M$Y$$$20240827$$CN$EG$EG
239440093$23944009$3$F$20240326$20240619$20240606$20240703$EXP$$DE-SANDOZ INC.-SDZ2024DE054923$SANDOZ$$$$E$F$Y$60$KG$20240703$$HP$DE$DE
239440143$23944014$3$F$20240501$20240912$20240606$20240916$EXP$$KW-SANDOZ INC.-SDZ2024KW054571$SANDOZ$$27$YR$$F$Y$$$20240916$$CN$KW$KW
239440192$23944019$2$F$20240531$20240913$20240606$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US055063$SANDOZ$$46$YR$$F$Y$$$20240919$$CN$US$US
239440312$23944031$2$F$20240528$20240909$20240606$20240912$30DAY$$GR-SANDOZ INC.-SDZ2024GR053035$SANDOZ$$13$YR$$M$Y$$$20240912$$CN$GR$GR
239440353$23944035$3$F$20240527$20240812$20240606$20240814$PER$$US-AMGEN-USASP2024108802$AMGEN$$68$YR$E$M$Y$$$20240813$$MD$US$US
239440492$23944049$2$F$$20240617$20240606$20240703$EXP$$PT-TEVA-VS-3205633$TEVA$Duarte RR, Sousa A, Claudio FD, Abreu TT, Jacinto M. TO ANTIPLATELET OR NOT ANTIPLATELET, IS THAT THE QUESTION?. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl.) 184 abstr. 2168 .; Duarte RR, Sousa A, Claudio FD, Abreu TT, Jacinto M. TO ANTIPLATELET OR NOT ANTIPLATELET, IS THAT THE QUESTION?. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl.) 184 abstr. 2168 .$72$YR$$M$Y$$$20240703$$HP$PT$PT
239440502$23944050$2$F$20231101$20240701$20240606$20240711$EXP$$RS-EMD Serono-2023496210$EMD SERONO INC$$27$YR$A$F$Y$$$20240711$$CN$RS$RS
239440582$23944058$2$F$$20240731$20240606$20240802$EXP$$US-ABBVIE-5787927$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
239440594$23944059$4$F$20240101$20240801$20240606$20240805$EXP$$US-UCBSA-2024027885$UCB$$$$$M$Y$$$20240805$$CN$US$US
239440602$23944060$2$F$20240507$20240625$20240606$20240703$EXP$$CA-CELLTRION INC.-2024CA012480$CELLTRION$$$$$$Y$$$20240703$$MD$CA$CA
239440722$23944072$2$F$$20240524$20240606$20240711$EXP$$ES-UCBSA-2024027447$UCB$$$$C$M$Y$$$20240711$$MD$ES$ES
239440802$23944080$2$F$20240601$20240627$20240606$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406002340$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240701$$PH$US$US
239440842$23944084$2$F$$20240704$20240606$20240709$PER$$US-AMGEN-USASP2024109376$AMGEN$$69$YR$E$F$Y$$$20240709$$MD$US$US
239440862$23944086$2$F$$20240725$20240606$20240731$EXP$$GB-ROCHE-3571472$ROCHE$$$$A$F$Y$$$20240731$$MD$GB$GB
239440872$23944087$2$F$$20240715$20240606$20240718$EXP$$AU-TAKEDA-2024TUS056137$TAKEDA$$$$$F$Y$$$20240718$$MD$AU$AU
239440892$23944089$2$F$$20240801$20240606$20240806$EXP$$DE-JNJFOC-20240585715$JOHNSON AND JOHNSON$$77$YR$E$F$Y$79$KG$20240806$$MD$DE$DE
239440932$23944093$2$F$20240501$20240719$20240606$20240806$PER$$US-ALXN-202405USA002145US$ALEXION PHARMACEUTICALS$$75$YR$$F$Y$$$20240719$$CN$US$US
239440963$23944096$3$F$20240508$20240702$20240606$20240703$EXP$$NVSC2024DE118220$NOVARTIS$$68$YR$$M$Y$$$20240703$$MD$DE$DE
239441042$23944104$2$F$$20240716$20240606$20240724$EXP$$HR-AstraZeneca-2024A127840$ASTRAZENECA$$$$$M$Y$$$20240724$$MD$HR$
239441063$23944106$3$F$20220101$20240722$20240606$20240729$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031760$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240729$$CN$BR$BR
239441072$23944107$2$F$20240101$20240812$20240606$20240819$EXP$$CZ-JNJFOC-20240589029$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240819$$HP$CZ$CZ
239441093$23944109$3$F$20240501$20240702$20240606$20240705$PER$$US-UNITED THERAPEUTICS-UNT-2024-011713$UNITED THERAPEUTICS$$81$YR$$F$Y$56.689$KG$20240705$$$US$US
239441122$23944112$2$F$$20240706$20240606$20240716$EXP$$IT-AUROBINDO-AUR-APL-2024-026480$AUROBINDO$Scarone C, Dovere V, Traverso C, Lillo F. Failure to diagnose factor X deficiency in patient treated with anticoagulant therapy. Clin-Chim-Acta. 2024;558 (Suppl. 1):P1421$$$$$Y$$$20240716$$HP$IT$IT
239441155$23944115$5$F$20240123$20240906$20240606$20240917$EXP$$DE-TAKEDA-2024TUS007675$TAKEDA$$36$YR$$F$Y$$$20240917$$CN$DE$DE
239441342$23944134$2$F$$20240620$20240606$20240710$PER$$AU-TOLMAR, INC.-24AU049268$TOLMAR$$$$$M$Y$$$20240709$$PH$AU$AU
239441402$23944140$2$F$20240401$20240910$20240606$20240916$EXP$$US-AMGEN-USASP2024108830$AMGEN$$80$YR$E$M$Y$$$20240916$$CN$US$US
239441552$23944155$2$F$$20240704$20240606$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-087413$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240709$$PH$JP$JP
239441842$23944184$2$F$20240430$20240604$20240606$20240910$PER$$US-MankindUS-000174$MANKIND PHARMA$$6$YR$C$M$Y$25.31$KG$20240910$$CN$US$US
239441884$23944188$4$F$20240601$20240816$20240606$20240821$PER$$US-AMGEN-USASP2024109798$AMGEN$$81$YR$E$F$Y$$$20240820$$CN$US$US
239441892$23944189$2$F$20240501$20240604$20240606$20240701$PER$$US-AMGEN-USASP2024108843$AMGEN$$73$YR$E$F$Y$$$20240701$$CN$US$US
239441932$23944193$2$F$20240528$20240711$20240606$20240718$30DAY$$US-GSK-US2024067767$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240718$$CN$US$US
239441943$23944194$3$F$$20240822$20240606$20240827$EXP$$US-GSK-US2024AMR068591$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
239442093$23944209$3$F$20240101$20240629$20240606$20240705$PER$$US-UNITED THERAPEUTICS-UNT-2024-016649$UNITED THERAPEUTICS$$$$$F$Y$82.54$KG$20240705$$$US$US
239442146$23944214$6$F$20240401$20240916$20240606$20240917$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-022013$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240917$$MD$CA$CA
239442203$23944220$3$F$20240101$20240626$20240606$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016665$UNITED THERAPEUTICS$$$$$F$Y$97.052$KG$20240705$$$US$US
239442362$23944236$2$F$20230726$20240626$20240606$20240704$EXP$$CA-CELLTRION INC.-2023CA015311$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
239442572$23944257$2$F$$20240603$20240606$20240710$EXP$$JP-UCBSA-2024027379$UCB$$$$$$Y$$$20240710$$MD$JP$JP
239442582$23944258$2$F$20220301$20240701$20240606$20240714$EXP$GB-MHRA-MED-202405291424443490-MPNTB$GB-LUPIN PHARMACEUTICALS INC.-2024-04515$LUPIN$$$$$$Y$$$20240714$$MD$GB$GB
239442592$23944259$2$F$20240603$20240606$20240606$20240716$PER$$US-AMGEN-USASP2024111014$AMGEN$$61$YR$A$F$Y$$$20240716$$CN$US$US
239442602$23944260$2$F$$20240709$20240606$20240722$EXP$GR-AMGEN-GRCSP2024098017$GR-ROCHE-3570835$ROCHE$Mamalis S, Lazaraki G and Soufleris K. Response ofapatientwith mixed metastatic cholangiocarci noma, hepatocellular carcinoma and endstage Renal failure to low-dose regorafenib. 22nd Panhellenic Congress on Hepatology. 2024;:-.$63$YR$A$M$Y$$$20240722$$HP$GR$GR
239442722$23944272$2$F$$20240708$20240606$20240718$EXP$$US-862174955-ML2024-03315$Unknown Manufacturer$$77$YR$E$F$Y$63$KG$20240718$$CN$US$US
239442772$23944277$2$F$$20240916$20240606$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US055365$SANDOZ$$$$$M$Y$$$20240919$$CN$US$US
239442874$23944287$4$F$$20240802$20240606$20240807$EXP$$CA-TAKEDA-2024TUS043166$TAKEDA$$$$$F$Y$$$20240807$$HP$CA$CA
239442902$23944290$2$F$20240307$20240719$20240606$20240725$EXP$$JP-AMGEN-JPNSP2024109342$AMGEN$$8$DEC$E$M$Y$$$20240725$$MD$JP$JP
239442932$23944293$2$F$20240531$20240731$20240606$20240803$PER$$US-AMGEN-USASP2024109939$AMGEN$$80$YR$E$M$Y$$$20240803$$CN$US$US
239442982$23944298$2$F$20240601$20240821$20240606$20240823$PER$$US-AMGEN-USASP2024110224$AMGEN$$71$YR$E$F$Y$$$20240823$$CN$US$US
239443003$23944300$3$F$$20240624$20240606$20240702$30DAY$$US-JNJFOC-20240604586$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240702$$PH$US$US
239443452$23944345$2$F$20240501$20240709$20240606$20240715$EXP$$MX-JNJFOC-20240590040$JOHNSON AND JOHNSON$$27$YR$A$M$Y$87$KG$20240715$$CN$MX$MX
239443552$23944355$2$F$$20240727$20240606$20240731$EXP$$GB-AMGEN-GBRSP2024108575$AMGEN$$52$YR$A$F$Y$$$20240731$$CN$GB$GB
239443573$23944357$3$F$20240531$20240705$20240606$20240708$PER$$US-AMGEN-USASP2024110839$AMGEN$$74$YR$E$M$Y$$$20240708$$CN$US$US
239443602$23944360$2$F$20220504$20240830$20240606$20240910$EXP$$CA-AMGEN-CANSL2023078613$AMGEN$$75$YR$E$F$Y$$$20240910$$HP$CA$CA
239443732$23944373$2$F$20240501$20240910$20240606$20240916$EXP$$JP-009507513-2405JPN003610J$MERCK$$57$YR$$F$Y$$$20240916$$MD$JP$JP
239443745$23944374$5$F$20240419$20240711$20240606$20240718$EXP$$FR-GSK-FR2024EME068516$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$PH$FR$FR
239443783$23944378$3$F$$20240910$20240606$20240917$EXP$$US-GSK-US2024AMR068536$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$US$US
239443902$23944390$2$F$20230615$20240622$20240606$20240701$EXP$$CA-CELLTRION INC.-2023CA016302$CELLTRION$$$$$$Y$$$20240701$$HP$CA$CA
239444023$23944402$3$F$20240101$20240712$20240606$20240717$EXP$$CA-ABBVIE-5787611$ABBVIE$$48$YR$$M$Y$61$KG$20240717$$CN$CA$CA
239444042$23944404$2$F$$20240802$20240606$20240829$PER$$US-AstraZeneca-2024A129834$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
239444144$23944414$4$F$20231123$20240624$20240606$20240702$EXP$$CA-CELLTRION INC.-2024CA001361$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
239444182$23944418$2$F$$20240719$20240606$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087746$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240723$$CN$US$US
239444302$23944430$2$F$$20240620$20240606$20240704$EXP$$JP-JNJFOC-20240612837$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240704$$MD$JP$JP
239444373$23944437$3$F$20240429$20240731$20240606$20240801$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032270$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240801$$MD$JP$JP
239444494$23944449$4$F$$20240731$20240606$20240808$EXP$$CA-AstraZeneca-2024A130757$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$CA$
239444612$23944461$2$F$20240529$20240925$20240606$20240926$30DAY$$IT-SANDOZ INC.-SDZ2024IT055341$SANDOZ$$15$YR$$M$Y$54$KG$20240926$$CN$IT$IT
239444692$23944469$2$F$20240508$20240731$20240606$20240802$30DAY$$US-SANDOZ INC.-SDZ2024US054339$SANDOZ$$3$YR$$M$Y$$$20240802$$HP$US$US
239444726$23944472$6$F$20240505$20240809$20240606$20240815$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001117$BLUEPRINT MEDICINES$$79$YR$E$M$Y$$$20240815$$CN$US$US
239444922$23944492$2$F$$20240722$20240606$20240729$EXP$$US-TAKEDA-2024TUS046757$TAKEDA$$$$$M$Y$$$20240729$$CN$US$US
239444962$23944496$2$F$$20240627$20240606$20240701$EXP$$AU-TAKEDA-2024TUS055925$TAKEDA$$$$$F$Y$$$20240701$$CN$AU$AU
239444976$23944497$6$F$20240601$20240801$20240606$20240803$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016655$UNITED THERAPEUTICS$$6$YR$$F$Y$24.036$KG$20240803$$PH$US$US
239445022$23944502$2$F$$20240902$20240606$20240910$EXP$$CO-EMD Serono-2024030065$EMD SERONO INC$$$$A$M$Y$$$20240910$$CN$CO$CO
239445032$23944503$2$F$$20240724$20240606$20240802$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001144$BLUEPRINT MEDICINES$$$$A$$Y$$$20240802$$MD$US$US
239445082$23944508$2$F$20240501$20240709$20240606$20240710$PER$$US-JNJFOC-20240586365$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240710$$CN$US$US
239445102$23944510$2$F$$20240701$20240606$20240709$EXP$$PT-AUROBINDO-AUR-APL-2024-026515$AUROBINDO$Branco C.G, Reis M.F, Vilas A.P. OCTREOTIDE IN COLONIC PSEUDOOBSTRUCTION IN PARKINSON^S DISEASE. European Journal of Case Reports in Internal Medicine.. 2021;8(1):160$77$YR$$M$Y$$$20240709$$HP$PT$PT
239445122$23944512$2$F$20240101$20240626$20240606$20240704$EXP$$CA-CELLTRION INC.-2024CA013245$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
239445192$23944519$2$F$20240530$20240806$20240606$20240808$PER$$US-AMGEN-USASP2024108842$AMGEN$$55$YR$A$F$Y$$$20240807$$CN$US$US
239445263$23944526$3$F$20240101$20240715$20240606$20240729$EXP$$US-UCBSA-2024014331$UCB$$$$$M$Y$$$20240729$$HP$US$US
239445603$23944560$3$F$20240516$20240617$20240606$20240702$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-449504$RANBAXY$$$$E$F$Y$$$20240702$$HP$ES$ES
239445752$23944575$2$F$$20240913$20240606$20240927$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448709$RANBAXY$Apraxine M, Levecque P, Druez P, Dahan K, Cambier J-F, Lengele J-P. Severe hypomagnesemia induced by proton pump inhibitors: description of two cases and review of the literature. Louvain Med. 2019;138(7):446-451$54$YR$$M$Y$$$20240927$$HP$BE$BE
239445792$23944579$2$F$$20240913$20240606$20240927$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449621$RANBAXY$Mantiero M, Ducceschi M, Polignano M, Bini M, Lopez S, Cavalli C, et al. REAL-LIFE EXPERIENCE of PAZOPANIB in UTERINE LEYOMIOSARCOMA (ULMS) in A TERTIARY ONCOLOGIC CENTER in ITALY: EVALUATION of SAFETY and EFFECTIVENESS. Int J Gynecol Cancer. 2023;33 (S3):A219; #269$$$$F$Y$$$20240927$$HP$IT$IT
239445912$23944591$2$F$20240501$20240626$20240606$20240703$PER$$US-AMGEN-USASP2024108758$AMGEN$$66$YR$E$F$Y$$$20240703$$CN$US$US
239446082$23944608$2$F$$20240712$20240606$20240723$EXP$$PT-AUROBINDO-AUR-APL-2024-026848$AUROBINDO$Pinto C.; Aguiar A.R.; Cunha M... UNILATERAL UPPER ARM SENSORY AND MOTOR BLOCKADE ASSOCIATED WITH IPSILATERAL HORNER^S SYNDROME AFTER EPIDURAL ANESTHESIA FOR URGENT CESAREAN-SECTION.. Regional Anesthesia and Pain Medicine.. 2022;47:A216$23$YR$$F$Y$$$20240723$$MD$PT$PT
239446162$23944616$2$F$$20240624$20240606$20240701$EXP$$FR-AUROBINDO-AUR-APL-2023-055135$AUROBINDO$Gasnier M, Frajerman A, Haddadi N, Herrero H, Faulet T, Martin S et al.. Amantadine-induced hypersexuality in a non-parkinsonian patient with catatonia: a case report... Psychiatry and clinical neurosciences... 2023;77(10):573-574$54$YR$$M$Y$$$20240701$$HP$FR$FR
239446252$23944625$2$F$$20240628$20240606$20240705$EXP$$AT-TAKEDA-2024TUS056609$TAKEDA$$$$$M$Y$$$20240705$$HP$AT$AT
239446272$23944627$2$F$$20240904$20240606$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-090701$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240904$$MD$JP$JP
239446302$23944630$2$F$$20240812$20240606$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088690$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240816$$HP$US$US
239446323$23944632$3$F$20240528$20240904$20240606$20240913$30DAY$$US-GSK-US2024067771$GLAXOSMITHKLINE$$41$YR$$F$Y$66.213$KG$20240913$$MD$US$US
239446424$23944642$4$F$20240323$20240903$20240606$20240910$EXP$$CO-TAKEDA-2024TUS032860$TAKEDA$$66$YR$$M$Y$78$KG$20240910$$CN$CO$CO
239446433$23944643$3$F$$20240807$20240606$20240813$EXP$$FR-TAKEDA-2024TUS056559$TAKEDA$$70$YR$$M$Y$$$20240813$$HP$FR$FR
239446442$23944644$2$F$$20240702$20240606$20240703$EXP$$US-ORGANON-O2406USA000290$ORGANON$$$$$F$Y$$$20240703$$HP$US$US
239446465$23944646$5$F$20230220$20240911$20240606$20240919$EXP$$CA-TAKEDA-2022TUS040240$TAKEDA$$57$YR$$F$Y$$$20240919$$CN$CA$CA
239446473$23944647$3$F$20240523$20240703$20240606$20240715$EXP$$CH-BEH-2024173150$CSL BEHRING$$$$A$F$Y$$$20240715$$MD$CH$CH
239446483$23944648$3$F$20231001$20240625$20240606$20240702$EXP$$SK-ASTELLAS-2024EU005433$ASTELLAS$Tresova I, Ihnatkova L, Sopko L, Rohon P, Ziakovz B, Ihnatko M et al. Targeted treatment of relapsed secondary acute myeloblastic leukemia. Onkologie. 2024;No information:28-35$49$YR$$F$Y$$$20240702$$MD$SK$SK
239446523$23944652$3$F$20230901$20240708$20240606$20240710$EXP$$US-UCBSA-2023044682$UCB$$25$YR$$M$Y$$$20240710$$CN$US$US
239446672$23944667$2$F$20231201$20240919$20240606$20240926$EXP$$CA-GSK-CA2023167112$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$CA$CA
239446812$23944681$2$F$20240603$20240709$20240606$20240711$PER$$US-AMGEN-USASP2024109974$AMGEN$$85$YR$E$M$Y$$$20240711$$CN$US$US
239447192$23944719$2$F$20240401$20240618$20240606$20240702$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00425$UPSHER-SMITH$$42$YR$$F$Y$$$20240702$$HP$US$US
239447293$23944729$3$F$20240602$20240810$20240606$20240814$PER$$US-AMGEN-USASP2024109710$AMGEN$$72$YR$E$F$Y$$$20240814$$CN$US$US
239447304$23944730$4$F$20231201$20240715$20240606$20240730$EXP$$US-EXELIXIS-CABO-24077950$EXELIXIS$$81$YR$$M$Y$$$20240729$$CN$US$US
239447415$23944741$5$F$20230808$20240816$20240606$20240826$EXP$$CA-CELLTRION INC.-2023CA017706$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
239447572$23944757$2$F$20240524$20240627$20240606$20240708$EXP$$US-APOTEX-2024AP006838$APOTEX$$$$$M$Y$$$20240708$$CN$US$US
239447584$23944758$4$F$20240101$20240716$20240606$20240718$EXP$$US-UCBSA-2024027375$UCB$$$$$M$Y$$$20240718$$HP$US$US
239447602$23944760$2$F$$20240812$20240606$20240819$EXP$$IN-ROCHE-3576624$ROCHE$$$$$$Y$$$20240819$$HP$IN$IN
239447712$23944771$2$F$20240101$20240712$20240606$20240716$EXP$$JP-JNJFOC-20240613163$JOHNSON AND JOHNSON$$7$DEC$E$M$Y$$$20240716$$MD$JP$JP
239447762$23944776$2$F$$20240626$20240606$20240704$EXP$$JP-TAKEDA-2024TUS053141$TAKEDA$$93$YR$$M$Y$$$20240704$$HP$JP$JP
239447772$23944777$2$F$$20240709$20240606$20240709$PER$$NVSC2024US118451$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
239447835$23944783$5$F$$20240909$20240606$20240912$EXP$$US-TAKEDA-2024TUS054664$TAKEDA$$$$$M$Y$$$20240912$$MD$US$US
239447914$23944791$4$F$20240713$20240812$20240606$20240819$EXP$$IN-ROCHE-3572745$ROCHE$$61$YR$A$M$Y$$$20240819$$CN$IN$IN
239447982$23944798$2$F$20230101$20240903$20240606$20240906$EXP$$US-JNJFOC-20240585563$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$PH$US$US
239448193$23944819$3$F$20240301$20240808$20240606$20240816$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-091098$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$67.59$KG$20240816$$CN$PR$PR
239448223$23944822$3$F$20231201$20240924$20240606$20240927$EXP$$JP-GSK-JP2024070200$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$JP$JP
239448262$23944826$2$F$20240423$20240821$20240606$20240830$EXP$$JP-ROCHE-3556179$ROCHE$$45$YR$A$F$Y$$$20240830$$MD$JP$JP
239448432$23944843$2$F$$20240716$20240606$20240722$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-11028$IPSEN$$$$$F$Y$$$20240719$$CN$GB$GB
239448643$23944864$3$F$20240505$20240625$20240606$20240709$EXP$$CA-ROCHE-2910907$ROCHE$$56$YR$A$F$Y$82.5$KG$20240709$$CN$CA$CA
239448673$23944867$3$F$$20240731$20240606$20240801$PER$$NVSC2024US118815$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
239448712$23944871$2$F$$20240703$20240606$20240705$PER$$US-HALEON-2180255$Haleon PLC$$$$$F$Y$$$20240705$$CN$US$US
239448792$23944879$2$F$$20240718$20240606$20240724$EXP$$CA-JNJFOC-20240607795$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240724$$HP$CA$CA
239448803$23944880$3$F$20240101$20240731$20240606$20240802$EXP$$CA-UCBSA-2024027406$UCB$$$$$F$Y$$$20240802$$CN$CA$CA
239449032$23944903$2$F$$20240903$20240606$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089668$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240904$$MD$US$US
239449045$23944904$5$F$20240501$20240829$20240606$20240904$EXP$$JP-GSK-JP2024JPN067898$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$JP$JP
239449062$23944906$2$F$$20240711$20240606$20240716$EXP$$TR-COHERUS BIOSCIENCES, INC-2024-COH-TR000413$PAREXEL$Zeynep Kira? ?nal , Ajda Bal, Yasemin Tombak, Deniz D?lgeroglu,  Ebru Umay. Anti-Tumor Necrosis Factor-?-Induced Systemic Lupus Erythematosus in Patients with Axial Spondiloarthritis A Single Center Experience. East J Med.. 2024;29:215-221$$$$$Y$$$20240716$$MD$TR$TR
239449072$23944907$2$F$20240530$20240709$20240606$20240716$PER$$US-AMGEN-USASP2024108368$AMGEN$$58$YR$A$F$Y$96.4$KG$20240716$$PH$US$US
239449192$23944919$2$F$$20240717$20240606$20240724$EXP$$US-ASTELLAS-2024EU004325$ASTELLAS$$$$$M$Y$$$20240724$$CN$US$US
239449213$23944921$3$F$20240101$20240710$20240606$20240715$PER$$US-AMGEN-USASP2024110878$AMGEN$$22$YR$A$F$Y$$$20240715$$HP$US$US
239449292$23944929$2$F$20240318$20240715$20240606$20240717$EXP$FR-AFSSAPS-TO2024000918$FR-UCBSA-2024028101$UCB$$43$YR$$M$Y$63.2$KG$20240717$$MD$FR$FR
239449302$23944930$2$F$$20240210$20240606$20240710$PER$$IN-ROCHE-3509197$ROCHE$$43$YR$A$F$Y$$$20240628$$CN$IN$IN
239449422$23944942$2$F$20240530$20240716$20240606$20240718$30DAY$$US-GSK-US2024067714$GLAXOSMITHKLINE$$82$YR$$M$Y$$$20240718$$CN$US$US
239449432$23944943$2$F$$20240711$20240606$20240716$EXP$$TR-COHERUS BIOSCIENCES, INC-2024-COH-TR000412$PAREXEL$Zeynep Kirac unal, Ajda Bal, Yasemin Tombak, Deniz Dulgeroglu, Ebru Umay. Anti-Tumor Necrosis Factor-?-Induced Systemic Lupus Erythematosus in Patients with Axial Spondiloarthritis A Single Center Experience. East J Med. 2024;29:216-221$$$$$Y$$$20240716$$MD$TR$TR
239449483$23944948$3$F$$20240719$20240606$20240806$PER$$US-ALXN-202405USA002134US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239449493$23944949$3$F$$20240805$20240606$20240812$PER$$US-ALXN-202405USA002043US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
239449852$23944985$2$F$20240701$20240808$20240606$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202406002332$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240812$$CN$US$US
239450112$23945011$2$F$20240528$20240718$20240606$20240727$EXP$$US-JNJFOC-20240586150$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240727$$PH$US$US
239450132$23945013$2$F$20240405$20240729$20240606$20240801$EXP$$CA-JNJFOC-20240587803$JOHNSON AND JOHNSON$$65$YR$E$F$Y$76$KG$20240801$$HP$CA$CA
239450163$23945016$3$F$20230508$20240807$20240606$20240808$EXP$$US-TAKEDA-2023TUS047287$TAKEDA$$70$YR$$F$Y$$$20240808$$HP$US$US
239450195$23945019$5$F$20240626$20240828$20240606$20240902$EXP$$US-TAKEDA-2024TUS017562$TAKEDA$$73$YR$$F$Y$49.887$KG$20240902$$HP$US$US
239450242$23945024$2$F$$20240722$20240606$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091360$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$PH$JP$JP
239450312$23945031$2$F$20240101$20240805$20240606$20240807$EXP$$MY-JNJFOC-20240580241$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240807$$MD$MY$MY
239451053$23945105$3$F$$20240806$20240606$20240814$EXP$$JP-EMD Serono-2024029909$EMD SERONO INC$$67$YR$E$F$Y$$$20240814$$MD$JP$JP
239451093$23945109$3$F$$20240712$20240606$20240723$EXP$$PT-AUROBINDO-AUR-APL-2024-026884$AUROBINDO$Tania da Silva Carvalho*, Beatriz Lagarteira, Mariana Flor de Lima, Magda Bento. HORNER SYNDROME AFTER COMBINED SPINALEPIDURAL LABOUR ANALGESIA: A CASE REPORT.. Regional Anesthesia and Pain Medicine.. 2023;48:A132-3$20$YR$$F$Y$$$20240723$$MD$PT$PT
239451123$23945112$3$F$$20240702$20240606$20240709$PER$$US-ROCHE-3572197$ROCHE$$$$A$F$Y$$$20240709$$CN$US$US
239451152$23945115$2$F$20240404$20240822$20240606$20240903$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-081321$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240903$$HP$ES$ES
239451392$23945139$2$F$$20240603$20240606$20240722$EXP$$RU-SA-2024SA169489$SANOFI AVENTIS$$71$YR$E$M$Y$115$KG$20240722$$HP$RU$CA
239451424$23945142$4$F$20240530$20240705$20240606$20240717$30DAY$$US-JNJFOC-20240586010$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
239451494$23945149$4$F$20200101$20240830$20240606$20240904$EXP$$RO-MYLANLABS-2024M1049858$MYLAN$Mustafa A, Danciu AI, Ionescu M. Acute coronary syndrome and cancer in the young male patient. Medical Life. 2024;10:13$32$YR$$M$Y$$$20240904$$MD$RO$RO
239451833$23945183$3$F$20240501$20240618$20240606$20240701$PER$$JP-Eisai-EC-2024-166687$EISAI$$61$YR$A$F$Y$$$20240701$$MD$JP$JP
239452013$23945201$3$F$20230821$20240827$20240606$20240830$PER$$US-BIOGEN-2024BI01267774$BIOGEN$$55$YR$$M$Y$$$20240830$$CN$US$US
239452023$23945202$3$F$20240601$20240808$20240606$20240810$PER$$US-AMGEN-USASP2024110283$AMGEN$$83$YR$E$F$Y$$$20240810$$CN$US$US
239452052$23945205$2$F$$20240731$20240606$20240801$EXP$$US-OTSUKA-2024_015579$OTSUKA$$$$$M$Y$86.18$KG$20240801$$CN$US$US
239452092$23945209$2$F$20240401$20240902$20240606$20240915$EXP$FR-AFSSAPS-NT2024000602$FR-STRIDES ARCOLAB LIMITED-2024SP006525$STRIDES$$$$$$Y$$$20240916$$MD$FR$FR
239452193$23945219$3$F$20240307$20240819$20240606$20240822$EXP$$NVSC2024US116094$NOVARTIS$$74$YR$$F$Y$$$20240822$$CN$US$US
239452283$23945228$3$F$20240524$20240805$20240606$20240808$EXP$$US-ABBVIE-5787400$ABBVIE$$20$YR$$M$Y$46$KG$20240808$$CN$US$US
239452292$23945229$2$F$$20240814$20240606$20240820$EXP$$US-OTSUKA-2024_015697$OTSUKA$$$$$M$Y$102.51$KG$20240820$$CN$US$US
239452362$23945236$2$F$$20240716$20240606$20240718$EXP$$GB-MYLANLABS-2024M1050356$MYLAN$$$$$F$Y$$$20240718$$PH$GB$GB
239452372$23945237$2$F$20240524$20240629$20240606$20240702$EXP$$US-MYLANLABS-2024M1050403$MYLAN$$52$YR$$M$Y$$$20240702$$HP$US$US
239452432$23945243$2$F$$20240716$20240606$20240719$EXP$$US-AstraZeneca-2024A129139$ASTRAZENECA$$$$$M$Y$$$20240719$$MD$US$
239452652$23945265$2$F$$20240919$20240606$20240930$PER$$US-SA-2024SA164818$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240930$$CN$US$US
239452683$23945268$3$F$20240101$20240702$20240606$20240709$PER$$US-SA-2024SA166094$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240709$$CN$US$US
239452762$23945276$2$F$$20240913$20240606$20240923$PER$$US-SA-2024SA164643$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240923$$MD$US$US
239452812$23945281$2$F$$20240913$20240606$20240925$PER$$US-SA-2024SA164669$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240925$$MD$US$US
239452852$23945285$2$F$$20240621$20240606$20240705$PER$$US-SA-2024SA166140$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
239452883$23945288$3$F$20240101$20240721$20240606$20240731$PER$$US-SA-2024SA164640$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240731$$MD$US$US
239452912$23945291$2$F$$20240903$20240606$20240912$PER$$US-SA-2024SA164703$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240912$$MD$US$US
239453002$23945300$2$F$$20240717$20240606$20240725$PER$$US-SA-2024SA165929$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$CN$US$US
239453012$23945301$2$F$20220530$20240826$20240606$20240909$PER$$US-SA-2024SA168087$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240909$$MD$US$US
239453072$23945307$2$F$20230101$20240809$20240606$20240820$PER$$US-SA-2024SA166998$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240820$$MD$US$US
239453142$23945314$2$F$$20240716$20240606$20240725$PER$$US-SA-2024SA167548$SANOFI AVENTIS$$$$E$M$Y$102.05$KG$20240725$$MD$US$US
239453212$23945321$2$F$$20240625$20240606$20240704$PER$$US-SA-2024SA165003$SANOFI AVENTIS$$$$$F$Y$$$20240704$$HP$US$US
239453222$23945322$2$F$20240101$20240809$20240606$20240819$PER$$US-SA-2024SA168085$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240819$$MD$US$US
239453333$23945333$3$F$$20240815$20240606$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091626$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240816$$CN$US$US
239453385$23945338$5$F$20240101$20240809$20240606$20240820$PER$$US-SA-2024SA169185$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240820$$MD$US$US
239453492$23945349$2$F$20240101$20240719$20240606$20240801$EXP$$US-INSMED, INC.-2024-02037-US$INSMED$$$$$F$Y$$$20240801$$CN$US$US
239453512$23945351$2$F$$20240729$20240606$20240802$EXP$$US-ABBVIE-5787455$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
239453522$23945352$2$F$20231214$20240812$20240606$20240819$EXP$GB-MHRA-MED-202406022025282920-JWGKS$GB-OTSUKA-2024_015743$OTSUKA$$34$YR$$F$Y$90$KG$20240819$$CN$GB$GB
239453532$23945353$2$F$20240515$20240816$20240606$20240827$EXP$$US-SA-2024SA162592$SANOFI AVENTIS$$56$YR$A$M$Y$181.7$KG$20240827$$MD$US$US
239453563$23945356$3$F$20240101$20240703$20240606$20240715$EXP$$US-ALKERMES INC.-ALK-2024-001492$ALKERMES$$$$$M$Y$68.299$KG$20240715$$HP$US$US
239453573$23945357$3$F$20240426$20240730$20240606$20240809$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-005986$AURINIA PHARMACEUTICALS$$68$YR$$M$Y$149.66$KG$20240809$$CN$US$US
239453642$23945364$2$F$$20240812$20240606$20240816$EXP$$IT-AMGEN-ITASP2024107494$AMGEN$Adami G.; Pedrollo E.; Rossini M. et al.. Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study. JBMR plus. 2024;8 (4):1-12$$$$$Y$$$20240816$$HP$IT$IT
239453672$23945367$2$F$20240511$20240806$20240606$20240819$EXP$$JP-UCBSA-2024028501$UCB$$48$YR$$M$Y$$$20240819$$PH$JP$JP
239453704$23945370$4$F$20240603$20240711$20240606$20240713$PER$$US-AMGEN-USASP2024111106$AMGEN$$76$YR$E$M$Y$$$20240713$$CN$US$US
239453732$23945373$2$F$$20240627$20240606$20240710$30DAY$$FR-JNJFOC-20240605809$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$PH$FR$FR
239453782$23945378$2$F$$20240913$20240606$20240919$EXP$$IL-PFIZER INC-202400186490$PFIZER$$14$YR$$M$Y$$$20240919$$HP$IL$IL
239453793$23945379$3$F$20240415$20240816$20240606$20240820$EXP$$RU-PFIZER INC-PV202400072283$PFIZER$$66$YR$$F$Y$$$20240820$$MD$RU$RU
239453803$23945380$3$F$$20240702$20240606$20240805$PER$$US-AVEVA-000648$AVEVA$$$$$M$Y$$$20240804$$HP$US$US
239454032$23945403$2$F$$20240604$20240606$20240902$PER$$US-AUROBINDO-AUR-APL-2024-020478$AUROBINDO$$$$$F$Y$$$20240902$$CN$US$US
239454123$23945412$3$F$20240101$20240911$20240606$20240926$PER$$US-SA-2024SA166681$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240926$$MD$US$US
239454162$23945416$2$F$20240101$20240903$20240606$20240913$PER$$US-SA-2024SA165412$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240913$$MD$US$US
239454172$23945417$2$F$$20240625$20240606$20240704$PER$$US-SA-2024SA168383$SANOFI AVENTIS$$$$A$F$Y$115.12$KG$20240704$$MD$US$US
239454192$23945419$2$F$$20240624$20240606$20240701$PER$$US-SA-2024SA168762$SANOFI AVENTIS$$63$YR$A$M$Y$69.85$KG$20240701$$MD$US$US
239454204$23945420$4$F$$20240922$20240606$20240926$30DAY$$US-PFIZER INC-202400184862$PFIZER$$6$YR$$F$Y$$$20240926$$CN$US$US
239454224$23945422$4$F$20240501$20240827$20240606$20240830$30DAY$$US-PFIZER INC-202400182405$PFIZER$$13$YR$$M$Y$$$20240830$$CN$US$US
239454235$23945423$5$F$20240530$20240921$20240606$20240925$30DAY$$US-PFIZER INC-202400184877$PFIZER$$14$YR$$M$Y$46.27$KG$20240925$$MD$US$US
239454254$23945425$4$F$$20240919$20240606$20240924$30DAY$$US-PFIZER INC-202400181414$PFIZER$$13$YR$$M$Y$$$20240924$$CN$US$US
239454264$23945426$4$F$20240401$20240815$20240606$20240820$30DAY$$US-PFIZER INC-202400181443$PFIZER$$16$YR$$F$Y$43.09$KG$20240820$$HP$US$US
239454274$23945427$4$F$$20240921$20240606$20240925$30DAY$$US-PFIZER INC-202400172856$PFIZER$$66$YR$$M$Y$$$20240925$$HP$US$US
239454299$23945429$9$F$$20240920$20240606$20240924$30DAY$$US-PFIZER INC-202400185564$PFIZER$$14$YR$$M$Y$45.36$KG$20240924$$CN$US$US
239454313$23945431$3$F$20240601$20240725$20240606$20240802$PER$$US-BIOGEN-2024BI01260754$BIOGEN$$58$YR$$F$Y$$$20240802$$CN$US$US
239454405$23945440$5$F$20240101$20240709$20240606$20240717$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011884$UNITED THERAPEUTICS$$$$$F$Y$67.12$KG$20240717$$$US$US
239454432$23945443$2$F$$20240705$20240606$20240715$30DAY$$US-GSK-US2024AMR069890$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
239454483$23945448$3$F$20240516$20240823$20240606$20240830$30DAY$$US-GSK-US2024068944$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240830$$CN$US$US
239454542$23945454$2$F$$20240724$20240606$20240725$PER$$NVSC2024US119058$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
239454573$23945457$3$F$$20240807$20240606$20240814$EXP$$JP-AstraZeneca-2024A126909$ASTRAZENECA$$$$$$Y$$$20240814$$PH$JP$
239454703$23945470$3$F$$20240703$20240606$20240711$PER$$US-UNITED THERAPEUTICS-UNT-2024-016892$UNITED THERAPEUTICS$$$$$F$Y$119.73$KG$20240711$$$US$US
239454932$23945493$2$F$20240515$20240702$20240606$20240711$EXP$$US-BEH-2024173276$CSL BEHRING$$5$YR$C$M$Y$$$20240711$$HP$US$US
239455032$23945503$2$F$$20240731$20240606$20240814$PER$$US-SA-2024SA167225$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240814$$MD$US$US
239455062$23945506$2$F$$20240731$20240606$20240806$EXP$$US-SA-2024SA149088$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240806$$MD$US$US
239455214$23945521$4$F$20240524$20240916$20240606$20240918$EXP$$NVSC2024GB111736$NOVARTIS$$33$YR$$F$Y$$$20240918$$CN$GB$GB
239455363$23945536$3$F$$20240821$20240606$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090732$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$90.72$KG$20240905$$CN$US$US
239455392$23945539$2$F$$20240724$20240606$20240731$30DAY$$US-GSK-US2024068923$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$HP$US$US
239455465$23945546$5$F$20211229$20240917$20240606$20240920$EXP$$NVSC2024FR082459$NOVARTIS$$$$E$F$Y$68$KG$20240920$$MD$FR$FR
239455492$23945549$2$F$20240501$20240704$20240606$20240710$EXP$$NVSJ2024JP006494$NOVARTIS$$$$A$F$Y$$$20240710$$MD$JP$JP
239455553$23945555$3$F$$20240722$20240606$20240726$EXP$$GB-MYLANLABS-2024M1050711$MYLAN$$$$$M$Y$$$20240726$$PH$GB$GB
239455692$23945569$2$F$20240227$20240710$20240606$20240716$EXP$IT-MINISAL02-987227$IT-MYLANLABS-2024M1049986$MYLAN$$61$YR$$M$Y$80$KG$20240716$$MD$IT$IT
239455782$23945578$2$F$20231031$20240719$20240606$20240725$EXP$$JP-TAKEDA-2024TUS054161$TAKEDA$$87$YR$$M$Y$60$KG$20240725$$MD$JP$JP
239455843$23945584$3$F$20240101$20240719$20240606$20240802$PER$$US-SA-2024SA166529$SANOFI AVENTIS$$66$YR$E$F$Y$70$KG$20240802$$MD$US$US
239455912$23945591$2$F$20240418$20240624$20240606$20240704$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-14311$SAMSUNG BIOEPIS$$7$YR$C$M$Y$$$20240704$$HP$CA$CA
239455972$23945597$2$F$20210927$20240715$20240606$20240718$EXP$NL-LRB-00976556$NL-PFIZER INC-202400182325$PFIZER$$56$YR$$F$Y$72$KG$20240718$$PH$NL$NL
239455982$23945598$2$F$$20240707$20240606$20240709$PER$$US-PFIZER INC-PV202400073798$PFIZER$$$$$F$Y$$$20240709$$HP$US$US
239456012$23945601$2$F$$20240707$20240606$20240709$PER$$US-PFIZER INC-PV202400073872$PFIZER$$$$$$Y$$$20240709$$CN$US$US
239456104$23945610$4$F$$20240912$20240606$20240916$PER$$NVSC2024US118801$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
239456144$23945614$4$F$$20240921$20240606$20240925$30DAY$$US-PFIZER INC-202400185727$PFIZER$$13$YR$$M$Y$$$20240925$$CN$US$US
239456185$23945618$5$F$$20240925$20240606$20240930$30DAY$$US-PFIZER INC-202400185198$PFIZER$$14$YR$$M$Y$$$20240930$$CN$US$US
239456202$23945620$2$F$$20240727$20240606$20240729$EXP$$US-PFIZER INC-PV202400073401$PFIZER$$30$YR$$M$Y$$$20240729$$CN$US$US
239456213$23945621$3$F$$20240911$20240606$20240913$30DAY$$US-PFIZER INC-202400185222$PFIZER$$10$YR$$F$Y$$$20240913$$CN$US$US
239456252$23945625$2$F$20240531$20240807$20240606$20240815$EXP$$US-AMGEN-USASL2024098293$AMGEN$$70$YR$E$F$Y$$$20240815$$CN$US$US
239456272$23945627$2$F$$20240626$20240606$20240704$30DAY$$US-GSK-US2024068932$GLAXOSMITHKLINE$$$$$M$Y$$$20240704$$CN$US$US
239456282$23945628$2$F$$20240722$20240606$20240801$30DAY$$US-GSK-US2024068947$GLAXOSMITHKLINE$$$$$M$Y$$$20240801$$CN$US$US
239456412$23945641$2$F$$20240712$20240606$20240716$30DAY$$US-PFIZER INC-PV202400044137$PFIZER$$$$$F$Y$$$20240716$$HP$US$US
239456423$23945642$3$F$$20240819$20240606$20240823$30DAY$$US-PFIZER INC-202400184787$PFIZER$$11$YR$$F$Y$24.49$KG$20240823$$CN$US$US
239456447$23945644$7$F$20240123$20240717$20240606$20240724$EXP$$NVSC2024DE115026$NOVARTIS$$$$A$F$Y$$$20240724$$MD$DE$DE
239456512$23945651$2$F$20240101$20240620$20240606$20240906$PER$$US-ALVOGEN-2024094679$ALVOGEN$$$$$F$Y$$$20240906$$CN$US$US
239456522$23945652$2$F$20240201$20240701$20240606$20240705$EXP$$SI-009507513-2406SVN000131$MERCK$$78$YR$$F$Y$85$KG$20240705$$MD$SI$SI
239456722$23945672$2$F$20240527$20240822$20240606$20240826$EXP$$US-BAYER-2024A082227$BAYER$$65$YR$E$M$Y$$$20240826$$HP$US$US
239456892$23945689$2$F$$20240801$20240606$20240812$PER$$JP-BEH-2024173216$CSL BEHRING$$40$YR$A$M$Y$$$20240812$$HP$JP$JP
239456902$23945690$2$F$20171213$20240717$20240606$20240722$EXP$$CN-ROCHE-2244133$ROCHE$$38$YR$A$F$Y$50$KG$20240719$$CN$CN$CN
239456924$23945692$4$F$20230823$20240919$20240606$20240926$EXP$$CA-GSK-CA2023AMR089220$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CA$CA
239456992$23945699$2$F$20240529$20240715$20240606$20240719$EXP$$GB-UCBSA-2024027378$UCB$$70$YR$$M$Y$$$20240719$$PH$GB$GB
239457082$23945708$2$F$$20240624$20240606$20240702$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-124710$DAIICHI$$$$E$$Y$$$20240702$$PH$JP$JP
239457242$23945724$2$F$20240201$20240815$20240606$20240821$EXP$$US-ABBVIE-5787717$ABBVIE$$42$YR$$M$Y$$$20240821$$CN$US$US
239457252$23945725$2$F$20240427$20240703$20240606$20240713$EXP$FR-AFSSAPS-AM2024000424$FR-TEVA-VS-3204262$TEVA$$76$YR$$M$Y$90$KG$20240713$$MD$FR$FR
239457463$23945746$3$F$20240101$20240702$20240606$20240705$EXP$$JP-DSJP-DSJ-2024-124687$DAIICHI$$55$YR$$F$Y$37.8$KG$20240705$$PH$JP$JP
239457532$23945753$2$F$20240101$20240625$20240606$20240704$PER$$US-SA-2024SA167892$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240704$$MD$US$US
239457873$23945787$3$F$$20240827$20240606$20240829$30DAY$$US-PFIZER INC-202400185645$PFIZER$$13$YR$$M$Y$$$20240829$$PH$US$US
239457922$23945792$2$F$$20240717$20240606$20240717$30DAY$$JO-PFIZER INC-202400108199$PFIZER$$16$YR$$M$Y$$$20240717$$CN$JO$JO
239457934$23945793$4$F$20231201$20240731$20240606$20240731$EXP$$CA-PFIZER INC-202400186272$PFIZER$$69$YR$$F$Y$$$20240731$$MD$CA$CA
239457944$23945794$4$F$20240530$20240820$20240606$20240826$30DAY$$GR-PFIZER INC-PV202400072475$PFIZER$$8$YR$$M$Y$23$KG$20240826$$CN$GR$GR
239457953$23945795$3$F$20240526$20240916$20240606$20240919$30DAY$$AR-PFIZER INC-202400179361$PFIZER$$11$YR$$F$Y$$$20240919$$HP$AR$AR
239458063$23945806$3$F$20240522$20240822$20240606$20240828$30DAY$$AR-PFIZER INC-202400174977$PFIZER$$12$YR$$M$Y$$$20240828$$CN$AR$AR
239458082$23945808$2$F$$20240912$20240606$20240917$30DAY$$JO-PFIZER INC-202400187129$PFIZER$$$$$$Y$$$20240917$$CN$JO$JO
239458093$23945809$3$F$$20240906$20240606$20240910$30DAY$$CO-PFIZER INC-PV202400070512$PFIZER$$12$YR$$M$Y$$$20240910$$CN$CO$CO
239458133$23945813$3$F$20240301$20240728$20240606$20240729$EXP$$CA-PFIZER INC-PV202400047941$PFIZER$$76$YR$$F$Y$$$20240729$$HP$CA$CA
239458142$23945814$2$F$20240215$20240823$20240606$20240828$EXP$$ES-PFIZER INC-202400185046$PFIZER$$64$YR$$M$Y$$$20240828$$MD$ES$ES
239458192$23945819$2$F$20231001$20240728$20240606$20240729$EXP$$CA-PFIZER INC-202300331240$PFIZER$$72$YR$$M$Y$$$20240729$$MD$CA$CA
239458202$23945820$2$F$$20240728$20240606$20240729$EXP$$CA-PFIZER INC-202400187625$PFIZER$$49$YR$$F$Y$$$20240729$$HP$CA$CA
239458223$23945822$3$F$20240424$20240727$20240606$20240729$EXP$$US-PFIZER INC-202400185567$PFIZER$$67$YR$$F$Y$61.6$KG$20240729$$PH$US$US
239458492$23945849$2$F$20240524$20240731$20240606$20240808$EXP$$US-VERTEX PHARMACEUTICALS-2024-009160$VERTEX$$22$YR$$F$Y$$$20240808$$CN$US$US
239458542$23945854$2$F$20231201$20240712$20240606$20240716$EXP$$US-PFIZER INC-202400186805$PFIZER$$27$YR$$F$Y$$$20240716$$HP$US$US
239458552$23945855$2$F$$20240711$20240606$20240716$PER$$US-PFIZER INC-202400186953$PFIZER$$75$YR$$F$Y$$$20240716$$CN$US$US
239458563$23945856$3$F$20240102$20240604$20240606$20240913$EXP$$AT-PFIZER INC-202400186042$PFIZER$$69$YR$$M$Y$$$20240913$$MD$AT$AT
239458642$23945864$2$F$$20240628$20240606$20240703$PER$$US-PFIZER INC-PV202400073948$PFIZER$$62$YR$$M$Y$$$20240703$$CN$US$US
239458672$23945867$2$F$$20240624$20240606$20240701$PER$$US-PFIZER INC-PV202400074049$PFIZER$$$$$F$Y$$$20240701$$MD$US$US
239458714$23945871$4$F$$20240703$20240606$20240704$EXP$$US-PFIZER INC-PV202400064991$PFIZER$$83$YR$$F$Y$$$20240704$$CN$US$US
239458742$23945874$2$F$20240320$20240624$20240606$20240701$PER$$US-PFIZER INC-PV202400073404$PFIZER$$15$YR$$M$Y$57.143$KG$20240701$$MD$US$US
239458822$23945882$2$F$20240101$20240626$20240606$20240711$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00433$UPSHER-SMITH$$$$$M$Y$$$20240711$$MD$US$US
239458954$23945895$4$F$20240611$20240812$20240606$20240816$30DAY$$FR-PFIZER INC-202400187359$PFIZER$$75$YR$$M$Y$$$20240816$$HP$FR$FR
239459012$23945901$2$F$$20240711$20240606$20240716$EXP$$CA-SANDOZ INC.-SDZ2024CA053286$SANDOZ$$$$$F$Y$$$20240716$$MD$CA$CA
239459032$23945903$2$F$$20240620$20240606$20240705$30DAY$$HK-JNJFOC-20240603060$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$HK$HK
239459262$23945926$2$F$20200401$20240627$20240606$20240704$30DAY$$US-TAKEDA-US202015766$TAKEDA$$48$YR$$F$Y$$$20240704$$CN$US$US
239459273$23945927$3$F$$20240611$20240606$20240809$EXP$$US-TEVA-VS-3204911$TEVA$Nazareno R, Patel D, Monday LM. Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation; A Medication Use and Safety Analysis. Open-Forum-Infect-Dis 2023; 10 (Suppl. 2) S505-S506 abstr. 927.; Nazareno R, Patel D, Monday LM. Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation; A Medication Use and Safety Analysis. Open-Forum-Infect-Dis 2023; 10 (Suppl. 2) S505-S...$48$YR$$F$Y$$$20240809$$HP$US$US
239459332$23945933$2$F$20240522$20240624$20240606$20240702$PER$$US-SA-2024SA160837$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240702$$MD$US$US
239459363$23945936$3$F$20240503$20240703$20240606$20240709$EXP$$IN-ASTELLAS-2024US016261$ASTELLAS$$66$YR$$F$Y$$$20240709$$CN$IN$IN
239459443$23945944$3$F$$20240812$20240606$20240819$30DAY$$AT-JNJFOC-20240600049$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$AT$AT
239459523$23945952$3$F$20240101$20240808$20240606$20240812$EXP$$CA-UCBSA-2024023535$UCB$$$$$M$Y$$$20240812$$CN$CA$CA
239459533$23945953$3$F$$20240701$20240606$20240703$EXP$$GB-PFIZER INC-PV202400073847$PFIZER$$$$$F$Y$$$20240703$$CN$GB$GB
239459545$23945954$5$F$$20240923$20240606$20240926$30DAY$$GB-PFIZER INC-202400186255$PFIZER$$$$$$Y$$$20240926$$HP$GB$GB
239459742$23945974$2$F$$20240701$20240606$20240709$PER$$US-SA-2024SA168630$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240709$$CN$US$US
239460054$23946005$4$F$$20240925$20240606$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090161$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240928$$CN$US$US
239460162$23946016$2$F$$20240730$20240606$20240806$30DAY$$NZ-JNJFOC-20240588370$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$NZ$NZ
239460173$23946017$3$F$$20240730$20240606$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202405016349$ELI LILLY AND CO$$$$$$Y$$$20240802$$CN$US$US
239460342$23946034$2$F$$20240828$20240606$20240912$PER$$US-SA-2024SA167222$SANOFI AVENTIS$$$$E$F$Y$$$20240912$$MD$US$US
239460373$23946037$3$F$20240101$20240702$20240606$20240704$PER$$US-AMGEN-USASP2024110166$AMGEN$$44$YR$A$F$Y$$$20240704$$HP$US$US
239460434$23946043$4$F$$20240918$20240606$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-081408$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$115.21$KG$20240924$$CN$US$US
239460572$23946057$2$F$$20240727$20240606$20240805$PER$$US-SA-2024SA165270$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240805$$MD$US$US
239460583$23946058$3$F$$20240925$20240606$20240930$EXP$$NVSC2024GB116443$NOVARTIS$$$$$F$Y$$$20240929$$CN$GB$GB
239460613$23946061$3$F$20240501$20240807$20240606$20240816$PER$$US-SA-2024SA166092$SANOFI AVENTIS$$60$YR$A$F$Y$68.4$KG$20240816$$MD$US$US
239460822$23946082$2$F$20240501$20240924$20240606$20240930$PER$$JP-Eisai-EC-2024-166900$EISAI$$72$YR$E$F$Y$$$20240930$$MD$JP$JP
239460925$23946092$5$F$20240101$20240918$20240606$20240926$PER$$US-SA-2024SA166561$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240926$$MD$US$US
239461043$23946104$3$F$$20240828$20240606$20240906$EXP$$CN-BEH-2024173377$CSL BEHRING$$76$YR$E$$Y$$$20240906$$CN$CN$CN
239461082$23946108$2$F$$20240719$20240606$20240725$EXP$$NVSC2024AU118906$NOVARTIS$Forcey DS, Wong V, Pham A, Patil S, Basu G. Post allogeneic stem cell transplant nephrotic syndrome secondary to de novo glomerulopathy: A case series. JOURNAL OF ONCO-NEPHROLOGY. 2024;8$58$YR$$M$Y$$$20240725$$HP$AU$AU
239461093$23946109$3$F$$20240913$20240606$20240926$30DAY$$IL-JNJFOC-20240587178$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$PH$IL$IL
239461112$23946111$2$F$$20240625$20240606$20240703$30DAY$$TW-JNJFOC-20240587337$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$TW$TW
239461242$23946124$2$F$$20240705$20240606$20240718$PER$$US-Calliditas-2024CAL00884$CALLIDITAS THERAPEUTICS$$30$YR$A$M$Y$$$20240718$$CN$US$US
239461382$23946138$2$F$$20240627$20240606$20240701$EXP$$US-TAKEDA-2023TUS052354$TAKEDA$$$$$F$Y$$$20240701$$CN$US$US
239461402$23946140$2$F$$20240702$20240606$20240706$EXP$$NVSC2024US116887$NOVARTIS$$$$$M$Y$$$20240706$$HP$US$US
239461443$23946144$3$F$20240430$20240801$20240606$20240808$EXP$$US-BEH-2024173274$CSL BEHRING$$64$YR$E$F$Y$97.052$KG$20240808$$CN$US$US
239461453$23946145$3$F$20240501$20240709$20240606$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04610$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239461466$23946146$6$F$20180101$20240918$20240606$20240926$EXP$$US-AMGEN-USASP2024106510$AMGEN$$64$YR$A$M$Y$$$20240926$$MD$US$US
239461542$23946154$2$F$20240502$20240712$20240606$20240716$PER$$TH-Eisai-EC-2024-167184$EISAI$$79$YR$E$M$Y$$$20240716$$MD$TH$TH
239461552$23946155$2$F$$20240725$20240606$20240731$PER$$US-RDY-SPO/USA/24/0007948$DR REDDYS$$18$YR$T$F$Y$$$20240731$$MD$US$US
239461643$23946164$3$F$$20240621$20240606$20240709$PER$$US-AVEVA-000669$AVEVA$$$$$F$Y$$$20240709$$HP$US$US
239461722$23946172$2$F$$20240613$20240606$20240708$PER$$US-AVEVA-000656$AVEVA$$$$$F$Y$$$20240708$$CN$US$US
239462093$23946209$3$F$20240531$20240703$20240606$20240711$PER$$US-AMGEN-USASP2024109837$AMGEN$$81$YR$E$F$Y$$$20240711$$CN$US$US
239462243$23946224$3$F$20240320$20240731$20240606$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091279$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240808$$PH$US$US
239462252$23946225$2$F$$20240621$20240606$20240704$EXP$$US-FARMAPROD-202405-2032$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240704$$CN$US$US
239462322$23946232$2$F$20240603$20240604$20240606$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA055125$SANDOZ$$59$YR$$M$Y$$$20240912$$CN$CA$CA
239462342$23946234$2$F$20240101$20240624$20240606$20240702$PER$$US-SA-2024SA167316$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240702$$MD$US$US
239462352$23946235$2$F$20240101$20240912$20240606$20240923$PER$$US-SA-2024SA165249$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240923$$MD$US$US
239462394$23946239$4$F$$20240709$20240606$20240715$EXP$$IN-PFIZER INC-PV202400073119$PFIZER$Lingarapu, M.. Co-occurrence of rhino-orbital mucormycosis and acute lymphoblastic leukemia post-COVID-19 infection in a young adolescent male: A case report from a low middle-income country. Clinical Case Reports. 2024;12(6):10.1002/ccr3.8972$16$YR$$M$Y$$$20240715$$HP$IN$IN
239462402$23946240$2$F$$20240705$20240606$20240708$EXP$$NVSC2024CH061309$NOVARTIS$$31$YR$$M$Y$$$20240708$$MD$CH$CH
239462432$23946243$2$F$20240528$20240716$20240606$20240725$EXP$$US-VANTIVE-2024VAN017365$Vantive US Healthcare$$52$YR$$M$Y$84$KG$20240725$$MD$US$US
239462622$23946262$2$F$$20240624$20240606$20240702$EXP$$CH-AstraZeneca-2024A129435$ASTRAZENECA$$$$$F$Y$$$20240702$$MD$CH$
239462765$23946276$5$F$20240602$20240910$20240606$20240911$PER$$US-AMGEN-USASP2024112032$AMGEN$$51$YR$A$M$Y$$$20240911$$CN$US$US
239462835$23946283$5$F$20240620$20240916$20240606$20240925$EXP$$CA-TAKEDA-2024TUS056431$TAKEDA$$33$YR$$F$Y$$$20240925$$CN$CA$CA
239462904$23946290$4$F$$20240805$20240606$20240816$EXP$$US-RDY-SPO/USA/24/0008100$DR REDDYS$$$$A$F$Y$$$20240816$$HP$US$US
239463063$23946306$3$F$$20240703$20240606$20240711$30DAY$$BR-JNJFOC-20240576227$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$PH$BR$BR
239463262$23946326$2$F$$20240717$20240606$20240722$EXP$$IN-PFIZER INC-PV202300024535$PFIZER$$63$YR$$F$Y$$$20240722$$CN$IN$IN
239463443$23946344$3$F$$20240812$20240606$20240813$EXP$$US-PFIZER INC-PV202400073620$PFIZER$$74$YR$$F$Y$$$20240813$$HP$US$US
239463584$23946358$4$F$20240531$20240910$20240606$20240913$EXP$$GR-PFIZER INC-PV202400072494$PFIZER$$5$YR$$M$Y$19$KG$20240913$$HP$GR$GR
239463612$23946361$2$F$20240501$20240708$20240606$20240715$EXP$$US-009507513-2406USA000256$MERCK$$86$YR$$M$Y$$$20240715$$CN$US$US
239463622$23946362$2$F$20240416$20240807$20240606$20240815$EXP$$JP-ROCHE-3576228$ROCHE$$8$DEC$E$M$Y$$$20240815$$MD$JP$JP
239463782$23946378$2$F$20240220$20240828$20240606$20240830$EXP$$JP-EXELIXIS-CABO-24078058$EXELIXIS$$59$YR$$M$Y$59$KG$20240830$$PH$JP$JP
239463852$23946385$2$F$$20240904$20240606$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091773$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240904$$CN$US$US
239463862$23946386$2$F$20240501$20240904$20240606$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091544$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240904$$CN$US$US
239463895$23946389$5$F$20240520$20240903$20240606$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-060214$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$72.4$KG$20240911$$MD$JP$JP
239464163$23946416$3$F$20240430$20240626$20240606$20240705$EXP$$US-OTSUKA-2024_002883$OTSUKA$$55$YR$$F$Y$69.85$KG$20240705$$HP$US$US
239464292$23946429$2$F$$20240716$20240606$20240724$PER$$US-BAYER-2024A081549$BAYER$$25$YR$A$F$Y$$$20240724$$MD$US$US
239464362$23946436$2$F$20240420$20240904$20240606$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091855$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240904$$CN$US$US
239464412$23946441$2$F$20240521$20240628$20240606$20240708$EXP$$GB-SA-2024SA165150$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240708$$PH$GB$GB
239464492$23946449$2$F$$20240809$20240606$20240812$EXP$$US-PFIZER INC-PV202400073879$PFIZER$$80$YR$$M$Y$$$20240812$$HP$US$US
239464504$23946450$4$F$20240603$20240716$20240606$20240722$30DAY$$US-JNJFOC-20240611213$JOHNSON AND JOHNSON$$35$YR$A$$Y$$$20240723$$HP$US$US
239464544$23946454$4$F$20240729$20240802$20240606$20240806$EXP$$US-PFIZER INC-202400102330$PFIZER$$61$YR$$F$Y$165.53$KG$20240806$$HP$US$US
239464603$23946460$3$F$20240523$20240812$20240606$20240821$EXP$$US-PFIZER INC-PV202400072340$PFIZER$$77$YR$$M$Y$78.1$KG$20240821$$MD$US$US
239464623$23946462$3$F$20240522$20240627$20240606$20240701$PER$$US-Eisai-EC-2024-167458$EISAI$$62$YR$A$F$Y$$$20240701$$CN$US$US
239464662$23946466$2$F$20240501$20240906$20240606$20240916$EXP$$JP-TAKEDA-2024TUS054569$TAKEDA$$7$DEC$$M$Y$$$20240916$$MD$JP$JP
239464692$23946469$2$F$20240101$20240905$20240606$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086977$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240905$$CN$US$US
239464734$23946473$4$F$20231201$20240918$20240606$20240925$EXP$$CA-GSK-CA2023155472$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$CA$CA
239464762$23946476$2$F$$20240702$20240606$20240704$30DAY$$US-MYLANLABS-2024M1050827$MYLAN$$$$$F$Y$$$20240704$$CN$US$US
239464782$23946478$2$F$$20240604$20240606$20240823$EXP$$NZ-MYLANLABS-2024M1051468$MYLAN$$$$$M$Y$$$20240823$$HP$NZ$NZ
239464882$23946488$2$F$$20240726$20240606$20240730$EXP$$PK-AMGEN-PAKSP2024108568$AMGEN$$69$YR$E$M$Y$50$KG$20240729$$CN$PK$PK
239464892$23946489$2$F$$20240726$20240606$20240731$EXP$$PK-AMGEN-PAKSP2022104545$AMGEN$$16$YR$T$F$Y$$$20240731$$CN$PK$PK
239464912$23946491$2$F$$20240722$20240606$20240725$EXP$$NZ-MYLANLABS-2024M1051292$MYLAN$$$$$M$Y$$$20240725$$HP$NZ$NZ
239464922$23946492$2$F$20230831$20240625$20240606$20240703$EXP$$JP-BAYER-2024A077299$BAYER$$61$YR$A$M$Y$$$20240703$$MD$JP$JP
239464962$23946496$2$F$$20240719$20240606$20240725$EXP$$NVSC2024AU118911$NOVARTIS$Forcey DS, Wong V, Pham A, Patil S., Basu G. Post allogeneic stem cell transplant nephrotic syndrome secondary to de novo glomerulopathy: a case series. JOURNAL OF ONCO-NEPHROLOGY. 2024;8:3-12$54$YR$$M$Y$$$20240725$$HP$AU$AU
239465003$23946500$3$F$$20240719$20240606$20240723$EXP$$NVSC2024AU118710$NOVARTIS$Forcey DS, Wong V, Pham A, Patil S, Basu G. Post allogeneic stem cell transplant nephrotic syndrome secondary to de novo glomerulopathy: A case series. JOURNAL OF ONCO-NEPHROLOGY. 2024;8(1):3-12$67$YR$$F$Y$$$20240723$$HP$AU$AU
239465063$23946506$3$F$$20240710$20240606$20240715$EXP$$GB-MYLANLABS-2024M1050847$MYLAN$$$$$M$Y$$$20240715$$PH$GB$GB
239465152$23946515$2$F$20240101$20240827$20240606$20240830$EXP$$US-PFIZER INC-PV202400039642$PFIZER$$61$YR$$F$Y$$$20240830$$HP$US$US
239465185$23946518$5$F$20231025$20240830$20240606$20240910$EXP$$CN-PFIZER INC-2023SGN11908$PFIZER$$23$YR$$M$Y$102$KG$20240910$$MD$CN$CN
239465258$23946525$8$F$20240220$20240830$20240606$20240903$EXP$$CN-PFIZER INC-2024SGN02053$PFIZER$$80$YR$$F$Y$45$KG$20240903$$MD$CN$CN
239465292$23946529$2$F$$20240904$20240606$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091935$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240904$$CN$US$US
239465512$23946551$2$F$20240530$20240715$20240606$20240717$PER$$US-DSJP-DSU-2024-125087$DAIICHI$$72$YR$$F$Y$$$20240717$$PH$US$US
239465572$23946557$2$F$20240101$20240702$20240606$20240705$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003136$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240705$$CN$US$US
239465692$23946569$2$F$$20240710$20240606$20240722$PER$$US-RDY-SPO/USA/24/0007957$DR REDDYS$$2$YR$C$F$Y$13.2$KG$20240719$$CN$US$US
239465822$23946582$2$F$20240501$20240611$20240606$20240708$PER$$FR-TOLMAR, INC.-24FR049343$TOLMAR$$68$YR$$M$Y$$$20240708$$HP$FR$FR
239465852$23946585$2$F$$20240806$20240606$20240830$PER$$CA-TOLMAR, INC.-24CA049384$TOLMAR$$$$$M$Y$$$20240830$$CN$CA$CA
239465882$23946588$2$F$20240514$20240612$20240606$20240708$PER$$FR-TOLMAR, INC.-24FR049380$TOLMAR$$79$YR$$M$Y$$$20240708$$PH$FR$FR
239466137$23946613$7$F$20240501$20240913$20240606$20240919$30DAY$$US-PFIZER INC-202400180939$PFIZER$$10$YR$$M$Y$26$KG$20240919$$MD$US$US
239466142$23946614$2$F$$20240719$20240606$20240725$PER$$US-MYLANLABS-2024M1046379$MYLAN$$$$$F$Y$$$20240725$$HP$US$US
239466162$23946616$2$F$20240604$20240809$20240606$20240812$PER$$US-AMGEN-USASP2024112103$AMGEN$$65$YR$E$M$Y$$$20240812$$CN$US$US
239466182$23946618$2$F$20200101$20240919$20240606$20240924$EXP$$US-ABBVIE-5785309$ABBVIE$$45$YR$$F$Y$$$20240924$$CN$US$US
239466262$23946626$2$F$20240514$20240709$20240606$20240710$PER$$US-JNJFOC-20240586811$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240710$$HP$US$US
239466272$23946627$2$F$$20240904$20240606$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091419$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240904$$CN$US$US
239466302$23946630$2$F$$20240815$20240606$20240816$PER$$NVSC2024US118812$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
239466355$23946635$5$F$20240322$20240715$20240606$20240717$EXP$$ES-SANDOZ INC.-SDZ2024ES039607$SANDOZ$$58$YR$$F$Y$63.1$KG$20240717$$MD$ES$ES
239466412$23946641$2$F$20240517$20240905$20240606$20240911$EXP$$US-BAYER-2024A081517$BAYER$$24$YR$A$M$Y$$$20240911$$HP$US$US
239466544$23946654$4$F$20230701$20240731$20240606$20240805$EXP$$AU-AMGEN-AUSSP2024109839$AMGEN$$85$YR$E$F$Y$$$20240805$$PH$AU$AU
239466593$23946659$3$F$20220721$20240701$20240606$20240703$EXP$$BG-TAKEDA-2022TUS050198$TAKEDA$$53$YR$$F$Y$$$20240703$$CN$BG$BG
239466635$23946663$5$F$$20240718$20240606$20240722$EXP$$US-SANDOZ INC.-NVSC2022US094019$SANDOZ$$$$$F$Y$56.689$KG$20240722$$CN$US$US
239466765$23946676$5$F$20240530$20240910$20240606$20240912$30DAY$$AR-PFIZER INC-202400185416$PFIZER$$9$YR$$F$Y$$$20240912$$CN$AR$AR
239466783$23946678$3$F$20181004$20240630$20240606$20240702$PER$$US-PFIZER INC-PV202400073757$PFIZER$$69$YR$$F$Y$158.73$KG$20240702$$CN$US$US
239466805$23946680$5$F$$20240727$20240606$20240730$PER$$US-PFIZER INC-202400186624$PFIZER$$$$A$$Y$$$20240730$$MD$US$US
239466862$23946686$2$F$$20240702$20240606$20240703$PER$$US-PFIZER INC-PV202400074068$PFIZER$$32$YR$$M$Y$$$20240703$$HP$US$US
239466922$23946692$2$F$$20240707$20240606$20240709$PER$$US-PFIZER INC-PV202400072796$PFIZER$$$$$$Y$$$20240709$$HP$US$US
239467012$23946701$2$F$$20240628$20240606$20240702$PER$$US-PFIZER INC-2021100860$PFIZER$$39$YR$$M$Y$$$20240702$$HP$US$US
239467043$23946704$3$F$20240101$20240708$20240606$20240709$PER$$US-PFIZER INC-202400187505$PFIZER$$74$YR$$F$Y$63.492$KG$20240709$$CN$US$US
239467173$23946717$3$F$20240512$20240730$20240606$20240801$PER$$US-PFIZER INC-202400187476$PFIZER$$75$YR$$F$Y$$$20240801$$CN$US$US
239467212$23946721$2$F$20240604$20240624$20240606$20240701$PER$$US-PFIZER INC-202400187543$PFIZER$$36$YR$$F$Y$65.31$KG$20240701$$CN$US$US
239467312$23946731$2$F$$20240722$20240606$20240726$EXP$$JP-INCYTE CORPORATION-2024IN006027$INCYTE$$$$$$Y$$$20240726$$PH$JP$JP
239467325$23946732$5$F$20240523$20240925$20240606$20240930$30DAY$$CA-PFIZER INC-202400074832$PFIZER$$11$YR$$M$Y$30.4$KG$20240930$$HP$CA$CA
239467346$23946734$6$F$20240514$20240809$20240606$20240813$EXP$$US-PFIZER INC-202400186060$PFIZER$$62$YR$$F$Y$72.57$KG$20240813$$HP$US$US
239467353$23946735$3$F$20240602$20240913$20240606$20240919$30DAY$$PA-PFIZER INC-202400185489$PFIZER$$14$YR$$M$Y$$$20240919$$CN$PA$PA
239467374$23946737$4$F$20240531$20240910$20240606$20240912$30DAY$$AR-PFIZER INC-202400185419$PFIZER$$4$YR$$F$Y$$$20240912$$HP$AR$AR
239467392$23946739$2$F$20240601$20240820$20240606$20240821$30DAY$$AR-PFIZER INC-202400186653$PFIZER$$8$YR$$M$Y$$$20240821$$CN$AR$AR
239467424$23946742$4$F$$20240802$20240606$20240806$PER$$US-PFIZER INC-PV202400074288$PFIZER$$72$YR$$F$Y$$$20240806$$HP$US$US
239467492$23946749$2$F$$20240724$20240606$20240806$PER$$US-Calliditas-2024CAL00876$CALLIDITAS THERAPEUTICS$$58$YR$A$F$Y$63$KG$20240806$$CN$US$US
239467712$23946771$2$F$20240423$20240729$20240606$20240801$EXP$$DE-FreseniusKabi-FK202408852$FRESENIUS KABI$$52$YR$A$F$Y$$$20240801$$MD$DE$DE
239467732$23946773$2$F$$20240701$20240606$20240709$EXP$$GB-ROCHE-3577883$ROCHE$$$$$F$Y$$$20240709$$CN$GB$GB
239467742$23946774$2$F$$20240713$20240606$20240715$30DAY$$CL-PFIZER INC-PV202400054033$PFIZER$$4$YR$$M$Y$$$20240715$$CN$CL$CL
239468213$23946821$3$F$$20240913$20240606$20240919$30DAY$$CO-PFIZER INC-202400186368$PFIZER$$$$$$Y$$$20240919$$CN$CO$CO
239468223$23946822$3$F$$20240826$20240606$20240829$30DAY$$IL-PFIZER INC-202400187963$PFIZER$$$$$$Y$$$20240829$$CN$IL$IL
239468372$23946837$2$F$20240501$20240911$20240606$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091365$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240912$$HP$US$US
239468522$23946852$2$F$20240101$20240425$20240606$20240710$PER$$JP-ROCHE-3564207$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
239468643$23946864$3$F$20240420$20240527$20240606$20240816$EXP$$FR-ROCHE-3568744$ROCHE$$68$YR$E$F$Y$$$20240817$$MD$FR$FR
239468693$23946869$3$F$20211201$20240701$20240606$20240702$EXP$HU-ORG100013348-CHEM0010958$HU-UCBSA-2024028182$UCB$$40$YR$$F$Y$$$20240702$$MD$HU$HU
239468732$23946873$2$F$20230101$20240709$20240606$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091459$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240711$$MD$JP$JP
239469123$23946912$3$F$20240517$20240829$20240606$20240904$EXP$$CA-ROCHE-3571826$ROCHE$$31$YR$A$F$Y$$$20240904$$MD$CA$CA
239469142$23946914$2$F$$20240717$20240606$20240720$PER$$US-AMGEN-USASP2024111991$AMGEN$$$$$F$Y$$$20240720$$PH$US$US
239469162$23946916$2$F$$20240805$20240606$20240809$EXP$PT-OPELLA-2024OHG017606$PT-PERRIGO-24PT005069$PERRIGO$Ramalho D., Canelas A., Samoes B., Da Costa I. ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-INDUCED. European Journal of Case Reports in Internal Medicine. A CASE. Eur. J. Case Rep. Intern. Med. 2019-01-01; 226. doi:10.12890/2019_V6Supl.$73$YR$$M$Y$$$20240809$$HP$PT$PT
239469385$23946938$5$F$20240529$20240807$20240606$20240812$EXP$$VN-SANDOZ INC.-SDZ2024VN055461$SANDOZ$$65$YR$$M$Y$49.9$KG$20240812$$MD$VN$VN
239469473$23946947$3$F$$20240801$20240606$20240809$EXP$$JP-EMD Serono-2024029999$EMD SERONO INC$$$$$F$Y$80$KG$20240809$$CN$JP$JP
239469582$23946958$2$F$20211230$20240828$20240606$20240829$EXP$$US-TAKEDA-US201801778$TAKEDA$$68$YR$$F$Y$$$20240829$$HP$US$US
239469762$23946976$2$F$20240301$20240917$20240606$20240926$PER$$JP-Eisai-EC-2024-167196$EISAI$$$$E$F$Y$$$20240926$$MD$JP$JP
239469782$23946978$2$F$$20240709$20240606$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091636$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240711$$MD$JP$JP
239469792$23946979$2$F$20231229$20240709$20240606$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091462$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240711$$MD$JP$JP
239469816$23946981$6$F$20240527$20240626$20240606$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-085962$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240705$$PH$JP$JP
239469872$23946987$2$F$20240416$20240625$20240606$20240701$EXP$$JP-BAYER-2024A082222$BAYER$$74$YR$E$M$Y$$$20240701$$MD$JP$JP
239470032$23947003$2$F$$20240708$20240606$20240716$EXP$$CZ-ROCHE-3573454$ROCHE$$73$YR$E$M$Y$$$20240716$$MD$CZ$CZ
239470082$23947008$2$F$20240501$20240917$20240606$20240926$PER$$JP-Eisai-EC-2024-167198$EISAI$$$$E$F$Y$$$20240926$$MD$JP$JP
239470163$23947016$3$F$$20240920$20240606$20240926$EXP$$US-BIOVITRUM-2024-US-008094$BIOVITRUM$$63$YR$$M$Y$$$20240926$$CN$US$US
239470232$23947023$2$F$20240601$20240820$20240606$20240823$PER$$US-AMGEN-USASP2024109669$AMGEN$$73$YR$E$F$Y$$$20240823$$CN$US$US
239470253$23947025$3$F$20240517$20240808$20240606$20240816$EXP$$CA-RDY-SPO/CAN/24/0007796$DR REDDYS$$72$YR$E$M$Y$60.8$KG$20240816$$HP$CA$CA
239470263$23947026$3$F$20231202$20240710$20240606$20240723$PER$$US-Calliditas-2024CAL00880$CALLIDITAS THERAPEUTICS$$68$YR$E$M$Y$51.7$KG$20240723$$CN$US$US
239470482$23947048$2$F$$20240723$20240606$20240802$30DAY$$US-GSK-US2024068916$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$CN$US$US
239470503$23947050$3$F$$20240708$20240606$20240720$30DAY$$US-GSK-US2024067758$GLAXOSMITHKLINE$$$$$F$Y$$$20240720$$CN$US$US
239470522$23947052$2$F$20240829$20240830$20240606$20240903$30DAY$$US-GSK-US2024067161$GLAXOSMITHKLINE$$81$YR$$M$Y$$$20240903$$CN$US$US
239470532$23947053$2$F$$20240625$20240606$20240703$30DAY$$US-GSK-US2024067167$GLAXOSMITHKLINE$$$$$M$Y$$$20240703$$CN$US$US
239470562$23947056$2$F$20230101$20240529$20240606$20240718$EXP$$NVSC2024HU116464$NOVARTIS$$70$YR$$F$Y$$$20240718$$MD$HU$HU
239470572$23947057$2$F$20240602$20240813$20240606$20240816$PER$$US-AMGEN-USASP2024109636$AMGEN$$78$YR$E$M$Y$$$20240816$$CN$US$US
239470582$23947058$2$F$20240101$20240626$20240606$20240703$EXP$$US-Vifor (International) Inc.-VIT-2024-04955$VIFOR$$$$$F$Y$86.6$KG$20240703$$MD$US$US
239470614$23947061$4$F$20240301$20240712$20240606$20240724$EXP$$BR-BAYER-2024A077398$BAYER$$57$YR$A$M$Y$$$20240724$$CN$BR$BR
239470623$23947062$3$F$20240602$20240815$20240606$20240816$PER$$NVSC2024US119240$NOVARTIS$$37$YR$$F$Y$$$20240816$$CN$US$US
239470742$23947074$2$F$$20240712$20240606$20240716$EXP$$CA-AstraZeneca-2024A126977$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$CA$
239470773$23947077$3$F$20240603$20240701$20240606$20240703$PER$$US-AMGEN-USASP2024112098$AMGEN$$64$YR$A$F$Y$$$20240703$$CN$US$US
239470784$23947078$4$F$20240604$20240718$20240606$20240723$PER$$US-AMGEN-USASP2024111712$AMGEN$$56$YR$A$F$Y$69.841$KG$20240723$$CN$US$US
239470854$23947085$4$F$20240519$20240528$20240606$20240710$EXP$$BR-APELLIS-2024-APL-0000196$APELLIS PHARMACEUTICALS$$$$$$Y$60$KG$20240710$$CN$BR$BR
239470862$23947086$2$F$20230801$20240805$20240606$20240808$EXP$$ES-JNJFOC-20240581496$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$ES$ES
239470912$23947091$2$F$$20240617$20240606$20240705$EXP$$PT-TEVA-VS-3205944$TEVA$Mateus DB, Marques M, Cruz S, Abreu J, Pereira JT, Simoes ACC, et al. IATROGENIC RHABDOMYOLYSIS - ABOUT A CLINICAL CASE REPORT. Eur-J-Case-Rep-Intern-Med 2022; 9 (Suppl.) 605-606 abstr. 2050 / #EV1272.; Mateus DB, Marques M, Cruz S, Abreu J, Pereira JT, Simoes ACC, et al. IATROGENIC RHABDOMYOLYSIS - ABOUT A CLINICAL CASE REPORT. Eur-J-Case-Rep-Intern-Med 2022; 9 (Suppl.) 605-606 abstr. 2050 / #EV1272.$69$YR$$F$Y$$$20240705$$HP$PT$PT
239470962$23947096$2$F$$20240628$20240606$20240702$EXP$$US-BIOMARINAP-US-2024-158264$BIOMARIN$$$$$$Y$$$20240702$$CN$US$US
239471022$23947102$2$F$$20240726$20240606$20240726$PER$$US-PFIZER INC-202300268288$PFIZER$$23$YR$$M$Y$$$20240726$$MD$US$US
239471042$23947104$2$F$$20240706$20240606$20240708$PER$$US-PFIZER INC-202400187167$PFIZER$$14$YR$$M$Y$$$20240708$$CN$US$US
239471107$23947110$7$F$20240401$20240830$20240606$20240903$EXP$$JP-ABBVIE-5767601$ABBVIE$$50$YR$$M$Y$$$20240903$$CN$JP$JP
239471503$23947150$3$F$20240501$20240702$20240606$20240709$EXP$$IT-BIOMARINAP-IT-2024-158377$BIOMARIN$$$$$$Y$$$20240709$$CN$IT$IT
239471537$23947153$7$F$20240701$20240826$20240606$20240828$EXP$$US-SANDOZ INC.-SDZ2024US055433$SANDOZ$$48$YR$$F$Y$$$20240828$$CN$US$US
239471562$23947156$2$F$$20240904$20240606$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091550$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$MD$JP$JP
239471632$23947163$2$F$$20240625$20240606$20240703$EXP$$US-BIOGEN-2024BI01267122$BIOGEN$$$$$F$Y$$$20240703$$HP$US$US
239471684$23947168$4$F$$20240906$20240606$20240909$PER$$NVSC2024US119209$NOVARTIS$$$$$F$Y$$$20240909$$MD$US$US
239472018$23947201$8$F$20230321$20240828$20240606$20240902$EXP$$CN-PFIZER INC-2023SGN10725$PFIZER$$32$YR$$M$Y$$$20240902$$MD$CN$CN
239472082$23947208$2$F$20240101$20240711$20240606$20240716$EXP$$CA-JNJFOC-20240589297$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240716$$HP$CA$CA
239472092$23947209$2$F$20240502$20240619$20240606$20240701$EXP$$US-APELLIS-2024-APL-0000116$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240701$$MD$US$US
239472276$23947227$6$F$20240516$20240917$20240606$20240923$EXP$$GB-MYLANLABS-2024M1051419$MYLAN$$53$YR$$M$Y$87$KG$20240923$$MD$GB$GB
239472402$23947240$2$F$20240501$20240903$20240606$20240904$PER$$NVSC2024US118415$NOVARTIS$$53$YR$$M$Y$82$KG$20240904$$CN$US$US
239472462$23947246$2$F$$20240810$20240606$20240813$EXP$$NVSC2024IL116132$NOVARTIS$Jacoby E, Ghorashian S, Vormoor B, Moerloose BD, Bodmer N, Molostova O et al.. CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study. LEUKEMIA. 2022;36:1525-32$$$$$Y$$$20240813$$HP$IL$IL
239472592$23947259$2$F$20240513$20240703$20240606$20240712$PER$$US-MYLANLABS-2024M1046838$MYLAN$$86$YR$$F$Y$58.05$KG$20240712$$CN$US$US
239472622$23947262$2$F$$20240531$20240606$20240718$EXP$$US-Taiho Oncology Inc-2024-003700$TAIHO ONCOLOGY INC$$$$E$F$Y$$$20240718$$CN$US$US
239472672$23947267$2$F$$20240810$20240606$20240813$EXP$$NVSC2024IL116136$NOVARTIS$Jacoby E, Ghorashian S, Vormoor B, De Moerloose B, Bodmer N, Molostova O et al.. CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study. LEUKEMIA. 2022;36:1525-32$$$$$Y$$$20240813$$HP$IL$IL
239472692$23947269$2$F$20240514$20240828$20240606$20240905$EXP$FR-AFSSAPS-BX2024001042$FR-TEVA-VS-3205147$TEVA$$63$YR$$M$Y$75$KG$20240905$$MD$FR$FR
239472712$23947271$2$F$20240327$20240624$20240606$20240702$EXP$$CN-AstraZeneca-2024A111670$ASTRAZENECA$$52$YR$$F$Y$$$20240702$$MD$CN$
239472822$23947282$2$F$20240401$20240923$20240606$20240930$EXP$$US-BAYER-2024A082107$BAYER$$82$YR$E$M$Y$$$20240930$$CN$US$US
239472912$23947291$2$F$20240101$20240904$20240606$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091575$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240904$$CN$US$US
239472922$23947292$2$F$20231116$20240709$20240606$20240714$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091448$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240715$$MD$JP$JP
239472962$23947296$2$F$20240101$20240904$20240606$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091589$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240904$$CN$US$US
239473132$23947313$2$F$20240501$20240723$20240606$20240726$PER$$US-PFIZER INC-PV202400074080$PFIZER$$69$YR$$M$Y$$$20240726$$CN$US$US
239473173$23947317$3$F$$20240710$20240606$20240729$PER$$US-INCYTE CORPORATION-2024IN005249$INCYTE$$$$$$Y$$$20240729$$CN$US$US
239473186$23947318$6$F$$20240702$20240606$20240724$EXP$$CA-JNJFOC-20240538232$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240724$$PH$CA$CA
239473253$23947325$3$F$20240301$20240731$20240606$20240814$PER$$US-Calliditas-2024CAL00877$CALLIDITAS THERAPEUTICS$$24$YR$A$F$Y$$$20240813$$CN$US$US
239473263$23947326$3$F$20240517$20240809$20240606$20240816$EXP$$US-Calliditas-2024CAL00902$CALLIDITAS THERAPEUTICS$$65$YR$E$F$Y$80.3$KG$20240816$$CN$US$US
239473373$23947337$3$F$20231001$20240830$20240606$20240904$EXP$$NVSC2023ES250360$NOVARTIS$$47$YR$$F$Y$$$20240904$$CN$ES$ES
239473493$23947349$3$F$$20240515$20240606$20240709$PER$$US-MYLANLABS-2024M1046439$MYLAN$$$$$$Y$$$20240709$$CN$US$US
239473532$23947353$2$F$20240530$20240613$20240606$20240701$PER$$US-INCYTE CORPORATION-2024IN005250$INCYTE$$$$$$Y$$$20240701$$HP$US$US
239473553$23947355$3$F$20240501$20240628$20240606$20240701$EXP$$SA-KYOWAKIRIN-2024KK012584$KYOWA$$$$$$Y$$$20240701$$HP$AE$SA
239473672$23947367$2$F$$20240530$20240606$20240801$PER$$US-MYLANLABS-2024M1049214$MYLAN$$$$$F$Y$$$20240801$$PH$US$US
239473742$23947374$2$F$$20240604$20240606$20240823$EXP$$NZ-MYLANLABS-2024M1051456$MYLAN$$$$$M$Y$$$20240823$$MD$NZ$NZ
239473772$23947377$2$F$20240503$20240712$20240606$20240716$EXP$$GB-MYLANLABS-2024M1051415$MYLAN$$$$$F$Y$$$20240716$$PH$GB$GB
239474014$23947401$4$F$20210101$20240705$20240606$20240711$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-026204$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240711$$CN$US$US
239474033$23947403$3$F$20230430$20240809$20240606$20240812$EXP$$DK-SANDOZ INC.-SDZ2024DK054866$SANDOZ$$61$YR$$F$Y$54$KG$20240812$$MD$DK$DK
239474062$23947406$2$F$$20240708$20240606$20240710$PER$$US-BIOVITRUM-2024-US-008113$BIOVITRUM$$53$YR$$F$Y$$$20240710$$CN$US$US
239474363$23947436$3$F$20240515$20240805$20240606$20240813$EXP$$JP-009507513-2405JPN003790J$MERCK$$69$YR$$M$Y$$$20240813$$MD$JP$JP
239474384$23947438$4$F$$20240709$20240606$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032386$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240710$$CN$US$US
239474842$23947484$2$F$$20240705$20240606$20240706$PER$$US-AstraZeneca-2024A130947$ASTRAZENECA$$$$$$Y$$$20240706$$HP$US$
239474883$23947488$3$F$$20240716$20240606$20240720$EXP$$NVSC2024US117123$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
239474915$23947491$5$F$20240509$20240903$20240606$20240910$EXP$$CA-TAKEDA-2024TUS054512$TAKEDA$$40$YR$$F$Y$$$20240910$$CN$CA$CA
239475082$23947508$2$F$20240101$20240626$20240606$20240701$PER$$US-Eisai-EC-2024-167329$EISAI$$57$YR$A$M$Y$$$20240701$$CN$US$US
239475132$23947513$2$F$20220916$20240709$20240606$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091581$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240711$$MD$JP$JP
239475272$23947527$2$F$20240420$20240709$20240606$20240716$EXP$$US-GILEAD-2024-0671214$GILEAD$$81$YR$E$F$Y$69.8$KG$20240716$$HP$US$US
239475512$23947551$2$F$$20240904$20240606$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091790$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240904$$CN$US$US
239475522$23947552$2$F$$20240628$20240606$20240705$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004701$SAREPTA THERAPEUTICS$$$$$M$Y$51.2$KG$20240705$$HP$US$US
239475582$23947558$2$F$$20240531$20240606$20240902$PER$$US-ASTELLAS-2024US015974$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
239475612$23947561$2$F$20170628$20240807$20240606$20240809$EXP$$CA-TAKEDA-2024TUS056849$TAKEDA$$28$YR$$F$Y$$$20240809$$HP$CA$CA
239475724$23947572$4$F$20240522$20240827$20240606$20240828$EXP$$NVSC2024FR118297$NOVARTIS$$$$A$F$Y$$$20240828$$MD$FR$FR
239475762$23947576$2$F$$20240827$20240606$20240829$PER$$US-MYLANLABS-2024M1049186$MYLAN$$$$$F$Y$$$20240829$$HP$US$US
239475793$23947579$3$F$20240501$20240925$20240606$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091925$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240926$$HP$US$US
239475884$23947588$4$F$20240526$20240606$20240606$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088719$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$83.46$KG$20240710$$CN$US$US
239475902$23947590$2$F$$20240702$20240606$20240703$PER$$US-JNJFOC-20240613144$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240703$$CN$US$US
239476173$23947617$3$F$$20240913$20240606$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091754$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$75.3$KG$20240916$$CN$US$US
239476212$23947621$2$F$$20240527$20240606$20240828$EXP$$CZ-TEVA-VS-3205429$TEVA$Liachovicka K, Sztuchlikova V, Lyskova L, Orsag J, Kosatikova Z, Hruby M, et al. Unusual presentation of  Rhabdomyolysis secondary to rosuvastatin. [Czech]. Vnitr-Lek 2023; 69 (8): 488-493; Liachovicka K, Sztuchlikova V, Lyskova L, Orsag J, Kosatikova Z, Hruby M, et al. Unusual presentation of rhabdomyolysis. [Czech]. Vnitr-Lek 2023; 69 (8): 488-493.$72$YR$$F$Y$$$20240828$$MD$CZ$CZ
239476492$23947649$2$F$20240501$20240703$20240606$20240704$EXP$$US-KYOWAKIRIN-2024KK013539$KYOWA$$$$$$Y$$$20240704$$HP$US$US
239476812$23947681$2$F$20240528$20240719$20240606$20240806$PER$$US-ALXN-202405USA002047US$ALEXION PHARMACEUTICALS$$63$YR$$F$Y$$$20240719$$CN$US$US
239476842$23947684$2$F$$20240904$20240606$20240909$PER$$US-ALXN-202405USA002135US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
239477376$23947737$6$F$$20240731$20240606$20240806$EXP$$CA-TAKEDA-2024TUS056718$TAKEDA$$$$$F$Y$$$20240806$$MD$CA$CA
239477553$23947755$3$F$20200101$20240715$20240606$20240722$EXP$$US-BEH-2024173160$CSL BEHRING$$$$E$F$Y$$$20240722$$CN$US$US
239477712$23947771$2$F$$20240903$20240606$20240909$EXP$$CA-009507513-2405CAN009184$MERCK$$34$YR$$F$Y$$$20240909$$HP$CA$CA
239478103$23947810$3$F$$20240725$20240606$20240818$EXP$GB-MHRA-MED-202406061911485120-PGVTD$GB-JNJFOC-20240615393$JOHNSON AND JOHNSON$$$$$M$Y$$$20240818$$HP$GB$GB
239478262$23947826$2$F$$20240905$20240606$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087811$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$HP$US$US
239478472$23947847$2$F$$20240529$20240606$20240802$PER$$US-BAUSCHBL-2024BNL028083$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240802$$CN$US$US
239478522$23947852$2$F$$20240808$20240606$20240813$EXP$$US-BIOGEN-2024BI01267814$BIOGEN$$$$$M$Y$$$20240813$$CN$US$US
239478532$23947853$2$F$20240518$20240625$20240606$20240702$EXP$$CO-ABBVIE-5788964$ABBVIE$$68$YR$$F$Y$80$KG$20240702$$HP$CO$CO
239478814$23947881$4$F$20240424$20240624$20240606$20240705$30DAY$$FI-JNJFOC-20240542243$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240705$$CN$FI$FI
239478823$23947882$3$F$$20240703$20240606$20240712$30DAY$$EG-JNJFOC-20240545752$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$PH$EG$EG
239478883$23947888$3$F$$20240628$20240606$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002392$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239479005$23947900$5$F$$20240814$20240606$20240822$EXP$$US-BIOGEN-2024BI01267981$BIOGEN$$$$$M$Y$$$20240822$$CN$US$US
239479013$23947901$3$F$20230101$20240604$20240606$20240816$EXP$$CA-BIOGEN-2024BI01268035$BIOGEN$$$$$F$Y$$$20240816$$HP$CA$CA
239479043$23947904$3$F$$20240627$20240606$20240709$PER$$US-AMGEN-USASP2024110372$AMGEN$$74$YR$E$F$Y$$$20240708$$CN$US$US
239479102$23947910$2$F$$20240612$20240606$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002397$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
239479133$23947913$3$F$20240101$20240919$20240606$20240925$EXP$$ES-ABBVIE-5767992$ABBVIE$$$$$M$Y$60$KG$20240925$$HP$ES$ES
239479172$23947917$2$F$20240328$20240708$20240606$20240709$EXP$$US-BIOGEN-2024BI01268045$BIOGEN$$70$YR$$F$Y$$$20240709$$CN$US$US
239479252$23947925$2$F$20240101$20240827$20240606$20240830$EXP$$CO-ABBVIE-5789055$ABBVIE$$$$$M$Y$62$KG$20240830$$CN$CO$CO
239479339$23947933$9$F$20240117$20240917$20240606$20240925$EXP$$CA-JNJFOC-20230600775$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240925$$CN$CA$CA
239479442$23947944$2$F$20240101$20240708$20240606$20240717$EXP$$JP-EMD Serono-2024030848$EMD SERONO INC$$75$YR$E$F$Y$$$20240718$$PH$JP$JP
239479552$23947955$2$F$20230207$20240819$20240606$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089144$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240903$$HP$US$US
239479582$23947958$2$F$$20240712$20240606$20240724$EXP$$JP-BIOCON BIOLOGICS LIMITED-BBL2024004132$BIOCON$Miwako Kido, Takashi Tokashiki, Kohei Tamaki, Daigo Yasutomi, Yuichiro oya, et al.. Caution with sensory ataxia: Investigation of the causative diseases of sensory ataxia due to peripheral nerve disorder. The 65th Annual Meeting of the Japanese Society of Neurology. 2024;465$$$$$Y$$$20240724$$HP$JP$JP
239479592$23947959$2$F$$20240806$20240606$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002401$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
239479602$23947960$2$F$$20240917$20240606$20240920$EXP$$JP-JNJFOC-20240612775$JOHNSON AND JOHNSON$Tomoe HAYASHI et al. Department of Hematology, Kanazawa Municipal Hospital. Three cases of venous thromboembolism complicating multiple myeloma. Japanese Journal of Thrombosis and Hemostasis. Proceedings of the 46th Congress of the Japanese Society on Thrombosis and Hemostasis;2024.6.13, 14, 15; Kanazawa Ishikawa:35(2)353$8$DEC$E$F$Y$$$20240920$$MD$JP$JP
239479672$23947967$2$F$$20240625$20240607$20240701$EXP$$JP-JNJFOC-20240616462$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$PH$JP$JP
239479684$23947968$4$F$20240722$20240723$20240607$20240731$EXP$$CA-CELLTRION INC.-2024CA013247$CELLTRION$$$$$$Y$$$20240731$$CN$CA$CA
239479942$23947994$2$F$20240301$20240715$20240607$20240717$EXP$HR-HALMED-300085292$HR-ROCHE-3572500$ROCHE$$36$YR$A$F$Y$65$KG$20240717$$MD$HR$HR
239480042$23948004$2$F$$20240919$20240607$20240924$EXP$$US-ABBVIE-5787402$ABBVIE$$$$$F$Y$62$KG$20240924$$CN$US$US
239480292$23948029$2$F$20231022$20240709$20240607$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091728$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240711$$MD$JP$JP
239480432$23948043$2$F$20240301$20240912$20240607$20240918$EXP$$US-ABBVIE-5787628$ABBVIE$$55$YR$$F$Y$$$20240918$$CN$US$US
239480664$23948066$4$F$20240201$20240909$20240607$20240917$EXP$$CA-CELLTRION INC.-2024CA011798$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
239480692$23948069$2$F$$20240627$20240607$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002421$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
239480752$23948075$2$F$20240501$20240626$20240607$20240701$PER$$US-ABBVIE-5787099$ABBVIE$$61$YR$$F$Y$81.646$KG$20240701$$CN$US$US
239480802$23948080$2$F$20240503$20240723$20240607$20240731$EXP$$US-ABBVIE-5785875$ABBVIE$$$$$$Y$$$20240731$$HP$US$US
239480862$23948086$2$F$20240524$20240911$20240607$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US053775$SANDOZ$$73$YR$$F$Y$$$20240913$$CN$US$US
239480924$23948092$4$F$20240101$20240627$20240607$20240702$EXP$$US-ABBVIE-5787370$ABBVIE$$48$YR$$F$Y$120.2$KG$20240702$$CN$US$US
239480942$23948094$2$F$20220510$20240709$20240607$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091667$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240711$$MD$JP$JP
239480962$23948096$2$F$$20240719$20240607$20240725$PER$$US-ALXN-202405USA002175US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239481053$23948105$3$F$20240515$20240612$20240607$20240708$PER$$FR-TOLMAR, INC.-24FR049428$TOLMAR$$70$YR$$M$Y$$$20240708$$PH$FR$FR
239481062$23948106$2$F$20240516$20240613$20240607$20240708$PER$$FR-TOLMAR, INC.-24FR049486$TOLMAR$$84$YR$$M$Y$$$20240708$$PH$FR$FR
239481072$23948107$2$F$20240517$20240613$20240607$20240708$PER$$FR-TOLMAR, INC.-24FR049493$TOLMAR$$65$YR$$M$Y$$$20240708$$PH$FR$FR
239481082$23948108$2$F$20240517$20240613$20240607$20240708$PER$$FR-TOLMAR, INC.-24FR049516$TOLMAR$$65$YR$$M$Y$$$20240708$$PH$FR$FR
239481092$23948109$2$F$20240516$20240613$20240607$20240708$PER$$FR-TOLMAR, INC.-24FR049494$TOLMAR$$59$YR$$M$Y$$$20240708$$MD$FR$FR
239481112$23948111$2$F$20240515$20240702$20240607$20240813$PER$$TR-TOLMAR, INC.-24TR049422$TOLMAR$$66$YR$$$Y$$$20240813$$HP$TR$TR
239481132$23948113$2$F$20240501$20240621$20240607$20240715$PER$$GT-TOLMAR, INC.-24GT049455$TOLMAR$$88$YR$$M$Y$$$20240715$$CN$GT$GT
239481172$23948117$2$F$20231023$20240709$20240607$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091615$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240711$$MD$JP$JP
239481224$23948122$4$F$20211213$20240714$20240607$20240718$EXP$$CN-ABBVIE-5786731$ABBVIE$So H, Cheng IT, Li M, Wong CK, Tam LS. Effect of JAK1 inhibition on erosion repair in rheumatoid arthritis: A pilot HR-PQCT study. Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):735.$56$YR$$M$Y$63.6$KG$20240718$$HP$HK$HK
239481243$23948124$3$F$$20240830$20240607$20240903$PER$$US-AMGEN-USASP2024110388$AMGEN$$$$$M$Y$$$20240903$$CN$US$US
239481463$23948146$3$F$20240101$20240728$20240607$20240805$EXP$$CA-CELLTRION INC.-2024CA013417$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
239481532$23948153$2$F$20240601$20240813$20240607$20240814$PER$$US-AMGEN-USASP2024112009$AMGEN$$76$YR$E$F$Y$$$20240814$$CN$US$US
239481602$23948160$2$F$20240501$20240731$20240607$20240808$EXP$$JP-AMGEN-JPNSP2024110339$AMGEN$$9$DEC$E$M$Y$$$20240808$$MD$JP$JP
239481642$23948164$2$F$$20240701$20240607$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002428$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
239481673$23948167$3$F$20240508$20240729$20240607$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002429$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240822$$CN$US$US
239481732$23948173$2$F$$20240530$20240607$20240918$PER$$US-CELLTRION INC.-2024US012227$CELLTRION$$$$$$Y$$$20240918$$CN$US$US
239481792$23948179$2$F$20240530$20240728$20240607$20240805$EXP$$CA-CELLTRION INC.-2024CA007406$CELLTRION$$$$$$Y$$$20240805$$MD$CA$CA
239481802$23948180$2$F$20240501$20240705$20240607$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088716$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240712$$CN$US$US
239481812$23948181$2$F$20240401$20240904$20240607$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091679$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$MD$JP$JP
239481842$23948184$2$F$$20240905$20240607$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091876$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240909$$CN$US$US
239481873$23948187$3$F$20240501$20240802$20240607$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091837$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240806$$PH$US$US
239481882$23948188$2$F$20240514$20240719$20240607$20240722$PER$$US-AstraZeneca-2024A131656$ASTRAZENECA$$51$YR$$M$Y$$$20240722$$MD$US$
239481913$23948191$3$F$20180119$20240823$20240607$20240902$EXP$$CA-CELLTRION INC.-2021CA011505$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
239481942$23948194$2$F$$20240627$20240607$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002457$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
239481982$23948198$2$F$20231122$20240726$20240607$20240805$EXP$$US-INTERCEPT-PM2024001119$INTERCEPT PHARMACEUTICALS$$59$YR$$F$Y$$$20240805$$CN$US$US
239482022$23948202$2$F$20240501$20240709$20240607$20240716$EXP$$CA-JNJFOC-20240588687$JOHNSON AND JOHNSON$$40$YR$A$F$Y$50.7$KG$20240716$$HP$CA$CA
239482042$23948204$2$F$$20240719$20240607$20240725$PER$$US-ALXN-202405USA002167US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239482122$23948212$2$F$20240531$20240709$20240607$20240710$PER$$US-AMGEN-USASP2024110813$AMGEN$$73$YR$E$F$Y$$$20240710$$HP$US$US
239482152$23948215$2$F$$20240708$20240607$20240712$EXP$$JP-ROCHE-3577031$ROCHE$$73$YR$E$F$Y$$$20240712$$MD$JP$JP
239482202$23948220$2$F$20230901$20240724$20240607$20240801$EXP$$FR-SA-2024SA170233$SANOFI AVENTIS$$$$E$M$Y$$$20240801$$MD$FR$FR
239482222$23948222$2$F$20221009$20240716$20240607$20240801$EXP$$JP-SA-2024SA166921$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240719$$MD$JP$JP
239482242$23948224$2$F$20240101$20240819$20240607$20240822$EXP$$US-SA-2024SA168037$SANOFI AVENTIS$$18$MON$I$M$Y$$$20240822$$MD$US$US
239482322$23948232$2$F$20240101$20240624$20240607$20240703$PER$$US-SA-2024SA166193$SANOFI AVENTIS$$31$YR$A$F$Y$53$KG$20240703$$MD$US$US
239482332$23948233$2$F$20240527$20240805$20240607$20240813$PER$$US-SA-2024SA166147$SANOFI AVENTIS$$35$YR$A$F$Y$58.9$KG$20240814$$MD$US$US
239482352$23948235$2$F$20240501$20240624$20240607$20240703$PER$$US-SA-2024SA164570$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240703$$MD$US$US
239482402$23948240$2$F$20240501$20240911$20240607$20240925$PER$$US-SA-2024SA077163$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240925$$MD$US$US
239482422$23948242$2$F$20240501$20240626$20240607$20240705$PER$$US-SA-2024SA165892$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240705$$MD$US$US
239482502$23948250$2$F$$20240826$20240607$20240916$PER$$US-SA-2024SA167184$SANOFI AVENTIS$$$$A$F$Y$57.6$KG$20240916$$MD$US$US
239482602$23948260$2$F$20240201$20240821$20240607$20240905$PER$$US-SA-2024SA164385$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240905$$MD$US$US
239482622$23948262$2$F$$20240625$20240607$20240704$PER$$US-SA-2024SA164809$SANOFI AVENTIS$$$$E$M$Y$$$20240704$$HP$US$US
239482692$23948269$2$F$20240101$20240718$20240607$20240727$PER$$US-SA-2024SA165233$SANOFI AVENTIS$$41$YR$A$M$Y$101.6$KG$20240727$$MD$US$US
239482782$23948278$2$F$$20240912$20240607$20240923$PER$$US-SA-2024SA166300$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240923$$MD$US$US
239482792$23948279$2$F$20240201$20240726$20240607$20240806$PER$$US-SA-2024SA168271$SANOFI AVENTIS$$$$A$M$Y$$$20240806$$MD$US$US
239482812$23948281$2$F$20240530$20240717$20240607$20240725$PER$$US-SA-2024SA166203$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240725$$MD$US$US
239482822$23948282$2$F$20240101$20240718$20240607$20240729$PER$$US-SA-2024SA167472$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240729$$MD$US$US
239482892$23948289$2$F$20240101$20240725$20240607$20240805$PER$$US-SA-2024SA166259$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
239482922$23948292$2$F$20240307$20240802$20240607$20240813$EXP$$TR-ROCHE-3576858$ROCHE$$78$YR$E$F$Y$$$20240813$$CN$TR$TR
239482932$23948293$2$F$20240501$20240912$20240607$20240923$PER$$US-SA-2024SA167313$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240923$$MD$US$US
239482942$23948294$2$F$$20240603$20240607$20240723$PER$$US-SA-2024SA168283$SANOFI AVENTIS$$$$$F$Y$$$20240723$$CN$US$US
239482962$23948296$2$F$20240101$20240820$20240607$20240830$PER$$US-SA-2024SA168177$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240830$$MD$US$US
239482972$23948297$2$F$20240101$20240729$20240607$20240807$PER$$US-SA-2024SA167966$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240807$$MD$US$US
239483032$23948303$2$F$20240401$20240912$20240607$20240926$PER$$US-SA-2024SA167406$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240926$$MD$US$US
239483103$23948310$3$F$20240101$20240705$20240607$20240717$PER$$US-SA-2024SA167188$SANOFI AVENTIS$$69$YR$E$M$Y$77.098$KG$20240717$$MD$US$US
239483132$23948313$2$F$20240701$20240730$20240607$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002446$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240822$$CN$US$US
239483243$23948324$3$F$20240527$20240726$20240607$20240731$EXP$$US-ARGENX-2024-ARGX-US003991$ARGENX BVBA$$$$$$Y$$$20240731$$CN$US$US
239483412$23948341$2$F$20240511$20240808$20240607$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002458$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240829$$CN$US$US
239483422$23948342$2$F$20240101$20240606$20240607$20240704$30DAY$$BR-UCBSA-2024027734$UCB$$$$$M$Y$$$20240704$$CN$BR$BR
239483542$23948354$2$F$$20240719$20240607$20240725$PER$$US-ALXN-202405USA002157US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239483592$23948359$2$F$$20240625$20240607$20240701$30DAY$$US-GSK-US2024067184$GLAXOSMITHKLINE$$$$$M$Y$$$20240701$$CN$US$US
239483605$23948360$5$F$$20240703$20240607$20240713$PER$$US-ROCHE-3577737$ROCHE$$$$E$M$Y$$$20240713$$CN$US$US
239483653$23948365$3$F$$20240712$20240607$20240719$30DAY$$US-JNJFOC-20240611180$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$PH$US$US
239483793$23948379$3$F$$20240913$20240607$20240918$EXP$$US-JAZZ-2019-US-013078$JAZZ$$$$$F$Y$$$20240918$$MD$US$US
239484102$23948410$2$F$20240527$20240628$20240607$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406001829$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240702$$CN$US$US
239484233$23948423$3$F$20240523$20240627$20240607$20240701$EXP$$US-UCBSA-2024027731$UCB$$14$YR$$M$Y$90$KG$20240701$$CN$US$US
239484272$23948427$2$F$20240603$20240820$20240607$20240823$PER$$US-AMGEN-USASP2024110285$AMGEN$$69$YR$E$M$Y$$$20240823$$CN$US$US
239484372$23948437$2$F$20240216$20240718$20240607$20240725$EXP$$CA-GSK-CA2024009430$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$HP$CA$CA
239484414$23948441$4$F$20240525$20240709$20240607$20240715$EXP$$CA-JNJFOC-20240584191$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240715$$PH$CA$CA
239484422$23948442$2$F$20240101$20240921$20240607$20240928$EXP$$JP-AMGEN-JPNSP2024109767$AMGEN$$77$YR$E$M$Y$$$20240928$$MD$JP$JP
239484449$23948444$9$F$20240101$20240828$20240607$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-016780$UNITED THERAPEUTICS$$$$$F$Y$$$20240906$$$US$US
239484583$23948458$3$F$$20240816$20240607$20240819$PER$$NVSC2024US119338$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
239484692$23948469$2$F$$20240913$20240607$20240913$EXP$$CA-PFIZER INC-202400187061$PFIZER$$54$YR$$F$Y$$$20240913$$HP$CA$CA
239484883$23948488$3$F$20240501$20240920$20240607$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016902$UNITED THERAPEUTICS$$75$YR$$M$Y$63.492$KG$20240928$$$US$US
239484902$23948490$2$F$$20240719$20240607$20240806$PER$$US-ALXN-202405USA002155US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239484932$23948493$2$F$20240501$20240808$20240607$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002418$ACADIA PHARMACEUTICALS$$41$YR$$F$Y$$$20240829$$CN$US$US
239485054$23948505$4$F$20240101$20240709$20240607$20240715$PER$$US-BIOGEN-2024BI01244323$BIOGEN$$47$YR$$F$Y$$$20240715$$CN$US$US
239485073$23948507$3$F$20240122$20240704$20240607$20240713$EXP$$JP-ROCHE-3574305$ROCHE$Nochi Y, Nakao S, Hiratsuka Y, Yamamoto S, Hiratsuka T, Shinohara D. A case in which intraocular inflammation and occlusive vasculitis associated with intravitreal injection of faricimab occurred. The 816th Tokyo Ophthalmology. 2024;$9$DEC$E$F$Y$$$20240713$$MD$JP$JP
239485193$23948519$3$F$$20240715$20240607$20240724$EXP$$PT-AUROBINDO-AUR-APL-2024-026895$AUROBINDO$Sales F, Maldonado A, Torres J. B403 Peripheral nerve block for phantom limb pain ? more than a temporary fix... Reg Anesth Pain Med. 2022;47A:274-275$35$YR$$F$Y$$$20240724$$HP$PT$PT
239485352$23948535$2$F$20231106$20240716$20240607$20240718$EXP$IT-MINISAL02-987371$IT-009507513-2406ITA000094$MERCK$$68$YR$$M$Y$70$KG$20240718$$MD$IT$IT
239485513$23948551$3$F$20240101$20240923$20240607$20240927$EXP$$US-ABBVIE-5788876$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
239485522$23948552$2$F$20231201$20240703$20240607$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092070$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240709$$CN$US$US
239485532$23948553$2$F$20240529$20240711$20240607$20240723$30DAY$$US-GSK-US2024067636$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240723$$CN$US$US
239485602$23948560$2$F$20230601$20240815$20240607$20240818$EXP$$JP-TAKEDA-2024TJP008249$TAKEDA$$54$YR$$M$Y$$$20240818$$MD$JP$JP
239485652$23948565$2$F$$20240730$20240607$20240802$EXP$$US-ABBVIE-5787517$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
239485702$23948570$2$F$20240429$20240906$20240607$20240918$EXP$$US-UCBSA-2024022829$UCB$$35$YR$$F$Y$$$20240918$$CN$US$US
239485763$23948576$3$F$20240501$20240710$20240607$20240712$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031124$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240712$$MD$SK$SK
239485792$23948579$2$F$20230512$20240709$20240607$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091835$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240712$$MD$JP$JP
239485832$23948583$2$F$20231210$20240709$20240607$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091716$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240712$$MD$JP$JP
239485933$23948593$3$F$20240101$20240718$20240607$20240728$PER$$US-SA-2024SA167714$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240728$$MD$US$US
239485942$23948594$2$F$$20240830$20240607$20240912$PER$$US-SA-2024SA167793$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240912$$MD$US$US
239486093$23948609$3$F$$20240701$20240607$20240710$PER$$US-SA-2024SA167658$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$HP$US$US
239486103$23948610$3$F$20240301$20240905$20240607$20240912$PER$$US-BIOGEN-2024BI01267473$BIOGEN$$66$YR$$M$Y$$$20240912$$CN$US$US
239486152$23948615$2$F$$20240706$20240607$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-026710$AUROBINDO$Abouelazm A, Philops K, Amine A, Golam Y. Statin-induced, immune-mediated necrotising myopathy triggered by malignancy successfully treated with immunosuppression. Clin-Med-London. 2024;24:No.3$78$YR$$M$Y$$$20240717$$HP$GB$GB
239486162$23948616$2$F$20240101$20240716$20240607$20240731$EXP$$US-PROCTER+GAMBLE-PH24004448$PROCTER AND GAMBLE$$80$YR$$F$Y$$$20240731$$CN$US$US
239486323$23948632$3$F$20240601$20240703$20240607$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002423$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240726$$CN$US$US
239486342$23948634$2$F$20240425$20240612$20240607$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002422$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240707$$CN$US$US
239486372$23948637$2$F$20240101$20240627$20240607$20240705$EXP$$JP-ROCHE-3575985$ROCHE$$7$DEC$E$$Y$$$20240706$$MD$JP$JP
239486382$23948638$2$F$20240516$20240627$20240607$20240704$EXP$IT-MINISAL02-987654$IT-SA-2024SA168882$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240704$$MD$IT$IT
239486442$23948644$2$F$20220601$20240604$20240607$20240702$PER$$US-BEIGENE-BGN-2024-008567$BEIGENE$$$$$$Y$$$20240702$$CN$US$US
239486573$23948657$3$F$20240501$20240618$20240607$20240702$30DAY$$FR-JNJFOC-20240534598$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240702$$PH$FR$FR
239486592$23948659$2$F$20230715$20240730$20240607$20240809$EXP$$JP-ORPHANEU-2023007941$RECORDATI$Nakagawa Y, Sakasegawa N, Yoshikawa G, Shibayama M, Soga A, Yamaguchi Y et al. A case of Cushing disease patient who became pregnant while taking Osilodrostat and underwent delivery with Pasireotide and Metyrapone$$$$$Y$$$20240809$$MD$JP$JP
239486612$23948661$2$F$20240604$20240702$20240607$20240706$PER$$US-AMGEN-USASP2024111800$AMGEN$$79$YR$E$F$Y$$$20240706$$CN$US$US
239486662$23948666$2$F$$20240826$20240607$20240829$EXP$$US-SANDOZ INC.-SDZ2024US055163$SANDOZ$$$$$F$Y$94$KG$20240829$$CN$US$US
239486784$23948678$4$F$20240420$20240625$20240607$20240701$EXP$$CO-ORPHALAN-CO-ORP-24-00094$ORPHALAN$$$$$$Y$$$20240701$$HP$CO$CO
239486882$23948688$2$F$20231201$20240605$20240607$20240809$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032197$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240809$$CN$US$US
239487042$23948704$2$F$$20240802$20240607$20240812$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002284$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
239487052$23948705$2$F$20240213$20240628$20240607$20240704$30DAY$$TR-JNJFOC-20240548343$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$PH$TR$TR
239487132$23948713$2$F$20240525$20240721$20240607$20240731$30DAY$$US-GSK-US2024067182$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240731$$CN$US$US
239487182$23948718$2$F$20240514$20240618$20240607$20240703$30DAY$$US-JNJFOC-20240548602$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240703$$CN$US$US
239487222$23948722$2$F$20240501$20240703$20240607$20240710$30DAY$$US-AMGEN-USASP2024109336$AMGEN$$$$$F$Y$$$20240710$$HP$US$US
239487413$23948741$3$F$$20240814$20240607$20240820$EXP$$US-SANDOZ INC.-NVSC2023US013766$SANDOZ$$$$$F$Y$$$20240820$$MD$US$US
239487753$23948775$3$F$$20240722$20240607$20240815$EXP$$GB-CELLTRION INC.-2024GB007149$CELLTRION$$$$$$Y$$$20240815$$CN$GB$GB
239487762$23948776$2$F$20240501$20240806$20240607$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092119$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$63.05$KG$20240808$$CN$US$US
239487842$23948784$2$F$20240505$20240620$20240607$20240704$30DAY$$FR-JNJFOC-20240534595$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240704$$CN$FR$FR
239487863$23948786$3$F$20240525$20240625$20240607$20240701$EXP$$CA-BIOGEN-2024BI01267803$BIOGEN$$56$YR$$F$Y$$$20240630$$MD$CA$CA
239487886$23948788$6$F$20240505$20240730$20240607$20240813$EXP$$DE-SA-2024SA169048$SANOFI AVENTIS$$12$YR$T$F$Y$45.6$KG$20240813$$CN$DE$DE
239487892$23948789$2$F$20240510$20240903$20240607$20240909$EXP$$US-BIOGEN-2024BI01268107$BIOGEN$$45$YR$$F$Y$$$20240909$$CN$US$US
239487922$23948792$2$F$20240201$20240701$20240607$20240704$EXP$$US-UCBSA-2024028876$UCB$$57$YR$$M$Y$$$20240704$$HP$US$US
239487963$23948796$3$F$20231003$20240829$20240607$20240909$EXP$$CA-INTERCEPT-PM2023002044$INTERCEPT PHARMACEUTICALS$$61$YR$$F$Y$$$20240909$$MD$CA$CA
239487983$23948798$3$F$20240509$20240716$20240607$20240722$EXP$PT-INFARMED-T202405-553$PT-ORGANON-O2406PRT000191$ORGANON$$59$YR$$F$Y$63$KG$20240722$$CN$PT$PT
239488005$23948800$5$F$20240524$20240702$20240607$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016470$UNITED THERAPEUTICS$$70$YR$$F$Y$91.61$KG$20240705$$$US$US
239488032$23948803$2$F$20230401$20240806$20240607$20240812$EXP$$TW-JNJFOC-20240577969$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240812$$CN$TW$TW
239488122$23948812$2$F$$20240808$20240607$20240815$EXP$$US-GSK-US2024070104$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$HP$US$US
239488153$23948815$3$F$$20240803$20240607$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002452$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
239488224$23948822$4$F$20240516$20240611$20240607$20240704$EXP$$MX-JNJFOC-20240557113$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$PH$MX$MX
239488243$23948824$3$F$$20240826$20240607$20240917$EXP$$JP-MTPC-MTPC2024-0011600$MITSUBISHI TANABE PHARMA$Matsuo H, Hamada S, Tamura R, Yabata H, Yamakawa I, Urushitani M, et al.. A-01 An autopsy case of amyotrophic lateral sclerosis with relatively preserved activities of daily living until late in life. The 128th Meeting of Japanese Society of Neurology Kinki Branch. 2024;28$80$YR$$M$Y$$$20240917$$MD$JP$JP
239488383$23948838$3$F$$20240904$20240607$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090918$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240904$$CN$US$US
239488402$23948840$2$F$20240603$20240628$20240607$20240703$PER$$US-AMGEN-USASP2024111980$AMGEN$$77$YR$E$F$Y$$$20240703$$HP$US$US
239488414$23948841$4$F$20231027$20240702$20240607$20240708$EXP$$NVSJ2024JP006549$NOVARTIS$$74$YR$$M$Y$69.9$KG$20240709$$MD$JP$JP
239488463$23948846$3$F$20240101$20240919$20240607$20240928$EXP$$CA-CELLTRION INC.-2024CA013604$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
239488642$23948864$2$F$20240516$20240619$20240607$20240702$30DAY$$US-JNJFOC-20240580908$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
239488692$23948869$2$F$$20240923$20240607$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088439$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240924$$CN$US$US
239488743$23948874$3$F$20240530$20240710$20240607$20240725$30DAY$$US-AMGEN-USASP2024108228$AMGEN$$$$$F$Y$$$20240724$$MD$US$US
239488792$23948879$2$F$$20240726$20240607$20240807$EXP$$US-ELI_LILLY_AND_COMPANY-US202405015171$ELI LILLY AND CO$$$$I$$Y$6.349$KG$20240807$$CN$US$US
239488834$23948883$4$F$20240101$20240820$20240607$20240831$EXP$$US-UCBSA-2024022767$UCB$$$$$F$Y$$$20240831$$CN$US$US
239489035$23948903$5$F$20240131$20240908$20240607$20240913$EXP$$SA-ROCHE-3506827$ROCHE$$6$YR$C$M$Y$23.75$KG$20240913$$CN$SA$SA
239489053$23948905$3$F$20240818$20240903$20240607$20240907$EXP$$CA-JNJFOC-20240170136$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240907$$HP$CA$CA
239489143$23948914$3$F$20240501$20240912$20240607$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086272$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240913$$HP$US$US
239489153$23948915$3$F$20240101$20240718$20240607$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089392$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$88$KG$20240724$$PH$US$US
239489282$23948928$2$F$$20240617$20240607$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002456$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
239489462$23948946$2$F$20231211$20240709$20240607$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091455$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240712$$MD$JP$JP
239489482$23948948$2$F$20240516$20240718$20240607$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088964$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$114.3$KG$20240722$$HP$US$US
239489682$23948968$2$F$20240328$20240702$20240607$20240704$EXP$$CA-ABBVIE-5790442$ABBVIE$$$$A$F$Y$$$20240704$$HP$CA$CA
239489742$23948974$2$F$$20240729$20240607$20240731$PER$$US-ALXN-202405USA002305US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239489842$23948984$2$F$20240704$20240704$20240607$20240708$EXP$$CA-TAKEDA-2024TUS056788$TAKEDA$$65$YR$$F$Y$$$20240708$$CN$CA$CA
239489858$23948985$8$F$20240513$20240904$20240607$20240910$EXP$$CA-TAKEDA-2024TUS049046$TAKEDA$$12$YR$$M$Y$$$20240910$$CN$CA$CA
239489872$23948987$2$F$$20240912$20240607$20240923$EXP$$US-TAKEDA-2024TUS006971$TAKEDA$$$$$F$Y$$$20240923$$CN$US$US
239490012$23949001$2$F$20240604$20240801$20240607$20240817$PER$$US-AstraZeneca-2024A131651$ASTRAZENECA$$24609$DY$$F$Y$$$20240817$$CN$US$
239490414$23949041$4$F$20231224$20240826$20240607$20240909$EXP$$CA-UCBSA-2023061347$UCB$$24$YR$$F$Y$$$20240909$$CN$CA$CA
239490484$23949048$4$F$$20240819$20240607$20240823$PER$$US-LEO Pharma-370931$LEO PHARM$$41$YR$$F$Y$$$20240823$$PH$US$US
239490502$23949050$2$F$$20240821$20240607$20240821$PER$$NVSC2024US119822$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
239490623$23949062$3$F$20240702$20240816$20240607$20240824$EXP$$US-ALXN-202405USA002172US$ALEXION PHARMACEUTICALS$$77$YR$$M$Y$100.24$KG$20240824$$CN$US$US
239490732$23949073$2$F$20220715$20240626$20240607$20240703$EXP$$ES-CELLTRION INC.-2024ES013214$CELLTRION$$$$$$Y$$$20240703$$MD$ES$ES
239490742$23949074$2$F$$20240807$20240607$20240817$EXP$$DE-TEVA-VS-3206222$TEVA$$55$YR$$F$Y$$$20240817$$CN$DE$DE
239490852$23949085$2$F$$20240807$20240607$20240809$PER$$US-TAKEDA-2024TUS057114$TAKEDA$$$$$F$Y$60$KG$20240809$$MD$US$US
239490872$23949087$2$F$$20240709$20240607$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04608$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239490932$23949093$2$F$20240504$20240704$20240607$20240714$EXP$$IT-AMGEN-ITASP2024109858$AMGEN$$8$YR$C$F$Y$$$20240714$$MD$IT$IT
239491133$23949113$3$F$20240603$20240813$20240607$20240814$PER$$US-JNJFOC-20240609045$JOHNSON AND JOHNSON$$41$YR$A$F$Y$58.566$KG$20240814$$HP$US$US
239491212$23949121$2$F$$20240719$20240607$20240725$PER$$US-ALXN-202405USA002168US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239491243$23949124$3$F$$20240905$20240607$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091727$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240911$$CN$US$US
239491262$23949126$2$F$20240505$20240731$20240607$20240803$PER$$US-AMGEN-USASP2024112407$AMGEN$$79$YR$E$F$Y$$$20240803$$CN$US$US
239491294$23949129$4$F$20240301$20240829$20240607$20240906$EXP$$JP-TEVA-VS-3200506$TEVA$$67$YR$$M$Y$$$20240906$$PH$JP$JP
239491372$23949137$2$F$$20240510$20240607$20240716$PER$$US-009507513-2405USA003557$MERCK$Combs T, Stoner BJ, McCoy P, Reda H, Sekela M, El-Dalati S. Invasive Candida Infection in Patients With Bacterial Infective Endocarditis. Open Forum Infectious Diseases. 2024;11(4)$31$YR$$F$Y$$$20240716$$HP$US$US
239491412$23949141$2$F$$20240527$20240607$20240912$EXP$$US-GRAVITIPHARMA-GRA-2405-US-LIT-0165$GRAVITI PHARMACEUTICALS$%Chionatos%.Alcohol-related posterior reversible encephalopathy syndrome: a case report of a patient managed with a benzodiazepine-sparing regimen for alcohol withdrawal.NEUROCASE .03-may-2024;1-6$68$YR$A$M$Y$70$KG$20240912$$HP$US$US
239491446$23949144$6$F$20240510$20240702$20240607$20240711$EXP$$US-ROCHE-3575625$ROCHE$$51$YR$A$F$Y$$$20240711$$CN$US$US
239491472$23949147$2$F$20240603$20240708$20240607$20240710$PER$$US-AMGEN-USASP2024112171$AMGEN$$85$YR$E$M$Y$$$20240710$$CN$US$US
239491492$23949149$2$F$$20240510$20240607$20240716$PER$$US-009507513-2406USA001781$MERCK$Combs T, Stoner BJ, McCoy P, Reda H, Sekela M, El-Dalati S. Invasive Candida Infection in Patients With Bacterial Infective Endocarditis. Open Forum Infectious Diseases. 2024;11(4)$41$YR$$M$Y$$$20240716$$HP$US$US
239491503$23949150$3$F$20240101$20240727$20240607$20240806$EXP$$CA-CELLTRION INC.-2024CA013246$CELLTRION$$$$$$Y$$$20240806$$CN$CA$CA
239491602$23949160$2$F$20240522$20240715$20240607$20240718$EXP$$LB-ROCHE-3573240$ROCHE$$43$YR$A$F$Y$$$20240718$$CN$LB$LB
239491643$23949164$3$F$20240625$20240705$20240607$20240711$EXP$$CA-TAKEDA-2024TUS056705$TAKEDA$$76$YR$$M$Y$$$20240711$$HP$CA$CA
239491683$23949168$3$F$$20240719$20240607$20240720$PER$$NVSC2024US119021$NOVARTIS$$$$$M$Y$$$20240719$$CN$US$US
239491712$23949171$2$F$$20240703$20240607$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002373$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
239491723$23949172$3$F$20230512$20240703$20240607$20240705$EXP$$AT-TAKEDA-2024TUS057002$TAKEDA$$$$E$M$Y$$$20240705$$MD$AT$AT
239491793$23949179$3$F$20240514$20240917$20240607$20240920$30DAY$$US-SANDOZ INC.-SDZ2024US051013$SANDOZ$$6$YR$$F$Y$$$20240920$$CN$US$US
239491915$23949191$5$F$20240503$20240729$20240607$20240813$EXP$$DE-HIKMA PHARMACEUTICALS-DE-H14001-24-04741$HIKMA$$28$YR$$F$Y$108$KG$20240813$$CN$DE$DE
239492015$23949201$5$F$20240101$20240709$20240607$20240712$EXP$$ES-ABBVIE-5788994$ABBVIE$$$$$M$Y$$$20240712$$CN$ES$ES
239492133$23949213$3$F$20240101$20240723$20240607$20240730$EXP$$CA-ABBVIE-5785196$ABBVIE$$42$YR$$M$Y$$$20240730$$CN$CA$CA
239492142$23949214$2$F$20240307$20240605$20240607$20240701$EXP$GB-MHRA-MED-202406051058087430-DVHRQ$GB-HALEON-2180162$Haleon PLC$$41$YR$$M$Y$130$KG$20240701$$CN$GB$GB
239492162$23949216$2$F$$20240510$20240607$20240716$PER$$US-009507513-2406USA001782$MERCK$Combs T, Stoner BJ, McCoy P, Reda H, Sekela M, El-Dalati S. Invasive Candida Infection in Patients With Bacterial Infective Endocarditis. Open Forum Infectious Diseases. 2024;11(4)$40$YR$$M$Y$$$20240716$$HP$US$US
239492202$23949220$2$F$$20240621$20240607$20240715$EXP$$NL-HALEON-2179520$Haleon PLC$$51$YR$$F$Y$75$KG$20240715$$CN$NL$NL
239492472$23949247$2$F$$20240712$20240607$20240723$PER$$US-SA-2024SA167814$SANOFI AVENTIS$$$$A$$Y$$$20240723$$CN$US$US
239492482$23949248$2$F$20240501$20240621$20240607$20240703$PER$$US-SA-2024SA167249$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240703$$MD$US$US
239492644$23949264$4$F$20230310$20240806$20240607$20240813$PER$$US-SA-2024SA167705$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240814$$MD$US$US
239492772$23949277$2$F$20240101$20240701$20240607$20240708$PER$$US-SA-2024SA167959$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240708$$MD$US$US
239492873$23949287$3$F$20240101$20240814$20240607$20240827$PER$$US-SA-2024SA170658$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240828$$MD$US$US
239492942$23949294$2$F$20240101$20240702$20240607$20240711$PER$$US-SA-2024SA169216$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240711$$MD$US$US
239493023$23949302$3$F$$20240821$20240607$20240919$PER$$US-SA-2024SA169353$SANOFI AVENTIS$$67$YR$E$F$Y$86.18$KG$20240919$$HP$US$US
239493052$23949305$2$F$$20240712$20240607$20240724$EXP$$US-ROCHE-3484657$ROCHE$Waterhouse J, Holdich A, Mina F,  Obeid M, Joshi K, Barrett S, Rajakumar L, McCormick G, Seymour S, Koliou P, Sylva R, Ayodele O, Gautam A, Smith J, McKeon J, Strawson-Smith T,  Douglas R, Borley A, Konstantis A and McGrath S Safety and efficacy of Atezolizumab in combination with nab-Paclitaxel in patients with PD-L1 positive metastatic or locally advanced triple-negative breast cancer: A pan-UK cancer centre experience. (abstract number: PO3-17-12). Cancer Research 2023;84 (9):-.$$$$$Y$$$20240724$$HP$US$US
239493075$23949307$5$F$20240530$20240828$20240607$20240904$EXP$$CN-ROCHE-3574976$ROCHE$$77$YR$E$M$Y$$$20240904$$MD$CN$CN
239493103$23949310$3$F$20240530$20240826$20240607$20240902$PER$$US-AMGEN-USASP2024109610$AMGEN$$87$YR$E$F$Y$$$20240902$$CN$US$US
239493372$23949337$2$F$20230608$20240808$20240607$20240813$EXP$IT-MINISAL02-935298$IT-CHEPLA-2023009104$CHEPLAPHARM$$81$YR$$M$Y$74$KG$20240813$$MD$COUNTRY NOT SPECIFIED$IT
239493422$23949342$2$F$20230406$20240920$20240607$20240926$EXP$$US-ABBVIE-5509471$ABBVIE$$69$YR$$F$Y$78.017$KG$20240926$$CN$US$US
239493562$23949356$2$F$$20240709$20240607$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04605$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239493632$23949363$2$F$$20240823$20240607$20240901$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092008$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$72.12$KG$20240902$$HP$US$US
239493782$23949378$2$F$$20240619$20240607$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449738$RANBAXY$Liccioli G, Tomei L, Pessina B, Caubet J-C, Barni S, Giovannini M, et al. The importance of clinical history in the diagnosis of drug hypersensitivity in children. Pediatr Allergy Immunol. 2024;35 (3):e14091/ 1-8$$$C$$Y$$$20240704$$HP$IT$IT
239493802$23949380$2$F$$20240729$20240607$20240813$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449845$RANBAXY$Oliveira A, Ferreria A, Farinha F. Pulmonary nodules in patients with rheumatoid arthritis. Eur J Case Rep Intern Med. 2022;9 (Suppl.):584(2026)(EV 1225)$64$YR$$M$Y$$$20240813$$HP$PT$PT
239494022$23949402$2$F$$20240619$20240607$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449763$RANBAXY$Liccioli G, Tomei L, Pessina B, Caubet JC, Barni S, Giovannini M, et al. The importance of clinical history in the diagnosis of drug hypersensitivity in children. Pediatr Allergy Immunol. 2024;35:e14091; 1-8$$$C$$Y$$$20240704$$HP$IT$IT
239494182$23949418$2$F$$20240619$20240607$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449762$RANBAXY$Liccioli G, Tomei L, Pessina B, Caubet JC, Barni S, Giovannini M, et al. The importance of clinical history in the diagnosis of drug hypersensitivity in children. Pediatr Allergy Immunol. 2024;35:e14091; 1-8$$$C$$Y$$$20240704$$HP$IT$IT
239494324$23949432$4$F$20240520$20240723$20240607$20240730$EXP$$NVSC2024US115760$NOVARTIS$$38$YR$$F$Y$$$20240730$$HP$US$US
239494392$23949439$2$F$20230501$20240912$20240607$20240920$EXP$$US-AMGEN-USASP2024111070$AMGEN$$$$$F$Y$$$20240920$$HP$US$US
239494482$23949448$2$F$20240321$20240617$20240607$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-450316$RANBAXY$$$$A$F$Y$$$20240702$$CN$FR$FR
239494494$23949449$4$F$20240527$20240624$20240607$20240709$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450022$RANBAXY$-. -. -. -;-:-$73$YR$$M$Y$50$KG$20240709$$HP$CN$CN
239494523$23949452$3$F$$20240618$20240607$20240703$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448697$RANBAXY$Ximenes C, Cabral D, Cavalcanti F. Intravenous Human Immunoglobulin in the Treatment of BK Virus Nephropathy in Kidney Transplant: A Case Report. Transplant Proc. 2024;May 21;0 (0):4;no pagination$37$YR$$M$Y$$$20240703$$HP$BR$BR
239494632$23949463$2$F$$20240619$20240607$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449739$RANBAXY$Liccioli G, Tomei L, Pessina B, Caubet JC, Barni S, Giovannini M, et al. The importance of clinical history in the diagnosis of drug hypersensitivity in children. Pediatr Allergy Immunol. 2024;35:e14091; 1-8$$$C$$Y$$$20240704$$HP$IT$IT
239494642$23949464$2$F$$20240725$20240607$20240805$EXP$$JP-ROCHE-3575048$ROCHE$$8$DEC$E$M$Y$$$20240805$$MD$JP$JP
239494732$23949473$2$F$20240501$20240920$20240607$20240925$EXP$$US-SA-2024SA170020$SANOFI AVENTIS$$54$YR$A$M$Y$94$KG$20240925$$MD$US$US
239494772$23949477$2$F$20240525$20240822$20240607$20240830$EXP$$CA-JNJFOC-20240602650$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240830$$HP$CA$CA
239494952$23949495$2$F$20240101$20240809$20240607$20240812$EXP$$JP-ASTELLAS-2024JP003892$ASTELLAS$$9$DEC$$M$Y$$$20240812$$MD$JP$JP
239495052$23949505$2$F$20210101$20240802$20240607$20240807$EXP$$DE-SA-2024SA169009$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240807$$CN$DE$DE
239495073$23949507$3$F$20231105$20240918$20240607$20240920$EXP$$JP-Merz Pharmaceuticals GmbH-24-01913$MERZ$$85$YR$$F$Y$$$20240920$$MD$JP$JP
239495122$23949512$2$F$20240502$20240719$20240607$20240722$EXP$$US-AstraZeneca-2024A131458$ASTRAZENECA$$24926$DY$$M$Y$$$20240722$$MD$US$
239495163$23949516$3$F$20240501$20240723$20240607$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002411$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240816$$CN$US$US
239495202$23949520$2$F$$20240726$20240607$20240730$EXP$$US-TAKEDA-2024TUS056392$TAKEDA$$$$$F$Y$86$KG$20240730$$HP$US$US
239495212$23949521$2$F$20240606$20240729$20240607$20240803$EXP$$US-TAKEDA-US202023689$TAKEDA$$55$YR$$F$Y$$$20240803$$HP$US$US
239495242$23949524$2$F$$20240716$20240607$20240724$PER$$US-SA-2024SA167922$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240724$$CN$US$US
239495263$23949526$3$F$20240101$20240624$20240607$20240701$PER$$US-SA-2024SA168746$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240701$$MD$US$US
239495393$23949539$3$F$20240229$20240626$20240607$20240702$EXP$$CA-TAKEDA-2024TUS034035$TAKEDA$$65$YR$$F$Y$$$20240702$$MD$CA$CA
239495474$23949547$4$F$20240327$20240621$20240607$20240725$EXP$$NVSC2024CH118494$NOVARTIS$$$$C$F$Y$$$20240725$$MD$CH$CH
239495512$23949551$2$F$20240528$20240712$20240607$20240715$PER$$US-AMGEN-USASP2024109690$AMGEN$$85$YR$E$M$Y$$$20240715$$CN$US$US
239495712$23949571$2$F$20240605$20240702$20240607$20240705$PER$$US-AMGEN-USASP2024111244$AMGEN$$73$YR$E$F$Y$$$20240704$$CN$US$US
239495752$23949575$2$F$$20240530$20240607$20240704$EXP$$US-AstraZeneca-2024A126761$ASTRAZENECA$$71$YR$$F$Y$$$20240704$$MD$US$
239495884$23949588$4$F$$20240913$20240607$20240920$EXP$$NVSC2024GB115638$NOVARTIS$$$$A$M$Y$$$20240920$$CN$GB$GB
239495943$23949594$3$F$20240101$20240819$20240607$20240828$EXP$$US-ROCHE-3575446$ROCHE$$57$YR$A$M$Y$75.8$KG$20240828$$CN$US$US
239495992$23949599$2$F$$20240628$20240607$20240703$EXP$$NVSC2024DE118894$NOVARTIS$$9$YR$$F$Y$$$20240703$$MD$DE$DE
239496173$23949617$3$F$20240508$20240725$20240607$20240730$EXP$$NVSC2024IE118006$NOVARTIS$$64$YR$$F$Y$$$20240730$$CN$IE$IE
239496403$23949640$3$F$$20240731$20240607$20240802$EXP$$GB-MYLANLABS-2024M1047948$MYLAN$$$$$M$Y$$$20240802$$HP$GB$GB
239496452$23949645$2$F$$20240604$20240607$20240823$EXP$$NZ-MYLANLABS-2024M1051508$MYLAN$$$$$F$Y$$$20240823$$HP$NZ$NZ
239496525$23949652$5$F$$20240611$20240607$20240703$PER$$US-ROCHE-3575940$ROCHE$$$$$M$Y$$$20240703$$CN$US$US
239496602$23949660$2$F$$20240701$20240607$20240708$EXP$$US-AUROBINDO-AUR-APL-2024-026819$AUROBINDO$Moon JS, Nepal S, Koteish A, Zhang D, Cambridge B. PELIOSIS HEPATIS IN THE SETTING OF AROMATASE INHIBITOR USE LEADING TO INTRAPERITONEAL HEMORRHAGE. Critical Care Medicine. 2024;52(1):S177$57$YR$$F$Y$$$20240708$$MD$US$US
239496763$23949676$3$F$20240422$20240620$20240607$20240709$PER$$US-AstraZeneca-2024A116053$ASTRAZENECA$$69$YR$$M$Y$102.1$KG$20240709$$CN$US$
239496883$23949688$3$F$20150701$20240823$20240607$20240903$EXP$$PL-AUROBINDO-AUR-APL-2019-091602$AUROBINDO$Banaszkiewicz M, Krzanowska K, Chowaniec E, Krzanowski M, Okon K, Sulowicz W.. Coexistence of 2 malignant urogenital neoplasms: a testicular seminoma and adenocarcinoma of the prostate gland in a patient 1 year after kidney transplantation.. Polskie Archiwum Medycyny Wewnetrznej. 2016;126(5):367-368$65$YR$$M$Y$$$20240903$$MD$PL$PL
239496912$23949691$2$F$20240401$20240802$20240607$20240808$PER$$US-SA-2024SA166290$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240809$$MD$US$US
239497082$23949708$2$F$20240528$20240709$20240607$20240722$EXP$$JP-ROCHE-3577015$ROCHE$$63$YR$A$F$Y$52.4$KG$20240722$$MD$JP$JP
239497202$23949720$2$F$20240103$20240620$20240607$20240701$EXP$$US-SA-2024SA164922$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240701$$HP$US$US
239497442$23949744$2$F$20230101$20240703$20240607$20240706$PER$$US-AMGEN-USASP2024109561$AMGEN$$86$YR$E$F$Y$$$20240705$$CN$US$US
239497533$23949753$3$F$$20240718$20240607$20240729$EXP$$ES-AUROBINDO-AUR-APL-2024-027418$AUROBINDO$Latorre S., Moreno I., Gordillo M.J.. Case Report: Three Years of Refractory Atypical Depression Successfully Treated With?Old School? Moclobemide (maoi-r).. European Psychiatry.. 2017;41:s239$54$YR$$F$Y$$$20240729$$MD$ES$ES
239497695$23949769$5$F$20240101$20240812$20240607$20240819$EXP$$CA-CELLTRION INC.-2024CA013458$CELLTRION$$$$$$Y$$$20240819$$HP$CA$CA
239497812$23949781$2$F$20240222$20240802$20240607$20240806$EXP$$IT-MYLANLABS-2024M1050487$MYLAN$$65$YR$$M$Y$70$KG$20240806$$MD$IT$IT
239498035$23949803$5$F$20240101$20240828$20240607$20240905$EXP$$CA-CELLTRION INC.-2024CA013535$CELLTRION$$$$$$Y$$$20240905$$CN$CA$CA
239498073$23949807$3$F$20240531$20240730$20240607$20240805$PER$$US-AMGEN-USASP2024108605$AMGEN$$68$YR$E$F$Y$74.8$KG$20240805$$PH$US$US
239498122$23949812$2$F$$20240628$20240607$20240701$EXP$$CZ-TAKEDA-2024TUS056937$TAKEDA$$51$YR$$M$Y$$$20240701$$HP$CZ$CZ
239498152$23949815$2$F$20240201$20240712$20240607$20240715$EXP$IT-MINISAL02-988458$IT-ROCHE-3577899$ROCHE$$31$YR$A$F$Y$78$KG$20240715$$MD$IT$IT
239498383$23949838$3$F$20190901$20240730$20240607$20240805$EXP$$PT-MYLANLABS-2024M1050718$MYLAN$$73$YR$$M$Y$$$20240805$$MD$PT$PT
239498433$23949843$3$F$20240512$20240812$20240607$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002412$ACADIA PHARMACEUTICALS$$17$YR$$F$Y$$$20240905$$CN$US$US
239498483$23949848$3$F$$20240906$20240607$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091932$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$100.22$KG$20240906$$CN$US$US
239498532$23949853$2$F$$20240625$20240607$20240703$EXP$$US-GSK-US2024068299$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$US$US
239498782$23949878$2$F$$20240814$20240607$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202406003082$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240820$$PH$US$US
239499042$23949904$2$F$$20240705$20240607$20240711$30DAY$$BE-JNJFOC-20240611220$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$BE$BE
239499105$23949910$5$F$20240408$20240620$20240607$20240704$EXP$$JP-ALXN-202405JPN002102JP$ALEXION PHARMACEUTICALS$$7$DEC$$M$Y$$$20240704$$MD$JP$JP
239499132$23949913$2$F$20210101$20240624$20240607$20240703$EXP$FR-AFSSAPS-PA2024000915$FR-NORDICGR-056207$NORDIC PHARMA$$65$YR$$M$Y$$$20240702$$PH$FR$FR
239499152$23949915$2$F$20140101$20240624$20240607$20240708$EXP$$NL-NORDICGR-056234$NORDIC PHARMA$$$$A$F$Y$$$20240708$$MD$NL$NL
239499192$23949919$2$F$20240813$20240814$20240607$20240822$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02034$AMNEAL$$1$YR$$M$Y$12.698$KG$20240822$$PH$US$US
239499222$23949922$2$F$$20240610$20240607$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002415$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
239499253$23949925$3$F$20240101$20240716$20240607$20240725$EXP$$CA-CELLTRION INC.-2024CA013597$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
239499362$23949936$2$F$20240508$20240628$20240607$20240702$EXP$$US-MYLANLABS-2024M1050220$MYLAN$$76$YR$$M$Y$$$20240702$$HP$US$US
239499399$23949939$9$F$$20240918$20240607$20240924$EXP$$GB-ORGANON-O2404GBR000392$ORGANON$$$$$M$Y$$$20240924$$MD$GB$GB
239499422$23949942$2$F$$20240620$20240607$20240701$30DAY$$DE-JNJFOC-20240611123$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$PH$DE$DE
239499522$23949952$2$F$20240418$20240824$20240607$20240830$EXP$$CO-TAKEDA-2024TUS042876$TAKEDA$$20$YR$$M$Y$49.7$KG$20240830$$CN$CO$CO
239499532$23949953$2$F$20240406$20240709$20240607$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091786$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240711$$MD$JP$JP
239499552$23949955$2$F$$20240719$20240607$20240726$EXP$$CA-TAKEDA-2024TUS056000$TAKEDA$$$$$F$Y$$$20240726$$CN$CA$CA
239499682$23949968$2$F$$20240515$20240607$20240703$EXP$$US-IMP-2024000294$Harrow Health$$68$YR$E$F$Y$104$KG$20240703$$CN$US$US
239499822$23949982$2$F$$20240710$20240607$20240719$EXP$$IT-AMGEN-ITASP2024106876$AMGEN$$$$$$Y$$$20240718$$CN$FR$FR
239499872$23949987$2$F$$20240717$20240607$20240807$PER$$US-AstraZeneca-2024A129737$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
239499912$23949991$2$F$20240429$20240703$20240607$20240713$EXP$$DE-TEVA-VS-3205392$TEVA$$61$YR$$F$Y$57$KG$20240713$$MD$DE$DE
239500083$23950008$3$F$20240529$20240701$20240607$20240702$EXP$$TW-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032326$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$60$KG$20240702$$MD$TW$TW
239500112$23950011$2$F$$20240910$20240607$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092184$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240913$$HP$US$US
239500182$23950018$2$F$$20240706$20240607$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-027349$AUROBINDO$Perez RK, Lighthall G.. Profound Coronary Vasospasm Associated with Intraoperative Ketamine Administration. A-A-Pract. 2024;18 (5):E01786$62$YR$$F$Y$$$20240718$$MD$US$US
239500192$23950019$2$F$20240501$20240809$20240607$20240821$EXP$$JP-ROCHE-3575120$ROCHE$$7$DEC$E$$Y$62$KG$20240821$$MD$JP$JP
239500232$23950023$2$F$20220301$20240701$20240607$20240711$EXP$GB-MHRA-MED-202405291424443490-MPNTB$GB-Accord-428104$ACCORD$$52$YR$A$F$Y$$$20240711$$MD$GB$GB
239500322$23950032$2$F$$20240722$20240607$20240726$EXP$$NZ-MYLANLABS-2024M1051972$MYLAN$$$$$M$Y$$$20240726$$HP$NZ$NZ
239500563$23950056$3$F$20240101$20240701$20240607$20240709$EXP$$NL-AUROBINDO-AUR-APL-2024-026767$AUROBINDO$$62$YR$$M$Y$$$20240709$$HP$NL$NL
239500622$23950062$2$F$$20240826$20240607$20240905$EXP$$JP-ROCHE-3576043$ROCHE$$$$E$M$Y$$$20240905$$MD$JP$JP
239500712$23950071$2$F$$20240706$20240607$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-027441$AUROBINDO$Elkhatib S, Pellegrino P, Johnson D. CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME: SEVERE PRESENTATION AND MANAGEMENT OF A RARE DISEASE. Crit-Care-Med. 2024;52 (Suppl.)(1):S204$33$YR$$M$Y$$$20240717$$HP$US$US
239500902$23950090$2$F$$20240701$20240607$20240708$EXP$$US-AUROBINDO-AUR-APL-2024-026686$AUROBINDO$Ruff MW, Hooshmand SJ, Chohan KL, Raghunathan A, Renaud DL.. BRAT1-Associated Leukodystrophy Exacerbated by Classic Hodgkin Lymphoma-Directed Therapy.. The Neurologist. 2024;29(3):170-72$66$YR$$M$Y$$$20240708$$MD$US$US
239501062$23950106$2$F$$20240702$20240607$20240712$30DAY$$BE-JNJFOC-20240610872$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$BE$BE
239501202$23950120$2$F$$20240627$20240607$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-026783$AUROBINDO$Basbayraktar B, Mirembe L, Yaqub S, Afroze T, Naguib T. Serotonin syndrome with ocular myoclonus and inducible clonus: an uncommon clinical presentation. Am-J-Med-Sci. 2024;367 (Suppl. 1):S213?S387$64$YR$$M$Y$$$20240705$$HP$US$US
239501323$23950132$3$F$$20240702$20240607$20240705$PER$$US-AMGEN-USASP2024110799$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
239501362$23950136$2$F$20240525$20240702$20240607$20240710$EXP$$JP-ROCHE-3574921$ROCHE$$$$E$$Y$$$20240710$$MD$JP$JP
239501382$23950138$2$F$20240604$20240719$20240607$20240722$PER$$NVSC2024US119326$NOVARTIS$$1$MON$$$Y$$$20240722$$MD$US$US
239501472$23950147$2$F$$20240903$20240607$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089895$BRISTOL MYERS SQUIBB$$77$YR$E$$Y$$$20240904$$PH$US$US
239501492$23950149$2$F$$20240625$20240607$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091646$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240702$$MD$JP$JP
239501712$23950171$2$F$20190713$20240801$20240607$20240809$PER$$US-SA-2024SA167539$SANOFI AVENTIS$$3$YR$C$M$Y$29.3$KG$20240809$$MD$US$US
239501743$23950174$3$F$$20240620$20240607$20240708$PER$$US-AstraZeneca-2024A129312$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$US$
239501775$23950177$5$F$20240605$20240715$20240607$20240717$PER$$US-JNJFOC-20240612759$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240717$$CN$US$US
239501823$23950182$3$F$20240126$20240725$20240607$20240729$EXP$$CA-MYLANLABS-2024M1051446$MYLAN$$72$YR$$F$Y$98.9$KG$20240729$$CN$CA$CA
239501992$23950199$2$F$20240513$20240913$20240607$20240923$PER$$JP-Eisai-EC-2024-166907$EISAI$$65$YR$E$F$Y$40$KG$20240923$$MD$JP$JP
2395020410$23950204$10$F$20231229$20240915$20240607$20240924$EXP$$JP-ROCHE-3505851$ROCHE$$68$YR$E$F$Y$59.8$KG$20240924$$MD$JP$JP
239502053$23950205$3$F$$20240626$20240607$20240701$EXP$$JP-JNJFOC-20240613629$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$$COUNTRY NOT SPECIFIED$JP
239502062$23950206$2$F$20240401$20240702$20240607$20240704$EXP$$US-GILEAD-2024-0672698$GILEAD$$40$YR$A$M$Y$$$20240704$$CN$US$US
239502093$23950209$3$F$$20240627$20240607$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002434$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
239502182$23950218$2$F$$20240903$20240607$20240911$EXP$$JP-Eisai-EC-2024-167088$EISAI$$75$YR$E$F$Y$$$20240911$$MD$JP$JP
239502212$23950221$2$F$20240531$20240807$20240607$20240814$PER$$JP-Eisai-EC-2024-167069$EISAI$$79$YR$E$M$Y$$$20240814$$MD$JP$JP
239502252$23950225$2$F$$20240711$20240607$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092269$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240715$$CN$US$US
239502282$23950228$2$F$$20240627$20240607$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR069741$VIIV$$$$$$Y$$$20240705$$HP$US$US
239502313$23950231$3$F$20230101$20240719$20240607$20240730$PER$$US-SA-2024SA168499$SANOFI AVENTIS$$32$YR$A$M$Y$150$KG$20240730$$HP$US$US
239502332$23950233$2$F$20240101$20240917$20240607$20240925$PER$$US-SA-2024SA167930$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240925$$MD$US$US
239502353$23950235$3$F$20240101$20240920$20240607$20240927$EXP$$US-TG THERAPEUTICS INC.-TGT003657$TG THERAPEUTICS$$$$$$Y$$$20240927$$CN$US$US
239502382$23950238$2$F$$20240523$20240607$20240813$EXP$$US-BRAEBURN-US-BRA-24-000501$BRAEBURN PHARMACEUTICALS$Eshghabadi M.A. Long-term buprenorphine use and prevalence of sleep apnea: a case series. Sleep. 2024;47:A499-A500$46$YR$$M$Y$$$20240813$$HP$US$US
239502392$23950239$2$F$$20240701$20240607$20240816$PER$$US-LUNDBECK-DKLU3077609$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
239502432$23950243$2$F$20240602$20240717$20240607$20240722$PER$$US-AMGEN-USASP2024112201$AMGEN$$76$YR$E$$Y$$$20240722$$CN$US$US
239502474$23950247$4$F$$20240716$20240607$20240722$EXP$$US-BAYER-2024A079117$BAYER$$61$YR$A$F$Y$76.644$KG$20240722$$CN$US$US
239502602$23950260$2$F$20240603$20240702$20240607$20240705$PER$$US-AMGEN-USASP2024110888$AMGEN$$$$$$Y$$$20240705$$HP$US$US
239502682$23950268$2$F$20240501$20240827$20240607$20240902$EXP$$US-ABBVIE-5789201$ABBVIE$$68$YR$$M$Y$113$KG$20240902$$CN$US$US
239502733$23950273$3$F$$20240626$20240607$20240701$EXP$$JP-JNJFOC-20240613627$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$$COUNTRY NOT SPECIFIED$JP
239502853$23950285$3$F$20240101$20240710$20240607$20240715$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-081018$REGENERON$$$$$F$Y$$$20240715$$CN$US$US
239502942$23950294$2$F$$20240722$20240607$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002433$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
239503033$23950303$3$F$$20240809$20240607$20240816$EXP$$GB-TAKEDA-2023TUS054463$TAKEDA$$$$$F$Y$$$20240816$$CN$GB$GB
239503062$23950306$2$F$$20240625$20240607$20240705$30DAY$$TW-JNJFOC-20240605785$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$TW$TW
239503182$23950318$2$F$$20240708$20240607$20240715$EXP$$US-TAKEDA-2024TUS039932$TAKEDA$$$$$M$Y$$$20240715$$CN$US$US
239503192$23950319$2$F$20240518$20240716$20240607$20240725$EXP$$US-RADIUS HEALTH, INC.-2024US003734$RADIUS PHARM$$64$YR$$F$Y$$$20240725$$MD$US$US
239503213$23950321$3$F$20230101$20240718$20240607$20240722$EXP$$US-PUMA BIOTECHNOLOGY, LTD.-2023-PUM-US001911$PUMA$$$$$$Y$$$20240722$$HP$US$US
239503532$23950353$2$F$$20240602$20240607$20240814$EXP$$NVSC2023IN280128$NOVARTIS$$63$YR$$F$Y$$$20240814$$CN$IN$IN
239503562$23950356$2$F$20240531$20240702$20240607$20240705$PER$$US-AMGEN-USASP2024111904$AMGEN$$83$YR$E$M$Y$$$20240705$$CN$US$US
239503612$23950361$2$F$$20240719$20240607$20240725$PER$$US-ALXN-202405USA002234US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239503672$23950367$2$F$20240201$20240719$20240607$20240723$EXP$IT-MINISAL02-984920$NVSC2024IT102312$NOVARTIS$$60$YR$$F$Y$$$20240723$$MD$IT$IT
239503732$23950373$2$F$$20240705$20240607$20240710$30DAY$$JP-JNJFOC-20240603893$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$JP$JP
239503752$23950375$2$F$20240529$20240805$20240607$20240813$PER$$US-SA-2024SA167453$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240814$$MD$US$US
239503912$23950391$2$F$$20240725$20240607$20240725$PER$$NVSC2024US119831$NOVARTIS$$$$$M$Y$$$20240725$$CN$US$US
239504012$23950401$2$F$$20240718$20240607$20240725$30DAY$$US-GSK-US2024067678$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$MD$US$US
239504162$23950416$2$F$20240324$20240626$20240607$20240704$EXP$$PL-ROCHE-3575764$ROCHE$$69$YR$E$M$Y$$$20240704$$MD$PL$PL
239504312$23950431$2$F$$20240627$20240607$20240701$PER$$US-AMGEN-USASP2024112868$AMGEN$$$$$M$Y$$$20240701$$CN$US$US
239504422$23950442$2$F$$20240705$20240607$20240712$30DAY$$JP-JNJFOC-20240603048$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$PH$JP$JP
239504434$23950443$4$F$20220101$20240716$20240607$20240724$PER$$US-SA-2024SA169786$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240724$$CN$US$US
239504452$23950445$2$F$20240604$20240702$20240607$20240708$EXP$$CA-TAKEDA-2024TUS055977$TAKEDA$$73$YR$$F$Y$$$20240708$$CN$CA$CA
239504482$23950448$2$F$20240516$20240721$20240607$20240730$30DAY$$US-GSK-US2024067757$GLAXOSMITHKLINE$$24$YR$$F$Y$$$20240730$$CN$US$US
239504522$23950452$2$F$$20240711$20240607$20240712$EXP$$NVSC2024RU119315$NOVARTIS$$$$A$M$Y$$$20240712$$MD$RU$RU
239504764$23950476$4$F$$20240917$20240607$20240924$EXP$$CA-TAKEDA-2024TUS056710$TAKEDA$$$$$F$Y$$$20240924$$CN$CA$CA
239504822$23950482$2$F$20240514$20240722$20240607$20240729$PER$$US-BIOGEN-2024BI01267166$BIOGEN$$66$YR$$F$Y$$$20240729$$CN$US$US
239504862$23950486$2$F$$20240523$20240607$20240813$EXP$$US-BRAEBURN-US-BRA-24-000502$BRAEBURN PHARMACEUTICALS$Eshghabadi M.A.. Long-term buprenorphine use and prevalence of sleep apnea: a case series. Sleep. 2024;47:A499-A500$66$YR$$M$Y$$$20240813$$HP$US$US
239504912$23950491$2$F$20240401$20240801$20240607$20240810$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-007003$JAZZ$$50$YR$$F$Y$$$20240810$$CN$US$US
239504933$23950493$3$F$20240101$20240628$20240607$20240705$EXP$$US-VERTEX PHARMACEUTICALS-2024-009027$VERTEX$$$$$M$Y$$$20240705$$MD$US$US
239504952$23950495$2$F$$20240822$20240607$20240828$PER$$US-VERTEX PHARMACEUTICALS-2024-009550$VERTEX$$$$$$Y$$$20240828$$CN$US$US
239505005$23950500$5$F$20240101$20240819$20240607$20240821$EXP$$US-PFIZER INC-PV202400073178$PFIZER$$60$YR$$M$Y$$$20240821$$MD$US$US
239505182$23950518$2$F$20210927$20240716$20240607$20240723$EXP$NL-LRB-00976556$NL-009507513-2406NLD001100$MERCK$$56$YR$$F$Y$72$KG$20240723$$PH$NL$NL
239505242$23950524$2$F$$20240904$20240607$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090992$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240904$$CN$US$US
239505294$23950529$4$F$20240604$20240713$20240607$20240716$PER$$US-AMGEN-USASP2024112192$AMGEN$$58$YR$A$F$Y$$$20240716$$CN$US$US
239505742$23950574$2$F$20230714$20240731$20240607$20240805$EXP$$JP-EXELIXIS-CABO-24077359$EXELIXIS$$79$YR$$M$Y$$$20240805$$MD$JP$JP
239505779$23950577$9$F$20240501$20240919$20240607$20240927$EXP$$FR-EXELIXIS-XL18424077386$EXELIXIS$$$$$$Y$$$20240926$$MD$FR$FR
239505862$23950586$2$F$$20240523$20240607$20240813$EXP$$US-BRAEBURN-US-BRA-24-000503$BRAEBURN PHARMACEUTICALS$Eshghabadi M.A.. Long-term buprenorphine use and prevalence of sleep apnea: a case series. Sleep. 2024;47:A499-A500$28$YR$$M$Y$$$20240813$$HP$US$US
239505902$23950590$2$F$$20240523$20240607$20240813$EXP$$US-BRAEBURN-US-BRA-24-000504$BRAEBURN PHARMACEUTICALS$Eshghabadi M.A. LONG-TERM BUPRENORPHINE USE AND PREVALENCE OF SLEEP APNEA: A CASE SERIES. Sleep. 2024;47:A499-A500$68$YR$$M$Y$$$20240813$$HP$US$US
239505962$23950596$2$F$$20240627$20240607$20240710$30DAY$$AU-JNJFOC-20240601086$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$AU$AU
239506127$23950612$7$F$20240312$20240821$20240607$20240905$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449642$RANBAXY$$86$YR$E$F$Y$53$KG$20240905$$MD$CN$CN
239506184$23950618$4$F$20240126$20240819$20240607$20240828$EXP$$JP-ROCHE-3536079$ROCHE$$43$YR$A$F$Y$68$KG$20240828$$MD$JP$JP
239506202$23950620$2$F$20231027$20240624$20240607$20240705$EXP$$CO-RECORDATI-2023007547$RECORDATI$$$$$$Y$$$20240705$$CN$CO$CO
239506262$23950626$2$F$$20240604$20240607$20240819$EXP$$US-SA-2024SA168580$SANOFI AVENTIS$Chen ST, Cochran RL, Jain S, Stagner AM.. Case 15-2024: A 73-Year-Old Woman with Worsening Rash.. N Engl J Med.. 2024;390:1803-13.$73$YR$E$F$Y$$$20240819$$MD$US$US
239506302$23950630$2$F$20240403$20240903$20240607$20240911$EXP$$US-RADIUS HEALTH, INC.-2024US003831$RADIUS PHARM$$69$YR$$F$Y$$$20240911$$CN$US$US
239506382$23950638$2$F$20240428$20240723$20240607$20240724$EXP$$US-KYOWAKIRIN-2024KK013787$KYOWA$$$$$$Y$$$20240724$$CN$US$US
239506392$23950639$2$F$20220101$20240607$20240607$20240703$PER$$US-AMGEN-USASP2024112203$AMGEN$$83$YR$E$F$Y$$$20240703$$CN$US$US
239506494$23950649$4$F$20240603$20240701$20240607$20240703$EXP$$US-AMGEN-USASP2024110334$AMGEN$$77$YR$E$F$Y$$$20240703$$CN$US$US
239506672$23950667$2$F$20230626$20240625$20240607$20240703$PER$$US-SA-2024SA166027$SANOFI AVENTIS$$29$YR$A$F$Y$69.853$KG$20240704$$MD$US$US
239506824$23950682$4$F$20240101$20240711$20240607$20240722$EXP$$US-UCBSA-2024024401$UCB$$$$$F$Y$55.011$KG$20240722$$CN$US$US
239507082$23950708$2$F$20240514$20240617$20240607$20240710$PER$$FR-TOLMAR, INC.-24FR049391$TOLMAR$$67$YR$$$Y$$$20240710$$PH$FR$FR
239507112$23950711$2$F$20240516$20240729$20240607$20240807$PER$$BR-Eisai-EC-2024-166768$EISAI$$83$YR$E$M$Y$93$KG$20240807$$CN$BR$BR
239507122$23950712$2$F$20240514$20240702$20240607$20240813$PER$$TR-TOLMAR, INC.-24TR049370$TOLMAR$$71$YR$$M$Y$$$20240813$$HP$TR$TR
239507132$23950713$2$F$$20240613$20240607$20240705$PER$$US-TOLMAR, INC.-24US048792$TOLMAR$$$$$$Y$$$20240705$$HP$US$US
239507152$23950715$2$F$20240419$20240612$20240607$20240705$PER$$US-TOLMAR, INC.-24US048879$TOLMAR$$73$YR$$M$Y$$$20240705$$HP$US$US
239507162$23950716$2$F$20240513$20240625$20240607$20240724$PER$$US-TOLMAR, INC.-24US049280$TOLMAR$$65$YR$$M$Y$$$20240724$$HP$US$US
239507172$23950717$2$F$$20240614$20240607$20240704$PER$$US-TOLMAR, INC.-24US049255$TOLMAR$$$$$M$Y$$$20240703$$HP$US$US
239507182$23950718$2$F$$20240614$20240607$20240702$PER$$US-TOLMAR, INC.-24US048945$TOLMAR$$$$$M$Y$$$20240702$$HP$US$US
239507192$23950719$2$F$20240514$20240625$20240607$20240724$PER$$US-TOLMAR, INC.-24US049367$TOLMAR$$$$$M$Y$$$20240724$$HP$US$US
239507202$23950720$2$F$20240430$20240626$20240607$20240724$PER$$US-TOLMAR, INC.-24US049366$TOLMAR$$$$$M$Y$$$20240724$$PH$US$US
239507563$23950756$3$F$20240521$20240628$20240607$20240702$EXP$$RO-JNJFOC-20240610324$JOHNSON AND JOHNSON$$73$YR$E$M$Y$82$KG$20240702$$MD$RO$RO
239507882$23950788$2$F$$20240701$20240607$20240720$PER$$US-TEVA-VS-3193780$TEVA$$$$$$Y$$$20240720$$CN$US$US
239508252$23950825$2$F$$20240709$20240607$20240718$EXP$$US-NOVOPROD-1230280$NOVO NORDISK$$$$$F$Y$$$20240718$$CN$US$US
239508442$23950844$2$F$20231201$20240814$20240607$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090508$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240821$$HP$US$US
239508492$23950849$2$F$$20240906$20240607$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092637$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240906$$CN$US$US
239508672$23950867$2$F$$20240807$20240607$20240807$PER$$US-ALXN-202405USA002173US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
239508692$23950869$2$F$20240422$20240703$20240607$20240708$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405003079$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240708$$CN$JP$JP
239508712$23950871$2$F$20240312$20240621$20240607$20240701$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406002803$ELI LILLY AND CO$$70$YR$E$F$Y$51.8$KG$20240701$$CN$JP$JP
239508722$23950872$2$F$$20240717$20240607$20240726$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405017598$ELI LILLY AND CO$$69$YR$E$F$Y$51$KG$20240726$$CN$JP$JP
239508742$23950874$2$F$$20240903$20240607$20240904$EXP$$NVSC2024US118504$NOVARTIS$$$$$M$Y$$$20240904$$CN$US$US
239508803$23950880$3$F$20240524$20240903$20240607$20240911$EXP$$US-NOVOPROD-1231358$NOVO NORDISK$$33$YR$$F$Y$$$20240911$$MD$US$US
239509343$23950934$3$F$$20240610$20240607$20240709$EXP$$KZ-SUNPHARMA-2024R1-449495AA$RANBAXY$$$$$F$Y$$$20240709$$MD$KZ$KZ
239509642$23950964$2$F$20240101$20240711$20240607$20240730$PER$$US-KARYOPHARM-2024KPT001145$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240730$$CN$US$US
239509864$23950986$4$F$20240620$20240730$20240607$20240807$EXP$$US-Calliditas-2024CAL00918$CALLIDITAS THERAPEUTICS$$67$YR$E$M$Y$88$KG$20240807$$CN$US$US
239509992$23950999$2$F$$20240918$20240607$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US055773$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
239510053$23951005$3$F$$20240911$20240607$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US055826$SANDOZ$$$$$F$Y$$$20240913$$CN$US$US
239510112$23951011$2$F$$20240917$20240607$20240920$30DAY$$US-SANDOZ INC.-SDZ2024US055766$SANDOZ$$$$$$Y$$$20240920$$CN$US$US
239510393$23951039$3$F$$20240626$20240607$20240701$EXP$$JP-JNJFOC-20240613660$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$JP$JP
239510402$23951040$2$F$20240601$20240730$20240607$20240802$PER$$US-AMGEN-USASP2024110406$AMGEN$$69$YR$E$F$Y$$$20240802$$CN$US$US
239510562$23951056$2$F$20230501$20240722$20240607$20240725$EXP$$NVSC2024FR119496$NOVARTIS$$22$YR$$F$Y$$$20240725$$MD$FR$FR
239510844$23951084$4$F$20240101$20240904$20240607$20240913$EXP$$CA-CELLTRION INC.-2024CA013322$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
239511142$23951114$2$F$$20240916$20240607$20240923$PER$$US-SA-2024SA166239$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240923$$MD$US$US
239511162$23951116$2$F$20240513$20240903$20240607$20240926$PER$$CA-TOLMAR, INC.-24CA049369$TOLMAR$$61$YR$$M$Y$$$20240926$$CN$CA$CA
239511172$23951117$2$F$20240513$20240813$20240607$20240904$PER$$CA-TOLMAR, INC.-24CA049378$TOLMAR$$87$YR$$M$Y$$$20240904$$CN$CA$CA
239511202$23951120$2$F$20240510$20240625$20240607$20240717$PER$$CA-TOLMAR, INC.-24CA049389$TOLMAR$$$$$M$Y$$$20240717$$HP$CA$CA
239511233$23951123$3$F$20240501$20240704$20240607$20240730$PER$$FR-TOLMAR, INC.-24FR049319$TOLMAR$$88$YR$$M$Y$$$20240730$$PH$FR$FR
239511242$23951124$2$F$20240501$20240611$20240607$20240708$PER$$FR-TOLMAR, INC.-24FR049321$TOLMAR$$$$E$M$Y$$$20240708$$PH$FR$FR
239511252$23951125$2$F$20240513$20240611$20240607$20240708$PER$$FR-TOLMAR, INC.-24FR049344$TOLMAR$$73$YR$$M$Y$$$20240708$$PH$FR$FR
239511263$23951126$3$F$20240513$20240723$20240607$20240819$PER$$FR-TOLMAR, INC.-24FR049323$TOLMAR$$77$YR$$M$Y$$$20240819$$PH$FR$FR
239511322$23951132$2$F$$20240729$20240607$20240731$EXP$$US-ALXN-202405USA002312US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
239511333$23951133$3$F$20240531$20240703$20240607$20240717$EXP$$US-EXELIXIS-CABO-24073611$EXELIXIS$$83$YR$$M$Y$$$20240717$$CN$US$US
239511962$23951196$2$F$$20240723$20240607$20240726$EXP$$IE-MYLANLABS-2024M1050499$MYLAN$$2$YR$$M$Y$$$20240726$$PH$IE$IE
239512053$23951205$3$F$20240501$20240805$20240607$20240814$PER$$US-SA-2024SA167965$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240814$$CN$US$US
239512073$23951207$3$F$20140101$20240716$20240607$20240725$EXP$$CO-NOVOPROD-1227765$NOVO NORDISK$$62$YR$$F$Y$71$KG$20240725$$CN$CO$CO
239512103$23951210$3$F$$20240620$20240607$20240702$EXP$$US-TRAVERE-2024TVT00570$TRAVERE THERAPEUTICS$$51$YR$A$M$Y$204.1$KG$20240702$$CN$US$US
239512133$23951213$3$F$20240512$20240827$20240607$20240905$EXP$$DE-FreseniusKabi-FK202408848$FRESENIUS KABI$$77$YR$E$F$Y$58$KG$20240905$$MD$DE$DE
239512152$23951215$2$F$$20240805$20240607$20240807$EXP$$NVSC2024BR119252$NOVARTIS$$$$$$Y$$$20240807$$MD$BR$BR
239512223$23951222$3$F$20240602$20240709$20240607$20240711$PER$$US-AMGEN-USASP2024112745$AMGEN$$77$YR$E$M$Y$$$20240710$$CN$US$US
239512302$23951230$2$F$$20240530$20240607$20240808$EXP$$CO-NOVOPROD-1232098$NOVO NORDISK$$67$YR$$F$Y$$$20240808$$CN$CO$CO
239512414$23951241$4$F$20240214$20240807$20240607$20240819$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406002235$ELI LILLY AND CO$$76$YR$E$M$Y$58$KG$20240819$$CN$JP$JP
239512543$23951254$3$F$20240401$20240626$20240607$20240705$EXP$$US-BAYER-2024A080738$BAYER$$58$YR$A$F$Y$$$20240705$$CN$US$US
239512564$23951256$4$F$20240601$20240816$20240607$20240823$EXP$$US-Calliditas-2024CAL00936$CALLIDITAS THERAPEUTICS$$46$YR$A$M$Y$132$KG$20240823$$CN$US$US
239512592$23951259$2$F$20240412$20240718$20240607$20240724$EXP$$DE-009507513-2406DEU002239$MERCK$$70$YR$$M$Y$187$KG$20240724$$MD$DE$DE
239512762$23951276$2$F$$20240716$20240607$20240722$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0600063$MYOVANT SCIENCES$$$$$M$Y$$$20240722$$CN$US$US
239513054$23951305$4$F$$20240919$20240607$20240919$EXP$$CA-PFIZER INC-202400188124$PFIZER$$75$YR$$M$Y$$$20240919$$HP$CA$CA
239513062$23951306$2$F$$20240731$20240607$20240731$EXP$$CA-PFIZER INC-202400187908$PFIZER$$71$YR$$M$Y$$$20240731$$MD$CA$CA
239513086$23951308$6$F$20240101$20240909$20240607$20240910$EXP$$CA-PFIZER INC-202400184286$PFIZER$$56$YR$$F$Y$$$20240910$$HP$CA$CA
239513133$23951313$3$F$20230701$20240723$20240607$20240726$EXP$$CA-PFIZER INC-202400187768$PFIZER$$56$YR$$F$Y$$$20240726$$HP$CA$CA
239513232$23951323$2$F$20210101$20240731$20240607$20240805$EXP$$AU-PFIZER INC-202400187723$PFIZER$$$$$F$Y$$$20240805$$CN$AU$AU
239513303$23951330$3$F$20230430$20240808$20240607$20240813$EXP$$DK-PFIZER INC-202400186063$PFIZER$$61$YR$$F$Y$54$KG$20240813$$MD$DK$DK
239513402$23951340$2$F$20231201$20240624$20240607$20240701$EXP$$US-KOWA-24US001373$KOWA PHARM$$$$$$Y$$$20240701$$CN$US$US
239513482$23951348$2$F$$20240624$20240607$20240708$EXP$$CA-HLS-202401435$HLS THERAPEUTICS$$$$E$M$Y$$$20240708$$HP$CA$CA
239513703$23951370$3$F$20240501$20240827$20240607$20240828$EXP$$GB-MYLANLABS-2024M1050839$MYLAN$$$$$M$Y$$$20240828$$PH$GB$GB
239513722$23951372$2$F$20240530$20240924$20240607$20240927$EXP$$US-MYLANLABS-2024M1050264$MYLAN$$62$YR$$M$Y$67.49$KG$20240927$$HP$US$US
239513752$23951375$2$F$20240524$20240802$20240607$20240807$EXP$$US-MYLANLABS-2024M1050239$MYLAN$$62$YR$$M$Y$$$20240807$$CN$US$US
239513772$23951377$2$F$$20240823$20240607$20240828$EXP$$GB-MYLANLABS-2024M1050589$MYLAN$$$$$M$Y$$$20240828$$PH$GB$GB
239513882$23951388$2$F$20240520$20240716$20240607$20240723$EXP$IT-MINISAL02-987570$IT-BEH-2024173219$CSL BEHRING$$61$YR$A$F$Y$50$KG$20240723$$MD$IT$IT
239514112$23951411$2$F$$20240816$20240607$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092160$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240826$$CN$US$US
239514243$23951424$3$F$20240603$20240916$20240607$20240920$EXP$$CA-PFIZER INC-202400186544$PFIZER$$88$YR$$M$Y$$$20240920$$HP$CA$CA
239514253$23951425$3$F$20240812$20240813$20240607$20240817$EXP$$US-TAKEDA-2024TUS057198$TAKEDA$$65$YR$$F$Y$$$20240817$$HP$US$US
239514392$23951439$2$F$20240529$20240708$20240607$20240709$PER$$US-HALEON-2180333$Haleon PLC$$29$YR$$M$Y$$$20240709$$CN$US$US
239514522$23951452$2$F$20240510$20240610$20240607$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002403$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240705$$CN$US$US
239514592$23951459$2$F$$20240705$20240607$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090975$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240716$$CN$US$US
239514692$23951469$2$F$20240201$20240729$20240607$20240731$PER$$US-ALXN-202405USA002308US$ALEXION PHARMACEUTICALS$$65$YR$$F$Y$$$20240731$$CN$US$US
239514862$23951486$2$F$20240430$20240704$20240607$20240705$EXP$$ES-ASTELLAS-2024US016393$ASTELLAS$$82$YR$$M$Y$$$20240705$$CN$ES$ES
239515033$23951503$3$F$20240501$20240813$20240607$20240823$EXP$$IL-AMRYT PHARMACEUTICALS DAC-AEGR007168$AEGERION$$$$$$Y$$$20240823$$MD$IL$IL
239515042$23951504$2$F$$20240717$20240607$20240725$EXP$$US-Calliditas-2024CAL00942$CALLIDITAS THERAPEUTICS$$32$YR$A$F$Y$$$20240725$$CN$US$US
239515132$23951513$2$F$$20240717$20240607$20240726$30DAY$$US-GSK-US2024068304$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
239515343$23951534$3$F$20240101$20240801$20240607$20240805$EXP$$US-PFIZER INC-PV202400074551$PFIZER$$50$YR$$F$Y$$$20240805$$HP$US$US
239515364$23951536$4$F$$20240928$20240607$20240930$EXP$$US-PFIZER INC-202400188012$PFIZER$$72$YR$$$Y$$$20240930$$CN$US$US
239515573$23951557$3$F$20240101$20240730$20240607$20240801$PER$$US-PFIZER INC-PV202400074899$PFIZER$$67$YR$$F$Y$55.329$KG$20240801$$CN$US$US
239515682$23951568$2$F$20240601$20240703$20240607$20240708$PER$$US-PFIZER INC-202400187700$PFIZER$$79$YR$$F$Y$67.13$KG$20240708$$CN$US$US
239515752$23951575$2$F$20231101$20240708$20240607$20240711$PER$$US-PFIZER INC-PV202400073392$PFIZER$$38$YR$$F$Y$84.4$KG$20240711$$MD$US$US
239515802$23951580$2$F$$20240910$20240607$20240912$PER$$US-PFIZER INC-PV202400072372$PFIZER$$83$YR$$F$Y$53.515$KG$20240912$$MD$US$US
239515812$23951581$2$F$$20240723$20240607$20240726$PER$$US-PFIZER INC-PV202400074382$PFIZER$$44$YR$$F$Y$$$20240726$$HP$US$US
239515843$23951584$3$F$20240101$20240829$20240607$20240904$PER$$US-PFIZER INC-PV202400074696$PFIZER$$34$YR$$F$Y$$$20240904$$CN$US$US
239515872$23951587$2$F$20240101$20240719$20240607$20240724$PER$$US-PFIZER INC-202400186612$PFIZER$$50$YR$$F$Y$$$20240724$$CN$US$US
239515892$23951589$2$F$20240901$20240913$20240607$20240918$PER$$US-PFIZER INC-202400188489$PFIZER$$80$YR$$F$Y$$$20240918$$HP$US$US
239515992$23951599$2$F$$20240919$20240607$20240923$PER$$US-PFIZER INC-202400187027$PFIZER$$1$YR$$F$Y$$$20240923$$MD$US$US
239516077$23951607$7$F$20230715$20240624$20240607$20240709$EXP$$JP-ORG100014127-2024000155$HRA PHARMA$Yukako N et al. A case of Cushing^s disease resulting in pregnancy while using osilodrostat and delivery with pasireotide and metyrapone. Folia endocrinological Japonica (Journal of the Japan Endocrine Society) 2024,100(1)316./The 97th Annual Meeting of the Japan Endocrine Society. 2024-Jun-6 to 8.$37$YR$$F$Y$$$20240709$$MD$JP$JP
239516402$23951640$2$F$20240401$20240726$20240607$20240801$EXP$FR-AFSSAPS-PB2024000578$FR-009507513-2406FRA000606$MERCK$$59$YR$$F$Y$$$20240801$$MD$FR$FR
239516532$23951653$2$F$$20240808$20240607$20240828$EXP$$US-PHARMING-PHAUS2024000454$PHARMING GROUP$$$$$$Y$$$20240815$$CN$US$US
239516755$23951675$5$F$20240501$20240711$20240607$20240715$EXP$$CA-FERRINGPH-2024FE02960$FERRING$$$$$$Y$$$20240715$$CN$CA$CA
239516902$23951690$2$F$20240101$20240708$20240607$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090179$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$62.14$KG$20240710$$CN$US$US
239517092$23951709$2$F$20230101$20240723$20240607$20240726$EXP$$CO-SANDOZ INC.-SDZ2024CO055345$SANDOZ$$$$$F$Y$$$20240726$$CN$CO$CO
239517113$23951711$3$F$20231201$20240730$20240607$20240731$PER$$US-BIOMARINAP-US-2024-158331$BIOMARIN$$$$$$Y$$$20240731$$CN$US$US
239517232$23951723$2$F$20240506$20240708$20240607$20240711$EXP$$US-AstraZeneca-2024A131365$ASTRAZENECA$$59$YR$$M$Y$$$20240711$$HP$US$
239517242$23951724$2$F$$20240626$20240607$20240705$EXP$$GB-AMRYT PHARMACEUTICALS DAC-AEGR006750$AEGERION$$$$$$Y$$$20240705$$CN$GB$GB
239517252$23951725$2$F$20240401$20240712$20240607$20240717$EXP$$US-MYLANLABS-2024M1046401$MYLAN$$49$YR$$F$Y$$$20240717$$MD$US$US
239517292$23951729$2$F$$20240923$20240607$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US055809$SANDOZ$$$$$F$Y$$$20240926$$CN$US$US
239517364$23951736$4$F$$20240624$20240607$20240704$EXP$$JP-ORG100014127-2024000156$HRA PHARMA$Yukako N, et al. A case of Cushing^s disease resulting in pregnancy while using osilodrostat and delivery with pasireotide and metyrapone. Folia endocrinological Japonica (Journal of the Japan Endocrine Society) 2024,100(1)316 / The 97th Annual Meeting of the Japan Endocrine Society(2024/6/6-8).$$$N$$Y$0.871$KG$20240705$$MD$JP$JP
239517484$23951748$4$F$20240507$20240918$20240607$20240920$EXP$$NVSC2024GB101100$NOVARTIS$$39$YR$$F$Y$$$20240920$$CN$GB$GB
239517634$23951763$4$F$20240518$20240802$20240607$20240813$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405015817$ELI LILLY AND CO$$72$YR$E$M$Y$74$KG$20240813$$CN$JP$JP
239517852$23951785$2$F$$20240926$20240607$20240930$EXP$$NL-ALXN-202406GLO000135NL$ALEXION PHARMACEUTICALS$$73$YR$E$$Y$62$KG$20240930$$MD$NL$NL
239518073$23951807$3$F$$20240621$20240607$20240703$EXP$$US-BIOGEN-2024BI01268219$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
239518232$23951823$2$F$20240501$20240822$20240607$20240826$EXP$$US-KYOWAKIRIN-2024KK013711$KYOWA$$$$$$Y$$$20240826$$HP$US$US
239518242$23951824$2$F$$20240809$20240607$20240819$EXP$$CZ-TEVA-VS-3204571$TEVA$M?llerov? A. Complete tumor regression in a patient with 0% PD-L1 expression. FARMAKOTERAPIE. 2024;(3):316-317$75$YR$$M$Y$$$20240819$$MD$CZ$CZ
239518403$23951840$3$F$$20240822$20240607$20240830$PER$$US-ALXN-202405USA002156US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$HP$US$US
239518452$23951845$2$F$$20240603$20240607$20240902$PER$$US-ASTELLAS-2024US016195$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
239518463$23951846$3$F$20240603$20240702$20240607$20240705$5DAY$$US-ASTELLAS-2024US016208$ASTELLAS$$$$$$Y$$$20240705$$MD$US$US
239518512$23951851$2$F$20170401$20240906$20240607$20240906$EXP$$SK-BRISTOL-MYERS SQUIBB COMPANY-2024-086704$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240906$$HP$SK$SK
239518852$23951885$2$F$$20240729$20240607$20240801$EXP$$US-ABBVIE-5787567$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
239518882$23951888$2$F$$20240603$20240607$20240722$EXP$$GB-BIOGEN-2024BI01268201$BIOGEN$$$$$M$Y$$$20240722$$MD$GB$GB
239519144$23951914$4$F$$20240722$20240607$20240722$PER$$US-ALXN-202406USA000077US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$PH$US$US
239519262$23951926$2$F$20231208$20240731$20240607$20240731$EXP$$CA-PFIZER INC-202300443425$PFIZER$$67$YR$$M$Y$$$20240731$$MD$CA$CA
239519312$23951931$2$F$20240501$20240627$20240607$20240703$EXP$$TR-JNJFOC-20240605581$JOHNSON AND JOHNSON$$$$$M$Y$120$KG$20240703$$CN$TR$TR
239519373$23951937$3$F$20240101$20240702$20240607$20240706$PER$$US-AMGEN-USASP2024109358$AMGEN$$64$YR$A$M$Y$$$20240706$$CN$US$US
239519412$23951941$2$F$$20240809$20240607$20240819$EXP$$CZ-TEVA-VS-3204587$TEVA$Kuba V. Description of an unusual case of polyarthritis with development into a picture of rheumatoid arthritis, with an unusual onset, development and response to therapy. FARMAKOTERAPIE. 2024;(3):274, 276; Literature Reference: Kuba V. Description of an unusual case of polyarthritis with development into a picture of rheumatoid arthritis, with an unusual onset, development and response to therapy. FARMAKOTERAPIE. 2024;(3):274, 276$$$A$F$Y$$$20240819$$MD$CZ$CZ
239519522$23951952$2$F$$20240729$20240607$20240731$EXP$$US-TAKEDA-2024TUS055741$TAKEDA$$$$$F$Y$$$20240731$$MD$US$US
239519532$23951953$2$F$20180101$20240715$20240607$20240721$EXP$$US-ABBVIE-5784769$ABBVIE$$$$$F$Y$75$KG$20240721$$CN$US$US
239519843$23951984$3$F$$20240710$20240607$20240710$PER$$US-PFIZER INC-202400186760$PFIZER$$6$YR$$F$Y$$$20240710$$CN$US$US
239519864$23951986$4$F$$20240819$20240607$20240822$PER$$US-PFIZER INC-202400187568$PFIZER$$77$YR$$F$Y$$$20240822$$MD$US$US
239519873$23951987$3$F$$20240820$20240607$20240822$30DAY$$ES-PFIZER INC-202400186274$PFIZER$$$$$$Y$$$20240822$$CN$ES$ES
239519922$23951992$2$F$20240530$20240627$20240607$20240703$PER$$US-JNJFOC-20240590238$JOHNSON AND JOHNSON$$24$YR$A$F$Y$72.64$KG$20240703$$PH$US$US
239519933$23951993$3$F$$20240702$20240607$20240708$EXP$$JP-JNJFOC-20240616249$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$$COUNTRY NOT SPECIFIED$JP
239519942$23951994$2$F$20240528$20240624$20240607$20240703$EXP$$GB-TEVA-VS-3206251$TEVA$$61$YR$$M$Y$108$KG$20240703$$HP$GB$GB
239519953$23951995$3$F$20240101$20240624$20240607$20240709$PER$$US-SA-2024SA165724$SANOFI AVENTIS$$66$YR$E$F$Y$72.5$KG$20240709$$MD$US$US
239519972$23951997$2$F$20240515$20240826$20240607$20240903$EXP$$US-BAYER-2024A082241$BAYER$$33$YR$A$M$Y$$$20240903$$CN$US$US
239520103$23952010$3$F$20240309$20240611$20240607$20240729$EXP$$BR-ASTELLAS-2024EU005650$ASTELLAS$$6$YR$$F$Y$$$20240729$$CN$BR$BR
239520163$23952016$3$F$20240401$20240904$20240607$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091134$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240904$$HP$US$US
239520172$23952017$2$F$$20240904$20240607$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091506$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240904$$PH$US$US
239520203$23952020$3$F$20240408$20240723$20240607$20240731$EXP$$US-DSJP-DSU-2024-125527$DAIICHI$$73$YR$$F$Y$69$KG$20240731$$PH$US$US
239520272$23952027$2$F$20220101$20240829$20240607$20240903$EXP$$US-PFIZER INC-PV202400038040$PFIZER$$81$YR$$F$Y$67.59$KG$20240903$$CN$US$US
239520283$23952028$3$F$$20240917$20240607$20240924$EXP$$US-GSK-US2024070036$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$US$US
239520512$23952051$2$F$20240527$20240624$20240607$20240701$PER$$US-SA-2024SA164569$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240701$$HP$US$US
239520542$23952054$2$F$20240423$20240817$20240607$20240822$EXP$$US-SA-2024SA167826$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240822$$MD$US$US
239520562$23952056$2$F$$20240719$20240607$20240725$PER$$US-ALXN-202405USA002163US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239520642$23952064$2$F$20240508$20240628$20240607$20240704$30DAY$$CH-JNJFOC-20240549502$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$PH$CH$CH
239520942$23952094$2$F$$20240906$20240607$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092752$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$$$20240906$$CN$US$US
239520952$23952095$2$F$20240601$20240705$20240607$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092607$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240709$$CN$US$US
239520972$23952097$2$F$20240422$20240904$20240607$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085768$BRISTOL MYERS SQUIBB$$26$DY$N$M$Y$$$20240905$$CN$US$US
239521093$23952109$3$F$$20240625$20240607$20240710$EXP$$CA-HLS-202401441$HLS THERAPEUTICS$$22$YR$A$F$Y$61$KG$20240710$$HP$CA$CA
239521162$23952116$2$F$$20240724$20240607$20240801$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202311007975$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240801$$CN$CA$CA
239521234$23952123$4$F$$20240822$20240607$20240827$30DAY$$US-PFIZER INC-202400186781$PFIZER$$13$YR$$M$Y$40.82$KG$20240827$$CN$US$US
239521242$23952124$2$F$20240520$20240712$20240607$20240726$EXP$$CN-PFIZER INC-PV202400074184$PFIZER$$45$YR$$M$Y$75$KG$20240726$$HP$CN$CN
239521274$23952127$4$F$$20240829$20240607$20240903$30DAY$$US-PFIZER INC-202400185819$PFIZER$$12$YR$$M$Y$$$20240903$$CN$US$US
239521514$23952151$4$F$20231111$20240815$20240607$20240822$EXP$$US-GSK-US2024AMR068956$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$US$US
239521544$23952154$4$F$$20240826$20240607$20240830$EXP$$CA-AstraZeneca-2024A126985$ASTRAZENECA$$$$$F$Y$$$20240830$$MD$CA$
239521563$23952156$3$F$$20240716$20240607$20240724$EXP$$US-AstraZeneca-2024A126798$ASTRAZENECA$$$$A$F$Y$$$20240724$$MD$US$
239521622$23952162$2$F$20240301$20240715$20240607$20240718$EXP$$BR-AstraZeneca-2024A132342$ASTRAZENECA$$$$$F$Y$$$20240718$$MD$BR$
239521682$23952168$2$F$$20240703$20240607$20240709$PER$$US-AMGEN-USASP2024112787$AMGEN$$$$$M$Y$$$20240709$$CN$US$US
239521774$23952177$4$F$20240101$20240828$20240607$20240909$EXP$$US-SA-2024SA166883$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240909$$MD$US$US
239521794$23952179$4$F$20240514$20240624$20240607$20240709$EXP$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000410$PAREXEL$$$$$$Y$$$20240709$$PH$US$US
239521947$23952194$7$F$$20240916$20240607$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091875$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240918$$CN$US$US
239521972$23952197$2$F$$20240905$20240607$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-092441$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240905$$MD$JP$JP
239522063$23952206$3$F$20240501$20240808$20240607$20240809$EXP$$TH-BAYER-2024A078571$BAYER$$62$YR$A$M$Y$$$20240809$$CN$TH$TH
239522193$23952219$3$F$20240301$20240711$20240607$20240715$EXP$$ES-PFIZER INC-202400076870$PFIZER$$47$YR$$F$Y$$$20240715$$MD$ES$ES
239522422$23952242$2$F$$20240628$20240607$20240705$PER$$US-ALXN-202405USA000853US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240705$$HP$US$US
239522453$23952245$3$F$20240101$20240829$20240607$20240906$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-024749$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$$$20240906$$CN$US$US
239522472$23952247$2$F$20240501$20240829$20240607$20240916$EXP$$US-SA-2024SA169770$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240916$$MD$US$US
239522483$23952248$3$F$20240101$20240819$20240607$20240828$PER$$US-SA-2024SA166912$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240828$$MD$US$US
239522702$23952270$2$F$20220101$20240906$20240607$20240924$EXP$$US-SA-2024SA171426$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240924$$MD$US$US
239522885$23952288$5$F$20240524$20240806$20240607$20240816$EXP$FR-AFSSAPS-LL2024001022$FR-BEH-2024173271$CSL BEHRING$$71$YR$E$F$Y$77$KG$20240816$$MD$FR$FR
239522913$23952291$3$F$$20240701$20240607$20240703$EXP$$JP-ABBVIE-4143568$ABBVIE$Shirakura D, Kunisaki R, Kurimura K, Haruyama S, Nakamori Y, Matsubayashi M, et al. O9-2 A case of neonatal cerebellar hemorrhage believed to be caused by vitamin K malabsorption attributable to the short bowel syndrome of the mother with Crohn^s disease. The 14th Annual Meeting of Japanese Society for Inflammatory Bowel Disease. 2023;139.; Shirakura D, Kunisaki R, Kurimura K, et al. O9-2 A case of Cerebellar haemorrhage neonatal thought to be caused by impaired vitamin K absorption due to th...$35$YR$$F$Y$49$KG$20240703$$MD$JP$JP
239522982$23952298$2$F$$20240913$20240607$20240916$EXP$$NVSC2024CA118371$NOVARTIS$$$$$F$Y$$$20240916$$MD$CA$CA
239523002$23952300$2$F$20240521$20240727$20240607$20240802$EXP$GB-MHRA-MED-202405311106380720-SRNGH$GB-TEVA-VS-3206206$TEVA$$$$$M$Y$$$20240802$$HP$GB$GB
239523224$23952322$4$F$20240507$20240718$20240607$20240731$EXP$$CA-BIOGEN-2024BI01267262$BIOGEN$$18$YR$$M$Y$$$20240731$$MD$CA$CA
239523302$23952330$2$F$$20240521$20240607$20240717$PER$$US-INCYTE CORPORATION-2024IN005430$INCYTE$$$$$$Y$$$20240717$$CN$US$US
239523333$23952333$3$F$20240529$20240906$20240607$20240913$EXP$$JP-009507513-2406JPN000144J$MERCK$$67$YR$$F$Y$$$20240913$$MD$JP$JP
239523783$23952378$3$F$$20240802$20240607$20240819$PER$$US-Calliditas-2024CAL00895$CALLIDITAS THERAPEUTICS$$25$YR$A$M$Y$90.7$KG$20240819$$CN$US$US
239523886$23952388$6$F$20230609$20240725$20240607$20240730$EXP$$CN-PFIZER INC-2023SGN09273$PFIZER$$30$YR$$M$Y$75$KG$20240730$$MD$CN$CN
239524098$23952409$8$F$20240301$20240905$20240607$20240913$EXP$$JP-APELLIS-2024-APL-0000039$APELLIS PHARMACEUTICALS$$$$$$Y$58$KG$20240913$$CN$JP$JP
239524102$23952410$2$F$20240101$20240917$20240607$20240927$EXP$$CN-ABBVIE-5780604$ABBVIE$$$$$$Y$$$20240927$$CN$CN$CN
239524122$23952412$2$F$$20240708$20240607$20240719$PER$$US-RADIUS HEALTH, INC.-2024US003880$RADIUS PHARM$$$$$F$Y$$$20240719$$MD$US$US
239524132$23952413$2$F$$20240708$20240607$20240718$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006005$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239524157$23952415$7$F$$20240926$20240607$20240926$30DAY$$US-PFIZER INC-202400181708$PFIZER$$7$YR$$F$Y$$$20240926$$CN$US$US
239524195$23952419$5$F$$20240925$20240607$20240930$30DAY$$US-PFIZER INC-202400185751$PFIZER$$11$YR$$M$Y$$$20240930$$MD$US$US
239524203$23952420$3$F$$20240830$20240607$20240903$30DAY$$GB-PFIZER INC-202400179282$PFIZER$$5$YR$$F$Y$$$20240903$$CN$GB$GB
239524213$23952421$3$F$$20240926$20240607$20240930$30DAY$$US-PFIZER INC-202400185871$PFIZER$$9$YR$$M$Y$24.036$KG$20240930$$HP$US$US
239524254$23952425$4$F$$20240911$20240607$20240913$30DAY$$DE-PFIZER INC-202400185132$PFIZER$$$$$F$Y$$$20240913$$PH$DE$DE
239524264$23952426$4$F$20240531$20240920$20240607$20240926$30DAY$$US-PFIZER INC-202400184269$PFIZER$$11$YR$$M$Y$$$20240926$$CN$US$US
239524324$23952432$4$F$20240531$20240925$20240607$20240930$30DAY$$US-PFIZER INC-202400185766$PFIZER$$12$YR$$F$Y$52.62$KG$20240930$$CN$US$US
239524422$23952442$2$F$20240604$20240905$20240607$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092320$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240911$$CN$US$US
239524522$23952452$2$F$$20240719$20240607$20240725$PER$$US-ALXN-202405USA002279US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239524542$23952454$2$F$$20240806$20240607$20240918$PER$$US-LUNDBECK-DKLU3077671$LUNDBECK$$$$$$Y$$$20240918$$HP$US$US
239524672$23952467$2$F$20240731$20240819$20240607$20240829$PER$$US-SA-2024SA164758$SANOFI AVENTIS$$2$YR$C$M$Y$14$KG$20240829$$MD$US$US
239524682$23952468$2$F$20240501$20240723$20240607$20240801$PER$$US-SA-2024SA165705$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240801$$MD$US$US
239524692$23952469$2$F$20240710$20240729$20240607$20240806$EXP$$US-SA-2024SA170070$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240806$$MD$US$US
239524713$23952471$3$F$$20240625$20240607$20240709$PER$$US-SA-2024SA165282$SANOFI AVENTIS$$$$E$F$Y$63$KG$20240709$$MD$US$US
239524862$23952486$2$F$$20240711$20240607$20240719$EXP$$CA-TEVA-VS-3204800$TEVA$$5$DEC$$F$Y$$$20240719$$HP$CA$CA
239524902$23952490$2$F$20240401$20240704$20240607$20240705$EXP$$BR-BEIGENE-BGN-2024-008745$BEIGENE$$$$$$Y$$$20240705$$MD$BR$BR
239524912$23952491$2$F$$20240905$20240607$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-092224$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240905$$MD$JP$JP
239524922$23952492$2$F$$20240906$20240607$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092617$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240906$$MD$US$US
239524952$23952495$2$F$$20240702$20240607$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092662$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240704$$CN$US$US
239525022$23952502$2$F$20240220$20240612$20240607$20240802$PER$$US-LUNDBECK-DKLU3077779$LUNDBECK$$$$$$Y$$$20240802$$HP$US$US
239525042$23952504$2$F$$20240628$20240607$20240702$EXP$$JP-ABBVIE-5791956$ABBVIE$$70$YR$$M$Y$$$20240702$$MD$JP$JP
239525153$23952515$3$F$20240531$20240705$20240607$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092418$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240716$$PH$US$US
239525212$23952521$2$F$$20240722$20240607$20240801$EXP$$CA-TEVA-VS-3205798$TEVA$$41$YR$$F$Y$$$20240801$$CN$CA$CA
239525353$23952535$3$F$$20240712$20240607$20240712$EXP$$NZ-ALXN-202405OCE002054NZ$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240712$$MD$NZ$NZ
239525402$23952540$2$F$20240529$20240628$20240607$20240709$EXP$$US-APELLIS-2024-APL-0000227$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240709$$HP$US$US
239525432$23952543$2$F$$20240715$20240607$20240721$EXP$$US-MYLANLABS-2024M1050597$MYLAN$$$$$F$Y$40.82$KG$20240719$$MD$US$US
239525713$23952571$3$F$$20240821$20240607$20240904$PER$$US-Calliditas-2024CAL00893$CALLIDITAS THERAPEUTICS$$47$YR$A$F$Y$68$KG$20240904$$MD$US$US
239525812$23952581$2$F$20231001$20240729$20240607$20240807$EXP$$CA-Amarin Pharma, Inc-2024AMR000275$AMARIN$$62$YR$A$M$Y$$$20240807$$CN$CA$CA
239525832$23952583$2$F$20240101$20240605$20240607$20240902$EXP$$PL-GENMAB-2024-01993$GENMAB$$84$YR$$M$Y$$$20240902$$MD$PL$PL
239525842$23952584$2$F$20240101$20240719$20240607$20240726$EXP$$CA-Amarin Pharma, Inc-2024AMR000285$AMARIN$$87$YR$E$F$Y$$$20240726$$CN$CA$CA
239525952$23952595$2$F$20240410$20240808$20240607$20240812$EXP$GB-MHRA-MED-202404121507429560-DWFJM$GB-MYLANLABS-2024M1034246$MYLAN$$37$YR$$F$Y$57$KG$20240812$$CN$GB$GB
239525972$23952597$2$F$20240226$20240715$20240607$20240724$PER$$US-APELLIS-APL-2024-003933$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
239526093$23952609$3$F$20240401$20240923$20240607$20240927$EXP$$GR-PFIZER INC-202400185061$PFIZER$$91$YR$$F$Y$67$KG$20240927$$MD$GR$GR
239526113$23952611$3$F$20170628$20240807$20240607$20240814$EXP$$CA-PFIZER INC-202400008212$PFIZER$$28$YR$$F$Y$42$KG$20240814$$HP$CA$CA
239526122$23952612$2$F$20240508$20240731$20240607$20240805$EXP$$IL-PFIZER INC-PV202400073867$PFIZER$$77$YR$$F$Y$67.2$KG$20240805$$HP$IL$IL
239526154$23952615$4$F$20230601$20240911$20240607$20240912$30DAY$$AR-PFIZER INC-202400185460$PFIZER$$10$YR$$F$Y$$$20240912$$CN$AR$AR
239526163$23952616$3$F$$20240826$20240607$20240828$30DAY$$US-PFIZER INC-202400175929$PFIZER$$59$YR$$F$Y$$$20240828$$HP$US$US
239526203$23952620$3$F$20240501$20240730$20240607$20240814$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0234$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240813$$MD$US$US
239526223$23952622$3$F$20240219$20240724$20240607$20240801$EXP$$JP-APELLIS-APL-2024-004236$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$JP$JP
239526422$23952642$2$F$$20240911$20240607$20240912$EXP$$JP-009507513-2406JPN000447J$MERCK$Toeda M, Morita K, Yamaguchi S, Itoda K, Shimizu Y, Hayasi N, et al.. 17 A case of encephalopathy during combination therapy with lenvatinib mesylate and pembrolizumab for recurrent uterine cancer. The Joint meeting of the 409th Regular Meeting of Tokyo Society of Obstetrics an$$$$F$Y$$$20240912$$MD$JP$JP
239526497$23952649$7$F$$20240920$20240607$20240923$EXP$$NVSC2024US118410$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
239526514$23952651$4$F$20240417$20240722$20240607$20240724$EXP$$UM-ROCHE-3578459$ROCHE$$48$YR$A$F$Y$98.4$KG$20240724$$PH$UM$US
239526582$23952658$2$F$$20240702$20240607$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089265$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240703$$CN$US$US
239526642$23952664$2$F$$20240829$20240607$20240912$PER$$US-Calliditas-2024CAL00897$CALLIDITAS THERAPEUTICS$$33$YR$A$M$Y$80.7$KG$20240912$$CN$US$US
239526662$23952666$2$F$20230425$20240712$20240607$20240717$EXP$FR-AFSSAPS-CN2024000312$FR-009507513-2406FRA000430$MERCK$$45$YR$$F$Y$119$KG$20240717$$MD$FR$FR
239526673$23952667$3$F$$20240913$20240607$20240919$30DAY$$US-PFIZER INC-PV202400068304$PFIZER$$15$YR$$M$Y$$$20240919$$MD$US$US
239526683$23952668$3$F$20240503$20240731$20240607$20240731$EXP$$US-PFIZER INC-202400188147$PFIZER$$$$A$F$Y$$$20240731$$CN$US$US
239526693$23952669$3$F$$20240916$20240607$20240919$30DAY$$US-PFIZER INC-PV202400065711$PFIZER$$14$YR$$M$Y$$$20240919$$HP$US$US
239526704$23952670$4$F$$20240910$20240607$20240913$30DAY$$US-PFIZER INC-202400185828$PFIZER$$19$YR$$M$Y$$$20240913$$CN$US$US
239526723$23952672$3$F$$20240913$20240607$20240919$30DAY$$PR-PFIZER INC-202400175871$PFIZER$$13$YR$$M$Y$40.37$KG$20240919$$CN$US$US
239526732$23952673$2$F$$20240710$20240607$20240710$30DAY$$US-PFIZER INC-PV202300131283$PFIZER$$15$YR$$M$Y$$$20240710$$CN$US$US
239526746$23952674$6$F$$20240831$20240607$20240904$30DAY$$US-PFIZER INC-202400185889$PFIZER$$15$YR$$M$Y$$$20240904$$CN$US$US
239526796$23952679$6$F$$20240722$20240607$20240725$30DAY$$US-PFIZER INC-202400185569$PFIZER$$14$YR$$M$Y$61.6$KG$20240725$$MD$US$US
239526842$23952684$2$F$$20240923$20240607$20240925$EXP$$NVSC2024US119237$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
239526933$23952693$3$F$20240516$20240711$20240607$20240819$EXP$$IL-Taiho Oncology Inc-2024-004723$TAIHO ONCOLOGY INC$$31$YR$A$M$Y$$$20240819$$CN$IL$IL
239526953$23952695$3$F$20210201$20240710$20240607$20240719$EXP$PT-INFARMED-J202405-505$PT-GUERBET / LLC-PT-20240011$GUERBET$$64$YR$A$M$Y$$$20240719$$MD$PT$PT
239526982$23952698$2$F$$20240712$20240607$20240716$EXP$$IE-PFIZER INC-PV202400075144$PFIZER$Isa, N.. Rheumatology Module 364 Clinical focus: Psoriatic disease management. Hospital Doctor of Ireland. 2024;30:23-28$33$YR$$F$Y$$$20240716$$MD$IE$IE
239527034$23952703$4$F$20240517$20240701$20240607$20240703$EXP$$PL-PFIZER INC-PV202400075091$PFIZER$$85$YR$$M$Y$180$KG$20240703$$MD$PL$PL
239527104$23952710$4$F$20220427$20240627$20240607$20240703$EXP$$KR-PFIZER INC-PV202400074154$PFIZER$$23$YR$$F$Y$45.4$KG$20240703$$MD$KR$KR
239527193$23952719$3$F$$20240713$20240607$20240715$30DAY$$US-PFIZER INC-202400185830$PFIZER$$56$YR$$M$Y$$$20240715$$CN$US$US
239527223$23952722$3$F$$20240726$20240607$20240730$EXP$$US-PFIZER INC-202400188017$PFIZER$$64$YR$$F$Y$$$20240730$$HP$US$US
239527245$23952724$5$F$20240401$20240708$20240607$20240712$EXP$$FR-AstraZeneca-2024A128913$ASTRAZENECA$$509$MON$$F$Y$50$KG$20240713$$MD$FR$
239527273$23952727$3$F$$20240830$20240607$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091054$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240906$$CN$US$US
239527453$23952745$3$F$20240529$20240726$20240607$20240802$PER$$US-ALXN-202405USA002292US$ALEXION PHARMACEUTICALS$$71$YR$$M$Y$$$20240802$$CN$US$US
239527472$23952747$2$F$$20240807$20240607$20240808$EXP$$US-ALXN-A202309753$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240808$$CN$US$US
239527582$23952758$2$F$20240514$20240718$20240607$20240806$PER$$US-GE HEALTHCARE-2024CSU005525$GE HEALTHCARE$$45$YR$$F$Y$$$20240806$$MD$US$US
239527723$23952772$3$F$$20240813$20240607$20240828$EXP$$CA-HLS-202401456$HLS THERAPEUTICS$$$$A$M$Y$$$20240828$$PH$CA$CA
239527834$23952783$4$F$20240503$20240624$20240607$20240723$PER$$US-APELLIS-2024-APL-0000095$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240723$$HP$US$US
239528192$23952819$2$F$20240515$20240621$20240607$20240702$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00865$AIMMUNE$$$$$$Y$$$20240702$$HP$US$US
239528202$23952820$2$F$$20240528$20240607$20240722$PER$$US-009507513-2405USA009616$MERCK$Louis-Gray K, Khanna S, Camelo-Piragua S, Capizzano AA, Trobe JD, Robertson PL, et al.. A Teenage Boy With a Radiation-Induced High-Grade Astrocytoma. Journal of Neuro-Ophthalmology. 2024;44(44):280-4$17$YR$$M$Y$$$20240722$$MD$US$US
239528282$23952828$2$F$20200207$20240829$20240607$20240903$EXP$$US-ALXN-202405GLO002122US$ALEXION PHARMACEUTICALS$$45$YR$$M$Y$$$20240903$$MD$US$US
239528302$23952830$2$F$$20240705$20240607$20240709$PER$$US-AstraZeneca-2024A130694$ASTRAZENECA$$$$$F$Y$$$20240709$$MD$US$
239528313$23952831$3$F$$20240719$20240607$20240827$PER$$US-AstraZeneca-2024A120880$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
239528333$23952833$3$F$$20240625$20240607$20240722$EXP$$JP-AstraZeneca-2024A129673$ASTRAZENECA$$82$YR$$F$Y$50$KG$20240722$$MD$JP$
239528342$23952834$2$F$20240428$20240730$20240607$20240812$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI05536$NEUROCRINE BIOSCIENCES$$58$YR$$F$Y$$$20240812$$MD$JP$JP
239528472$23952847$2$F$$20240726$20240607$20240802$EXP$$JP-ROCHE-3576946$ROCHE$$8$DEC$E$$Y$$$20240803$$MD$JP$JP
239528672$23952867$2$F$20240201$20240620$20240607$20240702$EXP$$PK-ROCHE-3578560$ROCHE$$27$YR$A$F$Y$$$20240702$$CN$PK$PK
239528772$23952877$2$F$20240101$20240905$20240607$20240912$PER$$US-ABBVIE-5787434$ABBVIE$$$$$F$Y$79$KG$20240912$$MD$US$US
239528932$23952893$2$F$$20240729$20240607$20240731$PER$$US-ALXN-202405USA002331US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
239528942$23952894$2$F$20240101$20240829$20240607$20240911$PER$$US-SA-2024SA168801$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240911$$HP$US$US
239529062$23952906$2$F$20240328$20240627$20240607$20240710$EXP$$FR-ALXN-202406EEA000212FR$ALEXION PHARMACEUTICALS$$70$YR$$F$Y$59$KG$20240710$$MD$FR$FR
239529073$23952907$3$F$20231001$20240730$20240607$20240806$EXP$$US-ABBVIE-5789347$ABBVIE$$76$YR$$M$Y$$$20240806$$CN$US$US
239529132$23952913$2$F$20240101$20240731$20240607$20240805$EXP$$US-ABBVIE-5787620$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
239529192$23952919$2$F$$20240814$20240607$20240828$PER$$US-SA-2024SA168755$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
239529272$23952927$2$F$$20240618$20240608$20240711$EXP$$ZA-ABBVIE-5791933$ABBVIE$$79$YR$$M$Y$$$20240711$$CN$ZA$ZA
239529373$23952937$3$F$$20240826$20240608$20240903$EXP$$US-ABBVIE-5785580$ABBVIE$$$$$F$Y$98$KG$20240903$$CN$US$US
239529382$23952938$2$F$20240513$20240913$20240608$20240917$EXP$$NVSC2024GB093463$NOVARTIS$$35$YR$$F$Y$$$20240918$$CN$GB$GB
239529512$23952951$2$F$$20240713$20240608$20240725$EXP$$CN-ROCHE-3575982$ROCHE$Chen F, Niu J, Wang M, Zhu H and Guo Z. The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy. Doi:10.1186/s13014-024-02458-x. Radiation oncology (London, England) 2024 May 30;19 (1):67-.$$$$$Y$$$20240725$$HP$CN$CN
239529702$23952970$2$F$$20240909$20240608$20240922$EXP$$CA-UCBSA-2023057176$UCB$$$$$F$Y$$$20240922$$CN$CA$CA
239529772$23952977$2$F$20240422$20240709$20240608$20240711$EXP$$US-UCBSA-2024027926$UCB$$39$YR$$F$Y$149$KG$20240711$$HP$US$US
239529902$23952990$2$F$20240301$20240801$20240608$20240802$EXP$$FR-ALXN-202406EEA000201FR$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240802$$PH$FR$FR
239529976$23952997$6$F$20240509$20240916$20240608$20240921$EXP$$IT-ROCHE-3577753$ROCHE$$46$YR$A$M$Y$74$KG$20240921$$HP$IT$IT
239529983$23952998$3$F$20240516$20240805$20240608$20240809$EXP$$CA-ROCHE-3575938$ROCHE$$78$YR$E$M$Y$67$KG$20240809$$HP$CA$CA
239530012$23953001$2$F$20240301$20240709$20240608$20240717$EXP$$BR-CELLTRION INC.-2024BR013449$CELLTRION$$$$$$Y$$$20240717$$CN$BR$BR
239530022$23953002$2$F$20240523$20240705$20240608$20240715$EXP$$BR-CELLTRION INC.-2024BR013473$CELLTRION$$$$$$Y$$$20240715$$CN$BR$BR
239530123$23953012$3$F$20240101$20240809$20240608$20240812$EXP$$US-UCBSA-2024019972$UCB$$$$$F$Y$$$20240812$$CN$US$US
239530153$23953015$3$F$$20240712$20240608$20240712$EXP$$NZ-ALXN-202405OCE002055NZ$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240712$$MD$NZ$NZ
239530392$23953039$2$F$20231102$20240701$20240608$20240710$PER$$US-SA-2024SA168174$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240710$$MD$US$US
239530475$23953047$5$F$$20240729$20240608$20240731$EXP$$CA-ROCHE-3311577$ROCHE$$39$YR$A$F$Y$87.54$KG$20240731$$HP$CA$CA
239530482$23953048$2$F$$20240709$20240608$20240716$PER$$US-AstraZeneca-2024A132812$ASTRAZENECA$$60$YR$$F$Y$$$20240716$$MD$US$
239530552$23953055$2$F$$20240625$20240608$20240704$PER$$US-SA-2024SA168555$SANOFI AVENTIS$$$$C$M$Y$$$20240704$$MD$US$US
239530614$23953061$4$F$20240101$20240807$20240608$20240820$EXP$$US-UCBSA-2024027945$UCB$$$$$M$Y$53$KG$20240820$$CN$US$US
239530632$23953063$2$F$$20240814$20240608$20240824$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016746$UNITED THERAPEUTICS$$$$$F$Y$86.168$KG$20240824$$$US$US
239530782$23953078$2$F$20240506$20240620$20240608$20240702$EXP$$PK-ROCHE-3578458$ROCHE$$61$YR$A$M$Y$$$20240702$$CN$PK$PK
239531043$23953104$3$F$$20240718$20240608$20240902$PER$$US-SA-2024SA166211$SANOFI AVENTIS$$60$YR$A$F$Y$59.42$KG$20240902$$MD$US$US
239531072$23953107$2$F$$20240810$20240608$20240820$EXP$$CZ-TEVA-VS-3206221$TEVA$Mocikova H. Treatment of angioimmunoblastic lymphoma with a combination of brentuximab vedotin with cyclophosphamide, doxorubicin and prednisone. FARMAKOTERAPIE. 2024;(Supplementum 6 - Ext 1/2):11-12; Mocikova H. Treatment of angioimmunoblastic lymphoma with a combination of brentuximab vedotin with cyclophosphamide, doxorubicin and prednisone. FARMAKOTERAPIE. 2024;(Supplementum 6 - Ext 1/2):11-12; Literature Reference: Mocikova H. Treatment of angioimmunoblastic lymphoma with a combination o...$71$YR$$M$Y$$$20240820$$HP$CZ$CZ
239531292$23953129$2$F$20220101$20240805$20240608$20240812$EXP$$US-AMGEN-USASP2024108608$AMGEN$$79$YR$E$F$Y$102.31$KG$20240812$$LW$US$US
239531302$23953130$2$F$20240808$20240809$20240608$20240814$PER$$US-AMGEN-USASP2024112354$AMGEN$$66$YR$E$F$Y$$$20240813$$CN$US$US
239531312$23953131$2$F$20210210$20240624$20240608$20240704$EXP$$US-HORIZON THERAPEUTICS-HZN-2021-005740$AMGEN$$66$YR$E$F$Y$$$20240704$$MD$US$US
239531362$23953136$2$F$$20240829$20240608$20240911$EXP$$CA-AUROBINDO-AUR-APL-2024-026732$AUROBINDO$Pirouzmand N, Micieli JA. Optic Disc Restricted Diffusion in Papilledema-Related Anterior Ischemic Optic Neuropathy. The Canadian Journal of Neurological Sciences. 2023;50(3):464-465$48$YR$$M$Y$$$20240911$$MD$CA$CA
239531372$23953137$2$F$20240216$20240708$20240608$20240710$EXP$$DE-ALXN-202405EEA000998DE$ALEXION PHARMACEUTICALS$$36$YR$$M$Y$$$20240710$$MD$DE$DE
239531462$23953146$2$F$20240101$20240719$20240608$20240725$EXP$$US-ABBVIE-5789287$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
239531602$23953160$2$F$$20240716$20240608$20240722$EXP$$US-ABBVIE-5790101$ABBVIE$$$$$M$Y$127$KG$20240722$$CN$US$US
239531622$23953162$2$F$$20240712$20240608$20240716$EXP$$BG-ABBVIE-5790286$ABBVIE$$38$YR$$M$Y$$$20240716$$CN$BG$BG
239531633$23953163$3$F$$20240810$20240608$20240917$EXP$$CZ-TEVA-VS-3206313$TEVA$Jan?kov? A. ALCL treatment in an elderly patient with comorbidities. FARMAKOTERAPIE. 2024;(Supplementum 6 - Ext 1/2):9-10; Jan?kov? A. ALCL treatment in an elderly patient with comorbidities. FARMAKOTERAPIE. 2024;(Supplementum 6 - Ext 1/2):9-10; Jan?kov? A. ALCL treatment in an elderly patient with comorbidities. FARMAKOTERAPIE. 2024;(Supplementum 6 - Ext 1/2):9-10$85$YR$$M$Y$$$20240917$$MD$CZ$CZ
239531772$23953177$2$F$$20240703$20240608$20240708$PER$$US-ABBVIE-5785128$ABBVIE$$$$$F$Y$58$KG$20240708$$CN$US$US
239531812$23953181$2$F$$20240717$20240608$20240726$EXP$$US-AMGEN-USASP2024109588$AMGEN$$$$$F$Y$$$20240726$$LW$US$US
239531982$23953198$2$F$$20240805$20240608$20240816$EXP$$PT-AUROBINDO-AUR-APL-2024-026722$AUROBINDO$Gaspar C, Greenfield H, Carneiro L.. DONEPEZIL AS A CAUSE OF CARDIOGENIC SYNCOPE - ELDERLY HEAVEN OR HELL.. European Journal of Case Reports in Internal Medicine.. 2019;6 (Suppl. 1):116-7$80$YR$$F$Y$$$20240816$$MD$PT$PT
239532003$23953200$3$F$$20240810$20240608$20240822$EXP$$CZ-TEVA-VS-3206454$TEVA$Mocikova H. Treatment of peripheral T-cell lymphoma with hemophagocytic lymphohistiocytosis. FARMAKOTERAPIE. 2024;(Supplementum 6 - Ext 1/2):13-14; Mocikova H. Treatment of peripheral T-cell lymphoma with hemophagocytic lymphohistiocytosis. FARMAKOTERAPIE. 2024;(Supplementum 6 - Ext 1/2):13-14; Literature Reference:  Mocikova H. Treatment of peripheral T-cell lymphoma with hemophagocytic lymphohistiocytosis. FARMAKOTERAPIE. 2024;(Supplementum 6 - Ext 1/2):13-14; Literature Reference:  Mocikov...$41$YR$$F$Y$$$20240822$$MD$CZ$CZ
239532023$23953202$3$F$$20240729$20240608$20240731$PER$$US-ALXN-202405USA002310US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239532075$23953207$5$F$20240528$20240822$20240608$20240828$EXP$$JP-AMGEN-JPNSP2024106954$AMGEN$$$$A$$Y$$$20240828$$MD$JP$JP
239532182$23953218$2$F$$20240729$20240608$20240731$PER$$US-ALXN-202405USA002323US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
239532262$23953226$2$F$20240605$20240807$20240608$20240814$PER$$US-ABBVIE-5791907$ABBVIE$$37$YR$$F$Y$72$KG$20240814$$HP$US$US
239532293$23953229$3$F$$20240628$20240608$20240716$EXP$$US-ROCHE-3576277$ROCHE$$34$YR$A$M$Y$103$KG$20240716$$CN$US$US
239532343$23953234$3$F$20240401$20240712$20240608$20240712$EXP$$BR-ALXN-202405SAM002281BR$ALEXION PHARMACEUTICALS$$15$YR$$F$Y$55$KG$20240712$$MD$BR$BR
239532372$23953237$2$F$$20240807$20240608$20240809$EXP$$NVSC2024US119716$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
239532402$23953240$2$F$$20240706$20240608$20240717$EXP$$PT-AUROBINDO-AUR-APL-2024-026757$AUROBINDO$Rodrigues AI, Fernandes RM, Sousa D, Calderon H, Granja C.. ADDISONIAN CRISIS - A RARE DISEASE ENTITY. European Journal of Case Reports in Internal Medicine. 2019;6:274-275 abstr. 1422.$40$YR$$M$Y$$$20240717$$HP$PT$PT
239532552$23953255$2$F$$20240528$20240608$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-027503$AUROBINDO$He M, Bordern S, Profozich E, Jeong D, Gillespie A. A UNIQUE CASE OF POSTERIOR REVERSIBLE ENCEPHALOPATHYSYNDROME (PRES) IN AN ESKD PATIENT. Am-J-Kidney-Dis. 2024;83 (Suppl. 2)(4:S23$56$YR$$M$Y$$$20240802$$HP$US$US
239532613$23953261$3$F$$20240806$20240608$20240809$EXP$$US-ABBVIE-5787993$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
239532664$23953266$4$F$20240531$20240816$20240608$20240822$EXP$$FR-ABBVIE-5790831$ABBVIE$$68$YR$$M$Y$$$20240822$$HP$FR$FR
239532752$23953275$2$F$20240401$20240620$20240608$20240702$EXP$$PK-ROCHE-3578611$ROCHE$$38$YR$A$F$Y$$$20240702$$CN$PK$PK
239532772$23953277$2$F$$20240708$20240608$20240711$PER$$US-AstraZeneca-2024A131729$ASTRAZENECA$$$$$$Y$$$20240711$$MD$US$
239532792$23953279$2$F$$20240719$20240608$20240725$PER$$US-ALXN-202405USA002287US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239532802$23953280$2$F$$20240807$20240608$20240808$PER$$US-ALXN-202405USA002284US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
239532832$23953283$2$F$20230117$20240723$20240608$20240731$EXP$$JP-ROCHE-3578582$ROCHE$Hashimura H, Mori K, Kinoshita K, Morino K, Yoshimi K, Matoba K et al. A case of unresectable hepatocellular carcinoma in which polymyalgia rheumatica as an immune-related adverse event was caused by atezolizmab and an antitumour effect was maintained even after the interruption of the drug.. The 60th Annual Meeting of the Japan Society of Hepatology / Kanzo 2024;65 (S1):A509-.$7$DEC$E$M$Y$64$KG$20240731$$MD$JP$JP
239532852$23953285$2$F$20240517$20240729$20240608$20240802$EXP$$US-ABBVIE-5788787$ABBVIE$$81$YR$$M$Y$$$20240802$$CN$US$US
239532952$23953295$2$F$20230828$20240712$20240608$20240715$EXP$ES-AEMPS-1528490$ES-ROCHE-3576941$ROCHE$$72$YR$E$F$Y$$$20240715$$MD$ES$ES
239532972$23953297$2$F$$20240701$20240608$20240712$EXP$$PL-AUROBINDO-AUR-APL-2024-026535$AUROBINDO$Tomasz Pychy?skiABC, Aleksandra Bereza-AndrzejewskaBCDE, Joanna Mil?y?skaBC, Wojciech Pychy?ski. Lemierre^s syndrome - case report.(Zesp?? Lemierre?a ? opis przypadku). POL OTORHINO REV.. 2024;13(1):48-53$44$YR$$M$Y$$$20240712$$HP$PL$PL
239533182$23953318$2$F$$20230921$20240608$20240813$PER$$US-SPECGX-T202301928$SPECGX$$$$$$Y$$$20240813$$CN$US$US
239533322$23953332$2$F$20240101$20240305$20240608$20240814$PER$$US-SPECGX-T202400720$SPECGX$$$$$M$Y$$$20240814$$PH$US$US
239533512$23953351$2$F$$20230803$20240608$20240814$EXP$$US-SPECGX-T202301668$SPECGX$$$$$M$Y$$$20240814$$CN$US$US
239533612$23953361$2$F$$20240711$20240608$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004342$JAZZ$$$$$F$Y$$$20240717$$CN$US$US
239533646$23953364$6$F$20240101$20240904$20240608$20240913$EXP$$CA-CELLTRION INC.-2024CA005316$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
239533652$23953365$2$F$20240429$20240716$20240608$20240725$EXP$$US-ABBVIE-5789285$ABBVIE$$77$YR$$F$Y$67$KG$20240725$$CN$US$US
239533664$23953366$4$F$20190101$20240823$20240608$20240902$EXP$$CA-ROCHE-2991139$ROCHE$$45$YR$A$M$Y$105$KG$20240902$$HP$CA$CA
239533673$23953367$3$F$20240501$20240801$20240608$20240805$PER$$US-AMGEN-USASP2024111115$AMGEN$$58$YR$A$F$Y$$$20240804$$CN$US$US
239533712$23953371$2$F$$20240723$20240608$20240731$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008759$JAZZ$$$$$F$Y$$$20240731$$MD$US$US
239533772$23953377$2$F$20230101$20240801$20240608$20240806$EXP$$US-SA-2024SA169431$SANOFI AVENTIS$$69$YR$E$M$Y$56.6$KG$20240806$$MD$US$US
239533793$23953379$3$F$20240101$20240820$20240608$20240828$EXP$$CA-CELLTRION INC.-2024CA013553$CELLTRION$$$$$$Y$$$20240828$$CN$CA$CA
239533862$23953386$2$F$$20240719$20240608$20240725$PER$$US-ALXN-202405USA002275US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239533892$23953389$2$F$20211109$20240725$20240608$20240729$EXP$$US-UCBSA-2024027385$UCB$$56$YR$$F$Y$171.97$KG$20240729$$HP$US$US
239533993$23953399$3$F$$20240625$20240608$20240703$PER$$US-ALXN-202405USA002311US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240703$$CN$US$US
239534042$23953404$2$F$20240604$20240809$20240608$20240812$EXP$$NVSC2024US119141$NOVARTIS$$$$$M$Y$$$20240812$$HP$US$US
239534144$23953414$4$F$20240408$20240703$20240608$20240726$EXP$$AU-ABBVIE-5789719$ABBVIE$$31$YR$$F$Y$$$20240726$$HP$AU$AU
239534172$23953417$2$F$$20240706$20240608$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-026747$AUROBINDO$Morgan A, Villalobos E, Kapoor S, Ramanan R, Shutter L. HYDROXOCOBALAMIN AS A RESCUE THERAPYFOR NIMODIPINE-INDUCED SEVERE REFRACTORYVASOPLEGIA. CritCare-Med. 2024;52 (Suppl.1):S260$59$YR$$F$Y$$$20240717$$HP$US$US
239534212$23953421$2$F$20220714$20240717$20240608$20240725$EXP$$US-AMGEN-USASP2024109790$AMGEN$$73$YR$E$M$Y$$$20240725$$LW$US$US
239534292$23953429$2$F$$20240706$20240608$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-027064$AUROBINDO$Mittal A, Ramos TI. UNVEILING A RARE CASE OF FINGOLIMODRELATED CRYPTOCOCCAL MENINGITIS IN A MULTIPLE SCLEROSIS PATIENT. Critical Care Medicine. 2024;52 (Suppl.)(1):S231$25$YR$$F$Y$$$20240717$$HP$US$US
239534312$23953431$2$F$20240301$20240710$20240608$20240801$PER$$US-SA-2024SA169082$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240719$$MD$US$US
239534332$23953433$2$F$$20240625$20240608$20240710$EXP$$MY-ROCHE-3577403$ROCHE$$$$A$$Y$$$20240710$$MD$MY$MY
239534412$23953441$2$F$$20240719$20240608$20240725$PER$$US-ALXN-202405USA002229US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239534442$23953444$2$F$$20240706$20240608$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-027473$AUROBINDO$Nguyen T, Ewing E, Gajarla S, Sanchez AU, Badalamenti J, Kochar T.. A CASE REPORT OF POSTPARTUM-ONSET CRESCENTIC GLOMERULONEPHRITIS IN THE SETTING OF COVID-19 INFECTION.. Am-J-Kidney-Dis. 2024;83 (Suppl. 2)(4:S113$23$YR$$F$Y$$$20240717$$HP$US$US
239534512$23953451$2$F$20240505$20240620$20240608$20240703$EXP$$PK-ROCHE-3578391$ROCHE$$64$YR$A$F$Y$$$20240703$$CN$PK$PK
239534602$23953460$2$F$$20240719$20240608$20240725$PER$$US-ALXN-202405USA002237US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239534712$23953471$2$F$$20240724$20240608$20240730$PER$$US-ALXN-202405USA002304US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
239534784$23953478$4$F$$20240816$20240608$20240822$EXP$$US-ABBVIE-5788666$ABBVIE$$$$$M$Y$102$KG$20240822$$CN$US$US
239534872$23953487$2$F$$20240712$20240608$20240718$EXP$$AU-AMGEN-AUSSP2024108993$AMGEN$$$$$M$Y$$$20240717$$MD$AU$AU
239534893$23953489$3$F$20210518$20240904$20240608$20240913$EXP$$JP-ROCHE-3553530$ROCHE$$77$YR$E$M$Y$61$KG$20240913$$MD$JP$JP
239534924$23953492$4$F$20231218$20240910$20240608$20240930$PER$$US-SA-2024SA167247$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240930$$MD$US$US
239534952$23953495$2$F$$20240719$20240608$20240725$PER$$US-ALXN-202405USA002254US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239535032$23953503$2$F$20231004$20240627$20240608$20240705$EXP$$JP-UNITED THERAPEUTICS-UNT-2023-029979$UNITED THERAPEUTICS$$49$YR$$M$Y$$$20240705$$$JP$JP
239535214$23953521$4$F$$20240701$20240608$20240710$EXP$$CN-AUROBINDO-AUR-APL-2024-026691$AUROBINDO$Yan Q, Fu M, Zhou X.. Sildenafil-induced bilateral ciliochoroidal effusion syndrome: Case report.. European journal of ophthalmology.. 2024;120672124125440$41$YR$$M$Y$$$20240710$$MD$CN$CN
239535267$23953526$7$F$20240419$20240627$20240608$20240813$EXP$$NVSC2024BR089634$NOVARTIS$$62$YR$$F$Y$$$20240813$$CN$BR$BR
239535302$23953530$2$F$20220324$20240823$20240608$20240831$EXP$$US-AMGEN-USASP2024109809$AMGEN$$64$YR$A$F$Y$$$20240831$$LW$US$US
239535364$23953536$4$F$20240101$20240821$20240608$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016700$UNITED THERAPEUTICS$$$$$M$Y$86.168$KG$20240829$$$US$US
239535372$23953537$2$F$$20240703$20240608$20240710$EXP$$JP-AMGEN-JPNSP2024105633$AMGEN$$$$E$F$Y$$$20240709$$MD$JP$JP
239535413$23953541$3$F$20240531$20240705$20240608$20240712$EXP$$KR-UNITED THERAPEUTICS-UNT-2024-017282$UNITED THERAPEUTICS$$61$YR$$F$Y$45$KG$20240712$$$KR$KR
239535643$23953564$3$F$20240101$20240903$20240608$20240917$PER$$US-SA-2024SA166954$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240918$$MD$US$US
239535653$23953565$3$F$$20240916$20240608$20240924$PER$$US-SA-2024SA166935$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240924$$MD$US$US
239535662$23953566$2$F$$20240708$20240608$20240715$PER$$US-SA-2024SA166947$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240715$$MD$US$US
239535672$23953567$2$F$20240101$20240703$20240608$20240708$EXP$$US-ABBVIE-5789301$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
239535792$23953579$2$F$20240521$20240719$20240608$20240725$PER$$US-ALXN-202405USA002286US$ALEXION PHARMACEUTICALS$$48$YR$$F$Y$$$20240719$$CN$US$US
239535842$23953584$2$F$20240531$20240719$20240608$20240725$PER$$US-ALXN-202405USA002289US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239535912$23953591$2$F$$20240709$20240608$20240717$EXP$$US-ALXN-A202306035$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
239535922$23953592$2$F$$20240701$20240608$20240702$PER$$US-JNJFOC-20240616423$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$US$US
239535952$23953595$2$F$$20240729$20240608$20240731$EXP$$CA-ROCHE-3577847$ROCHE$$$$A$F$Y$$$20240731$$CN$CA$CA
239535993$23953599$3$F$20240531$20240701$20240608$20240704$PER$$US-AMGEN-USASP2024110239$AMGEN$$51$YR$A$F$Y$$$20240704$$CN$US$US
239536093$23953609$3$F$20240603$20240807$20240608$20240808$PER$$US-AMGEN-USASP2024112988$AMGEN$$61$YR$A$F$Y$$$20240808$$CN$US$US
239536252$23953625$2$F$20230101$20240917$20240608$20240927$EXP$$JP-UNITED THERAPEUTICS-UNT-2023-023027$UNITED THERAPEUTICS$$48$YR$$F$Y$$$20240927$$$JP$JP
239536292$23953629$2$F$20240506$20240625$20240608$20240702$PER$$US-AMGEN-USASP2024111225$AMGEN$$86$YR$E$M$Y$$$20240701$$HP$US$US
239536312$23953631$2$F$20240101$20240911$20240608$20240923$PER$$US-SA-2024SA167014$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240923$$MD$US$US
239536432$23953643$2$F$20240101$20240822$20240608$20240904$PER$$US-SA-2024SA166029$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240904$$MD$US$US
239536442$23953644$2$F$$20240626$20240608$20240705$PER$$US-SA-2024SA166048$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240705$$MD$US$US
239536472$23953647$2$F$20240426$20240918$20240608$20240920$EXP$$FR-TAKEDA-2024TUS057436$TAKEDA$$60$YR$$F$Y$$$20240920$$HP$FR$FR
239536542$23953654$2$F$20230101$20240703$20240608$20240709$PER$$US-AMGEN-USASP2024112669$AMGEN$$14$YR$T$F$Y$$$20240709$$CN$US$US
239536622$23953662$2$F$20240606$20240816$20240608$20240820$PER$$US-AMGEN-USASP2024113159$AMGEN$$71$YR$E$F$Y$$$20240820$$CN$US$US
239536672$23953667$2$F$20240605$20240712$20240608$20240716$PER$$US-AMGEN-USASP2024113068$AMGEN$$62$YR$A$F$Y$$$20240716$$CN$US$US
239536762$23953676$2$F$20240101$20240705$20240608$20240717$PER$$US-SA-2024SA165296$SANOFI AVENTIS$$100$YR$E$F$Y$$$20240717$$MD$US$US
239536913$23953691$3$F$20240101$20240729$20240608$20240807$PER$$US-SA-2024SA169087$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240807$$MD$US$US
239536983$23953698$3$F$20240301$20240903$20240608$20240910$EXP$$US-ROCHE-3578255$ROCHE$$76$YR$E$M$Y$$$20240910$$MD$US$US
239536992$23953699$2$F$$20240603$20240608$20240709$EXP$$US-ROCHE-3576162$ROCHE$$51$YR$A$F$Y$$$20240628$$CN$US$US
239537004$23953700$4$F$20240308$20240918$20240608$20240930$EXP$$JP-ROCHE-3577871$ROCHE$$72$YR$E$F$Y$51$KG$20240930$$MD$JP$JP
239537184$23953718$4$F$20240513$20240919$20240608$20240923$EXP$$US-SA-2024SA171438$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240923$$MD$US$US
239537192$23953719$2$F$20240101$20240712$20240608$20240717$EXP$$US-SA-2024SA171452$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240717$$MD$US$US
239537252$23953725$2$F$20240101$20240822$20240608$20240916$PER$$US-SA-2024SA169119$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240916$$MD$US$US
239537262$23953726$2$F$20230501$20240705$20240608$20240710$EXP$$NVSC2024US119109$NOVARTIS$$56$YR$$M$Y$59$KG$20240710$$MD$US$US
239537322$23953732$2$F$$20240527$20240609$20240803$EXP$$ES-AUROBINDO-AUR-APL-2024-027428$AUROBINDO$Del Olmo LC, Del Palacio Tamarit M, Medrano MJD, Alonso BR, Leon SB, Moreno MP.. A CASE REPORT ON CAVERNOUS SINUS INFECTIOUS THROMBOPHLEBITIS IN A PATIENT WITH LOCALLYADVANCED OROPHARYNGEAL CANCER.. Eur-J-Case-Rep-Intern-Med. 2019;6 (Suppl. 1):206-207$74$YR$$F$Y$$$20240803$$HP$ES$ES
239537382$23953738$2$F$$20240724$20240609$20240726$PER$$US-UNITED THERAPEUTICS-UNT-2024-016910$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240726$$$US$US
239537472$23953747$2$F$$20240706$20240609$20240717$EXP$$DE-AUROBINDO-AUR-APL-2024-027755$AUROBINDO$Gottschling M, Blaas S, Geismann F, Lerzer C, Malfertheiner M, Salzberger B, et al. Postpartum cryptococcosis in an HIV-negative patient. Infection. 2024;52(2):691-696$20$YR$$F$Y$$$20240717$$HP$DE$DE
239537502$23953750$2$F$$20240706$20240609$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-027795$AUROBINDO$Damia C, Monceaux B, Hall C, Bhamrah P, Koothirezhi R, Liendo C, et al. INITIATION OF METHADONE FOR REFRACTORY RESTLESS LEG SYNDROME WITH SIGNIFICANT IMPROVEMENT OF SYMPTOMS. Sleep. 2024;47 (Suppl. 1):A516-A517$62$YR$$F$Y$$$20240717$$MD$US$US
239537535$23953753$5$F$20240508$20240807$20240609$20240810$EXP$$CA-ROCHE-3523656$ROCHE$$53$YR$A$F$Y$$$20240810$$MD$CA$CA
239537582$23953758$2$F$$20240731$20240609$20240809$PER$$US-SA-2024SA169387$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240809$$MD$US$US
239537642$23953764$2$F$20230101$20240624$20240609$20240703$PER$$US-SA-2024SA169590$SANOFI AVENTIS$$10$YR$C$F$Y$54.43$KG$20240703$$MD$US$US
239537662$23953766$2$F$20240601$20240624$20240609$20240711$30DAY$$US-AMGEN-USASP2024110796$AMGEN$$82$YR$E$M$Y$$$20240710$$HP$US$US
239537712$23953771$2$F$20180501$20240813$20240609$20240814$EXP$$FR-JNJFOC-20240601290$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240814$$MD$FR$FR
239537732$23953773$2$F$20240601$20240722$20240609$20240731$PER$$US-SA-2024SA169109$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240731$$HP$US$US
239537772$23953777$2$F$$20240725$20240609$20240821$PER$$US-AstraZeneca-2024A125443$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
239537972$23953797$2$F$$20240702$20240609$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008582$JAZZ$$$$$M$Y$$$20240708$$MD$US$US
239537992$23953799$2$F$20240101$20240723$20240609$20240731$EXP$$US-SA-2024SA171326$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240731$$MD$US$US
239538112$23953811$2$F$20240531$20240624$20240609$20240703$PER$$US-AstraZeneca-2024A128123$ASTRAZENECA$$17675$DY$$F$Y$$$20240703$$CN$US$
239538122$23953812$2$F$$20240703$20240609$20240716$PER$$US-AstraZeneca-2024A129157$ASTRAZENECA$$75$YR$$M$Y$$$20240716$$CN$US$
239538192$23953819$2$F$20240501$20240708$20240609$20240709$PER$$US-AstraZeneca-2024A129252$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
239538362$23953836$2$F$$20240701$20240609$20240709$PER$$US-SA-2024SA168420$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240709$$CN$US$US
239538444$23953844$4$F$20240528$20240815$20240609$20240824$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024067764$VIIV$$26$YR$$F$Y$107$KG$20240824$$HP$US$US
239538542$23953854$2$F$20240601$20240627$20240609$20240702$PER$$US-JNJFOC-20240614894$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240702$$CN$US$US
239538592$23953859$2$F$20240101$20240904$20240609$20240916$PER$$US-SA-2024SA169317$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240916$$MD$US$US
239538752$23953875$2$F$$20240626$20240609$20240705$PER$$US-SA-2024SA169801$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240705$$MD$US$US
239538802$23953880$2$F$$20240821$20240609$20240829$EXP$$US-ROCHE-3575911$ROCHE$$62$YR$A$F$Y$$$20240829$$HP$US$US
239538812$23953881$2$F$$20240717$20240609$20240718$PER$$US-ALXN-202405USA001492US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$HP$US$US
239538862$23953886$2$F$$20240722$20240609$20240728$PER$$US-AstraZeneca-2024A132163$ASTRAZENECA$$$$$F$Y$$$20240728$$HP$US$
239538912$23953891$2$F$$20240819$20240609$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202406003290$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240821$$CN$US$US
239539082$23953908$2$F$20230830$20240813$20240609$20240819$PER$$US-JNJFOC-20240590183$JOHNSON AND JOHNSON$$68$YR$E$M$Y$104$KG$20240820$$PH$US$US
239539112$23953911$2$F$20240213$20240813$20240609$20240818$PER$$US-JNJFOC-20240590212$JOHNSON AND JOHNSON$$64$YR$A$F$Y$73$KG$20240819$$PH$US$US
239539162$23953916$2$F$20240101$20240625$20240609$20240704$PER$$US-SA-2024SA169579$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240704$$MD$US$US
239539262$23953926$2$F$$20240801$20240609$20240807$30DAY$$AU-SA-2024SA166602$SANOFI AVENTIS$$$$A$$Y$$$20240807$$HP$AU$AU
239539302$23953930$2$F$$20240716$20240609$20240725$PER$$US-AstraZeneca-2024A126747$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
239539322$23953932$2$F$$20240808$20240609$20240821$PER$$US-SA-2024SA169126$SANOFI AVENTIS$$$$A$F$Y$58.957$KG$20240821$$MD$US$US
239539392$23953939$2$F$$20240718$20240609$20240726$30DAY$$US-GSK-US2024AMR068351$GLAXOSMITHKLINE$$$$$M$Y$$$20240726$$CN$US$US
239539512$23953951$2$F$$20240924$20240609$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202406003363$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240925$$CN$US$US
239539702$23953970$2$F$20240520$20240817$20240609$20240831$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-16852$SAMSUNG BIOEPIS$$36$YR$A$M$Y$$$20240831$$CN$CA$CA
239539822$23953982$2$F$$20240623$20240609$20240709$PER$$US-ROCHE-3522166$ROCHE$$$$A$F$Y$$$20240704$$CN$US$US
239539883$23953988$3$F$20240504$20240625$20240609$20240708$PER$$US-ROCHE-3563109$ROCHE$$51$YR$A$F$Y$54.4$KG$20240708$$CN$US$US
239539962$23953996$2$F$20240426$20240723$20240609$20240726$PER$$US-ROCHE-3572325$ROCHE$$55$YR$A$F$Y$$$20240726$$CN$US$US
239541142$23954114$2$F$$20240628$20240609$20240708$EXP$$NVSJ2024JP006756$NOVARTIS$$$$E$F$Y$35.9$KG$20240708$$MD$JP$JP
239541232$23954123$2$F$20240414$20240726$20240609$20240809$EXP$$DK-NOVOPROD-1230772$NOVO NORDISK$$65$YR$$F$Y$90.7$KG$20240809$$CN$DK$DK
239541252$23954125$2$F$20150921$20240523$20240609$20240703$EXP$$BE-ABBVIE-17K-013-3066262-00$ABBVIE$$76$YR$$F$Y$$$20240703$$HP$BE$BE
239541282$23954128$2$F$$20240702$20240609$20240709$PER$$US-BAUSCHBL-2024BNL028118$BAUSCH AND LOMB$$69$YR$$M$Y$$$20240710$$CN$US$US
239541303$23954130$3$F$20221122$20240710$20240609$20240715$EXP$$US-ABBVIE-5786046$ABBVIE$$32$YR$$F$Y$62.142$KG$20240715$$MD$US$US
239541312$23954131$2$F$$20240905$20240609$20240911$EXP$$US-ABBVIE-5789268$ABBVIE$$$$$F$Y$82$KG$20240911$$CN$US$US
239541404$23954140$4$F$20240516$20240716$20240609$20240722$EXP$$DE-ABBVIE-5789260$ABBVIE$$66$YR$$M$Y$52$KG$20240722$$HP$DE$DE
239541452$23954145$2$F$20240101$20240809$20240609$20240820$EXP$$US-NOVOPROD-1231691$NOVO NORDISK$$65$YR$$F$Y$$$20240820$$CN$US$US
239541723$23954172$3$F$20240520$20240913$20240609$20240919$EXP$$JP-GSK-JP2024068629$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$PH$JP$JP
239541735$23954173$5$F$20240508$20240718$20240609$20240729$EXP$$JP-JNJFOC-20240620507$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240729$$PH$JP$JP
239541793$23954179$3$F$20240101$20240730$20240609$20240805$EXP$$US-ABBVIE-5766583$ABBVIE$$$$$F$Y$90$KG$20240805$$CN$US$US
239541942$23954194$2$F$20240422$20240625$20240609$20240701$EXP$$PL-BIOGEN-2024BI01267919$BIOGEN$$31$YR$$F$Y$$$20240701$$MD$PL$PL
239541972$23954197$2$F$20240513$20240830$20240609$20240910$EXP$$US-NOVOPROD-1232345$NOVO NORDISK$$52$YR$$M$Y$$$20240910$$PH$US$US
239541983$23954198$3$F$20240601$20240827$20240609$20240923$EXP$$JP-SA-2024SA167259$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240924$$MD$JP$JP
239542074$23954207$4$F$$20240913$20240609$20240919$30DAY$$BR-NOVOPROD-1230010$NOVO NORDISK$$44$YR$$F$Y$89$KG$20240919$$CN$BR$BR
239542112$23954211$2$F$$20240705$20240609$20240709$EXP$$JP-TAKEDA-2024TJP008316$TAKEDA$$6$DEC$$F$Y$$$20240709$$MD$JP$JP
239542142$23954214$2$F$20240409$20240625$20240609$20240702$EXP$$NVSJ2024JP005026$NOVARTIS$$90$YR$$M$Y$$$20240702$$MD$JP$JP
239542152$23954215$2$F$20240318$20240704$20240609$20240710$EXP$$CA-JNJFOC-20240602940$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240710$$HP$CA$CA
239542183$23954218$3$F$20240602$20240730$20240609$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090998$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240801$$CN$US$US
239542263$23954226$3$F$$20240903$20240609$20240910$EXP$$US-BIOGEN-2024BI01268232$BIOGEN$$$$$M$Y$$$20240910$$CN$US$US
239542402$23954240$2$F$$20240820$20240609$20240823$EXP$$NVSC2024CA120307$NOVARTIS$$$$$F$Y$$$20240823$$CN$CA$CA
239542472$23954247$2$F$$20240719$20240609$20240725$PER$$US-ALXN-202405USA002271US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239542512$23954251$2$F$$20240703$20240609$20240709$EXP$$JP-JNJFOC-20240605245$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240709$$HP$JP$JP
239543522$23954352$2$F$$20240718$20240609$20240723$PER$$US-ROCHE-3510791$ROCHE$Sidiki S, Fatima R, Hernandez N C and Altorok N. Atezolizumab-Associated Retiform Purpura. DOI:10.1097/MJT.0000000000001665. American journal of therapeutics 2024 Feb 09;0:1-3.$65$YR$E$F$Y$$$20240723$$MD$US$US
239543832$23954383$2$F$$20240726$20240609$20240801$PER$$US-ROCHE-3424065$ROCHE$unknown. Atezolizumab and Bevacizumab. Who is guilty? (Abstract TP-A07). European Academy of Allergy and Clinical Immunology (EAACI) 2023;:-.;Rodriguez-Otero N, Rodriguez- Otero N B. Atezolizumab and bevacizumab. Who is guilty?.. Allergy.. 2023;78 ((SUPPL112)):548-9.$70$YR$E$F$Y$$$20240801$$HP$US$US
239543993$23954399$3$F$$20240624$20240610$20240703$EXP$$JP-SA-2024SA164868$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240703$$MD$JP$JP
239544122$23954412$2$F$20230801$20240729$20240610$20240808$EXP$$US-ROCHE-3409646$ROCHE$$72$YR$E$F$Y$$$20240808$$CN$US$US
239544142$23954414$2$F$20210101$20240702$20240610$20240715$PER$$US-ROCHE-3311846$ROCHE$$72$YR$E$M$Y$102.06$KG$20240715$$CN$US$US
239545222$23954522$2$F$20240510$20240627$20240610$20240710$PER$$US-ROCHE-3562597$ROCHE$$$$$F$Y$57.61$KG$20240710$$PH$US$US
239545252$23954525$2$F$20240521$20240801$20240610$20240808$PER$$US-ROCHE-3569188$ROCHE$$49$YR$A$F$Y$79.2$KG$20240808$$HP$US$US
239545802$23954580$2$F$$20240711$20240610$20240712$EXP$$US-JNJFOC-20240612558$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20240712$$CN$US$US
239545964$23954596$4$F$$20240802$20240610$20240806$EXP$$US-SANDOZ INC.-SDZ2024US055796$SANDOZ$$$$$M$Y$$$20240806$$CN$US$US
239545982$23954598$2$F$20240328$20240730$20240610$20240801$EXP$$US-JNJFOC-20240608995$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240801$$HP$US$US
239546823$23954682$3$F$$20240628$20240610$20240704$PER$$US-JNJFOC-20240608258$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$CN$US$US
239546972$23954697$2$F$$20240910$20240610$20240912$EXP$$US-JNJFOC-20240609032$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$HP$US$US
239546982$23954698$2$F$20240201$20240704$20240610$20240711$EXP$$ES-UCBSA-2024028550$UCB$$$$A$M$Y$$$20240711$$MD$ES$ES
239546994$23954699$4$F$20240601$20240717$20240610$20240725$EXP$$US-ABBVIE-5523922$ABBVIE$$74$YR$$M$Y$$$20240725$$CN$US$US
239547053$23954705$3$F$$20240701$20240610$20240711$EXP$$BE-ROCHE-3577647$ROCHE$Shiba S, Van K. Double bad luck pulmonary embolism and vaginal bleeding a case report. International Journal of Emergency Medicine. 2024;17 (63):1-4. doi:10.1186/s12245-024-00639-9.$47$YR$A$F$Y$83$KG$20240711$$HP$BE$BE
239547072$23954707$2$F$20230427$20240823$20240610$20240831$EXP$$US-AMGEN-USASP2024110002$AMGEN$$68$YR$E$F$Y$$$20240831$$LW$US$US
239547082$23954708$2$F$20230811$20240717$20240610$20240725$EXP$$US-AMGEN-USASP2024109732$AMGEN$$75$YR$E$M$Y$84$KG$20240725$$LW$US$US
239547092$23954709$2$F$20240101$20240829$20240610$20240905$EXP$$US-ABBVIE-5790219$ABBVIE$$59$YR$$F$Y$$$20240905$$CN$US$US
239547102$23954710$2$F$20221025$20240823$20240610$20240902$EXP$$US-AMGEN-USASP2024109826$AMGEN$$51$YR$A$M$Y$73$KG$20240902$$LW$US$US
239547212$23954721$2$F$20240424$20240919$20240610$20240926$EXP$$CA-ABBVIE-5789883$ABBVIE$$$$A$M$Y$$$20240926$$CN$CA$CA
239547343$23954734$3$F$20240503$20240729$20240610$20240802$EXP$$CA-ABBVIE-5789631$ABBVIE$$32$YR$$M$Y$$$20240802$$CN$CA$CA
239547382$23954738$2$F$20240101$20240709$20240610$20240713$EXP$$US-ABBVIE-5790291$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
239547402$23954740$2$F$$20240727$20240610$20240731$EXP$$SA-AMGEN-SAUSP2024112427$AMGEN$$$$$$Y$$$20240731$$MD$SA$SA
239547423$23954742$3$F$20240403$20240722$20240610$20240729$30DAY$$US-AMGEN-USASP2024109675$AMGEN$$56$YR$A$$Y$$$20240729$$HP$US$US
239547443$23954744$3$F$20231101$20240703$20240610$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-076830$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240709$$CN$US$US
239547462$23954746$2$F$20240111$20240604$20240610$20240725$EXP$$US-ABBVIE-5789986$ABBVIE$$67$YR$$F$Y$80$KG$20240725$$HP$US$US
239547702$23954770$2$F$$20240624$20240610$20240703$EXP$$JP-AMGEN-JPNSP2024112350$AMGEN$$68$YR$E$F$Y$$$20240703$$MD$JP$JP
239547723$23954772$3$F$$20240710$20240610$20240717$EXP$$US-TAKEDA-2024TUS056235$TAKEDA$$$$$M$Y$$$20240717$$MD$US$US
239547793$23954779$3$F$$20240710$20240610$20240722$EXP$$PK-ROCHE-3578840$ROCHE$$64$YR$A$F$Y$$$20240719$$CN$PK$PK
239547874$23954787$4$F$20240531$20240807$20240610$20240820$EXP$$US-PFIZER INC-202400172615$PFIZER$$70$YR$$F$Y$$$20240820$$CN$US$US
239547913$23954791$3$F$20170101$20240719$20240610$20240730$EXP$$US-Orexo US, Inc.-ORE202405-000025$OREXO$$44$YR$A$F$Y$68.03$KG$20240730$$CN$US$
239548062$23954806$2$F$20240101$20240801$20240610$20240807$EXP$$US-AMGEN-USASP2024111941$AMGEN$$54$YR$A$F$Y$$$20240807$$CN$US$US
239548152$23954815$2$F$$20240716$20240610$20240718$EXP$$NVSJ2024JP006769$NOVARTIS$$12$YR$$F$Y$$$20240719$$MD$JP$JP
239548402$23954840$2$F$20240504$20240628$20240610$20240703$EXP$$US-BAUSCH-BL-2024-007177$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240703$$CN$US$US
239548422$23954842$2$F$20240603$20240625$20240610$20240702$EXP$$CA-JNJFOC-20240609180$JOHNSON AND JOHNSON$$15$YR$T$F$Y$52$KG$20240702$$HP$CA$CA
239548453$23954845$3$F$20240530$20240705$20240610$20240710$EXP$$CO-GSK-CO2024AMR059851$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$CO$CO
239548506$23954850$6$F$20240101$20240911$20240610$20240919$EXP$$CA-CELLTRION INC.-2024CA013616$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
239548533$23954853$3$F$20240604$20240827$20240610$20240902$EXP$$CA-TAKEDA-2024TUS031757$TAKEDA$$69$YR$$M$Y$$$20240902$$CN$CA$CA
239548932$23954893$2$F$$20240628$20240610$20240704$EXP$$HU-HALEON-2180146$Haleon PLC$$$$$F$Y$$$20240704$$CN$HU$HU
239548982$23954898$2$F$$20240811$20240610$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092911$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$112.49$KG$20240812$$CN$US$US
239549093$23954909$3$F$20240508$20240610$20240610$20240920$EXP$$LB-HALEON-2177777$Haleon PLC$$57$YR$$M$Y$$$20240919$$CN$LB$LB
239549122$23954912$2$F$20240101$20240621$20240610$20240704$EXP$$JP-BIOGEN-2024BI01267482$BIOGEN$$$$$$Y$$$20240704$$MD$JP$JP
239549232$23954923$2$F$$20240704$20240610$20240709$EXP$$GB-JNJFOC-20240614191$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20240709$$CN$GB$GB
239549332$23954933$2$F$$20240717$20240610$20240723$PER$$US-AMGEN-USASP2024112385$AMGEN$$$$$$Y$$$20240723$$CN$US$US
239549392$23954939$2$F$20240101$20240702$20240610$20240706$EXP$$JP-ABBVIE-5791940$ABBVIE$$70$YR$$M$Y$$$20240706$$MD$JP$JP
239549412$23954941$2$F$$20240618$20240610$20240703$PER$$US-APOTEX-2024AP006213$APOTEX$$$$$$Y$$$20240703$$CN$US$US
239549602$23954960$2$F$20240101$20240723$20240610$20240731$EXP$$CA-CELLTRION INC.-2024CA004071$CELLTRION$$$$$$Y$$$20240731$$MD$CA$CA
239549772$23954977$2$F$20240101$20240712$20240610$20240723$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00495$CATALYST PHARMA$$$$$M$Y$46.259$KG$20240723$$CN$US$US
239549782$23954978$2$F$20240101$20240619$20240610$20240703$PER$$US-APOTEX-2024AP006317$APOTEX$$$$$$Y$$$20240703$$PH$US$US
239549812$23954981$2$F$$20240604$20240610$20240720$EXP$$JP-JNJFOC-20240616081$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$MD$JP$JP
239549883$23954988$3$F$20240603$20240724$20240610$20240801$EXP$$CA-CELLTRION INC.-2024CA013673$CELLTRION$$$$$$Y$$$20240801$$HP$CA$CA
239549933$23954993$3$F$20240511$20240726$20240610$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002340$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240819$$CN$US$US
239550072$23955007$2$F$$20240607$20240610$20240916$PER$$NVSC2024US120873$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
239550092$23955009$2$F$20240101$20240731$20240610$20240807$EXP$$CA-CELLTRION INC.-2024CA013629$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
239550222$23955022$2$F$20240101$20240620$20240610$20240708$PER$$US-APOTEX-2024AP006308$APOTEX$$$$$M$Y$$$20240708$$CN$US$US
239550243$23955024$3$F$20240101$20240710$20240610$20240712$EXP$$US-UCBSA-2024007551$UCB$$$$$M$Y$$$20240712$$CN$US$US
239550333$23955033$3$F$$20240913$20240610$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091408$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240913$$CN$US$US
239550423$23955042$3$F$20160101$20240730$20240610$20240813$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-04636$LUPIN$$35$YR$$$Y$$$20240813$$CN$AU$AU
239550432$23955043$2$F$$20240722$20240610$20240730$EXP$$US-AstraZeneca-2024A132330$ASTRAZENECA$$$$$F$Y$$$20240730$$MD$US$
239550483$23955048$3$F$$20240905$20240610$20240913$EXP$$US-EMD Serono-2024030374$EMD SERONO INC$$$$A$F$Y$$$20240913$$CN$US$US
239550565$23955056$5$F$$20240617$20240610$20240709$PER$$US-ROCHE-3578557$ROCHE$$22$YR$A$M$Y$$$20240702$$HP$US$US
239550572$23955057$2$F$$20240613$20240610$20240707$EXP$$MA-ROCHE-3576473$ROCHE$$$$$$Y$$$20240707$$MD$MA$MA
239550582$23955058$2$F$$20240809$20240610$20240814$EXP$$NVSC2024US066929$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
239550673$23955067$3$F$20240613$20240703$20240610$20240706$PER$$US-AMGEN-USASP2024112144$AMGEN$$64$YR$A$F$Y$$$20240706$$CN$US$US
239550702$23955070$2$F$$20240805$20240610$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002468$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
239550772$23955077$2$F$20240415$20240731$20240610$20240805$EXP$$US-AstraZeneca-2024A132581$ASTRAZENECA$$27937$DY$$M$Y$$$20240805$$MD$US$
239550842$23955084$2$F$$20240715$20240610$20240725$PER$$US-RDY-SPO/USA/24/0008099$DR REDDYS$$81$YR$E$F$Y$$$20240725$$CN$US$US
239550983$23955098$3$F$20240513$20240808$20240610$20240813$EXP$$BR-CELLTRION INC.-2024BR013153$CELLTRION$$$$$$Y$$$20240813$$CN$BR$BR
239551027$23955102$7$F$$20240924$20240610$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092564$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240927$$CN$US$US
239551052$23955105$2$F$$20240621$20240610$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04642$LUPIN$$$$$$Y$$$20240703$$CN$US$US
239551063$23955106$3$F$20070101$20240917$20240610$20240922$PER$$US-JNJFOC-20240607048$JOHNSON AND JOHNSON$$3$YR$C$M$Y$$$20240923$$LW$US$US
239551152$23955115$2$F$20240602$20240815$20240610$20240826$EXP$$CA-APOTEX-2024AP006984$APOTEX$$83$YR$E$M$Y$$$20240826$$HP$CA$CA
239551283$23955128$3$F$20180201$20240925$20240610$20240927$PER$$US-GILEAD-2024-0676206$GILEAD$$35$YR$A$M$Y$$$20240927$$LW$US$US
239551363$23955136$3$F$$20240724$20240610$20240729$EXP$$US-Indivior Limited-INDV-144300-2024$RECKITT BENCKISER$$$$$$Y$$$20240729$$MD$US$US
239551522$23955152$2$F$20240506$20240626$20240610$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002462$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240723$$CN$US$US
239551592$23955159$2$F$$20240805$20240610$20240809$EXP$$US-JNJFOC-20240616213$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20240809$$CN$US$US
239551632$23955163$2$F$$20240709$20240610$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092365$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240710$$HP$US$US
239551872$23955187$2$F$20240531$20240721$20240610$20240730$30DAY$$US-GSK-US2024068294$GLAXOSMITHKLINE$$61$YR$$M$Y$$$20240730$$CN$US$US
239551892$23955189$2$F$$20240719$20240610$20240722$PER$$US-AstraZeneca-2024A131304$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
239551982$23955198$2$F$20240501$20240829$20240610$20240906$EXP$$CA-CELLTRION INC.-2024CA013717$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
239552102$23955210$2$F$$20240625$20240610$20240701$EXP$$JP-GSK-JP2024JPN068422$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$PH$JP$JP
239552202$23955220$2$F$20240510$20240625$20240610$20240703$PER$$US-AMGEN-USASP2024113842$AMGEN$$67$YR$E$M$Y$$$20240703$$CN$US$US
239552322$23955232$2$F$$20240710$20240610$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093101$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$96.16$KG$20240711$$HP$US$US
239552332$23955233$2$F$20240101$20240709$20240610$20240711$EXP$$JP-GILEAD-2024-0668994$GILEAD$$83$YR$E$M$Y$$$20240711$$MD$JP$JP
239552392$23955239$2$F$20240908$20240909$20240610$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202406004938$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240911$$CN$US$US
239552412$23955241$2$F$20220101$20240621$20240610$20240702$PER$$US-AMGEN-USASP2024113570$AMGEN$$83$YR$E$F$Y$$$20240702$$CN$US$US
239552532$23955253$2$F$20240101$20240807$20240610$20240808$EXP$$US-UCBSA-2024028133$UCB$$$$$F$Y$$$20240808$$CN$US$US
239552542$23955254$2$F$20240514$20240827$20240610$20240902$EXP$$DE-ROCHE-3576582$ROCHE$$73$YR$E$M$Y$70$KG$20240902$$MD$DE$DE
239552552$23955255$2$F$$20240715$20240610$20240716$EXP$$NVSC2024US120242$NOVARTIS$$$$$$Y$$$20240716$$MD$US$US
239552613$23955261$3$F$$20240711$20240610$20240722$EXP$$US-ROCHE-3577208$ROCHE$Israilevich R, Mansour H, Patel S, Garg S, Klufas M, Yonekawa Y, Regillo C and Hsu J. Risk of Endophthalmitis Based on Cumulative Number of Anti-VEGF Intravitreal Injections, DOI: 10.1016/j.ophtha.2023.12.033. Ophthalmology 2024 Jun;131 (6):667-73.$$$$$Y$$$20240722$$MD$US$US
239552632$23955263$2$F$$20240719$20240610$20240731$EXP$$JP-AMGEN-JPNSP2024112371$AMGEN$$$$$$Y$$$20240730$$PH$JP$JP
239552692$23955269$2$F$$20240724$20240610$20240730$EXP$$CA-APOTEX-2024AP006906$APOTEX$$75$YR$$F$Y$58$KG$20240730$$HP$CA$CA
239552722$23955272$2$F$20240607$20240703$20240610$20240705$PER$$US-AMGEN-USASP2024113316$AMGEN$$69$YR$E$F$Y$$$20240705$$HP$US$US
239552903$23955290$3$F$$20240709$20240610$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04634$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239552932$23955293$2$F$20240408$20240711$20240610$20240717$EXP$$JP-ROCHE-3561452$ROCHE$$7$DEC$E$M$Y$$$20240717$$MD$JP$JP
239553092$23955309$2$F$$20240710$20240610$20240715$EXP$$JP-AMGEN-JPNSP2024111719$AMGEN$$$$E$F$Y$$$20240715$$MD$JP$JP
239553393$23955339$3$F$$20240716$20240610$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-092319$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240725$$MD$JP$JP
239553433$23955343$3$F$20240501$20240729$20240610$20240802$EXP$JP-MMM-GCLNZ7KQ$JP-GSK-JP2024068557$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$JP$JP
239553502$23955350$2$F$$20240702$20240610$20240715$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00386$Phathom Pharmaceuticals$$7$DEC$$F$Y$$$20240715$$MD$JP$JP
239553572$23955357$2$F$$20240822$20240610$20240828$EXP$$CA-TAKEDA-2024TUS056208$TAKEDA$$$$$F$Y$$$20240828$$CN$CA$CA
239553672$23955367$2$F$20220301$20240701$20240610$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-027258$AUROBINDO$$52$YR$$F$Y$$$20240708$$MD$GB$GB
239553714$23955371$4$F$20240101$20240822$20240610$20240826$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-082028$REGENERON$$$$$M$Y$$$20240826$$CN$US$US
239553723$23955372$3$F$20240101$20240729$20240610$20240731$EXP$$US-ABBVIE-5787980$ABBVIE$$$$$M$Y$58.966$KG$20240731$$CN$US$US
239553772$23955377$2$F$$20240911$20240610$20240920$PER$$US-TAKEDA-2024TUS057367$TAKEDA$$$$$F$Y$$$20240920$$HP$US$US
239553842$23955384$2$F$20230101$20240918$20240610$20240923$EXP$$GB-ABBVIE-5450391$ABBVIE$$55$YR$$M$Y$68$KG$20240923$$HP$GB$GB
239553902$23955390$2$F$$20240805$20240610$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093038$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$119.29$KG$20240809$$CN$US$US
239553913$23955391$3$F$20240114$20240722$20240610$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091067$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$58.06$KG$20240726$$MD$US$US
239553942$23955394$2$F$20240603$20240821$20240610$20240823$EXP$$US-TAKEDA-2024TUS057346$TAKEDA$$22$YR$$F$Y$$$20240823$$MD$US$US
239554093$23955409$3$F$$20240628$20240610$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-027244$AUROBINDO$$$$$M$Y$$$20240706$$PH$GB$GB
239554262$23955426$2$F$20240730$20240730$20240610$20240802$EXP$$CA-JNJFOC-20240607124$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240802$$HP$CA$CA
239554273$23955427$3$F$$20240624$20240610$20240702$EXP$$JP-SA-2024SA164863$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240703$$MD$JP$JP
239554332$23955433$2$F$20240516$20240624$20240610$20240702$EXP$$IT-AUROBINDO-AUR-APL-2024-027167$AUROBINDO$$75$YR$$M$Y$$$20240702$$MD$IT$IT
239554342$23955434$2$F$$20240722$20240610$20240722$PER$$US-ALXN-202406USA000100US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
239554383$23955438$3$F$$20240624$20240610$20240701$EXP$$JP-JNJFOC-20240622139$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$$COUNTRY NOT SPECIFIED$JP
239554412$23955441$2$F$$20240625$20240610$20240701$EXP$$JP-AMGEN-JPNSP2024112161$AMGEN$$64$YR$A$F$Y$$$20240701$$MD$JP$JP
239554532$23955453$2$F$$20240821$20240610$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092972$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240826$$CN$US$US
239554555$23955455$5$F$20240606$20240827$20240610$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092837$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240903$$CN$US$US
239554582$23955458$2$F$$20240726$20240610$20240802$EXP$$US-GSK-US2024008095$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$US$US
239554635$23955463$5$F$$20240723$20240610$20240727$EXP$$US-TAKEDA-2024TUS057195$TAKEDA$$$$$M$Y$113.38$KG$20240727$$CN$US$US
239554682$23955468$2$F$20240603$20240827$20240610$20240830$PER$$US-JNJFOC-20240607065$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20240830$$HP$US$US
239554728$23955472$8$F$20240607$20240911$20240610$20240919$EXP$$CA-TAKEDA-2024TUS053818$TAKEDA$$58$YR$$F$Y$$$20240919$$CN$CA$CA
239554882$23955488$2$F$20240101$20240703$20240610$20240708$EXP$$US-UCBSA-2024016668$UCB$$$$$F$Y$$$20240708$$CN$US$US
239555042$23955504$2$F$20240529$20240705$20240610$20240711$PER$$US-JNJFOC-20240582370$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240711$$CN$US$US
239555202$23955520$2$F$20240101$20240624$20240610$20240701$EXP$$CA-ABBVIE-5789207$ABBVIE$$39$YR$$F$Y$$$20240701$$CN$CA$CA
239555335$23955533$5$F$20240101$20240813$20240610$20240815$PER$$US-AMGEN-USASP2024112966$AMGEN$$39$YR$A$M$Y$$$20240815$$HP$US$US
239555373$23955537$3$F$20240522$20240708$20240610$20240716$EXP$$PT-AstraZeneca-2024A131915$ASTRAZENECA$$61$YR$$F$Y$$$20240716$$MD$PT$
239555412$23955541$2$F$$20240709$20240610$20240710$PER$$US-AstraZeneca-2024A132535$ASTRAZENECA$$$$$$Y$$$20240710$$MD$US$
239555522$23955552$2$F$$20240624$20240610$20240704$30DAY$$US-GSK-US2024068319$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$PH$US$US
239555552$23955555$2$F$$20240625$20240610$20240708$EXP$$AU-GENERIC HEALTH PTY. LTD.-2024-04593$LUPIN$Perucca P, Bourikas D, Voinescu PE, Vadlamudi L, Chellun D, Kumke T, et al. Lacosamide and pregnancy: Data from spontaneous and solicited reports. Epilepsia. 2024;65 (5):1275-1284$$$$$Y$$$20240708$$HP$AU$AU
239555572$23955557$2$F$20240408$20240812$20240610$20240813$EXP$GB-MHRA-MED-202406061130151180-MSYVH$GB-ORGANON-O2406GBR000515$ORGANON$$$$$F$Y$$$20240813$$CN$GB$GB
239555663$23955566$3$F$$20240703$20240610$20240704$EXP$$NVSC2024US120512$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
239555692$23955569$2$F$$20240909$20240610$20240909$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-092811$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240909$$MD$TW$TW
239556062$23955606$2$F$20240528$20240627$20240610$20240702$EXP$$CA-ABBVIE-5789414$ABBVIE$$60$YR$$M$Y$$$20240702$$CN$CA$CA
239556185$23955618$5$F$20240401$20240904$20240610$20240905$EXP$$US-GILEAD-2024-0675796$GILEAD$$77$YR$E$F$Y$$$20240905$$CN$US$US
239556223$23955622$3$F$$20230814$20240610$20240710$PER$$IN-ROCHE-3384051$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
239556292$23955629$2$F$20210101$20240827$20240610$20240902$EXP$$US-AMGEN-USASP2024109885$AMGEN$$$$$M$Y$73.9$KG$20240902$$LW$US$US
239556422$23955642$2$F$20220101$20240718$20240610$20240725$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032482$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240725$$CN$US$US
239556454$23955645$4$F$$20240715$20240610$20240716$30DAY$$DE-JNJFOC-20240618763$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$PH$DE$DE
239556564$23955656$4$F$20240601$20240731$20240610$20240805$EXP$$JP-SA-2024SA169346$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240806$$MD$JP$JP
239556632$23955663$2$F$$20240802$20240610$20240807$EXP$$AT-ROCHE-3576731$ROCHE$$58$YR$A$F$Y$$$20240807$$MD$AT$AT
239556722$23955672$2$F$$20240710$20240610$20240718$30DAY$$US-JNJFOC-20240614064$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$PH$US$US
239556864$23955686$4$F$20240607$20240711$20240610$20240712$PER$$US-AMGEN-USASP2024113406$AMGEN$$66$YR$E$F$Y$$$20240712$$HP$US$US
239556902$23955690$2$F$20230801$20240814$20240610$20240821$EXP$$US-ABBVIE-5713196$ABBVIE$$67$YR$$F$Y$$$20240821$$CN$US$US
239557133$23955713$3$F$20240101$20240703$20240610$20240710$PER$$US-AMGEN-USASP2024112779$AMGEN$$90$YR$E$M$Y$$$20240710$$CN$US$US
239557202$23955720$2$F$$20240912$20240610$20240919$EXP$$CA-JNJFOC-20240613339$JOHNSON AND JOHNSON$$3$YR$C$M$Y$$$20240919$$HP$CA$CA
239557252$23955725$2$F$$20240813$20240610$20240816$PER$$NVSC2024US120659$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
239557272$23955727$2$F$20230101$20240821$20240610$20240826$EXP$$CA-MYLANLABS-2024M1052050$MYLAN$$$$$F$Y$$$20240826$$HP$CA$CA
239557462$23955746$2$F$$20240703$20240610$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092875$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$53.07$KG$20240704$$CN$US$US
239557492$23955749$2$F$$20240722$20240610$20240729$EXP$$US-ROCHE-3577314$ROCHE$$77$YR$E$F$Y$$$20240729$$CN$US$US
239557513$23955751$3$F$20240530$20240830$20240610$20240905$EXP$$CN-ROCHE-3579481$ROCHE$$15$YR$T$M$Y$56$KG$20240905$$MD$CN$CN
239557542$23955754$2$F$$20240911$20240610$20240916$EXP$$JP-009507513-2406JPN000600J$MERCK$$66$YR$$M$Y$$$20240916$$MD$JP$JP
239557583$23955758$3$F$20240512$20240827$20240610$20240903$EXP$$DE-009507513-2406DEU001697$MERCK$$77$YR$$F$Y$58$KG$20240903$$MD$DE$DE
239557763$23955776$3$F$20240101$20240731$20240610$20240802$EXP$$FR-AstraZeneca-2024A133473$ASTRAZENECA$$70$YR$$F$Y$45$KG$20240802$$MD$FR$
239557813$23955781$3$F$20230908$20240917$20240610$20240923$EXP$$US-TAKEDA-2023TUS094476$TAKEDA$$11$YR$$F$Y$38$KG$20240923$$HP$US$US
239557902$23955790$2$F$$20240703$20240610$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093053$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$67.13$KG$20240704$$CN$US$US
239557912$23955791$2$F$20211225$20240809$20240610$20240815$EXP$AU-TGA-0000809154$AU-BAUSCH-BL-2024-008583$BAUSCH AND LOMB$$$$$M$Y$$$20240815$$HP$AU$AU
239557923$23955792$3$F$$20240805$20240610$20240807$EXP$$IT-BAUSCH-BL-2024-008898$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240807$$MD$IT$IT
239558053$23955805$3$F$$20240918$20240610$20240919$PER$$NVSC2024US120065$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
239558092$23955809$2$F$$20240807$20240610$20240819$EXP$$US-TEVA-VS-3206036$TEVA$$82$YR$$F$Y$$$20240819$$CN$US$US
239558124$23955812$4$F$$20240627$20240610$20240705$EXP$$DE-AUROBINDO-AUR-APL-2024-027047$AUROBINDO$Br?ning KK, Pelivan E, Heinrich MC, Bufler P, Kaindl A, Thumfart J, et,al.. Acute kidney injury in lamotrigine-induced DRESS syndrome. Pediatric nephrology. 2024;1-3$17$YR$$F$Y$47.3$KG$20240705$$MD$DE$DE
239558207$23955820$7$F$20230612$20240801$20240610$20240808$EXP$$IN-ROCHE-3298516$ROCHE$$65$YR$E$M$Y$$$20240808$$CN$IN$IN
239558242$23955824$2$F$20240606$20240805$20240610$20240807$PER$$US-AMGEN-USASP2024113808$AMGEN$$80$YR$E$F$Y$$$20240807$$CN$US$US
239558252$23955825$2$F$$20240806$20240610$20240808$EXP$$US-ASTELLAS-2024EU005573$ASTELLAS$$$$$M$Y$$$20240808$$CN$US$US
239558332$23955833$2$F$20231001$20240701$20240610$20240702$PER$$US-JNJFOC-20240559168$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240702$$CN$US$US
239558402$23955840$2$F$$20240701$20240610$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406004891$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240702$$CN$US$US
239558533$23955853$3$F$20230810$20240722$20240610$20240802$EXP$FR-AFSSAPS-LM2024000282$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-107932$ZYDUS PHARM$$$$$$Y$$$20240802$$MD$FR$FR
239558553$23955855$3$F$20220101$20240924$20240610$20240925$EXP$$US-GILEAD-2024-0676291$GILEAD$$$$A$M$Y$$$20240925$$LW$US$US
239558592$23955859$2$F$$20240709$20240610$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04705$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239558772$23955877$2$F$20240401$20240705$20240610$20240716$EXP$$GB-ROCHE-3579058$ROCHE$$75$YR$E$M$Y$83.7$KG$20240716$$HP$GB$GB
239558952$23955895$2$F$$20240620$20240610$20240703$EXP$$US-GRAVITIPHARMA-GRA-2405-US-LIT-0161$GRAVITI PHARMACEUTICALS$Kuhnly N, Zhu A, Chen L, Dulu A.WHYSO BLUE? SEROTONIN SYNDROME IN DAPSONEINDUCED METHEMOGLOBINEMIA.Critical Care Medicine.2024;52(1):S443$54$YR$A$F$Y$$$20240703$$HP$US$US
239558973$23955897$3$F$$20240709$20240610$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04730$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239559004$23955900$4$F$20240506$20240731$20240610$20240807$PER$$US-AMGEN-USASP2024113025$AMGEN$$66$YR$E$F$Y$$$20240806$$CN$US$US
239559032$23955903$2$F$20240528$20240714$20240610$20240806$PER$$US-AMGEN-USASP2024112305$AMGEN$$82$YR$E$M$Y$$$20240806$$PH$US$US
239559052$23955905$2$F$20220601$20240717$20240610$20240722$EXP$$US-AMGEN-USASP2024109090$AMGEN$$67$YR$E$M$Y$$$20240722$$LW$US$US
239559143$23955914$3$F$$20240709$20240610$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04662$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239559222$23955922$2$F$$20240705$20240610$20240712$30DAY$$AU-JNJFOC-20240605231$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$PH$AU$AU
239559273$23955927$3$F$$20240729$20240610$20240828$PER$$US-AstraZeneca-2024A129170$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
239559342$23955934$2$F$$20240718$20240610$20240801$EXP$$JP-ROCHE-3578074$ROCHE$$68$YR$E$$Y$$$20240801$$MD$JP$JP
239559416$23955941$6$F$20240606$20240827$20240610$20240828$PER$$US-HALEON-2180735$Haleon PLC$$57$YR$$M$Y$$$20240828$$CN$US$US
239559452$23955945$2$F$20221015$20240725$20240610$20240729$EXP$ES-AEMPS-1527393$ES-009507513-2406ESP001064$MERCK$$72$YR$$F$Y$$$20240729$$MD$ES$ES
239559472$23955947$2$F$$20240809$20240610$20240813$EXP$$NVSC2024US119101$NOVARTIS$$$$$M$Y$$$20240813$$HP$US$US
239559512$23955951$2$F$20240501$20240822$20240610$20240905$EXP$$US-UCBSA-2024028272$UCB$$45$YR$$F$Y$$$20240905$$HP$US$US
239559522$23955952$2$F$$20240710$20240610$20240712$PER$$US-BIOVITRUM-2024-US-008197$BIOVITRUM$$81$YR$$F$Y$$$20240712$$CN$US$US
239559712$23955971$2$F$$20240705$20240610$20240711$30DAY$$TR-JNJFOC-20240553426$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$PH$TR$TR
239559722$23955972$2$F$20240607$20240805$20240610$20240807$PER$$US-AMGEN-USASP2024113737$AMGEN$$81$YR$E$F$Y$$$20240807$$CN$US$US
239559802$23955980$2$F$20240601$20240709$20240610$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032833$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240711$$CN$US$US
239559842$23955984$2$F$$20240620$20240610$20240703$EXP$$US-GRAVITIPHARMA-GRA-2405-US-LIT-0160$GRAVITI PHARMACEUTICALS$Angappan S, Aggarwal A..BACLOFEN WITHDRAWAL SYNDROME IN THE ICU: A RARE BUT POTENTIALLYFATAL CONDITION.Critical Care Medicine.2024;52:S291$61$YR$A$M$Y$$$20240703$$HP$US$US
239559912$23955991$2$F$20240601$20240920$20240610$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093122$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$90.63$KG$20240924$$CN$US$US
239559933$23955993$3$F$20220101$20240906$20240610$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-092344$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240906$$MD$JP$JP
239559943$23955994$3$F$$20240709$20240610$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04604$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239559963$23955996$3$F$$20240827$20240610$20240830$EXP$$CA-JNJFOC-20240608794$JOHNSON AND JOHNSON$$47$YR$A$M$Y$98$KG$20240830$$HP$CA$CA
239560095$23956009$5$F$20240504$20240711$20240610$20240723$EXP$$FR-ROCHE-3577569$ROCHE$$76$YR$E$M$Y$$$20240723$$MD$FR$FR
239560102$23956010$2$F$$20240701$20240610$20240704$EXP$$US-GILEAD-2024-0675008$GILEAD$$$$A$F$Y$$$20240704$$CN$US$US
239560193$23956019$3$F$20150101$20240925$20240610$20240930$PER$$US-GILEAD-2024-0676208$GILEAD$$$$A$M$Y$$$20240930$$LW$US$US
239560292$23956029$2$F$20240521$20240628$20240610$20240705$EXP$$GB-TEVA-VS-3205273$TEVA$$57$YR$$F$Y$$$20240705$$PH$GB$GB
239560404$23956040$4$F$20240506$20240716$20240610$20240730$EXP$$US-ROCHE-3573170$ROCHE$$66$YR$E$M$Y$112.94$KG$20240730$$CN$US$US
239560453$23956045$3$F$$20240906$20240610$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093160$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240906$$CN$US$US
239560572$23956057$2$F$$20240717$20240610$20240724$EXP$$NVSC2024CZ118130$NOVARTIS$Hlusi A. Successful use of ravalizumab in first-line treatment with a complement inhibitor in a patient with paroxysmal nocturnal hemoglobinuria (Uspesne pouziti ravalizumabu v prvni linii lecby inhibitorem komplementu u pacientky s paroxysmaln? nocni hemoglobinurii). ACTA MEDICINAE. 2024;13(4 - Ext 1/3):26-8$$$A$F$Y$$$20240724$$HP$CZ$CZ
239560632$23956063$2$F$20210101$20240729$20240610$20240805$EXP$$AT-AMGEN-AUTSP2024112287$AMGEN$$76$YR$E$M$Y$$$20240805$$CN$AT$AT
239560642$23956064$2$F$20240501$20240622$20240610$20240708$PER$$US-CBL-002652$CONCORD BIOTECH$$44$YR$A$M$Y$$$20240706$$CN$US$US
239560663$23956066$3$F$20221017$20240729$20240610$20240809$EXP$$IT-AUROBINDO-AUR-APL-2024-012832$AUROBINDO$$65$YR$$M$Y$70$KG$20240809$$MD$IT$IT
239560742$23956074$2$F$$20240712$20240610$20240718$PER$$US-AstraZeneca-2024A132894$ASTRAZENECA$$$$$F$Y$$$20240718$$MD$US$
239560822$23956082$2$F$20230601$20240715$20240610$20240721$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091330$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$142.88$KG$20240722$$CN$US$US
239560992$23956099$2$F$$20240801$20240610$20240801$EXP$$CA-PFIZER INC-202400189321$PFIZER$$84$YR$$F$Y$$$20240801$$HP$CA$CA
239561052$23956105$2$F$20240201$20240808$20240610$20240813$EXP$$CL-PFIZER INC-PV202400074634$PFIZER$$51$YR$$F$Y$$$20240813$$CN$CL$CL
239561062$23956106$2$F$$20240804$20240610$20240805$EXP$$RO-PFIZER INC-PV202400073995$PFIZER$$53$YR$$$Y$$$20240805$$MD$RO$RO
239561073$23956107$3$F$20240101$20240803$20240610$20240805$EXP$$CA-PFIZER INC-202400189217$PFIZER$$64$YR$$F$Y$$$20240805$$CN$CA$CA
239561202$23956120$2$F$$20240708$20240610$20240710$EXP$$IN-GSK-IN2024APC069566$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$IN$IN
239561266$23956126$6$F$20240322$20240806$20240610$20240806$EXP$$CN-ASTELLAS-2024US016511$ASTELLAS$$68$YR$$M$Y$$$20240806$$MD$CN$CN
239561282$23956128$2$F$20230719$20240729$20240610$20240801$EXP$$JP-ROCHE-3578407$ROCHE$$74$YR$E$M$Y$$$20240801$$MD$JP$JP
239561345$23956134$5$F$20240101$20240906$20240610$20240918$EXP$$US-INSMED, INC.-2024-00875-US$INSMED$$$$$M$Y$$$20240918$$CN$US$US
239561383$23956138$3$F$20240514$20240621$20240610$20240705$EXP$FR-AFSSAPS-MP2024000848$FR-TEVA-VS-3206653$TEVA$$81$YR$$F$Y$50$KG$20240705$$PH$FR$FR
239561432$23956143$2$F$$20240719$20240610$20240722$PER$$US-JNJFOC-20240575939$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
239561474$23956147$4$F$20240529$20240705$20240610$20240722$30DAY$$US-JNJFOC-20240589712$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240721$$CN$US$US
239561583$23956158$3$F$$20240711$20240610$20240711$30DAY$$US-PFIZER INC-202400186190$PFIZER$$5$YR$$F$Y$10.431$KG$20240711$$CN$US$US
239561593$23956159$3$F$$20240911$20240610$20240913$30DAY$$US-PFIZER INC-202400181825$PFIZER$$9$YR$$F$Y$$$20240913$$CN$US$US
239561606$23956160$6$F$20240528$20240920$20240610$20240925$30DAY$$US-PFIZER INC-PV202400064392$PFIZER$$64$YR$$F$Y$$$20240925$$MD$US$US
239561622$23956162$2$F$$20240711$20240610$20240711$30DAY$$US-PFIZER INC-202400187057$PFIZER$$19$YR$$M$Y$$$20240711$$CN$US$US
239561653$23956165$3$F$20240408$20240718$20240610$20240729$EXP$$JP-ROCHE-3559221$ROCHE$$58$YR$A$F$Y$$$20240729$$PH$JP$JP
239561863$23956186$3$F$20240416$20240802$20240610$20240806$EXP$$ES-JNJFOC-20240531252$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240806$$HP$ES$ES
239561962$23956196$2$F$$20240904$20240610$20240913$PER$$US-SA-2024SA166283$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240913$$MD$US$US
239561972$23956197$2$F$20240101$20240806$20240610$20240814$PER$$US-SA-2024SA168771$SANOFI AVENTIS$$45$YR$A$M$Y$141.04$KG$20240815$$MD$US$US
239562092$23956209$2$F$20240509$20240628$20240610$20240710$PER$$US-SA-2024SA167311$SANOFI AVENTIS$$79$YR$E$F$Y$58.51$KG$20240710$$MD$US$US
239562272$23956227$2$F$20240101$20240702$20240610$20240711$PER$$US-SA-2024SA170523$SANOFI AVENTIS$$16$YR$T$M$Y$93.1$KG$20240711$$CN$US$US
239562322$23956232$2$F$20240101$20240821$20240610$20240910$PER$$US-SA-2024SA167781$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240910$$MD$US$US
239562433$23956243$3$F$20240101$20240808$20240610$20240813$PER$$US-SA-2024SA170634$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240814$$MD$US$US
239562443$23956244$3$F$20240101$20240819$20240610$20240828$PER$$US-SA-2024SA169250$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240828$$MD$US$US
239562452$23956245$2$F$20240101$20240701$20240610$20240710$PER$$US-SA-2024SA171335$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240710$$PH$US$US
239562473$23956247$3$F$20240603$20240802$20240610$20240813$PER$$US-SA-2024SA170742$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240814$$PH$US$US
239562482$23956248$2$F$$20240827$20240610$20240905$PER$$US-SA-2024SA168414$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240905$$MD$US$US
239562582$23956258$2$F$$20240722$20240610$20240731$PER$$US-SA-2024SA170598$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240731$$MD$US$US
239562592$23956259$2$F$$20240909$20240610$20240917$PER$$US-SA-2024SA170157$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240918$$MD$US$US
239562622$23956262$2$F$20240101$20240705$20240610$20240713$PER$$US-SA-2024SA170665$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240714$$CN$US$US
239562764$23956276$4$F$20240101$20240814$20240610$20240821$PER$$US-SA-2024SA171477$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240821$$MD$US$US
239562942$23956294$2$F$$20240916$20240610$20240923$PER$$US-SA-2024SA169724$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240923$$HP$US$US
239562972$23956297$2$F$20240501$20240629$20240610$20240708$PER$$US-SA-2024SA170555$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240708$$MD$US$US
239563072$23956307$2$F$$20240903$20240610$20240912$PER$$US-SA-2024SA170611$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240912$$MD$US$US
239563143$23956314$3$F$20240401$20240903$20240610$20240909$PER$$US-SA-2024SA169220$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240909$$HP$US$US
239563212$23956321$2$F$$20240625$20240610$20240701$PER$$US-SA-2024SA169896$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240701$$CN$US$US
239563234$23956323$4$F$20240101$20240805$20240610$20240812$PER$$US-SA-2024SA170002$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240812$$MD$US$US
239563333$23956333$3$F$20240507$20240712$20240610$20240717$EXP$$GB-MYLANLABS-2024M1051242$MYLAN$$57$YR$$M$Y$72.75$KG$20240717$$HP$GB$GB
239563482$23956348$2$F$$20240730$20240610$20240731$PER$$US-HALEON-2180799$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
239563522$23956352$2$F$20240229$20240702$20240610$20240709$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-092335$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$104$KG$20240709$$MD$ES$ES
239563632$23956363$2$F$$20240710$20240610$20240715$EXP$$CA-TAKEDA-2024TUS006949$TAKEDA$$$$$F$Y$$$20240715$$CN$CA$CA
239563722$23956372$2$F$$20240712$20240610$20240723$EXP$$JP-ROCHE-3575777$ROCHE$Fujisawa Y, Horita S and Wakabayashi K A Case of Macrophage Activation Syndrome With Elderly Onset Still^s Disease Under Tocilizumab Treatment. Doi: 10.7759/cureus.59285. Cureus 2024 Apr 29;16 (4):E59285-.$87$YR$E$F$Y$$$20240723$$HP$JP$JP
239563753$23956375$3$F$20240521$20240913$20240610$20240924$EXP$$US-UCBSA-2024028502$UCB$$16$YR$$F$Y$$$20240924$$CN$US$US
239564024$23956402$4$F$$20240916$20240610$20240919$EXP$$NVSC2024US061491$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
239564072$23956407$2$F$$20240620$20240610$20240703$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00452$UPSHER-SMITH$$$$$M$Y$66$KG$20240703$$HP$US$US
239564082$23956408$2$F$$20240911$20240610$20240916$EXP$$JP-009507513-2406JPN000599J$MERCK$$38$YR$$M$Y$$$20240916$$MD$JP$JP
239564132$23956413$2$F$20240401$20240722$20240610$20240731$PER$$US-SA-2024SA166302$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240731$$MD$US$US
239564202$23956420$2$F$20240101$20240917$20240610$20240924$PER$$US-SA-2024SA166470$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240924$$MD$US$US
239564323$23956432$3$F$20240101$20240703$20240610$20240712$PER$$US-SA-2024SA170515$SANOFI AVENTIS$$$$E$M$Y$79.3$KG$20240712$$MD$US$US
239564395$23956439$5$F$20240101$20240807$20240610$20240816$PER$$US-SA-2024SA170417$SANOFI AVENTIS$$53$YR$A$M$Y$99.7$KG$20240816$$MD$US$US
239564563$23956456$3$F$20240101$20240712$20240610$20240724$PER$$US-SA-2024SA170243$SANOFI AVENTIS$$54$YR$A$F$Y$58$KG$20240725$$MD$US$US
239564752$23956475$2$F$20240518$20240717$20240610$20240723$EXP$$IT-AUROBINDO-AUR-APL-2024-027177$AUROBINDO$$17$YR$$M$Y$$$20240723$$PH$IT$IT
239564782$23956478$2$F$$20240701$20240610$20240709$PER$$US-SA-2024SA169754$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240709$$PH$US$US
239564882$23956488$2$F$20240605$20240628$20240610$20240703$PER$$US-AMGEN-USASP2024113664$AMGEN$$67$YR$E$F$Y$$$20240703$$CN$US$US
239564892$23956489$2$F$$20240625$20240610$20240708$EXP$$AU-GENERIC HEALTH PTY. LTD.-2024-04596$LUPIN$Perucca P, Bourikas D, Voinescu PE, Vadlamudi L, Chellun D, Kumke T, et al. Lacosamide and pregnancy: Data from spontaneous and solicited reports. Epilepsia. 2024;65 (5):1275-1284.$$$$$Y$$$20240708$$HP$AU$AU
239564902$23956490$2$F$$20240717$20240610$20240722$EXP$$PT-AMGEN-PRTSP2024110379$AMGEN$$$$$M$Y$$$20240721$$MD$PT$PT
239565173$23956517$3$F$$20240708$20240610$20240715$PER$$US-SA-2024SA170602$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240715$$CN$US$US
239565183$23956518$3$F$20240201$20240812$20240610$20240819$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032587$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240819$$CN$US$US
239565293$23956529$3$F$20231212$20240912$20240610$20240919$EXP$$JP-GSK-JP2024070972$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$JP$JP
239565312$23956531$2$F$$20240717$20240610$20240718$EXP$$AU-PFIZER INC-202400188612$PFIZER$$$$$F$Y$$$20240718$$CN$AU$AU
239565432$23956543$2$F$20240510$20240716$20240610$20240726$EXP$$CN-PFIZER INC-PV202400074778$PFIZER$$77$YR$$M$Y$64$KG$20240726$$HP$CN$CN
239565562$23956556$2$F$20240412$20240909$20240610$20240913$EXP$$JP-009507513-2404JPN002084J$MERCK$$33$YR$$F$Y$$$20240913$$MD$JP$JP
239565635$23956563$5$F$$20240927$20240610$20240927$30DAY$$US-PFIZER INC-202400180986$PFIZER$$3$YR$$M$Y$$$20240927$$CN$US$US
239565942$23956594$2$F$$20240625$20240610$20240708$EXP$$AU-GENERIC HEALTH PTY. LTD.-2024-04602$LUPIN$Perucca P, Bourikas D, Voinescu PE, Vadlamudi L, Chellun D, Kumke T, et al. Lacosamide and pregnancy: Data from spontaneous and solicited reports. Epilepsia. 2024;65 (5):1275-1284$$$$$Y$$$20240708$$HP$AU$AU
239565954$23956595$4$F$20240528$20240815$20240610$20240827$PER$$US-JNJFOC-20240621615$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240827$$HP$US$US
239565973$23956597$3$F$$20240705$20240610$20240722$30DAY$$US-JNJFOC-20240607145$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$HP$US$US
239565993$23956599$3$F$$20240831$20240610$20240904$EXP$$IN-ROCHE-3576501$ROCHE$$61$YR$A$M$Y$62$KG$20240904$$CN$IN$IN
239566084$23956608$4$F$20230101$20240918$20240610$20240928$EXP$$CA-CELLTRION INC.-2023CA015622$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
239566113$23956611$3$F$20240413$20240821$20240610$20240903$EXP$$US-BIOCODEX2-2024000592$BIOCODEX$$10$YR$$F$Y$47.5$KG$20240902$$MD$US$US
239566142$23956614$2$F$$20240702$20240610$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093233$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240703$$CN$US$US
239566152$23956615$2$F$20240527$20240625$20240610$20240703$EXP$$US-ABBVIE-5795295$ABBVIE$$57$YR$$F$Y$$$20240703$$MD$US$US
239566162$23956616$2$F$20231214$20240812$20240610$20240822$EXP$GB-MHRA-MED-202406022025282920-JWGKS$GB-TEVA-VS-3206249$TEVA$$34$YR$$F$Y$90$KG$20240822$$CN$GB$GB
239566252$23956625$2$F$$20240709$20240610$20240718$PER$$US-SA-2024SA170586$SANOFI AVENTIS$$$$A$F$Y$117$KG$20240718$$MD$US$US
239566372$23956637$2$F$20240401$20240722$20240610$20240724$EXP$$US-UCBSA-2024028415$UCB$$74$YR$$F$Y$$$20240724$$CN$US$US
239566462$23956646$2$F$20240101$20240822$20240610$20240830$EXP$DE-DCGMA-24203390$DE-ROCHE-3575647$ROCHE$$89$YR$E$M$Y$72$KG$20240830$$MD$DE$DE
239566494$23956649$4$F$20240101$20240803$20240610$20240809$EXP$$US-KARYOPHARM-2024KPT001040$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240809$$CN$US$US
239566533$23956653$3$F$20210101$20240927$20240610$20240930$PER$$US-GILEAD-2024-0676296$GILEAD$$$$A$M$Y$$$20240930$$LW$US$US
239566605$23956660$5$F$20240515$20240627$20240610$20240710$30DAY$$US-JNJFOC-20240564833$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240710$$CN$US$US
2395666316$23956663$16$F$20240523$20240815$20240610$20240819$PER$$US-ROCHE-3578076$ROCHE$$76$YR$E$F$Y$$$20240819$$HP$US$US
239566662$23956666$2$F$$20240724$20240610$20240813$PER$$US-TEVA-VS-3203527$TEVA$$72$YR$$M$Y$89.77$KG$20240813$$PH$US$US
239566682$23956668$2$F$20240501$20240604$20240610$20240705$PER$$US-Eisai-EC-2024-165257$EISAI$$73$YR$E$F$Y$91$KG$20240705$$CN$US$US
239566782$23956678$2$F$20230201$20240718$20240610$20240726$EXP$$IT-AUROBINDO-AUR-APL-2024-027189$AUROBINDO$$85$YR$$F$Y$$$20240726$$MD$IT$IT
239566833$23956683$3$F$20200201$20240925$20240610$20240927$PER$$US-GILEAD-2024-0676209$GILEAD$$40$YR$A$M$Y$$$20240927$$LW$US$US
239566844$23956684$4$F$20120101$20240820$20240610$20240822$EXP$$PL-JNJFOC-20240614540$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240822$$MD$PL$PL
239566992$23956699$2$F$20240401$20240808$20240610$20240816$PER$$US-SA-2024SA169561$SANOFI AVENTIS$$31$YR$A$M$Y$87$KG$20240817$$MD$US$US
239567013$23956701$3$F$20240101$20240622$20240610$20240701$EXP$$JP-AMGEN-JPNSP2024109155$AMGEN$$73$YR$E$F$Y$$$20240701$$MD$JP$JP
239567082$23956708$2$F$$20240702$20240610$20240708$EXP$$AR-MYLANLABS-2024M1051782$MYLAN$$$$$M$Y$$$20240708$$CN$AR$AR
239567163$23956716$3$F$$20240603$20240610$20240710$PER$$SG-ROCHE-3577398$ROCHE$$39$YR$A$F$Y$$$20240628$$CN$SG$SG
239567212$23956721$2$F$20240108$20240903$20240610$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089151$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$74.3$KG$20240913$$PH$US$US
239567232$23956723$2$F$20240525$20240723$20240610$20240727$PER$$US-AstraZeneca-2024A127045$ASTRAZENECA$$24272$DY$$F$Y$$$20240728$$CN$US$
239567272$23956727$2$F$20240523$20240726$20240610$20240806$PER$$US-SA-2024SA170253$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240806$$MD$US$US
239567282$23956728$2$F$$20240709$20240610$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04731$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239567352$23956735$2$F$$20240706$20240610$20240717$EXP$$FR-AUROBINDO-AUR-APL-2024-027116$AUROBINDO$Le Bars T, Bulteau S, Bonnot O, Gollier-Briant F, Prevotel A, Choneau D, et al.. Home-based transcranial direct current stimulation in schizophrenia: Systematic literature review, a teenager case report with cost-utility analysis.. Schizophr-Res. 2024;267:441-443$16$YR$$F$Y$$$20240717$$HP$FR$FR
239567362$23956736$2$F$$20240912$20240610$20240917$30DAY$$US-SANDOZ INC.-SDZ2024US055810$SANDOZ$$$$$F$Y$$$20240917$$CN$US$US
239567372$23956737$2$F$20220101$20240604$20240610$20240829$EXP$$ES-SANDOZ INC.-SDZ2024ES055975$SANDOZ$$$$$F$Y$$$20240829$$PH$ES$ES
239567392$23956739$2$F$20240605$20240708$20240610$20240710$30DAY$$US-SANDOZ INC.-SDZ2024US053744$SANDOZ$$2$YR$$M$Y$$$20240710$$CN$US$US
239567482$23956748$2$F$$20240718$20240610$20240724$EXP$$JP-ROCHE-3578084$ROCHE$$7$DEC$E$$Y$$$20240724$$MD$JP$JP
239567525$23956752$5$F$20240101$20240809$20240610$20240809$PER$$US-PFIZER INC-202400187146$PFIZER$$74$YR$$F$Y$62.6$KG$20240809$$MD$US$US
239567582$23956758$2$F$$20240911$20240610$20240913$EXP$$GB-SANDOZ INC.-SDZ2024GB055991$SANDOZ$$$$E$F$Y$$$20240913$$CN$GB$GB
239567792$23956779$2$F$$20240703$20240610$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002454$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
239567802$23956780$2$F$$20240826$20240610$20240902$EXP$$NVSC2024US120116$NOVARTIS$$$$$F$Y$94$KG$20240902$$CN$US$US
239567822$23956782$2$F$20240311$20240725$20240610$20240803$EXP$$DE-TEVA-VS-3205750$TEVA$$$$$F$Y$$$20240803$$CN$DE$DE
239567842$23956784$2$F$$20240621$20240610$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002455$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
239567882$23956788$2$F$20240118$20240626$20240610$20240702$EXP$$JP-JNJFOC-20240616267$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240702$$MD$JP$JP
239567892$23956789$2$F$$20240808$20240610$20240809$EXP$$NVSC2024US120147$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
239567922$23956792$2$F$20240102$20240705$20240610$20240715$EXP$$IT-AUROBINDO-AUR-APL-2024-027193$AUROBINDO$$17$YR$$M$Y$60$KG$20240715$$MD$IT$IT
239567933$23956793$3$F$$20240711$20240610$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093153$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$123.38$KG$20240712$$CN$US$US
239567962$23956796$2$F$$20240627$20240610$20240814$PER$$US-LUNDBECK-DKLU3077545$LUNDBECK$$$$$$Y$$$20240814$$CN$US$US
239568022$23956802$2$F$$20240709$20240610$20240717$PER$$US-SA-2024SA155411$SANOFI AVENTIS$$$$E$M$Y$$$20240717$$MD$US$US
239568032$23956803$2$F$20240601$20240826$20240610$20240906$PER$$US-SA-2024SA167653$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240906$$MD$US$US
239568073$23956807$3$F$20240101$20240620$20240610$20240701$PER$$US-SA-2024SA170629$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240701$$MD$US$US
239568094$23956809$4$F$20240530$20240827$20240610$20240927$PER$$US-SA-2024SA170460$SANOFI AVENTIS$$60$YR$A$F$Y$68.18$KG$20240927$$MD$US$US
239568102$23956810$2$F$20240101$20240723$20240610$20240801$PER$$US-SA-2024SA170707$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240801$$MD$US$US
239568132$23956813$2$F$20240526$20240726$20240610$20240801$EXP$$AU-TAKEDA-2024TUS055275$TAKEDA$$83$YR$$F$Y$$$20240801$$CN$AU$AU
239568262$23956826$2$F$20240315$20240715$20240610$20240722$PER$$US-AMGEN-USASP2024109609$AMGEN$$63$YR$A$F$Y$$$20240722$$CN$US$US
239568283$23956828$3$F$20240225$20240815$20240610$20240819$PER$$US-AMGEN-USASP2024113778$AMGEN$$59$YR$A$F$Y$$$20240819$$CN$US$US
239568392$23956839$2$F$$20240712$20240610$20240716$EXP$$NVSC2024DE120193$NOVARTIS$$$$A$M$Y$$$20240716$$MD$DE$DE
239568533$23956853$3$F$20150101$20240919$20240610$20240923$EXP$$US-GILEAD-2024-0676283$GILEAD$$$$A$M$Y$$$20240923$$LW$US$US
239568642$23956864$2$F$20240514$20240910$20240610$20240925$30DAY$$US-BECTON DICKINSON-US-BD-24-000341$BECTON DICKINSON$$$$$$Y$$$20240925$$CN$US$US
239568692$23956869$2$F$$20240905$20240610$20240913$PER$$US-SA-2024SA169127$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240913$$MD$US$US
239568812$23956881$2$F$20240509$20240606$20240610$20240730$EXP$$US-BAYER-2024A083528$BAYER$$81$YR$E$M$Y$69.841$KG$20240730$$CN$US$US
239568922$23956892$2$F$$20240529$20240610$20240802$EXP$$PT-AUROBINDO-AUR-APL-2024-027719$AUROBINDO$Franco A, Ameiro R, Lareiro N, Martins A. HORNER^S SYNDROME A RARE COMPLICATION IN A COMMON TECHNIQUE. Region-Anesth-Pain-Med. 2023;48 (Suppl.)(1):A100$$$$F$Y$$$20240802$$HP$PT$PT
239569092$23956909$2$F$20231218$20240620$20240610$20240703$EXP$$DE-TEVA-VS-3206257$TEVA$$67$YR$$F$Y$45$KG$20240703$$MD$DE$DE
239569142$23956914$2$F$20240422$20240620$20240610$20240709$EXP$$PK-ROCHE-3578293$ROCHE$$30$YR$A$F$Y$$$20240705$$CN$PK$PK
239569153$23956915$3$F$$20240802$20240610$20240813$PER$$US-SA-2024SA169142$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240814$$MD$US$US
239569172$23956917$2$F$20240101$20240801$20240610$20240810$PER$$US-SA-2024SA169018$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240810$$MD$US$US
239569242$23956924$2$F$20180101$20240705$20240610$20240709$EXP$$NO-TAKEDA-2024TUS056706$TAKEDA$$$$A$M$Y$$$20240709$$CN$NO$NO
2395693711$23956937$11$F$$20240926$20240610$20240930$30DAY$$US-PFIZER INC-202400020523$PFIZER$$16$YR$$M$Y$52.4$KG$20240930$$CN$US$US
239569392$23956939$2$F$$20240723$20240610$20240726$PER$$US-PFIZER INC-202400187142$PFIZER$$68$YR$$F$Y$$$20240726$$CN$US$US
239569423$23956942$3$F$20240604$20240913$20240610$20240920$30DAY$$US-PFIZER INC-202400187565$PFIZER$$14$YR$$M$Y$$$20240920$$CN$US$US
239569435$23956943$5$F$20240601$20240828$20240610$20240904$PER$$US-PFIZER INC-PV202400073950$PFIZER$$71$YR$$F$Y$$$20240904$$HP$US$US
239569443$23956944$3$F$$20240916$20240610$20240917$30DAY$$AR-PFIZER INC-202400113151$PFIZER$$8$YR$$M$Y$$$20240917$$CN$AR$AR
239569453$23956945$3$F$$20240718$20240610$20240718$PER$$US-PFIZER INC-202400187834$PFIZER$$55$YR$$F$Y$95.25$KG$20240718$$CN$US$US
239569634$23956963$4$F$$20240812$20240610$20240816$30DAY$$AU-PFIZER INC-202400172029$PFIZER$$$$$F$Y$$$20240816$$PH$AU$AU
239569656$23956965$6$F$$20240820$20240610$20240830$30DAY$$US-PFIZER INC-202400186970$PFIZER$$11$YR$$M$Y$$$20240830$$CN$US$US
239569663$23956966$3$F$$20240826$20240610$20240903$30DAY$$DE-PFIZER INC-202400187168$PFIZER$$$$$$Y$$$20240903$$HP$DE$DE
239569672$23956967$2$F$20200124$20240802$20240610$20240802$EXP$$AR-PFIZER INC-202400188404$PFIZER$$6$YR$$M$Y$$$20240802$$CN$AR$AR
239569687$23956968$7$F$$20240809$20240610$20240819$30DAY$$US-PFIZER INC-202400187296$PFIZER$$14$YR$$M$Y$$$20240819$$HP$US$US
239569693$23956969$3$F$$20240922$20240610$20240925$30DAY$$US-PFIZER INC-202400181965$PFIZER$$17$YR$$M$Y$$$20240925$$CN$US$US
239569704$23956970$4$F$$20240626$20240610$20240701$EXP$$CA-PFIZER INC-202400185579$PFIZER$$59$YR$$F$Y$$$20240701$$HP$CA$CA
239569713$23956971$3$F$$20240915$20240610$20240918$30DAY$$CO-PFIZER INC-202400181694$PFIZER$$8$YR$$M$Y$$$20240918$$CN$CO$CO
239569732$23956973$2$F$20240530$20240729$20240610$20240801$EXP$$JP-ARGENX-2024-ARGX-JP004149AA$ARGENX BVBA$$$$$$Y$$$20240801$$MD$JP$JP
239569782$23956978$2$F$20220601$20240529$20240610$20240702$EXP$$RO-AUROBINDO-AUR-APL-2024-027422$AUROBINDO$unknown. Pneumologia.. 2022;71 No. 4$54$YR$$F$Y$$$20240702$$HP$RO$RO
239569952$23956995$2$F$$20240709$20240610$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093143$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$93.89$KG$20240710$$CN$US$US
239569982$23956998$2$F$$20240808$20240610$20240809$EXP$$DE-MYLANLABS-2024M1052329$MYLAN$Broecker S, Pragst F, Bakdash A, Herre S, Tsokos M. Combined use of liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) and high performance liquid chromatography with photodiode array detector (HPLC-DAD) in systematic toxicological analysis. Forensic-Sci-Int 2011; 215-226.$69$YR$$M$Y$$$20240809$$HP$DE$DE
239569992$23956999$2$F$20240602$20240813$20240610$20240820$EXP$$US-AMGEN-USASP2024110245$AMGEN$$65$YR$E$M$Y$$$20240820$$MD$US$US
239570142$23957014$2$F$20240311$20240726$20240610$20240806$EXP$$DE-AUROBINDO-AUR-APL-2024-027391$AUROBINDO$$$$$F$Y$$$20240806$$CN$DE$DE
239570163$23957016$3$F$20230810$20240805$20240610$20240815$EXP$FR-AFSSAPS-LM2024000282$FR-TEVA-VS-3205749$TEVA$$0$DY$$F$Y$2$KG$20240815$$MD$FR$FR
239570232$23957023$2$F$20240531$20240715$20240610$20240717$PER$$US-AMGEN-USASP2024111797$AMGEN$$34$YR$A$F$Y$$$20240717$$CN$US$US
239570393$23957039$3$F$20240318$20240708$20240610$20240709$EXP$GB-MHRA-MED-202406072253334710-KPMDR$GB-MYLANLABS-2024M1052518$MYLAN$$24$YR$$M$Y$78$KG$20240709$$CN$GB$GB
239570442$23957044$2$F$$20240814$20240610$20240816$30DAY$$KR-PFIZER INC-202400188675$PFIZER$$11$YR$$$Y$$$20240816$$CN$KR$KR
239570463$23957046$3$F$$20240820$20240610$20240822$30DAY$$KR-PFIZER INC-202400188586$PFIZER$$12$YR$$$Y$$$20240822$$CN$KR$KR
239570482$23957048$2$F$20240522$20240823$20240610$20240829$30DAY$$GB-PFIZER INC-PV202400075196$PFIZER$$$$$$Y$$$20240829$$HP$GB$GB
239570522$23957052$2$F$$20240626$20240610$20240701$EXP$$ES-AstraZeneca-2024A132501$ASTRAZENECA$$$$$F$Y$$$20240701$$MD$ES$
239570563$23957056$3$F$$20240813$20240610$20240823$PER$$US-RADIUS HEALTH, INC.-2024US004083$RADIUS PHARM$$$$$F$Y$$$20240823$$MD$US$US
239570602$23957060$2$F$$20240906$20240610$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-092836$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240906$$MD$JP$JP
239570642$23957064$2$F$$20240702$20240610$20240710$PER$$US-BIOGEN-2017BI00500872$BIOGEN$$$$$F$Y$$$20240710$$CN$US$US
239570782$23957078$2$F$$20240826$20240610$20240829$EXP$$JP-GILEAD-2024-0675591$GILEAD$Muraoka M, Osawa R, Komiyama Y, Suzuki Y, Sato M, Maekawa S, et al.. O-67 Study on establishment of a highly sensitive quantitative detection method for cell free DNA in mutated TERT promoter and evaluation of cancer risk after SVR in hepatitis C. Acta Hepatologica Japonica. 2024;65(S1):A383$$$$F$Y$$$20240829$$MD$JP$JP
239570803$23957080$3$F$20240113$20240807$20240610$20240814$EXP$$JP-BAYER-2024A018577$BAYER$$60$YR$A$M$Y$$$20240814$$MD$JP$JP
239570866$23957086$6$F$20221126$20240805$20240610$20240813$EXP$$FR-EMD Serono-2024031610$EMD SERONO INC$$92$YR$E$M$Y$$$20240813$$MD$FR$FR
239570912$23957091$2$F$20240101$20240725$20240610$20240729$EXP$$US-UCBSA-2024027797$UCB$$$$$M$Y$$$20240729$$CN$US$US
239570923$23957092$3$F$20240101$20240612$20240610$20240704$EXP$$US-ORGANON-O2406USA000616$ORGANON$$$$$F$Y$$$20240704$$MD$US$US
239571122$23957112$2$F$$20240625$20240610$20240705$EXP$$AU-GENERIC HEALTH PTY. LTD.-2024-04600$LUPIN$Perucca P, Bourikas D, Voinescu PE, Vadlamudi L, Chellun D, Kumke T, et al. Lacosamide and pregnancy: data from spontaneous and solicited reports. Epilepsia. 2024;65 (5):1275-1284$$$$$Y$$$20240705$$HP$AU$AU
239571222$23957122$2$F$20240604$20240806$20240610$20240808$PER$$US-AMGEN-USASP2024113756$AMGEN$$54$YR$A$F$Y$$$20240807$$CN$US$US
239571263$23957126$3$F$$20240606$20240610$20240711$EXP$$NVSC2024AR120638$NOVARTIS$$15$YR$$F$Y$$$20240711$$CN$AR$AR
239571302$23957130$2$F$$20240722$20240610$20240722$PER$$US-ALXN-202406USA000146US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$MD$US$US
239571313$23957131$3$F$$20240722$20240610$20240722$PER$$US-ALXN-202406USA000195US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
239571363$23957136$3$F$$20240624$20240610$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04733$LUPIN$$$$$$Y$$$20240705$$CN$US$US
239571412$23957141$2$F$20230316$20240716$20240610$20240717$EXP$$US-UCBSA-2024027577$UCB$$27$YR$$F$Y$53.1$KG$20240717$$MD$US$US
239571435$23957143$5$F$$20240725$20240610$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091501$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240729$$CN$US$US
239571522$23957152$2$F$$20240605$20240610$20240723$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-082004$REGENERON$$$$$F$Y$$$20240723$$CN$US$US
239571604$23957160$4$F$$20240903$20240610$20240906$PER$$US-PHARMING-PHAUS2024000442$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
239571623$23957162$3$F$$20240909$20240610$20240916$PER$$US-PHARMING-PHAUS2024000440$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
239571733$23957173$3$F$20240417$20240916$20240610$20240924$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-082898$REGENERON$$64$YR$$M$Y$$$20240924$$HP$CO$CO
239571752$23957175$2$F$20240411$20240703$20240610$20240712$EXP$$JP-BEH-2024172165$CSL BEHRING$$79$YR$E$M$Y$54$KG$20240712$$MD$JP$JP
239571922$23957192$2$F$20240329$20240725$20240610$20240726$EXP$FR-AFSSAPS-GR2024000662$FR-PFIZER INC-202400186130$PFIZER$$81$YR$$F$Y$$$20240726$$PH$FR$FR
239571932$23957193$2$F$$20240814$20240610$20240816$EXP$$US-PFIZER INC-202400062041$PFIZER$$88$YR$$F$Y$$$20240816$$HP$US$US
239571982$23957198$2$F$$20240710$20240610$20240715$EXP$$US-PFIZER INC-202400187975$PFIZER$$52$YR$$F$Y$$$20240715$$HP$US$US
239572012$23957201$2$F$20220101$20240805$20240610$20240805$EXP$$JP-PFIZER INC-PV202400074742$PFIZER$$7$DEC$$M$Y$60$KG$20240805$$PH$JP$JP
239572023$23957202$3$F$20231101$20240706$20240610$20240717$EXP$$ES-AUROBINDO-AUR-APL-2024-027321$AUROBINDO$$56$YR$$F$Y$$$20240717$$HP$ES$ES
239572033$23957203$3$F$20240301$20240725$20240610$20240731$EXP$$MX-TAKEDA-2024TUS032977$TAKEDA$$21$YR$$M$Y$$$20240731$$CN$MX$MX
239572055$23957205$5$F$20240501$20240925$20240610$20240930$EXP$$US-TAKEDA-2023TUS026504$TAKEDA$$60$YR$$F$Y$64$KG$20240930$$HP$US$US
239572072$23957207$2$F$20240401$20240627$20240610$20240702$PER$$US-SA-2024SA170372$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240702$$MD$US$US
239572174$23957217$4$F$20240602$20240812$20240610$20240812$PER$$US-ALXN-202406USA000107US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
239572352$23957235$2$F$20240501$20240701$20240610$20240704$PER$$US-MYLANLABS-2024M1043872$MYLAN$$77$YR$$F$Y$49.9$KG$20240704$$CN$US$US
239572452$23957245$2$F$20240418$20240628$20240610$20240712$EXP$$US-SA-2024SA144091$SANOFI AVENTIS$$56$YR$A$M$Y$82$KG$20240712$$MD$US$US
239572593$23957259$3$F$20240101$20240916$20240610$20240924$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00275$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
239572632$23957263$2$F$$20240717$20240610$20240723$EXP$$JP-OTSUKA-2024_015774$OTSUKA$$56$YR$$M$Y$$$20240723$$CN$JP$JP
239572683$23957268$3$F$$20240701$20240610$20240712$PER$$US-MYLANLABS-2024M1046970$MYLAN$$63$YR$$M$Y$$$20240712$$CN$US$US
239572733$23957273$3$F$$20240723$20240610$20240730$EXP$$GB-MYLANLABS-2024M1051562$MYLAN$$$$$M$Y$$$20240730$$HP$GB$GB
239572792$23957279$2$F$$20240724$20240610$20240729$EXP$$NZ-MYLANLABS-2024M1051515$MYLAN$$$$$F$Y$$$20240729$$CN$NZ$NZ
239572953$23957295$3$F$20230523$20240813$20240610$20240819$EXP$$JP-BEH-2024173430$CSL BEHRING$$12$YR$T$M$Y$33$KG$20240819$$MD$JP$JP
239573092$23957309$2$F$$20240729$20240610$20240731$PER$$US-ALXN-202406USA000165US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239573223$23957322$3$F$$20240624$20240610$20240703$PER$$US-SA-2024SA146324$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240703$$MD$US$US
239573232$23957323$2$F$$20240706$20240610$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-027400$AUROBINDO$Salwa N, Singh T. ASEPTIC PD ASSOCIATED PERITONITIS- A POSSIBLE RARE COMPLICATION CAUSED BY REJECTED RENAL GRAFT. Am-J-Kidney-Dis. 2024;83 (Suppl 2)(4):S150$61$YR$$F$Y$$$20240718$$HP$US$US
239573274$23957327$4$F$20240525$20240923$20240610$20240927$EXP$$US-AMGEN-USASP2024112081$AMGEN$$83$YR$E$F$Y$40.816$KG$20240927$$MD$US$US
239573303$23957330$3$F$20240514$20240911$20240610$20240921$EXP$$DE-AUROBINDO-AUR-APL-2024-027110$AUROBINDO$$$$A$F$Y$108$KG$20240921$$MD$DE$DE
239573312$23957331$2$F$20240530$20240715$20240610$20240719$EXP$$SE-DSJP-DSE-2024-125326$DAIICHI$$74$YR$$F$Y$$$20240719$$MD$SE$SE
239573342$23957334$2$F$20040101$20240726$20240610$20240730$EXP$$US-UCBSA-2024014241$UCB$$$$$F$Y$$$20240730$$CN$US$US
239573392$23957339$2$F$20240507$20240709$20240610$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-026827$AUROBINDO$$69$YR$$F$Y$73$KG$20240718$$MD$FR$FR
239573462$23957346$2$F$$20240709$20240610$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04721$LUPIN$$$$$$Y$$$20240801$$CN$US$US
239573613$23957361$3$F$20240101$20240812$20240610$20240820$PER$$US-SA-2024SA167711$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240820$$MD$US$US
239573676$23957367$6$F$20240602$20240717$20240610$20240723$30DAY$$US-JNJFOC-20240603306$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
239573712$23957371$2$F$$20240604$20240610$20240712$EXP$$NVSC2024AR120570$NOVARTIS$$$$$F$Y$$$20240712$$CN$AR$AR
239573733$23957373$3$F$20240517$20240819$20240610$20240830$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406002907$ELI LILLY AND CO$$63$YR$A$F$Y$72.5$KG$20240830$$CN$JP$JP
239573872$23957387$2$F$20240401$20240621$20240610$20240701$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406000854$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240701$$CN$JP$JP
239573912$23957391$2$F$20240201$20240730$20240610$20240807$EXP$$US-CELLTRION INC.-2024US013712$CELLTRION$$$$$$Y$$$20240807$$CN$US$US
239573993$23957399$3$F$20240101$20240731$20240610$20240813$PER$$US-INSUD PHARMA-2406US04523$INSUD PHARMA$$$$$$Y$$$20240813$$CN$US$US
239574015$23957401$5$F$20240510$20240815$20240610$20240822$EXP$$CA-ROCHE-3579491$ROCHE$$36$YR$A$F$Y$$$20240822$$MD$CA$CA
239574103$23957410$3$F$$20240722$20240610$20240722$PER$$US-ALXN-202406USA000099US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
239574153$23957415$3$F$20180101$20240925$20240610$20240927$PER$$US-GILEAD-2024-0676210$GILEAD$$$$A$M$Y$$$20240927$$LW$US$US
239574162$23957416$2$F$20240101$20240718$20240610$20240725$EXP$$US-ABBVIE-5789310$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
239574272$23957427$2$F$$20240916$20240610$20240923$PER$$US-SA-2024SA167427$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240923$$MD$US$US
239574412$23957441$2$F$$20240725$20240610$20240801$EXP$$US-GSK-US2024070115$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
239574496$23957449$6$F$20240101$20240821$20240610$20240904$EXP$$CA-UCBSA-2024015443$UCB$$$$$F$Y$$$20240904$$CN$CA$CA
239574502$23957450$2$F$$20240607$20240610$20240821$PER$$NVSC2024US120786$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
239574622$23957462$2$F$20220101$20240827$20240610$20240903$EXP$$CA-JNJFOC-20220842942$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240904$$HP$CA$CA
239574662$23957466$2$F$$20240627$20240610$20240701$EXP$$NVSC2024CN120216$NOVARTIS$$61$YR$$M$Y$$$20240701$$CN$CN$CN
239574813$23957481$3$F$20100812$20240924$20240610$20240926$EXP$$US-GILEAD-2024-0676359$GILEAD$$41$YR$A$M$Y$$$20240926$$LW$US$US
239574842$23957484$2$F$$20240718$20240610$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093197$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240719$$CN$US$US
239575032$23957503$2$F$20240515$20240621$20240610$20240703$EXP$$UA-ELI_LILLY_AND_COMPANY-GB202405016975$ELI LILLY AND CO$$49$YR$A$F$Y$82$KG$20240703$$HP$UA$GB
239575133$23957513$3$F$20230105$20240806$20240610$20240813$EXP$$JP-EXELIXIS-CABO-24078098$EXELIXIS$$80$YR$$M$Y$56.1$KG$20240812$$MD$JP$JP
239575142$23957514$2$F$20240201$20240801$20240610$20240812$EXP$$JP-ROCHE-3579557$ROCHE$$$$A$F$Y$$$20240812$$MD$JP$JP
239575292$23957529$2$F$$20240724$20240610$20240801$PER$$US-FreseniusKabi-FK202409043$FRESENIUS KABI$$$$$$Y$$$20240801$$PH$US$US
239575322$23957532$2$F$20240606$20240826$20240610$20240904$EXP$$JP-ROCHE-3579560$ROCHE$$77$YR$E$M$Y$$$20240904$$MD$JP$JP
239575442$23957544$2$F$$20240906$20240610$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091907$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240906$$HP$US$US
239575462$23957546$2$F$20240501$20240807$20240610$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089708$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240813$$CN$US$US
239575622$23957562$2$F$20230806$20240701$20240610$20240709$EXP$AU-ROCHE-3532897$AU-PERRIGO-24AU005303$PERRIGO$$75$YR$$M$Y$116$KG$20240709$$HP$AU$AU
239575684$23957568$4$F$20240701$20240910$20240610$20240918$PER$$US-SA-2024SA167536$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240918$$MD$US$US
239575832$23957583$2$F$20240425$20240614$20240610$20240703$PER$$US-TOLMAR, INC.-24US049092$TOLMAR$$$$$M$Y$$$20240703$$PH$US$US
239575842$23957584$2$F$$20240613$20240610$20240704$PER$$US-TOLMAR, INC.-24US049115$TOLMAR$$$$$M$Y$$$20240703$$HP$US$US
239575862$23957586$2$F$$20240613$20240610$20240704$PER$$US-TOLMAR, INC.-24US049116$TOLMAR$$$$$$Y$$$20240703$$PH$US$US
239575962$23957596$2$F$$20240621$20240610$20240716$PER$$US-TOLMAR, INC.-24US049434$TOLMAR$$$$$$Y$$$20240716$$HP$US$US
239575982$23957598$2$F$20240516$20240626$20240610$20240724$PER$$US-TOLMAR, INC.-24US049443$TOLMAR$$64$YR$$M$Y$82.54$KG$20240724$$HP$US$US
239576272$23957627$2$F$$20240813$20240610$20240820$EXP$$US-BAYER-2024A063442$BAYER$$78$YR$E$F$Y$$$20240820$$CN$US$US
239576412$23957641$2$F$20240301$20240829$20240610$20240923$PER$$US-SA-2024SA171614$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240923$$MD$US$US
239576542$23957654$2$F$$20240807$20240610$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092996$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240808$$CN$US$US
239576552$23957655$2$F$$20240627$20240610$20240701$EXP$$NVSC2024US120964$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
239576722$23957672$2$F$$20240723$20240610$20240723$EXP$$US-ALXN-202406USA000391US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$HP$US$US
239576744$23957674$4$F$20240429$20240725$20240610$20240802$EXP$$US-SA-2024SA172564$SANOFI AVENTIS$$76$YR$E$F$Y$76.6$KG$20240802$$MD$US$US
239576753$23957675$3$F$20240515$20240919$20240610$20240926$EXP$$US-OTSUKA-2024_015810$OTSUKA$$42$YR$$F$Y$110.22$KG$20240926$$MD$US$US
239576812$23957681$2$F$$20240628$20240610$20240708$PER$$US-MYLANLABS-2024M1044916$MYLAN$$$$$F$Y$45.35$KG$20240708$$CN$US$US
239576882$23957688$2$F$$20240703$20240610$20240705$PER$$US-AMGEN-USASP2024112149$AMGEN$$$$$F$Y$$$20240704$$HP$US$US
239576923$23957692$3$F$20240607$20240701$20240610$20240702$EXP$$JP-PFIZER INC-202400189017$PFIZER$$3$YR$$M$Y$14.2$KG$20240702$$MD$JP$JP
239576942$23957694$2$F$$20240628$20240610$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075009$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$90.72$KG$20240701$$CN$US$US
239576973$23957697$3$F$$20240807$20240610$20240807$EXP$$GB-JNJFOC-20230240023$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240807$$HP$GB$GB
239576983$23957698$3$F$$20240626$20240610$20240701$EXP$$JP-JNJFOC-20240621857$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$JP$JP
239577012$23957701$2$F$20230601$20240731$20240610$20240807$EXP$$US-AMGEN-USASP2024110028$AMGEN$$68$YR$E$M$Y$$$20240807$$LW$US$US
239577042$23957704$2$F$$20240708$20240610$20240711$EXP$$PL-MYLANLABS-2024M1048429$MYLAN$Wcislo S, Bojkowska-Otr?bska K, Salamon A, Skowronek A, Kandziora K, ?abuz-Roszak B. Cytotoxic lesion of the corpus callosum - three case reports. Polish Neurological Review. 2024;(20) 1:37-42$33$YR$$M$Y$$$20240711$$HP$PL$PL
239577203$23957720$3$F$20240322$20240709$20240610$20240716$EXP$$GB-ABBVIE-5795063$ABBVIE$$80$YR$$M$Y$97$KG$20240716$$MD$GB$GB
239577252$23957725$2$F$$20240713$20240610$20240723$PER$$US-SA-2024SA165530$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240723$$CN$US$US
239577382$23957738$2$F$$20240909$20240610$20240911$EXP$$US-BAYER-2024A083652$BAYER$$22$YR$A$M$Y$$$20240911$$HP$US$US
239577392$23957739$2$F$20240101$20240730$20240610$20240808$PER$$US-SA-2024SA165604$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240808$$MD$US$US
239577404$23957740$4$F$20231227$20240729$20240610$20240731$EXP$$LV-ROCHE-3579095$ROCHE$$14$YR$T$M$Y$35$KG$20240731$$MD$LV$LV
239577512$23957751$2$F$20230614$20240729$20240610$20240730$EXP$PT-INFARMED-J202405-868$PT-GILEAD-2024-0675570$GILEAD$$59$YR$A$M$Y$85$KG$20240730$$CN$PT$PT
239577655$23957765$5$F$$20240925$20240610$20240927$EXP$$CZ-MYLANLABS-2024M1051848$MYLAN$Cmunt E. Treatment of relapsed/progressed diffuse large cell lymphoma with the tafasitamab + lenalidomide regimen. ACTA MEDICINAE-Case reports and treatment options in oncology and haematooncol.. 2024;13(4-Ext 2/3)42:45-46$67$YR$$F$Y$$$20240927$$MD$CZ$CZ
239577942$23957794$2$F$$20240711$20240610$20240721$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-000962$AKEBIA THERAPEUTICS$$9$DEC$$F$Y$$$20240719$$MD$JP$JP
239577982$23957798$2$F$$20240614$20240610$20240729$EXP$GB-Zentiva-2024-ZT-010613$GB-MYLANLABS-2024M1052083$MYLAN$Jones S, Haigh D, Devine K. A case of haemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in a patient with advanced HIV. Clinical Infection in Practice. 2024;22$36$YR$$F$Y$$$20240729$$MD$GB$GB
239578332$23957833$2$F$$20240724$20240610$20240731$EXP$$CA-GSK-CA2024069283$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$CA$CA
239578402$23957840$2$F$20240606$20240718$20240610$20240722$PER$$US-JNJFOC-20240616061$JOHNSON AND JOHNSON$$66$YR$E$$Y$$$20240722$$HP$US$US
239578465$23957846$5$F$20240504$20240723$20240610$20240725$EXP$$MX-BIOVITRUM-2024-MX-008328$BIOVITRUM$$41$DY$$M$Y$4.6$KG$20240725$$CN$MX$MX
239578612$23957861$2$F$20240325$20240815$20240610$20240816$EXP$$NVSC2024TR119241$NOVARTIS$$39$YR$$M$Y$80$KG$20240816$$MD$TR$TR
239578642$23957864$2$F$20240601$20240909$20240610$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092800$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$75.465$KG$20240909$$CN$US$US
239578652$23957865$2$F$$20240704$20240610$20240711$EXP$$CA-GSK-CA2024069315$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$CA$CA
239578672$23957867$2$F$$20240529$20240610$20240703$EXP$$JP-AstraZeneca-2024A128491$ASTRAZENECA$$$$$$Y$$$20240703$$PH$JP$
239578692$23957869$2$F$20240511$20240821$20240610$20240822$30DAY$$CL-PFIZER INC-202400188384$PFIZER$$13$YR$$$Y$$$20240822$$CN$CL$CL
239578702$23957870$2$F$$20240727$20240610$20240730$30DAY$$CO-PFIZER INC-PV202400068300$PFIZER$$15$YR$$M$Y$$$20240730$$CN$CO$CO
239578715$23957871$5$F$$20240829$20240610$20240903$30DAY$$US-PFIZER INC-202400090257$PFIZER$$15$YR$$M$Y$$$20240903$$HP$US$US
239578803$23957880$3$F$$20240926$20240610$20240927$PER$$US-PFIZER INC-PV202400075533$PFIZER$$60$YR$$F$Y$$$20240927$$HP$US$US
239578942$23957894$2$F$$20240802$20240610$20240808$PER$$US-PFIZER INC-PV202400075481$PFIZER$$68$YR$$F$Y$$$20240808$$CN$US$US
239579032$23957903$2$F$20240101$20240813$20240610$20240814$PER$$US-PFIZER INC-202400189558$PFIZER$$68$YR$$F$Y$$$20240814$$HP$US$US
239579062$23957906$2$F$20240101$20240812$20240610$20240814$PER$$US-PFIZER INC-PV202400075101$PFIZER$$42$YR$$F$Y$$$20240814$$HP$US$US
239579123$23957912$3$F$$20240806$20240610$20240806$EXP$$US-PFIZER INC-PV202400075639$PFIZER$$70$YR$$F$Y$$$20240806$$HP$US$US
239579143$23957914$3$F$$20240625$20240610$20240701$PER$$US-PFIZER INC-202400189591$PFIZER$$67$YR$$F$Y$$$20240701$$HP$US$US
239579212$23957921$2$F$20200101$20240820$20240610$20240826$PER$$US-PFIZER INC-202400188898$PFIZER$$59$YR$$F$Y$$$20240826$$HP$US$US
239579342$23957934$2$F$20240606$20240702$20240610$20240704$PER$$US-PFIZER INC-202400189306$PFIZER$$80$YR$$F$Y$71.293$KG$20240704$$CN$US$US
239579372$23957937$2$F$$20240904$20240610$20240906$PER$$US-PFIZER INC-202400189030$PFIZER$$48$YR$$F$Y$$$20240906$$CN$US$US
239579393$23957939$3$F$$20240722$20240610$20240731$EXP$$US-TEVA-VS-3196526$TEVA$$34$WK$$M$Y$2.02$KG$20240731$$HP$US$US
239579403$23957940$3$F$20240501$20240703$20240610$20240711$EXP$$JP-009507513-2406JPN000455J$MERCK$$8$DEC$$F$Y$$$20240711$$MD$JP$JP
239579424$23957942$4$F$20240301$20240729$20240610$20240805$EXP$$NVSC2024KR120237$NOVARTIS$$41$YR$$F$Y$$$20240805$$MD$KR$KR
239579512$23957951$2$F$20240301$20240822$20240610$20240828$EXP$$JP-009507513-2406JPN000407J$MERCK$$60$YR$$F$Y$$$20240828$$MD$JP$JP
239579583$23957958$3$F$$20240812$20240610$20240816$EXP$$CA-JNJFOC-20240513737$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240816$$CN$CA$CA
239579695$23957969$5$F$20240101$20240709$20240610$20240725$EXP$$NZ-ADVANZ PHARMA-202405004655$ADVANZ PHARMA$$$$$$Y$$$20240725$$HP$NZ$NZ
239579702$23957970$2$F$20240525$20240606$20240610$20240724$PER$$US-GILEAD-2024-0676289$GILEAD$$$$$M$Y$$$20240724$$CN$US$US
239579743$23957974$3$F$20240227$20240626$20240610$20240704$EXP$$CA-AstraZeneca-2024A134036$ASTRAZENECA$$15172$DY$$F$Y$$$20240704$$CN$CA$
239579754$23957975$4$F$20240101$20240802$20240610$20240807$PER$$US-BIOGEN-2024BI01267518$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
239579832$23957983$2$F$20240525$20240703$20240610$20240708$EXP$$US-PFIZER INC-2024SGN05875$PFIZER$$62$YR$$M$Y$$$20240708$$CN$US$US
239579852$23957985$2$F$$20240703$20240610$20240714$EXP$$US-ZENPEP LLC-2024AIMT00903$AIMMUNE$$$$$$Y$$$20240714$$HP$US$US
239579872$23957987$2$F$$20240731$20240610$20240813$EXP$$ID-VER-202400001$VERITY PHARMACEUTICALS$$$$$F$Y$$$20240813$$MD$ID$ID
239579915$23957991$5$F$20240101$20240905$20240610$20240909$PER$$US-PFIZER INC-PV202400074279$PFIZER$$62$YR$$F$Y$$$20240909$$HP$US$US
239579922$23957992$2$F$$20240711$20240610$20240711$PER$$US-PFIZER INC-202400189681$PFIZER$$65$YR$$F$Y$$$20240711$$CN$US$US
239579942$23957994$2$F$$20240705$20240610$20240708$PER$$US-PFIZER INC-PV202300206379$PFIZER$$90$YR$$F$Y$$$20240708$$MD$US$US
239580252$23958025$2$F$20230101$20240710$20240610$20240717$EXP$$US-SANDOZ INC.-SDZ2023US007186$SANDOZ$$93$YR$$M$Y$$$20240717$$MD$US$US
239580292$23958029$2$F$20240604$20240710$20240610$20240710$PER$$US-AMGEN-USASP2024114049$AMGEN$$60$YR$A$M$Y$$$20240710$$CN$US$US
239580322$23958032$2$F$$20240620$20240610$20240701$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-000965$AKEBIA THERAPEUTICS$$$$$$Y$$$20240701$$MD$JP$JP
239580412$23958041$2$F$$20240909$20240610$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093263$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240909$$CN$US$US
239580422$23958042$2$F$$20240705$20240610$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092908$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240710$$CN$US$US
239580532$23958053$2$F$$20240726$20240610$20240730$EXP$$JP-WT-2024-066170$Waylis$$$$$M$Y$$$20240730$$PH$JP$JP
239580554$23958055$4$F$20240601$20240815$20240610$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-007998$JAZZ$$81$YR$$M$Y$$$20240821$$MD$US$US
239580683$23958068$3$F$$20240925$20240610$20240927$EXP$$US-TAKEDA-2024TUS016625$TAKEDA$$$$$F$Y$105$KG$20240927$$CN$US$US
239580762$23958076$2$F$$20240709$20240610$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093170$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$93.89$KG$20240710$$CN$US$US
239580832$23958083$2$F$$20240627$20240610$20240703$EXP$$CA-TAKEDA-2024TUS056796$TAKEDA$$$$$M$Y$$$20240703$$CN$CA$CA
239580873$23958087$3$F$$20240726$20240610$20240731$30DAY$$PL-MYLANLABS-2024M1051475$MYLAN$$$$$$Y$$$20240731$$CN$PL$PL
239581073$23958107$3$F$20231201$20240809$20240610$20240823$EXP$$DE-VER-202400004$VERITY PHARMACEUTICALS$$57$YR$A$M$Y$109$KG$20240823$$HP$DE$DE
239581125$23958112$5$F$20240512$20240823$20240610$20240829$EXP$$CA-TAKEDA-2024TUS056834$TAKEDA$$40$YR$$M$Y$$$20240829$$CN$CA$CA
239581182$23958118$2$F$$20240925$20240610$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093260$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240926$$CN$US$US
239581353$23958135$3$F$20240522$20240729$20240610$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024064993$VIIV$$$$$$Y$$$20240808$$PH$US$US
239581369$23958136$9$F$20240601$20240903$20240610$20240905$PER$$US-BIOGEN-2024BI01268150$BIOGEN$$57$YR$$F$Y$$$20240905$$CN$US$US
239581422$23958142$2$F$$20240723$20240610$20240731$PER$$US-INCYTE CORPORATION-2024IN005580$INCYTE$$$$$$Y$$$20240731$$MD$US$US
239581453$23958145$3$F$20240518$20240805$20240610$20240809$EXP$$US-SA-2024SA170433$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240809$$MD$US$US
239581462$23958146$2$F$$20240627$20240610$20240705$EXP$$US-Calliditas-2024CAL00978$CALLIDITAS THERAPEUTICS$$83$YR$E$M$Y$83$KG$20240705$$CN$US$US
239581472$23958147$2$F$$20240724$20240610$20240725$PER$$NVSC2024US120069$NOVARTIS$$$$$F$Y$$$20240725$$HP$US$US
239581498$23958149$8$F$20240401$20240910$20240610$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-015903$JAZZ$$50$YR$$M$Y$$$20240913$$CN$US$US
239581623$23958162$3$F$$20240918$20240610$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092188$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$86.64$KG$20240919$$CN$US$US
239581842$23958184$2$F$20240422$20240711$20240610$20240716$EXP$$JP-SHIONOGI INC.-2024001264$SHIONOGI$$$$$$Y$$$20240716$$MD$JP$JP
239581902$23958190$2$F$20230921$20240719$20240610$20240723$EXP$$US-ORGANON-O2406USA000636$ORGANON$$33$YR$$F$Y$98.413$KG$20240723$$HP$US$US
239581972$23958197$2$F$20240101$20240703$20240610$20240705$EXP$$US-PFIZER INC-PV202400074856$PFIZER$$70$YR$$F$Y$72.562$KG$20240705$$CN$US$US
239582092$23958209$2$F$20240801$20240813$20240610$20240815$PER$$US-PFIZER INC-PV202400075526$PFIZER$$71$YR$$F$Y$$$20240815$$HP$US$US
239582122$23958212$2$F$$20240705$20240610$20240709$EXP$$US-PFIZER INC-PV202400074756$PFIZER$Silverman, R.. Poststeroid Panniculitis: A Case Report. Pediatrics Dermatology. 1988;5(2):92-93$$$I$F$Y$$$20240709$$MD$US$US
239582153$23958215$3$F$20240101$20240701$20240610$20240702$EXP$$DE-PFIZER INC-202400188290$PFIZER$$$$$F$Y$65$KG$20240702$$MD$DE$DE
239582262$23958226$2$F$20240521$20240521$20240610$20240812$PER$$US-SA-2024SA171286$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240812$$CN$US$US
239582272$23958227$2$F$$20240715$20240610$20240723$PER$$US-SA-2024SA170183$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240723$$MD$US$US
239582292$23958229$2$F$20240523$20240724$20240610$20240730$30DAY$$CO-PFIZER INC-PV202400069101$PFIZER$$8$YR$$F$Y$22$KG$20240730$$PH$CO$CO
239582373$23958237$3$F$20240513$20240701$20240610$20240709$EXP$$FR-AstraZeneca-2024A134340$ASTRAZENECA$$56$YR$$M$Y$$$20240709$$MD$FR$
239582443$23958244$3$F$20231026$20240806$20240610$20240809$EXP$$GB-MYLANLABS-2023M1114225$MYLAN$$32$YR$$F$Y$$$20240809$$MD$GB$GB
239582703$23958270$3$F$$20240819$20240610$20240823$EXP$$GB-MYLANLABS-2024M1052021$MYLAN$$53$YR$$F$Y$77$KG$20240823$$MD$GB$GB
239582902$23958290$2$F$$20240806$20240610$20240808$EXP$$US-SANDOZ INC.-SDZ2024US056388$SANDOZ$$$$$F$Y$$$20240808$$CN$US$US
239582922$23958292$2$F$$20240916$20240610$20240918$30DAY$$US-SANDOZ INC.-SDZ2024US056274$SANDOZ$$$$$F$Y$$$20240918$$CN$US$US
239582962$23958296$2$F$$20240917$20240610$20240920$EXP$$US-SANDOZ INC.-SDZ2024US056405$SANDOZ$$$$$F$Y$$$20240920$$CN$US$US
239583092$23958309$2$F$20230101$20240702$20240610$20240703$EXP$$ES-SANDOZ INC.-SDZ2024ES054323$SANDOZ$$63$YR$$M$Y$54$KG$20240703$$CN$ES$ES
239583163$23958316$3$F$20240602$20240724$20240610$20240801$30DAY$$US-PFIZER INC-202400187046$PFIZER$$15$YR$$M$Y$$$20240801$$CN$US$US
239583182$23958318$2$F$$20240710$20240610$20240710$30DAY$$US-PFIZER INC-202400187437$PFIZER$$13$YR$$F$Y$$$20240710$$CN$US$US
239583283$23958328$3$F$$20240916$20240610$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US056374$SANDOZ$$$$$M$Y$$$20240919$$CN$US$US
239583563$23958356$3$F$$20240919$20240610$20240920$PER$$NVSC2024US120327$NOVARTIS$$$$$M$Y$$$20240921$$CN$US$US
239583573$23958357$3$F$20240604$20240701$20240610$20240704$5DAY$$US-ASTELLAS-2024US016550$ASTELLAS$$76$YR$$F$Y$$$20240704$$CN$US$US
239583582$23958358$2$F$$20240917$20240610$20240919$PER$$NVSC2024US120260$NOVARTIS$$$$$M$Y$$$20240919$$HP$US$US
239583722$23958372$2$F$$20240624$20240610$20240702$EXP$$ES-SANDOZ INC.-PHHY2019ES195386$SANDOZ$$74$YR$$F$Y$$$20240702$$MD$ES$ES
239583762$23958376$2$F$20230622$20240904$20240610$20240905$EXP$$CN-PFIZER INC-2023SGN07460$PFIZER$$22$YR$$F$Y$45$KG$20240905$$MD$CN$CN
239583785$23958378$5$F$$20240925$20240610$20240926$30DAY$$US-PFIZER INC-202400185882$PFIZER$$15$YR$$M$Y$$$20240926$$CN$US$US
239583842$23958384$2$F$20240602$20240628$20240610$20240702$PER$$US-AMGEN-USASP2024112967$AMGEN$$80$YR$E$F$Y$$$20240702$$PH$US$US
239583882$23958388$2$F$$20240912$20240610$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093198$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240916$$CN$US$US
239583933$23958393$3$F$$20240730$20240610$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093447$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$57.7$KG$20240801$$CN$US$US
239584052$23958405$2$F$20240612$20240705$20240610$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093110$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240705$$CN$US$US
239584124$23958412$4$F$$20240724$20240610$20240802$EXP$$ES-ABBVIE-5795490$ABBVIE$Hernandez-Garcia M, Nieto-Torres M, Guerra N, Michelena M, Ponce-Alonso M, Soriano- Cuesta C, et.al. Resistance to ceftazidime-avibactam in the high-risk, KPC-producing Klebsiella pneumoniae ST307 clone detected in patients and abiotic surfaces in an ICU. Spanish Society of Infectious Diseases and Clinical Microbiology. 2024.; Hernandez-Garcia M, Nieto-Torres M, Guerra N, Michelena M, Ponce-Alonso M, Soriano- Cuesta C, et.al. Resistance to ceftazidime-avibactam in the high-risk st ecg307 clon...$$$$$Y$$$20240802$$MD$ES$ES
239584223$23958422$3$F$20231001$20240702$20240610$20240703$EXP$$ES-BIOMARINAP-ES-2024-158403$BIOMARIN$$$$$$Y$$$20240703$$CN$ES$ES
239584282$23958428$2$F$$20240910$20240610$20240912$30DAY$$US-PFIZER INC-PV202400072388$PFIZER$$$$$$Y$$$20240912$$HP$US$US
239584322$23958432$2$F$20240529$20240701$20240610$20240703$EXP$$US-KYOWAKIRIN-2024KK013775$KYOWA$$$$$$Y$$$20240703$$HP$US$US
239584412$23958441$2$F$20240515$20240627$20240610$20240722$PER$$US-INCYTE CORPORATION-2024IN005372$INCYTE$$$$$$Y$$$20240719$$CN$US$US
239584583$23958458$3$F$20240520$20240812$20240610$20240828$PER$$US-INCYTE CORPORATION-2024IN005421$INCYTE$$$$$$Y$$$20240828$$HP$US$US
239584773$23958477$3$F$20240201$20240820$20240610$20240823$EXP$HR-HALMED-300085389$HR-BIOGEN-2024BI01268228$BIOGEN$$35$YR$$M$Y$75$KG$20240823$$MD$HR$HR
239584853$23958485$3$F$$20240725$20240610$20240802$EXP$$TH-PFIZER INC-2024SGN01215$PFIZER$$14$YR$$M$Y$$$20240802$$CN$TH$TH
239584942$23958494$2$F$20240618$20240730$20240610$20240801$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008704$JAZZ$$17$YR$$M$Y$$$20240801$$CN$US$US
239584993$23958499$3$F$20240711$20240715$20240610$20240723$EXP$$US-APELLIS-2024-APL-0000078$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
239585013$23958501$3$F$20240327$20240711$20240610$20240724$PER$$US-AMGEN-USASP2024114228$AMGEN$$$$$$Y$$$20240724$$HP$US$US
239585022$23958502$2$F$$20240719$20240610$20240719$PER$$NVSC2024US121305$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
239585053$23958505$3$F$$20240709$20240610$20240717$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001165$BLUEPRINT MEDICINES$$$$$F$Y$$$20240717$$CN$US$US
239585062$23958506$2$F$$20240729$20240610$20240806$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001162$BLUEPRINT MEDICINES$$$$$F$Y$$$20240806$$CN$US$US
239585202$23958520$2$F$$20240722$20240610$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093222$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$83.01$KG$20240723$$CN$US$US
239585212$23958521$2$F$$20240813$20240610$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093238$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$97.52$KG$20240814$$CN$US$US
239585232$23958523$2$F$$20240715$20240610$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093245$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$97.98$KG$20240719$$CN$US$US
239585254$23958525$4$F$20240407$20240814$20240610$20240819$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00649$AIMMUNE$$$$$$Y$$$20240819$$HP$US$US
239585426$23958542$6$F$20240715$20240826$20240610$20240904$PER$$US-APELLIS-2024-APL-0000123$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240904$$CN$US$US
239585442$23958544$2$F$20240601$20240722$20240610$20240729$PER$$US-ALXN-202406USA000080US$ALEXION PHARMACEUTICALS$$38$YR$$F$Y$$$20240729$$CN$US$US
239585482$23958548$2$F$$20240722$20240610$20240722$EXP$$US-ALXN-202406USA000090US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
239585492$23958549$2$F$$20240903$20240610$20240912$PER$$US-SA-2024SA171494$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240912$$MD$US$US
239585543$23958554$3$F$$20240816$20240610$20240822$PER$$US-ALXN-202406USA000095US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
239585634$23958563$4$F$20240101$20240813$20240610$20240821$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-16947$SAMSUNG BIOEPIS$$54$YR$A$F$Y$$$20240821$$CN$CA$CA
239585713$23958571$3$F$20240603$20240806$20240610$20240814$EXP$$CA-TAKEDA-2024TUS013166$TAKEDA$$76$YR$$M$Y$59.5$KG$20240814$$CN$CA$CA
239585724$23958572$4$F$20240119$20240712$20240610$20240722$EXP$$US-APELLIS-APL-2023-003495$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
239585752$23958575$2$F$20231224$20240802$20240610$20240805$PER$$US-ALXN-202406USA000009US$ALEXION PHARMACEUTICALS$$77$YR$$F$Y$$$20240805$$CN$US$US
239585802$23958580$2$F$$20240722$20240610$20240722$PER$$US-ALXN-202406USA000094US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
239585822$23958582$2$F$$20240703$20240610$20240710$PER$$US-PHARMING-PHAUS2024000459$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
239585902$23958590$2$F$20240423$20240710$20240610$20240716$EXP$$US-APELLIS-2024-APL-0000076$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
239585932$23958593$2$F$20240322$20240729$20240610$20240805$EXP$$IT-009507513-2406ITA001996$MERCK$$75$YR$$F$Y$$$20240805$$MD$IT$IT
239585964$23958596$4$F$20240523$20240902$20240610$20240910$EXP$$JP-APELLIS-APL-2024-004393$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240910$$CN$JP$JP
239585982$23958598$2$F$20230730$20240721$20240610$20240731$PER$$US-APELLIS-APL-2023-002767$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
239586012$23958601$2$F$20240101$20240627$20240610$20240705$EXP$$CA-BEH-2024173201$CSL BEHRING$$63$YR$A$M$Y$87.09$KG$20240705$$CN$CA$CA
239586054$23958605$4$F$20240517$20240703$20240610$20240709$EXP$$AR-TAKEDA-2024TUS053382$TAKEDA$$11$YR$$M$Y$33.4$KG$20240709$$CN$AR$AR
239586076$23958607$6$F$20240401$20240807$20240610$20240813$EXP$$US-APELLIS-2024-APL-0000086$APELLIS PHARMACEUTICALS$$$$$$Y$77.1$KG$20240813$$CN$US$US
239586082$23958608$2$F$$20240909$20240610$20240909$EXP$$TH-BRISTOL-MYERS SQUIBB COMPANY-2024-088953$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240909$$CN$TH$TH
239586113$23958611$3$F$$20240827$20240610$20240906$30DAY$$US-GSK-US2024068292$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
239586122$23958612$2$F$$20240625$20240610$20240702$30DAY$$US-GSK-US2024068303$GLAXOSMITHKLINE$$$$$M$Y$$$20240702$$CN$US$US
239586133$23958613$3$F$$20240919$20240610$20240927$PER$$US-GSK-US2024068286$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
239586143$23958614$3$F$$20240723$20240610$20240802$EXP$$IN-ROCHE-3575604$ROCHE$$70$YR$E$M$Y$$$20240802$$CN$IN$IN
239586152$23958615$2$F$$20240705$20240610$20240712$EXP$$US-GSK-US2024068721$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$US$US
239586172$23958617$2$F$$20240721$20240610$20240731$30DAY$$US-GSK-US2024068318$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$CN$US$US
239586183$23958618$3$F$20240531$20240722$20240610$20240731$30DAY$$US-GSK-US2024068308$GLAXOSMITHKLINE$$81$YR$$M$Y$$$20240731$$MD$US$US
239586192$23958619$2$F$20240531$20240912$20240610$20240919$30DAY$$US-GSK-US2024068320$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240919$$CN$US$US
239586202$23958620$2$F$$20240710$20240610$20240717$EXP$$US-GSK-US2024AMR069549$GLAXOSMITHKLINE$$$$$F$Y$87.54$KG$20240717$$CN$US$US
239586212$23958621$2$F$20240403$20240912$20240610$20240916$EXP$$JP-009507513-2406JPN000465J$MERCK$$64$YR$$F$Y$45.6$KG$20240916$$PH$JP$JP
239586322$23958632$2$F$$20240618$20240610$20240702$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI05279$NEUROCRINE BIOSCIENCES$$4$DEC$$M$Y$$$20240702$$HP$US$US
239586363$23958636$3$F$20220101$20240702$20240610$20240708$EXP$$US-ABBVIE-22K-163-4514344-00$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
239586463$23958646$3$F$20240201$20240723$20240610$20240726$EXP$$CO-BIOGEN-2024BI01268504$BIOGEN$$2$YR$$F$Y$7.8$KG$20240726$$CN$CO$CO
239586474$23958647$4$F$20200101$20240715$20240610$20240724$EXP$$BR-NOVOPROD-871211$NOVO NORDISK$$73$YR$$F$Y$82$KG$20240724$$CN$BR$BR
239586523$23958652$3$F$20240601$20240719$20240610$20240730$30DAY$$US-AMGEN-USASP2024111025$AMGEN$$65$YR$E$M$Y$104.85$KG$20240730$$PH$US$US
239586562$23958656$2$F$20240301$20240813$20240610$20240814$PER$$US-JNJFOC-20240612790$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240815$$HP$US$US
239586583$23958658$3$F$$20240628$20240610$20240704$30DAY$$BR-JNJFOC-20240567630$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$PH$BR$BR
239586594$23958659$4$F$20240101$20240912$20240610$20240920$EXP$$JP-009507513-2403JPN001962J$MERCK$$73$YR$$M$Y$$$20240920$$MD$JP$JP
239586703$23958670$3$F$$20240826$20240610$20240829$EXP$$JP-GSK-JP2024JPN069443$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$PH$JP$JP
239586732$23958673$2$F$20221025$20240621$20240610$20240702$EXP$$NO-NOVOPROD-1232387$NOVO NORDISK$$$$$F$Y$79$KG$20240702$$MD$NO$NO
239586832$23958683$2$F$$20240726$20240610$20240728$EXP$$GB-JNJFOC-20240477961$JOHNSON AND JOHNSON$$$$$$Y$$$20240728$$HP$GB$GB
239586862$23958686$2$F$$20240719$20240610$20240730$30DAY$CN-NMPA-21120000002024053002178428$CN-NOVOPROD-1233162$NOVO NORDISK$$68$YR$$F$Y$74$KG$20240730$$HP$CN$CN
239586892$23958689$2$F$20231001$20240821$20240610$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032959$BOEHRINGER INGELHEIM$$56$YR$A$M$Y$$$20240822$$CN$US$US
239587072$23958707$2$F$$20240726$20240610$20240801$EXP$$JP-GSK-JP2024JPN069397$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$PH$JP$JP
239587313$23958731$3$F$20240524$20240705$20240610$20240710$PER$$US-JNJFOC-20240583215$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240710$$CN$US$US
239587332$23958733$2$F$$20240704$20240610$20240717$EXP$$MA-Unichem Pharmaceuticals (USA) Inc-UCM202406-000685$UNICHEM$$26$YR$A$F$Y$$$20240717$$MD$MA$
239587402$23958740$2$F$20240501$20240703$20240610$20240708$EXP$$US-ABBVIE-5791413$ABBVIE$$39$YR$$F$Y$$$20240708$$CN$US$US
239587442$23958744$2$F$20240101$20240701$20240610$20240705$EXP$$US-ABBVIE-5789530$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
239587492$23958749$2$F$20240501$20240815$20240610$20240819$EXP$$NVSC2024US103717$NOVARTIS$$51$YR$$F$Y$$$20240819$$HP$US$US
239587543$23958754$3$F$$20240909$20240610$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093450$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240909$$CN$US$US
239587603$23958760$3$F$20180101$20240925$20240610$20240927$PER$$US-GILEAD-2024-0676212$GILEAD$$$$A$M$Y$$$20240927$$LW$US$US
239587613$23958761$3$F$$20240722$20240610$20240724$EXP$$US-JNJFOC-20240608004$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20240724$$CN$US$US
239587623$23958762$3$F$20240501$20240814$20240610$20240823$EXP$FR-AFSSAPS-TO2024000990$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-093342$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$97$KG$20240823$$PH$FR$FR
239587642$23958764$2$F$20240101$20240710$20240610$20240715$PER$$US-JNJFOC-20240621435$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$MD$US$US
239587683$23958768$3$F$$20240812$20240610$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202406004709$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240814$$HP$US$US
239587782$23958778$2$F$20230823$20240725$20240610$20240805$EXP$$JP-ROCHE-3448497$ROCHE$$54$YR$A$F$Y$55.6$KG$20240805$$MD$JP$JP
239587842$23958784$2$F$20240521$20240727$20240610$20240807$EXP$GB-MHRA-MED-202405311106380720-SRNGH$GB-ROCHE-3575210$ROCHE$$$$$M$Y$$$20240807$$HP$GB$GB
239587862$23958786$2$F$20240201$20240813$20240610$20240814$PER$$US-JNJFOC-20240605360$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240814$$CN$US$US
239587883$23958788$3$F$$20240801$20240610$20240806$30DAY$$FR-SANDOZ INC.-SDZ2024FR054524$SANDOZ$$17$YR$$M$Y$$$20240806$$CN$FR$FR
239587902$23958790$2$F$20240501$20240917$20240610$20240925$EXP$$NVSJ2024JP006608$NOVARTIS$$28$YR$$F$Y$$$20240925$$MD$JP$JP
239588002$23958800$2$F$20240606$20240708$20240611$20240709$PER$$US-AMGEN-USASP2024113700$AMGEN$$55$YR$A$M$Y$$$20240709$$CN$US$US
239588045$23958804$5$F$20240101$20240918$20240611$20240920$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-009790$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240920$$CN$CA$CA
239588062$23958806$2$F$$20240806$20240611$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093163$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$63.96$KG$20240812$$CN$US$US
239588234$23958823$4$F$$20240816$20240611$20240823$PER$$US-ALXN-202406USA000072US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
239588272$23958827$2$F$$20240625$20240611$20240703$EXP$$DE-ALCON LABORATORIES-ALC2024DE002852$ALCON$$$$$$Y$$$20240703$$HP$DE$DE
239588442$23958844$2$F$20240602$20240704$20240611$20240708$EXP$$CA-ABBVIE-5790532$ABBVIE$$72$YR$$F$Y$$$20240708$$CN$CA$CA
239588472$23958847$2$F$$20240606$20240611$20240708$EXP$$US-AstraZeneca-2024A133167$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$US$
239588622$23958862$2$F$$20240823$20240611$20240826$PER$$NVSC2024US120915$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
239588662$23958866$2$F$$20240722$20240611$20240722$PER$$US-ALXN-202406USA000089US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
239588672$23958867$2$F$20240101$20240702$20240611$20240705$EXP$$CA-ABBVIE-5789577$ABBVIE$$85$YR$$F$Y$$$20240705$$CN$CA$CA
239588766$23958876$6$F$20240101$20240725$20240611$20240730$PER$$US-SA-2024SA171364$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240730$$MD$US$US
239588773$23958877$3$F$20240101$20240823$20240611$20240906$PER$$US-SA-2024SA171936$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240906$$MD$US$US
239588792$23958879$2$F$20240101$20240905$20240611$20240915$PER$$US-SA-2024SA171450$SANOFI AVENTIS$$25$YR$A$F$Y$1$KG$20240915$$MD$US$US
239588843$23958884$3$F$$20240828$20240611$20240903$EXP$$US-ABBVIE-5790655$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
239588942$23958894$2$F$$20240903$20240611$20240913$PER$$US-SA-2024SA170764$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240913$$MD$US$US
239588952$23958895$2$F$20240413$20240610$20240611$20240711$EXP$$US-ABBVIE-5793950$ABBVIE$$74$YR$$M$Y$$$20240711$$MD$US$US
239589093$23958909$3$F$20240501$20240702$20240611$20240703$EXP$$CA-ABBVIE-5790368$ABBVIE$$67$YR$$F$Y$$$20240703$$CN$CA$CA
239589102$23958910$2$F$20230828$20240703$20240611$20240704$PER$$US-AMGEN-USASP2024113838$AMGEN$$46$YR$A$F$Y$$$20240704$$CN$US$US
239589224$23958922$4$F$$20240816$20240611$20240821$EXP$$US-PFIZER INC-202400076456$PFIZER$$68$YR$$M$Y$$$20240821$$CN$US$US
239589282$23958928$2$F$20240225$20240705$20240611$20240716$EXP$$GB-ROCHE-3579056$ROCHE$$56$YR$A$M$Y$106.8$KG$20240716$$HP$GB$GB
239589412$23958941$2$F$20240101$20240628$20240611$20240709$PER$$US-SA-2024SA171718$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240709$$MD$US$US
239589513$23958951$3$F$20240201$20240722$20240611$20240722$PER$$US-ALXN-202406USA000144US$ALEXION PHARMACEUTICALS$$87$YR$$F$Y$58.05$KG$20240722$$CN$US$US
239589554$23958955$4$F$20240101$20240703$20240611$20240710$EXP$$US-AMGEN-USASP2024113867$AMGEN$$65$YR$E$M$Y$$$20240710$$HP$US$US
239589562$23958956$2$F$$20240814$20240611$20240820$EXP$$JP-009507513-2406JPN000783J$MERCK$$$$$F$Y$$$20240820$$MD$JP$JP
239589575$23958957$5$F$20240430$20240918$20240611$20240925$EXP$$US-TAKEDA-2022TUS065304$TAKEDA$$72$YR$$M$Y$86$KG$20240925$$CN$US$US
239589622$23958962$2$F$20240101$20240905$20240611$20240910$EXP$$US-ABBVIE-5795003$ABBVIE$$$$$M$Y$68$KG$20240910$$CN$US$US
239589654$23958965$4$F$$20240925$20240611$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092298$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240926$$CN$US$US
239589662$23958966$2$F$20240101$20240909$20240611$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093477$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240909$$CN$US$US
239589712$23958971$2$F$20230801$20240924$20240611$20240925$PER$$US-GILEAD-2024-0676286$GILEAD$$59$YR$A$M$Y$$$20240925$$LW$US$US
239589792$23958979$2$F$20220701$20240701$20240611$20240712$EXP$$JP-ROCHE-3579296$ROCHE$Yoshida K, Hirai T, Sugiyama Y, Yokoi K, Matsumoto Y, Komiyama T SS5-2-13 A study of two cases of advanced hepatocellular carcinoma treated with immune checkpoint inhibitor combination drug therapy who underwent aspiration bone marrow for suspected haemophagocytic syndrome. Kanzo / The 60th Annual Meeting of the Japan Society of Hepatology. 2024;65(S1):A294-.$8$DEC$E$M$Y$$$20240712$$MD$JP$JP
239589902$23958990$2$F$$20240722$20240611$20240722$PER$$US-ALXN-202406USA000149US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
239589963$23958996$3$F$20240319$20240717$20240611$20240723$30DAY$$US-AMGEN-USASP2024109380$AMGEN$$$$$$Y$$$20240723$$HP$US$US
239589982$23958998$2$F$20240604$20240909$20240611$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093384$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240909$$CN$US$US
239590032$23959003$2$F$20240501$20240619$20240611$20240708$PER$$US-APOTEX-2024AP006311$APOTEX$$$$$$Y$$$20240708$$PH$US$US
239590092$23959009$2$F$20240401$20240725$20240611$20240805$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-01434$AMNEAL$$$$$$Y$$$20240805$$HP$JP$JP
239590102$23959010$2$F$20240603$20240722$20240611$20240722$PER$$US-ALXN-202406USA000137US$ALEXION PHARMACEUTICALS$$59$YR$$F$Y$$$20240722$$CN$US$US
239590112$23959011$2$F$20200101$20240807$20240611$20240813$EXP$$JP-JNJFOC-20240624791$JOHNSON AND JOHNSON$$63$YR$A$F$Y$91$KG$20240813$$MD$JP$JP
239590172$23959017$2$F$20240419$20240617$20240611$20240708$PER$$US-APOTEX-2024AP006836$APOTEX$$39$YR$A$F$Y$$$20240708$$CN$US$US
239590182$23959018$2$F$20240605$20240827$20240611$20240904$EXP$$US-JNJFOC-20240614853$JOHNSON AND JOHNSON$$70$YR$E$M$Y$97$KG$20240904$$HP$US$US
239590272$23959027$2$F$$20240626$20240611$20240705$PER$$US-SA-2024SA171852$SANOFI AVENTIS$$$$A$M$Y$81.6$KG$20240705$$MD$US$US
239590362$23959036$2$F$20240101$20240702$20240611$20240715$PER$$US-SA-2024SA168109$SANOFI AVENTIS$$$$$$Y$$$20240715$$CN$US$US
239590603$23959060$3$F$20240514$20240709$20240611$20240716$EXP$$US-VIIV HEALTHCARE LIMITED-US2024068852$VIIV$$$$$$Y$$$20240716$$HP$US$US
239590652$23959065$2$F$20240521$20240617$20240611$20240710$PER$$FR-TOLMAR, INC.-24FR049520$TOLMAR$$74$YR$$M$Y$$$20240710$$PH$FR$FR
239590663$23959066$3$F$20240501$20240617$20240611$20240710$PER$$FR-TOLMAR, INC.-24FR049521$TOLMAR$$80$YR$$M$Y$$$20240710$$HP$FR$FR
239590672$23959067$2$F$20240521$20240617$20240611$20240710$PER$$FR-TOLMAR, INC.-24FR049572$TOLMAR$$75$YR$$M$Y$$$20240710$$PH$FR$FR
239590702$23959070$2$F$20240521$20240702$20240611$20240808$PER$$TR-TOLMAR, INC.-24TR049577$TOLMAR$$82$YR$$M$Y$$$20240808$$PH$TR$TR
239590774$23959077$4$F$20240503$20240917$20240611$20240922$30DAY$$US-SANDOZ INC.-SDZ2024US056262$SANDOZ$$$$$F$Y$$$20240922$$CN$US$US
239590812$23959081$2$F$$20240626$20240611$20240708$EXP$$SK-MSNLABS-2024MSNLIT01233$MSN LABORATORIES$$$$$$Y$$$20240708$$MD$SK$SK
239590832$23959083$2$F$20230608$20240710$20240611$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-093042$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$58.4$KG$20240719$$MD$JP$JP
239590883$23959088$3$F$20160927$20240924$20240611$20240925$EXP$$US-GILEAD-2024-0676294$GILEAD$$49$YR$A$M$Y$$$20240925$$LW$US$US
239590965$23959096$5$F$$20240711$20240611$20240718$EXP$$US-ROCHE-3577299$ROCHE$$$$$$Y$$$20240718$$MD$US$US
239591133$23959113$3$F$20240801$20240812$20240611$20240821$PER$$US-SA-2024SA171317$SANOFI AVENTIS$$29$YR$A$F$Y$94$KG$20240821$$MD$US$US
239591162$23959116$2$F$20240101$20240731$20240611$20240809$PER$$US-SA-2024SA167450$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240809$$MD$US$US
239591222$23959122$2$F$$20240802$20240611$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093653$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240805$$CN$US$US
239591432$23959143$2$F$$20240709$20240611$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093633$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240711$$CN$US$US
239591475$23959147$5$F$20221203$20240818$20240611$20240826$EXP$$RU-BIOGEN-2024BI01268475$BIOGEN$$42$YR$$F$Y$$$20240826$$MD$RU$RU
239591643$23959164$3$F$20240531$20240820$20240611$20240828$EXP$$CA-CELLTRION INC.-2024CA013708$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
239591792$23959179$2$F$20240301$20240830$20240611$20240903$EXP$$CA-JNJFOC-20240522103$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240903$$CN$CA$CA
239591922$23959192$2$F$20240528$20240903$20240611$20240912$EXP$$GB-CELLTRION INC.-2024GB013621$CELLTRION$$$$$$Y$$$20240912$$CN$GB$GB
239591952$23959195$2$F$$20240917$20240611$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-093679$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240918$$MD$JP$JP
239592052$23959205$2$F$$20240705$20240611$20240715$EXP$$JP-TEVA-VS-3207521$TEVA$Endo K, Shimizu T, Muto Y, Kimishima Y, Abe S, Oikawa M, et al. Acute coronary syndrome with severe coronary calcification in a patient with pseudo-pseudohypoparathyroidism. J-Cardiol-Cases 2023; 28 (4): 172-175.; Endo K, Shimizu T, Muto Y, Kimishima Y, Abe S, Oikawa M, et al. Acute coronary syndrome with severe coronary calcification in a patient with pseudo-pseudohypoparathyroidism. J-Cardiol-Cases 2023; 28 (4): 172-175.; Endo K, Shimizu T, Muto Y, Kimishima Y, Abe S, Oikawa M, et al. Acute...$10$YR$$F$Y$$$20240715$$MD$JP$JP
239592242$23959224$2$F$20240101$20240716$20240611$20240728$PER$$US-APOTEX-2024AP006362$APOTEX$$$$$$Y$$$20240728$$CN$US$US
239592292$23959229$2$F$$20240823$20240611$20240826$PER$$NVSC2024US121456$NOVARTIS$$50$YR$$F$Y$$$20240826$$MD$US$US
239592384$23959238$4$F$20240509$20240718$20240611$20240808$EXP$$US-ROCHE-3577387$ROCHE$$69$YR$E$M$Y$$$20240808$$MD$US$US
239592502$23959250$2$F$20240101$20240705$20240611$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-007055$UNITED THERAPEUTICS$$$$$F$Y$$$20240706$$$US$US
239592542$23959254$2$F$$20240804$20240611$20240809$PER$$NVSC2024US121450$NOVARTIS$$$$$$Y$$$20240809$$CN$US$US
239592682$23959268$2$F$$20240621$20240611$20240701$PER$$US-HALEON-2180938$Haleon PLC$$$$$M$Y$$$20240701$$CN$US$US
239592705$23959270$5$F$$20240731$20240611$20240808$EXP$$US-ROCHE-3578584$ROCHE$$$$A$M$Y$$$20240808$$CN$US$US
239592722$23959272$2$F$20240101$20240626$20240611$20240702$EXP$$CA-ABBVIE-5786884$ABBVIE$$66$YR$$M$Y$$$20240702$$CN$CA$CA
239592753$23959275$3$F$20240531$20240709$20240611$20240710$PER$$US-JNJFOC-20240600001$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240710$$CN$US$US
239592902$23959290$2$F$20240530$20240903$20240611$20240906$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-093275$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$61.69$KG$20240906$$PH$PR$PR
239592924$23959292$4$F$20240101$20240815$20240611$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-016246$UNITED THERAPEUTICS$$$$$M$Y$73.923$KG$20240820$$$US$US
239592973$23959297$3$F$$20240710$20240611$20240712$PER$$NVSC2024US121433$NOVARTIS$$$$$$Y$$$20240712$$CN$US$US
239592992$23959299$2$F$20231228$20240711$20240611$20240718$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00316$VELOXIS PHARMACEUTICALS$$42$YR$$F$Y$$$20240718$$MD$US$US
239593102$23959310$2$F$20220101$20240716$20240611$20240724$EXP$$US-AMGEN-USASP2024110739$AMGEN$$83$YR$E$M$Y$88.435$KG$20240723$$LW$US$US
239593123$23959312$3$F$$20240912$20240611$20240919$EXP$$CA-JNJFOC-20240332070$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240919$$HP$CA$CA
239593242$23959324$2$F$20240416$20240709$20240611$20240718$EXP$$PK-ROCHE-3578165$ROCHE$$85$YR$E$M$Y$$$20240718$$CN$PK$PK
239593304$23959330$4$F$20240601$20240714$20240611$20240814$EXP$$CA-UCBSA-2024028663$UCB$$61$YR$$F$Y$$$20240814$$CN$CA$CA
239593312$23959331$2$F$20240522$20240703$20240611$20240705$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-093517$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$75$KG$20240705$$MD$DE$DE
239593363$23959336$3$F$20240605$20240801$20240611$20240805$PER$$US-AMGEN-USASP2024114306$AMGEN$$49$YR$A$M$Y$$$20240805$$HP$US$US
239593472$23959347$2$F$20240101$20240627$20240611$20240705$EXP$$CA-CELLTRION INC.-2024CA009625$CELLTRION$$$$$$Y$$$20240705$$MD$CA$CA
239593582$23959358$2$F$20230301$20240828$20240611$20240910$EXP$$US-UCBSA-2023015525$UCB$$2$YR$$F$Y$$$20240910$$CN$US$US
239593622$23959362$2$F$$20240705$20240611$20240710$PER$$US-JNJFOC-20240612304$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$CN$US$US
239593684$23959368$4$F$20240101$20240826$20240611$20240905$EXP$$US-INSMED, INC.-2024-02061-US$INSMED$$$$$M$Y$$$20240905$$CN$US$US
239593712$23959371$2$F$$20240620$20240611$20240701$EXP$$JP-INSMED, INC.-2024-02308-JP$INSMED$Kenji Sakamoto. When to Start Treatment for Non-tuberculous Mycobacterial disease (MAC disease). Lecture. 2024$62$YR$$F$Y$$$20240701$$MD$JP$JP
239593812$23959381$2$F$$20240806$20240611$20240809$EXP$$JP-GSK-JP2024JPN071281$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$MD$JP$JP
239593922$23959392$2$F$20240401$20240628$20240611$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033021$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240703$$CN$US$US
239593992$23959399$2$F$20240603$20240625$20240611$20240718$PER$$US-AstraZeneca-2024A129362$ASTRAZENECA$$25728$DY$$F$Y$$$20240718$$CN$US$
239594062$23959406$2$F$20240201$20240802$20240611$20240810$EXP$$PL-ROCHE-3577508$ROCHE$$60$YR$A$M$Y$79$KG$20240810$$MD$PL$PL
239594122$23959412$2$F$$20240708$20240611$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093497$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240709$$HP$US$US
239594253$23959425$3$F$$20240920$20240611$20240923$PER$$NVSC2024US121371$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
239594363$23959436$3$F$20240318$20240709$20240611$20240710$EXP$GB-MHRA-MED-202406072253334710-KPMDR$GB-ORGANON-O2406GBR000645$ORGANON$$24$YR$$M$Y$78$KG$20240710$$CN$GB$GB
239594393$23959439$3$F$20240201$20240712$20240611$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093773$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240722$$CN$US$US
239594512$23959451$2$F$$20240722$20240611$20240722$PER$$US-ALXN-202406USA000097US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
239594634$23959463$4$F$20230211$20240918$20240611$20240927$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-000943$AKEBIA THERAPEUTICS$$89$YR$$M$Y$60$KG$20240927$$MD$JP$JP
239594644$23959464$4$F$$20240918$20240611$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US056259$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
239594662$23959466$2$F$20240315$20240701$20240611$20240711$EXP$$ES-BEH-2024171854$CSL BEHRING$$19$YR$A$M$Y$$$20240711$$HP$ES$ES
239594682$23959468$2$F$$20240909$20240611$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093809$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240909$$CN$US$US
239594702$23959470$2$F$$20240813$20240611$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093627$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240814$$CN$US$US
239594713$23959471$3$F$20240101$20240628$20240611$20240705$PER$$US-UNITED THERAPEUTICS-UNT-2024-016518$UNITED THERAPEUTICS$$$$$F$Y$80.272$KG$20240705$$$US$US
239594752$23959475$2$F$20240201$20240813$20240611$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001349$ACADIA PHARMACEUTICALS$$63$YR$$M$Y$$$20240830$$HP$US$US
239594852$23959485$2$F$20230620$20240701$20240611$20240716$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-000948$AKEBIA THERAPEUTICS$$84$YR$$F$Y$42$KG$20240716$$HP$JP$JP
239594944$23959494$4$F$20240605$20240703$20240611$20240723$30DAY$$US-JNJFOC-20240612581$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240724$$PH$US$US
239594952$23959495$2$F$$20240712$20240611$20240719$EXP$$IE-AMGEN-IRLSP2024113490$AMGEN$Isa, N.. Rheumatology Module 364 Clinical focus: Psoriatic disease management. Hospital Doctor of Ireland. 2024;30:23-28$33$YR$A$F$Y$$$20240719$$MD$IE$IE
239594963$23959496$3$F$$20240823$20240611$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002465$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
239595132$23959513$2$F$$20240703$20240611$20240712$EXP$$PT-AUROBINDO-AUR-APL-2024-022103$AUROBINDO$OLIVEIRA R, ALMEIDA M, LAVADO P, BAPTISTA  A et al. Pantoprazole-Induced Liver Injury in the Setting of Diabetic Ketoacidosis. Cartas ao Editor, Acta Med Port. 2024;37(4):291-314$54$YR$$F$Y$$$20240712$$MD$PT$PT
239595152$23959515$2$F$20240529$20240701$20240611$20240706$EXP$$EC-ROCHE-3575771$ROCHE$$70$YR$E$M$Y$$$20240706$$MD$EC$EC
239595283$23959528$3$F$20240509$20240624$20240611$20240705$30DAY$$CA-JNJFOC-20240537662$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240705$$HP$CA$CA
239595322$23959532$2$F$$20240926$20240611$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093625$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240927$$CN$US$US
239595332$23959533$2$F$$20240819$20240611$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-004500$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240820$$CN$US$US
239595352$23959535$2$F$$20240723$20240611$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093695$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$73.48$KG$20240725$$CN$US$US
239595482$23959548$2$F$$20240820$20240611$20240830$EXP$$JP-ROCHE-3579316$ROCHE$Nishikawa I, Hirata T, Miyazaki M, Morita N, Takai Y Case in which the authors were involved with the patient with lung cancer from the time of diagnosis, treatment to palliative care as primary pharmacists. [abstract number:P-128].. Journal of Japanese Society of Pharmaceutical Oncology/Annual Meeting of Japanes 2024;36:353-.$7$DEC$E$F$Y$$$20240830$$PH$JP$JP
239595492$23959549$2$F$$20240620$20240611$20240705$PER$$US-APOTEX-2024AP006346$APOTEX$$$$$M$Y$$$20240705$$CN$US$US
239595622$23959562$2$F$20240522$20240722$20240611$20240801$PER$$US-APOTEX-2024AP006347$APOTEX$$$$$M$Y$$$20240801$$CN$US$US
239595748$23959574$8$F$$20240909$20240611$20240917$EXP$$DE-ROCHE-3579103$ROCHE$$60$YR$A$F$Y$$$20240917$$MD$DE$DE
239595752$23959575$2$F$20240301$20240827$20240611$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-017090$UNITED THERAPEUTICS$$33$YR$$F$Y$$$20240904$$$US$US
239595852$23959585$2$F$20201215$20240719$20240611$20240802$EXP$$JP-ROCHE-3094259$ROCHE$$54$YR$A$F$Y$57.3$KG$20240802$$MD$JP$JP
239595962$23959596$2$F$$20240705$20240611$20240715$EXP$$JP-TEVA-VS-3207575$TEVA$Kinoshita Y, Takata K, Kushima H, Ishii H. Target sign of the lung. Respirol-Case-Rep 2024; 12 (5): e01386.; Kinoshita Y, Takata K, Kushima H, Ishii H. Target sign of the lung. Respirol-Case-Rep 2024; 12 (5): e01386.; Kinoshita Y, Takata K, Kushima H, Ishii H. Target sign of the lung. Respirol-Case-Rep 2024; 12 (5): e01386.$8$DEC$$M$Y$$$20240715$$HP$JP$JP
239596102$23959610$2$F$20240305$20240712$20240611$20240723$EXP$$US-ORPHANEU-2024001761$RECORDATI$$$$$$Y$$$20240723$$CN$US$US
239596132$23959613$2$F$$20240626$20240611$20240701$EXP$$JP-JNJFOC-20240621813$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$JP$JP
239596213$23959621$3$F$$20240724$20240611$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002490$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
239596324$23959632$4$F$$20240827$20240611$20240828$EXP$$CA-TAKEDA-2024TUS057780$TAKEDA$$$$$M$Y$$$20240828$$CN$CA$CA
239596364$23959636$4$F$$20240709$20240611$20240712$EXP$$CA-TAKEDA-2024TUS057679$TAKEDA$$$$$F$Y$$$20240712$$CN$CA$CA
239596603$23959660$3$F$20240602$20240829$20240611$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014737$UNITED THERAPEUTICS$$45$YR$$F$Y$95.238$KG$20240906$$$US$US
239596653$23959665$3$F$$20240821$20240611$20240825$EXP$$GB-SANDOZ INC.-SDZ2024GB054632$SANDOZ$$$$$F$Y$1$KG$20240825$$MD$GB$GB
239596686$23959668$6$F$20240603$20240718$20240611$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016914$UNITED THERAPEUTICS$$25$YR$$F$Y$72.971$KG$20240725$$$US$US
239596722$23959672$2$F$20240901$20240904$20240611$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093444$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240906$$CN$US$US
239596792$23959679$2$F$20240101$20240819$20240611$20240831$EXP$$US-UCBSA-2024027469$UCB$$$$$M$Y$170$KG$20240831$$HP$US$US
239596812$23959681$2$F$$20240730$20240611$20240806$PER$$NVSC2024US121696$NOVARTIS$$$$$$Y$$$20240806$$CN$US$US
239596852$23959685$2$F$$20240729$20240611$20240731$PER$$US-ALXN-202406USA000176US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
239596862$23959686$2$F$20240506$20240621$20240611$20240701$EXP$IT-MINISAL02-988278$IT-ESPERIONTHERAPEUTICS-2024ITA00848$ESPERION THERAPEUTICS$$65$YR$$M$Y$112$KG$20240701$$MD$IT$IT
239596922$23959692$2$F$$20240617$20240611$20240703$EXP$$US-TEVA-VS-3207087$TEVA$Patel R, Agarwal H, Chiwane S, Lowrie L. EXTRACORPOREAL SUPPORT FOR SPONTANEOUS PNEUMOMEDIASTINUM SECONDARY TO VIRAL INFECTION IN A CHILD. Crit-Care-Med 2024; 52 (Suppl.) (1): S337 abstr. 729.; Patel R, Agarwal H, Chiwane S, Lowrie L. EXTRACORPOREAL SUPPORT FOR SPONTANEOUS PNEUMOMEDIASTINUM SECONDARY TO VIRAL INFECTION IN A CHILD. Crit-Care-Med 2024; 52 (Suppl.) (1): S337 abstr. 729.$2$YR$$F$Y$$$20240703$$HP$US$US
239597013$23959701$3$F$20240321$20240912$20240611$20240917$EXP$$US-TAKEDA-2024TUS047605$TAKEDA$$64$YR$$F$Y$81$KG$20240917$$CN$US$US
239597022$23959702$2$F$$20240626$20240611$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002484$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239597032$23959703$2$F$20240723$20240810$20240611$20240812$EXP$$US-TAKEDA-2024TUS046444$TAKEDA$$47$YR$$M$Y$$$20240812$$MD$US$US
239597052$23959705$2$F$$20240826$20240611$20240902$EXP$$US-AMGEN-USASP2024111837$AMGEN$Suthar P.P.; Nagarajan M.; Bhabad S. et al.. Persistent Craniopharyngeal Canal. Radiology. 2024;311 (2):1-5$76$YR$E$F$Y$$$20240902$$MD$US$US
239597112$23959711$2$F$$20240910$20240611$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093798$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$MD$US$US
239597122$23959712$2$F$$20240626$20240611$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002496$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239597172$23959717$2$F$20240226$20240704$20240611$20240710$EXP$$CA-TAKEDA-2024TUS057352$TAKEDA$$58$YR$$F$Y$91$KG$20240710$$HP$CA$CA
239597183$23959718$3$F$20240529$20240624$20240611$20240703$EXP$$JP-UCBSA-2024028038$UCB$$80$YR$$F$Y$$$20240704$$PH$JP$JP
239597212$23959721$2$F$20211101$20240722$20240611$20240805$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-04718$LUPIN$$$$$M$Y$$$20240805$$CN$AU$AU
239597243$23959724$3$F$20231101$20240808$20240611$20240812$EXP$$US-GILEAD-2024-0668991$GILEAD$$65$YR$E$F$Y$$$20240812$$CN$US$US
239597262$23959726$2$F$$20240813$20240611$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003796$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
239597292$23959729$2$F$20240112$20240821$20240611$20240902$EXP$$CA-ROCHE-3579165$ROCHE$$77$YR$E$M$Y$$$20240902$$HP$CA$CA
239597553$23959755$3$F$20240101$20240626$20240611$20240701$PER$$US-LEO Pharma-370997$LEO PHARM$$$$$M$Y$$$20240701$$CN$US$US
239597574$23959757$4$F$$20240722$20240611$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090500$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240731$$CN$US$US
239597634$23959763$4$F$20231018$20240716$20240611$20240730$EXP$$JP-VERICEL-JP-VCEL-23-000335$VERICEL$$28$YR$$F$Y$69.5$KG$20240730$$MD$JP$JP
239597672$23959767$2$F$$20240701$20240611$20240703$EXP$$US-TAKEDA-2024TUS017735$TAKEDA$$$$$F$Y$$$20240703$$MD$US$US
239597682$23959768$2$F$$20240702$20240611$20240715$EXP$$FR-TAKEDA-2024TUS056405$TAKEDA$$54$YR$$M$Y$$$20240715$$HP$FR$FR
239597692$23959769$2$F$$20240719$20240611$20240725$EXP$$US-TAKEDA-2024TUS057990$TAKEDA$$$$$M$Y$72$KG$20240725$$MD$US$US
239597732$23959773$2$F$20231215$20240711$20240611$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202406004786$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240712$$CN$US$US
239597892$23959789$2$F$20240501$20240909$20240611$20240927$PER$$CA-TOLMAR, INC.-24CA049548$TOLMAR$$84$YR$$M$Y$$$20240927$$CN$CA$CA
239597912$23959791$2$F$$20240802$20240611$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093599$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240805$$CN$US$US
239597962$23959796$2$F$20230809$20240705$20240611$20240712$EXP$$CA-TAKEDA-2023TUS068496$TAKEDA$$72$YR$$M$Y$$$20240712$$MD$CA$CA
239598144$23959814$4$F$20240514$20240702$20240611$20240710$30DAY$$US-JNJFOC-20240556862$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240710$$CN$US$US
239598153$23959815$3$F$$20240624$20240611$20240703$EXP$$BR-JNJFOC-20240603278$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240703$$HP$BR$BR
239598202$23959820$2$F$20240522$20240910$20240611$20240918$EXP$$ZA-EMD Serono-2024030566$EMD SERONO INC$$55$YR$A$F$Y$$$20240918$$CN$ZA$ZA
239598222$23959822$2$F$$20240809$20240611$20240811$EXP$$NVSC2024US120764$NOVARTIS$$54$YR$$M$Y$$$20240811$$CN$US$US
239598372$23959837$2$F$20210719$20240627$20240611$20240702$EXP$$AT-TAKEDA-2021TUS048124$TAKEDA$$64$YR$$F$Y$$$20240702$$CN$AT$AT
239598442$23959844$2$F$$20240710$20240611$20240711$PER$$US-JNJFOC-20240620154$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$HP$US$US
239598562$23959856$2$F$20240529$20240624$20240611$20240701$30DAY$$US-AMGEN-USASP2024109571$AMGEN$$39$YR$A$F$Y$65.3$KG$20240701$$PH$US$US
239598593$23959859$3$F$20240530$20240626$20240611$20240702$PER$$US-AMGEN-USASP2024109744$AMGEN$$$$$$Y$$$20240702$$PH$US$US
239598682$23959868$2$F$20240202$20240719$20240611$20240722$EXP$$DO-AstraZeneca-2024A131444$ASTRAZENECA$$24868$DY$$F$Y$$$20240722$$MD$DO$
239598704$23959870$4$F$$20240917$20240611$20240920$PER$$NVSC2024US119964$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
239598822$23959882$2$F$$20240712$20240611$20240716$EXP$$BG-ABBVIE-5790853$ABBVIE$$33$YR$$F$Y$$$20240716$$CN$BG$BG
239598842$23959884$2$F$20240608$20240807$20240611$20240809$PER$$US-AMGEN-USASP2024114794$AMGEN$$69$YR$E$M$Y$$$20240808$$CN$US$US
239598872$23959887$2$F$20240604$20240709$20240611$20240715$30DAY$$US-AMGEN-USASP2024111836$AMGEN$$67$YR$E$M$Y$92$KG$20240714$$PH$US$US
239598922$23959892$2$F$$20240625$20240611$20240703$EXP$$US-ALXN-202406USA000136US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240703$$CN$US$US
239598963$23959896$3$F$20240501$20240710$20240611$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091354$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240712$$PH$US$US
239599053$23959905$3$F$20230809$20240927$20240611$20240930$EXP$$US-GILEAD-2024-0676475$GILEAD$$57$YR$A$F$Y$$$20240930$$LW$US$US
239599065$23959906$5$F$$20240807$20240611$20240814$EXP$$US-GSK-US2024AMR069033$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
239599073$23959907$3$F$20240622$20240920$20240611$20240926$PER$$US-GSK-US2024AMR069591$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240926$$CN$US$US
239599282$23959928$2$F$$20240716$20240611$20240724$EXP$$US-AstraZeneca-2024A129417$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
239599295$23959929$5$F$20240525$20240712$20240611$20240719$EXP$$KR-AstraZeneca-2024A123982$ASTRAZENECA$$25576$DY$$M$Y$$$20240719$$CN$KR$
239599393$23959939$3$F$20240606$20240718$20240611$20240720$PER$$US-JNJFOC-20240616054$JOHNSON AND JOHNSON$$66$YR$E$$Y$$$20240720$$HP$US$US
239599492$23959949$2$F$20240608$20240802$20240611$20240806$PER$$US-AMGEN-USASP2024114919$AMGEN$$76$YR$E$M$Y$$$20240806$$CN$US$US
239599532$23959953$2$F$$20240617$20240611$20240703$EXP$$US-TEVA-VS-3207277$TEVA$Baskaran B, Lipford M. AN UNSHAKEABLE CASE OF REFRACTORY RLSANDROGEN RECEPTOR INHIBITOR THERAPY AS A CAUSE OF RLS EXACERBATION. Sleep 2024; 47 (Suppl. 1) A504-A505 abstr. 1179.; Baskaran B, Lipford M. AN UNSHAKEABLE CASE OF REFRACTORY RLSANDROGEN RECEPTOR INHIBITOR THERAPY AS A CAUSE OF RLS EXACERBATION. Sleep 2024; 47 (Suppl. 1) A504-A505 abstr. 1179.$58$YR$$M$Y$$$20240703$$HP$US$US
239599673$23959967$3$F$20240601$20240812$20240611$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092105$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$84.37$KG$20240819$$CN$US$US
239599852$23959985$2$F$$20240627$20240611$20240702$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-082484$REGENERON$$$$$M$Y$$$20240702$$HP$US$US
239599923$23959992$3$F$20240529$20240812$20240611$20240820$EXP$$DE-Ipsen Biopharmaceuticals, Inc.-2024-11256$IPSEN$$35$YR$A$F$Y$60$KG$20240820$$MD$DE$DE
239599973$23959997$3$F$20130813$20240927$20240611$20240930$EXP$$US-GILEAD-2024-0676483$GILEAD$$40$YR$A$M$Y$$$20240930$$LW$US$US
239600002$23960000$2$F$$20240708$20240611$20240716$EXP$$US-SA-2024SA170836$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240716$$MD$US$US
239600012$23960001$2$F$$20240719$20240611$20240725$EXP$$JP-AstraZeneca-2024A133231$ASTRAZENECA$Miyamoto Y, et al.. O-01 A case of hypomagnesaemia during panitumumab administration improved with discontinuation of a proton pump inhibitor.. Journal of Japanese Society of Pharmaceutical Oncology 2024;36:148.$70$YR$$M$Y$$$20240725$$PH$JP$
239600243$23960024$3$F$$20240722$20240611$20240722$PER$$US-ALXN-202406USA000142US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
239600522$23960052$2$F$20240607$20240822$20240611$20240822$PER$$NVSC2024US121299$NOVARTIS$$5$MON$$F$Y$$$20240822$$MD$US$US
239600542$23960054$2$F$20240609$20240709$20240611$20240711$PER$$US-AMGEN-USASP2024114812$AMGEN$$60$YR$A$F$Y$$$20240711$$CN$US$US
239600662$23960066$2$F$$20240718$20240611$20240725$30DAY$$US-GSK-US2024071431$GLAXOSMITHKLINE$$$$$M$Y$$$20240725$$CN$US$US
239600723$23960072$3$F$20240609$20240805$20240611$20240808$PER$$US-AMGEN-USASP2024114672$AMGEN$$61$YR$A$F$Y$$$20240807$$CN$US$US
239600853$23960085$3$F$$20240627$20240611$20240709$EXP$$ZA-MACLEODS PHARMA-MAC2024047553$MACLEODS$$$$$$Y$$$20240709$$CN$ZA$ZA
239600882$23960088$2$F$20180101$20240724$20240611$20240805$EXP$$PT-AUROBINDO-AUR-APL-2024-027395$AUROBINDO$$73$YR$$M$Y$$$20240805$$MD$PT$PT
239600992$23960099$2$F$20240501$20240905$20240611$20240912$EXP$$US-ABBVIE-5793140$ABBVIE$$56$YR$$F$Y$$$20240912$$CN$US$US
239601082$23960108$2$F$20240501$20240719$20240611$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093886$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240722$$CN$US$US
239601112$23960111$2$F$$20240716$20240611$20240724$EXP$$US-ROCHE-3579831$ROCHE$$58$YR$A$M$Y$$$20240724$$CN$US$US
239601142$23960114$2$F$20240530$20240705$20240611$20240707$PER$$US-JNJFOC-20240589545$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240707$$CN$US$US
239601203$23960120$3$F$$20240921$20240611$20240928$EXP$$CO-GSK-CO2023AMR178165$GLAXOSMITHKLINE$$$$$$Y$$$20240928$$PH$CO$CO
239601412$23960141$2$F$$20240617$20240611$20240722$EXP$$US-ROCHE-3577743$ROCHE$$$$A$F$Y$$$20240722$$CN$US$US
239601502$23960150$2$F$$20240718$20240611$20240726$EXP$$GB-TEVA-VS-3206580$TEVA$$79$YR$$F$Y$$$20240726$$HP$GB$GB
239601562$23960156$2$F$$20240822$20240611$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093696$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240826$$CN$US$US
239601732$23960173$2$F$20230801$20240709$20240611$20240715$EXP$$US-ROCHE-3578829$ROCHE$$56$YR$A$M$Y$64.86$KG$20240715$$HP$US$US
239601833$23960183$3$F$20240601$20240722$20240611$20240724$PER$$US-AMGEN-USASP2024114834$AMGEN$$67$YR$E$F$Y$$$20240724$$CN$US$US
239601862$23960186$2$F$20240325$20240905$20240611$20240911$EXP$$US-ABBVIE-5791225$ABBVIE$$78$YR$$F$Y$69.4$KG$20240911$$CN$US$US
239601902$23960190$2$F$20230915$20240814$20240611$20240827$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04762$LUPIN$$$$$$Y$$$20240827$$CN$US$US
239602042$23960204$2$F$$20240722$20240611$20240722$PER$$US-ALXN-202406USA000196US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
239602052$23960205$2$F$$20240809$20240611$20240819$EXP$$US-TEVA-VS-3206318$TEVA$$53$YR$$F$Y$$$20240819$$CN$US$US
239602154$23960215$4$F$20240416$20240724$20240611$20240802$EXP$$DE-JNJFOC-20240611372$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240802$$HP$DE$DE
239602402$23960240$2$F$20220101$20240614$20240611$20240906$EXP$$IR-BAUSCH-BL-2024-008720$BAUSCH AND LOMB$Shabani M, Fathy M, Pourmoshtagh H, Maghsudloo F. Steroid-Induced Progressive Multifocal Leukoencephalopathy (PML) in HIV Patient: A Paradoxical Effect. Archives of Clinical Infectious Diseases. 2024 MAR 14;19(2):1-4. doi:10.5812/archcid-140933$37$YR$$M$Y$$$20240906$$HP$IR$IR
239602442$23960244$2$F$20240513$20240627$20240611$20240724$PER$$US-TOLMAR, INC.-24US049374$TOLMAR$$46$YR$$M$Y$$$20240724$$HP$US$US
239602472$23960247$2$F$20240101$20240613$20240611$20240705$PER$$US-JNJFOC-20240542167$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20240705$$CN$US$US
239602492$23960249$2$F$20240606$20240624$20240611$20240701$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-083839$REGENERON$$$$$F$Y$$$20240701$$MD$CA$CA
239602722$23960272$2$F$$20240924$20240611$20240926$EXP$$PL-AUROBINDO-AUR-APL-2024-027565$AUROBINDO$Wcis?o S, Bojkowska-Otr?bska K, Salamon A, Skowronek A, Kandziora K, ?abuz-Roszak B.. Zespo? cytotoksycznego uszkodzenia cia?a modzelowatego - opis trzech przypadkow.. POLSKI PRZEGL?D NEUROLOGICZNY (Polish Review of Neurology). 2024;20(1):37-42.$33$YR$$M$Y$$$20240926$$MD$PL$PL
239602733$23960273$3$F$$20240805$20240611$20240902$30DAY$$JP-SA-2024SA171829$SANOFI AVENTIS$$$$A$$Y$$$20240902$$HP$JP$JP
239602822$23960282$2$F$20240607$20240626$20240611$20240702$PER$$US-AMGEN-USASP2024114830$AMGEN$$63$YR$A$F$Y$$$20240702$$CN$US$US
239602872$23960287$2$F$20240604$20240701$20240611$20240709$EXP$$US-ROCHE-3579842$ROCHE$$88$YR$E$F$Y$$$20240709$$CN$US$US
239602893$23960289$3$F$$20240820$20240611$20240823$EXP$$US-ROCHE-3579441$ROCHE$$72$YR$E$F$Y$$$20240823$$CN$US$US
239602932$23960293$2$F$$20240722$20240611$20240726$EXP$$US-GILEAD-2024-0676256$GILEAD$$$$E$F$Y$$$20240726$$CN$US$US
239602952$23960295$2$F$20240101$20240912$20240611$20240917$PER$$US-BIOGEN-2024BI01268358$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
239602962$23960296$2$F$20240601$20240709$20240611$20240716$PER$$US-AMGEN-USASP2024109112$AMGEN$$$$$F$Y$$$20240716$$CN$US$US
239602975$23960297$5$F$20240101$20240712$20240611$20240913$EXP$$US-Axsome Therapeutics, Inc.-AXS202406-000762$AXSOME THERAPEUTICS$$68$YR$E$F$Y$$$20240913$$CN$US$
239603022$23960302$2$F$$20240722$20240611$20240722$PER$$US-ALXN-202406USA000139US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
239603042$23960304$2$F$20240101$20240726$20240611$20240805$EXP$FR-AFSSAPS-TS2024000618$FR-SA-2024SA168369$SANOFI AVENTIS$$70$YR$E$F$Y$45$KG$20240805$$MD$FR$FR
239603304$23960330$4$F$20240703$20240712$20240611$20240716$EXP$$CA-TAKEDA-2020TUS028766$TAKEDA$$82$YR$$F$Y$$$20240716$$CN$CA$CA
239603322$23960332$2$F$20240509$20240719$20240611$20240729$PER$$US-AMGEN-USASP2024112616$AMGEN$$63$YR$A$M$Y$71$KG$20240729$$HP$US$US
239603412$23960341$2$F$$20240627$20240611$20240704$PER$$US-HETERO-HET2024US01650$HETERO$$$$$M$Y$$$20240704$$HP$US$US
239603594$23960359$4$F$20240610$20240802$20240611$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093825$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240819$$PH$US$US
239603612$23960361$2$F$$20240716$20240611$20240721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093864$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240722$$HP$US$US
239603665$23960366$5$F$20220106$20240731$20240611$20240809$EXP$DE-ROCHE-3057001$DE-ROCHE-3057001$ROCHE$$31$YR$A$F$Y$85$KG$20240809$$MD$DE$DE
239603832$23960383$2$F$$20240712$20240611$20240716$PER$$US-AstraZeneca-2024A133741$ASTRAZENECA$$$$$F$Y$$$20240716$$HP$US$
239604042$23960404$2$F$20240508$20240917$20240611$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US056342$SANDOZ$$$$$$Y$$$20240919$$CN$US$US
239604122$23960412$2$F$20240421$20240917$20240611$20240923$EXP$$US-SANDOZ INC.-SDZ2024US056373$SANDOZ$$$$$F$Y$$$20240923$$PH$US$US
239604132$23960413$2$F$$20240917$20240611$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US056258$SANDOZ$$$$$$Y$$$20240923$$CN$US$US
239604402$23960440$2$F$$20240925$20240611$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093760$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240926$$HP$US$US
239604462$23960446$2$F$$20240812$20240611$20240812$EXP$$IT-SCIEGENP-2024SCLIT00301$SCIEGEN$Pistolesi C, et al..LIVER INJURY INDUCED BY THE  ASSOCIATION OF LAMOTRIGINE AND  SERTRALINE IN AN ADULT FEMALE WITH  RECURRENT MAJOR DEPRESSION: A CASE  REPORT.European Journal of Case Reports in Internal Medicine.jan-2023;10:236-237$$$$F$Y$$$20240812$$HP$IT$IT
239604482$23960448$2$F$20220101$20240822$20240611$20240829$EXP$$US-GSK-US2024069328$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$MD$US$US
239604503$23960450$3$F$$20240624$20240611$20240701$EXP$$JP-JNJFOC-20240624376$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$$COUNTRY NOT SPECIFIED$JP
239604542$23960454$2$F$20240604$20240716$20240611$20240720$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-083675$REGENERON$$6$DEC$$M$Y$$$20240719$$MD$JP$JP
239604593$23960459$3$F$20240401$20240711$20240611$20240724$EXP$$JP-UCBSA-2024028789$UCB$$8$DEC$$F$Y$$$20240724$$MD$JP$JP
239604652$23960465$2$F$20240221$20240627$20240611$20240705$EXP$$DE-AUROBINDO-AUR-APL-2024-027411$AUROBINDO$$$$E$F$Y$81$KG$20240705$$HP$DE$DE
239604673$23960467$3$F$20240607$20240830$20240611$20240902$PER$$US-AMGEN-USASP2024114902$AMGEN$$53$YR$A$F$Y$$$20240902$$CN$US$US
239604772$23960477$2$F$$20240706$20240611$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-027449$AUROBINDO$Sheppard R, Evanson B, Campbell I, Shand A. Chronic diarrhoea, weight loss and a positive antitissue transglutaminase antibody: A case report of olmesartan-induced enteropathy.. BMJ-Case-Rep. 2024;17(5):1-4$4$DEC$$F$Y$$$20240717$$HP$GB$GB
239604842$23960484$2$F$20240514$20240905$20240611$20240911$EXP$$US-ABBVIE-5793877$ABBVIE$$87$YR$$F$Y$$$20240911$$CN$US$US
239605022$23960502$2$F$20240501$20240829$20240611$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450317$RANBAXY$$81$YR$E$M$Y$50$KG$20240913$$MD$CN$CN
239605172$23960517$2$F$$20240701$20240611$20240716$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-450490$RANBAXY$$59$YR$$F$Y$81$KG$20240716$$CN$NL$NL
239605392$23960539$2$F$$20240604$20240611$20240916$EXP$$RU-AstraZeneca-2024A133519$ASTRAZENECA$$$$$M$Y$$$20240916$$MD$RU$
239605444$23960544$4$F$$20240909$20240611$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093954$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240909$$CN$US$US
239605493$23960549$3$F$20240605$20240725$20240611$20240801$PER$$US-AMGEN-USASP2024111623$AMGEN$$70$YR$E$F$Y$103.2$KG$20240801$$HP$US$US
239605652$23960565$2$F$20240604$20240925$20240611$20240926$30DAY$$IT-SANDOZ INC.-SDZ2024IT056385$SANDOZ$$44$YR$$M$Y$108$KG$20240926$$CN$IT$IT
239605702$23960570$2$F$20220901$20240715$20240611$20240723$EXP$$CO-SANDOZ INC.-NVSC2022CO224186$SANDOZ$$67$YR$$F$Y$64$KG$20240723$$CN$CO$CO
239605822$23960582$2$F$$20240627$20240611$20240712$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-450753$RANBAXY$Klevor R, Jarti M, Chraa M, Louhab N, Krati K, Kissani N. Metronidazole-Induced Encephalopathy With Probable Crohn Encephalitis: A Case Report. Clin Neuropharmacol. 2024;47 (3):104-107$26$YR$$F$Y$$$20240712$$MD$JP$MA
239605992$23960599$2$F$20240402$20240717$20240611$20240723$EXP$$JP-BAYER-2024A056909$BAYER$$80$YR$E$M$Y$$$20240723$$MD$JP$JP
239606032$23960603$2$F$20221115$20240725$20240611$20240731$EXP$$RO-PFIZER INC-202400187059$PFIZER$$63$YR$$M$Y$$$20240731$$MD$RO$RO
239606052$23960605$2$F$$20240804$20240611$20240805$EXP$$RO-PFIZER INC-202400188336$PFIZER$$60$YR$$$Y$$$20240805$$MD$RO$RO
239606062$23960606$2$F$20210401$20240807$20240611$20240807$EXP$$IT-PFIZER INC-202400187966$PFIZER$$42$YR$$F$Y$$$20240807$$MD$IT$IT
239606102$23960610$2$F$$20240804$20240611$20240805$EXP$$RO-PFIZER INC-202400188335$PFIZER$$52$YR$$$Y$$$20240805$$MD$RO$RO
239606273$23960627$3$F$$20240706$20240611$20240718$EXP$$CZ-Accord-428682$ACCORD$Mocikova H. Lecba periferniho T-bunecneho lymfomu s hemofagocytujici lymfohistiocytozou. FARMAKOTERAPIE. 2024;(Supplementum 6 - Ext 1/2):13-14.$41$YR$A$F$Y$$$20240718$$MD$CZ$CZ
239606473$23960647$3$F$20220801$20240801$20240611$20240814$EXP$$JP-UCBSA-2024028779$UCB$Iguchi A, Yabe T, Miyashita M, Mizutani T, Yamaguchi K, Oyoshi H, et al. Improving EEG findings on wakefulness drastically by discontinuing lacosamide in a 8-year-old boy. No to Hattatsu (Brain and Development). 2024;56:S322$8$YR$$M$Y$$$20240814$$MD$JP$JP
239606562$23960656$2$F$$20240624$20240611$20240702$EXP$DE-BFARM-24003731$DE-THEA-2024001218$Thea Pharma$$$$E$F$Y$63$KG$20240702$$CN$DE$DE
239606662$23960666$2$F$$20240705$20240611$20240717$EXP$CA-MHPD-E2B_07049704$CA-Accord-427623$ACCORD$$74$YR$E$F$Y$54$KG$20240717$$HP$CA$CA
239606954$23960695$4$F$20220101$20240808$20240611$20240813$EXP$$US-PFIZER INC-202400190526$PFIZER$$87$YR$$F$Y$$$20240813$$CN$US$US
239606982$23960698$2$F$$20240708$20240611$20240710$EXP$$AU-PFIZER INC-PV202400075602$PFIZER$$80$YR$$M$Y$88$KG$20240710$$MD$AU$AU
239607132$23960713$2$F$$20240723$20240611$20240725$EXP$$US-PFIZER INC-202400189595$PFIZER$$66$YR$$F$Y$$$20240725$$MD$US$US
239607413$23960741$3$F$20240603$20240626$20240611$20240701$PER$$US-AMGEN-USASP2024115129$AMGEN$$54$YR$A$F$Y$$$20240701$$MD$US$US
239607932$23960793$2$F$$20240909$20240611$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093813$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240909$$CN$US$US
239607962$23960796$2$F$20240402$20240625$20240611$20240704$EXP$$JP-TAKEDA-2024TUS057996$TAKEDA$$8$DEC$$$Y$$$20240704$$MD$JP$JP
239608132$23960813$2$F$$20240530$20240611$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-027506$AUROBINDO$$57$YR$$M$Y$$$20240808$$HP$FR$FR
239608402$23960840$2$F$20230219$20240625$20240611$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-027465$AUROBINDO$$15$YR$$M$Y$$$20240703$$MD$FR$FR
239608512$23960851$2$F$20240401$20240828$20240611$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-027485$AUROBINDO$$63$YR$$F$Y$$$20240906$$MD$FR$FR
239608673$23960867$3$F$20240610$20240718$20240611$20240722$PER$$US-AMGEN-USASP2024115079$AMGEN$$87$YR$E$$Y$$$20240721$$CN$US$US
239608782$23960878$2$F$$20240722$20240611$20240722$PER$$US-ALXN-202406USA000300US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$HP$US$US
239608814$23960881$4$F$$20240902$20240611$20240902$PER$$US-ALXN-202406USA000060US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240902$$CN$US$US
239608852$23960885$2$F$$20240814$20240611$20240816$EXP$$NVSC2024GB047686$NOVARTIS$$$$$M$Y$$$20240816$$CN$GB$GB
239608943$23960894$3$F$$20240911$20240611$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093861$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240918$$HP$US$US
239608953$23960895$3$F$20240601$20240607$20240611$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093040$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240702$$HP$US$US
239609042$23960904$2$F$20240604$20240627$20240611$20240703$30DAY$$US-GSK-US2024071645$GLAXOSMITHKLINE$$79$YR$$M$Y$$$20240703$$HP$US$US
239609053$23960905$3$F$20240604$20240805$20240611$20240828$30DAY$$US-GSK-US2024069194$GLAXOSMITHKLINE$$84$YR$$F$Y$$$20240828$$CN$US$US
239609259$23960925$9$F$$20240909$20240611$20240913$EXP$$NVSC2024CZ119095$NOVARTIS$Vydra J. Syndrom obstrukce sinusoid / venookluzivni nemoc jater po alogenni transplantaci krvetvorby [Sinusoidal obstruction syndrome / hepatic veno-occlusive disease after allogeneic transplantation of hematopoiesis]. ACTA MEDICINAE. 2024;13(4-Ext 2/3):33-4, 37$40$YR$$M$Y$$$20240913$$HP$CZ$CZ
239609262$23960926$2$F$20230113$20240723$20240611$20240725$EXP$$NVSC2023IT192146$NOVARTIS$$49$YR$$F$Y$$$20240725$$MD$IT$IT
239609502$23960950$2$F$20240101$20240718$20240611$20240727$EXP$$BE-AMGEN-BELSP2024110155$AMGEN$$19$YR$$F$Y$57$KG$20240727$$MD$BE$BE
239609564$23960956$4$F$$20240703$20240611$20240708$EXP$$HU-PFIZER INC-202400188966$PFIZER$Juhasz, M.. Hemorrhagic Pneumonia in a Kidney Transplant Recipient Caused by Stenotrophomonas Maltophilia Infection: A Case Report. Transplantation proceedings. 2024;1-4$73$YR$$M$Y$83$KG$20240708$$MD$HU$HU
239609582$23960958$2$F$$20240709$20240611$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032981$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240712$$CN$US$US
239609952$23960995$2$F$20220801$20240916$20240611$20240924$PER$$US-SA-2024SA166083$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240924$$MD$US$US
239610133$23961013$3$F$$20240723$20240611$20240730$PER$$US-SA-2024SA167831$SANOFI AVENTIS$$$$E$F$Y$$$20240730$$MD$US$US
239610142$23961014$2$F$20240101$20240809$20240611$20240820$PER$$US-SA-2024SA167545$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240820$$MD$US$US
239610183$23961018$3$F$20240101$20240822$20240611$20240905$PER$$US-SA-2024SA167513$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240905$$MD$US$US
239610272$23961027$2$F$20230101$20240912$20240611$20240920$PER$$US-SA-2024SA166796$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240921$$MD$US$US
239610302$23961030$2$F$20240101$20240725$20240611$20240803$PER$$US-SA-2024SA167420$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240803$$MD$US$US
239610322$23961032$2$F$20240101$20240913$20240611$20240923$PER$$US-SA-2024SA167230$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240923$$MD$US$US
239610332$23961033$2$F$20240101$20240820$20240611$20240830$PER$$US-SA-2024SA168852$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240830$$MD$US$US
239610352$23961035$2$F$$20240910$20240611$20240923$PER$$US-SA-2024SA168268$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240923$$MD$US$US
239610383$23961038$3$F$$20240919$20240611$20240930$PER$$US-SA-2024SA168749$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240930$$MD$US$US
239610552$23961055$2$F$20240525$20240819$20240611$20240829$PER$$US-SA-2024SA169259$SANOFI AVENTIS$$60$YR$A$F$Y$70.748$KG$20240829$$MD$US$US
239610592$23961059$2$F$20240101$20240708$20240611$20240716$PER$$US-SA-2024SA169384$SANOFI AVENTIS$$67$YR$E$M$Y$86.18$KG$20240716$$CN$US$US
239610622$23961062$2$F$$20240705$20240611$20240715$PER$$US-SA-2024SA170943$SANOFI AVENTIS$$$$A$F$Y$$$20240715$$MD$US$US
239610632$23961063$2$F$20240301$20240717$20240611$20240726$PER$$US-SA-2024SA169176$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240726$$MD$US$US
239610742$23961074$2$F$$20240912$20240611$20240923$PER$$US-SA-2024SA169382$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240923$$MD$US$US
239610782$23961078$2$F$$20240913$20240611$20240922$PER$$US-SA-2024SA171736$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240923$$MD$US$US
239610832$23961083$2$F$$20240709$20240611$20240718$PER$$US-SA-2024SA170386$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240718$$MD$US$US
239610863$23961086$3$F$20240101$20240826$20240611$20240923$PER$$US-SA-2024SA172794$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240923$$CN$US$US
239610874$23961087$4$F$20231001$20240705$20240611$20240714$EXP$$US-SA-2024SA169218$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240714$$CN$US$US
239610884$23961088$4$F$$20240717$20240611$20240724$30DAY$$US-SA-2024SA171443$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240724$$CN$US$US
239610902$23961090$2$F$$20240812$20240611$20240821$PER$$US-SA-2024SA172785$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240821$$MD$US$US
239610912$23961091$2$F$20240101$20240723$20240611$20240801$PER$$US-SA-2024SA170559$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240801$$MD$US$US
239610942$23961094$2$F$$20240828$20240611$20240917$PER$$US-SA-2024SA172132$SANOFI AVENTIS$$$$A$F$Y$104.5$KG$20240918$$MD$US$US
239611042$23961104$2$F$20240101$20240627$20240611$20240709$PER$$US-SA-2024SA172267$SANOFI AVENTIS$$37$YR$A$F$Y$135$KG$20240709$$MD$US$US
239611153$23961115$3$F$20240501$20240827$20240611$20240910$PER$$US-SA-2024SA169036$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240910$$MD$US$US
239611292$23961129$2$F$$20240827$20240611$20240904$PER$$US-SA-2024SA168622$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240904$$MD$US$US
239611303$23961130$3$F$$20240823$20240611$20240913$PER$$US-SA-2024SA171922$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240913$$MD$US$US
239611423$23961142$3$F$$20240830$20240611$20240913$PER$$US-SA-2024SA169405$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240913$$MD$US$US
239611462$23961146$2$F$20240526$20240621$20240611$20240705$PER$$US-SA-2024SA171950$SANOFI AVENTIS$$52$YR$A$F$Y$56.6$KG$20240705$$MD$US$US
239611482$23961148$2$F$$20240725$20240611$20240807$PER$$US-SA-2024SA169318$SANOFI AVENTIS$$$$E$F$Y$$$20240807$$MD$US$US
239611502$23961150$2$F$$20240815$20240611$20240828$PER$$US-SA-2024SA171754$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240828$$MD$US$US
239611532$23961153$2$F$20240209$20240828$20240611$20240904$EXP$$JP-009507513-2402JPN002195J$MERCK$$8$DEC$$M$Y$$$20240904$$MD$JP$JP
239611563$23961156$3$F$20240603$20240719$20240611$20240727$EXP$$CA-CELLTRION INC.-2024CA012625$CELLTRION$$$$$$Y$$$20240727$$HP$CA$CA
239611852$23961185$2$F$$20240621$20240611$20240702$PER$$US-SA-2024SA172854$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240702$$HP$US$US
239611892$23961189$2$F$20240901$20240912$20240611$20240923$PER$$US-SA-2024SA172741$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240923$$MD$US$US
239611942$23961194$2$F$20240531$20240703$20240611$20240712$PER$$US-SA-2024SA173333$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240712$$MD$US$US
239611952$23961195$2$F$20240101$20240801$20240611$20240809$PER$$US-SA-2024SA172198$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240809$$MD$US$US
239612082$23961208$2$F$$20240606$20240611$20240722$PER$$US-SA-2024SA171846$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240722$$CN$US$US
239612142$23961214$2$F$$20240703$20240611$20240716$EXP$$IT-ROCHE-3578315$ROCHE$$36$YR$A$F$Y$$$20240716$$MD$IT$IT
239612192$23961219$2$F$$20240729$20240611$20240801$PER$$NVSC2024US121733$NOVARTIS$$42$YR$$$Y$$$20240802$$CN$US$US
239612263$23961226$3$F$20240604$20240717$20240611$20240723$EXP$$ES-PFIZER INC-PV202400073993$PFIZER$$12$YR$$F$Y$34$KG$20240723$$MD$ES$ES
239612362$23961236$2$F$20240422$20240725$20240611$20240727$PER$$US-JNJFOC-20240624584$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240727$$CN$US$US
239612503$23961250$3$F$20240522$20240806$20240611$20240820$PER$$JP-BRACCO-2024JP03166$BRACCO$$78$YR$$F$Y$$$20240820$$CN$JP$JP
239612602$23961260$2$F$$20240813$20240611$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091022$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240820$$HP$US$US
239612782$23961278$2$F$$20240626$20240611$20240710$PER$$US-MYLANLABS-2024M1049430$MYLAN$$$$$$Y$$$20240710$$CN$US$US
239612974$23961297$4$F$$20240730$20240611$20240807$PER$$US-SA-2024SA172272$SANOFI AVENTIS$$$$E$F$Y$$$20240807$$MD$US$US
239613032$23961303$2$F$$20240627$20240611$20240711$30DAY$$JP-JNJFOC-20240606238$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$MD$JP$JP
239613042$23961304$2$F$20240501$20240829$20240611$20240911$PER$$US-SA-2024SA057326$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240911$$MD$US$US
239613222$23961322$2$F$20240101$20240628$20240611$20240712$PER$$US-SA-2024SA172326$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240712$$MD$US$US
239613232$23961323$2$F$20240101$20240823$20240611$20240909$PER$$US-SA-2024SA172852$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240909$$MD$US$US
239613302$23961330$2$F$$20240719$20240611$20240726$PER$$US-MYLANLABS-2024M1047422$MYLAN$$$$$F$Y$58.97$KG$20240726$$CN$US$US
239613412$23961341$2$F$20240603$20240812$20240611$20240820$PER$$US-SA-2024SA168747$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240820$$MD$US$US
239613423$23961342$3$F$20240204$20240719$20240611$20240726$EXP$$HR-TAKEDA-2024TUS011838$TAKEDA$$69$YR$$M$Y$$$20240726$$HP$HR$HR
239613433$23961343$3$F$$20240701$20240611$20240709$PER$$US-SA-2024SA169882$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240709$$MD$US$US
239613522$23961352$2$F$20240322$20240719$20240611$20240725$EXP$$KR-TAKEDA-2024TUS055991$TAKEDA$$$$E$F$Y$$$20240725$$MD$KR$KR
239613583$23961358$3$F$20240609$20240806$20240611$20240808$PER$$US-AMGEN-USASP2024114840$AMGEN$$67$YR$E$F$Y$$$20240808$$CN$US$US
239613633$23961363$3$F$20240527$20240812$20240611$20240821$EXP$$US-MYLANLABS-2024M1050464$MYLAN$$42$YR$$F$Y$49.9$KG$20240821$$CN$US$US
239613702$23961370$2$F$$20240702$20240611$20240705$EXP$$CA-TAKEDA-2024TUS047862$TAKEDA$$$$$M$Y$$$20240705$$CN$CA$CA
239613735$23961373$5$F$$20240806$20240611$20240808$EXP$$CA-JNJFOC-20240617901$JOHNSON AND JOHNSON$$14$YR$T$F$Y$45$KG$20240808$$PH$CA$CA
239613762$23961376$2$F$20240101$20240910$20240611$20240919$PER$$US-SA-2024SA168572$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240919$$MD$US$US
239613855$23961385$5$F$$20240918$20240611$20240925$EXP$$TR-ASTELLAS-2024US016341$ASTELLAS$$71$YR$E$M$Y$$$20240925$$MD$TR$TR
239613882$23961388$2$F$20240528$20240712$20240611$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-028147$AUROBINDO$$35$YR$$F$Y$$$20240722$$PH$US$US
239614002$23961400$2$F$20240101$20240723$20240611$20240731$EXP$$US-SERVIER-S24006960$SERVIER$$$$$$Y$$$20240731$$CN$US$US
239614014$23961401$4$F$$20240626$20240611$20240703$EXP$$JP-JNJFOC-20240624391$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$$COUNTRY NOT SPECIFIED$JP
239614163$23961416$3$F$$20240801$20240611$20240807$EXP$GB-009507513-2405GBR005942$GB-RDY-SPO/GBR/24/0008297$DR REDDYS$$$$$M$Y$$$20240807$$CN$GB$GB
239614252$23961425$2$F$20240101$20240703$20240611$20240715$PER$$US-MYLANLABS-2024M1051082$MYLAN$$$$$$Y$65.77$KG$20240715$$CN$US$US
239614292$23961429$2$F$$20240722$20240611$20240722$PER$$US-ALXN-202406USA000308US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
239614302$23961430$2$F$$20240722$20240611$20240722$PER$$US-ALXN-202406USA000059US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
239614312$23961431$2$F$$20240712$20240611$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202406004809$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240717$$HP$US$US
239614362$23961436$2$F$20240607$20240806$20240611$20240807$PER$$US-AMGEN-USASP2024114116$AMGEN$$80$YR$E$M$Y$$$20240807$$CN$US$US
239614412$23961441$2$F$$20240705$20240611$20240711$30DAY$$TH-JNJFOC-20240605752$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$TH$TH
239614543$23961454$3$F$$20240809$20240611$20240819$EXP$$GB-TEVA-VS-3207038$TEVA$Kumaria A, Kirkman MA, Howarth SP, Macarthur DC. Beating a skullduggerous infantile hemispheric high-rade glioma. British Journal of Neurosurgery. 2024;38(2):544-545 on 10 Apr 2024; Kumaria A, Kirkman MA, Howarth SP, Macarthur DC.?Beating a skullduggerous infantile hemispheric high-grade glioma. British?Journal of Neurosurgery. 2024;38(2)_544-545 on 10 Apr 2024.$5$MON$$M$Y$$$20240819$$MD$GB$GB
239614642$23961464$2$F$20240708$20240709$20240611$20240815$PER$$US-TRAVERE-2024TVT00496$TRAVERE THERAPEUTICS$$23$YR$A$M$Y$$$20240815$$CN$US$US
239614712$23961471$2$F$20220101$20240909$20240611$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090798$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$40.82$KG$20240909$$CN$US$US
239614722$23961472$2$F$20240212$20240603$20240611$20240830$EXP$$US-SA-2022SA490660$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240830$$MD$US$US
239614853$23961485$3$F$20240607$20240918$20240611$20240919$EXP$$US-TAKEDA-2024TUS058242$TAKEDA$$41$YR$$F$Y$$$20240919$$CN$US$US
239614862$23961486$2$F$20240401$20240702$20240611$20240702$PER$$US-BAYER-2024A081042$BAYER$$$$$F$Y$$$20240702$$HP$US$US
239614983$23961498$3$F$20240401$20240708$20240611$20240710$PER$$US-BAYER-2024A080897$BAYER$$43$YR$A$F$Y$$$20240710$$CN$US$US
239615092$23961509$2$F$$20240702$20240611$20240717$30DAY$$AR-JNJFOC-20240605155$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$AR$AR
239615164$23961516$4$F$$20240916$20240611$20240919$PER$$NVSC2024US119057$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
239615252$23961525$2$F$20210101$20240701$20240611$20240702$EXP$$HR-SANDOZ INC.-SDZ2024HR056367$SANDOZ$$61$YR$$M$Y$$$20240702$$MD$HR$HR
239615503$23961550$3$F$20240101$20240912$20240611$20240918$PER$$US-SA-2024SA168321$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240918$$MD$US$US
239615782$23961578$2$F$$20240815$20240611$20240826$30DAY$$GR-JNJFOC-20240604996$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$GR$GR
239615792$23961579$2$F$20240524$20240702$20240611$20240709$PER$$US-MYLANLABS-2024M1049651$MYLAN$$89$YR$$F$Y$68.04$KG$20240709$$CN$US$US
239615942$23961594$2$F$20240330$20240705$20240611$20240715$EXP$$DE-PFIZER INC-PV202400073118$PFIZER$$54$YR$$F$Y$71$KG$20240715$$MD$DE$DE
239615962$23961596$2$F$20230625$20240717$20240611$20240726$EXP$$CN-PFIZER INC-2023SGN08515$PFIZER$$66$YR$$F$Y$49.7$KG$20240726$$MD$CN$CN
239615973$23961597$3$F$20230922$20240724$20240611$20240729$EXP$$CN-PFIZER INC-2023SGN11540$PFIZER$$60$YR$$M$Y$72$KG$20240729$$MD$CN$CN
239615992$23961599$2$F$20110912$20240710$20240611$20240722$EXP$$CZ-UCBSA-2024028266$UCB$$68$YR$$F$Y$55$KG$20240722$$MD$CZ$CZ
239616152$23961615$2$F$20240409$20240624$20240611$20240717$PER$$US-JNJFOC-20240577029$JOHNSON AND JOHNSON$$77$YR$E$F$Y$66.7$KG$20240717$$CN$US$US
239616312$23961631$2$F$20221001$20240625$20240611$20240702$EXP$$CN-PFIZER INC-2022SGN11196$PFIZER$$29$YR$$F$Y$57.2$KG$20240702$$MD$CN$CN
239616502$23961650$2$F$$20240528$20240611$20240712$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-12637$SAMSUNG BIOEPIS$$79$YR$E$F$Y$$$20240712$$CN$CA$CA
239616634$23961663$4$F$$20240726$20240611$20240726$PER$$NVSC2024US122015$NOVARTIS$$$$$M$Y$$$20240726$$CN$US$US
239616662$23961666$2$F$$20240606$20240611$20240708$PER$$US-LUNDBECK-DKLU4000153$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
239616813$23961681$3$F$20240523$20240722$20240611$20240805$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406003038$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240805$$CN$JP$JP
239616844$23961684$4$F$$20240628$20240611$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202405013261$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240705$$CN$US$US
239616902$23961690$2$F$20240220$20240719$20240611$20240813$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406002805$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240813$$CN$JP$JP
239617002$23961700$2$F$20221109$20240710$20240611$20240712$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406005152$ELI LILLY AND CO$$94$YR$E$M$Y$57.3$KG$20240712$$CN$JP$JP
239617093$23961709$3$F$$20240628$20240611$20240712$30DAY$$TR-JNJFOC-20240548284$JOHNSON AND JOHNSON$$37$YR$A$M$Y$60$KG$20240712$$PH$TR$TR
2396172010$23961720$10$F$20240509$20240926$20240611$20240930$EXP$$IT-MYLANLABS-2024M1051719$MYLAN$$46$YR$$M$Y$74$KG$20240930$$MD$IT$IT
239617232$23961723$2$F$$20240709$20240611$20240711$30DAY$$US-AMGEN-USASP2024107707$AMGEN$$$$$M$Y$85.7$KG$20240711$$HP$US$US
239617282$23961728$2$F$$20240712$20240611$20240712$30DAY$$US-PFIZER INC-202400187473$PFIZER$$11$YR$$M$Y$$$20240712$$CN$US$US
239617313$23961731$3$F$$20240828$20240611$20240903$30DAY$$US-PFIZER INC-202400188081$PFIZER$$2$YR$$M$Y$11.8$KG$20240903$$HP$US$US
239617324$23961732$4$F$$20240923$20240611$20240926$30DAY$$US-PFIZER INC-202400187873$PFIZER$$$$$F$Y$$$20240926$$CN$US$US
239617332$23961733$2$F$$20240712$20240611$20240712$30DAY$$US-PFIZER INC-202400187013$PFIZER$$12$YR$$F$Y$$$20240712$$CN$US$US
239617346$23961734$6$F$$20240914$20240611$20240919$30DAY$$US-PFIZER INC-202400189031$PFIZER$$4$MON$$M$Y$$$20240919$$CN$US$US
239617355$23961735$5$F$20240601$20240906$20240611$20240910$30DAY$$US-PFIZER INC-202400185601$PFIZER$$13$YR$$M$Y$$$20240910$$MD$US$US
239617382$23961738$2$F$$20240802$20240611$20240808$EXP$$US-OTSUKA-2024_015833$OTSUKA$$$$$M$Y$86.18$KG$20240808$$CN$US$US
239617472$23961747$2$F$$20240711$20240611$20240717$30DAY$$JP-JNJFOC-20240603816$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$PH$JP$JP
239617563$23961756$3$F$20240530$20240829$20240611$20240903$EXP$$CA-JNJFOC-20240616911$JOHNSON AND JOHNSON$$16$YR$T$F$Y$52$KG$20240903$$HP$CA$CA
239617572$23961757$2$F$$20240626$20240611$20240705$EXP$$CA-OTSUKA-2024_016163$OTSUKA$$$$$F$Y$$$20240705$$HP$CA$CA
239617803$23961780$3$F$$20240619$20240611$20240701$EXP$$CA-TAKEDA-2024TUS054843$TAKEDA$$$$$M$Y$$$20240701$$CN$CA$CA
239617833$23961783$3$F$$20240722$20240611$20240726$EXP$$CA-MYLANLABS-2024M1052918$MYLAN$$$$$F$Y$$$20240726$$CN$CA$CA
239617847$23961784$7$F$20231201$20240909$20240611$20240913$EXP$DE-BFARM-24003670$DE-MYLANLABS-2024M1051570$MYLAN$$66$YR$$F$Y$83$KG$20240913$$CN$DE$DE
239618202$23961820$2$F$$20240914$20240611$20240918$PER$$US-BAYER-2024A084276$BAYER$$33$YR$A$F$Y$$$20240918$$CN$US$US
239618233$23961823$3$F$20230930$20240702$20240611$20240708$EXP$$DE-MYLANLABS-2024M1052675$MYLAN$$66$YR$$F$Y$$$20240708$$CN$DE$DE
239618243$23961824$3$F$$20240715$20240611$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04778$LUPIN$$$$$$Y$$$20240813$$CN$US$US
239618293$23961829$3$F$$20240814$20240611$20240820$EXP$$CA-TAKEDA-2023TUS024779$TAKEDA$$$$$F$Y$$$20240820$$MD$CA$CA
239618343$23961834$3$F$$20240709$20240611$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04715$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239618502$23961850$2$F$$20240709$20240611$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04686$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239618603$23961860$3$F$20240409$20240731$20240611$20240806$EXP$$CA-JNJFOC-20240505763$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240806$$PH$CA$CA
239618643$23961864$3$F$$20240709$20240611$20240722$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04766$LUPIN$$$$$$Y$$$20240722$$CN$US$US
239618653$23961865$3$F$$20240709$20240611$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04735$LUPIN$$$$$$Y$$$20240804$$PH$US$US
239618693$23961869$3$F$20240507$20240726$20240611$20240801$EXP$$US-BIOGEN-2024BI01268079$BIOGEN$$57$YR$$F$Y$$$20240801$$CN$US$US
239618794$23961879$4$F$$20240909$20240611$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093395$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240909$$CN$US$US
239618812$23961881$2$F$$20240703$20240611$20240705$PER$$US-JNJFOC-20240603844$JOHNSON AND JOHNSON$$$$$F$Y$88.984$KG$20240705$$PH$US$US
239618822$23961882$2$F$20240501$20240709$20240611$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04716$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239618843$23961884$3$F$20240604$20240725$20240611$20240730$EXP$$NVSC2024DE119254$NOVARTIS$$$$A$F$Y$92$KG$20240730$$MD$DE$DE
239618853$23961885$3$F$$20240724$20240611$20240730$EXP$$NVSC2024US121182$NOVARTIS$$$$$M$Y$$$20240730$$CN$US$US
239618932$23961893$2$F$$20240704$20240611$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04771$LUPIN$$$$$$Y$$$20240730$$CN$US$US
239618992$23961899$2$F$$20240916$20240611$20240919$30DAY$$US-PFIZER INC-PV202400072376$PFIZER$$$$$$Y$$$20240919$$HP$US$US
239619044$23961904$4$F$20181001$20240701$20240611$20240703$EXP$$US-UCBSA-2024016047$UCB$$74$YR$$F$Y$164$KG$20240703$$CN$US$US
239619052$23961905$2$F$20240601$20240827$20240611$20240829$30DAY$$US-PFIZER INC-202400188827$PFIZER$$$$$F$Y$$$20240829$$CN$US$US
239619063$23961906$3$F$$20240916$20240611$20240919$30DAY$$US-PFIZER INC-202400010777$PFIZER$$15$YR$$M$Y$$$20240919$$CN$US$US
239619074$23961907$4$F$$20240912$20240611$20240917$30DAY$$US-PFIZER INC-202400186507$PFIZER$$9$YR$$M$Y$27.22$KG$20240917$$CN$US$US
239619083$23961908$3$F$$20240820$20240611$20240823$30DAY$$US-PFIZER INC-202400186566$PFIZER$$14$YR$$M$Y$$$20240823$$CN$US$US
239619094$23961909$4$F$20240101$20240721$20240611$20240722$30DAY$$US-PFIZER INC-202400186183$PFIZER$$12$YR$$M$Y$$$20240722$$MD$US$US
239619123$23961912$3$F$20240524$20240827$20240611$20240830$30DAY$$US-PFIZER INC-202400187177$PFIZER$$15$YR$$M$Y$$$20240830$$CN$US$US
239619136$23961913$6$F$20240101$20240909$20240611$20240919$EXP$$US-INSMED, INC.-2024-02226-US$INSMED$$$$$M$Y$$$20240919$$CN$US$US
239619156$23961915$6$F$20230101$20240812$20240611$20240815$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032497$BOEHRINGER INGELHEIM$$49$YR$A$M$Y$$$20240815$$CN$DE$DE
239619183$23961918$3$F$$20240722$20240611$20240729$30DAY$$US-PFIZER INC-202400182134$PFIZER$$14$YR$$M$Y$45.36$KG$20240729$$CN$US$US
239619194$23961919$4$F$$20240913$20240611$20240923$30DAY$$US-PFIZER INC-202400182276$PFIZER$$7$YR$$M$Y$$$20240923$$CN$US$US
239619333$23961933$3$F$20240604$20240709$20240611$20240713$EXP$$CA-JNJFOC-20230868152$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240713$$HP$CA$CA
239619392$23961939$2$F$20240810$20240813$20240611$20240820$EXP$$CA-GSK-CA2024070705$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$HP$CA$CA
239619402$23961940$2$F$$20240709$20240611$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04734$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239619442$23961944$2$F$20240101$20240816$20240611$20240828$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-001211$SK LIFE SCIENCE$$$$$$Y$$$20240828$$HP$CA$CA
239620532$23962053$2$F$$20240709$20240611$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04760$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239620542$23962054$2$F$$20240812$20240611$20240820$PER$$US-SA-2024SA172770$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240820$$CN$US$US
239620553$23962055$3$F$$20240812$20240611$20240814$30DAY$$US-PFIZER INC-202400186515$PFIZER$$9$YR$$F$Y$21.77$KG$20240814$$CN$US$US
239620573$23962057$3$F$$20240925$20240611$20240925$30DAY$$US-PFIZER INC-202400188803$PFIZER$$9$YR$$F$Y$$$20240925$$CN$US$US
239620593$23962059$3$F$$20240913$20240611$20240918$30DAY$$US-PFIZER INC-202400188165$PFIZER$$28$YR$$F$Y$$$20240918$$CN$US$US
239620604$23962060$4$F$$20240913$20240611$20240919$30DAY$$US-PFIZER INC-202400187844$PFIZER$$11$YR$$M$Y$$$20240919$$CN$US$US
239620613$23962061$3$F$$20240913$20240611$20240919$30DAY$$US-PFIZER INC-202400187967$PFIZER$$13$YR$$F$Y$40.1$KG$20240919$$CN$US$US
239620626$23962062$6$F$20240101$20240924$20240611$20240926$30DAY$$US-PFIZER INC-202400188795$PFIZER$$13$YR$$F$Y$31.1$KG$20240926$$CN$US$US
239620643$23962064$3$F$20240525$20240723$20240611$20240729$30DAY$$CA-JNJFOC-20240578111$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240730$$HP$CA$CA
239620852$23962085$2$F$20240515$20240701$20240611$20240725$PER$$US-TOLMAR, INC.-24US049485$TOLMAR$$$$$M$Y$$$20240725$$HP$US$US
239620882$23962088$2$F$20240517$20240701$20240611$20240725$PER$$US-TOLMAR, INC.-24US049491$TOLMAR$$82$YR$$M$Y$$$20240725$$HP$US$US
239620912$23962091$2$F$$20240709$20240611$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04712$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239620923$23962092$3$F$$20240920$20240611$20240923$PER$$NVSC2024US121919$NOVARTIS$$$$$F$Y$$$20240923$$MD$US$US
239620942$23962094$2$F$$20240809$20240611$20240812$EXP$$NVSC2024US120988$NOVARTIS$$$$$M$Y$$$20240812$$HP$US$US
239621012$23962101$2$F$$20240611$20240611$20240731$PER$$US-AstraZeneca-2024A128911$ASTRAZENECA$$$$$F$Y$$$20240731$$HP$US$
239621102$23962110$2$F$20240201$20240605$20240611$20240905$EXP$IT-MINISAL02-986620$IT-Ipsen Biopharmaceuticals, Inc.-2024-10297$IPSEN$$44$YR$A$M$Y$65$KG$20240905$$MD$IT$IT
239621112$23962111$2$F$$20240709$20240611$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04775$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239621162$23962116$2$F$$20240717$20240611$20240724$EXP$$US-ALXN-202406USA000013US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
239621252$23962125$2$F$20240424$20240830$20240611$20240904$EXP$$JP-BEH-2024173303$CSL BEHRING$$62$YR$A$F$Y$41.6$KG$20240904$$PH$JP$JP
239621283$23962128$3$F$$20240709$20240611$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04539$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239621316$23962131$6$F$$20240924$20240611$20240924$30DAY$$US-PFIZER INC-202400180071$PFIZER$$$$$F$Y$$$20240924$$CN$US$US
239621403$23962140$3$F$20240517$20240625$20240611$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-078623$BRISTOL MYERS SQUIBB$$64$YR$A$$Y$$$20240705$$PH$JP$JP
239621452$23962145$2$F$$20240912$20240611$20240917$PER$$NVSC2024US120087$NOVARTIS$$$$$M$Y$$$20240917$$CN$US$US
239621462$23962146$2$F$20240501$20240605$20240611$20240705$PER$$US-009507513-2406USA002848$MERCK$$$$$M$Y$$$20240705$$MD$US$US
239621572$23962157$2$F$20240101$20240718$20240611$20240729$PER$$US-SA-2024SA170772$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240729$$MD$US$US
239621592$23962159$2$F$20240501$20240717$20240611$20240726$PER$$US-SA-2024SA172977$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240726$$MD$US$US
239621603$23962160$3$F$20240403$20240715$20240611$20240722$30DAY$$US-AMGEN-USASP2024109379$AMGEN$$$$$$Y$$$20240722$$CN$US$US
239621642$23962164$2$F$$20240708$20240611$20240712$EXP$$JP-JNJFOC-20240624377$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$MD$JP$JP
239621843$23962184$3$F$20240101$20240726$20240611$20240806$PER$$US-SA-2024SA170119$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240806$$CN$US$US
239621862$23962186$2$F$20240708$20240724$20240611$20240727$EXP$$MY-TAKEDA-2024TUS057851$TAKEDA$$80$YR$$M$Y$72.7$KG$20240727$$MD$MY$MY
239621902$23962190$2$F$$20240709$20240611$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04873$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239621932$23962193$2$F$$20240708$20240611$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093241$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240709$$HP$US$US
239621942$23962194$2$F$$20240710$20240611$20240716$EXP$$US-TAKEDA-2024TUS057518$TAKEDA$$$$$M$Y$$$20240716$$CN$US$US
239622232$23962223$2$F$$20240805$20240611$20240815$EXP$$US-ELI_LILLY_AND_COMPANY-US202406000134$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240815$$PH$US$US
239622244$23962224$4$F$20240604$20240910$20240611$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406002917$ELI LILLY AND CO$$35$YR$A$M$Y$130$KG$20240920$$CN$JP$JP
239622292$23962229$2$F$$20240724$20240611$20240730$EXP$$US-TAKEDA-2021TUS002692$TAKEDA$$$$$F$Y$$$20240730$$CN$US$US
239622392$23962239$2$F$$20240625$20240611$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450426$RANBAXY$Mentesoglu D, Elkiran L, Kurmus GI, Kartal SP. A pediatric case of two Nicolau syndrome lesions following leuprolide injection in the upper extremity. Indian J Pharmacol. 2024;56 (2):141-143$9$YR$$F$Y$$$20240710$$HP$TR$TR
239622452$23962245$2$F$20240520$20240813$20240611$20240828$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450319$RANBAXY$$75$YR$E$F$Y$37$KG$20240828$$MD$CN$CN
239622712$23962271$2$F$$20240808$20240611$20240813$EXP$$JP-JNJFOC-20240625380$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$PH$JP$JP
239622733$23962273$3$F$$20240718$20240611$20240725$PER$$US-AMGEN-USASP2024113506$AMGEN$$55$YR$A$F$Y$95.25$KG$20240725$$CN$US$US
239622823$23962282$3$F$20240330$20240718$20240611$20240724$EXP$DE-PFIZER INC-PV202400073118$NVSC2024DE121177$NOVARTIS$$54$YR$$F$Y$71$KG$20240724$$MD$DE$DE
239622972$23962297$2$F$20240101$20240709$20240611$20240717$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000514$DECIPHERA PHARMACEUTICALS$$72$YR$E$F$Y$$$20240717$$CN$US$US
239622994$23962299$4$F$20240526$20240918$20240611$20240919$EXP$$NVSC2024US120464$NOVARTIS$$35$YR$$F$Y$$$20240920$$CN$US$US
239623093$23962309$3$F$20240603$20240716$20240611$20240723$EXP$$CO-GSK-CO2024AMR070503$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$CO$CO
239623105$23962310$5$F$20240604$20240703$20240611$20240720$30DAY$$US-JNJFOC-20240608409$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240719$$CN$US$US
239623143$23962314$3$F$20240521$20240702$20240611$20240709$30DAY$$JP-JNJFOC-20240576578$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$PH$JP$JP
239623183$23962318$3$F$$20240709$20240611$20240710$PER$$US-AMGEN-USASP2024115247$AMGEN$$$$$M$Y$$$20240710$$CN$US$US
239623272$23962327$2$F$$20240723$20240611$20240731$EXP$$NVSC2024JP121865$NOVARTIS$Hiramatsu Y, Takahashi K, Shimomura M, Taniguchi K, Okura Y, Nawate M, et al.. Hypothermia, bradycardia and hypotension during glucocorticoid or cyclosporine A therapy in a boy with Kikuchi-Fujimoto disease.. MODERN RHEUMATOLOGY CASE REPORTS. 2024;1-5$$$C$M$Y$$$20240731$$HP$JP$JP
239623292$23962329$2$F$20240318$20240906$20240611$20240906$EXP$FR-AFSSAPS-LM2024000304$NVSC2024FR121111$NOVARTIS$$67$YR$$F$Y$70$KG$20240906$$MD$FR$FR
239623302$23962330$2$F$$20240814$20240611$20240816$EXP$$NVSC2024US120770$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
239623422$23962342$2$F$$20240909$20240611$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094055$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240909$$CN$US$US
239623432$23962343$2$F$$20240910$20240611$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093710$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240910$$CN$US$US
239623442$23962344$2$F$20240502$20240909$20240611$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-092889$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240909$$PH$JP$JP
239623452$23962345$2$F$$20240629$20240611$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04769$LUPIN$$$$$$Y$$$20240717$$CN$US$US
239623504$23962350$4$F$$20240710$20240611$20240724$PER$$US-AMGEN-USASP2024112793$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
239623589$23962358$9$F$20231218$20240904$20240611$20240912$EXP$FR-AFSSAPS-RS2024000538$FR-JNJFOC-20240622445$JOHNSON AND JOHNSON$$32$YR$A$F$Y$100$KG$20240912$$MD$FR$FR
239623655$23962365$5$F$20240515$20240823$20240611$20240903$30DAY$$CO-PFIZER INC-202400181761$PFIZER$$7$YR$$M$Y$16$KG$20240903$$CN$CO$CO
239623742$23962374$2$F$20240101$20240722$20240611$20240724$EXP$$US-Eisai-EC-2024-163843$EISAI$$69$YR$E$M$Y$$$20240724$$CN$US$US
239623853$23962385$3$F$20240520$20240726$20240611$20240805$EXP$$US-JNJFOC-20240607407$JOHNSON AND JOHNSON$$80$YR$E$M$Y$55.5$KG$20240805$$HP$US$US
239623932$23962393$2$F$20240527$20240626$20240611$20240701$EXP$$CA-IMMUNOCORE, LTD-2024-IMC-002724$IMMUNOCORE$$$$$$Y$$$20240701$$PH$CA$CA
239623943$23962394$3$F$$20240828$20240611$20240903$30DAY$$JO-PFIZER INC-202400172108$PFIZER$$$$$$Y$$$20240903$$CN$JO$JO
239623974$23962397$4$F$$20240915$20240611$20240918$30DAY$$CO-PFIZER INC-PV202400070511$PFIZER$$13$YR$$M$Y$$$20240918$$CN$CO$CO
239623982$23962398$2$F$20240601$20240628$20240611$20240702$PER$$US-BAYER-2024A082524$BAYER$$93$YR$E$M$Y$$$20240702$$CN$US$US
239623992$23962399$2$F$$20240801$20240611$20240801$EXP$$CA-PFIZER INC-202400190193$PFIZER$$60$YR$$F$Y$$$20240801$$HP$CA$CA
239624053$23962405$3$F$20240304$20240903$20240611$20240910$EXP$$NVSC2024FR121608$NOVARTIS$$$$A$F$Y$$$20240910$$MD$FR$FR
239624162$23962416$2$F$20240101$20240710$20240611$20240715$EXP$$US-JNJFOC-20240609433$JOHNSON AND JOHNSON$$28$YR$A$M$Y$72.095$KG$20240715$$CN$US$US
239624172$23962417$2$F$20240101$20240819$20240611$20240823$EXP$$CA-JNJFOC-20240621375$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240823$$CN$CA$CA
239624273$23962427$3$F$$20240626$20240611$20240703$PER$$US-PFIZER INC-PV202400075784$PFIZER$$77$YR$$F$Y$$$20240703$$CN$US$US
239624303$23962430$3$F$$20240807$20240611$20240812$PER$$US-PFIZER INC-PV202400074707$PFIZER$$79$YR$$F$Y$$$20240812$$CN$US$US
239624312$23962431$2$F$20240608$20240628$20240611$20240701$PER$$US-PFIZER INC-202400190479$PFIZER$$42$YR$$M$Y$$$20240701$$CN$US$US
239624382$23962438$2$F$20240101$20240716$20240611$20240719$PER$$US-PFIZER INC-PV202400074302$PFIZER$$21$YR$$F$Y$$$20240719$$MD$US$US
239624405$23962440$5$F$$20240816$20240611$20240820$PER$$US-PFIZER INC-202400188452$PFIZER$$77$YR$$F$Y$$$20240820$$CN$US$US
239624472$23962447$2$F$20230421$20240808$20240611$20240812$PER$$US-PFIZER INC-202400190664$PFIZER$$55$YR$$F$Y$$$20240812$$HP$US$US
239624492$23962449$2$F$$20240711$20240611$20240711$PER$$US-PFIZER INC-202400189733$PFIZER$$$$$$Y$$$20240711$$CN$US$US
239624522$23962452$2$F$$20240729$20240611$20240731$PER$$US-PFIZER INC-PV202400075543$PFIZER$$63$YR$$F$Y$$$20240731$$CN$US$US
239624572$23962457$2$F$20240609$20240625$20240611$20240701$PER$$US-PFIZER INC-202400190260$PFIZER$$72$YR$$M$Y$58.957$KG$20240701$$CN$US$US
239624596$23962459$6$F$20240601$20240724$20240611$20240729$PER$$US-PFIZER INC-PV202400075566$PFIZER$$45$YR$$F$Y$$$20240729$$HP$US$US
239624643$23962464$3$F$20240101$20240820$20240611$20240909$PER$$US-SA-2024SA173342$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240909$$MD$US$US
239624672$23962467$2$F$$20240628$20240611$20240703$PER$$US-PFIZER INC-PV202400075994$PFIZER$$63$YR$$F$Y$$$20240703$$CN$US$US
239624812$23962481$2$F$$20240701$20240611$20240703$PER$$US-PFIZER INC-202400190425$PFIZER$$77$YR$$F$Y$87.54$KG$20240703$$CN$US$US
239624872$23962487$2$F$20240523$20240628$20240611$20240701$PER$$US-PFIZER INC-PV202400011246$PFIZER$$70$YR$$F$Y$62.1$KG$20240701$$CN$US$US
239624992$23962499$2$F$$20240715$20240611$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093782$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240716$$CN$US$US
239625014$23962501$4$F$$20240619$20240611$20240702$30DAY$$US-JNJFOC-20240590206$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
239625144$23962514$4$F$$20240802$20240611$20240806$EXP$$NVSC2024TR120289$NOVARTIS$Gecgel A, On S, Ciftci Y, Ozkan O, Acar FP, Karaca B. Guillain-barre syndrome due to adjuvant therapy with dabrafenib plus trametinib. BALKAN MED J. 2024$55$YR$$M$Y$$$20240806$$HP$TR$TR
239625192$23962519$2$F$$20240819$20240611$20240826$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001171$BLUEPRINT MEDICINES$$$$$F$Y$$$20240827$$CN$US$US
239625254$23962525$4$F$20240401$20240822$20240611$20240827$EXP$$US-PFIZER INC-202400190464$PFIZER$$68$YR$$M$Y$90.703$KG$20240827$$HP$US$US
239625264$23962526$4$F$20240603$20240915$20240611$20240919$30DAY$$GR-PFIZER INC-PV202400073925$PFIZER$$9$YR$$M$Y$25$KG$20240919$$HP$GR$GR
239625283$23962528$3$F$20240101$20240826$20240611$20240830$30DAY$$GR-PFIZER INC-PV202400073974$PFIZER$$7$YR$$F$Y$20$KG$20240830$$CN$GR$GR
239625356$23962535$6$F$$20240905$20240611$20240919$EXP$$US-APELLIS-2024-APL-0000163$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240919$$MD$US$US
239625412$23962541$2$F$20240602$20240710$20240611$20240712$PER$$US-AMGEN-USASP2024109941$AMGEN$$66$YR$E$F$Y$$$20240712$$HP$US$US
239625454$23962545$4$F$20240501$20240801$20240611$20240810$PER$$US-SA-2024SA168867$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240810$$MD$US$US
239625552$23962555$2$F$$20240708$20240611$20240727$PER$$US-INSUD PHARMA-2405US04282$INSUD PHARMA$$$$$$Y$$$20240728$$CN$US$US
239625562$23962556$2$F$20240101$20240708$20240611$20240711$PER$$US-BIOGEN-2024BI01268559$BIOGEN$$$$$M$Y$$$20240711$$CN$US$US
239625633$23962563$3$F$20220601$20240906$20240611$20240917$EXP$$DE-ROCHE-3577466$ROCHE$$34$YR$A$F$Y$$$20240917$$MD$DE$DE
239625742$23962574$2$F$20220101$20240722$20240611$20240813$PER$$US-INCYTE CORPORATION-2024IN005784$INCYTE$$$$$$Y$$$20240813$$MD$US$US
239625752$23962575$2$F$20201101$20240717$20240611$20240724$EXP$$NVSC2020BR305807$NOVARTIS$$79$YR$$F$Y$68$KG$20240724$$CN$BR$BR
239625812$23962581$2$F$$20240708$20240611$20240710$PER$$US-PFIZER INC-PV202400075793$PFIZER$$51$YR$$F$Y$70.748$KG$20240710$$CN$US$US
239625882$23962588$2$F$20240101$20240918$20240611$20240927$PER$$US-SA-2024SA169235$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240927$$MD$US$US
239625902$23962590$2$F$20230701$20240626$20240611$20240702$EXP$$JP-009507513-2404JPN003998J$MERCK$$75$YR$$F$Y$70$KG$20240702$$PH$JP$JP
239625952$23962595$2$F$20240507$20240806$20240611$20240819$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500405$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
239625972$23962597$2$F$$20240628$20240611$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017484$UNITED THERAPEUTICS$$$$$M$Y$86.168$KG$20240706$$$US$US
239625982$23962598$2$F$$20240708$20240611$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092903$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240709$$CN$US$US
239625992$23962599$2$F$$20240701$20240611$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093223$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240702$$CN$US$US
239626032$23962603$2$F$$20240827$20240611$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092817$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240829$$CN$US$US
239626042$23962604$2$F$20230101$20240826$20240611$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094059$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$83.01$KG$20240902$$CN$US$US
239626062$23962606$2$F$$20240724$20240611$20240802$EXP$$EG-TAKEDA-2024TUS056720$TAKEDA$$$$$M$Y$$$20240802$$MD$EG$EG
239626232$23962623$2$F$$20240724$20240611$20240731$EXP$$HU-MYLANLABS-2024M1052211$MYLAN$$27$YR$$F$Y$$$20240731$$CN$HU$HU
239626242$23962624$2$F$20240604$20240723$20240611$20240729$30DAY$$US-MYLANLABS-2024M1051627$MYLAN$$33$YR$$F$Y$104.33$KG$20240729$$CN$US$US
239626284$23962628$4$F$$20240814$20240611$20240905$30DAY$$JP-SA-2024SA171831$SANOFI AVENTIS$$$$A$$Y$$$20240905$$HP$JP$JP
239626422$23962642$2$F$$20240712$20240611$20240722$PER$$US-SA-2024SA168477$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240722$$CN$US$US
239626433$23962643$3$F$$20240626$20240611$20240703$EXP$$JP-JNJFOC-20240624392$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$MD$JP$JP
239626733$23962673$3$F$20240604$20240624$20240611$20240704$EXP$$US-TAKEDA-2024TUS056991$TAKEDA$$64$YR$$F$Y$63$KG$20240704$$HP$US$US
239626742$23962674$2$F$$20240717$20240611$20240814$PER$$US-INCYTE CORPORATION-2024IN005809$INCYTE$$$$$$Y$$$20240814$$CN$US$US
239626832$23962683$2$F$$20240722$20240611$20240813$PER$$US-INCYTE CORPORATION-2024IN005790$INCYTE$$$$$$Y$$$20240813$$HP$US$US
239626862$23962686$2$F$20240101$20240821$20240611$20240911$PER$$US-SA-2024SA166961$SANOFI AVENTIS$$36$YR$A$F$Y$99.773$KG$20240911$$MD$US$US
239627742$23962774$2$F$$20240712$20240611$20240806$PER$$US-GALDERMA-US2024008539$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
239629482$23962948$2$F$$20240715$20240611$20240806$PER$$US-GALDERMA-US2024009293$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
239630683$23963068$3$F$20240101$20240806$20240611$20240813$EXP$$US-SA-2024SA173662$SANOFI AVENTIS$$62$YR$A$F$Y$67.13$KG$20240813$$CN$US$US
239630712$23963071$2$F$20240404$20240731$20240611$20240805$EXP$$US-OTSUKA-2024_009369$OTSUKA$$$$$F$Y$$$20240805$$CN$US$US
239630722$23963072$2$F$$20240729$20240611$20240806$EXP$$US-ROCHE-3576857$ROCHE$$66$YR$E$F$Y$$$20240806$$CN$US$US
239630732$23963073$2$F$$20240704$20240611$20240711$EXP$$FR-MYLANLABS-2024M1051713$MYLAN$$62$YR$$M$Y$$$20240711$$PH$FR$FR
239630742$23963074$2$F$$20240709$20240611$20240712$EXP$$NVSC2024US121645$NOVARTIS$$$$$F$Y$$$20240712$$CN$US$US
239630772$23963077$2$F$$20240716$20240611$20240725$PER$$US-APELLIS-2024-APL-0000097$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
239630832$23963083$2$F$$20240722$20240611$20240722$PER$$US-ALXN-202406USA000145US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
239630862$23963086$2$F$$20240701$20240611$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088754$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240702$$CN$US$US
239631132$23963113$2$F$$20240905$20240611$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092359$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240905$$CN$US$US
239631142$23963114$2$F$$20240918$20240611$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089049$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240919$$HP$US$US
239631342$23963134$2$F$$20240603$20240611$20240724$EXP$$US-AMGEN-USASP2024109359$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
239631393$23963139$3$F$20240509$20240624$20240611$20240702$EXP$$US-VERTEX PHARMACEUTICALS-2024-008794$VERTEX$$32$YR$$M$Y$86$KG$20240702$$MD$US$US
239631442$23963144$2$F$20240603$20240820$20240611$20240822$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003202$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240822$$HP$US$US
239631462$23963146$2$F$20240301$20240725$20240611$20240726$EXP$DE-009507513-2405DEU009373$DE-SANDOZ INC.-SDZ2024DE056316$SANDOZ$$81$YR$$M$Y$75$KG$20240726$$MD$DE$DE
239631472$23963147$2$F$$20240802$20240611$20240805$PER$$US-ALXN-202406USA000108US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
239631512$23963151$2$F$$20240626$20240611$20240704$EXP$$US-ROCHE-3577598$ROCHE$$71$YR$E$M$Y$$$20240704$$CN$US$US
239631564$23963156$4$F$20240603$20240827$20240611$20240902$EXP$$US-AMGEN-USASP2024111973$AMGEN$$44$YR$A$M$Y$$$20240902$$PH$US$US
239631663$23963166$3$F$20240518$20240805$20240611$20240812$30DAY$$US-ALKERMES INC.-ALK-2024-001419$ALKERMES$$$$$$Y$$$20240812$$HP$US$US
239631712$23963171$2$F$20240413$20240711$20240611$20240712$EXP$$JP-Eisai-EC-2024-163901$EISAI$$74$YR$E$F$Y$46$KG$20240712$$MD$JP$JP
239631794$23963179$4$F$20240301$20240725$20240611$20240801$EXP$$US-Calliditas-2024CAL00911$CALLIDITAS THERAPEUTICS$$59$YR$A$F$Y$76.7$KG$20240801$$CN$US$US
239631812$23963181$2$F$20240501$20240702$20240611$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202406004778$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240704$$CN$US$US
239631845$23963184$5$F$20240101$20240829$20240611$20240902$EXP$$NVSC2024AR076485$NOVARTIS$$55$YR$$F$Y$$$20240902$$CN$AR$AR
239631902$23963190$2$F$$20240624$20240611$20240704$EXP$$GB-ALCON LABORATORIES-ALC2024GB002794$ALCON$$$$A$F$Y$$$20240704$$HP$GB$GB
239632107$23963210$7$F$20231101$20240823$20240611$20240904$EXP$$US-APELLIS-2024-APL-0000126$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240830$$CN$US$US
239632162$23963216$2$F$$20240808$20240611$20240820$PER$$US-SA-2024SA171984$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240820$$MD$US$US
239632604$23963260$4$F$$20240923$20240611$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094007$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240926$$CN$US$US
239633332$23963333$2$F$20240101$20240722$20240611$20240725$EXP$$CA-PFIZER INC-202400190176$PFIZER$$77$YR$$F$Y$$$20240725$$PH$CA$CA
239633482$23963348$2$F$$20240701$20240611$20240702$EXP$GB-MHRA-DEFECT- 202406041322167900-NVZKW$GB-ORGANON-O2406GBR000756$ORGANON$$$$$F$Y$$$20240702$$HP$GB$GB
239633547$23963354$7$F$20240526$20240916$20240611$20240923$EXP$$CZ-BIOGEN-2024BI01268493$BIOGEN$$11$YR$$M$Y$$$20240923$$MD$CZ$CZ
239633592$23963359$2$F$20240607$20240711$20240611$20240711$PER$$US-PFIZER INC-202400189556$PFIZER$$9$YR$$F$Y$$$20240711$$CN$US$US
239633604$23963360$4$F$20230630$20240719$20240611$20240725$EXP$$US-PFIZER INC-202400188346$PFIZER$$65$YR$$M$Y$129.25$KG$20240725$$CN$US$US
239633613$23963361$3$F$$20240711$20240611$20240711$PER$$US-PFIZER INC-2021708317$PFIZER$$62$YR$$M$Y$83.4$KG$20240711$$CN$US$US
239633624$23963362$4$F$20230526$20240801$20240611$20240801$PER$$US-PFIZER INC-PV202400075246$PFIZER$$13$YR$$F$Y$32.4$KG$20240801$$MD$US$US
239633633$23963363$3$F$20240411$20240801$20240611$20240808$EXP$$JP-Eisai-EC-2024-167741$EISAI$$79$YR$E$F$Y$45$KG$20240808$$MD$JP$JP
239633652$23963365$2$F$20240101$20240708$20240611$20240717$PER$$US-SA-2024SA168768$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240717$$MD$US$US
239633732$23963373$2$F$20240627$20240628$20240611$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202406004785$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240711$$CN$US$US
239633852$23963385$2$F$20240531$20240701$20240611$20240709$EXP$$US-AstraZeneca-2024A129106$ASTRAZENECA$$23637$DY$$M$Y$$$20240709$$CN$US$
239633922$23963392$2$F$20240520$20240719$20240611$20240726$EXP$$US-AstraZeneca-2024A129044$ASTRAZENECA$$24262$DY$$F$Y$86.2$KG$20240726$$CN$US$
239633954$23963395$4$F$20240604$20240921$20240611$20240925$30DAY$$US-PFIZER INC-202400188001$PFIZER$$9$YR$$F$Y$$$20240925$$CN$US$US
239633973$23963397$3$F$20240415$20240813$20240611$20240814$EXP$$DE-JNJFOC-20240580219$JOHNSON AND JOHNSON$$18$YR$A$F$Y$55$KG$20240814$$MD$DE$DE
239634002$23963400$2$F$20240606$20240805$20240611$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094169$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240814$$HP$US$US
239634026$23963402$6$F$20240326$20240722$20240611$20240806$EXP$$CA-HLS-202401388$HLS THERAPEUTICS$$34$YR$A$M$Y$81$KG$20240806$$MD$CA$CA
239634212$23963421$2$F$$20240712$20240611$20240712$30DAY$$PR-PFIZER INC-202400188301$PFIZER$$12$YR$$M$Y$$$20240712$$CN$PR$PR
239634332$23963433$2$F$20240527$20240911$20240611$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094052$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240911$$CN$US$US
239634393$23963439$3$F$20240531$20240814$20240611$20240816$30DAY$$US-PFIZER INC-202400187377$PFIZER$$8$YR$$F$Y$$$20240816$$CN$US$US
239634632$23963463$2$F$20240113$20240917$20240611$20240918$EXP$$JP-AstraZeneca-2024A132829$ASTRAZENECA$$86$YR$$F$Y$$$20240918$$MD$JP$
239634652$23963465$2$F$20240605$20240716$20240611$20240725$30DAY$$US-MYLANLABS-2024M1052476$MYLAN$$13$YR$$M$Y$$$20240725$$CN$US$US
239634752$23963475$2$F$20240101$20240807$20240611$20240807$EXP$$US-PFIZER INC-202400189583$PFIZER$$66$YR$$F$Y$68.95$KG$20240807$$CN$US$US
239634763$23963476$3$F$$20240812$20240611$20240816$30DAY$$US-PFIZER INC-202400174359$PFIZER$$$$$$Y$$$20240816$$PH$US$US
239634952$23963495$2$F$$20240723$20240611$20240726$EXP$$HR-SANDOZ INC.-SDZ2024HR056280$SANDOZ$$56$YR$$F$Y$$$20240726$$MD$HR$HR
239635023$23963502$3$F$20240101$20240617$20240611$20240711$EXP$$US-RIGEL PHARMACEUTICALS, INC.-2024FOS000664$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
239635072$23963507$2$F$20231215$20240821$20240611$20240826$EXP$$GB-MYLANLABS-2024M1033276$MYLAN$$61$YR$$M$Y$97$KG$20240826$$MD$GB$GB
239635082$23963508$2$F$$20240729$20240611$20240731$PER$$US-ALXN-202406USA000163US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239635252$23963525$2$F$20180517$20240819$20240611$20240820$EXP$$DE-SANDOZ INC.-NVSC2022DE298230$SANDOZ$$46$YR$$F$Y$$$20240820$$CN$DE$DE
239635302$23963530$2$F$20221117$20240722$20240611$20240725$EXP$$US-KYOWAKIRIN-2024KK013976$KYOWA$$$$$$Y$$$20240725$$HP$US$US
239635322$23963532$2$F$$20240903$20240611$20240903$EXP$$FR-SANDOZ INC.-SDZ2024FR056444$SANDOZ$$70$YR$$M$Y$$$20240903$$HP$FR$FR
239635352$23963535$2$F$$20240725$20240611$20240725$PER$$NVSC2024US121943$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
239635453$23963545$3$F$$20240809$20240611$20240813$EXP$$NVSC2024US121435$NOVARTIS$$3$MON$$$Y$$$20240813$$MD$US$US
239635534$23963553$4$F$20240606$20240828$20240611$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092702$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240830$$CN$US$US
239635543$23963554$3$F$$20240801$20240611$20240811$EXP$$GB-TEVA-VS-3206317$TEVA$$$$$M$Y$$$20240811$$CN$GB$GB
239635722$23963572$2$F$$20240904$20240611$20240906$PER$$US-JAZZ PHARMACEUTICALS-2022-US-006132$JAZZ$$$$$F$Y$$$20240906$$MD$US$US
239635782$23963578$2$F$$20240801$20240611$20240807$EXP$$CA-MYLANLABS-2024M1052475$MYLAN$$71$YR$$F$Y$89$KG$20240807$$HP$CA$CA
239635854$23963585$4$F$20200101$20240909$20240611$20240912$EXP$$US-ABBVIE-5792418$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
239635903$23963590$3$F$$20240814$20240611$20240820$30DAY$$HK-PFIZER INC-202400190686$PFIZER$$$$$$Y$$$20240820$$PH$HK$HK
239635914$23963591$4$F$$20240925$20240611$20240925$30DAY$$CO-PFIZER INC-202400181731$PFIZER$$9$YR$$F$Y$$$20240925$$CN$CO$CO
239635923$23963592$3$F$20240526$20240909$20240611$20240910$30DAY$$AR-PFIZER INC-202400181051$PFIZER$$12$YR$$M$Y$$$20240910$$CN$AR$AR
239635935$23963593$5$F$20210521$20240727$20240611$20240806$EXP$$US-ABBVIE-5276107$ABBVIE$$70$YR$$F$Y$70$KG$20240806$$CN$US$US
239636073$23963607$3$F$$20240925$20240611$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093992$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240926$$CN$US$US
239636162$23963616$2$F$$20240821$20240611$20240826$30DAY$$US-PFIZER INC-PV202400072384$PFIZER$$$$$F$Y$$$20240826$$CN$US$US
239636332$23963633$2$F$20220101$20240702$20240611$20240708$PER$$US-SA-2024SA168813$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240708$$MD$US$US
239636422$23963642$2$F$20240520$20240909$20240611$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094037$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240909$$CN$US$US
239636582$23963658$2$F$$20240628$20240611$20240701$PER$$US-PFIZER INC-202400190338$PFIZER$$56$YR$$M$Y$$$20240701$$CN$US$US
239636616$23963661$6$F$$20240718$20240611$20240722$PER$$US-PFIZER INC-PV202400076116$PFIZER$$71$YR$$F$Y$$$20240722$$CN$US$US
239636656$23963665$6$F$20240101$20240821$20240611$20240827$EXP$$US-PFIZER INC-PV202400075120$PFIZER$$83$YR$$F$Y$$$20240827$$PH$US$US
239636672$23963667$2$F$$20240726$20240611$20240731$PER$$US-PFIZER INC-PV202400075469$PFIZER$$70$YR$$F$Y$$$20240731$$HP$US$US
239636743$23963674$3$F$$20240917$20240611$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093833$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240919$$CN$US$US
239636793$23963679$3$F$20240301$20240723$20240611$20240725$EXP$$US-BAUSCHBL-2024BNL028188$BAUSCH AND LOMB$$$$$F$Y$$$20240726$$CN$US$US
239636832$23963683$2$F$20240520$20240710$20240611$20240715$EXP$IT-MINISAL02-988045$IT-009507513-2406ITA002850$MERCK$$65$YR$$M$Y$51$KG$20240715$$MD$IT$IT
239636933$23963693$3$F$$20240719$20240611$20240730$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004644$JAZZ$$$$$F$Y$$$20240730$$CN$US$US
239636952$23963695$2$F$$20240719$20240611$20240724$PER$$US-BIOMARINAP-US-2024-158439$BIOMARIN$$$$$$Y$$$20240724$$CN$US$US
239637165$23963716$5$F$20240627$20240909$20240611$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093763$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240912$$CN$US$US
239637182$23963718$2$F$$20240906$20240611$20240916$EXP$$GR-EMD Serono-2024031468$EMD SERONO INC$$74$YR$E$F$Y$$$20240916$$MD$GR$GR
239637222$23963722$2$F$20240604$20240805$20240611$20240807$PER$$US-AMGEN-USASP2024111957$AMGEN$$54$YR$A$F$Y$$$20240807$$CN$US$US
239637283$23963728$3$F$$20240827$20240611$20240910$PER$$US-Calliditas-2024CAL00907$CALLIDITAS THERAPEUTICS$$59$YR$A$F$Y$$$20240910$$CN$US$US
239637292$23963729$2$F$20240501$20240711$20240611$20240801$PER$$US-APELLIS-2024-APL-0000101$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
239638352$23963835$2$F$$20240729$20240611$20240801$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-016775$JAZZ$$$$$M$Y$$$20240731$$CN$US$US
239638412$23963841$2$F$20230826$20240705$20240611$20240711$EXP$$US-INCYTE CORPORATION-2024IN006123$INCYTE$$$$$$Y$$$20240711$$MD$US$US
239638423$23963842$3$F$20240518$20240711$20240611$20240724$PER$$US-APELLIS-2024-APL-0000187$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
239638442$23963844$2$F$20240531$20240819$20240611$20240820$EXP$$US-INCYTE CORPORATION-2024IN006201$INCYTE$$$$$$Y$$$20240820$$MD$US$US
239638512$23963851$2$F$20231125$20240628$20240611$20240702$30DAY$$US-GSK-US2024068715$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240702$$MD$US$US
239638542$23963854$2$F$20230524$20240627$20240611$20240705$30DAY$$US-GSK-US2024068904$GLAXOSMITHKLINE$$84$YR$$M$Y$$$20240705$$CN$US$US
239638572$23963857$2$F$$20240709$20240611$20240718$30DAY$$US-GSK-US2024068901$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
239638612$23963861$2$F$$20240725$20240611$20240801$EXP$$US-Calliditas-2024CAL00973$CALLIDITAS THERAPEUTICS$$60$YR$A$M$Y$78.4$KG$20240801$$CN$US$US
239638623$23963862$3$F$20240625$20240716$20240611$20240726$PER$$US-Calliditas-2024CAL00914$CALLIDITAS THERAPEUTICS$$67$YR$E$F$Y$$$20240726$$CN$US$US
239638643$23963864$3$F$20231001$20240703$20240611$20240709$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019035$JAZZ$$53$YR$$M$Y$$$20240709$$CN$US$US
239638652$23963865$2$F$20240521$20240904$20240611$20240905$EXP$$JP-BAYER-2024A084259$BAYER$$81$YR$E$M$Y$$$20240905$$MD$JP$JP
239638762$23963876$2$F$20240513$20240627$20240611$20240701$EXP$$US-KYOWAKIRIN-2024KK013910$KYOWA$$$$$$Y$$$20240701$$HP$US$US
239638972$23963897$2$F$$20240716$20240611$20240726$30DAY$$US-GSK-US2024069396$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
239638993$23963899$3$F$$20240816$20240611$20240826$30DAY$$US-GSK-US2024068948$GLAXOSMITHKLINE$$$$$M$Y$$$20240826$$CN$US$US
239639012$23963901$2$F$$20240718$20240611$20240724$30DAY$$US-GSK-US2024AMR069997$GLAXOSMITHKLINE$$$$$M$Y$$$20240724$$CN$US$US
239639022$23963902$2$F$$20240722$20240611$20240801$30DAY$$US-GSK-US2024069379$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
239639032$23963903$2$F$$20240718$20240611$20240724$30DAY$$US-GSK-US2024069389$GLAXOSMITHKLINE$$$$$M$Y$$$20240724$$CN$US$US
239639273$23963927$3$F$$20240627$20240611$20240926$PER$$US-GSK-US2024AMR071228$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
239639363$23963936$3$F$20240318$20240626$20240611$20240705$EXP$$NZ-BEH-2024172380$CSL BEHRING$$9$YR$C$M$Y$$$20240705$$CN$NZ$NZ
239639402$23963940$2$F$$20240718$20240611$20240729$EXP$$JP-ROCHE-3578048$ROCHE$$6$DEC$A$$Y$$$20240729$$MD$JP$JP
239639412$23963941$2$F$$20240916$20240611$20240927$PER$$US-ALKERMES INC.-ALK-2024-001524$ALKERMES$$$$$F$Y$$$20240927$$HP$US$US
239639542$23963954$2$F$20240116$20240712$20240611$20240716$EXP$IT-MINISAL02-989582$NVSC2024IT121137$NOVARTIS$$45$YR$$F$Y$$$20240716$$PH$IT$IT
239639692$23963969$2$F$20240501$20240625$20240611$20240702$PER$$US-ALXN-202406USA000098US$ALEXION PHARMACEUTICALS$$51$YR$$M$Y$210$KG$20240703$$CN$US$US
239639743$23963974$3$F$$20240724$20240611$20240726$PER$$NVSC2024US121916$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
239639812$23963981$2$F$$20240703$20240611$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094072$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240704$$HP$US$US
239640042$23964004$2$F$$20240722$20240611$20240723$PER$$US-ALXN-202406USA000224US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239640052$23964005$2$F$$20240729$20240611$20240731$PER$$US-ALXN-202406USA000159US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
239640072$23964007$2$F$$20240903$20240611$20240906$EXP$$ES-JNJFOC-20240607611$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$MD$ES$ES
239640232$23964023$2$F$$20240702$20240611$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-092421$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240709$$MD$JP$JP
239640292$23964029$2$F$$20240625$20240611$20240702$EXP$$CL-JNJFOC-20240610967$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240702$$CN$CL$CL
239640302$23964030$2$F$20240608$20240802$20240611$20240806$PER$$US-AMGEN-USASP2024114760$AMGEN$$71$YR$E$M$Y$$$20240806$$CN$US$US
239640352$23964035$2$F$$20240621$20240611$20240710$30DAY$$BR-JNJFOC-20240610826$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$BR$BR
239640363$23964036$3$F$20240515$20240626$20240611$20240701$EXP$$JP-009507513-2406JPN000760J$MERCK$$76$YR$$M$Y$$$20240701$$PH$JP$JP
239640502$23964050$2$F$20240602$20240816$20240611$20240901$PER$$US-BAUSCHBL-2024BNL028165$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240829$$CN$US$US
239640512$23964051$2$F$20240604$20240916$20240611$20240923$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001172$BLUEPRINT MEDICINES$$47$YR$A$F$Y$$$20240923$$CN$US$US
239640593$23964059$3$F$20240401$20240612$20240611$20240703$30DAY$$CA-JNJFOC-20240577720$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240703$$PH$CA$CA
239640663$23964066$3$F$20240522$20240729$20240611$20240808$PER$$US-JNJFOC-20240623622$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$PH$US$US
239640673$23964067$3$F$20191101$20240610$20240611$20240723$EXP$$FR-ABBVIE-5795817$ABBVIE$$38$YR$$F$Y$$$20240723$$MD$FR$FR
239642592$23964259$2$F$20240101$20240812$20240611$20240816$EXP$$US-ABBVIE-5792483$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
239642682$23964268$2$F$$20240814$20240611$20240820$EXP$$JP-009507513-2406JPN000775J$MERCK$$$$$F$Y$$$20240820$$MD$JP$JP
239642695$23964269$5$F$20220418$20240729$20240611$20240805$EXP$$JP-009507513-2406JPN000932J$MERCK$$77$YR$$F$Y$$$20240804$$MD$JP$JP
239642702$23964270$2$F$20240222$20240708$20240611$20240715$EXP$$JP-AMGEN-JPNSP2024114467$AMGEN$$6$DEC$A$M$Y$$$20240715$$MD$JP$JP
239642762$23964276$2$F$20240603$20240716$20240611$20240717$EXP$$JP-JNJFOC-20240628071$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240717$$MD$JP$JP
239642812$23964281$2$F$20180127$20240610$20240611$20240702$EXP$$IE-ABBVIE-5796204$ABBVIE$$19$YR$$F$Y$$$20240702$$MD$IE$IE
239642893$23964289$3$F$$20240711$20240611$20240715$EXP$$JP-JNJFOC-20240628072$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240715$$PH$JP$JP
239642982$23964298$2$F$20240301$20240717$20240611$20240721$EXP$$CO-ABBVIE-5797544$ABBVIE$$63$YR$$M$Y$60$KG$20240721$$CN$CO$CO
239643035$23964303$5$F$20240525$20240830$20240611$20240902$EXP$$NVSC2024GB120479$NOVARTIS$$55$YR$$M$Y$$$20240903$$CN$GB$GB
239643112$23964311$2$F$$20240807$20240611$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202405018963$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240819$$MD$US$US
239643173$23964317$3$F$20230701$20240806$20240611$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202405018276$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240814$$MD$US$US
239643323$23964332$3$F$20190923$20240731$20240611$20240805$EXP$$CA-TAKEDA-2019TUS053795$TAKEDA$$41$YR$$F$Y$$$20240805$$HP$CA$CA
239643334$23964333$4$F$$20240819$20240611$20240821$30DAY$$CA-JNJFOC-20240561940$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$HP$CA$CA
239643562$23964356$2$F$$20240801$20240612$20240807$EXP$$ES-AMGEN-ESPSP2024112961$AMGEN$Blanco Caceres B.; Andreu-suarez A.; Valero M. et al.. SAPHO SYNDROME, CLINIC CHARACTERISTICS FROM THE SAPHO-SORCOM COHORT. Annals of the Rheumatic Diseases. 2023;82 (SUPPL_1):1163-1164$$$$$Y$$$20240807$$HP$ES$ES
239644242$23964424$2$F$20240521$20240719$20240612$20240731$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202406000721$ELI LILLY AND CO$$56$YR$A$F$Y$70$KG$20240731$$CN$FR$FR
239644716$23964471$6$F$20240101$20240806$20240611$20240808$EXP$$CH-ABBVIE-5796246$ABBVIE$$$$$M$Y$$$20240808$$CN$CH$CH
239644773$23964477$3$F$$20240814$20240612$20240819$30DAY$$JP-PFIZER INC-PV202400071285$PFIZER$$$$$F$Y$$$20240819$$CN$JP$JP
239644842$23964484$2$F$$20240620$20240611$20240701$PER$$US-SA-2024SA169698$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240701$$HP$US$US
239644874$23964487$4$F$$20240916$20240611$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US056423$SANDOZ$$$$$F$Y$$$20240919$$CN$US$US
239644932$23964493$2$F$20230703$20240716$20240612$20240720$EXP$$CO-ABBVIE-5318337$ABBVIE$$43$YR$$F$Y$75$KG$20240720$$CN$CO$CO
239644983$23964498$3$F$$20240819$20240612$20240821$PER$$AE-PFIZER INC-PV202400070927$PFIZER$$$$$$Y$$$20240821$$CN$AE$AE
239644992$23964499$2$F$$20240627$20240612$20240704$EXP$$NVSC2024BR043298$NOVARTIS$$$$$F$Y$$$20240704$$CN$BR$BR
239645025$23964502$5$F$20220610$20240830$20240612$20240906$EXP$$US-ABBVIE-5792831$ABBVIE$$67$YR$$M$Y$101$KG$20240906$$CN$US$US
239645053$23964505$3$F$20240101$20240625$20240612$20240701$EXP$$US-ABBVIE-5791984$ABBVIE$$59$YR$$F$Y$146$KG$20240701$$CN$US$US
239645133$23964513$3$F$20240601$20240712$20240612$20240719$30DAY$$US-AMGEN-USASL2024111604$AMGEN$$70$YR$E$M$Y$$$20240719$$PH$US$US
239645153$23964515$3$F$20240416$20240710$20240612$20240712$PER$$US-JNJFOC-20240626100$JOHNSON AND JOHNSON$$21$YR$A$$Y$67.2$KG$20240712$$MD$US$US
239645222$23964522$2$F$$20240904$20240612$20240906$EXP$$US-TAKEDA-2024TUS012919$TAKEDA$$$$$F$Y$$$20240906$$HP$US$US
239645302$23964530$2$F$20240101$20240711$20240612$20240715$EXP$$UY-ABBVIE-5793865$ABBVIE$$$$$F$Y$$$20240715$$CN$UY$UY
239645312$23964531$2$F$20240410$20240722$20240612$20240727$EXP$$US-ABBVIE-5792933$ABBVIE$$79$YR$$F$Y$$$20240727$$CN$US$US
239645472$23964547$2$F$20240501$20240715$20240612$20240717$PER$$US-AMGEN-USASP2024113106$AMGEN$$85$YR$E$F$Y$$$20240716$$CN$US$US
239645572$23964557$2$F$20240604$20240918$20240612$20240918$PER$$US-AMGEN-USASP2024113211$AMGEN$$57$YR$A$M$Y$$$20240918$$CN$US$US
239645633$23964563$3$F$$20240813$20240612$20240830$PER$$US-MYLANLABS-2024M1050029$MYLAN$$$$$M$Y$$$20240830$$CN$US$US
239645734$23964573$4$F$20240529$20240702$20240612$20240728$30DAY$$US-JNJFOC-20240590021$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240729$$CN$US$US
239645802$23964580$2$F$20240524$20240603$20240612$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024069356$VIIV$$39$YR$$M$Y$$$20240726$$CN$US$US
239645842$23964584$2$F$20240501$20240709$20240612$20240713$EXP$$US-ABBVIE-5795125$ABBVIE$$39$YR$$M$Y$$$20240713$$CN$US$US
239645873$23964587$3$F$20240501$20240828$20240612$20240830$EXP$$CL-ABBVIE-5797244$ABBVIE$$72$YR$$F$Y$$$20240830$$CN$CL$CL
239645902$23964590$2$F$20240101$20240829$20240612$20240905$EXP$$CA-ABBVIE-5795133$ABBVIE$$18$YR$$F$Y$$$20240905$$CN$CA$CA
239646322$23964632$2$F$20240101$20240905$20240612$20240911$EXP$$US-ABBVIE-5793960$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
239646432$23964643$2$F$$20240717$20240612$20240726$EXP$$US-ABBVIE-5743299$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
239646462$23964646$2$F$20240101$20240626$20240612$20240701$EXP$$US-ABBVIE-5794086$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
239646612$23964661$2$F$20240610$20240709$20240612$20240711$PER$$US-AMGEN-USASP2024115009$AMGEN$$67$YR$E$F$Y$$$20240711$$CN$US$US
239646622$23964662$2$F$20240101$20240926$20240612$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-088742$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240930$$CN$US$US
239646732$23964673$2$F$$20240903$20240612$20240913$EXP$CA-TEVA-VS-3204050$CA-Accord-429665$ACCORD$$$$$$Y$$$20240913$$HP$CA$CA
239646752$23964675$2$F$$20240814$20240612$20240815$PER$$NVSC2024US122381$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
239646762$23964676$2$F$20240603$20240719$20240612$20240726$PER$$US-AMGEN-USASP2024110802$AMGEN$$71$YR$E$F$Y$76.6$KG$20240726$$PH$US$US
239646794$23964679$4$F$20240501$20240905$20240612$20240915$EXP$$US-UCBSA-2024029500$UCB$$76$YR$$F$Y$$$20240915$$HP$US$US
239646822$23964682$2$F$$20240917$20240612$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-093189$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240918$$MD$JP$JP
239646872$23964687$2$F$20240602$20240806$20240612$20240808$PER$$US-JNJFOC-20240603241$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240808$$CN$US$US
239646883$23964688$3$F$$20240710$20240612$20240712$PER$$US-JNJFOC-20240589756$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$CN$US$US
239646922$23964692$2$F$20240501$20240809$20240612$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US056626$SANDOZ$$20$YR$$F$Y$50.1$KG$20240812$$HP$US$US
239646942$23964694$2$F$20240101$20240711$20240612$20240720$EXP$$CA-CELLTRION INC.-2024CA013906$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
239647013$23964701$3$F$20150428$20240828$20240612$20240830$EXP$$US-GILEAD-2024-0676832$GILEAD$$55$YR$A$F$Y$$$20240830$$LW$US$US
239647192$23964719$2$F$20240522$20240815$20240612$20240903$PER$$CA-TOLMAR, INC.-24CA049627$TOLMAR$$71$YR$$M$Y$$$20240902$$CN$CA$CA
239647232$23964723$2$F$$20240708$20240612$20240711$PER$$NVSC2024US121787$NOVARTIS$$50$YR$$F$Y$$$20240711$$CN$US$US
239647285$23964728$5$F$20240602$20240628$20240612$20240711$30DAY$$US-JNJFOC-20240603973$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240711$$CN$US$US
239647292$23964729$2$F$20231218$20240724$20240612$20240806$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024070626$VIIV$$28$YR$$F$Y$120$KG$20240806$$HP$US$US
239647316$23964731$6$F$20240101$20240906$20240612$20240916$EXP$$CA-CELLTRION INC.-2024CA003161$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
239647342$23964734$2$F$20220707$20240829$20240612$20240902$PER$$US-GILEAD-2024-0676833$GILEAD$$35$YR$A$F$Y$$$20240902$$LW$US$US
239647402$23964740$2$F$20240212$20240710$20240612$20240715$EXP$$US-ABBVIE-5732888$ABBVIE$$19$YR$$M$Y$80$KG$20240715$$MD$US$US
239647443$23964744$3$F$20240527$20240711$20240612$20240713$PER$$US-AMGEN-USASP2024114768$AMGEN$$77$YR$E$M$Y$$$20240713$$CN$US$US
239647497$23964749$7$F$20240701$20240814$20240612$20240824$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016890$UNITED THERAPEUTICS$$76$YR$$M$Y$126.98$KG$20240824$$$US$US
239647572$23964757$2$F$20231010$20240701$20240612$20240703$EXP$$JP-TAKEDA-2024TJP008533$TAKEDA$$63$YR$$M$Y$$$20240703$$MD$JP$JP
239647582$23964758$2$F$20240301$20240806$20240612$20240808$PER$$US-AMGEN-USASP2024113706$AMGEN$$57$YR$A$F$Y$$$20240807$$PH$US$US
239647653$23964765$3$F$20160525$20240924$20240612$20240926$EXP$$US-GILEAD-2024-0676835$GILEAD$$44$YR$A$F$Y$$$20240926$$LW$US$US
239647702$23964770$2$F$20240319$20240710$20240612$20240717$EXP$$JP-ROCHE-3555478$ROCHE$$61$YR$A$M$Y$66.5$KG$20240717$$MD$JP$JP
239647852$23964785$2$F$20230101$20240722$20240612$20240722$PER$$US-ALXN-202406USA000204US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
239647902$23964790$2$F$20240101$20240917$20240612$20240925$EXP$$US-ABBVIE-5792299$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
239647922$23964792$2$F$20240101$20240701$20240612$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-017063$UNITED THERAPEUTICS$$$$$F$Y$108.39$KG$20240703$$$US$US
239648032$23964803$2$F$20230801$20240613$20240612$20240709$EXP$$PE-ROCHE-3579150$ROCHE$$$$$F$Y$$$20240628$$CN$PE$PE
239648044$23964804$4$F$20240522$20240705$20240612$20240711$30DAY$$JP-JNJFOC-20240569264$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240711$$HP$JP$JP
239648072$23964807$2$F$$20240903$20240612$20240926$PER$$CA-TOLMAR, INC.-24CA049636$TOLMAR$$$$$M$Y$$$20240926$$CN$CA$CA
239648244$23964824$4$F$20240311$20240710$20240612$20240808$EXP$$DE-HALEON-2177484$Haleon PLC$$$$$F$Y$$$20240808$$CN$DE$DE
239648295$23964829$5$F$20240605$20240724$20240612$20240806$EXP$$KR-ABBVIE-5792322$ABBVIE$$70$YR$$M$Y$56$KG$20240806$$MD$KR$KR
239648332$23964833$2$F$20240208$20240904$20240612$20240912$EXP$$NVSC2024BR055686$NOVARTIS$$54$YR$$F$Y$$$20240912$$CN$BR$BR
239648342$23964834$2$F$20240501$20240626$20240612$20240711$PER$$US-AMGEN-USASP2024113659$AMGEN$$63$YR$A$F$Y$$$20240711$$CN$US$US
239648373$23964837$3$F$20180109$20240828$20240612$20240830$PER$$US-GILEAD-2024-0676857$GILEAD$$38$YR$A$M$Y$$$20240830$$LW$US$US
239648433$23964843$3$F$$20240729$20240612$20240801$PER$$NVSC2024US122428$NOVARTIS$$$$A$F$Y$$$20240801$$HP$US$US
239648532$23964853$2$F$$20240629$20240612$20240704$PER$$US-HETERO-HET2024US01720$HETERO$$$$$$Y$$$20240704$$CN$US$US
239648682$23964868$2$F$$20240625$20240612$20240703$PER$$US-HETERO-HET2024US01749$HETERO$$$$$$Y$$$20240703$$CN$US$US
239648695$23964869$5$F$20240508$20240617$20240612$20240710$PER$$US-ROCHE-3579551$ROCHE$$63$YR$A$M$Y$$$20240710$$CN$US$US
239649034$23964903$4$F$$20240627$20240612$20240711$EXP$$US-ROCHE-3579001$ROCHE$$$$A$M$Y$$$20240711$$CN$US$US
239649052$23964905$2$F$$20240802$20240612$20240805$EXP$$US-ALXN-202406USA000278US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
239649092$23964909$2$F$20240216$20240722$20240612$20240726$EXP$$JP-EXELIXIS-CABO-24078165$EXELIXIS$$8$DEC$$F$Y$$$20240726$$MD$JP$JP
239649212$23964921$2$F$20240301$20240822$20240612$20240823$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-019531$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$$$20240823$$CN$US$US
239649253$23964925$3$F$20240101$20240730$20240612$20240812$EXP$$US-UCBSA-2024028802$UCB$$$$$F$Y$99.773$KG$20240812$$HP$US$US
239649342$23964934$2$F$20240517$20240722$20240612$20240723$PER$$US-JNJFOC-20240626532$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
239649352$23964935$2$F$20240601$20240625$20240612$20240701$EXP$$DE-JNJFOC-20240611493$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240701$$HP$DE$DE
239649383$23964938$3$F$$20240801$20240612$20240807$PER$$US-ALXN-202406USA000174US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
239649442$23964944$2$F$20211119$20240627$20240612$20240704$EXP$$JP-GSK-JP2024JPN064359$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$HP$JP$JP
239649712$23964971$2$F$20231001$20240813$20240612$20240815$EXP$$ES-JNJFOC-20240614283$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240816$$MD$ES$ES
239649723$23964972$3$F$20240325$20240723$20240612$20240730$EXP$$DE-JNJFOC-20240612719$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240731$$HP$DE$DE
239649822$23964982$2$F$20240425$20240718$20240612$20240812$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002491$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240812$$CN$US$US
239650042$23965004$2$F$20240501$20240723$20240612$20240808$PER$$US-APOTEX-2024AP006775$APOTEX$$68$YR$E$F$Y$$$20240808$$CN$US$US
239650113$23965011$3$F$20240606$20240712$20240612$20240717$EXP$$US-TAKEDA-2024TUS057223$TAKEDA$$4$YR$$F$Y$$$20240717$$CN$US$US
239650122$23965012$2$F$$20240722$20240612$20240801$30DAY$$US-GSK-US2024070131$GLAXOSMITHKLINE$$$$$M$Y$$$20240801$$CN$US$US
239650143$23965014$3$F$20240523$20240626$20240612$20240709$30DAY$$GB-JNJFOC-20240570077$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240709$$CN$GB$GB
239650192$23965019$2$F$$20240715$20240612$20240722$PER$$US-ALXN-202402USA001253US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
239650203$23965020$3$F$20240624$20240704$20240612$20240715$EXP$$SE-ROCHE-3578992$ROCHE$$76$YR$E$F$Y$$$20240715$$MD$SE$SE
239650223$23965022$3$F$20240607$20240806$20240612$20240904$PER$$US-AstraZeneca-2024A134487$ASTRAZENECA$$25157$DY$$F$Y$$$20240904$$CN$US$
239650262$23965026$2$F$20240501$20240621$20240612$20240708$PER$$US-APOTEX-2024AP006782$APOTEX$$$$$$Y$$$20240708$$PH$US$US
239650333$23965033$3$F$20230101$20240629$20240612$20240708$EXP$$ES-AUROBINDO-AUR-APL-2024-027828$AUROBINDO$$63$YR$$M$Y$54$KG$20240708$$HP$ES$ES
239650432$23965043$2$F$20230608$20240808$20240612$20240815$EXP$IT-MINISAL02-935298$IT-ROCHE-3394326$ROCHE$$81$YR$E$M$Y$74$KG$20240815$$MD$IT$IT
239650472$23965047$2$F$$20240722$20240612$20240722$PER$$US-ALXN-202406USA000154US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
239650544$23965054$4$F$20240607$20240919$20240612$20240924$PER$$NVSC2024US122475$NOVARTIS$$61$YR$$F$Y$$$20240924$$CN$US$US
239650642$23965064$2$F$20220501$20240628$20240612$20240704$EXP$$CZ-ABBVIE-5792779$ABBVIE$$72$YR$$M$Y$88$KG$20240704$$MD$CZ$CZ
239650663$23965066$3$F$$20240715$20240612$20240722$EXP$$US-BIOGEN-2024BI01268644$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
239650855$23965085$5$F$20240603$20240711$20240612$20240722$EXP$$US-ROCHE-3577507$ROCHE$$41$YR$A$F$Y$86.18$KG$20240722$$CN$US$US
239650912$23965091$2$F$$20240810$20240612$20240823$EXP$$IN-ROCHE-3578967$ROCHE$$74$YR$E$M$Y$$$20240823$$CN$IN$IN
239650932$23965093$2$F$$20240625$20240612$20240709$EXP$$ZA-ROCHE-3366397$ROCHE$$$$A$F$Y$$$20240709$$MD$ZA$ZA
239650962$23965096$2$F$$20240718$20240612$20240725$PER$$NVSC2024US121372$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
239651044$23965104$4$F$20240611$20240619$20240612$20240702$EXP$$US-ROCHE-3580011$ROCHE$$$$$$Y$$$20240702$$CN$US$US
239651133$23965113$3$F$20240501$20240709$20240612$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04724$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239651182$23965118$2$F$$20240709$20240612$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04761$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239651193$23965119$3$F$$20240709$20240612$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04773$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239651292$23965129$2$F$$20240729$20240612$20240731$PER$$US-ALXN-202406USA000175US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239651414$23965141$4$F$20240501$20240715$20240612$20240718$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016863$UNITED THERAPEUTICS$$72$YR$$F$Y$55.329$KG$20240718$$PH$US$US
239651522$23965152$2$F$20240609$20240709$20240612$20240712$EXP$$US-GSK-US2024072030$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$US$US
239651562$23965156$2$F$$20240722$20240612$20240723$PER$$US-ALXN-202406USA000235US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239651582$23965158$2$F$$20240625$20240612$20240701$EXP$$US-AMGEN-USASP2024113276$AMGEN$Choi M. Y.; Guan H.; Yoshida K. et al.. Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 2024;67:1-9$$$$$Y$$$20240701$$MD$US$US
239651613$23965161$3$F$$20240909$20240612$20240911$30DAY$$US-PFIZER INC-202400180349$PFIZER$$15$YR$$M$Y$$$20240911$$CN$US$US
239651683$23965168$3$F$20240815$20240815$20240612$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094403$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240820$$CN$US$US
239651693$23965169$3$F$$20240709$20240612$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04682$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239651712$23965171$2$F$20240516$20240725$20240612$20240805$EXP$$CA-TAKEDA-2024TUS049559$TAKEDA$$76$YR$$F$Y$$$20240805$$MD$CA$CA
239651722$23965172$2$F$$20240624$20240612$20240702$PER$$US-ALXN-202406USA000203US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240702$$CN$US$US
239651832$23965183$2$F$20240201$20240802$20240612$20240812$EXP$$JP-SA-2024SA169344$SANOFI AVENTIS$$80$YR$E$F$Y$40$KG$20240813$$MD$JP$JP
239651853$23965185$3$F$$20240823$20240612$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04708$LUPIN$$$$$$Y$$$20240830$$CN$US$US
239651902$23965190$2$F$$20240702$20240612$20240706$EXP$$DE-ROCHE-3579876$ROCHE$$$$$$Y$$$20240706$$MD$DE$DE
239651922$23965192$2$F$$20240628$20240612$20240708$EXP$$PT-TEVA-VS-3207251$TEVA$Gomes S, Medeiros C, Loureiro M, Simoes O, Ferreira F. THE CURE AND THE CAUSE - ANTHRACYCLINE-INDUCED CARDIOTOXICITY A CASE REPORT. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl.) 82-83.; Gomes S, Medeiros C, Loureiro M, Simoes O, Ferreira F. THE CURE AND THE CAUSE - ANTHRACYCLINE-INDUCED CARDIOTOXICITY A CASE REPORT. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl.) 82-83.$52$YR$$F$Y$$$20240708$$HP$PT$PT
239651932$23965193$2$F$$20240705$20240612$20240715$EXP$$US-TEVA-VS-3206906$TEVA$Gallardo MS, Savasan S. Rapid molluscum contagiosum resolution after maintenance chemotherapy completion. Arch-Dis-Child 2023; 108 (5): 410.; Gallardo MS, Savasan S. Rapid molluscum contagiosum resolution after maintenance chemotherapy completion. Arch-Dis-Child 2023; 108 (5): 410.; Gallardo MS, Savasan S. Rapid molluscum contagiosum resolution after maintenance chemotherapy completion. Arch-Dis-Child 2023; 108 (5): 410.$10$YR$$F$Y$$$20240715$$HP$US$US
239652112$23965211$2$F$$20240709$20240612$20240711$EXP$$US-TAKEDA-2024TUS030862$TAKEDA$$$$$M$Y$$$20240711$$CN$US$US
239652143$23965214$3$F$20240610$20240808$20240612$20240810$PER$$US-AMGEN-USASP2024114512$AMGEN$$53$YR$A$M$Y$$$20240810$$MD$US$US
239652222$23965222$2$F$20240516$20240610$20240612$20240723$PER$$US-TRAVERE-2024TVT00501$TRAVERE THERAPEUTICS$$54$YR$A$M$Y$$$20240723$$CN$US$US
239652242$23965224$2$F$$20240710$20240612$20240715$EXP$$US-TAKEDA-2024TUS032007$TAKEDA$$$$$M$Y$$$20240715$$CN$US$US
239652262$23965226$2$F$20231120$20240709$20240612$20240724$EXP$$JP-BRAINTREE LABORATORIES, INC.-2024BTE00334$BRAINTREE$$90$YR$$F$Y$$$20240724$$MD$JP$JP
239652332$23965233$2$F$20240530$20240917$20240612$20240924$EXP$$CA-JNJFOC-20240610631$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240924$$HP$CA$CA
239652503$23965250$3$F$20240530$20240807$20240612$20240812$PER$$US-ALXN-202406USA000207US$ALEXION PHARMACEUTICALS$$81$YR$$M$Y$$$20240812$$CN$US$US
239652542$23965254$2$F$$20240826$20240612$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094280$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240827$$HP$US$US
239652872$23965287$2$F$20240412$20240904$20240612$20240910$EXP$IT-MINISAL02-989578$IT-ABBVIE-5795681$ABBVIE$$55$YR$$M$Y$$$20240910$$MD$IT$IT
239652885$23965288$5$F$20240601$20240715$20240612$20240719$EXP$$ES-ABBVIE-5793095$ABBVIE$$75$YR$$M$Y$$$20240719$$HP$ES$ES
239652942$23965294$2$F$20230915$20240703$20240612$20240708$EXP$$US-ABBVIE-5707531$ABBVIE$$66$YR$$F$Y$73$KG$20240708$$CN$US$US
239653134$23965313$4$F$20240101$20240628$20240612$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015367$UNITED THERAPEUTICS$$$$$M$Y$$$20240705$$$US$US
239653222$23965322$2$F$20231229$20240619$20240612$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093585$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240702$$PH$US$US
239653242$23965324$2$F$$20240918$20240612$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-093858$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240926$$MD$JP$JP
239653323$23965332$3$F$20240501$20240722$20240612$20240801$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108215$ZYDUS PHARM$$$$$$Y$$$20240801$$CN$US$US
239653332$23965333$2$F$20240419$20240903$20240612$20240917$EXP$$US-COOPERSURGICAL, INC.-2024CPS001622$COOPERSURGICAL$$37$YR$$F$Y$54.966$KG$20240917$$CN$US$US
239653355$23965335$5$F$20240101$20240912$20240612$20240926$EXP$$CA-UCBSA-2024026495$UCB$$$$$F$Y$$$20240926$$CN$CA$CA
239653372$23965337$2$F$$20240724$20240612$20240725$PER$$NVSC2024US122810$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
239653472$23965347$2$F$20180604$20240613$20240612$20240709$EXP$$DE-ROCHE-3138428$ROCHE$$50$YR$A$F$Y$48$KG$20240703$$MD$DE$DE
239653552$23965355$2$F$$20240715$20240612$20240717$PER$$NVSC2024US122673$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
239653583$23965358$3$F$20240608$20240812$20240612$20240813$PER$$US-AMGEN-USASP2024115348$AMGEN$$71$YR$E$F$Y$$$20240813$$CN$US$US
239653592$23965359$2$F$20240524$20240709$20240612$20240715$PER$$US-AMGEN-USASP2024113745$AMGEN$$40$YR$A$F$Y$73.469$KG$20240714$$HP$US$US
239653613$23965361$3$F$20240601$20240722$20240612$20240725$PER$$US-AMGEN-USASP2024115518$AMGEN$$57$YR$A$F$Y$$$20240725$$CN$US$US
239653674$23965367$4$F$20231110$20240619$20240612$20240704$EXP$FR-AFSSAPS-NC2024000650$FR-CHATTEMPRD-2024OHG020210$CHATTEM$$37$YR$A$F$Y$205$KG$20240704$$MD$FR$FR
239654012$23965401$2$F$$20240910$20240612$20240912$EXP$$US-JNJFOC-20240622181$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
239654072$23965407$2$F$$20240806$20240612$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-092202$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240809$$MD$JP$JP
239654115$23965411$5$F$$20240701$20240612$20240703$EXP$$NVSC2024US122528$NOVARTIS$$$$$M$Y$73.8$KG$20240703$$HP$US$US
239654133$23965413$3$F$$20240919$20240612$20240920$PER$$NVSC2024US121961$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
239654252$23965425$2$F$20240524$20240603$20240612$20240727$PER$$US-JNJFOC-20240628775$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240727$$CN$US$US
239654332$23965433$2$F$$20240703$20240612$20240715$EXP$$IT-ROCHE-3578279$ROCHE$$41$YR$A$F$Y$$$20240715$$MD$IT$IT
239654342$23965434$2$F$20231001$20240711$20240612$20240725$EXP$$CN-ROCHE-3577925$ROCHE$$39$YR$A$F$Y$73$KG$20240725$$CN$CN$CN
239654382$23965438$2$F$20240605$20240627$20240612$20240704$EXP$$JP-SAKK-2024SA170749AA$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240705$$MD$JP$JP
239654423$23965442$3$F$20210409$20240731$20240612$20240815$EXP$$JP-ROCHE-3131265$ROCHE$Okamoto T, Yamakawa T, Kurihara S, Saika R, Yamamoto T, Hayashi Y et al.. Pj-058-2 Study on neuromyelitis optica spectrum disorder accompanied by severe complication during administration of satralizumab. The 65th Annual Meeting of the Japanese Society of Neurology / The 19th Asian Oc. 2024;487$48$YR$A$F$Y$38$KG$20240815$$MD$JP$JP
239654452$23965445$2$F$$20240624$20240612$20240704$30DAY$$US-GSK-US2024069375$GLAXOSMITHKLINE$$$$$M$Y$$$20240704$$MD$US$US
239654473$23965447$3$F$$20240705$20240612$20240708$PER$$US-AMGEN-USASP2024114344$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
239654503$23965450$3$F$$20240718$20240612$20240730$EXP$$CA-INTERCEPT-PM2023001260$INTERCEPT PHARMACEUTICALS$$72$YR$$F$Y$$$20240730$$MD$CA$CA
239654542$23965454$2$F$$20240920$20240612$20240926$EXP$$CA-TAKEDA-2024TUS058049$TAKEDA$$79$YR$$M$Y$75$KG$20240926$$HP$CA$CA
239654653$23965465$3$F$20240512$20240823$20240612$20240827$EXP$$DE-ROCHE-3576976$ROCHE$$77$YR$E$F$Y$58$KG$20240827$$MD$DE$DE
239654692$23965469$2$F$20240408$20240613$20240612$20240701$PER$$BR-TOLMAR, INC.-24BR049679$TOLMAR$$9$YR$$F$Y$$$20240701$$PH$BR$BR
239654712$23965471$2$F$20240301$20240814$20240612$20240906$PER$$BR-TOLMAR, INC.-24BR049681$TOLMAR$$9$YR$$F$Y$$$20240906$$MD$BR$BR
239654723$23965472$3$F$$20240710$20240612$20240717$PER$$US-ALXN-202406USA000152US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
239654793$23965479$3$F$20230309$20240802$20240612$20240809$EXP$$BG-AKCEA THERAPEUTICS, INC.-2024IS005020$AKCEA THERAPEUTICS$$$$$$Y$$$20240808$$HP$BG$BG
239654862$23965486$2$F$$20240909$20240612$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-094029$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$MD$JP$JP
239654902$23965490$2$F$20240101$20240626$20240612$20240703$EXP$$BR-AMGEN-BRASP2024112888$AMGEN$$$$$F$Y$$$20240702$$MD$BR$BR
239655082$23965508$2$F$20240530$20240715$20240612$20240718$EXP$$US-JNJFOC-20240613597$JOHNSON AND JOHNSON$$28$YR$A$F$Y$49.895$KG$20240719$$HP$US$US
239655092$23965509$2$F$$20240819$20240612$20240822$PER$$US-JNJFOC-20240609467$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
239655132$23965513$2$F$$20240610$20240612$20240816$EXP$$GB-ROCHE-3580139$ROCHE$$16$MON$I$M$Y$$$20240816$$MD$GB$GB
239655274$23965527$4$F$$20240917$20240612$20240922$30DAY$$US-SANDOZ INC.-SDZ2024US056264$SANDOZ$$$$$M$Y$$$20240922$$CN$US$US
239655283$23965528$3$F$20240101$20240722$20240612$20240724$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-015571$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$76$KG$20240724$$CN$ES$ES
239655372$23965537$2$F$20240101$20240627$20240612$20240701$EXP$$CA-ABBVIE-5791510$ABBVIE$$68$YR$$M$Y$$$20240701$$CN$CA$CA
239655403$23965540$3$F$20240610$20240802$20240612$20240806$PER$$US-AMGEN-USASP2024115487$AMGEN$$58$YR$A$F$Y$$$20240806$$CN$US$US
239655492$23965549$2$F$$20240731$20240612$20240807$EXP$$US-ABBVIE-5792529$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
239655682$23965568$2$F$20240413$20240701$20240612$20240705$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033281$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$78.47$KG$20240705$$CN$US$US
239655762$23965576$2$F$20240101$20240723$20240612$20240806$EXP$$FR-CIPLA LTD.-2024FR05767$CIPLA$$$$$$Y$$$20240806$$MD$FR$FR
239655822$23965582$2$F$20240529$20240801$20240612$20240807$EXP$$US-LEO Pharma-371015$LEO PHARM$$86$YR$$F$Y$54$KG$20240807$$CN$US$US
239656063$23965606$3$F$20240326$20240905$20240612$20240911$EXP$$US-TAKEDA-2024TUS030573$TAKEDA$$61$YR$$F$Y$$$20240911$$CN$US$US
239656082$23965608$2$F$20240501$20240709$20240612$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094299$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240719$$HP$US$US
239656102$23965610$2$F$$20240925$20240612$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094371$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$77.11$KG$20240926$$CN$US$US
239656112$23965611$2$F$$20240919$20240612$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-093965$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240925$$MD$JP$JP
239656202$23965620$2$F$20240603$20240711$20240612$20240716$PER$$US-AMGEN-USASP2024110748$AMGEN$$67$YR$E$M$Y$$$20240716$$PH$US$US
239656282$23965628$2$F$$20240924$20240612$20240924$EXP$$CA-ROCHE-3580178$ROCHE$$68$YR$E$F$Y$$$20240925$$HP$CA$CA
239656563$23965656$3$F$20240529$20240708$20240612$20240710$PER$$US-AMGEN-USASP2024107153$AMGEN$$50$YR$A$F$Y$$$20240710$$CN$US$US
239656792$23965679$2$F$20240415$20240718$20240612$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00339$IMMUNOGEN$$37$YR$$F$Y$$$20240829$$PH$US$US
239656842$23965684$2$F$$20240628$20240612$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00404$IMMUNOGEN$$66$YR$$F$Y$68.027$KG$20240829$$HP$US$US
239656862$23965686$2$F$$20240806$20240612$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00399$IMMUNOGEN$$$$E$F$Y$$$20240829$$CN$US$US
239656952$23965695$2$F$20220101$20240717$20240612$20240722$EXP$$US-ABBVIE-5792288$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
239657113$23965711$3$F$20240609$20240708$20240612$20240727$PER$$US-AMGEN-USASP2024115542$AMGEN$$74$YR$E$F$Y$$$20240727$$CN$US$US
239657382$23965738$2$F$$20240801$20240612$20240807$30DAY$$US-GSK-US2024070660$GLAXOSMITHKLINE$$$$$M$Y$$$20240807$$CN$US$US
239657474$23965747$4$F$20240512$20240820$20240612$20240902$EXP$$DE-AUROBINDO-AUR-APL-2024-027698$AUROBINDO$$77$YR$$F$Y$58$KG$20240902$$MD$DE$DE
239657482$23965748$2$F$$20240722$20240612$20240722$PER$$US-ALXN-202406USA000221US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
239657532$23965753$2$F$$20240702$20240612$20240705$EXP$$CA-TAKEDA-2024TUS056975$TAKEDA$$$$$M$Y$$$20240705$$CN$CA$CA
239657672$23965767$2$F$20240531$20240820$20240612$20240826$EXP$$US-JNJFOC-20240608977$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240826$$CN$US$US
239657752$23965775$2$F$$20240716$20240612$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094568$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240717$$CN$US$US
239657914$23965791$4$F$$20240904$20240612$20240912$EXP$$ZA-Vifor (International) Inc.-VIT-2024-05036$VIFOR$$$$A$M$Y$$$20240912$$MD$ZA$ZA
239657972$23965797$2$F$20240101$20240716$20240612$20240718$EXP$$US-ABBVIE-5792499$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
239657992$23965799$2$F$$20240813$20240612$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091204$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240816$$CN$US$US
239658013$23965801$3$F$20240605$20240724$20240612$20240731$30DAY$$US-AMGEN-USASP2024112816$AMGEN$$51$YR$A$$Y$$$20240731$$HP$US$US
239658022$23965802$2$F$20240605$20240711$20240612$20240716$PER$$US-AMGEN-USASP2024112601$AMGEN$$56$YR$A$F$Y$76.2$KG$20240716$$HP$US$US
239658042$23965804$2$F$20240531$20240708$20240612$20240710$30DAY$$US-AMGEN-USASP2024112590$AMGEN$$59$YR$A$F$Y$66$KG$20240710$$PH$US$US
239658153$23965815$3$F$20240430$20240711$20240612$20240718$30DAY$$US-AMGEN-USASP2024112598$AMGEN$$58$YR$A$F$Y$92.5$KG$20240718$$PH$US$US
239658542$23965854$2$F$$20240722$20240612$20240725$PER$$US-AMGEN-USASP2024115306$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
239658612$23965861$2$F$20240501$20240715$20240612$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092968$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240719$$CN$US$US
239658625$23965862$5$F$20240325$20240912$20240612$20240918$EXP$$JP-GSK-JP2024JPN070165$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$JP$JP
239658732$23965873$2$F$20211004$20240820$20240612$20240823$EXP$$ES-PFIZER INC-202400189961$PFIZER$$71$YR$$M$Y$94$KG$20240823$$MD$ES$ES
239659082$23965908$2$F$20240101$20240712$20240612$20240719$EXP$$JP-009507513-2406JPN001161J$MERCK$$74$YR$$F$Y$$$20240719$$MD$JP$JP
239659172$23965917$2$F$$20240918$20240612$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-094389$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240919$$MD$JP$JP
239659212$23965921$2$F$$20240910$20240612$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092580$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240910$$HP$US$US
239659222$23965922$2$F$20230921$20240715$20240612$20240722$EXP$$CA-TAKEDA-2024TUS054931$TAKEDA$$9$YR$$M$Y$$$20240722$$CN$CA$CA
239659242$23965924$2$F$$20240627$20240612$20240705$EXP$$IT-AUROBINDO-AUR-APL-2024-027975$AUROBINDO$Cavestro C, Morra F, Legati A, D^Amato M, Nasca A, Iuso A et al.. Emerging variants, unique phenotypes, and transcriptomic signatures: an integrated study of COASY-associated diseases.. Annals of Clinical and Translational Neurology.. 2024$$$$F$Y$$$20240705$$MD$IT$IT
239659292$23965929$2$F$$20240724$20240612$20240730$EXP$$US-ASTELLAS-2024US016370$ASTELLAS$$9$DEC$$F$Y$$$20240730$$CN$US$US
239659332$23965933$2$F$20240518$20240718$20240612$20240724$EXP$$CA-AMGEN-CANSL2024113806$AMGEN$$68$YR$E$M$Y$127.4$KG$20240724$$CN$CA$CA
239659462$23965946$2$F$20240215$20240708$20240612$20240716$EXP$$MX-EMD Serono-2024031439$EMD SERONO INC$$11$YR$C$M$Y$$$20240716$$CN$MX$MX
239659694$23965969$4$F$20231114$20240625$20240612$20240704$EXP$$DE-EMD Serono-2024031210$EMD SERONO INC$$33$YR$A$F$Y$67$KG$20240704$$MD$DE$DE
239659732$23965973$2$F$$20240722$20240612$20240723$PER$$US-ALXN-202406USA000296US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239659973$23965997$3$F$20240601$20240709$20240612$20240712$PER$$US-AMGEN-USASP2024114363$AMGEN$$71$YR$E$M$Y$$$20240712$$CN$US$US
239660002$23966000$2$F$$20240712$20240612$20240718$EXP$$US-AMGEN-USASP2024113073$AMGEN$Allen C.E.; Chandrakasan S.; Jordan M.B. et al.. Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Blood Advances. 2024;8 (9):2248-2258$$$$$Y$$$20240718$$HP$US$US
239660074$23966007$4$F$20230201$20240924$20240612$20240930$EXP$$DE-EXELIXIS-XL18423062129$EXELIXIS$$$$$$Y$$$20240930$$MD$DE$DE
239660212$23966021$2$F$20240606$20240612$20240612$20240720$PER$$US-AMGEN-USASP2024115354$AMGEN$$79$YR$E$M$Y$$$20240720$$CN$US$US
239660443$23966044$3$F$$20240822$20240612$20240830$EXP$$CA-Novartis Pharma AG-NVSC2024CA117035$SANDOZ$$65$YR$$F$Y$$$20240830$$HP$CA$CA
239660492$23966049$2$F$$20240708$20240612$20240712$PER$$US-AstraZeneca-2024A120847$ASTRAZENECA$$$$$F$Y$$$20240712$$HP$US$
239660502$23966050$2$F$20240618$20240619$20240612$20240711$PER$$US-BEH-2024173037$CSL BEHRING$$60$YR$A$F$Y$$$20240711$$HP$US$US
239660522$23966052$2$F$20240526$20240709$20240612$20240712$PER$$US-AstraZeneca-2024A124297$ASTRAZENECA$$16270$DY$$F$Y$$$20240713$$CN$US$
239660622$23966062$2$F$$20240624$20240612$20240705$PER$$US-CHATTEMPRD-2024OHG020472$CHATTEM$$$$$F$Y$$$20240705$$CN$US$US
239660722$23966072$2$F$20240101$20240709$20240612$20240715$EXP$$JP-AMGEN-JPNSP2024111767$AMGEN$$$$A$M$Y$$$20240715$$MD$JP$JP
239661162$23966116$2$F$$20240724$20240612$20240724$PER$$NVSC2024US122924$NOVARTIS$$$$$F$Y$$$20240724$$MD$US$US
239661193$23966119$3$F$20240611$20240815$20240612$20240820$PER$$US-AMGEN-USASP2024115382$AMGEN$$73$YR$E$F$Y$$$20240819$$CN$US$US
239661312$23966131$2$F$20240603$20240721$20240612$20240730$30DAY$$US-GSK-US2024068941$GLAXOSMITHKLINE$$50$YR$$M$Y$$$20240730$$CN$US$US
239661342$23966134$2$F$20240602$20240711$20240612$20240717$30DAY$$US-GSK-US2024070014$GLAXOSMITHKLINE$$55$YR$$F$Y$82$KG$20240717$$HP$US$US
239661462$23966146$2$F$20240609$20240708$20240612$20240709$PER$$US-AMGEN-USASP2024115695$AMGEN$$59$YR$A$F$Y$$$20240709$$CN$US$US
239661532$23966153$2$F$$20240909$20240612$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091614$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240909$$CN$US$US
239661702$23966170$2$F$20240608$20240612$20240612$20240920$PER$$US-AMGEN-USASP2024115525$AMGEN$$69$YR$E$M$Y$$$20240920$$CN$US$US
239661735$23966173$5$F$20240201$20240624$20240612$20240830$EXP$$NL-ABBVIE-5797931$ABBVIE$$$$E$M$Y$$$20240828$$CN$NL$NL
239661742$23966174$2$F$$20240910$20240612$20240919$EXP$GR-EMA-DD-20240603-7482643-070339$GR-SANDOZ INC.-SDZ2024GR055835$SANDOZ$$46$YR$$F$Y$$$20240919$$MD$GR$GR
239661763$23966176$3$F$20240603$20240819$20240612$20240821$EXP$$JP-JNJFOC-20240628533$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240821$$MD$JP$JP
239661922$23966192$2$F$$20240715$20240612$20240722$30DAY$$IE-JNJFOC-20240614693$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$IE$IE
239661962$23966196$2$F$20240101$20240629$20240612$20240705$EXP$$GB-AMGEN-GBRSL2024098315$AMGEN$$79$YR$E$M$Y$$$20240705$$CN$GB$GB
239662013$23966201$3$F$20240422$20240708$20240612$20240718$EXP$$US-RDY-CLI/USA/24/0008308$DR REDDYS$$24$YR$A$F$Y$$$20240718$$MD$US$US
239662052$23966205$2$F$$20240703$20240612$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094545$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$89.36$KG$20240705$$CN$US$US
239662132$23966213$2$F$$20240606$20240612$20240801$PER$$US-AstraZeneca-2024A133853$ASTRAZENECA$$$$$$Y$$$20240801$$PH$US$
239662272$23966227$2$F$20231201$20240610$20240612$20240917$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01474$AMNEAL$$$$$F$Y$$$20240917$$CN$US$US
239662282$23966228$2$F$$20240603$20240612$20240917$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01436$AMNEAL$$$$$F$Y$63.492$KG$20240917$$CN$US$US
239662413$23966241$3$F$20240702$20240729$20240612$20240803$EXP$$NVSC2024AR122388$NOVARTIS$$39$YR$$M$Y$$$20240803$$MD$AR$AR
239662682$23966268$2$F$20240208$20240531$20240612$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003658$TG THERAPEUTICS$$41$YR$$F$Y$$$20240715$$CN$US$US
239662692$23966269$2$F$$20240912$20240612$20240919$EXP$$JP-009507513-2406JPN000941J$MERCK$$6$DEC$$M$Y$$$20240919$$HP$JP$JP
239662782$23966278$2$F$20240529$20240619$20240612$20240701$EXP$$DE-BAYER-2024A079425$BAYER$$38$YR$A$F$Y$$$20240701$$CN$DE$DE
239662804$23966280$4$F$$20240711$20240612$20240712$EXP$$US-TAKEDA-2024TUS044715$TAKEDA$$$$$F$Y$$$20240712$$MD$US$US
239662962$23966296$2$F$$20240712$20240612$20240718$30DAY$$FR-JNJFOC-20240611584$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$CN$FR$FR
239663003$23966300$3$F$$20240919$20240612$20240923$EXP$$US-SANDOZ INC.-SDZ2024US056981$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
239663122$23966312$2$F$20240503$20240626$20240612$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR069557$VIIV$$34$YR$$M$Y$113$KG$20240705$$MD$US$US
239663386$23966338$6$F$$20240903$20240612$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-150545$BRISTOL MYERS SQUIBB$Honda H, Tsubamoto H, Miura M, Hamada K, Takimoto Y, Taniguchi R. Four cases of immune checkpoint preparation-induced irAEs in patients with malignant melanoma. Advances in Obstetrics and Gynecology. 2023;75(4):562.$42$YR$A$F$Y$40.1$KG$20240913$$MD$JP$JP
239663412$23966341$2$F$20240501$20240911$20240612$20240922$EXP$$US-UCBSA-2024029700$UCB$$36$YR$$M$Y$$$20240922$$HP$US$US
239663512$23966351$2$F$$20240708$20240612$20240709$EXP$$CA-BAUSCH-BL-2024-009011$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240709$$MD$CA$CA
239663552$23966355$2$F$20240605$20240719$20240612$20240726$PER$$US-AMGEN-USASP2024113309$AMGEN$$78$YR$E$M$Y$$$20240725$$CN$US$US
239663565$23966356$5$F$20240529$20240705$20240612$20240716$30DAY$$US-AMGEN-USASP2024112561$AMGEN$$68$YR$E$F$Y$67.574$KG$20240715$$PH$US$US
239663572$23966357$2$F$20240607$20240624$20240612$20240701$30DAY$$US-AMGEN-USASP2024113610$AMGEN$$43$YR$A$F$Y$60.2$KG$20240701$$PH$US$US
239663613$23966361$3$F$20221201$20240703$20240612$20240705$EXP$$US-BAUSCH-BL-2023-002419$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240705$$CN$US$US
239663852$23966385$2$F$$20240710$20240612$20240716$30DAY$$AU-JNJFOC-20240608591$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$HP$AU$AU
239664042$23966404$2$F$$20240814$20240612$20240820$EXP$$JP-009507513-2406JPN000777J$MERCK$$$$$F$Y$$$20240820$$MD$JP$JP
239664113$23966411$3$F$20190214$20240919$20240612$20240923$EXP$$US-GILEAD-2024-0676830$GILEAD$$59$YR$A$M$Y$$$20240923$$LW$US$US
239664123$23966412$3$F$20240101$20240801$20240612$20240808$EXP$$CA-CELLTRION INC.-2024CA013900$CELLTRION$$$$$$Y$$$20240808$$HP$CA$CA
239664222$23966422$2$F$20210927$20240711$20240612$20240722$EXP$NL-LRB-00976556$NL-Accord-428643$ACCORD$$56$YR$A$F$Y$72$KG$20240722$$PH$NL$NL
239664292$23966429$2$F$20240501$20240710$20240612$20240714$PER$$US-JNJFOC-20240628538$JOHNSON AND JOHNSON$$$$$$Y$$$20240714$$MD$US$US
239664532$23966453$2$F$$20240719$20240612$20240731$EXP$$RO-Accord-425836$ACCORD$Rosu S, Tiba DS, Ichim A, Balteanu M. Combination with reserved prognosis: TB- rheumatoid arthritis. Pneumologia. Vol. 71, No. 4, 2022. 150-153$54$YR$A$F$Y$$$20240731$$HP$RO$RO
239664842$23966484$2$F$$20240529$20240612$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00353$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$US$US
239664933$23966493$3$F$$20240902$20240612$20240909$EXP$$NVSC2023AU247880$NOVARTIS$McMullen L, Khoo L, Anderson L, Strasser S, Gracey DM. BK viraemia as a cause of anaemia in after ABO?incompatible liver transplant: a case report. BMC INFECTIOUS DISEASES. 2023;23(1):1-358$59$YR$$M$Y$$$20240909$$HP$AU$AU
239665184$23966518$4$F$$20240913$20240612$20240919$30DAY$$GB-PFIZER INC-PV202400074626$PFIZER$$10$YR$$M$Y$$$20240919$$CN$GB$GB
239665313$23966531$3$F$20181003$20240919$20240612$20240923$PER$$US-GILEAD-2024-0676859$GILEAD$$43$YR$A$M$Y$$$20240923$$LW$US$US
239665452$23966545$2$F$20130101$20240801$20240612$20240807$PER$$US-BIOGEN-2024BI01268378$BIOGEN$$$$$M$Y$$$20240807$$CN$US$US
239665502$23966550$2$F$$20240802$20240612$20240805$PER$$US-ALXN-202406USA000274US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
239665575$23966557$5$F$20240522$20240808$20240612$20240812$EXP$$DE-PFIZER INC-PV202400071168$PFIZER$$83$YR$$F$Y$60$KG$20240812$$MD$DE$DE
239665633$23966563$3$F$20240531$20240717$20240612$20240722$PER$$US-AMGEN-USASP2024112592$AMGEN$$61$YR$A$F$Y$71.42$KG$20240722$$HP$US$US
239665642$23966564$2$F$20240501$20240820$20240612$20240828$EXP$$JP-AMGEN-JPNSP2024100102$AMGEN$$$$$F$Y$$$20240827$$MD$JP$JP
239665692$23966569$2$F$20240507$20240704$20240612$20240711$PER$$US-AstraZeneca-2024A130447$ASTRAZENECA$$29027$DY$$M$Y$$$20240711$$CN$US$
239665714$23966571$4$F$$20240829$20240612$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093807$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240902$$CN$US$US
239665722$23966572$2$F$$20240703$20240612$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094550$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240703$$CN$US$US
239665755$23966575$5$F$20240603$20240718$20240612$20240724$EXP$$JP-PHARMAESSENTIA CORPORATION-JP-2024-PEC-003927$PHARMAESSENTIA$$40$YR$$F$Y$$$20240724$$HP$JP$JP
239665854$23966585$4$F$$20240807$20240612$20240812$EXP$$CA-BAYER-2024A083697$BAYER$$$$$F$Y$$$20240812$$MD$CA$CA
239665872$23966587$2$F$20180808$20240831$20240612$20240903$PER$$US-GILEAD-2024-0676863$GILEAD$$39$YR$A$F$Y$$$20240903$$LW$US$US
239665922$23966592$2$F$20240521$20240727$20240612$20240807$EXP$GB-MHRA-MED-202405311106380720-SRNGH$GB-Accord-428616$ACCORD$$$$$M$Y$$$20240807$$HP$GB$GB
239666053$23966605$3$F$20240404$20240724$20240612$20240725$PER$$NVSC2024US123092$NOVARTIS$$61$YR$$F$Y$$$20240725$$HP$US$US
239666162$23966616$2$F$20240609$20240724$20240612$20240729$PER$$US-AMGEN-USASP2024114314$AMGEN$$58$YR$A$M$Y$$$20240729$$HP$US$US
239666182$23966618$2$F$20240601$20240705$20240612$20240710$PER$$US-BIOGEN-2024BI01268464$BIOGEN$$66$YR$$M$Y$$$20240710$$MD$US$US
239666222$23966622$2$F$20240604$20240717$20240612$20240724$PER$$US-BIOGEN-2024BI01268453$BIOGEN$$40$YR$$F$Y$$$20240724$$CN$US$US
239666332$23966633$2$F$20240607$20240731$20240612$20240803$PER$$US-AMGEN-USASP2024114357$AMGEN$$77$YR$E$F$Y$$$20240803$$CN$US$US
239666352$23966635$2$F$20231002$20240628$20240612$20240704$EXP$$IE-TAKEDA-2023TUS095835$TAKEDA$$68$YR$$M$Y$78$KG$20240704$$CN$IE$IE
239666462$23966646$2$F$20240408$20240828$20240612$20240905$EXP$$UY-JNJFOC-20240490395$JOHNSON AND JOHNSON$$8$YR$C$M$Y$36$KG$20240905$$CN$UY$UY
239666472$23966647$2$F$20240603$20240716$20240612$20240725$EXP$$US-CHIESI-2024CHF03378$CHIESI$$62$YR$$F$Y$57.2$KG$20240725$$CN$US$US
239666492$23966649$2$F$20240209$20240705$20240612$20240709$EXP$$CA-AMERICAN REGENT INC-2024002208$AMERICAN REGENT$$33$YR$$F$Y$$$20240709$$HP$CA$CA
239666512$23966651$2$F$$20240703$20240612$20240815$PER$$US-TRAVERE-2024TVT00498$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240815$$CN$US$US
239666614$23966661$4$F$20240530$20240819$20240612$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091635$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$87.54$KG$20240828$$CN$US$US
239666622$23966662$2$F$$20240920$20240612$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-089487$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240923$$CN$US$US
239666632$23966663$2$F$$20240712$20240612$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094624$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$76.2$KG$20240717$$CN$US$US
239666693$23966669$3$F$20240603$20240706$20240612$20240717$PER$$US-ROCHE-3577060$ROCHE$$14$YR$T$M$Y$44$KG$20240717$$CN$US$US
239666772$23966677$2$F$20231214$20240812$20240612$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-028050$AUROBINDO$$34$YR$$F$Y$90$KG$20240822$$CN$GB$GB
239666843$23966684$3$F$$20240718$20240612$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-013471$UNITED THERAPEUTICS$$$$$F$Y$92.517$KG$20240723$$$US$US
239667134$23966713$4$F$20240101$20240714$20240612$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-011119$UNITED THERAPEUTICS$$$$$F$Y$138.78$KG$20240718$$$US$US
239667253$23966725$3$F$$20240702$20240612$20240911$EXP$$US-BEH-2024173504$CSL BEHRING$$35$YR$A$F$Y$80.726$KG$20240911$$HP$US$US
239667333$23966733$3$F$20240416$20240710$20240612$20240714$EXP$$US-JNJFOC-20240621434$JOHNSON AND JOHNSON$$21$YR$A$M$Y$67.2$KG$20240714$$MD$US$US
239667472$23966747$2$F$$20240919$20240612$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-093909$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240927$$MD$JP$JP
239667492$23966749$2$F$20240608$20240822$20240612$20240826$PER$$US-AMGEN-USASP2024114292$AMGEN$$27$YR$A$F$Y$$$20240826$$CN$US$US
239667542$23966754$2$F$$20240805$20240612$20240902$30DAY$$JP-SA-2024SA171812$SANOFI AVENTIS$$$$A$$Y$$$20240902$$HP$JP$JP
239667572$23966757$2$F$$20240723$20240612$20240801$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001179$BLUEPRINT MEDICINES$$$$$F$Y$$$20240801$$MD$US$US
239667752$23966775$2$F$$20240621$20240612$20240702$EXP$$CA-PFIZER INC-202300276773$PFIZER$$37$YR$$M$Y$93$KG$20240702$$MD$CA$CA
239667783$23966778$3$F$$20240704$20240612$20240712$EXP$$ES-ALCON LABORATORIES-ALC2024ES002845$ALCON$$$$$$Y$$$20240712$$HP$ES$ES
239667882$23966788$2$F$$20240910$20240612$20240913$PER$$US-JNJFOC-20240601392$JOHNSON AND JOHNSON$$69$YR$E$$Y$$$20240914$$MD$US$US
239667916$23966791$6$F$20230801$20240920$20240612$20240926$EXP$$NVSC2023MX277169$NOVARTIS$$68$YR$$F$Y$62$KG$20240926$$CN$MX$MX
239668055$23966805$5$F$20240101$20240917$20240612$20240927$EXP$$US-INSMED, INC.-2024-01412-US$INSMED$$$$$F$Y$$$20240927$$CN$US$US
239668083$23966808$3$F$20231126$20240815$20240612$20240822$EXP$$US-TAKEDA-2023TUS116018$TAKEDA$$72$YR$$F$Y$$$20240822$$MD$US$US
239668112$23966811$2$F$$20240923$20240612$20240927$EXP$$GB-MYLANLABS-2024M1052591$MYLAN$$$$$F$Y$$$20240927$$MD$GB$GB
239668172$23966817$2$F$$20240622$20240612$20240701$PER$$US-INCYTE CORPORATION-2024IN005919$INCYTE$$$$$$Y$$$20240701$$HP$US$US
239668344$23966834$4$F$20230324$20240818$20240612$20240826$EXP$$RU-BIOGEN-2024BI01268661$BIOGEN$$44$YR$$F$Y$$$20240826$$MD$RU$RU
239668442$23966844$2$F$20230727$20240807$20240612$20240813$EXP$$US-SA-2024SA175404$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240813$$CN$US$US
239668463$23966846$3$F$$20240617$20240612$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406006383$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240701$$CN$US$US
239668903$23966890$3$F$20230424$20240906$20240612$20240916$EXP$$US-TAKEDA-2023TUS042106$TAKEDA$$73$YR$$F$Y$$$20240916$$CN$US$US
239669252$23966925$2$F$20240516$20240724$20240612$20240726$EXP$$US-BAYER-2024A083713$BAYER$$21$YR$A$M$Y$$$20240726$$CN$US$US
239669272$23966927$2$F$$20240910$20240612$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084960$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$HP$US$US
239669293$23966929$3$F$20240603$20240719$20240612$20240726$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-084220$REGENERON$$90$YR$$M$Y$$$20240726$$CN$CO$CO
239669434$23966943$4$F$20240201$20240625$20240612$20240701$EXP$$NVSC2024EG122161$NOVARTIS$$77$YR$$M$Y$$$20240701$$CN$EG$EG
239669494$23966949$4$F$$20240712$20240612$20240716$EXP$$CA-BIOGEN-2024BI01268270$BIOGEN$$$$$F$Y$$$20240716$$CN$CA$CA
239669533$23966953$3$F$20240401$20240902$20240612$20240912$EXP$$IL-Ipsen Biopharmaceuticals, Inc.-2024-11219$IPSEN$$$$$F$Y$$$20240912$$CN$IL$IL
239669594$23966959$4$F$$20240712$20240612$20240718$EXP$$AU-PFIZER INC-PV202200066658$PFIZER$$42$YR$$F$Y$94$KG$20240718$$HP$AU$AU
239669616$23966961$6$F$20240510$20240829$20240612$20240904$EXP$$US-BEH-2024173447$CSL BEHRING$$51$YR$A$F$Y$47.166$KG$20240904$$HP$US$US
239669642$23966964$2$F$20230101$20240716$20240612$20240723$EXP$$CA-JNJFOC-20230845295$JOHNSON AND JOHNSON$$56$YR$A$M$Y$100$KG$20240723$$HP$CA$CA
239669682$23966968$2$F$20240220$20240717$20240612$20240723$EXP$$US-OTSUKA-2024_016496$OTSUKA$$50$YR$$F$Y$$$20240723$$MD$US$US
239669793$23966979$3$F$20240101$20240709$20240612$20240711$PER$$US-AMGEN-USASP2024115310$AMGEN$$$$$$Y$$$20240710$$CN$US$US
239669972$23966997$2$F$20240529$20240724$20240612$20240801$EXP$$US-MYLANLABS-2024M1052558$MYLAN$$37$YR$$F$Y$$$20240801$$PH$US$US
239670012$23967001$2$F$$20240724$20240612$20240729$EXP$$NZ-MYLANLABS-2024M1053159$MYLAN$$$$$F$Y$106$KG$20240729$$PH$NZ$NZ
239670035$23967003$5$F$20231224$20240905$20240612$20240910$EXP$$US-MYLANLABS-2024M1052924$MYLAN$$35$YR$$M$Y$70.31$KG$20240910$$CN$US$US
239670173$23967017$3$F$20240503$20240717$20240612$20240731$PER$$US-Calliditas-2024CAL00932$CALLIDITAS THERAPEUTICS$$56$YR$A$M$Y$$$20240731$$CN$US$US
239670273$23967027$3$F$20240101$20240823$20240612$20240828$EXP$$US-PFIZER INC-202400184211$PFIZER$$63$YR$$F$Y$$$20240828$$HP$US$US
239670312$23967031$2$F$20210101$20240701$20240612$20240703$EXP$$HR-PFIZER INC-202400190119$PFIZER$$61$YR$$M$Y$$$20240703$$MD$HR$HR
239670352$23967035$2$F$20240101$20240917$20240612$20240924$EXP$$JP-009507513-2406JPN000418J$MERCK$$6$DEC$$M$Y$$$20240924$$MD$JP$JP
239670392$23967039$2$F$$20240820$20240612$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094378$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240822$$CN$US$US
239670402$23967040$2$F$20231201$20240628$20240612$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-094438$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240704$$MD$JP$JP
239670442$23967044$2$F$20240429$20240718$20240612$20240725$EXP$$IL-BIOGEN-2024BI01268683$BIOGEN$$0$YR$$M$Y$$$20240725$$MD$IL$IL
239670482$23967048$2$F$20240111$20240729$20240612$20240802$EXP$$FI-PFIZER INC-202400027114$PFIZER$$70$YR$$F$Y$96$KG$20240802$$MD$FI$FI
239670562$23967056$2$F$$20240801$20240612$20240805$PER$$US-PFIZER INC-PV202400076270$PFIZER$$49$YR$$F$Y$$$20240805$$HP$US$US
239670575$23967057$5$F$20240101$20240820$20240612$20240820$30DAY$$JP-PFIZER INC-PV202400072424$PFIZER$$10$YR$$M$Y$30$KG$20240820$$MD$JP$JP
239670605$23967060$5$F$$20240729$20240612$20240801$30DAY$$JP-PFIZER INC-202400186873$PFIZER$$69$YR$$F$Y$$$20240801$$PH$JP$JP
239670622$23967062$2$F$$20240826$20240612$20240829$PER$$US-PFIZER INC-202400073130$PFIZER$$14$YR$$M$Y$$$20240829$$HP$US$US
239670823$23967082$3$F$$20240913$20240612$20240919$30DAY$$CH-PFIZER INC-202400187052$PFIZER$$$$$$Y$$$20240919$$HP$CH$CH
239670862$23967086$2$F$20240201$20240906$20240612$20240909$EXP$$NVSC2024DE122327$NOVARTIS$$39$YR$$M$Y$$$20240909$$CN$DE$DE
239670932$23967093$2$F$$20240604$20240612$20240716$EXP$$US-AstraZeneca-2024A131456$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
239671334$23967133$4$F$20240605$20240802$20240612$20240809$EXP$$US-AMGEN-USASP2024113358$AMGEN$$86$YR$E$F$Y$$$20240808$$MD$US$US
239671382$23967138$2$F$20240518$20240725$20240612$20240803$EXP$IT-MINISAL02-987740$IT-TEVA-VS-3207242$TEVA$$17$YR$$M$Y$$$20240803$$PH$IT$IT
239672613$23967261$3$F$$20240701$20240612$20240707$EXP$$JP-JNJFOC-20240628582$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$$COUNTRY NOT SPECIFIED$JP
239672632$23967263$2$F$20240101$20240627$20240612$20240704$EXP$$US-JNJFOC-20240539008$JOHNSON AND JOHNSON$$67$YR$E$F$Y$61.4$KG$20240704$$HP$US$US
239672703$23967270$3$F$$20240708$20240612$20240722$PER$$US-Calliditas-2024CAL00917$CALLIDITAS THERAPEUTICS$$59$YR$A$M$Y$118.3$KG$20240722$$CN$US$US
239672812$23967281$2$F$20240419$20240708$20240612$20240718$EXP$$CA-BAYER-2024A062694$BAYER$$72$YR$E$F$Y$$$20240718$$MD$CA$CA
239672872$23967287$2$F$$20240801$20240612$20240808$EXP$$DE-SA-2024SA175838$SANOFI AVENTIS$$$$A$M$Y$$$20240808$$MD$DE$DE
239672922$23967292$2$F$$20240611$20240612$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033312$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240717$$CN$US$US
239672933$23967293$3$F$20240530$20240904$20240612$20240911$EXP$$JP-OTSUKA-2024_015761$OTSUKA$$27$YR$$F$Y$$$20240911$$MD$JP$JP
239673002$23967300$2$F$$20240702$20240612$20240704$EXP$$NVSC2024US121636$NOVARTIS$$$$$M$Y$$$20240704$$HP$US$US
239673032$23967303$2$F$20240328$20240725$20240612$20240809$PER$$US-RISINGPHARMA-US-2024RISSPO00185$RISING PHARMACEUTICALS$$57$YR$A$$Y$$$20240809$$CN$US$US
239673063$23967306$3$F$$20240628$20240612$20240705$EXP$$JP-JNJFOC-20240629272$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$$COUNTRY NOT SPECIFIED$JP
239673092$23967309$2$F$20240515$20240904$20240612$20240911$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-17784$SAMSUNG BIOEPIS$$62$YR$A$M$Y$109.5$KG$20240912$$MD$DE$DE
239673132$23967313$2$F$20230830$20240725$20240612$20240729$EXP$$CA-UCBSA-2023029927$UCB$$35$YR$$F$Y$$$20240729$$PH$CA$CA
239673212$23967321$2$F$20240601$20240709$20240612$20240722$PER$$US-Calliditas-2024CAL00923$CALLIDITAS THERAPEUTICS$$44$YR$A$F$Y$66.9$KG$20240722$$CN$US$US
239673433$23967343$3$F$20240411$20240805$20240612$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094732$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240808$$HP$US$US
239673513$23967351$3$F$$20240826$20240612$20240829$30DAY$$US-PFIZER INC-202400181946$PFIZER$$46$YR$$F$Y$$$20240829$$PH$US$US
239673524$23967352$4$F$$20240919$20240612$20240924$30DAY$$US-PFIZER INC-202400188549$PFIZER$$32$YR$$F$Y$$$20240924$$CN$US$US
239673534$23967353$4$F$$20240813$20240612$20240816$30DAY$$US-PFIZER INC-202400189572$PFIZER$$11$YR$$F$Y$$$20240816$$CN$US$US
239673572$23967357$2$F$20240101$20240801$20240612$20240802$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-125920$DAIICHI$$$$$F$Y$$$20240802$$HP$US$US
239673742$23967374$2$F$20240604$20240715$20240612$20240723$EXP$$BR-AstraZeneca-2024A134008$ASTRAZENECA$$$$$M$Y$$$20240723$$MD$BR$
239674012$23967401$2$F$$20240815$20240612$20240816$PER$$NVSC2024US120274$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
239674032$23967403$2$F$20240423$20240802$20240612$20240807$EXP$$DE-MYLANLABS-2024M1052219$MYLAN$$52$YR$$F$Y$$$20240807$$MD$DE$DE
239674053$23967405$3$F$$20240724$20240612$20240726$EXP$$FR-PFIZER INC-PV202400074535$PFIZER$$$$E$F$Y$62$KG$20240726$$MD$FR$FR
239674112$23967411$2$F$20240426$20240815$20240612$20240826$EXP$$US-BAYER-2024A082190$BAYER$$22$YR$A$F$Y$$$20240826$$CN$US$US
239674183$23967418$3$F$20240609$20240913$20240612$20240918$30DAY$$US-PFIZER INC-202400190440$PFIZER$$14$YR$$F$Y$$$20240918$$CN$US$US
239674194$23967419$4$F$20240607$20240827$20240612$20240830$30DAY$$US-PFIZER INC-202400189253$PFIZER$$6$YR$$M$Y$18.14$KG$20240830$$HP$US$US
239674232$23967423$2$F$$20240716$20240612$20240723$PER$$US-VERTEX PHARMACEUTICALS-2024-009631$VERTEX$$$$$$Y$$$20240723$$CN$US$US
239674666$23967466$6$F$20240525$20240925$20240612$20240930$EXP$$US-BAYER-2024A082969$BAYER$$43$YR$A$M$Y$$$20240930$$HP$US$US
239674682$23967468$2$F$20240718$20240718$20240612$20240723$EXP$$CA-TAKEDA-2023TUS100081$TAKEDA$$45$YR$$F$Y$$$20240723$$CN$CA$CA
239674812$23967481$2$F$$20240910$20240612$20240913$EXP$$US-JNJFOC-20240623067$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240913$$CN$US$US
239674862$23967486$2$F$20240718$20240722$20240612$20240730$EXP$$US-Calliditas-2024CAL00970$CALLIDITAS THERAPEUTICS$$33$YR$A$F$Y$53$KG$20240730$$CN$US$US
239674874$23967487$4$F$20240528$20240827$20240612$20240910$PER$$US-Calliditas-2024CAL00921$CALLIDITAS THERAPEUTICS$$77$YR$E$M$Y$80.7$KG$20240910$$CN$US$US
239674923$23967492$3$F$20240610$20240814$20240612$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094636$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240819$$CN$US$US
239674983$23967498$3$F$20240101$20240808$20240612$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-016568$UNITED THERAPEUTICS$$$$$F$Y$$$20240814$$$US$US
239675022$23967502$2$F$$20240628$20240612$20240708$EXP$$US-TEVA-VS-3207274$TEVA$Shamloul N, Kamrani P, Horissian M, Helm MF, Cartee TV, Hollins LC. Inadvertent intravascular injection of hyaluronic acid following osteoarthritis treatment: A rare but important complication to recognize. Int-J-Dermatol 2024; 63 (1): 115-116.; Shamloul N, Kamrani P, Horissian M, Helm MF, Cartee TV, Hollins LC. Inadvertent intravascular injection of hyaluronic acid following osteoarthritis treatment: A rare but important complication to recognize. Int-J-Dermatol 2024; 63 (1): 115-116.$40$YR$$F$Y$$$20240708$$MD$US$US
239675282$23967528$2$F$20231218$20240726$20240612$20240802$EXP$FR-AFSSAPS-RS2024000538$FR-VIIV HEALTHCARE LIMITED-FR2024071873$VIIV$$$$$$Y$$$20240802$$MD$FR$FR
239675314$23967531$4$F$20230301$20240703$20240612$20240715$EXP$$DE-MSNLABS-2024MSNSPO01208$MSN LABORATORIES$$$$$$Y$$$20240715$$CN$DE$DE
239675326$23967532$6$F$$20240723$20240612$20240729$PER$$US-BIOVITRUM-2024-US-008470$BIOVITRUM$$80$YR$$M$Y$$$20240729$$CN$US$US
239675583$23967558$3$F$$20240718$20240612$20240725$EXP$$US-JNJFOC-20240611224$JOHNSON AND JOHNSON$$$$$M$Y$$$20240725$$CN$US$US
239675663$23967566$3$F$20240529$20240708$20240612$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202406005142$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240719$$CN$US$US
239675763$23967576$3$F$20231228$20240902$20240612$20240905$EXP$$ES-MYLANLABS-2024M1052277$MYLAN$$47$YR$$F$Y$$$20240905$$CN$ES$ES
239675772$23967577$2$F$20240102$20240703$20240612$20240709$EXP$$DE-MYLANLABS-2024M1052775$MYLAN$$$$E$F$Y$$$20240709$$MD$DE$DE
239675872$23967587$2$F$20240529$20240625$20240612$20240705$EXP$$US-MSNLABS-2024MSNSPO01206$MSN LABORATORIES$$$$$$Y$$$20240705$$CN$US$US
239675912$23967591$2$F$20240414$20240802$20240612$20240802$EXP$PT-INFARMED-J202405-917$PT-ASTELLAS-2024EU005684$ASTELLAS$$75$YR$$M$Y$$$20240802$$CN$PT$PT
239675932$23967593$2$F$20240101$20240704$20240612$20240707$EXP$$CA-JNJFOC-20240613877$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240707$$PH$CA$CA
239675942$23967594$2$F$20240412$20240614$20240612$20240711$PER$$US-MYLANLABS-2024M1044911$MYLAN$$64$YR$$F$Y$$$20240711$$CN$US$US
239675993$23967599$3$F$20240510$20240821$20240612$20240827$EXP$FR-AFSSAPS-GR2024000656$FR-009507513-2406FRA002208$MERCK$$69$YR$$F$Y$46$KG$20240827$$PH$FR$FR
239676172$23967617$2$F$20231201$20240701$20240612$20240710$PER$$US-SA-2024SA170679$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240710$$CN$US$US
239676182$23967618$2$F$20240801$20240603$20240612$20240923$PER$$US-SA-2024SA169975$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240923$$MD$US$US
239676322$23967632$2$F$20240529$20240627$20240612$20240709$PER$$US-SA-2024SA171021$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240709$$MD$US$US
239676372$23967637$2$F$20240101$20240722$20240612$20240731$PER$$US-SA-2024SA169161$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240731$$MD$US$US
239676382$23967638$2$F$$20240627$20240612$20240708$PER$$US-SA-2024SA173283$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240708$$MD$US$US
239676402$23967640$2$F$$20240830$20240612$20240924$PER$$US-SA-2024SA171991$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$MD$US$US
239676472$23967647$2$F$$20240911$20240612$20240912$EXP$$GB-JNJFOC-20240627090$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$MD$GB$GB
239676492$23967649$2$F$20240101$20240701$20240612$20240709$PER$$US-SA-2024SA171460$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240709$$CN$US$US
239676542$23967654$2$F$20240101$20240814$20240612$20240828$PER$$US-SA-2024SA171102$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240828$$MD$US$US
239676572$23967657$2$F$$20240819$20240612$20240830$PER$$US-SA-2024SA142877$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240830$$MD$US$US
239676633$23967663$3$F$20240101$20240903$20240612$20240918$PER$$US-SA-2024SA169379$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240918$$MD$US$US
239676642$23967664$2$F$$20240906$20240612$20240916$PER$$US-SA-2024SA170254$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240916$$MD$US$US
239676652$23967665$2$F$20240101$20240806$20240612$20240816$PER$$US-SA-2024SA172006$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240816$$MD$US$US
239676662$23967666$2$F$20240101$20240718$20240612$20240729$PER$$US-SA-2024SA173361$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240729$$CN$US$US
239676792$23967679$2$F$$20240621$20240612$20240705$PER$$US-SA-2024SA173182$SANOFI AVENTIS$$76$YR$E$F$Y$56.1$KG$20240705$$MD$US$US
239676812$23967681$2$F$20240101$20240806$20240612$20240814$PER$$US-SA-2024SA169457$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240814$$MD$US$US
239677053$23967705$3$F$20240101$20240719$20240612$20240730$PER$$US-SA-2024SA164582$SANOFI AVENTIS$$5$YR$C$F$Y$19.68$KG$20240730$$MD$US$US
239677142$23967714$2$F$20240602$20240621$20240612$20240702$PER$$US-SA-2024SA169005$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240702$$MD$US$US
239677252$23967725$2$F$$20240829$20240612$20240910$PER$$US-SA-2024SA169756$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240910$$MD$US$US
239677332$23967733$2$F$20240101$20240707$20240612$20240715$PER$$US-SA-2024SA173315$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240715$$MD$US$US
239677412$23967741$2$F$20190701$20240722$20240612$20240725$EXP$$IT-MYLANLABS-2024M1053141$MYLAN$$61$YR$$M$Y$$$20240725$$MD$IT$IT
239677422$23967742$2$F$20220101$20240822$20240612$20240826$EXP$$GB-MYLANLABS-2024M1043287$MYLAN$$$$$M$Y$178$KG$20240826$$MD$GB$GB
239677432$23967743$2$F$$20240702$20240612$20240705$EXP$$US-ABBVIE-5797299$ABBVIE$$$$$M$Y$$$20240705$$MD$US$US
239677462$23967746$2$F$20240409$20240725$20240612$20240805$PER$$US-SA-2024SA174593$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240804$$MD$US$US
239677523$23967752$3$F$20240101$20240701$20240612$20240708$PER$$US-SA-2024SA172819$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240708$$MD$US$US
239677532$23967753$2$F$20230101$20240719$20240612$20240801$PER$$US-SA-2024SA174783$SANOFI AVENTIS$$41$YR$A$M$Y$73$KG$20240801$$MD$US$US
239677882$23967788$2$F$20240101$20240813$20240612$20240828$PER$$US-SA-2024SA174671$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240828$$MD$US$US
239677982$23967798$2$F$20230101$20240627$20240612$20240708$PER$$US-SA-2024SA175012$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240708$$CN$US$US
239678072$23967807$2$F$$20240726$20240612$20240802$EXP$$JP-AMGEN-JPNSP2024113214$AMGEN$$$$$$Y$$$20240802$$HP$JP$JP
239678103$23967810$3$F$$20240806$20240612$20240808$EXP$$US-PFIZER INC-PV202400076602$PFIZER$$64$YR$$F$Y$$$20240808$$HP$US$US
239678142$23967814$2$F$20240607$20240710$20240612$20240711$PER$$US-PFIZER INC-202400190034$PFIZER$$73$YR$$F$Y$58.97$KG$20240711$$CN$US$US
239678252$23967825$2$F$20240101$20240621$20240612$20240701$PER$$US-SA-2024SA175091$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240701$$CN$US$US
239678345$23967834$5$F$$20240920$20240612$20240924$30DAY$$US-PFIZER INC-202400181013$PFIZER$$12$YR$$F$Y$$$20240924$$MD$US$US
239678782$23967878$2$F$20240603$20240606$20240612$20240702$PER$$US-SA-2024SA173351$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240702$$MD$US$US
239679512$23967951$2$F$20240524$20240820$20240612$20240827$EXP$AU-MMM-WPGAFH3K$AU-GSK-AU2024070296$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$HP$AU$AU
239679522$23967952$2$F$20190801$20240708$20240612$20240711$EXP$$AR-GSK-AR2024AMR071026$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$AR$AR
239679722$23967972$2$F$20240101$20240619$20240612$20240701$EXP$$US-RIGEL PHARMACEUTICALS, INC.-2024FOS000580$RIGEL PHARMACEUTICALS$$$$$$Y$$$20240701$$CN$US$US
239679743$23967974$3$F$20240501$20240911$20240612$20240920$EXP$$US-RIGEL PHARMACEUTICALS, INC.-2024FOS000662$RIGEL PHARMACEUTICALS$$78$YR$$F$Y$54$KG$20240920$$HP$US$US
239679803$23967980$3$F$20240101$20240731$20240612$20240814$EXP$$DE-UCBSA-2024029165$UCB$$$$$M$Y$90$KG$20240814$$MD$DE$DE
239679852$23967985$2$F$20240606$20240626$20240612$20240703$EXP$$NVSC2024AR122575$NOVARTIS$$5$YR$$F$Y$$$20240703$$MD$AR$AR
239679902$23967990$2$F$20220317$20240816$20240612$20240819$EXP$$NVSC2022US075079$NOVARTIS$$15$YR$$F$Y$56.6$KG$20240819$$MD$US$US
239679912$23967991$2$F$$20240917$20240612$20240920$EXP$$US-TAKEDA-2024TUS058719$TAKEDA$$$$$F$Y$76$KG$20240920$$HP$US$US
239680282$23968028$2$F$20230505$20240703$20240612$20240708$EXP$$CA-TAKEDA-2023TUS041412$TAKEDA$$60$YR$$F$Y$$$20240708$$CN$CA$CA
239680312$23968031$2$F$20240501$20240617$20240612$20240702$PER$$US-AstraZeneca-2024A127128$ASTRAZENECA$$27668$DY$$F$Y$$$20240702$$CN$US$
239681462$23968146$2$F$$20240815$20240612$20240820$EXP$$GB-JNJFOC-20240621821$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240821$$CN$GB$GB
239681683$23968168$3$F$20240715$20240807$20240612$20240820$PER$$US-Calliditas-2024CAL00915$CALLIDITAS THERAPEUTICS$$73$YR$E$M$Y$$$20240820$$CN$US$US
239681832$23968183$2$F$$20240716$20240612$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094539$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$72.12$KG$20240718$$CN$US$US
239682222$23968222$2$F$20240101$20240813$20240612$20240827$PER$$US-SA-2024SA170061$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240827$$MD$US$US
239682243$23968224$3$F$20240101$20240806$20240612$20240821$PER$$US-SA-2024SA168858$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240821$$MD$US$US
239682342$23968234$2$F$20240101$20240731$20240612$20240809$PER$$US-SA-2024SA170373$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240809$$MD$US$US
239682962$23968296$2$F$$20240723$20240612$20240723$PER$$US-ALXN-202406USA000385US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239683242$23968324$2$F$20240610$20240722$20240612$20240723$PER$$US-JNJFOC-20240627223$JOHNSON AND JOHNSON$$42$YR$A$$Y$$$20240723$$PH$US$US
239683254$23968325$4$F$20240307$20240906$20240612$20240912$EXP$$AR-SA-2024SA128255$SANOFI AVENTIS$$59$YR$A$F$Y$67$KG$20240912$$HP$AR$AR
239683302$23968330$2$F$$20240904$20240612$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094740$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240905$$CN$US$US
239683383$23968338$3$F$20240201$20240715$20240612$20240801$EXP$$ES-SA-2024SA172305$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240719$$MD$ES$ES
239683472$23968347$2$F$$20240701$20240612$20240702$PER$$US-HALEON-2181368$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
239683482$23968348$2$F$20220706$20240823$20240612$20240924$EXP$$FR-SA-2022SA334744$SANOFI AVENTIS$$75$YR$E$M$Y$80$KG$20240924$$HP$FR$FR
239683582$23968358$2$F$20240516$20240619$20240612$20240702$EXP$$JP-ARGENX-2024-ARGX-JP004121AA$ARGENX BVBA$$$$$$Y$$$20240702$$HP$JP$JP
239683774$23968377$4$F$$20240830$20240612$20240912$30DAY$$JO-PFIZER INC-202400172099$PFIZER$$$$$$Y$$$20240912$$CN$JO$JO
239683785$23968378$5$F$$20240924$20240612$20240927$EXP$$CA-PFIZER INC-202400190972$PFIZER$$63$YR$$F$Y$$$20240927$$MD$CA$CA
239683823$23968382$3$F$$20240909$20240612$20240911$30DAY$$CO-PFIZER INC-202400173952$PFIZER$$$$$$Y$$$20240911$$CN$CO$CO
239683835$23968383$5$F$20240607$20240829$20240612$20240903$30DAY$$GR-PFIZER INC-202400189760$PFIZER$$11$YR$$M$Y$41$KG$20240903$$CN$GR$GR
239683863$23968386$3$F$$20240718$20240612$20240718$30DAY$$JO-PFIZER INC-202400182451$PFIZER$$$$$$Y$$$20240718$$CN$JO$JO
239684072$23968407$2$F$20240101$20240625$20240612$20240702$EXP$$EE-009507513-2406EST002471$MERCK$$57$YR$$F$Y$$$20240702$$MD$EE$EE
239684122$23968412$2$F$20240516$20240802$20240612$20240806$EXP$$ES-VANTIVE-2024VAN017485$Vantive US Healthcare$$70$YR$$M$Y$$$20240806$$MD$ES$ES
239684172$23968417$2$F$$20240530$20240612$20240710$PER$$US-GILEAD-2024-0675937$GILEAD$$$$$$Y$$$20240710$$CN$US$US
239684202$23968420$2$F$20240321$20240620$20240612$20240703$EXP$ES-AEMPS-1527366$ES-TEVA-VS-3207288$TEVA$$$$E$M$Y$$$20240703$$HP$ES$ES
239684212$23968421$2$F$$20240918$20240612$20240923$PER$$US-PFIZER INC-PV202400076522$PFIZER$$84$YR$$F$Y$$$20240923$$MD$US$US
239684235$23968423$5$F$$20240920$20240612$20240925$EXP$$US-PFIZER INC-PV202400075600$PFIZER$$81$YR$$F$Y$$$20240925$$HP$US$US
239684312$23968431$2$F$$20240809$20240612$20240809$PER$$US-PFIZER INC-PV202400075465$PFIZER$$47$YR$$M$Y$$$20240809$$MD$US$US
239684332$23968433$2$F$$20240703$20240612$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094996$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240704$$CN$US$US
239684373$23968437$3$F$$20240827$20240612$20240829$30DAY$$US-PFIZER INC-202400187161$PFIZER$$8$YR$$M$Y$$$20240829$$CN$US$US
239684403$23968440$3$F$20240101$20240826$20240612$20240830$EXP$$US-PFIZER INC-PV202400075757$PFIZER$$41$YR$$M$Y$$$20240830$$CN$US$US
239684492$23968449$2$F$20240605$20240701$20240612$20240709$PER$$US-SA-2024SA172511$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240709$$CN$US$US
239684542$23968454$2$F$$20240820$20240612$20240823$PER$$US-JNJFOC-20240620813$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240823$$CN$US$US
239684552$23968455$2$F$20240420$20240629$20240612$20240701$PER$$US-JNJFOC-20240588916$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240701$$CN$US$US
239684562$23968456$2$F$20240530$20240910$20240612$20240912$EXP$$US-JNJFOC-20240612078$JOHNSON AND JOHNSON$$69$YR$E$F$Y$82.764$KG$20240912$$HP$US$US
239684652$23968465$2$F$$20240917$20240612$20240924$EXP$$JP-009507513-2406JPN000758J$MERCK$$$$$F$Y$$$20240924$$MD$JP$JP
239684723$23968472$3$F$20240101$20240830$20240612$20240911$PER$$US-SA-2024SA168955$SANOFI AVENTIS$$16$YR$T$F$Y$65.3$KG$20240911$$MD$US$US
239684792$23968479$2$F$$20240603$20240612$20240720$EXP$$US-JNJFOC-20240603474$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$CN$US$US
239684822$23968482$2$F$20240129$20240812$20240612$20240822$EXP$$US-TEVA-VS-3164459$TEVA$$67$YR$$F$Y$84$KG$20240822$$MD$US$US
239684835$23968483$5$F$$20240903$20240612$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094286$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240913$$CN$US$US
239684842$23968484$2$F$$20240703$20240612$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087223$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240705$$CN$US$US
239684883$23968488$3$F$20231005$20240626$20240612$20240704$EXP$$CO-UCBSA-2024029727$UCB$$71$YR$$M$Y$59$KG$20240704$$CN$CO$CO
239684902$23968490$2$F$20240415$20240913$20240612$20240918$EXP$$US-ABBVIE-5792102$ABBVIE$$83$YR$$M$Y$$$20240918$$CN$US$US
239684942$23968494$2$F$20240524$20240812$20240612$20240819$EXP$PT-INFARMED-F202405-946$PT-PFIZER INC-202400192017$PFIZER$$58$YR$$F$Y$$$20240819$$PH$PT$PT
239684982$23968498$2$F$20230627$20240803$20240612$20240805$EXP$$CA-PFIZER INC-202400189717$PFIZER$$56$YR$$F$Y$$$20240805$$MD$CA$CA
239685143$23968514$3$F$$20240821$20240612$20240822$30DAY$$CO-PFIZER INC-PV202400075162$PFIZER$$8$YR$$M$Y$$$20240822$$CN$CO$CO
239685172$23968517$2$F$$20240628$20240612$20240708$EXP$$US-TEVA-VS-3207079$TEVA$Sinha S, Chiwane S, Kaulas H, Keup C, Hayajneh W, Guzman M, et al. FULMINANT AND FATAL SEPTIC CAVERNOUS SINUS THROMBOSIS IN BACTERIAL AND VIRAL COINFECTION. Crit-Care-Med 2024; 52 (Suppl.) (1): S383.; Sinha S, Chiwane S, Kaulas H, Keup C, Hayajneh W, Guzman M, et al. FULMINANT AND FATAL SEPTIC CAVERNOUS SINUS THROMBOSIS IN BACTERIAL AND VIRAL COINFECTION. Crit-Care-Med 2024; 52 (Suppl.) (1): S383.$19$MON$$F$Y$$$20240708$$HP$US$US
239685182$23968518$2$F$20240701$20240718$20240612$20240731$PER$$US-SA-2024SA170863$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240731$$MD$US$US
239685235$23968523$5$F$$20240710$20240612$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093895$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240715$$CN$US$US
239685413$23968541$3$F$20240101$20240820$20240612$20240902$PER$$US-SA-2024SA168832$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240902$$MD$US$US
239685472$23968547$2$F$$20240809$20240612$20240813$EXP$$CN-TAKEDA-2024TUS057115$TAKEDA$$$$$M$Y$$$20240813$$CN$CN$CN
239685642$23968564$2$F$$20240628$20240612$20240708$EXP$$US-TEVA-VS-3207200$TEVA$Kovuri M, McLeish D. BEYOND THE NORM: A RARE CASE OF BILATERAL BREAST CALCIPHYLAXIS IN A PATIENT WITH LONG DIALYSIS VINTAGE. Am-J-Kidney-Dis 2024; 83 (Suppl.) (4): S72 abstr. 237.; Kovuri M, McLeish D. BEYOND THE NORM: A RARE CASE OF BILATERAL BREAST CALCIPHYLAXIS IN A PATIENT WITH LONG DIALYSIS VINTAGE. Am-J-Kidney-Dis 2024; 83 (Suppl.) (4): S72 abstr. 237.$62$YR$$F$Y$$$20240708$$HP$US$US
239685742$23968574$2$F$$20240716$20240612$20240729$PER$$US-Calliditas-2024CAL00922$CALLIDITAS THERAPEUTICS$$20$YR$A$F$Y$$$20240729$$CN$US$US
239685792$23968579$2$F$$20240709$20240612$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093596$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240715$$CN$US$US
239685832$23968583$2$F$20240301$20240829$20240612$20240905$EXP$$BR-AMERICAN REGENT INC-2024002181$AMERICAN REGENT$$45$YR$$F$Y$67$KG$20240905$$CN$BR$BR
239685852$23968585$2$F$$20240814$20240612$20240821$EXP$$JP-009507513-2406JPN000779J$MERCK$$$$$F$Y$$$20240821$$MD$JP$JP
239685885$23968588$5$F$20240503$20240823$20240612$20240830$PER$$NVSC2024US123264$NOVARTIS$$61$YR$$F$Y$$$20240830$$CN$US$US
239685902$23968590$2$F$20240501$20240709$20240612$20240718$PER$$US-SA-2024SA169873$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240718$$MD$US$US
239685912$23968591$2$F$$20240807$20240612$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094743$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$57.61$KG$20240812$$CN$US$US
239686022$23968602$2$F$$20240716$20240612$20240809$PER$$US-009507513-2406USA001888$MERCK$$8$DEC$$F$Y$$$20240809$$MD$US$US
239686082$23968608$2$F$20231001$20240710$20240612$20240715$EXP$$US-SA-2024SA174808$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240715$$MD$US$US
239686122$23968612$2$F$$20240705$20240612$20240711$EXP$$CA-PFIZER INC-202400190559$PFIZER$$87$YR$$M$Y$$$20240711$$HP$CA$CA
239686173$23968617$3$F$20240301$20240826$20240612$20240830$EXP$$US-ABBVIE-5690715$ABBVIE$$74$YR$$F$Y$91$KG$20240830$$CN$US$US
239686193$23968619$3$F$20240531$20240822$20240612$20240827$EXP$$CA-LUNDBECK-DKLU4000224$LUNDBECK$$$$$$Y$$$20240827$$HP$CA$CA
239686222$23968622$2$F$20240605$20240709$20240612$20240715$30DAY$$US-MYLANLABS-2024M1052303$MYLAN$$71$YR$$M$Y$$$20240715$$CN$US$US
239686232$23968623$2$F$20240605$20240711$20240612$20240717$30DAY$$US-MYLANLABS-2024M1052431$MYLAN$$48$YR$$M$Y$$$20240717$$CN$US$US
239686433$23968643$3$F$$20240715$20240612$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA056566$SANDOZ$$65$YR$$F$Y$34$KG$20240722$$MD$CA$CA
239686453$23968645$3$F$20240101$20240816$20240612$20240823$EXP$$US-BIOGEN-2024BI01268643$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
239686543$23968654$3$F$$20240711$20240612$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094897$BRISTOL MYERS SQUIBB$$98$YR$E$M$Y$$$20240716$$CN$US$US
239686642$23968664$2$F$20240401$20240904$20240612$20240913$EXP$FR-AFSSAPS-NT2024000602$FR-TEVA-VS-3207796$TEVA$$63$YR$$F$Y$$$20240913$$MD$FR$FR
239686742$23968674$2$F$20240515$20240702$20240612$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094872$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240704$$CN$US$US
239686752$23968675$2$F$$20240807$20240612$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093684$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240808$$HP$US$US
239686932$23968693$2$F$$20240823$20240612$20240823$PER$$NVSC2024US123340$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
239686943$23968694$3$F$20240601$20240917$20240612$20240919$30DAY$$AR-PFIZER INC-202400190370$PFIZER$$13$YR$$M$Y$$$20240919$$HP$AR$AR
239686972$23968697$2$F$$20240722$20240612$20240722$EXP$$US-ALXN-202406USA000087US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
239686982$23968698$2$F$20240101$20240731$20240612$20240809$EXP$FR-AFSSAPS-TS2024000618$FR-TEVA-VS-3207816$TEVA$$70$YR$$F$Y$45$KG$20240809$$MD$FR$FR
239687062$23968706$2$F$$20240910$20240612$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094883$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240910$$CN$US$US
239687102$23968710$2$F$20240606$20240627$20240612$20240702$EXP$$US-BIOMARINAP-US-2024-158513$BIOMARIN$$$$$$Y$$$20240702$$CN$US$US
239687144$23968714$4$F$$20240820$20240612$20240904$PER$$US-SA-2024SA169715$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240904$$MD$US$US
239687182$23968718$2$F$20240101$20240625$20240612$20240704$PER$$US-SA-2024SA169749$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240704$$CN$US$US
239687192$23968719$2$F$$20240709$20240612$20240719$EXP$$FR-TEVA-VS-3207403$TEVA$Hamimed C, Lahousse H, Defebvre L, Labeyrie C, Bruge C, Tard C. How should we diagnose CNS involvement of transthyretin amyloidosis?. Rev-Neurol-Paris 2023; 179 (4): 373-375.; Hamimed C, Lahousse H, Defebvre L, Labeyrie C, Bruge C, Tard C. How should we diagnose CNS involvement of transthyretin amyloidosis?. Rev-Neurol-Paris 2023; 179 (4): 373-375.$56$YR$$F$Y$$$20240719$$HP$FR$FR
239687243$23968724$3$F$20240515$20240807$20240612$20240821$PER$$US-Calliditas-2024CAL00924$CALLIDITAS THERAPEUTICS$$64$YR$A$M$Y$112.2$KG$20240821$$CN$US$US
239687262$23968726$2$F$$20240725$20240612$20240726$PER$$NVSC2024US123181$NOVARTIS$$$$$M$Y$$$20240726$$CN$US$US
239687432$23968743$2$F$20240519$20240724$20240612$20240802$30DAY$$US-GSK-US2024068936$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240802$$CN$US$US
239687773$23968777$3$F$20240529$20240702$20240612$20240709$PER$$CN-Eisai-EC-2024-167784$EISAI$$46$YR$A$M$Y$55.5$KG$20240709$$MD$CN$CN
239687825$23968782$5$F$20240414$20240814$20240612$20240827$PER$$US-Calliditas-2024CAL00934$CALLIDITAS THERAPEUTICS$$42$YR$A$M$Y$104.3$KG$20240827$$CN$US$US
239687892$23968789$2$F$$20240611$20240612$20240709$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00555$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
239688032$23968803$2$F$$20240816$20240612$20240819$PER$$NVSC2024US123287$NOVARTIS$$$$$M$Y$$$20240820$$MD$US$US
239688052$23968805$2$F$20240403$20240912$20240612$20240919$PER$$JP-Eisai-EC-2024-167491$EISAI$$64$YR$A$F$Y$45.6$KG$20240919$$PH$JP$JP
239688102$23968810$2$F$20190101$20240910$20240612$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094694$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240910$$CN$US$US
239688122$23968812$2$F$20240602$20240729$20240612$20240806$EXP$$US-AstraZeneca-2024A130812$ASTRAZENECA$$28181$DY$$M$Y$$$20240806$$CN$US$
239688234$23968823$4$F$20240524$20240910$20240612$20240925$EXP$$US-PARI RESPIRATORY EQUIPMENT, INC.-2024PAR00047$PARI RESPIRATORY EQUIPMENT$$22$YR$$F$Y$90.794$KG$20240925$$PH$US$US
239688252$23968825$2$F$$20240710$20240612$20240715$EXP$$US-BIOGEN-2024BI01268710$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
239688262$23968826$2$F$$20240625$20240612$20240701$EXP$$DE-MYLANLABS-2022M1030066$MYLAN$Bonnet U, Kanti AK, Scherbaum N, Specka M.. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study.. Journal of Psychoactive Drugs. 2023;55 (1):102-111$34$YR$$F$Y$$$20240701$$HP$DE$DE
239688272$23968827$2$F$$20240603$20240612$20240730$PER$$US-LUNDBECK-DKLU3078030$LUNDBECK$$$$$$Y$$$20240730$$CN$US$US
239688282$23968828$2$F$$20240705$20240612$20240715$EXP$$US-TEVA-VS-3206959$TEVA$Literature Reference: Shah S, Weaver CT, Agarwal G. Acute Kidney Injury with Use of Inhaled Tobramycin. J-Am-Soc-Nephrol 2016; 27 1004A abstr. PUB432.; Shah S, Weaver CT, Agarwal G. Acute Kidney Injury with Use of Inhaled Tobramycin. J-Am-Soc-Nephrol 2016; 27 1004A abstr. PUB432.$57$YR$$F$Y$$$20240715$$HP$US$US
239688402$23968840$2$F$$20240705$20240612$20240715$EXP$$US-TEVA-VS-3207037$TEVA$Thamcharoen N, Rajapakse RP, Rosen RM, D^Agati VD. Steroid May Be an Effective Treatment for Warfarin Related Nephropathy. J-Am-Soc-Nephrol 2016; 27 991A.; Thamcharoen N, Rajapakse RP, Rosen RM, D^Agati VD. Steroid May Be an Effective Treatment for Warfarin Related Nephropathy. J-Am-Soc-Nephrol 2016; 27 991A.$83$YR$$M$Y$$$20240715$$HP$US$US
239688442$23968844$2$F$$20240705$20240612$20240715$EXP$$US-TEVA-VS-3207041$TEVA$Kunjal RA, Hasan A, Baher AAA, Harris C, Poenariu A. Morton Lite Salt Induced Hyperkalemia. J-Am-Soc-Nephrol 2016; 27 (11):.; Kunjal RA, Hasan A, Baher AAA, Harris C, Poenariu A. Morton Lite Salt Induced Hyperkalemia. J-Am-Soc-Nephrol 2016; 27 (11):.$61$YR$$M$Y$$$20240715$$HP$US$US
239688472$23968847$2$F$$20240705$20240612$20240715$EXP$$US-TEVA-VS-3207006$TEVA$Le P, Monika F, Kovar J. A Case of Recurrent Gastrointestinal Stromal Tumor with Chondroid Differentiation. Am-J-Clin-Pathol 2023; 160 (Suppl. 1) S37-S38.; Le P, Monika F, Kovar J. A Case of Recurrent Gastrointestinal Stromal Tumor with Chondroid Differentiation. Am-J-Clin-Pathol 2023; 160 (Suppl. 1) S37-S38.$58$YR$$F$Y$$$20240715$$HP$US$US
239688623$23968862$3$F$20240101$20240913$20240612$20240920$EXP$$JP-009507513-2406JPN000804J$MERCK$$6$DEC$$F$Y$$$20240920$$MD$JP$JP
239688712$23968871$2$F$20220101$20240916$20240612$20240918$EXP$$CA-PFIZER INC-202400189339$PFIZER$$65$YR$$M$Y$$$20240918$$HP$CA$CA
239688722$23968872$2$F$20231121$20240813$20240612$20240816$EXP$$FR-BIOGEN-2024BI01268714$BIOGEN$$$$$$Y$$$20240816$$MD$FR$FR
2396888510$23968885$10$F$20230101$20240914$20240612$20240924$EXP$$CO-PFIZER INC-2023SGN05565$PFIZER$$35$YR$$M$Y$98$KG$20240924$$CN$CO$CO
239689032$23968903$2$F$$20240918$20240612$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US056817$SANDOZ$$$$$M$Y$$$20240923$$CN$US$US
239689107$23968910$7$F$20240602$20240916$20240612$20240918$30DAY$$CO-PFIZER INC-202400188480$PFIZER$$9$YR$$F$Y$$$20240918$$CN$CO$CO
239689122$23968912$2$F$$20240829$20240612$20240904$EXP$$JP-Eisai-EC-2024-167737$EISAI$$$$$$Y$$$20240904$$MD$JP$JP
239689162$23968916$2$F$$20240809$20240612$20240812$PER$$NVSC2024US123399$NOVARTIS$$$$$$Y$$$20240812$$HP$US$US
239689202$23968920$2$F$20240101$20240820$20240612$20240903$PER$$US-SA-2024SA173318$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240903$$MD$US$US
239689284$23968928$4$F$20240101$20240911$20240612$20240917$PER$$US-BIOGEN-2024BI01262600$BIOGEN$$$$$F$Y$51.302$KG$20240917$$CN$US$US
239689422$23968942$2$F$20240520$20240702$20240612$20240711$PER$$US-BIOGEN-2024BI01268075$BIOGEN$$25$YR$$F$Y$$$20240711$$MD$US$US
239689532$23968953$2$F$20190515$20240730$20240612$20240807$PER$$US-BIOGEN-2019BI00739483$BIOGEN$$67$YR$$F$Y$$$20240807$$CN$US$US
239689553$23968955$3$F$20240404$20240606$20240612$20240711$EXP$$CH-APELLIS-2024-APL-0000245$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$MD$CH$CH
239689762$23968976$2$F$$20240711$20240612$20240724$PER$$US-Calliditas-2024CAL00933$CALLIDITAS THERAPEUTICS$$43$YR$A$F$Y$67$KG$20240724$$CN$US$US
239689783$23968978$3$F$$20240924$20240612$20240924$PER$$NVSC2024US123356$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
239689822$23968982$2$F$$20240903$20240612$20240911$EXP$$JP-Eisai-EC-2023-133231$EISAI$$77$YR$E$M$Y$$$20240911$$MD$JP$JP
239689852$23968985$2$F$20240512$20240712$20240612$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202406003629$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240719$$CN$US$US
239689893$23968989$3$F$20240602$20240707$20240612$20240709$PER$$US-GILEAD-2024-0677007$GILEAD$$$$$F$Y$$$20240709$$CN$US$US
239689902$23968990$2$F$$20240809$20240612$20240812$EXP$$NVSC2024US122139$NOVARTIS$$$$$M$Y$$$20240812$$CN$US$US
239691033$23969103$3$F$20240523$20240912$20240612$20240919$EXP$$US-GSK-US2024070576$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$US$US
239691052$23969105$2$F$$20240724$20240612$20240731$30DAY$$US-GSK-US2024070109$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$CN$US$US
239691083$23969108$3$F$$20240716$20240612$20240724$EXP$$US-AstraZeneca-2024A130129$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
239691144$23969114$4$F$20240101$20240729$20240612$20240731$PER$$US-KARYOPHARM-2024KPT001133$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240731$$CN$US$US
239691162$23969116$2$F$20240101$20240720$20240612$20240913$PER$$US-KARYOPHARM-2024KPT001139$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240913$$CN$US$US
239691202$23969120$2$F$20240501$20240627$20240612$20240703$EXP$$JP-Eisai-EC-2024-167352$EISAI$$$$E$F$Y$$$20240703$$MD$JP$JP
239691443$23969144$3$F$$20240805$20240612$20240812$PER$$US-ALXN-202406USA000236US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
239691455$23969145$5$F$20240509$20240703$20240612$20240718$PER$$US-APELLIS-2024-APL-0000120$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240718$$CN$US$US
239691484$23969148$4$F$20240401$20240912$20240612$20240920$EXP$$US-Calliditas-2024CAL00941$CALLIDITAS THERAPEUTICS$$77$YR$E$M$Y$78$KG$20240920$$CN$US$US
239691522$23969152$2$F$$20240822$20240612$20240823$EXP$$US-KYOWAKIRIN-2024KK014185$KYOWA$$$$$$Y$$$20240823$$HP$US$US
239691585$23969158$5$F$20240601$20240812$20240612$20240823$PER$$US-PFIZER INC-PV202400076853$PFIZER$$49$YR$$F$Y$$$20240823$$CN$US$US
239691652$23969165$2$F$20240526$20240610$20240612$20240827$PER$$US-AstraZeneca-2024A135670$ASTRAZENECA$$21282$DY$$F$Y$$$20240827$$CN$US$
239691766$23969176$6$F$$20240820$20240612$20240826$EXP$$US-OTSUKA-2023_029080$OTSUKA$$$$$F$Y$70.31$KG$20240826$$CN$US$US
239691792$23969179$2$F$20240527$20240909$20240612$20240918$EXP$$NVSC2024MA113397$NOVARTIS$$$$A$F$Y$$$20240919$$PH$MA$MA
239691804$23969180$4$F$20240713$20240911$20240612$20240913$EXP$$US-ALXN-202406USA000198US$ALEXION PHARMACEUTICALS$$83$YR$$M$Y$$$20240913$$CN$US$US
239691832$23969183$2$F$$20240715$20240612$20240723$EXP$$BR-AstraZeneca-2024A136021$ASTRAZENECA$$$$$$Y$$$20240723$$MD$BR$
239691972$23969197$2$F$20240523$20240909$20240612$20240927$PER$$CA-TOLMAR, INC.-24CA049671$TOLMAR$$83$YR$$M$Y$$$20240927$$CN$CA$CA
239691983$23969198$3$F$20240615$20240801$20240612$20240826$PER$$CA-TOLMAR, INC.-24CA049662$TOLMAR$$80$YR$$M$Y$$$20240826$$CN$CA$CA
239692002$23969200$2$F$20240524$20240816$20240612$20240903$PER$$CA-TOLMAR, INC.-24CA049688$TOLMAR$$80$YR$$M$Y$$$20240902$$CN$CA$CA
239692052$23969205$2$F$20240516$20240612$20240612$20240708$PER$$FR-TOLMAR, INC.-24FR049474$TOLMAR$$86$YR$$M$Y$$$20240708$$PH$FR$FR
239692082$23969208$2$F$$20240910$20240612$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094689$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240910$$CN$US$US
239692122$23969212$2$F$$20240708$20240612$20240717$EXP$$BR-BIOMARINAP-BR-2024-158437$BIOMARIN$$$$$$Y$$$20240717$$MD$BR$BR
239692243$23969224$3$F$20240101$20240830$20240612$20240902$PER$$US-AMGEN-HZN-2024-003138$AMGEN$$62$YR$A$F$Y$$$20240902$$CN$US$US
239692292$23969229$2$F$$20240722$20240612$20240723$EXP$$US-ALXN-202406USA000249US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239692363$23969236$3$F$20240526$20240624$20240612$20240701$EXP$$CA-AstraZeneca-2024A125119$ASTRAZENECA$$21005$DY$$F$Y$$$20240701$$CN$CA$
239692432$23969243$2$F$20240415$20240812$20240612$20240827$EXP$$DK-ASTELLAS-2024US016405$ASTELLAS$$67$YR$E$F$Y$$$20240822$$MD$DK$DK
239692442$23969244$2$F$$20240722$20240612$20240723$PER$$US-ALXN-202406USA000231US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239692452$23969245$2$F$$20240802$20240612$20240902$PER$$US-ASTELLAS-2024US016188$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
239692554$23969255$4$F$$20240816$20240612$20240826$PER$$US-BAUSCHBL-2024BNL028285$BAUSCH AND LOMB$$37$YR$$F$Y$$$20240826$$CN$US$US
239692562$23969256$2$F$$20240809$20240612$20240809$EXP$$NVSC2024US122114$NOVARTIS$$$$$$Y$$$20240809$$PH$US$US
239692582$23969258$2$F$$20240719$20240612$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094707$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240722$$CN$US$US
239692622$23969262$2$F$20230905$20240628$20240612$20240708$EXP$$US-APELLIS-APL-2023-002958$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$US$US
239692762$23969276$2$F$$20240722$20240612$20240723$EXP$$US-ALXN-202406USA000312US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$MD$US$US
239692772$23969277$2$F$$20240722$20240612$20240723$PER$$US-ALXN-202406USA000298US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
239692812$23969281$2$F$20240604$20240722$20240612$20240723$PER$$US-ALXN-202406USA000283US$ALEXION PHARMACEUTICALS$$52$YR$$$Y$$$20240723$$CN$US$US
239692822$23969282$2$F$20240325$20240626$20240612$20240711$PER$$US-APELLIS-APL-2024-004085$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$US$US
239692843$23969284$3$F$20240401$20240906$20240612$20240912$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI05691$NEUROCRINE BIOSCIENCES$$35$YR$$F$Y$$$20240912$$HP$US$US
239692872$23969287$2$F$$20240906$20240612$20240912$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001170$BLUEPRINT MEDICINES$$$$$F$Y$$$20240912$$CN$US$US
239693072$23969307$2$F$$20240822$20240612$20240828$EXP$$JP-SAKK-2024SA173569AA$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240829$$MD$JP$JP
239693123$23969312$3$F$$20240812$20240612$20240813$EXP$$FR-SANDOZ INC.-SDZ2024FR056438$SANDOZ$$70$YR$$M$Y$$$20240813$$HP$FR$FR
239693142$23969314$2$F$$20240701$20240612$20240708$EXP$$NVSJ2024JP006900$NOVARTIS$$71$YR$$M$Y$$$20240708$$PH$JP$JP
239693202$23969320$2$F$20240527$20240725$20240612$20240730$EXP$$US-ABBVIE-5792092$ABBVIE$$47$YR$$F$Y$$$20240730$$CN$US$US
239693212$23969321$2$F$$20240625$20240612$20240701$PER$$US-BAUSCHBL-2024BNL028298$BAUSCH AND LOMB$$$$$F$Y$$$20240701$$CN$US$US
239693262$23969326$2$F$20240404$20240710$20240612$20240722$EXP$$US-NOVOPROD-1234124$NOVO NORDISK$$72$YR$$M$Y$$$20240722$$CN$US$US
239693312$23969331$2$F$20240531$20240808$20240612$20240821$EXP$$US-NOVOPROD-1234254$NOVO NORDISK$$34$YR$$F$Y$$$20240821$$CN$US$US
239693402$23969340$2$F$20240423$20240716$20240612$20240723$EXP$$CA-JNJFOC-20231260370$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240723$$HP$CA$CA
239693422$23969342$2$F$$20240626$20240612$20240702$EXP$$JP-SMPA-2024SMP008535$SUNOVION$$$$$$Y$$$20240702$$CN$JP$JP
239693502$23969350$2$F$20240501$20240722$20240612$20240731$EXP$$JP-NOVOPROD-1234409$NOVO NORDISK$$66$YR$$F$Y$$$20240731$$MD$JP$JP
239693522$23969352$2$F$$20240705$20240612$20240715$EXP$$US-TEVA-VS-3207045$TEVA$Theodorou M, Bond JK, Vellanki K. Succinylcholine Induced Hyperkalemia in Pregnancy: A Unique Clinical Presentation. J-Am-Soc-Nephrol 2016; 27 105A-106A.; Theodorou M, Bond JK, Vellanki K. Succinylcholine Induced Hyperkalemia in Pregnancy: A Unique Clinical Presentation. J-Am-Soc-Nephrol 2016; 27 105A-106A.$38$YR$$F$Y$$$20240715$$HP$US$US
239693542$23969354$2$F$$20240722$20240612$20240729$EXP$$US-SANDOZ INC.-SDZ2024US057123$SANDOZ$$$$$$Y$$$20240729$$CN$US$US
239693552$23969355$2$F$20240329$20240628$20240612$20240701$EXP$GB-MHRA-MED-202406120600400060-ZQTDY$GB-SANDOZ INC.-SDZ2024GB057113$SANDOZ$$23$YR$$F$Y$$$20240701$$CN$GB$GB
239693572$23969357$2$F$20230801$20240620$20240612$20240701$EXP$$BE-ESPERION THERAPEUTICS, INC-2024BEL00866$ESPERION THERAPEUTICS$$69$YR$$F$Y$$$20240701$$MD$BE$BE
239693582$23969358$2$F$$20240709$20240612$20240719$EXP$$US-TEVA-VS-3207410$TEVA$Shabtaie S, Tan NY, MacIntyre C, Killu AM, Deshmukh AJ, Del Carpio Munoz F. PO-05-037 THE PERFECT STORM: ARRHYTHMIC MITRAL VALVE PROLAPSE AND CONCEALED LONG QT SYNDROME TYPE 1 RESULTING IN RECURRENT PVC-INDUCED VENTRICULAR FIBRILLATION. Heart-Rhythm 2024; 21 (Suppl.) (5): S588 abstr. PO-05-037.; Shabtaie S, Tan NY, MacIntyre C, Killu AM, Deshmukh AJ, Del Carpio Munoz F. PO-05-037 THE PERFECT STORM: ARRHYTHMIC MITRAL VALVE PROLAPSE AND CONCEALED LONG QT SYNDROME TYPE 1 RESULTING IN RECURRENT P...$36$YR$$F$Y$$$20240719$$HP$US$US
239693612$23969361$2$F$$20240814$20240612$20240821$EXP$$JP-009507513-2406JPN000782J$MERCK$$$$$F$Y$$$20240821$$MD$JP$JP
239693632$23969363$2$F$$20240625$20240612$20240709$PER$$US-AstraZeneca-2024A133428$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
239693642$23969364$2$F$$20240905$20240612$20240911$EXP$$NVSJ2024JP006799$NOVARTIS$$$$A$F$Y$76$KG$20240911$$MD$JP$JP
239693712$23969371$2$F$$20240705$20240612$20240715$EXP$$US-TEVA-VS-3207002$TEVA$Montalvan E, Pasha MA, Jackson B. Concomitant Primary and Secondary Adrenal Insufficiency due to Immune Checkpoint Inhibitor Therapy. South-Med-J 2022; 115 548-549.; Montalvan E, Pasha MA, Jackson B. Concomitant Primary and Secondary Adrenal Insufficiency due to Immune Checkpoint Inhibitor Therapy. South-Med-J 2022; 115 548-549.$68$YR$$F$Y$$$20240715$$HP$US$US
239693922$23969392$2$F$$20240628$20240612$20240708$EXP$$US-TEVA-VS-3207219$TEVA$Peev V. Rapamycin Induced Minimal Change Disease in a Renal Transplant Recipient: A Case Report. J-Am-Soc-Nephrol 2016; 27 1085A.; Peev V. Rapamycin Induced Minimal Change Disease in a Renal Transplant Recipient: A Case Report. J-Am-Soc-Nephrol 2016; 27 1085A.$42$YR$$M$Y$$$20240708$$HP$US$US
239693953$23969395$3$F$20240605$20240709$20240612$20240719$30DAY$$US-JNJFOC-20240612415$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240719$$PH$US$US
239693984$23969398$4$F$20240101$20240705$20240612$20240711$EXP$$PT-ABBVIE-5790071$ABBVIE$$88$YR$$F$Y$$$20240711$$MD$PT$PT
239694002$23969400$2$F$20240603$20240819$20240612$20240820$EXP$$JP-TAKEDA-2024TJP008592$TAKEDA$$8$DEC$$M$Y$$$20240820$$MD$JP$JP
239694012$23969401$2$F$$20240711$20240612$20240712$PER$$US-JNJFOC-20240590010$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$HP$US$US
239694032$23969403$2$F$$20240823$20240612$20240825$PER$$NVSC2024US123466$NOVARTIS$$15$MON$$M$Y$$$20240826$$MD$US$US
239694053$23969405$3$F$20230101$20240903$20240612$20240903$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-017181$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240903$$CN$JP$JP
239694064$23969406$4$F$$20240717$20240612$20240725$30DAY$$IL-JNJFOC-20240567328$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$CN$IL$IL
239694142$23969414$2$F$20240610$20240702$20240612$20240704$EXP$$JP-JNJFOC-20240632182$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240704$$MD$JP$JP
239694173$23969417$3$F$20240101$20240912$20240612$20240918$EXP$$US-ABBVIE-5794058$ABBVIE$$$$$F$Y$83$KG$20240918$$CN$US$US
239694272$23969427$2$F$20240603$20240705$20240612$20240725$EXP$$CA-BIOGEN-2024BI01268937$BIOGEN$$56$YR$$F$Y$$$20240725$$CN$CA$CA
239694332$23969433$2$F$20230101$20240924$20240612$20240930$EXP$$US-BIOGEN-2024BI01268711$BIOGEN$$$$$M$Y$$$20240930$$MD$US$US
239694432$23969443$2$F$$20240724$20240612$20240731$PER$$NVSC2024US123299$NOVARTIS$$$$$$Y$$$20240731$$CN$US$US
239694462$23969446$2$F$20230908$20240625$20240612$20240701$EXP$$US-ABBVIE-5794113$ABBVIE$$78$YR$$F$Y$65.317$KG$20240701$$CN$US$US
239694493$23969449$3$F$$20240703$20240612$20240708$EXP$$CA-ABBVIE-5795086$ABBVIE$$$$A$F$Y$$$20240708$$CN$CA$CA
239694552$23969455$2$F$20240604$20240712$20240612$20240716$EXP$$US-ABBVIE-5798844$ABBVIE$$74$YR$$F$Y$$$20240716$$HP$US$US
239694612$23969461$2$F$$20240724$20240612$20240802$EXP$$JP-009507513-2405JPN002544J$MERCK$Nishizawa K, Matsusita T, Nakagawa N, Goto S, Fukuzawa S. PP-30-07 Treatment outcomes of advanced urothelial carcinoma at Shimada General Medical Center. The 111th Annual Meeting of the Japanese Urological Association. 951$72$YR$$M$Y$$$20240802$$MD$JP$JP
239694632$23969463$2$F$20240605$20240712$20240612$20240717$EXP$$US-AMGEN-USASP2024113132$AMGEN$$56$YR$A$M$Y$$$20240716$$MD$US$US
239694672$23969467$2$F$20180501$20240819$20240612$20240826$EXP$$FR-ABBVIE-5795494$ABBVIE$$45$YR$$F$Y$$$20240826$$MD$FR$FR
239694732$23969473$2$F$20240602$20240807$20240612$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094678$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240809$$CN$US$US
239694772$23969477$2$F$$20240708$20240612$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA056974$SANDOZ$$74$YR$$M$Y$$$20240709$$MD$CA$CA
239694785$23969478$5$F$20240101$20240919$20240612$20240928$EXP$$CA-CELLTRION INC.-2024CA011620$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
239694872$23969487$2$F$20240101$20240705$20240612$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094437$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$83.46$KG$20240708$$CN$US$US
239694923$23969492$3$F$$20240803$20240612$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002480$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
239694943$23969494$3$F$$20240830$20240612$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094617$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$71.21$KG$20240906$$CN$US$US
239695002$23969500$2$F$$20240722$20240612$20240723$PER$$US-ALXN-202406USA000338US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239695012$23969501$2$F$$20240722$20240612$20240723$PER$$US-ALXN-202406USA000343US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
239695032$23969503$2$F$20240605$20240812$20240612$20240820$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406007783$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$DE$CN
239695122$23969512$2$F$$20240722$20240612$20240802$EXP$$IL-ELI_LILLY_AND_COMPANY-IL202406002497$ELI LILLY AND CO$$$$$M$Y$$$20240802$$CN$IL$IL
239695162$23969516$2$F$$20240731$20240612$20240807$EXP$$CA-CELLTRION INC.-2024CA013901$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
239695182$23969518$2$F$$20240628$20240612$20240708$EXP$$US-TEVA-VS-3207235$TEVA$Patel A, Hochfeld U, Kim K, Sheth V, Patadia D. Pulmonary Tuberculosis Leading to Severe Acute Respiratory Distress Syndrome. Am-J-Respir-Crit-Care-Med 2023; 207.; Patel A, Hochfeld U, Kim K, Sheth V, Patadia D. Pulmonary Tuberculosis Leading to Severe Acute Respiratory Distress Syndrome. Am-J-Respir-Crit-Care-Med 2023; 207.$65$YR$$M$Y$$$20240708$$HP$US$US
239695262$23969526$2$F$$20240802$20240612$20240807$EXP$$US-ABBVIE-5797460$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
239695332$23969533$2$F$20240401$20240807$20240612$20240812$EXP$GR-GREOF-202400556$GR-AMGEN-GRCSP2024115315$AMGEN$$$$$F$Y$71$KG$20240812$$MD$GR$GR
239695372$23969537$2$F$$20240726$20240613$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094659$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240729$$CN$US$US
239695422$23969542$2$F$$20240709$20240613$20240717$EXP$$TR-TEVA-VS-3207393$TEVA$Sahin B, Guvenc B. Neoadjuvant chemoimmunotherapy for a patient with micro-stallete instabile gastric cancer resulted a pathological complete response. Hematol-Transfus-Cell-Ther 2024; 46 (Suppl. 3) 11-12 abstr. OP20.; Sahin B, Guvenc B. Neoadjuvant chemoimmunotherapy for a patient with micro-stallete instabile gastric cancer resulted a pathological complete response. Hematol-Transfus-Cell-Ther 2024; 46 (Suppl. 3) 11-12 abstr. OP20.$44$YR$$M$Y$$$20240717$$HP$TR$TR
239695444$23969544$4$F$20240428$20240921$20240613$20240926$EXP$$US-ABBVIE-5791501$ABBVIE$$78$YR$$F$Y$77$KG$20240926$$CN$US$US
239695502$23969550$2$F$$20240614$20240613$20240701$PER$$US-APOTEX-2024AP006944$APOTEX$$$$E$F$Y$$$20240701$$CN$US$US
239695533$23969553$3$F$20240501$20240726$20240613$20240807$PER$$US-AstraZeneca-2024A125771$ASTRAZENECA$$66$YR$$F$Y$$$20240807$$CN$US$
239695542$23969554$2$F$$20240726$20240613$20240726$PER$$NVSC2024US123410$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
239695592$23969559$2$F$20220701$20240707$20240613$20240709$EXP$$US-ABBVIE-5797715$ABBVIE$$81$YR$$F$Y$$$20240709$$CN$US$US
239695642$23969564$2$F$$20240722$20240613$20240723$PER$$US-ALXN-202406USA000289US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239695732$23969573$2$F$20240320$20240715$20240613$20240723$EXP$$US-JNJFOC-20240609806$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240723$$HP$US$US
239695852$23969585$2$F$20240101$20240711$20240613$20240716$EXP$$US-ABBVIE-5797376$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
239695892$23969589$2$F$$20240911$20240613$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095254$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240911$$CN$US$US
239695992$23969599$2$F$20230601$20240718$20240613$20240722$EXP$$JP-ABBVIE-5798841$ABBVIE$$66$YR$$M$Y$63.5$KG$20240722$$MD$JP$JP
239696063$23969606$3$F$20240217$20240914$20240613$20240925$EXP$$CA-JNJFOC-20240254861$JOHNSON AND JOHNSON$$52$YR$A$F$Y$61$KG$20240925$$HP$CA$CA
239696072$23969607$2$F$20240101$20240625$20240613$20240704$EXP$$JP-JNJFOC-20240618504$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240704$$MD$JP$JP
239696116$23969611$6$F$20240501$20240826$20240613$20240907$EXP$$US-CELLTRION INC.-2024US013936$CELLTRION$$$$$$Y$$$20240907$$CN$US$US
239696122$23969612$2$F$20230810$20240812$20240613$20240816$EXP$FR-AFSSAPS-LM2024000282$FR-HALEON-2181018$Haleon PLC$$$$$F$Y$2$KG$20240814$$MD$FR$FR
239696162$23969616$2$F$$20240702$20240613$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094379$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240709$$HP$US$US
239696174$23969617$4$F$$20240712$20240613$20240712$PER$$US-ALXN-202405USA002346US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240712$$HP$US$US
239696242$23969624$2$F$20240101$20240711$20240613$20240714$EXP$$CA-ABBVIE-5797847$ABBVIE$$80$YR$$F$Y$$$20240714$$CN$CA$CA
239696262$23969626$2$F$20240101$20240730$20240613$20240809$30DAY$$US-APOTEX-2024AP006964$APOTEX$$$$$$Y$$$20240809$$PH$US$US
239696282$23969628$2$F$$20240913$20240613$20240920$EXP$$BE-ABBVIE-5791587$ABBVIE$$$$E$M$Y$$$20240920$$HP$BE$BE
239696353$23969635$3$F$20240411$20240612$20240613$20240722$EXP$SE-SEMPA-2024-004825$SE-ABBVIE-5798635$ABBVIE$$64$YR$$M$Y$$$20240719$$MD$SE$SE
239696413$23969641$3$F$$20240801$20240613$20240814$PER$$US-APOTEX-2024AP006965$APOTEX$$$$$F$Y$$$20240814$$CN$US$US
239696433$23969643$3$F$20240101$20240719$20240613$20240725$EXP$$US-ABBVIE-5795290$ABBVIE$$$$$F$Y$106.14$KG$20240725$$CN$US$US
239696453$23969645$3$F$20240402$20240711$20240613$20240718$EXP$$US-JNJFOC-20240617076$JOHNSON AND JOHNSON$$67$YR$E$M$Y$93.4$KG$20240719$$HP$US$US
239696463$23969646$3$F$$20240701$20240613$20240705$EXP$$US-JNJFOC-20240621057$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240705$$HP$US$US
239696632$23969663$2$F$20240101$20240627$20240613$20240703$EXP$$JP-SAKK-2024SA172196AA$SANOFI AVENTIS$$$$$$Y$$$20240703$$MD$JP$JP
239696664$23969666$4$F$$20240717$20240613$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA057065$SANDOZ$$53$YR$$M$Y$$$20240722$$CN$CA$CA
239696732$23969673$2$F$20240401$20240711$20240613$20240720$EXP$$BR-CELLTRION INC.-2024BR013849$CELLTRION$$$$$$Y$$$20240720$$CN$BR$BR
239696782$23969678$2$F$20240530$20240705$20240613$20240706$PER$$US-JNJFOC-20240604204$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240706$$CN$US$US
239696822$23969682$2$F$20240607$20240717$20240613$20240724$PER$$US-AMGEN-USASP2024114489$AMGEN$$$$$$Y$$$20240724$$HP$US$US
239696833$23969683$3$F$20240608$20240716$20240613$20240717$PER$$US-AMGEN-USASP2024116221$AMGEN$$$$$F$Y$$$20240716$$CN$US$US
239696842$23969684$2$F$$20240917$20240613$20240923$PER$$US-SA-2024SA169676$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240923$$MD$US$US
239696852$23969685$2$F$$20240729$20240613$20240807$PER$$US-SA-2024SA176281$SANOFI AVENTIS$$$$A$M$Y$$$20240807$$CN$US$US
239696872$23969687$2$F$20240101$20240624$20240613$20240703$PER$$US-SA-2024SA094604$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240703$$MD$US$US
239696904$23969690$4$F$20230101$20240724$20240613$20240801$EXP$$CA-CELLTRION INC.-2023CA011316$CELLTRION$$$$$$Y$$$20240801$$HP$CA$CA
239697162$23969716$2$F$20240530$20240627$20240613$20240704$PER$$US-ALXN-202406USA000234US$ALEXION PHARMACEUTICALS$$28$YR$$F$Y$$$20240704$$CN$US$US
239697202$23969720$2$F$20231123$20240701$20240613$20240708$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-277126$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$56.69$KG$20240708$$CN$US$US
239697362$23969736$2$F$20240401$20240626$20240613$20240708$EXP$$US-ENDO USA, INC.-2024-002445$ENDO$$21$YR$$M$Y$$$20240708$$HP$US$US
239697372$23969737$2$F$20240605$20240719$20240613$20240727$30DAY$$US-AMGEN-USASP2024113572$AMGEN$$72$YR$E$F$Y$70$KG$20240727$$PH$US$US
239697404$23969740$4$F$20240424$20240827$20240613$20240903$EXP$$CA-JNJFOC-20240482099$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240903$$HP$CA$CA
239697422$23969742$2$F$20240605$20240924$20240613$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US057277$SANDOZ$$52$YR$$M$Y$$$20240926$$CN$US$US
239697462$23969746$2$F$$20240808$20240613$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095173$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$64.41$KG$20240810$$CN$US$US
239697553$23969755$3$F$20240521$20240823$20240613$20240826$PER$$NVSC2024US123491$NOVARTIS$$$$$F$Y$$$20240826$$HP$US$US
239697562$23969756$2$F$$20240726$20240613$20240726$PER$$NVSC2024US123598$NOVARTIS$$$$$$Y$$$20240726$$MD$US$US
239697572$23969757$2$F$20240605$20240627$20240613$20240705$EXP$$ZA-CELLTRION INC.-2024ZA013782$CELLTRION$$$$$$Y$$$20240705$$MD$ZA$ZA
239697653$23969765$3$F$20230906$20240710$20240613$20240723$EXP$$CZ-MSNLABS-2024MSNLIT01255$MSN LABORATORIES$Mocikova H.Treatment of peripheral T-cell lymphoma with hemophagocytic lymphohistiocytosis..PHARMACOTHERAPY.2024;20 (Supp 6):13-14$$$$$Y$$$20240723$$MD$CZ$CZ
239697692$23969769$2$F$$20240715$20240613$20240722$PER$$US-BIOGEN-2024BI01265102$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
239697723$23969772$3$F$$20240730$20240613$20240806$EXP$$CO-CELLTRION INC.-2024CO013623$CELLTRION$$$$$$Y$$$20240806$$HP$CO$CO
239697782$23969778$2$F$$20240705$20240613$20240715$EXP$$US-TEVA-VS-3207025$TEVA$Anderson A, Bourgeois C, Rogers L, Sanne S. Methotrexate toxicity in an unusual presentation. Am-J-Med-Sci 2024; 367 (Suppl.) S43 abstr. 71.; Anderson A, Bourgeois C, Rogers L, Sanne S. Methotrexate toxicity in an unusual presentation. Am-J-Med-Sci 2024; 367 (Suppl.) S43 abstr. 71.$65$YR$$F$Y$$$20240715$$HP$US$US
239697863$23969786$3$F$$20240709$20240613$20240712$PER$$US-BIOGEN-2024BI01268633$BIOGEN$$$$$F$Y$$$20240712$$CN$US$US
239697902$23969790$2$F$$20240620$20240613$20240712$PER$$US-TOLMAR, INC.-24US049276$TOLMAR$$$$$M$Y$$$20240712$$HP$US$US
239697912$23969791$2$F$20240501$20240621$20240613$20240712$PER$$US-TOLMAR, INC.-24US049282$TOLMAR$$$$$M$Y$$$20240712$$HP$US$US
239697932$23969793$2$F$20240514$20240625$20240613$20240724$PER$$US-TOLMAR, INC.-24US049386$TOLMAR$$69$YR$$M$Y$$$20240724$$HP$US$US
239697942$23969794$2$F$20240515$20240627$20240613$20240724$PER$$US-TOLMAR, INC.-24US049438$TOLMAR$$81$YR$$M$Y$$$20240724$$HP$US$US
239697962$23969796$2$F$20240517$20240701$20240613$20240725$PER$$US-TOLMAR, INC.-24US049527$TOLMAR$$72$YR$$M$Y$$$20240725$$HP$US$US
239697972$23969797$2$F$20240520$20240701$20240613$20240722$PER$$US-TOLMAR, INC.-24US049574$TOLMAR$$75$YR$$M$Y$$$20240718$$HP$US$US
239697992$23969799$2$F$20240520$20240702$20240613$20240725$PER$$US-TOLMAR, INC.-24US049595$TOLMAR$$$$$F$Y$$$20240725$$HP$US$US
239698002$23969800$2$F$20240523$20240624$20240613$20240725$PER$$US-TOLMAR, INC.-24US049643$TOLMAR$$$$$M$Y$$$20240725$$PH$US$US
239698012$23969801$2$F$20240523$20240708$20240613$20240805$PER$$US-TOLMAR, INC.-24US049661$TOLMAR$$76$YR$$M$Y$$$20240805$$HP$US$US
239698082$23969808$2$F$20231101$20240627$20240613$20240702$EXP$$US-GSK-US2024070753$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$US$US
239698122$23969812$2$F$$20240619$20240613$20240705$PER$$US-KOANAAP-SML-US-2024-00511$Unknown Manufacturer$$$$$$Y$$$20240705$$HP$US$US
239698172$23969817$2$F$$20240704$20240613$20240705$PER$$NVSC2024US123514$NOVARTIS$$$$$$Y$$$20240705$$CN$US$US
239698224$23969822$4$F$20240627$20240820$20240613$20240828$EXP$$NVSC2023CO113386$NOVARTIS$$58$YR$$F$Y$58$KG$20240828$$CN$CO$CO
239698383$23969838$3$F$20221012$20240702$20240613$20240711$EXP$$FR-BEH-2023153829$CSL BEHRING$$50$YR$A$M$Y$75$KG$20240711$$MD$FR$FR
239698453$23969845$3$F$$20240814$20240613$20240820$30DAY$$US-GSK-US2024071662$GLAXOSMITHKLINE$$$$$F$Y$$$20240820$$CN$US$US
239698493$23969849$3$F$20240607$20240627$20240613$20240702$PER$$US-AMGEN-USASP2024116176$AMGEN$$61$YR$A$F$Y$$$20240701$$CN$US$US
239698514$23969851$4$F$20240517$20240628$20240613$20240711$30DAY$$US-JNJFOC-20240589706$JOHNSON AND JOHNSON$$63$YR$A$M$Y$104$KG$20240711$$CN$US$US
239698523$23969852$3$F$$20240821$20240613$20240830$EXP$$US-JNJFOC-20240614101$JOHNSON AND JOHNSON$$92$YR$E$M$Y$76.7$KG$20240830$$CN$US$US
239698562$23969856$2$F$20240101$20240703$20240613$20240704$PER$$US-AMGEN-USASP2024111259$AMGEN$$61$YR$A$F$Y$$$20240704$$CN$US$US
239698572$23969857$2$F$20240608$20240626$20240613$20240701$PER$$US-AMGEN-USASP2024115529$AMGEN$$78$YR$E$F$Y$$$20240630$$CN$US$US
239698612$23969861$2$F$20240101$20240626$20240613$20240702$PER$$US-AMGEN-USASP2024114382$AMGEN$$$$$M$Y$91$KG$20240702$$PH$US$US
239698622$23969862$2$F$20191101$20240802$20240613$20240808$EXP$$PK-AMGEN-PAKSP2022070821$AMGEN$$33$YR$A$F$Y$72$KG$20240808$$CN$PK$PK
239698662$23969866$2$F$$20240903$20240613$20240912$PER$$US-SA-2024SA176303$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240912$$MD$US$US
239698772$23969877$2$F$$20240722$20240613$20240723$PER$$US-ALXN-202406USA000256US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
239698812$23969881$2$F$$20240708$20240613$20240711$EXP$$ES-UCBSA-2024029925$UCB$$$$C$M$Y$$$20240711$$MD$ES$ES
239698823$23969882$3$F$$20240716$20240613$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-092295$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240731$$MD$JP$JP
239698844$23969884$4$F$20231213$20240724$20240613$20240731$30DAY$$US-AMGEN-USASP2024114307$AMGEN$$82$YR$E$M$Y$57.1$KG$20240731$$HP$US$US
239699082$23969908$2$F$$20240626$20240613$20240702$30DAY$$US-GSK-US2024068930$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
239699112$23969911$2$F$$20240627$20240613$20240702$PER$$NVSC2024US123456$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
239699152$23969915$2$F$20230329$20240708$20240613$20240712$EXP$$JP-TAKEDA-2024TJP008575$TAKEDA$$43$YR$$F$Y$67.8$KG$20240712$$MD$JP$JP
239699213$23969921$3$F$$20240715$20240613$20240717$PER$$US-JNJFOC-20240603484$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240717$$CN$US$US
239699242$23969924$2$F$$20240611$20240613$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094489$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240709$$HP$US$US
239699612$23969961$2$F$$20240705$20240613$20240716$EXP$$US-UCBSA-2024021424$UCB$$$$$F$Y$$$20240717$$CN$US$US
239699722$23969972$2$F$$20240910$20240613$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092459$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240912$$CN$US$US
239699733$23969973$3$F$$20240923$20240613$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095334$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240926$$CN$US$US
239699753$23969975$3$F$20211001$20240913$20240613$20240923$EXP$$CA-CELLTRION INC.-2021CA017796$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
239699762$23969976$2$F$20230901$20240605$20240613$20240924$EXP$$NVSC2024AR120448$NOVARTIS$$77$YR$$F$Y$$$20240924$$CN$AR$AR
239699772$23969977$2$F$$20240722$20240613$20240723$PER$$US-ALXN-202406USA000335US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239699792$23969979$2$F$20240508$20240702$20240613$20240709$EXP$IT-MINISAL02-988889$IT-UCBSA-2024029393$UCB$$83$YR$$F$Y$$$20240709$$MD$IT$IT
239699812$23969981$2$F$20211208$20240712$20240613$20240715$EXP$$JP-EMD Serono-2024031647$EMD SERONO INC$$73$YR$E$M$Y$63$KG$20240715$$HP$JP$JP
239699832$23969983$2$F$20240601$20240917$20240613$20240919$PER$$US-JNJFOC-20240607839$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$CN$US$US
239699872$23969987$2$F$20220101$20240828$20240613$20240830$EXP$$US-INDIVIOR US-INDV-145420-2024$RECKITT BENCKISER$Vinita Akula; Jessica Jones. Dense Breast Tissue in a High-Risk African-American Woman with DCIS and Nodal Metastasis of Intra-ductal Carcinoma: A Case Report and Discussion on the Current USPSTF Draft Recommendation. Cancer Research. 2024;84(9)$$$$$Y$$$20240830$$MD$US$US
239699913$23969991$3$F$$20240701$20240613$20240712$PER$$US-AstraZeneca-2024A135318$ASTRAZENECA$$$$$M$Y$$$20240712$$HP$US$
239700012$23970001$2$F$$20240712$20240613$20240716$EXP$$DE-ABBVIE-5795219$ABBVIE$$56$YR$$F$Y$$$20240716$$MD$DE$DE
239700062$23970006$2$F$$20240909$20240613$20240912$EXP$$GB-JNJFOC-20240627085$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$MD$GB$GB
239700072$23970007$2$F$$20240626$20240613$20240711$30DAY$$US-JNJFOC-20240572509$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$HP$US$US
239700152$23970015$2$F$20231021$20240708$20240613$20240710$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033156$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$95$KG$20240710$$CN$US$US
239700213$23970021$3$F$$20240827$20240613$20240903$EXP$$US-GSK-US2024071419$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$MD$US$US
239700356$23970035$6$F$20240530$20240620$20240613$20240701$PER$$US-AMGEN-USASP2024109735$AMGEN$$49$YR$A$F$Y$$$20240701$$HP$US$US
239700373$23970037$3$F$20240607$20240625$20240613$20240715$PER$$US-AMGEN-USASP2024114801$AMGEN$$77$YR$E$F$Y$65.76$KG$20240715$$PH$US$US
239700432$23970043$2$F$20240601$20240716$20240613$20240724$EXP$$US-ABBVIE-5797516$ABBVIE$$72$YR$$F$Y$$$20240724$$CN$US$US
239700472$23970047$2$F$$20240704$20240613$20240712$EXP$$IT-AUROBINDO-AUR-APL-2024-016393$AUROBINDO$Liccioli G, Tomei L, Pessina B, Caubet J. C, Barni S, Giovannini M, et al.. The importance of clinical history in the diagnosis of drug hypersensitivity in children. Pediatric Allergy and Immunology. 2024;35 e14091:1-8$$$C$$Y$$$20240712$$HP$IT$IT
239700572$23970057$2$F$20240403$20240905$20240613$20240911$PER$$US-ABBVIE-5794835$ABBVIE$$59$YR$$F$Y$61.234$KG$20240911$$CN$US$US
239700582$23970058$2$F$$20240709$20240613$20240719$EXP$$NL-TEVA-VS-3207293$TEVA$Vuijk S, Klomberg R, Hellendoorn A, Kemos P, Aardoom M, Ruemmele F, et al. Renal failure in children with inflammatory bowel disease. J-Crohn^s-Colitis 2024; 18 (Suppl. 1) i640-i641 abstr. P274.; Vuijk S, Klomberg R, Hellendoorn A, Kemos P, Aardoom M, Ruemmele F, et al. Renal failure in children with inflammatory bowel disease. J-Crohn^s-Colitis 2024; 18 (Suppl. 1) i640-i641 abstr. P274.$$$$$Y$$$20240719$$HP$NL$NL
239700683$23970068$3$F$20240516$20240907$20240613$20240917$EXP$$CA-CELLTRION INC.-2024CA014162$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
239700725$23970072$5$F$20240519$20240816$20240613$20240822$EXP$$CA-JNJFOC-20240613374$JOHNSON AND JOHNSON$$36$YR$A$F$Y$62$KG$20240823$$CN$CA$CA
239700802$23970080$2$F$$20240728$20240613$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094736$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$93.44$KG$20240802$$CN$US$US
239700812$23970081$2$F$$20240723$20240613$20240723$PER$$US-ALXN-202406USA000352US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239700882$23970088$2$F$$20240704$20240613$20240711$EXP$$IT-AUROBINDO-AUR-APL-2024-016293$AUROBINDO$Liccioli G, Tomei L, Pessina B, Caubet J. C, Barni S, Giovannini M, et al.. The importance of clinical history in the diagnosis of drug hypersensitivity in children.. Pediatric Allergy and Immunology.. 2024;35:e14091:1-8$$$$$Y$$$20240711$$HP$IT$IT
239700942$23970094$2$F$20230101$20240813$20240613$20240815$EXP$$PL-BIOGEN-2024BI01268741$BIOGEN$$27$YR$$F$Y$$$20240815$$MD$PL$PL
239700963$23970096$3$F$$20240910$20240613$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-094630$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240910$$MD$JP$JP
239700973$23970097$3$F$$20240901$20240613$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094941$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$69.85$KG$20240903$$CN$US$US
239700982$23970098$2$F$20170401$20240609$20240613$20240703$EXP$GB-MHRA-MED-202406091905545930-PTFCN$GB-ORGANON-O2406GBR000676$ORGANON$$44$YR$$M$Y$72$KG$20240703$$CN$GB$GB
239701003$23970100$3$F$$20240708$20240613$20240720$30DAY$$US-JNJFOC-20240623604$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$HP$US$US
239701062$23970106$2$F$$20240723$20240613$20240723$PER$$US-ALXN-202406USA000345US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239701102$23970110$2$F$20240602$20240823$20240613$20240901$30DAY$$US-GSK-US2024069358$GLAXOSMITHKLINE$$50$YR$$F$Y$48.98$KG$20240901$$CN$US$US
239701213$23970121$3$F$20220101$20240726$20240613$20240802$EXP$$NVSC2024FR121611$NOVARTIS$$$$A$F$Y$75$KG$20240802$$MD$FR$FR
239701292$23970129$2$F$$20240627$20240613$20240704$EXP$$JP-CHEPLA-2024007246$CHEPLAPHARM$Igari, Hidetoshi; Sakao, Seiichiro; Ishige, Takayuki; Saito, Kengo; Murata, Shota; Yahaba,et al.. Dynamic diversity of SARS-CoV-2?genetic mutations in a lung transplantation patient with persistent COVID-19. Nature Communications.2024;15:1$6$DEC$$$Y$$$20240704$$HP$COUNTRY NOT SPECIFIED$JP
239701322$23970132$2$F$$20240805$20240613$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202406007872$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240809$$CN$US$US
239701364$23970136$4$F$$20240911$20240613$20240923$EXP$$CA-HALEON-2177597$Haleon PLC$$43$YR$$F$Y$96$KG$20240921$$HP$CA$CA
239701392$23970139$2$F$20240101$20240913$20240613$20240925$EXP$$JP-AMGEN-JPNSP2024072441$AMGEN$$85$YR$E$M$Y$$$20240925$$CN$JP$JP
239701443$23970144$3$F$20240513$20240708$20240613$20240715$EXP$$RU-JNJFOC-20240622669$JOHNSON AND JOHNSON$$$$A$M$Y$46$KG$20240715$$MD$RU$RU
239701452$23970145$2$F$$20240712$20240613$20240715$PER$$US-AstraZeneca-2024A134096$ASTRAZENECA$$$$$F$Y$$$20240716$$MD$US$
239701544$23970154$4$F$$20240911$20240613$20240918$EXP$$US-JNJFOC-20240611842$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240918$$PH$US$US
239701873$23970187$3$F$$20240627$20240613$20240702$PER$$US-AMGEN-USASP2024116116$AMGEN$$$$$F$Y$$$20240702$$CN$US$US
239701882$23970188$2$F$20240610$20240814$20240613$20240816$PER$$US-AMGEN-USASP2024115884$AMGEN$$73$YR$E$F$Y$$$20240816$$CN$US$US
239701922$23970192$2$F$$20240724$20240613$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202406006345$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240725$$CN$US$US
239702053$23970205$3$F$20240101$20240820$20240613$20240827$EXP$$JP-009507513-2406JPN000265J$MERCK$$8$DEC$$F$Y$$$20240827$$MD$JP$JP
239702234$23970223$4$F$20240802$20240806$20240613$20240813$EXP$$BR-CELLTRION INC.-2024BR013911$CELLTRION$$$$$$Y$$$20240813$$CN$BR$BR
239702302$23970230$2$F$$20240910$20240613$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091871$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240910$$CN$US$US
239702383$23970238$3$F$$20240701$20240613$20240708$PER$$US-MTPC-MTDA2024-0012155$Unknown Manufacturer$$$$E$F$Y$$$20240708$$CN$US$US
239702392$23970239$2$F$20210430$20240801$20240613$20240808$EXP$$JP-MTPC-MTPC2024-0012036$UNKNOWN$$75$YR$$F$Y$$$20240808$$PH$JP$JP
239702642$23970264$2$F$20220907$20240701$20240613$20240704$EXP$AU-TGA-0000809298$AU-JNJFOC-20240626786$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240705$$CN$AU$AU
239702652$23970265$2$F$$20240723$20240613$20240723$PER$$US-ALXN-202406USA000384US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239702673$23970267$3$F$$20240703$20240613$20240711$EXP$$CA-TOLMAR, INC.-24CA049992$TOLMAR$$$$$M$Y$$$20240711$$HP$CA$CA
239702802$23970280$2$F$$20240816$20240613$20240819$EXP$$NVSC2024US123319$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
239702836$23970283$6$F$20240601$20240729$20240613$20240731$PER$$US-AMGEN-USASP2024115808$AMGEN$$65$YR$E$F$Y$$$20240731$$CN$US$US
239702855$23970285$5$F$20240609$20240830$20240613$20240902$EXP$$NVSC2024US122019$NOVARTIS$$56$YR$$F$Y$$$20240902$$CN$US$US
239702923$23970292$3$F$$20240628$20240613$20240705$30DAY$$BR-JNJFOC-20240567514$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$PH$BR$BR
239703054$23970305$4$F$20240524$20240712$20240613$20240718$EXP$$NO-AMGEN-NORSP2024114868$AMGEN$$73$YR$E$M$Y$114$KG$20240718$$MD$NO$NO
239703082$23970308$2$F$20240401$20240710$20240613$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013212$UNITED THERAPEUTICS$$56$YR$$M$Y$50.794$KG$20240719$$$US$US
239703152$23970315$2$F$20240531$20240722$20240613$20240729$EXP$$US-GSK-US2024068912$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$PH$US$US
239703315$23970331$5$F$20240101$20240812$20240613$20240820$EXP$$CA-CELLTRION INC.-2024CA011992$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
239703362$23970336$2$F$$20240705$20240613$20240715$EXP$$US-TEVA-VS-3206917$TEVA$Yang T, Khan AI, Hanan A, Kataria N, Khan A. Acute myeloid leukemia with t(16;21)(q24;q22), CBFA2T3::RUNX1, in post-treatment setting, a case report. Am-J-Clin-Pathol 2023; 160 (Suppl. 1) S72.; Yang T, Khan AI, Hanan A, Kataria N, Khan A. Acute myeloid leukemia with t(16;21)(q24;q22), CBFA2T3::RUNX1, in post-treatment setting, a case report. Am-J-Clin-Pathol 2023; 160 (Suppl. 1) S72.$52$YR$$F$Y$$$20240715$$HP$US$US
239703472$23970347$2$F$$20240607$20240613$20240718$EXP$$US-Taiho Oncology Inc-2024-000496$TAIHO ONCOLOGY INC$$$$A$M$Y$$$20240718$$MD$US$US
239703573$23970357$3$F$$20240701$20240613$20240707$EXP$$JP-JNJFOC-20240628552$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$$COUNTRY NOT SPECIFIED$JP
239703742$23970374$2$F$$20240808$20240613$20240809$PER$$NVSC2024US123450$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
239703753$23970375$3$F$$20240701$20240613$20240704$EXP$$JP-JNJFOC-20240628499$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$$COUNTRY NOT SPECIFIED$JP
239703772$23970377$2$F$$20240910$20240613$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094925$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240910$$CN$US$US
239703882$23970388$2$F$$20240705$20240613$20240715$EXP$$US-TEVA-VS-3206923$TEVA$Bradley J, Stout D, Akong K, Fireizen Y. Three Year Longitudinal Assessment of Pseudomonas aeruginosa (Pa) Antibiotic Susceptibility in Children with Cystic Fibrosis (CF) in the Era of Modulator Therapy. Open-Forum-Infect-Dis 2023; 10 (Suppl. 2) S48-S49 abstr. 1107.; Bradley J, Stout D, Akong K, Fireizen Y. Three Year Longitudinal Assessment of Pseudomonas aeruginosa (Pa) Antibiotic Susceptibility in Children with Cystic Fibrosis (CF) in the Era of Modulator Therapy. Open-Forum-Infect-Dis 202...$16$YR$$$Y$$$20240715$$MD$US$US
239703972$23970397$2$F$20240603$20240712$20240613$20240718$EXP$$US-UCBSA-2024029102$UCB$$8$YR$$M$Y$$$20240718$$CN$US$US
239704122$23970412$2$F$$20240705$20240613$20240712$EXP$$US-TAKEDA-2024TUS017037$TAKEDA$$$$$M$Y$87$KG$20240712$$CN$US$US
239704172$23970417$2$F$$20240726$20240613$20240803$EXP$$US-TAKEDA-2024TUS030315$TAKEDA$$$$$F$Y$$$20240803$$HP$US$US
239704392$23970439$2$F$20220724$20240628$20240613$20240703$EXP$$US-TAKEDA-2021TUS045481$TAKEDA$$39$YR$$F$Y$66$KG$20240703$$HP$US$US
239704424$23970442$4$F$20240101$20240722$20240613$20240730$EXP$$CA-CELLTRION INC.-2024CA013843$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
239704432$23970443$2$F$$20240910$20240613$20240912$EXP$$CN-TAKEDA-2024TUS057533$TAKEDA$$$$$F$Y$$$20240912$$CN$CN$CN
239704573$23970457$3$F$$20240806$20240613$20240812$EXP$$BR-TAKEDA-2024TUS057912$TAKEDA$$$$$F$Y$$$20240812$$CN$BR$BR
239704612$23970461$2$F$$20240628$20240613$20240708$EXP$$PT-TEVA-VS-3207247$TEVA$Santos R, Costa M, Rosario C. FLUOROURACIL AND LONG-TERM CARDIOTOXICITY: A CASE DESCRIPTION. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl.) 28.; Santos R, Costa M, Rosario C. FLUOROURACIL AND LONG-TERM CARDIOTOXICITY: A CASE DESCRIPTION. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl.) 28.$64$YR$$F$Y$$$20240708$$HP$PT$PT
239704632$23970463$2$F$$20240909$20240613$20240913$EXP$$US-ABBVIE-5795111$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
239704672$23970467$2$F$$20240722$20240613$20240730$EXP$$US-AstraZeneca-2024A132769$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
239704702$23970470$2$F$$20240628$20240613$20240708$EXP$$US-TEVA-VS-3207231$TEVA$Niyas AM, Haseefa F, Cox JC, Movahed MR. Suspected colchicine-induced late myocardial rupture occurring after the late presentation of acute inferior ST-elevation myocardial infarction. Am-J-Cardiovasc-Dis 2024; 14 (2): 116-120.; Niyas AM, Haseefa F, Cox JC, Movahed MR. Suspected colchicine-induced late myocardial rupture occurring after the late presentation of acute inferior ST-elevation myocardial infarction. Am-J-Cardiovasc-Dis 2024; 14 (2): 116-120.; Niyas AM, Haseefa F, Cox JC, Movahed ...$61$YR$$M$Y$$$20240708$$HP$US$US
239704732$23970473$2$F$$20240830$20240613$20240903$EXP$$US-TAKEDA-2024TUS016089$TAKEDA$$$$$M$Y$$$20240903$$HP$US$US
239704743$23970474$3$F$20240526$20240826$20240613$20240827$EXP$$US-TAKEDA-2024TUS053769$TAKEDA$$34$YR$$F$Y$$$20240827$$CN$US$US
239704792$23970479$2$F$$20240823$20240613$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04757$LUPIN$$$$$$Y$$$20240901$$CN$US$US
239704853$23970485$3$F$20240514$20240709$20240613$20240717$EXP$$AU-TAKEDA-2024TUS048709$TAKEDA$$86$YR$$M$Y$$$20240717$$MD$AU$AU
239704862$23970486$2$F$20240410$20240715$20240613$20240716$EXP$$NVSC2024GB113338$NOVARTIS$$81$YR$$M$Y$92$KG$20240716$$CN$GB$GB
239704932$23970493$2$F$$20240715$20240613$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095427$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$58.97$KG$20240718$$CN$US$US
239704942$23970494$2$F$$20240718$20240613$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095031$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240726$$CN$US$US
239704982$23970498$2$F$20231101$20240819$20240613$20240823$EXP$$NVSC2024MX122600$NOVARTIS$$40$YR$$F$Y$$$20240823$$CN$MX$MX
239704992$23970499$2$F$20240101$20240802$20240613$20240806$EXP$$CA-CELLTRION INC.-2024CA014055$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
239705002$23970500$2$F$20231001$20240705$20240613$20240715$30DAY$$US-GSK-US2024072454$GLAXOSMITHKLINE$$84$YR$$F$Y$52.16$KG$20240715$$MD$US$US
239705082$23970508$2$F$$20240924$20240613$20240926$EXP$$NVSC2024US122140$NOVARTIS$$38$YR$$M$Y$$$20240926$$CN$US$US
239705102$23970510$2$F$20240101$20240723$20240613$20240725$PER$$US-AMGEN-USASP2024114419$AMGEN$$65$YR$E$M$Y$$$20240725$$CN$US$US
239705112$23970511$2$F$$20240723$20240613$20240822$PER$$US-AstraZeneca-2024A124271$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
239705183$23970518$3$F$$20240701$20240613$20240708$EXP$$JP-JNJFOC-20240628502$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$$COUNTRY NOT SPECIFIED$JP
239705252$23970525$2$F$$20240911$20240613$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094847$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240911$$CN$US$US
239705302$23970530$2$F$$20240623$20240613$20240702$EXP$$GB-ADVANZ PHARMA-202406004681$ADVANZ PHARMA$$$$$$Y$$$20240702$$HP$GB$GB
239705392$23970539$2$F$20240322$20240802$20240613$20240815$EXP$$PL-UCBSA-2024029735$UCB$$25$YR$$F$Y$63$KG$20240815$$MD$PL$PL
239705404$23970540$4$F$20240619$20240819$20240613$20240827$EXP$$CA-TAKEDA-2024TUS055970$TAKEDA$$54$YR$$M$Y$$$20240827$$CN$CA$CA
239705503$23970550$3$F$$20240626$20240613$20240701$EXP$$JP-JNJFOC-20240628519$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$$COUNTRY NOT SPECIFIED$JP
239705542$23970554$2$F$20240527$20240911$20240613$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094646$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$72.12$KG$20240912$$CN$US$US
239705602$23970560$2$F$$20240628$20240613$20240708$EXP$$CA-TEVA-VS-3207081$TEVA$Gilmour GS, Salmon A, Josephson CB. Functional seizures in the elderly: Accurate diagnosis can reduce iatrogenic harm. Can-J-Neurol-Sci 2024; 51 (2): 330-332.; Gilmour GS, Salmon A, Josephson CB. Functional seizures in the elderly: Accurate diagnosis can reduce iatrogenic harm. Can-J-Neurol-Sci 2024; 51 (2): 330-332.$87$YR$$M$Y$$$20240708$$HP$CA$CA
239705612$23970561$2$F$$20240611$20240613$20240909$EXP$$NVSC2024CA123434$NOVARTIS$$78$YR$$F$Y$$$20240909$$HP$CA$CA
239705792$23970579$2$F$$20240708$20240613$20240711$EXP$$US-ABBVIE-5791971$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
239705882$23970588$2$F$$20240701$20240613$20240709$EXP$$US-ARGENX-2024-ARGX-US004064$ARGENX BVBA$$$$$$Y$$$20240709$$CN$US$US
239706002$23970600$2$F$$20240910$20240613$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094244$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240910$$PH$US$US
239706074$23970607$4$F$$20240723$20240613$20240802$EXP$$GB-BAXTER-2024BAX019622$BAXTER$$79$YR$$F$Y$$$20240802$$HP$GB$GB
239706293$23970629$3$F$20240516$20240812$20240613$20240821$EXP$$CN-BAXTER-2024BAX019470$BAXTER$$72$YR$$F$Y$47.5$KG$20240821$$MD$CN$CN
239706332$23970633$2$F$20230828$20240624$20240613$20240703$EXP$ES-AEMPS-1528490$ES-BAXTER-2024BAX019302$BAXTER$$72$YR$$F$Y$$$20240703$$MD$ES$ES
239706362$23970636$2$F$20240425$20240517$20240613$20240805$EXP$$US-BAXTER-2024BAX019188$BAXTER$$$$$$Y$$$20240805$$CN$US$US
239706372$23970637$2$F$$20240624$20240613$20240704$EXP$NL-LRB-00980713$NL-BAXTER-2024BAX019310$BAXTER$$52$YR$$F$Y$85$KG$20240704$$MD$NL$NL
239706403$23970640$3$F$20240501$20240722$20240613$20240801$EXP$$US-BAXTER-2024BAX019134$BAXTER$$30$YR$$F$Y$88.8$KG$20240801$$HP$US$US
239706712$23970671$2$F$20240601$20240917$20240613$20240919$EXP$$IT-ABBVIE-5792305$ABBVIE$$74$YR$$M$Y$$$20240919$$CN$IT$IT
239706752$23970675$2$F$20240603$20240711$20240613$20240717$PER$$US-JNJFOC-20240607366$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240717$$HP$US$US
239706762$23970676$2$F$20231218$20240716$20240613$20240723$EXP$$FR-GILEAD-2024-0676421$GILEAD$$32$YR$A$F$Y$100$KG$20240723$$MD$FR$FR
239706794$23970679$4$F$20240611$20240823$20240613$20240823$PER$$NVSC2024US123377$NOVARTIS$$21$YR$$$Y$$$20240823$$CN$US$US
239706864$23970686$4$F$20240101$20240915$20240613$20240918$EXP$$US-ABBVIE-5794059$ABBVIE$$$$$F$Y$72$KG$20240918$$CN$US$US
239706883$23970688$3$F$20240101$20240823$20240613$20240830$EXP$$US-ABBVIE-5792138$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
239706912$23970691$2$F$$20240730$20240613$20240805$EXP$$US-SA-2024SA174390$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240805$$HP$US$US
239707012$23970701$2$F$20230101$20240905$20240613$20240912$EXP$$US-ABBVIE-5795223$ABBVIE$$$$$M$Y$75$KG$20240912$$CN$US$US
239707082$23970708$2$F$20240507$20240725$20240613$20240806$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05146$HIKMA$$20$YR$$M$Y$$$20240806$$CN$US$US
239707152$23970715$2$F$20240101$20240702$20240613$20240708$EXP$$AU-ASTELLAS-2024US016678$ASTELLAS$$53$YR$$F$Y$$$20240708$$CN$AU$AU
239707182$23970718$2$F$$20240722$20240613$20240722$PER$$US-ALXN-202406USA000272US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
239707277$23970727$7$F$$20240924$20240613$20240925$PER$$NVSC2024US123109$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
239707303$23970730$3$F$20240402$20240701$20240613$20240705$EXP$$TW-ASTELLAS-2024US016148$ASTELLAS$$68$YR$$M$Y$$$20240705$$MD$TW$TW
239707362$23970736$2$F$20230828$20240628$20240613$20240708$EXP$ES-AEMPS-1528490$ES-TEVA-VS-3208313$TEVA$$72$YR$$F$Y$$$20240708$$MD$ES$ES
239707382$23970738$2$F$$20240703$20240613$20240705$EXP$$JP-ASTELLAS-2024JP004026$ASTELLAS$$7$DEC$$M$Y$$$20240705$$PH$JP$JP
239707422$23970742$2$F$$20240920$20240613$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095379$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$57.15$KG$20240923$$CN$US$US
239707432$23970743$2$F$$20240917$20240613$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095130$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240919$$HP$US$US
239707523$23970752$3$F$20230430$20240806$20240613$20240817$EXP$$DK-AUROBINDO-AUR-APL-2024-028220$AUROBINDO$$61$YR$$F$Y$54$KG$20240817$$MD$DK$DK
239707553$23970755$3$F$$20240701$20240613$20240705$EXP$$CA-AstraZeneca-2024A136209$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$CA$
239707592$23970759$2$F$$20240830$20240613$20240902$PER$$NVSC2024US123645$NOVARTIS$$$$$$Y$$$20240902$$HP$US$US
239707604$23970760$4$F$20240506$20240703$20240613$20240711$30DAY$$US-AMGEN-USASP2024112957$AMGEN$$73$YR$E$F$Y$95.4$KG$20240711$$HP$US$US
239707612$23970761$2$F$20240501$20240723$20240613$20240723$PER$$US-ALXN-202406USA000367US$ALEXION PHARMACEUTICALS$$49$YR$$M$Y$$$20240723$$CN$US$US
239707652$23970765$2$F$20240606$20240624$20240613$20240701$PER$$US-AMGEN-USASP2024114723$AMGEN$$73$YR$E$M$Y$$$20240630$$HP$US$US
239707763$23970776$3$F$20240101$20240909$20240613$20240919$EXP$$US-UCBSA-2024029750$UCB$$$$$M$Y$158.73$KG$20240919$$HP$US$US
239707822$23970782$2$F$$20240627$20240613$20240709$30DAY$$BE-JNJFOC-20240630433$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$PH$BE$BE
239707862$23970786$2$F$$20240624$20240613$20240704$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-092866$BRISTOL MYERS SQUIBB$Benesova V. Successful long-term palliative treatment of pancreatic cancer with gemcitabine +nab-paclitaxel sequence ? nal-IRI (onivyde) + 5-FU/LV in an elderly woman with a good performance status. Farmakoterapie. 2024;20(3):307-10.$75$YR$E$F$Y$$$20240704$$MD$CZ$CZ
239707872$23970787$2$F$$20240725$20240613$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095365$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240726$$CN$US$US
239707882$23970788$2$F$$20240904$20240613$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095240$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240906$$CN$US$US
239708032$23970803$2$F$$20240705$20240613$20240715$EXP$$US-TEVA-VS-3206997$TEVA$Vu K, Frank MJ. CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse. Blood-Adv 2023; 7 (3): 375-378.; Vu K, Frank MJ. CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse. Blood-Adv 2023; 7 (3): 375-378.; Vu K, Frank MJ. CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse. Blood-Adv 2023; 7 (3): 375-378.$74$YR$$F$Y$$$20240715$$HP$US$US
239708062$23970806$2$F$$20240708$20240613$20240712$EXP$$US-ASTELLAS-2024US016705$ASTELLAS$$$$$M$Y$$$20240712$$CN$US$US
239708092$23970809$2$F$20240507$20240910$20240613$20240917$EXP$$JP-AstraZeneca-2024A134415$ASTRAZENECA$$85$YR$$F$Y$53$KG$20240917$$MD$JP$
239708182$23970818$2$F$$20240805$20240613$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094949$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240812$$PH$US$US
239708392$23970839$2$F$20240311$20240627$20240613$20240702$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017248$UNITED THERAPEUTICS$$77$YR$$M$Y$107.94$KG$20240702$$$US$US
239708672$23970867$2$F$20240516$20240702$20240613$20240710$EXP$IT-MINISAL02-987654$IT-TEVA-VS-3207291$TEVA$$75$YR$$M$Y$$$20240710$$MD$IT$IT
239708792$23970879$2$F$$20240717$20240613$20240723$30DAY$$US-JNJFOC-20240616226$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$US$US
239708822$23970882$2$F$$20240705$20240613$20240715$EXP$$US-TEVA-VS-3206948$TEVA$Beutler BD, Shinozuka K, Tabaac BJ, Arenas A, Cherian K, Evans VD, et al. Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD). Am-J-Ther 2024; 31 (2): e104-e111.; Beutler BD, Shinozuka K, Tabaac BJ, Arenas A, Cherian K, Evans VD, et al. Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD). Am-J-Ther 2024; 31 (2): e104-e111.; Beutler BD, Shinozuka K, Tabaac BJ, Arenas A, Cherian K, Evans VD, et al. Psychedelic Therapy...$26$YR$$M$Y$$$20240715$$HP$US$GB
239709252$23970925$2$F$20240101$20240715$20240613$20240718$EXP$$DE-ABBVIE-5797809$ABBVIE$$$$$M$Y$$$20240718$$CN$DE$DE
239709362$23970936$2$F$20240530$20240719$20240613$20240730$EXP$$IT-AUROBINDO-AUR-APL-2024-028351$AUROBINDO$$74$YR$$M$Y$85$KG$20240730$$MD$IT$IT
239709382$23970938$2$F$20240101$20240729$20240613$20240809$EXP$FR-AFSSAPS-TS2024000618$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108128$ZYDUS PHARM$$$$$$Y$$$20240809$$MD$FR$FR
239709412$23970941$2$F$$20240911$20240613$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095476$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240911$$MD$US$US
239709452$23970945$2$F$20240524$20240627$20240613$20240705$EXP$$US-AMGEN-USASP2024115840$AMGEN$$37$YR$A$M$Y$$$20240705$$CN$US$US
239709542$23970954$2$F$$20240729$20240613$20240731$PER$$US-ALXN-202406USA000171US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239709682$23970968$2$F$20240602$20240716$20240613$20240722$EXP$$IL-ABBVIE-5796297$ABBVIE$$76$YR$$F$Y$$$20240719$$CN$IL$IL
239709702$23970970$2$F$20240527$20240709$20240613$20240718$EXP$$JP-VIATRISJAPAN-2024M1051183AA$MYLAN$$96$YR$$F$Y$34$KG$20240718$$PH$JP$JP
239709772$23970977$2$F$20240609$20240709$20240613$20240712$PER$$US-AMGEN-USASP2024115385$AMGEN$$83$YR$E$F$Y$$$20240712$$CN$US$US
239709782$23970978$2$F$20240607$20240708$20240613$20240711$PER$$US-AMGEN-USASP2024114132$AMGEN$$$$$$Y$$$20240711$$HP$US$US
239709823$23970982$3$F$20240522$20240725$20240613$20240730$EXP$$JP-ASTELLAS-2024JP003881$ASTELLAS$$84$YR$$M$Y$$$20240730$$MD$JP$JP
239709852$23970985$2$F$20240529$20240910$20240613$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094349$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240910$$HP$US$US
239709962$23970996$2$F$$20240723$20240613$20240725$PER$$US-ALXN-202406USA000450US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239710032$23971003$2$F$$20240802$20240613$20240808$EXP$$CA-ASTELLAS-2024US016733$ASTELLAS$$$$$M$Y$$$20240808$$MD$CA$CA
239710088$23971008$8$F$20240101$20240919$20240613$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-015999$UNITED THERAPEUTICS$$$$$F$Y$57.143$KG$20240927$$$US$US
239710114$23971011$4$F$20240101$20240806$20240613$20240809$PER$$US-BIOGEN-2024BI01250081$BIOGEN$$$$$F$Y$$$20240809$$CN$US$US
239710142$23971014$2$F$20240703$20240813$20240613$20240819$EXP$$US-MYLANLABS-2024M1053561$MYLAN$$51$YR$$F$Y$$$20240819$$PH$US$US
239710202$23971020$2$F$$20240815$20240613$20240819$EXP$$NVSC2024US123518$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
239710473$23971047$3$F$20210301$20240621$20240613$20240705$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-451276$RANBAXY$$66$YR$$M$Y$94$KG$20240705$$CN$IT$IT
239710642$23971064$2$F$$20240708$20240613$20240722$30DAY$$SK-JNJFOC-20240616180$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$SK$SK
239710652$23971065$2$F$$20240703$20240613$20240802$PER$$JP-Merz Pharmaceuticals GmbH-24-02011$MERZ$$80$YR$$F$Y$52.9$KG$20240802$$MD$JP$JP
239710683$23971068$3$F$20240101$20240717$20240613$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-017594$UNITED THERAPEUTICS$$$$$M$Y$98.413$KG$20240723$$$US$US
239710863$23971086$3$F$20240502$20240705$20240613$20240720$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-450453$RANBAXY$$$$E$M$Y$$$20240719$$CN$IT$IT
239711253$23971125$3$F$20231001$20240828$20240613$20240906$EXP$$ES-AUROBINDO-AUR-APL-2023-074990$AUROBINDO$$47$YR$$F$Y$$$20240906$$CN$ES$ES
239711283$23971128$3$F$$20240909$20240613$20240909$EXP$$DE-BAYER-2024A083944$BAYER$$$$$M$Y$$$20240909$$PH$DE$DE
239711292$23971129$2$F$20240501$20240813$20240613$20240814$EXP$$US-CIPLA LTD.-2024US05509$CIPLA$$$$$$Y$$$20240814$$CN$US$US
239711312$23971131$2$F$20240130$20240705$20240613$20240712$EXP$$CA-AMERICAN REGENT INC-2024002206$AMERICAN REGENT$$21$YR$$F$Y$$$20240712$$HP$CA$CA
239711393$23971139$3$F$20240527$20240823$20240613$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-028088$AUROBINDO$$74$YR$$M$Y$103$KG$20240903$$MD$DE$DE
239711562$23971156$2$F$$20240815$20240613$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093804$BRISTOL MYERS SQUIBB$$63$YR$$F$Y$$$20240829$$HP$US$US
239711603$23971160$3$F$$20240911$20240613$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095400$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240911$$CN$US$US
239711663$23971166$3$F$20240227$20240806$20240613$20240808$EXP$$CA-JNJFOC-20240262445$JOHNSON AND JOHNSON$$14$YR$T$M$Y$55$KG$20240808$$HP$CA$CA
239711712$23971171$2$F$$20240821$20240613$20240826$EXP$$GB-MYLANLABS-2024M1053377$MYLAN$$$$$M$Y$$$20240826$$PH$GB$GB
239711762$23971176$2$F$20230430$20240704$20240613$20240711$EXP$$DK-009507513-2406DNK002084$MERCK$$61$YR$$F$Y$54$KG$20240711$$MD$DK$DK
239711812$23971181$2$F$20240430$20240610$20240613$20240716$EXP$$FR-GENMAB-2024-01655AA$GENMAB$$74$YR$$M$Y$$$20240716$$MD$FR$FR
239711882$23971188$2$F$20240310$20240712$20240613$20240722$EXP$FR-AFSSAPS-SE2024000441$FR-TEVA-VS-3207779$TEVA$$45$YR$$M$Y$110$KG$20240722$$MD$FR$FR
239711932$23971193$2$F$$20240530$20240613$20240906$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158090$JIANGSU HENGRUI MEDICINE$A Case of Severe Lethal Allergic Reaction Caused by Iodixanol After Digital Subtraction Angiography$61$YR$$F$Y$$$20240906$$MD$CN$CN
239712082$23971208$2$F$20231101$20240628$20240613$20240709$EXP$FR-AFSSAPS-BX2024001072$FR-Accord-429357$ACCORD$$75$YR$E$F$Y$46$KG$20240709$$HP$FR$FR
239712333$23971233$3$F$$20240626$20240613$20240705$EXP$$CA-APOTEX-2024AP007095$APOTEX$$$$E$F$Y$$$20240705$$MD$CA$CA
239712572$23971257$2$F$20240101$20240903$20240613$20240909$PER$$US-INSUD PHARMA-2406US04454$INSUD PHARMA$$$$$$Y$$$20240909$$CN$US$US
239712633$23971263$3$F$20240101$20240913$20240613$20240920$EXP$$JP-AMGEN-JPNSP2024113029$AMGEN$$$$$$Y$$$20240920$$MD$JP$JP
239712682$23971268$2$F$20231214$20240812$20240613$20240822$EXP$GB-MHRA-MED-202406022025282920-JWGKS$GB-Accord-428597$ACCORD$$34$YR$A$F$Y$90$KG$20240822$$CN$GB$GB
239712882$23971288$2$F$20240101$20240808$20240613$20240808$EXP$$CA-PFIZER INC-202400192177$PFIZER$$36$YR$$F$Y$$$20240808$$HP$CA$CA
239713063$23971306$3$F$20240520$20240629$20240613$20240708$PER$$US-ALXN-202406USA000392US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
239713182$23971318$2$F$$20240911$20240613$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094971$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240911$$CN$US$US
239713263$23971326$3$F$$20240709$20240613$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04809$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239713384$23971338$4$F$20221201$20240712$20240613$20240717$EXP$$CA-PFIZER INC-202201296203$PFIZER$$21$YR$$M$Y$109.3$KG$20240717$$MD$CA$CA
239713492$23971349$2$F$20240228$20240723$20240613$20240726$EXP$$GB-DSJP-DSE-2024-126167$DAIICHI$$60$YR$$F$Y$$$20240726$$MD$GB$GB
239713562$23971356$2$F$$20240705$20240613$20240715$EXP$$US-TEVA-VS-3207054$TEVA$Gowda S, Sandow L, Heinrich MC. Treatment of BRAF V600E mutant gastrointestinal stromal tumor with dabrafenib: a case report. J-Gastrointest-Oncol 2024; 15 (2): 788-793.; Gowda S, Sandow L, Heinrich MC. Treatment of BRAF V600E mutant gastrointestinal stromal tumor with dabrafenib: a case report. J-Gastrointest-Oncol 2024; 15 (2): 788-793.; Gowda S, Sandow L, Heinrich MC. Treatment of BRAF V600E mutant gastrointestinal stromal tumor with dabrafenib: a case report. J-Gastrointest-Oncol 2024; 15...$67$YR$$F$Y$$$20240715$$HP$US$US
239713582$23971358$2$F$20240709$20240711$20240613$20240715$EXP$$US-TAKEDA-2024TUS047633$TAKEDA$$38$YR$$M$Y$$$20240715$$MD$US$US
239713602$23971360$2$F$20240610$20240710$20240613$20240712$PER$$US-AMGEN-USASP2024116150$AMGEN$$32$YR$A$M$Y$$$20240712$$CN$US$US
239713612$23971361$2$F$20220503$20240705$20240613$20240719$EXP$$US-MDD US Operations-MDD202205-001111$MDD OPERATIONS$$76$YR$$M$Y$$$20240719$$HP$US$
239713802$23971380$2$F$20240305$20240726$20240613$20240801$EXP$$ES-MYLANLABS-2024M1052752$MYLAN$$59$YR$$F$Y$$$20240801$$MD$ES$ES
239713814$23971381$4$F$$20240805$20240613$20240812$EXP$$FR-MYLANLABS-2024M1048156$MYLAN$$86$YR$$F$Y$$$20240812$$HP$FR$FR
239713853$23971385$3$F$20240416$20240711$20240613$20240715$EXP$$US-MYLANLABS-2024M1053794$MYLAN$$0$YR$$M$Y$3.4$KG$20240715$$MD$US$US
239714023$23971402$3$F$$20240716$20240613$20240723$30DAY$$IL-JNJFOC-20240616146$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$IL$IL
239714062$23971406$2$F$20240517$20240701$20240613$20240710$EXP$$US-ARGENX-2024-ARGX-US004122$ARGENX BVBA$$$$$$Y$$$20240709$$CN$US$US
239714152$23971415$2$F$20240427$20240704$20240613$20240716$EXP$IT-MINISAL02-987980$IT-Accord-429321$ACCORD$$52$YR$A$F$Y$$$20240716$$MD$IT$IT
239714182$23971418$2$F$$20240913$20240613$20240923$EXP$$US-BEH-2024173692$CSL BEHRING$$$$E$F$Y$$$20240923$$HP$US$US
239714233$23971423$3$F$20240608$20240813$20240613$20240816$PER$$US-AMGEN-USASP2024116415$AMGEN$$74$YR$E$F$Y$$$20240816$$CN$US$US
239714282$23971428$2$F$20240603$20240704$20240613$20240705$EXP$$CA-ABBVIE-5799508$ABBVIE$$82$YR$$M$Y$$$20240705$$HP$CA$CA
239714292$23971429$2$F$$20240709$20240613$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04736$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239714304$23971430$4$F$20240818$20240819$20240613$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095355$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240824$$CN$US$US
239714342$23971434$2$F$20240501$20240709$20240613$20240711$EXP$$US-UCBSA-2024029751$UCB$$17$YR$$M$Y$$$20240711$$CN$US$US
239714423$23971442$3$F$20240528$20240619$20240613$20240926$PER$$US-GSK-US2024AMR070030$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240926$$CN$US$US
239714462$23971446$2$F$20240604$20240701$20240613$20240709$30DAY$$US-GSK-US2024070122$GLAXOSMITHKLINE$$84$YR$$M$Y$$$20240709$$PH$US$US
239714492$23971449$2$F$$20240626$20240613$20240702$30DAY$$US-GSK-US2024AMR070147$GLAXOSMITHKLINE$$19$YR$$M$Y$$$20240702$$CN$US$US
239714504$23971450$4$F$$20240823$20240613$20240902$EXP$$US-GSK-US2024AMR069849$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$CN$US$US
239714552$23971455$2$F$$20240717$20240613$20240723$EXP$$US-SANDOZ INC.-SDZ2024US057443$SANDOZ$$$$$$Y$$$20240723$$CN$US$US
239714572$23971457$2$F$$20240712$20240613$20240718$30DAY$$FR-JNJFOC-20240614668$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$FR$FR
239714602$23971460$2$F$$20240703$20240613$20240710$EXP$$CA-TAKEDA-2024TUS058539$TAKEDA$$$$$F$Y$$$20240710$$MD$CA$CA
239714614$23971461$4$F$$20240718$20240613$20240812$EXP$$US-GILEAD-2024-0675799$GILEAD$$$$N$F$Y$3.072$KG$20240812$$HP$US$US
239714702$23971470$2$F$$20240830$20240613$20240902$PER$$NVSC2024US123888$NOVARTIS$$$$$F$Y$$$20240902$$MD$US$US
239714722$23971472$2$F$20240501$20240903$20240613$20240923$PER$$US-TEVA-VS-3206140$TEVA$$35$YR$$M$Y$$$20240923$$CN$US$US
239714732$23971473$2$F$20240607$20240611$20240613$20240812$EXP$$TW-BAYER-2024A085114$BAYER$$71$YR$E$M$Y$$$20240812$$PH$TW$TW
239714837$23971483$7$F$20231201$20240827$20240613$20240827$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033642$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$65$KG$20240827$$CN$DE$DE
239714953$23971495$3$F$20240418$20240808$20240613$20240820$EXP$FR-AFSSAPS-RE2024000498$FR-Accord-428900$ACCORD$$85$YR$E$M$Y$77$KG$20240820$$MD$FR$FR
239715243$23971524$3$F$$20240816$20240613$20240820$EXP$$NVSC2024US098333$NOVARTIS$$$$$$Y$$$20240820$$CN$US$US
239715353$23971535$3$F$20240608$20240722$20240613$20240724$PER$$US-AMGEN-USASP2024115336$AMGEN$$74$YR$E$M$Y$$$20240724$$CN$US$US
239715422$23971542$2$F$$20240829$20240613$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095517$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240903$$CN$US$US
239715432$23971543$2$F$$20240705$20240613$20240715$EXP$$US-AUROBINDO-AUR-APL-2024-028733$AUROBINDO$Gonzalez JM, Lowenhaar G, Mehta C, Cangemi R, Guidi J. RUPTURED ROOT ABSCESS WITH AORTOPULMONARYFISTULA CAUSED BYVANCOMYCIN-RESISTANT-ENTEROCOCCUS PROSTHETIC VALVE ENDOCARDITIS. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):4281$77$YR$$F$Y$$$20240715$$HP$US$US
239715532$23971553$2$F$20240612$20240704$20240613$20240709$EXP$GB-MHRA-MED-202406121927336890-TFBHM$GB-MYLANLABS-2024M1053969$MYLAN$$31$YR$$F$Y$97$KG$20240709$$MD$GB$GB
239715542$23971554$2$F$20240603$20240725$20240613$20240731$EXP$$DE-SEPTODONT-2024018708$SEPTODONT$$$$A$M$Y$$$20240731$$HP$DE$DE
239715563$23971556$3$F$20240101$20240705$20240613$20240709$EXP$$BR-UCBSA-2024020756$UCB$$$$$F$Y$63$KG$20240709$$CN$BR$BR
239715582$23971558$2$F$20240608$20240710$20240613$20240715$EXP$$GB-PFIZER INC-PV202400076351$PFIZER$$75$YR$$M$Y$$$20240715$$CN$GB$GB
239715602$23971560$2$F$20231101$20240923$20240613$20240925$EXP$$US-PFIZER INC-PV202400018215$PFIZER$$72$YR$$M$Y$65.77$KG$20240925$$CN$US$US
239715626$23971562$6$F$20240101$20240708$20240613$20240716$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016742$UNITED THERAPEUTICS$$$$$F$Y$53.061$KG$20240716$$$US$US
239715723$23971572$3$F$20240720$20240726$20240613$20240731$EXP$$GB-MYLANLABS-2024M1000737$MYLAN$$$$$M$Y$$$20240731$$HP$GB$GB
239715764$23971576$4$F$$20240903$20240613$20240906$EXP$$GB-MYLANLABS-2024M1045431$MYLAN$$$$$M$Y$$$20240906$$PH$GB$GB
239715783$23971578$3$F$$20240712$20240613$20240717$30DAY$$US-PFIZER INC-202400188842$PFIZER$$$$$$Y$$$20240717$$CN$US$US
239715805$23971580$5$F$$20240924$20240613$20240927$30DAY$$US-PFIZER INC-202400189629$PFIZER$$$$$F$Y$$$20240927$$CN$US$US
239715817$23971581$7$F$20240101$20240829$20240613$20240903$30DAY$$US-PFIZER INC-202400190434$PFIZER$$14$YR$$M$Y$56.7$KG$20240903$$CN$US$US
239715833$23971583$3$F$$20240913$20240613$20240918$30DAY$$US-PFIZER INC-202400189973$PFIZER$$14$YR$$M$Y$$$20240918$$CN$US$US
239715845$23971584$5$F$20240604$20240703$20240613$20240709$EXP$$US-PFIZER INC-202400188095$PFIZER$$10$YR$$M$Y$32.21$KG$20240709$$MD$US$US
239715883$23971588$3$F$$20240915$20240613$20240919$30DAY$$US-PFIZER INC-202400181569$PFIZER$$15$YR$$M$Y$$$20240919$$CN$US$US
239715892$23971589$2$F$$20240801$20240613$20240805$30DAY$$US-PFIZER INC-PV202400044159$PFIZER$$$$$$Y$$$20240805$$HP$US$US
239715912$23971591$2$F$$20240709$20240613$20240722$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04840$LUPIN$$$$$$Y$$$20240722$$CN$US$US
239716014$23971601$4$F$$20240826$20240613$20240829$30DAY$$US-PFIZER INC-202400189578$PFIZER$$13$YR$$M$Y$$$20240829$$CN$US$US
239716032$23971603$2$F$$20240704$20240613$20240709$EXP$$FR-HALEON-2181385$Haleon PLC$$70$YR$$M$Y$$$20240709$$HP$FR$FR
239716042$23971604$2$F$20190101$20240731$20240613$20240814$EXP$$JP-GRANULES-JP-2024GRALIT00224$GRANULES INDIA$Shoichiro Amari.Fatality owing to pulmonary hemorrhage following pamidronate disodium administration in a neonate with osteogenesis imperfecta type 2: A case report.Clinical Pediatric Endocrinology.17-JAN-2024;33(2):76-81$$$I$F$Y$1.9$KG$20240814$$MD$JP$JP
239716055$23971605$5$F$$20240823$20240613$20240828$30DAY$$US-PFIZER INC-202400189817$PFIZER$$12$YR$$M$Y$35.374$KG$20240828$$CN$US$US
239716064$23971606$4$F$$20240827$20240613$20240830$30DAY$$US-PFIZER INC-202400190469$PFIZER$$8$YR$$M$Y$$$20240830$$CN$US$US
239716076$23971607$6$F$20240524$20240915$20240613$20240919$30DAY$$US-PFIZER INC-202400189370$PFIZER$$10$YR$$F$Y$23.583$KG$20240919$$CN$US$US
239716096$23971609$6$F$20240602$20240727$20240613$20240729$30DAY$$US-PFIZER INC-PV202400018741$PFIZER$$10$YR$$M$Y$22.68$KG$20240729$$MD$US$US
239716113$23971611$3$F$$20240910$20240613$20240912$30DAY$$US-PFIZER INC-202400188587$PFIZER$$14$YR$$F$Y$$$20240912$$HP$US$US
239716322$23971632$2$F$$20240807$20240613$20240821$EXP$$US-INSMED, INC.-2024-02257-US$INSMED$$$$$F$Y$$$20240821$$CN$US$US
239716402$23971640$2$F$$20240711$20240613$20240717$30DAY$$TW-JNJFOC-20240612765$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$HP$TW$TW
239716443$23971644$3$F$20240225$20240703$20240613$20240708$PER$$US-BAYER-2024A073644$BAYER$$24$YR$A$F$Y$$$20240708$$CN$US$US
239716482$23971648$2$F$20240501$20240806$20240613$20240808$EXP$$IN-PFIZER INC-PV202400077490$PFIZER$$37$YR$$F$Y$$$20240808$$CN$IN$IN
239716492$23971649$2$F$20240101$20240626$20240613$20240701$EXP$$US-PFIZER INC-202300441214$PFIZER$$71$YR$$F$Y$$$20240701$$CN$US$US
239716522$23971652$2$F$$20240628$20240613$20240708$EXP$$US-TEVA-VS-3207270$TEVA$Bornhorst M, Eze A, Bhattacharya S, Putnam E, Almira-Suarez MI, Rossi C, et al. Optical genome mapping identifies a novel pediatric embryonal tumor with a ZNF532::NUTM1 fusion. J-Pathol 2023; 260 (3): 329-338.; Bornhorst M, Eze A, Bhattacharya S, Putnam E, Almira-Suarez MI, Rossi C, et al. Optical genome mapping identifies a novel pediatric embryonal tumor with a ZNF532::NUTM1 fusion. J-Pathol 2023; 260 (3): 329-338.$17$MON$$M$Y$$$20240708$$HP$US$US
239716753$23971675$3$F$20240501$20240724$20240613$20240725$EXP$$US-PFIZER INC-PV202400077087$PFIZER$$51$YR$$M$Y$53.968$KG$20240725$$CN$US$US
239716832$23971683$2$F$20240517$20240905$20240613$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090943$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240905$$HP$US$US
239716842$23971684$2$F$$20240910$20240613$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094057$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240910$$CN$US$US
239716873$23971687$3$F$20240420$20240702$20240613$20240704$EXP$$CA-UCBSA-2024020017$UCB$$54$YR$$F$Y$$$20240704$$CN$CA$CA
239716932$23971693$2$F$20240401$20240710$20240613$20240716$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-084753$REGENERON$$76$YR$$F$Y$$$20240716$$HP$CO$CO
239716987$23971698$7$F$$20240928$20240613$20240930$30DAY$$US-PFIZER INC-202400188459$PFIZER$$6$YR$$M$Y$$$20240930$$HP$US$US
239716992$23971699$2$F$$20240713$20240613$20240715$30DAY$$US-PFIZER INC-PV202400048380$PFIZER$$2$YR$$M$Y$$$20240715$$HP$US$US
239717013$23971701$3$F$$20240820$20240613$20240826$30DAY$$US-PFIZER INC-202400189978$PFIZER$$59$YR$$F$Y$65.77$KG$20240826$$CN$US$US
239717054$23971705$4$F$20240605$20240827$20240613$20240829$30DAY$$US-PFIZER INC-202400189606$PFIZER$$12$YR$$F$Y$$$20240829$$CN$US$US
239717102$23971710$2$F$$20240705$20240613$20240709$EXP$$US-GILEAD-2024-0676509$GILEAD$$43$YR$A$M$Y$$$20240709$$CN$US$US
239717162$23971716$2$F$20221213$20240626$20240613$20240705$EXP$$CA-MYLANLABS-2022M1140307$BIOCON$$$$$$Y$$$20240705$$CN$CA$CA
239717172$23971717$2$F$20240520$20240809$20240613$20240815$EXP$$JP-009507513-2406JPN000733J$MERCK$$8$DEC$$F$Y$$$20240815$$MD$JP$JP
239717322$23971732$2$F$$20240822$20240613$20240827$EXP$$CA-TAKEDA-2024TUS057963$TAKEDA$$$$$F$Y$$$20240827$$MD$CA$CA
239717332$23971733$2$F$$20240709$20240613$20240719$EXP$$GB-TEVA-VS-3207297$TEVA$Oke AR, Yein K, Ahmed A. EFFECTIVE TREATMENT OF LUPUS NEPHRITIS AND VASCULITIC FIBRINOID NECROTIC ULCER WITH BELIMUMAB AS ADD-ON THERAPY. Lupus-Sci-Med 2024; 11 (Suppl. 1) A107 abstr. P91.; Oke AR, Yein K, Ahmed A. EFFECTIVE TREATMENT OF LUPUS NEPHRITIS AND VASCULITIC FIBRINOID NECROTIC ULCER WITH BELIMUMAB AS ADD-ON THERAPY. Lupus-Sci-Med 2024; 11 (Suppl. 1) A107 abstr. P91.$35$YR$$F$Y$$$20240719$$HP$GB$GB
239717392$23971739$2$F$$20240709$20240613$20240716$EXP$$US-GSK-US2024070599$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$MD$US$US
239717413$23971741$3$F$20240621$20240627$20240613$20240704$EXP$$US-GSK-US2024070667$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
239717482$23971748$2$F$20240501$20240807$20240613$20240814$EXP$$US-ABBVIE-5797937$ABBVIE$$88$YR$$M$Y$$$20240814$$CN$US$US
239717664$23971766$4$F$20240601$20240813$20240613$20240815$EXP$$US-PFIZER INC-PV202400076530$PFIZER$$59$YR$$F$Y$$$20240815$$HP$US$US
239717712$23971771$2$F$20240529$20240730$20240613$20240817$PER$$US-AstraZeneca-2024A127936$ASTRAZENECA$$19813$DY$$F$Y$$$20240817$$CN$US$
239717733$23971773$3$F$20240524$20240620$20240613$20240708$PER$$US-AstraZeneca-2024A127781$ASTRAZENECA$$27699$DY$$F$Y$$$20240708$$CN$US$
239717762$23971776$2$F$20240101$20240717$20240613$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016596$UNITED THERAPEUTICS$$$$$M$Y$$$20240725$$$US$US
239717793$23971779$3$F$$20240702$20240613$20240710$EXP$$GB-CELLTRION INC.-2024GB013447$CELLTRION$Kafagi AH, Li AS,Jayne D, Brix SR.. Anti-GBM disease in pregnancy. BMJ Case Reports. 2024;17(4):e257767$$$$$Y$$$20240710$$MD$GB$GB
239717815$23971781$5$F$$20240902$20240613$20240904$30DAY$$US-PFIZER INC-202400190125$PFIZER$$15$YR$$M$Y$$$20240904$$CN$US$US
239717832$23971783$2$F$20221204$20240625$20240613$20240701$EXP$FR-AFSSAPS-PP2024000589$FR-MYLANLABS-2024M1052741$MYLAN$$63$YR$$F$Y$54.6$KG$20240701$$MD$FR$FR
239717874$23971787$4$F$$20240822$20240613$20240828$30DAY$$US-PFIZER INC-202400190647$PFIZER$$74$YR$$F$Y$$$20240828$$CN$US$US
239717886$23971788$6$F$$20240913$20240613$20240920$30DAY$$US-PFIZER INC-202400189570$PFIZER$$10$YR$$M$Y$$$20240920$$CN$US$US
239717895$23971789$5$F$20240101$20240723$20240613$20240805$30DAY$$GB-PFIZER INC-PV202400075124$PFIZER$$60$YR$$M$Y$$$20240805$$CN$GB$GB
239717902$23971790$2$F$$20240830$20240613$20240905$30DAY$$US-PFIZER INC-202400188954$PFIZER$$20$YR$$F$Y$74.84$KG$20240905$$CN$US$US
239717933$23971793$3$F$20240605$20240825$20240613$20240829$30DAY$$AR-PFIZER INC-202400188234$PFIZER$$11$YR$$F$Y$$$20240829$$CN$AR$AR
239717943$23971794$3$F$$20240826$20240613$20240830$30DAY$$NL-PFIZER INC-202400189037$PFIZER$$$$$$Y$$$20240830$$PH$NL$NL
239717982$23971798$2$F$$20240715$20240613$20240718$30DAY$$IS-JNJFOC-20240612600$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$PH$IS$IS
239718032$23971803$2$F$$20240807$20240613$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-095295$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240814$$MD$JP$JP
239718343$23971834$3$F$20240411$20240701$20240613$20240703$PER$$US-PFIZER INC-PV202400076521$PFIZER$$72$YR$$M$Y$93.605$KG$20240703$$CN$US$US
239718352$23971835$2$F$$20240714$20240613$20240715$PER$$US-PFIZER INC-PV202400075636$PFIZER$$49$YR$$F$Y$$$20240715$$CN$US$US
239718382$23971838$2$F$$20240804$20240613$20240805$EXP$$CA-PFIZER INC-202400190913$PFIZER$$74$YR$$M$Y$$$20240805$$PH$CA$CA
239718432$23971843$2$F$$20240808$20240613$20240808$EXP$$CA-PFIZER INC-202400190563$PFIZER$$75$YR$$M$Y$$$20240808$$HP$CA$CA
239718464$23971846$4$F$20230101$20240726$20240613$20240801$EXP$$HU-BIOGEN-2024BI01267047$BIOGEN$$42$YR$$F$Y$$$20240801$$MD$HU$HU
239718492$23971849$2$F$20240516$20240718$20240613$20240725$PER$$US-PFIZER INC-202400190753$PFIZER$$70$YR$$M$Y$114.3$KG$20240725$$HP$US$US
239718504$23971850$4$F$20240101$20240904$20240613$20240904$EXP$$CA-PFIZER INC-202400049597$PFIZER$$67$YR$$M$Y$$$20240904$$HP$CA$CA
239718512$23971851$2$F$$20240618$20240613$20240703$EXP$$IT-TEVA-VS-3208461$TEVA$Liccioli G, Tomei L, Pessina B, Caubet J-C, Barni S, Giovannini M, et al. The importance of clinical history in the diagnosis of drug hypersensitivity in children. Pediatr-Allergy-Immunol 2024; 35 (3):.; Liccioli G, Tomei L, Pessina B, Caubet J-C, Barni S, Giovannini M, et al. The importance of clinical history in the diagnosis of drug hypersensitivity in children. Pediatr-Allergy-Immunol 2024; 35 (3):.$$$C$$Y$$$20240703$$HP$IT$IT
239718543$23971854$3$F$$20240820$20240613$20240903$PER$$US-Calliditas-2024CAL00931$CALLIDITAS THERAPEUTICS$$60$YR$A$F$Y$74$KG$20240903$$CN$US$US
239718552$23971855$2$F$$20240920$20240613$20240926$EXP$$CA-JNJFOC-20240618267$JOHNSON AND JOHNSON$$13$YR$T$M$Y$36$KG$20240926$$PH$CA$CA
239718595$23971859$5$F$20240608$20240724$20240613$20240729$EXP$$US-009507513-2406USA003081$MERCK$$52$YR$$F$Y$110.1$KG$20240729$$MD$US$US
239718752$23971875$2$F$20240509$20240723$20240613$20240727$PER$$US-AstraZeneca-2024A134261$ASTRAZENECA$$$$$M$Y$$$20240727$$CN$US$
239718795$23971879$5$F$20230101$20240905$20240613$20240913$EXP$$JP-AstraZeneca-2024A044935$ASTRAZENECA$$77$YR$$M$Y$58$KG$20240913$$MD$JP$
239718844$23971884$4$F$20240101$20240815$20240613$20240816$EXP$$BR-JNJFOC-20240572603$JOHNSON AND JOHNSON$$59$YR$A$F$Y$62$KG$20240816$$CN$BR$BR
239718854$23971885$4$F$$20240527$20240613$20240717$EXP$$NVSC2024BR115424$NOVARTIS$$$$$M$Y$70$KG$20240717$$CN$BR$BR
239718913$23971891$3$F$20240101$20240719$20240613$20240731$EXP$$JP-AMGEN-JPNSP2024091107$AMGEN$$81$YR$E$F$Y$56.4$KG$20240731$$MD$JP$JP
239718982$23971898$2$F$$20240709$20240613$20240719$EXP$$US-TEVA-VS-3207411$TEVA$Marcus M, Kyrouac D, Rosenblatt A, Bennett AJ, Godfrey S, Cheng G, et al. STELLATE GANGLION BLOCK AS A BRIDGE TO STEREOTACTIC ABLATIVE BODY RADIOTHERAPY IN ELECTRICAL STORM. Heart-Rhythm 2024; 21 (Suppl.) (5): S225 abstr. PO-01-031.; Marcus M, Kyrouac D, Rosenblatt A, Bennett AJ, Godfrey S, Cheng G, et al. STELLATE GANGLION BLOCK AS A BRIDGE TO STEREOTACTIC ABLATIVE BODY RADIOTHERAPY IN ELECTRICAL STORM. Heart-Rhythm 2024; 21 (Suppl.) (5): S225 abstr. PO-01-031.$60$YR$$M$Y$$$20240719$$HP$US$US
239719042$23971904$2$F$20220404$20240817$20240613$20240823$EXP$$ES-AUROBINDO-AUR-APL-2024-028668$AUROBINDO$$71$YR$$M$Y$94$KG$20240823$$MD$ES$ES
239719142$23971914$2$F$$20240801$20240613$20240802$EXP$$CA-ALXN-202406CAN000577CA$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240802$$MD$CA$CA
239719162$23971916$2$F$20240605$20240702$20240613$20240708$EXP$$US-AMGEN-USASP2024113731$AMGEN$$40$YR$A$M$Y$87.99$KG$20240708$$MD$US$US
239719192$23971919$2$F$$20240821$20240613$20240826$EXP$$US-PFIZER INC-202400105855$PFIZER$$80$YR$$F$Y$$$20240826$$HP$US$US
239719312$23971931$2$F$$20240712$20240613$20240716$30DAY$$JP-JNJFOC-20240610840$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$PH$JP$JP
239719322$23971932$2$F$$20240719$20240613$20240726$EXP$$US-TAKEDA-2022TUS093597$TAKEDA$$$$$M$Y$$$20240726$$CN$US$US
239719424$23971942$4$F$20240101$20240916$20240613$20240926$EXP$$US-RADIUS HEALTH, INC.-2024US003948$RADIUS PHARM$$$$$F$Y$$$20240926$$CN$US$US
239719452$23971945$2$F$$20240807$20240613$20240813$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003295$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240813$$CN$US$US
239719462$23971946$2$F$$20240628$20240613$20240708$EXP$$US-TEVA-VS-3207269$TEVA$Saowapa S, Polpichai N, Yingchoncharoen P, Thongpiya J, Duangkham S, Siladech P, et al. The uncommon struggle: a case report of aggressive non small cell lung cancer (NSCLC) in a young individual. Am-J-Med-Sci 2024; 367 (Suppl.) S187-S188 abstr. 317.; Saowapa S, Polpichai N, Yingchoncharoen P, Thongpiya J, Duangkham S, Siladech P, et al. The uncommon struggle: a case report of aggressive non small cell lung cancer (NSCLC) in a young individual. Am-J-Med-Sci 2024; 367 (Suppl.) S187-S188 abstr....$37$YR$$F$Y$$$20240708$$HP$US$US
239719533$23971953$3$F$20220101$20240805$20240613$20240808$EXP$$US-ABBVIE-5797563$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
239719602$23971960$2$F$20220704$20240803$20240613$20240805$EXP$$CA-PFIZER INC-202400192750$PFIZER$$50$YR$$F$Y$$$20240805$$MD$CA$CA
239719632$23971963$2$F$20240611$20240709$20240613$20240710$PER$$US-AMGEN-USASP2024115436$AMGEN$$56$YR$A$$Y$$$20240710$$HP$US$US
239719842$23971984$2$F$$20240723$20240613$20240723$PER$$US-ALXN-202406USA000371US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239719932$23971993$2$F$$20240723$20240613$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091863$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240725$$CN$US$US
239719942$23971994$2$F$$20240809$20240613$20240813$EXP$$NVSC2024US123262$NOVARTIS$$$$$F$Y$$$20240813$$CN$US$US
239719953$23971995$3$F$$20240823$20240613$20240826$PER$$NVSC2024US124249$NOVARTIS$$$$$$Y$$$20240826$$MD$US$US
239720012$23972001$2$F$20220201$20240705$20240613$20240709$EXP$$IT-PFIZER INC-202400190033$PFIZER$$39$YR$$F$Y$$$20240709$$MD$IT$IT
239720082$23972008$2$F$$20240628$20240613$20240709$EXP$$US-TEVA-VS-3207205$TEVA$Tolleson T, Moore J, Batten L, Hassouneh L, Marri P, Nair A, et al. Life threatening complication of Kawasaki disease. Am-J-Med-Sci 2024; 367 (Suppl. 1) S282-S283 abstr. 470.; Tolleson T, Moore J, Batten L, Hassouneh L, Marri P, Nair A, et al. Life threatening complication of Kawasaki disease. Am-J-Med-Sci 2024; 367 (Suppl. 1) S282-S283 abstr. 470.$7$YR$$M$Y$$$20240709$$HP$US$US
239720183$23972018$3$F$20230720$20240705$20240613$20240710$30DAY$$BR-AMGEN-BRASP2024112586$AMGEN$$$$$$Y$$$20240710$$PH$BR$BR
239720353$23972035$3$F$20240101$20240809$20240613$20240816$EXP$$JP-009507513-2403JPN003887J$MERCK$$84$YR$$M$Y$$$20240816$$MD$JP$JP
239720393$23972039$3$F$20240101$20240819$20240613$20240901$EXP$$JP-UCBSA-2024029603$UCB$$5$YR$$M$Y$$$20240901$$MD$JP$JP
239720403$23972040$3$F$20240705$20240920$20240613$20240930$EXP$$CA-TAKEDA-2024TUS057728$TAKEDA$$65$YR$$M$Y$$$20240930$$HP$CA$CA
239720662$23972066$2$F$$20240709$20240613$20240719$EXP$$US-TEVA-VS-3207408$TEVA$Lee R, Zaidi W, Deanda S, Razia D, Arjuna A. CALCIUM-ALKALI SYNDROME DUE TO CALCIUM CARBONATE USE IN A LUNG TRANSPLANT RECIPIENT. Crit-Care-Med 2024; 52 (Suppl.) (1): S737 abstr. 1533.; Lee R, Zaidi W, Deanda S, Razia D, Arjuna A. CALCIUM-ALKALI SYNDROME DUE TO CALCIUM CARBONATE USE IN A LUNG TRANSPLANT RECIPIENT. Crit-Care-Med 2024; 52 (Suppl.) (1): S737 abstr. 1533.$52$YR$$M$Y$$$20240719$$HP$US$US
239720722$23972072$2$F$20231020$20240903$20240613$20240909$EXP$$JP-009507513-2311JPN000008J$MERCK$$49$YR$$M$Y$$$20240909$$MD$JP$JP
239720982$23972098$2$F$20240506$20240913$20240613$20240916$30DAY$$CL-PFIZER INC-202400192291$PFIZER$$$$$$Y$$$20240916$$CN$CL$CL
239720992$23972099$2$F$$20240808$20240613$20240808$EXP$$CA-PFIZER INC-202400191482$PFIZER$$67$YR$$F$Y$$$20240808$$CN$CA$CA
239721002$23972100$2$F$$20240728$20240613$20240730$30DAY$$CO-PFIZER INC-202400189158$PFIZER$$14$YR$$M$Y$$$20240730$$CN$CO$CO
239721013$23972101$3$F$$20240916$20240613$20240919$30DAY$$CL-PFIZER INC-PV202400071780$PFIZER$$12$YR$$F$Y$$$20240919$$CN$CL$CL
239721292$23972129$2$F$$20240911$20240613$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095533$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240911$$HP$US$US
239721322$23972132$2$F$$20240911$20240613$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092717$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240912$$CN$US$US
239721452$23972145$2$F$$20240723$20240613$20240807$EXP$$US-MDD US Operations-MDD202304-001760$MDD OPERATIONS$$66$YR$$F$Y$67.99$KG$20240807$$CN$US$
239721582$23972158$2$F$20240401$20240701$20240613$20240704$EXP$$US-UCBSA-2024028256$UCB$$28$YR$$F$Y$$$20240704$$HP$US$US
239721673$23972167$3$F$$20240828$20240613$20240903$30DAY$$MA-PFIZER INC-PV202400070636$PFIZER$$9$YR$$F$Y$$$20240903$$HP$MA$MA
239721752$23972175$2$F$20240528$20240712$20240613$20240717$PER$$US-AMGEN-USASP2024106163$AMGEN$$47$YR$A$F$Y$$$20240717$$CN$US$US
239721802$23972180$2$F$20240501$20240709$20240613$20240715$EXP$$US-ASTELLAS-2024US014863$ASTELLAS$$85$YR$$M$Y$$$20240715$$CN$US$US
239721884$23972188$4$F$20240401$20240912$20240613$20240917$PER$$US-Calliditas-2024CAL00926$CALLIDITAS THERAPEUTICS$$63$YR$A$M$Y$$$20240917$$CN$US$US
239722076$23972207$6$F$20240601$20240917$20240613$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095597$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240919$$CN$US$US
239722152$23972215$2$F$20240101$20240731$20240613$20240806$PER$$US-PFIZER INC-202400190635$PFIZER$$59$YR$$F$Y$64.41$KG$20240806$$CN$US$US
239722233$23972223$3$F$$20240911$20240613$20240918$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007116$AEGERION$$$$$F$Y$14.599$KG$20240918$$CN$US$US
239722392$23972239$2$F$$20240910$20240613$20240912$PER$$US-PFIZER INC-202400191353$PFIZER$$72$YR$$F$Y$$$20240912$$CN$US$US
239722402$23972240$2$F$20240601$20240611$20240613$20240703$PER$$US-PFIZER INC-202400191672$PFIZER$$57$YR$$F$Y$$$20240703$$HP$US$US
239722436$23972243$6$F$$20240926$20240613$20240930$EXP$$US-PFIZER INC-PV202400076738$PFIZER$$77$YR$$F$Y$$$20240930$$HP$US$US
239722453$23972245$3$F$$20240919$20240613$20240923$PER$$US-PFIZER INC-PV202400076590$PFIZER$$71$YR$$M$Y$93.9$KG$20240923$$CN$US$US
239722482$23972248$2$F$$20240802$20240613$20240802$PER$$US-PFIZER INC-202400188488$PFIZER$$72$YR$$F$Y$$$20240802$$CN$US$US
239722515$23972251$5$F$$20240820$20240613$20240822$PER$$US-PFIZER INC-PV202400076875$PFIZER$$73$YR$$F$Y$$$20240822$$CN$US$US
239722552$23972255$2$F$20221205$20240712$20240613$20240715$EXP$$JP-EMD Serono-2024031661$EMD SERONO INC$$80$YR$E$F$Y$46$KG$20240715$$MD$JP$JP
239722684$23972268$4$F$20240630$20240725$20240613$20240807$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-IBA-000194$THERATECHNOLOGIES$$$$$$Y$$$20240807$$MD$US$US
239722712$23972271$2$F$$20240612$20240613$20240730$EXP$$NVSC2024US123801$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
239722742$23972274$2$F$$20240913$20240613$20240918$EXP$$US-INCYTE CORPORATION-2024IN006161$INCYTE$$$$$$Y$$$20240918$$CN$US$US
239722812$23972281$2$F$$20240910$20240613$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094433$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240910$$CN$US$US
239722872$23972287$2$F$$20240718$20240613$20240722$EXP$$GB-ABBVIE-5799638$ABBVIE$$$$A$$Y$$$20240722$$HP$GB$GB
239723022$23972302$2$F$$20240709$20240613$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04852$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239723044$23972304$4$F$20230701$20240909$20240613$20240927$EXP$$US-SA-2024SA172455$SANOFI AVENTIS$$15$YR$T$M$Y$68.18$KG$20240927$$HP$US$US
239723112$23972311$2$F$20240515$20240912$20240613$20240918$EXP$FR-AFSSAPS-TS2024000642$FR-ABBVIE-5796302$ABBVIE$$73$YR$$M$Y$91$KG$20240918$$MD$FR$FR
239723232$23972323$2$F$20240101$20240627$20240613$20240702$EXP$$US-SA-2024SA175713$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240702$$CN$US$US
239723302$23972330$2$F$20210701$20240709$20240613$20240719$EXP$$BE-TEVA-VS-3207400$TEVA$Salif A, Bigirimana F, Willems S, Reichman G, Noels J, Wijngaert SVD, et al. Bacillus Calmette-Guerin (BCG) prostato-epididymitis in a patient treated for a non-invasive urothelial cancer: A case report. IDCases 2024; 36.; Salif A, Bigirimana F, Willems S, Reichman G, Noels J, Wijngaert SVD, et al. Bacillus Calmette-Guerin (BCG) prostato-epididymitis in a patient treated for a non-invasive urothelial cancer: A case report. IDCases 2024; 36.; Salif A, Bigirimana F, Willems S, Reichman G, Noels...$65$YR$$M$Y$$$20240719$$HP$BE$BE
239723342$23972334$2$F$20240901$20240911$20240613$20240920$PER$$US-SA-2024SA166990$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240920$$MD$US$US
239723352$23972335$2$F$20240101$20240823$20240613$20240909$PER$$US-SA-2024SA167024$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240909$$MD$US$US
239723412$23972341$2$F$20240101$20240809$20240613$20240820$PER$$US-SA-2024SA168676$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240820$$MD$US$US
239723514$23972351$4$F$20240101$20240718$20240613$20240913$PER$$US-KARYOPHARM-2024KPT001132$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240913$$CN$US$US
239723522$23972352$2$F$20240401$20240829$20240613$20240911$PER$$US-SA-2024SA170591$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240911$$MD$US$US
239723602$23972360$2$F$$20240828$20240613$20240910$PER$$US-SA-2024SA170490$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240910$$MD$US$US
239723642$23972364$2$F$20240101$20240830$20240613$20240912$PER$$US-SA-2024SA171027$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240912$$MD$US$US
239723832$23972383$2$F$20240101$20240903$20240613$20240928$PER$$US-SA-2024SA171659$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240928$$CN$US$US
239723902$23972390$2$F$20240529$20240913$20240613$20240923$PER$$US-SA-2024SA172341$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240923$$MD$US$US
239724033$23972403$3$F$20240101$20240718$20240613$20240728$PER$$US-SA-2024SA170747$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240728$$MD$US$US
239724062$23972406$2$F$20240523$20240720$20240613$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04841$LUPIN$$$$$$Y$$$20240816$$CN$US$US
239724182$23972418$2$F$$20240715$20240613$20240722$PER$$US-SA-2024SA171232$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240722$$MD$US$US
239724233$23972423$3$F$20240101$20240904$20240613$20240913$PER$$US-SA-2024SA172008$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240913$$MD$US$US
239724262$23972426$2$F$20240508$20240620$20240613$20240701$PER$$US-SA-2024SA172661$SANOFI AVENTIS$$31$YR$A$M$Y$112$KG$20240701$$MD$US$US
239724433$23972443$3$F$20240301$20240726$20240613$20240805$EXP$$ES-AURINIA PHARMACEUTICALS INC.-AUR-006018$AURINIA PHARMACEUTICALS$LN with persistent proteinuria with preserved eGFR. Voclosporin: Renal Clinical Practice$$$$$Y$$$20240805$$MD$ES$ES
239724502$23972450$2$F$20240101$20240917$20240613$20240925$PER$$US-SA-2024SA170195$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240925$$MD$US$US
239724642$23972464$2$F$$20240717$20240613$20240726$PER$$US-SA-2024SA170570$SANOFI AVENTIS$$$$A$F$Y$86.1$KG$20240726$$MD$US$US
239724722$23972472$2$F$20240101$20240703$20240613$20240712$PER$$US-SA-2024SA170696$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240712$$MD$US$US
239724732$23972473$2$F$20240101$20240724$20240613$20240802$PER$$US-SA-2024SA172767$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240802$$MD$US$US
239724803$23972480$3$F$20240101$20240807$20240613$20240821$PER$$US-SA-2024SA170766$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240821$$MD$US$US
239724812$23972481$2$F$$20240903$20240613$20240912$PER$$US-SA-2024SA170551$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240912$$MD$US$US
239724902$23972490$2$F$20240501$20240815$20240613$20240828$PER$$US-SA-2024SA170556$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240828$$MD$US$US
239724923$23972492$3$F$20240604$20240903$20240613$20240928$PER$$US-SA-2024SA171253$SANOFI AVENTIS$$12$MON$I$M$Y$$$20240928$$MD$US$US
239725054$23972505$4$F$$20240912$20240613$20240913$30DAY$$CL-PFIZER INC-202400088930$PFIZER$$11$YR$$F$Y$$$20240913$$CN$CL$CL
239725152$23972515$2$F$20240605$20240705$20240613$20240717$PER$$US-SA-2024SA114880$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240717$$CN$US$US
239725222$23972522$2$F$20240501$20240826$20240613$20240917$PER$$US-SA-2024SA172085$SANOFI AVENTIS$$14$YR$T$M$Y$74.55$KG$20240918$$MD$US$US
239725252$23972525$2$F$$20240809$20240613$20240816$EXP$$CA-GSK-CA2024032321$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$CA$CA
239725272$23972527$2$F$20240401$20240722$20240613$20240731$PER$$US-SA-2024SA175945$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240731$$MD$US$US
239725284$23972528$4$F$20240101$20240725$20240613$20240730$EXP$$US-SA-2024SA172975$SANOFI AVENTIS$$54$YR$A$M$Y$88.435$KG$20240730$$CN$US$US
239725312$23972531$2$F$20240101$20240826$20240613$20240909$PER$$US-SA-2024SA174631$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240909$$MD$US$US
239725332$23972533$2$F$20240101$20240808$20240613$20240815$PER$$US-SA-2024SA174765$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240815$$MD$US$US
239725362$23972536$2$F$$20240916$20240613$20240923$PER$$US-SA-2024SA172147$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240923$$MD$US$US
239725482$23972548$2$F$20240606$20240702$20240613$20240711$PER$$US-SA-2024SA172935$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240711$$CN$US$US
239725492$23972549$2$F$20240401$20240628$20240613$20240709$PER$$US-SA-2024SA174912$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240709$$MD$US$US
239725622$23972562$2$F$20240101$20240821$20240613$20240905$PER$$US-SA-2024SA175877$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240905$$MD$US$US
239725663$23972566$3$F$20240531$20240701$20240613$20240716$PER$$US-SA-2024SA176014$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240716$$MD$US$US
239725692$23972569$2$F$20240101$20240730$20240613$20240808$PER$$US-SA-2024SA175393$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240808$$MD$US$US
239725822$23972582$2$F$$20240627$20240613$20240708$PER$$US-SA-2024SA176104$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240708$$MD$US$US
239725902$23972590$2$F$$20240717$20240613$20240725$PER$$US-SA-2024SA175888$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240725$$HP$US$US
239725942$23972594$2$F$20240607$20240707$20240613$20240715$PER$$US-SA-2024SA175781$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240715$$CN$US$US
239726112$23972611$2$F$20231212$20240722$20240613$20240729$EXP$FR-AFSSAPS-AM2024000456$FR-SA-2024SA173148$SANOFI AVENTIS$$22$WK$I$M$Y$$$20240729$$MD$FR$FR
239726212$23972621$2$F$$20240705$20240613$20240715$EXP$$US-AUROBINDO-AUR-APL-2024-028463$AUROBINDO$Akel MB, Condren ME, Passmore SJ. Brexpiprazole toxicity in a paediatric patient.. BMJ-CaseRep. 2024;17:5$$$C$M$Y$25.4$KG$20240715$$HP$US$US
239726222$23972622$2$F$20240501$20240719$20240613$20240729$PER$$US-SA-2024SA170518$SANOFI AVENTIS$$76$YR$E$F$Y$61.2$KG$20240729$$CN$US$US
239726272$23972627$2$F$$20240705$20240613$20240715$EXP$$US-TEVA-VS-3207066$TEVA$Rankine M, Hoppe I, Wright-Sexton L. FATAL DISEASE DISGUISED AS ARM SWELLING IN A PEDIATRIC PATIENT. Crit-Care-Med 2024; 52 (Suppl.) (1): S380 abstr. 816.; Rankine M, Hoppe I, Wright-Sexton L. FATAL DISEASE DISGUISED AS ARM SWELLING IN A PEDIATRIC PATIENT. Crit-Care-Med 2024; 52 (Suppl.) (1): S380 abstr. 816.$2$YR$$F$Y$$$20240715$$HP$US$US
239726282$23972628$2$F$20240507$20240620$20240613$20240701$EXP$$JP-UCBSA-2024030208$UCB$$49$YR$$M$Y$$$20240701$$MD$JP$JP
239726392$23972639$2$F$$20240705$20240613$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095351$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240724$$CN$US$US
239726432$23972643$2$F$$20240705$20240613$20240715$EXP$$US-TEVA-VS-3206958$TEVA$Taseer AR, Velez JCQ. MIDODRINE-INDUCED URINARY RETENTION AS A CAUSE OF ACUTE KIDNEY INJURY IN CIRRHOSIS: NOT ALWAYS HEPATORENAL BUT THE FAILED THERAPY FOR IT. Am-J-Kidney-Dis 2024; 83 (Suppl. 2) (4): S4-S5 abstr. 13.; Taseer AR, Velez JCQ. MIDODRINE-INDUCED URINARY RETENTION AS A CAUSE OF ACUTE KIDNEY INJURY IN CIRRHOSIS: NOT ALWAYS HEPATORENAL BUT THE FAILED THERAPY FOR IT. Am-J-Kidney-Dis 2024; 83 (Suppl. 2) (4): S4-S5 abstr. 13.$66$YR$$M$Y$$$20240715$$HP$US$US
239726566$23972656$6$F$20240601$20240923$20240613$20240926$EXP$$NZ-MYLANLABS-2024M1053631$MYLAN$$63$YR$$M$Y$92.998$KG$20240926$$CN$NZ$NZ
239726632$23972663$2$F$20240101$20240701$20240613$20240709$PER$$US-JNJFOC-20240627891$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240709$$HP$US$US
239726814$23972681$4$F$$20240821$20240613$20240826$30DAY$$US-PFIZER INC-202400186564$PFIZER$$15$YR$$M$Y$46.9$KG$20240826$$MD$US$US
239726883$23972688$3$F$20240401$20240717$20240613$20240721$EXP$$NVSC2024US100641$NOVARTIS$$58$YR$$F$Y$$$20240722$$CN$US$US
239726933$23972693$3$F$20240425$20240714$20240613$20240715$PER$$US-PFIZER INC-PV202400051156$PFIZER$$70$YR$$F$Y$$$20240715$$CN$US$US
239727018$23972701$8$F$20240101$20240826$20240613$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-016107$UNITED THERAPEUTICS$$$$$F$Y$88.435$KG$20240904$$$US$US
239727033$23972703$3$F$20240101$20240809$20240613$20240819$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-009197$JAZZ$$20$YR$$M$Y$$$20240819$$MD$JP$JP
239727673$23972767$3$F$20231023$20240714$20240613$20240715$EXP$$AU-PFIZER INC-202400182350$PFIZER$$75$YR$$F$Y$90$KG$20240715$$MD$AT$AT
239727693$23972769$3$F$20240521$20240802$20240613$20240808$EXP$$DE-GSK-DE2024EME070533$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$MD$DE$DE
239727753$23972775$3$F$$20240919$20240613$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202406002228$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240923$$CN$US$US
239727822$23972782$2$F$$20240703$20240613$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202406001094$ELI LILLY AND CO$$79$YR$E$F$Y$104$KG$20240715$$MD$US$US
239727832$23972783$2$F$$20240606$20240613$20240801$PER$$US-LUNDBECK-DKLU3078323$LUNDBECK$$$$$$Y$$$20240801$$CN$US$US
239727912$23972791$2$F$20240605$20240920$20240613$20240926$EXP$$CA-JNJFOC-20240626229$JOHNSON AND JOHNSON$$6$YR$C$F$Y$$$20240926$$HP$CA$CA
239727965$23972796$5$F$20240531$20240710$20240613$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008825$JAZZ$$25$YR$$F$Y$$$20240716$$MD$US$US
239728192$23972819$2$F$$20240718$20240613$20240724$EXP$$JP-PFIZER INC-202400191774$PFIZER$$$$$F$Y$$$20240724$$MD$JP$JP
239728332$23972833$2$F$$20240719$20240613$20240722$EXP$$US-AstraZeneca-2024A131583$ASTRAZENECA$$$$A$F$Y$$$20240722$$HP$US$
239728352$23972835$2$F$20180201$20240628$20240613$20240708$EXP$$US-TEVA-VS-3207232$TEVA$Lu Z, Afzal M, Shirai K. Durable complete response to early immunotherapy discontinuation in a kidney transplant recipient with advanced cutaneous squamous cell carcinoma: A case report and review of literature. Transpl-Immunol 2023; 81.; Lu Z, Afzal M, Shirai K. Durable complete response to early immunotherapy discontinuation in a kidney transplant recipient with advanced cutaneous squamous cell carcinoma: A case report and review of literature. Transpl-Immunol 2023; 81.$77$YR$$M$Y$$$20240708$$MD$US$US
239728423$23972842$3$F$20240101$20240816$20240613$20240821$PER$$US-AMGEN-USASP2024116471$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
239728482$23972848$2$F$20240507$20240708$20240613$20240722$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT001483$CORCEPT$$$$$$Y$$$20240722$$MD$US$US
239728563$23972856$3$F$20240101$20240909$20240613$20240916$PER$$US-BEH-2024173128$CSL BEHRING$$65$YR$E$F$Y$71.655$KG$20240916$$HP$US$US
239728603$23972860$3$F$20240214$20240715$20240613$20240720$30DAY$$US-AMGEN-USASP2024112949$AMGEN$$90$YR$E$F$Y$48.5$KG$20240720$$HP$US$US
239728693$23972869$3$F$20211122$20240703$20240613$20240712$EXP$IE-HPRA-2024-113115$IE-TEVA-VS-3206961$TEVA$$$$N$F$Y$1.535$KG$20240712$$MD$IE$IE
239728704$23972870$4$F$20230301$20240905$20240613$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-094513$BRISTOL MYERS SQUIBB$Yabuki S, Hirai H, Moriya C, Kusano Y, Hasegawa T. Case report: strong GAD antibody positivity and type 1 diabetes-HLA-susceptible haplotype-DRB1*04:05-DQB1*04:01 in a Japanese patient with immune checkpoint inhibitor-induced type 1 diabetes. Frontiers in Endocrinology. 2024 May 22;15:1-9. doi:10.3389/fendo.2024.1407192.$66$YR$E$M$Y$62.1$KG$20240917$$MD$JP$JP
239728712$23972871$2$F$$20240910$20240613$20240912$EXP$$US-JNJFOC-20240618244$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
239729003$23972900$3$F$20231101$20240813$20240613$20240904$EXP$$JP-BAYER-2024A059994$BAYER$$74$YR$E$M$Y$45.3$KG$20240904$$MD$JP$JP
239729012$23972901$2$F$20240510$20240708$20240613$20240711$EXP$$NVSC2024MX112624$NOVARTIS$$60$YR$$F$Y$92$KG$20240711$$CN$MX$MX
239729162$23972916$2$F$20240612$20240619$20240613$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095665$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240718$$CN$US$US
239729253$23972925$3$F$20240531$20240806$20240613$20240809$EXP$$GB-JNJFOC-20240622711$JOHNSON AND JOHNSON$$$$A$F$Y$92$KG$20240809$$MD$GB$GB
239729262$23972926$2$F$20240521$20240618$20240613$20240715$EXP$$CH-LUNDBECK-DKLU4000347$LUNDBECK$$$$$$Y$$$20240715$$MD$CH$CH
239729282$23972928$2$F$$20240712$20240613$20240718$EXP$$BE-MYLANLABS-2024M1052943$MYLAN$Teuwen DE, Ndayisenga A, Garrez I, Sebera F, Mutungirehe S, Umwiringirwa J, et al.. Challenges to epilepsy management in Rwandan women living with epilepsy. European Journal of Neurology. 2024;31(6):1-10$$$$F$Y$$$20240718$$HP$BE$BE
239729302$23972930$2$F$$20240709$20240613$20240712$EXP$$FR-MYE-2023M1012094AA$MYLAN$Ridley A, Vial-Cholley E, Robert G, Jounis-Jahan F, Lervat C, Betremieux P, et al.. Nationwide Study of Continuous Deep Sedation Practices Among Pediatric Palliative Care Teams.. J-Pain-Symptom-Manage. 2023;65 (4):308-317$19$YR$$F$Y$50$KG$20240712$$MD$FR$FR
239729332$23972933$2$F$20240606$20240612$20240613$20240708$PER$$US-AstraZeneca-2024A132533$ASTRAZENECA$$29416$DY$$F$Y$$$20240708$$CN$US$
239729352$23972935$2$F$$20240723$20240613$20240723$PER$$US-ALXN-202406USA000463US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$PH$US$US
239729373$23972937$3$F$$20240711$20240613$20240718$PER$$US-ALXN-202405USA002350US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
239729432$23972943$2$F$20230101$20240704$20240613$20240710$EXP$$CO-JNJFOC-20231075169$JOHNSON AND JOHNSON$$64$YR$A$M$Y$85$KG$20240710$$HP$CO$CO
239729452$23972945$2$F$20230101$20240628$20240613$20240702$EXP$$BR-JNJFOC-20240589630$JOHNSON AND JOHNSON$$19$YR$A$M$Y$50$KG$20240702$$CN$BR$BR
239729492$23972949$2$F$$20240723$20240613$20240801$PER$$US-SA-2024SA173275$SANOFI AVENTIS$$$$A$F$Y$92.531$KG$20240801$$MD$US$US
239729552$23972955$2$F$$20240725$20240613$20240725$PER$$NVSC2024US124100$NOVARTIS$$$$$$Y$$$20240726$$MD$US$US
239729573$23972957$3$F$20240401$20240627$20240613$20240702$EXP$$US-ABBVIE-5784817$ABBVIE$$54$YR$$M$Y$$$20240702$$CN$US$US
239729612$23972961$2$F$20220401$20240715$20240613$20240723$PER$$US-SA-2024SA171796$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240723$$MD$US$US
239729623$23972962$3$F$$20240807$20240613$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-013180$JAZZ$$$$$M$Y$$$20240813$$CN$US$US
239729632$23972963$2$F$$20240620$20240613$20240703$EXP$$ES-TEVA-VS-3207583$TEVA$Cabezas-Camarero S, Garcia-Barberan V, Perez-Alfayate R, del Pulgar MEG, Cabrera-Martin MN, Casado-Farinas I, et al. Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With Vismodegib. Oncologist 2024; 29 (5): 377-383.; Cabezas-Camarero S, Garcia-Barberan V, Perez-Alfayate R, del Pulgar MEG, Cabrera-Martin MN, Casado-Farinas I, et al. Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With Vism...$23$YR$$F$Y$$$20240703$$MD$ES$ES
239729643$23972964$3$F$20240801$20240820$20240613$20240829$PER$$US-SA-2024SA176235$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240829$$MD$US$US
239729702$23972970$2$F$20240601$20240722$20240613$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033705$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240723$$CN$US$US
239729723$23972972$3$F$20240509$20240827$20240613$20240903$EXP$$DE-FreseniusKabi-FK202409165$FRESENIUS KABI$$73$YR$E$M$Y$100$KG$20240903$$HP$DE$DE
239729762$23972976$2$F$20240301$20240729$20240613$20240806$EXP$$DE-FreseniusKabi-FK202409167$FRESENIUS KABI$$81$YR$E$M$Y$75$KG$20240806$$MD$DE$DE
239729833$23972983$3$F$20240101$20240703$20240613$20240718$PER$$US-Eisai-EC-2024-165786$EISAI$$79$YR$E$M$Y$109$KG$20240718$$CN$US$US
239729842$23972984$2$F$20240530$20240612$20240613$20240705$PER$$US-Eisai-EC-2024-167170$EISAI$$83$YR$E$M$Y$83$KG$20240705$$HP$US$US
239729942$23972994$2$F$20240413$20240627$20240613$20240703$EXP$$US-JNJFOC-20240622424$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240703$$CN$US$US
239730043$23973004$3$F$$20240726$20240613$20240729$EXP$$US-PFIZER INC-PV202400077169$PFIZER$$57$YR$$F$Y$69.388$KG$20240729$$HP$US$US
239730075$23973007$5$F$20240101$20240816$20240613$20240821$EXP$$US-SA-2024SA171918$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240821$$MD$US$US
239730132$23973013$2$F$20231001$20240805$20240613$20240814$PER$$US-SA-2024SA171797$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240814$$MD$US$US
239730512$23973051$2$F$$20230623$20240613$20240715$EXP$$US-NOVOPROD-1222304$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
239730552$23973055$2$F$$20240705$20240613$20240709$EXP$$HU-ABBVIE-5798393$ABBVIE$$$$$M$Y$$$20240709$$MD$HU$HU
239730574$23973057$4$F$20240607$20240910$20240613$20240911$30DAY$$AR-PFIZER INC-202400190550$PFIZER$$11$YR$$F$Y$28.3$KG$20240911$$CN$AR$AR
239730592$23973059$2$F$$20240604$20240613$20240716$PER$$US-TRAVERE-2024TVT00506$TRAVERE THERAPEUTICS$$39$YR$A$F$Y$$$20240716$$CN$US$US
239730716$23973071$6$F$20230921$20240809$20240613$20240812$EXP$ES-AEMPS-1532996$ES-BIOVITRUM-2024-ES-008508$BIOVITRUM$$83$YR$$F$Y$$$20240812$$MD$ES$ES
239730802$23973080$2$F$20230330$20240809$20240613$20240812$EXP$$JP-ABBVIE-5798139$ABBVIE$$57$YR$$F$Y$$$20240812$$PH$JP$JP
239730833$23973083$3$F$20240607$20240826$20240613$20240905$EXP$$JP-009507513-2406JPN000954J$MERCK$$8$DEC$$M$Y$$$20240905$$MD$JP$JP
239730963$23973096$3$F$20240523$20240731$20240613$20240808$EXP$$JP-AstraZeneca-2024A132993$ASTRAZENECA$$89$YR$$F$Y$43$KG$20240808$$MD$JP$
239730972$23973097$2$F$$20240723$20240613$20240723$PER$$US-ALXN-202406USA000383US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239730984$23973098$4$F$$20240709$20240613$20240726$EXP$$JP-ORG100014127-2024000164$HRA PHARMA$K Sato, T Suzuki, K Akaike, D Uchihara, O Ichii, M Tai, T Takagi  ? H Hakozaki, Y Ejiri. A case of gallbladder neuroendocrine carcinoma complicated by ectopic adrenocorticotropic hormone syndrome and resulting in rapid fetal outcomes due to sepsis. Received: 12 March 2024 / Accepted: 14 May 2024.;Akaike K, Hakozaki H, Kato T, Sasajima T, Kida S, Uchihara D, et al. Autopsy case of primary neuroendocrine carcinoma of the gallbladder presenting with Cushing^s syndrome. The 170 Annual Meeting of th$52$YR$$F$Y$$$20240726$$MD$JP$JP
239731232$23973123$2$F$20230223$20240701$20240613$20240709$EXP$FR-AFSSAPS-TO2024000894$FR-TEVA-VS-3207813$TEVA$$9$YR$$M$Y$25$KG$20240709$$MD$FR$FR
239731312$23973131$2$F$$20240705$20240613$20240715$EXP$$US-TEVA-VS-3207057$TEVA$Nowakowski H, Atari M, Dossabhoy N, Obi Y, Hassanein M. NOT YOUR BASIC SHOCK: PROFOUND METFORMIN-ASSOCIATED LACTIC ACIDOSIS REFRACTORY TO FOUR VASOPRESSORS. Am-J-Kidney-Dis 2024; 83 (Suppl. 2) (4): S39 abstr. 131.; Nowakowski H, Atari M, Dossabhoy N, Obi Y, Hassanein M. NOT YOUR BASIC SHOCK: PROFOUND METFORMIN-ASSOCIATED LACTIC ACIDOSIS REFRACTORY TO FOUR VASOPRESSORS. Am-J-Kidney-Dis 2024; 83 (Suppl. 2) (4): S39 abstr. 131.$26$YR$$F$Y$$$20240715$$HP$US$US
239731396$23973139$6$F$20240401$20240822$20240613$20240829$EXP$$CA-GSK-CA2023AMR100106$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$HP$CA$CA
239731413$23973141$3$F$20240501$20240710$20240613$20240715$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003266$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240715$$HP$CA$CA
239731594$23973159$4$F$$20240910$20240613$20240930$PER$$US-TRAVERE-2024TVT00507$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
239731622$23973162$2$F$$20240912$20240613$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095766$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$PH$US$US
239731642$23973164$2$F$$20240911$20240613$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095375$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240911$$HP$US$US
239731762$23973176$2$F$$20240712$20240613$20240722$PER$$US-SA-2024SA171444$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240722$$MD$US$US
239731783$23973178$3$F$$20240816$20240613$20240823$EXP$$US-TAKEDA-2021TUS037485$TAKEDA$$$$$F$Y$92$KG$20240823$$CN$US$US
239731822$23973182$2$F$20240601$20240627$20240613$20240701$EXP$$DE-KYOWAKIRIN-2024KK014347$KYOWA$$$$$$Y$$$20240701$$HP$DE$DE
239731942$23973194$2$F$$20240723$20240613$20240731$EXP$$SE-AstraZeneca-2024A133824$ASTRAZENECA$$$$$M$Y$$$20240731$$HP$SE$
239731992$23973199$2$F$20240503$20240705$20240613$20240710$PER$$US-MYLANLABS-2024M1052858$MYLAN$$47$YR$$$Y$59$KG$20240710$$CN$US$US
239732033$23973203$3$F$$20240623$20240613$20240708$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK091438$GLENMARK$Ilyas-Feldmann M, Langer O, Bauer M, Asselin M, Hendrikse NH, Sisodiya SM et al.. Tolerability of tariquidar -a third generation p-gp inhibitor as add-on medication to antiseizure medications in drug-resistant epilepsy.. Seizure. 2024;119:44-51$$$$$Y$$$20240708$$HP$GB$GB
239732062$23973206$2$F$$20240703$20240613$20240709$PER$$US-BIOMARINAP-US-2024-158490$BIOMARIN$$$$$$Y$$$20240709$$CN$US$US
239732192$23973219$2$F$$20240714$20240613$20240715$PER$$US-PFIZER INC-PV202400076565$PFIZER$$2$YR$$M$Y$14.9$KG$20240715$$HP$US$US
239732392$23973239$2$F$$20240621$20240613$20240701$PER$$US-AstraZeneca-2024A135414$ASTRAZENECA$$$$$M$Y$$$20240701$$CN$US$
239732483$23973248$3$F$20240101$20240618$20240613$20240703$EXP$$GB-APELLIS-APL-2024-003917$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240703$$HP$GB$GB
239732575$23973257$5$F$$20240917$20240613$20240920$30DAY$$US-PFIZER INC-202400190992$PFIZER$$14$YR$$F$Y$$$20240920$$CN$US$US
239732584$23973258$4$F$$20240909$20240613$20240911$30DAY$$CO-PFIZER INC-202400185376$PFIZER$$9$YR$$F$Y$$$20240911$$CN$CO$CO
239732613$23973261$3$F$$20240704$20240613$20240706$EXP$$BR-JNJFOC-20240623901$JOHNSON AND JOHNSON$$$$$M$Y$$$20240706$$CN$BR$BR
239732622$23973262$2$F$20240101$20240702$20240613$20240711$EXP$$US-TEVA-VS-3205694$TEVA$$20$YR$$F$Y$$$20240711$$HP$US$US
239732642$23973264$2$F$20240101$20240726$20240613$20240731$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003190$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240731$$MD$US$US
239732662$23973266$2$F$20210407$20240701$20240613$20240704$EXP$$FR-KYOWA KIRIN , INC.-2024KK011803$KYOWA$$$$$$Y$$$20240704$$HP$FR$FR
239732714$23973271$4$F$20240327$20240717$20240613$20240726$PER$$NVSC2024US124307$NOVARTIS$$72$YR$$F$Y$67.5$KG$20240726$$MD$US$US
239732855$23973285$5$F$20240601$20240805$20240613$20240807$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-126377$DAIICHI$$63$YR$$M$Y$$$20240807$$CN$US$US
239732892$23973289$2$F$$20240701$20240613$20240710$EXP$$DK-ELI_LILLY_AND_COMPANY-DK202406003453$ELI LILLY AND CO$$$$$M$Y$$$20240710$$CN$DK$DK
239733072$23973307$2$F$20240425$20240731$20240613$20240806$EXP$$US-APELLIS-2024-APL-0000113$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240806$$HP$US$US
239733132$23973313$2$F$$20240710$20240613$20240715$PER$$NVSC2024US124305$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
239733203$23973320$3$F$20190501$20240717$20240613$20240719$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-094336$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$76.2$KG$20240719$$CN$CA$CA
239733332$23973333$2$F$20231110$20240624$20240613$20240708$EXP$FR-AFSSAPS-NC2024000650$FR-MYLANLABS-2024M1052729$MYLAN$$37$YR$$F$Y$205$KG$20240708$$MD$FR$FR
239733783$23973378$3$F$$20240913$20240613$20240919$30DAY$$VE-PFIZER INC-202400174879$PFIZER$$$$$$Y$$$20240919$$CN$VE$VE
239733812$23973381$2$F$20230901$20240722$20240613$20240801$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2024-084338$REGENERON$$61$YR$$M$Y$$$20240801$$MD$GB$GB
239733984$23973398$4$F$20240602$20240708$20240613$20240812$EXP$$US-APELLIS-2024-APL-0000234$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240808$$MD$US$US
239734013$23973401$3$F$20230101$20240628$20240613$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202402010819$ELI LILLY AND CO$$63$YR$A$F$Y$56.236$KG$20240705$$CN$US$US
239734042$23973404$2$F$$20240628$20240613$20240708$EXP$$US-TEVA-VS-3207216$TEVA$Levin MF, Cochrane AB, Tanna S, Patel A, Marinak L, Kopp M, et al. Scedosporium Brain Abscess in a Lung Transplant Recipient Treated with Belatacept. J-Heart-Lung-Transplant 2024; 43 (Suppl.) (4): S482 abstr. 1033.; Levin MF, Cochrane AB, Tanna S, Patel A, Marinak L, Kopp M, et al. Scedosporium Brain Abscess in a Lung Transplant Recipient Treated with Belatacept. J-Heart-Lung-Transplant 2024; 43 (Suppl.) (4): S482 abstr. 1033.$65$YR$$F$Y$$$20240708$$HP$US$US
239734062$23973406$2$F$20240612$20240703$20240613$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095244$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240704$$CN$US$US
239734113$23973411$3$F$$20240723$20240613$20240805$EXP$$US-ALXN-202406USA000390US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
239734142$23973414$2$F$20230727$20240708$20240613$20240722$EXP$$US-MDD US Operations-MDD202310-003907$MDD OPERATIONS$$83$YR$$F$Y$$$20240722$$CN$US$
239734302$23973430$2$F$20231023$20240820$20240613$20240903$EXP$$US-MDD US Operations-MDD202310-004165$MDD OPERATIONS$$73$YR$$M$Y$$$20240903$$HP$US$
239734742$23973474$2$F$20240501$20240830$20240613$20240905$EXP$$NVSC2024GB097973$NOVARTIS$$$$$F$Y$$$20240905$$CN$GB$GB
239734792$23973479$2$F$$20240604$20240613$20240731$PER$$US-LUNDBECK-DKLU3078517$LUNDBECK$$$$$$Y$$$20240731$$CN$US$US
239734852$23973485$2$F$20240606$20240716$20240613$20240725$30DAY$$US-MYLANLABS-2024M1052582$MYLAN$$5$YR$$M$Y$$$20240725$$CN$US$US
239734913$23973491$3$F$20240213$20240708$20240613$20240712$EXP$$US-UROVANT SCIENCES GMBH-202406-URV-000830$UROVANT SCIENCES$$69$YR$$F$Y$116.1$KG$20240712$$CN$US$US
239734923$23973492$3$F$$20240813$20240613$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002526$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
239734955$23973495$5$F$20240508$20240820$20240613$20240823$EXP$$JP-Eisai-EC-2024-167642$EISAI$$68$YR$E$F$Y$$$20240823$$MD$JP$JP
239734983$23973498$3$F$$20240813$20240613$20240816$EXP$$US-MYLANLABS-2024M1053867$MYLAN$$$$$F$Y$$$20240816$$CN$US$US
239735012$23973501$2$F$$20240912$20240613$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095635$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$PH$US$US
239735043$23973504$3$F$$20240819$20240613$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002532$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
239735052$23973505$2$F$20240802$20240805$20240613$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002529$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240828$$CN$US$US
239735142$23973514$2$F$20240607$20240920$20240613$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US056975$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
239735154$23973515$4$F$20240611$20240723$20240613$20240729$30DAY$$US-JNJFOC-20240627483$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240729$$HP$US$US
239735162$23973516$2$F$$20240625$20240613$20240710$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00453$UPSHER-SMITH$$$$$M$Y$$$20240710$$HP$US$US
239735172$23973517$2$F$20240601$20240801$20240613$20240807$PER$$US-BIOGEN-2024BI01268253$BIOGEN$$44$YR$$F$Y$$$20240807$$CN$US$US
239735253$23973525$3$F$$20240731$20240613$20240808$EXP$$CA-AstraZeneca-2024A089902$ASTRAZENECA$$$$$M$Y$$$20240808$$HP$CA$
239735494$23973549$4$F$20240101$20240827$20240613$20240910$EXP$$US-MDD US Operations-MDD202401-000058$MDD OPERATIONS$$79$YR$$F$Y$$$20240910$$HP$US$
239735873$23973587$3$F$20230606$20240731$20240613$20240807$EXP$$CA-SANDOZ INC.-NVSC2023CA132044$SANDOZ$$77$YR$$M$Y$$$20240807$$MD$CA$CA
239735912$23973591$2$F$20210801$20240826$20240613$20240829$30DAY$$CA-SANDOZ INC.-NVSC2021CA229407$SANDOZ$$60$YR$$F$Y$$$20240829$$CN$CA$CA
239736012$23973601$2$F$20240605$20240703$20240613$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406006318$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240705$$CN$US$US
239736152$23973615$2$F$$20240628$20240613$20240708$EXP$$US-TEVA-VS-3207276$TEVA$Bliton K, Jordan M, Patterson P, Warren J. RESTLESSNESS IS A PAIN: METHADONE INDUCED AUGMENTATION. Sleep 2024; 47 (Suppl. 1) A505 abstr. 1180.; Bliton K, Jordan M, Patterson P, Warren J. RESTLESSNESS IS A PAIN: METHADONE INDUCED AUGMENTATION. Sleep 2024; 47 (Suppl. 1) A505 abstr. 1180.$$$$M$Y$$$20240708$$HP$US$US
239736163$23973616$3$F$$20240710$20240613$20240715$EXP$$CA-SANDOZ INC.-SDZ2024CA056979$SANDOZ$$65$YR$$M$Y$$$20240715$$HP$CA$CA
239736183$23973618$3$F$$20240722$20240613$20240722$PER$$US-ALXN-202406USA000202US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
239736192$23973619$2$F$20240101$20240628$20240613$20240701$EXP$$US-PFIZER INC-PV202400077671$PFIZER$$52$YR$$F$Y$77.111$KG$20240701$$CN$US$US
239736402$23973640$2$F$$20240702$20240613$20240703$PER$$US-PFIZER INC-PV202400076442$PFIZER$$69$YR$$F$Y$$$20240703$$HP$US$US
239736422$23973642$2$F$$20240620$20240613$20240703$EXP$$JP-TEVA-VS-3207523$TEVA$Akimoto T, Hara M, Hirose S, Nakamichi K, Nakajima H. Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome. Neurol-Int 2023; 15 (3): 917-925.; Akimoto T, Hara M, Hirose S, Nakamichi K, Nakajima H. Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome. Neurol-Int 2023; 15 (3): 917-925.$57$YR$$F$Y$$$20240703$$HP$JP$JP
239737052$23973705$2$F$$20240815$20240613$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094875$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240820$$CN$US$US
239737142$23973714$2$F$$20240722$20240613$20240723$EXP$$US-ALXN-202406USA000320US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239737162$23973716$2$F$$20240712$20240613$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095181$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240716$$CN$US$US
239737242$23973724$2$F$$20240628$20240613$20240708$EXP$$US-TEVA-VS-3207268$TEVA$Slamowitz A, Nickerson T. PROLONGED ECMO REQUIREMENT FOR AN ADOLESCENT WITH AMLODIPINE OVERDOSE. Crit-Care-Med 2024; 52 (Suppl.) (1): S719 abstr. 1496.; Slamowitz A, Nickerson T. PROLONGED ECMO REQUIREMENT FOR AN ADOLESCENT WITH AMLODIPINE OVERDOSE. Crit-Care-Med 2024; 52 (Suppl.) (1): S719 abstr. 1496.$17$YR$$F$Y$$$20240708$$HP$US$US
239737272$23973727$2$F$$20240818$20240613$20240823$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001194$BLUEPRINT MEDICINES$$$$$F$Y$$$20240823$$CN$US$US
239737402$23973740$2$F$20200801$20240620$20240613$20240703$EXP$$CH-TEVA-VS-3207676$TEVA$Wiss FM, Allemann SS, Meyer zu Schwabedissen HE, Stauble CK, Mikoteit T, Lampert ML. Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction. Front-Psychiatry 2024; 15 (0):.; Wiss FM, Allemann SS, Meyer zu Schwabedissen HE, Stauble CK, Mikoteit T, Lampert ML. Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction. Front-Psychiatry 2024; 15 (0):.$36$YR$$M$Y$$$20240703$$HP$CH$CH
239737562$23973756$2$F$$20240628$20240613$20240708$EXP$$US-TEVA-VS-3207280$TEVA$Damia C, Monceaux B, Hall C, Bhamrah P, Koothirezhi R, Liendo C, et al. INITIATION OF METHADONE FOR REFRACTORY RESTLESS LEG SYNDROME WITH SIGNIFICANT IMPROVEMENT OF SYMPTOMS. Sleep 2024; 47 (Suppl. 1) A516.; Damia C, Monceaux B, Hall C, Bhamrah P, Koothirezhi R, Liendo C, et al. INITIATION OF METHADONE FOR REFRACTORY RESTLESS LEG SYNDROME WITH SIGNIFICANT IMPROVEMENT OF SYMPTOMS. Sleep 2024; 47 (Suppl. 1) A516.$62$YR$$F$Y$$$20240708$$HP$US$US
239737603$23973760$3$F$20240609$20240918$20240613$20240925$EXP$$JP-SHIONOGI INC.-2024001327$SHIONOGI$$85$YR$E$F$Y$32.4$KG$20240925$$MD$JP$JP
239737802$23973780$2$F$20230101$20240924$20240613$20240930$EXP$$JP-009507513-2309JPN002906J$MERCK$$31$YR$$F$Y$$$20240928$$MD$JP$JP
239738102$23973810$2$F$20240401$20240703$20240613$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094833$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240705$$CN$US$US
239738113$23973811$3$F$20180719$20240910$20240613$20240918$EXP$$JP-BIOGEN-2019BI00790735$BIOGEN$$17$YR$$M$Y$$$20240918$$MD$JP$JP
239738162$23973816$2$F$20090101$20240709$20240613$20240722$EXP$$IE-TEVA-VS-3207319$TEVA$Merrick D, Duncan HF, Bolas A, Hughes A, O^Sullivan M. Multiple External Cervical Resorption Lesions in Patient with Graft versus Host Disease Treated with Systemic Bleomycin: A Case Report. J-Endod 2024; 50 (5): 674-679.; Merrick D, Duncan HF, Bolas A, Hughes A, O^Sullivan M. Multiple External Cervical Resorption Lesions in Patient with Graft versus Host Disease Treated with Systemic Bleomycin: A Case Report. J-Endod 2024; 50 (5): 674-679.$22$YR$$M$Y$$$20240722$$HP$IE$IE
239738202$23973820$2$F$$20240714$20240613$20240715$PER$$US-PFIZER INC-PV202400073722$PFIZER$$9$YR$$M$Y$$$20240715$$MD$US$US
239738272$23973827$2$F$$20240711$20240613$20240717$EXP$$US-TAKEDA-2024TUS058707$TAKEDA$$$$$M$Y$$$20240717$$CN$US$US
239738483$23973848$3$F$20231203$20240802$20240613$20240807$PER$$JP-Eisai-EC-2024-167599$EISAI$$$$$F$Y$$$20240807$$MD$JP$JP
239738492$23973849$2$F$20240201$20240711$20240613$20240715$EXP$HR-HALMED-300085526$NVSC2024HR123879$NOVARTIS$$64$YR$$F$Y$70$KG$20240715$$MD$HR$HR
239738552$23973855$2$F$20231201$20240717$20240613$20240726$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00902$AIMMUNE$$$$$$Y$$$20240726$$HP$US$US
239739053$23973905$3$F$20240605$20240715$20240613$20240723$PER$$US-BAUSCHBL-2024BNL028308$BAUSCH AND LOMB$$24$YR$$M$Y$72.57$KG$20240723$$CN$US$US
239739072$23973907$2$F$$20240620$20240613$20240705$EXP$$JP-AMGEN-JPNSP2024115360$AMGEN$$76$YR$E$M$Y$$$20240705$$MD$JP$JP
239739282$23973928$2$F$20240101$20240830$20240613$20240905$EXP$$JP-009507513-2406JPN001157J$MERCK$$62$YR$$M$Y$$$20240905$$MD$JP$JP
239739502$23973950$2$F$20240605$20240703$20240613$20240705$PER$$US-JNJFOC-20240612386$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240705$$PH$US$US
239739663$23973966$3$F$$20240906$20240613$20240912$EXP$$CA-ABBVIE-5795475$ABBVIE$$$$A$F$Y$$$20240912$$CN$CA$CA
239739682$23973968$2$F$20231211$20240729$20240613$20240803$EXP$$US-ABBVIE-5793851$ABBVIE$$64$YR$$F$Y$109$KG$20240803$$HP$US$US
239739692$23973969$2$F$20240601$20240722$20240613$20240723$PER$$US-JNJFOC-20240603924$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240723$$CN$US$US
239739703$23973970$3$F$$20240710$20240613$20240722$EXP$$IT-NOVOPROD-1234567$NOVO NORDISK$$58$YR$$F$Y$$$20240719$$CN$IT$IT
239739912$23973991$2$F$$20240621$20240613$20240702$EXP$$JP-NOVOPROD-1234306$NOVO NORDISK$$50$YR$$F$Y$$$20240702$$PH$JP$JP
239739922$23973992$2$F$20231115$20240722$20240613$20240731$EXP$$US-NOVOPROD-1236595$NOVO NORDISK$$32$YR$$F$Y$107$KG$20240731$$MD$US$US
239739994$23973999$4$F$20240101$20240712$20240613$20240715$PER$$US-AMGEN-USASP2024116476$AMGEN$$71$YR$E$F$Y$$$20240715$$CN$US$US
239740014$23974001$4$F$20240604$20240718$20240613$20240723$PER$$US-JNJFOC-20240612276$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240723$$HP$US$US
239740073$23974007$3$F$$20240726$20240613$20240806$30DAY$$US-NOVOPROD-1235478$NOVO NORDISK$$$$$F$Y$$$20240806$$CN$US$US
239740153$23974015$3$F$20240525$20240705$20240613$20240710$30DAY$$US-AMGEN-USASP2024114823$AMGEN$$74$YR$E$F$Y$78.912$KG$20240709$$HP$US$US
239740202$23974020$2$F$20240604$20240703$20240613$20240705$PER$$US-JNJFOC-20240608308$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240705$$HP$US$US
239740222$23974022$2$F$$20240723$20240613$20240723$PER$$US-ALXN-202406USA000376US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239740373$23974037$3$F$$20240703$20240613$20240708$EXP$$US-ABBVIE-5798968$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
239740432$23974043$2$F$20230201$20240626$20240613$20240708$EXP$$JP-AMGEN-JPNSP2024115398$AMGEN$$61$YR$A$M$Y$$$20240708$$MD$JP$JP
239740474$23974047$4$F$20240605$20240724$20240613$20240726$EXP$$US-JNJFOC-20240615043$JOHNSON AND JOHNSON$$53$YR$A$F$Y$39.498$KG$20240726$$MD$US$US
239740533$23974053$3$F$20230101$20240816$20240613$20240824$EXP$$CH-ABBVIE-5453033$ABBVIE$$$$$F$Y$$$20240824$$HP$CH$CH
239740542$23974054$2$F$20240101$20240715$20240613$20240717$EXP$$US-ABBVIE-5798932$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
239740552$23974055$2$F$20240604$20240719$20240613$20240720$PER$$US-JNJFOC-20240608253$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240720$$HP$US$US
239740602$23974060$2$F$$20240717$20240613$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095846$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240719$$CN$US$US
239740612$23974061$2$F$20200101$20240626$20240613$20240701$EXP$$JP-SAKK-2024SA175148AA$SANOFI AVENTIS$$70$YR$E$F$Y$50$KG$20240701$$MD$JP$JP
239740672$23974067$2$F$20240421$20240923$20240613$20240927$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-050423$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$101.1$KG$20240927$$MD$CA$CA
239740732$23974073$2$F$20240608$20240809$20240613$20240816$EXP$$US-ABBVIE-5797781$ABBVIE$$66$YR$$M$Y$$$20240816$$CN$US$US
239740812$23974081$2$F$20240101$20240726$20240613$20240731$EXP$$US-ABBVIE-5797954$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
239740872$23974087$2$F$$20240705$20240614$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091313$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240708$$CN$US$US
239740942$23974094$2$F$$20240904$20240614$20240906$EXP$$JP-GSK-JP2024JPN073352$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$JP$JP
239740974$23974097$4$F$20240531$20240718$20240614$20240723$EXP$$GR-ABBVIE-5796421$ABBVIE$$74$YR$$M$Y$69$KG$20240723$$CN$GR$GR
239741172$23974117$2$F$20230806$20240626$20240614$20240710$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-12132$ALKEM$$79$YR$$M$Y$$$20240710$$PH$GB$GB
239741243$23974124$3$F$$20240801$20240614$20240809$EXP$$US-EMD Serono-2024024083$EMD SERONO INC$$$$A$M$Y$68$KG$20240809$$CN$US$US
239741253$23974125$3$F$$20240723$20240614$20240729$EXP$$ES-JNJFOC-20240623266$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240729$$CN$ES$ES
239741263$23974126$3$F$20240101$20240719$20240614$20240725$PER$$US-009507513-2406USA002171$MERCK$$70$YR$$F$Y$$$20240725$$HP$US$US
239741282$23974128$2$F$20240510$20240624$20240614$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002489$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240718$$CN$US$US
239741294$23974129$4$F$20231101$20240719$20240614$20240729$EXP$$JP-AMGEN-JPNSP2024090769$AMGEN$$81$YR$E$F$Y$56.4$KG$20240728$$MD$JP$JP
239741302$23974130$2$F$$20240731$20240614$20240807$EXP$$JP-AMGEN-JPNSP2024114196$AMGEN$$73$YR$E$F$Y$$$20240807$$PH$JP$JP
239741313$23974131$3$F$20240517$20240726$20240614$20240801$EXP$$US-AMGEN-USASP2024114793$AMGEN$$74$YR$E$F$Y$$$20240801$$HP$US$US
239741322$23974132$2$F$20240603$20240718$20240614$20240719$PER$$US-JNJFOC-20240608081$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240719$$CN$US$US
239741343$23974134$3$F$$20240722$20240614$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033817$BOEHRINGER INGELHEIM$$$$$$Y$$$20240723$$CN$US$US
239741372$23974137$2$F$$20240618$20240614$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002492$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
239741443$23974144$3$F$20240524$20240626$20240614$20240705$30DAY$$US-JNJFOC-20240575177$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240705$$HP$US$US
239741523$23974152$3$F$20240501$20240703$20240614$20240717$EXP$$JP-AMGEN-JPNSP2024116465$AMGEN$$76$YR$E$M$Y$$$20240717$$MD$JP$JP
239741622$23974162$2$F$20240401$20240827$20240614$20240905$PER$$US-ABBVIE-5791611$ABBVIE$$43$YR$$F$Y$63.049$KG$20240905$$CN$US$US
239741722$23974172$2$F$20240501$20240620$20240614$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002501$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240712$$CN$US$US
239741734$23974173$4$F$20240202$20240702$20240614$20240709$EXP$$DE-JNJFOC-20240621905$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240709$$HP$DE$DE
239741772$23974177$2$F$20240611$20240701$20240614$20240704$EXP$$NVSC2024GB122422$NOVARTIS$$29$YR$$M$Y$$$20240704$$CN$GB$GB
239741844$23974184$4$F$20240612$20240822$20240614$20240827$PER$$US-AMGEN-USASP2024116964$AMGEN$$82$YR$E$F$Y$56.689$KG$20240827$$HP$US$US
239741962$23974196$2$F$$20240626$20240614$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002521$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239742022$23974202$2$F$20200323$20240802$20240614$20240806$EXP$$US-TAKEDA-US202011807$TAKEDA$$47$YR$$F$Y$$$20240806$$HP$US$US
239742132$23974213$2$F$$20240708$20240614$20240709$PER$$US-JNJFOC-20240608670$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$HP$US$US
239742162$23974216$2$F$20240101$20240806$20240614$20240809$EXP$$US-ABBVIE-5799315$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
239742194$23974219$4$F$20240101$20240813$20240614$20240821$PER$$US-SA-2024SA145417$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240821$$HP$US$US
239742232$23974223$2$F$$20240730$20240614$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002557$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
239742342$23974234$2$F$$20240624$20240614$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002556$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
239742422$23974242$2$F$20240101$20240722$20240614$20240724$EXP$$US-JNJFOC-20240621034$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240724$$HP$US$US
239742432$23974243$2$F$$20240725$20240614$20240729$PER$$US-AMGEN-USASP2024113783$AMGEN$$85$YR$E$F$Y$$$20240729$$CN$US$US
239742442$23974244$2$F$20240525$20240701$20240614$20240706$EXP$$US-HETERO-HET2024US01671$HETERO$$87$YR$$F$Y$63.5$KG$20240706$$CN$US$US
239742483$23974248$3$F$20240101$20240723$20240614$20240801$PER$$US-SA-2024SA171951$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240801$$MD$US$US
239742522$23974252$2$F$20231101$20240710$20240614$20240718$EXP$$BR-CELLTRION INC.-2024BR013741$CELLTRION$$$$$$Y$$$20240718$$CN$BR$BR
239742572$23974257$2$F$$20240906$20240614$20240913$EXP$$FI-EMA-DD-20210322-jain_h1-103937$Haleon PLC$Kivivuori, S.. Zygomycosis presenting a major clinical?challenge: case report on Rhizomucor pusillus infection?in a stem-cell-transplant recipient. Mycopathologia.?2011;172 (3):241-245. doi:10.1007/s11046-011-9424-8; Kivivuori S, Karikoski R, Koukila-Kahkola P, Anttila V, Saarinen-Pihkala U. Zygomycosis Presenting a Major Clinical Challenge: Case Report on Rhizomucor pusillus Infection in a Stem-Cell-Transplant Recipient. Mycopathologia. 2011;172(24):1-245.$14$YR$$F$Y$$$20240913$$MD$FI$FI
239742582$23974258$2$F$$20240726$20240614$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002519$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
239742602$23974260$2$F$20240606$20240621$20240614$20240701$EXP$$CA-JNJFOC-20240621100$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$PH$CA$CA
239742622$23974262$2$F$$20240723$20240614$20240723$PER$$US-ALXN-202406USA000444US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
239742653$23974265$3$F$$20240722$20240614$20240729$EXP$$ZA-VIIV HEALTHCARE LIMITED-ZA2024EME071676$VIIV$$$$$$Y$$$20240729$$MD$ZA$ZA
239742673$23974267$3$F$$20240722$20240614$20240729$EXP$$ZA-GSK-ZA2024EME071676$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$MD$ZA$ZA
239742745$23974274$5$F$20240101$20240801$20240614$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017314$UNITED THERAPEUTICS$$$$$F$Y$58.05$KG$20240809$$$US$US
239742822$23974282$2$F$$20240819$20240614$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002551$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
239742873$23974287$3$F$20240608$20240701$20240614$20240706$PER$$US-AMGEN-USASP2024115874$AMGEN$$58$YR$A$F$Y$$$20240706$$CN$US$US
239742882$23974288$2$F$20240102$20240628$20240614$20240829$EXP$$GB-AMGEN-GBRSP2024115094$AMGEN$$57$YR$A$M$Y$104$KG$20240828$$HP$GB$GB
239743002$23974300$2$F$20240531$20240712$20240614$20240716$PER$$US-JNJFOC-20240590059$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240716$$CN$US$US
239743072$23974307$2$F$$20240717$20240614$20240720$PER$$NVSC2024US124444$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
239743112$23974311$2$F$20220824$20240918$20240614$20240927$EXP$$ES-CELLTRION INC.-2024ES013977$CELLTRION$$$$$$Y$$$20240927$$PH$ES$ES
239743152$23974315$2$F$20240524$20240702$20240614$20240712$EXP$$CN-BAXTER-2024BAX019534$BAXTER$$61$YR$$F$Y$46.2$KG$20240712$$MD$CN$CN
239743162$23974316$2$F$20240325$20240624$20240614$20240703$EXP$$DE-BAXTER-2024BAX015943$BAXTER$$72$YR$$M$Y$$$20240703$$HP$DE$DE
239743202$23974320$2$F$$20240719$20240614$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002533$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
239743252$23974325$2$F$20240601$20240627$20240614$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-017340$UNITED THERAPEUTICS$$58$YR$$F$Y$66.667$KG$20240704$$$US$US
239743312$23974331$2$F$$20240709$20240614$20240712$EXP$$US-BIOGEN-2024BI01268736$BIOGEN$$$$$F$Y$$$20240712$$CN$US$US
239743342$23974334$2$F$$20240719$20240614$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085732$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$CN$US$US
239743383$23974338$3$F$20240701$20240813$20240614$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002555$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240830$$CN$US$US
239743407$23974340$7$F$20230614$20240904$20240614$20240916$EXP$$CA-CELLTRION INC.-2023CA013544$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
239743412$23974341$2$F$20240605$20240813$20240614$20240823$30DAY$$US-GSK-US2024070108$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240823$$CN$US$US
239743872$23974387$2$F$$20240617$20240614$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002535$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
239743902$23974390$2$F$$20240906$20240614$20240911$EXP$$US-INTERCEPT-PM2024001195$INTERCEPT PHARMACEUTICALS$$$$$F$Y$52.154$KG$20240911$$CN$US$US
239743962$23974396$2$F$20240603$20240715$20240614$20240716$EXP$$US-JNJFOC-20240611292$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240716$$CN$US$US
239744043$23974404$3$F$20240608$20240709$20240614$20240710$PER$$US-AMGEN-USASP2024115320$AMGEN$$47$YR$A$M$Y$$$20240709$$CN$US$US
239744193$23974419$3$F$20240601$20240820$20240614$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002538$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240912$$CN$US$US
239744205$23974420$5$F$$20240823$20240614$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450276$RANBAXY$$$$E$M$Y$$$20240906$$CN$US$US
239744372$23974437$2$F$$20240705$20240614$20240715$EXP$$US-AUROBINDO-AUR-APL-2024-028579$AUROBINDO$Kurt M, Naqvi TZ. Post-cardioversion atrial stunning - Not to be forgotten. Echocardiography. 2023;40(3):266-270$60$YR$$M$Y$$$20240715$$MD$US$US
239744382$23974438$2$F$$20240710$20240614$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202406007646$ELI LILLY AND CO$$$$A$M$Y$$$20240719$$CN$US$US
239744393$23974439$3$F$$20240618$20240614$20240730$EXP$$US-SUNPHARMA-2024R1-451418AA$RANBAXY$$$$E$M$Y$$$20240730$$CN$US$US
239744432$23974443$2$F$$20240705$20240614$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-028571$AUROBINDO$Lee M, Vellanki S, Zheng LS, Turley JS.. INFECTIOUS ORIGINS OF PULMONARY HYPERTENSION AND RIGHT VENTRICULAR FAILURE: MILIARY COCCIDIOIDOMYCOSIS UNVEILED. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):2783$33$YR$$M$Y$$$20240716$$HP$US$US
239744472$23974447$2$F$$20240705$20240614$20240708$PER$$NVSC2024US124418$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
239744592$23974459$2$F$$20240822$20240614$20240822$PER$$NVSC2024US124387$NOVARTIS$$$$$F$Y$$$20240822$$HP$US$US
239744605$23974460$5$F$20240620$20240822$20240614$20240829$EXP$$US-GSK-US2024AMR070514$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$US$US
239744642$23974464$2$F$$20240705$20240614$20240715$EXP$$US-AUROBINDO-AUR-APL-2024-028553$AUROBINDO$Bou-Maroun L, Walkovich K, Weinberg J, Leopold K, Hanibal M, Frazier L, et al.. A Peculiar Presentation: STAT3 Loss of Function with Recurrent Osteomyelitis and Review of the Literature. Clin-Immunol. 2024;262 (Suppl.):15-16$18$YR$$F$Y$$$20240715$$MD$US$US
239744863$23974486$3$F$20240101$20240628$20240614$20240705$EXP$$CA-APOTEX-2024AP007124$APOTEX$$$$A$F$Y$$$20240705$$CN$CA$CA
239744892$23974489$2$F$20231127$20240920$20240614$20240925$EXP$$CA-AMGEN-CANSP2024112862$AMGEN$$64$YR$A$F$Y$66.8$KG$20240925$$PH$CA$CA
239744902$23974490$2$F$$20240729$20240614$20240801$EXP$$US-BIOGEN-2024BI01269184$BIOGEN$$$$$M$Y$$$20240801$$CN$US$US
239744912$23974491$2$F$20240423$20240912$20240614$20240924$EXP$$JP-AMGEN-JPNSP2024115476$AMGEN$$75$YR$E$M$Y$$$20240924$$HP$JP$JP
239744962$23974496$2$F$20240401$20240625$20240614$20240709$PER$$US-APOTEX-2024AP006945$APOTEX$$$$$$Y$$$20240709$$CN$US$US
239745022$23974502$2$F$20240520$20240807$20240614$20240816$EXP$$US-GSK-US2024AMR072547$GLAXOSMITHKLINE$$79$YR$$F$Y$49.206$KG$20240816$$CN$US$US
239745052$23974505$2$F$20240201$20240810$20240614$20240816$PER$$US-SA-2024SA176103$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240816$$MD$US$US
239745083$23974508$3$F$$20240805$20240614$20240812$EXP$$US-ALXN-202406USA000407US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
239745092$23974509$2$F$$20240708$20240614$20240717$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014276$UNITED THERAPEUTICS$$$$$F$Y$68.934$KG$20240717$$$US$US
239745153$23974515$3$F$20240601$20240708$20240614$20240713$EXP$$US-SA-2024SA176250$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240713$$MD$US$US
239745262$23974526$2$F$$20240718$20240614$20240724$EXP$$US-ABBVIE-5799305$ABBVIE$$$$$F$Y$66.77$KG$20240724$$CN$US$US
239745482$23974548$2$F$$20240711$20240614$20240726$PER$$US-APOTEX-2024AP006942$APOTEX$$$$$$Y$$$20240726$$CN$US$US
239745612$23974561$2$F$20240511$20240725$20240614$20240730$EXP$$NVSJ2024JP007087$NOVARTIS$$74$YR$$F$Y$$$20240731$$MD$JP$JP
239745692$23974569$2$F$$20240911$20240614$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095333$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240911$$CN$US$US
239745852$23974585$2$F$20240507$20240720$20240614$20240729$30DAY$$US-AMGEN-USASP2024115000$AMGEN$$79$YR$E$F$Y$62$KG$20240729$$HP$US$US
239745952$23974595$2$F$20240521$20240808$20240614$20240816$PER$$US-SA-2024SA128339$SANOFI AVENTIS$$61$YR$A$F$Y$72.562$KG$20240817$$HP$US$US
239746013$23974601$3$F$20240604$20240813$20240614$20240820$EXP$$US-SA-2024SA174725$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240820$$HP$US$US
239746022$23974602$2$F$20230701$20240819$20240614$20240830$PER$$US-SA-2024SA173912$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240830$$MD$US$US
239746063$23974606$3$F$20240301$20240704$20240614$20240717$PER$$US-APOTEX-2024AP006969$APOTEX$$40$YR$$F$Y$$$20240717$$CN$US$US
239746192$23974619$2$F$$20240626$20240614$20240704$PER$$US-BIOGEN-2024BI01264728$BIOGEN$$$$$F$Y$$$20240704$$CN$US$US
239746262$23974626$2$F$$20240707$20240614$20240709$PER$$NVSC2024US124279$NOVARTIS$$$$$$Y$$$20240709$$CN$US$US
239746412$23974641$2$F$20240604$20240710$20240614$20240712$EXP$$US-VIIV HEALTHCARE LIMITED-US2024070589$VIIV$$54$YR$$M$Y$$$20240712$$CN$US$US
239746442$23974644$2$F$20240601$20240711$20240614$20240722$EXP$$DE-AUROBINDO-AUR-APL-2024-028972$AUROBINDO$$71$YR$$F$Y$59$KG$20240722$$PH$DE$DE
239746472$23974647$2$F$$20240625$20240614$20240704$EXP$$XI-TEVA-VS-3198118$TEVA$$51$YR$$M$Y$$$20240704$$CN$GB$GB
239746512$23974651$2$F$20240101$20240924$20240614$20240930$EXP$$US-ABBVIE-5797656$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
239746552$23974655$2$F$20240201$20240827$20240614$20240910$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-04388$SAMSUNG BIOEPIS$$32$YR$A$F$Y$$$20240909$$CN$CA$CA
239746643$23974664$3$F$$20240724$20240614$20240724$PER$$US-ALXN-202406USA000510US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
239746652$23974665$2$F$20240101$20240819$20240614$20240828$EXP$$US-UCBSA-2024030036$UCB$$$$$F$Y$$$20240828$$HP$US$US
239746673$23974667$3$F$$20240711$20240614$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095978$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$95.25$KG$20240715$$CN$US$US
239746812$23974681$2$F$$20240724$20240614$20240730$EXP$$US-ABBVIE-5799740$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
239746823$23974682$3$F$20240101$20240829$20240614$20240906$EXP$$CA-CELLTRION INC.-2024CA006468$CELLTRION$$$$$$Y$$$20240906$$MD$CA$CA
239746894$23974689$4$F$20240701$20240810$20240614$20240816$EXP$$US-SA-2024SA176222$SANOFI AVENTIS$$41$YR$A$M$Y$98.8$KG$20240816$$MD$US$US
239747002$23974700$2$F$20220301$20240820$20240614$20240826$EXP$$AT-JNJFOC-20240621952$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240826$$MD$AT$AT
239747072$23974707$2$F$20231201$20240802$20240614$20240812$30DAY$$US-GSK-US2024072456$GLAXOSMITHKLINE$$$$A$F$Y$$$20240812$$CN$US$US
239747082$23974708$2$F$$20240725$20240614$20240802$30DAY$$US-GSK-US2024072660$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$CN$US$US
239747102$23974710$2$F$$20240809$20240614$20240819$30DAY$$US-GSK-US2024071827$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
239747213$23974721$3$F$20240201$20240820$20240614$20240827$EXP$$US-EXELIXIS-CABO-24077444$EXELIXIS$$64$YR$$M$Y$$$20240827$$CN$US$US
239747222$23974722$2$F$20240701$20240722$20240614$20240726$EXP$$US-BAUSCH-BL-2024-007959$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240726$$CN$US$US
239747232$23974723$2$F$$20240801$20240614$20240809$EXP$$CA-CELLTRION INC.-2024CA014210$CELLTRION$$$$$$Y$$$20240809$$HP$CA$CA
239747292$23974729$2$F$20240510$20240711$20240614$20240722$EXP$$US-UCBSA-2024029921$UCB$$23$YR$$F$Y$$$20240722$$HP$US$US
239747443$23974744$3$F$$20240705$20240614$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-028484$AUROBINDO$Saowapa S, Polpichai N, Yingchoncharoen P, Thongpiya J, Duangkham S, Siladech P, et al.. : a case report of aggressive non small cell lung cancer (NSCLC) in a young individual.. American Journal of the Medical Sciences. 2024;367 (Suppl.):S187-S188 abstr. 317$37$YR$$F$Y$$$20240716$$MD$US$US
239747552$23974755$2$F$$20240703$20240614$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202406008178$ELI LILLY AND CO$$45$YR$A$F$Y$118.82$KG$20240714$$CN$US$US
239747582$23974758$2$F$20240609$20240709$20240614$20240711$PER$$US-AMGEN-USASP2024116525$AMGEN$$85$YR$E$F$Y$$$20240711$$CN$US$US
239747613$23974761$3$F$20240308$20240819$20240614$20240821$EXP$$US-UCBSA-2024012657$UCB$$54$YR$$F$Y$$$20240821$$HP$US$US
239747652$23974765$2$F$$20240808$20240614$20240814$EXP$$JP-GSK-JP2024JPN072279$GLAXOSMITHKLINE$Eto Y, Ishibashi K, Imada T, Odagawa S, Higuchi H, Mashino J. P-155 A case of syndrome of inappropriate secretion of antidiuretic hormone associated with left facial herpes zoster. The 15th Annual conference of Japan Primary Care Association. 387$$$$$Y$$$20240814$$MD$JP$JP
239747692$23974769$2$F$$20240801$20240614$20240809$EXP$$CA-CELLTRION INC.-2024CA003049$CELLTRION$$$$$$Y$$$20240809$$HP$CA$CA
239747733$23974773$3$F$20240610$20240709$20240614$20240712$PER$$US-AMGEN-USASP2024117022$AMGEN$$77$YR$E$F$Y$$$20240712$$CN$US$US
239747752$23974775$2$F$$20240822$20240614$20240822$PER$$NVSC2024US124242$NOVARTIS$$$$$$Y$$$20240822$$MD$US$US
239747774$23974777$4$F$$20240828$20240614$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-013009$UNITED THERAPEUTICS$$$$$M$Y$$$20240906$$$US$US
239747862$23974786$2$F$$20240701$20240614$20240711$EXP$$JP-AMGEN-JPNSP2024115508$AMGEN$$$$$$Y$$$20240711$$PH$JP$JP
239747962$23974796$2$F$20230601$20240819$20240614$20240822$EXP$$JP-ABBVIE-5799287$ABBVIE$$67$YR$$F$Y$58$KG$20240822$$MD$JP$JP
239748012$23974801$2$F$20220407$20240701$20240614$20240704$EXP$$US-TAKEDA-2024TUS058127$TAKEDA$$32$YR$$F$Y$$$20240704$$CN$US$US
239748022$23974802$2$F$$20240604$20240614$20240715$EXP$$-ENDO USA, INC.-2024-002520$ENDO$Tahiraj X, Bakalli A, Krasniqi X, Citaku H, Krasniqi F, Kocinaj D.. Acute myocardial infarction and polycythemia rubra vera: The double effect of treatment with hydroxyurea. Radiology Case Reports. 2024;19(8):3386-3389$35$YR$$F$Y$$$20240715$$MD$COUNTRY NOT SPECIFIED$
239748042$23974804$2$F$20240603$20240708$20240614$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095391$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$65$KG$20240712$$PH$US$US
239748063$23974806$3$F$$20240809$20240614$20240812$EXP$$US-BEH-2024173144$CSL BEHRING$$$$A$M$Y$$$20240812$$HP$US$US
239748072$23974807$2$F$$20240822$20240614$20240829$EXP$$CA-EMD Serono-2024031256$EMD SERONO INC$$$$A$F$Y$$$20240829$$CN$CA$CA
239748082$23974808$2$F$20240612$20240705$20240614$20240706$EXP$$JP-ABBVIE-5799716$ABBVIE$$10$YR$$M$Y$60$KG$20240706$$MD$JP$JP
239748106$23974810$6$F$20220501$20240726$20240614$20240805$EXP$$CA-CELLTRION INC.-2024CA005321$CELLTRION$$$$$$Y$$$20240805$$HP$CA$CA
239748182$23974818$2$F$$20240823$20240614$20240823$PER$$NVSC2024US124675$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
239748195$23974819$5$F$20240424$20240912$20240614$20240921$EXP$$CA-CELLTRION INC.-2024CA011319$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
239748232$23974823$2$F$$20240916$20240614$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095922$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240917$$HP$US$US
239748264$23974826$4$F$$20240823$20240614$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095932$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$92.08$KG$20240826$$CN$US$US
239748332$23974833$2$F$20240101$20240722$20240614$20240805$PER$$US-JNJFOC-20240588346$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240805$$CN$US$US
239748344$23974834$4$F$20240521$20240913$20240614$20240917$EXP$$US-TAKEDA-2024TUS057799$TAKEDA$$31$YR$$$Y$$$20240917$$MD$US$US
239748492$23974849$2$F$20240101$20240701$20240614$20240703$PER$$US-AMGEN-USASP2024116444$AMGEN$$66$YR$E$F$Y$$$20240703$$CN$US$US
239748502$23974850$2$F$$20240819$20240614$20240823$PER$$US-AMGEN-USASP2024117175$AMGEN$$74$YR$E$M$Y$$$20240823$$CN$US$US
239748602$23974860$2$F$$20240715$20240614$20240806$30DAY$$US-ALVOGEN-2024094734$ALVOGEN$$$$$F$Y$$$20240806$$CN$US$US
239748616$23974861$6$F$$20240904$20240614$20240906$EXP$$US-BIOVITRUM-2024-US-006393$BIOVITRUM$$19$YR$$M$Y$$$20240906$$CN$US$US
239748652$23974865$2$F$20240606$20240703$20240614$20240710$EXP$$US-JNJFOC-20240620745$JOHNSON AND JOHNSON$$44$YR$A$F$Y$94.5$KG$20240710$$HP$US$US
239748702$23974870$2$F$20240101$20240702$20240614$20240801$30DAY$$US-ALVOGEN-2024094701$ALVOGEN$$$$$F$Y$$$20240801$$CN$US$US
239748792$23974879$2$F$$20240717$20240614$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095461$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$106.59$KG$20240719$$CN$US$US
239748822$23974882$2$F$20240501$20240829$20240614$20240831$PER$$US-AMGEN-USASP2024114971$AMGEN$$57$YR$A$F$Y$$$20240831$$CN$US$US
239748882$23974888$2$F$20240506$20240710$20240614$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002497$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240731$$CN$US$US
239748912$23974891$2$F$20240611$20240717$20240614$20240723$EXP$$CN-AMGEN-CHNSP2024115180$AMGEN$$$$$F$Y$$$20240723$$CN$CN$CN
239748964$23974896$4$F$$20240916$20240614$20240923$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-095430$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$57.15$KG$20240923$$CN$PR$PR
239749082$23974908$2$F$$20240711$20240614$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202406003577$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240715$$CN$US$US
239749234$23974923$4$F$20240519$20240723$20240614$20240801$EXP$$JP-AMGEN-JPNSP2024115484$AMGEN$$81$YR$E$M$Y$$$20240801$$PH$JP$JP
239749392$23974939$2$F$$20240829$20240614$20240906$30DAY$$US-GSK-US2024070537$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$HP$US$US
239749453$23974945$3$F$20240523$20240611$20240614$20240802$EXP$$AR-JNJFOC-20240582762$JOHNSON AND JOHNSON$$67$YR$E$F$Y$58$KG$20240802$$MD$AR$AR
239749462$23974946$2$F$20240501$20240722$20240614$20240814$PER$$US-JNJFOC-20240605630$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240814$$CN$US$US
239749482$23974948$2$F$20240101$20240716$20240614$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-017206$UNITED THERAPEUTICS$$$$$M$Y$74.83$KG$20240723$$$US$US
239749492$23974949$2$F$20240523$20240712$20240614$20240715$EXP$FR-AFSSAPS-TO2024001033$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033882$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$74$KG$20240715$$MD$FR$FR
239749633$23974963$3$F$20230101$20240627$20240614$20240708$EXP$$US-PFIZER INC-PV202400077276$PFIZER$$72$YR$$F$Y$$$20240708$$CN$US$US
239749662$23974966$2$F$$20240816$20240614$20240819$EXP$$CN-PFIZER INC-PV202400076604$PFIZER$$$$A$F$Y$$$20240819$$CN$CN$CN
239749722$23974972$2$F$20240430$20240724$20240614$20240726$EXP$$NL-ABBVIE-5798479$ABBVIE$$$$$F$Y$$$20240726$$HP$NL$NL
239749753$23974975$3$F$$20240724$20240614$20240801$EXP$$CO-HALEON-2181389$Haleon PLC$$32$YR$$F$Y$80$KG$20240801$$CN$CO$CO
239749882$23974988$2$F$20240101$20240705$20240614$20240717$PER$$US-SA-2024SA175380$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240717$$MD$US$US
239749895$23974989$5$F$20240101$20240911$20240614$20240916$PER$$US-SA-2024SA177296$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240916$$MD$US$US
239750002$23975000$2$F$$20240705$20240614$20240717$PER$$US-SA-2024SA174863$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240717$$CN$US$US
239750112$23975011$2$F$20240602$20240628$20240614$20240710$EXP$$US-ELI_LILLY_AND_COMPANY-US202406004791$ELI LILLY AND CO$$58$YR$A$F$Y$87.54$KG$20240710$$CN$US$US
239750172$23975017$2$F$$20240730$20240614$20240805$EXP$$US-BIOGEN-2023BI01237733$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
239750202$23975020$2$F$20240413$20240628$20240614$20240705$PER$$US-AMGEN-USASP2024116865$AMGEN$$78$YR$E$M$Y$$$20240705$$CN$US$US
239750213$23975021$3$F$20231201$20240806$20240614$20240807$EXP$$US-UCBSA-2024029696$UCB$$36$YR$$M$Y$$$20240807$$CN$US$US
239750302$23975030$2$F$20240610$20240702$20240614$20240708$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001219$BLUEPRINT MEDICINES$$65$YR$E$F$Y$$$20240708$$CN$US$US
239750342$23975034$2$F$$20240918$20240614$20240925$EXP$$US-862174955-ML2024-03401$Unknown Manufacturer$$77$YR$E$F$Y$72.5$KG$20240925$$CN$US$US
239750352$23975035$2$F$20240528$20240624$20240614$20240703$EXP$$US-862174955-ML2024-03385$Unknown Manufacturer$$84$YR$E$$Y$$$20240703$$PH$US$US
239750444$23975044$4$F$20231101$20240805$20240614$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-036217$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$59.9$KG$20240814$$PH$JP$JP
239750502$23975050$2$F$$20240712$20240614$20240716$PER$$US-AstraZeneca-2024A135515$ASTRAZENECA$$$$$F$Y$$$20240716$$MD$US$
239750544$23975054$4$F$$20240723$20240614$20240723$PER$$US-ALXN-202406USA000443US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
239750613$23975061$3$F$20240527$20240701$20240614$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017291$UNITED THERAPEUTICS$$71$YR$$F$Y$54.422$KG$20240706$$$US$US
239750712$23975071$2$F$$20240820$20240614$20240821$EXP$$FR-JNJFOC-20240606459$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240822$$MD$FR$FR
239750792$23975079$2$F$$20240717$20240614$20240723$EXP$$JP-GSK-JP2024JPN070974$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$PH$JP$JP
239750832$23975083$2$F$20240531$20240802$20240614$20240810$EXP$$CA-CELLTRION INC.-2024CA014137$CELLTRION$$$$$$Y$$$20240810$$HP$CA$CA
239750893$23975089$3$F$20240515$20240815$20240614$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002494$ACADIA PHARMACEUTICALS$$89$YR$$M$Y$80$KG$20240830$$CN$US$US
239750934$23975093$4$F$20240617$20240907$20240614$20240916$EXP$$CA-TAKEDA-2020TUS030309$TAKEDA$$30$YR$$F$Y$$$20240916$$CN$CA$CA
239750952$23975095$2$F$20240501$20240905$20240614$20240913$EXP$$GR-EMD Serono-2024031192$EMD SERONO INC$$63$YR$A$F$Y$$$20240913$$MD$GR$GR
239751002$23975100$2$F$$20240723$20240614$20240723$PER$$US-ALXN-202406USA000374US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
239751022$23975102$2$F$$20240703$20240614$20240709$PER$$US-LEO Pharma-371130$LEO PHARM$$25$YR$$F$Y$$$20240709$$PH$US$US
239751442$23975144$2$F$$20240903$20240614$20240911$EXP$$CA-JNJFOC-20240626883$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$HP$CA$CA
239751514$23975151$4$F$20240101$20240806$20240614$20240816$EXP$$JP-TEVA-VS-3165525$TEVA$$34$YR$$F$Y$52$KG$20240816$$MD$JP$JP
239751593$23975159$3$F$$20240821$20240614$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095882$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240823$$CN$US$US
239751642$23975164$2$F$20240101$20240802$20240614$20240807$EXP$$CA-UCBSA-2024029849$UCB$$$$$M$Y$$$20240807$$CN$CA$CA
239751652$23975165$2$F$20180101$20240705$20240614$20240712$EXP$$US-AMAROX PHARMA-HET2024US01751$HETERO$$28$YR$$F$Y$90.7$KG$20240712$$CN$US$US
239751662$23975166$2$F$20240516$20240710$20240614$20240711$EXP$$US-UCBSA-2024030294$UCB$$32$YR$$F$Y$$$20240711$$HP$US$US
239751713$23975171$3$F$$20240815$20240614$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002530$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
239751762$23975176$2$F$$20240723$20240614$20240723$PER$$US-ALXN-202406USA000427US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
239751772$23975177$2$F$$20240822$20240614$20240830$EXP$$JP-009507513-2406JPN001631J$MERCK$$53$YR$$F$Y$$$20240830$$MD$JP$JP
239751883$23975188$3$F$$20240823$20240614$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095895$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$87.54$KG$20240827$$PH$US$US
239751893$23975189$3$F$$20240627$20240614$20240709$EXP$$JP-VERICEL-JP-VCEL-24-000217$VERICEL$$64$YR$$M$Y$122$KG$20240709$$MD$JP$JP
239751953$23975195$3$F$20240221$20240820$20240614$20240823$EXP$$US-ABBVIE-5797806$ABBVIE$$72$YR$$M$Y$$$20240823$$CN$US$US
239752153$23975215$3$F$$20240819$20240614$20240821$EXP$$NVSC2024US123487$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
239752182$23975218$2$F$$20240813$20240614$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095281$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240822$$CN$US$US
239752263$23975226$3$F$$20240725$20240614$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002531$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
239752304$23975230$4$F$20240610$20240924$20240614$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096169$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$68.95$KG$20240925$$CN$US$US
239752483$23975248$3$F$20240101$20240715$20240614$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-017526$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240723$$$US$US
239752502$23975250$2$F$20240101$20240808$20240614$20240812$EXP$$US-UCBSA-2024030055$UCB$$$$$$Y$$$20240812$$CN$US$US
239752542$23975254$2$F$$20240716$20240614$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096195$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240718$$CN$US$US
239752662$23975266$2$F$20240612$20240729$20240614$20240731$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033820$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$$$20240731$$CN$US$US
239752743$23975274$3$F$20240101$20240726$20240614$20240819$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002542$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240819$$CN$US$US
239752763$23975276$3$F$20240501$20240722$20240614$20240802$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05142$HIKMA$$30$YR$$F$Y$88.8$KG$20240802$$HP$US$US
239752772$23975277$2$F$20240601$20240802$20240614$20240810$EXP$$CA-CELLTRION INC.-2024CA014188$CELLTRION$$$$$$Y$$$20240810$$CN$CA$CA
239752803$23975280$3$F$20240607$20240715$20240614$20240719$PER$$US-AMGEN-USASP2024114965$AMGEN$$81$YR$E$M$Y$$$20240719$$CN$US$US
239752812$23975281$2$F$20240422$20240723$20240614$20240730$EXP$$DE-AMGEN-DEUSP2024115872$AMGEN$$56$YR$A$F$Y$52$KG$20240730$$MD$DE$DE
239752833$23975283$3$F$20240606$20240715$20240614$20240729$30DAY$$US-JNJFOC-20240623264$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240729$$CN$US$US
239752852$23975285$2$F$$20240723$20240614$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096082$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240731$$MD$US$US
239752862$23975286$2$F$$20240628$20240614$20240712$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-17489$SAMSUNG BIOEPIS$$59$YR$A$F$Y$$$20240712$$HP$CA$CA
239752873$23975287$3$F$$20240821$20240614$20240827$30DAY$$US-GSK-US2024070133$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
239752932$23975293$2$F$$20240726$20240614$20240802$EXP$$US-AstraZeneca-2024A134005$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
239752942$23975294$2$F$20240610$20240613$20240614$20240703$PER$$US-AMGEN-USASP2024117014$AMGEN$$74$YR$E$F$Y$$$20240703$$CN$US$US
239753262$23975326$2$F$20240208$20240813$20240614$20240826$EXP$$US-UCBSA-2024011741$UCB$$54$YR$$M$Y$79.4$KG$20240826$$CN$US$US
239753552$23975355$2$F$20200612$20240709$20240614$20240712$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-069235$REGENERON$$$$$M$Y$$$20240712$$MD$US$US
239753933$23975393$3$F$$20240625$20240614$20240709$EXP$$RO-SAMSUNG BIOEPIS-SB-2024-17088$SAMSUNG BIOEPIS$$55$YR$A$F$Y$$$20240709$$MD$RO$RO
239754192$23975419$2$F$20240201$20240726$20240614$20240726$PER$$TW-REGENERON PHARMACEUTICALS, INC.-2024-085364$REGENERON$$$$$M$Y$$$20240726$$CN$TW$TW
239754212$23975421$2$F$20240607$20240724$20240614$20240802$30DAY$$US-GSK-US2024071423$GLAXOSMITHKLINE$$71$YR$$M$Y$$$20240802$$CN$US$US
239754532$23975453$2$F$20240729$20240730$20240614$20240731$PER$$US-TAKEDA-2024TUS059387$TAKEDA$$45$YR$$F$Y$$$20240731$$CN$US$US
239754812$23975481$2$F$20240212$20240607$20240614$20240704$EXP$$ES-AstraZeneca-2024A137230$ASTRAZENECA$$70$YR$$F$Y$$$20240704$$MD$ES$
239755002$23975500$2$F$20240320$20240621$20240614$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04853$LUPIN$$$$$$Y$$$20240703$$CN$US$US
239755142$23975514$2$F$$20240912$20240614$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096009$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240912$$CN$US$US
239755183$23975518$3$F$20240101$20240812$20240614$20240813$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-096053$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$56.25$KG$20240813$$CN$PR$PR
239755332$23975533$2$F$$20240917$20240614$20240919$EXP$$US-JNJFOC-20240618970$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$PH$US$US
239755652$23975565$2$F$20240610$20240717$20240614$20240724$EXP$$US-AMGEN-USASP2024115870$AMGEN$$63$YR$A$F$Y$66.34$KG$20240724$$HP$US$US
239755924$23975592$4$F$20240101$20240910$20240614$20240923$EXP$$US-UCBSA-2024009382$UCB$$$$$F$Y$$$20240923$$CN$US$US
239756033$23975603$3$F$20240101$20240717$20240614$20240722$EXP$$US-UCBSA-2024030058$UCB$$$$$F$Y$$$20240719$$CN$US$US
239756463$23975646$3$F$20240611$20240620$20240614$20240701$PER$$US-SA-2024SA173305$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240701$$MD$US$US
239756504$23975650$4$F$20240101$20240808$20240614$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014043$UNITED THERAPEUTICS$$$$$M$Y$$$20240816$$$US$US
239756612$23975661$2$F$20220624$20240910$20240614$20240927$PER$$US-SA-2024SA176978$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240927$$MD$US$US
239756662$23975666$2$F$$20240806$20240614$20240812$PER$$US-ALXN-202406USA000386US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
239756762$23975676$2$F$20240605$20240724$20240614$20240801$PER$$US-SA-2024SA172181$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240801$$MD$US$US
239756842$23975684$2$F$20240101$20240802$20240614$20240812$PER$$US-SA-2024SA177703$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240812$$CN$US$US
239757002$23975700$2$F$20240101$20240813$20240614$20240827$EXP$$AU-UCBSA-2024030141$UCB$$$$$F$Y$$$20240827$$CN$AU$AU
239757037$23975703$7$F$20240101$20240702$20240614$20240718$EXP$$BR-JNJFOC-20240618966$JOHNSON AND JOHNSON$$56$YR$A$F$Y$90$KG$20240718$$HP$BR$BR
239757132$23975713$2$F$20240520$20240716$20240614$20240722$PER$$US-AMGEN-USASP2024115932$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
239757202$23975720$2$F$20240101$20240709$20240614$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095366$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240712$$CN$US$US
239757232$23975723$2$F$20240529$20240816$20240614$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095997$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240826$$HP$US$US
239757242$23975724$2$F$$20240716$20240614$20240720$EXP$$NVSJ2024JP007000$NOVARTIS$$10$YR$$M$Y$$$20240719$$MD$JP$JP
239757362$23975736$2$F$$20240820$20240614$20240909$PER$$CA-TOLMAR, INC.-24CA049716$TOLMAR$$$$$M$Y$$$20240906$$CN$CA$CA
239757372$23975737$2$F$20240525$20240828$20240614$20240918$PER$$CA-TOLMAR, INC.-24CA049722$TOLMAR$$86$YR$$M$Y$$$20240918$$CN$CA$CA
239757412$23975741$2$F$20240522$20240613$20240614$20240708$PER$$US-TOLMAR, INC.-24US049675$TOLMAR$$$$$M$Y$$$20240708$$HP$US$US
239757436$23975743$6$F$$20240812$20240614$20240819$EXP$$NVSC2024CZ121942$NOVARTIS$Bloomfield M, Klocperk A, Schneiderova H, Hlavackova E, Turnovec M, Tichy L et. al.. The expansion of national newborn screening marks an advancement in diagnosing patients with severe inborn errors of immunity. CESKO-SLOVENSKA PEDIATRIE.. 2024;79(3):136-41$7$WK$$M$Y$$$20240819$$HP$CZ$CZ
239757462$23975746$2$F$$20240705$20240614$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-028670$AUROBINDO$Gowda S, Sandow L, Heinrich MC.. Treatment of BRAF V600E mutant gastrointestinal stromal tumor with dabrafenib: a case report. J-Gastrointest-Oncol. 2024;15(2):788-793$67$YR$$F$Y$$$20240716$$MD$US$US
239757532$23975753$2$F$20240529$20240725$20240614$20240731$EXP$$JP-Eisai-EC-2024-167600$EISAI$$69$YR$E$F$Y$$$20240731$$MD$JP$JP
239757553$23975755$3$F$20240601$20240726$20240614$20240730$EXP$$JP-Eisai-EC-2024-167605$EISAI$$77$YR$E$F$Y$$$20240730$$MD$JP$JP
239757656$23975765$6$F$$20240709$20240614$20240715$EXP$$BE-MYLANLABS-2024M1051247$MYLAN$Shiba S, Jan Van Keer. Double bad luck: pulmonary embolism and vaginal bleeding - a case report. International Journal of Emergency Medicine. 2024;17:1-4$47$YR$$F$Y$83$KG$20240715$$HP$BE$BE
239757793$23975779$3$F$20240702$20240814$20240614$20240828$PER$$US-SA-2024SA176931$SANOFI AVENTIS$$46$YR$A$F$Y$52.154$KG$20240828$$MD$US$US
239757842$23975784$2$F$20240418$20240726$20240614$20240802$EXP$$US-AstraZeneca-2024A133508$ASTRAZENECA$$63$YR$$F$Y$45.9$KG$20240802$$HP$US$
239758012$23975801$2$F$$20240919$20240614$20240925$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-126179$DAIICHI$$$$$M$Y$$$20240925$$MD$US$US
239758082$23975808$2$F$$20240805$20240614$20240813$PER$$US-SA-2024SA174279$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240814$$MD$US$US
239758092$23975809$2$F$20240101$20240917$20240614$20240920$PER$$US-SA-2024SA171007$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240920$$MD$US$US
239758542$23975854$2$F$$20240725$20240614$20240725$PER$$NVSC2024US124245$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
239758553$23975855$3$F$20240520$20240708$20240614$20240711$EXP$HR-HALMED-300085510$NVSC2024HR123955$NOVARTIS$$63$YR$$M$Y$70$KG$20240711$$MD$HR$HR
239758563$23975856$3$F$20240101$20240828$20240614$20240831$EXP$$US-ABBVIE-5798016$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
239758609$23975860$9$F$$20240923$20240614$20240926$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-126380$DAIICHI$$$$$F$Y$$$20240926$$CN$US$US
239758652$23975865$2$F$20230301$20240702$20240614$20240711$PER$$US-SA-2024SA174962$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240711$$MD$US$US
239758693$23975869$3$F$$20240709$20240614$20240717$EXP$$CN-AstraZeneca-2024A133620$ASTRAZENECA$$$$$$Y$$$20240717$$CN$CN$
239758792$23975879$2$F$20240514$20240819$20240614$20240822$EXP$$US-ABBVIE-5797942$ABBVIE$$66$YR$$M$Y$$$20240822$$CN$US$US
239758812$23975881$2$F$$20240912$20240614$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096033$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$51.26$KG$20240912$$HP$US$US
239758822$23975882$2$F$20240427$20240730$20240614$20240805$EXP$$AU-ORPHANEU-2024004353$RECORDATI$$$$$$Y$$$20240805$$MD$AU$AU
239758833$23975883$3$F$20180101$20240710$20240614$20240723$EXP$CN-MLMSERVICE-20240531-PI085421-00059-4$CN-STRIDES ARCOLAB LIMITED-2024SP006814$STRIDES$Zhang C, Lin Y, Kuang Q, Li H, Jiang Q, Yang X.. Case report: A highly active refractory myasthenia gravis with treatment of telitacicept combined with efgartigimod.. Frontiers in Immunology.. 2024;15:1400459$4$DEC$$F$Y$$$20240723$$MD$CN$CN
239758873$23975887$3$F$20240606$20240730$20240614$20240809$30DAY$$US-GSK-US2024070762$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240809$$MD$US$US
239758892$23975889$2$F$20230101$20240703$20240614$20240713$EXP$$CA-TEVA-VS-3207528$TEVA$$58$YR$$M$Y$$$20240713$$CN$CA$CA
239759032$23975903$2$F$$20240715$20240614$20240715$PER$$US-AMGEN-USASP2024116978$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
239759062$23975906$2$F$$20240710$20240614$20240722$EXP$$JP-AMGEN-JPNSP2024116298$AMGEN$$$$E$F$Y$$$20240721$$PH$JP$JP
239759182$23975918$2$F$20240501$20240815$20240614$20240829$PER$$US-SA-2024SA173391$SANOFI AVENTIS$$13$YR$T$F$Y$81.64$KG$20240829$$MD$US$US
239759272$23975927$2$F$20240101$20240627$20240614$20240701$EXP$$US-UCBSA-2024022701$UCB$$$$$M$Y$48$KG$20240701$$CN$US$US
239759302$23975930$2$F$$20240605$20240614$20240714$EXP$$US-BAYER-2024A085939$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240714$$MD$US$US
239759472$23975947$2$F$$20240605$20240614$20240714$EXP$$US-BAYER-2024A085940$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240714$$MD$US$US
239759482$23975948$2$F$20240613$20240811$20240614$20240816$EXP$$NVSC2024IL124315$NOVARTIS$$14$YR$$M$Y$$$20240816$$MD$IL$IL
239759562$23975956$2$F$$20240723$20240614$20240723$PER$$US-ALXN-202406USA000357US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
239759602$23975960$2$F$20240610$20240705$20240614$20240710$PER$$US-AMGEN-USASP2024114727$AMGEN$$70$YR$E$F$Y$80.7$KG$20240710$$HP$US$US
239759633$23975963$3$F$20240220$20240717$20240614$20240729$EXP$$JP-AMGEN-JPNSP2024116368$AMGEN$$75$YR$E$F$Y$$$20240729$$MD$JP$JP
239759662$23975966$2$F$20231214$20240705$20240614$20240710$30DAY$$US-AMGEN-USASP2024114725$AMGEN$$67$YR$E$M$Y$99.6$KG$20240709$$HP$US$US
239759725$23975972$5$F$$20240726$20240614$20240801$EXP$$GB-MYLANLABS-2024M1054054$MYLAN$$$$$M$Y$$$20240801$$MD$GB$GB
239759872$23975987$2$F$$20240711$20240614$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096022$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240712$$CN$US$US
239760002$23976000$2$F$20240603$20240620$20240614$20240701$EXP$GB-MHRA-MED-202406030823038770-GHTNR$GB-MACLEODS PHARMA-MAC2024047623$MACLEODS$$$$$$Y$$$20240701$$CN$GB$GB
239760042$23976004$2$F$20240525$20240814$20240614$20240820$EXP$$NVSC2024US115765$NOVARTIS$$0$YR$$M$Y$$$20240820$$CN$US$US
239760262$23976026$2$F$$20240605$20240614$20240705$EXP$$US-BAYER-2024A086024$BAYER$Saini A.; Wilkie G.; Dumont T.. Catastrophic antiphospholipid syndrome after pregnancy complicated by hemolysis, elevated liver enzymes and low platelets syndrome. Obstetric Medicine. 2024;17:2:124-128$27$YR$A$F$Y$$$20240705$$HP$US$US
239760272$23976027$2$F$20240517$20240805$20240614$20240816$EXP$$US-TAKEDA-2024TUS059362$TAKEDA$$75$YR$$M$Y$64$KG$20240816$$MD$US$US
239760293$23976029$3$F$$20240810$20240614$20240813$EXP$$NVSC2024US124301$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
239760733$23976073$3$F$20240101$20240805$20240614$20240813$PER$$US-SA-2024SA175707$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240814$$MD$US$US
239760782$23976078$2$F$$20240710$20240614$20240718$PER$$US-SA-2024SA173181$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240718$$MD$US$US
239760823$23976082$3$F$20240101$20240905$20240614$20240915$PER$$US-SA-2024SA171974$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240915$$MD$US$US
239760992$23976099$2$F$20240520$20240731$20240614$20240813$EXP$IT-MINISAL02-988045$IT-Axellia-005219$XELLIA PHARMACEUTICALS$$65$YR$E$M$Y$51$KG$20240813$$MD$IT$IT
239761072$23976107$2$F$20231207$20240711$20240614$20240715$EXP$$PL-PFIZER INC-202400191020$PFIZER$$69$YR$$F$Y$71$KG$20240715$$MD$PL$PL
239761112$23976111$2$F$20240301$20240724$20240614$20240801$EXP$$DE-PFIZER INC-202400189975$PFIZER$$81$YR$$M$Y$75$KG$20240801$$MD$DE$DE
239761252$23976125$2$F$20240423$20240924$20240614$20240927$EXP$$FR-PFIZER INC-202400190052$PFIZER$$74$YR$$M$Y$72$KG$20240927$$MD$FR$FR
239761292$23976129$2$F$20240603$20240625$20240614$20240701$EXP$$DE-JNJFOC-20240616897$JOHNSON AND JOHNSON$$48$YR$A$M$Y$89$KG$20240701$$MD$DE$DE
239761302$23976130$2$F$20240610$20240710$20240614$20240717$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000527$DECIPHERA PHARMACEUTICALS$$79$YR$E$M$Y$$$20240717$$CN$US$US
239761385$23976138$5$F$$20240730$20240614$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093928$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240731$$CN$US$US
239761403$23976140$3$F$$20240802$20240614$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094854$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240808$$CN$US$US
239761432$23976143$2$F$20240601$20240716$20240614$20240718$PER$$US-AMGEN-USASP2024114656$AMGEN$$43$YR$A$F$Y$$$20240717$$CN$US$US
239761462$23976146$2$F$$20240730$20240614$20240805$30DAY$$US-GSK-US2024072087$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
239761582$23976158$2$F$20240604$20240625$20240614$20240708$PER$$US-AstraZeneca-2024A130225$ASTRAZENECA$$23331$DY$$M$Y$$$20240708$$CN$US$
239761592$23976159$2$F$20190701$20240715$20240614$20240723$EXP$$IT-AUROBINDO-AUR-APL-2024-028511$AUROBINDO$$61$YR$$M$Y$$$20240723$$MD$IT$IT
239761652$23976165$2$F$20200101$20240715$20240614$20240717$EXP$$CA-PFIZER INC-202400192336$PFIZER$$66$YR$$F$Y$74.8$KG$20240717$$HP$CA$CA
239761692$23976169$2$F$$20240916$20240614$20240920$EXP$$CA-PFIZER INC-202400189334$PFIZER$$38$YR$$M$Y$$$20240920$$HP$CA$CA
239761733$23976173$3$F$20231204$20240731$20240614$20240806$EXP$$CA-PFIZER INC-202300284565$PFIZER$$74$YR$$F$Y$70$KG$20240806$$MD$CA$CA
239761792$23976179$2$F$20230906$20240729$20240614$20240801$EXP$$CA-PFIZER INC-202300294303$PFIZER$$69$YR$$M$Y$91$KG$20240801$$HP$CA$CA
239761882$23976188$2$F$20240101$20240815$20240614$20240828$PER$$US-SA-2024SA172357$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240828$$MD$US$US
239761932$23976193$2$F$$20240827$20240614$20240903$EXP$$US-ABBVIE-5798098$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
239761972$23976197$2$F$$20240805$20240614$20240808$EXP$$US-ASTELLAS-2024US014579$ASTELLAS$$$$$M$Y$$$20240808$$CN$US$US
239762013$23976201$3$F$$20240718$20240614$20240718$30DAY$$US-PFIZER INC-202400188671$PFIZER$$13$YR$$M$Y$$$20240718$$CN$US$US
239762025$23976202$5$F$$20240925$20240614$20240925$30DAY$$US-PFIZER INC-202400189744$PFIZER$$14$YR$$M$Y$$$20240925$$CN$US$US
239762034$23976203$4$F$20240606$20240911$20240614$20240913$30DAY$$US-PFIZER INC-202400190793$PFIZER$$9$YR$$M$Y$$$20240913$$CN$US$US
239762044$23976204$4$F$$20240820$20240614$20240822$30DAY$$US-PFIZER INC-202400189663$PFIZER$$18$YR$$M$Y$$$20240822$$CN$US$US
239762073$23976207$3$F$20240610$20240901$20240614$20240906$30DAY$$US-PFIZER INC-202400190398$PFIZER$$13$YR$$M$Y$68.04$KG$20240906$$CN$US$US
239762102$23976210$2$F$$20240705$20240614$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-028764$AUROBINDO$Bornhorst M, Eze A, Bhattacharya S, Putnam E, Almira-Suarez MI, Rossi C, et al.. Optical genome mapping identifies a novel pediatric embryonal tumor with a ZNF532::NUTM1 fusion. J-Pathol. 2023;260(3):329-338$18$MON$$M$Y$$$20240716$$HP$US$US
239762222$23976222$2$F$$20240924$20240614$20240930$EXP$$BR-SANDOZ INC.-SDZ2024BR035185$SANDOZ$$$$$F$Y$$$20240930$$CN$BR$BR
239762282$23976228$2$F$20240401$20240821$20240614$20240826$EXP$$CA-SANDOZ INC.-PHHY2017CA022683$SANDOZ$$35$YR$$F$Y$$$20240826$$MD$CA$CA
239762602$23976260$2$F$$20240713$20240614$20240715$PER$$US-AMGEN-USASP2024116644$AMGEN$$54$YR$A$M$Y$$$20240715$$MD$US$US
239762962$23976296$2$F$$20240821$20240614$20240822$EXP$$CA-PFIZER INC-202400193173$PFIZER$$56$YR$$F$Y$$$20240822$$HP$CA$CA
239763132$23976313$2$F$20240101$20240702$20240614$20240709$30DAY$$US-PFIZER INC-202400191649$PFIZER$$12$YR$$M$Y$40.816$KG$20240709$$CN$US$US
239763143$23976314$3$F$20240609$20240911$20240614$20240913$30DAY$$US-PFIZER INC-202400191654$PFIZER$$13$YR$$M$Y$45.36$KG$20240913$$HP$US$US
239763175$23976317$5$F$$20240911$20240614$20240916$30DAY$$US-PFIZER INC-202400191647$PFIZER$$4$MON$$M$Y$$$20240916$$CN$US$US
239763183$23976318$3$F$$20240913$20240614$20240918$30DAY$$US-PFIZER INC-202400192154$PFIZER$$11$YR$$F$Y$$$20240918$$CN$US$US
239763193$23976319$3$F$$20240808$20240614$20240808$EXP$$CA-PFIZER INC-202400192548$PFIZER$$77$YR$$F$Y$$$20240808$$HP$CA$CA
239763403$23976340$3$F$20230101$20240809$20240614$20240816$EXP$$JP-009507513-2304JPN003514J$MERCK$$73$YR$$M$Y$$$20240816$$MD$JP$JP
239763442$23976344$2$F$20240101$20240916$20240614$20240923$PER$$US-SA-2024SA172525$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240923$$MD$US$US
239763462$23976346$2$F$20240207$20240703$20240614$20240706$EXP$$JP-ABBVIE-5797930$ABBVIE$$71$YR$$M$Y$69$KG$20240706$$MD$JP$JP
239763522$23976352$2$F$20240610$20240717$20240614$20240717$30DAY$$US-PFIZER INC-202400191486$PFIZER$$1$YR$$M$Y$5.5$KG$20240717$$CN$US$US
239763584$23976358$4$F$$20240802$20240614$20240805$PER$$US-ALXN-202406USA000370US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
239763602$23976360$2$F$20240106$20240717$20240614$20240727$30DAY$$US-GSK-US2024AMR069810$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240727$$PH$US$US
239763682$23976368$2$F$$20240710$20240614$20240723$EXP$$US-MSNLABS-2024MSNSPO01259$MSN LABORATORIES$$$$$$Y$$$20240723$$CN$US$US
239763712$23976371$2$F$20240101$20240916$20240614$20240923$PER$$US-SA-2024SA172036$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240923$$MD$US$US
239763772$23976377$2$F$20220101$20240809$20240614$20240816$PER$$US-SA-2024SA177342$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240817$$MD$US$US
239763804$23976380$4$F$20240520$20240710$20240614$20240712$PER$$US-AMGEN-USASP2024116413$AMGEN$$45$YR$A$F$Y$$$20240712$$MD$US$US
239763812$23976381$2$F$20240326$20240803$20240614$20240805$EXP$$TR-PFIZER INC-PV202400077665$PFIZER$$57$YR$$M$Y$$$20240805$$MD$TR$TR
239763853$23976385$3$F$20240518$20240904$20240614$20240905$30DAY$$CL-PFIZER INC-202400191247$PFIZER$$16$YR$$M$Y$$$20240905$$CN$CL$CL
239763942$23976394$2$F$$20240705$20240614$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-028575$AUROBINDO$Chirumamilla Y, Edupuganti S, Bachuwa G, Alkotob L.. Right atrial thrombus leading to pulmonary embolism in a patient with dermatomyositis and COVID-19 managed with FlowTriever device thrombectomy. BMJ-Case-Rep. 2023;16:e255385$$$A$F$Y$$$20240716$$MD$US$US
239763973$23976397$3$F$20240101$20240912$20240614$20240920$PER$$US-SA-2024SA172216$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240921$$MD$US$US
239763982$23976398$2$F$20240609$20240802$20240614$20240807$PER$$US-AMGEN-USASP2024114741$AMGEN$$72$YR$E$M$Y$$$20240807$$CN$US$US
239764002$23976400$2$F$$20240705$20240614$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-028674$AUROBINDO$Orme F, Ran R, Campos L, Hubel K.. BLOCKED TWICE: PULMONARYEMBOLISM AS ETIOLOGYOF COMPLETE HEART BLOCK. Crit-Care-Med. 2024;52(1):S59$71$YR$$M$Y$$$20240716$$HP$US$US
239764043$23976404$3$F$$20240701$20240614$20240709$EXP$$JP-JNJFOC-20240636667$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$$COUNTRY NOT SPECIFIED$JP
239764262$23976426$2$F$$20240705$20240614$20240715$EXP$$US-AUROBINDO-AUR-APL-2024-028479$AUROBINDO$Evans A, Sullian S, Davalos J, Yingchoncharoen P, Ashour F, Iwuji K. AUTOIMMUNE GFAP ASTROCYTOPATHYIN THE MEDICAL INTENSIVE CARE UNIT. Critical-Care-Medicine. 2024;52 (Suppl.)(1):S278 abstr. 609$43$YR$$M$Y$$$20240715$$HP$US$US
239764292$23976429$2$F$20240603$20240620$20240614$20240701$EXP$GB-MHRA-MED-202406030823038770-GHTNR$GB-Accord-429108$ACCORD$$53$YR$A$M$Y$74$KG$20240701$$CN$GB$GB
239764302$23976430$2$F$20240206$20240809$20240614$20240813$EXP$DE-EMA-2024605-AUTODUP-1717616573980$DE-Accord-430128$ACCORD$$79$YR$E$F$Y$57.2$KG$20240813$$MD$DE$DE
239764362$23976436$2$F$$20240711$20240614$20240801$30DAY$$US-GSK-US2024070137$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
239764492$23976449$2$F$20240501$20240717$20240614$20240729$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406002790$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240729$$CN$JP$JP
239764753$23976475$3$F$20230101$20240812$20240614$20240819$EXP$$US-ABBVIE-5739025$ABBVIE$$77$YR$$F$Y$$$20240819$$CN$US$US
239764874$23976487$4$F$$20240816$20240614$20240930$PER$$US-LUNDBECK-DKLU3078156$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
239764912$23976491$2$F$$20240718$20240614$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096173$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240719$$CN$US$US
239764924$23976492$4$F$$20240705$20240614$20240715$EXP$$PL-AUROBINDO-AUR-APL-2024-028806$AUROBINDO$Cisowska M, Katarzyna P, Lidia Stopyra. Przemko, K.. Uog?lniona posta?  bartonellozy ? rzadka posta? choroby  kociego pazura.(Generalized form  bartonellosis ? a rare form of the disease  cat^s claw). PEDIATRIA PO DYPLOMIE. 2024;(2):x$14$YR$$M$Y$$$20240715$$HP$PL$PL
239764982$23976498$2$F$$20240626$20240614$20240705$30DAY$$US-GSK-US2024070125$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
239765074$23976507$4$F$20240401$20240722$20240614$20240807$PER$$NVSC2024US123920$NOVARTIS$$46$YR$$F$Y$97$KG$20240807$$HP$US$US
239765173$23976517$3$F$$20240620$20240614$20240705$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450860$RANBAXY$Sasaki N, Miura A, Suzuki K, Haruki S, Yamaguchi K. A Case of Specific Pneumonia Diagnosed as Peritumoral Infiltration during Nivolumab Treatment for Esophageal Cancer. Jpn J Cancer Chemother. 2023;Apr; 50 (4):526-528$54$YR$$M$Y$$$20240705$$HP$JP$JP
239765313$23976531$3$F$$20240628$20240614$20240712$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450846$RANBAXY$Li S, Lili C, Guangbiao H. Deutetrabenazine in the treatment of tardive dyskinesia induced by antipsychotics: a case report [Chinese].. Chin J Psychiatry. 2022;Apr; 55 (2):142-144$19$YR$$F$Y$$$20240712$$HP$CN$CN
239765662$23976566$2$F$20120313$20240619$20240614$20240704$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-451196$RANBAXY$$70$YR$$F$Y$$$20240704$$MD$ES$ES
239765772$23976577$2$F$20240105$20240807$20240614$20240822$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409623$RANBAXY$$12$YR$C$M$Y$$$20240822$$MD$US$US
239765902$23976590$2$F$$20240814$20240614$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-451576$RANBAXY$$56$YR$$F$Y$$$20240829$$HP$FR$FR
239766333$23976633$3$F$$20240625$20240614$20240715$PER$$US-AstraZeneca-2024A130233$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
239766342$23976634$2$F$$20240705$20240614$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-028585$AUROBINDO$Harmouche E, Stueve P, Howland MA, Su MK. Massive Apixaban Overdose Confirmed with Blood Concentrations and Managed Without Bleeding: A Single Case Report.. Journal of Pharmacy Practice. 2023;37 (3):761?765$76$YR$$M$Y$88.5$KG$20240716$$HP$US$US
239766422$23976642$2$F$20240501$20240730$20240614$20240814$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0241$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240814$$HP$US$US
239766433$23976643$3$F$20231101$20240717$20240614$20240722$EXP$$CA-UCBSA-2024021089$UCB$$25$YR$$F$Y$$$20240722$$CN$CA$CA
239766462$23976646$2$F$20240101$20240910$20240614$20240913$30DAY$$GR-PFIZER INC-202400180722$PFIZER$$14$YR$$M$Y$52$KG$20240913$$HP$GR$GR
239766492$23976649$2$F$20240101$20240727$20240614$20240805$PER$$US-SA-2024SA171838$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240805$$MD$US$US
239766522$23976652$2$F$20240611$20240719$20240614$20240722$PER$$US-AMGEN-USASP2024117179$AMGEN$$$$$$Y$$$20240722$$CN$US$US
239766772$23976677$2$F$$20240702$20240614$20240708$EXP$$HU-INCYTE CORPORATION-2024IN006240$INCYTE$A. Jona, E. Kiss, A. Kenyeres, L. Gergely, Z. Simon, A. Illes. Our experience with Mosunetuzumab. Hematology-Transfusiology. 2024;76$$$$$Y$$$20240708$$MD$HU$HU
239766972$23976697$2$F$20240607$20240706$20240614$20240710$EXP$$AU-ABBVIE-5799028$ABBVIE$$89$YR$$M$Y$$$20240710$$MD$AU$AU
239766982$23976698$2$F$$20240925$20240614$20240925$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-451426$RANBAXY$Morita Y, Koizumi H, Arisawa Y, Fukaura R, Sugawara K. Successful control of Morbihan disease with dapsone: a case report and literature review. J Cutan Immunol Allerg. 2024;7 (0):01-04$48$YR$$F$Y$$$20240925$$HP$JP$JP
239767042$23976704$2$F$20240603$20240709$20240614$20240716$EXP$$US-SA-2024SA177243$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240716$$MD$US$US
239767082$23976708$2$F$20230731$20240725$20240614$20240802$EXP$$JP-AstraZeneca-2024A092445$ASTRAZENECA$$51$YR$$F$Y$73$KG$20240802$$MD$JP$
239767102$23976710$2$F$20240101$20240804$20240614$20240805$EXP$$CA-PFIZER INC-202400191849$PFIZER$$64$YR$$M$Y$$$20240805$$HP$CA$CA
239767163$23976716$3$F$20240101$20240830$20240614$20240911$PER$$US-SA-2024SA176779$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240911$$MD$US$US
239767192$23976719$2$F$$20240813$20240614$20240819$EXP$$CH-TAKEDA-2024TUS013172$TAKEDA$$$$$M$Y$$$20240819$$MD$CH$CH
239767262$23976726$2$F$$20240625$20240614$20240708$PER$$US-Calliditas-2024CAL00938$CALLIDITAS THERAPEUTICS$$45$YR$A$M$Y$86.4$KG$20240708$$CN$US$US
239767273$23976727$3$F$$20240819$20240614$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096314$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240826$$HP$US$US
239767302$23976730$2$F$$20240722$20240614$20240723$PER$$US-JNJFOC-20240630448$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$HP$US$US
239767314$23976731$4$F$$20240917$20240614$20240926$PER$$US-INCYTE CORPORATION-2024IN006043$INCYTE$$$$$$Y$$$20240926$$CN$US$US
239767392$23976739$2$F$20240501$20240805$20240614$20240815$PER$$US-MYLANLABS-2024M1052552$MYLAN$$52$YR$$F$Y$72.57$KG$20240815$$MD$US$US
239767402$23976740$2$F$$20240624$20240614$20240703$PER$$AU-SA-2024SA177227$SANOFI AVENTIS$$$$E$M$Y$$$20240703$$CN$US$AU
239767412$23976741$2$F$20240101$20240702$20240614$20240708$EXP$$US-ABBVIE-5800095$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
239767482$23976748$2$F$20240306$20240627$20240614$20240701$EXP$$US-OTSUKA-2024_016613$OTSUKA$$79$YR$$M$Y$$$20240701$$CN$US$US
239767512$23976751$2$F$$20240718$20240614$20240723$EXP$$JP-OTSUKA-2024_016371$OTSUKA$$26$YR$$F$Y$$$20240723$$PH$JP$JP
239767542$23976754$2$F$20240601$20240905$20240614$20240911$30DAY$$MX-PFIZER INC-PV202400075245$PFIZER$$$$$F$Y$$$20240911$$CN$MX$MX
239767555$23976755$5$F$$20240921$20240614$20240926$30DAY$$US-PFIZER INC-202400174330$PFIZER$$$$$M$Y$$$20240926$$CN$US$US
239767624$23976762$4$F$$20240809$20240614$20240819$EXP$$FR-TEVA-VS-3207279$TEVA$$70$YR$$M$Y$$$20240819$$HP$FR$FR
239767653$23976765$3$F$$20240807$20240614$20240807$EXP$$US-PFIZER INC-PV202400077688$PFIZER$$$$$$Y$$$20240807$$HP$US$US
239767702$23976770$2$F$20240325$20240610$20240614$20240801$PER$$US-BAYER-2024A084249$BAYER$$25$YR$A$F$Y$$$20240801$$MD$US$US
239767752$23976775$2$F$$20240702$20240614$20240716$PER$$US-Calliditas-2024CAL00959$CALLIDITAS THERAPEUTICS$$62$YR$A$F$Y$99.3$KG$20240716$$CN$US$US
239767803$23976780$3$F$20230411$20240808$20240614$20240816$EXP$$CA-OTSUKA-2023_009956$OTSUKA$$54$YR$$M$Y$$$20240816$$HP$CA$CA
239767823$23976782$3$F$20240101$20240916$20240614$20240919$30DAY$$GB-PFIZER INC-202400190346$PFIZER$$$$$M$Y$$$20240919$$CN$GB$GB
239767873$23976787$3$F$20240101$20240624$20240614$20240702$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016533$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240702$$$US$US
239767926$23976792$6$F$20240606$20240918$20240614$20240924$30DAY$$GR-PFIZER INC-202400190021$PFIZER$$12$YR$$F$Y$38$KG$20240924$$CN$GR$GR
239767932$23976793$2$F$20240610$20240904$20240614$20240908$EXP$$US-ABBVIE-5798829$ABBVIE$$54$YR$$F$Y$$$20240908$$CN$US$US
239767982$23976798$2$F$$20240910$20240614$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092065$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$HP$US$US
239768002$23976800$2$F$$20240702$20240614$20240709$30DAY$$HR-JNJFOC-20240614396$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$HR$HR
239768133$23976813$3$F$19980101$20240718$20240614$20240730$EXP$$ES-SA-2024SA175619$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240730$$MD$ES$ES
239768173$23976817$3$F$20240501$20240925$20240614$20240927$30DAY$$US-PFIZER INC-202400189682$PFIZER$$82$YR$$F$Y$53.52$KG$20240927$$CN$US$US
239768204$23976820$4$F$$20240718$20240614$20240722$EXP$$US-JNJFOC-20240607840$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
239768252$23976825$2$F$$20240708$20240614$20240710$30DAY$$US-SANDOZ INC.-SDZ2024US057798$SANDOZ$$$$$F$Y$$$20240710$$HP$US$US
239768263$23976826$3$F$20240604$20240805$20240614$20240819$PER$$US-Calliditas-2024CAL00948$CALLIDITAS THERAPEUTICS$$74$YR$E$M$Y$99.5$KG$20240819$$CN$US$US
239768562$23976856$2$F$$20240711$20240614$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451228$RANBAXY$Schneider A, Sadhana J, Menindez MD, Jeevaratnam S, Balistreri L, Thomas C, et al. Hydroxychloroquine Induced Cardiotoxicity: A Case Series. Rom J Intern Med. 2024;62 (2):210-215$72$YR$$F$Y$$$20240726$$MD$US$US
239768782$23976878$2$F$20240101$20240822$20240614$20240830$EXP$$US-ABBVIE-5799999$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
239769022$23976902$2$F$20240612$20240724$20240614$20240725$PER$$US-AMGEN-USASP2024117154$AMGEN$$71$YR$E$M$Y$$$20240725$$CN$US$US
239769134$23976913$4$F$20240429$20240823$20240614$20240906$PER$$US-Calliditas-2024CAL00949$CALLIDITAS THERAPEUTICS$$25$YR$A$F$Y$106.3$KG$20240906$$CN$US$US
239769182$23976918$2$F$$20240808$20240614$20240813$EXP$$US-OTSUKA-2024_016526$OTSUKA$$$$$M$Y$89.36$KG$20240813$$CN$US$US
239769342$23976934$2$F$20231201$20240717$20240614$20240722$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032733$BOEHRINGER INGELHEIM$$51$YR$A$F$Y$$$20240722$$HP$US$US
239769362$23976936$2$F$20240522$20240725$20240614$20240801$EXP$$US-Eisai-EC-2024-167749$EISAI$$73$YR$E$F$Y$55.4$KG$20240801$$CN$US$US
239769392$23976939$2$F$20231001$20240710$20240614$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033816$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240715$$CN$US$US
239769622$23976962$2$F$$20240905$20240614$20240909$PER$$US-PFIZER INC-PV202400078009$PFIZER$$74$YR$$F$Y$57.15$KG$20240909$$CN$US$US
239769662$23976966$2$F$20240523$20240628$20240614$20240702$PER$$US-PFIZER INC-202400191909$PFIZER$$74$YR$$F$Y$49.9$KG$20240702$$CN$US$US
239769682$23976968$2$F$20240101$20240726$20240614$20240731$PER$$US-PFIZER INC-PV202400077781$PFIZER$$72$YR$$F$Y$$$20240731$$MD$US$US
239769693$23976969$3$F$$20240630$20240614$20240703$PER$$US-PFIZER INC-PV202400077253$PFIZER$$59$YR$$M$Y$$$20240703$$CN$US$US
239769762$23976976$2$F$20200306$20240807$20240614$20240813$PER$$US-PFIZER INC-202400192382$PFIZER$$57$YR$$M$Y$$$20240813$$HP$US$US
239769812$23976981$2$F$20240611$20240801$20240614$20240806$PER$$US-PFIZER INC-202400192724$PFIZER$$52$YR$$F$Y$49.9$KG$20240806$$CN$US$US
239770062$23977006$2$F$$20240827$20240614$20240904$PER$$US-PFIZER INC-PV202400078038$PFIZER$$61$YR$$M$Y$$$20240904$$CN$US$US
239770172$23977017$2$F$$20240702$20240614$20240704$PER$$US-PFIZER INC-202400193020$PFIZER$$78$YR$$F$Y$$$20240704$$HP$US$US
239770362$23977036$2$F$$20240618$20240614$20240703$30DAY$$GB-JNJFOC-20240553141$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240704$$CN$GB$GB
239770374$23977037$4$F$20240101$20240710$20240614$20240716$30DAY$$US-JNJFOC-20240617541$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240716$$CN$US$US
239770492$23977049$2$F$20240531$20240628$20240614$20240708$EXP$$JP-Eisai-EC-2024-167601$EISAI$$$$A$M$Y$$$20240708$$PH$JP$JP
239770522$23977052$2$F$20240601$20240909$20240614$20240919$EXP$$US-UCBSA-2024030282$UCB$$25$YR$$F$Y$$$20240919$$HP$US$US
239770615$23977061$5$F$$20240912$20240614$20240918$EXP$$IT-MYLANLABS-2023M1128015$MYLAN$Ricchiuto A, Antenora F, Valzano I, Montanaro V, Giorgio A, Manco A et al.. Diffuse alveolar hemorrhage associated with apixaban therapy. Respiration. 2023;102(8):704/111$58$YR$$M$Y$$$20240918$$HP$IT$IT
239770743$23977074$3$F$$20240801$20240614$20240806$EXP$$HU-SA-2024SA177468$SANOFI AVENTIS$Lakatos V, Gopcsa L, Balogh A, Fabian J, Remenyi P.. Treatment and transplantation in T-cell prolymphocytic leukaemia: Presentation of two cases.. Hematology?Transfusiology. 2024;65-6:69-9$62$YR$A$F$Y$$$20240807$$$COUNTRY NOT SPECIFIED$HU
239770752$23977075$2$F$20240101$20240715$20240614$20240724$PER$$US-SA-2024SA168114$SANOFI AVENTIS$$90$YR$E$M$Y$73$KG$20240724$$MD$US$US
239770792$23977079$2$F$$20240711$20240614$20240717$30DAY$$US-MYLANLABS-2024M1052363$MYLAN$$$$$F$Y$$$20240717$$PH$US$US
239770873$23977087$3$F$20240501$20240702$20240614$20240712$30DAY$$FI-JNJFOC-20240575051$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240712$$PH$FI$FI
239770882$23977088$2$F$20240610$20240723$20240614$20240729$PER$$US-JNJFOC-20240624796$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240729$$CN$US$US
239770989$23977098$9$F$20240611$20240909$20240614$20240916$PER$$US-GILEAD-2024-0677330$GILEAD$$51$YR$A$M$Y$$$20240916$$HP$US$US
239771033$23977103$3$F$20240501$20240721$20240614$20240723$30DAY$$CA-PFIZER INC-202400084385$PFIZER$$25$YR$$M$Y$$$20240723$$CN$CA$CA
239771042$23977104$2$F$20240418$20240923$20240614$20240926$30DAY$$US-PFIZER INC-PV202400072402$PFIZER$$$$$$Y$$$20240926$$HP$US$US
239771103$23977110$3$F$$20240808$20240614$20240813$EXP$$US-INCYTE CORPORATION-2024IN006229$INCYTE$$$$$$Y$$$20240813$$CN$US$US
239771142$23977114$2$F$$20240704$20240614$20240710$EXP$$DK-MYLANLABS-2024M1052901$MYLAN$$$$$M$Y$$$20240710$$CN$DK$DK
239771183$23977118$3$F$20240605$20240808$20240614$20240815$EXP$$CA-AKCEA THERAPEUTICS, INC.-2024IS005659$AKCEA THERAPEUTICS$$$$$$Y$$$20240814$$HP$CA$CA
239771213$23977121$3$F$$20240610$20240614$20240920$PER$$US-JNJFOC-20240615595$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$MD$US$US
239771232$23977123$2$F$20230918$20240910$20240614$20240913$30DAY$$US-PFIZER INC-PV202400072407$PFIZER$$$$$F$Y$$$20240913$$HP$US$US
239771292$23977129$2$F$20240101$20240806$20240614$20240812$EXP$$CA-ABBVIE-5799756$ABBVIE$$70$YR$$F$Y$$$20240812$$CN$CA$CA
239771302$23977130$2$F$$20240723$20240614$20240731$EXP$$US-AstraZeneca-2024A134165$ASTRAZENECA$$$$$F$Y$$$20240731$$HP$US$
239771315$23977131$5$F$$20240801$20240614$20240807$EXP$$FR-AstraZeneca-2024A137466$ASTRAZENECA$$$$$M$Y$77$KG$20240807$$MD$FR$
239771352$23977135$2$F$$20240801$20240614$20240816$EXP$$US-GRANULES-US-2024GRASPO00209$GRANULES INDIA$$$$$F$Y$$$20240816$$HP$US$US
239771442$23977144$2$F$$20240626$20240614$20240710$30DAY$$CA-JNJFOC-20240577884$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240710$$PH$CA$CA
239771565$23977156$5$F$20240611$20240924$20240614$20240925$PER$$NVSC2024US124091$NOVARTIS$$65$YR$$M$Y$$$20240925$$PH$US$US
239771724$23977172$4$F$20240607$20240709$20240614$20240715$PER$$US-AMGEN-USASP2024114240$AMGEN$$63$YR$A$F$Y$99.773$KG$20240715$$HP$US$US
239771732$23977173$2$F$20240606$20240711$20240614$20240716$30DAY$$US-AMGEN-USASP2024114275$AMGEN$$55$YR$A$F$Y$75$KG$20240716$$HP$US$US
239771792$23977179$2$F$20240612$20240717$20240614$20240718$PER$$US-JNJFOC-20240631474$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240718$$HP$US$US
239771882$23977188$2$F$$20240530$20240614$20240812$PER$$US-PURACAP-US-2024EPCSPO00681$PURACAP$$69$YR$E$F$Y$$$20240812$$CN$US$US
239771893$23977189$3$F$$20240820$20240614$20240821$30DAY$$CO-PFIZER INC-202400186492$PFIZER$$10$YR$$F$Y$$$20240821$$CN$CO$CO
239771933$23977193$3$F$20240301$20240913$20240614$20240919$30DAY$$CO-PFIZER INC-PV202400073350$PFIZER$$14$YR$$M$Y$$$20240919$$CN$CO$CO
239771944$23977194$4$F$20240527$20240921$20240614$20240924$30DAY$$CL-PFIZER INC-PV202400070510$PFIZER$$9$YR$$F$Y$$$20240924$$CN$CL$CL
239772082$23977208$2$F$20240101$20240627$20240614$20240708$PER$$US-SA-2024SA177787$SANOFI AVENTIS$$11$YR$C$M$Y$33.02$KG$20240708$$MD$US$US
239772162$23977216$2$F$$20240802$20240614$20240805$EXP$$US-AstraZeneca-2024A138278$ASTRAZENECA$$$$$M$Y$$$20240805$$MD$US$
239772264$23977226$4$F$20240101$20240909$20240614$20240910$PER$$US-AMGEN-USASP2024117814$AMGEN$$68$YR$E$F$Y$$$20240910$$CN$US$US
239772284$23977228$4$F$20230101$20240722$20240614$20240723$PER$$US-JNJFOC-20240619073$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
239772312$23977231$2$F$$20240806$20240614$20240809$EXP$$JP-PFIZER INC-202400192909$PFIZER$$9$DEC$$F$Y$$$20240809$$MD$JP$JP
239772403$23977240$3$F$20240522$20240709$20240614$20240718$30DAY$$US-ALKERMES INC.-ALK-2024-001421$ALKERMES$$50$YR$$M$Y$$$20240718$$HP$US$US
239772522$23977252$2$F$20240528$20240703$20240614$20240709$EXP$$US-GSK-US2024069320$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240709$$CN$US$US
239772742$23977274$2$F$$20240724$20240614$20240730$EXP$$IN-VANTIVE-2024VAN017742$Vantive US Healthcare$$14$YR$$M$Y$$$20240730$$CN$IN$IN
239772824$23977282$4$F$20240619$20240823$20240614$20240827$PER$$US-AMGEN-USASP2024118018$AMGEN$$80$YR$E$F$Y$$$20240827$$CN$US$US
239772862$23977286$2$F$$20240822$20240614$20240822$PER$$NVSC2024US124985$NOVARTIS$$$$$M$Y$$$20240822$$CN$US$US
239772932$23977293$2$F$20240501$20240906$20240614$20240917$PER$$JP-Eisai-EC-2024-167647$EISAI$$$$E$M$Y$$$20240917$$MD$JP$JP
239773102$23977310$2$F$$20240801$20240614$20240805$EXP$$US-SANDOZ INC.-SDZ2024US057840$SANDOZ$$$$$F$Y$$$20240805$$CN$US$US
239773233$23977323$3$F$20240522$20240729$20240614$20240808$30DAY$$US-JNJFOC-20240568997$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240808$$CN$US$US
239773312$23977331$2$F$20220928$20240913$20240614$20240926$PER$$US-SA-2024SA171133$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240926$$MD$US$US
239773342$23977334$2$F$20240101$20240805$20240614$20240814$EXP$$SE-ORPHANEU-2024004252$RECORDATI$$$$$$Y$$$20240814$$MD$SE$SE
239773382$23977338$2$F$20230906$20240627$20240614$20240703$PER$$US-BIOGEN-2024BI01249229$BIOGEN$$61$YR$$F$Y$$$20240703$$CN$US$US
239773452$23977345$2$F$20240524$20240715$20240614$20240724$EXP$$US-FreseniusKabi-FK202408984$FRESENIUS KABI$$41$YR$A$M$Y$60.6$KG$20240724$$MD$US$US
239773582$23977358$2$F$20240401$20240730$20240614$20240808$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004732$SAREPTA THERAPEUTICS$$6$YR$$M$Y$$$20240808$$CN$US$US
239773772$23977377$2$F$$20240815$20240614$20240823$EXP$$IL-ELI_LILLY_AND_COMPANY-IL202406005389$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240823$$CN$IL$IL
239773962$23977396$2$F$20170301$20240620$20240614$20240703$EXP$$PHHY2017CO020495$NOVARTIS$$81$YR$$F$Y$60$KG$20240703$$CN$CO$CO
239774003$23977400$3$F$20240426$20240805$20240614$20240809$PER$$JP-Eisai-EC-2024-167738$EISAI$$68$YR$E$F$Y$$$20240809$$MD$JP$JP
239774072$23977407$2$F$$20240605$20240614$20240703$EXP$$US-BAYER-2024A086027$BAYER$Saini A, Wilkie G, Dumont T.. Catastrophic antiphospholipid syndrome after pregnancy complicated by hemolysis, elevated liver enzymes and low platelets syndrome. Obstetric Medicine. 2024;17:2:124-128$$$N$$Y$0.386$KG$20240703$$HP$US$US
239774082$23977408$2$F$$20240716$20240614$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096324$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$69.4$KG$20240719$$CN$US$US
239774243$23977424$3$F$$20240813$20240614$20240820$EXP$$US-BIOGEN-2024BI01258329$BIOGEN$$$$$M$Y$$$20240820$$CN$US$US
239774412$23977441$2$F$$20240813$20240614$20240815$PER$$US-PFIZER INC-PV202400077302$PFIZER$$67$YR$$F$Y$58.503$KG$20240815$$HP$US$US
239774462$23977446$2$F$20240612$20240730$20240614$20240801$PER$$US-PFIZER INC-202400192828$PFIZER$$55$YR$$F$Y$49.89$KG$20240801$$CN$US$US
239774494$23977449$4$F$$20240913$20240614$20240916$30DAY$$CL-PFIZER INC-PV202400071170$PFIZER$$13$YR$$F$Y$$$20240916$$CN$CL$CL
239774533$23977453$3$F$20240601$20240913$20240614$20240913$30DAY$$AR-PFIZER INC-202400192036$PFIZER$$12$YR$$F$Y$$$20240913$$CN$AR$AR
239774553$23977455$3$F$$20240903$20240614$20240905$30DAY$$US-PFIZER INC-202400084015$PFIZER$$13$YR$$F$Y$$$20240905$$CN$US$US
239774702$23977470$2$F$20240529$20240626$20240614$20240705$30DAY$$US-GSK-US2024073170$GLAXOSMITHKLINE$$75$YR$$M$Y$$$20240705$$MD$US$US
239774872$23977487$2$F$20240221$20240604$20240614$20240906$EXP$$US-FARMAPROD-202402-0534$DOMPE FARMACEUTICI$$60$YR$A$F$Y$96.07$KG$20240904$$MD$US$US
239774902$23977490$2$F$$20240717$20240614$20240729$EXP$$US-FARMAPROD-202406-2134$DOMPE FARMACEUTICI$$$$E$F$Y$62.14$KG$20240729$$CN$US$US
239775022$23977502$2$F$$20240715$20240614$20240723$EXP$$CA-FreseniusKabi-FK202409262$FRESENIUS KABI$$33$YR$A$F$Y$$$20240723$$MD$CA$CA
239775072$23977507$2$F$$20240813$20240614$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095287$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240816$$CN$US$US
239775134$23977513$4$F$20240909$20240909$20240614$20240916$EXP$$CA-GSK-CA2023162630$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$CA$CA
239775442$23977544$2$F$$20240723$20240614$20240723$PER$$US-ALXN-202406USA000356US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
239775452$23977545$2$F$$20240722$20240614$20240725$30DAY$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-092711$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240725$$CN$GB$GB
239775582$23977558$2$F$20240301$20240823$20240614$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202406004412$ELI LILLY AND CO$$$$$F$Y$$$20240827$$PH$US$US
239775672$23977567$2$F$$20240823$20240614$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04811$LUPIN$$$$$$Y$$$20240905$$CN$US$US
239775682$23977568$2$F$20240523$20240619$20240614$20240711$PER$$FR-TOLMAR, INC.-24FR049622$TOLMAR$$75$YR$$M$Y$$$20240710$$PH$FR$FR
239775712$23977571$2$F$20240522$20240617$20240614$20240710$PER$$FR-TOLMAR, INC.-24FR049576$TOLMAR$$63$YR$$M$Y$$$20240710$$PH$FR$FR
239775722$23977572$2$F$20240521$20240617$20240614$20240710$PER$$FR-TOLMAR, INC.-24FR049575$TOLMAR$$80$YR$$M$Y$$$20240710$$PH$FR$FR
239775732$23977573$2$F$20240522$20240619$20240614$20240711$PER$$FR-TOLMAR, INC.-24FR049618$TOLMAR$$8$DEC$$M$Y$$$20240710$$PH$FR$FR
239775742$23977574$2$F$20240522$20240619$20240614$20240711$PER$$FR-TOLMAR, INC.-24FR049621$TOLMAR$$7$DEC$$M$Y$$$20240710$$PH$FR$FR
239775752$23977575$2$F$20240523$20240619$20240614$20240711$PER$$FR-TOLMAR, INC.-24FR049647$TOLMAR$$93$YR$$M$Y$$$20240710$$PH$FR$FR
239775762$23977576$2$F$20240524$20240621$20240614$20240711$PER$$FR-TOLMAR, INC.-24FR049669$TOLMAR$$73$YR$$M$Y$$$20240710$$HP$FR$FR
239775773$23977577$3$F$20240521$20240811$20240614$20240905$PER$$FR-TOLMAR, INC.-24FR049665$TOLMAR$$55$YR$$M$Y$$$20240905$$HP$FR$FR
239775822$23977582$2$F$20240523$20240702$20240614$20240808$PER$$TR-TOLMAR, INC.-24TR049615$TOLMAR$$73$YR$$M$Y$$$20240808$$HP$TR$TR
239775852$23977585$2$F$$20240725$20240614$20240730$PER$$US-AstraZeneca-2024A126043$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
239775942$23977594$2$F$$20240715$20240614$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096543$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240716$$CN$US$US
239775974$23977597$4$F$$20240812$20240614$20240822$30DAY$$US-GSK-US2024069388$GLAXOSMITHKLINE$$$$$M$Y$$$20240822$$CN$US$US
239776142$23977614$2$F$20240501$20240816$20240614$20240827$PER$$US-SA-2024SA173235$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240827$$MD$US$US
239776152$23977615$2$F$20240701$20240711$20240614$20240716$EXP$$US-SA-2024SA176187$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240716$$MD$US$US
239776185$23977618$5$F$20240606$20240911$20240614$20240916$30DAY$$US-PFIZER INC-202400188594$PFIZER$$7$YR$$M$Y$$$20240916$$HP$US$US
239776203$23977620$3$F$$20240820$20240614$20240821$30DAY$$CO-PFIZER INC-PV202400072637$PFIZER$$13$YR$$M$Y$$$20240821$$CN$CO$CO
239776292$23977629$2$F$$20240709$20240614$20240716$EXP$$CA-GSK-CA2024069966$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$CA$CA
239776333$23977633$3$F$20240501$20240716$20240614$20240722$EXP$$CH-BAYER-2024A085926$BAYER$$59$YR$A$M$Y$$$20240722$$PH$CH$CH
239776353$23977635$3$F$20230712$20240814$20240614$20240819$EXP$$DE-DSJP-DSE-2024-126159$DAIICHI$$72$YR$$M$Y$100$KG$20240819$$HP$DE$DE
239776365$23977636$5$F$20240529$20240626$20240614$20240704$EXP$$JP-AstraZeneca-2024A127377$ASTRAZENECA$$$$A$M$Y$$$20240704$$MD$JP$
239776403$23977640$3$F$20230404$20240717$20240614$20240725$EXP$$JP-ALXN-202406JPN000303JP$ALEXION PHARMACEUTICALS$$51$YR$$M$Y$$$20240725$$MD$JP$JP
239776412$23977641$2$F$20240415$20240606$20240614$20240705$EXP$$NL-TEVA-VS-3208859$TEVA$$51$YR$$F$Y$$$20240705$$HP$NL$NL
239776543$23977654$3$F$20240520$20240625$20240614$20240703$PER$$US-AMGEN-USASP2024114305$AMGEN$$$$$M$Y$101.2$KG$20240703$$HP$US$US
239776612$23977661$2$F$20240429$20240702$20240614$20240711$EXP$$US-Calliditas-2024CAL00988$CALLIDITAS THERAPEUTICS$$18$YR$A$M$Y$63.2$KG$20240711$$CN$US$US
239776662$23977666$2$F$20240101$20240828$20240614$20240906$PER$$US-SA-2024SA171845$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240906$$MD$US$US
239776752$23977675$2$F$$20240719$20240614$20240730$PER$$US-SA-2024SA172514$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240730$$MD$US$US
239776812$23977681$2$F$20240604$20240702$20240614$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095654$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240704$$CN$US$US
239776822$23977682$2$F$$20240703$20240614$20240715$30DAY$$US-GSK-US2024069969$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
239776882$23977688$2$F$20240603$20240723$20240614$20240730$EXP$$US-ANIPHARMA-2024-US-032221$ANI$$57$YR$$F$Y$99.79$KG$20240730$$CN$US$US
239777132$23977713$2$F$$20240806$20240614$20240808$EXP$$CA-TAKEDA-2024TUS059481$TAKEDA$$$$$F$Y$$$20240808$$CN$CA$CA
239777235$23977723$5$F$20240807$20240921$20240614$20240926$EXP$$IN-PFIZER INC-PV202400076343$PFIZER$$67$YR$$M$Y$$$20240926$$CN$IN$IN
239777314$23977731$4$F$20240606$20240725$20240614$20240729$EXP$$AR-ABBVIE-5802213$ABBVIE$$68$YR$$M$Y$68$KG$20240729$$MD$AR$AR
239777332$23977733$2$F$20240301$20240812$20240614$20240820$PER$$US-SA-2024SA172108$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240820$$MD$US$US
239777352$23977735$2$F$20240607$20240723$20240614$20240725$PER$$US-ALXN-202406USA000449US$ALEXION PHARMACEUTICALS$$56$YR$$F$Y$$$20240723$$CN$US$US
239777553$23977755$3$F$$20240620$20240614$20240813$PER$$US-LUNDBECK-DKLU3078292$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
239777572$23977757$2$F$20230804$20240820$20240614$20240826$EXP$$US-JNJFOC-20240612962$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240826$$CN$US$US
239777692$23977769$2$F$20230101$20240624$20240614$20240702$EXP$$JP-AstraZeneca-2024A134705$ASTRAZENECA$$72$YR$$F$Y$$$20240702$$MD$JP$
239777744$23977774$4$F$20240101$20240815$20240614$20240820$EXP$$US-ABBVIE-5797810$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
239777842$23977784$2$F$20221228$20240822$20240614$20240830$EXP$$JP-009507513-2406JPN001636J$MERCK$$75$YR$$F$Y$$$20240830$$MD$JP$JP
239777892$23977789$2$F$20240601$20240808$20240614$20240808$EXP$$CA-PFIZER INC-202400191636$PFIZER$$72$YR$$M$Y$$$20240808$$CN$CA$CA
239777944$23977794$4$F$20240514$20240709$20240614$20240717$PER$$JP-Eisai-EC-2024-167585$EISAI$$$$E$F$Y$$$20240717$$MD$JP$JP
239778073$23977807$3$F$$20240731$20240614$20240805$PER$$US-VERTEX PHARMACEUTICALS-2024-009883$VERTEX$$$$$F$Y$$$20240805$$CN$US$US
239778082$23977808$2$F$$20240709$20240614$20240715$EXP$$GB-VERTEX PHARMACEUTICALS-2024-009893$VERTEX$$$$$F$Y$$$20240715$$CN$GB$GB
239778212$23977821$2$F$20240508$20240731$20240614$20240809$EXP$$IL-BAXTER-2024BAX019525$BAXTER$$77$YR$$F$Y$67.2$KG$20240809$$HP$IL$IL
239778222$23977822$2$F$20230531$20240605$20240614$20240805$EXP$$ES-BAXTER-2024BAX019602$BAXTER$$59$YR$$F$Y$78.4$KG$20240805$$MD$ES$ES
239778423$23977842$3$F$20240621$20240731$20240614$20240802$PER$$US-PFIZER INC-202400191606$PFIZER$$57$YR$$F$Y$$$20240802$$CN$US$US
239778443$23977844$3$F$20230101$20240701$20240614$20240703$PER$$US-PFIZER INC-PV202400064270$PFIZER$$65$YR$$F$Y$$$20240703$$HP$US$US
239778462$23977846$2$F$$20240716$20240614$20240718$PER$$US-PFIZER INC-202400191673$PFIZER$$29$YR$$M$Y$74.921$KG$20240718$$MD$US$US
239778482$23977848$2$F$$20240724$20240614$20240731$PER$$US-ALXN-202406USA000515US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239778522$23977852$2$F$$20240723$20240614$20240723$PER$$US-ALXN-202406USA000464US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
239778543$23977854$3$F$20230207$20240813$20240614$20240819$EXP$$IT-JNJFOC-20240629474$JOHNSON AND JOHNSON$$60$YR$A$F$Y$77$KG$20240820$$MD$IT$IT
239778602$23977860$2$F$20221028$20240909$20240614$20240911$EXP$$IE-AstraZeneca-2024A138347$ASTRAZENECA$$8$DY$$F$Y$$$20240911$$MD$IE$
239778722$23977872$2$F$20230313$20240701$20240614$20240709$EXP$$US-AstraZeneca-2024A135389$ASTRAZENECA$$67$YR$$M$Y$79.8$KG$20240709$$HP$US$
239778743$23977874$3$F$$20240623$20240614$20240703$EXP$$GB-TEVA-VS-3206474$TEVA$Ilyas-Feldmann M, Langer O, Bauer M, Asselin M, Hendrikse NH, Sisodiya SM et al.. Tolerability of tariquidar -a third generation p-gp inhibitor as add-on medication to antiseizure medications in drug-resistant epilepsy. SEIZURE. 2024;119_44-51. doi_10.1016_j.seizure.2024.05.007; Ilyas-Feldmann M, Langer O, Bauer M, Asselin M, Hendrikse NH, Sisodiya SM et al. Tolerability of tariquidar -A third generation P-gp inhibitor as add-on medication to antiseizure medications in drug-resistant epilepsy...$38$YR$$F$Y$$$20240703$$HP$GB$GB
239778932$23977893$2$F$20240327$20240630$20240614$20240708$EXP$$NVSC2024RU075053$NOVARTIS$$76$YR$$F$Y$85$KG$20240708$$MD$RU$RU
239778942$23977894$2$F$$20240628$20240614$20240709$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0600275$MYOVANT SCIENCES$$$$$M$Y$$$20240709$$CN$US$US
239779032$23977903$2$F$$20240709$20240614$20240724$EXP$$US-PARI RESPIRATORY EQUIPMENT, INC.-2024PAR00044$PARI RESPIRATORY EQUIPMENT$$$$$F$Y$69.796$KG$20240724$$HP$US$US
239779113$23977911$3$F$20240101$20240812$20240614$20240815$EXP$$CA-PFIZER INC-202400192695$PFIZER$$77$YR$$F$Y$$$20240815$$CN$CA$CA
239779162$23977916$2$F$$20240903$20240614$20240912$EXP$$JP-JNJFOC-20240633327$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240913$$MD$JP$JP
239779222$23977922$2$F$$20240829$20240614$20240903$EXP$$US-MYLANLABS-2024M1054300$MYLAN$$$$$F$Y$$$20240903$$MD$US$US
239779502$23977950$2$F$$20240911$20240614$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095344$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240912$$CN$US$US
239779582$23977958$2$F$$20240723$20240614$20240731$EXP$$US-AstraZeneca-2024A133603$ASTRAZENECA$$$$$F$Y$$$20240731$$MD$US$
239779592$23977959$2$F$$20240705$20240614$20240709$EXP$$FR-AstraZeneca-2024A135997$ASTRAZENECA$$41$YR$$F$Y$$$20240709$$MD$FR$
239779612$23977961$2$F$20240501$20240624$20240614$20240702$EXP$$JP-AstraZeneca-2024A135447$ASTRAZENECA$$50$YR$$F$Y$70$KG$20240702$$MD$JP$
239779632$23977963$2$F$$20240726$20240614$20240802$EXP$$AU-MYLANLABS-2024M1053465$MYLAN$$$$$F$Y$$$20240802$$CN$AU$AU
239779682$23977968$2$F$20231005$20240719$20240614$20240723$PER$$JP-Eisai-EC-2024-168098$EISAI$$71$YR$E$F$Y$36$KG$20240723$$PH$JP$JP
239779702$23977970$2$F$$20240701$20240614$20240703$PER$$NVSC2024US125276$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
239779732$23977973$2$F$$20240723$20240614$20240723$PER$$US-ALXN-202406USA000382US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
239779832$23977983$2$F$20231101$20240726$20240614$20240925$EXP$$CZ-Ipsen Biopharmaceuticals, Inc.-2024-11490$IPSEN$HRABCAKOVA T. Challenges in the diagnosis and treatment of G1 NET in a malcompliant patient. Neuroendocrine Tumors News. 2024;9(1): 18-20.$44$YR$A$M$Y$$$20240925$$MD$CZ$CZ
239779872$23977987$2$F$20231128$20240715$20240614$20240723$EXP$$ES-JNJFOC-20240263914$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240723$$CN$ES$ES
239779902$23977990$2$F$20240219$20240722$20240614$20240723$EXP$$NO-TAKEDA-2024TUS059372$TAKEDA$$66$YR$$F$Y$$$20240723$$HP$NO$NO
239779972$23977997$2$F$$20240604$20240614$20240926$PER$$US-GSK-US2024AMR070361$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
239780022$23978002$2$F$20230101$20240723$20240614$20240731$EXP$$US-AstraZeneca-2024A133846$ASTRAZENECA$$368$MON$$M$Y$68$KG$20240731$$CN$US$
239780102$23978010$2$F$$20240904$20240614$20240920$PER$$US-JNJFOC-20240628045$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$CN$US$US
239780142$23978014$2$F$20221123$20240730$20240614$20240806$EXP$$JP-009507513-2401JPN001826J$MERCK$Akasu R, Yoshida M, Demitsu T, Osada H, Kyuba K. 17 A case of Bullous Pemphigoid Induced by Pembrolizumab in a Patient with Laryngeal Cancer. The 45th Annual Meeting of Bullous Dermatosis. 11$79$YR$$M$Y$164$KG$20240806$$MD$JP$JP
239780312$23978031$2$F$$20240627$20240614$20240710$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091400$GLENMARK$$$$$$Y$$$20240710$$CN$US$US
239780472$23978047$2$F$$20240718$20240614$20240727$30DAY$$US-GSK-US2024070114$GLAXOSMITHKLINE$$$$$F$Y$$$20240727$$CN$US$US
239780622$23978062$2$F$20230908$20240722$20240614$20240725$EXP$$KR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003336$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240725$$HP$KR$KR
239780683$23978068$3$F$$20240912$20240614$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095124$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240912$$HP$US$US
239780712$23978071$2$F$20240528$20240703$20240614$20240708$EXP$$US-AstraZeneca-2024A135587$ASTRAZENECA$$66$YR$$M$Y$88.9$KG$20240708$$MD$US$
239780763$23978076$3$F$20240603$20240708$20240614$20240722$PER$$US-Calliditas-2024CAL00958$CALLIDITAS THERAPEUTICS$$60$YR$A$F$Y$69.85$KG$20240722$$CN$US$US
239780843$23978084$3$F$$20240705$20240614$20240711$EXP$$JP-JNJFOC-20240638254$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$HP$JP$JP
239780902$23978090$2$F$20240701$20240711$20240614$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095949$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$61.23$KG$20240715$$CN$US$US
239780962$23978096$2$F$$20240912$20240614$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096393$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240912$$HP$US$US
239780985$23978098$5$F$$20240816$20240614$20240822$EXP$$US-VIIV HEALTHCARE LIMITED-US2024069300$VIIV$$$$$$Y$$$20240822$$PH$US$US
239781212$23978121$2$F$$20240627$20240614$20240708$PER$$US-SA-2024SA172030$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240708$$MD$US$US
239781242$23978124$2$F$$20240724$20240614$20240731$PER$$US-ALXN-202406USA000521US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
239781272$23978127$2$F$$20240721$20240614$20240723$30DAY$$CL-PFIZER INC-PV202400076496$PFIZER$$9$YR$$M$Y$$$20240723$$CN$CL$CL
239781293$23978129$3$F$20240601$20240917$20240614$20240920$30DAY$$AR-PFIZER INC-202400190329$PFIZER$$13$YR$$M$Y$$$20240920$$CN$AR$AR
239781342$23978134$2$F$20240603$20240911$20240614$20240916$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-095985$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240916$$HP$PR$PR
239781353$23978135$3$F$20240612$20240724$20240614$20240731$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-096233$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240731$$CN$PR$PR
239781412$23978141$2$F$$20240903$20240614$20240910$EXP$$US-ABBVIE-5762947$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
239781462$23978146$2$F$$20240730$20240614$20240809$30DAY$$US-GSK-US2024070776$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
239781496$23978149$6$F$20240101$20240917$20240614$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-013792$UNITED THERAPEUTICS$$$$$M$Y$91.156$KG$20240925$$$US$US
239781722$23978172$2$F$20240101$20240717$20240614$20240719$EXP$$MY-009507513-2406MYS003352$MERCK$$1$YR$$F$Y$$$20240719$$MD$MY$MY
239781732$23978173$2$F$$20240709$20240614$20240719$30DAY$$US-GSK-US2024AMR071109$GLAXOSMITHKLINE$$$$$M$Y$$$20240719$$PH$US$US
239781782$23978178$2$F$$20240827$20240614$20240830$PER$$US-BIOGEN-2024BI01268933$BIOGEN$$$$$$Y$$$20240830$$CN$US$US
239781892$23978189$2$F$20240120$20240709$20240614$20240719$EXP$$CZ-ELI_LILLY_AND_COMPANY-CZ202406003356$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240719$$CN$CZ$CZ
239782012$23978201$2$F$20240101$20240530$20240614$20240912$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000066$LANNETT$$$$$F$Y$$$20240912$$CN$US$US
239782123$23978212$3$F$20240604$20240704$20240614$20240711$PER$$US-HETERO-HET2024US01752$HETERO$$56$YR$$F$Y$172$KG$20240711$$PH$US$US
239782153$23978215$3$F$$20240811$20240614$20240816$PER$$NVSC2024US125263$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
239782162$23978216$2$F$20220101$20240805$20240614$20240808$EXP$$US-ABBVIE-5795095$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
239782212$23978221$2$F$$20240709$20240614$20240711$EXP$$JP-ABBVIE-5800142$ABBVIE$$65$YR$$M$Y$$$20240711$$CN$JP$JP
239782225$23978222$5$F$20231016$20240820$20240614$20240827$EXP$$CA-TAKEDA-2023TUS101016$TAKEDA$$61$YR$$F$Y$$$20240827$$CN$CA$CA
239782262$23978226$2$F$20230214$20240902$20240614$20240904$EXP$$IN-PFIZER INC-PV202300045789$PFIZER$$63$YR$$F$Y$$$20240904$$CN$IN$IN
239782314$23978231$4$F$$20240801$20240614$20240806$EXP$$US-TAKEDA-2023TUS006853$TAKEDA$$$$$M$Y$78$KG$20240806$$HP$US$US
239782342$23978234$2$F$$20240812$20240614$20240816$EXP$$BR-AMGEN-BRASP2024114300$AMGEN$$77$YR$E$F$Y$$$20240816$$CN$BR$BR
239782352$23978235$2$F$20240607$20240625$20240614$20240701$PER$$US-AMGEN-USASP2024113615$AMGEN$$76$YR$E$M$Y$72$KG$20240701$$HP$US$US
239782362$23978236$2$F$$20240920$20240614$20240923$EXP$$NVSC2024CA124446$NOVARTIS$$$$$M$Y$$$20240923$$MD$CA$CA
239782383$23978238$3$F$20240606$20240725$20240614$20240801$PER$$US-AMGEN-USASP2024113708$AMGEN$$81$YR$E$F$Y$56.7$KG$20240801$$PH$US$US
239782483$23978248$3$F$$20240802$20240614$20240805$EXP$$US-ALXN-202406USA000432US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$MD$US$US
239782563$23978256$3$F$$20240723$20240614$20240821$PER$$US-ALXN-202406USA000442US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
239782632$23978263$2$F$20190701$20240715$20240614$20240730$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202406002471$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240730$$CN$IT$IT
239782652$23978265$2$F$20240501$20240801$20240614$20240805$EXP$$CA-JNJFOC-20240481609$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240805$$HP$CA$CA
239782794$23978279$4$F$$20240905$20240614$20240908$PER$$US-ALXN-202406USA000493US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$CN$US$US
239782802$23978280$2$F$$20240709$20240614$20240718$PER$$US-SA-2024SA177974$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
239782872$23978287$2$F$20240501$20240913$20240614$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096436$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$105.69$KG$20240913$$CN$US$US
239782952$23978295$2$F$$20240626$20240614$20240702$EXP$$US-UROVANT SCIENCES GMBH-202406-URV-000848$UROVANT SCIENCES$$91$YR$$F$Y$$$20240702$$HP$US$US
239782993$23978299$3$F$20240604$20240926$20240614$20240927$EXP$$JP-CARA THERAPEUTICS, INC.-2024-00302-JP$CARA THERAPEUTICS$$9$DEC$$M$Y$$$20240927$$PH$JP$JP
239783023$23978302$3$F$$20240917$20240614$20240920$PER$$US-PFIZER INC-202400191492$PFIZER$$12$YR$$F$Y$$$20240920$$CN$US$US
239783052$23978305$2$F$20240601$20240709$20240614$20240717$EXP$$JP-SMPA-2024SMP008416$SUNOVION$$$$$$Y$$$20240717$$CN$JP$JP
239783082$23978308$2$F$$20240718$20240614$20240718$PER$$US-PFIZER INC-PV202400077599$PFIZER$$67$YR$$F$Y$$$20240718$$CN$US$US
239783174$23978317$4$F$20240517$20240715$20240614$20240721$EXP$$CA-SANDOZ INC.-SDZ2024CA056753$SANDOZ$$74$YR$$F$Y$$$20240721$$CN$CA$CA
239783182$23978318$2$F$$20240812$20240614$20240823$EXP$$US-RADIUS HEALTH INC.-2024US004034$RADIUS PHARM$$$$$F$Y$$$20240823$$CN$US$US
239783192$23978319$2$F$20240301$20240716$20240614$20240729$PER$$US-Calliditas-2024CAL00962$CALLIDITAS THERAPEUTICS$$50$YR$A$F$Y$$$20240729$$CN$US$US
239783472$23978347$2$F$20231201$20240916$20240614$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202406006989$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240919$$CN$US$US
239783503$23978350$3$F$$20240722$20240614$20240723$PER$$US-ALXN-202406USA000333US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
239783552$23978355$2$F$20240607$20240611$20240614$20240927$PER$$US-BIOMARINAP-US-2024-158526$BIOMARIN$$$$$$Y$$$20240927$$CN$US$US
239783562$23978356$2$F$$20240725$20240614$20240725$PER$$NVSC2024US125220$NOVARTIS$$$$$M$Y$$$20240726$$PH$US$US
239783582$23978358$2$F$$20240814$20240614$20240822$EXP$$NVSC2024TW124365$NOVARTIS$Chu Y-C, Chen N-C, Chen C-L. A case of Listeria monocytogenes brain abscess with a clinical  presentation mimicking stroke. ACTA NEUROLOGICA TAIWANICA. 2024;33 (1):36-40$62$YR$$M$Y$$$20240822$$HP$TW$TW
239783602$23978360$2$F$20240518$20240627$20240614$20240711$PER$$US-Calliditas-2024CAL00965$CALLIDITAS THERAPEUTICS$$28$YR$A$F$Y$$$20240711$$CN$US$
239783694$23978369$4$F$$20240703$20240614$20240716$EXP$$LU-BEH-2023164862$CSL BEHRING$$$$A$F$Y$70$KG$20240716$$HP$LU$LU
239783742$23978374$2$F$$20240724$20240614$20240731$PER$$US-ALXN-202406USA000498US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
239783752$23978375$2$F$20240603$20240723$20240614$20240723$PER$$US-ALXN-202406USA000410US$ALEXION PHARMACEUTICALS$$11$YR$$M$Y$$$20240723$$CN$US$US
239783772$23978377$2$F$$20240914$20240614$20240915$EXP$$US-ALXN-202406USA000157US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
239783833$23978383$3$F$$20240912$20240614$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096388$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$77.11$KG$20240912$$CN$US$US
239783872$23978387$2$F$20240101$20240723$20240614$20240802$EXP$$US-TEVA-VS-3208844$TEVA$$24$YR$$F$Y$$$20240802$$HP$US$US
239783912$23978391$2$F$$20240603$20240614$20240722$PER$$US-INCYTE CORPORATION-2024IN005940$INCYTE$$$$$$Y$$$20240722$$CN$US$US
239783992$23978399$2$F$20240614$20240614$20240614$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202406010097$ELI LILLY AND CO$$$$$M$Y$$$20240823$$CN$US$US
239784012$23978401$2$F$$20240723$20240614$20240731$EXP$$US-AstraZeneca-2024A134456$ASTRAZENECA$$$$$$Y$$$20240731$$MD$US$
239784222$23978422$2$F$$20240905$20240614$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US026016$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
239784232$23978423$2$F$20240429$20240912$20240614$20240921$EXP$$US-TEVA-VS-3208565$TEVA$$25$YR$$F$Y$$$20240921$$HP$US$US
239784242$23978424$2$F$$20240724$20240614$20240731$PER$$US-ALXN-202406USA000517US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
239784302$23978430$2$F$$20240814$20240614$20240820$EXP$$JP-009507513-2406JPN000776J$MERCK$$$$$F$Y$$$20240820$$MD$JP$JP
239784412$23978441$2$F$20240606$20240722$20240614$20240730$EXP$$US-AstraZeneca-2024A132753$ASTRAZENECA$$6562$DY$$M$Y$$$20240730$$MD$US$
239784432$23978443$2$F$$20240624$20240614$20240702$EXP$$JP-AstraZeneca-2024A135830$ASTRAZENECA$Murakami Y.. 57 A case of lung adenocarcinoma with radiation recall pneumonitis in the early phase of osimertinib administration.. The 120th the Kansai Branch of the Japan Lung Cancer Society, Academic Meeting Program, Abstracts. 2024;$79$YR$$F$Y$$$20240702$$MD$JP$
239784532$23978453$2$F$$20240612$20240614$20240711$EXP$$CA-AstraZeneca-2024A136989$ASTRAZENECA$$44$YR$$F$Y$97$KG$20240711$$MD$CA$
239784542$23978454$2$F$$20240912$20240614$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095506$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240912$$HP$US$US
239784592$23978459$2$F$20240401$20240627$20240614$20240701$EXP$$US-ORGANON-O2406USA000927$ORGANON$$66$YR$$F$Y$65.76$KG$20240701$$MD$US$US
239784683$23978468$3$F$20240101$20240627$20240614$20240705$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004739$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240705$$CN$US$US
239784772$23978477$2$F$$20240912$20240614$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096576$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240912$$CN$US$US
239784803$23978480$3$F$20240601$20240819$20240614$20240827$EXP$$US-Calliditas-2024CAL00972$CALLIDITAS THERAPEUTICS$$72$YR$E$M$Y$85.9$KG$20240827$$CN$US$US
239784833$23978483$3$F$20240604$20240731$20240614$20240821$PER$$US-INCYTE CORPORATION-2024IN006032$INCYTE$$$$$$Y$$$20240821$$CN$US$US
239785133$23978513$3$F$$20240819$20240614$20240822$EXP$$US-PFIZER INC-202400193015$PFIZER$$86$YR$$F$Y$$$20240822$$HP$US$US
239785343$23978534$3$F$$20240815$20240614$20240822$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202406001398$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$DE$DE
239785352$23978535$2$F$20240529$20240801$20240614$20240807$PER$$US-ALKERMES INC.-ALK-2024-001528$ALKERMES$$25$YR$$F$Y$140.09$KG$20240807$$MD$US$US
239785382$23978538$2$F$20240201$20240626$20240614$20240701$EXP$$JP-Covis Pharma GmbH-2024COV00725$COVIS PHARMA$Yonekura N. A-14 A case of amyotrophic lateral sclerosis complicated by interstitial pneumonia suspected to be drug-induced lung disorder due to riluzole.. The 92nd Respiratory Joint Hokuriku Regional Meeting.$70$YR$E$M$Y$$$20240701$$HP$JP$JP
239785402$23978540$2$F$$20240624$20240614$20240722$PER$$US-INCYTE CORPORATION-2024IN005686$INCYTE$$$$$$Y$$$20240719$$CN$US$US
239785474$23978547$4$F$$20240917$20240614$20240926$PER$$US-GSK-US2024AMR070256$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$HP$US$US
239785496$23978549$6$F$20240101$20240828$20240614$20240830$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-126582$DAIICHI$$$$$M$Y$$$20240830$$CN$US$US
239785562$23978556$2$F$20240412$20240627$20240614$20240707$EXP$$FR-ORPHANEU-2024004301$RECORDATI$$$$$$Y$$$20240707$$MD$FR$FR
239785632$23978563$2$F$$20240724$20240614$20240730$EXP$$US-Calliditas-2024CAL00954$CALLIDITAS THERAPEUTICS$$63$YR$A$F$Y$$$20240730$$CN$US$US
239785673$23978567$3$F$20240605$20240723$20240614$20240723$PER$$US-ALXN-202406USA000453US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
239785773$23978577$3$F$20240513$20240709$20240614$20240716$EXP$$JP-GENMAB-2024-02022$GENMAB$$85$YR$$F$Y$$$20240716$$MD$JP$JP
239785823$23978582$3$F$20240513$20240625$20240614$20240705$EXP$$JP-RADIUS HEALTH INC.-2024JP004210$RADIUS PHARM$$81$YR$$F$Y$$$20240705$$MD$JP$JP
239785902$23978590$2$F$$20240730$20240614$20240904$PER$$US-LUNDBECK-DKLU4000383$LUNDBECK$$$$$$Y$$$20240904$$CN$US$US
239785932$23978593$2$F$$20240724$20240614$20240724$PER$$US-ALXN-202406USA000574US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240724$$MD$US$US
239785962$23978596$2$F$20240101$20240702$20240614$20240710$EXP$$JP-RADIUS HEALTH INC.-2024JP002576$RADIUS PHARM$$84$YR$$F$Y$$$20240710$$MD$JP$JP
239786122$23978612$2$F$$20240904$20240614$20240910$EXP$$US-JNJFOC-20240625544$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$HP$US$US
239786182$23978618$2$F$$20240710$20240614$20240718$EXP$$US-AstraZeneca-2024A134185$ASTRAZENECA$$51$YR$$F$Y$$$20240718$$MD$US$
239786202$23978620$2$F$$20240815$20240614$20240819$EXP$$NVSC2024US124006$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
239786222$23978622$2$F$$20240703$20240614$20240706$EXP$$CN-TAKEDA-2024TUS057476$TAKEDA$$$$$F$Y$$$20240706$$CN$CN$CN
239786282$23978628$2$F$20240610$20240813$20240614$20240814$PER$$US-AMGEN-USASP2024115736$AMGEN$$49$YR$A$M$Y$$$20240814$$CN$US$US
239786302$23978630$2$F$$20240705$20240614$20240705$PER$$US-AstraZeneca-2024A127510$ASTRAZENECA$$47$YR$$F$Y$$$20240705$$MD$US$
239786412$23978641$2$F$$20240703$20240614$20240709$PER$$US-BIOMARINAP-US-2024-158512$BIOMARIN$$$$$$Y$$$20240709$$CN$US$US
239786504$23978650$4$F$20240520$20240719$20240614$20240814$EXP$$US-BEH-2024173161$CSL BEHRING$$36$YR$A$F$Y$$$20240814$$CN$US$US
239786522$23978652$2$F$20240101$20240916$20240614$20240919$EXP$$AU-009507513-2406AUS003882$MERCK$$46$YR$$F$Y$$$20240919$$MD$AU$AU
239786553$23978655$3$F$$20240808$20240614$20240828$PER$$US-AstraZeneca-2024A135291$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
239786572$23978657$2$F$20240612$20240726$20240614$20240731$PER$$US-AstraZeneca-2024A137731$ASTRAZENECA$$62$YR$$F$Y$$$20240731$$HP$US$
239786712$23978671$2$F$20240101$20240801$20240614$20240806$EXP$$CA-ABBVIE-5800310$ABBVIE$$81$YR$$M$Y$$$20240806$$CN$CA$CA
239786752$23978675$2$F$20240517$20240717$20240614$20240720$EXP$$CA-ABBVIE-5801443$ABBVIE$$78$YR$$F$Y$$$20240720$$CN$CA$CA
239786954$23978695$4$F$20240607$20240808$20240614$20240810$PER$$US-AMGEN-USASP2024116143$AMGEN$$59$YR$A$F$Y$$$20240810$$CN$US$US
239787016$23978701$6$F$20240101$20240812$20240614$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-016430$UNITED THERAPEUTICS$$$$$M$Y$102.04$KG$20240821$$$US$US
239787022$23978702$2$F$$20240718$20240614$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-017693$UNITED THERAPEUTICS$$$$$F$Y$51.701$KG$20240727$$$US$US
239787035$23978703$5$F$20240101$20240918$20240614$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017367$UNITED THERAPEUTICS$$$$$F$Y$77.098$KG$20240926$$$US$US
239787052$23978705$2$F$$20240702$20240614$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-017290$UNITED THERAPEUTICS$$$$$M$Y$111.11$KG$20240704$$$US$US
239787202$23978720$2$F$20240101$20240711$20240614$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-015371$UNITED THERAPEUTICS$$$$$F$Y$73.923$KG$20240718$$$US$US
239787218$23978721$8$F$20240101$20240913$20240614$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017894$UNITED THERAPEUTICS$$$$$F$Y$48.98$KG$20240921$$$US$US
239787272$23978727$2$F$20210101$20240718$20240614$20240722$EXP$$CO-ABBVIE-5801122$ABBVIE$$$$$F$Y$60$KG$20240722$$CN$CO$CO
239787373$23978737$3$F$20240518$20240711$20240615$20240715$30DAY$$DE-JNJFOC-20240625827$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240715$$MD$DE$DE
239787434$23978743$4$F$20240606$20240725$20240615$20240730$EXP$$AR-GENMAB-2024-02086$GENMAB$$68$YR$$M$Y$68$KG$20240730$$MD$AR$AR
239787572$23978757$2$F$20230101$20240628$20240615$20240705$EXP$$US-ABBVIE-5798411$ABBVIE$$8$YR$$F$Y$44$KG$20240705$$CN$US$US
239787662$23978766$2$F$$20240705$20240615$20240716$EXP$$CN-AUROBINDO-AUR-APL-2024-028783$AUROBINDO$Fangang M, Jianguo Z, Gan Y, Zhang Y, Gao Y, Xue T, et al.. Efficacy and safety of combined deep brain stimulation with capsulotomy for comorbid motor and psychiatric symptoms in Tourette^s syndrome: Experience and evidence. Asian-J-Psychiatr. 2024;94:103960$24$YR$$M$Y$$$20240716$$HP$CN$CN
239787782$23978778$2$F$20230201$20240722$20240615$20240801$EXP$IT-MINISAL02-987684$IT-Accord-428898$ACCORD$$85$YR$E$F$Y$$$20240801$$MD$IT$IT
239787832$23978783$2$F$20240716$20240716$20240615$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202406009347$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240717$$CN$US$US
239788142$23978814$2$F$$20240723$20240615$20240727$PER$$US-AMGEN-USASP2024116079$AMGEN$$$$$$Y$$$20240726$$PH$US$US
239788182$23978818$2$F$$20240624$20240615$20240708$PER$$US-AstraZeneca-2024A129095$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$US$
239788242$23978824$2$F$20240415$20240808$20240615$20240810$PER$$US-AMGEN-USASP2024114995$AMGEN$$80$YR$E$M$Y$$$20240810$$CN$US$US
239788273$23978827$3$F$$20240708$20240615$20240715$EXP$GB-MHRA-ADR 28748881$GB-SA-2024SA171271$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240715$$HP$GB$GB
239788332$23978833$2$F$20240101$20240712$20240615$20240718$EXP$$US-ABBVIE-5797833$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
239788394$23978839$4$F$20240101$20240828$20240615$20240905$EXP$$CA-CELLTRION INC.-2024CA014345$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
239788432$23978843$2$F$20240611$20240715$20240615$20240731$PER$$US-AMGEN-USASP2024116890$AMGEN$$75$YR$E$F$Y$77.2$KG$20240731$$HP$US$US
239788482$23978848$2$F$20240530$20240717$20240615$20240722$EXP$$TH-SA-2024SA176599$SANOFI AVENTIS$$51$YR$A$F$Y$75$KG$20240720$$HP$TH$TH
239788644$23978864$4$F$20240101$20240710$20240615$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-017348$UNITED THERAPEUTICS$$$$$F$Y$$$20240717$$$US$US
239788802$23978880$2$F$$20240719$20240615$20240730$EXP$$US-AUROBINDO-AUR-APL-2024-029141$AUROBINDO$$23$YR$$M$Y$93.44$KG$20240730$$PH$US$US
239788832$23978883$2$F$20200101$20240706$20240615$20240717$EXP$$FR-AUROBINDO-AUR-APL-2024-028439$AUROBINDO$$24$YR$$M$Y$$$20240717$$PH$FR$FR
239788952$23978895$2$F$$20240701$20240615$20240713$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091401$GLENMARK$$$$$$Y$$$20240713$$CN$US$US
239788983$23978898$3$F$20240616$20240709$20240615$20240713$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017361$UNITED THERAPEUTICS$$38$YR$$F$Y$65.76$KG$20240713$$MD$US$US
239789092$23978909$2$F$20240101$20240831$20240615$20240916$PER$$US-SA-2024SA176707$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240916$$MD$US$US
239789165$23978916$5$F$20180101$20240703$20240615$20240807$EXP$$NL-AUROBINDO-AUR-APL-2024-028782$AUROBINDO$Weringh GV , Koolwijk LV, Haan LD, Touw DJ, de Koning MK. Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/ norclozapine ratio after switching valproic acid to carbamazepine: a case report. Ther Adv Psychopharmacol. 2024;14:1?8$42$YR$$M$Y$65.9$KG$20240807$$HP$NL$NL
239789172$23978917$2$F$$20240701$20240615$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-024586$AUROBINDO$$68$YR$$M$Y$77$KG$20240709$$PH$US$US
239789183$23978918$3$F$20240101$20240730$20240615$20240806$EXP$$US-UCBSA-2024027995$UCB$$$$$M$Y$$$20240806$$CN$US$US
239789242$23978924$2$F$20240101$20240701$20240615$20240705$PER$$US-AMGEN-USASP2024116504$AMGEN$$82$YR$E$F$Y$$$20240705$$CN$US$US
239789304$23978930$4$F$20230101$20240822$20240615$20240830$PER$$US-AMGEN-USASP2024116832$AMGEN$$54$YR$A$F$Y$$$20240829$$CN$US$US
239789522$23978952$2$F$20240611$20240807$20240615$20240808$PER$$US-AMGEN-USASP2024116850$AMGEN$$65$YR$E$F$Y$$$20240808$$CN$US$US
239789544$23978954$4$F$$20240816$20240615$20240826$EXP$$US-GSK-US2024069949$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
239789572$23978957$2$F$$20240705$20240615$20240715$EXP$$US-AUROBINDO-AUR-APL-2024-028794$AUROBINDO$Mekraksakit P, Salman Sheikh M, Zoghby Z. PSEUDOHYPONATREMIA AND ACUTE KIDNEY INJURYIN THE SETTING OF HYPERCHOLESTEROLEMIA MEDIATED BYLIPOPROTEIN X IN A LIVER TRANSPLANT PATIENT. Am-J-Kidney-Dis. 2024;83 (Suppl.)(4):S2$60$YR$$M$Y$$$20240715$$HP$US$US
239789632$23978963$2$F$$20240812$20240615$20240813$EXP$$CA-UCBSA-2023044606$UCB$$$$$M$Y$$$20240813$$MD$CA$CA
239789723$23978972$3$F$$20240909$20240615$20240911$EXP$$NVSC2024US097341$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
239789794$23978979$4$F$20240301$20240819$20240615$20240827$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017507$UNITED THERAPEUTICS$$64$YR$$M$Y$78.458$KG$20240827$$$US$US
239789872$23978987$2$F$20240101$20240919$20240615$20240924$EXP$$CA-ABBVIE-5798371$ABBVIE$$33$YR$$M$Y$$$20240924$$CN$CA$CA
239790203$23979020$3$F$20240610$20240808$20240615$20240809$PER$$US-AMGEN-USASP2024115904$AMGEN$$81$YR$E$M$Y$$$20240809$$CN$US$US
239790234$23979023$4$F$20240606$20240724$20240615$20240801$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017768$UNITED THERAPEUTICS$$60$YR$$F$Y$68.481$KG$20240801$$$US$US
239790254$23979025$4$F$20231228$20240715$20240615$20240724$EXP$$IT-AUROBINDO-AUR-APL-2024-028364$AUROBINDO$$72$YR$$M$Y$54$KG$20240724$$HP$IT$IT
239790292$23979029$2$F$$20240822$20240615$20240906$PER$$US-SA-2024SA177981$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240906$$MD$US$US
239790324$23979032$4$F$$20240710$20240615$20240715$EXP$$CA-JNJFOC-20240632706$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240715$$HP$CA$CA
239790333$23979033$3$F$$20240903$20240615$20240913$EXP$$PT-AUROBINDO-AUR-APL-2024-024854$AUROBINDO$Peixoto M, Lopes JR, Antunes E, Silva I, Caridade S... Olmesartan-Induced Enteropathy - A Case Report.. European Journal of Case Reports in Internal Medicine. 2021;8(1):166$83$YR$$M$Y$$$20240913$$HP$PT$PT
239790453$23979045$3$F$20240401$20240709$20240615$20240712$EXP$$US-AstraZeneca-2024A135431$ASTRAZENECA$$768$MON$$M$Y$$$20240712$$CN$US$
239790485$23979048$5$F$20240604$20240912$20240615$20240920$EXP$$US-GSK-US2024AMR071104$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240920$$CN$US$US
239790502$23979050$2$F$20230501$20240603$20240615$20240716$EXP$$GB-AUROBINDO-AUR-APL-2024-028969$AUROBINDO$$73$YR$$F$Y$66$KG$20240716$$HP$GB$GB
239790542$23979054$2$F$20240520$20240722$20240615$20240725$EXP$$CO-ABBVIE-5801474$ABBVIE$$74$YR$$F$Y$52$KG$20240725$$CN$CO$CO
239790792$23979079$2$F$$20240704$20240615$20240711$PER$$US-HETERO-HET2024US01776$HETERO$$$$$F$Y$$$20240711$$CN$US$US
239790833$23979083$3$F$20240610$20240917$20240615$20240918$PER$$US-AMGEN-USASP2024116384$AMGEN$$55$YR$A$F$Y$$$20240918$$CN$US$US
239790952$23979095$2$F$$20240705$20240615$20240711$PER$$US-HETERO-HET2024US01809$HETERO$$$$$M$Y$$$20240711$$CN$US$US
239790974$23979097$4$F$20240610$20240628$20240615$20240808$EXP$$TR-ABBVIE-5799704$ABBVIE$$70$YR$$M$Y$$$20240808$$CN$TR$TR
239791022$23979102$2$F$$20240802$20240615$20240805$EXP$$JP-ABBVIE-5800267$ABBVIE$$74$YR$$F$Y$$$20240804$$HP$JP$JP
239791082$23979108$2$F$20240610$20240717$20240615$20240726$EXP$$JP-ABBVIE-19K-087-2897659-00$ABBVIE$$73$YR$$M$Y$50$KG$20240726$$CN$JP$JP
239791092$23979109$2$F$20240607$20240630$20240615$20240703$EXP$$US-ABBVIE-5800688$ABBVIE$$88$YR$$M$Y$$$20240703$$CN$US$US
239791262$23979126$2$F$$20240912$20240615$20240924$EXP$$IT-Accord-429450$ACCORD$Pizzini AM, Fantoni C, Zaccaroni S, Silingardi M. Acute severe renal failure in a patient receiving apixaban: a case report. Italian Journal of Medicine. 2024;18(2):doi:10.4081/itjm.2024.1718.$74$YR$E$M$Y$$$20240924$$HP$IT$IT
239791272$23979127$2$F$20230101$20240725$20240615$20240806$EXP$$US-Accord-429084$ACCORD$Valido K, Patel V, Murphy MJ, Junejo MH, Patel DK, Deutsch A, et al. Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach. JAAD Case Reports. 2024;48:49-53.$52$YR$A$F$Y$$$20240806$$MD$US$US
239791332$23979133$2$F$$20240801$20240615$20240830$PER$$US-AstraZeneca-2024A132688$ASTRAZENECA$$$$$$Y$$$20240830$$CN$US$
239791362$23979136$2$F$20231201$20240808$20240615$20240815$EXP$$US-ABBVIE-5575588$ABBVIE$$62$YR$$F$Y$$$20240815$$CN$US$US
239791384$23979138$4$F$20240101$20240828$20240615$20240906$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-018069$UNITED THERAPEUTICS$$71$YR$$F$Y$53$KG$20240906$$MD$JP$JP
239791412$23979141$2$F$$20240604$20240615$20240912$EXP$$US-GRAVITIPHARMA-GRA-2406-US-LIT-0173$GRAVITI PHARMACEUTICALS$Taseer AR, Velez JCQ.MIDODRINE-INDUCED URINARY RETENTION AS A CAUSE OF ACUTE KIDNEYINJURYIN CIRRHOSIS: NOT ALWAYS HEPATORENAL BUT THE FAILED THERAPYFOR IT.Am-J-Kidney-Dis.2024;83 (Suppl. 2):S4-S5$66$YR$A$M$Y$$$20240912$$HP$US$US
239791572$23979157$2$F$20240601$20240722$20240615$20240725$EXP$$JP-JNJFOC-20240630605$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240725$$MD$JP$JP
239791683$23979168$3$F$20240101$20240717$20240615$20240731$EXP$$US-UCBSA-2024024915$UCB$$$$$M$Y$$$20240731$$CN$US$US
239791723$23979172$3$F$20240701$20240801$20240615$20240808$PER$$US-SA-2024SA177751$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240808$$MD$US$US
239791773$23979177$3$F$20120101$20240826$20240615$20240904$EXP$$PL-AUROBINDO-AUR-APL-2024-028483$AUROBINDO$$42$YR$$F$Y$$$20240904$$MD$PL$PL
239791822$23979182$2$F$$20240705$20240615$20240716$EXP$$US-AUROBINDO-AUR-APL-2020-049011$AUROBINDO$Wolf SM, McGoldrick PE, Garg N, Ghatan S, Panov F, Moss R et al.,. Responsive Neurostimulation for Intractable Epilepsy in Phelan-McDermid Syndrome. Journal of Pediatric Epilepsy. 2020;9(2):42-47$6$YR$$F$Y$$$20240716$$HP$US$US
239791942$23979194$2$F$$20240815$20240615$20240821$EXP$$US-ABBVIE-5795388$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
239791953$23979195$3$F$20240607$20240718$20240615$20240722$EXP$$NVSC2024ZA124519$NOVARTIS$$32$YR$$F$Y$$$20240723$$CN$ZA$ZA
239792053$23979205$3$F$20240101$20240715$20240615$20240722$EXP$$US-ABBVIE-5799961$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
239792092$23979209$2$F$20240612$20240625$20240615$20240701$PER$$US-AMGEN-USASP2024116502$AMGEN$$81$YR$E$F$Y$$$20240630$$CN$US$US
239792112$23979211$2$F$20240101$20240701$20240615$20240708$PER$$US-AMGEN-USASP2024116948$AMGEN$$69$YR$E$M$Y$$$20240708$$CN$US$US
239792173$23979217$3$F$20240613$20240628$20240615$20240718$PER$$US-AMGEN-USASP2024117749$AMGEN$$65$YR$E$F$Y$$$20240718$$CN$US$US
239792213$23979221$3$F$$20240718$20240615$20240729$EXP$$GB-MACLEODS PHARMA-MAC2024047636$MACLEODS$$$$$$Y$$$20240729$$MD$GB$GB
239792254$23979225$4$F$20240101$20240705$20240615$20240711$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016775$UNITED THERAPEUTICS$$$$$F$Y$73.469$KG$20240711$$$US$US
239792312$23979231$2$F$20240201$20240725$20240615$20240801$EXP$$FR-AUROBINDO-AUR-APL-2024-029026$AUROBINDO$$61$YR$$M$Y$$$20240801$$MD$FR$FR
239792402$23979240$2$F$$20240612$20240615$20240913$PER$$US-AUROBINDO-AUR-APL-2024-024097$AUROBINDO$$$$$F$Y$$$20240913$$CN$US$US
239792532$23979253$2$F$20240501$20240715$20240615$20240722$EXP$$SA-ABBVIE-5799819$ABBVIE$$52$YR$$F$Y$$$20240719$$MD$SA$SA
239792692$23979269$2$F$20240430$20240621$20240615$20240703$EXP$FR-AFSSAPS-AN2024000735$FR-Accord-428572$ACCORD$$75$YR$E$F$Y$72.5$KG$20240703$$HP$FR$FR
239793013$23979301$3$F$20240520$20240709$20240615$20240722$EXP$$US-Accord-428710$ACCORD$$73$YR$E$F$Y$68.9$KG$20240719$$HP$US$US
239793056$23979305$6$F$20240101$20240905$20240615$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017497$UNITED THERAPEUTICS$$$$$M$Y$89.342$KG$20240914$$$US$US
239793062$23979306$2$F$$20240618$20240615$20240703$EXP$$CA-TEVA-VS-3202544$TEVA$Picard M, Filion CA, Auclair M-H, Noujaim J, de Guerke L, Dionne J-L, et al. Cytokine profiling, pretreatment with anakinra, and tolerance development in platinum-induced mixed hypersensitivity reactions. Ann-Allergy-Asthma-Immunol 2023; 131 (4): 501-512.; Picard M, Filion CA, Auclair M-H, Noujaim J, de Guerke L, Dionne J-L, et al. Cytokine profiling, pretreatment with anakinra, and tolerance development in platinum-induced mixed hypersensitivity reactions. Ann-Allergy-Asthma-Immunol 2023; 13...$59$YR$$F$Y$$$20240703$$MD$CA$CA
239793252$23979325$2$F$20240101$20240708$20240615$20240713$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013417$UNITED THERAPEUTICS$$$$$M$Y$94.331$KG$20240713$$$US$US
239793273$23979327$3$F$$20240912$20240615$20240924$EXP$$CZ-Accord-429235$ACCORD$Vydra J. Sinusoidal obstruction syndrome /veno-occlusive liver disease after allogeneic hematopoietic transplantation. ACTA MEDICINAE. 2024;13(4 - Ext 2/3):33-34, 37.$40$YR$A$M$Y$$$20240924$$MD$CZ$CZ
239793283$23979328$3$F$20201001$20240628$20240615$20240710$EXP$$US-Accord-418245$ACCORD$$56$YR$A$F$Y$$$20240710$$LW$US$US
239793402$23979340$2$F$20240609$20240626$20240615$20240701$PER$$US-AMGEN-USASP2024115885$AMGEN$$85$YR$E$M$Y$$$20240701$$CN$US$US
239793512$23979351$2$F$20240613$20240627$20240615$20240703$PER$$US-AMGEN-USASP2024117764$AMGEN$$72$YR$E$M$Y$$$20240703$$CN$US$US
239793643$23979364$3$F$20240101$20240702$20240615$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-016260$UNITED THERAPEUTICS$$$$$F$Y$$$20240709$$$US$US
239793663$23979366$3$F$$20240817$20240615$20240822$EXP$$US-TAKEDA-2024TUS058278$TAKEDA$$$$$M$Y$$$20240822$$HP$US$US
239793673$23979367$3$F$$20240712$20240615$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-017765$UNITED THERAPEUTICS$$$$$F$Y$73.469$KG$20240718$$$US$US
239793716$23979371$6$F$20240602$20240816$20240615$20240904$PER$$US-AstraZeneca-2024A135179$ASTRAZENECA$$28229$DY$$F$Y$$$20240904$$PH$US$
239793732$23979373$2$F$20240608$20240809$20240615$20240812$PER$$US-AMGEN-USASP2024116338$AMGEN$$67$YR$E$F$Y$$$20240812$$CN$US$US
239793772$23979377$2$F$$20240811$20240615$20240821$EXP$$US-JNJFOC-20240617295$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$HP$US$US
239793813$23979381$3$F$20240101$20240802$20240615$20240811$PER$$US-SA-2024SA177726$SANOFI AVENTIS$$10$YR$C$F$Y$45$KG$20240811$$MD$US$US
239793843$23979384$3$F$20240101$20240806$20240615$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017073$UNITED THERAPEUTICS$$$$$F$Y$104.31$KG$20240816$$$US$US
239793912$23979391$2$F$20240101$20240702$20240615$20240709$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010268$UNITED THERAPEUTICS$$$$$M$Y$89.796$KG$20240709$$$US$US
239793932$23979393$2$F$$20240708$20240615$20240714$PER$$US-AstraZeneca-2024A134105$ASTRAZENECA$$$$$M$Y$$$20240714$$CN$US$
239793942$23979394$2$F$20240608$20240710$20240615$20240711$PER$$US-JNJFOC-20240623860$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
239793963$23979396$3$F$$20240823$20240615$20240828$EXP$$NVSC2024US099944$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
239794012$23979401$2$F$20240607$20240701$20240615$20240703$EXP$$US-TAKEDA-2024TUS059648$TAKEDA$$59$YR$$F$Y$$$20240703$$MD$US$US
239794084$23979408$4$F$20240509$20240829$20240615$20240911$EXP$DE-PEI-202400012283$DE-Accord-429737$ACCORD$$73$YR$E$M$Y$100$KG$20240911$$MD$DE$DE
239794112$23979411$2$F$20240101$20240719$20240615$20240729$PER$$US-SA-2024SA177167$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240729$$MD$US$US
239794143$23979414$3$F$20240614$20240712$20240615$20240717$PER$$US-AMGEN-USASP2024119052$AMGEN$$62$YR$A$M$Y$$$20240716$$CN$US$US
239794154$23979415$4$F$20240601$20240820$20240615$20240827$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00935$AIMMUNE$$$$$$Y$$$20240828$$HP$US$US
239794252$23979425$2$F$20240401$20240725$20240615$20240801$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-11909$IPSEN$$72$YR$E$F$Y$$$20240801$$MD$JP$JP
239794332$23979433$2$F$20240511$20240626$20240615$20240720$30DAY$$US-JNJFOC-20240622340$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240719$$CN$US$US
239794493$23979449$3$F$20240405$20240708$20240615$20240720$30DAY$$US-JNJFOC-20240623662$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$HP$US$US
239794502$23979450$2$F$20240603$20240718$20240615$20240725$EXP$$US-AMGEN-USASP2024115403$AMGEN$$56$YR$A$F$Y$$$20240725$$HP$US$US
239794612$23979461$2$F$$20240712$20240615$20240716$PER$$US-AstraZeneca-2024A136349$ASTRAZENECA$$$$$F$Y$$$20240716$$HP$US$
239794632$23979463$2$F$20240611$20240821$20240615$20240826$PER$$US-AMGEN-USASP2024118400$AMGEN$$76$YR$E$M$Y$$$20240826$$CN$US$US
239794662$23979466$2$F$20240527$20240610$20240615$20240823$EXP$$CL-Hugel Aesthetics-2158154$Hugel Aesthetics$$64$YR$$F$Y$$$20240823$$$CL$CL
239794734$23979473$4$F$20240717$20240718$20240615$20240726$EXP$$US-ZENPEP LLC-2024AIMT00923$AIMMUNE$$$$$$Y$$$20240726$$HP$US$US
239794912$23979491$2$F$$20240620$20240616$20240701$EXP$$US-SA-2024SA174028$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240701$$MD$US$US
239794922$23979492$2$F$$20240821$20240616$20240822$PER$$NVSC2024US124440$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
239794932$23979493$2$F$20240607$20240904$20240616$20240925$PER$$US-SA-2024SA173980$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240925$$MD$US$US
239794982$23979498$2$F$20240101$20240730$20240616$20240731$PER$$US-AstraZeneca-2024A138574$ASTRAZENECA$$$$$M$Y$$$20240731$$MD$US$
239794992$23979499$2$F$$20240626$20240616$20240705$PER$$US-SA-2024SA177218$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240705$$CN$US$US
239795002$23979500$2$F$$20240715$20240616$20240725$EXP$$US-JNJFOC-20240623433$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240725$$CN$US$US
239795064$23979506$4$F$$20240927$20240616$20240930$EXP$$NVSC2024US028026$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
239795092$23979509$2$F$$20240701$20240616$20240710$EXP$NL-EMA-DD-20240603-7482707-135631$NL-JUBILANT CADISTA PHARMACEUTICALS-2024NL000772$JUBILANT$Joosen AMCP, Alcala LSM, Ermens AAM, van Gammeren AJ.. Aplastic bone marrowwith Cabot rings in blood due to high-dose olmesartan. eJHaem. 2022;3(2):537-538$67$YR$$M$Y$$$20240710$$HP$NL$NL
239795172$23979517$2$F$$20240722$20240616$20240730$PER$$US-RDY-SPO/USA/24/0008475$DR REDDYS$$29$YR$A$F$Y$$$20240730$$CN$US$US
239795195$23979519$5$F$20240603$20240718$20240616$20240728$PER$$US-JNJFOC-20240620096$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240729$$HP$US$US
239795243$23979524$3$F$20240101$20240803$20240616$20240805$PER$$US-AMGEN-USASP2024115728$AMGEN$$54$YR$A$M$Y$$$20240805$$HP$US$US
239795292$23979529$2$F$$20240627$20240616$20240716$PER$$US-AstraZeneca-2024A133952$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
239795392$23979539$2$F$$20240626$20240616$20240701$PER$$NVSC2024US124417$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
239795433$23979543$3$F$20240101$20240724$20240616$20240731$PER$$US-SA-2024SA175932$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240731$$MD$US$US
239795493$23979549$3$F$20240601$20240709$20240616$20240715$PER$$US-SA-2024SA177588$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240715$$MD$US$US
239795602$23979560$2$F$20240101$20240722$20240616$20240731$PER$$US-SA-2024SA172981$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240731$$MD$US$US
239795633$23979563$3$F$20240418$20240820$20240616$20240829$EXP$$CA-JNJFOC-20240469458$JOHNSON AND JOHNSON$$26$YR$A$F$Y$87$KG$20240829$$HP$CA$CA
239795643$23979564$3$F$20240101$20240629$20240616$20240708$PER$$US-SA-2024SA169714$SANOFI AVENTIS$$41$YR$A$M$Y$63.04$KG$20240708$$MD$US$US
239795692$23979569$2$F$$20240703$20240616$20240712$PER$$US-SA-2024SA173268$SANOFI AVENTIS$$$$A$M$Y$$$20240712$$MD$US$US
239795852$23979585$2$F$$20240819$20240616$20240828$PER$$US-SA-2024SA172804$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240828$$MD$US$US
239795882$23979588$2$F$20240521$20240629$20240616$20240701$PER$$US-JNJFOC-20240603061$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
239795892$23979589$2$F$20240101$20240813$20240616$20240826$PER$$US-SA-2024SA172838$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240826$$MD$US$US
239795913$23979591$3$F$20240101$20240715$20240616$20240720$EXP$$US-JNJFOC-20240626852$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240719$$CN$US$US
239795983$23979598$3$F$20240502$20240708$20240616$20240722$PER$$US-SA-2024SA177677$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240722$$CN$US$US
239796173$23979617$3$F$20240610$20240628$20240616$20240709$PER$$US-SA-2024SA176817$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240709$$MD$US$US
239796192$23979619$2$F$20240101$20240701$20240616$20240710$PER$$US-SA-2024SA172691$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240710$$MD$US$US
239796212$23979621$2$F$20240101$20240708$20240616$20240715$PER$$US-SA-2024SA177680$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240715$$CN$US$US
239796223$23979622$3$F$20240509$20240822$20240616$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-028574$AUROBINDO$$73$YR$$M$Y$100$KG$20240903$$MD$DE$DE
239796352$23979635$2$F$$20240716$20240616$20240719$PER$$US-AstraZeneca-2024A136722$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$US$
239796362$23979636$2$F$$20240729$20240616$20240827$PER$$US-AstraZeneca-2024A128159$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
239796412$23979641$2$F$$20240705$20240616$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-028829$AUROBINDO$Vendrame M, Poduri A, Loddenkemper T, Kluger G, Coppola G, Kothare SV. Treatment of malignant migrating partial epilepsy of infancy with rufinamide: Report of five cases.. Epileptic-Disord. 2011;13(1):18-21$36$MON$$M$Y$$$20240716$$HP$US$US
239796462$23979646$2$F$20240101$20240703$20240616$20240710$PER$$US-SA-2024SA177144$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240710$$CN$US$US
239796482$23979648$2$F$$20240705$20240616$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-029037$AUROBINDO$Shah S, Weaver CT, Agarwal G.. Acute Kidney Injury with Use of Inhaled Tobramycin. J-Am-SocNephrol. 2016;271004:271004A abstr. PUB432.$57$YR$$F$Y$$$20240716$$HP$US$US
239796863$23979686$3$F$20240224$20240815$20240616$20240821$EXP$$NVSC2023AR130633$NOVARTIS$$49$YR$$F$Y$$$20240821$$CN$AR$AR
239796973$23979697$3$F$$20240730$20240616$20240808$PER$$US-SA-2024SA177970$SANOFI AVENTIS$$91$YR$E$F$Y$56.69$KG$20240808$$MD$US$US
239796983$23979698$3$F$$20240704$20240616$20240708$EXP$$GR-JNJFOC-20240629708$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$$COUNTRY NOT SPECIFIED$GR
239797082$23979708$2$F$$20240627$20240616$20240702$30DAY$$US-GSK-US2024070758$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
239797182$23979718$2$F$$20240719$20240616$20240722$PER$$US-AstraZeneca-2024A138670$ASTRAZENECA$$$$$F$Y$$$20240722$$MD$US$
239797202$23979720$2$F$20240101$20240624$20240616$20240703$PER$$US-SA-2024SA177780$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240703$$MD$US$US
239797212$23979721$2$F$$20240806$20240616$20240831$PER$$US-AstraZeneca-2024A134140$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$US$
239797292$23979729$2$F$20240801$20240814$20240616$20240828$PER$$US-SA-2024SA172202$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240828$$MD$US$US
239797432$23979743$2$F$20240401$20240809$20240616$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-084063$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240814$$HP$US$US
239797452$23979745$2$F$20240605$20240719$20240616$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095804$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240723$$CN$US$US
239797473$23979747$3$F$20240506$20240830$20240616$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096074$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$97.5$KG$20240903$$CN$US$US
239797542$23979754$2$F$20240601$20240821$20240616$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096640$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240830$$CN$US$US
239797622$23979762$2$F$$20240606$20240616$20240718$EXP$$AE-ABBVIE-5802251$ABBVIE$$$$$F$Y$2.5$KG$20240718$$MD$AE$AE
239797652$23979765$2$F$$20240716$20240616$20240717$EXP$$NVSJ2024JP007038$NOVARTIS$$85$YR$$F$Y$40$KG$20240718$$MD$JP$JP
239797754$23979775$4$F$20231128$20240813$20240616$20240820$EXP$$US-ABBVIE-5799322$ABBVIE$$68$YR$$F$Y$65.771$KG$20240820$$CN$US$US
239797812$23979781$2$F$20240301$20240731$20240616$20240801$EXP$$NVSJ2024JP007054$NOVARTIS$$51$YR$$M$Y$$$20240802$$MD$JP$JP
239797882$23979788$2$F$20231122$20240912$20240616$20240916$EXP$$NVSJ2024JP007065$NOVARTIS$$$$A$M$Y$$$20240917$$MD$JP$JP
239797902$23979790$2$F$20231013$20240903$20240616$20240908$EXP$$NVSJ2024JP007057$NOVARTIS$$60$YR$$M$Y$52$KG$20240909$$MD$JP$JP
239797932$23979793$2$F$20240101$20240611$20240616$20240710$PER$$US-ROCHE-3578069$ROCHE$$85$YR$E$F$Y$72.21$KG$20240709$$CN$US$US
239797952$23979795$2$F$$20240701$20240616$20240708$EXP$$JP-SA-2024SA173531$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240708$$MD$JP$JP
239797992$23979799$2$F$20240601$20240625$20240616$20240701$PER$$US-AMGEN-USASP2024117118$AMGEN$$51$YR$A$F$Y$$$20240630$$CN$US$US
239798212$23979821$2$F$20220101$20240809$20240616$20240812$PER$$US-AMGEN-USASP2024115898$AMGEN$$77$YR$E$F$Y$$$20240811$$CN$US$US
239798252$23979825$2$F$20240101$20240629$20240616$20240703$EXP$$US-ABBVIE-5802799$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
239798262$23979826$2$F$$20240805$20240616$20240809$EXP$$US-ABBVIE-5751649$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
239798304$23979830$4$F$$20240716$20240616$20240720$EXP$$DE-ABBVIE-5799873$ABBVIE$$$$$F$Y$$$20240720$$CN$DE$DE
239798315$23979831$5$F$20230101$20240715$20240616$20240803$EXP$$US-ABBVIE-5371405$ABBVIE$$$$$F$Y$70.76$KG$20240803$$CN$US$US
239798363$23979836$3$F$20240523$20240705$20240616$20240708$EXP$$US-ABBVIE-5800414$ABBVIE$$66$YR$$M$Y$93.893$KG$20240708$$CN$US$US
239798373$23979837$3$F$$20240809$20240616$20240816$EXP$$US-ABBVIE-5799941$ABBVIE$$$$$F$Y$70.307$KG$20240816$$CN$US$US
239798382$23979838$2$F$20240101$20240627$20240616$20240707$PER$$US-SA-2024SA175279$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240707$$HP$US$US
239798392$23979839$2$F$$20240708$20240617$20240711$EXP$$US-ABBVIE-5799813$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
239798452$23979845$2$F$20230101$20240628$20240617$20240702$EXP$$US-PFIZER INC-PV202400070281$PFIZER$$55$YR$$F$Y$72.57$KG$20240702$$CN$US$US
239798492$23979849$2$F$$20240625$20240617$20240719$30DAY$$AU-JNJFOC-20240580954$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$CN$AU$AU
239798512$23979851$2$F$20240521$20240619$20240617$20240712$30DAY$$AU-JNJFOC-20240576599$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$PH$AU$AU
239798612$23979861$2$F$20240528$20240703$20240617$20240705$PER$$US-JNJFOC-20240612608$JOHNSON AND JOHNSON$$19$YR$A$$Y$$$20240705$$PH$US$US
239798642$23979864$2$F$20240610$20240715$20240617$20240718$PER$$US-JNJFOC-20240630928$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240718$$HP$US$US
239798653$23979865$3$F$20240605$20240705$20240617$20240710$PER$$US-JNJFOC-20240612664$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240710$$CN$US$US
239798922$23979892$2$F$20240101$20240729$20240617$20240807$PER$$US-SA-2024SA176977$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240807$$MD$US$US
239799013$23979901$3$F$20240601$20240703$20240617$20240715$PER$$US-SA-2024SA176993$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240715$$MD$US$US
239799022$23979902$2$F$20240401$20240625$20240617$20240703$PER$$US-SA-2024SA175959$SANOFI AVENTIS$$55$YR$A$F$Y$68.03$KG$20240704$$MD$US$US
239799073$23979907$3$F$20240507$20240705$20240617$20240718$PER$$US-SA-2024SA177268$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240718$$MD$US$US
239799112$23979911$2$F$20240612$20240701$20240617$20240703$EXP$$JP-SAKK-2024SA175777AA$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240704$$MD$JP$JP
239799243$23979924$3$F$20240522$20240809$20240617$20240814$EXP$$US-BIOGEN-2024BI01268944$BIOGEN$$69$YR$$M$Y$$$20240814$$CN$US$US
239799255$23979925$5$F$$20240925$20240617$20240927$PER$$NVSC2024US125304$NOVARTIS$$26$YR$$F$Y$66.667$KG$20240927$$CN$US$US
239799352$23979935$2$F$$20240701$20240617$20240714$30DAY$$CO-JNJFOC-20240629993$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$CO$CO
239799372$23979937$2$F$20240603$20240904$20240617$20240905$PER$$US-JNJFOC-20240607089$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240905$$HP$US$US
239799392$23979939$2$F$20240510$20240625$20240617$20240724$PER$$US-TOLMAR, INC.-24US049197$TOLMAR$$94$YR$$M$Y$$$20240724$$HP$US$US
239799412$23979941$2$F$20240508$20240627$20240617$20240724$PER$$US-TOLMAR, INC.-24US049279$TOLMAR$$67$YR$$M$Y$$$20240724$$PH$US$US
239799422$23979942$2$F$20240514$20240621$20240617$20240712$PER$$US-TOLMAR, INC.-24US049394$TOLMAR$$74$YR$$M$Y$$$20240712$$PH$US$US
239799432$23979943$2$F$20240501$20240624$20240617$20240725$PER$$US-TOLMAR, INC.-24US049403$TOLMAR$$71$YR$$M$Y$$$20240725$$HP$US$US
239799442$23979944$2$F$20240502$20240627$20240617$20240724$PER$$US-TOLMAR, INC.-24US049461$TOLMAR$$$$$M$Y$$$20240724$$HP$US$US
239799452$23979945$2$F$20240510$20240701$20240617$20240725$PER$$US-TOLMAR, INC.-24US049522$TOLMAR$$$$$M$Y$$$20240725$$HP$US$US
239799462$23979946$2$F$20240520$20240702$20240617$20240725$PER$$US-TOLMAR, INC.-24US049525$TOLMAR$$76$YR$$M$Y$$$20240725$$HP$US$US
239799492$23979949$2$F$20240514$20240702$20240617$20240725$PER$$US-TOLMAR, INC.-24US049512$TOLMAR$$70$YR$$M$Y$$$20240725$$HP$US$US
239799502$23979950$2$F$20240509$20240701$20240617$20240725$PER$$US-TOLMAR, INC.-24US049523$TOLMAR$$$$$M$Y$$$20240725$$HP$US$US
239799512$23979951$2$F$20240520$20240701$20240617$20240725$PER$$US-TOLMAR, INC.-24US049534$TOLMAR$$73$YR$$M$Y$$$20240725$$HP$US$US
239799533$23979953$3$F$20240723$20240729$20240617$20240802$EXP$$CA-BIOGEN-2024BI01269205$BIOGEN$$69$YR$$M$Y$$$20240802$$CN$CA$CA
239799542$23979954$2$F$20240612$20240731$20240617$20240806$PER$$US-AMGEN-USASP2024117240$AMGEN$$67$YR$E$F$Y$$$20240805$$CN$US$US
239799562$23979956$2$F$20240401$20240731$20240617$20240806$EXP$$US-BIOGEN-2024BI01268053$BIOGEN$$71$YR$$F$Y$$$20240806$$CN$US$US
239799582$23979958$2$F$$20231227$20240617$20240711$EXP$$CA-HALEON-2166604$Haleon PLC$$$$$F$Y$$$20240711$$HP$CA$CA
239799682$23979968$2$F$20240329$20240617$20240617$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-001669$ACADIA PHARMACEUTICALS$$21$YR$$F$Y$$$20240712$$CN$US$US
239799732$23979973$2$F$20240511$20240620$20240617$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002186$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240712$$CN$US$US
239799762$23979976$2$F$$20240918$20240617$20240927$EXP$$GB-BIOCON BIOLOGICS LIMITED-BBL2024001350$BIOCON$$$$$$Y$$$20240927$$MD$GB$GB
239799782$23979978$2$F$20240101$20240710$20240617$20240716$EXP$$JP-TAKEDA-2024TJP008773$TAKEDA$$13$YR$$M$Y$58$KG$20240716$$MD$JP$JP
239799832$23979983$2$F$20210801$20240725$20240617$20240802$EXP$$JP-TAKEDA-2024TUS059640$TAKEDA$$5$DEC$$M$Y$$$20240802$$MD$JP$JP
239799862$23979986$2$F$$20240808$20240617$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002575$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
239799882$23979988$2$F$20240610$20240704$20240617$20240707$EXP$$JP-TAKEDA-2024TJP008854$TAKEDA$$59$YR$$M$Y$$$20240707$$MD$JP$JP
239799942$23979994$2$F$$20240801$20240617$20240805$EXP$$JP-TAKEDA-2024TJP008814$TAKEDA$$17$YR$$F$Y$$$20240804$$MD$JP$JP
239799972$23979997$2$F$$20240812$20240617$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002553$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
239800022$23980002$2$F$$20240829$20240617$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202406007361$ELI LILLY AND CO$$$$$M$Y$$$20240905$$CN$US$US
239800093$23980009$3$F$20240503$20240716$20240617$20240722$30DAY$$US-AMGEN-USASP2024114299$AMGEN$$67$YR$E$F$Y$80.5$KG$20240722$$HP$US$US
239800132$23980013$2$F$20240208$20240701$20240617$20240708$EXP$$JP-GSK-JP2024074520$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$JP$JP
239800174$23980017$4$F$$20240726$20240617$20240730$EXP$$DE-ABBVIE-5803377$ABBVIE$$$$$$Y$$$20240730$$CN$DE$DE
239800182$23980018$2$F$$20240710$20240617$20240715$EXP$$US-JNJFOC-20240628327$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$MD$US$US
239800243$23980024$3$F$20240503$20240622$20240617$20240702$EXP$$ZA-CELLTRION INC.-2024ZA005068$CELLTRION$$$$$$Y$$$20240702$$CN$ZA$ZA
239800252$23980025$2$F$20240101$20240730$20240617$20240806$EXP$$US-SA-2024SA175359$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240806$$MD$US$US
239800357$23980035$7$F$$20240910$20240617$20240918$EXP$$GB-TAKEDA-2021TUS018649$TAKEDA$$$$$F$Y$$$20240918$$CN$GB$GB
239800392$23980039$2$F$20240601$20240710$20240617$20240714$PER$$US-AMGEN-USASP2024115604$AMGEN$$$$E$F$Y$$$20240714$$MD$US$US
239800612$23980061$2$F$$20240620$20240617$20240702$EXP$$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108321$ZYDUS PHARM$Kamel ME, Marzullo C, Maguet H, Checkouri A, Pointurier V, Oudeville P.. Acidose metabolique dans un contexte d^intoxication chronique au paracetamol.. Toxicologie Analytique et Clinique. 2024;36(2):S42$$$$$Y$$$20240702$$MD$FR$FR
239800645$23980064$5$F$$20240913$20240617$20240924$EXP$$GB-BAXTER-2023BAX038286$BAXTER$$$$$F$Y$$$20240924$$MD$IE$GB
239800712$23980071$2$F$20240420$20240805$20240617$20240815$EXP$$CN-BAXTER-2024BAX019599$BAXTER$$62$YR$$M$Y$54.8$KG$20240815$$MD$CN$CN
239800822$23980082$2$F$$20240621$20240617$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002525$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
239800882$23980088$2$F$20240101$20240718$20240617$20240723$EXP$$US-ABBVIE-5751726$ABBVIE$$60$YR$$F$Y$102.96$KG$20240723$$CN$US$US
239800944$23980094$4$F$20231002$20240822$20240617$20240830$EXP$$CA-CELLTRION INC.-2024CA000905$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
239801092$23980109$2$F$$20240723$20240617$20240730$EXP$$US-EXELIXIS-CABO-24078271$EXELIXIS$$$$$M$Y$$$20240729$$CN$US$US
239801142$23980114$2$F$$20240905$20240617$20240913$EXP$$US-ABBVIE-5800750$ABBVIE$$$$$F$Y$61$KG$20240913$$CN$US$US
239801232$23980123$2$F$20240607$20240625$20240617$20240704$PER$$US-SA-2024SA178543$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240704$$MD$US$US
239801243$23980124$3$F$$20240814$20240617$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002562$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
239801263$23980126$3$F$$20240918$20240617$20240924$EXP$$JP-GSK-JP2024JPN072123$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
239801312$23980131$2$F$$20240628$20240617$20240701$PER$$NVSC2024US125540$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
239801372$23980137$2$F$20240426$20240625$20240617$20240711$PER$$US-AstraZeneca-2024A102409$ASTRAZENECA$$55$YR$$M$Y$$$20240711$$CN$US$
239801402$23980140$2$F$20240401$20240704$20240617$20240710$PER$$US-AMGEN-USASP2024118923$AMGEN$$2$YR$C$F$Y$$$20240710$$CN$US$US
239801413$23980141$3$F$20190401$20240826$20240617$20240902$EXP$$CA-SHIRE-CA201917937AA$TAKEDA$$41$YR$$F$Y$$$20240902$$MD$CA$CA
239801462$23980146$2$F$$20240826$20240617$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04847$LUPIN$$$$$$Y$$$20240913$$CN$US$US
239801593$23980159$3$F$20140101$20240719$20240617$20240722$PER$$US-GILEAD-2024-0677543$GILEAD$$58$YR$A$M$Y$$$20240722$$LW$US$US
239801623$23980162$3$F$20210601$20240719$20240617$20240722$PER$$US-GILEAD-2024-0677545$GILEAD$$61$YR$A$M$Y$$$20240722$$LW$US$US
239801662$23980166$2$F$20240513$20240618$20240617$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002566$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240712$$CN$US$US
239801752$23980175$2$F$$20240910$20240617$20240920$EXP$$CA-HALEON-2178729$Haleon PLC$$75$YR$$F$Y$$$20240919$$HP$CA$CA
239801812$23980181$2$F$$20240924$20240617$20240930$EXP$$CA-HALEON-CACH2023AMR057057$Haleon PLC$$48$YR$$F$Y$68$KG$20240930$$HP$CA$CA
239801842$23980184$2$F$$20240917$20240617$20240919$EXP$$US-JNJFOC-20240619539$JOHNSON AND JOHNSON$$$$N$F$Y$$$20240919$$MD$US$US
239801853$23980185$3$F$20230405$20240918$20240617$20240923$EXP$$IT-JNJFOC-20230414827$JOHNSON AND JOHNSON$$46$YR$A$M$Y$85$KG$20240924$$MD$IT$IT
239801913$23980191$3$F$$20240724$20240617$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002565$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
239801953$23980195$3$F$20240609$20240709$20240617$20240723$30DAY$$US-JNJFOC-20240623188$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240723$$CN$US$US
239801973$23980197$3$F$20240526$20240814$20240617$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002558$ACADIA PHARMACEUTICALS$$41$YR$$F$Y$$$20240822$$CN$US$US
239802042$23980204$2$F$$20240708$20240617$20240716$EXP$$GB-CELLTRION INC.-2024GB014277$CELLTRION$$$$$$Y$$$20240716$$CN$GB$GB
239802202$23980220$2$F$20240501$20240830$20240617$20240904$EXP$$JP-GSK-JP2024064822$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$PH$JP$JP
239802213$23980221$3$F$20240523$20240820$20240617$20240826$EXP$$US-ARGENX-2024-ARGX-US004271$ARGENX BVBA$$$$$$Y$$$20240826$$CN$US$US
239802265$23980226$5$F$$20240918$20240617$20240925$EXP$$GB-JNJFOC-20240636146$JOHNSON AND JOHNSON$$62$YR$A$M$Y$77.5$KG$20240925$$CN$GB$GB
239802353$23980235$3$F$20220701$20240719$20240617$20240722$PER$$US-GILEAD-2024-0677547$GILEAD$$54$YR$A$M$Y$$$20240722$$LW$US$US
239802362$23980236$2$F$$20240723$20240617$20240726$EXP$$PL-AMGEN-POLSP2024116673$AMGEN$Urbanski B.; Wegner O.; Subocz E. et al.. Multidrug rescue for pediatric refractory ITP complicated by intracranial bleeding. Acta Haematologica Polonica. 2024;55 (2):126-128$3$MON$I$M$Y$$$20240726$$HP$PL$PL
239802393$23980239$3$F$$20240709$20240617$20240711$EXP$$JP-GSK-JP2024074150$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$PH$JP$JP
239802402$23980240$2$F$$20240716$20240617$20240718$EXP$$US-GILEAD-2024-0677532$GILEAD$$$$$M$Y$$$20240718$$LW$US$US
239802462$23980246$2$F$20240822$20240916$20240617$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202403008816$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240919$$CN$US$US
239802555$23980255$5$F$20240319$20240701$20240617$20240713$EXP$$DE-ABBVIE-5795765$ABBVIE$$53$YR$$M$Y$$$20240713$$MD$DE$DE
239802593$23980259$3$F$$20240708$20240617$20240718$30DAY$$IL-JNJFOC-20240600550$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$CN$IL$IL
239802746$23980274$6$F$20080101$20240722$20240617$20240801$PER$$US-GILEAD-2024-0677539$GILEAD$$61$YR$A$M$Y$$$20240801$$LW$US$US
239802762$23980276$2$F$$20240917$20240617$20240919$PER$$US-JNJFOC-20240628854$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240919$$CN$US$US
239802782$23980278$2$F$20240101$20240709$20240617$20240713$EXP$$CA-JNJFOC-20240632093$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240713$$HP$CA$CA
239802922$23980292$2$F$20240101$20240925$20240617$20240928$EXP$$US-SA-2024SA178510$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240928$$MD$US$US
239802932$23980293$2$F$20240426$20240626$20240617$20240704$EXP$$CA-CELLTRION INC.-2024CA014360$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
239802962$23980296$2$F$$20240816$20240617$20240820$EXP$$NVSC2024US125497$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
239803002$23980300$2$F$$20240822$20240617$20240823$EXP$DE-DCGMA-24203347$DE-ROCHE-3577728$ROCHE$$83$YR$E$F$Y$61$KG$20240823$$MD$DE$DE
239803012$23980301$2$F$20240401$20240708$20240617$20240715$PER$$US-AstraZeneca-2024A129327$ASTRAZENECA$$850$MON$$F$Y$$$20240715$$CN$US$
239803024$23980302$4$F$20200620$20240719$20240617$20240729$EXP$$US-GILEAD-2024-0677540$GILEAD$$51$YR$A$F$Y$$$20240729$$LW$US$US
239803042$23980304$2$F$$20240709$20240617$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04822$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239803062$23980306$2$F$20240320$20240606$20240617$20240701$EXP$$CL-ROCHE-3579147$ROCHE$$71$YR$E$F$Y$$$20240701$$CN$CL$CL
239803132$23980313$2$F$20240516$20240715$20240617$20240722$30DAY$$US-AMGEN-USASP2024115999$AMGEN$$$$$F$Y$$$20240721$$HP$US$US
239803203$23980320$3$F$20240612$20240801$20240617$20240807$PER$$NVSC2024US125668$NOVARTIS$$65$YR$$F$Y$68.027$KG$20240807$$HP$US$US
239803282$23980328$2$F$20240607$20240715$20240617$20240718$30DAY$$US-AMGEN-USASP2024114866$AMGEN$$46$YR$A$F$Y$76$KG$20240718$$PH$US$US
239803332$23980333$2$F$20240606$20240731$20240617$20240805$PER$$US-ALXN-202406USA000533US$ALEXION PHARMACEUTICALS$$84$YR$$M$Y$$$20240805$$CN$US$US
239803344$23980334$4$F$20240313$20240823$20240617$20240827$EXP$$NVSJ2024JP007060$NOVARTIS$$70$YR$$F$Y$$$20240828$$MD$JP$JP
239803352$23980335$2$F$20230101$20240725$20240617$20240806$EXP$$US-AUROBINDO-AUR-APL-2024-028469$AUROBINDO$Valido K, Patel V, Murphy MJ, Junejo MH, Patel DK, Deutsch A, et al.. Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach.. JAAD Case Reports.. 2024;48:49-53$52$YR$$F$Y$$$20240806$$MD$US$US
239803383$23980338$3$F$20240101$20240918$20240617$20240925$EXP$$CA-ABBVIE-5800701$ABBVIE$$$$E$F$Y$$$20240925$$CN$CA$CA
239803402$23980340$2$F$20240101$20240729$20240617$20240801$EXP$$US-ABBVIE-5800535$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
239803432$23980343$2$F$20151125$20240812$20240617$20240814$PER$$US-GILEAD-2024-0677541$GILEAD$$51$YR$A$M$Y$$$20240814$$LW$US$US
239803443$23980344$3$F$20240101$20240729$20240617$20240801$EXP$$CH-ABBVIE-5800819$ABBVIE$$$$$M$Y$$$20240801$$HP$CH$CH
239803452$23980345$2$F$20240101$20240807$20240617$20240815$EXP$$US-INTERCEPT-PM2024000593$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240815$$CN$US$US
239803462$23980346$2$F$20240607$20240724$20240617$20240731$30DAY$$US-AMGEN-USASP2024114939$AMGEN$$56$YR$A$M$Y$114$KG$20240731$$HP$US$US
239803524$23980352$4$F$20240612$20240715$20240617$20240723$EXP$$PT-ABBVIE-5802730$ABBVIE$$80$YR$$M$Y$$$20240723$$CN$PT$PT
239803604$23980360$4$F$$20240813$20240617$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202406009215$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240818$$CN$US$US
239803748$23980374$8$F$20240101$20240828$20240617$20240905$EXP$$CA-CELLTRION INC.-2024CA014019$CELLTRION$$$$$$Y$$$20240905$$MD$CA$CA
239803793$23980379$3$F$$20240730$20240617$20240819$PER$$US-BAUSCHBL-2024BNL028417$BAUSCH AND LOMB$$$$$F$Y$$$20240819$$CN$US$US
239803864$23980386$4$F$20230101$20240723$20240617$20240730$PER$$US-BIOGEN-2024BI01252548$BIOGEN$$$$$F$Y$$$20240730$$CN$US$US
239803892$23980389$2$F$$20240709$20240617$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04827$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239803913$23980391$3$F$$20240819$20240617$20240823$EXP$$JP-GSK-JP2024JPN071510$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$JP$JP
239803922$23980392$2$F$$20240722$20240617$20240730$EXP$$JP-GSK-JP2024JPN063075$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$MD$JP$JP
239803972$23980397$2$F$20230101$20240913$20240617$20240917$PER$$US-GILEAD-2024-0677542$GILEAD$$52$YR$A$M$Y$$$20240917$$LW$US$US
239803992$23980399$2$F$$20240712$20240617$20240716$EXP$$JP-TAKEDA-2024TJP008844$TAKEDA$$$$A$M$Y$$$20240716$$MD$JP$JP
239804022$23980402$2$F$$20240708$20240617$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04843$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239804162$23980416$2$F$20190901$20240815$20240617$20240827$EXP$DE-EMA-2024530-AUTODUP-1717097769717$DE-Accord-429442$ACCORD$$$$E$F$Y$99$KG$20240827$$HP$DE$DE
239804202$23980420$2$F$20240522$20240731$20240617$20240812$EXP$IT-MINISAL02-988847$IT-Accord-429659$ACCORD$$55$YR$A$F$Y$$$20240812$$PH$IT$IT
239804345$23980434$5$F$20240101$20240827$20240617$20240904$EXP$$CA-CELLTRION INC.-2024CA014362$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
239804483$23980448$3$F$$20240719$20240617$20240723$EXP$$JP-TAKEDA-2024TJP008631$TAKEDA$$40$YR$$F$Y$$$20240723$$MD$JP$JP
239804502$23980450$2$F$$20240809$20240617$20240815$EXP$$AU-CELLTRION INC.-2024AU014495$CELLTRION$$$$$$Y$$$20240815$$MD$AU$AU
239804532$23980453$2$F$20240101$20240803$20240617$20240810$EXP$$CA-CELLTRION INC.-2024CA014297$CELLTRION$$$$$$Y$$$20240810$$HP$CA$CA
239804562$23980456$2$F$20240101$20240628$20240617$20240710$EXP$$US-INSMED, INC.-2024-02343-US$INSMED$$$$$F$Y$$$20240710$$CN$US$US
239804623$23980462$3$F$$20240807$20240617$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04823$LUPIN$$$$$$Y$$$20240822$$CN$US$US
239804652$23980465$2$F$$20240621$20240617$20240701$EXP$$JP-AMGEN-JPNSP2024118117$AMGEN$$$$$$Y$$$20240630$$MD$JP$JP
239804663$23980466$3$F$20150101$20240904$20240617$20240906$EXP$$US-GILEAD-2024-0677544$GILEAD$$41$YR$A$M$Y$$$20240906$$LW$US$US
239804673$23980467$3$F$20240601$20240812$20240617$20240819$EXP$$CA-CELLTRION INC.-2024CA014303$CELLTRION$$$$$$Y$$$20240819$$CN$CA$CA
239804773$23980477$3$F$20240603$20240819$20240617$20240826$EXP$$CA-CELLTRION INC.-2024CA014327$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
239804792$23980479$2$F$$20240806$20240617$20240808$EXP$$US-JNJFOC-20240582629$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
239804812$23980481$2$F$20230101$20240725$20240617$20240806$EXP$$US-AUROBINDO-AUR-APL-2024-028437$AUROBINDO$Valido K, Patel V, Murphy MJ, Junejo MH, Patel DK, Deutsch A, et al.. Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach.. JAAD Case Reports.. 2024;48:49-53$52$YR$$F$Y$$$20240806$$MD$US$US
239804872$23980487$2$F$$20240812$20240617$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202406010660$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240814$$CN$US$US
239805052$23980505$2$F$$20240621$20240617$20240703$EXP$$JP-AMGEN-JPNSP2024118125$AMGEN$$$$$$Y$$$20240703$$MD$JP$JP
239805077$23980507$7$F$20240101$20240911$20240617$20240920$EXP$$CA-CELLTRION INC.-2024CA014337$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
239805384$23980538$4$F$20240101$20240905$20240617$20240914$EXP$$CA-CELLTRION INC.-2024CA014346$CELLTRION$$$$$$Y$$$20240914$$CN$CA$CA
239805443$23980544$3$F$$20240810$20240617$20240823$EXP$US-MLMSERVICE-20240308-4872781-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-05208$ALKEM$Le V, Surineni K, Elias G.. A Case of Partially Reversible Oral-buccal-lingual Dyskinesia after Prolonged Levetiracetam Exposure. American Journal of Geriatric Psychiatry. 2024;32(4):S106$86$YR$$F$Y$$$20240823$$MD$US$US
239805493$23980549$3$F$$20240709$20240617$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04826$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239805653$23980565$3$F$20240608$20240716$20240617$20240723$30DAY$$US-AMGEN-USASP2024115031$AMGEN$$73$YR$E$M$Y$93.9$KG$20240723$$HP$US$US
239805662$23980566$2$F$20240101$20240905$20240617$20240914$EXP$$CA-CELLTRION INC.-2024CA014498$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
239805674$23980567$4$F$20240601$20240626$20240617$20240704$EXP$$CA-CELLTRION INC.-2024CA014499$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
239805792$23980579$2$F$$20240621$20240617$20240703$EXP$$JP-TEVA-VS-3208982$TEVA$Nagao K, Sakai A, Tsumura H, Iemoto T, Hirata Y, Hori H, et al. Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy. J-Gastroenterol 2024; 59 (5): 424-433.; Nagao K, Sakai A, Tsumura H, Iemoto T, Hirata Y, Hori H, et al. Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy. J-Gastroenterol 2024; 59 (5): 424-433.; Nagao K, Sakai A, Tsumura H, Iemoto T, Hirata Y, Hori H, et al. Pancreatic ...$74$YR$$F$Y$$$20240703$$HP$JP$JP
239805852$23980585$2$F$$20240723$20240617$20240802$EXP$$US-PADAGIS-2024PAD00990$PADAGIS$Sinha A, Cantrell S, Kozman DM, Jelovsek JE. Ectopic Prostatic Tissue in Female Urethral Diverticulum. Obstetrics and Gynecology. 2024;144:e35-e9$$$$$Y$$$20240802$$MD$US$US
239805862$23980586$2$F$$20240809$20240617$20240814$EXP$$JP-GILEAD-2024-0677198$GILEAD$$88$YR$E$M$Y$$$20240814$$PH$JP$JP
239805952$23980595$2$F$$20240702$20240617$20240705$EXP$$NVSC2024CA124043$NOVARTIS$$68$YR$$F$Y$$$20240705$$CN$CA$CA
239806002$23980600$2$F$$20240709$20240617$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04829$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239806042$23980604$2$F$$20240817$20240617$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04831$LUPIN$$$$$$Y$$$20240902$$PH$US$US
239806082$23980608$2$F$$20240804$20240617$20240811$EXP$$CA-CELLTRION INC.-2024CA014326$CELLTRION$$$$$$Y$$$20240812$$HP$CA$CA
239806122$23980612$2$F$$20240709$20240617$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04842$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239806132$23980613$2$F$$20240917$20240617$20240919$EXP$$US-JNJFOC-20240620676$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$HP$US$US
239806252$23980625$2$F$20230612$20240910$20240617$20240916$EXP$ES-AEMPS-1503047$ES-BIOCON BIOLOGICS LIMITED-BBL2024004217$BIOCON$$$$$$Y$$$20240916$$MD$ES$ES
239806282$23980628$2$F$$20240709$20240617$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04845$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239806302$23980630$2$F$$20240621$20240617$20240703$EXP$$JP-TEVA-VS-3208998$TEVA$Kachi S, Sumitomo S, Oka H, Hata A, Ohmura K. Case report: Inflammatory sternoclavicular joint arthritis induced by an immune checkpoint inhibitor with remarkable responsiveness to infliximab. Front-Immunol 2024; 15.; Kachi S, Sumitomo S, Oka H, Hata A, Ohmura K. Case report: Inflammatory sternoclavicular joint arthritis induced by an immune checkpoint inhibitor with remarkable responsiveness to infliximab. Front-Immunol 2024; 15.; Kachi S, Sumitomo S, Oka H, Hata A, Ohmura K. Case report: In...$48$YR$$F$Y$$$20240703$$HP$JP$JP
239806322$23980632$2$F$20240101$20240718$20240617$20240723$EXP$$US-ABBVIE-5689177$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
239806372$23980637$2$F$$20240625$20240617$20240703$EXP$$US-TAKEDA-2024TUS057850$TAKEDA$$$$$F$Y$97$KG$20240703$$MD$US$US
239806382$23980638$2$F$$20240731$20240617$20240802$PER$$US-TAKEDA-2024TUS058572$TAKEDA$$$$$F$Y$$$20240802$$HP$US$US
239806412$23980641$2$F$$20240709$20240617$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04846$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239806422$23980642$2$F$20230529$20240705$20240617$20240709$EXP$$CA-ABBVIE-5743690$ABBVIE$$75$YR$$F$Y$$$20240709$$MD$CA$CA
239806442$23980644$2$F$$20240801$20240617$20240811$EXP$$US-TAKEDA-2024TUS015916$TAKEDA$$$$$M$Y$$$20240811$$CN$US$US
239806454$23980645$4$F$$20240828$20240617$20240904$EXP$$US-TAKEDA-2024TUS037580$TAKEDA$$$$$F$Y$51$KG$20240904$$CN$US$US
239806472$23980647$2$F$20221201$20240724$20240617$20240731$PER$$US-ALXN-202406USA000528US$ALEXION PHARMACEUTICALS$$62$YR$$M$Y$$$20240731$$CN$US$US
239806482$23980648$2$F$$20240722$20240617$20240729$PER$$US-ALXN-A202310001$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240729$$CN$US$US
239806492$23980649$2$F$$20240702$20240617$20240724$PER$$BR-TOLMAR, INC.-24BR049532$TOLMAR$$68$YR$$M$Y$$$20240724$$PH$BR$BR
239806642$23980664$2$F$20231101$20240822$20240617$20240829$EXP$$US-TAKEDA-2023TUS122281$TAKEDA$$80$YR$$F$Y$$$20240829$$MD$US$US
239806702$23980670$2$F$20240601$20240627$20240617$20240705$EXP$$US-TAKEDA-2024TUS057003$TAKEDA$$71$YR$$M$Y$71.12$KG$20240705$$CN$US$US
239806842$23980684$2$F$$20240917$20240617$20240920$EXP$$US-JNJFOC-20240628922$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
239806883$23980688$3$F$$20240701$20240617$20240704$EXP$$DK-TAKEDA-2024TUS059505$TAKEDA$Ravn C., Bendix M., Lyhne S.. Acute Pancreatitis In A Patient With Ulcerative Colitis Treated With Vedolizumab And Budesonide. Ugeskrift For Laeger. 2024;186 (22):1-3$21$YR$$M$Y$$$20240704$$MD$DK$DK
239806962$23980696$2$F$$20240621$20240617$20240703$EXP$$JP-TEVA-VS-3209003$TEVA$Kameda Y, Osawa H, Sueishi Y, Ishikawa Y, Maehara T. A case of delayed bleeding of the chest wall after VATS treated with transcatheter arterial embolization. J-Surg-Case-Rep 2024; 2024 (5): rjae271.; Kameda Y, Osawa H, Sueishi Y, Ishikawa Y, Maehara T. A case of delayed bleeding of the chest wall after VATS treated with transcatheter arterial embolization. J-Surg-Case-Rep 2024; 2024 (5): rjae271.$81$YR$$F$Y$$$20240703$$HP$JP$JP
239807062$23980706$2$F$$20240717$20240617$20240720$EXP$$CA-TAKEDA-2024TUS026865$TAKEDA$$$$$F$Y$$$20240720$$MD$CA$CA
239807082$23980708$2$F$20220101$20240715$20240617$20240722$EXP$$CA-Orion Corporation ORION PHARMA-24_00030369$ORION$$68$YR$E$F$Y$74.8$KG$20240722$$MD$CA$
239807112$23980711$2$F$$20240709$20240617$20240712$EXP$$CA-TAKEDA-2024TUS058867$TAKEDA$$$$$M$Y$$$20240712$$CN$CA$CA
239807203$23980720$3$F$20240717$20240916$20240617$20240918$EXP$$US-GILEAD-2024-0671180$GILEAD$$50$YR$A$F$Y$$$20240918$$CN$US$US
239807232$23980723$2$F$20240604$20240920$20240617$20240930$EXP$$GB-TAKEDA-2024TUS056146$TAKEDA$$78$YR$$F$Y$$$20240930$$CN$GB$GB
239807244$23980724$4$F$20240424$20240725$20240617$20240730$EXP$$CA-JNJFOC-20240625821$JOHNSON AND JOHNSON$$35$YR$A$M$Y$84$KG$20240730$$HP$CA$CA
239807263$23980726$3$F$$20240715$20240617$20240718$EXP$$US-TAKEDA-2024TUS058615$TAKEDA$$$$$F$Y$$$20240718$$CN$US$US
239807282$23980728$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000844US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$US$US
239807303$23980730$3$F$$20240610$20240617$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451328$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
239807317$23980731$7$F$20240522$20240730$20240617$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448521$RANBAXY$$46$YR$A$M$Y$98.866$KG$20240813$$CN$US$US
239807323$23980732$3$F$20240501$20240729$20240617$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451632$RANBAXY$$25$YR$A$F$Y$$$20240813$$MD$US$US
239807353$23980735$3$F$$20240629$20240617$20240701$PER$$US-TAKEDA-2024TUS059490$TAKEDA$$$$$F$Y$58$KG$20240701$$HP$US$US
239807432$23980743$2$F$$20240202$20240617$20240705$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR071563$VIIV$$$$$$Y$$$20240705$$CN$US$US
239807452$23980745$2$F$$20240809$20240617$20240820$30DAY$$US-GSK-US2024AMR072153$GLAXOSMITHKLINE$$$$$M$Y$$$20240820$$CN$US$US
239807492$23980749$2$F$$20240705$20240617$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-028860$AUROBINDO$Kaufman KR, Struck PJ.. Activation of suicidal ideation with adjunctive rufinamide in bipolar disorder. Epilepsy-Behav. 2011;20(2):386-389$33$YR$$F$Y$$$20240716$$HP$US$US
239807622$23980762$2$F$$20240709$20240617$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04864$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239807685$23980768$5$F$20240701$20240903$20240617$20240909$EXP$$CA-JNJFOC-20240630081$JOHNSON AND JOHNSON$$16$YR$T$M$Y$67$KG$20240909$$PH$CA$CA
239807702$23980770$2$F$20231129$20240816$20240617$20240822$EXP$$US-JNJFOC-20240631916$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240822$$CN$US$US
239807813$23980781$3$F$$20240709$20240617$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04866$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239807875$23980787$5$F$20240319$20240902$20240617$20240905$EXP$$NVSC2024DE123385$NOVARTIS$$$$E$F$Y$61$KG$20240905$$MD$DE$DE
239807913$23980791$3$F$20240610$20240723$20240617$20240726$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-085460$REGENERON$$$$$F$Y$$$20240726$$MD$US$US
239807932$23980793$2$F$$20240621$20240617$20240701$EXP$$JP-TEVA-VS-3208951$TEVA$Kanno A, Sumitomo K, Narai D, Suzuki K, Katsuta Y, Kurosawa E, et al. Significant dysphagia and abdominal distension were caused by central adrenal insufficiency in an elderly man. Geriatr-Gerontol-Int 2023; 23 (6): 450-451.; Kanno A, Sumitomo K, Narai D, Suzuki K, Katsuta Y, Kurosawa E, et al. Significant dysphagia and abdominal distension were caused by central adrenal insufficiency in an elderly man. Geriatr-Gerontol-Int 2023; 23 (6): 450-451.$88$YR$$M$Y$$$20240701$$HP$JP$JP
239808163$23980816$3$F$20240702$20240904$20240617$20240909$EXP$$US-TAKEDA-2024TUS046492$TAKEDA$$43$YR$$F$Y$47$KG$20240909$$CN$US$US
239808182$23980818$2$F$$20240709$20240617$20240802$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04869$LUPIN$$$$$$Y$$$20240802$$CN$US$US
239808402$23980840$2$F$20240527$20240627$20240617$20240702$EXP$$JP-ABBVIE-5801250$ABBVIE$$80$YR$$M$Y$$$20240702$$PH$JP$JP
239808462$23980846$2$F$$20240620$20240617$20240705$EXP$$CN-GILEAD-2024-0677173$GILEAD$$$$A$M$Y$$$20240705$$CN$CN$CN
239808492$23980849$2$F$$20240911$20240617$20240916$EXP$$NVSC2024PY125344$NOVARTIS$$$$$F$Y$$$20240916$$CN$PY$PY
239808693$23980869$3$F$20200101$20240624$20240617$20240725$EXP$$EE-AMGEN-ESTSP2024114463$AMGEN$$$$$F$Y$73$KG$20240725$$MD$EE$EE
239808722$23980872$2$F$$20240821$20240617$20240823$EXP$$CA-Orion Corporation ORION PHARMA-24_00030365$ORION$$56$YR$A$F$Y$$$20240823$$HP$CA$
239808732$23980873$2$F$20230801$20240725$20240617$20240726$EXP$FR-AFSSAPS-AN2024000749$FR-BAUSCH-BL-2024-009252$BAUSCH AND LOMB$$67$YR$$F$Y$58$KG$20240726$$PH$FR$FR
239808782$23980878$2$F$20240101$20240905$20240617$20240911$EXP$$US-ABBVIE-5802002$ABBVIE$$$$$F$Y$$$20240911$$MD$US$US
239808886$23980888$6$F$20240301$20240910$20240617$20240918$EXP$$US-ASTELLAS-2024US013309$ASTELLAS$$81$YR$E$M$Y$$$20240918$$CN$US$US
239808962$23980896$2$F$$20240719$20240617$20240730$EXP$$GB-AUROBINDO-AUR-APL-2024-028403$AUROBINDO$$79$YR$$F$Y$$$20240730$$HP$GB$GB
239808993$23980899$3$F$20240520$20240813$20240617$20240821$EXP$IT-MINISAL02-988045$IT-TEVA-VS-3209122$TEVA$$65$YR$$M$Y$51$KG$20240821$$MD$IT$IT
239809072$23980907$2$F$20240101$20240624$20240617$20240701$EXP$$JP-MYE-2024M1052229AA$MYLAN$$73$YR$$M$Y$$$20240701$$PH$JP$JP
239809212$23980921$2$F$20230801$20240725$20240617$20240729$EXP$FR-AFSSAPS-AN2024000749$FR-JNJFOC-20240637804$JOHNSON AND JOHNSON$$67$YR$E$F$Y$58$KG$20240729$$PH$FR$FR
239809323$23980932$3$F$$20240819$20240617$20240827$EXP$$US-TAKEDA-2024TUS035598$TAKEDA$$$$$F$Y$89$KG$20240827$$HP$US$US
239809333$23980933$3$F$20240501$20240916$20240617$20240919$EXP$FR-AFSSAPS-BX2024001185$FR-GILEAD-2024-0677414$GILEAD$$62$YR$A$F$Y$51$KG$20240919$$HP$FR$FR
239809372$23980937$2$F$$20240605$20240617$20240903$PER$$US-TEVA-VS-3207019$TEVA$$64$YR$$F$Y$$$20240903$$CN$US$US
239809412$23980941$2$F$$20240709$20240617$20240715$EXP$$CN-HETERO-HET2024CN01812$HETERO$$$$$M$Y$28$KG$20240715$$HP$CN$CN
239809512$23980951$2$F$$20240704$20240617$20240712$EXP$$JP-DSJP-DSJ-2024-126127$DAIICHI$Morimoto K, Miyasaka S, Nii R, Ikeda Y. Acute Aortic Dissection Managed with Nafamostat for Heparin Resistance in the Presence of DOAC Reversal Agent: a Case Report. The Journal of the Japanese Society for Cardiovascular Surgery. 2024;53:127-30$7$DEC$$F$Y$$$20240712$$MD$JP$JP
239809522$23980952$2$F$$20240917$20240617$20240919$PER$$US-JNJFOC-20240630293$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240919$$MD$US$US
239809632$23980963$2$F$$20240809$20240617$20240831$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04956$LUPIN$$$$$$Y$$$20240831$$CN$US$US
239809692$23980969$2$F$$20240709$20240617$20240715$EXP$$CA-ABBVIE-5802276$ABBVIE$$$$A$M$Y$$$20240715$$MD$CA$CA
239809902$23980990$2$F$20240126$20240625$20240617$20240703$EXP$$EE-TAKEDA-2024TUS058493$TAKEDA$$$$$F$Y$73$KG$20240703$$HP$EE$EE
239809912$23980991$2$F$$20240724$20240617$20240724$PER$$US-ALXN-202406USA000663US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240724$$MD$US$US
239810053$23981005$3$F$20240602$20240909$20240617$20240920$EXP$$EG-SANDOZ INC.-SDZ2024EG055237$SANDOZ$$11$YR$$F$Y$$$20240920$$CN$EG$EG
239810073$23981007$3$F$20181201$20240806$20240617$20240814$EXP$$BG-TEVA-VS-3208542$TEVA$$65$YR$$M$Y$$$20240814$$MD$BG$BG
239810323$23981032$3$F$$20240726$20240617$20240730$30DAY$$US-GSK-US2024AMR073972$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$CN$US$US
239810473$23981047$3$F$$20240625$20240617$20240702$EXP$$US-BIOGEN-2024BI01268788$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
239810483$23981048$3$F$20220801$20240716$20240617$20240716$EXP$FR-AFSSAPS-TS2024000683$FR-JNJFOC-20240638363$JOHNSON AND JOHNSON$$52$YR$A$F$Y$108$KG$20240717$$PH$FR$FR
239810552$23981055$2$F$$20240614$20240617$20240701$EXP$$US-GILEAD-2024-0677408$GILEAD$$$$$F$Y$$$20240701$$MD$CH$CH
239810903$23981090$3$F$20240520$20240816$20240617$20240828$EXP$IT-MINISAL02-988045$IT-Accord-429449$ACCORD$$65$YR$E$M$Y$51$KG$20240828$$MD$IT$IT
239810952$23981095$2$F$$20240704$20240617$20240716$EXP$CA-MHPD-E2B_07005421$CA-Accord-429685$ACCORD$$37$YR$A$F$Y$$$20240716$$HP$CA$CA
239811052$23981105$2$F$20230101$20240619$20240617$20240701$EXP$$CN-MACLEODS PHARMA-MAC2024047661$MACLEODS$Dai B, Jiang Y, Dai Y..Central Retinal Artery Occlusion after Peribulbar Injection of Triamcinolone Acetonide in Thyroid-associated Ophthalmopathy.The Journal of Craniofacial Surgery.2024;00(00):10-97$$$$$Y$$$20240701$$MD$CN$CN
239811183$23981118$3$F$20240613$20240703$20240617$20240709$EXP$$US-PFIZER INC-2024SGN05200$PFIZER$$77$YR$$F$Y$$$20240709$$CN$US$US
239811202$23981120$2$F$20130101$20240625$20240617$20240710$EXP$$ES-Merck Healthcare KGaA-2024031402$MERCK KGAA$$51$YR$A$M$Y$90$KG$20240705$$CN$ES$ES
239811222$23981122$2$F$20240101$20240723$20240617$20240726$EXP$$US-PFIZER INC-202400192193$PFIZER$$75$YR$$F$Y$63.5$KG$20240726$$CN$US$US
239811333$23981133$3$F$$20240626$20240617$20240703$EXP$$JP-JNJFOC-20240636686$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$$COUNTRY NOT SPECIFIED$JP
239811365$23981136$5$F$20240123$20240704$20240617$20240712$EXP$$JP-009507513-2406JPN001270J$MERCK$Yokota K, Kitayama S, Yamashita T, Nagamoto S, Tachibana K, Chon S, et al.. A case of advanced bladder urothelial carcinoma in which KL-6 continued to increase associated with disease progression without clinical findings of interstitial pneumonia (46). The 94th Saitama Regional Meeting of the Japanese Urological Association. 2024;17$79$YR$$M$Y$$$20240712$$MD$JP$JP
239811402$23981140$2$F$$20240607$20240617$20240926$PER$$US-GSK-US2024AMR071445$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
239811622$23981162$2$F$20240528$20240712$20240617$20240725$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202405017081$ELI LILLY AND CO$$78$YR$E$M$Y$70$KG$20240725$$CN$DE$DE
239811652$23981165$2$F$20240501$20240621$20240617$20240705$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202406004113$ELI LILLY AND CO$$58$YR$A$M$Y$80$KG$20240705$$CN$BR$BR
239811702$23981170$2$F$20240520$20240807$20240617$20240812$EXP$$US-ABBVIE-5800055$ABBVIE$$49$YR$$M$Y$$$20240812$$CN$US$US
239812102$23981210$2$F$20240606$20240807$20240617$20240808$PER$$US-AMGEN-USASP2024117878$AMGEN$$75$YR$E$M$Y$$$20240808$$CN$US$US
239812113$23981211$3$F$20240611$20240711$20240617$20240715$30DAY$$US-AMGEN-USASP2024115886$AMGEN$$56$YR$A$F$Y$81$KG$20240715$$PH$US$US
239812243$23981224$3$F$20240601$20240821$20240617$20240830$EXP$$US-GSK-US2024AMR071552$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240830$$CN$US$US
239812302$23981230$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000773US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$MD$US$US
239812332$23981233$2$F$20240608$20240703$20240617$20240708$EXP$$US-ABBVIE-5800972$ABBVIE$$74$YR$$F$Y$78$KG$20240708$$CN$US$US
239812403$23981240$3$F$20240318$20240708$20240617$20240717$EXP$GB-MHRA-MED-202406072253334710-KPMDR$GB-TEVA-VS-3208209$TEVA$$24$YR$$M$Y$78$KG$20240717$$CN$GB$GB
239812532$23981253$2$F$20220701$20240627$20240617$20240702$EXP$$US-AMGEN-USASP2024115303$AMGEN$$66$YR$E$F$Y$$$20240702$$HP$US$US
239812653$23981265$3$F$20170301$20240913$20240617$20240925$EXP$$GB-PFIZER INC-PV202400078532$PFIZER$$$$C$M$Y$$$20240925$$HP$GB$GB
239812742$23981274$2$F$20240607$20240717$20240617$20240801$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024071752$VIIV$$70$YR$$M$Y$$$20240801$$HP$US$US
239812753$23981275$3$F$20240701$20240802$20240617$20240812$EXP$$US-GSK-US2024AMR071996$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240812$$CN$US$US
239812762$23981276$2$F$$20240627$20240617$20240704$30DAY$$US-GSK-US2024071647$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
239812772$23981277$2$F$$20240812$20240617$20240822$30DAY$$US-GSK-US2024AMR072284$GLAXOSMITHKLINE$$$$$M$Y$$$20240822$$CN$US$US
239812903$23981290$3$F$20240527$20240812$20240617$20240823$EXP$$CN-Accord-430544$ACCORD$$59$YR$A$F$Y$60$KG$20240823$$MD$CN$CN
239812962$23981296$2$F$$20240724$20240617$20240724$PER$$US-ALXN-202406USA000671US$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240724$$MD$US$US
239813062$23981306$2$F$20200101$20240705$20240617$20240709$EXP$GB-MHRA-MED-202406121251144660-JCQDY$GB-MYLANLABS-2024M1053957$MYLAN$$$$$F$Y$$$20240709$$MD$GB$GB
239813098$23981309$8$F$20240607$20240807$20240617$20240812$EXP$$GB-MYLANLABS-2024M1052861$MYLAN$$17$YR$$F$Y$38$KG$20240812$$MD$GB$GB
239813273$23981327$3$F$$20240916$20240617$20240919$30DAY$$US-PFIZER INC-202400190658$PFIZER$$6$YR$$F$Y$$$20240919$$CN$US$US
239813364$23981336$4$F$20240520$20240916$20240617$20240919$30DAY$$US-PFIZER INC-202400191864$PFIZER$$3$YR$$M$Y$$$20240919$$CN$US$US
239813373$23981337$3$F$$20240820$20240617$20240821$30DAY$$CO-PFIZER INC-PV202400074105$PFIZER$$13$YR$$M$Y$$$20240821$$CN$CO$CO
239813403$23981340$3$F$20210511$20240726$20240617$20240801$EXP$$DE-MYLANLABS-2022M1004385$MYLAN$$$$E$F$Y$66$KG$20240801$$HP$DE$DE
239813453$23981345$3$F$20230801$20240806$20240617$20240816$EXP$$JP-AMGEN-JPNSP2024118217$AMGEN$$75$YR$E$F$Y$$$20240816$$MD$JP$JP
239813462$23981346$2$F$20240612$20240711$20240617$20240715$PER$$US-AMGEN-USASP2024117867$AMGEN$$58$YR$A$F$Y$$$20240715$$CN$US$US
239813572$23981357$2$F$20240501$20240619$20240617$20240701$EXP$$ES-BAYER-2024A083648$BAYER$$32$YR$A$F$Y$$$20240701$$CN$ES$ES
239813742$23981374$2$F$$20240903$20240617$20240916$PER$$US-SA-2024SA173021$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240916$$MD$US$US
239813762$23981376$2$F$20240605$20240708$20240617$20240715$PER$$US-SA-2024SA174183$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240715$$CN$US$US
239813903$23981390$3$F$20240101$20240807$20240617$20240815$EXP$$JP-009507513-2405JPN000725J$MERCK$$8$DEC$$M$Y$$$20240815$$MD$JP$JP
239813922$23981392$2$F$$20240809$20240617$20240820$PER$$US-SA-2024SA176728$SANOFI AVENTIS$$9$YR$C$M$Y$31.2$KG$20240820$$MD$US$US
239814042$23981404$2$F$$20240705$20240617$20240714$PER$$US-SA-2024SA173790$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240715$$CN$US$US
239814172$23981417$2$F$20240608$20240709$20240617$20240718$PER$$US-SA-2024SA174416$SANOFI AVENTIS$$62$YR$A$F$Y$51.2$KG$20240718$$MD$US$US
239814232$23981423$2$F$$20240903$20240617$20240912$PER$$US-SA-2024SA178482$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240912$$MD$US$US
239814262$23981426$2$F$20240301$20240906$20240617$20240917$PER$$US-SA-2024SA178656$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240918$$MD$US$US
239814293$23981429$3$F$20240601$20240913$20240617$20240925$PER$$US-SA-2024SA178540$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240925$$MD$US$US
239814333$23981433$3$F$20240531$20240721$20240617$20240725$PER$$US-AMGEN-USASP2024118348$AMGEN$$72$YR$E$M$Y$$$20240725$$CN$US$US
239814344$23981434$4$F$20150201$20240719$20240617$20240729$EXP$$US-GILEAD-2024-0677621$GILEAD$$38$YR$A$F$Y$$$20240729$$LW$US$US
239814352$23981435$2$F$20240101$20240710$20240617$20240718$PER$$US-SA-2024SA178700$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240718$$MD$US$US
239814362$23981436$2$F$20240101$20240905$20240617$20240914$PER$$US-SA-2024SA178661$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240914$$MD$US$US
239814452$23981445$2$F$20240609$20240611$20240617$20240814$PER$$US-SA-2024SA176895$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240814$$MD$US$US
239814632$23981463$2$F$20240101$20240813$20240617$20240828$PER$$US-SA-2024SA177813$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240828$$MD$US$US
239814662$23981466$2$F$20240101$20240704$20240617$20240710$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-086226$REGENERON$$71$YR$$F$Y$$$20240710$$CN$CO$CO
239814712$23981471$2$F$$20240619$20240617$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04973$LUPIN$$$$$$Y$$$20240702$$CN$US$US
239814722$23981472$2$F$$20240621$20240617$20240701$EXP$$US-TEVA-VS-3204503$TEVA$Shim KG, Crain M, Augustin K, Oetjen KA. Management of acute promyelocytic leukemia in the setting of acute COVID-19 infection. Leukemia-Research-Reports 2022; 18 100353.; Shim KG, Crain M, Augustin K, Oetjen KA. Management of acute promyelocytic leukemia in the setting of acute COVID-19 infection. Leukemia-Research-Reports 2022; 18 100353.$60$YR$$F$Y$$$20240701$$HP$US$US
239814732$23981473$2$F$$20240702$20240617$20240709$EXP$$GB-MYLANLABS-2024M1054071$MYLAN$$$$$M$Y$$$20240709$$PH$GB$GB
239814742$23981474$2$F$20240101$20240715$20240617$20240722$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-086139$REGENERON$$76$YR$$F$Y$$$20240722$$HP$CO$CO
239814782$23981478$2$F$20240101$20240814$20240617$20240819$EXP$$DE-SANDOZ INC.-SDZ2024DE057785$SANDOZ$$$$$F$Y$105.7$KG$20240819$$HP$DE$DE
239814842$23981484$2$F$$20240715$20240617$20240720$EXP$$CA-SANDOZ INC.-SDZ2024CA057291$SANDOZ$$63$YR$$F$Y$58$KG$20240720$$CN$CA$CA
239814885$23981488$5$F$20240528$20240830$20240617$20240905$EXP$$JP-PFIZER INC-PV202400077248$PFIZER$$76$YR$$F$Y$30.3$KG$20240905$$PH$JP$JP
239815072$23981507$2$F$20240610$20240627$20240617$20240707$PER$$US-SA-2024SA176082$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240707$$HP$US$US
239815092$23981509$2$F$20240101$20240710$20240617$20240712$EXP$$US-PFIZER INC-PV202400077465$PFIZER$$77$YR$$F$Y$$$20240712$$HP$US$US
239815173$23981517$3$F$$20240626$20240617$20240703$EXP$$JP-JNJFOC-20240636664$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$$COUNTRY NOT SPECIFIED$JP
239815212$23981521$2$F$$20240718$20240617$20240728$PER$$US-SA-2024SA177100$SANOFI AVENTIS$$$$E$F$Y$$$20240728$$MD$US$US
239815232$23981523$2$F$$20240605$20240617$20240715$EXP$$US-BAYER-2024A085941$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240715$$MD$US$US
239815244$23981524$4$F$20180101$20240910$20240617$20240916$PER$$US-GILEAD-2024-0677622$GILEAD$$52$YR$A$M$Y$$$20240916$$LW$US$US
239815283$23981528$3$F$$20240617$20240617$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-028736$AUROBINDO$Ghafari-Saravi A, Greiling TM.. Recurrent bullous erythema multiforme due to oral contraceptive therapy.. International Journal of Women^s Dermatology.. 2024;10(2):E142$22$YR$$F$Y$$$20240808$$MD$US$US
239815364$23981536$4$F$20190114$20240722$20240617$20240729$PER$$US-GILEAD-2024-0677630$GILEAD$$56$YR$A$M$Y$$$20240729$$LW$US$US
239815452$23981545$2$F$$20240605$20240617$20240716$EXP$$US-BAYER-2024A085950$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240716$$MD$US$US
239815502$23981550$2$F$20240601$20240902$20240617$20240902$EXP$$IL-ALXN-202406EEA000425IL$ALEXION PHARMACEUTICALS$$$$C$M$Y$$$20240902$$HP$IL$IL
239815542$23981554$2$F$20240501$20240618$20240617$20240703$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0600004$MYOVANT SCIENCES$$71$YR$$M$Y$$$20240703$$CN$US$US
239815613$23981561$3$F$20200101$20240722$20240617$20240724$PER$$US-GILEAD-2024-0677623$GILEAD$$37$YR$A$M$Y$$$20240724$$LW$US$US
239815642$23981564$2$F$$20240611$20240617$20240723$PER$$US-SA-2024SA177951$SANOFI AVENTIS$$$$A$F$Y$78$KG$20240723$$MD$US$US
239815664$23981566$4$F$20240101$20240916$20240617$20240924$PER$$US-AMGEN-USASP2024116393$AMGEN$$$$$F$Y$$$20240924$$CN$US$US
239815692$23981569$2$F$$20240801$20240617$20240805$EXP$$GB-MYLANLABS-2024M1054523$MYLAN$$$$$F$Y$$$20240805$$PH$GB$GB
239815722$23981572$2$F$$20240620$20240617$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05295$LUPIN$$$$$$Y$$$20240702$$PH$US$US
239815773$23981577$3$F$20240605$20240627$20240617$20240710$PER$$US-Calliditas-2024CAL00947$CALLIDITAS THERAPEUTICS$$41$YR$A$F$Y$$$20240710$$CN$US$US
239815782$23981578$2$F$$20240621$20240617$20240701$EXP$$US-TEVA-VS-3203428$TEVA$Zhang MY, Nuthulaganti SR, Suryanarayana PG. ADENOSINE-INDUCED TRANSFORMATION OF WIDE COMPLEX TACHYCARDIA TO VENTRICULAR FIBRILLATION. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3681.; Zhang MY, Nuthulaganti SR, Suryanarayana PG. ADENOSINE-INDUCED TRANSFORMATION OF WIDE COMPLEX TACHYCARDIA TO VENTRICULAR FIBRILLATION. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3681.$77$YR$$M$Y$$$20240701$$HP$US$US
239815822$23981582$2$F$20240213$20240627$20240617$20240701$EXP$FR-AFSSAPS-PC2024000445$FR-MYLANLABS-2024M1054214$MYLAN$$53$YR$$M$Y$104$KG$20240701$$PH$FR$FR
239815952$23981595$2$F$20240101$20240625$20240617$20240701$EXP$FR-AFSSAPS-AVMP2024000160$FR-MYLANLABS-2024M1053219$MYLAN$$36$YR$$F$Y$$$20240701$$PH$FR$FR
239816002$23981600$2$F$$20240729$20240617$20240729$PER$$US-ALXN-202406USA000742US$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240729$$MD$US$US
239816332$23981633$2$F$$20240724$20240617$20240826$PER$$US-GALDERMA-US2024009692$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
239816682$23981668$2$F$20240523$20240725$20240617$20240730$EXP$$US-OTSUKA-2024_016601$OTSUKA$$31$YR$$F$Y$$$20240730$$MD$US$US
239816732$23981673$2$F$$20240807$20240617$20240809$EXP$$JP-BAYER-2024A085031$BAYER$$82$YR$E$M$Y$$$20240809$$MD$JP$JP
239816832$23981683$2$F$$20240703$20240617$20240712$EXP$$JP-AMGEN-JPNSP2024116498$AMGEN$$72$YR$E$M$Y$$$20240712$$MD$JP$JP
239816852$23981685$2$F$20231213$20240709$20240617$20240716$30DAY$$US-AMGEN-USASP2024115802$AMGEN$$73$YR$E$F$Y$72.2$KG$20240716$$HP$US$US
239816866$23981686$6$F$$20240913$20240617$20240917$PER$$US-BIOGEN-2024BI01268020$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
239816912$23981691$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000850US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$US$US
239816962$23981696$2$F$20240621$20240708$20240617$20240710$30DAY$$US-GSK-US2024071751$GLAXOSMITHKLINE$$83$YR$$M$Y$$$20240710$$CN$US$US
239816973$23981697$3$F$20240606$20240625$20240617$20240725$PER$$US-AMGEN-USASP2024113622$AMGEN$$75$YR$E$F$Y$50.5$KG$20240724$$PH$US$US
239817072$23981707$2$F$$20240730$20240617$20240802$EXP$$VE-PFIZER INC-PV202400077881$PFIZER$$78$YR$$M$Y$$$20240802$$CN$VE$VE
239817162$23981716$2$F$$20240621$20240617$20240701$EXP$$US-TEVA-VS-3203427$TEVA$Ahmed A, Naeem N, Domench DI, Mohamed MS, Waheed SH, Rao M. PROPAFENONE INDUCED BRUGADA TYPE I PATTERN AND WIDE COMPLEX TACHYCARDIA. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 2893.; Ahmed A, Naeem N, Domench DI, Mohamed MS, Waheed SH, Rao M. PROPAFENONE INDUCED BRUGADA TYPE I PATTERN AND WIDE COMPLEX TACHYCARDIA. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 2893.$69$YR$$M$Y$$$20240701$$HP$US$US
239817182$23981718$2$F$$20240712$20240617$20240718$PER$$US-AstraZeneca-2024A134265$ASTRAZENECA$$$$$F$Y$$$20240718$$MD$US$
239817193$23981719$3$F$$20240724$20240617$20240726$EXP$$GB-AstraZeneca-2024A139310$ASTRAZENECA$Buka R.J., Krishna M.T., Sutton D.J.. Fatal drug reaction to andexanet alfa: a case report.. eJHaem 2024;1-4.$85$YR$$M$Y$98$KG$20240726$$HP$GB$
239817322$23981732$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000763US$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240730$$MD$US$US
239817342$23981734$2$F$$20240717$20240617$20240725$PER$$US-SA-2024SA176072$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240725$$CN$US$US
239817356$23981735$6$F$20240605$20240813$20240617$20240820$EXP$$US-GSK-US2024AMR071671$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$US$US
239817363$23981736$3$F$20240608$20240723$20240617$20240729$EXP$$JP-PFIZER INC-PV202400077257$PFIZER$$83$YR$$M$Y$67.5$KG$20240729$$MD$JP$JP
239817412$23981741$2$F$$20240807$20240617$20240809$EXP$$JP-BAYER-2024A085669$BAYER$$73$YR$E$M$Y$$$20240809$$MD$JP$JP
239817472$23981747$2$F$$20240619$20240617$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04994$LUPIN$$$$$$Y$$$20240702$$CN$US$US
239817492$23981749$2$F$$20240724$20240617$20240731$PER$$US-ALXN-202406USA000534US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
239817512$23981751$2$F$20220701$20240806$20240617$20240819$EXP$IE-HPRA-2024-113304$NVSC2024IE125843$NOVARTIS$$54$YR$$F$Y$$$20240819$$CN$IE$IE
239817753$23981775$3$F$$20240628$20240617$20240704$EXP$$JP-JNJFOC-20240637123$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$$COUNTRY NOT SPECIFIED$JP
239817892$23981789$2$F$$20240808$20240617$20240813$PER$$US-PFIZER INC-PV202400078758$PFIZER$$21$YR$$M$Y$$$20240813$$CN$US$US
239817902$23981790$2$F$$20240829$20240617$20240904$PER$$US-PFIZER INC-202400194279$PFIZER$$62$YR$$F$Y$$$20240904$$CN$US$US
239817922$23981792$2$F$$20240730$20240617$20240801$PER$$US-PFIZER INC-PV202400079066$PFIZER$$48$YR$$M$Y$$$20240801$$HP$US$US
239818082$23981808$2$F$20180727$20240726$20240617$20240805$EXP$$BR-TAKEDA-2018TUS036219$TAKEDA$$67$YR$$F$Y$$$20240805$$CN$BR$BR
239818092$23981809$2$F$$20240703$20240617$20240712$PER$$US-SA-2024SA176948$SANOFI AVENTIS$$$$T$M$Y$70.2$KG$20240712$$MD$US$US
239818142$23981814$2$F$20240501$20240702$20240617$20240715$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000193$Unknown Manufacturer$$$$$$Y$$$20240715$$CN$US$US
239818163$23981816$3$F$$20240909$20240617$20240918$EXP$$JP-PFIZER INC-PV202400076173$PFIZER$Nakatake, N.. A case of type 2 diabetes mellitus seemingly exacerbated by medroxyprogesterone. Journal of the Japan Diabetes Society. 2024;67(S1):S300$56$YR$$F$Y$$$20240918$$MD$JP$JP
239818182$23981818$2$F$20240410$20240625$20240617$20240708$PER$$US-Calliditas-2024CAL00951$CALLIDITAS THERAPEUTICS$$34$YR$A$M$Y$95$KG$20240708$$CN$US$US
239818272$23981827$2$F$$20240709$20240617$20240723$30DAY$$US-GSK-US2024AMR072753$GLAXOSMITHKLINE$$$$$F$Y$78.005$KG$20240723$$PH$US$US
239818382$23981838$2$F$$20240708$20240617$20240712$EXP$$CA-TAKEDA-2024TUS058165$TAKEDA$$$$$M$Y$$$20240712$$HP$CA$CA
239818412$23981841$2$F$$20240731$20240617$20240812$EXP$$US-NOVOPROD-1235189$NOVO NORDISK$$$$$F$Y$$$20240812$$CN$US$US
239818442$23981844$2$F$20240530$20240622$20240617$20240703$EXP$$CN-NOVOPROD-1231525$NOVO NORDISK$$59$YR$$F$Y$87.5$KG$20240703$$CN$CN$CN
239818472$23981847$2$F$20230101$20240729$20240617$20240809$EXP$$US-NOVOPROD-1235775$NOVO NORDISK$$$$E$F$Y$78.458$KG$20240809$$MD$US$US
239818532$23981853$2$F$20240606$20240924$20240617$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US057645$SANDOZ$$13$YR$$M$Y$$$20240926$$HP$US$US
239818564$23981856$4$F$$20240719$20240617$20240728$EXP$$US-SANDOZ INC.-SDZ2024US058172$SANDOZ$$54$YR$$F$Y$$$20240728$$CN$US$US
239818602$23981860$2$F$20230701$20240815$20240617$20240821$EXP$$US-ABBVIE-5798675$ABBVIE$$55$YR$$F$Y$$$20240821$$CN$US$US
239818622$23981862$2$F$$20240909$20240617$20240913$EXP$$CA-SANDOZ INC.-NVSC2022CA189450$SANDOZ$$$$$F$Y$$$20240913$$CN$CA$CA
239818833$23981883$3$F$$20240626$20240617$20240703$EXP$$JP-JNJFOC-20240636660$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$$COUNTRY NOT SPECIFIED$JP
239818842$23981884$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000846US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$US$US
239818873$23981887$3$F$$20240724$20240617$20240731$PER$$US-ALXN-202406USA000585US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239818922$23981892$2$F$$20240710$20240617$20240717$30DAY$$US-JNJFOC-20240639544$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$PH$US$US
239819032$23981903$2$F$$20240605$20240617$20240702$PER$$US-INCYTE CORPORATION-2024IN006037$INCYTE$$$$$$Y$$$20240702$$CN$US$US
239819062$23981906$2$F$20240329$20240628$20240617$20240702$EXP$GB-MHRA-MED-202406120600400060-ZQTDY$GB-MYLANLABS-2024M1053672$MYLAN$$23$YR$$F$Y$$$20240702$$CN$GB$GB
239819083$23981908$3$F$20240304$20240712$20240617$20240717$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-013994$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240717$$CN$JP$JP
239819152$23981915$2$F$$20240909$20240617$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096950$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$113.85$KG$20240910$$CN$US$US
239819222$23981922$2$F$20240503$20240911$20240617$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095501$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240911$$PH$US$US
239819232$23981923$2$F$$20240816$20240617$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096843$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240819$$CN$US$US
239819262$23981926$2$F$$20240610$20240617$20240708$EXP$$ZA-AstraZeneca-2024A136282$ASTRAZENECA$$81$YR$$M$Y$$$20240708$$CN$ZA$
239819314$23981931$4$F$$20240823$20240617$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-096247$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240830$$MD$JP$JP
239819333$23981933$3$F$$20240911$20240617$20240913$30DAY$$US-PFIZER INC-202400191523$PFIZER$$10$YR$$M$Y$$$20240913$$CN$US$US
239819422$23981942$2$F$$20240716$20240617$20240718$30DAY$$BE-JNJFOC-20240634266$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$PH$BE$BE
239819432$23981943$2$F$$20240917$20240617$20240919$EXP$$US-JNJFOC-20240620748$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$MD$US$US
239819492$23981949$2$F$20240105$20240611$20240617$20240830$EXP$GB-MHRA-MED-202406091453155270-LWQKJ$GB-SEPTODONT-2024018721$SEPTODONT$$83$YR$E$M$Y$86$KG$20240830$$CN$GB$GB
239819522$23981952$2$F$20240201$20240801$20240617$20240806$EXP$$NVSC2024AU125568$NOVARTIS$$47$YR$$F$Y$$$20240806$$MD$AU$AU
239819582$23981958$2$F$20231205$20240820$20240617$20240829$PER$$US-MYLANLABS-2024M1053821$MYLAN$$41$YR$$$Y$86.18$KG$20240829$$CN$US$US
239819602$23981960$2$F$$20240724$20240617$20240731$PER$$US-ALXN-202406USA000540US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239819652$23981965$2$F$$20240604$20240617$20240708$EXP$$GB-LABORATORIOS LICONSA S.A.-2406GB04627$INSUD PHARMA$$$$$M$Y$$$20240708$$CN$GB$GB
239819702$23981970$2$F$20231012$20240627$20240617$20240705$EXP$$US-Calliditas-2024CAL00977$CALLIDITAS THERAPEUTICS$$72$YR$E$M$Y$$$20240705$$CN$US$US
239819734$23981973$4$F$20240601$20240912$20240617$20240919$EXP$$CA-GSK-CA2023AMR093332$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$HP$CA$CA
239819872$23981987$2$F$20240501$20240620$20240617$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406007551$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$US$US
239819962$23981996$2$F$20240109$20240628$20240617$20240702$PER$$US-PFIZER INC-PV202400004197$PFIZER$$74$YR$$F$Y$70.295$KG$20240702$$CN$US$US
239819982$23981998$2$F$20240612$20240823$20240617$20240827$PER$$US-AMGEN-USASP2024117736$AMGEN$$66$YR$E$M$Y$$$20240827$$CN$US$US
239819992$23981999$2$F$$20240719$20240617$20240801$30DAY$$GB-JNJFOC-20240575759$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$GB$GB
239820003$23982000$3$F$$20240701$20240617$20240707$EXP$$JP-JNJFOC-20240636661$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$$COUNTRY NOT SPECIFIED$JP
239820072$23982007$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000847US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$US$US
239820092$23982009$2$F$$20240603$20240617$20240701$PER$$US-INCYTE CORPORATION-2024IN005924$INCYTE$$$$$$Y$$$20240701$$CN$US$US
239820102$23982010$2$F$$20240701$20240617$20240712$30DAY$$JP-JNJFOC-20240636199$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$PH$JP$JP
239820155$23982015$5$F$$20240712$20240617$20240723$EXP$$CA-JNJFOC-20240630701$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240719$$HP$CA$CA
239820232$23982023$2$F$20240606$20240627$20240617$20240701$30DAY$$US-GSK-US2024071416$GLAXOSMITHKLINE$$81$YR$$F$Y$$$20240701$$CN$US$US
239820243$23982024$3$F$20240124$20240726$20240617$20240802$EXP$$CA-GSK-CA2024011844$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$PH$CA$CA
239820292$23982029$2$F$$20240701$20240617$20240707$EXP$$JP-JNJFOC-20240637244$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$MD$JP$JP
239820304$23982030$4$F$$20240827$20240617$20240912$PER$$US-Calliditas-2024CAL00975$CALLIDITAS THERAPEUTICS$$45$YR$A$M$Y$95$KG$20240912$$CN$US$US
239820332$23982033$2$F$$20240604$20240617$20240710$PER$$US-INCYTE CORPORATION-2024IN005977$INCYTE$$$$$$Y$$$20240710$$CN$US$US
239820392$23982039$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000848US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$US$US
239820422$23982042$2$F$$20240626$20240617$20240701$EXP$$JP-JNJFOC-20240636663$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$JP$JP
239820512$23982051$2$F$20240401$20240813$20240617$20240820$EXP$$NVSC2024US094060$NOVARTIS$$69$YR$$F$Y$74.7$KG$20240820$$CN$US$US
239820562$23982056$2$F$$20240717$20240617$20240721$EXP$$US-PFIZER INC-202400193612$PFIZER$$69$YR$$F$Y$$$20240721$$CN$US$US
239820713$23982071$3$F$20220308$20240911$20240617$20240916$EXP$$IL-ALNYLAM NETHERLANDS BV-ALN-2024-003310$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240916$$HP$IL$IL
239820766$23982076$6$F$20240101$20240822$20240617$20240828$PER$$US-PFIZER INC-PV202400078239$PFIZER$$69$YR$$F$Y$100.2$KG$20240828$$HP$US$US
239820822$23982082$2$F$20240101$20240702$20240617$20240708$PER$$US-PFIZER INC-2024SGN05627$PFIZER$$55$YR$$M$Y$$$20240708$$HP$US$US
239820832$23982083$2$F$$20240711$20240617$20240716$PER$$US-PFIZER INC-202400193237$PFIZER$$71$YR$$F$Y$$$20240716$$MD$US$US
239820842$23982084$2$F$20240101$20240730$20240617$20240801$PER$$US-PFIZER INC-202400191873$PFIZER$$65$YR$$M$Y$$$20240801$$MD$US$US
239820883$23982088$3$F$20240604$20240624$20240617$20240704$EXP$$US-JNJFOC-20240622315$JOHNSON AND JOHNSON$$41$YR$A$$Y$$$20240704$$CN$US$US
239821122$23982112$2$F$$20240725$20240617$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095259$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$69.85$KG$20240729$$CN$US$US
239821142$23982114$2$F$$20240710$20240617$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096638$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240717$$CN$US$US
239821293$23982129$3$F$$20240624$20240617$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095256$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$84.82$KG$20240702$$CN$US$US
239821462$23982146$2$F$$20240912$20240617$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-096154$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$PH$JP$JP
239821594$23982159$4$F$$20240821$20240617$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096860$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240827$$CN$US$US
239821602$23982160$2$F$20240612$20240701$20240617$20240704$PER$$US-AMGEN-USASP2024118340$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
239821642$23982164$2$F$20240604$20240605$20240617$20240906$EXP$$US-FARMAPROD-202406-2153$DOMPE FARMACEUTICI$$63$YR$A$F$Y$$$20240904$$CN$US$US
239821703$23982170$3$F$20240524$20240702$20240617$20240708$30DAY$$US-JNJFOC-20240572630$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
239821724$23982172$4$F$20231201$20240809$20240617$20240818$EXP$$JP-009507513-2404JPN004003J$MERCK$$74$YR$$M$Y$57$KG$20240818$$MD$JP$JP
239821803$23982180$3$F$$20240701$20240617$20240703$PER$$US-PFIZER INC-PV202400078280$PFIZER$$89$YR$$F$Y$$$20240703$$HP$US$US
239821822$23982182$2$F$$20240719$20240617$20240723$PER$$US-PFIZER INC-202400193531$PFIZER$$16$YR$$F$Y$$$20240723$$MD$US$US
239821852$23982185$2$F$20240208$20240808$20240617$20240814$EXP$$CA-OTSUKA-2024_005324$OTSUKA$$76$YR$$M$Y$$$20240814$$MD$CA$CA
239822004$23982200$4$F$20230701$20240923$20240617$20240927$EXP$$CA-TAKEDA-2023TUS066594$TAKEDA$$49$YR$$M$Y$$$20240927$$MD$CA$CA
239822053$23982205$3$F$20160412$20240724$20240617$20240726$PER$$US-GILEAD-2024-0677628$GILEAD$$34$YR$A$M$Y$$$20240726$$LW$US$US
239822212$23982221$2$F$20240424$20240701$20240617$20240705$EXP$$FR-ASTELLAS-2024US016407$ASTELLAS$$65$YR$$F$Y$$$20240705$$PH$FR$FR
239822244$23982224$4$F$$20240717$20240617$20240723$EXP$$US-PFIZER INC-2024SGN05207$PFIZER$$61$YR$$F$Y$$$20240723$$CN$US$US
239822272$23982227$2$F$$20240916$20240617$20240919$EXP$$US-BAYER-2024A085516$BAYER$$37$YR$A$M$Y$$$20240919$$HP$US$US
239822342$23982234$2$F$$20240719$20240617$20240725$30DAY$$US-JNJFOC-20240635958$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$PH$US$US
239822392$23982239$2$F$$20240626$20240617$20240705$EXP$$CA-GSK-CA2024068207$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$CA$CA
239822415$23982241$5$F$20240528$20240830$20240617$20240903$EXP$$JP-PFIZER INC-PV202400077474$PFIZER$$73$YR$$M$Y$54$KG$20240903$$PH$JP$JP
239822464$23982246$4$F$20240529$20240629$20240617$20240709$EXP$$US-LUNDBECK-DKLU3078704$LUNDBECK$$$$$$Y$$$20240709$$CN$US$US
239822472$23982247$2$F$20230101$20240627$20240617$20240702$EXP$$JP-OTSUKA-2024_016964$OTSUKA$$8$DEC$$F$Y$$$20240702$$MD$JP$JP
239822512$23982251$2$F$$20240605$20240617$20240906$PER$$US-FARMAPROD-202405-1925$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$US
239822522$23982252$2$F$$20240724$20240617$20240726$EXP$$JP-OTSUKA-2024_017060$OTSUKA$$10$DEC$$F$Y$$$20240726$$PH$JP$JP
239822542$23982254$2$F$20240601$20240920$20240617$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US057577$SANDOZ$$46$YR$$F$Y$$$20240925$$CN$US$US
239822553$23982255$3$F$20240509$20240628$20240617$20240706$EXP$$DE-AMGEN-DEUSP2024113354$AMGEN$$73$YR$E$M$Y$100$KG$20240706$$MD$DE$DE
239822772$23982277$2$F$$20240724$20240617$20240726$EXP$$US-SANDOZ INC.-SDZ2024US058056$SANDOZ$$$$$F$Y$$$20240726$$CN$US$US
239822864$23982286$4$F$20110501$20240722$20240617$20240729$PER$$US-GILEAD-2024-0677627$GILEAD$$42$YR$A$M$Y$$$20240729$$LW$US$US
239822912$23982291$2$F$20240611$20240806$20240617$20240808$PER$$US-AMGEN-USASP2024118321$AMGEN$$49$YR$A$F$Y$$$20240808$$CN$US$US
239822923$23982292$3$F$20231211$20240711$20240617$20240722$EXP$$JP-009507513-2312JPN002067J$MERCK$$70$YR$$M$Y$$$20240719$$MD$JP$JP
239822963$23982296$3$F$20230201$20240714$20240617$20240722$EXP$$US-AstraZeneca-2024A135709$ASTRAZENECA$$73$YR$$M$Y$127$KG$20240722$$CN$US$
239823052$23982305$2$F$$20240729$20240617$20240729$PER$$US-ALXN-202406USA000750US$ALEXION PHARMACEUTICALS$$$$E$F$Y$$$20240729$$MD$US$US
239823062$23982306$2$F$$20240729$20240617$20240729$PER$$US-ALXN-202406USA000747US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$MD$US$US
239823082$23982308$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000849US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$US$US
239823102$23982310$2$F$$20240712$20240617$20240718$30DAY$$CA-JNJFOC-20240620428$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$CA$CA
239823232$23982323$2$F$20240605$20240619$20240617$20240718$PER$$US-INCYTE CORPORATION-2024IN006083$INCYTE$$$$$$Y$$$20240718$$CN$US$US
239823302$23982330$2$F$$20240621$20240617$20240701$EXP$$US-TEVA-VS-3203412$TEVA$Fialkowski A, Shaffer K, Ball-Burack M, Brooks TL, Trinh N-HT, Potter JE, et al. Trauma-Informed Care for Hospitalized Adolescents. Curr-Pediatr-Rep 2022; 10 45-54.; Fialkowski A, Shaffer K, Ball-Burack M, Brooks TL, Trinh N-HT, Potter JE, et al. Trauma-Informed Care for Hospitalized Adolescents. Curr-Pediatr-Rep 2022; 10 45-54.; Fialkowski A, Shaffer K, Ball-Burack M, Brooks TL, Trinh N-HT, Potter JE, et al. Trauma-Informed Care for Hospitalized Adolescents. Curr-Pediatr-Rep 2022; 10 45-54.$19$YR$$$Y$$$20240701$$HP$US$US
239823312$23982331$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000764US$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240730$$MD$US$US
239823323$23982332$3$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000769US$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240730$$MD$US$US
239823393$23982339$3$F$$20240913$20240617$20240918$30DAY$$US-PFIZER INC-202400191880$PFIZER$$14$YR$$M$Y$$$20240918$$CN$US$US
239823402$23982340$2$F$20240611$20240718$20240617$20240718$30DAY$$US-PFIZER INC-202400191733$PFIZER$$$$$M$Y$$$20240718$$CN$US$US
239823493$23982349$3$F$20240606$20240822$20240617$20240826$30DAY$$US-PFIZER INC-202400192474$PFIZER$$8$YR$$F$Y$34.02$KG$20240826$$HP$US$US
239823523$23982352$3$F$$20240705$20240617$20240722$30DAY$$FR-JNJFOC-20240606829$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240722$$PH$FR$FR
239823542$23982354$2$F$$20240911$20240617$20240916$PER$$US-BIOGEN-2024BI01269171$BIOGEN$$$$$M$Y$147.55$KG$20240916$$MD$US$US
239823555$23982355$5$F$20240619$20240720$20240617$20240726$EXP$$US-Calliditas-2024CAL00968$CALLIDITAS THERAPEUTICS$$57$YR$A$M$Y$$$20240726$$CN$US$US
239823872$23982387$2$F$$20240722$20240617$20240730$EXP$$PE-AMGEN-PERSP2024093032$AMGEN$$43$YR$A$M$Y$$$20240729$$CN$PE$PE
239823922$23982392$2$F$$20240709$20240617$20240716$EXP$$CA-GSK-CA2024AMR072350$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$HP$CA$CA
239823982$23982398$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000842US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$US$US
239824172$23982417$2$F$$20240705$20240617$20240717$30DAY$$IL-JNJFOC-20240622337$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$HP$IL$IL
239824302$23982430$2$F$20240525$20240627$20240617$20240703$PER$$US-BAYER-2024A084760$BAYER$$19$YR$A$F$Y$$$20240703$$MD$US$US
239824322$23982432$2$F$$20240730$20240617$20240805$PER$$US-ABBVIE-5802832$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
239824392$23982439$2$F$20240601$20240711$20240617$20240717$PER$$US-JNJFOC-20240640505$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240717$$HP$US$US
239824433$23982443$3$F$20240510$20240726$20240617$20240729$EXP$$BR-AstraZeneca-2024A139111$ASTRAZENECA$$1585$WK$$F$Y$68$KG$20240729$$MD$BR$
239824562$23982456$2$F$20240613$20240614$20240617$20240713$PER$$US-AMGEN-USASP2024117379$AMGEN$$75$YR$E$F$Y$$$20240712$$CN$US$US
239824804$23982480$4$F$20160601$20240722$20240617$20240723$PER$$US-GILEAD-2024-0677624$GILEAD$$48$YR$A$M$Y$$$20240723$$LW$US$US
239824842$23982484$2$F$20231201$20240704$20240617$20240717$PER$$US-MYLANLABS-2024M1053782$MYLAN$$71$YR$$M$Y$$$20240717$$CN$US$US
239824852$23982485$2$F$$20240810$20240617$20240813$PER$$NVSC2024US125933$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
239825002$23982500$2$F$$20240605$20240617$20240716$EXP$$US-BAYER-2024A085936$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240716$$MD$US$US
239825023$23982502$3$F$$20240718$20240617$20240726$EXP$$JP-ALXN-202406JPN000455JP$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240726$$MD$JP$JP
239825162$23982516$2$F$20220805$20240814$20240617$20240816$EXP$$US-UCBSA-2023011232$UCB$$58$YR$$F$Y$$$20240816$$PH$US$US
239825254$23982525$4$F$20180401$20240722$20240617$20240801$PER$$US-GILEAD-2024-0677625$GILEAD$$61$YR$A$M$Y$$$20240801$$LW$US$US
239825342$23982534$2$F$20240604$20240704$20240617$20240710$EXP$$CA-JNJFOC-20240610358$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240710$$PH$CA$CA
239825362$23982536$2$F$20240514$20240723$20240617$20240730$EXP$$US-GSK-US2024072068$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$US$US
239825412$23982541$2$F$$20240914$20240617$20240915$PER$$US-ALXN-202406USA000851US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240915$$MD$US$US
239825422$23982542$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000843US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$US$US
239825445$23982544$5$F$$20240729$20240617$20240731$PER$$NVSC2024US125917$NOVARTIS$$$$$M$Y$$$20240731$$MD$US$US
239825462$23982546$2$F$20240601$20240705$20240617$20240718$PER$$US-SA-2024SA173719$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240718$$MD$US$US
239825613$23982561$3$F$20240530$20240710$20240617$20240716$EXP$$PH-PFIZER INC-2023SGN08884$PFIZER$$28$YR$$M$Y$$$20240716$$CN$PH$PH
239825662$23982566$2$F$20240501$20240722$20240617$20240723$EXP$FR-AFSSAPS-BX2024001171$NVSC2024FR125010$NOVARTIS$$61$YR$$F$Y$47$KG$20240723$$MD$FR$FR
239825772$23982577$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000852US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$US$US
239825783$23982578$3$F$20090103$20240719$20240617$20240722$EXP$$US-GILEAD-2024-0677626$GILEAD$$37$YR$A$M$Y$$$20240722$$LW$US$US
239825792$23982579$2$F$$20240621$20240617$20240701$EXP$$US-TEVA-VS-3203084$TEVA$Lee GH, Guzman AK, Divito SJ, Soiffer RJ, Silk AW, Schmults CD. Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxolitinib or Belumosudil. N-Engl-J-Med 2023; 389 (2): 188-190.; Lee GH, Guzman AK, Divito SJ, Soiffer RJ, Silk AW, Schmults CD. Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxolitinib or Belumosudil. N-Engl-J-Med 2023; 389 (2): 188-190.; Lee GH, Guzman AK, Divito SJ, Soiffer RJ, Silk AW, Schmults CD. Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxoliti...$73$YR$$M$Y$$$20240701$$MD$US$US
239825903$23982590$3$F$$20240703$20240617$20240708$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-009221$JAZZ$$74$YR$$F$Y$$$20240708$$HP$CA$CA
239825912$23982591$2$F$20240701$20240722$20240617$20240801$PER$$US-Calliditas-2024CAL00961$CALLIDITAS THERAPEUTICS$$52$YR$A$M$Y$$$20240801$$CN$US$US
239825923$23982592$3$F$20240701$20240829$20240617$20240909$EXP$$US-Calliditas-2024CAL00963$CALLIDITAS THERAPEUTICS$$45$YR$A$F$Y$$$20240909$$CN$US$US
239825934$23982593$4$F$20240606$20240906$20240617$20240912$EXP$$US-BEH-2024173785$CSL BEHRING$$10$YR$C$M$Y$37.9$KG$20240912$$PH$US$US
239825962$23982596$2$F$20240524$20240821$20240617$20240912$EXP$$US-SA-2024SA179589$SANOFI AVENTIS$$30$YR$A$F$Y$54.431$KG$20240912$$MD$US$US
239826053$23982605$3$F$20240524$20240911$20240617$20240920$EXP$IE-HPRA-2024-113327$IE-BAUSCH-BL-2024-009203$BAUSCH AND LOMB$$33$YR$$M$Y$77$KG$20240920$$CN$IE$IE
239826082$23982608$2$F$$20240726$20240617$20240801$PER$$US-PFIZER INC-202400193233$PFIZER$$66$YR$$F$Y$$$20240801$$HP$US$US
239826142$23982614$2$F$20240515$20240809$20240617$20240813$PER$$US-PFIZER INC-202400192487$PFIZER$$66$YR$$F$Y$$$20240813$$HP$US$US
239826152$23982615$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000853US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$US$US
239826185$23982618$5$F$20240701$20240913$20240617$20240917$PER$$US-PFIZER INC-202400193157$PFIZER$$39$YR$$F$Y$73.94$KG$20240917$$CN$US$US
239826262$23982626$2$F$$20240903$20240617$20240918$EXP$$CA-HLS-202401514$HLS THERAPEUTICS$$$$E$M$Y$79$KG$20240917$$HP$CA$CA
239826372$23982637$2$F$20240524$20240812$20240617$20240822$EXP$$US-NOVOPROD-1236317$NOVO NORDISK$$67$YR$$F$Y$$$20240822$$MD$US$US
239826662$23982666$2$F$20231001$20240719$20240617$20240726$EXP$$JP-GILEAD-2024-0677325$GILEAD$Kimura K, Naruse S, Sahashi S, Suzuki K, Iwai M, Ozawa Y.. B-IV-1 A case of CD5-positive diffuse large B-cell lymphoma refractory to CAR-T therapy in which epcoritamab was effective. The 13th Tokai Regional Meeting to the Japanese Society of Hematology. 2024;unk:34$51$YR$A$F$Y$$$20240726$$MD$JP$JP
239826702$23982670$2$F$20240613$20240926$20240617$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US057930$SANDOZ$$57$YR$$F$Y$$$20240930$$CN$US$US
239826772$23982677$2$F$$20240614$20240617$20240712$EXP$$DE-AstraZeneca-2024A139026$ASTRAZENECA$$$$$M$Y$$$20240712$$PH$DE$
239826782$23982678$2$F$20240205$20240705$20240617$20240711$EXP$$CA-AMERICAN REGENT INC-2024002207$AMERICAN REGENT$$63$YR$$F$Y$56$KG$20240711$$PH$CA$CA
239826832$23982683$2$F$20240613$20240701$20240617$20240703$PER$$US-AMGEN-USASP2024117876$AMGEN$$68$YR$E$M$Y$$$20240703$$MD$US$US
239826962$23982696$2$F$$20240713$20240617$20240715$PER$$US-JNJFOC-20240637166$JOHNSON AND JOHNSON$$78$YR$E$M$Y$77.6$KG$20240715$$CN$US$US
239827066$23982706$6$F$$20240807$20240617$20240812$EXP$$US-MYLANLABS-2024M1053841$MYLAN$$$$$F$Y$66.67$KG$20240812$$CN$US$US
239827112$23982711$2$F$$20240606$20240617$20240731$PER$$US-LUNDBECK-DKLU3078466$LUNDBECK$$$$$$Y$$$20240731$$HP$US$US
239827212$23982721$2$F$$20240608$20240617$20240801$EXP$$EG-NOVOPROD-1229193$NOVO NORDISK$$53$YR$$M$Y$$$20240801$$CN$EG$EG
239827333$23982733$3$F$20240129$20240528$20240617$20240815$EXP$$US-APELLIS-2024-APL-0000212$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$US$US
239827412$23982741$2$F$20170101$20240621$20240617$20240701$EXP$$CA-TEVA-VS-3202497$TEVA$Kryshtalskyj MT, Devenyi RG, Roy M. Bilateral Panuveitis Associated with Morvan Syndrome: A Case Report and Review of the Literature. Ocular-Immunol-Inflamm 2023; 31 (4): 851-855.; Kryshtalskyj MT, Devenyi RG, Roy M. Bilateral Panuveitis Associated with Morvan Syndrome: A Case Report and Review of the Literature. Ocular-Immunol-Inflamm 2023; 31 (4): 851-855.$57$YR$$M$Y$$$20240701$$MD$CA$CA
239827442$23982744$2$F$20240607$20240815$20240617$20240819$EXP$$US-KYOWAKIRIN-2024KK014469$KYOWA$$$$$$Y$$$20240819$$HP$US$US
239827472$23982747$2$F$$20240708$20240617$20240716$EXP$$US-PFIZER INC-202400194218$PFIZER$$83$YR$$M$Y$$$20240716$$CN$US$US
239827482$23982748$2$F$20240506$20240812$20240617$20240821$EXP$$NL-TEVA-VS-3208201$TEVA$$57$YR$$F$Y$$$20240821$$CN$NL$NL
239827602$23982760$2$F$20240608$20240701$20240617$20240705$EXP$$US-GILEAD-2024-0677216$GILEAD$$71$YR$E$F$Y$106.6$KG$20240705$$HP$US$US
239827643$23982764$3$F$$20240710$20240617$20240821$PER$$US-LUNDBECK-DKLU3078303$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
239827742$23982774$2$F$$20240721$20240617$20240725$PER$$US-AMGEN-USASP2024118039$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
239827772$23982777$2$F$20240607$20240624$20240617$20240701$EXP$$CA-LUNDBECK-DKLU4000464$LUNDBECK$$$$$$Y$$$20240701$$CN$CA$CA
239827803$23982780$3$F$20240515$20240715$20240617$20240719$EXP$FR-AFSSAPS-BX2024001159$FR-009507513-2406FRA003676$MERCK$$59$YR$$F$Y$53$KG$20240719$$PH$FR$FR
239827957$23982795$7$F$20240531$20240820$20240617$20240823$PER$$US-AMGEN-USASP2024119218$AMGEN$$72$YR$E$F$Y$$$20240823$$CN$US$US
239827962$23982796$2$F$$20240704$20240617$20240705$PER$$US-BAYER-2024A086476$BAYER$$$$$F$Y$$$20240705$$CN$US$US
239827992$23982799$2$F$20240618$20240722$20240617$20240725$EXP$$US-PFIZER INC-202400193069$PFIZER$$72$YR$$F$Y$62$KG$20240725$$HP$US$US
239828034$23982803$4$F$20240607$20240819$20240617$20240829$EXP$$US-GSK-US2024AMR071692$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240829$$CN$US$US
239828082$23982808$2$F$20240308$20240612$20240617$20240802$PER$$US-LUNDBECK-DKLU3078202$LUNDBECK$$$$$$Y$$$20240802$$CN$US$US
239828094$23982809$4$F$20240612$20240924$20240617$20240925$PER$$NVSC2024US125606$NOVARTIS$$22$YR$$F$Y$$$20240925$$CN$US$US
239828152$23982815$2$F$20240310$20240730$20240617$20240807$PER$$US-MYLANLABS-2024M1053739$MYLAN$$51$YR$$F$Y$52.16$KG$20240807$$CN$US$US
239828162$23982816$2$F$$20240711$20240617$20240715$PER$$US-ABBVIE-5798242$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
239828173$23982817$3$F$20231101$20240813$20240617$20240815$EXP$$US-BIOGEN-2023BI01237670$BIOGEN$$66$YR$$F$Y$$$20240815$$CN$US$US
239828193$23982819$3$F$20240501$20240801$20240617$20240812$PER$$US-JNJFOC-20240609559$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
239828325$23982832$5$F$$20240813$20240617$20240816$EXP$$NVSC2024IL124438$NOVARTIS$$88$YR$$F$Y$$$20240816$$MD$IL$IL
239828362$23982836$2$F$20240501$20240715$20240617$20240722$EXP$$US-JNJFOC-20240630690$JOHNSON AND JOHNSON$$48$YR$A$F$Y$152$KG$20240721$$PH$US$US
239828592$23982859$2$F$20240201$20240703$20240617$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-000698$JAZZ$$32$YR$$F$Y$$$20240708$$CN$US$US
239828692$23982869$2$F$20240526$20240628$20240617$20240711$PER$$US-Calliditas-2024CAL00980$CALLIDITAS THERAPEUTICS$$59$YR$A$M$Y$139.7$KG$20240711$$CN$US$US
239828713$23982871$3$F$$20240828$20240617$20240910$PER$$US-Calliditas-2024CAL00989$CALLIDITAS THERAPEUTICS$$63$YR$A$M$Y$$$20240910$$CN$US$US
239828792$23982879$2$F$$20240709$20240617$20240727$PER$$US-INSUD PHARMA-2406US04619$INSUD PHARMA$$$$$$Y$$$20240728$$CN$US$US
239828802$23982880$2$F$20240501$20240703$20240617$20240722$PER$$US-INSUD PHARMA-2406US04522$INSUD PHARMA$$$$$$Y$$$20240722$$PH$US$US
239828812$23982881$2$F$20240101$20240703$20240617$20240722$PER$$US-INSUD PHARMA-2406US04779$INSUD PHARMA$$$$$$Y$$$20240722$$PH$US$US
239828842$23982884$2$F$20240607$20240702$20240617$20240708$30DAY$$US-AMGEN-USASP2024116457$AMGEN$$62$YR$A$F$Y$111.57$KG$20240708$$PH$US$US
239828862$23982886$2$F$20210801$20240717$20240617$20240719$EXP$$NVSC2024GB122529$NOVARTIS$$72$YR$$F$Y$$$20240719$$HP$GB$GB
239828933$23982893$3$F$$20240809$20240617$20240814$30DAY$$AU-MYLANLABS-2024M1053199$MYLAN$$$$$F$Y$$$20240814$$PH$AU$AU
239828942$23982894$2$F$$20240718$20240617$20240724$30DAY$$US-MYLANLABS-2024M1053418$MYLAN$$$$$M$Y$$$20240724$$CN$US$US
239828973$23982897$3$F$20110523$20240913$20240617$20240917$PER$$US-BIOGEN-2024BI01260615$BIOGEN$$35$YR$$F$Y$$$20240917$$CN$US$US
239829003$23982900$3$F$20231201$20240627$20240617$20240704$PER$$US-BIOGEN-2023BI01226026$BIOGEN$$41$YR$$M$Y$129.1$KG$20240704$$CN$US$US
239829152$23982915$2$F$20240606$20240917$20240617$20240918$PER$$US-AMGEN-USASP2024118649$AMGEN$$38$YR$A$M$Y$$$20240918$$HP$US$US
239829183$23982918$3$F$20230101$20240912$20240617$20240918$EXP$$CA-BAUSCH-BL-2023-013485$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240918$$CN$CA$CA
239829192$23982919$2$F$20240101$20240712$20240617$20240717$EXP$$CA-BAUSCH-BL-2024-009161$BAUSCH AND LOMB$$52$YR$$F$Y$76.272$KG$20240717$$CN$CA$CA
239829203$23982920$3$F$$20240822$20240617$20240829$EXP$$US-ABBVIE-5804243$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
239829222$23982922$2$F$$20240706$20240617$20240711$EXP$$US-SA-2024SA179427$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240711$$MD$US$US
239829232$23982923$2$F$$20240628$20240617$20240716$EXP$$US-GSK-US2024071650$GLAXOSMITHKLINE$$$$$F$Y$$$20240716$$HP$US$US
239829282$23982928$2$F$20240621$20240627$20240617$20240705$EXP$$US-Calliditas-2024CAL00984$CALLIDITAS THERAPEUTICS$$26$YR$A$M$Y$81$KG$20240705$$CN$US$US
239829502$23982950$2$F$20240604$20240709$20240617$20240712$PER$$US-MYLANLABS-2024M1051954$MYLAN$$22$YR$$F$Y$74.84$KG$20240712$$CN$US$US
239829522$23982952$2$F$$20240829$20240617$20240830$PER$$NVSC2024US126229$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
239829562$23982956$2$F$$20240709$20240617$20240722$PER$$US-Calliditas-2024CAL00983$CALLIDITAS THERAPEUTICS$$51$YR$A$M$Y$76.2$KG$20240722$$CN$US$US
239829582$23982958$2$F$20240612$20240806$20240617$20240808$PER$$US-AMGEN-USASP2024118015$AMGEN$$66$YR$E$M$Y$$$20240808$$CN$US$US
239829606$23982960$6$F$$20240903$20240617$20240910$PER$$US-PURDUE PHARMA-USA-2024-0310204$PURDUE$$$$$F$Y$$$20240910$$CN$US$US
239829622$23982962$2$F$20230101$20240723$20240617$20240801$EXP$$US-RADIUS HEALTH, INC.-2024US004113$RADIUS PHARM$$$$$F$Y$$$20240801$$HP$US$US
239829712$23982971$2$F$$20240724$20240617$20240724$PER$$US-ALXN-202406USA000656US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240724$$MD$US$US
239829733$23982973$3$F$$20240729$20240617$20240802$PER$$US-PFIZER INC-2024SGN02317$PFIZER$$50$YR$$$Y$$$20240802$$CN$US$US
239829864$23982986$4$F$$20240906$20240617$20240917$PER$$US-INCYTE CORPORATION-2024IN006160$INCYTE$$$$$$Y$$$20240917$$CN$US$US
239829902$23982990$2$F$20240705$20240706$20240617$20240710$EXP$$US-APELLIS-2024-APL-0000125$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
239829912$23982991$2$F$$20240724$20240617$20240724$PER$$US-ALXN-202406USA000660US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240724$$MD$US$US
239829952$23982995$2$F$$20240626$20240617$20240709$PER$$US-Calliditas-2024CAL01009$CALLIDITAS THERAPEUTICS$$26$YR$A$M$Y$95$KG$20240709$$CN$US$US
239830012$23983001$2$F$$20240923$20240617$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US057708$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
239830074$23983007$4$F$20240101$20240709$20240617$20240711$30DAY$$EG-SANDOZ INC.-SDZ2024EG057536$SANDOZ$$14$YR$$M$Y$50$KG$20240711$$HP$EG$EG
239830092$23983009$2$F$20240601$20240729$20240617$20240730$EXP$GB-MHRA-MED-202406151759074680-GZKVT$GB-SANDOZ INC.-SDZ2024GB058144$SANDOZ$$61$YR$$M$Y$110$KG$20240730$$CN$GB$GB
239830182$23983018$2$F$$20240726$20240617$20240730$EXP$$US-SANDOZ INC.-SDZ2024US058379$SANDOZ$$$$$M$Y$$$20240730$$CN$US$US
239830282$23983028$2$F$20240611$20240809$20240617$20240813$PER$$US-AMGEN-USASP2024116960$AMGEN$$61$YR$A$M$Y$$$20240813$$CN$US$US
239830342$23983034$2$F$20240301$20240625$20240617$20240708$PER$$US-Calliditas-2024CAL01008$CALLIDITAS THERAPEUTICS$$32$YR$A$F$Y$$$20240708$$CN$US$US
239830352$23983035$2$F$$20240724$20240617$20240724$PER$$US-ALXN-202406USA000683US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
239830364$23983036$4$F$20240601$20240724$20240617$20240729$PER$$US-SA-2024SA178063$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240729$$MD$US$US
239830392$23983039$2$F$20240529$20240625$20240617$20240710$PER$$US-Calliditas-2024CAL01001$CALLIDITAS THERAPEUTICS$$32$YR$A$F$Y$76.6$KG$20240710$$CN$US$US
239830412$23983041$2$F$$20240802$20240617$20240809$EXP$$US-Calliditas-2024CAL01003$CALLIDITAS THERAPEUTICS$$24$YR$A$M$Y$$$20240809$$CN$US$US
239830432$23983043$2$F$20240522$20240626$20240617$20240705$EXP$$US-Calliditas-2024CAL00992$CALLIDITAS THERAPEUTICS$$26$YR$A$M$Y$$$20240705$$CN$US$US
239830482$23983048$2$F$$20240627$20240617$20240709$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI05662$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240710$$CN$US$US
239830492$23983049$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000752US$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240730$$MD$US$US
239830522$23983052$2$F$$20240723$20240617$20240724$PER$$US-AstraZeneca-2024A133854$ASTRAZENECA$$$$$F$Y$$$20240724$$HP$US$
239830694$23983069$4$F$20240101$20240816$20240617$20240823$EXP$$CA-BAUSCH-BL-2024-009148$BAUSCH AND LOMB$$85$YR$$M$Y$$$20240823$$PH$CA$CA
239830772$23983077$2$F$$20240702$20240617$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-092651$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240710$$CN$US$US
239830902$23983090$2$F$$20240911$20240617$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094963$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240911$$CN$US$US
239830932$23983093$2$F$20240410$20240725$20240617$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-096351$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240730$$MD$JP$JP
239831172$23983117$2$F$$20240916$20240617$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-097037$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$MD$JP$JP
239831202$23983120$2$F$$20240710$20240617$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096918$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$78.02$KG$20240711$$CN$US$US
239831272$23983127$2$F$20240614$20240702$20240617$20240705$EXP$$RS-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034160$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240705$$MD$RS$RS
239831312$23983131$2$F$20210101$20240701$20240617$20240705$EXP$$HR-FreseniusKabi-FK202409256$FRESENIUS KABI$$61$YR$A$M$Y$$$20240705$$MD$HR$HR
239831322$23983132$2$F$20230101$20240810$20240617$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097080$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240813$$PH$US$US
239831332$23983133$2$F$20240701$20240709$20240617$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097339$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240716$$CN$US$US
239831572$23983157$2$F$20231201$20240625$20240617$20240705$EXP$$MX-BIOVITRUM-2024-MX-000048$BIOVITRUM$$74$DY$$M$Y$7.8$KG$20240705$$CN$MX$MX
239831582$23983158$2$F$20230101$20240916$20240617$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097204$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240916$$CN$US$US
239831722$23983172$2$F$20240527$20240916$20240617$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096956$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$79.83$KG$20240916$$HP$US$US
239832062$23983206$2$F$$20240701$20240617$20240701$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-097322$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240701$$PH$DE$DE
239832312$23983231$2$F$$20240724$20240617$20240731$PER$$US-RDY-SPO/USA/24/0008465$DR REDDYS$$29$YR$A$$Y$59.87$KG$20240731$$HP$US$US
239832353$23983235$3$F$$20240710$20240617$20240726$PER$$US-Taiho Oncology Inc-2024-005602$TAIHO ONCOLOGY INC$$$$$M$Y$$$20240726$$MD$US$US
239832363$23983236$3$F$20240101$20240726$20240617$20240729$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-020356$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240729$$CN$US$US
239832412$23983241$2$F$$20240813$20240617$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097475$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240813$$CN$US$US
239832442$23983244$2$F$20240601$20240624$20240617$20240703$EXP$$US-Eisai-EC-2024-167787$EISAI$$79$YR$E$F$Y$$$20240703$$MD$US$US
239832452$23983245$2$F$$20240916$20240617$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097241$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240916$$HP$US$US
239832463$23983246$3$F$20240717$20240802$20240617$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097144$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240805$$CN$US$US
239832502$23983250$2$F$$20240916$20240617$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096371$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240916$$CN$US$US
239832522$23983252$2$F$$20240829$20240617$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094887$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$77.56$KG$20240905$$CN$US$US
239832563$23983256$3$F$$20240712$20240617$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096581$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240716$$CN$US$US
239832592$23983259$2$F$20240607$20240729$20240617$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093720$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240801$$HP$US$US
239832622$23983262$2$F$$20240625$20240617$20240702$EXP$$GR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033396$BOEHRINGER INGELHEIM$Nikitidou E, Tserektsidou M, Tsiftsi P, Kouravanas I, Gasil S, Mademidis D. A strange syncopal episode.. 36th Panhellenic congress on general/family medicine. 2024 May 09;$75$YR$E$M$Y$$$20240702$$MD$GR$GR
239832672$23983267$2$F$$20240723$20240617$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097050$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240724$$CN$US$US
239832752$23983275$2$F$$20240916$20240617$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095526$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$92.99$KG$20240916$$HP$US$US
239832773$23983277$3$F$$20240916$20240617$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097273$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240916$$MD$US$US
239832782$23983278$2$F$$20240630$20240617$20240705$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034167$BOEHRINGER INGELHEIM$$$$$F$Y$70$KG$20240705$$MD$IT$IT
239832832$23983283$2$F$20240501$20240812$20240617$20240813$EXP$$GB-ORGANON-O2406GBR001405$ORGANON$$24$YR$$F$Y$$$20240813$$MD$GB$GB
239832874$23983287$4$F$$20240624$20240617$20240701$EXP$$NVSC2024NL125757$NOVARTIS$Van Weringh G, Van Koolwijk L, Haan LD, Touw DJ, De Koning MB. Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/norclozapine ratio after switching valproic acid to carbamazepine: a case report.. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY. 2024;14:1-8$42$YR$$M$Y$65.9$KG$20240701$$HP$NL$NL
239832882$23983288$2$F$$20240926$20240617$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095143$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240930$$CN$US$US
239832902$23983290$2$F$$20240730$20240617$20240730$PER$$US-ALXN-202406USA000761US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$MD$US$US
239833003$23983300$3$F$20240401$20240812$20240617$20240827$EXP$$GB-APELLIS-APL-2024-004193$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240827$$HP$GB$GB
239833013$23983301$3$F$20230126$20240729$20240617$20240808$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI05943$NEUROCRINE BIOSCIENCES$$37$YR$$F$Y$$$20240808$$MD$JP$JP
239833033$23983303$3$F$20240220$20240712$20240617$20240717$EXP$$US-AstraZeneca-2024A139558$ASTRAZENECA$$59$YR$$F$Y$97.5$KG$20240717$$HP$US$
239833153$23983315$3$F$20240520$20240709$20240617$20240723$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-17956$SAMSUNG BIOEPIS$$46$YR$$F$Y$$$20240723$$CN$CA$CA
239833172$23983317$2$F$$20240724$20240617$20240731$PER$$US-ALXN-202406USA000576US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239833242$23983324$2$F$$20240724$20240617$20240731$PER$$US-ALXN-202406USA000551US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
239833332$23983333$2$F$$20240724$20240617$20240731$PER$$US-ALXN-202406USA000552US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239833342$23983334$2$F$$20240731$20240617$20240805$PER$$NVSC2024US126313$NOVARTIS$$$$$$Y$$$20240805$$PH$US$US
239833472$23983347$2$F$20240601$20240702$20240617$20240708$EXP$$JP-SA-2024SA175595$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240709$$MD$JP$JP
239833502$23983350$2$F$$20240910$20240617$20240919$PER$$US-SA-2024SA178521$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240919$$MD$US$US
239833633$23983363$3$F$20240612$20240614$20240617$20240701$PER$$US-ABBVIE-5801569$ABBVIE$$68$YR$$F$Y$52$KG$20240701$$CN$US$US
239833682$23983368$2$F$$20240731$20240617$20240805$PER$$US-ALXN-202406USA000537US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
239833702$23983370$2$F$20240212$20240723$20240617$20240731$EXP$$PK-AMGEN-PAKSP2023210889$AMGEN$$60$YR$A$F$Y$69$KG$20240730$$CN$PK$PK
239833725$23983372$5$F$$20240917$20240617$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-096265$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240925$$MD$JP$JP
239833733$23983373$3$F$20200702$20240808$20240617$20240813$EXP$$JP-JNJFOC-20240625669$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240813$$MD$JP$JP
239833852$23983385$2$F$20240530$20240702$20240617$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202406000401$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240704$$MD$US$US
239833922$23983392$2$F$$20240701$20240617$20240711$EXP$$US-MALLINCKRODT-MNK202403858$MALLINCKRODT$$$$$F$Y$$$20240711$$CN$US$US
239833972$23983397$2$F$20240427$20240731$20240617$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097528$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240802$$HP$US$US
239834072$23983407$2$F$$20240820$20240617$20240916$PER$$US-SA-2024SA176792$SANOFI AVENTIS$$$$A$F$Y$74.55$KG$20240916$$MD$US$US
239834083$23983408$3$F$20240101$20240627$20240617$20240709$30DAY$$US-JNJFOC-20240522948$JOHNSON AND JOHNSON$$12$YR$T$F$Y$$$20240709$$HP$US$US
239834123$23983412$3$F$20240521$20240905$20240617$20240909$EXP$$US-ABBVIE-5802328$ABBVIE$$78$YR$$F$Y$90$KG$20240909$$CN$US$US
239834232$23983423$2$F$$20240822$20240617$20240822$PER$$NVSC2024US126366$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
239834273$23983427$3$F$$20240926$20240617$20240927$PER$$NVSC2024US126361$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
239834352$23983435$2$F$20230822$20240821$20240617$20240828$EXP$$DE-BIOGEN-2023BI01222955$BIOGEN$$35$YR$$F$Y$121.5$KG$20240828$$CN$DE$DE
239834373$23983437$3$F$$20240802$20240617$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097083$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240806$$CN$US$US
239834454$23983445$4$F$20240101$20240716$20240617$20240723$30DAY$$GB-JNJFOC-20240626236$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240722$$CN$GB$GB
239834463$23983446$3$F$20240415$20240705$20240617$20240717$EXP$$BE-EMD Serono-2024032227$EMD SERONO INC$$51$YR$A$F$Y$$$20240717$$CN$BE$BE
239834472$23983447$2$F$$20240624$20240617$20240703$PER$$US-SA-2024SA178037$SANOFI AVENTIS$$$$A$M$Y$82.086$KG$20240703$$MD$US$US
239834563$23983456$3$F$20240610$20240702$20240617$20240708$30DAY$$US-AMGEN-USASP2024116917$AMGEN$$48$YR$A$F$Y$134.7$KG$20240708$$HP$US$US
239834622$23983462$2$F$20240614$20240916$20240617$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097042$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240916$$CN$US$US
239834672$23983467$2$F$20240301$20240806$20240617$20240811$EXP$$CA-ABBVIE-5799130$ABBVIE$$71$YR$$M$Y$$$20240811$$CN$CA$CA
239834693$23983469$3$F$20240603$20240808$20240617$20240809$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034099$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240809$$CN$US$US
239834722$23983472$2$F$$20240702$20240617$20240703$PER$$NVSC2024US126407$NOVARTIS$$$$$M$Y$$$20240703$$CN$US$US
239834943$23983494$3$F$20240612$20240724$20240617$20240725$PER$$US-JNJFOC-20240637144$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240725$$CN$US$US
239835023$23983502$3$F$$20240916$20240617$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-096496$BRISTOL MYERS SQUIBB$$8$DEC$E$$Y$$$20240916$$MD$JP$JP
239835042$23983504$2$F$$20240821$20240617$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097136$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240826$$CN$US$US
239835083$23983508$3$F$$20240708$20240617$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097134$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240715$$CN$US$US
239835102$23983510$2$F$20240501$20240828$20240617$20240830$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033812$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240830$$CN$US$US
239835162$23983516$2$F$20240603$20240719$20240617$20240724$EXP$$US-Taiho Oncology Inc-2024-005869$TAIHO ONCOLOGY INC$$62$YR$A$M$Y$$$20240724$$CN$US$US
239835283$23983528$3$F$20240702$20240708$20240617$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-094686$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240723$$PH$JP$JP
239835362$23983536$2$F$20240601$20240923$20240617$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097452$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240926$$CN$US$US
239835393$23983539$3$F$$20240902$20240617$20240912$EXP$$PT-AUROBINDO-AUR-APL-2024-030146$AUROBINDO$Campos ID, Moreira H, Portal F, Paiva JA. Unusual presentation of benzodiazepine withdrawal with Takotsubo syndrome: a case report. European Heart Journal - Case Reports.. 2024;8(4):ytae136$58$YR$$F$Y$$$20240912$$MD$PT$PT
239835422$23983542$2$F$20240521$20240904$20240617$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095996$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240905$$CN$US$US
239835432$23983543$2$F$$20240624$20240617$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-095955$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$MD$JP$JP
239835612$23983561$2$F$20240609$20240726$20240618$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097120$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$63.2$KG$20240730$$PH$US$US
239835653$23983565$3$F$20240601$20240909$20240618$20240916$EXP$$SE-JNJFOC-20240642366$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240917$$MD$SE$SE
239835664$23983566$4$F$20240201$20240703$20240618$20240716$EXP$$BE-BEH-2024168899$CSL BEHRING$$$$A$M$Y$$$20240716$$HP$BE$BE
239835793$23983579$3$F$20240604$20240716$20240618$20240723$PER$$US-JNJFOC-20240607443$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240723$$CN$US$US
239835882$23983588$2$F$20240101$20240722$20240618$20240725$EXP$$US-ABBVIE-5799770$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
239835933$23983593$3$F$$20240702$20240618$20240704$PER$$NVSC2024US126358$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
239835942$23983594$2$F$20240514$20240629$20240618$20240704$EXP$$AT-AMGEN-AUTSP2024116431$AMGEN$$61$YR$A$M$Y$66$KG$20240704$$MD$AT$AT
239835952$23983595$2$F$20240101$20240820$20240618$20240904$PER$$US-SA-2024SA175663$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240905$$MD$US$US
239836072$23983607$2$F$20240614$20240701$20240618$20240724$PER$$US-AstraZeneca-2024A139380$ASTRAZENECA$$30374$DY$$F$Y$$$20240724$$CN$US$
239836082$23983608$2$F$$20240612$20240618$20240716$EXP$$US-AstraZeneca-2024A137173$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
239836142$23983614$2$F$$20240726$20240618$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096601$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240730$$CN$US$US
239836175$23983617$5$F$20240101$20240830$20240618$20240918$PER$$US-SA-2024SA177640$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240918$$MD$US$US
239836305$23983630$5$F$20240101$20240802$20240618$20240810$EXP$$ES-ABBVIE-5802338$ABBVIE$$$$$F$Y$58$KG$20240810$$CN$ES$ES
239836442$23983644$2$F$20240611$20240821$20240618$20240826$PER$$US-AMGEN-USASP2024118252$AMGEN$$76$YR$E$F$Y$$$20240826$$CN$US$US
239836513$23983651$3$F$20240610$20240618$20240618$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202406011456$ELI LILLY AND CO$$$$$M$Y$$$20240704$$CN$US$US
239836652$23983665$2$F$20240405$20240619$20240618$20240704$EXP$FR-AFSSAPS-AM2024000366$FR-TEVA-VS-3209367$TEVA$$31$YR$$F$Y$120$KG$20240704$$MD$FR$FR
239836733$23983673$3$F$20240612$20240701$20240618$20240704$EXP$$TR-ABBVIE-5802234$ABBVIE$$61$YR$$F$Y$55$KG$20240704$$CN$TR$TR
239836783$23983678$3$F$20240101$20240824$20240618$20240829$EXP$JP-MMM-6XKBO7QL$JP-ABBVIE-5804199$ABBVIE$$$$E$M$Y$$$20240829$$HP$JP$JP
239836872$23983687$2$F$$20240822$20240618$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-139211$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240826$$MD$US$US
239836955$23983695$5$F$20240101$20240905$20240618$20240916$EXP$$NL-ABBVIE-5803464$ABBVIE$$67$YR$$M$Y$$$20240916$$CN$NL$NL
239836972$23983697$2$F$20240509$20240614$20240618$20240801$PER$$US-AMGEN-USASP2024118460$AMGEN$$46$YR$A$F$Y$$$20240801$$PH$US$US
239837042$23983704$2$F$20240604$20240624$20240618$20240702$30DAY$$US-AMGEN-USASP2024115964$AMGEN$$65$YR$E$F$Y$86.6$KG$20240702$$PH$US$US
239837133$23983713$3$F$20240401$20240726$20240618$20240731$EXP$$US-ABBVIE-5802777$ABBVIE$$40$YR$$M$Y$65.77$KG$20240731$$CN$US$US
239837142$23983714$2$F$20240528$20240625$20240618$20240716$PER$$FR-TOLMAR, INC.-24FR049755$TOLMAR$$68$YR$$M$Y$$$20240716$$PH$FR$FR
239837152$23983715$2$F$20240514$20240613$20240618$20240708$PER$$FR-TOLMAR, INC.-24FR049492$TOLMAR$$92$YR$$M$Y$$$20240708$$PH$FR$FR
239837162$23983716$2$F$20240501$20240621$20240618$20240711$PER$$FR-TOLMAR, INC.-24FR049682$TOLMAR$$80$YR$$M$Y$$$20240710$$PH$FR$FR
239837182$23983718$2$F$20240527$20240702$20240618$20240809$PER$$TR-TOLMAR, INC.-24TR049785$TOLMAR$$76$YR$$M$Y$$$20240809$$MD$TR$TR
239837202$23983720$2$F$20240528$20240702$20240618$20240809$PER$$TR-TOLMAR, INC.-24TR049794$TOLMAR$$79$YR$$M$Y$$$20240809$$HP$TR$TR
239837292$23983729$2$F$20240101$20240703$20240618$20240709$EXP$$US-ABBVIE-5760200$ABBVIE$$$$$M$Y$$$20240709$$CN$US$US
239837402$23983740$2$F$20240601$20240711$20240618$20240715$PER$$US-JNJFOC-20240604720$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240715$$CN$US$US
239837484$23983748$4$F$20240525$20240903$20240618$20240918$EXP$$JP-AMGEN-JPNSP2024118604$AMGEN$$63$YR$A$M$Y$49.5$KG$20240917$$PH$JP$JP
239837492$23983749$2$F$20240611$20240625$20240618$20240701$30DAY$$US-AMGEN-USASP2024116503$AMGEN$$69$YR$E$F$Y$128.6$KG$20240701$$PH$US$US
239837512$23983751$2$F$$20240730$20240618$20240731$EXP$$US-ALXN-202406USA000755US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
239837692$23983769$2$F$20240405$20240617$20240618$20240701$EXP$$GB-AMGEN-GBRNI2024118591$AMGEN$$76$YR$E$M$Y$59.4$KG$20240701$$HP$GB$GB
239837792$23983779$2$F$20240603$20240701$20240618$20240705$PER$$US-JNJFOC-20240626802$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240705$$HP$US$US
239837842$23983784$2$F$$20240606$20240618$20240830$EXP$$US-NOVOPROD-1238638$NOVO NORDISK$$$$$F$Y$$$20240830$$CN$US$US
239837852$23983785$2$F$$20240731$20240618$20240809$EXP$$US-NOVOPROD-1236860$NOVO NORDISK$$59$YR$$M$Y$$$20240809$$CN$US$US
239837922$23983792$2$F$20231205$20240607$20240618$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-000187$AUROBINDO$$34$YR$$F$Y$$$20240831$$MD$FR$FR
239838203$23983820$3$F$$20240730$20240618$20240805$EXP$$US-BIOGEN-2024BI01269454$BIOGEN$$$$$M$Y$$$20240805$$HP$US$US
239838272$23983827$2$F$20240501$20240627$20240618$20240708$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108538$ZYDUS PHARM$$$$$$Y$$$20240708$$CN$US$US
239838313$23983831$3$F$$20240729$20240618$20240731$PER$$NVSC2024US125600$NOVARTIS$$26$YR$$F$Y$147$KG$20240731$$CN$US$US
239838393$23983839$3$F$20240523$20240711$20240618$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202405015304$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240718$$CN$US$US
239838453$23983845$3$F$$20240924$20240618$20240930$EXP$$PL-BELUPO-SafetyCase004048$Haleon PLC$Woron AJ, Siwek M, Ba K, Bol Low back pain as a consequence of interactions of tadalafil with sertraline administered to a patient suffering from depression. Psychopharmacology in practice 2022; 85(2): 54-6.; Woron AJ, Siwek M, Ba K, Bol Low back pain as a consequence of interactions of tadalafil with sertraline administered to a patient suffering from depression. Psychopharmacology in practice 2022; 85(2): 54-6.; PRACTICAL MEDICINE-PSYCHIATRY. Woron J, Siwek M. Lower back pain as a consequen...$31$YR$$M$Y$$$20240930$$HP$PL$PL
239838482$23983848$2$F$$20240828$20240618$20240828$PER$$NVSC2024US126510$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
239838542$23983854$2$F$$20240821$20240618$20240828$EXP$$LU-BIOGEN-2024BI01269317$BIOGEN$$60$YR$$$Y$$$20240828$$MD$LU$LU
239838552$23983855$2$F$20240501$20240701$20240618$20240704$EXP$$US-BIOGEN-2024BI01268943$BIOGEN$$69$YR$$F$Y$$$20240704$$CN$US$US
239838563$23983856$3$F$20240101$20240715$20240618$20240722$EXP$$US-BIOGEN-2024BI01269217$BIOGEN$$55$YR$$F$Y$$$20240722$$CN$US$US
239838612$23983861$2$F$$20240819$20240618$20240902$EXP$$CA-HALEON-2176335$Haleon PLC$$40$YR$$F$Y$73$KG$20240830$$MD$CA$CA
239838632$23983863$2$F$20240605$20240712$20240618$20240716$PER$$US-JNJFOC-20240612657$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240716$$CN$US$US
239838772$23983877$2$F$20231023$20240826$20240618$20240831$EXP$$JP-AMGEN-JPNSP2023191018$AMGEN$$$$E$F$Y$$$20240831$$PH$JP$JP
239838962$23983896$2$F$$20240725$20240618$20240731$EXP$$US-BIOGEN-2024BI01269653$BIOGEN$$$$$M$Y$$$20240731$$CN$US$US
239838972$23983897$2$F$$20240617$20240618$20240808$EXP$$CA-HALEON-2176166$Haleon PLC$$$$$F$Y$97$KG$20240807$$MD$CA$CA
239839052$23983905$2$F$20240429$20240919$20240618$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-013327$UNITED THERAPEUTICS$$62$YR$$F$Y$73.923$KG$20240926$$$US$US
239839082$23983908$2$F$20240607$20240628$20240618$20240703$30DAY$$US-AMGEN-USASP2024113775$AMGEN$$53$YR$A$F$Y$58.8$KG$20240703$$PH$US$US
239839133$23983913$3$F$20240509$20240712$20240618$20240718$30DAY$$US-AMGEN-USASP2024117093$AMGEN$$66$YR$E$M$Y$56.4$KG$20240718$$PH$US$US
239839143$23983914$3$F$20240301$20240715$20240618$20240718$PER$$US-AMGEN-USASP2024118097$AMGEN$$88$YR$E$M$Y$$$20240718$$CN$US$US
239839233$23983923$3$F$20240703$20240708$20240618$20240715$EXP$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000304$Day One Biopharmaceuticals$$$$$$Y$$$20240715$$HP$US$US
239839253$23983925$3$F$20240101$20240717$20240618$20240723$PER$$US-AMGEN-USASP2024117949$AMGEN$$71$YR$E$F$Y$$$20240723$$CN$US$US
239839262$23983926$2$F$$20240627$20240618$20240709$30DAY$$GB-JNJFOC-20240632448$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$GB$GB
239839322$23983932$2$F$20240605$20240901$20240618$20240909$EXP$$US-BEH-2024173736$CSL BEHRING$$69$YR$E$M$Y$$$20240909$$HP$US$US
239839352$23983935$2$F$$20240712$20240618$20240719$PER$$US-AMGEN-USASP2024118440$AMGEN$$62$YR$$F$Y$$$20240718$$CN$US$US
239839382$23983938$2$F$$20240513$20240618$20240710$EXP$$CA-HALEON-2175698$Haleon PLC$$$$$F$Y$$$20240709$$HP$CA$CA
239839472$23983947$2$F$20240801$20240903$20240618$20240912$PER$$US-SA-2024SA172693$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240912$$MD$US$US
239839482$23983948$2$F$20240801$20240827$20240618$20240905$PER$$US-SA-2024SA172692$SANOFI AVENTIS$$$$C$F$Y$$$20240905$$MD$US$US
239839493$23983949$3$F$20240101$20240709$20240618$20240718$PER$$US-SA-2024SA176216$SANOFI AVENTIS$$35$YR$A$M$Y$86.182$KG$20240718$$MD$US$US
239839633$23983963$3$F$20240101$20240726$20240618$20240729$EXP$$US-UCBSA-2024025890$UCB$$$$$M$Y$68.209$KG$20240729$$HP$US$US
239839742$23983974$2$F$20240101$20240627$20240618$20240705$EXP$$US-BEH-2024173738$CSL BEHRING$$6$YR$C$M$Y$$$20240705$$MD$US$US
239839822$23983982$2$F$20240111$20240804$20240618$20240812$EXP$$CA-CELLTRION INC.-2024CA014193$CELLTRION$$$$$$Y$$$20240812$$HP$CA$CA
239839952$23983995$2$F$$20240702$20240618$20240708$PER$$US-AstraZeneca-2024A126890$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$US$
239839972$23983997$2$F$20240101$20240812$20240618$20240819$EXP$$US-ABBVIE-5751360$ABBVIE$$$$$F$Y$111$KG$20240819$$CN$US$US
239840022$23984002$2$F$20240319$20240703$20240618$20240709$EXP$$DE-PFIZER INC-202400103356$PFIZER$$53$YR$$M$Y$$$20240709$$MD$DE$DE
239840042$23984004$2$F$20240101$20240719$20240618$20240724$PER$$US-JNJFOC-20240565765$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240724$$CN$US$US
239840055$23984005$5$F$20240123$20240724$20240618$20240805$EXP$$DE-AUROBINDO-AUR-APL-2024-029172$AUROBINDO$$$$A$F$Y$$$20240805$$MD$DE$DE
239840133$23984013$3$F$$20240903$20240618$20240908$PER$$US-ALXN-202406USA000536US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240908$$CN$US$US
239840153$23984015$3$F$$20240723$20240618$20240729$EXP$$US-BIOGEN-2024BI01269438$BIOGEN$$$$$F$Y$$$20240729$$HP$US$US
239840183$23984018$3$F$$20240821$20240618$20240827$EXP$$US-BIOGEN-2024BI01269441$BIOGEN$$$$$M$Y$$$20240827$$MD$US$US
239840194$23984019$4$F$20240318$20240708$20240618$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-028851$AUROBINDO$$24$YR$$M$Y$78$KG$20240718$$CN$GB$GB
239840303$23984030$3$F$20240501$20240906$20240618$20240916$EXP$$JP-009507513-2406JPN000903J$MERCK$$8$DEC$$M$Y$$$20240916$$MD$JP$JP
239840382$23984038$2$F$$20240625$20240618$20240705$PER$$US-TEVA-VS-3208084$TEVA$$70$YR$$F$Y$$$20240705$$PH$US$US
239840452$23984045$2$F$20240101$20240716$20240618$20240725$EXP$$US-ARDELYX-2024ARDX004105$ARDELYX$$62$YR$$M$Y$$$20240725$$HP$US$US
239840473$23984047$3$F$20240516$20240618$20240618$20240701$EXP$$DE-ALK-ABELLO A/S-2024AA002419$ALK-ABELLO$$$$$$Y$$$20240701$$MD$DE$DE
239840482$23984048$2$F$20240522$20240626$20240618$20240701$30DAY$$US-AMGEN-USASP2024115396$AMGEN$$61$YR$A$$Y$78.912$KG$20240701$$HP$US$US
239840492$23984049$2$F$20240607$20240703$20240618$20240708$30DAY$$US-AMGEN-USASP2024114483$AMGEN$$$$$F$Y$$$20240708$$HP$US$US
239840522$23984052$2$F$20240508$20240701$20240618$20240702$PER$$US-AMGEN-USASP2024118305$AMGEN$$72$YR$E$F$Y$$$20240702$$CN$US$US
239840534$23984053$4$F$20230101$20240905$20240618$20240914$EXP$$CA-CELLTRION INC.-2023CA021820$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
239840593$23984059$3$F$$20240627$20240618$20240708$EXP$$JP-GSK-JP2024074542$GLAXOSMITHKLINE$$$$E$F$Y$$$20240708$$MD$JP$JP
239840692$23984069$2$F$20230101$20240709$20240618$20240718$EXP$$CA-CELLTRION INC.-2023CA022644$CELLTRION$$$$$$Y$$$20240718$$MD$CA$CA
239840702$23984070$2$F$20240614$20240909$20240618$20240910$PER$$US-AMGEN-USASP2024119227$AMGEN$$19$YR$A$F$Y$$$20240910$$CN$US$US
239840802$23984080$2$F$20230301$20240918$20240618$20240927$EXP$$CA-CELLTRION INC.-2022CA010098$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
239840842$23984084$2$F$$20240726$20240618$20240726$PER$$NVSC2024US125978$NOVARTIS$$$$$M$Y$$$20240726$$CN$US$US
239840882$23984088$2$F$20240611$20240708$20240618$20240715$30DAY$$BR-AMGEN-BRASP2024116928$AMGEN$$$$$$Y$$$20240715$$HP$BR$BR
239840892$23984089$2$F$20240612$20240801$20240618$20240805$PER$$US-AMGEN-USASP2024118302$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
239840974$23984097$4$F$20240612$20240909$20240618$20240917$EXP$$CA-JNJFOC-20240639032$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240917$$HP$CA$CA
239841032$23984103$2$F$20240531$20240705$20240618$20240710$PER$$US-AMGEN-USASP2024112684$AMGEN$$75$YR$E$F$Y$57$KG$20240710$$HP$US$US
239841052$23984105$2$F$$20240712$20240618$20240716$EXP$$US-UCBSA-2024030584$UCB$$$$$M$Y$$$20240716$$CN$US$US
239841062$23984106$2$F$20240101$20240729$20240618$20240731$EXP$$US-UCBSA-2024024294$UCB$$$$$F$Y$$$20240731$$CN$US$US
239841072$23984107$2$F$20240101$20240803$20240618$20240812$EXP$$CA-CELLTRION INC.-2024CA014302$CELLTRION$$$$$$Y$$$20240812$$MD$CA$CA
239841092$23984109$2$F$20240430$20240628$20240618$20240702$EXP$$SE-ORGANON-O2406SWE001371$ORGANON$$35$YR$$F$Y$$$20240702$$HP$SE$SE
239841102$23984110$2$F$$20240705$20240618$20240722$30DAY$$PT-JNJFOC-20240628332$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$PT$PT
239841112$23984111$2$F$$20240715$20240618$20240718$30DAY$$JP-JNJFOC-20240632029$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$PH$JP$JP
239841224$23984122$4$F$$20240906$20240618$20240916$EXP$$CA-CELLTRION INC.-2024CA014268$CELLTRION$$$$$$Y$$$20240916$$CN$CA$CA
239841272$23984127$2$F$20240524$20240923$20240618$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US052251$SANDOZ$$71$YR$$M$Y$$$20240926$$MD$US$US
239841315$23984131$5$F$20240101$20240820$20240618$20240827$EXP$$JP-GENMAB-2024-01285$GENMAB$$79$YR$$F$Y$44.2$KG$20240827$$MD$JP$JP
239841352$23984135$2$F$$20240703$20240618$20240710$EXP$$JP-AMGEN-JPNSP2024115184$AMGEN$$$$$F$Y$$$20240709$$PH$JP$JP
239841402$23984140$2$F$$20240801$20240618$20240805$PER$$NVSC2024US126789$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
239841452$23984145$2$F$20240613$20240812$20240618$20240814$PER$$US-AMGEN-USASP2024119058$AMGEN$$64$YR$A$M$Y$$$20240814$$CN$US$US
239841472$23984147$2$F$$20240703$20240618$20240705$EXP$$JP-GSK-JP2024JPN073916$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$PH$JP$JP
239841502$23984150$2$F$$20240621$20240618$20240701$EXP$$US-TEVA-VS-3209474$TEVA$Schneider A, Sadhana J, Menindez MD, Jeevaratnam S, Balistreri L, Thomas C, et al. Hydroxychloroquine Induced Cardiotoxicity: A Case Series. Rom-J-Intern-Med 2024; 62 (2): 210-215.; Schneider A, Sadhana J, Menindez MD, Jeevaratnam S, Balistreri L, Thomas C, et al. Hydroxychloroquine Induced Cardiotoxicity: A Case Series. Rom-J-Intern-Med 2024; 62 (2): 210-215.$62$YR$$F$Y$$$20240701$$MD$US$US
239841512$23984151$2$F$$20240627$20240618$20240703$EXP$$BR-009507513-2406BRA004464$MERCK$$$$A$F$Y$$$20240703$$HP$BR$BR
239841612$23984161$2$F$$20240708$20240618$20240717$30DAY$$CO-JNJFOC-20240636133$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$HP$CO$CO
239841645$23984164$5$F$$20240803$20240618$20240822$PER$$US-AstraZeneca-2024A138437$ASTRAZENECA$$$$$F$Y$$$20240822$$MD$US$
239841693$23984169$3$F$$20240717$20240618$20240720$PER$$US-JNJFOC-20240625691$JOHNSON AND JOHNSON$$$$$F$Y$$$20240720$$HP$US$US
239841702$23984170$2$F$$20240716$20240618$20240718$30DAY$$FR-JNJFOC-20240636178$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$PH$FR$FR
239841762$23984176$2$F$20240502$20240814$20240618$20240826$EXP$$US-UCBSA-2024024577$UCB$$51$YR$$F$Y$$$20240826$$HP$US$US
239841773$23984177$3$F$20240101$20240916$20240618$20240927$EXP$$US-UCBSA-2024030470$UCB$$$$$F$Y$82.676$KG$20240927$$CN$US$US
239841823$23984182$3$F$20221001$20240806$20240618$20240809$EXP$$US-ABBVIE-5800363$ABBVIE$$75$YR$$M$Y$81$KG$20240809$$CN$US$US
239841852$23984185$2$F$20240601$20240719$20240618$20240727$EXP$$IT-ABBVIE-5800635$ABBVIE$$78$YR$$F$Y$$$20240727$$CN$IT$IT
239841913$23984191$3$F$20240101$20240820$20240618$20240827$EXP$$BR-ABBVIE-5799672$ABBVIE$$18$YR$$M$Y$$$20240827$$MD$BR$BR
239841942$23984194$2$F$20240401$20240904$20240618$20240909$EXP$$US-ABBVIE-5801593$ABBVIE$$67$YR$$F$Y$$$20240909$$CN$US$US
239841972$23984197$2$F$20240528$20240710$20240618$20240716$EXP$$US-AMGEN-USASP2024116074$AMGEN$$76$YR$E$M$Y$$$20240716$$CN$US$US
239842074$23984207$4$F$20210615$20240804$20240618$20240812$EXP$$CA-CELLTRION INC.-2021CA009055$CELLTRION$$$$$$Y$$$20240812$$MD$CA$CA
239842202$23984220$2$F$$20240726$20240618$20240802$EXP$$NL-ABBVIE-5800586$ABBVIE$$$$E$F$Y$$$20240802$$CN$NL$NL
239842382$23984238$2$F$20220101$20240701$20240618$20240703$EXP$$CA-UCBSA-2022042822$UCB$$$$$M$Y$$$20240703$$CN$CA$CA
239842392$23984239$2$F$20240314$20240619$20240618$20240701$EXP$$JP-INSMED, INC.-2024-02396-JP$INSMED$$67$YR$$M$Y$$$20240701$$CN$JP$JP
239842442$23984244$2$F$$20240703$20240618$20240705$EXP$$JP-GSK-JP2024JPN073910$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$PH$JP$JP
239842472$23984247$2$F$20151013$20240626$20240618$20240705$EXP$$NL-ORPHANEU-2024004370$RECORDATI$$$$$$Y$$$20240705$$CN$NL$NL
239842482$23984248$2$F$20240611$20240719$20240618$20240724$EXP$$US-JNJFOC-20240630846$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240724$$HP$US$US
239842503$23984250$3$F$20240501$20240729$20240618$20240805$PER$$US-ABBVIE-5797314$ABBVIE$$53$YR$$F$Y$$$20240805$$CN$US$US
239842513$23984251$3$F$20240501$20240729$20240618$20240805$PER$$US-ABBVIE-5797799$ABBVIE$$44$YR$$F$Y$$$20240805$$CN$US$US
239842586$23984258$6$F$20240101$20240722$20240618$20240726$EXP$$PT-ABBVIE-5794747$ABBVIE$$72$YR$$F$Y$$$20240726$$CN$PT$PT
239842623$23984262$3$F$20231211$20240807$20240618$20240814$EXP$$JP-GSK-JP2024JPN022858$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$JP$JP
239842632$23984263$2$F$20240401$20240704$20240618$20240710$EXP$$CA-GSK-CA2024056831$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$HP$CA$CA
239842692$23984269$2$F$20240101$20240628$20240618$20240705$EXP$$US-CHIESI-2024CHF03517$CHIESI$$$$$M$Y$$$20240705$$MD$US$US
239842712$23984271$2$F$20240324$20240603$20240618$20240912$PER$$US-BIOGEN-2024BI01269230$BIOGEN$$66$YR$$M$Y$$$20240912$$CN$US$US
239842732$23984273$2$F$$20240701$20240618$20240704$EXP$$JP-AMGEN-JPNSP2024117109$AMGEN$$82$YR$E$F$Y$$$20240704$$PH$JP$JP
239842884$23984288$4$F$$20240701$20240618$20240708$EXP$$JP-JNJFOC-20240641455$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$$COUNTRY NOT SPECIFIED$JP
239842892$23984289$2$F$20240101$20240815$20240618$20240827$PER$$US-SA-2024SA176262$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240827$$MD$US$US
239842952$23984295$2$F$20240101$20240712$20240618$20240726$PER$$US-SA-2024SA177136$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240726$$MD$US$US
239843313$23984331$3$F$$20240816$20240618$20240819$30DAY$$US-SANDOZ INC.-SDZ2024US058401$SANDOZ$$$$$M$Y$$$20240819$$CN$US$US
239843322$23984332$2$F$$20240611$20240618$20240701$EXP$$GB-SANDOZ INC.-SDZ2024GB025171$SANDOZ$$$$$M$Y$$$20240701$$CN$GB$GB
239843352$23984335$2$F$$20240729$20240618$20240808$EXP$$JP-MSNLABS-2024MSNLIT01284$MSN LABORATORIES$Nishio T, Toukairin Y, Hoshi T, Arai T, Nogami M.A case of lacosamide and mirtazapine self-poisoning.Legal Medicine.2024;69:102457$$$$$Y$$$20240808$$MD$JP$JP
239843452$23984345$2$F$20170101$20240704$20240618$20240712$EXP$$SI-TAKEDA-2024TUS059908$TAKEDA$$$$E$M$Y$$$20240712$$MD$SI$SI
239843542$23984354$2$F$$20240626$20240618$20240702$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-086440$REGENERON$$$$$M$Y$$$20240702$$CN$CA$CA
239843582$23984358$2$F$20240416$20240711$20240618$20240717$PER$$US-AMGEN-USASP2024114308$AMGEN$$68$YR$E$F$Y$104.6$KG$20240717$$HP$US$US
239843592$23984359$2$F$$20240716$20240618$20240722$PER$$NVSC2024US126481$NOVARTIS$$$$$$Y$$$20240722$$CN$US$US
239843652$23984365$2$F$20240605$20240704$20240618$20240711$EXP$$JP-GENMAB-2024-02027$GENMAB$$9$DEC$$M$Y$$$20240711$$MD$JP$JP
239843663$23984366$3$F$20240701$20240815$20240618$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002579$ACADIA PHARMACEUTICALS$$43$YR$$F$Y$$$20240830$$CN$US$US
239843712$23984371$2$F$20220201$20240723$20240618$20240726$EXP$$US-TAKEDA-2024TUS059888$TAKEDA$$63$YR$$M$Y$$$20240726$$HP$US$US
239843734$23984373$4$F$20210901$20240724$20240618$20240805$EXP$$NL-AUROBINDO-AUR-APL-2024-029603$AUROBINDO$van der Heide DH, Bogers JPAM, Schulte PRFJ. Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma. Schizophrenia Research. 2024;267:72-4$54$YR$$M$Y$95$KG$20240805$$MD$NL$NL
239843743$23984374$3$F$20220615$20240906$20240618$20240918$EXP$$US-UCBSA-2024025192$UCB$$14$YR$$M$Y$44.9$KG$20240918$$CN$US$US
239843763$23984376$3$F$$20240626$20240618$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-028870$AUROBINDO$Preskorn SH, Masolak DD. Cerebral Anoxia in an 18-year-old Patient Being Treated for Major Depressive Disorder: How Forensic Detective Work Uses Medical Knowledge Including Clinical Pharmacology to Solve Cases.. Journal of psychiatric practice. 2024;30 (3):212-219.$18$YR$$M$Y$$$20240704$$MD$US$US
239843862$23984386$2$F$20240607$20240725$20240618$20240729$PER$$US-AMGEN-USASP2024118702$AMGEN$$62$YR$A$F$Y$$$20240729$$CN$US$US
239843872$23984387$2$F$$20240806$20240618$20240813$EXP$$JP-AMGEN-JPNSP2024118188$AMGEN$$$$$$Y$$$20240813$$PH$JP$JP
239843882$23984388$2$F$$20240718$20240618$20240725$EXP$$GB-TAKEDA-2024TUS059553$TAKEDA$$$$$F$Y$$$20240725$$CN$GB$GB
239843923$23984392$3$F$20240523$20240628$20240618$20240711$30DAY$$US-JNJFOC-20240571729$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240711$$CN$US$US
239843942$23984394$2$F$20240101$20240812$20240618$20240823$EXP$$US-UCBSA-2024030458$UCB$$$$$F$Y$$$20240823$$HP$US$US
239843982$23984398$2$F$$20240812$20240618$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002601$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
239844022$23984402$2$F$$20240730$20240618$20240805$EXP$$CA-TAKEDA-2024TUS059164$TAKEDA$$$$$F$Y$$$20240805$$MD$CA$CA
239844053$23984405$3$F$20170809$20240807$20240618$20240813$EXP$$CA-TAKEDA-2022TUS103515$TAKEDA$$65$YR$$M$Y$$$20240813$$CN$CA$CA
239844122$23984412$2$F$20240613$20240613$20240618$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202406010069$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240715$$CN$US$US
239844634$23984463$4$F$20240417$20240723$20240618$20240726$EXP$$JP-009507513-2405JPN000101$MERCK$$69$YR$$F$Y$$$20240726$$MD$JP$JP
239844653$23984465$3$F$20240420$20240830$20240618$20240925$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002081$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240925$$CN$US$US
239844672$23984467$2$F$$20240820$20240618$20240823$EXP$$CA-SPECGX-T202401299$SPECGX$$$$C$$Y$$$20240823$$HP$CA$CA
239844783$23984478$3$F$$20240730$20240618$20240813$30DAY$$NO-SA-2024SA175000$SANOFI AVENTIS$$$$A$$Y$$$20240814$$HP$NO$NO
239844883$23984488$3$F$$20240801$20240618$20240809$PER$$US-SA-2024SA175048$SANOFI AVENTIS$$$$A$M$Y$$$20240809$$CN$US$US
239844922$23984492$2$F$20240101$20240903$20240618$20240924$PER$$US-SA-2024SA179233$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240924$$MD$US$US
239845002$23984500$2$F$20240610$20240723$20240618$20240801$PER$$US-SA-2024SA179801$SANOFI AVENTIS$$72$YR$E$M$Y$86$KG$20240801$$MD$US$US
239845062$23984506$2$F$20240604$20240830$20240618$20240904$EXP$$PR-ABBVIE-5801145$ABBVIE$$69$YR$$F$Y$61$KG$20240904$$CN$PR$PR
239845132$23984513$2$F$$20230824$20240618$20240722$PER$$US-ASTELLAS-2023US025773$ASTELLAS$$90$YR$$M$Y$$$20240722$$CN$US$US
239845262$23984526$2$F$20230930$20240621$20240618$20240705$EXP$DE-AMAROX PHARMA-AMR2024DE01514$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-12219$ALKEM$$66$YR$$F$Y$$$20240705$$CN$DE$DE
239845293$23984529$3$F$20240417$20240826$20240618$20240827$EXP$$NVSC2024AU122348$NOVARTIS$$74$YR$$M$Y$$$20240827$$CN$AU$AU
239845352$23984535$2$F$$20231219$20240618$20240722$PER$$US-ASTELLAS-2023US038523$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
239845362$23984536$2$F$$20240102$20240618$20240722$PER$$US-ASTELLAS-2024US000269$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
239845382$23984538$2$F$20230601$20230922$20240618$20240722$PER$$US-ASTELLAS-2023US028923$ASTELLAS$$63$YR$$F$Y$$$20240722$$CN$US$US
239845393$23984539$3$F$20240628$20240918$20240618$20240924$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001207$BLUEPRINT MEDICINES$$50$YR$A$F$Y$$$20240924$$HP$US$US
239845425$23984542$5$F$20240601$20240806$20240618$20240815$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001206$BLUEPRINT MEDICINES$$64$YR$A$F$Y$$$20240816$$CN$US$US
239845492$23984549$2$F$$20240710$20240618$20240723$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000522$DECIPHERA PHARMACEUTICALS$$52$YR$A$F$Y$$$20240723$$CN$US$US
239845532$23984553$2$F$$20240301$20240618$20240722$PER$$US-ASTELLAS-2024US006866$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
239845573$23984557$3$F$20240529$20240626$20240618$20240703$PER$$US-AMGEN-USASP2024116799$AMGEN$$68$YR$E$M$Y$65.5$KG$20240703$$HP$US$US
239845634$23984563$4$F$20240609$20240830$20240618$20240902$PER$$US-AMGEN-USASP2024117313$AMGEN$$78$YR$E$F$Y$$$20240902$$CN$US$US
239845722$23984572$2$F$$20240704$20240618$20240710$EXP$$JP-009507513-2406JPN001349J$MERCK$$8$DEC$$F$Y$$$20240710$$MD$JP$JP
239845792$23984579$2$F$$20240626$20240618$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002583$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
239845953$23984595$3$F$$20240705$20240618$20240709$PER$$US-HALEON-2182294$Haleon PLC$$80$YR$$F$Y$$$20240709$$CN$US$US
239845972$23984597$2$F$$20240730$20240618$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002590$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
239846023$23984602$3$F$$20240709$20240618$20240718$PER$$US-SA-2024SA180178$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240718$$HP$US$US
239846042$23984604$2$F$$20240624$20240618$20240703$PER$$US-SA-2024SA173293$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240703$$HP$US$US
239846193$23984619$3$F$$20240823$20240618$20240904$EXP$23063437$US-LUPIN PHARMACEUTICALS INC.-2024-05069$LUPIN$$$$$$Y$$$20240904$$CN$US$US
239846252$23984625$2$F$$20240806$20240618$20240828$PER$$US-PHARMING-PHAUS2024000473$PHARMING GROUP$$$$$$Y$$$20240812$$CN$US$US
239846362$23984636$2$F$$20240625$20240618$20240711$PER$$US-PHARMING-PHAUS2024000471$PHARMING GROUP$$$$$$Y$$$20240711$$CN$US$US
239846432$23984643$2$F$$20240729$20240618$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024068289$VIIV$$$$$$Y$$$20240808$$MD$US$US
239846493$23984649$3$F$20230101$20240829$20240618$20240903$EXP$$US-ALXN-202406USA000670US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
239846622$23984662$2$F$20240101$20240722$20240618$20240801$EXP$$DE-AUROBINDO-AUR-APL-2024-028988$AUROBINDO$$81$YR$$M$Y$75$KG$20240801$$MD$DE$DE
239846652$23984665$2$F$20240606$20240903$20240618$20240918$EXP$$GB-SA-2024SA179470$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240918$$CN$GB$GB
239846742$23984674$2$F$20240101$20240906$20240618$20240916$PER$$US-SA-2024SA175418$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240916$$MD$US$US
239846772$23984677$2$F$$20240709$20240618$20240718$PER$$US-AstraZeneca-2024A139799$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
239846812$23984681$2$F$$20240620$20240618$20240703$30DAY$$CH-JNJFOC-20240626640$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$CH$CH
239846823$23984682$3$F$$20240912$20240618$20240917$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-126798$DAIICHI$$$$$M$Y$$$20240917$$MD$US$US
239846903$23984690$3$F$20240501$20240910$20240618$20240917$EXP$$CA-CELLTRION INC.-2024CA014475$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
239846983$23984698$3$F$20240603$20240618$20240618$20240722$PER$$US-EPICPHARMA-US-2024EPCSPO00734$EPIC PHARM$$76$YR$E$F$Y$160$KG$20240722$$CN$US$US
239847052$23984705$2$F$20240330$20240701$20240618$20240705$EXP$FR-JAZZ PHARMACEUTICALS-2024-FR-008318$FR-UCBSA-2024030710$UCB$$19$YR$$F$Y$58$KG$20240705$$MD$FR$FR
239847063$23984706$3$F$20240201$20240718$20240618$20240725$EXP$$US-GSK-US2024072565$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$US$US
239847072$23984707$2$F$20240704$20240711$20240618$20240717$EXP$$CA-GSK-CA2021AMR203498$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$HP$CA$CA
239847173$23984717$3$F$20240101$20240715$20240618$20240719$PER$$US-AMGEN-USASP2024117682$AMGEN$$66$YR$E$F$Y$$$20240718$$CN$US$US
239847402$23984740$2$F$20230701$20240729$20240618$20240802$EXP$$NVSC2024GB125135$NOVARTIS$$58$YR$$F$Y$77.8$KG$20240802$$HP$GB$GB
239847442$23984744$2$F$20230901$20240709$20240618$20240712$EXP$$PE-UCBSA-2024030079$UCB$$0$YR$$M$Y$2.8$KG$20240712$$CN$PE$PE
239847694$23984769$4$F$$20240808$20240618$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-029043$AUROBINDO$$70$YR$$M$Y$$$20240820$$HP$FR$FR
239847733$23984773$3$F$20240101$20240916$20240618$20240922$PER$$US-SA-2024SA176463$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240923$$MD$US$US
239847782$23984778$2$F$20240423$20240827$20240618$20240830$PER$$US-JNJFOC-20240640879$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240830$$HP$US$US
239847792$23984779$2$F$$20240917$20240618$20240920$EXP$$US-JNJFOC-20240638289$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
239847914$23984791$4$F$$20240726$20240618$20240731$EXP$$CA-JNJFOC-20240640584$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240731$$HP$CA$CA
239847962$23984796$2$F$$20240909$20240618$20240916$EXP$$JP-009507513-2406JPN001933J$MERCK$$70$YR$$M$Y$$$20240916$$MD$JP$JP
239848002$23984800$2$F$$20240627$20240618$20240702$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00711$AMNEAL$$$$$M$Y$77.098$KG$20240702$$CN$US$US
239848042$23984804$2$F$$20240621$20240618$20240703$EXP$$US-TEVA-VS-3202983$TEVA$Agrawal A, Kandah F, Mahowald M. ACUTE PANCREATITIS SECONDARY TO LISINOPRIL USE. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3179.; Agrawal A, Kandah F, Mahowald M. ACUTE PANCREATITIS SECONDARY TO LISINOPRIL USE. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3179.$55$YR$$F$Y$$$20240703$$HP$US$US
239848052$23984805$2$F$$20240701$20240618$20240703$PER$$US-JNJFOC-20240635010$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$US$US
239848224$23984822$4$F$20240101$20240910$20240618$20240917$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000520$DECIPHERA PHARMACEUTICALS$$87$YR$E$M$Y$$$20240917$$CN$US$US
239848262$23984826$2$F$$20240723$20240618$20240731$EXP$$US-AstraZeneca-2024A134779$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
239848292$23984829$2$F$20220301$20240703$20240618$20240710$EXP$$IT-AUROBINDO-AUR-APL-2024-029064$AUROBINDO$$39$YR$$F$Y$$$20240710$$MD$IT$IT
239848303$23984830$3$F$$20240917$20240618$20240925$EXP$$US-ASTELLAS-2024EU005900$ASTELLAS$$$$E$M$Y$$$20240925$$CN$US$US
239848342$23984834$2$F$$20240708$20240618$20240709$PER$$US-JNJFOC-20240641276$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240709$$HP$US$US
239848372$23984837$2$F$20240101$20240701$20240618$20240710$EXP$IT-MINISAL02-987500$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-05498$HIKMA$$74$YR$$M$Y$$$20240710$$MD$IT$IT
239848412$23984841$2$F$$20240607$20240618$20240722$PER$$US-SA-2024SA174419$SANOFI AVENTIS$$$$C$F$Y$$$20240722$$CN$US$US
239848463$23984846$3$F$20240520$20240808$20240618$20240814$EXP$$CA-CHIESI-2024CHF02892$CHIESI$$58$YR$$F$Y$54.5$KG$20240814$$CN$CA$CA
239848494$23984849$4$F$$20240826$20240618$20240903$EXP$$NVSC2024US126105$NOVARTIS$$$$$$Y$$$20240904$$MD$US$US
239848573$23984857$3$F$20240608$20240625$20240618$20240702$EXP$$KR-ABBVIE-5800598$ABBVIE$$80$YR$$F$Y$62$KG$20240702$$MD$KR$KR
239848583$23984858$3$F$20240404$20240625$20240618$20240703$EXP$$ES-AUROBINDO-AUR-APL-2024-029187$AUROBINDO$$71$YR$$F$Y$56.5$KG$20240703$$MD$ES$ES
239848684$23984868$4$F$20240607$20240627$20240618$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017479$UNITED THERAPEUTICS$$69$YR$$F$Y$54.422$KG$20240705$$$US$US
239848762$23984876$2$F$$20240823$20240618$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05059$LUPIN$$$$$$Y$$$20240903$$CN$US$US
239848772$23984877$2$F$$20240916$20240618$20240923$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000067$Unknown Manufacturer$$$$$$Y$$$20240923$$HP$US$US
239848792$23984879$2$F$20240523$20240710$20240618$20240715$EXP$$US-ABBVIE-5802882$ABBVIE$$22$YR$$F$Y$$$20240715$$CN$US$US
239849012$23984901$2$F$$20240801$20240618$20240814$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000466$DECIPHERA PHARMACEUTICALS$$59$YR$A$M$Y$$$20240814$$CN$US$US
239849043$23984904$3$F$$20240627$20240618$20240705$EXP$$JP-JNJFOC-20240641459$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$$COUNTRY NOT SPECIFIED$JP
239849062$23984906$2$F$20220601$20240912$20240618$20240914$EXP$$DE-ALXN-202406GLO000790DE$ALEXION PHARMACEUTICALS$$34$YR$$F$Y$$$20240915$$MD$DE$DE
239849092$23984909$2$F$$20240731$20240618$20240805$PER$$US-ALXN-202406USA000676US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
239849132$23984913$2$F$20240201$20240711$20240618$20240717$EXP$$US-GSK-US2024072613$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$HP$US$US
239849272$23984927$2$F$20240701$20240723$20240618$20240801$PER$$US-SA-2024SA178969$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240801$$MD$US$US
239849355$23984935$5$F$20240318$20240730$20240618$20240805$EXP$$US-ABBVIE-5802366$ABBVIE$$24$YR$$M$Y$72.574$KG$20240805$$CN$PR$PR
239849672$23984967$2$F$$20240625$20240618$20240702$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02198$AMNEAL$$$$$$Y$$$20240702$$CN$US$US
239849933$23984993$3$F$20240529$20240701$20240618$20240704$PER$$US-AMGEN-USASP2024118948$AMGEN$$72$YR$E$F$Y$$$20240704$$HP$US$US
239849953$23984995$3$F$20240101$20240702$20240618$20240709$EXP$$CA-CELLTRION INC.-2024CA014576$CELLTRION$$$$$$Y$$$20240709$$HP$CA$CA
239849972$23984997$2$F$20211101$20240627$20240618$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-229416$RANBAXY$$76$YR$$F$Y$58.957$KG$20240712$$CN$US$US
239850092$23985009$2$F$$20240710$20240618$20240716$EXP$$CA-BAUSCH-BL-2024-009149$BAUSCH AND LOMB$$$$$F$Y$$$20240716$$HP$CA$CA
239850272$23985027$2$F$20220522$20240919$20240618$20240920$PER$$US-GILEAD-2024-0677771$GILEAD$$68$YR$E$M$Y$$$20240920$$LW$US$US
239850462$23985046$2$F$20240306$20240807$20240618$20240813$EXP$$US-ABBVIE-5689130$ABBVIE$$67$YR$$F$Y$$$20240813$$CN$US$US
239850493$23985049$3$F$20240101$20240629$20240618$20240704$PER$$US-LEO Pharma-371189$LEO PHARM$$79$YR$$M$Y$$$20240704$$CN$US$US
239850653$23985065$3$F$$20240809$20240618$20240822$PER$$US-Calliditas-2024CAL01019$CALLIDITAS THERAPEUTICS$$73$YR$E$M$Y$96.6$KG$20240822$$CN$US$US
239850673$23985067$3$F$$20240701$20240618$20240707$EXP$$JP-JNJFOC-20240636662$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$$COUNTRY NOT SPECIFIED$JP
239850682$23985068$2$F$20240610$20240627$20240618$20240705$EXP$$CA-JNJFOC-20240637484$JOHNSON AND JOHNSON$$13$YR$T$M$Y$38$KG$20240705$$HP$CA$CA
239850792$23985079$2$F$$20240705$20240618$20240713$EXP$$JP-AMGEN-JPNSP2024115212$AMGEN$Ota E.. Pustular psoriasis relapse after COVID-19 infection. The Japanese Journal of Dermatology. 2024;134 (5):04-2$46$YR$A$F$Y$$$20240712$$MD$JP$JP
239850863$23985086$3$F$20240318$20240708$20240618$20240722$EXP$GB-MHRA-MED-202406072253334710-KPMDR$GB-Accord-429876$ACCORD$$24$YR$A$M$Y$78$KG$20240718$$CN$GB$GB
239850963$23985096$3$F$20150318$20240912$20240618$20240917$EXP$$US-GILEAD-2024-0677774$GILEAD$$50$YR$A$M$Y$$$20240917$$LW$US$US
239851032$23985103$2$F$$20240702$20240618$20240710$EXP$$US-AMAROX PHARMA-HET2024US01850$HETERO$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL.. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor  lysis syndrome: a case series. Pediatric Nephrology.. 2024;1-3$6$YR$$F$Y$24.5$KG$20240710$$HP$US$US
239851142$23985114$2$F$$20240711$20240618$20240717$30DAY$$US-GSK-US2024AMR074942$GLAXOSMITHKLINE$$$$$M$Y$$$20240717$$CN$US$US
239851184$23985118$4$F$$20240808$20240618$20240813$EXP$$GB-MYLANLABS-2024M1044259$MYLAN$$$$$M$Y$$$20240813$$MD$GB$GB
239851203$23985120$3$F$20240530$20240729$20240618$20240731$EXP$$GB-MYLANLABS-2024M1054033$MYLAN$$56$YR$$M$Y$$$20240731$$MD$GB$GB
239851345$23985134$5$F$20240101$20240806$20240618$20240816$EXP$$US-INSMED, INC.-2024-02048-US$INSMED$$$$$M$Y$$$20240816$$CN$US$US
239851383$23985138$3$F$20240220$20240710$20240618$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-452068$RANBAXY$$18$YR$$F$Y$55$KG$20240725$$MD$FR$FR
239851542$23985154$2$F$20240212$20240711$20240618$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-451873$RANBAXY$$$$A$M$Y$$$20240726$$PH$FR$FR
239851682$23985168$2$F$20231218$20240617$20240618$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-451859$RANBAXY$$58$YR$$F$Y$114$KG$20240702$$PH$FR$FR
239851912$23985191$2$F$20240531$20240912$20240618$20240920$PER$$US-SA-2024SA177712$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240920$$MD$US$US
239852003$23985200$3$F$$20240801$20240618$20240805$EXP$$NVSJ2024JP007113$NOVARTIS$Ito T. A case of an elderly patient with chronic myeloid leukemia (CML). The Journal of Japan Physicians Association. 2023;38(4):215-216$66$YR$$M$Y$$$20240805$$HP$JP$JP
239852032$23985203$2$F$20210806$20240912$20240618$20240916$PER$$US-GILEAD-2024-0677775$GILEAD$$52$YR$A$M$Y$$$20240916$$LW$US$US
239852052$23985205$2$F$20240611$20240712$20240618$20240723$30DAY$$US-AMGEN-USASP2024117103$AMGEN$$70$YR$E$F$Y$84.8$KG$20240723$$PH$US$US
239852102$23985210$2$F$$20240619$20240618$20240704$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-452136$RANBAXY$Konishi T, Kitahiro Y, Fujiwara N, Yamamoto K, Hashimoto M, Ito T, et al. Pharmacokinetics of brexpiprazole, quetiapine, risperidone, and its active metabolite paliperidone in a postpartum woman and her baby. Ther Drug Monit. 2024;00(00):1-5$30$YR$$F$Y$$$20240704$$HP$JP$JP
239852132$23985213$2$F$20240106$20240627$20240618$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-452012$RANBAXY$$77$YR$$F$Y$59$KG$20240712$$PH$FR$FR
239852182$23985218$2$F$$20240918$20240618$20240927$EXP$$US-TEVA-VS-3206978$TEVA$$80$YR$$F$Y$$$20240927$$PH$US$US
239852192$23985219$2$F$$20240619$20240618$20240701$PER$$US-Calliditas-2024CAL01017$CALLIDITAS THERAPEUTICS$$28$YR$A$M$Y$84.7$KG$20240701$$CN$US$US
239852442$23985244$2$F$$20240712$20240618$20240717$EXP$$NVSC2024GB126538$NOVARTIS$$$$$F$Y$$$20240717$$CN$GB$GB
239852462$23985246$2$F$$20240705$20240618$20240717$PER$$US-USAntibiotics-000318$USAntibiotics$$$$$F$Y$$$20240717$$CN$US$
239852522$23985252$2$F$20240613$20240806$20240618$20240808$EXP$$US-JNJFOC-20240635182$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240808$$CN$US$US
239852582$23985258$2$F$$20240717$20240618$20240722$30DAY$$JP-JNJFOC-20240644056$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$PH$JP$JP
239852602$23985260$2$F$20240101$20240705$20240618$20240713$EXP$$JP-AMGEN-JPNSP2024102300$AMGEN$$$$E$M$Y$$$20240713$$HP$JP$JP
239852612$23985261$2$F$20240613$20240801$20240618$20240806$PER$$US-AMGEN-USASP2024117864$AMGEN$$31$YR$A$M$Y$$$20240806$$CN$US$US
239852642$23985264$2$F$$20240716$20240618$20240721$EXP$$GB-MYLANLABS-2024M1054417$MYLAN$$$$$M$Y$$$20240719$$HP$GB$GB
239852742$23985274$2$F$$20240820$20240618$20240829$30DAY$$US-GSK-US2024072611$GLAXOSMITHKLINE$$$$$F$Y$81.65$KG$20240829$$HP$US$US
239852852$23985285$2$F$20240614$20240918$20240618$20240919$PER$$US-AMGEN-USASP2024118891$AMGEN$$54$YR$A$M$Y$$$20240919$$CN$US$US
239852872$23985287$2$F$20240529$20240618$20240618$20240701$EXP$$CN-ASTELLAS-2024US017323$ASTELLAS$$70$YR$$M$Y$$$20240701$$CN$CN$CN
239852932$23985293$2$F$20240529$20240619$20240618$20240701$PER$$US-Calliditas-2024CAL01020$CALLIDITAS THERAPEUTICS$$38$YR$A$M$Y$111.1$KG$20240701$$CN$US$US
239852944$23985294$4$F$20240526$20240726$20240618$20240814$PER$$US-Calliditas-2024CAL01016$CALLIDITAS THERAPEUTICS$$69$YR$E$M$Y$$$20240812$$CN$US$US
239852952$23985295$2$F$$20240702$20240618$20240712$30DAY$$FR-JNJFOC-20240637848$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$PH$FR$FR
239852982$23985298$2$F$$20240627$20240618$20240707$PER$$US-SA-2024SA177418$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240707$$HP$US$US
239853105$23985310$5$F$20090101$20240919$20240618$20240920$PER$$US-GILEAD-2024-0677773$GILEAD$$$$A$F$Y$$$20240920$$LW$US$US
239853172$23985317$2$F$20240101$20240725$20240618$20240807$PER$$US-SA-2024SA175943$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240807$$MD$US$US
239853202$23985320$2$F$20221102$20240611$20240618$20240902$EXP$$FR-SA-2024SA110356$SANOFI AVENTIS$$55$YR$A$F$Y$65$KG$20240902$$MD$FR$FR
239853276$23985327$6$F$20240123$20240802$20240618$20240808$EXP$$DE-MYLANLABS-2024M1054059$MYLAN$$$$A$F$Y$$$20240808$$MD$DE$DE
239853324$23985332$4$F$20240530$20240815$20240618$20240819$EXP$$US-TAKEDA-2024TUS059506$TAKEDA$$40$YR$$F$Y$48$KG$20240819$$HP$US$US
239853403$23985340$3$F$20100101$20240720$20240618$20240731$EXP$$NL-AUROBINDO-AUR-APL-2024-029412$AUROBINDO$van Dijk L.M.M.; van Zwol A.; Buizer A.I.; van de Pol L.A.; Slot K.M.; de Wildt S.N.; Bonouvri? L.A.. Potentially Life-Threatening Interaction between Opioids and Intrathecal Baclofen in Individuals with a Childhood-Onset Neurological Disorder: A Case Series and Review of the Literature. Neuropediatric. 2024$8$YR$$F$Y$22$KG$20240731$$MD$NL$NL
239853433$23985343$3$F$$20240813$20240618$20240821$EXP$$CA-JNJFOC-20240637978$JOHNSON AND JOHNSON$$$$$M$Y$49$KG$20240821$$HP$CA$CA
239853452$23985345$2$F$$20240621$20240618$20240701$EXP$$CA-TEVA-VS-3202469$TEVA$Fournier C, Hirsch I, Spreafico A, Butler MO, Dhani N, Sauder MB. Dupilumab as a treatment for cutaneous immune-related adverse events induced by immune checkpoint inhibitors: A case series and review of the literature. SAGE-Open-Med-Case-Rep 2023; 11.; Fournier C, Hirsch I, Spreafico A, Butler MO, Dhani N, Sauder MB. Dupilumab as a treatment for cutaneous immune-related adverse events induced by immune checkpoint inhibitors: A case series and review of the literature. SAGE-Open-Med-Case-Rep ...$78$YR$$M$Y$$$20240701$$HP$CA$CA
239853712$23985371$2$F$$20240716$20240618$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097448$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240718$$CN$US$US
239853853$23985385$3$F$$20240830$20240618$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097568$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$84.82$KG$20240902$$CN$US$US
239853952$23985395$2$F$$20240819$20240618$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097566$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$64.86$KG$20240820$$CN$US$US
239854012$23985401$2$F$20240101$20240718$20240618$20240731$PER$$US-SA-2024SA175676$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240731$$CN$US$US
239854022$23985402$2$F$20240705$20240705$20240618$20240718$PER$$US-Calliditas-2024CAL01014$CALLIDITAS THERAPEUTICS$$35$YR$A$M$Y$79$KG$20240718$$CN$US$US
239854072$23985407$2$F$20240601$20240912$20240618$20240918$EXP$$CA-TAKEDA-2024TUS030095$TAKEDA$$63$YR$$M$Y$$$20240918$$HP$CA$CA
239854132$23985413$2$F$$20240918$20240618$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202406008882$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240923$$CN$US$US
239854286$23985428$6$F$20240613$20240904$20240618$20240905$EXP$$NVSC2024US125819$NOVARTIS$$1$YR$$M$Y$5.442$KG$20240905$$MD$US$US
239854342$23985434$2$F$$20240624$20240618$20240723$30DAY$$US-JNJFOC-20240626695$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
239854392$23985439$2$F$$20240626$20240618$20240701$EXP$$JP-009507513-2406JPN001581J$MERCK$Yoshimoto K, Furusawa S, Ishikawa T, Onizuka K, Nakamura R, Kadokami T, et al.. [11 2 Cases of Shock with Coronary Spasm during Induction of Anesthesia for Non-Cardiac Surgery]. The 345th Kyushu Regional Meeting of The Japanese Society of Internal Medicine$$$$M$Y$51$KG$20240701$$MD$JP$JP
239854512$23985451$2$F$20220101$20240720$20240618$20240731$EXP$$NL-AUROBINDO-AUR-APL-2024-029163$AUROBINDO$van Dijk LMM, van Zwol A, Buizer AI, van de PolLA, Slot KM, de Wildt SN, et al.. Potentially Life-Threatening Interaction between Opioids and Intrathecal Baclofen in Individuals with a Childhood-Onset Neurological Disorder: A Case Series and Review of the Literature. Neuropediatrics. 2024$15$YR$$F$Y$34.5$KG$20240731$$MD$NL$NL
239854542$23985454$2$F$20240101$20240729$20240618$20240828$PER$$US-IMP-2024000349$Harrow Health$$$$A$F$Y$$$20240828$$CN$US$US
239854774$23985477$4$F$20240101$20240828$20240618$20240903$PER$$US-BIOGEN-2024BI01269261$BIOGEN$$$$$F$Y$$$20240903$$CN$US$US
239854914$23985491$4$F$$20240813$20240618$20240816$30DAY$$US-PFIZER INC-202400190477$PFIZER$$10$YR$$F$Y$$$20240816$$CN$US$US
239854923$23985492$3$F$$20240916$20240618$20240920$30DAY$$US-PFIZER INC-202400187429$PFIZER$$9$YR$$F$Y$$$20240920$$HP$US$US
239854942$23985494$2$F$$20240910$20240618$20240912$30DAY$$US-PFIZER INC-PV202400072393$PFIZER$$$$$$Y$$$20240912$$HP$US$US
239854984$23985498$4$F$$20240920$20240618$20240925$30DAY$$US-PFIZER INC-202400190698$PFIZER$$16$YR$$M$Y$$$20240925$$CN$US$US
239854994$23985499$4$F$$20240923$20240618$20240927$30DAY$$US-PFIZER INC-PV202400063487$PFIZER$$14$YR$$M$Y$$$20240927$$MD$US$US
239855006$23985500$6$F$$20240826$20240618$20240829$30DAY$$US-PFIZER INC-PV202400048389$PFIZER$$14$YR$$M$Y$$$20240829$$MD$US$US
239855013$23985501$3$F$20230801$20240820$20240618$20240824$EXP$$US-ABBVIE-5801533$ABBVIE$$46$YR$$F$Y$95$KG$20240824$$CN$US$US
239855044$23985504$4$F$20240117$20240814$20240618$20240820$EXP$$FR-BAUSCH-BL-2024-009253$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240820$$HP$FR$FR
239855113$23985511$3$F$$20240712$20240618$20240723$PER$$US-SA-2024SA179292$SANOFI AVENTIS$$$$A$F$Y$86.1$KG$20240723$$MD$US$US
239855252$23985525$2$F$$20240909$20240618$20240916$EXP$$JP-009507513-2403JPN003516J$MERCK$$74$YR$$M$Y$$$20240916$$MD$JP$JP
239855442$23985544$2$F$20120101$20240720$20240618$20240731$EXP$$NL-AUROBINDO-AUR-APL-2024-029118$AUROBINDO$van Dijk LMM, van Zwol A, Buizer AI, van de PolLA, Slot KM, de Wildt SN, et al.. Potentially Life-Threatening Interaction between Opioids and Intrathecal Baclofen in Individuals with a Childhood-Onset Neurological Disorder: A Case Series and Review of the Literature.. Neuropediatrics. 2024$24$YR$$M$Y$44$KG$20240731$$MD$NL$NL
239855495$23985549$5$F$20240611$20240701$20240618$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009195$JAZZ$$39$YR$$F$Y$$$20240708$$MD$US$US
239855594$23985559$4$F$$20240913$20240618$20240919$30DAY$$US-PFIZER INC-202400191888$PFIZER$$10$YR$$F$Y$25.4$KG$20240919$$CN$US$US
239855607$23985560$7$F$20240607$20240911$20240618$20240913$30DAY$$US-PFIZER INC-202400191391$PFIZER$$12$YR$$F$Y$$$20240913$$MD$US$US
239855614$23985561$4$F$$20240828$20240618$20240830$30DAY$$US-PFIZER INC-202400190551$PFIZER$$13$YR$$M$Y$$$20240830$$CN$US$US
239855844$23985584$4$F$$20240911$20240618$20240913$30DAY$$US-PFIZER INC-202400192300$PFIZER$$15$YR$$M$Y$$$20240913$$CN$US$US
239855872$23985587$2$F$$20240718$20240618$20240728$30DAY$$FR-JNJFOC-20240630309$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$PH$FR$FR
239856053$23985605$3$F$20190129$20240627$20240618$20240703$EXP$$CA-TAKEDA-2024TUS059056$TAKEDA$$33$YR$$M$Y$80$KG$20240703$$PH$CA$CA
239856063$23985606$3$F$20240515$20240626$20240618$20240702$EXP$$JP-009507513-2406JPN001372J$MERCK$$62$YR$$F$Y$$$20240702$$MD$JP$JP
239856083$23985608$3$F$20240628$20240703$20240618$20240710$PER$$US-SA-2024SA176470$SANOFI AVENTIS$$11$YR$C$M$Y$36.7$KG$20240710$$MD$US$US
239856112$23985611$2$F$20240101$20240627$20240618$20240708$PER$$US-SA-2024SA175301$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240708$$MD$US$US
239856203$23985620$3$F$$20240917$20240618$20240925$EXP$$CA-OTSUKA-2021_035261$OTSUKA$$$$$M$Y$$$20240925$$MD$CA$CA
239856242$23985624$2$F$$20240716$20240618$20240720$30DAY$$BR-SANDOZ INC.-SDZ2024BR035416$SANDOZ$$$$$M$Y$$$20240720$$CN$BR$BR
239856264$23985626$4$F$20230101$20240807$20240618$20240813$EXP$$US-SANDOZ INC.-SDZ2024US058084$SANDOZ$$$$$F$Y$47.619$KG$20240813$$CN$US$US
239856283$23985628$3$F$$20240821$20240618$20240827$EXP$$GT-JNJFOC-20240522400$JOHNSON AND JOHNSON$$72$YR$E$M$Y$68$KG$20240827$$CN$GT$GT
239856343$23985634$3$F$$20240910$20240618$20240912$30DAY$$US-PFIZER INC-202400192483$PFIZER$$10$YR$$F$Y$$$20240912$$CN$US$US
239856413$23985641$3$F$20240229$20240715$20240618$20240722$EXP$$ES-MYLANLABS-2024M1054611$MYLAN$$78$YR$$M$Y$104$KG$20240722$$MD$ES$ES
239856672$23985667$2$F$20240410$20240716$20240618$20240722$EXP$$US-JNJFOC-20240433465$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240723$$MD$US$US
239856702$23985670$2$F$20240607$20240624$20240618$20240702$PER$$US-AMGEN-USASP2024116538$AMGEN$$$$$F$Y$$$20240702$$HP$US$US
239856743$23985674$3$F$20240612$20240627$20240618$20240708$PER$$US-SA-2024SA180210$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240708$$HP$US$US
239856782$23985678$2$F$20240609$20240723$20240618$20240724$EXP$$IL-BIOMARINAP-IL-2024-158620$BIOMARIN$$$$$$Y$$$20240724$$CN$IL$IL
239856813$23985681$3$F$20230401$20240718$20240618$20240724$EXP$$NVSC2024CZ124553$NOVARTIS$Rous Z. Ofatumumab v terapii roztrousene sklerozy a adherence k lecbe -kazuistika [Ofatumumab in the treatment of multiple sclerosis and adherence to this therapy - a case study]. REMEDIA. 2024;34 (3):241-2$$$$F$Y$$$20240724$$HP$CZ$CZ
239856922$23985692$2$F$$20240718$20240618$20240723$EXP$GB-MHRA-TPP30083486C8465534YC1718193520034$GB-MYLANLABS-2024M1054426$MYLAN$$71$YR$$M$Y$85$KG$20240723$$MD$GB$GB
239856942$23985694$2$F$20240419$20240702$20240618$20240710$EXP$$US-TAKEDA-2024TUS046759$TAKEDA$$67$YR$$F$Y$$$20240710$$MD$US$US
239856982$23985698$2$F$20240605$20240802$20240618$20240809$EXP$$JP-009507513-2406JPN001779J$MERCK$$59$YR$$F$Y$37$KG$20240809$$PH$JP$JP
239857032$23985703$2$F$$20240621$20240618$20240701$EXP$$US-TEVA-VS-3202929$TEVA$Amezquita JALA, Becerra-Gonzales VG, Martinez MAV, Iskander M, Quintero-Martinez JA, Rojas IAM, et al. FROM GAINS TO STRAINS: A CASE OF ANABOLIC STEROID INDUCED MYOCARDITIS. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 4351.; Amezquita JALA, Becerra-Gonzales VG, Martinez MAV, Iskander M, Quintero-Martinez JA, Rojas IAM, et al. FROM GAINS TO STRAINS: A CASE OF ANABOLIC STEROID INDUCED MYOCARDITIS. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 4351.$29$YR$$M$Y$$$20240701$$HP$US$US
239857103$23985710$3$F$$20240830$20240618$20240830$EXP$$CA-PFIZER INC-202300278895$PFIZER$$84$YR$$M$Y$$$20240830$$MD$CA$CA
239857252$23985725$2$F$20240416$20240809$20240618$20240809$EXP$$CA-PFIZER INC-202400053593$PFIZER$$62$YR$$F$Y$$$20240809$$HP$CA$CA
239857262$23985726$2$F$20230320$20240809$20240618$20240809$EXP$$CA-PFIZER INC-202300118769$PFIZER$$68$YR$$F$Y$54$KG$20240809$$MD$CA$CA
239857353$23985735$3$F$20171221$20240828$20240618$20240903$EXP$$IN-PFIZER INC-2018436942$PFIZER$$66$YR$$F$Y$55$KG$20240903$$CN$IN$IN
239857362$23985736$2$F$20240301$20240722$20240618$20240802$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202406004137$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240802$$CN$DE$DE
239857372$23985737$2$F$20240601$20240809$20240618$20240814$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202406008092$ELI LILLY AND CO$$$$E$M$Y$77$KG$20240814$$CN$FR$FR
239857452$23985745$2$F$20240531$20240731$20240618$20240806$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202406003908$ELI LILLY AND CO$$51$YR$A$F$Y$65$KG$20240806$$CN$IT$IT
239857532$23985753$2$F$$20240624$20240618$20240702$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406007290$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$JP$JP
239857572$23985757$2$F$$20240718$20240618$20240727$EXP$$GB-TAKEDA-2024TUS059961$TAKEDA$$36$YR$$F$Y$$$20240727$$CN$GB$GB
239857592$23985759$2$F$20240529$20240715$20240618$20240723$EXP$IT-MINISAL02-988934$IT-BAXTER-2024BAX019728$BAXTER$$21$YR$$M$Y$$$20240723$$PH$IT$IT
239857625$23985762$5$F$20240520$20240913$20240618$20240918$EXP$$CN-BAXTER-2024BAX019546$BAXTER$$62$YR$$F$Y$59.5$KG$20240918$$MD$CN$CN
239857703$23985770$3$F$$20240925$20240618$20240930$30DAY$$US-PFIZER INC-202400192219$PFIZER$$14$YR$$M$Y$$$20240930$$CN$US$US
239857724$23985772$4$F$$20240731$20240618$20240731$30DAY$$US-PFIZER INC-202400185069$PFIZER$$3$YR$$F$Y$$$20240731$$CN$US$US
239857736$23985773$6$F$$20240903$20240618$20240905$30DAY$$US-PFIZER INC-202400192208$PFIZER$$6$YR$$M$Y$$$20240905$$CN$US$US
239857743$23985774$3$F$20230531$20240820$20240618$20240823$EXP$$JP-GILEAD-2024-0677243$GILEAD$Arii A, Iriyama C, Inamoto Y, Goto N, Okamoto A, Yamamoto H, et al.. B-I-3 A case of first-line treatment-resistant transformed DLBCL that was resistant to CAR-T, haploidentical transplant and bispecific antibody therapy. The 13th Tokai Regional Meeting of the Japanese Society of Hematology. 2024;unk:29$51$YR$A$F$Y$$$20240823$$MD$JP$JP
239857752$23985775$2$F$$20240621$20240618$20240703$EXP$$CA-TEVA-VS-3202505$TEVA$Baxter CL, Martin EG, Marwa BM, Pacaud D, Cummings EA. Very severe hypertriglyceridemia complicating pediatric acute lymphoblastic leukemia treatment: a call for management guidelines. J-Pediatr-Endocrinol-Metab 2023; 36 978-982.; Baxter CL, Martin EG, Marwa BM, Pacaud D, Cummings EA. Very severe hypertriglyceridemia complicating pediatric acute lymphoblastic leukemia treatment: a call for management guidelines. J-Pediatr-Endocrinol-Metab 2023; 36 978-982.$11$YR$$F$Y$$$20240703$$HP$CA$CA
239857763$23985776$3$F$20240101$20240717$20240618$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-014161$UNITED THERAPEUTICS$$$$$M$Y$$$20240725$$$US$US
239857843$23985784$3$F$$20240911$20240618$20240913$30DAY$$US-PFIZER INC-202400191550$PFIZER$$6$YR$$F$Y$$$20240913$$CN$US$US
239857853$23985785$3$F$$20240913$20240618$20240919$30DAY$$US-PFIZER INC-202400192554$PFIZER$$21$YR$$F$Y$$$20240919$$CN$US$US
239857862$23985786$2$F$20240605$20240715$20240618$20240718$30DAY$$US-AMGEN-USASP2024111391$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
239857903$23985790$3$F$20240531$20240626$20240618$20240702$30DAY$$US-AMGEN-USASP2024117649$AMGEN$$67$YR$E$F$Y$98$KG$20240702$$HP$US$US
239857952$23985795$2$F$20240410$20240619$20240618$20240701$PER$$US-Calliditas-2024CAL01028$CALLIDITAS THERAPEUTICS$$47$YR$A$M$Y$81.6$KG$20240701$$CN$US$US
239858013$23985801$3$F$20240501$20240712$20240618$20240725$PER$$US-Calliditas-2024CAL01032$CALLIDITAS THERAPEUTICS$$51$YR$A$M$Y$$$20240725$$CN$US$US
239858034$23985803$4$F$20240101$20240710$20240618$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-017178$UNITED THERAPEUTICS$$$$$M$Y$124.26$KG$20240718$$$US$US
239858062$23985806$2$F$$20240612$20240618$20240701$PER$$US-BIOMARINAP-US-2024-158578$BIOMARIN$$$$$$Y$$$20240701$$CN$US$US
239858082$23985808$2$F$$20240612$20240618$20240701$PER$$US-BIOMARINAP-US-2024-158579$BIOMARIN$$$$$$Y$$$20240701$$CN$US$US
239858244$23985824$4$F$20240101$20240730$20240618$20240805$EXP$$CA-PFIZER INC-202400190184$PFIZER$$67$YR$$M$Y$$$20240804$$CN$CA$CA
239858282$23985828$2$F$20240522$20240715$20240618$20240722$EXP$FR-AFSSAPS-AN2024000781$FR-PFIZER INC-202400193593$PFIZER$$59$YR$$M$Y$$$20240722$$PH$FR$FR
239858312$23985831$2$F$$20240717$20240618$20240722$EXP$$CA-OTSUKA-2023_001050$OTSUKA$$$$$M$Y$$$20240722$$PH$CA$CA
239858333$23985833$3$F$$20240712$20240618$20240719$EXP$$US-OTSUKA-2023_013192$OTSUKA$$$$$M$Y$$$20240719$$MD$US$US
239858402$23985840$2$F$$20240702$20240618$20240708$EXP$$US-OTSUKA-2024_016954$OTSUKA$$$$$M$Y$91.72$KG$20240708$$CN$US$US
239858442$23985844$2$F$20240611$20240628$20240618$20240705$30DAY$$US-AMGEN-USASP2024116595$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
239858612$23985861$2$F$20240823$20240907$20240618$20240916$PER$$US-SA-2024SA179033$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240916$$MD$US$US
239858642$23985864$2$F$20240101$20240716$20240618$20240724$PER$$US-SA-2024SA176832$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240724$$MD$US$US
239858693$23985869$3$F$20240607$20240620$20240618$20240701$PER$$US-SA-2024SA175823$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240701$$HP$US$US
239858742$23985874$2$F$$20240917$20240618$20240920$PER$$US-JNJFOC-20240637929$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$CN$US$US
239858773$23985877$3$F$$20240621$20240618$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04833$LUPIN$$$$$M$Y$81.633$KG$20240704$$PH$US$US
239858833$23985883$3$F$$20240711$20240618$20240718$EXP$$NVSC2024GR111472$NOVARTIS$$76$YR$$M$Y$$$20240718$$MD$GR$GR
239859212$23985921$2$F$20240617$20240625$20240618$20240702$PER$$US-JNJFOC-20240645528$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240702$$CN$US$US
239859223$23985922$3$F$20240601$20240704$20240618$20240709$EXP$$JP-PFIZER INC-202400192365$PFIZER$$$$$$Y$$$20240709$$MD$JP$JP
239859342$23985934$2$F$$20240813$20240618$20240819$PER$$US-AGIOS-2406US03793$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
239859512$23985951$2$F$$20240821$20240618$20240822$EXP$$NVSC2024US126255$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
239859554$23985955$4$F$20240517$20240815$20240618$20240828$PER$$US-Calliditas-2024CAL01046$CALLIDITAS THERAPEUTICS$$19$YR$A$M$Y$92.6$KG$20240828$$CN$US$US
239859602$23985960$2$F$$20240829$20240618$20240903$EXP$$BR-TAKEDA-2024TUS059211$TAKEDA$$$$$F$Y$$$20240903$$CN$BR$BR
239859712$23985971$2$F$$20240710$20240618$20240715$EXP$$US-ABBVIE-5801446$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
239859725$23985972$5$F$$20240709$20240618$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04917$LUPIN$$$$$$Y$$$20240805$$PH$US$US
239859733$23985973$3$F$$20240709$20240618$20240722$EXP$$JP-UCBSA-2024029943$UCB$$3$DEC$$M$Y$$$20240721$$MD$JP$JP
239859742$23985974$2$F$20231215$20240703$20240618$20240705$EXP$$JP-DSJP-DSJ-2024-117724$DAIICHI$$76$YR$$F$Y$50$KG$20240705$$MD$JP$JP
239859793$23985979$3$F$20240609$20240903$20240618$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001210$BLUEPRINT MEDICINES$$85$YR$E$F$Y$$$20240911$$CN$US$US
239859803$23985980$3$F$20240502$20240909$20240618$20240917$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001216$BLUEPRINT MEDICINES$$63$YR$A$F$Y$$$20240917$$CN$US$US
239859873$23985987$3$F$20240501$20240624$20240618$20240701$EXP$$KR-DSJP-DSJ-2024-126677$DAIICHI$$45$YR$$F$Y$$$20240701$$CN$KR$KR
239859892$23985989$2$F$20240401$20240703$20240618$20240708$EXP$$ES-OTSUKA-2024_014992$OTSUKA$$$$$F$Y$$$20240708$$MD$ES$ES
239859933$23985993$3$F$20240101$20240808$20240618$20240808$EXP$$CA-PFIZER INC-202400193325$PFIZER$$69$YR$$F$Y$$$20240808$$CN$CA$CA
239859964$23985996$4$F$$20240812$20240618$20240816$EXP$$US-PFIZER INC-202400187486$PFIZER$$$$$$Y$$$20240816$$MD$US$US
239859973$23985997$3$F$$20240812$20240618$20240816$EXP$$DK-PFIZER INC-202400188205$PFIZER$$$$$$Y$$$20240816$$PH$DK$DK
239860013$23986001$3$F$$20240805$20240618$20240813$EXP$$GB-AstraZeneca-2024A140152$ASTRAZENECA$$$$$M$Y$$$20240813$$MD$GB$
239860123$23986012$3$F$20240517$20240705$20240618$20240713$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-015953$UNITED THERAPEUTICS$$82$YR$$F$Y$34$KG$20240713$$$JP$JP
239860172$23986017$2$F$20240506$20240624$20240618$20240708$PER$$US-Calliditas-2024CAL01031$CALLIDITAS THERAPEUTICS$$58$YR$A$M$Y$107.5$KG$20240708$$CN$US$US
239860222$23986022$2$F$20240430$20240725$20240618$20240801$EXP$$US-SA-2024SA179644$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240801$$CN$US$US
239860233$23986023$3$F$20240601$20240916$20240618$20240919$PER$$US-SA-2024SA176964$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240919$$MD$US$US
239860354$23986035$4$F$20240605$20240712$20240618$20240717$EXP$$JP-BAYER-2024A087760$BAYER$$65$YR$E$M$Y$$$20240717$$MD$JP$JP
239860383$23986038$3$F$20240605$20240814$20240618$20240815$EXP$$US-BAYER-2024A086406$BAYER$$34$YR$A$F$Y$$$20240815$$MD$US$US
239860463$23986046$3$F$$20240723$20240618$20240730$PER$$US-TAKEDA-2024TUS060018$TAKEDA$$$$$M$Y$$$20240730$$MD$US$US
239860542$23986054$2$F$$20240621$20240618$20240701$EXP$$US-TEVA-VS-3203187$TEVA$Mohy-Ud-Din N, Jonassaint N. Severe Liver and Renal Injury from Tribulus Terrestris. ACG-Case-Rep-J 2024; 11 (2): E01267.; Mohy-Ud-Din N, Jonassaint N. Severe Liver and Renal Injury from Tribulus Terrestris. ACG-Case-Rep-J 2024; 11 (2): E01267.$46$YR$$M$Y$$$20240701$$MD$US$US
239860582$23986058$2$F$$20240917$20240618$20240920$EXP$$US-JNJFOC-20240620247$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
239860652$23986065$2$F$$20240910$20240618$20240912$30DAY$$AR-PFIZER INC-202400179247$PFIZER$$$$$$Y$$$20240912$$CN$AR$AR
239860662$23986066$2$F$20240501$20240809$20240618$20240809$EXP$$AR-PFIZER INC-202400190458$PFIZER$$12$YR$$F$Y$$$20240809$$CN$AR$AR
239860714$23986071$4$F$$20240715$20240618$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04929$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239860723$23986072$3$F$$20240712$20240618$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009212$JAZZ$$$$$F$Y$$$20240716$$HP$US$US
239860782$23986078$2$F$20240501$20240913$20240618$20240917$EXP$$AR-PFIZER INC-202400192340$PFIZER$$15$YR$$F$Y$$$20240917$$CN$AR$AR
239860862$23986086$2$F$$20240719$20240618$20240725$PER$$US-AstraZeneca-2024A138775$ASTRAZENECA$$$$$F$Y$$$20240726$$HP$US$
239860902$23986090$2$F$$20240812$20240618$20240819$EXP$$CA-JNJFOC-20240641256$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240819$$HP$CA$CA
239860912$23986091$2$F$$20240822$20240618$20240826$EXP$$NVSC2024US126716$NOVARTIS$$41$YR$$F$Y$$$20240826$$CN$US$US
239860932$23986093$2$F$20240405$20240701$20240618$20240715$PER$$US-Calliditas-2024CAL01030$CALLIDITAS THERAPEUTICS$$73$YR$E$M$Y$94.3$KG$20240715$$CN$US$US
239860943$23986094$3$F$$20240806$20240618$20240820$PER$$US-Calliditas-2024CAL01025$CALLIDITAS THERAPEUTICS$$56$YR$A$F$Y$67.5$KG$20240820$$CN$US$US
239860972$23986097$2$F$$20240621$20240618$20240701$EXP$$US-TEVA-VS-3202460$TEVA$Santiago-Vazquez M, Gonzalez-Molina VJ, Rodriguez-Ramos FM, Colon-Fontanez F, Carrasquillo OY. Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab. Clin-Pediatr-Phila 2023; 62 541-547.; Santiago-Vazquez M, Gonzalez-Molina VJ, Rodriguez-Ramos FM, Colon-Fontanez F, Carrasquillo OY. Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab. Clin-Pediatr-Phila 2023; 62 541-547.; Santiago-Vazquez M, Gonzalez-Molina VJ, Rodriguez-Ramos FM, Colon-F...$14$YR$$F$Y$$$20240701$$MD$US$US
239861052$23986105$2$F$20230101$20240711$20240618$20240712$PER$$US-ORGANON-O2406USA001413$ORGANON$$$$$F$Y$$$20240712$$HP$US$US
239861083$23986108$3$F$$20240910$20240618$20240912$30DAY$$US-PFIZER INC-202400188071$PFIZER$$12$YR$$M$Y$$$20240912$$CN$US$US
239861094$23986109$4$F$20240527$20240926$20240618$20240926$30DAY$$CO-PFIZER INC-202400188250$PFIZER$$9$YR$$M$Y$$$20240926$$CN$CO$CO
239861143$23986114$3$F$20230731$20240709$20240618$20240712$EXP$$NVSC2024DE125113$NOVARTIS$$$$C$M$Y$31.6$KG$20240712$$MD$DE$DE
239861582$23986158$2$F$$20240719$20240618$20240726$EXP$$IN-VANTIVE-2024VAN017291$Vantive US Healthcare$$52$YR$$F$Y$$$20240726$$CN$IN$IN
239861623$23986162$3$F$$20240703$20240618$20240710$30DAY$$US-PFIZER INC-202400192288$PFIZER$$24$YR$$F$Y$75.737$KG$20240710$$CN$US$US
239861642$23986164$2$F$$20240724$20240618$20240724$30DAY$$CL-PFIZER INC-PV202400074709$PFIZER$$14$YR$$F$Y$$$20240724$$CN$CL$CL
239861654$23986165$4$F$$20240911$20240618$20240913$30DAY$$GB-PFIZER INC-202400191972$PFIZER$$$$$$Y$$$20240913$$HP$GB$GB
239861762$23986176$2$F$$20240720$20240618$20240729$EXP$$DE-AUROBINDO-AUR-APL-2024-030144$AUROBINDO$Derungs T, Poddubnyy D, Schneider T.. Pancytopenia following adjuvant therapy with interferon-gamma in a patient with disseminated nocardiosis.. International Journal of Infectious Diseases.. 2024;142:106997$78$YR$$F$Y$$$20240729$$HP$DE$DE
239861773$23986177$3$F$$20240701$20240618$20240707$EXP$$JP-JNJFOC-20240636665$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$$COUNTRY NOT SPECIFIED$JP
239861942$23986194$2$F$20240605$20240619$20240618$20240701$PER$$US-Calliditas-2024CAL01029$CALLIDITAS THERAPEUTICS$$55$YR$A$M$Y$81.1$KG$20240701$$CN$US$US
239861992$23986199$2$F$20240501$20240924$20240618$20240930$EXP$$JP-009507513-2406JPN001752J$MERCK$$7$DEC$$F$Y$$$20240930$$MD$JP$JP
239862043$23986204$3$F$20240510$20240822$20240618$20240918$PER$$US-GILEAD-2024-0677788$GILEAD$$33$YR$A$M$Y$57.143$KG$20240918$$HP$US$US
239862103$23986210$3$F$$20240814$20240618$20240820$EXP$$FR-MYLANLABS-2024M1053811$MYLAN$$70$YR$$M$Y$$$20240820$$HP$FR$FR
239862212$23986221$2$F$20240902$20240903$20240618$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202406011802$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240904$$CN$US$US
239862304$23986230$4$F$$20240627$20240618$20240705$EXP$FR-EMA-20170621-tiwarievprod-111930350$FR-SA-2024SA178926$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240705$$HP$FR$FR
239862322$23986232$2$F$20240101$20240814$20240618$20240828$PER$$US-SA-2024SA175025$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240828$$MD$US$US
239862504$23986250$4$F$$20240822$20240618$20240828$EXP$$US-TAKEDA-2024TUS056742$TAKEDA$$$$$M$Y$$$20240828$$CN$US$US
239862512$23986251$2$F$$20240617$20240618$20240717$EXP$$CA-002147023-NVSC2024CA031690$Haleon PLC$$40$YR$$F$Y$$$20240716$$HP$CA$CA
239862692$23986269$2$F$$20240705$20240618$20240710$EXP$$PH-AMGEN-PHLSP2024118163$AMGEN$Wong S.N.; Febro R.D.; Perillo E.S. et al.. Cure can be Achieved by Conversion to Microwave Ablation following Atezolizumab Bevacizumab Therapy in Unresectable Hepatocellular Carcinoma. Journal of liver cancer (Online). 2024;1-16$$$$$Y$$$20240710$$MD$PH$PH
239862707$23986270$7$F$20240609$20240912$20240618$20240916$EXP$$JP-OTSUKA-2024_017213$OTSUKA$$59$YR$$M$Y$49.7$KG$20240916$$MD$JP$JP
239862712$23986271$2$F$$20240702$20240618$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04920$LUPIN$$$$$$Y$$$20240724$$CN$US$US
239862732$23986273$2$F$20240502$20240716$20240618$20240720$EXP$$NVSC2024BR125453$NOVARTIS$$82$YR$$F$Y$57$KG$20240720$$CN$BR$BR
239862962$23986296$2$F$$20240621$20240618$20240701$EXP$$US-TEVA-VS-3202464$TEVA$Leong R, Grantham CJ, Richardson TH, Concepcion BP. Mystery Lung Mass in a Kidney Transplant Recipient. J-Am-Soc-Nephrol 2023; 34 332 abstr. TH-PO866.; Leong R, Grantham CJ, Richardson TH, Concepcion BP. Mystery Lung Mass in a Kidney Transplant Recipient. J-Am-Soc-Nephrol 2023; 34 332 abstr. TH-PO866.$65$YR$$F$Y$$$20240701$$HP$US$US
239862983$23986298$3$F$$20240812$20240618$20240814$EXP$$CA-JNJFOC-20240640689$JOHNSON AND JOHNSON$$11$YR$C$F$Y$30$KG$20240814$$PH$CA$CA
239863053$23986305$3$F$20240101$20240819$20240618$20240905$PER$$US-KARYOPHARM-2024KPT001174$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240905$$CN$US$US
239863062$23986306$2$F$20231201$20240627$20240618$20240701$EXP$$CA-AMERICAN REGENT INC-2024002223$AMERICAN REGENT$$30$YR$$F$Y$$$20240701$$HP$CA$CA
239863072$23986307$2$F$$20240705$20240618$20240710$EXP$$PH-AMGEN-PHLSP2024118169$AMGEN$Wong S.N.; Febro R.D.; Perillo E.S. et al.. Cure can be Achieved by Conversion to Microwave Ablation following Atezolizumab Bevacizumab Therapy in Unresectable Hepatocellular Carcinoma. Journal of liver cancer (Online). 2024;1-16$$$$$Y$$$20240710$$MD$PH$PH
239863082$23986308$2$F$$20240705$20240618$20240711$EXP$$JP-OTSUKA-2024_017082$OTSUKA$$88$YR$$F$Y$$$20240711$$MD$JP$JP
239863102$23986310$2$F$$20240910$20240618$20240918$PER$$US-Calliditas-2024CAL01024$CALLIDITAS THERAPEUTICS$$67$YR$E$M$Y$$$20240918$$CN$US$US
239863112$23986311$2$F$20240601$20240814$20240618$20240903$PER$$US-KARYOPHARM-2024KPT001164$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
239863152$23986315$2$F$$20240705$20240618$20240709$EXP$$PH-AMGEN-PHLSP2024118179$AMGEN$Wong S.N.; Febro R.D.; Perillo E.S. et al.. Cure can be Achieved by Conversion to Microwave Ablation following Atezolizumab Bevacizumab Therapy in Unresectable Hepatocellular Carcinoma. Journal of liver cancer (Online). 2024;1-16$$$$$Y$$$20240709$$MD$PH$PH
239863172$23986317$2$F$$20240705$20240618$20240710$EXP$$PH-AMGEN-PHLSP2024118172$AMGEN$Wong S.N.; Febro R.D.; Perillo E.S. et al.. Cure can be Achieved by Conversion to Microwave Ablation following Atezolizumab Bevacizumab Therapy in Unresectable Hepatocellular Carcinoma. Journal of liver cancer (Online). 2024;1-16$$$$$Y$$$20240710$$MD$PH$PH
239863192$23986319$2$F$$20240703$20240618$20240712$PER$$US-SA-2024SA175305$SANOFI AVENTIS$$$$E$F$Y$$$20240712$$MD$US$US
239863232$23986323$2$F$$20240710$20240618$20240715$EXP$$US-GILEAD-2024-0676779$GILEAD$$$$A$F$Y$$$20240715$$HP$US$US
239863442$23986344$2$F$20240501$20240808$20240618$20240814$PER$$US-PFIZER INC-PV202400078029$PFIZER$$56$YR$$M$Y$$$20240814$$HP$US$US
239863702$23986370$2$F$$20240720$20240618$20240722$PER$$US-PFIZER INC-202400195141$PFIZER$$72$YR$$F$Y$$$20240722$$CN$US$US
239863713$23986371$3$F$$20240722$20240618$20240730$PER$$US-PFIZER INC-PV202400078207$PFIZER$$62$YR$$M$Y$$$20240730$$HP$US$US
239863742$23986374$2$F$20240101$20240806$20240618$20240809$EXP$$PR-PFIZER INC-202400193516$PFIZER$$68$YR$$F$Y$$$20240809$$HP$PR$PR
239863763$23986376$3$F$$20240719$20240618$20240723$PER$$US-PFIZER INC-PV202400076527$PFIZER$$72$YR$$M$Y$$$20240723$$MD$US$US
239863793$23986379$3$F$20220501$20240618$20240618$20240701$EXP$$NVSC2024DE126057$NOVARTIS$$70$YR$$F$Y$78$KG$20240701$$HP$DE$DE
239863942$23986394$2$F$20230830$20240805$20240618$20240813$EXP$$PT-OTSUKA-2024_010405$OTSUKA$$55$YR$$M$Y$89$KG$20240813$$MD$PT$PT
239864192$23986419$2$F$$20240723$20240618$20240806$PER$$US-ALKERMES INC.-ALK-2024-001583$ALKERMES$$$$$M$Y$$$20240806$$MD$US$US
239864223$23986422$3$F$20240501$20240710$20240618$20240716$EXP$$US-AMGEN-USASP2024115486$AMGEN$$83$YR$E$F$Y$$$20240716$$CN$US$US
239864272$23986427$2$F$20240601$20240627$20240618$20240711$EXP$$US-TILDE SCIENCES LLC-2024TIL00010$Tilde Sciences$$60$YR$$M$Y$59.421$KG$20240711$$CN$US$US
239864292$23986429$2$F$20230101$20240712$20240618$20240715$EXP$$JP-AstraZeneca-2024A098382$ASTRAZENECA$$47$YR$$M$Y$$$20240715$$MD$JP$
239864302$23986430$2$F$20230928$20240814$20240618$20240822$EXP$$US-AstraZeneca-2024A139508$ASTRAZENECA$$73$YR$$M$Y$61.1$KG$20240822$$HP$US$
239864382$23986438$2$F$20240501$20240806$20240618$20240816$PER$$US-SA-2024SA173370$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240816$$MD$US$US
239864602$23986460$2$F$$20240613$20240618$20240927$EXP$$NVSC2024CO126451$NOVARTIS$$$$$F$Y$$$20240927$$CN$CO$CO
239864652$23986465$2$F$$20240810$20240618$20240812$30DAY$$CO-PFIZER INC-202400187358$PFIZER$$13$YR$$M$Y$$$20240812$$CN$CO$CO
239864662$23986466$2$F$20240101$20240815$20240618$20240819$30DAY$$JP-PFIZER INC-PV202400075589$PFIZER$$$$$F$Y$$$20240819$$CN$JP$JP
239864674$23986467$4$F$20240607$20240915$20240618$20240917$30DAY$$AT-PFIZER INC-202400191215$PFIZER$$26$YR$$F$Y$53$KG$20240917$$HP$AT$AT
239864922$23986492$2$F$20240301$20240620$20240618$20240704$EXP$$IT-CIPLA LTD.-2024IT05949$CIPLA$$$$$$Y$$$20240704$$PH$IT$IT
239864952$23986495$2$F$$20240801$20240618$20240816$PER$$US-AstraZeneca-2024A130527$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
239864973$23986497$3$F$20240605$20240827$20240618$20240830$30DAY$$DE-PFIZER INC-202400191967$PFIZER$$50$YR$$F$Y$$$20240830$$HP$DE$DE
239864982$23986498$2$F$$20240723$20240618$20240731$EXP$$US-AstraZeneca-2024A135088$ASTRAZENECA$$$$$F$Y$$$20240731$$MD$US$
239864993$23986499$3$F$20240607$20240825$20240618$20240828$30DAY$$US-PFIZER INC-202400190472$PFIZER$$2$YR$$F$Y$14.512$KG$20240828$$CN$US$US
239865252$23986525$2$F$20240227$20240716$20240618$20240722$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003410$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240722$$MD$IT$IT
239865353$23986535$3$F$$20240708$20240618$20240711$EXP$$US-GILEAD-2024-0677186$GILEAD$$$$E$M$Y$$$20240711$$MD$US$US
239865442$23986544$2$F$20240524$20240621$20240618$20240711$PER$$FR-TOLMAR, INC.-24FR050016$TOLMAR$$77$YR$$M$Y$$$20240710$$PH$FR$FR
239865515$23986551$5$F$$20240819$20240618$20240821$EXP$$US-ORGANON-O2406USA001531$ORGANON$$28$YR$$F$Y$208.16$KG$20240821$$HP$US$US
239865612$23986561$2$F$$20240716$20240618$20240718$PER$$US-PFIZER INC-PV202400076410$PFIZER$$66$YR$$F$Y$$$20240718$$CN$US$US
239866002$23986600$2$F$20240101$20240726$20240618$20240807$PER$$US-SA-2024SA179339$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240807$$MD$US$US
239866243$23986624$3$F$20240601$20240705$20240618$20240712$EXP$$US-SA-2024SA178857$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240712$$MD$US$US
239866263$23986626$3$F$20240611$20240723$20240618$20240731$30DAY$$US-JNJFOC-20240631630$JOHNSON AND JOHNSON$$53$YR$A$$Y$74.91$KG$20240731$$PH$US$US
239866363$23986636$3$F$$20240723$20240618$20240729$PER$$US-BEH-2024173819$CSL BEHRING$$$$A$F$Y$$$20240729$$CN$US$US
239866392$23986639$2$F$20240624$20240718$20240618$20240726$EXP$$US-JNJFOC-20240641652$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240726$$CN$US$US
239866462$23986646$2$F$20240610$20240610$20240618$20240723$EXP$$BR-AstraZeneca-2024A138194$ASTRAZENECA$$$$$M$Y$$$20240723$$MD$BR$
239866472$23986647$2$F$20240609$20240730$20240618$20240807$EXP$$JP-AstraZeneca-2024A138696$ASTRAZENECA$$77$YR$$F$Y$$$20240807$$MD$JP$
239866504$23986650$4$F$20240522$20240715$20240618$20240725$PER$$US-Calliditas-2024CAL01056$CALLIDITAS THERAPEUTICS$$40$YR$A$M$Y$73.5$KG$20240725$$CN$US$US
239866662$23986666$2$F$$20240605$20240618$20240714$EXP$$US-BAYER-2024A085948$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240714$$MD$US$US
239866782$23986678$2$F$20240615$20240712$20240618$20240716$PER$$US-AMGEN-USASP2024119842$AMGEN$$$$$F$Y$$$20240716$$CN$US$US
239866805$23986680$5$F$$20240829$20240618$20240903$PER$$US-BIOGEN-2024BI01267624$BIOGEN$$$$$F$Y$$$20240903$$CN$US$US
239866862$23986686$2$F$$20240716$20240618$20240722$30DAY$$FR-JNJFOC-20240641740$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$FR$FR
239866962$23986696$2$F$20240512$20240816$20240618$20240820$EXP$$NVSC2024US124727$NOVARTIS$$55$YR$$F$Y$$$20240820$$CN$US$US
239866983$23986698$3$F$$20240709$20240618$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04919$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239867023$23986702$3$F$20240101$20240808$20240618$20240820$PER$$US-SA-2024SA174315$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240820$$MD$US$US
239867183$23986718$3$F$$20240821$20240618$20240904$PER$$US-Calliditas-2024CAL01050$CALLIDITAS THERAPEUTICS$$50$YR$A$F$Y$$$20240904$$CN$US$US
239867222$23986722$2$F$$20240815$20240618$20240822$EXP$$US-BIOGEN-2024BI01265517$BIOGEN$$$$$M$Y$$$20240822$$CN$US$US
239867272$23986727$2$F$$20240709$20240618$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04921$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239867342$23986734$2$F$$20240809$20240618$20240820$PER$$US-SA-2024SA175093$SANOFI AVENTIS$$$$C$F$Y$$$20240820$$MD$US$US
239867352$23986735$2$F$$20240722$20240618$20240725$PER$$US-HALEON-2182408$Haleon PLC$$35$YR$$F$Y$$$20240725$$CN$US$US
239867363$23986736$3$F$20240603$20240910$20240618$20240918$EXP$$US-CLARIONBRANDS-2024-US-031703$CLARION BRANDS$$74$YR$$M$Y$72.58$KG$20240918$$CN$US$US
239867402$23986740$2$F$$20240812$20240618$20240822$EXP$$PT-TEVA-VS-3206558$TEVA$Frois AT, Fonseca HG. Diabetes and pancreatic cancer: a case series in primary health care. AIMGF Magazine. 2023;13(2):21-7; Frois AT, Fonseca HG. Diabetes and pancreatic cancer: a case series in primary health care. AIMGF Magazine. 2023;13(2):21-7$69$YR$$F$Y$$$20240822$$MD$PT$PT
239867472$23986747$2$F$$20240823$20240618$20240828$EXP$$US-ABBVIE-5803803$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
239867653$23986765$3$F$20240101$20240731$20240618$20240807$EXP$$US-SA-2024SA179788$SANOFI AVENTIS$$39$YR$A$M$Y$148.77$KG$20240807$$MD$US$US
239867722$23986772$2$F$$20240821$20240618$20240827$EXP$$NVSC2024CA126516$NOVARTIS$$72$YR$$M$Y$$$20240827$$HP$CA$CA
239867742$23986774$2$F$$20240731$20240618$20240814$PER$$US-Calliditas-2024CAL01049$CALLIDITAS THERAPEUTICS$$31$YR$A$M$Y$$$20240813$$CN$US$US
239867782$23986778$2$F$20240613$20240702$20240618$20240705$PER$$US-AMGEN-USASP2024117775$AMGEN$$68$YR$E$M$Y$113$KG$20240705$$PH$US$US
239867872$23986787$2$F$20240806$20240812$20240618$20240822$EXP$$US-BAYER-2024A086596$BAYER$$44$YR$A$M$Y$$$20240822$$HP$US$US
239868042$23986804$2$F$$20240626$20240618$20240701$PER$$US-PFIZER INC-202400194311$PFIZER$$$$$$Y$$$20240701$$CN$US$US
239868062$23986806$2$F$20240101$20240909$20240618$20240911$EXP$$US-PFIZER INC-PV202400078216$PFIZER$$68$YR$$F$Y$$$20240911$$HP$US$US
239868102$23986810$2$F$$20240814$20240618$20240816$PER$$US-PFIZER INC-202400195669$PFIZER$$52$YR$$F$Y$$$20240816$$PH$US$US
239868126$23986812$6$F$$20240722$20240618$20240724$EXP$$US-PFIZER INC-PV202400077588$PFIZER$$64$YR$$F$Y$$$20240724$$CN$US$US
239868162$23986816$2$F$20240501$20240719$20240618$20240723$PER$$US-PFIZER INC-PV202400078984$PFIZER$$80$YR$$F$Y$$$20240723$$HP$US$US
239868202$23986820$2$F$20231101$20240701$20240618$20240702$PER$$US-PFIZER INC-202101059154$PFIZER$$59$YR$$F$Y$$$20240702$$HP$US$US
239868212$23986821$2$F$$20240720$20240618$20240722$PER$$US-PFIZER INC-PV202400077885$PFIZER$$56$YR$$F$Y$$$20240722$$MD$US$US
239868224$23986822$4$F$20240101$20240723$20240618$20240729$PER$$US-PFIZER INC-202400193244$PFIZER$$64$YR$$F$Y$$$20240729$$HP$US$US
239868232$23986823$2$F$$20240718$20240618$20240723$PER$$US-PFIZER INC-202400193339$PFIZER$$59$YR$$F$Y$$$20240723$$HP$US$US
239868272$23986827$2$F$20240606$20240819$20240618$20240826$PER$$US-PFIZER INC-202400193257$PFIZER$$71$YR$$F$Y$$$20240826$$HP$US$US
239868343$23986834$3$F$$20240918$20240618$20240923$PER$$US-PFIZER INC-202400195281$PFIZER$$97$YR$$F$Y$$$20240923$$CN$US$US
239868354$23986835$4$F$$20240912$20240618$20240913$PER$$US-PFIZER INC-202400186243$PFIZER$$42$YR$$F$Y$$$20240913$$HP$US$US
239868372$23986837$2$F$20240601$20240710$20240618$20240715$PER$$US-PFIZER INC-202400192565$PFIZER$$$$$$Y$$$20240715$$CN$US$US
239868412$23986841$2$F$20240601$20240710$20240618$20240715$PER$$US-PFIZER INC-202400192564$PFIZER$$$$$$Y$$$20240715$$CN$US$US
239868502$23986850$2$F$20240613$20240613$20240618$20240703$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-086136$REGENERON$$$$$M$Y$$$20240703$$PH$CA$CA
239868532$23986853$2$F$$20240730$20240618$20240730$PER$$US-ALXN-202406USA000765US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
239868557$23986855$7$F$20240619$20240906$20240618$20240916$EXP$$CA-TAKEDA-2024TUS053812$TAKEDA$$45$YR$$F$Y$105$KG$20240916$$CN$CA$CA
239868563$23986856$3$F$20240705$20240801$20240618$20240807$EXP$$CA-TAKEDA-2024TUS053011$TAKEDA$$33$YR$$F$Y$$$20240807$$CN$CA$CA
239868592$23986859$2$F$$20240625$20240618$20240701$EXP$$US-PFIZER INC-PV202400078347$PFIZER$Yasir, M.. Rare Case of Resistant Aspergillus Niger Invasive Pulmonary Aspergillosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3586$70$YR$$F$Y$$$20240701$$HP$US$US
239868623$23986862$3$F$20240101$20240809$20240618$20240809$EXP$$CA-PFIZER INC-202400193201$PFIZER$$52$YR$$F$Y$$$20240809$$HP$CA$CA
239868683$23986868$3$F$20240101$20240711$20240618$20240715$EXP$$CA-PFIZER INC-202400193190$PFIZER$$42$YR$$M$Y$$$20240715$$HP$CA$CA
239868712$23986871$2$F$$20240715$20240618$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202406011730$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240717$$CN$US$US
239868752$23986875$2$F$$20240620$20240618$20240710$PER$$US-Calliditas-2024CAL01048$CALLIDITAS THERAPEUTICS$$23$YR$A$M$Y$103$KG$20240710$$CN$US$US
239868845$23986884$5$F$20240509$20240723$20240618$20240731$EXP$$CA-TAKEDA-2024TUS058833$TAKEDA$$64$YR$$F$Y$$$20240731$$HP$CA$CA
239868854$23986885$4$F$20240528$20240730$20240618$20240812$30DAY$$MX-JNJFOC-20240604243$JOHNSON AND JOHNSON$$42$YR$A$F$Y$60$KG$20240812$$CN$MX$MX
239868862$23986886$2$F$20240609$20240619$20240618$20240701$EXP$$US-ZENPEP LLC-2024AIMT00946$AIMMUNE$$$$$$Y$$$20240701$$HP$US$US
239868872$23986887$2$F$20190101$20240708$20240618$20240713$EXP$$US-ABBVIE-5732317$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
239868882$23986888$2$F$$20240724$20240618$20240731$EXP$$US-ALXN-202406USA000657US$ALEXION PHARMACEUTICALS$$$$$F$Y$45.351$KG$20240731$$MD$US$US
239868892$23986889$2$F$$20240621$20240618$20240701$EXP$$US-TEVA-VS-3203186$TEVA$Eddens T, Song E, Ardura MI, Kolls JK. A protracted course of Pneumocystis pneumonia in the setting of an immunosuppressed child with GMS-negative bronchoalveolar lavage. Med-Mycol-Case-Reports 2016; 11 48-52.; Eddens T, Song E, Ardura MI, Kolls JK. A protracted course of Pneumocystis pneumonia in the setting of an immunosuppressed child with GMS-negative bronchoalveolar lavage. Med-Mycol-Case-Reports 2016; 11 48-52.; Eddens T, Song E, Ardura MI, Kolls JK. A protracted course of Pneumocystis ...$5$YR$$M$Y$$$20240701$$HP$US$US
239868902$23986890$2$F$$20240724$20240618$20240731$PER$$US-ALXN-202406USA000627US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239869155$23986915$5$F$20240603$20240913$20240618$20240924$EXP$$CN-BAXTER-2024BAX019816$BAXTER$$63$YR$$M$Y$48.8$KG$20240924$$MD$CN$CN
239869272$23986927$2$F$$20240716$20240618$20240726$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202406008517$ELI LILLY AND CO$$$$A$F$Y$$$20240726$$CN$AE$AE
239869314$23986931$4$F$$20240716$20240618$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202406003992$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240731$$CN$US$US
239869452$23986945$2$F$$20240903$20240618$20240912$PER$$US-SA-2024SA175662$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240912$$MD$US$US
239869612$23986961$2$F$$20240731$20240618$20240814$PER$$US-Calliditas-2024CAL01045$CALLIDITAS THERAPEUTICS$$73$YR$E$M$Y$104$KG$20240813$$CN$US$US
239869662$23986966$2$F$20240524$20240802$20240618$20240815$EXP$$IT-CIPLA LTD.-2024IT05959$CIPLA$$$$$$Y$$$20240815$$MD$IT$IT
239869683$23986968$3$F$$20240819$20240618$20240823$EXP$$NVSC2024CA126563$NOVARTIS$$5$DEC$$F$Y$$$20240823$$HP$CA$CA
239869752$23986975$2$F$$20240724$20240618$20240724$30DAY$$CL-PFIZER INC-PV202400077139$PFIZER$$12$YR$$M$Y$$$20240724$$CN$CL$CL
239869766$23986976$6$F$$20240916$20240618$20240919$30DAY$$CL-PFIZER INC-PV202400078599$PFIZER$$10$YR$$F$Y$$$20240919$$CN$CL$CL
239869892$23986989$2$F$$20240903$20240618$20240910$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202406007812$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240910$$CN$DE$DE
239869962$23986996$2$F$$20240810$20240618$20240814$EXP$$JP-OTSUKA-2024_017179$OTSUKA$Miyazawa M, Yanagi M, Chiba T, Kido H, Matsuo T, Nishitani M, et al.. Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease. Internal Medicine. 2024;63:1563-8$53$YR$$F$Y$$$20240814$$MD$JP$JP
239869982$23986998$2$F$20240601$20240710$20240618$20240715$PER$$US-PFIZER INC-202400192287$PFIZER$$$$$$Y$$$20240715$$CN$US$US
239870062$23987006$2$F$$20240624$20240618$20240701$EXP$$US-PFIZER INC-PV202400078427$PFIZER$Bollam, R.. Persistent Pseudomonas Aeruginosa Pneumonia Due to Antimicrobial Resistance Development Requiring Lobectomy. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2400$56$YR$$F$Y$$$20240701$$HP$US$US
239870092$23987009$2$F$$20240703$20240618$20240708$PER$$US-PFIZER INC-202400193299$PFIZER$$64$YR$$F$Y$$$20240708$$CN$US$US
239870162$23987016$2$F$20240610$20240724$20240618$20240802$EXP$$JP-FERRINGPH-2024FE03120$FERRING$$$$$$Y$$$20240802$$PH$JP$JP
239870192$23987019$2$F$$20240702$20240618$20240709$EXP$$PL-MYLANLABS-2024M1051476$MYLAN$Slusarczyk WT, Laskowski M, Kwiatkowska M A, Koperczak A. Double spinal cord stimulators (SCS) with different types of stimulation implanted percutaneously case report and literature review. Annales Academiae Medicae Silesiensis. 2024;78:104?107$51$YR$$M$Y$$$20240709$$MD$PL$PL
239870342$23987034$2$F$20240604$20240829$20240618$20240910$EXP$$US-FARMAPROD-202406-2165$DOMPE FARMACEUTICI$$99$YR$E$F$Y$$$20240910$$MD$US$US
239870382$23987038$2$F$$20240804$20240618$20240808$PER$$US-AMGEN-HZN-2024-005695$AMGEN$$$$$$Y$$$20240808$$CN$US$US
239870442$23987044$2$F$20240620$20240628$20240618$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097631$BRISTOL MYERS SQUIBB$$40$YR$A$M$Y$$$20240701$$CN$US$US
239870452$23987045$2$F$$20240708$20240618$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096856$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$63.05$KG$20240711$$CN$US$US
239870533$23987053$3$F$20240619$20240903$20240618$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097217$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240910$$MD$US$US
239870564$23987056$4$F$20240101$20240814$20240618$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097601$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$83.91$KG$20240816$$CN$US$US
239870643$23987064$3$F$$20240912$20240618$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095535$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240913$$CN$US$US
239870652$23987065$2$F$$20240626$20240618$20240703$EXP$$US-862174955-ML2024-03379$Unknown Manufacturer$$83$YR$E$F$Y$$$20240703$$CN$US$US
239870673$23987067$3$F$$20240711$20240618$20240719$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-09521$IPSEN$$28$YR$A$M$Y$59.7$KG$20240719$$CN$US$US
239870683$23987068$3$F$$20240819$20240618$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097836$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240820$$CN$US$US
239870782$23987078$2$F$20240329$20240507$20240618$20240812$EXP$FR-AFSSAPS-AN2024000613$FR-TEVA-VS-3209525$TEVA$$59$YR$$M$Y$$$20240812$$MD$FR$FR
239871082$23987108$2$F$$20240704$20240618$20240712$EXP$$SI-TAKEDA-2024TUS060112$TAKEDA$$$$E$M$Y$$$20240712$$MD$SI$SI
239871102$23987110$2$F$$20240709$20240618$20240723$PER$$US-Calliditas-2024CAL01043$CALLIDITAS THERAPEUTICS$$62$YR$A$M$Y$71$KG$20240723$$CN$US$US
239871112$23987111$2$F$20220621$20240806$20240618$20240812$EXP$$CA-TAKEDA-2024TUS060250$TAKEDA$$60$YR$$M$Y$$$20240812$$CN$CA$CA
239871293$23987129$3$F$20240601$20240913$20240618$20240919$PER$$US-PFIZER INC-202400191697$PFIZER$$13$YR$$M$Y$$$20240919$$CN$US$US
239871332$23987133$2$F$$20240626$20240618$20240701$EXP$$US-PFIZER INC-PV202400078371$PFIZER$Pandey, M.. Pneumocystis Pneumonia in a Patient With Prolonged Steroid Therapy. American Journal of Respiratory and Critical Care Medicine. 2024;209$65$YR$$M$Y$$$20240701$$HP$US$US
239871342$23987134$2$F$$20240710$20240618$20240722$EXP$$US-ANIPHARMA-2024-US-033285$ANI$$$$$M$Y$$$20240722$$CN$US$US
239871454$23987145$4$F$$20240913$20240618$20240924$PER$$US-PFIZER INC-202400193064$PFIZER$$15$YR$$M$Y$58.05$KG$20240924$$CN$US$US
239871604$23987160$4$F$$20240913$20240618$20240919$30DAY$$US-PFIZER INC-202400192905$PFIZER$$14$YR$$M$Y$$$20240919$$CN$US$US
239871792$23987179$2$F$20240603$20240702$20240618$20240724$PER$$US-P+L Developments of Newyork Corporation-2158272$PL DEVELOPMENTS$$62$YR$$F$Y$$$20240724$$$US$US
239871855$23987185$5$F$$20240829$20240618$20240906$30DAY$$US-PFIZER INC-202400193981$PFIZER$$12$YR$$F$Y$41.723$KG$20240906$$CN$US$US
239871882$23987188$2$F$20240101$20240624$20240618$20240723$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000094$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
239871953$23987195$3$F$20231016$20240828$20240618$20240903$EXP$$JP-009507513-2406JPN001612J$MERCK$$71$YR$$M$Y$$$20240903$$MD$JP$JP
239871995$23987199$5$F$20240611$20240802$20240618$20240917$PER$$US-LUNDBECK-DKLU4000508$LUNDBECK$$$$$$Y$$$20240917$$CN$US$US
239872102$23987210$2$F$$20240604$20240618$20240704$EXP$$FR-ASTELLAS-2024EU004897$ASTELLAS$$12$YR$$F$Y$42$KG$20240704$$HP$FR$FR
239872132$23987213$2$F$$20240712$20240618$20240716$EXP$$US-PFIZER INC-PV202400079108$PFIZER$Torelli, V.. Rapidly Progressive Interstitial Lung Disease Due to Silicosis in an Otherwise Healthy Jeweler. American Journal of Respiratory and Critical Care Medicine. 2024;209$83$YR$$F$Y$$$20240716$$HP$US$US
239872192$23987219$2$F$20240510$20240702$20240618$20240710$EXP$$US-AstraZeneca-2024A135122$ASTRAZENECA$$30002$DY$$F$Y$65.4$KG$20240710$$HP$US$
239872204$23987220$4$F$$20240703$20240618$20240828$PER$$US-AstraZeneca-2024A128917$ASTRAZENECA$$$$$$Y$$$20240828$$CN$US$
239872374$23987237$4$F$20240301$20240807$20240618$20240809$EXP$$JP-ALXN-202406JPN000812JP$ALEXION PHARMACEUTICALS$$70$YR$$F$Y$$$20240809$$MD$JP$JP
239872402$23987240$2$F$$20240716$20240618$20240723$EXP$$GB-TAKEDA-2024TUS059615$TAKEDA$$$$$M$Y$$$20240723$$CN$GB$GB
239872464$23987246$4$F$$20240621$20240618$20240924$EXP$$NVSC2024US127198$NOVARTIS$$$$$M$Y$$$20240924$$CN$US$US
239872502$23987250$2$F$$20240724$20240618$20240731$EXP$$US-ALXN-202406USA000654US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239872672$23987267$2$F$20240506$20240628$20240618$20240702$EXP$$NVSC2024FI125973$NOVARTIS$$$$E$F$Y$$$20240702$$CN$FI$FI
239872772$23987277$2$F$$20240626$20240618$20240709$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI05948$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240709$$PH$JP$JP
239872892$23987289$2$F$$20240806$20240618$20240820$PER$$US-Calliditas-2024CAL01036$CALLIDITAS THERAPEUTICS$$65$YR$E$M$Y$$$20240820$$CN$US$US
239872972$23987297$2$F$$20240816$20240618$20240820$EXP$$NVSC2024PL126511$NOVARTIS$$$$$F$Y$$$20240820$$MD$PL$PL
239872992$23987299$2$F$$20240820$20240618$20240826$EXP$$FR-APELLIS-2024-APL-0000273$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240826$$MD$FR$FR
239873013$23987301$3$F$$20240621$20240618$20240705$EXP$$DK-BAUSCH-BL-2024-009037$BAUSCH AND LOMB$Ravn C, Bendix M, Lyhne S. Akut pankreatitis hos patient med colitis ulcerosa i behandling med vedolizumab og budesonid. Ugeskr Laeger. 2024 MAY 27;186:V01240025. doi:10.61409/V01240025$21$YR$$M$Y$$$20240705$$MD$DK$DK
239873113$23987311$3$F$20240801$20240912$20240618$20240913$PER$$US-PFIZER INC-202400193647$PFIZER$$13$YR$$F$Y$$$20240913$$CN$US$US
239873242$23987324$2$F$20240531$20240724$20240618$20240801$EXP$$CA-APELLIS-2024-APL-0000271$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$CA$CA
239873305$23987330$5$F$$20240719$20240618$20240724$EXP$$US-PFIZER INC-PV202400078403$PFIZER$Tan, E.. Assay Interference Causing Persistently Elevated Vancomycin Levels Ultimately Leading to Treatment Failure and Fatal Outcome.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5673$69$YR$$F$Y$170$KG$20240724$$HP$US$US
239873362$23987336$2$F$$20240626$20240618$20240701$EXP$$CA-SANDOZ INC.-NVSC2023CA130973$SANDOZ$$$$$F$Y$$$20240701$$CN$CA$CA
239873392$23987339$2$F$$20240614$20240618$20240806$PER$$US-LUNDBECK-DKLU4000294$LUNDBECK$$$$$$Y$$$20240806$$CN$US$US
239873445$23987344$5$F$$20240711$20240618$20240715$EXP$$US-GILEAD-2024-0677419$GILEAD$$$$A$F$Y$$$20240715$$CN$US$US
239873465$23987346$5$F$20240518$20240819$20240618$20240829$PER$$US-Calliditas-2024CAL01052$CALLIDITAS THERAPEUTICS$$43$YR$A$F$Y$55$KG$20240829$$CN$US$US
239873473$23987347$3$F$$20240821$20240618$20240829$EXP$$US-Calliditas-2024CAL01054$CALLIDITAS THERAPEUTICS$$47$YR$A$M$Y$78$KG$20240829$$CN$US$US
239873572$23987357$2$F$$20240715$20240618$20240722$PER$$US-ABBVIE-5802677$ABBVIE$$$$$$Y$$$20240722$$CN$US$US
239873632$23987363$2$F$$20240701$20240618$20240708$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001226$BLUEPRINT MEDICINES$$$$$F$Y$$$20240708$$HP$US$US
239873782$23987378$2$F$20230915$20240605$20240618$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202406004214$ELI LILLY AND CO$$$$$$Y$$$20240717$$CN$US$US
239873812$23987381$2$F$$20240730$20240618$20240730$PER$$US-ALXN-202406USA000762US$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240730$$MD$US$US
239873822$23987382$2$F$$20240724$20240618$20240731$EXP$$US-ALXN-202406USA000669US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240731$$MD$US$US
239873832$23987383$2$F$$20240702$20240618$20240716$PER$$US-Calliditas-2024CAL01078$CALLIDITAS THERAPEUTICS$$47$YR$A$M$Y$98.4$KG$20240716$$CN$US$US
239873912$23987391$2$F$20240701$20240701$20240618$20240715$PER$$US-ALKERMES INC.-ALK-2024-001568$ALKERMES$$69$YR$$F$Y$44.898$KG$20240715$$CN$US$US
239874022$23987402$2$F$20240607$20240717$20240618$20240802$PER$$US-JNJFOC-20240642240$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240802$$HP$US$US
239874162$23987416$2$F$20240501$20240702$20240618$20240716$PER$$US-Calliditas-2024CAL01062$CALLIDITAS THERAPEUTICS$$66$YR$E$M$Y$103.8$KG$20240716$$CN$US$US
239874282$23987428$2$F$$20240610$20240618$20240708$EXP$$US-VIIV HEALTHCARE LIMITED-US2024GSK072505$VIIV$Cadle RM, Zenon GJ, Rodriguez-Barradas MC, Hamill RJ. Fluconazole-induced symptomatic phenytoin toxicity. Ann Pharmacother. 1994;28(2):191-195$$$$$Y$$$20240708$$PH$US$US
239874353$23987435$3$F$$20240710$20240618$20240720$EXP$GB-MHRA-ADR 28748881$XI-TEVA-VS-3208584$TEVA$$31$YR$$F$Y$$$20240720$$CN$GB$GB
239874372$23987437$2$F$$20240711$20240618$20240723$PER$$US-JNJFOC-20240626125$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240723$$CN$US$US
239874412$23987441$2$F$$20240716$20240618$20240720$PER$$NVSC2024US127277$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
239874422$23987442$2$F$20240614$20240621$20240618$20240701$PER$$US-BIOMARINAP-US-2024-158658$BIOMARIN$$$$$$Y$$$20240701$$CN$US$US
239874435$23987443$5$F$20240726$20240820$20240618$20240825$EXP$$US-GILEAD-2024-0677739$GILEAD$$44$YR$A$F$Y$$$20240825$$HP$US$US
239874462$23987446$2$F$$20240808$20240618$20240809$PER$$NVSC2024US127278$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
239874472$23987447$2$F$$20240823$20240618$20240902$EXP$$US-BAUSCHBL-2024BNL028523$BAUSCH AND LOMB$$88$YR$$M$Y$$$20240902$$CN$US$US
239874482$23987448$2$F$20240526$20240703$20240618$20240711$EXP$$DE-BEH-2024173632$CSL BEHRING$$89$YR$E$M$Y$85$KG$20240711$$MD$DE$DE
239874544$23987454$4$F$20240529$20240814$20240618$20240827$PER$$US-Calliditas-2024CAL01067$CALLIDITAS THERAPEUTICS$$48$YR$A$M$Y$$$20240827$$CN$US$US
239874604$23987460$4$F$20240501$20240906$20240618$20240917$PER$$US-Calliditas-2024CAL01070$CALLIDITAS THERAPEUTICS$$72$YR$E$M$Y$104$KG$20240917$$CN$US$US
239874613$23987461$3$F$$20240808$20240618$20240822$PER$$US-Calliditas-2024CAL01068$CALLIDITAS THERAPEUTICS$$65$YR$E$M$Y$70$KG$20240822$$CN$US$US
239874673$23987467$3$F$20240708$20240917$20240618$20240925$EXP$$US-Calliditas-2024CAL01072$CALLIDITAS THERAPEUTICS$$69$YR$E$F$Y$104.78$KG$20240925$$CN$US$US
239874753$23987475$3$F$20240101$20240731$20240618$20240812$PER$$US-ALKERMES INC.-ALK-2024-001594$ALKERMES$$$$$F$Y$$$20240812$$HP$US$US
239874772$23987477$2$F$$20240627$20240618$20240717$PER$$BR-TOLMAR, INC.-24BR049365$TOLMAR$$$$$M$Y$$$20240717$$PH$BR$BR
239874922$23987492$2$F$20240217$20240624$20240618$20240709$PER$$US-APELLIS-APL-2024-004125$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
239874942$23987494$2$F$$20240917$20240618$20240919$PER$$US-JNJFOC-20240632989$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$HP$US$US
239875182$23987518$2$F$20240604$20240708$20240618$20240709$PER$$US-JNJFOC-20240611257$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240709$$PH$US$US
239875222$23987522$2$F$$20240621$20240618$20240702$PER$$US-INCYTE CORPORATION-2024IN006249$INCYTE$$$$$$Y$$$20240702$$CN$US$US
239875262$23987526$2$F$20240117$20240627$20240618$20240701$EXP$$FR-BAUSCHBL-2024BNL028655$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240701$$HP$FR$FR
239875282$23987528$2$F$20240501$20240711$20240618$20240716$EXP$$AU-ABBVIE-5800447$ABBVIE$$91$YR$$M$Y$$$20240716$$CN$AU$AU
239875292$23987529$2$F$20240604$20240715$20240618$20240717$PER$$US-JNJFOC-20240608138$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240717$$CN$US$US
239875322$23987532$2$F$20220507$20240627$20240618$20240701$EXP$$CN-PFIZER INC-2022SGN11544$PFIZER$$27$YR$$F$Y$72$KG$20240701$$MD$CN$CN
239875348$23987534$8$F$20220407$20240903$20240618$20240906$EXP$$CN-PFIZER INC-2023SGN00872$PFIZER$$34$YR$$F$Y$45$KG$20240906$$MD$CN$CN
239875364$23987536$4$F$20231229$20240829$20240618$20240904$EXP$$CA-PFIZER INC-202300092078$PFIZER$$51$YR$$F$Y$$$20240904$$HP$CA$CA
239875442$23987544$2$F$20210923$20240821$20240618$20240828$EXP$$US-INCYTE CORPORATION-2024IN006278$INCYTE$$$$$$Y$$$20240828$$MD$US$US
239875462$23987546$2$F$$20240827$20240618$20240830$EXP$$US-ABBVIE-5801544$ABBVIE$$$$$M$Y$119.75$KG$20240830$$CN$US$US
239875702$23987570$2$F$20240612$20240905$20240618$20240911$EXP$$US-ABBVIE-5803440$ABBVIE$$65$YR$$F$Y$72$KG$20240911$$CN$US$US
239875712$23987571$2$F$$20240724$20240618$20240731$PER$$US-ALXN-202406USA000642US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239875722$23987572$2$F$20240528$20240724$20240618$20240731$PER$$US-ALXN-202406USA000672US$ALEXION PHARMACEUTICALS$$83$YR$$M$Y$$$20240731$$CN$US$US
239875802$23987580$2$F$20230101$20240628$20240618$20240703$PER$$US-AMGEN-USASP2024119138$AMGEN$$82$YR$E$F$Y$$$20240703$$CN$US$US
239876022$23987602$2$F$$20240829$20240618$20240910$EXP$$JP-ASTELLAS-2024JP004120$ASTELLAS$$83$YR$E$M$Y$$$20240910$$PH$JP$JP
239876042$23987604$2$F$$20240823$20240618$20240828$EXP$$NVSC2024US126243$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
239876052$23987605$2$F$20240525$20240820$20240618$20240828$EXP$$IT-ABBVIE-5802158$ABBVIE$$65$YR$$M$Y$$$20240828$$MD$IT$IT
239876093$23987609$3$F$20230911$20240821$20240618$20240828$EXP$$BE-BIOGEN-2024BI01269458$BIOGEN$$47$YR$$F$Y$$$20240828$$HP$BE$BE
239876122$23987612$2$F$20230101$20240702$20240618$20240708$EXP$$PL-BIOGEN-2024BI01269291$BIOGEN$$$$$F$Y$$$20240708$$MD$PL$PL
239876153$23987615$3$F$20240701$20240727$20240618$20240731$EXP$$US-ABBVIE-5799692$ABBVIE$$49$YR$$M$Y$86.182$KG$20240731$$CN$PR$PR
239876172$23987617$2$F$20240529$20240722$20240618$20240724$PER$$US-JNJFOC-20240604678$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240724$$CN$US$US
239876243$23987624$3$F$$20240716$20240618$20240722$EXP$$US-BIOGEN-2024BI01269721$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
239876252$23987625$2$F$20240101$20240806$20240618$20240808$EXP$$US-BIOGEN-2024BI01269709$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
239876363$23987636$3$F$$20240919$20240619$20240924$EXP$$US-BIOGEN-2024BI01269681$BIOGEN$$$$$M$Y$$$20240924$$CN$US$US
239876373$23987637$3$F$20240401$20240723$20240619$20240728$EXP$$US-ABBVIE-5803432$ABBVIE$$56$YR$$F$Y$$$20240728$$CN$US$US
239876382$23987638$2$F$20240101$20240905$20240619$20240910$EXP$$US-ABBVIE-5803881$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
239876452$23987645$2$F$20240615$20240905$20240619$20240909$EXP$$US-ABBVIE-5805875$ABBVIE$$90$YR$$F$Y$$$20240909$$CN$US$US
239876472$23987647$2$F$20240101$20240805$20240619$20240808$EXP$$US-ABBVIE-5803642$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
239876522$23987652$2$F$20210107$20240706$20240619$20240709$EXP$$US-BIOGEN-2021BI01003800$BIOGEN$$41$YR$$M$Y$$$20240709$$CN$US$US
239876552$23987655$2$F$20240101$20240716$20240619$20240722$EXP$$AR-BIOGEN-2024BI01269434$BIOGEN$$$$$M$Y$$$20240722$$CN$AR$AR
239876574$23987657$4$F$20240611$20240906$20240619$20240911$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406007609$ELI LILLY AND CO$$15$YR$T$F$Y$52$KG$20240911$$CN$JP$JP
239876603$23987660$3$F$20240520$20240813$20240619$20240820$EXP$$US-BIOGEN-2024BI01266908$BIOGEN$$73$YR$$F$Y$$$20240820$$CN$US$US
239876763$23987676$3$F$20240518$20240716$20240619$20240807$PER$$US-AstraZeneca-2024A117934$ASTRAZENECA$$68$YR$$F$Y$$$20240807$$CN$US$
239876944$23987694$4$F$20240101$20240813$20240619$20240820$EXP$$CA-ABBVIE-5804965$ABBVIE$$77$YR$$M$Y$$$20240820$$HP$CA$CA
239877014$23987701$4$F$$20240716$20240619$20240724$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000214$EMCURE$$$$$$Y$$$20240724$$CN$US$US
239877052$23987705$2$F$20171204$20240610$20240619$20240702$EXP$$BE-ABBVIE-5804075$ABBVIE$$40$YR$$M$Y$$$20240702$$MD$BE$BE
239877134$23987713$4$F$$20240923$20240619$20240925$EXP$$US-SANDOZ INC.-SDZ2024US057961$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
239877252$23987725$2$F$$20240613$20240619$20240702$EXP$$JP-009507513-2307JPN000364J$MERCK$Nishimura A, Ishida C, Tanaka A, Kimura T, Yoshii Y, Uemura H, et al.. O-83 Treatment Selection after Onset of irAE Due to Immune Checkpoint Inhibitors for Head and Neck Cancer. The 4th Annual Meeting of The Japan Society of Immunology Allergology and Infect. 224$67$YR$$$Y$$$20240702$$MD$JP$JP
239877392$23987739$2$F$$20240722$20240619$20240724$EXP$$JP-JNJFOC-20240647991$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240724$$MD$JP$JP
239877436$23987743$6$F$$20240717$20240619$20240725$EXP$$US-ALXN-202404USA000616US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
239877503$23987750$3$F$$20240916$20240619$20240920$EXP$$US-ABBVIE-5803660$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
239877523$23987752$3$F$$20240820$20240619$20240821$PER$$NVSC2024US127285$NOVARTIS$$$$$M$Y$$$20240821$$HP$US$US
239877572$23987757$2$F$20170201$20240610$20240619$20240702$EXP$$BE-ABBVIE-5804067$ABBVIE$$34$YR$$M$Y$$$20240702$$MD$BE$BE
239877582$23987758$2$F$20240610$20240610$20240619$20240718$PER$$US-AMGEN-USASP2024115718$AMGEN$$37$YR$A$M$Y$$$20240718$$CN$US$US
239877762$23987776$2$F$20240401$20240701$20240619$20240711$EXP$$US-NOVOPROD-1224509$NOVO NORDISK$$57$YR$$F$Y$$$20240711$$HP$US$US
239877802$23987780$2$F$20240601$20240624$20240619$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017490$UNITED THERAPEUTICS$$61$YR$$M$Y$$$20240703$$$US$US
239877943$23987794$3$F$20240606$20240722$20240619$20240731$EXP$$US-NOVOPROD-1238884$NOVO NORDISK$$68$YR$$F$Y$$$20240731$$CN$US$US
239878022$23987802$2$F$20240205$20240725$20240619$20240802$EXP$$BE-NOVOPROD-1239012$NOVO NORDISK$$$$A$F$Y$80$KG$20240802$$MD$BE$BE
239878042$23987804$2$F$20240401$20240715$20240619$20240725$EXP$$US-NOVOPROD-1239261$NOVO NORDISK$$81$YR$$M$Y$59.42$KG$20240725$$CN$US$US
239878062$23987806$2$F$20210101$20240910$20240619$20240919$EXP$$US-NOVOPROD-1240052$NOVO NORDISK$$75$YR$$F$Y$$$20240919$$CN$US$US
239878115$23987811$5$F$20240601$20240807$20240619$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-014885$UNITED THERAPEUTICS$$60$YR$$F$Y$58.503$KG$20240813$$$US$US
239878152$23987815$2$F$$20240729$20240619$20240805$EXP$$US-AMGEN-USASP2024114979$AMGEN$$$$A$F$Y$$$20240805$$HP$US$US
239878194$23987819$4$F$20240101$20240711$20240619$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-017154$UNITED THERAPEUTICS$$$$$F$Y$76.644$KG$20240717$$$US$US
239878224$23987822$4$F$$20240712$20240619$20240715$PER$$US-AMGEN-USASP2024118881$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
239878252$23987825$2$F$20240501$20240719$20240619$20240730$EXP$$US-AUROBINDO-AUR-APL-2024-030344$AUROBINDO$$$$$M$Y$$$20240730$$MD$US$BR
239878272$23987827$2$F$$20240913$20240619$20240920$EXP$FR-AFSSAPS-NT2024000602$FR-HALEON-2181982$Haleon PLC$$63$YR$$F$Y$$$20240920$$MD$FR$FR
239878472$23987847$2$F$20240529$20240821$20240619$20240910$PER$$CA-TOLMAR, INC.-24CA049847$TOLMAR$$74$YR$$M$Y$$$20240909$$CN$CA$CA
239878502$23987850$2$F$20240627$20240627$20240619$20240722$PER$$CA-TOLMAR, INC.-24CA049855$TOLMAR$$77$YR$$M$Y$$$20240719$$CN$CA$CA
239878542$23987854$2$F$20231114$20240903$20240619$20240918$EXP$$CA-CELLTRION INC.-2023CA023360$CELLTRION$$$$$$Y$$$20240918$$CN$CA$CA
239878752$23987875$2$F$20240105$20240912$20240619$20240920$EXP$$JP-JNJFOC-20240647085$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240920$$MD$JP$JP
239878844$23987884$4$F$$20240925$20240619$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US058312$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
239878863$23987886$3$F$20210101$20240727$20240619$20240801$PER$$US-ABBVIE-5803904$ABBVIE$$$$$F$Y$62$KG$20240801$$CN$US$US
239879052$23987905$2$F$$20240729$20240619$20240729$PER$$US-ALXN-202406USA001036US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
239879115$23987911$5$F$20240611$20240725$20240619$20240806$30DAY$$US-JNJFOC-20240636335$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240806$$CN$US$US
239879172$23987917$2$F$20240620$20240628$20240619$20240705$EXP$$CA-JNJFOC-20240481606$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20240705$$HP$CA$CA
239879182$23987918$2$F$20240605$20240717$20240619$20240722$EXP$$JP-JNJFOC-20240647977$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240722$$PH$JP$JP
239879283$23987928$3$F$$20240905$20240619$20240909$EXP$$US-TAKEDA-2023TUS120787$TAKEDA$$$$$M$Y$79$KG$20240909$$CN$US$US
239879313$23987931$3$F$20240101$20240624$20240619$20240703$PER$$US-ABBVIE-5805537$ABBVIE$$$$$F$Y$68$KG$20240703$$CN$US$US
239879342$23987934$2$F$20240503$20240830$20240619$20240904$PER$$US-BIOGEN-2023BI01208960$BIOGEN$$40$YR$$F$Y$$$20240904$$HP$US$US
239879392$23987939$2$F$20240524$20240702$20240619$20240705$EXP$$JP-ABBVIE-5783791$ABBVIE$$30$YR$$M$Y$$$20240705$$MD$JP$JP
239879402$23987940$2$F$20240101$20240627$20240619$20240703$PER$$US-BIOGEN-2024BI01260174$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
239879422$23987942$2$F$20230407$20240610$20240619$20240829$EXP$FR-AFSSAPS-PO2024000608$FR-UCBSA-2024030898$UCB$$27$YR$$F$Y$46$KG$20240829$$MD$FR$FR
239879452$23987945$2$F$20240606$20240703$20240619$20240705$PER$$US-JNJFOC-20240636374$JOHNSON AND JOHNSON$$44$YR$A$F$Y$94.5$KG$20240705$$HP$US$US
239879462$23987946$2$F$$20240703$20240619$20240704$PER$$US-JNJFOC-20240623707$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$US$US
239879543$23987954$3$F$20240521$20240708$20240619$20240716$EXP$$RO-TOLMAR, INC.-24RO050086$TOLMAR$$73$YR$$M$Y$82$KG$20240716$$MD$RO$RO
239879563$23987956$3$F$20240613$20240625$20240619$20240702$EXP$$US-BIOGEN-2024BI01269373$BIOGEN$$41$YR$$F$Y$$$20240702$$MD$US$US
239879612$23987961$2$F$$20240729$20240619$20240808$PER$$US-JNJFOC-20240647049$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$MD$US$US
239880412$23988041$2$F$20240101$20240809$20240619$20240817$EXP$$CA-CELLTRION INC.-2024CA014575$CELLTRION$$$$$$Y$$$20240817$$HP$CA$CA
239880482$23988048$2$F$$20240816$20240619$20240822$EXP$$CA-002147023-NVSC2024CA054144$Haleon PLC$$43$YR$$F$Y$96$KG$20240822$$HP$CA$CA
239880502$23988050$2$F$$20240704$20240619$20240717$PER$$US-APOTEX-2024AP006963$APOTEX$$$$$F$Y$$$20240717$$CN$US$US
239880542$23988054$2$F$20240606$20240809$20240619$20240814$EXP$$PE-AMGEN-PERSP2024119911$AMGEN$$43$YR$A$F$Y$$$20240814$$CN$PE$PE
239880652$23988065$2$F$$20240619$20240619$20240717$EXP$$US-INFO-20240166$INFORLIFE$$$$$$Y$$$20240716$$HP$US$
239880702$23988070$2$F$$20240904$20240619$20240917$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-18217$SAMSUNG BIOEPIS$$19$YR$A$F$Y$63$KG$20240917$$CN$CA$CA
239880733$23988073$3$F$20240601$20240705$20240619$20240715$PER$$US-CHATTEMPRD-2024OHG020790$CHATTEM$$67$YR$E$F$Y$$$20240715$$CN$US$US
239880742$23988074$2$F$20240601$20240723$20240619$20240730$PER$$US-CHATTEMPRD-2024OHG020382$CHATTEM$$$$$F$Y$$$20240730$$CN$US$US
239880752$23988075$2$F$$20240910$20240619$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097602$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$44.91$KG$20240911$$CN$US$US
239880852$23988085$2$F$20240611$20240912$20240619$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095907$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240913$$HP$US$US
239880864$23988086$4$F$$20240919$20240619$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097701$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240923$$CN$US$US
239880942$23988094$2$F$20240123$20240708$20240619$20240711$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034400$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$100$KG$20240711$$MD$DE$DE
239880962$23988096$2$F$20240608$20240829$20240619$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-097006$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$57$KG$20240906$$PH$JP$JP
239881013$23988101$3$F$$20240905$20240619$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-097200$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$39$KG$20240917$$MD$JP$JP
239881152$23988115$2$F$20240617$20240716$20240619$20240718$PER$$US-AMGEN-USASP2024119498$AMGEN$$70$YR$E$F$Y$$$20240718$$CN$US$US
239881162$23988116$2$F$20240613$20240702$20240619$20240708$30DAY$$US-AMGEN-USASP2024117940$AMGEN$$68$YR$E$F$Y$63.129$KG$20240708$$HP$US$US
239881242$23988124$2$F$$20240605$20240619$20240713$PER$$JP-WT-2024-057752$Waylis$$$$$M$Y$$$20240713$$MD$JP$JP
239881252$23988125$2$F$20240101$20240629$20240619$20240715$PER$$US-APOTEX-2024AP006968$APOTEX$$$$$M$Y$$$20240715$$CN$US$US
239881323$23988132$3$F$20240413$20240710$20240619$20240712$EXP$$RO-ABBVIE-5804534$ABBVIE$$55$YR$$F$Y$$$20240712$$MD$RO$RO
239881362$23988136$2$F$$20240708$20240619$20240709$PER$$US-AMGEN-USASP2024117784$AMGEN$$76$YR$E$F$Y$$$20240709$$CN$US$US
239881394$23988139$4$F$20240607$20240724$20240619$20240813$PER$$US-AMGEN-USASP2024116905$AMGEN$$61$YR$A$M$Y$121$KG$20240813$$PH$US$US
239881403$23988140$3$F$20240614$20240711$20240619$20240715$30DAY$$US-SANDOZ INC.-SDZ2024US058579$SANDOZ$$56$YR$$F$Y$$$20240715$$CN$US$US
239881412$23988141$2$F$20240608$20240731$20240619$20240801$30DAY$$US-SANDOZ INC.-SDZ2024US057969$SANDOZ$$9$YR$$M$Y$$$20240801$$HP$US$US
239881462$23988146$2$F$20240101$20240711$20240619$20240717$PER$$US-ORGANON-O2405USA000460$ORGANON$$$$$F$Y$135.6$KG$20240717$$HP$US$US
239881512$23988151$2$F$$20240722$20240619$20240724$PER$$US-AMGEN-USASP2024118453$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
239881522$23988152$2$F$$20240705$20240619$20240715$EXP$$JP-MTPC-MTPC2024-0012483$Unknown Manufacturer$$54$YR$$F$Y$$$20240715$$PH$JP$JP
239881672$23988167$2$F$20240525$20240624$20240619$20240702$30DAY$$US-AMGEN-USASP2024117921$AMGEN$$55$YR$A$F$Y$83.1$KG$20240702$$PH$US$US
239881702$23988170$2$F$$20240909$20240619$20240927$PER$$CA-TOLMAR, INC.-23CA044276$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
239881802$23988180$2$F$20240608$20240701$20240619$20240707$30DAY$$US-AMGEN-USASP2024116226$AMGEN$$68$YR$E$F$Y$64.5$KG$20240707$$PH$US$US
239881835$23988183$5$F$20240101$20240814$20240619$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-016345$UNITED THERAPEUTICS$$$$$F$Y$62.585$KG$20240823$$$US$US
239881843$23988184$3$F$$20240812$20240619$20240821$EXP$$CA-APOTEX-2024AP007294$APOTEX$$$$$F$Y$$$20240821$$HP$CA$CA
239881852$23988185$2$F$20240606$20240628$20240619$20240704$PER$$US-AMGEN-USASP2024117920$AMGEN$$64$YR$A$F$Y$$$20240704$$HP$US$US
239881874$23988187$4$F$20240330$20240905$20240619$20240917$EXP$$DE-AUROBINDO-AUR-APL-2024-029267$AUROBINDO$$54$YR$$F$Y$71$KG$20240917$$MD$DE$DE
239881922$23988192$2$F$20240101$20240806$20240619$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015730$UNITED THERAPEUTICS$$$$$M$Y$138.32$KG$20240816$$$US$US
239881972$23988197$2$F$20240523$20240711$20240619$20240802$PER$$US-TOLMAR, INC.-24US049721$TOLMAR$$71$YR$$M$Y$$$20240802$$HP$US$US
239882034$23988203$4$F$$20240909$20240619$20240910$EXP$$PT-UCBSA-2024030739$UCB$$82$YR$$M$Y$$$20240910$$HP$PT$PT
239882072$23988207$2$F$$20240621$20240619$20240701$EXP$$GB-AMGEN-GBRSP2024091194$AMGEN$$67$YR$E$F$Y$$$20240701$$CN$GB$GB
239882092$23988209$2$F$20240101$20240703$20240619$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-018347$UNITED THERAPEUTICS$$$$$M$Y$76.19$KG$20240706$$$US$US
239882123$23988212$3$F$$20240730$20240619$20240801$PER$$US-AMGEN-USASP2024118605$AMGEN$$$$$M$Y$$$20240801$$CN$US$US
239882162$23988216$2$F$$20240613$20240619$20240718$EXP$$CA-002147023-NVSC2024CA031439$Haleon PLC$$50$YR$$F$Y$$$20240718$$HP$CA$CA
239882203$23988220$3$F$20240101$20240703$20240619$20240705$PER$$US-AMGEN-USASP2024119834$AMGEN$$51$YR$A$F$Y$$$20240705$$CN$US$US
239882473$23988247$3$F$20210101$20240709$20240619$20240807$PER$$US-AMGEN-USASP2024120093$AMGEN$$$$$F$Y$$$20240807$$MD$US$US
239882522$23988252$2$F$$20240813$20240619$20240819$EXP$$GB-SANDOZ INC.-NVSC2020GB115888$SANDOZ$$$$$M$Y$$$20240819$$CN$GB$GB
239882592$23988259$2$F$20230601$20240710$20240619$20240715$EXP$$TW-JNJFOC-20240637467$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240715$$CN$TW$TW
239882656$23988265$6$F$20240415$20240924$20240619$20240926$EXP$$FR-ORGANON-O2406FRA001594$ORGANON$$20$YR$$F$Y$51$KG$20240926$$MD$FR$FR
239882672$23988267$2$F$20240601$20240814$20240619$20240820$EXP$$US-BEH-2024170613$CSL BEHRING$$60$YR$A$M$Y$58.957$KG$20240820$$HP$US$US
239882693$23988269$3$F$20240613$20240812$20240619$20240909$PER$$US-AstraZeneca-2024A139519$ASTRAZENECA$$26745$DY$$F$Y$$$20240909$$CN$US$
239882702$23988270$2$F$20230901$20240627$20240619$20240710$EXP$$US-BEH-2024173554$CSL BEHRING$$17$YR$T$M$Y$$$20240710$$CN$US$US
239882762$23988276$2$F$20240301$20240619$20240619$20240703$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-18062$SAMSUNG BIOEPIS$$46$YR$A$F$Y$67$KG$20240703$$HP$CA$CA
239882786$23988278$6$F$20231201$20240913$20240619$20240920$EXP$$BR-CELLTRION INC.-2024BR014496$CELLTRION$$$$$$Y$$$20240920$$CN$BR$BR
239882824$23988282$4$F$20240520$20240912$20240619$20240914$EXP$$US-ABBVIE-5805986$ABBVIE$$71$YR$$F$Y$$$20240914$$CN$US$US
239883112$23988311$2$F$$20240628$20240619$20240702$EXP$$US-UCBSA-2024030973$UCB$$$$$M$Y$$$20240702$$CN$US$US
239883192$23988319$2$F$20240606$20240625$20240619$20240708$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-18205$SAMSUNG BIOEPIS$$52$YR$A$M$Y$$$20240708$$CN$CA$CA
239883205$23988320$5$F$20240101$20240726$20240619$20240801$30DAY$$US-JNJFOC-20240638680$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240802$$CN$US$US
239883282$23988328$2$F$20240117$20240627$20240619$20240704$EXP$$US-ABBVIE-5801698$ABBVIE$$60$YR$$F$Y$90$KG$20240704$$CN$US$US
239883322$23988332$2$F$20210101$20240708$20240619$20240712$EXP$$US-ABBVIE-5800339$ABBVIE$$$$$M$Y$140.61$KG$20240712$$CN$US$US
239883392$23988339$2$F$20240501$20240711$20240619$20240720$EXP$$CA-CELLTRION INC.-2024CA014465$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
239883432$23988343$2$F$20240609$20240718$20240619$20240727$EXP$$US-VIIV HEALTHCARE LIMITED-US2024072725$VIIV$$59$YR$$M$Y$$$20240727$$CN$US$US
239883443$23988344$3$F$20211001$20240920$20240619$20240925$EXP$$US-GSK-US2021227418$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$US$US
239883522$23988352$2$F$$20240709$20240619$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04915$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239883552$23988355$2$F$20221005$20240806$20240619$20240823$EXP$$US-TEVA-VS-3209316$TEVA$$57$YR$$M$Y$99$KG$20240823$$LW$US$US
239883573$23988357$3$F$20240201$20240725$20240619$20240727$EXP$$US-ABBVIE-5805570$ABBVIE$$80$YR$$M$Y$$$20240727$$CN$US$US
239883622$23988362$2$F$$20240715$20240619$20240723$30DAY$$FR-JNJFOC-20240565815$JOHNSON AND JOHNSON$$7$DEC$E$F$Y$$$20240723$$PH$FR$FR
239883632$23988363$2$F$$20240715$20240619$20240725$30DAY$$FR-JNJFOC-20240575342$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240725$$PH$FR$FR
239883693$23988369$3$F$20240101$20240829$20240619$20240904$EXP$$US-ABBVIE-5801546$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
239883773$23988377$3$F$$20240626$20240619$20240704$EXP$$CL-JNJFOC-20240643285$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240704$$CN$CL$CL
239883792$23988379$2$F$20240501$20240709$20240619$20240723$30DAY$$FR-JNJFOC-20240565577$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240722$$PH$FR$FR
239883804$23988380$4$F$$20240708$20240619$20240712$30DAY$$AU-JNJFOC-20240589676$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$PH$AU$AU
239883842$23988384$2$F$20240610$20240627$20240619$20240704$PER$$US-ALXN-202406USA000649US$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240704$$CN$US$US
239883862$23988386$2$F$$20240709$20240619$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04916$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239883882$23988388$2$F$20230101$20240710$20240619$20240927$EXP$$BR-JNJFOC-20240639419$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240927$$CN$BR$BR
239883892$23988389$2$F$20240213$20240624$20240619$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-029192$AUROBINDO$$53$YR$$M$Y$104$KG$20240702$$PH$FR$FR
239883933$23988393$3$F$20240401$20240812$20240619$20240821$EXP$$US-ELI_LILLY_AND_COMPANY-US202406012010$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240821$$CN$US$US
239884013$23988401$3$F$$20240708$20240619$20240710$PER$$US-JNJFOC-20240623802$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$HP$US$US
239884022$23988402$2$F$20240427$20240717$20240619$20240720$PER$$US-JNJFOC-20240627863$JOHNSON AND JOHNSON$$$$$M$Y$$$20240720$$HP$US$US
239884052$23988405$2$F$$20240627$20240619$20240708$30DAY$$CA-JNJFOC-20240633328$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$HP$CA$CA
239884073$23988407$3$F$20240101$20240702$20240619$20240706$PER$$US-AMGEN-USASP2024120028$AMGEN$$74$YR$E$M$Y$$$20240705$$CN$US$US
239884083$23988408$3$F$$20240812$20240619$20240814$PER$$US-AMGEN-USASP2024119168$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
239884133$23988413$3$F$20230701$20240625$20240619$20240703$EXP$$PT-AUROBINDO-AUR-APL-2024-029403$AUROBINDO$$63$YR$$M$Y$$$20240703$$MD$PT$PT
239884152$23988415$2$F$$20240801$20240619$20240805$PER$$NVSC2024US127324$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
239884172$23988417$2$F$20240501$20240911$20240619$20240919$EXP$$US-ABBVIE-5803959$ABBVIE$$89$YR$$F$Y$$$20240919$$CN$US$US
239884193$23988419$3$F$$20240626$20240619$20240704$EXP$$CZ-AUROBINDO-AUR-APL-2024-029245$AUROBINDO$Mocikova H.. Treatment of peripheral T-cell lymphoma with hemophagocytic lymphohistiocytosis/L??ba perifern?ho T-bun??n?ho lymfomu s hemofagocytuj?c? lymfohistiocyt?zou.. FARMAKOTERAPIE. 2024;(Supplementum 6:13-14$41$YR$$F$Y$$$20240704$$MD$CZ$CZ
239884202$23988420$2$F$$20240709$20240619$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04922$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239884262$23988426$2$F$$20240610$20240619$20240826$EXP$$US-TEVA-VS-3209468$TEVA$Bello R, Ramamurthi A, Aldakkak M, Erickson B, Hall WA, Tsai S, et al. Incidence of gastrointestinal bleeding following neoadjuvant chemotherapy and chemoradiation for localized pancreatic cancer. HPB 2024; 26 (Suppl. 1) S340 abstr. EP02C-119.; Bello R, Ramamurthi A, Aldakkak M, Erickson B, Hall WA, Tsai S, et al. Incidence of gastrointestinal bleeding following neoadjuvant chemotherapy and chemoradiation for localized pancreatic cancer. HPB 2024; 26 (Suppl. 1) S340 abstr. EP02C-119.$72$YR$$$Y$$$20240826$$HP$US$US
239884303$23988430$3$F$20240327$20240924$20240619$20240930$EXP$$SA-GSK-SA2024EME050414$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$SA$SA
239884313$23988431$3$F$20240501$20240730$20240619$20240806$EXP$$CA-GSK-CA2024049320$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$CA$CA
239884332$23988433$2$F$20240425$20240705$20240619$20240715$EXP$$DE-AUROBINDO-AUR-APL-2024-029284$AUROBINDO$$$$E$F$Y$105.7$KG$20240715$$MD$DE$DE
239884352$23988435$2$F$$20240626$20240619$20240701$EXP$$US-ABBVIE-5803961$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
239884402$23988440$2$F$$20240709$20240619$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04923$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239884742$23988474$2$F$$20240617$20240619$20240707$PER$$US-ELI_LILLY_AND_COMPANY-US202406012084$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240707$$CN$US$US
239884842$23988484$2$F$20240101$20240712$20240619$20240715$PER$$US-JNJFOC-20240610148$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240715$$HP$US$US
239884862$23988486$2$F$20240613$20240821$20240619$20240826$EXP$$NVSC2024US126244$NOVARTIS$$82$YR$$F$Y$$$20240826$$CN$US$US
239884892$23988489$2$F$$20240709$20240619$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04924$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239884923$23988492$3$F$20240616$20240716$20240619$20240718$PER$$US-AMGEN-USASP2024119437$AMGEN$$65$YR$E$M$Y$$$20240718$$CN$US$US
239884964$23988496$4$F$20240101$20240919$20240619$20240928$EXP$$CA-CELLTRION INC.-2024CA004914$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
239884982$23988498$2$F$20240201$20240806$20240619$20240810$EXP$$FR-VIIV HEALTHCARE LIMITED-FR2024073359$VIIV$$$$$$Y$$$20240810$$PH$FR$FR
239884992$23988499$2$F$20240208$20240619$20240619$20240704$EXP$PT-INFARMED-B202403-757$PT-SAMSUNG BIOEPIS-SB-2024-17520$SAMSUNG BIOEPIS$$62$YR$A$M$Y$57$KG$20240704$$MD$PT$PT
239885052$23988505$2$F$20240501$20240813$20240619$20240820$PER$$US-JNJFOC-20240625694$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240820$$CN$US$US
239885103$23988510$3$F$20240319$20240711$20240619$20240720$EXP$$BR-CELLTRION INC.-2024BR014181$CELLTRION$$$$$$Y$$$20240720$$CN$BR$BR
239885142$23988514$2$F$$20240823$20240619$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04958$LUPIN$$$$$$Y$$$20240909$$CN$US$US
239885203$23988520$3$F$20240101$20240725$20240619$20240731$EXP$$US-ABBVIE-5716476$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
239885212$23988521$2$F$20240106$20240711$20240619$20240717$EXP$$US-GSK-US2024073205$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$HP$US$US
239885223$23988522$3$F$20240101$20240827$20240619$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017480$UNITED THERAPEUTICS$$$$$F$Y$48.98$KG$20240905$$$US$US
239885232$23988523$2$F$$20240703$20240619$20240709$PER$$US-AstraZeneca-2024A132345$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
239885303$23988530$3$F$20240101$20240718$20240619$20240724$EXP$$CA-JNJFOC-20240614723$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240724$$HP$CA$CA
239885332$23988533$2$F$20240101$20240731$20240619$20240801$EXP$$US-UCBSA-2024001322$UCB$$$$$M$Y$$$20240801$$MD$US$US
239885362$23988536$2$F$$20240702$20240619$20240710$EXP$$US-AMAROX PHARMA-HET2024US01851$HETERO$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series. Pediatric Nephrology. 2024;1-3$15$YR$$M$Y$55$KG$20240710$$HP$US$US
239885412$23988541$2$F$20240610$20240625$20240619$20240703$EXP$$GB-TEVA-VS-3208853$TEVA$$41$YR$$M$Y$89$KG$20240703$$MD$GB$GB
239885442$23988544$2$F$$20240705$20240619$20240712$EXP$$PH-AMGEN-PHLSP2024118183$AMGEN$Wong S.N.; Febro R.D.; Perillo E.S. et al.. Cure can be Achieved by Conversion to Microwave Ablation following Atezolizumab Bevacizumab Therapy in Unresectable Hepatocellular Carcinoma. Journal of liver cance. 2024$$$$$Y$$$20240711$$MD$PH$PH
239885462$23988546$2$F$$20240709$20240619$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04926$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239885632$23988563$2$F$20231207$20240709$20240619$20240718$EXP$$PL-AUROBINDO-AUR-APL-2024-029687$AUROBINDO$$69$YR$$F$Y$71$KG$20240718$$MD$PL$PL
239885692$23988569$2$F$$20240722$20240619$20240727$EXP$$US-TAKEDA-2024TUS022977$TAKEDA$$$$$M$Y$$$20240727$$CN$US$US
239885732$23988573$2$F$20240614$20240614$20240619$20240701$PER$$US-AMGEN-USASP2024119089$AMGEN$$59$YR$A$F$Y$$$20240701$$CN$US$US
239885762$23988576$2$F$$20240626$20240619$20240703$EXP$$PT-ASPEN-GLO2024PT004025$ASPEN$Maia S, Xavier B, Sa M, Antunes E, Morais D, Sampaio J. Negative Pressure Pulmonary Oedema: An Unexpected Intercurrence. JOURNAL OF THE PORTUGUESE SOCIETY OF ANAESTHESIOLOGY/REVISTA DA SOCIEDADE PORTUG. 2024;33(S1):49$$$$$Y$$$20240703$$HP$PT$PT
239885812$23988581$2$F$$20240627$20240619$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04953$LUPIN$$$$$F$Y$87.982$KG$20240716$$PH$US$US
239885832$23988583$2$F$20240603$20240808$20240619$20240814$EXP$$JP-009507513-2406JPN001919J$MERCK$$6$DEC$$M$Y$$$20240814$$MD$JP$JP
239886012$23988601$2$F$$20240703$20240619$20240709$EXP$$US-TAKEDA-2024TUS056239$TAKEDA$$$$$M$Y$$$20240709$$CN$US$US
239886152$23988615$2$F$$20240709$20240619$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04954$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239886202$23988620$2$F$20240101$20240722$20240619$20240723$EXP$$US-UCBSA-2024021019$UCB$$$$$F$Y$$$20240723$$CN$US$US
239886222$23988622$2$F$20240524$20240628$20240619$20240703$30DAY$$US-AMGEN-USASP2024118355$AMGEN$$55$YR$A$M$Y$104$KG$20240703$$HP$US$US
239886232$23988623$2$F$$20240703$20240619$20240715$EXP$$JP-AMGEN-JPNSP2024119337$AMGEN$$22$YR$A$F$Y$$$20240715$$MD$JP$JP
239886242$23988624$2$F$$20240626$20240619$20240702$EXP$$GB-TAKEDA-2024TUS059898$TAKEDA$$$$$F$Y$$$20240702$$MD$GB$GB
239886333$23988633$3$F$20240318$20240709$20240619$20240723$EXP$$GB-CIPLA LTD.-2024GB06090$CIPLA$$$$$$Y$$$20240723$$CN$GB$GB
239886342$23988634$2$F$$20240725$20240619$20240803$30DAY$$US-GSK-US2024072089$GLAXOSMITHKLINE$$$$$M$Y$$$20240803$$CN$US$US
239886434$23988643$4$F$20240412$20240708$20240619$20240711$30DAY$$US-AMGEN-USASP2024116802$AMGEN$$$$$$Y$$$20240711$$PH$US$US
239886502$23988650$2$F$$20240614$20240619$20240717$PER$$US-AMGEN-USASP2024119095$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
239886534$23988653$4$F$20240617$20240718$20240619$20240723$PER$$US-AMGEN-USASP2024120109$AMGEN$$75$YR$E$F$Y$$$20240722$$PH$US$US
239886562$23988656$2$F$$20240626$20240619$20240702$EXP$$US-TAKEDA-2023TUS112552$TAKEDA$$$$$M$Y$$$20240702$$CN$US$US
239886602$23988660$2$F$20240201$20240813$20240619$20240819$EXP$$CA-TAKEDA-2024TUS059312$TAKEDA$$77$YR$$F$Y$$$20240819$$CN$CA$CA
239886752$23988675$2$F$$20240627$20240619$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04955$LUPIN$$$$$$Y$$$20240714$$CN$US$US
239886792$23988679$2$F$$20240720$20240619$20240731$EXP$$US-AUROBINDO-AUR-APL-2024-029678$AUROBINDO$Rivero A, Shaughnessy M, Noska A.. An Unusual Case of Cellulitis in a Patient With Systemic Lupus Erythematosus.. Clinical Infectious Diseases.. 2024;78(3):797-9$56$YR$$F$Y$$$20240731$$MD$US$US
239886913$23988691$3$F$$20240913$20240619$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202406010838$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240924$$CN$US$US
239886933$23988693$3$F$20240501$20240823$20240619$20240830$PER$$US-BIOGEN-2024BI01266704$BIOGEN$$40$YR$$F$Y$$$20240830$$CN$US$US
239886982$23988698$2$F$$20240709$20240619$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04963$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239887002$23988700$2$F$$20240729$20240619$20240809$PER$$US-AstraZeneca-2024A139927$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
239887012$23988701$2$F$20221101$20240624$20240619$20240702$EXP$$IT-AUROBINDO-AUR-APL-2024-029226$AUROBINDO$$79$YR$$M$Y$$$20240702$$PH$IT$IT
239887072$23988707$2$F$$20240711$20240619$20240719$EXP$$US-TAKEDA-2024TUS057815$TAKEDA$$$$$M$Y$73$KG$20240719$$MD$US$US
239887133$23988713$3$F$20240525$20240703$20240619$20240704$EXP$$NVSC2024US127282$NOVARTIS$$79$YR$$M$Y$$$20240704$$HP$US$US
239887162$23988716$2$F$$20240709$20240619$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04964$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239887322$23988732$2$F$20240609$20240716$20240619$20240724$EXP$$US-AstraZeneca-2024A136249$ASTRAZENECA$$29506$DY$$M$Y$$$20240724$$CN$US$
239887377$23988737$7$F$20240101$20240820$20240619$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018053$UNITED THERAPEUTICS$$$$$F$Y$80.726$KG$20240828$$$US$US
239887442$23988744$2$F$$20240709$20240619$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04965$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239887482$23988748$2$F$19960101$20240626$20240619$20240702$EXP$$US-ABBVIE-5711733$ABBVIE$$$$$M$Y$90$KG$20240702$$CN$US$US
239887564$23988756$4$F$20240501$20240902$20240619$20240906$EXP$$US-ABBVIE-5804168$ABBVIE$$68$YR$$M$Y$54$KG$20240906$$CN$US$US
239887583$23988758$3$F$$20240708$20240619$20240710$PER$$US-AMGEN-USASP2024120796$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
239887602$23988760$2$F$$20240802$20240619$20240807$PER$$US-AMGEN-USASP2024119497$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
239887634$23988763$4$F$20240610$20240813$20240619$20240823$30DAY$$US-GSK-US2024072112$GLAXOSMITHKLINE$$83$YR$$F$Y$$$20240823$$HP$US$US
239887652$23988765$2$F$$20240626$20240619$20240703$EXP$$JP-JNJFOC-20240641543$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$MD$JP$JP
239887672$23988767$2$F$20200901$20240719$20240619$20240730$EXP$$PL-AUROBINDO-AUR-APL-2024-029093$AUROBINDO$$61$YR$$M$Y$143$KG$20240730$$MD$PL$PL
239887682$23988768$2$F$20240614$20240819$20240619$20240821$PER$$US-AMGEN-USASP2024119235$AMGEN$$74$YR$E$F$Y$$$20240821$$CN$US$US
239887703$23988770$3$F$$20240808$20240619$20240815$EXP$$CA-CELLTRION INC.-2024CA014765$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
239887732$23988773$2$F$$20240808$20240619$20240815$EXP$$CA-CELLTRION INC.-2024CA010829$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
239887772$23988777$2$F$$20240626$20240619$20240701$EXP$$JP-JNJFOC-20240641541$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$JP$JP
239887902$23988790$2$F$$20240627$20240619$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05014$LUPIN$$$$$$Y$$$20240714$$CN$US$US
239888012$23988801$2$F$$20240610$20240619$20240705$EXP$$JP-009507513-2406JPN001378J$MERCK$Hamamoto Y, Ogasawara J, Shimizu H. 38 A case of a 57-year-old patient who simultaneously experienced nervous, muscular, and renal immune-related adverse events. The 130th Chugoku Regional Meeting of the Japanese Society of Internal Medicine$57$YR$$F$Y$$$20240705$$MD$JP$JP
239888022$23988802$2$F$20240201$20240723$20240619$20240731$EXP$$US-AstraZeneca-2024A136108$ASTRAZENECA$$68$YR$$F$Y$$$20240731$$MD$US$
239888034$23988803$4$F$$20240812$20240619$20240813$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-127003$DAIICHI$$$$$M$Y$$$20240813$$CN$US$US
239888124$23988812$4$F$20240616$20240815$20240619$20240821$PER$$US-AMGEN-USASP2024119420$AMGEN$$72$YR$E$M$Y$$$20240821$$CN$US$US
239888313$23988831$3$F$20240608$20240801$20240619$20240813$EXP$$CA-TEVA-VS-3209312$TEVA$$55$YR$$M$Y$79$KG$20240813$$MD$CA$CA
239888382$23988838$2$F$20240623$20240709$20240619$20240711$EXP$$US-TAKEDA-2024TUS046313$TAKEDA$$72$YR$$F$Y$$$20240711$$CN$US$US
239888562$23988856$2$F$20240101$20240823$20240619$20240829$EXP$$US-UCBSA-2024011123$UCB$$$$$F$Y$70.295$KG$20240829$$HP$US$US
239888572$23988857$2$F$20231108$20240808$20240619$20240818$EXP$PT-INFARMED-V202403-843$PT-SAMSUNG BIOEPIS-SB-2024-17549$SAMSUNG BIOEPIS$$23$YR$A$M$Y$$$20240818$$PH$PT$PT
239888932$23988893$2$F$20240608$20240701$20240619$20240708$30DAY$$US-AMGEN-USASP2024115950$AMGEN$$$$$M$Y$$$20240707$$HP$US$US
239888953$23988895$3$F$$20240817$20240619$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05074$LUPIN$$$$$$Y$$$20240830$$CN$US$US
239889022$23988902$2$F$$20240715$20240619$20240719$EXP$$US-EXELIXIS-CABO-24078427$EXELIXIS$$$$$M$Y$$$20240719$$CN$US$US
239889032$23988903$2$F$$20240711$20240619$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009245$JAZZ$$$$$M$Y$$$20240716$$HP$US$US
239889152$23988915$2$F$$20240709$20240619$20240723$EXP$$CA-APOTEX-2024AP007179$APOTEX$$$$$F$Y$$$20240723$$HP$CA$CA
239889192$23988919$2$F$20240605$20240711$20240619$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202406011998$ELI LILLY AND CO$$57$YR$A$M$Y$148$KG$20240717$$CN$US$US
239889293$23988929$3$F$20240612$20240924$20240619$20240928$EXP$$JP-009507513-2406JPN001922J$MERCK$$78$YR$$F$Y$$$20240928$$MD$JP$JP
239889322$23988932$2$F$20240617$20240708$20240619$20240712$PER$$US-AstraZeneca-2024A140899$ASTRAZENECA$$26893$DY$$F$Y$$$20240712$$CN$US$
239889562$23988956$2$F$20240605$20240708$20240619$20240718$EXP$$CO-TAKEDA-2024TUS059704$TAKEDA$$39$YR$$M$Y$62$KG$20240718$$MD$CO$CO
239889572$23988957$2$F$20240101$20240627$20240619$20240702$PER$$US-AMGEN-USASP2024119552$AMGEN$$59$YR$A$M$Y$$$20240701$$CN$US$US
239889585$23988958$5$F$20240207$20240909$20240619$20240916$EXP$$NVSC2024KR099406$NOVARTIS$$63$YR$$F$Y$61$KG$20240916$$MD$KR$KR
239889652$23988965$2$F$20231226$20240807$20240619$20240812$EXP$$CA-JNJFOC-20231275325$JOHNSON AND JOHNSON$$34$YR$A$F$Y$90$KG$20240812$$HP$CA$CA
239889712$23988971$2$F$20240611$20240625$20240619$20240702$EXP$$CO-AMGEN-COLSL2024118052$AMGEN$$61$YR$A$M$Y$$$20240702$$CN$CO$CO
239889742$23988974$2$F$$20240625$20240619$20240705$EXP$$US-TEVA-VS-3210138$TEVA$Reda H. Neurologic Complications of Endocrine Disorders. Continuum-Minneap-Minn 2023; 29 (3): 887-902.; Reda H. Neurologic Complications of Endocrine Disorders. Continuum-Minneap-Minn 2023; 29 (3): 887-902.$70$YR$$M$Y$$$20240705$$MD$US$US
239889784$23988978$4$F$20230613$20240917$20240619$20240924$EXP$$CA-GSK-CA2023090014$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$CA$CA
239889792$23988979$2$F$$20240719$20240619$20240722$PER$$US-JNJFOC-20240623620$JOHNSON AND JOHNSON$$$$$$Y$$$20240721$$HP$US$US
239889832$23988983$2$F$$20240722$20240619$20240729$EXP$$GB-AMGEN-GBRSP2024117172$AMGEN$Xu K.. Secondary plasma cell leukaemia (PCL) with plasmablastic morphology. Journal of Hematopathology. 2024;17 (2):117-119$71$YR$E$F$Y$$$20240729$$HP$GB$GB
239889863$23988986$3$F$$20240807$20240619$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202406012721$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240819$$CN$US$US
239889872$23988987$2$F$20240501$20240910$20240619$20240923$EXP$$US-UCBSA-2024031031$UCB$$41$YR$$M$Y$$$20240923$$HP$US$US
239889933$23988993$3$F$$20240618$20240619$20240702$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451844$RANBAXY$Simmer P, Ghandi P, Gulati S. Hot and bothered: a rare case of dyskinesia hyperpyrexia syndrome. Crit Care Med. 2024;52 (Suppl.)(1):S289/632$53$YR$$F$Y$$$20240702$$HP$US$US
239889942$23988994$2$F$$20240731$20240619$20240807$EXP$$JP-AMGEN-JPNSP2024119404$AMGEN$$70$YR$E$F$Y$$$20240806$$MD$JP$JP
239890043$23989004$3$F$20231201$20240822$20240619$20240826$EXP$$CA-TAKEDA-2023TUS118549$TAKEDA$$47$YR$$M$Y$$$20240826$$MD$CA$CA
239890113$23989011$3$F$20240603$20240722$20240619$20240802$EXP$$US-GSK-US2024072697$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$US$US
239890162$23989016$2$F$20240601$20240730$20240619$20240801$EXP$FR-AFSSAPS-LM2024000337$FR-JNJFOC-20240646803$JOHNSON AND JOHNSON$$30$YR$A$M$Y$73$KG$20240801$$MD$FR$FR
239890232$23989023$2$F$20240101$20240724$20240619$20240801$EXP$$JP-TAKEDA-2024TUS060096$TAKEDA$$5$DEC$$M$Y$$$20240801$$MD$JP$JP
239890252$23989025$2$F$$20240617$20240619$20240702$EXP$$US-ADAMAS Pharma-ADM202406-002035$ADAMAS PHARMA$$50$YR$$M$Y$$$20240702$$$COUNTRY NOT SPECIFIED$
239890272$23989027$2$F$20240129$20240813$20240619$20240820$EXP$$CH-SA-2024SA080260$SANOFI AVENTIS$$75$YR$E$F$Y$50$KG$20240820$$CN$CH$CH
239890312$23989031$2$F$20240609$20240723$20240619$20240731$EXP$$US-AstraZeneca-2024A136232$ASTRAZENECA$$20524$DY$$F$Y$$$20240731$$CN$US$
239890522$23989052$2$F$$20240808$20240619$20240813$EXP$$US-SA-2024SA181282$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240813$$MD$US$US
239890544$23989054$4$F$20240527$20240828$20240619$20240906$EXP$$JP-ASTELLAS-2024JP003787$ASTELLAS$$8$DEC$E$M$Y$$$20240906$$MD$JP$JP
239890552$23989055$2$F$20240416$20240710$20240619$20240716$EXP$$JP-ASTELLAS-2024JP002581$ASTELLAS$$9$DEC$$M$Y$$$20240716$$MD$JP$JP
239890772$23989077$2$F$$20240720$20240619$20240731$EXP$$US-AUROBINDO-AUR-APL-2024-029575$AUROBINDO$Peringeth G, Abbi B, Mahmood S.. Treatment of myopathy and cutaneous ulcers in anti-MDA5-positive dermatomyositis with triple therapy.. BMJ case reports.. 2024;17(3):e253960$3$DEC$$M$Y$$$20240731$$MD$US$US
239890792$23989079$2$F$$20240628$20240619$20240710$EXP$$CO-MACLEODS PHARMA-MAC2024047723$MACLEODS$Puerta-Botero JE, Jaramillo S, Restrepo-Garces CE, Uribe M, Velasquez-Jaramillo M, Puerta-Martinez F, et al..Epidural Hematoma Associated with Red Clover Use after EpiduralInjection: A Case Report..A and A Practice.2024;18(5):E01787$$$$$Y$$$20240710$$MD$CO$CO
239890832$23989083$2$F$$20240628$20240619$20240701$PER$$US-JNJFOC-20240576026$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
239891282$23989128$2$F$$20240814$20240619$20240821$EXP$$CA-TAKEDA-2024TUS058766$TAKEDA$$80$YR$$M$Y$89$KG$20240821$$HP$CA$CA
239891312$23989131$2$F$$20240912$20240619$20240920$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024072069$VIIV$$$$A$F$Y$$$20240920$$PH$US$US
239891332$23989133$2$F$$20240910$20240619$20240918$EXP$$US-GSK-US2024073735$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$US$US
239891452$23989145$2$F$20240604$20240913$20240619$20240916$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-086911$REGENERON$$$$$F$Y$$$20240916$$CN$CA$CA
239891622$23989162$2$F$$20240913$20240619$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451271$RANBAXY$Adames A, O^Brien DR, Kelly AR, Saltz LB, Garcia-Aguilar J, Zinovoy M, et al. Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series. Int J Colorectal Dis. 2024;39(1):1-8$53$YR$$M$Y$$$20240927$$HP$US$US
239891712$23989171$2$F$20220101$20240618$20240619$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-331468$RANBAXY$$72$YR$$F$Y$$$20240730$$CN$US$US
239891772$23989177$2$F$$20240913$20240619$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451261$RANBAXY$Adames A, O^Brien DR, Kelly AR, Saltz LB, Garcia-Aguilar J, Zinovoy M, et al. Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series. Int J Colorectal Dis. 2024;39 (1):1-8$52$YR$$M$Y$$$20240927$$HP$US$US
239891802$23989180$2$F$$20240703$20240619$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451317$RANBAXY$Carletti P, Shah A, Bair C, Curran C, Mai A, Patel R, et al. The spectrum of COVID-19-associated chorioretinal vasculopathy. Am J Ophthalmol Case Rep. 2023;31:101857, 1-16$33$YR$$M$Y$$$20240718$$HP$US$US
239891812$23989181$2$F$$20240711$20240619$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451258$RANBAXY$Truong RD, Cheyney S, Vo M, Garcia J, Desai NN,Kropf J, et al. Successful Treatment of Massive Pulmonary Embolism in Pregnancy with Catheter-Directed Embolectomy. AJP Rep. 2024;14(2):E140-E144$37$YR$$F$Y$$$20240726$$MD$US$US
239891832$23989183$2$F$$20240627$20240619$20240705$EXP$$AU-Orion Corporation ORION PHARMA-22_00020285$ORION$$42$YR$A$F$Y$94$KG$20240705$$HP$AU$
239891852$23989185$2$F$$20240627$20240619$20240705$EXP$$JP-JNJFOC-20240641689$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$MD$JP$JP
239891912$23989191$2$F$20240513$20240701$20240619$20240705$EXP$$JP-BAYER-2024A084098$BAYER$$76$YR$E$M$Y$59.3$KG$20240705$$MD$JP$JP
239891942$23989194$2$F$20230101$20240725$20240619$20240806$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05238$HIKMA$Valido K, Patel V, Murphy MJ, Junejo MH, Patel DK, Deutsch A, et al.. Valido K, Patel V, Murphy MJ, Junejo MH, Patel DK, Deutsch A, et al. Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach.. JAAD Case Reports. 2024;48:1-5$$$$$Y$$$20240806$$MD$US$US
239891972$23989197$2$F$20240604$20240624$20240619$20240704$EXP$GB-MHRA-MED-202406091756198760-PZSFT$GB-Accord-430036$ACCORD$$49$YR$A$F$Y$$$20240704$$MD$GB$GB
239892032$23989203$2$F$$20240913$20240619$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451275$RANBAXY$Adames A, O^Brien DR, Kelly AR, Saltz LB, Garcia-Aguilar J, Zinovoy M, et al. Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series. Int J Colorectal Dis. 2024;39 (1):75$67$YR$$M$Y$$$20240927$$HP$US$US
239892062$23989206$2$F$$20240605$20240619$20240716$EXP$$US-BAYER-2024A085959$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240716$$MD$US$US
239892083$23989208$3$F$$20240919$20240619$20240926$EXP$$US-GSK-US2024073827$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
239892222$23989222$2$F$$20240710$20240619$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009191$JAZZ$$$$$M$Y$$$20240722$$MD$US$US
239892362$23989236$2$F$$20240625$20240619$20240705$EXP$$DE-TEVA-VS-3209268$TEVA$Derungs T, Poddubnyy D, Schneider T. Pancytopenia following adjuvant therapy with interferon-gamma in a patient with disseminated nocardiosis. Int-J-Infect-Dis 2024; 142.; Derungs T, Poddubnyy D, Schneider T. Pancytopenia following adjuvant therapy with interferon-gamma in a patient with disseminated nocardiosis. Int-J-Infect-Dis 2024; 142.$78$YR$$F$Y$$$20240705$$HP$DE$DE
239892432$23989243$2$F$$20240819$20240619$20240823$EXP$$NVSC2024CA126883$NOVARTIS$$72$YR$$M$Y$$$20240823$$HP$CA$CA
239892462$23989246$2$F$$20240821$20240619$20240826$EXP$$NVSC2024US126620$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
239892502$23989250$2$F$20230618$20240626$20240619$20240702$EXP$IT-MINISAL02-990042$NVSC2024IT124944$NOVARTIS$$8$YR$$F$Y$25$KG$20240702$$MD$IT$IT
239892572$23989257$2$F$$20240709$20240619$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04990$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239892582$23989258$2$F$20240611$20240708$20240619$20240710$PER$$US-JNJFOC-20240627511$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240710$$PH$US$US
239892602$23989260$2$F$20240607$20240722$20240619$20240728$PER$$US-JNJFOC-20240630595$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240729$$PH$US$US
239892683$23989268$3$F$$20240709$20240619$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05010$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239892762$23989276$2$F$$20240709$20240619$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04998$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239893012$23989301$2$F$$20240716$20240619$20240724$EXP$$BR-ABBVIE-5806077$ABBVIE$$$$A$F$Y$76$KG$20240724$$CN$BR$BR
239893263$23989326$3$F$$20240830$20240619$20240906$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05416$HIKMA$$$$$$Y$$$20240906$$CN$US$US
239893283$23989328$3$F$$20240822$20240619$20240901$EXP$$ES-JNJFOC-20240628482$JOHNSON AND JOHNSON$$$$$$Y$$$20240901$$HP$ES$ES
239893333$23989333$3$F$$20240828$20240619$20240902$EXP$$US-TAKEDA-2024TUS049073$TAKEDA$$$$$M$Y$111.57$KG$20240902$$HP$US$US
239893383$23989338$3$F$20240601$20240624$20240619$20240702$EXP$$CN-BAYER-2024A088072$BAYER$$67$YR$E$$Y$$$20240702$$CN$CN$CN
239893392$23989339$2$F$20220101$20240715$20240619$20240717$EXP$$US-ABBVIE-5803098$ABBVIE$$75$YR$$F$Y$$$20240717$$CN$US$US
239893454$23989345$4$F$20240616$20240703$20240619$20240708$PER$$US-AMGEN-USASP2024119495$AMGEN$$74$YR$E$F$Y$$$20240708$$CN$US$US
239893512$23989351$2$F$$20240709$20240619$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05009$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239893532$23989353$2$F$20221101$20240720$20240619$20240731$EXP$$US-AUROBINDO-AUR-APL-2024-029591$AUROBINDO$Aijaz A, Wahid Y, Guerra JA, Gorthi JR. A case of recurrent cardiomems infection in a heart transplant patient. Journal of the American College of Cardiology. 2024;83(13) Suppl A:3208$68$YR$$M$Y$$$20240731$$MD$US$US
239893563$23989356$3$F$$20240917$20240619$20240918$EXP$$FR-AstraZeneca-2023A233785$ASTRAZENECA$$$$$M$Y$67$KG$20240918$$MD$FR$
239893652$23989365$2$F$20240101$20240731$20240619$20240806$PER$$US-AMGEN-USASP2024119710$AMGEN$$68$YR$E$M$Y$$$20240806$$CN$US$US
239894002$23989400$2$F$$20240720$20240619$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-029361$AUROBINDO$El Kamel M, Marzullo C, Maguet H, Checkouri A, Pointurier V et al. Acidose m?tabolique dans un contexte d?intoxication chronique au parac?tamol (Metabolic acidosis in a context of chronic paracetamol intoxication). Toxicologie Analytique et Clinique. 2024;36(2):S42$$$$$Y$$$20240731$$HP$FR$FR
239894032$23989403$2$F$20240101$20240703$20240619$20240711$EXP$$US-SA-2024SA179201$SANOFI AVENTIS$$18$YR$A$F$Y$63.3$KG$20240711$$MD$US$US
239894342$23989434$2$F$20220204$20240624$20240619$20240709$EXP$$IT-SERVIER-S24007143$SERVIER$$$$$$Y$$$20240709$$MD$IT$IT
239894352$23989435$2$F$20210723$20240812$20240619$20240819$EXP$$US-GSK-US2023GSK016783$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$MD$US$US
239894412$23989441$2$F$20240307$20240620$20240619$20240704$EXP$$US-MEDEXUS PHARMA, INC.-2024MED00263$MEDEXUS PHARMA$$61$YR$$F$Y$97.506$KG$20240704$$CN$US$US
239894473$23989447$3$F$20240617$20240802$20240619$20240806$PER$$US-AMGEN-USASP2024120340$AMGEN$$54$YR$A$F$Y$$$20240806$$CN$US$US
239894522$23989452$2$F$$20240801$20240619$20240806$30DAY$$US-PFIZER INC-PV202400044195$PFIZER$$$$$$Y$$$20240806$$CN$US$US
239894893$23989489$3$F$20240611$20240628$20240619$20240724$PER$$US-009507513-2406USA003658$MERCK$$$$$$Y$$$20240724$$HP$US$US
239894962$23989496$2$F$$20240620$20240619$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04991$LUPIN$$$$$$Y$$$20240703$$CN$US$US
239894995$23989499$5$F$20240610$20240716$20240619$20240719$EXP$$NVSC2024US127611$NOVARTIS$$68$YR$$M$Y$$$20240719$$HP$US$US
239895003$23989500$3$F$20240608$20240820$20240619$20240829$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-018483$UNITED THERAPEUTICS$$59$YR$$F$Y$53$KG$20240829$$$JP$JP
239895115$23989511$5$F$$20240820$20240619$20240903$PER$$US-Calliditas-2024CAL01085$CALLIDITAS THERAPEUTICS$$53$YR$A$F$Y$61.6$KG$20240903$$CN$US$US
239895152$23989515$2$F$20210101$20240624$20240619$20240703$EXP$$IT-TEVA-VS-3209186$TEVA$Vaghi G, Vegezzi E, Bini P, Gastaldi M, Diamanti L, Marchioni E, et al. A Case of Anti-Ma2 Encephalitis Presenting with Pendular Torsional Nystagmus. Cerebellum 2024; 23 1249-1253.; Vaghi G, Vegezzi E, Bini P, Gastaldi M, Diamanti L, Marchioni E, et al. A Case of Anti-Ma2 Encephalitis Presenting with Pendular Torsional Nystagmus. Cerebellum 2024; 23 1249-1253.$71$YR$$F$Y$$$20240703$$HP$IT$IT
239895233$23989523$3$F$$20240625$20240619$20240729$EXP$$US-CELLTRION INC.-2024US014619$CELLTRION$$$$$$Y$$$20240729$$HP$US$US
239895242$23989524$2$F$20230906$20240702$20240619$20240705$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-085491$REGENERON$Morishita H, Edura M, Hasegawa T, Yamada S, Hoshino J, Okada S, et al. Two Cases of Aortic Emergency During Antiangiogenic Therapy. Journal of the Japanese Society for Vascular Surgery. 2024;33:416$82$YR$$M$Y$$$20240705$$HP$JP$JP
239895273$23989527$3$F$20240612$20240911$20240619$20240913$30DAY$$US-PFIZER INC-202400193507$PFIZER$$9$YR$$M$Y$$$20240913$$MD$US$US
239895282$23989528$2$F$$20240720$20240619$20240722$30DAY$$US-PFIZER INC-202400194193$PFIZER$$8$YR$$F$Y$$$20240722$$CN$US$US
239895303$23989530$3$F$$20240911$20240619$20240913$30DAY$$US-PFIZER INC-202400192882$PFIZER$$14$YR$$M$Y$$$20240913$$CN$US$US
239895316$23989531$6$F$20240601$20240917$20240619$20240920$30DAY$$US-PFIZER INC-202400193180$PFIZER$$14$YR$$M$Y$52.16$KG$20240920$$CN$US$US
239895325$23989532$5$F$$20240826$20240619$20240829$30DAY$$US-PFIZER INC-202400193517$PFIZER$$7$YR$$M$Y$$$20240829$$CN$US$US
239895333$23989533$3$F$20240609$20240925$20240619$20240930$30DAY$$US-PFIZER INC-202400192837$PFIZER$$10$YR$$F$Y$$$20240930$$MD$US$US
239895365$23989536$5$F$$20240823$20240619$20240828$30DAY$$US-PFIZER INC-PV202400076723$PFIZER$$18$YR$$M$Y$$$20240828$$CN$US$US
239895372$23989537$2$F$$20240720$20240619$20240722$30DAY$$US-PFIZER INC-202400192834$PFIZER$$13$YR$$M$Y$$$20240722$$CN$US$US
239895382$23989538$2$F$20231129$20240821$20240619$20240822$EXP$$NVSC2024US125918$NOVARTIS$$40$YR$$F$Y$76.204$KG$20240822$$HP$US$US
239895443$23989544$3$F$20240601$20240731$20240619$20240808$EXP$$US-BAYER-2024A087974$BAYER$$19$YR$A$M$Y$65.76$KG$20240808$$CN$US$US
239895632$23989563$2$F$$20240702$20240619$20240705$EXP$$JP-GILEAD-2024-0677585$GILEAD$$3$DEC$A$F$Y$$$20240705$$MD$JP$JP
239895644$23989564$4$F$$20240813$20240619$20240815$30DAY$$US-PFIZER INC-202400195241$PFIZER$$16$YR$$M$Y$$$20240815$$CN$US$US
239895802$23989580$2$F$$20240702$20240619$20240705$EXP$$JP-GILEAD-2024-0677586$GILEAD$$7$DEC$E$M$Y$$$20240705$$MD$JP$JP
239895972$23989597$2$F$$20240702$20240619$20240705$EXP$$JP-GILEAD-2024-0677587$GILEAD$$7$DEC$E$F$Y$$$20240705$$MD$JP$JP
239896012$23989601$2$F$20240416$20240712$20240619$20240716$EXP$$US-TAKEDA-2024TUS022559$TAKEDA$$69$YR$$F$Y$$$20240716$$MD$US$US
239896022$23989602$2$F$$20240912$20240619$20240922$PER$$US-GSK-US2024072657$GLAXOSMITHKLINE$$$$$F$Y$$$20240922$$CN$US$US
239896036$23989603$6$F$$20240819$20240619$20240828$EXP$$US-GSK-US2024AMR072276$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$CN$US$US
239896092$23989609$2$F$$20240709$20240619$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05011$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239896145$23989614$5$F$$20240720$20240619$20240729$EXP$$IT-AUROBINDO-AUR-APL-2024-029629$AUROBINDO$Rubino R, Trizzino M, Pipito L, Sucato G, Santoro M, Maugeri R, et al.. A difficult case of ventriculitis in a 40-year-old woman with acute myeloid leukemia. Antibiotics. 2024;13(5):432$40$YR$$F$Y$$$20240729$$MD$IT$IT
239896183$23989618$3$F$$20240709$20240619$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05033$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239896192$23989619$2$F$20221204$20240628$20240619$20240708$EXP$FR-AFSSAPS-PP2024000589$FR-TEVA-VS-3210105$TEVA$$63$YR$$F$Y$54.6$KG$20240708$$MD$FR$FR
239896214$23989621$4$F$20240101$20240725$20240619$20240731$PER$$US-BAYER-2024A085699$BAYER$$58$YR$A$F$Y$$$20240731$$CN$US$US
239896262$23989626$2$F$$20240624$20240619$20240702$EXP$$FR-TEVA-VS-3209213$TEVA$Michel V, Mahlaoui N, Bougnoux ME, Garcia-Hermoso D, Lanternier F, Levy R. Prolonged Remission of Azole-Resistant Lung Aspergillosis with Olorofim, in an Adolescent with X-Linked Chronic Granulomatous Disease. J-Clin-Immunol 2023; 43 (6): 1170-1172.; Michel V, Mahlaoui N, Bougnoux ME, Garcia-Hermoso D, Lanternier F, Levy R. Prolonged Remission of Azole-Resistant Lung Aspergillosis with Olorofim, in an Adolescent with X-Linked Chronic Granulomatous Disease. J-Clin-Immunol 2023; 43 (6): 1170-11...$14$YR$$M$Y$$$20240702$$HP$FR$FR
239896382$23989638$2$F$$20240719$20240619$20240723$PER$$US-JNJFOC-20240623757$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
239896403$23989640$3$F$20240513$20240628$20240619$20240708$EXP$$US-AGIOS-2405US03757$AGIOS PHARMACEUTICALS$$31$YR$$M$Y$94.331$KG$20240708$$CN$US$US
239896422$23989642$2$F$$20240716$20240619$20240718$PER$$US-AMGEN-USASP2024120845$AMGEN$$$$$$Y$$$20240718$$CN$US$US
239896462$23989646$2$F$$20240702$20240619$20240709$PER$$NVSC2024US127995$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
239896703$23989670$3$F$$20240709$20240619$20240715$PER$$NVSC2024US127243$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
239896722$23989672$2$F$$20240628$20240619$20240703$EXP$$US-OTSUKA-2024_017029$OTSUKA$$$$E$F$Y$$$20240703$$HP$US$US
239896742$23989674$2$F$$20240628$20240619$20240705$EXP$$US-OTSUKA-2024_017028$OTSUKA$$$$E$M$Y$$$20240705$$HP$US$US
239896763$23989676$3$F$$20240624$20240619$20240702$30DAY$$US-JNJFOC-20240630329$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
239896792$23989679$2$F$$20240913$20240619$20240918$PER$$US-TAKEDA-2024TUS060291$TAKEDA$$$$$M$Y$$$20240918$$CN$US$US
239896823$23989682$3$F$$20240917$20240619$20240920$EXP$$US-GILEAD-2024-0677531$GILEAD$$66$YR$E$F$Y$$$20240920$$CN$US$US
239896898$23989689$8$F$20240618$20240823$20240619$20240827$30DAY$$US-PFIZER INC-202400193306$PFIZER$$6$YR$$F$Y$$$20240827$$MD$US$US
239896904$23989690$4$F$$20240829$20240619$20240905$30DAY$$US-PFIZER INC-202400184889$PFIZER$$12$YR$$M$Y$$$20240905$$CN$US$US
239896992$23989699$2$F$$20240705$20240619$20240718$PER$$US-Calliditas-2024CAL01073$CALLIDITAS THERAPEUTICS$$46$YR$A$M$Y$87$KG$20240718$$CN$US$US
239897152$23989715$2$F$$20240702$20240619$20240705$PER$$US-AGIOS-2406US03795$AGIOS PHARMACEUTICALS$$$$$$Y$$$20240705$$CN$US$US
239897182$23989718$2$F$20240220$20240712$20240619$20240722$EXP$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00299$Unknown Manufacturer$$$$$$Y$$$20240722$$HP$US$US
239897232$23989723$2$F$20240613$20240719$20240619$20240722$PER$$US-AstraZeneca-2024A138509$ASTRAZENECA$$74$YR$$F$Y$$$20240722$$HP$US$
239897242$23989724$2$F$20240516$20240619$20240619$20240702$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000195$Unknown Manufacturer$$$$$$Y$$$20240702$$CN$US$US
239897302$23989730$2$F$20240615$20240702$20240619$20240703$EXP$$US-PFIZER INC-PV202400080253$PFIZER$$77$YR$$M$Y$81.633$KG$20240703$$HP$US$US
239897364$23989736$4$F$20231227$20240822$20240619$20240829$EXP$$JP-Vifor (International) Inc.-VIT-2024-03051$VIFOR$$50$YR$$F$Y$$$20240829$$PH$JP$JP
239897453$23989745$3$F$20240605$20240828$20240619$20240903$EXP$$US-AMGEN-USASP2024118366$AMGEN$$34$YR$A$M$Y$$$20240902$$PH$US$US
239897552$23989755$2$F$20240604$20240619$20240619$20240706$PER$$US-AMGEN-USASP2024120169$AMGEN$$70$YR$E$F$Y$$$20240706$$CN$US$US
239897562$23989756$2$F$20240615$20240628$20240619$20240705$PER$$US-AMGEN-USASP2024119854$AMGEN$$68$YR$E$F$Y$77.098$KG$20240704$$HP$US$US
239897652$23989765$2$F$20210101$20240807$20240619$20240814$EXP$$ES-OTSUKA-2024_017012$OTSUKA$$12$YR$$F$Y$$$20240814$$MD$ES$ES
239897672$23989767$2$F$$20240625$20240619$20240705$EXP$$US-TEVA-VS-3209447$TEVA$Bello R, Ramamurthi A, Aldakkak M, Erickson B, Hall WA, Tsai S, et al. Incidence of gastrointestinal bleeding following neoadjuvant chemotherapy and chemoradiation for localized pancreatic cancer. HPB 2024; 26 (Suppl. 1) S340 abstr. EP02C-119.; Bello R, Ramamurthi A, Aldakkak M, Erickson B, Hall WA, Tsai S, et al. Incidence of gastrointestinal bleeding following neoadjuvant chemotherapy and chemoradiation for localized pancreatic cancer. HPB 2024; 26 (Suppl. 1) S340 abstr. EP02C-119.; Bello R...$70$YR$$$Y$$$20240705$$HP$US$US
239897733$23989773$3$F$20240610$20240804$20240619$20240812$EXP$$CA-CELLTRION INC.-2024CA014463$CELLTRION$$$$$$Y$$$20240812$$HP$CA$CA
239897892$23989789$2$F$20240612$20240701$20240619$20240703$EXP$$OM-PFIZER INC-PV202400078513$PFIZER$$51$YR$$$Y$$$20240703$$MD$OM$OM
239897902$23989790$2$F$$20240904$20240619$20240905$EXP$$US-PFIZER INC-202400195296$PFIZER$$67$YR$$F$Y$$$20240905$$CN$US$US
239897984$23989798$4$F$20240301$20240811$20240619$20240812$EXP$$CA-PFIZER INC-202201264774$PFIZER$$57$YR$$F$Y$$$20240812$$MD$CA$CA
239898002$23989800$2$F$$20240712$20240619$20240716$EXP$$CA-PFIZER INC-202400194097$PFIZER$$17$YR$$M$Y$$$20240716$$HP$CA$CA
239898133$23989813$3$F$20221101$20240627$20240619$20240703$EXP$IT-MINISAL02-989737$IT-MYLANLABS-2024M1054171$MYLAN$$79$YR$$M$Y$$$20240703$$PH$IT$IT
239898152$23989815$2$F$20240207$20240626$20240619$20240709$PER$$US-Calliditas-2024CAL01075$CALLIDITAS THERAPEUTICS$$35$YR$A$F$Y$$$20240709$$CN$US$US
239898192$23989819$2$F$$20240917$20240619$20240921$EXP$$US-JNJFOC-20240633026$JOHNSON AND JOHNSON$$$$$M$Y$$$20240921$$HP$US$US
239898203$23989820$3$F$20240612$20240627$20240619$20240702$PER$$US-JNJFOC-20240638465$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240702$$CN$US$US
239898222$23989822$2$F$20240101$20240909$20240619$20240919$PER$$US-JNJFOC-20240643845$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240920$$CN$US$US
239898243$23989824$3$F$$20240716$20240619$20240720$EXP$$NVSC2024DE127199$NOVARTIS$$83$YR$$F$Y$$$20240719$$PH$DE$DE
239898293$23989829$3$F$$20240730$20240619$20240807$EXP$$DE-TEVA-VS-3210568$TEVA$$91$YR$$F$Y$$$20240807$$PH$DE$DE
239898372$23989837$2$F$20240319$20240719$20240619$20240729$EXP$FR-AFSSAPS-RE2024000449$FR-TEVA-VS-3210000$TEVA$$85$YR$$M$Y$64$KG$20240729$$MD$FR$FR
239898462$23989846$2$F$$20240621$20240619$20240701$EXP$$GB-MYLANLABS-2024M1054687$MYLAN$$$$$F$Y$$$20240701$$CN$GB$GB
239898502$23989850$2$F$$20240626$20240619$20240701$EXP$$US-MYLANLABS-2024M1054881$MYLAN$$$$$F$Y$$$20240701$$HP$US$US
239898582$23989858$2$F$$20240719$20240619$20240720$PER$$US-JNJFOC-20240627880$JOHNSON AND JOHNSON$$$$$$Y$$$20240720$$HP$US$US
239898772$23989877$2$F$20240501$20240711$20240619$20240715$EXP$$US-PFIZER INC-PV202400079232$PFIZER$$37$YR$$F$Y$52$KG$20240715$$MD$US$US
239898862$23989886$2$F$20230731$20240708$20240619$20240710$EXP$$US-PFIZER INC-202400196302$PFIZER$$36$YR$$F$Y$107.94$KG$20240710$$MD$US$US
239898882$23989888$2$F$$20240708$20240619$20240710$EXP$$US-PFIZER INC-PV202400079285$PFIZER$$76$YR$$F$Y$56.6$KG$20240710$$MD$US$US
239898902$23989890$2$F$20240521$20240701$20240619$20240702$EXP$FR-AFSSAPS-PV2024000531$FR-PFIZER INC-202400193486$PFIZER$$68$YR$$M$Y$90$KG$20240702$$MD$FR$FR
239898922$23989892$2$F$20240310$20240704$20240619$20240708$EXP$$TW-PFIZER INC-PV202400078394$PFIZER$$78$YR$$F$Y$56.4$KG$20240708$$PH$TW$TW
239898962$23989896$2$F$20240429$20240711$20240619$20240711$EXP$PT-INFARMED-J202406-283$PT-PFIZER INC-202400195436$PFIZER$$62$YR$$F$Y$$$20240711$$PH$PT$PT
239898974$23989897$4$F$$20240628$20240619$20240703$EXP$$US-PFIZER INC-202400195573$PFIZER$$68$YR$$F$Y$$$20240703$$CN$US$US
239899003$23989900$3$F$20240101$20240814$20240619$20240819$EXP$$CA-PFIZER INC-202400193280$PFIZER$$61$YR$$M$Y$$$20240819$$CN$CA$CA
239899012$23989901$2$F$20240410$20240627$20240619$20240702$EXP$FR-AFSSAPS-NY2024000650$FR-PFIZER INC-202400192679$PFIZER$$78$YR$$M$Y$77$KG$20240702$$MD$FR$FR
239899032$23989903$2$F$$20240722$20240619$20240724$EXP$$US-PFIZER INC-202400193990$PFIZER$$78$YR$$F$Y$$$20240724$$CN$US$US
239899062$23989906$2$F$20220701$20240826$20240619$20240905$EXP$$DE-TEVA-VS-3210950$TEVA$$82$YR$$F$Y$$$20240905$$CN$DE$DE
239899173$23989917$3$F$$20240811$20240619$20240812$EXP$$US-PFIZER INC-202400194457$PFIZER$$62$YR$$F$Y$$$20240812$$CN$US$US
239899202$23989920$2$F$20240403$20240630$20240619$20240701$EXP$$IR-SA-2024SA182603$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240701$$MD$IR$IR
239899312$23989931$2$F$$20240911$20240619$20240916$EXP$$CN-TAKEDA-2024TUS060075$TAKEDA$$$$$F$Y$$$20240916$$CN$CN$CN
239899342$23989934$2$F$$20240701$20240619$20240710$PER$$US-Calliditas-2024CAL01081$CALLIDITAS THERAPEUTICS$$58$YR$A$M$Y$114$KG$20240710$$CN$US$US
239899357$23989935$7$F$$20240809$20240619$20240821$EXP$$US-Calliditas-2024CAL01077$CALLIDITAS THERAPEUTICS$$68$YR$E$M$Y$113$KG$20240821$$CN$US$US
239899367$23989936$7$F$20240706$20240719$20240619$20240726$PER$$US-AMGEN-USASP2024119845$AMGEN$$61$YR$A$F$Y$$$20240726$$PH$US$US
239899483$23989948$3$F$$20240626$20240619$20240701$EXP$FR-AFSSAPS-LL2024001112$FR-PFIZER INC-202400194789$PFIZER$$57$YR$$F$Y$$$20240701$$MD$FR$FR
239899522$23989952$2$F$20240701$20240829$20240619$20240903$EXP$$IN-PFIZER INC-PV202300124351$PFIZER$$40$YR$$F$Y$$$20240903$$CN$IN$IN
239899574$23989957$4$F$$20240830$20240619$20240830$EXP$$CH-PFIZER INC-PV202400079227$PFIZER$$$$$M$Y$$$20240830$$MD$CH$CH
239899582$23989958$2$F$20210820$20240723$20240619$20240729$EXP$$US-PFIZER INC-PV202200132742$PFIZER$$76$YR$$F$Y$89.796$KG$20240729$$MD$US$US
239899682$23989968$2$F$$20240711$20240619$20240723$30DAY$$US-GSK-US2024072090$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$CN$US$US
239899703$23989970$3$F$20240101$20240812$20240619$20240819$EXP$$US-SA-2024SA175822$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240819$$MD$US$US
239899713$23989971$3$F$20240101$20240807$20240619$20240821$PER$$US-SA-2024SA175063$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240821$$MD$US$US
239899862$23989986$2$F$20240101$20240829$20240619$20240912$PER$$US-SA-2024SA110875$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240912$$MD$US$US
239899952$23989995$2$F$$20240628$20240619$20240712$PER$$US-SA-2024SA178584$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240712$$MD$US$US
239899992$23989999$2$F$20240609$20240820$20240619$20240830$PER$$US-SA-2024SA176708$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240830$$MD$US$US
239900122$23990012$2$F$$20240705$20240619$20240715$PER$$US-SA-2024SA179043$SANOFI AVENTIS$$$$A$M$Y$$$20240715$$MD$US$US
239900132$23990013$2$F$20240603$20240708$20240619$20240717$PER$$US-SA-2024SA175391$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240717$$HP$US$US
239900192$23990019$2$F$20240521$20240813$20240619$20240826$PER$$US-SA-2024SA177191$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240826$$MD$US$US
239900322$23990032$2$F$20240101$20240724$20240619$20240802$PER$$US-SA-2024SA177943$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240802$$MD$US$US
239900333$23990033$3$F$$20240723$20240619$20240801$PER$$US-SA-2024SA177447$SANOFI AVENTIS$$$$A$F$Y$$$20240801$$MD$US$US
239900362$23990036$2$F$$20240715$20240619$20240724$PER$$US-SA-2024SA121760$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$MD$US$US
239900402$23990040$2$F$$20240701$20240619$20240709$PER$$US-SA-2024SA176955$SANOFI AVENTIS$$54$YR$A$F$Y$72$KG$20240709$$CN$US$US
239900472$23990047$2$F$$20240913$20240619$20240923$PER$$US-SA-2024SA179655$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240923$$MD$US$US
239900522$23990052$2$F$$20240724$20240619$20240802$PER$$US-SA-2019SA158311$SANOFI AVENTIS$$24$YR$A$F$Y$58.05$KG$20240802$$MD$US$US
239900574$23990057$4$F$20240101$20240830$20240619$20240911$EXP$$US-SA-2024SA176686$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240911$$MD$US$US
239900602$23990060$2$F$20240101$20240717$20240619$20240725$PER$$US-SA-2024SA178632$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240725$$MD$US$US
239900642$23990064$2$F$20240501$20240717$20240619$20240724$EXP$$JP-ARGENX-2024-ARGX-JP004128AA$ARGENX BVBA$$$$$$Y$$$20240724$$MD$JP$JP
239900662$23990066$2$F$20240801$20240820$20240619$20240916$PER$$US-SA-2024SA177299$SANOFI AVENTIS$$54$YR$A$F$Y$54.4$KG$20240916$$MD$US$US
239900672$23990067$2$F$20240101$20240718$20240619$20240728$PER$$US-SA-2023SA354632$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240728$$CN$US$US
239900694$23990069$4$F$20240101$20240916$20240619$20240919$EXP$$US-SA-2024SA177090$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240919$$MD$US$US
239900712$23990071$2$F$$20240829$20240619$20240918$PER$$US-SA-2024SA177408$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$MD$US$US
239900742$23990074$2$F$20240101$20240709$20240619$20240717$PER$$US-SA-2024SA177519$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240717$$MD$US$US
239900792$23990079$2$F$$20240904$20240619$20240918$PER$$US-SA-2024SA180283$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240918$$MD$US$US
239900882$23990088$2$F$20200101$20240710$20240619$20240718$PER$$US-SA-2024SA176301$SANOFI AVENTIS$$57$YR$A$M$Y$102$KG$20240718$$MD$US$US
239901012$23990101$2$F$$20240720$20240619$20240725$PER$$US-AMGEN-USASP2024120333$AMGEN$$72$YR$E$F$Y$$$20240725$$CN$US$US
239901132$23990113$2$F$20240601$20240802$20240619$20240816$PER$$US-SA-2024SA179966$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240816$$MD$US$US
239901162$23990116$2$F$$20240905$20240619$20240915$PER$$US-SA-2024SA179782$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240915$$MD$US$US
239901272$23990127$2$F$$20240816$20240619$20240819$EXP$$NVSC2024DK125349$NOVARTIS$$$$$F$Y$$$20240819$$HP$DK$DK
239901333$23990133$3$F$$20240628$20240619$20240704$PER$$US-TRIS PHARMA, INC.-24US011544$TRIS PHARM$$$$$$Y$$$20240704$$CN$US$US
239901362$23990136$2$F$$20240625$20240619$20240703$EXP$$US-Calliditas-2024CAL01037$CALLIDITAS THERAPEUTICS$$55$YR$A$M$Y$$$20240703$$CN$US$US
239901392$23990139$2$F$20240424$20240705$20240619$20240708$EXP$$FR-AMERICAN REGENT INC-2024002333$AMERICAN REGENT$$63$YR$$F$Y$$$20240708$$PH$FR$FR
239901442$23990144$2$F$20240610$20240807$20240619$20240815$30DAY$$US-GSK-US2024072093$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240815$$CN$US$US
239901513$23990151$3$F$20240501$20240717$20240619$20240726$PER$$US-SA-2024SA176729$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240726$$MD$US$US
239901533$23990153$3$F$20240101$20240827$20240619$20240906$PER$$US-SA-2024SA176292$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240906$$MD$US$US
239901713$23990171$3$F$20240430$20240614$20240619$20240715$PER$$US-BAYER-2024A087080$BAYER$$42$YR$A$F$Y$$$20240715$$MD$US$US
239901733$23990173$3$F$20240601$20240827$20240619$20240906$EXP$$US-INSMED, INC.-2024-02405-US$INSMED$$70$YR$$F$Y$$$20240906$$HP$US$US
239901792$23990179$2$F$$20240828$20240619$20240918$PER$$US-SA-2024SA176986$SANOFI AVENTIS$$$$A$M$Y$79.3$KG$20240918$$MD$US$US
239901842$23990184$2$F$20240401$20240822$20240619$20240904$PER$$US-SA-2024SA177060$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240904$$MD$US$US
239901952$23990195$2$F$$20240704$20240619$20240711$EXP$$JP-AstraZeneca-2024A140280$ASTRAZENECA$$71$YR$$F$Y$$$20240711$$PH$JP$
239901982$23990198$2$F$$20240626$20240619$20240701$EXP$$GB-MYLANLABS-2024M1054994$MYLAN$$$$$F$Y$$$20240701$$CN$GB$GB
239901993$23990199$3$F$20240424$20240730$20240619$20240801$EXP$$IE-MYLANLABS-2024M1054987$MYLAN$$49$YR$$M$Y$$$20240801$$PH$IE$IE
239902004$23990200$4$F$$20240722$20240619$20240821$PER$$US-AstraZeneca-2024A138769$ASTRAZENECA$$44$YR$$F$Y$$$20240821$$PH$US$
239902012$23990201$2$F$20240603$20240730$20240619$20240813$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0274$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240809$$HP$US$US
239902088$23990208$8$F$20240617$20240823$20240619$20240830$EXP$$CA-GSK-CA2024073773$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$CA$CA
239902122$23990212$2$F$20240525$20240624$20240619$20240718$PER$$FR-TOLMAR, INC.-24FR049685$TOLMAR$$64$YR$$M$Y$$$20240718$$PH$FR$FR
239902203$23990220$3$F$$20240916$20240619$20240925$EXP$$US-Calliditas-2024CAL01089$CALLIDITAS THERAPEUTICS$$49$YR$A$F$Y$47.5$KG$20240925$$CN$US$US
239902222$23990222$2$F$20240205$20240918$20240619$20240925$EXP$$NVSC2024US127201$NOVARTIS$$$$$F$Y$$$20240925$$HP$US$US
239902252$23990225$2$F$20240501$20240725$20240619$20240729$EXP$$US-UCBSA-2024031005$UCB$$23$YR$$F$Y$$$20240729$$HP$US$US
239902332$23990233$2$F$$20240823$20240619$20240903$EXP$$US-ASTELLAS-2024US016941$ASTELLAS$$$$$$Y$$$20240903$$MD$US$US
239902342$23990234$2$F$$20240717$20240619$20240722$EXP$CA-SA-SAC20240617000358$CA-SA-2024SA179837$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240722$$HP$CA$CA
239902422$23990242$2$F$20240615$20240826$20240619$20240828$PER$$US-AMGEN-USASP2024120218$AMGEN$$68$YR$E$M$Y$$$20240828$$CN$US$US
239902454$23990245$4$F$20240524$20240813$20240619$20240826$PER$$US-Calliditas-2024CAL01094$CALLIDITAS THERAPEUTICS$$59$YR$A$M$Y$93$KG$20240826$$CN$US$US
239902502$23990250$2$F$20240612$20240722$20240619$20240723$PER$$US-JNJFOC-20240633196$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240723$$CN$US$US
239902523$23990252$3$F$$20240801$20240619$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05001$LUPIN$$$$$$Y$$$20240820$$CN$US$US
239902572$23990257$2$F$$20240624$20240619$20240702$EXP$$IT-TEVA-VS-3209234$TEVA$Del Ricco VF, Occhineri S, Leonildi A, Falcone M, Lupetti A, Rindi L. A rare case of primary cutaneous Nocardia vinacea in an immunocompetent patient: A case report and a review of the literature. Diagn-Microbiol-Infect-Dis 2024; 109 (3):.; Del Ricco VF, Occhineri S, Leonildi A, Falcone M, Lupetti A, Rindi L. A rare case of primary cutaneous Nocardia vinacea in an immunocompetent patient: A case report and a review of the literature. Diagn-Microbiol-Infect-Dis 2024; 109 (3):.; Del Ricco VF, O...$79$YR$$M$Y$$$20240702$$HP$IT$IT
239902642$23990264$2$F$$20240916$20240619$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097777$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240916$$CN$US$US
239902655$23990265$5$F$20240606$20240722$20240619$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096701$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$76.2$KG$20240726$$HP$US$US
239902673$23990267$3$F$$20240605$20240619$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091920$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240613$$MD$US$US
239902818$23990281$8$F$20240520$20240718$20240619$20240723$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-11525$IPSEN$$58$YR$A$F$Y$$$20240723$$MD$US$US
239902852$23990285$2$F$20240525$20240617$20240619$20240705$PER$$US-Eisai-EC-2024-166821$EISAI$$80$YR$E$F$Y$$$20240705$$CN$US$US
239902922$23990292$2$F$$20240712$20240619$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096674$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240717$$CN$US$US
239902934$23990293$4$F$20240606$20240725$20240619$20240731$PER$$JP-Eisai-EC-2024-167831$EISAI$$76$YR$E$M$Y$43.5$KG$20240731$$PH$JP$JP
239903025$23990302$5$F$$20240917$20240619$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097775$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240917$$CN$US$US
239903093$23990309$3$F$$20240925$20240619$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095725$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240926$$CN$US$US
239903213$23990321$3$F$20240312$20240802$20240619$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-053052$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240808$$MD$JP$JP
239903273$23990327$3$F$20230101$20240716$20240619$20240723$PER$$JP-Eisai-EC-2023-154864$EISAI$Yokozeki H. Len-Pem treatment and adverse events in advanced renal cell carcinoma.. Lenvatinib AE management Seminar in Tajima. 2024 Jul;$63$YR$A$M$Y$$$20240723$$MD$JP$JP
239903303$23990330$3$F$20240610$20240812$20240619$20240820$EXP$$US-RDY-CLI/USA/24/0008610$DR REDDYS$$20$YR$A$F$Y$$$20240820$$MD$US$US
239903323$23990332$3$F$$20240909$20240619$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098182$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240911$$CN$US$US
239903423$23990342$3$F$$20240911$20240619$20240930$PER$$US-TRAVERE-2024TVT00542$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
239903452$23990345$2$F$20230531$20240709$20240619$20240715$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-182287$BRISTOL MYERS SQUIBB$Sekimori K, et al. A case of myasthenia gravis with myositis after SOX + nivolumab combination therapy for unresectable, advanced gastric carcinoma. The 139th Annual Meeting of the Tokai Branch of the Japanese Society of Gastroenterology. 2023;78.$75$YR$E$F$Y$$$20240715$$MD$JP$JP
239903472$23990347$2$F$$20240916$20240619$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-097797$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$MD$JP$JP
239903483$23990348$3$F$20240601$20240711$20240619$20240725$EXP$$CH-TRAVERE-2024TVT00596$TRAVERE THERAPEUTICS$$59$YR$A$M$Y$84$KG$20240725$$MD$CH$CH
239903523$23990352$3$F$20240111$20240805$20240619$20240813$EXP$$FI-FreseniusKabi-FK202409223$FRESENIUS KABI$$70$YR$E$F$Y$96$KG$20240813$$MD$FI$FI
239903552$23990355$2$F$20220513$20240823$20240619$20240828$PER$$US-RDY-OTH/USA/23/0181548$DR REDDYS$$23$YR$A$$Y$$$20240828$$MD$US$US
239903563$23990356$3$F$20240601$20240916$20240619$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096123$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240924$$PH$US$US
239903593$23990359$3$F$$20240812$20240619$20240822$EXP$$FR-FreseniusKabi-FK202409205$FRESENIUS KABI$$70$YR$E$M$Y$$$20240822$$HP$FR$FR
239903633$23990363$3$F$20231227$20240815$20240619$20240821$EXP$$JP-Eisai-EC-2024-168327$EISAI$$57$YR$A$F$Y$76$KG$20240821$$MD$JP$JP
239903652$23990365$2$F$$20240813$20240619$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097826$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240815$$CN$US$US
239903672$23990367$2$F$$20240917$20240619$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097232$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240917$$HP$US$US
239903743$23990374$3$F$$20240626$20240619$20240822$PER$$US-TRAVERE-2024TVT00521$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
239903772$23990377$2$F$$20240726$20240619$20240730$PER$$US-BIOVITRUM-2023-US-015128$BIOVITRUM$$62$YR$$F$Y$$$20240730$$CN$US$US
239903812$23990381$2$F$$20240805$20240619$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097165$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240808$$CN$US$US
239903852$23990385$2$F$$20240905$20240619$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093319$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240912$$HP$US$US
239903862$23990386$2$F$$20240723$20240619$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-097046$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240731$$PH$JP$JP
239903902$23990390$2$F$20240607$20240624$20240619$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-096036$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240708$$PH$JP$JP
239903954$23990395$4$F$20240701$20240813$20240619$20240821$PER$$US-SA-2024SA177771$SANOFI AVENTIS$$50$YR$A$F$Y$84$KG$20240821$$CN$US$US
239904002$23990400$2$F$20230208$20240723$20240619$20240729$EXP$$US-BIOVITRUM-2024-US-008739$BIOVITRUM$$64$YR$$M$Y$$$20240729$$CN$US$US
239904092$23990409$2$F$$20240819$20240619$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098168$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240822$$CN$US$US
239904122$23990412$2$F$20240607$20240624$20240619$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-097026$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240704$$PH$JP$JP
239904183$23990418$3$F$20240601$20240711$20240619$20240725$EXP$$US-RDY-CLI/USA/24/0008608$DR REDDYS$$48$YR$A$F$Y$$$20240725$$MD$US$US
239904192$23990419$2$F$$20240710$20240619$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098083$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240712$$CN$US$US
239904203$23990420$3$F$$20240801$20240619$20240808$PER$$US-TRAVERE-2024TVT00499$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240808$$CN$US$US
239904252$23990425$2$F$20240521$20240603$20240619$20240715$PER$$US-TRAVERE-2024TVT00518$TRAVERE THERAPEUTICS$$43$YR$A$M$Y$$$20240715$$CN$US$US
239904332$23990433$2$F$$20240625$20240619$20240731$PER$$US-TRAVERE-2024TVT00519$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240731$$CN$US$US
239904373$23990437$3$F$20240601$20240703$20240619$20240710$PER$$CN-Eisai-EC-2024-168160$EISAI$$58$YR$A$F$Y$56$KG$20240710$$MD$CN$CN
239904412$23990441$2$F$20240318$20240807$20240619$20240814$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-019186$BOEHRINGER INGELHEIM$$59$YR$A$F$Y$65.23$KG$20240814$$CN$US$US
239904442$23990444$2$F$20240425$20240620$20240619$20240705$PER$$US-Eisai-EC-2024-165033$EISAI$$73$YR$E$F$Y$$$20240705$$CN$US$US
239904504$23990450$4$F$20240611$20240731$20240619$20240805$EXP$$JP-Eisai-EC-2024-168128$EISAI$$58$YR$A$F$Y$$$20240805$$MD$JP$JP
239904532$23990453$2$F$20220501$20240705$20240619$20240708$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-096668$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$88$KG$20240708$$MD$CZ$CZ
239904582$23990458$2$F$$20240805$20240619$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096835$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240809$$CN$US$US
239904602$23990460$2$F$$20240718$20240619$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098200$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240719$$CN$US$US
239904632$23990463$2$F$20240101$20240701$20240619$20240708$PER$$US-Eisai-EC-2024-162577$EISAI$$50$YR$A$M$Y$$$20240708$$CN$US$US
239904652$23990465$2$F$$20240716$20240619$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097896$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240719$$CN$US$US
239904672$23990467$2$F$20240605$20240731$20240619$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098164$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240801$$CN$US$US
239904692$23990469$2$F$$20240703$20240619$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097546$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$72.57$KG$20240704$$CN$US$US
239904733$23990473$3$F$$20240730$20240619$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098236$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240801$$CN$US$US
239904772$23990477$2$F$$20240830$20240619$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098283$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240903$$HP$US$US
239904792$23990479$2$F$$20240813$20240619$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097955$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240813$$HP$US$US
239904862$23990486$2$F$20210601$20240607$20240619$20240709$EXP$$SI-BRISTOL-MYERS SQUIBB COMPANY-2024-096206$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240709$$MD$SI$SI
239904883$23990488$3$F$20240101$20240813$20240619$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098196$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240814$$CN$US$US
239905032$23990503$2$F$$20240715$20240619$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098194$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240719$$CN$US$US
239905152$23990515$2$F$$20240716$20240619$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034549$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240718$$CN$US$US
239905182$23990518$2$F$$20240718$20240619$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097614$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240729$$CN$US$US
239905263$23990526$3$F$20230726$20240703$20240619$20240712$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-095307$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$108$KG$20240705$$MD$PL$PL
239905276$23990527$6$F$20240501$20240917$20240619$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098187$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240917$$CN$US$US
239905312$23990531$2$F$$20240716$20240619$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098284$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240719$$CN$US$US
239905392$23990539$2$F$20240501$20240628$20240619$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098394$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240704$$CN$US$US
239905453$23990545$3$F$20240602$20240721$20240619$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097932$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$58.51$KG$20240722$$HP$US$US
239905522$23990552$2$F$$20240626$20240619$20240703$EXP$$CA-EMD Serono-9303158$EMD SERONO INC$$$$A$F$Y$$$20240703$$CN$CA$CA
239905672$23990567$2$F$$20240723$20240619$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098460$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$83.46$KG$20240724$$CN$US$US
239905682$23990568$2$F$$20240704$20240619$20240707$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-097687$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240707$$CN$GB$GB
239905732$23990573$2$F$20240604$20240916$20240619$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097807$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240917$$HP$US$US
239905812$23990581$2$F$$20240708$20240619$20240710$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034499$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240709$$CN$US$US
239905832$23990583$2$F$$20240715$20240619$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098288$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240719$$CN$US$US
239905892$23990589$2$F$$20240916$20240619$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097740$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240916$$CN$US$US
239906013$23990601$3$F$20240713$20240917$20240619$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098344$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240918$$CN$US$US
239906052$23990605$2$F$$20240726$20240619$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097451$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240805$$CN$US$US
239906122$23990612$2$F$$20240918$20240619$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098121$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240919$$CN$US$US
239906143$23990614$3$F$$20240814$20240619$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098176$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240818$$CN$US$US
239906202$23990620$2$F$$20240722$20240619$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098632$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240722$$CN$US$US
239906222$23990622$2$F$$20240628$20240619$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-098528$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240827$$MD$JP$JP
239906233$23990623$3$F$$20240825$20240619$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098588$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$80.74$KG$20240827$$CN$US$US
239906342$23990634$2$F$$20240829$20240619$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-085752$BRISTOL MYERS SQUIBB$$4$DEC$A$F$Y$83.91$KG$20240829$$CN$US$US
239906362$23990636$2$F$20240604$20240821$20240619$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095495$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$117.03$KG$20240829$$HP$US$US
239906383$23990638$3$F$$20240729$20240619$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-097558$BRISTOL MYERS SQUIBB$Nakahara Y, Kobayashi Y, Nakajo K, Miyamoto J, Ishizaki J, Tanaka M. Two cases of stevens-johnson syndrome (SJS) with prolonged ophthalmic symptoms suspected of being associated with immune checkpoint inhibitors. The Japanese Journal of Dermatology. 2024;134(5):1520.$69$YR$E$M$Y$$$20240806$$MD$JP$JP
239906412$23990641$2$F$$20240917$20240619$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098053$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240917$$CN$US$US
239906422$23990642$2$F$20240710$20240712$20240619$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098485$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240716$$CN$US$US
239906512$23990651$2$F$$20240703$20240619$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-046314$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$59.34$KG$20240704$$CN$US$US
239906602$23990660$2$F$$20240624$20240619$20240701$EXP$DE-BFARM-24003731$DE-862174955-ML2024-03461$MICRO LABS$$$$E$F$Y$63$KG$20240701$$CN$DE$DE
239906642$23990664$2$F$20240401$20240826$20240619$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098103$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$72.12$KG$20240828$$CN$US$US
239906652$23990665$2$F$$20240917$20240619$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097201$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240917$$HP$US$US
239906703$23990670$3$F$20240726$20240813$20240619$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098511$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$56.7$KG$20240815$$CN$US$US
239906712$23990671$2$F$20221013$20240710$20240619$20240722$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-12142$IPSEN$Kasai T, Eto H, Sato S, Nagashima A, Ushiyama R?Ikeda N, et al.. EUS-PD for Obstructive Pancreatitis after Long-Term Chemotherapy for Pancreatic Cancer: A Case Report. Progress of Digestive Endoscopyv. 2024;105:s119$75$YR$E$F$Y$$$20240719$$MD$JP$JP
239906732$23990673$2$F$20240624$20240624$20240619$20240702$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-11478$IPSEN$$81$YR$E$F$Y$57$KG$20240702$$CN$US$US
239906752$23990675$2$F$$20240628$20240619$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098571$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240701$$HP$US$US
239906802$23990680$2$F$20240513$20240624$20240619$20240708$EXP$$NL-GUERBET / LLC-NL-20240015$GUERBET$$45$YR$A$F$Y$63$KG$20240708$$CN$NL$NL
239906962$23990696$2$F$$20240918$20240619$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095991$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240918$$HP$US$US
239907023$23990702$3$F$20230918$20240617$20240619$20240702$EXP$$FR-Ipsen Biopharmaceuticals, Inc.-2024-07410$IPSEN$$53$YR$A$F$Y$76$KG$20240702$$MD$FR$FR
239907222$23990722$2$F$20210701$20240912$20240619$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096149$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240913$$CN$US$US
239907372$23990737$2$F$20240101$20240913$20240619$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095153$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240917$$HP$US$US
239907458$23990745$8$F$$20240826$20240619$20240828$PER$$US-BIOVITRUM-2024-US-008808$BIOVITRUM$$72$YR$$F$Y$$$20240828$$CN$US$US
239907463$23990746$3$F$20240610$20240905$20240619$20240906$EXP$$IT-BIOVITRUM-2024-IT-008811$BIOVITRUM$$$$A$M$Y$$$20240906$$MD$IT$IT
239907492$23990749$2$F$$20240724$20240619$20240725$PER$$US-JNJFOC-20240646950$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$HP$US$US
239907502$23990750$2$F$$20240916$20240619$20240916$EXP$$RO-BRISTOL-MYERS SQUIBB COMPANY-2024-097674$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240916$$MD$RO$RO
239907542$23990754$2$F$20240610$20240626$20240619$20240704$EXP$$AR-ALXN-202406SAM000635AR$ALEXION PHARMACEUTICALS$$23$YR$$M$Y$67$KG$20240704$$CN$AR$AR
239907572$23990757$2$F$20240627$20240627$20240619$20240701$EXP$$CA-TAKEDA-2024TUS055827$TAKEDA$$25$YR$$F$Y$$$20240701$$CN$CA$CA
239907602$23990760$2$F$$20240711$20240619$20240718$EXP$$IN-VANTIVE-2024VAN017734$Vantive US Healthcare$$63$YR$$M$Y$$$20240718$$CN$IN$IN
239907613$23990761$3$F$$20240710$20240619$20240722$EXP$$CA-VANTIVE-2024VAN017707$Vantive US Healthcare$$$$$M$Y$$$20240722$$CN$CA$CA
239907682$23990768$2$F$20240616$20240808$20240619$20240814$EXP$$PH-VANTIVE-2024VAN017835$Vantive US Healthcare$$52$YR$$F$Y$$$20240814$$CN$PH$PH
239907812$23990781$2$F$$20240709$20240619$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05004$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239907832$23990783$2$F$$20240610$20240619$20240703$EXP$$JP-009507513-2406JPN001403J$MERCK$Gotsu T, Tasaki M.. P-13 A case of an outpatient pharmacist intervention for adrenal hypofunction and cardiac failure during lenvatinib/pembrolizumab therapy. The 16th Annual Meeting of the Japanese Society of Oncology Pharmacy Practitione. 59$$$$F$Y$$$20240703$$PH$JP$JP
239907862$23990786$2$F$20240528$20240629$20240619$20240702$EXP$$US-TAKEDA-2024TUS060775$TAKEDA$$48$YR$$M$Y$$$20240702$$MD$US$US
239907964$23990796$4$F$$20240821$20240619$20240826$30DAY$$US-SANDOZ INC.-SDZ2024US058713$SANDOZ$$$$$M$Y$$$20240826$$CN$US$US
239907992$23990799$2$F$$20240708$20240619$20240709$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009365$JAZZ$$$$$M$Y$$$20240709$$HP$US$US
239908052$23990805$2$F$$20240807$20240619$20240814$PER$$US-SA-2024SA177575$SANOFI AVENTIS$$$$T$M$Y$$$20240814$$MD$US$US
239908082$23990808$2$F$$20240802$20240619$20240820$PER$$US-AstraZeneca-2024A129433$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
239908103$23990810$3$F$$20240718$20240619$20240726$EXP$$RS-AstraZeneca-2024A139295$ASTRAZENECA$$65$YR$$F$Y$$$20240726$$MD$RS$
239908112$23990811$2$F$$20240706$20240619$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05007$LUPIN$$$$$$Y$$$20240804$$CN$US$US
239908327$23990832$7$F$20230724$20240903$20240619$20240906$EXP$$CN-PFIZER INC-2023SGN09930$PFIZER$$66$YR$$M$Y$67.5$KG$20240906$$MD$CN$CN
239908342$23990834$2$F$$20240828$20240619$20240901$EXP$$NVSC2024US127420$NOVARTIS$$$$$M$Y$$$20240902$$HP$US$US
239908513$23990851$3$F$20240101$20240909$20240619$20240919$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406005833$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240919$$CN$JP$JP
239908582$23990858$2$F$20240601$20240826$20240619$20240902$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202406003632$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240902$$CN$AU$AU
239908602$23990860$2$F$20240101$20240812$20240619$20240820$EXP$$FR-SA-2024SA103769$SANOFI AVENTIS$$74$YR$E$M$Y$73$KG$20240820$$HP$FR$FR
239908632$23990863$2$F$20240501$20240806$20240619$20240813$EXP$$CA-GSK-CA2024034214$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$CA$CA
239908682$23990868$2$F$$20240620$20240619$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05119$LUPIN$$$$$$Y$$$20240702$$CN$US$US
239908692$23990869$2$F$20240101$20240825$20240619$20240829$EXP$$US-ABBVIE-5802699$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
239908872$23990887$2$F$20240419$20240624$20240619$20240701$EXP$$US-CIPLA (EU) LIMITED-2024US06063$CIPLA$$$$$$Y$$$20240701$$MD$US$US
239908892$23990889$2$F$$20240711$20240619$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098689$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240715$$CN$US$US
239908902$23990890$2$F$20240611$20240808$20240619$20240809$PER$$US-JNJFOC-20240631261$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240809$$HP$US$US
239908972$23990897$2$F$20190101$20240624$20240619$20240702$EXP$$IT-TEVA-VS-3209222$TEVA$Mauri G, Gori V, Patelli G, Roazzi L, Rizzetto F, De Carlis L, et al. Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report. World-J-Surg-Oncol 2023; 21 1-6.; Mauri G, Gori V, Patelli G, Roazzi L, Rizzetto F, De Carlis L, et al. Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report. World-J-Surg-Oncol 2023; 21 1-6.; Mauri G, Gori V, Patelli G, Roazzi L, Rizzetto ...$42$YR$$F$Y$$$20240702$$HP$IT$IT
239908982$23990898$2$F$20240101$20240708$20240619$20240712$EXP$$CA-JNJFOC-20240407982$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240712$$HP$CA$CA
239908992$23990899$2$F$$20240627$20240619$20240701$PER$$US-JNJFOC-20240636286$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$MD$US$US
239909112$23990911$2$F$$20240703$20240619$20240708$EXP$DE-GERMAN-LIT/DEU/24/0008671$DE-RDY-LIT/DEU/24/0008671$DR REDDYS$Riedhammer C, Dull J, Kestle C, Kadel S, Franz J, Weis P, et al. Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma. Annals of Hematology. 2024 Apr;103(4): 1327-1332. doi:10.1007/s00277-023-05586-8.$60$YR$A$M$Y$$$20240708$$HP$DE$DE
239909122$23990912$2$F$20230213$20240805$20240619$20240814$EXP$$JP-ABBVIE-5806826$ABBVIE$$81$YR$$F$Y$$$20240814$$HP$JP$JP
239909172$23990917$2$F$$20240626$20240619$20240704$EXP$$US-AstraZeneca-2024A140856$ASTRAZENECA$Silva, K; Geringer, R; Sahasranaman, V. Hyperimmunoglobulin E Syndrome: A Rare Autoimmune Masquerade of Th2 Asthma. American Journal of Respiratory and Critical Care Medicine C32. ALL THAT WHEEZES (AND THEN SOME): CASE STUDIES 2024;209:A5291- A5291.$54$YR$$M$Y$$$20240704$$HP$US$
239909272$23990927$2$F$$20240705$20240619$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098890$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240709$$CN$US$US
239909283$23990928$3$F$20231115$20240903$20240619$20240910$EXP$$CA-JNJFOC-20231151708$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20240910$$HP$CA$CA
239909302$23990930$2$F$20230201$20240823$20240619$20240831$EXP$$US-AMGEN-USASP2024119105$AMGEN$$66$YR$E$F$Y$52.05$KG$20240830$$LW$US$US
239909342$23990934$2$F$20221101$20240731$20240619$20240808$PER$$US-SA-2024SA178366$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240808$$MD$US$US
239909442$23990944$2$F$20240101$20240709$20240619$20240718$PER$$US-SA-2024SA177012$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240718$$MD$US$US
239909522$23990952$2$F$$20240801$20240619$20240810$PER$$US-SA-2024SA179770$SANOFI AVENTIS$$29$YR$A$F$Y$51.25$KG$20240810$$MD$US$US
239909552$23990955$2$F$$20240822$20240619$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097791$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240824$$CN$US$US
239909562$23990956$2$F$20220501$20240917$20240619$20240917$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-091522$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$80.5$KG$20240917$$HP$GB$GB
239909582$23990958$2$F$$20240827$20240619$20240829$EXP$$DE-JNJFOC-20240626913$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$HP$DE$DE
239909623$23990962$3$F$$20240723$20240619$20240725$PER$$US-AMGEN-USASP2024120979$AMGEN$$$$$$Y$$$20240725$$CN$US$US
239909654$23990965$4$F$20240502$20240808$20240619$20240815$EXP$$IE-TAKEDA-2024TUS058919$TAKEDA$$60$YR$$F$Y$$$20240815$$MD$IE$IE
239909712$23990971$2$F$$20240823$20240619$20240827$EXP$$NVSC2024CA126950$NOVARTIS$$$$$F$Y$$$20240827$$MD$CA$CA
239909733$23990973$3$F$$20240627$20240619$20240705$EXP$$JP-JNJFOC-20240641697$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$$COUNTRY NOT SPECIFIED$JP
239909764$23990976$4$F$20240326$20240722$20240619$20240725$EXP$$JP-AstraZeneca-2024A137416$ASTRAZENECA$$76$YR$$M$Y$37$KG$20240725$$MD$JP$
239909802$23990980$2$F$20231204$20240702$20240619$20240704$EXP$$US-KYOWAKIRIN-2024KK014713$KYOWA$$$$$$Y$$$20240704$$HP$US$US
239909892$23990989$2$F$$20240718$20240619$20240724$EXP$$US-GILEAD-2024-0677744$GILEAD$$64$YR$A$F$Y$$$20240724$$CN$US$US
239909922$23990992$2$F$20240617$20240620$20240619$20240708$PER$$US-JNJFOC-20240647890$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240708$$CN$US$US
239909942$23990994$2$F$20240511$20240617$20240619$20240705$PER$$US-Eisai-EC-2024-166193$EISAI$$68$YR$E$M$Y$73$KG$20240705$$MD$US$US
239909993$23990999$3$F$20240401$20240813$20240619$20240829$EXP$$US-AstraZeneca-2024A141619$ASTRAZENECA$$42$YR$$F$Y$83.5$KG$20240829$$CN$US$
239910172$23991017$2$F$20240101$20240828$20240619$20240909$PER$$US-SA-2024SA179660$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240909$$MD$US$US
239910222$23991022$2$F$20240101$20240715$20240619$20240725$EXP$$US-PYROS PHARMACEUTICALS, INC-2024-PYROS-US000022$Pyros Pharmaceuticals$$$$$M$Y$9.977$KG$20240725$$CN$US$US
239910242$23991024$2$F$$20240711$20240619$20240722$EXP$$US-JNJFOC-20240616821$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240722$$HP$US$US
239910322$23991032$2$F$20240101$20240805$20240619$20240813$PER$$US-SA-2024SA175392$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240814$$MD$US$US
239910632$23991063$2$F$$20240626$20240619$20240705$EXP$$US-Calliditas-2024CAL01079$CALLIDITAS THERAPEUTICS$$54$YR$A$M$Y$107.9$KG$20240705$$CN$US$US
239910642$23991064$2$F$20240521$20240731$20240619$20240808$PER$$US-SA-2024SA179706$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240808$$HP$US$US
239910742$23991074$2$F$$20240625$20240619$20240705$EXP$$BE-TEVA-VS-3209415$TEVA$Shiba S, Van Keer J. Double bad luck: pulmonary embolism and vaginal bleeding - a case report. Int-J-Emerg-Med 2024; 17 (1): 1-4.; Shiba S, Van Keer J. Double bad luck: pulmonary embolism and vaginal bleeding - a case report. Int-J-Emerg-Med 2024; 17 (1): 1-4.; Shiba S, Van Keer J. Double bad luck: pulmonary embolism and vaginal bleeding - a case report. Int-J-Emerg-Med 2024; 17 (1): 1-4.$47$YR$$F$Y$$$20240705$$HP$BE$BE
239910814$23991081$4$F$$20240712$20240619$20240801$EXP$JP-MLMSERVICE-20240605-PI088284-00181-1$JP-SA-2024SA178511$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240719$$HP$JP$JP
239911003$23991100$3$F$$20240829$20240619$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202406008184$ELI LILLY AND CO$$60$YR$A$$Y$78.458$KG$20240905$$CN$US$US
239911072$23991107$2$F$20240608$20240717$20240619$20240720$PER$$US-JNJFOC-20240631832$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240719$$HP$US$US
239911162$23991116$2$F$$20240717$20240619$20240816$PER$$US-AstraZeneca-2024A139622$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
239911202$23991120$2$F$$20240709$20240619$20240717$EXP$$JP-AstraZeneca-2024A138694$ASTRAZENECA$Minami Y, et al.. Study on efficacy of ferric delisomaltose for anemia caused by chemotherapy for gynecological cancers.. The Japanese Journal of Obstetrical, Gynecological + Neonatal Hematology 2024;34(1):15-16.$50$YR$$F$Y$$$20240717$$MD$JP$
239911245$23991124$5$F$20240516$20240812$20240619$20240823$EXP$$US-Calliditas-2024CAL01069$CALLIDITAS THERAPEUTICS$$81$YR$E$F$Y$57.6$KG$20240823$$CN$US$US
239911333$23991133$3$F$$20240626$20240619$20240705$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001228$BLUEPRINT MEDICINES$$$$$M$Y$$$20240705$$CN$US$US
239911343$23991134$3$F$$20240724$20240619$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001227$BLUEPRINT MEDICINES$$$$$F$Y$$$20240731$$CN$US$US
239911402$23991140$2$F$20240201$20240710$20240619$20240717$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-096589$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240717$$MD$ES$ES
239911432$23991143$2$F$$20240724$20240619$20240726$PER$$US-TAKEDA-2024TUS060773$TAKEDA$$$$$F$Y$$$20240726$$MD$US$US
239911444$23991144$4$F$20230621$20240905$20240619$20240912$EXP$$CA-TAKEDA-2024TUS059550$TAKEDA$$17$YR$$F$Y$$$20240912$$CN$CA$CA
239911472$23991147$2$F$20240101$20240709$20240619$20240718$PER$$US-SA-2024SA175897$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240718$$MD$US$US
239911542$23991154$2$F$20240101$20240724$20240619$20240801$PER$$US-SA-2024SA177241$SANOFI AVENTIS$$47$YR$A$F$Y$55.782$KG$20240801$$CN$US$US
239911583$23991158$3$F$20240705$20240705$20240619$20240710$EXP$$CA-TAKEDA-2024TUS058607$TAKEDA$$43$YR$$F$Y$$$20240710$$CN$CA$CA
239911612$23991161$2$F$$20240717$20240619$20240731$PER$$US-SA-2024SA175002$SANOFI AVENTIS$$12$YR$T$F$Y$52$KG$20240731$$MD$US$US
239911633$23991163$3$F$$20240722$20240619$20240726$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-126429$DAIICHI$$67$YR$$M$Y$$$20240726$$MD$JP$JP
239911732$23991173$2$F$20240611$20240611$20240619$20240709$EXP$$RO-AstraZeneca-2024A138188$ASTRAZENECA$$30$YR$$F$Y$74$KG$20240709$$MD$RO$
239911742$23991174$2$F$20240609$20240730$20240619$20240802$EXP$$US-AstraZeneca-2024A139064$ASTRAZENECA$$35679$DY$$M$Y$$$20240802$$HP$US$
239911793$23991179$3$F$$20240809$20240619$20240814$EXP$$BE-BEH-2024173656$CSL BEHRING$$$$A$M$Y$84$KG$20240814$$HP$BE$BE
239911802$23991180$2$F$20240614$20240630$20240619$20240704$EXP$$NVSC2024CA125070$NOVARTIS$$53$YR$$M$Y$$$20240704$$CN$CA$CA
239911822$23991182$2$F$$20240717$20240619$20240726$EXP$$US-Stemline Therapeutics, Inc.-2024ST003103$STEMLINE THERAPEUTICS$$43$YR$A$F$Y$$$20240726$$CN$US$US
239911842$23991184$2$F$$20240625$20240619$20240705$EXP$$ZA-TEVA-VS-3209419$TEVA$Omar S, Parris P, Gurke CR. Hemoadsorption Therapy for Calcium Channel Blocker Overdose: A Case Report. J-Emerg-Med 2024; 66 (4): e463-e466.; Omar S, Parris P, Gurke CR. Hemoadsorption Therapy for Calcium Channel Blocker Overdose: A Case Report. J-Emerg-Med 2024; 66 (4): e463-e466.$$$$M$Y$$$20240705$$MD$ZA$ZA
239911872$23991187$2$F$20240101$20240624$20240619$20240709$EXP$$US-OTTER-US-2024AST000240$Unknown Manufacturer$$$$$F$Y$$$20240709$$MD$US$US
239911922$23991192$2$F$$20240627$20240619$20240702$EXP$$CA-JNJFOC-20240641448$JOHNSON AND JOHNSON$$69$YR$E$F$Y$89$KG$20240702$$HP$CA$CA
239911972$23991197$2$F$20240502$20240708$20240619$20240710$EXP$$FR-PFIZER INC-202400193588$PFIZER$$$$E$F$Y$82.7$KG$20240710$$MD$FR$FR
239911982$23991198$2$F$20230704$20240731$20240619$20240801$EXP$$IN-PFIZER INC-PV202400080557$PFIZER$$31$YR$$F$Y$53$KG$20240801$$CN$IN$IN
239912122$23991212$2$F$$20240625$20240619$20240705$EXP$$BG-TEVA-VS-3210839$TEVA$Nikolova D, Yordanov A, Maslarova A, Sokolova L, Radinov A. Good clinical response following Ibrutinib treatment of a rare case of lymphoplasmacytic lymphoma secreting IgA kappa paraprotein: A case report. Oncology letters. 2024;28(2):1-8$$$A$F$Y$$$20240705$$MD$BG$BG
239912152$23991215$2$F$$20240720$20240619$20240722$PER$$US-PFIZER INC-PV202400078682$PFIZER$$13$YR$$M$Y$$$20240722$$MD$US$US
239912184$23991218$4$F$20240531$20240627$20240619$20240705$30DAY$$GB-JNJFOC-20240605390$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240705$$CN$GB$GB
239912192$23991219$2$F$$20240730$20240619$20240809$30DAY$$US-GSK-US2024072092$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
239912223$23991222$3$F$$20240913$20240619$20240918$PER$$US-PFIZER INC-PV202300160527$PFIZER$$13$YR$$M$Y$$$20240918$$CN$US$US
239912302$23991230$2$F$20220506$20240724$20240619$20240729$EXP$$DK-JNJFOC-20240620339$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240729$$MD$DK$DK
239912342$23991234$2$F$$20240916$20240619$20240920$PER$$US-PFIZER INC-PV202400079891$PFIZER$$54$YR$$F$Y$$$20240920$$HP$US$US
239912582$23991258$2$F$$20240821$20240619$20240903$EXP$$GB-TAKEDA-2023TUS120428$TAKEDA$$$$$F$Y$$$20240903$$HP$GB$GB
239912682$23991268$2$F$$20240625$20240619$20240705$EXP$$RO-TEVA-VS-3209432$TEVA$Popescu I, Dudau A-M, Dima S, Herlea V, Croitoru VM, Dinu IM, et al. Multimodal Treatment of Metastatic Rectal Cancer in a Young Patient: Case Report and Literature Review. Medicina-Kaunas 2024; 60 (5):.; Popescu I, Dudau A-M, Dima S, Herlea V, Croitoru VM, Dinu IM, et al. Multimodal Treatment of Metastatic Rectal Cancer in a Young Patient: Case Report and Literature Review. Medicina-Kaunas 2024; 60 (5):.; Popescu I, Dudau A-M, Dima S, Herlea V, Croitoru VM, Dinu IM, et al. Multimodal Treatme...$38$YR$$F$Y$$$20240705$$HP$RO$RO
239912732$23991273$2$F$$20240613$20240619$20240702$EXP$$JP-AstraZeneca-2024A138452$ASTRAZENECA$$60$YR$$M$Y$$$20240702$$MD$JP$
239912782$23991278$2$F$20240515$20240820$20240619$20240823$EXP$$JP-Eisai-EC-2024-168127$EISAI$$80$YR$E$F$Y$70$KG$20240823$$MD$JP$JP
239912833$23991283$3$F$20240101$20240919$20240619$20240925$PER$$JP-Eisai-EC-2024-168251$EISAI$$$$E$F$Y$$$20240925$$MD$JP$JP
239912872$23991287$2$F$20240612$20240709$20240619$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-095388$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240717$$CN$JP$JP
239912892$23991289$2$F$$20240702$20240619$20240710$EXP$$US-TEVA-VS-3208890$TEVA$$44$YR$$M$Y$$$20240710$$CN$US$US
239912932$23991293$2$F$$20240624$20240619$20240702$EXP$$TR-TEVA-VS-3209013$TEVA$Istanbullu C, Kayan Ocakoglu B, Karacetin G. A case of Pitt-Hopkins syndrome: psychopharmacological approach for anxiety, insomnia, and agitation. Neurocase 2023; 29 (4): 117-120.; Istanbullu C, Kayan Ocakoglu B, Karacetin G. A case of Pitt-Hopkins syndrome: psychopharmacological approach for anxiety, insomnia, and agitation. Neurocase 2023; 29 (4): 117-120.$$$$F$Y$$$20240702$$HP$TR$TR
239912942$23991294$2$F$$20240625$20240619$20240701$EXP$DE-EMA-20141022-ahujaprd-103314160$DE-BAUSCH-BL-2024-009261$BAUSCH AND LOMB$Buschmann C, Theile A, Tsokos M, Pueschel K, Schulz F. Todesfaelle nach Low-dose-Therapie mit Methotrexat. Rechtsmedizin. 2007 MAR 01;17(2):89-93. doi:10.1007/s00194-007-0430-6$$$E$F$Y$$$20240701$$HP$DE$DE
239912972$23991297$2$F$$20240809$20240619$20240822$PER$$US-TRAVERE-2024TVT00531$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
239913142$23991314$2$F$$20240827$20240619$20240829$PER$$US-PFIZER INC-PV202400080232$PFIZER$$68$YR$$F$Y$$$20240829$$CN$US$US
239913173$23991317$3$F$$20240708$20240619$20240716$EXP$$DE-AstraZeneca-2024A137125$ASTRAZENECA$$$$$F$Y$$$20240716$$MD$DE$
239913193$23991319$3$F$20240530$20240816$20240619$20240819$EXP$$JP-AstraZeneca-2024A138662$ASTRAZENECA$$83$YR$$F$Y$$$20240819$$MD$JP$
239913332$23991333$2$F$20230101$20240717$20240619$20240724$PER$$US-SA-2024SA178698$SANOFI AVENTIS$$8$YR$C$F$Y$36.51$KG$20240724$$MD$US$US
239913383$23991338$3$F$20240531$20240712$20240619$20240717$PER$$US-AMGEN-USASP2024115892$AMGEN$$61$YR$A$F$Y$67.2$KG$20240717$$PH$US$US
239913522$23991352$2$F$$20240702$20240619$20240708$PER$$US-PFIZER INC-202400195971$PFIZER$$$$$M$Y$$$20240708$$CN$US$US
239913552$23991355$2$F$20240612$20240702$20240619$20240704$PER$$US-PFIZER INC-202400194148$PFIZER$$74$YR$$M$Y$108.86$KG$20240704$$CN$US$US
239913594$23991359$4$F$$20240701$20240619$20240703$PER$$US-PFIZER INC-PV202400078659$PFIZER$$55$YR$$F$Y$$$20240703$$MD$US$US
239913662$23991366$2$F$$20240711$20240619$20240715$PER$$US-PFIZER INC-PV202400056281$PFIZER$$82$YR$$F$Y$$$20240715$$MD$US$US
239913702$23991370$2$F$20240614$20240722$20240619$20240725$PER$$US-PFIZER INC-202400193912$PFIZER$$41$YR$$F$Y$81.633$KG$20240725$$CN$US$US
239913732$23991373$2$F$$20240722$20240619$20240726$PER$$US-PFIZER INC-202400196254$PFIZER$$16$YR$$F$Y$$$20240726$$HP$US$US
239913782$23991378$2$F$$20240710$20240619$20240712$PER$$US-PFIZER INC-202400196169$PFIZER$$10$YR$$F$Y$$$20240712$$HP$US$US
239913853$23991385$3$F$20240601$20240628$20240619$20240701$PER$$US-PFIZER INC-202400195065$PFIZER$$32$YR$$M$Y$$$20240701$$HP$US$US
239913873$23991387$3$F$$20240626$20240619$20240701$PER$$US-PFIZER INC-202400195687$PFIZER$$23$YR$$M$Y$$$20240701$$MD$US$US
239913882$23991388$2$F$20240616$20240712$20240619$20240716$PER$$US-PFIZER INC-202400196054$PFIZER$$73$YR$$M$Y$88.435$KG$20240716$$CN$US$US
239913952$23991395$2$F$20240614$20240702$20240619$20240704$PER$$US-PFIZER INC-PV202400080216$PFIZER$$74$YR$$F$Y$74.376$KG$20240704$$CN$US$US
239913992$23991399$2$F$$20240729$20240619$20240731$PER$$US-ALXN-202406USA000734US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
239914062$23991406$2$F$20240601$20240626$20240619$20240701$PER$$US-Eisai-EC-2024-168196$EISAI$$63$YR$A$F$Y$119$KG$20240701$$CN$US$US
239914082$23991408$2$F$$20240611$20240619$20240731$EXP$$US-AstraZeneca-2024A136315$ASTRAZENECA$$$$$F$Y$$$20240731$$HP$US$
239914092$23991409$2$F$$20240730$20240619$20240802$EXP$$US-AstraZeneca-2024A137532$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
239914142$23991414$2$F$20240601$20240826$20240619$20240829$PER$$US-Eisai-EC-2024-168336$EISAI$$68$YR$E$F$Y$$$20240829$$CN$US$US
239914172$23991417$2$F$20240607$20240625$20240619$20240704$EXP$$US-BIOCODEX2-2024000785$BIOCODEX$$5$YR$$M$Y$21$KG$20240701$$MD$US$US
239914232$23991423$2$F$20240613$20240814$20240619$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099056$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240820$$CN$US$US
239914292$23991429$2$F$20240326$20240718$20240619$20240722$EXP$$US-ORGANON-O2404USA003472$ORGANON$$24$YR$$F$Y$91.62$KG$20240722$$MD$US$US
239914323$23991432$3$F$20240526$20240610$20240619$20240710$EXP$$US-BEH-2024173660$CSL BEHRING$$54$YR$A$F$Y$$$20240710$$HP$US$US
239914363$23991436$3$F$20240610$20240830$20240619$20240903$30DAY$$KR-PFIZER INC-202400195198$PFIZER$$11$YR$$$Y$$$20240903$$CN$KR$KR
239914372$23991437$2$F$$20240811$20240619$20240812$EXP$$CA-PFIZER INC-202400193254$PFIZER$$61$YR$$M$Y$$$20240812$$CN$CA$CA
239914382$23991438$2$F$$20240911$20240619$20240913$PER$$US-BIOGEN-2024BI01269489$BIOGEN$$$$$F$Y$$$20240913$$CN$US$US
239914402$23991440$2$F$20240419$20240723$20240619$20240730$PER$$US-BIOGEN-2023BI01239172$BIOGEN$$49$YR$$F$Y$$$20240730$$CN$US$US
239914455$23991445$5$F$$20240916$20240619$20240920$EXP$$CA-PFIZER INC-202400192995$PFIZER$$$$$F$Y$$$20240920$$CN$CA$CA
239914463$23991446$3$F$$20240911$20240619$20240913$30DAY$$GB-PFIZER INC-202400190366$PFIZER$$9$YR$$F$Y$$$20240913$$CN$GB$GB
239914474$23991447$4$F$$20240920$20240619$20240923$30DAY$$KR-PFIZER INC-202400195212$PFIZER$$11$YR$$$Y$$$20240923$$CN$KR$KR
239914483$23991448$3$F$$20240915$20240619$20240916$30DAY$$FR-PFIZER INC-202400192001$PFIZER$$78$YR$$M$Y$$$20240916$$PH$FR$FR
239914495$23991449$5$F$20240101$20240922$20240619$20240925$EXP$$CA-PFIZER INC-202400194108$PFIZER$$77$YR$$F$Y$$$20240925$$HP$CA$CA
239914504$23991450$4$F$20240603$20240918$20240619$20240920$30DAY$$GB-PFIZER INC-202400193846$PFIZER$$14$YR$$M$Y$$$20240920$$HP$GB$GB
239914512$23991451$2$F$$20240806$20240619$20240813$30DAY$$DE-PFIZER INC-202400195569$PFIZER$$$$$$Y$$$20240813$$HP$DE$DE
239914572$23991457$2$F$20240101$20240827$20240619$20240905$PER$$US-SA-2024SA177217$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240905$$MD$US$US
239914592$23991459$2$F$20240401$20240705$20240619$20240711$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00635$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$US$US
239914602$23991460$2$F$20240101$20240711$20240619$20240718$PER$$US-BIOGEN-2024BI01269391$BIOGEN$$$$$M$Y$$$20240718$$CN$US$US
239914662$23991466$2$F$$20240813$20240619$20240821$EXP$$US-Calliditas-2024CAL01091$CALLIDITAS THERAPEUTICS$$58$YR$A$M$Y$$$20240821$$CN$US$US
239914722$23991472$2$F$$20240730$20240619$20240801$PER$$US-ALXN-202406USA000813US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
239914752$23991475$2$F$$20240712$20240619$20240717$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-098986$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$58.06$KG$20240717$$CN$PR$PR
239914772$23991477$2$F$$20240917$20240619$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098518$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240917$$HP$US$US
239914872$23991487$2$F$20140305$20240919$20240619$20240930$EXP$$US-SA-2024SA179683$SANOFI AVENTIS$$74$YR$E$F$Y$74.09$KG$20240930$$HP$US$US
239914882$23991488$2$F$20240101$20240820$20240619$20240903$PER$$US-SA-2024SA179221$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240903$$MD$US$US
239914942$23991494$2$F$$20240720$20240619$20240722$30DAY$$US-PFIZER INC-202400193245$PFIZER$$13$YR$$F$Y$$$20240722$$CN$US$US
239914952$23991495$2$F$$20240708$20240619$20240710$EXP$$CA-PFIZER INC-202300214224$PFIZER$$81$YR$$F$Y$71$KG$20240710$$MD$CA$CA
239914992$23991499$2$F$$20240722$20240619$20240726$EXP$$US-BEH-2024173751$CSL BEHRING$$$$$F$Y$$$20240726$$CN$US$US
239915012$23991501$2$F$$20240806$20240619$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098789$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240808$$HP$US$US
239915202$23991520$2$F$20240229$20240806$20240619$20240807$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034753$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240807$$CN$US$US
239915302$23991530$2$F$$20240711$20240619$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009317$JAZZ$$$$$F$Y$$$20240717$$MD$US$US
239915377$23991537$7$F$20240401$20240925$20240619$20240930$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-098795$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$61.23$KG$20240930$$CN$PR$PR
239915443$23991544$3$F$$20240802$20240619$20240805$EXP$$AU-ALXN-202406OCE000573AU$ALEXION PHARMACEUTICALS$$30$YR$$F$Y$55.7$KG$20240805$$MD$AU$AU
239915523$23991552$3$F$20240101$20240909$20240619$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-017161$UNITED THERAPEUTICS$$$$$F$Y$$$20240914$$$US$US
239915542$23991554$2$F$$20240722$20240619$20240723$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006549$JAZZ$$$$$F$Y$$$20240723$$MD$US$US
239915712$23991571$2$F$$20240917$20240619$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098987$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240917$$HP$US$US
239915942$23991594$2$F$20240601$20240725$20240619$20240726$PER$$US-PURDUE-USA-2024-0310232$PURDUE$$69$YR$$F$Y$88$KG$20240726$$CN$US$US
2399160013$23991600$13$F$$20240924$20240619$20240930$EXP$$US-SANDOZ INC.-NVSC2021US290008$SANDOZ$$$$$M$Y$47.166$KG$20240930$$CN$US$US
239916102$23991610$2$F$$20240818$20240619$20240822$EXP$$US-APELLIS-APL-2023-002865$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240821$$CN$US$US
239916243$23991624$3$F$$20240814$20240619$20240822$EXP$$US-ALXN-202406USA000716US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
239916282$23991628$2$F$$20240611$20240619$20240701$EXP$$US-ALXN-202406USA000728US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240701$$MD$US$US
239916352$23991635$2$F$$20240716$20240619$20240720$EXP$$NVSC2024US126536$NOVARTIS$$$$$$Y$$$20240719$$CN$US$US
239916383$23991638$3$F$$20240925$20240619$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202405013368$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240926$$CN$US$US
239916392$23991639$2$F$20240601$20240705$20240619$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202406012955$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240708$$CN$US$US
239916803$23991680$3$F$$20240623$20240619$20240702$PER$$US-PFIZER INC-PV202400080390$PFIZER$$75$YR$$F$Y$$$20240702$$CN$US$US
239916822$23991682$2$F$20240401$20240621$20240619$20240703$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00479$UPSHER-SMITH$$19$YR$$M$Y$81.647$KG$20240703$$CN$US$US
239916872$23991687$2$F$$20240903$20240619$20240912$EXP$$JP-Eisai-EC-2024-168126$EISAI$Majima Takuya. A case of type 1 diabetes mellitus which developed during combination therapy with lenvatinib and pembrolizumab for recurrent uterine body cancer. Japanese Journal of Gynecological Oncology. 2024; 42(3): 195-195.$72$YR$E$F$Y$$$20240912$$MD$JP$JP
239916933$23991693$3$F$$20240925$20240619$20240930$EXP$$CA-SANDOZ INC.-SDZ2024CA058926$SANDOZ$$$$$F$Y$$$20240930$$CN$CA$CA
239916953$23991695$3$F$$20240917$20240619$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099007$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240919$$CN$US$US
239916962$23991696$2$F$20240701$20240814$20240619$20240820$EXP$$US-GILEAD-2024-0677678$GILEAD$$71$YR$E$F$Y$$$20240820$$CN$US$US
239917024$23991702$4$F$20240601$20240730$20240619$20240731$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-253311$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$$$20240731$$CN$US$US
239917042$23991704$2$F$20240603$20240819$20240619$20240903$PER$$US-SAGE-2024SAGE000071$SAGE$$24$YR$$F$Y$$$20240903$$MD$US$US
239917052$23991705$2$F$$20240912$20240619$20240926$PER$$US-JNJFOC-20240650279$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240926$$PH$US$US
239917064$23991706$4$F$20220831$20240725$20240619$20240731$EXP$$DE-SANDOZ INC.-SDZ2024DE058899$SANDOZ$$$$E$F$Y$$$20240731$$CN$DE$DE
239917142$23991714$2$F$$20240719$20240619$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098326$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240723$$CN$US$US
239917222$23991722$2$F$$20240716$20240619$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098994$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240722$$HP$US$US
239917232$23991723$2$F$20240517$20240621$20240619$20240701$EXP$$US-APELLIS-2024-APL-0000170$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240701$$CN$US$US
239917282$23991728$2$F$20240501$20240916$20240619$20240922$EXP$$US-TAKEDA-2024TUS043096$TAKEDA$$76$YR$$F$Y$$$20240922$$CN$US$US
239917353$23991735$3$F$$20240812$20240619$20240813$PER$$NVSC2024US128180$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
239917394$23991739$4$F$20240101$20240829$20240619$20240910$EXP$$US-MALLINCKRODT-MNK202403747$MALLINCKRODT$$79$YR$E$F$Y$$$20240910$$HP$US$US
239917404$23991740$4$F$$20240725$20240619$20240806$EXP$$US-MALLINCKRODT-MNK202403864$MALLINCKRODT$$67$YR$E$F$Y$$$20240806$$HP$US$US
239917492$23991749$2$F$$20240703$20240619$20240718$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI05709$NEUROCRINE BIOSCIENCES$$$$A$F$Y$$$20240719$$HP$US$US
239917542$23991754$2$F$20240515$20240618$20240619$20240705$PER$$US-APELLIS-2024-APL-0000140$APELLIS PHARMACEUTICALS$$$$$$Y$57.29$KG$20240705$$HP$US$US
239917554$23991755$4$F$20240101$20240712$20240619$20240717$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034178$BOEHRINGER INGELHEIM$$92$YR$E$F$Y$$$20240717$$CN$BR$BR
239917614$23991761$4$F$20240603$20240719$20240619$20240722$EXP$FR-AFSSAPS-TO2024001044$FR-JNJFOC-20240646219$JOHNSON AND JOHNSON$$67$YR$E$F$Y$54$KG$20240722$$PH$FR$FR
239917633$23991763$3$F$$20240816$20240619$20240903$PER$$US-AstraZeneca-2024A141145$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
239917642$23991764$2$F$20240614$20240815$20240619$20240831$PER$$US-AstraZeneca-2024A141144$ASTRAZENECA$$25411$DY$$F$Y$$$20240831$$CN$US$
239917702$23991770$2$F$$20240625$20240619$20240705$EXP$$US-TEVA-VS-3209969$TEVA$Khosla AA, Saunders H, Helgeson S, Hikida H, Aslam N, Salem F, et al. The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis. Case-Rep-Pulmon 2023; 2023 (1):.; Khosla AA, Saunders H, Helgeson S, Hikida H, Aslam N, Salem F, et al. The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis. Case-Rep-Pulmon 2023; 2023 (1):.; Khosla AA, Saunders H, Helgeson S, Hikida H, Aslam N, Salem F, et al. The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Assoc...$72$YR$$F$Y$$$20240705$$HP$US$US
239917742$23991774$2$F$20220415$20240704$20240619$20240708$EXP$$NVSJ2024JP007184$NOVARTIS$$88$YR$$F$Y$$$20240709$$MD$JP$JP
239917762$23991776$2$F$20240621$20240718$20240619$20240723$EXP$$AR-EMD Serono-2024032649$EMD SERONO INC$$33$YR$A$F$Y$$$20240724$$CN$AR$AR
239917812$23991781$2$F$$20240625$20240619$20240705$EXP$$US-TEVA-VS-3209400$TEVA$Madan V, Marchitto MC, Sunshine JC. Pembrolizumab-Induced Lichen Planus Pemphigoides in a Patient with Metastatic Adrenocortical Cancer: A Case Report and Literature Review. Dermatopathology 2023; 10 (3): 244-258.; Madan V, Marchitto MC, Sunshine JC. Pembrolizumab-Induced Lichen Planus Pemphigoides in a Patient with Metastatic Adrenocortical Cancer: A Case Report and Literature Review. Dermatopathology 2023; 10 (3): 244-258.; Madan V, Marchitto MC, Sunshine JC. Pembrolizumab-Induced Lichen Pl...$46$YR$$F$Y$$$20240705$$HP$US$US
239917822$23991782$2$F$20240529$20240710$20240619$20240711$EXP$$US-ABBVIE-5806630$ABBVIE$$58$YR$$F$Y$$$20240711$$CN$US$US
239917832$23991783$2$F$20240617$20240710$20240619$20240711$EXP$$NVSJ2024JP007305$NOVARTIS$$75$YR$$M$Y$$$20240712$$PH$JP$JP
239917852$23991785$2$F$$20240717$20240619$20240725$30DAY$$DE-JNJFOC-20240642582$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$PH$DE$DE
239917882$23991788$2$F$20240619$20240805$20240619$20240807$PER$$NVSC2024US128222$NOVARTIS$$73$YR$$$Y$$$20240807$$HP$US$US
239917952$23991795$2$F$$20240813$20240619$20240821$EXP$$CA-APOTEX-2024AP007164$APOTEX$$80$YR$$M$Y$89$KG$20240821$$HP$CA$CA
239918322$23991832$2$F$20240614$20240704$20240619$20240710$EXP$$JP-ASTELLAS-2024JP004176$ASTELLAS$$$$E$F$Y$$$20240710$$PH$JP$JP
239918332$23991833$2$F$$20240816$20240619$20240820$EXP$$NVSC2024US126747$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
239918352$23991835$2$F$$20240723$20240619$20240726$EXP$$US-ABBVIE-5806599$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
239918423$23991842$3$F$$20240723$20240619$20240802$30DAY$$TR-JNJFOC-20240638778$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$TR$TR
239918503$23991850$3$F$20240531$20240830$20240619$20240904$EXP$$CA-TAKEDA-2024TUS060677$TAKEDA$$52$YR$$M$Y$$$20240904$$MD$CA$CA
239918582$23991858$2$F$20240101$20240725$20240619$20240730$EXP$$US-JNJFOC-20240630730$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240730$$CN$US$US
239918613$23991861$3$F$$20240917$20240619$20240920$PER$$US-JNJFOC-20240642900$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$55.2$KG$20240920$$MD$US$US
239918672$23991867$2$F$20240528$20240625$20240619$20240702$PER$$US-AMGEN-USASP2024120456$AMGEN$$64$YR$A$F$Y$$$20240701$$CN$US$US
239918685$23991868$5$F$20231230$20240826$20240619$20240902$EXP$$US-BIOGEN-2024BI01270128$BIOGEN$$52$YR$$F$Y$$$20240902$$HP$US$US
239918702$23991870$2$F$$20240729$20240619$20240805$EXP$$US-ABBVIE-4710865$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
239918802$23991880$2$F$20240607$20240703$20240619$20240709$EXP$$CN-ASTELLAS-2024US017464$ASTELLAS$$74$YR$$M$Y$$$20240709$$CN$CN$CN
239918832$23991883$2$F$$20240712$20240619$20240725$30DAY$$FR-JNJFOC-20240636293$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$PH$FR$FR
239918842$23991884$2$F$$20240625$20240619$20240705$EXP$$IT-TEVA-VS-3210537$TEVA$Bonis A, Dell^Amore A, Verzeletti V, Melan L, Zambello G, Nardocci C, et al. Hepatoid Adenocarcinoma of the Lung: A Review of the Most Updated Literature and a Presentation of Three Cases. J-Clin-Med 2023; 12 (4):.; Bonis A, Dell^Amore A, Verzeletti V, Melan L, Zambello G, Nardocci C, et al. Hepatoid Adenocarcinoma of the Lung: A Review of the Most Updated Literature and a Presentation of Three Cases. J-Clin-Med 2023; 12 (4):.; Bonis A, Dell^Amore A, Verzeletti V, Melan L, Zambello G, Nardocc...$67$YR$$F$Y$$$20240705$$HP$IT$IT
239918882$23991888$2$F$20240614$20240701$20240619$20240703$PER$$US-AMGEN-USASP2024120465$AMGEN$$52$YR$A$F$Y$$$20240703$$CN$US$US
239918892$23991889$2$F$20240501$20240716$20240619$20240724$PER$$US-SA-2024SA179845$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240724$$MD$US$US
239918912$23991891$2$F$20231030$20240719$20240619$20240725$EXP$$DE-ABBVIE-5802893$ABBVIE$$40$YR$$M$Y$$$20240725$$MD$DE$DE
239918932$23991893$2$F$$20240827$20240619$20240829$EXP$$US-JNJFOC-20240630776$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$CN$US$US
239918944$23991894$4$F$20240101$20240820$20240619$20240822$EXP$$ES-ABBVIE-5783869$ABBVIE$$$$$M$Y$$$20240822$$CN$ES$ES
239919032$23991903$2$F$20240614$20240628$20240620$20240702$PER$$US-AMGEN-USASP2024120174$AMGEN$$70$YR$E$M$Y$$$20240702$$CN$US$US
239919062$23991906$2$F$20240227$20240716$20240620$20240723$EXP$$US-ABBVIE-5803958$ABBVIE$$59$YR$$F$Y$76.203$KG$20240723$$HP$US$US
239919263$23991926$3$F$20240401$20240705$20240620$20240707$EXP$$DE-BAUSCHBL-2024BNL028719$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240707$$HP$DE$DE
239919482$23991948$2$F$$20240717$20240620$20240725$30DAY$$TR-JNJFOC-20240634836$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$PH$TR$TR
239919582$23991958$2$F$20240101$20240704$20240620$20240708$EXP$$CA-ABBVIE-5806721$ABBVIE$$72$YR$$M$Y$$$20240708$$PH$CA$CA
239919593$23991959$3$F$20240630$20240630$20240620$20240705$EXP$$GR-ABBVIE-5806551$ABBVIE$$85$YR$$F$Y$$$20240705$$CN$GR$GR
239919622$23991962$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3210130$TEVA$Young SR, Stoianovici RN, Louie EL. Fusarium Isolates in Burn-injured Patients: Clinical Characteristics and Susceptibility Patterns. J-Burn-Care-Res 2024; 45 (Suppl.) S114.; Young SR, Stoianovici RN, Louie EL. Fusarium Isolates in Burn-injured Patients: Clinical Characteristics and Susceptibility Patterns. J-Burn-Care-Res 2024; 45 (Suppl.) S114.$$$$$Y$$$20240705$$PH$US$US
239919804$23991980$4$F$$20240724$20240620$20240727$EXP$$CA-ROCHE-3579766$ROCHE$$$$A$F$Y$$$20240727$$CN$CA$CA
239919822$23991982$2$F$20240610$20240618$20240620$20240708$EXP$$CN-ROCHE-10000002376$ROCHE$$57$YR$A$M$Y$80$KG$20240708$$HP$CN$CN
239919844$23991984$4$F$$20240617$20240620$20240702$PER$$US-ROCHE-10000001676$ROCHE$Gilani S, Rifai Z, Singanallur P, Song M. Prolonged COVID-19 Pneumonia in a Patient on Obinutuzumab for Treatment of Follicular Lymphoma. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:A5676.$62$YR$A$M$Y$$$20240702$$HP$US$US
239919853$23991985$3$F$$20240702$20240620$20240715$PER$$US-ROCHE-10000001163$ROCHE$$$$$$Y$$$20240715$$MD$US$US
239919893$23991989$3$F$$20240611$20240620$20240708$PER$$US-ROCHE-10000002344$ROCHE$$$$$F$Y$$$20240708$$CN$US$US
239919914$23991991$4$F$$20240801$20240620$20240805$PER$$US-ROCHE-10000001858$ROCHE$$45$YR$A$M$Y$$$20240805$$CN$US$US
239919972$23991997$2$F$$20240610$20240620$20240708$EXP$$US-ROCHE-10000001482$ROCHE$$53$YR$A$F$Y$$$20240708$$CN$US$US
239920014$23992001$4$F$20240501$20240701$20240620$20240715$PER$$US-ROCHE-3571668$ROCHE$$65$YR$E$F$Y$107.5$KG$20240715$$CN$US$US
239920032$23992003$2$F$$20240609$20240620$20240705$PER$$US-ROCHE-10000001131$ROCHE$$$$$$Y$$$20240705$$CN$US$US
239920042$23992004$2$F$$20240716$20240620$20240729$PER$$US-ROCHE-10000000157$ROCHE$$18$YR$A$F$Y$$$20240729$$HP$US$US
239920062$23992006$2$F$$20240607$20240620$20240708$PER$$US-ROCHE-10000000729$ROCHE$$$$$$Y$$$20240708$$CN$US$US
2399201010$23992010$10$F$$20240528$20240620$20240710$PER$$US-ROCHE-3543638$ROCHE$$$$A$F$Y$44.32$KG$20240628$$CN$US$US
239920122$23992012$2$F$20240610$20240628$20240620$20240704$PER$$US-ROCHE-10000001212$ROCHE$$37$YR$A$M$Y$$$20240704$$CN$US$US
239920142$23992014$2$F$$20240611$20240620$20240704$PER$$US-ROCHE-10000001453$ROCHE$$$$$F$Y$$$20240704$$HP$US$US
239920182$23992018$2$F$20240614$20240617$20240620$20240709$EXP$$CN-ROCHE-10000001108$ROCHE$$31$YR$A$M$Y$65$KG$20240703$$HP$CN$CN
239920192$23992019$2$F$$20240501$20240620$20240710$PER$$US-ROCHE-3556910$ROCHE$$60$YR$A$F$Y$$$20240701$$MD$US$US
239920233$23992023$3$F$$20240705$20240620$20240712$PER$$US-ROCHE-10000002019$ROCHE$Xiong J, Prasad S, Embry E, Singh K, Singh M. Resistant Pneumocystis Jiroveci Pneumonia in Patients With ANCAAssociated Vasculitis. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:$68$YR$E$M$Y$$$20240712$$HP$US$US
239920262$23992026$2$F$20240508$20240607$20240620$20240701$EXP$$CN-ROCHE-3580408$ROCHE$$97$YR$E$F$Y$51$KG$20240701$$HP$CN$CN
239920292$23992029$2$F$$20240610$20240620$20240709$EXP$$US-ROCHE-10000001885$ROCHE$$79$YR$E$M$Y$$$20240709$$CN$US$US
239920322$23992032$2$F$$20240917$20240620$20240925$EXP$$CA-ROCHE-10000000772$ROCHE$$16$YR$T$F$Y$$$20240925$$HP$CA$CA
239920333$23992033$3$F$20240603$20240619$20240620$20240704$EXP$$US-ROCHE-10000001843$ROCHE$$84$YR$E$M$Y$$$20240704$$CN$US$US
239920362$23992036$2$F$$20240617$20240620$20240702$EXP$$IN-ROCHE-10000001981$ROCHE$Kene R, Singhai P, Raman R, Dutta Majumder P. Presumed Fungal Retinitis Following Adalimumab Therapy for Juvenile Idiopathic Arthritis: A Rare Case Report. Ocular Immunology and Inflammation. 2024;1-4. doi:10.1080/09273948.2024.2361355.$20$YR$A$F$Y$$$20240702$$HP$IN$IN
239920392$23992039$2$F$20240526$20240617$20240620$20240702$EXP$$CN-ROCHE-10000001063$ROCHE$$61$YR$A$F$Y$$$20240702$$HP$CN$CN
239920424$23992042$4$F$20231110$20240719$20240620$20240728$PER$$US-ROCHE-3578638$ROCHE$$67$YR$E$F$Y$52.07$KG$20240728$$CN$US$US
239920432$23992043$2$F$$20240701$20240620$20240707$EXP$$JP-ROCHE-10000002177$ROCHE$$8$DEC$E$M$Y$$$20240707$$MD$JP$JP
239920452$23992045$2$F$$20240613$20240620$20240701$PER$$US-ROCHE-10000000069$ROCHE$Barrows C, Horton M, Allaham A, Israel, H. Case of Acute Hypoxic Respiratory Failure After Administration of Rituximab. American Journal of Respiratory and Critical Care Medicine 209 American Thoracic Society. 2024-May;209:A6326.$61$YR$A$M$Y$$$20240701$$HP$US$US
239920473$23992047$3$F$$20240609$20240620$20240704$EXP$$US-ROCHE-10000001870$ROCHE$$$$$$Y$$$20240704$$CN$US$US
239920502$23992050$2$F$$20240604$20240620$20240709$PER$$US-ROCHE-10000001051$ROCHE$Valdo Giugni M, Gottlieb R and Spak C. Adjunctive Cytogam and CMV Insight T-Cell Immunity Assay for Refractory CMV Disease in Heart Transplant Recipients - Single-CenterCase Series of Challenging Cases. The Journal of Heart and Lung Transplantation. 2024;(43):S454.$53$YR$A$M$Y$$$20240702$$HP$US$US
239920522$23992052$2$F$$20240620$20240620$20240703$PER$$US-ROCHE-10000000142$ROCHE$$64$YR$A$F$Y$$$20240703$$MD$US$US
239920534$23992053$4$F$$20240613$20240620$20240709$PER$$US-ROCHE-10000000040$ROCHE$Virk S, Niranjan S, Patel D, Javed A, Nasrullah A, And Malik K. Breathing Battles: The Ongoing Struggle of Recurrent Covid-19-related Respiratory Failure in a Patient With Hashimoto^s Encephalopathy Under Intermittent Immunosuppression. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:A5589.$42$YR$A$F$Y$$$20240709$$HP$US$US
239920563$23992056$3$F$$20240729$20240620$20240802$EXP$$US-ROCHE-10000001964$ROCHE$$53$YR$A$F$Y$$$20240802$$HP$US$US
239920606$23992060$6$F$$20240705$20240620$20240709$EXP$$US-ROCHE-10000000059$ROCHE$Gul M, Taylor K, Bailey K, Adickes E. An Unexpected Cause of Acute Liver Failure. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:A1723.$81$YR$E$M$Y$$$20240709$$HP$US$US
239920613$23992061$3$F$20240101$20240610$20240620$20240704$EXP$$US-ROCHE-10000000755$ROCHE$$70$YR$E$F$Y$112.49$KG$20240704$$CN$US$US
239920624$23992062$4$F$20240516$20240716$20240620$20240723$EXP$$US-ROCHE-3566482$ROCHE$$83$YR$E$F$Y$$$20240723$$CN$US$US
239920632$23992063$2$F$$20240613$20240620$20240708$PER$$US-ROCHE-10000000061$ROCHE$Dhillon J, Gasbeck T, Misra N. Rodent Invasion! A Case of Hantavirus in an Immunocompromised Patient Causing Hantavirus Pulmonary Syndrome. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:$69$YR$E$F$Y$$$20240709$$HP$US$US
239920644$23992064$4$F$$20240614$20240620$20240709$EXP$$US-ROCHE-10000000119$ROCHE$$65$YR$E$M$Y$$$20240709$$CN$US$US
239920684$23992068$4$F$20240405$20240703$20240620$20240710$EXP$$RU-ROCHE-10000000002$ROCHE$$55$YR$A$F$Y$$$20240710$$MD$RU$RU
239920693$23992069$3$F$20240422$20240617$20240620$20240709$EXP$$CN-ROCHE-10000001154$ROCHE$$54$YR$A$F$Y$53$KG$20240704$$HP$CN$CN
239920722$23992072$2$F$$20240608$20240620$20240708$PER$$US-ROCHE-10000000806$ROCHE$$$$$$Y$$$20240708$$CN$US$US
239920732$23992073$2$F$20240531$20240617$20240620$20240701$EXP$$CN-ROCHE-10000001279$ROCHE$$32$YR$A$F$Y$51$KG$20240701$$HP$CN$CN
239920862$23992086$2$F$20240604$20240627$20240620$20240703$PER$$US-ROCHE-10000000554$ROCHE$$11$YR$C$M$Y$$$20240703$$CN$US$US
239920922$23992092$2$F$$20240613$20240620$20240709$PER$$US-ROCHE-10000000350$ROCHE$Raymond-Forde S, Godfrey A. The Gift of a Heart, With Strings Attached: A Case of Strongyloides Stercoralis Hyperinfection Syndrome With Fulminant Respiratory Failure. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:1-2.$43$YR$A$F$Y$$$20240701$$HP$US$US
239920932$23992093$2$F$$20240705$20240620$20240710$EXP$$UY-ROCHE-3580265$ROCHE$$$$$F$Y$$$20240710$$MD$UY$UY
239920964$23992096$4$F$$20240616$20240620$20240701$PER$$US-ROCHE-10000000269$ROCHE$$63$YR$A$M$Y$$$20240701$$CN$US$US
239920982$23992098$2$F$$20240604$20240620$20240709$PER$$US-ROCHE-3580407$ROCHE$Sahoo A, Shulman J, Sader E, Takahashi C, Kaliaev A. Acute occlusion of the fetal posterior cerebral artery: diagnosis and management paradigms. Neuroradiology Journal. 2024;37 (3):381-5. doi:10.1177/19714009211019383..$7$DEC$E$M$Y$$$20240701$$HP$US$US
239920995$23992099$5$F$$20240819$20240620$20240822$PER$$US-ROCHE-3579996$ROCHE$$59$YR$A$F$Y$$$20240822$$CN$US$US
239921054$23992105$4$F$$20240708$20240620$20240715$PER$$US-ROCHE-10000000042$ROCHE$Razia D, Zaidi W, Lee R, Arjuna A, Et al.. Post-transplant Lymphoproliferative Disorder: A Nodular Area That Kept Growing. American Journal of Respiratory and Critical Care Medicine.209:$79$YR$E$F$Y$$$20240715$$HP$US$US
239921062$23992106$2$F$$20240611$20240620$20240705$EXP$$US-ROCHE-10000000838$ROCHE$$79$YR$E$M$Y$$$20240705$$CN$US$US
239921075$23992107$5$F$20230911$20240620$20240620$20240709$EXP$$CA-ROCHE-3235425$ROCHE$$25$YR$A$F$Y$$$20240704$$HP$CA$CA
239921113$23992111$3$F$$20240909$20240620$20240915$EXP$$DE-ROCHE-10000000331$ROCHE$$$$A$M$Y$$$20240915$$CN$DE$DE
239921152$23992115$2$F$$20240705$20240620$20240712$PER$$US-ROCHE-10000000063$ROCHE$Weichold A, Bowers K. Is Therapeutic Plasma Exchange an Underused Treatment for Antimelanoma Differentiation-Associated Gene 5 (MDA 5) Amyopathic Dermatomyositis [Abstract nu ber: C42]. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:A5556.$50$YR$A$F$Y$$$20240712$$MD$US$US
239921245$23992124$5$F$$20240916$20240620$20240924$EXP$$US-ROCHE-3579187$ROCHE$$73$YR$E$F$Y$$$20240924$$CN$US$US
239921253$23992125$3$F$20240607$20240617$20240620$20240730$PER$$US-ROCHE-10000000238$ROCHE$$14$YR$T$F$Y$$$20240730$$CN$US$US
239921262$23992126$2$F$$20240705$20240620$20240708$PER$$US-ROCHE-10000000075$ROCHE$Maldarelli M, Grier W. A Noxious Mimic-Pulmonary Nocardiosis Presenting as a Lung Mass in an Orthotopic Liver Transplant Patient. American Journal of Respiratory and Critical Care Medicine. 2024-May;209: doi:10.1164/ajrccm-conference.2024.209.1.$72$YR$E$M$Y$$$20240708$$MD$US$US
239921272$23992127$2$F$$20240705$20240620$20240730$PER$$US-ROCHE-10000000121$ROCHE$$$$A$F$Y$$$20240730$$CN$US$US
239921312$23992131$2$F$$20240918$20240620$20240924$EXP$$CA-ROCHE-3580044$ROCHE$$44$YR$A$F$Y$$$20240924$$HP$CA$CA
239921403$23992140$3$F$$20240612$20240620$20240705$PER$$US-ROCHE-10000000098$ROCHE$$$$$F$Y$$$20240705$$CN$US$US
239921485$23992148$5$F$20240514$20240715$20240620$20240827$PER$$US-ROCHE-10000000417$ROCHE$$46$YR$A$M$Y$$$20240827$$CN$US$US
239921532$23992153$2$F$$20240612$20240620$20240709$PER$$US-ROCHE-10000000468$ROCHE$$$$A$F$Y$$$20240618$$CN$US$US
239921642$23992164$2$F$$20240924$20240620$20240930$EXP$$CA-ROCHE-3580000$ROCHE$$65$YR$E$F$Y$34$KG$20240930$$HP$CA$CA
239921683$23992168$3$F$$20240710$20240620$20240711$PER$$US-ROCHE-3580055$ROCHE$$33$YR$A$F$Y$79.2$KG$20240711$$CN$US$US
239921832$23992183$2$F$$20240611$20240620$20240711$PER$$US-ROCHE-10000000011$ROCHE$$47$YR$A$F$Y$$$20240711$$HP$US$US
239921892$23992189$2$F$20240501$20240905$20240620$20240913$EXP$$JP-ROCHE-3580411$ROCHE$$60$YR$A$F$Y$$$20240913$$PH$JP$JP
239921912$23992191$2$F$$20240919$20240620$20240925$EXP$$CA-ROCHE-3580352$ROCHE$$11$YR$C$F$Y$31$KG$20240925$$HP$CA$CA
239921923$23992192$3$F$20210301$20240613$20240620$20240701$EXP$$PL-ROCHE-3580241$ROCHE$$82$YR$E$M$Y$$$20240701$$MD$PL$PL
239921982$23992198$2$F$$20240718$20240620$20240729$30DAY$$BR-JNJFOC-20240634566$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$HP$BR$BR
239921992$23992199$2$F$$20240711$20240620$20240722$30DAY$$GB-JNJFOC-20240632352$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$GB$GB
239922122$23992212$2$F$$20240708$20240620$20240710$EXP$$ES-TAKEDA-2024TUS060487$TAKEDA$$$$$$Y$$$20240710$$CN$ES$ES
239922202$23992220$2$F$$20240627$20240620$20240701$EXP$$CA-ABBVIE-5800948$ABBVIE$$$$A$M$Y$71$KG$20240701$$CN$CA$CA
239922283$23992228$3$F$20240101$20240704$20240620$20240708$EXP$$ES-ABBVIE-5805213$ABBVIE$$$$$F$Y$$$20240708$$MD$ES$ES
239922312$23992231$2$F$20230420$20240625$20240620$20240701$EXP$$US-ABBVIE-5802776$ABBVIE$$61$YR$$F$Y$69$KG$20240701$$HP$US$US
239922422$23992242$2$F$$20240807$20240620$20240813$EXP$$CH-ABBVIE-5802153$ABBVIE$$$$$F$Y$$$20240813$$HP$CH$CH
239922542$23992254$2$F$$20240730$20240620$20240808$PER$$US-SA-2024SA180176$SANOFI AVENTIS$$$$A$F$Y$$$20240808$$MD$US$US
239922602$23992260$2$F$20240101$20240709$20240620$20240715$PER$$US-AMGEN-USASP2024118419$AMGEN$$62$YR$A$F$Y$$$20240715$$CN$US$US
239922672$23992267$2$F$20240101$20240709$20240620$20240720$EXP$$JP-ARDELYX-2024ARDX004307$ARDELYX$$5$DEC$$F$Y$$$20240718$$PH$JP$JP
239922683$23992268$3$F$20240101$20240919$20240620$20240925$EXP$$JP-009507513-2406JPN002275J$MERCK$$7$DEC$$F$Y$$$20240925$$MD$JP$JP
239922694$23992269$4$F$$20240802$20240620$20240812$EXP$$JP-ARDELYX-2024ARDX004383$ARDELYX$$7$DEC$$$Y$$$20240811$$MD$JP$JP
239922732$23992273$2$F$$20240617$20240620$20240704$EXP$$CA-HALEON-2182121$Haleon PLC$$44$YR$$F$Y$97$KG$20240703$$HP$CA$CA
239922743$23992274$3$F$20240315$20240709$20240620$20240717$EXP$$US-CHIESI-2024CHF03153$CHIESI$$7$YR$$M$Y$19.6$KG$20240717$$MD$US$US
239922833$23992283$3$F$20240529$20240806$20240620$20240808$EXP$JP-NBI-BJ202410450$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034908$BOEHRINGER INGELHEIM$$50$YR$A$M$Y$104$KG$20240808$$PH$JP$JP
239922845$23992284$5$F$20240101$20240908$20240620$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-018369$UNITED THERAPEUTICS$$$$$F$Y$58.05$KG$20240917$$$US$US
239922892$23992289$2$F$$20240912$20240620$20240923$PER$$US-SA-2024SA179465$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240923$$MD$US$US
239922944$23992294$4$F$20240528$20240828$20240620$20240905$EXP$$CA-CELLTRION INC.-2024CA014633$CELLTRION$$$$$$Y$$$20240905$$CN$CA$CA
239923024$23992302$4$F$20240513$20240911$20240620$20240913$PER$$US-ROCHE-10000001527$ROCHE$$44$YR$A$F$Y$87.09$KG$20240913$$CN$US$US
239923063$23992306$3$F$20240603$20240711$20240620$20240716$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-095752$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240716$$MD$TR$TR
239923102$23992310$2$F$$20240624$20240620$20240708$EXP$$JP-NOVOPROD-1239649$NOVO NORDISK$$90$YR$$F$Y$$$20240708$$PH$JP$JP
239923206$23992320$6$F$$20240703$20240620$20240710$PER$$US-ROCHE-10000001785$ROCHE$$$$A$F$Y$$$20240710$$CN$US$US
239923332$23992333$2$F$$20240722$20240620$20240821$PER$$US-AstraZeneca-2024A141744$ASTRAZENECA$$$$$M$Y$$$20240821$$MD$US$
239923422$23992342$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209389$TEVA$Kazanjian K, Joseph O, Chen L, Chawla S. CRYPTOCOCCAL MENINGITIS: A DIAGNOSTIC CONUNDRUM IN AN ENCEPHALOPATHIC PATIENT WITH MULTIPLE MYELOMA. Crit-Care-Med 2024; 52 (Suppl.) (1): S250 abstr. 554.; Kazanjian K, Joseph O, Chen L, Chawla S. CRYPTOCOCCAL MENINGITIS: A DIAGNOSTIC CONUNDRUM IN AN ENCEPHALOPATHIC PATIENT WITH MULTIPLE MYELOMA. Crit-Care-Med 2024; 52 (Suppl.) (1): S250 abstr. 554.$74$YR$$M$Y$$$20240705$$HP$US$US
239923583$23992358$3$F$20240604$20240801$20240620$20240805$EXP$$TR-GSK-TR2024TRK074184$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$TR$TR
239923612$23992361$2$F$20240601$20240705$20240620$20240708$PER$$US-AMGEN-USASP2024120458$AMGEN$$52$YR$A$M$Y$$$20240708$$CN$US$US
239923642$23992364$2$F$$20240705$20240620$20240706$PER$$US-JNJFOC-20240623574$JOHNSON AND JOHNSON$$$$$$Y$$$20240706$$HP$US$US
239923673$23992367$3$F$$20240917$20240620$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098566$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240918$$CN$US$US
239923682$23992368$2$F$20240615$20240703$20240620$20240705$EXP$GB-MHRA-MED-202406171146230370-MZGPH$GB-SANDOZ INC.-SDZ2024GB059053$SANDOZ$$72$YR$$$Y$$$20240705$$CN$GB$GB
239923752$23992375$2$F$20240601$20240708$20240620$20240720$30DAY$$CA-JNJFOC-20240606010$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240719$$HP$CA$CA
239923782$23992378$2$F$20240507$20240708$20240620$20240708$PER$$US-JNJFOC-20240630516$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$HP$US$US
239923813$23992381$3$F$$20240701$20240620$20240708$EXP$$GR-CHIESI-2024CHF03565$CHIESI$$$$$M$Y$$$20240708$$MD$GR$GR
239923862$23992386$2$F$20240610$20240618$20240620$20240703$EXP$$CN-ROCHE-10000002337$ROCHE$$43$YR$A$F$Y$63$KG$20240703$$HP$CN$CN
239923962$23992396$2$F$20240101$20240820$20240620$20240826$PER$$US-JNJFOC-20240632434$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$CN$US$US
239923992$23992399$2$F$20240524$20240711$20240620$20240801$PER$$US-TOLMAR, INC.-24US049827$TOLMAR$$68$YR$$M$Y$$$20240801$$HP$US$US
239924022$23992402$2$F$20240529$20240709$20240620$20240729$PER$$US-TOLMAR, INC.-24US049791$TOLMAR$$72$YR$$M$Y$$$20240729$$PH$US$US
239924042$23992404$2$F$20240529$20240711$20240620$20240801$PER$$US-TOLMAR, INC.-24US049828$TOLMAR$$63$YR$$M$Y$$$20240801$$PH$US$US
239924052$23992405$2$F$20240529$20240711$20240620$20240801$PER$$US-TOLMAR, INC.-24US049836$TOLMAR$$$$$M$Y$$$20240801$$HP$US$US
239924062$23992406$2$F$$20240711$20240620$20240801$PER$$US-TOLMAR, INC.-24US049831$TOLMAR$$$$$M$Y$$$20240801$$HP$US$US
239924072$23992407$2$F$$20240711$20240620$20240801$PER$$US-TOLMAR, INC.-24US049860$TOLMAR$$$$$M$Y$$$20240801$$HP$US$US
239924082$23992408$2$F$20240514$20240710$20240620$20240801$PER$$US-TOLMAR, INC.-24US049865$TOLMAR$$69$YR$$M$Y$$$20240801$$HP$US$US
239924092$23992409$2$F$$20240711$20240620$20240801$PER$$US-TOLMAR, INC.-24US049861$TOLMAR$$$$$M$Y$$$20240801$$HP$US$US
239924102$23992410$2$F$20240501$20240711$20240620$20240801$PER$$US-TOLMAR, INC.-24US049916$TOLMAR$$69$YR$$M$Y$$$20240801$$HP$US$US
239924112$23992411$2$F$20240521$20240711$20240620$20240801$PER$$US-TOLMAR, INC.-24US049880$TOLMAR$$80$YR$$M$Y$$$20240801$$PH$US$US
239924122$23992412$2$F$20240531$20240711$20240620$20240801$PER$$US-TOLMAR, INC.-24US049875$TOLMAR$$66$YR$$M$Y$$$20240801$$PH$US$US
239924193$23992419$3$F$20240307$20240722$20240620$20240726$EXP$$NVSJ2024JP007185$NOVARTIS$$86$YR$$F$Y$$$20240726$$MD$JP$JP
239924233$23992423$3$F$20240101$20240723$20240620$20240728$EXP$$US-ROCHE-10000001989$ROCHE$$45$YR$A$F$Y$$$20240728$$MD$US$US
239924242$23992424$2$F$20240608$20240708$20240620$20240710$PER$$US-JNJFOC-20240624455$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240710$$PH$US$US
239924253$23992425$3$F$20220101$20240711$20240620$20240723$30DAY$$GB-JNJFOC-20240603352$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240723$$CN$GB$GB
239924362$23992436$2$F$$20240620$20240620$20240703$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108297$ZYDUS PHARM$He M, Wong A, Sutton K, Gondim MJB, Samson C.. Very-Early onset chronic active colitis with heterozygous variants in LRBA1 and CARD11, a Case of ^Immune TOR-Opathies^.. Fetal-Pediatr-Pathol. 2022;42(2):297-306$$$$$Y$$$20240703$$HP$US$US
239924412$23992441$2$F$20210317$20240617$20240620$20240821$EXP$$DK-ROCHE-10000002494$ROCHE$$$$A$F$Y$$$20240821$$MD$DK$DK
239924422$23992442$2$F$20240401$20240629$20240620$20240705$PER$$US-ABBVIE-5804033$ABBVIE$$69$YR$$M$Y$$$20240705$$MD$US$US
239924443$23992444$3$F$20240101$20240719$20240620$20240729$EXP$$CA-CELLTRION INC.-2024CA009451$CELLTRION$$$$$$Y$$$20240729$$HP$CA$CA
239924492$23992449$2$F$20240529$20240625$20240620$20240716$PER$$FR-TOLMAR, INC.-24FR049789$TOLMAR$$$$$M$Y$$$20240716$$PH$FR$FR
239924502$23992450$2$F$20240531$20240626$20240620$20240724$PER$$FR-TOLMAR, INC.-24FR049867$TOLMAR$$74$YR$$M$Y$$$20240724$$PH$FR$FR
239924512$23992451$2$F$20240528$20240626$20240620$20240724$PER$$FR-TOLMAR, INC.-24FR049790$TOLMAR$$$$E$M$Y$$$20240724$$PH$FR$FR
239924522$23992452$2$F$20240529$20240626$20240620$20240718$PER$$FR-TOLMAR, INC.-24FR049872$TOLMAR$$82$YR$$M$Y$$$20240718$$PH$FR$FR
239924553$23992455$3$F$$20240829$20240620$20240902$EXP$$CA-HALEON-2166536$Haleon PLC$$43$YR$$F$Y$$$20240830$$HP$CA$CA
239924562$23992456$2$F$20240529$20240702$20240620$20240809$PER$$TR-TOLMAR, INC.-24TR049795$TOLMAR$$69$YR$$M$Y$$$20240809$$PH$TR$TR
239924572$23992457$2$F$20240531$20240702$20240620$20240809$PER$$TR-TOLMAR, INC.-24TR049871$TOLMAR$$$$E$M$Y$$$20240809$$HP$TR$TR
239924582$23992458$2$F$20240530$20240702$20240620$20240809$PER$$TR-TOLMAR, INC.-24TR049925$TOLMAR$$85$YR$$M$Y$$$20240809$$HP$TR$TR
239924602$23992460$2$F$20240524$20240702$20240620$20240809$PER$$TR-TOLMAR, INC.-24TR049723$TOLMAR$$75$YR$$M$Y$$$20240809$$MD$TR$TR
239924622$23992462$2$F$20240510$20240815$20240620$20240819$EXP$$NVSC2024GB107663$NOVARTIS$$58$YR$$F$Y$$$20240819$$CN$GB$GB
239924802$23992480$2$F$20221101$20240701$20240620$20240709$EXP$$US-EMD Serono-2024033015$EMD SERONO INC$$67$YR$E$M$Y$$$20240709$$CN$US$US
239924962$23992496$2$F$$20240416$20240620$20240716$EXP$$CA-HALEON-2169901$Haleon PLC$$$$$F$Y$$$20240716$$HP$CA$CA
239925002$23992500$2$F$20240529$20240903$20240620$20240924$30DAY$$CO-BECTON DICKINSON-CO-BD-24-000351$BECTON DICKINSON$$$$$$Y$$$20240924$$CN$CO$CO
239925012$23992501$2$F$$20240712$20240620$20240722$EXP$$MX-AUROBINDO-AUR-APL-2024-029999$AUROBINDO$Villarreal-Gonzalez RV, Vidal-Gutierrez O, Martinez-Moyano JA, Madrazo-Morales M, Saenz-Cantu KS, Rodriguez-Nino P. Hypersensitivity reactions to paclitaxel and carboplatin in breast cancer: safety and effectiveness of desensitization. Cancer-Res. 2024;84 (Suppl.)No.9:PO3-12-08$46$YR$$F$Y$$$20240722$$HP$MX$MX
239925033$23992503$3$F$20240617$20240722$20240620$20240726$PER$$US-AMGEN-USASP2024119734$AMGEN$$56$YR$A$M$Y$$$20240726$$CN$US$US
239925062$23992506$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209817$TEVA$Balbach ML, Hewlett JR, Wermers RA, Warrington KJ, Bobo Tanner S, Chew EY. Giant cell arteritis associated with intravenous zoledronic acid administration. JBMR-Plus 2024; 8 (4): 1-5.; Balbach ML, Hewlett JR, Wermers RA, Warrington KJ, Bobo Tanner S, Chew EY. Giant cell arteritis associated with intravenous zoledronic acid administration. JBMR-Plus 2024; 8 (4): 1-5.; Balbach ML, Hewlett JR, Wermers RA, Warrington KJ, Bobo Tanner S, Chew EY. Giant cell arteritis associated with intravenous zol...$79$YR$$F$Y$$$20240705$$HP$US$US
239925072$23992507$2$F$$20240709$20240620$20240717$EXP$$CA-APOTEX-2024AP007198$APOTEX$$53$YR$$M$Y$$$20240717$$CN$CA$CA
239925092$23992509$2$F$$20240716$20240620$20240724$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016335$UNITED THERAPEUTICS$$$$$F$Y$58.05$KG$20240724$$$US$US
239925143$23992514$3$F$$20240703$20240620$20240717$EXP$GB-MLMSERVICE-20240517-PI059713-00270-2$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-12458$ALKEM$Kafagi AH, Li AS, Jayne D, Brix SR.. Anti-GBM disease in pregnancy. BMJ Case Rep. 2024;17(4):e257767$$$N$F$Y$806$KG$20240717$$MD$GB$GB
239925153$23992515$3$F$$20240620$20240620$20240704$30DAY$$AU-JNJFOC-20240601254$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$PH$AU$AU
239925192$23992519$2$F$$20240820$20240620$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097053$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$$$20240822$$CN$US$US
239925272$23992527$2$F$$20240618$20240620$20240702$EXP$TW-MLMSERVICE-20240529-PI081870-00258-1$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-12495$ALKEM$Hsieh Y, Lin C, Chen C. Serotonin Syndrome from the Complex Drug Interactions of Second-Generation Antipsychotics in Older Patients: Case Report and Literature Review. American Journal of Therapeutics. 2024;31(3):E300-46$67$YR$$M$Y$$$20240702$$MD$TW$TW
239925422$23992542$2$F$$20240912$20240620$20240923$EXP$$US-UCBSA-2024014157$UCB$$$$$F$Y$60.771$KG$20240923$$HP$US$US
239925462$23992546$2$F$$20240703$20240620$20240705$PER$$US-AMGEN-USASP2024120366$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
239925532$23992553$2$F$$20240904$20240620$20240906$EXP$$AU-HALEON-2181746$Haleon PLC$$$$$M$Y$$$20240906$$CN$AU$AU
239925552$23992555$2$F$20240613$20240715$20240620$20240723$PER$$US-JNJFOC-20240639231$JOHNSON AND JOHNSON$$44$YR$A$F$Y$72.3$KG$20240722$$HP$US$US
239925612$23992561$2$F$20240101$20240626$20240620$20240703$PER$$US-BIOGEN-2024BI01269597$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
239925632$23992563$2$F$20141115$20240701$20240620$20240705$PER$$US-BIOGEN-2015BI012871$BIOGEN$$53$YR$$F$Y$85.7$KG$20240705$$MD$US$US
239925822$23992582$2$F$20240505$20240624$20240620$20240701$PER$$US-BIOGEN-2024BI01269575$BIOGEN$$68$YR$$F$Y$$$20240701$$CN$US$US
239925842$23992584$2$F$20240417$20240618$20240620$20240709$EXP$$CN-ROCHE-10000002160$ROCHE$$47$YR$A$F$Y$$$20240701$$HP$CN$CN
239925873$23992587$3$F$$20240617$20240620$20240702$PER$$US-ROCHE-10000002242$ROCHE$$34$YR$A$F$Y$$$20240702$$MD$US$US
239925922$23992592$2$F$20240601$20240718$20240620$20240722$PER$$US-AMGEN-USASP2024121176$AMGEN$$66$YR$E$M$Y$$$20240722$$CN$US$US
239926112$23992611$2$F$$20240916$20240620$20240917$PER$$US-BIOVITRUM-2024-US-008764$BIOVITRUM$$78$YR$$F$Y$$$20240917$$CN$US$US
239926122$23992612$2$F$$20240802$20240620$20240814$EXP$$DE-AMGEN-DEUSP2024119472$AMGEN$$$$$M$Y$$$20240814$$CN$DE$DE
239926143$23992614$3$F$20240613$20240702$20240620$20240704$EXP$$NVSC2024US128095$NOVARTIS$$63$YR$$F$Y$84.4$KG$20240704$$HP$US$US
239926162$23992616$2$F$$20240626$20240620$20240704$PER$$US-AstraZeneca-2024A125466$ASTRAZENECA$$64$YR$$M$Y$83.4$KG$20240704$$MD$US$
239926222$23992622$2$F$$20240819$20240620$20240903$EXP$$CA-HALEON-2176349$Haleon PLC$$43$YR$$F$Y$96$KG$20240903$$HP$CA$CA
239926242$23992624$2$F$$20240711$20240620$20240722$30DAY$$US-GSK-US2024073196$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$HP$US$US
239926282$23992628$2$F$20240609$20240708$20240620$20240710$PER$$US-JNJFOC-20240624241$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240710$$HP$US$US
239926372$23992637$2$F$20240401$20240805$20240620$20240811$EXP$$CA-JNJFOC-20240508953$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240811$$PH$CA$CA
239926382$23992638$2$F$$20240621$20240620$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05100$LUPIN$$$$$$Y$$$20240703$$CN$US$US
239926493$23992649$3$F$$20240709$20240620$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05099$LUPIN$$$$$$Y$$$20240725$$CN$US$US
239926532$23992653$2$F$20240514$20240812$20240620$20240817$EXP$$CA-JNJFOC-20240534373$JOHNSON AND JOHNSON$$19$YR$A$F$Y$$$20240817$$HP$CA$CA
239926562$23992656$2$F$$20240709$20240620$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05090$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239926603$23992660$3$F$$20240823$20240620$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05032$LUPIN$$$$$$Y$$$20240905$$CN$US$US
239926652$23992665$2$F$$20240627$20240620$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095068$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$HP$US$US
239926662$23992666$2$F$$20240729$20240620$20240801$PER$$US-ALXN-202406USA000973US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
239926674$23992667$4$F$20240606$20240809$20240620$20240813$PER$$US-AMGEN-USASP2024116818$AMGEN$$71$YR$E$M$Y$81.1$KG$20240813$$HP$US$US
239926682$23992668$2$F$20240501$20240701$20240620$20240708$30DAY$$US-AMGEN-USASP2024118303$AMGEN$$54$YR$A$F$Y$77.4$KG$20240708$$PH$US$US
239926712$23992671$2$F$$20240615$20240620$20240718$EXP$$CA-HALEON-2176464$Haleon PLC$$$$$F$Y$$$20240717$$HP$CA$CA
239926722$23992672$2$F$20240521$20240705$20240620$20240710$30DAY$$US-AMGEN-USASP2024118763$AMGEN$$$$A$F$Y$$$20240710$$PH$US$US
239926773$23992677$3$F$20240610$20240627$20240620$20240701$30DAY$$US-AMGEN-USASP2024117900$AMGEN$$59$YR$A$M$Y$126.08$KG$20240701$$HP$US$US
239926783$23992678$3$F$$20240709$20240620$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05078$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239926802$23992680$2$F$$20240712$20240620$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA058992$SANDOZ$$6$MON$$M$Y$$$20240717$$CN$CA$CA
239926962$23992696$2$F$$20240807$20240620$20240814$30DAY$$US-GSK-US2024072073$GLAXOSMITHKLINE$$$$$M$Y$$$20240814$$CN$US$US
239927194$23992719$4$F$20240101$20240729$20240620$20240802$PER$$US-BIOGEN-2024BI01269571$BIOGEN$$$$$F$Y$$$20240802$$CN$US$US
239927222$23992722$2$F$$20240709$20240620$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05092$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239927242$23992724$2$F$20220908$20240627$20240620$20240705$EXP$$BR-CELLTRION INC.-2022BR017206$CELLTRION$$$$$$Y$$$20240705$$CN$BR$BR
239927253$23992725$3$F$20240501$20240726$20240620$20240815$PER$$US-TRAVERE-2024TVT00557$TRAVERE THERAPEUTICS$$67$YR$E$M$Y$$$20240815$$CN$US$US
239927262$23992726$2$F$$20240621$20240620$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05087$LUPIN$$$$$$Y$$$20240703$$CN$US$US
239927294$23992729$4$F$20220101$20240825$20240620$20240909$EXP$$US-UCBSA-2024021389$UCB$$$$$F$Y$$$20240909$$HP$US$US
239927385$23992738$5$F$20240611$20240719$20240620$20240801$30DAY$$US-JNJFOC-20240632231$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
239927403$23992740$3$F$20240617$20240918$20240620$20240920$EXP$$NVSC2024US128121$NOVARTIS$$58$YR$$F$Y$$$20240920$$CN$US$US
239927422$23992742$2$F$$20240709$20240620$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05030$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239927574$23992757$4$F$20240517$20240704$20240620$20240711$EXP$$CN-JNJFOC-20240618513$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240711$$MD$CN$CN
239927592$23992759$2$F$$20240918$20240620$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094650$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240919$$HP$US$US
239927602$23992760$2$F$20240616$20240710$20240620$20240712$PER$$US-AMGEN-USASP2024120472$AMGEN$$80$YR$E$M$Y$$$20240712$$CN$US$US
239927612$23992761$2$F$20240510$20240614$20240620$20240912$EXP$$US-SA-2024SA182177$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240912$$MD$US$US
239927672$23992767$2$F$20240617$20240716$20240620$20240718$PER$$US-AMGEN-USASP2024119442$AMGEN$$71$YR$E$F$Y$$$20240718$$CN$US$US
239927712$23992771$2$F$20240528$20240627$20240620$20240730$PER$$US-TRAVERE-2024TVT00550$TRAVERE THERAPEUTICS$$38$YR$A$F$Y$$$20240730$$CN$US$US
239927732$23992773$2$F$20240611$20240726$20240620$20240727$PER$$US-JNJFOC-20240627461$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240727$$PH$US$US
239927752$23992775$2$F$$20240705$20240620$20240720$30DAY$$CA-JNJFOC-20240628271$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$CN$CA$CA
239927823$23992782$3$F$$20240709$20240620$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05089$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239927992$23992799$2$F$20240501$20240529$20240620$20240808$PER$$CO-TOLMAR, INC.-24CO049696$TOLMAR$$65$YR$$M$Y$$$20240808$$CN$CO$CO
239928033$23992803$3$F$20240419$20240722$20240620$20240731$30DAY$$US-JNJFOC-20240639281$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$HP$US$US
239928112$23992811$2$F$$20240608$20240620$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093479$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$90$KG$20240719$$CN$US$US
239928122$23992812$2$F$20240430$20240711$20240620$20240718$EXP$$US-LEO Pharma-371208$LEO PHARM$$46$YR$$F$Y$$$20240718$$CN$US$US
239928222$23992822$2$F$20240606$20240917$20240620$20240923$PER$$US-JNJFOC-20240628576$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$HP$US$US
239928312$23992831$2$F$$20240628$20240620$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099269$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240708$$MD$JP$JP
239928333$23992833$3$F$$20240709$20240620$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05105$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239928432$23992843$2$F$20240603$20240719$20240620$20240725$PER$$US-AMGEN-USASP2024117930$AMGEN$$64$YR$A$F$Y$56.236$KG$20240724$$HP$US$US
239928453$23992845$3$F$20240612$20240712$20240620$20240729$30DAY$$US-JNJFOC-20240631918$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240729$$PH$US$US
239928512$23992851$2$F$$20240621$20240620$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05149$LUPIN$$$$$$Y$$$20240702$$CN$US$US
239928532$23992853$2$F$$20240712$20240620$20240723$PER$$US-TRAVERE-2024TVT00548$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240719$$CN$US$US
239928592$23992859$2$F$$20240820$20240620$20240822$EXP$$NVSC2024AU128177$NOVARTIS$$$$$$Y$$$20240822$$MD$AU$AU
239928722$23992872$2$F$20240612$20240626$20240620$20240705$PER$$US-AMGEN-USASP2024117653$AMGEN$$66$YR$E$F$Y$56.9$KG$20240704$$HP$US$US
239928842$23992884$2$F$$20240923$20240620$20240930$PER$$US-TRAVERE-2024TVT00547$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
239928852$23992885$2$F$$20240805$20240620$20240822$PER$$US-TRAVERE-2024TVT00543$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
239928874$23992887$4$F$20240527$20240708$20240620$20240815$PER$$US-TRAVERE-2024TVT00544$TRAVERE THERAPEUTICS$$41$YR$A$M$Y$$$20240815$$CN$US$US
239928887$23992888$7$F$20240101$20240905$20240620$20240917$EXP$$CA-CELLTRION INC.-2024CA014846$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
239928922$23992892$2$F$$20240702$20240620$20240705$PER$$US-TAKEDA-2024TUS060933$TAKEDA$$$$$F$Y$$$20240705$$CN$US$US
239928932$23992893$2$F$20240308$20240807$20240620$20240809$EXP$$CA-JNJFOC-20240417448$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240809$$HP$CA$CA
239928942$23992894$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209881$TEVA$Tan DW, Yan CL, Yeh DD, Thakkar-Rivera N. Enterocutaneous fistula formation after cardiac transplantation due to injury from LVAD driveline migration. BMJ-Case-Rep 2023; 16 (6): 1-5.; Tan DW, Yan CL, Yeh DD, Thakkar-Rivera N. Enterocutaneous fistula formation after cardiac transplantation due to injury from LVAD driveline migration. BMJ-Case-Rep 2023; 16 (6): 1-5.$$$$M$Y$$$20240705$$HP$US$US
239929063$23992906$3$F$20240323$20240625$20240620$20240703$PER$$US-CHATTEMPRD-2024OHG021082$CHATTEM$$94$YR$E$F$Y$$$20240703$$CN$US$US
239929122$23992912$2$F$$20240712$20240620$20240716$EXP$$CA-ABBVIE-5806516$ABBVIE$$89$YR$$M$Y$$$20240716$$CN$CA$CA
239929283$23992928$3$F$$20240709$20240620$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05102$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239929442$23992944$2$F$20240614$20240709$20240620$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098644$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$81.19$KG$20240712$$HP$US$US
239929452$23992945$2$F$$20240905$20240620$20240915$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-086081$BRISTOL MYERS SQUIBB$Novellis DD, Raimondo A, Serio B, Baldi C, Giudice V, Lembo S, et al. Lenalidomide?induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B. Photodermatology Photoimmunology Photomedicine. 2024 May;40(3):1-4. doi:10.1111/phpp.12965.$55$YR$A$M$Y$$$20240915$$HP$IT$IT
239929464$23992946$4$F$$20240709$20240620$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05029$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239929482$23992948$2$F$20240523$20240709$20240620$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-029754$AUROBINDO$$71$YR$$F$Y$76.203$KG$20240718$$HP$US$US
239929593$23992959$3$F$$20240709$20240620$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05091$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239929652$23992965$2$F$$20240710$20240620$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009271$JAZZ$$$$$F$Y$$$20240716$$MD$US$US
239929715$23992971$5$F$20240101$20240716$20240620$20240723$EXP$$JP-ABBVIE-5806154$ABBVIE$$30$YR$$M$Y$$$20240723$$MD$JP$JP
239929863$23992986$3$F$20240611$20240722$20240620$20240816$30DAY$$US-JNJFOC-20240631183$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$CN$US$US
239929872$23992987$2$F$20240604$20240724$20240620$20240730$EXP$$DE-JNJFOC-20240640531$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240730$$HP$DE$DE
239929933$23992993$3$F$$20240708$20240620$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05024$LUPIN$$$$$$Y$$$20240805$$CN$US$US
239929962$23992996$2$F$$20240621$20240620$20240705$EXP$$US-CIPLA LTD.-2024US06192$CIPLA$Benandi K, Wolf K, Sieving D. A rare case of Meloxicam-induced pseudoporphyria. Dermatology Online Journal. 2024;30(2):19:1 to 3$$$$$Y$$$20240705$$HP$US$US
239929992$23992999$2$F$20240617$20240716$20240620$20240718$PER$$US-AMGEN-USASP2024121327$AMGEN$$68$YR$E$F$Y$$$20240718$$PH$US$US
239930013$23993001$3$F$20240611$20240718$20240620$20240729$PER$$US-JNJFOC-20240631828$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240729$$HP$US$US
239930122$23993012$2$F$$20240730$20240620$20240809$30DAY$$US-GSK-US2024072117$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
239930183$23993018$3$F$20240101$20240702$20240620$20240711$EXP$$CA-TEVA-VS-3206915$TEVA$$84$YR$$F$Y$$$20240711$$CN$CA$CA
239930203$23993020$3$F$$20240722$20240620$20240728$PER$$US-AstraZeneca-2024A132615$ASTRAZENECA$$$$$M$Y$$$20240728$$CN$US$
239930213$23993021$3$F$$20240709$20240620$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05028$LUPIN$$$$$$Y$$$20240806$$CN$US$US
239930222$23993022$2$F$$20240624$20240620$20240712$EXP$$US-CHATTEMPRD-2024OHG021145$CHATTEM$$18$YR$A$M$Y$65.5$KG$20240712$$MD$US$US
239930452$23993045$2$F$$20240627$20240620$20240704$EXP$$NVSC2023CO105339$NOVARTIS$$$$$F$Y$48$KG$20240704$$CN$CO$CO
239930462$23993046$2$F$20240101$20240702$20240620$20240710$EXP$$US-009507513-2406USA005634$MERCK$$$$$F$Y$$$20240710$$HP$US$US
239930482$23993048$2$F$$20240709$20240620$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05088$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239930512$23993051$2$F$20240613$20240723$20240620$20240729$PER$$US-AMGEN-USASP2024118931$AMGEN$$67$YR$E$M$Y$67.846$KG$20240729$$HP$US$US
239930524$23993052$4$F$20240613$20240809$20240620$20240813$30DAY$$US-AMGEN-USASP2024118807$AMGEN$$55$YR$A$F$Y$72.9$KG$20240813$$HP$US$US
239930563$23993056$3$F$$20240709$20240620$20240716$EXP$$CA-APOTEX-2024AP007160$APOTEX$$$$$F$Y$$$20240716$$HP$CA$CA
239930592$23993059$2$F$20221012$20240627$20240620$20240701$EXP$$FR-TAKEDA-2024TUS060749$TAKEDA$$50$YR$$M$Y$75$KG$20240701$$HP$FR$FR
239930752$23993075$2$F$20240501$20240731$20240620$20240802$EXP$$US-ABBVIE-5803873$ABBVIE$$73$YR$$M$Y$$$20240802$$CN$US$US
239930902$23993090$2$F$20240501$20240801$20240620$20240808$EXP$$JP-AMGEN-JPNSP2024118927$AMGEN$$$$E$F$Y$$$20240808$$MD$JP$JP
239930913$23993091$3$F$20240101$20240730$20240620$20240802$EXP$$US-ABBVIE-5806025$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
239930923$23993092$3$F$$20240828$20240620$20240903$EXP$$GB-TAKEDA-2024TUS060545$TAKEDA$$$$$M$Y$$$20240903$$CN$GB$GB
239930963$23993096$3$F$$20240709$20240620$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05097$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239930972$23993097$2$F$20240612$20240704$20240620$20240708$EXP$GB-MHRA-MED-202406121927336890-TFBHM$GB-TEVA-VS-3209472$TEVA$$31$YR$$F$Y$97$KG$20240708$$MD$GB$GB
239931012$23993101$2$F$20240126$20240731$20240620$20240805$EXP$$US-TAKEDA-2024TUS009227$TAKEDA$$58$YR$$F$Y$$$20240805$$CN$US$US
239931192$23993119$2$F$20231105$20240628$20240620$20240705$EXP$FR-AFSSAPS-LL2024001080$FR-EMD Serono-2024032725$EMD SERONO INC$$37$YR$A$F$Y$61$KG$20240705$$MD$FR$FR
239931272$23993127$2$F$$20240625$20240620$20240701$PER$$US-LEO Pharma-371314$LEO PHARM$$16$YR$$F$Y$$$20240701$$CN$US$US
239931323$23993132$3$F$$20240709$20240620$20240718$EXP$$CA-APOTEX-2024AP007209$APOTEX$$53$YR$$M$Y$$$20240718$$CN$CA$CA
239931353$23993135$3$F$20240601$20240708$20240620$20240710$PER$$US-AMGEN-USASP2024120863$AMGEN$$52$YR$A$F$Y$$$20240710$$CN$US$US
239931433$23993143$3$F$$20240708$20240620$20240712$EXP$$CA-GSK-CA2024037859$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$HP$CA$CA
239931452$23993145$2$F$$20240612$20240620$20240723$EXP$$US-AstraZeneca-2024A136961$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
239931532$23993153$2$F$$20240723$20240620$20240725$30DAY$$TW-JNJFOC-20240649013$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$PH$TW$TW
239931542$23993154$2$F$20240901$20240909$20240620$20240912$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-099241$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$44.91$KG$20240912$$CN$PR$PR
239931572$23993157$2$F$20240601$20240731$20240620$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099280$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240806$$CN$US$US
239931622$23993162$2$F$$20240712$20240620$20240722$PER$$US-PHARMING-PHAUS2024000489$PHARMING GROUP$$$$$$Y$$$20240722$$CN$US$US
239931692$23993169$2$F$$20240617$20240620$20240703$30DAY$$DE-JNJFOC-20240634595$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$DE$DE
239931736$23993173$6$F$20240605$20240722$20240620$20240730$EXP$$FR-JNJFOC-20240640004$JOHNSON AND JOHNSON$$59$YR$A$F$Y$64$KG$20240730$$HP$FR$FR
239931742$23993174$2$F$20240615$20240701$20240620$20240703$PER$$US-AMGEN-USASP2024120668$AMGEN$$64$YR$A$M$Y$$$20240703$$CN$US$US
239931773$23993177$3$F$20240101$20240809$20240620$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-018118$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240817$$$US$US
239931795$23993179$5$F$$20240920$20240620$20240924$EXP$$NVSC2024US083206$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
239931822$23993182$2$F$20240301$20240702$20240620$20240715$EXP$$JP-UCBSA-2024029582$UCB$$$$$M$Y$$$20240715$$MD$JP$JP
239931872$23993187$2$F$20240614$20240807$20240620$20240808$PER$$US-AMGEN-USASP2024120306$AMGEN$$62$YR$A$F$Y$$$20240808$$HP$US$US
239932052$23993205$2$F$20240610$20240708$20240620$20240718$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-05271$HIKMA$$51$YR$$F$Y$75$KG$20240718$$HP$EG$EG
239932082$23993208$2$F$$20240724$20240620$20240731$PER$$US-ALXN-202406USA000919US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
239932094$23993209$4$F$$20240801$20240620$20240805$EXP$$US-ABBVIE-5806851$ABBVIE$$$$$F$Y$$$20240804$$CN$US$US
239932122$23993212$2$F$20240101$20240807$20240620$20240813$EXP$$CA-CELLTRION INC.-2024CA014652$CELLTRION$$$$$$Y$$$20240813$$MD$CA$CA
239932175$23993217$5$F$20240601$20240822$20240620$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017296$UNITED THERAPEUTICS$$41$YR$$M$Y$65.306$KG$20240831$$$US$US
239932223$23993222$3$F$$20240916$20240620$20240923$EXP$$CA-GSK-CA2023AMR116410$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$PH$CA$CA
239932333$23993233$3$F$$20240904$20240620$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099089$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240905$$CN$US$US
239932342$23993234$2$F$20240101$20240712$20240620$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-018363$UNITED THERAPEUTICS$$$$$M$Y$65.76$KG$20240718$$$US$US
239932352$23993235$2$F$$20240702$20240620$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099117$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240704$$CN$US$US
239932433$23993243$3$F$20230101$20240806$20240620$20240816$EXP$$JP-009507513-2406JPN000442J$MERCK$Takahashi S, Morita K, Tokunaga M, Ichikawa Y, Yamashita A, Shibata A, et al.. P-141 A Case of IrAE pneumonitis After Pembrolizumab Treatment for Lung Adenocarcinoma Treated with Tocilizumab.. Journal of Japanese Society of Pharmaceutical Oncology/Annual Meeting of Japanes. 2024;36:366$$$$M$Y$$$20240816$$MD$JP$JP
239932502$23993250$2$F$20240613$20240725$20240620$20240729$PER$$US-AMGEN-USASP2024119131$AMGEN$$58$YR$A$F$Y$$$20240729$$CN$US$US
239932512$23993251$2$F$$20240909$20240620$20240914$EXP$$US-ABBVIE-5806511$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
239932562$23993256$2$F$20240513$20240619$20240620$20240726$EXP$FR-AFSSAPS-NC2024000705$FR-GSK-FR2024076408$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$HP$FR$FR
239932612$23993261$2$F$20240530$20240701$20240620$20240709$PER$$US-JNJFOC-20240588653$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240709$$CN$US$US
239932702$23993270$2$F$$20240711$20240620$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202406013047$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240712$$CN$US$US
239932724$23993272$4$F$20240701$20240813$20240620$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099214$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240821$$HP$US$US
239932882$23993288$2$F$20240501$20240621$20240620$20240830$PER$$US-JNJFOC-20240610292$JOHNSON AND JOHNSON$$54$YR$A$F$Y$63.6$KG$20240830$$CN$US$US
239932922$23993292$2$F$20240101$20240628$20240620$20240705$PER$$US-UNITED THERAPEUTICS-UNT-2024-018170$UNITED THERAPEUTICS$$$$$M$Y$81.633$KG$20240705$$$US$US
239933012$23993301$2$F$$20240918$20240620$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099039$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240918$$HP$US$US
239933063$23993306$3$F$$20240711$20240620$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04970$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239933103$23993310$3$F$$20240731$20240620$20240802$EXP$$NVSC2024CA126826$NOVARTIS$$40$YR$$F$Y$96$KG$20240802$$HP$CA$CA
239933142$23993314$2$F$$20240625$20240620$20240705$EXP$$PT-TEVA-VS-3210530$TEVA$Pereira D, Carreira Figueiredo I, Marinho M, Fernandes R, Viveiros V. Antidepressant withdrawal mania: Two case reports. Eur-Psychiatry 2017; 41 (Suppl.) S540 abstr. EV0418.; Pereira D, Carreira Figueiredo I, Marinho M, Fernandes R, Viveiros V. Antidepressant withdrawal mania: Two case reports. Eur-Psychiatry 2017; 41 (Suppl.) S540 abstr. EV0418.$60$YR$$F$Y$$$20240705$$HP$PT$PT
239933244$23993324$4$F$$20240808$20240620$20240813$EXP$$FR-MYLANLABS-2024M1054411$MYLAN$El Kamel M, Marzullo C, Maguet H, Checkouri A, Pointurier V, Oudeville P.. Metabolic acidosis in a context of  chronic paracetamol intoxication.. Analytical and Clinical Toxicology.. 2024;36(2):S42$18$YR$$F$Y$$$20240813$$HP$FR$FR
239933293$23993329$3$F$20220504$20240918$20240620$20240924$EXP$$ZA-TAKEDA-2022TUS022427$TAKEDA$$64$YR$$M$Y$$$20240924$$MD$ZA$ZA
239933413$23993341$3$F$$20240618$20240620$20240701$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04992$LUPIN$Preskorn SH, Masolak DD. Cerebral anoxia in an 18-year-old patient being treated for major depressive disorder: How forensic detective work uses medical knowledge including clinical pharmacology to solve cases. Journal of Psychiatric Practice. 2024;30 (3):212-219$18$YR$$M$Y$65.533$KG$20240701$$MD$US$US
239933422$23993342$2$F$$20240830$20240620$20240909$EXP$$CA-APOTEX-2024AP007309$APOTEX$$71$YR$$F$Y$$$20240909$$MD$CA$CA
239933473$23993347$3$F$$20240629$20240620$20240702$PER$$NVSC2024US128210$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
239933482$23993348$2$F$20240611$20240718$20240620$20240726$PER$$US-AMGEN-USASP2024118014$AMGEN$$69$YR$E$F$Y$96.2$KG$20240725$$HP$US$US
239933535$23993353$5$F$20240101$20240826$20240620$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017853$UNITED THERAPEUTICS$$$$$F$Y$85.261$KG$20240905$$$US$US
239933583$23993358$3$F$20240614$20240726$20240620$20240731$30DAY$$US-AMGEN-USASP2024118855$AMGEN$$57$YR$A$M$Y$$$20240731$$CN$US$US
239933782$23993378$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209958$TEVA$Pham C, Cannon SM, Lopresti JS. Therapeutic Dosing of Steroids In Patients On Mitotane. J-Endocr-Soc 2023; 7 (Suppl. 1) A174 abstr. SAT313.; Pham C, Cannon SM, Lopresti JS. Therapeutic Dosing of Steroids In Patients On Mitotane. J-Endocr-Soc 2023; 7 (Suppl. 1) A174 abstr. SAT313.$43$YR$$F$Y$$$20240705$$MD$US$US
239933793$23993379$3$F$20240608$20240705$20240620$20240726$PER$$US-AMGEN-USASP2024121390$AMGEN$$70$YR$E$F$Y$$$20240726$$CN$US$US
239933822$23993382$2$F$20220809$20240911$20240620$20240917$EXP$$US-CHATTEMPRD-2024OHG021106$CHATTEM$$64$YR$A$F$Y$$$20240917$$LW$US$US
239933882$23993388$2$F$20240204$20240802$20240620$20240807$PER$$US-JNJFOC-20240641371$JOHNSON AND JOHNSON$$53$YR$A$M$Y$97.156$KG$20240807$$HP$US$US
239933892$23993389$2$F$20240301$20240703$20240620$20240709$PER$$US-AMGEN-USASP2024119481$AMGEN$$76$YR$E$F$Y$54.422$KG$20240709$$HP$US$US
239933912$23993391$2$F$20240612$20240712$20240620$20240718$EXP$$GB-ASTELLAS-2024US017344$ASTELLAS$$15$YR$$F$Y$$$20240718$$CN$GB$GB
239933922$23993392$2$F$$20240806$20240620$20240814$EXP$$US-CHATTEMPRD-2024OHG021129$CHATTEM$$74$YR$E$M$Y$$$20240814$$LW$US$US
239934012$23993401$2$F$20240610$20240730$20240620$20240809$30DAY$$US-GSK-US2024AMR073486$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240809$$CN$US$US
239934023$23993402$3$F$20240101$20240913$20240620$20240926$EXP$$JP-JNJFOC-20240642506$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240926$$PH$JP$JP
239934052$23993405$2$F$$20240712$20240620$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098930$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240717$$CN$US$US
239934142$23993414$2$F$$20240704$20240620$20240707$EXP$$NVSC2024CA128153$NOVARTIS$$$$A$F$Y$$$20240708$$MD$CA$CA
239934183$23993418$3$F$20240613$20240710$20240620$20240715$30DAY$$US-AMGEN-USASP2024118451$AMGEN$$63$YR$A$F$Y$$$20240715$$HP$US$US
239934242$23993424$2$F$20240401$20240716$20240620$20240805$PER$$US-JNJFOC-20240585041$JOHNSON AND JOHNSON$$68$YR$E$M$Y$84$KG$20240804$$MD$US$US
239934263$23993426$3$F$$20240701$20240620$20240705$EXP$$US-UCBSA-2024031208$UCB$$$$$F$Y$$$20240705$$CN$US$US
239934282$23993428$2$F$$20240730$20240620$20240801$PER$$US-JNJFOC-20240642353$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240801$$CN$US$US
239934292$23993429$2$F$$20240917$20240620$20240925$EXP$$JP-ASTELLAS-2024JP004146$ASTELLAS$$46$YR$A$M$Y$$$20240925$$MD$JP$JP
239934322$23993432$2$F$20240201$20240703$20240620$20240705$EXP$$JP-ASTELLAS-2024JP002440$ASTELLAS$$9$DEC$$M$Y$$$20240705$$PH$JP$JP
239934354$23993435$4$F$20240613$20240813$20240620$20240819$PER$$US-AMGEN-USASP2024118954$AMGEN$$75$YR$E$M$Y$71.2$KG$20240819$$HP$US$US
239934364$23993436$4$F$20240615$20240723$20240620$20240731$30DAY$$US-AMGEN-USASP2024119711$AMGEN$$56$YR$A$F$Y$86.8$KG$20240731$$HP$US$US
239934403$23993440$3$F$20231201$20240729$20240620$20240807$EXP$$NL-MIRUM PHARMACEUTICALS, INC.-NL-MIR-24-00361$MIRUM PHARMACEUTICALS$$$$$$Y$$$20240807$$MD$NL$NL
239934462$23993446$2$F$20220101$20240719$20240620$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-097535$BRISTOL MYERS SQUIBB$Hirano S, Takahashi H, Nakamura S, Matsuda K, Ishikawa R, Tamura K, et al. A case of pulmonary tuberculosis that developed during nivolumab and ipilimumab treatment for pulmonary adenocarcinoma that recurred two months after completion of anti-tuberculous treatment. Chinese Clinical Oncology. 2024 Jun;13(3):1-6. doi:10.21037/cco-23-153.$67$YR$E$M$Y$$$20240725$$MD$JP$JP
239934472$23993447$2$F$20220101$20240719$20240620$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099317$BRISTOL MYERS SQUIBB$Hirano S, Takahashi H, Nakamura S, Matsuda K, Ishikawa R, Tamura K, et al. A case of pulmonary tuberculosis that developed during nivolumab and ipilimumab treatment for pulmonary adenocarcinoma that recurred two months after completion of anti-tuberculous treatment. Chinese Clinical Oncology. 2024 Jun;13(3):1-6. doi:10.21037/cco-23-153.$67$YR$E$M$Y$$$20240725$$MD$JP$JP
239934522$23993452$2$F$20240615$20240806$20240620$20240808$PER$$US-AMGEN-USASP2024121320$AMGEN$$79$YR$E$M$Y$$$20240807$$CN$US$US
239934572$23993457$2$F$$20240725$20240620$20240806$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-18463$SAMSUNG BIOEPIS$$$$$M$Y$84$KG$20240806$$HP$CA$CA
239934602$23993460$2$F$20240608$20240721$20240620$20240724$PER$$US-AMGEN-USASP2024120215$AMGEN$$74$YR$E$M$Y$$$20240724$$CN$US$US
239934622$23993462$2$F$20240329$20240628$20240620$20240708$EXP$GB-MHRA-MED-202406120600400060-ZQTDY$GB-862174955-ML2024-03505$Unknown Manufacturer$$23$YR$A$F$Y$$$20240708$$CN$GB$GB
239934643$23993464$3$F$20230101$20240705$20240620$20240715$EXP$$GB-TEVA-VS-3210628$TEVA$$$$$F$Y$$$20240715$$MD$GB$GB
239934672$23993467$2$F$20240521$20240620$20240620$20240704$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-18560$SAMSUNG BIOEPIS$$43$YR$A$M$Y$96$KG$20240704$$CN$CA$CA
239934684$23993468$4$F$20230101$20240704$20240620$20240715$PER$$US-AstraZeneca-2024A137975$ASTRAZENECA$$71$YR$$M$Y$$$20240715$$CN$US$
239934742$23993474$2$F$$20240715$20240620$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202406013354$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240729$$CN$US$US
239934792$23993479$2$F$20240611$20240703$20240620$20240711$30DAY$$US-AMGEN-USASP2024119026$AMGEN$$61$YR$A$F$Y$67$KG$20240710$$HP$US$US
239934812$23993481$2$F$20240529$20240815$20240620$20240823$EXP$$BR-TEVA-VS-3209303$TEVA$$68$YR$$F$Y$$$20240823$$PH$BR$BR
239934892$23993489$2$F$$20240705$20240620$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01631$AMNEAL$$$$$$Y$$$20240715$$HP$US$US
239934902$23993490$2$F$$20240705$20240620$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01421$AMNEAL$$$$$F$Y$$$20240715$$PH$US$US
239934912$23993491$2$F$20240410$20240705$20240620$20240927$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01346$AMNEAL$$44$YR$$$Y$$$20240927$$HP$US$US
239934932$23993493$2$F$$20240705$20240620$20240927$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01630$AMNEAL$$$$$F$Y$$$20240927$$CN$US$US
239934943$23993494$3$F$$20240708$20240620$20240722$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01571$AMNEAL$$$$$F$Y$$$20240722$$CN$US$US
239935044$23993504$4$F$$20240815$20240620$20240821$EXP$$US-TAKEDA-2024TUS026189$TAKEDA$$$$$M$Y$$$20240821$$CN$US$US
239935123$23993512$3$F$20240610$20240905$20240620$20240920$30DAY$$US-GSK-US2024072083$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240920$$CN$US$US
239935202$23993520$2$F$$20240819$20240620$20240902$EXP$$US-INSMED, INC.-2024-02375-US$INSMED$$$$$F$Y$$$20240902$$CN$US$US
239935233$23993523$3$F$20240601$20240701$20240620$20240709$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015749$UNITED THERAPEUTICS$$59$YR$$F$Y$56.236$KG$20240709$$$US$US
239935262$23993526$2$F$$20240801$20240620$20240807$EXP$$US-JNJFOC-20240631683$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240808$$CN$US$US
239935293$23993529$3$F$20240101$20240916$20240620$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-014339$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240920$$$US$US
239935412$23993541$2$F$20230101$20240618$20240620$20240703$EXP$$GB-UCBSA-2024031149$UCB$$$$$M$Y$$$20240703$$CN$GB$GB
239935442$23993544$2$F$$20240705$20240620$20240715$EXP$$AU-CIPLA LTD.-2024AU06088$CIPLA$Perucca P, Bourikas D, Voinescu PE, Vadlamudi L, Chellun D, Kumke T et.al. Lacosamide and pregnancy: Data from spontaneous and solicited reports. Epilepsia. 2024;65 (5):1275 to 1284$$$$$Y$$$20240715$$HP$AU$AU
239935512$23993551$2$F$$20240719$20240620$20240729$30DAY$$US-GSK-US2024AMR072763$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
239935782$23993578$2$F$$20240709$20240620$20240724$EXP$$US-PHARMAAND GMBH-2024PHR00375$pharmaAND$$$$$F$Y$$$20240724$$CN$US$US
239936052$23993605$2$F$$20240701$20240620$20240712$EXP$CA-MHPD-E2B_001082877$CA-Accord-430186$ACCORD$$35$YR$A$F$Y$$$20240712$$HP$CA$CA
239936152$23993615$2$F$$20240709$20240620$20240709$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034921$BOEHRINGER INGELHEIM$$$$$$Y$$$20240709$$PH$JP$JP
239936263$23993626$3$F$$20240620$20240620$20240702$EXP$$NZ-Accord-430533$ACCORD$March de Ribot F, Jirapanyayut P, March de Ribot A. Bilateral macular oedema secondary to docetaxel treatment. N Z Med J. 2024 Jun 7;137(1596):94-98.$67$YR$E$M$Y$$$20240702$$HP$NZ$NZ
239936312$23993631$2$F$$20240702$20240620$20240712$EXP$$US-Accord-430546$ACCORD$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: A case series. Pediatric nephrology (Berlin, Germany). 2024.$15$YR$T$M$Y$55$KG$20240712$$HP$US$US
239936383$23993638$3$F$20220301$20240913$20240620$20240923$30DAY$$GB-PFIZER INC-PV202400078544$PFIZER$$15$YR$$M$Y$$$20240923$$HP$GB$GB
239936522$23993652$2$F$20220101$20240708$20240620$20240718$EXP$$SI-AUROBINDO-AUR-APL-2024-021985$AUROBINDO$Koro?ec HL, Blagus T, Reden?ek TS, Dol?an V, Bon J, Pjevac M. Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics. Frontiers in Psychiatry. 2024;15:1-9$60$YR$$F$Y$$$20240718$$MD$SI$SI
239936633$23993663$3$F$$20240621$20240620$20240701$EXP$$DE-AUROBINDO-AUR-APL-2022-012559$AUROBINDO$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. J Psychoactive Drugs. 2022;55(1):102-111$29$YR$$M$Y$$$20240701$$HP$DE$DE
239936644$23993664$4$F$20240615$20240805$20240620$20240809$EXP$$US-ABBVIE-5807525$ABBVIE$$75$YR$$F$Y$$$20240809$$CN$US$US
239936814$23993681$4$F$20240517$20240917$20240620$20240918$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-029387$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$$$20240918$$CN$JP$JP
239936844$23993684$4$F$$20240806$20240620$20240816$EXP$$GB-TEVA-VS-3209095$TEVA$Chou, M.. Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy. BMJ case reports.. 2024;17 (3)_10.1136_bcr-2023-256961. doi_10.1136_bcr-2023-256961; Ritchie, A.. Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy. BMJ case reports.. 2024;17(3)_10.1136_bcr-2023-256961. doi_10.1136_bcr-2023-256961; Chou M, Lai L, Neveu M, Ritchie A.. Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy.. BMJ Case Reports. 2...$$$T$M$Y$$$20240816$$HP$GB$GB
239936873$23993687$3$F$20231029$20240705$20240620$20240718$EXP$$ES-MACLEODS PHARMA-MAC2024047157$MACLEODS$$$$$$Y$$$20240718$$MD$ES$ES
239937242$23993724$2$F$20240424$20240701$20240620$20240715$PER$$US-ALKERMES INC.-ALK-2024-001628$ALKERMES$$56$YR$$M$Y$101.13$KG$20240716$$HP$US$US
239937372$23993737$2$F$20240329$20240628$20240620$20240708$EXP$GB-MHRA-MED-202406120600400060-ZQTDY$GB-TEVA-VS-3209547$TEVA$$23$YR$$F$Y$$$20240708$$CN$GB$GB
239937402$23993740$2$F$$20240709$20240620$20240723$EXP$$IN-LUPIN LIMITED-2024-05064$LUPIN$Jain A, Nashi S, Mailankody P, Srijithesh PR, Kulkarni GB, Alladi S et al. OPA1 mutation presenting as Ethambutol-induced optic neuropathy. Annals of Indian Academy of Neurology. 2024;20:1-4$28$YR$$F$Y$$$20240723$$HP$IN$IN
239937922$23993792$2$F$20240201$20240730$20240620$20240809$EXP$FR-AFSSAPS-NT2024000646$FR-Accord-430419$ACCORD$$61$YR$A$M$Y$$$20240809$$MD$FR$FR
239938142$23993814$2$F$20240227$20240617$20240620$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-452230$RANBAXY$$43$YR$$F$Y$63$KG$20240702$$MD$FR$FR
239938192$23993819$2$F$20240606$20240710$20240620$20240716$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-087453$REGENERON$$$$$F$Y$$$20240716$$HP$DE$DE
239938322$23993832$2$F$20240501$20240626$20240620$20240704$EXP$$CA-CELLTRION INC.-2024CA014716$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
239938402$23993840$2$F$$20240917$20240620$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096376$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240917$$HP$US$US
239938412$23993841$2$F$$20240904$20240620$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099078$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240909$$CN$US$US
239938682$23993868$2$F$$20240703$20240620$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451444$RANBAXY$Loveday W,Dashputre G, Jurai S. Case study and Discussion: Sugammadex in pregnant patients undergoing non-obstetric surgery and non-pregnant patients taking hormonal contraceptives. Int J Obstet Anesth. 2024;58 (Suppl.):104145/71/6301743$$$$F$Y$$$20240718$$HP$US$US
239938743$23993874$3$F$20240427$20240822$20240620$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451992$RANBAXY$$62$YR$A$M$Y$61$KG$20240906$$MD$CN$CN
239938852$23993885$2$F$$20240723$20240620$20240730$PER$$US-BIOGEN-2024BI01269718$BIOGEN$$$$$F$Y$$$20240730$$CN$US$US
239939183$23993918$3$F$20240615$20240919$20240620$20240923$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-099079$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$98$KG$20240923$$MD$DE$DE
239939212$23993921$2$F$20240612$20240717$20240620$20240719$PER$$US-JNJFOC-20240631992$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240719$$CN$US$US
239939242$23993924$2$F$20240501$20240723$20240620$20240805$PER$$US-BAYER-2024A087175$BAYER$$31$YR$A$F$Y$$$20240805$$HP$US$US
239939372$23993937$2$F$20240213$20240625$20240620$20240704$EXP$FR-AFSSAPS-PC2024000445$FR-Accord-430130$ACCORD$$53$YR$A$M$Y$104$KG$20240704$$PH$FR$FR
239939422$23993942$2$F$$20240802$20240620$20240813$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-05225$HIKMA$$7$DEC$$M$Y$$$20240813$$HP$CA$CA
239939613$23993961$3$F$$20240627$20240620$20240711$EXP$AU-ALVOGEN-2024094909$AU-ALVOGEN-2024094909$ALVOGEN$$42$YR$$F$Y$94$KG$20240711$$HP$AU$US
239939823$23993982$3$F$20190101$20240917$20240620$20240919$EXP$$US-JNJFOC-20240634379$JOHNSON AND JOHNSON$$81$YR$E$F$Y$127.12$KG$20240919$$MD$US$US
239939892$23993989$2$F$$20240823$20240620$20240902$EXP$$CA-BAXTER-2024BAX019851$BAXTER$$52$YR$$M$Y$$$20240902$$HP$CA$CA
239939945$23993994$5$F$20240612$20240813$20240620$20240829$30DAY$$BR-AMGEN-BRASP2024118771$AMGEN$$70$YR$E$M$Y$$$20240828$$PH$BR$BR
239940002$23994000$2$F$20240603$20240628$20240620$20240705$EXP$$JP-ASTELLAS-2024US017469$ASTELLAS$$70$YR$$F$Y$$$20240705$$CN$CH$JP
239940083$23994008$3$F$20211101$20240814$20240620$20240822$PER$$US-BIOGEN-2024BI01269365$BIOGEN$$38$YR$$F$Y$88.53$KG$20240822$$HP$US$US
239940102$23994010$2$F$20240423$20240705$20240620$20240712$EXP$$JP-LEO Pharma-371203$LEO PHARM$$63$YR$$M$Y$$$20240712$$MD$JP$JP
239940242$23994024$2$F$20240418$20240729$20240620$20240802$EXP$$JP-BAYER-2024A088937$BAYER$$67$YR$E$M$Y$$$20240802$$MD$JP$JP
239940273$23994027$3$F$$20240627$20240620$20240701$EXP$$CA-GSK-CA2023099449$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$PH$CA$CA
239940452$23994045$2$F$$20240718$20240620$20240725$EXP$$US-AMAROX PHARMA-HET2024US01766$HETERO$$$$$$Y$78.005$KG$20240725$$CN$US$US
239940462$23994046$2$F$$20240627$20240620$20240703$PER$$US-AGIOS-2406US03796$AGIOS PHARMACEUTICALS$$$$$$Y$80.726$KG$20240703$$CN$US$US
239940472$23994047$2$F$20240101$20240702$20240620$20240709$EXP$$US-009507513-2406USA005234$MERCK$$57$YR$$F$Y$$$20240709$$HP$US$US
239940494$23994049$4$F$$20240828$20240620$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05125$LUPIN$$$$$$Y$$$20240918$$CN$US$US
239940552$23994055$2$F$20240506$20240716$20240620$20240724$EXP$$TW-BAYER-2024A069745$BAYER$$60$YR$A$M$Y$$$20240724$$CN$TW$TW
239940673$23994067$3$F$20240613$20240827$20240620$20240904$EXP$$CA-CELLTRION INC.-2023CA023865$CELLTRION$$$$$$Y$$$20240904$$MD$CA$CA
239940782$23994078$2$F$$20240617$20240620$20240701$EXP$$JP-VERICEL-JP-VCEL-24-000222$VERICEL$$73$YR$$M$Y$$$20240701$$MD$JP$JP
239940832$23994083$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3210462$TEVA$Eliava S, Pope DJ, Patel D. THE CASE OF AN ASYMPTOMATIC YOUNG WOMAN DIAGNOSED WITH PRIMARY BILIARY CHOLANGITIS AFTER 10 YEARS OF HAVING ABNORMAL LIVER FUNCTION TESTS. Gastroenterology 2024; 166 (Suppl.) (5): S-1712 abstr. Mo1606.; Eliava S, Pope DJ, Patel D. THE CASE OF AN ASYMPTOMATIC YOUNG WOMAN DIAGNOSED WITH PRIMARY BILIARY CHOLANGITIS AFTER 10 YEARS OF HAVING ABNORMAL LIVER FUNCTION TESTS. Gastroenterology 2024; 166 (Suppl.) (5): S-1712 abstr. Mo1606.$$$A$F$Y$$$20240705$$HP$US$US
239941113$23994111$3$F$20240604$20240627$20240620$20240712$EXP$$GT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-452577$RANBAXY$$61$YR$$F$Y$34.5$KG$20240712$$HP$GT$GT
239941182$23994118$2$F$$20240620$20240620$20240705$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-452608$RANBAXY$Lukac O. Hypophosphatemia - an overlooked electrolyte. Oncology. 2024;18(2):142-144$$$$F$Y$$$20240705$$HP$DE$DE
239941222$23994122$2$F$$20240926$20240620$20240930$EXP$$JP-JNJFOC-20240625664$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$MD$JP$JP
239941317$23994131$7$F$$20240813$20240620$20240820$30DAY$$JP-PFIZER INC-PV202400078162$PFIZER$$12$YR$$F$Y$$$20240820$$CN$JP$JP
239941323$23994132$3$F$20240129$20240920$20240620$20240924$30DAY$$JP-PFIZER INC-PV202400078153$PFIZER$$$$$$Y$$$20240924$$PH$JP$JP
239941332$23994133$2$F$20240601$20240905$20240620$20240905$EXP$$CN-PFIZER INC-PV202400078367$PFIZER$$17$YR$$M$Y$$$20240905$$CN$CN$CN
239941532$23994153$2$F$20230901$20240709$20240620$20240712$EXP$$PE-UCBSA-2024029789$UCB$$36$YR$$F$Y$$$20240712$$CN$PE$PE
239941543$23994154$3$F$20240625$20240716$20240620$20240726$EXP$$US-JNJFOC-20240635336$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240726$$HP$US$US
239941576$23994157$6$F$20240526$20240830$20240620$20240909$30DAY$$FI-JNJFOC-20240582239$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240910$$PH$FI$FI
239941583$23994158$3$F$$20240709$20240620$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05061$LUPIN$$$$$$Y$$$20240808$$CN$US$US
239941712$23994171$2$F$$20240621$20240620$20240701$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR074833$VIIV$$$$$M$Y$$$20240701$$CN$US$US
239941743$23994174$3$F$20231201$20240904$20240620$20240916$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202406006955$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240916$$CN$BR$BR
239941762$23994176$2$F$20240101$20240730$20240620$20240802$EXP$$US-UCBSA-2024025539$UCB$$$$$F$Y$$$20240802$$CN$US$US
239941832$23994183$2$F$$20240627$20240620$20240701$EXP$$NVSC2024CN128714$NOVARTIS$$$$$$Y$$$20240701$$MD$CN$CN
239941864$23994186$4$F$20240501$20240917$20240620$20240924$EXP$$US-GILEAD-2024-0677864$GILEAD$$66$YR$E$F$Y$$$20240924$$CN$US$US
239941983$23994198$3$F$20240612$20240717$20240620$20240722$PER$$US-AstraZeneca-2024A138234$ASTRAZENECA$$24919$DY$$F$Y$$$20240722$$CN$US$
239942132$23994213$2$F$20240505$20240715$20240620$20240724$EXP$$US-TEVA-VS-3210664$TEVA$$27$YR$$F$Y$$$20240724$$HP$US$US
239942142$23994214$2$F$$20240720$20240620$20240731$EXP$$US-AUROBINDO-AUR-APL-2024-029759$AUROBINDO$Notta SN, Al Akeel M, Slough S, Jagadish A, Notta N, Nemalikanti S.. Unveiling a medical enigma: haloperidol-triggered SIADH in a complex clinical scenario.. American Journal of the Medical Sciences.. 2024;367(Supplement:S307-8$72$YR$$F$Y$$$20240731$$MD$US$US
239942224$23994222$4$F$20240101$20240912$20240620$20240918$EXP$$US-ABBVIE-5803968$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
239942272$23994227$2$F$20240229$20240710$20240620$20240718$EXP$$ES-AUROBINDO-AUR-APL-2024-029639$AUROBINDO$$78$YR$$M$Y$104$KG$20240718$$MD$ES$ES
239942314$23994231$4$F$20240508$20240809$20240620$20240925$PER$$US-LUNDBECK-DKLU3077802$LUNDBECK$$$$$$Y$$$20240925$$CN$US$US
239942323$23994232$3$F$20240603$20240705$20240620$20240706$PER$$US-AMGEN-USASP2024121562$AMGEN$$85$YR$E$F$Y$$$20240706$$CN$US$US
239942332$23994233$2$F$$20240624$20240620$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-030108$AUROBINDO$$34$YR$$M$Y$$$20240702$$MD$US$US
239942343$23994234$3$F$20200101$20240716$20240620$20240724$EXP$$US-BAYER-2024A085859$BAYER$$21$YR$A$F$Y$62.596$KG$20240724$$HP$US$US
239942352$23994235$2$F$$20240708$20240620$20240709$PER$$US-JNJFOC-20240619070$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$HP$US$US
239942423$23994242$3$F$20240509$20240705$20240620$20240715$EXP$$DE-TEVA-VS-3210697$TEVA$$73$YR$$M$Y$100$KG$20240715$$MD$DE$DE
239942442$23994244$2$F$20240601$20240801$20240620$20240809$EXP$$JP-009507513-2406JPN001903J$MERCK$$6$DEC$$F$Y$$$20240809$$PH$JP$JP
239942603$23994260$3$F$20240601$20240823$20240620$20240827$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-098675$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$55.34$KG$20240827$$PH$PR$PR
239942632$23994263$2$F$$20240712$20240620$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-013813$UNITED THERAPEUTICS$$$$$M$Y$83.9$KG$20240719$$$US$US
239942652$23994265$2$F$20230101$20240621$20240620$20240704$EXP$$US-INSMED, INC.-2023-03829-US$INSMED$$$$$F$Y$$$20240704$$CN$US$US
239942682$23994268$2$F$$20240703$20240620$20240708$EXP$$ES-INCYTE CORPORATION-2024IN006413$INCYTE$$$$$$Y$$$20240708$$MD$ES$ES
239942752$23994275$2$F$$20240720$20240620$20240725$PER$$US-AMGEN-USASP2024120532$AMGEN$$67$YR$E$F$Y$$$20240725$$MD$US$US
239942953$23994295$3$F$20240205$20240715$20240620$20240718$PER$$US-JNJFOC-20240631047$JOHNSON AND JOHNSON$$74$YR$E$F$Y$56.296$KG$20240718$$CN$US$US
239942962$23994296$2$F$$20240806$20240620$20240809$EXP$$US-JNJFOC-20240635406$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$CN$US$US
239943375$23994337$5$F$20240101$20240829$20240620$20240909$EXP$$US-INSMED, INC.-2024-01537-US$INSMED$$$$$M$Y$$$20240909$$CN$US$US
239943462$23994346$2$F$$20240619$20240620$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05151$LUPIN$$$$$$Y$$$20240702$$CN$US$US
239943472$23994347$2$F$$20240712$20240620$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-029427$AUROBINDO$Momin Z, O^Bryant S, Meskill S.. Prolonged Fever, Travel, and the Changing Examination in an 8- year-old Girl.. Pediatr-Rev. 2022;43(5):280-284$8$YR$$F$Y$$$20240723$$MD$US$US
239943612$23994361$2$F$20240614$20240814$20240620$20240819$30DAY$$US-PFIZER INC-202400194261$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
239943734$23994373$4$F$$20240915$20240620$20240916$30DAY$$US-PFIZER INC-202400194256$PFIZER$$16$YR$$M$Y$$$20240916$$CN$US$US
239943744$23994374$4$F$$20240902$20240620$20240904$30DAY$$US-PFIZER INC-202400190932$PFIZER$$14$YR$$M$Y$$$20240904$$HP$US$US
239943752$23994375$2$F$20240627$20240703$20240620$20240718$PER$$US-Eisai-EC-2024-165195$EISAI$$75$YR$$F$Y$$$20240718$$CN$US$US
239943763$23994376$3$F$$20240911$20240620$20240916$30DAY$$US-PFIZER INC-PV202400052355$PFIZER$$15$YR$$M$Y$$$20240916$$HP$US$US
239943783$23994378$3$F$$20240731$20240620$20240806$EXP$$US-PFIZER INC-PV202400079585$PFIZER$$45$YR$$M$Y$75.3$KG$20240806$$HP$US$US
239943962$23994396$2$F$$20240722$20240620$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202406012940$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240725$$CN$US$US
239944032$23994403$2$F$20240614$20240731$20240620$20240803$PER$$US-AMGEN-USASP2024120314$AMGEN$$61$YR$A$M$Y$$$20240803$$CN$US$US
239944255$23994425$5$F$$20240724$20240620$20240822$PER$$US-BEH-2024173396$CSL BEHRING$$$$C$M$Y$$$20240822$$CN$US$US
239944262$23994426$2$F$20240601$20240627$20240620$20240709$EXP$$FR-BIOGEN-2024BI01268492$BIOGEN$$30$YR$$F$Y$56$KG$20240709$$MD$FR$FR
239944314$23994431$4$F$20240611$20240808$20240620$20240814$PER$$US-ALXN-202406USA000782US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
239944342$23994434$2$F$20240101$20240716$20240620$20240724$EXP$$DE-BIOVITRUM-2024-DE-008737$ADC THERAPEUTICS$$$$A$M$Y$$$20240724$$PH$DE$DE
239944353$23994435$3$F$20240101$20240829$20240620$20240925$PER$$US-Eisai-EC-2024-165252$EISAI$$78$YR$E$F$Y$$$20240925$$CN$US$US
239944392$23994439$2$F$20240101$20240729$20240620$20240801$EXP$$US-009507513-2406USA004289$MERCK$$$$$F$Y$$$20240801$$CN$US$US
239944443$23994444$3$F$20240403$20240708$20240620$20240722$30DAY$$US-JNJFOC-20240623229$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$HP$US$US
239944512$23994451$2$F$20240214$20240703$20240620$20240709$EXP$$FR-EXELIXIS-XL18424078571$EXELIXIS$$$$$$Y$$$20240709$$MD$FR$FR
239944542$23994454$2$F$$20240717$20240620$20240720$EXP$$SK-AMGEN-SVKSP2024116317$AMGEN$Zahorak M.. The use of stem cells in the orophacial region. Tooth medicine. 2024;8:7-9$79$YR$E$F$Y$$$20240719$$MD$SK$SK
239944552$23994455$2$F$20240614$20240725$20240620$20240726$PER$$US-GILEAD-2024-0677581$GILEAD$$30$YR$A$F$Y$91.61$KG$20240726$$HP$US$US
239944622$23994462$2$F$$20240805$20240620$20240807$EXP$$IN-MYLANLABS-2024M1055514$MYLAN$Chatterjee A, Kazi M, Ostwal V, Ramaswamy A, Desouza A, Saklani A. Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases. Ind-J-Surg-Oncol 2023; 14 192-197.$32$YR$$M$Y$60$KG$20240807$$HP$IN$IN
239944665$23994466$5$F$$20240710$20240620$20240716$EXP$$DK-MYLANLABS-2024M1054510$MYLAN$Christel Dupont Ravn, Mia Bendix, Soren Lyhne.. Acute Pancreatitis In A Patient With Ulcerative Colitis Treated With Vedolizumab And Budesonide. Ugeskrift For Laeger. 2024;186(22):1-3$21$YR$$M$Y$$$20240716$$HP$DK$DK
239944692$23994469$2$F$$20240805$20240620$20240809$EXP$$IN-MYLANLABS-2024M1055519$MYLAN$Chatterjee A, Kazi M, Ostwal V, Ramaswamy A, Desouza A, Saklani A. Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases. Ind-J-Surg-Oncol 2023; 14 192-197.$49$YR$$F$Y$49$KG$20240809$$HP$IN$IN
239944704$23994470$4$F$$20240726$20240620$20240801$EXP$$CZ-MYLANLABS-2024M1054410$MYLAN$Lachnit M. Hradska K, Duras J, Hajek J. Treatment of a patient with ALK-negative anaplastic large cell lymphoma. FARMAKOTERAPIE. 2024;20, 6 - Ext 2/2:30-31$49$YR$$F$Y$32$KG$20240801$$MD$CZ$CZ
239944762$23994476$2$F$20240427$20240729$20240620$20240729$PER$$US-ALXN-202406USA000960US$ALEXION PHARMACEUTICALS$$75$YR$$F$Y$$$20240729$$CN$US$US
239944796$23994479$6$F$$20240826$20240620$20240829$EXP$$US-GILEAD-2024-0677577$GILEAD$$73$YR$E$F$Y$73.5$KG$20240829$$HP$US$US
239944842$23994484$2$F$20240609$20240809$20240620$20240814$PER$$US-BIOGEN-2024BI01268849$BIOGEN$$32$YR$$F$Y$$$20240814$$CN$US$US
239944953$23994495$3$F$20240101$20240918$20240620$20240924$EXP$$CA-PFIZER INC-202400194376$PFIZER$$30$YR$$F$Y$$$20240924$$HP$CA$CA
239945003$23994500$3$F$20240101$20240911$20240620$20240916$30DAY$$US-PFIZER INC-202400057763$PFIZER$$12$YR$$M$Y$40.82$KG$20240916$$MD$US$US
239945012$23994501$2$F$$20240814$20240620$20240816$30DAY$$US-PFIZER INC-202400194225$PFIZER$$11$YR$$M$Y$$$20240816$$CN$US$US
239945024$23994502$4$F$$20240917$20240620$20240923$30DAY$$US-PFIZER INC-202400194352$PFIZER$$13$YR$$M$Y$$$20240923$$CN$US$US
239945124$23994512$4$F$20240615$20240912$20240620$20240916$PER$$US-AMGEN-USASP2024121377$AMGEN$$70$YR$E$M$Y$$$20240916$$MD$US$US
239945163$23994516$3$F$$20240812$20240620$20240820$EXP$$CA-APOTEX-2024AP007148$APOTEX$$65$YR$$F$Y$$$20240820$$HP$CA$CA
239945176$23994517$6$F$20240101$20240808$20240620$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016681$UNITED THERAPEUTICS$$$$$F$Y$100.23$KG$20240816$$$US$US
239945242$23994524$2$F$$20240701$20240620$20240709$EXP$$IN-VANTIVE-2024VAN017754$Vantive US Healthcare$$62$YR$$M$Y$$$20240709$$CN$IN$IN
239945342$23994534$2$F$$20240815$20240620$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099293$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$60.78$KG$20240826$$CN$US$US
239945782$23994578$2$F$20240220$20240712$20240620$20240722$PER$$US-AstraZeneca-2024A142415$ASTRAZENECA$$59$YR$$F$Y$$$20240722$$HP$US$
239945912$23994591$2$F$$20240703$20240620$20240709$EXP$$CA-ABBVIE-5806628$ABBVIE$$$$A$M$Y$$$20240709$$CN$CA$CA
239945922$23994592$2$F$20240508$20240717$20240620$20240722$EXP$$US-AMGEN-USASP2024119043$AMGEN$$72$YR$E$F$Y$40$KG$20240722$$CN$US$US
239946022$23994602$2$F$$20240810$20240620$20240812$EXP$$CA-PFIZER INC-202400196284$PFIZER$$59$YR$$M$Y$$$20240812$$HP$CA$CA
239946062$23994606$2$F$20240615$20240717$20240620$20240723$EXP$$US-PFIZER INC-202400195536$PFIZER$$69$YR$$F$Y$76.644$KG$20240723$$CN$US$US
239946102$23994610$2$F$20230628$20240810$20240620$20240812$EXP$$CA-PFIZER INC-202300239355$PFIZER$$68$YR$$F$Y$$$20240812$$HP$CA$CA
239946112$23994611$2$F$$20240814$20240620$20240814$EXP$$CA-PFIZER INC-202400195388$PFIZER$$67$YR$$M$Y$$$20240814$$HP$CA$CA
239946133$23994613$3$F$20230908$20240903$20240620$20240909$EXP$$CN-PFIZER INC-2024SGN04459$PFIZER$$67$YR$$M$Y$64$KG$20240909$$MD$CN$CN
239946192$23994619$2$F$$20240722$20240620$20240723$EXP$$CA-PFIZER INC-202400196081$PFIZER$$88$YR$$F$Y$$$20240723$$HP$CA$CA
239946212$23994621$2$F$20200101$20240625$20240620$20240703$PER$$US-BAYER-2024A088708$BAYER$$37$YR$A$F$Y$$$20240703$$CN$US$US
239946242$23994624$2$F$20240618$20240805$20240620$20240807$PER$$US-AMGEN-USASP2024121668$AMGEN$$62$YR$A$M$Y$$$20240807$$CN$US$US
239946453$23994645$3$F$20240101$20240715$20240620$20240722$EXP$$US-ABBVIE-5556765$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
239946532$23994653$2$F$20240101$20240815$20240620$20240822$EXP$$CA-CURRAX PHARMACEUTICALS LLC-CA-2024CUR002286$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$CA$CA
239946603$23994660$3$F$$20240803$20240620$20240805$30DAY$$GB-PFIZER INC-202400193705$PFIZER$$$$$$Y$$$20240805$$CN$GB$GB
239946622$23994662$2$F$20240830$20240830$20240620$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096471$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240906$$CN$US$US
239946652$23994665$2$F$20240101$20240708$20240620$20240715$EXP$$DE-FreseniusKabi-FK202409467$FRESENIUS KABI$$$$$F$Y$65$KG$20240715$$MD$DE$DE
239946672$23994667$2$F$20230215$20240729$20240620$20240808$EXP$$CA-Vifor (International) Inc.-VIT-2024-02286$VIFOR$$55$YR$$F$Y$$$20240808$$CN$CA$CA
239946712$23994671$2$F$20240531$20240705$20240620$20240709$PER$$US-AMGEN-USASP2024115987$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
239946992$23994699$2$F$$20240805$20240620$20240808$EXP$$US-TAKEDA-2024TUS060437$TAKEDA$$$$$F$Y$$$20240808$$CN$US$US
239947053$23994705$3$F$20240422$20240715$20240620$20240726$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-12845$SAMSUNG BIOEPIS$$41$YR$A$F$Y$115$KG$20240726$$HP$CA$CA
239947072$23994707$2$F$20240616$20240809$20240620$20240813$PER$$US-AMGEN-USASP2024121949$AMGEN$$53$YR$A$M$Y$$$20240813$$CN$US$US
239947082$23994708$2$F$20101101$20240622$20240620$20240701$EXP$DE-BFARM-11105590$DE-ORGANON-O2406DEU001614$ORGANON$Schott-Seidenschwanz I, Wille H, Muehlbauer B.. Death Trap Metamizole? (Todesfalle Metamizol?).. Bremer Aerztejournal. 2011;64:20$24$YR$$F$Y$$$20240701$$MD$DE$DE
239947152$23994715$2$F$20240101$20240827$20240620$20240830$EXP$$JP-AstraZeneca-2024A141938$ASTRAZENECA$$69$YR$$M$Y$$$20240830$$MD$JP$
239947172$23994717$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3210009$TEVA$Kincaid CM, Sharma AN, Arnold JD, Horton L, Lee BA, Mesinkovska NA. Multicentric reticulohistiocytosis after severe COVID-19 infection. JAAD-Case-Rep 2023; 33 73-76.; Kincaid CM, Sharma AN, Arnold JD, Horton L, Lee BA, Mesinkovska NA. Multicentric reticulohistiocytosis after severe COVID-19 infection. JAAD-Case-Rep 2023; 33 73-76.; Kincaid CM, Sharma AN, Arnold JD, Horton L, Lee BA, Mesinkovska NA. Multicentric reticulohistiocytosis after severe COVID-19 infection. JAAD-Case-Rep 2023; 33 73-76.$56$YR$$F$Y$$$20240705$$HP$US$US
239947242$23994724$2$F$20240501$20240731$20240620$20240814$PER$$US-GRANULES-US-2024GRASPO00226$GRANULES INDIA$$61$YR$$F$Y$135$KG$20240814$$CN$US$US
239947272$23994727$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3210011$TEVA$Rajeurs A, Joshi S, Deacon J, Carella D, Quinones-Cardona V, Menkiti O. Inflammatory markers in a pediatric patient with Systemic Inflammatory Response Syndrome on Extracorporeal Membrane Oxygenation. ASAIO-J 2024; 70 (Suppl. 2) 13 abstr. 13.; Rajeurs A, Joshi S, Deacon J, Carella D, Quinones-Cardona V, Menkiti O. Inflammatory markers in a pediatric patient with Systemic Inflammatory Response Syndrome on Extracorporeal Membrane Oxygenation. ASAIO-J 2024; 70 (Suppl. 2) 13 abstr. 13.$10$YR$$F$Y$$$20240705$$MD$US$US
239947382$23994738$2$F$$20240730$20240620$20240801$PER$$US-ALXN-202406USA000828US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
239947592$23994759$2$F$$20240814$20240620$20240820$30DAY$$GR-PFIZER INC-PV202400078574$PFIZER$$11$YR$$F$Y$$$20240820$$CN$GR$GR
239947612$23994761$2$F$20240613$20240723$20240620$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202406012743$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240725$$CN$US$US
239947773$23994777$3$F$$20240701$20240620$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05132$LUPIN$$$$$$Y$$$20240718$$CN$US$US
239947792$23994779$2$F$$20240729$20240620$20240729$PER$$US-ALXN-202406USA000970US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
239947812$23994781$2$F$$20240701$20240620$20240702$PER$$US-JNJFOC-20240635838$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$PH$US$US
239947822$23994782$2$F$20240612$20240719$20240620$20240723$PER$$US-JNJFOC-20240632401$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240722$$CN$US$US
239947862$23994786$2$F$20231101$20240816$20240620$20240822$EXP$$US-PFIZER INC-202400195033$PFIZER$$68$YR$$F$Y$$$20240822$$HP$US$US
239947962$23994796$2$F$20240611$20240701$20240620$20240705$EXP$PT-INFARMED-E202406-275$PT-FreseniusKabi-FK202409572$FRESENIUS KABI$$77$YR$E$M$Y$130$KG$20240705$$PH$PT$PT
239947972$23994797$2$F$$20240826$20240620$20240830$EXP$$US-MYLANLABS-2024M1054725$MYLAN$$81$YR$$M$Y$$$20240830$$CN$US$US
239948002$23994800$2$F$20240101$20240809$20240620$20240809$EXP$$CA-PFIZER INC-202400195317$PFIZER$$49$YR$$F$Y$$$20240809$$MD$CA$CA
239948052$23994805$2$F$$20240718$20240620$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099460$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$96.16$KG$20240719$$CN$US$US
239948083$23994808$3$F$$20240806$20240620$20240809$EXP$$CN-PFIZER INC-202400192283$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240809$$MD$CN$CN
239948102$23994810$2$F$20240604$20240708$20240620$20240711$EXP$PT-INFARMED-J202406-165$PT-FreseniusKabi-FK202409570$FRESENIUS KABI$$51$YR$A$F$Y$$$20240711$$PH$PT$PT
239948135$23994813$5$F$20240101$20240816$20240620$20240816$EXP$$CA-PFIZER INC-202400074836$PFIZER$$55$YR$$M$Y$95$KG$20240816$$MD$CA$CA
239948154$23994815$4$F$20240101$20240802$20240620$20240806$EXP$$JP-PFIZER INC-PV202400080646$PFIZER$$54$YR$$F$Y$$$20240806$$MD$JP$JP
239948162$23994816$2$F$20240517$20240812$20240620$20240814$EXP$$FR-PFIZER INC-202400193591$PFIZER$$$$E$M$Y$171$KG$20240814$$MD$FR$FR
239948172$23994817$2$F$20240522$20240715$20240620$20240722$EXP$FR-AFSSAPS-AN2024000781$FR-FreseniusKabi-FK202409603$FRESENIUS KABI$$59$YR$A$M$Y$$$20240719$$PH$FR$FR
239948202$23994820$2$F$$20240729$20240620$20240806$EXP$$US-PFIZER INC-202400196353$PFIZER$$49$YR$$F$Y$$$20240806$$HP$US$US
239948223$23994822$3$F$$20240806$20240620$20240809$EXP$$CN-PFIZER INC-202400192306$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240809$$MD$CN$CN
239948262$23994826$2$F$20220301$20240724$20240620$20240726$EXP$FR-AFSSAPS-TO2024001107$FR-ABBVIE-5807251$ABBVIE$$28$YR$$M$Y$66$KG$20240726$$CN$FR$FR
239948302$23994830$2$F$20230830$20240618$20240620$20240703$EXP$FR-AFSSAPS-AVCN2024000442$FR-Waylis Therapeutics LLC-ATNAHS20240601740$Waylis$$33$YR$A$M$Y$$$20240702$$MD$FR$FR
239948322$23994832$2$F$$20240728$20240620$20240730$30DAY$$CL-PFIZER INC-PV202400075720$PFIZER$$9$YR$$M$Y$$$20240730$$CN$CL$CL
239948372$23994837$2$F$20240305$20240708$20240620$20240713$EXP$$JP-AstraZeneca-2024A108186$ASTRAZENECA$$86$YR$$M$Y$54$KG$20240713$$MD$JP$
239948472$23994847$2$F$$20240806$20240620$20240812$EXP$$JP-OTSUKA-2024_017089$OTSUKA$$9$DEC$$F$Y$$$20240812$$PH$JP$JP
239948522$23994852$2$F$$20240719$20240620$20240722$EXP$$CL-PFIZER INC-PV202400080270$PFIZER$$80$YR$$M$Y$$$20240722$$CN$CL$CL
239948603$23994860$3$F$20240522$20240810$20240620$20240812$EXP$$CA-PFIZER INC-202400196327$PFIZER$$71$YR$$F$Y$$$20240812$$HP$CA$CA
239948642$23994864$2$F$$20240716$20240620$20240717$EXP$$CA-PFIZER INC-202400196816$PFIZER$$77$YR$$M$Y$$$20240717$$MD$CA$CA
239948703$23994870$3$F$20240319$20240711$20240620$20240715$EXP$$US-PFIZER INC-PV202400080550$PFIZER$$55$YR$$M$Y$88.9$KG$20240715$$HP$US$US
239948722$23994872$2$F$$20240704$20240620$20240708$EXP$$GB-PFIZER INC-202400195000$PFIZER$$80$YR$$M$Y$$$20240708$$CN$GB$GB
239948863$23994886$3$F$20240101$20240716$20240620$20240722$EXP$$CA-PFIZER INC-202400196032$PFIZER$$64$YR$$F$Y$$$20240722$$PH$CA$CA
239948894$23994889$4$F$$20240925$20240620$20240930$30DAY$$US-PFIZER INC-202400191060$PFIZER$$21$YR$$M$Y$$$20240930$$CN$US$US
239948902$23994890$2$F$20240101$20240626$20240620$20240701$EXP$$CA-PFIZER INC-PV202400080847$PFIZER$$53$YR$$F$Y$$$20240701$$CN$CA$CA
239948972$23994897$2$F$$20240628$20240620$20240702$EXP$$US-UCBSA-2024031201$UCB$$$$$F$Y$$$20240702$$CN$US$US
239948982$23994898$2$F$20240510$20240805$20240620$20240812$EXP$$DE-ESPERIONTHERAPEUTICS-2024DEU00902$ESPERION THERAPEUTICS$$66$YR$$F$Y$57$KG$20240813$$MD$DE$DE
239949042$23994904$2$F$$20240808$20240620$20240815$EXP$$CA-CELLTRION INC.-2024CA014647$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
239949102$23994910$2$F$20230830$20240618$20240620$20240701$EXP$$CO-AMICUS THERAPEUTICS, INC.-AMI_3187$AMICUS THERAPEUTICS$$46$YR$$F$Y$70$KG$20240701$$HP$CO$CO
239949132$23994913$2$F$$20240702$20240620$20240709$EXP$$US-BAYER-2024A086973$BAYER$$$$$M$Y$$$20240709$$MD$US$US
239949172$23994917$2$F$20230201$20240724$20240620$20240724$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034993$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240724$$CN$ES$ES
239949242$23994924$2$F$$20240705$20240620$20240709$EXP$$US-PFIZER INC-PV202400079353$PFIZER$Patel, S.. West Nile Virus Meningoencephalitis in Liver Transplantation. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7041$69$YR$$M$Y$$$20240709$$HP$US$US
239949372$23994937$2$F$20240604$20240705$20240620$20240712$EXP$$US-RDY-CLI/USA/24/0008805$DR REDDYS$$27$YR$A$F$Y$$$20240712$$MD$US$US
239949442$23994944$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3210004$TEVA$Thakurdesai A, Rivera-Matos L, Nagra N, Busch B, Mais DD, Cave MC. Severe Drug-Induced Liver Injury Due to Self-administration of the Veterinary Anthelmintic Medication, Fenbendazole. ACG-Case-Rep-J 2024; 11 (5): E01354.; Thakurdesai A, Rivera-Matos L, Nagra N, Busch B, Mais DD, Cave MC. Severe Drug-Induced Liver Injury Due to Self-administration of the Veterinary Anthelmintic Medication, Fenbendazole. ACG-Case-Rep-J 2024; 11 (5): E01354.$67$YR$$F$Y$$$20240705$$MD$US$US
239949492$23994949$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3210010$TEVA$Lakhani DA, Deng F. A young man with amnesia after drug overdose. Eur-J-Intern-Med 2024; 122 117-118.; Lakhani DA, Deng F. A young man with amnesia after drug overdose. Eur-J-Intern-Med 2024; 122 117-118.$29$YR$$M$Y$$$20240705$$HP$US$US
239949562$23994956$2$F$20240101$20240615$20240620$20240903$PER$$US-Merz Pharmaceuticals GmbH-24-01686$MERZ$$47$YR$$F$Y$86.183$KG$20240904$$HP$US$US
239949582$23994958$2$F$20230401$20240704$20240620$20240711$EXP$$CA-GSK-CA2023143088$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$CA$CA
239949682$23994968$2$F$20240604$20240701$20240620$20240709$EXP$GB-MHRA-MED-202406141107368500-PTGCN$GB-TEVA-VS-3210518$TEVA$$33$YR$$M$Y$53$KG$20240709$$HP$GB$GB
239949773$23994977$3$F$$20240910$20240620$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099457$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240911$$CN$US$US
239949894$23994989$4$F$20240607$20240627$20240620$20240705$EXP$$BR-CELLTRION INC.-2024BR014720$CELLTRION$$$$$$Y$$$20240705$$CN$BR$BR
239949922$23994992$2$F$20240611$20240722$20240620$20240724$PER$$US-JNJFOC-20240631398$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$CN$US$US
239949932$23994993$2$F$$20240617$20240620$20240702$EXP$$PH-ROCHE-10000001728$ROCHE$Barcena L, Cortez K, Buccat J. Diffuse Alveolar Hemorrhage in Lupus: A Rare Favorable Outcome to Therapeutic Plasma Exchange Plus Rituximab: A Case Series. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:A5331.$28$YR$A$F$Y$$$20240702$$HP$PH$PH
239949992$23994999$2$F$$20240611$20240620$20240704$PER$$US-ROCHE-10000001916$ROCHE$$$$$$Y$$$20240704$$CN$US$US
239950003$23995000$3$F$$20240704$20240620$20240712$EXP$$JP-ROCHE-3506127$ROCHE$$8$DEC$E$F$Y$$$20240712$$MD$JP$JP
239950042$23995004$2$F$$20240617$20240620$20240702$EXP$$TN-ROCHE-10000002481$ROCHE$Kmira Z, Hajer B, Sana M, Nesrine B, Monia G, Meriem T, et al. Isolated Cutaneous Chronic Lymphocytic Leukemia: A Case Report. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-4. doi:10.1177/23247096231204736.$69$YR$E$M$Y$$$20240702$$HP$TN$TN
239950052$23995005$2$F$20220901$20240923$20240620$20240924$EXP$$IT-ROCHE-10000001963$ROCHE$$28$YR$A$F$Y$$$20240924$$MD$IT$IT
239950062$23995006$2$F$20240605$20240801$20240620$20240806$PER$$US-ROCHE-10000002830$ROCHE$$$$$$Y$$$20240806$$HP$US$US
239950084$23995008$4$F$$20230127$20240620$20240708$EXP$$US-ROCHE-10000002728$ROCHE$$$$$$Y$$$20240708$$MD$US$US
239950122$23995012$2$F$$20240611$20240620$20240706$PER$$US-ROCHE-10000002519$ROCHE$$$$$$Y$$$20240706$$CN$US$US
239950152$23995015$2$F$$20240611$20240620$20240709$PER$$US-ROCHE-10000002572$ROCHE$$$$$$Y$$$20240705$$HP$US$US
239950193$23995019$3$F$$20240705$20240620$20240712$PER$$US-ROCHE-10000001387$ROCHE$Yarlagadda K, Uribe P. Anasarca As Presenting Sign In Hemophagocytic Lymphohistiocytosis: Are We Missing Something?. American Journal of Respiratory and Critical Care Medicine. 2024;(209):$66$YR$E$M$Y$$$20240712$$HP$US$US
239950206$23995020$6$F$$20240705$20240620$20240712$EXP$$US-ROCHE-10000002029$ROCHE$Tissavirasingham F, Singh S, Calvo Ayala E. Where are the antibodies? a case of prolonged COVID19 infection in an immunocompromised patient status post rituximab therapy. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:A1348.$34$YR$A$M$Y$$$20240712$$HP$US$US
239950245$23995024$5$F$20240515$20240718$20240620$20240723$EXP$$US-ROCHE-3574317$ROCHE$$57$YR$A$F$Y$101.6$KG$20240723$$CN$US$US
239950254$23995025$4$F$20230501$20240613$20240620$20240709$PER$$US-ROCHE-10000000664$ROCHE$Virk S, Niranjan S, Patel D, Javed A, Nasrullah A, Disilvio B. Rising From the Shadows: A Case of Delayed Organizing Pneumonia in Granulomatosis With Polyangiitis Post-mild COVID-19. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:$66$YR$E$M$Y$$$20240701$$HP$US$US
239950272$23995027$2$F$$20240723$20240620$20240724$PER$$US-ROCHE-3579366$ROCHE$$$$A$M$Y$$$20240724$$CN$US$US
239950322$23995032$2$F$$20240705$20240620$20240709$EXP$$JP-ROCHE-10000002687$ROCHE$Yamaguchi T, Shimizu J, Shigematsu F, Watanabe N, Hasegawa T, Horio Y, et al. Atezolizumab and nintedanib in patients with non-small cell lung cancer and interstitial lung disease. Journal of Thoracic Disease. 2024-May-31;16 (5):3371-80. doi:10.21037/jtd-24-45.$86$YR$E$F$Y$$$20240709$$MD$JP$JP
239950335$23995033$5$F$$20240710$20240620$20240713$EXP$$US-ROCHE-10000001021$ROCHE$$12$YR$T$F$Y$72$KG$20240713$$CN$US$US
239950392$23995039$2$F$$20240617$20240620$20240716$PER$$US-ROCHE-10000000060$ROCHE$$68$YR$E$F$Y$$$20240716$$CN$US$US
239950403$23995040$3$F$20220210$20240731$20240620$20240802$EXP$$GB-ROCHE-3574389$ROCHE$$84$YR$E$M$Y$77.1$KG$20240803$$MD$GB$GB
239950444$23995044$4$F$$20240624$20240620$20240709$EXP$$US-ROCHE-10000001804$ROCHE$$$$$M$Y$$$20240628$$HP$US$US
239950452$23995045$2$F$20240505$20240726$20240620$20240803$EXP$$JP-ROCHE-10000001552$ROCHE$$76$YR$E$M$Y$$$20240803$$PH$JP$JP
239950512$23995051$2$F$20240613$20240710$20240620$20240711$PER$$US-ROCHE-10000002833$ROCHE$$72$YR$E$F$Y$$$20240711$$CN$US$US
239950524$23995052$4$F$$20240617$20240620$20240702$PER$$US-ROCHE-10000001942$ROCHE$Patel D, Niranjan S, Virk S, Nasrullah A, Malik K, Disilvio B. Rituximab Rendezvous: When COVID-19 Lingers and Lungs Throw Curveballs. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:A5677.$53$YR$A$F$Y$$$20240702$$HP$US$US
239950542$23995054$2$F$20240609$20240618$20240620$20240703$EXP$$CN-ROCHE-10000002518$ROCHE$$51$YR$A$M$Y$$$20240703$$HP$CN$CN
239950553$23995055$3$F$$20240705$20240620$20240712$PER$$US-ROCHE-10000002828$ROCHE$Jamison K, Medepalli L, Ye S. Isolated Pericardial Effusion Without Associated Myocarditis in a Small-Cell Lung Cancer Patient Undergoing Atezolizumab Therapy.. Cureus. 2024-May-13;16 (5):1-7. doi:10.7759/cureus.60184.$67$YR$E$M$Y$$$20240712$$HP$US$US
239950602$23995060$2$F$20240123$20240618$20240620$20240702$EXP$$CN-ROCHE-10000002524$ROCHE$$49$YR$A$F$Y$$$20240702$$HP$CN$CN
239950612$23995061$2$F$20220117$20240731$20240620$20240810$EXP$$JP-ROCHE-10000000803$ROCHE$$49$YR$A$M$Y$57.1$KG$20240810$$MD$JP$JP
239950622$23995062$2$F$$20240613$20240620$20240701$PER$$US-ROCHE-10000000179$ROCHE$Gupta A, Wojnowski K, Gurung P. Mucormycosis - A Rare Etiology of Empyema Nessisitans. American Journal of Respiratory and Critical Care Medicine. 2024-May;(209):A2386.$55$YR$A$M$Y$$$20240701$$HP$US$US
239950732$23995073$2$F$20231101$20240820$20240620$20240823$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406009138$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240823$$CN$JP$JP
239950802$23995080$2$F$20240618$20240717$20240620$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202406012934$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240718$$HP$US$US
239950813$23995081$3$F$20240401$20240809$20240620$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202406008230$ELI LILLY AND CO$$71$YR$E$F$Y$98.6$KG$20240822$$CN$US$US
239950992$23995099$2$F$$20240809$20240620$20240814$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202406010032$ELI LILLY AND CO$$61$YR$A$F$Y$67$KG$20240814$$CN$ES$ES
239951113$23995111$3$F$20240606$20240722$20240620$20240725$EXP$$US-ELI_LILLY_AND_COMPANY-US202406012590$ELI LILLY AND CO$$31$YR$A$F$Y$43.084$KG$20240725$$CN$US$US
239951122$23995112$2$F$$20240719$20240620$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202406013635$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240723$$CN$US$US
239951152$23995115$2$F$$20240723$20240620$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202406012821$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240725$$CN$US$US
239951162$23995116$2$F$$20240809$20240620$20240814$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202406010030$ELI LILLY AND CO$$60$YR$A$F$Y$60$KG$20240814$$CN$ES$ES
239951202$23995120$2$F$$20240610$20240620$20240704$EXP$$US-ROCHE-10000002004$ROCHE$$49$YR$A$F$Y$$$20240704$$HP$US$US
239951242$23995124$2$F$20240603$20240605$20240620$20240704$PER$$US-AstraZeneca-2024A130197$ASTRAZENECA$$18845$DY$$F$Y$$$20240704$$HP$US$
239951372$23995137$2$F$$20240809$20240620$20240814$EXP$$US-VERTEX PHARMACEUTICALS-2024-010245$VERTEX$$$$$$Y$63$KG$20240814$$CN$US$US
239951424$23995142$4$F$$20240809$20240620$20240819$PER$$US-VERTEX PHARMACEUTICALS-2024-009992$VERTEX$$$$$$Y$$$20240819$$CN$US$US
239951432$23995143$2$F$$20240703$20240620$20240711$EXP$$US-VERTEX PHARMACEUTICALS-2024-010111$VERTEX$$$$$M$Y$$$20240711$$MD$US$US
239951622$23995162$2$F$20230510$20240705$20240620$20240709$EXP$$JP-BAYER-2024A089024$BAYER$$84$YR$E$M$Y$$$20240709$$MD$JP$JP
239951642$23995164$2$F$20221121$20240806$20240620$20240808$EXP$$CA-TAKEDA-2022TUS092187$TAKEDA$$57$YR$$F$Y$$$20240808$$CN$CA$CA
239951653$23995165$3$F$$20240630$20240620$20240805$PER$$US-ROCHE-10000003718$ROCHE$$$$$F$Y$$$20240805$$CN$US$US
239951885$23995188$5$F$20240101$20240830$20240620$20240909$EXP$$JP-JNJFOC-20240649963$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240909$$MD$JP$JP
239951903$23995190$3$F$20240601$20240624$20240620$20240701$PER$$US-AMGEN-USASP2024120259$AMGEN$$71$YR$E$M$Y$$$20240630$$CN$US$US
239951932$23995193$2$F$$20240918$20240620$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099313$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240918$$MD$JP$JP
239952003$23995200$3$F$20210702$20240917$20240620$20240927$EXP$$JP-EXELIXIS-CABO-24078596$EXELIXIS$$73$YR$$M$Y$67.4$KG$20240927$$MD$JP$JP
239952353$23995235$3$F$$20240805$20240620$20240813$PER$$US-SA-2024SA176436$SANOFI AVENTIS$$$$A$F$Y$72.109$KG$20240814$$MD$US$US
239952392$23995239$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3210012$TEVA$Hidalgo J, Rao A, Bommu V, Khan W, Yaziji M, Kozlova N, et al. CLOSTRIDIUM SORDELLII AND ASPERGILLUS FUMIGATUS IN AN IMMUNOCOMPETENT CAUSING NECROTIZING PNEUMONIA. Crit-Care-Med 2024; 52 (Suppl.) (1): S245 abstr. 543.; Hidalgo J, Rao A, Bommu V, Khan W, Yaziji M, Kozlova N, et al. CLOSTRIDIUM SORDELLII AND ASPERGILLUS FUMIGATUS IN AN IMMUNOCOMPETENT CAUSING NECROTIZING PNEUMONIA. Crit-Care-Med 2024; 52 (Suppl.) (1): S245 abstr. 543.$56$YR$$M$Y$$$20240705$$HP$US$US
239952582$23995258$2$F$20240531$20240830$20240620$20240904$30DAY$$MY-PFIZER INC-PV202400074442$PFIZER$$$$$$Y$$$20240904$$PH$MY$MY
239952615$23995261$5$F$$20240919$20240620$20240919$EXP$$US-PFIZER INC-PV202400079264$PFIZER$$81$YR$$F$Y$97.07$KG$20240919$$HP$US$US
239952632$23995263$2$F$20231129$20240912$20240620$20240916$EXP$$JP-PFIZER INC-PV202400077987$PFIZER$$67$YR$$F$Y$44.5$KG$20240916$$PH$JP$JP
239952654$23995265$4$F$$20240903$20240620$20240906$30DAY$$US-PFIZER INC-202400193277$PFIZER$$26$YR$$F$Y$$$20240906$$CN$US$US
239952682$23995268$2$F$20240101$20240816$20240620$20240816$EXP$$CA-PFIZER INC-PV202400080895$PFIZER$$81$YR$$F$Y$$$20240816$$PH$CA$CA
239952713$23995271$3$F$$20240806$20240620$20240809$EXP$$CN-PFIZER INC-202400192308$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240809$$MD$CN$CN
239952763$23995276$3$F$20240101$20240920$20240620$20240927$PER$$US-SA-2024SA173844$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240927$$CN$US$US
239952882$23995288$2$F$$20240709$20240620$20240808$PER$$US-MYLANLABS-2024M1053445$MYLAN$$$$$F$Y$$$20240808$$CN$US$US
239952962$23995296$2$F$20240101$20240715$20240620$20240724$PER$$US-SA-2024SA174150$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240724$$MD$US$US
239953012$23995301$2$F$20190101$20240708$20240620$20240717$PER$$US-SA-2024SA174973$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240717$$MD$US$US
239953063$23995306$3$F$20240101$20240821$20240620$20240915$PER$$US-SA-2024SA141401$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240915$$MD$US$US
239953163$23995316$3$F$20240101$20240812$20240620$20240821$PER$$US-SA-2024SA179185$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240821$$MD$US$US
239953242$23995324$2$F$20240101$20240812$20240620$20240826$PER$$US-SA-2024SA178655$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240826$$MD$US$US
239953252$23995325$2$F$20240601$20240713$20240620$20240801$PER$$US-SA-2024SA180015$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240719$$MD$US$US
239953422$23995342$2$F$20240101$20240701$20240620$20240710$PER$$US-SA-2024SA178736$SANOFI AVENTIS$$24$YR$A$M$Y$68.03$KG$20240711$$MD$US$US
239953453$23995345$3$F$20240101$20240911$20240620$20240913$PER$$BR-SA-2024SA153388$SANOFI AVENTIS$$45$YR$A$F$Y$70$KG$20240913$$CN$BR$BR
239953613$23995361$3$F$20240101$20240715$20240620$20240723$PER$$US-SA-2024SA178171$SANOFI AVENTIS$$35$YR$A$F$Y$61.224$KG$20240723$$MD$US$US
239953642$23995364$2$F$20240101$20240815$20240620$20240829$PER$$US-SA-2024SA176669$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240829$$MD$US$US
239953862$23995386$2$F$20240101$20240716$20240620$20240720$EXP$$US-ABBVIE-5669814$ABBVIE$$$$$F$Y$74$KG$20240720$$CN$US$US
239953942$23995394$2$F$$20240702$20240620$20240711$PER$$US-SA-2024SA179012$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240711$$CN$US$US
239954016$23995401$6$F$20240531$20240828$20240620$20240909$EXP$$US-UCBSA-2024030512$UCB$$20$YR$$F$Y$$$20240909$$MD$US$US
239954073$23995407$3$F$20240613$20240826$20240620$20240828$30DAY$$US-PFIZER INC-202400194248$PFIZER$$13$YR$$M$Y$38.1$KG$20240828$$CN$US$US
239954113$23995411$3$F$20240610$20240906$20240620$20240912$EXP$$JP-PFIZER INC-PV202400078231$PFIZER$$69$YR$$M$Y$56$KG$20240912$$HP$JP$JP
239954122$23995412$2$F$$20240821$20240620$20240903$PER$$US-SA-2024SA179874$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240903$$MD$US$US
239954142$23995414$2$F$20240801$20240916$20240620$20240920$PER$$US-SA-2024SA178041$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240920$$MD$US$US
239954152$23995415$2$F$20240601$20240712$20240620$20240722$PER$$US-SA-2024SA178983$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240722$$MD$US$US
239954303$23995430$3$F$20240101$20240809$20240620$20240925$PER$$US-SA-2024SA179295$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240925$$MD$US$US
239954442$23995444$2$F$20240101$20240627$20240620$20240710$PER$$US-SA-2024SA178341$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240710$$PH$US$US
239954542$23995454$2$F$$20240711$20240620$20240716$EXP$$GB-TAKEDA-2024TUS032934$TAKEDA$$$$$M$Y$$$20240716$$CN$GB$GB
239954603$23995460$3$F$20240601$20240624$20240620$20240701$PER$$US-SA-2024SA181379$SANOFI AVENTIS$$49$YR$A$M$Y$81.64$KG$20240701$$MD$US$US
239954652$23995465$2$F$$20240709$20240620$20240717$PER$$US-SA-2024SA179796$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240717$$CN$US$US
239954663$23995466$3$F$20240807$20240808$20240620$20240816$PER$$US-SA-2024SA138079$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240816$$MD$US$US
239954732$23995473$2$F$20200101$20240911$20240620$20240924$PER$$US-SA-2024SA180785$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240924$$CN$US$US
239954742$23995474$2$F$$20240912$20240620$20240923$PER$$US-SA-2024SA181102$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240923$$MD$US$US
239954865$23995486$5$F$$20240725$20240620$20240805$PER$$US-SA-2024SA181124$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240805$$MD$US$US
239954872$23995487$2$F$20240301$20240628$20240620$20240712$PER$$US-SA-2024SA183160$SANOFI AVENTIS$$19$YR$A$M$Y$70.76$KG$20240712$$MD$US$US
239954942$23995494$2$F$20240601$20240702$20240620$20240705$EXP$$US-KARYOPHARM-2024KPT001185$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240705$$CN$US$US
239955022$23995502$2$F$20240613$20240712$20240620$20240722$PER$$US-SA-2024SA181707$SANOFI AVENTIS$$$$$M$Y$$$20240720$$CN$US$US
239955093$23995509$3$F$$20240626$20240620$20240701$EXP$$JP-JNJFOC-20240643942$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$$COUNTRY NOT SPECIFIED$JP
239955152$23995515$2$F$$20240730$20240620$20240801$PER$$US-ALXN-202406USA000825US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
239955492$23995549$2$F$20230601$20240918$20240620$20240925$EXP$$US-ABBVIE-5617829$ABBVIE$$56$YR$$F$Y$$$20240925$$CN$US$US
239955583$23995558$3$F$$20240806$20240620$20240809$EXP$$CN-PFIZER INC-202400192315$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240809$$MD$CN$CN
239955752$23995575$2$F$$20240710$20240620$20240717$30DAY$$US-JNJFOC-20240633589$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$HP$US$US
239955764$23995576$4$F$20240601$20240909$20240620$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099546$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240911$$CN$US$US
239955774$23995577$4$F$20210101$20240712$20240620$20240805$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-098235$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$60$KG$20240806$$MD$DE$DE
239955882$23995588$2$F$20240601$20240830$20240620$20240909$EXP$$MX-BIOMARINAP-MX-2024-158667$BIOMARIN$$$$$$Y$$$20240909$$CN$MX$MX
239955943$23995594$3$F$$20240625$20240620$20240916$EXP$$CA-TEVA-VS-3209435$TEVA$Mackay S, Salh B. Anti-N-Methyl-D Receptor Encephalitis during Long-Term Adalimumab Therapy for Crohn^s Disease. ACG-Case-Rep-J 2024; 11 (5):.; Mackay S, Salh B. Anti-N-Methyl-D Receptor Encephalitis during Long-Term Adalimumab Therapy for Crohn^s Disease. ACG-Case-Rep-J 2024; 11 (5):.$46$YR$$F$Y$$$20240916$$MD$CA$CA
239956103$23995610$3$F$$20240621$20240620$20240705$PER$$US-ROCHE-3575748$ROCHE$$$$$F$Y$$$20240705$$CN$US$US
239956113$23995611$3$F$20240612$20240716$20240620$20240830$EXP$$US-ABBVIE-5801844$ABBVIE$$63$YR$$F$Y$82$KG$20240830$$CN$US$US
239956134$23995613$4$F$20240607$20240719$20240620$20240723$PER$$US-ROCHE-3579823$ROCHE$$45$YR$A$M$Y$104.78$KG$20240723$$CN$US$US
239956174$23995617$4$F$20240604$20240909$20240620$20240920$EXP$$US-BAYER-2024A087091$BAYER$$37$YR$A$M$Y$$$20240920$$CN$US$US
239956212$23995621$2$F$20240101$20240909$20240620$20240919$PER$$US-SA-2024SA177204$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240919$$MD$US$US
239956223$23995622$3$F$$20240627$20240620$20240712$PER$$US-SA-2024SA172275$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240712$$MD$US$US
239956294$23995629$4$F$$20240911$20240620$20240913$30DAY$$US-PFIZER INC-202400195160$PFIZER$$1$YR$$F$Y$$$20240913$$HP$US$US
239956322$23995632$2$F$$20240725$20240620$20240725$EXP$$CO-PFIZER INC-PV202400080814$PFIZER$$$$$F$Y$$$20240725$$MD$CO$CO
239956334$23995633$4$F$$20240827$20240620$20240829$30DAY$$US-PFIZER INC-202400186952$PFIZER$$15$YR$$M$Y$$$20240829$$CN$US$US
239956342$23995634$2$F$20240613$20240730$20240620$20240805$30DAY$$JP-PFIZER INC-202400193293$PFIZER$$$$$F$Y$$$20240805$$CN$JP$JP
239956353$23995635$3$F$$20240806$20240620$20240812$EXP$$CN-PFIZER INC-202400192309$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240812$$MD$CN$CN
239956462$23995646$2$F$$20240627$20240620$20240705$EXP$$JP-JNJFOC-20240643944$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$MD$JP$JP
239956482$23995648$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209459$TEVA$Kodavanti CKM, Ravender R, Shaffi SK. Abiraterone-Associated Syndrome of Mineralocorticoid Excess (SAME). J-Am-Soc-Nephrol 2023; 34 (Suppl.) 478-479.; Kodavanti CKM, Ravender R, Shaffi SK. Abiraterone-Associated Syndrome of Mineralocorticoid Excess (SAME). J-Am-Soc-Nephrol 2023; 34 (Suppl.) 478-479.$77$YR$$M$Y$$$20240705$$HP$US$US
239956662$23995666$2$F$$20240715$20240620$20240723$30DAY$$US-JNJFOC-20240633554$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$US$US
239956683$23995668$3$F$20240514$20240529$20240620$20240711$EXP$$US-BEH-2024173152$CSL BEHRING$$68$YR$E$F$Y$$$20240711$$MD$US$US
239957032$23995703$2$F$$20240614$20240620$20240703$EXP$$AU-MYLANLABS-2024M1054878$MYLAN$$$$$M$Y$$$20240703$$HP$AU$AU
239957123$23995712$3$F$$20240705$20240620$20240715$EXP$$DE-SANDOZ INC.-PHHY2017DE204325$SANDOZ$$63$YR$$F$Y$$$20240715$$MD$DE$DE
239957142$23995714$2$F$$20240918$20240620$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099305$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240918$$HP$US$US
239957202$23995720$2$F$$20240724$20240620$20240730$EXP$$CA-JNJFOC-20240562368$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240730$$HP$CA$CA
239957372$23995737$2$F$20240101$20240912$20240620$20240918$EXP$$GB-ABBVIE-5805197$ABBVIE$$53$YR$$M$Y$$$20240918$$CN$GB$GB
239957432$23995743$2$F$20240618$20240709$20240620$20240711$PER$$US-AMGEN-USASP2024121812$AMGEN$$60$YR$A$M$Y$$$20240710$$CN$US$US
239957482$23995748$2$F$$20240730$20240620$20240801$EXP$$US-ALXN-202406USA000809US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
239957492$23995749$2$F$$20240729$20240620$20240731$PER$$US-ALXN-202406USA000722US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
239957503$23995750$3$F$$20240806$20240620$20240812$EXP$$CN-PFIZER INC-202400192311$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240812$$MD$CN$CN
239957553$23995755$3$F$20240501$20240712$20240620$20240722$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406008457$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240722$$CN$JP$JP
239957562$23995756$2$F$$20240711$20240620$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202406005942$ELI LILLY AND CO$$74$YR$E$F$Y$76.644$KG$20240722$$MD$US$US
239957672$23995767$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209674$TEVA$Siddiqui AS. A Fatal Case of Legionella bozemanii Pneumonia in an Immunocompetent Patient. Case-Rep-Pulmon 2024; 2024 1-3.; Siddiqui AS. A Fatal Case of Legionella bozemanii Pneumonia in an Immunocompetent Patient. Case-Rep-Pulmon 2024; 2024 1-3.$59$YR$$F$Y$$$20240705$$HP$US$US
239957683$23995768$3$F$$20240806$20240620$20240812$EXP$$CN-PFIZER INC-202400192324$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240812$$MD$CN$CN
239957693$23995769$3$F$$20240806$20240620$20240809$EXP$$CN-PFIZER INC-202400192316$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240809$$MD$CN$CN
239957752$23995775$2$F$20240201$20240711$20240620$20240717$EXP$$US-ABBVIE-5806714$ABBVIE$$64$YR$$F$Y$90$KG$20240717$$CN$US$US
239957762$23995776$2$F$$20240709$20240620$20240713$EXP$$CA-ABBVIE-5807152$ABBVIE$$32$YR$$F$Y$$$20240713$$CN$CA$CA
239957772$23995777$2$F$$20240703$20240620$20240718$30DAY$$US-JNJFOC-20240632241$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$US$US
239958102$23995810$2$F$$20240619$20240620$20240701$EXP$$KR-GILEAD-2024-0677588$GILEAD$$6$DEC$A$F$Y$$$20240701$$PH$KR$KR
239958163$23995816$3$F$20230902$20240902$20240620$20240912$EXP$$JP-DSJP-DSJ-2023-131639$DAIICHI$$85$YR$$M$Y$61$KG$20240912$$MD$JP$JP
239958204$23995820$4$F$20240601$20240827$20240620$20240830$EXP$$JP-AstraZeneca-2024A140741$ASTRAZENECA$$73$YR$$M$Y$$$20240830$$MD$JP$
239958262$23995826$2$F$$20240726$20240620$20240802$EXP$$US-AstraZeneca-2024A137052$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
239958292$23995829$2$F$20240603$20240618$20240620$20240702$EXP$$CN-ROCHE-10000002223$ROCHE$$52$YR$A$F$Y$80.4$KG$20240702$$HP$CN$CN
239958322$23995832$2$F$20240614$20240726$20240620$20240730$EXP$$US-MYLANLABS-2024M1055557$MYLAN$$43$YR$$M$Y$$$20240730$$HP$US$US
239958534$23995853$4$F$20071101$20240905$20240620$20240920$PER$$US-TPU-TPU-2024-00344$TEIKOKU$$61$YR$A$F$Y$$$20240920$$CN$US$US
239958554$23995855$4$F$$20240712$20240620$20240718$EXP$$CZ-OTSUKA-2024_017386$OTSUKA$Veres M, Ustohal L.. Malignant catatonia in a patient with undifferentiated schizophrenia. Psychiatrie pro praxi. 2024;25(2):99-102$46$YR$$M$Y$$$20240718$$MD$CZ$CZ
239958625$23995862$5$F$20240611$20240716$20240620$20240722$30DAY$$US-JNJFOC-20240630930$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240722$$CN$US$US
239958743$23995874$3$F$$20240806$20240620$20240812$EXP$$CN-PFIZER INC-202400192317$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240812$$MD$CN$CN
239958822$23995882$2$F$20240101$20240705$20240620$20240720$PER$$US-INSUD PHARMA-2406US04669$INSUD PHARMA$$$$$$Y$$$20240720$$CN$US$US
239958922$23995892$2$F$$20240924$20240620$20240927$EXP$$US-JNJFOC-20240635479$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240927$$MD$US$US
239958973$23995897$3$F$$20240808$20240620$20240816$EXP$$CN-AstraZeneca-2024A119177$ASTRAZENECA$$63$YR$$M$Y$$$20240816$$CN$CN$
239958982$23995898$2$F$$20240726$20240620$20240802$EXP$$US-AstraZeneca-2024A137738$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
239959014$23995901$4$F$20240616$20240814$20240620$20240826$EXP$$NL-MYLANLABS-2024M1055119$MYLAN$$73$YR$$M$Y$$$20240826$$CN$NL$NL
239959076$23995907$6$F$20240101$20240924$20240620$20240926$EXP$$US-KARYOPHARM-2024KPT001180$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240926$$CN$US$US
239959152$23995915$2$F$$20240623$20240620$20240701$PER$$US-PFIZER INC-PV202400080198$PFIZER$$92$YR$$F$Y$$$20240701$$HP$US$US
239959183$23995918$3$F$$20240806$20240620$20240809$EXP$$CN-PFIZER INC-202400192322$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240809$$MD$CN$CN
239959252$23995925$2$F$20240613$20240730$20240620$20240805$PER$$US-PFIZER INC-202400195597$PFIZER$$62$YR$$F$Y$72.562$KG$20240805$$CN$US$US
239959333$23995933$3$F$$20240628$20240620$20240708$EXP$$IT-MYLANLABS-2024M1055083$MYLAN$Rubino R, Trizzino M, Pipito L, Sucato G, Santoro M, Maugeri R, Iacopino DG, Giammanco MG, Siragusa S, Cascio A et al. A difficult case of ventriculitis in a 40-year-old woman with acute myeloid leukemia.. Antibiotics. 2024;13(5):432$40$YR$$F$Y$$$20240708$$MD$IT$IT
239959455$23995945$5$F$$20240910$20240620$20240912$PER$$US-PFIZER INC-202400194204$PFIZER$$14$YR$$M$Y$$$20240912$$CN$US$US
239959483$23995948$3$F$$20240911$20240620$20240917$30DAY$$CO-PFIZER INC-PV202400079453$PFIZER$$$$$M$Y$$$20240917$$CN$CO$CO
239959493$23995949$3$F$20230101$20240913$20240620$20240926$PER$$US-KARYOPHARM-2024KPT001170$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240926$$CN$US$US
239959503$23995950$3$F$$20240916$20240620$20240919$30DAY$$US-PFIZER INC-202400192199$PFIZER$$$$$M$Y$$$20240919$$CN$US$US
239959552$23995955$2$F$20240101$20240904$20240620$20240912$PER$$US-SA-2024SA180329$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240912$$MD$US$US
239959562$23995956$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3210017$TEVA$Nasir AZ, Egwuatu N, Jameson A. Metagenomic next-generation sequencing identifying a rare case of Mycobacterium xenopi discitis. BMJ-Case-Rep 2023; 16 no pagination.; Nasir AZ, Egwuatu N, Jameson A. Metagenomic next-generation sequencing identifying a rare case of Mycobacterium xenopi discitis. BMJ-Case-Rep 2023; 16 no pagination.$$$$F$Y$$$20240705$$HP$US$US
239959642$23995964$2$F$$20240711$20240620$20240716$PER$$US-PFIZER INC-202400196992$PFIZER$$61$YR$$F$Y$$$20240716$$HP$US$US
239959684$23995968$4$F$20240101$20240729$20240620$20240801$EXP$$PR-PFIZER INC-202400093728$PFIZER$$89$YR$$F$Y$$$20240801$$HP$PR$PR
239959752$23995975$2$F$20240604$20240712$20240620$20240716$PER$$US-PFIZER INC-202400193408$PFIZER$$17$YR$$M$Y$63.492$KG$20240716$$MD$US$US
239959792$23995979$2$F$$20240625$20240620$20240701$PER$$US-PFIZER INC-202400195157$PFIZER$$78$YR$$F$Y$$$20240701$$PH$US$US
239959883$23995988$3$F$$20240806$20240620$20240812$EXP$$CN-PFIZER INC-202400192318$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240812$$MD$CN$CN
239959993$23995999$3$F$$20240924$20240620$20240927$PER$$US-PFIZER INC-202400026690$PFIZER$$51$YR$$F$Y$$$20240927$$MD$US$US
239960002$23996000$2$F$$20240801$20240620$20240806$PER$$US-PFIZER INC-PV202400079769$PFIZER$$69$YR$$M$Y$$$20240806$$MD$US$US
239960013$23996001$3$F$$20240806$20240620$20240812$EXP$$CN-PFIZER INC-202400192320$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240812$$MD$CN$CN
239960033$23996003$3$F$20240607$20240705$20240620$20240710$PER$$US-AMGEN-USASP2024114416$AMGEN$$$$$F$Y$$$20240710$$HP$US$US
239960052$23996005$2$F$20210101$20240625$20240620$20240705$EXP$$IT-TEVA-VS-3210126$TEVA$Novelli F, Puppo G, Barisione E, Tagliabue E, Sivori M, Pinelli V. Anti-MDA5-Dermatomyositis Associated RP-ILD Triggered by SARS-CoV-2 Infection. Respiration 2023; 102 (8): 775 abstr. 240.; Novelli F, Puppo G, Barisione E, Tagliabue E, Sivori M, Pinelli V. Anti-MDA5-Dermatomyositis Associated RP-ILD Triggered by SARS-CoV-2 Infection. Respiration 2023; 102 (8): 775 abstr. 240.$43$YR$$M$Y$$$20240705$$HP$IT$IT
239960062$23996006$2$F$20001123$20240626$20240620$20240701$PER$$US-PFIZER INC-PV202400080544$PFIZER$$63$YR$$F$Y$$$20240701$$HP$US$US
239960102$23996010$2$F$$20240625$20240620$20240705$EXP$$ES-TEVA-VS-3209227$TEVA$Del Hoyo CuendaB, Luna CN, Arnanz AA, Ortiz BM, Osorio MG, Gonzalez MB, et al. STATIN INDUCED MYOPATHY. Eur-J-Case-Rep-Intern-Med 2023; 10 (Suppl.) 519.; Del Hoyo CuendaB, Luna CN, Arnanz AA, Ortiz BM, Osorio MG, Gonzalez MB, et al. STATIN INDUCED MYOPATHY. Eur-J-Case-Rep-Intern-Med 2023; 10 (Suppl.) 519.$67$YR$$F$Y$$$20240705$$HP$ES$ES
239960112$23996011$2$F$20240401$20240802$20240620$20240808$EXP$$US-JNJFOC-20240636010$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
239960122$23996012$2$F$20240607$20240709$20240620$20240723$30DAY$$US-JNJFOC-20240619343$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240723$$CN$US$US
239960203$23996020$3$F$$20240806$20240620$20240809$EXP$$CN-PFIZER INC-202400192321$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240809$$MD$CN$CN
239960222$23996022$2$F$20240504$20240628$20240620$20240702$EXP$$US-BAYER-2024A081350$BAYER$$36$YR$A$M$Y$81.633$KG$20240702$$CN$US$US
239960326$23996032$6$F$20240101$20240719$20240620$20240729$EXP$$US-KARYOPHARM-2024KPT000883$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240729$$CN$US$CA
239960333$23996033$3$F$20240828$20240909$20240620$20240914$EXP$$US-TAKEDA-2024TUS035870$TAKEDA$$54$YR$$M$Y$$$20240914$$CN$US$US
239960342$23996034$2$F$$20240802$20240620$20240807$EXP$$CA-TAKEDA-2018TUS007437$TAKEDA$$$$$M$Y$$$20240807$$CN$CA$CA
239960363$23996036$3$F$20240617$20240703$20240620$20240708$PER$$US-PFIZER INC-PV202400081087$PFIZER$$69$YR$$F$Y$61.235$KG$20240708$$CN$US$US
239960386$23996038$6$F$20240401$20240916$20240620$20240918$PER$$US-PFIZER INC-PV202400074718$PFIZER$$65$YR$$F$Y$$$20240918$$HP$US$US
239960392$23996039$2$F$20230919$20240808$20240620$20240815$EXP$$US-APELLIS-APL-2023-003024$APELLIS PHARMACEUTICALS$$$$$$Y$49$KG$20240815$$CN$US$US
239960422$23996042$2$F$$20240918$20240620$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099394$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240918$$CN$US$US
239960522$23996052$2$F$$20240620$20240620$20240704$PER$$US-IDORSIA-008079-2024-US$IDORSIA PHARMACEUTICALS$$$$$F$Y$$$20240704$$CN$US$US
239960532$23996053$2$F$20240508$20240918$20240620$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099173$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$72.2$KG$20240918$$HP$US$US
239960622$23996062$2$F$$20240729$20240620$20240729$PER$$US-ALXN-202406USA000953US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
239960652$23996065$2$F$$20240626$20240620$20240703$PER$$US-ROCHE-10000003667$ROCHE$$$$A$M$Y$$$20240703$$CN$US$US
239960702$23996070$2$F$$20240709$20240620$20240724$30DAY$$US-JNJFOC-20240630475$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
239960733$23996073$3$F$$20240806$20240620$20240812$EXP$$CN-PFIZER INC-202400192323$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240812$$MD$CN$CN
239960762$23996076$2$F$$20240612$20240620$20240708$PER$$US-ROCHE-10000003201$ROCHE$$$$$$Y$$$20240708$$MD$US$US
239960803$23996080$3$F$$20240925$20240620$20240927$PER$$US-PFIZER INC-202400196274$PFIZER$$74$YR$$F$Y$$$20240927$$CN$US$US
239960812$23996081$2$F$$20240913$20240620$20240918$PER$$US-PFIZER INC-2020018863$PFIZER$$66$YR$$F$Y$$$20240918$$MD$US$US
239960822$23996082$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209822$TEVA$Bivona L, Williamson A, Emery SE, Stokes WA. Late Retropharyngeal and Parapharyngeal Abscess in Patients with a History of Anterior Cervical Discectomy and Fusion. Ann-Otol-Rhinol-Laryngol 2023; 132 (3): 294-303.; Bivona L, Williamson A, Emery SE, Stokes WA. Late Retropharyngeal and Parapharyngeal Abscess in Patients with a History of Anterior Cervical Discectomy and Fusion. Ann-Otol-Rhinol-Laryngol 2023; 132 (3): 294-303.; Bivona L, Williamson A, Emery SE, Stokes WA. Late Retropharyngeal and...$37$YR$$F$Y$$$20240705$$MD$US$US
239960973$23996097$3$F$$20240703$20240620$20240705$PER$$NVSC2024US129065$NOVARTIS$$$$$M$Y$106$KG$20240705$$HP$US$US
239961002$23996100$2$F$20220101$20240703$20240620$20240705$PER$$US-ORGANON-O2406USA001226$ORGANON$$$$$F$Y$81.633$KG$20240705$$MD$US$US
239961042$23996104$2$F$$20240814$20240620$20240827$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-001338$SK LIFE SCIENCE$$$$$$Y$$$20240827$$HP$CA$CA
239961192$23996119$2$F$20240301$20240919$20240620$20240925$EXP$$CA-OTSUKA-2024_010818$OTSUKA$$44$YR$$M$Y$$$20240925$$CN$CA$CA
239961362$23996136$2$F$$20240916$20240620$20240919$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-001673$AMGEN$$23$YR$A$F$Y$$$20240919$$CN$US$US
239961373$23996137$3$F$20240430$20240708$20240620$20240722$30DAY$$GB-JNJFOC-20240615051$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$GB$GB
239961442$23996144$2$F$20240604$20240620$20240620$20240702$EXP$IT-MINISAL02-989520$IT-ELI_LILLY_AND_COMPANY-IT202406013238$ELI LILLY AND CO$$54$YR$A$M$Y$82$KG$20240702$$CN$DE$IT
239961452$23996145$2$F$20240301$20240718$20240620$20240723$EXP$$US-PFIZER INC-PV202400081088$PFIZER$$62$YR$$F$Y$$$20240723$$HP$US$US
239961562$23996156$2$F$$20240909$20240620$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099325$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240911$$CN$US$US
239961604$23996160$4$F$$20240731$20240620$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097480$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240807$$CN$US$US
239961642$23996164$2$F$$20240826$20240620$20240909$PER$$US-SA-2024SA178011$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240909$$MD$US$US
239961672$23996167$2$F$$20240708$20240620$20240716$EXP$$ES-AstraZeneca-2024A142544$ASTRAZENECA$MIR CROS M, RIUS PERERA J, GILABERT SOTOCA M, MANGUES BAFALLUY I. Medullary aplasia associated with osimertinib: a case report. CLINICAL CASES / Rev. OFIL?ILAPHAR 2024;34(1):$69$YR$$F$Y$$$20240716$$HP$ES$
239961702$23996170$2$F$$20240717$20240620$20240722$EXP$$CA-PFIZER INC-202400196066$PFIZER$$50$YR$$M$Y$$$20240722$$CN$CA$CA
239961713$23996171$3$F$$20240730$20240620$20240801$EXP$$US-ALXN-202406USA000830US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
239961724$23996172$4$F$$20240816$20240620$20240822$EXP$$JP-ALXN-202406JPN000601JP$ALEXION PHARMACEUTICALS$$12$YR$$M$Y$$$20240822$$MD$JP$JP
239961762$23996176$2$F$20231101$20240701$20240620$20240704$EXP$$NVSC2023AR195396$NOVARTIS$$75$YR$$F$Y$$$20240704$$CN$AR$AR
239961782$23996178$2$F$$20240902$20240620$20240912$EXP$$JP-ROCHE-10000002330$ROCHE$Obata Y, Takemoto M, Sakaue T, Mukai K, Miyashita K, Kozawa J et al.. I-16-5 A case of type 1 diabetes mellitus which developed more than five months after discontinuation of atezolizumab. Journal of the Japan Diabetes Society / The 67th Annual Meeting of the Japan Dia. 2024;67:S176$76$YR$E$F$Y$54$KG$20240912$$MD$JP$JP
239961802$23996180$2$F$20231027$20240709$20240620$20240712$EXP$$US-INCYTE CORPORATION-2024IN006310$INCYTE$$$$$$Y$$$20240712$$CN$US$US
239961942$23996194$2$F$19990101$20240712$20240620$20240716$EXP$$US-ABBVIE-5804445$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
239961962$23996196$2$F$20240416$20240626$20240620$20240705$EXP$FR-AFSSAPS-AN2024000721$FR-TEVA-VS-3211147$TEVA$$66$YR$$M$Y$93$KG$20240705$$MD$FR$FR
239961983$23996198$3$F$$20240627$20240620$20240704$PER$$US-HALEON-2182578$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
2399620311$23996203$11$F$20240805$20240923$20240620$20240926$EXP$$AU-MYLANLABS-2024M1047161$MYLAN$$58$YR$$M$Y$$$20240926$$HP$AU$AU
239962062$23996206$2$F$$20240820$20240620$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099532$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240823$$CN$US$US
239962152$23996215$2$F$20240101$20240709$20240620$20240717$EXP$$SK-ABBVIE-5806466$ABBVIE$$44$YR$$M$Y$84$KG$20240717$$MD$SK$SK
239962262$23996226$2$F$20240618$20240911$20240620$20240912$PER$$US-AMGEN-USASP2024121451$AMGEN$$82$YR$E$M$Y$$$20240912$$CN$US$US
239962392$23996239$2$F$20240101$20240917$20240620$20240920$EXP$$CA-PFIZER INC-202400196611$PFIZER$$68$YR$$M$Y$$$20240920$$HP$CA$CA
239962402$23996240$2$F$20211014$20240726$20240620$20240802$EXP$$JP-AstraZeneca-2023A286789$ASTRAZENECA$$26602$DY$$F$Y$47$KG$20240802$$MD$JP$
239962505$23996250$5$F$$20240923$20240620$20240927$EXP$$GB-TAKEDA-2024TUS061042$TAKEDA$$$$$M$Y$$$20240927$$CN$GB$GB
239962512$23996251$2$F$20240617$20240701$20240620$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099431$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240702$$HP$US$US
239962522$23996252$2$F$$20240917$20240620$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098520$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240918$$CN$US$US
239962536$23996253$6$F$20240617$20240917$20240620$20240918$EXP$$NZ-MYLANLABS-2024M1055364$MYLAN$$81$YR$$F$Y$78$KG$20240918$$HP$NZ$NZ
239962583$23996258$3$F$$20240806$20240620$20240809$EXP$$CN-PFIZER INC-202400192314$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240809$$MD$CN$CN
239962602$23996260$2$F$$20240918$20240620$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099477$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240918$$CN$US$US
239962612$23996261$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209386$TEVA$Tiwari A, George N, Anumolu P, Malik N, Kambhatla S. Clozapine-Related Functional Bowel Obstruction: A Rare Adverse Effect Unmasking Quetiapine and Benztropine Interaction Raising Need for Bowel Surveillance. ACG-Case-Rep-J 2024; 11 (5):.; Tiwari A, George N, Anumolu P, Malik N, Kambhatla S. Clozapine-Related Functional Bowel Obstruction: A Rare Adverse Effect Unmasking Quetiapine and Benztropine Interaction Raising Need for Bowel Surveillance. ACG-Case-Rep-J 2024; 11 (5):.$34$YR$$M$Y$$$20240705$$MD$US$US
239962682$23996268$2$F$$20240626$20240620$20240703$EXP$$DE-BAUSCH-BL-2024-009237$BAUSCH AND LOMB$Renner K. Was im Alter zu beachten ist. Pharmazeutische Zeitung. 2024;169(15):22-29.$78$YR$$F$Y$$$20240703$$PH$DE$DE
239962882$23996288$2$F$$20240626$20240620$20240701$EXP$$JP-PFIZER INC-PV202400078717$PFIZER$Yahata, M.. Immunoglobulin A nephropathy with massive paramesangial deposits caused by antivascular endothelial growth factor therapy for metastatic rectal cancer: a case report and review of the literature. BMC Research Notes. 2013;6 (1):450$63$YR$$M$Y$$$20240701$$HP$JP$JP
239962903$23996290$3$F$20130101$20240626$20240620$20240701$EXP$$JP-PFIZER INC-PV202400078718$PFIZER$Tomita, M.. [A case of thrombotic microangiopathy with glomerular subendothelial IgA deposition due to bevacizumab]. The Japanese Journal of Nephrology. 2014;56 (5):612-617$57$YR$$F$Y$46.6$KG$20240701$$HP$JP$JP
239962913$23996291$3$F$20240601$20240809$20240620$20240809$30DAY$$CO-PFIZER INC-202400195031$PFIZER$$16$YR$$M$Y$28.5$KG$20240809$$CN$CO$CO
239962952$23996295$2$F$20240524$20240725$20240620$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099129$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240729$$CN$US$US
239962982$23996298$2$F$20240617$20240801$20240620$20240805$30DAY$$AU-MYLANLABS-2024M1055449$MYLAN$$$$$$Y$$$20240805$$CN$AU$AU
239962993$23996299$3$F$$20240826$20240620$20240830$30DAY$$SI-MYLANLABS-2024M1054134$MYLAN$$$$$F$Y$$$20240830$$CN$SI$SI
239963023$23996302$3$F$20240601$20240919$20240620$20240923$EXP$$NVSC2024GB128249$NOVARTIS$$61$YR$$M$Y$$$20240923$$CN$GB$GB
239963062$23996306$2$F$$20240625$20240620$20240705$EXP$$ES-TEVA-VS-3209209$TEVA$Garcia AG, Munoz EC, Samaniego NT, Fernandez-Bravo IG, Do Rego AT, Martinez EB. NON CARDIOGENIC ACUTE PULMONARY EDEMA. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl.) 54-55 abstr. 803.; Garcia AG, Munoz EC, Samaniego NT, Fernandez-Bravo IG, Do Rego AT, Martinez EB. NON CARDIOGENIC ACUTE PULMONARY EDEMA. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl.) 54-55 abstr. 803.$74$YR$$F$Y$$$20240705$$HP$ES$ES
239963083$23996308$3$F$20231201$20240718$20240620$20240725$EXP$$JP-RADIUS HEALTH, INC.-2023JP006853$RADIUS PHARM$$80$YR$$F$Y$$$20240725$$CN$JP$JP
239963092$23996309$2$F$$20240912$20240620$20240925$PER$$US-BEH-2024173410$CSL BEHRING$$63$YR$A$F$Y$$$20240925$$HP$US$US
239963108$23996310$8$F$20240401$20240924$20240620$20240926$EXP$$DE-BAUSCH-BL-2024-009318$BAUSCH AND LOMB$$72$YR$$F$Y$68.6$KG$20240926$$HP$DE$DE
239963112$23996311$2$F$20240613$20240830$20240620$20240830$PER$$NVSC2024US127999$NOVARTIS$$12$YR$$F$Y$$$20240830$$CN$US$US
239963162$23996316$2$F$$20240618$20240620$20240709$PER$$CA-TOLMAR, INC.-24CA049899$TOLMAR$$$$$M$Y$$$20240709$$CN$CA$CA
239963213$23996321$3$F$20240601$20240722$20240620$20240819$PER$$FR-TOLMAR, INC.-24FR049869$TOLMAR$$88$YR$$M$Y$$$20240819$$PH$FR$FR
239963223$23996322$3$F$20240523$20240702$20240620$20240809$PER$$FR-TOLMAR, INC.-24FR049874$TOLMAR$$57$YR$$M$Y$$$20240809$$PH$FR$FR
239963232$23996323$2$F$20240603$20240702$20240620$20240808$PER$$FR-TOLMAR, INC.-24FR049905$TOLMAR$$96$YR$$M$Y$$$20240808$$PH$FR$FR
239963242$23996324$2$F$20240603$20240702$20240620$20240809$PER$$FR-TOLMAR, INC.-24FR049931$TOLMAR$$77$YR$$M$Y$$$20240809$$PH$FR$FR
239963252$23996325$2$F$20240601$20240702$20240620$20240809$PER$$FR-TOLMAR, INC.-24FR049942$TOLMAR$$83$YR$$M$Y$$$20240809$$PH$FR$FR
239963273$23996327$3$F$$20240806$20240620$20240812$EXP$$CN-PFIZER INC-202400192313$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240812$$MD$CN$CN
239963302$23996330$2$F$$20240806$20240620$20240812$EXP$$CN-PFIZER INC-202400192282$PFIZER$Wang, X.. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine. 2024;103(20):10.1097/MD.0000000000038174$$$A$$Y$$$20240812$$MD$CN$CN
239963382$23996338$2$F$20240613$20240715$20240620$20240718$30DAY$$US-AMGEN-USASL2024117529$AMGEN$$50$YR$A$F$Y$$$20240718$$CN$US$US
239963392$23996339$2$F$$20240821$20240620$20240828$EXP$$SK-BAUSCH-BL-2024-009499$BAUSCH AND LOMB$$$$$M$Y$$$20240828$$MD$SK$SK
239963402$23996340$2$F$$20240715$20240620$20240718$EXP$$ES-BAUSCH-BL-2024-009398$BAUSCH AND LOMB$Lemus Calderon J, Montoro Ferrer A, Lopez Hortelano S, Lopez Salgueiro R. Anaphylactic shock after rosuvastatin with basophil activation test positive. Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI). 2024;1.$64$YR$$M$Y$$$20240718$$HP$ES$ES
239963582$23996358$2$F$20240208$20240626$20240620$20240704$EXP$$JP-AstraZeneca-2024A042194$ASTRAZENECA$$71$YR$$F$Y$$$20240704$$MD$JP$
239963602$23996360$2$F$$20240614$20240620$20240717$EXP$$FR-AstraZeneca-2024A143094$ASTRAZENECA$$$$$$Y$$$20240717$$HP$FR$
239963862$23996386$2$F$$20240625$20240620$20240705$EXP$$PL-TEVA-VS-3210145$TEVA$Adamczyk M, Krasowska D. Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs. Prz-Dermatol 2023; 110 (6): 698-702.; Adamczyk M, Krasowska D. Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs. Prz-Dermatol 2023; 110 (6): 698-702.$$$A$M$Y$$$20240705$$HP$PL$PL
239963883$23996388$3$F$$20240725$20240620$20240729$PER$$US-AMGEN-USASP2024121414$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
239963962$23996396$2$F$20240530$20240731$20240620$20240801$PER$$US-JNJFOC-20240649151$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240802$$HP$US$US
239964082$23996408$2$F$20240318$20240612$20240620$20240827$EXP$FR-AFSSAPS-PP2024000606$FR-TEVA-VS-3210693$TEVA$$51$YR$$M$Y$64.1$KG$20240827$$MD$FR$FR
239964112$23996411$2$F$20240516$20240718$20240620$20240806$PER$$US-GE HEALTHCARE-2024CSU006331$GE HEALTHCARE$$$$$F$Y$$$20240806$$HP$US$US
239964132$23996413$2$F$$20240820$20240620$20240826$EXP$GB-MHRA-MED-202406200035020410-NFZCY$GB-MYLANLABS-2024M1056253$MYLAN$$$$$M$Y$36$KG$20240826$$CN$GB$GB
239964262$23996426$2$F$$20240708$20240620$20240715$EXP$$NVSC2024FR127273$NOVARTIS$$$$E$F$Y$$$20240715$$MD$FR$FR
239964333$23996433$3$F$$20240807$20240620$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099145$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240814$$HP$US$US
239964492$23996449$2$F$$20240709$20240620$20240712$PER$$US-ALXN-202406USA000727US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
239964502$23996450$2$F$$20240730$20240620$20240812$EXP$$US-SMPA-2024SPA000050$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
239964692$23996469$2$F$$20240625$20240620$20240705$EXP$$DE-TEVA-VS-3209199$TEVA$Broecker S, Pragst F, Bakdash A, Herre S, Tsokos M. Combined use of liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) and high performance liquid chromatography with photodiode array detector (HPLC-DAD) in systematic toxicological analysis. Forensic-Sci-Int 2011; 215-226.; Broecker S, Pragst F, Bakdash A, Herre S, Tsokos M. Combined use of liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) and high performance liquid chrom...$59$YR$$M$Y$$$20240705$$HP$DE$DE
239964792$23996479$2$F$$20240806$20240620$20240806$PER$$US-PURDUE PHARMA-USA-2024-0310278$PURDUE$$$$$F$Y$$$20240806$$HP$US$US
239964822$23996482$2$F$20240401$20240711$20240620$20240716$EXP$$JP-PFIZER INC-202400196491$PFIZER$$65$YR$$M$Y$60.8$KG$20240716$$PH$JP$JP
239964862$23996486$2$F$20240501$20240708$20240620$20240716$PER$$US-MYLANLABS-2024M1052003$MYLAN$$85$YR$$F$Y$32.2$KG$20240716$$CN$US$US
239964923$23996492$3$F$$20240802$20240620$20240805$PER$$US-ALXN-202406USA000717US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
239965092$23996509$2$F$20240513$20240627$20240620$20240703$EXP$FR-AFSSAPS-LL2024001083$FR-MYLANLABS-2024M1054581$MYLAN$$21$YR$$F$Y$$$20240703$$MD$FR$FR
239965202$23996520$2$F$20240519$20240701$20240620$20240703$EXP$$IT-AMERICAN REGENT INC-2024002365$AMERICAN REGENT$$23$YR$$F$Y$$$20240703$$MD$IT$IT
239965332$23996533$2$F$20240128$20240913$20240620$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-098003$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$54$KG$20240913$$PH$JP$JP
239965362$23996536$2$F$20240322$20240724$20240620$20240729$EXP$$JP-KYOWAKIRIN-2024KK014769$KYOWA$$$$$$Y$$$20240729$$HP$JP$JP
239965452$23996545$2$F$$20240702$20240620$20240710$EXP$$US-NOVOPROD-1205529$NOVO NORDISK$$48$YR$$F$Y$$$20240710$$CN$US$US
239965572$23996557$2$F$20240318$20240703$20240620$20240718$PER$$US-Eisai-EC-2024-165545$EISAI$$73$YR$E$M$Y$77$KG$20240718$$HP$US$US
239965602$23996560$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3210133$TEVA$Ghafari-Saravi A, Foster E. Treatment of Refractory Vulvar Lichen Sclerosus With Methotrexate. J-Low-Genit-Tract-Dis 2024; 28 (2): 202-204.; Ghafari-Saravi A, Foster E. Treatment of Refractory Vulvar Lichen Sclerosus With Methotrexate. J-Low-Genit-Tract-Dis 2024; 28 (2): 202-204.$35$YR$$F$Y$$$20240705$$HP$US$US
239965663$23996566$3$F$20230101$20240802$20240620$20240805$PER$$US-ALXN-202406USA000800US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
239965672$23996567$2$F$$20240729$20240620$20240731$EXP$$US-ALXN-202406USA000729US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
239965692$23996569$2$F$20231201$20240717$20240620$20240718$EXP$$US-ALXN-202405USA001732US$ALEXION PHARMACEUTICALS$$77$YR$$M$Y$$$20240718$$HP$US$US
239965762$23996576$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209422$TEVA$Sabeti S, Foulad DP, Linden K. Doxycyline-induced hypoglycemia in a nondiabetic older woman. JAAD-Case-Rep 2024; 48 33-35.; Sabeti S, Foulad DP, Linden K. Doxycyline-induced hypoglycemia in a nondiabetic older woman. JAAD-Case-Rep 2024; 48 33-35.; Sabeti S, Foulad DP, Linden K. Doxycyline-induced hypoglycemia in a nondiabetic older woman. JAAD-Case-Rep 2024; 48 33-35.$71$YR$$F$Y$$$20240705$$HP$US$US
239965812$23996581$2$F$20240413$20240703$20240620$20240718$PER$$US-Eisai-EC-2024-165544$EISAI$$70$YR$E$F$Y$57$KG$20240718$$HP$US$US
239965882$23996588$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209897$TEVA$Ware C, Meledathu S, Tariq Z, Yee R, Lichtenberger JP, Siegel MO. Cryptococcal pneumonia and meningitis in a renal transplant recipient with a false negative serum cryptococcal antigen due to postzone phenomenon. IDCases 2023; 34.; Ware C, Meledathu S, Tariq Z, Yee R, Lichtenberger JP, Siegel MO. Cryptococcal pneumonia and meningitis in a renal transplant recipient with a false negative serum cryptococcal antigen due to postzone phenomenon. IDCases 2023; 34.$51$YR$$M$Y$$$20240705$$HP$US$US
239965922$23996592$2$F$20240612$20240709$20240620$20240712$EXP$$GB-SANDOZ INC.-SDZ2024GB059062$SANDOZ$$15$YR$$F$Y$$$20240712$$MD$GB$GB
239966012$23996601$2$F$$20240625$20240620$20240705$EXP$$SK-TEVA-VS-3209289$TEVA$Penesova A, Minarik P, Huckova M, Vlcek M, Szantova M, Krizanova O. 5-Fluorouracil Induced Hypertriglyceridemia During the Colorectal Cancer Treatment in a Patient With Multifactorial Chylomicronemia Syndrome: A Case Report. Clin-Ther 2024;.; Penesova A, Minarik P, Huckova M, Vlcek M, Szantova M, Krizanova O. 5-Fluorouracil Induced Hypertriglyceridemia During the Colorectal Cancer Treatment in a Patient With Multifactorial Chylomicronemia Syndrome: A Case Report. Clin-Ther 2024;.$47$YR$$F$Y$$$20240705$$MD$SK$SK
239966042$23996604$2$F$$20240610$20240620$20240708$PER$$US-ROCHE-10000001547$ROCHE$$$$$$Y$$$20240708$$MD$US$US
239966062$23996606$2$F$$20240729$20240620$20240729$PER$$US-ALXN-202406USA000944US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$PH$US$US
239966102$23996610$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209428$TEVA$Adderley P, Tejera Quesada C, Bali SD. A Life-Threatening Combination: A Case of Burkholderia Gladioli Pneumonia in a Patient With Coronavirus Disease 2019. Am-J-Respir-Crit-Care-Med 2023; 207 A5267.; Adderley P, Tejera Quesada C, Bali SD. A Life-Threatening Combination: A Case of Burkholderia Gladioli Pneumonia in a Patient With Coronavirus Disease 2019. Am-J-Respir-Crit-Care-Med 2023; 207 A5267.$56$YR$$M$Y$$$20240705$$HP$US$US
239966163$23996616$3$F$20240617$20240830$20240620$20240916$PER$$US-JNJFOC-20240642602$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240916$$MD$US$US
239966172$23996617$2$F$$20240619$20240620$20240725$EXP$$US-BAUSCH-BL-2024-009202$BAUSCH AND LOMB$$$$$$Y$$$20240725$$PH$US$US
239966222$23996622$2$F$$20240701$20240620$20240702$PER$$NVSC2024US129052$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
239966262$23996626$2$F$$20240617$20240620$20240805$PER$$US-LUNDBECK-DKLU4000213$LUNDBECK$$$$$$Y$$$20240805$$CN$US$US
239966272$23996627$2$F$$20240618$20240620$20240807$PER$$US-LUNDBECK-DKLU3078095$LUNDBECK$$$$$$Y$$$20240807$$CN$US$US
239966312$23996631$2$F$19800101$20240703$20240620$20240714$EXP$$US-ZENPEP LLC-2024AIMT00956$AIMMUNE$$$$$$Y$$$20240714$$HP$US$US
239966322$23996632$2$F$$20240605$20240620$20240715$PER$$US-009507513-2406USA002375$MERCK$Tu, B.H., Khalyfa, A.K, Bellizzi, A.M., Tanaka, T.. Hepatocellular Carcinoma with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Absence of Cirrhosis. ACG Case Reports Journal. 2024;11 (11):e:01348$77$YR$$M$Y$$$20240715$$HP$US$US
239966382$23996638$2$F$20240101$20240718$20240620$20240725$EXP$$JP-009507513-2406JPN001433J$MERCK$$8$DEC$$M$Y$$$20240725$$MD$JP$JP
239966393$23996639$3$F$$20240815$20240620$20240821$EXP$$PA-SANDOZ INC.-NVSC2022PA231624$SANDOZ$$$$$F$Y$$$20240821$$CN$PA$PA
239966412$23996641$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209830$TEVA$Brown DJ, Sedaghati M, Kumari P, Chao C, Rajbhandari GL, Bachan M, et al. The Difficulty With Treating Alcohol Withdrawal in Severe Chronic Obstructive Pulmonary Disease. Am-J-Respir-Crit-Care-Med 2023; 207 abstr. B41.; Brown DJ, Sedaghati M, Kumari P, Chao C, Rajbhandari GL, Bachan M, et al. The Difficulty With Treating Alcohol Withdrawal in Severe Chronic Obstructive Pulmonary Disease. Am-J-Respir-Crit-Care-Med 2023; 207 abstr. B41.$67$YR$$M$Y$$$20240705$$HP$US$US
239966482$23996648$2$F$20240530$20240701$20240620$20240704$EXP$$NVSC2024IN123578$NOVARTIS$$25$YR$$F$Y$$$20240704$$CN$IN$IN
239966532$23996653$2$F$$20240625$20240620$20240705$EXP$$RO-TEVA-VS-3210125$TEVA$Vaduva CC, Saceanu S, Cartu D, Novac MB, Boldeanu MV, Goganau AM, et al. Acute fatty liver with pancreatitis in pregnancy after in vitro fertilization - literature review and case report. [Review]. Eur-Rev-Med-Pharmacol-Sci 2024; 28 (8): 3251-3262.; Vaduva CC, Saceanu S, Cartu D, Novac MB, Boldeanu MV, Goganau AM, et al. Acute fatty liver with pancreatitis in pregnancy after in vitro fertilization - literature review and case report. [Review]. Eur-Rev-Med-Pharmacol-Sci 2024; 28 (8): 3251-3262.$25$YR$$F$Y$$$20240705$$HP$RO$RO
239966552$23996655$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3210134$TEVA$Nguyen D, Deitiker P. Sustained control of recalcitrant chronic spontaneous urticaria after initiation of inflammatory airway diseases treatment: two case reports. J-Med-Case-Rep 2024; 18 (1): 113.; Nguyen D, Deitiker P. Sustained control of recalcitrant chronic spontaneous urticaria after initiation of inflammatory airway diseases treatment: two case reports. J-Med-Case-Rep 2024; 18 (1): 113.$26$YR$$F$Y$$$20240705$$HP$US$US
239966593$23996659$3$F$$20240617$20240620$20240909$PER$$US-ABBVIE-5807440$ABBVIE$$$$A$$Y$$$20240909$$HP$US$US
239966612$23996661$2$F$20200101$20240625$20240620$20240705$EXP$$PL-TEVA-VS-3210525$TEVA$Baran K, Furmanczyk-Zawiska A, Wieczorek-Godlewska R, Nitek P, Durlik M. Pneumocystis jirovecii Pneumonia in a Liver Transplant Recipient With an Adverse Reaction to Trimethoprim/Sulfamethoxazole Treated With a Sulfonamide Desensitization Protocol: Case Report. Transplant-Proc 2024;.; Baran K, Furmanczyk-Zawiska A, Wieczorek-Godlewska R, Nitek P, Durlik M. Pneumocystis jirovecii Pneumonia in a Liver Transplant Recipient With an Adverse Reaction to Trimethoprim/Sulfamethoxazole Treated With a ...$23$YR$$M$Y$$$20240705$$HP$PL$PL
239966652$23996665$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3209953$TEVA$Bastin MT, Neyra J, Morris P, Woodward B, Flannery A. IMPACT OF VANCOMYCIN AND BETALACTAM COMBINATIONS ON RENAL TUBULE MARKERS OF INJURY AND SECRETION. Crit-Care-Med 2024; 52 (Suppl.) (1): S641.; Bastin MT, Neyra J, Morris P, Woodward B, Flannery A. IMPACT OF VANCOMYCIN AND BETALACTAM COMBINATIONS ON RENAL TUBULE MARKERS OF INJURY AND SECRETION. Crit-Care-Med 2024; 52 (Suppl.) (1): S641.$$$$$Y$$$20240705$$HP$US$US
239966684$23996668$4$F$$20240711$20240620$20240716$EXP$$IR-PFIZER INC-202400193875$PFIZER$Shahbazi, F.. Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases. Current drug safety. 2024;10.2174/0115748863299100240507$49$YR$$M$Y$85$KG$20240716$$HP$IR$IR
239966732$23996673$2$F$20231122$20240625$20240620$20240710$EXP$$US-COOPERSURGICAL, INC.-2024CPS001838$COOPERSURGICAL$$42$YR$$F$Y$65.7$KG$20240710$$CN$US$US
239966742$23996674$2$F$$20240910$20240620$20240920$EXP$$CA-SANDOZ INC.-SDZ2024CA059237$SANDOZ$$65$YR$$F$Y$34$KG$20240920$$MD$CA$CA
239966932$23996693$2$F$$20240719$20240620$20240723$EXP$$NVSC2024AT128189$NOVARTIS$$39$YR$$M$Y$$$20240723$$MD$AT$AT
239966943$23996694$3$F$20240513$20240801$20240620$20240808$EXP$$HU-VERTEX PHARMACEUTICALS-2024-010150$VERTEX$$26$YR$$F$Y$$$20240808$$MD$HU$HU
239966952$23996695$2$F$$20240718$20240620$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099663$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240726$$HP$US$US
239967023$23996702$3$F$20240401$20240819$20240620$20240829$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI05820$NEUROCRINE BIOSCIENCES$$19$YR$$M$Y$$$20240829$$CN$US$US
239967072$23996707$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3210016$TEVA$Fox B, Backes F. Varying presentations of immune checkpoint inhibitor-associated myocarditis: A case report of the clinical characteristics and outcomes of three patients. Gynecol-Oncol-Rep 2023; 49.; Fox B, Backes F. Varying presentations of immune checkpoint inhibitor-associated myocarditis: A case report of the clinical characteristics and outcomes of three patients. Gynecol-Oncol-Rep 2023; 49.$60$YR$$F$Y$$$20240705$$HP$US$US
239967083$23996708$3$F$20240513$20240816$20240620$20240827$EXP$$US-APELLIS-2024-APL-0000309$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240827$$HP$US$US
239967093$23996709$3$F$20240601$20240904$20240620$20240910$PER$$PH-Eisai-EC-2024-168334$EISAI$$34$YR$A$F$Y$$$20240910$$MD$PH$PH
239967122$23996712$2$F$$20240625$20240620$20240705$EXP$$US-TEVA-VS-3210132$TEVA$Olliverrie AE, Diaz JA, Samad S, Cyr NS. ^PERSISTENT CHOLESTASIS^ A RARE CASE OF VANISHING BILE DUCT SYNDROME. Gastroenterology 2024; 166 (Suppl.) (5): S-1620-S-1621 abstr. Su1506.; Olliverrie AE, Diaz JA, Samad S, Cyr NS. ^PERSISTENT CHOLESTASIS^ A RARE CASE OF VANISHING BILE DUCT SYNDROME. Gastroenterology 2024; 166 (Suppl.) (5): S-1620-S-1621 abstr. Su1506.$46$YR$$F$Y$$$20240705$$HP$US$US
239967132$23996713$2$F$$20240801$20240620$20240808$PER$$US-ALXN-202406USA000784US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
239967272$23996727$2$F$$20240620$20240620$20240703$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034969$BOEHRINGER INGELHEIM$$$$$$Y$$$20240703$$CN$US$US
239967372$23996737$2$F$$20240919$20240620$20240927$EXP$$JP-BIOGEN-2024BI01270016$BIOGEN$$$$$F$Y$$$20240927$$MD$JP$JP
239967552$23996755$2$F$20240606$20240614$20240620$20240705$EXP$$US-APELLIS-2024-APL-0000252$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240705$$CN$US$US
239967692$23996769$2$F$20240101$20240924$20240620$20240930$EXP$$JP-009507513-2406JPN001980J$MERCK$$70$YR$$F$Y$$$20240930$$MD$JP$JP
239967828$23996782$8$F$20240304$20240814$20240620$20240820$EXP$$DE-JNJFOC-20240316933$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240821$$HP$DE$DE
239967832$23996783$2$F$$20240708$20240620$20240710$EXP$$NVSJ2024JP007236$NOVARTIS$$$$E$M$Y$$$20240711$$MD$JP$JP
239967852$23996785$2$F$20240604$20240803$20240620$20240820$PER$$US-AstraZeneca-2024A130113$ASTRAZENECA$$6667$DY$$F$Y$$$20240820$$CN$US$
239967862$23996786$2$F$20240604$20240723$20240620$20240726$EXP$$US-JNJFOC-20240636453$JOHNSON AND JOHNSON$$71$YR$E$F$Y$73.548$KG$20240726$$HP$US$US
239967902$23996790$2$F$20240501$20240723$20240620$20240802$EXP$$US-ASTELLAS-2024US017190$ASTELLAS$$59$YR$$F$Y$$$20240802$$CN$US$US
239967934$23996793$4$F$20240612$20240809$20240620$20240812$PER$$US-AMGEN-USASP2024120339$AMGEN$$68$YR$E$F$Y$$$20240812$$CN$US$US
239967992$23996799$2$F$20230909$20240703$20240620$20240707$EXP$$NVSJ2024JP007265$NOVARTIS$$79$YR$$F$Y$80.5$KG$20240708$$MD$JP$JP
239968182$23996818$2$F$20240609$20240626$20240620$20240701$EXP$$FR-BIOGEN-2024BI01269850$BIOGEN$$64$YR$$F$Y$82$KG$20240630$$MD$FR$FR
239968202$23996820$2$F$20240502$20240801$20240620$20240806$EXP$$US-JNJFOC-20240557502$JOHNSON AND JOHNSON$$70$YR$E$M$Y$75$KG$20240806$$CN$US$US
239968222$23996822$2$F$$20240909$20240620$20240919$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-18640$SAMSUNG BIOEPIS$$59$YR$A$F$Y$$$20240919$$CN$CA$CA
239968232$23996823$2$F$20240611$20240625$20240620$20240708$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-18650$SAMSUNG BIOEPIS$$44$YR$A$M$Y$$$20240708$$HP$CA$CA
239968342$23996834$2$F$20210101$20240926$20240620$20240930$EXP$$JP-JNJFOC-20240648819$JOHNSON AND JOHNSON$Aizaki T, Aizaki T. Experience with D-MPB therapy for transplant-ineligible MM.$72$YR$E$M$Y$$$20240930$$MD$JP$JP
239968382$23996838$2$F$20240615$20240704$20240620$20240710$EXP$$AR-TAKEDA-2024TUS061381$TAKEDA$$9$YR$$F$Y$28$KG$20240710$$CN$AR$AR
239968423$23996842$3$F$$20240827$20240620$20240903$EXP$$US-BIOGEN-2024BI01270340$BIOGEN$$$$$M$Y$$$20240903$$CN$US$US
239968502$23996850$2$F$20240505$20240624$20240620$20240701$EXP$$KR-CELLTRION INC.-2024KR011748$CELLTRION$$$$$$Y$$$20240702$$MD$KR$KR
239968682$23996868$2$F$$20240919$20240620$20240927$EXP$$JP-BIOGEN-2024BI01270226$BIOGEN$$$$$F$Y$$$20240927$$MD$JP$JP
239968832$23996883$2$F$20240614$20240814$20240620$20240814$PER$$US-AMGEN-USASP2024119056$AMGEN$$63$YR$A$F$Y$$$20240814$$CN$US$US
239968862$23996886$2$F$20240603$20240708$20240620$20240710$EXP$$US-ABBVIE-5807008$ABBVIE$$80$YR$$M$Y$$$20240710$$CN$US$US
239968882$23996888$2$F$$20240702$20240620$20240703$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035128$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240703$$CN$CA$CA
239968982$23996898$2$F$20240101$20240802$20240620$20240805$EXP$$US-ABBVIE-5807042$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
239969022$23996902$2$F$$20240712$20240620$20240718$EXP$$JP-GSK-JP2024JPN074028$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$JP$JP
239969042$23996904$2$F$20220101$20240611$20240620$20240701$EXP$$US-ABBVIE-5809089$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
239969122$23996912$2$F$$20240722$20240620$20240726$EXP$$JP-TAKEDA-2024TJP009056$TAKEDA$$8$DEC$$F$Y$$$20240726$$MD$JP$JP
239969212$23996921$2$F$20240521$20240718$20240620$20240721$EXP$$NVSJ2024JP007273$NOVARTIS$$$$$$Y$$$20240722$$MD$JP$JP
239969222$23996922$2$F$20240423$20240909$20240620$20240917$PER$$US-SA-2024SA179516$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240918$$MD$US$US
239969236$23996923$6$F$20240401$20240920$20240620$20240920$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-019312$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240920$$CN$CA$CA
239969243$23996924$3$F$$20240905$20240620$20240908$EXP$$JP-JNJFOC-20240652375$JOHNSON AND JOHNSON$$7$DEC$$M$Y$$$20240909$$MD$JP$JP
239969283$23996928$3$F$20240101$20240621$20240620$20240702$EXP$$US-ABBVIE-5803896$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
239969302$23996930$2$F$20231219$20240829$20240620$20240907$EXP$$CA-CELLTRION INC.-2023CA024664$CELLTRION$$$$$$Y$$$20240907$$CN$CA$CA
239969322$23996932$2$F$$20240729$20240620$20240801$PER$$US-JNJFOC-20240638325$JOHNSON AND JOHNSON$$54$YR$A$M$Y$76.272$KG$20240802$$PH$US$US
239969372$23996937$2$F$20210906$20240716$20240620$20240728$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099682$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$75.11$KG$20240729$$CN$US$US
239969412$23996941$2$F$$20240712$20240620$20240712$EXP$$IT-ALXN-202406EEA000904IT$ALEXION PHARMACEUTICALS$$$$N$F$Y$$$20240712$$MD$IT$IT
239969472$23996947$2$F$20240101$20240724$20240620$20240726$EXP$$JP-ABBVIE-5771307$ABBVIE$$40$YR$$F$Y$$$20240726$$MD$JP$JP
239969563$23996956$3$F$20240501$20240918$20240620$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099529$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240918$$HP$US$US
239969613$23996961$3$F$20240501$20240806$20240621$20240812$EXP$$US-BIOGEN-2024BI01269917$BIOGEN$$23$YR$$M$Y$$$20240812$$MD$US$US
239969632$23996963$2$F$$20240709$20240621$20240724$EXP$$JP-AMGEN-JPNSP2024121491$AMGEN$$$$$$Y$$$20240724$$PH$JP$JP
239969674$23996967$4$F$20240607$20240628$20240621$20240701$EXP$$US-BIOGEN-2024BI01269903$BIOGEN$$7$YR$$M$Y$$$20240701$$HP$US$US
239969686$23996968$6$F$20240601$20240923$20240621$20240930$EXP$$GB-BIOGEN-2024BI01270087$BIOGEN$$71$YR$$F$Y$$$20240930$$CN$GB$GB
239969764$23996976$4$F$20240501$20240810$20240621$20240813$EXP$$US-ABBVIE-5807907$ABBVIE$$70$YR$$F$Y$$$20240813$$CN$US$US
239969794$23996979$4$F$20240607$20240717$20240621$20240812$30DAY$$US-JNJFOC-20240619060$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240812$$CN$US$US
239969802$23996980$2$F$20240101$20240916$20240621$20240921$EXP$$US-ABBVIE-5718325$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
239969882$23996988$2$F$20240528$20240716$20240621$20240716$EXP$GR-GREOF-202400644$GR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035015$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240716$$MD$GR$GR
239969932$23996993$2$F$$20240712$20240621$20240717$EXP$$CH-CHEPLA-2024007756$CHEPLAPHARM$Hosek N, Montani M, Mani LY. Acute post-renal kidney graft dysfunction due to cytomegalovirus-positive nephrogenic adenoma-case report and review of the literature. Front Med (Lausanne). 2024 May 29;11:1394028. p1-7; doi: 10.3389/fmed.2024.1394028. ?PMID: 38873192; PMCID: PMC11175655.$33$YR$$M$Y$$$20240717$$MD$COUNTRY NOT SPECIFIED$CH
239970032$23997003$2$F$$20240729$20240621$20240729$PER$$US-ALXN-202406USA000993US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$MD$US$US
239970062$23997006$2$F$20240616$20240725$20240621$20240806$EXP$$US-AstraZeneca-2024A141520$ASTRAZENECA$$26814$DY$$F$Y$$$20240806$$HP$US$
239970132$23997013$2$F$$20240710$20240621$20240712$30DAY$$US-GSK-US2024072655$GLAXOSMITHKLINE$$$$$M$Y$$$20240712$$CN$US$US
239970182$23997018$2$F$$20240621$20240621$20240705$PER$$US-LEADINGPHARMA-US-2024LEASPO00236$LEADING PHARMA$$68$YR$E$M$Y$220$KG$20240705$$CN$US$US
239970233$23997023$3$F$20240101$20240827$20240621$20240905$PER$$US-SA-2024SA181213$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240905$$MD$US$US
239970243$23997024$3$F$20240102$20240802$20240621$20240809$EXP$$US-ABBVIE-5804274$ABBVIE$$63$YR$$F$Y$84$KG$20240809$$CN$US$US
239970354$23997035$4$F$20240615$20240815$20240621$20240826$EXP$$CA-NOVOPROD-1179331$NOVO NORDISK$$43$YR$$F$Y$94.1$KG$20240826$$CN$CA$CA
239970362$23997036$2$F$20240501$20240722$20240621$20240731$EXP$$EC-NOVOPROD-1236761$NOVO NORDISK$$44$YR$$F$Y$84$KG$20240731$$PH$EC$EC
239970442$23997044$2$F$20240510$20240626$20240621$20240703$EXP$$US-ROCHE-10000002138$ROCHE$$77$YR$E$M$Y$$$20240703$$MD$US$US
239970662$23997066$2$F$20240501$20240718$20240621$20240724$PER$$US-AMGEN-USASP2024118773$AMGEN$$59$YR$A$F$Y$90.3$KG$20240724$$PH$US$US
239970702$23997070$2$F$$20240807$20240621$20240813$EXP$$US-ALXN-202403USA000674US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$HP$US$US
239970723$23997072$3$F$20240615$20240723$20240621$20240729$30DAY$$US-AMGEN-USASP2024119731$AMGEN$$51$YR$A$F$Y$108.22$KG$20240729$$HP$US$US
239970814$23997081$4$F$20240612$20240816$20240621$20240826$EXP$$CA-CELLTRION INC.-2024CA014920$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
239970852$23997085$2$F$$20240801$20240621$20240816$PER$$US-GRANULES-US-2024GRASPO00228$GRANULES INDIA$$75$YR$E$F$Y$86.2$KG$20240816$$CN$US$US
239970912$23997091$2$F$20240504$20240719$20240621$20240722$PER$$US-JNJFOC-20240630407$JOHNSON AND JOHNSON$$$$$F$Y$$$20240721$$HP$US$US
239970922$23997092$2$F$$20240703$20240621$20240704$PER$$US-JNJFOC-20240630506$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$US$US
239970952$23997095$2$F$20240101$20240722$20240621$20240731$PER$$US-SA-2024SA181220$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240731$$MD$US$US
239971023$23997102$3$F$20240618$20240722$20240621$20240725$PER$$US-AMGEN-USASP2024121790$AMGEN$$54$YR$A$M$Y$$$20240725$$CN$US$US
239971282$23997128$2$F$$20240710$20240621$20240711$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009335$JAZZ$$$$$F$Y$$$20240711$$HP$US$US
239971312$23997131$2$F$20240527$20240628$20240621$20240718$30DAY$$US-JNJFOC-20240590105$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240718$$HP$US$US
239971373$23997137$3$F$20230801$20240702$20240621$20240712$EXP$$US-NOVOPROD-1240618$NOVO NORDISK$$66$YR$$F$Y$$$20240712$$CN$US$US
239971382$23997138$2$F$$20240731$20240621$20240809$30DAY$$BR-NOVOPROD-1236856$NOVO NORDISK$$$$$F$Y$$$20240809$$CN$BR$BR
239971442$23997144$2$F$20240524$20240613$20240621$20240709$EXP$$US-ROCHE-3578605$ROCHE$$87$YR$E$M$Y$$$20240703$$CN$US$US
239971613$23997161$3$F$$20240705$20240621$20240712$EXP$$CH-ROCHE-10000001735$ROCHE$Cammann V, Tresch A, Himmelmann A, Sommerstein R, Bachli E. Fatal Hemophagocytic Lymphohistiocytosis triggered by Epstein-Barr Virus in a patient with immunosuppression.(Abstract number: P140). Swiss Medical Weekly. 2024-May;154 (Suppl 276):110S-111S. doi:10.57187/s.3896.$43$YR$A$M$Y$$$20240712$$HP$CH$CH
239971622$23997162$2$F$20231013$20240617$20240621$20240712$EXP$SI-JAZMP-NCPHV-2024SI0549_0549$SI-BRISTOL-MYERS SQUIBB COMPANY-2024-097371$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240712$$PH$SI$SI
239971632$23997163$2$F$$20240702$20240621$20240702$EXP$$JP-TAKEDA-2024TJP009280$TAKEDA$Keisuke Watanabe, Tatsuhiko Yamamoto, Tsutomu Takahashi. Experience with mirtazapine for sleep disorders in Angelman syndrome. Official Journal of the Japanese Society of Child Neurology. 2024;56(S):S351$5$YR$$M$Y$$$20240702$$MD$JP$JP
239971652$23997165$2$F$20240605$20240619$20240621$20240702$EXP$$CN-ROCHE-10000003429$ROCHE$$69$YR$E$M$Y$80$KG$20240702$$HP$CN$CN
239971882$23997188$2$F$20240520$20240702$20240621$20240725$PER$$US-TOLMAR, INC.-24US049528$TOLMAR$$80$YR$$M$Y$$$20240725$$HP$US$US
239971892$23997189$2$F$20240516$20240702$20240621$20240725$PER$$US-TOLMAR, INC.-24US049536$TOLMAR$$71$YR$$M$Y$$$20240725$$HP$US$US
239971902$23997190$2$F$20240510$20240701$20240621$20240725$PER$$US-TOLMAR, INC.-24US049533$TOLMAR$$82$YR$$M$Y$$$20240725$$HP$US$US
239971932$23997193$2$F$20240520$20240702$20240621$20240725$PER$$US-TOLMAR, INC.-24US049592$TOLMAR$$65$YR$$M$Y$$$20240725$$PH$US$US
239971942$23997194$2$F$20240523$20240702$20240621$20240726$PER$$US-TOLMAR, INC.-24US049639$TOLMAR$$61$YR$$M$Y$$$20240726$$HP$US$US
239971952$23997195$2$F$20240523$20240708$20240621$20240805$PER$$US-TOLMAR, INC.-24US049659$TOLMAR$$77$YR$$M$Y$$$20240805$$HP$US$US
239971962$23997196$2$F$20230401$20240708$20240621$20240805$PER$$US-TOLMAR, INC.-24US049653$TOLMAR$$65$YR$$M$Y$$$20240805$$HP$US$US
239972123$23997212$3$F$$20240723$20240621$20240802$EXP$$US-INTERCEPT-PM2024001223$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240802$$HP$US$US
239972132$23997213$2$F$20231201$20240729$20240621$20240808$EXP$$CA-INTERCEPT-PM2023001546$INTERCEPT PHARMACEUTICALS$$70$YR$$F$Y$$$20240808$$CN$CA$CA
239972172$23997217$2$F$20240111$20240725$20240621$20240801$PER$$US-JAZZ PHARMACEUTICALS-2024-US-000772$JAZZ$$36$YR$$F$Y$$$20240801$$CN$US$US
239972182$23997218$2$F$$20240719$20240621$20240729$EXP$$US-INTERCEPT-PM2024001227$INTERCEPT PHARMACEUTICALS$$$$$F$Y$58.957$KG$20240729$$CN$US$US
239972242$23997224$2$F$$20240709$20240621$20240716$EXP$$US-ABBVIE-5807987$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
239972422$23997242$2$F$$20240611$20240621$20240717$PER$$US-ROCHE-10000003073$ROCHE$$$$$$Y$$$20240717$$HP$US$US
239972492$23997249$2$F$$20240821$20240621$20240822$PER$$NVSC2024US129382$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
239972822$23997282$2$F$20240614$20240723$20240621$20240730$30DAY$$US-AMGEN-USASP2024119743$AMGEN$$44$YR$A$F$Y$89$KG$20240729$$PH$US$US
239973133$23997313$3$F$20240229$20240624$20240621$20240701$EXP$$ID-EMD Serono-2024032666$EMD SERONO INC$$16$YR$T$M$Y$37$KG$20240701$$CN$ID$ID
239973162$23997316$2$F$$20240730$20240621$20240802$PER$$US-ALXN-202406USA000858US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
239973464$23997346$4$F$20240612$20240717$20240621$20240801$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000533$DECIPHERA PHARMACEUTICALS$$74$YR$E$F$Y$$$20240801$$CN$US$US
239973473$23997347$3$F$20240614$20240926$20240621$20240930$30DAY$$GR-SANDOZ INC.-SDZ2024GR058974$SANDOZ$$14$YR$$M$Y$$$20240930$$CN$GR$GR
239973492$23997349$2$F$20240521$20240718$20240621$20240721$EXP$$NVSJ2024JP006464$NOVARTIS$$34$YR$$F$Y$$$20240722$$MD$JP$JP
239973542$23997354$2$F$20240608$20240627$20240621$20240702$EXP$$US-ABBVIE-5808087$ABBVIE$$43$YR$$F$Y$130$KG$20240702$$CN$US$US
239973703$23997370$3$F$$20240826$20240621$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099858$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240829$$CN$US$US
239973752$23997375$2$F$20240422$20240917$20240621$20240918$PER$$NVSC2024US122497$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
239973832$23997383$2$F$$20240529$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000243$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
239973842$23997384$2$F$20240101$20240529$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000274$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
239973922$23997392$2$F$$20240517$20240621$20240814$EXP$$CA-HALEON-2177537$Haleon PLC$$75$YR$$F$Y$70$KG$20240814$$HP$CA$CA
239973932$23997393$2$F$$20240515$20240621$20240718$EXP$$CA-HALEON-2175331$Haleon PLC$$44$YR$$F$Y$$$20240718$$HP$CA$CA
239973944$23997394$4$F$20201001$20240712$20240621$20240801$EXP$$JP-UCBSA-2021033182$UCB$$7$DEC$$M$Y$$$20240801$$MD$JP$JP
239974142$23997414$2$F$20240131$20240527$20240621$20240702$EXP$$CN-SA-2024SA160175$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240702$$CN$CN$CN
239974383$23997438$3$F$20240613$20240827$20240621$20240904$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000531$DECIPHERA PHARMACEUTICALS$$71$YR$E$F$Y$$$20240904$$CN$US$US
239974465$23997446$5$F$20220301$20240828$20240621$20240905$EXP$$CA-CELLTRION INC.-2022CA005520$CELLTRION$$$$$$Y$$$20240905$$MD$CA$CA
239974643$23997464$3$F$20240510$20240916$20240621$20240922$PER$$US-SA-2024SA176971$SANOFI AVENTIS$$22$YR$A$M$Y$63.9$KG$20240923$$MD$US$US
239974662$23997466$2$F$20240101$20240827$20240621$20240911$PER$$US-SA-2024SA082971$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240911$$MD$US$US
239974712$23997471$2$F$20240101$20240814$20240621$20240827$PER$$US-SA-2024SA177962$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240827$$MD$US$US
239974733$23997473$3$F$20240101$20240624$20240621$20240704$PER$$US-SA-2024SA179068$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240704$$MD$US$US
239974792$23997479$2$F$$20240523$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000396$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$PH$US$US
239974942$23997494$2$F$20240219$20240617$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000369$BRAEBURN PHARMACEUTICALS$$37$YR$$M$Y$$$20240920$$MD$US$US
239974972$23997497$2$F$$20240731$20240621$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099602$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$114.31$KG$20240801$$CN$US$US
239974982$23997498$2$F$$20240720$20240621$20240731$EXP$$US-AUROBINDO-AUR-APL-2024-029720$AUROBINDO$Shrestha N, Ibodeng G, Subedi P. Portal vein thrombosis with cavernous transformation in a patient with cocaine use in adjunction with testosterone injection: a case report. The American Journal of the Medical Sciences. 2024;367(Supplement):S134$42$YR$$M$Y$$$20240731$$MD$US$US
239975072$23997507$2$F$20240101$20240529$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000399$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
239975104$23997510$4$F$20240314$20240920$20240621$20240930$EXP$$CA-CELLTRION INC.-2024CA006955$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
239975122$23997512$2$F$20240304$20240603$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000416$BRAEBURN PHARMACEUTICALS$$27$YR$$F$Y$106.03$KG$20240920$$HP$US$US
239975132$23997513$2$F$$20240613$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000424$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
239975142$23997514$2$F$$20240610$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000418$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
239975162$23997516$2$F$20240501$20240604$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000417$BRAEBURN PHARMACEUTICALS$$34$YR$$F$Y$64.399$KG$20240920$$HP$US$US
239975492$23997549$2$F$$20240709$20240621$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202406011946$ELI LILLY AND CO$$$$$F$Y$$$20240711$$CN$US$US
239975742$23997574$2$F$20240508$20240612$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000465$BRAEBURN PHARMACEUTICALS$$42$YR$$M$Y$$$20240920$$CN$US$US
239975882$23997588$2$F$20240520$20240618$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000481$BRAEBURN PHARMACEUTICALS$$70$YR$$F$Y$$$20240920$$PH$US$US
239975932$23997593$2$F$$20240526$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000482$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
239975942$23997594$2$F$$20240614$20240621$20240920$PER$$US-BRAEBURN-US-BRA-24-000483$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
239975992$23997599$2$F$$20240716$20240621$20240717$PER$$US-HALEON-2182847$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
239976002$23997600$2$F$$20240712$20240621$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-029676$AUROBINDO$Reda H.. Neurologic Complications of Endocrine Disorders.. Continuum-Minneap-Minn. 2023;29(3):887-902$70$YR$$M$Y$$$20240722$$MD$US$US
239976012$23997601$2$F$$20240828$20240621$20240906$EXP$$GB-ROCHE-10000001715$ROCHE$$50$YR$A$M$Y$$$20240906$$CN$GB$GB
239976044$23997604$4$F$20230101$20240909$20240621$20240917$EXP$$CA-CELLTRION INC.-2023CA025290$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
239976173$23997617$3$F$20240626$20240826$20240621$20240828$PER$$US-AMGEN-USASP2024121209$AMGEN$$61$YR$A$M$Y$$$20240828$$CN$US$US
239976182$23997618$2$F$20240603$20240812$20240621$20240902$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002584$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240902$$CN$US$US
239976225$23997622$5$F$$20240910$20240621$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097440$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240912$$CN$US$US
239976252$23997625$2$F$$20240912$20240621$20240924$EXP$$CA-APOTEX-2024AP007243$APOTEX$$90$YR$$F$Y$60$KG$20240924$$HP$CA$CA
239976262$23997626$2$F$$20240619$20240621$20240702$PER$$US-MSNLABS-2024MSNSPO01256$MSN LABORATORIES$$$$$$Y$$$20240702$$CN$US$US
239976352$23997635$2$F$$20240708$20240621$20240708$PER$$NVSC2024US129454$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
239976362$23997636$2$F$20231013$20240911$20240621$20240917$EXP$$US-ABBVIE-5805839$ABBVIE$$67$YR$$F$Y$76$KG$20240917$$CN$US$US
239976374$23997637$4$F$20240101$20240711$20240621$20240718$PER$$US-SA-2024SA181288$SANOFI AVENTIS$$52$YR$A$F$Y$74.8$KG$20240718$$MD$US$US
239976474$23997647$4$F$20240617$20240807$20240621$20240812$EXP$$GR-ABBVIE-5805634$ABBVIE$$49$YR$$M$Y$71$KG$20240812$$MD$GR$GR
239976572$23997657$2$F$20231227$20240814$20240621$20240822$EXP$$CA-CELLTRION INC.-2023CA025420$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
239976582$23997658$2$F$$20240710$20240621$20240715$PER$$US-HETERO-HET2024US01834$HETERO$$$$$M$Y$$$20240715$$CN$US$US
239976703$23997670$3$F$20230823$20240819$20240621$20240823$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-259748$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$$$20240823$$CN$US$US
239976722$23997672$2$F$$20240807$20240621$20240814$PER$$US-BIOGEN-2024BI01269890$BIOGEN$$$$$F$Y$$$20240814$$HP$US$US
239976742$23997674$2$F$20240101$20240719$20240621$20240725$PER$$US-BIOGEN-2024BI01269622$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
239976803$23997680$3$F$20240619$20240702$20240621$20240708$EXP$$US-AMGEN-USASP2024121189$AMGEN$$80$YR$E$M$Y$$$20240708$$CN$US$US
239976823$23997682$3$F$20231201$20240822$20240621$20240830$EXP$$US-GSK-US2023180191$GLAXOSMITHKLINE$$80$YR$$F$Y$45.351$KG$20240830$$HP$US$US
239976852$23997685$2$F$20240604$20240711$20240621$20240720$30DAY$$JP-JNJFOC-20240621733$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$PH$JP$JP
239976882$23997688$2$F$20240601$20240722$20240621$20240728$PER$$US-AstraZeneca-2024A142702$ASTRAZENECA$$$$$F$Y$$$20240728$$HP$US$
239976942$23997694$2$F$20240409$20240708$20240621$20240709$PER$$US-JNJFOC-20240623736$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$HP$US$US
239976954$23997695$4$F$20240607$20240722$20240621$20240802$30DAY$$US-JNJFOC-20240639686$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240802$$CN$US$US
239976983$23997698$3$F$20240101$20240820$20240621$20240829$PER$$US-SA-2024SA173929$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240829$$MD$US$US
239976992$23997699$2$F$20240610$20240717$20240621$20240729$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00539$CATALYST PHARMA$$66$YR$$F$Y$80.272$KG$20240729$$CN$US$US
239977022$23997702$2$F$20240101$20240625$20240621$20240701$PER$$US-AMGEN-USASP2024120903$AMGEN$$43$YR$A$F$Y$$$20240701$$CN$US$US
239977062$23997706$2$F$20240601$20240624$20240621$20240702$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00548$CATALYST PHARMA$$81$YR$$F$Y$41.27$KG$20240702$$CN$US$US
239977293$23997729$3$F$20240610$20240716$20240621$20240718$EXP$$US-KYOWAKIRIN-2024KK014886$KYOWA$$$$$$Y$$$20240718$$HP$US$US
239977332$23997733$2$F$$20240626$20240621$20240705$EXP$$US-TEVA-VS-3209410$TEVA$Trinkino B, Ma NS. Treatment of a young child with multicentric carpotarsal osteolysis exhibiting joint inflammation and dysfunctional bone formation. Bone-Rep 2023; 19.; Trinkino B, Ma NS. Treatment of a young child with multicentric carpotarsal osteolysis exhibiting joint inflammation and dysfunctional bone formation. Bone-Rep 2023; 19.; Trinkino B, Ma NS. Treatment of a young child with multicentric carpotarsal osteolysis exhibiting joint inflammation and dysfunctional bone formation. Bone...$4$YR$$F$Y$$$20240705$$HP$US$US
239977443$23997744$3$F$20240618$20240913$20240621$20240916$PER$$US-AMGEN-USASP2024121308$AMGEN$$76$YR$E$M$Y$$$20240916$$MD$US$US
239977463$23997746$3$F$$20240820$20240621$20240830$EXP$$US-GSK-US2024AMR072949$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
239977532$23997753$2$F$20240410$20240625$20240621$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-029701$AUROBINDO$$78$YR$$M$Y$77$KG$20240703$$MD$FR$FR
239977554$23997755$4$F$$20240705$20240621$20240712$EXP$$US-ROCHE-10000002522$ROCHE$Gilani S, Rifai Z, Singanallur P, Song M. Prolonged COVID-19 pneumonia in a patient on obinutuzumab for treatment of follicular lymphoma [Abstract number: C44]. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:A5676.$62$YR$A$M$Y$$$20240712$$HP$US$US
239977602$23997760$2$F$20240501$20240621$20240621$20240702$EXP$$DE-CELLTRION INC.-2024DE014889$CELLTRION$$$$$$Y$$$20240702$$MD$DE$DE
239977643$23997764$3$F$$20240906$20240621$20240917$EXP$$JP-UCBSA-2024030610$UCB$Aoyama H, Kawaguchi R, Fujimoto H, Kokubo T. A case of movement disorder and poor oral intake caused by levetiracetam. No To Hattatsu. 2024;56(S):S349$26$YR$$F$Y$$$20240917$$MD$JP$JP
239977662$23997766$2$F$$20240612$20240621$20240701$EXP$$US-BEH-2024173822$CSL BEHRING$$$$A$F$Y$$$20240701$$HP$US$US
239977802$23997780$2$F$20240601$20240628$20240621$20240702$EXP$$US-UCBSA-2024031304$UCB$$48$YR$$F$Y$$$20240702$$MD$US$US
239977855$23997785$5$F$20240613$20240726$20240621$20240805$30DAY$$US-JNJFOC-20240638585$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240805$$CN$US$US
239977982$23997798$2$F$20231001$20240701$20240621$20240704$EXP$$IT-ESPERIONTHERAPEUTICS-2024ITA00933$ESPERION THERAPEUTICS$Sbrana F, Bigazzi F, Corciulo C, Dal?Pino B. A therapeutic cooperation by?bempedoic acid and?proprotein convertase subtilisin/kexin type 9 inhibitors in?statin intolerance inherited dyslipidemias. Internal and Emergency Medicine. 2024$79$YR$$F$Y$$$20240704$$MD$IT$IT
239978044$23997804$4$F$20240701$20240828$20240621$20240828$PER$$NVSC2024US127604$NOVARTIS$$31$YR$$F$Y$$$20240828$$CN$US$US
239978144$23997814$4$F$$20240820$20240621$20240824$PER$$US-AMGEN-USASP2024121347$AMGEN$$82$YR$E$M$Y$$$20240824$$CN$US$US
239978164$23997816$4$F$20240318$20240710$20240621$20240712$EXP$$FR-JAZZ PHARMACEUTICALS-2024-FR-005167$JAZZ$$$$$$Y$$$20240712$$MD$FR$FR
239978172$23997817$2$F$$20240620$20240621$20240722$PER$$NVSC2024US129446$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
239978182$23997818$2$F$$20240621$20240621$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002822$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
239978202$23997820$2$F$$20240416$20240621$20240806$EXP$$CA-HALEON-2168688$Haleon PLC$$$$$F$Y$$$20240805$$HP$CA$CA
239978242$23997824$2$F$20220101$20240620$20240621$20240813$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194200$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$71.5$KG$20240813$$CN$ES$ES
239978302$23997830$2$F$$20240816$20240621$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202406012769$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240821$$CN$US$US
239978512$23997851$2$F$20240501$20240813$20240621$20240904$PER$$CA-TOLMAR, INC.-24CA049765$TOLMAR$$75$YR$$M$Y$$$20240904$$PH$CA$CA
239978682$23997868$2$F$$20240722$20240621$20240730$EXP$$GB-CELLTRION INC.-2024GB014929$CELLTRION$$$$$$Y$$$20240730$$CN$GB$GB
239978732$23997873$2$F$20240101$20240723$20240621$20240801$PER$$US-SA-2024SA175064$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240801$$CN$US$US
239978822$23997882$2$F$$20240729$20240621$20240801$PER$$US-ALXN-202406USA001000US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
239978853$23997885$3$F$20240318$20240709$20240621$20240723$EXP$GB-MHRA-MED-202406072253334710-KPMDR$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-12607$ALKEM$$24$YR$$M$Y$78$KG$20240723$$CN$GB$GB
239978892$23997889$2$F$$20240708$20240621$20240712$EXP$$JP-JNJFOC-20240651636$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240712$$MD$JP$JP
239979063$23997906$3$F$$20240829$20240621$20240904$PER$$NVSC2024US128975$NOVARTIS$$$$$F$Y$$$20240904$$MD$US$US
239979082$23997908$2$F$$20240914$20240621$20240915$PER$$US-ALXN-202406USA000999US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
239979103$23997910$3$F$20240208$20240701$20240621$20240709$EXP$$PL-CELLTRION INC.-2024PL014869$CELLTRION$$$$$$Y$$$20240709$$MD$PL$PL
239979114$23997911$4$F$$20240705$20240621$20240712$PER$$US-ROCHE-10000001506$ROCHE$Gomez R, Lin G, Golts E, Lin C, Kafi A, Yung G, et al. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024-May;(209):A3706.$31$YR$A$F$Y$$$20240712$$HP$US$US
239979223$23997922$3$F$20240721$20240730$20240621$20240801$EXP$$US-SA-2024SA176453$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240801$$MD$US$US
239979242$23997924$2$F$$20240625$20240621$20240704$PER$$US-SA-2024SA182701$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240704$$CN$US$US
239979262$23997926$2$F$20240201$20240903$20240621$20240905$EXP$$JP-TAKEDA-2024TJP005585$TAKEDA$$9$DEC$$M$Y$$$20240905$$MD$JP$JP
239979342$23997934$2$F$20240501$20240627$20240621$20240703$EXP$$NVSC2024AR055076$NOVARTIS$$39$YR$$F$Y$$$20240703$$CN$AR$AR
239979372$23997937$2$F$$20240729$20240621$20240801$PER$$US-ALXN-202406USA000991US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
239979383$23997938$3$F$$20240809$20240621$20240813$EXP$$US-GILEAD-2024-0677876$GILEAD$$$$E$F$Y$$$20240813$$CN$US$US
239979473$23997947$3$F$20240618$20240624$20240621$20240704$PER$$US-AMGEN-USASP2024121757$AMGEN$$79$YR$E$M$Y$$$20240704$$CN$US$US
239979502$23997950$2$F$$20240611$20240621$20240925$PER$$US-ABBVIE-5801326$ABBVIE$$21$YR$$F$Y$$$20240925$$CN$US$US
239979542$23997954$2$F$$20240702$20240621$20240709$30DAY$$US-GSK-US2024072528$GLAXOSMITHKLINE$$70$YR$$M$Y$$$20240709$$CN$US$US
239979564$23997956$4$F$20240531$20240717$20240621$20240725$30DAY$$US-JNJFOC-20240642574$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240725$$CN$US$US
239979642$23997964$2$F$20240101$20240620$20240621$20240702$PER$$US-SA-2024SA176486$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240702$$MD$US$US
239979702$23997970$2$F$$20240628$20240621$20240709$PER$$US-SA-2024SA178560$SANOFI AVENTIS$$13$YR$T$F$Y$42$KG$20240709$$MD$US$US
239979713$23997971$3$F$20220518$20240718$20240621$20240727$EXP$$US-SA-2024SA178221$SANOFI AVENTIS$$37$YR$A$M$Y$91.2$KG$20240727$$CN$US$US
239979733$23997973$3$F$20240531$20240904$20240621$20240920$PER$$US-SA-2024SA176939$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240920$$MD$US$US
239979772$23997977$2$F$20240616$20240624$20240621$20240702$PER$$US-AMGEN-USASP2024120939$AMGEN$$93$YR$E$F$Y$$$20240702$$MD$US$US
239979782$23997978$2$F$$20240628$20240621$20240704$PER$$US-AMGEN-USASP2024119380$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
239979792$23997979$2$F$20240403$20240716$20240621$20240726$EXP$$JP-ROCHE-10000003765$ROCHE$$79$YR$E$M$Y$57.3$KG$20240726$$MD$JP$JP
239979832$23997983$2$F$20240501$20240730$20240621$20240808$PER$$US-SA-2024SA042218$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240808$$MD$US$US
239979842$23997984$2$F$20240101$20240911$20240621$20240919$PER$$US-SA-2024SA181477$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240919$$MD$US$US
239979872$23997987$2$F$$20240729$20240621$20240729$PER$$US-ALXN-202406USA001052US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
239979903$23997990$3$F$20240528$20240726$20240621$20240730$PER$$US-JNJFOC-20240648762$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240730$$HP$US$US
239979952$23997995$2$F$20240101$20240626$20240621$20240702$PER$$US-AMGEN-USASP2024121353$AMGEN$$73$YR$E$M$Y$$$20240702$$CN$US$US
239980002$23998000$2$F$$20240702$20240621$20240703$PER$$NVSC2024US129576$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
239980014$23998001$4$F$20240601$20240718$20240621$20240723$30DAY$$US-AMGEN-USASL2024118574$AMGEN$$41$YR$A$F$Y$132$KG$20240722$$PH$US$US
239980022$23998002$2$F$$20240903$20240621$20240911$30DAY$$US-GSK-US2024072572$GLAXOSMITHKLINE$$$$$F$Y$$$20240911$$CN$US$US
239980044$23998004$4$F$$20240903$20240621$20240910$30DAY$$US-GSK-US2024073098$GLAXOSMITHKLINE$$$$$F$Y$$$20240910$$HP$US$US
239980114$23998011$4$F$20240614$20240724$20240621$20240729$30DAY$$US-AMGEN-USASP2024119753$AMGEN$$55$YR$A$M$Y$77.098$KG$20240729$$HP$US$US
239980122$23998012$2$F$20240604$20240625$20240621$20240701$30DAY$$US-AMGEN-USASL2024118857$AMGEN$$53$YR$A$M$Y$$$20240701$$PH$US$US
239980142$23998014$2$F$20240615$20240826$20240621$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099627$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$50.35$KG$20240903$$PH$US$US
239980223$23998022$3$F$$20240801$20240621$20240806$EXP$DE-ARISTO PHARMA-CLIN202004061-L2A-125317$DE-SANDOZ INC.-SDZ2024DE059208$SANDOZ$Blassmann U, Bockler D, Hoppe-Tichy T. The challenge of peripheral occlusive artery disease: Anticoagulants, antibiotics and analgesics pose a high interaction risk. Dtsch-Apoth-Ztg. 2019;A33:159(51)$55$YR$$M$Y$$$20240806$$PH$DE$DE
239980283$23998028$3$F$20240617$20240725$20240621$20240730$PER$$US-JNJFOC-20240650777$JOHNSON AND JOHNSON$$41$YR$A$F$Y$100.79$KG$20240730$$HP$US$US
239980353$23998035$3$F$20240605$20240705$20240621$20240710$PER$$US-AMGEN-USASP2024118663$AMGEN$$$$$$Y$$$20240710$$HP$US$US
239980372$23998037$2$F$$20240703$20240621$20240708$PER$$US-AMGEN-USASP2024121833$AMGEN$$$$$M$Y$$$20240708$$HP$US$US
239980383$23998038$3$F$20240528$20240725$20240621$20240731$30DAY$$US-AMGEN-USASP2024118793$AMGEN$$74$YR$E$M$Y$94.1$KG$20240731$$HP$US$US
239980402$23998040$2$F$$20240917$20240621$20240927$PER$$US-GSK-US2024AMR076274$GLAXOSMITHKLINE$$$$$F$Y$50.34$KG$20240927$$CN$US$US
239980452$23998045$2$F$20240410$20240722$20240621$20240807$PER$$US-AstraZeneca-2024A142837$ASTRAZENECA$$53$YR$$F$Y$93.9$KG$20240807$$CN$US$
239980492$23998049$2$F$20240607$20240624$20240621$20240701$30DAY$$US-AMGEN-USASP2024120084$AMGEN$$65$YR$E$M$Y$$$20240701$$HP$US$US
239980525$23998052$5$F$$20240716$20240621$20240723$EXP$$CA-ROCHE-10000003216$ROCHE$$$$A$F$Y$$$20240723$$CN$CA$CA
239980552$23998055$2$F$20240501$20240709$20240621$20240711$EXP$$US-UCBSA-2024031043$UCB$$45$YR$$F$Y$$$20240711$$HP$US$US
239980572$23998057$2$F$20240612$20240624$20240621$20240701$PER$$US-BIOGEN-2024BI01269682$BIOGEN$$$$$M$Y$$$20240701$$CN$US$US
239980593$23998059$3$F$$20240730$20240621$20240821$EXP$$US-GILEAD-2024-0677868$GILEAD$$57$YR$A$M$Y$94.8$KG$20240821$$CN$US$US
239980623$23998062$3$F$$20240823$20240621$20240903$EXP$$CA-CELLTRION INC.-2024CA014980$CELLTRION$$$$$$Y$$$20240903$$CN$CA$CA
239980643$23998064$3$F$20240501$20240624$20240621$20240702$EXP$$BR-CELLTRION INC.-2024BR014847$CELLTRION$$$$$$Y$$$20240702$$CN$BR$BR
239980693$23998069$3$F$20240101$20240816$20240621$20240823$EXP$$US-BIOGEN-2024BI01261666$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
239980704$23998070$4$F$20240611$20240820$20240621$20240827$EXP$$TW-BIOGEN-2024BI01270293$BIOGEN$$23$YR$$M$Y$60$KG$20240827$$HP$TW$TW
239980755$23998075$5$F$20240601$20240909$20240621$20240917$EXP$$CA-CELLTRION INC.-2024CA015111$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
239980762$23998076$2$F$20240602$20240625$20240621$20240701$EXP$$JP-JNJFOC-20240651481$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240701$$PH$JP$JP
239980814$23998081$4$F$$20240716$20240621$20240726$30DAY$$US-JNJFOC-20240641772$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$CN$US$US
239980842$23998084$2$F$$20240819$20240621$20240822$PER$$US-ROCHE-10000002260$ROCHE$$$$$$Y$$$20240822$$HP$US$US
239980922$23998092$2$F$$20240702$20240621$20240703$PER$$NVSC2024US129735$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
239980942$23998094$2$F$20240101$20240730$20240621$20240803$PER$$US-AMGEN-USASP2024121607$AMGEN$$81$YR$E$M$Y$$$20240803$$CN$US$US
239980952$23998095$2$F$$20240712$20240621$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-029900$AUROBINDO$Krishna V, Mindel J, Sammartino F, Block C, Dwivedi AK, VanGompel JJ, et al. A phase 1 open- label trial evaluating focused ultrasound unilateral anterior thalamotomy for focal onset epilepsy. Epilepsia. 2023;64:831-842$57$YR$$M$Y$$$20240722$$HP$US$US
239980962$23998096$2$F$20240618$20240809$20240621$20240813$PER$$US-AMGEN-USASP2024121762$AMGEN$$61$YR$A$M$Y$$$20240813$$CN$US$US
239981042$23998104$2$F$20240519$20240703$20240621$20240705$EXP$$US-GSK-US2024075648$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$HP$US$US
239981063$23998106$3$F$20231101$20240823$20240621$20240902$30DAY$$US-GSK-US2024072548$GLAXOSMITHKLINE$$56$YR$$M$Y$$$20240902$$CN$US$US
239981082$23998108$2$F$$20240626$20240621$20240705$EXP$$US-TEVA-VS-3210014$TEVA$Crume M, Scoville S, Schwartz D, Seabrook R. Post-Repair Pulmonary Hemorrhage in a Neonate with Congenital Diaphragmatic Hernia (CDH). ASAIO-J 2024; 70 (Suppl. 2) 66 abstr. 66.; Crume M, Scoville S, Schwartz D, Seabrook R. Post-Repair Pulmonary Hemorrhage in a Neonate with Congenital Diaphragmatic Hernia (CDH). ASAIO-J 2024; 70 (Suppl. 2) 66 abstr. 66.$7$DY$$F$Y$$$20240705$$HP$US$US
239981092$23998109$2$F$20240101$20240918$20240621$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097652$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240918$$MD$US$US
239981102$23998110$2$F$$20240722$20240621$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097449$BRISTOL MYERS SQUIBB$Mosquera GS, Brazee T, Ogbonna S. A fatal case of diffuse alveolar hemorrhage in a patient on apixaban for occlusive extensive internal jugular thrombus. American Journal of Respiratory and Critical Care Medicine. 2024 May 01;209:A5576.$55$YR$A$F$Y$$$20240725$$HP$US$US
239981112$23998111$2$F$$20240709$20240621$20240716$EXP$$DE-LEO Pharma-366808$LEO PHARM$$$$A$M$Y$$$20240716$$MD$DE$DE
239981182$23998118$2$F$20240101$20240729$20240621$20240801$EXP$$AR-JNJFOC-20240638701$JOHNSON AND JOHNSON$$67$YR$E$F$Y$76$KG$20240801$$CN$AR$AR
239981254$23998125$4$F$20240604$20240710$20240621$20240715$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-097112$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240715$$PH$JP$JP
239981333$23998133$3$F$20240301$20240708$20240621$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035191$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240715$$CN$US$US
239981424$23998142$4$F$20200401$20240822$20240621$20240828$EXP$$US-ABBVIE-5804431$ABBVIE$$67$YR$$F$Y$73$KG$20240828$$HP$US$US
239981482$23998148$2$F$20230601$20240703$20240621$20240711$EXP$$JP-AMGEN-JPNSP2024118993$AMGEN$$$$$F$Y$$$20240710$$HP$JP$JP
239981493$23998149$3$F$20240101$20240909$20240621$20240917$EXP$$CA-CELLTRION INC.-2024CA014844$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
239981514$23998151$4$F$20240101$20240911$20240621$20240930$EXP$$JP-AMGEN-JPNSP2024119857$AMGEN$$66$YR$E$F$Y$50$KG$20240930$$MD$JP$JP
239981584$23998158$4$F$$20240923$20240621$20240926$EXP$$CH-TAKEDA-2024TUS060894$TAKEDA$$$$E$M$Y$$$20240926$$CN$CH$CH
239981662$23998166$2$F$$20240910$20240621$20240912$EXP$$JP-GILEAD-2024-0677898$GILEAD$Watanabe T, Hirama T, Akiba M, Watanabe T, Watanabe Y, Oishi H, et al.. COVID-19 pneumonia in lung transplant recipients: understanding risk factors and treatment outcomes in Japan.. Clinical + Experimental Medicine. 2024;24(1):1-9. doi:10.1007/s10238-024-01388-y$57$YR$A$F$Y$$$20240912$$MD$JP$JP
239981682$23998168$2$F$$20240712$20240621$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-029448$AUROBINDO$Botero L, McNeill K, Makower D. Axial Neuropathy in Two Breast Cancer Patients receiving Fam-trastuzumab deruxtecan. Cancer-Res. 2024;84 (Suppl.)(9):PO3-12-12$56$YR$$F$Y$$$20240722$$HP$US$US
239981832$23998183$2$F$$20240813$20240621$20240814$PER$$NVSC2024US129255$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
239981862$23998186$2$F$20240614$20240711$20240621$20240716$30DAY$$US-AMGEN-USASP2024120823$AMGEN$$$$$M$Y$$$20240716$$HP$US$US
239982052$23998205$2$F$20230725$20240925$20240621$20240930$EXP$$KR-TAKEDA-2024TUS060251$TAKEDA$$39$YR$$F$Y$43.2$KG$20240930$$MD$KR$KR
239982123$23998212$3$F$20240610$20240906$20240621$20240912$EXP$$JP-JNJFOC-20240638193$JOHNSON AND JOHNSON$$69$YR$E$M$Y$56$KG$20240912$$HP$JP$JP
239982142$23998214$2$F$20240501$20240618$20240621$20240701$PER$$US-LEO Pharma-371309$LEO PHARM$$$$$F$Y$$$20240625$$CN$US$US
239982162$23998216$2$F$$20240624$20240621$20240702$EXP$$GB-TAKEDA-2024TUS059568$TAKEDA$$$$E$M$Y$$$20240702$$CN$GB$GB
239982183$23998218$3$F$20240501$20240716$20240621$20240731$EXP$$US-TEVA-VS-3210285$TEVA$$72$YR$$F$Y$$$20240731$$MD$US$US
239982242$23998224$2$F$20240614$20240703$20240621$20240708$30DAY$$US-AMGEN-USASP2024120587$AMGEN$$55$YR$A$F$Y$70$KG$20240708$$PH$US$US
239982252$23998225$2$F$20240615$20240628$20240621$20240702$PER$$US-AMGEN-USASP2024121017$AMGEN$$90$YR$E$F$Y$$$20240702$$CN$US$US
239982292$23998229$2$F$$20240621$20240621$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05181$LUPIN$$$$$$Y$$$20240702$$CN$US$US
239982343$23998234$3$F$20240101$20240913$20240621$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-018174$UNITED THERAPEUTICS$$$$$F$Y$56.236$KG$20240921$$$US$US
239982365$23998236$5$F$20201203$20240802$20240621$20240812$EXP$$CA-TAKEDA-2024TUS060579$TAKEDA$$66$YR$$M$Y$$$20240812$$MD$CA$CA
239982373$23998237$3$F$20240613$20240729$20240621$20240730$EXP$$US-TAKEDA-2024TUS034989$TAKEDA$$54$YR$$M$Y$$$20240730$$CN$US$US
239982384$23998238$4$F$20240617$20240626$20240621$20240704$PER$$US-AMGEN-USASP2024121722$AMGEN$$56$YR$A$F$Y$66.667$KG$20240704$$HP$US$US
239982392$23998239$2$F$20240601$20240910$20240621$20240917$PER$$US-ABBVIE-5802824$ABBVIE$$64$YR$$F$Y$$$20240917$$CN$US$US
239982442$23998244$2$F$20240723$20240723$20240621$20240726$EXP$$CA-TAKEDA-2024TUS060572$TAKEDA$$47$YR$$F$Y$$$20240726$$CN$CA$CA
239982472$23998247$2$F$$20240621$20240621$20240701$EXP$$CA-TAKEDA-2024TUS057424$TAKEDA$$$$$F$Y$$$20240701$$HP$CA$CA
239982502$23998250$2$F$$20240712$20240621$20240718$PER$$US-BIOGEN-2024BI01269814$BIOGEN$$$$$F$Y$$$20240718$$CN$US$US
239982543$23998254$3$F$$20240722$20240621$20240724$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035299$BOEHRINGER INGELHEIM$$6$DEC$A$M$Y$$$20240724$$MD$JP$JP
239982602$23998260$2$F$$20240626$20240621$20240706$EXP$$CA-TEVA-VS-3203417$TEVA$Gandhi P, Healy D, Bozinoff N. Severe alcohol use disorder after initiation of selective serotonin reuptake inhibitor therapy. CMAJ 2023; 195 (40): E1380-E1382.; Gandhi P, Healy D, Bozinoff N. Severe alcohol use disorder after initiation of selective serotonin reuptake inhibitor therapy. CMAJ 2023; 195 (40): E1380-E1382.; Gandhi P, Healy D, Bozinoff N. Severe alcohol use disorder after initiation of selective serotonin reuptake inhibitor therapy. CMAJ 2023; 195 (40): E1380-E1382.$52$YR$$F$Y$$$20240706$$HP$CA$CA
239982672$23998267$2$F$20240618$20240813$20240621$20240815$PER$$US-AMGEN-USASP2024121286$AMGEN$$63$YR$A$F$Y$$$20240815$$CN$US$US
239982722$23998272$2$F$$20240611$20240621$20240703$EXP$$US-ROCHE-10000002712$ROCHE$$77$YR$E$M$Y$$$20240703$$CN$US$US
239982863$23998286$3$F$20240605$20240814$20240621$20240821$EXP$$CA-CELLTRION INC.-2024CA014842$CELLTRION$$$$$$Y$$$20240821$$CN$CA$CA
239982902$23998290$2$F$20240613$20240925$20240621$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US058545$SANDOZ$$22$YR$$M$Y$$$20240930$$CN$US$US
239983015$23998301$5$F$20240101$20240725$20240621$20240803$EXP$$CA-CELLTRION INC.-2024CA014977$CELLTRION$$$$$$Y$$$20240803$$CN$CA$CA
239983022$23998302$2$F$$20240730$20240621$20240807$EXP$$US-AstraZeneca-2024A139820$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
239983083$23998308$3$F$20240610$20240709$20240621$20240715$EXP$$JP-ASTELLAS-2024JP004194$ASTELLAS$$8$DEC$$M$Y$$$20240715$$MD$JP$JP
239983092$23998309$2$F$$20240708$20240621$20240711$EXP$$JP-ASTELLAS-2024JP004195$ASTELLAS$$5$DEC$$F$Y$$$20240711$$PH$JP$JP
239983182$23998318$2$F$20240612$20240626$20240621$20240705$EXP$$FR-TEVA-VS-3209713$TEVA$$80$YR$$F$Y$$$20240705$$CN$FR$FR
239983203$23998320$3$F$20240101$20240725$20240621$20240801$EXP$$CA-CELLTRION INC.-2024CA014944$CELLTRION$$$$$$Y$$$20240801$$CN$CA$CA
239983252$23998325$2$F$20240607$20240705$20240621$20240712$PER$$US-ROCHE-10000002335$ROCHE$$$$$F$Y$$$20240712$$CN$US$US
239983322$23998332$2$F$20240618$20240805$20240621$20240807$PER$$US-AMGEN-USASP2024122174$AMGEN$$64$YR$A$M$Y$$$20240807$$CN$US$US
239983362$23998336$2$F$20240101$20240916$20240621$20240924$PER$$US-SA-2024SA182442$SANOFI AVENTIS$$33$YR$A$F$Y$122$KG$20240924$$MD$US$US
239983412$23998341$2$F$$20240909$20240621$20240918$PER$$US-SA-2024SA087152$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240918$$MD$US$US
239983452$23998345$2$F$20210101$20240805$20240621$20240812$EXP$$US-HORIZON THERAPEUTICS-HZN-2021-003001$AMGEN$$70$YR$E$F$Y$55.782$KG$20240812$$MD$US$US
239983582$23998358$2$F$$20240718$20240621$20240722$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035306$BOEHRINGER INGELHEIM$$56$YR$A$M$Y$$$20240722$$MD$JP$JP
239983723$23998372$3$F$$20240625$20240621$20240703$EXP$$CA-TOLMAR, INC.-24CA050296$TOLMAR$$$$$M$Y$$$20240703$$CN$CA$CA
239983773$23998377$3$F$20230101$20240913$20240621$20240919$EXP$$CO-ABBVIE-5808352$ABBVIE$$$$$F$Y$63$KG$20240919$$CN$CO$CO
239983962$23998396$2$F$20190502$20240712$20240621$20240716$EXP$$CA-TAKEDA-2019TUS001744$TAKEDA$$33$YR$$M$Y$$$20240716$$CN$CA$CA
239984292$23998429$2$F$20240601$20240701$20240621$20240705$EXP$$US-AstraZeneca-2024A140372$ASTRAZENECA$$26081$DY$$M$Y$117$KG$20240705$$HP$US$
239984322$23998432$2$F$$20240820$20240621$20240826$EXP$$RE-AstraZeneca-2024A140651$ASTRAZENECA$$$$A$F$Y$$$20240826$$MD$FR$
239984382$23998438$2$F$20240401$20240610$20240621$20240705$PER$$US-ROCHE-10000000872$ROCHE$$66$YR$E$F$Y$46.72$KG$20240705$$CN$US$US
239984453$23998445$3$F$$20240912$20240621$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05197$LUPIN$$$$$$Y$$$20240930$$CN$US$US
239984487$23998448$7$F$$20240807$20240621$20240809$PER$$US-ROCHE-10000001677$ROCHE$$$$$$Y$$$20240809$$HP$US$US
239984552$23998455$2$F$$20240611$20240621$20240723$PER$$US-ROCHE-10000003263$ROCHE$$$$$$Y$$$20240723$$CN$US$US
239984562$23998456$2$F$$20240729$20240621$20240801$PER$$US-ALXN-202406USA000945US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
239984602$23998460$2$F$20240313$20240626$20240621$20240704$EXP$$JP-ARDELYX-2024ARDX004423$ARDELYX$$36$YR$$F$Y$$$20240704$$MD$JP$JP
239984642$23998464$2$F$$20240718$20240621$20240727$EXP$$JP-ROCHE-10000002201$ROCHE$KIMOTO , Tomioka A, Yoshioka M, Ando Y, Esaki K, Kawabata K. A case of emphysematous gastritis with portal venous gas which improved with conservative treatment. Progress of Digestive Endoscopy/The 118th Regular Meeting of Japan Gastroenterol. 2024;105:s114.$6$DEC$A$M$Y$$$20240727$$MD$JP$JP
239984772$23998477$2$F$20240510$20240627$20240621$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002628$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240723$$CN$US$US
239984782$23998478$2$F$$20240910$20240621$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002629$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
239984892$23998489$2$F$$20240621$20240621$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002625$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
239985034$23998503$4$F$20240614$20240729$20240621$20240731$PER$$US-JNJFOC-20240638628$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240731$$PH$US$US
239985072$23998507$2$F$$20240624$20240621$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05143$LUPIN$$$$$$Y$$$20240705$$CN$US$US
239985092$23998509$2$F$20240514$20240706$20240621$20240710$EXP$$HU-TAKEDA-2024TUS060542$TAKEDA$$64$YR$$M$Y$82$KG$20240710$$CN$HU$HU
239985152$23998515$2$F$20240601$20240627$20240621$20240704$PER$$US-BIOGEN-2024BI01269794$BIOGEN$$35$YR$$F$Y$$$20240704$$CN$US$US
239985172$23998517$2$F$$20240711$20240621$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099142$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240715$$CN$US$US
239985263$23998526$3$F$20231101$20240726$20240621$20240730$PER$$US-BIOGEN-2024BI01244820$BIOGEN$$61$YR$$M$Y$$$20240730$$CN$US$US
239985402$23998540$2$F$20240401$20240712$20240621$20240719$PER$$US-ALXN-202406USA000867US$ALEXION PHARMACEUTICALS$$29$YR$$F$Y$$$20240719$$MD$US$US
239985512$23998551$2$F$$20240812$20240621$20240819$EXP$$US-ABBVIE-5807951$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
239985642$23998564$2$F$20240610$20240701$20240621$20240709$EXP$$TW-JNJFOC-20240656707$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240709$$MD$TW$TW
239985662$23998566$2$F$20240101$20240913$20240621$20240918$PER$$US-SA-2024SA183384$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240918$$MD$US$US
239985742$23998574$2$F$20240614$20240719$20240621$20240730$PER$$US-SA-2024SA182319$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240730$$MD$US$US
239985773$23998577$3$F$$20240830$20240621$20240911$EXP$$US-ALVOGEN-2024094335$ALVOGEN$$$$$M$Y$$$20240911$$PH$US$US
239985832$23998583$2$F$$20240730$20240621$20240807$PER$$US-AstraZeneca-2024A141894$ASTRAZENECA$$$$A$$Y$$$20240807$$HP$US$
239985933$23998593$3$F$20240501$20240805$20240621$20240807$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-095677$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$55$KG$20240807$$HP$DE$DE
239985942$23998594$2$F$$20240720$20240621$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05141$LUPIN$$$$$$Y$$$20240816$$CN$US$US
239986142$23998614$2$F$$20240717$20240621$20240721$EXP$$NVSC2024US128328$NOVARTIS$$$$$M$Y$$$20240721$$CN$US$US
239986192$23998619$2$F$$20240715$20240621$20240722$30DAY$$IT-JNJFOC-20240644532$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$IT$IT
239986202$23998620$2$F$20240506$20240715$20240621$20240724$EXP$$GR-CELLTRION INC.-2024GR014932$CELLTRION$$$$$$Y$$$20240724$$CN$GR$GR
239986232$23998623$2$F$$20240618$20240621$20240807$EXP$$NVSC2024US018657$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
239986242$23998624$2$F$$20240717$20240621$20240724$PER$$NVSC2024US129246$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
239986263$23998626$3$F$20240521$20240916$20240621$20240918$EXP$FR-AFSSAPS-SE2024000472$FR-ORGANON-O2406FRA001630$ORGANON$$74$YR$$F$Y$74$KG$20240918$$PH$FR$FR
239986342$23998634$2$F$20230428$20240723$20240621$20240728$EXP$$JP-ABBVIE-4705385$ABBVIE$$74$YR$$M$Y$70$KG$20240728$$MD$JP$JP
239986412$23998641$2$F$20240501$20240712$20240621$20240725$EXP$$US-UCBSA-2024031560$UCB$$32$YR$$M$Y$$$20240725$$HP$US$US
239986442$23998644$2$F$20240506$20240903$20240621$20240906$EXP$$IT-ABBVIE-5808061$ABBVIE$$46$YR$$M$Y$66$KG$20240906$$MD$IT$IT
239986653$23998665$3$F$20240520$20240701$20240621$20240704$EXP$$BR-UCBSA-2024031589$UCB$$39$YR$$F$Y$80$KG$20240704$$CN$BR$BR
239986662$23998666$2$F$20220501$20240904$20240621$20240919$PER$$US-SA-2024SA178168$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240919$$MD$US$US
239986672$23998667$2$F$$20240626$20240621$20240705$PER$$US-SA-2024SA002443$SANOFI AVENTIS$$49$YR$A$M$Y$78.01$KG$20240705$$MD$US$US
239986732$23998673$2$F$20240615$20240805$20240621$20240809$EXP$$NVSC2024US129290$NOVARTIS$$30$YR$$F$Y$84.09$KG$20240809$$MD$US$US
239986782$23998678$2$F$$20240911$20240621$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100141$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$94.8$KG$20240913$$CN$US$US
239986864$23998686$4$F$20161114$20240916$20240621$20240923$EXP$$CA-TAKEDA-2024TUS060783$TAKEDA$$66$YR$$F$Y$$$20240923$$CN$CA$CA
239986942$23998694$2$F$$20240725$20240621$20240802$30DAY$$US-GSK-US2024072693$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$CN$US$US
239986952$23998695$2$F$20240501$20240725$20240621$20240801$EXP$$US-GSK-US2024074414$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
239986972$23998697$2$F$20240101$20240725$20240621$20240726$EXP$$US-UCBSA-2024019466$UCB$$$$$M$Y$$$20240726$$CN$US$US
239987032$23998703$2$F$$20240628$20240621$20240709$PER$$US-SA-2024SA180880$SANOFI AVENTIS$$7$YR$C$F$Y$27$KG$20240709$$MD$US$US
239987052$23998705$2$F$20240101$20240712$20240621$20240718$PER$$US-SA-2024SA180293$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240718$$MD$US$US
239987245$23998724$5$F$20240415$20240827$20240621$20240827$EXP$$FR-JNJFOC-20240417258$JOHNSON AND JOHNSON$$79$YR$E$M$Y$70$KG$20240828$$MD$FR$FR
239987292$23998729$2$F$20240401$20240626$20240621$20240705$EXP$$US-EMD Serono-2024032580$EMD SERONO INC$$62$YR$A$F$Y$$$20240705$$CN$US$US
239987312$23998731$2$F$20240501$20240704$20240621$20240712$EXP$$RO-AstraZeneca-2024A141461$ASTRAZENECA$$69$YR$$F$Y$$$20240712$$CN$RO$
239987372$23998737$2$F$20240410$20240625$20240621$20240704$EXP$FR-AFSSAPS-NY2024000650$FR-Accord-430588$ACCORD$$78$YR$E$M$Y$77$KG$20240704$$MD$FR$FR
239987402$23998740$2$F$$20240620$20240621$20240701$EXP$$JP-Accord-428072$ACCORD$Matsumura Y, Sato S, Haji K, Masuda T, Yoneda H, Ogino H, et al. A case of pleural mesothelioma with immunohistochemical staining positive for Krebs von den Lungen-6. Respiratory Medicine Case Reports. 2024;50:102040$71$YR$E$M$Y$52.25$KG$20240701$$MD$JP$JP
239987412$23998741$2$F$$20240702$20240621$20240711$EXP$$US-Accord-430545$ACCORD$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series. Pediatr Nephrol. 2024 Jun 6.$6$YR$C$F$Y$24.5$KG$20240711$$HP$US$US
239987452$23998745$2$F$$20240823$20240621$20240826$EXP$$NVSC2024US129200$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
239987542$23998754$2$F$$20240626$20240621$20240706$EXP$$PT-TEVA-VS-3209436$TEVA$Mariana F. Cardoso, Rita Carvalho, F?bio Pereira Correia, Joana C. Branco, Mariana Nuno Costa, Alexandra Martins; Autoimmune Hepatitis Induced by Hepatitis Delta Virus: A Conundrum. GE Port J Gastroenterol 2024-06-04; 31 (3): 203-208.; Mariana F. Cardoso, Rita Carvalho, F?bio Pereira Correia, Joana C. Branco, Mariana Nuno Costa, Alexandra Martins; Autoimmune Hepatitis Induced by Hepatitis Delta Virus: A Conundrum. GE Port J Gastroenterol 2024-06-04; 31 (3): 203-208.$46$YR$$F$Y$45$KG$20240706$$MD$PT$PT
239987562$23998756$2$F$20240629$20240701$20240621$20240710$PER$$US-SA-2024SA182422$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240710$$MD$US$US
239987632$23998763$2$F$$20240716$20240621$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099725$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240718$$CN$US$US
239987702$23998770$2$F$$20240619$20240621$20240701$EXP$$IN-MACLEODS PHARMA-MAC2024047766$MACLEODS$Bedi GN, Acharya S, Kumar S, Mapari SA, Sawant R..Central Pontine Myelinolysis: A Rare and LifeThreatening Adverse Effect of Clobazam and Quetiapine.Cureus.09-MAY-2024;16(5):e60007$$$$$Y$$$20240701$$MD$IN$IN
239987763$23998776$3$F$$20240712$20240621$20240723$30DAY$$FR-JNJFOC-20240614903$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$PH$FR$FR
239987772$23998777$2$F$20231129$20240617$20240621$20240704$EXP$$CN-UCBSA-2023057264$UCB$$37$YR$$F$Y$58$KG$20240704$$MD$CN$CN
239987822$23998782$2$F$20240601$20240626$20240621$20240701$EXP$$US-Merz Pharmaceuticals GmbH-24-02084$MERZ$$39$YR$A$F$Y$$$20240701$$MD$US$US
239987882$23998788$2$F$20240604$20240724$20240621$20240730$EXP$$NVSC2024RU128924$NOVARTIS$$48$YR$$F$Y$$$20240730$$MD$RU$RU
239987903$23998790$3$F$$20240730$20240621$20240809$EXP$$JP-ROCHE-10000004666$ROCHE$Sugimoto T, Mizuta M, Fukui Y, Endo S, Tsubono M. Recurrent Breast Cancer with Pulmonary Lymphangitis Carcinomatosis Case Responding to Trastuzumab Deruxtecan. Japanese Journal of Cancer and Chemotherapy. 2024-May;51 (5):571-4.$40$YR$A$F$Y$$$20240809$$HP$JP$JP
239987943$23998794$3$F$$20240711$20240621$20240717$EXP$$US-GSK-US2024073652$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$US$US
239987982$23998798$2$F$20240101$20240624$20240621$20240709$PER$$US-APOTEX-2024AP007128$APOTEX$$$$$$Y$$$20240709$$CN$US$US
239988082$23998808$2$F$$20240906$20240621$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099777$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240917$$CN$US$US
239988092$23998809$2$F$$20240705$20240621$20240715$EXP$$US-AUROBINDO-AUR-APL-2024-029522$AUROBINDO$Kalra K, Failor RA, Nguyen TT.. Hypercalcemia in a Patient With Gastrointestinal Stromal Tumor (GIST): Evaluation and Treatment Strategies. J-Endocr-Soc. 2022;6 (Suppl. 1):A186-A187 abstr. ODP627$52$YR$$F$Y$$$20240715$$HP$US$US
239988144$23998814$4$F$$20240715$20240621$20240820$EXP$$CA-ROCHE-10000002356$ROCHE$$65$YR$E$F$Y$34$KG$20240820$$MD$CA$CA
239988154$23998815$4$F$20240610$20240731$20240621$20240805$PER$$US-JNJFOC-20240649185$JOHNSON AND JOHNSON$$32$YR$A$$Y$$$20240805$$HP$US$US
239988202$23998820$2$F$20240501$20240620$20240621$20240702$EXP$FR-AFSSAPS-NY2024000676$FR-Accord-430575$ACCORD$$52$YR$A$F$Y$$$20240701$$MD$FR$FR
239988373$23998837$3$F$20240213$20240620$20240621$20240729$EXP$FR-AFSSAPS-PC2024000445$FR-TEVA-VS-3210297$TEVA$$53$YR$$M$Y$104$KG$20240729$$PH$FR$FR
239988382$23998838$2$F$$20240708$20240621$20240712$PER$$US-GILEAD-2024-0677644$GILEAD$$$$A$M$Y$$$20240712$$HP$US$US
239988455$23998845$5$F$20240615$20240722$20240621$20240726$PER$$US-AMGEN-USASP2024120371$AMGEN$$71$YR$E$F$Y$$$20240726$$HP$US$US
239988552$23998855$2$F$20230921$20240620$20240621$20240701$EXP$ES-AEMPS-1532996$ES-Accord-430875$ACCORD$$83$YR$E$F$Y$$$20240701$$MD$ES$ES
239988632$23998863$2$F$20240101$20240709$20240621$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096035$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240717$$HP$US$US
239988662$23998866$2$F$20231029$20240705$20240621$20240717$EXP$ES-EMA-2024509-AUTODUP-1715284073513$ES-Accord-427219$ACCORD$$44$YR$A$M$Y$74$KG$20240717$$MD$ES$ES
239988682$23998868$2$F$20231027$20240621$20240621$20240704$EXP$$JP-ROCHE-10000002466$ROCHE$Mitamura Y, Murakami E, Uchikawa S, Fujino H, Ono A, Kawaoka T. case of acute-onset type 1 diabetes mellitus during the therapy with atezolizumab and bevacizumab for hepatocellular carcinoma [Abstract number: 48]. The 130th Chugoku Regional Meeting of the Japanese Society of Internal Medicine. 2024;$8$DEC$E$M$Y$$$20240704$$MD$JP$JP
239988692$23998869$2$F$20240615$20240816$20240621$20240819$PER$$US-AMGEN-USASP2024119994$AMGEN$$73$YR$E$M$Y$$$20240819$$CN$US$US
239988702$23998870$2$F$20240612$20240814$20240621$20240819$EXP$$GB-AMGEN-GBRSP2024120983$AMGEN$$78$YR$E$F$Y$$$20240819$$CN$GB$GB
239988812$23998881$2$F$$20240712$20240621$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-029985$AUROBINDO$Dima A, Abdelsamie A, Clark-Castillo R, Webb-Wilson H, Shergill SS, Stanton B, et al. Overcoming Obstacles to Clozapine Treatment: A Case of Clozapine Rechallenge in ECT-Resistant Schizophrenia With Catatonic Features.. J-Clin-Psychopharmacol. 2024;44(2):182-185$55$YR$$M$Y$$$20240722$$MD$GB$GB
239988872$23998887$2$F$$20240618$20240621$20240705$PER$$US-AstraZeneca-2024A141988$ASTRAZENECA$$$$$M$Y$$$20240705$$MD$US$
239988882$23998888$2$F$20240616$20240716$20240621$20240722$PER$$US-ALXN-202406USA001040US$ALEXION PHARMACEUTICALS$$37$YR$$F$Y$$$20240722$$CN$US$US
239988902$23998890$2$F$20230601$20240707$20240621$20240708$EXP$$TW-BAYER-2024A089232$BAYER$$75$YR$E$M$Y$$$20240708$$MD$TW$TW
239989013$23998901$3$F$20240618$20240725$20240621$20240725$PER$$US-PFIZER INC-202400196868$PFIZER$$14$YR$$M$Y$$$20240725$$CN$US$US
239989422$23998942$2$F$20240613$20240729$20240621$20240731$PER$$US-JNJFOC-20240639248$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240731$$CN$US$US
239989492$23998949$2$F$20240619$20240805$20240621$20240807$PER$$US-AMGEN-USASP2024122565$AMGEN$$79$YR$E$M$Y$$$20240807$$CN$US$US
239989512$23998951$2$F$$20240721$20240621$20240722$PER$$US-PFIZER INC-202400196276$PFIZER$$39$YR$$M$Y$$$20240722$$MD$US$US
239989522$23998952$2$F$$20240721$20240621$20240722$PER$$US-PFIZER INC-PV202400080940$PFIZER$$63$YR$$F$Y$$$20240722$$CN$US$US
239989552$23998955$2$F$$20240703$20240621$20240709$PER$$US-ROCHE-10000004287$ROCHE$$81$YR$E$F$Y$$$20240708$$CN$US$US
239989603$23998960$3$F$$20240716$20240621$20240722$EXP$GB-MHRA-ADR 28748881$GB-ABBVIE-5808311$ABBVIE$$31$YR$$F$Y$$$20240722$$CN$GB$GB
239989612$23998961$2$F$$20240902$20240621$20240903$EXP$$JP-BAYER-2024A087628$BAYER$$86$YR$E$F$Y$$$20240903$$MD$JP$JP
239989642$23998964$2$F$$20240624$20240621$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05176$LUPIN$$$$$$Y$$$20240704$$CN$US$US
239989684$23998968$4$F$20240202$20240710$20240621$20240715$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-02570$IPSEN$$71$YR$E$F$Y$$$20240715$$MD$CA$CA
239989732$23998973$2$F$$20240723$20240621$20240726$EXP$$US-AMGEN-USASP2024119511$AMGEN$$$$$F$Y$$$20240726$$HP$US$US
239989828$23998982$8$F$20240101$20240806$20240621$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-018385$UNITED THERAPEUTICS$$$$$F$Y$75.737$KG$20240810$$$US$US
239989892$23998989$2$F$$20240708$20240621$20240711$EXP$$NVSC2024US128877$NOVARTIS$$$$$F$Y$$$20240711$$CN$US$US
239990002$23999000$2$F$$20240728$20240621$20240730$30DAY$$NZ-PFIZER INC-202400194675$PFIZER$$48$YR$$F$Y$$$20240730$$CN$NZ$NZ
239990312$23999031$2$F$$20240711$20240621$20240723$EXP$$US-ALVOGEN-2024094699$ALVOGEN$$$$$F$Y$$$20240723$$HP$US$US
239990333$23999033$3$F$20240502$20240809$20240621$20240812$PER$$US-AMGEN-USASP2024120242$AMGEN$$76$YR$E$F$Y$$$20240812$$CN$US$US
239990343$23999034$3$F$$20240719$20240621$20240723$PER$$US-AMGEN-USASP2024120313$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
239990352$23999035$2$F$20240601$20240717$20240621$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098580$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$87.54$KG$20240723$$PH$US$US
239990492$23999049$2$F$20240101$20240710$20240621$20240712$PER$$US-PFIZER INC-PV202400081195$PFIZER$$54$YR$$F$Y$$$20240712$$CN$US$US
239990533$23999053$3$F$20240601$20240730$20240621$20240801$PER$$US-PFIZER INC-202400197372$PFIZER$$78$YR$$F$Y$63.5$KG$20240801$$CN$US$US
239990572$23999057$2$F$20240501$20240725$20240621$20240730$PER$$US-PFIZER INC-202400197849$PFIZER$$42$YR$$M$Y$$$20240730$$HP$US$US
239990622$23999062$2$F$$20240908$20240621$20240913$EXP$$GB-TAKEDA-2024TUS060400$TAKEDA$$$$$F$Y$$$20240913$$CN$GB$GB
239990632$23999063$2$F$$20240905$20240621$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100047$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240906$$HP$US$US
239990652$23999065$2$F$$20240910$20240621$20240912$EXP$$JP-GILEAD-2024-0677900$GILEAD$Watanabe T, Hirama T, Akiba M, Watanabe T, Watanabe Y, Oishi H, et al.. COVID-19 pneumonia in lung transplant recipients: understanding risk factors and treatment outcomes in Japan.. Clinical + Experimental Medicine. 2024;24(1):1-9. doi:10.1007/s10238-024-01388-y$53$YR$A$F$Y$$$20240912$$MD$JP$JP
239990742$23999074$2$F$$20240815$20240621$20240821$EXP$$US-OTSUKA-2024_010424$OTSUKA$$$$$F$Y$$$20240821$$CN$US$US
239990792$23999079$2$F$20240522$20240716$20240621$20240722$EXP$FR-AFSSAPS-AN2024000781$FR-MYLANLABS-2024M1055055$MYLAN$$59$YR$$M$Y$$$20240722$$PH$FR$FR
239990802$23999080$2$F$20240604$20240710$20240621$20240716$EXP$$FR-MYLANLABS-2024M1055070$MYLAN$$$$E$F$Y$82.7$KG$20240716$$MD$FR$FR
239990882$23999088$2$F$$20240704$20240621$20240709$PER$$US-ROCHE-10000000088$ROCHE$Kirven R, Fisher K, Kaffenberger B, Chung C. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;6 (316): doi:10.1007/s00403-024-03083-0.$75$YR$E$M$Y$$$20240706$$MD$US$US
239990892$23999089$2$F$20240531$20240627$20240621$20240703$EXP$$JP-PFIZER INC-202400196520$PFIZER$$73$YR$$M$Y$$$20240703$$MD$JP$JP
239990933$23999093$3$F$20240620$20240903$20240621$20240904$PER$$US-AMGEN-USASP2024122254$AMGEN$$66$YR$E$M$Y$$$20240904$$CN$US$US
239991034$23999103$4$F$20231219$20240726$20240621$20240726$EXP$$CA-PFIZER INC-202300453348$PFIZER$$60$YR$$F$Y$111$KG$20240726$$HP$CA$CA
239991093$23999109$3$F$$20240730$20240621$20240802$EXP$$US-ALXN-202406USA000864US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
239991102$23999110$2$F$20240614$20240717$20240621$20240720$PER$$US-JNJFOC-20240644113$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240719$$CN$US$US
239991173$23999117$3$F$20230328$20240917$20240621$20240925$EXP$$JP-ROCHE-3354804$ROCHE$$68$YR$E$F$Y$80.8$KG$20240925$$MD$JP$JP
239991232$23999123$2$F$$20240725$20240621$20240726$EXP$$CA-PFIZER INC-202400197613$PFIZER$$63$YR$$M$Y$$$20240726$$PH$CA$CA
239991332$23999133$2$F$20240617$20240728$20240621$20240730$EXP$$GB-MYLANLABS-2024M1056613$MYLAN$$$$$F$Y$$$20240730$$HP$GB$GB
239991442$23999144$2$F$20240607$20240703$20240621$20240705$EXP$$JP-BAYER-2024A089041$BAYER$$63$YR$A$M$Y$$$20240705$$MD$JP$JP
239991562$23999156$2$F$$20240712$20240621$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-029953$AUROBINDO$Gooley B, Willenbring B, Wilkinson J.. Amifampridine overdose leading to refractory status epilepticus. American Journal of Emergency Medicine. 2024;80:231.e1?231.e2$67$YR$$M$Y$$$20240722$$HP$US$US
239991604$23999160$4$F$20230901$20240829$20240621$20240903$EXP$$US-AMGEN-USASP2024122210$AMGEN$$77$YR$E$F$Y$$$20240903$$CN$US$US
239991633$23999163$3$F$20230801$20240807$20240621$20240809$EXP$FR-AFSSAPS-AN2024000749$FR-AMGEN-FRASP2024118329$AMGEN$$67$YR$E$F$Y$58$KG$20240809$$PH$FR$FR
239991662$23999166$2$F$20240710$20240710$20240621$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-018239$UNITED THERAPEUTICS$$50$YR$$F$Y$$$20240718$$$US$US
239991672$23999167$2$F$$20240624$20240621$20240708$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05552$HIKMA$$$$$M$Y$$$20240708$$CN$US$US
239991682$23999168$2$F$$20240710$20240621$20240716$PER$$JP-BRACCO-2024JP03579$BRACCO$Nakamura, G; Ozaki, M; Yasuda, Y; Yoshida, T; Inoue, T. Radiocontrast Medium-Induced Kounis Syndrome in a Dialysis Patient: A Case Report. Cureus. 2024;16:5$58$YR$$M$Y$$$20240716$$HP$JP$JP
239991712$23999171$2$F$$20240613$20240621$20240704$EXP$$FR-ABBVIE-5807057$ABBVIE$$86$YR$$M$Y$$$20240704$$MD$FR$FR
239991722$23999172$2$F$$20240703$20240621$20240708$EXP$$US-INCYTE CORPORATION-2024IN006251$INCYTE$$$$$$Y$$$20240708$$HP$US$US
239991772$23999177$2$F$20200101$20240705$20240621$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-029734$AUROBINDO$$$$$F$Y$$$20240715$$MD$GB$GB
239991842$23999184$2$F$20220418$20220623$20240621$20240805$EXP$$BR-HORIZON THERAPEUTICS-HZN-2022-002969$AMGEN$$11$YR$C$F$Y$$$20240805$$MD$BR$BR
239991922$23999192$2$F$20230921$20240705$20240621$20240715$EXP$$ES-AUROBINDO-AUR-APL-2024-029872$AUROBINDO$$83$YR$$F$Y$$$20240715$$MD$ES$ES
239992034$23999203$4$F$20240101$20240820$20240621$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018420$UNITED THERAPEUTICS$$$$$F$Y$45.805$KG$20240823$$PH$US$US
239992062$23999206$2$F$$20240711$20240621$20240717$EXP$$GB-ROCHE-10000002139$ROCHE$Thambirajah N, Logou G, Sumaria S, Howard R, Kullmann D, Spillane J. Efficacy, safety, and factors predicting response in Rituximab therapy for generalised Myasthenia Gravis: A single centre study [Abstract no. NMJ+C08]. Journal of Neuromuscular Diseases. 2024;11 (1):S48. doi:10.3233/JND-249001.$$$$$Y$$$20240717$$MD$GB$GB
239992102$23999210$2$F$20240531$20240709$20240621$20240717$30DAY$$US-JNJFOC-20240590137$JOHNSON AND JOHNSON$$19$YR$A$F$Y$$$20240717$$CN$US$US
239992332$23999233$2$F$$20240617$20240621$20240702$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451448$RANBAXY$Ataei Azimi S, Qoorchi Moheb Seraj F, Jafarian AH, Shariatmaghani SS, Shamsabadi E. Gastric epithelioid rhabdomyosarcoma: a case report. Middle East J Cancer. 2023;14 (3):463-468$67$YR$$M$Y$$$20240702$$MD$IR$IR
239992673$23999267$3$F$$20240729$20240621$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451639$RANBAXY$Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J Med Toxicol. 2024;20:308-313$41$YR$$F$Y$$$20240919$$HP$US$US
239992682$23999268$2$F$$20240703$20240621$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451791$RANBAXY$Bathia JN, Poddar S, Sinha R,Pal P.. Sjogren syndrome: single disease different presentation. Pediatr Rheumatol. 2023;21 (Suppl.)(2):165/ P191$7$YR$$F$Y$$$20240718$$HP$IN$IN
239992712$23999271$2$F$$20240729$20240621$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451667$RANBAXY$Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J Med Toxicol. 2024;20:308-313$$$N$M$Y$$$20240813$$HP$US$US
239992952$23999295$2$F$$20240722$20240621$20240725$PER$$US-BAUSCH-BL-2024-009426$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240725$$CN$US$US
239993072$23999307$2$F$20231114$20240625$20240621$20240710$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-452855$RANBAXY$$15$YR$$F$Y$$$20240710$$HP$SE$SE
239993412$23999341$2$F$$20240809$20240621$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451555$RANBAXY$Delahunt S, Choksey F. Thrombocytopenia and Anaemia - A less common cause. Int J Obstet Anesth. 2024;58S1:104129 (6301534)$31$YR$$F$Y$$$20240823$$HP$US$US
239993492$23999349$2$F$20240529$20240626$20240621$20240703$PER$$US-AMGEN-USASP2024119271$AMGEN$$61$YR$A$F$Y$$$20240703$$HP$US$US
239993784$23999378$4$F$20240619$20240929$20240621$20240930$EXP$$DE-BAUSCH-BL-2024-009528$BAUSCH AND LOMB$$8$DEC$$F$Y$80$KG$20240930$$MD$DE$DE
239993802$23999380$2$F$$20240626$20240621$20240702$EXP$$HU-BAUSCH-BL-2024-009395$BAUSCH AND LOMB$Ronaszeki B, Sandi D, Adam O, Szabo N, Dezsi L, Tajti J, Piukovics K. Verseny az idovel: a POEMS szindroma. Ideggyogy Sz. 2024;77 (5-6):212-216. doi:10.18071/isz.77.0212$46$YR$$M$Y$$$20240702$$MD$HU$HU
239993834$23999383$4$F$20240601$20240723$20240621$20240802$30DAY$$US-GSK-US2024073272$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240802$$CN$US$US
239993842$23999384$2$F$$20240813$20240621$20240823$30DAY$$US-GSK-US2024AMR072957$GLAXOSMITHKLINE$$$$$M$Y$$$20240823$$CN$US$US
239993863$23999386$3$F$20240501$20240808$20240621$20240820$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002600$ACADIA PHARMACEUTICALS$$16$YR$$F$Y$39$KG$20240820$$CN$US$US
239993942$23999394$2$F$20200622$20240717$20240621$20240723$EXP$$JP-PFIZER INC-PV202400081576$PFIZER$$6$DEC$$F$Y$74.2$KG$20240723$$MD$JP$JP
239993992$23999399$2$F$20240620$20240717$20240621$20240722$EXP$$US-PFIZER INC-202400198225$PFIZER$$52$YR$$F$Y$$$20240722$$HP$US$US
239994142$23999414$2$F$20240610$20240624$20240621$20240705$EXP$$US-BAYER-2024A089677$BAYER$$66$YR$E$F$Y$90.703$KG$20240705$$CN$US$US
239994162$23999416$2$F$20240301$20240719$20240621$20240724$EXP$$US-ABBVIE-5808145$ABBVIE$$57$YR$$F$Y$$$20240724$$CN$US$US
239994172$23999417$2$F$20240611$20240614$20240621$20240808$EXP$$US-ABBVIE-5804207$ABBVIE$$50$YR$$F$Y$58$KG$20240808$$HP$US$US
239994233$23999423$3$F$20220101$20240709$20240621$20240722$EXP$$US-CIPLA LTD.-2024US06217$CIPLA$$$$$$Y$$$20240722$$CN$US$US
239994354$23999435$4$F$$20240826$20240621$20240829$EXP$$FR-OTSUKA-2024_007307$OTSUKA$Descamps V.. Carbamazepine: a potential DRESS inducer. The Letter of the Neurologist. 2024;28(1-2):56-8$56$YR$$F$Y$$$20240829$$MD$FR$FR
239994413$23999441$3$F$20240522$20240725$20240621$20240729$EXP$$DE-MYLANLABS-2024M1052252$MYLAN$$83$YR$$F$Y$60$KG$20240729$$MD$DE$DE
239994424$23999442$4$F$20240109$20240717$20240621$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-046692$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$39$KG$20240725$$MD$JP$JP
239994432$23999443$2$F$$20240802$20240621$20240805$PER$$US-ALXN-202406USA000963US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
239994442$23999444$2$F$20240531$20240621$20240621$20240802$PER$$US-FDC-2024USSPO00453$FDC LIMITED$$90$YR$E$M$Y$72.5$KG$20240802$$CN$US$US
239994482$23999448$2$F$20240617$20240903$20240621$20240905$EXP$$US-MYLANLABS-2024M1056016$MYLAN$$71$YR$$M$Y$95.25$KG$20240905$$HP$US$US
239994532$23999453$2$F$20240604$20240703$20240621$20240715$EXP$$JP-ROCHE-10000001724$ROCHE$$7$YR$C$M$Y$$$20240715$$MD$JP$JP
239994542$23999454$2$F$20240613$20240830$20240621$20240903$EXP$$US-MYLANLABS-2024M1056038$MYLAN$$22$YR$$M$Y$$$20240903$$HP$US$US
239994583$23999458$3$F$20240517$20240726$20240621$20240727$PER$$US-JNJFOC-20240635620$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240727$$CN$US$US
239994643$23999464$3$F$$20240704$20240621$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05228$LUPIN$$$$$$Y$$$20240731$$CN$US$US
239994663$23999466$3$F$20240801$20240830$20240621$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018532$UNITED THERAPEUTICS$$51$YR$$F$Y$58.957$KG$20240906$$$US$US
239994694$23999469$4$F$20230906$20240923$20240621$20240926$EXP$$AR-MYLANLABS-2023M1097817$MYLAN$$59$YR$$F$Y$$$20240926$$HP$AR$AR
239994722$23999472$2$F$$20240804$20240621$20240808$EXP$$HR-AMGEN-HRVSP2024121698$AMGEN$Pahek K; Durakovic N; Desnica L. et al.. THRONMOPOIETIN RECEPTOR AGONISTS FOR PERSISTENT SEVERE THROMBOCYTOPENIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION-5 YEARS SINGLE CENTRE RETROSPECTIVE ANALYSIS. Bone Marrow Transplantation. 2023;58 (SUPPL_1):p.550$$$$$Y$$$20240808$$HP$HR$HR
239994782$23999478$2$F$$20240708$20240621$20240716$PER$$US-SA-2022SA445649$SANOFI AVENTIS$$60$YR$A$M$Y$95.238$KG$20240716$$CN$US$US
239994834$23999483$4$F$20240611$20240710$20240621$20240725$30DAY$$JP-JNJFOC-20240632383$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240725$$PH$JP$JP
239994853$23999485$3$F$20240608$20240717$20240621$20240729$30DAY$$US-JNJFOC-20240623679$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240729$$HP$US$US
239994938$23999493$8$F$20240101$20240809$20240621$20240816$PER$$US-SA-2024SA176496$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240816$$MD$US$US
239994942$23999494$2$F$20240101$20240709$20240621$20240718$PER$$US-SA-2024SA173786$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240718$$CN$US$US
239995013$23999501$3$F$$20240729$20240621$20240731$PER$$US-AMGEN-USASP2024122550$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
239995082$23999508$2$F$20240618$20240703$20240621$20240709$EXP$$TW-PFIZER INC-PV202400081250$PFIZER$$$$C$F$Y$$$20240709$$HP$TW$TW
239995143$23999514$3$F$20240615$20240814$20240621$20240819$EXP$$IN-PFIZER INC-PV202400079093$PFIZER$$49$YR$$F$Y$63$KG$20240819$$CN$IN$IN
239995212$23999521$2$F$20240810$20240824$20240621$20240829$EXP$$IN-PFIZER INC-202200801232$PFIZER$$58$YR$$F$Y$$$20240829$$CN$IN$IN
239995223$23999522$3$F$20240712$20240803$20240621$20240807$EXP$$IN-PFIZER INC-PV202400011183$PFIZER$$41$YR$$F$Y$$$20240807$$CN$IN$IN
239995243$23999524$3$F$20240618$20240722$20240621$20240725$EXP$$US-PFIZER INC-PV202400081253$PFIZER$$81$YR$$F$Y$99.2$KG$20240725$$CN$US$US
239995324$23999532$4$F$$20240711$20240621$20240716$EXP$$IR-PFIZER INC-202400193874$PFIZER$Shahbazi, F.. Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases. Current drug safety. 2024;10.2174/0115748863299100240507$52$YR$$F$Y$75$KG$20240716$$HP$IR$IR
239995463$23999546$3$F$20231219$20240723$20240621$20240725$EXP$$US-PFIZER INC-202400197183$PFIZER$$45$YR$$F$Y$68$KG$20240725$$PH$US$US
239995492$23999549$2$F$$20240826$20240621$20240903$EXP$$US-Vifor (International) Inc.-VIT-2024-05369$VIFOR$$$$$M$Y$$$20240903$$HP$US$US
239995672$23999567$2$F$20230101$20240814$20240621$20240814$EXP$$CA-PFIZER INC-202300316113$PFIZER$$60$YR$$M$Y$$$20240814$$HP$CA$CA
239995693$23999569$3$F$20240501$20240810$20240621$20240812$EXP$$CA-PFIZER INC-202400196899$PFIZER$$24$YR$$M$Y$$$20240812$$CN$CA$CA
239995702$23999570$2$F$20240522$20240628$20240621$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002608$ACADIA PHARMACEUTICALS$$11$YR$$F$Y$$$20240723$$CN$US$US
2399957212$23999572$12$F$$20240909$20240621$20240914$EXP$$US-ROCHE-10000001315$ROCHE$$$$$F$Y$$$20240914$$HP$US$US
239995735$23999573$5$F$20240501$20240815$20240621$20240820$EXP$$CA-PFIZER INC-202400190359$PFIZER$$54$YR$$F$Y$$$20240820$$HP$CA$CA
239995762$23999576$2$F$$20240702$20240621$20240705$EXP$$JP-ABBVIE-5807393$ABBVIE$$26$YR$$F$Y$$$20240705$$PH$JP$JP
239995824$23999582$4$F$20240419$20240812$20240621$20240820$EXP$$CA-TAKEDA-2024TUS059851$TAKEDA$$15$YR$$F$Y$$$20240820$$CN$CA$CA
239995852$23999585$2$F$20240402$20240607$20240621$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000239$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
239996073$23999607$3$F$$20240627$20240621$20240703$EXP$$SK-MYLANLABS-2024M1055366$MYLAN$Kazimirova A. Therapy of Acquired Hemophilia A with aPPC Concentrate in a Polymorbid Patient. ACTA MEDICINAE. 2024;13 (4 - Ext 1/):11-12$91$YR$$F$Y$$$20240703$$HP$SK$SK
239996112$23999611$2$F$20240614$20240729$20240621$20240801$PER$$US-ALXN-202406USA000988US$ALEXION PHARMACEUTICALS$$38$YR$$M$Y$$$20240801$$CN$US$US
239996622$23999662$2$F$20240410$20240611$20240621$20240701$EXP$$US-ORG100014127-2024000169$HRA PHARMA$$75$YR$$F$Y$$$20240701$$CN$US$US
239996632$23999663$2$F$$20240628$20240621$20240708$PER$$US-TAKEDA-2024TUS061934$TAKEDA$$$$$F$Y$62.132$KG$20240708$$MD$US$US
239996662$23999666$2$F$$20240826$20240621$20240904$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00551$CATALYST PHARMA$$$$$F$Y$57.601$KG$20240904$$CN$US$US
239996682$23999668$2$F$$20240625$20240621$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05187$LUPIN$$$$$$Y$$$20240711$$MD$US$US
239996712$23999671$2$F$20240101$20240716$20240621$20240725$30DAY$$US-GSK-US2024072583$GLAXOSMITHKLINE$$78$YR$$F$Y$88$KG$20240725$$MD$US$US
239996743$23999674$3$F$$20240806$20240621$20240808$EXP$$JP-SA-2024SA182616$SANOFI AVENTIS$Hamakawa M, Tanaka A, Tokioka F, Ishida T.. CASE SERIES Feasibility of continued treatment with dupilumab in patients with type 2 inflammatory disease who developed eosinophilic pneumonia: 3 case reports. Respirology Case Reports. 2024;12:1-6$77$YR$E$F$Y$$$20240809$$MD$JP$JP
239996883$23999688$3$F$$20240821$20240621$20240826$30DAY$$US-PFIZER INC-202400196482$PFIZER$$20$YR$$F$Y$$$20240826$$CN$US$US
239996922$23999692$2$F$$20240715$20240621$20240729$EXP$CA-LEO Pharma-371190$CA-LEO Pharma-371190$LEO PHARM$$43$YR$$F$Y$96$KG$20240729$$HP$CA$CA
239997032$23999703$2$F$20240101$20240820$20240621$20240909$PER$$US-SA-2024SA174059$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240909$$MD$US$US
239997232$23999723$2$F$$20240716$20240621$20240726$30DAY$$US-JNJFOC-20240639561$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$CN$US$US
239997282$23999728$2$F$20240605$20240722$20240621$20240729$30DAY$$US-AMGEN-USASP2024116786$AMGEN$$65$YR$E$F$Y$$$20240729$$HP$US$US
239997292$23999729$2$F$20240610$20240828$20240621$20240830$30DAY$$CA-PFIZER INC-202400193224$PFIZER$$76$YR$$F$Y$$$20240830$$HP$CA$CA
239997313$23999731$3$F$20240603$20240812$20240621$20240826$PER$$US-Eisai-EC-2024-167868$EISAI$$75$YR$E$M$Y$72$KG$20240826$$CN$US$US
239997332$23999733$2$F$20240521$20240621$20240621$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002610$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240716$$CN$US$US
239997363$23999736$3$F$$20240809$20240621$20240814$EXP$$JP-SA-2024SA182627$SANOFI AVENTIS$Hamakawa M, Tanaka A, Tokioka F, Ishida T.. CASE SERIES Feasibility of continued treatment with dupilumab in patients with type 2 inflammatory disease who developed eosinophilic pneumonia: 3 case reports.. Respirology Case Reports.. 2024;12:1-6$50$YR$A$F$Y$$$20240815$$MD$JP$JP
239997414$23999741$4$F$20240101$20240909$20240621$20240922$EXP$$CA-UCBSA-2024025934$UCB$$$$$M$Y$$$20240922$$CN$CA$CA
239997582$23999758$2$F$$20240626$20240621$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002612$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
239997593$23999759$3$F$20240614$20240806$20240621$20240810$PER$$US-AMGEN-USASP2024120265$AMGEN$$68$YR$E$F$Y$$$20240810$$HP$US$US
239997682$23999768$2$F$20240201$20240903$20240621$20240913$EXP$$CA-ASTELLAS-2024US017375$ASTELLAS$$102$YR$E$M$Y$$$20240913$$PH$CA$CA
239997692$23999769$2$F$20240617$20240805$20240621$20240807$EXP$$US-SANDOZ INC.-NVSC2021US140053$SANDOZ$$17$YR$$F$Y$59.864$KG$20240807$$CN$US$US
239997772$23999777$2$F$20240520$20240620$20240621$20240705$PER$$US-Eisai-EC-2024-166177$EISAI$$72$YR$E$F$Y$$$20240705$$CN$US$US
239997882$23999788$2$F$$20240813$20240621$20240823$30DAY$$US-GSK-US2024072666$GLAXOSMITHKLINE$$$$$M$Y$$$20240823$$CN$US$US
239997982$23999798$2$F$20240601$20240718$20240621$20240722$EXP$$IT-PFIZER INC-202400197648$PFIZER$$$$A$M$Y$$$20240722$$MD$IT$IT
239998012$23999801$2$F$20230101$20240627$20240621$20240701$EXP$$AT-PFIZER INC-202400194644$PFIZER$$64$YR$$F$Y$$$20240701$$MD$AT$AT
239998022$23999802$2$F$$20240610$20240621$20240722$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-11774$IPSEN$$$$$F$Y$58.01$KG$20240722$$CN$US$US
239998193$23999819$3$F$$20240821$20240621$20240826$30DAY$$US-PFIZER INC-PV202400044261$PFIZER$$$$$$Y$$$20240826$$HP$US$US
239998203$23999820$3$F$$20240727$20240621$20240730$30DAY$$US-PFIZER INC-202400193300$PFIZER$$13$YR$$F$Y$$$20240730$$PH$US$US
239998233$23999823$3$F$20240611$20240911$20240621$20240913$30DAY$$US-PFIZER INC-202400193326$PFIZER$$11$YR$$M$Y$$$20240913$$CN$US$US
239998244$23999824$4$F$20240517$20240903$20240621$20240905$30DAY$$CO-PFIZER INC-PV202400079496$PFIZER$$13$YR$$M$Y$$$20240905$$CN$CO$CO
239998263$23999826$3$F$$20240917$20240621$20240923$30DAY$$US-PFIZER INC-202400188540$PFIZER$$14$YR$$F$Y$$$20240923$$CN$US$US
239998303$23999830$3$F$$20240710$20240621$20240717$EXP$$IT-Waylis Therapeutics LLC-ATNAHS20240601790$Waylis$Giorgetti A, Gro e Perdekamp M, Franchetti G, Pircher R, Pollak S, Pelotti S, et al. Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities. International journal of legal medicine. 2024. DOI: 10.1007/s00414-024-03263-7.$31$YR$A$M$Y$$$20240717$$MD$IT$IT
239998332$23999833$2$F$20240122$20240910$20240621$20240918$PER$$JP-Eisai-EC-2024-168129$EISAI$$$$E$F$Y$$$20240918$$MD$JP$JP
239998684$23999868$4$F$20240520$20240815$20240621$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002605$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240830$$CN$US$US
239998694$23999869$4$F$20240603$20240911$20240621$20240916$EXP$$US-ROCHE-10000000572$ROCHE$$6$YR$C$M$Y$$$20240916$$CN$US$US
239998762$23999876$2$F$$20240919$20240621$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100301$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240919$$PH$US$US
239998772$23999877$2$F$$20240724$20240621$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099966$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240729$$HP$US$US
239998833$23999883$3$F$$20240717$20240621$20240724$EXP$$PL-PFIZER INC-202400194845$PFIZER$Woron, J.. Stosowanie sertraliny i perazyny jako przyczyna zapalen p?uc u pacjentki cierpiacej na przewlek?a obturacyjna chorob? pluc. Medycyna Praktyczna - Psychiatria. 2024;3:20-21$67$YR$$F$Y$$$20240724$$MD$PL$PL
239998872$23999887$2$F$20240101$20240626$20240621$20240701$EXP$$US-PFIZER INC-202400196000$PFIZER$$67$YR$$M$Y$107$KG$20240701$$MD$US$US
239998943$23999894$3$F$20240101$20240705$20240621$20240710$EXP$$US-PFIZER INC-202400186633$PFIZER$$74$YR$$F$Y$92.517$KG$20240710$$HP$US$US
239998983$23999898$3$F$20231128$20240710$20240621$20240716$EXP$$DE-PFIZER INC-202400197394$PFIZER$$61$YR$$F$Y$57$KG$20240716$$HP$DE$DE
239998992$23999899$2$F$20240501$20240701$20240621$20240708$EXP$$DE-PFIZER INC-202400194550$PFIZER$$68$YR$$M$Y$63$KG$20240708$$MD$DE$DE
239999042$23999904$2$F$$20240730$20240621$20240807$EXP$$MX-AstraZeneca-2024A140108$ASTRAZENECA$$$$$M$Y$$$20240807$$MD$MX$
239999093$23999909$3$F$20240418$20240711$20240621$20240719$EXP$$JP-AMGEN-JPNSP2024119735$AMGEN$$$$E$$Y$$$20240719$$MD$JP$JP
239999185$23999918$5$F$20240101$20240911$20240621$20240913$30DAY$$US-PFIZER INC-202400196589$PFIZER$$16$YR$$M$Y$58.97$KG$20240913$$CN$US$US
239999234$23999923$4$F$20230101$20240925$20240621$20240926$EXP$$US-PFIZER INC-PV202400081245$PFIZER$$67$YR$$F$Y$$$20240926$$HP$US$US
239999243$23999924$3$F$$20240626$20240621$20240701$EXP$$US-PFIZER INC-202400193745$PFIZER$Dumic, I.. Drug-Induced Liver Injury Due to Doxycycline: A Case Report and Review of Literature. Cureus. 2024;16(5):e59687$28$YR$$M$Y$$$20240701$$MD$US$US
239999284$23999928$4$F$20240517$20240820$20240621$20240827$30DAY$$JP-PFIZER INC-202400178929$PFIZER$$80$YR$$F$Y$$$20240827$$PH$JP$JP
239999304$23999930$4$F$20240601$20240911$20240621$20240913$30DAY$$US-PFIZER INC-202400196372$PFIZER$$10$YR$$M$Y$$$20240913$$CN$US$US
239999332$23999933$2$F$20240617$20240721$20240621$20240722$30DAY$$US-PFIZER INC-202400195974$PFIZER$$20$YR$$F$Y$$$20240722$$CN$US$US
239999343$23999934$3$F$$20240911$20240621$20240913$30DAY$$US-PFIZER INC-202400196487$PFIZER$$15$YR$$M$Y$$$20240913$$CN$US$US
239999356$23999935$6$F$$20240919$20240621$20240925$30DAY$$US-PFIZER INC-202400196556$PFIZER$$14$YR$$M$Y$45.36$KG$20240925$$CN$US$US
239999362$23999936$2$F$$20240624$20240621$20240701$EXP$$US-PFIZER INC-PV202400078588$PFIZER$Im, S.. Latent melioidosis activation presenting with urinary tract infection and bacteremia. IDCases. 2024;36:10.1016/j.idcr.2024.e02007$68$YR$$F$Y$$$20240701$$HP$US$US
239999372$23999937$2$F$$20240722$20240621$20240725$EXP$$SA-PFIZER INC-202400196034$PFIZER$Alahwal, H.. COVID?19?induced immune thrombocytopenia management approach: A case report and literature review. Clinical Case Reports. 2024;12(6):10.1002/ccr3.9070$39$YR$$M$Y$$$20240725$$HP$SA$SA
239999412$23999941$2$F$20240603$20240724$20240621$20240801$PER$$US-MYLANLABS-2024M1053777$MYLAN$$83$YR$$M$Y$68.04$KG$20240801$$CN$US$US
239999453$23999945$3$F$$20240715$20240621$20240717$EXP$$GB-MYLANLABS-2024M1052232$MYLAN$$$$$F$Y$$$20240717$$CN$GB$GB
239999512$23999951$2$F$20240801$20240829$20240621$20240910$PER$$US-SA-2024SA182015$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240910$$MD$US$US
239999532$23999953$2$F$$20240708$20240621$20240711$EXP$$US-SA-2024SA184228$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240711$$HP$US$US
239999564$23999956$4$F$20240603$20240826$20240621$20240902$EXP$$JP-JNJFOC-20240656788$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240902$$MD$JP$JP
239999802$23999980$2$F$$20240708$20240621$20240709$PER$$US-AMGEN-USASP2024122481$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
239999893$23999989$3$F$20240614$20240813$20240621$20240818$EXP$$NVSC2024CA129145$NOVARTIS$$48$YR$$F$Y$$$20240818$$CN$CA$CA
239999902$23999990$2$F$20240101$20240702$20240621$20240809$PER$$US-KARYOPHARM-2024KPT001058$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240809$$CN$US$US
239999992$23999999$2$F$20240101$20240916$20240621$20240920$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-087560$REGENERON$$66$YR$$F$Y$$$20240920$$HP$CO$CO
240000084$24000008$4$F$$20240716$20240621$20240724$EXP$$GB-AstraZeneca-2024A035482$ASTRAZENECA$$38$YR$$F$Y$$$20240724$$MD$GB$
240000183$24000018$3$F$$20240715$20240621$20240717$PER$$US-JNJFOC-20240639040$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$PH$US$US
240000192$24000019$2$F$$20240719$20240621$20240731$30DAY$$US-JNJFOC-20240639555$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$PH$US$US
240000204$24000020$4$F$20240611$20240718$20240621$20240725$30DAY$$US-JNJFOC-20240631758$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240726$$PH$US$US
240000222$24000022$2$F$$20240712$20240621$20240717$EXP$$US-ABBVIE-5808505$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
240000312$24000031$2$F$$20240701$20240621$20240703$PER$$US-PFIZER INC-PV202400081400$PFIZER$$58$YR$$F$Y$$$20240703$$HP$US$US
240000343$24000034$3$F$$20240925$20240621$20240930$30DAY$$US-PFIZER INC-202400193479$PFIZER$$11$YR$$M$Y$$$20240930$$CN$US$US
240000373$24000037$3$F$$20240724$20240621$20240724$PER$$US-PFIZER INC-202400194422$PFIZER$$51$YR$$M$Y$$$20240724$$MD$US$US
240000383$24000038$3$F$$20240911$20240621$20240913$30DAY$$CO-PFIZER INC-202400195913$PFIZER$$6$YR$$F$Y$$$20240913$$CN$CO$CO
240000473$24000047$3$F$20240501$20240703$20240621$20240715$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202406011483$ELI LILLY AND CO$$$$$F$Y$$$20240715$$MD$BR$BR
240000582$24000058$2$F$$20240628$20240621$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406013603$ELI LILLY AND CO$$18$YR$A$M$Y$$$20240702$$CN$US$US
240000753$24000075$3$F$20240607$20240826$20240621$20240829$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406013440$ELI LILLY AND CO$$69$YR$E$M$Y$66.5$KG$20240829$$CN$JP$JP
240001202$24000120$2$F$20231101$20240724$20240621$20240726$EXP$$JP-DSJP-DSJ-2024-127390$DAIICHI$$89$YR$$F$Y$47.5$KG$20240726$$MD$JP$JP
240001372$24000137$2$F$20240601$20240716$20240621$20240723$EXP$$CA-GSK-CA2024AMR075272$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$CA$CA
240001462$24000146$2$F$20240514$20240708$20240621$20240923$PER$$US-ARDELYX-2024ARDX004264$ARDELYX$$70$YR$$F$Y$84.8$KG$20240922$$PH$US$US
240001502$24000150$2$F$20240609$20240913$20240621$20240917$30DAY$$AR-PFIZER INC-202400192247$PFIZER$$6$YR$$F$Y$$$20240917$$HP$AR$AR
240001562$24000156$2$F$20240301$20240613$20240621$20240717$EXP$$US-ROCHE-10000000433$ROCHE$$$$$$Y$$$20240717$$CN$US$US
240001683$24000168$3$F$$20240902$20240621$20240910$EXP$$CA-AstraZeneca-2024A125544$ASTRAZENECA$$$$$M$Y$$$20240910$$MD$CA$
240001742$24000174$2$F$20240501$20240626$20240621$20240702$EXP$$NVSC2024GH128208$NOVARTIS$$50$YR$$M$Y$95$KG$20240702$$PH$GH$GH
240001812$24000181$2$F$$20240625$20240621$20240701$EXP$$NVSC2024CA126776$NOVARTIS$$$$$F$Y$$$20240701$$HP$CA$CA
240001872$24000187$2$F$$20240729$20240621$20240801$PER$$US-ALXN-202406USA001029US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240001983$24000198$3$F$$20240724$20240621$20240801$EXP$$JP-EMD Serono-2024032691$EMD SERONO INC$$62$YR$A$M$Y$56.8$KG$20240801$$MD$JP$JP
240002024$24000202$4$F$20240610$20240827$20240621$20240829$EXP$$US-GSK-US2024073256$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240829$$HP$US$US
240002042$24000204$2$F$20240613$20240912$20240621$20240917$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024073833$VIIV$$46$YR$$M$Y$$$20240917$$PH$US$US
240002133$24000213$3$F$$20240715$20240621$20240717$PER$$US-PFIZER INC-PV202400081624$PFIZER$$60$YR$$F$Y$$$20240717$$HP$US$US
240002262$24000226$2$F$20240101$20240626$20240621$20240701$PER$$US-PFIZER INC-PV202400081618$PFIZER$$21$YR$$F$Y$$$20240701$$HP$US$US
240002332$24000233$2$F$$20240711$20240621$20240715$PER$$AU-PFIZER INC-202400196139$PFIZER$$$$$F$Y$$$20240715$$CN$AU$AU
240002352$24000235$2$F$$20240920$20240621$20240925$PER$$US-PFIZER INC-PV202400081796$PFIZER$$68$YR$$M$Y$$$20240925$$CN$US$US
240002402$24000240$2$F$$20240715$20240621$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05196$LUPIN$$$$$$Y$$$20240813$$CN$US$US
240002592$24000259$2$F$$20240729$20240621$20240801$PER$$US-ALXN-202406USA001012US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240002612$24000261$2$F$$20240712$20240621$20240712$EXP$$GR-ALXN-202406EEA000829GR$ALEXION PHARMACEUTICALS$$62$YR$$M$Y$$$20240712$$MD$GR$GR
240002684$24000268$4$F$20240616$20240724$20240621$20240801$30DAY$$US-JNJFOC-20240642649$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240801$$PH$US$US
240002712$24000271$2$F$20240501$20240717$20240621$20240725$30DAY$$US-GSK-US2024073322$GLAXOSMITHKLINE$$90$YR$$F$Y$$$20240725$$CN$US$US
240002733$24000273$3$F$20240101$20240817$20240621$20240823$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-087537$REGENERON$$78$YR$$F$Y$$$20240823$$HP$CO$CO
240002742$24000274$2$F$$20240807$20240621$20240816$PER$$US-SA-2024SA177394$SANOFI AVENTIS$$$$A$F$Y$69.3$KG$20240816$$MD$US$US
240002833$24000283$3$F$20240101$20240701$20240621$20240702$PER$$US-ORGANON-O2406USA001811$ORGANON$$$$$F$Y$131.52$KG$20240702$$MD$US$US
240002892$24000289$2$F$20240101$20240810$20240621$20240812$EXP$$CA-PFIZER INC-202400197656$PFIZER$$56$YR$$F$Y$$$20240812$$HP$CA$CA
240002952$24000295$2$F$20240601$20240731$20240621$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098709$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$106.14$KG$20240807$$CN$US$US
240002993$24000299$3$F$$20240804$20240621$20240805$30DAY$$US-PFIZER INC-202400196198$PFIZER$$16$YR$$M$Y$$$20240805$$CN$US$US
240003002$24000300$2$F$20160620$20240829$20240621$20240902$EXP$$CA-TAKEDA-2018TUS034237$TAKEDA$$45$YR$$M$Y$$$20240902$$MD$CA$CA
240003022$24000302$2$F$20240301$20240828$20240621$20240904$EXP$$NVSC2024DE128007$NOVARTIS$$$$A$M$Y$85$KG$20240904$$MD$DE$DE
240003084$24000308$4$F$20240101$20240827$20240621$20240910$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-001299$SK LIFE SCIENCE$$$$$$Y$$$20240910$$HP$CA$CA
240003102$24000310$2$F$$20240822$20240621$20240827$EXP$$US-SANDOZ INC.-SDZ2024US059691$SANDOZ$$83$YR$$F$Y$$$20240827$$CN$US$US
240003153$24000315$3$F$20240101$20240717$20240621$20240729$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-001348$SK LIFE SCIENCE$$$$$$Y$$$20240729$$HP$CA$CA
240003183$24000318$3$F$20240528$20240711$20240621$20240718$EXP$$US-SANDOZ INC.-SDZ2024US059674$SANDOZ$$$$$F$Y$$$20240718$$CN$US$US
240003193$24000319$3$F$20231201$20240711$20240621$20240730$EXP$$US-ABBVIE-5807336$ABBVIE$$$$$M$Y$$$20240730$$MD$US$US
240003212$24000321$2$F$20230422$20240826$20240621$20240827$EXP$$NVSC2023CA084326$NOVARTIS$$54$YR$$F$Y$$$20240827$$CN$CA$CA
240003233$24000323$3$F$$20240624$20240621$20240707$EXP$$CA-SANDOZ INC.-SDZ2024CA059317$SANDOZ$$53$YR$$M$Y$$$20240707$$CN$CA$CA
240003262$24000326$2$F$20230701$20240701$20240621$20240703$EXP$$PT-FreseniusKabi-FK202409568$FRESENIUS KABI$$63$YR$A$M$Y$$$20240703$$MD$PT$PT
240003343$24000334$3$F$20240101$20240709$20240621$20240712$EXP$$CA-ABBVIE-5804006$ABBVIE$$61$YR$$F$Y$$$20240712$$CN$CA$CA
240003412$24000341$2$F$$20240626$20240621$20240701$EXP$$US-PFIZER INC-PV202400079948$PFIZER$Pham, L.. New Onset Refractory Status Epilepticus in Prion Disease. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5614$60$YR$$F$Y$$$20240701$$HP$US$US
240003424$24000342$4$F$$20240705$20240621$20240709$EXP$$US-PFIZER INC-PV202400079824$PFIZER$Simone, C.. Levetiracetam-associated Rhabdomyolysis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5704-A5704$20$YR$$M$Y$$$20240709$$HP$US$US
240003452$24000345$2$F$$20240703$20240621$20240724$30DAY$$US-Baxter Healthcare-2158379$BAXTER$$$$$$Y$$$20240724$$$US$US
240003535$24000353$5$F$20230101$20240909$20240621$20240917$EXP$$CA-JNJFOC-20230400842$JOHNSON AND JOHNSON$$24$YR$A$F$Y$55$KG$20240917$$HP$CA$CA
240003562$24000356$2$F$20240610$20240710$20240621$20240712$EXP$$JP-AstraZeneca-2024A142306$ASTRAZENECA$$73$YR$$M$Y$80$KG$20240712$$MD$JP$
240003753$24000375$3$F$20240101$20240919$20240621$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099855$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240919$$MD$JP$JP
240003794$24000379$4$F$20240201$20240715$20240621$20240723$EXP$$US-ROCHE-10000001814$ROCHE$$62$YR$A$M$Y$$$20240723$$PH$US$US
240003802$24000380$2$F$20240501$20240703$20240621$20240709$EXP$$US-Eisai-EC-2024-165933$EISAI$$80$YR$E$F$Y$$$20240709$$CN$US$US
240004044$24000404$4$F$20240418$20240905$20240621$20240915$EXP$$JP-ARDELYX-2024ARDX004494$ARDELYX$$71$YR$$F$Y$$$20240916$$MD$JP$JP
240004052$24000405$2$F$20240514$20240704$20240621$20240713$EXP$$JP-ARDELYX-2024ARDX004470$ARDELYX$$75$YR$$M$Y$$$20240713$$MD$JP$JP
240004062$24000406$2$F$$20240816$20240621$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100035$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$61.23$KG$20240821$$CN$US$US
240004083$24000408$3$F$20240416$20240701$20240621$20240803$EXP$$JP-ARDELYX-2024ARDX003786$ARDELYX$$58$YR$$F$Y$47$KG$20240803$$PH$JP$JP
240004194$24000419$4$F$20240726$20240913$20240621$20240918$EXP$$AU-MYLANLABS-2024M1056225$MYLAN$$48$YR$$M$Y$$$20240918$$HP$AU$AU
240004202$24000420$2$F$$20240919$20240621$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099831$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240923$$CN$US$US
240004252$24000425$2$F$$20240624$20240621$20240701$EXP$$JP-FreseniusKabi-FK202409657$FRESENIUS KABI$Kosugi K, Nachi H, Goto T, Sakurai S. Case of Generalized Tonic Convulsion after General Anesthesia. Journal of Japanese Dental Society of Anesthesiology. 2018;46(1): 22-24.$37$YR$A$M$Y$66$KG$20240701$$HP$JP$JP
240004263$24000426$3$F$20240619$20240812$20240621$20240903$PER$$US-AstraZeneca-2024A139791$ASTRAZENECA$$63$YR$$F$Y$$$20240903$$CN$US$
240004282$24000428$2$F$$20240628$20240621$20240702$EXP$$CA-TAKEDA-2024TUS061806$TAKEDA$$$$$F$Y$$$20240702$$CN$CA$CA
240004434$24000443$4$F$$20240925$20240621$20240930$PER$$NVSC2024US129861$NOVARTIS$$$$$F$Y$$$20240930$$HP$US$US
240004444$24000444$4$F$20220106$20240822$20240621$20240829$EXP$$CN-PFIZER INC-2022SGN03806$PFIZER$$49$YR$$M$Y$52$KG$20240829$$MD$CN$CN
240004502$24000450$2$F$$20240809$20240621$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202406013648$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240814$$CN$US$US
240004583$24000458$3$F$$20240717$20240621$20240722$EXP$$CA-ORGANON-O2406CAN001835$ORGANON$$53$YR$$M$Y$$$20240722$$CN$CA$CA
240004813$24000481$3$F$20240101$20240814$20240621$20240827$PER$$US-SA-2024SA175669$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240827$$MD$US$US
240004973$24000497$3$F$20240307$20240729$20240621$20240809$EXP$$KR-JAZZ PHARMACEUTICALS-2024-KR-008025$JAZZ$$67$YR$$M$Y$58.1$KG$20240808$$MD$KR$KR
240005423$24000542$3$F$20240101$20240711$20240621$20240723$EXP$$GB-VERTEX PHARMACEUTICALS-2024-010300$VERTEX$$$$A$F$Y$$$20240723$$CN$GB$GB
240005672$24000567$2$F$$20240611$20240621$20240916$EXP$$DE-AstraZeneca-2024A088373$ASTRAZENECA$Polzing P, Erzkamp S, Hage D, Dartsch D, Rose O.. Eine Patientin mit st?ndiger M?digkeit nach Klinikaufenthalt.. Deutsche Apotheker Zeitung 2024;$70$YR$$F$Y$51$KG$20240916$$HP$DE$
240005732$24000573$2$F$$20240616$20240621$20240705$EXP$$US-SA-2024SA181650$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240705$$MD$US$US
240005742$24000574$2$F$20240601$20240816$20240621$20240827$PER$$US-MYLANLABS-2024M1052926$MYLAN$$77$YR$$F$Y$66.68$KG$20240827$$CN$US$US
240005772$24000577$2$F$$20240724$20240621$20240729$PER$$US-BIOVITRUM-2024-US-008250$BIOVITRUM$$57$YR$$M$Y$$$20240729$$CN$US$US
240005804$24000580$4$F$20240615$20240812$20240621$20240820$EXP$$CO-AMGEN-COLSL2024120750$AMGEN$$39$YR$A$F$Y$$$20240819$$CN$CO$CO
240005812$24000581$2$F$20240201$20240624$20240621$20240701$EXP$$US-AMGEN-USASP2024119452$AMGEN$$79$YR$E$F$Y$83$KG$20240701$$HP$US$US
240005865$24000586$5$F$20240603$20240806$20240621$20240808$EXP$$JP-DSJP-DSJ-2024-125587$DAIICHI$$73$YR$$F$Y$46.9$KG$20240808$$MD$JP$JP
240006032$24000603$2$F$20240430$20240708$20240621$20240711$PER$$AU-Eisai-EC-2024-168323$EISAI$$61$YR$E$F$Y$65$KG$20240711$$MD$AU$AU
240006082$24000608$2$F$20240611$20240611$20240621$20240917$EXP$GB-MHRA-MED-202406110820326390-HSLPQ$GB-TORRENT-00036763$TORRENT$$52$YR$A$M$Y$80$KG$20240917$$CN$GB$GB
240006132$24000613$2$F$20240329$20240628$20240621$20240709$EXP$GB-MHRA-MED-202406120600400060-ZQTDY$GB-TORRENT-00036775$TORRENT$$23$YR$A$F$Y$$$20240709$$CN$GB$GB
240006242$24000624$2$F$20240101$20240626$20240621$20240701$EXP$$JP-AstraZeneca-2024A134408$ASTRAZENECA$$80$YR$$M$Y$$$20240701$$PH$JP$
240006373$24000637$3$F$$20240903$20240621$20240903$EXP$$KR-ALXN-202406KOR001120KR$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$MD$KR$KR
240006392$24000639$2$F$20240501$20240626$20240621$20240704$PER$$US-SCIEGENP-2024SCSPO00310$SCIEGEN$$78$YR$$F$Y$137$KG$20240704$$CN$US$US
240006622$24000662$2$F$$20240711$20240621$20240717$EXP$$PH-OTSUKA-2024_017475$OTSUKA$$$$$M$Y$$$20240717$$CN$PH$PH
240006823$24000682$3$F$$20240802$20240621$20240805$PER$$US-ALXN-202406USA001018US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240006842$24000684$2$F$$20240624$20240621$20240702$30DAY$$GB-JNJFOC-20240639508$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$GB$GB
240006992$24000699$2$F$$20240702$20240621$20240704$PER$$US-PFIZER INC-202400197674$PFIZER$$14$YR$$M$Y$$$20240704$$MD$US$US
240007102$24000710$2$F$$20240823$20240621$20240828$PER$$US-PFIZER INC-202400099467$PFIZER$$64$YR$$F$Y$$$20240828$$MD$US$US
240007302$24000730$2$F$$20240913$20240621$20240919$PER$$JP-Eisai-EC-2024-168100$EISAI$$$$$$Y$$$20240919$$PH$JP$JP
240007313$24000731$3$F$20240606$20240704$20240621$20240712$PER$$JP-Eisai-EC-2024-168248$EISAI$$67$YR$E$M$Y$$$20240712$$MD$JP$JP
240007322$24000732$2$F$20240101$20240624$20240621$20240705$PER$$US-Eisai-EC-2024-165741$EISAI$$69$YR$E$M$Y$$$20240705$$MD$US$US
240007332$24000733$2$F$20240611$20240826$20240621$20240830$EXP$$JP-Eisai-EC-2024-168540$EISAI$$68$YR$E$F$Y$$$20240830$$MD$JP$JP
240007432$24000743$2$F$$20240628$20240621$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100223$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240702$$CN$US$US
240007482$24000748$2$F$$20240628$20240621$20240702$PER$$US-AMGEN-USASP2024121759$AMGEN$$71$YR$E$F$Y$$$20240702$$CN$US$US
240007652$24000765$2$F$$20240903$20240621$20240905$EXP$$US-JNJFOC-20240654931$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$HP$US$US
240007702$24000770$2$F$20210101$20240625$20240621$20240701$EXP$$ID-PFIZER INC-2021608330$PFIZER$$66$YR$$F$Y$63$KG$20240701$$CN$ID$ID
240007792$24000779$2$F$$20240722$20240621$20240730$30DAY$$CA-JNJFOC-20240639396$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$CN$CA$CA
240007803$24000780$3$F$20220501$20240625$20240621$20240709$EXP$$ES-AstraZeneca-2024A143234$ASTRAZENECA$$47$YR$$F$Y$$$20240709$$MD$ES$
240007832$24000783$2$F$20240527$20240826$20240621$20240828$30DAY$$AR-PFIZER INC-202400180908$PFIZER$$10$YR$$M$Y$$$20240828$$CN$AR$AR
240007844$24000784$4$F$20240101$20240914$20240621$20240918$EXP$$CA-PFIZER INC-202400078918$PFIZER$$76$YR$$M$Y$$$20240918$$MD$CA$CA
240007853$24000785$3$F$$20240916$20240621$20240925$30DAY$$US-PFIZER INC-202400196457$PFIZER$$13$YR$$F$Y$$$20240925$$CN$US$US
240007872$24000787$2$F$$20240725$20240621$20240731$EXP$$GB-PFIZER INC-2003160542GB$PFIZER$Rippin, J.. Serious hyperkalaemia after short use of low molecular weight heparin in a diabetic patient. Clinical Medicine. 2003;3(1):87$45$YR$$F$Y$$$20240731$$HP$GB$GB
240007922$24000792$2$F$20240101$20240709$20240621$20240713$EXP$$US-SA-2024SA183853$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240713$$MD$US$US
240007942$24000794$2$F$20240101$20240903$20240621$20240926$PER$$US-Eisai-EC-2024-165756$EISAI$$81$YR$E$F$Y$50$KG$20240926$$CN$US$US
240008032$24000803$2$F$$20240617$20240621$20240702$EXP$$JP-009507513-2406JPN002568J$MERCK$Okano T, Hobo T, Wakou A, Nishibayashi N, Sakai T, Takano Y, et al.. 53 A case of small intestinal perforation due to pembrolizumab + lenvatinib therapy. The 872nd Surgeon gathering [Tokyo Branch of the Japan Surgical Association]. 30$77$YR$$M$Y$$$20240702$$MD$JP$JP
240008052$24000805$2$F$$20240726$20240621$20240802$PER$$US-ALXN-202406USA000997US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
240008252$24000825$2$F$20240101$20240703$20240621$20240710$EXP$FR-AFSSAPS-SE2024000480$FR-ABBVIE-5807365$ABBVIE$$34$YR$$M$Y$85$KG$20240710$$MD$FR$FR
240008606$24000860$6$F$$20240702$20240621$20240711$EXP$$CZ-PFIZER INC-202400195469$PFIZER$Tuskova, L.. Lecba ALK-pozitivniho anaplastickeho velkobunecneho T-lymfomu rezimem CHEPA komplikovana mikroangiopatii a periferni neuropatii. Pharmacotherapy. 2024;20(6):26-27$39$YR$$F$Y$$$20240711$$MD$CZ$CZ
240008663$24000866$3$F$20240411$20240618$20240621$20240705$EXP$$BR-AstraZeneca-2024A101683$ASTRAZENECA$$$$A$F$Y$$$20240705$$CN$BR$
240008842$24000884$2$F$$20240729$20240621$20240801$PER$$US-ALXN-202406USA000996US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240008932$24000893$2$F$20240419$20240731$20240621$20240810$EXP$$AU-TEVA-VS-3210972$TEVA$$79$YR$$M$Y$$$20240810$$HP$AU$AU
240008953$24000895$3$F$20240701$20240819$20240621$20240826$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001246$BLUEPRINT MEDICINES$$35$YR$A$F$Y$$$20240827$$CN$US$US
240009083$24000908$3$F$20240601$20240702$20240621$20240703$PER$$US-Eisai-EC-2024-168545$EISAI$$68$YR$E$F$Y$$$20240703$$CN$US$US
240009132$24000913$2$F$$20240715$20240621$20240717$PER$$US-JNJFOC-20240638862$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$PH$US$US
240009152$24000915$2$F$$20240919$20240621$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099571$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$98$KG$20240919$$CN$US$US
240009212$24000921$2$F$$20240724$20240621$20240731$PER$$US-ALXN-202406USA000900US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
240009252$24000925$2$F$20240401$20240809$20240621$20240814$EXP$$CN-TAKEDA-2024TUS061960$TAKEDA$$47$YR$$M$Y$68.6$KG$20240814$$HP$CN$CN
240009272$24000927$2$F$20240101$20240710$20240621$20240712$EXP$$BR-Ipsen Biopharmaceuticals, Inc.-2024-12077$IPSEN$$$$$F$Y$$$20240712$$HP$BR$BR
240009302$24000930$2$F$20240610$20240624$20240621$20240702$EXP$$JP-AstraZeneca-2024A140639$ASTRAZENECA$$69$YR$$F$Y$$$20240702$$MD$JP$
240009322$24000932$2$F$20240601$20240716$20240621$20240724$EXP$$US-AstraZeneca-2024A139351$ASTRAZENECA$$1086$MON$$F$Y$$$20240724$$CN$US$
240009372$24000937$2$F$$20240821$20240621$20240828$EXP$$IT-BIOGEN-2024BI01270097$BIOGEN$$$$A$F$Y$$$20240828$$MD$IT$IT
240009492$24000949$2$F$$20240617$20240621$20240702$EXP$$BR-ROCHE-10000003675$ROCHE$Nobre L, Rosas C, Kalichsztein B, Nobre G, Kalichsztein M, Marinho A, et al. Recurrent Pulmonary Hemorrhage in a Young Adult. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:A7055.$48$YR$A$F$Y$$$20240702$$HP$BR$BR
240009502$24000950$2$F$20240617$20240724$20240621$20240729$EXP$$US-KYOWAKIRIN-2024KK015015$KYOWA$$$$$$Y$$$20240729$$HP$US$US
240009692$24000969$2$F$20240101$20240626$20240621$20240705$PER$$US-SA-2024SA180216$SANOFI AVENTIS$$24$YR$A$M$Y$90.6$KG$20240705$$CN$US$US
240009803$24000980$3$F$20240404$20240710$20240621$20240715$EXP$$US-KYOWAKIRIN-2024KK015085$KYOWA$$$$$$Y$$$20240715$$HP$US$US
240009823$24000982$3$F$20240419$20240730$20240621$20240813$EXP$$CA-HLS-202401483$HLS THERAPEUTICS$$26$YR$A$M$Y$$$20240813$$MD$CA$CA
240010112$24001011$2$F$20240516$20240703$20240621$20240712$30DAY$$US-AMGEN-USASP2024118765$AMGEN$$77$YR$E$F$Y$80.74$KG$20240712$$HP$US$US
240010182$24001018$2$F$20230101$20240715$20240621$20240720$PER$$US-AMGEN-USASP2024120957$AMGEN$$58$YR$A$M$Y$$$20240720$$CN$US$US
240010222$24001022$2$F$20240114$20240627$20240621$20240702$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003492$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240702$$MD$JP$JP
240010422$24001042$2$F$20240722$20240917$20240621$20240919$EXP$$US-PFIZER INC-202400197861$PFIZER$$65$YR$$F$Y$$$20240919$$HP$US$US
240010452$24001045$2$F$20240621$20240627$20240621$20240702$EXP$$US-TAKEDA-2024TUS061077$TAKEDA$$51$YR$$F$Y$48$KG$20240702$$HP$US$US
240010463$24001046$3$F$20230110$20240805$20240621$20240806$EXP$$US-TAKEDA-2023TUS013782$TAKEDA$$48$YR$$F$Y$$$20240806$$MD$US$US
240010522$24001052$2$F$$20240924$20240621$20240930$EXP$$US-JNJFOC-20240646630$JOHNSON AND JOHNSON$$$$$F$Y$$$20240929$$MD$US$US
240010553$24001055$3$F$20240101$20240717$20240621$20240731$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-009538$JAZZ$$65$YR$$F$Y$$$20240731$$MD$JP$JP
240010652$24001065$2$F$$20240626$20240621$20240708$EXP$$JP-INCYTE CORPORATION-2024IN006402$INCYTE$$$$$$Y$$$20240708$$MD$JP$JP
240010782$24001078$2$F$$20240729$20240621$20240805$30DAY$$IN-JNJFOC-20240639518$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$IN$IN
240010842$24001084$2$F$$20240710$20240621$20240718$EXP$$CA-AstraZeneca-2024A144058$ASTRAZENECA$$$$$F$Y$$$20240718$$MD$CA$
240010892$24001089$2$F$$20240627$20240621$20240702$EXP$$US-PFIZER INC-PV202400081611$PFIZER$$64$YR$$M$Y$$$20240702$$HP$US$US
240010953$24001095$3$F$20240609$20240712$20240621$20240724$PER$$US-AMGEN-USASP2024120688$AMGEN$$72$YR$E$M$Y$$$20240724$$CN$US$US
240011072$24001107$2$F$$20240704$20240621$20240711$EXP$$BR-UCBSA-2024031391$UCB$$$$$M$Y$$$20240711$$CN$BR$BR
240011183$24001118$3$F$$20240731$20240621$20240801$EXP$$GB-JNJFOC-20240656136$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240801$$HP$GB$GB
240011262$24001126$2$F$$20240613$20240621$20240708$PER$$US-TRAVERE-2024TVT00608$TRAVERE THERAPEUTICS$$$$$$Y$$$20240708$$CN$US$US
240011363$24001136$3$F$20240529$20240725$20240621$20240726$PER$$US-JNJFOC-20240649190$JOHNSON AND JOHNSON$$42$YR$A$$Y$$$20240726$$HP$US$US
240011385$24001138$5$F$$20240805$20240621$20240926$PER$$US-GSK-US2024AMR073389$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
240011402$24001140$2$F$20240614$20240729$20240621$20240801$PER$$US-ALXN-202406USA001033US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
240011452$24001145$2$F$20231001$20240628$20240621$20240705$EXP$$JP-AstraZeneca-2023A263532$ASTRAZENECA$$51$YR$$M$Y$62$KG$20240705$$MD$JP$
240011482$24001148$2$F$20220403$20240614$20240621$20240717$EXP$$FR-AstraZeneca-2024A005104$ASTRAZENECA$$$$$$Y$$$20240717$$HP$FR$
240011502$24001150$2$F$$20240919$20240621$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099527$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240920$$CN$US$US
240011512$24001151$2$F$$20240618$20240621$20240715$EXP$$FR-AstraZeneca-2024A143455$ASTRAZENECA$$85$YR$$F$Y$$$20240715$$MD$FR$
240011532$24001153$2$F$20240101$20240716$20240621$20240725$EXP$$US-RADIUS HEALTH, INC.-2024US003897$RADIUS PHARM$$$$$F$Y$$$20240725$$CN$US$US
240011542$24001154$2$F$20230614$20240801$20240621$20240809$EXP$PT-INFARMED-J202405-868$PT-TEVA-VS-3210613$TEVA$$59$YR$$M$Y$85$KG$20240809$$CN$PT$PT
240011572$24001157$2$F$20240501$20240702$20240621$20240710$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001245$BLUEPRINT MEDICINES$$65$YR$E$M$Y$$$20240710$$CN$US$US
240011592$24001159$2$F$$20240730$20240621$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100140$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240801$$CN$US$US
240011612$24001161$2$F$$20240713$20240621$20240722$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001238$BLUEPRINT MEDICINES$$$$$F$Y$$$20240722$$CN$US$US
240011646$24001164$6$F$20230202$20240923$20240621$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE059663$SANDOZ$$$$E$F$Y$65$KG$20240926$$MD$DE$DE
240011662$24001166$2$F$$20240820$20240621$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002622$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
240011693$24001169$3$F$20240615$20240705$20240621$20240711$EXP$$CO-BIOMARINAP-CO-2024-158682$BIOMARIN$$$$$$Y$$$20240711$$CN$CO$CO
240011752$24001175$2$F$20240601$20240726$20240621$20240728$PER$$US-JNJFOC-20240646823$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240728$$HP$US$US
240012223$24001222$3$F$$20240926$20240621$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100030$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240930$$CN$US$US
240012322$24001232$2$F$20240401$20240627$20240621$20240701$PER$$US-JNJFOC-20240647686$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240701$$CN$US$US
240012463$24001246$3$F$20240607$20240712$20240621$20240716$PER$$US-ROCHE-10000005722$ROCHE$$15$YR$T$M$Y$$$20240716$$CN$US$US
240012502$24001250$2$F$$20240614$20240621$20240716$EXP$$CA-AstraZeneca-2024A096564$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$CA$
240012573$24001257$3$F$$20240612$20240621$20240819$PER$$US-ABBVIE-5804096$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
240012702$24001270$2$F$20240611$20240626$20240621$20240701$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003454$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240701$$CN$US$US
240012722$24001272$2$F$20240618$20240715$20240621$20240718$EXP$$CA-Taiho Oncology Inc-2024-005858$TAIHO ONCOLOGY INC$$54$YR$A$M$Y$$$20240718$$CN$CA$CA
240012732$24001273$2$F$20240529$20240628$20240621$20240708$EXP$$US-BAYER-2024A085949$BAYER$$$$$M$Y$$$20240708$$CN$US$US
240012772$24001277$2$F$20240201$20240712$20240621$20240717$EXP$$ES-BAUSCH-BL-2024-009339$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240717$$MD$ES$ES
240012792$24001279$2$F$$20240612$20240621$20240702$PER$$US-ROCHE-10000003188$ROCHE$$6$YR$C$$Y$$$20240702$$PH$US$US
240012902$24001290$2$F$$20240709$20240621$20240710$PER$$NVSC2024US130147$NOVARTIS$$$$$$Y$$$20240710$$HP$US$US
240012972$24001297$2$F$$20240729$20240621$20240801$PER$$US-ALXN-202406USA001016US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240013013$24001301$3$F$$20240813$20240621$20240821$EXP$$FR-AstraZeneca-2024A141701$ASTRAZENECA$$82$YR$$M$Y$$$20240821$$MD$FR$
240013152$24001315$2$F$$20240618$20240621$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202406013589$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240701$$CN$US$US
240013173$24001317$3$F$20220803$20240626$20240621$20240701$EXP$$CN-PFIZER INC-202400195240$PFIZER$Liu, K.. The role of gut microbiota and the gut-lung axis in sepsis: A case study of a pregnant woman with severe rickettsial pneumonia and septic shock complicated by MODS. Clinical case reports. 2024;12(6):10.35366/114665$27$YR$$F$Y$$$20240701$$MD$CN$CN
240013232$24001323$2$F$$20240701$20240621$20240710$EXP$$JP-TAKEDA-2024TUS060265$TAKEDA$$70$YR$$M$Y$67$KG$20240710$$MD$JP$JP
240013264$24001326$4$F$$20240617$20240621$20240729$EXP$$NVSC2023CA279152$NOVARTIS$$44$YR$$F$Y$97$KG$20240729$$HP$CA$CA
240013342$24001334$2$F$20240501$20240729$20240621$20240801$PER$$US-ALXN-202406USA000959US$ALEXION PHARMACEUTICALS$$64$YR$$M$Y$$$20240801$$CN$US$US
240013422$24001342$2$F$20240601$20240718$20240621$20240722$EXP$$CA-PFIZER INC-202400197393$PFIZER$$78$YR$$M$Y$$$20240722$$CN$CA$CA
240013432$24001343$2$F$$20240723$20240621$20240725$PER$$NVSC2024US130155$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
240013452$24001345$2$F$20230831$20240709$20240621$20240712$EXP$$NVSC2023CA192524$NOVARTIS$$32$YR$$M$Y$$$20240712$$CN$CA$CA
240013482$24001348$2$F$20230510$20240819$20240621$20240827$EXP$$JP-DSJP-DSJ-2024-123753$DAIICHI$Oka M, Nishina T, Maeda R, Sumiyoshi M, Kajiwara Y, Ito M. EP-0681 Experience with Trastuzumab Deruxtecan (T-Dxd) for HER2-low metastatic and recurrent breast cancer at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;348$$$$F$Y$$$20240827$$MD$JP$JP
240013513$24001351$3$F$$20240724$20240621$20240729$EXP$$US-AstraZeneca-2024A141596$ASTRAZENECA$$68$YR$$F$Y$63$KG$20240729$$CN$US$
240013572$24001357$2$F$20240101$20240716$20240621$20240718$PER$$US-AMGEN-USASP2024121044$AMGEN$$65$YR$E$M$Y$$$20240718$$HP$US$US
240013582$24001358$2$F$20230801$20240723$20240621$20240726$EXP$FR-AFSSAPS-AN2024000749$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-094995$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$58$KG$20240726$$PH$FR$FR
240013623$24001362$3$F$$20240805$20240621$20240816$EXP$$US-SMPA-2024SPA000064$SUNOVION$$$$$$Y$$$20240816$$CN$US$US
240013783$24001378$3$F$20240610$20240801$20240621$20240815$EXP$$JP-ALXN-202406JPN000805JP$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240815$$MD$JP$JP
240013812$24001381$2$F$$20240716$20240621$20240719$PER$$US-PFIZER INC-PV202400081183$PFIZER$$78$YR$$F$Y$$$20240719$$PH$US$US
240013822$24001382$2$F$20240529$20240918$20240621$20240919$30DAY$$CL-PFIZER INC-202400193087$PFIZER$$10$YR$$$Y$$$20240919$$CN$CL$CL
240013866$24001386$6$F$20240601$20240915$20240621$20240916$30DAY$$AR-PFIZER INC-202400196971$PFIZER$$13$YR$$M$Y$$$20240916$$CN$AR$AR
240013943$24001394$3$F$20220103$20240729$20240621$20240807$EXP$DE-CADRBFARM-2024328441$DE-GUERBET / LLC-DE-20240020$GUERBET$$45$YR$A$F$Y$63$KG$20240807$$MD$DE$DE
240013952$24001395$2$F$$20240716$20240621$20240724$PER$$US-SA-2024SA179856$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$MD$US$US
240013962$24001396$2$F$$20240611$20240621$20240701$EXP$$US-BEH-2024173943$CSL BEHRING$$74$YR$E$F$Y$$$20240701$$HP$US$US
240014093$24001409$3$F$20240423$20240802$20240621$20240805$PER$$US-ALXN-202406USA001027US$ALEXION PHARMACEUTICALS$$75$YR$$F$Y$$$20240805$$CN$US$US
240014133$24001413$3$F$$20240820$20240621$20240902$PER$$US-JNJFOC-20240637912$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240902$$CN$US$US
240014222$24001422$2$F$20240614$20240625$20240621$20240702$EXP$$CO-BAYER-2024A088147$BAYER$$44$YR$A$F$Y$$$20240702$$CN$CO$CO
240014262$24001426$2$F$20240510$20240705$20240621$20240717$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406005807AA$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240717$$CN$JP$JP
240014312$24001431$2$F$$20240811$20240621$20240812$EXP$$US-PFIZER INC-PV202400081747$PFIZER$$$$$F$Y$$$20240812$$HP$US$US
240014352$24001435$2$F$$20240730$20240621$20240802$EXP$$US-ALXN-202406USA000865US$ALEXION PHARMACEUTICALS$$61$YR$$F$Y$$$20240802$$MD$US$US
240014462$24001446$2$F$$20240724$20240621$20240724$PER$$US-PFIZER INC-202400196059$PFIZER$$16$YR$$M$Y$$$20240724$$CN$US$US
240014492$24001449$2$F$$20240830$20240621$20240904$EXP$$US-ASTELLAS-2024US017501$ASTELLAS$$$$$$Y$$$20240904$$MD$US$US
240014532$24001453$2$F$$20240715$20240621$20240725$PER$$US-RDY-SPO/USA/24/0008756$DR REDDYS$$81$YR$E$F$Y$$$20240725$$CN$US$US
240014593$24001459$3$F$20240611$20240708$20240621$20240722$EXP$$JP-Eisai-EC-2024-168254$EISAI$$78$YR$E$F$Y$36$KG$20240722$$MD$JP$JP
240014602$24001460$2$F$20231128$20240625$20240621$20240703$EXP$$CN-Ipsen Biopharmaceuticals, Inc.-2023-27407$IPSEN$$72$YR$E$M$Y$80$KG$20240703$$MD$CN$CN
240014623$24001462$3$F$$20240704$20240621$20240709$EXP$$ES-BAUSCH-BL-2024-009196$BAUSCH AND LOMB$Mohino-Farre N, Just-Sarobe M, Pujol-Montcusi J, Martin-Callizo C, Pastor-Jane L. Usefulness of photodynamic diagnosis for the follow-up of non-surgical extramammary Paget^s disease. Photodermatology Photoimmunology and Photomedicine. 2024;40(3):1-4. doi:10.1111/phpp.12976$72$YR$$F$Y$$$20240709$$HP$ES$ES
240014632$24001463$2$F$$20240626$20240621$20240706$EXP$$AT-TEVA-VS-3210428$TEVA$Adreana Kleinveld VE, Wanschitz J, Loscher WN, Hotter A, Cornelia Horlings CG. Deterioration in multifocal motor neuropathy upon treatment of immune-related adverse events of checkpoint inhibition.. Immunotherapy. 2024;16:1-5; Adreana Kleinveld VE, Wanschitz J, Loscher WN, Hotter A, Cornelia Horlings CG. Deterioration in multifocal motor neuropathy upon treatment of immune-related adverse events of checkpoint inhibition.. Immunotherapy. 2024;16:1-5$72$YR$$M$Y$$$20240706$$HP$AT$AT
240014643$24001464$3$F$$20240715$20240621$20240716$EXP$$US-INCYTE CORPORATION-2024IN006475$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240014702$24001470$2$F$$20240703$20240621$20240705$EXP$$JP-BAUSCH-BL-2024-009584$BAUSCH AND LOMB$$$$$$Y$$$20240705$$PH$JP$JP
240014852$24001485$2$F$20240408$20240628$20240621$20240701$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035398$BOEHRINGER INGELHEIM$$88$YR$E$M$Y$$$20240701$$CN$US$US
240014892$24001489$2$F$$20240626$20240621$20240708$EXP$$AT-ELI_LILLY_AND_COMPANY-AT202406005509$ELI LILLY AND CO$$68$YR$E$M$Y$60$KG$20240708$$CN$AT$AT
240014953$24001495$3$F$20240601$20240731$20240621$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100088$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240801$$CN$US$US
240015104$24001510$4$F$20240429$20240620$20240621$20240701$EXP$$DE-PFIZER INC-202400198448$PFIZER$$79$YR$$M$Y$85$KG$20240701$$HP$DE$DE
240015112$24001511$2$F$20240604$20240628$20240621$20240708$PER$$US-INCYTE CORPORATION-2024IN006345$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240015182$24001518$2$F$20231201$20240911$20240621$20240919$EXP$$CA-VER-202400340$VERITY PHARMACEUTICALS$$68$YR$E$M$Y$$$20240919$$HP$CA$CA
240015237$24001523$7$F$20240601$20240923$20240621$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093932$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240930$$CN$US$US
240015242$24001524$2$F$$20240802$20240621$20240805$EXP$$ES-ALXN-202406EEA000906ES$ALEXION PHARMACEUTICALS$$12$YR$$M$Y$$$20240805$$MD$ES$ES
240015272$24001527$2$F$20240609$20240626$20240621$20240705$PER$$US-SA-2024SA177426$SANOFI AVENTIS$$12$YR$T$M$Y$54$KG$20240705$$MD$US$US
240015293$24001529$3$F$20240315$20240910$20240621$20240917$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406007619$ELI LILLY AND CO$$38$YR$A$M$Y$74$KG$20240917$$CN$JP$JP
240015482$24001548$2$F$20100101$20240626$20240621$20240703$EXP$$JP-TEVA-VS-3211558$TEVA$$8$DEC$$M$Y$$$20240703$$CN$JP$JP
240015524$24001552$4$F$$20240726$20240621$20240807$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202403000537$ELI LILLY AND CO$$78$YR$E$M$Y$60$KG$20240807$$CN$CN$CN
240015612$24001561$2$F$20240505$20240705$20240621$20240709$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009519$JAZZ$$15$YR$$M$Y$$$20240709$$CN$US$US
240015702$24001570$2$F$$20240729$20240621$20240801$PER$$US-ALXN-202406USA000969US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
240015862$24001586$2$F$$20240814$20240621$20240826$EXP$$CA-PFIZER INC-202400196739$PFIZER$$80$YR$$M$Y$89$KG$20240826$$HP$CA$CA
240015912$24001591$2$F$$20240729$20240621$20240801$PER$$US-ALXN-202406USA000966US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
240016112$24001611$2$F$$20240924$20240621$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA059169$SANDOZ$$25$YR$$F$Y$$$20240925$$HP$CA$CA
240016122$24001612$2$F$20240801$20240917$20240621$20240925$EXP$$AU-SANDOZ INC.-SDZ2024AU059395$SANDOZ$$59$YR$$M$Y$$$20240925$$MD$AU$AU
240016132$24001613$2$F$$20240624$20240621$20240701$EXP$$GB-SANDOZ INC.-SDZ2023GB000932$SANDOZ$$$$$M$Y$$$20240701$$PH$GB$GB
240016182$24001618$2$F$20240612$20240814$20240621$20240819$EXP$$US-GILEAD-2024-0677964$GILEAD$$42$YR$A$F$Y$$$20240819$$CN$US$US
240016202$24001620$2$F$$20240705$20240621$20240711$EXP$$CL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-022320$BOEHRINGER INGELHEIM$$45$YR$A$F$Y$$$20240711$$MD$CL$CL
240016222$24001622$2$F$20240122$20240910$20240621$20240916$EXP$$JP-009507513-2406JPN001931J$MERCK$$7$DEC$$F$Y$$$20240916$$MD$JP$JP
240016233$24001623$3$F$20240101$20240826$20240621$20240905$PER$$US-SA-2024SA174606$SANOFI AVENTIS$$81$YR$E$F$Y$60.327$KG$20240905$$MD$US$US
240016273$24001627$3$F$20200101$20240717$20240621$20240719$EXP$$US-TAKEDA-2024TUS061981$TAKEDA$$$$$M$Y$$$20240719$$HP$US$US
240016283$24001628$3$F$$20240802$20240621$20240805$EXP$$US-ALXN-202406USA000990US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$MD$US$US
240016343$24001634$3$F$20240301$20240807$20240621$20240819$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202406008934$ELI LILLY AND CO$$59$YR$A$M$Y$106$KG$20240819$$CN$DE$DE
240016412$24001641$2$F$20231020$20240628$20240621$20240712$EXP$$NL-VER-202400046$VERITY PHARMACEUTICALS$$75$YR$E$M$Y$122$KG$20240712$$HP$NL$NL
240016482$24001648$2$F$$20240816$20240621$20240821$EXP$$AU-SANDOZ INC.-SDZ2024AU058831$SANDOZ$$45$YR$$F$Y$$$20240821$$MD$AU$AU
240016534$24001653$4$F$20240730$20240814$20240621$20240926$EXP$$US-APELLIS-APL-2022-001473$APELLIS PHARMACEUTICALS$$$$$$Y$98.87$KG$20240910$$CN$US$US
240016642$24001664$2$F$$20240724$20240621$20240731$PER$$US-ALXN-202406USA000914US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
240016662$24001666$2$F$$20240724$20240621$20240729$EXP$$JP-009507513-2406JPN002549J$MERCK$Miyazawa M, Yanagi M, Chiba T, Kido H, Matsuo T, Nishitani M, et al.. [CASE REPORT] Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease. Internal Medicine. 2024;63(11):1563-8$53$YR$$F$Y$$$20240729$$MD$JP$JP
240016763$24001676$3$F$20240704$20240829$20240621$20240905$EXP$$US-BIOMARINAP-US-2024-158586$BIOMARIN$$$$$$Y$$$20240905$$CN$US$US
240016912$24001691$2$F$20240618$20240729$20240621$20240801$PER$$US-AMGEN-USASP2024120849$AMGEN$$77$YR$E$M$Y$$$20240801$$CN$US$US
240016962$24001696$2$F$20240201$20240726$20240621$20240731$PER$$JP-Eisai-EC-2024-168293$EISAI$$77$YR$E$F$Y$$$20240731$$MD$JP$JP
240016982$24001698$2$F$20240415$20240801$20240621$20240809$EXP$$JP-Eisai-EC-2024-165669$EISAI$$$$E$M$Y$$$20240809$$MD$JP$JP
240016992$24001699$2$F$20240616$20240807$20240621$20240809$PER$$US-AMGEN-USASP2024122219$AMGEN$$62$YR$A$M$Y$$$20240809$$CN$US$US
240017032$24001703$2$F$$20240711$20240621$20240719$30DAY$$US-GSK-US2024AMR074896$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$CN$US$US
240017103$24001710$3$F$20240101$20240722$20240621$20240731$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00243$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240731$$HP$US$US
240017192$24001719$2$F$20240101$20240625$20240621$20240701$EXP$$MX-GENMAB-2024-02170$GENMAB$$$$$M$Y$64$KG$20240701$$MD$MX$MX
240017382$24001738$2$F$20240618$20240628$20240622$20240703$PER$$US-AMGEN-USASP2024122137$AMGEN$$69$YR$E$M$Y$$$20240703$$CN$US$US
240017562$24001756$2$F$20240604$20240719$20240622$20240723$EXP$$CO-ABBVIE-5808476$ABBVIE$$55$YR$$F$Y$61$KG$20240723$$CN$CO$CO
240017652$24001765$2$F$$20240628$20240622$20240702$EXP$$JP-UCBSA-2024030202$UCB$Katata Y, Seiji O, Haruo N, Naoya N, Jun T, Fanfu W, et al. A case of a girl with CNKSR2 pathogenic variant with severe DEE-SWAS due to skewed x-chromosome inactivation. Official Journal of the Japanese Society of Child Neurology, Brain + Development. 2024;56:S312$7$YR$$F$Y$$$20240702$$MD$JP$JP
240017663$24001766$3$F$20230101$20240816$20240622$20240822$EXP$$CO-ABBVIE-5592217$ABBVIE$$$$$F$Y$55$KG$20240822$$CN$CO$CO
240017697$24001769$7$F$20240601$20240913$20240622$20240917$EXP$$JP-ABBVIE-5805366$ABBVIE$$28$YR$$M$Y$64$KG$20240917$$MD$JP$JP
240017713$24001771$3$F$$20240718$20240622$20240801$EXP$$JP-UCBSA-2024030416$UCB$Moriyama S, Kawata N, Taguchi H, Kawakami A, Suzuki H, Mori H, et al.. A case of neonatal epilepsy with good seizure control with lidocaine and lacosamide. No To Hattatsu (Brain and Development). 2024;56(S):S292$38$DY$$$Y$$$20240801$$MD$JP$JP
240017723$24001772$3$F$$20240710$20240622$20240716$PER$$NVSC2024US129997$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
240017732$24001773$2$F$20240601$20240827$20240622$20240831$EXP$$DE-ABBVIE-5809249$ABBVIE$$26$YR$$F$Y$$$20240831$$CN$DE$DE
240017752$24001775$2$F$$20240626$20240622$20240701$EXP$$JP-JNJFOC-20240656143$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$$COUNTRY NOT SPECIFIED$JP
240017792$24001779$2$F$20240618$20240627$20240622$20240702$PER$$US-AMGEN-USASP2024121020$AMGEN$$35$YR$A$F$Y$145.19$KG$20240702$$MD$US$US
240017823$24001782$3$F$$20240708$20240622$20240713$EXP$$JP-JNJFOC-20240656114$JOHNSON AND JOHNSON$$$$$$Y$$$20240713$$$COUNTRY NOT SPECIFIED$JP
240017833$24001783$3$F$$20240628$20240622$20240710$EXP$$JP-UCBSA-2024030428$UCB$Maizuru K, Usami A, Inagi T, Yano N, Yoshida K. A case of good response to levetiracetam for seizures associated with the VAMP2 variant. Official Journal of the Japanese Society of Child Neurology, Brain + Development. 2024;56(S):S314$41$YR$$M$Y$$$20240710$$MD$JP$JP
240017883$24001788$3$F$$20240708$20240622$20240713$EXP$$JP-JNJFOC-20240654978$JOHNSON AND JOHNSON$$$$$$Y$$$20240713$$$COUNTRY NOT SPECIFIED$JP
240017953$24001795$3$F$20240301$20240809$20240622$20240814$PER$$US-AMGEN-USASP2024121205$AMGEN$$49$YR$A$M$Y$$$20240814$$HP$US$US
240017983$24001798$3$F$20240202$20240910$20240622$20240919$EXP$$DE-CELLTRION INC.-2024DE014893$CELLTRION$$$$$$Y$$$20240919$$MD$DE$DE
240018002$24001800$2$F$20240610$20240628$20240622$20240705$EXP$$KR-UNITED THERAPEUTICS-UNT-2024-018128$UNITED THERAPEUTICS$$1$YR$$M$Y$7$KG$20240705$$$KR$KR
240018043$24001804$3$F$20240101$20240710$20240622$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018269$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240719$$$US$US
240018073$24001807$3$F$$20240717$20240622$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-018402$UNITED THERAPEUTICS$$$$$F$Y$100.68$KG$20240723$$$US$US
240018163$24001816$3$F$20240620$20240826$20240622$20240905$EXP$$US-JNJFOC-20240653927$JOHNSON AND JOHNSON$$84$YR$E$M$Y$80.812$KG$20240905$$CN$US$US
240018182$24001818$2$F$20240601$20240903$20240622$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-017987$UNITED THERAPEUTICS$$81$YR$$F$Y$54.875$KG$20240912$$$US$US
240018223$24001822$3$F$$20240913$20240622$20240926$EXP$$JP-UCBSA-2024030433$UCB$Nishiya T, Takamono K, Tsujihama K, Tokazu H. A case of drug-induced hypersensitivity syndrome recurrence with severe hepatic disorder. The Japanese Journal of Dermatology/The 123rd Annual Meeting of the Japanese Der. 2024;134(5):1519-20$50$YR$$M$Y$$$20240926$$MD$JP$JP
240018262$24001826$2$F$20240522$20240702$20240622$20240710$EXP$$CA-CELLTRION INC.-2024CA014997$CELLTRION$$$$$$Y$$$20240710$$HP$CA$CA
240018273$24001827$3$F$$20240708$20240622$20240714$EXP$$JP-JNJFOC-20240654942$JOHNSON AND JOHNSON$$$$$$Y$$$20240714$$$COUNTRY NOT SPECIFIED$JP
240018293$24001829$3$F$$20240708$20240622$20240713$EXP$$JP-JNJFOC-20240654939$JOHNSON AND JOHNSON$$$$$$Y$$$20240713$$$COUNTRY NOT SPECIFIED$JP
240018323$24001832$3$F$20240617$20240710$20240622$20240718$EXP$$US-AMGEN-USASP2024120240$AMGEN$$77$YR$E$F$Y$$$20240718$$CN$US$US
240018352$24001835$2$F$$20240703$20240622$20240705$EXP$$JP-JNJFOC-20240654943$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$$COUNTRY NOT SPECIFIED$JP
240018364$24001836$4$F$20200922$20240717$20240622$20240731$EXP$$JP-UCBSA-2024030442$UCB$Nakazawa M, Abe S, Ikeno M, Igarashi A, Shimizu T. A Case of Altered Consciousness and EEG Slowing with Lacosamide Administration.. The 66th Annual Meeting of the Japanese Society of child Neurology. 2024;56(S):P8-036$8$YR$$F$Y$$$20240731$$MD$JP$JP
240018382$24001838$2$F$20240606$20240711$20240622$20240715$PER$$US-JNJFOC-20240630835$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240715$$CN$US$US
240018403$24001840$3$F$$20240708$20240622$20240713$EXP$$JP-JNJFOC-20240654977$JOHNSON AND JOHNSON$$$$$$Y$$$20240713$$$COUNTRY NOT SPECIFIED$JP
240018453$24001845$3$F$$20240724$20240622$20240807$EXP$$JP-UCBSA-2024030443$UCB$Sugitate R, Oda K, Yaki N, Shimizu M, Matsui A, Ogata A, et al. ASED due to COVID-19 shifting seizures focus laterality accompanied by characteristic blood flow signal changes on MRI. No To Hattatsu. 2024;56:S301$6$YR$$$Y$$$20240807$$MD$JP$JP
240018482$24001848$2$F$20240611$20240703$20240622$20240712$EXP$$US-GSK-US2024AMR075399$GLAXOSMITHKLINE$$59$YR$$F$Y$82.086$KG$20240712$$CN$US$US
240018505$24001850$5$F$20240101$20240917$20240622$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018426$UNITED THERAPEUTICS$$$$$F$Y$75.737$KG$20240926$$$US$US
240018512$24001851$2$F$20240101$20240730$20240622$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013970$UNITED THERAPEUTICS$$$$$M$Y$109.3$KG$20240807$$$US$US
240018554$24001855$4$F$20240610$20240826$20240622$20240902$EXP$$US-GSK-US2024AMR075632$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240902$$CN$US$US
240018582$24001858$2$F$20240301$20240801$20240622$20240805$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009487$JAZZ$$35$YR$$M$Y$$$20240805$$CN$US$US
240018612$24001861$2$F$20240401$20240823$20240622$20240827$EXP$$NVSC2024US125858$NOVARTIS$$31$YR$$F$Y$$$20240827$$CN$US$US
240018644$24001864$4$F$20240619$20240730$20240622$20240803$PER$$US-AMGEN-USASP2024123066$AMGEN$$71$YR$E$F$Y$$$20240803$$MD$US$US
240018683$24001868$3$F$20240614$20240708$20240622$20240718$EXP$$US-GSK-US2024AMR075636$GLAXOSMITHKLINE$$57$YR$$F$Y$81.633$KG$20240718$$HP$US$US
240018702$24001870$2$F$$20240731$20240622$20240807$EXP$$IN-VANTIVE-2024VAN017795$Vantive US Healthcare$$61$YR$$F$Y$$$20240807$$CN$IN$IN
240018782$24001878$2$F$20240615$20240704$20240622$20240712$EXP$$CN-VANTIVE-2024VAN017793$Vantive US Healthcare$$28$YR$$M$Y$$$20240712$$CN$CN$CN
240018822$24001882$2$F$$20240729$20240622$20240801$PER$$US-ALXN-202406USA001015US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240018852$24001885$2$F$20200729$20240812$20240622$20240820$EXP$$CA-CELLTRION INC.-2020CA024904$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
240018872$24001887$2$F$20240612$20240813$20240622$20240823$30DAY$$US-GSK-US2024AMR074630$GLAXOSMITHKLINE$$71$YR$$M$Y$$$20240823$$CN$US$US
240018882$24001888$2$F$20240613$20240826$20240622$20240904$EXP$$JP-UCBSA-2024030445$UCB$$54$YR$$M$Y$$$20240904$$PH$JP$JP
240018902$24001890$2$F$20210624$20240823$20240622$20240902$EXP$$US-AMGEN-USASP2024119011$AMGEN$$57$YR$A$F$Y$74.83$KG$20240902$$LW$US$US
240018972$24001897$2$F$20231201$20240826$20240622$20240830$EXP$$JP-AMGEN-JPNSP2024121172$AMGEN$$84$YR$E$F$Y$$$20240830$$MD$JP$JP
240019042$24001904$2$F$20240616$20240801$20240622$20240803$PER$$US-AMGEN-USASP2024120232$AMGEN$$66$YR$E$M$Y$$$20240803$$CN$US$US
240019052$24001905$2$F$20240610$20240802$20240622$20240806$PER$$US-AMGEN-USASP2024119856$AMGEN$$78$YR$E$F$Y$$$20240806$$CN$US$US
240019103$24001910$3$F$$20240701$20240622$20240712$PER$$US-AstraZeneca-2024A144060$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
240019173$24001917$3$F$20240101$20240718$20240622$20240723$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009289$JAZZ$$54$YR$$F$Y$$$20240723$$MD$US$US
240019233$24001923$3$F$20220501$20240821$20240622$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-019060$JAZZ$$58$YR$$M$Y$$$20240825$$HP$US$US
240019279$24001927$9$F$20240101$20240830$20240622$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017254$UNITED THERAPEUTICS$$$$$F$Y$50.794$KG$20240906$$$US$US
240019353$24001935$3$F$20220101$20240710$20240622$20240725$EXP$$ES-AMGEN-ESPNI2024123120$AMGEN$$67$YR$E$F$Y$$$20240725$$CN$ES$ES
240019362$24001936$2$F$20240617$20240627$20240622$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018782$UNITED THERAPEUTICS$$79$YR$$M$Y$72.562$KG$20240706$$$US$US
240019433$24001943$3$F$20231013$20240712$20240622$20240716$EXP$$US-ABBVIE-5811740$ABBVIE$$68$YR$$M$Y$88$KG$20240716$$MD$US$US
240019523$24001952$3$F$$20240802$20240622$20240812$EXP$$US-GSK-US2024AMR076831$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
240019583$24001958$3$F$20240101$20240822$20240622$20240830$EXP$$US-ABBVIE-5809116$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
240019592$24001959$2$F$$20240802$20240622$20240808$EXP$$GB-TAKEDA-2024TUS025416$TAKEDA$$$$$M$Y$$$20240808$$CN$GB$GB
240019623$24001962$3$F$20240530$20240703$20240622$20240808$EXP$$FR-Accord-431452$ACCORD$$67$YR$E$F$Y$52$KG$20240808$$PH$FR$FR
240019723$24001972$3$F$$20240708$20240622$20240713$EXP$$JP-JNJFOC-20240656144$JOHNSON AND JOHNSON$$$$$$Y$$$20240713$$$COUNTRY NOT SPECIFIED$JP
240019733$24001973$3$F$$20240710$20240622$20240712$PER$$US-AMGEN-USASP2024121820$AMGEN$$$$A$M$Y$$$20240712$$CN$US$US
240019802$24001980$2$F$$20240718$20240622$20240728$30DAY$$US-GSK-US2024073851$GLAXOSMITHKLINE$$$$$M$Y$$$20240728$$HP$US$US
240019823$24001982$3$F$20240101$20240821$20240622$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-005478$JAZZ$$$$$F$Y$$$20240826$$CN$US$US
240019832$24001983$2$F$$20240627$20240622$20240701$EXP$$JP-JNJFOC-20240656725$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$$COUNTRY NOT SPECIFIED$JP
240019842$24001984$2$F$20240101$20240626$20240622$20240704$PER$$US-AMGEN-USASP2024121431$AMGEN$$47$YR$A$M$Y$$$20240704$$CN$US$US
240019883$24001988$3$F$$20240809$20240622$20240817$EXP$$JP-AMGEN-JPNSP2024119343$AMGEN$$$$$F$Y$$$20240817$$HP$JP$JP
240019902$24001990$2$F$$20240701$20240622$20240707$EXP$$JP-JNJFOC-20240656115$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$MD$JP$JP
240019972$24001997$2$F$20231010$20240531$20240622$20240920$EXP$$US-Accord-424197$ACCORD$$77$YR$E$F$Y$92.5$KG$20240920$$HP$US$US
240019992$24001999$2$F$$20240625$20240622$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-030325$AUROBINDO$$62$YR$$M$Y$$$20240704$$HP$US$US
240020052$24002005$2$F$20240101$20240723$20240622$20240725$EXP$$US-ABBVIE-5808413$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
240020093$24002009$3$F$$20240913$20240622$20240923$PER$$US-GSK-US2024073301$GLAXOSMITHKLINE$$$$$M$Y$$$20240923$$CN$US$US
240020122$24002012$2$F$20240601$20240702$20240622$20240710$EXP$$CA-ABBVIE-5808459$ABBVIE$$58$YR$$M$Y$$$20240710$$CN$CA$CA
240020153$24002015$3$F$20240618$20240801$20240622$20240805$PER$$US-AMGEN-USASP2024122002$AMGEN$$75$YR$E$M$Y$$$20240805$$CN$US$US
240020176$24002017$6$F$20240627$20240829$20240622$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010664$UNITED THERAPEUTICS$$36$YR$$M$Y$52.154$KG$20240906$$$US$US
240020184$24002018$4$F$20240101$20240813$20240622$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-018351$UNITED THERAPEUTICS$$$$$F$Y$47.619$KG$20240821$$$US$US
240020252$24002025$2$F$$20240712$20240622$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-029995$AUROBINDO$Suchitra Muralidharan, Andrew T Mariano, Dhruv J, Trisha EW, Seban L, Ahsan B. A Rare Case of Drug-Induced Sweet Syndrome After Pembrolizumab Therapy. Cureus. 2024;16(6):e62027$68$YR$$M$Y$$$20240723$$HP$US$US
240020264$24002026$4$F$20240601$20240702$20240622$20240711$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018388$UNITED THERAPEUTICS$$73$YR$$M$Y$76.19$KG$20240711$$$US$US
240020333$24002033$3$F$20240101$20240724$20240622$20240802$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014727$UNITED THERAPEUTICS$$44$YR$$F$Y$72.562$KG$20240802$$$US$US
240020342$24002034$2$F$20240619$20240706$20240622$20240708$PER$$US-AMGEN-USASP2024122047$AMGEN$$57$YR$A$M$Y$$$20240708$$CN$US$US
240020352$24002035$2$F$$20240903$20240622$20240916$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-09061$SAMSUNG BIOEPIS$$$$$M$Y$$$20240916$$CN$CA$CA
240020492$24002049$2$F$$20240712$20240622$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-030003$AUROBINDO$Haddad S, Graff S, Hadfield M, Wang Y, Taneja C, Leonard K, et al. Safety and efficacy of KEYNOTE-522 in combination with anti-retroviral therapy in a patient with HIV and triple-negative breast cancer. Cancer-Res. 2024;84 (Suppl.)(9):abstr. PO2-20-11$55$YR$$F$Y$$$20240722$$HP$US$US
240020502$24002050$2$F$$20240624$20240622$20240703$30DAY$$US-GSK-US2024074251$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240020512$24002051$2$F$20240603$20240716$20240622$20240725$EXP$$US-GSK-US2024073801$GLAXOSMITHKLINE$$44$YR$$M$Y$225$KG$20240725$$HP$US$US
240020583$24002058$3$F$20240603$20240703$20240622$20240703$EXP$$AU-ABBVIE-5807976$ABBVIE$$70$YR$$M$Y$72$KG$20240703$$MD$AU$AU
240020594$24002059$4$F$20240101$20240903$20240622$20240911$PER$$US-UNITED THERAPEUTICS-UNT-2024-018547$UNITED THERAPEUTICS$$$$$F$Y$67.12$KG$20240911$$$US$US
240020603$24002060$3$F$20240101$20240703$20240622$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-018790$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240706$$$US$US
240020612$24002061$2$F$20230203$20240709$20240622$20240715$EXP$$US-ABBVIE-5807993$ABBVIE$$63$YR$$F$Y$111$KG$20240715$$CN$US$US
240020732$24002073$2$F$20240521$20240809$20240622$20240817$EXP$$CA-CELLTRION INC.-2024CA015129$CELLTRION$$$$$$Y$$$20240817$$HP$CA$CA
240020743$24002074$3$F$$20240722$20240622$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-018859$UNITED THERAPEUTICS$$$$$M$Y$63.492$KG$20240727$$$US$US
240020792$24002079$2$F$20240619$20240722$20240622$20240724$PER$$US-AMGEN-USASP2024121677$AMGEN$$37$YR$A$F$Y$$$20240724$$HP$US$US
240020903$24002090$3$F$20240618$20240814$20240622$20240819$PER$$US-AMGEN-USASP2024122170$AMGEN$$61$YR$A$M$Y$$$20240819$$MD$US$US
240020952$24002095$2$F$20230101$20240801$20240622$20240808$EXP$$US-ABBVIE-5764807$ABBVIE$$$$$F$Y$46$KG$20240808$$CN$US$US
240021022$24002102$2$F$20240501$20240702$20240622$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098876$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240703$$CN$US$US
240021062$24002106$2$F$20230801$20240723$20240622$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-029887$AUROBINDO$$67$YR$$F$Y$58$KG$20240802$$PH$FR$FR
240021072$24002107$2$F$$20240830$20240622$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100446$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240906$$CN$US$US
240021122$24002112$2$F$20200218$20240709$20240622$20240723$EXP$$JP-ABBVIE-5812138$ABBVIE$$80$YR$$F$Y$$$20240723$$MD$JP$JP
240021132$24002113$2$F$20240314$20240625$20240622$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-030224$AUROBINDO$$76$YR$$M$Y$65$KG$20240703$$MD$FR$FR
240021173$24002117$3$F$$20240806$20240622$20240814$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-18785$SAMSUNG BIOEPIS$$77$YR$E$M$Y$$$20240814$$CN$GB$GB
240021202$24002120$2$F$20240617$20240701$20240622$20240703$PER$$US-AMGEN-USASP2024122106$AMGEN$$71$YR$E$F$Y$$$20240703$$MD$US$US
240021222$24002122$2$F$$20240717$20240622$20240723$PER$$US-AMGEN-USASP2024123588$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
240021242$24002124$2$F$20240601$20240725$20240622$20240807$PER$$US-JNJFOC-20240652347$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240807$$CN$US$US
240021264$24002126$4$F$20240101$20240731$20240622$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017564$UNITED THERAPEUTICS$$$$$F$Y$95.238$KG$20240809$$$US$US
240021292$24002129$2$F$$20240626$20240622$20240705$EXP$$US-TEVA-VS-3202452$TEVA$Kang BY, Khanna R, Patel MH, Glembocki DJ, Jeffy BG, Thosani MK, et al. Cemiplimab-Associated Eruption of Generalized Eruptive Keratoacanthoma of Grzybowski. Cutis 2024; 113 (1): E8-E10.; Kang BY, Khanna R, Patel MH, Glembocki DJ, Jeffy BG, Thosani MK, et al. Cemiplimab-Associated Eruption of Generalized Eruptive Keratoacanthoma of Grzybowski. Cutis 2024; 113 (1): E8-E10.$94$YR$$F$Y$$$20240705$$MD$US$US
240021412$24002141$2$F$20240522$20240711$20240622$20240722$EXP$FR-AFSSAPS-AN2024000781$FR-Accord-430594$ACCORD$$59$YR$A$M$Y$$$20240722$$PH$FR$FR
240021432$24002143$2$F$20240314$20240625$20240622$20240705$EXP$FR-AFSSAPS-NY2024000658$FR-Accord-430709$ACCORD$$76$YR$E$M$Y$65$KG$20240705$$MD$FR$FR
240021492$24002149$2$F$$20240627$20240622$20240703$EXP$$JP-ABBVIE-2210894US$ABBVIE$Shigeta H, Hukuda T, Watanabe S, Igarashi R, Hoshina T. Two neonates with abstinence syndrome due to prenatal escitalopram exposure. The 66th Annual Meeting of the Japanese Society of Child Neurology. 2024.; Hideomi S. Two neonates with abstinence syndrome due to prenatal escitalopram exposure. The 66th Annual Meeting of the Japanese Society of Child Neurology. 2024.$$$$F$Y$$$20240703$$MD$JP$JP
240021503$24002150$3$F$20240617$20240802$20240622$20240806$PER$$US-AMGEN-USASP2024121169$AMGEN$$77$YR$E$F$Y$$$20240806$$CN$US$US
240021525$24002152$5$F$20240101$20240730$20240622$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-018396$UNITED THERAPEUTICS$$$$$F$Y$67.574$KG$20240807$$$US$US
240021535$24002153$5$F$20240101$20240913$20240622$20240918$PER$$US-AMGEN-USASP2024122227$AMGEN$$69$YR$E$F$Y$$$20240917$$CN$US$US
240021574$24002157$4$F$20240101$20240716$20240622$20240723$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018465$UNITED THERAPEUTICS$$$$$M$Y$111.11$KG$20240723$$PH$US$US
240021602$24002160$2$F$20240501$20240920$20240622$20240930$EXP$$US-UCBSA-2024031787$UCB$$37$YR$$F$Y$$$20241001$$HP$US$US
240021622$24002162$2$F$$20240813$20240622$20240817$EXP$$FR-AMGEN-FRASP2024121499$AMGEN$$$$$M$Y$$$20240817$$PH$FR$FR
240021693$24002169$3$F$20240514$20240703$20240622$20240717$EXP$$FR-Accord-431821$ACCORD$$38$YR$A$F$Y$48$KG$20240717$$PH$FR$FR
240021792$24002179$2$F$20240615$20240705$20240622$20240713$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-019087$UNITED THERAPEUTICS$$60$YR$$M$Y$$$20240713$$$JP$JP
240021812$24002181$2$F$$20240627$20240622$20240703$EXP$$US-TAKEDA-2024TUS057310$TAKEDA$$$$$F$Y$$$20240703$$HP$US$US
240021923$24002192$3$F$$20240702$20240622$20240703$PER$$NVSC2024US130270$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240021952$24002195$2$F$20240522$20240711$20240622$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-029836$AUROBINDO$$59$YR$$M$Y$$$20240720$$PH$FR$FR
240021992$24002199$2$F$20240601$20240729$20240622$20240801$PER$$US-ALXN-202406USA000992US$ALEXION PHARMACEUTICALS$$55$YR$$F$Y$$$20240801$$CN$US$US
240022012$24002201$2$F$20240401$20240826$20240622$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002611$ACADIA PHARMACEUTICALS$$62$YR$$M$Y$$$20240918$$CN$US$US
240022052$24002205$2$F$20240101$20240720$20240622$20240730$PER$$US-UNITED THERAPEUTICS-UNT-2024-004955$UNITED THERAPEUTICS$$$$$F$Y$$$20240730$$$US$US
240022093$24002209$3$F$20240601$20240829$20240622$20240902$EXP$$US-ABBVIE-5811199$ABBVIE$$51$YR$$F$Y$$$20240902$$CN$US$US
240022142$24002214$2$F$20240101$20240712$20240622$20240716$PER$$US-AMGEN-USASP2024119371$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240022152$24002215$2$F$20240619$20240708$20240622$20240712$PER$$US-AMGEN-USASP2024123221$AMGEN$$74$YR$E$F$Y$$$20240712$$CN$US$US
240022162$24002216$2$F$20240615$20240618$20240622$20240716$PER$$US-AMGEN-USASP2024121356$AMGEN$$73$YR$E$M$Y$$$20240716$$CN$US$US
240022173$24002217$3$F$20240614$20240813$20240622$20240826$EXP$$AT-UCBSA-2024031439$UCB$$$$A$F$Y$70$KG$20240826$$MD$AT$AT
240022194$24002219$4$F$20220901$20240906$20240622$20240914$EXP$$JP-AMGEN-JPNSP2024120357$AMGEN$Tanahashi,Y;. A case of pseudohypoparathyroidism suspected from characteristic physical findings of hypocalcemia during treatment of thoracic and lumbar compression fractures. Journal of the Japan Endocrine Society. 2024;100 (1):P2-21-3$62$YR$A$F$Y$$$20240914$$MD$JP$JP
240022212$24002221$2$F$$20240813$20240622$20240904$PER$$US-AstraZeneca-2024A141990$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
240022302$24002230$2$F$20240101$20240806$20240622$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-011389$UNITED THERAPEUTICS$$$$$F$Y$43.084$KG$20240809$$$US$US
240022322$24002232$2$F$20240620$20240808$20240622$20240812$PER$$US-AMGEN-USASP2024123240$AMGEN$$55$YR$A$M$Y$$$20240811$$CN$US$US
240022342$24002234$2$F$$20240702$20240622$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-018726$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240710$$$US$US
240022403$24002240$3$F$20240601$20240725$20240622$20240806$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-127888$DAIICHI$$46$YR$$F$Y$$$20240806$$CN$US$US
240022422$24002242$2$F$$20240701$20240622$20240703$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-127890$DAIICHI$$$$$F$Y$$$20240703$$MD$US$US
240022445$24002244$5$F$20240101$20240730$20240622$20240808$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018792$UNITED THERAPEUTICS$$$$$F$Y$27.211$KG$20240808$$$US$US
240022454$24002245$4$F$$20240709$20240622$20240710$PER$$US-AMGEN-USASP2024121530$AMGEN$$$$$M$Y$$$20240710$$CN$US$US
240022482$24002248$2$F$$20240715$20240622$20240717$PER$$US-AMGEN-USASP2024119389$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
240022492$24002249$2$F$$20240802$20240622$20240806$PER$$US-AstraZeneca-2024A142662$ASTRAZENECA$$$$$F$Y$$$20240806$$MD$US$
240022572$24002257$2$F$$20240730$20240622$20240730$PER$$US-ALXN-202406USA001182US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
240022582$24002258$2$F$20240616$20240626$20240622$20240701$PER$$US-AMGEN-USASP2024122590$AMGEN$$85$YR$E$F$Y$$$20240701$$CN$US$US
240022822$24002282$2$F$20240101$20240717$20240622$20240722$PER$$US-AMGEN-USASP2024123078$AMGEN$$72$YR$E$F$Y$$$20240722$$CN$US$US
240022862$24002286$2$F$20240613$20240912$20240622$20240918$PER$$US-JNJFOC-20240657717$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240918$$PH$US$US
240022913$24002291$3$F$20240614$20240628$20240622$20240703$PER$$US-AMGEN-USASP2024123850$AMGEN$$81$YR$E$M$Y$$$20240703$$CN$US$US
240022944$24002294$4$F$20240620$20240703$20240622$20240704$PER$$US-AMGEN-USASP2024123842$AMGEN$$66$YR$E$M$Y$$$20240704$$CN$US$US
240022973$24002297$3$F$$20240822$20240622$20240831$30DAY$$US-ABBVIE-5811776$ABBVIE$$$$$$Y$$$20240831$$MD$US$US
240022983$24002298$3$F$$20240717$20240622$20240723$PER$$US-AMGEN-USASP2024122713$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
240022992$24002299$2$F$20240615$20240701$20240622$20240708$PER$$US-AstraZeneca-2024A144000$ASTRAZENECA$$22306$DY$$F$Y$$$20240708$$HP$US$
240023082$24002308$2$F$20240619$20240702$20240622$20240704$PER$$US-AMGEN-USASP2024121323$AMGEN$$74$YR$E$F$Y$$$20240704$$CN$US$US
240023112$24002311$2$F$$20240614$20240622$20240711$PER$$US-JNJFOC-20240641582$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240023152$24002315$2$F$20240515$20240715$20240622$20240723$30DAY$$US-GSK-US2024073234$GLAXOSMITHKLINE$$42$YR$$F$Y$$$20240723$$MD$US$US
240023172$24002317$2$F$20240620$20240718$20240622$20240723$PER$$US-AMGEN-USASP2024123160$AMGEN$$73$YR$E$M$Y$$$20240723$$PH$US$US
240023192$24002319$2$F$$20240624$20240622$20240703$PER$$US-AMGEN-USASP2024122772$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240023352$24002335$2$F$$20240812$20240623$20240905$PER$$US-AstraZeneca-2024A142152$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
240023432$24002343$2$F$$20240628$20240623$20240703$EXP$$JP-UCBSA-2024030444$UCB$Okubo Y, Hozuki C, Yanagi H, Tohru A, Takami T, Sawa S, et al. Auriculocondylar syndrome type 2 (ARCND2) caused by PLCB4 de novo missense variant with polymicrogyria and epilepsy. No To Hattatsu. 2024;56(S):S312$5$YR$$M$Y$$$20240703$$MD$JP$JP
240023452$24002345$2$F$$20240730$20240623$20240801$PER$$US-AstraZeneca-2024A142102$ASTRAZENECA$$$$$F$Y$$$20240801$$MD$US$
240023553$24002355$3$F$$20240828$20240623$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202406014398$ELI LILLY AND CO$$$$$$Y$$$20240831$$CN$US$US
240023572$24002357$2$F$$20240803$20240623$20240812$EXP$$CA-ROCHE-3580343$ROCHE$$$$$F$Y$$$20240812$$HP$CA$CA
240023683$24002368$3$F$$20240723$20240623$20240727$PER$$US-JNJFOC-20240634020$JOHNSON AND JOHNSON$$$$$M$Y$$$20240727$$CN$US$US
240023712$24002371$2$F$$20240711$20240623$20240718$30DAY$$US-GSK-US2024073332$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
240023762$24002376$2$F$$20240702$20240623$20240716$PER$$US-AstraZeneca-2024A136235$ASTRAZENECA$$67$YR$$M$Y$92.5$KG$20240716$$MD$US$
240023852$24002385$2$F$20240605$20240726$20240623$20240802$PER$$US-AMGEN-USASP2024117860$AMGEN$$$$$F$Y$$$20240801$$HP$US$US
240023902$24002390$2$F$20240525$20240724$20240623$20240731$EXP$$CN-GSK-CN2024APC067402$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$CN$CN
240023913$24002391$3$F$20240613$20240628$20240623$20240709$PER$$US-AMGEN-USASP2024118291$AMGEN$$55$YR$A$F$Y$99.773$KG$20240708$$HP$US$US
240023932$24002393$2$F$20240601$20240711$20240623$20240715$PER$$US-AMGEN-USASP2024122104$AMGEN$$90$YR$$M$Y$$$20240715$$CN$US$US
240023952$24002395$2$F$20240615$20240711$20240623$20240718$PER$$US-AstraZeneca-2024A140361$ASTRAZENECA$$24107$DY$$M$Y$$$20240718$$CN$US$
240023993$24002399$3$F$20240528$20240712$20240623$20240723$30DAY$$MX-JNJFOC-20240586380$JOHNSON AND JOHNSON$$50$YR$A$F$Y$73$KG$20240723$$CN$MX$MX
240024144$24002414$4$F$$20240704$20240623$20240725$EXP$$DE-JNJFOC-20240615659$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$DE$DE
240024192$24002419$2$F$$20240711$20240623$20240802$30DAY$$IE-JNJFOC-20240619034$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$PH$IE$IE
240024303$24002430$3$F$20240620$20240910$20240623$20240911$PER$$US-AMGEN-USASP2024122907$AMGEN$$77$YR$E$F$Y$52.6$KG$20240911$$MD$US$US
240024472$24002447$2$F$$20240705$20240623$20240715$EXP$$JP-UCBSA-2024030684$UCB$$4$YR$$M$Y$$$20240715$$PH$JP$JP
240024503$24002450$3$F$20230301$20240626$20240623$20240704$PER$$US-AMGEN-USASP2024122837$AMGEN$$62$YR$A$F$Y$95.8$KG$20240704$$CN$US$US
240024612$24002461$2$F$$20240720$20240623$20240731$EXP$$US-AUROBINDO-AUR-APL-2024-029954$AUROBINDO$Bansal D, Mahadevia H, Ponvilawan B, Al-Obaidi A, Buckley J, Subramanian J. Exceptional synergistic response of PARP inhibitor and immune checkpoint inhibitor in esophageal adenocarcinoma with a germline BRCA2 mutation: a case report. Therapeutic Advances in Medical Oncology. 2024;16:1-9$83$YR$$M$Y$$$20240731$$MD$US$US
240024622$24002462$2$F$20240615$20240628$20240623$20240708$30DAY$$US-GSK-US2024074997$GLAXOSMITHKLINE$$38$YR$$F$Y$$$20240708$$CN$US$US
240024733$24002473$3$F$20230101$20240709$20240623$20240711$EXP$$NVSC2024RO120138$NOVARTIS$$75$YR$$F$Y$$$20240711$$CN$RO$RO
240024813$24002481$3$F$$20240701$20240623$20240718$30DAY$$CH-JNJFOC-20240581472$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$PH$CH$CH
240024852$24002485$2$F$20240618$20240717$20240623$20240724$EXP$$TH-AMGEN-THASP2024121786$AMGEN$$80$YR$E$M$Y$$$20240723$$MD$TH$TH
240024892$24002489$2$F$$20240816$20240623$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099859$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240827$$CN$US$US
240024902$24002490$2$F$$20240709$20240623$20240710$PER$$US-AstraZeneca-2024A132950$ASTRAZENECA$$$$A$$Y$$$20240710$$MD$US$
240024932$24002493$2$F$20240916$20240917$20240623$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099800$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240925$$CN$US$US
240024962$24002496$2$F$20240614$20240827$20240623$20240906$30DAY$$US-GSK-US2024075842$GLAXOSMITHKLINE$$59$YR$$M$Y$$$20240906$$PH$US$US
240025092$24002509$2$F$20240401$20240628$20240623$20240704$PER$$US-AMGEN-USASP2024119214$AMGEN$$58$YR$A$F$Y$$$20240704$$MD$US$US
240025102$24002510$2$F$$20240827$20240623$20240905$EXP$$US-GSK-US2024AMR075459$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
240025183$24002518$3$F$$20240731$20240623$20240801$PER$$US-JNJFOC-20240648018$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
240025192$24002519$2$F$$20240716$20240623$20240718$EXP$$NVSJ2024JP007257$NOVARTIS$$92$YR$$M$Y$$$20240719$$MD$JP$JP
240025202$24002520$2$F$$20240702$20240623$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202406013769$ELI LILLY AND CO$$$$$M$Y$$$20240704$$CN$US$US
240025312$24002531$2$F$$20240717$20240623$20240723$EXP$$JP-BEH-2024173813$CSL BEHRING$$20$YR$A$M$Y$$$20240723$$PH$JP$JP
240025362$24002536$2$F$20240615$20240708$20240623$20240715$EXP$$JP-BEH-2024173866$CSL BEHRING$$$$$M$Y$$$20240715$$MD$JP$JP
240025392$24002539$2$F$$20240806$20240623$20240808$EXP$$NVSJ2024JP007227$NOVARTIS$$84$YR$$M$Y$$$20240809$$PH$JP$JP
240025463$24002546$3$F$20240525$20240621$20240623$20240712$30DAY$$CA-JNJFOC-20240600189$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$CA$CA
240025472$24002547$2$F$$20240724$20240623$20240728$EXP$$CN-JNJFOC-20240645128$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$MD$CN$CN
240025526$24002552$6$F$20230413$20240906$20240623$20240912$EXP$$JP-009507513-2406JPN002082J$MERCK$Idegami D. P-019 A case of recto-vesico-vaginal fistula developed after chemotherapy including PEM and Bev for post-CCRT recurrent advanced cervix carcinoma. The 66th Annual Meeting of Japan Society of Gynecologic Oncology. 2024;42(3):75$66$YR$$F$Y$$$20240912$$MD$JP$JP
240025532$24002553$2$F$20240615$20240919$20240623$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099904$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240919$$CN$US$US
240025592$24002559$2$F$20240514$20240708$20240623$20240717$30DAY$$FR-JNJFOC-20240562652$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240717$$PH$FR$FR
240025643$24002564$3$F$20240615$20240827$20240623$20240902$EXP$$US-JNJFOC-20240644910$JOHNSON AND JOHNSON$$41$YR$A$F$Y$45.8$KG$20240902$$HP$US$US
240025662$24002566$2$F$20240501$20240618$20240623$20240701$PER$$US-BAUSCHBL-2024BNL027972$BAUSCH AND LOMB$$92$YR$$F$Y$$$20240701$$CN$US$US
240025822$24002582$2$F$20240101$20240701$20240623$20240703$EXP$$JP-TAKEDA-2024TJP009288$TAKEDA$$9$DEC$$M$Y$$$20240703$$HP$JP$JP
240025913$24002591$3$F$$20240719$20240623$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099871$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240725$$HP$US$US
240025923$24002592$3$F$$20240717$20240623$20240722$30DAY$$AT-JNJFOC-20240621159$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$PH$AT$AT
240025932$24002593$2$F$20240601$20240625$20240623$20240701$EXP$$PT-JNJFOC-20240645290$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240701$$MD$PT$PT
240025962$24002596$2$F$20240617$20240802$20240623$20240806$PER$$US-AMGEN-USASP2024120978$AMGEN$$64$YR$A$F$Y$$$20240806$$CN$US$US
240026013$24002601$3$F$$20240625$20240623$20240711$EXP$$CA-SANDOZ INC.-NVSC2021CA297173$SANDOZ$$59$YR$$F$Y$68$KG$20240711$$HP$CA$CA
240026145$24002614$5$F$20240613$20240716$20240623$20240730$30DAY$$US-JNJFOC-20240635859$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240730$$CN$US$US
240026152$24002615$2$F$20230801$20240709$20240623$20240709$EXP$IT-MINISAL02-990804$IT-JNJFOC-20240650077$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240710$$MD$IT$IT
240026183$24002618$3$F$$20240708$20240623$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099208$BRISTOL MYERS SQUIBB$$94$YR$E$$Y$58.8$KG$20240712$$PH$JP$JP
240026202$24002620$2$F$$20240920$20240623$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100263$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240920$$CN$US$US
240026213$24002621$3$F$20240101$20240625$20240623$20240702$EXP$$US-ABBVIE-5810322$ABBVIE$$$$$F$Y$46.266$KG$20240702$$CN$US$US
240026232$24002623$2$F$20240615$20240815$20240623$20240815$EXP$$CA-PFIZER INC-202400196153$PFIZER$$84$YR$$F$Y$$$20240815$$CN$CA$CA
240026343$24002634$3$F$$20240712$20240623$20240718$EXP$$HU-ASTELLAS-2024EU006122$ASTELLAS$$52$YR$$M$Y$$$20240718$$CN$NL$HU
240026372$24002637$2$F$$20240712$20240623$20240717$30DAY$$TR-JNJFOC-20240581906$JOHNSON AND JOHNSON$$$$E$$Y$$$20240717$$HP$TR$TR
240026502$24002650$2$F$20240101$20240806$20240624$20240808$EXP$$US-ABBVIE-5807972$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
240026513$24002651$3$F$$20240806$20240624$20240808$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035425$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240808$$MD$CA$CA
240026532$24002653$2$F$20240607$20240710$20240624$20240712$PER$$US-JNJFOC-20240631714$JOHNSON AND JOHNSON$$24$YR$A$M$Y$67.192$KG$20240712$$CN$US$US
240026552$24002655$2$F$20240401$20240702$20240624$20240709$EXP$$NL-ABBVIE-5808417$ABBVIE$$$$E$F$Y$$$20240709$$HP$NL$NL
240026572$24002657$2$F$$20240724$20240624$20240725$PER$$US-HALEON-2183149$Haleon PLC$$83$YR$$$Y$$$20240725$$CN$US$US
240026612$24002661$2$F$$20240621$20240624$20240701$PER$$US-ABBVIE-5812174$ABBVIE$$$$$F$Y$72.574$KG$20240701$$HP$US$US
240026644$24002664$4$F$$20240708$20240624$20240725$30DAY$$US-JNJFOC-20240623336$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$HP$US$US
240026682$24002668$2$F$$20240827$20240624$20240831$EXP$$US-ABBVIE-5808297$ABBVIE$$$$$M$Y$82$KG$20240831$$CN$US$US
240026715$24002671$5$F$20240101$20240709$20240624$20240711$EXP$$PT-ABBVIE-5794760$ABBVIE$$73$YR$$M$Y$81$KG$20240711$$CN$PT$PT
240026772$24002677$2$F$20240610$20240712$20240624$20240719$30DAY$$US-AMGEN-USASP2024119885$AMGEN$$65$YR$E$M$Y$$$20240719$$PH$US$US
240026782$24002678$2$F$20240426$20240710$20240624$20240711$PER$$US-JNJFOC-20240630505$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$HP$US$US
240026822$24002682$2$F$$20240716$20240624$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100433$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240718$$CN$US$US
240026842$24002684$2$F$20230801$20240704$20240624$20240709$EXP$$CA-AMGEN-CANSL2023141096$AMGEN$$61$YR$A$M$Y$62$KG$20240708$$HP$CA$CA
240026853$24002685$3$F$20240614$20240702$20240624$20240708$30DAY$$US-AMGEN-USASP2024119900$AMGEN$$65$YR$E$F$Y$74.83$KG$20240707$$HP$US$US
240026862$24002686$2$F$20240525$20240618$20240624$20240702$30DAY$$CA-JNJFOC-20240584434$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240702$$PH$CA$CA
240026873$24002687$3$F$$20240920$20240624$20240925$EXP$$NVSJ2024JP007382$NOVARTIS$Yoshizawa S, Hirano D, Shoji Y, Sakaguchi H, Saito A, Takamasa Y et al.. A Patient who Developed Reversible Oligohydramnios due to Overdose of Angiotensin II Receptor Blocker during Pregnancy. JAPANESE JOURNAL OF PEDIATRIC NEPHROLOGY/THE 59TH ANNUAL MEETING OF THE JAPANESE. 2024;37(up):P-75$$$N$$Y$2.458$KG$20240926$$HP$JP$JP
240027022$24002702$2$F$20230101$20240701$20240624$20240703$EXP$$US-ABBVIE-5809523$ABBVIE$$$$$F$Y$77$KG$20240703$$CN$US$US
240027042$24002704$2$F$$20240712$20240624$20240714$EXP$$BG-ABBVIE-5811987$ABBVIE$$53$YR$$M$Y$$$20240714$$CN$BG$BG
240027092$24002709$2$F$$20240730$20240624$20240807$EXP$$JP-AMGEN-JPNSP2024123005$AMGEN$$$$$$Y$$$20240807$$PH$JP$JP
240027122$24002712$2$F$20230810$20240725$20240624$20240805$EXP$FR-AFSSAPS-LM2024000282$FR-Accord-428286$ACCORD$$0$DY$$F$Y$2$KG$20240805$$MD$FR$FR
240027272$24002727$2$F$$20240704$20240624$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100350$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$82.55$KG$20240705$$CN$US$US
240027292$24002729$2$F$20240610$20240730$20240624$20240801$PER$$US-AMGEN-USASP2024122959$AMGEN$$66$YR$E$F$Y$$$20240801$$CN$US$US
240027302$24002730$2$F$20240601$20240724$20240624$20240729$30DAY$$US-AMGEN-USASL2024122084$AMGEN$$59$YR$$M$Y$$$20240729$$CN$US$US
240027312$24002731$2$F$20240616$20240709$20240624$20240713$EXP$$CA-ABBVIE-5811398$ABBVIE$$$$$M$Y$$$20240713$$MD$CA$CA
240027363$24002736$3$F$20240531$20240701$20240624$20240715$30DAY$$CA-JNJFOC-20240616536$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240716$$PH$CA$CA
240027372$24002737$2$F$20240530$20240703$20240624$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002624$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240726$$CN$US$US
240027412$24002741$2$F$$20240919$20240624$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099015$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240919$$CN$US$US
240027422$24002742$2$F$$20240710$20240624$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100324$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$81.65$KG$20240712$$CN$US$US
240027472$24002747$2$F$20240619$20240627$20240624$20240701$PER$$US-AMGEN-USASP2024121817$AMGEN$$70$YR$E$M$Y$$$20240701$$CN$US$US
240027522$24002752$2$F$20240604$20240809$20240624$20240813$EXP$$US-ABBVIE-5808391$ABBVIE$$76$YR$$F$Y$$$20240813$$CN$US$US
240027532$24002753$2$F$20240519$20240918$20240624$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095712$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240924$$HP$US$US
240027562$24002756$2$F$$20240919$20240624$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100076$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240924$$CN$US$US
240027702$24002770$2$F$$20240724$20240624$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100243$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240726$$CN$US$US
240027722$24002772$2$F$$20240617$20240624$20240701$EXP$$GB-SANDOZ INC.-SDZ2024GB059172$SANDOZ$$$$$M$Y$$$20240701$$CN$GB$GB
240027734$24002773$4$F$$20240925$20240624$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US058397$SANDOZ$$$$$M$Y$$$20240930$$CN$US$US
240027782$24002778$2$F$$20240701$20240624$20240702$EXP$$CZ-SANDOZ INC.-NVSC2022CZ195899$SANDOZ$$52$YR$$F$Y$88$KG$20240702$$MD$CZ$CZ
240027992$24002799$2$F$$20240619$20240624$20240703$EXP$$UY-HALEON-2182716$Haleon PLC$Mena Y, Casuriaga A, Notejane M. Paracetamol poisoning in adolescents. Report of a series of cases. Revista Medica del Uruguay. 2024; 40(2): e701.$14$YR$$F$Y$$$20240702$$HP$UY$UY
240028012$24002801$2$F$$20240722$20240624$20240723$EXP$$US-ROCHE-10000004110$ROCHE$$74$YR$E$M$Y$$$20240723$$CN$US$US
240028102$24002810$2$F$$20240619$20240624$20240703$EXP$$UY-HALEON-2182717$Haleon PLC$Mena Y, Casuriaga A, Notejane M. Paracetamol poisoning in adolescents. Report of a series of cases. Revista Medica del Uruguay. 2024; 40(2): e701.$12$YR$$F$Y$$$20240702$$HP$UY$UY
240028163$24002816$3$F$$20240902$20240624$20240903$PER$$NVSC2024US130437$NOVARTIS$$$$$$Y$$$20240903$$MD$US$US
240028213$24002821$3$F$20070402$20240910$20240624$20240916$PER$$US-JNJFOC-20240645803$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20240916$$LW$US$US
240028222$24002822$2$F$20240501$20240627$20240624$20240704$EXP$$US-JNJFOC-20240637142$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240704$$CN$US$US
240028242$24002824$2$F$$20240613$20240624$20240713$EXP$$US-ROCHE-10000004707$ROCHE$$73$YR$E$M$Y$$$20240713$$CN$US$US
240028302$24002830$2$F$20230829$20240827$20240624$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-134369$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$64.9$KG$20240829$$MD$JP$JP
240028332$24002833$2$F$$20240619$20240624$20240704$EXP$$UY-HALEON-2182721$Haleon PLC$Mena Y, Casuriaga A, Notejane M. Paracetamol poisoning in adolescents. Report of a series of cases. Revista Medica del Uruguay. 2024; 40(2): e701.$14$YR$$F$Y$$$20240703$$HP$UY$UY
240028352$24002835$2$F$20221209$20240622$20240624$20240702$EXP$$US-NOVOPROD-1240232$NOVO NORDISK$$59$YR$$F$Y$99.773$KG$20240702$$CN$US$US
240028372$24002837$2$F$20240629$20240702$20240624$20240709$EXP$$US-TAKEDA-2023TUS101421$TAKEDA$$47$YR$$F$Y$$$20240709$$CN$US$US
240028383$24002838$3$F$20140101$20240715$20240624$20240725$EXP$$BR-NOVOPROD-1227672$NOVO NORDISK$$77$YR$$F$Y$82$KG$20240725$$CN$BR$BR
240028403$24002840$3$F$20240605$20240910$20240624$20240920$30DAY$$DE-NOVOPROD-1238628$NOVO NORDISK$$$$A$M$Y$$$20240920$$HP$DE$DE
240028552$24002855$2$F$$20240619$20240624$20240703$EXP$$UY-HALEON-2182718$Haleon PLC$Mena Y, Casuriaga A, Notejane M. Paracetamol poisoning in adolescents. Report of a series of cases. Revista Medica del Uruguay. 2024; 40(2): e701.$14$YR$$F$Y$$$20240702$$HP$UY$UY
240028582$24002858$2$F$$20240731$20240624$20240826$PER$$CA-TOLMAR, INC.-24CA049469$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
240028674$24002867$4$F$20240619$20240905$20240624$20240911$PER$$US-AMGEN-USASP2024122589$AMGEN$$71$YR$E$M$Y$$$20240910$$MD$US$US
240028682$24002868$2$F$20230101$20240618$20240624$20240707$PER$$US-AMGEN-USASL2023204982$AMGEN$$56$YR$A$M$Y$$$20240707$$CN$US$US
240028892$24002889$2$F$$20240624$20240624$20240702$EXP$$CA-TOLMAR, INC.-24CA050010$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240028932$24002893$2$F$$20240619$20240624$20240703$EXP$$UY-HALEON-2182719$Haleon PLC$Mena Y, Casuriaga A, Notejane M. Paracetamol poisoning in adolescents. Report of a series of cases. Revista Medica del Uruguay. 2024; 40(2): e701.$13$YR$$F$Y$$$20240702$$HP$UY$UY
240028944$24002894$4$F$$20240731$20240624$20240807$EXP$$CA-002147023-NVSC2024CA054087$Haleon PLC$$40$YR$$F$Y$96$KG$20240806$$HP$CA$CA
240028982$24002898$2$F$$20240610$20240624$20240703$PER$$US-ROCHE-10000002630$ROCHE$$$$$$Y$$$20240703$$PH$US$US
240029133$24002913$3$F$20240611$20240703$20240624$20240706$PER$$US-AMGEN-USASP2024121839$AMGEN$$79$YR$E$F$Y$$$20240706$$CN$US$US
240029172$24002917$2$F$$20240619$20240624$20240703$EXP$$UY-HALEON-2182720$Haleon PLC$Mena Y, Casuriaga A, Notejane M. Paracetamol poisoning in adolescents. Report of a series of cases. Revista Medica del Uruguay. 2024; 40(2): e701.$14$YR$$F$Y$$$20240702$$HP$UY$UY
240029222$24002922$2$F$$20240913$20240624$20240918$EXP$$US-BIOGEN-2024BI01270334$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
240029232$24002923$2$F$$20240923$20240624$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098965$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240923$$CN$US$US
240029292$24002929$2$F$$20240619$20240624$20240704$EXP$$UY-HALEON-2182722$Haleon PLC$Mena Y, Casuriaga A, Notejane M. Paracetamol poisoning in adolescents. Report of a series of cases. Revista Medica del Uruguay. 2024; 40(2): e701.$13$YR$$F$Y$$$20240703$$HP$UY$UY
240029343$24002934$3$F$20240821$20240822$20240624$20240823$EXP$$GB-SANDOZ INC.-SDZ2024GB059955$SANDOZ$$90$YR$$F$Y$$$20240823$$CN$GB$GB
240029477$24002947$7$F$20240503$20240903$20240624$20240909$EXP$$FR-SA-2024SA177142$SANOFI AVENTIS$$69$YR$E$F$Y$55.2$KG$20240909$$HP$FR$FR
240029615$24002961$5$F$20240101$20240708$20240624$20240713$EXP$$US-SA-2024SA182946$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240713$$MD$US$US
240029692$24002969$2$F$$20240717$20240624$20240722$EXP$$US-SA-2024SA183368$SANOFI AVENTIS$$$$A$M$Y$$$20240722$$MD$US$US
240029743$24002974$3$F$20240101$20240904$20240624$20240911$EXP$$US-SA-2024SA184323$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240911$$MD$US$US
240029763$24002976$3$F$20240101$20240912$20240624$20240917$EXP$$US-SA-2024SA182458$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240917$$MD$US$US
240029782$24002978$2$F$20240529$20240617$20240624$20240810$EXP$$GB-SA-2024SA182131$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240810$$CN$US$US
240029815$24002981$5$F$20240101$20240715$20240624$20240801$EXP$$US-SA-2024SA181152$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240719$$MD$US$US
240029822$24002982$2$F$20240120$20240918$20240624$20240920$EXP$CA-SA-SAC20240620001577$CA-SA-2024SA185034$SANOFI AVENTIS$$40$YR$A$F$Y$84$KG$20240920$$MD$CA$CA
240029963$24002996$3$F$20240701$20240808$20240624$20240820$PER$$US-SA-2024SA179794$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240820$$MD$US$US
240030072$24003007$2$F$20240601$20240808$20240624$20240820$PER$$US-SA-2024SA181098$SANOFI AVENTIS$$65$YR$E$F$Y$86$KG$20240820$$MD$US$US
240030102$24003010$2$F$20240521$20240702$20240624$20240723$PER$$CA-TOLMAR, INC.-24CA049546$TOLMAR$$75$YR$$M$Y$$$20240723$$HP$CA$CA
240030112$24003011$2$F$20240528$20240916$20240624$20240924$PER$$CA-TOLMAR, INC.-24CA049477$TOLMAR$$74$YR$$M$Y$$$20240924$$CN$CA$CA
240030232$24003023$2$F$20240101$20240719$20240624$20240730$PER$$US-SA-2024SA180190$SANOFI AVENTIS$$89$YR$E$F$Y$49.8$KG$20240730$$MD$US$US
240030262$24003026$2$F$$20240909$20240624$20240918$PER$$US-SA-2024SA179895$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240918$$MD$US$US
240030372$24003037$2$F$20240601$20240709$20240624$20240718$PER$$US-SA-2024SA179896$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240718$$MD$US$US
240030392$24003039$2$F$$20240619$20240624$20240704$EXP$$UY-HALEON-2182723$Haleon PLC$Mena Y, Casuriaga A, Notejane M. Paracetamol poisoning in adolescents. Report of a series of cases. Revista Medica del Uruguay. 2024; 40(2): e701.$14$YR$$F$Y$$$20240703$$HP$UY$UY
240030422$24003042$2$F$20240101$20240906$20240624$20240914$PER$$US-SA-2024SA179302$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240914$$MD$US$US
240030512$24003051$2$F$20240701$20240910$20240624$20240919$PER$$US-SA-2024SA179032$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240919$$MD$US$US
240030522$24003052$2$F$20240101$20240807$20240624$20240816$PER$$US-SA-2024SA179158$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240816$$MD$US$US
240030552$24003055$2$F$$20240625$20240624$20240704$PER$$US-SA-2024SA180161$SANOFI AVENTIS$$$$A$M$Y$$$20240704$$MD$US$US
240030582$24003058$2$F$20240101$20240813$20240624$20240827$PER$$US-SA-2024SA180990$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240827$$MD$US$US
240030602$24003060$2$F$$20240726$20240624$20240805$PER$$US-SA-2024SA157003$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
240030623$24003062$3$F$$20240722$20240624$20240731$PER$$US-SA-2024SA179500$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240731$$MD$US$US
240030682$24003068$2$F$20240101$20240823$20240624$20240906$PER$$US-SA-2024SA178840$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240906$$MD$US$US
240030752$24003075$2$F$20240101$20240827$20240624$20240911$PER$$US-SA-2024SA178790$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240911$$MD$US$US
240030772$24003077$2$F$20240101$20240805$20240624$20240813$PER$$US-SA-2024SA180512$SANOFI AVENTIS$$36$YR$A$F$Y$75$KG$20240814$$CN$US$US
240030782$24003078$2$F$20240801$20240906$20240624$20240919$PER$$US-SA-2024SA179028$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240919$$MD$US$US
240030952$24003095$2$F$$20240906$20240624$20240916$PER$$US-SA-2024SA178986$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240916$$MD$US$US
240031002$24003100$2$F$20240101$20240724$20240624$20240802$PER$$US-SA-2024SA131750$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240802$$MD$US$US
240031122$24003112$2$F$20240101$20240724$20240624$20240802$PER$$US-SA-2024SA179037$SANOFI AVENTIS$$20$YR$A$M$Y$91.62$KG$20240802$$MD$US$US
240031382$24003138$2$F$20240101$20240912$20240624$20240926$PER$$US-SA-2024SA148283$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240926$$CN$US$US
240031462$24003146$2$F$$20240620$20240624$20240704$PER$$US-SA-2024SA179207$SANOFI AVENTIS$$$$$F$Y$$$20240704$$MD$US$US
240031472$24003147$2$F$20240101$20240703$20240624$20240708$EXP$$US-ABBVIE-5808500$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240031532$24003153$2$F$20240401$20240828$20240624$20240906$PER$$US-SA-2024SA182829$SANOFI AVENTIS$$10$YR$C$F$Y$39.92$KG$20240906$$MD$US$US
240031672$24003167$2$F$$20240619$20240624$20240704$EXP$$UY-HALEON-2182724$Haleon PLC$Mena Y, Casuriaga A, Notejane M. Paracetamol poisoning in adolescents. Report of a series of cases. Revista Medica del Uruguay. 2024; 40(2): e701.$11$YR$$F$Y$$$20240703$$HP$UY$UY
240031762$24003176$2$F$20240101$20240719$20240624$20240731$PER$$US-SA-2024SA181536$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240731$$MD$US$US
240031782$24003178$2$F$20240101$20240829$20240624$20240923$PER$$US-SA-2024SA182658$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240923$$CN$US$US
240031802$24003180$2$F$20240101$20240717$20240624$20240726$PER$$US-SA-2024SA183472$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240726$$CN$US$US
240031852$24003185$2$F$20240501$20240715$20240624$20240723$PER$$US-SA-2023SA288237$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240723$$MD$US$US
240031892$24003189$2$F$20240101$20240820$20240624$20240829$PER$$US-SA-2024SA082034$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240829$$MD$US$US
240031902$24003190$2$F$20240101$20240826$20240624$20240903$PER$$US-SA-2024SA183699$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240903$$MD$US$US
240031913$24003191$3$F$20240101$20240918$20240624$20240930$PER$$US-SA-2024SA183008$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240930$$MD$US$US
240031972$24003197$2$F$20240101$20240801$20240624$20240810$PER$$US-SA-2024SA183458$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240810$$MD$US$US
240032003$24003200$3$F$20240603$20240805$20240624$20240813$PER$$US-SA-2024SA150378$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240814$$MD$US$US
240032013$24003201$3$F$20240101$20240810$20240624$20240819$PER$$US-SA-2024SA182086$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240819$$MD$US$US
240032102$24003210$2$F$$20240712$20240624$20240723$PER$$US-SA-2024SA181811$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240724$$MD$US$US
240032124$24003212$4$F$20240501$20240715$20240624$20240722$PER$$US-SA-2024SA183252$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240722$$MD$US$US
240032262$24003226$2$F$20240101$20240715$20240624$20240723$PER$$US-SA-2024SA182773$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240723$$MD$US$US
240032313$24003231$3$F$20240301$20240809$20240624$20240820$PER$$US-SA-2024SA184675$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240820$$MD$US$US
240032342$24003234$2$F$20240618$20240618$20240624$20240724$PER$$US-SA-2024SA183094$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240724$$MD$US$US
240032443$24003244$3$F$$20240816$20240624$20240830$PER$$US-SA-2024SA179761$SANOFI AVENTIS$$89$YR$E$F$Y$59.87$KG$20240830$$MD$US$US
240032542$24003254$2$F$20240601$20240722$20240624$20240731$PER$$US-SA-2024SA183156$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240731$$MD$US$US
240032572$24003257$2$F$20240801$20240829$20240624$20240911$PER$$US-SA-2024SA183990$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240911$$MD$US$US
240032593$24003259$3$F$$20240806$20240624$20240812$PER$$US-SA-2024SA184825$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240812$$CN$US$US
240032722$24003272$2$F$$20240805$20240624$20240814$PER$$US-SA-2024SA183514$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
240032762$24003276$2$F$20240101$20240815$20240624$20240828$PER$$US-SA-2024SA183102$SANOFI AVENTIS$$67$YR$E$F$Y$97$KG$20240828$$MD$US$US
240032782$24003278$2$F$20240501$20240719$20240624$20240726$EXP$$US-ABBVIE-5809170$ABBVIE$$77$YR$$F$Y$$$20240726$$CN$US$US
240032873$24003287$3$F$$20240711$20240624$20240801$PER$$US-SA-2024SA183101$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240719$$MD$US$US
240032912$24003291$2$F$$20240816$20240624$20240828$PER$$US-SA-2024SA185220$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240828$$CN$US$US
240032962$24003296$2$F$$20240726$20240624$20240805$PER$$US-SA-2024SA184428$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240805$$MD$US$US
240033062$24003306$2$F$20230101$20240724$20240624$20240802$PER$$US-SA-2024SA184819$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240802$$CN$US$US
240033092$24003309$2$F$20240101$20240711$20240624$20240801$PER$$US-SA-2024SA183843$SANOFI AVENTIS$$29$YR$A$F$Y$43$KG$20240719$$MD$US$US
240033112$24003311$2$F$20240101$20240730$20240624$20240808$PER$$US-SA-2024SA183417$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240808$$MD$US$US
240033122$24003312$2$F$$20240712$20240624$20240722$PER$$US-SA-2024SA183828$SANOFI AVENTIS$$$$$F$Y$$$20240722$$MD$US$US
240033143$24003314$3$F$$20240807$20240624$20240816$PER$$US-SA-2024SA183883$SANOFI AVENTIS$$$$A$F$Y$54.38$KG$20240816$$MD$US$US
240033262$24003326$2$F$$20240715$20240624$20240722$PER$$US-SA-2024SA182703$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240722$$CN$US$US
240033282$24003328$2$F$$20240715$20240624$20240723$PER$$US-SA-2024SA183171$SANOFI AVENTIS$$$$E$M$Y$$$20240723$$MD$US$US
240033292$24003329$2$F$20240101$20240909$20240624$20240917$PER$$US-SA-2024SA183945$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240918$$MD$US$US
240033473$24003347$3$F$$20240624$20240624$20240717$EXP$$CA-HALEON-2182937$Haleon PLC$$53$YR$$M$Y$$$20240716$$CN$CA$CA
240033492$24003349$2$F$$20240705$20240624$20240708$PER$$US-ROCHE-10000001615$ROCHE$Kharode N, Januska M, Vicencio A. Transbronchial Lung Cryobiopsy in a Pediatric Renal Transplant Patient With Diffuse Lung Disease (Abstract number: A28). American Journal of Respiratory and Critical Care Medicine. 2024-May;209:A1237.$16$YR$T$M$Y$$$20240708$$HP$US$US
240033512$24003351$2$F$$20240627$20240624$20240708$EXP$$AU-NOVOPROD-1240002$NOVO NORDISK$$$$$M$Y$$$20240708$$PH$AU$AU
240033522$24003352$2$F$$20240619$20240624$20240701$EXP$$CN-NOVOPROD-1240008$NOVO NORDISK$$55$YR$$M$Y$60$KG$20240701$$CN$CN$CN
240033582$24003358$2$F$20220801$20240625$20240624$20240704$EXP$$JP-NOVOPROD-1240242$NOVO NORDISK$$$$$M$Y$59.6$KG$20240704$$HP$JP$JP
240033602$24003360$2$F$$20240619$20240624$20240704$EXP$$UY-HALEON-2182725$Haleon PLC$Mena Y, Casuriaga A, Notejane M. Paracetamol poisoning in adolescents. Report of a series of cases. Revista Medica del Uruguay. 2024; 40(2): e701.$13$YR$$F$Y$$$20240703$$HP$UY$UY
240033643$24003364$3$F$$20240909$20240624$20240916$EXP$$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108424$ZYDUS PHARM$$$$$$Y$$$20240916$$HP$FR$FR
240033702$24003370$2$F$20230422$20240625$20240624$20240704$EXP$$JP-NOVOPROD-1240356$NOVO NORDISK$$$$$M$Y$59.6$KG$20240704$$HP$JP$JP
240033862$24003386$2$F$20220501$20240726$20240624$20240730$PER$$US-ROCHE-10000002955$ROCHE$$52$YR$A$M$Y$95.25$KG$20240730$$CN$US$US
240033872$24003387$2$F$20240101$20240911$20240624$20240917$EXP$$GB-ABBVIE-5810215$ABBVIE$$$$A$F$Y$$$20240917$$CN$GB$GB
240033882$24003388$2$F$$20240624$20240624$20240730$PER$$US-ROCHE-10000001613$ROCHE$$80$YR$E$M$Y$$$20240730$$CN$US$US
240033932$24003393$2$F$20240206$20240808$20240624$20240809$EXP$$NVSC2024AU126684$NOVARTIS$$50$YR$$F$Y$$$20240809$$CN$AU$AU
240033943$24003394$3$F$20240525$20240620$20240624$20240705$PER$$US-ROCHE-10000003391$ROCHE$$79$YR$E$M$Y$68.03$KG$20240705$$CN$US$US
240033972$24003397$2$F$$20240625$20240624$20240701$EXP$$CA-BIOGEN-2024BI01270417$BIOGEN$$$$$F$Y$$$20240701$$CN$CA$CA
240033994$24003399$4$F$$20240717$20240624$20240722$PER$$US-ROCHE-10000003504$ROCHE$$$$$$Y$$$20240722$$MD$US$US
240034095$24003409$5$F$20240618$20240828$20240624$20240902$EXP$$JP-BEH-2024173940$CSL BEHRING$$51$YR$A$M$Y$80$KG$20240902$$MD$JP$JP
240034142$24003414$2$F$$20240621$20240624$20240704$PER$$US-ROCHE-10000004987$ROCHE$$77$YR$E$F$Y$$$20240704$$CN$US$US
240034162$24003416$2$F$$20240624$20240624$20240701$PER$$US-CHATTEMPRD-2024OHG021355$CHATTEM$$$$$$Y$$$20240701$$CN$US$US
240034232$24003423$2$F$$20240802$20240624$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002639$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
240034256$24003425$6$F$20240521$20240819$20240624$20240927$EXP$$US-ROCHE-10000000111$ROCHE$$53$YR$A$M$Y$101.38$KG$20240927$$CN$US$US
240034302$24003430$2$F$$20240820$20240624$20240826$EXP$$IN-TAKEDA-2022TUS067084$TAKEDA$$$$$M$Y$$$20240826$$CN$IN$IN
240034322$24003432$2$F$$20240917$20240624$20240919$EXP$$US-TAKEDA-2024TUS060653$TAKEDA$$$$$F$Y$$$20240919$$CN$US$US
240034342$24003434$2$F$$20240627$20240624$20240709$EXP$$CA-INTERCEPT-PM2023001113$INTERCEPT PHARMACEUTICALS$$52$YR$$F$Y$$$20240709$$PH$CA$CA
240034362$24003436$2$F$20220401$20240625$20240624$20240702$EXP$$CA-INTERCEPT-PM2021002770$INTERCEPT PHARMACEUTICALS$$48$YR$$F$Y$$$20240702$$MD$CA$CA
240034372$24003437$2$F$20231201$20240830$20240624$20240906$EXP$$US-INTERCEPT-PM2023002177$INTERCEPT PHARMACEUTICALS$$63$YR$$F$Y$70.748$KG$20240906$$CN$US$US
240034494$24003449$4$F$20240101$20240917$20240624$20240918$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035293$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$85.7$KG$20240918$$CN$US$US
240034522$24003452$2$F$$20240919$20240624$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097155$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240919$$PH$US$US
240034532$24003453$2$F$20240618$20240923$20240624$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100090$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240923$$CN$US$US
240034542$24003454$2$F$$20240920$20240624$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100605$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240920$$MD$US$US
240034552$24003455$2$F$20240611$20240826$20240624$20240903$EXP$$JP-009507513-2406JPN002820J$MERCK$$68$YR$$F$Y$$$20240903$$MD$JP$JP
240034572$24003457$2$F$20240101$20240807$20240624$20240811$PER$$US-AMGEN-USASP2024119807$AMGEN$$72$YR$E$F$Y$44.444$KG$20240811$$CN$US$US
240034592$24003459$2$F$20240614$20240628$20240624$20240704$EXP$$US-JNJFOC-20240646432$JOHNSON AND JOHNSON$$36$YR$A$M$Y$71.8$KG$20240704$$HP$US$US
240034612$24003461$2$F$20240401$20240709$20240624$20240712$EXP$FR-AFSSAPS-BS2024000374$FR-JNJFOC-20240659245$JOHNSON AND JOHNSON$$78$YR$E$M$Y$60$KG$20240712$$MD$FR$FR
240034622$24003462$2$F$$20240701$20240624$20240709$EXP$$PL-JNJFOC-20240642447$JOHNSON AND JOHNSON$$90$YR$E$$Y$63$KG$20240709$$MD$PL$PL
240034632$24003463$2$F$$20240924$20240624$20240927$EXP$$US-JNJFOC-20240641213$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$PH$US$US
240034692$24003469$2$F$20230929$20240710$20240624$20240716$EXP$$IT-TAKEDA-2023TUS113904$TAKEDA$$76$YR$$F$Y$$$20240716$$CN$IT$IT
240034772$24003477$2$F$$20240827$20240624$20240916$PER$$CA-TOLMAR, INC.-24CA049819$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
240034782$24003478$2$F$20240911$20240911$20240624$20240927$PER$$CA-TOLMAR, INC.-24CA049817$TOLMAR$$83$YR$$M$Y$$$20240927$$CN$CA$CA
240034872$24003487$2$F$20240617$20240627$20240624$20240708$EXP$$US-JNJFOC-20240648864$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240708$$MD$US$US
240034884$24003488$4$F$$20240709$20240624$20240723$30DAY$$US-JNJFOC-20240631704$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
240034894$24003489$4$F$$20240621$20240624$20240702$30DAY$$US-JNJFOC-20240630487$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
240034902$24003490$2$F$20240512$20240830$20240624$20240918$PER$$CA-TOLMAR, INC.-24CA049594$TOLMAR$$66$YR$$M$Y$$$20240918$$CN$CA$CA
240035062$24003506$2$F$20240509$20240702$20240624$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002657$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240726$$CN$US$US
240035082$24003508$2$F$$20240819$20240624$20240831$EXP$$JP-UCBSA-2024030894$UCB$$68$YR$$M$Y$$$20240831$$PH$JP$JP
240035122$24003512$2$F$20240612$20240626$20240624$20240701$EXP$$JP-JNJFOC-20240661663$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240702$$MD$JP$JP
240035172$24003517$2$F$$20240612$20240624$20240710$PER$$US-ROCHE-10000005825$ROCHE$$$$$$Y$$$20240710$$CN$US$US
240035212$24003521$2$F$20240610$20240809$20240624$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002653$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240830$$CN$US$US
240035372$24003537$2$F$$20240822$20240624$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099886$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240826$$HP$US$US
240035396$24003539$6$F$$20240910$20240624$20240912$PER$$US-ROCHE-10000004984$ROCHE$$$$$F$Y$$$20240912$$HP$US$US
240035412$24003541$2$F$20240101$20240624$20240624$20240701$PER$$US-AMGEN-USASP2024123451$AMGEN$$65$YR$E$F$Y$$$20240630$$CN$US$US
240035472$24003547$2$F$$20240612$20240624$20240709$EXP$$US-ROCHE-10000003639$ROCHE$$65$YR$E$F$Y$$$20240703$$HP$US$US
240035502$24003550$2$F$20240201$20240802$20240624$20240812$EXP$FR-AFSSAPS-NT2024000646$FR-TEVA-VS-3211505$TEVA$$61$YR$$M$Y$$$20240812$$MD$FR$FR
240035564$24003556$4$F$$20240821$20240624$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002632$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
240035592$24003559$2$F$20240101$20240812$20240624$20240820$EXP$$CA-APOTEX-2024AP007458$APOTEX$$$$E$F$Y$$$20240820$$HP$CA$CA
240035622$24003562$2$F$20240501$20240703$20240624$20240709$PER$$US-AstraZeneca-2024A126513$ASTRAZENECA$$25253$DY$$F$Y$$$20240709$$CN$US$
240035692$24003569$2$F$20240602$20240923$20240624$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100105$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240923$$CN$US$US
240035783$24003578$3$F$20240603$20240906$20240624$20240912$EXP$$CA-TAKEDA-2024TUS060598$TAKEDA$$48$YR$$M$Y$78$KG$20240912$$CN$CA$CA
240035892$24003589$2$F$20231115$20240710$20240624$20240710$EXP$$GR-ABBVIE-5811178$ABBVIE$$76$YR$$M$Y$$$20240710$$MD$GR$GR
240035932$24003593$2$F$$20240710$20240624$20240802$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05198$LUPIN$$$$$$Y$$$20240802$$CN$US$US
240035962$24003596$2$F$$20240807$20240624$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098228$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240809$$CN$US$US
240035973$24003597$3$F$$20240816$20240624$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100482$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240821$$CN$US$US
240036022$24003602$2$F$20240616$20240724$20240624$20240801$PER$$US-BEH-2024174249$CSL BEHRING$$$$A$M$Y$$$20240801$$PH$US$US
240036052$24003605$2$F$$20240812$20240624$20240815$PER$$US-ROCHE-10000003470$ROCHE$$$$E$M$Y$84.36$KG$20240815$$CN$US$US
240036082$24003608$2$F$$20240617$20240624$20240701$30DAY$$US-JNJFOC-20240643662$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$PH$US$US
240036112$24003611$2$F$20230627$20240712$20240624$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-029684$AUROBINDO$Torres HA, Mustafayev K, Nastoupil LJ, Shelburne SA.. Severe reactivation of seronegative occult hepatitis B after chemotherapy for lymphoma.. The Lancet.. 2024;403:1372-3$78$YR$$M$Y$65$KG$20240722$$MD$US$US
240036122$24003612$2$F$20240510$20240712$20240624$20240714$EXP$$BG-ABBVIE-5811984$ABBVIE$$56$YR$$M$Y$$$20240714$$CN$BG$BG
240036162$24003616$2$F$20240528$20240904$20240624$20240925$EXP$$CA-ABBVIE-5804058$ABBVIE$$81$YR$$M$Y$$$20240925$$MD$CA$CA
240036203$24003620$3$F$20240616$20240701$20240624$20240703$PER$$US-AMGEN-USASP2024123103$AMGEN$$68$YR$E$M$Y$$$20240703$$PH$US$US
240036212$24003621$2$F$20240613$20240905$20240624$20240917$30DAY$$US-GSK-US2024074413$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240917$$CN$US$US
240036272$24003627$2$F$20230901$20240713$20240624$20240716$EXP$$ES-BIOVITRUM-2024-ES-005827$BIOVITRUM$$63$YR$$F$Y$$$20240716$$MD$ES$ES
240036283$24003628$3$F$$20240719$20240624$20240726$PER$$US-ROCHE-10000002698$ROCHE$$$$$$Y$$$20240726$$CN$US$US
240036342$24003634$2$F$$20240812$20240624$20240821$EXP$$US-ROCHE-10000004104$ROCHE$$75$YR$E$M$Y$$$20240821$$CN$US$US
240036372$24003637$2$F$$20240614$20240624$20240705$PER$$US-ROCHE-10000005482$ROCHE$$$$$$Y$$$20240705$$PH$US$US
240036384$24003638$4$F$$20240719$20240624$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452394$RANBAXY$$$$A$M$Y$$$20240802$$CN$US$US
240036442$24003644$2$F$20240101$20240815$20240624$20240823$EXP$$US-ABBVIE-5808786$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
240036462$24003646$2$F$20240506$20240814$20240624$20240820$PER$$US-ROCHE-3571767$ROCHE$$39$YR$A$F$Y$$$20240820$$CN$US$US
240036572$24003657$2$F$20240101$20240919$20240624$20240925$EXP$$US-ABBVIE-5809238$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
240036622$24003662$2$F$20240601$20240827$20240624$20240829$PER$$US-JNJFOC-20240641594$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240829$$CN$US$US
240036655$24003665$5$F$20230101$20240905$20240624$20240914$EXP$$CA-CELLTRION INC.-2023CA019775$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
240036662$24003666$2$F$20240607$20240703$20240624$20240705$PER$$US-AMGEN-USASP2024121048$AMGEN$$74$YR$E$F$Y$$$20240705$$CN$US$US
240036692$24003669$2$F$$20240710$20240624$20240711$PER$$US-JNJFOC-20240631765$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$HP$US$US
240036713$24003671$3$F$$20240625$20240624$20240704$EXP$$PT-CHATTEMPRD-2024OHG021320$CHATTEM$$$$E$$Y$$$20240704$$HP$PT$PT
240036722$24003672$2$F$20240301$20240702$20240624$20240709$EXP$$US-GSK-US2024075070$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$US$US
240036744$24003674$4$F$20240613$20240923$20240624$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100308$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$91$KG$20240923$$CN$US$US
240036764$24003676$4$F$$20240705$20240624$20240715$EXP$$US-ROCHE-10000002496$ROCHE$Giles C, Sriram I, Curran M, Weinman J, Galambos C, Deterding R. Atypical Granulomatosis With Polyangiitis With Severe Rapidly Progressive Obstructive Lung Disease Requiring Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:A2278.$17$YR$T$M$Y$$$20240715$$HP$US$US
240036792$24003679$2$F$20240130$20240621$20240624$20240701$EXP$$ES-EMD Serono-2024032867$EMD SERONO INC$$69$YR$E$F$Y$$$20240701$$MD$ES$ES
240036822$24003682$2$F$20240101$20240918$20240624$20240924$EXP$$US-ABBVIE-5808143$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
240036853$24003685$3$F$$20240723$20240624$20240729$EXP$$JP-AMGEN-JPNSP2024121068$AMGEN$$$$$$Y$$$20240729$$PH$JP$JP
240036863$24003686$3$F$20231201$20240709$20240624$20240721$EXP$$JP-ABBVIE-5812764$ABBVIE$$73$YR$$F$Y$$$20240721$$HP$JP$JP
240036892$24003689$2$F$$20240709$20240624$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05217$LUPIN$$$$$$Y$$$20240808$$CN$US$US
240036903$24003690$3$F$20240512$20240827$20240624$20240829$EXP$$US-ABBVIE-5808455$ABBVIE$$76$YR$$F$Y$127$KG$20240829$$CN$US$US
240037042$24003704$2$F$20240101$20240724$20240624$20240729$EXP$$US-ABBVIE-5808765$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
240037062$24003706$2$F$20240601$20240828$20240624$20240904$EXP$$FR-BIOGEN-2024BI01270292$BIOGEN$$20$YR$$F$Y$$$20240904$$MD$FR$FR
240037232$24003723$2$F$$20240924$20240624$20240925$PER$$NVSC2024US130684$NOVARTIS$$$$$$Y$$$20240925$$HP$US$US
240037302$24003730$2$F$20240301$20240913$20240624$20240918$EXP$$CA-ABBVIE-5810311$ABBVIE$$54$YR$$F$Y$$$20240918$$CN$CA$CA
240037352$24003735$2$F$20240612$20240618$20240624$20240716$PER$$US-AMGEN-USASP2024121211$AMGEN$$87$YR$E$F$Y$$$20240716$$CN$US$US
240037422$24003742$2$F$$20240723$20240624$20240730$PER$$US-ROCHE-10000003524$ROCHE$$$$A$M$Y$$$20240730$$MD$US$US
240037462$24003746$2$F$$20240715$20240624$20240718$EXP$$CA-SANDOZ INC.-NVSC2023CA056544$SANDOZ$$69$YR$$F$Y$$$20240718$$PH$CA$CA
240037502$24003750$2$F$20240101$20240627$20240624$20240705$EXP$$US-SANDOZ INC.-SDZ2024US059673$SANDOZ$$$$$F$Y$$$20240705$$CN$US$US
240037523$24003752$3$F$$20240626$20240624$20240703$EXP$$AU-SANDOZ INC.-SDZ2024AU058499$SANDOZ$$87$YR$$M$Y$51$KG$20240703$$HP$AU$AU
240037533$24003753$3$F$20240615$20240711$20240624$20240717$30DAY$$US-AMGEN-USASP2024120422$AMGEN$$75$YR$E$M$Y$78.5$KG$20240717$$PH$US$US
240037562$24003756$2$F$$20240703$20240624$20240705$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035572$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240706$$MD$JP$JP
240037633$24003763$3$F$20240101$20240627$20240624$20240704$PER$$US-AMGEN-USASP2024123635$AMGEN$$75$YR$E$F$Y$$$20240704$$CN$US$US
240037684$24003768$4$F$$20240613$20240624$20240704$EXP$$US-ROCHE-3561732$ROCHE$$$$E$M$Y$72.57$KG$20240704$$CN$US$US
240037712$24003771$2$F$20230720$20240726$20240624$20240802$EXP$$BR-TAKEDA-2023TUS021779$TAKEDA$$18$YR$$F$Y$$$20240802$$CN$BR$BR
240037882$24003788$2$F$20221122$20240919$20240624$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-100205$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240920$$MD$JP$JP
240037912$24003791$2$F$19920906$20240718$20240624$20240729$EXP$$DE-AUROBINDO-AUR-APL-2024-029787$AUROBINDO$Bein T. A CASE OF SEVERE LEGIONELLOSIS FOLLOWING ABUSE OF ANTI-INFLAMMATORY DRUGS (ANTIPHLOGISTICS) - DIAGNOSTIC AND INTENSIVETREATMENT ASPECTS BASED ON A CASE REPORT (GERMAN). ANAESTHESIOL. INTENSIVMED. NOTFALLMED. SCHMERZTHER. 1995;30:252-256$52$YR$$M$Y$$$20240729$$MD$DE$DE
240037934$24003793$4$F$$20240705$20240624$20240712$EXP$$US-ROCHE-10000002388$ROCHE$Niranjan S, Rosa B, Patel D, Virk S, Nasrullah A, Bajwa Y, et al. Rituximab Meets COVID-19: When Lung Tales Take an Unexpected Twist!. American Journal of Respiratory and Critical Care Medicine. 2024-May;(209):A2055.$63$YR$A$M$Y$$$20240712$$HP$US$US
240037992$24003799$2$F$$20240805$20240624$20240823$PER$$US-UniquePharma-US-2024UPLSPO00014$UNIQUE PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
240038052$24003805$2$F$20240519$20240705$20240624$20240708$EXP$FR-AFSSAPS-AN2024000772$FR-GSK-FR2024077919$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$FR$FR
240038072$24003807$2$F$20240616$20240918$20240624$20240921$EXP$$ES-ABBVIE-5807969$ABBVIE$$76$YR$$M$Y$$$20240921$$CN$ES$ES
240038162$24003816$2$F$$20240712$20240624$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-029738$AUROBINDO$Batra-Sharma H, Sivakumar S, Ashok Kumar P, Sokol E, Shatsky R, Ross J. Genomic Landscape and Clinical Outcomes of Triple-Negative Invasive Lobular Carcinoma. Cancer-Res. 2024;84 (Suppl.)No.:PO5-06-14$$$$F$Y$$$20240723$$HP$US$US
240038202$24003820$2$F$20240201$20240703$20240624$20240707$EXP$$US-ROCHE-10000002868$ROCHE$$72$YR$E$M$Y$58.97$KG$20240707$$CN$US$US
240038212$24003821$2$F$$20240712$20240624$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-029739$AUROBINDO$Batra-Sharma H, Sivakumar S, Ashok Kumar P, Sokol E, Shatsky R, Ross J. G. Genomic Landscape and Clinical Outcomes of Triple-Negative Invasive Lobular Carcinoma. CancerRes. 2024;84 (Suppl.9):PO5-06-14$$$$F$Y$$$20240722$$HP$US$US
240038223$24003822$3$F$20240508$20240710$20240624$20240717$EXP$$JP-ABBVIE-5813072$ABBVIE$$58$YR$$M$Y$58$KG$20240717$$MD$JP$JP
240038282$24003828$2$F$20240510$20240626$20240624$20240708$PER$$US-ROCHE-3564354$ROCHE$$41$YR$A$F$Y$$$20240708$$HP$US$US
240038342$24003834$2$F$20240423$20240711$20240624$20240716$EXP$FR-AFSSAPS-BX2024001177$FR-CHEPLA-2024007752$CHEPLAPHARM$$68$YR$$F$Y$$$20240716$$PH$COUNTRY NOT SPECIFIED$FR
240038372$24003837$2$F$$20240725$20240624$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-030226$AUROBINDO$$20$YR$$M$Y$$$20240805$$PH$US$US
240038452$24003845$2$F$$20240613$20240624$20240708$PER$$US-ROCHE-10000001310$ROCHE$Cota S,  Unknown. Unknown. 2014;$45$YR$A$M$Y$$$20240708$$HP$US$US
240038462$24003846$2$F$20240620$20240906$20240624$20240909$PER$$US-AMGEN-USASP2024122593$AMGEN$$76$YR$E$F$Y$$$20240909$$HP$US$US
240038482$24003848$2$F$$20240611$20240624$20240704$PER$$US-BAUSCHBL-2024BNL028626$BAUSCH AND LOMB$$89$YR$$F$Y$$$20240705$$CN$US$US
240038492$24003849$2$F$$20240712$20240624$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-030020$AUROBINDO$Akula V, Jones J. Dense Breast Tissue in a High-Risk AfricanAmerican Woman with DCIS and Nodal Metastasis of Intra-ductal Carcinoma: A Case Report and Discussion on the Current USPSTF Draft Recommendation. Cancer-Res. 2024;84 (Suppl.)(9):abstr. PO4-20-07$29$YR$$F$Y$$$20240722$$HP$US$US
240038542$24003854$2$F$$20240612$20240624$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-029868$AUROBINDO$Maciej K, Sarvarinder G, Kevin K, Karan O, Robert L. Hepatic veno-occlusive disease complicated with extreme hyperammonaemia (920 ?mol/L) treated with defibrotide, lactulose, rifampin and haemodialysis. BMJ Case Reports. 2024;17:e258876$3$DEC$$M$Y$$$20240724$$MD$US$US
240038632$24003863$2$F$20240601$20240618$20240624$20240702$EXP$$US-ABBVIE-5808559$ABBVIE$$23$YR$$F$Y$$$20240702$$CN$US$US
240038643$24003864$3$F$$20240822$20240624$20240828$30DAY$$US-GSK-US2024074418$GLAXOSMITHKLINE$$$$$M$Y$$$20240828$$CN$US$US
240038663$24003866$3$F$20240601$20240722$20240624$20240726$EXP$$US-EXELIXIS-CABO-24078578$EXELIXIS$$61$YR$$M$Y$$$20240726$$CN$US$US
240038673$24003867$3$F$20240531$20240808$20240624$20240815$EXP$$US-ABBVIE-5810172$ABBVIE$$18$YR$$F$Y$71$KG$20240815$$CN$US$US
240038713$24003871$3$F$20240403$20240709$20240624$20240720$30DAY$$US-JNJFOC-20240623566$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$HP$US$US
240038722$24003872$2$F$20170301$20240902$20240624$20240909$EXP$$FR-SANDOZ INC.-SDZ2024FR059016$SANDOZ$$37$YR$$F$Y$$$20240909$$PH$FR$FR
240038752$24003875$2$F$$20240626$20240624$20240701$EXP$$CA-SANDOZ INC.-NVSC2020CA064933$SANDOZ$$74$YR$$F$Y$$$20240701$$CN$CA$CA
240038772$24003877$2$F$20240601$20240712$20240624$20240718$EXP$$US-BIOGEN-2024BI01270191$BIOGEN$$30$YR$$F$Y$$$20240718$$CN$US$US
240038802$24003880$2$F$$20240718$20240624$20240726$EXP$$US-Stemline Therapeutics, Inc.-2024ST003717$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240723$$CN$US$US
240038893$24003889$3$F$$20240918$20240624$20240925$EXP$$CA-SA-2024SA183881$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240925$$HP$CA$CA
240038933$24003893$3$F$$20240711$20240624$20240722$EXP$$US-Stemline Therapeutics, Inc.-2024ST003462$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240717$$CN$US$US
240038942$24003894$2$F$20230101$20240731$20240624$20240807$EXP$$JP-009507513-2312JPN003987J$MERCK$$90$YR$$F$Y$$$20240807$$MD$JP$JP
240038982$24003898$2$F$20240601$20240801$20240624$20240805$PER$$US-AMGEN-USASP2024121650$AMGEN$$79$YR$E$M$Y$$$20240805$$CN$US$US
240039032$24003903$2$F$20240329$20240628$20240624$20240705$EXP$$GB-AUROBINDO-AUR-APL-2024-029576$AUROBINDO$$23$YR$$F$Y$$$20240705$$CN$GB$GB
240039162$24003916$2$F$$20240716$20240624$20240718$EXP$$NVSJ2024JP007259$NOVARTIS$$82$YR$$M$Y$$$20240719$$MD$JP$JP
240039204$24003920$4$F$20240627$20240830$20240624$20240910$EXP$$CA-TAKEDA-2024TUS060302$TAKEDA$$38$YR$$M$Y$$$20240910$$HP$CA$CA
240039334$24003933$4$F$20240401$20240910$20240624$20240912$EXP$$JP-TAKEDA-2024TJP009250$TAKEDA$$50$YR$$F$Y$40$KG$20240912$$MD$JP$JP
240039383$24003938$3$F$20240709$20240729$20240624$20240802$EXP$$CA-TAKEDA-2024TUS060581$TAKEDA$$69$YR$$M$Y$$$20240802$$CN$CA$CA
240039442$24003944$2$F$20240501$20240702$20240624$20240708$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035468$BOEHRINGER INGELHEIM$$90$YR$E$F$Y$$$20240708$$CN$US$US
240039492$24003949$2$F$20240529$20240708$20240624$20240709$EXP$$JP-TAKEDA-2024TJP009405$TAKEDA$$$$$F$Y$$$20240709$$MD$JP$JP
240039592$24003959$2$F$$20240812$20240624$20240814$EXP$$FR-ROCHE-10000003703$ROCHE$$$$$F$Y$$$20240814$$MD$FR$FR
240039722$24003972$2$F$$20240617$20240624$20240701$EXP$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-13036$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-13036$ALKEM$Fernandes G, Patil M, Harinkhede N, Khumanthem G, Rojekar A. Renal allograft failure resulting from diffuse cortical necrosis. Indian J Pathol Microbiol. 2024;Unk:Unk$28$YR$$F$Y$$$20240701$$MD$IN$IN
240039753$24003975$3$F$$20240701$20240624$20240715$EXP$ES-MLMSERVICE-20240604-PI088155-00090-3$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-12654$ALKEM$Soto-Moreno A, D?az-Calvillo P, Arias-Santiago S.. Kounis Syndrome. Mast Cells Beyond the Skin. 2024;unk:1-2$51$YR$$M$Y$$$20240715$$MD$ES$ES
240039782$24003978$2$F$$20240617$20240624$20240701$EXP$US-MLMSERVICE-20240603-PI086146-00275-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12660$ALKEM$Preskorn SH, Masolak DD. Cerebral Anoxia in an 18-year-old Patient Being Treated for Major Depressive Disorder: How Forensic Detective Work Uses Medical Knowledge Including Clinical Pharmacology to Solve Cases. Journal of psychiatric practice. 2024;30(3):212-219$18$YR$$M$Y$65.5$KG$20240701$$MD$US$US
240039802$24003980$2$F$$20240618$20240624$20240702$EXP$IN-MLMSERVICE-20240531-PI084796-00232-1$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-12655$ALKEM$Aggarwal J, Kumar DJ, Rathore V, Mehta R, Kumar A, Ravina M.. Acute airway obstruction: An unusual presentation of posttransplant lymphoproliferative disorder in a renal transplant recipient. Experimental and Clinical Transplantation. 2024;22(4):307-310$26$YR$$M$Y$$$20240702$$HP$IN$IN
240039812$24003981$2$F$$20240618$20240624$20240702$EXP$PT-MLMSERVICE-20240603-PI060223-00275-1$PT-ALKEM LABORATORIES LIMITED-PT-ALKEM-2024-12657$ALKEM$Machado F, Gouveia H, Amorim A, Freitas S. Refractory Electrical Cardiac Storm During A Twin Pregnancy Delivery: A Challenging Clinical Case. Regional Anesthesia and Pain Medicine. 2024;48(Supple 1):A242$28$YR$$F$Y$$$20240702$$MD$PT$PT
240039822$24003982$2$F$$20240626$20240624$20240705$EXP$$TR-TEVA-VS-3176163$TEVA$Kum YE, Pamukcu O, Canpolat M. Fingolimod-related atrioventricular block in paediatric age group with multiple sclerosis: two case reports. Cardiol-Young 2023; 33 (11): 2384-2386.; Kum YE, Pamukcu O, Canpolat M. Fingolimod-related atrioventricular block in paediatric age group with multiple sclerosis: two case reports. Cardiol-Young 2023; 33 (11): 2384-2386.; Kum YE, Pamukcu O, Canpolat M. Fingolimod-related atrioventricular block in paediatric age group with multiple sclerosis: two case repo...$13$YR$$F$Y$$$20240705$$MD$TR$TR
240039853$24003985$3$F$$20240702$20240624$20240716$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-12770$ALKEM$Renner K.. Was im Alter zu beachten ist. Pharmazeutische Zeitung. 2024;169(15):22-29$78$YR$$F$Y$$$20240716$$PH$DE$DE
240040014$24004001$4$F$20240515$20240719$20240624$20240725$EXP$$US-BIOGEN-2024BI01270177$BIOGEN$$29$YR$$F$Y$$$20240725$$MD$US$US
240040192$24004019$2$F$$20240621$20240624$20240702$30DAY$$US-GSK-US2024074391$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
240040203$24004020$3$F$20240806$20240806$20240624$20240813$EXP$$CA-CELLTRION INC.-2022CA022432$CELLTRION$$$$$$Y$$$20240813$$MD$CA$CA
240040212$24004021$2$F$20240501$20240713$20240624$20240718$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-025759$BOEHRINGER INGELHEIM$$57$YR$A$M$Y$$$20240718$$CN$US$US
240040242$24004024$2$F$$20240801$20240624$20240802$PER$$NVSC2024US129901$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
240040273$24004027$3$F$$20240624$20240624$20240708$PER$$US-AstraZeneca-2024A136300$ASTRAZENECA$$59$YR$$M$Y$$$20240708$$CN$US$
240040342$24004034$2$F$20240617$20240807$20240624$20240809$EXP$$AU-TAKEDA-2024TUS061054$TAKEDA$$71$YR$$F$Y$$$20240809$$CN$AU$AU
240040363$24004036$3$F$20240101$20240807$20240624$20240812$EXP$$GB-ABBVIE-5810131$ABBVIE$$55$YR$$F$Y$$$20240812$$CN$GB$GB
240040372$24004037$2$F$$20240814$20240624$20240821$PER$$US-ROCHE-10000001030$ROCHE$$$$A$F$Y$$$20240821$$HP$US$US
240040422$24004042$2$F$$20240626$20240624$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406014467$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240703$$CN$US$US
240040432$24004043$2$F$$20240717$20240624$20240724$PER$$US-TAKEDA-2024TUS060513$TAKEDA$$58$YR$$F$Y$$$20240724$$CN$US$US
240040492$24004049$2$F$20240601$20240717$20240624$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202406015073$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240723$$CN$US$US
240040552$24004055$2$F$$20240619$20240624$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202406014029$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240716$$CN$US$US
240040742$24004074$2$F$20240527$20240911$20240624$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-029505$AUROBINDO$$28$YR$$F$Y$52$KG$20240919$$MD$FR$FR
240040783$24004078$3$F$20240301$20240715$20240624$20240722$EXP$$DE-LEO Pharma-371244$LEO PHARM$$60$YR$$F$Y$$$20240722$$MD$DE$DE
240040842$24004084$2$F$$20240704$20240624$20240709$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-100040$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$53$KG$20240709$$CN$AU$AU
240040873$24004087$3$F$20240201$20240717$20240624$20240725$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00658$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
240041022$24004102$2$F$20240101$20240701$20240624$20240703$EXP$$US-ABBVIE-5743969$ABBVIE$$$$$M$Y$99$KG$20240703$$CN$US$US
240041242$24004124$2$F$$20240723$20240624$20240731$EXP$$MX-EMD Serono-2024033509$EMD SERONO INC$$$$A$F$Y$$$20240731$$CN$MX$MX
240041272$24004127$2$F$20200301$20240801$20240624$20240805$EXP$$NVSC2024FR130116$NOVARTIS$$42$YR$$M$Y$$$20240805$$MD$FR$FR
240041292$24004129$2$F$$20240907$20240624$20240910$PER$$NVSC2024US129061$NOVARTIS$$49$YR$$M$Y$$$20240910$$CN$US$US
240041312$24004131$2$F$20240430$20240628$20240624$20240704$EXP$$US-AstraZeneca-2024A142631$ASTRAZENECA$$32672$DY$$F$Y$$$20240704$$CN$US$
240041342$24004134$2$F$$20240801$20240624$20240808$EXP$$CA-EMD Serono-2024033411$EMD SERONO INC$$$$E$F$Y$$$20240808$$CN$CA$CA
240041422$24004142$2$F$$20240624$20240624$20240705$EXP$$TR-Accord-430833$ACCORD$Kayabasi M, Ayhan Z, Lebe B, ozkutuk AA, Soylev Bajin M, Nazli A et al. Endogenous Endophthalmitis Caused by Aspergillus lentulus in an Immunocompromised Patient with Lung Cancer. Turk J Ophthalmol. 2024 Jun 11.$78$YR$E$M$Y$$$20240705$$HP$TR$TR
240041454$24004145$4$F$20220501$20240717$20240624$20240726$EXP$$JP-ASTELLAS-2024JP004240$ASTELLAS$$66$YR$$M$Y$$$20240726$$MD$JP$JP
240041632$24004163$2$F$$20240823$20240624$20240831$PER$$US-AstraZeneca-2024A139755$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
240041665$24004166$5$F$20240522$20240814$20240624$20240827$EXP$$DE-AUROBINDO-AUR-APL-2024-028089$AUROBINDO$$83$YR$$F$Y$60$KG$20240827$$MD$DE$DE
240041722$24004172$2$F$20240612$20240617$20240624$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202406014220$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240715$$CN$US$US
240041742$24004174$2$F$$20240820$20240624$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100695$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240830$$CN$US$US
240041792$24004179$2$F$$20240720$20240624$20240801$EXP$$US-AUROBINDO-AUR-APL-2024-030143$AUROBINDO$Chindris A, Rao SN, Chirila RM, Dumitrascu AG.. A case of celiac plexus block causing iatrogenic Cushing^s syndrome.. Clinical Case Reports.. 2024;12(4):e8777$62$YR$$F$Y$99.5$KG$20240801$$MD$US$US
240041802$24004180$2$F$$20240911$20240624$20240919$EXP$$NVSC2024CA127095$NOVARTIS$$54$YR$$F$Y$$$20240919$$CN$CA$CA
240041832$24004183$2$F$20230101$20240709$20240624$20240716$EXP$$AT-CELLTRION INC.-2024AT014910$CELLTRION$Jarolim S.. Multiple Sklerose: Auf dem Weg zur prodromalen. Therapie. 2024;1$$$$$Y$$$20240716$$MD$AT$AT
240041854$24004185$4$F$20220101$20240828$20240624$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-030171$AUROBINDO$Dierks S, Buchholz SM, K?nig A, Liersch T, Schanz J.. Incomplete DPYD haplotype B3 in a patient with locally advanced gastric cancer: Reconsidering the 5-FU dosage strategy.. European Journal of Cancer. 2024;204:114076$65$YR$$M$Y$$$20240910$$MD$DE$DE
240041912$24004191$2$F$$20240910$20240624$20240916$EXP$$NL-SANDOZ INC.-PHHY2016NL073198$SANDOZ$Dos Santos CO, Zijlstra JG, Porte RJ, Kampinga GA, van Diepeningen AD, Sinha B et al.. Emerging pan-resistance in Trichosporon species: A case report.. BMC INFECTIOUS DISEASES. 2016;16(148):1-4$48$YR$$M$Y$$$20240916$$MD$NL$NL
240042012$24004201$2$F$$20240905$20240624$20240913$EXP$$PT-AUROBINDO-AUR-APL-2024-030181$AUROBINDO$Costa LC, Morgado C, Alves JN, Machado C, Ferreira V. HEM?LISE E TROMBOCITOPENIA AP?SLEVETIRACETAM: QUANDO O DOENTE NOS D? UM CART?O AMARELO (HEMOLYSIS AND THROMBOCYTOPENIA AFTER SLEEVETIRACETAM: WHEN THE PATIENT GIVES US A YELLOW CARD). Sinapse (Synapse). 2023;23 (Suppl. 1):274$82$YR$$M$Y$$$20240913$$HP$PT$PT
240042032$24004203$2$F$20240501$20240715$20240624$20240722$EXP$$US-ABBVIE-5811236$ABBVIE$$68$YR$$M$Y$90.718$KG$20240722$$CN$US$US
240042052$24004205$2$F$20100101$20240626$20240624$20240704$EXP$$JP-TAKEDA-2024TUS062301$TAKEDA$$8$DEC$$M$Y$$$20240704$$CN$JP$JP
240042113$24004211$3$F$$20240712$20240624$20240719$EXP$$US-ALXN-202406USA001081US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240719$$CN$US$US
240042202$24004220$2$F$20240213$20240701$20240624$20240715$EXP$FR-AFSSAPS-PC2024000445$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108413$ZYDUS PHARM$$$$$$Y$$$20240715$$PH$FR$FR
240042332$24004233$2$F$$20240702$20240624$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-030257$AUROBINDO$Alexander G, Moore SA, Lenert PS. Eosinophilic granulomatosis with polyangiitis and its association with montelukast: a case-based review. Clinical Rheumatology. 2024;43(6):2153-2165$44$YR$$F$Y$$$20240711$$MD$US$US
240042395$24004239$5$F$$20240910$20240624$20240912$EXP$$NVSC2024CA129423$NOVARTIS$$54$YR$$F$Y$$$20240912$$CN$CA$CA
240042402$24004240$2$F$20240611$20240702$20240624$20240705$EXP$$JP-ASTELLAS-2024JP003984$ASTELLAS$$$$E$M$Y$$$20240705$$HP$JP$JP
240042442$24004244$2$F$$20240911$20240624$20240918$EXP$$JP-GSK-JP2024078227$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$JP$JP
240042502$24004250$2$F$$20240626$20240624$20240704$EXP$$IT-AUROBINDO-AUR-APL-2024-030259$AUROBINDO$Giorgetti A, Gro?e Perdekamp M, Franchetti G, Pircher R, Pollak S, Pelotti S, et al.. Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities.. International journal of legal medicine.. 2024$31$YR$$M$Y$$$20240704$$MD$IT$IT
240042652$24004265$2$F$$20240627$20240624$20240702$EXP$$FR-SA-2024SA184240$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240702$$CN$FR$FR
240042722$24004272$2$F$20240601$20240618$20240624$20240701$EXP$$CN-SA-2024SA184244$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240701$$CN$CN$CN
240042743$24004274$3$F$20200109$20240627$20240624$20240705$EXP$$CA-TAKEDA-2021TUS034945$TAKEDA$$55$YR$$M$Y$$$20240705$$CN$CA$CA
240042752$24004275$2$F$20221102$20230313$20240624$20240828$EXP$$CA-CELLTRION INC.-2022CA019674$CELLTRION$$$$$$Y$$$20240828$$CN$CA$CA
240042822$24004282$2$F$$20240808$20240624$20240812$EXP$$NVSC2024US130073$NOVARTIS$$$$$$Y$$$20240812$$CN$US$US
240042842$24004284$2$F$$20240722$20240624$20240723$PER$$US-JNJFOC-20240651000$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
240042912$24004291$2$F$$20240918$20240624$20240924$EXP$$CA-SA-2024SA184593$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240924$$HP$CA$CA
240043072$24004307$2$F$$20240711$20240624$20240726$PER$$US-JNJFOC-20240637495$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$US$US
240043112$24004311$2$F$20240607$20240913$20240624$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099796$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240920$$MD$JP$JP
240043122$24004312$2$F$20210222$20240820$20240624$20240828$EXP$$CA-CELLTRION INC.-2021CA003743$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
240043152$24004315$2$F$$20240724$20240624$20240730$30DAY$$US-JNJFOC-20240655946$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$HP$US$US
240043192$24004319$2$F$20240604$20240731$20240624$20240809$EXP$$JP-ROCHE-10000003522$ROCHE$$7$DEC$E$M$Y$$$20240809$$MD$JP$JP
240043213$24004321$3$F$$20240624$20240624$20240717$EXP$$CA-AstraZeneca-2024A144347$ASTRAZENECA$$53$YR$$M$Y$$$20240717$$MD$CA$
240043252$24004325$2$F$$20240617$20240624$20240822$EXP$$CO-ROCHE-10000001319$ROCHE$Canas C, Posso-Osorio I, PErez-Uribe V, Erazo-Mart?nez V. Bronchiectasis, lymphadenopathies related to BAFF overexpression and lymphoplasmacytic cystitis as adverse events associated with prolonged use of rituximab in systemic autoimmune rheumatic diseases. Revista clinica espanola. 2024-Jun-05;1-5. doi:10.1016/j.rceng.2024.06.001.$$$$$Y$$$20240822$$MD$CO$CO
240043265$24004326$5$F$20240206$20240719$20240624$20240729$EXP$DE-SEATTLE GENETICS-2024SGN01848$DE-ROCHE-10000004053$ROCHE$$79$YR$E$F$Y$57.2$KG$20240729$$CN$DE$DE
240043284$24004328$4$F$20240601$20240807$20240624$20240812$PER$$US-BIOGEN-2024BI01270145$BIOGEN$$59$YR$$F$Y$$$20240812$$CN$US$US
240043303$24004330$3$F$20240531$20240718$20240624$20240722$PER$$US-AMGEN-USASP2024123108$AMGEN$$64$YR$A$F$Y$$$20240721$$CN$US$US
240043332$24004333$2$F$$20240807$20240624$20240818$EXP$$US-AUROBINDO-AUR-APL-2024-029928$AUROBINDO$Martino J, Elfessi Z, Szaflarska K, Suh M, Antonishina K. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use. Journal of pharmacy practice. 2024;1-4$25$YR$$M$Y$$$20240818$$PH$US$US
240043382$24004338$2$F$20240425$20240613$20240624$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000319$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
240043582$24004358$2$F$20240601$20240612$20240624$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000326$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
240043612$24004361$2$F$20240418$20240805$20240624$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000322$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
240043643$24004364$3$F$20190327$20240812$20240624$20240821$EXP$$CA-ROCHE-10000003459$ROCHE$$48$YR$A$F$Y$84$KG$20240821$$CN$CA$CA
240043762$24004376$2$F$20230101$20240919$20240624$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099895$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240919$$MD$JP$JP
240043952$24004395$2$F$20240101$20240626$20240624$20240702$EXP$$US-ABBVIE-5808502$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240044072$24004407$2$F$$20240808$20240624$20240814$PER$$US-AstraZeneca-2024A143936$ASTRAZENECA$$$$$$Y$$$20240815$$MD$US$
240044142$24004414$2$F$$20240704$20240624$20240716$EXP$$GB-TEVA-VS-3211051$TEVA$$$$E$M$Y$$$20240716$$CN$GB$GB
240044153$24004415$3$F$20240611$20240923$20240624$20240926$EXP$$GB-TAKEDA-2024TUS060402$TAKEDA$$78$YR$$M$Y$$$20240926$$CN$GB$GB
240044222$24004422$2$F$$20240807$20240624$20240820$EXP$$CN-Unichem Pharmaceuticals (USA) Inc-UCM202406-000736$UNICHEM$$49$YR$A$M$Y$$$20240820$$HP$CN$
240044233$24004423$3$F$20240401$20240710$20240624$20240711$EXP$FR-AFSSAPS-AM2024000489$FR-JNJFOC-20240653263$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240711$$MD$FR$FR
240044442$24004444$2$F$20240227$20240704$20240624$20240710$EXP$$FR-EXELIXIS-XL18424078538$EXELIXIS$$72$YR$$F$Y$62$KG$20240710$$MD$FR$FR
240044452$24004445$2$F$20240401$20240718$20240624$20240722$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035608$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$$$20240722$$MD$JP$JP
240044582$24004458$2$F$$20240826$20240624$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100648$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$136.08$KG$20240829$$CN$US$US
240044593$24004459$3$F$$20240925$20240624$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100621$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240926$$CN$US$US
240044602$24004460$2$F$$20240807$20240624$20240821$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-096933$BRISTOL MYERS SQUIBB$$29$YR$A$F$Y$$$20240821$$MD$DE$DE
240044632$24004463$2$F$20240601$20240905$20240624$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100389$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$94.6$KG$20240912$$PH$US$US
240044642$24004464$2$F$$20240706$20240624$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100610$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$51.71$KG$20240711$$CN$US$US
240044742$24004474$2$F$$20240903$20240624$20240905$EXP$$US-JNJFOC-20240646974$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$US$US
240044752$24004475$2$F$$20240724$20240624$20240801$30DAY$$TR-JNJFOC-20240648065$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$CN$TR$TR
240044782$24004478$2$F$$20240809$20240624$20240814$EXP$$CA-AMGEN-CANSP2024122065$AMGEN$$73$YR$E$F$Y$$$20240814$$HP$CA$CA
240044885$24004488$5$F$20231106$20240923$20240624$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-100209$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240925$$MD$JP$JP
240044962$24004496$2$F$20240617$20240722$20240624$20240724$PER$$US-JNJFOC-20240646386$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240724$$HP$US$US
240044973$24004497$3$F$20230403$20240918$20240624$20240920$EXP$$AU-MYLANLABS-2024M1038221$MYLAN$$57$YR$$F$Y$$$20240920$$CN$AU$AU
240045052$24004505$2$F$$20240626$20240624$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05188$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240045062$24004506$2$F$20220101$20240805$20240624$20240809$EXP$$US-UCBSA-2024030226$UCB$$$$$M$Y$79.365$KG$20240809$$MD$US$US
240045092$24004509$2$F$20230719$20240909$20240624$20240916$EXP$$JP-EXELIXIS-CABO-24078703$EXELIXIS$$80$YR$$M$Y$60$KG$20240916$$MD$JP$JP
240045192$24004519$2$F$20230101$20240718$20240624$20240724$EXP$$US-ABBVIE-5811436$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
240045202$24004520$2$F$$20240820$20240624$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100468$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240821$$HP$US$US
240045362$24004536$2$F$20240516$20240625$20240624$20240702$EXP$$DE-CHIESI-2024CHF03618$CHIESI$$$$A$M$Y$70$KG$20240702$$HP$DE$DE
240045602$24004560$2$F$20240620$20240716$20240624$20240718$PER$$US-AMGEN-USASP2024122339$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
240045682$24004568$2$F$$20240715$20240624$20240722$EXP$$US-SA-2024SA184215$SANOFI AVENTIS$$$$A$F$Y$$$20240720$$MD$US$US
240045792$24004579$2$F$$20240705$20240624$20240802$PER$$US-ALXN-202406USA000719US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
240045803$24004580$3$F$20240601$20240730$20240624$20240801$PER$$US-ALXN-202406USA001155US$ALEXION PHARMACEUTICALS$$52$YR$$F$Y$$$20240801$$CN$US$US
240045952$24004595$2$F$20240521$20240628$20240624$20240710$PER$$US-BAYER-2024A085455$BAYER$$27$YR$A$F$Y$65$KG$20240710$$MD$US$US
240045992$24004599$2$F$20240524$20240709$20240624$20240715$EXP$$JP-ROCHE-10000004129$ROCHE$$$$A$F$Y$$$20240715$$MD$JP$JP
240046092$24004609$2$F$20240612$20240701$20240624$20240706$PER$$US-BAYER-2024A085722$BAYER$$54$YR$A$F$Y$$$20240706$$CN$US$US
240046112$24004611$2$F$$20240710$20240624$20240725$30DAY$$US-JNJFOC-20240647913$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$HP$US$US
240046143$24004614$3$F$20240617$20240626$20240624$20240701$PER$$US-JNJFOC-20240647227$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240701$$CN$US$US
240046182$24004618$2$F$20240614$20240916$20240624$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024074400$VIIV$$47$YR$$F$Y$$$20240926$$HP$US$US
240046232$24004623$2$F$$20240620$20240624$20240701$EXP$$PS-Accord-431132$ACCORD$Maqboul I, Daraghmeh L, Eleiwi MR, Qasrawi H, Akkawi M, AwadGhanem A. Atraumatic splenic rupture after administering aspirin, clopidogrel, and heparin to a patient with unstable angina: A case report. SAGE Open Med Case Rep. 2024 Jun 10;12:2050313X241259379.$49$YR$A$M$Y$$$20240701$$HP$PS$PS
240046252$24004625$2$F$$20240620$20240624$20240702$EXP$$IR-Accord-431120$ACCORD$Emami AH, Alizadehasl A, Sayad M, Shavandi F, Firoozbakhsh P, Meshgi S, et al. Diagnosis and management of cancer therapy-related myocarditis in a young female: A case report and review of literature. BMC cardiovascular disorders. 2024;24(1):299. DOI: 10.1186/s12872-024-03960-6.$19$YR$A$F$Y$$$20240701$$HP$IR$IR
240046272$24004627$2$F$$20240625$20240624$20240705$EXP$$US-Accord-431435$ACCORD$Pagliuca S, Wagner C, Pietruszka BL, Jindal S. Thiazide Induced Hyponatremia Presenting as a Fall in an Older Adult. Journal of the American Geriatrics Society. 2023;71(Supplement 1):S199. DOI: 10.1111/jgs.18336.$10$DEC$E$M$Y$87$KG$20240705$$MD$US$US
240046422$24004642$2$F$20240501$20240907$20240624$20240913$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-088195$REGENERON$$60$YR$$F$Y$$$20240913$$HP$CO$CO
240046575$24004657$5$F$20240101$20240813$20240624$20240819$30DAY$$US-PFIZER INC-202400197036$PFIZER$$14$YR$$M$Y$46$KG$20240819$$CN$US$US
240046742$24004674$2$F$$20240613$20240624$20240708$PER$$US-ROCHE-10000005699$ROCHE$Moghaddasi S,  Unknown. Unknown. 2016;$65$YR$E$M$Y$$$20240708$$HP$US$US
240046752$24004675$2$F$$20240816$20240624$20240826$30DAY$$US-GSK-US2024AMR075409$GLAXOSMITHKLINE$$$$E$F$Y$$$20240826$$CN$US$US
240046772$24004677$2$F$20240606$20240801$20240624$20240807$EXP$$JP-GSK-JP2024078405$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$JP$JP
240046824$24004682$4$F$$20240911$20240624$20240916$30DAY$$US-PFIZER INC-202400195310$PFIZER$$13$YR$$M$Y$88.45$KG$20240916$$CN$US$US
240046852$24004685$2$F$20240613$20240913$20240624$20240918$30DAY$$US-PFIZER INC-202400194259$PFIZER$$14$YR$$F$Y$$$20240918$$HP$US$US
240046863$24004686$3$F$$20240911$20240624$20240913$30DAY$$US-PFIZER INC-202400195354$PFIZER$$13$YR$$M$Y$$$20240913$$CN$US$US
240046972$24004697$2$F$20240319$20240618$20240624$20240703$EXP$FR-AFSSAPS-PP2024000635$FR-TEVA-VS-3211120$TEVA$$62$YR$$M$Y$86$KG$20240703$$MD$FR$FR
240047033$24004703$3$F$$20240917$20240624$20240920$30DAY$$US-PFIZER INC-202400193570$PFIZER$$15$YR$$M$Y$$$20240920$$CN$US$US
240047044$24004704$4$F$$20240802$20240624$20240802$30DAY$$US-PFIZER INC-202400197203$PFIZER$$9$YR$$F$Y$$$20240802$$HP$US$US
240047063$24004706$3$F$20240617$20240911$20240624$20240913$30DAY$$US-PFIZER INC-202400197017$PFIZER$$9$YR$$F$Y$$$20240913$$MD$US$US
240047082$24004708$2$F$$20240624$20240624$20240702$PER$$US-ALXN-202406USA001058US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240702$$CN$US$US
240047092$24004709$2$F$20240419$20240822$20240624$20240826$PER$$US-AMGEN-USASP2024121725$AMGEN$$56$YR$A$F$Y$$$20240826$$CN$US$US
240047122$24004712$2$F$20240515$20240821$20240624$20240823$PER$$NVSC2024US130443$NOVARTIS$$50$YR$$F$Y$$$20240823$$HP$US$US
240047172$24004717$2$F$$20240627$20240624$20240708$EXP$$IN-Accord-431155$ACCORD$Kene R, Singhai P, Raman R, Dutta Majumder P. Presumed Fungal Retinitis Following Adalimumab Therapy for Juvenile Idiopathic Arthritis: A Rare Case Report. Ocul Immunol Inflamm. 2024 Jun 10:1-4. doi: 10.1080$20$YR$A$F$Y$$$20240708$$HP$IN$IN
240047272$24004727$2$F$20240612$20240710$20240624$20240716$EXP$$GB-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00355$VELOXIS PHARMACEUTICALS$$15$YR$$F$Y$$$20240716$$MD$GB$GB
240047302$24004730$2$F$20240606$20240624$20240624$20240702$EXP$$US-Eisai-EC-2024-168218$EISAI$$63$YR$A$M$Y$68$KG$20240702$$MD$US$US
240047392$24004739$2$F$$20240925$20240624$20240927$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-088260$REGENERON$$$$$$Y$$$20240927$$MD$JP$JP
240047422$24004742$2$F$$20240802$20240624$20240809$EXP$$CA-GSK-CA2023103513$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$MD$CA$CA
240047432$24004743$2$F$20240315$20240618$20240624$20240705$EXP$$JP-GILEAD-2024-0671036$GILEAD$$49$YR$A$M$Y$$$20240705$$MD$JP$JP
240047496$24004749$6$F$$20240826$20240624$20240829$30DAY$$US-PFIZER INC-202400191601$PFIZER$$$$$$Y$$$20240829$$PH$US$US
240047514$24004751$4$F$$20240812$20240624$20240816$30DAY$$US-PFIZER INC-202400192241$PFIZER$$80$YR$$F$Y$$$20240816$$CN$US$US
240047525$24004752$5$F$$20240903$20240624$20240905$30DAY$$US-PFIZER INC-202400192406$PFIZER$$$$$$Y$$$20240905$$CN$US$US
240047562$24004756$2$F$$20240718$20240624$20240722$EXP$$CA-ORGANON-O2406CAN001875$ORGANON$$43$YR$$F$Y$96$KG$20240722$$HP$CA$CA
240047592$24004759$2$F$$20240812$20240624$20240814$EXP$$GB-MYLANLABS-2024M1056212$MYLAN$$$$$F$Y$$$20240814$$MD$GB$GB
240047642$24004764$2$F$$20240710$20240624$20240725$30DAY$$US-JNJFOC-20240647866$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$HP$US$US
240047732$24004773$2$F$$20240617$20240624$20240802$PER$$US-ROCHE-10000000424$ROCHE$$52$YR$A$F$Y$$$20240802$$CN$US$US
240047802$24004780$2$F$20240515$20240701$20240624$20240722$PER$$US-APELLIS-2024-APL-0000131$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
240047852$24004785$2$F$20230103$20240816$20240624$20240816$EXP$$CA-PFIZER INC-202300063698$PFIZER$$74$YR$$M$Y$$$20240816$$HP$CA$CA
240047873$24004787$3$F$$20240726$20240624$20240729$EXP$$CA-PFIZER INC-202400196364$PFIZER$$22$YR$$F$Y$$$20240729$$MD$CA$CA
240047912$24004791$2$F$20240301$20240814$20240624$20240814$EXP$$CA-PFIZER INC-202400196119$PFIZER$$78$YR$$F$Y$45.45$KG$20240814$$HP$CA$CA
240048172$24004817$2$F$$20240703$20240624$20240705$PER$$US-ABBVIE-5806073$ABBVIE$$86$YR$$F$Y$$$20240705$$CN$US$US
240048182$24004818$2$F$$20240625$20240624$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05180$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240048203$24004820$3$F$$20240823$20240624$20240828$30DAY$$DE-PFIZER INC-202400179906$PFIZER$$$$$M$Y$$$20240828$$CN$DE$DE
240048213$24004821$3$F$20240520$20240805$20240624$20240807$EXP$$NVSC2024ZA107991$NOVARTIS$$36$YR$$F$Y$$$20240807$$HP$ZA$ZA
240048223$24004822$3$F$$20240815$20240624$20240820$30DAY$$JP-PFIZER INC-PV202400072512$PFIZER$$$$C$$Y$$$20240820$$HP$JP$JP
240048242$24004824$2$F$$20240623$20240624$20240701$PER$$US-ROCHE-10000006382$ROCHE$$$$A$F$Y$$$20240701$$MD$US$US
240048262$24004826$2$F$$20240911$20240624$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100616$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240915$$CN$US$US
240048283$24004828$3$F$$20240819$20240624$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100488$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240827$$CN$US$US
240048302$24004830$2$F$20230629$20240722$20240624$20240729$EXP$$DE-EMD Serono-2024033992$EMD SERONO INC$$78$YR$E$M$Y$$$20240729$$MD$DE$DE
240048372$24004837$2$F$$20240628$20240624$20240703$EXP$$CA-JNJFOC-20240645933$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240703$$CN$CA$CA
240048432$24004843$2$F$$20240702$20240624$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-030227$AUROBINDO$Alexander G, Moore SA, Lenert PS. Eosinophilic granulomatosis with polyangiitis and its association with montelukast: a case-based review. Clinical Rheumatology. 2024;43(6):2153-65$21$YR$$M$Y$$$20240711$$MD$US$US
240048443$24004844$3$F$$20240819$20240624$20240822$30DAY$$JP-PFIZER INC-PV202400078741$PFIZER$$14$YR$$$Y$$$20240822$$MD$JP$JP
240048454$24004845$4$F$20240601$20240814$20240624$20240820$30DAY$$RO-PFIZER INC-PV202400078553$PFIZER$$12$YR$$M$Y$58$KG$20240820$$CN$RO$RO
240048463$24004846$3$F$20240611$20240905$20240624$20240910$30DAY$$AR-PFIZER INC-202400192060$PFIZER$$8$YR$$M$Y$$$20240910$$HP$AR$AR
240048512$24004851$2$F$20240617$20240628$20240624$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100406$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$103.1$KG$20240704$$CN$US$US
240048573$24004857$3$F$20240411$20240617$20240624$20240703$EXP$$CN-ROCHE-10000001247$ROCHE$$65$YR$E$M$Y$78$KG$20240703$$HP$CN$CN
240048597$24004859$7$F$20240612$20240830$20240624$20240904$30DAY$$GR-PFIZER INC-202400193942$PFIZER$$7$YR$$M$Y$19$KG$20240904$$CN$GR$GR
240048603$24004860$3$F$20240613$20240816$20240624$20240816$30DAY$$UY-PFIZER INC-202400194928$PFIZER$$7$YR$$M$Y$$$20240816$$HP$UY$UY
240048642$24004864$2$F$$20240727$20240624$20240730$30DAY$$FR-PFIZER INC-202400194919$PFIZER$$$$$F$Y$$$20240730$$PH$FR$FR
240048652$24004865$2$F$20240101$20240819$20240624$20240822$PER$$CA-PFIZER INC-202400194018$PFIZER$$18$YR$$F$Y$$$20240822$$HP$CA$CA
240048663$24004866$3$F$20240601$20240911$20240624$20240913$30DAY$$CL-PFIZER INC-PV202400077067$PFIZER$$13$YR$$M$Y$$$20240913$$CN$BE$BE
240048673$24004867$3$F$20240601$20240822$20240624$20240827$30DAY$$GR-PFIZER INC-PV202400080110$PFIZER$$13$YR$$M$Y$35$KG$20240827$$CN$GR$GR
240048682$24004868$2$F$20240315$20240918$20240624$20240923$EXP$$NVSC2024US068164$NOVARTIS$$46$YR$$F$Y$$$20240923$$CN$US$US
240048694$24004869$4$F$20220224$20240909$20240624$20240916$EXP$$NVSC2024KR119339$NOVARTIS$$59$YR$$F$Y$$$20240916$$MD$KR$KR
240048712$24004871$2$F$$20240711$20240624$20240722$30DAY$$US-GSK-US2024076542$GLAXOSMITHKLINE$$$$$F$Y$77.11$KG$20240722$$CN$US$US
240048722$24004872$2$F$$20240722$20240624$20240731$30DAY$$US-JNJFOC-20240645536$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
240048845$24004884$5$F$$20240919$20240624$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099396$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240926$$HP$US$US
240048912$24004891$2$F$20240501$20240812$20240624$20240820$EXP$$US-SA-2024SA183584$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240820$$MD$US$US
240048953$24004895$3$F$$20240625$20240624$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453150$RANBAXY$$$$A$F$Y$$$20240710$$CN$US$US
240049012$24004901$2$F$20240329$20240626$20240624$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453149$RANBAXY$$76$YR$$F$Y$59$KG$20240711$$CN$GB$GB
240049102$24004910$2$F$20070101$20240702$20240624$20240709$EXP$$IT-AUROBINDO-AUR-APL-2024-030167$AUROBINDO$Ripamonti, C. Treatment of osteonecrosis of the jaw (ONJ) by medical ozone gas insufflation. A case report.. Tumori. 2012;98(3):e72-e75$75$YR$$M$Y$$$20240709$$MD$IT$IT
240049182$24004918$2$F$$20240705$20240624$20240711$EXP$$BE-MYLANLABS-2024M1055841$MYLAN$$12$YR$$M$Y$85$KG$20240711$$CN$BE$BE
240049202$24004920$2$F$20240531$20240730$20240624$20240801$EXP$$US-MYLANLABS-2024M1056131$MYLAN$$48$YR$$F$Y$78.2$KG$20240801$$HP$US$US
240049262$24004926$2$F$20240502$20240617$20240624$20240828$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034369$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240828$$HP$DE$DE
240049422$24004942$2$F$20240613$20240703$20240624$20240704$PER$$US-JNJFOC-20240638945$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240705$$HP$US$US
240049542$24004954$2$F$20191004$20240902$20240624$20240905$EXP$$JP-GILEAD-2020-0489641$GILEAD$$65$YR$E$M$Y$$$20240905$$MD$JP$JP
240049583$24004958$3$F$20220801$20240717$20240624$20240722$EXP$FR-AFSSAPS-TS2024000683$FR-EMD Serono-2024032956$EMD SERONO INC$$52$YR$A$F$Y$108$KG$20240722$$PH$FR$FR
240049652$24004965$2$F$$20240711$20240624$20240724$PER$$US-LUPIN HEALTHCARE (UK) LIMITED-2024-05036$LUPIN$$$$$$Y$$$20240724$$PH$US$US
240049686$24004968$6$F$20240601$20240801$20240624$20240802$PER$$US-JNJFOC-20240658470$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240802$$CN$US$US
240049713$24004971$3$F$20240617$20240708$20240624$20240711$EXP$$GB-MYLANLABS-2024M1055973$MYLAN$$$$$F$Y$$$20240711$$CN$GB$GB
240049853$24004985$3$F$20240506$20240712$20240624$20240722$EXP$$US-APELLIS-2024-APL-0000137$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
240049892$24004989$2$F$20240610$20240624$20240624$20240702$EXP$$IL-EMD Serono-2024033025$EMD SERONO INC$$75$YR$E$F$Y$$$20240702$$CN$IL$IL
240050102$24005010$2$F$20240617$20240726$20240624$20240802$EXP$$JP-009507513-2406JPN002325J$MERCK$$50$YR$$F$Y$$$20240802$$HP$JP$JP
240050202$24005020$2$F$$20240602$20240624$20240722$EXP$$US-AstraZeneca-2024A144741$ASTRAZENECA$$$$$F$Y$$$20240722$$MD$US$
240050253$24005025$3$F$20240420$20240614$20240624$20240822$PER$$US-APELLIS-2024-APL-0000259$APELLIS PHARMACEUTICALS$$$$$$Y$63.503$KG$20240822$$CN$US$US
240050472$24005047$2$F$$20240619$20240624$20240723$EXP$$US-009507513-2406GRC006889$MERCK$Akinboboye OI, Walls S, Akpan I, Abib O. Eosinophilic Storm: Unraveling Daptomycin Induced Eosinophilic Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024;209$65$YR$$M$Y$$$20240723$$HP$US$US
240050592$24005059$2$F$20240610$20240626$20240624$20240702$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-087254$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240702$$CN$CA$CA
240050622$24005062$2$F$$20240703$20240624$20240710$EXP$$BR-009507513-2406BRA006857$MERCK$$16$YR$$M$Y$$$20240710$$CN$BR$BR
240050692$24005069$2$F$20240801$20240820$20240624$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099976$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240821$$CN$US$US
240050712$24005071$2$F$20240615$20240709$20240624$20240710$PER$$US-AMGEN-USASP2024120457$AMGEN$$74$YR$E$M$Y$$$20240710$$CN$US$US
240050732$24005073$2$F$20240618$20240626$20240624$20240702$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-088322$REGENERON$$$$$F$Y$$$20240702$$MD$CA$CA
240050742$24005074$2$F$$20240725$20240624$20240731$30DAY$$TR-JNJFOC-20240645531$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$TR$TR
240050812$24005081$2$F$$20240729$20240624$20240801$PER$$US-ALXN-202406USA001057US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
240050972$24005097$2$F$$20240716$20240624$20240723$EXP$$NVSJ2024JP007217$NOVARTIS$$5$YR$$F$Y$$$20240723$$MD$JP$JP
240050982$24005098$2$F$20240101$20240629$20240624$20240705$PER$$US-BAYER-2024A088335$BAYER$$28$YR$A$F$Y$76.19$KG$20240705$$MD$US$US
240051092$24005109$2$F$$20240621$20240624$20240909$EXP$$SI-BAUSCH-BL-2024-009616$BAUSCH AND LOMB$$$$E$M$Y$$$20240909$$MD$SI$SI
240051113$24005111$3$F$20140101$20240917$20240624$20240923$EXP$$GB-MYLANLABS-2024M1053849$MYLAN$$84$YR$$M$Y$$$20240923$$CN$GB$GB
240051143$24005114$3$F$$20240708$20240624$20240712$EXP$$IE-MYLANLABS-2024M1056254$MYLAN$$$$$M$Y$$$20240712$$PH$IE$IE
240051152$24005115$2$F$20220120$20240702$20240624$20240705$EXP$$US-ABBVIE-5811833$ABBVIE$$62$YR$$M$Y$107.5$KG$20240705$$CN$US$US
240051182$24005118$2$F$$20240716$20240624$20240723$EXP$$JP-ROCHE-10000002316$ROCHE$$8$DEC$E$$Y$$$20240723$$MD$JP$JP
240051212$24005121$2$F$20230401$20240722$20240624$20240731$EXP$$JP-009507513-2406JPN002812J$MERCK$$8$DEC$$M$Y$$$20240731$$MD$JP$JP
240051272$24005127$2$F$$20240715$20240624$20240725$30DAY$$FR-JNJFOC-20240644346$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$PH$FR$FR
240051312$24005131$2$F$20240611$20240721$20240624$20240724$PER$$US-AMGEN-USASP2024123080$AMGEN$$51$YR$A$F$Y$$$20240724$$CN$US$US
240051352$24005135$2$F$20240615$20240719$20240624$20240723$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-088259$REGENERON$$78$YR$$$Y$$$20240723$$MD$JP$JP
240051382$24005138$2$F$$20240628$20240624$20240705$EXP$$NVSC2024IT129363$NOVARTIS$$$$C$M$Y$$$20240705$$MD$IT$IT
240051482$24005148$2$F$20240130$20240722$20240624$20240730$EXP$$US-ASTELLAS-2024EU004933$ASTELLAS$$72$YR$$M$Y$111$KG$20240730$$CN$US$US
240051652$24005165$2$F$$20240725$20240624$20240731$30DAY$$IL-JNJFOC-20240642345$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$PH$IL$IL
240051673$24005167$3$F$20240517$20240729$20240624$20240801$PER$$US-ALXN-202406USA001043US$ALEXION PHARMACEUTICALS$$35$YR$$F$Y$$$20240801$$CN$US$US
240051932$24005193$2$F$$20240708$20240624$20240716$EXP$$JP-DSJP-DSJ-2024-127106$DAIICHI$Kinoshita Y, Hatakeyama M, Otsuki M, Ishiguro T, Saji E, Kanazawa M, et al.. Cerebellar compensation: a case of aphasia due to cerebellar hemorrhage. Journal of Neurology. 2024;271:3639-3642$77$YR$$F$Y$$$20240716$$MD$JP$JP
240051942$24005194$2$F$$20240718$20240624$20240731$30DAY$$US-JNJFOC-20240639581$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
240051952$24005195$2$F$20240620$20240711$20240624$20240713$PER$$US-AMGEN-USASP2024122314$AMGEN$$65$YR$E$F$Y$$$20240712$$CN$US$US
240051962$24005196$2$F$20230721$20240801$20240624$20240806$30DAY$$BR-AMGEN-BRASP2024120745$AMGEN$$$$$$Y$$$20240806$$PH$BR$BR
240051972$24005197$2$F$20240615$20240830$20240624$20240905$EXP$$JP-009507513-2406JPN002827J$MERCK$$6$DEC$$F$Y$$$20240905$$MD$JP$JP
240051994$24005199$4$F$$20240909$20240624$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099683$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$170.1$KG$20240913$$CN$US$US
240052054$24005205$4$F$$20240705$20240624$20240711$EXP$$US-PFIZER INC-202400198885$PFIZER$Rozenbaum Lerner, G.. Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3531$68$YR$$M$Y$84$KG$20240711$$MD$US$US
240052102$24005210$2$F$20240405$20240621$20240624$20240809$EXP$$CA-VANTIVE-2024VAN017845$Vantive US Healthcare$$62$YR$$F$Y$56.24$KG$20240809$$CN$CA$CA
240052222$24005222$2$F$20240526$20240829$20240624$20240911$EXP$$CO-ORPHANEU-2024004148$RECORDATI$$$$$$Y$$$20240911$$CN$CO$CO
240052313$24005231$3$F$20240605$20240710$20240624$20240813$PER$$US-INCYTE CORPORATION-2024IN006522$INCYTE$$$$$$Y$$$20240813$$MD$US$US
240052422$24005242$2$F$$20240725$20240624$20240725$30DAY$$US-PFIZER INC-202400195996$PFIZER$$13$YR$$M$Y$$$20240725$$CN$US$US
240052473$24005247$3$F$20240621$20240717$20240624$20240722$PER$$US-AMGEN-USASP2024123411$AMGEN$$76$YR$E$F$Y$$$20240722$$CN$US$US
240052512$24005251$2$F$20231201$20240718$20240624$20240724$PER$$US-BAYER-2024A089768$BAYER$$32$YR$A$F$Y$107$KG$20240724$$HP$US$US
240052532$24005253$2$F$$20240626$20240624$20240703$EXP$$TR-BIOGEN-2024BI01269873$BIOGEN$$$$$$Y$$$20240703$$MD$TR$TR
240052612$24005261$2$F$20211225$20240821$20240624$20240826$EXP$$AU-ORGANON-O2406AUS001946$ORGANON$$$$$M$Y$$$20240826$$HP$AU$AU
240052627$24005262$7$F$20240501$20240915$20240624$20240919$30DAY$$US-PFIZER INC-202400195526$PFIZER$$11$YR$$M$Y$29.03$KG$20240919$$CN$US$US
240052634$24005263$4$F$$20240911$20240624$20240913$30DAY$$US-PFIZER INC-202400197058$PFIZER$$51$YR$$F$Y$$$20240913$$CN$US$US
240052643$24005264$3$F$$20240730$20240624$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099764$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240801$$HP$US$US
240052663$24005266$3$F$$20240719$20240624$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099768$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$68.49$KG$20240722$$CN$US$US
240052823$24005282$3$F$20240402$20240702$20240624$20240712$PER$$JP-Eisai-EC-2024-168359$EISAI$$78$YR$E$F$Y$$$20240712$$PH$JP$JP
240052893$24005289$3$F$20240412$20240807$20240624$20240813$EXP$$NVSJ2024JP007430$NOVARTIS$$69$YR$$F$Y$$$20240813$$MD$JP$JP
240052912$24005291$2$F$20240601$20240710$20240624$20240717$EXP$$NVSC2024MX093400$NOVARTIS$$37$YR$$F$Y$68$KG$20240717$$CN$MX$MX
240053122$24005312$2$F$$20240628$20240624$20240704$EXP$$NVSC2024CA129958$NOVARTIS$$59$YR$$M$Y$$$20240704$$CN$CA$CA
240053152$24005315$2$F$$20240916$20240624$20240917$EXP$$NVSC2024DE130168$NOVARTIS$$$$A$F$Y$$$20240917$$MD$DE$DE
240053204$24005320$4$F$$20240701$20240624$20240702$EXP$$SI-PFIZER INC-202400194967$PFIZER$Grasselli Kmet, N.. Successful use of tocilizumab and casirivimab/imdevimab in a twin pregnancy with critical COVID-19 - A case report. Heliyon. 2024;10$$$N$M$Y$2.82$KG$20240702$$HP$SI$SI
240053282$24005328$2$F$$20240721$20240624$20240725$PER$$US-AMGEN-USASP2024123201$AMGEN$$53$YR$A$F$Y$$$20240725$$CN$US$US
240053302$24005330$2$F$20240613$20240625$20240624$20240703$PER$$US-ALXN-202406USA001062US$ALEXION PHARMACEUTICALS$$69$YR$$M$Y$$$20240703$$CN$US$US
240053372$24005337$2$F$$20240626$20240624$20240702$EXP$$CZ-MYLANLABS-2024M1055913$MYLAN$Cmunt E.. Treatment of relapse/progression of diffuse large cell lymphoma with the tafasitamab lenalidomide regimen.. Acta medicinae.. 2024;4:42-46$78$YR$$M$Y$$$20240702$$HP$CZ$CZ
240053402$24005340$2$F$$20240722$20240624$20240724$EXP$$JP-JNJFOC-20240651635$JOHNSON AND JOHNSON$$75$YR$E$M$Y$53.7$KG$20240724$$MD$JP$JP
240053412$24005341$2$F$$20240709$20240624$20240715$EXP$$HU-PFIZER INC-202400195804$PFIZER$Jona, A.. Our experience with Mosunetuzumab. Hematologia-Transzfuziologia. 2024;57(1):76$64$YR$$M$Y$$$20240715$$MD$HU$HU
240053482$24005348$2$F$20240619$20240701$20240624$20240705$PER$$US-AMGEN-USASP2024122812$AMGEN$$64$YR$E$F$Y$$$20240705$$CN$US$US
240053512$24005351$2$F$$20240709$20240624$20240715$EXP$$JP-OTSUKA-2024_017400$OTSUKA$$33$YR$$F$Y$$$20240715$$PH$JP$JP
240053692$24005369$2$F$$20240730$20240624$20240730$PER$$US-ALXN-202406USA001175US$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240730$$MD$US$US
240053772$24005377$2$F$$20240612$20240624$20240709$EXP$$US-ROCHE-10000003807$ROCHE$$81$YR$E$M$Y$$$20240709$$MD$US$US
240053883$24005388$3$F$20240604$20240723$20240624$20240731$EXP$$GB-PFIZER INC-202400198912$PFIZER$$22$YR$$M$Y$113$KG$20240731$$MD$GB$GB
240053922$24005392$2$F$20230101$20240816$20240624$20240816$EXP$$CA-PFIZER INC-202400196332$PFIZER$$64$YR$$F$Y$$$20240816$$MD$CA$CA
240053934$24005393$4$F$20240505$20240918$20240624$20240924$EXP$$TW-PFIZER INC-PV202400081199$PFIZER$$60$YR$$F$Y$85.6$KG$20240924$$MD$TW$TW
240053992$24005399$2$F$20240524$20240715$20240624$20240718$PER$$US-JNJFOC-20240639501$JOHNSON AND JOHNSON$$38$YR$A$$Y$$$20240718$$HP$US$US
240054003$24005400$3$F$20240606$20240708$20240624$20240717$EXP$$JP-009507513-2406JPN001958J$MERCK$$73$YR$$M$Y$$$20240717$$PH$JP$JP
240054033$24005403$3$F$20240101$20240717$20240624$20240723$EXP$$US-KARYOPHARM-2024KPT001195$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240723$$CN$US$US
240054122$24005412$2$F$20240501$20240920$20240624$20240924$EXP$$NVSC2024CN130162$NOVARTIS$$$$$M$Y$$$20240924$$CN$CN$CN
240054172$24005417$2$F$$20240709$20240624$20240716$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0600680$MYOVANT SCIENCES$$$$$M$Y$$$20240716$$CN$US$US
240054432$24005443$2$F$20230101$20240716$20240624$20240717$EXP$$TW-BAYER-2024A090210$BAYER$$$$A$M$Y$$$20240717$$CN$TW$TW
240054583$24005458$3$F$$20240830$20240624$20240903$EXP$$IN-PFIZER INC-PV202400081360$PFIZER$$57$YR$$M$Y$$$20240903$$CN$IN$IN
240054612$24005461$2$F$20231204$20240919$20240624$20240919$EXP$$JP-BAYER-2024A090135$BAYER$$78$YR$E$M$Y$$$20240919$$MD$JP$JP
240054632$24005463$2$F$20240101$20240619$20240624$20240717$PER$$US-009507513-2406USA006941$MERCK$$41$YR$$F$Y$$$20240717$$CN$US$US
240054642$24005464$2$F$$20240626$20240624$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05236$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240054662$24005466$2$F$20230519$20240612$20240624$20240703$EXP$$FR-ACRAF SpA-2024-034840$SK LIFE SCIENCE$$$$$$Y$$$20240703$$MD$FR$FR
240054704$24005470$4$F$$20240923$20240624$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101003$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240925$$CN$US$US
240054732$24005473$2$F$20230122$20240702$20240624$20240705$EXP$$JP-EMD Serono-2024033891$EMD SERONO INC$$81$YR$E$F$Y$42$KG$20240705$$MD$JP$JP
240054742$24005474$2$F$$20240620$20240624$20240709$PER$$US-ROCHE-10000003906$ROCHE$$$$$F$Y$$$20240705$$CN$US$US
240054932$24005493$2$F$20240610$20240805$20240624$20240807$EXP$$US-MYLANLABS-2024M1056778$MYLAN$$33$YR$$M$Y$68.22$KG$20240807$$MD$US$US
240054952$24005495$2$F$$20240611$20240624$20240709$PER$$US-ROCHE-10000004142$ROCHE$$$$$$Y$$$20240705$$PH$US$US
240055093$24005509$3$F$$20240817$20240624$20240819$EXP$$PK-PFIZER INC-PV202400011200$PFIZER$$35$YR$$F$Y$63$KG$20240819$$CN$PK$PK
240055122$24005512$2$F$20210712$20240620$20240624$20240711$EXP$$ES-PFIZER INC-202400197297$PFIZER$$61$YR$$M$Y$74$KG$20240711$$CN$ES$ES
240055232$24005523$2$F$20240101$20240705$20240624$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA059784$SANDOZ$$$$$F$Y$$$20240710$$MD$CA$CA
240055352$24005535$2$F$20200101$20240705$20240624$20240722$EXP$GB-MHRA-MED-202406121251144660-JCQDY$GB-LUPIN PHARMACEUTICALS INC.-2024-05166$LUPIN$$$$$$Y$$$20240719$$MD$GB$GB
240055462$24005546$2$F$20230915$20240702$20240624$20240705$EXP$$JP-EMD Serono-2024033980$EMD SERONO INC$$79$YR$E$F$Y$36$KG$20240705$$MD$JP$JP
240055582$24005558$2$F$20240228$20240814$20240624$20240820$EXP$$GB-MYLANLABS-2024M1019402$MYLAN$$52$YR$$M$Y$$$20240820$$MD$GB$GB
240055653$24005565$3$F$20240619$20240709$20240624$20240717$PER$$US-AMGEN-USASP2024122384$AMGEN$$73$YR$E$F$Y$$$20240717$$CN$US$US
240055722$24005572$2$F$$20240830$20240624$20240902$EXP$$CA-SANDOZ INC.-NVSC2021CA296035$SANDOZ$$44$YR$$F$Y$97$KG$20240902$$HP$CA$CA
240055923$24005592$3$F$20240609$20240627$20240624$20240708$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406014740$ELI LILLY AND CO$$22$YR$A$M$Y$$$20240708$$CN$DE$CN
240055932$24005593$2$F$20240515$20240702$20240624$20240709$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406014417$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240709$$CN$JP$JP
240056134$24005613$4$F$$20240924$20240624$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101097$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240924$$CN$US$US
240056142$24005614$2$F$$20240923$20240624$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100817$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240925$$HP$US$US
240056222$24005622$2$F$20230909$20240703$20240624$20240709$EXP$$JP-OTSUKA-2024_017398$OTSUKA$$79$YR$$F$Y$80.5$KG$20240709$$MD$JP$JP
240056272$24005627$2$F$20230101$20240919$20240624$20240924$PER$$US-PFIZER INC-PV202400082340$PFIZER$$63$YR$$F$Y$$$20240924$$HP$US$US
240056292$24005629$2$F$$20240724$20240624$20240724$PER$$US-PFIZER INC-202400197438$PFIZER$$51$YR$$F$Y$$$20240724$$CN$US$US
240056333$24005633$3$F$$20240630$20240624$20240708$PER$$US-PFIZER INC-PV202400078451$PFIZER$$76$YR$$F$Y$50.2$KG$20240708$$MD$US$US
240056423$24005642$3$F$20220101$20240726$20240624$20240731$PER$$US-PFIZER INC-202400196460$PFIZER$$66$YR$$M$Y$$$20240731$$CN$US$US
240056462$24005646$2$F$20240601$20240903$20240624$20240905$PER$$US-PFIZER INC-202400198818$PFIZER$$59$YR$$F$Y$117.91$KG$20240905$$CN$US$US
240056482$24005648$2$F$20240620$20240627$20240624$20240701$PER$$US-PFIZER INC-202400198667$PFIZER$$68$YR$$F$Y$51.71$KG$20240701$$CN$US$US
240056492$24005649$2$F$$20240819$20240624$20240821$PER$$US-PFIZER INC-202400192575$PFIZER$$54$YR$$F$Y$$$20240821$$HP$US$US
240056562$24005656$2$F$$20240710$20240624$20240711$PER$$US-PFIZER INC-202400198639$PFIZER$$87$YR$$F$Y$$$20240711$$CN$US$US
240056572$24005657$2$F$$20240719$20240624$20240723$PER$$US-PFIZER INC-PV202300131138$PFIZER$$60$YR$$M$Y$$$20240723$$CN$US$US
240056593$24005659$3$F$20240715$20240821$20240624$20240827$PER$$US-PFIZER INC-202400199140$PFIZER$$65$YR$$F$Y$$$20240827$$CN$US$US
240056623$24005662$3$F$20240227$20240812$20240624$20240819$EXP$$US-OTSUKA-2024_005505$OTSUKA$$$$$F$Y$$$20240819$$CN$US$US
240056674$24005667$4$F$20240413$20240718$20240624$20240724$PER$$JP-Eisai-EC-2024-168669$EISAI$$$$E$F$Y$$$20240724$$MD$JP$JP
240056762$24005676$2$F$$20240704$20240624$20240708$EXP$$JP-PFIZER INC-PV202400082226$PFIZER$$85$YR$$F$Y$$$20240708$$HP$JP$JP
240056832$24005683$2$F$20240101$20240708$20240624$20240717$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00107$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
240056845$24005684$5$F$20190101$20240923$20240624$20240924$EXP$$US-PFIZER INC-PV202300175407$PFIZER$$34$YR$$F$Y$$$20240924$$HP$US$US
240057012$24005701$2$F$20240602$20240627$20240624$20240710$30DAY$$CA-JNJFOC-20240621130$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240710$$PH$CA$CA
240057063$24005706$3$F$$20240812$20240624$20240816$30DAY$$ES-SA-2024SA181702$SANOFI AVENTIS$$$$$$Y$$$20240816$$HP$ES$ES
240057073$24005707$3$F$20240201$20240709$20240624$20240711$EXP$$NVSC2024DE129737$NOVARTIS$$65$YR$$F$Y$72$KG$20240711$$MD$DE$DE
240057112$24005711$2$F$20230427$20240703$20240624$20240705$EXP$$JP-EMD Serono-2024034047$EMD SERONO INC$$87$YR$E$F$Y$53$KG$20240705$$MD$JP$JP
240057182$24005718$2$F$20240528$20240814$20240624$20240819$EXP$RU-RZN-2410051$RU-BAYER-2024A089491$BAYER$$69$YR$E$M$Y$74$KG$20240819$$MD$RU$RU
240057193$24005719$3$F$20240601$20240715$20240624$20240720$PER$$US-AMGEN-USASP2024123592$AMGEN$$47$YR$A$F$Y$$$20240720$$PH$US$US
240057212$24005721$2$F$20240620$20240709$20240624$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202406014460$ELI LILLY AND CO$$$$$M$Y$$$20240711$$CN$US$US
240057323$24005732$3$F$20240329$20240626$20240624$20240708$PER$$US-ROCHE-3541428$ROCHE$$6$YR$C$M$Y$$$20240708$$CN$US$US
240057333$24005733$3$F$$20240923$20240624$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100690$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240924$$HP$US$US
240057382$24005738$2$F$20231007$20240730$20240624$20240812$EXP$$IN-INCYTE CORPORATION-2020IN013725$INCYTE$$$$$$Y$$$20240812$$CN$IN$IN
240057412$24005741$2$F$$20240625$20240624$20240701$PER$$US-PFIZER INC-PV202400082140$PFIZER$$81$YR$$F$Y$$$20240701$$CN$US$US
240057432$24005743$2$F$$20240816$20240624$20240820$PER$$US-PFIZER INC-PV202400082376$PFIZER$$64$YR$$F$Y$53.6$KG$20240820$$MD$US$US
240057492$24005749$2$F$20240601$20240627$20240624$20240701$PER$$US-PFIZER INC-202400198791$PFIZER$$41$YR$$F$Y$$$20240701$$HP$US$US
240057533$24005753$3$F$$20240813$20240624$20240814$EXP$$US-PFIZER INC-202400197896$PFIZER$$78$YR$$F$Y$$$20240814$$MD$US$US
240057642$24005764$2$F$20240101$20240708$20240624$20240717$PER$$US-SA-2024SA178980$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240717$$MD$US$US
240057732$24005773$2$F$20230901$20240708$20240624$20240710$EXP$$CA-ABBVIE-5810635$ABBVIE$$78$YR$$M$Y$$$20240710$$CN$CA$CA
240057823$24005782$3$F$20240101$20240909$20240624$20240918$PER$$US-SA-2024SA179499$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240918$$MD$US$US
240057833$24005783$3$F$20240603$20240801$20240624$20240810$PER$$US-SA-2024SA179003$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240810$$MD$US$US
240057882$24005788$2$F$$20240806$20240624$20240813$PER$$US-SA-2024SA181292$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240814$$MD$US$US
240057902$24005790$2$F$20240612$20240709$20240624$20240717$PER$$US-SA-2024SA179517$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240717$$MD$US$US
240057933$24005793$3$F$20240401$20240718$20240624$20240726$PER$$US-SA-2024SA179363$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240726$$MD$US$US
240058153$24005815$3$F$20240613$20240730$20240624$20240807$PER$$US-SA-2024SA181123$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240807$$MD$US$US
240058212$24005821$2$F$20240101$20240806$20240624$20240814$PER$$US-SA-2024SA182430$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240814$$MD$US$US
240058362$24005836$2$F$20220101$20240904$20240624$20240930$PER$$US-SA-2024SA183982$SANOFI AVENTIS$$90$YR$E$F$Y$52.6$KG$20240929$$HP$US$US
240058443$24005844$3$F$$20240726$20240624$20240805$PER$$US-SA-2024SA181131$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240805$$MD$US$US
240058542$24005854$2$F$20240613$20240717$20240624$20240724$PER$$US-SA-2024SA183925$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240725$$MD$US$US
240058684$24005868$4$F$$20240802$20240624$20240807$EXP$$BE-BEH-2024170493$CSL BEHRING$$80$YR$E$F$Y$$$20240807$$HP$BE$BE
240058695$24005869$5$F$$20240920$20240624$20240925$30DAY$$PR-PFIZER INC-202400196111$PFIZER$$12$YR$$M$Y$$$20240925$$CN$PR$US
240058702$24005870$2$F$20240315$20240718$20240624$20240724$EXP$FR-AFSSAPS-AN2024000806$FR-PFIZER INC-202400198340$PFIZER$$50$YR$$F$Y$69$KG$20240724$$PH$FR$FR
240058772$24005877$2$F$20240101$20240805$20240624$20240814$PER$$US-SA-2024SA185452$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240814$$CN$US$US
240058782$24005878$2$F$$20240725$20240624$20240805$PER$$US-SA-2024SA183996$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240804$$CN$US$US
240058832$24005883$2$F$20240101$20240816$20240624$20240829$PER$$US-SA-2024SA185116$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240829$$MD$US$US
240058842$24005884$2$F$20240101$20240911$20240624$20240917$PER$$US-SA-2024SA182279$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240918$$MD$US$US
240058872$24005887$2$F$$20240719$20240624$20240729$PER$$US-SA-2024SA184096$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240729$$CN$US$US
240059002$24005900$2$F$20240101$20240711$20240624$20240722$PER$$US-SA-2024SA183391$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240722$$MD$US$US
240059122$24005912$2$F$$20240806$20240624$20240812$EXP$$CA-OTSUKA-2023_021755$OTSUKA$$$$$M$Y$$$20240812$$HP$CA$CA
240059132$24005913$2$F$20240613$20240724$20240624$20240731$PER$$US-AMGEN-USASP2024119831$AMGEN$$$$$F$Y$$$20240731$$HP$US$US
240059142$24005914$2$F$20240615$20240710$20240624$20240714$30DAY$$US-AMGEN-USASP2024119526$AMGEN$$41$YR$A$F$Y$$$20240714$$PH$US$US
240059152$24005915$2$F$20240601$20240830$20240624$20240904$30DAY$$AR-PFIZER INC-202400191222$PFIZER$$6$YR$$M$Y$$$20240904$$CN$AR$AR
240059162$24005916$2$F$$20240811$20240624$20240812$30DAY$$CO-PFIZER INC-PV202400081491$PFIZER$$$$$$Y$$$20240812$$MD$CO$CO
240059173$24005917$3$F$$20240911$20240624$20240913$30DAY$$CO-PFIZER INC-202400196761$PFIZER$$$$$$Y$$$20240913$$CN$CO$CO
240059232$24005923$2$F$$20240709$20240624$20240715$EXP$$JP-ABBVIE-5799301$ABBVIE$$76$YR$$F$Y$$$20240715$$MD$JP$JP
240059272$24005927$2$F$20230101$20240813$20240624$20240816$EXP$$US-ABBVIE-5810726$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
240059282$24005928$2$F$20240101$20240710$20240624$20240716$PER$$US-AMGEN-USASP2024115787$AMGEN$$$$$$Y$$$20240716$$HP$US$US
240059392$24005939$2$F$20240614$20240621$20240624$20240701$EXP$$IE-BAXTER-2024BAX020107$BAXTER$$23$YR$$M$Y$$$20240701$$MD$IE$IE
240059474$24005947$4$F$20240611$20240730$20240624$20240809$EXP$$JP-BAXTER-2024BAX020052$BAXTER$$60$YR$$M$Y$64.1$KG$20240809$$MD$JP$JP
240059502$24005950$2$F$20240612$20240704$20240624$20240713$EXP$GB-MHRA-MED-202406121927336890-TFBHM$GB-BAXTER-2024BAX019878$BAXTER$$31$YR$$F$Y$97$KG$20240713$$MD$GB$GB
240059572$24005957$2$F$20240319$20240711$20240624$20240721$EXP$$US-BAXTER-2024BAX019719$BAXTER$$$$$$Y$$$20240721$$CN$US$US
240059632$24005963$2$F$20240801$20240924$20240624$20240927$PER$$US-PFIZER INC-PV202400082534$PFIZER$$61$YR$$F$Y$$$20240927$$HP$US$US
240059692$24005969$2$F$20240101$20240627$20240624$20240701$PER$$US-PFIZER INC-PV202400081499$PFIZER$$87$YR$$F$Y$$$20240701$$CN$US$US
240059712$24005971$2$F$$20240911$20240624$20240917$EXP$$PT-MYLANLABS-2024M1055500$MYLAN$Costa LC, Morgado C, Alves JN, Machado C, Ferreira C.. Hemolysis and thrombocytopenia after slevetiracetam: when the patient gives us a yellow card. Sinapse. 2023;23 (1):274$82$YR$$M$Y$$$20240917$$HP$PT$PT
240059722$24005972$2$F$$20240923$20240624$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100304$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240925$$CN$US$US
240059972$24005997$2$F$20240601$20240628$20240624$20240702$EXP$$US-PFIZER INC-202400197423$PFIZER$$62$YR$$F$Y$$$20240702$$CN$US$US
240060292$24006029$2$F$20240601$20240809$20240624$20240819$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-12432$IPSEN$$14$YR$T$M$Y$$$20240819$$CN$US$US
240060382$24006038$2$F$$20240827$20240624$20240829$EXP$$CA-PFIZER INC-202400197733$PFIZER$$60$YR$$F$Y$$$20240829$$HP$CA$CA
240060443$24006044$3$F$20240607$20240716$20240624$20240720$30DAY$$CL-JNJFOC-20240620081$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240719$$CN$CL$CL
240060499$24006049$9$F$20240507$20240917$20240624$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006759$JAZZ$$21$YR$$F$Y$$$20240922$$HP$US$US
240060523$24006052$3$F$$20240917$20240624$20240920$30DAY$$KR-PFIZER INC-202400199033$PFIZER$$7$YR$$$Y$$$20240920$$CN$KR$KR
240060583$24006058$3$F$$20240905$20240624$20240911$EXP$$US-ROCHE-10000000444$ROCHE$$$$A$M$Y$$$20240911$$CN$US$US
240060782$24006078$2$F$$20240609$20240624$20240701$EXP$IT-MYLANLABS-2021M1083823$IT-LEO Pharma-339768$LEO PHARM$Marasca C., Fornaro L., Martora F., Picone V., Fabbrocini G., Megna M. Onset of vitiligo in a psoriasis patient on ixekizumab. Dermatologic Therapy. volume 34 issue 5 pages e15102-n/a September 2021; doi:10.1111/dth.15102$53$YR$$M$Y$$$20240627$$MD$IT$IT
240060832$24006083$2$F$20240601$20240718$20240624$20240723$PER$$US-KARYOPHARM-2024KPT001193$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240723$$HP$US$US
240060882$24006088$2$F$20240101$20240717$20240624$20240723$EXP$$US-ABBVIE-5811295$ABBVIE$$$$$F$Y$86$KG$20240723$$CN$US$US
240060892$24006089$2$F$20240101$20240823$20240624$20240828$EXP$$GB-ABBVIE-5811616$ABBVIE$$$$E$F$Y$$$20240828$$CN$GB$GB
240061092$24006109$2$F$$20240919$20240624$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA059659$SANDOZ$$$$$F$Y$$$20240923$$MD$CA$CA
240061213$24006121$3$F$20240518$20240624$20240624$20240807$PER$$US-AMGEN-USASP2024123270$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
240061222$24006122$2$F$20240603$20240709$20240624$20240723$30DAY$$AU-JNJFOC-20240606414$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240722$$CN$AU$AU
240061292$24006129$2$F$$20240702$20240624$20240708$EXP$US-MLMSERVICE-20240611-PI091830-00043-2$US-RDY-SPO/USA/24/0008827$DR REDDYS$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: A case series. Pediatric nephrology (Berlin, Germany). 2024. DOI: 10.1007/s00467-024-06413-6.$15$YR$T$M$Y$55$KG$20240708$$MD$US$US
240061392$24006139$2$F$20240527$20240814$20240624$20240819$EXP$RU-RZN-241006$RU-BAYER-2024A089478$BAYER$$72$YR$E$F$Y$51$KG$20240819$$MD$RU$RU
240061453$24006145$3$F$$20240703$20240624$20240712$PER$$US-SA-2024SA182637$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240061464$24006146$4$F$20240614$20240730$20240624$20240805$EXP$$VN-SANDOZ INC.-SDZ2024VN059999$SANDOZ$$64$YR$$M$Y$52$KG$20240804$$MD$VN$VN
240061504$24006150$4$F$20240604$20240823$20240624$20240828$PER$$US-BIOVITRUM-2024-US-008980$BIOVITRUM$$70$YR$$F$Y$$$20240828$$CN$US$US
240061512$24006151$2$F$20211001$20240715$20240624$20240722$EXP$SK-SUKLSK-20219821$SK-ABBVIE-5813259$ABBVIE$$43$YR$$M$Y$68$KG$20240722$$MD$SK$SK
240061712$24006171$2$F$$20240618$20240624$20240729$EXP$$US-AstraZeneca-2024A144830$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
240061732$24006173$2$F$20240101$20240709$20240624$20240710$EXP$$US-UCBSA-2024031590$UCB$$$$$F$Y$$$20240710$$CN$US$US
240061812$24006181$2$F$20240613$20240723$20240624$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-100174$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240726$$MD$JP$JP
240061862$24006186$2$F$20240619$20240625$20240624$20240705$PER$$US-JNJFOC-20240657644$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240705$$CN$US$US
240061982$24006198$2$F$$20240911$20240624$20240917$EXP$$CA-009507513-2406CAN007808$MERCK$$$$$F$Y$$$20240917$$HP$CA$CA
240062192$24006219$2$F$20240517$20240717$20240624$20240720$EXP$$JP-ABBVIE-5813276$ABBVIE$$$$$F$Y$$$20240720$$PH$JP$JP
240062374$24006237$4$F$20240501$20240703$20240624$20240712$PER$$US-ROCHE-3573318$ROCHE$$60$YR$A$F$Y$$$20240712$$HP$US$US
240062442$24006244$2$F$20240509$20240913$20240624$20240919$EXP$$FR-INCYTE CORPORATION-2024IN006544$INCYTE$$$$$$Y$$$20240919$$MD$FR$FR
240062462$24006246$2$F$$20240730$20240624$20240802$PER$$US-JNJFOC-20240657689$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$HP$US$US
240062512$24006251$2$F$20240101$20240621$20240624$20240704$PER$$US-SA-2024SA183491$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240704$$MD$US$US
240062572$24006257$2$F$$20240713$20240624$20240718$PER$$US-SA-2024SA184265$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
240062672$24006267$2$F$$20240617$20240624$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098116$BRISTOL MYERS SQUIBB$Puri C, Khan AA, Sher N. A case of emphysematous gastritis with septic shock and clostridioides difficile. American Journal of Respiratory and Critical Care Medicine. 2024 May 01;209:A1630. doi:10.1164/ajrccm-conference.2024.209.1.$72$YR$E$F$Y$$$20240702$$HP$US$US
240062722$24006272$2$F$$20240711$20240624$20240801$PER$$US-SA-2024SA185201$SANOFI AVENTIS$$$$A$F$Y$65.7$KG$20240719$$MD$US$US
240062742$24006274$2$F$$20240807$20240624$20240816$EXP$$US-JNJFOC-20240647728$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$HP$US$US
240062902$24006290$2$F$$20240628$20240624$20240708$EXP$$US-TEVA-VS-3212408$TEVA$Jumaili WA, Gburi NA, Chaudhary N, Brown K, Jain S. Two Cases of Montelukast-Associated Psychosis in Children. Prim-Care-Companion-CNS-Disord 2024; 26 (3):.; Jumaili WA, Gburi NA, Chaudhary N, Brown K, Jain S. Two Cases of Montelukast-Associated Psychosis in Children. Prim-Care-Companion-CNS-Disord 2024; 26 (3):.$15$YR$$F$Y$$$20240708$$MD$US$US
240063032$24006303$2$F$$20240613$20240624$20240903$EXP$$US-TORRENT-00013625$TORRENT$$44$YR$A$F$Y$$$20240903$$MD$US$US
240063062$24006306$2$F$$20240620$20240624$20240701$EXP$$US-TORRENT-00013628$TORRENT$$20$YR$A$M$Y$$$20240701$$MD$US$US
240063123$24006312$3$F$20240621$20240627$20240624$20240701$PER$$US-PFIZER INC-202400198752$PFIZER$$36$YR$$M$Y$$$20240701$$CN$US$US
240063202$24006320$2$F$20240501$20240624$20240624$20240705$EXP$$KR-AstraZeneca-2024A140981$ASTRAZENECA$$19937$DY$$M$Y$$$20240705$$CN$KR$
240063263$24006326$3$F$20240620$20240805$20240624$20240807$PER$$US-AMGEN-USASP2024122372$AMGEN$$73$YR$E$M$Y$$$20240807$$CN$US$US
240063374$24006337$4$F$20230101$20240918$20240624$20240925$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-001979$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240925$$MD$JP$JP
240063382$24006338$2$F$$20240804$20240624$20240808$EXP$$HR-AMGEN-HRVSP2024121625$AMGEN$Pahek K; Durakovic N; Desnica L. et al.. THRONMOPOIETIN RECEPTOR AGONISTS FOR PERSISTENT SEVERE THROMBOCYTOPENIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION-5 YEARS SINGLE CENTRE RETROSPECTIVE ANALYSIS. Bone Marrow Transplantation. 2023;58 (SUPPL_1):p.550$$$$$Y$$$20240808$$HP$HR$HR
240063393$24006339$3$F$$20240611$20240624$20240708$EXP$$CA-ROCHE-1591225$ROCHE$$70$YR$E$M$Y$107$KG$20240708$$HP$CA$CA
240063566$24006356$6$F$20240101$20240815$20240624$20240828$PER$$US-SA-2024SA183177$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240828$$MD$US$US
240063583$24006358$3$F$20231209$20240808$20240624$20240815$EXP$$GB-TAKEDA-2023TUS033645$TAKEDA$$73$YR$$F$Y$$$20240815$$CN$GB$GB
240063602$24006360$2$F$$20240618$20240624$20240730$PER$$US-MYLANLABS-2024M1056064$MYLAN$$$$$F$Y$$$20240730$$CN$US$US
240063683$24006368$3$F$20240612$20240731$20240624$20240807$30DAY$$US-GSK-US2024074409$GLAXOSMITHKLINE$$83$YR$$M$Y$$$20240807$$CN$US$US
240063843$24006384$3$F$20230207$20240624$20240624$20240716$EXP$$NVSC2024DE130783$NOVARTIS$$$$E$M$Y$$$20240716$$MD$DE$DE
240063903$24006390$3$F$$20240905$20240624$20240909$PER$$US-PFIZER INC-PV202300205863$PFIZER$$69$YR$$$Y$$$20240909$$HP$US$US
240063912$24006391$2$F$$20240802$20240624$20240805$PER$$NVSC2024US130801$NOVARTIS$$$$$$Y$$$20240805$$MD$US$US
240063993$24006399$3$F$$20240708$20240624$20240715$PER$$US-ABBVIE-5812876$ABBVIE$$$$$$Y$$$20240715$$HP$US$US
240064002$24006400$2$F$20240610$20240913$20240624$20240918$PER$$US-PFIZER INC-202400194136$PFIZER$$8$YR$$M$Y$$$20240918$$HP$US$US
240064092$24006409$2$F$$20240628$20240624$20240704$EXP$GB-MHRA-DEFECT-202406101848103410-LDHFB$GB-ORGANON-O2406GBR002032$ORGANON$$$$$F$Y$$$20240704$$MD$GB$GB
240064132$24006413$2$F$$20240617$20240624$20240704$EXP$$JP-009507513-2406JPN002563J$MERCK$Kato M, Okumura T, Ujihira T. Case Report: Two cases of pelvic exenteration for recurrence of cervical adenocarcinoma in the irradiated field. Japanese Journal of Gynecological Oncology. 2024;42(2):228-33$39$YR$$F$Y$$$20240704$$MD$JP$JP
240064155$24006415$5$F$20240621$20240723$20240624$20240726$PER$$US-JNJFOC-20240658546$JOHNSON AND JOHNSON$$60$YR$A$M$Y$74.002$KG$20240726$$HP$US$US
240064232$24006423$2$F$20240524$20240625$20240624$20240701$EXP$IT-MINISAL02-990514$IT-MYLANLABS-2024M1056458$MYLAN$$81$YR$$F$Y$65$KG$20240701$$MD$IT$IT
240064314$24006431$4$F$20240613$20240715$20240624$20240723$EXP$$US-JNJFOC-20240640935$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240723$$MD$US$US
240064362$24006436$2$F$20240406$20240722$20240624$20240725$EXP$$JP-009507513-2406JPN002591J$MERCK$$78$YR$$M$Y$$$20240725$$PH$JP$JP
240064372$24006437$2$F$20240604$20240710$20240624$20240717$EXP$$FR-009507513-2406FRA006395$MERCK$$$$E$F$Y$82.7$KG$20240717$$MD$FR$FR
240064482$24006448$2$F$$20240729$20240624$20240731$EXP$$NVSC2024AU130748$NOVARTIS$$32$YR$$M$Y$$$20240731$$CN$AU$AU
240064572$24006457$2$F$$20240808$20240624$20240812$EXP$$JP-FERRINGPH-2024FE03146$FERRING$Nagatomo T, Kaku H, Maehara E, Arimura T, Hyakuna Y, Kawamura N et al.. 15 A case of non-cardiogenic pulmonary oedema associated with ovarian hyperstimulation syndrome. The 345th Kyushu Regional Meeting of the Japanese Society of Internal Medicine. 2024;1$$$$$Y$$$20240812$$MD$JP$JP
240064632$24006463$2$F$20221213$20240717$20240624$20240723$EXP$$US-ABBVIE-4729189$ABBVIE$$50$YR$$F$Y$110$KG$20240723$$CN$US$US
240064643$24006464$3$F$20240614$20240724$20240624$20240802$PER$$US-AMGEN-USASP2024121171$AMGEN$$$$$$Y$$$20240802$$HP$US$US
240064692$24006469$2$F$$20240626$20240624$20240702$EXP$$DE-MYLANLABS-2024M1055468$MYLAN$$$$E$F$Y$$$20240702$$CN$DE$DE
240064812$24006481$2$F$20240101$20240802$20240624$20240807$EXP$$US-UCBSA-2024031859$UCB$$$$$M$Y$$$20240807$$CN$US$US
240064923$24006492$3$F$20211220$20240809$20240624$20240819$EXP$$CA-TAKEDA-2024TUS059082$TAKEDA$$73$YR$$M$Y$$$20240819$$CN$CA$CA
240064932$24006493$2$F$20221201$20240812$20240624$20240815$EXP$$CA-TAKEDA-2022TUS041729$TAKEDA$$31$YR$$M$Y$$$20240815$$CN$CA$CA
240065022$24006502$2$F$$20240918$20240624$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099181$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240918$$MD$US$US
240065044$24006504$4$F$$20240924$20240624$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101109$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240924$$CN$US$US
240065082$24006508$2$F$$20240708$20240624$20240711$EXP$$US-GSK-US2024074994$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$US$US
240065123$24006512$3$F$20240625$20240718$20240624$20240723$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003468$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240723$$MD$US$US
240065222$24006522$2$F$$20240923$20240624$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100563$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$PH$US$US
240065462$24006546$2$F$$20240620$20240624$20240701$EXP$$US-TORRENT-00013639$TORRENT$$49$YR$A$M$Y$$$20240701$$MD$US$US
240065533$24006553$3$F$20240101$20240806$20240624$20240817$PER$$US-SA-2024SA184028$SANOFI AVENTIS$$30$YR$A$F$Y$63$KG$20240817$$MD$US$US
240065582$24006558$2$F$$20240924$20240624$20240927$EXP$$US-JNJFOC-20240647324$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$HP$US$US
240065592$24006559$2$F$$20240701$20240624$20240704$EXP$$NVSC2024CH110570$NOVARTIS$$12$YR$$F$Y$$$20240704$$MD$CH$CH
240065623$24006562$3$F$20240607$20240821$20240624$20240826$EXP$$US-ABBVIE-5811737$ABBVIE$$77$YR$$M$Y$$$20240826$$HP$US$US
240065664$24006566$4$F$$20240910$20240624$20240911$PER$$US-ROCHE-10000006239$ROCHE$$$$A$M$Y$$$20240911$$CN$US$US
240065703$24006570$3$F$20240101$20240628$20240624$20240701$PER$$US-ABBVIE-5809981$ABBVIE$$77$YR$$M$Y$$$20240701$$CN$US$US
240065742$24006574$2$F$$20240709$20240624$20240717$PER$$US-BIOGEN-2024BI01269419$BIOGEN$$$$$F$Y$$$20240717$$CN$US$US
240065752$24006575$2$F$$20240613$20240624$20240703$PER$$US-ROCHE-10000005049$ROCHE$$$$$$Y$$$20240703$$CN$US$US
240065862$24006586$2$F$$20240913$20240624$20240926$PER$$US-SA-2024SA184831$SANOFI AVENTIS$$62$YR$A$M$Y$108.8$KG$20240926$$MD$US$US
240065974$24006597$4$F$$20240812$20240624$20240820$EXP$$FR-TAKEDA-2024TUS061345$TAKEDA$$$$$M$Y$$$20240820$$CN$FR$FR
240065992$24006599$2$F$20240728$20240730$20240624$20240801$PER$$US-ROCHE-10000005741$ROCHE$$38$YR$A$M$Y$$$20240801$$CN$US$US
240066193$24006619$3$F$$20240702$20240624$20240717$PER$$US-ROCHE-10000001001$ROCHE$$$$A$F$Y$$$20240717$$CN$US$US
240066262$24006626$2$F$20231115$20240702$20240624$20240712$EXP$$TR-BIOGEN-2024BI01264306$BIOGEN$$60$YR$$F$Y$$$20240712$$MD$TR$TR
240066332$24006633$2$F$20240430$20240626$20240624$20240703$PER$$US-ROCHE-3557614$ROCHE$$$$$F$Y$$$20240703$$CN$US$US
240066362$24006636$2$F$$20240725$20240624$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099963$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240726$$CN$US$US
240066492$24006649$2$F$20240614$20240717$20240624$20240720$PER$$US-JNJFOC-20240642453$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240719$$HP$US$US
240066522$24006652$2$F$$20240806$20240624$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095503$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$81.19$KG$20240809$$CN$US$US
240066544$24006654$4$F$20240701$20240801$20240624$20240807$EXP$$NL-MYLANLABS-2024M1055576$MYLAN$$$$A$F$Y$$$20240807$$CN$NL$NL
240066562$24006656$2$F$$20240815$20240624$20240828$PER$$US-SA-2024SA178224$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240828$$MD$US$US
240066702$24006670$2$F$$20240708$20240624$20240712$PER$$US-BIOGEN-2024BI01270267$BIOGEN$$$$$F$Y$$$20240712$$CN$US$US
240066742$24006674$2$F$20240613$20240906$20240624$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099913$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240913$$PH$US$US
240066752$24006675$2$F$$20240814$20240624$20240814$EXP$$US-PFIZER INC-PV202400079406$PFIZER$$$$$F$Y$$$20240814$$HP$US$US
240066772$24006677$2$F$20240101$20240819$20240624$20240822$EXP$$US-PFIZER INC-202300263619$PFIZER$$15$YR$$M$Y$$$20240822$$CN$US$US
240066802$24006680$2$F$$20240703$20240624$20240708$30DAY$$NL-MYLANLABS-2024M1055516$MYLAN$$$$$$Y$$$20240708$$CN$NL$NL
240066822$24006682$2$F$20240501$20240628$20240624$20240702$EXP$$US-ABBVIE-5811208$ABBVIE$$49$YR$$M$Y$111$KG$20240702$$CN$US$US
240066832$24006683$2$F$$20240924$20240624$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101040$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$64.46$KG$20240924$$HP$US$US
240066872$24006687$2$F$20240401$20240704$20240624$20240709$EXP$$US-PFIZER INC-2024SGN05531$PFIZER$$42$YR$$F$Y$$$20240709$$CN$US$US
240066924$24006692$4$F$20240610$20240806$20240624$20240813$EXP$$JP-009507513-2406JPN002837J$MERCK$$68$YR$$F$Y$$$20240813$$MD$JP$JP
240067032$24006703$2$F$$20240925$20240624$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100757$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240926$$HP$US$US
240067042$24006704$2$F$20200708$20240828$20240624$20240903$EXP$$CA-TAKEDA-2024TUS051734$TAKEDA$$65$YR$$M$Y$$$20240903$$MD$CA$CA
240067072$24006707$2$F$20240618$20240701$20240624$20240703$EXP$$US-BAYER-2024A089452$BAYER$$32$YR$A$M$Y$$$20240703$$HP$US$US
240067172$24006717$2$F$$20240625$20240624$20240701$PER$$US-VERTEX PHARMACEUTICALS-2024-010296$VERTEX$$$$$F$Y$$$20240701$$CN$US$US
240067202$24006720$2$F$$20240702$20240624$20240708$PER$$US-VERTEX PHARMACEUTICALS-2024-010280$VERTEX$$$$$M$Y$$$20240708$$CN$US$US
240067275$24006727$5$F$20240611$20240828$20240624$20240909$EXP$$US-BEH-2024172570$CSL BEHRING$$43$YR$A$F$Y$89.796$KG$20240909$$MD$US$US
240067302$24006730$2$F$$20240701$20240624$20240704$PER$$US-PFIZER INC-202400198241$PFIZER$$65$YR$$F$Y$58.957$KG$20240704$$CN$US$US
240067312$24006731$2$F$$20240725$20240624$20240729$PER$$US-PFIZER INC-202400198385$PFIZER$$85$YR$$F$Y$$$20240729$$CN$US$US
240067422$24006742$2$F$$20240621$20240624$20240705$EXP$$US-ROCHE-10000000791$ROCHE$$85$YR$E$F$Y$$$20240705$$CN$US$US
240067432$24006743$2$F$20231005$20240806$20240624$20240812$EXP$$CA-TAKEDA-2024TUS059499$TAKEDA$$40$YR$$F$Y$$$20240812$$CN$CA$CA
240067452$24006745$2$F$$20240809$20240624$20240815$EXP$$CA-TAKEDA-2023TUS119069$TAKEDA$$$$$F$Y$$$20240815$$CN$CA$CA
240067572$24006757$2$F$20240419$20240703$20240624$20240705$PER$$NVSC2024US131333$NOVARTIS$$57$YR$$F$Y$66.9$KG$20240705$$PH$US$US
240067862$24006786$2$F$20210101$20240717$20240624$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202406011565$ELI LILLY AND CO$$70$YR$E$F$Y$83$KG$20240722$$HP$US$US
240067894$24006789$4$F$20240516$20240708$20240624$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202406009684$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240719$$CN$US$US
240067942$24006794$2$F$$20240827$20240624$20240830$EXP$$US-ABBVIE-5811698$ABBVIE$$$$$F$Y$39$KG$20240830$$CN$US$US
240068052$24006805$2$F$$20240702$20240624$20240704$EXP$GB-TAKEDA-2024TUS059568$GB-SANDOZ INC.-SDZ2024GB059978$SANDOZ$$$$E$M$Y$$$20240704$$CN$GB$GB
240068062$24006806$2$F$$20240802$20240624$20240805$PER$$US-ALXN-202406USA001049US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240068082$24006808$2$F$$20240819$20240624$20240823$EXP$$US-SANDOZ INC.-SDZ2024US059925$SANDOZ$$$$$F$Y$$$20240823$$CN$US$US
240068292$24006829$2$F$$20240718$20240624$20240724$EXP$$US-ABBVIE-5776753$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
240068342$24006834$2$F$20240508$20240621$20240624$20240812$EXP$EE-SAM-1612405303$EE-BAYER-2024A089936$BAYER$$43$YR$A$M$Y$102$KG$20240812$$HP$EE$EE
240068352$24006835$2$F$20240101$20240711$20240624$20240726$EXP$$US-HLS-202400170$HLS THERAPEUTICS$$49$YR$A$M$Y$$$20240726$$CN$US$US
240068492$24006849$2$F$20240522$20240716$20240624$20240722$EXP$FR-AFSSAPS-AN2024000781$FR-009507513-2406FRA006455$MERCK$$59$YR$$M$Y$$$20240719$$PH$FR$FR
240068634$24006863$4$F$20240601$20240912$20240624$20240920$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-009599$JAZZ$$$$C$$Y$$$20240920$$MD$JP$JP
240068662$24006866$2$F$$20240730$20240624$20240801$PER$$US-ALXN-202406USA001132US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240068687$24006868$7$F$20240101$20240828$20240624$20240912$EXP$$DE-Ascend Therapeutics US, LLC-2158485$ASCEND$$49$YR$$F$Y$$$20240912$$$DE$DE
240068692$24006869$2$F$$20240716$20240624$20240723$PER$$US-INCYTE CORPORATION-2024IN006498$INCYTE$$$$$$Y$$$20240723$$CN$US$US
240068733$24006873$3$F$20240101$20240820$20240624$20240822$EXP$$US-SA-2024SA185552$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240822$$MD$US$US
240068802$24006880$2$F$$20240823$20240624$20240827$EXP$$NVSC2024US130194$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
240068892$24006889$2$F$20240614$20240719$20240624$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100472$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240723$$PH$US$US
240068942$24006894$2$F$$20240628$20240624$20240705$EXP$$CA-AstraZeneca-2024A144884$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$CA$
240068952$24006895$2$F$20240306$20240725$20240624$20240802$EXP$$JP-AstraZeneca-2024A098263$ASTRAZENECA$$70$YR$$M$Y$65$KG$20240802$$MD$JP$
240069082$24006908$2$F$20240610$20240722$20240624$20240802$EXP$$US-BEH-2024173783$CSL BEHRING$$45$YR$A$M$Y$186.4$KG$20240802$$HP$US$US
240069114$24006911$4$F$20230523$20240909$20240624$20240917$EXP$$NVSC2024KR130030$NOVARTIS$$52$YR$$F$Y$$$20240917$$MD$KR$KR
240069143$24006914$3$F$$20240810$20240624$20240813$PER$$NVSC2024US129104$NOVARTIS$$33$YR$$F$Y$$$20240813$$CN$US$US
240069152$24006915$2$F$$20240705$20240624$20240708$PER$$NVSC2024US131376$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
240069212$24006921$2$F$20240718$20240718$20240624$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101103$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240723$$CN$US$US
240069223$24006922$3$F$$20240919$20240624$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099373$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240919$$MD$JP$JP
240069274$24006927$4$F$$20240811$20240624$20240814$PER$$NVSC2024US131213$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
240069307$24006930$7$F$$20240711$20240624$20240724$EXP$$CZ-PFIZER INC-202400198390$PFIZER$Lachnit, M.. Lecba pacientky s ALK-negativnim anaplastickym velkobunecnym lymfomem. Farmakoterapie. 2024;Supp 6(Ext 2/2):30-31$49$YR$$F$Y$$$20240724$$MD$CZ$CZ
240069363$24006936$3$F$20240101$20240725$20240624$20240730$EXP$$US-009507513-2405USA008150$MERCK$$$$$F$Y$$$20240730$$HP$US$US
240069392$24006939$2$F$$20240923$20240624$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100700$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240924$$CN$US$US
240069432$24006943$2$F$$20240626$20240624$20240706$EXP$$JP-TEVA-VS-3211439$TEVA$Yanai R, lkari Y, Michizu Y, Yajima N. A rare case of iatrogenic bladder perforation caused by bladder catheterization in a patient with lupus cystitis. Int-J-Rheum-Diseases 2023; 26 1622-1623.; Yanai R, lkari Y, Michizu Y, Yajima N. A rare case of iatrogenic bladder perforation caused by bladder catheterization in a patient with lupus cystitis. Int-J-Rheum-Diseases 2023; 26 1622-1623.$67$YR$$F$Y$$$20240706$$HP$JP$JP
240069454$24006945$4$F$20240101$20240913$20240624$20240916$EXP$$US-PFIZER INC-202400197877$PFIZER$$76$YR$$F$Y$$$20240916$$CN$US$US
240069474$24006947$4$F$20230101$20240820$20240624$20240826$EXP$$FR-MYLANLABS-2024M1056825$MYLAN$$82$YR$$F$Y$46$KG$20240826$$CN$FR$FR
240069492$24006949$2$F$20220801$20240906$20240624$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097798$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240909$$CN$US$US
240069502$24006950$2$F$$20240626$20240624$20240706$EXP$$GB-TEVA-VS-3207159$TEVA$Jones S, Haigh D, Devine K. A case of haemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in a patient with advanced HIV. Clinical Infection in Practice. 2024;22_100353.; Jones S, Haigh D, Devine K. A case of haemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in a patient with advanced HIV. Clinical Infection in Practice. 2024;22_100353.$36$YR$$F$Y$$$20240706$$MD$GB$GB
240069703$24006970$3$F$20231101$20240805$20240624$20240815$EXP$$JP-009507513-2406JPN002569J$MERCK$Yagi M, Gen T, Shizu M, Yaguchi D, Takahata N, Abe D, et al.. P12-1 A case of tracheal chondritis which occurred after administration of pembrolizumab for glottis carcinoma. The Journal of the Japan Society for Respiratory Endoscopy / The 47th Annual Mee. 2024;46(S):S296$76$YR$$M$Y$$$20240815$$MD$JP$JP
240069713$24006971$3$F$20240101$20240731$20240624$20240807$EXP$$US-AMGEN-USASL2024121409$AMGEN$$41$YR$A$M$Y$$$20240807$$HP$US$US
240069722$24006972$2$F$20141025$20240701$20240624$20240705$EXP$FR-AFSSAPS-PB2024000645$FR-BAYER-2024A090460$BAYER$$48$YR$A$M$Y$101$KG$20240705$$CN$FR$FR
240069762$24006976$2$F$$20240823$20240624$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100809$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240827$$CN$US$US
240069792$24006979$2$F$20240101$20240711$20240624$20240714$PER$$US-JNJFOC-20240605993$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240714$$CN$US$US
240069832$24006983$2$F$20240613$20240912$20240624$20240917$PER$$US-PURDUE PHARMA-USA-2024-0310327$PURDUE$$$$$M$Y$$$20240917$$CN$US$US
240069842$24006984$2$F$$20240715$20240624$20240716$PER$$US-PURDUE PHARMA-USA-2024-0310326$PURDUE$$$$$$Y$$$20240716$$CN$US$US
240069852$24006985$2$F$$20240904$20240624$20240909$PER$$US-ABBVIE-5813002$ABBVIE$$$$$F$Y$135.6$KG$20240909$$HP$US$US
240070272$24007027$2$F$20240521$20240703$20240624$20240726$PER$$US-TOLMAR, INC.-24US049567$TOLMAR$$74$YR$$M$Y$$$20240726$$HP$US$US
240070282$24007028$2$F$20240529$20240709$20240624$20240729$PER$$US-TOLMAR, INC.-24US049793$TOLMAR$$$$$M$Y$$$20240729$$HP$US$US
240070332$24007033$2$F$20240510$20240712$20240624$20240801$PER$$US-TOLMAR, INC.-24US049898$TOLMAR$$$$$$Y$$$20240801$$HP$US$US
240070342$24007034$2$F$$20240802$20240624$20240813$PER$$US-APELLIS-APL-2024-003594$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240813$$CN$US$US
240070373$24007037$3$F$$20240723$20240624$20240731$PER$$US-SA-2024SA179314$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240731$$MD$US$US
240070394$24007039$4$F$20240424$20240820$20240624$20240826$EXP$FR-AFSSAPS-LL2024001126$FR-009507513-2406FRA007071$MERCK$$81$YR$$F$Y$$$20240826$$MD$FR$FR
240070463$24007046$3$F$20240101$20240627$20240624$20240704$PER$$US-JNJFOC-20240651102$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240704$$CN$US$US
240070555$24007055$5$F$$20240911$20240624$20240918$EXP$$NVSC2024CA126902$NOVARTIS$$72$YR$$F$Y$$$20240919$$CN$CA$CA
240070592$24007059$2$F$$20240705$20240624$20240710$EXP$$BR-009507513-2406BRA007387$MERCK$$$$$F$Y$$$20240710$$MD$BR$BR
240070622$24007062$2$F$20240101$20240927$20240624$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100727$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240930$$HP$US$US
240070632$24007063$2$F$$20240924$20240624$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100855$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240924$$CN$US$US
240070682$24007068$2$F$20240130$20240703$20240624$20240708$EXP$$CN-GILEAD-2024-0678296$GILEAD$$73$YR$E$M$Y$$$20240708$$HP$CN$CN
240070703$24007070$3$F$$20240628$20240624$20240826$EXP$$GB-SMPA-2024SPA000070$SUNOVION$$$$$$Y$$$20240826$$MD$ES$ES
240070762$24007076$2$F$20240401$20240705$20240624$20240712$EXP$FR-AFSSAPS-PO2024000659$FR-009507513-2406FRA006463$MERCK$$79$YR$$F$Y$82$KG$20240712$$MD$FR$FR
240070852$24007085$2$F$20240620$20240620$20240624$20240702$PER$$US-SA-2024SA185771$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240702$$MD$US$US
240070882$24007088$2$F$$20240708$20240624$20240715$EXP$$CH-GILEAD-2024-0678367$GILEAD$$$$E$M$Y$$$20240715$$HP$CH$CH
240071012$24007101$2$F$$20240729$20240624$20240801$EXP$$US-ALXN-202406USA001054US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
240071053$24007105$3$F$20240101$20240917$20240624$20240924$EXP$$JP-009507513-2406JPN002552J$MERCK$Mase J, Ou B, Kokiso A, Nagao I. O1-2 Two cases of pancytopenia developed after preoperative pharmacotherapy for triple-negative breast cancer. The 21st Chubu Regional Meeting of Japanese Breast Cancer Society. 65$77$YR$$F$Y$$$20240924$$MD$JP$JP
240071113$24007111$3$F$20230101$20240925$20240624$20240930$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-099727$BRISTOL MYERS SQUIBB$Dai B, Jiang Y, Dai Y. Central retinal artery occlusion after peribulbar injection of triamcinolone acetonide in thyroid-associated ophthalmopathy. The Journal of Craniofacial Surgery. 2024 Jul;35(5):e482-4. doi:10.1097/SCS.0000000000010377.$38$YR$A$F$Y$$$20241001$$MD$CN$CN
240071162$24007116$2$F$$20240620$20240624$20240708$PER$$US-APELLIS-2024-APL-0000186$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$US$US
240071172$24007117$2$F$$20240806$20240624$20240807$PER$$NVSC2024US131383$NOVARTIS$$$$$M$Y$$$20240807$$HP$US$US
240071212$24007121$2$F$$20240626$20240624$20240701$PER$$US-AMGEN-USASP2024122194$AMGEN$$$$$M$Y$$$20240701$$CN$US$US
240071263$24007126$3$F$$20240624$20240624$20240704$EXP$$NVSC2024TW129434$NOVARTIS$$$$C$M$Y$$$20240704$$MD$TW$TW
240071332$24007133$2$F$$20240903$20240624$20240909$PER$$US-BEH-2024173578$CSL BEHRING$$$$E$M$Y$$$20240909$$HP$US$US
240071402$24007140$2$F$20240512$20240621$20240624$20240702$EXP$$US-APELLIS-2024-APL-0000225$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240702$$CN$US$US
240071452$24007145$2$F$20240604$20240619$20240624$20240701$PER$$US-ALKERMES INC.-ALK-2024-001607$ALKERMES$$50$YR$$M$Y$$$20240701$$HP$US$US
240071462$24007146$2$F$20240612$20240625$20240624$20240708$PER$$US-ALKERMES INC.-ALK-2024-001618$ALKERMES$$28$YR$$M$Y$$$20240708$$PH$US$US
240071483$24007148$3$F$$20240830$20240624$20240904$PER$$NVSC2024US131048$NOVARTIS$$$$$$Y$$$20240904$$CN$US$US
240071562$24007156$2$F$$20240902$20240624$20240903$EXP$$NVSC2024FR130853$NOVARTIS$$$$$F$Y$$$20240903$$MD$FR$FR
240071572$24007157$2$F$20240519$20240612$20240624$20240709$EXP$$CN-ROCHE-10000003835$ROCHE$$55$YR$A$M$Y$70$KG$20240701$$HP$CN$CN
240071582$24007158$2$F$20240523$20240730$20240624$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-084222$BRISTOL MYERS SQUIBB$$9$DEC$E$F$Y$$$20240807$$PH$JP$JP
240071592$24007159$2$F$20240101$20240618$20240624$20240717$PER$$US-AMGEN-USASP2024120870$AMGEN$$79$YR$E$M$Y$$$20240717$$CN$US$US
240071692$24007169$2$F$$20240819$20240624$20240823$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-100559$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240823$$MD$JP$JP
240071795$24007179$5$F$$20240627$20240624$20240704$EXP$$US-JNJFOC-20240655665$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240071802$24007180$2$F$$20240617$20240624$20240702$EXP$$CA-SANDOZ INC.-SDZ2024CA059602$SANDOZ$$97$YR$$F$Y$$$20240702$$HP$CA$CA
240071912$24007191$2$F$$20240711$20240624$20240717$EXP$$JP-SA-2024SA179153$SANOFI AVENTIS$$72$YR$E$M$Y$58.1$KG$20240718$$MD$JP$JP
240071962$24007196$2$F$20240615$20240729$20240624$20240801$PER$$US-ALXN-202406USA001059US$ALEXION PHARMACEUTICALS$$86$YR$$F$Y$$$20240801$$CN$US$US
240071972$24007197$2$F$20240607$20240701$20240624$20240703$EXP$$JP-TAKEDA-2024TJP009403$TAKEDA$$$$$M$Y$$$20240703$$MD$JP$JP
240072122$24007212$2$F$20240608$20240818$20240624$20240821$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-098349$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240821$$MD$AU$AU
240072132$24007213$2$F$$20240619$20240624$20240723$EXP$$US-009507513-2406USA006843$MERCK$Torelli VA, Ernest JR., Tran E.. Acute Hypoxic Respiratory Failure Secondary to Daptomycin-induced Eosinophilic Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024$86$YR$$F$Y$$$20240723$$HP$US$US
240072284$24007228$4$F$20240201$20240920$20240624$20240924$EXP$$CO-ABBVIE-5811995$ABBVIE$$87$YR$$M$Y$90$KG$20240924$$CN$CO$CO
240072303$24007230$3$F$20230101$20240806$20240624$20240815$EXP$$US-ABBVIE-5808548$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
240072333$24007233$3$F$20240606$20240712$20240624$20240716$PER$$US-AMGEN-USASP2024123660$AMGEN$$67$YR$E$F$Y$$$20240715$$CN$US$US
240072363$24007236$3$F$20220101$20240809$20240624$20240813$EXP$$US-ABBVIE-5765702$ABBVIE$$$$$F$Y$64.9$KG$20240813$$CN$US$US
240072454$24007245$4$F$20240601$20240806$20240624$20240808$EXP$$JP-ASTELLAS-2024JP004339$ASTELLAS$$9$DEC$$M$Y$$$20240808$$MD$JP$JP
240072463$24007246$3$F$20240601$20240628$20240624$20240703$EXP$$US-ABBVIE-5811588$ABBVIE$$62$YR$$F$Y$78$KG$20240703$$CN$US$US
240072543$24007254$3$F$$20240912$20240624$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099750$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$206.38$KG$20240913$$HP$US$US
240072572$24007257$2$F$20240101$20240729$20240624$20240805$EXP$$US-ABBVIE-5811510$ABBVIE$$$$$F$Y$$$20240804$$CN$US$US
240072626$24007262$6$F$20240701$20240809$20240624$20240909$PER$$US-ROCHE-10000000738$ROCHE$$10$YR$C$F$Y$$$20240909$$CN$US$US
240072642$24007264$2$F$$20240626$20240624$20240701$PER$$US-AMGEN-USASP2024122905$AMGEN$$$$$M$Y$$$20240701$$CN$US$US
240072672$24007267$2$F$20240601$20240613$20240624$20240703$PER$$US-BAUSCHBL-2024BNL028744$BAUSCH AND LOMB$$$$$F$Y$$$20240704$$CN$US$US
240072722$24007272$2$F$$20240730$20240624$20240801$PER$$US-ALXN-202406USA001135US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
240072792$24007279$2$F$20240521$20240718$20240624$20240723$EXP$$US-ABBVIE-5811563$ABBVIE$$26$YR$$F$Y$$$20240723$$CN$US$US
240072802$24007280$2$F$$20240704$20240624$20240708$EXP$$NVSJ2024JP007424$NOVARTIS$Asou S, Tachibana M,  Nakagawa C, Fujigawa A, Genge N, Miyazaki K, et al.. HEMOPHAGOCYTIC SYNDROME ASSOCIATED WITH PEMBROLIZUMAB THERAPY FOR RENAL CANCER: A CASE REPORT WITH DOCETAXEL AND LOCAL RADIATION THERAPY: A CASE REPORT. Nishinihon Urology. 2023;86:78-84$64$YR$$M$Y$$$20240709$$MD$JP$JP
240072863$24007286$3$F$20240617$20240726$20240624$20240805$30DAY$$US-JNJFOC-20240643785$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240806$$PH$US$US
240072902$24007290$2$F$$20240716$20240624$20240722$EXP$$DE-BIOGEN-2024BI01270387$BIOGEN$$$$$F$Y$$$20240722$$MD$DE$DE
240072952$24007295$2$F$20240617$20240724$20240624$20240726$PER$$US-AMGEN-USASP2024121403$AMGEN$$67$YR$E$M$Y$$$20240726$$CN$US$US
240072972$24007297$2$F$20240529$20240626$20240624$20240702$EXP$$JP-SA-2024SA182890$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240702$$MD$JP$JP
240073022$24007302$2$F$$20240805$20240624$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098112$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240812$$MD$US$US
240073062$24007306$2$F$20240501$20240716$20240624$20240722$EXP$$GR-009507513-2406GRC001329$MERCK$$47$YR$$F$Y$$$20240722$$MD$GR$GR
240073212$24007321$2$F$20240605$20240701$20240624$20240704$PER$$US-JNJFOC-20240651977$JOHNSON AND JOHNSON$$63$YR$A$M$Y$87.622$KG$20240705$$HP$US$US
240073243$24007324$3$F$20240620$20240712$20240624$20240714$PER$$US-AMGEN-USASP2024124131$AMGEN$$81$YR$E$M$Y$$$20240714$$CN$US$US
240073262$24007326$2$F$20240601$20240730$20240624$20240801$PER$$US-ALXN-202406USA001216US$ALEXION PHARMACEUTICALS$$77$YR$$M$Y$$$20240801$$CN$US$US
240073352$24007335$2$F$20240101$20240806$20240624$20240810$EXP$$US-ABBVIE-5812917$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
240073372$24007337$2$F$20240522$20240918$20240624$20240919$EXP$$JP-ABBVIE-5809793$ABBVIE$$60$YR$$F$Y$$$20240919$$MD$JP$JP
240073393$24007339$3$F$20240101$20240731$20240624$20240815$EXP$$JP-SAKK-2024SA148351AA$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240816$$PH$JP$JP
240073402$24007340$2$F$20240410$20240708$20240624$20240712$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-005144$JAZZ$$25$YR$$F$Y$$$20240712$$CN$US$US
240073452$24007345$2$F$20240101$20240729$20240624$20240807$PER$$US-SA-2024SA182779$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240807$$MD$US$US
240073492$24007349$2$F$$20240902$20240624$20240904$EXP$$JP-TAKEDA-2024TJP009411$TAKEDA$$8$DEC$$F$Y$$$20240904$$MD$JP$JP
240073522$24007352$2$F$$20240625$20240624$20240709$EXP$$JP-RDY-LIT/JPN/24/0009081$DR REDDYS$Sunao T, Okabayashi K, Soejima I, Oniki A, Ishihara S, Tomimitsu H. Delayed Superior Orbital Fissure Syndrome  Arising More than  One Month after Herpes ZosterOphthalmicus and Meningitis. Intern Med.. 2024 Jun 06;doi:10.2169/internalmedicine.3652-24.$79$YR$E$F$Y$$$20240709$$HP$JP$JP
240073792$24007379$2$F$$20240619$20240625$20240725$EXP$$US-009507513-2406USA006974$MERCK$Hossain S, Patten E, Anigbogu J.. Daptomycin-induced Lung Injury. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2004$55$YR$$M$Y$$$20240725$$HP$US$US
240073863$24007386$3$F$20240501$20240718$20240625$20240725$EXP$$CA-BEIGENE-BGN-2024-009297$BEIGENE$$$$$$Y$$$20240725$$CN$CA$CA
240074052$24007405$2$F$$20240805$20240625$20240809$EXP$$US-AstraZeneca-2024A143674$ASTRAZENECA$$$$$F$Y$$$20240809$$HP$US$
240074114$24007411$4$F$$20240709$20240625$20240715$30DAY$$US-AMGEN-USASL2024115867$AMGEN$$$$$F$Y$$$20240715$$HP$US$US
240074132$24007413$2$F$$20240625$20240625$20240702$EXP$$JP-MALLINCKRODT-MNK202403989$MALLINCKRODT$$7$DEC$$M$Y$$$20240702$$HP$JP$JP
240074232$24007423$2$F$20240620$20240717$20240625$20240722$EXP$$US-AstraZeneca-2024A144312$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
240074362$24007436$2$F$20240607$20240703$20240625$20240709$PER$$US-ABBVIE-5812381$ABBVIE$$68$YR$$F$Y$$$20240709$$HP$US$US
240074402$24007440$2$F$20240610$20240624$20240625$20240701$PER$$US-AMGEN-USASP2024124018$AMGEN$$69$YR$E$$Y$$$20240701$$CN$US$US
240074532$24007453$2$F$20240613$20240621$20240625$20240702$EXP$$US-NOVOPROD-1242396$NOVO NORDISK$$$$$M$Y$$$20240702$$CN$US$US
240074562$24007456$2$F$20231201$20240712$20240625$20240723$EXP$$US-NOVOPROD-1232475$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
240074632$24007463$2$F$20240613$20240715$20240625$20240718$EXP$$CO-ABBVIE-5813531$ABBVIE$$74$YR$$F$Y$54$KG$20240718$$HP$CO$CO
240074682$24007468$2$F$20231001$20240703$20240625$20240706$EXP$$IN-ABBVIE-5812844$ABBVIE$$66$YR$$M$Y$73$KG$20240706$$CN$IN$IN
240074703$24007470$3$F$20240105$20240827$20240625$20240903$EXP$$US-BIOGEN-2024BI01270611$BIOGEN$$68$YR$$F$Y$$$20240903$$CN$US$US
240074712$24007471$2$F$$20240705$20240625$20240710$EXP$$FR-SA-2024SA185657$SANOFI AVENTIS$Cauchy L, Mousty E, Pageaux GP, Moranne O.. Successful pregnancy after 10 consecutive failures in a liver transplant patient with advanced kidney failure.. J Nephrol.. 2024;37(3):747-51$$$$M$Y$$$20240710$$HP$FR$FR
240074752$24007475$2$F$$20240708$20240625$20240716$EXP$$JP-SA-2024SA180388$SANOFI AVENTIS$$80$YR$E$$Y$$$20240716$$CN$JP$JP
240074942$24007494$2$F$20240520$20240620$20240625$20240703$EXP$$CA-BIOGEN-2024BI01266375$BIOGEN$$65$YR$$F$Y$$$20240703$$CN$CA$CA
240074956$24007495$6$F$$20240802$20240625$20240807$EXP$$US-BIOGEN-2024BI01270442$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
240075113$24007511$3$F$$20240710$20240625$20240722$EXP$$JP-NOVOPROD-1241134$NOVO NORDISK$$78$YR$$M$Y$$$20240719$$HP$JP$JP
240075172$24007517$2$F$20220101$20240620$20240625$20240701$EXP$$US-NOVOPROD-1242295$NOVO NORDISK$$$$$$Y$$$20240701$$CN$US$US
240075313$24007531$3$F$20240301$20240701$20240625$20240708$PER$$US-AMGEN-USASP2024122764$AMGEN$$72$YR$E$F$Y$$$20240708$$CN$US$US
240075394$24007539$4$F$20230101$20240704$20240625$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452158$RANBAXY$$$$A$F$Y$$$20240719$$CN$US$US
240075424$24007542$4$F$$20240819$20240625$20240828$EXP$$CA-HALEON-2182671$Haleon PLC$$53$YR$$M$Y$$$20240827$$CN$CA$CA
240075582$24007558$2$F$20240603$20240702$20240625$20240808$PER$$FR-TOLMAR, INC.-24FR049930$TOLMAR$$71$YR$$M$Y$$$20240808$$PH$FR$FR
240075622$24007562$2$F$20240101$20240815$20240625$20240820$EXP$$US-AMGEN-USASP2024121342$AMGEN$$82$YR$E$M$Y$$$20240820$$CN$US$US
240075672$24007567$2$F$$20240618$20240625$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202406013175$ELI LILLY AND CO$$$$$M$Y$$$20240716$$CN$US$US
240075703$24007570$3$F$$20240612$20240625$20240715$EXP$$US-ROCHE-3545137$ROCHE$$90$YR$E$F$Y$$$20240715$$MD$US$US
240075712$24007571$2$F$20240523$20240722$20240625$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100497$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240724$$CN$US$US
240075832$24007583$2$F$$20240621$20240625$20240822$EXP$$AU-ROCHE-10000005338$ROCHE$$$$$$Y$$$20240822$$MD$AU$AU
240076072$24007607$2$F$$20240730$20240625$20240730$PER$$US-ALXN-202406USA001253US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240730$$HP$US$US
240076112$24007611$2$F$$20240815$20240625$20240826$EXP$GB-PFIZER INC-202400103397$GB-JUBILANT PHARMA LTD-2024GB000838$JUBILANT$$79$YR$$F$Y$$$20240826$$CN$GB$GB
240076142$24007614$2$F$$20240709$20240625$20240717$EXP$$JP-SA-2024SA180369$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240717$$MD$JP$JP
240076252$24007625$2$F$$20240625$20240625$20240710$EXP$$CA-HALEON-2182913$Haleon PLC$$43$YR$$F$Y$96$KG$20240710$$HP$CA$CA
240076272$24007627$2$F$$20240702$20240625$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101064$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$70.31$KG$20240708$$HP$US$US
240076292$24007629$2$F$$20240621$20240625$20240701$EXP$$US-AUROBINDO-AUR-APL-2024-030330$AUROBINDO$Benandi K, Sieving D, Wolf K. rare case of meloxicam-induced pseudoporphyria. Dermatology Online Journal. 2024;30(2):19$55$YR$$F$Y$84$KG$20240701$$MD$US$US
240076312$24007631$2$F$20240612$20240701$20240625$20240709$PER$$US-AMGEN-USASP2024118885$AMGEN$$53$YR$A$F$Y$116$KG$20240708$$PH$US$US
240076323$24007632$3$F$20160101$20240816$20240625$20240819$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035704$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240819$$CN$US$US
240076362$24007636$2$F$20240307$20240625$20240625$20240703$EXP$$CA-TOLMAR, INC.-24CA050243$TOLMAR$$84$YR$$M$Y$$$20240703$$PH$CA$CA
240076392$24007639$2$F$$20240705$20240625$20240708$PER$$US-AMGEN-USASP2024122729$AMGEN$$$$$F$Y$$$20240708$$HP$US$US
240076494$24007649$4$F$$20240905$20240625$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101147$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240911$$CN$US$US
240076522$24007652$2$F$$20240612$20240625$20240709$PER$$US-ROCHE-10000006157$ROCHE$$$$$$Y$$$20240708$$CN$US$US
240076545$24007654$5$F$20240616$20240808$20240625$20240813$EXP$$ES-JNJFOC-20240646658$JOHNSON AND JOHNSON$$85$YR$E$M$Y$85$KG$20240813$$MD$ES$ES
240076552$24007655$2$F$$20240705$20240625$20240708$PER$$US-AMGEN-USASP2024122430$AMGEN$$$$$F$Y$$$20240708$$HP$US$US
240076632$24007663$2$F$$20240808$20240625$20240823$PER$$US-RISINGPHARMA-US-2024RISSPO00208$RISING PHARMACEUTICALS$$81$YR$E$M$Y$180$KG$20240823$$CN$US$US
240076673$24007667$3$F$20240614$20240723$20240625$20240813$PER$$US-AMGEN-USASP2024121807$AMGEN$$69$YR$E$$Y$97.5$KG$20240812$$HP$US$US
240076682$24007668$2$F$20240501$20240827$20240625$20240903$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2024052565$VIIV$$$$$$Y$$$20240903$$HP$CA$CA
240076692$24007669$2$F$20240705$20240705$20240625$20240712$EXP$$CA-GSK-CA2024076419$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$CA$CA
240076772$24007677$2$F$$20240628$20240625$20240701$EXP$$HU-BRISTOL-MYERS SQUIBB COMPANY-2024-097494$BRISTOL MYERS SQUIBB$Jona A, Kiss E, Kenyeres A, Gergely L, Simon Z, Illes A. Our experience with mosunetuzumab. Hematology-Transfusiology. 2024;76.$64$YR$A$M$Y$$$20240701$$MD$HU$HU
240076822$24007682$2$F$20240101$20240731$20240625$20240801$EXP$$US-UCBSA-2024018157$UCB$$$$$F$Y$107.18$KG$20240801$$HP$US$US
240076862$24007686$2$F$$20240912$20240625$20240926$EXP$$PL-HALEON-2181255$Haleon PLC$Szlauer-Stefanska A, Kaminska-Winciorek G. Patient with chronic cutaneous and mucosal form of graft versus host disease. POSTGRADUATE DERMATOLOGY [DERMATOLOGIA PO DYPLOMIE]. 2024; Szlauer-Stefanska A, Kaminska-Winciorek G Patient with chronic cutaneous and mucosal form of graft versus host disease. Postgraduate Dermatology [Dermatologia po Dyplomie] 2024;:-.$30$YR$$M$Y$$$20240926$$MD$PL$PL
240076892$24007689$2$F$20240610$20240612$20240625$20240704$EXP$$MX-ROCHE-10000005972$ROCHE$$51$YR$A$F$Y$76$KG$20240704$$MD$MX$MX
240077093$24007709$3$F$20240621$20240814$20240625$20240819$PER$$US-AMGEN-USASP2024124108$AMGEN$$85$YR$E$F$Y$$$20240819$$CN$US$US
240077122$24007712$2$F$20240618$20240621$20240625$20240705$EXP$$CA-ROCHE-10000002222$ROCHE$$34$YR$A$F$Y$$$20240705$$CN$CA$CA
240077152$24007715$2$F$20240614$20240903$20240625$20240910$PER$$US-ROCHE-10000006602$ROCHE$$63$YR$A$M$Y$99.7$KG$20240910$$CN$US$US
240077182$24007718$2$F$20240607$20240626$20240625$20240702$PER$$US-BIOGEN-2024BI01270319$BIOGEN$$$$$M$Y$$$20240702$$CN$US$US
240077232$24007723$2$F$20240227$20240715$20240625$20240717$EXP$$CA-TAKEDA-2024TUS019185$TAKEDA$$12$YR$$M$Y$$$20240717$$CN$CA$CA
240077243$24007724$3$F$20240501$20240912$20240625$20240920$EXP$$CA-TAKEDA-2024TUS051744$TAKEDA$$32$YR$$M$Y$$$20240920$$HP$CA$CA
240077262$24007726$2$F$20240511$20240923$20240625$20240926$EXP$$FR-TAKEDA-2024TUS061662$TAKEDA$$66$YR$$F$Y$$$20240926$$HP$FR$FR
240077302$24007730$2$F$$20240805$20240625$20240807$PER$$US-TAKEDA-2024TUS062368$TAKEDA$$$$$M$Y$$$20240807$$MD$US$US
240077392$24007739$2$F$$20240718$20240625$20240725$EXP$$BR-TAKEDA-2024TUS060445$TAKEDA$$$$$$Y$$$20240725$$CN$BR$BR
240077412$24007741$2$F$$20240830$20240625$20240904$PER$$US-TAKEDA-2024TUS061704$TAKEDA$$$$$F$Y$58.96$KG$20240904$$HP$US$US
240077432$24007743$2$F$$20240708$20240625$20240715$EXP$$US-TAKEDA-2024TUS056017$TAKEDA$$$$$M$Y$$$20240715$$CN$US$US
240077442$24007744$2$F$$20240702$20240625$20240709$EXP$$US-TAKEDA-2024TUS035984$TAKEDA$$$$$M$Y$$$20240709$$CN$US$US
240077483$24007748$3$F$20240501$20240820$20240625$20240826$EXP$$CA-TAKEDA-2024TUS034650$TAKEDA$$72$YR$$F$Y$$$20240826$$CN$CA$CA
240077552$24007755$2$F$$20240724$20240625$20240725$EXP$$US-TAKEDA-2024TUS061658$TAKEDA$$$$$F$Y$$$20240725$$CN$US$US
240077665$24007766$5$F$20240601$20240826$20240625$20240903$EXP$$CA-CELLTRION INC.-2024CA012396$CELLTRION$$$$$$Y$$$20240903$$MD$CA$CA
240077675$24007767$5$F$20240101$20240715$20240625$20240717$PER$$US-BIOGEN-2024BI01270490$BIOGEN$$$$$M$Y$$$20240717$$CN$US$US
240077842$24007784$2$F$20240601$20240729$20240625$20240807$PER$$US-SA-2024SA184962$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240807$$MD$US$US
240077882$24007788$2$F$20240530$20240621$20240625$20240702$PER$$US-SA-2024SA180500$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240702$$MD$US$US
240077912$24007791$2$F$20240618$20240805$20240625$20240807$PER$$US-AMGEN-USASP2024123810$AMGEN$$55$YR$A$F$Y$$$20240807$$HP$US$US
240077982$24007798$2$F$$20240706$20240625$20240710$PER$$US-ROCHE-10000001708$ROCHE$Falzoni W, Iwasa S. Ozone therapy for a difficult sjogren syndrome case. Phenomenon that can only be understood by bi-digital o-ring test. Acupuncture and electro-therapeutics research. 2024-May;48 (4):318-9. doi:10.3727/036012924X17151836600113.$45$YR$A$M$Y$$$20240709$$MD$US$US
240077992$24007799$2$F$20240601$20240906$20240625$20240910$EXP$$JP-SAKK-2024SA184165AA$SANOFI AVENTIS$$$$$M$Y$$$20240911$$MD$JP$JP
240078042$24007804$2$F$20240620$20240705$20240625$20240709$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-101163$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$74.39$KG$20240709$$CN$PR$PR
240078072$24007807$2$F$$20240625$20240625$20240704$PER$$US-SA-2024SA180517$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240704$$MD$US$US
240078122$24007812$2$F$20230127$20240705$20240625$20240718$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-02293$AMNEAL$$$$$$Y$$$20240718$$PH$JP$JP
240078202$24007820$2$F$20240601$20240718$20240625$20240722$EXP$$CA-UCBSA-2024031758$UCB$$64$YR$$F$Y$$$20240722$$HP$CA$CA
240078233$24007823$3$F$$20240827$20240625$20240902$EXP$$US-JNJFOC-20240646000$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240902$$CN$US$US
240078283$24007828$3$F$$20240809$20240625$20240822$EXP$$CA-AMGEN-CANSP2024124141$AMGEN$$38$YR$A$F$Y$$$20240821$$MD$CA$CA
240078382$24007838$2$F$$20240722$20240625$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-030335$AUROBINDO$Patel K, McQuaid S, Ketterl T, Benedetti DJ, Sokol E. Two cases of hepatoblastoma in Bohring?Opitz syndrome: An emerging association. Pediatric Blood and Cancer. 2024;71(7)$2$YR$$M$Y$$$20240802$$MD$US$US
240078402$24007840$2$F$20240101$20240719$20240625$20240726$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-101046$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240726$$CN$PR$PR
240078422$24007842$2$F$$20240827$20240625$20240829$PER$$US-JNJFOC-20240652200$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$CN$US$US
240078432$24007843$2$F$20220101$20240711$20240625$20240715$EXP$$CA-UCBSA-2022071180$UCB$$$$$M$Y$$$20240715$$CN$CA$CA
240078442$24007844$2$F$$20240729$20240625$20240808$EXP$$US-ARDELYX-2024ARDX004321$ARDELYX$$66$YR$$M$Y$$$20240808$$HP$US$US
240078523$24007852$3$F$20240101$20240709$20240625$20240723$EXP$$CZ-AUROBINDO-AUR-APL-2024-030363$AUROBINDO$Skopal D, Belada, D.. L??ba 1. linie nod?ln?ho TFH lymfomu, angioimunoblastick? subtyp (First-line treatment of nodal TFH lymphoma, angioimmunoblastic subtype). FARMAKOTERAPIE.. 2024;20 (sup. 6):15-16$60$YR$$F$Y$$$20240719$$MD$CZ$CZ
240078553$24007855$3$F$20240101$20240729$20240625$20240807$EXP$$US-MALLINCKRODT-MNK202403892$MALLINCKRODT$$85$YR$E$F$Y$126$KG$20240807$$HP$US$US
240078566$24007856$6$F$$20240812$20240625$20240822$EXP$$PL-AUROBINDO-AUR-APL-2024-030345$AUROBINDO$Woro? J, Siwek M.. Stosowanie sertraliny i perazyny jako przyczyna zapale? p?uc u pacjentki cierpi?cej na przewlek?? obturacyjn? chorob? p?uc. [The use of Sertraline and Perazine as a cause of pneumonia in a patient with chronic obstructive pulmonary disease].. Medycyna Praktyczna - Psychiatria. 2024;1898-4878:19-21$67$YR$$F$Y$$$20240822$$MD$PL$PL
240078603$24007860$3$F$20240608$20240711$20240625$20240716$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-097148$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240716$$PH$JP$JP
240078612$24007861$2$F$$20240719$20240625$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100619$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$44.45$KG$20240723$$CN$US$US
240078682$24007868$2$F$$20240716$20240625$20240725$30DAY$$US-GSK-US2024077262$GLAXOSMITHKLINE$$$$$M$Y$$$20240725$$CN$US$US
240078722$24007872$2$F$20240101$20240625$20240625$20240702$EXP$$US-ABBVIE-5811807$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240078832$24007883$2$F$20240501$20240614$20240625$20240926$PER$$US-CIPLA LTD.-2024US05838$CIPLA$$$$$$Y$$$20240927$$MD$US$US
240078842$24007884$2$F$$20240820$20240625$20240827$EXP$$JP-ROCHE-10000003479$ROCHE$$8$DEC$E$$Y$$$20240827$$MD$JP$JP
240078852$24007885$2$F$20240901$20240913$20240625$20240923$PER$$US-SA-2023SA284343$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240923$$MD$US$US
240078892$24007889$2$F$20240620$20240710$20240625$20240718$PER$$US-SA-2024SA185758$SANOFI AVENTIS$$71$YR$E$M$Y$83$KG$20240718$$MD$US$US
240078912$24007891$2$F$20240101$20240705$20240625$20240715$PER$$US-SA-2024SA180950$SANOFI AVENTIS$$13$YR$T$F$Y$69.5$KG$20240715$$MD$US$US
240078944$24007894$4$F$$20240725$20240625$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05278$LUPIN$$$$$$Y$$$20240817$$PH$US$US
240078952$24007895$2$F$$20240708$20240625$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002652$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
240078992$24007899$2$F$$20240701$20240625$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002638$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
240079012$24007901$2$F$$20240722$20240625$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101170$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240725$$CN$US$US
240079023$24007902$3$F$20240101$20240809$20240625$20240816$EXP$$CA-CELLTRION INC.-2024CA014081$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
240079082$24007908$2$F$20240528$20240621$20240625$20240703$EXP$$ES-AUROBINDO-AUR-APL-2024-030355$AUROBINDO$$73$YR$$M$Y$$$20240703$$PH$ES$ES
240079142$24007914$2$F$20240617$20240909$20240625$20240911$EXP$$US-TAKEDA-2024TUS062869$TAKEDA$$34$YR$$M$Y$$$20240911$$MD$US$US
240079212$24007921$2$F$20240101$20240801$20240625$20240805$EXP$$US-UCBSA-2024031529$UCB$$$$$F$Y$$$20240805$$CN$US$US
240079232$24007923$2$F$$20240830$20240625$20240902$PER$$NVSC2024US129834$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
240079242$24007924$2$F$$20240702$20240625$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-030170$AUROBINDO$Manti M, Kamperidis N, Toskas A, Martin H, Misra R. Acute severe ulcerative colitis flare complicated by myopericarditis and infliximab-induced hepatitis. European Journal of Case Reports in Internal Medicine. 202;11(4):1 to 3$25$YR$$M$Y$$$20240711$$MD$GB$GB
240079412$24007941$2$F$20240324$20240712$20240625$20240717$PER$$US-ABBVIE-5813108$ABBVIE$$$$$$Y$$$20240717$$CN$US$US
240079483$24007948$3$F$20240616$20240716$20240625$20240724$EXP$$CA-CELLTRION INC.-2024CA015012$CELLTRION$$$$$$Y$$$20240724$$CN$CA$CA
240079552$24007955$2$F$$20240628$20240625$20240718$PER$$US-KOANAAP-SML-US-2024-00537$Unknown Manufacturer$$$$$F$Y$$$20240718$$CN$US$US
240079682$24007968$2$F$$20240708$20240625$20240711$EXP$$US-TAKEDA-2024TUS060374$TAKEDA$$$$$F$Y$$$20240711$$CN$US$US
240079753$24007975$3$F$20240801$20240920$20240625$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-048714$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240925$$CN$US$US
240079764$24007976$4$F$20240207$20240704$20240625$20240711$EXP$$BE-CELLTRION INC.-2024BE015024$CELLTRION$$$$$$Y$$$20240711$$MD$BE$BE
240079833$24007983$3$F$20240101$20240814$20240625$20240820$EXP$$CA-JNJFOC-20240211216$JOHNSON AND JOHNSON$$62$YR$A$F$Y$104$KG$20240820$$HP$CA$CA
240079922$24007992$2$F$$20240807$20240625$20240808$PER$$US-ALXN-A202309109$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240808$$CN$US$US
240079942$24007994$2$F$20240525$20240711$20240625$20240712$EXP$$NVSC2024MW131264$NOVARTIS$$26$YR$$M$Y$45$KG$20240712$$MD$MW$MW
240080012$24008001$2$F$$20240904$20240625$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098957$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240906$$CN$US$US
240080042$24008004$2$F$20240606$20240628$20240625$20240711$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001413$Alvotech$$39$YR$$F$Y$$$20240711$$CN$CA$CA
240080063$24008006$3$F$$20240909$20240625$20240924$EXP$$FR-PHARMAAND GMBH-2024PHR00388$pharmaAND$$$$$F$Y$$$20240924$$CN$FR$FR
240080122$24008012$2$F$20230801$20240810$20240625$20240819$EXP$$CA-CELLTRION INC.-2023CA017636$CELLTRION$$$$$$Y$$$20240819$$HP$CA$CA
240080132$24008013$2$F$$20240705$20240625$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101152$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240712$$CN$US$US
240080233$24008023$3$F$$20240905$20240625$20240914$PER$$US-SA-2024SA185718$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240914$$MD$US$US
240080244$24008024$4$F$20240615$20240812$20240625$20240814$PER$$US-AMGEN-USASP2024123375$AMGEN$$71$YR$E$M$Y$$$20240814$$HP$US$US
240080542$24008054$2$F$20240418$20240807$20240625$20240819$EXP$$DE-BEH-2024173993$CSL BEHRING$$40$YR$A$F$Y$82$KG$20240819$$CN$DE$DE
240080565$24008056$5$F$20240701$20240909$20240625$20240919$EXP$$US-BEH-2024173802$CSL BEHRING$$36$YR$A$M$Y$145.13$KG$20240919$$MD$US$US
240080593$24008059$3$F$20240601$20240718$20240625$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101050$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240722$$PH$US$US
240080632$24008063$2$F$20240101$20240628$20240625$20240711$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00490$UPSHER-SMITH$$$$$F$Y$61.224$KG$20240711$$MD$US$US
240080652$24008065$2$F$20240621$20240708$20240625$20240709$PER$$US-AMGEN-USASP2024124085$AMGEN$$78$YR$E$F$Y$$$20240709$$CN$US$US
240080702$24008070$2$F$$20240624$20240625$20240702$30DAY$$US-GSK-US2024075141$GLAXOSMITHKLINE$$$$A$F$Y$$$20240702$$CN$US$US
240080722$24008072$2$F$$20240902$20240625$20240909$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-099558$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240909$$HP$ES$ES
240080752$24008075$2$F$$20240626$20240625$20240709$EXP$$US-ChurchDwight-2024-CDW-00957$CHURCH + DWIGHT$$$$$F$Y$$$20240709$$CN$US$US
240080852$24008085$2$F$20240101$20240716$20240625$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202406013828$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240718$$CN$US$US
240080892$24008089$2$F$20240816$20240819$20240625$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002663$ACADIA PHARMACEUTICALS$$87$YR$$F$Y$$$20240912$$CN$US$US
240080963$24008096$3$F$$20240610$20240625$20240709$PER$$US-ROCHE-3560903$ROCHE$$46$YR$A$M$Y$$$20240705$$CN$US$US
240081062$24008106$2$F$20240531$20240625$20240625$20240702$EXP$$CO-JNJFOC-20240651054$JOHNSON AND JOHNSON$$58$YR$A$M$Y$75$KG$20240702$$HP$CO$CO
240081102$24008110$2$F$$20240624$20240625$20240705$PER$$US-ABBVIE-5810724$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240081132$24008113$2$F$$20240827$20240625$20240829$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-101158$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$60.78$KG$20240829$$CN$PR$PR
240081142$24008114$2$F$$20240625$20240625$20240704$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-098220$BRISTOL MYERS SQUIBB$Law NC, Lomma C. Pancreatic adenocarcinoma with brain metastases. BMJ Case Reports. 2023 Mar 20;16(3):1-4. doi:10.1136/bcr-2022-253557.$80$YR$E$M$Y$$$20240705$$MD$AU$AU
240081233$24008123$3$F$20240618$20240620$20240625$20240704$PER$$US-AMGEN-USASP2024123386$AMGEN$$74$YR$E$M$Y$$$20240704$$CN$US$US
240081252$24008125$2$F$20240601$20240628$20240625$20240703$PER$$US-AMGEN-USASP2024122600$AMGEN$$19$YR$A$F$Y$$$20240703$$PH$US$US
240081283$24008128$3$F$$20240715$20240625$20240716$PER$$NVSC2024US131644$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240081303$24008130$3$F$20231229$20240716$20240625$20240724$EXP$$DE-SA-2024SA184317$SANOFI AVENTIS$$21$YR$A$F$Y$58$KG$20240724$$MD$DE$DE
240081312$24008131$2$F$20240101$20240724$20240625$20240730$EXP$$US-SA-2024SA184241$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240730$$MD$US$US
240081382$24008138$2$F$$20240730$20240625$20240801$PER$$US-ALXN-202406USA001246US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240081442$24008144$2$F$$20240611$20240625$20240716$EXP$$US-ROCHE-3016673$ROCHE$$$$A$F$Y$81.65$KG$20240716$$CN$US$US
240081512$24008151$2$F$20231224$20240625$20240625$20240703$EXP$$DE-CELLTRION INC.-2024DE015001$CELLTRION$$$$$$Y$$$20240703$$MD$DE$DE
240081612$24008161$2$F$20220701$20240717$20240625$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100536$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240725$$HP$US$US
240081642$24008164$2$F$20240814$20240816$20240625$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101155$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240826$$CN$US$US
240081672$24008167$2$F$$20240709$20240625$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-030265$AUROBINDO$Stratman S, Zhou L, Kim RH, Phelps RG, Glickman J, Mikhaylov D, et al. Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic symptoms. JAAD Case Reports. 2024;49:36-9$77$YR$$F$Y$$$20240719$$MD$US$US
240081732$24008173$2$F$$20240626$20240625$20240701$PER$$US-ABBVIE-5813647$ABBVIE$$$$$$Y$$$20240701$$HP$US$US
240081792$24008179$2$F$$20240620$20240625$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05276$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240081822$24008182$2$F$$20240708$20240625$20240722$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00454$Phathom Pharmaceuticals$$82$YR$$F$Y$$$20240722$$MD$JP$JP
240081892$24008189$2$F$$20240625$20240625$20240704$EXP$$CA-APOTEX-2024AP007570$APOTEX$$$$E$F$Y$$$20240704$$HP$CA$CA
240081982$24008198$2$F$$20240619$20240625$20240709$PER$$US-ROCHE-10000007796$ROCHE$$48$YR$A$F$Y$$$20240702$$CN$US$US
240082002$24008200$2$F$20200101$20240702$20240625$20240708$EXP$$US-SANDOZ INC.-SDZ2024US058802$SANDOZ$$$$$F$Y$$$20240708$$HP$US$US
240082203$24008220$3$F$$20240807$20240625$20240809$EXP$$NVSC2024US124872$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
240082282$24008228$2$F$$20240827$20240625$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100286$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240905$$CN$US$US
240082332$24008233$2$F$20240601$20240718$20240625$20240722$EXP$$JP-TAKEDA-2024TJP009407$TAKEDA$$48$YR$$F$Y$$$20240722$$MD$JP$JP
240082412$24008241$2$F$20240601$20240701$20240625$20240710$EXP$$BR-RECORDATI RARE DISEASES-2024004619$RECORDATI$$$$$$Y$$$20240710$$MD$BR$BR
240082493$24008249$3$F$$20240829$20240625$20240904$PER$$US-ROCHE-10000003102$ROCHE$$$$$$Y$$$20240904$$CN$US$US
240082582$24008258$2$F$20240618$20240719$20240625$20240720$PER$$US-JNJFOC-20240650563$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240720$$PH$US$US
240082592$24008259$2$F$20240617$20240729$20240625$20240730$PER$$US-JNJFOC-20240647450$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240730$$PH$US$US
240082612$24008261$2$F$20231105$20240624$20240625$20240701$EXP$$JP-009507513-2405JPN001211J$MERCK$$58$YR$$F$Y$$$20240701$$MD$JP$JP
240082662$24008266$2$F$20240601$20240702$20240625$20240705$EXP$$CA-ABBVIE-5806898$ABBVIE$$69$YR$$F$Y$$$20240705$$CN$CA$CA
240082694$24008269$4$F$$20240822$20240625$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101453$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$68.04$KG$20240827$$CN$US$US
240082733$24008273$3$F$20240620$20240716$20240625$20240726$PER$$US-AMGEN-USASP2024123707$AMGEN$$21$YR$A$F$Y$$$20240726$$MD$US$US
240082836$24008283$6$F$$20240614$20240625$20240712$PER$$US-ROCHE-10000006822$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240082862$24008286$2$F$20240614$20240614$20240625$20240715$EXP$$US-ROCHE-10000005985$ROCHE$$55$YR$A$M$Y$$$20240715$$CN$US$US
240082912$24008291$2$F$$20240708$20240625$20240717$PER$$US-GILEAD-2024-0678457$GILEAD$$$$$M$Y$$$20240717$$HP$US$US
240082952$24008295$2$F$20240525$20240726$20240625$20240730$EXP$$US-UCBSA-2024031869$UCB$$71$YR$$F$Y$128$KG$20240730$$CN$US$US
240082982$24008298$2$F$$20240617$20240625$20240712$PER$$US-ROCHE-10000006955$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240082993$24008299$3$F$20221123$20240725$20240625$20240801$EXP$$CA-CELLTRION INC.-2022CA012698$CELLTRION$$$$$$Y$$$20240801$$HP$CA$CA
240083013$24008301$3$F$$20240617$20240625$20240712$PER$$US-ROCHE-10000006096$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240083062$24008306$2$F$$20240729$20240625$20240808$30DAY$$US-GSK-US2024075143$GLAXOSMITHKLINE$$$$$M$Y$$$20240808$$CN$US$US
240083072$24008307$2$F$20240101$20240626$20240625$20240701$PER$$US-AMGEN-USASP2024124624$AMGEN$$77$YR$E$F$Y$$$20240701$$MD$US$US
240083112$24008311$2$F$20240619$20240708$20240625$20240805$PER$$US-AstraZeneca-2024A144112$ASTRAZENECA$$28813$DY$$F$Y$$$20240806$$CN$US$
240083153$24008315$3$F$$20240822$20240625$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002676$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
240083163$24008316$3$F$$20240717$20240625$20240720$PER$$NVSC2024US131905$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
240083202$24008320$2$F$$20240718$20240625$20240723$EXP$$US-ABBVIE-5811724$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
240083312$24008331$2$F$20240601$20240701$20240625$20240708$30DAY$$US-AMGEN-USASP2024122440$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240083322$24008332$2$F$20240601$20240723$20240625$20240729$PER$$US-AMGEN-USASP2024118056$AMGEN$$53$YR$A$F$Y$150.7$KG$20240729$$PH$US$US
240083352$24008335$2$F$20240307$20240628$20240625$20240705$30DAY$$US-AMGEN-USASP2024119836$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240083422$24008342$2$F$$20240702$20240625$20240705$EXP$$US-BIOGEN-2024BI01270414$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
240083462$24008346$2$F$$20240705$20240625$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST003221$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240710$$CN$US$US
240083472$24008347$2$F$20240301$20240708$20240625$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101517$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240709$$CN$US$US
240083493$24008349$3$F$20240101$20240821$20240625$20240828$EXP$$CA-CELLTRION INC.-2024CA011778$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
240083512$24008351$2$F$20230525$20240729$20240625$20240805$EXP$DE-EMA-2024611-AUTODUP-1718134334534$DE-CHEPLA-2024007820$CHEPLAPHARM$$44$YR$$F$Y$111$KG$20240805$$MD$COUNTRY NOT SPECIFIED$DE
240083602$24008360$2$F$$20240716$20240625$20240731$EXP$$US-TEVA-VS-3210724$TEVA$$42$YR$$F$Y$$$20240731$$CN$US$US
240083645$24008364$5$F$20231215$20240820$20240625$20240824$EXP$$MX-TAKEDA-2023TUS124322$TAKEDA$$34$YR$$F$Y$$$20240824$$CN$MX$MX
240083832$24008383$2$F$20240620$20240729$20240625$20240731$EXP$$AU-TAKEDA-2024TUS063001$TAKEDA$$47$YR$$F$Y$$$20240731$$CN$AU$AU
240083882$24008388$2$F$20240701$20240820$20240625$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099864$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240828$$HP$US$US
240083912$24008391$2$F$$20240628$20240625$20240704$EXP$$US-Stemline Therapeutics, Inc.-2024ST003836$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240703$$HP$US$US
240083992$24008399$2$F$20240523$20240723$20240625$20240731$EXP$$GB-Stemline Therapeutics, Inc.-2024ST003860$STEMLINE THERAPEUTICS$$70$YR$E$M$Y$87.1$KG$20240726$$MD$GB$GB
240084082$24008408$2$F$20240621$20240708$20240625$20240710$PER$$US-AMGEN-USASP2024123456$AMGEN$$70$YR$E$M$Y$$$20240709$$CN$US$US
240084333$24008433$3$F$$20240708$20240625$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05237$LUPIN$$$$$$Y$$$20240805$$CN$US$US
240084723$24008472$3$F$$20240731$20240625$20240801$PER$$NVSC2024US131916$NOVARTIS$$$$$M$Y$$$20240802$$HP$US$US
240084753$24008475$3$F$20240101$20240817$20240625$20240827$EXP$$US-CELLTRION INC.-2024US014802$CELLTRION$$$$$$Y$$$20240827$$CN$US$US
240084764$24008476$4$F$20240607$20240723$20240625$20240725$EXP$$CA-TAKEDA-2024TUS061301$TAKEDA$$69$YR$$F$Y$85$KG$20240725$$CN$CA$CA
240085032$24008503$2$F$$20240701$20240625$20240712$PER$$US-ROCHE-10000002169$ROCHE$$$$A$F$Y$81.65$KG$20240712$$CN$US$US
240085043$24008504$3$F$$20240716$20240625$20240716$PER$$NVSC2024US131907$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
240085192$24008519$2$F$20240621$20240629$20240625$20240702$PER$$US-AMGEN-USASP2024123511$AMGEN$$65$YR$E$F$Y$88.617$KG$20240702$$HP$US$US
240085232$24008523$2$F$$20240827$20240625$20240828$EXP$$NVSC2024ES130457$NOVARTIS$$$$$$Y$$$20240828$$MD$ES$ES
240085244$24008524$4$F$$20240710$20240625$20240712$EXP$$NVSC2024US128146$NOVARTIS$$40$YR$$F$Y$$$20240712$$HP$US$US
240085303$24008530$3$F$20240624$20240701$20240625$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100666$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240702$$CN$US$US
240085312$24008531$2$F$$20240920$20240625$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-100351$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240920$$MD$JP$JP
240085362$24008536$2$F$$20240711$20240625$20240719$EXP$$JP-AMGEN-JPNSP2024122475$AMGEN$$$$$$Y$$$20240718$$MD$JP$JP
240085382$24008538$2$F$20240101$20240723$20240625$20240729$PER$$US-AMGEN-USASP2024123633$AMGEN$$84$YR$E$M$Y$$$20240728$$CN$US$US
240085452$24008545$2$F$20240301$20240627$20240625$20240722$PER$$US-TOLMAR, INC.-24US049812$TOLMAR$$49$YR$$M$Y$$$20240719$$HP$US$US
240085462$24008546$2$F$$20240805$20240625$20240816$EXP$$US-AUROBINDO-AUR-APL-2024-030751$AUROBINDO$$$$A$F$Y$$$20240816$$HP$US$US
240085532$24008553$2$F$20240621$20240722$20240625$20240726$PER$$US-AMGEN-USASP2024123413$AMGEN$$78$YR$E$F$Y$$$20240726$$CN$US$US
240085582$24008558$2$F$20221222$20240701$20240625$20240710$EXP$$US-RDY-CLI/USA/22/0159137$DR REDDYS$$23$YR$A$F$Y$152.3$KG$20240710$$CN$US$US
240085622$24008562$2$F$20230601$20240625$20240625$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-030264$AUROBINDO$Haghparast P, Nadybal M, Yuan C.. Treatment-Resistant Priapism in a 61-Year-Old Male After Combined Use of Trazodone, Quetiapine, and Fluoxetine.. Journal of clinical psychopharmacology.. 2024;44(3):316-7$61$YR$$M$Y$105$KG$20240703$$PH$US$US
240085632$24008563$2$F$20240614$20240717$20240625$20240727$30DAY$$US-GSK-US2024075147$GLAXOSMITHKLINE$$59$YR$$M$Y$52.16$KG$20240727$$HP$US$US
240085642$24008564$2$F$$20240614$20240625$20240704$EXP$$US-ROCHE-10000006145$ROCHE$$55$YR$A$F$Y$$$20240704$$CN$US$US
240085682$24008568$2$F$20240101$20240917$20240625$20240920$EXP$$US-SA-2024SA182559$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240920$$MD$US$US
240085712$24008571$2$F$$20240821$20240625$20240823$EXP$$NVSC2024BR131293$NOVARTIS$$$$$$Y$$$20240823$$MD$BR$BR
240085743$24008574$3$F$$20240805$20240625$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002640$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
240085763$24008576$3$F$$20240815$20240625$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101494$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$76.66$KG$20240822$$CN$US$US
240085772$24008577$2$F$$20240924$20240625$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100969$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$74.84$KG$20240924$$HP$US$US
240085852$24008585$2$F$$20240904$20240625$20240913$EXP$$CZ-AUROBINDO-AUR-APL-2023-065544$AUROBINDO$Vojt??ek Petr. Nalos Daniel: Serotoninergn? syndrom ? kazuistika.. Anest. intenziv. Med.. 2011;s. 159? 162$70$YR$$F$Y$$$20240913$$MD$CZ$CZ
240085882$24008588$2$F$20231124$20240731$20240625$20240806$EXP$$US-009507513-2406USA007017$MERCK$$76$YR$$F$Y$$$20240806$$HP$US$US
240085932$24008593$2$F$$20240613$20240625$20240701$EXP$$JP-AMGEN-JPNSP2024124115$AMGEN$$$$$$Y$$$20240701$$MD$JP$JP
240085972$24008597$2$F$20240610$20240816$20240625$20240905$EXP$$US-862174955-ML2024-03574$Unknown Manufacturer$$40$YR$A$F$Y$108.8$KG$20240905$$CN$US$US
240085982$24008598$2$F$$20240828$20240625$20240905$EXP$$US-862174955-ML2024-03530$Unknown Manufacturer$$$$$M$Y$73.5$KG$20240905$$CN$US$US
240085993$24008599$3$F$$20240914$20240625$20240919$EXP$$US-862174955-ML2024-03312$Unknown Manufacturer$$62$YR$A$F$Y$86$KG$20240919$$CN$US$US
240086003$24008600$3$F$20240531$20240911$20240625$20240918$EXP$$US-862174955-ML2024-03380$MICRO LABS$$$$$F$Y$$$20240918$$CN$US$US
240086102$24008610$2$F$20240607$20240919$20240625$20240923$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-101303$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$98$KG$20240923$$MD$DE$DE
240086112$24008611$2$F$20240115$20240822$20240625$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098887$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$90.72$KG$20240902$$CN$US$US
240086142$24008614$2$F$20240614$20240614$20240625$20240917$EXP$GB-MHRA-MED-202406140911290890-GVPFM$GB-TORRENT-00036807$TORRENT$$54$YR$A$M$Y$69$KG$20240917$$CN$GB$GB
240086272$24008627$2$F$$20240802$20240625$20240805$PER$$US-ALXN-202406USA001417US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240086283$24008628$3$F$$20240911$20240625$20240913$PER$$US-ROCHE-10000007590$ROCHE$$24$YR$A$F$Y$$$20240913$$MD$US$US
240086292$24008629$2$F$20240603$20240723$20240625$20240730$EXP$$DE-ABBVIE-5813026$ABBVIE$$83$YR$$M$Y$$$20240730$$PH$DE$DE
240086323$24008632$3$F$$20240807$20240625$20240821$EXP$$US-INSMED, INC.-2024-02447-US$INSMED$$$$$F$Y$$$20240821$$CN$US$US
240086332$24008633$2$F$20240614$20240916$20240625$20240930$PER$$US-JNJFOC-20240662474$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240930$$HP$US$US
240086422$24008642$2$F$$20240530$20240625$20240712$PER$$US-ALK-ABELLO A/S-2024AA002372$ALK-ABELLO$$$$$$Y$$$20240712$$MD$US$US
240086514$24008651$4$F$20230303$20240729$20240625$20240809$EXP$$HU-AUROBINDO-AUR-APL-2024-030365$AUROBINDO$Lakatos V, Gopcsa L, Balogh A, Fabian J, Remenyi P.. Treatment and transplantation in T-cell prolymphocytic leukaemia: Presentation of two cases.. Hematol?gia - Transzfuziol?gia (Haematology - Transfusiology).. 2024;1:65-66, 69-69$62$YR$$F$Y$$$20240809$$MD$HU$HU
240086582$24008658$2$F$$20240624$20240625$20240731$PER$$US-ROCHE-10000002064$ROCHE$Valenzuela A,  Successful Management of Recurrent Ankle Hemarthrosis in a Patient with Von Willebrand Disease Type 3 using Emicizumab: A Case Report (Abstract number: PB0287). ISTH 2024 Congress. 2024;$19$YR$A$M$Y$$$20240731$$CN$US$US
240086602$24008660$2$F$$20240802$20240625$20240802$PER$$US-ALXN-202406USA001372US$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240802$$HP$US$US
240086612$24008661$2$F$$20240802$20240625$20240802$PER$$US-ALXN-202406USA001365US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240802$$MD$US$US
240086622$24008662$2$F$$20240721$20240625$20240725$EXP$$NVSC2024US130646$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
240086652$24008665$2$F$$20240816$20240625$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100675$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240822$$CN$US$US
240086722$24008672$2$F$$20240924$20240625$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101192$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240924$$HP$US$US
240086742$24008674$2$F$$20240709$20240625$20240722$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001969$Alvotech$$50$YR$$F$Y$$$20240722$$CN$CA$CA
240086762$24008676$2$F$20240619$20240729$20240625$20240731$EXP$$US-ABBVIE-5810422$ABBVIE$$76$YR$$M$Y$$$20240731$$CN$US$US
240086772$24008677$2$F$$20240704$20240625$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05283$LUPIN$$$$$$Y$$$20240730$$PH$US$US
240086803$24008680$3$F$$20240715$20240625$20240723$EXP$$US-BAUSCH-BL-2024-009464$BAUSCH AND LOMB$Mikhail E, Jankowski M, Alexander D, Pandya D, Kunadi A. Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature. Journal of Community Hospital Internal Medicine Perspectives. 2024 MAR 04;14(2):96-99. doi:10.55729/2000-9666.1321$72$YR$$F$Y$$$20240723$$HP$US$US
240086982$24008698$2$F$20240228$20240701$20240625$20240709$EXP$$CA-AstraZeneca-2024A137566$ASTRAZENECA$$25228$DY$$F$Y$$$20240709$$CN$CA$
240087022$24008702$2$F$20240101$20240805$20240625$20240808$EXP$$US-ABBVIE-5808472$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
240087163$24008716$3$F$20240620$20240805$20240625$20240807$PER$$US-AMGEN-USASP2024123388$AMGEN$$63$YR$A$M$Y$$$20240807$$CN$US$US
240087203$24008720$3$F$20210101$20240912$20240625$20240914$EXP$$HU-ROCHE-10000005484$ROCHE$Gulyas A, Berzy K, Agnes Domotor M, Santa H, Laszlo Batai A. High-grade  transformation in our patient treated for lymphoplasmacytic lymphoma-Case report. Haematology-Transfusiology. 2024;68-9.$58$YR$A$F$Y$$$20240914$$HP$HU$HU
240087312$24008731$2$F$20240127$20240822$20240625$20240827$EXP$$CA-TAKEDA-2024TUS060449$TAKEDA$$67$YR$$M$Y$$$20240827$$CN$CA$CA
240087323$24008732$3$F$20230101$20240903$20240625$20240905$EXP$$US-ABBVIE-5808690$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
240087392$24008739$2$F$$20240619$20240625$20240704$PER$$US-ROCHE-10000006262$ROCHE$$$$A$F$Y$$$20240704$$CN$US$US
240087452$24008745$2$F$$20240716$20240625$20240725$30DAY$$US-GSK-US2024075853$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$MD$US$US
240087482$24008748$2$F$20240601$20240702$20240625$20240809$PER$$FR-TOLMAR, INC.-24FR049941$TOLMAR$$$$A$M$Y$$$20240809$$PH$FR$FR
240087492$24008749$2$F$20240604$20240703$20240625$20240808$PER$$FR-TOLMAR, INC.-24FR049984$TOLMAR$$$$A$M$Y$$$20240808$$PH$FR$FR
240087542$24008754$2$F$20240501$20240702$20240625$20240725$PER$$US-TOLMAR, INC.-24US049600$TOLMAR$$$$$M$Y$$$20240725$$HP$US$US
240087552$24008755$2$F$20240530$20240711$20240625$20240801$PER$$US-TOLMAR, INC.-24US049921$TOLMAR$$$$$M$Y$$$20240801$$PH$US$US
240087572$24008757$2$F$20240604$20240712$20240625$20240801$PER$$US-TOLMAR, INC.-24US049951$TOLMAR$$$$$$Y$$$20240801$$PH$US$US
240087602$24008760$2$F$$20240924$20240625$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101016$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240924$$MD$US$US
240087634$24008763$4$F$20240803$20240924$20240625$20240927$EXP$$CA-TAKEDA-2024TUS061810$TAKEDA$$66$YR$$M$Y$$$20240927$$CN$CA$CA
240087894$24008789$4$F$20240216$20240917$20240625$20240925$EXP$$CA-TAKEDA-2023TUS124614$TAKEDA$$67$YR$$F$Y$$$20240925$$CN$CA$CA
240087952$24008795$2$F$20240527$20240716$20240625$20240722$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-089021$REGENERON$$80$YR$$M$Y$$$20240722$$MD$JP$JP
240088152$24008815$2$F$20240401$20240703$20240625$20240708$EXP$DE-PEI-CADR2024328871$NVSC2024DE130866$NOVARTIS$$59$YR$$M$Y$$$20240709$$HP$DE$DE
240088182$24008818$2$F$$20240809$20240625$20240813$PER$$US-HALEON-2183568$Haleon PLC$$27$YR$$F$Y$$$20240813$$CN$US$US
240088213$24008821$3$F$$20240815$20240625$20240823$EXP$$GB-TEVA-VS-3200189$TEVA$$79$YR$$F$Y$$$20240823$$CN$GB$GB
240088234$24008823$4$F$20240101$20240910$20240625$20240924$EXP$$US-INSMED, INC.-2024-02446-US$INSMED$$$$$M$Y$$$20240924$$CN$US$US
240088372$24008837$2$F$$20240830$20240625$20240830$PER$$NVSC2024US131490$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
240088402$24008840$2$F$$20240618$20240625$20240705$EXP$$JP-009507513-2402JPN001393J$MERCK$$61$YR$$M$Y$$$20240705$$MD$JP$JP
240088412$24008841$2$F$20240423$20240706$20240625$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-030376$AUROBINDO$$68$YR$$F$Y$$$20240716$$PH$FR$FR
240088463$24008846$3$F$$20240729$20240625$20240731$PER$$US-ROCHE-10000005306$ROCHE$$$$$$Y$$$20240731$$HP$US$US
240088612$24008861$2$F$$20240805$20240625$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100848$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240807$$CN$US$US
240088643$24008864$3$F$20230101$20240729$20240625$20240807$EXP$$CA-JNJFOC-20230502773$JOHNSON AND JOHNSON$$75$YR$E$M$Y$80$KG$20240807$$CN$CA$CA
240088893$24008889$3$F$$20240819$20240625$20240821$PER$$US-AMGEN-USASP2024123908$AMGEN$$$$$F$Y$$$20240821$$PH$US$US
240089164$24008916$4$F$20240615$20240710$20240625$20240711$EXP$$US-UCBSA-2024032142$UCB$$45$YR$$M$Y$$$20240711$$CN$US$US
240089282$24008928$2$F$$20240627$20240625$20240705$EXP$NL-EMA-20160719-dkevhp-134157769$NL-STERISCIENCE B.V.-2024-ST-000852$Steriscience PTE$Oliveira dos Santos C, Zijlstra JG, Porte RJ, Kampinga GA, van Diepeningen AD, Sinha B et al.. Emerging pan-resistance in Trichosporon species: A case report.. BMC Infectious Diseases. 2016;16(1):Article Number 148$48$YR$$M$Y$$$20240705$$MD$NL$NL
240089452$24008945$2$F$$20240730$20240625$20240801$EXP$$US-ALXN-202406USA001145US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240089482$24008948$2$F$$20240812$20240625$20240815$EXP$$US-ABBVIE-5807105$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
240089492$24008949$2$F$20240505$20240701$20240625$20240712$EXP$IT-MINISAL02-989563$IT-SERVIER-S24007383$SERVIER$$$$$$Y$$$20240712$$PH$IT$IT
240089502$24008950$2$F$20240101$20240716$20240625$20240722$EXP$$JP-AMGEN-JPNSP2024120793$AMGEN$$86$YR$E$F$Y$$$20240722$$PH$JP$JP
240089552$24008955$2$F$20240601$20240627$20240625$20240701$PER$$US-ABBVIE-5810944$ABBVIE$$73$YR$$F$Y$73$KG$20240701$$HP$US$US
240089572$24008957$2$F$20240101$20240827$20240625$20240829$EXP$$US-JNJFOC-20240644837$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$CN$US$US
240089602$24008960$2$F$20240618$20240710$20240625$20240717$EXP$$JP-AMGEN-JPNSP2024122230$AMGEN$$$$E$F$Y$$$20240717$$MD$JP$JP
240089912$24008991$2$F$20211120$20240810$20240625$20240819$EXP$$CA-CELLTRION INC.-2021CA018065$CELLTRION$$$$$$Y$$$20240819$$MD$CA$CA
240089972$24008997$2$F$20240618$20240805$20240625$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100290$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$77.56$KG$20240808$$CN$US$US
240090023$24009002$3$F$$20240720$20240625$20240801$EXP$$MX-AUROBINDO-AUR-APL-2024-030236$AUROBINDO$Garc?a-Uribe PA, Preciado M.. Crystalline keratopathy secondary to the use of ciprofloxacin after cataract surgery with confirmation by histopathological study: A case report and review of the literature.. rchivos de la Sociedad Espanola de Oftalmologia. 2024;99 (6):229?231$75$YR$$M$Y$$$20240801$$MD$MX$MX
240090112$24009011$2$F$$20240726$20240625$20240802$EXP$$JP-AstraZeneca-2024A143712$ASTRAZENECA$$90$YR$$M$Y$$$20240802$$MD$JP$
240090122$24009012$2$F$$20240722$20240625$20240730$EXP$$FR-AstraZeneca-2024A144957$ASTRAZENECA$$$$E$M$Y$$$20240730$$MD$FR$
240090143$24009014$3$F$20220101$20240622$20240625$20240703$EXP$$HU-ASTELLAS-2024EU006121$ASTELLAS$$62$YR$$F$Y$$$20240703$$CN$HU$HU
240090232$24009023$2$F$20240601$20240910$20240625$20240917$EXP$$US-ABBVIE-5811486$ABBVIE$$67$YR$$F$Y$$$20240917$$CN$US$US
240090362$24009036$2$F$$20240724$20240625$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05212$LUPIN$$$$$$Y$$$20240815$$CN$US$US
240090382$24009038$2$F$20240101$20240724$20240625$20240805$EXP$$DE-INSMED, INC.-2024-01801-DE$INSMED$$64$YR$$M$Y$58$KG$20240805$$HP$DE$DE
240090427$24009042$7$F$20240617$20240920$20240625$20240925$EXP$$NZ-MYLANLABS-2024M1057026$MYLAN$$66$YR$$M$Y$$$20240925$$HP$NZ$NZ
240090432$24009043$2$F$$20240702$20240625$20240709$EXP$$GB-MYLANLABS-2024M1057065$MYLAN$$$$E$M$Y$$$20240709$$CN$GB$GB
240090722$24009072$2$F$20240604$20240617$20240625$20240816$EXP$IT-MINISAL02-990006$IT-BEH-2024173942$CSL BEHRING$$83$YR$E$F$Y$60$KG$20240816$$MD$IT$IT
240091042$24009104$2$F$20240524$20240827$20240625$20240902$EXP$$US-JNJFOC-20240649219$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
240091062$24009106$2$F$$20240716$20240625$20240725$30DAY$$US-GSK-US2024AMR076907$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
240091163$24009116$3$F$20240619$20240705$20240625$20240709$30DAY$$US-AMGEN-USASP2024122935$AMGEN$$82$YR$E$M$Y$94.785$KG$20240709$$PH$US$US
240091182$24009118$2$F$$20240730$20240625$20240806$EXP$$JP-AMGEN-JPNSP2024124118$AMGEN$$$$$$Y$$$20240806$$PH$JP$JP
240091193$24009119$3$F$20240621$20240819$20240625$20240917$30DAY$$US-AstraZeneca-2024A144630$ASTRAZENECA$$25749$DY$$F$Y$$$20240918$$CN$US$
240091272$24009127$2$F$$20240703$20240625$20240709$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406011520$ELI LILLY AND CO$$$$$F$Y$$$20240709$$CN$JP$JP
240091512$24009151$2$F$20240408$20240809$20240625$20240813$EXP$$CA-Orion Corporation ORION PHARMA-24_00029287$ORION$$66$YR$E$F$Y$$$20240813$$MD$CA$
240091522$24009152$2$F$20240430$20240805$20240625$20240808$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-100323$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240809$$HP$FR$FR
240091542$24009154$2$F$20240605$20240913$20240625$20240930$PER$$US-SAGE-2024SAGE000072$SAGE$$30$YR$$M$Y$$$20240930$$MD$US$US
2400921013$24009210$13$F$$20240731$20240625$20240805$PER$$US-ROCHE-10000000883$ROCHE$$$$E$F$Y$$$20240805$$CN$US$US
240092302$24009230$2$F$$20240625$20240625$20240703$PER$$US-ALXN-202406USA001108US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
240092552$24009255$2$F$$20240719$20240625$20240729$30DAY$$US-GSK-US2024075156$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
240092634$24009263$4$F$20230801$20240713$20240625$20240720$EXP$$NVSC2024BR130661$NOVARTIS$$67$YR$$M$Y$98$KG$20240719$$MD$BR$BR
240092673$24009267$3$F$20240328$20240715$20240625$20240722$EXP$$MX-TAKEDA-2024TUS038597$TAKEDA$$24$YR$$F$Y$$$20240722$$CN$MX$MX
240092682$24009268$2$F$20240101$20240625$20240625$20240710$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0315$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240092774$24009277$4$F$20240618$20240814$20240625$20240826$PER$$US-AMGEN-USASP2024121679$AMGEN$$$$$F$Y$$$20240826$$PH$US$US
240092923$24009292$3$F$$20240626$20240625$20240703$PER$$US-TEVA-VS-3210567$TEVA$$43$YR$$$Y$$$20240703$$CN$US$US
240092963$24009296$3$F$20240610$20240906$20240625$20240919$EXP$$JP-TAKEDA-2024TUS062143$TAKEDA$$69$YR$$M$Y$56$KG$20240919$$HP$JP$JP
240092993$24009299$3$F$20221201$20240704$20240625$20240711$PER$$US-HETERO-HET2024US01810$HETERO$$79$YR$$$Y$81.64$KG$20240711$$CN$US$US
240093004$24009300$4$F$$20240905$20240625$20240910$EXP$$CA-TAKEDA-2024TUS061716$TAKEDA$$$$$M$Y$$$20240910$$CN$CA$CA
240093142$24009314$2$F$20240618$20240729$20240625$20240801$30DAY$$US-AMGEN-USASP2024122317$AMGEN$$82$YR$E$F$Y$73.6$KG$20240801$$PH$US$US
240093152$24009315$2$F$20240615$20240913$20240625$20240920$EXP$$JP-009507513-2406JPN002612J$MERCK$$$$$F$Y$$$20240920$$MD$JP$JP
240093232$24009323$2$F$$20240701$20240625$20240704$EXP$$AR-TAKEDA-2024TUS062891$TAKEDA$$$$$F$Y$$$20240704$$CN$AR$AR
240093252$24009325$2$F$20240611$20240627$20240625$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099349$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240710$$CN$US$US
240093292$24009329$2$F$20240611$20240620$20240625$20240701$EXP$$CN-ORGANON-O2406CHN002074$ORGANON$$85$YR$$F$Y$48$KG$20240701$$HP$CN$CN
240093512$24009351$2$F$20240618$20240620$20240625$20240701$PER$$US-AMGEN-USASP2024122371$AMGEN$$66$YR$E$F$Y$$$20240701$$PH$US$US
240093632$24009363$2$F$$20240719$20240625$20240723$PER$$US-AstraZeneca-2024A143002$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
240093643$24009364$3$F$20240610$20240729$20240625$20240806$EXP$$BR-AstraZeneca-2024A143595$ASTRAZENECA$$81$YR$$F$Y$68$KG$20240806$$MD$BR$
240093673$24009367$3$F$20240601$20240729$20240625$20240802$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035872$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240802$$CN$US$US
240093712$24009371$2$F$$20240628$20240625$20240702$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-100231$BRISTOL MYERS SQUIBB$Mlot B, Rzepecki P. The history of a great battle, i.e. a case report of acute myeloid leukemia. Onkologia Po Dyplomie. 2024 Mar;$46$YR$A$M$Y$$$20240702$$MD$PL$PL
240093732$24009373$2$F$20240611$20240807$20240625$20240812$PER$$US-AMGEN-USASP2024121684$AMGEN$$$$$$Y$$$20240812$$HP$US$US
240093742$24009374$2$F$20240202$20240624$20240625$20240724$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-089137$REGENERON$$68$YR$$F$Y$$$20240724$$HP$DE$DE
240093822$24009382$2$F$20240528$20240620$20240625$20240701$EXP$PT-INFARMED-F202406-389$PT-Accord-431837$ACCORD$$48$YR$A$F$Y$53$KG$20240701$$HP$PT$PT
240093842$24009384$2$F$20240404$20240629$20240625$20240704$EXP$FR-AFSSAPS-2024054093$FR-Accord-432151$ACCORD$$77$YR$E$M$Y$79$KG$20240702$$MD$FR$FR
240093882$24009388$2$F$$20240711$20240625$20240716$EXP$$JO-AMERICAN REGENT INC-2024002408$AMERICAN REGENT$$$$$$Y$$$20240716$$HP$JO$JO
240093942$24009394$2$F$$20240704$20240625$20240709$PER$$NVSC2024US131369$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240094062$24009406$2$F$$20240807$20240625$20240811$PER$$US-JAZZ PHARMACEUTICALS-2023-US-006721$JAZZ$$$$$M$Y$$$20240811$$MD$US$US
240094132$24009413$2$F$$20240802$20240625$20240807$30DAY$$NZ-MYLANLABS-2024M1056366$MYLAN$$$$$$Y$$$20240807$$PH$NZ$NZ
240094162$24009416$2$F$20240420$20240627$20240625$20240708$EXP$$CA-BEH-2024171739$CSL BEHRING$$57$YR$A$F$Y$57.3$KG$20240708$$HP$CA$CA
240094192$24009419$2$F$$20240624$20240625$20240709$EXP$$AR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452307$RANBAXY$Kochen S, Villanueva M, Bayarres L, Daza-Restrepo A, Gonzalez Martinez S, Oddo S. Cannabidiol as an adjuvant treatment in adults with drug-resistant focal epilepsy. Epilepsy Behav. 2023;144:109210(1-6)$$$A$$Y$$$20240709$$HP$AR$AR
240094582$24009458$2$F$$20240705$20240625$20240720$EXP$$BG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451743$RANBAXY$Vassileva Z, Pavlova E, Marinov R, Ibryam I, Radulova P. Fetal ductal constriction caused by SSRI: a case report. J Clin Ultrasound. 2024;Jun 7 0 (0):1-4$34$YR$$F$Y$$$20240719$$MD$BG$BG
240094843$24009484$3$F$$20240705$20240625$20240720$EXP$$BG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451742$RANBAXY$Vassileva Z, Pavlova E, Marinov R, Ibryam I, Radulova P. Fetal ductal constriction caused by SSRI: a case report. J Clin Ultrasound. 2024;Jun7 0 (0):1-4$$$N$F$Y$1.7$KG$20240719$$MD$BG$BG
240094873$24009487$3$F$20240514$20240724$20240625$20240725$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035673$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$82$KG$20240725$$MD$CA$CA
240094932$24009493$2$F$20240610$20240816$20240625$20240821$EXP$$NVSC2024CN129888$NOVARTIS$$38$YR$$F$Y$67.7$KG$20240821$$MD$CN$CN
240094992$24009499$2$F$$20240815$20240625$20240819$EXP$$GB-AMGEN-GBRSP2024093783$AMGEN$$73$YR$E$M$Y$$$20240819$$CN$GB$GB
240095072$24009507$2$F$$20240723$20240625$20240801$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001242$BLUEPRINT MEDICINES$$$$$F$Y$$$20240801$$CN$US$US
240095243$24009524$3$F$$20240815$20240625$20240819$EXP$$NVSC2024US131225$NOVARTIS$$$$$M$Y$$$20240819$$CN$US$US
240095366$24009536$6$F$$20240919$20240625$20240924$30DAY$$US-PFIZER INC-202400197100$PFIZER$$13$YR$$M$Y$$$20240924$$CN$US$US
240095393$24009539$3$F$$20240911$20240625$20240913$30DAY$$US-PFIZER INC-202400197022$PFIZER$$4$YR$$F$Y$$$20240913$$CN$US$US
240095422$24009542$2$F$$20240729$20240625$20240801$PER$$US-ALXN-202406USA001050US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
240095452$24009545$2$F$$20240722$20240625$20240726$EXP$$NVSJ2024JP007497$NOVARTIS$$$$$$Y$$$20240726$$MD$JP$JP
240095536$24009553$6$F$20240101$20240923$20240625$20240927$PER$$US-AMGEN-USASP2024122961$AMGEN$$29$YR$A$F$Y$$$20240926$$MD$US$US
240095563$24009556$3$F$20240613$20240911$20240625$20240916$30DAY$$US-PFIZER INC-202400197027$PFIZER$$50$YR$$M$Y$$$20240916$$CN$US$US
240095575$24009557$5$F$20240614$20240826$20240625$20240829$30DAY$$US-PFIZER INC-202400195650$PFIZER$$21$YR$$M$Y$63.5$KG$20240829$$HP$US$US
240095593$24009559$3$F$$20240913$20240625$20240918$30DAY$$US-PFIZER INC-202400195538$PFIZER$$4$YR$$M$Y$$$20240918$$CN$US$US
240095614$24009561$4$F$20200117$20240913$20240625$20240916$EXP$$BR-BAYER-2024A089769$BAYER$$46$YR$A$F$Y$$$20240916$$CN$BR$BR
240095623$24009562$3$F$$20240610$20240625$20240710$PER$$DE-ROCHE-3580053$ROCHE$$37$YR$A$M$Y$$$20240701$$MD$DE$DE
240095692$24009569$2$F$20240410$20240628$20240625$20240708$EXP$FR-AFSSAPS-NY2024000650$FR-BAXTER-2024BAX019961$BAXTER$$78$YR$$M$Y$77$KG$20240708$$MD$FR$FR
240095732$24009573$2$F$$20240613$20240625$20240902$PER$$US-ASTELLAS-2024US017146$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
240095742$24009574$2$F$$20240610$20240625$20240903$PER$$US-ASTELLAS-2024US016835$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
240095782$24009578$2$F$20240314$20240628$20240625$20240708$EXP$FR-AFSSAPS-NY2024000658$FR-BAXTER-2024BAX020106$BAXTER$$76$YR$$M$Y$65$KG$20240708$$MD$FR$FR
240095903$24009590$3$F$$20240816$20240625$20240823$EXP$$US-GSK-US2024AMR076874$GLAXOSMITHKLINE$$$$$F$Y$56$KG$20240823$$CN$US$US
240095912$24009591$2$F$$20240624$20240625$20240703$EXP$$CA-BAXTER-2024BAX020304$BAXTER$$42$YR$$F$Y$81$KG$20240703$$HP$CA$CA
240095962$24009596$2$F$20240111$20240710$20240625$20240720$EXP$$DE-GRUNENTHAL-2024-115442$AVERITAS$$$$$F$Y$$$20240719$$MD$DE$DE
240095982$24009598$2$F$20240621$20240819$20240625$20240902$PER$$US-AstraZeneca-2024A145117$ASTRAZENECA$$72$YR$$F$Y$$$20240902$$CN$US$
240096082$24009608$2$F$$20240814$20240625$20240814$EXP$$US-PFIZER INC-202400195961$PFIZER$$15$YR$$M$Y$$$20240814$$CN$US$US
240096093$24009609$3$F$$20240911$20240625$20240913$30DAY$$US-PFIZER INC-202400195044$PFIZER$$15$YR$$M$Y$$$20240913$$CN$US$US
240096103$24009610$3$F$$20240828$20240625$20240903$30DAY$$US-PFIZER INC-202400196287$PFIZER$$16$YR$$M$Y$$$20240903$$CN$US$US
240096124$24009612$4$F$20240614$20240817$20240625$20240821$30DAY$$US-PFIZER INC-202400194220$PFIZER$$14$YR$$M$Y$47.63$KG$20240821$$CN$US$US
240096133$24009613$3$F$20240613$20240917$20240625$20240920$30DAY$$US-PFIZER INC-202400194423$PFIZER$$6$YR$$M$Y$$$20240920$$CN$US$US
240096144$24009614$4$F$20240616$20240821$20240625$20240826$30DAY$$US-PFIZER INC-202400197290$PFIZER$$15$YR$$M$Y$$$20240826$$MD$US$US
240096178$24009617$8$F$$20240911$20240625$20240916$EXP$$US-PFIZER INC-202400195263$PFIZER$$13$YR$$F$Y$$$20240916$$CN$US$US
240096262$24009626$2$F$$20240725$20240625$20240805$30DAY$$US-GSK-US2024075140$GLAXOSMITHKLINE$$$$$F$Y$$$20240804$$CN$US$US
240096322$24009632$2$F$$20240610$20240625$20240709$PER$$US-ROCHE-10000000977$ROCHE$$$$$$Y$$$20240709$$CN$US$US
240096362$24009636$2$F$$20240626$20240625$20240701$EXP$$NVSC2024IL118036$NOVARTIS$$62$YR$$F$Y$$$20240701$$HP$IL$IL
240096372$24009637$2$F$20230405$20240715$20240625$20240717$EXP$$CA-TAKEDA-2024TUS062947$TAKEDA$$69$YR$$F$Y$$$20240717$$CN$CA$CA
240096385$24009638$5$F$20240601$20240918$20240625$20240918$30DAY$$US-PFIZER INC-202400197379$PFIZER$$16$YR$$M$Y$58.97$KG$20240918$$CN$US$US
240096404$24009640$4$F$20240619$20240911$20240625$20240913$30DAY$$US-PFIZER INC-202400198126$PFIZER$$13$YR$$F$Y$43.084$KG$20240913$$HP$US$US
240096414$24009641$4$F$$20240923$20240625$20240926$30DAY$$US-PFIZER INC-202400198913$PFIZER$$11$YR$$M$Y$$$20240926$$CN$US$US
240096423$24009642$3$F$20240601$20240911$20240625$20240913$30DAY$$US-PFIZER INC-202400197051$PFIZER$$9$YR$$M$Y$$$20240913$$CN$US$US
240096465$24009646$5$F$$20240921$20240625$20240925$30DAY$$US-PFIZER INC-202400197156$PFIZER$$16$YR$$F$Y$$$20240925$$CN$US$US
240096512$24009651$2$F$20240605$20240716$20240625$20240722$EXP$$US-ABBVIE-5811638$ABBVIE$$57$YR$$F$Y$$$20240722$$CN$US$US
240096762$24009676$2$F$20240515$20240711$20240625$20240723$EXP$$US-TAKEDA-2024TUS062745$TAKEDA$$37$YR$$F$Y$60.77$KG$20240723$$MD$US$US
240096922$24009692$2$F$$20240628$20240625$20240702$PER$$NVSC2024US130848$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240096983$24009698$3$F$20240328$20240920$20240625$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-005299$JAZZ$$42$YR$$F$Y$$$20240926$$HP$US$US
240097015$24009701$5$F$20240301$20240716$20240625$20240731$EXP$$US-ABBVIE-5812986$ABBVIE$$49$YR$$F$Y$$$20240731$$CN$US$US
240097183$24009718$3$F$20220101$20240705$20240625$20240712$EXP$$US-SA-2024SA184929$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240712$$MD$US$US
240097233$24009723$3$F$20230101$20240820$20240625$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002637$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
240097273$24009727$3$F$$20240820$20240625$20240824$EXP$$NVSC2022CO165121$NOVARTIS$$$$$M$Y$98$KG$20240824$$CN$CO$CO
240097293$24009729$3$F$20240101$20240810$20240625$20240819$EXP$$CA-CELLTRION INC.-2024CA015168$CELLTRION$$$$$$Y$$$20240819$$PH$CA$CA
240097332$24009733$2$F$20240618$20240716$20240625$20240723$30DAY$$US-AMGEN-USASP2024122387$AMGEN$$75$YR$E$M$Y$83.46$KG$20240722$$PH$US$US
240097373$24009737$3$F$20180405$20240731$20240625$20240805$EXP$$JP-ORGANON-O2405JPN000147$ORGANON$$88$YR$$F$Y$$$20240805$$MD$JP$JP
240097444$24009744$4$F$$20240823$20240625$20240827$EXP$$JP-ALXN-202406JPN001380JP$ALEXION PHARMACEUTICALS$$57$YR$$F$Y$$$20240827$$MD$JP$JP
240097502$24009750$2$F$$20240626$20240625$20240708$EXP$$US-MYLANLABS-2024M1057275$MYLAN$Bernstein M, Han M. Laparoscopic Management of Short-Interval Interstitial Pregnancy After Recent Tubal Ectopic: A Case Report. Obstet-Gynecol 2024; 41.$24$YR$$F$Y$$$20240708$$HP$US$US
240097683$24009768$3$F$20240618$20240823$20240625$20240828$30DAY$$GR-PFIZER INC-PV202400081999$PFIZER$$14$YR$$M$Y$40$KG$20240828$$CN$GR$GR
240097692$24009769$2$F$20240501$20240816$20240625$20240816$EXP$$CA-PFIZER INC-202400199805$PFIZER$$68$YR$$M$Y$$$20240816$$HP$CA$CA
240097702$24009770$2$F$20240101$20240815$20240625$20240815$EXP$$US-PFIZER INC-202400199159$PFIZER$$13$YR$$M$Y$$$20240815$$CN$US$US
240097712$24009771$2$F$$20240827$20240625$20240902$EXP$$CA-TAKEDA-2024TUS061782$TAKEDA$$$$$F$Y$$$20240902$$MD$CA$CA
240097742$24009774$2$F$$20240731$20240625$20240731$30DAY$$CA-PFIZER INC-202400197678$PFIZER$$11$YR$$F$Y$$$20240731$$CN$CA$CA
240097762$24009776$2$F$20240510$20240717$20240625$20240723$30DAY$$CO-PFIZER INC-202400193071$PFIZER$$13$YR$$M$Y$35$KG$20240723$$CN$CO$CO
240097775$24009777$5$F$20240619$20240912$20240625$20240919$30DAY$$GR-PFIZER INC-PV202400081379$PFIZER$$8$YR$$M$Y$22$KG$20240919$$CN$GR$GR
240097784$24009778$4$F$20240601$20240906$20240625$20240911$30DAY$$GR-PFIZER INC-PV202400080756$PFIZER$$10$YR$$M$Y$34$KG$20240911$$CN$GR$GR
240097812$24009781$2$F$$20240815$20240625$20240815$EXP$$CA-PFIZER INC-202400199049$PFIZER$$66$YR$$F$Y$$$20240815$$CN$CA$CA
240097822$24009782$2$F$$20240911$20240625$20240916$30DAY$$PA-PFIZER INC-PV202400076538$PFIZER$$13$YR$$M$Y$$$20240916$$HP$PA$PA
240097833$24009783$3$F$$20240911$20240625$20240916$30DAY$$US-PFIZER INC-PV202400079584$PFIZER$$$$$M$Y$$$20240916$$CN$US$US
240097852$24009785$2$F$$20240705$20240625$20240711$30DAY$$GB-PFIZER INC-PV202400079373$PFIZER$$9$YR$$M$Y$$$20240711$$CN$GB$GB
240097873$24009787$3$F$$20240816$20240625$20240816$EXP$$CA-PFIZER INC-202400197755$PFIZER$$66$YR$$F$Y$$$20240816$$HP$CA$CA
240097904$24009790$4$F$$20240624$20240625$20240708$EXP$$JP-AKEBIA THERAPEUTICS, INC.-JP-AKEB-24-001023$AKEBIA THERAPEUTICS$$8$DEC$$F$Y$$$20240708$$PH$JP$JP
240097912$24009791$2$F$20240601$20240814$20240625$20240819$EXP$$DE-ABBVIE-5814485$ABBVIE$$59$YR$$M$Y$60$KG$20240819$$MD$DE$DE
240097932$24009793$2$F$20240614$20240702$20240625$20240704$EXP$$NVSC2024CA130746$NOVARTIS$$24$YR$$F$Y$$$20240704$$MD$CA$CA
240098273$24009827$3$F$20240617$20240708$20240625$20240709$EXP$$NVSC2024US131790$NOVARTIS$$77$YR$$M$Y$69$KG$20240709$$HP$US$US
240098285$24009828$5$F$20240609$20240801$20240625$20240812$EXP$$US-ASTELLAS-2024US017891$ASTELLAS$$62$YR$$F$Y$$$20240812$$HP$US$US
240098315$24009831$5$F$20240611$20240719$20240625$20240724$PER$$US-ROCHE-10000006553$ROCHE$$$$$$Y$$$20240724$$HP$US$US
240098383$24009838$3$F$20240101$20240717$20240625$20240725$PER$$US-Eisai-EC-2024-166001$EISAI$$56$YR$A$M$Y$79$KG$20240725$$CN$US$US
240098413$24009841$3$F$20240617$20240730$20240625$20240801$PER$$US-ALXN-202406USA001176US$ALEXION PHARMACEUTICALS$$14$YR$$F$Y$$$20240801$$CN$US$US
240098426$24009842$6$F$20240601$20240904$20240625$20240914$30DAY$$US-GSK-US2024077742$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240914$$MD$US$US
240098442$24009844$2$F$20210701$20240717$20240625$20240724$EXP$$CA-GSK-CA2021AMR149205$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$CA$CA
240098462$24009846$2$F$$20240620$20240625$20240702$EXP$PT-EMA-DD-20240612-7482645-081752$PT-Accord-430895$ACCORD$$$$E$$Y$$$20240702$$HP$PT$PT
240098522$24009852$2$F$$20240719$20240625$20240725$30DAY$$US-JNJFOC-20240655350$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$PH$US$US
240098542$24009854$2$F$20240622$20240814$20240625$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101460$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240821$$CN$US$US
240098632$24009863$2$F$20231001$20240920$20240625$20240930$EXP$$DE-UCBSA-2024032158$UCB$$44$YR$$F$Y$$$20240930$$MD$DE$DE
240098662$24009866$2$F$$20240612$20240625$20240906$PER$$US-FARMAPROD-202404-1641$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$US
240098713$24009871$3$F$20240621$20240708$20240625$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101666$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240711$$CN$US$US
240099232$24009923$2$F$20240401$20240617$20240625$20240718$EXP$$CO-AstraZeneca-2024A141396$ASTRAZENECA$$32599$DY$$F$Y$$$20240718$$CN$CO$
240099272$24009927$2$F$$20240711$20240625$20240715$PER$$US-JNJFOC-20240635649$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240099292$24009929$2$F$20240522$20240708$20240625$20240722$PER$$US-Calliditas-2024CAL01076$CALLIDITAS THERAPEUTICS$$66$YR$E$M$Y$80.7$KG$20240722$$HP$US$US
240099322$24009932$2$F$20240524$20240610$20240625$20240717$EXP$$PK-ROCHE-10000005541$ROCHE$$70$YR$E$M$Y$$$20240717$$CN$PK$PK
240099342$24009934$2$F$20240527$20240701$20240625$20240702$EXP$$GB-MYLANLABS-2024M1057624$MYLAN$$$$$M$Y$$$20240702$$PH$GB$GB
240099402$24009940$2$F$$20240628$20240625$20240703$EXP$$RO-BAUSCH-BL-2024-009604$BAUSCH AND LOMB$Cosofret E, Ailioaie O. Polineuropatie senzitivo motorie ?n cadrul vascularitelor asociate ANCA prezentare a doua cazuri clinice. Medical Market - Neurologie - Psihiatrie. 2024 MAY 27;1-4.$65$YR$$$Y$$$20240703$$MD$RO$RO
240099422$24009942$2$F$$20240620$20240625$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05235$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240099464$24009946$4$F$20240601$20240919$20240625$20240923$EXP$$US-OTSUKA-2024_017539$OTSUKA$$57$YR$$F$Y$77.56$KG$20240923$$PH$US$US
240099512$24009951$2$F$20230920$20240712$20240625$20240716$EXP$$JP-EMD Serono-2024034138$EMD SERONO INC$$65$YR$E$M$Y$$$20240716$$MD$JP$JP
240099883$24009988$3$F$20220531$20240711$20240625$20240717$EXP$$ZA-TAKEDA-2022TUS037125$TAKEDA$$67$YR$$F$Y$$$20240717$$CN$ZA$ZA
240099962$24009996$2$F$$20240719$20240625$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035863$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240722$$CN$US$US
240099993$24009999$3$F$20240601$20240806$20240625$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001258$BLUEPRINT MEDICINES$$80$YR$E$M$Y$88.757$KG$20240815$$HP$US$US
240100092$24010009$2$F$$20240717$20240625$20240729$EXP$$US-FARMAPROD-202405-2026$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240729$$CN$US$US
240100102$24010010$2$F$20240101$20240808$20240625$20240821$EXP$$US-UCBSA-2024024790$UCB$$$$$F$Y$81.37$KG$20240821$$HP$US$US
240100112$24010011$2$F$20181106$20240702$20240625$20240708$EXP$$IT-AMGEN-ITANI2024123682$AMGEN$$$$$$Y$$$20240708$$MD$IT$IT
240100122$24010012$2$F$$20240715$20240625$20240715$PER$$US-PFIZER INC-PV202400082796$PFIZER$$$$$$Y$$$20240715$$CN$US$US
240100223$24010022$3$F$20240622$20240717$20240625$20240722$EXP$$US-PFIZER INC-PV202400082780$PFIZER$$73$YR$$F$Y$70.748$KG$20240722$$CN$US$US
240100252$24010025$2$F$20240601$20240626$20240625$20240701$PER$$US-PFIZER INC-202400199729$PFIZER$$72$YR$$F$Y$$$20240701$$CN$US$US
240100282$24010028$2$F$20240623$20240716$20240625$20240717$PER$$US-PFIZER INC-202400199705$PFIZER$$67$YR$$F$Y$74.83$KG$20240717$$CN$US$US
240100344$24010034$4$F$$20240715$20240625$20240717$EXP$$US-PFIZER INC-202400198997$PFIZER$$66$YR$$F$Y$$$20240717$$CN$US$US
240100363$24010036$3$F$20220101$20240619$20240625$20240703$EXP$$FR-PFIZER INC-PV202200109204$PFIZER$$55$YR$$F$Y$74$KG$20240703$$HP$FR$FR
240100432$24010043$2$F$20240607$20240626$20240625$20240702$EXP$$US-VERTEX PHARMACEUTICALS-2024-009227$VERTEX$$25$YR$$M$Y$$$20240702$$PH$US$US
240100452$24010045$2$F$20240401$20240723$20240625$20240729$EXP$$JP-OTSUKA-2024_017598$OTSUKA$$$$$M$Y$$$20240729$$MD$JP$JP
240100472$24010047$2$F$$20240724$20240625$20240731$30DAY$$BR-JNJFOC-20240652780$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$HP$BR$BR
240100502$24010050$2$F$20240613$20240705$20240625$20240711$EXP$$TW-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003475$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$TW$TW
240100562$24010056$2$F$$20240711$20240625$20240717$PER$$AU-TOLMAR, INC.-24AU050000$TOLMAR$$$$$M$Y$$$20240717$$HP$AU$AU
240100582$24010058$2$F$20240419$20240918$20240625$20240919$PER$$NVSC2024US122498$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
240100602$24010060$2$F$20240225$20240827$20240625$20240903$EXP$$NVSC2024AR045368$NOVARTIS$$71$YR$$M$Y$$$20240903$$CN$AR$AR
240100652$24010065$2$F$$20240726$20240625$20240730$PER$$US-AMGEN-USASP2024124300$AMGEN$$$$$M$Y$$$20240730$$PH$US$US
240100672$24010067$2$F$$20240617$20240625$20240702$PER$$US-TRIS PHARMA, INC.-24US011546$TRIS PHARM$$$$$$Y$$$20240702$$CN$US$US
240100712$24010071$2$F$20230829$20240808$20240625$20240813$EXP$$NVSC2023IL267059$NOVARTIS$$5$YR$$M$Y$19$KG$20240813$$MD$IL$IL
240100732$24010073$2$F$20240531$20240702$20240625$20240710$EXP$$NVSC2021MX041174$NOVARTIS$$46$YR$$F$Y$71$KG$20240710$$CN$MX$MX
240100832$24010083$2$F$20231023$20240704$20240625$20240710$EXP$$NVSC2024CA131596$NOVARTIS$$34$YR$$F$Y$$$20240710$$HP$CA$CA
240100964$24010096$4$F$20240621$20240724$20240625$20240805$30DAY$$US-JNJFOC-20240658519$JOHNSON AND JOHNSON$$73$YR$E$M$Y$104$KG$20240806$$PH$US$US
240100983$24010098$3$F$$20240724$20240625$20240731$30DAY$$DE-JNJFOC-20240650641$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$PH$DE$DE
240100992$24010099$2$F$20240624$20240628$20240625$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101433$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$83.91$KG$20240703$$HP$US$US
240101072$24010107$2$F$20231201$20240704$20240625$20240712$EXP$$US-BAYER-2024A090732$BAYER$$$$$F$Y$$$20240712$$MD$US$US
240101102$24010110$2$F$$20240625$20240625$20240709$30DAY$$AU-JNJFOC-20240645574$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$PH$AU$AU
240101202$24010120$2$F$20240620$20240726$20240625$20240730$30DAY$$US-PFIZER INC-202400198006$PFIZER$$$$$F$Y$$$20240730$$CN$US$US
240101364$24010136$4$F$20240403$20240819$20240625$20240821$EXP$$GB-ORGANON-O2406GBR002036$ORGANON$$41$YR$$F$Y$$$20240821$$MD$GB$GB
240101432$24010143$2$F$20240614$20240717$20240625$20240725$EXP$$PT-AstraZeneca-2024A140145$ASTRAZENECA$$11$YR$$M$Y$46$KG$20240725$$MD$PT$
240101452$24010145$2$F$20150701$20160711$20240625$20240702$EXP$$NL-SANDOZ INC.-PHHY2015NL091255$SANDOZ$$40$YR$$F$Y$$$20240702$$MD$NL$NL
240101462$24010146$2$F$$20240906$20240625$20240912$EXP$$US-GILEAD-2024-0678468$GILEAD$$82$YR$E$F$Y$$$20240912$$MD$US$US
240101472$24010147$2$F$20240623$20240705$20240625$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101756$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$64.86$KG$20240708$$PH$US$US
240101483$24010148$3$F$$20240906$20240625$20240912$EXP$$US-GILEAD-2024-0678469$GILEAD$$71$YR$E$F$Y$$$20240912$$MD$US$US
240101492$24010149$2$F$$20240817$20240625$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05393$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240101522$24010152$2$F$$20240730$20240625$20240731$PER$$US-ALXN-202406USA000801US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
240101572$24010157$2$F$$20240705$20240625$20240711$PER$$US-ROCHE-10000005665$ROCHE$Wireko F, Ryu J. Successful Pregnancies in a Patient With Severe Antisynthetase Syndrome-Related Interstitial Lung Disease (AS-ILD). American Journal of Respiratory and Critical Care Medicine. 2024-May;209:$$$$F$Y$$$20240711$$HP$US$US
240101603$24010160$3$F$$20240906$20240625$20240913$EXP$$US-GILEAD-2024-0678470$GILEAD$$56$YR$A$M$Y$$$20240913$$MD$US$US
240101632$24010163$2$F$20161001$20240627$20240625$20240710$EXP$$AE-ROCHE-1858475$ROCHE$$17$YR$T$M$Y$72$KG$20240710$$MD$AE$AE
240101643$24010164$3$F$$20240906$20240625$20240913$EXP$$US-GILEAD-2024-0678472$GILEAD$$66$YR$E$M$Y$$$20240913$$MD$US$US
240101652$24010165$2$F$$20240906$20240625$20240911$EXP$$US-GILEAD-2024-0678477$GILEAD$$70$YR$E$M$Y$$$20240911$$MD$US$US
240101672$24010167$2$F$20240210$20240905$20240625$20240919$PER$$US-MYLANLABS-2024M1053333$MYLAN$$74$YR$$M$Y$81.65$KG$20240919$$CN$US$US
240101792$24010179$2$F$20240614$20240712$20240625$20240716$PER$$US-BELCHER PHARMACEUTICALS, LLC-2024US002017$PAREXEL$$$$$$Y$$$20240716$$HP$US$US
240101832$24010183$2$F$20240621$20240621$20240625$20240710$PER$$US-AMGEN-USASP2024124277$AMGEN$$$$$M$Y$$$20240709$$CN$US$US
240101872$24010187$2$F$20200526$20240702$20240625$20240709$EXP$$NVSJ2024JP007495$NOVARTIS$$$$$$Y$$$20240709$$MD$JP$JP
240101892$24010189$2$F$20211225$20240912$20240625$20240926$EXP$$AU-CIPLA LTD.-2024AU06411$CIPLA$$$$$$Y$$$20240926$$HP$AU$AU
240101914$24010191$4$F$$20240808$20240625$20240902$PER$$US-AstraZeneca-2024A144757$ASTRAZENECA$$67$YR$$F$Y$$$20240902$$HP$US$
240102092$24010209$2$F$$20240708$20240625$20240715$EXP$$HU-BAUSCH-BL-2024-009463$BAUSCH AND LOMB$Adam J, Evelin K, Anna K, Lajos G, Zsofia S, Arpad I. Mosunetuzumabbal szerzett tapasztalatain. Hematologia-Transzfuziologia. 2024;76:.$$$A$M$Y$$$20240715$$HP$HU$HU
240102142$24010214$2$F$$20240723$20240625$20240726$EXP$$JP-OTSUKA-2024_017388$OTSUKA$$4$DEC$$F$Y$57.4$KG$20240726$$MD$JP$JP
240102152$24010215$2$F$20240528$20240712$20240625$20240726$EXP$$CN-PFIZER INC-PV202400082240$PFIZER$$79$YR$$M$Y$$$20240726$$HP$CN$CN
240102252$24010225$2$F$20230222$20240614$20240625$20240711$EXP$$GE-ROCHE-10000002179$ROCHE$$51$YR$A$M$Y$$$20240711$$HP$GE$GE
240102302$24010230$2$F$$20240730$20240625$20240809$EXP$$HU-BIOCON BIOLOGICS LIMITED-BBL2024004646$BIOCON$Cegledi A, Batai A, Dolgos J, Fekete M, Gopcsa L, Kiraly V, et al.. Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol.. Pathology and Oncology Research.. 2024;30$$$$$Y$$$20240809$$HP$HU$HU
240102332$24010233$2$F$$20240614$20240625$20240704$EXP$$US-ROCHE-10000005681$ROCHE$$48$YR$A$M$Y$$$20240704$$CN$US$US
240102342$24010234$2$F$20240101$20240716$20240625$20240805$PER$$US-AMGEN-USASP2024123364$AMGEN$$83$YR$E$M$Y$$$20240805$$CN$US$US
240102374$24010237$4$F$20240623$20240727$20240625$20240730$PER$$US-AMGEN-USASP2024125299$AMGEN$$77$YR$E$F$Y$$$20240730$$CN$US$US
240102392$24010239$2$F$$20240806$20240625$20240812$EXP$$JP-OTSUKA-2024_017487AA$OTSUKA$$6$DEC$$F$Y$$$20240812$$MD$JP$JP
240102402$24010240$2$F$$20240710$20240625$20240716$EXP$$AR-TAKEDA-2024TUS063119$TAKEDA$$$$$M$Y$51$KG$20240716$$CN$AR$AR
240102502$24010250$2$F$$20240617$20240625$20240730$EXP$$CA-SA-2024SA184998$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240730$$HP$CA$CA
240102554$24010255$4$F$20240529$20240705$20240625$20240711$EXP$$AE-AstraZeneca-2024A138881$ASTRAZENECA$$49$YR$$M$Y$75$KG$20240711$$MD$AE$
240102562$24010256$2$F$$20240625$20240625$20240709$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05280$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240102622$24010262$2$F$$20240624$20240625$20240701$EXP$$US-PFIZER INC-202400197466$PFIZER$Korman, A.. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316(6):279$49$YR$$F$Y$$$20240701$$MD$US$US
240102662$24010266$2$F$20221101$20240916$20240625$20240919$EXP$$CA-PFIZER INC-202400199645$PFIZER$$64$YR$$F$Y$$$20240919$$MD$CA$CA
240102672$24010267$2$F$20240415$20240614$20240625$20240919$EXP$$US-FERRINGPH-2024FE02906$FERRING$$65$YR$$F$Y$$$20240919$$HP$US$US
240102693$24010269$3$F$20220928$20240904$20240625$20240910$EXP$$CO-PFIZER INC-2022SGN01341$PFIZER$$58$YR$$F$Y$59.9$KG$20240910$$CN$CO$CO
240102762$24010276$2$F$20230718$20240628$20240625$20240703$EXP$$CN-PFIZER INC-2023SGN08947$PFIZER$$65$YR$$F$Y$72$KG$20240703$$MD$CN$CN
240102782$24010278$2$F$20240414$20240916$20240625$20240925$EXP$$DE-PFIZER INC-202400173677$PFIZER$$76$YR$$M$Y$$$20240925$$HP$DE$DE
240102792$24010279$2$F$$20240828$20240625$20240902$EXP$$CA-PFIZER INC-202400078915$PFIZER$$63$YR$$F$Y$$$20240902$$CN$CA$CA
240102823$24010282$3$F$20230525$20240817$20240625$20240819$EXP$$CA-PFIZER INC-202300181545$PFIZER$$57$YR$$F$Y$111$KG$20240819$$MD$CA$CA
240102888$24010288$8$F$20230906$20240808$20240625$20240819$EXP$$CZ-PFIZER INC-PV202400071755$PFIZER$Mocikova, H.. Lecba periferniho T-bunecneho lymfomu s hemofagocytujici lymfohistiocytozou. FARMAKOTERAPIE. 2024;Suppl6-Ext 1/2:13-14$41$YR$$F$Y$$$20240819$$MD$CZ$CZ
240102894$24010289$4$F$20230526$20240724$20240625$20240725$EXP$$FR-PFIZER INC-202400196564$PFIZER$$75$YR$$M$Y$$$20240725$$MD$FR$FR
240102922$24010292$2$F$20240101$20240701$20240625$20240701$EXP$$MY-PFIZER INC-PV202400082676$PFIZER$$82$YR$$F$Y$$$20240701$$PH$MY$MY
240102942$24010294$2$F$$20240625$20240625$20240701$EXP$$US-PFIZER INC-202400199997$PFIZER$Ayat, P.. Wherever You Go, Cryptococcus Is There: A Case Series. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1_MeetingA:A6327$73$YR$$$Y$$$20240701$$MD$US$US
240103002$24010300$2$F$$20240624$20240625$20240701$EXP$$US-PFIZER INC-202400197465$PFIZER$Korman, A.. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316(6):279$63$YR$$F$Y$$$20240701$$MD$US$US
240103012$24010301$2$F$$20240624$20240625$20240701$EXP$$US-PFIZER INC-202400198297$PFIZER$Hourigan, E.. A Case of Beta-Blocker Induced Cardiogenic Shock in a Female With Suspected Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1595$41$YR$$F$Y$$$20240701$$MD$US$US
240103022$24010302$2$F$$20240624$20240625$20240701$EXP$$US-PFIZER INC-202400197467$PFIZER$Korman, A.. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316(6):279$26$YR$$F$Y$$$20240701$$MD$US$US
240103067$24010306$7$F$20240101$20240821$20240625$20240827$EXP$$CO-SA-2024SA184134$SANOFI AVENTIS$$1$DY$N$M$Y$2.5$KG$20240827$$CN$CO$CO
240103114$24010311$4$F$$20240923$20240625$20240925$30DAY$$US-PFIZER INC-202400196030$PFIZER$$17$YR$$M$Y$63.5$KG$20240925$$CN$US$US
240103253$24010325$3$F$20180703$20240705$20240625$20240709$EXP$$IT-AMGEN-ITANI2024122111$AMGEN$$65$YR$E$$Y$$$20240709$$MD$IT$IT
240103292$24010329$2$F$20240403$20240725$20240625$20240801$EXP$$BR-GSK-BR2024AMR014189$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$BR$BR
240103334$24010333$4$F$20240101$20240920$20240625$20240927$EXP$$FR-SA-2024SA185825$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240927$$MD$FR$FR
240103343$24010334$3$F$20240101$20240805$20240625$20240810$EXP$$CA-SA-2024SA049169$SANOFI AVENTIS$$8$MON$I$M$Y$8$KG$20240810$$MD$CA$CA
240103362$24010336$2$F$20240606$20240722$20240625$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202406015673$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240723$$CN$US$US
240103433$24010343$3$F$20240101$20240819$20240625$20240828$EXP$$US-PFIZER INC-PV202400082570$PFIZER$$64$YR$$F$Y$$$20240828$$HP$US$US
240103522$24010352$2$F$20240623$20240716$20240625$20240718$PER$$US-PFIZER INC-PV202400083243$PFIZER$$$$$$Y$$$20240718$$CN$US$US
240103653$24010365$3$F$$20240724$20240625$20240731$30DAY$$IN-JNJFOC-20240644489$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$IN$IN
240103692$24010369$2$F$$20240716$20240625$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099250$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$62.6$KG$20240717$$CN$US$US
240103722$24010372$2$F$$20240813$20240625$20240822$EXP$$GB-ROCHE-10000006585$ROCHE$$$$A$F$Y$$$20240822$$CN$GB$GB
240103752$24010375$2$F$$20240620$20240625$20240717$EXP$$DE-SA-2024SA187098$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240717$$MD$DE$DE
240103842$24010384$2$F$20240530$20240710$20240625$20240717$EXP$$US-BAYER-2024A090576$BAYER$$24$YR$A$M$Y$$$20240717$$CN$US$US
240103863$24010386$3$F$$20240923$20240625$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101824$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240925$$CN$US$US
240103874$24010387$4$F$20240101$20240813$20240625$20240816$EXP$$CA-PFIZER INC-202400197759$PFIZER$$75$YR$$M$Y$$$20240816$$PH$CA$CA
240103963$24010396$3$F$20240101$20240802$20240625$20240806$EXP$$CA-PFIZER INC-202400198523$PFIZER$$66$YR$$F$Y$$$20240806$$PH$CA$CA
240103972$24010397$2$F$20240101$20240716$20240625$20240722$EXP$$AU-PFIZER INC-PV202400081872$PFIZER$$80$YR$$M$Y$78$KG$20240722$$MD$AU$AU
240103992$24010399$2$F$20240101$20240821$20240625$20240826$EXP$$CA-PFIZER INC-202400198906$PFIZER$$42$YR$$F$Y$$$20240826$$CN$CA$CA
240104022$24010402$2$F$$20240817$20240625$20240819$EXP$$CA-PFIZER INC-202400199034$PFIZER$$75$YR$$M$Y$$$20240819$$MD$CA$CA
240104092$24010409$2$F$$20240716$20240625$20240718$EXP$$GB-MYLANLABS-2024M1057118$MYLAN$$$$$M$Y$$$20240718$$PH$GB$GB
240104132$24010413$2$F$$20240625$20240625$20240710$EXP$$CA-002147023-NVSC2024CA009083$Haleon PLC$$43$YR$$F$Y$68$KG$20240709$$HP$CA$CA
240104222$24010422$2$F$$20240701$20240625$20240711$PER$$US-BAYER-2024A088703$BAYER$$43$YR$A$F$Y$82.55$KG$20240711$$HP$US$US
240104292$24010429$2$F$20240530$20240909$20240625$20240912$PER$$US-PFIZER INC-202400058750$PFIZER$$55$YR$$F$Y$53.52$KG$20240912$$CN$US$US
240104322$24010432$2$F$20240619$20240730$20240625$20240805$PER$$US-PFIZER INC-202400197633$PFIZER$$48$YR$$F$Y$105.23$KG$20240805$$HP$US$US
240104372$24010437$2$F$20240621$20240621$20240625$20240705$PER$$US-AMGEN-USASP2024123254$AMGEN$$79$YR$E$F$Y$$$20240705$$CN$US$US
240104432$24010443$2$F$$20240926$20240625$20240930$EXP$$CA-ORGANON-O2406CAN001913$ORGANON$Unknown. Unknown. Unknown. UNK$17$YR$$M$Y$$$20240930$$MD$CA$CA
240104442$24010444$2$F$$20240815$20240625$20240821$EXP$$US-ABBVIE-5789479$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
240104462$24010446$2$F$$20240625$20240625$20240702$EXP$$CA-TAKEDA-2024TUS046971$TAKEDA$$$$$F$Y$$$20240702$$CN$CA$CA
240104477$24010447$7$F$20240613$20240916$20240625$20240926$PER$$US-ASTELLAS-2024US017894$ASTELLAS$$76$YR$E$F$Y$$$20240926$$CN$US$US
240104482$24010448$2$F$20240618$20240629$20240625$20240704$EXP$$NVSC2024CN130132$NOVARTIS$$70$YR$$F$Y$51$KG$20240704$$MD$CN$CN
240104502$24010450$2$F$$20240923$20240625$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101620$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240925$$CN$US$US
240104514$24010451$4$F$$20240910$20240625$20240916$EXP$$CA-HALEON-2182885$Haleon PLC$$43$YR$$F$Y$96$KG$20240915$$HP$CA$CA
240104593$24010459$3$F$$20240716$20240625$20240806$30DAY$$CH-JNJFOC-20240656706$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$CH$CH
240104613$24010461$3$F$$20240611$20240625$20240701$EXP$$NVSC2024TW126040$NOVARTIS$Hsieh C-Y, Tsai Y-J, Tsai T-F. Use of biologics in Chinese pregnant patients with deficiency of interleukin-36 receptor antagonist (DITRA): A case series. TAIWANESE JOURNAL OF OBSTETRICS + GYNECOLOGY. 2024;63 (3):405-408$31$YR$$F$Y$$$20240701$$HP$TW$TW
240104752$24010475$2$F$$20240723$20240625$20240806$PER$$US-ALKERMES INC.-ALK-2024-001704$ALKERMES$$$$$M$Y$62.585$KG$20240806$$MD$US$US
240104802$24010480$2$F$$20240626$20240625$20240704$PER$$US-RDY-SPO/USA/24/0008795$DR REDDYS$$$$$$Y$$$20240704$$CN$US$US
240105112$24010511$2$F$$20240823$20240625$20240827$EXP$$NVSC2024US130260$NOVARTIS$$$$$M$Y$$$20240827$$CN$US$US
240105232$24010523$2$F$$20240625$20240625$20240701$PER$$US-PFIZER INC-PV202400082096$PFIZER$$90$YR$$F$Y$$$20240701$$CN$US$US
240105262$24010526$2$F$$20240823$20240625$20240828$PER$$US-PFIZER INC-202400063460$PFIZER$$64$YR$$F$Y$$$20240828$$CN$US$US
240105422$24010542$2$F$$20240724$20240625$20240731$30DAY$$IL-JNJFOC-20240643180$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$PH$IL$IL
240105572$24010557$2$F$$20240627$20240625$20240708$PER$$US-RDY-SPO/USA/24/0009014$DR REDDYS$$75$YR$E$F$Y$$$20240708$$CN$US$US
240105644$24010564$4$F$20230725$20240829$20240625$20240905$EXP$CA-MMM-VKGA7R1T$CA-GSK-CA2023101821$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$CA$CA
240105652$24010565$2$F$20240415$20240724$20240625$20240725$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006195$JAZZ$$3$YR$$F$Y$13.6$KG$20240725$$HP$US$US
240105673$24010567$3$F$20240516$20240820$20240625$20240822$EXP$$TW-PFIZER INC-2024SGN05949$PFIZER$$79$YR$$F$Y$$$20240822$$MD$TW$TW
240105683$24010568$3$F$$20240826$20240625$20240827$EXP$$CA-PFIZER INC-202400199712$PFIZER$$50$YR$$F$Y$$$20240827$$HP$CA$CA
240105692$24010569$2$F$20240201$20240731$20240625$20240808$EXP$$FR-Merck Healthcare KGaA-2024032245$MERCK KGAA$$61$YR$A$M$Y$$$20240808$$HP$FR$FR
240105823$24010582$3$F$20240101$20240829$20240625$20240909$EXP$$US-JNJFOC-20240651865$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240910$$CN$US$US
240105862$24010586$2$F$20240501$20240730$20240625$20240807$EXP$$US-AstraZeneca-2024A140393$ASTRAZENECA$$923$MON$$F$Y$95.3$KG$20240807$$CN$US$
240105892$24010589$2$F$20140101$20240807$20240625$20240808$PER$$US-BAUSCH-BL-2024-009693$BAUSCH AND LOMB$$$$$F$Y$$$20240808$$CN$US$US
240105923$24010592$3$F$20231212$20240801$20240625$20240803$EXP$$NVSC2024DE101480$NOVARTIS$$$$E$F$Y$82.4$KG$20240803$$HP$DE$DE
240105952$24010595$2$F$$20240729$20240625$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05239$LUPIN$$$$$$Y$$$20240822$$CN$US$US
240106032$24010603$2$F$$20240722$20240625$20240724$PER$$US-PFIZER INC-202400199750$PFIZER$$43$YR$$F$Y$$$20240724$$HP$US$US
240106043$24010604$3$F$$20240802$20240625$20240807$PER$$US-PFIZER INC-PV202400082510$PFIZER$$75$YR$$M$Y$$$20240807$$HP$US$US
240106082$24010608$2$F$$20240909$20240625$20240910$PER$$US-PFIZER INC-PV202400083068$PFIZER$$66$YR$$F$Y$$$20240910$$CN$US$US
240106102$24010610$2$F$$20240726$20240625$20240726$PER$$US-PFIZER INC-PV202400082795$PFIZER$$54$YR$$$Y$$$20240726$$CN$US$US
240106464$24010646$4$F$$20240708$20240625$20240711$PER$$US-ROCHE-10000007666$ROCHE$$$$A$M$Y$117.93$KG$20240711$$CN$US$US
240106572$24010657$2$F$$20240905$20240625$20240913$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007140$AEGERION$$$$$F$Y$70.39$KG$20240913$$CN$US$US
240106612$24010661$2$F$$20240626$20240625$20240701$EXP$$US-TAKEDA-2024TUS056520$TAKEDA$$$$$M$Y$53$KG$20240701$$HP$US$US
240106822$24010682$2$F$$20240917$20240625$20240925$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007173$AEGERION$$$$$M$Y$21.397$KG$20240925$$CN$US$US
240106902$24010690$2$F$20240307$20240716$20240625$20240726$EXP$$CN-PFIZER INC-PV202400082228$PFIZER$$77$YR$$F$Y$60$KG$20240726$$HP$CN$CN
240106912$24010691$2$F$20240101$20240705$20240625$20240709$EXP$$CA-PFIZER INC-202400197007$PFIZER$$61$YR$$F$Y$$$20240709$$HP$CA$CA
240106922$24010692$2$F$20240101$20240705$20240625$20240710$EXP$$CA-PFIZER INC-202400030122$PFIZER$$14$YR$$F$Y$$$20240710$$MD$CA$CA
240106932$24010693$2$F$20240506$20240905$20240625$20240909$EXP$NO-NOMAADVRE-PASRAPP-2024-V5jqpg$NO-PFIZER INC-202400198152$PFIZER$$49$YR$$F$Y$$$20240909$$CN$NO$NO
240106962$24010696$2$F$$20240627$20240625$20240702$EXP$$US-PFIZER INC-PV202400082569$PFIZER$$75$YR$$M$Y$$$20240702$$MD$US$US
240106972$24010697$2$F$20240522$20240627$20240625$20240702$EXP$$CN-PFIZER INC-PV202400082192$PFIZER$$55$YR$$F$Y$56$KG$20240702$$HP$CN$CN
240106992$24010699$2$F$$20240725$20240625$20240726$EXP$$CA-PFIZER INC-202400198695$PFIZER$$54$YR$$M$Y$112$KG$20240726$$HP$CA$CA
240107002$24010700$2$F$$20240729$20240625$20240805$EXP$$CA-SANDOZ INC.-SDZ2024CA057698$SANDOZ$$$$$F$Y$$$20240805$$HP$CA$CA
240107062$24010706$2$F$$20240711$20240625$20240715$PER$$US-AstraZeneca-2024A129500$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
240107102$24010710$2$F$$20240612$20240625$20240724$PER$$US-AstraZeneca-2024A139741$ASTRAZENECA$$79$YR$$M$Y$$$20240724$$CN$US$
240107114$24010711$4$F$20240620$20240807$20240625$20240809$PER$$US-AMGEN-USASP2024125032$AMGEN$$74$YR$E$F$Y$$$20240808$$CN$US$US
240107142$24010714$2$F$$20240816$20240625$20240823$EXP$$CA-TAKEDA-2024TUS063093$TAKEDA$$$$$F$Y$$$20240823$$MD$CA$CA
240107172$24010717$2$F$20240101$20240624$20240625$20240703$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2024-001329$SK LIFE SCIENCE$$$$$$Y$$$20240703$$CN$US$US
240107203$24010720$3$F$20240616$20240626$20240625$20240703$PER$$US-AMGEN-USASP2024125052$AMGEN$$69$YR$E$F$Y$$$20240703$$CN$US$US
240107213$24010721$3$F$$20240625$20240625$20240702$EXP$$US-GSK-US2022096215$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$US$US
240107302$24010730$2$F$20240101$20240717$20240625$20240722$PER$$US-BAYER-2024A089474$BAYER$$37$YR$A$F$Y$$$20240722$$HP$US$US
240107332$24010733$2$F$$20240619$20240625$20240705$EXP$$US-GILEAD-2024-0678089$GILEAD$Ruff K., Wikenheiser-Brokamp K, Critser P., Hirsch R., Burg G., Hayes D., et al.. Pulmonary Capillary Hemangiomatosis: A Rare Disorder With a Nonspecific Presentation. American Journal of Respiratory and Critical Care Medicine. 2024;209:UNK. doi:UNK$9$YR$C$F$Y$$$20240705$$HP$US$US
240107412$24010741$2$F$$20240627$20240625$20240703$EXP$$FR-MYLANLABS-2024M1056051$MYLAN$$70$YR$$M$Y$$$20240703$$HP$FR$FR
240107432$24010743$2$F$20240618$20240626$20240625$20240711$30DAY$$US-AMGEN-USASP2024121699$AMGEN$$52$YR$A$F$Y$104.31$KG$20240711$$HP$US$US
240107452$24010745$2$F$20240620$20240712$20240625$20240717$PER$$US-AMGEN-USASP2024124650$AMGEN$$65$YR$E$M$Y$$$20240717$$PH$US$US
240107463$24010746$3$F$20240606$20240924$20240625$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-100453$BRISTOL MYERS SQUIBB$$5$DEC$A$$Y$$$20240925$$MD$JP$JP
240107512$24010751$2$F$$20240711$20240625$20240715$EXP$$GB-PFIZER INC-202400198646$PFIZER$$38$YR$$F$Y$$$20240715$$MD$GB$GB
240107533$24010753$3$F$20240601$20240701$20240625$20240702$EXP$$US-PFIZER INC-202400199076$PFIZER$$80$YR$$M$Y$138.35$KG$20240702$$CN$US$US
240107542$24010754$2$F$20240101$20240708$20240625$20240711$EXP$$US-PFIZER INC-202400099233$PFIZER$$75$YR$$F$Y$54.43$KG$20240711$$MD$US$US
240107572$24010757$2$F$$20240702$20240625$20240704$EXP$$CO-PFIZER INC-PV202400082775$PFIZER$$$$A$F$Y$$$20240704$$MD$CO$CO
240107606$24010760$6$F$20240101$20240904$20240625$20240904$EXP$$CA-PFIZER INC-202400198743$PFIZER$$19$YR$$M$Y$$$20240904$$HP$CA$CA
240107722$24010772$2$F$$20240618$20240625$20240801$EXP$$CA-SA-2024SA183031$SANOFI AVENTIS$$40$YR$A$F$Y$96$KG$20240801$$HP$CA$CA
240107953$24010795$3$F$20231018$20240912$20240625$20240920$EXP$$DE-VERTEX PHARMACEUTICALS-2024-010454$VERTEX$Othmer JT, Roehmel J, Temmesfeld-Wollbruck B, Mall M, Thee S, Syunyaeva Z, et al.. Idiopathic pulmonary fibrosis in a patient with cystic fibrosis. J Cyst Fibros. 2024;23:S112$70$YR$$M$Y$$$20240920$$HP$DE$DE
240107972$24010797$2$F$20240613$20240815$20240625$20240821$EXP$$US-ABBVIE-5809629$ABBVIE$$86$YR$$M$Y$$$20240821$$CN$US$US
240108032$24010803$2$F$20240612$20240627$20240625$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406016452$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240701$$CN$US$US
240108102$24010810$2$F$20240505$20240716$20240625$20240717$PER$$US-ROCHE-10000006163$ROCHE$$35$YR$A$M$Y$$$20240717$$CN$US$US
240108123$24010812$3$F$20240301$20240705$20240625$20240711$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-101577$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240711$$PH$FR$FR
240108143$24010814$3$F$$20240709$20240625$20240714$EXP$$US-ABBVIE-5812791$ABBVIE$$$$$M$Y$$$20240714$$CN$US$US
240108162$24010816$2$F$20240617$20240627$20240625$20240701$EXP$$US-KYOWAKIRIN-2024KK015209$KYOWA$$$$$$Y$$$20240701$$HP$US$US
240108212$24010821$2$F$20240522$20240808$20240625$20240813$PER$$US-BIOVITRUM-2024-US-009062$BIOVITRUM$$57$YR$$F$Y$$$20240813$$CN$US$US
240108242$24010824$2$F$$20240627$20240625$20240722$PER$$US-ROCHE-10000000383$ROCHE$$61$YR$A$M$Y$$$20240722$$CN$US$US
240108262$24010826$2$F$20240614$20240730$20240625$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101625$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$86.138$KG$20240805$$PH$US$US
240108342$24010834$2$F$$20240730$20240625$20240805$EXP$$US-AMGEN-USASP2024123984$AMGEN$Miller J.; Aribindi K.; Rosen J.et.al. Go With the Flow: Diagnosis of PulmonaryT-Cell Prolymphocytic Leukemia. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A4640-A4640$38$YR$A$M$Y$$$20240805$$HP$US$US
240108622$24010862$2$F$$20240702$20240625$20240710$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0600864$MYOVANT SCIENCES$$$$$M$Y$$$20240710$$CN$US$US
240108632$24010863$2$F$20240711$20240712$20240625$20240722$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0600816$MYOVANT SCIENCES$$87$YR$$M$Y$$$20240722$$CN$US$US
240108702$24010870$2$F$$20240716$20240625$20240722$EXP$$JP-AMGEN-JPNSP2024121040$AMGEN$$$$$$Y$$$20240722$$PH$JP$JP
240108732$24010873$2$F$20240430$20240904$20240625$20240906$EXP$IT-MINISAL02-991662$IT-PFIZER INC-202400199224$PFIZER$$55$YR$$F$Y$62$KG$20240906$$MD$IT$IT
240108842$24010884$2$F$20240617$20240717$20240625$20240720$PER$$US-JNJFOC-20240644303$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240719$$CN$US$US
240108852$24010885$2$F$20230101$20240917$20240625$20240924$EXP$$NVSC2024CA130632$NOVARTIS$$68$YR$$M$Y$85$KG$20240924$$PH$CA$CA
240108862$24010886$2$F$20240520$20240625$20240625$20240708$EXP$FR-AFSSAPS-AN2024000786$FR-009507513-2406FRA008175$MERCK$$83$YR$$F$Y$50.3$KG$20240708$$PH$FR$FR
240109004$24010900$4$F$20240620$20240905$20240625$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100615$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$88.45$KG$20240912$$PH$US$US
240109072$24010907$2$F$20230101$20240712$20240625$20240720$EXP$$JP-AMGEN-JPNSP2024121859$AMGEN$Hirayama Sho. Treatment results of romosozumab in our hospital. Journal of Japanese Society for Dialysis Therapy. 2024;57(S1):P-1-097$$$E$M$Y$$$20240719$$MD$JP$JP
240109093$24010909$3$F$20240617$20240730$20240625$20240801$PER$$US-JNJFOC-20240646450$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240801$$CN$US$US
240109152$24010915$2$F$20240201$20240703$20240625$20240709$EXP$$BE-PFIZER INC-202400199766$PFIZER$$$$A$M$Y$60$KG$20240709$$MD$BE$BE
240109202$24010920$2$F$20240622$20240712$20240625$20240716$PER$$US-PFIZER INC-202400199107$PFIZER$$70$YR$$F$Y$68.027$KG$20240716$$CN$US$US
240109242$24010924$2$F$$20240626$20240625$20240701$EXP$$JP-PFIZER INC-202400199082$PFIZER$$$$$$Y$$$20240701$$MD$JP$JP
240109282$24010928$2$F$$20240628$20240625$20240701$EXP$$US-PFIZER INC-PV202400082530$PFIZER$$55$YR$$F$Y$$$20240701$$CN$US$US
240109312$24010931$2$F$20240116$20240722$20240625$20240726$EXP$$US-OTSUKA-2024_001469$OTSUKA$$$$$F$Y$$$20240726$$CN$US$US
240109406$24010940$6$F$20240517$20240904$20240625$20240910$EXP$$NVSC2024CN111161$NOVARTIS$$54$YR$$F$Y$$$20240910$$CN$CN$CN
240109522$24010952$2$F$20230301$20240810$20240625$20240812$EXP$$DE-TAKEDA-2023TUS114391$TAKEDA$$51$YR$$F$Y$$$20240812$$HP$DE$DE
240109662$24010966$2$F$$20240627$20240625$20240702$EXP$$US-TAKEDA-2024TUS062735$TAKEDA$$$$$M$Y$27$KG$20240702$$CN$US$US
240109702$24010970$2$F$$20240730$20240625$20240807$EXP$$US-AstraZeneca-2024A140666$ASTRAZENECA$$$$$F$Y$$$20240807$$MD$US$
240109712$24010971$2$F$20230716$20240909$20240625$20240913$EXP$$GB-ORGANON-O2406GBR002209$ORGANON$$38$YR$$F$Y$88.3$KG$20240913$$MD$GB$GB
240109722$24010972$2$F$20240613$20240718$20240625$20240726$EXP$$JP-AstraZeneca-2024A143775$ASTRAZENECA$$60$YR$$F$Y$$$20240726$$MD$JP$
240109732$24010973$2$F$$20240711$20240625$20240719$EXP$$CA-AstraZeneca-2024A143798$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$CA$
240109762$24010976$2$F$$20240730$20240625$20240801$PER$$US-ALXN-202406USA001136US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240109773$24010977$3$F$19900101$20240621$20240625$20240701$PER$$US-ABBVIE-5807901$ABBVIE$$$$$F$Y$45.359$KG$20240701$$CN$US$US
240109805$24010980$5$F$20240609$20240726$20240625$20240807$30DAY$$FI-JNJFOC-20240630932$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240807$$PH$FI$FI
240109923$24010992$3$F$$20240624$20240625$20240703$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202406009602$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240703$$MD$AU$AU
240109932$24010993$2$F$20240101$20240904$20240625$20240912$EXP$$US-SA-2024SA186356$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240912$$MD$US$US
240109942$24010994$2$F$$20240809$20240625$20240814$EXP$$US-SA-2024SA185815$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240814$$CN$US$US
240109992$24010999$2$F$20201201$20240814$20240625$20240820$PER$$US-AMGEN-USASP2024122836$AMGEN$$81$YR$E$F$Y$72.381$KG$20240820$$HP$US$US
240110072$24011007$2$F$$20240724$20240625$20240725$EXP$$CA-PFIZER INC-202400198724$PFIZER$$$$$F$Y$67$KG$20240725$$MD$CA$CA
240110192$24011019$2$F$$20240730$20240625$20240801$PER$$US-ALXN-202406USA001101US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
240110202$24011020$2$F$$20240716$20240625$20240726$30DAY$$FR-JNJFOC-20240620380$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$PH$FR$FR
240110282$24011028$2$F$$20240805$20240625$20240813$EXP$$US-AstraZeneca-2024A143686$ASTRAZENECA$$13$YR$$$Y$$$20240813$$MD$US$
240110312$24011031$2$F$20240617$20240617$20240625$20240917$EXP$$JP-AstraZeneca-2024A143664$ASTRAZENECA$$60$YR$$M$Y$$$20240917$$MD$JP$
240110333$24011033$3$F$$20240808$20240625$20240812$EXP$$FR-AstraZeneca-2024A145370$ASTRAZENECA$$$$$M$Y$57$KG$20240812$$MD$FR$
240110372$24011037$2$F$20240101$20240923$20240625$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100777$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240924$$HP$US$US
240110402$24011040$2$F$20240601$20240702$20240625$20240708$EXP$$CA-JNJFOC-20240652205$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240708$$CN$CA$CA
240110423$24011042$3$F$20240601$20240910$20240625$20240918$EXP$$CA-JNJFOC-20240653416$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20240918$$PH$CA$CA
240110522$24011052$2$F$$20240731$20240625$20240801$PER$$US-JNJFOC-20240660136$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$PH$US$US
240110712$24011071$2$F$$20240625$20240625$20240701$EXP$$SG-PFIZER INC-202400199898$PFIZER$Wong, J.. Who^s to Blame? A Case of Drug-Induced Pneumonitis With Multiple Potential Culprits. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A2006$62$YR$$M$Y$$$20240701$$MD$SG$SG
240110813$24011081$3$F$$20240617$20240625$20240715$EXP$$JP-AstraZeneca-2024A143772$ASTRAZENECA$$73$YR$$M$Y$$$20240715$$MD$JP$
240110842$24011084$2$F$$20240906$20240625$20240912$EXP$$US-GILEAD-2024-0678471$GILEAD$$82$YR$E$F$Y$$$20240912$$MD$US$US
240110884$24011088$4$F$20240619$20240703$20240625$20240717$PER$$US-AMGEN-USASP2024125024$AMGEN$$57$YR$A$F$Y$$$20240717$$CN$US$US
240110912$24011091$2$F$$20240709$20240625$20240719$EXP$$CA-AstraZeneca-2024A145627$ASTRAZENECA$$53$YR$$$Y$$$20240719$$CN$CA$
240111062$24011106$2$F$$20240906$20240625$20240913$EXP$$US-GILEAD-2024-0678474$GILEAD$$62$YR$A$M$Y$$$20240913$$MD$US$US
240111092$24011109$2$F$$20240906$20240625$20240913$EXP$$US-GILEAD-2024-0678473$GILEAD$$50$YR$A$M$Y$$$20240913$$MD$US$US
240111103$24011110$3$F$$20240906$20240625$20240913$EXP$$US-GILEAD-2024-0678475$GILEAD$$65$YR$E$M$Y$$$20240913$$MD$US$US
240111163$24011116$3$F$$20240906$20240625$20240912$EXP$$US-GILEAD-2024-0678476$GILEAD$$66$YR$E$M$Y$$$20240912$$MD$US$US
240111362$24011136$2$F$20240620$20240730$20240625$20240806$EXP$$CN-GSK-CN2024APC076882$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$CN$CN
240111732$24011173$2$F$20240601$20240627$20240625$20240701$EXP$$DE-KYOWAKIRIN-2024KK015082$KYOWA$$$$$$Y$$$20240701$$HP$DE$DE
240111752$24011175$2$F$$20240627$20240625$20240705$EXP$$PL-TEVA-VS-3209301$TEVA$$25$YR$$M$Y$$$20240705$$MD$PL$PL
240111802$24011180$2$F$20240109$20240702$20240625$20240709$EXP$$NVSC2024FR130665$NOVARTIS$$$$E$F$Y$110$KG$20240709$$MD$FR$FR
240111842$24011184$2$F$$20240625$20240625$20240701$EXP$$US-PFIZER INC-202400200193$PFIZER$Alsheimer, K.. Genitourinary Tuberculosis Resulting in Hydronephrosis.. American Journal of Respiratory and Critical Care Medicine. 2024;209(1_Meeting):A2354$$$$M$Y$$$20240701$$MD$US$US
240111862$24011186$2$F$$20240819$20240625$20240829$EXP$$CA-PFIZER INC-202400197623$PFIZER$$40$YR$$F$Y$73$KG$20240829$$MD$CA$CA
240111942$24011194$2$F$$20240923$20240625$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101808$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240925$$HP$US$US
240112152$24011215$2$F$$20240821$20240625$20240823$EXP$$NVSC2024BR131628$NOVARTIS$$$$$$Y$$$20240823$$MD$BR$BR
240112222$24011222$2$F$20240319$20240705$20240625$20240711$EXP$GB-MHRA-MED-202403191414145890-LWKHY$GB-GE HEALTHCARE-2024CSU006910$GE HEALTHCARE$$64$YR$$M$Y$$$20240711$$HP$GB$GB
240112232$24011223$2$F$$20240624$20240625$20240701$PER$$US-PFIZER INC-202400200009$PFIZER$$75$YR$$F$Y$$$20240701$$HP$US$US
240112382$24011238$2$F$$20240726$20240625$20240726$PER$$US-PFIZER INC-202400198425$PFIZER$$16$YR$$M$Y$$$20240726$$CN$US$US
240112423$24011242$3$F$$20240705$20240625$20240710$EXP$GR-MLMSERVICE-20240613-PI097274-00033-1$GR-SA-2024SA187348$SANOFI AVENTIS$Kontes I, Bontinis V, Bontinis A, Manaki V, Chorti A, Giannopoulos A et al.. Sequential Graft Limb Occlusion Following Endovascular Aneurysm Repair: A Case Report and Literature Review.. Cureus. 2024;16(5):unknown$64$YR$A$M$Y$$$20240710$$MD$GR$GR
240112432$24011243$2$F$$20240903$20240625$20240910$EXP$$US-SA-2024SA185001$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240910$$MD$US$US
240112722$24011272$2$F$$20240626$20240625$20240701$EXP$$PL-GILEAD-2024-0678237$GILEAD$$27$YR$A$F$Y$$$20240701$$HP$PL$PL
240112744$24011274$4$F$$20240823$20240625$20240827$EXP$$CA-TAKEDA-2023TUS113650$TAKEDA$$$$$F$Y$$$20240827$$CN$CA$CA
240112763$24011276$3$F$$20240830$20240625$20240902$PER$$NVSC2024US131928$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
240113002$24011300$2$F$$20240919$20240625$20240920$PER$$NVSC2024US122326$NOVARTIS$$$$$M$Y$$$20240920$$HP$US$US
240113102$24011310$2$F$$20240624$20240625$20240702$EXP$$AT-AstraZeneca-2024A136068$ASTRAZENECA$$50$YR$$F$Y$64$KG$20240702$$MD$AT$
240113122$24011312$2$F$$20240719$20240625$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101726$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240725$$HP$US$US
240113132$24011313$2$F$20240602$20240828$20240625$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101442$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240903$$HP$US$US
240113152$24011315$2$F$$20240917$20240625$20240919$PER$$NVSC2024US122471$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
240113162$24011316$2$F$$20240730$20240625$20240731$PER$$NVSC2024US132299$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
240113183$24011318$3$F$20230101$20240723$20240625$20240802$EXP$$JP-BAYER-2024A091044$BAYER$$73$YR$E$M$Y$$$20240802$$MD$JP$JP
240113233$24011323$3$F$20240101$20240813$20240625$20240821$EXP$$JP-AMGEN-JPNSP2024120038$AMGEN$$$$E$M$Y$$$20240821$$MD$JP$JP
240113263$24011326$3$F$$20240919$20240625$20240924$PER$$NVSC2024US122550$NOVARTIS$$$$$F$Y$$$20240924$$HP$US$US
240113442$24011344$2$F$20120401$20240806$20240625$20240812$EXP$$DE-JNJFOC-20230409663$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240812$$HP$DE$DE
240113542$24011354$2$F$$20240923$20240625$20240924$PER$$NVSC2024US122641$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
240113583$24011358$3$F$$20240906$20240625$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101697$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240912$$HP$US$US
240113592$24011359$2$F$$20240813$20240625$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097978$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240821$$HP$US$US
240113652$24011365$2$F$20231010$20240711$20240625$20240716$EXP$$JP-DSJP-DSJ-2024-124706$DAIICHI$$79$YR$$F$Y$40$KG$20240716$$MD$JP$JP
240113662$24011366$2$F$20240524$20240719$20240625$20240724$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-127447$DAIICHI$$73$YR$$F$Y$44$KG$20240724$$MD$JP$JP
240113712$24011371$2$F$$20240920$20240625$20240923$PER$$NVSC2024US122643$NOVARTIS$$$$$F$Y$$$20240923$$HP$US$US
240113819$24011381$9$F$20240101$20240912$20240625$20240917$EXP$$CA-AstraZeneca-2024A142632$ASTRAZENECA$$73$YR$$F$Y$73.4$KG$20240917$$MD$CA$
240113822$24011382$2$F$$20240828$20240625$20240902$EXP$$FR-AstraZeneca-2024A144366$ASTRAZENECA$$$$$F$Y$58$KG$20240902$$CN$FR$
240113962$24011396$2$F$$20240920$20240625$20240923$PER$$NVSC2024US122304$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
240114012$24011401$2$F$$20240710$20240625$20240716$PER$$US-INCYTE CORPORATION-2024IN006576$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240114022$24011402$2$F$20240429$20240917$20240625$20240919$PER$$NVSC2024US122458$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
240114052$24011405$2$F$$20240826$20240625$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101423$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240829$$CN$US$US
240114062$24011406$2$F$20240611$20240625$20240625$20240701$EXP$$GB-ABBVIE-5788674$ABBVIE$$44$YR$$M$Y$$$20240701$$CN$GB$GB
240114072$24011407$2$F$20240522$20240705$20240625$20240906$EXP$$US-FARMAPROD-202406-2279$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240904$$CN$US$US
240114243$24011424$3$F$20230419$20240913$20240625$20240920$EXP$$CA-LUNDBECK-DKLU3061183$LUNDBECK$$$$$$Y$$$20240920$$CN$CA$CA
240114254$24011425$4$F$20240601$20240812$20240625$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101655$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240814$$CN$US$US
240114362$24011436$2$F$20240604$20240802$20240625$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202406015431$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240806$$CN$US$US
240114402$24011440$2$F$20240101$20240924$20240625$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101709$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240925$$CN$US$US
240114422$24011442$2$F$20240418$20240917$20240625$20240920$PER$$NVSC2024US122648$NOVARTIS$$$$$M$Y$$$20240920$$HP$US$US
240114445$24011444$5$F$$20240717$20240625$20240722$EXP$$DE-BIOMARINAP-DE-2024-158683$BIOMARIN$$$$$$Y$$$20240722$$HP$DE$DE
240114462$24011446$2$F$20240621$20240716$20240625$20240720$PER$$US-AMGEN-USASP2024124633$AMGEN$$$$$F$Y$$$20240720$$CN$US$US
240114522$24011452$2$F$$20240717$20240625$20240723$PER$$NVSC2024US123652$NOVARTIS$$$$$M$Y$$$20240723$$HP$US$US
240114632$24011463$2$F$20240531$20240808$20240625$20240814$EXP$$CA-JNJFOC-20240657327$JOHNSON AND JOHNSON$$15$YR$T$F$Y$47$KG$20240814$$HP$CA$CA
240114752$24011475$2$F$$20240628$20240625$20240705$PER$$US-ALXN-202406USA001060US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
240114762$24011476$2$F$$20240920$20240625$20240920$PER$$NVSC2024US122558$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
240114802$24011480$2$F$$20240718$20240625$20240725$EXP$$US-GSK-US2024075843$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$HP$US$US
240114812$24011481$2$F$$20240710$20240625$20240715$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266263$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240715$$CN$CA$CA
240114922$24011492$2$F$20240601$20240717$20240625$20240725$PER$$US-APELLIS-2024-APL-0000246$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
240114942$24011494$2$F$20240529$20240708$20240625$20240710$EXP$$US-TAKEDA-2024TUS053543$TAKEDA$$61$YR$$F$Y$$$20240710$$CN$US$US
240114982$24011498$2$F$$20240828$20240625$20240829$EXP$$NVSC2024US130458$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
240115002$24011500$2$F$20240624$20240624$20240625$20240704$PER$$US-AMGEN-USASP2024123958$AMGEN$$66$YR$E$F$Y$$$20240704$$CN$US$US
240115022$24011502$2$F$20240614$20240723$20240625$20240726$30DAY$$US-MYLANLABS-2024M1056920$MYLAN$$71$YR$$M$Y$$$20240726$$CN$US$US
240115042$24011504$2$F$$20240713$20240625$20240718$EXP$$US-SA-2023SA001162$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240718$$CN$US$US
240115072$24011507$2$F$20240816$20240820$20240625$20240828$EXP$$BR-TAKEDA-2024TUS061434$TAKEDA$$18$YR$$F$Y$$$20240828$$CN$BR$BR
240115083$24011508$3$F$$20240919$20240625$20240924$EXP$$CA-TAKEDA-2024TUS063050$TAKEDA$$$$$M$Y$$$20240924$$CN$CA$CA
240115112$24011511$2$F$20231208$20240619$20240625$20240829$EXP$$IT-Eisai-EC-2024-167859$EISAI$$60$YR$A$M$Y$$$20240829$$HP$IT$IT
240115132$24011513$2$F$$20240725$20240625$20240801$EXP$$NVSC2024CA129430$NOVARTIS$$60$YR$$F$Y$$$20240801$$CN$CA$CA
240115143$24011514$3$F$20240101$20240805$20240625$20240810$EXP$$US-SA-2024SA187213$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240810$$MD$US$US
240115303$24011530$3$F$$20240715$20240625$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101763$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240717$$CN$US$US
240115353$24011535$3$F$$20240911$20240625$20240920$EXP$$BR-TAKEDA-2023TUS102338$TAKEDA$$$$$M$Y$$$20240920$$CN$BR$BR
240115382$24011538$2$F$20240620$20240627$20240625$20240701$EXP$$GB-MYLANLABS-2024M1057214$MYLAN$$$$$M$Y$$$20240701$$HP$GB$GB
240115432$24011543$2$F$20240519$20240708$20240625$20240711$EXP$$US-TAKEDA-2024TUS062652$TAKEDA$$37$YR$$M$Y$$$20240711$$CN$US$US
240115442$24011544$2$F$20240501$20240703$20240625$20240709$EXP$$NL-MYLANLABS-2024M1056060$MYLAN$$$$$M$Y$$$20240709$$CN$NL$NL
240115483$24011548$3$F$20230101$20240704$20240625$20240710$EXP$$CO-VERTEX PHARMACEUTICALS-2024-010335$VERTEX$$11$YR$$F$Y$$$20240710$$MD$CO$CO
240115522$24011552$2$F$20240621$20240812$20240625$20240816$EXP$$CA-TAKEDA-2024TUS005854$TAKEDA$$20$YR$$M$Y$$$20240816$$MD$CA$CA
240115532$24011553$2$F$20240507$20240618$20240625$20240806$PER$$US-LUNDBECK-DKLU3078080$LUNDBECK$$$$$$Y$$$20240806$$CN$US$US
240115542$24011554$2$F$20240601$20240709$20240625$20240712$PER$$US-JNJFOC-20240663235$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240712$$CN$US$US
240115603$24011560$3$F$20240510$20240905$20240625$20240912$EXP$$JP-009507513-2406JPN002873J$MERCK$$34$YR$$F$Y$$$20240912$$HP$JP$JP
240115612$24011561$2$F$$20240816$20240625$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099641$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240822$$MD$US$US
240115632$24011563$2$F$$20240923$20240625$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100918$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240924$$HP$US$US
240115652$24011565$2$F$$20240923$20240625$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101556$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240925$$HP$US$US
240115702$24011570$2$F$20240620$20240906$20240625$20240909$EXP$$AR-SANDOZ INC.-SDZ2024AR060295$SANDOZ$$33$YR$$F$Y$$$20240909$$CN$AR$AR
240115793$24011579$3$F$20240617$20240718$20240625$20240730$30DAY$$US-JNJFOC-20240646880$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240730$$CN$US$US
240115802$24011580$2$F$20231219$20240821$20240625$20240821$EXP$$CA-PFIZER INC-202300452982$PFIZER$$76$YR$$M$Y$50$KG$20240821$$HP$CA$CA
240115812$24011581$2$F$$20240627$20240625$20240701$EXP$$US-PFIZER INC-PV202400082349$PFIZER$$65$YR$$M$Y$78$KG$20240701$$MD$US$US
240115872$24011587$2$F$20240603$20240626$20240625$20240709$EXP$$US-APELLIS-2024-APL-0000249$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240709$$MD$US$US
240115932$24011593$2$F$20240601$20240729$20240625$20240801$EXP$$US-ALXN-202406USA001077US$ALEXION PHARMACEUTICALS$$72$YR$$M$Y$$$20240801$$CN$US$US
240115992$24011599$2$F$20240614$20240827$20240625$20240903$EXP$$US-MYLANLABS-2024M1057436$MYLAN$$15$YR$$F$Y$$$20240903$$HP$US$US
240116132$24011613$2$F$$20240711$20240625$20240717$PER$$US-BIOGEN-2024BI01270549$BIOGEN$$$$$$Y$$$20240717$$CN$US$US
240116232$24011623$2$F$$20240912$20240625$20240913$EXP$$US-PFIZER INC-PV202400083305$PFIZER$$67$YR$$F$Y$$$20240913$$CN$US$US
240116243$24011624$3$F$$20240806$20240625$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101898$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240808$$CN$US$US
240116253$24011625$3$F$20240501$20240614$20240625$20240703$PER$$DE-Eisai-EC-2024-167306$EISAI$$64$YR$$F$Y$$$20240703$$PH$DE$DE
240116293$24011629$3$F$$20240625$20240625$20240701$EXP$$CA-LUNDBECK-DKLU4000801$LUNDBECK$$$$$$Y$$$20240701$$CN$CA$CA
240116382$24011638$2$F$$20240720$20240625$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100662$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240723$$CN$US$US
240116402$24011640$2$F$$20240625$20240625$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100896$BRISTOL MYERS SQUIBB$Husain-Krautter S, Ellison JM. Concurrent treatment with SRIs and anticoagulants: minimizing the hemorrhagic hazard. Psychiatric Times. 2022 Nov 23.$67$YR$E$M$Y$$$20240703$$MD$US$US
240116444$24011644$4$F$$20240731$20240625$20240808$EXP$$US-ALXN-202406USA001112US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
240116453$24011645$3$F$$20240729$20240625$20240801$PER$$US-ALXN-202406USA001071US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240116462$24011646$2$F$$20240626$20240625$20240711$EXP$IN-MLMSERVICE-20240612-PI096128-00275-1$IN-LUNDBECK-DKLU4000799$LUNDBECK$Bedi GN, Acharya S, Kumar S, Mapari SA, Sawant R.. Central Pontine Myelinolysis: A Rare and Life-Threatening Adverse Effect of Clobazam and Quetiapine. .. 2024;16(5). Cureus. 2024;16(5):UNK. doi:10.7759/cureus.60007$$$$$Y$$$20240711$$MD$IN$IN
2401165511$24011655$11$F$20240701$20240904$20240625$20240912$EXP$$US-DSJP-DSU-2024-127884$DAIICHI$$31$YR$$M$Y$$$20240912$$CN$US$US
240116565$24011656$5$F$$20240820$20240625$20240826$EXP$$PL-MYLANLABS-2024M1056324$MYLAN$Woro? J, Siwek M.. The use of sertraline and perazine as a cause of pneumonia in a patient suffering from chronic obstructive pulmonary disease. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2024;98(3):19-21$67$YR$$F$Y$$$20240826$$MD$PL$PL
240116582$24011658$2$F$20220501$20240710$20240625$20240716$EXP$$CZ-MYLANLABS-2024M1056083$MYLAN$$72$YR$$M$Y$$$20240716$$MD$CZ$CZ
240116622$24011662$2$F$20240423$20240628$20240625$20240709$EXP$$AU-INCYTE CORPORATION-2024IN006616$INCYTE$$$$$$Y$$$20240709$$MD$AU$AU
240116783$24011678$3$F$20240301$20240729$20240625$20240805$PER$$US-JNJFOC-20240602563$JOHNSON AND JOHNSON$$95$YR$E$M$Y$$$20240804$$CN$US$US
240116812$24011681$2$F$$20240729$20240625$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101792$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240801$$CN$US$US
240117133$24011713$3$F$$20240719$20240625$20240812$30DAY$$ES-JNJFOC-20240624601$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$PH$ES$ES
240117152$24011715$2$F$20240501$20240710$20240625$20240718$EXP$$BE-BEH-2024173990$CSL BEHRING$$49$YR$A$M$Y$80$KG$20240718$$HP$BE$BE
240117252$24011725$2$F$$20240628$20240625$20240712$PER$$US-Calliditas-2024CAL01124$CALLIDITAS THERAPEUTICS$$70$YR$E$F$Y$69.3$KG$20240712$$CN$US$US
240117263$24011726$3$F$$20240621$20240625$20240813$PER$$US-LUNDBECK-DKLU4000059$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
240117272$24011727$2$F$$20240715$20240625$20240718$PER$$US-AMGEN-USASP2024124644$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
240117302$24011730$2$F$$20240710$20240625$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101613$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$66.68$KG$20240715$$CN$US$US
240117332$24011733$2$F$$20240915$20240625$20240923$EXP$$NVSC2024US131500$NOVARTIS$$$$$$Y$$$20240923$$CN$US$US
240117362$24011736$2$F$$20240705$20240625$20240712$PER$$US-INCYTE CORPORATION-2024IN006507$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240117412$24011741$2$F$$20240925$20240625$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101696$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240925$$CN$US$US
240117452$24011745$2$F$$20240726$20240625$20240726$PER$$US-PFIZER INC-202400200064$PFIZER$$84$YR$$F$Y$63.5$KG$20240726$$CN$US$US
240117602$24011760$2$F$20240101$20240806$20240625$20240808$EXP$$JP-PFIZER INC-PV202400081736$PFIZER$$77$YR$$F$Y$51.6$KG$20240808$$PH$JP$JP
240117632$24011763$2$F$20090101$20240802$20240625$20240807$EXP$$BR-PFIZER INC-202400195005$PFIZER$$86$YR$$F$Y$$$20240807$$CN$BR$BR
240117692$24011769$2$F$$20240701$20240625$20240705$EXP$$IT-PURDUE-USA-2024-0310392$PURDUE$Rizzo G, Bussolin L, Genitori L. Zicca A, Messeri A, Lenge M. Giordano F.et.al. The use of opioids in children receiving intrathecal baclofen therapy. Child^s Nervous System. 2019;35:1213-1218$13$YR$$F$Y$30.7$KG$20240705$$HP$IT$IT
240117793$24011779$3$F$$20240813$20240625$20240816$PER$$NVSC2024US132066$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
240118002$24011800$2$F$20240501$20240729$20240625$20240806$EXP$$US-AstraZeneca-2024A141151$ASTRAZENECA$$70$YR$$F$Y$$$20240806$$HP$US$
240118312$24011831$2$F$20240519$20240708$20240625$20240717$30DAY$$US-GSK-US2024078594$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240717$$CN$US$US
240118523$24011852$3$F$20240129$20240726$20240625$20240729$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035949$BOEHRINGER INGELHEIM$$57$YR$A$M$Y$$$20240729$$MD$DE$DE
240118544$24011854$4$F$20240618$20240905$20240625$20240919$EXP$$CA-HLS-202401605$HLS THERAPEUTICS$$27$YR$A$M$Y$$$20240919$$MD$CA$CA
240118562$24011856$2$F$$20240820$20240625$20240827$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010607$UNITED THERAPEUTICS$$$$$M$Y$$$20240827$$$US$US
240118582$24011858$2$F$20240607$20240701$20240625$20240709$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018625$UNITED THERAPEUTICS$$61$YR$$F$Y$138.78$KG$20240709$$$US$US
240118602$24011860$2$F$20240617$20240719$20240625$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018740$UNITED THERAPEUTICS$$83$YR$$F$Y$73.923$KG$20240725$$$US$US
240118622$24011862$2$F$20240101$20240625$20240625$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017972$UNITED THERAPEUTICS$$$$$M$Y$117.91$KG$20240703$$$US$US
240118635$24011863$5$F$20240101$20240819$20240625$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018122$UNITED THERAPEUTICS$$$$$F$Y$60.771$KG$20240828$$$US$US
240118643$24011864$3$F$20240612$20240730$20240625$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018548$UNITED THERAPEUTICS$$73$YR$$F$Y$78.912$KG$20240807$$$US$US
240118683$24011868$3$F$20240101$20240801$20240625$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-010922$UNITED THERAPEUTICS$$$$$F$Y$55.329$KG$20240806$$$US$US
240118692$24011869$2$F$$20240702$20240625$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-005834$UNITED THERAPEUTICS$$$$$F$Y$104.31$KG$20240704$$$US$US
240118722$24011872$2$F$20240401$20240717$20240625$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-010865$UNITED THERAPEUTICS$$61$YR$$M$Y$102.04$KG$20240725$$$US$US
240118742$24011874$2$F$20240101$20240627$20240625$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-009819$UNITED THERAPEUTICS$$$$$F$Y$60.317$KG$20240703$$$US$US
240118755$24011875$5$F$$20240920$20240625$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-018988$UNITED THERAPEUTICS$$$$$F$Y$65.76$KG$20240927$$$US$US
240118763$24011876$3$F$$20240829$20240625$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-018644$UNITED THERAPEUTICS$$$$$F$Y$65.76$KG$20240906$$$US$US
240118796$24011879$6$F$20240101$20240807$20240625$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-013967$UNITED THERAPEUTICS$$$$$M$Y$92.063$KG$20240814$$$US$US
240118813$24011881$3$F$20240622$20240702$20240625$20240714$PER$$US-AMGEN-USASP2024124102$AMGEN$$71$YR$E$M$Y$$$20240714$$CN$US$US
240118855$24011885$5$F$20240617$20240807$20240625$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-010202$UNITED THERAPEUTICS$$49$YR$$F$Y$81.633$KG$20240816$$$US$US
240118872$24011887$2$F$20240501$20240916$20240625$20240925$PER$$US-BAUSCH-BL-2024-009481$BAUSCH AND LOMB$$37$YR$$M$Y$$$20240925$$CN$US$US
240118922$24011892$2$F$$20240729$20240625$20240801$PER$$US-ALXN-202406USA001072US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
240118972$24011897$2$F$$20240828$20240625$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA059882$SANDOZ$$34$YR$$F$Y$$$20240830$$HP$CA$CA
240119052$24011905$2$F$$20240619$20240625$20240722$EXP$$CA-009507513-2406CAN007265$MERCK$$$$$M$Y$$$20240722$$MD$CA$CA
240119102$24011910$2$F$$20240613$20240625$20240709$30DAY$$RO-SA-2024SA131795$SANOFI AVENTIS$$$$$$Y$$$20240709$$HP$RO$RO
240119142$24011914$2$F$20240624$20240705$20240625$20240709$PER$$US-JNJFOC-20240663938$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240709$$HP$US$US
240119152$24011915$2$F$$20240827$20240625$20240829$EXP$$SE-SA-2024SA180812$SANOFI AVENTIS$Boberg E, Kimiaei A, Karlstr?m C, Ljungqvist M, ?gren A, Bruzelius M.. Iatrogenic hemorrhage and extensive venous thromboembolism during iTTP treatment with caplacizumab-A case report. eJHaem. 2024;unknown:1-4$30$YR$A$F$Y$$$20240829$$HP$SE$SE
240119162$24011916$2$F$$20240912$20240625$20240912$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036082$BOEHRINGER INGELHEIM$$$$$$Y$$$20240912$$CN$US$US
240119222$24011922$2$F$$20240715$20240625$20240729$EXP$$CA-HLS-202401602$HLS THERAPEUTICS$$$$A$M$Y$$$20240729$$PH$CA$CA
240119233$24011923$3$F$$20240715$20240625$20240721$EXP$$CA-SANDOZ INC.-NVSC2021CA315859$SANDOZ$$44$YR$$F$Y$97$KG$20240721$$HP$CA$CA
240119382$24011938$2$F$20240601$20240621$20240625$20240702$PER$$US-SA-2024SA179726$SANOFI AVENTIS$$15$YR$T$F$Y$56.4$KG$20240702$$MD$US$US
240119393$24011939$3$F$20240101$20240829$20240625$20240924$PER$$US-SA-2024SA180099$SANOFI AVENTIS$$47$YR$A$F$Y$156$KG$20240924$$MD$US$US
240119562$24011956$2$F$$20240701$20240625$20240710$PER$$US-SA-2024SA179638$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240710$$CN$US$US
240119612$24011961$2$F$20240101$20240723$20240625$20240801$PER$$US-SA-2024SA179964$SANOFI AVENTIS$$13$YR$T$F$Y$88.45$KG$20240801$$MD$US$US
240119702$24011970$2$F$$20240903$20240625$20240915$PER$$US-SA-2024SA180336$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240915$$MD$US$US
240119742$24011974$2$F$$20240621$20240625$20240705$PER$$US-SA-2024SA179256$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240705$$HP$US$US
240119832$24011983$2$F$20240601$20240627$20240625$20240707$PER$$US-SA-2024SA179112$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240707$$MD$US$US
240119882$24011988$2$F$$20240708$20240625$20240717$EXP$$PL-TAKEDA-2024TUS062842$TAKEDA$$66$YR$$F$Y$$$20240717$$MD$PL$PL
240119952$24011995$2$F$$20240717$20240625$20240726$PER$$US-SA-2024SA183122$SANOFI AVENTIS$$$$T$F$Y$37.64$KG$20240726$$MD$US$US
240120012$24012001$2$F$20240603$20240904$20240625$20240919$PER$$US-SA-2024SA182587$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240919$$MD$US$US
240120032$24012003$2$F$$20240701$20240625$20240710$PER$$US-SA-2024SA181383$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240710$$CN$US$US
240120092$24012009$2$F$20240101$20240806$20240625$20240816$PER$$US-SA-2024SA185151$SANOFI AVENTIS$$36$YR$A$M$Y$70.3$KG$20240816$$MD$US$US
240120132$24012013$2$F$20240601$20240621$20240625$20240701$PER$$US-SA-2024SA184525$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240701$$MD$US$US
240120173$24012017$3$F$20240101$20240814$20240625$20240828$PER$$US-SA-2024SA183260$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240828$$CN$US$US
240120232$24012023$2$F$$20240620$20240625$20240702$PER$$US-SA-2024SA184377$SANOFI AVENTIS$$13$YR$T$M$Y$46$KG$20240702$$MD$US$US
240120352$24012035$2$F$20240101$20240810$20240625$20240819$PER$$US-SA-2024SA185664$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240819$$MD$US$US
240120392$24012039$2$F$$20240716$20240625$20240722$PER$$US-SA-2024SA185143$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240722$$CN$US$US
240120603$24012060$3$F$$20240911$20240625$20240917$30DAY$$CL-PFIZER INC-PV202400082055$PFIZER$$13$YR$$M$Y$$$20240917$$CN$CL$CL
240120622$24012062$2$F$20240101$20240912$20240625$20240920$PER$$US-SA-2024SA185756$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240920$$MD$US$US
240120732$24012073$2$F$20240101$20240725$20240625$20240805$PER$$US-SA-2024SA095618$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
240120792$24012079$2$F$20240101$20240903$20240625$20240924$PER$$US-SA-2024SA184921$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240925$$CN$US$US
240120812$24012081$2$F$$20240708$20240625$20240717$PER$$US-SA-2024SA184859$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240717$$CN$US$US
240120893$24012089$3$F$20240217$20240729$20240625$20240802$EXP$$IT-009507513-2406ITA007302$MERCK$$72$YR$$M$Y$66$KG$20240802$$MD$IT$IT
240120934$24012093$4$F$20240101$20240802$20240625$20240813$PER$$US-SA-2023SA340230$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240814$$MD$US$US
240120942$24012094$2$F$$20240723$20240625$20240801$PER$$US-SA-2024SA183550$SANOFI AVENTIS$$9$YR$C$M$Y$29$KG$20240801$$MD$US$US
240120982$24012098$2$F$$20240703$20240625$20240712$PER$$US-SA-2024SA183567$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240712$$CN$US$US
240121052$24012105$2$F$20240501$20240730$20240625$20240807$PER$$US-SA-2024SA184393$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240807$$MD$US$US
240121153$24012115$3$F$20240101$20240910$20240625$20240916$PER$$US-SA-2024SA185256$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240916$$MD$US$US
240121262$24012126$2$F$20240619$20240828$20240625$20240904$PER$$US-SA-2024SA185787$SANOFI AVENTIS$$6$YR$C$F$Y$20.41$KG$20240904$$MD$US$US
240121292$24012129$2$F$$20240917$20240625$20240923$PER$$US-SA-2024SA185757$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240923$$MD$US$US
240121352$24012135$2$F$$20240715$20240625$20240722$PER$$US-SA-2024SA183943$SANOFI AVENTIS$$$$$F$Y$$$20240722$$CN$US$US
240121382$24012138$2$F$20240101$20240711$20240625$20240723$PER$$US-SA-2024SA172411$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240723$$MD$US$US
240121393$24012139$3$F$20240101$20240801$20240625$20240809$PER$$US-SA-2024SA184356$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240809$$MD$US$US
240121412$24012141$2$F$$20240828$20240625$20240919$PER$$US-SA-2024SA184573$SANOFI AVENTIS$$63$YR$A$M$Y$76.2$KG$20240919$$MD$US$US
240121462$24012146$2$F$$20240909$20240625$20240930$PER$$US-SA-2024SA185407$SANOFI AVENTIS$$$$A$M$Y$$$20240930$$MD$US$US
240121493$24012149$3$F$20240101$20240821$20240625$20240911$PER$$US-SA-2024SA185734$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240911$$MD$US$US
240121522$24012152$2$F$$20240903$20240625$20240913$PER$$US-SA-2024SA185358$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240913$$MD$US$US
240121552$24012155$2$F$20240101$20240701$20240625$20240710$PER$$US-SA-2024SA185766$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240710$$MD$US$US
240121602$24012160$2$F$$20240715$20240625$20240722$PER$$US-SA-2024SA150715$SANOFI AVENTIS$$$$A$F$Y$$$20240720$$HP$US$US
240121672$24012167$2$F$20240601$20240820$20240625$20240829$PER$$US-SA-2024SA184333$SANOFI AVENTIS$$53$YR$A$M$Y$82.1$KG$20240829$$MD$US$US
240121722$24012172$2$F$20240601$20240829$20240625$20240913$PER$$US-SA-2024SA184288$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240913$$MD$US$US
240121802$24012180$2$F$$20240807$20240625$20240815$PER$$US-SA-2024SA185932$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240815$$CN$US$US
240121822$24012182$2$F$20240101$20240724$20240625$20240802$PER$$US-SA-2024SA186752$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240802$$HP$US$US
240121832$24012183$2$F$$20240703$20240625$20240712$PER$$US-SA-2024SA186809$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240712$$CN$US$US
240121853$24012185$3$F$20090101$20240624$20240625$20240703$PER$$US-SA-2024SA185947$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240703$$HP$US$US
240121872$24012187$2$F$20240601$20240619$20240625$20240701$PER$$US-SA-2024SA182542$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240701$$MD$US$US
240121982$24012198$2$F$20240618$20240809$20240625$20240816$EXP$$BR-SANDOZ INC.-SDZ2024BR059100$SANDOZ$$$$$F$Y$$$20240816$$CN$BR$BR
240121992$24012199$2$F$$20240729$20240625$20240801$PER$$US-ALXN-202406USA001073US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
240122112$24012211$2$F$$20240805$20240625$20240813$EXP$$US-TAKEDA-2024TUS024267$TAKEDA$$$$$F$Y$$$20240813$$MD$US$US
240122202$24012220$2$F$$20240710$20240625$20240710$EXP$IT-EMA-DD-20240621-7482659-111615$IT-SANDOZ INC.-SDZ2024IT060430$SANDOZ$$64$YR$$M$Y$$$20240710$$MD$IT$IT
240122222$24012222$2$F$$20240625$20240625$20240703$EXP$$CA-SANDOZ INC.-NVSC2022CA013104$SANDOZ$$63$YR$$F$Y$$$20240703$$HP$CA$CA
240122302$24012230$2$F$$20240902$20240625$20240903$EXP$$NVSC2024FR130669$NOVARTIS$$$$$$Y$$$20240903$$MD$FR$FR
240122312$24012231$2$F$$20240719$20240625$20240723$PER$$US-AMGEN-USASP2024124594$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
240122382$24012238$2$F$20211225$20240820$20240625$20240822$EXP$$AU-SANDOZ INC.-SDZ2024AU059340$SANDOZ$$$$$M$Y$$$20240822$$HP$AU$AU
240122405$24012240$5$F$20231212$20240801$20240625$20240805$EXP$$DE-SANDOZ INC.-SDZ2024DE049584$SANDOZ$$$$E$F$Y$82.4$KG$20240805$$HP$DE$DE
240122422$24012242$2$F$$20240730$20240625$20240801$PER$$US-ALXN-202406USA001171US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240122432$24012243$2$F$20240220$20240624$20240625$20240709$PER$$US-APELLIS-APL-2024-003593$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
240122462$24012246$2$F$20190101$20240627$20240625$20240708$PER$$US-ALKERMES INC.-ALK-2024-001606$ALKERMES$$$$$F$Y$56.689$KG$20240708$$CN$US$US
240122472$24012247$2$F$20240525$20240626$20240625$20240705$EXP$$US-ZENPEP LLC-2024AIMT00971$AIMMUNE$$$$$$Y$$$20240705$$MD$US$US
240122502$24012250$2$F$$20240730$20240625$20240801$PER$$US-ALXN-202406USA001222US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
240122513$24012251$3$F$$20240730$20240625$20240801$PER$$US-ALXN-202406USA001224US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240122523$24012252$3$F$20240501$20240730$20240625$20240801$PER$$US-ALXN-202406USA001223US$ALEXION PHARMACEUTICALS$$58$YR$$M$Y$163$KG$20240801$$CN$US$US
240122552$24012255$2$F$20210101$20240802$20240625$20240808$PER$$US-ABBVIE-5807830$ABBVIE$$$$$F$Y$58.059$KG$20240808$$CN$US$US
240122732$24012273$2$F$$20240719$20240625$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099220$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240729$$PH$JP$JP
240122893$24012289$3$F$$20240711$20240625$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-100669$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240717$$MD$JP$JP
240122943$24012294$3$F$20240601$20240826$20240625$20240904$EXP$$JP-009507513-2406JPN002869J$MERCK$$68$YR$$M$Y$$$20240904$$PH$JP$JP
240122966$24012296$6$F$20240527$20240620$20240625$20240709$EXP$$US-ROCHE-10000007826$ROCHE$$80$YR$E$F$Y$52.16$KG$20240701$$CN$US$US
240122972$24012297$2$F$20240607$20240913$20240625$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099946$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$MD$JP$JP
240122993$24012299$3$F$$20240919$20240625$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-076620$BRISTOL MYERS SQUIBB$Sakai H, Hori M, Kuwabara S. A case of psoriasis vulgaris complicated by atopic dermatitis who developed acne and skin abscess after starting treatment with deucravacitinib. The 39th Annual Meeting of the Japanese Society for Psoriasis Research (Programs and Abstracts). 2024;202.$26$YR$A$M$Y$$$20240927$$MD$JP$JP
240123002$24012300$2$F$20240601$20240722$20240625$20240729$EXP$$NVSJ2024JP007496$NOVARTIS$$$$$$Y$$$20240729$$MD$JP$JP
240123052$24012305$2$F$$20240830$20240625$20240903$EXP$$NVSC2024CA130202$NOVARTIS$$38$YR$$F$Y$$$20240903$$MD$CA$CA
240123062$24012306$2$F$$20240626$20240625$20240703$EXP$$JP-GSK-JP2024076393$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$HP$JP$JP
240123073$24012307$3$F$20240101$20240625$20240625$20240701$EXP$$ES-ABBVIE-5808449$ABBVIE$$$$$F$Y$63$KG$20240701$$CN$ES$ES
240123154$24012315$4$F$20240316$20240905$20240625$20240908$EXP$$NVSJ2024JP007528$NOVARTIS$$61$YR$$M$Y$66$KG$20240909$$MD$JP$JP
240123192$24012319$2$F$20240411$20240925$20240625$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101785$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240925$$CN$US$US
240123273$24012327$3$F$$20240924$20240625$20240924$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-101182$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240924$$MD$DE$DE
240123282$24012328$2$F$20240601$20240626$20240625$20240701$EXP$$US-PFIZER INC-202400200038$PFIZER$$5$MON$$M$Y$$$20240701$$MD$US$US
240123292$24012329$2$F$20240606$20240802$20240625$20240807$EXP$$DE-PFIZER INC-202400199776$PFIZER$$38$YR$$M$Y$73$KG$20240807$$HP$DE$DE
240123313$24012331$3$F$20240601$20240724$20240625$20240731$EXP$$US-ABBVIE-5802369$ABBVIE$$77$YR$$M$Y$85.275$KG$20240731$$CN$US$US
240123332$24012333$2$F$$20240702$20240625$20240707$EXP$$US-PFIZER INC-202400200125$PFIZER$$60$YR$$M$Y$$$20240707$$MD$US$US
240123343$24012334$3$F$20240101$20240710$20240625$20240715$EXP$$CN-PFIZER INC-PV202400081352$PFIZER$$74$YR$$M$Y$$$20240715$$CN$CN$CN
240123405$24012340$5$F$20240606$20240717$20240625$20240807$30DAY$$US-JNJFOC-20240619002$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240807$$HP$US$US
240123424$24012342$4$F$$20240709$20240625$20240731$PER$$US-JNJFOC-20240631803$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240731$$CN$US$US
240123612$24012361$2$F$20240601$20240617$20240625$20240801$EXP$$IL-ABBVIE-5814426$ABBVIE$$29$YR$$M$Y$$$20240801$$HP$IL$IL
240123633$24012363$3$F$$20240911$20240625$20240914$EXP$$US-ABBVIE-5730651$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
240123642$24012364$2$F$$20240716$20240625$20240719$30DAY$$IL-JNJFOC-20240608692$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$PH$IL$IL
240123702$24012370$2$F$$20240719$20240625$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100175$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240723$$CN$US$US
240123762$24012376$2$F$$20240809$20240625$20240819$EXP$$NVSJ2024JP007533$NOVARTIS$$88$YR$$F$Y$$$20240820$$MD$JP$JP
240123792$24012379$2$F$20240621$20240628$20240625$20240703$PER$$US-AMGEN-USASP2024123912$AMGEN$$80$YR$E$F$Y$86.712$KG$20240703$$HP$US$US
240123862$24012386$2$F$20240101$20240702$20240625$20240710$PER$$US-SA-2024SA184043$SANOFI AVENTIS$$34$YR$A$M$Y$65$KG$20240710$$CN$US$US
240123893$24012389$3$F$$20240819$20240625$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009529$JAZZ$$$$$F$Y$$$20240823$$CN$US$US
240123903$24012390$3$F$$20240806$20240625$20240807$PER$$US-JNJFOC-20240660272$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240807$$CN$US$US
240123932$24012393$2$F$$20240627$20240625$20240702$EXP$PS-MLMSERVICE-20240613-PI097278-00033-2$PS-SA-2024SA186588$SANOFI AVENTIS$Maqboul I, Daraghmeh L, Eleiwi MR, Qasrawi H, Akkawi M, AwadGhanem A.. Atraumatic splenic rupture after administering aspirin, clopidogrel, and heparin to a patient with unstable angina: A case report.. SAGE open medical case reports.. 2024;12:1-5$49$YR$A$M$Y$$$20240702$$MD$PS$PS
240123942$24012394$2$F$$20240730$20240625$20240805$PER$$US-BIOGEN-2024BI01270638$BIOGEN$$$$$M$Y$$$20240805$$MD$US$US
240123972$24012397$2$F$20240101$20240703$20240625$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100547$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$65.77$KG$20240704$$CN$US$US
240124022$24012402$2$F$20240601$20240925$20240625$20240930$EXP$$US-Taiho Oncology Inc-2024-006210$TAIHO ONCOLOGY INC$$69$YR$E$M$Y$$$20240930$$CN$US$US
240124154$24012415$4$F$$20240905$20240625$20240912$EXP$$NVSC2024US129917$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
240124163$24012416$3$F$$20240819$20240625$20240822$EXP$$NVSJ2024JP007535$NOVARTIS$$$$$F$Y$78.5$KG$20240823$$MD$JP$JP
240124184$24012418$4$F$$20240725$20240625$20240801$EXP$$GB-JNJFOC-20240640618$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240802$$CN$GB$GB
240124192$24012419$2$F$$20240715$20240625$20240724$30DAY$$CA-JNJFOC-20240660604$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$PH$CA$CA
240124213$24012421$3$F$20240101$20240715$20240625$20240717$PER$$US-AMGEN-USASP2024123961$AMGEN$$75$YR$E$F$Y$$$20240716$$CN$US$US
240124252$24012425$2$F$$20240724$20240625$20240725$PER$$NVSC2024US132401$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
240124292$24012429$2$F$$20240625$20240625$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406016662$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240702$$CN$US$US
240124333$24012433$3$F$20240101$20240718$20240625$20240723$EXP$$ES-ABBVIE-5811871$ABBVIE$$$$$F$Y$$$20240723$$CN$ES$ES
240124394$24012439$4$F$20240614$20240712$20240625$20240722$EXP$$BR-CELLTRION INC.-2024BR015079$CELLTRION$$$$$$Y$$$20240722$$CN$BR$BR
240124422$24012442$2$F$20240601$20240703$20240625$20240710$EXP$$DE-GSK-DE2024EME077575$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$DE$DE
240124432$24012443$2$F$$20240827$20240625$20240830$EXP$$US-ABBVIE-5808561$ABBVIE$$$$$M$Y$93.89$KG$20240830$$CN$US$US
240124492$24012449$2$F$$20240729$20240625$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100124$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240801$$CN$US$US
240124543$24012454$3$F$20230101$20240701$20240625$20240708$EXP$$ES-SANDOZ INC.-SDZ2024ES060438$SANDOZ$$68$YR$$F$Y$$$20240708$$HP$ES$ES
240124622$24012462$2$F$$20240923$20240625$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101379$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240924$$CN$US$US
240124683$24012468$3$F$$20240731$20240625$20240805$EXP$$IT-ALXN-202406EEA001126IT$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$MD$IT$IT
240124742$24012474$2$F$20240201$20240719$20240625$20240724$EXP$$CL-JNJFOC-20240654609$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240724$$CN$CL$CL
240124892$24012489$2$F$$20240823$20240626$20240827$EXP$$NVSC2024US130013$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
240124902$24012490$2$F$20240621$20240703$20240626$20240708$EXP$$NVSC2024US129378$NOVARTIS$$53$YR$$F$Y$$$20240709$$CN$US$US
240124972$24012497$2$F$$20240625$20240626$20240701$PER$$US-LEO Pharma-371422$LEO PHARM$$79$YR$$M$Y$$$20240701$$CN$US$US
240125072$24012507$2$F$20240620$20240819$20240626$20240822$PER$$US-AMGEN-USASP2024123790$AMGEN$$70$YR$E$F$Y$$$20240821$$CN$US$US
240125113$24012511$3$F$20240101$20240724$20240626$20240729$PER$$US-ABBVIE-5814003$ABBVIE$$$$$F$Y$44$KG$20240729$$CN$US$US
240125202$24012520$2$F$$20240626$20240626$20240701$PER$$US-JNJFOC-20240650985$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240701$$HP$US$US
240125232$24012523$2$F$20160511$20240626$20240626$20240702$EXP$$JP-JNJFOC-20230765240$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240702$$MD$JP$JP
240125262$24012526$2$F$$20240710$20240626$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009730$JAZZ$$30$YR$$F$Y$$$20240716$$CN$US$US
240125272$24012527$2$F$20240606$20240621$20240626$20240703$EXP$$US-ABBVIE-5812857$ABBVIE$$72$YR$$F$Y$$$20240703$$CN$US$US
240125302$24012530$2$F$20240607$20240621$20240626$20240703$PER$$US-AMGEN-USASP2024123818$AMGEN$$80$YR$E$F$Y$$$20240703$$PH$US$US
240125334$24012533$4$F$$20240829$20240626$20240907$PER$$US-BIOGEN-2024BI01270751$BIOGEN$$$$$M$Y$$$20240907$$CN$US$US
240125342$24012534$2$F$$20240702$20240626$20240704$PER$$US-BIOGEN-2024BI01248058$BIOGEN$$$$$M$Y$$$20240704$$MD$US$US
240125354$24012535$4$F$20240613$20240903$20240626$20240912$EXP$$ZA-CELLTRION INC.-2024ZA015205$CELLTRION$$$$$$Y$$$20240912$$CN$ZA$ZA
240125372$24012537$2$F$20170301$20240628$20240626$20240708$EXP$$FR-CELLTRION INC.-2024FR015087$CELLTRION$$$$$$Y$$$20240708$$MD$FR$FR
240125392$24012539$2$F$$20240924$20240626$20240924$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-087804$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240924$$MD$IT$IT
240125452$24012545$2$F$20220212$20240830$20240626$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009613$JAZZ$$62$YR$$F$Y$$$20240902$$HP$US$US
240125512$24012551$2$F$20240601$20240715$20240626$20240717$EXP$$US-ABBVIE-5811354$ABBVIE$$51$YR$$F$Y$$$20240717$$CN$US$US
240125562$24012556$2$F$$20240618$20240626$20240809$EXP$$NVSC2024CA083529$NOVARTIS$$64$YR$$F$Y$$$20240809$$CN$CA$CA
240125592$24012559$2$F$$20240710$20240626$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009733$JAZZ$$28$YR$$F$Y$54$KG$20240716$$CN$US$US
240125652$24012565$2$F$$20240708$20240626$20240712$EXP$$IT-STERISCIENCE B.V.-2024-ST-000847$Steriscience PTE$Rubino R, Trizzino M, Pipito L, Sucato G, Santoro M, Maugeri R, et al.. A difficult case of ventriculitis in a 40-year-old woman with acute myeloid leukemia.. Antibiotics. 2024;13(5):432$40$YR$$F$Y$$$20240712$$MD$IT$IT
240125662$24012566$2$F$20240601$20240723$20240626$20240731$PER$$US-SA-2024SA185687$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240731$$MD$US$US
240125722$24012572$2$F$20240101$20240703$20240626$20240708$EXP$$GB-ABBVIE-5814305$ABBVIE$$$$A$F$Y$$$20240708$$CN$GB$GB
240125822$24012582$2$F$$20240820$20240626$20240909$PER$$CA-TOLMAR, INC.-24CA049829$TOLMAR$$$$$M$Y$$$20240906$$CN$CA$CA
240125842$24012584$2$F$20240601$20240822$20240626$20240910$PER$$CA-TOLMAR, INC.-24CA050003$TOLMAR$$85$YR$$M$Y$$$20240909$$CN$CA$CA
240125882$24012588$2$F$20240605$20240828$20240626$20240918$PER$$CA-TOLMAR, INC.-24CA050025$TOLMAR$$72$YR$$M$Y$$$20240918$$CN$CA$CA
240125922$24012592$2$F$20240101$20240904$20240626$20240924$PER$$CA-TOLMAR, INC.-24CA050050$TOLMAR$$$$$M$Y$$$20240924$$CN$CA$CA
240125952$24012595$2$F$20240606$20240827$20240626$20240916$PER$$CA-TOLMAR, INC.-24CA050063$TOLMAR$$65$YR$$M$Y$$$20240916$$CN$CA$CA
240126062$24012606$2$F$$20240625$20240626$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091317$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
240126072$24012607$2$F$20240601$20240715$20240626$20240723$30DAY$$CA-JNJFOC-20240629820$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240723$$HP$CA$CA
240126152$24012615$2$F$$20240730$20240626$20240801$PER$$NVSC2024US132645$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
240126172$24012617$2$F$$20240712$20240626$20240717$EXP$$NVSJ2024JP007518$NOVARTIS$$51$YR$$M$Y$$$20240717$$MD$JP$JP
240126254$24012625$4$F$20240618$20240731$20240626$20240805$PER$$US-JNJFOC-20240647267$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240805$$CN$US$US
240126282$24012628$2$F$$20240911$20240626$20240917$EXP$$JP-GSK-JP2024JPN075974$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$JP$JP
240126342$24012634$2$F$20240501$20240807$20240626$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002647$ACADIA PHARMACEUTICALS$$64$YR$$F$Y$$$20240829$$CN$US$US
240126392$24012639$2$F$20240615$20240814$20240626$20240820$EXP$$CA-TAKEDA-2024TUS063203$TAKEDA$$59$YR$$F$Y$$$20240820$$MD$CA$CA
240126412$24012641$2$F$20240624$20240705$20240626$20240709$PER$$US-JNJFOC-20240665967$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$HP$US$US
240126502$24012650$2$F$$20240618$20240626$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202406014871$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240710$$CN$US$US
240126522$24012652$2$F$$20240709$20240626$20240716$EXP$$US-TAKEDA-2024TUS060850$TAKEDA$$$$$F$Y$$$20240716$$HP$US$US
240126652$24012665$2$F$$20240714$20240626$20240724$30DAY$$US-GSK-US2024075856$GLAXOSMITHKLINE$$$$$F$Y$$$20240724$$CN$US$US
240126783$24012678$3$F$20240601$20240719$20240626$20240728$PER$$US-AMGEN-USASP2024125097$AMGEN$$69$YR$E$M$Y$$$20240728$$MD$US$US
240126912$24012691$2$F$20240618$20240815$20240626$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101980$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$53.98$KG$20240819$$CN$US$US
240126932$24012693$2$F$20230901$20240827$20240626$20240829$EXP$$US-JNJFOC-20240642995$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
240126962$24012696$2$F$$20240805$20240626$20240811$EXP$$US-BIOGEN-2024BI01253156$BIOGEN$$$$$M$Y$$$20240811$$CN$US$US
240126973$24012697$3$F$20240402$20240802$20240626$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024075825$VIIV$$57$YR$$M$Y$81.633$KG$20240830$$HP$US$US
240127052$24012705$2$F$$20240729$20240626$20240802$EXP$$CA-JNJFOC-20240600964$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240802$$HP$CA$CA
240127062$24012706$2$F$20240101$20240806$20240626$20240813$EXP$$US-BIOGEN-2024BI01267008$BIOGEN$$$$$F$Y$$$20240813$$HP$US$US
240127085$24012708$5$F$$20240716$20240626$20240827$EXP$$US-ROCHE-10000006173$ROCHE$$$$A$M$Y$$$20240827$$HP$US$US
240127113$24012711$3$F$20230101$20240709$20240626$20240716$EXP$$US-ABBVIE-5809138$ABBVIE$$$$$F$Y$61.688$KG$20240716$$HP$US$US
240127134$24012713$4$F$20240622$20240819$20240626$20240820$EXP$$JP-TAKEDA-2024TJP009462$TAKEDA$$9$DEC$$M$Y$63$KG$20240820$$MD$JP$JP
240127172$24012717$2$F$20240501$20240719$20240626$20240726$EXP$$JP-GENMAB-2024-02136$GENMAB$$77$YR$$M$Y$$$20240726$$MD$JP$JP
240127192$24012719$2$F$20240123$20240903$20240626$20240904$EXP$$US-ROCHE-10000005893$ROCHE$$1$YR$I$F$Y$6$KG$20240904$$CN$US$US
240127202$24012720$2$F$$20240625$20240626$20240716$PER$$CA-TOLMAR, INC.-24CA050082$TOLMAR$$$$$M$Y$$$20240716$$MD$CA$CA
240127402$24012740$2$F$$20240627$20240626$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406016243$ELI LILLY AND CO$$58$YR$A$$Y$$$20240701$$CN$US$US
240127473$24012747$3$F$20240611$20240709$20240626$20240722$EXP$$CA-NOVOPROD-1241433$NOVO NORDISK$$68$YR$$F$Y$$$20240719$$PH$CA$CA
240127482$24012748$2$F$20220401$20240627$20240626$20240711$EXP$$US-NOVOPROD-1243023$NOVO NORDISK$$$$$F$Y$$$20240711$$CN$US$US
240127573$24012757$3$F$$20240703$20240626$20240705$PER$$US-AMGEN-USASP2024124561$AMGEN$$$$$M$Y$$$20240705$$CN$US$US
240127582$24012758$2$F$20240619$20240722$20240626$20240725$PER$$US-AMGEN-USASP2024125113$AMGEN$$63$YR$A$F$Y$$$20240724$$CN$US$US
240127592$24012759$2$F$20240103$20240628$20240626$20240707$30DAY$$US-AMGEN-USASL2024120810$AMGEN$$66$YR$E$F$Y$$$20240707$$CN$US$US
240127652$24012765$2$F$20240323$20240621$20240626$20240702$EXP$$US-NOVOPROD-1241973$NOVO NORDISK$$$$A$M$Y$$$20240702$$CN$US$US
240127662$24012766$2$F$20240615$20240705$20240626$20240716$EXP$$GR-NOVOPROD-1242039$NOVO NORDISK$$53$YR$$F$Y$95$KG$20240716$$CN$GR$GR
240127733$24012773$3$F$$20240918$20240626$20240926$EXP$$US-JNJFOC-20240346050$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$HP$US$US
240127747$24012774$7$F$20230101$20240724$20240626$20240726$PER$$US-JNJFOC-20240654614$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240726$$CN$US$US
240127812$24012781$2$F$20240520$20240627$20240626$20240708$EXP$$US-BAXTER-2024BAX020329$BAXTER$$$$$F$Y$$$20240708$$HP$US$US
240127822$24012782$2$F$20240606$20240708$20240626$20240710$EXP$$JP-TAKEDA-2024TJP009491$TAKEDA$$3$DEC$$F$Y$$$20240710$$MD$JP$JP
240127884$24012788$4$F$$20240820$20240626$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101835$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240826$$CN$US$US
240127972$24012797$2$F$20240601$20240715$20240626$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-018461$UNITED THERAPEUTICS$$49$YR$$F$Y$123.36$KG$20240718$$$US$US
240127982$24012798$2$F$20240610$20240708$20240626$20240712$30DAY$$US-AMGEN-USASL2024120825$AMGEN$$82$YR$E$F$Y$73.8$KG$20240712$$PH$US$US
240128022$24012802$2$F$20240624$20240807$20240626$20240809$PER$$US-AMGEN-USASP2024124606$AMGEN$$72$YR$E$M$Y$$$20240809$$CN$US$US
240128032$24012803$2$F$$20240710$20240626$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009728$JAZZ$$39$YR$$F$Y$$$20240716$$CN$US$US
240128053$24012805$3$F$$20240919$20240626$20240924$EXP$$NVSC2024KR012806$NOVARTIS$$$$A$M$Y$$$20240924$$HP$KR$KR
240128072$24012807$2$F$20240101$20240620$20240626$20240701$EXP$$JP-JNJFOC-20240215545$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$60$KG$20240701$$MD$JP$JP
240128132$24012813$2$F$20240614$20240809$20240626$20240830$30DAY$$US-GSK-US2024075155$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240830$$CN$US$US
240128142$24012814$2$F$$20240729$20240626$20240812$EXP$$JP-AMGEN-JPNSP2024124142$AMGEN$$78$YR$E$F$Y$$$20240811$$PH$JP$JP
240128153$24012815$3$F$20240601$20240802$20240626$20240812$EXP$$US-GSK-US2024AMR076020$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240812$$CN$US$US
240128172$24012817$2$F$20240517$20240628$20240626$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009734$JAZZ$$37$YR$$M$Y$97$KG$20240704$$CN$US$US
240128252$24012825$2$F$20240601$20240705$20240626$20240709$EXP$$JP-JNJFOC-20240667897$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240709$$HP$JP$JP
240128312$24012831$2$F$20240706$20240805$20240626$20240807$PER$$NVSC2024US132715$NOVARTIS$$75$YR$$M$Y$87$KG$20240807$$HP$US$US
240128333$24012833$3$F$$20240722$20240626$20240723$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009811$JAZZ$$$$$F$Y$114.8$KG$20240723$$HP$US$US
240128542$24012854$2$F$20240617$20240626$20240626$20240702$EXP$$CA-ABBVIE-5811858$ABBVIE$$81$YR$$M$Y$$$20240702$$PH$CA$CA
240128552$24012855$2$F$$20240701$20240626$20240709$EXP$$US-TEVA-VS-3212291$TEVA$Hatfield JS, Godar CM, Vietor NO, Hoang TD, Shakir MKM. Medical Management of Cushing^s Syndrome Caused By Primary Bilateral Macronodular Adrenal Hyperplasia (PBMA) With Low Dose of Ketoconazole. J-Endocr-Soc 2023; 7 A142-A143 abstr. FRI266 .; Hatfield JS, Godar CM, Vietor NO, Hoang TD, Shakir MKM. Medical Management of Cushing^s Syndrome Caused By Primary Bilateral Macronodular Adrenal Hyperplasia (PBMA) With Low Dose of Ketoconazole. J-Endocr-Soc 2023; 7 A142-A143 abstr. FRI266 .$62$YR$$F$Y$$$20240709$$HP$US$US
240128602$24012860$2$F$$20240707$20240626$20240710$EXP$GB-LABORATORIOS LICONSA S.A.-2406GB04627$GB-DEXPHARM-2024-1982$DEXCEL$$$$$M$Y$$$20240710$$HP$GB$GB
240128632$24012863$2$F$$20240712$20240626$20240722$EXP$$CA-APOTEX-2024AP007331$APOTEX$$15$YR$$M$Y$50$KG$20240722$$MD$CA$CA
240128642$24012864$2$F$20240301$20240612$20240626$20240926$PER$$US-CIPLA LTD.-2024US03099$CIPLA$$$$$$Y$$$20240927$$CN$US$US
240128682$24012868$2$F$20240601$20240924$20240626$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101301$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240924$$HP$US$US
240128702$24012870$2$F$20240601$20240731$20240626$20240801$EXP$$US-ABBVIE-5814378$ABBVIE$$74$YR$$M$Y$$$20240801$$HP$US$US
240128892$24012889$2$F$20240531$20240711$20240626$20240801$PER$$US-TOLMAR, INC.-24US049976$TOLMAR$$77$YR$$M$Y$$$20240801$$HP$US$US
240128902$24012890$2$F$20240612$20240708$20240626$20240715$EXP$$JP-JNJFOC-20240661492$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240715$$$COUNTRY NOT SPECIFIED$JP
240128922$24012892$2$F$$20240702$20240626$20240715$EXP$$US-BEH-2024173925$CSL BEHRING$$$$A$$Y$$$20240715$$CN$US$US
240129003$24012900$3$F$$20240624$20240626$20240704$EXP$$US-ROCHE-10000007462$ROCHE$$54$YR$A$F$Y$$$20240704$$CN$US$US
240129022$24012902$2$F$20240610$20240611$20240626$20240712$EXP$$PK-ROCHE-10000008597$ROCHE$$36$YR$A$F$Y$$$20240712$$CN$PK$PK
240129072$24012907$2$F$20240109$20240718$20240626$20240819$PER$$US-BIOVITRUM-2024-US-009090$BIOVITRUM$$78$YR$$M$Y$$$20240819$$CN$US$US
240129122$24012912$2$F$20240101$20240722$20240626$20240722$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036117$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240722$$CN$US$US
240129214$24012921$4$F$20240605$20240730$20240626$20240801$EXP$$US-ALXN-202406USA001188US$ALEXION PHARMACEUTICALS$$74$YR$$F$Y$$$20240801$$HP$US$US
240129272$24012927$2$F$$20240827$20240626$20240906$30DAY$$US-GSK-US2024AMR076513$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
240129282$24012928$2$F$$20240710$20240626$20240718$EXP$$CA-CELLTRION INC.-2024CA015082$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
240129633$24012963$3$F$20240606$20240718$20240626$20240726$EXP$$US-GSK-US2024074979$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240726$$HP$US$US
240129642$24012964$2$F$$20240809$20240626$20240817$30DAY$$US-GSK-US2024075175$GLAXOSMITHKLINE$$$$$M$Y$$$20240817$$CN$US$US
240129662$24012966$2$F$20240614$20240806$20240626$20240809$EXP$$JP-JNJFOC-20240659730$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240809$$MD$JP$JP
240129752$24012975$2$F$$20240626$20240626$20240701$PER$$US-AMGEN-USASP2024124618$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240129762$24012976$2$F$20221101$20240704$20240626$20240711$EXP$$FR-AUROBINDO-AUR-APL-2024-030468$AUROBINDO$$76$YR$$F$Y$$$20240711$$CN$FR$FR
240129833$24012983$3$F$$20240808$20240626$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091229$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$106.59$KG$20240809$$CN$US$US
240129852$24012985$2$F$20240601$20240729$20240626$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-030250$AUROBINDO$$61$YR$$M$Y$110$KG$20240808$$CN$GB$GB
240129915$24012991$5$F$$20240710$20240626$20240723$EXP$$CZ-AUROBINDO-AUR-APL-2024-030612$AUROBINDO$MUDr. Martin Vere?. Malign? katatonie u pacienta s nediferencovanou schizofreni? (EN title: Malignant catatonia in a patient with undifferentiated schizophrenia). Psychiatrie pro praxi. 2024;25(2):99-102.$46$YR$$M$Y$$$20240719$$MD$CZ$CZ
240129923$24012992$3$F$$20240724$20240626$20240730$EXP$$US-BIOGEN-2024BI01270606$BIOGEN$$$$$M$Y$$$20240730$$HP$US$US
240129962$24012996$2$F$$20240624$20240626$20240701$EXP$$US-BIOGEN-2024BI01270608$BIOGEN$$$$$F$Y$$$20240701$$CN$US$US
240130002$24013000$2$F$$20240626$20240626$20240701$PER$$US-LEO Pharma-371443$LEO PHARM$$53$YR$$M$Y$$$20240701$$CN$US$US
240130012$24013001$2$F$20240607$20240624$20240626$20240701$EXP$$CA-JNJFOC-20240621094$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240701$$PH$CA$CA
240130022$24013002$2$F$20230101$20240812$20240626$20240816$PER$$US-JNJFOC-20240603016$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240816$$CN$US$US
240130142$24013014$2$F$20230101$20240624$20240626$20240701$EXP$$ES-AUROBINDO-AUR-APL-2024-030922$AUROBINDO$Fernandez Martinez V, Garcia-Avello F-C, Valencia Soto CM, Barbadillo Villanueva S, Ochagavia Sufrategui M, Rioja Carrera M, et al.. Pembrolizumab-induced agranulocytosis. J-Oncol-Pharm-Pract. 2024;30 (4):767-771$68$YR$$M$Y$$$20240701$$HP$ES$ES
240130172$24013017$2$F$20230808$20240810$20240626$20240819$EXP$$CA-CELLTRION INC.-2023CA016025$CELLTRION$$$$$$Y$$$20240819$$HP$CA$CA
240130222$24013022$2$F$20230623$20240708$20240626$20240723$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001021$AKEBIA THERAPEUTICS$$89$YR$$F$Y$41$KG$20240723$$MD$JP$JP
240130272$24013027$2$F$$20240902$20240626$20240912$EXP$$US-UCBSA-2024032313$UCB$$$$$F$Y$$$20240912$$HP$US$US
240130672$24013067$2$F$20201113$20240628$20240626$20240716$EXP$$US-ROCHE-10000004211$ROCHE$$59$YR$A$F$Y$85.28$KG$20240716$$MD$US$US
240130712$24013071$2$F$20240623$20240705$20240626$20240716$PER$$US-JNJFOC-20240662427$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240716$$CN$US$US
240130742$24013074$2$F$$20240724$20240626$20240801$PER$$US-JNJFOC-20240643896$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$PH$US$US
240130753$24013075$3$F$$20240721$20240626$20240724$PER$$US-AMGEN-USASP2024124123$AMGEN$$55$YR$A$F$Y$$$20240724$$MD$US$US
240130772$24013077$2$F$20210101$20240627$20240626$20240703$EXP$$FR-SANDOZ INC.-SDZ2023FR046118$SANDOZ$$30$YR$$M$Y$$$20240703$$CN$FR$FR
240130882$24013088$2$F$20240101$20240723$20240626$20240731$EXP$$CA-CELLTRION INC.-2024CA015279$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
240130943$24013094$3$F$20240101$20240716$20240626$20240725$EXP$$US-SA-2024SA155696$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240725$$MD$US$US
240131002$24013100$2$F$20240530$20240815$20240626$20240823$EXP$$CA-CELLTRION INC.-2024CA015389$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
240131063$24013106$3$F$$20240806$20240626$20240807$PER$$US-JNJFOC-20240577457$JOHNSON AND JOHNSON$$40$YR$A$F$Y$82.1$KG$20240807$$CN$US$US
240131072$24013107$2$F$$20240731$20240626$20240801$PER$$US-JNJFOC-20240660634$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
240131182$24013118$2$F$20040101$20240905$20240626$20240912$EXP$$GB-ABBVIE-5813831$ABBVIE$$77$YR$$F$Y$$$20240912$$CN$GB$GB
240131193$24013119$3$F$20240628$20240711$20240626$20240725$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-18509$SAMSUNG BIOEPIS$$67$YR$E$F$Y$$$20240725$$HP$CA$CA
240131273$24013127$3$F$$20240730$20240626$20240731$EXP$$HU-ROCHE-10000007287$ROCHE$Lakatos V, Lakatos V, Gopcsa L, B, Fabian J, Remenyi P. T-cell prolymphocytic leukaemia treatment and transplantation presented through two case reports. Haematology - Transfusiology. 2024;69-69.$62$YR$A$F$Y$$$20240731$$HP$HU$HU
240131302$24013130$2$F$$20240625$20240626$20240705$PER$$US-HALEON-2183415$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240131312$24013131$2$F$20240401$20240807$20240626$20240814$EXP$$ES-LEO Pharma-371255$LEO PHARM$$25$YR$$M$Y$$$20240814$$MD$ES$ES
240131322$24013132$2$F$20240101$20240701$20240626$20240704$EXP$$US-ABBVIE-5814959$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240131372$24013137$2$F$20240501$20240705$20240626$20240712$EXP$$FR-GSK-FR2024077527$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$MD$FR$FR
240131392$24013139$2$F$20240623$20240712$20240626$20240716$PER$$US-AMGEN-USASP2024125341$AMGEN$$73$YR$E$F$Y$$$20240716$$CN$US$US
240131402$24013140$2$F$20240621$20240809$20240626$20240812$PER$$US-AMGEN-USASP2024124835$AMGEN$$61$YR$A$F$Y$$$20240812$$CN$US$US
240131422$24013142$2$F$20240201$20240701$20240626$20240705$EXP$$DE-AstraZeneca-2024A143815$ASTRAZENECA$$57$YR$$F$Y$$$20240705$$MD$DE$
240131446$24013144$6$F$20240101$20240912$20240626$20240921$EXP$$CA-CELLTRION INC.-2024CA015427$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
240131472$24013147$2$F$20240313$20240617$20240626$20240801$EXP$CH-SM-2024-13359$CH-ABBVIE-5814508$ABBVIE$$38$YR$$F$Y$48$KG$20240801$$PH$CH$CH
240131483$24013148$3$F$$20240807$20240626$20240828$EXP$$JP-EXELIXIS-CABO-24078799$EXELIXIS$$72$YR$$M$Y$$$20240827$$MD$JP$JP
240131502$24013150$2$F$$20240705$20240626$20240710$30DAY$$US-GSK-US2024075162$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
240131532$24013153$2$F$$20240927$20240626$20240930$EXP$$CA-JNJFOC-20240653123$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240930$$HP$CA$CA
240131623$24013162$3$F$20240601$20240711$20240626$20240712$PER$$US-JNJFOC-20240667485$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240712$$CN$US$US
240131662$24013166$2$F$20240615$20240702$20240626$20240704$PER$$US-AMGEN-USASP2024124290$AMGEN$$40$YR$A$F$Y$$$20240704$$CN$US$US
240131672$24013167$2$F$$20240831$20240626$20240910$30DAY$$GB-JNJFOC-20240563221$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240910$$CN$GB$GB
240131682$24013168$2$F$20230325$20240711$20240626$20240720$EXP$$RO-CELLTRION INC.-2024RO015088$CELLTRION$$$$$$Y$$$20240720$$MD$RO$RO
240131743$24013174$3$F$20240101$20240704$20240626$20240715$EXP$$US-SA-2024SA185540$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240715$$MD$US$US
240131802$24013180$2$F$$20240718$20240626$20240723$EXP$$US-GSK-US2024AMR077138$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$CN$US$US
240131812$24013181$2$F$$20240827$20240626$20240903$EXP$$US-GSK-US2024076577$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
240131842$24013184$2$F$20240619$20240708$20240626$20240716$EXP$$JP-SA-2024SA182082$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240716$$MD$JP$JP
240131893$24013189$3$F$20240613$20240730$20240626$20240808$PER$$US-JAZZ PHARMACEUTICALS-2024-US-002281$JAZZ$$49$YR$$M$Y$$$20240808$$CN$US$US
240131922$24013192$2$F$$20240701$20240626$20240703$PER$$US-AMGEN-USASP2024124452$AMGEN$$$$$F$Y$$$20240703$$HP$US$US
240132053$24013205$3$F$$20240627$20240626$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406015341$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240703$$CN$US$US
240132132$24013213$2$F$20230601$20240813$20240626$20240820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-100524$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$36.8$KG$20240820$$PH$JP$JP
240132182$24013218$2$F$20240515$20240626$20240626$20240705$PER$$AT-ALK-ABELLO A/S-2024AA002560$ALK-ABELLO$$$$$$Y$$$20240705$$MD$AT$AT
240132232$24013223$2$F$20240208$20240711$20240626$20240723$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002512$JAZZ$$42$YR$$F$Y$$$20240723$$HP$US$US
240132243$24013224$3$F$20240128$20240711$20240626$20240720$EXP$$DE-CELLTRION INC.-2024DE015014$CELLTRION$$$$$$Y$$$20240720$$MD$DE$DE
240132262$24013226$2$F$20240611$20240725$20240626$20240801$EXP$$NVSC2024JP132140$NOVARTIS$$46$YR$$F$Y$$$20240801$$MD$JP$JP
240132272$24013227$2$F$$20240701$20240626$20240709$EXP$$US-TEVA-VS-3212176$TEVA$Andrews K, Meshinchi S, Marri P, Siddiqui AH, Polski J, Molina A, et al. Pediatric Acute Myeloid Leukemia with Co-Occurring BCR::ABL and CBFA2T3::GLIS2 Dual Fusion with Deep Response to FOLR1-Targeting Antibody Drug Conjugate Stro-002 and Tyrosine Kinase Inhibitor. Blood 2022; 140 (Suppl. 1) 11757-11758.; Andrews K, Meshinchi S, Marri P, Siddiqui AH, Polski J, Molina A, et al. Pediatric Acute Myeloid Leukemia with Co-Occurring BCR::ABL and CBFA2T3::GLIS2 Dual Fusion with Deep Response to FOLR...$2$YR$$F$Y$$$20240709$$HP$US$US
240132352$24013235$2$F$$20240627$20240626$20240701$EXP$$US-BIOGEN-2024BI01271028$BIOGEN$$$$$F$Y$$$20240701$$HP$US$US
240132382$24013238$2$F$$20240612$20240626$20240708$EXP$$PK-ROCHE-10000006686$ROCHE$$78$YR$E$F$Y$$$20240708$$CN$PK$PK
240132402$24013240$2$F$$20240724$20240626$20240731$PER$$US-ABBVIE-5811223$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
240132522$24013252$2$F$$20240627$20240626$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05311$LUPIN$$2$YR$$F$Y$$$20240714$$CN$US$US
240133492$24013349$2$F$$20240530$20240626$20240923$PER$$US-ROCHE-3573458$ROCHE$Portillo D, Lathrop K. A rare unilateral expression of hand-foot syndrome: a case report, [Abstract number: PO1-20-09], DOI: 10.1158/1538-7445.SABCS23-PO1-20-09. Cancer Research 2024 May;84 (9):1-2.$38$YR$A$F$Y$$$20240923$$HP$US$US
240133515$24013351$5$F$20240621$20240805$20240626$20240807$PER$$US-AMGEN-USASP2024123885$AMGEN$$82$YR$E$M$Y$$$20240807$$MD$US$US
240133532$24013353$2$F$20240601$20240718$20240626$20240723$30DAY$$US-AMGEN-USASP2024123566$AMGEN$$49$YR$A$F$Y$$$20240723$$PH$US$US
240133583$24013358$3$F$$20240807$20240626$20240808$PER$$NVSC2024US132361$NOVARTIS$$46$YR$$F$Y$$$20240808$$HP$US$US
240133682$24013368$2$F$$20240802$20240626$20240812$EXP$$US-SA-2024SA184512$SANOFI AVENTIS$$67$YR$E$F$Y$86.59$KG$20240812$$HP$US$US
240133722$24013372$2$F$$20240916$20240626$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU058971$SANDOZ$$51$YR$$M$Y$$$20240920$$HP$AU$AU
240133892$24013389$2$F$$20240701$20240626$20240709$EXP$$US-TEVA-VS-3212195$TEVA$Duke JD, Reisenauer J. EP14.03-04 Rare but Aggressive: A Case of Primary Pulmonary Synovial Sarcoma. J-Thorac-Oncol 2023; 18 (Suppl.) (11): S722.; Duke JD, Reisenauer J. EP14.03-04 Rare but Aggressive: A Case of Primary Pulmonary Synovial Sarcoma. J-Thorac-Oncol 2023; 18 (Suppl.) (11): S722.$58$YR$$$Y$$$20240709$$HP$US$US
240133913$24013391$3$F$$20240728$20240626$20240801$PER$$NVSC2024US131345$NOVARTIS$$$$$$Y$$$20240801$$CN$US$US
240133952$24013395$2$F$$20240625$20240626$20240704$EXP$$EC-ROCHE-10000007751$ROCHE$$$$$$Y$$$20240704$$CN$EC$EC
240133992$24013399$2$F$20240301$20240713$20240626$20240718$EXP$$CL-ROCHE-10000008850$ROCHE$$32$YR$A$M$Y$61$KG$20240718$$CN$CL$CL
240134002$24013400$2$F$$20240621$20240626$20240704$PER$$US-ROCHE-10000002864$ROCHE$$$$$$Y$$$20240704$$MD$US$US
240134032$24013403$2$F$$20240711$20240626$20240716$EXP$$NVSJ2024JP007388$NOVARTIS$Liang Y, Maeda O, Shimokata T, Yokota K, Koike H, Sakai T, et al.. Potential drug interactions between pazopanib and proton pump inhibitors/potassium-competitive acid blockers in patients with soft tissue sarcoma. International Cancer Conference Journal. 2024;13:63-67$76$YR$$F$Y$$$20240716$$HP$JP$JP
240134112$24013411$2$F$20240201$20240920$20240626$20240928$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-017895$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240928$$CN$US$US
240134122$24013412$2$F$$20240716$20240626$20240728$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2024-05215$LUPIN$$$$$$Y$$$20240728$$MD$DE$DE
240134172$24013417$2$F$20240613$20240822$20240626$20240830$30DAY$$US-GSK-US2024075119$GLAXOSMITHKLINE$$27$YR$$F$Y$$$20240830$$CN$US$US
240134212$24013421$2$F$$20240701$20240626$20240709$EXP$$IT-TEVA-VS-3212607$TEVA$Minca G, Meneghel A, Cagnato ML, Agazzi A, Tirelli F, Martini G, et al. Isotretinoin in SAPHO syndrome: A triggering factor for acute onset?. Pediatr-Rheumatol 2023; 21 (Suppl. 2) 276 abstr. P426.; Minca G, Meneghel A, Cagnato ML, Agazzi A, Tirelli F, Martini G, et al. Isotretinoin in SAPHO syndrome: A triggering factor for acute onset?. Pediatr-Rheumatol 2023; 21 (Suppl. 2) 276 abstr. P426.$13$YR$$M$Y$$$20240709$$HP$IT$IT
240134252$24013425$2$F$20240424$20240815$20240626$20240823$EXP$$CA-CELLTRION INC.-2024CA011320$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
240134303$24013430$3$F$20240618$20240930$20240626$20240930$PER$$NVSC2024US130021$NOVARTIS$$40$YR$$F$Y$$$20240930$$CN$US$US
240134382$24013438$2$F$20240615$20240715$20240626$20240722$PER$$US-BAUSCHBL-2024BNL028750$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240722$$CN$US$US
240134413$24013441$3$F$20240606$20240711$20240626$20240719$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00664$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240719$$CN$US$US
240134423$24013442$3$F$20240101$20240710$20240626$20240712$EXP$$US-AMGEN-USASP2024121744$AMGEN$$19$YR$A$F$Y$$$20240711$$CN$US$US
240134462$24013446$2$F$20240615$20240715$20240626$20240722$PER$$US-BAUSCHBL-2024BNL028853$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240722$$CN$US$US
240134473$24013447$3$F$20240601$20240830$20240626$20240908$PER$$US-BAUSCHBL-2024BNL028873$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240909$$PH$US$US
240134492$24013449$2$F$$20240618$20240626$20240710$PER$$US-BAUSCHBL-2024BNL028884$BAUSCH AND LOMB$$$$$F$Y$$$20240710$$CN$US$US
240134602$24013460$2$F$$20240624$20240626$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406016504$ELI LILLY AND CO$$34$YR$A$$Y$$$20240702$$CN$US$US
240134713$24013471$3$F$20240619$20240731$20240626$20240731$PER$$US-ALXN-202406USA001410US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$HP$US$US
240134732$24013473$2$F$$20240624$20240626$20240702$EXP$$LU-AUROBINDO-AUR-APL-2019-101177$AUROBINDO$Kaysen A, Heintz-Buschart A, Muller EEL, Narayanasamy S, Wampach L, Laczny CC et al.. Integrated meta-omic analyses of the gastrointestinal tract microbiome in patients undergoing allogeneic hematopoietic stem cell transplantation.. Translational Research. 2017;(186):79-94$63$YR$$F$Y$$$20240702$$MD$LU$LU
240134742$24013474$2$F$$20240813$20240626$20240819$EXP$$CA-TAKEDA-2022TUS084805$TAKEDA$$$$$F$Y$$$20240819$$CN$CA$CA
240134782$24013478$2$F$20240301$20240812$20240626$20240815$EXP$$US-ABBVIE-5812979$ABBVIE$$49$YR$$F$Y$$$20240815$$CN$US$US
240134843$24013484$3$F$20231201$20240715$20240626$20240724$EXP$$DE-AUROBINDO-AUR-APL-2024-030501$AUROBINDO$$66$YR$$F$Y$83$KG$20240724$$CN$DE$DE
240134852$24013485$2$F$20230801$20240614$20240626$20240716$EXP$$US-ROCHE-10000006956$ROCHE$$58$YR$A$F$Y$77.11$KG$20240716$$CN$US$US
240134883$24013488$3$F$20240419$20240808$20240626$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-030374$AUROBINDO$$63$YR$$F$Y$$$20240818$$PH$FR$FR
240134902$24013490$2$F$20240401$20240809$20240626$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015609$UNITED THERAPEUTICS$$77$YR$$F$Y$78.005$KG$20240817$$$US$US
240134922$24013492$2$F$$20240625$20240626$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452704$RANBAXY$$$$E$F$Y$$$20240710$$CN$US$US
240134932$24013493$2$F$20240601$20240722$20240626$20240723$EXP$$GB-UCBSA-2024032185$UCB$$77$YR$$F$Y$$$20240723$$CN$GB$GB
240134953$24013495$3$F$$20240715$20240626$20240724$EXP$$GB-CELLTRION INC.-2024GB015494$CELLTRION$$$$$$Y$$$20240724$$CN$GB$GB
240135002$24013500$2$F$$20240806$20240626$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101663$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$PH$US$US
240135014$24013501$4$F$20240523$20240923$20240626$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102091$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$99.79$KG$20240926$$CN$US$US
240135033$24013503$3$F$20240619$20240620$20240626$20240703$PER$$US-JNJFOC-20240650591$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240703$$CN$US$US
240135043$24013504$3$F$20240614$20240729$20240626$20240801$EXP$$AR-JNJFOC-20240654224$JOHNSON AND JOHNSON$$48$YR$A$M$Y$84$KG$20240801$$CN$AR$AR
240135083$24013508$3$F$$20240701$20240626$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05332$LUPIN$$$$$$Y$$$20240718$$CN$US$US
240135102$24013510$2$F$$20240720$20240626$20240731$EXP$$US-AUROBINDO-AUR-APL-2024-030136$AUROBINDO$Peake KN, Tessier S, Longo S, Stahlnecker DM, Idahosa O, Ido F, et al.. Metformin toxicity in the intensive care unit: A case series and review of the literature.. International journal of critical illness and injury science.. 2024;14 (1):51-8$49$YR$$F$Y$$$20240731$$MD$US$US
240135172$24013517$2$F$20100415$20240615$20240626$20240722$EXP$$DE-AUROBINDO-AUR-APL-2024-030556$AUROBINDO$unknown. Arzneimittelkommission der deutschen Aerzteschaft. ^Aus der UAW-Datenbank^. Agranulozytose nach Metamizol - sehr selten, aber haeufiger als gedacht.. Dtsch Aerztebl. 2011;108:33:A1758-A1759.$41$YR$$F$Y$72$KG$20240722$$MD$DE$DE
240135192$24013519$2$F$$20240702$20240626$20240707$EXP$$JP-JNJFOC-20240668017$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$PH$JP$JP
240135213$24013521$3$F$$20240729$20240626$20240802$EXP$$JP-JNJFOC-20240669193$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240802$$PH$JP$JP
240135222$24013522$2$F$$20240911$20240626$20240916$EXP$$US-TAKEDA-2024TUS050772$TAKEDA$$$$$F$Y$75$KG$20240916$$HP$US$US
240135234$24013523$4$F$20240611$20240801$20240626$20240803$PER$$US-ROCHE-10000003502$ROCHE$$77$YR$E$$Y$$$20240803$$MD$US$US
240135302$24013530$2$F$$20240807$20240626$20240807$PER$$NVSC2024US132981$NOVARTIS$$$$$M$Y$$$20240807$$HP$US$US
240135343$24013534$3$F$$20240819$20240626$20240829$EXP$$US-GSK-US2024AMR076354$GLAXOSMITHKLINE$$$$$F$Y$142$KG$20240829$$CN$US$US
240135353$24013535$3$F$$20240913$20240626$20240921$EXP$$GB-TAKEDA-2024TUS063035$TAKEDA$$$$$F$Y$$$20240921$$CN$GB$GB
240135442$24013544$2$F$$20240625$20240626$20240704$EXP$$US-ROCHE-3224109$ROCHE$$51$YR$A$M$Y$75.3$KG$20240704$$MD$US$US
240135492$24013549$2$F$20231124$20240924$20240626$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099469$BRISTOL MYERS SQUIBB$$40$YR$A$M$Y$$$20240924$$CN$US$US
240135503$24013550$3$F$20210101$20240913$20240626$20240923$EXP$$CA-CELLTRION INC.-2024CA012885$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
240135513$24013551$3$F$$20240716$20240626$20240725$EXP$$JP-JNJFOC-20211136748$JOHNSON AND JOHNSON$$52$YR$A$F$Y$70.1$KG$20240725$$MD$JP$JP
240135532$24013553$2$F$$20240910$20240626$20240926$30DAY$$FR-BECTON DICKINSON-FR-BD-24-000381$BECTON DICKINSON$$$$$$Y$$$20240926$$MD$FR$FR
240135632$24013563$2$F$$20240720$20240626$20240731$EXP$$CA-AUROBINDO-AUR-APL-2024-030284$AUROBINDO$Wu H, Hill V.. Serotonin Syndrome and Catatonia in the Absence of a Serotonergic Agent Following Abrupt Withdrawal of Clozapine. Canadian Journal of Hospital Pharmacy.. 2024;77(1):e3452$47$YR$$M$Y$$$20240731$$MD$CA$CA
240135652$24013565$2$F$20240419$20240731$20240626$20240812$EXP$AU-TGA-0000808151$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-13446$ALKEM$$79$YR$$M$Y$$$20240812$$HP$AU$AU
240135662$24013566$2$F$$20240624$20240626$20240708$EXP$GB-EMA-DD-20180423-negievprod-142533$LU-ALKEM LABORATORIES LIMITED-DE-ALKEM-2017-02160$ALKEM$Kaysen A, Heintz-Buschart A, Muller EEL, Narayanasamy S and et al.. Integrated meta-omic analyses of the gastrointestinal tract microbiome in patients undergoing allogeneic hematopoietic stem cell transplantation. Translational Research.. 2017;186:79-94$63$YR$$F$Y$$$20240708$$HP$LU$LU
240135693$24013569$3$F$20240621$20240702$20240626$20240706$PER$$US-AMGEN-USASP2024125274$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240135702$24013570$2$F$$20240823$20240626$20240826$PER$$NVSC2024US132292$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
240135803$24013580$3$F$20230619$20240730$20240626$20240730$EXP$$JP-ABBVIE-5814602$ABBVIE$$80$YR$$F$Y$48$KG$20240730$$MD$JP$JP
240135902$24013590$2$F$20240501$20240730$20240626$20240807$EXP$$US-AstraZeneca-2024A141917$ASTRAZENECA$$48$YR$$F$Y$$$20240807$$HP$US$
240135912$24013591$2$F$$20240711$20240626$20240716$EXP$$US-AstraZeneca-2024A144548$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240135953$24013595$3$F$$20240703$20240626$20240713$EXP$$BR-CELLTRION INC.-2024BR015451$CELLTRION$$$$$$Y$$$20240713$$CN$BR$BR
240135972$24013597$2$F$$20240924$20240626$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101988$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240925$$HP$US$US
240135983$24013598$3$F$$20240626$20240626$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100235$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$67.13$KG$20240701$$HP$US$US
240136033$24013603$3$F$20240617$20240725$20240626$20240730$PER$$US-AMGEN-USASP2024124500$AMGEN$$77$YR$E$F$Y$$$20240730$$CN$US$US
240136062$24013606$2$F$$20240720$20240626$20240801$EXP$$US-AUROBINDO-AUR-APL-2024-030131$AUROBINDO$Ido F, Tessier S, Longo S, Stahlnecker DM, Idahosa O, Zanders T, et al. Metformin toxicity in the intensive care unit: A case series and review of the literature. International journal of critical illness and injury science. 2024;14(1):51-8$68$YR$$M$Y$$$20240801$$MD$US$US
240136082$24013608$2$F$20240101$20240703$20240626$20240704$EXP$$GB-UCBSA-2024032055$UCB$$$$$F$Y$$$20240704$$CN$GB$GB
240136244$24013624$4$F$20240622$20240802$20240626$20240812$EXP$$US-GSK-US2024AMR076815$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240812$$CN$US$US
240136382$24013638$2$F$$20240819$20240626$20240821$PER$$US-AMGEN-USASP2024124656$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
240136592$24013659$2$F$$20240830$20240626$20240902$EXP$$NVSC2024US129244$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
240136622$24013662$2$F$$20240829$20240626$20240902$EXP$$NVSC2024US130267$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
240136692$24013669$2$F$20240622$20240628$20240626$20240703$PER$$US-AMGEN-USASP2024124564$AMGEN$$83$YR$E$F$Y$$$20240703$$CN$US$US
240136702$24013670$2$F$20240619$20240626$20240626$20240702$PER$$US-AMGEN-USASP2024124566$AMGEN$$64$YR$A$F$Y$$$20240701$$CN$US$US
240136712$24013671$2$F$$20240712$20240626$20240719$EXP$$JP-AMGEN-JPNSP2024123101$AMGEN$$$$E$F$Y$$$20240719$$MD$JP$JP
240136742$24013674$2$F$20220906$20240719$20240626$20240723$EXP$$JP-ABBVIE-5815126$ABBVIE$$68$YR$$F$Y$48$KG$20240723$$MD$JP$JP
240136812$24013681$2$F$$20240624$20240626$20240704$EXP$$CN-Accord-431372$ACCORD$Lei M, Cao Y, Yuan M, Xiong J, He H. Case report: A case of bradycardia triggered by diarrhea. Front Med (Lausanne). 2024 May 30;11:1405494. doi: 10.3389/fmed.2024.1405494. PMID: 38873207; PMCID: PMC11169780.$92$YR$E$M$Y$$$20240704$$HP$CN$US
240136972$24013697$2$F$$20240626$20240626$20240703$EXP$$ES-VANTIVE-2024VAN017837$Vantive US Healthcare$$$$$F$Y$$$20240703$$HP$ES$ES
240136982$24013698$2$F$$20240701$20240626$20240709$EXP$$US-TEVA-VS-3212262$TEVA$Fabbri M, Alkalbani M, Mehta A, Desai SS, Isseh I, Psotka M, et al. A CASE OF REFRACTORY CARDIOGENIC SHOCK AND RECENT BREAST CANCER TREATED WITH SURGICAL RESECTION AND ORTHOTOPIC HEART TRANSPLANT. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 2840.; Fabbri M, Alkalbani M, Mehta A, Desai SS, Isseh I, Psotka M, et al. A CASE OF REFRACTORY CARDIOGENIC SHOCK AND RECENT BREAST CANCER TREATED WITH SURGICAL RESECTION AND ORTHOTOPIC HEART TRANSPLANT. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 2840.$41$YR$$F$Y$$$20240709$$HP$US$US
240136992$24013699$2$F$$20240801$20240626$20240808$EXP$$IN-VANTIVE-2024VAN017862$Vantive US Healthcare$$53$YR$$M$Y$$$20240808$$CN$IN$IN
240137242$24013724$2$F$$20240830$20240626$20240910$EXP$$JP-ASTELLAS-2024JP004374$ASTELLAS$$76$YR$E$M$Y$$$20240910$$PH$JP$JP
240137312$24013731$2$F$20240607$20240611$20240626$20240715$EXP$$PK-ROCHE-10000008331$ROCHE$$38$YR$A$M$Y$$$20240715$$CN$PK$PK
240137372$24013737$2$F$20230201$20240627$20240626$20240705$EXP$$DK-ALK-ABELLO A/S-2024AA002586$ALK-ABELLO$$$$$$Y$$$20240705$$HP$DK$DK
240137414$24013741$4$F$20240819$20240912$20240626$20240920$EXP$$GB-TAKEDA-2024TUS062994$TAKEDA$$35$YR$$F$Y$$$20240920$$CN$GB$GB
240137442$24013744$2$F$20240618$20240624$20240626$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018744$UNITED THERAPEUTICS$$71$YR$$F$Y$52.154$KG$20240703$$$US$US
240137582$24013758$2$F$$20240718$20240626$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035835$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240719$$CN$US$US
240137892$24013789$2$F$$20240627$20240626$20240701$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-12510$IPSEN$$$$$F$Y$$$20240701$$CN$GB$GB
240137905$24013790$5$F$20240221$20240829$20240626$20240906$EXP$$DE-ROCHE-10000008542$ROCHE$$64$YR$A$F$Y$$$20240906$$MD$DE$DE
240137984$24013798$4$F$20240101$20240807$20240626$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018565$UNITED THERAPEUTICS$$$$$M$Y$95.238$KG$20240816$$$US$US
240138152$24013815$2$F$$20240716$20240626$20240722$EXP$$US-PHARMING-PHAUS2024000491$PHARMING GROUP$$$$$$Y$$$20240722$$CN$US$US
240138433$24013843$3$F$$20240815$20240626$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099832$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240819$$CN$US$US
240138522$24013852$2$F$$20240624$20240626$20240702$PER$$US-JNJFOC-20240665692$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240138622$24013862$2$F$20231001$20240731$20240626$20240812$EXP$$JP-ROCHE-3452788$ROCHE$$60$YR$A$M$Y$$$20240812$$MD$JP$JP
240138752$24013875$2$F$20240610$20240909$20240626$20240919$PER$$US-ROCHE-10000002582$ROCHE$$$$$M$Y$$$20240919$$MD$US$US
240138762$24013876$2$F$20240601$20240708$20240626$20240710$EXP$$US-ABBVIE-5812686$ABBVIE$$81$YR$$M$Y$$$20240710$$CN$US$US
240138832$24013883$2$F$20240529$20240708$20240626$20240720$EXP$$JP-ARDELYX-2024ARDX004558$ARDELYX$$68$YR$$M$Y$$$20240718$$MD$JP$JP
240138892$24013889$2$F$$20240725$20240626$20240731$30DAY$$JP-JNJFOC-20240654142$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$PH$JP$JP
240138902$24013890$2$F$20240607$20240611$20240626$20240714$EXP$$PK-ROCHE-10000008293$ROCHE$$44$YR$A$F$Y$$$20240714$$CN$PK$PK
240138973$24013897$3$F$20240617$20240905$20240626$20240909$EXP$$US-TAKEDA-2024TUS063379$TAKEDA$$46$YR$$M$Y$$$20240909$$PH$US$US
240138983$24013898$3$F$20240601$20240709$20240626$20240715$30DAY$$US-AMGEN-USASL2024119469$AMGEN$$46$YR$A$M$Y$$$20240715$$PH$US$US
240138992$24013899$2$F$20240620$20240802$20240626$20240825$30DAY$$US-AMGEN-USASP2024122357$AMGEN$$56$YR$A$M$Y$110.5$KG$20240825$$PH$US$US
240139022$24013902$2$F$$20240624$20240626$20240701$PER$$US-AMGEN-USASP2024125283$AMGEN$$$$$M$Y$$$20240630$$CN$US$US
240139162$24013916$2$F$$20240715$20240626$20240725$30DAY$$US-JNJFOC-20240653452$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
240139234$24013923$4$F$20240615$20240802$20240626$20240805$PER$$US-HALEON-2183816$Haleon PLC$$58$YR$$M$Y$$$20240805$$CN$US$US
240139312$24013931$2$F$20221101$20240917$20240626$20240923$EXP$$CA-Orion Corporation ORION PHARMA-24_00030517$ORION$$64$YR$A$F$Y$$$20240923$$MD$CA$
240139352$24013935$2$F$20240501$20240725$20240626$20240801$EXP$$JP-GENMAB-2024-01893AA$GENMAB$$69$YR$$F$Y$55.3$KG$20240801$$MD$JP$JP
240139442$24013944$2$F$20240610$20240701$20240626$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102012$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240702$$CN$US$US
240139482$24013948$2$F$$20240815$20240626$20240820$EXP$$US-ABBVIE-5815135$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
240139512$24013951$2$F$20240601$20240906$20240626$20240914$EXP$$CA-JNJFOC-20240649658$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240914$$CN$CA$CA
240139532$24013953$2$F$$20240704$20240626$20240712$30DAY$$US-GSK-US2024AMR076932$GLAXOSMITHKLINE$$75$YR$$$Y$$$20240712$$CN$US$US
240139723$24013972$3$F$$20240816$20240626$20240829$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-05297$LUPIN$Schuelke F, Brendt P. Simple yet effective-sterile water injections to treat labor pain in the transport environment. Air Medical Journal. 2024;43:174-176$$$$$Y$$$20240829$$HP$AU$AU
240139782$24013978$2$F$20240512$20240712$20240626$20240724$PER$$US-MSNLABS-2024MSNSPO01305$MSN LABORATORIES$$$$$$Y$$$20240724$$CN$US$US
240139824$24013982$4$F$$20240716$20240626$20240926$PER$$US-GSK-US2024AMR077302$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
240139886$24013988$6$F$20240522$20240828$20240626$20240903$EXP$$CA-JNJFOC-20240664858$JOHNSON AND JOHNSON$$66$YR$E$F$Y$53$KG$20240903$$HP$CA$CA
240139932$24013993$2$F$20190101$20240701$20240626$20240708$EXP$$CA-ABBVIE-5808720$ABBVIE$$$$$F$Y$$$20240708$$CN$CA$CA
240139952$24013995$2$F$$20240715$20240626$20240725$EXP$$US-PADAGIS-2024PAD01056$PADAGIS$$$$$$Y$$$20240725$$CN$US$US
240139982$24013998$2$F$$20240730$20240626$20240801$PER$$US-ALXN-202406USA001185US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240140006$24014000$6$F$20240101$20240918$20240626$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-014511$UNITED THERAPEUTICS$$$$$F$Y$$$20240925$$$US$US
240140012$24014001$2$F$$20240701$20240626$20240710$EXP$$UA-TEVA-VS-3212520$TEVA$Vysochanska VV, Babych MS, Kohutych AI, Halamba AA. A case of leptospirosis in transcarpathia complicated with Jarisch-Herxheimer reaction. Wiad-Lek 2024; 77 (3): 608-612.; Vysochanska VV, Babych MS, Kohutych AI, Halamba AA. A case of leptospirosis in transcarpathia complicated with Jarisch-Herxheimer reaction. Wiad-Lek 2024; 77 (3): 608-612.$72$YR$$M$Y$$$20240710$$HP$UA$UA
240140124$24014012$4$F$20240617$20240808$20240626$20240812$EXP$$US-ABBVIE-5813020$ABBVIE$$50$YR$$F$Y$93$KG$20240812$$CN$US$US
240140223$24014022$3$F$20240601$20240627$20240626$20240704$EXP$$ES-ABBVIE-5811822$ABBVIE$$76$YR$$M$Y$80$KG$20240704$$CN$ES$ES
240140234$24014023$4$F$$20240906$20240626$20240911$EXP$$US-ROCHE-10000007423$ROCHE$$$$$$Y$$$20240911$$MD$US$US
240140242$24014024$2$F$20240418$20240626$20240626$20240709$PER$$US-ROCHE-3556622$ROCHE$$59$YR$A$F$Y$$$20240705$$CN$US$US
240140324$24014032$4$F$20240101$20240705$20240626$20240715$EXP$$CA-CELLTRION INC.-2024CA012409$CELLTRION$$$$$$Y$$$20240715$$CN$CA$CA
240140342$24014034$2$F$$20240624$20240626$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05377$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240140403$24014040$3$F$20240624$20240718$20240626$20240722$PER$$US-AMGEN-USASP2024125410$AMGEN$$84$YR$E$F$Y$$$20240722$$CN$US$US
240140503$24014050$3$F$20240623$20240719$20240626$20240723$PER$$US-AMGEN-USASP2024125128$AMGEN$$51$YR$A$F$Y$$$20240723$$CN$US$US
240140575$24014057$5$F$20240601$20240703$20240626$20240708$EXP$$PT-ABBVIE-5814371$ABBVIE$$85$YR$$F$Y$$$20240708$$CN$PT$PT
240140693$24014069$3$F$20230401$20240829$20240626$20240905$EXP$CA-MMM-KBQVY5GD$CA-GSK-CA2023110679$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$CA$CA
240140702$24014070$2$F$20240612$20240701$20240626$20240709$EXP$$TW-JNJFOC-20240668910$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240709$$MD$TW$TW
240140792$24014079$2$F$$20240617$20240626$20240702$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453170$RANBAXY$Adams PE, Ehyayee V, Ahmed A. A Case of CD4+T-Cell Lymphoma with Gamma-Delta Phenotype, Incidentally Manifesting in a Wound Debridement Sample. Am J Dermatopathol. 2024;Jun; 46 (6):383-385$85$YR$$M$Y$$$20240702$$HP$US$US
240140802$24014080$2$F$$20240705$20240626$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102253$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$161.4$KG$20240709$$CN$US$US
240140832$24014083$2$F$20240621$20240708$20240626$20240712$PER$$US-AMGEN-USASP2024123596$AMGEN$$69$YR$E$F$Y$67$KG$20240711$$HP$US$US
240140843$24014084$3$F$20240623$20240809$20240626$20240813$PER$$US-AMGEN-USASP2024124898$AMGEN$$70$YR$E$M$Y$$$20240812$$CN$US$US
240140862$24014086$2$F$20240601$20240907$20240626$20240918$EXP$$IT-ROCHE-10000008076$ROCHE$$41$YR$A$F$Y$$$20240918$$MD$IT$IT
240140882$24014088$2$F$20210101$20240703$20240626$20240710$EXP$$BR-009507513-2406BRA007585$MERCK$$62$YR$$M$Y$$$20240710$$MD$BR$BR
240140902$24014090$2$F$20240101$20240628$20240626$20240703$EXP$$CA-UCBSA-2024007829$UCB$$$$$F$Y$$$20240703$$CN$CA$CA
240141242$24014124$2$F$$20240705$20240626$20240718$EXP$GB-MHRA-MED-202406141859256240-VGQKJ$GB-MACLEODS PHARMA-MAC2024047821$MACLEODS$$$$$$Y$$$20240718$$CN$GB$GB
240141363$24014136$3$F$20240101$20240722$20240626$20240725$PER$$US-Eisai-EC-2024-168282$EISAI$$64$YR$A$M$Y$77$KG$20240725$$CN$US$US
240141482$24014148$2$F$20240101$20240628$20240626$20240702$EXP$FR-AFSSAPS-AN2024000813$FR-LEO Pharma-371428$LEO PHARM$$62$YR$$F$Y$$$20240702$$PH$FR$FR
240141506$24014150$6$F$20240618$20240819$20240626$20240829$EXP$$US-GSK-US2024AMR077355$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240829$$CN$US$US
240141682$24014168$2$F$20240614$20240816$20240626$20240823$EXP$$CA-CELLTRION INC.-2024CA015445$CELLTRION$$$$$$Y$$$20240823$$MD$CA$CA
240141702$24014170$2$F$20240412$20240613$20240626$20240709$EXP$$PK-ROCHE-10000008325$ROCHE$$56$YR$A$M$Y$$$20240709$$CN$PK$PK
240141724$24014172$4$F$20240605$20240821$20240626$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017803$UNITED THERAPEUTICS$$52$YR$$F$Y$$$20240830$$$US$US
240141832$24014183$2$F$$20240730$20240626$20240806$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004585$BIOCON$$$$$$Y$$$20240806$$HP$CA$CA
240141872$24014187$2$F$$20240722$20240626$20240730$30DAY$$BR-JNJFOC-20240639249$JOHNSON AND JOHNSON$$40$YR$A$F$Y$67$KG$20240730$$CN$BR$BR
240141892$24014189$2$F$$20240701$20240626$20240705$EXP$$JP-JNJFOC-20240662044$JOHNSON AND JOHNSON$Jun TAKAHASHI et al. Department of Psychiatry, Dokkyo Medical University. A case of rhabdomyolysis after overdosing of RISPERIDONE. Proceeding of the 54th Annual Meeting of the Japanese Society of Neuropsychopharmacology/the 34th Annual Meeting of the Japanese Society of Clinical Neuropsychopharmacology (JSNP-JSCNP joint meeting);2024.5.24,25,26;Chioda-ku Tokyo:2024.$6$DEC$A$F$Y$$$20240705$$MD$JP$JP
240141912$24014191$2$F$20231201$20240621$20240626$20240702$EXP$$US-Accord-431623$ACCORD$$66$YR$E$F$Y$$$20240702$$CN$US$US
240141932$24014193$2$F$20240601$20240703$20240626$20240704$PER$$US-AMGEN-USASP2024121710$AMGEN$$67$YR$E$M$Y$$$20240704$$HP$US$US
240142042$24014204$2$F$$20240701$20240626$20240709$EXP$$US-TEVA-VS-3212149$TEVA$Midkiff JP, Gaba A, Munjal S. When Lorazepam Worsens Delirium in Your Catatonic Patient. Prim-Care-Comp-CNS-Disorders 2024; 26 (1):.; Midkiff JP, Gaba A, Munjal S. When Lorazepam Worsens Delirium in Your Catatonic Patient. Prim-Care-Comp-CNS-Disorders 2024; 26 (1):.; Midkiff JP, Gaba A, Munjal S. When Lorazepam Worsens Delirium in Your Catatonic Patient. Prim-Care-Comp-CNS-Disorders 2024; 26 (1):.$77$YR$$F$Y$$$20240709$$HP$US$US
240142128$24014212$8$F$20240101$20240830$20240626$20240907$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017425$UNITED THERAPEUTICS$$$$$F$Y$85.714$KG$20240907$$$US$US
240142172$24014217$2$F$$20240702$20240626$20240704$PER$$US-AMGEN-USASP2024125544$AMGEN$$$$$F$Y$$$20240704$$PH$US$US
240142182$24014218$2$F$20240619$20240729$20240626$20240731$30DAY$$US-AMGEN-USASP2024123590$AMGEN$$66$YR$E$F$Y$55.3$KG$20240731$$HP$US$US
240142272$24014227$2$F$20240601$20240703$20240626$20240705$PER$$US-AMGEN-USASP2024124641$AMGEN$$80$YR$E$F$Y$$$20240704$$CN$US$US
240142312$24014231$2$F$$20240808$20240626$20240813$PER$$US-AstraZeneca-2024A147264$ASTRAZENECA$$70$YR$$M$Y$$$20240813$$HP$US$
240142322$24014232$2$F$$20240723$20240626$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-019248$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240727$$$US$US
240142362$24014236$2$F$$20240814$20240626$20240821$EXP$$GB-TAKEDA-2024TUS037993$TAKEDA$$$$$F$Y$$$20240821$$CN$GB$GB
240142422$24014242$2$F$$20240703$20240626$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-091644$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240710$$PH$JP$JP
240142452$24014245$2$F$$20240701$20240626$20240709$EXP$$GB-TEVA-VS-3212508$TEVA$Dima A, Abdelsamie A, Clark-Castillo R, Webb-Wilson H, Shergill SS, Stanton B, et al. Overcoming Obstacles to Clozapine Treatment: A Case of Clozapine Rechallenge in ECT-Resistant Schizophrenia With Catatonic Features. J-Clin-Psychopharmacol 2024; 44 (2): 182-185.; Dima A, Abdelsamie A, Clark-Castillo R, Webb-Wilson H, Shergill SS, Stanton B, et al. Overcoming Obstacles to Clozapine Treatment: A Case of Clozapine Rechallenge in ECT-Resistant Schizophrenia With Catatonic Features. J-Clin-Psych...$55$YR$$M$Y$$$20240709$$MD$GB$GB
240142462$24014246$2$F$$20240731$20240626$20240806$EXP$$NVSJ2024JP007384$NOVARTIS$Honda Haruka, Nagatani Koji, Hayashi Masatoshi. Histological changes in WT1-nephropathy in which there were Alport syndrome-like changes and IgA deposition in the basement membrane. Japanese Journal of Pediatric Nephrology, the 59th Annual Meeting of the Japanes. 2024;38$10$YR$$F$Y$$$20240806$$HP$JP$JP
240142482$24014248$2$F$$20240923$20240626$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101122$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$HP$US$US
240142492$24014249$2$F$20240601$20240626$20240626$20240703$EXP$$US-ALKERMES INC.-ALK-2024-001605$ALKERMES$$55$YR$$M$Y$$$20240703$$HP$US$US
240142502$24014250$2$F$20240424$20240618$20240626$20240701$30DAY$$US-ALKERMES INC.-ALK-2024-001505$ALKERMES$$$$$$Y$$$20240701$$HP$US$US
240142512$24014251$2$F$$20240705$20240626$20240711$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001260$BLUEPRINT MEDICINES$$$$$M$Y$$$20240711$$CN$US$US
240142662$24014266$2$F$20240211$20240703$20240626$20240705$EXP$FR-AFSSAPS-NT2024000750$FR-SANDOZ INC.-SDZ2024FR060568$SANDOZ$$33$YR$$M$Y$81$KG$20240705$$MD$FR$FR
240142702$24014270$2$F$20240428$20240612$20240626$20240709$EXP$$PK-ROCHE-10000009081$ROCHE$$34$YR$A$M$Y$$$20240709$$CN$PK$PK
240142722$24014272$2$F$$20240626$20240626$20240701$PER$$US-ABBVIE-5814020$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240142752$24014275$2$F$20240508$20240710$20240626$20240713$EXP$GB-MHRA-MED-202406221014364970-LHFVP$GB-ABBVIE-5814553$ABBVIE$$$$$$Y$$$20240713$$CN$GB$GB
240142762$24014276$2$F$20240101$20240622$20240626$20240702$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015040$UNITED THERAPEUTICS$$$$$F$Y$63.946$KG$20240702$$$US$US
240142782$24014278$2$F$20240619$20240627$20240626$20240702$30DAY$$US-AMGEN-USASL2024122383$AMGEN$$67$YR$E$M$Y$$$20240702$$HP$US$US
240142792$24014279$2$F$20230801$20240705$20240626$20240715$EXP$$IT-AUROBINDO-AUR-APL-2024-030550$AUROBINDO$$80$YR$$M$Y$$$20240715$$MD$IT$IT
240142803$24014280$3$F$20210101$20240617$20240626$20240815$EXP$$US-ABBVIE-5809242$ABBVIE$$$$$F$Y$$$20240815$$MD$US$US
240142962$24014296$2$F$20240401$20240629$20240626$20240705$EXP$$JP-GENMAB-2024-01133$GENMAB$$82$YR$$F$Y$$$20240705$$MD$JP$JP
240143082$24014308$2$F$$20240703$20240626$20240705$EXP$$BR-ROCHE-10000000605$ROCHE$$74$YR$E$M$Y$$$20240706$$MD$BR$BR
240143112$24014311$2$F$20230522$20240713$20240626$20240716$PER$$US-AMGEN-USASP2024123649$AMGEN$$74$YR$E$F$Y$$$20240715$$CN$US$US
240143172$24014317$2$F$$20240717$20240626$20240722$EXP$$JP-JNJFOC-20240606030$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240722$$MD$JP$JP
240143202$24014320$2$F$$20240628$20240626$20240704$EXP$$JP-JNJFOC-20240665136$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$PH$JP$JP
240143522$24014352$2$F$$20240726$20240626$20240809$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202406-000743$UNICHEM$$18$YR$A$M$Y$$$20240809$$MD$US$
240143692$24014369$2$F$$20240716$20240626$20240726$30DAY$$US-GSK-US2024077258$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
240143742$24014374$2$F$$20240701$20240626$20240709$EXP$$US-TEVA-VS-3212675$TEVA$Hand J, Shah K, Chang A. Iatrogenic Cushing^s Syndrome With a Remote History of Synthetic Glucocorticoid Use in the Setting of a CYP3A4 Inhibitor - Location Matters. J-Endocr-Soc 2022; 6 (Suppl.) A110-A111.; Hand J, Shah K, Chang A. Iatrogenic Cushing^s Syndrome With a Remote History of Synthetic Glucocorticoid Use in the Setting of a CYP3A4 Inhibitor - Location Matters. J-Endocr-Soc 2022; 6 (Suppl.) A110-A111.$34$YR$$M$Y$$$20240709$$MD$US$US
240143932$24014393$2$F$$20240708$20240626$20240712$EXP$$GB-JNJFOC-20240666667$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240712$$CN$GB$GB
240143962$24014396$2$F$20240101$20240705$20240626$20240709$EXP$$RU-ABBVIE-5814960$ABBVIE$$5$YR$$F$Y$16$KG$20240709$$MD$RU$RU
240143974$24014397$4$F$20240521$20240815$20240626$20240822$EXP$$JP-GENMAB-2024-01816AA$GENMAB$$81$YR$$M$Y$$$20240822$$HP$JP$JP
240143992$24014399$2$F$$20240719$20240626$20240802$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451506$RANBAXY$Kene R, Singhai P, Raman R, Majumder PD. Presumed Fungal Retinitis Following Adalimumab Therapy for Juvenile Idiopathic Arthritis: A Rare Case Report. Ocul Immunol Inflamm. 2024;Jun10:1-5$20$YR$$F$Y$$$20240802$$MD$IN$IN
240144092$24014409$2$F$20231018$20240904$20240626$20240919$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453366$RANBAXY$$84$YR$$F$Y$48.5$KG$20240919$$MD$FR$FR
240144442$24014444$2$F$20231201$20240710$20240626$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453153$RANBAXY$$86$YR$$M$Y$58$KG$20240725$$MD$FR$FR
240144612$24014461$2$F$20240601$20240617$20240626$20240717$EXP$FR-AFSSAPS-LM2024000336$FR-009507513-2406FRA008429$MERCK$$48$YR$$F$Y$$$20240717$$MD$FR$FR
240144622$24014462$2$F$20240523$20240804$20240626$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449846$RANBAXY$$90$YR$E$M$Y$60$KG$20240816$$MD$CN$CN
240144726$24014472$6$F$20240101$20240815$20240626$20240823$PER$$US-ALKERMES INC.-ALK-2024-001701$ALKERMES$$33$YR$$M$Y$$$20240823$$HP$US$US
240144732$24014473$2$F$$20240627$20240626$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05301$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240144762$24014476$2$F$20240701$20240718$20240626$20240726$EXP$$US-GSK-US2024AMR076821$GLAXOSMITHKLINE$$58$YR$$F$Y$63$KG$20240726$$CN$US$US
240144792$24014479$2$F$20240503$20240622$20240626$20240703$EXP$FR-AFSSAPS-AM2024000500$FR-Accord-431048$ACCORD$$61$YR$A$F$Y$$$20240703$$MD$FR$FR
240145032$24014503$2$F$$20240823$20240626$20240827$EXP$$NVSC2023US266936$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
240145533$24014553$3$F$20240531$20240715$20240626$20240718$PER$$US-AMGEN-USASP2024122913$AMGEN$$65$YR$E$F$Y$82.37$KG$20240718$$HP$US$US
240145542$24014554$2$F$20230108$20240619$20240626$20240704$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452679$RANBAXY$Zhang D, Zheng Z. A Case of Long-Term SARS-CoV-2 Infection in a Patient with Follicular Lymphoma. Clin Lab. 2024;May; 70 (5):1051-1054$65$YR$$M$Y$$$20240704$$HP$CN$CN
240145552$24014555$2$F$20240616$20240715$20240626$20240715$PER$$US-AMGEN-USASP2024125319$AMGEN$$57$YR$A$F$Y$$$20240715$$CN$US$US
240145602$24014560$2$F$20240617$20240715$20240626$20240718$EXP$$AU-TAKEDA-2019TUS040543$TAKEDA$$57$YR$$F$Y$$$20240718$$CN$AU$AU
240145652$24014565$2$F$$20240701$20240626$20240703$PER$$NVSC2024US133130$NOVARTIS$$$$$F$Y$64$KG$20240703$$CN$US$US
240145882$24014588$2$F$20240611$20240709$20240626$20240712$PER$$US-BAYER-2024A090748$BAYER$$36$YR$A$F$Y$91.156$KG$20240712$$MD$US$US
240145913$24014591$3$F$$20240827$20240626$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-048513$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240903$$MD$JP$JP
240145933$24014593$3$F$$20240924$20240626$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-095592$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$PH$US$US
240146092$24014609$2$F$20240722$20240724$20240626$20240801$EXP$$US-AstraZeneca-2024A142969$ASTRAZENECA$$24447$DY$$F$Y$$$20240801$$CN$US$
240146102$24014610$2$F$$20240726$20240626$20240730$EXP$$US-GILEAD-2024-0677252$GILEAD$$$$E$F$Y$$$20240730$$MD$US$US
240146202$24014620$2$F$20230101$20240801$20240626$20240811$EXP$$BR-TEVA-VS-3211646$TEVA$$48$YR$$F$Y$$$20240811$$CN$BR$BR
240146212$24014621$2$F$$20240924$20240626$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102061$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240925$$CN$US$US
240146262$24014626$2$F$$20240704$20240626$20240715$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-02310$AMNEAL$$$$$$Y$$$20240715$$HP$JP$JP
240146282$24014628$2$F$$20240701$20240626$20240710$EXP$$DE-TEVA-VS-3212679$TEVA$Bruning KK, Pelivan E, Heinrich M-C, Bufler P, Kaindl A, Thumfart J. Acute kidney injury in lamotrigine-induced DRESS syndrome. Pediatr-Nephrol 2024;.; Bruning KK, Pelivan E, Heinrich M-C, Bufler P, Kaindl A, Thumfart J. Acute kidney injury in lamotrigine-induced DRESS syndrome. Pediatr-Nephrol 2024;.$17$YR$$F$Y$$$20240710$$HP$DE$DE
240146292$24014629$2$F$20150807$20240624$20240626$20240701$EXP$$JP-009507513-1508JPN004995$MERCK$$$$E$M$Y$$$20240701$$HP$JP$JP
240146392$24014639$2$F$20240615$20240705$20240626$20240715$EXP$$FR-TEVA-VS-3212601$TEVA$$51$YR$$M$Y$$$20240715$$PH$FR$FR
240146412$24014641$2$F$20240501$20240716$20240626$20240801$EXP$$US-SA-2024SA187132$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240719$$MD$US$US
240146442$24014644$2$F$20240201$20240617$20240626$20240923$EXP$$CZ-BAYER-2024A080731$BAYER$$29$YR$A$F$Y$$$20240923$$CN$CZ$CZ
240146482$24014648$2$F$20240617$20240702$20240626$20240709$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018647$UNITED THERAPEUTICS$$52$YR$$F$Y$54.422$KG$20240709$$PH$US$US
240146502$24014650$2$F$20240524$20240723$20240626$20240802$EXP$$DE-TEVA-VS-3212118$TEVA$$63$YR$$F$Y$95$KG$20240802$$MD$DE$DE
240146512$24014651$2$F$20240529$20240715$20240626$20240720$PER$$US-AMGEN-USASP2024122903$AMGEN$$67$YR$E$F$Y$85.7$KG$20240719$$PH$US$US
240146552$24014655$2$F$$20240830$20240626$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102381$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240903$$HP$US$US
240146602$24014660$2$F$$20240821$20240626$20240827$EXP$$JP-AMGEN-JPNSP2024123034$AMGEN$$$$E$F$Y$$$20240827$$HP$JP$JP
240146673$24014667$3$F$20240617$20240711$20240626$20240711$EXP$$GB-BAYER-2024A088203$BAYER$$51$YR$A$F$Y$$$20240711$$MD$GB$GB
240146722$24014672$2$F$$20240702$20240626$20240722$PER$$US-TEVA-VS-3210327$TEVA$$$$E$F$Y$$$20240722$$PH$US$US
240146785$24014678$5$F$$20240819$20240626$20240827$EXP$$CA-ROCHE-10000008748$ROCHE$$$$A$M$Y$$$20240827$$CN$CA$CA
240146832$24014683$2$F$$20240627$20240626$20240702$EXP$$US-GSK-US2024077168$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
240146932$24014693$2$F$$20240726$20240626$20240809$EXP$$MY-ROCHE-10000002532$ROCHE$$52$YR$A$F$Y$$$20240809$$CN$MY$MY
240147232$24014723$2$F$20231201$20240829$20240626$20240830$EXP$$NVSC2024US131449$NOVARTIS$$$$$$Y$$$20240830$$CN$US$US
240147273$24014727$3$F$$20240729$20240626$20240801$PER$$NVSC2024US133178$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
240147292$24014729$2$F$$20240910$20240626$20240918$PER$$US-ROCHE-10000006503$ROCHE$$$$A$F$Y$$$20240918$$MD$US$US
240147322$24014732$2$F$$20240730$20240626$20240807$EXP$$JP-Eisai-EC-2024-168455$EISAI$$43$YR$A$F$Y$$$20240807$$MD$JP$JP
240147453$24014745$3$F$$20240708$20240626$20240715$EXP$$HU-MYLANLABS-2024M1056412$MYLAN$A. Jona, E. Kiss, A. Kenyeres, L. Gergely, Z. Simon, A. Illes.. Our experience with Mosunetuzumab. Hematology-Transfusiology. 2024;76$64$YR$$M$Y$$$20240715$$MD$HU$HU
240147513$24014751$3$F$20240324$20240702$20240626$20240717$EXP$$US-TG THERAPEUTICS INC.-TGT003705$TG THERAPEUTICS$$$$$$Y$$$20240717$$HP$US$US
240147532$24014753$2$F$20240609$20240816$20240626$20240819$PER$$US-AMGEN-USASP2024125078$AMGEN$$85$YR$E$F$Y$$$20240819$$CN$US$US
240147643$24014764$3$F$$20240702$20240626$20240709$EXP$$GB-TERSERA THERAPEUTICS LLC-2024TRS003244$TERSERA THERAPEUTICS$$$$$$Y$$$20240709$$HP$GB$GB
240147692$24014769$2$F$20240624$20240624$20240626$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406016535$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240703$$CN$US$US
240147932$24014793$2$F$$20240925$20240626$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100199$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240925$$CN$US$US
240147942$24014794$2$F$$20240925$20240626$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102382$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$HP$US$US
240147952$24014795$2$F$20240301$20240829$20240626$20240903$EXP$$KR-BAYER-2024A089177$BAYER$$27$YR$A$F$Y$$$20240903$$MD$KR$KR
240148123$24014812$3$F$$20240729$20240626$20240805$EXP$$JP-ROCHE-10000008288$ROCHE$$$$A$F$Y$$$20240805$$MD$JP$JP
240148162$24014816$2$F$20231006$20240718$20240626$20240723$EXP$$JP-DSJP-DSJ-2024-124410$DAIICHI$$71$YR$$M$Y$58$KG$20240723$$MD$JP$JP
240148192$24014819$2$F$$20240715$20240626$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101470$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$100.7$KG$20240717$$CN$US$US
240148213$24014821$3$F$20240616$20240616$20240626$20240710$PER$$DE-Eisai-EC-2024-168662$EISAI$$20$YR$A$F$Y$60$KG$20240710$$PH$DE$DE
240148222$24014822$2$F$$20240702$20240626$20240710$EXP$$US-TEVA-VS-3212276$TEVA$El-Mais I, Nabil S, Nona P. A Case of Mesalamine Induced Myopericarditis. Circulation 2023; 148 (Suppl. 1) abstr. 12523.; El-Mais I, Nabil S, Nona P. A Case of Mesalamine Induced Myopericarditis. Circulation 2023; 148 (Suppl. 1) abstr. 12523.$18$YR$$M$Y$$$20240710$$HP$US$US
240148252$24014825$2$F$$20240705$20240626$20240711$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001261$BLUEPRINT MEDICINES$$$$$F$Y$$$20240711$$CN$US$US
240148263$24014826$3$F$$20240705$20240626$20240712$PER$$US-HALEON-2183856$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240148302$24014830$2$F$$20240725$20240626$20240730$PER$$US-AMGEN-USASP2024125693$AMGEN$$51$YR$A$F$Y$$$20240730$$MD$US$US
240148364$24014836$4$F$$20240819$20240626$20240913$30DAY$$AR-JNJFOC-20240635803$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$AR$AR
240148403$24014840$3$F$20240605$20240718$20240626$20240722$EXP$$TR-ROCHE-10000001769$ROCHE$$56$YR$A$$Y$56$KG$20240719$$MD$TR$TR
240148432$24014843$2$F$$20240729$20240626$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100519$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$59.87$KG$20240731$$CN$US$US
240148472$24014847$2$F$20240612$20240625$20240626$20240702$PER$$US-AMGEN-USASP2024117999$AMGEN$$40$YR$A$F$Y$$$20240702$$HP$US$US
240148622$24014862$2$F$$20240724$20240626$20240730$EXP$$CA-APOTEX-2024AP007467$APOTEX$$54$YR$$M$Y$$$20240730$$HP$CA$CA
240148672$24014867$2$F$$20240703$20240626$20240705$EXP$$JP-BEH-2024174607$CSL BEHRING$$$$$F$Y$$$20240705$$HP$JP$JP
240148715$24014871$5$F$20240322$20240717$20240626$20240724$PER$$US-AMGEN-USASP2024122402$AMGEN$$$$$F$Y$$$20240724$$PH$US$US
240148773$24014877$3$F$20240618$20240718$20240626$20240731$30DAY$$US-AMGEN-USASP2024122810$AMGEN$$52$YR$A$F$Y$87.982$KG$20240730$$PH$US$US
240148782$24014878$2$F$$20240628$20240626$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406016319$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240702$$CN$US$US
240148813$24014881$3$F$$20240716$20240626$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101858$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240719$$CN$US$US
240148822$24014882$2$F$$20240627$20240626$20240704$EXP$$US-ROCHE-10000008141$ROCHE$$77$YR$E$F$Y$$$20240704$$CN$US$US
240148872$24014887$2$F$20240601$20240703$20240626$20240710$EXP$$NVSC2024FR132259$NOVARTIS$$$$A$F$Y$$$20240710$$MD$FR$FR
240148912$24014891$2$F$$20240701$20240626$20240710$EXP$$US-TEVA-VS-3212277$TEVA$Almasri M, Ayyad M, Sanders E, Orcutt JW, Masri A, Zakaria D. A RARE CASE OF NEONATAL VENTRICULAR TACHYCARDIA. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3108.; Almasri M, Ayyad M, Sanders E, Orcutt JW, Masri A, Zakaria D. A RARE CASE OF NEONATAL VENTRICULAR TACHYCARDIA. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3108.$4$WK$$M$Y$$$20240710$$HP$US$US
240148953$24014895$3$F$$20240809$20240626$20240819$PER$$US-VERTEX PHARMACEUTICALS-2024-010512$VERTEX$$16$MON$$M$Y$$$20240819$$CN$US$US
240149012$24014901$2$F$20231213$20240717$20240626$20240724$EXP$$CA-TAKEDA-2023TUS065713$TAKEDA$$72$YR$$M$Y$$$20240724$$CN$CA$CA
240149063$24014906$3$F$20240601$20240731$20240626$20240808$PER$$US-BAYER-2024A090770$BAYER$$24$YR$A$F$Y$$$20240808$$MD$US$US
240149073$24014907$3$F$20201221$20240718$20240626$20240725$EXP$$DE-AMGEN-DEUNI2021050515$AMGEN$$54$YR$A$F$Y$91$KG$20240724$$MD$DE$DE
240149082$24014908$2$F$20220613$20240721$20240626$20240729$EXP$$CN-PFIZER INC-2022SGN12599$PFIZER$$78$YR$$M$Y$56$KG$20240729$$MD$CN$CN
240149112$24014911$2$F$$20240916$20240626$20240918$PER$$US-AGIOS-2406US03802$AGIOS PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
240149164$24014916$4$F$$20240614$20240626$20240709$PER$$US-ROCHE-10000004994$ROCHE$Salemi T F, McLean V R, Jnah A J. Congenital and Postnatal Cytomegalovirus: Case Series and State of the Science for Neonatal Providers. Neonatal Network.2024;Apr 1;43(2):92-104 DOI: 10.1891/NN-2023-0069.$$$I$F$Y$2.23$KG$20240701$$HP$US$US
240149192$24014919$2$F$20240619$20240625$20240626$20240710$PER$$US-IDORSIA-008134-2024-US$IDORSIA PHARMACEUTICALS$$63$YR$$F$Y$$$20240710$$CN$US$US
240149272$24014927$2$F$$20240711$20240626$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102568$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240715$$CN$US$US
240149424$24014942$4$F$20240620$20240708$20240626$20240711$PER$$US-AMGEN-USASP2024124547$AMGEN$$89$YR$E$M$Y$$$20240711$$CN$US$US
240149512$24014951$2$F$20240101$20240916$20240626$20240920$EXP$$US-ABBVIE-5815054$ABBVIE$$78$YR$$F$Y$$$20240920$$CN$US$US
240149522$24014952$2$F$20240624$20240729$20240626$20240803$EXP$$US-ABBVIE-5815120$ABBVIE$$66$YR$$F$Y$$$20240803$$CN$US$US
240149542$24014954$2$F$20240205$20240624$20240626$20240710$EXP$$CN-ROCHE-3569287$ROCHE$$79$YR$E$F$Y$$$20240710$$MD$CN$CN
240149612$24014961$2$F$20240521$20240703$20240626$20240708$EXP$$US-MYLANLABS-2024M1056987$MYLAN$$36$YR$$F$Y$97.52$KG$20240708$$MD$US$US
240149662$24014966$2$F$$20240625$20240626$20240701$EXP$$US-PFIZER INC-202400198319$PFIZER$Vallabhajosyula, S.. Fighting the Recovering Heart While Drowning in Volume: Role of VA-V ECMO Configuration in Migrating Mixing Cloud Effect. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5582$43$YR$$F$Y$$$20240701$$MD$US$US
240149672$24014967$2$F$$20240625$20240626$20240701$EXP$$US-PFIZER INC-202400199451$PFIZER$Sinha, A.. Ectopic Prostatic Tissue in Female Urethral Diverticulum. Obstetrics and gynecology. 2024;1-5$53$YR$$F$Y$$$20240701$$MD$US$US
240149684$24014968$4$F$20240620$20240711$20240626$20240716$EXP$$CA-PFIZER INC-202400198628$PFIZER$$70$YR$$F$Y$47.5$KG$20240716$$HP$CA$CA
240149693$24014969$3$F$20060423$20240702$20240626$20240704$EXP$$ES-PFIZER INC-202400200910$PFIZER$$74$YR$$M$Y$70$KG$20240704$$MD$ES$ES
240149702$24014970$2$F$$20240624$20240626$20240701$EXP$$US-PFIZER INC-202400198317$PFIZER$Shenouda, S.. A Rare Presentation of Local Anesthetic Systemic Toxicity. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3645$55$YR$$F$Y$$$20240701$$MD$US$US
240149714$24014971$4$F$20240612$20240717$20240626$20240717$EXP$$JP-PFIZER INC-PV202400081834$PFIZER$$81$YR$$M$Y$66.5$KG$20240717$$MD$JP$JP
240149722$24014972$2$F$$20240625$20240626$20240701$EXP$$US-PFIZER INC-202400200005$PFIZER$Carranza Morales, A.. A Painful Case of Asthma. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1_Meeting):A5999$43$YR$$F$Y$$$20240701$$MD$US$US
240149752$24014975$2$F$$20240625$20240626$20240701$EXP$$US-PFIZER INC-202400198324$PFIZER$Pickos, J.. Management of DIC in the Setting of Lung Adenocarcinoma Complicated by Pulmonary Embolism and Hemorrhagic Pericardial Effusion With Tamponade. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1_Meeting):A3551$63$YR$$F$Y$$$20240701$$MD$US$US
240149766$24014976$6$F$20230808$20240905$20240626$20240905$EXP$$AT-PFIZER INC-202400199731$PFIZER$$60$YR$$M$Y$$$20240905$$CN$AT$AT
240149782$24014978$2$F$$20240702$20240626$20240705$EXP$$GB-LABORATORIOS LICONSA S.A.-2406GB04969$INSUD PHARMA$$$$E$M$Y$$$20240705$$CN$GB$GB
240149815$24014981$5$F$$20240806$20240626$20240814$EXP$$GB-LABORATORIOS LICONSA S.A.-2406GB04973$INSUD PHARMA$$38$YR$$F$Y$$$20240814$$MD$GB$GB
240150092$24015009$2$F$$20240708$20240626$20240722$30DAY$$FR-JNJFOC-20240603504$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$PH$FR$FR
240150102$24015010$2$F$20240601$20240628$20240626$20240708$EXP$$CN-GILEAD-2024-0677348$GILEAD$$74$YR$E$F$Y$$$20240708$$HP$CN$CN
240150122$24015012$2$F$20240101$20240722$20240626$20240728$EXP$$US-ABBVIE-5815136$ABBVIE$$$$$M$Y$$$20240728$$CN$US$US
240150172$24015017$2$F$20240603$20240626$20240626$20240701$PER$$US-JNJFOC-20240629311$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240701$$CN$US$US
240150295$24015029$5$F$$20240703$20240626$20240722$PER$$US-PFIZER INC-202400199135$PFIZER$$63$YR$$F$Y$$$20240722$$MD$US$US
240150302$24015030$2$F$20240604$20240817$20240626$20240819$EXP$$CA-PFIZER INC-PV202400073382$PFIZER$$77$YR$$M$Y$89.3$KG$20240819$$MD$CA$CA
240150426$24015042$6$F$20220602$20240924$20240626$20240927$EXP$$CA-PFIZER INC-202200719969$PFIZER$$68$YR$$M$Y$$$20240927$$CN$CA$CA
240150452$24015045$2$F$20220428$20240716$20240626$20240722$EXP$$US-ROCHE-10000002196$ROCHE$$58$YR$A$F$Y$65.77$KG$20240719$$CN$US$US
240150482$24015048$2$F$$20240718$20240626$20240723$EXP$$GB-MYLANLABS-2024M1056857$MYLAN$$$$A$$Y$$$20240723$$HP$GB$GB
240150553$24015055$3$F$20240621$20240805$20240626$20240808$EXP$$BR-AMGEN-BRASP2024123703$AMGEN$$$$$F$Y$$$20240808$$CN$BR$BR
240150562$24015056$2$F$20240619$20240625$20240626$20240701$30DAY$$US-AMGEN-USASP2024121526$AMGEN$$$$$F$Y$$$20240701$$PH$US$US
240150822$24015082$2$F$20240531$20240717$20240626$20240722$EXP$$GB-MYLANLABS-2024M1057711$MYLAN$$$$$F$Y$$$20240722$$PH$GB$GB
240150842$24015084$2$F$$20240625$20240626$20240701$EXP$$GB-MYLANLABS-2024M1057732$MYLAN$$$$$M$Y$$$20240701$$HP$GB$GB
240150902$24015090$2$F$$20240712$20240626$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202406016765$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240717$$CN$US$US
240151045$24015104$5$F$20240530$20240715$20240626$20240724$PER$$US-ROCHE-3575404$ROCHE$$74$YR$E$F$Y$60.33$KG$20240724$$CN$US$US
240151062$24015106$2$F$20220901$20240812$20240626$20240816$EXP$$NVSC2024EG131416$NOVARTIS$$45$YR$$F$Y$82$KG$20240816$$CN$EG$EG
240151182$24015118$2$F$$20240702$20240626$20240709$EXP$US-MLMSERVICE-20240611-PI091830-00043-1$US-RDY-SPO/USA/24/0008824$DR REDDYS$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: A case series. Pediatric nephrology (Berlin, Germany). 2024. DOI: 10.1007/s00467-024-06413-6.$6$YR$C$F$Y$24.5$KG$20240709$$MD$US$US
240151192$24015119$2$F$$20240624$20240626$20240703$EXP$$JP-ARGENX-2024-ARGX-JP004498$ARGENX BVBA$$$$$$Y$$$20240703$$CN$JP$JP
240151222$24015122$2$F$20240601$20240730$20240626$20240807$PER$$US-MYLANLABS-2024M1054296$MYLAN$$53$YR$$F$Y$86.18$KG$20240807$$CN$US$US
240151273$24015127$3$F$$20240819$20240626$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099549$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240827$$CN$US$US
240151302$24015130$2$F$$20240719$20240626$20240724$EXP$$CA-ROCHE-10000008711$ROCHE$$$$A$F$Y$$$20240724$$CN$CA$CA
240151322$24015132$2$F$20240220$20240904$20240626$20240906$PER$$US-MYLANLABS-2024M1055583$MYLAN$$75$YR$$M$Y$81.65$KG$20240906$$CN$US$US
240151352$24015135$2$F$$20240625$20240626$20240703$PER$$NVSC2024US133277$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240151382$24015138$2$F$$20240701$20240626$20240709$EXP$$US-TEVA-VS-3212409$TEVA$Mohamed Jiffry MZ, Ahmed-khan MA, Vargas JA, Thomas T, Josey S. Hemophagocytic Lymphohystiocytosis in a Patient with Post-Acute COVID-19 Infection. Blood 2022; 140 (1) 11183.; Mohamed Jiffry MZ, Ahmed-khan MA, Vargas JA, Thomas T, Josey S. Hemophagocytic Lymphohystiocytosis in a Patient with Post-Acute COVID-19 Infection. Blood 2022; 140 (1) 11183.$73$YR$$M$Y$$$20240709$$HP$US$US
240151393$24015139$3$F$20240611$20240716$20240626$20240731$30DAY$$GB-JNJFOC-20240634210$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$GB$GB
240151404$24015140$4$F$20240618$20240819$20240626$20240822$EXP$$NVSC2024DE130278$NOVARTIS$$70$YR$$F$Y$$$20240822$$MD$DE$DE
240151493$24015149$3$F$20240602$20240710$20240626$20240712$EXP$$US-ORGANON-O2406USA002318$ORGANON$$20$YR$$F$Y$78.912$KG$20240712$$MD$US$US
240151702$24015170$2$F$20230101$20240709$20240626$20240717$EXP$$FR-REGENERON PHARMACEUTICALS, INC.-2024-016985$REGENERON$$84$YR$$F$Y$$$20240717$$CN$FR$FR
240151713$24015171$3$F$$20240719$20240626$20240731$EXP$$IN-ROCHE-10000008968$ROCHE$$71$YR$E$F$Y$$$20240731$$CN$IN$IN
240151792$24015179$2$F$$20240919$20240626$20240927$EXP$$JP-009507513-2406JPN003014J$MERCK$$54$YR$$F$Y$$$20240927$$MD$JP$JP
240151843$24015184$3$F$20230927$20240827$20240626$20240906$EXP$$GB-AMRYT PHARMACEUTICALS DAC-AEGR007214$AEGERION$$$$$$Y$$$20240906$$PH$GB$GB
240152024$24015202$4$F$20240621$20240829$20240626$20240904$PER$$US-PFIZER INC-202400198825$PFIZER$$69$YR$$F$Y$72.562$KG$20240904$$CN$US$US
240152042$24015204$2$F$20240625$20240702$20240626$20240703$PER$$US-PFIZER INC-202400200700$PFIZER$$79$YR$$M$Y$80.29$KG$20240703$$CN$US$US
240152062$24015206$2$F$20240601$20240625$20240626$20240701$PER$$US-PFIZER INC-202400197767$PFIZER$$41$YR$$F$Y$$$20240701$$CN$US$US
240152102$24015210$2$F$20240622$20240730$20240626$20240802$PER$$US-PFIZER INC-202400198835$PFIZER$$72$YR$$F$Y$58.957$KG$20240802$$HP$US$US
240152213$24015221$3$F$20240101$20240911$20240626$20240913$PER$$US-PFIZER INC-PV202400083752$PFIZER$$77$YR$$F$Y$$$20240913$$CN$US$US
240152313$24015231$3$F$20240601$20240719$20240626$20240724$PER$$US-PFIZER INC-PV202400082574$PFIZER$$79$YR$$M$Y$$$20240724$$HP$US$US
240152464$24015246$4$F$20240618$20240725$20240626$20240801$30DAY$$US-JNJFOC-20240653830$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240801$$HP$US$US
240152552$24015255$2$F$20240601$20240727$20240626$20240729$PER$$US-PFIZER INC-202400200949$PFIZER$$13$YR$$M$Y$37.8$KG$20240729$$HP$US$US
240152593$24015259$3$F$20240616$20240702$20240626$20240705$EXP$$US-KARYOPHARM-2024KPT001204$KARYOPHARM THERAPEUTICS$$53$YR$$M$Y$86.6$KG$20240705$$MD$US$US
240152622$24015262$2$F$20240529$20240729$20240626$20240807$PER$$US-MYLANLABS-2024M1055672$MYLAN$$75$YR$$M$Y$114.31$KG$20240807$$CN$US$US
240152664$24015266$4$F$20240101$20240821$20240626$20240828$EXP$$JP-009507513-2406JPN003011J$MERCK$$7$DEC$$F$Y$$$20240828$$MD$JP$JP
240152684$24015268$4$F$20240606$20240719$20240626$20240906$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007083$AEGERION$$0$YR$$F$Y$4.639$KG$20240906$$CN$US$US
240152744$24015274$4$F$$20240826$20240626$20240829$30DAY$$US-PFIZER INC-202400197187$PFIZER$$6$YR$$M$Y$17.24$KG$20240829$$MD$US$US
240152753$24015275$3$F$$20240913$20240626$20240918$30DAY$$US-PFIZER INC-202400197788$PFIZER$$15$YR$$F$Y$$$20240918$$CN$US$US
240152775$24015277$5$F$$20240912$20240626$20240916$30DAY$$US-PFIZER INC-202400197636$PFIZER$$12$YR$$M$Y$$$20240916$$CN$US$US
240152784$24015278$4$F$$20240919$20240626$20240924$30DAY$$US-PFIZER INC-202400196986$PFIZER$$13$YR$$M$Y$41.28$KG$20240924$$CN$US$US
240152803$24015280$3$F$$20240911$20240626$20240913$30DAY$$US-PFIZER INC-202400197114$PFIZER$$15$YR$$M$Y$$$20240913$$CN$US$US
240152815$24015281$5$F$$20240822$20240626$20240827$30DAY$$US-PFIZER INC-202400195323$PFIZER$$43$YR$$F$Y$74.39$KG$20240827$$CN$US$US
240152822$24015282$2$F$$20240818$20240626$20240819$30DAY$$CO-PFIZER INC-PV202400082080$PFIZER$$6$YR$$M$Y$$$20240819$$CN$CO$CO
240152846$24015284$6$F$$20240819$20240626$20240821$30DAY$$US-PFIZER INC-202400197391$PFIZER$$22$YR$$F$Y$51.26$KG$20240821$$CN$US$US
240152856$24015285$6$F$$20240923$20240626$20240926$30DAY$$US-PFIZER INC-202400198189$PFIZER$$17$YR$$M$Y$147.42$KG$20240926$$MD$US$US
240152864$24015286$4$F$20240601$20240813$20240626$20240816$30DAY$$US-PFIZER INC-202400197999$PFIZER$$10$YR$$M$Y$$$20240816$$CN$US$US
240152873$24015287$3$F$$20240911$20240626$20240916$30DAY$$US-PFIZER INC-202400191529$PFIZER$$3$YR$$F$Y$$$20240916$$CN$US$US
240152932$24015293$2$F$20240607$20240704$20240626$20240709$EXP$$NVSC2024GB125415$NOVARTIS$$$$$F$Y$$$20240709$$CN$GB$GB
240152964$24015296$4$F$$20240814$20240626$20240819$EXP$$US-BEH-2024174490$CSL BEHRING$$$$E$F$Y$$$20240819$$HP$US$US
240153132$24015313$2$F$20240101$20240916$20240626$20240920$EXP$$US-ABBVIE-5813082$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
240153162$24015316$2$F$20240620$20240808$20240626$20240810$PER$$US-AMGEN-USASP2024123605$AMGEN$$50$YR$A$M$Y$$$20240810$$CN$US$US
240153182$24015318$2$F$20231201$20240716$20240626$20240724$EXP$$US-ABBVIE-5807479$ABBVIE$$76$YR$$F$Y$$$20240724$$CN$US$US
240153192$24015319$2$F$20240613$20240626$20240626$20240710$EXP$$AU-ROCHE-3568263$ROCHE$$44$YR$A$F$Y$$$20240710$$HP$AU$AU
240153212$24015321$2$F$20240621$20240719$20240626$20240723$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036010$BOEHRINGER INGELHEIM$$58$YR$A$F$Y$30$KG$20240723$$HP$CO$CO
240153273$24015327$3$F$$20240628$20240626$20240705$PER$$US-BIOGEN-2024BI01271035$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
240153302$24015330$2$F$20240624$20240705$20240626$20240709$PER$$US-AMGEN-USASP2024124889$AMGEN$$15$YR$T$M$Y$$$20240709$$PH$US$US
240153324$24015332$4$F$$20240906$20240626$20240910$30DAY$$CA-PFIZER INC-202400191376$PFIZER$$$$$F$Y$$$20240910$$HP$CA$CA
240153332$24015333$2$F$$20240904$20240626$20240910$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001253$BLUEPRINT MEDICINES$$$$$F$Y$$$20240910$$MD$US$US
240153345$24015334$5$F$20240101$20240918$20240626$20240924$EXP$$CA-PFIZER INC-202400093720$PFIZER$$34$YR$$F$Y$$$20240924$$MD$CA$CA
240153362$24015336$2$F$$20240712$20240626$20240718$EXP$$CZ-PFIZER INC-202400200568$PFIZER$Janikova, A.. Treatment of ALCL in an elderly patient with comorbidities. Farmakoterapie. 2024;20 (Suppl 6):9-10$85$YR$$M$Y$$$20240718$$MD$CZ$CZ
240153452$24015345$2$F$20240621$20240624$20240626$20240712$PER$$US-ABBVIE-5815639$ABBVIE$$$$$F$Y$$$20240712$$MD$US$US
240153462$24015346$2$F$$20240722$20240626$20240730$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001259$BLUEPRINT MEDICINES$$$$$F$Y$$$20240730$$CN$US$US
240153496$24015349$6$F$20240101$20240926$20240626$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100298$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$98.4$KG$20240930$$CN$US$US
240153512$24015351$2$F$$20240724$20240626$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100521$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$72.57$KG$20240802$$CN$US$US
240153522$24015352$2$F$20240601$20240724$20240626$20240730$EXP$$PT-ORGANON-O2406PRT002211$ORGANON$$25$YR$$F$Y$$$20240730$$MD$PT$PT
240153572$24015357$2$F$$20240910$20240626$20240916$EXP$$US-ABBVIE-5813119$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
240153736$24015373$6$F$20240610$20240816$20240626$20240823$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-095569$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$59.7$KG$20240823$$HP$CH$CH
240153753$24015375$3$F$20240130$20240611$20240626$20240802$EXP$$PL-ROCHE-10000002186$ROCHE$$72$YR$E$M$Y$$$20240802$$MD$PL$PL
240153892$24015389$2$F$20240419$20240711$20240626$20240717$EXP$FR-AFSSAPS-BX2024001179$FR-MYLANLABS-2024M1056437$MYLAN$$63$YR$$F$Y$$$20240717$$PH$FR$FR
240153963$24015396$3$F$20240701$20240715$20240626$20240724$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001263$BLUEPRINT MEDICINES$$73$YR$E$M$Y$$$20240724$$HP$US$US
240153972$24015397$2$F$$20240702$20240626$20240725$PER$$US-TOLMAR, INC.-24US049588$TOLMAR$$$$$M$Y$$$20240725$$HP$US$US
240153982$24015398$2$F$20240523$20240709$20240626$20240729$PER$$US-TOLMAR, INC.-24US049739$TOLMAR$$68$YR$$M$Y$$$20240729$$MD$US$US
240153992$24015399$2$F$20240522$20240711$20240626$20240801$PER$$US-TOLMAR, INC.-24US049744$TOLMAR$$$$$$Y$$$20240801$$HP$US$US
240154002$24015400$2$F$$20240625$20240626$20240703$PER$$CA-PFM-2024-03679$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240703$$MD$CA$CA
240154032$24015403$2$F$20240501$20240624$20240626$20240702$EXP$$BR-JNJFOC-20240619538$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240702$$CN$BR$BR
240154082$24015408$2$F$$20240627$20240626$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05300$LUPIN$$$$$$Y$$$20240714$$PH$US$US
240154112$24015411$2$F$20230912$20240702$20240626$20240709$EXP$$CA-GSK-CA2023125959$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$HP$CA$CA
240154162$24015416$2$F$20240612$20240701$20240626$20240702$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406009275$ELI LILLY AND CO$$89$YR$E$F$Y$$$20240702$$CN$JP$JP
240154264$24015426$4$F$20240615$20240829$20240626$20240904$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406014683$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240904$$CN$JP$JP
240154533$24015453$3$F$20240101$20240703$20240626$20240705$PER$$US-AMGEN-USASP2024125432$AMGEN$$68$YR$E$M$Y$$$20240705$$CN$US$US
240154662$24015466$2$F$$20240701$20240626$20240708$EXP$$US-TAKEDA-2024TUS038635$TAKEDA$$$$$M$Y$$$20240708$$MD$US$US
240154755$24015475$5$F$20240501$20240815$20240626$20240830$PER$$US-ASTELLAS-2024US017895$ASTELLAS$$50$YR$A$F$Y$$$20240830$$MD$US$US
240154782$24015478$2$F$20240101$20240823$20240626$20240830$EXP$$US-AMGEN-USASL2024124254$AMGEN$$77$YR$E$F$Y$$$20240829$$CN$US$US
240154862$24015486$2$F$20240501$20240710$20240626$20240717$EXP$$JP-AMGEN-JPNSP2024121542$AMGEN$$$$E$F$Y$$$20240716$$MD$JP$JP
240154903$24015490$3$F$20240514$20240805$20240626$20240809$EXP$$JP-AMGEN-JPNSP2024110202$AMGEN$$89$YR$E$F$Y$40$KG$20240809$$MD$JP$JP
240155052$24015505$2$F$20240423$20240711$20240626$20240717$EXP$FR-AFSSAPS-BX2024001177$FR-MYLANLABS-2024M1056434$MYLAN$$68$YR$$F$Y$$$20240717$$PH$FR$FR
240155082$24015508$2$F$20240501$20240726$20240626$20240809$PER$$US-MYLANLABS-2024M1056024$MYLAN$$68$YR$$F$Y$71.66$KG$20240809$$CN$US$US
240155092$24015509$2$F$$20240802$20240626$20240808$EXP$$ES-MYLANLABS-2024M1056495$MYLAN$$66$YR$$F$Y$$$20240808$$MD$ES$ES
240155282$24015528$2$F$$20240726$20240626$20240726$PER$$US-PFIZER INC-PV202400082855$PFIZER$$13$YR$$M$Y$$$20240726$$MD$US$US
240155362$24015536$2$F$20240623$20240701$20240626$20240701$PER$$US-PFIZER INC-202400199446$PFIZER$$$$$F$Y$$$20240701$$CN$US$US
240155422$24015542$2$F$20240622$20240722$20240626$20240726$PER$$US-AMGEN-USASP2024124530$AMGEN$$66$YR$E$M$Y$$$20240726$$CN$US$US
240155452$24015545$2$F$20240607$20240801$20240626$20240806$EXP$$CO-JNJFOC-20240663953$JOHNSON AND JOHNSON$$71$YR$E$F$Y$65$KG$20240806$$HP$CO$CO
240155462$24015546$2$F$20240601$20240806$20240626$20240808$PER$$US-AMGEN-USASP2024124489$AMGEN$$75$YR$E$F$Y$$$20240808$$CN$US$US
240155532$24015553$2$F$20240101$20240821$20240626$20240821$EXP$$CA-PFIZER INC-202400199978$PFIZER$$49$YR$$M$Y$$$20240821$$CN$CA$CA
240155593$24015559$3$F$$20240820$20240626$20240828$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001269$BLUEPRINT MEDICINES$$$$$M$Y$$$20240828$$CN$US$US
240155832$24015583$2$F$$20240718$20240626$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001274$BLUEPRINT MEDICINES$$$$$F$Y$$$20240726$$CN$US$US
240155882$24015588$2$F$20240325$20240704$20240626$20240712$EXP$$FR-JNJFOC-20240653847$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240712$$MD$FR$FR
240155982$24015598$2$F$20240101$20240627$20240626$20240706$EXP$$CA-AMGEN-CANSL2024123714$AMGEN$$60$YR$A$F$Y$$$20240706$$MD$CA$CA
240156032$24015603$2$F$20240601$20240708$20240626$20240711$EXP$$PT-ABBVIE-5814368$ABBVIE$$57$YR$$M$Y$$$20240711$$CN$PT$PT
240156082$24015608$2$F$$20240806$20240626$20240820$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000876$ALEMBIC$Pattupara A, Nguyen D, Gaikwad M, Gnirke M, Yarra S, Su M. et.al.. Breaking the Spell: A Rare Case of Prolonged Benzodiazepine Elimination. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240820$$HP$US$US
240156192$24015619$2$F$$20240820$20240626$20240827$EXP$$CA-ABBVIE-5814983$ABBVIE$$82$YR$$F$Y$$$20240827$$CN$CA$CA
240156202$24015620$2$F$20240609$20240709$20240626$20240718$PER$$US-AstraZeneca-2024A144871$ASTRAZENECA$$26086$DY$$M$Y$$$20240718$$CN$US$
240156252$24015625$2$F$$20240722$20240626$20240730$EXP$$BR-TPU-TPU-2024-00348$TEIKOKU$$78$YR$E$M$Y$$$20240731$$CN$BR$BR
240156312$24015631$2$F$20240101$20240702$20240626$20240704$EXP$$US-JNJFOC-20240660800$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240704$$HP$US$US
240156322$24015632$2$F$20240101$20240924$20240626$20240927$EXP$$US-JNJFOC-20240658989$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240927$$CN$US$US
240156434$24015643$4$F$20230216$20240926$20240626$20240930$EXP$$CH-ABBVIE-4320102$ABBVIE$$70$YR$$M$Y$77$KG$20240930$$MD$CH$CH
240156495$24015649$5$F$20231001$20240815$20240626$20240820$30DAY$$US-PFIZER INC-202400194268$PFIZER$$12$YR$$M$Y$$$20240820$$CN$US$US
240156542$24015654$2$F$$20240924$20240626$20240930$EXP$$US-INCYTE CORPORATION-2024IN006669$INCYTE$$$$$$Y$$$20240930$$CN$US$US
240156682$24015668$2$F$$20240730$20240626$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST003847$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240801$$CN$US$US
240156734$24015673$4$F$20240605$20240805$20240626$20240812$30DAY$$US-ALKERMES INC.-ALK-2024-001564$ALKERMES$$$$$F$Y$$$20240812$$MD$US$US
240156742$24015674$2$F$20240318$20240819$20240626$20240903$EXP$$NL-AMGEN-NLDNI2024063571$AMGEN$$51$YR$A$M$Y$$$20240902$$CN$NL$NL
240156825$24015682$5$F$20231001$20240723$20240626$20240726$EXP$$US-PFIZER INC-202400200175$PFIZER$$48$YR$$F$Y$88.45$KG$20240726$$CN$US$US
240156833$24015683$3$F$$20240819$20240626$20240823$EXP$$CA-PFIZER INC-202300458036$PFIZER$$86$YR$$M$Y$70.2$KG$20240823$$HP$CA$CA
240156852$24015685$2$F$$20240711$20240626$20240718$EXP$$CA-PFIZER INC-202400199811$PFIZER$$73$YR$$M$Y$$$20240718$$HP$CA$CA
240156862$24015686$2$F$20230101$20240820$20240626$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202406011032$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240827$$MD$US$US
240157032$24015703$2$F$$20240624$20240626$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014102$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240705$$CN$US$US
240157062$24015706$2$F$20240505$20240704$20240626$20240713$EXP$IT-MINISAL02-989563$IT-TEVA-VS-3211476$TEVA$$6$YR$$M$Y$28$KG$20240713$$PH$IT$IT
240157122$24015712$2$F$20240531$20240716$20240626$20240813$30DAY$$US-Kaleo, Inc.-2024KL000015$KALEO$$14$YR$T$F$Y$$$20240812$$CN$US$US
240157132$24015713$2$F$$20240715$20240626$20240724$EXP$$CZ-MYLANLABS-2024M1057421$MYLAN$Veres M, Ustohal L. Malignant catatonia in a patient with undifferentiated schizophrenia. PSYCHIATRIE PRO PRAX. 2024;25(2):99-102$46$YR$$M$Y$$$20240724$$MD$CZ$CZ
240157312$24015731$2$F$20240516$20240916$20240626$20240919$EXP$$ES-JNJFOC-20240662430$JOHNSON AND JOHNSON$$72$YR$E$F$Y$157$KG$20240919$$HP$ES$ES
240157452$24015745$2$F$$20240710$20240626$20240711$EXP$$ES-SANDOZ INC.-SDZ2024ES060587$SANDOZ$$41$YR$$F$Y$$$20240711$$MD$ES$ES
240157512$24015751$2$F$20240607$20240628$20240626$20240701$EXP$$CN-PFIZER INC-PV202400083019$PFIZER$$7$YR$$M$Y$20.5$KG$20240701$$HP$CN$CN
240157552$24015755$2$F$20240620$20240627$20240626$20240703$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003518$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240703$$CN$CA$CA
240157582$24015758$2$F$20240614$20240626$20240626$20240701$EXP$IT-MINISAL02-991614$IT-PFIZER INC-202400199343$PFIZER$$62$YR$$M$Y$95$KG$20240701$$HP$IT$IT
240157622$24015762$2$F$20130204$20240627$20240626$20240701$EXP$$BR-PFIZER INC-2013050737$PFIZER$$63$YR$$F$Y$68$KG$20240701$$CN$BR$BR
240157632$24015763$2$F$$20240820$20240626$20240824$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035837$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240824$$CN$US$US
240157642$24015764$2$F$20240520$20240702$20240626$20240703$EXP$FR-AFSSAPS-AN2024000826$FR-ORGANON-O2406FRA002300$ORGANON$$58$YR$$F$Y$90$KG$20240703$$PH$FR$FR
240157703$24015770$3$F$20240524$20240723$20240626$20240725$EXP$$US-PFIZER INC-202400180338$PFIZER$$77$YR$$F$Y$$$20240725$$CN$US$US
240157733$24015773$3$F$20240613$20240715$20240626$20240717$EXP$IT-MINISAL02-991673$IT-PFIZER INC-202400199324$PFIZER$$64$YR$$F$Y$43$KG$20240717$$MD$IT$IT
240157753$24015775$3$F$$20240807$20240626$20240813$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001281$BLUEPRINT MEDICINES$$$$$M$Y$$$20240813$$HP$US$US
240157772$24015777$2$F$$20240628$20240626$20240705$EXP$$KR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035225$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$$$20240705$$MD$KR$KR
240157822$24015782$2$F$$20240626$20240626$20240701$PER$$US-LEO Pharma-371424$LEO PHARM$$22$YR$$M$Y$$$20240701$$HP$US$US
240157842$24015784$2$F$20240618$20240731$20240626$20240806$EXP$$CN-PFIZER INC-PV202400069743$PFIZER$$22$YR$$M$Y$$$20240806$$CN$CN$CN
240157852$24015785$2$F$$20240625$20240626$20240701$EXP$$US-PFIZER INC-202400200249$PFIZER$Barrows, C.. A Case of Acute Hypoxic Respiratory Failure After Administration of Rituximab. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6326$61$YR$$M$Y$$$20240701$$MD$US$US
240157903$24015790$3$F$$20240701$20240626$20240702$EXP$$US-PFIZER INC-202400198330$PFIZER$Wireko, F.. Lung Transplant for Acute Exacerbation in Interstitial Pneumonia With Autoimmune Features (IPAF). American Journal of Respiratory and Critical Care Medicine. 2024;209 (1_Meeting):A5934$63$YR$$M$Y$$$20240702$$MD$US$US
240157943$24015794$3$F$$20240719$20240626$20240723$EXP$$US-PFIZER INC-202400199907$PFIZER$$96$YR$$F$Y$45.351$KG$20240723$$CN$US$US
240157953$24015795$3$F$20240101$20240828$20240626$20240829$EXP$$US-UCBSA-2024032433$UCB$$$$$F$Y$$$20240829$$CN$US$US
240157982$24015798$2$F$$20240708$20240626$20240710$EXP$$NVSC2024US131622$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
240158012$24015801$2$F$20240202$20240709$20240626$20240712$PER$$US-AMGEN-USASP2024123044$AMGEN$$59$YR$A$F$Y$86.2$KG$20240712$$PH$US$US
240158022$24015802$2$F$20240620$20240722$20240626$20240729$30DAY$$US-AMGEN-USASL2024124464$AMGEN$$66$YR$E$M$Y$$$20240729$$PH$US$US
240158032$24015803$2$F$20240101$20240624$20240626$20240702$PER$$US-AMGEN-USASP2024124763$AMGEN$$84$YR$E$F$Y$$$20240702$$CN$US$US
240158073$24015807$3$F$20240108$20240722$20240626$20240729$EXP$$CA-GSK-CA2023061555$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$PH$CA$CA
240158135$24015813$5$F$$20240913$20240626$20240913$30DAY$$US-PFIZER INC-202400199074$PFIZER$$14$YR$$M$Y$$$20240913$$CN$US$US
240158155$24015815$5$F$20240501$20240911$20240626$20240913$30DAY$$US-PFIZER INC-202400198728$PFIZER$$7$YR$$F$Y$21$KG$20240913$$CN$US$US
240158182$24015818$2$F$$20240905$20240626$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202406016994$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240918$$CN$US$US
240158253$24015825$3$F$$20240723$20240626$20240731$EXP$$US-Stemline Therapeutics, Inc.-2024ST003869$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240726$$CN$US$US
240158592$24015859$2$F$20240506$20240712$20240626$20240722$PER$$US-MYLANLABS-2024M1055644$MYLAN$$51$YR$$F$Y$77.11$KG$20240722$$CN$US$US
240158602$24015860$2$F$20240201$20240715$20240626$20240722$EXP$$ES-MYLANLABS-2024M1057737$MYLAN$$73$YR$$F$Y$$$20240722$$MD$ES$ES
240158632$24015863$2$F$$20240701$20240626$20240704$EXP$$US-CIPLA LTD.-2024US06536$CIPLA$Almazan EP, Ellaicy O, Carter DJ, Kaleka K, Faruqi M.. Another case of the blues, methylene blue as adjunctive therapy in calcium-channel blocker induced vasoplegia. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5655$$$$$Y$$$20240704$$MD$US$US
240158722$24015872$2$F$$20240723$20240626$20240725$EXP$$IL-PFIZER INC-PV202400084050$PFIZER$$50$YR$$F$Y$$$20240725$$MD$IL$IL
240158762$24015876$2$F$$20240710$20240626$20240715$EXP$$MY-PFIZER INC-202400200303$PFIZER$$38$YR$$M$Y$$$20240715$$PH$MY$MY
240158832$24015883$2$F$$20240822$20240626$20240822$EXP$$PK-PFIZER INC-PV202400056768$PFIZER$$58$YR$$M$Y$85$KG$20240822$$CN$PK$PK
240158852$24015885$2$F$20240120$20240626$20240626$20240711$EXP$$EG-CIPLA LTD.-2024EG06333$CIPLA$$$$$$Y$$$20240711$$PH$EG$EG
240158862$24015886$2$F$20231122$20240626$20240626$20240711$EXP$$EG-CIPLA LTD.-2024EG06334$CIPLA$$$$$$Y$$$20240711$$CN$EG$EG
240158872$24015887$2$F$$20240620$20240626$20240704$EXP$$US-CIPLA LTD.-2024US06542$CIPLA$Beesley S, Lanspa MJ.. Calcium channel overdose and insulin therapy dosing. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7313$$$$$Y$$$20240704$$MD$US$US
240158922$24015892$2$F$$20240701$20240626$20240703$EXP$$US-CIPLA LTD.-2024US06476$CIPLA$Delgado D, Gomez M.. A case of Keppra-induced Torsades de Pointes in a patient with congenital long QT Syndrome.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A3647$$$$$Y$$$20240703$$MD$US$US
240159002$24015900$2$F$$20240621$20240626$20240703$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091700$GLENMARK$Benandi K, Sieving D, Wolf K.. A rare case of meloxicam-induced pseudoporphyria. Dermatology Online Journal. 2024;30(2): 19:1-3$$$$$Y$$$20240703$$MD$US$US
240159012$24015901$2$F$$20240619$20240626$20240918$EXP$$NVSC2024US132019$NOVARTIS$$$$$$Y$$$20240918$$CN$US$US
240159112$24015911$2$F$$20240920$20240626$20240930$EXP$$JP-Eisai-EC-2024-168360$EISAI$$63$YR$A$M$Y$$$20240930$$PH$JP$JP
240159133$24015913$3$F$$20240826$20240626$20240912$PER$$US-Calliditas-2024CAL00737$CALLIDITAS THERAPEUTICS$$58$YR$A$M$Y$$$20240912$$CN$US$US
240159252$24015925$2$F$20240611$20240702$20240626$20240709$EXP$$CA-GSK-CA2024077148$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$CA$CA
240159392$24015939$2$F$$20240618$20240626$20240712$EXP$$JP-AstraZeneca-2021A032987$ASTRAZENECA$Nishida,M et al.. Two cases of PPI/P-CAB-associated gastric polyps that presented with bleeding and shrunk or disappeared after discontinuation of PPI/P-CAB medication. The Japanese Society of Gastroenterology + Japan Gastroenterological Endoscopy Society 2024;$54$YR$$M$Y$$$20240712$$MD$JP$
240159442$24015944$2$F$$20240613$20240626$20240731$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-11994$IPSEN$$$$$$Y$$$20240731$$PH$US$US
240159492$24015949$2$F$$20240730$20240626$20240807$EXP$$BR-BIOVITRUM-2024-BR-009114$BIOVITRUM$$$$$F$Y$$$20240807$$MD$BR$BR
240159573$24015957$3$F$$20240822$20240626$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101753$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240826$$CN$US$US
240159622$24015962$2$F$20230929$20240718$20240626$20240723$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2023-173938$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240723$$CN$IT$IT
240159694$24015969$4$F$$20240711$20240626$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101210$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240716$$CN$US$US
240159702$24015970$2$F$$20240924$20240626$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102121$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$HP$US$US
240159813$24015981$3$F$20240623$20240912$20240626$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101767$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$76.2$KG$20240920$$CN$US$US
240159854$24015985$4$F$20240601$20240925$20240626$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102617$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240925$$CN$US$US
240159882$24015988$2$F$20240528$20240925$20240626$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102067$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240925$$HP$US$US
240159913$24015991$3$F$$20240813$20240626$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101178$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240820$$CN$US$US
240159974$24015997$4$F$20230704$20240716$20240626$20240723$EXP$$MY-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036182$BOEHRINGER INGELHEIM$$37$YR$A$M$Y$$$20240719$$PH$MY$MY
240159982$24015998$2$F$20240614$20240710$20240626$20240715$EXP$$JP-SHIONOGI INC.-2024001427$SHIONOGI$$$$$$Y$$$20240715$$MD$JP$JP
240160002$24016000$2$F$20240522$20240709$20240626$20240710$EXP$$NVSC2024GB131309$NOVARTIS$$87$YR$$M$Y$82.3$KG$20240711$$HP$GB$GB
240160063$24016006$3$F$20240621$20240903$20240626$20240904$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-129138$DAIICHI$$30$YR$$M$Y$$$20240904$$HP$US$US
240160122$24016012$2$F$$20240627$20240626$20240703$PER$$US-ROCHE-10000008986$ROCHE$$$$A$M$Y$80.29$KG$20240703$$CN$US$US
240160144$24016014$4$F$20240301$20240826$20240626$20240829$PER$$US-ROCHE-10000008585$ROCHE$$38$YR$A$M$Y$83.5$KG$20240829$$MD$US$US
240160222$24016022$2$F$20240610$20240722$20240626$20240729$PER$$US-ROCHE-10000008107$ROCHE$$13$YR$T$M$Y$$$20240729$$CN$US$US
240160232$24016023$2$F$20240608$20240703$20240626$20240709$PER$$US-ROCHE-10000007969$ROCHE$$25$YR$A$F$Y$$$20240709$$CN$US$US
240160362$24016036$2$F$$20240624$20240626$20240704$EXP$$US-AstraZeneca-2024A142423$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$US$
240160433$24016043$3$F$20240601$20240910$20240626$20240918$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036132$BOEHRINGER INGELHEIM$$9$YR$C$M$Y$20.3$KG$20240918$$MD$US$US
240160523$24016052$3$F$$20240801$20240626$20240806$EXP$$US-TAKEDA-2024TUS063143$TAKEDA$$$$$M$Y$$$20240806$$CN$US$US
240160542$24016054$2$F$$20240808$20240626$20240812$EXP$$PE-JNJFOC-20240658739$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240812$$HP$PE$PE
240160582$24016058$2$F$$20240627$20240626$20240702$EXP$DE-DEXPHARM-20110349$DE-BAUSCH-BL-2024-009602$BAUSCH AND LOMB$Pfersdorff M, Spes J, Kraus M. 17-Jahriger Patient mit Neutropenie und Fieber unter Therapie mit Analgetika. Kasuistik. 2011 FEB 01;136:365-368. doi:10.1055/s-0031-1272537$17$YR$$M$Y$$$20240702$$HP$DE$DE
240160602$24016060$2$F$20240525$20240722$20240626$20240725$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003536$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
240160612$24016061$2$F$$20240724$20240626$20240801$30DAY$$AU-JNJFOC-20240629541$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$PH$AU$AU
240160703$24016070$3$F$20050930$20240722$20240626$20240729$EXP$$NL-FERRINGPH-2005FE00805$FERRING$$$$$$Y$$$20240729$$HP$NL$NL
240160725$24016072$5$F$20240531$20240906$20240626$20240911$EXP$$US-TAKEDA-2024TUS060000$TAKEDA$$55$YR$$F$Y$72$KG$20240911$$CN$US$US
240160803$24016080$3$F$$20240703$20240626$20240730$EXP$$CA-SA-2024SA186421$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240730$$HP$CA$CA
240160832$24016083$2$F$$20240619$20240626$20240702$PER$$US-ROCHE-10000008363$ROCHE$$49$YR$A$F$Y$$$20240702$$HP$US$US
240160853$24016085$3$F$$20240725$20240626$20240801$30DAY$$BR-JNJFOC-20240627232$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$PH$BR$BR
240160922$24016092$2$F$20240706$20240708$20240626$20240710$PER$$US-PFIZER INC-202400200197$PFIZER$$70$YR$$M$Y$92.08$KG$20240710$$CN$US$US
240160962$24016096$2$F$20240101$20240829$20240626$20240904$PER$$US-PFIZER INC-PV202400083227$PFIZER$$45$YR$$F$Y$$$20240904$$HP$US$US
240161013$24016101$3$F$$20240820$20240626$20240822$30DAY$$US-PFIZER INC-202400193561$PFIZER$$4$YR$$M$Y$$$20240822$$CN$US$US
240161023$24016102$3$F$$20240927$20240626$20240930$30DAY$$US-PFIZER INC-202400197663$PFIZER$$6$YR$$F$Y$$$20240930$$CN$US$US
240161053$24016105$3$F$20240622$20240715$20240626$20240717$PER$$US-PFIZER INC-202400199770$PFIZER$$73$YR$$M$Y$$$20240717$$CN$US$US
240161072$24016107$2$F$20230101$20240826$20240626$20240829$PER$$US-PFIZER INC-PV202400083198$PFIZER$$64$YR$$F$Y$$$20240829$$HP$US$US
240161098$24016109$8$F$$20240718$20240626$20240722$PER$$US-PFIZER INC-PV202400077905$PFIZER$$85$YR$$M$Y$$$20240722$$MD$US$US
240161102$24016110$2$F$$20240626$20240626$20240918$30DAY$$AT-PFIZER INC-202400201138$PFIZER$$$$$$Y$$$20240918$$HP$AT$AT
240161132$24016113$2$F$$20240821$20240626$20240822$PER$$NVSC2024US133385$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
240161252$24016125$2$F$20240101$20240809$20240626$20240826$PER$$US-SA-2024SA179486$SANOFI AVENTIS$$$$A$M$Y$128$KG$20240826$$MD$US$US
240161262$24016126$2$F$20240501$20240618$20240626$20240701$PER$$HM-SA-2024SA182793$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240701$$MD$US$US
240161312$24016131$2$F$$20240711$20240626$20240801$PER$$US-SA-2024SA181813$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240719$$CN$US$US
240161372$24016137$2$F$$20240911$20240626$20240919$PER$$US-SA-2024SA182018$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240919$$MD$US$US
240161432$24016143$2$F$20230101$20240617$20240626$20240701$PER$$US-SA-2024SA182318$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240701$$MD$US$US
240161552$24016155$2$F$20240101$20240718$20240626$20240729$PER$$US-SA-2024SA182222$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240729$$MD$US$US
240161653$24016165$3$F$20240101$20240618$20240626$20240702$PER$$US-SA-2024SA181447$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240702$$HP$US$US
240161692$24016169$2$F$20240615$20240624$20240626$20240704$PER$$US-SA-2024SA184270$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240704$$MD$US$US
240161723$24016172$3$F$20240617$20240729$20240626$20240801$30DAY$$US-AMGEN-USASP2024121665$AMGEN$$51$YR$A$F$Y$116.55$KG$20240801$$PH$US$US
240161732$24016173$2$F$20240614$20240725$20240626$20240731$PER$$US-AMGEN-USASP2024121642$AMGEN$$$$$$Y$$$20240731$$PH$US$US
240161743$24016174$3$F$20240619$20240727$20240626$20240730$PER$$US-AMGEN-USASP2024125824$AMGEN$$81$YR$E$M$Y$$$20240730$$CN$US$US
240161753$24016175$3$F$20240606$20240729$20240626$20240801$PER$$US-AMGEN-USASP2024122126$AMGEN$$$$$$Y$$$20240801$$PH$US$US
240161863$24016186$3$F$20240101$20240722$20240626$20240728$PER$$US-SA-2024SA185945$SANOFI AVENTIS$$75$YR$E$M$Y$104.3$KG$20240728$$MD$US$US
240161972$24016197$2$F$20240501$20240705$20240626$20240717$PER$$US-SA-2024SA186473$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240717$$MD$US$US
240162022$24016202$2$F$20240101$20240708$20240626$20240717$PER$$US-SA-2024SA186493$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240717$$MD$US$US
240162052$24016205$2$F$$20240814$20240626$20240828$PER$$US-SA-2024SA183426$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
240162062$24016206$2$F$20240101$20240712$20240626$20240723$PER$$US-SA-2024SA184610$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240723$$MD$US$US
240162073$24016207$3$F$20240101$20240831$20240626$20240917$PER$$US-SA-2024SA182949$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240918$$MD$US$US
240162122$24016212$2$F$$20240703$20240626$20240712$PER$$US-SA-2024SA186926$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240712$$CN$US$US
240162132$24016213$2$F$$20240620$20240626$20240704$PER$$US-SA-2024SA186929$SANOFI AVENTIS$$$$T$F$Y$104.3$KG$20240704$$MD$US$US
240162152$24016215$2$F$20240101$20240719$20240626$20240731$PER$$US-SA-2024SA185192$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240731$$MD$US$US
240162242$24016224$2$F$$20240821$20240626$20240830$PER$$US-SA-2024SA183468$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240830$$MD$US$US
240162292$24016229$2$F$20240601$20240625$20240626$20240702$PER$$US-SA-2024SA186114$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240702$$MD$US$US
240162334$24016233$4$F$20240101$20240809$20240626$20240820$PER$$US-SA-2024SA182408$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240820$$MD$US$US
240162392$24016239$2$F$$20240626$20240626$20240705$PER$$US-SA-2024SA183999$SANOFI AVENTIS$$90$YR$E$F$Y$$$20240705$$CN$US$US
240162402$24016240$2$F$$20240822$20240626$20240914$PER$$US-SA-2024SA186628$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$MD$US$US
240162503$24016250$3$F$20240910$20240911$20240626$20240917$PER$$US-SA-2024SA183034$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240918$$MD$US$US
240162592$24016259$2$F$20240613$20240628$20240626$20240708$30DAY$$US-ALKERMES INC.-ALK-2024-001634$ALKERMES$$35$YR$$M$Y$165$KG$20240708$$HP$US$US
240162603$24016260$3$F$20240603$20240708$20240626$20240722$30DAY$$US-ALKERMES INC.-ALK-2024-001542$ALKERMES$$44$YR$$F$Y$$$20240722$$HP$US$US
240162632$24016263$2$F$$20240731$20240626$20240809$PER$$US-SA-2024SA185278$SANOFI AVENTIS$$$$C$M$Y$15.92$KG$20240809$$MD$US$US
240162762$24016276$2$F$20240601$20240627$20240626$20240708$PER$$US-SA-2024SA186471$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240708$$MD$US$US
240162792$24016279$2$F$20240301$20240911$20240626$20240918$PER$$US-SA-2024SA185293$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240918$$MD$US$US
240162942$24016294$2$F$20240101$20240814$20240626$20240827$PER$$US-SA-2024SA177803$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240827$$MD$US$US
240162972$24016297$2$F$20240101$20240813$20240626$20240826$PER$$US-SA-2024SA186454$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240826$$MD$US$US
240163102$24016310$2$F$20230101$20240730$20240626$20240808$PER$$US-SA-2024SA184767$SANOFI AVENTIS$$$$A$M$Y$79.3$KG$20240808$$MD$US$US
240163142$24016314$2$F$20240305$20240702$20240626$20240711$PER$$US-SA-2024SA184048$SANOFI AVENTIS$$34$YR$A$M$Y$65$KG$20240711$$MD$US$US
240163163$24016316$3$F$20240101$20240828$20240626$20240910$PER$$US-SA-2024SA184022$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240910$$MD$US$US
240163182$24016318$2$F$20240601$20240702$20240626$20240711$PER$$US-SA-2024SA184011$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240711$$MD$US$US
240163202$24016320$2$F$$20240719$20240626$20240801$PER$$US-SA-2024SA183428$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240801$$MD$US$US
240163212$24016321$2$F$20240101$20240904$20240626$20240913$PER$$US-SA-2024SA183979$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240913$$MD$US$US
240163262$24016326$2$F$$20240813$20240626$20240828$PER$$US-SA-2024SA182655$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240828$$MD$US$US
240163533$24016353$3$F$20240618$20240815$20240626$20240826$PER$$US-SA-2024SA187687$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240826$$MD$US$US
240163712$24016371$2$F$20240620$20240621$20240626$20240705$PER$$US-SA-2024SA185504$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240705$$HP$US$US
240163723$24016372$3$F$20240620$20240708$20240626$20240717$PER$$US-SA-2024SA187702$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240717$$MD$US$US
240163792$24016379$2$F$$20240729$20240626$20240807$PER$$US-SA-2024SA187952$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240807$$MD$US$US
240163812$24016381$2$F$$20240624$20240626$20240703$PER$$US-SA-2024SA188372$SANOFI AVENTIS$$74$YR$E$F$Y$60$KG$20240703$$MD$US$US
240163863$24016386$3$F$$20240904$20240626$20240906$30DAY$$CA-PFIZER INC-202400200855$PFIZER$$$$$$Y$$$20240906$$HP$CA$CA
240163875$24016387$5$F$$20240917$20240626$20240919$30DAY$$DO-PFIZER INC-PV202400082066$PFIZER$$6$YR$$M$Y$$$20240919$$HP$DO$DO
240163883$24016388$3$F$$20240820$20240626$20240822$30DAY$$US-PFIZER INC-202400198971$PFIZER$$7$YR$$F$Y$$$20240822$$CN$US$US
240163892$24016389$2$F$$20240726$20240626$20240726$30DAY$$US-PFIZER INC-PV202400082612$PFIZER$$$$$M$Y$$$20240726$$CN$US$US
240163912$24016391$2$F$$20240806$20240626$20240816$PER$$US-SA-2024SA186649$SANOFI AVENTIS$$$$A$F$Y$64.4$KG$20240816$$MD$US$US
240163943$24016394$3$F$20240616$20240702$20240626$20240709$PER$$US-SA-2024SA183995$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240709$$MD$US$US
240164012$24016401$2$F$20220104$20240712$20240626$20240718$EXP$$ES-MYLANLABS-2022M1016228$MYLAN$$51$YR$$M$Y$89$KG$20240718$$HP$ES$ES
240164082$24016408$2$F$20240601$20240625$20240626$20240702$PER$$US-SA-2024SA184889$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240702$$CN$US$US
240164202$24016420$2$F$20240605$20240807$20240626$20240812$EXP$$CA-JNJFOC-20240660227$JOHNSON AND JOHNSON$$0$YR$N$F$Y$2.724$KG$20240812$$HP$CA$CA
240164312$24016431$2$F$20240101$20240913$20240626$20240923$PER$$US-SA-2024SA186664$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240923$$MD$US$US
240164333$24016433$3$F$20240605$20240718$20240626$20240731$30DAY$$FR-JNJFOC-20240617480$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240731$$PH$FR$FR
240164352$24016435$2$F$$20240925$20240626$20240927$30DAY$$CO-PFIZER INC-PV202400082776$PFIZER$$$$$$Y$$$20240927$$CN$CO$CO
240164374$24016437$4$F$$20240926$20240626$20240930$30DAY$$US-PFIZER INC-202400199116$PFIZER$$14$YR$$M$Y$$$20240930$$CN$US$US
240164383$24016438$3$F$$20240916$20240626$20240919$30DAY$$CO-PFIZER INC-202400198788$PFIZER$$$$$M$Y$$$20240919$$CN$CO$CO
240164492$24016449$2$F$$20240726$20240626$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA060639$SANDOZ$$58$YR$$M$Y$$$20240730$$HP$CA$CA
240164642$24016464$2$F$$20240701$20240626$20240710$EXP$$DE-INCYTE CORPORATION-2024IN006771$INCYTE$$$$$$Y$$$20240710$$MD$DE$DE
240164663$24016466$3$F$20240604$20240709$20240626$20240725$30DAY$$FR-JNJFOC-20240612676$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240725$$PH$FR$FR
240164782$24016478$2$F$$20240712$20240626$20240717$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-129149$DAIICHI$$$$$M$Y$$$20240717$$CN$US$US
240164872$24016487$2$F$$20240702$20240626$20240703$PER$$US-PFIZER INC-202400200784$PFIZER$$$$$F$Y$$$20240703$$CN$US$US
240164882$24016488$2$F$$20240630$20240626$20240702$PER$$US-PFIZER INC-PV202400071195$PFIZER$$66$YR$$F$Y$$$20240702$$CN$US$US
240164892$24016489$2$F$20240624$20240625$20240626$20240701$PER$$US-PFIZER INC-202400199829$PFIZER$$77$YR$$M$Y$71.67$KG$20240701$$CN$US$US
240164902$24016490$2$F$$20240828$20240626$20240906$EXP$$US-ASTELLAS-2022US026223$ASTELLAS$$78$YR$E$M$Y$85.3$KG$20240906$$CN$US$US
240164932$24016493$2$F$20240101$20240626$20240626$20240701$PER$$US-AMGEN-USASP2024125589$AMGEN$$69$YR$E$F$Y$$$20240701$$CN$US$US
240164942$24016494$2$F$20240520$20240701$20240626$20240702$EXP$$FR-AMERICAN REGENT INC-2024002388$AMERICAN REGENT$$72$YR$$M$Y$83$KG$20240702$$MD$FR$FR
240164963$24016496$3$F$20240101$20240711$20240626$20240726$PER$$US-APOTEX-2024AP007221$APOTEX$$$$E$M$Y$$$20240726$$CN$US$US
240164973$24016497$3$F$$20240716$20240626$20240718$EXP$$KR-TAKEDA-2024TUS063376$TAKEDA$$62$YR$$F$Y$$$20240718$$CN$KR$KR
240165113$24016511$3$F$20240625$20240916$20240626$20240917$PER$$US-AMGEN-USASP2024125623$AMGEN$$92$YR$E$F$Y$$$20240917$$PH$US$US
240165123$24016512$3$F$20240610$20240730$20240626$20240801$PER$$US-ALXN-202406USA001221US$ALEXION PHARMACEUTICALS$$55$YR$$F$Y$101.59$KG$20240801$$CN$US$US
240165303$24016530$3$F$20240101$20240809$20240626$20240812$EXP$$DE-SANDOZ INC.-SDZ2024DE022829$SANDOZ$$62$YR$$M$Y$140$KG$20240812$$HP$DE$DE
240165313$24016531$3$F$20240620$20240718$20240626$20240723$EXP$$DE-BIOMARINAP-DE-2024-158770$BIOMARIN$$$$$$Y$$$20240723$$HP$DE$DE
240165342$24016534$2$F$$20240821$20240626$20240822$30DAY$$US-SANDOZ INC.-SDZ2024US060819$SANDOZ$$$$$F$Y$$$20240822$$CN$US$US
240165372$24016537$2$F$$20240715$20240626$20240717$EXP$$US-SANDOZ INC.-SDZ2024US060372$SANDOZ$$$$$$Y$$$20240717$$CN$US$US
240165412$24016541$2$F$$20240708$20240626$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101708$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$72.57$KG$20240711$$CN$US$US
240165424$24016542$4$F$$20240819$20240626$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102563$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240822$$CN$US$US
240165432$24016543$2$F$20240507$20240701$20240626$20240709$PER$$US-APELLIS-2024-APL-0000122$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
240165603$24016560$3$F$20240531$20240716$20240626$20240722$PER$$US-SA-2024SA186691$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240720$$MD$US$US
240165613$24016561$3$F$20240101$20240829$20240626$20240913$PER$$US-SA-2024SA187610$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240913$$CN$US$US
240165702$24016570$2$F$$20240705$20240626$20240716$EXP$$US-INSMED, INC.-2024-02489-US$INSMED$$$$$M$Y$$$20240716$$CN$US$US
240165712$24016571$2$F$$20240701$20240626$20240703$PER$$US-BIOMARINAP-US-2024-158714$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240165733$24016573$3$F$20240202$20240827$20240626$20240905$EXP$$JP-BIOMARINAP-JP-2024-158802$BIOMARIN$$$$$$Y$$$20240905$$CN$JP$JP
240165753$24016575$3$F$20230714$20240912$20240626$20240916$EXP$$US-AMERICAN REGENT INC-2024002424$AMERICAN REGENT$$38$YR$$F$Y$$$20240916$$PH$US$US
240165852$24016585$2$F$20240520$20240813$20240626$20240816$EXP$FR-AFSSAPS-PO2024000702$FR-ABBVIE-5813634$ABBVIE$$60$YR$$F$Y$107$KG$20240816$$MD$FR$FR
240165882$24016588$2$F$$20240719$20240626$20240729$PER$$US-SA-2024SA184016$SANOFI AVENTIS$$$$A$F$Y$151.5$KG$20240729$$MD$US$US
240165962$24016596$2$F$20240618$20240912$20240626$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202406017685$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240913$$CN$US$US
240166013$24016601$3$F$20230526$20240717$20240626$20240729$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202406012473$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240729$$CN$FR$FR
240166034$24016603$4$F$20240211$20240923$20240626$20240926$EXP$$TH-TAKEDA-2024TUS061027$TAKEDA$$14$YR$$M$Y$63$KG$20240926$$HP$TH$TH
240166062$24016606$2$F$20220411$20240719$20240626$20240726$EXP$$US-ABBVIE-5811296$ABBVIE$$43$YR$$M$Y$81$KG$20240726$$CN$US$US
240166553$24016655$3$F$$20240722$20240626$20240725$PER$$NVSC2024US131969$NOVARTIS$$$$$M$Y$91$KG$20240725$$HP$US$US
240166563$24016656$3$F$20230720$20240701$20240626$20240705$EXP$$US-ABBVIE-4760860$ABBVIE$$30$YR$$F$Y$77.11$KG$20240705$$CN$US$US
240166602$24016660$2$F$$20240802$20240626$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102372$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240808$$HP$US$US
240166633$24016663$3$F$$20240924$20240626$20240930$EXP$$JP-APELLIS-2024-APL-0000346$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240930$$CN$JP$JP
240166672$24016667$2$F$20240101$20240802$20240626$20240806$EXP$$CA-ABBVIE-5815482$ABBVIE$$64$YR$$F$Y$$$20240806$$MD$CA$CA
240166682$24016668$2$F$$20240607$20240626$20240802$PER$$US-INCYTE CORPORATION-2024IN006153$INCYTE$$$$$$Y$$$20240802$$CN$US$US
240166733$24016673$3$F$20240415$20240828$20240626$20240903$EXP$PT-INFARMED-T202406-83$PT-MYLANLABS-2024M1056537$MYLAN$$51$YR$$F$Y$63$KG$20240903$$PH$PT$PT
240166822$24016682$2$F$20240101$20240625$20240626$20240701$EXP$$US-ABBVIE-5813096$ABBVIE$$$$$M$Y$108.86$KG$20240701$$CN$US$US
240166843$24016684$3$F$20240101$20240701$20240626$20240708$EXP$$DE-ABBVIE-5814375$ABBVIE$$$$$F$Y$$$20240708$$CN$DE$DE
240166942$24016694$2$F$20240101$20240704$20240626$20240716$PER$$US-SA-2024SA186893$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240716$$MD$US$US
240166972$24016697$2$F$20240101$20240627$20240626$20240701$EXP$$US-ABBVIE-5815736$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240167042$24016704$2$F$$20240819$20240626$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102624$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240827$$CN$US$US
240167092$24016709$2$F$20240606$20240626$20240626$20240708$EXP$$US-APELLIS-2024-APL-0000300$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$US$US
240167143$24016714$3$F$20240615$20240627$20240626$20240710$EXP$$CA-PFIZER INC-2021664942$PFIZER$$55$YR$$M$Y$$$20240710$$CN$CA$CA
240167153$24016715$3$F$20220411$20240628$20240626$20240702$EXP$$CN-PFIZER INC-2022SGN03851$PFIZER$$26$YR$$M$Y$70$KG$20240702$$MD$CN$CN
240167173$24016717$3$F$$20240910$20240626$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202406016028$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240912$$CN$US$US
240167202$24016720$2$F$$20240620$20240626$20240702$EXP$$NVSC2024GT131615$NOVARTIS$$$$$M$Y$$$20240702$$CN$GT$GT
240167232$24016723$2$F$20240601$20240625$20240626$20240703$EXP$$JP-AstraZeneca-2024A143693$ASTRAZENECA$$80$YR$$M$Y$$$20240703$$MD$JP$
240167262$24016726$2$F$20240605$20240815$20240626$20240821$EXP$$JP-009507513-2406JPN002857J$MERCK$$$$$F$Y$$$20240821$$MD$JP$JP
240167403$24016740$3$F$20240423$20240911$20240626$20240917$EXP$$JP-PFIZER INC-202400200275$PFIZER$$72$YR$$M$Y$63.7$KG$20240917$$MD$JP$JP
240167442$24016744$2$F$20140101$20240625$20240626$20240710$EXP$$US-PARTNER THERAPEUTICS-2024PTX00027$SYMOGEN$$$$$F$Y$65.76$KG$20240710$$CN$US$US
240167532$24016753$2$F$$20240826$20240626$20240910$PER$$US-SA-2024SA186333$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$MD$US$US
240167613$24016761$3$F$$20240827$20240626$20240829$EXP$$CA-PFIZER INC-202400200755$PFIZER$$54$YR$$F$Y$$$20240829$$HP$CA$CA
240167722$24016772$2$F$20240301$20240704$20240626$20240709$EXP$$MX-BAYER-2024A092112$BAYER$$6$YR$C$M$Y$$$20240709$$CN$MX$MX
240167752$24016775$2$F$20240101$20240808$20240626$20240815$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-088055$REGENERON$$$$$F$Y$$$20240815$$CN$US$US
240167762$24016776$2$F$$20240619$20240626$20240904$EXP$$NVSC2024US130733$NOVARTIS$Lam E, Santos C, Patrawalla AS. A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose. AM-J-RESPIR-CRIT-CARE-MED. 2024;209:A5651$32$YR$$F$Y$$$20240904$$HP$US$US
240167772$24016777$2$F$20240623$20240729$20240626$20240731$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009825$JAZZ$$46$YR$$M$Y$$$20240731$$HP$US$US
240167792$24016779$2$F$$20240625$20240626$20240709$EXP$$US-GILEAD-2024-0678601$GILEAD$$$$$F$Y$$$20240709$$HP$US$US
240167812$24016781$2$F$20230501$20240621$20240626$20240705$EXP$$NVSC2023DE158719$NOVARTIS$$65$YR$$F$Y$$$20240705$$CN$DE$DE
240167852$24016785$2$F$$20240702$20240626$20240715$EXP$$PT-SMPA-2024SPA000073$SUNOVION$$$$$$Y$$$20240715$$CN$PT$PT
240167923$24016792$3$F$$20240815$20240626$20240823$PER$$US-ABBVIE-5813570$ABBVIE$$$$$$Y$$$20240823$$HP$US$US
240168012$24016801$2$F$$20240807$20240626$20240923$PER$$US-LUNDBECK-DKLU3077909$LUNDBECK$$$$$$Y$$$20240923$$HP$US$US
240168173$24016817$3$F$20240101$20240726$20240626$20240730$EXP$$US-PFIZER INC-202400199823$PFIZER$$73$YR$$M$Y$81.65$KG$20240730$$CN$US$US
240168252$24016825$2$F$$20240901$20240626$20240903$EXP$$NVSC2024US130169$NOVARTIS$Schultz L, Davis KL, Walkush A, Baggott C, Erickson C, Ramakrishna S et al. Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD.. JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023;11 (e004851):1-4$$$C$F$Y$$$20240903$$HP$US$US
240168284$24016828$4$F$20240722$20240827$20240626$20240829$EXP$$US-JNJFOC-20240655046$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240829$$CN$US$US
240168352$24016835$2$F$20240505$20240719$20240626$20240725$EXP$$JP-Eisai-EC-2024-168361$EISAI$$$$E$F$Y$$$20240725$$MD$JP$JP
240168422$24016842$2$F$$20240802$20240626$20240805$PER$$NVSC2024US133297$NOVARTIS$$45$YR$$F$Y$$$20240805$$MD$US$US
240168502$24016850$2$F$$20240627$20240626$20240702$EXP$$TW-009507513-2406TWN009059$MERCK$$72$YR$$M$Y$$$20240702$$MD$TW$TW
240168512$24016851$2$F$20240529$20240624$20240626$20240709$PER$$US-APELLIS-2024-APL-0000240$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
240168522$24016852$2$F$20230914$20240711$20240626$20240724$EXP$$US-APELLIS-APL-2023-002976$APELLIS PHARMACEUTICALS$Andre J. Witkin, MD, FASRS1 , Glenn J. Jaffe, MD2, Sunil K. Srivastava, MD3, Janet L. Davis, MD4, Judy E. Kim, MD, FARVO, FASRS5, and the ReST Committee. Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee.Journal of VitreoRetinal Diseases . 2023;. doi:10.1177/24741264231220224$$$$$Y$$$20240724$$MD$US$US
240168574$24016857$4$F$$20240808$20240626$20240816$EXP$$GB-APELLIS-2024-APL-0000321$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240816$$HP$GB$GB
240168742$24016874$2$F$20240708$20240708$20240626$20240709$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036356$BOEHRINGER INGELHEIM$$67$YR$E$$Y$$$20240709$$CN$US$US
240168782$24016878$2$F$$20240927$20240626$20240930$30DAY$$GR-SANDOZ INC.-SDZ2024GR059738$SANDOZ$$10$YR$$M$Y$$$20240930$$CN$GR$GR
240168862$24016886$2$F$20240501$20240830$20240626$20240902$EXP$$NVSC2024US124499$NOVARTIS$$36$YR$$F$Y$43.5$KG$20240902$$CN$US$US
240168882$24016888$2$F$$20240709$20240626$20240716$PER$$US-JNJFOC-20240669107$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$CN$US$US
240168913$24016891$3$F$$20240802$20240626$20240805$PER$$US-ALXN-202406USA001180US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240168942$24016894$2$F$20240622$20240711$20240626$20240715$EXP$$DE-TAKEDA-2024TUS063857$TAKEDA$$63$YR$$F$Y$$$20240715$$CN$DE$DE
240168972$24016897$2$F$20240101$20240723$20240626$20240903$PER$$US-Merz Pharmaceuticals GmbH-24-01798$MERZ$$58$YR$$F$Y$$$20240904$$HP$US$US
240169082$24016908$2$F$20240122$20240724$20240626$20240801$EXP$$JP-APELLIS-2024-APL-0000332$APELLIS PHARMACEUTICALS$$$$$$Y$55$KG$20240801$$MD$JP$JP
240169163$24016916$3$F$20231001$20240628$20240626$20240710$EXP$$ES-APELLIS-APL-2023-003211$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240710$$MD$ES$ES
240169305$24016930$5$F$$20240903$20240626$20240909$EXP$$JP-AMGEN-JPNSP2024124630$AMGEN$$$$$F$Y$$$20240909$$CN$JP$JP
240169342$24016934$2$F$$20240705$20240626$20240709$PER$$US-JNJFOC-20240657712$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$LW$US$US
240169362$24016936$2$F$$20240618$20240626$20240703$PER$$US-BIOGEN-2024BI01270390$BIOGEN$$41$YR$$F$Y$$$20240703$$MD$US$US
240169382$24016938$2$F$20240423$20240711$20240626$20240716$PER$$US-JNJFOC-20240654020$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240716$$PH$US$US
240169503$24016950$3$F$20240620$20240802$20240626$20240806$PER$$US-AMGEN-USASP2024124077$AMGEN$$56$YR$A$F$Y$$$20240806$$CN$US$US
240169532$24016953$2$F$20240620$20240723$20240626$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035912$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240724$$CN$US$US
240169632$24016963$2$F$20240501$20240807$20240626$20240808$30DAY$$CA-JNJFOC-20240633353$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240808$$HP$CA$CA
240169843$24016984$3$F$20240610$20240725$20240626$20240731$30DAY$$US-AMGEN-USASP2024121653$AMGEN$$76$YR$E$F$Y$75.2$KG$20240731$$PH$US$US
240169852$24016985$2$F$20240620$20240626$20240626$20240704$PER$$US-AMGEN-USASP2024124192$AMGEN$$68$YR$E$F$Y$$$20240704$$CN$US$US
240169902$24016990$2$F$20240610$20240807$20240626$20240807$PER$$NVSC2024US133303$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
240169942$24016994$2$F$$20240627$20240626$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102483$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240701$$CN$US$US
240169982$24016998$2$F$20231001$20240831$20240626$20240905$EXP$$JP-BAYER-2024A089549$BAYER$$70$YR$E$M$Y$$$20240905$$MD$JP$JP
240170002$24017000$2$F$20231001$20240831$20240626$20240904$EXP$$JP-BAYER-2024A089095$BAYER$$78$YR$E$M$Y$$$20240904$$MD$JP$JP
240170032$24017003$2$F$20240618$20240621$20240626$20240702$PER$$US-AMGEN-USASP2024123440$AMGEN$$83$YR$E$M$Y$$$20240702$$PH$US$US
240170043$24017004$3$F$20240601$20240711$20240626$20240717$EXP$$JP-SAKK-2024SA185510AA$SANOFI AVENTIS$$$$$$Y$$$20240717$$PH$JP$JP
240170073$24017007$3$F$20240501$20240627$20240626$20240704$EXP$$US-ABBVIE-5811659$ABBVIE$$64$YR$$M$Y$$$20240704$$CN$US$US
240170092$24017009$2$F$$20240801$20240626$20240806$EXP$$CA-ALXN-202406CAN001445CA$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$MD$CA$CA
240170102$24017010$2$F$20240101$20240812$20240626$20240820$EXP$$CA-ABBVIE-5813117$ABBVIE$$$$E$F$Y$$$20240820$$CN$CA$CA
240170113$24017011$3$F$20240318$20240703$20240626$20240708$EXP$$US-ABBVIE-5813080$ABBVIE$$65$YR$$M$Y$$$20240708$$CN$US$US
240170122$24017012$2$F$20240625$20240625$20240626$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101679$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240701$$CN$US$US
240170312$24017031$2$F$20240622$20240703$20240626$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406017684$ELI LILLY AND CO$$25$YR$A$M$Y$$$20240705$$CN$US$US
240170342$24017034$2$F$$20240716$20240626$20240724$EXP$$US-ABBVIE-5815745$ABBVIE$$$$$M$Y$91$KG$20240724$$CN$US$US
240170373$24017037$3$F$20230801$20240726$20240626$20240812$EXP$$US-ABBVIE-5709588$ABBVIE$$64$YR$$M$Y$79$KG$20240812$$CN$US$US
240170382$24017038$2$F$20200120$20240705$20240626$20240710$EXP$$KR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035710$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$68$KG$20240710$$MD$KR$KR
240170484$24017048$4$F$20240531$20240902$20240626$20240909$EXP$$NVSJ2024JP007360$NOVARTIS$$88$YR$$F$Y$42.1$KG$20240909$$MD$JP$JP
240170492$24017049$2$F$$20240828$20240626$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102269$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240829$$CN$US$US
240170554$24017055$4$F$20240501$20240717$20240626$20240724$PER$$US-ALXN-202406USA001208US$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240724$$CN$US$US
240170573$24017057$3$F$20240529$20240717$20240626$20240820$EXP$$NVSJ2024JP007586$NOVARTIS$$70$YR$$M$Y$$$20240820$$MD$JP$JP
240170682$24017068$2$F$20240623$20240624$20240626$20240701$PER$$US-AMGEN-USASP2024126001$AMGEN$$49$YR$A$M$Y$$$20240701$$CN$US$US
240170692$24017069$2$F$$20240628$20240626$20240708$EXP$$US-ENDO USA, INC.-2024-002707$ENDO$Leiser A, Virdee R, Kinniry P.. Severe Epinephrine-Induced Lactic Acidosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3414$69$YR$$M$Y$$$20240707$$HP$US$US
240170712$24017071$2$F$20240101$20240726$20240626$20240731$EXP$$BR-ABBVIE-5815566$ABBVIE$$$$$F$Y$100$KG$20240731$$CN$BR$BR
240170752$24017075$2$F$$20240827$20240626$20240901$EXP$$US-ABBVIE-5813093$ABBVIE$$$$$M$Y$98.42$KG$20240901$$CN$US$US
240170824$24017082$4$F$20240101$20240716$20240626$20240720$EXP$$JP-JNJFOC-20240660001$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$MD$JP$JP
240170842$24017084$2$F$$20240626$20240626$20240701$PER$$US-AMGEN-USASP2024125980$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240170942$24017094$2$F$$20240911$20240626$20240915$EXP$$US-ABBVIE-5815518$ABBVIE$$$$$F$Y$$$20240915$$CN$US$US
240170982$24017098$2$F$$20240722$20240626$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036362$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240723$$CN$US$US
240171002$24017100$2$F$20240604$20240724$20240626$20240729$EXP$$US-ABBVIE-5811874$ABBVIE$$58$YR$$F$Y$$$20240729$$CN$US$US
240171023$24017102$3$F$20240623$20240809$20240626$20240810$PER$$US-AMGEN-USASP2024125411$AMGEN$$81$YR$E$F$Y$$$20240810$$CN$US$US
240171043$24017104$3$F$20240524$20240628$20240626$20240708$EXP$$BR-CELLTRION INC.-2024BR015291$CELLTRION$$$$$$Y$$$20240708$$HP$BR$BR
240171106$24017110$6$F$20240624$20240917$20240626$20240923$EXP$$JP-ASTELLAS-2024JP004389$ASTELLAS$$8$DEC$E$F$Y$$$20240923$$MD$JP$JP
240171253$24017125$3$F$$20240702$20240626$20240711$EXP$$DE-JNJFOC-20240656412$JOHNSON AND JOHNSON$$73$YR$E$M$Y$85$KG$20240711$$MD$DE$DE
240171272$24017127$2$F$20240207$20240704$20240626$20240712$EXP$$FR-JNJFOC-20240655019$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240712$$MD$FR$FR
240171402$24017140$2$F$$20240701$20240627$20240709$EXP$$GB-CELLTRION INC.-2024GB015148$CELLTRION$$$$$$Y$$$20240710$$CN$GB$GB
240171444$24017144$4$F$20240201$20240802$20240627$20240805$EXP$$US-ALXN-202406USA001390US$ALEXION PHARMACEUTICALS$$69$YR$$F$Y$$$20240805$$MD$US$US
240171572$24017157$2$F$20170101$20240701$20240627$20240708$EXP$$CA-ABBVIE-5808683$ABBVIE$$$$$F$Y$$$20240708$$CN$CA$CA
240171612$24017161$2$F$$20240701$20240627$20240710$PER$$US-SA-2024SA186862$SANOFI AVENTIS$$$$$F$Y$$$20240710$$CN$US$US
240171632$24017163$2$F$$20240828$20240627$20240829$EXP$$NVSC2024GB132443$NOVARTIS$$40$YR$$F$Y$$$20240829$$CN$GB$GB
240171733$24017173$3$F$20240601$20240923$20240627$20240928$PER$$US-AMGEN-USASP2024125469$AMGEN$$83$YR$E$M$Y$$$20240928$$CN$US$US
240171782$24017178$2$F$$20240624$20240627$20240703$PER$$US-SA-2024SA184034$SANOFI AVENTIS$$$$A$M$Y$$$20240703$$HP$US$US
240171852$24017185$2$F$$20240702$20240627$20240702$EXP$$DE-JNJFOC-20240662670$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240703$$HP$DE$DE
240171944$24017194$4$F$20240501$20240802$20240627$20240809$EXP$$BR-CELLTRION INC.-2024BR015255$CELLTRION$$$$$$Y$$$20240809$$CN$BR$BR
240172173$24017217$3$F$20240422$20240731$20240627$20240803$EXP$$NVSC2024TH005301$NOVARTIS$$84$YR$$F$Y$$$20240803$$CN$TH$TH
240172253$24017225$3$F$20240101$20240704$20240627$20240713$EXP$$PL-ABBVIE-5817516$ABBVIE$$$$$F$Y$$$20240713$$MD$PL$PL
240172292$24017229$2$F$$20240614$20240627$20240703$PER$$US-ROCHE-10000002714$ROCHE$$$$A$F$Y$$$20240703$$CN$US$US
240172353$24017235$3$F$20240501$20240723$20240627$20240724$EXP$$JP-TAKEDA-2024TJP009514$TAKEDA$$38$YR$$M$Y$$$20240724$$MD$JP$JP
240172384$24017238$4$F$20240604$20240710$20240627$20240726$30DAY$$GB-JNJFOC-20240611578$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240726$$CN$GB$GB
240172422$24017242$2$F$20240607$20240710$20240627$20240718$EXP$$CA-TOLMAR, INC.-24CA050084$TOLMAR$$78$YR$$M$Y$$$20240718$$HP$CA$CA
240172442$24017244$2$F$20240606$20240722$20240627$20240816$PER$$US-TOLMAR, INC.-24US050064$TOLMAR$$$$$$Y$$$20240816$$PH$US$US
240172452$24017245$2$F$$20240722$20240627$20240816$PER$$US-TOLMAR, INC.-24US050081$TOLMAR$$$$$M$Y$$$20240816$$HP$US$US
240172482$24017248$2$F$20240523$20240708$20240627$20240710$EXP$$JP-TAKEDA-2024TJP009415$TAKEDA$$4$DEC$$M$Y$$$20240710$$MD$JP$JP
240172542$24017254$2$F$20240624$20240712$20240627$20240722$PER$$US-SA-2024SA188719$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240722$$MD$US$US
240172552$24017255$2$F$20240605$20240708$20240627$20240717$30DAY$$CA-JNJFOC-20231169741$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240717$$HP$CA$CA
240172632$24017263$2$F$$20240801$20240627$20240809$EXP$$US-CELLTRION INC.-2024US015175$CELLTRION$$$$$$Y$$$20240809$$MD$US$US
240172652$24017265$2$F$$20240702$20240627$20240712$EXP$$US-TEVA-VS-3212265$TEVA$Haeri NS, Mahmud H, Korytkowski MT. Paraneoplastic Hypoglycemia Leading to Insulin Independence in a Patient With Type 1 Diabetes. J-Endocr-Soc 2021; 5 (Suppl.) A1003-A1004.; Haeri NS, Mahmud H, Korytkowski MT. Paraneoplastic Hypoglycemia Leading to Insulin Independence in a Patient With Type 1 Diabetes. J-Endocr-Soc 2021; 5 (Suppl.) A1003-A1004.$59$YR$$F$Y$$$20240712$$HP$US$US
240172722$24017272$2$F$20240611$20240715$20240627$20240715$PER$$US-Y-MABS THERAPEUTICS, INC.-SPO2024-US-001619$Y-MABS THERAPEUTICS$$$$$$Y$$$20240715$$MD$US$US
240172732$24017273$2$F$20231228$20240705$20240627$20240711$EXP$$JP-COLLEGIUM PHARMACEUTICAL, INC.-20240600472$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240711$$MD$JP$JP
240172792$24017279$2$F$20240101$20240802$20240627$20240809$PER$$US-SA-2024SA186786$SANOFI AVENTIS$$34$YR$A$F$Y$81.646$KG$20240809$$MD$US$US
240172842$24017284$2$F$20240612$20240826$20240627$20240831$EXP$$US-ABBVIE-5816236$ABBVIE$$33$YR$$M$Y$$$20240831$$CN$US$US
240172872$24017287$2$F$$20240617$20240627$20240703$PER$$US-ROCHE-10000008389$ROCHE$$55$YR$A$M$Y$$$20240703$$HP$US$US
240172992$24017299$2$F$$20240823$20240627$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102352$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240827$$CN$US$US
240173022$24017302$2$F$$20240702$20240627$20240710$EXP$$US-TEVA-VS-3212412$TEVA$Perkins R, Mullen T. TREATING POLYSUBSTANCE INGESTION WITH CONTINUOUS RENAL REPLACEMENT THERAPY AND TOTAL PLASMA EXCHANGE. Crit-Care-Med 2024; 52 (Suppl.) (1): S342.; Perkins R, Mullen T. TREATING POLYSUBSTANCE INGESTION WITH CONTINUOUS RENAL REPLACEMENT THERAPY AND TOTAL PLASMA EXCHANGE. Crit-Care-Med 2024; 52 (Suppl.) (1): S342.$16$YR$$F$Y$$$20240710$$HP$US$US
240173042$24017304$2$F$20240101$20240817$20240627$20240826$PER$$US-SA-2024SA187764$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240826$$MD$US$US
240173052$24017305$2$F$$20240805$20240627$20240813$PER$$US-SA-2024SA183967$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
240173072$24017307$2$F$20240610$20240620$20240627$20240701$PER$$US-SA-2024SA183604$SANOFI AVENTIS$$74$YR$E$F$Y$56.69$KG$20240701$$MD$US$US
240173093$24017309$3$F$20240101$20240713$20240627$20240722$PER$$US-SA-2024SA183047$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240722$$HP$US$US
240173162$24017316$2$F$20240620$20240702$20240627$20240705$EXP$$US-UCBSA-2024032424$UCB$$13$YR$$M$Y$$$20240705$$CN$US$US
240173202$24017320$2$F$$20240628$20240627$20240706$EXP$$DE-AUROBINDO-AUR-APL-2024-030872$AUROBINDO$Riedhammer C, Dull J, Kestle C, Kadel S, Franz J, Weis P, et al.. Dismal prognosis of Pneumocystis jirovecii pneumonia in patients  with multiple myeloma. Annals of Hematology. 2024;103(4):1327-1332$60$YR$$M$Y$$$20240706$$MD$DE$DE
240173232$24017323$2$F$$20240613$20240627$20240704$PER$$US-ROCHE-10000005360$ROCHE$$$$$$Y$$$20240704$$CN$US$US
240173292$24017329$2$F$20240610$20240628$20240627$20240703$PER$$US-AMGEN-USASP2024125592$AMGEN$$70$YR$E$F$Y$$$20240703$$CN$US$US
240173472$24017347$2$F$$20240628$20240627$20240703$EXP$$US-UCBSA-2024032343$UCB$$$$$M$Y$$$20240703$$MD$US$US
240173532$24017353$2$F$20240618$20240815$20240627$20240821$PER$$US-BIOGEN-2024BI01270527$BIOGEN$$24$YR$$F$Y$$$20240821$$CN$US$US
240173563$24017356$3$F$$20240726$20240627$20240803$PER$$US-SA-2024SA185586$SANOFI AVENTIS$$$$E$F$Y$$$20240803$$CN$US$US
240173572$24017357$2$F$20240821$20240821$20240627$20240905$PER$$US-SA-2024SA187882$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240905$$MD$US$US
240173723$24017372$3$F$$20240723$20240627$20240726$EXP$$US-TAKEDA-2024TUS063950$TAKEDA$$$$$F$Y$$$20240726$$HP$US$US
240173752$24017375$2$F$$20240705$20240627$20240718$PER$$US-TAKEDA-2024TUS060159$TAKEDA$$67$YR$$M$Y$$$20240718$$CN$US$US
240173783$24017378$3$F$20220101$20240918$20240627$20240926$EXP$$US-ROCHE-10000009385$ROCHE$$63$YR$A$M$Y$70.31$KG$20240926$$CN$US$US
240173892$24017389$2$F$$20240620$20240627$20240704$EXP$$US-CIPLA LTD.-2024US06532$CIPLA$Elsayed M.. An interesting case of drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis with pulmonary and renal involvement. Am J Respir Crit Care Med. 2024;209:A5780$$$$$Y$$$20240704$$MD$US$US
240173912$24017391$2$F$20240405$20240917$20240627$20240925$EXP$$JP-ROCHE-3546718$ROCHE$$8$DEC$E$M$Y$$$20240925$$MD$JP$JP
240173972$24017397$2$F$$20240925$20240627$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102446$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240925$$CN$US$US
240174002$24017400$2$F$20240101$20240814$20240627$20240816$EXP$$US-UCBSA-2024032477$UCB$$$$$F$Y$$$20240816$$HP$US$US
240174092$24017409$2$F$$20240701$20240627$20240702$EXP$$PL-ABBVIE-5817042$ABBVIE$Sirek S, Woszczek D, Szklarek E, Wilczynski T, Wygledowska-Promienska D. Central decompressive vitrectomy with cataract phacoemulsification and implantation of an artificial intraocular lens in the left eye. Case report of a 51-year-old woman suffering from angle closure glaucoma. Ophthalmology. 2024;XXVII(79-82).; Sirek S, Woszczek D, Szklarek E, Wilczynski T, Wygledowska-Promienska D. Central decompressive vitrectomy with cataract phacoemulsification and implantation of an artificial intrao...$51$YR$$F$Y$$$20240702$$MD$PL$PL
240174132$24017413$2$F$20240101$20240701$20240627$20240710$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000555$DECIPHERA PHARMACEUTICALS$$66$YR$A$F$Y$$$20240710$$CN$US$US
240174162$24017416$2$F$$20240926$20240627$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100863$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240926$$PH$US$US
240174182$24017418$2$F$20230913$20240704$20240627$20240718$EXP$$JP-AMGEN-JPNSP2024125408$AMGEN$$75$YR$E$F$Y$$$20240717$$MD$JP$JP
240174192$24017419$2$F$$20240705$20240627$20240710$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009832$JAZZ$$$$$M$Y$65$KG$20240710$$HP$US$US
240174243$24017424$3$F$20240601$20240806$20240627$20240807$EXP$$US-ALXN-202406USA001330US$ALEXION PHARMACEUTICALS$$77$YR$$F$Y$$$20240807$$HP$US$US
240174262$24017426$2$F$$20240702$20240627$20240712$EXP$$DE-TEVA-VS-3212630$TEVA$Schmidt T, Agkatsev S, Feldheim J, Oster C, Blau T, Sure U, et al. Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma. Neurooncol-Adv 2023; 5 (1): no pagination.; Schmidt T, Agkatsev S, Feldheim J, Oster C, Blau T, Sure U, et al. Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma. Neurooncol-Adv 2023; 5 (1): no pagination.; Schmidt T, Agkatsev S, Feldheim J, Oster C, Blau T, Sure U, et al. Feasibility and tolerability of ...$$$$$Y$$$20240712$$HP$DE$DE
240174383$24017438$3$F$$20240702$20240627$20240710$EXP$$US-ROCHE-10000008447$ROCHE$$71$YR$E$M$Y$$$20240710$$CN$US$US
240174392$24017439$2$F$20240602$20240706$20240627$20240718$EXP$$DK-ROCHE-10000002708$ROCHE$$43$YR$A$F$Y$$$20240718$$MD$DK$DK
240174443$24017444$3$F$$20240808$20240627$20240812$EXP$$US-ROCHE-10000008700$ROCHE$$$$A$F$Y$$$20240812$$CN$US$US
240174473$24017447$3$F$$20240816$20240627$20240822$PER$$US-ROCHE-10000009349$ROCHE$$$$A$F$Y$$$20240822$$CN$US$US
240174482$24017448$2$F$$20240823$20240627$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05534$LUPIN$$$$$$Y$$$20240911$$CN$US$US
240174493$24017449$3$F$20210506$20240629$20240627$20240724$EXP$$US-BEH-2024173998$CSL BEHRING$$53$YR$A$M$Y$$$20240724$$MD$US$US
240174502$24017450$2$F$20240515$20240628$20240627$20240705$EXP$$DE-CELLTRION INC.-2024DE015453$CELLTRION$$$$$$Y$$$20240705$$HP$DE$DE
240174532$24017453$2$F$$20240712$20240627$20240716$EXP$$AR-TAKEDA-2024TUS063624$TAKEDA$$$$$M$Y$$$20240716$$CN$AR$AR
240174582$24017458$2$F$$20240815$20240627$20240822$EXP$$US-TAKEDA-2024TUS001014$TAKEDA$$$$$F$Y$$$20240822$$MD$US$US
240174603$24017460$3$F$20240101$20240917$20240627$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011691$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240926$$$US$US
240174612$24017461$2$F$20240604$20240705$20240627$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101267$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240711$$CN$US$US
240174682$24017468$2$F$20240523$20240702$20240627$20240708$EXP$$JP-SETONPHARMA-2024SETSPO00002$SETON$$26$YR$A$F$Y$67.7$KG$20240708$$MD$JP$JP
240174693$24017469$3$F$$20240920$20240627$20240926$EXP$$NVSC2024GB062983$NOVARTIS$$$$A$M$Y$$$20240926$$CN$GB$GB
240174702$24017470$2$F$$20240703$20240627$20240712$EXP$$JP-AMGEN-JPNSP2024125585$AMGEN$$$$$M$Y$$$20240711$$PH$JP$JP
240174782$24017478$2$F$20240621$20240628$20240627$20240707$30DAY$$US-AMGEN-USASP2024123575$AMGEN$$$$$$Y$$$20240707$$PH$US$US
240174816$24017481$6$F$$20240711$20240627$20240722$PER$$US-ROCHE-10000006951$ROCHE$$$$A$F$Y$61.235$KG$20240722$$MD$US$US
240174822$24017482$2$F$$20240623$20240627$20240701$PER$$US-ROCHE-10000006443$ROCHE$$17$YR$T$F$Y$$$20240701$$CN$US$US
240174842$24017484$2$F$$20240619$20240627$20240701$PER$$US-ROCHE-10000008228$ROCHE$$80$YR$E$M$Y$$$20240701$$MD$US$US
240174872$24017487$2$F$20240403$20240820$20240627$20240822$EXP$$US-ROCHE-10000008491$ROCHE$$4$YR$C$F$Y$10.43$KG$20240822$$CN$US$US
240174896$24017489$6$F$20240501$20240801$20240627$20240809$PER$$US-ROCHE-10000006363$ROCHE$$44$YR$A$F$Y$88$KG$20240809$$CN$US$US
240174934$24017493$4$F$20240624$20240809$20240627$20240826$30DAY$$US-JNJFOC-20240666376$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240826$$CN$US$US
240174952$24017495$2$F$20240518$20240819$20240627$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002665$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240830$$CN$US$US
240174973$24017497$3$F$$20240730$20240627$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102784$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240801$$CN$US$US
240175014$24017501$4$F$$20240830$20240627$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002672$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
240175022$24017502$2$F$$20240617$20240627$20240709$PER$$US-ROCHE-10000006340$ROCHE$$$$$M$Y$$$20240702$$CN$US$US
240175032$24017503$2$F$$20240802$20240627$20240806$PER$$US-ROCHE-10000003424$ROCHE$$$$$M$Y$$$20240806$$CN$US$US
240175043$24017504$3$F$20240515$20240620$20240627$20240808$PER$$US-ROCHE-10000003676$ROCHE$$59$YR$A$M$Y$$$20240808$$CN$US$US
240175083$24017508$3$F$20240618$20240716$20240627$20240722$PER$$US-AMGEN-USASP2024123628$AMGEN$$$$$F$Y$$$20240722$$HP$US$US
240175113$24017511$3$F$$20240612$20240627$20240709$PER$$US-ROCHE-10000004546$ROCHE$$$$$$Y$$$20240705$$MD$US$US
240175162$24017516$2$F$$20240628$20240627$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002696$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
240175192$24017519$2$F$$20240702$20240627$20240712$EXP$$US-TEVA-VS-3212250$TEVA$Allencherril J, Birnbaum I. Heart failure in thyrotoxic cardiomopathy: Extracorporeal membrane oxygenation treatment for graves^ disease. J-Extra-Corpor-Technol 2015; 47 (4): 231-232.; Allencherril J, Birnbaum I. Heart failure in thyrotoxic cardiomopathy: Extracorporeal membrane oxygenation treatment for graves^ disease. J-Extra-Corpor-Technol 2015; 47 (4): 231-232.$29$YR$$M$Y$$$20240712$$HP$US$US
240175303$24017530$3$F$20240619$20240719$20240627$20240729$EXP$$US-LEO Pharma-371511$LEO PHARM$$82$YR$$M$Y$$$20240729$$CN$US$US
240175315$24017531$5$F$20231101$20240717$20240627$20240723$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-270751$BOEHRINGER INGELHEIM$$54$YR$A$M$Y$$$20240719$$CN$CA$CA
240175342$24017534$2$F$20240623$20240628$20240627$20240703$PER$$US-AMGEN-USASP2024125353$AMGEN$$80$YR$E$M$Y$$$20240703$$CN$US$US
240175352$24017535$2$F$$20240725$20240627$20240730$PER$$US-AMGEN-USASP2024123939$AMGEN$$76$YR$E$F$Y$$$20240730$$MD$US$US
240175383$24017538$3$F$20240401$20240708$20240627$20240718$EXP$FR-AFSSAPS-AM2024000489$FR-ADVANZ PHARMA-202405005116$ADVANZ PHARMA$$$$$$Y$$$20240718$$MD$FR$FR
240175452$24017545$2$F$20240101$20240912$20240627$20240923$PER$$US-SA-2024SA184657$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240923$$MD$US$US
240175612$24017561$2$F$20240610$20240710$20240627$20240718$EXP$$CA-AstraZeneca-2024A138505$ASTRAZENECA$$20092$DY$$F$Y$$$20240718$$PH$CA$
240175634$24017563$4$F$20240601$20240719$20240627$20240725$PER$$US-ROCHE-3576585$ROCHE$$59$YR$A$F$Y$$$20240725$$HP$US$US
240175712$24017571$2$F$$20240626$20240627$20240701$PER$$US-AMGEN-USASP2024125460$AMGEN$$$$$F$Y$$$20240630$$CN$US$US
240175812$24017581$2$F$20231123$20240627$20240627$20240702$EXP$PT-INFARMED-T202405-977$PT-009507513-2406PRT005999$MERCK$$56$YR$$F$Y$$$20240702$$PH$PT$PT
240175873$24017587$3$F$20240101$20240701$20240627$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-019228$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240709$$$US$US
240175885$24017588$5$F$20240101$20240912$20240627$20240925$EXP$$CA-TAKEDA-2024TUS060232$TAKEDA$$$$$F$Y$45.5$KG$20240925$$CN$CA$CA
240175982$24017598$2$F$$20240917$20240627$20240919$EXP$$NVSC2024GB132521$NOVARTIS$$$$$F$Y$$$20240919$$CN$GB$GB
240176022$24017602$2$F$20240524$20240708$20240627$20240715$EXP$$US-VIIV HEALTHCARE LIMITED-US2024074930$VIIV$$64$YR$$F$Y$108.86$KG$20240715$$CN$US$US
240176032$24017603$2$F$$20240802$20240627$20240807$EXP$$US-AstraZeneca-2024A142723$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
240176082$24017608$2$F$20240601$20240710$20240627$20240716$PER$$US-UNITED THERAPEUTICS-UNT-2024-019407$UNITED THERAPEUTICS$$74$YR$$F$Y$104.31$KG$20240716$$$US$US
240176095$24017609$5$F$20240101$20240905$20240627$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-019418$UNITED THERAPEUTICS$$$$$M$Y$58.957$KG$20240912$$$US$US
240176112$24017611$2$F$20240229$20240625$20240627$20240711$EXP$$CN-JNJFOC-20240669926$JOHNSON AND JOHNSON$$58$YR$A$M$Y$60$KG$20240712$$HP$CN$CN
240176242$24017624$2$F$$20240919$20240627$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102753$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$46.72$KG$20240925$$CN$US$US
240176252$24017625$2$F$20230221$20240625$20240627$20240708$PER$$FR-IGSA-BIG0029483$GRIFOLS$$50$YR$$M$Y$75$KG$20240708$$MD$FR$FR
240176283$24017628$3$F$20240520$20240820$20240627$20240828$EXP$$CA-CELLTRION INC.-2024CA012518$CELLTRION$$$$$$Y$$$20240828$$CN$CA$CA
240176362$24017636$2$F$20240101$20240726$20240627$20240803$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019040$UNITED THERAPEUTICS$$$$$M$Y$97.052$KG$20240803$$$US$US
240176372$24017637$2$F$$20240702$20240627$20240709$EXP$$TR-JNJFOC-20240665825$JOHNSON AND JOHNSON$$21$YR$A$M$Y$60$KG$20240709$$CN$TR$TR
240176452$24017645$2$F$20230526$20240704$20240627$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-030543$AUROBINDO$$75$YR$$M$Y$$$20240712$$MD$FR$FR
240176512$24017651$2$F$$20240731$20240627$20240806$30DAY$$US-GSK-US2024077257$GLAXOSMITHKLINE$$$$$M$Y$$$20240806$$CN$US$US
240176682$24017668$2$F$20230101$20240722$20240627$20240731$EXP$$JP-UNITED THERAPEUTICS-UNT-2023-037432$UNITED THERAPEUTICS$$75$YR$$F$Y$$$20240731$$$JP$JP
240176722$24017672$2$F$$20240703$20240627$20240712$EXP$$BR-TEVA-VS-3212966$TEVA$Zuniga D, Stumpf MAM, Monteiro ALS, Glezer A. Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review. [Review]. J-Endocrinol-Invest 2024; 47 (5): 1295-1303.; Zuniga D, Stumpf MAM, Monteiro ALS, Glezer A. Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review. [Review]. J-Endocrinol-Invest 2024; 47 (5):...$27$YR$$M$Y$$$20240712$$HP$BR$BR
240176813$24017681$3$F$20240621$20240729$20240627$20240802$30DAY$$US-AMGEN-USASP2024123625$AMGEN$$71$YR$E$M$Y$117$KG$20240802$$PH$US$US
240176843$24017684$3$F$$20240923$20240627$20240924$EXP$$CA-ORGANON-O2406CAN002128$ORGANON$$43$YR$$F$Y$96$KG$20240924$$HP$CA$CA
240176872$24017687$2$F$$20240821$20240627$20240827$EXP$$PK-AMGEN-PAKSP2024126617$AMGEN$$$$$$Y$$$20240826$$MD$PK$PK
240176912$24017691$2$F$$20240824$20240627$20240829$EXP$$US-TAKEDA-2024TUS033742$TAKEDA$$$$$M$Y$82$KG$20240829$$CN$US$US
240176962$24017696$2$F$20240101$20240626$20240627$20240705$PER$$US-SA-2024SA183362$SANOFI AVENTIS$$63$YR$A$F$Y$53.52$KG$20240705$$CN$US$US
240176982$24017698$2$F$$20240812$20240627$20240826$PER$$US-SA-2024SA182800$SANOFI AVENTIS$$$$A$F$Y$76.2$KG$20240826$$MD$US$US
240177122$24017712$2$F$20240603$20240828$20240627$20240903$EXP$$CA-JNJFOC-20240656353$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240903$$HP$CA$CA
240177202$24017720$2$F$20240101$20240712$20240627$20240718$EXP$$US-ABBVIE-5815371$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
240177213$24017721$3$F$20240101$20240816$20240627$20240823$EXP$$US-ABBVIE-5815211$ABBVIE$$59$YR$$F$Y$69$KG$20240823$$CN$US$US
240177233$24017723$3$F$$20240823$20240627$20240829$EXP$$JP-009507513-2406JPN002575J$MERCK$Nakamura K, Yamazaki M, Bando M, Inamasu Y, Yoshida K. O53 A case of oesophageal ulcer with hematemesis during pembrolizumab therapy which was successfully treated with steroids. The 123rd Kyushu Branch Meeting of the Japanese Society of Gastroenterology, The. 154$74$YR$$M$Y$$$20240829$$HP$JP$JP
240177264$24017726$4$F$20240624$20240911$20240627$20240917$EXP$$US-ABBVIE-5816756$ABBVIE$$67$YR$$M$Y$101$KG$20240917$$PH$US$US
240177363$24017736$3$F$$20240725$20240627$20240802$EXP$$US-CELLTRION INC.-2024US015240$CELLTRION$$$$$$Y$$$20240802$$CN$US$US
240177402$24017740$2$F$20240617$20240626$20240627$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102524$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$96.62$KG$20240703$$CN$US$US
240177423$24017742$3$F$20240514$20240709$20240627$20240725$PER$$US-AMGEN-USASP2024122778$AMGEN$$$$A$F$Y$$$20240725$$PH$US$US
240177542$24017754$2$F$20240101$20240819$20240627$20240830$PER$$US-SA-2024SA186257$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240830$$MD$US$US
240177552$24017755$2$F$$20240702$20240627$20240711$PER$$US-SA-2024SA166367$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240711$$CN$US$US
240177562$24017756$2$F$20240101$20240725$20240627$20240801$PER$$US-SA-2024SA187897$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240801$$MD$US$US
240177612$24017761$2$F$20240619$20240626$20240627$20240704$EXP$$JP-ARDELYX-2024ARDX004627$ARDELYX$$72$YR$$M$Y$$$20240704$$PH$JP$JP
240177622$24017762$2$F$$20240626$20240627$20240702$EXP$$BR-CELLTRION INC.-2024BR015292$CELLTRION$$$$$$Y$$$20240702$$CN$BR$BR
240177642$24017764$2$F$20240418$20240703$20240627$20240713$EXP$$JP-ARDELYX-2024ARDX004637$ARDELYX$$40$YR$$M$Y$$$20240713$$MD$JP$JP
240177682$24017768$2$F$$20240701$20240627$20240708$EXP$$TW-SA-2024SA189321$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240708$$CN$TW$TW
240177692$24017769$2$F$20240101$20240724$20240627$20240802$PER$$US-SA-2024SA187904$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240802$$MD$US$US
240177702$24017770$2$F$$20240621$20240627$20240702$PER$$US-SA-2024SA187378$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240702$$HP$US$US
240177763$24017776$3$F$20240101$20240903$20240627$20240925$PER$$US-SA-2024SA182001$SANOFI AVENTIS$$78$YR$E$F$Y$66.667$KG$20240925$$MD$US$US
240177842$24017784$2$F$$20240913$20240627$20240919$EXP$$US-ABBVIE-5815570$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
240177862$24017786$2$F$20240617$20240703$20240627$20240711$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108622$ZYDUS PHARM$$$$$$Y$$$20240711$$CN$US$US
240177902$24017790$2$F$20240423$20240708$20240627$20240718$EXP$FR-AFSSAPS-BX2024001177$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108755$ZYDUS PHARM$$$$$$Y$$$20240718$$PH$FR$FR
240177972$24017797$2$F$20231130$20240709$20240627$20240712$EXP$$VN-AMGEN-VNMSP2024125843$AMGEN$$47$YR$A$M$Y$$$20240712$$PH$VN$VN
240177982$24017798$2$F$20240618$20240708$20240627$20240716$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019046$UNITED THERAPEUTICS$$65$YR$$F$Y$92.063$KG$20240716$$$US$US
240178032$24017803$2$F$$20240703$20240627$20240709$EXP$GB-TAKEDA-2024TUS059568$GB-DEXPHARM-2024-2021$DEXCEL$$$$E$M$Y$$$20240709$$HP$GB$GB
240178042$24017804$2$F$20210826$20240823$20240627$20240830$EXP$$NVSC2021IN197994$NOVARTIS$$41$YR$$F$Y$60$KG$20240830$$CN$IN$IN
240178122$24017812$2$F$$20240724$20240627$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002684$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
240178232$24017823$2$F$20240101$20240712$20240627$20240717$EXP$$CA-ABBVIE-5816899$ABBVIE$$63$YR$$F$Y$67$KG$20240717$$CN$CA$CA
240178333$24017833$3$F$20240620$20240710$20240627$20240715$EXP$$US-AMGEN-USASP2024122381$AMGEN$$81$YR$E$$Y$$$20240715$$CN$US$US
240178404$24017840$4$F$20230410$20240911$20240627$20240913$EXP$$US-JNJFOC-20230960256$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240913$$CN$US$US
240178472$24017847$2$F$20230101$20240717$20240627$20240726$EXP$$US-APOTEX-2024AP007568$APOTEX$Valido K, Patel V, Murphy MJ, Junejo MH, Patel DK, Deutsch A, et al.. Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach. Journal of the American Academy of Dermatology-Case Reports. 2024;48:49-53$52$YR$$F$Y$$$20240726$$HP$US$US
240178503$24017850$3$F$20240605$20240904$20240627$20240924$PER$$FR-TOLMAR, INC.-24FR049991$TOLMAR$$69$YR$$M$Y$$$20240923$$PH$FR$FR
240178512$24017851$2$F$20240528$20240626$20240627$20240724$PER$$FR-TOLMAR, INC.-24FR049849$TOLMAR$$72$YR$$M$Y$$$20240724$$PH$FR$FR
240178522$24017852$2$F$20240601$20240703$20240627$20240809$PER$$FR-TOLMAR, INC.-24FR050015$TOLMAR$$80$YR$$M$Y$$$20240809$$PH$FR$FR
240178532$24017853$2$F$20240606$20240705$20240627$20240809$PER$$FR-TOLMAR, INC.-24FR050033$TOLMAR$$83$YR$$M$Y$$$20240809$$PH$FR$FR
240178542$24017854$2$F$20240605$20240703$20240627$20240808$PER$$FR-TOLMAR, INC.-24FR050019$TOLMAR$$81$YR$$M$Y$$$20240808$$PH$FR$FR
240178552$24017855$2$F$20240606$20240703$20240627$20240809$PER$$FR-TOLMAR, INC.-24FR050043$TOLMAR$$83$YR$$M$Y$$$20240809$$PH$FR$FR
240178643$24017864$3$F$$20240725$20240627$20240821$PER$$US-AstraZeneca-2024A142151$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
240178682$24017868$2$F$$20240702$20240627$20240710$EXP$$US-TEVA-VS-3212081$TEVA$Dowd-Green C, Brown D, Wilson A, Streiff M. Supratherapeutic INR During Treatment With Nirmatrelvir/Ritonavir and Warfarin and Acute Illness With COVID-19: A Case Report. J-Pharm-Pract 2024;.; Dowd-Green C, Brown D, Wilson A, Streiff M. Supratherapeutic INR During Treatment With Nirmatrelvir/Ritonavir and Warfarin and Acute Illness With COVID-19: A Case Report. J-Pharm-Pract 2024;.; Dowd-Green C, Brown D, Wilson A, Streiff M. Supratherapeutic INR During Treatment With Nirmatrelvir/Ritonavir a...$68$YR$$F$Y$$$20240710$$PH$US$US
240178752$24017875$2$F$20240601$20240815$20240627$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002677$ACADIA PHARMACEUTICALS$$31$YR$$F$Y$$$20240909$$CN$US$US
240178812$24017881$2$F$20240501$20240701$20240627$20240702$EXP$$MX-ROCHE-10000006037$ROCHE$$68$YR$E$M$Y$78$KG$20240702$$CN$MX$MX
240179034$24017903$4$F$20220101$20240911$20240627$20240919$EXP$$CA-CELLTRION INC.-2022CA013006$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
240179083$24017908$3$F$$20240909$20240627$20240920$EXP$HR-EMA-DD-20240612-7482647-065456$HR-STERISCIENCE B.V.-2024-ST-000853$Steriscience PTE$$63$YR$$M$Y$$$20240920$$MD$HR$HR
240179113$24017911$3$F$20240619$20240625$20240627$20240702$PER$$US-JNJFOC-20240659190$JOHNSON AND JOHNSON$$19$YR$A$F$Y$$$20240702$$CN$US$US
240179162$24017916$2$F$$20240712$20240627$20240723$EXP$$JP-ABBVIE-5815191$ABBVIE$$$$$$Y$$$20240723$$MD$JP$JP
240179172$24017917$2$F$20240605$20240810$20240627$20240816$EXP$$CA-GSK-CA2023169664$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$HP$CA$CA
240179212$24017921$2$F$$20240612$20240627$20240709$EXP$$CA-ROCHE-3580349$ROCHE$$44$YR$A$F$Y$$$20240701$$HP$CA$CA
240179223$24017922$3$F$$20240822$20240627$20240903$PER$$US-AstraZeneca-2024A144940$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
240179262$24017926$2$F$20240601$20240730$20240627$20240812$EXP$GB-MHRA-MED-202406151759074680-GZKVT$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13319$ALKEM$$61$YR$$M$Y$110$KG$20240812$$CN$GB$GB
240179344$24017934$4$F$20240621$20240725$20240627$20240801$30DAY$$US-JNJFOC-20240657698$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240801$$CN$US$US
240179372$24017937$2$F$$20240702$20240627$20240712$EXP$$US-TEVA-VS-3212085$TEVA$Huang W, Yin C, Briley KP, Dalzell WAB, Fallon JT. Dynamic Evolution of SARS-CoV-2 in a Patient on Chemotherapy. Viruses 2023; 15 (8): 1-8.; Huang W, Yin C, Briley KP, Dalzell WAB, Fallon JT. Dynamic Evolution of SARS-CoV-2 in a Patient on Chemotherapy. Viruses 2023; 15 (8): 1-8.$17$YR$$M$Y$$$20240712$$HP$US$US
240179479$24017947$9$F$20240101$20240921$20240627$20240926$EXP$$CA-PFIZER INC-202400197605$PFIZER$$89$YR$$F$Y$67.8$KG$20240926$$CN$CA$CA
240179522$24017952$2$F$20240501$20240722$20240627$20240729$EXP$$JP-009507513-2406JPN003152J$MERCK$$8$DEC$$F$Y$$$20240729$$MD$JP$JP
240179563$24017956$3$F$20240624$20240726$20240627$20240801$30DAY$$US-JNJFOC-20240663407$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240801$$PH$US$US
240179593$24017959$3$F$20240601$20240923$20240627$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102672$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240924$$CN$US$US
240179752$24017975$2$F$$20240813$20240627$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202406016674$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240815$$CN$US$US
240179883$24017988$3$F$$20240924$20240627$20240930$EXP$$US-TAKEDA-2024TUS056816$TAKEDA$$$$$M$Y$$$20240930$$HP$US$US
240179973$24017997$3$F$$20240724$20240627$20240726$PER$$US-JNJFOC-20240660667$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$LW$US$US
240180072$24018007$2$F$$20240731$20240627$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002687$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
240180095$24018009$5$F$20240501$20240916$20240627$20240919$EXP$$EC-ROCHE-10000007631$ROCHE$$$$$$Y$$$20240919$$MD$EC$EC
240180122$24018012$2$F$$20240806$20240627$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102334$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$78.02$KG$20240808$$CN$US$US
240180144$24018014$4$F$20240821$20240918$20240627$20240919$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-102539$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$63.96$KG$20240919$$CN$PR$PR
240180172$24018017$2$F$20240301$20240817$20240627$20240826$EXP$$CA-CELLTRION INC.-2024CA015605$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
240180182$24018018$2$F$20230901$20240627$20240627$20240702$EXP$$NVSC2024SK133241$NOVARTIS$$$$$M$Y$$$20240702$$MD$SK$SK
240180264$24018026$4$F$20240601$20240713$20240627$20240718$EXP$$PT-ABBVIE-5815479$ABBVIE$$79$YR$$F$Y$$$20240718$$CN$PT$PT
240180334$24018033$4$F$20240529$20240917$20240627$20240924$PER$$US-GSK-US2024075724$GLAXOSMITHKLINE$$59$YR$$F$Y$98$KG$20240924$$CN$US$US
240180372$24018037$2$F$20240623$20240716$20240627$20240722$PER$$US-ALXN-202406USA001489US$ALEXION PHARMACEUTICALS$$17$YR$$M$Y$$$20240722$$CN$US$US
240180542$24018054$2$F$20240623$20240628$20240627$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017212$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240701$$CN$US$US
240180572$24018057$2$F$$20240924$20240627$20240925$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-098418$BRISTOL MYERS SQUIBB$$83$YR$E$$Y$$$20240925$$MD$CH$CH
240180612$24018061$2$F$20230101$20240820$20240627$20240828$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036395$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$81.6$KG$20240828$$MD$US$US
240180632$24018063$2$F$$20240723$20240627$20240730$EXP$$FR-JNJFOC-20240666371$JOHNSON AND JOHNSON$$76$YR$E$M$Y$58$KG$20240730$$MD$FR$FR
240180702$24018070$2$F$20240201$20240711$20240627$20240720$EXP$$AT-CELLTRION INC.-2024AT015124$CELLTRION$$$$$$Y$$$20240720$$HP$AT$AT
240180892$24018089$2$F$20240101$20240626$20240627$20240703$EXP$$BR-RECORDATI-2024004747$RECORDATI$$$$$$Y$$$20240703$$MD$BR$BR
240180954$24018095$4$F$20240423$20240810$20240627$20240819$EXP$$CA-CELLTRION INC.-2024CA011464$CELLTRION$$$$$$Y$$$20240819$$HP$CA$CA
240181062$24018106$2$F$20240401$20240722$20240627$20240801$PER$$US-ABBVIE-5814049$ABBVIE$$67$YR$$F$Y$64.41$KG$20240801$$CN$US$US
240181142$24018114$2$F$$20240904$20240627$20240905$PER$$US-JNJFOC-20240665600$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
240181162$24018116$2$F$$20240718$20240627$20240725$30DAY$$US-GSK-US2024075795$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
240181242$24018124$2$F$$20240702$20240627$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102928$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$67.59$KG$20240703$$CN$US$US
240181272$24018127$2$F$$20240624$20240627$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-030602$AUROBINDO$Mansfield PK, Moody R, Li Y, Heinecke G. A rare case of lichen planus pemphigoides with palmoplantar hyperkeratotic plaques. JAAD Case Reports. 2024;49:14-6$64$YR$$F$Y$$$20240702$$MD$US$US
240181282$24018128$2$F$20231003$20240629$20240627$20240703$EXP$$GB-ORGANON-O2406GBR002391$ORGANON$$93$YR$$M$Y$$$20240703$$CN$GB$GB
240181312$24018131$2$F$$20240620$20240627$20240702$PER$$US-ROCHE-10000009607$ROCHE$$54$YR$A$F$Y$$$20240702$$HP$US$US
240181322$24018132$2$F$20240613$20240819$20240627$20240821$EXP$$US-JNJFOC-20240649202$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240821$$MD$US$US
240181372$24018137$2$F$$20240626$20240627$20240702$EXP$$CA-SANDOZ INC.-SDZ2024CA060948$SANDOZ$$69$YR$$F$Y$$$20240702$$CN$CA$CA
240181442$24018144$2$F$$20240703$20240627$20240712$EXP$$US-TEVA-VS-3212905$TEVA$Puzio H, Nachawi N, Hamaty M, Rao P. A Remission of Hypocalcemia in Idiopathic Hypoparathyroidism. J-Endocr-Soc 2022; 6 (1) A213 abstr. PSAT209 .; Puzio H, Nachawi N, Hamaty M, Rao P. A Remission of Hypocalcemia in Idiopathic Hypoparathyroidism. J-Endocr-Soc 2022; 6 (1) A213 abstr. PSAT209 .$24$YR$$M$Y$$$20240712$$MD$US$US
240181502$24018150$2$F$$20240628$20240627$20240703$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-12481$IPSEN$$$$$F$Y$$$20240703$$HP$GB$GB
240181642$24018164$2$F$$20240719$20240627$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102651$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240725$$CN$US$US
240181652$24018165$2$F$$20240924$20240627$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102068$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240925$$CN$US$US
240181666$24018166$6$F$20240918$20240918$20240627$20240926$EXP$$IN-VANTIVE-2024VAN017928$Vantive US Healthcare$$57$YR$$F$Y$$$20240926$$CN$IN$IN
240181763$24018176$3$F$20200626$20240628$20240627$20240708$30DAY$$US-GSK-US2024079167$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240708$$CN$US$US
240181772$24018177$2$F$20240101$20240708$20240627$20240716$EXP$$JP-GSK-JP2024JPN075959$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$MD$JP$JP
240181792$24018179$2$F$$20240625$20240627$20240701$PER$$US-AMGEN-USASP2024126345$AMGEN$$$$$M$Y$$$20240701$$CN$US$US
240181832$24018183$2$F$20240616$20240627$20240627$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017574$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240701$$PH$US$US
240181902$24018190$2$F$20230101$20240716$20240627$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202406016499$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240717$$HP$US$US
240181942$24018194$2$F$20240606$20240816$20240627$20240821$EXP$$CA-ROCHE-3579981$ROCHE$$21$YR$A$F$Y$$$20240821$$CN$CA$CA
240182012$24018201$2$F$20240614$20240722$20240627$20240726$EXP$$US-ROCHE-10000006856$ROCHE$$69$YR$E$M$Y$$$20240726$$CN$US$US
240182062$24018206$2$F$20240607$20240731$20240627$20240808$EXP$$JP-AstraZeneca-2024A143717$ASTRAZENECA$$45$YR$$M$Y$58$KG$20240808$$MD$JP$
240182112$24018211$2$F$20240305$20240612$20240627$20240708$EXP$$PK-ROCHE-10000007506$ROCHE$$73$YR$E$M$Y$$$20240708$$CN$PK$PK
240182132$24018213$2$F$$20240810$20240627$20240819$EXP$$CA-CELLTRION INC.-2024CA015401$CELLTRION$$$$$$Y$$$20240819$$MD$CA$CA
240182222$24018222$2$F$20230101$20240924$20240627$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102071$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240924$$CN$US$US
240182252$24018225$2$F$20240701$20240828$20240627$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102726$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240904$$HP$US$US
240182262$24018226$2$F$$20240924$20240627$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-102380$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$MD$JP$JP
240182293$24018229$3$F$20240623$20240708$20240627$20240708$PER$$US-AMGEN-USASP2024126317$AMGEN$$74$YR$E$F$Y$$$20240708$$CN$US$US
240182422$24018242$2$F$20240621$20240806$20240627$20240808$PER$$US-AMGEN-USASP2024123997$AMGEN$$72$YR$E$F$Y$$$20240807$$CN$US$US
240182435$24018243$5$F$20240615$20240801$20240627$20240808$PER$$US-ROCHE-10000008059$ROCHE$$84$YR$E$F$Y$$$20240808$$CN$US$US
240182443$24018244$3$F$20240501$20240827$20240627$20240903$EXP$$US-ABBVIE-5815406$ABBVIE$$41$YR$$F$Y$$$20240903$$CN$US$US
240182582$24018258$2$F$$20240717$20240627$20240723$EXP$$US-862174955-ML2024-03599$Unknown Manufacturer$$$$$M$Y$$$20240723$$CN$US$US
240182603$24018260$3$F$20240613$20240710$20240627$20240715$EXP$$IE-ROCHE-10000008786$ROCHE$$$$$F$Y$$$20240715$$CN$IE$IE
240182702$24018270$2$F$$20240710$20240627$20240719$EXP$$JP-BIOCON BIOLOGICS LIMITED-BBL2024004726$BIOCON$Takuya Maki, Yuki Arisawa, Mahori Tago, Eri Sakaida, Mirai Hotta, Teruyuki Mitsuma. Acute generalised exanthematous pustulosis occurring during treatment of hidradenitis suppurativa. The 308th Meeting of the Tokai Division of Japanese Dermatological Association. 2024;11$$$$$Y$$$20240719$$HP$JP$JP
240182902$24018290$2$F$$20240919$20240627$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202406017659$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240920$$CN$US$US
240183016$24018301$6$F$$20240814$20240627$20240820$EXP$$US-ROCHE-10000006802$ROCHE$$$$A$M$Y$124.28$KG$20240820$$CN$US$US
240183052$24018305$2$F$$20240829$20240627$20240830$EXP$$NVSC2024US132135$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
240183073$24018307$3$F$$20240705$20240627$20240709$EXP$$DE-TAKEDA-2024TUS063526$TAKEDA$$60$YR$$M$Y$$$20240709$$HP$DE$DE
240183222$24018322$2$F$$20240729$20240627$20240806$EXP$$JP-ARGENX-2024-ARGX-JP004593AA$ARGENX BVBA$$$$$$Y$$$20240806$$MD$JP$JP
240183262$24018326$2$F$$20240703$20240627$20240713$EXP$$AU-TEVA-VS-3213048$TEVA$Dhaliwal N, Roberts DM. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clin-Toxicol-(Phila) 2024; 0 (0): 1-6.; Dhaliwal N, Roberts DM. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clin-Toxicol-(Phila) 2024; 0 (0): 1-6.; Dhaliwal N, Roberts DM. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clin-Toxi...$$$$$Y$$$20240713$$HP$AU$AU
240183362$24018336$2$F$$20240828$20240627$20240901$EXP$$NVSC2024US003443$NOVARTIS$$$$$F$Y$$$20240901$$CN$US$US
240183382$24018338$2$F$20240201$20240813$20240627$20240821$EXP$$DE-JNJFOC-20240656965$JOHNSON AND JOHNSON$$44$YR$A$M$Y$70$KG$20240821$$MD$DE$DE
240183412$24018341$2$F$$20240723$20240627$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101149$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240724$$CN$US$US
240183503$24018350$3$F$$20240722$20240627$20240728$PER$$US-AstraZeneca-2024A147418$ASTRAZENECA$$$$$$Y$$$20240728$$CN$US$
240183532$24018353$2$F$$20240924$20240627$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102184$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240924$$HP$US$US
240183542$24018354$2$F$20200203$20240703$20240627$20240711$EXP$$CA-CELLTRION INC.-2020CA021820$CELLTRION$$$$$$Y$$$20240711$$MD$CA$CA
240183563$24018356$3$F$20240101$20240719$20240627$20240725$PER$$US-AMGEN-USASP2024125522$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
240183613$24018361$3$F$20240101$20240826$20240627$20240904$EXP$$US-INSMED, INC.-2024-00657-US$INSMED$$$$$M$Y$$$20240904$$CN$US$US
240183624$24018362$4$F$20240101$20240815$20240627$20240827$EXP$$US-INSMED, INC.-2024-00392-US$INSMED$$$$$F$Y$$$20240827$$CN$US$US
240183662$24018366$2$F$$20240621$20240627$20240703$EXP$$KR-ALXN-202405KOR002354KR$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240703$$MD$KR$KR
240183712$24018371$2$F$20240101$20240726$20240627$20240730$EXP$$US-ABBVIE-5817213$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
240183862$24018386$2$F$$20240716$20240627$20240722$EXP$$US-GILEAD-2024-0671633$GILEAD$$$$E$F$Y$$$20240719$$CN$US$US
240183872$24018387$2$F$20101101$20240730$20240627$20240808$EXP$$DE-AUROBINDO-AUR-APL-2011-03553$AUROBINDO$Schott-Seidenschwanz I, Wille H, Muehlbauer B.. Death Trap Metamizole? (Todesfalle Metamizol?). Bremer Aerztejournal. 2011;64:20$25$YR$$F$Y$$$20240808$$MD$DE$DE
240183932$24018393$2$F$20240617$20240925$20240627$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102504$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240925$$CN$US$US
240184072$24018407$2$F$20240614$20240618$20240627$20240702$EXP$$JP-UCBSA-2024031703$UCB$$50$YR$$M$Y$166.2$KG$20240702$$MD$JP$JP
240184082$24018408$2$F$$20240916$20240627$20240923$EXP$$NVSC2024IN132141$NOVARTIS$$$$$F$Y$$$20240923$$CN$IN$IN
240184112$24018411$2$F$$20240621$20240627$20240701$PER$$US-JNJFOC-20240660795$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$MD$US$US
240184162$24018416$2$F$$20240626$20240627$20240708$PER$$US-AstraZeneca-2024A147913$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$US$
240184172$24018417$2$F$$20240803$20240627$20240828$PER$$US-AstraZeneca-2024A133731$ASTRAZENECA$$$$$$Y$$$20240828$$HP$US$
240184293$24018429$3$F$20230101$20240717$20240627$20240724$EXP$$US-ABBVIE-5815453$ABBVIE$$$$$M$Y$94$KG$20240724$$CN$US$US
240184352$24018435$2$F$20240618$20240709$20240627$20240713$EXP$$IT-TAKEDA-2024TUS063853$TAKEDA$$$$$F$Y$$$20240713$$HP$IT$IT
240184623$24018462$3$F$$20240801$20240627$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102864$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$51.71$KG$20240802$$CN$US$US
240184722$24018472$2$F$$20240802$20240627$20240805$PER$$US-ALXN-202406USA001336US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240184732$24018473$2$F$$20240802$20240627$20240805$PER$$US-ALXN-202406USA001349US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
240184882$24018488$2$F$20240501$20240712$20240627$20240717$EXP$$US-JNJFOC-20240655147$JOHNSON AND JOHNSON$$68$YR$$M$Y$$$20240717$$CN$US$US
240184922$24018492$2$F$$20240710$20240627$20240722$EXP$$CA-ROCHE-10000007241$ROCHE$$44$YR$A$M$Y$$$20240719$$HP$CA$CA
240185022$24018502$2$F$20240101$20240717$20240627$20240723$PER$$US-AMGEN-USASP2024124095$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
240185052$24018505$2$F$20240501$20240827$20240627$20240903$EXP$$CO-GSK-CO2024AMR053255$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$CO$CO
240185102$24018510$2$F$$20240722$20240627$20240726$EXP$$US-JNJFOC-20240658577$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$PH$US$US
240185123$24018512$3$F$$20240827$20240627$20240909$EXP$$PT-CHATTEMPRD-2024OHG021638$CHATTEM$$$$E$$Y$$$20240909$$HP$PT$PT
240185282$24018528$2$F$20220801$20240719$20240627$20240729$EXP$FR-AFSSAPS-TS2024000683$FR-TEVA-VS-3212759$TEVA$$52$YR$$F$Y$108$KG$20240729$$PH$FR$FR
240185302$24018530$2$F$$20240804$20240627$20240810$EXP$$US-ROCHE-10000008563$ROCHE$$72$YR$E$F$Y$$$20240810$$HP$US$US
240185312$24018531$2$F$$20240918$20240627$20240930$EXP$$CA-CHATTEMPRD-2024OHG021861$CHATTEM$$44$YR$A$F$Y$$$20240930$$HP$CA$CA
240185334$24018533$4$F$20240101$20240814$20240627$20240819$EXP$$CA-ABBVIE-5817049$ABBVIE$$36$YR$$M$Y$$$20240819$$CN$CA$CA
240185422$24018542$2$F$$20240823$20240627$20240828$EXP$$BR-ROCHE-10000005261$ROCHE$$$$$F$Y$$$20240828$$CN$BR$BR
240185462$24018546$2$F$$20240719$20240627$20240726$EXP$$US-ROCHE-10000008619$ROCHE$$65$YR$E$M$Y$$$20240726$$CN$US$US
240185542$24018554$2$F$$20240709$20240627$20240718$EXP$US-MLMSERVICE-20240612-PI096223-00030-1$US-STRIDES ARCOLAB LIMITED-2024SP007469$STRIDES$Raza HS, Love JS, Mikolajczyk AE.. Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding.. ACG case reports journal.. 2024;11(6):e01378$$$$$Y$$$20240718$$MD$US$US
240185553$24018555$3$F$$20240710$20240627$20240715$PER$$US-ROCHE-10000007461$ROCHE$$57$YR$A$M$Y$$$20240715$$CN$US$US
240185703$24018570$3$F$$20240710$20240627$20240717$EXP$$US-ABBVIE-4315535$ABBVIE$$$$$F$Y$$$20240717$$MD$US$US
240185774$24018577$4$F$$20240729$20240627$20240802$EXP$$US-TAKEDA-2024TUS063280$TAKEDA$$$$$F$Y$$$20240802$$CN$US$US
240185802$24018580$2$F$$20240708$20240627$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102837$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$81.65$KG$20240711$$CN$US$US
240185813$24018581$3$F$20240601$20240806$20240627$20240813$EXP$$BR-BEH-2024173973$CSL BEHRING$$41$YR$A$F$Y$$$20240813$$MD$BR$BR
240185832$24018583$2$F$$20240624$20240627$20240705$EXP$$CN-Accord-431749$ACCORD$Yang M, Cai Y, Wan L, Ji L, Song XM. Case report: Autoimmune encephalomyelitis following cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Front Med (Lausanne). 2024 May 30;11:1373062. doi: 10.3389/fmed.2024.1373062.$53$YR$A$F$Y$$$20240705$$HP$CN$CN
240185842$24018584$2$F$20231201$20240821$20240627$20240829$EXP$$CO-ASTELLAS-2024US018106$ASTELLAS$$68$YR$E$M$Y$53$KG$20240829$$CN$CO$CO
240185864$24018586$4$F$$20240827$20240627$20240830$PER$$US-ROCHE-10000009095$ROCHE$$$$$$Y$$$20240830$$CN$US$US
240185972$24018597$2$F$$20240718$20240627$20240722$EXP$$NVSJ2024JP007575$NOVARTIS$$$$$$Y$$$20240722$$CN$JP$JP
240186012$24018601$2$F$20240309$20240701$20240627$20240708$EXP$$NVSJ2024JP007567$NOVARTIS$$$$A$M$Y$$$20240708$$MD$JP$JP
240186072$24018607$2$F$$20240925$20240627$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102634$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240925$$CN$US$US
240186103$24018610$3$F$20240501$20240816$20240627$20240830$EXP$$MX-BRISTOL-MYERS SQUIBB COMPANY-2024-100187$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240830$$MD$MX$MX
240186172$24018617$2$F$20240415$20240718$20240627$20240722$EXP$FR-AFSSAPS-AN2024000807$FR-ASTELLAS-2024EU006221$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$FR$FR
240186222$24018622$2$F$$20240717$20240627$20240724$EXP$$IT-ASTELLAS-2024EU006342$ASTELLAS$$$$N$M$Y$$$20240724$$MD$IT$IT
240186236$24018623$6$F$$20240618$20240627$20240709$EXP$$US-ROCHE-10000001592$ROCHE$$36$YR$A$F$Y$$$20240701$$CN$US$US
240186242$24018624$2$F$20240130$20240703$20240627$20240717$EXP$$BE-ALIMERA SCIENCES INC.-BE-A16013-24-000345$ALIMERA$$46$YR$$M$Y$$$20240717$$MD$BE$BE
240186272$24018627$2$F$$20240626$20240627$20240709$EXP$$IN-ALVOGEN-2024094934$ALVOGEN$Shinde S, Guntiboina VA, Nag A, Podder D, Chattopadhyay D, Kumar J, Bhave S, Mishra DK, Chandy M, Nair R. Melphalan-associated encephalopathy following autologous stem cell transplant: a transpIanter^s nightmare!. Blood Cell Therapy-The official journal of APBMT. 2024 May 25;7(2):33-36. doi:https://dx.doi.org/10.31547/bct-2023-025$63$YR$$M$Y$$$20240709$$HP$IN$IN
240186332$24018633$2$F$$20240703$20240627$20240703$PER$$US-JNJFOC-20240663389$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$PH$US$US
240186362$24018636$2$F$$20240620$20240627$20240709$PER$$US-BAYER-2024A091871$BAYER$$72$YR$E$M$Y$$$20240709$$CN$US$US
240186442$24018644$2$F$20240604$20240702$20240627$20240708$EXP$$GB-MYLANLABS-2024M1057806$MYLAN$$$$$F$Y$$$20240708$$PH$GB$GB
240186472$24018647$2$F$$20240702$20240627$20240710$EXP$$US-TEVA-VS-3212095$TEVA$Meehan AM, Joyce JB, Tande AJ. Gram negative pyomyositis: Two case reports and a review of the literature. IDCases 2023; 31.; Meehan AM, Joyce JB, Tande AJ. Gram negative pyomyositis: Two case reports and a review of the literature. IDCases 2023; 31.$64$YR$$M$Y$$$20240710$$HP$US$US
240186572$24018657$2$F$20240620$20240625$20240627$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017664$ELI LILLY AND CO$$64$YR$A$F$Y$54.422$KG$20240701$$CN$US$US
240186644$24018664$4$F$20240101$20240627$20240627$20240705$EXP$$CA-ABBVIE-5817452$ABBVIE$$66$YR$$F$Y$$$20240705$$CN$CA$CA
240186652$24018665$2$F$20240415$20240727$20240627$20240808$EXP$$US-ELI_LILLY_AND_COMPANY-US202406016050$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240808$$CN$US$US
240186712$24018671$2$F$20240601$20240729$20240627$20240809$EXP$GB-MHRA-MED-202406151759074680-GZKVT$GB-MACLEODS PHARMA-MAC2024047827$MACLEODS$$$$$$Y$$$20240809$$CN$GB$GB
240186752$24018675$2$F$$20240702$20240627$20240709$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-090121$REGENERON$$$$$M$Y$$$20240709$$CN$CA$CA
240186912$24018691$2$F$20200101$20240705$20240627$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453357$RANBAXY$$$$$F$Y$$$20240719$$MD$GB$GB
240187002$24018700$2$F$20240620$20240724$20240627$20240729$PER$$US-AMGEN-USASP2024122514$AMGEN$$$$$F$Y$96.75$KG$20240729$$CN$US$US
240187013$24018701$3$F$20240101$20240709$20240627$20240715$PER$$US-AMGEN-USASP2024126215$AMGEN$$70$YR$E$F$Y$$$20240715$$CN$US$US
240187072$24018707$2$F$$20240710$20240627$20240712$EXP$$US-GILEAD-2024-0678489$GILEAD$$37$YR$A$M$Y$134.2$KG$20240712$$HP$US$US
240187112$24018711$2$F$20230101$20240624$20240627$20240705$EXP$$CN-Accord-431399$ACCORD$Yan C, Liu TT, Gao LT. Chronic inflammatory demyelinating polyneuropathy with pulmonary nocardiosis: A case report. Medicine (Baltimore). 2024 Jun 14;103(24):e38544.$65$YR$E$M$Y$$$20240705$$MD$CN$CN
240187225$24018722$5$F$20240623$20240729$20240627$20240812$30DAY$$US-JNJFOC-20240662924$JOHNSON AND JOHNSON$$11$YR$C$F$Y$$$20240812$$HP$US$US
240187272$24018727$2$F$20100226$20240626$20240627$20240703$EXP$$US-JNJFOC-20100307489$JOHNSON AND JOHNSON$$40$YR$A$F$Y$99.9$KG$20240703$$MD$US$US
240187312$24018731$2$F$20240613$20240708$20240627$20240722$EXP$$US-UCBSA-2024032677$UCB$$76$YR$$M$Y$$$20240719$$HP$US$US
240187342$24018734$2$F$20240620$20240718$20240627$20240728$30DAY$$US-GSK-US2024078110$GLAXOSMITHKLINE$$63$YR$$M$Y$144$KG$20240728$$MD$US$US
240187412$24018741$2$F$20240410$20240628$20240627$20240708$EXP$$CA-TAKEDA-2024TUS027870$TAKEDA$$29$YR$$F$Y$$$20240708$$CN$CA$CA
240187495$24018749$5$F$20240101$20240724$20240627$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036492$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240729$$MD$US$US
240187526$24018752$6$F$20240101$20240904$20240627$20240906$EXP$$CA-Orion Corporation ORION PHARMA-24_00030527$ORION$$19$YR$A$M$Y$$$20240906$$HP$CA$
240187573$24018757$3$F$20240502$20240812$20240627$20240820$EXP$$NVSC2024IE094331$NOVARTIS$$50$YR$$F$Y$$$20240820$$HP$IE$IE
240187602$24018760$2$F$$20240710$20240627$20240711$PER$$US-BAYER-2024A091762$BAYER$$73$YR$E$F$Y$$$20240711$$CN$US$US
240187632$24018763$2$F$20240419$20240624$20240627$20240705$EXP$$US-ROCHE-3554182$ROCHE$$85$YR$E$F$Y$43.3$KG$20240705$$MD$US$US
240187652$24018765$2$F$20240614$20240719$20240627$20240726$30DAY$$US-AMGEN-USASP2024123187$AMGEN$$74$YR$E$F$Y$67.2$KG$20240726$$PH$US$US
240187682$24018768$2$F$20240621$20240802$20240627$20240806$EXP$$IT-UCBSA-2024032330$UCB$$44$YR$$F$Y$129$KG$20240806$$MD$IT$IT
240187702$24018770$2$F$$20240626$20240627$20240711$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00471$Phathom Pharmaceuticals$$68$YR$$M$Y$$$20240711$$MD$JP$JP
240187744$24018774$4$F$20240606$20240816$20240627$20240826$EXP$$BR-BAXTER-2024BAX020467$BAXTER$$64$YR$$M$Y$65$KG$20240826$$MD$BR$BR
240187782$24018778$2$F$20240601$20240627$20240627$20240702$EXP$$NVSC2024SK133250$NOVARTIS$$$$$M$Y$$$20240702$$MD$SK$SK
240187842$24018784$2$F$$20240802$20240627$20240805$PER$$US-ALXN-202406USA001339US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240187902$24018790$2$F$$20240924$20240627$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102370$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$HP$US$US
240187922$24018792$2$F$$20240829$20240627$20240906$EXP$$US-ROCHE-10000009231$ROCHE$$67$YR$E$M$Y$$$20240906$$CN$US$US
240187932$24018793$2$F$20220818$20240702$20240627$20240710$EXP$$FR-CELLTRION INC.-2024FR015342$CELLTRION$$$$$$Y$$$20240710$$PH$FR$FR
240187952$24018795$2$F$20231001$20240703$20240627$20240709$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-024069$JAZZ$$45$YR$$F$Y$$$20240709$$MD$US$US
240187962$24018796$2$F$$20240628$20240627$20240706$PER$$US-AMGEN-USASP2024125017$AMGEN$$$$$F$Y$$$20240706$$PH$US$US
240187992$24018799$2$F$$20240827$20240627$20240906$30DAY$$US-GSK-US2024075139$GLAXOSMITHKLINE$$$$$M$Y$$$20240906$$PH$US$US
240188012$24018801$2$F$$20240815$20240627$20240819$EXP$$NVSC2024US131021$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
240188032$24018803$2$F$$20240702$20240627$20240710$EXP$$US-TEVA-VS-3212210$TEVA$Hwang AS, Hoss E, Pittelkow MR, Yang YW. Treatment of Hydroxyurea-Induced Ulcers with Timolol. JAMA-Dermatol 2023; 159 1277-1279.; Hwang AS, Hoss E, Pittelkow MR, Yang YW. Treatment of Hydroxyurea-Induced Ulcers with Timolol. JAMA-Dermatol 2023; 159 1277-1279.; Hwang AS, Hoss E, Pittelkow MR, Yang YW. Treatment of Hydroxyurea-Induced Ulcers with Timolol. JAMA-Dermatol 2023; 159 1277-1279.$66$YR$$F$Y$$$20240710$$HP$US$US
240188202$24018820$2$F$$20240626$20240627$20240708$EXP$$CA-ROCHE-3525244$ROCHE$$$$E$M$Y$$$20240708$$HP$CA$CA
240188233$24018823$3$F$20240601$20240909$20240627$20240924$PER$$US-SA-2024SA179059$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240924$$MD$US$US
240188242$24018824$2$F$20240101$20240828$20240627$20240910$PER$$US-SA-2024SA185214$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240910$$MD$US$US
240188252$24018825$2$F$20240612$20240822$20240627$20240917$PER$$US-SA-2024SA181528$SANOFI AVENTIS$$35$YR$A$M$Y$80.28$KG$20240918$$MD$US$US
240188362$24018836$2$F$20240618$20240703$20240627$20240712$PER$$US-SA-2024SA185066$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240712$$MD$US$US
240188392$24018839$2$F$20240601$20240618$20240627$20240701$PER$$US-SA-2024SA184554$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240701$$CN$US$US
240188412$24018841$2$F$$20240618$20240627$20240702$PER$$US-SA-2024SA183822$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240702$$CN$US$US
240188442$24018844$2$F$20240528$20240530$20240627$20240801$PER$$US-BAYER-2024A090648$BAYER$$$$$F$Y$$$20240801$$CN$US$US
240188452$24018845$2$F$20240521$20240710$20240627$20240722$EXP$$NZ-TASMAN PHARMA, INC.-2024TSM00205$TASMAN PHARMA$$45$YR$$F$Y$$$20240722$$HP$NZ$NZ
240188493$24018849$3$F$20240101$20240801$20240627$20240809$PER$$US-SA-2024SA185421$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240809$$CN$US$US
240188542$24018854$2$F$20240621$20240621$20240627$20240704$PER$$US-AMGEN-USASP2024124134$AMGEN$$57$YR$A$M$Y$$$20240704$$CN$US$US
240188553$24018855$3$F$20240101$20240819$20240627$20240828$PER$$US-SA-2024SA186646$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240828$$MD$US$US
240188602$24018860$2$F$$20240916$20240627$20240920$PER$$US-SA-2024SA183607$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240920$$MD$US$US
240188612$24018861$2$F$20240619$20240701$20240627$20240710$PER$$US-SA-2024SA187909$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240710$$HP$US$US
240188693$24018869$3$F$$20240625$20240627$20240705$EXP$$NVSC2021CA318452$NOVARTIS$$59$YR$$F$Y$68$KG$20240705$$HP$CA$CA
240188822$24018882$2$F$20240624$20240625$20240627$20240703$PER$$US-SA-2024SA189383$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240703$$HP$US$US
240188872$24018887$2$F$20230101$20240624$20240627$20240718$PER$$US-AMGEN-USASP2024124981$AMGEN$$55$YR$A$M$Y$$$20240717$$CN$US$US
240188896$24018889$6$F$20230301$20240903$20240627$20240905$PER$$US-ROCHE-3579728$ROCHE$$78$YR$E$F$Y$$$20240905$$CN$US$US
240189102$24018910$2$F$$20240722$20240627$20240807$PER$$AU-TOLMAR, INC.-24AU049975$TOLMAR$$$$$$Y$$$20240806$$HP$AU$AU
240189192$24018919$2$F$20240604$20240712$20240627$20240801$PER$$US-TOLMAR, INC.-24US049950$TOLMAR$$6$YR$$F$Y$$$20240801$$HP$US$US
240189432$24018943$2$F$$20240702$20240627$20240706$EXP$$JP-ABBVIE-5816777$ABBVIE$$50$YR$$F$Y$$$20240706$$MD$JP$JP
240189512$24018951$2$F$$20240925$20240627$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103012$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$PH$US$US
240189522$24018952$2$F$20240624$20240626$20240627$20240701$EXP$$AU-MYLANLABS-2024M1057733$MYLAN$$28$YR$$M$Y$$$20240701$$HP$AU$AU
240189533$24018953$3$F$20240622$20240628$20240627$20240703$EXP$$US-MYLANLABS-2024M1058287$MYLAN$$53$YR$$M$Y$$$20240703$$HP$US$US
240189552$24018955$2$F$$20240813$20240627$20240816$PER$$US-ROCHE-10000008931$ROCHE$$$$$$Y$$$20240816$$PH$US$US
240189572$24018957$2$F$$20240802$20240627$20240805$PER$$US-ALXN-202406USA001342US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240189702$24018970$2$F$20240416$20240910$20240627$20240926$30DAY$$CA-BECTON DICKINSON-CA-BD-24-000383$BECTON DICKINSON$$$$$$Y$$$20240926$$CN$CA$CA
240189743$24018974$3$F$20171114$20240705$20240627$20240706$EXP$$IT-AMGEN-ITANI2024124054$AMGEN$$$$$$Y$$$20240706$$MD$IT$IT
240189773$24018977$3$F$20240621$20240731$20240627$20240803$PER$$US-AMGEN-USASP2024124094$AMGEN$$74$YR$E$M$Y$$$20240803$$CN$US$US
240189892$24018989$2$F$20240101$20240625$20240627$20240704$PER$$US-SA-2024SA186519$SANOFI AVENTIS$$37$YR$A$M$Y$92$KG$20240704$$MD$US$US
240189942$24018994$2$F$20240618$20240703$20240627$20240712$PER$$US-SA-2024SA185280$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240712$$CN$US$US
240190092$24019009$2$F$20240601$20240717$20240627$20240726$PER$$US-SA-2024SA186193$SANOFI AVENTIS$$65$YR$E$M$Y$102$KG$20240726$$MD$US$US
240190132$24019013$2$F$20240101$20240731$20240627$20240809$PER$$US-SA-2024SA187195$SANOFI AVENTIS$$7$YR$C$F$Y$26.8$KG$20240809$$MD$US$US
240190162$24019016$2$F$$20240716$20240627$20240724$PER$$US-SA-2024SA185288$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$MD$US$US
240190182$24019018$2$F$20240620$20240701$20240627$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101206$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240703$$CN$US$US
240190232$24019023$2$F$$20240703$20240627$20240712$PER$$US-SA-2024SA187815$SANOFI AVENTIS$$72$YR$E$M$Y$105$KG$20240712$$MD$US$US
240190323$24019032$3$F$20240610$20240909$20240627$20240919$EXP$$HU-RECORDATI RARE DISEASE INC.-2024004603$RECORDATI$$$$$$Y$$$20240919$$MD$HU$HU
240190492$24019049$2$F$$20240821$20240627$20240826$EXP$$IN-ROCHE-10000008261$ROCHE$$58$YR$A$F$Y$$$20240826$$CN$IN$IN
240190533$24019053$3$F$20240113$20240826$20240627$20240912$EXP$$DE-SERB S.A.S.-2158604$LABORATOIRES SERB$$80$YR$$F$Y$$$20240912$$MD$DE$DE
240190543$24019054$3$F$20230716$20240826$20240627$20240830$EXP$$DE-SERB S.A.S.-2158602$LABORATOIRES SERB$$53$YR$$M$Y$$$20240830$$MD$DE$DE
240190552$24019055$2$F$$20240925$20240627$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102868$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240925$$CN$US$US
240190572$24019057$2$F$20230628$20240806$20240627$20240822$EXP$$DE-SERB S.A.S.-2158595$LABORATOIRES SERB$$20$YR$$F$Y$$$20240822$$MD$DE$DE
240190642$24019064$2$F$$20240830$20240627$20240903$EXP$$US-TAKEDA-2023TUS119447$TAKEDA$$$$$F$Y$$$20240903$$CN$US$US
240190672$24019067$2$F$20231201$20240627$20240627$20240701$EXP$$IT-GSK-IT2024GSK079621$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$IT$IT
240190702$24019070$2$F$20231007$20240806$20240627$20240822$EXP$$DE-SERB S.A.S.-2158605$LABORATOIRES SERB$$63$YR$$M$Y$$$20240822$$MD$DE$DE
240190732$24019073$2$F$20240401$20240626$20240627$20240703$EXP$$AU-GILEAD-2024-0678657$GILEAD$$$$$F$Y$$$20240703$$MD$AU$AU
240190742$24019074$2$F$$20240702$20240627$20240712$EXP$$US-TEVA-VS-3212075$TEVA$Carmen De Los Santos Kuri M, Wright L. Inaccurate Hemoglobin A1c in a Transman Patient with Diabetes: Implications for Treatment and Surveillance. J-Endocr-Soc 2019; 3 (Suppl. 1).; Carmen De Los Santos Kuri M, Wright L. Inaccurate Hemoglobin A1c in a Transman Patient with Diabetes: Implications for Treatment and Surveillance. J-Endocr-Soc 2019; 3 (Suppl. 1).$52$YR$$M$Y$$$20240712$$HP$US$US
240190922$24019092$2$F$20240619$20240902$20240627$20240905$EXP$$SE-JNJFOC-20240653761$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$MD$SE$SE
240190952$24019095$2$F$$20240627$20240627$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05429$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240190983$24019098$3$F$20240608$20240820$20240627$20240821$EXP$$NZ-MYLANLABS-2024M1058576$MYLAN$$66$YR$$M$Y$$$20240821$$HP$NZ$NZ
240191172$24019117$2$F$$20240701$20240627$20240702$EXP$$DE-TAKEDA-2024TUS063868$TAKEDA$$58$YR$$F$Y$$$20240702$$HP$DE$DE
240191352$24019135$2$F$$20240711$20240627$20240716$30DAY$$US-MYLANLABS-2024M1057066$MYLAN$$$$$M$Y$$$20240716$$CN$US$US
240191423$24019142$3$F$$20240817$20240627$20240819$EXP$$CA-PFIZER INC-202400200842$PFIZER$$77$YR$$$Y$$$20240819$$PH$CA$CA
240191453$24019145$3$F$20240617$20240821$20240627$20240822$EXP$$CA-PFIZER INC-202400195649$PFIZER$$45$YR$$F$Y$$$20240822$$HP$CA$CA
240191472$24019147$2$F$20240601$20240628$20240627$20240702$EXP$GB-MHRA-MED-202406211203206560-HCTBV$GB-PFIZER INC-202400198513$PFIZER$$$$$F$Y$$$20240702$$CN$GB$GB
240191492$24019149$2$F$20240417$20240701$20240627$20240716$EXP$$CN-PFIZER INC-PV202400083048$PFIZER$$51$YR$$F$Y$71$KG$20240716$$HP$CN$CN
240191512$24019151$2$F$20200818$20240723$20240627$20240725$EXP$$BR-PFIZER INC-202400200614$PFIZER$$36$YR$$F$Y$51$KG$20240725$$HP$BR$BR
240191523$24019152$3$F$20210601$20240626$20240627$20240702$EXP$$HR-PFIZER INC-202400200123$PFIZER$Spicijaric, M.. Latrogenic hyperkalemia caused by incorrect medication intake - a case report. Medicina Fluminensis. 2024;60(2):224-228$67$YR$$M$Y$$$20240702$$MD$HR$HR
240191542$24019154$2$F$$20240905$20240627$20240905$EXP$$CN-PFIZER INC-202400199149$PFIZER$$$$$$Y$$$20240905$$MD$CN$CN
240191602$24019160$2$F$20231128$20240718$20240627$20240808$EXP$$NVSC2024DE133403$NOVARTIS$$55$YR$$M$Y$$$20240808$$HP$DE$DE
240191632$24019163$2$F$20231214$20240702$20240627$20240705$EXP$FR-AFSSAPS-TO2024000808$FR-ORGANON-O2406FRA002222$ORGANON$$88$YR$$M$Y$75$KG$20240705$$PH$FR$FR
240191772$24019177$2$F$20240101$20240725$20240627$20240803$EXP$$US-TEVA-VS-3211427$TEVA$$67$YR$$M$Y$$$20240803$$CN$US$US
240191792$24019179$2$F$20240618$20240730$20240627$20240806$EXP$$CA-CELLTRION INC.-2024CA015448$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
240191902$24019190$2$F$20240620$20240710$20240627$20240712$EXP$$GB-DSJP-DSE-2024-129120$DAIICHI$$66$YR$$F$Y$54$KG$20240712$$MD$GB$GB
240192002$24019200$2$F$20240517$20240718$20240627$20240725$EXP$$CO-GSK-CO2024AMR050271$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$CO$CO
240192022$24019202$2$F$$20240716$20240627$20240724$30DAY$$US-GSK-US2024078090$GLAXOSMITHKLINE$$$$$F$Y$$$20240724$$CN$US$US
240192162$24019216$2$F$$20240812$20240627$20240816$PER$$US-VERTEX PHARMACEUTICALS-2024-010622$VERTEX$$70$YR$$F$Y$$$20240816$$CN$US$US
240192232$24019223$2$F$$20240710$20240627$20240711$EXP$$MY-PFIZER INC-202400200280$PFIZER$$1$YR$$M$Y$$$20240711$$MD$MY$MY
240192273$24019227$3$F$20240625$20240630$20240627$20240701$EXP$$US-PFIZER INC-202400200809$PFIZER$$65$YR$$$Y$$$20240701$$CN$US$US
240192373$24019237$3$F$20240101$20240719$20240627$20240723$EXP$$KR-DSJP-DSJ-2024-128286$DAIICHI$$$$$F$Y$$$20240723$$CN$KR$KR
240192412$24019241$2$F$20240101$20240903$20240627$20240913$PER$$US-SA-2024SA183729$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240913$$MD$US$US
240192462$24019246$2$F$20240101$20240711$20240627$20240723$PER$$US-SA-2024SA180519$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240723$$MD$US$US
240192526$24019252$6$F$20240101$20240917$20240627$20240922$EXP$$US-SA-2024SA183687$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240923$$MD$US$US
240192533$24019253$3$F$20240501$20240730$20240627$20240808$PER$$US-SA-2024SA183929$SANOFI AVENTIS$$53$YR$A$F$Y$57.596$KG$20240808$$MD$US$US
240192572$24019257$2$F$20220301$20240716$20240627$20240722$PER$$US-BAYER-2024A089482$BAYER$$31$YR$A$F$Y$$$20240722$$CN$US$US
240192592$24019259$2$F$20240101$20240710$20240627$20240715$EXP$$CA-JNJFOC-20240668048$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240715$$HP$CA$CA
240192602$24019260$2$F$$20240904$20240627$20240905$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-090166$REGENERON$$$$$F$Y$$$20240905$$HP$CA$CA
240192642$24019264$2$F$$20240702$20240627$20240710$EXP$$US-TEVA-VS-3212126$TEVA$Hachey DM, Wood BR, Buitrago M, Burde A. Therapy for HIV-associated cryptococcal meningitis: a case report demonstrating a new treatment approach emphasizing updated treatment guidelines. Drug-Ther-Perspect 2023; 39 (6): 216-221.; Hachey DM, Wood BR, Buitrago M, Burde A. Therapy for HIV-associated cryptococcal meningitis: a case report demonstrating a new treatment approach emphasizing updated treatment guidelines. Drug-Ther-Perspect 2023; 39 (6): 216-221.$69$YR$$M$Y$$$20240710$$HP$US$US
240192653$24019265$3$F$$20240717$20240627$20240726$EXP$$US-AMGEN-USASP2024126080$AMGEN$$$$A$M$Y$$$20240726$$CN$US$US
240192662$24019266$2$F$$20240627$20240627$20240702$EXP$$HU-BAUSCH-BL-2024-009851$BAUSCH AND LOMB$Szigethi T, Tanai E, Molnar L, Zima E, Sax B, Szappanos A, Becker D, Merkely B. Gyogyszer-indukalta autoimmun hemolitikus anemia es akut koronaria szindroma. Cardiologia Hungarica. 2024;54(SUPPLEMENT C):C275.$$$$M$Y$$$20240702$$HP$HU$HU
240192802$24019280$2$F$$20240925$20240627$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101431$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240930$$CN$US$US
240192912$24019291$2$F$20240601$20240903$20240627$20240916$PER$$US-SA-2024SA185473$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240916$$MD$US$US
240192932$24019293$2$F$20240601$20240829$20240627$20240911$PER$$US-SA-2024SA185478$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240911$$MD$US$US
240192952$24019295$2$F$$20240827$20240627$20240911$PER$$US-SA-2024SA185381$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240911$$MD$US$US
240192992$24019299$2$F$$20240627$20240627$20240701$EXP$$US-PFIZER INC-202400201407$PFIZER$$74$YR$$F$Y$$$20240701$$CN$US$US
240193002$24019300$2$F$20230101$20240919$20240627$20240919$EXP$$CA-PFIZER INC-202300454008$PFIZER$$64$YR$$F$Y$85$KG$20240919$$HP$CA$CA
240193022$24019302$2$F$20240530$20240916$20240627$20240918$EXP$FR-AFSSAPS-LL2024001165$FR-PFIZER INC-202400200442$PFIZER$$47$YR$$F$Y$$$20240918$$MD$FR$FR
240193032$24019303$2$F$$20240626$20240627$20240701$EXP$$JP-PFIZER INC-202400200417$PFIZER$Hamada, M.. Diagnostic utility of cytology in a patient with Epstein-Barr virus-positive mucocutaneous ulcer in palatine tonsils: A case report. Diagnostic Cytopathology. 2024;52(7):E154?E158$82$YR$$M$Y$$$20240701$$MD$JP$JP
240193042$24019304$2$F$20200201$20240712$20240627$20240716$EXP$$JP-PFIZER INC-PV202400043255$PFIZER$$49$YR$$M$Y$52$KG$20240716$$MD$JP$JP
240193082$24019308$2$F$20240101$20240729$20240627$20240731$EXP$FR-AFSSAPS-PB2024000685$FR-PFIZER INC-202400200228$PFIZER$$32$YR$$F$Y$50$KG$20240731$$PH$FR$FR
240193093$24019309$3$F$$20240918$20240627$20240923$EXP$$PK-PFIZER INC-PV202200104567$PFIZER$$51$YR$$F$Y$$$20240923$$CN$PK$PK
240193192$24019319$2$F$20240101$20240627$20240627$20240702$PER$$US-UNITED THERAPEUTICS-UNT-2024-018772$UNITED THERAPEUTICS$$$$$F$Y$126.08$KG$20240702$$$US$US
240193282$24019328$2$F$20240603$20240701$20240627$20240709$EXP$$KR-SAMSUNG BIOEPIS-SB-2024-18995$SAMSUNG BIOEPIS$$69$YR$E$F$Y$48$KG$20240709$$MD$KR$KR
240193312$24019331$2$F$$20240819$20240627$20240828$PER$$US-SA-2024SA185443$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240828$$MD$US$US
240193322$24019332$2$F$20240729$20240802$20240627$20240813$PER$$US-SA-2024SA185433$SANOFI AVENTIS$$56$YR$A$F$Y$112$KG$20240814$$MD$US$US
240193342$24019334$2$F$$20240702$20240627$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101990$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240702$$HP$US$US
240193362$24019336$2$F$$20240711$20240627$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101943$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240716$$HP$US$US
240193372$24019337$2$F$$20240927$20240627$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101974$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240930$$CN$US$US
240193382$24019338$2$F$20240619$20240801$20240627$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-102043$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240807$$PH$JP$JP
240193392$24019339$2$F$20240419$20240828$20240627$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-086198$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240828$$MD$JP$JP
240193412$24019341$2$F$$20240809$20240627$20240813$PER$$US-ROCHE-10000007133$ROCHE$$55$YR$A$F$Y$$$20240813$$CN$US$US
240193453$24019345$3$F$$20240705$20240627$20240711$EXP$$CA-TAKEDA-2024TUS063003$TAKEDA$$$$$M$Y$$$20240711$$CN$CA$CA
240193522$24019352$2$F$$20240724$20240627$20240730$EXP$$US-EXELIXIS-CABO-24078748$EXELIXIS$$$$$M$Y$70.04$KG$20240730$$CN$US$US
240193533$24019353$3$F$20240127$20240920$20240627$20240926$EXP$$JP-009507513-2406JPN002584J$MERCK$Asako Y, Masubuchi T, Asano H, Aoki R, Yamazaki M, Kushihashi Y, et al.. P-087 A case of acute necrotising oesophagitis which developed after administration of FP+ pembrolizumab and led to fatal outcome. Head and Neck Cancer/The 48th Annual Meeting of Japan Society for Head and Neck. 2024;50(2):221$77$YR$$M$Y$57$KG$20240926$$MD$JP$JP
240193582$24019358$2$F$$20240820$20240627$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036477$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240821$$CN$US$US
240193652$24019365$2$F$$20240613$20240627$20240705$EXP$$US-ROCHE-10000003710$ROCHE$$84$YR$E$M$Y$$$20240706$$CN$US$US
240193673$24019367$3$F$20240514$20240820$20240627$20240827$EXP$$US-JNJFOC-20240650443$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240828$$CN$US$US
240193703$24019370$3$F$$20240315$20240627$20240710$PER$$GB-ROCHE-3528875$ROCHE$$$$T$F$Y$$$20240701$$CN$GB$GB
240193802$24019380$2$F$20240622$20240625$20240627$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406016495$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240701$$CN$US$US
240193892$24019389$2$F$20240219$20240722$20240627$20240724$EXP$$JP-PFIZER INC-202400201100$PFIZER$$49$YR$$F$Y$44.8$KG$20240724$$MD$JP$JP
240193923$24019392$3$F$20210101$20240904$20240627$20240909$EXP$$US-PFIZER INC-202400200805$PFIZER$$81$YR$$F$Y$$$20240909$$CN$US$US
240194082$24019408$2$F$$20240709$20240627$20240711$EXP$$JP-ABBVIE-5355236$ABBVIE$$60$YR$$F$Y$$$20240711$$MD$JP$JP
240194122$24019412$2$F$$20240904$20240627$20240917$EXP$$FR-SA-2024SA189161$SANOFI AVENTIS$$$$$F$Y$$$20240917$$MD$FR$FR
240194132$24019413$2$F$$20240702$20240627$20240710$EXP$$US-TEVA-VS-3212078$TEVA$Jalal E, Baldwin C. Supratherapeutic estrogen Levels in Transgender women Likely From Sublingual estradiol . J-Endocr-Soc 2023; 7 A1095-A1096 abstr. SAT391.; Jalal E, Baldwin C. Supratherapeutic estrogen Levels in Transgender women Likely From Sublingual estradiol . J-Endocr-Soc 2023; 7 A1095-A1096 abstr. SAT391.$38$YR$$M$Y$$$20240710$$MD$US$US
240194173$24019417$3$F$20240101$20240809$20240627$20240820$PER$$US-SA-2024SA188195$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240820$$MD$US$US
240194183$24019418$3$F$20240601$20240917$20240627$20240925$PER$$US-SA-2024SA187836$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240925$$MD$US$US
240194202$24019420$2$F$20240623$20240716$20240627$20240717$EXP$$IL-TAKEDA-2024TUS062914$TAKEDA$$$$E$M$Y$$$20240717$$MD$IL$IL
240194252$24019425$2$F$$20240808$20240627$20240814$EXP$$JP-JNJFOC-20240673082$JOHNSON AND JOHNSON$Ueda H, Uragami T Omachi T, Yamauchi S, Fujii Y, Kaneko K. [A-2 Case of a female patient with incomplete Behcet^s disease who was diagnosed early and achieved rapid remission] The journal of the Osaka Pediatric Society. The 242nd Meeting of Osaka Pediatric Society. 2024.6;2024.6.15;41:2:6$14$YR$T$F$Y$$$20240814$$MD$JP$JP
240194323$24019432$3$F$$20240717$20240627$20240724$PER$$US-AMGEN-USASP2024124577$AMGEN$$27$YR$A$F$Y$$$20240723$$MD$US$US
240194372$24019437$2$F$$20240620$20240627$20240702$EXP$$DE-LABORATORIOS LICONSA S.A.-2406DE04910$INSUD PHARMA$Suwalski P, Wilke F, Fairweather D, Landmesser U, Heidecker B. Application of magnetocardiography for myocarditis assessment in a testosterone-substituted female-to-male individual. American Heart Journal Plus: Cardiology Research and Practice. 2024;43:100412$38$YR$$F$Y$$$20240702$$MD$DE$DE
240194413$24019441$3$F$20240101$20240802$20240627$20240808$EXP$$JP-RADIUS HEALTH, INC.-2024JP002288$RADIUS PHARM$$76$YR$$F$Y$$$20240808$$MD$JP$JP
240194433$24019443$3$F$$20240716$20240627$20240802$EXP$$US-AMAROX PHARMA-HET2024US02049$HETERO$$75$YR$$F$Y$77$KG$20240802$$PH$US$US
240194442$24019444$2$F$20240513$20240709$20240627$20240711$EXP$$SK-BAYER-2024A091030$BAYER$$56$YR$A$M$Y$73$KG$20240711$$HP$SK$SK
240194562$24019456$2$F$$20240723$20240627$20240725$EXP$$PL-INCYTE CORPORATION-2024IN006808$INCYTE$$$$$$Y$$$20240725$$HP$PL$PL
240194572$24019457$2$F$20240611$20240814$20240627$20240821$EXP$$EC-ROCHE-10000004806$ROCHE$$57$YR$A$M$Y$$$20240821$$MD$EC$EC
240194582$24019458$2$F$$20240725$20240627$20240731$EXP$$US-AMGEN-USASP2024122929$AMGEN$$$$$F$Y$$$20240731$$HP$US$US
240194642$24019464$2$F$$20240716$20240627$20240723$EXP$$RU-BIOGEN-2024BI01270661$BIOGEN$Kotov S, Belova Y. Progressive multifocal leukoencephalopathy in the Clinical practice of Neurology. DOI: 10.26442/20751753.2024.2.202673. Consilium Medicum. 2024;26(2):88-92.$36$YR$$F$Y$$$20240723$$MD$RU$RU
240194653$24019465$3$F$20240101$20240705$20240627$20240712$EXP$$BR-009507513-2406BRA008561$MERCK$$55$YR$$F$Y$$$20240712$$PH$BR$BR
240194692$24019469$2$F$$20240620$20240627$20240704$EXP$$US-CIPLA LTD.-2024US06507$CIPLA$Sasidharan S, Jatoi T, Milla C, Mallappallil M, Agarwal S, Puri I. Triple whammy of amlodipine, carvedilol and diphenhydramine overdose. Am J Respir Crit Care Med. 2024;209:A5669$$$$$Y$$$20240704$$MD$US$US
240194722$24019472$2$F$20240625$20240823$20240627$20240823$EXP$$NVSC2024US133472$NOVARTIS$$54$YR$$F$Y$$$20240823$$CN$US$US
240194743$24019474$3$F$20240501$20240709$20240627$20240715$EXP$$US-EXELIXIS-CABO-24077822$EXELIXIS$$71$YR$$F$Y$$$20240715$$CN$US$US
240194752$24019475$2$F$$20240718$20240627$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202406015832$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240723$$CN$US$US
240194772$24019477$2$F$20230101$20240627$20240627$20240701$EXP$$CN-PFIZER INC-202400201532$PFIZER$Yan, C.. Chronic inflammatory demyelinating polyneuropathy with pulmonary nocardiosis: A case report. Medicine. 2024;103(24):10.1097/MD.0000000000038544$65$YR$$M$Y$$$20240701$$MD$CN$CN
240194783$24019478$3$F$20230601$20240711$20240627$20240716$EXP$$PT-PFIZER INC-202400199608$PFIZER$Salvado, J. Pretomanid Active Pharmacovigilance Program. Arsylvt$51$YR$$F$Y$55$KG$20240716$$PH$PT$PT
240194802$24019480$2$F$$20240722$20240627$20240724$EXP$$PT-PFIZER INC-202400199591$PFIZER$Costa, L. Hemolise e Trombocitopenia apos Levetiracetam: quando o doente nos da um cartao. Sinapse. 2023;23(Suppl1):274$82$YR$$M$Y$$$20240724$$HP$PT$PT
240194823$24019482$3$F$$20240701$20240627$20240712$PER$$US-ROCHE-10000003582$ROCHE$$$$E$M$Y$92.53$KG$20240712$$CN$US$US
240194872$24019487$2$F$$20240702$20240627$20240712$EXP$$US-TEVA-VS-3212234$TEVA$Gupta A, Jatwani K, Gupta K, Qiu J, Dy GK. Loss of Rb1 Associated With the Onset of Acquired Resistance to Trastuzumab Deruxtecan in TP53-/HER2-Mutated Non-Small-Cell Lung Cancer: Case Series. JCO-Precis-Oncol 2023; 7.; Gupta A, Jatwani K, Gupta K, Qiu J, Dy GK. Loss of Rb1 Associated With the Onset of Acquired Resistance to Trastuzumab Deruxtecan in TP53-/HER2-Mutated Non-Small-Cell Lung Cancer: Case Series. JCO-Precis-Oncol 2023; 7.$33$YR$$M$Y$$$20240712$$MD$US$US
240194983$24019498$3$F$$20240918$20240627$20240924$EXP$$US-OTSUKA-2024_017893$OTSUKA$$$$$F$Y$102.95$KG$20240924$$MD$US$US
240195012$24019501$2$F$$20240620$20240627$20240704$EXP$$US-CIPLA LTD.-2024US06474$CIPLA$Simone C, Axelband J. Levetiracetam-associated rhabdomyolysis. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5704$$$$$Y$$$20240704$$MD$US$US
240195042$24019504$2$F$20230901$20240624$20240627$20240703$EXP$$NVSC2024PL131341$NOVARTIS$$50$YR$$F$Y$$$20240703$$MD$PL$PL
240195082$24019508$2$F$$20240620$20240627$20240704$EXP$$US-CIPLA LTD.-2024US06545$CIPLA$Kamel A, Yacoub T, Helliwell A, Blundin MF.. A rare case of anabolic Testosterone induced acute lung injury with pulmonary eosinophilia. Am J Respir Crit Care Med. 2024;209:A6001$$$$$Y$$$20240704$$MD$US$US
240195192$24019519$2$F$20240701$20240917$20240627$20240925$EXP$$US-INCYTE CORPORATION-2024IN006470$INCYTE$$$$$$Y$$$20240925$$CN$US$US
240195292$24019529$2$F$20240101$20240617$20240627$20240705$PER$$US-ROCHE-10000000294$ROCHE$$76$YR$E$F$Y$$$20240705$$CN$US$US
240195392$24019539$2$F$$20240709$20240627$20240716$PER$$US-BAYER-2024A089464$BAYER$$32$YR$A$F$Y$57.596$KG$20240716$$HP$US$US
240195422$24019542$2$F$$20240910$20240627$20240916$EXP$$CA-JNJFOC-20240660297$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$HP$CA$CA
240195563$24019556$3$F$20230602$20240705$20240627$20240708$EXP$$JP-OTSUKA-2024_016156$OTSUKA$$85$YR$$F$Y$$$20240708$$MD$JP$JP
240195592$24019559$2$F$20240701$20240711$20240627$20240722$PER$$US-SA-2024SA185683$SANOFI AVENTIS$$59$YR$A$F$Y$63.3$KG$20240722$$MD$US$US
240195612$24019561$2$F$20240521$20240715$20240627$20240717$PER$$US-BAYER-2024A089783$BAYER$$50$YR$A$F$Y$$$20240717$$CN$US$US
240195622$24019562$2$F$20240601$20240711$20240627$20240715$EXP$$US-INCYTE CORPORATION-2024IN006739$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240195672$24019567$2$F$20240511$20240619$20240627$20240709$EXP$$FR-AstraZeneca-2024A147829$ASTRAZENECA$$64$YR$$F$Y$$$20240710$$MD$FR$
240195682$24019568$2$F$$20240620$20240627$20240704$PER$$US-SA-2024SA186214$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240704$$CN$US$US
240195712$24019571$2$F$20230101$20240725$20240627$20240805$PER$$US-SA-2024SA186067$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240804$$MD$US$US
240195742$24019574$2$F$$20240902$20240627$20240909$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-100377$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240909$$HP$ES$ES
240195774$24019577$4$F$$20240926$20240627$20240930$PER$$US-ROCHE-10000008465$ROCHE$$$$A$M$Y$72.03$KG$20240930$$CN$US$US
240195812$24019581$2$F$$20240718$20240627$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103084$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$100.24$KG$20240722$$CN$US$US
240195822$24019582$2$F$20240531$20240725$20240627$20240731$EXP$$US-AMGEN-USASP2024124651$AMGEN$$65$YR$E$$Y$$$20240731$$CN$US$US
240195842$24019584$2$F$20240516$20240625$20240627$20240704$EXP$$MX-JNJFOC-20240614849$JOHNSON AND JOHNSON$$75$YR$E$F$Y$59.8$KG$20240704$$MD$MX$MX
240195872$24019587$2$F$20240609$20240715$20240627$20240721$PER$$US-BAYER-2024A090347$BAYER$$$$$F$Y$$$20240719$$CN$US$US
240195952$24019595$2$F$$20240813$20240627$20240815$PER$$US-ROCHE-10000010368$ROCHE$$$$T$M$Y$$$20240815$$CN$US$US
240196082$24019608$2$F$20240724$20240719$20240627$20240724$PER$$US-AMGEN-USASP2024126577$AMGEN$$73$YR$E$F$Y$$$20240724$$CN$US$US
240196183$24019618$3$F$$20240730$20240627$20240829$PER$$US-AstraZeneca-2024A141383$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
240196232$24019623$2$F$20220501$20240724$20240627$20240810$PER$$US-TEVA-VS-3211331$TEVA$$84$YR$$M$Y$$$20240810$$CN$US$US
240196362$24019636$2$F$20240612$20240725$20240627$20240806$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406015182$ELI LILLY AND CO$$82$YR$E$F$Y$37.9$KG$20240806$$CN$JP$JP
240196463$24019646$3$F$$20240717$20240627$20240729$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406011253$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$CN$CN
240196502$24019650$2$F$$20240716$20240627$20240725$EXP$$CO-CELLTRION INC.-2024CO015238$CELLTRION$$$$$$Y$$$20240725$$HP$CO$CO
240196542$24019654$2$F$20240505$20240704$20240627$20240710$EXP$$ES-AUROBINDO-AUR-APL-2024-031277$AUROBINDO$$90$YR$$M$Y$$$20240710$$PH$ES$ES
240196572$24019657$2$F$$20240628$20240627$20240702$PER$$US-HALEON-2183808$Haleon PLC$$18$YR$$F$Y$$$20240702$$CN$US$US
240196612$24019661$2$F$$20240709$20240627$20240710$PER$$NVSC2024US134023$NOVARTIS$$$$$F$Y$$$20240710$$PH$US$US
240196742$24019674$2$F$20240501$20240708$20240627$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000148$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
240196802$24019680$2$F$20240614$20240627$20240627$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000211$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
240196882$24019688$2$F$20231201$20240612$20240627$20240916$EXP$$RS-ROCHE-10000007337$ROCHE$$46$YR$A$F$Y$$$20240916$$MD$RS$RS
240197072$24019707$2$F$20240207$20240701$20240627$20240708$EXP$$GR-EMD Serono-2024033491$EMD SERONO INC$$43$YR$A$M$Y$$$20240709$$MD$GR$GR
240197152$24019715$2$F$20240429$20240726$20240627$20240806$PER$$US-KARYOPHARM-2024KPT001045$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240806$$CN$US$US
240197162$24019716$2$F$$20240806$20240627$20240925$EXP$$US-PFIZER INC-202400197910$PFIZER$$$$$$Y$$$20240925$$PH$US$US
240197183$24019718$3$F$$20240911$20240627$20240916$30DAY$$US-PFIZER INC-202400200129$PFIZER$$14$YR$$M$Y$$$20240916$$CN$US$US
240197203$24019720$3$F$$20240813$20240627$20240819$30DAY$$US-PFIZER INC-PV202400083210$PFIZER$$$$$M$Y$$$20240819$$HP$US$US
240197222$24019722$2$F$20220606$20240705$20240627$20240708$EXP$$IN-PFIZER INC-PV202200007989$PFIZER$$65$YR$$F$Y$$$20240708$$CN$IN$IN
240197263$24019726$3$F$$20240820$20240627$20240822$30DAY$$US-PFIZER INC-202400194255$PFIZER$$15$YR$$M$Y$$$20240822$$CN$US$US
240197274$24019727$4$F$20230711$20240703$20240627$20240710$30DAY$$US-PFIZER INC-202400200015$PFIZER$$11$YR$$M$Y$$$20240710$$HP$US$US
240197316$24019731$6$F$20240601$20240912$20240627$20240913$30DAY$$US-PFIZER INC-202400199815$PFIZER$$15$YR$$M$Y$$$20240913$$CN$US$US
240197326$24019732$6$F$$20240911$20240627$20240916$30DAY$$US-PFIZER INC-202400200924$PFIZER$$$$$M$Y$$$20240916$$CN$US$US
240197372$24019737$2$F$20230629$20240806$20240627$20240822$EXP$$DE-SERB S.A.S.-2158611$LABORATOIRES SERB$$22$YR$$M$Y$$$20240822$$MD$DE$DE
240197392$24019739$2$F$$20240712$20240627$20240716$EXP$$GB-TAKEDA-2024TUS064176$TAKEDA$$$$$F$Y$$$20240716$$CN$GB$GB
240197432$24019743$2$F$20240101$20240718$20240627$20240723$PER$$US-Eisai-EC-2024-167624$EISAI$$67$YR$E$M$Y$79$KG$20240723$$CN$US$US
240197562$24019756$2$F$20240101$20240619$20240627$20240705$EXP$$CA-CELLTRION INC.-2024CA015483$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
240197584$24019758$4$F$20240101$20240910$20240627$20240912$30DAY$$US-PFIZER INC-PV202400061069$PFIZER$$13$YR$$M$Y$$$20240912$$MD$US$US
240197595$24019759$5$F$20240620$20240924$20240627$20240927$30DAY$$DE-PFIZER INC-202400198434$PFIZER$$$$$F$Y$$$20240927$$PH$DE$DE
240197604$24019760$4$F$$20240917$20240627$20240920$30DAY$$US-PFIZER INC-202400199903$PFIZER$$11$YR$$F$Y$$$20240920$$CN$US$US
240197613$24019761$3$F$$20240826$20240627$20240828$30DAY$$CO-PFIZER INC-202400195819$PFIZER$$15$YR$$M$Y$$$20240828$$CN$CO$CO
240197642$24019764$2$F$20240101$20240709$20240627$20240711$PER$$CA-PFIZER INC-202400200771$PFIZER$$74$YR$$F$Y$$$20240711$$HP$CA$CA
240197653$24019765$3$F$$20240919$20240627$20240919$30DAY$$CL-PFIZER INC-PV202400083512$PFIZER$$12$YR$$F$Y$$$20240919$$CN$CL$CL
240197664$24019766$4$F$$20240922$20240627$20240925$30DAY$$US-PFIZER INC-202400199810$PFIZER$$10$YR$$F$Y$$$20240925$$CN$US$US
240197733$24019773$3$F$20240101$20240911$20240627$20240920$EXP$$GB-CELLTRION INC.-2024GB015473$CELLTRION$$$$$$Y$$$20240920$$CN$GB$GB
240197743$24019774$3$F$20240601$20240708$20240627$20240715$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-089862$REGENERON$$76$YR$$F$Y$$$20240715$$MD$CO$CO
240197763$24019776$3$F$$20240925$20240627$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101011$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240925$$CN$US$US
240197773$24019777$3$F$20240621$20240728$20240627$20240730$30DAY$$PR-PFIZER INC-202400199132$PFIZER$$29$YR$$M$Y$$$20240730$$CN$PR$PR
240198222$24019822$2$F$$20240728$20240627$20240729$30DAY$$US-PFIZER INC-202400195477$PFIZER$$8$YR$$M$Y$$$20240729$$CN$US$US
240198302$24019830$2$F$20240101$20240828$20240627$20240905$EXP$$BE-TEVA-VS-3212770$TEVA$$$$A$F$Y$$$20240905$$CN$BE$BE
240198313$24019831$3$F$20230525$20240917$20240627$20240924$EXP$$NVSC2024RU133783$NOVARTIS$$67$YR$$F$Y$$$20240924$$MD$RU$RU
240198342$24019834$2$F$20240625$20240807$20240627$20240809$PER$$US-AMGEN-USASP2024126480$AMGEN$$78$YR$E$F$Y$$$20240808$$CN$US$US
240198632$24019863$2$F$$20240731$20240627$20240812$EXP$$JP-EMD Serono-2024034033$EMD SERONO INC$Chikagawa OK, Chikagawa OK, Akahoshi S, Akahoshi S, Uchiyama Y, Uchiyama Y, et al. Two cases with metformin-associated lactic acidosis (MALA) who were saved with emergency dialysis. Journal of Japanese Society for Dialysis Therapy (The 69th Annual meeting of the Japanese Society for Dialysis Therapy held on 07 - 09 Jun 2024). 2024 Jun;57(Suppl: 1): P-1-071-P-1-071.$81$YR$E$M$Y$$$20240812$$HP$JP$JP
240198712$24019871$2$F$$20240624$20240627$20240709$EXP$$IE-ROCHE-10000010633$ROCHE$$$$$F$Y$$$20240701$$CN$IE$IE
240198802$24019880$2$F$20240621$20240806$20240627$20240808$PER$$US-AMGEN-USASP2024125150$AMGEN$$53$YR$A$M$Y$$$20240808$$CN$US$US
240198862$24019886$2$F$$20240725$20240627$20240802$EXP$$CA-SA-2024SA183197$SANOFI AVENTIS$$$$$F$Y$$$20240802$$HP$CA$CA
240198873$24019887$3$F$20240419$20240718$20240627$20240808$EXP$$US-APELLIS-2024-APL-0000315$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240808$$MD$US$US
240199102$24019910$2$F$$20240702$20240627$20240710$EXP$$DE-TEVA-VS-3212621$TEVA$Riedhammer C, Dull J, Kestler C, Kadel S, Franz J, Weis P, et al. Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma. Ann-Hematol 2024; 103 (4): 1327-1332.; Riedhammer C, Dull J, Kestler C, Kadel S, Franz J, Weis P, et al. Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma. Ann-Hematol 2024; 103 (4): 1327-1332.$66$YR$$F$Y$$$20240710$$HP$DE$DE
240199123$24019912$3$F$$20240911$20240627$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103102$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$83.91$KG$20240912$$CN$US$US
240199133$24019913$3$F$$20240925$20240627$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-103036$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240925$$MD$JP$JP
240199212$24019921$2$F$$20240716$20240627$20240722$PER$$US-SA-2024SA186814$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240722$$HP$US$US
240199222$24019922$2$F$20240501$20240627$20240627$20240703$EXP$$US-KYOWAKIRIN-2024KK015372$KYOWA$$$$$$Y$$$20240703$$HP$US$US
240199272$24019927$2$F$$20240709$20240627$20240709$PER$$US-BAYER-2024A092283$BAYER$$$$$F$Y$$$20240709$$CN$US$US
240199392$24019939$2$F$20240922$20240923$20240627$20240925$EXP$$GB-SANDOZ INC.-NVSC2021GB078319$SANDOZ$$71$YR$$F$Y$$$20240925$$CN$GB$GB
240199444$24019944$4$F$20231127$20240820$20240627$20240829$EXP$$JP-EMD Serono-2024033900$EMD SERONO INC$Tsubomura M, Fukata F, Masunaga M, Tsubomura M, Fukata F, Masunaga M. A case of reversible metabolic encephalopathy treated with metformin hydrochloride in a patient on maintenance dialysis. Journal of The Japanese Society for Dialysis Therapy (the 69th Annual meeting of the Japanese Society for Dialysis Therapy held between 07 and 09 Jun 2024). 2024;57(S1): O-0664-O-0664.$66$YR$E$M$Y$61$KG$20240829$$HP$JP$JP
240199453$24019945$3$F$$20240911$20240627$20240913$30DAY$$US-PFIZER INC-202400195260$PFIZER$$13$YR$$F$Y$$$20240913$$CN$US$US
240199463$24019946$3$F$$20240921$20240627$20240926$30DAY$$US-PFIZER INC-PV202400068222$PFIZER$$20$YR$$F$Y$64.41$KG$20240926$$MD$US$US
240199643$24019964$3$F$$20240829$20240627$20240910$EXP$$JP-ROCHE-10000007954$ROCHE$Kitade N, Yokoyama R, Kitamura N, Ojima T, Shimoyama K. Two cases of metastatic pulmonary tumour complicated by refractory pneumothorax after chemotherapy. [Abstract number:  OPL4-3]. The 67th Annual Meeting of Kansai Thoracic Surgical Association. 2024;211.$44$YR$A$F$Y$$$20240910$$MD$JP$JP
240199834$24019983$4$F$$20240926$20240627$20240930$30DAY$$US-PFIZER INC-202400197370$PFIZER$$10$YR$$M$Y$$$20240930$$CN$US$US
240199952$24019995$2$F$$20240702$20240627$20240705$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406015220$ELI LILLY AND CO$$$$$$Y$$$20240705$$CN$JP$JP
240200002$24020000$2$F$$20240708$20240627$20240718$EXP$$BE-NOVOPROD-1241993$NOVO NORDISK$$43$YR$$M$Y$$$20240718$$MD$BE$BE
240200032$24020003$2$F$20240606$20240718$20240627$20240729$EXP$$HU-NOVOPROD-1241841$NOVO NORDISK$$28$YR$$F$Y$137$KG$20240729$$HP$HU$HU
240200072$24020007$2$F$$20240916$20240627$20240919$30DAY$$CO-PFIZER INC-202400197828$PFIZER$$$$T$$Y$$$20240919$$MD$CO$CO
240200092$24020009$2$F$$20240723$20240627$20240726$EXP$$US-PFIZER INC-202400200791$PFIZER$$74$YR$$F$Y$$$20240726$$HP$US$US
240200203$24020020$3$F$20230327$20240827$20240627$20240906$EXP$$JP-EMD Serono-2024033516$EMD SERONO INC$Hattori. A case of metformin-associated lactic acidosis in which the patient^s life was saved by continuous hemodiafiltration. Journal of the Japanese Society for Dialysis Therapy (The 69th Annual Meeting of the Japanese Society for Dialysis Therapy) held between 07 and 09 Jun 2024. 2024;57(S1): O-0289-O-0289.$70$YR$E$M$Y$64$KG$20240906$$HP$JP$JP
240200242$24020024$2$F$$20240619$20240627$20240806$EXP$$AU-OTSUKA-2024_017980$OTSUKA$$$$$$Y$$$20240806$$MD$AU$AU
240200272$24020027$2$F$20240529$20240628$20240627$20240703$EXP$$US-AMGEN-USASP2024122615$AMGEN$$78$YR$E$F$Y$$$20240703$$CN$US$US
240200362$24020036$2$F$20240101$20240801$20240627$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000189$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
240200382$24020038$2$F$$20240730$20240627$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000138$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
240200412$24020041$2$F$20240101$20240809$20240627$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000156$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
240200462$24020046$2$F$20240507$20240521$20240627$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000170$UNKNOWN$$$$$$Y$$$20240805$$CN$US$US
240200503$24020050$3$F$20240501$20240905$20240627$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000198$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
240200562$24020056$2$F$20240101$20240909$20240627$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000155$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
240200602$24020060$2$F$$20240703$20240627$20240711$EXP$$US-BIOMARINAP-US-2024-158730$BIOMARIN$$$$$$Y$$$20240711$$CN$US$US
240200612$24020061$2$F$20240619$20240627$20240627$20240710$EXP$$CA-BIOMARINAP-CA-2024-158809$BIOMARIN$$$$$$Y$$$20240710$$MD$CA$CA
240200772$24020077$2$F$20240524$20240715$20240627$20240718$EXP$$CA-OTSUKA-2024_014702$OTSUKA$$24$YR$$F$Y$$$20240718$$MD$CA$CA
240200942$24020094$2$F$20240611$20240612$20240627$20240709$EXP$$PK-ROCHE-10000008312$ROCHE$$77$YR$E$M$Y$$$20240709$$CN$PK$PK
240200965$24020096$5$F$20240617$20240729$20240627$20240802$30DAY$$US-JNJFOC-20240648960$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240802$$CN$US$US
240200972$24020097$2$F$$20240627$20240627$20240703$EXP$$US-JNJFOC-20240649171$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240201022$24020102$2$F$20240101$20240620$20240627$20240924$PER$$US-ABBVIE-5811534$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
240201152$24020115$2$F$20240411$20240624$20240627$20240708$EXP$IT-MINISAL02-991329$IT-MYLANLABS-2024M1057682$MYLAN$$62$YR$$F$Y$$$20240708$$MD$IT$IT
240201162$24020116$2$F$$20240706$20240627$20240716$EXP$$CN-ROCHE-10000009848$ROCHE$Zhan Y, Yang F, Wang J, Fu H, Shen F, Liu J. Bevacizumab-induced immune thrombocytopenia in an ovarian cancer patient with mixed connective tissue disease: case report and literature review. Frontiers in immunology. 2024-Jun-05;15:1-6. doi:10.3389/fimmu.2024.1382964.$68$DY$I$F$Y$$$20240716$$HP$CN$CN
240201192$24020119$2$F$20240101$20240709$20240627$20240718$PER$$US-SA-2024SA185302$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240718$$MD$US$US
240201212$24020121$2$F$$20240823$20240627$20240828$EXP$$SE-AstraZeneca-2024A146575$ASTRAZENECA$Nikkarinen A, Glimelius I. Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma ? A case report. eJHaem 2024;5(4):820-824.$77$YR$$F$Y$$$20240828$$HP$SE$
240201233$24020123$3$F$20240316$20240708$20240627$20240710$EXP$$IT-ROCHE-10000005158$ROCHE$$36$YR$A$F$Y$$$20240710$$MD$IT$IT
240201282$24020128$2$F$$20240702$20240627$20240710$EXP$$US-TEVA-VS-3212306$TEVA$Kottschade LA, Fazer-Posorske C, Schwecke AJ. Triple M Syndrome: Implications for Hematology-Oncology Advanced Practice Providers. Clin-J-Oncol-Nurs 2023; 27 (5): 463-467.; Kottschade LA, Fazer-Posorske C, Schwecke AJ. Triple M Syndrome: Implications for Hematology-Oncology Advanced Practice Providers. Clin-J-Oncol-Nurs 2023; 27 (5): 463-467.$76$YR$$M$Y$$$20240710$$HP$US$US
240201292$24020129$2$F$$20240701$20240627$20240704$EXP$$US-ABBVIE-5818080$ABBVIE$$$$$M$Y$$$20240704$$HP$US$US
240201312$24020131$2$F$20240607$20240624$20240627$20240702$EXP$CZ-CZSUKL-24001688$CZ-ROCHE-10000009042$ROCHE$$49$YR$A$M$Y$100$KG$20240702$$MD$CZ$CZ
240201345$24020134$5$F$20240613$20240904$20240627$20240913$EXP$$CN-G1 THERAPEUTICS-2024G1CN0000076$G1 THERAPEUTICS$$$$$$Y$$$20240913$$MD$CN$CN
240201352$24020135$2$F$$20240819$20240627$20240826$EXP$$GB-VERTEX PHARMACEUTICALS-2024-010409$VERTEX$Valamparampil J, Davies B, Van Mourik I, Desai M.. Can elexacaftor/tezacaftor/ivacaftor be prescribed in children with cystic fibrosis associated liver disease?. J Cyst Fibros. 2024;23:S151$$$T$$Y$$$20240826$$MD$GB$GB
240201493$24020149$3$F$20240216$20240918$20240627$20240923$EXP$$CA-TAKEDA-2024TUS062780$TAKEDA$$26$YR$$F$Y$$$20240923$$CN$CA$CA
240201505$24020150$5$F$$20240618$20240627$20240730$EXP$$US-ROCHE-10000008512$ROCHE$$$$$F$Y$$$20240730$$CN$US$US
240201512$24020151$2$F$20240601$20240715$20240627$20240719$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003569$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240719$$CN$US$US
240201522$24020152$2$F$20211001$20240822$20240627$20240830$EXP$$SG-AMGEN-SGPSP2024124525$AMGEN$Shah J.M.; Fong W.; De Silva D. et al.. NeuroBehcet^s-related intracranial hypertension without cerebral venous thrombosis: case report and review of literature. BMC Neurology. 2024;24 (1):1-8$28$YR$A$F$Y$$$20240830$$HP$SG$SG
240201592$24020159$2$F$20230501$20240816$20240627$20240820$EXP$$US-PFIZER INC-2024SGN02565$PFIZER$$65$YR$$F$Y$$$20240820$$CN$US$US
240201603$24020160$3$F$20231201$20240801$20240627$20240805$EXP$$US-PFIZER INC-2024SGN00573$PFIZER$$69$YR$$F$Y$$$20240805$$CN$US$US
240201615$24020161$5$F$20230928$20240819$20240627$20240819$EXP$$CN-PFIZER INC-2023SGN12831$PFIZER$$79$YR$$F$Y$42.5$KG$20240819$$MD$CN$CN
240201623$24020162$3$F$$20240911$20240627$20240913$30DAY$$US-PFIZER INC-202400198025$PFIZER$$10$YR$$M$Y$$$20240913$$CN$US$US
240201633$24020163$3$F$$20240923$20240627$20240926$30DAY$$KR-PFIZER INC-PV202400082499$PFIZER$$11$YR$$$Y$$$20240926$$CN$KR$KR
240201702$24020170$2$F$20240601$20240718$20240627$20240725$EXP$$CA-GSK-CA2024077177$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$HP$CA$CA
240201822$24020182$2$F$$20240708$20240627$20240722$EXP$$HR-ASTELLAS-2021US035952$ASTELLAS$$63$YR$$M$Y$$$20240722$$CN$CH$HR
240201842$24020184$2$F$20220905$20240724$20240627$20240730$EXP$$DE-MYLANLABS-2024M1057819$MYLAN$$$$E$F$Y$67$KG$20240730$$HP$DE$DE
240201854$24020185$4$F$20240501$20240812$20240627$20240823$EXP$$US-JNJFOC-20240660098$JOHNSON AND JOHNSON$$33$YR$A$M$Y$90.8$KG$20240823$$HP$US$US
240201862$24020186$2$F$$20240702$20240627$20240710$EXP$$US-TEVA-VS-3212315$TEVA$Fall A, Campodonico VL, Howard C, Gallagher N, Bailey G, Kajon AE, et al. Dissemination and genome characterization of a human adenovirus F41 in a patient with B-Cell lymphoma. Virol-J 2023; 20.; Fall A, Campodonico VL, Howard C, Gallagher N, Bailey G, Kajon AE, et al. Dissemination and genome characterization of a human adenovirus F41 in a patient with B-Cell lymphoma. Virol-J 2023; 20.; Fall A, Campodonico VL, Howard C, Gallagher N, Bailey G, Kajon AE, et al. Dissemination and genome charac...$$$A$M$Y$$$20240710$$HP$US$US
240201893$24020189$3$F$20221001$20240713$20240627$20240723$EXP$$US-JNJFOC-20240656037$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240722$$HP$US$US
240202012$24020201$2$F$$20240723$20240627$20240801$PER$$US-SA-2024SA188808$SANOFI AVENTIS$$44$YR$A$M$Y$91.1$KG$20240801$$CN$US$US
240202053$24020205$3$F$20240703$20240712$20240627$20240722$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001264$BLUEPRINT MEDICINES$$30$YR$A$F$Y$$$20240722$$CN$US$US
240202082$24020208$2$F$$20240808$20240627$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001289$BLUEPRINT MEDICINES$$$$$M$Y$$$20240815$$CN$US$US
240202094$24020209$4$F$20240611$20240913$20240627$20240920$EXP$$CA-GSK-CA2024064014$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$CA$CA
240202142$24020214$2$F$$20240830$20240627$20240902$EXP$$NVSC2024GB133282$NOVARTIS$$$$E$F$Y$$$20240902$$CN$GB$GB
240202152$24020215$2$F$$20240828$20240627$20240829$EXP$$NVSC2024US132697$NOVARTIS$$$$$$Y$$$20240829$$CN$US$US
240202173$24020217$3$F$20240101$20240826$20240627$20240828$EXP$$US-AMGEN-USASP2024125921$AMGEN$$69$YR$E$F$Y$46.712$KG$20240828$$MD$US$US
240202322$24020232$2$F$20240401$20240627$20240627$20240701$EXP$$US-ABBVIE-5817033$ABBVIE$$32$YR$$M$Y$81.646$KG$20240701$$CN$US$US
240202542$24020254$2$F$$20240702$20240627$20240712$EXP$$US-TEVA-VS-3212003$TEVA$Serhal A, Bisbee C, Catania R, Omar IM. Rapidly Progressive Idiopathic Arthritis of the Hip After Intra-articular Steroid and Anesthetic Injection in Patients with Hip Osteoarthritis: Incidence and Risk Factors. Adv-Clin-Radiol 2023; 5 (1): 99-106.; Serhal A, Bisbee C, Catania R, Omar IM. Rapidly Progressive Idiopathic Arthritis of the Hip After Intra-articular Steroid and Anesthetic Injection in Patients with Hip Osteoarthritis: Incidence and Risk Factors. Adv-Clin-Radiol 2023; 5 (1): 99-106.$69$YR$$F$Y$$$20240712$$MD$US$US
240202552$24020255$2$F$$20240702$20240627$20240703$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036171$BOEHRINGER INGELHEIM$$37$YR$A$F$Y$$$20240703$$MD$CN$CN
240202632$24020263$2$F$20240613$20240701$20240627$20240703$PER$$US-JNJFOC-20240668552$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240703$$CN$US$US
240202773$24020277$3$F$20240818$20240819$20240627$20240822$EXP$$CA-GSK-CA2024078014$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$CA$CA
240202842$24020284$2$F$20240228$20240624$20240627$20240708$EXP$IT-MINISAL02-991353$IT-MYLANLABS-2024M1057759$MYLAN$$60$YR$$F$Y$$$20240708$$MD$IT$IT
240202962$24020296$2$F$20240428$20240731$20240627$20240809$PER$$US-SA-2024SA156063$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240809$$CN$US$US
240202982$24020298$2$F$20230501$20240710$20240627$20240712$PER$$US-BIOVITRUM-2024-US-009051$BIOVITRUM$$$$C$M$Y$$$20240712$$MD$US$US
240203112$24020311$2$F$20210506$20240925$20240627$20240930$EXP$$US-SANDOZ INC.-NVSC2021US077289$SANDOZ$$70$YR$$M$Y$113.38$KG$20240930$$CN$US$US
240203122$24020312$2$F$$20240722$20240627$20240725$EXP$$CA-SANDOZ INC.-SDZ2024CA057467$SANDOZ$$$$$F$Y$$$20240725$$CN$CA$CA
240203173$24020317$3$F$$20240823$20240627$20240828$EXP$$US-SANDOZ INC.-NVSC2023US115510$SANDOZ$$$$$F$Y$46.36$KG$20240828$$CN$US$US
240203202$24020320$2$F$20240614$20240722$20240627$20240808$30DAY$$CO-AMGEN-COLSP2024123641$AMGEN$$$$$$Y$$$20240808$$HP$CO$CO
240203233$24020323$3$F$$20240809$20240627$20240809$30DAY$$US-PFIZER INC-202400198015$PFIZER$$27$YR$$M$Y$$$20240809$$CN$US$US
240203245$24020324$5$F$$20240912$20240627$20240918$30DAY$$US-PFIZER INC-202400198661$PFIZER$$23$YR$$F$Y$72.57$KG$20240918$$HP$US$US
240203285$24020328$5$F$$20240916$20240627$20240920$PER$$US-PFIZER INC-202400198331$PFIZER$$7$YR$$M$Y$$$20240920$$CN$US$US
240203292$24020329$2$F$$20240628$20240627$20240703$EXP$$US-PFIZER INC-PV202400019862$PFIZER$Howland, M.. C-L service Initiates Palliative ECT for Catatonia in a Terminal Cancer Patient: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64(Suppl):S63$78$YR$$M$Y$$$20240703$$MD$US$US
240203412$24020341$2$F$$20240722$20240627$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102853$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240723$$CN$US$US
240203522$24020352$2$F$20240622$20240625$20240627$20240711$PER$$US-AMGEN-USASP2024125523$AMGEN$$72$YR$E$F$Y$$$20240711$$CN$US$US
240203552$24020355$2$F$20240510$20240801$20240627$20240809$EXP$$CA-VANTIVE-2024VAN017892$Vantive US Healthcare$$$$$M$Y$$$20240809$$HP$CA$CA
240203672$24020367$2$F$$20240725$20240627$20240731$30DAY$$US-AMGEN-USASP2024123965$AMGEN$$$$$$Y$$$20240731$$PH$US$US
240203682$24020368$2$F$20240619$20240707$20240627$20240716$PER$$US-AMGEN-USASP2024123577$AMGEN$$81$YR$E$F$Y$62.5$KG$20240716$$PH$US$US
240203722$24020372$2$F$$20240715$20240627$20240725$EXP$$US-NOVOPROD-1243811$NOVO NORDISK$$$$$$Y$$$20240725$$CN$US$US
240203812$24020381$2$F$20240410$20240709$20240627$20240722$EXP$$US-NOVOPROD-1243031$NOVO NORDISK$$67$YR$$F$Y$94.966$KG$20240719$$CN$US$US
240203822$24020382$2$F$20240430$20240717$20240627$20240729$EXP$$US-NOVOPROD-1242338$NOVO NORDISK$$50$YR$$F$Y$$$20240729$$CN$US$US
240203904$24020390$4$F$20231017$20240717$20240627$20240723$30DAY$$US-AMGEN-USASP2024122861$AMGEN$$76$YR$E$M$Y$$$20240723$$PH$US$US
240204012$24020401$2$F$20240613$20240707$20240627$20240710$30DAY$$US-AMGEN-USASP2024123713$AMGEN$$41$YR$A$F$Y$106$KG$20240710$$PH$US$US
240204052$24020405$2$F$$20240624$20240627$20240708$PER$$US-AMGEN-USASP2024124518$AMGEN$$93$YR$E$F$Y$$$20240707$$CN$US$US
240204083$24020408$3$F$$20240726$20240627$20240728$EXP$$CN-JNJFOC-20240657461$JOHNSON AND JOHNSON$$$$$$Y$$$20240728$$MD$CN$CN
240204402$24020440$2$F$$20240617$20240627$20240702$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453171$RANBAXY$Perkins R, Mullen T. TREATING POLYSUBSTANCE INGESTION WITH CONTINUOUS RENAL REPLACEMENT THERAPY AND TOTAL PLASMA EXCHANGE. Crit Care Med. 2024;52 (Suppl 1):S342; 739$16$YR$$F$Y$$$20240702$$HP$US$US
240204522$24020452$2$F$$20240624$20240627$20240709$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453291$RANBAXY$Murali S, Bhat PI, Prathiba JP, Jithendriya M. Disseminated molluscum contagiosum presenting during fingolimod treatment in a child. Int J Dermatol. 2024;Mar;63 (6):816-817$10$YR$$$Y$$$20240709$$HP$IN$IN
240204643$24020464$3$F$20240620$20240802$20240622$20240808$EXP$$US-AstraZeneca-2024A144108$ASTRAZENECA$$27157$DY$$M$Y$$$20240808$$CN$US$
240204693$24020469$3$F$20170101$20240910$20240622$20240916$EXP$$CA-TAKEDA-2017TUS018122$TAKEDA$$40$YR$$M$Y$$$20240916$$CN$CA$CA
240204732$24020473$2$F$$20240624$20240627$20240709$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453710$RANBAXY$Mir TH, Zargar PA, Jabeen B, Latief M, Sharma A, Wani NA, et al. ANCA-associated large and small vessel vasculitis with aorto-pulmonary-renal syndrome. Lancet Rheumatol. 2024;JUN; 6 (6):e409-e410$65$YR$$M$Y$$$20240709$$MD$IN$IN
240204882$24020488$2$F$20240403$20240627$20240627$20240701$EXP$$TR-SANDOZ INC.-SDZ2024TR060814$SANDOZ$$51$YR$$F$Y$47$KG$20240701$$MD$TR$TR
240204942$24020494$2$F$20240601$20240708$20240627$20240712$PER$$US-Eisai-EC-2024-168271$EISAI$$69$YR$E$F$Y$$$20240712$$CN$US$US
240205003$24020500$3$F$$20240710$20240627$20240716$EXP$$HU-ABBVIE-5815253$ABBVIE$Lakatos V, Gopcsa L, Balogh A, Fabian J, Remenyi P. Treatment and transplantation in T-cell prolymphocytic leukaemia: Presentation of two cases. Hematology-Transfusiology. 2024;65-66.; Lakatos V, Gopcsa L, Balogh A, Fabian J, Remenyi P. Treatment and transplantation in T-cell prolymphocytic leukaemia: Presentation of two cases. Hematology-Transfusiology. 2024;65-66.$52$YR$$M$Y$$$20240716$$HP$HU$HU
240205032$24020503$2$F$20240101$20240718$20240627$20240722$PER$$US-AMGEN-USASP2024125349$AMGEN$$$$$$Y$$$20240721$$PH$US$US
240205082$24020508$2$F$20230724$20240716$20240627$20240719$EXP$$JP-AstraZeneca-2023A191801$ASTRAZENECA$$71$YR$$M$Y$59$KG$20240719$$MD$JP$
240205103$24020510$3$F$$20240811$20240627$20240820$EXP$$XI-AstraZeneca-2024A139551$ASTRAZENECA$$$$$F$Y$$$20240820$$MD$XI$
240205222$24020522$2$F$$20240702$20240627$20240717$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453289$RANBAXY$Zhang H, Xia P, Wu N,Chen J, Liu Y. Neutrophilic dermatosis of the dorsal hands treated with baricitinib. Clin Exp Dermatol. 2023;48:1274-1276$50$YR$$F$Y$$$20240717$$HP$CN$CN
240205282$24020528$2$F$20240528$20240710$20240627$20240717$EXP$$US-APELLIS-2024-APL-0000253$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
240205302$24020530$2$F$$20240620$20240627$20240705$PER$$US-BIOGEN-2024BI01270732$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
240205402$24020540$2$F$20220701$20240828$20240627$20240829$EXP$$NVSC2022GB225480$NOVARTIS$$49$YR$$M$Y$$$20240829$$CN$GB$GB
240205532$24020553$2$F$$20240703$20240627$20240712$EXP$$ES-TEVA-VS-3213068$TEVA$Fendian AM, Albanell-Fernandez M, Tuset M, Pitart C, Castro P, Soy D, et al. Real-Life Data on the Effectiveness and Safety of Cefiderocol in Severely Infected Patients: A Case Series. Infect-Dis-Therapy 2023; 12 (4): 1205-1216.; Fendian AM, Albanell-Fernandez M, Tuset M, Pitart C, Castro P, Soy D, et al. Real-Life Data on the Effectiveness and Safety of Cefiderocol in Severely Infected Patients: A Case Series. Infect-Dis-Therapy 2023; 12 (4): 1205-1216.$71$YR$$$Y$$$20240712$$HP$ES$ES
240205552$24020555$2$F$20240610$20240802$20240627$20240811$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099637$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$76.66$KG$20240812$$PH$US$US
240205562$24020556$2$F$$20240626$20240627$20240703$PER$$NVSC2024US133913$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240205572$24020557$2$F$$20240726$20240627$20240729$EXP$$NVSC2024ZA134189$NOVARTIS$$52$YR$$F$Y$57$KG$20240729$$HP$ZA$ZA
240205592$24020559$2$F$20081128$20240624$20240627$20240708$EXP$AU-TGA-0000803564$NVSC2024CA133382$NOVARTIS$$39$YR$$F$Y$$$20240708$$CN$AU$CA
240205612$24020561$2$F$20240603$20240712$20240627$20240801$PER$$US-TOLMAR, INC.-24US049917$TOLMAR$$70$YR$$M$Y$$$20240801$$HP$US$US
240205622$24020562$2$F$$20240711$20240627$20240801$PER$$US-TOLMAR, INC.-24US049904$TOLMAR$$$$$M$Y$$$20240801$$HP$US$US
240205642$24020564$2$F$20240612$20240626$20240627$20240702$EXP$$US-KYOWAKIRIN-2024KK015516$KYOWA$$$$$$Y$$$20240702$$HP$US$US
240205762$24020576$2$F$$20240801$20240627$20240820$PER$$US-BIOVITRUM-2024-US-009157$BIOVITRUM$$79$YR$$M$Y$$$20240820$$CN$US$US
240205772$24020577$2$F$$20240702$20240627$20240710$EXP$$PL-TEVA-VS-3212505$TEVA$Czarnecka P, Czarnecka K, Tronina O. Unexpectedly Rapid Onset of Severe Sarcopenia in an Elderly Diabetic Man following SGLT2i Administration: A Case Report. J-Clin-Med 2024; 13 (10): 1-7.; Czarnecka P, Czarnecka K, Tronina O. Unexpectedly Rapid Onset of Severe Sarcopenia in an Elderly Diabetic Man following SGLT2i Administration: A Case Report. J-Clin-Med 2024; 13 (10): 1-7.$$$$M$Y$$$20240710$$HP$PL$PL
240205846$24020584$6$F$$20240620$20240627$20240923$PER$$NVSC2024US130857$NOVARTIS$$$$$F$Y$$$20240923$$MD$US$US
240205912$24020591$2$F$20230101$20240808$20240627$20240816$PER$$US-SA-2024SA181431$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240816$$MD$US$US
240205953$24020595$3$F$$20240627$20240627$20240711$PER$$US-ROCHE-3566838$ROCHE$$$$$F$Y$$$20240711$$PH$US$US
240205962$24020596$2$F$$20240703$20240627$20240705$EXP$$CA-BAUSCH-BL-2024-009951$BAUSCH AND LOMB$Chinnadurai A, Strum S, Ghassemian A, Fortin D, Foster C, Breadner D. A Rare Association of Mixed Autoimmune Hemolytic Anemia with Gastric Carcinoma. Case Reports in Oncology. 2023 OCT 20;16:1209-1216. doi:10.1159/000534278$70$YR$$F$Y$$$20240705$$HP$CA$CA
240206032$24020603$2$F$20240522$20240710$20240627$20240718$EXP$$JP-AstraZeneca-2024A143687$ASTRAZENECA$$74$YR$$M$Y$59$KG$20240718$$MD$JP$
240206114$24020611$4$F$$20240803$20240627$20240814$EXP$$US-INNOVIVA SPECIALTY THERAPEUTICS-2024-INNO-US000043$PAREXEL$$$$$$Y$$$20240814$$PH$US$US
240206142$24020614$2$F$20240624$20240812$20240627$20240814$EXP$$US-MYLANLABS-2024M1058411$MYLAN$$31$YR$$F$Y$$$20240814$$PH$US$US
240206152$24020615$2$F$20221225$20240612$20240627$20240807$EXP$$PL-ROCHE-10000007979$ROCHE$$67$YR$E$F$Y$$$20240807$$MD$PL$PL
240206203$24020620$3$F$20240521$20240917$20240627$20240920$PER$FR-AFSSAPS-SE2024000472$FR-BRACCO-2024FR03693$BRACCO$$74$YR$$F$Y$$$20240920$$PH$FR$FR
240206282$24020628$2$F$$20240902$20240627$20240905$EXP$$SE-JNJFOC-20240657003$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$MD$SE$SE
240206302$24020630$2$F$20240620$20240725$20240627$20240730$EXP$$US-JNJFOC-20240657974$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240730$$HP$US$US
240206412$24020641$2$F$$20240617$20240627$20240702$EXP$$RU-RDY-LIT/RUS/24/0008995$DR REDDYS$Sheveleva PV, Morozova EV, Osipova AA, Paina OV, Slesarchuk OA, Botina AV, et al. Clinical course of chronic myeloid leukemia with t315i mutation ofbcr-abl gene in pediatric and adolescent patients. Cellular Therapy and Transplantation. 2023 Jun 30;12(2): 32-39. doi:10.18620/ctt-1866-8836.$$$$F$Y$$$20240702$$HP$RU$RU
240206442$24020644$2$F$$20240627$20240627$20240704$EXP$$CA-GSK-CA2024077207$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$CA$CA
240206512$24020651$2$F$20240618$20240628$20240627$20240702$EXP$$US-BAYER-2024A092812$BAYER$$22$YR$A$F$Y$$$20240702$$HP$US$US
240206534$24020653$4$F$20240529$20240802$20240627$20240808$PER$$US-AMGEN-USASP2024124084$AMGEN$$67$YR$E$F$Y$$$20240808$$MD$US$US
240206573$24020657$3$F$20240712$20240724$20240627$20240730$EXP$$US-OTSUKA-2024_004820$OTSUKA$$35$YR$$F$Y$$$20240730$$HP$US$US
240206584$24020658$4$F$20240607$20240905$20240627$20240913$EXP$$GB-ABBVIE-5816852$ABBVIE$$90$YR$$M$Y$78.8$KG$20240913$$CN$GB$GB
240206732$24020673$2$F$$20240925$20240627$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103351$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$HP$US$US
240206742$24020674$2$F$20240601$20240731$20240627$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102388$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240801$$HP$US$US
240206752$24020675$2$F$$20240725$20240627$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST003893$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240731$$CN$US$US
240206772$24020677$2$F$$20240903$20240627$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103195$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240906$$CN$US$US
240206812$24020681$2$F$20240416$20240702$20240627$20240710$EXP$LV-SAM-2024068252$LV-Merck Healthcare KGaA-2024033048$MERCK KGAA$$43$YR$A$F$Y$63$KG$20240709$$CN$LV$LV
240206822$24020682$2$F$$20240702$20240627$20240712$EXP$$US-TEVA-VS-3212101$TEVA$Rockstrom M, Lutz R, Dickeson K, O^Rorke EV, Narita M, Amram O, et al. Fulminant pulmonary tuberculosis in a previously healthy young woman from the Marshall Islands: Potential risk factors. J-Clin-Tuberc-Other-Mycobact-Dis 2023; 31.; Rockstrom M, Lutz R, Dickeson K, O^Rorke EV, Narita M, Amram O, et al. Fulminant pulmonary tuberculosis in a previously healthy young woman from the Marshall Islands: Potential risk factors. J-Clin-Tuberc-Other-Mycobact-Dis 2023; 31.; Rockstrom M, Lutz R, Dickes...$19$YR$$F$Y$$$20240712$$HP$US$US
240206873$24020687$3$F$20240626$20240715$20240627$20240717$EXP$$US-TAKEDA-2024TUS064236$TAKEDA$$53$YR$$M$Y$$$20240717$$CN$US$US
240206892$24020689$2$F$20240706$20240719$20240627$20240730$EXP$$US-Stemline Therapeutics, Inc.-2024ST003884$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240726$$CN$US$US
240207002$24020700$2$F$$20240708$20240627$20240710$PER$$US-PFIZER INC-202400201191$PFIZER$$71$YR$$F$Y$68.027$KG$20240710$$CN$US$US
240207012$24020701$2$F$20230801$20240731$20240627$20240809$EXP$FR-AFSSAPS-AN2024000749$FR-TEVA-VS-3212681$TEVA$$67$YR$$F$Y$58$KG$20240809$$PH$FR$FR
240207022$24020702$2$F$$20240723$20240627$20240724$PER$$US-PFIZER INC-PV202400083871$PFIZER$$53$YR$$M$Y$$$20240724$$HP$US$US
240207053$24020705$3$F$$20240728$20240627$20240730$PER$$US-PFIZER INC-PV202400083970$PFIZER$$$$$$Y$$$20240730$$HP$US$US
240207062$24020706$2$F$20240201$20240627$20240627$20240701$PER$$US-PFIZER INC-202400201681$PFIZER$$37$YR$$F$Y$$$20240701$$HP$US$US
240207112$24020711$2$F$20240625$20240627$20240627$20240701$PER$$US-PFIZER INC-202400201087$PFIZER$$$$$$Y$$$20240701$$CN$US$US
240207133$24020713$3$F$$20240801$20240627$20240806$PER$$US-PFIZER INC-PV202400083938$PFIZER$$51$YR$$M$Y$$$20240806$$CN$US$US
240207174$24020717$4$F$20240620$20240827$20240627$20240904$PER$$US-PFIZER INC-202400200139$PFIZER$$69$YR$$F$Y$78.47$KG$20240904$$CN$US$US
240207182$24020718$2$F$$20240715$20240627$20240719$PER$$US-PFIZER INC-PV202400083491$PFIZER$$68$YR$$F$Y$71.519$KG$20240719$$MD$US$US
240207192$24020719$2$F$$20240909$20240627$20240911$PER$$US-PFIZER INC-PV202400083275$PFIZER$$58$YR$$F$Y$$$20240911$$HP$US$US
240207222$24020722$2$F$20240101$20240808$20240627$20240813$PER$$US-PFIZER INC-PV202400083505$PFIZER$$22$YR$$F$Y$$$20240813$$HP$US$US
240207252$24020725$2$F$$20240827$20240627$20240830$PER$$US-PFIZER INC-PV202300200854$PFIZER$$79$YR$$M$Y$$$20240830$$PH$US$US
240207283$24020728$3$F$20240625$20240628$20240627$20240702$PER$$US-PFIZER INC-202400201431$PFIZER$$59$YR$$F$Y$$$20240702$$HP$US$US
240207312$24020731$2$F$20240620$20240630$20240627$20240702$PER$$US-PFIZER INC-202400200023$PFIZER$$61$YR$$M$Y$$$20240702$$HP$US$US
240207342$24020734$2$F$20240623$20240624$20240627$20240701$PER$$US-PFIZER INC-202400199828$PFIZER$$$$$$Y$$$20240701$$CN$US$US
240207352$24020735$2$F$$20240913$20240627$20240916$PER$$US-PFIZER INC-202400199779$PFIZER$$75$YR$$F$Y$60.33$KG$20240916$$CN$US$US
240207402$24020740$2$F$$20240702$20240627$20240711$PER$$US-SA-2024SA186138$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240711$$MD$US$US
240207462$24020746$2$F$$20240920$20240627$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103218$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$55.79$KG$20240923$$CN$US$US
240207493$24020749$3$F$$20240906$20240627$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102500$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$69.4$KG$20240910$$CN$US$US
240207507$24020750$7$F$20240621$20240906$20240627$20240910$EXP$$GB-ABBVIE-5818471$ABBVIE$$33$YR$$M$Y$101$KG$20240910$$MD$GB$GB
240207593$24020759$3$F$20240411$20240718$20240627$20240726$EXP$RU-SEPTODONT-2024018671$RU-SEPTODONT-2024018671$SEPTODONT$$55$YR$A$F$Y$98$KG$20240726$$HP$RU$RU
240207615$24020761$5$F$20240603$20240731$20240627$20240805$EXP$$PT-009507513-2406PRT007841$MERCK$$$$A$F$Y$91.3$KG$20240805$$MD$PT$PT
240207675$24020767$5$F$20210401$20240922$20240627$20240926$EXP$$US-ABBVIE-5817262$ABBVIE$$96$YR$$F$Y$58$KG$20240926$$CN$US$US
240207732$24020773$2$F$$20240802$20240627$20240805$PER$$US-ALXN-202406USA001354US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240207742$24020774$2$F$$20240621$20240627$20240701$EXP$$US-TEVA-VS-3213097$TEVA$$63$YR$$F$Y$90.72$KG$20240701$$CN$US$US
240207812$24020781$2$F$$20240702$20240627$20240710$EXP$$US-TEVA-VS-3212084$TEVA$Honjo K, Russell RM, Li R, Liu W, Stoltz R, Tabengwa EM, et al. Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency. Cell-Rep-Med 2021; 2 (1): 100164.; Honjo K, Russell RM, Li R, Liu W, Stoltz R, Tabengwa EM, et al. Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency. Cell-Rep-Med 2021; 2 (1): 100164.; Honjo K, Russell RM, Li R, Liu W, Stoltz R, Tabengwa EM, et al. Convalescent plasma-mediated resolution of ...$72$YR$$F$Y$$$20240710$$HP$US$US
240207863$24020786$3$F$20230221$20240829$20240627$20240902$EXP$$JP-AstraZeneca-2023A122101$ASTRAZENECA$$64$YR$$M$Y$62$KG$20240902$$MD$JP$
240207872$24020787$2$F$20230429$20240829$20240627$20240902$EXP$$JP-AstraZeneca-2023A122138$ASTRAZENECA$$66$YR$$F$Y$69$KG$20240902$$MD$JP$
240207883$24020788$3$F$$20240709$20240627$20240717$EXP$$CA-AstraZeneca-2024A146406$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CA$
240207892$24020789$2$F$$20240627$20240627$20240703$EXP$$NVSC2024GB133548$NOVARTIS$$$$E$M$Y$$$20240703$$CN$GB$GB
240207903$24020790$3$F$20230417$20240829$20240627$20240904$EXP$$JP-AstraZeneca-2023A122113$ASTRAZENECA$$59$YR$$M$Y$$$20240904$$MD$JP$
240208002$24020800$2$F$$20240701$20240627$20240713$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091814$GLENMARK$Goldberg E., Syed A., Desai S., Franco R., Ali Z.. Diffuse Alveolar Hemorrhage Secondary to Hydralazine-induced Vasculitis Causing Pulmonaryrenal Syndrome. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2007$$$$$Y$$$20240713$$HP$US$US
240208302$24020830$2$F$20240617$20240627$20240627$20240701$PER$$US-FreseniusKabi-FK202409987$FRESENIUS KABI$$39$YR$A$F$Y$$$20240701$$MD$US$US
240208332$24020833$2$F$20240606$20240722$20240627$20240729$EXP$FR-AFSSAPS-GR2024000738$FR-FreseniusKabi-FK202409948$FRESENIUS KABI$$54$YR$A$M$Y$80$KG$20240729$$PH$FR$FR
240208452$24020845$2$F$20240607$20240722$20240627$20240729$EXP$$US-GSK-US2024AMR079048$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
240208462$24020846$2$F$$20240705$20240627$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102732$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240709$$CN$US$US
240208522$24020852$2$F$$20240628$20240627$20240705$EXP$$NVSC2024MX131509$NOVARTIS$$$$$F$Y$$$20240705$$CN$MX$MX
240208572$24020857$2$F$$20240925$20240627$20240925$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-102385$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240925$$CN$KR$KR
240208592$24020859$2$F$$20240830$20240627$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101582$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240903$$CN$US$US
240208602$24020860$2$F$$20240925$20240627$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102513$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240930$$PH$US$US
240208622$24020862$2$F$20240606$20240627$20240627$20240711$EXP$IT-MINISAL02-990785$IT-GUERBET / LLC-IT-20240059$GUERBET$$37$YR$A$M$Y$$$20240711$$MD$IT$IT
240208663$24020866$3$F$20240513$20240906$20240627$20240909$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036060$BOEHRINGER INGELHEIM$$53$YR$A$M$Y$112$KG$20240909$$MD$US$US
240208703$24020870$3$F$20240619$20240724$20240627$20240801$EXP$$JP-ALXN-202406JPN001103JP$ALEXION PHARMACEUTICALS$$79$YR$$F$Y$35$KG$20240801$$MD$JP$JP
240208943$24020894$3$F$$20240813$20240627$20240819$30DAY$$JP-PFIZER INC-PV202400078743$PFIZER$$$$$$Y$$$20240819$$CN$JP$JP
240208974$24020897$4$F$20220101$20240718$20240627$20240724$EXP$$CA-PFIZER INC-202201271627$PFIZER$$31$YR$$F$Y$$$20240724$$MD$CA$CA
240209033$24020903$3$F$20240611$20240904$20240627$20240905$30DAY$$CL-PFIZER INC-PV202400078627$PFIZER$$16$YR$$M$Y$$$20240905$$CN$CL$CL
240209143$24020914$3$F$$20240831$20240627$20240904$EXP$$NVSC2024GB133499$NOVARTIS$$$$A$M$Y$$$20240904$$CN$GB$GB
240209173$24020917$3$F$20240619$20240708$20240627$20240716$30DAY$$US-AMGEN-USASP2024122925$AMGEN$$73$YR$E$M$Y$$$20240716$$HP$US$US
240209304$24020930$4$F$20240325$20240717$20240627$20240725$EXP$$JP-ALXN-202405JPN000977JP$ALEXION PHARMACEUTICALS$$47$YR$$F$Y$$$20240725$$MD$JP$JP
240209317$24020931$7$F$20240503$20240811$20240627$20240829$EXP$$CN-DSJP-DSJ-2024-120349$DAIICHI$$$$E$F$Y$156$KG$20240829$$MD$CN$CN
240209333$24020933$3$F$20240614$20240709$20240627$20240720$EXP$$GB-TAKEDA-2024TUS062922$TAKEDA$$26$YR$$F$Y$44$KG$20240720$$CN$GB$GB
240209362$24020936$2$F$$20240702$20240627$20240712$EXP$$HU-TEVA-VS-3212569$TEVA$Juhasz M, Antal B, Herczeg G, Nemes B, Fulesdi B, Vegh T. Hemorrhagic Pneumonia in a Kidney Transplant Recipient Caused by Stenotrophomonas Maltophilia Infection: A Case Report. Transplant-Proc 2024; 0 (0):.; Juhasz M, Antal B, Herczeg G, Nemes B, Fulesdi B, Vegh T. Hemorrhagic Pneumonia in a Kidney Transplant Recipient Caused by Stenotrophomonas Maltophilia Infection: A Case Report. Transplant-Proc 2024; 0 (0):.$73$YR$$M$Y$$$20240712$$HP$HU$HU
240209552$24020955$2$F$$20240610$20240627$20240705$PER$$US-INCYTE CORPORATION-2024IN006212$INCYTE$$$$$$Y$$$20240705$$PH$US$US
240209562$24020956$2$F$$20240715$20240627$20240725$EXP$$US-Calliditas-2024CAL00706$CALLIDITAS THERAPEUTICS$$43$YR$A$M$Y$$$20240725$$CN$US$US
240209682$24020968$2$F$20240501$20240710$20240627$20240715$30DAY$$US-AMGEN-USASP2024123180$AMGEN$$85$YR$E$F$Y$84.354$KG$20240715$$HP$US$US
240209692$24020969$2$F$20240620$20240708$20240627$20240715$30DAY$$US-AMGEN-USASP2024123559$AMGEN$$76$YR$E$M$Y$$$20240715$$PH$US$US
240209712$24020971$2$F$$20240806$20240627$20240816$EXP$$PT-NOVOPROD-1241815$NOVO NORDISK$$56$YR$$M$Y$$$20240816$$MD$PT$PT
240209722$24020972$2$F$$20240701$20240627$20240711$EXP$$JP-NOVOPROD-1243245$NOVO NORDISK$$68$YR$$M$Y$65$KG$20240711$$MD$JP$JP
240209762$24020976$2$F$20240101$20240822$20240627$20240826$EXP$$US-JNJFOC-20240664650$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240826$$HP$US$US
240209772$24020977$2$F$$20240808$20240627$20240817$EXP$$IT-TEVA-VS-3213470$TEVA$$$$$M$Y$$$20240817$$CN$IT$IT
240209822$24020982$2$F$20240601$20240912$20240627$20240919$PER$$US-JNJFOC-20240654053$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240919$$HP$US$US
240209844$24020984$4$F$20240617$20240828$20240627$20240830$30DAY$$US-PFIZER INC-202400200859$PFIZER$$48$YR$$F$Y$$$20240830$$CN$US$US
240209862$24020986$2$F$20240501$20240730$20240627$20240805$EXP$$US-ALXN-202406USA000226US$ALEXION PHARMACEUTICALS$$63$YR$$M$Y$$$20240806$$CN$US$US
240209963$24020996$3$F$20240612$20240912$20240627$20240916$PER$$JP-Eisai-EC-2024-168868$EISAI$$$$$$Y$$$20240916$$MD$JP$JP
240210052$24021005$2$F$$20240725$20240627$20240805$EXP$$JP-EMD Serono-2024034052$EMD SERONO INC$Yumika S, Takaya H, Momoko I, Yoshiya M, Yoshiaki H, Tatsuo T, et al. A case of metformin-associated lactic acidosis in which the patient^s life was saved by early blood purification therapy. Journal of The Japanese Society for Dialysis Therapy (The 69th Annual meeting of the Japanese Society for Dialysis Therapy (held between 07 and 09 Jun 2024). 2024;57(S1): O-0288-O-0288.$8$DEC$E$F$Y$$$20240805$$HP$JP$JP
240210082$24021008$2$F$$20240805$20240627$20240813$PER$$US-SA-2024SA182680$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
240210092$24021009$2$F$$20240925$20240627$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103187$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240930$$CN$US$US
240210142$24021014$2$F$$20240701$20240627$20240703$PER$$US-JNJFOC-20240653763$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240210262$24021026$2$F$20240509$20240702$20240627$20240705$PER$$NVSC2024US134391$NOVARTIS$$79$YR$$M$Y$$$20240705$$HP$US$US
240210294$24021029$4$F$20240501$20240722$20240627$20240806$PER$$JP-Eisai-EC-2024-168701$EISAI$$$$$F$Y$$$20240806$$MD$JP$JP
240210332$24021033$2$F$20240804$20240818$20240627$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103155$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$63.96$KG$20240821$$CN$US$US
240210418$24021041$8$F$$20240809$20240627$20240819$EXP$$GB-TEVA-VS-3212822$TEVA$$38$YR$$F$Y$$$20240819$$MD$GB$GB
240210422$24021042$2$F$$20240627$20240627$20240709$PER$$US-APELLIS-2024-APL-0000226$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
240210432$24021043$2$F$$20240702$20240627$20240710$EXP$$US-TEVA-VS-3212518$TEVA$Rimal P, Musurakis C, Gilden J. Is this a case of surreptitious hormonal supplements?. J-Endocr-Soc 2022; 6 (Suppl. 1) A673-A674 abstr. ODP600.; Rimal P, Musurakis C, Gilden J. Is this a case of surreptitious hormonal supplements?. J-Endocr-Soc 2022; 6 (Suppl. 1) A673-A674 abstr. ODP600.$63$YR$$M$Y$$$20240710$$HP$US$US
240210472$24021047$2$F$$20240925$20240627$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-103007$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$HP$JP$JP
240210625$24021062$5$F$$20240921$20240627$20240925$30DAY$$US-PFIZER INC-202400198918$PFIZER$$12$YR$$F$Y$$$20240925$$CN$US$US
240210632$24021063$2$F$$20240701$20240627$20240702$30DAY$$US-PFIZER INC-202400199077$PFIZER$$$$$M$Y$$$20240702$$CN$US$US
240210652$24021065$2$F$$20240731$20240627$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103194$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240802$$CN$US$US
240210663$24021066$3$F$20240101$20240624$20240627$20240805$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR002682$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$CA$CA
240210772$24021077$2$F$$20240701$20240627$20240708$EXP$IT-GERMAN-LIT/ITA/24/0009155$IT-RDY-LIT/ITA/24/0009155$DR REDDYS$Lorenzo AD, Rindi LV, Campogiani L, Imeneo A, Alessioa G, Pace PG, et al. Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review. Chemotherapy. 2024;69(2): 85-99. doi:10.1159/000535190.$82$YR$E$M$Y$$$20240708$$HP$IT$IT
240210862$24021086$2$F$20240701$20240829$20240627$20240903$EXP$$US-PFIZER INC-PV202400084525$PFIZER$$40$YR$$F$Y$$$20240903$$HP$US$US
240210902$24021090$2$F$20240530$20240723$20240627$20240724$EXP$$CN-PFIZER INC-PV202400084355$PFIZER$$82$YR$$M$Y$60$KG$20240724$$HP$CN$CN
240210933$24021093$3$F$20240101$20240717$20240627$20240722$EXP$$CA-PFIZER INC-202400087914$PFIZER$$59$YR$$M$Y$$$20240722$$HP$CA$CA
240210983$24021098$3$F$$20240729$20240627$20240806$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-088043$REGENERON$$$$$M$Y$$$20240806$$CN$US$US
240211032$24021103$2$F$20240420$20240720$20240627$20240724$EXP$$AR-MYLANLABS-2024M1037655$MYLAN$$25$YR$$F$Y$$$20240724$$CN$AR$AR
240211062$24021106$2$F$$20240625$20240627$20240701$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036458$BOEHRINGER INGELHEIM$Chunmei C, Yang Y, Meijuan H. Afatinib Treatment for Advanced Mixed Non-small Cell Lung Cancer with CRISPLD2- NRG1 Fusion: A Case Report and Literature Review. Chinese Journal of Lung Cancer. 2024 May;5:27: 399-404.$67$YR$E$M$Y$$$20240701$$HP$CN$CN
240211152$24021115$2$F$20240507$20240718$20240627$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202406013495$ELI LILLY AND CO$$71$YR$E$F$Y$106.1$KG$20240731$$MD$US$US
240211212$24021121$2$F$$20240625$20240627$20240813$PER$$US-LUNDBECK-DKLU3078222$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
240211222$24021122$2$F$20240613$20240627$20240627$20240709$EXP$$US-GUERBET / LLC-US-20240101$GUERBET$$59$YR$A$M$Y$173.72$KG$20240709$$HP$US$US
240211274$24021127$4$F$20240606$20240819$20240627$20240821$EXP$$BR-ORGANON-O2406BRA002305$ORGANON$$64$YR$$M$Y$65$KG$20240821$$MD$BR$BR
240211342$24021134$2$F$$20240730$20240627$20240801$PER$$US-ALXN-202406USA001325US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
240211363$24021136$3$F$20240701$20240722$20240627$20240725$PER$$US-PFIZER INC-PV202400084408$PFIZER$$79$YR$$F$Y$$$20240725$$HP$US$US
240211426$24021142$6$F$$20240910$20240627$20240911$PER$$US-PFIZER INC-202400201942$PFIZER$$43$YR$$F$Y$$$20240911$$CN$US$US
240211454$24021145$4$F$20240610$20240828$20240627$20240830$PER$$US-PFIZER INC-202400201999$PFIZER$$67$YR$$F$Y$122$KG$20240830$$CN$US$US
240211523$24021152$3$F$20240301$20240823$20240627$20240828$PER$$US-PFIZER INC-202400201774$PFIZER$$47$YR$$F$Y$85$KG$20240828$$MD$US$US
240211587$24021158$7$F$$20240919$20240627$20240920$PER$$US-PFIZER INC-PV202400084557$PFIZER$$84$YR$$F$Y$$$20240920$$HP$US$US
240211692$24021169$2$F$$20240626$20240627$20240701$PER$$US-PFIZER INC-202400201657$PFIZER$$$$$F$Y$$$20240701$$CN$US$US
240211732$24021173$2$F$$20240728$20240627$20240730$PER$$US-PFIZER INC-202400201639$PFIZER$$$$$$Y$$$20240730$$MD$US$US
240211812$24021181$2$F$$20240728$20240627$20240730$PER$$US-PFIZER INC-PV202400083436$PFIZER$$42$YR$$F$Y$$$20240730$$HP$US$US
240211822$24021182$2$F$20240101$20240618$20240627$20240717$EXP$$DE-ABBVIE-5817748$ABBVIE$$82$YR$$F$Y$58$KG$20240717$$MD$DE$DE
240211832$24021183$2$F$20240201$20240716$20240627$20240827$PER$$US-LUNDBECK-DKLU3078076$LUNDBECK$$$$$$Y$$$20240827$$CN$US$US
240211852$24021185$2$F$20240523$20240704$20240627$20240710$EXP$$RU-JNJFOC-20240589109$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$124$KG$20240710$$MD$RU$RU
240211882$24021188$2$F$20240531$20240710$20240627$20240718$EXP$$BE-BEH-2024173983$CSL BEHRING$$2$YR$C$M$Y$15$KG$20240718$$HP$BE$BE
240211913$24021191$3$F$20240625$20240725$20240627$20240730$EXP$$CA-LUNDBECK-DKLU4000912$LUNDBECK$$$$$$Y$$$20240730$$CN$CA$CA
240211923$24021192$3$F$20240624$20240909$20240627$20240911$EXP$$JP-Eisai-EC-2024-168869$EISAI$$80$YR$E$M$Y$63$KG$20240911$$MD$JP$JP
240212022$24021202$2$F$20240614$20240802$20240627$20240805$PER$$US-ALXN-202406USA001356US$ALEXION PHARMACEUTICALS$$65$YR$$F$Y$$$20240805$$CN$US$US
240212113$24021211$3$F$$20240918$20240627$20240920$EXP$$CA-ORGANON-O2406CAN002151$ORGANON$$$$$F$Y$$$20240920$$HP$CA$CA
240212142$24021214$2$F$$20240721$20240627$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103004$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$110.68$KG$20240722$$CN$US$US
240212182$24021218$2$F$$20240624$20240627$20240701$EXP$$DE-MYLANLABS-2024M1041578$MYLAN$Koschitzki K, Karrer S, Berneburg M, Niebel D, Drexler K. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).. Journal of the German Society of Dermatology. 2024;22 (6):1-4$53$YR$$M$Y$$$20240701$$HP$DE$DE
240212193$24021219$3$F$20240624$20240629$20240627$20240708$EXP$$US-MYLANLABS-2024M1058257$MYLAN$$27$YR$$F$Y$$$20240708$$HP$US$US
240212242$24021224$2$F$$20240920$20240627$20240930$EXP$$NVSJ2024JP007378$NOVARTIS$Yoshizawa S, Hirano D, Shoji Y, Sakaguchi H, Saito A, Takamasa Y, et al. A Patient who Developed Reversible Oligohydramnios due to Overdose of Angiotensin II Receptor Blocker during Pregnancy. JAPANESE JOURNAL OF PEDIATRIC NEPHROLOGY/THE 59TH ANNUAL MEETING OF THE JAPANESE. 2024;37:75$23$YR$$F$Y$$$20241001$$HP$JP$JP
240212252$24021225$2$F$$20240621$20240627$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406016125$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240701$$CN$US$US
240212282$24021228$2$F$$20240731$20240627$20240809$EXP$$US-BEH-2024174184$CSL BEHRING$$$$A$F$Y$72.562$KG$20240809$$CN$US$US
240212292$24021229$2$F$$20240626$20240627$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103065$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240711$$CN$US$US
240212323$24021232$3$F$20240611$20240919$20240627$20240923$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-103070$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$65.77$KG$20240923$$CN$PR$PR
240212332$24021233$2$F$$20240926$20240627$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103130$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240926$$CN$US$US
240212342$24021234$2$F$20240801$20240909$20240627$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103076$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240913$$HP$US$US
240212392$24021239$2$F$$20240702$20240627$20240704$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034100$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$105$KG$20240704$$MD$DE$DE
240212402$24021240$2$F$20240608$20240617$20240627$20240703$EXP$$CN-BEH-2024174185$CSL BEHRING$$51$YR$A$M$Y$60$KG$20240703$$CN$CN$CN
240212442$24021244$2$F$20240501$20240930$20240627$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103214$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240930$$HP$US$US
240212552$24021255$2$F$20240101$20240701$20240627$20240711$EXP$$US-RIGEL-20240600005$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
240212572$24021257$2$F$20221023$20240624$20240627$20240701$EXP$$NVSC2022DE243968$NOVARTIS$$$$A$M$Y$$$20240701$$CN$DE$DE
240212652$24021265$2$F$$20240802$20240627$20240806$PER$$US-ALXN-202406USA001450US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$CN$US$US
240212662$24021266$2$F$20240531$20240628$20240627$20240702$EXP$$AR-BIOMARINAP-AR-2024-158828$BIOMARIN$$$$$$Y$$$20240702$$CN$AR$AR
240212692$24021269$2$F$$20240715$20240627$20240718$EXP$$NVSC2020CA096649$NOVARTIS$$37$YR$$F$Y$$$20240718$$CN$CA$CA
240212712$24021271$2$F$20240601$20240805$20240627$20240806$PER$$US-ALXN-202406USA001443US$ALEXION PHARMACEUTICALS$$89$YR$$M$Y$$$20240806$$CN$US$US
240212722$24021272$2$F$20240601$20240626$20240627$20240702$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009685$JAZZ$$32$YR$$F$Y$$$20240702$$CN$US$US
240212762$24021276$2$F$20240201$20240819$20240627$20240822$EXP$$CA-SANDOZ INC.-SDZ2023CA054792$SANDOZ$$87$YR$$M$Y$$$20240822$$HP$CA$CA
240212802$24021280$2$F$$20240626$20240627$20240711$EXP$$US-GSK-US2024GSK079428$GLAXOSMITHKLINE$Roma N, Padala V, Pattoli M, Desai S, Krinock M, Durkin M etal.. BRASH Syndrome: A Rare Clinical Phenomenon. CJC Open. 2024;6(6):840-842$$$$$Y$$$20240711$$MD$US$US
240212905$24021290$5$F$20240711$20240904$20240627$20240909$EXP$$CA-TAKEDA-2023TUS116473$TAKEDA$$71$YR$$F$Y$$$20240909$$CN$CA$CA
240212972$24021297$2$F$20240501$20240724$20240627$20240807$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI05964$NEUROCRINE BIOSCIENCES$$60$YR$$F$Y$$$20240807$$HP$US$US
240213012$24021301$2$F$20240621$20240712$20240627$20240722$PER$$PR-MTPC-MTDA2024-0013257$Unknown Manufacturer$$59$YR$$M$Y$$$20240722$$CN$PR$PR
240213043$24021304$3$F$$20240716$20240627$20240722$PER$$US-AstraZeneca-2024A139641$ASTRAZENECA$$69$YR$$M$Y$90.7$KG$20240722$$CN$US$
240213082$24021308$2$F$$20240802$20240627$20240805$PER$$US-ALXN-202406USA001396US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240213122$24021312$2$F$$20240802$20240627$20240805$PER$$US-ALXN-202406USA001397US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240213192$24021319$2$F$$20240719$20240627$20240723$PER$$US-BIOMARINAP-US-2024-158696$BIOMARIN$$$$$$Y$$$20240723$$CN$US$US
240213202$24021320$2$F$20240624$20240628$20240627$20240702$PER$$US-BIOMARINAP-US-2024-158763$BIOMARIN$$$$$$Y$$$20240702$$HP$US$US
240213392$24021339$2$F$20240624$20240626$20240627$20240701$PER$$US-AMGEN-USASP2024124851$AMGEN$$80$YR$E$M$Y$$$20240701$$CN$US$US
240213552$24021355$2$F$20240719$20240729$20240627$20240801$PER$$US-APELLIS-APL-2022-001663$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
240213753$24021375$3$F$$20240216$20240627$20240710$PER$$ZA-ROCHE-3514653$ROCHE$$25$YR$A$M$Y$$$20240628$$HP$ZA$ZA
240213792$24021379$2$F$$20240329$20240627$20240710$PER$$US-ROCHE-3536577$ROCHE$$53$YR$A$M$Y$$$20240628$$MD$US$US
240213932$24021393$2$F$20240502$20240627$20240627$20240701$PER$$NVSC2024US133525$NOVARTIS$$47$YR$$F$Y$$$20240701$$HP$US$US
240213994$24021399$4$F$$20240626$20240627$20240716$EXP$$US-ROCHE-10000006514$ROCHE$$$$E$F$Y$$$20240716$$CN$US$US
240214004$24021400$4$F$$20240417$20240627$20240710$PER$$CA-ROCHE-3466234$ROCHE$$$$A$M$Y$$$20240628$$MD$CA$CA
240214252$24021425$2$F$$20240229$20240627$20240710$PER$$US-ROCHE-3519241$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$US$US
240214262$24021426$2$F$$20240415$20240627$20240710$PER$$ZA-ROCHE-3544958$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$ZA$ZA
240214342$24021434$2$F$20240501$20240620$20240627$20240702$EXP$$CN-ROCHE-3559734$ROCHE$$69$YR$E$M$Y$$$20240702$$CN$CN$CN
240214355$24021435$5$F$20231221$20240523$20240627$20240710$PER$$CA-ROCHE-3466236$ROCHE$$91$YR$E$F$Y$$$20240628$$MD$CA$CA
240214453$24021445$3$F$20240313$20240412$20240627$20240710$PER$$CA-ROCHE-3529890$ROCHE$$94$YR$E$F$Y$$$20240628$$CN$CA$CA
240214543$24021454$3$F$$20240306$20240627$20240710$PER$$AU-ROCHE-3522559$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240214602$24021460$2$F$$20240503$20240627$20240710$PER$$US-ROCHE-3558437$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$US$US
240214673$24021467$3$F$$20240429$20240627$20240710$PER$$FR-ROCHE-3536570$ROCHE$$84$YR$E$F$Y$$$20240628$$MD$FR$FR
240214883$24021488$3$F$20230613$20240326$20240627$20240710$PER$$US-ROCHE-3533864$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$US$US
240214983$24021498$3$F$20240212$20240318$20240627$20240710$PER$$DE-ROCHE-3529447$ROCHE$$$$$F$Y$$$20240628$$MD$DE$DE
240215072$24021507$2$F$$20240329$20240627$20240710$PER$$US-ROCHE-3522581$ROCHE$$64$YR$A$F$Y$$$20240628$$HP$US$US
240215103$24021510$3$F$$20240404$20240627$20240710$PER$$US-ROCHE-3228824$ROCHE$$69$YR$E$F$Y$82.55$KG$20240628$$MD$US$US
240215122$24021512$2$F$$20240410$20240627$20240710$PER$$US-ROCHE-3538078$ROCHE$$78$YR$E$F$Y$109.77$KG$20240628$$CN$US$US
240215162$24021516$2$F$20240618$20240729$20240627$20240807$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-19360$SAMSUNG BIOEPIS$$16$YR$T$F$Y$152$KG$20240807$$HP$CA$CA
240215176$24021517$6$F$20240123$20240318$20240627$20240710$PER$$US-ROCHE-3499101$ROCHE$$85$YR$E$F$Y$$$20240628$$MD$US$US
240215353$24021535$3$F$20240210$20240318$20240627$20240710$PER$$IN-ROCHE-3529958$ROCHE$$61$YR$A$M$Y$$$20240628$$CN$IN$IN
240215383$24021538$3$F$$20240416$20240627$20240710$PER$$US-ROCHE-3532383$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240215392$24021539$2$F$$20240201$20240627$20240710$PER$$US-ROCHE-3469424$ROCHE$$17$YR$T$F$Y$$$20240628$$MD$US$US
240215482$24021548$2$F$$20240718$20240627$20240723$PER$$US-AMGEN-USASP2024124855$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
240215512$24021551$2$F$$20240417$20240627$20240710$PER$$ZA-ROCHE-3547026$ROCHE$$$$E$M$Y$$$20240628$$MD$ZA$ZA
240215564$24021556$4$F$$20240314$20240627$20240710$PER$$AU-ROCHE-3526645$ROCHE$$$$$F$Y$$$20240628$$MD$AU$AU
240215743$24021574$3$F$20240126$20240402$20240627$20240710$PER$$FR-ROCHE-3533477$ROCHE$$84$YR$E$F$Y$63$KG$20240628$$MD$FR$FR
240215803$24021580$3$F$$20240405$20240627$20240710$PER$$US-ROCHE-3509219$ROCHE$$41$YR$A$M$Y$95.25$KG$20240628$$MD$US$US
240215853$24021585$3$F$20240130$20240227$20240627$20240710$PER$$IN-ROCHE-3503653$ROCHE$$61$YR$A$M$Y$$$20240628$$CN$IN$IN
240215862$24021586$2$F$20240408$20240408$20240627$20240710$PER$$US-ROCHE-3542300$ROCHE$$60$YR$A$M$Y$$$20240628$$CN$US$US
240215915$24021591$5$F$$20240523$20240627$20240710$PER$$CA-ROCHE-3547734$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$CA$CA
240215963$24021596$3$F$20231219$20240305$20240627$20240710$PER$$SE-ROCHE-3510350$ROCHE$$86$YR$E$F$Y$$$20240628$$MD$SE$SE
240216035$24021603$5$F$20240505$20240923$20240627$20240926$EXP$$FR-ROCHE-3573657$ROCHE$$77$YR$E$M$Y$$$20240926$$PH$FR$FR
240216182$24021618$2$F$$20240913$20240627$20240923$EXP$$CN-ROCHE-3574077$ROCHE$$73$YR$E$F$Y$$$20240923$$CN$CN$CN
240216242$24021624$2$F$$20240131$20240627$20240710$PER$$US-ROCHE-3502990$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$US$US
240216252$24021625$2$F$$20240311$20240627$20240710$PER$$CA-ROCHE-3498969$ROCHE$$$$A$M$Y$$$20240628$$CN$CA$CA
240216272$24021627$2$F$$20240312$20240627$20240710$PER$$US-ROCHE-3526654$ROCHE$$63$YR$A$M$Y$$$20240628$$CN$US$US
240216312$24021631$2$F$$20240305$20240627$20240710$PER$$US-ROCHE-3522584$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$US$US
240216325$24021632$5$F$20240118$20240429$20240627$20240710$PER$$IN-ROCHE-3497934$ROCHE$$73$YR$E$M$Y$$$20240628$$CN$IN$IN
240216343$24021634$3$F$$20240217$20240627$20240710$PER$$AU-ROCHE-3512950$ROCHE$$$$A$M$Y$$$20240628$$MD$AU$AU
240216402$24021640$2$F$$20240305$20240627$20240710$PER$$SE-ROCHE-3523565$ROCHE$$$$$$Y$$$20240628$$MD$SE$SE
240216503$24021650$3$F$20230112$20240410$20240627$20240710$PER$$JP-ROCHE-3315201$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$JP$JP
240216532$24021653$2$F$$20240209$20240627$20240710$PER$$GB-ROCHE-3509045$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$GB$GB
240216632$24021663$2$F$$20240222$20240627$20240710$PER$$US-ROCHE-3508812$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$US$US
240216682$24021668$2$F$20240213$20240312$20240627$20240710$PER$$AU-ROCHE-3512347$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$AU$AU
240216982$24021698$2$F$$20240319$20240627$20240710$PER$$BR-ROCHE-3517606$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$BR$BR
240217104$24021710$4$F$20230905$20240208$20240627$20240710$PER$$US-ROCHE-3506925$ROCHE$$86$YR$E$M$Y$$$20240628$$CN$US$US
240217125$24021712$5$F$20240307$20240516$20240627$20240710$PER$$FR-ROCHE-3525203$ROCHE$$89$YR$E$F$Y$$$20240628$$HP$FR$FR
240217173$24021717$3$F$$20240526$20240627$20240710$PER$$SE-ROCHE-3513098$ROCHE$$75$YR$E$F$Y$$$20240628$$CN$SE$SE
240217213$24021721$3$F$$20240214$20240627$20240710$PER$$US-ROCHE-3510081$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$US$US
240217232$24021723$2$F$20240111$20240308$20240627$20240710$PER$$US-ROCHE-3523788$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$US$US
240217365$24021736$5$F$$20240417$20240627$20240710$PER$$CA-ROCHE-3466201$ROCHE$$$$E$F$Y$$$20240628$$HP$CA$CA
240217472$24021747$2$F$$20240314$20240627$20240710$PER$$US-ROCHE-3527001$ROCHE$$67$YR$E$M$Y$106.59$KG$20240628$$CN$US$US
240217523$24021752$3$F$$20240308$20240627$20240710$PER$$DE-ROCHE-3484567$ROCHE$$$$$$Y$$$20240628$$PH$DE$DE
240217542$24021754$2$F$20240223$20240304$20240627$20240710$PER$$IN-ROCHE-3517295$ROCHE$$39$YR$A$M$Y$$$20240628$$CN$IN$IN
240217562$24021756$2$F$$20240312$20240627$20240710$PER$$US-ROCHE-3524671$ROCHE$$80$YR$E$F$Y$$$20240628$$CN$US$US
240217573$24021757$3$F$$20240203$20240627$20240710$PER$$US-ROCHE-3505642$ROCHE$$82$YR$E$M$Y$$$20240628$$MD$US$US
240217662$24021766$2$F$$20240305$20240627$20240710$PER$$SE-ROCHE-3523501$ROCHE$$$$$$Y$$$20240628$$MD$SE$SE
240217682$24021768$2$F$$20240202$20240627$20240710$PER$$NO-ROCHE-3506358$ROCHE$$$$$$Y$$$20240628$$MD$NO$NO
240217696$24021769$6$F$20240309$20240404$20240627$20240710$PER$$FR-ROCHE-3525209$ROCHE$$60$YR$A$M$Y$83$KG$20240628$$MD$FR$FR
240217724$24021772$4$F$$20240314$20240627$20240710$PER$$AU-ROCHE-3517217$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240217814$24021781$4$F$20240302$20240423$20240627$20240710$PER$$IN-ROCHE-3522876$ROCHE$$57$YR$A$M$Y$$$20240628$$CN$IN$IN
240217862$24021786$2$F$$20240131$20240627$20240710$PER$$GB-ROCHE-3503043$ROCHE$$$$$M$Y$$$20240628$$MD$GB$GB
240217876$24021787$6$F$20240201$20240314$20240627$20240710$PER$$IN-ROCHE-3504416$ROCHE$$76$YR$E$M$Y$$$20240628$$CN$IN$IN
240217905$24021790$5$F$20240212$20240408$20240627$20240710$PER$$IN-ROCHE-3510609$ROCHE$$67$YR$E$M$Y$$$20240628$$CN$IN$IN
240217932$24021793$2$F$$20240402$20240627$20240710$PER$$BR-ROCHE-3525193$ROCHE$$75$YR$E$M$Y$$$20240628$$MD$BR$BR
240218072$24021807$2$F$$20240215$20240627$20240710$PER$$US-ROCHE-3511150$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$US$US
240218092$24021809$2$F$20240101$20240731$20240627$20240805$EXP$$TW-009507513-2406TWN005504$MERCK$$51$YR$$M$Y$$$20240805$$HP$TW$TW
240218133$24021813$3$F$20240222$20240306$20240627$20240710$PER$$IN-ROCHE-3524023$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$IN$IN
240218142$24021814$2$F$20240221$20240301$20240627$20240710$PER$$IN-ROCHE-3521483$ROCHE$$73$YR$E$M$Y$$$20240628$$CN$IN$IN
240218232$24021823$2$F$$20240502$20240627$20240710$PER$$GB-ROCHE-3554275$ROCHE$$79$YR$E$F$Y$$$20240628$$MD$GB$GB
240218273$24021827$3$F$$20240212$20240627$20240710$PER$$DE-ROCHE-3504850$ROCHE$$$$$$Y$$$20240628$$CN$DE$DE
240218282$24021828$2$F$20240309$20240318$20240627$20240710$PER$$IN-ROCHE-3527415$ROCHE$$62$YR$A$F$Y$$$20240628$$CN$IN$IN
240218292$24021829$2$F$$20240215$20240627$20240710$PER$$CA-ROCHE-3508209$ROCHE$$89$YR$E$M$Y$$$20240628$$CN$CA$CA
240218442$24021844$2$F$20240221$20240227$20240627$20240710$PER$$IN-ROCHE-3516844$ROCHE$$79$YR$E$M$Y$$$20240628$$CN$IN$IN
240218452$24021845$2$F$$20240213$20240627$20240710$PER$$AU-ROCHE-3511532$ROCHE$$$$$$Y$$$20240628$$PH$AU$AU
240218512$24021851$2$F$$20240507$20240627$20240710$PER$$US-ROCHE-3559385$ROCHE$$56$YR$A$F$Y$$$20240628$$MD$US$US
240218573$24021857$3$F$$20240212$20240627$20240710$PER$$US-ROCHE-3509246$ROCHE$$82$YR$E$F$Y$57.61$KG$20240628$$CN$US$US
240218592$24021859$2$F$20240220$20240226$20240627$20240710$PER$$IN-ROCHE-3514783$ROCHE$$80$YR$E$F$Y$$$20240628$$CN$IN$IN
240218635$24021863$5$F$$20240508$20240627$20240710$PER$$ES-ROCHE-3547845$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$ES$ES
240218672$24021867$2$F$20240112$20240209$20240627$20240710$PER$$IN-ROCHE-3510052$ROCHE$$74$YR$E$M$Y$$$20240628$$CN$IN$IN
240218682$24021868$2$F$20240221$20240304$20240627$20240710$PER$$IN-ROCHE-3518797$ROCHE$$54$YR$A$F$Y$$$20240628$$CN$IN$IN
240218712$24021871$2$F$$20240423$20240627$20240710$PER$$US-ROCHE-3546054$ROCHE$$69$YR$E$F$Y$$$20240628$$MD$US$US
240218762$24021876$2$F$$20240222$20240627$20240710$PER$$US-ROCHE-3515230$ROCHE$$4$MON$I$M$Y$$$20240628$$MD$US$US
240218963$24021896$3$F$$20240327$20240627$20240710$PER$$AU-ROCHE-3530740$ROCHE$$86$YR$E$F$Y$$$20240628$$MD$AU$AU
240219012$24021901$2$F$20240208$20240410$20240627$20240710$PER$$US-ROCHE-3537013$ROCHE$$55$YR$A$$Y$$$20240628$$MD$US$US
240219192$24021919$2$F$20240215$20240219$20240627$20240710$PER$$IN-ROCHE-3512933$ROCHE$$64$YR$A$F$Y$$$20240628$$CN$IN$IN
240219282$24021928$2$F$$20240307$20240627$20240710$PER$$US-ROCHE-3522652$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$US$US
240219382$24021938$2$F$20240229$20240229$20240627$20240710$PER$$IN-ROCHE-3520384$ROCHE$$28$YR$A$M$Y$$$20240628$$CN$IN$IN
240219473$24021947$3$F$$20240403$20240627$20240710$PER$$FR-ROCHE-3536337$ROCHE$$81$YR$E$F$Y$$$20240628$$MD$FR$FR
240219504$24021950$4$F$20240120$20240205$20240627$20240710$PER$$US-ROCHE-3499188$ROCHE$$79$YR$E$M$Y$$$20240628$$MD$US$US
240219642$24021964$2$F$$20240326$20240627$20240710$PER$$AU-ROCHE-3533175$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240219665$24021966$5$F$$20240305$20240627$20240710$PER$$CA-ROCHE-3464528$ROCHE$$$$$$Y$$$20240628$$HP$CA$CA
240219682$24021968$2$F$$20240329$20240627$20240710$PER$$US-ROCHE-3535940$ROCHE$$74$YR$E$M$Y$108.86$KG$20240628$$CN$US$US
240219752$24021975$2$F$$20240418$20240627$20240710$PER$$US-ROCHE-3549307$ROCHE$$77$YR$E$M$Y$90.72$KG$20240628$$CN$US$US
240219972$24021997$2$F$20240305$20240409$20240627$20240710$PER$$FR-ROCHE-3538182$ROCHE$$89$YR$E$F$Y$50$KG$20240628$$MD$FR$FR
240219992$24021999$2$F$$20240405$20240627$20240710$PER$$US-ROCHE-3540740$ROCHE$$81$YR$E$M$Y$$$20240628$$CN$US$US
240220004$24022000$4$F$$20240213$20240627$20240710$PER$$FR-ROCHE-3510992$ROCHE$$86$YR$E$F$Y$$$20240628$$CN$FR$FR
240220092$24022009$2$F$$20240426$20240627$20240710$PER$$US-ROCHE-3554745$ROCHE$$95$YR$E$F$Y$$$20240628$$CN$US$US
240220282$24022028$2$F$$20240410$20240627$20240710$PER$$CA-ROCHE-3544078$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$CA$CA
240220313$24022031$3$F$20240201$20240314$20240627$20240710$PER$$IN-ROCHE-3528922$ROCHE$$80$YR$E$F$Y$$$20240628$$CN$IN$IN
240220473$24022047$3$F$$20240424$20240627$20240710$PER$$US-ROCHE-3479908$ROCHE$$79$YR$E$M$Y$$$20240628$$MD$US$US
240220482$24022048$2$F$$20240408$20240627$20240710$PER$$KR-ROCHE-3535229$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$KR$KR
240220492$24022049$2$F$20240208$20240412$20240627$20240710$PER$$IN-ROCHE-3547439$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$IN$IN
240220582$24022058$2$F$20240115$20240301$20240627$20240710$PER$$IN-ROCHE-3518932$ROCHE$$60$YR$A$F$Y$$$20240628$$CN$IN$IN
240220634$24022063$4$F$20240228$20240308$20240627$20240710$PER$$FR-ROCHE-3520293$ROCHE$$85$YR$E$F$Y$$$20240628$$CN$FR$FR
240220772$24022077$2$F$20240207$20240425$20240627$20240710$PER$$GB-ROCHE-3528551$ROCHE$$80$YR$E$F$Y$$$20240628$$MD$GB$GB
240220794$24022079$4$F$$20240417$20240627$20240710$PER$$CA-ROCHE-3547749$ROCHE$$64$YR$A$F$Y$$$20240628$$MD$CA$CA
240220832$24022083$2$F$$20240321$20240627$20240710$PER$$US-ROCHE-3531679$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240220842$24022084$2$F$$20240330$20240627$20240710$PER$$US-ROCHE-3537039$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240220942$24022094$2$F$20240127$20240201$20240627$20240710$PER$$IN-ROCHE-3502092$ROCHE$$66$YR$E$M$Y$$$20240628$$CN$IN$IN
240220982$24022098$2$F$$20240209$20240627$20240710$PER$$US-ROCHE-3509561$ROCHE$$21$YR$A$M$Y$$$20240628$$MD$US$US
240220992$24022099$2$F$$20240415$20240627$20240710$PER$$IT-ROCHE-3546590$ROCHE$$$$E$M$Y$$$20240628$$MD$IT$IT
240221014$24022101$4$F$$20240229$20240627$20240710$PER$$DE-ROCHE-3519424$ROCHE$$$$$F$Y$$$20240628$$MD$DE$DE
240221032$24022103$2$F$20240224$20240301$20240627$20240710$PER$$IN-ROCHE-3520149$ROCHE$$76$YR$E$F$Y$$$20240628$$CN$IN$IN
240221142$24022114$2$F$$20240501$20240627$20240710$PER$$US-ROCHE-3527477$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$US$US
240221362$24022136$2$F$20240129$20240311$20240627$20240710$PER$$IN-ROCHE-3524694$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$IN$IN
240221375$24022137$5$F$20240131$20240522$20240627$20240710$PER$$GB-ROCHE-3503245$ROCHE$$88$YR$E$F$Y$$$20240628$$MD$GB$GB
240221392$24022139$2$F$$20240422$20240627$20240710$PER$$US-ROCHE-3485246$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$US$US
240221442$24022144$2$F$20230814$20240305$20240627$20240710$PER$$AU-ROCHE-3513799$ROCHE$$88$YR$E$F$Y$$$20240628$$MD$AU$AU
240221612$24022161$2$F$20240201$20240222$20240627$20240710$PER$$US-ROCHE-3515676$ROCHE$$89$YR$E$F$Y$$$20240628$$CN$US$US
240221633$24022163$3$F$20240605$20240704$20240627$20240709$EXP$$PH-ROCHE-10000004020$ROCHE$$73$YR$E$F$Y$$$20240709$$HP$PH$PH
240221652$24022165$2$F$$20240220$20240627$20240710$PER$$CA-ROCHE-3511760$ROCHE$$85$YR$E$F$Y$$$20240628$$CN$CA$CA
240221802$24022180$2$F$$20240220$20240627$20240710$PER$$CL-ROCHE-3513997$ROCHE$$$$$$Y$$$20240628$$CN$CL$CL
240221812$24022181$2$F$$20240214$20240627$20240710$PER$$ZA-ROCHE-3513880$ROCHE$$$$E$M$Y$$$20240628$$HP$ZA$ZA
240221822$24022182$2$F$20240214$20240215$20240627$20240710$PER$$IN-ROCHE-3512744$ROCHE$$81$YR$E$M$Y$$$20240628$$CN$IN$IN
240221852$24022185$2$F$$20240417$20240627$20240710$PER$$IT-ROCHE-3546512$ROCHE$$$$$F$Y$$$20240628$$MD$IT$IT
240221862$24022186$2$F$$20240404$20240627$20240710$PER$$US-ROCHE-3539240$ROCHE$$75$YR$E$F$Y$$$20240628$$CN$US$US
240221872$24022187$2$F$$20240318$20240627$20240710$PER$$IN-ROCHE-3531514$ROCHE$$67$YR$E$M$Y$$$20240628$$CN$IN$IN
240221952$24022195$2$F$20240219$20240415$20240627$20240710$PER$$FR-ROCHE-3527751$ROCHE$$62$YR$A$F$Y$58$KG$20240628$$MD$FR$FR
240221972$24022197$2$F$$20240406$20240627$20240710$PER$$IN-ROCHE-3540370$ROCHE$$73$YR$E$M$Y$$$20240628$$CN$IN$IN
240222142$24022214$2$F$$20240305$20240627$20240710$PER$$JP-ROCHE-3522114$ROCHE$$$$$$Y$$$20240628$$HP$JP$JP
240222154$24022215$4$F$$20240522$20240627$20240710$PER$$IT-ROCHE-3544371$ROCHE$$79$YR$E$M$Y$76$KG$20240628$$MD$IT$IT
240222232$24022223$2$F$$20240221$20240627$20240710$PER$$GB-ROCHE-3514512$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240222252$24022225$2$F$$20240322$20240627$20240710$PER$$US-ROCHE-3532578$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240222382$24022238$2$F$$20240424$20240627$20240710$PER$$ZA-ROCHE-3549621$ROCHE$$$$E$F$Y$$$20240628$$MD$ZA$ZA
240222392$24022239$2$F$$20240327$20240627$20240710$PER$$GB-ROCHE-3535002$ROCHE$$$$$$Y$$$20240628$$MD$GB$GB
240222592$24022259$2$F$$20240417$20240627$20240710$PER$$IT-ROCHE-3546527$ROCHE$$$$$M$Y$$$20240628$$MD$IT$IT
240222602$24022260$2$F$$20240325$20240627$20240710$PER$$US-ROCHE-3533103$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240222682$24022268$2$F$$20240417$20240627$20240710$PER$$IT-ROCHE-3546685$ROCHE$$$$E$M$Y$$$20240628$$MD$IT$IT
240222692$24022269$2$F$$20240419$20240627$20240710$PER$$AT-ROCHE-3550687$ROCHE$$$$$$Y$$$20240628$$PH$AT$AT
240222712$24022271$2$F$$20240314$20240627$20240710$PER$$US-ROCHE-3527776$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$US$US
240222822$24022282$2$F$$20240408$20240627$20240710$PER$$US-ROCHE-3532666$ROCHE$$43$YR$A$$Y$$$20240628$$MD$US$US
240222942$24022294$2$F$20240213$20240320$20240627$20240710$PER$$IN-ROCHE-3532664$ROCHE$$27$YR$A$M$Y$$$20240628$$CN$IN$IN
240222992$24022299$2$F$20240118$20240524$20240627$20240710$PER$$JP-ROCHE-3549268$ROCHE$$10$DEC$E$F$Y$$$20240628$$MD$JP$JP
240223012$24022301$2$F$$20240312$20240627$20240710$PER$$CA-ROCHE-3526344$ROCHE$$80$YR$E$M$Y$$$20240628$$CN$CA$CA
240223045$24022304$5$F$$20240521$20240627$20240710$PER$$US-ROCHE-3485816$ROCHE$$11$YR$C$F$Y$$$20240628$$MD$US$US
240223143$24022314$3$F$$20231226$20240627$20240710$PER$$JP-ROCHE-3484037$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$JP$JP
240223192$24022319$2$F$$20240301$20240627$20240710$PER$$US-ROCHE-3522279$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240223222$24022322$2$F$20230727$20231228$20240627$20240710$PER$$JP-ROCHE-3488205$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240223317$24022331$7$F$20231124$20240422$20240627$20240710$PER$$BO-ROCHE-3466948$ROCHE$$$$$F$Y$$$20240628$$CN$BO$BO
240223333$24022333$3$F$$20240329$20240627$20240710$PER$$US-ROCHE-3522573$ROCHE$$88$YR$E$F$Y$$$20240628$$HP$US$US
240223342$24022334$2$F$$20240419$20240627$20240710$PER$$FR-ROCHE-3540573$ROCHE$$$$$$Y$$$20240628$$MD$FR$FR
240223352$24022335$2$F$$20240318$20240627$20240710$PER$$PH-ROCHE-3528586$ROCHE$$$$$$Y$$$20240628$$MD$PH$PH
240223562$24022356$2$F$20240215$20240315$20240627$20240710$PER$$IN-ROCHE-3529970$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$IN$IN
240223712$24022371$2$F$$20240715$20240627$20240722$EXP$US-MLMSERVICE-20240613-PI098382-00217-1$US-RDY-SPO/USA/24/0009119$DR REDDYS$Mikhail E, Alexander D, Jankowski M, Pandya D, Kunadi A. Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3410. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A3410.$72$YR$E$F$Y$$$20240722$$MD$US$US
240223753$24022375$3$F$$20240401$20240627$20240710$PER$$US-ROCHE-3528575$ROCHE$$23$YR$A$F$Y$$$20240628$$MD$US$US
240223952$24022395$2$F$$20240327$20240627$20240710$PER$$US-ROCHE-3534841$ROCHE$$$$$M$Y$$$20240628$$CN$US$US
240224073$24022407$3$F$20230901$20240508$20240627$20240710$PER$$LT-ROCHE-3557773$ROCHE$$59$YR$A$F$Y$72$KG$20240628$$MD$LT$LT
240224102$24022410$2$F$20230629$20240124$20240627$20240710$PER$$AU-ROCHE-3498211$ROCHE$$46$YR$A$M$Y$71$KG$20240628$$MD$AU$AU
240224216$24022421$6$F$20231002$20240529$20240627$20240710$PER$$TR-ROCHE-3515248$ROCHE$$71$YR$E$M$Y$81$KG$20240628$$MD$TR$TR
240224412$24022441$2$F$$20240429$20240627$20240710$PER$$DK-ROCHE-3550028$ROCHE$$$$$M$Y$$$20240628$$HP$DK$DK
240224452$24022445$2$F$20240306$20240314$20240627$20240710$PER$$AR-ROCHE-3525213$ROCHE$$83$YR$E$F$Y$46$KG$20240628$$MD$AR$AR
240224515$24022451$5$F$20211125$20240314$20240627$20240710$PER$$TR-ROCHE-3005244$ROCHE$$57$YR$A$M$Y$76$KG$20240628$$MD$TR$TR
240224542$24022454$2$F$$20240318$20240627$20240710$PER$$PT-ROCHE-3529380$ROCHE$$$$E$F$Y$$$20240628$$MD$PT$PT
240224584$24022458$4$F$20220512$20231109$20240627$20240710$PER$$TR-ROCHE-3202068$ROCHE$$50$YR$A$M$Y$$$20240628$$MD$TR$TR
240224632$24022463$2$F$20220324$20231120$20240627$20240710$PER$$AT-ROCHE-3077880$ROCHE$$59$YR$A$F$Y$56$KG$20240628$$MD$AT$AT
240224692$24022469$2$F$20240102$20240124$20240627$20240710$PER$$JP-ROCHE-3503322$ROCHE$$85$YR$E$F$Y$$$20240628$$MD$JP$JP
240224702$24022470$2$F$20230601$20231012$20240627$20240710$PER$$AU-ROCHE-3438382$ROCHE$$39$YR$A$M$Y$67$KG$20240628$$MD$AU$AU
240224754$24022475$4$F$20221018$20230915$20240627$20240710$PER$$VN-ROCHE-3255897$ROCHE$$69$YR$E$F$Y$55$KG$20240628$$MD$VN$VN
240224852$24022485$2$F$20231001$20231012$20240627$20240710$PER$$CN-ROCHE-3440317$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$CN$CN
240224873$24022487$3$F$$20240314$20240627$20240710$PER$$BR-ROCHE-3527762$ROCHE$$$$$M$Y$$$20240628$$CN$BR$BR
240224953$24022495$3$F$$20230926$20240627$20240710$PER$$BR-ROCHE-3416505$ROCHE$$42$YR$A$F$Y$$$20240628$$PH$BR$BR
2402249911$24022499$11$F$20220629$20240531$20240627$20240710$PER$$CN-ROCHE-3140819$ROCHE$$42$YR$A$F$Y$70$KG$20240628$$MD$CN$CN
240225022$24022502$2$F$$20240409$20240627$20240710$PER$$FR-ROCHE-3543780$ROCHE$$$$$$Y$$$20240628$$MD$FR$FR
240225062$24022506$2$F$$20240315$20240627$20240710$PER$$US-ROCHE-3528415$ROCHE$$84$YR$E$F$Y$$$20240628$$MD$US$US
240225082$24022508$2$F$20221001$20240222$20240627$20240710$PER$$AU-ROCHE-3209987$ROCHE$$60$YR$A$M$Y$86.7$KG$20240628$$MD$AU$AU
240225102$24022510$2$F$20240118$20240413$20240627$20240710$PER$$DE-ROCHE-3496185$ROCHE$$87$YR$E$F$Y$$$20240628$$MD$DE$DE
240225252$24022525$2$F$20230203$20230818$20240627$20240710$PER$$CN-ROCHE-3349735$ROCHE$$44$YR$A$M$Y$62.5$KG$20240628$$MD$CN$CN
240225294$24022529$4$F$$20240527$20240627$20240710$PER$$CN-ROCHE-3307999$ROCHE$$62$YR$A$F$Y$72$KG$20240628$$MD$CN$CN
240225322$24022532$2$F$20230701$20230814$20240627$20240710$PER$$CN-ROCHE-3405570$ROCHE$$37$YR$A$M$Y$72$KG$20240628$$CN$CN$CN
240225383$24022538$3$F$20240109$20240426$20240627$20240710$PER$$IN-ROCHE-3508710$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$IN$IN
240225553$24022555$3$F$20240131$20240410$20240627$20240710$PER$$IN-ROCHE-3506502$ROCHE$$75$YR$E$M$Y$$$20240628$$CN$IN$IN
240225604$24022560$4$F$20240129$20240426$20240627$20240710$PER$$IN-ROCHE-3502611$ROCHE$$81$YR$E$F$Y$$$20240628$$CN$IN$IN
240225612$24022561$2$F$$20231103$20240627$20240710$PER$$CA-ROCHE-3363675$ROCHE$$$$A$M$Y$$$20240628$$CN$CA$CA
240225783$24022578$3$F$$20240403$20240627$20240710$PER$$IL-ROCHE-3535594$ROCHE$$68$YR$E$M$Y$$$20240628$$HP$IL$IL
240225873$24022587$3$F$20240101$20240405$20240627$20240710$PER$$DE-ROCHE-3541847$ROCHE$$$$$F$Y$$$20240628$$MD$DE$DE
240225924$24022592$4$F$20230519$20230711$20240627$20240710$PER$$CN-ROCHE-3381755$ROCHE$$58$YR$A$F$Y$70$KG$20240628$$MD$CN$CN
240225942$24022594$2$F$$20240214$20240627$20240710$PER$$US-ROCHE-3511619$ROCHE$$79$YR$E$F$Y$$$20240628$$MD$US$US
240225952$24022595$2$F$$20240513$20240627$20240710$PER$$IN-ROCHE-3515452$ROCHE$$86$YR$E$F$Y$$$20240628$$CN$IN$IN
240225974$24022597$4$F$20221007$20231126$20240627$20240710$PER$$CN-ROCHE-3210085$ROCHE$$58$YR$A$M$Y$75$KG$20240628$$CN$CN$CN
240225983$24022598$3$F$20230621$20230919$20240627$20240710$PER$$RO-ROCHE-3425579$ROCHE$$71$YR$E$M$Y$$$20240628$$MD$RO$RO
240225992$24022599$2$F$20231201$20240729$20240627$20240802$PER$$US-ROCHE-3516637$ROCHE$$37$YR$A$M$Y$102$KG$20240802$$PH$US$US
240226052$24022605$2$F$$20230908$20240627$20240710$PER$$CO-ROCHE-3421431$ROCHE$$30$YR$A$F$Y$$$20240628$$CN$CO$CO
240226093$24022609$3$F$20230520$20231004$20240627$20240710$PER$$AT-ROCHE-3401443$ROCHE$$60$YR$A$F$Y$50$KG$20240628$$MD$AT$AT
240226112$24022611$2$F$$20240304$20240627$20240710$PER$$US-ROCHE-3521131$ROCHE$$69$YR$E$M$Y$$$20240628$$HP$US$US
240226162$24022616$2$F$$20240516$20240627$20240710$PER$$IT-ROCHE-3564554$ROCHE$$$$A$F$Y$$$20240628$$MD$IT$IT
240226255$24022625$5$F$20240118$20240510$20240627$20240710$PER$$IN-ROCHE-3496036$ROCHE$$56$YR$A$M$Y$$$20240628$$CN$IN$IN
240226282$24022628$2$F$$20240101$20240627$20240710$PER$$AU-ROCHE-3450739$ROCHE$$$$E$M$Y$$$20240628$$MD$AU$AU
240226313$24022631$3$F$$20240525$20240627$20240710$PER$$IN-ROCHE-3519845$ROCHE$$66$YR$E$M$Y$85$KG$20240628$$CN$IN$IN
240226324$24022632$4$F$20240116$20240301$20240627$20240710$PER$$IN-ROCHE-3497940$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$IN$IN
240226343$24022634$3$F$20221116$20230704$20240627$20240710$PER$$AU-ROCHE-3382548$ROCHE$$66$YR$E$M$Y$$$20240628$$MD$AU$AU
240226422$24022642$2$F$$20240605$20240627$20240710$PER$$KR-ROCHE-3525699$ROCHE$$83$YR$E$M$Y$$$20240628$$CN$KR$KR
240226464$24022646$4$F$$20240529$20240627$20240710$PER$$IN-ROCHE-3526580$ROCHE$$85$YR$E$M$Y$$$20240628$$CN$IN$IN
240226482$24022648$2$F$$20240606$20240627$20240710$PER$$US-ROCHE-3525108$ROCHE$$60$YR$A$M$Y$$$20240628$$HP$US$US
240226502$24022650$2$F$$20240306$20240627$20240710$PER$$JP-ROCHE-3377237$ROCHE$$6$DEC$A$M$Y$46.9$KG$20240628$$MD$JP$JP
240226515$24022651$5$F$20211101$20240522$20240627$20240710$PER$$AU-ROCHE-3342920$ROCHE$$45$YR$A$F$Y$50.3$KG$20240628$$MD$AU$AU
240226532$24022653$2$F$20240101$20240603$20240627$20240710$PER$$JP-ROCHE-3548192$ROCHE$$58$YR$A$M$Y$$$20240628$$MD$JP$JP
240226606$24022660$6$F$20230711$20230911$20240627$20240710$PER$$CN-ROCHE-3413803$ROCHE$$60$YR$A$M$Y$75$KG$20240628$$MD$CN$CN
240226612$24022661$2$F$20220607$20230711$20240627$20240710$PER$$CN-ROCHE-3307818$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$CN$CN
240226673$24022667$3$F$$20230928$20240627$20240710$PER$$FR-ROCHE-2780322$ROCHE$$11$YR$C$M$Y$44$KG$20240628$$MD$FR$FR
240226712$24022671$2$F$$20240528$20240627$20240710$PER$$AT-ROCHE-3574555$ROCHE$$$$$F$Y$$$20240628$$MD$AT$AT
240226722$24022672$2$F$$20231011$20240627$20240710$PER$$MX-ROCHE-3436217$ROCHE$$37$YR$A$F$Y$$$20240628$$CN$MX$MX
240226732$24022673$2$F$$20240605$20240627$20240710$PER$$TW-ROCHE-3576027$ROCHE$$$$A$F$Y$$$20240628$$MD$TW$TW
240226762$24022676$2$F$20240309$20240315$20240627$20240710$PER$$IN-ROCHE-3529796$ROCHE$$78$YR$E$F$Y$$$20240628$$CN$IN$IN
240226783$24022678$3$F$20240321$20240418$20240627$20240710$PER$$IN-ROCHE-3533939$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$IN$IN
240226907$24022690$7$F$20230721$20240608$20240627$20240710$PER$$PT-ROCHE-3362252$ROCHE$$42$YR$A$F$Y$62.7$KG$20240628$$MD$PT$PT
240226942$24022694$2$F$$20240122$20240627$20240710$PER$$US-ROCHE-3495676$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240227002$24022700$2$F$$20240528$20240627$20240710$PER$$IN-ROCHE-3534774$ROCHE$$64$YR$A$M$Y$$$20240628$$CN$IN$IN
240227013$24022701$3$F$20240304$20240305$20240627$20240710$PER$$IN-ROCHE-3521067$ROCHE$$86$YR$E$F$Y$$$20240628$$CN$IN$IN
240227022$24022702$2$F$$20240926$20240627$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103209$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240926$$CN$US$US
240227033$24022703$3$F$20240318$20240508$20240627$20240710$PER$$IN-ROCHE-3537958$ROCHE$$84$YR$E$F$Y$$$20240628$$CN$IN$IN
240227054$24022705$4$F$20240301$20240416$20240627$20240710$PER$$IN-ROCHE-3522955$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$IN$IN
240227062$24022706$2$F$$20240527$20240627$20240710$PER$$KR-ROCHE-3535637$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$KR$KR
240227152$24022715$2$F$$20240510$20240627$20240710$PER$$MY-ROCHE-3563634$ROCHE$$54$YR$A$F$Y$$$20240628$$CN$MY$MY
240227253$24022725$3$F$20220509$20231206$20240627$20240710$PER$$PT-ROCHE-3196629$ROCHE$$72$YR$E$M$Y$78.5$KG$20240628$$MD$PT$PT
240227282$24022728$2$F$20220412$20240319$20240627$20240710$PER$$IL-ROCHE-3450984$ROCHE$$86$YR$E$F$Y$62$KG$20240628$$MD$IL$IL
240227292$24022729$2$F$20230124$20230928$20240627$20240710$PER$$IT-ROCHE-3379429$ROCHE$$66$YR$E$F$Y$55$KG$20240628$$MD$IT$IT
240227325$24022732$5$F$20230312$20230825$20240627$20240710$PER$$IT-ROCHE-3413980$ROCHE$$80$YR$E$M$Y$75$KG$20240628$$MD$IT$IT
240227402$24022740$2$F$20230913$20240301$20240627$20240710$PER$$VN-ROCHE-3451715$ROCHE$$45$YR$A$F$Y$58$KG$20240628$$MD$VN$VN
240227435$24022743$5$F$20230913$20240529$20240627$20240710$PER$$PE-ROCHE-3438673$ROCHE$$64$YR$A$F$Y$55.5$KG$20240628$$MD$PE$PE
240227442$24022744$2$F$20240101$20240717$20240627$20240722$PER$$US-ROCHE-3573622$ROCHE$$$$$F$Y$$$20240719$$MD$US$US
240227462$24022746$2$F$$20230808$20240627$20240710$PER$$CN-ROCHE-3212504$ROCHE$$43$YR$A$F$Y$$$20240628$$CN$CN$CN
240227493$24022749$3$F$20240305$20240402$20240627$20240710$PER$$IN-ROCHE-3523919$ROCHE$$40$YR$A$M$Y$$$20240628$$CN$IN$IN
240227503$24022750$3$F$20240226$20240228$20240627$20240710$PER$$IN-ROCHE-3519657$ROCHE$$78$YR$E$M$Y$$$20240628$$CN$IN$IN
240227513$24022751$3$F$20211207$20240530$20240627$20240710$PER$$CN-ROCHE-3065025$ROCHE$$52$YR$A$M$Y$87$KG$20240628$$MD$CN$CN
240227542$24022754$2$F$$20240430$20240627$20240710$PER$$US-ROCHE-3540864$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$US$US
240227553$24022755$3$F$20230701$20230726$20240627$20240710$PER$$FR-ROCHE-3396399$ROCHE$$45$YR$A$F$Y$$$20240628$$CN$FR$FR
240227592$24022759$2$F$20240207$20240530$20240627$20240710$PER$$IN-ROCHE-3544452$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$IN$IN
240227754$24022775$4$F$20221110$20231227$20240627$20240710$PER$$CO-ROCHE-3251094$ROCHE$$69$YR$E$M$Y$56$KG$20240628$$MD$CO$CO
240227774$24022777$4$F$20230816$20240531$20240627$20240710$PER$$CL-ROCHE-3417293$ROCHE$$57$YR$A$F$Y$59.5$KG$20240628$$MD$CL$CL
240227806$24022780$6$F$20230417$20240417$20240627$20240710$PER$$IT-ROCHE-3333379$ROCHE$$59$YR$A$F$Y$62$KG$20240628$$MD$IT$IT
240227833$24022783$3$F$20240202$20240203$20240627$20240710$PER$$IN-ROCHE-3504793$ROCHE$$56$YR$A$M$Y$$$20240628$$CN$IN$IN
240227862$24022786$2$F$$20240523$20240627$20240710$PER$$GB-ROCHE-3546505$ROCHE$$$$E$M$Y$$$20240628$$MD$GB$GB
240227943$24022794$3$F$20220421$20240502$20240627$20240710$PER$$AU-ROCHE-3151509$ROCHE$$44$YR$A$M$Y$71$KG$20240628$$MD$AU$AU
240227954$24022795$4$F$20230920$20240114$20240627$20240710$PER$$IL-ROCHE-3491810$ROCHE$$51$YR$A$M$Y$74$KG$20240628$$MD$IL$IL
240227963$24022796$3$F$20230308$20240507$20240627$20240710$PER$$TR-ROCHE-3337829$ROCHE$$83$YR$E$F$Y$$$20240628$$MD$TR$TR
240228002$24022800$2$F$20240408$20240418$20240627$20240710$PER$$IN-ROCHE-3548019$ROCHE$$55$YR$A$M$Y$$$20240628$$CN$IN$IN
240228033$24022803$3$F$$20240405$20240627$20240710$PER$$US-ROCHE-3541816$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240228042$24022804$2$F$20220501$20240410$20240627$20240710$PER$$US-ROCHE-3544320$ROCHE$$72$YR$E$M$Y$102.51$KG$20240628$$CN$US$US
240228084$24022808$4$F$20220725$20240430$20240627$20240710$PER$$AU-ROCHE-3164816$ROCHE$$42$YR$A$F$Y$61.7$KG$20240628$$MD$AU$AU
240228113$24022811$3$F$20221202$20240213$20240627$20240710$PER$$AT-ROCHE-3333988$ROCHE$$56$YR$A$F$Y$75$KG$20240628$$MD$AT$AT
240228223$24022822$3$F$20240302$20240510$20240627$20240710$PER$$IN-ROCHE-3524649$ROCHE$$78$YR$E$M$Y$$$20240628$$CN$IN$IN
240228244$24022824$4$F$20221102$20240419$20240627$20240710$PER$$TR-ROCHE-3527101$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$TR$TR
240228254$24022825$4$F$20230801$20230816$20240627$20240710$PER$$US-ROCHE-3407938$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
2402282810$24022828$10$F$20230314$20240419$20240627$20240710$PER$$IT-ROCHE-3352833$ROCHE$$63$YR$A$M$Y$56$KG$20240628$$MD$IT$IT
240228292$24022829$2$F$$20240423$20240627$20240710$PER$$GB-ROCHE-3549462$ROCHE$$$$E$M$Y$$$20240628$$MD$GB$GB
240228343$24022834$3$F$20240501$20240705$20240627$20240712$EXP$$AR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036036$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$84$KG$20240712$$CN$AR$AR
240228382$24022838$2$F$$20240527$20240627$20240710$PER$$KR-ROCHE-3535613$ROCHE$$80$YR$E$M$Y$$$20240628$$CN$KR$KR
240228423$24022842$3$F$$20230803$20240627$20240710$PER$$CN-ROCHE-3321598$ROCHE$$74$YR$E$M$Y$$$20240628$$CN$CN$CN
240228432$24022843$2$F$20240118$20240410$20240627$20240710$PER$$IN-ROCHE-3496603$ROCHE$$70$YR$E$F$Y$$$20240628$$CN$IN$IN
240228482$24022848$2$F$20220214$20240117$20240627$20240710$PER$$IT-ROCHE-3035161$ROCHE$$60$YR$A$M$Y$67$KG$20240628$$MD$IT$IT
240228514$24022851$4$F$20240229$20240402$20240627$20240710$PER$$IN-ROCHE-3520516$ROCHE$$74$YR$E$M$Y$$$20240628$$CN$IN$IN
240228532$24022853$2$F$$20240523$20240627$20240710$PER$$GB-ROCHE-3544349$ROCHE$$$$E$F$Y$$$20240628$$MD$GB$GB
240228583$24022858$3$F$20240210$20240405$20240627$20240710$PER$$IN-ROCHE-3543520$ROCHE$$87$YR$E$F$Y$$$20240628$$CN$IN$IN
240228632$24022863$2$F$$20240425$20240627$20240710$PER$$ZA-ROCHE-3549439$ROCHE$$$$$F$Y$$$20240628$$CN$ZA$ZA
240228643$24022864$3$F$20231101$20240130$20240627$20240710$PER$$US-ROCHE-3489531$ROCHE$$74$YR$E$F$Y$80.74$KG$20240628$$CN$US$US
240228655$24022865$5$F$20230801$20240219$20240627$20240710$PER$$CN-ROCHE-3503034$ROCHE$$42$YR$A$M$Y$80$KG$20240628$$MD$CN$CN
240228672$24022867$2$F$20220908$20230911$20240627$20240710$PER$$TR-ROCHE-3421140$ROCHE$$37$YR$A$M$Y$82$KG$20240628$$MD$TR$TR
240228725$24022872$5$F$20220302$20240109$20240627$20240710$PER$$CN-ROCHE-3050557$ROCHE$$42$YR$A$F$Y$74$KG$20240628$$MD$CN$CN
240228733$24022873$3$F$$20240312$20240627$20240710$PER$$CA-ROCHE-3466212$ROCHE$$$$E$M$Y$$$20240628$$MD$CA$CA
240228762$24022876$2$F$20240210$20240413$20240627$20240710$PER$$IN-ROCHE-3548368$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$IN$IN
240228884$24022888$4$F$20230111$20240606$20240627$20240710$PER$$BE-ROCHE-3267222$ROCHE$$79$YR$E$M$Y$55$KG$20240628$$MD$BE$BE
240228902$24022890$2$F$20240306$20240425$20240627$20240710$PER$$IN-ROCHE-3552123$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$IN$IN
240228922$24022892$2$F$20230601$20240322$20240627$20240710$PER$$CN-ROCHE-3489879$ROCHE$$56$YR$A$F$Y$56$KG$20240628$$MD$CN$CN
240228954$24022895$4$F$20221201$20240329$20240627$20240710$PER$$CN-ROCHE-3288094$ROCHE$$60$YR$A$F$Y$75$KG$20240628$$MD$CN$CN
240228963$24022896$3$F$20231010$20240122$20240627$20240710$PER$$PE-ROCHE-3483613$ROCHE$$36$YR$A$F$Y$49.7$KG$20240628$$MD$PE$PE
240228972$24022897$2$F$$20231215$20240627$20240710$PER$$US-ROCHE-3478509$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
2402290412$24022904$12$F$20220513$20240531$20240627$20240710$PER$$CN-ROCHE-3163505$ROCHE$$42$YR$A$F$Y$70$KG$20240628$$MD$CN$CN
240229052$24022905$2$F$20240423$20240502$20240627$20240710$PER$$CA-ROCHE-3553318$ROCHE$$58$YR$A$M$Y$$$20240628$$CN$CA$CA
240229082$24022908$2$F$20230907$20231011$20240627$20240710$PER$$IT-ROCHE-3438385$ROCHE$$62$YR$A$M$Y$90$KG$20240628$$MD$IT$IT
240229092$24022909$2$F$$20240426$20240627$20240710$PER$$CH-ROCHE-3553631$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240229112$24022911$2$F$20230101$20231030$20240627$20240710$PER$$CA-ROCHE-3450008$ROCHE$$83$YR$E$F$Y$$$20240628$$CN$CA$CA
240229178$24022917$8$F$20230427$20240424$20240627$20240710$PER$$CZ-ROCHE-3386858$ROCHE$$40$YR$A$M$Y$77$KG$20240628$$MD$CZ$CZ
240229183$24022918$3$F$$20240320$20240627$20240710$PER$$IN-ROCHE-3532181$ROCHE$$76$YR$E$F$Y$$$20240628$$CN$IN$IN
240229202$24022920$2$F$$20240410$20240627$20240710$PER$$JP-ROCHE-3498235$ROCHE$$$$E$M$Y$$$20240628$$MD$JP$JP
240229272$24022927$2$F$20240401$20240708$20240627$20240714$EXP$$CH-JNJFOC-20240650343$JOHNSON AND JOHNSON$$62$YR$A$F$Y$92$KG$20240715$$MD$CH$CH
240229284$24022928$4$F$20221110$20231026$20240627$20240710$PER$$PE-ROCHE-3350770$ROCHE$$42$YR$A$F$Y$49$KG$20240628$$MD$PE$PE
240229393$24022939$3$F$20240404$20240415$20240627$20240710$PER$$ZA-ROCHE-3549376$ROCHE$$$$E$M$Y$$$20240628$$MD$ZA$ZA
240229446$24022944$6$F$20230402$20240521$20240627$20240710$PER$$CO-ROCHE-3504317$ROCHE$$65$YR$E$M$Y$102.6$KG$20240628$$MD$CO$CO
240229498$24022949$8$F$20230113$20230828$20240627$20240710$PER$$TR-ROCHE-3280448$ROCHE$$$$A$M$Y$$$20240628$$MD$TR$TR
240229563$24022956$3$F$20220212$20231013$20240627$20240710$PER$$AU-ROCHE-3316223$ROCHE$$64$YR$A$F$Y$61.3$KG$20240628$$MD$AU$AU
240229572$24022957$2$F$$20240426$20240627$20240710$PER$$CH-ROCHE-3553622$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
2402296911$24022969$11$F$20220113$20240603$20240627$20240710$PER$$CN-ROCHE-3108220$ROCHE$$71$YR$E$F$Y$56$KG$20240628$$MD$CN$CN
240229703$24022970$3$F$20240322$20240415$20240627$20240710$PER$$US-ROCHE-3546655$ROCHE$$47$YR$A$F$Y$86.64$KG$20240628$$CN$US$US
240229714$24022971$4$F$20220921$20240517$20240627$20240710$PER$$CN-ROCHE-3276207$ROCHE$$60$YR$A$F$Y$75$KG$20240628$$MD$CN$CN
240229732$24022973$2$F$20220109$20230926$20240627$20240710$PER$$IT-ROCHE-3025024$ROCHE$$46$YR$A$M$Y$106$KG$20240628$$MD$IT$IT
240229743$24022974$3$F$20221005$20230911$20240627$20240710$PER$$TR-ROCHE-3421836$ROCHE$$37$YR$A$M$Y$82$KG$20240628$$MD$TR$TR
2402297513$24022975$13$F$20220714$20240223$20240627$20240710$PER$$CN-ROCHE-3317240$ROCHE$$64$YR$A$F$Y$50$KG$20240628$$MD$CN$CN
240229772$24022977$2$F$$20240129$20240627$20240710$PER$$JP-ROCHE-3484166$ROCHE$$4$DEC$A$$Y$$$20240628$$MD$JP$JP
240229802$24022980$2$F$20240304$20240503$20240627$20240710$PER$$IN-ROCHE-3557512$ROCHE$$73$YR$E$M$Y$$$20240628$$CN$IN$IN
240229815$24022981$5$F$20231024$20240604$20240627$20240710$PER$$PT-ROCHE-3461829$ROCHE$$71$YR$E$M$Y$83$KG$20240628$$MD$PT$PT
240229822$24022982$2$F$$20240626$20240627$20240704$EXP$$US-AMGEN-USASP2024122879$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240229839$24022983$9$F$20210603$20240508$20240627$20240710$PER$$TR-ROCHE-3096106$ROCHE$$68$YR$E$M$Y$78$KG$20240628$$MD$TR$TR
240229893$24022989$3$F$$20240409$20240627$20240710$PER$$CL-ROCHE-3545528$ROCHE$$76$YR$E$F$Y$58$KG$20240628$$CN$CL$CL
240229922$24022992$2$F$$20231106$20240627$20240710$PER$$JP-ROCHE-3456660$ROCHE$$4$DEC$A$$Y$$$20240628$$MD$JP$JP
240229935$24022993$5$F$$20240523$20240627$20240710$PER$$CA-ROCHE-3466220$ROCHE$$77$YR$E$M$Y$$$20240628$$MD$CA$CA
240229962$24022996$2$F$$20240530$20240627$20240710$PER$$US-ROCHE-3558297$ROCHE$$43$YR$A$M$Y$$$20240628$$HP$US$US
240229992$24022999$2$F$20240329$20240430$20240627$20240710$PER$$IN-ROCHE-3556322$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$IN$IN
2402300211$24023002$11$F$20220223$20240311$20240627$20240710$PER$$CN-ROCHE-3051003$ROCHE$$57$YR$A$F$Y$60.5$KG$20240628$$MD$CN$CN
240230083$24023008$3$F$20211213$20230823$20240627$20240710$PER$$IT-ROCHE-3273020$ROCHE$$64$YR$A$F$Y$57$KG$20240628$$MD$IT$IT
240230174$24023017$4$F$20240418$20240430$20240627$20240710$PER$$IN-ROCHE-3556845$ROCHE$$79$YR$E$F$Y$$$20240628$$CN$IN$IN
240230182$24023018$2$F$$20231020$20240627$20240710$PER$$US-ROCHE-3444306$ROCHE$$62$YR$A$F$Y$$$20240628$$CN$US$US
240230192$24023019$2$F$$20240603$20240627$20240710$PER$$KR-ROCHE-3551394$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$KR$KR
240230223$24023022$3$F$$20230728$20240627$20240710$PER$$US-ROCHE-3396525$ROCHE$$76$YR$E$F$Y$$$20240628$$CN$US$US
240230253$24023025$3$F$20240402$20240418$20240627$20240710$PER$$IN-ROCHE-3548363$ROCHE$$57$YR$A$F$Y$$$20240628$$CN$IN$IN
240230272$24023027$2$F$20240224$20240430$20240627$20240710$PER$$IN-ROCHE-3555323$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$IN$IN
240230312$24023031$2$F$$20240508$20240627$20240710$PER$$DE-ROCHE-3560384$ROCHE$$$$$$Y$$$20240628$$MD$DE$DE
240230327$24023032$7$F$20230203$20240608$20240627$20240710$PER$$PT-ROCHE-3279631$ROCHE$$68$YR$E$F$Y$55.2$KG$20240628$$MD$PT$PT
240230365$24023036$5$F$20240530$20240725$20240627$20240807$30DAY$$BR-JNJFOC-20240607895$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240808$$CN$BR$BR
240230378$24023037$8$F$20220211$20240516$20240627$20240710$PER$$CN-ROCHE-3075043$ROCHE$$66$YR$E$F$Y$63$KG$20240628$$MD$CN$CN
240230416$24023041$6$F$20230825$20240219$20240627$20240710$PER$$CO-ROCHE-3456096$ROCHE$$84$YR$E$M$Y$62$KG$20240628$$MD$CO$CO
240230425$24023042$5$F$$20240510$20240627$20240710$PER$$ES-ROCHE-3544642$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$ES$ES
240230463$24023046$3$F$$20240514$20240627$20240710$PER$$IN-ROCHE-3561251$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$IN$IN
240230492$24023049$2$F$20240429$20240529$20240627$20240710$PER$$AU-ROCHE-3561788$ROCHE$$87$YR$E$F$Y$$$20240628$$MD$AU$AU
240230534$24023053$4$F$20221121$20231211$20240627$20240710$PER$$CN-ROCHE-3277963$ROCHE$$71$YR$E$F$Y$51$KG$20240628$$MD$CN$CN
240230582$24023058$2$F$$20240514$20240627$20240710$PER$$US-ROCHE-3561223$ROCHE$$$$$M$Y$$$20240628$$MD$US$US
240230623$24023062$3$F$20240329$20240419$20240627$20240710$PER$$IN-ROCHE-3552034$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$IN$IN
240230632$24023063$2$F$$20240510$20240627$20240710$PER$$US-ROCHE-3562477$ROCHE$$84$YR$E$F$Y$$$20240628$$CN$US$US
240230693$24023069$3$F$20230313$20240103$20240627$20240710$PER$$IL-ROCHE-3376300$ROCHE$$70$YR$E$F$Y$65$KG$20240628$$MD$IL$IL
240230702$24023070$2$F$$20240430$20240627$20240710$PER$$US-ROCHE-3485212$ROCHE$$66$YR$E$M$Y$$$20240628$$CN$US$US
240230742$24023074$2$F$20210701$20240416$20240627$20240710$PER$$TR-ROCHE-2997271$ROCHE$$53$YR$A$F$Y$75$KG$20240628$$MD$TR$TR
240230763$24023076$3$F$20230918$20231212$20240627$20240710$PER$$IL-ROCHE-3471394$ROCHE$$69$YR$E$M$Y$$$20240628$$MD$IL$IL
240230793$24023079$3$F$20211201$20240119$20240627$20240710$PER$$PE-ROCHE-3265286$ROCHE$$67$YR$E$M$Y$69.5$KG$20240628$$MD$PE$PE
240230812$24023081$2$F$20230901$20231222$20240627$20240710$PER$$CN-ROCHE-3473067$ROCHE$$60$YR$A$M$Y$54$KG$20240628$$MD$CN$CN
240230823$24023082$3$F$20240512$20240916$20240627$20240925$EXP$$AU-ROCHE-3563173$ROCHE$$62$YR$A$F$Y$$$20240925$$MD$AU$AU
240230832$24023083$2$F$$20231218$20240627$20240710$PER$$FR-ROCHE-3479111$ROCHE$Siblini L, Schott R, Trensz P, Pencreach E and Bender L Primary resistance to ALK inhibitors in KLC1/ALK-rearranged pleural metastatic lung adenocarcinoma: a case report. DOI: 10.21037/tlcr-23-482. Translational Lung Cancer Research 2023 Nov 30;12 (11):2342-6.$$$$$Y$$$20240628$$HP$FR$FR
240230853$24023085$3$F$20230209$20240110$20240627$20240710$PER$$IT-ROCHE-3459820$ROCHE$$51$YR$A$F$Y$71$KG$20240628$$MD$IT$IT
240230916$24023091$6$F$20230801$20240411$20240627$20240710$PER$$BE-ROCHE-3424236$ROCHE$$74$YR$E$M$Y$83$KG$20240628$$MD$BE$BE
240230932$24023093$2$F$$20240509$20240627$20240710$PER$$TW-ROCHE-3561389$ROCHE$$74$YR$E$M$Y$$$20240628$$CN$TW$TW
240230952$24023095$2$F$20240427$20240531$20240627$20240710$PER$$IN-ROCHE-3558127$ROCHE$$83$YR$E$M$Y$$$20240628$$CN$IN$IN
240230982$24023098$2$F$20231214$20240122$20240627$20240710$PER$IT-MINISAL02-965404$IT-ROCHE-3494194$ROCHE$$50$YR$A$F$Y$$$20240628$$MD$IT$IT
240231012$24023101$2$F$$20230801$20240627$20240710$PER$$JP-ROCHE-3399689$ROCHE$$$$E$M$Y$$$20240628$$PH$JP$JP
2402310411$24023104$11$F$20211217$20240111$20240627$20240710$PER$$CN-ROCHE-3056597$ROCHE$$70$YR$E$F$Y$51$KG$20240628$$MD$CN$CN
240231052$24023105$2$F$$20230818$20240627$20240710$PER$$US-ROCHE-3409254$ROCHE$$31$YR$A$M$Y$$$20240628$$MD$US$US
240231103$24023110$3$F$20220509$20240312$20240627$20240710$PER$$CN-ROCHE-3346155$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$CN$CN
240231132$24023113$2$F$20240313$20240427$20240627$20240710$PER$$IN-ROCHE-3555144$ROCHE$$37$YR$A$F$Y$$$20240628$$CN$IN$IN
240231153$24023115$3$F$20240205$20240219$20240627$20240710$PER$$CO-ROCHE-3512925$ROCHE$$84$YR$E$M$Y$48$KG$20240628$$MD$CO$CO
240231163$24023116$3$F$20240207$20240509$20240627$20240710$PER$$IN-ROCHE-3509517$ROCHE$$$$E$M$Y$$$20240628$$CN$IN$IN
240231192$24023119$2$F$$20240521$20240627$20240710$PER$$US-ROCHE-3562643$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$US$US
240231242$24023124$2$F$$20240510$20240627$20240710$PER$$US-ROCHE-3561749$ROCHE$$67$YR$E$M$Y$$$20240628$$MD$US$US
240231263$24023126$3$F$$20240517$20240627$20240710$PER$$ZA-ROCHE-3561680$ROCHE$$$$E$F$Y$$$20240628$$MD$ZA$ZA
240231283$24023128$3$F$$20240426$20240627$20240710$PER$$CH-ROCHE-3556541$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240231293$24023129$3$F$20220514$20240108$20240627$20240710$PER$$AU-ROCHE-3488344$ROCHE$$38$YR$A$M$Y$67$KG$20240628$$MD$AU$AU
240231334$24023133$4$F$20220317$20240301$20240627$20240710$PER$$CN-ROCHE-3126955$ROCHE$$64$YR$A$F$Y$50$KG$20240628$$MD$CN$CN
240231342$24023134$2$F$20231210$20240514$20240627$20240710$PER$$US-ROCHE-3563214$ROCHE$$68$YR$E$M$Y$86.18$KG$20240628$$CN$US$US
240231394$24023139$4$F$20230708$20240522$20240627$20240710$PER$$RS-ROCHE-3464102$ROCHE$$62$YR$A$F$Y$68$KG$20240628$$MD$RS$RS
240231484$24023148$4$F$20230805$20230828$20240627$20240710$PER$$IT-ROCHE-3413720$ROCHE$$76$YR$E$F$Y$64$KG$20240628$$MD$IT$IT
240231524$24023152$4$F$20230906$20240116$20240627$20240710$PER$$IT-ROCHE-3430625$ROCHE$$75$YR$E$F$Y$65$KG$20240628$$MD$IT$IT
240231533$24023153$3$F$20230315$20230916$20240627$20240710$PER$$BE-ROCHE-3343075$ROCHE$$74$YR$E$M$Y$83$KG$20240628$$MD$BE$BE
240231575$24023157$5$F$20230117$20240504$20240627$20240710$PER$$VN-ROCHE-3340391$ROCHE$$76$YR$E$M$Y$42$KG$20240628$$MD$VN$VN
240231592$24023159$2$F$$20240402$20240627$20240710$PER$$KR-ROCHE-3538283$ROCHE$$48$YR$A$M$Y$$$20240628$$CN$KR$KR
240231623$24023162$3$F$20220815$20240125$20240627$20240710$PER$$TR-ROCHE-3182034$ROCHE$$66$YR$E$F$Y$54$KG$20240628$$MD$TR$TR
240231632$24023163$2$F$20220310$20231124$20240627$20240710$PER$$TR-ROCHE-3054382$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$TR$TR
240231772$24023177$2$F$$20240515$20240627$20240710$PER$$FI-ROCHE-3565542$ROCHE$$41$YR$A$M$Y$$$20240628$$MD$FI$FI
240231782$24023178$2$F$$20240515$20240627$20240710$PER$$FI-ROCHE-3565526$ROCHE$$74$YR$E$M$Y$$$20240628$$MD$FI$FI
240231792$24023179$2$F$20240216$20240228$20240627$20240710$PER$$TR-ROCHE-3518085$ROCHE$$84$YR$E$F$Y$$$20240628$$MD$TR$TR
240231843$24023184$3$F$$20240522$20240627$20240710$PER$$GB-ROCHE-3565479$ROCHE$$$$$$Y$$$20240628$$MD$GB$GB
240231858$24023185$8$F$20210808$20240605$20240627$20240710$PER$$TR-ROCHE-3094534$ROCHE$$36$YR$A$M$Y$68$KG$20240628$$MD$TR$TR
240231894$24023189$4$F$20230130$20240110$20240627$20240710$PER$$CN-ROCHE-3489781$ROCHE$$58$YR$A$F$Y$62$KG$20240628$$MD$CN$CN
2402319010$24023190$10$F$20221103$20240522$20240627$20240710$PER$$TR-ROCHE-3353081$ROCHE$$37$YR$A$M$Y$70$KG$20240628$$MD$TR$TR
240231955$24023195$5$F$$20240617$20240627$20240709$EXP$$ES-ROCHE-3566151$ROCHE$$68$YR$E$M$Y$$$20240705$$MD$ES$ES
240232012$24023201$2$F$$20240505$20240627$20240710$PER$$FR-ROCHE-3560481$ROCHE$$$$$$Y$$$20240628$$MD$FR$FR
240232062$24023206$2$F$$20240506$20240627$20240710$PER$$IN-ROCHE-3558683$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$IN$IN
240232103$24023210$3$F$20240406$20240618$20240627$20240712$EXP$$FR-ROCHE-3560494$ROCHE$$80$YR$E$F$Y$$$20240712$$MD$FR$FR
240232123$24023212$3$F$$20240502$20240627$20240710$PER$$CA-ROCHE-3558233$ROCHE$$83$YR$E$M$Y$$$20240628$$HP$CA$CA
240232199$24023219$9$F$20220223$20240604$20240627$20240710$PER$$TR-ROCHE-3094539$ROCHE$$37$YR$A$M$Y$65$KG$20240628$$MD$TR$TR
240232233$24023223$3$F$20230427$20240223$20240627$20240710$PER$$RS-ROCHE-3486602$ROCHE$$61$YR$A$F$Y$73$KG$20240628$$MD$RS$RS
240232363$24023236$3$F$20230908$20230927$20240627$20240710$PER$$IT-ROCHE-3430513$ROCHE$$67$YR$E$F$Y$58$KG$20240628$$MD$IT$IT
240232462$24023246$2$F$20230321$20230824$20240627$20240710$PER$$CN-ROCHE-3411205$ROCHE$$40$YR$A$F$Y$62.5$KG$20240628$$MD$CN$CN
240232478$24023247$8$F$20220126$20240321$20240627$20240710$PER$$CN-ROCHE-3157522$ROCHE$$55$YR$A$F$Y$56$KG$20240628$$MD$CN$CN
2402325711$24023257$11$F$20230218$20230902$20240627$20240710$PER$$CN-ROCHE-3394454$ROCHE$$59$YR$A$M$Y$70$KG$20240628$$MD$CN$CN
240232587$24023258$7$F$20211108$20230717$20240627$20240710$PER$$CN-ROCHE-2989736$ROCHE$$53$YR$A$F$Y$64$KG$20240628$$MD$CN$CN
240232612$24023261$2$F$20230310$20240508$20240627$20240710$PER$$RS-ROCHE-3546379$ROCHE$$52$YR$A$M$Y$78$KG$20240628$$MD$RS$RS
240232673$24023267$3$F$20230807$20240429$20240627$20240710$PER$$DK-ROCHE-3472303$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$DK$DK
240232742$24023274$2$F$$20231102$20240627$20240710$PER$$CZ-ROCHE-3453050$ROCHE$$43$YR$A$M$Y$$$20240628$$MD$CZ$CZ
240232763$24023276$3$F$20220719$20231206$20240627$20240710$PER$$TR-ROCHE-3337479$ROCHE$$58$YR$A$M$Y$$$20240628$$MD$TR$TR
240232843$24023284$3$F$20240318$20240329$20240627$20240710$PER$$TR-ROCHE-3532252$ROCHE$$41$YR$A$M$Y$$$20240628$$MD$TR$TR
240232855$24023285$5$F$20230220$20240508$20240627$20240710$PER$$IT-ROCHE-3389961$ROCHE$$75$YR$E$M$Y$81$KG$20240628$$MD$IT$IT
240232902$24023290$2$F$$20240207$20240627$20240710$PER$$US-ROCHE-3427498$ROCHE$$43$YR$A$$Y$$$20240628$$MD$US$US
240232944$24023294$4$F$20230525$20240312$20240627$20240710$PER$$IT-ROCHE-3409016$ROCHE$$63$YR$A$M$Y$55$KG$20240628$$MD$IT$IT
240232995$24023299$5$F$20220609$20231026$20240627$20240710$PER$$CO-ROCHE-3158915$ROCHE$$$$E$M$Y$54$KG$20240628$$MD$CO$CO
240233042$24023304$2$F$20240412$20240510$20240627$20240710$PER$$IN-ROCHE-3562305$ROCHE$$66$YR$E$M$Y$$$20240628$$CN$IN$IN
240233063$24023306$3$F$20240129$20240313$20240627$20240710$PER$$IN-ROCHE-3525446$ROCHE$$86$YR$E$F$Y$$$20240628$$CN$IN$IN
240233097$24023309$7$F$20230616$20240516$20240627$20240710$PER$$PT-ROCHE-3374351$ROCHE$$77$YR$E$F$Y$65.1$KG$20240628$$MD$PT$PT
240233174$24023317$4$F$20230401$20230929$20240627$20240710$PER$$BE-ROCHE-3351517$ROCHE$$45$YR$A$M$Y$88$KG$20240628$$MD$BE$BE
240233184$24023318$4$F$$20231101$20240627$20240710$PER$$AU-ROCHE-3162641$ROCHE$$33$YR$A$F$Y$$$20240628$$MD$AU$AU
240233194$24023319$4$F$20230301$20240119$20240627$20240710$PER$$PE-ROCHE-3351737$ROCHE$$69$YR$E$M$Y$69.5$KG$20240628$$MD$PE$PE
240233322$24023332$2$F$20211119$20231128$20240627$20240710$PER$$IT-ROCHE-3460664$ROCHE$$68$YR$E$M$Y$74$KG$20240628$$MD$IT$IT
240233334$24023333$4$F$20221010$20240606$20240627$20240710$PER$$BE-ROCHE-3204804$ROCHE$$78$YR$E$M$Y$55$KG$20240628$$MD$BE$BE
240233372$24023337$2$F$$20240717$20240627$20240722$PER$$US-BAUSCHBL-2024BNL027721$BAUSCH AND LOMB$$$$$F$Y$$$20240722$$CN$US$US
240233393$24023339$3$F$20230901$20231203$20240627$20240710$PER$$CN-ROCHE-3469059$ROCHE$$60$YR$A$M$Y$75$KG$20240628$$MD$CN$CN
240233413$24023341$3$F$$20240511$20240627$20240710$PER$$ES-ROCHE-3566397$ROCHE$$$$$M$Y$$$20240628$$MD$ES$ES
240233423$24023342$3$F$20231024$20240510$20240627$20240710$PER$$US-ROCHE-3564105$ROCHE$$57$YR$A$F$Y$66.7$KG$20240628$$MD$US$US
240233464$24023346$4$F$20230619$20240306$20240627$20240710$PER$$PT-ROCHE-3486615$ROCHE$$75$YR$E$M$Y$$$20240628$$MD$PT$PT
240233482$24023348$2$F$$20240116$20240627$20240710$PER$$CN-ROCHE-3493277$ROCHE$$$$$F$Y$$$20240628$$MD$CN$CN
240233492$24023349$2$F$20190422$20240109$20240627$20240710$PER$$CA-ROCHE-2310318$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$CA$CA
240233562$24023356$2$F$$20240529$20240627$20240710$PER$$ES-ROCHE-3566267$ROCHE$$70$YR$E$M$Y$$$20240628$$MD$ES$ES
240233614$24023361$4$F$20230101$20231013$20240627$20240710$PER$$AU-ROCHE-3312544$ROCHE$$45$YR$A$M$Y$71$KG$20240628$$MD$AU$AU
240233633$24023363$3$F$20230523$20240325$20240627$20240710$PER$$IL-ROCHE-3450988$ROCHE$$51$YR$A$F$Y$102$KG$20240628$$MD$IL$IL
240233702$24023370$2$F$$20231211$20240627$20240710$PER$$US-ROCHE-3473643$ROCHE$$81$YR$E$F$Y$$$20240628$$CN$US$US
240233723$24023372$3$F$$20240506$20240627$20240710$PER$$US-ROCHE-3487915$ROCHE$$34$YR$A$M$Y$$$20240628$$CN$US$US
240233732$24023373$2$F$$20240326$20240627$20240710$PER$$US-ROCHE-3462862$ROCHE$$40$YR$A$F$Y$$$20240628$$CN$US$US
240233757$24023375$7$F$20230913$20240520$20240627$20240710$PER$$AU-ROCHE-3446851$ROCHE$$78$YR$E$F$Y$$$20240628$$MD$AU$AU
240233832$24023383$2$F$$20240222$20240627$20240710$PER$$JP-ROCHE-3493970$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240233852$24023385$2$F$$20240529$20240627$20240710$PER$$ES-ROCHE-3568709$ROCHE$$$$$$Y$$$20240628$$MD$ES$ES
240233892$24023389$2$F$$20240521$20240627$20240710$PER$$ES-ROCHE-3568687$ROCHE$$$$$$Y$$$20240628$$MD$ES$ES
240233932$24023393$2$F$20240101$20240723$20240627$20240726$EXP$$GB-ABBVIE-5805191$ABBVIE$$$$$M$Y$$$20240726$$HP$GB$GB
240233952$24023395$2$F$$20240412$20240627$20240710$PER$$GB-ROCHE-3546620$ROCHE$$$$$M$Y$$$20240628$$MD$GB$GB
240233962$24023396$2$F$$20240406$20240627$20240710$PER$$GB-ROCHE-3542299$ROCHE$$81$YR$E$M$Y$$$20240628$$MD$GB$GB
240233992$24023399$2$F$$20240529$20240627$20240710$PER$$ES-ROCHE-3568958$ROCHE$$$$$$Y$$$20240628$$MD$ES$ES
240234032$24023403$2$F$20240501$20240814$20240627$20240913$PER$$US-Merz Pharmaceuticals GmbH-24-01895$MERZ$$54$YR$$F$Y$$$20240913$$HP$US$US
240234084$24023408$4$F$20211115$20230929$20240627$20240710$PER$$BE-ROCHE-3053044$ROCHE$$69$YR$E$M$Y$82.1$KG$20240628$$MD$BE$BE
240234185$24023418$5$F$20220718$20240510$20240627$20240710$PER$$TR-ROCHE-3161940$ROCHE$$59$YR$A$F$Y$100$KG$20240628$$MD$TR$TR
240234222$24023422$2$F$$20240416$20240627$20240710$PER$$FR-ROCHE-3548810$ROCHE$$81$YR$E$M$Y$$$20240628$$MD$FR$FR
240234232$24023423$2$F$$20230922$20240627$20240710$PER$$IN-ROCHE-3428443$ROCHE$$37$YR$A$F$Y$$$20240628$$MD$IN$IN
240234242$24023424$2$F$$20240411$20240627$20240710$PER$$GB-ROCHE-3546148$ROCHE$$$$E$M$Y$$$20240628$$MD$GB$GB
240234263$24023426$3$F$$20230801$20240627$20240710$PER$$IN-ROCHE-3399302$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$IN$IN
240234273$24023427$3$F$$20240203$20240627$20240710$PER$$IN-ROCHE-3505524$ROCHE$$35$YR$A$F$Y$$$20240628$$MD$IN$IN
240234313$24023431$3$F$20231205$20240304$20240627$20240710$PER$$IT-ROCHE-3522723$ROCHE$$70$YR$E$$Y$$$20240628$$HP$IT$IT
240234503$24023450$3$F$20240514$20240528$20240627$20240710$PER$$DE-ROCHE-3569850$ROCHE$$79$YR$E$F$Y$$$20240628$$MD$DE$DE
240234563$24023456$3$F$$20230922$20240627$20240710$PER$$CN-ROCHE-3427313$ROCHE$$45$YR$A$F$Y$$$20240628$$CN$CN$CN
240234582$24023458$2$F$$20240416$20240627$20240710$PER$$US-ROCHE-3548751$ROCHE$$$$E$F$Y$$$20240628$$MD$US$US
240234606$24023460$6$F$20220923$20231201$20240627$20240710$PER$$BE-ROCHE-3196777$ROCHE$$83$YR$E$F$Y$65.5$KG$20240628$$MD$BE$BE
240234615$24023461$5$F$$20230823$20240627$20240710$PER$$IN-ROCHE-3411246$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$IN$IN
240234685$24023468$5$F$20230117$20230803$20240627$20240710$PER$$IT-ROCHE-3304126$ROCHE$$62$YR$A$M$Y$54$KG$20240628$$MD$IT$IT
240234733$24023473$3$F$$20240412$20240627$20240710$PER$$ES-ROCHE-3545508$ROCHE$$$$$F$Y$$$20240628$$PH$ES$ES
240234782$24023478$2$F$20220101$20240725$20240627$20240731$EXP$$CO-JNJFOC-20240237297$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$60$KG$20240731$$HP$CO$CO
240234822$24023482$2$F$$20231106$20240627$20240710$PER$$CA-ROCHE-3215482$ROCHE$$$$E$F$Y$$$20240628$$CN$CA$CA
240234842$24023484$2$F$20230501$20230720$20240627$20240710$PER$$PE-ROCHE-3388475$ROCHE$$46$YR$A$F$Y$54.5$KG$20240628$$MD$PE$PE
240234865$24023486$5$F$20230617$20230829$20240627$20240710$PER$$CN-ROCHE-3413729$ROCHE$$60$YR$A$M$Y$68$KG$20240628$$MD$CN$CN
240234882$24023488$2$F$$20231106$20240627$20240710$PER$$IN-ROCHE-3435643$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$IN$IN
240234894$24023489$4$F$$20231009$20240627$20240710$PER$$ES-ROCHE-3436209$ROCHE$$$$$F$Y$$$20240628$$HP$ES$ES
240234906$24023490$6$F$$20231115$20240627$20240710$PER$$IN-ROCHE-3396881$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
240234952$24023495$2$F$$20230811$20240627$20240710$PER$$CN-ROCHE-3403893$ROCHE$$53$YR$A$M$Y$$$20240628$$CN$CN$CN
240234964$24023496$4$F$$20240416$20240627$20240710$PER$$IN-ROCHE-3549418$ROCHE$$48$YR$A$F$Y$$$20240628$$CN$IN$IN
240235007$24023500$7$F$$20230921$20240627$20240710$PER$$IN-ROCHE-3357233$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240235066$24023506$6$F$$20240131$20240627$20240710$PER$$IN-ROCHE-3415409$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$IN$IN
240235167$24023516$7$F$$20231016$20240627$20240710$PER$$IN-ROCHE-3365835$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$IN$IN
240235173$24023517$3$F$$20230717$20240627$20240710$PER$$US-ROCHE-3390375$ROCHE$$80$YR$E$F$Y$$$20240628$$HP$US$US
240235202$24023520$2$F$$20240510$20240627$20240710$PER$$US-ROCHE-3562889$ROCHE$$78$YR$E$M$Y$$$20240628$$MD$US$US
240235232$24023523$2$F$$20240626$20240627$20240702$EXP$$US-ABBVIE-5817501$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240235242$24023524$2$F$$20240731$20240627$20240803$PER$$US-AMGEN-USASP2024126313$AMGEN$$$$$$Y$$$20240803$$HP$US$US
240235273$24023527$3$F$$20240628$20240627$20240706$PER$$US-ROCHE-3570773$ROCHE$$80$YR$E$F$Y$$$20240706$$MD$US$US
240235332$24023533$2$F$20230901$20231016$20240627$20240710$PER$$CN-ROCHE-3441090$ROCHE$$43$YR$A$F$Y$57.5$KG$20240628$$CN$CN$CN
240235424$24023542$4$F$$20240509$20240627$20240710$PER$$IN-ROCHE-3330023$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
240235479$24023547$9$F$$20231007$20240627$20240710$PER$$IN-ROCHE-3336341$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240235493$24023549$3$F$$20231018$20240627$20240710$PER$$IN-ROCHE-3418579$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$IN$IN
240235512$24023551$2$F$$20230826$20240627$20240710$PER$$TH-ROCHE-3262960$ROCHE$$64$YR$A$F$Y$$$20240628$$CN$TH$TH
240235594$24023559$4$F$20230817$20240302$20240627$20240710$PER$$CN-ROCHE-3485021$ROCHE$$72$YR$E$F$Y$52.5$KG$20240628$$MD$CN$CN
240235632$24023563$2$F$20240314$20240425$20240627$20240710$PER$$IN-ROCHE-3554355$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$IN$IN
240235662$24023566$2$F$$20240520$20240627$20240710$PER$$US-ROCHE-3567370$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$US$US
240235674$24023567$4$F$$20231005$20240627$20240710$PER$$TH-ROCHE-3347744$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$TH$TH
240235702$24023570$2$F$$20240502$20240627$20240710$PER$$US-ROCHE-3557839$ROCHE$$85$YR$E$F$Y$$$20240628$$CN$US$US
2402357310$24023573$10$F$20220119$20240223$20240627$20240710$PER$$CN-ROCHE-3041631$ROCHE$$57$YR$A$F$Y$60.5$KG$20240628$$MD$CN$CN
240235752$24023575$2$F$20240619$20240628$20240627$20240701$EXP$$US-ABBVIE-5817729$ABBVIE$$69$YR$$M$Y$$$20240701$$CN$US$US
240235792$24023579$2$F$20240212$20240212$20240627$20240710$PER$$MX-ROCHE-3510981$ROCHE$$55$YR$A$F$Y$57$KG$20240628$$CN$MX$MX
240235872$24023587$2$F$20220217$20231120$20240627$20240710$PER$$AT-ROCHE-3077816$ROCHE$$59$YR$A$F$Y$56$KG$20240628$$MD$AT$AT
240235894$24023589$4$F$20220422$20240321$20240627$20240710$PER$$CN-ROCHE-3133938$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$CN$CN
240235992$24023599$2$F$$20230720$20240627$20240710$PER$$CN-ROCHE-3257015$ROCHE$$37$YR$A$F$Y$$$20240628$$CN$CN$CN
240236012$24023601$2$F$20240306$20240605$20240627$20240710$PER$$GB-ROCHE-3569909$ROCHE$$34$YR$A$F$Y$82.5$KG$20240628$$MD$GB$GB
240236032$24023603$2$F$$20240710$20240627$20240710$PER$$US-JNJFOC-20240670287$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$HP$US$US
240236043$24023604$3$F$$20240112$20240627$20240710$PER$$TH-ROCHE-3378675$ROCHE$$$$$F$Y$$$20240628$$CN$TH$TH
240236112$24023611$2$F$20230607$20231213$20240627$20240710$PER$$BE-ROCHE-3401597$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$BE$BE
240236132$24023613$2$F$$20231019$20240627$20240710$PER$$IN-ROCHE-3410470$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$IN$IN
240236143$24023614$3$F$20240621$20240916$20240627$20240925$PER$$US-SA-2024SA189159$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240925$$HP$US$US
240236155$24023615$5$F$20240101$20240912$20240627$20240917$EXP$$CH-ABBVIE-5811361$ABBVIE$$$$$M$Y$77$KG$20240917$$CN$CH$CH
240236173$24023617$3$F$20211022$20230712$20240627$20240710$PER$$AU-ROCHE-3131227$ROCHE$$56$YR$A$F$Y$$$20240628$$MD$AU$AU
240236212$24023621$2$F$$20230717$20240627$20240710$PER$$US-ROCHE-3389349$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240236258$24023625$8$F$$20240219$20240627$20240710$PER$$IN-ROCHE-3114357$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$IN$IN
240236272$24023627$2$F$$20230708$20240627$20240710$PER$$CN-ROCHE-3385892$ROCHE$$58$YR$A$M$Y$65$KG$20240628$$CN$CN$CN
240236303$24023630$3$F$$20240611$20240627$20240710$PER$$ES-ROCHE-3571380$ROCHE$$$$$F$Y$$$20240628$$MD$ES$ES
240236347$24023634$7$F$$20240126$20240627$20240710$PER$$IN-ROCHE-3408727$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$IN$IN
240236412$24023641$2$F$20240413$20240418$20240627$20240710$PER$$IN-ROCHE-3550981$ROCHE$$55$YR$A$M$Y$$$20240628$$CN$IN$IN
240236443$24023644$3$F$20240101$20240916$20240627$20240924$EXP$$AU-ABBVIE-5817553$ABBVIE$$$$$F$Y$$$20240924$$CN$AU$AU
240236493$24023649$3$F$$20231019$20240627$20240710$PER$$IN-ROCHE-3417615$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$IN$IN
240236604$24023660$4$F$20230802$20230825$20240627$20240710$PER$$CN-ROCHE-3412255$ROCHE$$72$YR$E$F$Y$61.5$KG$20240628$$CN$CN$CN
240236612$24023661$2$F$20230524$20231030$20240627$20240710$PER$$IN-ROCHE-3353264$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$IN$IN
240236622$24023662$2$F$20220713$20240309$20240627$20240710$PER$$CN-ROCHE-3189103$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$CN$CN
240236642$24023664$2$F$$20231009$20240627$20240710$PER$$IN-ROCHE-3438377$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$IN$IN
240236682$24023668$2$F$20211103$20231124$20240627$20240710$PER$$CO-ROCHE-3218313$ROCHE$$56$YR$A$M$Y$77$KG$20240628$$MD$CO$CO
240236732$24023673$2$F$20230909$20240223$20240627$20240710$PER$$IT-ROCHE-3447744$ROCHE$$52$YR$A$M$Y$80$KG$20240628$$MD$IT$IT
240236772$24023677$2$F$20230320$20240712$20240627$20240723$EXP$$JP-NOVOPROD-1245083$NOVO NORDISK$Y.Higuchi, et.al... A patient with type I diabetes complicated by panhypopituitarism requiring intra-week insulin dose changes following the switch from once-daily to once-weekly GH treatment. 97th Scientific Meeting of the Japanese Society of Endocrinology. 2024;100(1):2-7-8$51$YR$$M$Y$62$KG$20240723$$MD$JP$JP
240236793$24023679$3$F$20240615$20240729$20240627$20240809$EXP$$JP-NOVOPROD-1243772$NOVO NORDISK$$52$YR$$M$Y$83.4$KG$20240809$$MD$JP$JP
240236933$24023693$3$F$$20230927$20240627$20240710$PER$$MX-ROCHE-3432521$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$MX$MX
240236976$24023697$6$F$20230313$20240514$20240627$20240710$PER$$CN-ROCHE-3416093$ROCHE$$64$YR$A$F$Y$$$20240628$$MD$CN$CN
240237005$24023700$5$F$20220408$20240108$20240627$20240710$PER$$AU-ROCHE-3164445$ROCHE$$41$YR$A$F$Y$63.6$KG$20240628$$MD$AU$AU
240237023$24023702$3$F$20220601$20231023$20240627$20240710$PER$$CN-ROCHE-3306033$ROCHE$$60$YR$A$M$Y$71$KG$20240628$$CN$CN$CN
240237082$24023708$2$F$$20240522$20240627$20240710$PER$$US-ROCHE-3569183$ROCHE$$55$YR$A$M$Y$$$20240628$$HP$US$US
2402371010$24023710$10$F$$20240527$20240627$20240710$PER$$IN-ROCHE-3395633$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$IN$IN
240237182$24023718$2$F$20190601$20240628$20240627$20240709$EXP$$CN-NOVOPROD-1225933$NOVO NORDISK$$47$YR$$F$Y$110$KG$20240709$$CN$CN$CN
240237232$24023723$2$F$20220726$20231026$20240627$20240710$PER$$IT-ROCHE-3348743$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$IT$IT
240237275$24023727$5$F$20220818$20240417$20240627$20240710$PER$$FI-ROCHE-3346588$ROCHE$$74$YR$E$F$Y$$$20240628$$MD$FI$FI
240237292$24023729$2$F$20211123$20231130$20240627$20240710$PER$$AT-ROCHE-2973586$ROCHE$$69$YR$E$M$Y$52.5$KG$20240628$$MD$AT$AT
240237304$24023730$4$F$20220311$20240511$20240627$20240710$PER$$CN-ROCHE-3226270$ROCHE$$64$YR$A$F$Y$57$KG$20240628$$MD$CN$CN
240237352$24023735$2$F$20240117$20240311$20240627$20240710$PER$$JP-ROCHE-3513291$ROCHE$$6$DEC$A$F$Y$$$20240628$$HP$JP$JP
240237362$24023736$2$F$$20240305$20240627$20240710$PER$$PH-ROCHE-3473417$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$PH$PH
240237404$24023740$4$F$$20240424$20240627$20240710$PER$$IN-ROCHE-3392514$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240237462$24023746$2$F$$20231208$20240627$20240710$PER$$CH-ROCHE-3467820$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240237482$24023748$2$F$20211206$20231202$20240627$20240710$PER$$LT-ROCHE-2979247$ROCHE$$69$YR$E$F$Y$80$KG$20240628$$MD$LT$LT
240237503$24023750$3$F$$20231025$20240627$20240710$PER$$IN-ROCHE-3422849$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$IN$IN
240237542$24023754$2$F$$20231212$20240627$20240710$PER$$IN-ROCHE-3448020$ROCHE$$34$YR$A$F$Y$$$20240628$$MD$IN$IN
240237552$24023755$2$F$$20230719$20240627$20240710$PER$$RO-ROCHE-3393397$ROCHE$$58$YR$A$F$Y$80$KG$20240628$$CN$RO$RO
240237562$24023756$2$F$$20230710$20240627$20240710$PER$$ID-ROCHE-3386437$ROCHE$$47$YR$A$F$Y$$$20240628$$CN$ID$ID
240237602$24023760$2$F$$20240513$20240627$20240710$PER$$FI-ROCHE-3573611$ROCHE$$71$YR$E$F$Y$$$20240628$$MD$FI$FI
240237622$24023762$2$F$$20240521$20240627$20240710$PER$$DE-ROCHE-3568680$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$DE$DE
240237636$24023763$6$F$20220813$20230721$20240627$20240710$PER$$AU-ROCHE-3342940$ROCHE$$46$YR$A$F$Y$53.5$KG$20240628$$MD$AU$AU
240237653$24023765$3$F$$20231127$20240627$20240710$PER$$CN-ROCHE-3372644$ROCHE$$56$YR$A$F$Y$$$20240628$$CN$CN$CN
240237693$24023769$3$F$$20230720$20240627$20240710$PER$$IN-ROCHE-3392531$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240237713$24023771$3$F$20220509$20240103$20240627$20240710$PER$$CN-ROCHE-3126194$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$CN$CN
240237723$24023772$3$F$20230906$20230905$20240627$20240710$PER$$IL-ROCHE-3419479$ROCHE$$24$YR$A$F$Y$$$20240628$$CN$IL$IL
240237797$24023779$7$F$$20231221$20240627$20240710$PER$$US-ROCHE-3382312$ROCHE$$45$YR$A$F$Y$124.74$KG$20240628$$MD$US$US
240237832$24023783$2$F$20230329$20240418$20240627$20240710$PER$$DK-ROCHE-3389552$ROCHE$$71$YR$E$F$Y$$$20240628$$MD$DK$DK
240237884$24023788$4$F$$20231213$20240627$20240710$PER$$IN-ROCHE-3420207$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$IN$IN
240237906$24023790$6$F$20220722$20240522$20240627$20240710$PER$$CN-ROCHE-3260282$ROCHE$$53$YR$A$M$Y$$$20240628$$MD$CN$CN
240237952$24023795$2$F$20230519$20240513$20240627$20240710$PER$$US-ROCHE-3564199$ROCHE$$73$YR$E$F$Y$$$20240628$$HP$US$US
240237963$24023796$3$F$$20230928$20240627$20240710$PER$$GB-ROCHE-3430235$ROCHE$$$$$F$Y$$$20240628$$HP$GB$GB
240237972$24023797$2$F$$20240530$20240627$20240710$PER$$AU-ROCHE-3573328$ROCHE$$$$$$Y$$$20240628$$CN$AU$AU
240237983$24023798$3$F$$20230904$20240627$20240710$PER$$IN-ROCHE-3357556$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$IN$IN
240237993$24023799$3$F$$20240529$20240627$20240710$PER$$FI-ROCHE-3573032$ROCHE$$$$$$Y$$$20240628$$MD$FI$FI
240238052$24023805$2$F$$20231016$20240627$20240710$PER$$CN-ROCHE-3406232$ROCHE$$58$YR$A$M$Y$$$20240628$$CN$CN$CN
240238063$24023806$3$F$$20240129$20240627$20240710$PER$$US-ROCHE-2836673$ROCHE$$68$YR$E$F$Y$$$20240628$$MD$US$US
240238074$24023807$4$F$$20240124$20240627$20240710$PER$$AU-ROCHE-3312378$ROCHE$$47$YR$A$M$Y$$$20240628$$MD$AU$AU
240238103$24023810$3$F$20230728$20240304$20240627$20240710$PER$FR-AFSSAPS-SE2024000164$FR-ROCHE-3520184$ROCHE$$67$YR$E$F$Y$54$KG$20240628$$PH$FR$FR
240238147$24023814$7$F$$20231215$20240627$20240710$PER$$IN-ROCHE-3300204$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$IN$IN
240238172$24023817$2$F$20240201$20240411$20240627$20240710$PER$$IT-ROCHE-3545006$ROCHE$$63$YR$A$M$Y$63$KG$20240628$$MD$IT$IT
240238185$24023818$5$F$20201018$20240826$20240627$20240829$EXP$$CA-TAKEDA-2020TUS012896$TAKEDA$$51$YR$$F$Y$$$20240829$$CN$CA$CA
240238242$24023824$2$F$$20240102$20240627$20240710$PER$$GB-ROCHE-3486623$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240238332$24023833$2$F$$20231117$20240627$20240710$PER$$CO-ROCHE-3462972$ROCHE$$$$$$Y$$$20240628$$HP$CO$CO
240238363$24023836$3$F$20221117$20230823$20240627$20240710$PER$$IT-ROCHE-3352095$ROCHE$$50$YR$A$F$Y$73$KG$20240628$$MD$IT$IT
240238412$24023841$2$F$$20240426$20240627$20240710$PER$$CH-ROCHE-3556567$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240238452$24023845$2$F$20240622$20240628$20240627$20240703$EXP$$US-ABBVIE-5817459$ABBVIE$$73$YR$$F$Y$72.574$KG$20240703$$CN$US$US
240238542$24023854$2$F$$20240530$20240627$20240710$PER$$US-ROCHE-3573696$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$US$US
240238553$24023855$3$F$$20240324$20240627$20240710$PER$$US-ROCHE-3524236$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240238592$24023859$2$F$20240222$20240314$20240627$20240710$PER$$JP-ROCHE-3526151$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240238602$24023860$2$F$$20240426$20240627$20240710$PER$$CH-ROCHE-3556577$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240238632$24023863$2$F$$20240122$20240627$20240710$PER$$PH-ROCHE-3495061$ROCHE$$$$$F$Y$$$20240628$$MD$PH$PH
240238664$24023866$4$F$20230214$20231205$20240627$20240710$PER$$PT-ROCHE-3290966$ROCHE$$73$YR$E$M$Y$78.3$KG$20240628$$MD$PT$PT
240238672$24023867$2$F$$20231006$20240627$20240710$PER$$IN-ROCHE-3436452$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$IN$IN
240238774$24023877$4$F$20240301$20240522$20240627$20240710$PER$$PE-ROCHE-3534713$ROCHE$$37$YR$A$F$Y$49.9$KG$20240628$$MD$PE$PE
240238833$24023883$3$F$$20240531$20240627$20240710$PER$$SE-ROCHE-3574809$ROCHE$$$$E$F$Y$$$20240628$$MD$SE$SE
240238842$24023884$2$F$20240418$20240531$20240627$20240710$PER$$SE-ROCHE-3574764$ROCHE$$77$YR$E$M$Y$$$20240628$$MD$SE$SE
240238865$24023886$5$F$20230418$20240125$20240627$20240710$PER$$IT-ROCHE-3343091$ROCHE$$46$YR$A$F$Y$55$KG$20240628$$MD$IT$IT
240238903$24023890$3$F$20230623$20230919$20240627$20240710$PER$$IT-ROCHE-3425834$ROCHE$$80$YR$E$F$Y$68$KG$20240628$$MD$IT$IT
240238912$24023891$2$F$20240111$20240314$20240627$20240710$PER$$JP-ROCHE-3512595$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$JP$JP
240239002$24023900$2$F$$20231026$20240627$20240710$PER$$TH-ROCHE-3449359$ROCHE$$39$YR$A$F$Y$$$20240628$$CN$TH$TH
240239072$24023907$2$F$$20240521$20240627$20240710$PER$$ES-ROCHE-3568994$ROCHE$$$$$$Y$$$20240628$$MD$ES$ES
240239122$24023912$2$F$$20240521$20240627$20240710$PER$$ES-ROCHE-3568701$ROCHE$$$$$$Y$$$20240628$$MD$ES$ES
240239133$24023913$3$F$$20231228$20240627$20240710$PER$$IN-ROCHE-3478514$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$IN$IN
240239184$24023918$4$F$$20240523$20240627$20240710$PER$$SE-ROCHE-3569405$ROCHE$$$$$$Y$$$20240628$$MD$SE$SE
240239195$24023919$5$F$20230130$20231110$20240627$20240710$PER$$IT-ROCHE-3275748$ROCHE$$49$YR$A$F$Y$57$KG$20240628$$MD$IT$IT
240239212$24023921$2$F$$20230726$20240627$20240710$PER$$IT-ROCHE-3390300$ROCHE$$37$YR$A$M$Y$$$20240628$$CN$IT$IT
240239234$24023923$4$F$20221017$20230913$20240627$20240710$PER$$IN-ROCHE-3264247$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240239242$24023924$2$F$20231001$20231107$20240627$20240710$PER$$IL-ROCHE-3450385$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$IL$IL
240239273$24023927$3$F$20230909$20230920$20240627$20240710$PER$$IN-ROCHE-3428184$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$IN$IN
240239283$24023928$3$F$20240124$20240315$20240627$20240710$PER$$IT-ROCHE-3522727$ROCHE$$82$YR$E$$Y$$$20240628$$HP$IT$IT
240239304$24023930$4$F$20210910$20231026$20240627$20240710$PER$$TR-ROCHE-3286676$ROCHE$$57$YR$A$F$Y$64$KG$20240628$$MD$TR$TR
240239335$24023933$5$F$20230530$20240527$20240627$20240710$PER$$IT-ROCHE-3408779$ROCHE$$47$YR$A$F$Y$62$KG$20240628$$MD$IT$IT
240239352$24023935$2$F$$20240326$20240627$20240710$PER$$JP-ROCHE-3517238$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240239433$24023943$3$F$20240511$20240717$20240627$20240729$EXP$$SE-ROCHE-3575570$ROCHE$$88$YR$E$F$Y$$$20240729$$HP$SE$SE
240239526$24023952$6$F$20231012$20240507$20240627$20240710$PER$$TR-ROCHE-3528507$ROCHE$$59$YR$A$F$Y$58.2$KG$20240628$$MD$TR$TR
240239546$24023954$6$F$20230401$20231021$20240627$20240710$PER$$IN-ROCHE-3249380$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$IN$IN
240239592$24023959$2$F$$20240528$20240627$20240710$PER$$FI-ROCHE-3572908$ROCHE$$$$$$Y$$$20240628$$MD$FI$FI
240239613$24023961$3$F$$20231025$20240627$20240710$PER$$GB-ROCHE-3442169$ROCHE$$$$$F$Y$$$20240628$$MD$GB$GB
240239642$24023964$2$F$20240201$20240730$20240627$20240811$EXP$$JP-AMGEN-JPNSP2024126825$AMGEN$$51$YR$A$F$Y$$$20240811$$MD$JP$JP
2402397813$24023978$13$F$20230419$20240531$20240627$20240710$PER$$CN-ROCHE-3358849$ROCHE$$40$YR$A$F$Y$62.5$KG$20240628$$MD$CN$CN
240239893$24023989$3$F$20230301$20240305$20240627$20240710$PER$$LT-ROCHE-3345809$ROCHE$$65$YR$E$M$Y$87$KG$20240628$$MD$LT$LT
240239902$24023990$2$F$20240401$20240627$20240627$20240703$EXP$$US-SANDOZ INC.-SDZ2024US061258$SANDOZ$$$$$F$Y$$$20240703$$CN$US$US
240239922$24023992$2$F$$20240222$20240627$20240710$PER$$JP-ROCHE-3528017$ROCHE$$$$E$$Y$$$20240628$$MD$JP$JP
240239934$24023993$4$F$20231004$20240520$20240627$20240710$PER$$LT-ROCHE-3529313$ROCHE$$45$YR$A$M$Y$100$KG$20240628$$MD$LT$LT
240239942$24023994$2$F$20220415$20231103$20240627$20240710$PER$$CN-ROCHE-3193045$ROCHE$$67$YR$E$F$Y$52.5$KG$20240628$$CN$CN$CN
240240122$24024012$2$F$20220724$20231113$20240627$20240710$PER$$IL-ROCHE-3292200$ROCHE$$56$YR$A$F$Y$56$KG$20240628$$MD$IL$IL
240240143$24024014$3$F$$20231113$20240627$20240710$PER$$TW-ROCHE-3431324$ROCHE$$$$$$Y$$$20240628$$MD$TW$TW
240240174$24024017$4$F$20221010$20231013$20240627$20240710$PER$$AU-ROCHE-3210646$ROCHE$$45$YR$A$M$Y$71$KG$20240628$$MD$AU$AU
240240192$24024019$2$F$$20231215$20240627$20240710$PER$$US-ROCHE-3459369$ROCHE$$55$YR$A$F$Y$83.6$KG$20240628$$MD$US$US
240240222$24024022$2$F$20210801$20240626$20240627$20240704$EXP$$FR-CELLTRION INC.-2024FR015460$CELLTRION$$$$$$Y$$$20240704$$PH$FR$FR
240240242$24024024$2$F$20240501$20240524$20240627$20240710$PER$$CL-ROCHE-3572932$ROCHE$$92$YR$E$M$Y$$$20240628$$CN$CL$CL
240240282$24024028$2$F$$20240109$20240627$20240710$PER$$JP-ROCHE-3492408$ROCHE$$$$$F$Y$$$20240628$$PH$JP$JP
240240323$24024032$3$F$20240611$20240731$20240627$20240805$PER$$US-ALXN-202406USA001431US$ALEXION PHARMACEUTICALS$$70$YR$$M$Y$142.86$KG$20240805$$CN$US$US
240240362$24024036$2$F$20240608$20240711$20240627$20240724$PER$$US-APOTEX-2024AP007223$APOTEX$$$$$F$Y$$$20240724$$CN$US$US
240240392$24024039$2$F$$20231027$20240627$20240710$PER$$SE-ROCHE-3457046$ROCHE$$$$$M$Y$$$20240628$$HP$SE$SE
240240402$24024040$2$F$$20230804$20240627$20240710$PER$$US-ROCHE-3401076$ROCHE$$73$YR$E$F$Y$95.71$KG$20240628$$MD$US$US
240240413$24024041$3$F$20230621$20230920$20240627$20240710$PER$$VN-ROCHE-3408348$ROCHE$$33$YR$A$F$Y$60$KG$20240628$$MD$VN$VN
240240422$24024042$2$F$$20240526$20240627$20240710$PER$$BD-ROCHE-3572184$ROCHE$$$$$$Y$$$20240628$$MD$BD$BD
240240453$24024045$3$F$20220801$20240302$20240627$20240710$PER$$CO-ROCHE-3504401$ROCHE$$65$YR$E$M$Y$100$KG$20240628$$MD$CO$CO
240240552$24024055$2$F$$20230711$20240627$20240710$PER$$IN-ROCHE-3388596$ROCHE$$$$E$M$Y$$$20240628$$MD$IN$IN
240240568$24024056$8$F$20210628$20240605$20240627$20240710$PER$$TR-ROCHE-3126948$ROCHE$$36$YR$A$M$Y$68$KG$20240628$$MD$TR$TR
240240572$24024057$2$F$20240216$20240220$20240627$20240710$PER$$IN-ROCHE-3574478$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$IN$IN
240240663$24024066$3$F$$20240418$20240627$20240710$PER$$CH-ROCHE-3540432$ROCHE$$76$YR$E$F$Y$$$20240628$$HP$CH$CH
240240703$24024070$3$F$20231208$20240517$20240627$20240710$PER$$IT-ROCHE-3498923$ROCHE$$80$YR$E$F$Y$68$KG$20240628$$MD$IT$IT
240240732$24024073$2$F$$20240521$20240627$20240710$PER$$FR-ROCHE-3568691$ROCHE$$$$$M$Y$$$20240628$$MD$FR$FR
240240786$24024078$6$F$20221021$20240516$20240627$20240710$PER$$CN-ROCHE-3278473$ROCHE$$71$YR$E$F$Y$51$KG$20240628$$MD$CN$CN
240240802$24024080$2$F$20240115$20240404$20240627$20240710$PER$$IT-ROCHE-3522722$ROCHE$$50$YR$A$$Y$$$20240628$$HP$IT$IT
240240835$24024083$5$F$20240208$20240304$20240627$20240710$PER$$IT-ROCHE-3522720$ROCHE$$49$YR$A$$Y$$$20240628$$MD$IT$IT
240240853$24024085$3$F$20240213$20240404$20240627$20240710$PER$$IT-ROCHE-3522718$ROCHE$$59$YR$A$$Y$$$20240628$$HP$IT$IT
240240862$24024086$2$F$$20240607$20240627$20240710$PER$$GB-ROCHE-3577490$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240240882$24024088$2$F$$20240528$20240627$20240710$PER$$FI-ROCHE-3572986$ROCHE$$$$$$Y$$$20240628$$MD$FI$FI
240240916$24024091$6$F$20210602$20231109$20240627$20240710$PER$$TR-ROCHE-3074211$ROCHE$$48$YR$A$M$Y$$$20240628$$MD$TR$TR
240240927$24024092$7$F$20231112$20240418$20240627$20240710$PER$$AU-ROCHE-3459964$ROCHE$$43$YR$A$F$Y$65$KG$20240628$$MD$AU$AU
2402409511$24024095$11$F$$20231020$20240627$20240710$PER$$IN-ROCHE-3367210$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$IN$IN
240240982$24024098$2$F$$20240315$20240627$20240710$PER$$JP-ROCHE-3511084$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240240993$24024099$3$F$20230821$20240513$20240627$20240710$PER$$PT-ROCHE-3471553$ROCHE$$77$YR$E$F$Y$65.9$KG$20240628$$MD$PT$PT
240241022$24024102$2$F$$20240221$20240627$20240710$PER$$IN-ROCHE-3514622$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$IN$IN
240241032$24024103$2$F$$20231230$20240627$20240710$PER$$TH-ROCHE-3496164$ROCHE$$56$YR$A$F$Y$$$20240628$$CN$TH$TH
240241056$24024105$6$F$$20230921$20240627$20240710$PER$$IN-ROCHE-3416612$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$IN$IN
240241093$24024109$3$F$20230621$20230919$20240627$20240710$PER$$RO-ROCHE-3425537$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$RO$RO
240241102$24024110$2$F$20240515$20240529$20240627$20240710$PER$$SE-ROCHE-3575189$ROCHE$$$$E$M$Y$$$20240628$$MD$SE$SE
240241143$24024114$3$F$20221013$20230814$20240627$20240710$PER$$VN-ROCHE-3289391$ROCHE$$32$YR$A$F$Y$60$KG$20240628$$MD$VN$VN
240241195$24024119$5$F$$20231001$20240627$20240710$PER$$TH-ROCHE-3397251$ROCHE$$35$YR$A$F$Y$$$20240628$$CN$TH$TH
240241282$24024128$2$F$$20240803$20240627$20240903$PER$$US-Merz Pharmaceuticals GmbH-24-01716$MERZ$$44$YR$$F$Y$54.4$KG$20240904$$MD$US$US
240241312$24024131$2$F$20220215$20240625$20240627$20240703$EXP$$JP-PFIZER INC-2022SGN02498$PFIZER$$73$YR$$F$Y$58.4$KG$20240703$$MD$JP$JP
240241342$24024134$2$F$$20230724$20240627$20240710$PER$$US-ROCHE-3392368$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240241354$24024135$4$F$$20231024$20240627$20240710$PER$$IN-ROCHE-3422891$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240241382$24024138$2$F$20240412$20240516$20240627$20240710$PER$$FR-ROCHE-3561337$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$FR$FR
240241432$24024143$2$F$20231213$20240123$20240627$20240710$PER$$TR-ROCHE-3497889$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$TR$TR
240241472$24024147$2$F$$20240326$20240627$20240710$PER$$KR-ROCHE-3533887$ROCHE$$60$YR$A$F$Y$$$20240628$$CN$KR$KR
240241513$24024151$3$F$20230121$20240228$20240627$20240710$PER$$AU-ROCHE-3271092$ROCHE$$79$YR$E$F$Y$56$KG$20240628$$MD$AU$AU
240241522$24024152$2$F$20201001$20230905$20240627$20240710$PER$FR-AFSSAPS-MA2023002204$FR-ROCHE-3416668$ROCHE$$39$YR$A$F$Y$104$KG$20240628$$CN$FR$FR
240241542$24024154$2$F$$20240701$20240627$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102569$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240703$$CN$US$US
240241572$24024157$2$F$20240301$20240305$20240627$20240710$PER$$JP-ROCHE-3538504$ROCHE$$$$E$$Y$$$20240628$$MD$JP$JP
240241644$24024164$4$F$$20231021$20240627$20240710$PER$$IN-ROCHE-3297833$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240241672$24024167$2$F$$20240529$20240627$20240710$PER$$SE-ROCHE-3574783$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$SE$SE
240241694$24024169$4$F$20240101$20240201$20240627$20240710$PER$$SG-ROCHE-3503189$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$SG$SG
240241745$24024174$5$F$20220114$20240306$20240627$20240710$PER$$CN-ROCHE-3222364$ROCHE$$71$YR$E$M$Y$83$KG$20240628$$MD$CN$CN
240241913$24024191$3$F$20231103$20240219$20240627$20240710$PER$$CO-ROCHE-3456106$ROCHE$$84$YR$E$M$Y$59$KG$20240628$$MD$CO$CO
240241932$24024193$2$F$20240101$20240726$20240627$20240731$EXP$$JP-JNJFOC-20240671872$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240731$$MD$JP$JP
240241952$24024195$2$F$20240801$20240816$20240627$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002701$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240910$$CN$US$US
240241982$24024198$2$F$$20240529$20240627$20240710$PER$$PH-ROCHE-3575457$ROCHE$$80$YR$E$F$Y$$$20240628$$HP$PH$PH
240242072$24024207$2$F$$20240228$20240627$20240710$PER$$PH-ROCHE-3465792$ROCHE$$66$YR$E$F$Y$45$KG$20240628$$CN$PH$PH
240242102$24024210$2$F$$20231021$20240627$20240710$PER$$IN-ROCHE-3358877$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
240242123$24024212$3$F$20230405$20240509$20240627$20240710$PER$$CN-ROCHE-3377279$ROCHE$$47$YR$A$M$Y$78$KG$20240628$$MD$CN$CN
240242147$24024214$7$F$$20240304$20240627$20240710$PER$$IN-ROCHE-3440543$ROCHE$$64$YR$A$F$Y$$$20240628$$MD$IN$IN
240242173$24024217$3$F$20230519$20230922$20240627$20240710$PER$$IN-ROCHE-3343831$ROCHE$$43$YR$A$F$Y$$$20240628$$MD$IN$IN
240242182$24024218$2$F$20231130$20240306$20240627$20240710$PER$$CN-ROCHE-3522364$ROCHE$$81$YR$E$M$Y$60$KG$20240628$$MD$CN$CN
240242202$24024220$2$F$20231122$20240101$20240627$20240710$PER$$DK-ROCHE-3472581$ROCHE$$50$YR$A$M$Y$$$20240628$$MD$DK$DK
240242245$24024224$5$F$$20240304$20240627$20240710$PER$$IN-ROCHE-3417645$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$IN$IN
240242374$24024237$4$F$20231206$20240603$20240627$20240710$PER$$AU-ROCHE-3497598$ROCHE$$46$YR$A$M$Y$68.7$KG$20240628$$MD$AU$AU
240242465$24024246$5$F$$20240110$20240627$20240710$PER$$IN-ROCHE-3488203$ROCHE$$56$YR$A$F$Y$$$20240628$$MD$IN$IN
240242543$24024254$3$F$20220415$20231011$20240627$20240710$PER$$IT-ROCHE-3146880$ROCHE$$48$YR$A$F$Y$57$KG$20240628$$MD$IT$IT
240242595$24024259$5$F$20231130$20231220$20240627$20240710$PER$$ID-ROCHE-3471100$ROCHE$$38$YR$A$F$Y$$$20240628$$CN$ID$ID
240242604$24024260$4$F$20240601$20240827$20240627$20240831$EXP$$CA-TAKEDA-2024TUS061655$TAKEDA$$4$YR$$M$Y$$$20240831$$CN$CA$CA
240242722$24024272$2$F$20240623$20240805$20240627$20240807$PER$$US-AMGEN-USASP2024124859$AMGEN$$74$YR$E$F$Y$$$20240807$$CN$US$US
240242732$24024273$2$F$20230414$20240308$20240627$20240710$PER$$AR-ROCHE-3472526$ROCHE$$34$YR$A$M$Y$64$KG$20240628$$MD$AR$AR
240242773$24024277$3$F$$20240209$20240627$20240710$PER$$IN-ROCHE-3477538$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$IN$IN
240242802$24024280$2$F$$20240523$20240627$20240710$PER$$US-ROCHE-3441081$ROCHE$$61$YR$A$$Y$$$20240628$$HP$US$US
240242872$24024287$2$F$20221018$20231011$20240627$20240710$PER$$CN-ROCHE-3240798$ROCHE$$83$YR$E$M$Y$$$20240628$$MD$CN$CN
240242883$24024288$3$F$$20240507$20240627$20240710$PER$$US-ROCHE-3537234$ROCHE$$44$YR$A$M$Y$$$20240628$$MD$US$US
240242892$24024289$2$F$$20240606$20240627$20240710$PER$$US-ROCHE-3578699$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$US$US
240242934$24024293$4$F$$20240120$20240627$20240710$PER$$DE-ROCHE-3446276$ROCHE$$$$$F$Y$$$20240628$$MD$DE$DE
240242982$24024298$2$F$20240222$20240304$20240627$20240710$PER$$MX-ROCHE-3522742$ROCHE$$55$YR$A$F$Y$58$KG$20240628$$CN$MX$MX
240243013$24024301$3$F$20220705$20240430$20240627$20240710$PER$$AT-ROCHE-3197407$ROCHE$$53$YR$A$F$Y$69$KG$20240628$$MD$AT$AT
240243032$24024303$2$F$20231220$20240118$20240627$20240710$PER$$JP-ROCHE-3498169$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240243052$24024305$2$F$20231025$20240220$20240627$20240710$PER$$IT-ROCHE-3455134$ROCHE$$52$YR$A$F$Y$66.5$KG$20240628$$MD$IT$IT
240243102$24024310$2$F$$20240131$20240627$20240710$PER$$US-ROCHE-3503921$ROCHE$$64$YR$A$F$Y$$$20240628$$MD$US$US
240243142$24024314$2$F$$20230912$20240627$20240710$PER$$CN-ROCHE-3421700$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$CN$CN
240243174$24024317$4$F$20240208$20240325$20240627$20240710$PER$$MX-ROCHE-3513826$ROCHE$$55$YR$A$F$Y$57$KG$20240628$$CN$MX$MX
240243183$24024318$3$F$20230818$20240107$20240627$20240710$PER$$CN-ROCHE-3487520$ROCHE$$44$YR$A$F$Y$74$KG$20240628$$MD$CN$CN
240243213$24024321$3$F$$20240514$20240627$20240710$PER$$GB-ROCHE-3564627$ROCHE$$91$YR$E$M$Y$$$20240628$$CN$GB$GB
240243232$24024323$2$F$20220518$20240320$20240627$20240710$PER$$FI-ROCHE-3347355$ROCHE$$60$YR$A$M$Y$$$20240628$$MD$FI$FI
240243282$24024328$2$F$$20231213$20240627$20240710$PER$$US-ROCHE-3476005$ROCHE$$56$YR$A$F$Y$$$20240628$$CN$US$US
240243362$24024336$2$F$$20240502$20240627$20240710$PER$$IT-ROCHE-3560697$ROCHE$$$$$M$Y$$$20240628$$MD$IT$IT
240243412$24024341$2$F$20240101$20240725$20240627$20240731$PER$$US-ABBVIE-5817234$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
240243472$24024347$2$F$$20231214$20240627$20240710$PER$$TH-ROCHE-3477281$ROCHE$$$$$F$Y$$$20240628$$CN$TH$TH
240243506$24024350$6$F$$20240129$20240627$20240710$PER$$IN-ROCHE-3413030$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$IN$IN
240243552$24024355$2$F$$20231126$20240627$20240710$PER$$IL-ROCHE-3466946$ROCHE$$60$YR$A$F$Y$$$20240628$$CN$IL$IL
240243565$24024356$5$F$20220516$20231008$20240627$20240710$PER$$CN-ROCHE-3394801$ROCHE$$65$YR$E$F$Y$55$KG$20240628$$MD$CN$CN
240243574$24024357$4$F$20231120$20231206$20240627$20240710$PER$$ID-ROCHE-3464320$ROCHE$$77$YR$E$F$Y$56$KG$20240628$$CN$ID$ID
240243592$24024359$2$F$$20231127$20240627$20240710$PER$$CH-ROCHE-3468339$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240243658$24024365$8$F$20210810$20240328$20240628$20240710$PER$$CN-ROCHE-2942635$ROCHE$$58$YR$A$F$Y$75$KG$20240628$$MD$CN$CN
240243663$24024366$3$F$$20240319$20240628$20240710$PER$$GB-ROCHE-3532750$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240243682$24024368$2$F$$20240603$20240628$20240710$PER$$US-ROCHE-3204237$ROCHE$$37$YR$A$M$Y$$$20240628$$MD$US$US
240243693$24024369$3$F$20231108$20240116$20240628$20240710$PER$$IT-ROCHE-3464265$ROCHE$$68$YR$E$F$Y$80$KG$20240628$$MD$IT$IT
240243702$24024370$2$F$20240117$20240209$20240628$20240710$PER$$JP-ROCHE-3513314$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240243714$24024371$4$F$20230703$20240529$20240628$20240710$PER$$AT-ROCHE-3513443$ROCHE$$54$YR$A$F$Y$69$KG$20240628$$MD$AT$AT
240243752$24024375$2$F$$20240315$20240628$20240710$PER$$JP-ROCHE-3517094$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240243762$24024376$2$F$$20230817$20240628$20240710$PER$$IN-ROCHE-3325905$ROCHE$$46$YR$A$F$Y$$$20240628$$CN$IN$IN
240243822$24024382$2$F$$20231031$20240628$20240710$PER$$IN-ROCHE-3450719$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240243842$24024384$2$F$$20240312$20240628$20240710$PER$$IN-ROCHE-3527297$ROCHE$$40$YR$A$F$Y$$$20240628$$CN$IN$IN
240244022$24024402$2$F$$20240229$20240628$20240710$PER$$JP-ROCHE-3516236$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240244052$24024405$2$F$20231215$20231218$20240628$20240710$PER$$JP-ROCHE-3481165$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240244093$24024409$3$F$$20240317$20240628$20240710$PER$$IN-ROCHE-3353109$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$IN$IN
240244146$24024414$6$F$$20231218$20240628$20240710$PER$$IN-ROCHE-3418567$ROCHE$$35$YR$A$F$Y$$$20240628$$MD$IN$IN
240244175$24024417$5$F$20220816$20240228$20240628$20240710$PER$$BE-ROCHE-3247659$ROCHE$$62$YR$A$M$Y$84$KG$20240628$$MD$BE$BE
240244276$24024427$6$F$20220314$20231011$20240628$20240710$PER$$CN-ROCHE-3315128$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$CN$CN
240244286$24024428$6$F$20230701$20240423$20240628$20240710$PER$$AU-ROCHE-3395064$ROCHE$$78$YR$E$F$Y$$$20240628$$MD$AU$AU
240244312$24024431$2$F$20231118$20240107$20240628$20240710$PER$$CN-ROCHE-3485209$ROCHE$$72$YR$E$F$Y$55$KG$20240628$$MD$CN$CN
240244332$24024433$2$F$$20240201$20240628$20240710$PER$$CA-ROCHE-3500303$ROCHE$$78$YR$E$F$Y$$$20240628$$CN$CA$CA
240244383$24024438$3$F$$20231124$20240628$20240710$PER$$IN-ROCHE-3466307$ROCHE$$33$YR$A$F$Y$$$20240628$$MD$IN$IN
240244392$24024439$2$F$20231214$20231217$20240628$20240710$PER$$IL-ROCHE-3480852$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$IL$IL
240244403$24024440$3$F$20240219$20240404$20240628$20240710$PER$$IT-ROCHE-3522719$ROCHE$$56$YR$A$$Y$$$20240628$$HP$IT$IT
240244532$24024453$2$F$20240101$20240627$20240628$20240702$EXP$$US-ABBVIE-5816091$ABBVIE$$$$$F$Y$81$KG$20240702$$CN$US$US
240244562$24024456$2$F$20220324$20231031$20240628$20240710$PER$$AT-ROCHE-3077781$ROCHE$$59$YR$A$F$Y$56$KG$20240628$$MD$AT$AT
240244595$24024459$5$F$20220106$20240212$20240628$20240710$PER$$IL-ROCHE-3473970$ROCHE$$68$YR$E$M$Y$93$KG$20240628$$MD$IL$IL
240244613$24024461$3$F$20220909$20240508$20240628$20240710$PER$$CO-ROCHE-3465794$ROCHE$$69$YR$E$M$Y$72$KG$20240628$$MD$CO$CO
240244652$24024465$2$F$$20240123$20240628$20240710$PER$$JP-ROCHE-3475538$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240244676$24024467$6$F$20230418$20240112$20240628$20240710$PER$$IT-ROCHE-3363966$ROCHE$$67$YR$E$F$Y$65.5$KG$20240628$$MD$IT$IT
240244682$24024468$2$F$$20230914$20240628$20240710$PER$$IN-ROCHE-3401601$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$IN$IN
240244692$24024469$2$F$20211116$20231116$20240628$20240710$PER$$TR-ROCHE-3121144$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$TR$TR
240244702$24024470$2$F$20231101$20231219$20240628$20240710$PER$$US-ROCHE-3465698$ROCHE$$70$YR$E$F$Y$45.36$KG$20240628$$CN$US$US
240244732$24024473$2$F$20230714$20231012$20240628$20240710$PER$IT-MINISAL02-947977$IT-ROCHE-3438236$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IT$IT
240244753$24024475$3$F$20240621$20240916$20240628$20240923$PER$$US-SA-2024SA189126$SANOFI AVENTIS$$$$$F$Y$$$20240923$$HP$US$US
240244872$24024487$2$F$$20230707$20240628$20240710$PER$$IE-ROCHE-3387192$ROCHE$$$$$F$Y$$$20240628$$PH$IE$IE
240244913$24024491$3$F$20240101$20240408$20240628$20240710$PER$$CO-ROCHE-3512798$ROCHE$$84$YR$E$M$Y$48$KG$20240628$$MD$CO$CO
240244936$24024493$6$F$$20230718$20240628$20240710$PER$$IN-ROCHE-3144325$ROCHE$$64$YR$A$F$Y$$$20240628$$CN$IN$IN
240244952$24024495$2$F$$20231101$20240628$20240710$PER$$IN-ROCHE-3422623$ROCHE$$44$YR$A$F$Y$$$20240628$$MD$IN$IN
240245052$24024505$2$F$20240220$20240422$20240628$20240710$PER$$GB-ROCHE-3537341$ROCHE$$33$YR$A$F$Y$$$20240628$$HP$GB$GB
240245062$24024506$2$F$20231220$20240201$20240628$20240710$PER$$JP-ROCHE-3482036$ROCHE$$9$DEC$E$F$Y$$$20240628$$MD$JP$JP
240245253$24024525$3$F$20230427$20240106$20240628$20240710$PER$$CN-ROCHE-3367661$ROCHE$$55$YR$A$M$Y$50$KG$20240628$$MD$CN$CN
240245282$24024528$2$F$$20240816$20240628$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002722$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
240245322$24024532$2$F$$20240306$20240628$20240710$PER$$BF-ROCHE-3513097$ROCHE$$$$$F$Y$$$20240628$$CN$BF$BF
240245332$24024533$2$F$20231025$20231206$20240628$20240710$PER$$BE-ROCHE-3471323$ROCHE$$79$YR$E$M$Y$67$KG$20240628$$MD$BE$BE
240245342$24024534$2$F$$20240205$20240628$20240710$PER$$JP-ROCHE-3482691$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240245362$24024536$2$F$$20240301$20240628$20240710$PER$$US-ROCHE-3516863$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240245392$24024539$2$F$$20240119$20240628$20240710$PER$$JP-ROCHE-3499074$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240245422$24024542$2$F$$20240711$20240628$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024075876$VIIV$$$$$$Y$$$20240719$$HP$US$US
240245492$24024549$2$F$$20230803$20240628$20240710$PER$$IN-ROCHE-3360628$ROCHE$$34$YR$A$F$Y$$$20240628$$CN$IN$IN
240245503$24024550$3$F$20230401$20230823$20240628$20240710$PER$$IT-ROCHE-3351886$ROCHE$$51$YR$A$F$Y$71$KG$20240628$$MD$IT$IT
240245533$24024553$3$F$$20231030$20240628$20240710$PER$$JP-ROCHE-3453355$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240245692$24024569$2$F$$20240719$20240628$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002727$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
240245704$24024570$4$F$$20240828$20240628$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002723$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
240245712$24024571$2$F$$20231101$20240628$20240710$PER$$IN-ROCHE-3385418$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$IN$IN
240245722$24024572$2$F$$20240314$20240628$20240710$PER$$IN-ROCHE-3426531$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$IN$IN
240245752$24024575$2$F$$20230808$20240628$20240710$PER$$SG-ROCHE-3403873$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$SG$SG
240245773$24024577$3$F$$20240112$20240628$20240710$PER$$IN-ROCHE-3426750$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$IN$IN
240245784$24024578$4$F$$20240104$20240628$20240710$PER$$IN-ROCHE-3424428$ROCHE$$37$YR$A$F$Y$$$20240628$$MD$IN$IN
240245852$24024585$2$F$$20230731$20240628$20240710$PER$$US-ROCHE-3397874$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240245862$24024586$2$F$$20230727$20240628$20240710$PER$$IN-ROCHE-3397709$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$IN$IN
240245964$24024596$4$F$20231017$20240321$20240628$20240710$PER$$PT-ROCHE-3506136$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$PT$PT
240245974$24024597$4$F$20231005$20240508$20240628$20240710$PER$$RS-ROCHE-3546206$ROCHE$$52$YR$A$M$Y$81$KG$20240628$$MD$RS$RS
240246032$24024603$2$F$$20240509$20240628$20240710$PER$$JP-ROCHE-3557663$ROCHE$$5$DEC$A$$Y$$$20240628$$MD$JP$JP
240246112$24024611$2$F$20240615$20240711$20240628$20240712$EXP$GB-MHRA-MED-202406271513468140-WMRDY$GB-JNJFOC-20240674775$JOHNSON AND JOHNSON$$35$DY$I$M$Y$3$KG$20240712$$PH$GB$GB
240246132$24024613$2$F$20230417$20231123$20240628$20240710$PER$$AE-ROCHE-3463975$ROCHE$$56$YR$A$F$Y$63.6$KG$20240628$$MD$AE$AE
240246152$24024615$2$F$20230804$20231012$20240628$20240710$PER$IT-MINISAL02-947978$IT-ROCHE-3438267$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IT$IT
240246182$24024618$2$F$20231225$20240119$20240628$20240710$PER$$JP-ROCHE-3500809$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240246192$24024619$2$F$$20230724$20240628$20240710$PER$$IN-ROCHE-3392549$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$IN$IN
240246203$24024620$3$F$$20231115$20240628$20240710$PER$$IN-ROCHE-3460550$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$IN$IN
240246275$24024627$5$F$$20240207$20240628$20240710$PER$$IN-ROCHE-3368289$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$IN$IN
240246334$24024633$4$F$20240222$20240509$20240628$20240710$PER$$KR-ROCHE-3527061$ROCHE$$61$YR$A$$Y$$$20240628$$MD$KR$KR
240246432$24024643$2$F$20240620$20240701$20240628$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002728$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240725$$CN$US$US
240246443$24024644$3$F$20240220$20240502$20240628$20240710$PER$$IT-ROCHE-3529734$ROCHE$$68$YR$E$F$Y$68.5$KG$20240628$$MD$IT$IT
240246492$24024649$2$F$20231222$20240213$20240628$20240710$PER$$JP-ROCHE-3482905$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240246522$24024652$2$F$$20240325$20240628$20240710$PER$$CN-ROCHE-3532425$ROCHE$$52$YR$A$M$Y$$$20240628$$MD$CN$CN
240246532$24024653$2$F$20220326$20240108$20240628$20240710$PER$$AU-ROCHE-3076836$ROCHE$$41$YR$A$F$Y$63.6$KG$20240628$$MD$AU$AU
240246582$24024658$2$F$$20240130$20240628$20240710$PER$$JP-ROCHE-3507411$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$JP$JP
240246604$24024660$4$F$20240219$20240228$20240628$20240710$PER$$IT-ROCHE-3518097$ROCHE$$59$YR$A$F$Y$62$KG$20240628$$MD$IT$IT
240246612$24024661$2$F$$20240412$20240628$20240710$PER$$CA-ROCHE-2691201$ROCHE$$$$A$M$Y$$$20240628$$CN$CA$CA
240246622$24024662$2$F$$20240222$20240628$20240710$PER$$PH-ROCHE-3477786$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$PH$PH
240246735$24024673$5$F$20240313$20240830$20240628$20240904$EXP$$CN-TAKEDA-2024TUS062962$TAKEDA$$21$YR$$M$Y$57$KG$20240904$$MD$CN$CN
240246762$24024676$2$F$20240205$20240207$20240628$20240710$PER$$TR-ROCHE-3506762$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$TR$TR
240246782$24024678$2$F$$20240326$20240628$20240710$PER$$US-ROCHE-3533974$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240246812$24024681$2$F$$20231219$20240628$20240710$PER$$IN-ROCHE-3479550$ROCHE$$44$YR$A$F$Y$$$20240628$$MD$IN$IN
240246842$24024684$2$F$20240704$20240704$20240628$20240708$EXP$$CA-TAKEDA-2024TUS035327$TAKEDA$$30$YR$$M$Y$$$20240708$$CN$CA$CA
240246898$24024689$8$F$20230715$20240528$20240628$20240710$PER$$BE-ROCHE-3432211$ROCHE$$45$YR$A$M$Y$88$KG$20240628$$MD$BE$BE
240246933$24024693$3$F$$20240304$20240628$20240710$PER$$PH-ROCHE-3519283$ROCHE$$$$$$Y$$$20240628$$CN$PH$PH
240246972$24024697$2$F$20210907$20231108$20240628$20240710$PER$$CN-ROCHE-3023862$ROCHE$$78$YR$E$M$Y$75$KG$20240628$$MD$CN$CN
240247002$24024700$2$F$$20230813$20240628$20240710$PER$$US-ROCHE-3403458$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240247053$24024705$3$F$$20231021$20240628$20240710$PER$$IN-ROCHE-3338997$ROCHE$$62$YR$A$F$Y$$$20240628$$CN$IN$IN
240247073$24024707$3$F$20240816$20240816$20240628$20240820$EXP$$CA-TAKEDA-2024TUS063331$TAKEDA$$53$YR$$F$Y$$$20240820$$HP$CA$CA
240247092$24024709$2$F$$20240216$20240628$20240710$PER$$JP-ROCHE-3517171$ROCHE$$$$$M$Y$$$20240628$$HP$JP$JP
240247242$24024724$2$F$20230918$20240709$20240628$20240712$EXP$$AR-BIOGEN-2024BI01245356$BIOGEN$$28$YR$$F$Y$$$20240712$$CN$AR$AR
240247303$24024730$3$F$20230202$20231101$20240628$20240710$PER$$TR-ROCHE-3413715$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$TR$TR
240247323$24024732$3$F$$20240709$20240628$20240717$EXP$$BR-CELLTRION INC.-2024BR015486$CELLTRION$$$$$$Y$$$20240717$$CN$BR$BR
240247383$24024738$3$F$$20230807$20240628$20240710$PER$$PT-ROCHE-3387957$ROCHE$$$$$F$Y$$$20240628$$HP$PT$PT
240247525$24024752$5$F$20230901$20231003$20240628$20240710$PER$$PT-ROCHE-3433948$ROCHE$$42$YR$A$F$Y$64$KG$20240628$$MD$PT$PT
240247532$24024753$2$F$20220214$20240125$20240628$20240710$PER$$TR-ROCHE-3047013$ROCHE$$65$YR$E$F$Y$54$KG$20240628$$MD$TR$TR
240247622$24024762$2$F$$20240216$20240628$20240710$PER$$IN-ROCHE-3482551$ROCHE$$38$YR$A$F$Y$$$20240628$$MD$IN$IN
240247654$24024765$4$F$$20231025$20240628$20240710$PER$$RO-ROCHE-3442082$ROCHE$$65$YR$E$F$Y$60$KG$20240628$$PH$RO$RO
240247675$24024767$5$F$$20240510$20240628$20240710$PER$$US-ROCHE-3508342$ROCHE$$76$YR$E$F$Y$111.3$KG$20240628$$MD$US$US
240247723$24024772$3$F$$20230728$20240628$20240710$PER$$TH-ROCHE-3264463$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$TH$TH
240247772$24024777$2$F$20230726$20240318$20240628$20240710$PER$$IT-ROCHE-3529268$ROCHE$$54$YR$A$F$Y$51$KG$20240628$$MD$IT$IT
240247792$24024779$2$F$$20230717$20240628$20240710$PER$$RO-ROCHE-3391148$ROCHE$$62$YR$A$F$Y$80$KG$20240628$$CN$RO$RO
240247815$24024781$5$F$$20231009$20240628$20240710$PER$$IN-ROCHE-3393255$ROCHE$$43$YR$A$F$Y$$$20240628$$MD$IN$IN
240247852$24024785$2$F$$20231220$20240628$20240710$PER$$IN-ROCHE-3463386$ROCHE$$38$YR$A$F$Y$$$20240628$$MD$IN$IN
240247862$24024786$2$F$20231201$20240627$20240628$20240703$EXP$$US-ABBVIE-5815511$ABBVIE$$70$YR$$M$Y$117$KG$20240703$$CN$US$US
240247892$24024789$2$F$$20230926$20240628$20240710$PER$$US-ROCHE-3429826$ROCHE$Thompson J, Malik A and Puri S. Bilateral Optic Neuropathy Following Phesgo Injection for HER2+ Breast Cancer. DOI: 10.1097/WNO.0000000000001998. Journal of neuro-ophthalmology: the official journal of the North American Neuro-Ophthalmology Society 2023 Sep 18;:1-2.$62$YR$A$F$Y$$$20240628$$MD$US$US
240247942$24024794$2$F$20230701$20231226$20240628$20240710$PER$$PE-ROCHE-3482236$ROCHE$$71$YR$E$F$Y$61.5$KG$20240628$$MD$PE$PE
240247962$24024796$2$F$20220714$20240102$20240628$20240710$PER$$CN-ROCHE-3485541$ROCHE$$64$YR$A$F$Y$51$KG$20240628$$MD$CN$CN
240248032$24024803$2$F$$20240326$20240628$20240710$PER$$IN-ROCHE-3488579$ROCHE$$37$YR$A$F$Y$$$20240628$$MD$IN$IN
240248092$24024809$2$F$$20240619$20240628$20240702$EXP$$RU-ROCHE-10000008837$ROCHE$$55$YR$A$F$Y$$$20240702$$HP$RU$RU
240248132$24024813$2$F$$20240123$20240628$20240710$PER$$SG-ROCHE-3497805$ROCHE$$57$YR$A$F$Y$$$20240628$$CN$SG$SG
240248154$24024815$4$F$20230215$20240127$20240628$20240710$PER$$DK-ROCHE-3472722$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$DK$DK
240248164$24024816$4$F$20221201$20230808$20240628$20240710$PER$$MX-ROCHE-3212787$ROCHE$$42$YR$A$F$Y$$$20240628$$CN$MX$MX
240248182$24024818$2$F$20240529$20240724$20240628$20240729$EXP$$CA-ABBVIE-5816130$ABBVIE$$89$YR$$M$Y$$$20240729$$MD$CA$CA
240248227$24024822$7$F$$20230812$20240628$20240710$PER$$IN-ROCHE-3250422$ROCHE$$39$YR$A$F$Y$$$20240628$$MD$IN$IN
240248243$24024824$3$F$$20240304$20240628$20240710$PER$$FR-ROCHE-3515344$ROCHE$$43$YR$A$F$Y$$$20240628$$PH$FR$FR
240248342$24024834$2$F$$20240105$20240628$20240710$PER$$CA-ROCHE-3356359$ROCHE$$$$$M$Y$$$20240628$$CN$CA$CA
240248352$24024835$2$F$$20230920$20240628$20240710$PER$$JP-ROCHE-3396650$ROCHE$PRIVACY P, Toge H, Yamamoto M, Kato R, Ikeuchi T, Tomita K, Yamasaki A A Case in Which Alectinib Was Effective for EML4-ALK Fusion Gene-positive Pulmonary Neuroendocrine Carcinoma. The 61st Annual Meeting of the Chugoku/Shikoku Branch of the Japan Lung Cancer S 2023;98:-.$75$YR$E$M$Y$$$20240628$$MD$JP$JP
240248366$24024836$6$F$$20231018$20240628$20240710$PER$$IN-ROCHE-3433113$ROCHE$$68$YR$E$F$Y$$$20240628$$MD$IN$IN
240248372$24024837$2$F$20240125$20240219$20240628$20240710$PER$$TW-ROCHE-3501073$ROCHE$$53$YR$A$F$Y$$$20240628$$HP$TW$TW
240248402$24024840$2$F$$20240805$20240628$20240806$PER$$US-ALXN-202406USA001467US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$CN$US$US
240248443$24024844$3$F$20230928$20231026$20240628$20240710$PER$$TR-ROCHE-3442360$ROCHE$$31$YR$A$F$Y$58$KG$20240628$$MD$TR$TR
240248452$24024845$2$F$$20231014$20240628$20240710$PER$$IN-ROCHE-3442236$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$IN$IN
240248462$24024846$2$F$$20240216$20240628$20240710$PER$$IN-ROCHE-3512401$ROCHE$$57$YR$A$F$Y$$$20240628$$CN$IN$IN
240248472$24024847$2$F$20211202$20230831$20240628$20240710$PER$$PE-ROCHE-3265503$ROCHE$$$$A$F$Y$48.2$KG$20240628$$MD$PE$PE
240248493$24024849$3$F$20230106$20240306$20240628$20240710$PER$$PT-ROCHE-3349356$ROCHE$$62$YR$A$F$Y$71.5$KG$20240628$$MD$PT$PT
240248532$24024853$2$F$$20240716$20240628$20240724$EXP$US-MLMSERVICE-20240613-PI098212-00270-1$US-STRIDES ARCOLAB LIMITED-2024SP007578$STRIDES$Kretovics E, Keegan K, Burg G, Von Allmen D, Chima R, Benscoter D., et al.. Prolonged High-Dose Steroid Use in an Infant With Surfactant Protein-C Deficiency and Multiple Complications.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A2307$$$$$Y$$$20240724$$MD$US$US
240248565$24024856$5$F$20220824$20240217$20240628$20240710$PER$$CN-ROCHE-3189114$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$CN$CN
240248603$24024860$3$F$$20231122$20240628$20240710$PER$$FR-ROCHE-2788867$ROCHE$$5$YR$C$$Y$16.5$KG$20240628$$MD$FR$FR
240248622$24024862$2$F$$20230927$20240628$20240710$PER$$IN-ROCHE-3430281$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$IN$IN
240248654$24024865$4$F$20240619$20240909$20240628$20240911$EXP$$JP-TAKEDA-2024TJP009630$TAKEDA$$7$DEC$$F$Y$$$20240911$$MD$JP$JP
240248714$24024871$4$F$$20231202$20240628$20240710$PER$$IN-ROCHE-3470427$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$IN$IN
240248742$24024874$2$F$$20231219$20240628$20240710$PER$$RO-ROCHE-3474444$ROCHE$$70$YR$E$F$Y$83$KG$20240628$$CN$RO$RO
240248752$24024875$2$F$$20240226$20240628$20240710$PER$$IN-ROCHE-3349844$ROCHE$$49$YR$A$F$Y$79$KG$20240628$$MD$IN$IN
240248793$24024879$3$F$20230404$20231205$20240628$20240710$PER$$CN-ROCHE-3416238$ROCHE$$33$YR$A$F$Y$60$KG$20240628$$MD$CN$CN
240248804$24024880$4$F$20210901$20240529$20240628$20240710$PER$$CN-ROCHE-3280635$ROCHE$$59$YR$A$F$Y$55$KG$20240628$$MD$CN$CN
240248834$24024883$4$F$20220221$20240307$20240628$20240710$PER$$CN-ROCHE-3222361$ROCHE$$40$YR$A$F$Y$51$KG$20240628$$MD$CN$CN
240248872$24024887$2$F$$20230706$20240628$20240710$PER$$CN-ROCHE-3294966$ROCHE$$67$YR$E$M$Y$70$KG$20240628$$CN$CN$CN
240248902$24024890$2$F$20240524$20240813$20240628$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103185$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240814$$HP$US$US
240248932$24024893$2$F$$20240627$20240628$20240704$EXP$IR-MLMSERVICE-20240612-PI095425-00120-1$IR-STRIDES ARCOLAB LIMITED-2024SP007467$STRIDES$Lotfollahi L, Golmohammadi M, Gharehbagh FJ, Darazam IA.. Self-induced Anuria with Diclofenac: An Interesting Case of ^Quadruple Whammy^ Acute Kidney Injury.. International Journal of Medical Toxicology and Forensic Medicine.. 2024;14(2):E43065.$66$YR$$F$Y$$$20240704$$MD$IR$IR
240248946$24024894$6$F$20220816$20240105$20240628$20240710$PER$$CN-ROCHE-3274575$ROCHE$$59$YR$A$F$Y$75$KG$20240628$$MD$CN$CN
240248992$24024899$2$F$$20230728$20240628$20240710$PER$$RO-ROCHE-3398622$ROCHE$$56$YR$A$F$Y$76$KG$20240628$$CN$RO$RO
240249003$24024900$3$F$$20240508$20240628$20240710$PER$$JP-ROCHE-3475511$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240249022$24024902$2$F$$20231006$20240628$20240710$PER$$IN-ROCHE-3407531$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IN$IN
240249053$24024905$3$F$20240615$20240705$20240628$20240715$PER$$CA-TOLMAR, INC.-24CA050474$TOLMAR$$91$YR$$M$Y$$$20240715$$CN$CA$CA
240249093$24024909$3$F$20240101$20240911$20240628$20240917$EXP$$US-ABBVIE-5672276$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
240249102$24024910$2$F$$20240703$20240628$20240712$PER$$US-SA-2024SA187645$SANOFI AVENTIS$$30$YR$A$F$Y$52$KG$20240712$$MD$US$US
240249124$24024912$4$F$$20230706$20240628$20240710$PER$$IN-ROCHE-3374388$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$IN$IN
240249252$24024925$2$F$20230212$20240319$20240628$20240710$PER$$RU-ROCHE-3328525$ROCHE$$40$YR$A$F$Y$45$KG$20240628$$MD$RU$RU
240249282$24024928$2$F$$20231214$20240628$20240710$PER$$IN-ROCHE-3477181$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$IN$IN
240249413$24024941$3$F$20230131$20240606$20240628$20240710$PER$$PT-ROCHE-3348991$ROCHE$$75$YR$E$M$Y$$$20240628$$MD$PT$PT
240249432$24024943$2$F$20230701$20231009$20240628$20240710$PER$$RO-ROCHE-3387668$ROCHE$$59$YR$A$M$Y$62.6$KG$20240628$$MD$RO$RO
240249482$24024948$2$F$$20240117$20240628$20240710$PER$$US-ROCHE-3494518$ROCHE$$32$YR$A$F$Y$$$20240628$$CN$US$US
240249533$24024953$3$F$20240404$20240717$20240628$20240803$30DAY$$US-AMGEN-USASL2024124038$AMGEN$$65$YR$E$F$Y$$$20240803$$PH$US$US
240249653$24024965$3$F$20240101$20240723$20240628$20240801$EXP$$US-ABBVIE-5817229$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
240249682$24024968$2$F$$20240802$20240628$20240806$PER$$US-ALXN-202406USA001462US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$CN$US$US
240249882$24024988$2$F$$20230731$20240628$20240710$PER$$IN-ROCHE-3397990$ROCHE$$35$YR$A$F$Y$$$20240628$$MD$IN$IN
240249923$24024992$3$F$$20240423$20240628$20240710$PER$$IN-ROCHE-3475870$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$IN$IN
240249943$24024994$3$F$$20240405$20240628$20240710$PER$$FR-ROCHE-2630810$ROCHE$$14$YR$T$M$Y$53.5$KG$20240628$$MD$FR$FR
240250062$24025006$2$F$$20231207$20240628$20240710$PER$$JP-ROCHE-3448450$ROCHE$$6$DEC$A$M$Y$$$20240628$$MD$JP$JP
240250082$24025008$2$F$$20240206$20240628$20240710$PER$$SG-ROCHE-3506652$ROCHE$$48$YR$A$F$Y$$$20240628$$CN$SG$SG
240250093$24025009$3$F$$20240223$20240628$20240710$PER$$IN-ROCHE-3402100$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$IN$IN
240250102$24025010$2$F$$20231010$20240628$20240710$PER$$CN-ROCHE-3406241$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$CN$CN
240250143$24025014$3$F$20200901$20230711$20240628$20240710$PER$$CN-ROCHE-3296763$ROCHE$$42$YR$A$F$Y$57.5$KG$20240628$$CN$CN$CN
240250155$24025015$5$F$$20240118$20240628$20240710$PER$$IN-ROCHE-3449428$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$IN$IN
240250163$24025016$3$F$20230301$20231021$20240628$20240710$PER$$CN-ROCHE-3387597$ROCHE$$65$YR$E$M$Y$60$KG$20240628$$CN$CN$CN
240250192$24025019$2$F$$20240116$20240628$20240710$PER$$PH-ROCHE-3494205$ROCHE$$50$YR$A$F$Y$$$20240628$$CN$PH$PH
240250222$24025022$2$F$$20231101$20240628$20240710$PER$$IN-ROCHE-3362393$ROCHE$$49$YR$A$M$Y$$$20240628$$CN$IN$IN
240250247$24025024$7$F$20230302$20240531$20240628$20240710$PER$$CN-ROCHE-3358887$ROCHE$$40$YR$A$F$Y$62.5$KG$20240628$$MD$CN$CN
240250255$24025025$5$F$20211208$20240207$20240628$20240710$PER$$CN-ROCHE-3002700$ROCHE$$56$YR$A$F$Y$51$KG$20240628$$MD$CN$CN
240250282$24025028$2$F$$20230720$20240628$20240710$PER$$IN-ROCHE-3362646$ROCHE$$69$YR$E$F$Y$$$20240628$$MD$IN$IN
240250333$24025033$3$F$$20240320$20240628$20240710$PER$$SG-ROCHE-3500372$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$SG$SG
240250352$24025035$2$F$$20231221$20240628$20240710$PER$$GB-ROCHE-3464387$ROCHE$$$$$$Y$$$20240628$$CN$GB$GB
240250372$24025037$2$F$$20240208$20240628$20240710$PER$$PH-ROCHE-3507948$ROCHE$$$$$F$Y$$$20240628$$CN$PH$PH
240250414$24025041$4$F$20230701$20231112$20240628$20240710$PER$$CN-ROCHE-3332511$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$CN$CN
240250444$24025044$4$F$$20240311$20240628$20240710$PER$$IN-ROCHE-3460440$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$IN$IN
240250542$24025054$2$F$$20240815$20240628$20240820$EXP$$US-BEH-2024174652$CSL BEHRING$$80$YR$E$M$Y$$$20240820$$HP$US$US
240250562$24025056$2$F$20230711$20240916$20240628$20240922$EXP$$DE-ABBVIE-5817549$ABBVIE$$53$YR$$M$Y$$$20240922$$MD$DE$DE
240250592$24025059$2$F$20240621$20240718$20240628$20240722$EXP$$IT-ABBVIE-5816004$ABBVIE$$78$YR$$F$Y$$$20240722$$MD$IT$IT
240250622$24025062$2$F$20240304$20240304$20240628$20240710$PER$$US-ROCHE-3520891$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$US$US
240250684$24025068$4$F$20240101$20240904$20240628$20240912$EXP$$NL-ABBVIE-5817727$ABBVIE$$$$E$F$Y$58$KG$20240912$$HP$NL$NL
240250732$24025073$2$F$20240207$20240207$20240628$20240710$PER$$JP-ROCHE-3512573$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240250742$24025074$2$F$$20231002$20240628$20240710$PER$$DE-ROCHE-3406436$ROCHE$$$$$F$Y$$$20240628$$MD$DE$DE
240250852$24025085$2$F$20240304$20240311$20240628$20240710$PER$$CO-ROCHE-3525158$ROCHE$$59$YR$A$M$Y$73$KG$20240628$$CN$CO$CO
240250922$24025092$2$F$$20231201$20240628$20240710$PER$$GB-ROCHE-3459953$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240250994$24025099$4$F$20190701$20240228$20240628$20240710$PER$$DK-ROCHE-3472647$ROCHE$$53$YR$A$M$Y$$$20240628$$MD$DK$DK
240251015$24025101$5$F$20220602$20240508$20240628$20240710$PER$$AU-ROCHE-3159225$ROCHE$$63$YR$A$F$Y$87.1$KG$20240628$$MD$AU$AU
240251064$24025106$4$F$$20240221$20240628$20240710$PER$$IN-ROCHE-3427465$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240251072$24025107$2$F$20240613$20240708$20240628$20240712$30DAY$$US-AMGEN-USASP2024125083$AMGEN$$39$YR$A$M$Y$$$20240712$$PH$US$US
240251093$24025109$3$F$20240620$20240709$20240628$20240712$30DAY$$US-AMGEN-USASP2024123937$AMGEN$$69$YR$E$M$Y$91.7$KG$20240712$$PH$US$US
240251122$24025112$2$F$20230804$20231113$20240628$20240710$PER$IT-MINISAL02-953342$IT-ROCHE-3456823$ROCHE$$80$YR$E$F$Y$$$20240628$$MD$IT$IT
240251142$24025114$2$F$20230105$20230713$20240628$20240710$PER$$CN-ROCHE-3335700$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$CN$CN
240251152$24025115$2$F$$20231113$20240628$20240710$PER$$RO-ROCHE-3457940$ROCHE$$63$YR$A$F$Y$79$KG$20240628$$CN$RO$RO
240251172$24025117$2$F$$20230822$20240628$20240710$PER$$SG-ROCHE-3410322$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$SG$SG
240251223$24025122$3$F$20240601$20240723$20240628$20240727$EXP$$US-ABBVIE-5817647$ABBVIE$$80$YR$$M$Y$$$20240727$$CN$US$US
240251262$24025126$2$F$$20240722$20240628$20240729$PER$$US-ALXN-202406USA001456US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
240251363$24025136$3$F$20220707$20240222$20240628$20240710$PER$$AU-ROCHE-3164025$ROCHE$$33$YR$A$F$Y$$$20240628$$MD$AU$AU
240251392$24025139$2$F$$20230801$20240628$20240710$PER$$IN-ROCHE-3399246$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$IN$IN
240251615$24025161$5$F$$20240412$20240628$20240710$PER$$AR-ROCHE-3513862$ROCHE$$35$YR$A$F$Y$$$20240628$$CN$AR$AR
240251653$24025165$3$F$20240301$20240402$20240628$20240710$PER$$JP-ROCHE-3541659$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240251662$24025166$2$F$20240227$20240327$20240628$20240710$PER$$JP-ROCHE-3528074$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240251693$24025169$3$F$20230825$20230827$20240628$20240710$PER$$IL-ROCHE-3412572$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$IL$IL
240251742$24025174$2$F$20210927$20240913$20240628$20240917$EXP$$JP-TAKEDA-2024TJP009698$TAKEDA$Tomoyuki Ogisu, Akiko Yamaguchi, Hitomi Kako, Saori Onishi, Hitomi Amano, Yasutaka Kato, et al.. Two cases of ALK-positive non-small cell lung cancer complicated by drug-induced lung injury associated with second-line treatment with brigatinib. Japanese Journal of Lung Cancer. 2024;64(2)$68$YR$$F$Y$$$20240917$$MD$JP$JP
240251832$24025183$2$F$$20240117$20240628$20240710$PER$$PH-ROCHE-3493641$ROCHE$$50$YR$A$F$Y$43$KG$20240628$$CN$PH$PH
240251842$24025184$2$F$$20240422$20240628$20240710$PER$$GB-ROCHE-3535128$ROCHE$$$$$$Y$$$20240628$$PH$GB$GB
240251852$24025185$2$F$$20240319$20240628$20240710$PER$$US-ROCHE-3538679$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240251862$24025186$2$F$$20231123$20240628$20240710$PER$$IN-ROCHE-3465930$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$IN$IN
240251882$24025188$2$F$20230426$20230706$20240628$20240710$PER$$KR-ROCHE-3349009$ROCHE$$70$YR$E$$Y$$$20240628$$MD$KR$KR
240251892$24025189$2$F$20230501$20230720$20240628$20240710$PER$$CN-ROCHE-3319445$ROCHE$$73$YR$E$F$Y$70$KG$20240628$$CN$CN$CN
240251953$24025195$3$F$$20240710$20240628$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-018844$UNITED THERAPEUTICS$$$$$F$Y$57.596$KG$20240713$$$US$US
240251992$24025199$2$F$$20231027$20240628$20240710$PER$$PT-ROCHE-3450833$ROCHE$$47$YR$A$F$Y$$$20240628$$HP$PT$PT
240252032$24025203$2$F$$20240312$20240628$20240710$PER$$PH-ROCHE-3525011$ROCHE$$47$YR$A$F$Y$59$KG$20240628$$CN$PH$PH
240252132$24025213$2$F$20240101$20240314$20240628$20240710$PER$$JP-ROCHE-3544413$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$JP$JP
240252142$24025214$2$F$20240209$20240215$20240628$20240710$PER$$JP-ROCHE-3517072$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240252314$24025231$4$F$20220615$20240604$20240628$20240710$PER$$ES-ROCHE-3399563$ROCHE$$55$YR$A$$Y$$$20240628$$MD$ES$ES
240252335$24025233$5$F$20230607$20240517$20240628$20240710$PER$$TR-ROCHE-3386598$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$TR$TR
240252382$24025238$2$F$20230127$20231007$20240628$20240710$PER$$CN-ROCHE-3276979$ROCHE$$40$YR$A$M$Y$70$KG$20240628$$CN$CN$CN
240252505$24025250$5$F$$20231102$20240628$20240710$PER$$IN-ROCHE-3246801$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$IN$IN
240252522$24025252$2$F$$20240128$20240628$20240710$PER$$VN-ROCHE-3464952$ROCHE$$69$YR$E$F$Y$$$20240628$$MD$VN$VN
240252642$24025264$2$F$$20240702$20240628$20240705$EXP$$US-PIRAMAL CRITICAL CARE LIMITED-2024-PPL-000490$PIRAMAL$$$$$$Y$$$20240705$$HP$US$US
240252664$24025266$4$F$20230707$20230710$20240628$20240710$PER$$US-ROCHE-3385424$ROCHE$$39$YR$A$F$Y$$$20240628$$PH$US$US
240252683$24025268$3$F$$20231017$20240628$20240710$PER$$IN-ROCHE-3414085$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$IN$IN
240252782$24025278$2$F$$20240620$20240628$20240704$EXP$$US-CIPLA LTD.-2024US06541$CIPLA$Hourigan EK, Rattan M, Olsen ML. The right side of cardiogenic shock: A case of beta-blocker induced cardiogenic shock in a female with suspected pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1595$$$$$Y$$$20240704$$MD$US$US
240252792$24025279$2$F$$20240301$20240628$20240710$PER$$JP-ROCHE-3533636$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$JP$JP
240252802$24025280$2$F$$20240402$20240628$20240710$PER$$JP-ROCHE-3536160$ROCHE$$4$DEC$A$F$Y$$$20240628$$MD$JP$JP
240252946$24025294$6$F$$20230824$20240628$20240710$PER$$IN-ROCHE-3335127$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$IN$IN
240252954$24025295$4$F$$20230913$20240628$20240710$PER$$IL-ROCHE-3399136$ROCHE$$$$A$M$Y$$$20240628$$CN$IL$IL
240252982$24025298$2$F$20230414$20230818$20240628$20240710$PER$$VN-ROCHE-3408780$ROCHE$$69$YR$E$F$Y$55$KG$20240628$$MD$VN$VN
240253062$24025306$2$F$$20231028$20240628$20240710$PER$$IN-ROCHE-3451438$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$IN$IN
240253122$24025312$2$F$$20231213$20240628$20240710$PER$$AL-ROCHE-3462929$ROCHE$$47$YR$A$F$Y$$$20240628$$CN$AL$AL
240253292$24025329$2$F$20240623$20240626$20240628$20240701$PER$$US-AMGEN-USASP2024126082$AMGEN$$64$YR$A$M$Y$$$20240701$$PH$US$US
240253312$24025331$2$F$$20230803$20240628$20240710$PER$$TH-ROCHE-3400417$ROCHE$$$$$F$Y$$$20240628$$CN$TH$TH
240253372$24025337$2$F$$20231013$20240628$20240710$PER$$IN-ROCHE-3440857$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$IN$IN
240253403$24025340$3$F$20220101$20240508$20240628$20240710$PER$$AR-ROCHE-3361343$ROCHE$$52$YR$A$M$Y$$$20240628$$MD$AR$AR
240253435$24025343$5$F$20221110$20230831$20240628$20240710$PER$$VN-ROCHE-3245484$ROCHE$$65$YR$E$F$Y$50$KG$20240628$$MD$VN$VN
240253443$24025344$3$F$$20230814$20240628$20240710$PER$$IN-ROCHE-3405768$ROCHE$$47$YR$A$F$Y$$$20240628$$MD$IN$IN
240253474$24025347$4$F$$20240226$20240628$20240710$PER$$IN-ROCHE-3421277$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240253482$24025348$2$F$20231024$20231026$20240628$20240710$PER$$VN-ROCHE-3447594$ROCHE$$$$A$M$Y$$$20240628$$MD$VN$VN
240253522$24025352$2$F$$20230801$20240628$20240710$PER$$RO-ROCHE-3399551$ROCHE$$62$YR$A$F$Y$74$KG$20240628$$CN$RO$RO
240253592$24025359$2$F$$20240701$20240628$20240710$PER$$US-SA-2024SA188391$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240710$$MD$US$US
240253612$24025361$2$F$$20230904$20240628$20240710$PER$$PE-ROCHE-3419413$ROCHE$$51$YR$A$F$Y$$$20240628$$CN$PE$PE
240253672$24025367$2$F$$20230927$20240628$20240710$PER$$US-ROCHE-3430740$ROCHE$$41$YR$A$F$Y$$$20240628$$HP$US$US
240253765$24025376$5$F$$20240528$20240628$20240710$PER$$IN-ROCHE-3312834$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$IN$IN
240253803$24025380$3$F$$20230905$20240628$20240710$PER$$IN-ROCHE-3418666$ROCHE$$71$YR$E$F$Y$$$20240628$$MD$IN$IN
240253853$24025385$3$F$20220523$20240527$20240628$20240710$PER$$CN-ROCHE-3200460$ROCHE$$61$YR$A$F$Y$73$KG$20240628$$MD$CN$CN
240253872$24025387$2$F$$20231009$20240628$20240710$PER$$IN-ROCHE-3411990$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240253915$24025391$5$F$$20230724$20240628$20240710$PER$$IN-ROCHE-3394362$ROCHE$$35$YR$A$F$Y$$$20240628$$MD$IN$IN
240253928$24025392$8$F$$20231207$20240628$20240710$PER$$IN-ROCHE-3439638$ROCHE$$40$YR$A$F$Y$$$20240628$$MD$IN$IN
240253953$24025395$3$F$$20231031$20240628$20240710$PER$$TH-ROCHE-3403914$ROCHE$$70$YR$E$F$Y$$$20240628$$CN$TH$TH
240253982$24025398$2$F$$20231026$20240628$20240710$PER$$US-ROCHE-3431279$ROCHE$$75$YR$E$M$Y$$$20240628$$CN$US$US
240254022$24025402$2$F$$20240731$20240628$20240805$PER$$US-ALXN-202405USA002045US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240254042$24025404$2$F$20230922$20231101$20240628$20240710$PER$$IT-ROCHE-3437435$ROCHE$$49$YR$A$F$Y$57$KG$20240628$$MD$IT$IT
240254092$24025409$2$F$20220813$20231205$20240628$20240710$PER$$ES-ROCHE-3193911$ROCHE$$54$YR$A$$Y$$$20240628$$MD$ES$ES
240254122$24025412$2$F$$20240619$20240628$20240704$EXP$$PH-STRIDES ARCOLAB LIMITED-2024SP007486$STRIDES$Batara JMF, Apor ADAO, Mojica CV, Mondia MWL. Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis.. Neurooncol-Adv. 2022;4 (1)$70$YR$$M$Y$$$20240704$$MD$PH$PH
240254244$24025424$4$F$$20231206$20240628$20240710$PER$$TH-ROCHE-3407220$ROCHE$$47$YR$A$F$Y$$$20240628$$HP$TH$TH
240254253$24025425$3$F$$20240101$20240628$20240710$PER$$IN-ROCHE-3423514$ROCHE$$68$YR$E$F$Y$$$20240628$$MD$IN$IN
240254372$24025437$2$F$$20230710$20240628$20240710$PER$$SG-ROCHE-3385916$ROCHE$$$$$F$Y$$$20240628$$CN$SG$SG
240254382$24025438$2$F$$20240105$20240628$20240710$PER$$IN-ROCHE-3427176$ROCHE$$71$YR$E$F$Y$$$20240628$$MD$IN$IN
240254392$24025439$2$F$20230831$20230905$20240628$20240710$PER$$US-ROCHE-3415650$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240254424$24025442$4$F$20230711$20230824$20240628$20240710$PER$$CN-ROCHE-3411113$ROCHE$$41$YR$A$F$Y$62.5$KG$20240628$$MD$CN$CN
240254463$24025446$3$F$20230901$20231017$20240628$20240710$PER$$CL-ROCHE-3433066$ROCHE$$34$YR$A$F$Y$$$20240628$$CN$CL$CL
240254522$24025452$2$F$20240524$20240719$20240628$20240725$PER$$US-ALXN-202405USA002278US$ALEXION PHARMACEUTICALS$$52$YR$$F$Y$$$20240719$$CN$US$US
240254532$24025453$2$F$20220422$20230706$20240628$20240710$PER$$AU-ROCHE-3128267$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$AU$AU
240254592$24025459$2$F$$20231026$20240628$20240710$PER$$US-ROCHE-3447584$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$US$US
240254682$24025468$2$F$20240101$20240826$20240628$20240905$EXP$$US-UCBSA-2024004550$UCB$$$$$F$Y$$$20240905$$CN$US$US
240254763$24025476$3$F$20230405$20240507$20240628$20240710$PER$$AR-ROCHE-3398334$ROCHE$$34$YR$A$F$Y$61$KG$20240628$$MD$AR$AR
240254782$24025478$2$F$20230901$20231023$20240628$20240710$PER$$CN-ROCHE-3419180$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$CN$CN
240254822$24025482$2$F$20240419$20240628$20240628$20240710$EXP$$US-AstraZeneca-2024A147151$ASTRAZENECA$$29274$DY$$M$Y$$$20240710$$CN$US$
240254834$24025483$4$F$$20231103$20240628$20240710$PER$$IN-ROCHE-3421216$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$IN$IN
240254862$24025486$2$F$$20231017$20240628$20240710$PER$$PH-ROCHE-3443795$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$PH$PH
240254912$24025491$2$F$20230928$20231010$20240628$20240710$PER$$US-ROCHE-3418649$ROCHE$$66$YR$E$F$Y$60.33$KG$20240628$$HP$US$US
240254962$24025496$2$F$$20231125$20240628$20240710$PER$$IN-ROCHE-3448717$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IN$IN
240255023$24025502$3$F$$20230723$20240628$20240710$PER$$IN-ROCHE-3358098$ROCHE$$64$YR$A$F$Y$$$20240628$$CN$IN$IN
240255032$24025503$2$F$$20240202$20240628$20240710$PER$$FR-ROCHE-3443844$ROCHE$$25$YR$A$F$Y$$$20240628$$PH$FR$FR
240255042$24025504$2$F$20230801$20231110$20240628$20240710$PER$$JP-ROCHE-3411060$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240255142$24025514$2$F$$20231025$20240628$20240710$PER$$IN-ROCHE-3379940$ROCHE$$29$YR$A$F$Y$$$20240628$$MD$IN$IN
240255212$24025521$2$F$$20230704$20240628$20240710$PER$$IN-ROCHE-3383203$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$IN$IN
240255222$24025522$2$F$$20240702$20240628$20240709$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-103227$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240709$$CN$GB$GB
240255262$24025526$2$F$20220119$20231212$20240628$20240710$PER$$AU-ROCHE-3031545$ROCHE$$33$YR$A$F$Y$$$20240628$$MD$AU$AU
240255302$24025530$2$F$20230703$20240319$20240628$20240710$PER$$IL-ROCHE-3451060$ROCHE$$78$YR$E$M$Y$$$20240628$$MD$IL$IL
240255322$24025532$2$F$$20230918$20240628$20240710$PER$$LT-ROCHE-3425327$ROCHE$$$$$F$Y$$$20240628$$MD$LT$LT
240255354$24025535$4$F$$20240827$20240628$20240905$EXP$$US-GSK-US2024AMR078452$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
240255413$24025541$3$F$$20240102$20240628$20240710$PER$$IN-ROCHE-3425097$ROCHE$$64$YR$A$F$Y$$$20240628$$MD$IN$IN
240255452$24025545$2$F$$20231027$20240628$20240710$PER$$IN-ROCHE-3440077$ROCHE$$56$YR$A$F$Y$$$20240628$$MD$IN$IN
240255482$24025548$2$F$$20231102$20240628$20240710$PER$$US-ROCHE-3449354$ROCHE$$40$YR$A$F$Y$$$20240628$$CN$US$US
240255543$24025554$3$F$$20230706$20240628$20240710$PER$$IN-ROCHE-3386255$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$IN$IN
240255582$24025558$2$F$20240501$20240717$20240628$20240722$EXP$$NVSJ2024JP007622$NOVARTIS$$82$YR$$F$Y$$$20240722$$PH$JP$JP
240255652$24025565$2$F$$20231201$20240628$20240710$PER$$US-ROCHE-3425647$ROCHE$$48$YR$A$M$Y$$$20240628$$CN$US$US
240255682$24025568$2$F$20240606$20240703$20240628$20240809$PER$$FR-TOLMAR, INC.-24FR050042$TOLMAR$$73$YR$$M$Y$$$20240809$$PH$FR$FR
240255702$24025570$2$F$20240606$20240705$20240628$20240809$PER$$FR-TOLMAR, INC.-24FR050067$TOLMAR$$91$YR$$M$Y$$$20240809$$PH$FR$FR
240255712$24025571$2$F$20240601$20240709$20240628$20240809$PER$$FR-TOLMAR, INC.-24FR050107$TOLMAR$$69$YR$$M$Y$$$20240809$$PH$FR$FR
240255722$24025572$2$F$$20240709$20240628$20240813$PER$$FR-TOLMAR, INC.-24FR050109$TOLMAR$$$$$M$Y$$$20240813$$PH$FR$FR
240255732$24025573$2$F$20240610$20240709$20240628$20240813$PER$$FR-TOLMAR, INC.-24FR050111$TOLMAR$$70$YR$$M$Y$$$20240813$$PH$FR$FR
240255794$24025579$4$F$20240530$20240801$20240628$20240809$EXP$$US-JNJFOC-20240655669$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240809$$CN$US$US
240255812$24025581$2$F$$20240227$20240628$20240710$PER$$RO-ROCHE-3419474$ROCHE$$53$YR$A$F$Y$60$KG$20240628$$CN$RO$RO
240255863$24025586$3$F$20240601$20240703$20240628$20240710$PER$$US-ABBVIE-5818063$ABBVIE$$54$YR$$M$Y$70$KG$20240710$$CN$US$US
240255882$24025588$2$F$20230901$20230906$20240628$20240710$PER$$CN-ROCHE-3418348$ROCHE$$53$YR$A$M$Y$51$KG$20240628$$CN$CN$CN
240255892$24025589$2$F$20230401$20230810$20240628$20240710$PER$$CN-ROCHE-3331633$ROCHE$$57$YR$A$F$Y$55$KG$20240628$$CN$CN$CN
240255974$24025597$4$F$20230203$20240604$20240628$20240710$PER$$LT-ROCHE-3345788$ROCHE$$66$YR$E$M$Y$83$KG$20240628$$MD$LT$LT
240256014$24025601$4$F$20220501$20231004$20240628$20240710$PER$$RO-ROCHE-3370960$ROCHE$$65$YR$E$F$Y$54$KG$20240628$$CN$RO$RO
240256022$24025602$2$F$20230611$20230713$20240628$20240710$PER$$CN-ROCHE-3201104$ROCHE$$52$YR$A$M$Y$$$20240628$$CN$CN$CN
240256044$24025604$4$F$20231018$20231120$20240628$20240710$PER$$VN-ROCHE-3447280$ROCHE$$38$YR$A$F$Y$54$KG$20240628$$MD$VN$VN
240256062$24025606$2$F$$20240913$20240628$20240918$EXP$$IN-ROCHE-3395512$ROCHE$$58$YR$A$F$Y$$$20240918$$MD$IN$IN
240256072$24025607$2$F$$20230829$20240628$20240710$PER$$SG-ROCHE-3415510$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$SG$SG
240256082$24025608$2$F$$20230921$20240628$20240710$PER$$US-ROCHE-3426705$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240256102$24025610$2$F$$20230726$20240628$20240710$PER$$IN-ROCHE-3395379$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240256162$24025616$2$F$20230701$20230914$20240628$20240710$PER$$IN-ROCHE-3395616$ROCHE$$$$$F$Y$$$20240628$$MD$IN$IN
240256182$24025618$2$F$20220906$20230712$20240628$20240710$PER$$IL-ROCHE-3322481$ROCHE$$66$YR$E$M$Y$87$KG$20240628$$MD$IL$IL
240256232$24025623$2$F$20230519$20231204$20240628$20240710$PER$$DK-ROCHE-3368110$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$DK$DK
240256282$24025628$2$F$20230911$20230920$20240628$20240710$PER$$US-ROCHE-3420859$ROCHE$$80$YR$E$F$Y$$$20240628$$PH$US$US
240256362$24025636$2$F$$20240813$20240628$20240820$EXP$$DE-GSK-DE2024EME057050$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$MD$DE$DE
240256373$24025637$3$F$$20230908$20240628$20240710$PER$$IN-ROCHE-3421273$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$IN$IN
240256383$24025638$3$F$20220822$20240604$20240628$20240710$PER$$CN-ROCHE-3306084$ROCHE$$68$YR$E$M$Y$79$KG$20240628$$MD$CN$CN
240256404$24025640$4$F$$20231011$20240628$20240710$PER$$IN-ROCHE-3439992$ROCHE$$40$YR$A$F$Y$$$20240628$$MD$IN$IN
240256432$24025643$2$F$$20231101$20240628$20240710$PER$$US-ROCHE-3449981$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240256452$24025645$2$F$$20230828$20240628$20240710$PER$$RO-ROCHE-3414931$ROCHE$$41$YR$A$F$Y$55$KG$20240628$$CN$RO$RO
240256492$24025649$2$F$20240101$20240716$20240628$20240726$EXP$$US-INTERCEPT-PM2024001276$INTERCEPT PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
240256502$24025650$2$F$20240601$20240807$20240628$20240814$EXP$$US-INTERCEPT-PM2024001280$INTERCEPT PHARMACEUTICALS$$78$YR$$F$Y$72.562$KG$20240814$$CN$US$US
240256522$24025652$2$F$$20240802$20240628$20240805$PER$$US-ALXN-202406USA001415US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
240256533$24025653$3$F$20230626$20230713$20240628$20240710$PER$$TH-ROCHE-3382687$ROCHE$$54$YR$A$F$Y$$$20240628$$CN$TH$TH
240256603$24025660$3$F$$20240102$20240628$20240710$PER$$FR-ROCHE-2813378$ROCHE$$10$YR$C$F$Y$32.6$KG$20240628$$MD$FR$FR
240256664$24025666$4$F$20230722$20230731$20240628$20240710$PER$$CN-ROCHE-3394460$ROCHE$$69$YR$E$M$Y$79$KG$20240628$$MD$CN$CN
240256742$24025674$2$F$$20230713$20240628$20240710$PER$$US-ROCHE-3390265$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240256765$24025676$5$F$20230911$20230918$20240628$20240710$PER$$IL-ROCHE-3351407$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$IL$IL
240256793$24025679$3$F$$20230912$20240628$20240710$PER$$RO-ROCHE-3374667$ROCHE$$75$YR$E$F$Y$60$KG$20240628$$CN$RO$RO
240256842$24025684$2$F$20230411$20231206$20240628$20240710$PER$$BE-ROCHE-3334300$ROCHE$$79$YR$E$M$Y$67$KG$20240628$$MD$BE$BE
240256872$24025687$2$F$$20230711$20240628$20240710$PER$$CU-ROCHE-3388754$ROCHE$$$$$$Y$$$20240628$$CN$CU$CU
240256882$24025688$2$F$$20240913$20240628$20240917$EXP$$JP-TAKEDA-2024TJP009669$TAKEDA$Tomoyuki Ogisu, Akiko Yamaguchi, Hitomi Kako, Saori Onishi, Hitomi Amano, Yasutaka Kato, et al.. ALK-positive non-small cell lung cancer with concurrent drug-induced lung injury during second-line brigatinib therapy in 2 patients. Japanese Journal of Lung Cancer. 2024;64(2)$71$YR$$M$Y$$$20240917$$MD$JP$JP
240256913$24025691$3$F$$20230713$20240628$20240710$PER$$IN-ROCHE-3387908$ROCHE$$74$YR$E$F$Y$$$20240628$$MD$IN$IN
240256963$24025696$3$F$20230502$20240429$20240628$20240710$PER$$DK-ROCHE-3368268$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$DK$DK
240256982$24025698$2$F$$20230925$20240628$20240710$PER$$DE-ROCHE-3429247$ROCHE$$$$A$M$Y$$$20240628$$MD$DE$DE
240257022$24025702$2$F$$20230803$20240628$20240710$PER$$CA-ROCHE-3399638$ROCHE$$$$A$M$Y$$$20240628$$CN$CA$CA
240257063$24025706$3$F$$20230828$20240628$20240710$PER$$IN-ROCHE-3272034$ROCHE$$41$YR$A$F$Y$$$20240628$$MD$IN$IN
240257083$24025708$3$F$$20231027$20240628$20240710$PER$$US-ROCHE-2696721$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$US$US
240257125$24025712$5$F$20230727$20240511$20240628$20240710$PER$$FI-ROCHE-3413796$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$FI$FI
240257134$24025713$4$F$20220318$20230707$20240628$20240710$PER$$IT-ROCHE-3385292$ROCHE$$84$YR$E$M$Y$76$KG$20240628$$MD$IT$IT
240257143$24025714$3$F$20220121$20240124$20240628$20240710$PER$$IT-ROCHE-3328152$ROCHE$$84$YR$E$M$Y$76$KG$20240628$$MD$IT$IT
240257172$24025717$2$F$$20230809$20240628$20240710$PER$$ES-ROCHE-3403400$ROCHE$$$$$F$Y$$$20240628$$PH$ES$ES
240257182$24025718$2$F$20230614$20230803$20240628$20240710$PER$$RU-ROCHE-3399698$ROCHE$$61$YR$A$F$Y$99$KG$20240628$$MD$RU$RU
240257242$24025724$2$F$$20231004$20240628$20240710$PER$$IN-ROCHE-3405613$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$IN$IN
240257272$24025727$2$F$20220404$20230817$20240628$20240710$PER$$RS-ROCHE-3189894$ROCHE$$75$YR$E$F$Y$70$KG$20240628$$MD$RS$RS
240257306$24025730$6$F$20230228$20240527$20240628$20240710$PER$$IT-ROCHE-3353979$ROCHE$$47$YR$A$F$Y$62$KG$20240628$$MD$IT$IT
240257323$24025732$3$F$20211124$20240604$20240628$20240710$PER$$CN-ROCHE-3305813$ROCHE$$67$YR$E$M$Y$92$KG$20240628$$MD$CN$CN
240257333$24025733$3$F$$20230711$20240628$20240710$PER$$IN-ROCHE-3321644$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$IN$IN
240257342$24025734$2$F$$20230718$20240628$20240710$PER$$IN-ROCHE-3391853$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$IN$IN
240257373$24025737$3$F$20230513$20230901$20240628$20240710$PER$$CN-ROCHE-3416045$ROCHE$$59$YR$A$M$Y$$$20240628$$MD$CN$CN
240257382$24025738$2$F$$20240925$20240628$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100094$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240925$$CN$US$US
240257402$24025740$2$F$$20231014$20240628$20240710$PER$$IN-ROCHE-3369563$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$IN$IN
240257532$24025753$2$F$20230624$20230823$20240628$20240710$PER$$CO-ROCHE-3408827$ROCHE$$30$YR$A$F$Y$93$KG$20240628$$CN$CO$CO
240257552$24025755$2$F$$20230824$20240628$20240710$PER$$US-ROCHE-3410930$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240257572$24025757$2$F$$20231115$20240628$20240710$PER$$TH-ROCHE-3264532$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$TH$TH
240257587$24025758$7$F$20240603$20240726$20240628$20240807$EXP$$PT-AUROBINDO-AUR-APL-2024-030530$AUROBINDO$$$$A$F$Y$91.3$KG$20240807$$MD$PT$PT
240257622$24025762$2$F$$20230727$20240628$20240710$PER$$US-ROCHE-3395309$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240257643$24025764$3$F$20210623$20240608$20240628$20240710$PER$$TR-ROCHE-2898848$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$TR$TR
240257772$24025777$2$F$$20240605$20240628$20240710$PER$$US-ROCHE-2883627$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$US$US
240257802$24025780$2$F$$20230906$20240628$20240710$PER$$GB-ROCHE-3418391$ROCHE$$35$YR$A$F$Y$$$20240628$$HP$GB$GB
240257832$24025783$2$F$$20240515$20240628$20240710$PER$$FR-ROCHE-3102082$ROCHE$$5$YR$C$M$Y$22$KG$20240628$$PH$FR$FR
240257853$24025785$3$F$20230101$20240430$20240628$20240710$PER$$SG-ROCHE-3397253$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$SG$SG
240257883$24025788$3$F$20230801$20240517$20240628$20240710$PER$$BE-ROCHE-3453789$ROCHE$$86$YR$E$F$Y$47$KG$20240628$$MD$BE$BE
240257893$24025789$3$F$$20231219$20240628$20240710$PER$$IN-ROCHE-3411492$ROCHE$$34$YR$A$F$Y$$$20240628$$MD$IN$IN
240257903$24025790$3$F$20240614$20240717$20240628$20240726$PER$$US-UNITED THERAPEUTICS-UNT-2024-018933$UNITED THERAPEUTICS$$60$YR$$F$Y$$$20240726$$$US$US
240257953$24025795$3$F$20220815$20231206$20240628$20240710$PER$$BE-ROCHE-3180499$ROCHE$$56$YR$A$M$Y$74.8$KG$20240628$$MD$BE$BE
240257982$24025798$2$F$20230326$20240528$20240628$20240710$PER$$IN-ROCHE-3346165$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240257992$24025799$2$F$$20230908$20240628$20240710$PER$$CA-ROCHE-3419816$ROCHE$$$$A$F$Y$$$20240628$$CN$CA$CA
240258022$24025802$2$F$20230301$20240710$20240628$20240714$EXP$$CA-JNJFOC-20240656319$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$HP$CA$CA
240258073$24025807$3$F$$20240302$20240628$20240710$PER$$IN-ROCHE-3419036$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$IN$IN
240258085$24025808$5$F$$20240516$20240628$20240710$PER$$IN-ROCHE-3388684$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$IN$IN
240258092$24025809$2$F$20230901$20231002$20240628$20240710$PER$$US-ROCHE-3433990$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240258103$24025810$3$F$20231001$20231102$20240628$20240710$PER$$US-ROCHE-3451377$ROCHE$$$$A$F$Y$$$20240628$$HP$US$US
240258113$24025811$3$F$$20240410$20240628$20240710$PER$$IN-ROCHE-3478216$ROCHE$$33$YR$A$F$Y$$$20240628$$MD$IN$IN
240258123$24025812$3$F$20240621$20240723$20240628$20240730$PER$$US-AMGEN-USASP2024123927$AMGEN$$50$YR$A$F$Y$60.24$KG$20240730$$HP$US$US
240258182$24025818$2$F$20211206$20240522$20240628$20240710$PER$$IT-ROCHE-3203941$ROCHE$$55$YR$A$F$Y$60$KG$20240628$$MD$IT$IT
240258202$24025820$2$F$20211109$20240608$20240628$20240710$PER$$TR-ROCHE-2980736$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$TR$TR
240258213$24025821$3$F$20220308$20230818$20240628$20240710$PER$$BG-ROCHE-3211963$ROCHE$$76$YR$E$F$Y$60$KG$20240628$$MD$BG$BG
240258312$24025831$2$F$$20240102$20240628$20240710$PER$$PH-ROCHE-3470367$ROCHE$$46$YR$A$F$Y$67$KG$20240628$$CN$PH$PH
240258332$24025833$2$F$$20240416$20240628$20240710$PER$$IN-ROCHE-3455416$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
240258352$24025835$2$F$$20240703$20240628$20240712$PER$$US-SA-2024SA189298$SANOFI AVENTIS$$$$$M$Y$$$20240712$$CN$US$US
240258382$24025838$2$F$$20240215$20240628$20240710$PER$$ID-ROCHE-3495097$ROCHE$$60$YR$A$F$Y$$$20240628$$CN$ID$ID
240258392$24025839$2$F$20230601$20240719$20240628$20240731$PER$$US-SA-2023SA221433$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240731$$MD$US$US
240258403$24025840$3$F$20231213$20231227$20240628$20240710$PER$$JP-ROCHE-3479583$ROCHE$$47$YR$A$F$Y$$$20240628$$MD$JP$JP
240258414$24025841$4$F$$20240528$20240628$20240710$PER$$IN-ROCHE-3405572$ROCHE$$71$YR$E$F$Y$$$20240628$$MD$IN$IN
240258433$24025843$3$F$20240116$20240529$20240628$20240710$PER$$DK-ROCHE-3504866$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$DK$DK
240258453$24025845$3$F$20230824$20240101$20240628$20240710$PER$$DK-ROCHE-3472351$ROCHE$$83$YR$E$F$Y$$$20240628$$MD$DK$DK
240258473$24025847$3$F$$20240527$20240628$20240710$PER$$IN-ROCHE-3257652$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240258482$24025848$2$F$20240101$20240701$20240628$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-016868$UNITED THERAPEUTICS$$$$$F$Y$$$20240704$$$US$US
240258493$24025849$3$F$20240501$20240710$20240628$20240715$EXP$$CA-JNJFOC-20240661904$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240715$$HP$CA$CA
240258542$24025854$2$F$20240201$20240209$20240628$20240710$PER$$US-ROCHE-3508388$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240258554$24025855$4$F$20230519$20230830$20240628$20240710$PER$$PT-ROCHE-3358968$ROCHE$$50$YR$A$M$Y$82$KG$20240628$$MD$PT$PT
240258583$24025858$3$F$20231008$20231228$20240628$20240710$PER$$RS-ROCHE-3483603$ROCHE$$58$YR$A$F$Y$60$KG$20240628$$MD$RS$RS
240258603$24025860$3$F$$20240419$20240628$20240710$PER$$IN-ROCHE-3483689$ROCHE$$62$YR$A$M$Y$$$20240628$$CN$IN$IN
240258614$24025861$4$F$$20240405$20240628$20240710$PER$$IN-ROCHE-3494020$ROCHE$$50$YR$A$F$Y$$$20240628$$MD$IN$IN
240258652$24025865$2$F$20220215$20240517$20240628$20240710$PER$$CN-ROCHE-3274595$ROCHE$$59$YR$A$F$Y$75$KG$20240628$$MD$CN$CN
240258692$24025869$2$F$20231020$20240429$20240628$20240710$PER$$BG-ROCHE-3500403$ROCHE$$78$YR$E$F$Y$60$KG$20240628$$MD$BG$BG
240258714$24025871$4$F$20220923$20240531$20240628$20240710$PER$$CN-ROCHE-3490496$ROCHE$$77$YR$E$F$Y$66$KG$20240628$$MD$CN$CN
240258725$24025872$5$F$20220919$20240527$20240628$20240710$PER$$CN-ROCHE-3490672$ROCHE$$77$YR$E$F$Y$66$KG$20240628$$MD$CN$CN
240258732$24025873$2$F$20230523$20240520$20240628$20240710$PER$$IL-ROCHE-3494299$ROCHE$$62$YR$A$M$Y$86.6$KG$20240628$$MD$IL$IL
240258772$24025877$2$F$20240620$20240719$20240628$20240730$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-001122$Alvotech$$67$YR$$F$Y$$$20240730$$CN$CA$CA
240258853$24025885$3$F$$20240531$20240628$20240710$PER$$IN-ROCHE-3512842$ROCHE$$81$YR$E$F$Y$$$20240628$$MD$IN$IN
240258862$24025886$2$F$$20240514$20240628$20240710$PER$$PH-ROCHE-3508647$ROCHE$$$$$$Y$$$20240628$$CN$PH$PH
240258932$24025893$2$F$$20240815$20240628$20240821$EXP$$US-SA-2024SA189406$SANOFI AVENTIS$$$$A$M$Y$167$KG$20240821$$MD$US$US
240258982$24025898$2$F$20240620$20240627$20240628$20240708$PER$$US-SA-2024SA187273$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240708$$MD$US$US
240259113$24025911$3$F$$20230823$20240628$20240710$PER$$IN-ROCHE-3412520$ROCHE$$42$YR$A$F$Y$$$20240628$$MD$IN$IN
240259192$24025919$2$F$20221201$20231003$20240628$20240710$PER$$BE-ROCHE-3311993$ROCHE$$56$YR$A$M$Y$74.5$KG$20240628$$MD$BE$BE
240259313$24025931$3$F$20240113$20240413$20240628$20240710$PER$$BD-ROCHE-3491700$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$BD$BD
240259453$24025945$3$F$20220901$20240606$20240628$20240710$PER$$CO-ROCHE-3212587$ROCHE$$65$YR$E$M$Y$92.8$KG$20240628$$MD$CO$CO
240259462$24025946$2$F$$20231003$20240628$20240710$PER$$US-ROCHE-3433407$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$US$US
240259492$24025949$2$F$20240301$20240325$20240628$20240710$PER$$MX-ROCHE-3521921$ROCHE$$56$YR$A$F$Y$57$KG$20240628$$CN$MX$MX
240259512$24025951$2$F$20240202$20240514$20240628$20240710$PER$$IN-ROCHE-3522430$ROCHE$$48$YR$A$F$Y$$$20240628$$CN$IN$IN
240259554$24025955$4$F$$20240523$20240628$20240710$PER$$IN-ROCHE-3421932$ROCHE$$44$YR$A$F$Y$$$20240628$$MD$IN$IN
240259722$24025972$2$F$$20240415$20240628$20240710$PER$$IN-ROCHE-3531050$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240259732$24025973$2$F$$20240419$20240628$20240710$PER$$IN-ROCHE-3532316$ROCHE$$48$YR$A$M$Y$$$20240628$$MD$IN$IN
240259742$24025974$2$F$20220927$20240202$20240628$20240710$PER$$ES-ROCHE-3504854$ROCHE$$82$YR$E$$Y$$$20240628$$MD$ES$ES
240259752$24025975$2$F$$20240215$20240628$20240710$PER$$US-ROCHE-3509682$ROCHE$$66$YR$E$M$Y$$$20240628$$CN$US$US
240259853$24025985$3$F$20240101$20240710$20240628$20240716$EXP$$CA-JNJFOC-20240658069$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240716$$HP$CA$CA
240259912$24025991$2$F$$20240102$20240628$20240710$PER$$IN-ROCHE-3486363$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240259942$24025994$2$F$20240301$20240410$20240628$20240710$PER$$JP-ROCHE-3543504$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240259974$24025997$4$F$$20240523$20240628$20240710$PER$$US-ROCHE-3535834$ROCHE$$67$YR$E$F$Y$99.79$KG$20240628$$MD$US$US
240259983$24025998$3$F$$20240412$20240628$20240710$PER$$IN-ROCHE-3509294$ROCHE$$68$YR$E$M$Y$$$20240628$$MD$IN$IN
240260012$24026001$2$F$20240307$20240311$20240628$20240710$PER$$MX-ROCHE-3526029$ROCHE$$55$YR$A$F$Y$58$KG$20240628$$CN$MX$MX
240260023$24026002$3$F$$20240306$20240628$20240710$PER$$IN-ROCHE-3523961$ROCHE$$34$YR$A$F$Y$$$20240628$$MD$IN$IN
240260042$24026004$2$F$$20240322$20240628$20240710$PER$$US-ROCHE-3532600$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$US$US
240260055$24026005$5$F$$20240828$20240628$20240902$EXP$$IN-ROCHE-3411656$ROCHE$$60$YR$A$F$Y$$$20240902$$MD$IN$IN
240260073$24026007$3$F$$20240315$20240628$20240710$PER$$PH-ROCHE-3527478$ROCHE$$44$YR$A$F$Y$67.5$KG$20240628$$CN$PH$PH
240260082$24026008$2$F$$20231102$20240628$20240710$PER$$US-ROCHE-2584446$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$US$US
240260133$24026013$3$F$$20240624$20240628$20240709$EXP$$JP-ABBVIE-5815281$ABBVIE$$30$YR$$F$Y$$$20240709$$MD$JP$JP
240260152$24026015$2$F$20240624$20240717$20240628$20240723$PER$$US-AMGEN-USASP2024124934$AMGEN$$63$YR$A$M$Y$$$20240723$$CN$US$US
240260162$24026016$2$F$$20240802$20240628$20240810$PER$$US-AstraZeneca-2024A148444$ASTRAZENECA$$$$$$Y$$$20240810$$CN$US$
240260192$24026019$2$F$$20240806$20240628$20240814$EXP$$ES-AstraZeneca-2024A147431$ASTRAZENECA$$$$$F$Y$$$20240814$$MD$ES$
240260303$24026030$3$F$$20240806$20240628$20240830$PER$$US-CHATTEMPRD-2024OHG020540$CHATTEM$$30$YR$A$M$Y$$$20240830$$HP$US$US
240260312$24026031$2$F$$20240118$20240628$20240710$PER$$DE-ROCHE-3495330$ROCHE$$$$$F$Y$$$20240628$$CN$DE$DE
240260392$24026039$2$F$$20240730$20240628$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103360$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240806$$CN$US$US
240260402$24026040$2$F$20240101$20240422$20240628$20240710$PER$$IT-ROCHE-3515182$ROCHE$$50$YR$A$M$Y$$$20240628$$MD$IT$IT
240260422$24026042$2$F$$20240223$20240628$20240710$PER$$IN-ROCHE-3517178$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$IN$IN
240260433$24026043$3$F$$20230705$20240628$20240710$PER$$US-ROCHE-3383737$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$US$US
240260512$24026051$2$F$$20240705$20240628$20240712$PER$$US-CHATTEMPRD-2024OHG021912$CHATTEM$$67$YR$E$M$Y$$$20240712$$CN$US$US
240260522$24026052$2$F$20220221$20240523$20240628$20240710$PER$$CN-ROCHE-3060938$ROCHE$$56$YR$A$M$Y$63$KG$20240628$$MD$CN$CN
240260533$24026053$3$F$20220127$20230731$20240628$20240710$PER$$BE-ROCHE-3217456$ROCHE$$77$YR$E$M$Y$67$KG$20240628$$MD$BE$BE
240260542$24026054$2$F$$20231208$20240628$20240710$PER$$CH-ROCHE-3468412$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240260552$24026055$2$F$20231024$20240111$20240628$20240710$PER$$CN-ROCHE-3490526$ROCHE$$59$YR$A$F$Y$60.6$KG$20240628$$MD$CN$CN
240260563$24026056$3$F$$20240402$20240628$20240710$PER$$IN-ROCHE-3508406$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$IN$IN
240260572$24026057$2$F$$20230706$20240628$20240710$PER$$PH-ROCHE-3386205$ROCHE$$54$YR$A$F$Y$70$KG$20240628$$CN$PH$PH
240260652$24026065$2$F$$20240112$20240628$20240710$PER$$US-ROCHE-3493266$ROCHE$$75$YR$E$F$Y$$$20240628$$CN$US$US
240260694$24026069$4$F$20231208$20240522$20240628$20240710$PER$$TR-ROCHE-3475176$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$TR$TR
240260702$24026070$2$F$$20240606$20240628$20240710$PER$$IN-ROCHE-3531577$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$IN$IN
240260752$24026075$2$F$$20240411$20240628$20240710$PER$$TH-ROCHE-3512407$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$TH$TH
240260762$24026076$2$F$$20231010$20240628$20240710$PER$$IN-ROCHE-3438283$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$IN$IN
240260772$24026077$2$F$$20240425$20240628$20240710$PER$$IN-ROCHE-3550879$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$IN$IN
240260792$24026079$2$F$20240314$20240517$20240628$20240710$PER$$JP-ROCHE-3548616$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240260862$24026086$2$F$$20240410$20240628$20240710$PER$$IN-ROCHE-3545750$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$IN$IN
240260892$24026089$2$F$20240119$20240220$20240628$20240710$PER$$AT-ROCHE-3513387$ROCHE$$57$YR$A$F$Y$69$KG$20240628$$MD$AT$AT
240260923$24026092$3$F$$20230823$20240628$20240710$PER$$IN-ROCHE-3410275$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$IN$IN
240261002$24026100$2$F$$20240222$20240628$20240710$PER$$US-ROCHE-2838714$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$US$US
240261032$24026103$2$F$$20240514$20240628$20240710$PER$$RO-ROCHE-3556828$ROCHE$$52$YR$A$F$Y$36$KG$20240628$$CN$RO$RO
240261042$24026104$2$F$20240405$20240416$20240628$20240710$PER$$LV-ROCHE-3548108$ROCHE$$45$YR$A$F$Y$$$20240628$$CN$LV$LV
240261092$24026109$2$F$$20240711$20240628$20240724$EXP$$DE-UCBSA-2024032685$UCB$$$$$M$Y$$$20240724$$CN$US$DE
240261164$24026116$4$F$20240604$20240917$20240628$20240920$EXP$$US-TAKEDA-2023TUS023069$TAKEDA$$64$YR$$F$Y$63$KG$20240920$$HP$US$US
240261262$24026126$2$F$$20240508$20240628$20240710$PER$$US-ROCHE-3558130$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$US$US
240261292$24026129$2$F$$20240722$20240628$20240802$EXP$$EG-ROCHE-10000009415$ROCHE$$41$YR$A$F$Y$82$KG$20240802$$CN$EG$EG
240261304$24026130$4$F$20220217$20240517$20240628$20240710$PER$$CN-ROCHE-3487529$ROCHE$$58$YR$A$M$Y$75$KG$20240628$$MD$CN$CN
240261312$24026131$2$F$$20240126$20240628$20240710$PER$$JP-ROCHE-3506137$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240261372$24026137$2$F$$20240718$20240628$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05419$LUPIN$$$$$$Y$$$20240808$$CN$US$US
240261412$24026141$2$F$$20240701$20240628$20240711$EXP$$JP-AMGEN-JPNSP2024126693$AMGEN$P1-1 Case report of patients treated with chemotherapy for breast cancer with the use of a scalp cooling device - Future challenges obtained from the patients -. The 7th Gunma Pharmaceutical Meeting. 40$6$DEC$A$F$Y$$$20240711$$MD$JP$JP
240261442$24026144$2$F$$20240313$20240628$20240710$PER$$JP-ROCHE-3544059$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240261653$24026165$3$F$20211008$20240201$20240628$20240710$PER$$CN-ROCHE-2983446$ROCHE$$51$YR$A$F$Y$79$KG$20240628$$MD$CN$CN
240261662$24026166$2$F$$20240516$20240628$20240710$PER$$JP-ROCHE-3560014$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240261772$24026177$2$F$20220514$20240716$20240628$20240724$EXP$$GB-SANDOZ INC.-NVSC2022GB170048$SANDOZ$$49$YR$$M$Y$$$20240724$$PH$GB$GB
240261902$24026190$2$F$20230424$20230721$20240628$20240710$PER$$DK-ROCHE-3368250$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$DK$DK
240261924$24026192$4$F$20220914$20240422$20240628$20240710$PER$$CN-ROCHE-3189014$ROCHE$$52$YR$A$M$Y$87$KG$20240628$$MD$CN$CN
240261932$24026193$2$F$20240328$20240516$20240628$20240710$PER$$JP-ROCHE-3539282$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240261982$24026198$2$F$20240101$20240313$20240628$20240710$PER$$EG-ROCHE-3528311$ROCHE$$$$A$F$Y$$$20240628$$CN$EG$EG
240262012$24026201$2$F$$20240711$20240628$20240723$PER$$US-AstraZeneca-2024A140457$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
240262022$24026202$2$F$$20240805$20240628$20240806$PER$$US-ALXN-202406USA001473US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240262044$24026204$4$F$20220117$20240516$20240628$20240710$PER$$TR-ROCHE-3149619$ROCHE$$23$YR$A$F$Y$70$KG$20240628$$MD$TR$TR
240262053$24026205$3$F$20230123$20240222$20240628$20240710$PER$$IT-ROCHE-3348964$ROCHE$$69$YR$E$M$Y$$$20240628$$MD$IT$IT
240262062$24026206$2$F$20230615$20230725$20240628$20240710$PER$PT-INFARMED-B202307-357$PT-ROCHE-3393745$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$PT$PT
240262073$24026207$3$F$$20230920$20240628$20240710$PER$$IN-ROCHE-3421306$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240262092$24026209$2$F$20221212$20240416$20240628$20240710$PER$$CN-ROCHE-3285757$ROCHE$$30$YR$A$F$Y$65$KG$20240628$$MD$CN$CN
240262213$24026221$3$F$20221018$20240114$20240628$20240710$PER$$IL-ROCHE-3491941$ROCHE$$50$YR$A$M$Y$74$KG$20240628$$MD$IL$IL
240262282$24026228$2$F$20240209$20240227$20240628$20240710$PER$$JP-ROCHE-3526090$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240262312$24026231$2$F$20240309$20240312$20240628$20240710$PER$$JP-ROCHE-3542152$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240262322$24026232$2$F$$20240702$20240628$20240708$EXP$$US-Bion-013338$BIONPHARMA$$$$$$Y$$$20240708$$CN$US$US
240262392$24026239$2$F$20240206$20240530$20240628$20240710$PER$$JP-ROCHE-3559453$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240262412$24026241$2$F$20231221$20240410$20240628$20240710$PER$$JP-ROCHE-3522787$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$JP$JP
240262462$24026246$2$F$$20240216$20240628$20240710$PER$$JP-ROCHE-3517052$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240262472$24026247$2$F$$20240430$20240628$20240710$PER$$RO-ROCHE-3557402$ROCHE$$48$YR$A$F$Y$52$KG$20240628$$CN$RO$RO
240262533$24026253$3$F$20231108$20240303$20240628$20240710$PER$$RU-ROCHE-3519709$ROCHE$$29$YR$A$M$Y$100$KG$20240628$$MD$RU$RU
240262546$24026254$6$F$20240116$20240606$20240628$20240710$PER$$CN-ROCHE-3522847$ROCHE$$41$YR$A$F$Y$62.5$KG$20240628$$MD$CN$CN
240262553$24026255$3$F$20220624$20240325$20240628$20240710$PER$$BE-ROCHE-3181026$ROCHE$$44$YR$A$M$Y$87$KG$20240628$$MD$BE$BE
240262744$24026274$4$F$$20240416$20240628$20240710$PER$$RO-ROCHE-3549918$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$RO$RO
240262764$24026276$4$F$20240620$20240826$20240628$20240913$30DAY$$MX-AMGEN-MEXSP2024124474$AMGEN$$67$YR$E$F$Y$$$20240913$$MD$MX$MX
240262813$24026281$3$F$20211223$20240517$20240628$20240710$PER$$IT-ROCHE-3351562$ROCHE$$49$YR$A$F$Y$71$KG$20240628$$MD$IT$IT
240262835$24026283$5$F$20230309$20240315$20240628$20240710$PER$$RO-ROCHE-3492666$ROCHE$$54$YR$A$F$Y$84$KG$20240628$$MD$RO$RO
240262882$24026288$2$F$$20240822$20240628$20240906$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-11SUNGE29P$RANBAXY$Willemsen AE, van Herpen CM, Wesseling P, Bult P, van Laarhoven HW.. Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma.. Acta Oncol. 2011;50(3):462-5$53$YR$$F$Y$$$20240906$$MD$NL$NL
240262973$24026297$3$F$20230908$20231124$20240628$20240710$PER$$CN-ROCHE-3465161$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$CN$CN
240263082$24026308$2$F$$20240321$20240628$20240710$PER$$JP-ROCHE-3545748$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240263254$24026325$4$F$$20240506$20240628$20240710$PER$$BD-ROCHE-3558449$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$BD$BD
240263312$24026331$2$F$$20240524$20240628$20240710$PER$$ES-ROCHE-3569444$ROCHE$$$$A$F$Y$55$KG$20240628$$MD$ES$ES
240263323$24026332$3$F$20230328$20231116$20240628$20240710$PER$$IT-ROCHE-3459777$ROCHE$$71$YR$E$M$Y$$$20240628$$MD$IT$IT
240263333$24026333$3$F$20230301$20240327$20240628$20240710$PER$$CN-ROCHE-3354021$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$CN$CN
240263352$24026335$2$F$20240102$20240515$20240628$20240710$PER$$RS-ROCHE-3529836$ROCHE$$56$YR$A$F$Y$91$KG$20240628$$MD$RS$RS
240263432$24026343$2$F$20240219$20240802$20240628$20240807$EXP$$CO-TAKEDA-2024TUS016911$TAKEDA$$10$YR$$F$Y$30.5$KG$20240807$$CN$CO$CO
240263493$24026349$3$F$20220117$20240530$20240628$20240710$PER$$IT-ROCHE-3335918$ROCHE$$59$YR$A$F$Y$55$KG$20240628$$MD$IT$IT
240263563$24026356$3$F$20230401$20231018$20240628$20240710$PER$$PT-ROCHE-3445289$ROCHE$Pulido C, Albuquerque J, Correia J and Passos-coelho J Treatment with PHESGO in a patient receiving 1 hemodialysis. ;:-.$52$YR$A$F$Y$$$20240628$$MD$PT$PT
240263582$24026358$2$F$20220405$20240604$20240628$20240710$PER$$ES-ROCHE-3133103$ROCHE$$42$YR$A$$Y$$$20240628$$MD$ES$ES
240263702$24026370$2$F$20231201$20240311$20240628$20240710$PER$$CO-ROCHE-3520250$ROCHE$$74$YR$E$F$Y$48$KG$20240628$$CN$CO$CO
240263743$24026374$3$F$20220215$20240213$20240628$20240710$PER$$AT-ROCHE-3039324$ROCHE$$49$YR$A$F$Y$51$KG$20240628$$MD$AT$AT
240263822$24026382$2$F$20240619$20240723$20240628$20240729$30DAY$$US-AMGEN-USASP2024123532$AMGEN$$53$YR$A$M$Y$82.2$KG$20240729$$PH$US$US
240263852$24026385$2$F$$20240311$20240628$20240710$PER$$CO-ROCHE-3522516$ROCHE$$74$YR$E$F$Y$48$KG$20240628$$CN$CO$CO
240263886$24026388$6$F$20220509$20240403$20240628$20240710$PER$$CN-ROCHE-3101880$ROCHE$$64$YR$A$M$Y$69.6$KG$20240628$$MD$CN$CN
240263892$24026389$2$F$$20240327$20240628$20240710$PER$$JP-ROCHE-3551676$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240264032$24026403$2$F$20180401$20240327$20240628$20240710$PER$$AT-ROCHE-3215951$ROCHE$$76$YR$E$M$Y$$$20240628$$MD$AT$AT
240264082$24026408$2$F$$20240228$20240628$20240710$PER$$AU-ROCHE-3194368$ROCHE$$$$A$F$Y$69$KG$20240628$$MD$AU$AU
240264093$24026409$3$F$20240110$20240403$20240628$20240710$PER$$IT-ROCHE-3529175$ROCHE$$55$YR$A$F$Y$50$KG$20240628$$MD$IT$IT
240264263$24026426$3$F$20240516$20240521$20240628$20240710$PER$$CA-ROCHE-3566376$ROCHE$$82$YR$E$F$Y$$$20240628$$HP$CA$CA
240264402$24026440$2$F$$20240606$20240628$20240710$PER$$GB-ROCHE-3569453$ROCHE$$$$$$Y$$$20240628$$PH$GB$GB
240264422$24026442$2$F$$20240606$20240628$20240710$PER$$AL-ROCHE-3567852$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$AL$AL
240264442$24026444$2$F$20240601$20240916$20240628$20240924$PER$$US-SA-2024SA188170$SANOFI AVENTIS$$90$YR$E$M$Y$$$20240924$$MD$US$US
240264482$24026448$2$F$$20240119$20240628$20240710$PER$$RO-ROCHE-3497970$ROCHE$$66$YR$E$$Y$$$20240628$$MD$RO$RO
240264532$24026453$2$F$$20240620$20240628$20240704$EXP$$US-CIPLA LTD.-2024US06593$CIPLA$Tajfiroozeh D, Silva R, Otsuka KN, Wai A.. A rare presentation of hepatopulmonary syndrome in the setting of chemotherapy associated steatohepatitis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2289$$$$$Y$$$20240704$$MD$US$US
240264633$24026463$3$F$20230424$20240801$20240628$20240808$EXP$$CA-CELLTRION INC.-2023CA015656$CELLTRION$$$$$$Y$$$20240808$$HP$CA$CA
240264682$24026468$2$F$$20240116$20240628$20240710$PER$$DE-ROCHE-3495380$ROCHE$$$$$F$Y$$$20240628$$MD$DE$DE
240264712$24026471$2$F$20220913$20240710$20240628$20240712$EXP$$JP-EMD Serono-2024034806$EMD SERONO INC$$77$YR$E$M$Y$71$KG$20240712$$HP$JP$JP
240264722$24026472$2$F$20240701$20240828$20240628$20240905$EXP$$US-UCBSA-2024032756$UCB$$70$YR$$F$Y$$$20240906$$HP$US$US
240264952$24026495$2$F$20240415$20240415$20240628$20240710$PER$$JP-ROCHE-3559767$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$JP$JP
240265082$24026508$2$F$20240226$20240229$20240628$20240710$PER$$JP-ROCHE-3531210$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240265183$24026518$3$F$$20240415$20240628$20240710$PER$$US-ROCHE-3531643$ROCHE$$72$YR$E$M$Y$$$20240628$$CN$US$US
240265202$24026520$2$F$$20231115$20240628$20240710$PER$$IN-ROCHE-3460421$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$IN$IN
240265213$24026521$3$F$20220304$20240604$20240628$20240710$PER$$CN-ROCHE-3286456$ROCHE$$56$YR$A$F$Y$64.8$KG$20240628$$MD$CN$CN
240265223$24026522$3$F$$20240513$20240628$20240710$PER$$RO-ROCHE-3563845$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240265232$24026523$2$F$$20240409$20240628$20240710$PER$$US-ROCHE-3542065$ROCHE$$$$E$F$Y$59.87$KG$20240628$$CN$US$US
240265263$24026526$3$F$20220904$20231101$20240628$20240710$PER$$IL-ROCHE-3184770$ROCHE$$63$YR$A$M$Y$67$KG$20240628$$MD$IL$IL
240265272$24026527$2$F$20230605$20240408$20240628$20240710$PER$$JP-ROCHE-3538559$ROCHE$$43$YR$A$M$Y$$$20240628$$PH$JP$JP
240265355$24026535$5$F$20230509$20230825$20240628$20240710$PER$$TR-ROCHE-3413792$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$TR$TR
240265363$24026536$3$F$$20230912$20240628$20240710$PER$$IN-ROCHE-3421755$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240265373$24026537$3$F$20230607$20240506$20240628$20240710$PER$$AT-ROCHE-3364752$ROCHE$$31$YR$A$M$Y$80$KG$20240628$$MD$AT$AT
240265543$24026554$3$F$20230411$20231201$20240628$20240710$PER$$IT-ROCHE-3469295$ROCHE$$80$YR$E$M$Y$75$KG$20240628$$MD$IT$IT
240265672$24026567$2$F$20231211$20240307$20240628$20240710$PER$$AR-ROCHE-3523769$ROCHE$$66$YR$E$M$Y$104$KG$20240628$$MD$AR$AR
240265703$24026570$3$F$20240227$20240417$20240628$20240710$PER$$DK-ROCHE-3534509$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$DK$DK
240265713$24026571$3$F$$20230922$20240628$20240710$PER$$IN-ROCHE-3429490$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$IN$IN
240265732$24026573$2$F$$20240508$20240628$20240710$PER$$RO-ROCHE-3547151$ROCHE$$57$YR$A$F$Y$76$KG$20240628$$CN$RO$RO
240265852$24026585$2$F$$20240506$20240628$20240710$PER$$NO-ROCHE-3558918$ROCHE$$$$$$Y$$$20240628$$PH$NO$NO
240265862$24026586$2$F$20231220$20240424$20240628$20240710$PER$$PT-ROCHE-3522497$ROCHE$$50$YR$A$M$Y$82$KG$20240628$$MD$PT$PT
240265902$24026590$2$F$$20240625$20240628$20240712$EXP$$ZA-HALEON-2183772$Haleon PLC$$$$$$Y$$$20240710$$CN$ZA$ZA
240265933$24026593$3$F$20240219$20240408$20240628$20240710$PER$$TN-ROCHE-3514374$ROCHE$$60$YR$A$M$Y$$$20240628$$MD$TN$TN
240265954$24026595$4$F$20220916$20240607$20240628$20240710$PER$$RS-ROCHE-3218554$ROCHE$$77$YR$E$M$Y$81$KG$20240628$$MD$RS$RS
240266012$24026601$2$F$$20240702$20240628$20240705$EXP$$GB-JNJFOC-20240665508$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240705$$CN$GB$GB
240266082$24026608$2$F$$20240205$20240628$20240710$PER$$JP-ROCHE-3511111$ROCHE$$$$$F$Y$$$20240628$$PH$JP$JP
240266112$24026611$2$F$20240601$20240712$20240628$20240718$EXP$$US-JNJFOC-20240666632$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240718$$CN$US$US
240266244$24026624$4$F$20220403$20240308$20240628$20240710$PER$$CN-ROCHE-3101939$ROCHE$$64$YR$A$M$Y$70$KG$20240628$$MD$CN$CN
240266263$24026626$3$F$$20240708$20240628$20240711$30DAY$$FR-SANDOZ INC.-SDZ2024FR061367$SANDOZ$$$$C$F$Y$$$20240711$$CN$FR$FR
240266293$24026629$3$F$20221221$20231204$20240628$20240710$PER$$DK-ROCHE-3258235$ROCHE$$79$YR$E$F$Y$$$20240628$$MD$DK$DK
240266303$24026630$3$F$$20230710$20240628$20240710$PER$$IN-ROCHE-3349755$ROCHE$$74$YR$E$F$Y$$$20240628$$MD$IN$IN
240266334$24026633$4$F$20240205$20240429$20240628$20240710$PER$$DK-ROCHE-3519407$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$DK$DK
240266373$24026637$3$F$$20240507$20240628$20240710$PER$$US-ROCHE-3471029$ROCHE$$$$E$F$Y$$$20240628$$CN$US$US
240266482$24026648$2$F$$20240117$20240628$20240710$PER$$IN-ROCHE-3495168$ROCHE$$68$YR$E$M$Y$$$20240628$$MD$IN$IN
240266702$24026670$2$F$20240501$20240916$20240628$20240926$PER$$US-GSK-US2024GSK079419$GLAXOSMITHKLINE$$37$YR$$M$Y$$$20240926$$CN$US$US
240266712$24026671$2$F$$20240627$20240628$20240704$EXP$$CA-ABBVIE-5817668$ABBVIE$$$$E$F$Y$$$20240704$$CN$CA$CA
240266782$24026678$2$F$20240510$20240510$20240628$20240710$PER$$JP-ROCHE-3569623$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240266922$24026692$2$F$20240405$20240409$20240628$20240710$PER$$JP-ROCHE-3559335$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240266942$24026694$2$F$20230526$20230718$20240628$20240710$PER$$RU-ROCHE-3390762$ROCHE$$60$YR$A$F$Y$64$KG$20240628$$MD$RU$RU
240266963$24026696$3$F$20240101$20240627$20240628$20240704$PER$$US-BIOGEN-2024BI01261989$BIOGEN$$$$$F$Y$$$20240704$$CN$US$US
240267002$24026700$2$F$$20240709$20240628$20240802$PER$$US-BIOGEN-2024BI01270701$BIOGEN$$$$$F$Y$$$20240802$$CN$US$US
240267264$24026726$4$F$20230901$20240523$20240628$20240710$PER$$CN-ROCHE-3551824$ROCHE$$60$YR$A$M$Y$54$KG$20240628$$MD$CN$CN
240267296$24026729$6$F$20220323$20240606$20240628$20240710$PER$$BE-ROCHE-3066782$ROCHE$$83$YR$E$F$Y$65.5$KG$20240628$$MD$BE$BE
240267303$24026730$3$F$20220803$20240529$20240628$20240710$PER$$AU-ROCHE-3291528$ROCHE$$77$YR$E$F$Y$$$20240628$$MD$AU$AU
240267312$24026731$2$F$$20240514$20240628$20240710$PER$$IT-ROCHE-3552429$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$IT$IT
240267352$24026735$2$F$20211206$20240322$20240628$20240710$PER$$TR-ROCHE-2983523$ROCHE$$$$A$F$Y$$$20240628$$MD$TR$TR
240267392$24026739$2$F$20220525$20240311$20240628$20240710$PER$$IT-ROCHE-3137272$ROCHE$$47$YR$A$M$Y$73$KG$20240628$$MD$IT$IT
240267402$24026740$2$F$20240101$20240917$20240628$20240920$EXP$$US-ABBVIE-5817476$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
240267593$24026759$3$F$20240622$20240708$20240628$20240710$PER$$US-AMGEN-USASP2024126176$AMGEN$$$$$$Y$$$20240710$$HP$US$US
240267814$24026781$4$F$20230711$20240124$20240628$20240710$PER$$IT-ROCHE-3498598$ROCHE$$47$YR$A$F$Y$54$KG$20240628$$MD$IT$IT
240267843$24026784$3$F$$20240802$20240628$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002712$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
240267872$24026787$2$F$20240321$20240327$20240628$20240710$PER$$CL-ROCHE-3534696$ROCHE$$55$YR$A$F$Y$84$KG$20240628$$MD$CL$CL
240267902$24026790$2$F$$20240528$20240628$20240710$PER$$SK-ROCHE-3574602$ROCHE$$$$$F$Y$$$20240628$$PH$SK$SK
240267922$24026792$2$F$$20240521$20240628$20240710$PER$$IT-ROCHE-3554218$ROCHE$$74$YR$E$F$Y$$$20240628$$MD$IT$IT
240267955$24026795$5$F$$20240423$20240628$20240710$PER$$NL-ROCHE-3534162$ROCHE$$$$$$Y$$$20240628$$MD$NL$NL
240267973$24026797$3$F$20210727$20240419$20240628$20240710$PER$$CN-ROCHE-3004550$ROCHE$$55$YR$A$F$Y$58$KG$20240628$$MD$CN$CN
240268013$24026801$3$F$20230316$20240423$20240628$20240710$PER$$IT-ROCHE-3339659$ROCHE$$54$YR$A$F$Y$47$KG$20240628$$MD$IT$IT
240268023$24026802$3$F$20220214$20231018$20240628$20240710$PER$$CN-ROCHE-3350011$ROCHE$$33$YR$A$M$Y$77$KG$20240628$$MD$CN$CN
240268107$24026810$7$F$20240101$20240918$20240628$20240925$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000538$DECIPHERA PHARMACEUTICALS$$58$YR$A$F$Y$$$20240925$$MD$US$US
240268142$24026814$2$F$$20240521$20240628$20240710$PER$$IT-ROCHE-3554279$ROCHE$$40$YR$A$$Y$$$20240628$$MD$IT$IT
240268203$24026820$3$F$20230802$20240605$20240628$20240710$PER$$CU-ROCHE-3430118$ROCHE$$54$YR$A$M$Y$83$KG$20240628$$MD$CU$CU
240268212$24026821$2$F$$20240423$20240628$20240710$PER$$IT-ROCHE-3552481$ROCHE$$78$YR$E$M$Y$$$20240628$$MD$IT$IT
240268263$24026826$3$F$$20240903$20240628$20240913$EXP$$GB-AUROBINDO-AUR-APL-2024-024306$AUROBINDO$$79$YR$$F$Y$$$20240913$$CN$GB$GB
240268322$24026832$2$F$$20231004$20240628$20240710$PER$$US-ROCHE-3434520$ROCHE$$63$YR$A$M$Y$$$20240628$$CN$US$US
240268362$24026836$2$F$20230101$20240412$20240628$20240710$PER$$AT-ROCHE-3547163$ROCHE$$95$YR$E$F$Y$$$20240628$$MD$AT$AT
240268435$24026843$5$F$20211105$20240308$20240628$20240710$PER$$AR-ROCHE-3006133$ROCHE$$50$YR$A$M$Y$$$20240628$$MD$AR$AR
240268454$24026845$4$F$20231213$20240606$20240628$20240710$PER$$VN-ROCHE-3564911$ROCHE$$42$YR$A$F$Y$$$20240628$$MD$VN$VN
240268563$24026856$3$F$20220407$20240220$20240628$20240710$PER$$IT-ROCHE-3159218$ROCHE$$46$YR$A$F$Y$58$KG$20240628$$MD$IT$IT
240268682$24026868$2$F$$20240925$20240628$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA061181$SANDOZ$$47$YR$$F$Y$$$20240927$$MD$CA$CA
240268692$24026869$2$F$20230701$20240507$20240628$20240710$PER$$LT-ROCHE-3559906$ROCHE$$54$YR$A$F$Y$56$KG$20240628$$MD$LT$LT
240268702$24026870$2$F$20240123$20240131$20240628$20240710$PER$$DK-ROCHE-3504750$ROCHE$$37$YR$A$F$Y$$$20240628$$MD$DK$DK
240268712$24026871$2$F$20231103$20240228$20240628$20240710$PER$$DK-ROCHE-3519477$ROCHE$$43$YR$A$F$Y$$$20240628$$MD$DK$DK
240268732$24026873$2$F$20221101$20240912$20240628$20240919$PER$$US-ROCHE-3561554$ROCHE$$63$YR$A$F$Y$76.66$KG$20240919$$CN$US$US
240268743$24026874$3$F$20240111$20240131$20240628$20240710$PER$$DK-ROCHE-3504744$ROCHE$$70$YR$E$M$Y$$$20240628$$MD$DK$DK
240268812$24026881$2$F$20240422$20240515$20240628$20240710$PER$$BE-ROCHE-3563208$ROCHE$$77$YR$E$M$Y$74.3$KG$20240628$$MD$BE$BE
240268822$24026882$2$F$$20240812$20240628$20240813$EXP$$DE-SANDOZ INC.-SDZ2024DE061205$SANDOZ$$$$$F$Y$$$20240813$$HP$DE$DE
240268853$24026885$3$F$$20240806$20240628$20240809$EXP$$US-ROCHE-10000008396$ROCHE$$74$YR$E$M$Y$$$20240810$$CN$US$US
240268862$24026886$2$F$$20240708$20240628$20240716$EXP$$GB-CELLTRION INC.-2024GB015379$CELLTRION$$$$$$Y$$$20240716$$CN$GB$GB
240268882$24026888$2$F$20240616$20240626$20240628$20240726$PER$$US-AstraZeneca-2024A141686$ASTRAZENECA$$16246$DY$$M$Y$$$20240726$$CN$US$
240268912$24026891$2$F$20240626$20240627$20240628$20240705$PER$$US-AMGEN-USASP2024127667$AMGEN$$64$YR$A$F$Y$$$20240704$$CN$US$US
240268933$24026893$3$F$20240101$20240816$20240628$20240823$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000564$DECIPHERA PHARMACEUTICALS$$66$YR$A$$Y$$$20240823$$CN$US$US
240268942$24026894$2$F$20240215$20240701$20240628$20240709$EXP$$JP-AstraZeneca-2024A147235$ASTRAZENECA$$72$YR$$F$Y$$$20240709$$PH$JP$
240268952$24026895$2$F$$20240423$20240628$20240710$PER$$IT-ROCHE-3552439$ROCHE$$74$YR$E$M$Y$$$20240628$$MD$IT$IT
240268972$24026897$2$F$$20240115$20240628$20240710$PER$$US-ROCHE-3493000$ROCHE$$88$YR$E$F$Y$$$20240628$$CN$US$US
240269002$24026900$2$F$20231217$20240521$20240628$20240710$PER$$RS-ROCHE-3566608$ROCHE$$44$YR$A$F$Y$68$KG$20240628$$MD$RS$RS
240269012$24026901$2$F$$20240907$20240628$20240917$EXP$$IN-ROCHE-3566123$ROCHE$$59$YR$A$F$Y$$$20240917$$CN$IN$IN
240269083$24026908$3$F$20230101$20240419$20240628$20240710$PER$$FI-ROCHE-3509926$ROCHE$$72$YR$E$M$Y$101$KG$20240628$$MD$FI$FI
240269092$24026909$2$F$20230707$20240103$20240628$20240710$PER$$CN-ROCHE-3486703$ROCHE$$60$YR$A$F$Y$75$KG$20240628$$MD$CN$CN
240269103$24026910$3$F$20221129$20240328$20240628$20240710$PER$$CN-ROCHE-3535320$ROCHE$$65$YR$E$F$Y$50$KG$20240628$$MD$CN$CN
240269122$24026912$2$F$20230707$20240521$20240628$20240710$PER$$RS-ROCHE-3566571$ROCHE$$44$YR$A$F$Y$69$KG$20240628$$MD$RS$RS
240269132$24026913$2$F$20230120$20231024$20240628$20240710$PER$$RS-ROCHE-3285010$ROCHE$$60$YR$A$M$Y$64$KG$20240628$$MD$RS$RS
240269142$24026914$2$F$20240229$20240319$20240628$20240710$PER$$RS-ROCHE-3531168$ROCHE$$56$YR$A$F$Y$90$KG$20240628$$MD$RS$RS
240269192$24026919$2$F$20240318$20240603$20240628$20240710$PER$$LT-ROCHE-3567262$ROCHE$$45$YR$A$M$Y$100$KG$20240628$$MD$LT$LT
240269272$24026927$2$F$$20240516$20240628$20240710$PER$$US-ROCHE-3564973$ROCHE$$81$YR$E$F$Y$$$20240628$$MD$US$US
240269293$24026929$3$F$20231019$20240523$20240628$20240710$PER$$CN-ROCHE-3567259$ROCHE$$56$YR$A$F$Y$$$20240628$$MD$CN$CN
240269342$24026934$2$F$20240201$20240701$20240628$20240710$EXP$$BR-CELLTRION INC.-2024BR015477$CELLTRION$$$$$$Y$$$20240710$$CN$BR$BR
240269392$24026939$2$F$$20240903$20240628$20240906$PER$$US-ROCHE-3567486$ROCHE$$53$YR$A$M$Y$$$20240906$$CN$US$US
240269412$24026941$2$F$20221003$20240516$20240628$20240710$PER$$IT-ROCHE-3281155$ROCHE$$63$YR$A$F$Y$80$KG$20240628$$MD$IT$IT
240269432$24026943$2$F$$20240430$20240628$20240710$PER$$US-ROCHE-3557684$ROCHE$$64$YR$A$F$Y$$$20240628$$CN$US$US
240269482$24026948$2$F$$20240624$20240628$20240718$EXP$$CA-ORGANON-O2406CAN002180$ORGANON$$44$YR$$F$Y$$$20240718$$HP$CA$CA
240269523$24026952$3$F$20231020$20240529$20240628$20240710$PER$$AU-ROCHE-3567364$ROCHE$$78$YR$E$F$Y$$$20240628$$MD$AU$AU
240269582$24026958$2$F$$20240708$20240628$20240716$EXP$$US-GSK-US2024AMR079025$GLAXOSMITHKLINE$$$$$F$Y$69.887$KG$20240716$$CN$US$US
240269662$24026966$2$F$20220810$20240517$20240628$20240710$PER$$CN-ROCHE-3173769$ROCHE$$64$YR$A$F$Y$53$KG$20240628$$MD$CN$CN
240269702$24026970$2$F$20240522$20240529$20240628$20240710$PER$$TR-ROCHE-3569649$ROCHE$$71$YR$E$M$Y$81$KG$20240628$$MD$TR$TR
240269773$24026977$3$F$20220121$20240523$20240628$20240710$PER$$AT-ROCHE-3019811$ROCHE$$72$YR$E$F$Y$66$KG$20240628$$MD$AT$AT
240269783$24026978$3$F$$20240517$20240628$20240710$PER$$US-ROCHE-3567735$ROCHE$$74$YR$E$M$Y$88.9$KG$20240628$$CN$US$US
240269873$24026987$3$F$20231120$20240424$20240628$20240710$PER$$IT-ROCHE-3553093$ROCHE$$67$YR$E$F$Y$77$KG$20240628$$MD$IT$IT
240269892$24026989$2$F$20240620$20240926$20240628$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103409$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240926$$CN$US$US
240269902$24026990$2$F$20240426$20240729$20240628$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102622$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240806$$HP$US$US
240269915$24026991$5$F$$20240826$20240628$20240827$PER$$NVSC2024US134743$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
240269942$24026994$2$F$20240521$20240523$20240628$20240710$PER$$TR-ROCHE-3570021$ROCHE$$71$YR$E$M$Y$81$KG$20240628$$MD$TR$TR
240270082$24027008$2$F$20220704$20240220$20240628$20240710$PER$$IT-ROCHE-3157279$ROCHE$$46$YR$A$F$Y$62$KG$20240628$$MD$IT$IT
240270105$24027010$5$F$20240620$20240716$20240628$20240719$PER$$US-AMGEN-USASP2024124013$AMGEN$$68$YR$E$M$Y$63.492$KG$20240718$$CN$US$US
240270112$24027011$2$F$$20240702$20240628$20240711$PER$$US-ROCHE-10000006839$ROCHE$$$$A$F$Y$52.16$KG$20240711$$CN$US$US
240270193$24027019$3$F$20221201$20231206$20240628$20240710$PER$$TR-ROCHE-3247686$ROCHE$$35$YR$A$M$Y$88$KG$20240628$$MD$TR$TR
240270206$24027020$6$F$20230101$20240531$20240628$20240710$PER$$CN-ROCHE-3490529$ROCHE$$78$YR$E$F$Y$66$KG$20240628$$MD$CN$CN
240270224$24027022$4$F$20230922$20240527$20240628$20240710$PER$$CN-ROCHE-3571572$ROCHE$$78$YR$E$F$Y$66$KG$20240628$$MD$CN$CN
240270234$24027023$4$F$20230416$20240605$20240628$20240710$PER$$CN-ROCHE-3490494$ROCHE$$78$YR$E$F$Y$66$KG$20240628$$MD$CN$CN
240270242$24027024$2$F$20240509$20240517$20240628$20240710$PER$$IT-ROCHE-3566707$ROCHE$$81$YR$E$M$Y$68$KG$20240628$$MD$IT$IT
240270253$24027025$3$F$20240101$20240524$20240628$20240710$PER$$CN-ROCHE-3570705$ROCHE$$41$YR$A$F$Y$62.5$KG$20240628$$MD$CN$CN
240270284$24027028$4$F$20230807$20240111$20240628$20240710$PER$$CN-ROCHE-3490587$ROCHE$$78$YR$E$F$Y$66$KG$20240628$$MD$CN$CN
240270292$24027029$2$F$20220330$20231106$20240628$20240710$PER$$CN-ROCHE-3298224$ROCHE$$42$YR$A$F$Y$70$KG$20240628$$MD$CN$CN
240270315$24027031$5$F$20230101$20240507$20240628$20240710$PER$$LT-ROCHE-3529283$ROCHE$$49$YR$A$M$Y$124$KG$20240628$$MD$LT$LT
240270332$24027033$2$F$20240101$20240519$20240628$20240710$PER$$LT-ROCHE-3567253$ROCHE$$50$YR$A$M$Y$124$KG$20240628$$MD$LT$LT
240270382$24027038$2$F$20231101$20240801$20240628$20240809$PER$$US-SA-2024SA182985$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240809$$MD$US$US
240270392$24027039$2$F$20240624$20240715$20240628$20240718$EXP$$CA-ABBVIE-5817397$ABBVIE$$62$YR$$F$Y$$$20240718$$MD$CA$CA
240270412$24027041$2$F$$20240826$20240628$20240909$PER$$US-SA-2024SA184632$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240909$$MD$US$US
240270432$24027043$2$F$$20240701$20240628$20240706$PER$$US-ROCHE-3577343$ROCHE$$53$YR$A$F$Y$$$20240706$$CN$US$US
240270523$24027052$3$F$20220101$20240815$20240628$20240826$EXP$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000529$DECIPHERA PHARMACEUTICALS$$31$YR$A$F$Y$$$20240826$$CN$US$US
240270533$24027053$3$F$20220614$20240517$20240628$20240710$PER$$CN-ROCHE-3173346$ROCHE$$54$YR$A$M$Y$58$KG$20240628$$MD$CN$CN
240270583$24027058$3$F$20240110$20240502$20240628$20240710$PER$$CO-ROCHE-3523796$ROCHE$$40$YR$A$M$Y$73.5$KG$20240628$$MD$CO$CO
240270592$24027059$2$F$$20240613$20240628$20240704$PER$$US-ROCHE-10000003583$ROCHE$$$$$$Y$$$20240704$$CN$US$US
240270602$24027060$2$F$20231031$20240305$20240628$20240710$PER$$PT-ROCHE-3522490$ROCHE$$62$YR$A$F$Y$71.5$KG$20240628$$MD$PT$PT
240270623$24027062$3$F$20220412$20231113$20240628$20240710$PER$$IT-ROCHE-3457260$ROCHE$$71$YR$E$F$Y$61$KG$20240628$$MD$IT$IT
240270633$24027063$3$F$20240315$20240822$20240628$20240906$PER$$US-BIOGEN-2024BI01271260$BIOGEN$$49$YR$$F$Y$$$20240906$$CN$US$US
240270694$24027069$4$F$20240601$20240905$20240628$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002697$ACADIA PHARMACEUTICALS$$5$YR$$F$Y$$$20240926$$CN$US$US
240270732$24027073$2$F$20240328$20240624$20240628$20240709$PER$$US-ROCHE-10000004616$ROCHE$$75$YR$E$F$Y$69.4$KG$20240704$$CN$US$US
240270753$24027075$3$F$20230101$20240504$20240628$20240710$PER$$CO-ROCHE-3524265$ROCHE$$46$YR$A$F$Y$75$KG$20240628$$MD$CO$CO
240270772$24027077$2$F$$20240606$20240628$20240710$PER$$CA-ROCHE-3577492$ROCHE$$$$A$M$Y$$$20240628$$CN$CA$CA
240270802$24027080$2$F$20230809$20240508$20240628$20240710$PER$$RS-ROCHE-3560789$ROCHE$$75$YR$E$F$Y$62$KG$20240628$$MD$RS$RS
240270852$24027085$2$F$20230707$20240424$20240628$20240710$PER$$IT-ROCHE-3553383$ROCHE$$64$YR$A$M$Y$$$20240628$$MD$IT$IT
240270882$24027088$2$F$20231128$20240307$20240628$20240710$PER$$CN-ROCHE-3522916$ROCHE$$60$YR$A$M$Y$76$KG$20240628$$MD$CN$CN
240270912$24027091$2$F$$20240829$20240628$20240902$PER$$US-ROCHE-3580008$ROCHE$$65$YR$E$F$Y$$$20240902$$CN$US$US
240270922$24027092$2$F$$20240517$20240628$20240710$PER$$ID-ROCHE-3568455$ROCHE$$56$YR$A$M$Y$$$20240628$$MD$ID$ID
240270942$24027094$2$F$20230101$20240627$20240628$20240709$PER$$US-ROCHE-10000009544$ROCHE$$56$YR$A$M$Y$$$20240704$$CN$US$US
240270953$24027095$3$F$$20240610$20240628$20240709$PER$$US-ROCHE-3579976$ROCHE$$78$YR$E$M$Y$$$20240701$$CN$US$US
240270962$24027096$2$F$$20240404$20240628$20240710$PER$$TH-ROCHE-3560185$ROCHE$$54$YR$A$M$Y$$$20240628$$CN$TH$TH
240270972$24027097$2$F$20220413$20240424$20240628$20240710$PER$$IT-ROCHE-3552958$ROCHE$$38$YR$A$M$Y$$$20240628$$MD$IT$IT
240270993$24027099$3$F$20240101$20240605$20240628$20240710$PER$$US-ROCHE-3579063$ROCHE$$86$YR$E$F$Y$72.21$KG$20240628$$CN$COUNTRY NOT SPECIFIED$US
240271033$24027103$3$F$20240701$20240808$20240628$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103368$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$63.96$KG$20240813$$CN$US$US
240271062$24027106$2$F$20240328$20240515$20240628$20240710$PER$$PT-ROCHE-3565949$ROCHE$$69$YR$E$F$Y$55.5$KG$20240628$$MD$PT$PT
240271152$24027115$2$F$$20240614$20240628$20240722$EXP$$US-ROCHE-10000006241$ROCHE$$$$E$F$Y$57.15$KG$20240722$$CN$US$US
240271162$24027116$2$F$$20240622$20240628$20240702$PER$$US-ROCHE-3579697$ROCHE$$$$$$Y$$$20240702$$CN$US$US
240271182$24027118$2$F$20240614$20240723$20240628$20240725$EXP$$MX-ROCHE-10000008820$ROCHE$$39$YR$A$F$Y$56$KG$20240725$$CN$MX$MX
2402711910$24027119$10$F$20220101$20240705$20240628$20240902$PER$$US-ROCHE-10000002889$ROCHE$$71$YR$E$F$Y$94.35$KG$20240902$$CN$US$US
240271204$24027120$4$F$20240605$20240905$20240628$20240906$EXP$$US-ROCHE-10000009681$ROCHE$$69$YR$E$M$Y$75.29$KG$20240906$$HP$US$US
240271212$24027121$2$F$$20240624$20240628$20240711$PER$$US-ROCHE-10000010312$ROCHE$$79$YR$E$F$Y$89$KG$20240711$$MD$US$US
240271262$24027126$2$F$$20240802$20240628$20240810$PER$$US-AstraZeneca-2024A148385$ASTRAZENECA$$$$$$Y$$$20240810$$CN$US$
240271342$24027134$2$F$20230501$20240716$20240628$20240725$PER$$US-SA-2024SA182187$SANOFI AVENTIS$$15$YR$T$F$Y$56.2$KG$20240725$$CN$US$US
240271363$24027136$3$F$20120701$20240712$20240628$20240722$EXP$$CA-ROCHE-1120113$ROCHE$$51$YR$A$F$Y$112$KG$20240719$$HP$CA$CA
240271383$24027138$3$F$20240101$20240715$20240628$20240723$PER$$US-SA-2024SA189378$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240723$$MD$US$US
240271502$24027150$2$F$20240619$20240708$20240628$20240716$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018012$UNITED THERAPEUTICS$$44$YR$$F$Y$61.224$KG$20240716$$$US$US
240271514$24027151$4$F$$20240903$20240628$20240909$EXP$$US-TAKEDA-2024TUS063381$TAKEDA$$$$$F$Y$$$20240909$$CN$US$US
240271553$24027155$3$F$$20240724$20240628$20240806$EXP$$PT-AUROBINDO-AUR-APL-2024-030885$AUROBINDO$Sousa BS, de S? ZC, Ramos J. Decoding the enigma: Valproate encephalopathy in a bipolar affective disorder without hyperammonemia. Bipolar disorders. 2024;00:1?3$63$YR$$F$Y$$$20240806$$MD$PT$PT
240271593$24027159$3$F$20240101$20240724$20240628$20240805$EXP$$US-GAMIDA CELL LTD.-GC-24US000010$GAMIDA CELL$$$$$$Y$$$20240805$$MD$US$US
240271642$24027164$2$F$20240609$20240719$20240628$20240727$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-019438$UNITED THERAPEUTICS$$4$YR$$F$Y$$$20240727$$MD$JP$JP
240271762$24027176$2$F$20240617$20240621$20240628$20240702$EXP$$KR-SAMSUNG BIOEPIS-SB-2024-19532$SAMSUNG BIOEPIS$$65$YR$E$F$Y$46.6$KG$20240702$$MD$KR$KR
240271832$24027183$2$F$20200902$20240717$20240628$20240723$EXP$$CA-TAKEDA-2024TUS063000$TAKEDA$$23$YR$$F$Y$$$20240723$$CN$CA$CA
240271894$24027189$4$F$20240619$20240909$20240628$20240909$EXP$$US-ALXN-202406USA001212US$ALEXION PHARMACEUTICALS$$65$YR$$F$Y$$$20240909$$CN$US$US
240271952$24027195$2$F$20230228$20240710$20240628$20240711$EXP$$JP-EMD Serono-2024034767$EMD SERONO INC$$63$YR$A$M$Y$55$KG$20240711$$HP$JP$JP
240272002$24027200$2$F$20240501$20240627$20240628$20240704$30DAY$$US-GSK-US2023125303$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240704$$CN$US$US
240272012$24027201$2$F$$20240822$20240628$20240827$30DAY$$US-GSK-US2024075880$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$HP$US$US
240272022$24027202$2$F$$20240716$20240628$20240726$30DAY$$US-GSK-US2024077274$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
240272132$24027213$2$F$$20240730$20240628$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202406018508$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240801$$CN$US$US
240272164$24027216$4$F$20240414$20240816$20240628$20240823$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000536$DECIPHERA PHARMACEUTICALS$$71$YR$E$F$Y$$$20240823$$HP$US$US
240272292$24027229$2$F$20230112$20240710$20240628$20240711$EXP$$JP-EMD Serono-2024034736$EMD SERONO INC$$62$YR$A$F$Y$$$20240711$$HP$JP$JP
240272322$24027232$2$F$20210308$20240628$20240628$20240703$EXP$$CA-TAKEDA-2021TUS015594$TAKEDA$$54$YR$$M$Y$$$20240703$$HP$CA$CA
240272452$24027245$2$F$20231201$20240723$20240628$20240819$PER$$BR-TOLMAR, INC.-24BR050028$TOLMAR$$9$YR$$F$Y$$$20240814$$CN$BR$BR
240272483$24027248$3$F$20231212$20240805$20240628$20240826$PER$$BR-TOLMAR, INC.-24BR050066$TOLMAR$$9$YR$$F$Y$$$20240826$$CN$BR$BR
240272532$24027253$2$F$20240501$20240624$20240628$20240703$EXP$$TW-AMGEN-TWNSP2024126450$AMGEN$$$$E$F$Y$$$20240703$$HP$TW$TW
240272583$24027258$3$F$20230801$20240726$20240628$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103691$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240801$$HP$US$US
240272613$24027261$3$F$20240620$20240812$20240628$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103522$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240813$$PH$US$US
240272732$24027273$2$F$20240625$20240626$20240628$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406018475$ELI LILLY AND CO$$89$YR$E$M$Y$$$20240702$$CN$US$US
240272744$24027274$4$F$20210101$20240729$20240628$20240805$EXP$$NVSC2024MX102287$NOVARTIS$$58$YR$$M$Y$$$20240805$$CN$MX$MX
240272752$24027275$2$F$$20240704$20240628$20240709$EXP$$US-UCBSA-2024032504$UCB$$$$$M$Y$76.19$KG$20240709$$HP$US$US
240272772$24027277$2$F$$20240820$20240628$20240827$EXP$$US-GILEAD-2024-0678624$GILEAD$$69$YR$E$F$Y$$$20240827$$HP$US$US
240272812$24027281$2$F$20240617$20240705$20240628$20240709$PER$$US-AMGEN-USASP2024126390$AMGEN$$50$YR$A$M$Y$$$20240709$$MD$US$US
240272832$24027283$2$F$20240101$20240626$20240628$20240710$PER$$US-APOTEX-2024AP007219$APOTEX$$$$$M$Y$$$20240710$$CN$US$US
240272853$24027285$3$F$$20240805$20240628$20240813$PER$$US-ALXN-202406USA001543US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240813$$MD$US$US
240272862$24027286$2$F$$20240628$20240628$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094988$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240702$$CN$US$US
240272942$24027294$2$F$20040101$20240701$20240628$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002703$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
240272952$24027295$2$F$20240623$20240712$20240628$20240718$EXP$$US-GILEAD-2024-0678649$GILEAD$$37$YR$A$M$Y$$$20240718$$CN$US$US
240272962$24027296$2$F$$20240624$20240628$20240701$EXP$$NL-AUROBINDO-AUR-APL-2024-031252$AUROBINDO$De Jonge M.. Travelling ticks: verdere verspreiding van een zeldzaam virus in nederland. Tijdschrift voor Neurologie en Neurochirurgie. 2024;125(4):39-44$63$YR$$F$Y$$$20240701$$MD$NL$NL
240272992$24027299$2$F$$20240627$20240628$20240710$EXP$$CA-SANDOZ INC.-SDZ2023CA076614$SANDOZ$$44$YR$$F$Y$70$KG$20240710$$HP$CA$CA
240273133$24027313$3$F$20240301$20240813$20240628$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002667$ACADIA PHARMACEUTICALS$$9$YR$$F$Y$$$20240906$$CN$US$US
240273173$24027317$3$F$20240601$20240708$20240628$20240711$EXP$$US-GSK-US2024077077$GLAXOSMITHKLINE$$62$YR$$M$Y$$$20240711$$HP$US$US
240273212$24027321$2$F$20240420$20240710$20240628$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202406017235$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240711$$CN$US$US
240273302$24027330$2$F$20240601$20240722$20240628$20240726$EXP$$US-LEO Pharma-371513$LEO PHARM$$56$YR$$F$Y$$$20240726$$CN$US$US
240273584$24027358$4$F$20240812$20240906$20240628$20240912$EXP$$BE-BEH-2024174331$CSL BEHRING$$76$YR$E$M$Y$80$KG$20240912$$HP$BE$BE
240273674$24027367$4$F$$20240718$20240628$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103585$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240722$$CN$US$US
240273702$24027370$2$F$20240501$20240723$20240628$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018397$UNITED THERAPEUTICS$$44$YR$$F$Y$54.875$KG$20240726$$$US$US
240273772$24027377$2$F$$20240715$20240628$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103628$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240718$$CN$US$US
240273793$24027379$3$F$$20240726$20240628$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103154$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240729$$CN$US$US
240273902$24027390$2$F$20200304$20240704$20240628$20240712$EXP$$JP-AstraZeneca-2024A146294$ASTRAZENECA$$70$YR$$F$Y$$$20240712$$MD$JP$
240273993$24027399$3$F$20240610$20240704$20240628$20240708$EXP$IT-MINISAL02-992240$IT-BIOVITRUM-2024-IT-009190$BIOVITRUM$$20$YR$$M$Y$97$KG$20240708$$MD$IT$IT
240274012$24027401$2$F$$20240919$20240628$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103457$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$93.89$KG$20240923$$CN$US$US
240274043$24027404$3$F$20240613$20240710$20240628$20240722$EXP$$PK-ROCHE-10000008136$ROCHE$$61$YR$A$F$Y$$$20240722$$CN$PK$PK
240274063$24027406$3$F$$20240805$20240628$20240806$EXP$$US-TAKEDA-2022TUS076347$TAKEDA$$$$$M$Y$$$20240806$$HP$US$US
240274152$24027415$2$F$20240401$20240627$20240628$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018666$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240701$$CN$US$US
240274353$24027435$3$F$20240601$20240916$20240628$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102838$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$73.48$KG$20240918$$CN$US$US
240274382$24027438$2$F$$20240730$20240628$20240805$PER$$US-BIOGEN-2024BI01269975$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
240274462$24027446$2$F$$20240828$20240628$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103740$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240829$$CN$US$US
240274492$24027449$2$F$$20240718$20240628$20240726$30DAY$$US-GSK-US2024077266$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
240274504$24027450$4$F$20240701$20240718$20240628$20240925$PER$$US-GSK-US2024AMR077144$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240925$$HP$US$US
240274542$24027454$2$F$$20240805$20240628$20240813$EXP$$FR-AstraZeneca-2024A147521$ASTRAZENECA$$$$$$Y$$$20240813$$MD$FR$
240274584$24027458$4$F$$20240823$20240628$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002713$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
240274612$24027461$2$F$$20240621$20240628$20240702$EXP$$US-ROCHE-10000008656$ROCHE$$74$YR$E$M$Y$$$20240702$$CN$US$US
240274642$24027464$2$F$20240515$20240624$20240628$20240708$PER$$US-ROCHE-10000006423$ROCHE$$$$$$Y$$$20240708$$MD$US$US
240274652$24027465$2$F$20240606$20240729$20240628$20240731$PER$$US-AMGEN-USASP2024126381$AMGEN$$52$YR$A$F$Y$$$20240731$$HP$US$US
240274702$24027470$2$F$20240602$20240703$20240628$20240709$EXP$ES-AEMPS-1536359$ES-GILEAD-2024-0678582$GILEAD$$6$YR$C$F$Y$23$KG$20240709$$MD$ES$ES
240274733$24027473$3$F$$20240711$20240628$20240712$PER$$US-HALEON-2184074$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240274742$24027474$2$F$20240201$20240805$20240628$20240813$EXP$$AU-ABBVIE-5817192$ABBVIE$$$$A$F$Y$70$KG$20240813$$MD$AU$AU
240274882$24027488$2$F$20240626$20240702$20240628$20240709$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-102932$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$96.16$KG$20240709$$CN$PR$PR
240275103$24027510$3$F$20240707$20240917$20240628$20240920$EXP$$US-TEVA-VS-3213557$TEVA$$69$YR$$M$Y$108.86$KG$20240920$$LW$US$US
240275122$24027512$2$F$$20240625$20240628$20240704$PER$$US-AMGEN-USASP2024125575$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240275194$24027519$4$F$20240601$20240912$20240628$20240918$EXP$$JP-GSK-JP2024077605$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$JP$JP
240275213$24027521$3$F$20240814$20240909$20240628$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002716$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240919$$CN$US$US
240275282$24027528$2$F$$20240829$20240628$20240902$EXP$$NVSC2024US133964$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
240275372$24027537$2$F$20221201$20240710$20240628$20240711$EXP$$JP-EMD Serono-2024034902$EMD SERONO INC$$6$DEC$A$M$Y$53$KG$20240711$$HP$JP$JP
240275532$24027553$2$F$$20240624$20240628$20240702$EXP$AU-MLMSERVICE-20240613-PI100026-00270-1$AU-STRIDES ARCOLAB LIMITED-2024SP007574$STRIDES$Clifford L, Joseph F, Joshi T.. A clinical case of insulin autoimmune syndrome with monoclonal gammopathy of uncertain significance; complexity in management.. Oxford medical case reports. 2024;2024(6):232-234$91$YR$$F$Y$$$20240702$$MD$AU$AU
240275602$24027560$2$F$$20240628$20240628$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102787$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240705$$CN$US$US
240275662$24027566$2$F$$20240718$20240628$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202406018856$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240722$$CN$US$US
240275712$24027571$2$F$20240301$20240712$20240628$20240722$PER$$US-ROCHE-3540351$ROCHE$$48$YR$A$F$Y$$$20240723$$CN$US$US
240275753$24027575$3$F$$20240706$20240628$20240716$EXP$$US-ROCHE-3563243$ROCHE$Caraway H, Buresh R, Waghchoure S, Sampath R and Durairaj M Secondary organizing pneumonia due to COVID-19 in an immunocompromised patient with polymyositis (Abstract number: 1196). DOI:10.1097/01.ccm.0001002948.62895.b7. Critical Care Medicine 2024 Jan;52 (1) (SUPPL 1):-.$56$YR$A$M$Y$$$20240716$$HP$US$US
240275829$24027582$9$F$20240201$20240906$20240628$20240912$PER$$US-ROCHE-10000009034$ROCHE$$41$YR$A$F$Y$78.47$KG$20240912$$CN$US$US
240275832$24027583$2$F$20211208$20240708$20240628$20240711$EXP$$CO-UCBSA-2024032152$UCB$$33$YR$$F$Y$88$KG$20240711$$CN$CO$CO
240275863$24027586$3$F$20240701$20240724$20240628$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102982$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240725$$CN$US$US
240275882$24027588$2$F$$20240701$20240628$20240702$EXP$$TW-009507513-2406TWN009242$MERCK$$62$YR$$M$Y$$$20240702$$MD$TW$TW
240275892$24027589$2$F$20240624$20240702$20240628$20240705$PER$$US-AMGEN-USASP2024126364$AMGEN$$75$YR$E$F$Y$$$20240705$$HP$US$US
240275962$24027596$2$F$20231101$20240702$20240628$20240707$EXP$$JP-GSK-JP2024JPN078210$GLAXOSMITHKLINE$$$$$$Y$$$20240707$$MD$JP$JP
240275972$24027597$2$F$$20240814$20240628$20240824$30DAY$$US-GSK-US2024078686$GLAXOSMITHKLINE$$$$$M$Y$$$20240824$$CN$US$US
240275983$24027598$3$F$20240622$20240703$20240628$20240709$PER$$US-AMGEN-USASP2024127514$AMGEN$$76$YR$E$F$Y$$$20240708$$CN$US$US
240276134$24027613$4$F$20240602$20240710$20240628$20240714$PER$$US-AMGEN-USASP2024125131$AMGEN$$64$YR$A$M$Y$$$20240714$$PH$US$US
240276162$24027616$2$F$20221201$20240626$20240628$20240701$EXP$$US-AstraZeneca-2024A145979$ASTRAZENECA$$64$YR$$M$Y$$$20240701$$CN$US$
240276222$24027622$2$F$20230530$20240711$20240628$20240715$EXP$$JP-EMD Serono-2024034822$EMD SERONO INC$$78$YR$E$M$Y$49$KG$20240715$$HP$JP$JP
240276242$24027624$2$F$$20240726$20240628$20240801$30DAY$$EC-JNJFOC-20240656013$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$HP$EC$EC
240276273$24027627$3$F$$20240711$20240628$20240722$PER$$US-ROCHE-3577515$ROCHE$$61$YR$A$F$Y$$$20240722$$CN$US$US
240276332$24027633$2$F$$20240702$20240628$20240712$EXP$GB-MHRA-ADR 28748881$GB-BIOCON BIOLOGICS LIMITED-BBL2024004614$BIOCON$$$$$$Y$$$20240712$$CN$GB$GB
240276372$24027637$2$F$$20240729$20240628$20240807$PER$$US-009507513-2406USA000509$MERCK$$$$$F$Y$54$KG$20240807$$HP$US$US
240276482$24027648$2$F$20240501$20240820$20240628$20240826$EXP$$UY-ABBVIE-5817995$ABBVIE$$49$YR$$M$Y$$$20240826$$CN$UY$UY
240276502$24027650$2$F$$20240724$20240628$20240806$EXP$$US-AUROBINDO-AUR-APL-2024-030912$AUROBINDO$Lavin L, Chefitz G, Patel D, Baek WK, Khattri S.. Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect.. JAAD Case Reports.. 2024;49:40-43.$74$YR$$F$Y$$$20240806$$MD$US$US
240276615$24027661$5$F$$20240902$20240628$20240904$EXP$$US-ABBVIE-5818909$ABBVIE$$$$$F$Y$163$KG$20240904$$CN$US$US
240276632$24027663$2$F$$20240826$20240628$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-102951$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240830$$PH$JP$JP
240276642$24027664$2$F$$20240712$20240628$20240716$PER$$US-HALEON-2184160$Haleon PLC$$$$$F$Y$$$20240716$$CN$US$US
240276672$24027667$2$F$20231214$20240628$20240628$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-030768$AUROBINDO$$88$YR$$M$Y$75$KG$20240708$$PH$FR$FR
240276682$24027668$2$F$$20240805$20240628$20240805$PER$$US-ALXN-202406USA001634US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240276712$24027671$2$F$$20240808$20240628$20240812$30DAY$$US-GSK-US2024077275$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
240276762$24027676$2$F$20240601$20240715$20240628$20240718$EXP$$IT-ABBVIE-5804839$ABBVIE$$80$YR$$F$Y$45$KG$20240718$$MD$IT$IT
240276802$24027680$2$F$$20240613$20240628$20240711$PER$$US-ROCHE-10000009946$ROCHE$$$$E$F$Y$70.76$KG$20240711$$CN$US$US
240276832$24027683$2$F$$20240709$20240628$20240710$PER$$NVSC2024US135000$NOVARTIS$$$$$$Y$$$20240710$$HP$US$US
240276862$24027686$2$F$20240621$20240726$20240628$20240731$30DAY$$US-AMGEN-USASP2024125290$AMGEN$$67$YR$E$F$Y$81.6$KG$20240731$$PH$US$US
240276922$24027692$2$F$20240620$20240718$20240628$20240726$PER$$US-ABBVIE-5813906$ABBVIE$$74$YR$$M$Y$79.378$KG$20240726$$CN$US$US
240276932$24027693$2$F$$20240701$20240628$20240708$EXP$$NVSC2024RU132564$NOVARTIS$$45$YR$$F$Y$$$20240708$$MD$RU$RU
240276942$24027694$2$F$20231207$20240701$20240628$20240710$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000545$DECIPHERA PHARMACEUTICALS$$67$YR$A$F$Y$$$20240710$$HP$US$US
240277002$24027700$2$F$20240531$20240614$20240628$20240704$EXP$$PK-ROCHE-10000010091$ROCHE$$64$YR$A$M$Y$$$20240704$$CN$PK$PK
240277014$24027701$4$F$20240501$20240821$20240628$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002740$ACADIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240913$$CN$US$US
240277042$24027704$2$F$20240101$20240827$20240628$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103592$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240902$$CN$US$US
240277072$24027707$2$F$$20240724$20240628$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002746$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
240277093$24027709$3$F$$20240617$20240628$20240709$EXP$$IE-ROCHE-10000010939$ROCHE$$$$$F$Y$$$20240701$$CN$IE$IE
240277102$24027710$2$F$$20240802$20240628$20240806$PER$$US-ALXN-202406USA001418US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240277172$24027717$2$F$$20240701$20240628$20240708$EXP$$US-AUROBINDO-AUR-APL-2024-030902$AUROBINDO$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM.. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.. Archives of Dermatological Research. 2024;316(6):279$49$YR$$F$Y$$$20240708$$MD$US$US
240277225$24027722$5$F$20240610$20240919$20240628$20240926$EXP$$JP-ROCHE-10000009103$ROCHE$$65$YR$E$F$Y$39.5$KG$20240926$$PH$JP$JP
240277232$24027723$2$F$20240101$20240725$20240628$20240806$EXP$$NL-AUROBINDO-AUR-APL-2024-022498$AUROBINDO$$$$A$F$Y$$$20240806$$HP$NL$NL
240277382$24027738$2$F$20240116$20240805$20240628$20240807$EXP$$JP-ASTELLAS-2024JP000423$ASTELLAS$$9$YR$$M$Y$$$20240807$$MD$JP$JP
240277442$24027744$2$F$$20240701$20240628$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-030897$AUROBINDO$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM.. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316(6):279$26$YR$$F$Y$$$20240709$$MD$US$US
240277463$24027746$3$F$20240601$20240712$20240628$20240715$PER$$US-JNJFOC-20240664402$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240715$$CN$US$US
240277492$24027749$2$F$20240617$20240805$20240628$20240808$EXP$EU-ADIENNEP-2024AD000536$EU-ADIENNEP-2024AD000536$ADIENNE PHARMA + BIOTECH$$65$YR$$M$Y$102.4$KG$20240806$$MD$EU$EU
240277522$24027752$2$F$20231220$20240625$20240628$20240702$EXP$$JP-EMD Serono-2024034826$EMD SERONO INC$$$$E$F$Y$41$KG$20240702$$HP$JP$JP
240277532$24027753$2$F$20220901$20240629$20240628$20240702$EXP$$NVSC2024AU133471$NOVARTIS$$4$YR$$F$Y$$$20240702$$MD$AU$AU
240277662$24027766$2$F$$20240710$20240628$20240712$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-101871$BRISTOL MYERS SQUIBB$Belmin J, Broussier A, Boureau A, Donal E, Hanon O, Paccalin M, et al. Cardiac amyloidosis, an underdiagnosed disease in geriatrics. Revue Du Geriatrie. 2024;49(5):293-8.$86$YR$E$M$Y$$$20240712$$MD$FR$FR
240277742$24027774$2$F$$20240625$20240628$20240708$PER$$US-ROCHE-10000006474$ROCHE$$80$YR$E$M$Y$$$20240708$$CN$US$US
240277752$24027775$2$F$$20240712$20240628$20240722$EXP$$JP-BEH-2024174314$CSL BEHRING$$97$YR$E$F$Y$$$20240722$$HP$JP$JP
240277852$24027785$2$F$20240101$20240815$20240628$20240820$PER$$US-AMGEN-USASP2024125878$AMGEN$$70$YR$E$F$Y$$$20240820$$HP$US$US
240277873$24027787$3$F$$20240826$20240628$20240830$EXP$$US-ROCHE-10000009400$ROCHE$$8$YR$C$F$Y$$$20240830$$MD$US$US
240277882$24027788$2$F$$20240828$20240628$20240829$EXP$$NVSC2024US134565$NOVARTIS$$$$$F$Y$$$20240829$$MD$US$US
240277893$24027789$3$F$$20240717$20240628$20240725$EXP$$CA-BAXTER-2024BAX020591$BAXTER$$$$$$Y$$$20240725$$HP$CA$CA
240277962$24027796$2$F$$20240718$20240628$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102865$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240722$$HP$US$US
240278012$24027801$2$F$$20240704$20240628$20240710$PER$US-MLMSERVICE-20240613-PI097636-00246-1$US-RDY-SPO/USA/24/0009080$DR REDDYS$Ng ZK, Broussard BA. A Case of Diabetic Ketoacidosis (DKA) Secondary to Olanzapine Use. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3385. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A3385.$66$YR$E$F$Y$92$KG$20240710$$MD$US$US
240278082$24027808$2$F$20240601$20240627$20240628$20240704$EXP$$US-GSK-US2021053297$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
240278182$24027818$2$F$$20240701$20240628$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406019082$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240703$$CN$US$US
240278252$24027825$2$F$$20240802$20240628$20240806$PER$$US-ALXN-202406USA001430US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240278276$24027827$6$F$20240614$20240730$20240628$20240802$EXP$$US-ROCHE-10000008761$ROCHE$$74$YR$E$F$Y$$$20240802$$CN$US$US
240278374$24027837$4$F$20240607$20240708$20240628$20240717$PER$$US-ROCHE-10000001203$ROCHE$$14$YR$T$F$Y$50.8$KG$20240717$$CN$US$US
240278383$24027838$3$F$$20240705$20240628$20240711$PER$$US-AMGEN-USASP2024126944$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240278412$24027841$2$F$20230301$20240624$20240628$20240701$EXP$GB-MHRA-MED-202406231938116150-JFSVK$GB-ABBVIE-5813766$ABBVIE$$32$YR$$F$Y$84$KG$20240701$$CN$GB$GB
240278432$24027843$2$F$20240101$20240717$20240628$20240724$EXP$$US-BIOGEN-2024BI01271155$BIOGEN$$50$YR$$F$Y$$$20240724$$CN$US$US
240278463$24027846$3$F$20200606$20240909$20240628$20240920$EXP$$DE-AUROBINDO-AUR-APL-2024-031662$AUROBINDO$$$$A$F$Y$62$KG$20240920$$MD$DE$DE
240278592$24027859$2$F$20240601$20240702$20240628$20240712$PER$$US-PHARMING-PHAUS2024000510$PHARMING GROUP$$$$$$Y$$$20240712$$CN$US$US
240278622$24027862$2$F$$20240711$20240628$20240718$PER$$US-PHARMING-PHAUS2024000505$PHARMING GROUP$$$$$$Y$$$20240718$$CN$US$US
240278723$24027872$3$F$$20240709$20240628$20240718$EXP$$US-ROCHE-10000006086$ROCHE$$42$YR$A$F$Y$$$20240718$$MD$US$US
240278752$24027875$2$F$20240601$20240717$20240628$20240724$EXP$$GB-BIOGEN-2024BI01271241$BIOGEN$$53$YR$$F$Y$$$20240724$$CN$GB$GB
240278764$24027876$4$F$$20240628$20240628$20240712$EXP$$RU-ROCHE-10000002251$ROCHE$$49$YR$A$F$Y$$$20240712$$HP$RU$RU
240278772$24027877$2$F$20150101$20240708$20240628$20240712$EXP$$US-TAKEDA-US201848170$TAKEDA$$66$YR$$M$Y$$$20240712$$HP$US$US
240278863$24027886$3$F$20240101$20240730$20240628$20240806$EXP$$US-SA-2024SA190265$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240806$$MD$US$US
240278882$24027888$2$F$$20240826$20240628$20240829$EXP$$US-AstraZeneca-2024A148895$ASTRAZENECA$$$$$M$Y$$$20240829$$MD$US$
240278902$24027890$2$F$$20240808$20240628$20240816$EXP$$US-AstraZeneca-2024A144773$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
240278942$24027894$2$F$$20240828$20240628$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103591$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$117.93$KG$20240830$$CN$US$US
240279053$24027905$3$F$$20240626$20240628$20240708$EXP$$ES-009507513-2406ESP009138$MERCK$$$$$F$Y$$$20240708$$MD$ES$ES
240279202$24027920$2$F$$20240628$20240628$20240705$EXP$$HU-TAKEDA-2024TUS064677$TAKEDA$$46$YR$$M$Y$$$20240705$$HP$HU$HU
240279222$24027922$2$F$20240501$20240821$20240628$20240830$EXP$$US-GSK-US2024AMR077612$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240830$$CN$US$US
240279273$24027927$3$F$20240618$20240809$20240628$20240814$EXP$$NZ-BEH-2024174634$CSL BEHRING$$67$YR$E$M$Y$70$KG$20240814$$HP$NZ$NZ
240279323$24027932$3$F$20240101$20240815$20240628$20240822$EXP$$NVSC2024DE130136$NOVARTIS$$$$E$F$Y$67$KG$20240822$$CN$DE$DE
240279352$24027935$2$F$$20240730$20240628$20240806$EXP$$US-AMGEN-USASP2024124516$AMGEN$Austin C.; Grzybacz D.; Imburgio S. et al.. Chronic Eosinophilic Pneumonia: Shedding Light on an Under-recognized Syndrome Through a Comprehensive Case Report. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A5896$83$YR$E$M$Y$$$20240806$$HP$US$US
240279363$24027936$3$F$20240101$20240724$20240628$20240731$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013038$UNITED THERAPEUTICS$$$$$F$Y$80.272$KG$20240731$$$US$US
240279372$24027937$2$F$$20240625$20240628$20240708$PER$$NVSC2024US135019$NOVARTIS$$45$YR$$F$Y$$$20240708$$MD$US$US
240279396$24027939$6$F$20240601$20240726$20240628$20240801$EXP$$JP-ASTELLAS-2024JP003865$ASTELLAS$$9$DEC$$M$Y$$$20240801$$PH$JP$JP
240279445$24027944$5$F$20170101$20240912$20240628$20240917$EXP$$MX-TAKEDA-MX201927456$TAKEDA$$$$$M$Y$51$KG$20240917$$CN$MX$MX
240279542$24027954$2$F$$20240702$20240628$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103644$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240703$$CN$US$US
240279712$24027971$2$F$20210826$20240708$20240628$20240711$EXP$$JP-EMD Serono-2024034797$EMD SERONO INC$$89$YR$E$F$Y$46$KG$20240711$$HP$JP$JP
240279892$24027989$2$F$20230607$20240729$20240628$20240806$EXP$$CA-ROCHE-10000003481$ROCHE$$46$YR$A$M$Y$$$20240806$$CN$CA$CA
240279903$24027990$3$F$20240524$20240614$20240628$20240709$PER$$US-ROCHE-3575683$ROCHE$$66$YR$E$F$Y$$$20240705$$CN$US$US
240279912$24027991$2$F$$20240926$20240628$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103931$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240927$$HP$US$US
240279972$24027997$2$F$20240101$20240716$20240628$20240725$EXP$$CA-CELLTRION INC.-2024CA015672$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
240279982$24027998$2$F$$20240703$20240628$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002733$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$HP$US$US
240280133$24028013$3$F$$20240903$20240628$20240912$EXP$$US-GSK-US2024076587$GLAXOSMITHKLINE$$$$$F$Y$$$20240912$$CN$US$US
240280142$24028014$2$F$$20240716$20240628$20240726$30DAY$$US-GSK-US2024AMR077293$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
240280222$24028022$2$F$$20240620$20240628$20240702$EXP$US-STRIDES ARCOLAB LIMITED-2024SP007400$US-STRIDES ARCOLAB LIMITED-2024SP007400$STRIDES$Ghose M, Anwar M, Rajamohan A, Vangala A, Roy P, Weiner SM.. Vancomycin Induced Anaphylaxis Presenting With Cardiac Arrest: Judicious Use of Antibiotic in Low Risk Procedures.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5700$$$$$Y$$$20240702$$MD$US$US
240280252$24028025$2$F$$20240826$20240628$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102484$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240827$$CN$US$US
240280422$24028042$2$F$$20240828$20240628$20240919$30DAY$$FR-BECTON DICKINSON-FR-BD-24-000384$BECTON DICKINSON$$$$$$Y$$$20240919$$HP$FR$FR
240280452$24028045$2$F$20240612$20240801$20240628$20240828$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000385$BECTON DICKINSON$$$$$$Y$$$20240828$$CN$GB$GB
240280682$24028068$2$F$$20240726$20240628$20240731$EXP$$FI-ABBVIE-5819220$ABBVIE$$$$$M$Y$$$20240731$$HP$FI$FI
240280742$24028074$2$F$$20240729$20240628$20240808$30DAY$$US-GSK-US2024078681$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
240280902$24028090$2$F$$20240801$20240628$20240806$EXP$$US-JNJFOC-20240659031$JOHNSON AND JOHNSON$$57$YR$A$M$Y$94.8$KG$20240807$$CN$US$US
240280942$24028094$2$F$20240101$20240626$20240628$20240702$EXP$$US-ABBVIE-5818916$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240280982$24028098$2$F$20240607$20240801$20240628$20240801$PER$$US-AMGEN-USASP2024126261$AMGEN$$54$YR$A$F$Y$$$20240801$$CN$US$US
240281012$24028101$2$F$20240301$20240628$20240628$20240708$EXP$$BR-CELLTRION INC.-2024BR015158$CELLTRION$$$$$$Y$$$20240708$$CN$BR$BR
240281022$24028102$2$F$20240614$20240703$20240628$20240704$PER$$US-JNJFOC-20240642644$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240705$$HP$US$US
240281062$24028106$2$F$20240613$20240712$20240628$20240722$30DAY$$US-GSK-US2024075871$GLAXOSMITHKLINE$$67$YR$$M$Y$$$20240722$$MD$US$US
240281115$24028111$5$F$20240601$20240820$20240628$20240918$PER$$US-AstraZeneca-2024A145180$ASTRAZENECA$$73$YR$$F$Y$$$20240918$$CN$US$
240281153$24028115$3$F$$20240701$20240628$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406018461$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240705$$CN$US$US
240281263$24028126$3$F$20240101$20240917$20240628$20240930$EXP$$US-UCBSA-2024020873$UCB$$$$$M$Y$$$20240930$$CN$US$US
240281722$24028172$2$F$$20240703$20240628$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002685$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
240282022$24028202$2$F$20240616$20240719$20240628$20240729$PER$$US-JNJFOC-20240648505$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240729$$CN$US$US
240282032$24028203$2$F$20240623$20240709$20240628$20240711$PER$$US-AMGEN-USASP2024126504$AMGEN$$80$YR$E$F$Y$$$20240710$$CN$US$US
240282052$24028205$2$F$20200623$20240729$20240628$20240807$EXP$$AU-TAKEDA-2024TUS064285$TAKEDA$$70$YR$$M$Y$$$20240807$$MD$AU$AU
240282062$24028206$2$F$20240506$20240624$20240628$20240701$EXP$$CA-AMGEN-CANSP2024124663$AMGEN$$75$YR$E$F$Y$$$20240701$$CN$CA$CA
240282082$24028208$2$F$$20240802$20240628$20240808$EXP$US-MLMSERVICE-20240613-PI098860-00043-1$US-STRIDES ARCOLAB LIMITED-2024SP007493$STRIDES$Elsayed M.. An Interesting Case of Drug-Induced Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Pulmonary and Renal Involvement.. American Journal of Respiratory and Critical Care Medicine. 2024;209(plusposter):A5780$75$YR$$M$Y$$$20240808$$MD$US$US
240282112$24028211$2$F$20240612$20240820$20240628$20240902$EXP$$GB-ASTELLAS-2024US018270$ASTELLAS$$59$YR$A$M$Y$$$20240902$$MD$GB$GB
240282162$24028216$2$F$$20240822$20240628$20240829$EXP$$FR-ASTELLAS-2024US018300$ASTELLAS$$59$YR$A$M$Y$$$20240828$$MD$FR$FR
240282172$24028217$2$F$20240525$20240802$20240628$20240807$EXP$$DE-ASTELLAS-2024US016416$ASTELLAS$$81$YR$$F$Y$$$20240807$$MD$DE$DE
240282212$24028221$2$F$$20240731$20240628$20240808$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP007466$STRIDES$Sasako T, Suzuki K, Odawara S, Suwanai H, Akuta N, Kubota N, et al.. Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report.. Journal of Diabetes Investigation. 2024;15(6):782-785$28$YR$$F$Y$$$20240808$$MD$JP$JP
240282262$24028226$2$F$$20240715$20240628$20240723$EXP$$DE-AstraZeneca-2024A146924$ASTRAZENECA$$77$YR$$F$Y$$$20240723$$MD$DE$
240282302$24028230$2$F$20240420$20240618$20240628$20240826$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-089455$REGENERON$$83$YR$$M$Y$$$20240826$$MD$DE$DE
240282312$24028231$2$F$$20240620$20240628$20240703$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007652$STRIDES$Ampaw NA, Saad eldin M, Zhang R.. A Fatal Case of Cerebral Herniation Due to Elevated ICP in a Relapsed Case of Cryptococal Meningitis. Am-J-Respir-Crit-Care-Med. 2024;209$34$YR$$M$Y$$$20240703$$HP$US$US
240282422$24028242$2$F$$20240624$20240628$20240703$PER$$US-AMGEN-USASP2024125028$AMGEN$$61$YR$A$F$Y$$$20240703$$HP$US$US
240282433$24028243$3$F$20240621$20240814$20240628$20240816$PER$$US-AMGEN-USASP2024124507$AMGEN$$77$YR$E$M$Y$$$20240816$$CN$US$US
240282534$24028253$4$F$$20240821$20240628$20240827$EXP$$US-ABBVIE-5814143$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
240282572$24028257$2$F$$20240724$20240628$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202406018526$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240726$$MD$US$US
240282642$24028264$2$F$20240601$20240723$20240628$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202406019076$ELI LILLY AND CO$$$$$F$Y$$$20240725$$CN$US$US
240282652$24028265$2$F$20240601$20240711$20240628$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202406018203$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240715$$CN$US$US
240282722$24028272$2$F$$20240704$20240628$20240709$EXP$GB-TAKEDA-2024TUS059568$GB-STRIDES ARCOLAB LIMITED-2024SP007613$STRIDES$$$$E$M$Y$$$20240709$$CN$GB$GB
240282773$24028277$3$F$20240101$20240711$20240628$20240713$EXP$GB-MHRA-MED-202406261625494370-HVWBP$GB-ABBVIE-5818359$ABBVIE$$$$$F$Y$$$20240713$$PH$GB$GB
240282782$24028278$2$F$20240101$20240724$20240628$20240726$EXP$$US-UCBSA-2024032762$UCB$$$$$F$Y$71.655$KG$20240726$$HP$US$US
240282802$24028280$2$F$$20240619$20240628$20240702$EXP$$CA-ROCHE-10000010102$ROCHE$$$$A$F$Y$$$20240703$$CN$CA$CA
240282942$24028294$2$F$20240101$20240726$20240628$20240809$EXP$$US-UCBSA-2024027353$UCB$$$$$F$Y$$$20240809$$HP$US$US
240283002$24028300$2$F$20230101$20240815$20240628$20240822$EXP$$CA-CELLTRION INC.-2023CA024064$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
240283043$24028304$3$F$20240611$20240829$20240628$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103493$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240905$$HP$US$US
240283072$24028307$2$F$$20240705$20240628$20240717$EXP$$GR-Accord-431411$ACCORD$Kontes I, Bontinis V, Bontinis A, Manaki V, Chorti A, Giannopoulos A, Ktenidis K. Sequential Graft Limb Occlusion Following Endovascular Aneurysm Repair: A Case Report and Literature Review. Cureus. 2024 May 11;16(5):e60102. doi: 10.7759/cureus.60102.$64$YR$A$M$Y$$$20240717$$HP$GR$GR
240283142$24028314$2$F$20210101$20240625$20240628$20240704$EXP$FR-EMA-2023628-AUTODUP-1687986653487$FR-Accord-370472$ACCORD$$30$YR$A$M$Y$$$20240704$$CN$FR$FR
240283293$24028329$3$F$20221231$20240717$20240628$20240726$EXP$$IN-MACLEODS PHARMA-MAC2024047840$MACLEODS$Edison DC, Philip J, Mallhi RS, Basnotra R, Pynadath V, Sane K..Severe amlodipine toxicity: A medical dilemma managed with therapeutic plasma exchange.Transfusion and Apheresis Science.2024;63(4):103958$$$$$Y$$$20240726$$MD$IN$IN
240283313$24028331$3$F$$20240725$20240628$20240807$EXP$$NVSC2024AU131249$NOVARTIS$Yeoh K, Lass-Florl C, Lamoth F, Slavin MA, Williams E, Neofytos D. Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual. TRANSPLANT INFECTIOUS DISEASE. 2024;1-6$53$YR$$F$Y$$$20240807$$HP$AU$AU
240283352$24028335$2$F$$20240702$20240628$20240704$PER$$US-TAKEDA-2024TUS064603$TAKEDA$$$$$F$Y$$$20240704$$CN$US$US
240283473$24028347$3$F$$20240613$20240628$20240711$EXP$$BD-ROCHE-10000011682$ROCHE$$65$YR$E$M$Y$67$KG$20240711$$CN$BD$BD
240283502$24028350$2$F$$20240621$20240628$20240903$EXP$PL-URPL-2-938-2019$PL-THEA-2024001400$Thea Pharma$$70$YR$$$Y$80$KG$20240903$$CN$PL$PL
240283573$24028357$3$F$20231226$20240730$20240628$20240809$EXP$$AU-INSMED, INC.-2024-02587-AU$INSMED$$67$YR$$F$Y$$$20240809$$MD$AU$AU
240283652$24028365$2$F$$20240827$20240628$20240904$EXP$US-MLMSERVICE-20240614-PI095618-00206-1$US-STRIDES ARCOLAB LIMITED-2024SP007487$STRIDES$Hennen MA, Zhang V, Opler DJ.. An unwelcome side-effect of trazodone use in a trans-male.. Psychiatry and Clinical Neurosciences. 2024;78(6):376$$$$$Y$$$20240904$$MD$US$US
240283682$24028368$2$F$$20240701$20240628$20240701$EXP$$AU-BAYER-2024A090562$BAYER$$$$$F$Y$$$20240701$$HP$AU$AU
240283712$24028371$2$F$20231201$20240625$20240628$20240702$EXP$$NVSC2024DE132313$NOVARTIS$$79$YR$$M$Y$$$20240702$$CN$DE$DE
240283773$24028377$3$F$$20240613$20240628$20240703$EXP$$ES-ROCHE-10000004192$ROCHE$$64$YR$A$$Y$$$20240703$$MD$ES$ES
240283792$24028379$2$F$20240101$20240910$20240628$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-019099$UNITED THERAPEUTICS$$$$$M$Y$51.701$KG$20240919$$$US$US
240284145$24028414$5$F$20240101$20240918$20240628$20240920$EXP$$US-AMERICAN REGENT INC-2024002338$AMERICAN REGENT$$$$$F$Y$$$20240920$$CN$US$US
240284152$24028415$2$F$20240520$20240726$20240628$20240807$EXP$$US-ASTELLAS-2024US018075$ASTELLAS$$56$YR$$F$Y$$$20240807$$CN$US$US
240284172$24028417$2$F$20231001$20240920$20240628$20240925$PER$$US-ALKERMES INC.-ALK-2024-001699$ALKERMES$$26$YR$$M$Y$95.238$KG$20240925$$CN$US$US
240284393$24028439$3$F$$20240828$20240628$20240903$EXP$$US-TAKEDA-2024TUS060978$TAKEDA$$$$$M$Y$70$KG$20240903$$CN$US$US
240284422$24028442$2$F$$20240702$20240628$20240704$EXP$$NVSC2024BR124679$NOVARTIS$$63$YR$$F$Y$70$KG$20240704$$CN$BR$BR
240284432$24028443$2$F$$20240815$20240628$20240823$EXP$$NVSC2024US134385$NOVARTIS$$$$$F$Y$$$20240823$$PH$US$US
240284472$24028447$2$F$$20240722$20240628$20240807$30DAY$$CN-JNJFOC-20240669657$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$CN$CN
240284523$24028452$3$F$20231001$20240801$20240628$20240802$EXP$$US-ROCHE-10000011044$ROCHE$$72$YR$E$M$Y$79.38$KG$20240802$$HP$US$US
240284582$24028458$2$F$20240201$20240802$20240628$20240805$EXP$$US-ALXN-202406USA001310US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
240284593$24028459$3$F$$20240731$20240628$20240805$PER$$US-ALXN-202406USA001328US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240284642$24028464$2$F$20240625$20240625$20240628$20240710$EXP$$IL-ROCHE-10000011457$ROCHE$$60$YR$A$M$Y$$$20240710$$CN$IL$IL
240284703$24028470$3$F$$20240815$20240628$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05430$LUPIN$$$$$$Y$$$20240902$$CN$US$US
240284742$24028474$2$F$20231003$20240629$20240628$20240708$EXP$$GB-TEVA-VS-3213153$TEVA$$93$YR$$M$Y$$$20240708$$CN$GB$GB
240284802$24028480$2$F$20240524$20240731$20240628$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-031811$AUROBINDO$$$$A$M$Y$$$20240809$$CN$US$US
240284862$24028486$2$F$$20240903$20240628$20240909$EXP$$US-BIOGEN-2024BI01258949$BIOGEN$$$$$F$Y$$$20240909$$MD$US$US
240284895$24028489$5$F$20240506$20240828$20240628$20240829$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-101945$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$69.1$KG$20240829$$HP$ES$ES
240285042$24028504$2$F$20230101$20240619$20240628$20240704$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453829$RANBAXY$$76$YR$$F$Y$$$20240704$$CN$FR$FR
240285172$24028517$2$F$20230911$20240821$20240628$20240905$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453725$RANBAXY$$$$N$M$Y$$$20240905$$MD$IE$IE
240285232$24028523$2$F$20240601$20240722$20240628$20240724$PER$$US-JNJFOC-20240667973$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240724$$CN$US$US
240285252$24028525$2$F$20230512$20240625$20240628$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453763$RANBAXY$$74$YR$$F$Y$$$20240710$$MD$IT$IT
240285272$24028527$2$F$$20240701$20240628$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-030900$AUROBINDO$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM.. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.. Archives of Dermatological Research.. 2024;316(6):279$63$YR$$F$Y$$$20240710$$MD$US$US
240285302$24028530$2$F$$20240923$20240628$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202406019075$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240925$$CN$US$US
240285432$24028543$2$F$20240401$20240710$20240628$20240716$EXP$$US-ABBVIE-5815843$ABBVIE$$57$YR$$F$Y$94$KG$20240716$$CN$US$US
240285522$24028552$2$F$$20240627$20240628$20240716$PER$$US-AstraZeneca-2024A147186$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240285562$24028556$2$F$$20240724$20240628$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-030905$AUROBINDO$Korman AM, Fisher K, Kaffenberger BH, Chung CG,  Kirven RM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.. Archives of Dermatological Research. 2024;316(6):279$49$YR$$M$Y$$$20240803$$MD$US$US
240285592$24028559$2$F$$20240729$20240628$20240808$EXP$$BR-AUROBINDO-AUR-APL-2024-030879$AUROBINDO$Avancini J, Nico MM. Exanthematous Pustulosis Restricted to Striae Distensae. Journal of Cutaneous Medicine and Surgery. 2024;28(3):312$18$YR$$F$Y$$$20240808$$MD$BR$BR
240285616$24028561$6$F$20240613$20240726$20240628$20240806$EXP$$US-ROCHE-10000006596$ROCHE$$77$YR$E$$Y$$$20240806$$CN$US$US
240285662$24028566$2$F$$20240802$20240628$20240805$PER$$US-ALXN-202406USA001331US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240285682$24028568$2$F$$20240625$20240628$20240722$EXP$$ES-ALXN-202406EEA001663ES$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$MD$ES$ES
240285692$24028569$2$F$20240619$20240806$20240628$20240807$PER$$US-ALXN-202406USA001425US$ALEXION PHARMACEUTICALS$$68$YR$$F$Y$$$20240807$$CN$US$US
240285702$24028570$2$F$20240608$20240805$20240628$20240806$PER$$US-ALXN-202406USA001469US$ALEXION PHARMACEUTICALS$$75$YR$$F$Y$$$20240806$$CN$US$US
240285742$24028574$2$F$20240621$20240715$20240628$20240717$PER$$US-ROCHE-10000011620$ROCHE$$45$YR$A$M$Y$$$20240717$$CN$US$US
240285872$24028587$2$F$20240701$20240716$20240628$20240724$PER$$US-SA-2024SA182844$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240724$$MD$US$US
240285952$24028595$2$F$20240101$20240903$20240628$20240924$PER$$US-SA-2024SA183136$SANOFI AVENTIS$$$$E$M$Y$$$20240924$$MD$US$US
240285982$24028598$2$F$20240601$20240716$20240628$20240724$PER$$US-SA-2024SA182717$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240724$$MD$US$US
240286094$24028609$4$F$20240101$20240806$20240628$20240821$PER$$US-SA-2024SA182781$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240821$$MD$US$US
240286182$24028618$2$F$20240316$20240903$20240628$20240909$EXP$$CA-CHIESI-2024CHF03778$CHIESI$$27$YR$$F$Y$41.5$KG$20240909$$PH$CA$CA
240286243$24028624$3$F$$20240827$20240628$20240905$30DAY$$US-GSK-US2024AMR080508$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
240286402$24028640$2$F$$20240710$20240628$20240715$PER$$US-BAYER-2024A092732$BAYER$$32$YR$A$F$Y$$$20240715$$MD$US$US
240286422$24028642$2$F$20210601$20240716$20240628$20240718$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-003974$JAZZ$$57$YR$$F$Y$$$20240718$$CN$US$US
240286442$24028644$2$F$$20240709$20240628$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-103108$BRISTOL MYERS SQUIBB$Hiroki I, et al. A case of acute tubulointerstitial nephritis after nivolumab administration. The 69th Annual Meeting of the Japanese Society for Dialysis Therapy. 2024;57(S1):2388.$64$YR$A$M$Y$$$20240717$$MD$JP$JP
240286452$24028645$2$F$$20240731$20240628$20240801$30DAY$$IN-JNJFOC-20240664376$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$PH$IN$IN
240286482$24028648$2$F$20240101$20240708$20240628$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103666$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240719$$HP$US$US
240286502$24028650$2$F$20220905$20240717$20240628$20240729$EXP$$DE-AUROBINDO-AUR-APL-2024-030813$AUROBINDO$$$$E$F$Y$67$KG$20240729$$MD$DE$DE
240286552$24028655$2$F$20240101$20240815$20240628$20240824$EXP$$CA-CELLTRION INC.-2024CA007423$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
240286692$24028669$2$F$20240615$20240701$20240628$20240703$PER$$US-AMGEN-USASP2024126310$AMGEN$$66$YR$E$F$Y$$$20240703$$PH$US$US
240286732$24028673$2$F$$20240726$20240628$20240807$PER$$US-AstraZeneca-2024A147280$ASTRAZENECA$$$$$$Y$$$20240807$$CN$US$
240286842$24028684$2$F$$20240702$20240628$20240704$EXP$$DE-TAKEDA-2024TUS064079$TAKEDA$$65$YR$$F$Y$$$20240704$$HP$DE$DE
240286852$24028685$2$F$20230201$20240618$20240628$20240708$30DAY$$US-GSK-US2024075663$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240708$$CN$US$US
240286863$24028686$3$F$$20240716$20240628$20240723$30DAY$$US-GSK-US2024077241$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$CN$US$US
240286872$24028687$2$F$20240604$20240618$20240628$20240708$EXP$$US-VIIV HEALTHCARE LIMITED-US2024075811$VIIV$$37$YR$$M$Y$$$20240708$$CN$US$US
240286932$24028693$2$F$20240601$20240715$20240628$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202406018407$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240718$$CN$US$US
240286992$24028699$2$F$$20240730$20240628$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202406019024$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240731$$CN$US$US
240287112$24028711$2$F$$20240820$20240628$20240822$EXP$$NVSC2024CA132975$NOVARTIS$$73$YR$$F$Y$$$20240822$$HP$CA$CA
240287212$24028721$2$F$20240501$20240807$20240628$20240813$PER$$US-SA-2024SA184057$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240814$$MD$US$US
240287222$24028722$2$F$20240501$20240723$20240628$20240801$PER$$US-SA-2024SA183748$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240801$$MD$US$US
240287242$24028724$2$F$20180601$20240701$20240628$20240710$PER$$US-SA-2024SA183752$SANOFI AVENTIS$$39$YR$A$F$Y$62.59$KG$20240710$$MD$US$US
240287322$24028732$2$F$$20240819$20240628$20240830$EXP$$US-AUROBINDO-AUR-APL-2024-030847$AUROBINDO$Zayat N, Arora A, O^Brien J, Bal J, Sugarman R, Rivera L, et al.. Pregnancy-Associated Onset of Adult-Onset Still^s Disease. AJP Reports. 2024;14(2):E145-55$29$YR$$F$Y$$$20240830$$MD$US$US
240287363$24028736$3$F$20240619$20240711$20240628$20240716$EXP$$CA-JNJFOC-20240660284$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240716$$HP$CA$CA
240287373$24028737$3$F$$20240725$20240628$20240805$30DAY$$US-JNJFOC-20240666683$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$HP$US$US
240287412$24028741$2$F$$20240717$20240628$20240724$PER$$US-SA-2024SA186008$SANOFI AVENTIS$$54$YR$A$M$Y$126.98$KG$20240724$$MD$US$US
240287622$24028762$2$F$20201101$20240726$20240628$20240802$PER$$US-SA-2024SA187786$SANOFI AVENTIS$$42$YR$A$M$Y$79$KG$20240802$$MD$US$US
240287742$24028774$2$F$20231201$20240624$20240628$20240701$PER$$US-SA-2024SA189090$SANOFI AVENTIS$$37$YR$A$F$Y$86.18$KG$20240701$$MD$US$US
240287752$24028775$2$F$20240401$20240625$20240628$20240704$PER$$US-SA-2024SA189859$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240704$$MD$US$US
240287762$24028776$2$F$20240101$20240805$20240628$20240813$PER$$US-SA-2024SA187917$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240814$$MD$US$US
240287792$24028779$2$F$$20240705$20240628$20240727$PER$$US-SA-2024SA183098$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240727$$HP$US$US
240287822$24028782$2$F$20240622$20240729$20240628$20240805$PER$$US-SA-2024SA189012$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240805$$HP$US$US
240287842$24028784$2$F$$20240802$20240628$20240810$PER$$US-SA-2015SA004583$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240810$$HP$US$US
240287863$24028786$3$F$20240101$20240812$20240628$20240816$PER$$US-SA-2024SA188334$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240817$$MD$US$US
240287932$24028793$2$F$20240101$20240627$20240628$20240710$PER$$US-SA-2024SA189088$SANOFI AVENTIS$$22$YR$A$M$Y$80$KG$20240710$$MD$US$US
240287982$24028798$2$F$$20240716$20240628$20240724$PER$$US-SA-2024SA189100$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240724$$MD$US$US
240288032$24028803$2$F$20240101$20240718$20240628$20240730$PER$$US-SA-2024SA187911$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240730$$MD$US$US
240288153$24028815$3$F$20240601$20240717$20240628$20240725$PER$$JP-Eisai-EC-2024-168449$EISAI$$59$YR$A$F$Y$$$20240725$$MD$JP$JP
240288293$24028829$3$F$20231201$20240703$20240628$20240709$PER$$US-SA-2024SA191268$SANOFI AVENTIS$$71$YR$E$F$Y$49.8$KG$20240709$$MD$US$US
240288353$24028835$3$F$20240101$20240905$20240628$20240926$PER$$US-SA-2024SA183104$SANOFI AVENTIS$$41$YR$A$M$Y$62.585$KG$20240926$$CN$US$US
240288386$24028838$6$F$20240428$20240617$20240628$20240909$EXP$$US-ROCHE-10000006568$ROCHE$$55$YR$A$M$Y$149.68$KG$20240909$$CN$US$US
240288523$24028852$3$F$20240624$20240625$20240628$20240701$PER$$US-JNJFOC-20240664031$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240288542$24028854$2$F$$20240626$20240628$20240701$EXP$$JP-JNJFOC-20240675199$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240701$$PH$JP$JP
240288553$24028855$3$F$$20240712$20240628$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103329$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240718$$CN$US$US
240288572$24028857$2$F$$20240821$20240628$20240827$EXP$$CA-JNJFOC-20240567997$JOHNSON AND JOHNSON$$13$YR$T$M$Y$57$KG$20240827$$HP$CA$CA
240288602$24028860$2$F$$20240702$20240628$20240704$EXP$$US-EXELIXIS-CABO-24078780$EXELIXIS$$$$$$Y$$$20240704$$PH$US$US
240288612$24028861$2$F$$20240626$20240628$20240703$EXP$$EC-ROCHE-10000007758$ROCHE$$$$$$Y$$$20240703$$CN$EC$EC
240288712$24028871$2$F$20240621$20240701$20240628$20240705$EXP$$NVSC2024AU132319$NOVARTIS$$31$YR$$M$Y$$$20240705$$HP$AU$AU
240288812$24028881$2$F$20230601$20240717$20240628$20240722$EXP$$PT-AUROBINDO-AUR-APL-2024-031224$AUROBINDO$Salvado J, Cimadeira F, Inez R, Meireles C, Afonso R, Ribeiro N et all. Pretomanid Active Pharmacovigilance Program. arsylvt$51$YR$$F$Y$55$KG$20240722$$PH$PT$PT
240288972$24028897$2$F$20240101$20240626$20240628$20240709$EXP$$JP-ROCHE-10000007940$ROCHE$$7$DEC$E$F$Y$$$20240705$$PH$JP$JP
240289012$24028901$2$F$20240617$20240730$20240628$20240808$EXP$$US-RADIUS HEALTH, INC.-2024US004383$RADIUS PHARM$$64$YR$$F$Y$$$20240808$$MD$US$US
240289072$24028907$2$F$$20240731$20240628$20240802$EXP$$NVSJ2024JP007615$NOVARTIS$$30$YR$$M$Y$$$20240802$$PH$JP$JP
240289172$24028917$2$F$20201221$20240717$20240628$20240722$EXP$$DE-PFIZER INC-2021357686$PFIZER$$54$YR$$F$Y$91$KG$20240722$$MD$DE$DE
240289202$24028920$2$F$$20240725$20240628$20240730$EXP$$CA-PFIZER INC-202400199744$PFIZER$$66$YR$$M$Y$84$KG$20240730$$HP$CA$CA
240289242$24028924$2$F$20231209$20240918$20240628$20240920$EXP$$CA-SA-2024SA184708$SANOFI AVENTIS$$80$YR$E$F$Y$74.8$KG$20240920$$MD$CA$CA
240289342$24028934$2$F$$20240724$20240628$20240731$30DAY$$US-JNJFOC-20240664237$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$PH$US$US
240289402$24028940$2$F$20200107$20240620$20240628$20240702$EXP$$GB-ROCHE-2518535$ROCHE$$34$YR$A$M$Y$$$20240702$$HP$GB$GB
240289512$24028951$2$F$$20240722$20240628$20240724$PER$$US-ROCHE-10000010525$ROCHE$$$$T$F$Y$$$20240724$$MD$US$US
240289572$24028957$2$F$20230901$20240828$20240628$20240904$EXP$$US-009507513-2406USA008428$MERCK$$$$$F$Y$$$20240904$$CN$US$US
240289583$24028958$3$F$20240101$20240731$20240628$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019403$UNITED THERAPEUTICS$$$$$F$Y$81.633$KG$20240807$$$US$US
240289622$24028962$2$F$20240101$20240624$20240628$20240704$PER$$US-AMGEN-USASP2024125305$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240289632$24028963$2$F$$20240709$20240628$20240712$PER$$US-VERTEX PHARMACEUTICALS-2024-010357$VERTEX$$$$$$Y$$$20240712$$CN$US$US
240289673$24028967$3$F$20240306$20240614$20240628$20240709$EXP$$CA-ROCHE-3523876$ROCHE$$69$YR$E$F$Y$$$20240702$$MD$CA$CA
240289682$24028968$2$F$$20240712$20240628$20240723$PER$$US-VERTEX PHARMACEUTICALS-2024-010360$VERTEX$$$$$$Y$$$20240723$$CN$US$US
240289733$24028973$3$F$20240508$20240814$20240628$20240821$EXP$$GB-VERTEX PHARMACEUTICALS-2024-010571$VERTEX$$27$YR$$F$Y$$$20240821$$PH$GB$GB
240289764$24028976$4$F$20240618$20240722$20240628$20240731$30DAY$$US-JNJFOC-20240646849$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240731$$PH$US$US
240289814$24028981$4$F$20220420$20240815$20240628$20240823$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-01684$IPSEN$$29$YR$A$F$Y$$$20240823$$MD$JP$JP
240289872$24028987$2$F$$20240717$20240628$20240724$30DAY$$SI-JNJFOC-20240660505$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$SI$SI
240289892$24028989$2$F$$20240701$20240628$20240704$EXP$$US-PFIZER INC-202400201207$PFIZER$$83$YR$$F$Y$61.678$KG$20240704$$HP$US$US
240289912$24028991$2$F$$20240717$20240628$20240726$EXP$$US-Blueprint Medicines Corporation-LT-US-2024-001256$BLUEPRINT MEDICINES$$31$YR$A$M$Y$$$20240726$$MD$US$US
240289923$24028992$3$F$20230101$20240624$20240628$20240712$EXP$$CN-009507513-2406CHN009870$MERCK$$66$YR$$M$Y$$$20240712$$HP$CN$CN
240289933$24028993$3$F$20240601$20240826$20240628$20240829$EXP$$JP-Eisai-EC-2024-168603$EISAI$$68$YR$E$M$Y$$$20240829$$PH$JP$JP
240290012$24029001$2$F$20240621$20240726$20240628$20240810$PER$$US-AstraZeneca-2024A145313$ASTRAZENECA$$7158$DY$$F$Y$$$20240810$$CN$US$
240290043$24029004$3$F$20240610$20240709$20240628$20240809$PER$$FR-TOLMAR, INC.-24FR050134$TOLMAR$$78$YR$$M$Y$$$20240809$$PH$FR$FR
240290082$24029008$2$F$20240528$20240711$20240628$20240801$PER$$US-TOLMAR, INC.-24US049725$TOLMAR$$82$YR$$M$Y$$$20240801$$PH$US$US
240290123$24029012$3$F$20240506$20240909$20240628$20240927$PER$$US-TOLMAR, INC.-24US050057$TOLMAR$$38$YR$$F$Y$$$20240927$$HP$US$US
240290132$24029013$2$F$20240610$20240722$20240628$20240816$PER$$US-TOLMAR, INC.-24US050093$TOLMAR$$70$YR$$M$Y$$$20240816$$HP$US$US
240290142$24029014$2$F$20240605$20240711$20240628$20240801$PER$$US-TOLMAR, INC.-24US049994$TOLMAR$$66$YR$$M$Y$$$20240730$$HP$US$US
240290152$24029015$2$F$20240607$20240722$20240628$20240816$PER$$US-TOLMAR, INC.-24US050065$TOLMAR$$75$YR$$M$Y$$$20240816$$HP$US$US
240290162$24029016$2$F$20240524$20240722$20240628$20240819$PER$$US-TOLMAR, INC.-24US050106$TOLMAR$$78$YR$$M$Y$$$20240814$$HP$US$US
240290262$24029026$2$F$$20240708$20240628$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05557$LUPIN$$$$$$Y$$$20240806$$CN$US$US
240290322$24029032$2$F$20240624$20240925$20240628$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103071$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240926$$CN$US$US
240290362$24029036$2$F$$20240618$20240628$20240702$EXP$$BR-JNJFOC-20240651271$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240702$$CN$BR$BR
240290372$24029037$2$F$$20240719$20240628$20240729$PER$$US-SA-2024SA183619$SANOFI AVENTIS$$61$YR$A$F$Y$113$KG$20240729$$MD$US$US
240290472$24029047$2$F$$20240628$20240628$20240702$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02236$AMNEAL$$$$$F$Y$$$20240702$$CN$US$US
240290483$24029048$3$F$$20240925$20240628$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103765$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240927$$HP$US$US
240290493$24029049$3$F$$20240916$20240628$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100014$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$61.9$KG$20240924$$CN$US$US
240290562$24029056$2$F$$20240627$20240628$20240703$EXP$$DE-TAKEDA-2024TUS062867$TAKEDA$$$$$F$Y$$$20240703$$CN$DE$DE
240290612$24029061$2$F$20240501$20240916$20240628$20240920$EXP$$GB-MYLANLABS-2024M1058130$MYLAN$$$$$F$Y$$$20240920$$HP$GB$GB
240290622$24029062$2$F$20240510$20240729$20240628$20240731$EXP$PT-INFARMED-J202406-286$PT-EXELIXIS-CABO-24078887$EXELIXIS$$73$YR$$M$Y$$$20240731$$HP$PT$PT
240290662$24029066$2$F$20240619$20240715$20240628$20240722$EXP$$US-CHIESI-2024CHF03817$CHIESI$$77$YR$$M$Y$72.5$KG$20240719$$CN$US$US
240290723$24029072$3$F$20240620$20240819$20240628$20240823$EXP$$AU-MYLANLABS-2024M1058120$MYLAN$$6$YR$$M$Y$$$20240823$$CN$AU$AU
240290732$24029073$2$F$$20240724$20240628$20240729$30DAY$$US-MYLANLABS-2024M1057801$MYLAN$$$$$M$Y$42.64$KG$20240729$$CN$US$US
240290742$24029074$2$F$$20240719$20240628$20240725$30DAY$$CA-MYLANLABS-2024M1056552$MYLAN$$$$$M$Y$$$20240725$$CN$CA$CA
240290842$24029084$2$F$$20240701$20240628$20240708$EXP$$PL-GILEAD-2024-0678697$GILEAD$$76$YR$E$F$Y$$$20240708$$MD$PL$PL
240290873$24029087$3$F$20240502$20240719$20240628$20240730$PER$$US-ROCHE-3567276$ROCHE$$67$YR$E$$Y$$$20240730$$HP$US$US
240290882$24029088$2$F$20240618$20240723$20240628$20240729$PER$$US-JNJFOC-20240646865$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240729$$CN$US$US
240290942$24029094$2$F$$20240808$20240628$20240808$PER$$NVSC2024US133938$NOVARTIS$$$$$M$Y$$$20240808$$HP$US$US
240291082$24029108$2$F$$20240723$20240628$20240730$30DAY$$KZ-JNJFOC-20240660099$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$CN$KZ$KZ
240291102$24029110$2$F$$20240728$20240628$20240802$PER$$US-ABBVIE-5813475$ABBVIE$$$$$$Y$$$20240802$$HP$US$US
240291243$24029124$3$F$20240619$20240619$20240628$20240704$EXP$$CL-ROCHE-10000006042$ROCHE$$65$YR$E$$Y$$$20240704$$HP$CL$CL
240291252$24029125$2$F$$20240819$20240628$20240823$PER$$US-ALXN-202406USA001491US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
240291293$24029129$3$F$$20240819$20240628$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202406019034$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240821$$CN$US$US
240291352$24029135$2$F$20140101$20240802$20240628$20240805$EXP$$GB-MYLANLABS-2024M1060835$MYLAN$$$$$M$Y$$$20240805$$HP$GB$GB
240291362$24029136$2$F$20240619$20240725$20240628$20240726$EXP$$AU-MYLANLABS-2024M1060830$MYLAN$$27$YR$$M$Y$$$20240726$$HP$AU$AU
240291372$24029137$2$F$20240614$20240808$20240628$20240809$EXP$$GB-MYLANLABS-2024M1060833$MYLAN$$59$YR$$M$Y$$$20240809$$HP$GB$GB
240291402$24029140$2$F$$20240703$20240628$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002715$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
240291452$24029145$2$F$$20240723$20240628$20240731$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001288$BLUEPRINT MEDICINES$$$$$M$Y$$$20240731$$CN$US$US
240291662$24029166$2$F$$20240826$20240628$20240909$PER$$US-SA-2024SA186875$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240909$$MD$US$US
240291692$24029169$2$F$20240527$20240626$20240628$20240705$EXP$$AU-BAXTER-2024BAX020391$BAXTER$$77$YR$$F$Y$61.8$KG$20240705$$MD$AU$AU
240291723$24029172$3$F$$20240719$20240628$20240729$EXP$$US-TEVA-VS-3214534$TEVA$Gilani S, Rifai Z, Singanallur P, Song M. Prolonged COVID-19 Pneumonia in a Patient on Obinutuzumab for Treatment of Follicular Lymphoma. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A5676.; Gilani S, Rifai Z, Singanallur P, Song M. Prolonged covid-19 pneumonia in a patient on obinutuzumab for treatment of follicular lymphoma. American Journal of Respiratory and Critical Care Medicine. 2024;209:No Information; Gilani S, Rifai Z, Singanallur P, Song M. Prolonged covid-19 pneumonia in a patient o...$62$YR$$M$Y$$$20240729$$HP$US$US
240291732$24029173$2$F$20240619$20240827$20240628$20240903$EXP$$CA-JNJFOC-20240657937$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240903$$HP$CA$CA
240291782$24029178$2$F$$20240927$20240628$20240927$EXP$$US-BAYER-2024A092163$BAYER$$$$A$M$Y$$$20240927$$HP$US$US
240291862$24029186$2$F$20240101$20240620$20240628$20240704$PER$$US-SA-2024SA186468$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240704$$MD$US$US
240291885$24029188$5$F$$20240802$20240628$20240806$PER$$US-AMGEN-USASP2024126493$AMGEN$$$$A$F$Y$$$20240806$$CN$US$US
240291952$24029195$2$F$20240611$20240708$20240628$20240716$EXP$$JP-AstraZeneca-2024A146168$ASTRAZENECA$$80$YR$$$Y$$$20240716$$MD$JP$
240292024$24029202$4$F$20240619$20240715$20240628$20240722$EXP$$US-AMGEN-USASP2024125359$AMGEN$$62$YR$A$F$Y$$$20240722$$CN$US$US
240292102$24029210$2$F$$20240726$20240628$20240801$30DAY$$IT-JNJFOC-20240659960$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$IT$IT
240292122$24029212$2$F$20210201$20240715$20240628$20240720$PER$$US-JAZZ PHARMACEUTICALS-2021-US-009183$JAZZ$$69$YR$$F$Y$$$20240720$$MD$US$US
240292332$24029233$2$F$20240101$20240816$20240628$20240902$PER$$US-SA-2024SA185501$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240902$$MD$US$US
240292402$24029240$2$F$20240324$20240814$20240628$20240828$EXP$$US-COOPERSURGICAL, INC.-2024CPS001903$COOPERSURGICAL$$37$YR$$F$Y$67.029$KG$20240828$$CN$US$US
240292432$24029243$2$F$20240401$20240628$20240628$20240706$PER$$US-ABBVIE-5815898$ABBVIE$$72$YR$$F$Y$$$20240706$$CN$US$US
240292494$24029249$4$F$20220507$20240805$20240628$20240808$EXP$$JP-EMD Serono-2024035090$EMD SERONO INC$$72$YR$E$M$Y$59$KG$20240808$$HP$JP$JP
240292543$24029254$3$F$$20240706$20240628$20240717$EXP$$CN-ROCHE-10000010879$ROCHE$Cheng Y, Ting-Ting L, Li-Tao G, Et al.. Chronic inflammatory demyelinating polyneuropathy with pulmonary nocardiosis: A case report. Medicine. 2024-Jun-14;24 (103): doi:10.1097/MD.0000000000038544.$65$YR$E$M$Y$$$20240717$$MD$CN$CN
240292594$24029259$4$F$$20240822$20240628$20240824$PER$$US-AMGEN-USASP2024127769$AMGEN$$$$$F$Y$$$20240824$$CN$US$US
240292602$24029260$2$F$20240602$20240628$20240628$20240708$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240600049$RIGEL PHARMACEUTICALS$$83$YR$$F$Y$$$20240708$$PH$JP$JP
240292662$24029266$2$F$20230829$20240701$20240628$20240706$EXP$$TW-009507513-2406TWN009255$MERCK$$30$YR$$F$Y$$$20240706$$MD$TW$TW
240292672$24029267$2$F$20240618$20240715$20240628$20240724$EXP$$US-TEVA-VS-3212735$TEVA$$68$YR$$M$Y$$$20240724$$CN$US$US
240292682$24029268$2$F$$20240830$20240628$20240830$EXP$$NVSC2024US134488$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
240292692$24029269$2$F$20240618$20240805$20240628$20240806$PER$$US-JNJFOC-20240655416$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240806$$HP$US$US
240292752$24029275$2$F$$20240624$20240628$20240703$PER$$US-ROCHE-10000011348$ROCHE$$$$E$F$Y$62.7$KG$20240703$$HP$US$US
240292812$24029281$2$F$$20240624$20240628$20240705$EXP$$CA-ROCHE-10000006385$ROCHE$$$$A$F$Y$$$20240705$$CN$CA$CA
240292822$24029282$2$F$20240101$20240712$20240628$20240718$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003576$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240718$$MD$IT$IT
240292912$24029291$2$F$20240101$20240711$20240628$20240715$PER$$US-Eisai-EC-2024-165313$EISAI$$60$YR$A$F$Y$85$KG$20240715$$CN$US$US
240292943$24029294$3$F$20240101$20240806$20240628$20240809$EXP$$JP-OTSUKA-2024_018009$OTSUKA$$6$DEC$$F$Y$$$20240809$$MD$JP$JP
240292982$24029298$2$F$20210101$20240718$20240628$20240724$EXP$$CZ-ROCHE-10000012387$ROCHE$Pavlickova J,  Adherence to treatment in multiple sclerosis: case reports of three female patients on highly effective ocrelizumab therapy. Doi: 10.1007/s40120-021-00319-3. Neurol. practice. 2024;25 (3):10-6. doi:10.1007/s40120-021-00319-3.$20$YR$A$F$Y$$$20240724$$MD$CZ$CZ
240293012$24029301$2$F$$20240726$20240628$20240730$EXP$$IT-MYLANLABS-2024M1058077$MYLAN$$33$YR$$F$Y$$$20240730$$HP$IT$IT
240293042$24029304$2$F$20240607$20240724$20240628$20240729$EXP$$GB-MYLANLABS-2024M1052641$MYLAN$$$$$M$Y$$$20240729$$MD$GB$GB
240293223$24029322$3$F$20240101$20240709$20240628$20240712$EXP$$US-AMGEN-USASP2024123368$AMGEN$$75$YR$E$F$Y$$$20240712$$HP$US$US
240293262$24029326$2$F$$20240711$20240628$20240715$PER$$US-JNJFOC-20240667341$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$US$US
240293302$24029330$2$F$20240401$20240802$20240628$20240805$EXP$$JP-ABBVIE-5817814$ABBVIE$$60$YR$$M$Y$$$20240805$$MD$JP$JP
240293373$24029337$3$F$20240619$20240902$20240628$20240909$EXP$$JP-Eisai-EC-2024-168628$EISAI$$$$E$M$Y$$$20240909$$MD$JP$JP
240293652$24029365$2$F$20240101$20240716$20240628$20240720$PER$$US-BAYER-2024A093304$BAYER$$35$YR$A$F$Y$$$20240720$$MD$US$US
240293702$24029370$2$F$$20240813$20240628$20240816$EXP$$US-AstraZeneca-2024A149142$ASTRAZENECA$$$$$M$Y$$$20240816$$MD$US$
240293752$24029375$2$F$20240622$20240722$20240628$20240724$EXP$$CA-ABBVIE-5816955$ABBVIE$$86$YR$$F$Y$72.574$KG$20240724$$PH$CA$CA
240293792$24029379$2$F$$20240830$20240628$20240902$EXP$$NVSC2024US134075$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
240293812$24029381$2$F$20240625$20240627$20240628$20240702$EXP$$US-ABBVIE-5817203$ABBVIE$$75$YR$$M$Y$$$20240702$$CN$US$US
240293842$24029384$2$F$20240516$20240809$20240628$20240813$EXP$$US-ABBVIE-5814707$ABBVIE$$64$YR$$F$Y$$$20240813$$CN$US$US
240293902$24029390$2$F$$20240709$20240628$20240711$EXP$$CA-PFIZER INC-PV202400062832$PFIZER$$60$YR$$F$Y$79$KG$20240711$$HP$CA$CA
240293945$24029394$5$F$20230101$20240909$20240628$20240912$EXP$$CA-PFIZER INC-202400200808$PFIZER$$63$YR$$F$Y$$$20240912$$MD$CA$CA
240293992$24029399$2$F$20240624$20240822$20240628$20240822$EXP$$CA-PFIZER INC-202400201032$PFIZER$$23$YR$$M$Y$$$20240822$$HP$CA$CA
240294042$24029404$2$F$20240101$20240822$20240628$20240822$EXP$$CA-PFIZER INC-202400028629$PFIZER$$41$YR$$M$Y$108$KG$20240822$$HP$CA$CA
240294102$24029410$2$F$20240101$20240625$20240628$20240704$PER$$US-JNJFOC-20240667811$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240704$$CN$US$US
240294112$24029411$2$F$20240312$20240802$20240628$20240809$EXP$$TH-BAYER-2024A089112$BAYER$$79$YR$E$M$Y$$$20240809$$CN$TH$TH
240294122$24029412$2$F$20240101$20240705$20240628$20240913$PER$$US-KARYOPHARM-2024KPT001223$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240913$$CN$US$US
240294143$24029414$3$F$$20240716$20240628$20240723$EXP$GB-AstraZeneca-2024A035482$GB-RDY-SPO/GBR/24/0009187$DR REDDYS$$38$YR$A$F$Y$$$20240723$$MD$GB$GB
240294183$24029418$3$F$20240625$20240727$20240628$20240730$PER$$US-AMGEN-USASP2024126885$AMGEN$$74$YR$E$M$Y$$$20240730$$CN$US$US
240294212$24029421$2$F$$20240717$20240628$20240726$PER$$US-SA-2024SA183834$SANOFI AVENTIS$$$$A$F$Y$54$KG$20240726$$MD$US$US
240294252$24029425$2$F$$20240911$20240628$20240923$PER$$US-SA-2024SA182707$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240923$$MD$US$US
240294443$24029444$3$F$20240607$20240718$20240628$20240725$EXP$$PK-ROCHE-10000005607$ROCHE$$10$YR$C$M$Y$$$20240725$$CN$PK$PK
240294469$24029446$9$F$20230101$20240827$20240628$20240906$EXP$$IE-ABBVIE-5477013$ABBVIE$$73$YR$$M$Y$$$20240906$$HP$IE$IE
240294472$24029447$2$F$20231001$20240628$20240628$20240709$EXP$DE-EMBRYOTOX-202302193$DE-TORRENT-00026891$TORRENT$$$$$M$Y$3$KG$20240709$$MD$DE$DE
240294522$24029452$2$F$$20240704$20240628$20240715$EXP$GB-LABORATORIOS LICONSA S.A.-2406GB04627$GB-TORRENT-00036836$TORRENT$$$$E$M$Y$$$20240715$$CN$GB$GB
240294673$24029467$3$F$$20240924$20240628$20240926$EXP$$NVSC2024US131075$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
240294732$24029473$2$F$$20240909$20240628$20240910$EXP$$JP-BAYER-2024A093281$BAYER$$70$YR$E$M$Y$$$20240910$$PH$JP$JP
240294752$24029475$2$F$$20240610$20240628$20240712$EXP$$PK-ROCHE-10000010070$ROCHE$$60$YR$A$M$Y$$$20240712$$CN$PK$PK
240294813$24029481$3$F$20240615$20240830$20240628$20240906$EXP$$JP-AstraZeneca-2024A146038$ASTRAZENECA$$2$MON$$$Y$$$20240906$$MD$JP$
240294832$24029483$2$F$20240402$20240715$20240628$20240716$EXP$$AU-MYLANLABS-2024M1030703$MYLAN$$57$YR$$M$Y$$$20240716$$HP$AU$AU
240294872$24029487$2$F$20230511$20240628$20240628$20240705$EXP$$ES-ZAMBON SWITZERLAND LTD.-2024-ZAM-ES000036$PAREXEL$$$$$$Y$$$20240705$$MD$ES$ES
240294923$24029492$3$F$$20240730$20240628$20240731$PER$$US-HALEON-2184344$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
240294933$24029493$3$F$20240101$20240731$20240628$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100657$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$56.7$KG$20240807$$CN$US$US
240294963$24029496$3$F$20240318$20240911$20240628$20240919$EXP$$JP-AMGEN-JPNSP2024125141$AMGEN$$67$YR$E$F$Y$45$KG$20240919$$MD$JP$JP
240294982$24029498$2$F$20240622$20240724$20240628$20240730$30DAY$$US-MYLANLABS-2024M1058298$MYLAN$$7$YR$$M$Y$$$20240730$$CN$US$US
240294992$24029499$2$F$$20240726$20240628$20240730$30DAY$$US-MYLANLABS-2024M1058397$MYLAN$$$$$$Y$$$20240730$$HP$US$US
240295002$24029500$2$F$$20240806$20240628$20240809$30DAY$$US-MYLANLABS-2024M1058489$MYLAN$$$$$$Y$$$20240809$$HP$US$US
240295062$24029506$2$F$20240601$20240731$20240628$20240731$PER$$US-PFIZER INC-202400200776$PFIZER$$14$YR$$M$Y$$$20240731$$CN$US$US
240295072$24029507$2$F$$20240731$20240628$20240731$PER$$US-PFIZER INC-202400201882$PFIZER$$70$YR$$F$Y$$$20240731$$CN$US$US
240295132$24029513$2$F$20240618$20240730$20240628$20240809$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202406014743$ELI LILLY AND CO$$22$YR$A$F$Y$139.68$KG$20240809$$MD$CA$CA
240295302$24029530$2$F$$20240807$20240628$20240809$EXP$$JP-JNJFOC-20240675781$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240809$$PH$JP$JP
240295313$24029531$3$F$20240101$20240717$20240628$20240801$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-001416$SK LIFE SCIENCE$$$$$$Y$$$20240801$$MD$CA$CA
240295352$24029535$2$F$$20240808$20240628$20240809$PER$$US-TAKEDA-2024TUS064685$TAKEDA$$$$$M$Y$$$20240809$$MD$US$US
240295443$24029544$3$F$20240101$20240731$20240628$20240815$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-001427$SK LIFE SCIENCE$$$$$$Y$$$20240815$$HP$CA$CA
240295462$24029546$2$F$$20240820$20240628$20240904$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-000618$SK LIFE SCIENCE$$$$$$Y$$$20240904$$HP$CA$CA
240295492$24029549$2$F$20240625$20240912$20240628$20240913$EXP$$JP-BAYER-2024A093351$BAYER$$77$YR$E$M$Y$$$20240913$$MD$JP$JP
240295522$24029552$2$F$20230321$20240626$20240628$20240701$EXP$$BY-JNJFOC-20240670870$JOHNSON AND JOHNSON$$66$YR$E$M$Y$62$KG$20240701$$MD$BY$BY
240295532$24029553$2$F$20240528$20240703$20240628$20240709$EXP$$CA-TAKEDA-2023TUS095829$TAKEDA$$75$YR$$F$Y$$$20240709$$CN$CA$CA
240295542$24029554$2$F$20240625$20240816$20240628$20240820$PER$$US-AMGEN-USASP2024127632$AMGEN$$57$YR$A$F$Y$$$20240820$$CN$US$US
240295593$24029559$3$F$20240612$20240828$20240628$20240829$PER$$NVSC2024US133393$NOVARTIS$$59$YR$$F$Y$$$20240830$$CN$US$US
240295652$24029565$2$F$$20240826$20240628$20240827$EXP$$US-GILEAD-2024-0678727$GILEAD$$$$E$F$Y$$$20240827$$CN$US$US
240295712$24029571$2$F$20240819$20240904$20240628$20240917$EXP$$US-SA-2024SA181616$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240917$$MD$US$US
240295792$24029579$2$F$20230901$20240628$20240628$20240903$PER$$US-Merz Pharmaceuticals GmbH-24-02267$MERZ$$$$$F$Y$$$20240904$$HP$US$US
240296092$24029609$2$F$$20240712$20240628$20240717$EXP$$GB-MYLANLABS-2024M1060850$MYLAN$$$$$M$Y$$$20240717$$HP$GB$GB
240296222$24029622$2$F$$20240703$20240628$20240712$EXP$$NZ-ABBVIE-5819575$ABBVIE$Medicine-induced hyponatraemia: increased risks in older people. Prescriber Update. 2024;45(2):34-36.$68$YR$$F$Y$$$20240712$$MD$NZ$NZ
240296252$24029625$2$F$$20240815$20240628$20240821$EXP$$US-JNJFOC-20240660807$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240822$$HP$US$US
240296283$24029628$3$F$$20240724$20240628$20240805$30DAY$$DE-JNJFOC-20240656055$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$PH$DE$DE
240296322$24029632$2$F$20240310$20240624$20240628$20240717$EXP$$US-AstraZeneca-2024A146415$ASTRAZENECA$$31251$DY$$M$Y$$$20240717$$CN$US$
240296332$24029633$2$F$$20240808$20240628$20240816$EXP$$US-AstraZeneca-2024A144478$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
240296504$24029650$4$F$20240101$20240722$20240628$20240725$EXP$$NL-ABBVIE-5818996$ABBVIE$$56$YR$$M$Y$84$KG$20240725$$HP$NL$NL
240296512$24029651$2$F$20220824$20240813$20240628$20240816$EXP$$JP-DSJP-DSJ-2023-102948$DAIICHI$$43$YR$$F$Y$$$20240816$$MD$JP$JP
240296622$24029662$2$F$20240410$20240724$20240628$20240801$PER$$US-SA-2024SA182068$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240801$$MD$US$US
240296662$24029666$2$F$20230101$20240807$20240628$20240816$EXP$$US-JNJFOC-20240649370$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
240296682$24029668$2$F$20240612$20240719$20240628$20240730$30DAY$$CA-JNJFOC-20240655596$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$PH$CA$CA
240296733$24029673$3$F$20210401$20240905$20240628$20240916$EXP$$US-ASTELLAS-2024US015046$ASTELLAS$$81$YR$E$M$Y$$$20240916$$CN$US$US
240296742$24029674$2$F$$20240726$20240628$20240802$PER$$US-ALXN-202406USA001532US$ALEXION PHARMACEUTICALS$$$$$M$Y$114.74$KG$20240802$$CN$US$US
240296775$24029677$5$F$20240501$20240719$20240628$20240724$EXP$$NVSC2024DE133444$NOVARTIS$$$$E$M$Y$50$KG$20240724$$MD$DE$DE
240296972$24029697$2$F$20230101$20240802$20240628$20240806$EXP$$FR-AstraZeneca-2024A148487$ASTRAZENECA$$77$YR$$F$Y$$$20240806$$MD$FR$
240296982$24029698$2$F$$20240627$20240628$20240702$EXP$$US-AstraZeneca-2024A147178$ASTRAZENECA$$$$$M$Y$$$20240702$$HP$US$
240297085$24029708$5$F$20240531$20240917$20240628$20240924$EXP$$JP-ABBVIE-5815189$ABBVIE$$69$YR$$M$Y$45$KG$20240924$$MD$JP$JP
240297143$24029714$3$F$20240514$20240723$20240628$20240801$30DAY$$BR-JNJFOC-20240653425$JOHNSON AND JOHNSON$$49$YR$A$F$Y$45$KG$20240801$$CN$BR$BR
240297153$24029715$3$F$20220810$20240722$20240628$20240729$30DAY$$US-JNJFOC-20240650761$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240729$$CN$US$US
240297182$24029718$2$F$$20240807$20240628$20240808$PER$$US-ALXN-A202310282$ALEXION PHARMACEUTICALS$$$$A$M$Y$$$20240808$$CN$US$US
240297192$24029719$2$F$$20240702$20240628$20240703$EXP$$TW-PFIZER INC-PV202400084381$PFIZER$$61$YR$$F$Y$$$20240703$$HP$TW$TW
240297222$24029722$2$F$$20240628$20240628$20240701$EXP$$JP-PFIZER INC-PV202400084618$PFIZER$$$$$$Y$$$20240701$$MD$JP$JP
240297232$24029723$2$F$$20240626$20240628$20240701$EXP$$US-PFIZER INC-PV202400084094$PFIZER$Papsun, D.. Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances. American Journal of Forensic Medicine and Pathology, The. 2022;43 (4):315-327$41$YR$$M$Y$$$20240701$$HP$US$US
240297242$24029724$2$F$20230101$20240701$20240628$20240703$EXP$$US-PFIZER INC-PV202400084551$PFIZER$$67$YR$$M$Y$$$20240703$$HP$US$US
240297272$24029727$2$F$$20240628$20240628$20240701$EXP$$US-PFIZER INC-202400201852$PFIZER$$$$$F$Y$$$20240701$$HP$US$US
240297302$24029730$2$F$20240622$20240702$20240628$20240704$EXP$$CN-PFIZER INC-PV202400084318$PFIZER$$30$YR$$F$Y$80$KG$20240704$$HP$CN$CN
240297342$24029734$2$F$20240622$20240702$20240628$20240704$EXP$$CN-PFIZER INC-PV202400084363$PFIZER$$28$YR$$F$Y$62.5$KG$20240704$$HP$CN$CN
240297372$24029737$2$F$20240611$20240702$20240628$20240703$EXP$$CN-PFIZER INC-PV202400084301$PFIZER$$66$YR$$F$Y$$$20240703$$HP$CN$CN
240297542$24029754$2$F$$20240627$20240628$20240702$EXP$$CA-JNJFOC-20240672907$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240702$$HP$CA$CA
240297752$24029775$2$F$$20240628$20240628$20240704$EXP$$PH-PFIZER INC-PV202400083441$PFIZER$$$$$M$Y$$$20240704$$CN$PH$PH
240297788$24029778$8$F$20240101$20240828$20240628$20240903$EXP$$IN-PFIZER INC-PV202400079803$PFIZER$$52$YR$$M$Y$75.2$KG$20240903$$CN$IN$IN
240297802$24029780$2$F$20240112$20240628$20240628$20240701$EXP$$US-PFIZER INC-202400200323$PFIZER$$65$YR$$F$Y$104.33$KG$20240701$$CN$US$US
240297973$24029797$3$F$$20240921$20240628$20240925$EXP$$IN-PFIZER INC-PV202400084219$PFIZER$$35$YR$$M$Y$$$20240925$$CN$IN$IN
240298024$24029802$4$F$$20240926$20240628$20240927$EXP$$US-BIOVITRUM-2024-US-009219$BIOVITRUM$$75$YR$$F$Y$$$20240927$$CN$US$US
240298042$24029804$2$F$$20240701$20240628$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05417$LUPIN$$$$$$Y$$$20240718$$CN$US$US
240298052$24029805$2$F$20231218$20240802$20240628$20240805$PER$$US-JNJFOC-20240657400$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240806$$HP$US$US
240298072$24029807$2$F$$20240701$20240628$20240709$PER$$US-JNJFOC-20240671317$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240298082$24029808$2$F$$20240702$20240628$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05484$LUPIN$$$$$$Y$$$20240725$$CN$US$US
240298152$24029815$2$F$$20240628$20240628$20240703$EXP$$FR-AstraZeneca-2024A148411$ASTRAZENECA$Belmin J et al.. Cardiac amyloidosis, an underdiagnosed disease in geriatrics. Revue du gAcriatrie 49(5):293-298.$86$YR$$M$Y$$$20240703$$MD$FR$
240298182$24029818$2$F$$20240628$20240628$20240704$EXP$$MY-TAKEDA-2024TUS063700$TAKEDA$$$$$M$Y$$$20240704$$CN$MY$MY
240298263$24029826$3$F$20240408$20240806$20240628$20240808$EXP$$JP-OTSUKA-2024_018200$OTSUKA$$5$DEC$$F$Y$$$20240808$$MD$JP$JP
240298332$24029833$2$F$20240622$20240717$20240628$20240722$PER$$JP-Eisai-EC-2024-168938$EISAI$$$$E$F$Y$$$20240722$$MD$JP$JP
240298452$24029845$2$F$20240625$20240709$20240628$20240712$PER$$US-AMGEN-USASP2024125644$AMGEN$$68$YR$E$F$Y$$$20240712$$CN$US$US
240298463$24029846$3$F$20240624$20240806$20240628$20240807$PER$$US-AMGEN-USASP2024126797$AMGEN$$65$YR$E$F$Y$$$20240807$$CN$US$US
240298552$24029855$2$F$20230329$20240707$20240628$20240715$EXP$$IL-ALNYLAM NETHERLANDS BV-ALN-2023-001619$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240715$$MD$IL$IL
240298563$24029856$3$F$$20240717$20240628$20240720$EXP$$JP-JNJFOC-20240675739$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$$COUNTRY NOT SPECIFIED$JP
240298812$24029881$2$F$20240625$20240726$20240628$20240730$PER$$US-AMGEN-USASP2024126478$AMGEN$$90$YR$E$M$Y$$$20240730$$PH$US$US
240298822$24029882$2$F$$20240625$20240628$20240702$PER$$US-AMGEN-USASP2024126073$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240298832$24029883$2$F$20240621$20240626$20240628$20240701$EXP$$CA-PFIZER INC-PV202400084148$PFIZER$$56$YR$$M$Y$$$20240701$$CN$CA$CA
240298902$24029890$2$F$$20240823$20240628$20240823$EXP$$IN-PFIZER INC-PV202400075071$PFIZER$$54$YR$$F$Y$$$20240823$$CN$IN$IN
240298922$24029892$2$F$$20240628$20240628$20240703$EXP$$CA-BAUSCH-BL-2024-009944$BAUSCH AND LOMB$Balta K, Welch S, Vincent M, Breadner D. Near 5-year survival in metastatic pancreatic cancer patient  with ROS1 rearrangement, HER2 amplification, and KRAS G12C mutation-a case report. Journal of Gastrointestinal Oncology. 2023;14(5):2273-2278. doi:10.21037/jgo-23-190$52$YR$$M$Y$$$20240703$$HP$CA$CA
240298943$24029894$3$F$20240601$20240906$20240628$20240916$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006163$AURINIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240916$$CN$US$US
240299006$24029900$6$F$$20240829$20240628$20240906$EXP$$US-JNJFOC-20240669631$JOHNSON AND JOHNSON$$$$$M$Y$1$KG$20240906$$CN$US$US
240299034$24029903$4$F$20230428$20240704$20240628$20240710$EXP$$US-BAYER-2024A087808$BAYER$$14$YR$T$F$Y$$$20240710$$CN$US$US
240299042$24029904$2$F$20240511$20240801$20240628$20240903$PER$$US-Merz Pharmaceuticals GmbH-24-02003$MERZ$$44$YR$$F$Y$$$20240904$$HP$US$US
240299172$24029917$2$F$20240601$20240722$20240628$20240903$PER$$US-Merz Pharmaceuticals GmbH-24-01998$MERZ$$55$YR$$F$Y$$$20240904$$HP$US$US
240299422$24029942$2$F$20240101$20240829$20240628$20240912$PER$$US-SA-2024SA188294$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240912$$MD$US$US
240299442$24029944$2$F$$20240628$20240628$20240702$30DAY$$FR-SANDOZ INC.-SDZ2024FR061343$SANDOZ$$7$YR$$M$Y$$$20240702$$CN$FR$FR
240299562$24029956$2$F$20240501$20240604$20240628$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103805$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240719$$CN$US$US
240299584$24029958$4$F$20240617$20240905$20240628$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US061275$SANDOZ$$57$YR$$F$Y$$$20240909$$HP$US$US
240299653$24029965$3$F$20240617$20240911$20240628$20240919$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006000$AURINIA PHARMACEUTICALS$$45$YR$$F$Y$$$20240919$$CN$US$US
240299863$24029986$3$F$20240312$20240813$20240628$20240823$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202403009511$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240823$$CN$BR$BR
240299902$24029990$2$F$$20240814$20240628$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202406013822$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240826$$CN$US$US
240299952$24029995$2$F$$20240719$20240628$20240724$EXP$$DE-AstraZeneca-2024A146806$ASTRAZENECA$$$$$F$Y$$$20240724$$PH$DE$
240299962$24029996$2$F$$20240715$20240628$20240723$EXP$$DE-AstraZeneca-2024A146778$ASTRAZENECA$$$$$M$Y$$$20240723$$HP$DE$
240300042$24030004$2$F$$20240709$20240628$20240717$PER$$US-JAZZ-2022-US-007527$JAZZ$$$$$F$Y$72$KG$20240717$$HP$US$US
240300062$24030006$2$F$$20240621$20240628$20240710$PER$$US-Calliditas-2024CAL01123$CALLIDITAS THERAPEUTICS$$65$YR$E$M$Y$101$KG$20240710$$CN$US$US
240300312$24030031$2$F$20240601$20240802$20240628$20240808$PER$$US-RDY-SPO/USA/24/0009236$DR REDDYS$$14$YR$T$$Y$$$20240808$$CN$US$US
240300412$24030041$2$F$20220501$20240920$20240628$20240924$EXP$$US-TAKEDA-2022TUS031261$TAKEDA$$49$YR$$F$Y$$$20240924$$MD$US$US
240300603$24030060$3$F$$20240910$20240628$20240918$EXP$$US-TAKEDA-2024TUS063520$TAKEDA$$$$$M$Y$$$20240918$$CN$US$US
240300612$24030061$2$F$20240101$20240726$20240628$20240903$PER$$US-KARYOPHARM-2024KPT001225$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
240300645$24030064$5$F$$20240905$20240628$20240917$30DAY$$BR-JNJFOC-20240642827$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$HP$BR$BR
240300762$24030076$2$F$20240101$20240625$20240628$20240701$PER$$US-PFIZER INC-202400201028$PFIZER$$74$YR$$F$Y$$$20240701$$CN$US$US
240300783$24030078$3$F$20240101$20240814$20240628$20240820$PER$$US-PFIZER INC-202400200821$PFIZER$$69$YR$$M$Y$$$20240820$$HP$US$US
240300892$24030089$2$F$20240401$20240624$20240628$20240701$PER$$US-JNJFOC-20240653858$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240701$$CN$US$US
240300912$24030091$2$F$$20240903$20240628$20240905$PER$$US-PFIZER INC-202400179319$PFIZER$$39$YR$$M$Y$$$20240905$$CN$US$US
240300972$24030097$2$F$$20240628$20240628$20240703$PER$$US-PFIZER INC-202400201136$PFIZER$$43$YR$$F$Y$$$20240703$$HP$US$US
240300982$24030098$2$F$20240618$20240819$20240628$20240826$PER$$US-PFIZER INC-PV202400081380$PFIZER$$79$YR$$M$Y$$$20240826$$MD$US$US
240301003$24030100$3$F$20240601$20240712$20240628$20240716$PER$$US-PFIZER INC-202400200902$PFIZER$$84$YR$$M$Y$103.42$KG$20240716$$CN$US$US
240301032$24030103$2$F$20240404$20240716$20240628$20240717$PER$$US-PFIZER INC-PV202400083496$PFIZER$$68$YR$$F$Y$71.519$KG$20240717$$MD$US$US
240301052$24030105$2$F$20240401$20240903$20240628$20240909$PER$$US-PFIZER INC-PV202400084132$PFIZER$$73$YR$$F$Y$$$20240909$$HP$US$US
240301082$24030108$2$F$$20240625$20240628$20240702$PER$$US-PFIZER INC-PV202400084169$PFIZER$$$$$F$Y$$$20240702$$CN$US$US
240301174$24030117$4$F$20240611$20240726$20240628$20240731$PER$$CN-Eisai-EC-2024-168714$EISAI$$59$YR$A$M$Y$66$KG$20240731$$MD$CN$CN
240301232$24030123$2$F$$20240629$20240628$20240709$EXP$$CN-VANTIVE-2024VAN017911$Vantive US Healthcare$$62$YR$$M$Y$60$KG$20240709$$CN$CN$CN
240301272$24030127$2$F$$20240820$20240628$20240824$EXP$$JP-AstraZeneca-2024A148268$ASTRAZENECA$Shimizu J, et al.. PS2-6 A case of pulmonary tumor thrombotic microangiopathy associated with advanced lung cancer in which right heart failure due to pulmonary hypertension became apparent after pericardial drainage.. The 7th Annual Meeting of the Japanese Oncocardiology Society 2024;111-.$59$YR$$F$Y$$$20240823$$MD$JP$
240301522$24030152$2$F$20230101$20240701$20240628$20240708$EXP$$ES-MYLANLABS-2024M1058269$MYLAN$Fernandez Martinez V, Garcia-Avello F-C, Valencia Soto CM, Barbadillo Villanueva S, Ochagavia Sufrategui M, Rioja Carrera M, et al.. Pembrolizumab-induced agranulocytosis.. J-Oncol-Pharm-Pract. 2024;30 (4):767-771$68$YR$$F$Y$$$20240708$$HP$ES$ES
240301532$24030153$2$F$$20240627$20240628$20240701$PER$$NVSC2024US134848$NOVARTIS$$$$$F$Y$$$20240701$$MD$US$US
240301652$24030165$2$F$20240101$20240809$20240628$20240814$EXP$$US-ABBVIE-5817483$ABBVIE$$$$$F$Y$121$KG$20240814$$CN$US$US
240301672$24030167$2$F$$20240627$20240628$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104233$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240701$$CN$US$US
240301702$24030170$2$F$20170614$20240717$20240628$20240723$EXP$$CA-TAKEDA-2018TUS022999$TAKEDA$$8$YR$$F$Y$$$20240723$$HP$CA$CA
240301742$24030174$2$F$20240608$20240725$20240628$20240805$30DAY$$TR-JNJFOC-20240636837$JOHNSON AND JOHNSON$$24$YR$A$F$Y$50$KG$20240805$$PH$TR$TR
240301822$24030182$2$F$20240617$20240813$20240628$20240816$EXP$$US-AstraZeneca-2024A149571$ASTRAZENECA$$17285$DY$$M$Y$$$20240816$$HP$US$
240301852$24030185$2$F$20200831$20240828$20240628$20240903$EXP$$US-OTSUKA-2024_018172$OTSUKA$$54$YR$$F$Y$68.04$KG$20240903$$MD$US$US
240301863$24030186$3$F$20240619$20240702$20240628$20240711$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00510$PARATEK PHARMACEUTICALS$$64$YR$$F$Y$$$20240711$$MD$CN$CN
240301962$24030196$2$F$$20240719$20240628$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001284$BLUEPRINT MEDICINES$$$$$M$Y$$$20240726$$CN$US$US
240301982$24030198$2$F$$20240703$20240628$20240709$30DAY$$CO-PFIZER INC-PV202400069156$PFIZER$$$$$M$Y$$$20240709$$PH$CO$CO
240302022$24030202$2$F$20240501$20240812$20240628$20240820$EXP$$BR-BIOVITRUM-2024-BR-009192$BIOVITRUM$$$$$M$Y$8.1$KG$20240820$$CN$BR$BR
240302062$24030206$2$F$20240617$20240726$20240628$20240731$PER$$US-AMGEN-USASP2024125983$AMGEN$$$$$$Y$$$20240730$$HP$US$US
240302112$24030211$2$F$20240101$20240716$20240628$20240725$PER$$US-SA-2024SA189613$SANOFI AVENTIS$$52$YR$A$F$Y$99.773$KG$20240725$$MD$US$US
240302172$24030217$2$F$$20240802$20240628$20240806$PER$$US-ALXN-202406USA001832US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240302542$24030254$2$F$20240101$20240725$20240628$20240805$PER$$US-SA-2024SA186825$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240805$$MD$US$US
240302652$24030265$2$F$20230927$20240625$20240628$20240703$EXP$$GB-AstraZeneca-2024A145082$ASTRAZENECA$$28793$DY$$M$Y$66$KG$20240703$$MD$GB$
240302662$24030266$2$F$$20240705$20240628$20240709$EXP$$MX-AstraZeneca-2024A144324$ASTRAZENECA$$$$$M$Y$54$KG$20240709$$CN$MX$
240302722$24030272$2$F$20240214$20240627$20240628$20240703$EXP$$IN-AstraZeneca-2024A149010$ASTRAZENECA$$19085$DY$$F$Y$$$20240703$$CN$IN$
240302752$24030275$2$F$$20240623$20240628$20240807$EXP$$US-JNJFOC-20240665616$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$MD$US$US
240302773$24030277$3$F$$20240726$20240628$20240805$PER$$US-ABBVIE-5814186$ABBVIE$$56$YR$$F$Y$$$20240805$$MD$US$US
240302782$24030278$2$F$20130101$20240624$20240628$20240702$EXP$$NVSC2024HU133875$NOVARTIS$Palyu E, Palatka K. What I am Sorry the most about during pouch the pouch training?. CENTRAL EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY.. 2023;9(1):95-6$36$YR$$F$Y$$$20240702$$HP$HU$HU
240302822$24030282$2$F$$20240705$20240628$20240712$EXP$$NVSC2024US133121$NOVARTIS$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al.. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. RHEUMATOLOGY. 2024;63 (5):1291-6$42$YR$$M$Y$$$20240712$$HP$US$US
240302942$24030294$2$F$20240626$20240705$20240628$20240709$EXP$$US-BAYER-2024A092502$BAYER$$56$YR$A$F$Y$$$20240709$$CN$US$US
240303023$24030302$3$F$$20240914$20240628$20240918$EXP$$US-SANDOZ INC.-NVSC2022US182942$SANDOZ$$$$$M$Y$76.644$KG$20240918$$CN$US$US
240303032$24030303$2$F$$20240627$20240628$20240701$EXP$$US-SANDOZ INC.-SDZ2024US061540$SANDOZ$$$$$F$Y$$$20240701$$CN$US$US
240303062$24030306$2$F$$20240706$20240628$20240709$EXP$$US-SANDOZ INC.-SDZ2024US061086$SANDOZ$$$$$$Y$$$20240709$$CN$US$US
240303283$24030328$3$F$$20240709$20240628$20240722$EXP$$CA-BAXTER-2024BAX020387$BAXTER$$56$YR$$M$Y$$$20240722$$HP$CA$CA
240303312$24030331$2$F$20240601$20240718$20240628$20240725$PER$$US-VERTEX PHARMACEUTICALS-2024-010627$VERTEX$$$$$F$Y$$$20240725$$HP$US$US
240303322$24030332$2$F$20240201$20240718$20240628$20240726$EXP$$DE-AstraZeneca-2024A146611$ASTRAZENECA$$804$MON$$F$Y$$$20240726$$PH$DE$
240303342$24030334$2$F$20240516$20240823$20240628$20240828$EXP$$JP-AstraZeneca-2024A144913$ASTRAZENECA$$72$YR$$F$Y$27$KG$20240828$$MD$JP$
240303563$24030356$3$F$20240611$20240716$20240628$20240722$30DAY$$CA-JNJFOC-20240632756$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240722$$CN$CA$CA
240303572$24030357$2$F$$20240705$20240628$20240706$PER$$US-JNJFOC-20240675112$JOHNSON AND JOHNSON$$$$$$Y$$$20240706$$MD$US$US
240303632$24030363$2$F$$20240802$20240628$20240816$PER$$US-SA-2024SA185812$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240816$$MD$US$US
240303652$24030365$2$F$$20240711$20240628$20240715$EXP$$FR-ABBVIE-5818890$ABBVIE$$74$YR$$M$Y$$$20240715$$CN$FR$FR
240303722$24030372$2$F$$20240621$20240628$20240703$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091820$GLENMARK$Ocasio V, Kapoor S, Atteih S, Sadreameli SC, Mogayzel PJ.. A Case of Trimethoprim-sulfamethoxazole Associated Fulminant Respiratory Failure in a 15- year-old Male.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A2329$$$$$Y$$$20240703$$MD$US$US
240303732$24030373$2$F$$20240724$20240628$20240725$PER$$US-JNJFOC-20240666741$JOHNSON AND JOHNSON$$$$$M$Y$$$20240725$$HP$US$US
240303962$24030396$2$F$20240404$20240718$20240628$20240723$EXP$$US-OTSUKA-2024_010184$OTSUKA$$47$YR$$F$Y$124.28$KG$20240723$$MD$US$US
240304073$24030407$3$F$$20240827$20240628$20240905$EXP$$US-RADIUS HEALTH, INC.-2024US004489$RADIUS PHARM$$$$$F$Y$$$20240905$$CN$US$US
240304182$24030418$2$F$20240519$20240816$20240628$20240821$EXP$$GB-ORGANON-O2406GBR002632$ORGANON$$18$YR$$F$Y$35.991$KG$20240821$$MD$GB$GB
240304322$24030432$2$F$20230701$20240909$20240628$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202406012459$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240920$$HP$US$US
240304382$24030438$2$F$$20240725$20240628$20240809$EXP$$US-PHARMAAND GMBH-2024PHR00351$pharmaAND$$$$$F$Y$$$20240809$$CN$US$US
240304442$24030444$2$F$20240608$20240703$20240628$20240705$EXP$$TW-ABBVIE-5818594$ABBVIE$$50$YR$$M$Y$$$20240705$$CN$TW$TW
240304482$24030448$2$F$20240621$20240702$20240628$20240708$30DAY$$US-AMGEN-USASL2024124482$AMGEN$$67$YR$E$M$Y$$$20240707$$CN$US$US
240304612$24030461$2$F$$20240718$20240628$20240724$EXP$$US-PURDUE-USA-2024-0310484$PURDUE$Spungen HH, Mody K, Micetic B, Wade C, Kang AM.. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. Journal of medical toxicology. 2024$$$N$M$Y$$$20240724$$MD$US$US
240304673$24030467$3$F$20231209$20240815$20240628$20240820$EXP$$GB-MYLANLABS-2024M1058265$MYLAN$$73$YR$$F$Y$$$20240820$$CN$GB$GB
240304773$24030477$3$F$$20240625$20240628$20240702$PER$$US-BIOGEN-2024BI01271317$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
240304812$24030481$2$F$$20240618$20240628$20240906$EXP$$US-FARMAPROD-202311-3478$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
240304832$24030483$2$F$$20240705$20240628$20240906$EXP$$US-FARMAPROD-202406-2215$DOMPE FARMACEUTICI$$$$E$F$Y$81.65$KG$20240904$$CN$US$US
240304892$24030489$2$F$$20240703$20240628$20240712$EXP$$US-FARMAPROD-202406-2317$DOMPE FARMACEUTICI$$78$YR$E$F$Y$57$KG$20240712$$MD$US$US
240304902$24030490$2$F$$20240801$20240628$20240808$EXP$$TW-AstraZeneca-2024A145450$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$TW$
240304922$24030492$2$F$20090109$20240730$20240628$20240802$EXP$$DE-002147023-PHHY2009DE31021$MYLAN$$68$YR$$F$Y$53$KG$20240802$$MD$DE$DE
240305032$24030503$2$F$20240618$20240710$20240628$20240711$PER$$US-PURDUE PHARMA-USA-2024-0310455$PURDUE$$$$$M$Y$$$20240711$$HP$US$US
240305054$24030505$4$F$20240420$20240729$20240628$20240730$PER$$US-PURDUE PHARMA-USA-2024-0310425$PURDUE$$56$YR$$M$Y$88.45$KG$20240730$$CN$US$US
240305072$24030507$2$F$$20240624$20240628$20240709$EXP$$US-MYLANLABS-2024M1058386$MYLAN$$$$$F$Y$$$20240709$$CN$US$US
240305212$24030521$2$F$$20240924$20240628$20240926$EXP$IE-HPRA-2024-113646$IE-MYLANLABS-2024M1058564$MYLAN$$45$YR$$F$Y$$$20240926$$CN$IE$IE
240305252$24030525$2$F$20240501$20240717$20240628$20240726$PER$$US-SA-2024SA185782$SANOFI AVENTIS$$33$YR$A$F$Y$81$KG$20240726$$MD$US$US
240305262$24030526$2$F$20240619$20240620$20240628$20240705$PER$$US-SA-2024SA183762$SANOFI AVENTIS$$63$YR$A$F$Y$81.64$KG$20240705$$MD$US$US
240305382$24030538$2$F$$20240717$20240628$20240725$EXP$$CA-BAXTER-2024BAX020460$BAXTER$$34$YR$$M$Y$$$20240725$$CN$CA$CA
240305402$24030540$2$F$20240625$20240626$20240628$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406018653$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240703$$CN$US$US
240305424$24030542$4$F$20240101$20240828$20240628$20240903$30DAY$$CA-PFIZER INC-202400199933$PFIZER$$75$YR$$M$Y$$$20240903$$MD$CA$CA
240305452$24030545$2$F$$20240911$20240628$20240913$30DAY$$GB-PFIZER INC-202400201605$PFIZER$$$$$$Y$$$20240913$$CN$GB$GB
240305682$24030568$2$F$20240606$20240626$20240628$20240703$EXP$$NVSC2024CN135060$NOVARTIS$$75$YR$$F$Y$58$KG$20240703$$HP$CN$CN
240305743$24030574$3$F$$20240821$20240628$20240823$PER$$CA-PFIZER INC-202400193116$PFIZER$$60$YR$$F$Y$$$20240823$$HP$CA$CA
240305752$24030575$2$F$20240101$20240822$20240628$20240822$EXP$$CA-PFIZER INC-202400057135$PFIZER$$63$YR$$F$Y$42.63$KG$20240822$$HP$CA$CA
240306012$24030601$2$F$$20240704$20240628$20240710$PER$$US-BIOGEN-2024BI01271496$BIOGEN$$$$$F$Y$$$20240710$$HP$US$US
240306052$24030605$2$F$$20240801$20240628$20240821$PER$$US-INCYTE CORPORATION-2024IN006273$INCYTE$$$$$$Y$$$20240821$$MD$US$US
240306082$24030608$2$F$$20240703$20240628$20240705$PER$$US-AMGEN-USASP2024126400$AMGEN$$$$$M$Y$$$20240705$$PH$US$US
240306092$24030609$2$F$20240624$20240722$20240628$20240729$EXP$$US-ASTELLAS-2024EU006349$ASTELLAS$$67$YR$$M$Y$$$20240729$$CN$US$US
240306154$24030615$4$F$$20240705$20240628$20240712$EXP$$US-KYOWAKIRIN-2024KK015677$KYOWA$$$$$$Y$$$20240712$$HP$US$US
240306182$24030618$2$F$20230701$20240823$20240628$20240902$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014097$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240902$$CN$US$US
240306212$24030621$2$F$$20240717$20240628$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019540$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240722$$HP$US$US
240306232$24030623$2$F$20230101$20240916$20240628$20240923$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202406014113$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240923$$MD$FR$FR
240306293$24030629$3$F$$20240716$20240628$20240730$30DAY$$PE-JNJFOC-20240631997$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240730$$HP$PE$PE
240306303$24030630$3$F$20240613$20240814$20240628$20240820$EXP$$US-SA-2024SA187285$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240820$$HP$US$US
240306522$24030652$2$F$$20240724$20240628$20240730$EXP$$CA-TAKEDA-2024TUS063593$TAKEDA$$$$$F$Y$$$20240730$$CN$CA$CA
240306532$24030653$2$F$20240101$20240627$20240628$20240702$EXP$GB-MHRA-MED-202406261319015300-HZNRS$GB-ABBVIE-5817778$ABBVIE$$$$$F$Y$$$20240702$$HP$GB$GB
240306593$24030659$3$F$$20240906$20240628$20240909$PER$$NVSC2024US135138$NOVARTIS$$$$$F$Y$$$20240909$$HP$US$US
240306742$24030674$2$F$$20240829$20240628$20240904$EXP$$US-PFIZER INC-202400202185$PFIZER$$63$YR$$F$Y$$$20240904$$CN$US$US
240306792$24030679$2$F$$20240710$20240628$20240715$EXP$$MY-PFIZER INC-202400200301$PFIZER$$59$YR$$M$Y$$$20240715$$PH$MY$MY
240306812$24030681$2$F$$20240624$20240628$20240703$EXP$$US-PFIZER INC-PV202400083357$PFIZER$$$$C$F$Y$$$20240703$$CN$US$US
240306872$24030687$2$F$20240501$20240710$20240628$20240712$PER$$US-AMGEN-USASP2024125157$AMGEN$$76$YR$E$M$Y$$$20240712$$CN$US$US
240306892$24030689$2$F$20240612$20240702$20240628$20240710$PER$$US-JNJFOC-20240669952$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240710$$MD$US$US
240306952$24030695$2$F$20240619$20240712$20240628$20240726$EXP$$CN-PFIZER INC-PV202400084340$PFIZER$$88$YR$$M$Y$110$KG$20240726$$HP$CN$CN
240307002$24030700$2$F$$20240815$20240628$20240826$PER$$US-MYLANLABS-2024M1056970$MYLAN$$$$$F$Y$61.23$KG$20240826$$CN$US$US
240307123$24030712$3$F$20240722$20240722$20240628$20240802$EXP$$US-APELLIS-2024-APL-0000258$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240802$$CN$US$US
240307172$24030717$2$F$20180101$20240627$20240628$20240703$EXP$$CA-HLS-202401643$HLS THERAPEUTICS$$52$YR$A$M$Y$$$20240703$$MD$CA$CA
240307192$24030719$2$F$20220211$20240716$20240628$20240726$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001035$AKEBIA THERAPEUTICS$$75$YR$$F$Y$47.5$KG$20240726$$HP$JP$JP
240307212$24030721$2$F$20240101$20240819$20240628$20240822$PER$$US-PFIZER INC-202400186552$PFIZER$$56$YR$$F$Y$$$20240822$$HP$US$US
240307272$24030727$2$F$$20240910$20240628$20240911$PER$$US-PFIZER INC-PV202400043708$PFIZER$$70$YR$$F$Y$$$20240911$$HP$US$US
240307292$24030729$2$F$20240601$20240628$20240628$20240701$PER$$US-PFIZER INC-PV202400084463$PFIZER$$72$YR$$M$Y$$$20240701$$CN$US$US
240307323$24030732$3$F$$20240719$20240628$20240723$PER$$US-PFIZER INC-202200064780$PFIZER$$70$YR$$F$Y$$$20240723$$HP$US$US
240307362$24030736$2$F$$20240719$20240628$20240723$PER$$US-PFIZER INC-202400187703$PFIZER$$24$YR$$M$Y$$$20240723$$HP$US$US
240307382$24030738$2$F$20240101$20240808$20240628$20240813$PER$$US-PFIZER INC-202400202062$PFIZER$$59$YR$$F$Y$61.224$KG$20240813$$CN$US$US
240307392$24030739$2$F$$20240918$20240628$20240926$PER$$US-PFIZER INC-202400064166$PFIZER$$76$YR$$F$Y$$$20240926$$MD$US$US
240307484$24030748$4$F$20240101$20240806$20240628$20240812$PER$$US-PFIZER INC-PV202400084417$PFIZER$$68$YR$$F$Y$42.177$KG$20240812$$HP$US$US
240307502$24030750$2$F$$20240722$20240628$20240724$PER$$US-PFIZER INC-202400202393$PFIZER$$67$YR$$F$Y$$$20240724$$HP$US$US
240307554$24030755$4$F$$20240809$20240628$20240814$EXP$$US-PFIZER INC-202400202336$PFIZER$$54$YR$$F$Y$$$20240814$$CN$US$US
240307572$24030757$2$F$$20240911$20240628$20240911$PER$$US-PFIZER INC-PV202400084372$PFIZER$$46$YR$$M$Y$$$20240911$$MD$US$US
240307652$24030765$2$F$$20240627$20240628$20240702$PER$$US-PFIZER INC-202400202432$PFIZER$$$$$$Y$$$20240702$$HP$US$US
240307692$24030769$2$F$20240601$20240702$20240628$20240722$PER$$US-ALKERMES INC.-ALK-2024-001680$ALKERMES$$33$YR$$M$Y$108.84$KG$20240719$$CN$US$US
240307703$24030770$3$F$$20240801$20240628$20240805$EXP$$US-ALXN-202406USA001455US$ALEXION PHARMACEUTICALS$$55$YR$$M$Y$$$20240805$$MD$US$US
240307782$24030778$2$F$20240327$20240719$20240628$20240729$EXP$IT-MINISAL02-990090$IT-TEVA-VS-3212989$TEVA$$48$YR$$F$Y$65$KG$20240729$$MD$IT$IT
240307822$24030782$2$F$$20240724$20240628$20240726$PER$$NVSC2024US135409$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
240307833$24030783$3$F$20240627$20240828$20240628$20240830$PER$$NVSC2024US134608$NOVARTIS$$64$YR$$M$Y$$$20240830$$CN$US$US
240307942$24030794$2$F$20240503$20240704$20240628$20240712$EXP$$JP-AKEBIA THERAPEUTICS, INC.-JP-AKEB-24-001037$AKEBIA THERAPEUTICS$$$$$$Y$$$20240712$$MD$JP$JP
240307963$24030796$3$F$20240501$20240723$20240628$20240724$EXP$$GB-PFIZER INC-PV202400085337$PFIZER$$83$YR$$F$Y$65$KG$20240724$$CN$GB$GB
240308012$24030801$2$F$20240619$20240627$20240628$20240703$EXP$$US-PFIZER INC-202400202416$PFIZER$$75$YR$$F$Y$53.98$KG$20240703$$CN$US$US
240308042$24030804$2$F$$20240614$20240628$20240701$PER$$US-INCYTE CORPORATION-2024IN006424$INCYTE$$$$$$Y$$$20240701$$CN$US$US
240308112$24030811$2$F$$20240802$20240628$20240806$PER$$US-ALXN-202406USA001457US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240308232$24030823$2$F$$20240627$20240628$20240703$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009806$JAZZ$$$$$M$Y$108.8$KG$20240703$$CN$US$US
240308302$24030830$2$F$20230517$20240809$20240628$20240816$EXP$$DE-AstraZeneca-2023A120006$ASTRAZENECA$$74$YR$$F$Y$96$KG$20240816$$MD$DE$
240308342$24030834$2$F$$20240620$20240628$20240703$EXP$$US-RADIUS HEALTH, INC.-2024US004550$RADIUS PHARM$$$$$F$Y$$$20240703$$CN$US$US
240308372$24030837$2$F$20240401$20240719$20240628$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002071$JAZZ$$3$YR$$F$Y$$$20240723$$CN$US$US
240308393$24030839$3$F$$20240729$20240628$20240805$30DAY$$CH-JNJFOC-20240648112$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$MD$CH$CH
240308472$24030847$2$F$20240601$20240919$20240628$20240924$PER$$JP-Eisai-EC-2024-169058$EISAI$$$$$F$Y$$$20240924$$CN$JP$JP
240308492$24030849$2$F$20240101$20240705$20240628$20240709$EXP$$US-ALKERMES INC.-ALK-2024-001736$ALKERMES$$$$$M$Y$83.039$KG$20240709$$HP$US$US
240308502$24030850$2$F$$20240709$20240628$20240712$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406018070$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240712$$CN$JP$JP
240308533$24030853$3$F$20240525$20240819$20240628$20240826$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406017168$ELI LILLY AND CO$$53$YR$A$F$Y$87$KG$20240826$$CN$JP$JP
240308552$24030855$2$F$20240514$20240712$20240628$20240722$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405011037$ELI LILLY AND CO$$25$YR$A$M$Y$$$20240722$$CN$JP$JP
240308572$24030857$2$F$$20240715$20240628$20240723$EXP$$GB-APELLIS-APL-2024-004332$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240723$$HP$GB$GB
240308604$24030860$4$F$20240501$20240716$20240628$20240726$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-009591$JAZZ$$59$YR$$M$Y$$$20240726$$MD$JP$JP
240308624$24030862$4$F$20240610$20240724$20240628$20240730$EXP$$US-APELLIS-2024-APL-0000291$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240730$$CN$US$US
240308662$24030866$2$F$$20240703$20240628$20240703$PER$$US-PFIZER INC-PV202400085055$PFIZER$$$$$$Y$$$20240703$$CN$US$US
240308672$24030867$2$F$$20240725$20240628$20240730$PER$$US-PFIZER INC-PV202400085229$PFIZER$$32$YR$$M$Y$$$20240730$$CN$US$US
240308732$24030873$2$F$$20240806$20240628$20240809$PER$$US-PFIZER INC-PV202400085206$PFIZER$$17$YR$$F$Y$$$20240809$$CN$US$US
240308803$24030880$3$F$20240601$20240805$20240628$20240812$EXP$$US-KYOWAKIRIN-2024KK015535$KYOWA$$$$$$Y$$$20240812$$CN$US$US
240308822$24030882$2$F$20230801$20240619$20240628$20240708$PER$$US-INCYTE CORPORATION-2024IN006565$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240308862$24030886$2$F$$20240702$20240628$20240703$PER$$NVSC2024US135415$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240308882$24030888$2$F$$20240724$20240628$20240802$PER$$US-INCYTE CORPORATION-2024IN006672$INCYTE$$$$$$Y$$$20240802$$CN$US$US
240309082$24030908$2$F$$20240906$20240628$20240909$PER$$NVSC2024US133967$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
240309113$24030911$3$F$20240614$20240807$20240628$20240813$EXP$$US-APELLIS-2024-APL-0000292$APELLIS PHARMACEUTICALS$$$$$$Y$60.6$KG$20240813$$CN$US$US
240309262$24030926$2$F$$20240723$20240628$20240728$PER$$US-AstraZeneca-2024A143414$ASTRAZENECA$$$$$F$Y$$$20240728$$CN$US$
240309292$24030929$2$F$$20240730$20240628$20240811$PER$$US-009507513-2406USA007903$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24(1):206$1$YR$$$Y$$$20240811$$HP$US$US
240309322$24030932$2$F$20240201$20240701$20240628$20240712$PER$$CN-Blueprint Medicines Corporation-SP-CN-2024-001331$BLUEPRINT MEDICINES$$76$YR$E$F$Y$$$20240712$$CN$CN$CN
240309345$24030934$5$F$$20240929$20240628$20240930$30DAY$$US-PFIZER INC-202400200321$PFIZER$$9$YR$$M$Y$34.014$KG$20240930$$CN$US$US
240309364$24030936$4$F$$20240813$20240628$20240815$30DAY$$US-PFIZER INC-202400197770$PFIZER$$14$YR$$F$Y$$$20240815$$CN$US$US
240309373$24030937$3$F$$20240911$20240628$20240913$30DAY$$US-PFIZER INC-202400198673$PFIZER$$10$YR$$F$Y$34.93$KG$20240913$$CN$US$US
240309394$24030939$4$F$20240101$20240911$20240628$20240913$30DAY$$US-PFIZER INC-202400198970$PFIZER$$66$YR$$M$Y$$$20240913$$CN$US$US
240309402$24030940$2$F$20240620$20240827$20240628$20240829$30DAY$$US-PFIZER INC-202400199025$PFIZER$$15$YR$$M$Y$77.11$KG$20240829$$CN$US$US
240309413$24030941$3$F$$20240911$20240628$20240913$30DAY$$US-PFIZER INC-202400200731$PFIZER$$2$YR$$M$Y$11.79$KG$20240913$$CN$US$US
240309422$24030942$2$F$$20240913$20240628$20240918$30DAY$$US-PFIZER INC-202400199098$PFIZER$$12$YR$$M$Y$$$20240918$$CN$US$US
240309433$24030943$3$F$$20240916$20240628$20240919$30DAY$$US-PFIZER INC-PV202400079201$PFIZER$$$$$$Y$$$20240919$$PH$US$US
240309443$24030944$3$F$$20240731$20240628$20240731$30DAY$$US-PFIZER INC-202400173886$PFIZER$$7$YR$$F$Y$$$20240731$$HP$US$US
240309454$24030945$4$F$$20240911$20240628$20240913$30DAY$$US-PFIZER INC-202400197978$PFIZER$$12$YR$$M$Y$$$20240913$$MD$US$US
240309462$24030946$2$F$$20240916$20240628$20240919$EXP$FR-AFSSAPS-BX2024001168$FR-009507513-2406FRA008511$MERCK$$38$YR$$F$Y$$$20240919$$HP$FR$FR
240309532$24030953$2$F$$20240709$20240628$20240717$PER$$US-UROVANT SCIENCES GMBH-202406-URV-000944$UROVANT SCIENCES$$$$$F$Y$$$20240717$$CN$US$US
240309542$24030954$2$F$$20240708$20240628$20240712$EXP$$US-UROVANT SCIENCES GMBH-202406-URV-000929$UROVANT SCIENCES$$$$$M$Y$92.971$KG$20240712$$CN$US$US
240309583$24030958$3$F$20231227$20240710$20240628$20240717$EXP$$JP-FERRINGPH-2024FE02469$FERRING$$$$$$Y$$$20240717$$MD$JP$JP
240309652$24030965$2$F$$20240618$20240628$20240920$EXP$$US-HQ SPECIALTY-US-2024INT000064$INTERCHEM$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316:279$49$YR$$F$Y$$$20240920$$HP$US$US
240309662$24030966$2$F$$20240805$20240628$20240806$EXP$$US-ALXN-202406USA001697US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$PH$US$US
240309682$24030968$2$F$20240325$20240701$20240628$20240708$EXP$$PE-FERRINGPH-2024FE01553$FERRING$$$$$$Y$$$20240708$$CN$PE$PE
240309713$24030971$3$F$$20240911$20240628$20240913$30DAY$$US-PFIZER INC-202400200243$PFIZER$$15$YR$$M$Y$$$20240913$$CN$US$US
240309722$24030972$2$F$20240623$20240827$20240628$20240829$30DAY$$US-PFIZER INC-202400199900$PFIZER$$10$YR$$M$Y$$$20240829$$CN$US$US
240309753$24030975$3$F$20240601$20240916$20240628$20240919$30DAY$$US-PFIZER INC-202400200150$PFIZER$$14$YR$$M$Y$61.7$KG$20240919$$HP$US$US
240309782$24030978$2$F$$20240728$20240628$20240729$30DAY$$US-PFIZER INC-202400200163$PFIZER$$14$YR$$M$Y$$$20240729$$CN$US$US
240309842$24030984$2$F$20240621$20240625$20240628$20240708$PER$$US-JNJFOC-20240657782$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240708$$PH$US$US
240309852$24030985$2$F$$20240627$20240628$20240701$EXP$$BY-JNJFOC-20240673908$JOHNSON AND JOHNSON$$53$YR$A$M$Y$63$KG$20240701$$MD$BY$BY
240309912$24030991$2$F$20230619$20240812$20240628$20240819$EXP$$US-BAYER-2024A092462$BAYER$$73$YR$E$F$Y$$$20240819$$HP$US$US
240309922$24030992$2$F$20230531$20240709$20240628$20240718$EXP$$CA-TAKEDA-2024TUS060985$TAKEDA$$61$YR$$M$Y$$$20240718$$MD$CA$CA
240310022$24031002$2$F$$20240613$20240628$20240710$EXP$$US-OTTER-US-2024AST000247$Unknown Manufacturer$Lakhani M, Azulay H. From Rashes to Ruin: The Methotrexate Misadventure. American Journal of Respiratory and Critical Care Medicine. 2024;209$43$YR$$M$Y$$$20240710$$HP$US$US
240310032$24031003$2$F$$20240621$20240628$20240725$EXP$$US-009507513-2406USA008086$MERCK$Tebaldi M, Anderson Z, Belancourt F, Messina N, Wilson BC, Patel V.. Intravenous Immunoglobulin (IVIG) Triumph: Managing Pembrolizumab- Induced Pneumonitis in the Absence of Clear Guidelines. J Respir Crit Care Med. 2024;209:A7499$63$YR$$F$Y$$$20240725$$HP$US$US
240310122$24031012$2$F$20240430$20240623$20240628$20240702$EXP$NO-NOMAADVRE-RELISSO-2024-Vewnrj$NO-GE HEALTHCARE-2024CSU007010$GE HEALTHCARE$$48$YR$$F$Y$$$20240702$$HP$NO$NO
240310142$24031014$2$F$$20240906$20240628$20240909$PER$$NVSC2024US135403$NOVARTIS$$48$YR$$M$Y$$$20240909$$HP$US$US
240310282$24031028$2$F$$20240725$20240628$20240802$EXP$$US-AstraZeneca-2024A145156$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
240310313$24031031$3$F$$20240911$20240628$20240916$30DAY$$US-PFIZER INC-202400199028$PFIZER$$14$YR$$M$Y$$$20240916$$CN$US$US
240310422$24031042$2$F$$20240701$20240628$20240711$EXP$$PT-GILEAD-2024-0677595$GILEAD$$59$YR$A$F$Y$$$20240711$$MD$PT$PT
240310492$24031049$2$F$$20240701$20240628$20240711$PER$$US-BIOMARINAP-US-2024-158702$BIOMARIN$$$$$$Y$$$20240711$$CN$US$US
240310512$24031051$2$F$20240618$20240702$20240628$20240709$PER$$US-BIOMARINAP-US-2024-158709$BIOMARIN$$$$$$Y$$$20240709$$CN$US$US
240310532$24031053$2$F$$20240713$20240628$20240716$EXP$$PL-GILEAD-2024-0679007$GILEAD$$$$$M$Y$$$20240716$$HP$PL$PL
240310552$24031055$2$F$$20240617$20240628$20240708$EXP$$JP-APELLIS-2024-APL-0000343$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240708$$MD$JP$JP
240310562$24031056$2$F$$20240709$20240628$20240716$EXP$$US-BIOMARINAP-US-2024-158753$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240310622$24031062$2$F$$20240627$20240628$20240705$EXP$$AT-TAKEDA-2024TUS064660$TAKEDA$Scherr S, Ksiazek SH, Schwarz C, Saemann MD. SGLT2 inhibitor use for treatment of hypocitraturia in a distal renal tubular acidosis. KIDNEY MEDICINE. 2024;6(7):1-3$$$A$M$Y$$$20240705$$MD$AT$AT
240310702$24031070$2$F$20240601$20240710$20240628$20240712$PER$$US-BIOMARINAP-US-2024-158840$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240310722$24031072$2$F$20240527$20240705$20240628$20240709$PER$$US-BIOMARINAP-US-2024-158807$BIOMARIN$$$$$$Y$$$20240709$$CN$US$US
240310772$24031077$2$F$$20240627$20240628$20240702$EXP$$CA-HLS-202401592$HLS THERAPEUTICS$$$$A$M$Y$$$20240702$$PH$CA$CA
240310792$24031079$2$F$20240617$20240802$20240628$20240808$EXP$$JP-009507513-2406JPN003363J$MERCK$$61$YR$$F$Y$$$20240808$$MD$JP$JP
240310862$24031086$2$F$20230101$20240624$20240628$20240702$EXP$$TH-009507513-2406THA010254$MERCK$$21$YR$$F$Y$$$20240702$$MD$TH$TH
240310992$24031099$2$F$$20240725$20240628$20240731$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019257$JAZZ$$$$$M$Y$$$20240731$$CN$US$US
240311212$24031121$2$F$20220926$20240716$20240628$20240722$EXP$$GR-ABBVIE-4141584$ABBVIE$$87$YR$$M$Y$60$KG$20240722$$MD$GR$GR
240311252$24031125$2$F$20240501$20240819$20240628$20240823$EXP$$US-ABBVIE-5817390$ABBVIE$$58$YR$$M$Y$$$20240823$$CN$US$US
240311332$24031133$2$F$$20240722$20240628$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202406014328$ELI LILLY AND CO$$16$YR$T$M$Y$$$20240730$$CN$US$US
240311372$24031137$2$F$20240101$20240807$20240628$20240811$EXP$$US-ABBVIE-5816110$ABBVIE$$$$$M$Y$$$20240811$$CN$US$US
240311502$24031150$2$F$20240611$20240629$20240628$20240708$EXP$$CA-ABBVIE-5806696$ABBVIE$$40$YR$$M$Y$$$20240708$$CN$CA$CA
240311522$24031152$2$F$20240101$20240718$20240628$20240726$PER$$US-SA-2024SA190829$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240726$$MD$US$US
240311562$24031156$2$F$20240507$20240709$20240628$20240714$EXP$$CA-ABBVIE-5818448$ABBVIE$$76$YR$$F$Y$$$20240714$$MD$CA$CA
240311582$24031158$2$F$$20240620$20240628$20240711$EXP$$DE-ABBVIE-5820189$ABBVIE$$37$YR$$M$Y$173$KG$20240711$$MD$DE$DE
240311642$24031164$2$F$20240624$20240805$20240628$20240808$PER$$US-AMGEN-USASP2024125102$AMGEN$$80$YR$E$M$Y$$$20240807$$CN$US$US
240311752$24031175$2$F$20240101$20240906$20240629$20240912$EXP$$US-ABBVIE-5815241$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
240311772$24031177$2$F$20240101$20240702$20240629$20240709$EXP$$BE-AMGEN-BELSP2024127774$AMGEN$$88$YR$E$F$Y$64$KG$20240709$$MD$BE$BE
240311843$24031184$3$F$20240101$20240730$20240629$20240801$EXP$$US-ABBVIE-5817512$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
240311852$24031185$2$F$$20240702$20240629$20240715$PER$$US-ABBVIE-5818780$ABBVIE$$$$A$F$Y$$$20240715$$HP$US$US
240311902$24031190$2$F$20240101$20240905$20240629$20240909$EXP$$US-ABBVIE-5817849$ABBVIE$$$$$F$Y$61$KG$20240909$$CN$US$US
240311922$24031192$2$F$$20240801$20240629$20240803$EXP$$JP-ABBVIE-5817197$ABBVIE$$70$YR$$M$Y$$$20240803$$MD$JP$JP
240312003$24031200$3$F$20240611$20240917$20240629$20240920$EXP$$US-ABBVIE-5817244$ABBVIE$$79$YR$$M$Y$$$20240920$$CN$US$US
240312032$24031203$2$F$$20240628$20240629$20240701$EXP$$GB-ABBVIE-5820663$ABBVIE$$$$$$Y$$$20240701$$HP$GB$GB
240312054$24031205$4$F$20190416$20240729$20240629$20240807$EXP$$JP-ABBVIE-5819221$ABBVIE$$78$YR$$M$Y$$$20240807$$HP$JP$JP
240312103$24031210$3$F$20230101$20240827$20240629$20240830$EXP$$US-ABBVIE-5816733$ABBVIE$$$$$F$Y$91$KG$20240830$$CN$US$US
240312143$24031214$3$F$20200101$20240705$20240629$20240709$EXP$$US-ABBVIE-5817799$ABBVIE$$$$$F$Y$63$KG$20240709$$CN$US$US
240312153$24031215$3$F$20240101$20240717$20240629$20240727$EXP$$US-ABBVIE-5817134$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
240312202$24031220$2$F$20240101$20240705$20240629$20240717$PER$$US-SA-2024SA189429$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240717$$MD$US$US
240312212$24031221$2$F$20240101$20240716$20240629$20240719$EXP$$US-ABBVIE-5818990$ABBVIE$$$$$F$Y$66.678$KG$20240719$$CN$US$US
240312263$24031226$3$F$20240601$20240812$20240629$20240813$PER$$US-AMGEN-USASP2024125175$AMGEN$$78$YR$E$F$Y$$$20240813$$CN$US$US
240312292$24031229$2$F$20201201$20240629$20240629$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-026432$AUROBINDO$Sterle M, Schmitt A, Boulin M. The harms of inappropriate digoxin prescribing in cancer patients?: a drug-drug interaction with posaconazole.. Annales pharmaceutiques francaises. 2024$71$YR$$M$Y$$$20240706$$HP$FR$FR
240312403$24031240$3$F$20240208$20240817$20240629$20240826$EXP$$CA-CELLTRION INC.-2024CA003852$CELLTRION$$$$$$Y$$$20240826$$CN$CA$CA
240312412$24031241$2$F$19900101$20240712$20240629$20240716$EXP$$BR-SANDOZ INC.-SDZ2024BR060705$SANDOZ$$$$$F$Y$$$20240716$$CN$BR$BR
240312432$24031243$2$F$20240622$20240801$20240629$20240806$PER$$US-AMGEN-USASP2024128566$AMGEN$$74$YR$E$F$Y$$$20240806$$CN$US$US
240312465$24031246$5$F$20240101$20240806$20240629$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016221$UNITED THERAPEUTICS$$$$$M$Y$92.971$KG$20240816$$$US$US
240312522$24031252$2$F$$20240703$20240629$20240708$EXP$$US-ABBVIE-5817812$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240312632$24031263$2$F$20240402$20240911$20240629$20240913$EXP$$US-ABBVIE-5818700$ABBVIE$$64$YR$$F$Y$98.883$KG$20240913$$CN$US$US
240312682$24031268$2$F$20231001$20240627$20240629$20240705$EXP$$US-ABBVIE-5819517$ABBVIE$$80$YR$$M$Y$$$20240705$$CN$US$US
240312722$24031272$2$F$20240517$20240731$20240629$20240806$EXP$$JP-ABBVIE-5799518$ABBVIE$$21$YR$$M$Y$38$KG$20240806$$MD$JP$JP
240312772$24031277$2$F$20210428$20240715$20240629$20240729$EXP$$JP-ABBVIE-5820832$ABBVIE$$87$YR$$F$Y$$$20240729$$HP$JP$JP
240312793$24031279$3$F$$20240627$20240629$20240704$PER$$NVSC2024US135537$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240312852$24031285$2$F$20240621$20240703$20240629$20240706$PER$$US-AMGEN-USASP2024126613$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240312982$24031298$2$F$$20240926$20240629$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104030$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$75.75$KG$20240926$$HP$US$US
240312992$24031299$2$F$20240627$20240628$20240629$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104202$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240702$$PH$US$US
240313042$24031304$2$F$20240606$20240916$20240629$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103881$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240917$$HP$US$US
240313142$24031314$2$F$$20240730$20240629$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104221$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240801$$HP$US$US
240313182$24031318$2$F$20240403$20240911$20240629$20240913$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-101202$BRISTOL MYERS SQUIBB$$4$YR$C$F$Y$$$20240913$$MD$FR$FR
240313202$24031320$2$F$$20240719$20240629$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103856$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$89.81$KG$20240722$$CN$US$US
240313312$24031331$2$F$$20240724$20240629$20240725$PER$$US-AMGEN-USASP2024126207$AMGEN$$$$A$F$Y$$$20240725$$MD$US$US
240313332$24031333$2$F$$20240701$20240629$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-031332$AUROBINDO$Almazan EP, lmazan E, Ellaicy O, Carter DJ, Kaleka K, Faruqi M. Another Case of the Blues, Methylene Blue as Adjunctive Therapy in Calcium-channel Blocker Induced Vasoplegia. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5655$65$YR$$F$Y$$$20240709$$MD$US$US
240313444$24031344$4$F$20240101$20240716$20240629$20240723$EXP$$ES-ABBVIE-5788081$ABBVIE$$$$$F$Y$$$20240723$$HP$ES$ES
240313452$24031345$2$F$$20240716$20240629$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-031226$AUROBINDO$Rodriguez C, Yosry N, Qaiser S, Luzuriaga A, Adelizzi A. BRASH: A Deadly Acronym. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1596$84$YR$$F$Y$$$20240725$$MD$US$US
240313502$24031350$2$F$$20240723$20240629$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-031148$AUROBINDO$Vincent J, Greenberg J, Sanghani S, Finneran K, Nguyen N.. Profound Lactic Acidosis and Shock in a Patient Taking Metformin.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5702$52$YR$$F$Y$$$20240803$$MD$US$US
240313512$24031351$2$F$$20240624$20240629$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031192$AUROBINDO$Huang L, Ellis TJ, Bagavathy K. The Unfortunate Trifecta: Tuberculosis, EBV, and CMV Induced Hemophagocytic Lymphohistiocytosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7416$52$YR$$M$Y$$$20240702$$MD$US$US
240313523$24031352$3$F$20240612$20240729$20240629$20240802$EXP$$US-JNJFOC-20240660169$JOHNSON AND JOHNSON$$34$YR$A$F$Y$76.272$KG$20240802$$HP$US$US
240313545$24031354$5$F$$20240918$20240629$20240927$EXP$$PT-AUROBINDO-AUR-APL-2024-031248$AUROBINDO$Maia S, Xavier B, Sa M, Antunes E, Morais D, Sampaio J.. Edema Pulmonar por Pressao Negativa : Uma Intercorrencia Inesperada.. REVISTA DA SOCIEDADE PORTUGUESA DE ANESTESIOLOGIA. 2024;33(S1):49$19$YR$$M$Y$$$20240927$$MD$PT$PT
240313592$24031359$2$F$$20240625$20240629$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031098$AUROBINDO$Ghose M, Anwar M, Rajamohan A, Vangala A, Roy P, Weiner SM. Vancomycin Induced Anaphylaxis Presenting With Cardiac Arrest: Judicious Use of Antibiotic in Low Risk Procedures. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5700$74$YR$$F$Y$$$20240703$$MD$US$US
240313653$24031365$3$F$20240624$20240827$20240629$20240902$EXP$$HU-ABBVIE-5819510$ABBVIE$$81$YR$$F$Y$$$20240902$$CN$HU$HU
240313703$24031370$3$F$20240101$20240821$20240629$20240828$EXP$$CA-CELLTRION INC.-2024CA015685$CELLTRION$$$$$$Y$$$20240828$$CN$CA$CA
240313802$24031380$2$F$$20240626$20240629$20240705$PER$$US-AMGEN-HZN-2023-010126$AMGEN$$65$YR$E$F$Y$99.32$KG$20240704$$CN$US$US
240313842$24031384$2$F$$20240702$20240629$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-030986$AUROBINDO$Deanda S, Razia D, Zaidi W, Lee R, Arjuna A. post-transplant lymphoproliferative disorder: A nodular area that kept growing.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5942$79$YR$$F$Y$$$20240710$$MD$US$US
240313852$24031385$2$F$$20240627$20240629$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-031337$AUROBINDO$Renzetti M, Potnis K, Vemmou E, Hansen B, Lin D, Yaggi H. Salty, Sweet, and Severe: A Case of Linagliptin-induced Severe Hyponatremia. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7036$76$YR$$F$Y$$$20240704$$MD$US$US
240313903$24031390$3$F$20240101$20240819$20240629$20240916$PER$$US-SA-2024SA188007$SANOFI AVENTIS$$75$YR$E$F$Y$116.6$KG$20240916$$MD$US$US
240314113$24031411$3$F$20240101$20240801$20240629$20240805$EXP$$US-UCBSA-2024032816$UCB$$$$$F$Y$$$20240805$$CN$US$US
240314203$24031420$3$F$20240523$20240701$20240629$20240709$EXP$$NVSC2024RU121887$NOVARTIS$$1$YR$$M$Y$10.8$KG$20240709$$CN$RU$RU
240314233$24031423$3$F$20240101$20240829$20240629$20240906$EXP$$CA-CELLTRION INC.-2024CA010363$CELLTRION$$$$$$Y$$$20240906$$MD$CA$CA
240314283$24031428$3$F$20240622$20240821$20240629$20240823$PER$$US-AMGEN-USASP2024128722$AMGEN$$76$YR$E$F$Y$$$20240823$$CN$US$US
240314312$24031431$2$F$20240520$20240708$20240629$20240718$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024075691$VIIV$$59$YR$$M$Y$86.6$KG$20240718$$HP$US$US
240314324$24031432$4$F$20240601$20240823$20240629$20240902$EXP$$US-GSK-US2024AMR077520$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240902$$CN$US$US
240314352$24031435$2$F$$20240629$20240629$20240703$EXP$$CO-GSK-CO2024AMR078850$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CO$CO
240314452$24031445$2$F$20230905$20240806$20240629$20240812$EXP$$IN-GSK-IN2023APC170560$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$IN$IN
240314505$24031450$5$F$20240501$20240911$20240629$20240918$EXP$$CA-GSK-CA2024014867$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$CA$CA
240314522$24031452$2$F$20240618$20240808$20240629$20240820$EXP$$US-VIIV HEALTHCARE LIMITED-US2024075762$VIIV$$53$YR$$F$Y$$$20240820$$HP$US$US
240314602$24031460$2$F$20240626$20240626$20240629$20240703$EXP$$US-GSK-US2024078042$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$US$US
240314722$24031472$2$F$20230601$20240902$20240629$20240909$EXP$$CA-GSK-CA2023AMR098745$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$HP$CA$CA
240314782$24031478$2$F$$20240710$20240629$20240717$EXP$$US-ABBVIE-5792968$ABBVIE$$$$$M$Y$100.24$KG$20240717$$CN$US$US
240314853$24031485$3$F$20240101$20240715$20240629$20240718$PER$$US-SA-2024SA188958$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240718$$MD$US$US
240314872$24031487$2$F$$20240809$20240629$20240811$PER$$NVSC2024US134388$NOVARTIS$$$$$$Y$$$20240811$$HP$US$US
240314882$24031488$2$F$20240620$20240806$20240629$20240817$EXP$$JP-JNJFOC-20240675876$JOHNSON AND JOHNSON$$8$DEC$E$$Y$$$20240817$$MD$JP$JP
240314892$24031489$2$F$$20240627$20240629$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406019395$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240703$$CN$US$US
240314912$24031491$2$F$20190805$20240913$20240629$20240925$EXP$$FR-AUROBINDO-AUR-APL-2019-065227$AUROBINDO$$51$YR$$F$Y$99$KG$20240925$$MD$FR$FR
240315024$24031502$4$F$20240101$20240819$20240629$20240821$PER$$US-SA-2024SA188963$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240821$$MD$US$US
240315082$24031508$2$F$$20240702$20240629$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-031114$AUROBINDO$Simone C, Axelband J.. Levetiracetam-associated rhabdomyolysis.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5704$20$YR$$M$Y$$$20240710$$MD$US$US
240315103$24031510$3$F$20240323$20240708$20240629$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-030956$AUROBINDO$$24$YR$$$Y$$$20240717$$CN$GB$GB
240315123$24031512$3$F$$20240724$20240629$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05433$LUPIN$$$$$$Y$$$20240814$$CN$US$US
240315232$24031523$2$F$20240101$20240817$20240629$20240826$EXP$$CA-CELLTRION INC.-2024CA015751$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
240315312$24031531$2$F$$20240822$20240629$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-031029$AUROBINDO$Riedhammer C, Dull J, Kestle C, Kadel S, Franz J, Weis P, et al.. Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma.. Annals of Hematology.. 2024;103(4):1327-1332.$80$YR$$M$Y$$$20240903$$HP$DE$DE
240315332$24031533$2$F$$20240701$20240629$20240708$EXP$$US-AUROBINDO-AUR-APL-2024-031047$AUROBINDO$Tajfiroozeh D, Silva R, Otsuka KN, Wai A. A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2289$15$YR$$M$Y$$$20240708$$MD$US$US
240315352$24031535$2$F$$20240626$20240629$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-031069$AUROBINDO$Patel D, Chittal A, Malik K, Disilvio B.. ?Tail? of Caution: Pioglitazone Induced Recurrent Pleural Effusion.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A2015$68$YR$$F$Y$$$20240704$$MD$US$US
240315402$24031540$2$F$20240616$20240704$20240629$20240711$EXP$$ES-AUROBINDO-AUR-APL-2024-031019$AUROBINDO$$85$YR$$M$Y$85$KG$20240711$$HP$ES$ES
240315424$24031542$4$F$20160101$20240709$20240629$20240710$PER$$US-JNJFOC-20240634181$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
240315432$24031543$2$F$20240201$20240627$20240629$20240701$EXP$$SE-JNJFOC-20240665831$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240701$$CN$SE$SE
240315442$24031544$2$F$$20240626$20240629$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-031237$AUROBINDO$Santosh N, Savani S, Iskapalli S. Beefing Up! Fulminant Liver Failure Secondary to Anabolic Steroid Use. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5688$30$YR$$M$Y$$$20240704$$MD$US$US
240315492$24031549$2$F$$20240820$20240629$20240830$EXP$$GB-AUROBINDO-AUR-APL-2024-031006$AUROBINDO$$$$$M$Y$36$KG$20240830$$CN$GB$GB
240315542$24031554$2$F$$20240710$20240629$20240717$EXP$$DE-UNITED THERAPEUTICS-UNT-2024-019636$UNITED THERAPEUTICS$$$$A$$Y$$$20240717$$MD$DE$DE
240315582$24031558$2$F$$20240702$20240629$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-031110$AUROBINDO$Singh M, Kuo JK, Raza A.. Lamotrigine Induced Drug Reaction With Eosinophilia With Systemic Symptoms (DRESS)With HHV-6 Reactivation Causing Severe Encephalitis and Status Epilepticus. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1358$18$YR$$F$Y$$$20240712$$MD$US$US
240315642$24031564$2$F$20231207$20240708$20240629$20240710$EXP$$US-ABBVIE-5537212$ABBVIE$$61$YR$$M$Y$$$20240710$$CN$US$US
240315662$24031566$2$F$$20240906$20240629$20240909$PER$$NVSC2024US135028$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
240315733$24031573$3$F$20240101$20240819$20240629$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-019181$UNITED THERAPEUTICS$$$$$F$Y$$$20240828$$$US$US
240315843$24031584$3$F$20240301$20240806$20240629$20240807$EXP$$IL-TAKEDA-2024TUS062919$TAKEDA$$$$A$F$Y$$$20240807$$MD$IL$IL
240315872$24031587$2$F$$20240719$20240629$20240730$EXP$$DE-AUROBINDO-AUR-APL-2017-10879$AUROBINDO$Pfersdorff M, Spes J, Kraus MR.. 17-year-old patient with neutropenia and fever during therapy with analgesics.. Dtsch Med Wochenschr ( Deutsche medizinischewochenschrift,). 2011;136(8):365-368$17$YR$$M$Y$68$KG$20240730$$MD$DE$DE
240315883$24031588$3$F$20240622$20240826$20240629$20240831$EXP$JP-MMM-1LXDFS9P$JP-ABBVIE-5819313$ABBVIE$$82$YR$$F$Y$19$KG$20240831$$MD$JP$JP
240315922$24031592$2$F$20230901$20240708$20240629$20240710$EXP$$US-ABBVIE-5819875$ABBVIE$$73$YR$$M$Y$$$20240710$$CN$US$US
240315942$24031594$2$F$20240625$20240722$20240629$20240725$PER$$US-AMGEN-USASP2024125813$AMGEN$$60$YR$A$M$Y$$$20240725$$MD$US$US
240316003$24031600$3$F$20240614$20240710$20240629$20240717$PER$$US-AMGEN-USASP2024118749$AMGEN$$54$YR$A$F$Y$84.7$KG$20240717$$PH$US$US
240316012$24031601$2$F$$20240705$20240629$20240710$30DAY$$US-AMGEN-USASP2024121819$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240316052$24031605$2$F$$20240703$20240629$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-031220$AUROBINDO$Novoa F, Cheema S, Conner S. A Case of Symptomatic Hypercalcemia Secondary to Histoplasmosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6332$57$YR$$F$Y$$$20240712$$MD$US$US
240316152$24031615$2$F$20240620$20240711$20240629$20240720$EXP$$CA-CELLTRION INC.-2024CA015684$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
240316214$24031621$4$F$20200116$20240711$20240629$20240720$EXP$$DE-AUROBINDO-AUR-APL-2023-079350$AUROBINDO$$$$E$F$Y$69$KG$20240720$$HP$DE$DE
240316222$24031622$2$F$20240501$20240628$20240629$20240724$30DAY$$DE-UCBSA-2024028235$UCB$$$$$F$Y$$$20240724$$CN$DE$DE
240316302$24031630$2$F$$20240702$20240629$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-031111$AUROBINDO$Manjunath S, Khandhar P.. Atrial Fibrillation With Rapid Ventricular Response in Pediatric Lupus Carditis Following Pulse Steroid Therapy.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A1729$16$YR$$M$Y$$$20240711$$MD$US$US
240316352$24031635$2$F$$20240710$20240629$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-031120$AUROBINDO$Adams EW, Madison J, Bielick Kotkowski C. Nocardiosis With Rapid Radiographic Progression. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2416$85$YR$$M$Y$$$20240720$$MD$US$US
240316362$24031636$2$F$20240621$20240715$20240629$20240723$PER$$US-SA-2024SA189047$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240723$$MD$US$US
240316373$24031637$3$F$20240508$20240716$20240629$20240725$PER$$US-SA-2024SA188896$SANOFI AVENTIS$$41$YR$A$F$Y$52.6$KG$20240725$$MD$US$US
240316392$24031639$2$F$$20240701$20240629$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-031068$AUROBINDO$Pattupara A, Nguyen D, Gaikwad M, Gnirke M, Yarra S, Su M, et al.. Breaking the Spell: A Rare Case of Prolonged Benzodiazepine Elimination. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5703$67$YR$$M$Y$$$20240709$$MD$US$US
240316402$24031640$2$F$20240601$20240807$20240629$20240808$PER$$US-AMGEN-USASP2024126064$AMGEN$$86$YR$E$F$Y$$$20240808$$CN$US$US
240316443$24031644$3$F$20240101$20240815$20240629$20240820$EXP$$US-ABBVIE-5765707$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
240316472$24031647$2$F$$20240626$20240629$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-031268$AUROBINDO$Khawam S, Goudie M, Hartfield R, Hassan S, Padder F. A Case of Trazadone and Omeprazole Associated Wenckebach Phenomenon Disguised as Second-degree Mobitz Type 2 AV Block. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5664$26$YR$$F$Y$$$20240704$$MD$US$US
240316494$24031649$4$F$20240101$20240808$20240629$20240812$EXP$$US-JNJFOC-20240628691$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240812$$CN$US$US
240316552$24031655$2$F$$20240823$20240629$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05407$LUPIN$$$$$$Y$$$20240909$$CN$US$US
240316562$24031656$2$F$20240601$20240712$20240629$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019106$UNITED THERAPEUTICS$$71$YR$$F$Y$56.689$KG$20240719$$$US$US
240316672$24031667$2$F$20210218$20240811$20240629$20240819$EXP$$CA-CELLTRION INC.-2023CA024479$CELLTRION$$$$$$Y$$$20240819$$MD$CA$CA
240316682$24031668$2$F$20240617$20240820$20240629$20240828$EXP$$CO-TAKEDA-2024TUS010237$TAKEDA$$29$YR$$F$Y$58$KG$20240828$$CN$CO$CO
240316702$24031670$2$F$$20240705$20240629$20240714$PER$$US-SA-2024SA191331$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240714$$CN$US$US
240316712$24031671$2$F$$20240906$20240629$20240918$PER$$US-SA-2024SA185660$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240918$$MD$US$US
240316742$24031674$2$F$20240101$20240705$20240629$20240713$EXP$$CA-CELLTRION INC.-2024CA001289$CELLTRION$$$$$$Y$$$20240713$$HP$CA$CA
240316822$24031682$2$F$$20240703$20240629$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-031064$AUROBINDO$Hashmi N, Basaleli C, Gupta S, John G, Birnbaum B, Kim U, et al.. Acute Eosinophilic Pneumonia in the Setting of Intramuscular Progesterone Usage.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A6397$33$YR$$F$Y$$$20240712$$MD$US$US
240316832$24031683$2$F$$20240805$20240629$20240816$EXP$$US-AUROBINDO-AUR-APL-2024-031072$AUROBINDO$Moore M, King S, Aschner Y.. Endobronchial Mucormycosis Presenting as Stridor in a Diabetic Adult. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7420$49$YR$$M$Y$$$20240816$$MD$US$US
240316842$24031684$2$F$$20240702$20240629$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-031153$AUROBINDO$Hassan S, Khawam S, Hartfield R, Patel P, Cole R, Goudie MP. Unmasking the Peril of Minoxidil: A Case of Pericardial Effusion Leading to Tamponade in Resistant Hypertension. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5668$26$YR$$F$Y$$$20240710$$MD$US$US
240316873$24031687$3$F$$20240806$20240629$20240812$PER$$US-ABBVIE-5819593$ABBVIE$$$$$F$Y$68$KG$20240812$$CN$US$US
240316896$24031689$6$F$20240101$20240904$20240629$20240911$EXP$$CA-CELLTRION INC.-2024CA015712$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
240316902$24031690$2$F$$20240627$20240629$20240704$PER$$US-AMGEN-USASP2024128484$AMGEN$$$$$F$Y$$$20240703$$HP$US$US
240316962$24031696$2$F$$20240626$20240629$20240707$EXP$$CA-ABBVIE-5818530$ABBVIE$$$$A$F$Y$$$20240707$$CN$CA$CA
240316982$24031698$2$F$$20240701$20240629$20240710$EXP$DE-BFARM-24004314$DE-TORRENT-00026903$TORRENT$$$$$F$Y$$$20240710$$CN$DE$DE
240317052$24031705$2$F$20240623$20240701$20240629$20240708$PER$$US-AMGEN-USASP2024126413$AMGEN$$83$YR$E$F$Y$$$20240708$$MD$US$US
240317062$24031706$2$F$$20240703$20240629$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-031147$AUROBINDO$Barrows C, Horton M, Allaham A, Israel HP.. A Case of Acute Hypoxic Respiratory Failure After Administration of Rituximab.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A6326$61$YR$$M$Y$$$20240712$$MD$US$US
240317082$24031708$2$F$$20240817$20240629$20240826$EXP$$CA-CELLTRION INC.-2024CA015786$CELLTRION$$$$$$Y$$$20240826$$CN$CA$CA
240317102$24031710$2$F$$20240621$20240629$20240701$PER$$US-SA-2024SA190426$SANOFI AVENTIS$$$$T$M$Y$$$20240701$$MD$US$US
240317113$24031711$3$F$$20240903$20240629$20240916$EXP$$GB-MACLEODS PHARMA-MAC2024047323$MACLEODS$$$$$$Y$$$20240916$$CN$GB$GB
240317123$24031712$3$F$$20240705$20240629$20240719$EXP$$GR-MACLEODS PHARMA-MAC2024047845$MACLEODS$Kontes I, Bontinis V, Bontinis A, Manaki V, Chorti A, Giannopoulos A, et al..Sequential Graft Limb Occlusion Following Endovascular Aneurysm Repair: A Case Report and Literature Review..Cureus.2024;16(5):e60102$$$$$Y$$$20240719$$MD$GR$GR
240317172$24031717$2$F$$20240625$20240629$20240706$EXP$$FR-MACLEODS PHARMA-MAC2024047858$MACLEODS$Drevin G, Picard N, Baudriller A, Pena-Martin M, Ferec S, Leuger L,, et.al..Tramadol intoxication in children: An emerging issue.Therapie.03-JUN-2024;S0040-5957(24)00067-2$$$$$Y$$$20240706$$MD$FR$FR
240317203$24031720$3$F$20240101$20240801$20240629$20240809$PER$$US-SA-2024SA191676$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240809$$PH$US$US
240317332$24031733$2$F$20240501$20240624$20240629$20240703$PER$$US-AMGEN-USASP2024125777$AMGEN$$60$YR$A$M$Y$$$20240702$$HP$US$US
240317342$24031734$2$F$$20240702$20240629$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-031219$AUROBINDO$Maldarelli ME, Grier WR. A Noxious Mimic - Pulmonary Nocardiosis Presenting as a Lung Mass in an Orthotopic Liver Transplant Patient. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2434$72$YR$$M$Y$$$20240710$$MD$US$US
240317392$24031739$2$F$$20240627$20240629$20240708$EXP$$IR-Accord-431603$ACCORD$Lotfollahi L, Golmohammadi M, Javandoust Gharehbagh F, Alavi Darazam I. Self-induced Anuria with Diclofenac: An Interesting Case of ^Quadruple Whammy^ Acute Kidney Injury. International Journal of Medical Toxicology and Forensic Medicine. 2024;14(2):E43065$66$YR$E$F$Y$$$20240708$$MD$IR$IR
240317413$24031741$3$F$$20240903$20240629$20240918$EXP$$US-AUROBINDO-AUR-APL-2024-031154$AUROBINDO$Hennen MA, Zhang V, Opler DJ. An unwelcome side-effect of trazodone use in a trans-male. Psychiatry and Clinical Neurosciences. 2024;78(6):376$24$YR$$$Y$$$20240918$$MD$US$US
240317462$24031746$2$F$$20240701$20240629$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-031172$AUROBINDO$Crawford M, Trinh J, Chaudhary S.. A Case Report of Statin-induced Necrotizing Autoimmune Myopathy With Extramuscular Involvement.. American Journal of Respiratory and Critical Care Medicine.. 2024;209$75$YR$$F$Y$$$20240709$$MD$US$US
240317472$24031747$2$F$$20240628$20240629$20240701$PER$$US-JNJFOC-20240673650$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240317482$24031748$2$F$$20240702$20240629$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-031049$AUROBINDO$Mahmoud A, Le C, Kurt O, Zoarob D, Ayaz S. An Unsettling Twist: Unveiling Acute Hyponatremia Induced by Linezolid: A Case Report. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5671$88$YR$$F$Y$$$20240711$$MD$US$US
240317532$24031753$2$F$$20240702$20240629$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-031121$AUROBINDO$Barsoum A, Huang J, Kazemi M, Price J, Chakrabarty I.. Hydroxychloroquine Induced Hypoglycemia.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A1364$31$YR$$F$Y$$$20240711$$MD$US$US
240317542$24031754$2$F$$20240625$20240629$20240704$PER$$US-AMGEN-USASP2024125605$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240317572$24031757$2$F$20240507$20240821$20240629$20240824$EXP$DE-PEI-202400010863$DE-Accord-432934$ACCORD$$82$YR$E$F$Y$65$KG$20240824$$MD$DE$DE
240317584$24031758$4$F$20240611$20240829$20240629$20240909$EXP$$KR-Accord-432092$ACCORD$$65$YR$E$M$Y$$$20240909$$MD$KR$KR
240317592$24031759$2$F$$20240702$20240629$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-031042$AUROBINDO$Nunez Cuello L, Perozo M, Cedeno H, Shah P.. Indomethacin-induced Angioedema: A Rare and Challenging Case.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A1362$68$YR$$M$Y$$$20240711$$MD$US$US
240317622$24031762$2$F$$20240703$20240629$20240715$EXP$$US-AUROBINDO-AUR-APL-2024-031195$AUROBINDO$Hammond TC, Channick CL, Favano T, Purbhoo M, Exley MA, Vandiver MS, et al.. Persistent SARS-CoV-2 Viremia, COVID-19 Associated Acute Respiratory Distress Syndrome, Severe Coagulopathy and Massive Hemoptysis in a Renal Transplant Patient on Veno-Venous Extracorporeal Membrane Oxygenation.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5563$26$YR$$M$Y$$$20240715$$MD$US$US
240317632$24031763$2$F$$20240705$20240629$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-031176$AUROBINDO$Rozenbaum Lerner G, Villamizar JP, Pelaez A, Salgado JC.. Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3531$68$YR$$M$Y$84$KG$20240716$$MD$US$US
240317642$24031764$2$F$$20240626$20240629$20240708$EXP$$JP-Accord-432318$ACCORD$Furukawa S, Hiraki M, Sakurai R, Kohya N, Murayama K, Kamachi K et al. A Case of Consciousness Disorder Due to Hyperammonemia Induced by Modified FOLFOX6 for Multiple Liver Metastasis from Rectal Cancer. Gan To Kagaku Ryoho. 2024 May;51(5):567-570. Japanese.$74$YR$E$M$Y$61$KG$20240708$$HP$JP$JP
240317652$24031765$2$F$$20240715$20240629$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-031157$AUROBINDO$Mikhail E, Alexander D, Jankowski M, Pandya D, Kunadi A.. Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A3410$72$YR$$F$Y$$$20240724$$MD$US$US
240317673$24031767$3$F$20240610$20240705$20240629$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-031735$AUROBINDO$$$$C$F$Y$$$20240917$$MD$FR$FR
240317832$24031783$2$F$$20240702$20240629$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-031217$AUROBINDO$Kiley KD, Melnychuk E. A Controversial Topic: PJP Prophylaxis in Patients With Long-Term Immunologic Agents +/- Steroids. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3572$30$YR$$F$Y$42$KG$20240711$$MD$US$US
240317882$24031788$2$F$$20240702$20240629$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-031165$AUROBINDO$Gupta UD, Chowdhury T, Niriyan J, Bellamkonda A, Aryal B, Al-Ghuraibawi M.. Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A3415$43$YR$$F$Y$$$20240710$$MD$US$US
240317892$24031789$2$F$20240101$20240710$20240629$20240722$PER$$US-SA-2024SA189232$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240721$$MD$US$US
240318002$24031800$2$F$$20240717$20240629$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-031161$AUROBINDO$Wireko F, Ryu JH.. Lung Transplant for Acute Exacerbation in Interstitial Pneumonia With Autoimmune Features (IPAF).. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5934$63$YR$$M$Y$$$20240726$$MD$US$US
240318012$24031801$2$F$$20240708$20240629$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-031109$AUROBINDO$Wong C, Ang G, Malik M, Iqbal S.. From Tongue Swelling to Skin Sloughing: Azithromycin-induced SJS/TEN.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5659$71$YR$$F$Y$$$20240718$$MD$US$US
240318062$24031806$2$F$$20240729$20240629$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-031139$AUROBINDO$Beesley S, Lanspa MJ.. Calcium Channel Overdose and Insulin Therapy Dosing. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7313$28$YR$$M$Y$$$20240809$$MD$US$US
240318072$24031807$2$F$$20240909$20240629$20240911$EXP$$US-BAYER-2024A092144$BAYER$$42$YR$A$M$Y$$$20240911$$CN$US$US
240318093$24031809$3$F$$20240822$20240629$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-030997$AUROBINDO$Riedhammer C, Dull J, Kestler C, Kadel S, Franz J, Weis P, et al.. dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma.. Annals of Hematology.. 2024;103(4):1327-1332$65$YR$$F$Y$$$20240903$$MD$DE$DE
240318192$24031819$2$F$$20240725$20240629$20240730$PER$$US-AMGEN-USASP2024127780$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
240318222$24031822$2$F$20240501$20240709$20240629$20240715$EXP$$FR-JNJFOC-20240659149$JOHNSON AND JOHNSON$$47$YR$A$F$Y$52$KG$20240715$$MD$FR$FR
240318233$24031823$3$F$$20240807$20240629$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05431$LUPIN$$$$$$Y$$$20240822$$CN$US$US
240318283$24031828$3$F$$20240717$20240629$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-030972$AUROBINDO$Tan E, Pokhriyal SC, Khan A, Pasha M, Idris H. Assay Interference Causing Persistently Elevated Vancomycin Levels Ultimately Leading to Treatment Failure and Fatal Outcome. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5673$69$YR$$F$Y$170$KG$20240729$$MD$US$US
240318292$24031829$2$F$$20240703$20240629$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-031218$AUROBINDO$Bjork ST, Chen E. Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7429$74$YR$$F$Y$$$20240712$$MD$US$US
240318302$24031830$2$F$$20240702$20240629$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-030992$AUROBINDO$Braat J, Shacker M, Arjuna A. Atypical Presentation of Central Serous Chorioretinopathy (CSCR) After Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5938$59$YR$$F$Y$$$20240710$$HP$US$US
240318332$24031833$2$F$$20240723$20240629$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-031150$AUROBINDO$Kretovics E, Keegan K, Burg G, Von Allmen D, Chima R, Benscoter D., et al.. Prolonged High-Dose Steroid Use in an Infant With Surfactant Protein-C Deficiency and Multiple Complications.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A2307$3$MON$$M$Y$$$20240802$$MD$US$US
240318397$24031839$7$F$20240401$20240828$20240629$20240903$EXP$$NVSC2024MX133265$NOVARTIS$$79$YR$$F$Y$57$KG$20240903$$CN$MX$MX
240318423$24031842$3$F$20240529$20240816$20240629$20240912$EXP$$US-AMAROX PHARMA-HET2024US01982$HETERO$$63$YR$$F$Y$83$KG$20240823$$CN$US$US
240318504$24031850$4$F$20240101$20240808$20240629$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-015992$UNITED THERAPEUTICS$$$$$F$Y$49.887$KG$20240813$$$US$US
240318522$24031852$2$F$20240624$20240708$20240629$20240710$PER$$US-AMGEN-USASP2024126581$AMGEN$$$$$$Y$$$20240709$$HP$US$US
240318562$24031856$2$F$$20240704$20240629$20240704$PER$$US-JNJFOC-20240675018$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240704$$CN$US$US
240318572$24031857$2$F$20240101$20240815$20240629$20240820$PER$$US-AMGEN-USASP2024126566$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
240318612$24031861$2$F$20240601$20240709$20240629$20240710$PER$$US-JNJFOC-20240675215$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240710$$HP$US$US
240318676$24031867$6$F$20240101$20240821$20240629$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019212$UNITED THERAPEUTICS$$$$$F$Y$68.481$KG$20240830$$$US$US
240318792$24031879$2$F$20240627$20240806$20240629$20240807$PER$$US-JNJFOC-20240676618$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240807$$HP$US$US
240318872$24031887$2$F$$20240717$20240629$20240726$EXP$$CA-BAXTER-2024BAX020602$BAXTER$$$$$$Y$$$20240726$$HP$CA$CA
240318992$24031899$2$F$20240627$20240723$20240629$20240726$PER$$US-AMGEN-USASP2024127677$AMGEN$$76$YR$E$F$Y$$$20240726$$CN$US$US
240319005$24031900$5$F$20240101$20240909$20240629$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019404$UNITED THERAPEUTICS$$$$$F$Y$146.49$KG$20240918$$$US$US
240319024$24031902$4$F$20240524$20240807$20240629$20240817$EXP$$GB-BAXTER-2024BAX020338$BAXTER$$34$YR$$F$Y$78$KG$20240817$$HP$GB$GB
240319032$24031903$2$F$$20240628$20240629$20240708$EXP$$CA-BAXTER-2024BAX020468$BAXTER$$$$$M$Y$$$20240708$$HP$CA$CA
240319062$24031906$2$F$$20240729$20240629$20240802$EXP$$JP-AMGEN-JPNSP2024105613$AMGEN$$$$E$$Y$$$20240802$$MD$JP$JP
240319104$24031910$4$F$20231227$20240917$20240629$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-000665$UNITED THERAPEUTICS$$47$YR$$F$Y$68.934$KG$20240926$$$US$US
240319132$24031913$2$F$$20240625$20240629$20240703$PER$$US-AMGEN-USASP2024125572$AMGEN$$$$$M$Y$$$20240702$$CN$US$US
240319142$24031914$2$F$20240617$20240802$20240629$20240805$PER$$US-AMGEN-USASP2024126419$AMGEN$$77$YR$E$M$Y$$$20240805$$CN$US$US
240319192$24031919$2$F$$20240627$20240629$20240712$PER$$US-SA-2024SA191701$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240712$$HP$US$US
240319282$24031928$2$F$20240601$20240701$20240629$20240705$PER$$US-JNJFOC-20240672174$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240706$$CN$US$US
240319392$24031939$2$F$$20240624$20240629$20240701$EXP$$US-AMGEN-USASP2024125972$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240319453$24031945$3$F$$20240909$20240629$20240919$EXP$$JP-Eisai-EC-2024-168124$EISAI$$$$$F$Y$$$20240919$$MD$JP$JP
240319463$24031946$3$F$20240205$20240705$20240629$20240713$EXP$$US-JNJFOC-20240558954$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240713$$CN$US$US
240319553$24031955$3$F$$20240726$20240629$20240806$PER$$US-AstraZeneca-2024A141633$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
240319572$24031957$2$F$20240601$20240819$20240629$20240904$PER$$US-AstraZeneca-2024A141616$ASTRAZENECA$$796$MON$$F$Y$$$20240904$$CN$US$
240319592$24031959$2$F$20240624$20240801$20240629$20240805$PER$$US-AMGEN-USASP2024125829$AMGEN$$57$YR$A$F$Y$$$20240805$$HP$US$US
240319632$24031963$2$F$$20240624$20240630$20240704$PER$$US-AMGEN-USASP2024125394$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240319732$24031973$2$F$20240619$20240812$20240630$20240822$30DAY$$US-GSK-US2024077243$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240822$$CN$US$US
240319742$24031974$2$F$$20240709$20240630$20240715$30DAY$$US-GSK-US2024077252$GLAXOSMITHKLINE$$$$$M$Y$$$20240715$$MD$US$US
240319753$24031975$3$F$$20240906$20240630$20240916$30DAY$$US-GSK-US2024078088$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
240319762$24031976$2$F$20240626$20240827$20240630$20240906$30DAY$$US-GSK-US2024079876$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240906$$CN$US$US
240319772$24031977$2$F$$20240731$20240630$20240809$EXP$$US-GSK-US2024076584$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
240319782$24031978$2$F$$20240709$20240630$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024077288$VIIV$$$$$$Y$$$20240719$$PH$US$US
240319822$24031982$2$F$20240528$20240906$20240630$20240916$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024078078$VIIV$$43$YR$$F$Y$71$KG$20240916$$PH$US$US
240319872$24031987$2$F$$20240826$20240630$20240830$EXP$$US-GSK-US2024AMR079616$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
240319904$24031990$4$F$20240526$20240912$20240630$20240919$EXP$FR-AFSSAPS-RN2024000701$FR-GSK-FR2024080206$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$FR$FR
240319922$24031992$2$F$20240623$20240801$20240630$20240806$PER$$US-AMGEN-USASP2024128974$AMGEN$$64$YR$A$M$Y$$$20240805$$CN$US$US
240319942$24031994$2$F$20240626$20240723$20240630$20240725$PER$$US-AMGEN-USASP2024127790$AMGEN$$56$YR$A$F$Y$$$20240725$$CN$US$US
240319992$24031999$2$F$$20240903$20240630$20240906$EXP$$US-JNJFOC-20240654652$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240906$$MD$US$US
240320013$24032001$3$F$$20240806$20240630$20240813$EXP$$GB-JNJFOC-20240665309$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240813$$HP$GB$GB
240320022$24032002$2$F$$20240812$20240630$20240821$30DAY$$US-GSK-US2024078661$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
240320032$24032003$2$F$20240614$20240816$20240630$20240901$PER$$US-AstraZeneca-2024A140631$ASTRAZENECA$$23942$DY$$F$Y$$$20240901$$CN$US$
240320242$24032024$2$F$$20240708$20240630$20240716$30DAY$$US-GSK-US2024078632$GLAXOSMITHKLINE$$$$$M$Y$$$20240716$$HP$US$US
240320253$24032025$3$F$$20240924$20240630$20240926$EXP$$MY-SANDOZ INC.-SDZ2024MY061538$SANDOZ$$79$YR$$F$Y$$$20240926$$PH$MY$MY
240320313$24032031$3$F$20240624$20240808$20240630$20240815$EXP$$US-GSK-US2024AMR078931$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240815$$HP$US$US
240320333$24032033$3$F$20220824$20240914$20240630$20240920$EXP$$CA-GSK-CA2022128854$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$CA$CA
240320342$24032034$2$F$$20240621$20240630$20240720$PER$$US-JNJFOC-20240661749$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$CN$US$US
240320372$24032037$2$F$20240614$20240718$20240630$20240725$30DAY$$US-GSK-US2024079793$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240725$$CN$US$US
240320392$24032039$2$F$$20240701$20240630$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-031107$AUROBINDO$Prabhu S, Malempati S, Markowitz D.. Amlodipine: Not an Ace in the Hole.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A1361$56$YR$$M$Y$$$20240709$$MD$US$US
240320552$24032055$2$F$$20240626$20240630$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-031090$AUROBINDO$Alsheimer K, Burgei JW, Lantry J, Shah H, Lamichhane B.. Genitourinary Tuberculosis Resulting in Hydronephrosis.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A2354$$$$M$Y$$$20240704$$MD$US$US
240320593$24032059$3$F$$20240703$20240630$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008289$JAZZ$$$$$M$Y$$$20240710$$CN$US$US
240320712$24032071$2$F$$20240718$20240630$20240730$EXP$$GB-AUROBINDO-AUR-APL-2024-031415$AUROBINDO$$$$A$$Y$$$20240730$$HP$GB$GB
240320772$24032077$2$F$20240612$20240912$20240630$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-031315$AUROBINDO$$50$YR$$M$Y$79.4$KG$20240923$$MD$FR$FR
240320862$24032086$2$F$$20240702$20240630$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-031245$AUROBINDO$$$$$M$Y$$$20240709$$CN$GB$GB
240320895$24032089$5$F$20240101$20240722$20240630$20240729$EXP$$US-UROGEN PHARMA LTD.-2024-UGN-000087$UROGEN PHARMA$$$$$$Y$$$20240729$$MD$US$US
240320942$24032094$2$F$20210620$20240704$20240630$20240715$EXP$$IT-AUROBINDO-AUR-APL-2024-031664$AUROBINDO$$71$YR$$F$Y$$$20240715$$HP$IT$IT
240321092$24032109$2$F$$20240722$20240630$20240730$30DAY$$US-GSK-US2024077674$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$CN$US$US
240321133$24032113$3$F$20240622$20240729$20240630$20240808$30DAY$$US-GSK-US2024078690$GLAXOSMITHKLINE$$$$A$M$Y$$$20240808$$CN$US$US
240321193$24032119$3$F$20240614$20240621$20240630$20240709$EXP$$US-AMGEN-USASP2024119759$AMGEN$$77$YR$E$F$Y$$$20240709$$PH$US$US
240321286$24032128$6$F$20240101$20240827$20240630$20240828$EXP$$NVSC2024AU133479$NOVARTIS$$$$$F$Y$$$20240828$$HP$AU$AU
240321303$24032130$3$F$$20240806$20240630$20240827$PER$$US-AstraZeneca-2024A141665$ASTRAZENECA$$69$YR$$M$Y$$$20240827$$HP$US$
240321352$24032135$2$F$$20240730$20240630$20240802$PER$$US-RDY-SPO/USA/24/0009214$DR REDDYS$$28$YR$A$M$Y$$$20240802$$HP$US$US
240321432$24032143$2$F$20240222$20240823$20240630$20240828$PER$$US-BAYER-2024A091022$BAYER$$$$C$M$Y$$$20240828$$CN$US$US
240321542$24032154$2$F$20240101$20240711$20240630$20240722$EXP$$US-ZENPEP LLC-2024AIMT00991$AIMMUNE$$$$$$Y$$$20240722$$HP$US$US
240321552$24032155$2$F$20240601$20240708$20240630$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202406017586$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240712$$CN$US$US
240321582$24032158$2$F$20230723$20240627$20240630$20240702$EXP$$DE-SANDOZ INC.-SDZ2024DE061341$SANDOZ$$$$E$F$Y$$$20240702$$HP$DE$DE
240321622$24032162$2$F$20230101$20240719$20240630$20240723$EXP$$JP-JNJFOC-20240668294$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240723$$MD$JP$JP
240321672$24032167$2$F$20240624$20240701$20240630$20240703$PER$$US-JNJFOC-20240674893$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240703$$HP$US$US
240321712$24032171$2$F$$20240710$20240630$20240717$PER$$US-HETERO-HET2024US01983$HETERO$$82$YR$$M$Y$118$KG$20240717$$PH$US$US
240321733$24032173$3$F$$20240722$20240630$20240724$PER$$US-JNJFOC-20240666693$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$HP$US$US
240321802$24032180$2$F$$20240627$20240630$20240709$PER$$US-AVEVA-000687$AVEVA$$$$$F$Y$$$20240709$$CN$US$US
240321852$24032185$2$F$20240611$20240626$20240630$20240709$PER$$US-AMGEN-USASP2024127349$AMGEN$$61$YR$A$F$Y$$$20240709$$CN$US$US
240321958$24032195$8$F$$20240913$20240630$20240919$PER$$US-JNJFOC-20240678928$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240919$$CN$US$US
240322042$24032204$2$F$$20240726$20240630$20240806$PER$$US-AstraZeneca-2024A144549$ASTRAZENECA$$$$$F$Y$$$20240806$$PH$US$
240322052$24032205$2$F$$20240918$20240630$20240921$PER$$US-JNJFOC-20240675084$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$HP$US$US
240322072$24032207$2$F$20240610$20240730$20240630$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202406013759$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240809$$CN$US$US
240322082$24032208$2$F$20240619$20240628$20240630$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019080$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240701$$CN$US$US
240322162$24032216$2$F$$20240628$20240630$20240703$PER$$US-AMGEN-USASP2024127231$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240322172$24032217$2$F$20240524$20240627$20240630$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024077113$VIIV$$29$YR$$F$Y$$$20240705$$MD$US$US
240322212$24032221$2$F$$20240723$20240630$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202406019749$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240725$$CN$US$US
240322292$24032229$2$F$20240624$20240703$20240630$20240705$PER$$US-AMGEN-USASP2024126775$AMGEN$$83$YR$E$F$Y$$$20240705$$CN$US$US
240322312$24032231$2$F$20240520$20240708$20240630$20240722$PER$$US-JNJFOC-20240678784$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240722$$HP$US$US
240322382$24032238$2$F$$20240729$20240630$20240805$30DAY$$US-GSK-US2024079154$GLAXOSMITHKLINE$$67$YR$$M$Y$$$20240805$$CN$US$US
240322551$24032255$1$I$$20240408$20240408$20240408$EXP$$58-year-old male$STANFORD UNIV MEDCTR$$$$$$N$$$20240630$$$US$
240322582$24032258$2$F$$20240725$20240630$20240728$PER$$US-JNJFOC-20240666312$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$HP$US$US
240322672$24032267$2$F$20240626$20240702$20240630$20240704$EXP$$GB-ABBVIE-5820940$ABBVIE$$76$YR$$M$Y$$$20240704$$CN$GB$GB
240322682$24032268$2$F$$20240718$20240630$20240723$PER$$US-AMGEN-USASP2024128804$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
240322692$24032269$2$F$20240306$20240716$20240630$20240718$EXP$$FR-SANDOZ INC.-SDZ2024FR061441$SANDOZ$$73$YR$$F$Y$87$KG$20240718$$MD$FR$FR
240322713$24032271$3$F$$20240702$20240630$20240717$30DAY$$CA-JNJFOC-20240634167$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$CA$CA
240322824$24032282$4$F$20240601$20240710$20240630$20240715$EXP$$US-ABBVIE-5820741$ABBVIE$$85$YR$$F$Y$$$20240715$$CN$US$US
240322902$24032290$2$F$20201123$20210204$20240630$20240724$EXP$$JP-TAKEDA-SH202018393$TAKEDA$$12$YR$$F$Y$48$KG$20240724$$MD$JP$JP
240322932$24032293$2$F$$20240909$20240630$20240923$EXP$$PL-SANDOZ INC.-SDZ2024PL061503$SANDOZ$$48$YR$$F$Y$$$20240923$$HP$PL$PL
240322942$24032294$2$F$20240202$20240628$20240630$20240702$EXP$$TW-ABBVIE-5818485$ABBVIE$$44$YR$$M$Y$60$KG$20240702$$CN$TW$TW
240322962$24032296$2$F$20240429$20240722$20240630$20240729$30DAY$$US-AMGEN-USASP2024122807$AMGEN$$41$YR$A$M$Y$$$20240729$$HP$US$US
240322982$24032298$2$F$$20240821$20240630$20240826$EXP$$US-ABBVIE-5819785$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
240323162$24032316$2$F$20240601$20240624$20240630$20240703$PER$$IL-Blueprint Medicines Corporation-SP-IL-2024-001286$BLUEPRINT MEDICINES$$77$YR$E$F$Y$$$20240703$$MD$IL$IL
240323182$24032318$2$F$20240101$20240702$20240630$20240705$EXP$$US-ABBVIE-5820619$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240323293$24032329$3$F$20240625$20240807$20240630$20240808$PER$$US-AMGEN-USASP2024127190$AMGEN$$76$YR$E$F$Y$$$20240808$$CN$US$US
240323302$24032330$2$F$20240612$20240731$20240630$20240802$PER$$US-AMGEN-USASP2024128647$AMGEN$$62$YR$A$F$Y$$$20240802$$CN$US$US
240323383$24032338$3$F$20240623$20240710$20240630$20240712$PER$$US-AMGEN-USASP2024124959$AMGEN$$76$YR$E$M$Y$$$20240712$$CN$US$US
240323442$24032344$2$F$20240410$20240711$20240630$20240715$EXP$$ES-ABBVIE-5818405$ABBVIE$$43$YR$$M$Y$$$20240715$$MD$ES$ES
240323511$24032351$1$I$$20230915$20240701$20240701$PER$$US-AMGEN-USASP2023235016$AMGEN$$$$$$Y$$$20240630$$CN$US$US
240323521$24032352$1$I$$20240620$20240701$20240701$EXP$$US-AUROBINDO-AUR-APL-2024-031144$AUROBINDO$Pandhair O.. Confoundingly Persistent Pneumonia in a Heart Transplant Patient.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A2442$67$YR$$M$Y$$$20240701$$MD$US$US
240323531$24032353$1$I$20240101$20240618$20240701$20240701$EXP$$US-Emmaus Medical, Inc.-EMM202406-000305$EMMAUS LIFE SCIENCES$$31$YR$A$M$Y$$$20240701$$CN$US$
240323541$24032354$1$I$$20240617$20240701$20240701$EXP$$US-Emmaus Medical, Inc.-EMM202406-000300$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240701$$CN$US$
240323552$24032355$2$F$$20240702$20240701$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-031169$AUROBINDO$Yeates A, Monroe I, Ahmad F.. Fungal Duo: A Case of Disseminated Histoplasmosis and Pneumocystis Pneumonia Competing for the Spotlight. American Journal of Respiratory and Critical Care Medicine. 2024;A3575$66$YR$$M$Y$$$20240710$$MD$US$US
240323561$24032356$1$I$20240101$20240619$20240701$20240701$EXP$$US-Emmaus Medical, Inc.-EMM202406-000308$EMMAUS LIFE SCIENCES$$51$YR$A$F$Y$$$20240701$$CN$US$
240323571$24032357$1$I$$20240620$20240701$20240701$EXP$$US-AMAROX PHARMA-HET2024US01953$HETERO$Elsayed M.. An interesting case of drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis with pulmonary and renal involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5780$75$YR$$M$Y$$$20240701$$MD$US$US
240323581$24032358$1$I$$20240626$20240701$20240701$EXP$$ES-NOVITIUMPHARMA-2024ESNVP01111$NOVITIUM PHARMA$Izaskun Rubio.Green neutrophilic inclusions in patient with drug intoxication: a case report.Journal of Laboratory and Precision Medicine.20-NOV-2023;9:1-4$54$YR$A$F$Y$$$20240701$$HP$ES$ES
240323593$24032359$3$F$$20240717$20240701$20240720$EXP$$JP-JNJFOC-20240675362$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$MD$JP$JP
240323602$24032360$2$F$20200524$20240703$20240701$20240712$EXP$$IT-AUROBINDO-AUR-APL-2021-035172$AUROBINDO$$62$YR$$M$Y$$$20240712$$MD$IT$IT
240323622$24032362$2$F$$20240827$20240701$20240830$PER$$US-AMGEN-USASP2024128544$AMGEN$$$$$F$Y$$$20240830$$CN$US$US
240323631$24032363$1$I$$20240618$20240701$20240701$30DAY$$CA-SANDOZ INC.-SDZ2023CA011843$SANDOZ$$$$$F$Y$$$20240701$$CN$CA$CA
240323651$24032365$1$I$$20240621$20240701$20240701$EXP$$DE-AUROBINDO-AUR-APL-2022-012558$AUROBINDO$Bonnet U, Kanti AK, Scherbaum N, Specka M.. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study.. J Psychoactive Drugs.. 2022;55(1):102-111$20$YR$$M$Y$$$20240701$$HP$DE$DE
240323661$24032366$1$I$$20230512$20240701$20240701$PER$$US-AMGEN-USASP2023234989$AMGEN$$$$$$Y$$$20240630$$CN$US$US
240323671$24032367$1$I$20240622$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024127773$AMGEN$$87$YR$E$F$Y$$$20240630$$CN$US$US
240323681$24032368$1$I$20240428$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A147818$ASTRAZENECA$$$$$M$Y$$$20240701$$CN$US$
240323692$24032369$2$F$20230301$20240705$20240701$20240712$EXP$$JP-SMPA-2024SMP009407$SUNOVION$$$$$$Y$$$20240712$$CN$JP$JP
240323701$24032370$1$I$$20240624$20240701$20240701$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001296$BLUEPRINT MEDICINES$$$$$F$Y$$$20240701$$CN$US$US
240323711$24032371$1$I$20230101$20240623$20240701$20240701$EXP$$CA-JNJFOC-20230820605$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240701$$HP$CA$CA
240323722$24032372$2$F$$20240724$20240701$20240802$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001292$BLUEPRINT MEDICINES$$$$$M$Y$$$20240802$$PH$US$US
240323731$24032373$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127490$AMGEN$$$$$F$Y$$$20240630$$HP$US$US
240323741$24032374$1$I$$20240620$20240701$20240701$EXP$$JP-SMPA-2024SMP009540$SUNOVION$$$$$$Y$$$20240701$$CN$JP$JP
240323761$24032376$1$I$$20240619$20240701$20240701$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000222$EMCURE$$$$$$Y$$$20240701$$CN$US$US
240323771$24032377$1$I$$20231212$20240701$20240701$PER$$US-AMGEN-USASP2023234991$AMGEN$$$$$$Y$$$20240630$$PH$US$US
240323781$24032378$1$I$20240624$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024128423$AMGEN$$83$YR$E$F$Y$$$20240630$$CN$US$US
240323791$24032379$1$I$$20240626$20240701$20240701$EXP$$IR-NOVITIUMPHARMA-2024IRNVP01113$NOVITIUM PHARMA$Mehrdad Farrokhnia.Co-infection of coronavirus disease 19 and cytomegalovirus in a kidney transplant recipient.Clinical Case Reports.04-MAR-2023;11(3):1-5$43$YR$A$F$Y$$$20240701$$HP$IR$IR
240323801$24032380$1$I$$20240623$20240701$20240701$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001300$BLUEPRINT MEDICINES$$$$$$Y$$$20240701$$MD$US$US
240323811$24032381$1$I$$20240626$20240701$20240701$EXP$$BR-JNJFOC-20240674934$JOHNSON AND JOHNSON$$61$YR$A$F$Y$68$KG$20240701$$CN$BR$BR
240323833$24032383$3$F$20240101$20240722$20240701$20240730$EXP$$CA-CELLTRION INC.-2023CA000300$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
240323841$24032384$1$I$$20240617$20240701$20240701$EXP$$JP-SMPA-2024SMP009294$SUNOVION$$$$$$Y$$$20240701$$CN$JP$JP
240323851$24032385$1$I$$20240626$20240701$20240701$EXP$$DE-ABBVIE-5819233$ABBVIE$$$$$M$Y$$$20240701$$CN$DE$DE
240323862$24032386$2$F$$20240806$20240701$20240819$EXP$$JP-AMGEN-JPNSP2024127709$AMGEN$Madate H, Satomura K, Suda T, Miura M, Kaji K, Arai K. A case of microscopic polyangiitis suspected to be cholestatic drug-induced liver injury due to avacopan. The 137th Hokuriku branch regular meeting of The Japanese Society of Gastroenterology. 2024 JUN 16;48.$7$DEC$E$F$Y$$$20240819$$MD$JP$JP
240323871$24032387$1$I$$20240624$20240701$20240701$EXP$$CA-HALEON-2183423$Haleon PLC$$53$YR$$M$Y$$$20240628$$CN$CA$CA
240323882$24032388$2$F$20231001$20240625$20240701$20240708$EXP$$JP-NOVOPROD-1243400$NOVO NORDISK$$62$YR$$M$Y$$$20240708$$CN$JP$JP
240323891$24032389$1$I$$20240627$20240701$20240701$EXP$$US-ABBVIE-5819889$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240323903$24032390$3$F$$20240722$20240701$20240805$EXP$$JP-SMPA-2024SMP009336$SUNOVION$$$$$$Y$$$20240805$$CN$JP$JP
240323911$24032391$1$I$20240610$20240626$20240701$20240701$EXP$$JP-TAKEDA-2024TJP009647$TAKEDA$$84$YR$$F$Y$$$20240701$$PH$JP$JP
240323921$24032392$1$I$20200715$20240618$20240701$20240701$EXP$$JP-SMPA-2024SMP009430$SUNOVION$$$$$$Y$$$20240701$$CN$JP$JP
240323931$24032393$1$I$20240619$20240619$20240701$20240701$EXP$$JP-AMGEN-JPNSP2024127778$AMGEN$$71$YR$E$M$Y$$$20240630$$MD$JP$JP
240323941$24032394$1$I$20240507$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024125430$AMGEN$$78$YR$E$M$Y$$$20240630$$HP$US$US
240323951$24032395$1$I$$20240403$20240701$20240701$PER$$US-AMGEN-USASP2024129446$AMGEN$$$$$$Y$$$20240630$$PH$US$US
240323961$24032396$1$I$20240624$20240625$20240701$20240701$EXP$$KR-TAKEDA-2024TUS064044$TAKEDA$$46$YR$$M$Y$98$KG$20240701$$MD$KR$KR
240323971$24032397$1$I$20240501$20240627$20240701$20240701$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036549$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240701$$MD$PL$PL
240323981$24032398$1$I$20240522$20240628$20240701$20240701$EXP$$US-ABBVIE-5820916$ABBVIE$$45$YR$$$Y$39$KG$20240701$$CN$US$US
240323991$24032399$1$I$$20240625$20240701$20240701$EXP$$CA-JNJFOC-20240668998$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$HP$CA$CA
240324002$24032400$2$F$$20240904$20240701$20240918$EXP$$JP-AMGEN-JPNSP2024129078$AMGEN$$$$$$Y$$$20240917$$PH$JP$JP
240324011$24032401$1$I$20240418$20240624$20240701$20240701$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035911$BOEHRINGER INGELHEIM$$4$YR$C$M$Y$$$20240701$$HP$FR$FR
240324021$24032402$1$I$$20240627$20240701$20240701$EXP$$JP-TAKEDA-2024TJP009732$TAKEDA$$6$DEC$$$Y$$$20240701$$PH$JP$JP
240324031$24032403$1$I$$20240623$20240701$20240701$EXP$$NVSJ2024JP007543$NOVARTIS$$83$YR$$F$Y$$$20240701$$MD$JP$JP
240324041$24032404$1$I$$20240624$20240701$20240701$EXP$GB-MHRA-EMIS-1580-18e46120-eff4-4920-9d7f-77bed6ac0243$GB-ESPERIONTHERAPEUTICS-2024GBR00991$ESPERION THERAPEUTICS$$77$YR$$M$Y$80$KG$20240701$$PH$GB$GB
240324051$24032405$1$I$$20240624$20240701$20240701$EXP$$US-NOVITIUMPHARMA-2024USNVP01084$NOVITIUM PHARMA$P. Nauka.Does Occam^s Razor Even Apply in Severely Immunosuppressed Patients? A Case of a Patient With HIV/AIDS With Opportunistic Infections, Diffuse Large B-Cell Lymphoma, and Secondary Hemophagocytic Lymphohistiocytosis.American Journal of Respiratory and Critical Care Medicine.20-MAY-2023;209:A35-35$58$YR$A$M$Y$$$20240701$$HP$US$US
240324061$24032406$1$I$$20240621$20240701$20240701$EXP$$US-JNJFOC-20240658790$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$HP$US$US
240324071$24032407$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024126698$AMGEN$$$$$M$Y$$$20240630$$HP$US$US
240324083$24032408$3$F$20240601$20240724$20240701$20240805$EXP$$US-ABBVIE-5819837$ABBVIE$$64$YR$$F$Y$$$20240805$$CN$US$US
240324091$24032409$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018452$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240701$$CN$US$US
240324101$24032410$1$I$$20240626$20240701$20240701$PER$$PR-ABBVIE-5817882$ABBVIE$$30$YR$$F$Y$$$20240701$$MD$PR$PR
240324111$24032411$1$I$$20240622$20240701$20240701$PER$$NVSC2024US132028$NOVARTIS$$$$$$Y$$$20240701$$CN$US$US
240324122$24032412$2$F$$20240625$20240701$20240707$PER$$US-AMGEN-USASP2024126906$AMGEN$$$$$$Y$$$20240707$$MD$US$US
240324131$24032413$1$I$$20230504$20240701$20240701$PER$$US-AMGEN-USASP2023235029$AMGEN$$$$$$Y$$$20240630$$CN$US$US
240324141$24032414$1$I$20190101$20240619$20240701$20240701$PER$$US-TEVA-VS-3212016$TEVA$$$$E$F$Y$$$20240701$$CN$US$US
240324151$24032415$1$I$$20240623$20240701$20240701$EXP$$US-HETERO-HET2024US02020$HETERO$Dogrul BN, Park C.. Hydralazine Induced Visual and Auditory Hallucinations in a  Kidney Transplant Patient: Case Report. Journal of the Academy of Consultation?Liaison Psychiatry. 2024$49$YR$$F$Y$$$20240701$$MD$US$US
240324163$24032416$3$F$$20240711$20240701$20240718$EXP$$UY-ROCHE-10000011345$ROCHE$$66$YR$E$F$Y$$$20240718$$MD$UY$UY
240324171$24032417$1$I$$20240620$20240701$20240701$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007642$STRIDES$Phekoo A, Turk M, Torain J, Cate J, Java A, Sparks MA.. USE OF ECULIZUMAB DURING PREGNANCY IN A PATIENT WITH C3GN.. Am-J-Kidney-Dis. 2024;83 (S 2) (4):S44 abstr. 147.$$$$$Y$$$20240701$$HP$US$US
240324191$24032419$1$I$$20240627$20240701$20240701$PER$$US-TPU-TPU-2024-00372$TEIKOKU$$$$$F$Y$$$20240701$$CN$US$US
240324201$24032420$1$I$$20240621$20240701$20240701$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007660$STRIDES$Stone EG.. Unintended adverse consequences of a clinical decision support system: two cases.. J-Am-Med-Inf-Assoc. 2018;25 (5):564-567$$$$$Y$$$20240701$$HP$US$US
240324211$24032421$1$I$$20240607$20240701$20240701$PER$$US-TPU-TPU-2024-00294$TEIKOKU$$$$$F$Y$42.64$KG$20240701$$CN$US$US
240324222$24032422$2$F$$20240712$20240701$20240725$PER$$US-TPU-TPU-2024-00248$TEIKOKU$$$$$F$Y$$$20240725$$CN$US$US
240324231$24032423$1$I$$20240621$20240701$20240701$PER$$US-TPU-TPU-2024-00364$TEIKOKU$$$$$F$Y$$$20240701$$CN$US$US
240324241$24032424$1$I$$20240624$20240701$20240701$PER$$US-TPU-TPU-2024-00368$TEIKOKU$$$$$F$Y$$$20240701$$CN$US$US
240324251$24032425$1$I$$20240624$20240701$20240701$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01105$NOVITIUM PHARMA$Shiena Watanabe.Neurological insights on two siblings with GM3 synthase deficiency due to novel compound heterozygous ST3GAL5 variants.Brain and Development.21-JAN-2023;45(5):270-277$10$MON$N$F$Y$$$20240701$$HP$JP$JP
240324261$24032426$1$I$20240615$20240620$20240701$20240701$PER$$US-TPU-TPU-2024-00360$TEIKOKU$$85$YR$E$M$Y$$$20240701$$PH$US$US
240324271$24032427$1$I$$20240626$20240701$20240701$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01109$NOVITIUM PHARMA$Sara Munari.Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review.Drugs in Context.22-MAY-2024;13:1-11$64$YR$A$F$Y$$$20240701$$HP$IT$IT
240324281$24032428$1$I$$20240624$20240701$20240701$PER$$US-TPU-TPU-2024-00276$TEIKOKU$$95$YR$E$F$Y$$$20240701$$CN$US$US
240324292$24032429$2$F$20240623$20240711$20240701$20240724$PER$$US-TPU-TPU-2024-00365$TEIKOKU$$64$YR$A$F$Y$$$20240724$$CN$US$US
240324301$24032430$1$I$$20240124$20240701$20240701$PER$$US-JNJFOC-20240678781$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$HP$US$US
240324311$24032431$1$I$$20240622$20240701$20240701$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007673$STRIDES$Novoa FJ, Cheema S, Conner S.. A Case of Symptomatic Hypercalcemia Secondary to Histoplasmosis.. Am-J-Respir-Crit-Care-Med. 2024;209 (0):abstr. A6332.$$$$$Y$$$20240701$$HP$US$US
240324322$24032432$2$F$20240601$20240808$20240701$20240809$PER$$US-AMGEN-USASP2024127262$AMGEN$$30$YR$A$F$Y$$$20240809$$MD$US$US
240324331$24032433$1$I$20240101$20240624$20240701$20240701$PER$$US-AMGEN-USASP2024125586$AMGEN$$72$YR$E$F$Y$$$20240630$$CN$US$US
240324341$24032434$1$I$$20240623$20240701$20240701$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007663$STRIDES$Rao M, Casias M, Abidi MZ.. Disseminated Scedosporium infection in the early post-kidney transplant period.. Transpl-Infect-Dis. 2024;26(2)$$$$$Y$$$20240701$$HP$US$US
240324351$24032435$1$I$$20240625$20240701$20240701$EXP$$US-NOVITIUMPHARMA-2024USNVP01092$NOVITIUM PHARMA$M. Khan.Ticking All the Boxes: Case of Anaplasmosis With Acute Respiratory Distress Syndrome and Multi-Organ Failure.American Journal of Respiratory and Critical Care Medicine.20-MAY-2024;209:A3557$79$YR$E$F$Y$$$20240701$$HP$US$US
240324361$24032436$1$I$$20240621$20240701$20240701$PER$$US-AstraZeneca-2024A144487$ASTRAZENECA$$$$$M$Y$$$20240701$$CN$US$
240324371$24032437$1$I$$20240621$20240701$20240701$PER$$US-ABBVIE-5814533$ABBVIE$$50$YR$$F$Y$$$20240701$$CN$US$US
240324381$24032438$1$I$$20240624$20240701$20240701$EXP$$NVSC2024US133644$NOVARTIS$$63$YR$$F$Y$$$20240701$$CN$US$US
240324391$24032439$1$I$$20240621$20240701$20240701$PER$$NVSC2024US131491$NOVARTIS$$$$$$Y$$$20240701$$CN$US$US
240324401$24032440$1$I$20240620$20240624$20240701$20240701$30DAY$$US-GSK-US2024078515$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240701$$CN$US$US
240324411$24032441$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127628$AMGEN$$$$$$Y$$$20240630$$HP$US$US
240324421$24032442$1$I$$20240624$20240701$20240701$30DAY$$US-GSK-US2024AMR078485$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240324431$24032443$1$I$20240301$20240626$20240701$20240701$EXP$IT-MINISAL02-991758$IT-AMGEN-ITASP2024126618$AMGEN$$74$YR$E$F$Y$$$20240630$$CN$IT$IT
240324441$24032444$1$I$$20240618$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406013255$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240701$$CN$US$US
240324451$24032445$1$I$$20240104$20240701$20240701$PER$$US-ABBVIE-5820915$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240324462$24032446$2$F$20230901$20240730$20240701$20240801$EXP$$TR-ABBVIE-5818979$ABBVIE$$43$YR$$F$Y$62$KG$20240801$$CN$TR$TR
240324471$24032447$1$I$$20240618$20240701$20240701$EXP$$GR-STERISCIENCE B.V.-2024-ST-000892$Steriscience PTE$Zarras C, Iosifidis E, Simitsopoulou M, Pappa S, Kontou A, Roilides E, et al.. Neonatal Bloodstream Infection with Ceftazidime-Avibactam-Resistant blaKPC-2-Producing Klebsiella pneumoniae Carrying blaVEB-25.. Antibiotics-(Basel). 2023;12 (8):1-11$$$I$$Y$$$20240701$$HP$GR$GR
240324481$24032448$1$I$$20240627$20240701$20240701$EXP$$US-ABBVIE-5819415$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240324491$24032449$1$I$$20240621$20240701$20240701$EXP$$US-CHEPLA-2024007856$CHEPLAPHARM$$$$A$M$Y$$$20240628$$CN$COUNTRY NOT SPECIFIED$US
240324501$24032450$1$I$20240626$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127292$AMGEN$$$$$$Y$$$20240630$$CN$US$US
240324511$24032451$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127634$AMGEN$$$$$$Y$$$20240630$$HP$US$US
240324521$24032452$1$I$$20230411$20240701$20240701$PER$$US-AMGEN-USASP2023235004$AMGEN$$$$$$Y$$$20240630$$CN$US$US
240324531$24032453$1$I$20240626$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127225$AMGEN$$$$$$Y$$$20240630$$CN$US$US
240324551$24032455$1$I$$20240618$20240701$20240701$EXP$$CN-STERISCIENCE B.V.-2024-ST-000879$Steriscience PTE$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin.. J-Med-Case-Rep. 2024;18$38$YR$$M$Y$$$20240701$$HP$CN$CN
240324561$24032456$1$I$20240625$20240625$20240701$20240701$EXP$$US-JNJFOC-20240667568$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240701$$HP$US$US
240324571$24032457$1$I$$20240625$20240701$20240701$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01093$NOVITIUM PHARMA$Filomena Pietrantonio.Leptomeningeal carcinomatosis, an emerging disease in internal medicine departments with a generally poor prognosis: two case reports.Italian Journal of Medicine.2024;18:1-5$61$YR$A$F$Y$$$20240701$$HP$IT$IT
240324581$24032458$1$I$20240101$20240531$20240701$20240701$PER$$US-009507513-2406USA000338$MERCK$$$$$F$Y$$$20240701$$CN$US$US
240324591$24032459$1$I$$20240618$20240701$20240701$EXP$$CN-STERISCIENCE B.V.-2024-ST-000888$Steriscience PTE$Wu J, Zhou Y. Case analysis of hepatotoxicity caused by vancomycin.. J-Med-Case-Rep. 2024;18$56$YR$$F$Y$$$20240701$$HP$CN$CN
240324602$24032460$2$F$20221101$20240718$20240701$20240725$30DAY$$US-JNJFOC-20240651200$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240725$$CN$US$US
240324611$24032461$1$I$20220722$20240606$20240701$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002751$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240701$$CN$US$US
240324621$24032462$1$I$20221003$20240624$20240701$20240701$EXP$$FR-CELLTRION INC.-2024FR015518$CELLTRION$$$$$$Y$$$20240701$$PH$FR$FR
240324631$24032463$1$I$$20240618$20240701$20240701$PER$$US-JNJFOC-20240649056$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240324641$24032464$1$I$$20240618$20240701$20240701$EXP$$CN-STERISCIENCE B.V.-2024-ST-000891$Steriscience PTE$Wu J, Zhou Y. Case analysis of hepatotoxicity caused by vancomycin.. J-Med-Case-Rep. 2024;18$72$YR$$M$Y$$$20240701$$HP$CN$CN
240324651$24032465$1$I$$20240619$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000898$Steriscience PTE$Ghose M, Anwar M, Rajamohan A, Vangala A, Roy P, Weiner SM.. Vancomycin Induced Anaphylaxis Presenting With Cardiac Arrest: Judicious Use of Antibiotic in Low Risk Procedures.. Am-J-Respir-Crit-Care-Med. 2024;209$74$YR$$F$Y$$$20240701$$HP$US$US
240324661$24032466$1$I$$20240617$20240701$20240701$EXP$NO-MLMSERVICE-20240606-PI090099-00270-1$NO-STRIDES ARCOLAB LIMITED-2024SP007153$STRIDES$Krohn J, Power OA, Mylvaganam H, Askim AJ, Arnes JB, Blomberg B.. Endogenous fungal endophthalmitis caused by Cladophialophora devriesii: Report of a case and literature review.. Journal of ophthalmic inflammation and infection. 2024;14(1):25$73$YR$$F$Y$$$20240701$$MD$NO$NO
240324671$24032467$1$I$20240620$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126790$AMGEN$$53$YR$A$F$Y$$$20240630$$CN$US$US
240324682$24032468$2$F$20240101$20240821$20240701$20240827$EXP$$JP-GSK-JP2024JPN078294$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$JP$JP
240324691$24032469$1$I$$20240627$20240701$20240701$EXP$$NVSC2024US135436$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
240324701$24032470$1$I$$20240627$20240701$20240701$PER$$NVSC2024US135244$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
240324711$24032471$1$I$$20240619$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000902$Steriscience PTE$Sasidharan S, Ouyang J, Jatoi T, Mallappallil M, Puri I, Agarwal S.. Myxedema Coma Triggering BRASH Syndrome.. Am-J-Respir-Crit-Care-Med. 2024;209$56$YR$$F$Y$$$20240701$$HP$US$US
240324721$24032472$1$I$$20240619$20240701$20240701$EXP$$CA-STRIDES ARCOLAB LIMITED-2024SP007558$STRIDES$Marwaha AS, Cockcroft DW, Philipenko B.. Psyllium Husk (Metamucil) Induced Non-atopic Perennial Asthma: A Case Report.. Am-J-Respir-Crit-Care-Med. 2024;209$44$YR$$F$Y$$$20240701$$HP$CA$CA
240324731$24032473$1$I$20240522$20240626$20240701$20240701$PER$$US-ABBVIE-5819566$ABBVIE$$33$YR$$F$Y$$$20240701$$HP$US$US
240324741$24032474$1$I$$20240620$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406014796$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240701$$CN$US$US
240324751$24032475$1$I$20240623$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017407$ELI LILLY AND CO$$65$YR$E$$Y$$$20240701$$CN$US$US
240324763$24032476$3$F$20240305$20240912$20240701$20240918$EXP$$CA-TAKEDA-2024TUS010323$TAKEDA$$83$YR$$M$Y$$$20240918$$HP$CA$CA
240324771$24032477$1$I$20230923$20240624$20240701$20240701$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036005$BOEHRINGER INGELHEIM$$7$YR$C$M$Y$$$20240701$$HP$FR$FR
240324781$24032478$1$I$$20240620$20240701$20240701$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007651$STRIDES$Yao J, Le PT.. Sucking It Up: A Case of Negative Pressure Ventilation Use in Management of Lymphedema in Yellow Nail Syndrome.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$80$YR$$F$Y$$$20240701$$HP$US$US
240324792$24032479$2$F$20240607$20240819$20240701$20240831$EXP$$FR-GLENMARK PHARMACEUTICALS-2024GMK091732$GLENMARK$$$$$$Y$$$20240831$$HP$FR$FR
240324801$24032480$1$I$20240601$20240621$20240701$20240701$PER$$US-ABBVIE-5812418$ABBVIE$$$$$F$Y$$$20240701$$MD$US$US
240324813$24032481$3$F$$20240620$20240701$20240704$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP007634$STRIDES$Yuan YH, Zhang H, Xiao ZH, Zhang XP, Lu XL, Xu ZY, et al.. Therapeutic effect of plasma exchange on antibody mediated rejection after living relative donor liver transplantation in children. (Chinese). J-Clin-Pediatr-Surg. 2022;21 (5):425-430$7$MON$$M$Y$$$20240704$$HP$CN$CN
240324821$24032482$1$I$$20230126$20240701$20240701$PER$$US-AMGEN-USASP2023235015$AMGEN$$$$$$Y$$$20240630$$CN$US$US
240324841$24032484$1$I$20240611$20240624$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009655$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240324851$24032485$1$I$$20240620$20240701$20240701$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007636$STRIDES$Riha EN, Kim A, Tang J, Kesavan R, Girgawy E, Sarva S. Catching Flights and Malaria.. Respir-Crit-Care-Med. 2024;209$69$YR$$F$Y$$$20240701$$HP$US$US
240324861$24032486$1$I$20240523$20240627$20240701$20240701$EXP$$US-AstraZeneca-2024A149224$ASTRAZENECA$$24267$DY$$M$Y$$$20240701$$CN$US$
240324872$24032487$2$F$20240625$20240703$20240701$20240705$PER$$US-AMGEN-USASP2024127138$AMGEN$$70$YR$E$F$Y$$$20240705$$CN$US$US
240324881$24032488$1$I$$20240619$20240701$20240701$EXP$$TH-STERISCIENCE B.V.-2024-ST-000904$Steriscience PTE$Jaroonpipatkul A, Tripipitsiriwat A. ^Twisted Fate of Lung^: Spontaneous Lung Torsion Due to Pseudomonas Aeruginosa Pneumonia. Am-J-Respir-Crit-Care-Med. 2024;209$56$YR$$F$Y$$$20240701$$HP$TH$TH
240324891$24032489$1$I$$20240620$20240701$20240701$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007643$STRIDES$Singh N, Ramonell RP, Cody B, Dunlap DG.. A Growing Concern: Solitary Pulmonary Nodule Caused by Pneumocystis Jirovecci in an Immunocompromised Patient .. Am-J-Respir-Crit-Care-Med. 2024;209:A2381$71$YR$$M$Y$$$20240701$$HP$US$US
240324901$24032490$1$I$$20240619$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000905$Steriscience PTE$Lodh A, Blankenship S, Minish-Pron JM, Solomon GM.. Cyclophosphamide in the Treatment of Shrinking Lung Syndrome.. Am-J-Respir-Crit-Care-Med. 2024;209:abstr. A1985.$46$YR$$F$Y$$$20240701$$HP$US$US
240324911$24032491$1$I$$20240619$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000906$Steriscience PTE$Pham LL, Landeen C.. New Onset Refractory Status Epilepticus in Prion Disease.. Am-J-Respir-Crit-Care-Med. 2024;209:A5614$60$YR$$F$Y$$$20240701$$HP$US$US
240324921$24032492$1$I$20240101$20240603$20240701$20240701$PER$$US-JNJFOC-20240621951$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240701$$CN$US$US
240324931$24032493$1$I$$20240620$20240701$20240701$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007631$STRIDES$Magro CM, Kalomeris T, Shreve CR, Geyer JT, Patel SS.. Subcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administration.. Leuk-Lymphoma. 2024;65 (5):638-646$61$YR$$F$Y$$$20240701$$HP$US$US
240324941$24032494$1$I$$20240618$20240701$20240701$EXP$$US-NOVOPROD-1243744$NOVO NORDISK$$$$$F$Y$$$20240701$$CN$US$US
240324951$24032495$1$I$$20240618$20240701$20240701$EXP$$US-NOVOPROD-1243630$NOVO NORDISK$$$$A$M$Y$$$20240701$$CN$US$US
240324962$24032496$2$F$$20240805$20240701$20240819$EXP$$US-NOVOPROD-1243548$NOVO NORDISK$$81$YR$$M$Y$$$20240819$$CN$US$US
240324971$24032497$1$I$$20240618$20240701$20240701$EXP$$US-NOVOPROD-1244083$NOVO NORDISK$$70$YR$$F$Y$$$20240701$$CN$US$US
240324981$24032498$1$I$$20240618$20240701$20240701$EXP$$ZA-NOVOPROD-1242049$NOVO NORDISK$$31$YR$$M$Y$$$20240701$$HP$ZA$ZA
240324991$24032499$1$I$$20240618$20240701$20240701$EXP$$CA-NOVOPROD-1243261$NOVO NORDISK$$$$$F$Y$$$20240701$$CN$CA$CA
240325002$24032500$2$F$20240610$20240801$20240701$20240812$EXP$$US-NOVOPROD-1244432$NOVO NORDISK$$78$YR$$M$Y$$$20240812$$CN$US$US
240325012$24032501$2$F$20240328$20240705$20240701$20240716$EXP$GB-MHRA-MED-202404080941195000-RJVKT$GB-NOVOPROD-1243095$NOVO NORDISK$$65$YR$$F$Y$70$KG$20240716$$CN$GB$GB
240325021$24032502$1$I$20240618$20240618$20240701$20240701$EXP$GB-MHRA-MED-202406181012549970-GQLJV$GB-NOVOPROD-1243108$NOVO NORDISK$$$$$M$Y$15$KG$20240701$$MD$GB$GB
240325031$24032503$1$I$20240602$20240619$20240701$20240701$EXP$ES-AEMPS-1531632$ES-NOVOPROD-1242277$NOVO NORDISK$$$$A$F$Y$98$KG$20240701$$PH$ES$ES
240325041$24032504$1$I$20240101$20240627$20240701$20240701$EXP$$US-UCBSA-2024032983$UCB$$$$$F$Y$84.807$KG$20240701$$HP$US$US
240325051$24032505$1$I$$20240619$20240701$20240701$PER$$US-JNJFOC-20240650963$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$HP$US$US
240325061$24032506$1$I$$20240625$20240701$20240701$30DAY$$US-GSK-US2024079151$GLAXOSMITHKLINE$$$$$M$Y$$$20240701$$CN$US$US
240325071$24032507$1$I$20231114$20240620$20240701$20240701$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-023349$JAZZ$$37$YR$$F$Y$$$20240630$$CN$US$US
240325081$24032508$1$I$$20240620$20240701$20240701$EXP$US-MLMSERVICE-20240613-PI097146-00059-1$US-STRIDES ARCOLAB LIMITED-2024SP007484$STRIDES$Saleh Z, Kanaan J.. A Combination of Tezepelumab and Omalizumab for Severe Persistent Asthma.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5302$59$YR$$F$Y$$$20240701$$MD$US$US
240325091$24032509$1$I$20240613$20240624$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009653$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240325101$24032510$1$I$$20240619$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000908$Steriscience PTE$Peters AT, Case R, Kim SJ, McGregor M, Shifren A, Schroeder G, et al. Single-Agent Oral Therapy of Granulomatous-Lymphocytic Interstitial Lung Disease: A Case Series. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$$$$$Y$$$20240701$$HP$US$US
240325111$24032511$1$I$$20240621$20240701$20240701$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007661$STRIDES$Chang J-H, Kudose S, Droubi S, Verduzco HA, Awori J, Ratner LE, et al.. Four Cases of Kidney Transplants With Donor HCV-Derived Immune Complex Glomerulonephritis.. Kidney-Int-Rep. 2024;9 (6):1903-1907$60$YR$$M$Y$73$KG$20240701$$HP$US$US
240325121$24032512$1$I$$20240619$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000910$Steriscience PTE$Dabbas L, Baez Martinez V.. Unique Presentation of Leptospirosis in an Urban Setting: The Interplay of Social Determinants and Clinical Diagnostics.. Am-J-Respir-Crit-Care-Med. 2024;209.$64$YR$$M$Y$$$20240701$$HP$US$US
240325131$24032513$1$I$20240501$20240618$20240701$20240701$EXP$$US-NOVOPROD-1243835$NOVO NORDISK$$40$YR$$F$Y$$$20240701$$CN$US$US
240325141$24032514$1$I$$20240618$20240701$20240701$EXP$$US-NOVOPROD-1243848$NOVO NORDISK$$$$$F$Y$$$20240701$$CN$US$US
240325151$24032515$1$I$20231101$20240620$20240701$20240701$EXP$$CO-NOVOPROD-1241948$NOVO NORDISK$$33$YR$$M$Y$70$KG$20240701$$CN$CO$CO
240325161$24032516$1$I$20240520$20240628$20240701$20240701$EXP$$AU-ABBVIE-5820494$ABBVIE$$77$YR$$M$Y$$$20240701$$PH$AU$AU
240325171$24032517$1$I$$20240621$20240701$20240701$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007669$STRIDES$Yasmin M, Rojas LJ, Marshall SH, Hujer AM, Cmolik A, Marshall E, et al.. Characterization of a Novel Pathogen in Immunocompromised Patients: Elizabethkingia anophelis-Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and beta-lactamase Inhibitors. Open-Forum-Infect-Dis. 2023;10 (2)$60$YR$$F$Y$$$20240701$$HP$US$US
240325181$24032518$1$I$$20240621$20240701$20240701$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007670$STRIDES$Chang J-H, Kudose S, Droubi S, Verduzco HA, Awori J, Ratner LE, et al.. Four Cases of Kidney Transplants With Donor HCV-Derived Immune Complex Glomerulonephritis. Kidney-Int-Rep. 2024;9 (6)::1903-1907.$50$YR$$M$Y$75$KG$20240701$$HP$US$US
240325191$24032519$1$I$$20240625$20240701$20240701$EXP$GB-MHRA-MED-202406251346381960-TGLFH$GB-CHATTEMPRD-2024OHG022161$CHATTEM$$$$$$Y$$$20240701$$CN$GB$GB
240325201$24032520$1$I$$20240622$20240701$20240701$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007618$STRIDES$Baadh P, Kellermier H, Mudrakola HV.. Cryptogenic Organizing Pneumonia and Concomitant Usual Interstitial Pneumonia: An Unusual Presentation With an Accelerated Time-course.. Am-J-Respir-Crit-Care-Med. 2024;209$70$YR$$M$Y$$$20240701$$HP$US$US
240325213$24032521$3$F$$20240829$20240701$20240902$EXP$$JP-ABBVIE-5820221$ABBVIE$$69$YR$$M$Y$$$20240902$$MD$JP$JP
240325221$24032522$1$I$20240604$20240624$20240701$20240701$EXP$GB-MHRA-MED-202406201708236010-CLRMD$GB-STRIDES ARCOLAB LIMITED-2024SP007596$STRIDES$$24$YR$$M$Y$82$KG$20240701$$CN$GB$GB
240325231$24032523$1$I$$20231212$20240701$20240701$PER$$US-AMGEN-USASP2023234963$AMGEN$$$$$$Y$$$20240630$$PH$US$US
240325241$24032524$1$I$20240617$20240624$20240701$20240701$EXP$$US-VIIV HEALTHCARE LIMITED-US2024078492$VIIV$$67$YR$$M$Y$$$20240701$$CN$US$US
240325251$24032525$1$I$$20240621$20240701$20240701$PER$$US-ABBVIE-5814549$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240325261$24032526$1$I$$20240621$20240701$20240701$EXP$$IT-AVS-000012$AAVIS PHARMACEUTICALS$Serban AL, Zampetti B, Saladino A, Favero V, Chiodini I, Cozzi R. Case Report: Opposite Tumoral and Hormonal Responses to Low-dose Pasireotide in Cushing^s Disease. Endocr Metab Immune Disord Drug Targets. 2024;24(7):845-849. doi: 10.2174/0118715303260160231020070423.$54$YR$A$F$Y$$$20240629$$HP$IT$IT
240325271$24032527$1$I$$20240624$20240701$20240701$EXP$$US-JNJFOC-20240662846$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240325281$24032528$1$I$$20240624$20240701$20240701$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP007662$STRIDES$Gardin A, Cavallaro M, Labate A.. The importance of MRI in the acute phase of herpes encephalitis mimicking an acute ischemic stroke.. Neurol-Sci. 2023;44:4563-4567$80$YR$$M$Y$$$20240701$$HP$IT$IT
240325291$24032529$1$I$$20240621$20240701$20240701$EXP$$JP-CHEPLA-2024008032$CHEPLAPHARM$Miyajima K, et al. The complex diagnostic course of dementia with Lewy bodies: Insights from the complications of impaired consciousness and respiratory failure after psychiatric hospitalization. The 15th Annual conference of Japan Primary Care Association.2024;408.$76$YR$$F$Y$$$20240701$$MD$COUNTRY NOT SPECIFIED$JP
240325301$24032530$1$I$20220507$20240626$20240701$20240701$EXP$GB-MHRA-MED-202205091055060190-TYJW3$GB-STRIDES ARCOLAB LIMITED-2024SP007664$STRIDES$$61$YR$$F$Y$$$20240701$$PH$GB$GB
240325311$24032531$1$I$$20240621$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406015835$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240701$$CN$US$US
240325321$24032532$1$I$20240314$20240626$20240701$20240701$EXP$GB-MHRA-MED-202406241152331600-RZSNW$GB-STRIDES ARCOLAB LIMITED-2024SP007666$STRIDES$$22$YR$$F$Y$53$KG$20240701$$CN$GB$GB
240325331$24032533$1$I$20220630$20220728$20240701$20240701$EXP$$JP-TAKEDA-SH202207419$TAKEDA$$7$DEC$$M$Y$$$20240701$$MD$JP$JP
240325341$24032534$1$I$$20240623$20240701$20240701$PER$$US-BAUSCHBL-2024BNL029133$BAUSCH AND LOMB$$$$$F$Y$$$20240701$$CN$US$US
240325351$24032535$1$I$20240601$20240621$20240701$20240701$PER$$US-BAUSCHBL-2024BNL029058$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240701$$CN$US$US
240325362$24032536$2$F$$20240905$20240701$20240911$PER$$US-BAUSCHBL-2024BNL029151$BAUSCH AND LOMB$$$$$F$Y$$$20240912$$CN$US$US
240325371$24032537$1$I$$20240624$20240701$20240701$EXP$$NVSC2024US133515$NOVARTIS$$65$YR$$F$Y$$$20240701$$HP$US$US
240325381$24032538$1$I$$20240620$20240701$20240701$EXP$$CA-APOTEX-2024AP007603$APOTEX$$44$YR$$F$Y$$$20240701$$MD$CA$CA
240325391$24032539$1$I$$20240621$20240701$20240701$PER$$US-JNJFOC-20240659092$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240325401$24032540$1$I$$20240624$20240701$20240701$EXP$$US-JNJFOC-20240662859$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$HP$US$US
240325411$24032541$1$I$20240524$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127449$AMGEN$$79$YR$E$F$Y$$$20240630$$CN$US$US
240325422$24032542$2$F$20240601$20240731$20240701$20240801$PER$$US-AMGEN-USASP2024126426$AMGEN$$70$YR$E$M$Y$$$20240801$$CN$US$US
240325431$24032543$1$I$$20240627$20240701$20240701$PER$$NVSC2024US135723$NOVARTIS$$$$$$Y$$$20240701$$MD$US$US
240325441$24032544$1$I$$20240621$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100496$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240701$$CN$US$US
240325451$24032545$1$I$$20240625$20240701$20240701$EXP$$NVSC2024GB133565$NOVARTIS$$$$$M$Y$$$20240701$$CN$GB$GB
240325461$24032546$1$I$20240611$20240612$20240701$20240701$PER$$AR-TOLMAR, INC.-24AR050144$TOLMAR$$58$YR$$M$Y$$$20240701$$CN$AR$AR
240325471$24032547$1$I$$20240612$20240701$20240701$PER$$AU-TOLMAR, INC.-24AU050127$TOLMAR$$$$$M$Y$$$20240701$$CN$AU$AU
240325481$24032548$1$I$$20240613$20240701$20240701$PER$$AU-TOLMAR, INC.-24AU050164$TOLMAR$$$$$M$Y$$$20240701$$CN$AU$AU
240325491$24032549$1$I$$20240612$20240701$20240701$PER$$AU-TOLMAR, INC.-24AU050138$TOLMAR$$$$$M$Y$$$20240701$$CN$AU$AU
240325501$24032550$1$I$$20240612$20240701$20240701$PER$$AU-TOLMAR, INC.-24AU050165$TOLMAR$$$$$M$Y$$$20240701$$CN$AU$AU
240325511$24032551$1$I$$20240612$20240701$20240701$PER$$AU-TOLMAR, INC.-24AU050178$TOLMAR$$$$$M$Y$$$20240701$$CN$AU$AU
240325522$24032552$2$F$$20240722$20240701$20240808$PER$$BR-TOLMAR, INC.-24BR050083$TOLMAR$$$$$M$Y$$$20240807$$PH$BR$BR
240325531$24032553$1$I$$20240612$20240701$20240701$PER$$BR-TOLMAR, INC.-24BR050188$TOLMAR$$$$$F$Y$$$20240701$$CN$BR$BR
240325541$24032554$1$I$20240501$20240612$20240701$20240701$PER$$BR-TOLMAR, INC.-24BR050168$TOLMAR$$14$YR$$M$Y$$$20240701$$CN$BR$BR
240325551$24032555$1$I$$20240621$20240701$20240701$30DAY$$US-GSK-US2024AMR077999$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240325571$24032557$1$I$$20240614$20240701$20240701$PER$$US-TEVA-VS-3210872$TEVA$$73$YR$$M$Y$$$20240701$$CN$US$US
240325582$24032558$2$F$20240520$20240802$20240701$20240806$EXP$$NVSJ2024JP007683$NOVARTIS$$4$YR$$F$Y$$$20240807$$MD$JP$JP
240325591$24032559$1$I$$20240625$20240701$20240701$EXP$$NVSC2024US134657$NOVARTIS$$59$YR$$F$Y$$$20240701$$CN$US$US
240325601$24032560$1$I$20240621$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024125603$AMGEN$$64$YR$A$F$Y$112.1$KG$20240630$$PH$US$US
240325611$24032561$1$I$20231201$20240625$20240701$20240701$EXP$$US-ABBVIE-5817563$ABBVIE$$67$YR$$F$Y$$$20240701$$CN$US$US
240325621$24032562$1$I$20221215$20240624$20240701$20240701$EXP$$ES-CELLTRION INC.-2024ES015576$CELLTRION$$$$$$Y$$$20240701$$PH$ES$ES
240325631$24032563$1$I$20240102$20240624$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009659$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240325641$24032564$1$I$20230902$20240619$20240701$20240701$EXP$CN-NMPA-3608021009542202400022$CN-NOVOPROD-1242593$NOVO NORDISK$$32$YR$$F$Y$52$KG$20240701$$HP$CN$CN
240325651$24032565$1$I$20240607$20240619$20240701$20240701$EXP$CN-NMPA-3702131013825202400228$CN-NOVOPROD-1242608$NOVO NORDISK$$37$YR$$M$Y$107$KG$20240701$$HP$CN$CN
240325671$24032567$1$I$20231001$20240619$20240701$20240701$EXP$$CO-NOVOPROD-1243034$NOVO NORDISK$$58$YR$$F$Y$92$KG$20240701$$CN$CO$CO
240325681$24032568$1$I$$20240619$20240701$20240701$EXP$$GB-NOVOPROD-1242892$NOVO NORDISK$$$$E$F$Y$$$20240701$$HP$GB$GB
240325691$24032569$1$I$$20240619$20240701$20240701$EXP$$BR-NOVOPROD-1242898$NOVO NORDISK$$29$YR$$F$Y$$$20240701$$CN$BR$BR
240325701$24032570$1$I$20240101$20240626$20240701$20240701$EXP$$US-UCBSA-2024032664$UCB$$$$$F$Y$$$20240701$$CN$US$US
240325711$24032571$1$I$$20240621$20240701$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-161574$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$PH$JP$JP
240325721$24032572$1$I$$20240624$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102096$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240701$$PH$US$US
240325731$24032573$1$I$20240601$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103138$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$61.33$KG$20240701$$PH$US$US
240325741$24032574$1$I$20240620$20240625$20240701$20240701$EXP$$US-VIIV HEALTHCARE LIMITED-US2024079130$VIIV$$46$YR$$M$Y$$$20240701$$PH$US$US
240325751$24032575$1$I$20230403$20240624$20240701$20240701$EXP$$KR-009507513-2406KOR007653$MERCK$$$$$M$Y$$$20240701$$MD$KR$KR
240325763$24032576$3$F$20230726$20240822$20240701$20240901$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000127$DECIPHERA PHARMACEUTICALS$$60$YR$A$M$Y$88.254$KG$20240901$$MD$US$US
240325771$24032577$1$I$20240526$20240620$20240701$20240701$EXP$DE-BFARM-24004397$DE-NOVOPROD-1243047$NOVO NORDISK$$33$YR$$F$Y$$$20240701$$MD$DE$DE
240325781$24032578$1$I$20230925$20240620$20240701$20240701$EXP$SE-SEMPA-2024-005028$SE-NOVOPROD-1243050$NOVO NORDISK$$40$YR$$F$Y$106$KG$20240701$$CN$SE$SE
240325791$24032579$1$I$20240503$20240620$20240701$20240701$EXP$DE-BFARM-24004403$DE-NOVOPROD-1243061$NOVO NORDISK$$59$YR$$M$Y$113$KG$20240701$$MD$DE$DE
240325801$24032580$1$I$20240515$20240619$20240701$20240701$EXP$CN-NMPA-3508021010953202400413$CN-NOVOPROD-1242600$NOVO NORDISK$$83$YR$$M$Y$70$KG$20240701$$HP$CN$CN
240325811$24032581$1$I$20230101$20240620$20240701$20240701$EXP$IS-IMA-8717$IS-NOVOPROD-1243048$NOVO NORDISK$$64$YR$$F$Y$76$KG$20240701$$MD$IS$IS
240325823$24032582$3$F$20240615$20240730$20240701$20240801$PER$$US-JNJFOC-20240642715$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240801$$CN$US$US
240325831$24032583$1$I$$20240626$20240701$20240701$EXP$$NVSC2024GB134468$NOVARTIS$$$$A$M$Y$$$20240701$$CN$GB$GB
240325841$24032584$1$I$20240501$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103960$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240701$$HP$US$US
240325852$24032585$2$F$$20240926$20240701$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100116$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240926$$CN$US$US
240325863$24032586$3$F$$20240725$20240701$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104260$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240730$$HP$US$US
240325881$24032588$1$I$$20240626$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103746$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240701$$CN$US$US
240325891$24032589$1$I$$20240624$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102941$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240701$$HP$US$US
240325901$24032590$1$I$$20240625$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102641$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$79$KG$20240701$$PH$US$US
240325912$24032591$2$F$$20240828$20240701$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-102798$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$MD$JP$JP
240325921$24032592$1$I$20240101$20240620$20240701$20240701$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000554$DECIPHERA PHARMACEUTICALS$$69$YR$E$F$Y$$$20240701$$CN$US$US
240325931$24032593$1$I$20240612$20240627$20240701$20240701$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-104040$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$42.64$KG$20240701$$CN$PR$PR
240325941$24032594$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103679$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$65.77$KG$20240701$$MD$US$US
240325951$24032595$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127334$AMGEN$$$$$$Y$$$20240630$$CN$US$US
240325961$24032596$1$I$$20240625$20240701$20240701$EXP$$IN-AMGEN-INDSP2024125758$AMGEN$Kakkar D.. A tertiary care centre experience with Elranatamab: A report of three cases. Leukemia Research Reports. 2024;21:1-4$63$YR$A$M$Y$$$20240630$$HP$IN$IN
240325971$24032597$1$I$$20240626$20240701$20240701$EXP$$US-NOVITIUMPHARMA-2024USNVP01123$NOVITIUM PHARMA$Aruna Phekoo.USE OF ECULIZUMAB DURING PREGNANCY IN A PATIENT WITH C3GN.American Journal of Kidney Diseases.APR-2024;NA:1-4$24$YR$A$F$Y$$$20240701$$HP$US$US
240325981$24032598$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5819532$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240325991$24032599$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5819534$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240326001$24032600$1$I$20240301$20240626$20240701$20240701$EXP$$US-ABBVIE-5819439$ABBVIE$$68$YR$$M$Y$$$20240701$$CN$US$US
240326011$24032601$1$I$$20240624$20240701$20240701$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024078653$VIIV$$$$$M$Y$$$20240701$$HP$US$US
240326021$24032602$1$I$$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017781$ELI LILLY AND CO$$$$$M$Y$$$20240701$$CN$US$US
240326031$24032603$1$I$$20240619$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017895$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240701$$CN$US$US
240326041$24032604$1$I$20240601$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018071$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240326052$24032605$2$F$$20240712$20240701$20240722$EXP$$JP-BEH-2024174466$CSL BEHRING$$4$DEC$A$M$Y$$$20240722$$MD$JP$JP
240326061$24032606$1$I$20240215$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019060$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240701$$CN$US$US
240326071$24032607$1$I$20240625$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019180$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240701$$CN$US$US
240326081$24032608$1$I$20240621$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018766$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240701$$CN$US$US
240326091$24032609$1$I$20240622$20240626$20240701$20240701$EXP$$CO-ABBVIE-5821347$ABBVIE$$50$YR$$M$Y$$$20240701$$CN$CO$CO
240326101$24032610$1$I$$20240626$20240701$20240701$EXP$$IN-NOVITIUMPHARMA-2024INNVP01120$NOVITIUM PHARMA$Tajamul H Mir.ANCA-associated large and small vessel vasculitis with aorto-pulmonary-renal syndrome.The Lancet Rheumatology.22-AUG-2023;6(6):e409-e410$65$YR$A$M$Y$$$20240701$$HP$IN$IN
240326111$24032611$1$I$$20240626$20240701$20240701$EXP$PL-URPL-1-2519-2020$PL-HALEON-2184275$Haleon PLC$$19$YR$$M$Y$65$KG$20240701$$HP$PL$PL
240326121$24032612$1$I$20240615$20240627$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104253$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240701$$CN$US$US
240326131$24032613$1$I$20240329$20240628$20240701$20240701$EXP$SE-SEMPA-2024-003082$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-104257$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240701$$MD$SE$SE
240326141$24032614$1$I$$20240627$20240701$20240701$EXP$$NZ-BRISTOL-MYERS SQUIBB COMPANY-2024-103700$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240701$$PH$NZ$NZ
240326152$24032615$2$F$$20240628$20240701$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104266$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240710$$HP$US$US
240326162$24032616$2$F$20240601$20240630$20240701$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103615$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240712$$HP$US$US
240326172$24032617$2$F$20240229$20240718$20240701$20240728$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-103657$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$65$KG$20240729$$MD$DE$DE
240326181$24032618$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103849$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$52.62$KG$20240701$$HP$US$US
240326191$24032619$1$I$$20240627$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103816$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240701$$CN$US$US
240326202$24032620$2$F$$20240724$20240701$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102795$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$115.21$KG$20240725$$CN$US$US
240326211$24032621$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103476$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$CN$US$US
240326221$24032622$1$I$$20240614$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097369$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240701$$CN$US$US
240326231$24032623$1$I$$20240627$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104313$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240701$$CN$US$US
240326241$24032624$1$I$20240101$20240628$20240701$20240701$EXP$SI-JAZMP-NCPHV-2024SI0608_0608$SI-BRISTOL-MYERS SQUIBB COMPANY-2024-103973$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240701$$PH$SI$SI
240326251$24032625$1$I$$20240627$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104213$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240701$$CN$US$US
240326262$24032626$2$F$$20240819$20240701$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104322$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240829$$CN$US$US
240326281$24032628$1$I$$20240625$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103345$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240701$$CN$US$US
240326291$24032629$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104273$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$CN$US$US
240326303$24032630$3$F$20240609$20240911$20240701$20240914$EXP$$US-ABBVIE-5819894$ABBVIE$$29$YR$$M$Y$83$KG$20240914$$CN$US$US
240326311$24032631$1$I$20240201$20240626$20240701$20240701$EXP$$US-ABBVIE-5819669$ABBVIE$$57$YR$$F$Y$$$20240701$$CN$US$US
240326321$24032632$1$I$$20240624$20240701$20240701$EXP$$DE-SA-2024SA191312$SANOFI AVENTIS$$$$$$Y$$$20240701$$MD$DE$DE
240326332$24032633$2$F$$20240624$20240701$20240703$PER$$US-SA-2024SA189073$SANOFI AVENTIS$$8$YR$C$F$Y$40$KG$20240703$$CN$US$US
240326341$24032634$1$I$$20240624$20240701$20240701$EXP$$US-SA-2024SA188417$SANOFI AVENTIS$$$$A$F$Y$63.6$KG$20240701$$HP$US$US
240326351$24032635$1$I$$20240620$20240701$20240701$EXP$$US-SA-2024SA187736$SANOFI AVENTIS$$$$$M$Y$$$20240701$$HP$US$US
240326361$24032636$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA188386$SANOFI AVENTIS$$$$A$F$Y$90.72$KG$20240701$$MD$US$US
240326372$24032637$2$F$20240101$20240827$20240701$20240911$PER$$US-SA-2024SA189645$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240911$$MD$US$US
240326382$24032638$2$F$20240430$20240718$20240701$20240726$EXP$$US-SA-2024SA186839$SANOFI AVENTIS$$2$YR$C$F$Y$14$KG$20240726$$HP$US$US
240326391$24032639$1$I$20240601$20240624$20240701$20240701$PER$$US-SA-2024SA189852$SANOFI AVENTIS$$48$YR$A$F$Y$50.794$KG$20240701$$MD$US$US
240326401$24032640$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190062$SANOFI AVENTIS$$$$$F$Y$$$20240701$$CN$US$US
240326411$24032641$1$I$20240501$20240624$20240701$20240701$PER$$US-SA-2024SA189909$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240701$$MD$US$US
240326421$24032642$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA188168$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240701$$MD$US$US
240326431$24032643$1$I$$20240624$20240701$20240701$EXP$$JP-SA-2024SA186068$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240701$$MD$JP$JP
240326442$24032644$2$F$$20240708$20240701$20240715$EXP$$US-SA-2024SA185635$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240715$$CN$US$US
240326461$24032646$1$I$20240101$20240624$20240701$20240701$PER$$US-SA-2024SA190595$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240701$$MD$US$US
240326471$24032647$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA189134$SANOFI AVENTIS$$$$$$Y$$$20240701$$CN$US$US
240326481$24032648$1$I$$20240624$20240701$20240701$EXP$$US-SA-2024SA190021$SANOFI AVENTIS$$$$E$F$Y$$$20240701$$MD$US$US
240326491$24032649$1$I$20240101$20240620$20240701$20240701$PER$$US-SA-2024SA185725$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240701$$MD$US$US
240326501$24032650$1$I$20240101$20240625$20240701$20240701$PER$$US-SA-2024SA191140$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240701$$MD$US$US
240326521$24032652$1$I$$20240624$20240701$20240701$EXP$$US-SA-2024SA191539$SANOFI AVENTIS$$$$E$F$Y$$$20240701$$MD$US$US
240326531$24032653$1$I$20240611$20240619$20240701$20240701$PER$$US-SA-2024SA185205$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240701$$MD$US$US
240326541$24032654$1$I$$20240624$20240701$20240701$EXP$$US-SA-2024SA189370$SANOFI AVENTIS$$$$E$M$Y$$$20240701$$MD$US$US
240326551$24032655$1$I$20240101$20240626$20240701$20240701$PER$$US-SA-2024SA192103$SANOFI AVENTIS$$$$$$Y$$$20240701$$PH$US$US
240326571$24032657$1$I$20240601$20240621$20240701$20240701$PER$$US-SA-2024SA188779$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240701$$PH$US$US
240326581$24032658$1$I$20240101$20240624$20240701$20240701$EXP$$US-SA-2024SA190089$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240701$$MD$US$US
240326593$24032659$3$F$20240101$20240717$20240701$20240726$PER$$US-SA-2024SA189762$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240726$$MD$US$US
240326601$24032660$1$I$$20240622$20240701$20240701$PER$$US-SA-2024SA189616$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$MD$US$US
240326611$24032661$1$I$20240601$20240621$20240701$20240701$PER$$US-SA-2024SA188276$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240701$$MD$US$US
240326621$24032662$1$I$20240617$20240620$20240701$20240701$PER$$US-SA-2024SA188167$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240701$$MD$US$US
240326631$24032663$1$I$20240624$20240624$20240701$20240701$PER$$US-SA-2024SA189610$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240701$$MD$US$US
240326641$24032664$1$I$$20240626$20240701$20240701$PER$$US-SA-2024SA191008$SANOFI AVENTIS$$$$$F$Y$$$20240701$$CN$US$US
240326651$24032665$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA185589$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240701$$CN$US$US
240326661$24032666$1$I$20240101$20240621$20240701$20240701$PER$$US-SA-2024SA109847$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240701$$MD$US$US
240326671$24032667$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190604$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240701$$MD$US$US
240326681$24032668$1$I$20240501$20240624$20240701$20240701$PER$$US-SA-2024SA189894$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240701$$CN$US$US
240326691$24032669$1$I$$20240624$20240701$20240701$EXP$$US-SA-2024SA189576$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$MD$US$US
240326701$24032670$1$I$20240101$20240624$20240701$20240701$PER$$US-SA-2024SA189326$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240701$$CN$US$US
240326712$24032671$2$F$$20240702$20240701$20240711$EXP$$US-SA-2024SA185082$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240711$$CN$US$US
240326721$24032672$1$I$20240621$20240621$20240701$20240701$30DAY$$US-GSK-US2024078106$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240701$$CN$US$US
240326731$24032673$1$I$20240529$20240627$20240701$20240701$EXP$$JP-GSK-JP2024080681$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$JP$JP
240326741$24032674$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA188690$SANOFI AVENTIS$$94$YR$E$M$Y$$$20240701$$CN$US$US
240326751$24032675$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA185752$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240701$$MD$US$US
240326761$24032676$1$I$$20240619$20240701$20240701$PER$$US-SA-2024SA168875$SANOFI AVENTIS$$$$A$F$Y$77.1$KG$20240701$$MD$US$US
240326771$24032677$1$I$20240101$20240624$20240701$20240701$PER$$US-SA-2024SA189043$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240701$$MD$US$US
240326783$24032678$3$F$20240601$20240805$20240701$20240814$PER$$US-SA-2024SA189164$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240814$$MD$US$US
240326791$24032679$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA190295$SANOFI AVENTIS$$$$C$F$Y$14.1$KG$20240701$$MD$US$US
240326801$24032680$1$I$20240101$20240624$20240701$20240701$EXP$$RU-SA-2024SA160671$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240701$$MD$RU$RU
240326811$24032681$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA188592$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240701$$MD$US$US
240326821$24032682$1$I$$20240620$20240701$20240701$EXP$$US-SA-2024SA186368$SANOFI AVENTIS$$65$YR$E$M$Y$79.37$KG$20240701$$CN$US$US
240326831$24032683$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA188258$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240701$$MD$US$US
240326841$24032684$1$I$20240622$20240624$20240701$20240701$PER$$US-SA-2024SA189743$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240701$$HP$US$US
240326852$24032685$2$F$20240501$20240913$20240701$20240920$EXP$$US-SA-2024SA191299$SANOFI AVENTIS$$61$YR$A$F$Y$68.038$KG$20240920$$MD$US$US
240326861$24032686$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA167407$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240701$$CN$US$US
240326871$24032687$1$I$20240601$20240624$20240701$20240701$PER$$US-SA-2024SA191322$SANOFI AVENTIS$$38$YR$A$M$Y$87$KG$20240701$$MD$US$US
240326882$24032688$2$F$20240601$20240906$20240701$20240920$PER$$US-SA-2024SA189104$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240920$$HP$US$US
240326891$24032689$1$I$$20240620$20240701$20240701$EXP$PT-INFARMED-J202406-143$PT-SA-2024SA185187$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240701$$HP$PT$PT
240326901$24032690$1$I$$20240624$20240701$20240701$EXP$$US-SA-2024SA190219$SANOFI AVENTIS$$$$A$F$Y$92$KG$20240701$$MD$US$US
240326911$24032691$1$I$20240301$20240625$20240701$20240701$PER$$US-SA-2024SA189766$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240701$$MD$US$US
240326921$24032692$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA190037$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240701$$CN$US$US
240326931$24032693$1$I$20240101$20240620$20240701$20240701$PER$$US-SA-2024SA185846$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240701$$MD$US$US
240326942$24032694$2$F$20240606$20240910$20240701$20240925$EXP$$US-SA-2024SA190387$SANOFI AVENTIS$$17$YR$T$M$Y$77.1$KG$20240925$$MD$US$US
240326951$24032695$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA189354$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240701$$MD$US$US
240326961$24032696$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA190638$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240701$$MD$US$US
240326972$24032697$2$F$20240401$20240923$20240701$20240925$PER$$US-SA-2024SA190162$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240925$$MD$US$US
240326981$24032698$1$I$$20240626$20240701$20240701$PER$$US-SA-2024SA192043$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240701$$CN$US$US
240326991$24032699$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024125936$AMGEN$Khattri S.; Hren M. G.; Guenin S.. Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease. Journal of the American Academy of Dermatology. 2024;91(1):138-140$50$YR$A$$Y$$$20240630$$MD$US$US
240327001$24032700$1$I$20240619$20240620$20240701$20240701$PER$$US-SA-2024SA187703$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240701$$MD$US$US
240327013$24032701$3$F$20240426$20240902$20240701$20240904$EXP$$JP-SA-2024SA182891$SANOFI AVENTIS$$51$YR$A$F$Y$104$KG$20240904$$MD$JP$JP
240327021$24032702$1$I$20231201$20240624$20240701$20240701$PER$$US-SA-2024SA190355$SANOFI AVENTIS$$54$YR$A$F$Y$82$KG$20240701$$MD$US$US
240327031$24032703$1$I$20240101$20240626$20240701$20240701$EXP$$US-SA-2024SA191042$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240701$$MD$US$US
240327041$24032704$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190390$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240701$$CN$US$US
240327051$24032705$1$I$$20240626$20240701$20240701$EXP$$US-SA-2024SA192066$SANOFI AVENTIS$$$$E$F$Y$$$20240701$$MD$US$US
240327061$24032706$1$I$$20240624$20240701$20240701$EXP$$US-SA-2024SA190394$SANOFI AVENTIS$$$$A$M$Y$104$KG$20240701$$MD$US$US
240327071$24032707$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA188371$SANOFI AVENTIS$$$$A$M$Y$$$20240701$$MD$US$US
240327081$24032708$1$I$20240101$20240620$20240701$20240701$PER$$US-SA-2024SA152676$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240701$$CN$US$US
240327092$24032709$2$F$$20240619$20240701$20240726$PER$$US-SA-2024SA184714$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240726$$MD$US$US
240327101$24032710$1$I$20240101$20240624$20240701$20240701$EXP$$US-SA-2024SA191077$SANOFI AVENTIS$$31$YR$A$M$Y$90.7$KG$20240701$$MD$US$US
240327111$24032711$1$I$$20240618$20240701$20240701$PER$$US-SA-2024SA189830$SANOFI AVENTIS$$$$I$$Y$$$20240701$$CN$US$US
240327122$24032712$2$F$20240614$20240711$20240701$20240716$EXP$$US-SA-2024SA188704$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240716$$MD$US$US
240327131$24032713$1$I$20240623$20240624$20240701$20240701$EXP$$US-SA-2024SA189575$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240701$$MD$US$US
240327142$24032714$2$F$20230512$20240626$20240701$20240703$EXP$$US-SA-2024SA191595$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240703$$MD$US$US
240327151$24032715$1$I$$20240626$20240701$20240701$PER$$US-SA-2024SA192040$SANOFI AVENTIS$$$$$M$Y$$$20240701$$CN$US$US
240327161$24032716$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA188220$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$MD$US$US
240327171$24032717$1$I$20240531$20240621$20240701$20240701$PER$$US-SA-2024SA189507$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240701$$MD$US$US
240327181$24032718$1$I$$20240626$20240701$20240701$PER$$US-SA-2024SA192022$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$CN$US$US
240327191$24032719$1$I$20240101$20240620$20240701$20240701$PER$$US-SA-2024SA188901$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240701$$CN$US$US
240327201$24032720$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190038$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240701$$CN$US$US
240327211$24032721$1$I$20240621$20240621$20240701$20240701$PER$$US-SA-2024SA188241$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240701$$HP$US$US
240327222$24032722$2$F$20240801$20240813$20240701$20240826$PER$$US-SA-2024SA189271$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240826$$MD$US$US
240327233$24032723$3$F$$20240712$20240701$20240726$PER$$US-SA-2024SA188108$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240726$$CN$US$US
240327241$24032724$1$I$$20240626$20240701$20240701$EXP$$US-SA-2024SA191049$SANOFI AVENTIS$$$$E$F$Y$$$20240701$$MD$US$US
240327251$24032725$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA187122$SANOFI AVENTIS$$$$A$M$Y$77.1$KG$20240701$$MD$US$US
240327262$24032726$2$F$20240101$20240716$20240701$20240724$PER$$US-SA-2024SA190913$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240724$$CN$US$US
240327271$24032727$1$I$$20240620$20240701$20240701$30DAY$$TH-SA-2024SA185310$SANOFI AVENTIS$$$$A$$Y$$$20240701$$HP$TH$TH
240327282$24032728$2$F$$20240722$20240701$20240731$PER$$US-SA-2024SA190183$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240801$$CN$US$US
240327291$24032729$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA189837$SANOFI AVENTIS$$$$T$M$Y$81.64$KG$20240701$$MD$US$US
240327301$24032730$1$I$20240101$20240624$20240701$20240701$PER$$US-SA-2024SA190515$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240701$$MD$US$US
240327311$24032731$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA187916$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240701$$MD$US$US
240327321$24032732$1$I$20240610$20240624$20240701$20240701$PER$$US-SA-2024SA189845$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240701$$MD$US$US
240327331$24032733$1$I$20240101$20240621$20240701$20240701$PER$$US-SA-2024SA188936$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240701$$CN$US$US
240327342$24032734$2$F$20240613$20240816$20240701$20240830$PER$$US-SA-2024SA188341$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240830$$MD$US$US
240327351$24032735$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA192201$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$MD$US$US
240327361$24032736$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA188547$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240701$$MD$US$US
240327371$24032737$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA191270$SANOFI AVENTIS$$$$C$F$Y$$$20240701$$MD$US$US
240327382$24032738$2$F$$20240722$20240701$20240727$PER$$US-SA-2024SA188844$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240727$$CN$US$US
240327391$24032739$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA189798$SANOFI AVENTIS$$$$T$F$Y$$$20240701$$MD$US$US
240327402$24032740$2$F$20230901$20240826$20240701$20240906$PER$$US-SA-2024SA071644$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240906$$MD$US$US
240327411$24032741$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA189877$SANOFI AVENTIS$$$$C$F$Y$14.01$KG$20240701$$MD$US$US
240327421$24032742$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA192213$SANOFI AVENTIS$$12$YR$T$F$Y$62.7$KG$20240701$$CN$US$US
240327431$24032743$1$I$20240601$20240624$20240701$20240701$PER$$US-SA-2024SA189992$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240701$$MD$US$US
240327441$24032744$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA189242$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240701$$CN$US$US
240327451$24032745$1$I$$20240626$20240701$20240701$PER$$US-SA-2024SA192115$SANOFI AVENTIS$$$$$F$Y$$$20240701$$PH$US$US
240327461$24032746$1$I$20240101$20240624$20240701$20240701$PER$$US-SA-2024SA190597$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240701$$MD$US$US
240327471$24032747$1$I$20240601$20240624$20240701$20240701$PER$$US-SA-2024SA189549$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240701$$CN$US$US
240327481$24032748$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190379$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240701$$CN$US$US
240327491$24032749$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA192207$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240701$$MD$US$US
240327511$24032751$1$I$20240101$20240624$20240701$20240701$PER$$US-SA-2024SA190152$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240701$$MD$US$US
240327521$24032752$1$I$20240613$20240626$20240701$20240701$EXP$$CN-ROCHE-10000010221$ROCHE$$69$YR$E$F$Y$51$KG$20240701$$HP$CN$CN
240327531$24032753$1$I$20210101$20240624$20240701$20240701$EXP$$US-ABBVIE-5814326$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240327541$24032754$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103588$BRISTOL MYERS SQUIBB$$27$YR$A$F$Y$$$20240701$$HP$US$US
240327551$24032755$1$I$20240501$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103503$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240701$$HP$US$US
240327563$24032756$3$F$20240714$20240822$20240701$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103087$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$66.68$KG$20240827$$CN$US$US
240327571$24032757$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104048$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$68.04$KG$20240701$$PH$US$US
240327581$24032758$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103843$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240701$$CN$US$US
240327591$24032759$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103579$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$103.42$KG$20240701$$CN$US$US
240327601$24032760$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104247$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$126$KG$20240701$$PH$US$US
240327611$24032761$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103913$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$62.6$KG$20240701$$HP$US$US
240327621$24032762$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103844$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$85.28$KG$20240701$$CN$US$US
240327631$24032763$1$I$20240601$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102821$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240701$$HP$US$US
240327641$24032764$1$I$$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104094$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$66.68$KG$20240701$$CN$US$US
240327651$24032765$1$I$$20240624$20240701$20240701$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-104058$BRISTOL MYERS SQUIBB$Lin L, Houwink API, Van Dieren JM, Wolthuis EK, Van Thienen JV, Van der Heijden MS, et al. Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitors. Cancer Medicine. 2024 Jun 01;13(12):1-7. doi:10.1002/cam4.7302.$$$$$Y$$$20240701$$HP$NL$NL
240327661$24032766$1$I$20240501$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103534$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240701$$HP$US$US
240327671$24032767$1$I$$20240625$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102603$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240701$$HP$US$US
240327683$24032768$3$F$20231024$20240718$20240701$20240723$EXP$$US-CHATTEMPRD-2024OHG022136$CHATTEM$$77$YR$E$M$Y$$$20240723$$CN$US$US
240327691$24032769$1$I$20240625$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127359$AMGEN$$76$YR$E$M$Y$$$20240630$$CN$US$US
240327701$24032770$1$I$20240612$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103095$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$74.84$KG$20240701$$PH$US$US
240327713$24032771$3$F$20240621$20240716$20240701$20240718$PER$$US-AMGEN-USASP2024128339$AMGEN$$55$YR$A$F$Y$$$20240717$$CN$US$US
240327721$24032772$1$I$$20190330$20240701$20240701$PER$$US-CHATTEMPRD-2020SA372376$CHATTEM$$$$C$F$Y$$$20240701$$CN$US$US
240327731$24032773$1$I$$20240625$20240701$20240701$EXP$$US-AMGEN-USASP2024126050$AMGEN$$$$$F$Y$$$20240630$$CN$US$US
240327741$24032774$1$I$$20240624$20240701$20240701$PER$$US-AMGEN-USASP2024127255$AMGEN$Althoff A.; Rasouliyan L.. Switching From Anti-VEGF to Corticosteroid Implant Therapy in Diabetic Macular Edema Patients. Value in Health. 2024;27(6):S221$$$$$Y$$$20240630$$HP$US$US
240327761$24032776$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5819555$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240327771$24032777$1$I$$20231114$20240701$20240701$PER$$US-AMGEN-USASP2023235019$AMGEN$$$$$$Y$$$20240630$$PH$US$US
240327782$24032778$2$F$$20240715$20240701$20240716$PER$$US-AstraZeneca-2024A137024$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240327791$24032779$1$I$20240612$20240622$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009579$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240327801$24032780$1$I$$20240618$20240701$20240701$EXP$$US-SPECGX-T202401402$SPECGX$Yasir M, Gelaye AE. Rare case of resistant aspergillus niger invasive pulmonary aspergillosis. American Journal of Respiratory and Critical Care Medicine. 2024;209$70$YR$$F$Y$$$20240701$$HP$US$US
240327811$24032781$1$I$$20240626$20240701$20240701$EXP$$IL-NOVITIUMPHARMA-2024ILNVP01121$NOVITIUM PHARMA$Daniel L. Cohen.Predictors of Underlying Esophageal Motility Disorders in Patients Presenting with Esophageal Candidiasis.Southern Medical Journal.AUG-2023;116(8):701-706$34$YR$A$F$Y$$$20240701$$HP$IL$IL
240327821$24032782$1$I$20240611$20240624$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009674$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240327831$24032783$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05538$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240327841$24032784$1$I$$20240624$20240701$20240701$EXP$$PT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036012$BOEHRINGER INGELHEIM$PO-0303 - (4338) - DE MODIFICADOR DE PROGN?STICO A INDUTOR DE MORBILIDADE: GANGRENA DE FOURNIER SOB ISGLT2. Congressos da Sociedade Portuguesa de Medicina Interna: 30? Congresso Nacional de Medicina Interna - Livro de Resumos. 2024 May;668.$68$YR$E$M$Y$$$20240701$$HP$PT$PT
240327852$24032785$2$F$$20240712$20240701$20240718$EXP$$BE-AMGEN-BELSP2024126208$AMGEN$$$$$$Y$$$20240718$$MD$BE$BE
240327861$24032786$1$I$$20240626$20240701$20240701$EXP$$US-NOVITIUMPHARMA-2024USNVP01136$NOVITIUM PHARMA$Aruna Phekoo.USE OF ECULIZUMAB DURING PREGNANCY IN A PATIENT WITH C3GN.American Journal of Kidney Diseases.APR-2024;NA:S44$$$N$$Y$$$20240701$$HP$US$US
240327871$24032787$1$I$20230101$20240625$20240701$20240701$EXP$$US-PFIZER INC-202400200988$PFIZER$$47$YR$$F$Y$$$20240701$$HP$US$US
240327891$24032789$1$I$$20240625$20240701$20240701$EXP$$US-PFIZER INC-PV202400084704$PFIZER$$14$YR$$M$Y$$$20240701$$MD$US$US
240327901$24032790$1$I$$20240624$20240701$20240701$EXP$$US-ABBVIE-5815887$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240327911$24032791$1$I$$20240627$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103889$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$HP$US$US
240327921$24032792$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104335$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$78.02$KG$20240701$$CN$US$US
240327932$24032793$2$F$20230101$20240722$20240701$20240726$EXP$$NVSJ2024JP007704$NOVARTIS$$$$E$M$Y$$$20240726$$MD$JP$JP
240327941$24032794$1$I$20240101$20240619$20240701$20240701$PER$$US-SA-2024SA184956$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240701$$MD$US$US
240327951$24032795$1$I$$20240619$20240701$20240701$PER$$US-SA-2024SA184965$SANOFI AVENTIS$$$$E$F$Y$$$20240701$$MD$US$US
240327963$24032796$3$F$20240101$20240718$20240701$20240727$PER$$US-SA-2024SA187180$SANOFI AVENTIS$$49$YR$A$F$Y$68$KG$20240727$$MD$US$US
240327971$24032797$1$I$20240601$20240619$20240701$20240701$PER$$US-SA-2024SA185404$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240701$$MD$US$US
240327981$24032798$1$I$$20240619$20240701$20240701$PER$$US-SA-2024SA185956$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240701$$CN$US$US
240327992$24032799$2$F$$20240820$20240701$20240916$PER$$US-SA-2024SA188310$SANOFI AVENTIS$$$$T$F$Y$$$20240916$$MD$US$US
240328002$24032800$2$F$$20240917$20240701$20240924$PER$$US-SA-2024SA189384$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240924$$MD$US$US
240328012$24032801$2$F$20240601$20240717$20240701$20240726$PER$$US-SA-2024SA186747$SANOFI AVENTIS$$37$YR$A$F$Y$99.79$KG$20240726$$MD$US$US
240328022$24032802$2$F$20240601$20240912$20240701$20240917$PER$$US-SA-2024SA190857$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240918$$MD$US$US
240328031$24032803$1$I$20240101$20240502$20240701$20240701$PER$$US-TWI PHARMACEUTICAL, INC-2024SCTW000064$TWI PHARMACEUTICALS$$$$$$Y$$$20240624$$CN$US$US
240328041$24032804$1$I$20240621$20240624$20240701$20240701$PER$$US-SA-2024SA189117$SANOFI AVENTIS$$66$YR$E$M$Y$77$KG$20240701$$CN$US$US
240328051$24032805$1$I$20240601$20240624$20240701$20240701$PER$$US-SA-2024SA191629$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240701$$MD$US$US
240328061$24032806$1$I$20240402$20240624$20240701$20240701$EXP$$US-GSK-US2024078619$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$US$US
240328071$24032807$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA191314$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240701$$CN$US$US
240328081$24032808$1$I$20240624$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019359$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240701$$CN$US$US
240328091$24032809$1$I$20240523$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017553$ELI LILLY AND CO$$$$$M$Y$$$20240701$$CN$US$US
240328101$24032810$1$I$20240612$20240620$20240701$20240701$PER$$US-JNJFOC-20240656137$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$HP$US$US
240328111$24032811$1$I$20230920$20240614$20240701$20240701$PER$$US-009507513-2406USA005177$MERCK$$72$YR$$F$Y$$$20240701$$CN$US$US
240328121$24032812$1$I$$20240620$20240701$20240701$EXP$$CA-APOTEX-2024AP007597$APOTEX$$64$YR$$F$Y$$$20240701$$HP$CA$CA
240328131$24032813$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05492$LUPIN$$$$$$Y$$$20240701$$PH$US$US
240328141$24032814$1$I$20240624$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127311$AMGEN$$$$$$Y$$$20240630$$PH$US$US
240328151$24032815$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05540$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240328161$24032816$1$I$$20240625$20240701$20240701$EXP$$US-NOVITIUMPHARMA-2024USNVP01096$NOVITIUM PHARMA$A. Ryan.Cold and Confused: A Case of Suspected Adrenal Insufficiency After COVID-19.American Journal of Respiratory and Critical Care Medicine.20-MAY-2024;209:A3390$92$YR$E$F$Y$$$20240701$$HP$US$US
240328171$24032817$1$I$$20240604$20240701$20240701$PER$$US-AstraZeneca-2024A130124$ASTRAZENECA$$$$$$Y$$$20240701$$CN$US$
240328181$24032818$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127350$AMGEN$$$$$M$Y$$$20240630$$CN$US$US
240328191$24032819$1$I$20240521$20240625$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009763$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240328201$24032820$1$I$20230918$20240621$20240701$20240701$EXP$$DE-EMD Serono-2024011734$EMD SERONO INC$$27$YR$A$M$Y$127$KG$20240701$$MD$DE$DE
240328211$24032821$1$I$$20240622$20240701$20240701$PER$$US-AMGEN-USASP2024124354$AMGEN$Ukponmwan O.; Schattner G.; Curotto De La M. et al.. Persistence of Severe Asthma With a T2 Phenotype Following Stem-Cell Transplant. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A5299$58$YR$A$F$Y$$$20240630$$HP$US$US
240328222$24032822$2$F$20240101$20240708$20240701$20240717$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000563$DECIPHERA PHARMACEUTICALS$$65$YR$A$F$Y$$$20240717$$CN$US$US
240328232$24032823$2$F$$20240926$20240701$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103835$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240927$$CN$US$US
240328241$24032824$1$I$20240422$20240626$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103333$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240701$$HP$US$US
240328251$24032825$1$I$$20240619$20240701$20240701$EXP$$IL-NOVOPROD-1243514$NOVO NORDISK$$$$$M$Y$$$20240701$$CN$IL$IL
240328261$24032826$1$I$$20240619$20240701$20240701$EXP$$US-NOVOPROD-1243845$NOVO NORDISK$$$$$F$Y$$$20240701$$CN$US$US
240328271$24032827$1$I$$20240619$20240701$20240701$EXP$GB-MHRA-MED-202406191734586840-CQDWP$GB-NOVOPROD-1243934$NOVO NORDISK$$$$$M$Y$$$20240701$$CN$GB$GB
240328281$24032828$1$I$$20240619$20240701$20240701$EXP$$US-NOVOPROD-1244023$NOVO NORDISK$$$$E$F$Y$$$20240701$$HP$US$US
240328291$24032829$1$I$$20240620$20240701$20240701$EXP$$US-NOVOPROD-1244404$NOVO NORDISK$$$$A$$Y$$$20240701$$MD$US$US
240328301$24032830$1$I$$20240620$20240701$20240701$EXP$$CA-NOVOPROD-1243676$NOVO NORDISK$$$$A$F$Y$$$20240701$$MD$CA$CA
240328321$24032832$1$I$20240101$20240619$20240701$20240701$EXP$$US-NOVOPROD-1244100$NOVO NORDISK$$$$E$F$Y$$$20240701$$CN$US$US
240328331$24032833$1$I$$20240620$20240701$20240701$EXP$$US-NOVOPROD-1243719$NOVO NORDISK$$62$YR$$F$Y$$$20240701$$CN$US$US
240328341$24032834$1$I$$20240620$20240701$20240701$EXP$$US-NOVOPROD-1243721$NOVO NORDISK$$$$$M$Y$$$20240701$$CN$US$US
240328351$24032835$1$I$$20240620$20240701$20240701$EXP$$US-NOVOPROD-1243718$NOVO NORDISK$$$$$M$Y$$$20240701$$CN$US$US
240328361$24032836$1$I$$20240619$20240701$20240701$EXP$$US-NOVOPROD-1244097$NOVO NORDISK$$$$$M$Y$$$20240701$$CN$US$US
240328371$24032837$1$I$$20240619$20240701$20240701$EXP$$CA-NOVOPROD-1243438$NOVO NORDISK$$$$A$M$Y$$$20240701$$MD$CA$CA
240328381$24032838$1$I$20240301$20240619$20240701$20240701$EXP$$CA-NOVOPROD-1243673$NOVO NORDISK$$38$YR$$F$Y$$$20240701$$HP$CA$CA
240328392$24032839$2$F$20240616$20240809$20240701$20240820$EXP$$US-NOVOPROD-1244435$NOVO NORDISK$$88$YR$$M$Y$$$20240820$$CN$US$US
240328401$24032840$1$I$20240426$20240625$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009757$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240328412$24032841$2$F$$20240624$20240701$20240703$PER$$US-SMPA-2024SPA000076$SUNOVION$$$$$$Y$$$20240703$$CN$US$US
240328421$24032842$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432123$ACCORD$Yeates A, Monroe I, Ahmad F. Fungal Duo: A Case of Disseminated Histoplasmosis and Pneumocystis Pneumonia Competing for the Spotlight. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3575.$66$YR$E$M$Y$$$20240701$$MD$US$US
240328431$24032843$1$I$20231203$20240619$20240701$20240701$EXP$FR-AFSSAPS-BS2024000373$FR-Accord-431731$ACCORD$$29$YR$A$M$Y$77$KG$20240701$$MD$FR$FR
240328441$24032844$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432110$ACCORD$Viswanath P, Zhao H, Wayland J, Dean J, Heynekamp TR. Decoding the Enigma of Eosinophils in Pleural Fluid. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1945.$34$YR$A$M$Y$$$20240701$$MD$US$US
240328451$24032845$1$I$$20240620$20240701$20240701$EXP$$IN-Accord-431980$ACCORD$Puttaswamy R, Govindanayka P. Case Report of Methotrexate Induced Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2008. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2008.$45$YR$A$F$Y$$$20240701$$MD$IN$IN
240328461$24032846$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432105$ACCORD$Hammond TC, Channick CL, Favano T, Purbhoo M, Exley MA, Vandiver MS, et al. Persistent SARS-CoV-2 Viremia, COVID-19 Associated Acute Respiratory Distress Syndrome, Severe Coagulopathy and Massive Hemoptysis in a Renal Transplant Patient on Veno-Venous Extracorporeal Membrane Oxygenation. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5563. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5563.$26$YR$A$M$Y$$$20240701$$MD$US$US
240328471$24032847$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432133$ACCORD$Maldarelli ME, Grier WR. A Noxious Mimic - Pulmonary Nocardiosis Presenting as a Lung Mass in an Orthotopic Liver Transplant Patient. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2434.$72$YR$E$M$Y$$$20240701$$MD$US$US
240328481$24032848$1$I$$20240620$20240701$20240701$PER$$US-HALEON-2183288$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240328491$24032849$1$I$$20240625$20240701$20240701$EXP$$US-NOVITIUMPHARMA-2024USNVP01098$NOVITIUM PHARMA$L. Huang.The Unfortunate Trifecta: Tuberculosis, EBV, and CMV Induced Hemophagocytic Lymphohistiocytosis.American Journal of Respiratory and Critical Care Medicine.22-MAY-2024;209:A7416$52$YR$A$M$Y$$$20240701$$HP$US$US
240328501$24032850$1$I$$20240621$20240701$20240701$30DAY$$US-GSK-US2024078076$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240328511$24032851$1$I$20240101$20240626$20240701$20240701$EXP$$US-JNJFOC-20240671660$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240701$$CN$US$US
240328521$24032852$1$I$20240418$20240625$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009774$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240328531$24032853$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05535$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240328541$24032854$1$I$$20240620$20240701$20240701$EXP$$CA-APOTEX-2024AP007601$APOTEX$$$$$F$Y$$$20240701$$MD$CA$CA
240328551$24032855$1$I$$20240625$20240701$20240701$EXP$$PE-EMD Serono-2024034720$EMD SERONO INC$$11$YR$C$F$Y$$$20240701$$MD$PE$PE
240328561$24032856$1$I$$20240621$20240701$20240701$PER$$US-ABBVIE-5814184$ABBVIE$$$$$$Y$$$20240701$$CN$US$US
240328571$24032857$1$I$$20240624$20240701$20240701$PER$$US-AMGEN-USASP2024125231$AMGEN$Mccreary D. L.; Talon A.; Young K. et. al.. Acute Pulmonary Manifestations and Management of Idiopathic Inflammatory Myopathies. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A1972$61$YR$A$M$Y$$$20240630$$HP$US$US
240328581$24032858$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126510$AMGEN$Khattri S.; Hren M.G.; Guenin S.. Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease. Journal of the American Academy of Dermatology. 2024;91 (1):138-140$20$YR$A$$Y$$$20240630$$MD$US$US
240328591$24032859$1$I$20240623$20240623$20240701$20240701$PER$$US-AMGEN-USASP2024125091$AMGEN$$71$YR$E$M$Y$$$20240630$$CN$US$US
240328601$24032860$1$I$$20240619$20240701$20240701$EXP$$CN-WOCKHARDT LIMITED-2024WLD000022$WOCKHARDT$Lei M, Cao Y, Yuan M, Xiong J, He H. Case report: A case of bradycardia triggered by diarrhea.. Front Med (Lausanne). 2024$92$YR$$M$Y$$$20240627$$HP$CN$CN
240328611$24032861$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024126699$AMGEN$$$$$F$Y$$$20240630$$CN$US$US
240328621$24032862$1$I$20231218$20240625$20240701$20240701$EXP$$JP-009507513-2406JPN003572J$MERCK$$81$YR$$F$Y$36$KG$20240701$$PH$JP$JP
240328631$24032863$1$I$$20240624$20240701$20240701$EXP$$US-AMGEN-USASP2024128602$AMGEN$Abdelrahim M.; Esmail A.; Divatia M.K. et al.. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. Journal of Clinical Medicine. 2024;13 (11):3068$68$YR$E$M$Y$$$20240630$$HP$US$US
240328641$24032864$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024127421$AMGEN$$$$$$Y$$$20240630$$PH$US$US
240328651$24032865$1$I$20240101$20240617$20240701$20240701$EXP$$CN-SA-2024SA185862$SANOFI AVENTIS$$57$YR$A$F$Y$52$KG$20240701$$HP$CN$CN
240328661$24032866$1$I$$20240627$20240701$20240701$EXP$$JP-TAKEDA-2024TJP009774$TAKEDA$$7$DEC$$M$Y$$$20240701$$MD$JP$JP
240328671$24032867$1$I$20240321$20240621$20240701$20240701$EXP$FR-AFSSAPS-DJ2024000638$FR-SA-2024SA185123$SANOFI AVENTIS$$74$YR$E$M$Y$70.5$KG$20240701$$MD$FR$FR
240328691$24032869$1$I$$20240627$20240701$20240701$EXP$$US-GSK-US2024GSK080010$GLAXOSMITHKLINE$Reinsch N, Haq E, Ramakrishna K, Craft L. Cardiovascular Collapse Requiring Veno-Arterial Extracorporeal Membrane Oxygenation and Lidocaine: A Case of Massive Bupropion Overdose. Cureus. 2024;16(6)$$$$$Y$$$20240701$$MD$US$US
240328701$24032870$1$I$$20240626$20240701$20240701$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036475$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240701$$HP$CA$CA
240328711$24032871$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019666$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240701$$CN$US$US
240328721$24032872$1$I$20240601$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019759$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240328731$24032873$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019204$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240701$$CN$US$US
240328741$24032874$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019352$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240328751$24032875$1$I$20240627$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019495$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240701$$CN$US$US
240328761$24032876$1$I$$20240625$20240701$20240701$EXP$$US-JNJFOC-20240668673$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240701$$CN$US$US
240328771$24032877$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184387$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240328781$24032878$1$I$$20240627$20240701$20240701$EXP$$GB-ABBVIE-5821035$ABBVIE$$88$YR$$M$Y$$$20240701$$MD$GB$GB
240328791$24032879$1$I$$20240625$20240701$20240701$EXP$$CN-TAKEDA-2024TUS064039$TAKEDA$$$$$M$Y$$$20240701$$CN$CN$CN
240328812$24032881$2$F$20240527$20240711$20240701$20240926$PER$$US-TWI PHARMACEUTICAL, INC-2024SCTW000110$TWI PHARMACEUTICALS$$$$$$Y$$$20240916$$CN$US$US
240328821$24032882$1$I$20240501$20240606$20240701$20240701$PER$$US-TWI PHARMACEUTICAL, INC-2024SCTW000111$TWI PHARMACEUTICALS$$$$$$Y$$$20240625$$CN$US$US
240328832$24032883$2$F$20240514$20240715$20240701$20240722$EXP$$FR-AMGEN-FRASP2024126548$AMGEN$$76$YR$E$M$Y$$$20240721$$MD$FR$FR
240328843$24032884$3$F$20240322$20240725$20240701$20240807$30DAY$$US-JNJFOC-20240674074$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
240328851$24032885$1$I$20240101$20240625$20240701$20240701$PER$$US-SA-2024SA189904$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240701$$MD$US$US
240328861$24032886$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA189363$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240701$$MD$US$US
240328871$24032887$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA189369$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240701$$MD$US$US
240328881$24032888$1$I$20230101$20240123$20240701$20240701$PER$$US-APOTEX-2024AP001640$APOTEX$$$$A$M$Y$$$20240701$$CN$US$US
240328892$24032889$2$F$20240624$20240625$20240701$20240704$PER$$US-SA-2022SA024266$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240704$$MD$US$US
240328901$24032890$1$I$$20240627$20240701$20240701$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036876$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240701$$HP$US$US
240328911$24032891$1$I$20240612$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127306$AMGEN$$83$YR$E$M$Y$$$20240630$$CN$US$US
240328921$24032892$1$I$$20240624$20240701$20240701$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-101068$BRISTOL MYERS SQUIBB$Sherratt-Mayhew S, Nicolson PL. Use of IV immunoglobulin to treat steroid resistant, immune checkpoint inhibitor-induced pure red cell aplasia: a case report. eJHaem. 2024 Jan 01;1-4. doi:10.1002/jha2.937.$38$YR$A$F$Y$$$20240701$$HP$GB$GB
240328931$24032893$1$I$20170911$20240621$20240701$20240701$EXP$DE-EMA-DD-20210201-abdul_j-093839$DE-RDY-GER/GER/21/0133028$DR REDDYS$Ratuszny D, Skripuletz T, Wegner F, Gross M, Falk C, Jacobs R et al. Case Report: Daratumumab in a Patient With Severe Refractory Anti-NMDA Receptor Encephalitis. Frontiers in neurology. 2020;11:1-5. doi:10.3389/fneur.2020.602102$20$YR$A$F$Y$$$20240701$$HP$DE$DE
240328941$24032894$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05539$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240328951$24032895$1$I$20231224$20240624$20240701$20240701$EXP$$US-GSK-US2024078571$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$US$US
240328961$24032896$1$I$20240617$20240618$20240701$20240701$EXP$$GB-MSNLABS-2024MSNSPO01414$MSN LABORATORIES$$$$$$Y$$$20240701$$MD$GB$GB
240328973$24032897$3$F$20240501$20240820$20240701$20240830$EXP$$CA-ROCHE-10000009536$ROCHE$$76$YR$E$M$Y$$$20240830$$HP$CA$CA
240328983$24032898$3$F$20240601$20240716$20240701$20240724$PER$$US-AMGEN-USASP2024127287$AMGEN$$45$YR$A$F$Y$$$20240724$$CN$US$US
240328991$24032899$1$I$20240616$20240621$20240701$20240701$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158718$JIANGSU HENGRUI MEDICINE$$70$YR$$F$Y$66$KG$20240701$$MD$CN$CN
240329001$24032900$1$I$$20240501$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445642$RANBAXY$$$$A$M$Y$$$20240701$$MD$US$US
240329011$24032901$1$I$$20231230$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-426539$RANBAXY$$$$$F$Y$$$20240701$$CN$US$US
240329021$24032902$1$I$$20240411$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442633$RANBAXY$$$$$$Y$$$20240701$$HP$US$US
240329031$24032903$1$I$$20240209$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428369$RANBAXY$$$$$$Y$$$20240701$$HP$US$US
240329041$24032904$1$I$20240229$20240401$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-443092$RANBAXY$$21$YR$A$$Y$$$20240701$$PH$US$US
240329051$24032905$1$I$$20240515$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448184$RANBAXY$$$$$$Y$$$20240701$$HP$US$US
240329061$24032906$1$I$$20240304$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436691$RANBAXY$$$$$$Y$$$20240701$$PH$US$US
240329071$24032907$1$I$20240401$20240502$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445641$RANBAXY$$58$YR$A$$Y$$$20240701$$MD$US$US
240329082$24032908$2$F$$20240812$20240701$20240820$30DAY$$US-GSK-US2024078073$GLAXOSMITHKLINE$$$$$F$Y$$$20240820$$CN$US$US
240329092$24032909$2$F$$20240702$20240701$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05541$LUPIN$$$$$$Y$$$20240724$$CN$US$US
240329101$24032910$1$I$20240626$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024128100$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240329113$24032911$3$F$20240625$20240807$20240701$20240808$PER$$US-AMGEN-USASP2024126626$AMGEN$$72$YR$E$M$Y$$$20240808$$CN$US$US
240329121$24032912$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127510$AMGEN$$$$$F$Y$$$20240701$$MD$US$US
240329132$24032913$2$F$20240101$20240709$20240701$20240715$EXP$$FR-KYOWAKIRIN-2024KK015626$KYOWA$$$$$$Y$$$20240715$$MD$FR$FR
240329141$24032914$1$I$20240402$20240627$20240701$20240701$EXP$FR-AFSSAPS-GR2024000720$FR-HALEON-2184302$Haleon PLC$$17$YR$$F$Y$$$20240701$$MD$FR$FR
240329151$24032915$1$I$$20240627$20240701$20240701$PER$$US-JNJFOC-20240673854$JOHNSON AND JOHNSON$$42$YR$A$F$Y$49$KG$20240701$$CN$US$US
240329161$24032916$1$I$20240612$20240619$20240701$20240701$EXP$GB-MHRA-MED-202406181850594460-RFZHM$GB-MSNLABS-2024MSNSPO01417$MSN LABORATORIES$$$$$$Y$$$20240701$$CN$GB$GB
240329181$24032918$1$I$20240101$20240621$20240701$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-102944$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240701$$CN$JP$JP
240329191$24032919$1$I$20240619$20240625$20240701$20240701$EXP$$US-JNJFOC-20240668597$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240701$$CN$US$US
240329202$24032920$2$F$20240624$20240802$20240701$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103208$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240806$$CN$US$US
240329211$24032921$1$I$$20240619$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05895$HIKMA$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM.. Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316(6):279$75$YR$$M$Y$$$20240701$$MD$US$US
240329221$24032922$1$I$$20240619$20240701$20240701$EXP$$US-APOTEX-2024AP007624$APOTEX$Hussain M, Tiwana HZJ, Sivanandham R, Barsoum A, Bagheri S, Hussain S, et al.. Aripiprazole-Induced Diabetic Ketoacidosis and Hypertriglyceridemia Triggering Concurrent Pancreatitis: A Case Report. American Journal of Respiratory and Critical Care Medicine. 2024;209$35$YR$$M$Y$$$20240701$$HP$US$US
240329231$24032923$1$I$$20240621$20240701$20240701$EXP$$US-TAKEDA-2024TUS062524$TAKEDA$Hussain SA, Faisal H, Dy GK. Prolonged disease control despite alk inhibitor discontinuation in advanced alk-positive nsclc. European Journal of Case Reports In Internal Medicine. 2024;11$72$YR$$M$Y$$$20240701$$MD$US$US
240329241$24032924$1$I$20220101$20240621$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031314$AUROBINDO$$23$YR$$F$Y$$$20240701$$MD$FR$FR
240329252$24032925$2$F$20231001$20240710$20240701$20240716$EXP$$AU-AMGEN-AUSSP2024047326$AMGEN$$76$YR$E$F$Y$$$20240715$$MD$AU$AU
240329261$24032926$1$I$20240516$20240625$20240701$20240701$EXP$$US-AMGEN-USASP2024126483$AMGEN$$59$YR$A$F$Y$$$20240701$$CN$US$US
240329272$24032927$2$F$20240507$20240814$20240701$20240829$EXP$$US-GLK-002348$GLAUKOS$$31$YR$$F$Y$$$20240829$$MD$US$US
240329282$24032928$2$F$20240520$20240705$20240701$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-031304$AUROBINDO$$90$YR$$F$Y$$$20240715$$PH$FR$FR
240329291$24032929$1$I$20240621$20240622$20240701$20240701$EXP$$GB-AUROBINDO-AUR-APL-2024-031369$AUROBINDO$$27$YR$$F$Y$$$20240701$$CN$GB$GB
240329301$24032930$1$I$$20230309$20240701$20240701$PER$$US-ADVANZ PHARMA-202303009318$ADVANZ PHARMA$$$$$$Y$$$20240701$$CN$US$US
240329311$24032931$1$I$$20240620$20240701$20240701$EXP$$JP-BEH-2024174333$CSL BEHRING$$4$DEC$A$M$Y$40$KG$20240701$$MD$JP$JP
240329321$24032932$1$I$$20240617$20240701$20240701$EXP$$CA-INTERCEPT-PM2023000024$INTERCEPT PHARMACEUTICALS$$52$YR$$F$Y$$$20240701$$CN$CA$CA
240329334$24032933$4$F$20240501$20240802$20240701$20240813$EXP$$CA-INTERCEPT-PM2024001021$INTERCEPT PHARMACEUTICALS$$79$YR$$F$Y$$$20240813$$PH$CA$CA
240329341$24032934$1$I$20240626$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019466$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240701$$CN$US$US
240329351$24032935$1$I$20240621$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019290$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240701$$CN$US$US
240329361$24032936$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019491$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240329371$24032937$1$I$20240501$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018230$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240329381$24032938$1$I$20240619$20240625$20240701$20240701$EXP$$US-TAKEDA-2024TUS064860$TAKEDA$$68$YR$$F$Y$$$20240701$$CN$US$US
240329391$24032939$1$I$$20240621$20240701$20240701$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00588$CATALYST PHARMA$$$$$M$Y$131.52$KG$20240701$$CN$US$US
240329402$24032940$2$F$20230101$20240711$20240701$20240718$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00587$CATALYST PHARMA$$$$$F$Y$54$KG$20240718$$CN$US$US
240329411$24032941$1$I$20231124$20240621$20240701$20240701$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-23-00720$CATALYST PHARMA$$66$YR$$F$Y$$$20240701$$CN$US$US
240329425$24032942$5$F$$20240919$20240701$20240926$EXP$$US-BEH-2024173996$CSL BEHRING$$$$A$M$Y$$$20240926$$HP$US$US
240329431$24032943$1$I$20240619$20240622$20240701$20240701$EXP$$GB-AUROBINDO-AUR-APL-2024-031378$AUROBINDO$$20$YR$$M$Y$$$20240701$$CN$GB$GB
240329441$24032944$1$I$$20240628$20240701$20240701$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-104262$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$55$KG$20240701$$MD$IT$IT
240329451$24032945$1$I$20240609$20240621$20240701$20240701$EXP$$IT-AUROBINDO-AUR-APL-2024-031320$AUROBINDO$$40$YR$$F$Y$$$20240701$$MD$IT$IT
240329461$24032946$1$I$$20240623$20240701$20240701$EXP$$GB-AUROBINDO-AUR-APL-2024-031447$AUROBINDO$$$$$F$Y$$$20240701$$CN$GB$GB
240329471$24032947$1$I$20240601$20240620$20240701$20240701$EXP$$US-UCBSA-2024032063$UCB$$6$YR$$F$Y$$$20240701$$CN$US$US
240329481$24032948$1$I$$20240619$20240701$20240701$PER$$US-ROCHE-10000012085$ROCHE$$5$YR$C$F$Y$$$20240701$$MD$US$US
240329491$24032949$1$I$$20240619$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100086$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$PH$US$US
240329501$24032950$1$I$20240625$20240628$20240701$20240701$PER$$US-JNJFOC-20240678001$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240701$$CN$US$US
240329511$24032951$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05490$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240329521$24032952$1$I$$20240620$20240701$20240701$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000559$DECIPHERA PHARMACEUTICALS$$61$YR$A$M$Y$$$20240701$$CN$US$US
240329541$24032954$1$I$20240101$20240624$20240701$20240701$EXP$$US-AMGEN-USASP2024125400$AMGEN$$79$YR$E$F$Y$39.9$KG$20240701$$HP$US$US
240329551$24032955$1$I$$20240619$20240701$20240701$EXP$$US-APOTEX-2024AP007692$APOTEX$Huang J, Shehzad D, Ahmed I, Yu JC. Recognizing Veno-occlusive Disease After Inotuzumab Treatment: An Urgent Call to Physicians in Non-Transplant Centers. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-4$47$YR$$F$Y$$$20240701$$HP$US$US
240329561$24032956$1$I$$20240624$20240701$20240701$PER$$US-AMGEN-USASP2024124932$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240329571$24032957$1$I$$20240621$20240701$20240701$EXP$$US-UCBSA-2024033014$UCB$$$$$M$Y$$$20240701$$CN$US$US
240329582$24032958$2$F$$20240624$20240701$20240709$PER$$US-ROCHE-10000009626$ROCHE$Baran M, Ozgenc F, Berk O, et al. Giant cell hepatitis and autoimmune hemolytic anemia after chickenpox.. Turk J Gastroenterol. 2010;21 (4):448-51.$3$MON$I$$Y$$$20240709$$HP$US$US
240329591$24032959$1$I$$20240620$20240701$20240701$PER$$US-ROCHE-10000010160$ROCHE$$$$A$M$Y$$$20240701$$CN$US$US
240329601$24032960$1$I$$20240620$20240701$20240701$EXP$GB-MHRA-MED-202406201500457000-DRMVG$GB-NOVOPROD-1244640$NOVO NORDISK$$$$$M$Y$$$20240701$$CN$GB$GB
240329611$24032961$1$I$$20240619$20240701$20240701$EXP$$US-NOVOPROD-1244437$NOVO NORDISK$$$$A$F$Y$$$20240701$$CN$US$US
240329622$24032962$2$F$$20240806$20240701$20240814$30DAY$$AU-NOVOPROD-1240452$NOVO NORDISK$$$$$$Y$$$20240814$$CN$AU$AU
240329631$24032963$1$I$$20240620$20240701$20240701$EXP$$US-NOVOPROD-1244471$NOVO NORDISK$$$$A$F$Y$$$20240701$$CN$US$US
240329641$24032964$1$I$$20240620$20240701$20240701$EXP$$US-NOVOPROD-1244568$NOVO NORDISK$$$$$$Y$$$20240701$$HP$US$US
240329651$24032965$1$I$20220101$20240619$20240701$20240701$EXP$$US-NOVOPROD-1244613$NOVO NORDISK$$65$YR$$M$Y$$$20240701$$CN$US$US
240329661$24032966$1$I$$20240620$20240701$20240701$EXP$$US-NOVOPROD-1244441$NOVO NORDISK$$$$A$F$Y$$$20240701$$CN$US$US
240329671$24032967$1$I$20240101$20240619$20240701$20240701$EXP$$US-NOVOPROD-1244854$NOVO NORDISK$$$$A$F$Y$$$20240701$$CN$US$US
240329681$24032968$1$I$$20240620$20240701$20240701$EXP$$US-NOVOPROD-1245254$NOVO NORDISK$$$$$F$Y$$$20240701$$CN$US$US
240329693$24032969$3$F$$20240814$20240701$20240822$EXP$$EG-NOVOPROD-1244144$NOVO NORDISK$$408$MON$$M$Y$$$20240822$$CN$EG$EG
240329701$24032970$1$I$$20240620$20240701$20240701$EXP$$US-NOVOPROD-1244521$NOVO NORDISK$$$$$F$Y$$$20240701$$CN$US$US
240329711$24032971$1$I$$20240620$20240701$20240701$EXP$$US-NOVOPROD-1244834$NOVO NORDISK$$$$$F$Y$$$20240701$$CN$US$US
240329721$24032972$1$I$$20240620$20240701$20240701$EXP$$IL-NOVOPROD-1244644$NOVO NORDISK$$$$$M$Y$$$20240701$$CN$IL$IL
240329731$24032973$1$I$$20240620$20240701$20240701$EXP$$US-NOVOPROD-1244825$NOVO NORDISK$$$$A$F$Y$$$20240701$$CN$US$US
240329741$24032974$1$I$20240501$20240620$20240701$20240701$EXP$$US-NOVOPROD-1244612$NOVO NORDISK$$55$YR$$F$Y$115.65$KG$20240701$$CN$US$US
240329751$24032975$1$I$$20240619$20240701$20240701$EXP$$JP-NOVOPROD-1245157$NOVO NORDISK$$62$YR$$M$Y$$$20240701$$CN$JP$JP
240329761$24032976$1$I$20240614$20240620$20240701$20240701$EXP$GB-MHRA-MED-202406201227523860-BSKDM$GB-NOVOPROD-1244642$NOVO NORDISK$$36$YR$$F$Y$83$KG$20240701$$CN$GB$GB
240329771$24032977$1$I$$20240620$20240701$20240701$EXP$$US-NOVOPROD-1244837$NOVO NORDISK$$$$$F$Y$$$20240701$$CN$US$US
240329785$24032978$5$F$20240701$20240812$20240701$20240819$EXP$$EG-NOVOPROD-1245573$NOVO NORDISK$$$$$F$Y$65$KG$20240819$$CN$EG$EG
240329793$24032979$3$F$20240610$20240815$20240701$20240816$PER$$US-ROCHE-10000009924$ROCHE$$26$YR$A$M$Y$$$20240816$$CN$US$US
240329801$24032980$1$I$$20240620$20240701$20240701$PER$$US-ROCHE-10000011368$ROCHE$$$$C$M$Y$$$20240701$$CN$US$US
240329811$24032981$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127480$AMGEN$$$$$M$Y$$$20240701$$MD$US$US
240329822$24032982$2$F$20240628$20240628$20240701$20240705$PER$$US-AMGEN-USASP2024128966$AMGEN$$80$YR$E$M$Y$$$20240704$$CN$US$US
240329851$24032985$1$I$20240418$20240619$20240701$20240701$EXP$FR-AFSSAPS-TS2024000703$FR-Accord-431715$ACCORD$$63$YR$A$F$Y$$$20240701$$MD$FR$FR
240329861$24032986$1$I$$20240626$20240701$20240701$EXP$$JP-GSK-JP2024080531$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$JP$JP
240329871$24032987$1$I$$20240617$20240701$20240701$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05500$LUPIN$Dumais MG, Wengenack NL, Norgan AP, Amin S, Sia IG, Rhee PC, et al. Toto, we^re not in Kansas anymore: First reported case of M. persicum septic arthritis. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2023;31:100352$59$YR$$F$Y$$$20240701$$HP$US$US
240329881$24032988$1$I$$20240628$20240701$20240701$PER$$NVSC2024US135838$NOVARTIS$$$$$$Y$$$20240701$$PH$US$US
240329891$24032989$1$I$20240201$20240612$20240701$20240701$30DAY$$GB-JNJFOC-20240637015$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240701$$HP$GB$GB
240329902$24032990$2$F$20240226$20240702$20240701$20240709$PER$$US-ROCHE-10000011284$ROCHE$$38$YR$A$M$Y$88.45$KG$20240705$$CN$US$US
240329912$24032991$2$F$20240612$20240705$20240701$20240710$PER$$US-ROCHE-10000010486$ROCHE$$52$YR$A$M$Y$$$20240710$$CN$US$US
240329932$24032993$2$F$$20240731$20240701$20240807$30DAY$$US-GSK-US2024078092$GLAXOSMITHKLINE$$$$$M$Y$$$20240807$$CN$US$US
240329942$24032994$2$F$$20240624$20240701$20240708$PER$$US-ROCHE-10000009869$ROCHE$Unal S, Kuskonmaz B B. Autoimmune hemolytic anemia and giant cell hepatitis: Report of three infants.. Turk J Haematol. 2010;27:308-13. doi:10.1016/j.clinre.2024.102392.$2$MON$I$$Y$$$20240709$$HP$US$US
240329961$24032996$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019487$ELI LILLY AND CO$$$$A$M$Y$$$20240701$$CN$US$US
240329971$24032997$1$I$20240621$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019211$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240701$$CN$US$US
240329981$24032998$1$I$20240619$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019289$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240701$$CN$US$US
240329991$24032999$1$I$$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018774$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240701$$CN$US$US
240330001$24033000$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019291$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240330012$24033001$2$F$$20240620$20240701$20240704$PER$$US-ROCHE-10000012305$ROCHE$$34$YR$A$F$Y$$$20240704$$HP$US$US
240330031$24033003$1$I$20200101$20240624$20240701$20240701$EXP$$US-SHIRE-US202019319$TAKEDA$$59$YR$$F$Y$$$20240701$$HP$US$US
240330042$24033004$2$F$$20240626$20240701$20240704$EXP$$IT-ORGANON-O2406ITA002636$ORGANON$$$$$F$Y$$$20240704$$MD$IT$IT
240330051$24033005$1$I$20240619$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126377$AMGEN$$82$YR$E$M$Y$$$20240701$$CN$US$US
240330061$24033006$1$I$$20240619$20240701$20240701$EXP$$US-APOTEX-2024AP007711$APOTEX$Santosh N, Savani S, Iskapalli S.. Beefing Up! Fulminant Liver Failure Secondary to Anabolic Steroid Use. American Journal of Respiratory and Critical Care Medicine. 2024;209 (0):A5688$30$YR$$M$Y$$$20240701$$HP$US$US
240330071$24033007$1$I$20240627$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024127716$AMGEN$$85$YR$E$M$Y$$$20240701$$CN$US$US
240330081$24033008$1$I$20240625$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024128432$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240330091$24033009$1$I$$20240109$20240701$20240701$PER$$US-AMGEN-USASP2024127405$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240330102$24033010$2$F$$20240823$20240701$20240827$PER$$US-AMGEN-USASP2024127489$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
240330111$24033011$1$I$20240603$20240621$20240701$20240701$EXP$$IT-AUROBINDO-AUR-APL-2024-031302$AUROBINDO$$42$YR$$M$Y$$$20240701$$MD$IT$IT
240330121$24033012$1$I$20240613$20240621$20240701$20240701$EXP$$IT-AUROBINDO-AUR-APL-2024-031202$AUROBINDO$$64$YR$$F$Y$43$KG$20240701$$MD$IT$IT
240330131$24033013$1$I$$20240627$20240701$20240701$PER$$US-AstraZeneca-2024A149052$ASTRAZENECA$$$$$M$Y$$$20240701$$HP$US$
240330141$24033014$1$I$$20240620$20240701$20240701$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000558$DECIPHERA PHARMACEUTICALS$$73$YR$E$M$Y$$$20240701$$CN$US$US
240330151$24033015$1$I$20221204$20240624$20240701$20240701$EXP$$FR-CELLTRION INC.-2024FR015496$CELLTRION$$$$$$Y$$$20240701$$MD$FR$FR
240330162$24033016$2$F$$20240830$20240701$20240903$EXP$$NVSC2024US134701$NOVARTIS$$$$$F$Y$$$20240904$$HP$US$US
240330171$24033017$1$I$20190119$20240621$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100758$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240701$$CN$US$US
240330181$24033018$1$I$20240523$20240621$20240701$20240701$EXP$FR-AFSSAPS-AN2024000777$FR-TEVA-VS-3213084$TEVA$$78$YR$$M$Y$72$KG$20240701$$PH$FR$FR
240330191$24033019$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104154$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240701$$MD$US$US
240330202$24033020$2$F$$20240628$20240701$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05316$LUPIN$$$$$$Y$$$20240716$$CN$US$US
240330213$24033021$3$F$20240109$20240701$20240701$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-031303$AUROBINDO$$78$YR$$F$Y$45.8$KG$20240710$$MD$FR$FR
240330221$24033022$1$I$20240601$20240626$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103735$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$96.2$KG$20240701$$PH$US$US
240330231$24033023$1$I$20240617$20240617$20240701$20240701$EXP$$CA-ROCHE-10000002487$ROCHE$$103$YR$E$F$Y$$$20240701$$HP$CA$CA
240330243$24033024$3$F$20240726$20240730$20240701$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002607$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240822$$HP$US$US
240330251$24033025$1$I$20240606$20240607$20240701$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002739$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240701$$CN$US$US
240330261$24033026$1$I$$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024127502$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240330272$24033027$2$F$20240526$20240724$20240701$20240725$EXP$FR-AFSSAPS-RN2024000701$FR-JNJFOC-20240676251$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240726$$MD$FR$FR
240330282$24033028$2$F$$20240722$20240701$20240724$PER$$US-AMGEN-USASP2024127364$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
240330291$24033029$1$I$20240101$20240624$20240701$20240701$EXP$$HR-CELLTRION INC.-2024HR015528$CELLTRION$$$$$$Y$$$20240701$$MD$HR$HR
240330301$24033030$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05447$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240330311$24033031$1$I$$20240626$20240701$20240701$EXP$$US-ROCHE-10000011702$ROCHE$$$$$$Y$$$20240701$$PH$US$US
240330323$24033032$3$F$$20240725$20240701$20240726$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036883$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240726$$CN$US$US
240330332$24033033$2$F$20240622$20240624$20240701$20240703$PER$$US-SA-2024SA189357$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240703$$MD$US$US
240330341$24033034$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186197$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240701$$CN$US$US
240330351$24033035$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA187301$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240701$$CN$US$US
240330361$24033036$1$I$$20240623$20240701$20240701$PER$$US-SA-2024SA188046$SANOFI AVENTIS$$$$A$F$Y$49.4$KG$20240701$$MD$US$US
240330371$24033037$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186424$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240701$$CN$US$US
240330381$24033038$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA191959$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$MD$US$US
240330391$24033039$1$I$20220414$20240625$20240701$20240701$EXP$GB-MHRA-ADR 28164867$GB-CHEPLA-1300052882$CHEPLAPHARM$$78$YR$$F$Y$$$20240701$$MD$COUNTRY NOT SPECIFIED$GB
240330401$24033040$1$I$20240603$20240624$20240701$20240701$EXP$$CN-ROCHE-10000008369$ROCHE$$35$YR$A$M$Y$$$20240701$$HP$CN$CN
240330412$24033041$2$F$20240601$20240724$20240701$20240729$EXP$$JP-009507513-2406JPN003718J$MERCK$$60$YR$$F$Y$$$20240729$$MD$JP$JP
240330421$24033042$1$I$20240625$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024128152$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240330431$24033043$1$I$20231215$20240618$20240701$20240701$EXP$FR-AFSSAPS-TO2024001000$FR-SA-2024SA188155$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240701$$PH$FR$FR
240330441$24033044$1$I$$20231210$20240701$20240701$PER$$US-AMGEN-USASP2023234988$AMGEN$$$$$$Y$$$20240701$$MD$US$US
240330451$24033045$1$I$20240519$20240621$20240701$20240701$EXP$$GB-AUROBINDO-AUR-APL-2024-031399$AUROBINDO$$36$YR$$F$Y$$$20240701$$CN$GB$GB
240330463$24033046$3$F$$20240624$20240701$20240709$PER$$US-ROCHE-10000011316$ROCHE$$41$YR$A$F$Y$$$20240708$$MD$US$US
240330471$24033047$1$I$$20240624$20240701$20240701$EXP$$US-TEVA-VS-3213977$TEVA$$22$YR$$F$Y$$$20240701$$CN$US$US
240330481$24033048$1$I$$20240621$20240701$20240701$PER$$US-JNJFOC-20240658839$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240701$$CN$US$US
240330493$24033049$3$F$20230801$20240921$20240701$20240930$EXP$$CA-CELLTRION INC.-2022CA011348$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
240330501$24033050$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05491$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240330511$24033051$1$I$20240620$20240624$20240701$20240701$EXP$$US-BEH-2024174583$CSL BEHRING$$74$YR$E$M$Y$$$20240701$$HP$US$US
240330521$24033052$1$I$20240607$20240621$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031316$AUROBINDO$$82$YR$$M$Y$85$KG$20240701$$PH$FR$FR
240330531$24033053$1$I$$20240607$20240701$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002766$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
240330542$24033054$2$F$20240626$20240626$20240701$20240710$PER$$US-AMGEN-USASP2024127317$AMGEN$$79$YR$E$F$Y$$$20240709$$CN$US$US
240330551$24033055$1$I$$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024127555$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240330561$24033056$1$I$20240624$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127208$AMGEN$$72$YR$E$F$Y$$$20240701$$CN$US$US
240330571$24033057$1$I$$20240621$20240701$20240701$30DAY$$US-GSK-US2024AMR078490$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$US$US
240330581$24033058$1$I$20240626$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018285$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240701$$CN$US$US
240330591$24033059$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019497$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240701$$CN$US$US
240330601$24033060$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019187$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240701$$CN$US$US
240330611$24033061$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019475$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240701$$CN$US$US
240330621$24033062$1$I$20240601$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019220$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240701$$CN$US$US
240330631$24033063$1$I$20240626$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019652$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240701$$CN$US$US
240330641$24033064$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019095$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240701$$CN$US$US
240330651$24033065$1$I$$20240621$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406015795$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240330661$24033066$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019664$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240701$$CN$US$US
240330671$24033067$1$I$$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018908$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240701$$CN$US$US
240330681$24033068$1$I$20240626$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019188$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240701$$CN$US$US
240330691$24033069$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019222$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240701$$CN$US$US
240330701$24033070$1$I$20240427$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019520$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240701$$CN$US$US
240330711$24033071$1$I$$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019680$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240701$$CN$US$US
240330721$24033072$1$I$20240601$20240621$20240701$20240701$EXP$$US-GSK-US2024078021$GLAXOSMITHKLINE$$83$YR$$F$Y$$$20240701$$CN$US$US
240330731$24033073$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104259$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240701$$PH$US$US
240330741$24033074$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05536$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240330752$24033075$2$F$$20240704$20240701$20240705$EXP$$US-CIPLA LTD.-2024US06576$CIPLA$$$$$$Y$$$20240705$$CN$US$US
240330761$24033076$1$I$$20240607$20240701$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002767$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
240330772$24033077$2$F$20180801$20240709$20240701$20240711$EXP$$JP-TAKEDA-2024TJP006952$TAKEDA$$81$YR$$M$Y$$$20240711$$MD$JP$JP
240330781$24033078$1$I$$20240617$20240701$20240701$EXP$$GB-CIPLA LTD.-2024GB06531$CIPLA$$$$$$Y$$$20240701$$CN$GB$GB
240330791$24033079$1$I$20240619$20240622$20240701$20240701$PER$$US-ROCHE-10000010161$ROCHE$$35$YR$A$M$Y$$$20240701$$CN$US$US
240330801$24033080$1$I$$20240621$20240701$20240701$PER$$US-ROCHE-10000008984$ROCHE$$$$A$F$Y$$$20240701$$HP$US$US
240330811$24033081$1$I$$20230621$20240701$20240701$PER$$US-AMGEN-USASP2023234986$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240330821$24033082$1$I$$20240624$20240701$20240701$EXP$$US-GSK-US2024AMR079019$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$US$US
240330831$24033083$1$I$20240505$20240621$20240701$20240701$EXP$ES-AEMPS-1538238$ES-AMAROX PHARMA-AMR2024ES01948$HETERO$$90$YR$$M$Y$$$20240701$$PH$ES$ES
240330843$24033084$3$F$$20240621$20240701$20240712$PER$$US-ROCHE-10000011367$ROCHE$$4$YR$C$M$Y$$$20240712$$CN$US$US
240330851$24033085$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024128297$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240330861$24033086$1$I$20240625$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024126559$AMGEN$$86$YR$E$M$Y$$$20240701$$HP$US$US
240330872$24033087$2$F$$20240704$20240701$20240707$EXP$$DE-ROCHE-10000007126$ROCHE$Philipp A, Piseddu I, Jochheim L, Boettcher K, Scheiner B, Sinner F, et al. Early mortality in atezolizumab/bevacizumab for unresectable hepatocellular carcinoma: European, real-world study. Zeitschrift fur Gastroenterologie. 2024-May;62 (5):e447-8. doi:10.1055/s-0044-1785613.$$$$$Y$$$20240707$$HP$DE$DE
240330881$24033088$1$I$$20240627$20240701$20240701$PER$$US-ROCHE-10000011854$ROCHE$$$$$$Y$$$20240701$$PH$US$US
240330892$24033089$2$F$$20240702$20240701$20240708$EXP$GB-TAKEDA-2024TUS059568$GB-RDY-SPO/GBR/24/0009200$DR REDDYS$$$$$M$Y$$$20240708$$CN$GB$GB
240330901$24033090$1$I$20240525$20240628$20240701$20240701$EXP$FR-AFSSAPS-MP2024001098$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-104156$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240701$$MD$FR$FR
240330912$24033091$2$F$20230701$20240808$20240701$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104173$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$79.83$KG$20240813$$CN$US$US
240330922$24033092$2$F$20230301$20240625$20240701$20240703$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-009832$JAZZ$$24$YR$$F$Y$$$20240703$$CN$US$US
240330933$24033093$3$F$20231001$20240827$20240701$20240830$EXP$$JP-TAKEDA-2024TJP009741$TAKEDA$$13$YR$$M$Y$$$20240830$$MD$JP$JP
240330941$24033094$1$I$20200110$20240617$20240701$20240701$EXP$PL-URPL-1-1205-2020$PL-SERVIER-S20014481$SERVIER$$$$$$Y$$$20240701$$MD$PL$PL
240330961$24033096$1$I$$20240627$20240701$20240701$PER$$US-GILEAD-2024-0678888$GILEAD$$52$YR$A$M$Y$$$20240701$$CN$US$US
240330971$24033097$1$I$$20240624$20240701$20240701$PER$$US-ABBVIE-5817829$ABBVIE$$$$$$Y$$$20240701$$HP$US$US
240330982$24033098$2$F$$20240628$20240701$20240703$PER$$NVSC2024US135824$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240330992$24033099$2$F$20230511$20240711$20240701$20240718$EXP$$US-009507513-2406USA009157$MERCK$$46$YR$$M$Y$$$20240718$$HP$US$US
240331011$24033101$1$I$20231101$20240627$20240701$20240701$PER$$US-JNJFOC-20240675216$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240701$$MD$US$US
240331021$24033102$1$I$$20240621$20240701$20240701$PER$$US-JNJFOC-20240659200$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$US$US
240331032$24033103$2$F$20240410$20240709$20240701$20240723$30DAY$$US-JNJFOC-20240623790$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
240331041$24033104$1$I$20240612$20240624$20240701$20240701$EXP$$MA-JNJFOC-20240672155$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$MD$MA$MA
240331051$24033105$1$I$$20240626$20240701$20240701$PER$$US-JNJFOC-20240671730$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$US$US
240331061$24033106$1$I$$20240625$20240701$20240701$PER$$US-JNJFOC-20240666334$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$US$US
240331073$24033107$3$F$20240101$20240912$20240701$20240920$EXP$$CA-CELLTRION INC.-2024CA013370$CELLTRION$$$$$$Y$$$20240920$$MD$CA$CA
240331081$24033108$1$I$$20240620$20240701$20240701$PER$$US-ROCHE-10000011184$ROCHE$$35$YR$A$F$Y$$$20240701$$CN$US$US
240331093$24033109$3$F$$20240718$20240701$20240721$EXP$$JP-TAKEDA-2024TJP009736$TAKEDA$$9$DEC$$M$Y$$$20240721$$MD$JP$JP
240331101$24033110$1$I$$20240618$20240701$20240701$EXP$$GB-ROCHE-10000001652$ROCHE$$$$$$Y$$$20240701$$MD$GB$GB
240331122$24033112$2$F$$20240703$20240701$20240712$EXP$$TR-TEVA-VS-3213925$TEVA$Kilicaslan E, Canoglu K. Management of Latent Tuberculosis Infection Based on T-SPOT.TB Assay in Patients with Hematological Malignancies. Mediterr-J-Hematol-Infect-Dis 2023; 15 (1):.; Kilicaslan E, Canoglu K. Management of Latent Tuberculosis Infection Based on T-SPOT.TB Assay in Patients with Hematological Malignancies. Mediterr-J-Hematol-Infect-Dis 2023; 15 (1):.$$$$$Y$$$20240712$$HP$TR$TR
240331131$24033113$1$I$$20240618$20240701$20240701$EXP$$CL-ROCHE-10000003251$ROCHE$$$$$F$Y$$$20240701$$CN$CL$CL
240331141$24033114$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127920$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240331151$24033115$1$I$$20230710$20240701$20240701$PER$$US-AMGEN-USASP2024129459$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240331161$24033116$1$I$$20240620$20240701$20240701$PER$$US-ROCHE-10000011036$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240331171$24033117$1$I$20240530$20240621$20240701$20240701$EXP$$JP-AMGEN-JPNSP2024124418$AMGEN$$20$YR$A$F$Y$$$20240701$$MD$JP$JP
240331182$24033118$2$F$20231230$20240821$20240701$20240828$EXP$$JP-GENMAB-2024-02191$GENMAB$$54$YR$$F$Y$$$20240828$$MD$JP$JP
240331191$24033119$1$I$20240416$20240701$20240701$20240701$EXP$FR-AFSSAPS-CN2024000636$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036906$BOEHRINGER INGELHEIM$$68$YR$A$M$Y$90.5$KG$20240701$$MD$FR$FR
240331202$24033120$2$F$$20240628$20240701$20240701$PER$$US-JNJFOC-20240671763$JOHNSON AND JOHNSON$$$$$F$Y$112$KG$20240701$$CN$US$US
240331211$24033121$1$I$$20240628$20240701$20240701$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036837$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240701$$HP$US$US
240331221$24033122$1$I$$20240624$20240701$20240701$EXP$$US-UCBSA-2024032317$UCB$$$$$F$Y$$$20240701$$HP$US$US
240331231$24033123$1$I$$20240624$20240701$20240701$PER$$US-ROCHE-10000010937$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240331241$24033124$1$I$$20240625$20240701$20240701$EXP$$GB-HALEON-2183940$Haleon PLC$$$$$F$Y$$$20240701$$CN$GB$GB
240331261$24033126$1$I$$20240418$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05711$HIKMA$Hafiz S, Abu Hassan F, Afroze T, McMaster K.. Hafiz S, Abu Hassan F, Afroze T, McMaster K. Hypersensitivity reaction and pulmonary edema from heparin allergy.. American Journal of the Medical Sciences.. 10.1;S53:367(Supplement 1)$$$$$Y$$$20240701$$MD$US$US
240331271$24033127$1$I$$20240624$20240701$20240701$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001297$BLUEPRINT MEDICINES$$$$$M$Y$$$20240701$$CN$US$US
240331281$24033128$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018608$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240701$$CN$US$US
240331292$24033129$2$F$$20240822$20240701$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103455$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240824$$CN$US$US
240331301$24033130$1$I$$20240624$20240701$20240701$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001298$BLUEPRINT MEDICINES$$$$$M$Y$$$20240701$$CN$US$US
240331311$24033131$1$I$$20240610$20240701$20240701$30DAY$$US-JNJFOC-20240624709$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240331321$24033132$1$I$20240618$20240619$20240701$20240701$PER$$US-IGSA-BIG0029567$GRIFOLS$$78$YR$$M$Y$79.365$KG$20240701$$HP$US$US
240331332$24033133$2$F$20240101$20240906$20240701$20240918$EXP$$US-UCBSA-2024017398$UCB$$$$$F$Y$86.168$KG$20240918$$HP$US$US
240331341$24033134$1$I$$20240621$20240701$20240701$EXP$$CA-APOTEX-2024AP007681$APOTEX$$72$YR$$F$Y$$$20240701$$MD$CA$CA
240331351$24033135$1$I$$20240621$20240701$20240701$PER$$US-ABBVIE-5816038$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240331361$24033136$1$I$20240522$20240607$20240701$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002759$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240701$$CN$US$US
240331372$24033137$2$F$20200101$20240719$20240701$20240808$PER$$US-TEVA-VS-3211664$TEVA$$$$$M$Y$$$20240808$$CN$US$US
240331381$24033138$1$I$20231201$20240627$20240701$20240701$EXP$$FR-AFSSAPS-RE2024000052$Haleon PLC$$54$YR$$F$Y$93$KG$20240701$$MD$FR$FR
240331401$24033140$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104517$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240701$$PH$US$US
240331411$24033141$1$I$$20240620$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05754$HIKMA$Akingbemi W, Kurtz G, Yegya-Raman N, Plastaras JP, Schuster SJ, Chong EA.. Akingbemi W, Kurtz G, Yegya-Raman N, Plastaras JP, Schuster SJ, Chong EA. Stereotactic radiotherapy and CART for treatment of secondary CNS lymphoma.. Leukemia and Lymphoma. 2024;65(6):860-863$78$YR$$M$Y$$$20240701$$MD$US$US
240331421$24033142$1$I$$20240412$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05965$HIKMA$Rivero A, Shaughnessy M, Noska A.. Rivero A, Shaughnessy M, Noska A. An Unusual Case of Cellulitis in a Patient With Systemic Lupus Erythematosus.. Clinical Infectious Diseases.. 2024;78(3):797-799.$56$YR$$F$Y$$$20240701$$MD$US$US
240331431$24033143$1$I$$20240620$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05750$HIKMA$Kuzmishin GB, Turka J, Rudick A.. Kuzmishin GB, Turka J, Rudick A. Acute Onset of Multiorgan Toxicity With Bilateral Pleural Effusions Within 6 Weeks of Initiation of Amiodarone Therapy.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2033$72$YR$$M$Y$$$20240701$$MD$US$US
240331441$24033144$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024128410$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240331451$24033145$1$I$20190101$20240626$20240701$20240701$EXP$$AT-AMGEN-AUTSP2024126633$AMGEN$$46$YR$A$F$Y$$$20240701$$MD$AT$AT
240331461$24033146$1$I$$20230606$20240701$20240701$PER$$US-AMGEN-USASP2023235013$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240331471$24033147$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05512$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240331481$24033148$1$I$20240201$20240626$20240701$20240701$PER$$US-JNJFOC-20240670539$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240701$$CN$US$US
240331491$24033149$1$I$$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103930$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240701$$CN$US$US
240331502$24033150$2$F$$20240703$20240701$20240712$EXP$$JP-TEVA-VS-3214292$TEVA$Hiramatsu K, Tanaka A, Furusawa K, Inden Y, Murohara T. Refractory atrial tachycardia after transcatheter closure of an atrial septal defect, successfully treated by catheter ablation with transseptal approach via the side of the device. J-Cardiol-Cases 2024; 29 (6): 258-260.; Hiramatsu K, Tanaka A, Furusawa K, Inden Y, Murohara T. Refractory atrial tachycardia after transcatheter closure of an atrial septal defect, successfully treated by catheter ablation with transseptal approach via the s...$24$YR$$F$Y$$$20240712$$MD$JP$JP
240331513$24033151$3$F$20240513$20240716$20240701$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002763$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240809$$CN$US$US
240331521$24033152$1$I$$20240619$20240701$20240701$PER$$US-ROCHE-10000008622$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240331531$24033153$1$I$$20230524$20240701$20240701$PER$$US-AMGEN-USASP2023235003$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240331556$24033155$6$F$20240625$20240828$20240701$20240903$EXP$$JP-GENMAB-2024-02231$GENMAB$$77$YR$$M$Y$52.8$KG$20240903$$MD$JP$JP
240331561$24033156$1$I$$20240619$20240701$20240701$PER$$US-ROCHE-10000009359$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240331571$24033157$1$I$$20240419$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05986$HIKMA$Nguyen D, Qureshi H, Olejniczak M, Sanne S, McCarron R.. Nguyen D, Qureshi H, Olejniczak M, Sanne S, McCarron R. What the BRASH? American Journal of the Medical Sciences.. American Journal of the Medical Sciences.. 2024;S64:367(Supplement 1)$74$YR$$M$Y$$$20240701$$MD$US$US
240331581$24033158$1$I$20240401$20240624$20240701$20240701$PER$$US-ALXN-202406USA001547US$ALEXION PHARMACEUTICALS$$75$YR$$$Y$$$20240701$$CN$US$US
240331591$24033159$1$I$$20240617$20240701$20240701$EXP$$AU-TEVA-VS-3211389$TEVA$$63$YR$$M$Y$$$20240701$$HP$AU$AU
240331601$24033160$1$I$20240521$20240624$20240701$20240701$EXP$IT-MINISAL02-990647$IT-TEVA-VS-3213802$TEVA$$75$YR$$M$Y$$$20240701$$PH$IT$IT
240331611$24033161$1$I$$20240617$20240701$20240701$EXP$$AU-TEVA-VS-3211394$TEVA$$$$$F$Y$$$20240701$$HP$AU$AU
240331621$24033162$1$I$$20240625$20240701$20240701$EXP$$US-ABBVIE-5817140$ABBVIE$$$$$M$Y$$$20240629$$CN$US$US
240331631$24033163$1$I$$20240607$20240701$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002838$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
240331641$24033164$1$I$$20240607$20240701$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002735$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
240331651$24033165$1$I$20240626$20240626$20240701$20240701$EXP$$US-JNJFOC-20240674383$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20240701$$CN$US$US
240331661$24033166$1$I$20240409$20240624$20240701$20240701$EXP$ES-AEMPS-1535398$ES-TEVA-VS-3213784$TEVA$$55$YR$$M$Y$$$20240701$$MD$ES$ES
240331671$24033167$1$I$$20240618$20240701$20240701$EXP$$US-TEVA-VS-3211942$TEVA$$25$YR$$M$Y$$$20240701$$HP$US$US
240331682$24033168$2$F$$20240805$20240701$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002621$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$HP$US$US
2403316910$24033169$10$F$20240603$20240814$20240701$20240822$EXP$$US-ROCHE-10000010982$ROCHE$$54$YR$A$M$Y$84.82$KG$20240822$$CN$US$US
240331701$24033170$1$I$$20240618$20240701$20240701$PER$$US-TEVA-VS-3211796$TEVA$$$$$$Y$$$20240701$$HP$US$US
240331711$24033171$1$I$$20240418$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05940$HIKMA$Osman M, Hamaad M, Elmahi M, Elbadrawy M, Saadaldin M.. Osman M, Hamaad M, Elmahi M, Elbadrawy M, Saadaldin M. Rush for brash syndrome.. 367(Supplement 1):S381.. American Journal of the Medical Sciences. 2024;67:(Supplement 1):S381.$83$YR$$F$Y$$$20240701$$MD$US$US
240331721$24033172$1$I$$20240621$20240701$20240701$EXP$$ES-TEVA-VS-3214265$TEVA$$$$$F$Y$$$20240701$$MD$ES$ES
240331731$24033173$1$I$$20230509$20240701$20240701$PER$$US-SCILEX PHARMACEUTICALS INC.-US-SOR-23-00001$SCILEX PHARMACEUTICALS$$$$$$Y$$$20240628$$MD$US$US
240331741$24033174$1$I$$20240617$20240701$20240701$EXP$$SG-ROCHE-10000009229$ROCHE$Yuen YS, Holder GE, Lingam G, Shen TYT. Diffuse retinal dysfunction following immune reconstitution uveitis in patients with prior cytomegalovirus retinitis: a novel observation. Doc Ophthalmol. 2023;147:139?145. DOI: https://doi.org/10.1007/s10633-023-09947-6.$54$YR$A$M$Y$$$20240701$$HP$SG$SG
240331751$24033175$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024128745$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240331761$24033176$1$I$20240601$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126436$AMGEN$$69$YR$E$M$Y$$$20240701$$CN$US$US
240331771$24033177$1$I$$20240607$20240701$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-006007$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
240331781$24033178$1$I$$20240621$20240701$20240701$30DAY$$TH-SA-2024SA187118$SANOFI AVENTIS$$$$$$Y$$$20240701$$HP$TH$TH
240331791$24033179$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186644$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240701$$MD$US$US
240331802$24033180$2$F$20240501$20240625$20240701$20240704$PER$$US-SA-2024SA188251$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240704$$MD$US$US
240331811$24033181$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA189124$SANOFI AVENTIS$$$$A$M$Y$78.4$KG$20240701$$MD$US$US
240331821$24033182$1$I$20240101$20240620$20240701$20240701$PER$$US-SA-2024SA186674$SANOFI AVENTIS$$$$C$M$Y$$$20240701$$MD$US$US
240331831$24033183$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186663$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240701$$MD$US$US
240331841$24033184$1$I$20240619$20240621$20240701$20240701$EXP$$US-GSK-US2024078017$GLAXOSMITHKLINE$$86$YR$$F$Y$$$20240701$$HP$US$US
240331851$24033185$1$I$20240501$20240620$20240701$20240701$PER$$US-ROCHE-10000011736$ROCHE$$76$YR$E$$Y$$$20240701$$CN$US$US
240331861$24033186$1$I$20240613$20240624$20240701$20240701$PER$$US-ROCHE-10000011826$ROCHE$$25$YR$A$F$Y$79.38$KG$20240701$$CN$US$US
240331871$24033187$1$I$20240516$20240613$20240701$20240701$PER$$US-009507513-2406USA004455$MERCK$$75$YR$$M$Y$$$20240701$$CN$US$US
240331881$24033188$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190546$SANOFI AVENTIS$$95$YR$E$F$Y$$$20240701$$MD$US$US
240331891$24033189$1$I$$20240627$20240701$20240701$PER$$US-SA-2024SA192306$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240701$$CN$US$US
240331901$24033190$1$I$20240601$20240624$20240701$20240701$PER$$US-SA-2024SA190864$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240701$$MD$US$US
240331911$24033191$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA190320$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240701$$MD$US$US
240331921$24033192$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA191641$SANOFI AVENTIS$$$$$$Y$$$20240701$$MD$US$US
240331931$24033193$1$I$$20240621$20240701$20240701$PER$$US-SA-2023SA286762$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240701$$MD$US$US
240331941$24033194$1$I$20230101$20240624$20240701$20240701$PER$$US-SA-2024SA189140$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240701$$CN$US$US
240331951$24033195$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA126556$SANOFI AVENTIS$$64$YR$A$F$Y$66$KG$20240701$$HP$US$US
240331961$24033196$1$I$20240625$20240625$20240701$20240701$PER$$US-SA-2024SA190763$SANOFI AVENTIS$$60$YR$A$$Y$$$20240701$$CN$US$US
240331971$24033197$1$I$20240201$20240625$20240701$20240701$PER$$US-SA-2024SA190032$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240701$$HP$US$US
240331982$24033198$2$F$20240623$20240819$20240701$20240827$PER$$US-SA-2024SA190799$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240827$$MD$US$US
240331991$24033199$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA191313$SANOFI AVENTIS$$55$YR$A$M$Y$76$KG$20240701$$MD$US$US
240332001$24033200$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA187944$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240701$$MD$US$US
240332011$24033201$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA188383$SANOFI AVENTIS$$$$A$M$Y$$$20240701$$MD$US$US
240332021$24033202$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA190882$SANOFI AVENTIS$$$$$F$Y$$$20240701$$CN$US$US
240332031$24033203$1$I$20240101$20240624$20240701$20240701$PER$$US-SA-2024SA191287$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240701$$MD$US$US
240332041$24033204$1$I$20240617$20240624$20240701$20240701$PER$$US-SA-2024SA189315$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240701$$CN$US$US
240332051$24033205$1$I$$20240628$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104395$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240701$$CN$US$US
240332061$24033206$1$I$$20240621$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100983$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240701$$CN$US$US
240332072$24033207$2$F$20240614$20240617$20240701$20240703$EXP$$US-NOVOPROD-1242253$NOVO NORDISK$$69$YR$$F$Y$97.506$KG$20240703$$CN$US$US
240332082$24033208$2$F$$20240722$20240701$20240724$PER$$US-AMGEN-USASP2024128575$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
240332091$24033209$1$I$20240622$20240624$20240701$20240701$PER$$US-AMGEN-USASP2024125370$AMGEN$$54$YR$A$M$Y$$$20240701$$CN$US$US
240332101$24033210$1$I$$20240621$20240701$20240701$PER$$US-BAUSCHBL-2024BNL029046$BAUSCH AND LOMB$$6$DEC$$F$Y$$$20240701$$MD$US$US
240332111$24033211$1$I$20230101$20231207$20240701$20240701$PER$$US-APOTEX-2023AP017830$APOTEX$$$$$F$Y$$$20240701$$CN$US$US
240332121$24033212$1$I$$20231127$20240701$20240701$PER$$US-APOTEX-2023AP017476$APOTEX$Mostovaya M, Kalinchenko S, Vorslov L. Statin Intake as a Cause of Decreased Steroid Hormone Secretion. Journal of the Endocrine Society. 2022;6 (Suppl. 1):A729$64$YR$$M$Y$$$20240701$$HP$US$US
240332131$24033213$1$I$$20230719$20240701$20240701$PER$$US-APOTEX-2023AP011210$APOTEX$Singer S, Tan SY, Dewan AK, Davids M, LaCasce AS, Treon SP,  et al. Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor-induced dermatologic adverse events. Journal of the American Academy of Dermatology. 2023;88(6):1271-1281$$$E$M$Y$$$20240701$$HP$US$US
240332141$24033214$1$I$$20231219$20240701$20240701$PER$$US-APOTEX-2023AP018290$APOTEX$$$$$F$Y$$$20240701$$CN$US$US
240332151$24033215$1$I$$20230719$20240701$20240701$PER$$US-APOTEX-2023AP011110$APOTEX$Singer S, Tan SY, Dewan AK, Davids M, LaCasce AS, Treon SP,  et al. Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor-induced dermatologic adverse events. Journal of the American Academy of Dermatology. 2023;88(6):1271-1281$$$A$F$Y$$$20240701$$HP$US$US
240332161$24033216$1$I$$20231204$20240701$20240701$PER$$US-APOTEX-2023AP017712$APOTEX$$$$$$Y$$$20240701$$MD$US$US
240332171$24033217$1$I$$20231127$20240701$20240701$PER$$US-APOTEX-2023AP017475$APOTEX$Mostovaya M, Kalinchenko S, Vorslov L. Statin Intake as a Cause of Decreased Steroid Hormone Secretion. Journal of the Endocrine Society. 2022;6 (Suppl. 1):A729$58$YR$$M$Y$$$20240701$$HP$US$US
240332181$24033218$1$I$$20240122$20240701$20240701$PER$$US-APOTEX-2024AP001592$APOTEX$Nawaz N, Mistretta T, Karime C, Lewis J, Wolf E.. Cholestatic Drug-Induced Liver Injury in a Patient Taking High-Dose Niacin for Hyperlipidemia. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-3$79$YR$$M$Y$$$20240701$$MD$US$US
240332191$24033219$1$I$20220101$20230801$20240701$20240701$PER$$US-APOTEX-2023AP011686$APOTEX$$$$$F$Y$$$20240701$$CN$US$US
240332201$24033220$1$I$$20230929$20240701$20240701$PER$$US-APOTEX-2023AP014854$APOTEX$$$$$M$Y$$$20240701$$CN$US$US
240332211$24033221$1$I$20230801$20230828$20240701$20240701$PER$$US-APOTEX-2023AP013039$APOTEX$$$$$F$Y$$$20240701$$CN$US$US
240332221$24033222$1$I$$20230605$20240701$20240701$PER$$US-APOTEX-2023AP008839$APOTEX$$$$$M$Y$$$20240701$$CN$US$US
240332231$24033223$1$I$$20231125$20240701$20240701$PER$$US-APOTEX-2023AP017416$APOTEX$$$$$$Y$$$20240701$$CN$US$US
240332242$24033224$2$F$$20240725$20240701$20240803$EXP$$US-SA-2024SA190260$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240803$$MD$US$US
240332251$24033225$1$I$$20240621$20240701$20240701$PER$$US-BAUSCHBL-2024BNL029059$BAUSCH AND LOMB$$$$$M$Y$$$20240701$$CN$US$US
240332261$24033226$1$I$$20240621$20240701$20240701$EXP$FR-AFSSAPS-BR2024000502$FR-SA-2024SA186179$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240701$$MD$FR$FR
240332272$24033227$2$F$$20240617$20240701$20240701$EXP$$US-ROCHE-10000007245$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240332281$24033228$1$I$20240610$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126449$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240332291$24033229$1$I$$20240418$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05886$HIKMA$Smith D, Tsui BC, Khoo C.. Smith D, Tsui BC, Khoo C. Local Anesthetic Systemic Toxicity in Cardiac Surgery Patient with Erector Spinae Plane Catheter: A Case Report.. A+A practice. 2024;18(4):e01771.$38$YR$$F$Y$$$20240701$$MD$US$US
240332302$24033230$2$F$20240624$20240906$20240701$20240916$PER$$US-BAUSCHBL-2024BNL029094$BAUSCH AND LOMB$$$$$F$Y$$$20240916$$CN$US$US
240332311$24033231$1$I$20240607$20240624$20240701$20240701$EXP$ES-AEMPS-1535504$ES-TEVA-VS-3213760$TEVA$$69$YR$$M$Y$$$20240701$$PH$ES$ES
240332321$24033232$1$I$$20240621$20240701$20240701$30DAY$$US-GSK-US2024078087$GLAXOSMITHKLINE$$8$DEC$$F$Y$$$20240701$$CN$US$US
240332331$24033233$1$I$$20240617$20240701$20240701$PER$$US-ROCHE-10000005524$ROCHE$$$$A$F$Y$$$20240701$$CN$US$US
240332342$24033234$2$F$20240101$20240827$20240701$20240903$EXP$$JP-JNJFOC-20240700385$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240903$$PH$JP$JP
240332351$24033235$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104337$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$90.72$KG$20240701$$CN$US$US
240332361$24033236$1$I$$20240620$20240701$20240701$PER$US-MLMSERVICE-20240613-PI097390-00232-1$US-RDY-SPO/USA/24/0009088$DR REDDYS$Selch GT, Anderson LH, Guice KC, Fox SW. Cryptococcoma Presenting as a Cavitary Lung Lesion in a Renal Transplant Recipient. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6315. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6315.$32$YR$A$F$Y$$$20240701$$MD$US$US
240332373$24033237$3$F$$20240814$20240701$20240821$PER$$US-ROCHE-10000005463$ROCHE$$$$A$F$Y$$$20240821$$CN$US$US
240332381$24033238$1$I$20240602$20240624$20240701$20240701$EXP$FR-AFSSAPS-NT2024000724$FR-ALCON LABORATORIES-ALC2024FR003061$ALCON$$$$$$Y$$$20240701$$HP$FR$FR
240332402$24033240$2$F$$20240619$20240701$20240702$PER$$US-ROCHE-10000007691$ROCHE$$$$E$F$Y$$$20240702$$CN$US$US
240332421$24033242$1$I$$20240620$20240701$20240701$PER$$US-ROCHE-10000010825$ROCHE$$40$YR$A$F$Y$$$20240701$$CN$US$US
240332431$24033243$1$I$20240614$20240614$20240701$20240701$PER$$CA-TOLMAR, INC.-24CA049711$TOLMAR$$75$YR$$M$Y$$$20240701$$CN$CA$CA
240332441$24033244$1$I$$20240612$20240701$20240701$PER$$CA-TOLMAR, INC.-24CA049697$TOLMAR$$$$$M$Y$$$20240701$$CN$CA$CA
240332452$24033245$2$F$20240527$20240709$20240701$20240730$PER$$CA-TOLMAR, INC.-24CA049724$TOLMAR$$85$YR$$M$Y$$$20240730$$HP$CA$CA
240332461$24033246$1$I$$20240611$20240701$20240701$PER$$CA-TOLMAR, INC.-24CA050151$TOLMAR$$$$$M$Y$$$20240701$$CN$CA$CA
240332471$24033247$1$I$$20240611$20240701$20240701$PER$$CA-TOLMAR, INC.-24CA050155$TOLMAR$$$$$M$Y$$$20240701$$CN$CA$CA
240332481$24033248$1$I$$20240611$20240701$20240701$PER$$CA-TOLMAR, INC.-24CA050129$TOLMAR$$$$$M$Y$$$20240701$$CN$CA$CA
240332491$24033249$1$I$20240605$20240611$20240701$20240701$PER$$CA-TOLMAR, INC.-24CA050156$TOLMAR$$61$YR$$M$Y$$$20240701$$CN$CA$CA
240332501$24033250$1$I$20240101$20240611$20240701$20240701$PER$$CA-TOLMAR, INC.-24CA050159$TOLMAR$$$$$M$Y$$$20240701$$CN$CA$CA
240332511$24033251$1$I$20240611$20240611$20240701$20240701$PER$$CA-TOLMAR, INC.-24CA050170$TOLMAR$$69$YR$$M$Y$$$20240701$$CN$CA$CA
240332532$24033253$2$F$20240611$20240709$20240701$20240813$PER$$FR-TOLMAR, INC.-24FR050135$TOLMAR$$57$YR$$M$Y$$$20240813$$PH$FR$FR
240332542$24033254$2$F$$20240705$20240701$20240808$PER$$IT-TOLMAR, INC.-24IT050104$TOLMAR$$$$$$Y$$$20240808$$PH$IT$IT
240332551$24033255$1$I$$20240621$20240701$20240701$PER$$US-ROCHE-10000009818$ROCHE$$$$$$Y$$$20240701$$HP$US$US
240332563$24033256$3$F$$20240710$20240701$20240723$EXP$$CH-ROCHE-3548582$ROCHE$Hosek N, Montani M and Mani L.. Acute post-renal kidney graft dysfunction due to cytomegalovirus-positive nephrogenic adenoma-case report and review of the literature. Frontiers in Medicine. 2024-May-29;11:1-7. doi:10.3389/fmed.2024.1394028.$33$YR$A$M$Y$$$20240723$$MD$CH$CH
240332572$24033257$2$F$$20240805$20240701$20240806$PER$$US-ALXN-202406USA001528US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240332581$24033258$1$I$$20240626$20240701$20240701$EXP$$CY-BAUSCHBL-2024BNL029260$BAUSCH AND LOMB$Sotiriadou M. A 69-year-old patient with hypertension, suffering from multiple myeloma and to be treated with Carfilzomib due to disease progression, is referred to the Cardio-oncology clinic for evaluation. How do we manage this case. Hippocrates Cardiology Days. 2024;.$69$YR$$M$Y$$$20240701$$HP$CY$CY
240332601$24033260$1$I$20240528$20240611$20240701$20240701$PER$$NL-TOLMAR, INC.-24NL050089$TOLMAR$$75$YR$$M$Y$$$20240701$$CN$NL$NL
240332611$24033261$1$I$$20240628$20240701$20240701$EXP$$CZ-BAUSCHBL-2024BNL029312$BAUSCH AND LOMB$Lazanska R, Kratka K, Havrda M, Rychl?k I, Sykora M. EXPERIENCES WITH THE TREATMENT OF AL AMYLOIDOSIS WITH RENAL IMPAIRMENT.$63$YR$$M$Y$$$20240701$$HP$CZ$CZ
240332622$24033262$2$F$20190101$20240723$20240701$20240729$EXP$$ZA-ORPHANEU-2024004515$RECORDATI$$$$$$Y$$$20240726$$MD$ZA$ZA
240332631$24033263$1$I$$20240419$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05988$HIKMA$Lakhani DA, Deng F.. Lakhani DA, Deng F. A young man with amnesia after drug overdose. European Journal of Internal Medicine. 2024;122:117-18$29$YR$$M$Y$$$20240701$$MD$US$US
240332642$24033264$2$F$20240708$20240709$20240701$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002750$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240731$$CN$US$US
240332652$24033265$2$F$20240628$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104604$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$82$KG$20240701$$CN$US$US
240332661$24033266$1$I$$20240625$20240701$20240701$EXP$$US-ABBVIE-5816754$ABBVIE$$$$$$Y$$$20240701$$HP$US$US
240332671$24033267$1$I$20240526$20240624$20240701$20240701$EXP$NO-NOMAADVRE-RELISSO-2024-V7r5dr$NO-TEVA-VS-3214437$TEVA$$26$YR$$F$Y$$$20240701$$PH$NO$NO
240332681$24033268$1$I$20150901$20240618$20240701$20240701$EXP$$CA-ROCHE-10000005080$ROCHE$$51$YR$A$M$Y$$$20240701$$CN$CA$CA
240332691$24033269$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104494$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240701$$CN$US$US
240332701$24033270$1$I$$20240626$20240701$20240701$EXP$$US-JNJFOC-20240673295$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240332711$24033271$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104500$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240701$$CN$US$US
240332722$24033272$2$F$20240617$20240715$20240701$20240724$PER$$US-MSNLABS-2024MSNSPO01341$MSN LABORATORIES$$$$$$Y$$$20240724$$CN$US$US
240332731$24033273$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018237$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240701$$CN$US$US
240332742$24033274$2$F$20240301$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018406$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240332751$24033275$1$I$20230512$20240625$20240701$20240701$EXP$$DE-ABBVIE-5819236$ABBVIE$$0$YR$$M$Y$$$20240701$$MD$DE$DE
240332761$24033276$1$I$$20240618$20240701$20240701$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05383$LUPIN$Mansfield PK, Moody R, Li Y, Heinecke G. A rare case of lichen planus pemphigoides with palmoplantar hyperkeratotic plaques. Journal of the American Academy of Dermatology Case Reports. 2024;49:14-16$64$YR$$F$Y$$$20240701$$HP$US$US
240332771$24033277$1$I$20240401$20240613$20240701$20240701$PER$$US-ABBVIE-5821625$ABBVIE$$82$YR$$F$Y$$$20240701$$MD$US$US
240332781$24033278$1$I$20240530$20240621$20240701$20240701$EXP$GB-MHRA-TPP4345565C8860627YC1717062069712$GB-ESPERIONTHERAPEUTICS-2024GBR00976$ESPERION THERAPEUTICS$$71$YR$$M$Y$102$KG$20240701$$MD$GB$GB
240332792$24033279$2$F$20240627$20240628$20240701$20240705$PER$$US-AMGEN-USASP2024128600$AMGEN$$20$YR$A$F$Y$$$20240705$$CN$US$US
240332801$24033280$1$I$20230101$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024128485$AMGEN$$64$YR$A$F$Y$$$20240701$$CN$US$US
240332813$24033281$3$F$20230901$20240710$20240701$20240717$PER$$US-AMGEN-USASP2024128040$AMGEN$$59$YR$A$M$Y$$$20240717$$CN$US$US
240332821$24033282$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5819589$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240332831$24033283$1$I$$20240618$20240701$20240701$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05560$LUPIN$Karczewski D, Backer H, Andronic O, Bedi A, Adelhoefer S, Mullner M, et al. Serratia marcescens prosthetic joint infection: two case reports and a review of the literature. Journal of Medical Case Reports. 2023;17 (1):1-12$72$YR$$F$Y$$$20240701$$HP$US$US
240332841$24033284$1$I$20240507$20240607$20240701$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002744$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240701$$CN$US$US
240332851$24033285$1$I$$20240628$20240701$20240701$EXP$$IL-BIOVITRUM-2024-IL-009245$BIOVITRUM$Abumanhal M, Leibovitch I, Zisapel M, Eviatar T, Edel Y, Cnaan RB. Ocular and orbital manifestations in VEXAS syndrome. Eye (Basingstoke). 2024 Mar 28;38(9): 1748-1754. doi:10.1038/s41433-024-03014-3.$75$YR$$M$Y$$$20240701$$HP$IL$IL
240332861$24033286$1$I$$20240628$20240701$20240701$EXP$$IL-BIOVITRUM-2024-IL-009254$BIOVITRUM$Abumanhal M, Leibovitch I, Zisapel M, Eviatar T, Edel Y, Cnaan RB. Ocular and orbital manifestations in VEXAS syndrome. Eye (Basingstoke). 2024 Mar 28;38(9): 1748-1754. doi:10.1038/s41433-024-03014-3.$75$YR$$M$Y$$$20240701$$HP$IL$IL
240332871$24033287$1$I$$20240626$20240701$20240701$EXP$$US-JNJFOC-20240672581$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240332881$24033288$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5819376$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240332891$24033289$1$I$$20240628$20240701$20240701$EXP$$IL-BIOVITRUM-2024-IL-009256$BIOVITRUM$Abumanhal M, Leibovitch I, Zisapel M, Eviatar T, Edel Y, Cnaan RB. Ocular and orbital manifestations in VEXAS syndrome. Eye (Basingstoke). 2024 Mar 28;38(9): 1748-1754. doi:10.1038/s41433-024-03014-3.$74$YR$$M$Y$$$20240701$$HP$IL$IL
240332901$24033290$1$I$20240101$20240626$20240701$20240701$EXP$$US-ABBVIE-5819813$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240332911$24033291$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5819412$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240332922$24033292$2$F$$20240805$20240701$20240806$PER$$US-ALXN-202406USA001516US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240332934$24033293$4$F$20240502$20240820$20240701$20240827$EXP$$BR-Ipsen Biopharmaceuticals, Inc.-2024-07692$IPSEN$$67$YR$E$F$Y$69$KG$20240827$$CN$BR$BR
240332943$24033294$3$F$20240404$20240725$20240701$20240730$EXP$$CA-ABBVIE-5819470$ABBVIE$$$$E$M$Y$$$20240730$$CN$CA$CA
240332951$24033295$1$I$20240620$20240624$20240701$20240701$PER$$US-JNJFOC-20240663585$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240332961$24033296$1$I$$20240617$20240701$20240701$EXP$$US-TWI PHARMACEUTICAL, INC-2024SCTW000123$TWI PHARMACEUTICALS$Vincent J.; Greenberg J.; Sanghani S.; Finneran K.; Nguyen N.. Profound Lactic Acidosis and Shock in a Patient Taking Metformin. Am. J. Respir. Crit. Care Med.. 2024;209:A5702$$$$$Y$$$20240627$$$US$US
240332971$24033297$1$I$$20240623$20240701$20240701$EXP$$IN-HETERO-HET2024IN02050$HETERO$Khandelwal H, Jain K, Raj AB, Chahar A, Rajpurohit SS, Biyyala D, Nebhinani N, Suthar N, Soni P, Gupta T.. Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD. Journal of Clinical Psychopharmacology. 2024;44(4):434-6$12$YR$$M$Y$$$20240701$$MD$IN$IN
240332982$24033298$2$F$$20240706$20240701$20240717$EXP$$CA-AUROBINDO-AUR-APL-2024-031510$AUROBINDO$Mijovic H, Grant C, Couturier J.. Severe bradycardia following initiation of low-dose olanzapine in a patient with anorexia nervosa.. Paediatrics and Child Health.. 2016;21(Supplement5):e60$16$YR$$F$Y$$$20240717$$MD$CA$CA
240332991$24033299$1$I$20221001$20240617$20240701$20240701$EXP$$US-TWI PHARMACEUTICAL, INC-2024SCTW000120$TWI PHARMACEUTICALS$Ouyang J.; Sasidharan S.; Jatoi T.; Salifu M.. How High Can Anion Gaps Be in Patients With Metabolic Acidosis? A Case Report. Am J Respir Crit Care Med. 2024;209:A3409$$$$$Y$$$20240627$$$US$US
240333002$24033300$2$F$$20240619$20240701$20240917$PER$$US-TEVA-VS-3212940$TEVA$$$$A$$Y$$$20240917$$HP$US$US
240333011$24033301$1$I$20160825$20240624$20240701$20240701$EXP$$CA-TAKEDA-2024TUS040363$TAKEDA$$45$YR$$M$Y$134$KG$20240701$$CN$CA$CA
240333021$24033302$1$I$$20240617$20240701$20240701$EXP$$US-TWI PHARMACEUTICAL, INC-2024SCTW000118$TWI PHARMACEUTICALS$Mikhail E.; Alexander D.; Jankowski M.; Pandya D.; Kunadi A. Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature. Am. J. Respir. Crit. Care Med.. 2024;209:A3410$$$$$Y$$$20240627$$$US$US
240333033$24033303$3$F$$20240705$20240701$20240710$EXP$$CA-TAKEDA-2024TUS061798$TAKEDA$$$$$M$Y$$$20240710$$CN$CA$CA
240333041$24033304$1$I$20240626$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103272$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$53$KG$20240701$$PH$US$US
240333051$24033305$1$I$$20240319$20240701$20240701$EXP$$GB-SERB S.A.S.-2158719$LABORATOIRES SERB$Litteraure article of a lack of drug effect$80$YR$$M$Y$$$20240701$$$GB$GB
240333061$24033306$1$I$$20240618$20240701$20240701$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05501$LUPIN$Valido K, Patel V, Murphy MJ, Junejo MH, Patel DK, Deutsch A, et al. Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach. Journal of The American Academy of Dermatology Case reports. 2024;48:49-53$52$YR$$F$Y$$$20240701$$HP$US$US
240333071$24033307$1$I$20220101$20240624$20240701$20240701$EXP$$US-BAUSCHBL-2024BNL029175$BAUSCH AND LOMB$$93$YR$$F$Y$$$20240701$$CN$US$US
240333083$24033308$3$F$$20240905$20240701$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002749$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
240333091$24033309$1$I$$20240618$20240701$20240701$EXP$$IN-ROCHE-10000011643$ROCHE$$64$YR$A$F$Y$$$20240701$$CN$IN$IN
240333101$24033310$1$I$$20240617$20240701$20240701$EXP$$US-TWI PHARMACEUTICAL, INC-2024SCTW000124$TWI PHARMACEUTICALS$Oomrigar S.C.; Fernandez J.; Rivera Ortiz C.; Rajen H.; Toll A.; Perez Colome E. et al.. The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death. Am. J. Respir. Crit. Care Med. 2024;209:A5653$$$$$Y$$$20240626$$$US$US
240333111$24033311$1$I$$20240617$20240701$20240701$EXP$$US-TWI PHARMACEUTICAL, INC-2024SCTW000119$TWI PHARMACEUTICALS$Lam E.; Santos C.; Patrawalla A.S.. A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose. Am. J. Respir. Crit. Care Med.. 2024;209:A5651$$$$$Y$$$20240627$$$US$US
240333121$24033312$1$I$20240531$20240619$20240701$20240701$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158720$JIANGSU HENGRUI MEDICINE$$70$YR$$M$Y$60$KG$20240701$$MD$CN$CN
240333131$24033313$1$I$20240408$20240627$20240701$20240701$EXP$SE-SEMPA-2024-005083$SE-GSK-SE2024080552$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$SE$SE
240333142$24033314$2$F$20240610$20240708$20240701$20240722$PER$$US-MSNLABS-2024MSNSPO01342$MSN LABORATORIES$$$$$$Y$$$20240722$$PH$US$US
240333152$24033315$2$F$$20240625$20240701$20240705$PER$$US-ROCHE-10000010393$ROCHE$$52$YR$A$M$Y$$$20240705$$MD$US$US
240333161$24033316$1$I$$20240624$20240701$20240701$EXP$$TW-AMGEN-TWNSP2024126072$AMGEN$$$$$$Y$$$20240701$$MD$TW$TW
240333172$24033317$2$F$20240101$20240726$20240701$20240805$EXP$$NG-JNJFOC-20240661637$JOHNSON AND JOHNSON$$63$YR$A$F$Y$74$KG$20240806$$MD$NG$NG
240333181$24033318$1$I$20240626$20240626$20240701$20240701$EXP$$US-ABBVIE-5819843$ABBVIE$$88$YR$$F$Y$$$20240701$$CN$US$US
240333191$24033319$1$I$$20240618$20240701$20240701$EXP$$IN-ROCHE-10000004049$ROCHE$$$$A$M$Y$$$20240701$$CN$IN$IN
240333202$24033320$2$F$20240501$20240826$20240701$20240829$EXP$$US-ABBVIE-5820981$ABBVIE$$57$YR$$F$Y$$$20240829$$CN$US$US
240333211$24033321$1$I$$20240618$20240701$20240701$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05599$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240333221$24033322$1$I$$20240621$20240701$20240701$EXP$$US-SA-2024SA187286$SANOFI AVENTIS$$$$E$F$Y$$$20240701$$MD$US$US
240333231$24033323$1$I$20240504$20240621$20240701$20240701$EXP$FR-AFSSAPS-RE2024000572$FR-SA-2024SA187682$SANOFI AVENTIS$$90$YR$E$F$Y$56$KG$20240701$$PH$FR$FR
240333241$24033324$1$I$$20240621$20240701$20240701$EXP$$DE-AUROBINDO-AUR-APL-2024-031343$AUROBINDO$Hansel A, Oms E, Tronnier M.. Drug reaction with eosinophilia and systemic symptoms (DRESS): a hypersensitivity reaction with various symptoms.. Dermatologie.. 2024$47$YR$$F$Y$$$20240701$$HP$DE$DE
240333251$24033325$1$I$20240318$20240628$20240701$20240701$EXP$$US-ABBVIE-5821070$ABBVIE$$69$YR$$F$Y$$$20240701$$CN$US$US
240333261$24033326$1$I$20240501$20240627$20240701$20240701$PER$$US-JNJFOC-20240674993$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240701$$CN$US$US
240333271$24033327$1$I$$20240625$20240701$20240701$PER$$US-JNJFOC-20240667413$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$US$US
240333282$24033328$2$F$$20240703$20240701$20240708$EXP$$US-JNJFOC-20240672713$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
240333291$24033329$1$I$20221108$20240626$20240701$20240701$EXP$$BY-JNJFOC-20240673925$JOHNSON AND JOHNSON$$54$YR$A$M$Y$58$KG$20240701$$MD$BY$BY
240333301$24033330$1$I$20240601$20240619$20240701$20240701$PER$$US-JNJFOC-20240652203$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240701$$CN$US$US
240333311$24033331$1$I$20220101$20240628$20240701$20240701$EXP$$BG-ABBVIE-5820983$ABBVIE$$59$YR$$M$Y$$$20240701$$MD$BG$BG
240333321$24033332$1$I$$20240625$20240701$20240701$30DAY$$US-GSK-US2024079196$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240333331$24033333$1$I$20200201$20240622$20240701$20240701$EXP$$GB-AMGEN-GBRSP2024124377$AMGEN$Bond T. J.; Sharma P.. Collateral therapy? Clinical remission of ankylosing spondylitis following bone marrow transplant. Rheumatology. 2024;63:e183-e184$47$YR$A$F$Y$$$20240701$$HP$GB$GB
240333341$24033334$1$I$$20240605$20240701$20240701$PER$$US-BEIGENE-BGN-2024-008655$BEIGENE$$$$$$Y$$$20240701$$HP$US$US
240333351$24033335$1$I$$20240617$20240701$20240701$EXP$$US-TWI PHARMACEUTICAL, INC-2024SCTW000125$TWI PHARMACEUTICALS$Simpson M.; Awuah K.B.; Patel D.; Ogline O.; Pratapneni S.; Disilvio B.E.. Early Extra Corporeal Membrane Oxygenation (ECMO) and Esophagogastroduodenoscopy (EGD) Implementation: A Timely Intervention in a Patient With Extended-Release Bupropion Overdose. Am. J. Respir. Crit. Care Med. 2024;209:A5672$$$$$Y$$$20240626$$$US$US
240333362$24033336$2$F$20240601$20240717$20240701$20240719$EXP$$UY-ABBVIE-5821254$ABBVIE$$65$YR$$F$Y$$$20240719$$CN$UY$UY
240333371$24033337$1$I$20240519$20240628$20240701$20240701$EXP$$US-ABBVIE-5821148$ABBVIE$$64$YR$$F$Y$$$20240701$$MD$US$US
240333381$24033338$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127331$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240333393$24033339$3$F$20240809$20240918$20240701$20240924$PER$$US-AMGEN-USASP2024126717$AMGEN$$96$YR$E$F$Y$$$20240924$$HP$US$US
240333401$24033340$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019626$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240701$$CN$US$US
240333411$24033341$1$I$$20240618$20240701$20240701$EXP$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00315$Unknown Manufacturer$Henry PJ, Wen JH, Feldman EB, Vargas J. Minocycline Induced Parenchymal Lung Disease with Peripheral Eosinophilia. American Journal of Respiratory and Critical Care Medicine.. 2024$$$$$Y$$$20240701$$HP$US$US
240333431$24033343$1$I$20240520$20240621$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031213$AUROBINDO$$16$YR$$F$Y$$$20240701$$MD$FR$FR
240333441$24033344$1$I$$20240625$20240701$20240701$EXP$$US-ABBVIE-5817633$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240333451$24033345$1$I$$20240229$20240701$20240701$PER$$US-AMGEN-USASP2024128085$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240333462$24033346$2$F$$20240702$20240701$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05351$LUPIN$$$$$$Y$$$20240724$$CN$US$US
240333471$24033347$1$I$$20240626$20240701$20240701$EXP$$JP-009507513-2406JPN003987J$MERCK$$76$YR$$F$Y$$$20240701$$MD$JP$JP
240333481$24033348$1$I$$20240606$20240701$20240701$PER$$US-AMGEN-USASP2024128141$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240333491$24033349$1$I$$20240622$20240701$20240701$PER$$US-AMGEN-USASP2024125112$AMGEN$Venkatakrishna S. B.; Vasileiadi E.; Siu Navarro Y. et al.. Miliary meningeal tuberculosis - an unusual imaging presentation for an early definitive diagnosis. Child^s Nervous System. 2024;1-7$17$YR$T$F$Y$$$20240701$$HP$US$US
240333501$24033350$1$I$$20240326$20240701$20240701$PER$$BE-ROCHE-3535859$ROCHE$$$$$$Y$$$20240701$$MD$BE$BE
240333516$24033351$6$F$$20240819$20240701$20240826$PER$$US-ROCHE-10000002673$ROCHE$$$$$$Y$$$20240826$$HP$US$US
240333521$24033352$1$I$$20240617$20240701$20240701$PER$$PL-IGSA-BIG0029506$GRIFOLS$Przemyslaw Zdziarski, Andrzej Gamian. Role of B Cells beyond Antibodies in HBV-Induced Oncogenesis: Fulminant Cancer in Common Variable Immunodeficiency-Clinical and Immunotransplant Implications with a Review of the Literature. Diseases. 2024;12(5):80$28$YR$$M$Y$$$20240701$$HP$PL$PL
240333531$24033353$1$I$20230207$20240621$20240701$20240701$EXP$$DE-AUROBINDO-AUR-APL-2024-031323$AUROBINDO$$$$E$M$Y$$$20240701$$MD$DE$DE
240333542$24033354$2$F$$20240619$20240701$20240831$PER$$US-TEVA-VS-3213149$TEVA$$$$A$$Y$$$20240831$$HP$US$US
240333551$24033355$1$I$20230912$20240322$20240701$20240701$PER$$US-ROCHE-3445719$ROCHE$$47$YR$A$F$Y$99.79$KG$20240701$$CN$US$US
240333561$24033356$1$I$20240528$20240621$20240701$20240701$EXP$$US-AUROBINDO-AUR-APL-2024-031949$AUROBINDO$$66$YR$$M$Y$97.522$KG$20240701$$CN$US$US
240333571$24033357$1$I$$20240619$20240701$20240701$EXP$US-MLMSERVICE-20240612-PI096223-00030-1$US-RDY-SPO/USA/24/0008977$DR REDDYS$Raza HS, Love JS, Mikolajczyk AE. Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding. ACG case reports journal. 2024;11(6):e01378. DOI: 10.14309/crj.0000000000001378.$38$YR$A$M$Y$$$20240701$$MD$US$US
240333581$24033358$1$I$20240131$20240607$20240701$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002756$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240701$$CN$US$US
240333592$24033359$2$F$20240524$20240710$20240701$20240711$EXP$$CZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035996$BOEHRINGER INGELHEIM$$43$YR$A$M$Y$140$KG$20240711$$MD$CZ$CZ
240333602$24033360$2$F$$20240319$20240701$20240710$PER$$CA-ROCHE-3530363$ROCHE$$$$A$M$Y$$$20240701$$CN$CA$CA
240333613$24033361$3$F$$20240405$20240701$20240710$PER$$US-ROCHE-3513279$ROCHE$$$$T$M$Y$29.48$KG$20240701$$CN$US$US
240333621$24033362$1$I$20211101$20240412$20240701$20240701$PER$$DE-ROCHE-3165477$ROCHE$$38$YR$A$F$Y$45$KG$20240701$$MD$DE$DE
240333631$24033363$1$I$$20240216$20240701$20240701$PER$$BR-ROCHE-3435336$ROCHE$$27$YR$A$F$Y$58$KG$20240701$$CN$BR$BR
240333641$24033364$1$I$20240601$20240620$20240701$20240701$EXP$$US-JNJFOC-20240655551$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240701$$CN$US$US
240333651$24033365$1$I$20240609$20240620$20240701$20240701$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158721$JIANGSU HENGRUI MEDICINE$$69$YR$$M$Y$63$KG$20240701$$MD$CN$CN
240333661$24033366$1$I$$20240412$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05860$HIKMA$Torres A, Ibrahim M, Park S.. Torres A, Ibrahim M, Park S. Persistent Paradoxical Reaction to Midazolam despite General Anesthesia with Dexmedetomidine.. Case Rep. Anesthesiol. 2024;/:/$63$YR$$F$Y$106$KG$20240701$$MD$US$US
240333671$24033367$1$I$$20230301$20240701$20240701$PER$$US-AMGEN-USASP2023235011$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240333702$24033370$2$F$20240618$20240729$20240701$20240801$EXP$GB-MHRA-MED-202406271237292370-RFHKQ$GB-ORGANON-O2406GBR002603$ORGANON$$49$YR$$M$Y$79$KG$20240801$$CN$GB$GB
240333711$24033371$1$I$20240329$20240621$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031322$AUROBINDO$$69$YR$$M$Y$$$20240701$$MD$FR$FR
240333721$24033372$1$I$$20240624$20240701$20240701$PER$$US-AMGEN-USASP2024125254$AMGEN$Sahi A.; Quental A.; Bernstein E. L.. Alpha-1-Antitrypsin Deficiency Discovered Following Nephrectomy. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A5817-A5817$63$YR$A$M$Y$$$20240701$$HP$US$US
240333731$24033373$1$I$$20230703$20240701$20240701$PER$$US-UCBSA-2023033878$UCB$Haque T., Khan N., Brar J.. Refractory Seizures in Sturge Weber. Refractory Seizures in Sturge Weber. American Journal of Respiratory and Critical Care Medicine. 2023;207(1):-$44$YR$$F$Y$$$20240701$$MD$US$US
240333741$24033374$1$I$$20230626$20240701$20240701$PER$$US-UCBSA-2023032506$UCB$Shindo Y, Javier N, Gormley D. ^To Be or Not to Be?: A case of medical treatment over objection in an alert albeit cognitively impaired and delirious older adult. Journal of the American Geriatrics Society. 2023;71(1):S197$85$YR$$M$Y$$$20240701$$MD$US$US
240333751$24033375$1$I$$20230703$20240701$20240701$PER$$US-UCBSA-2023034182$UCB$Cao K., Nasrollahi F., Binder A.. Diagnosing Neuroleptic Malignant Syndrome the Intensive Care Unit: Identifying the Signs in Mechanically Ventilated Patients. American Journal of Respiratory and Critical Care Medicine. 2023;207(1):-$60$YR$$M$Y$$$20240701$$HP$US$US
240333761$24033376$1$I$$20230522$20240701$20240701$PER$$US-UCBSA-2023025952$UCB$Smith JC, Hamilton BK, VanDyke SA. Patient Comfort During Cataract Surgery: A Comparison of Troche and Intravenous Sedation. AANA Journal. 2020;88(6):429-435$$$$$Y$$$20240701$$HP$US$US
240333771$24033377$1$I$$20230605$20240701$20240701$PER$$US-UCBSA-2023028785$UCB$Mao Y, Shaikh R, Gadela NV, Kalahasty G, Kron J.. PO-04-025 A PERFECT STORM - REFRACTORY TORSADES IN A PATIENT WITH MITOCHONDRIAL DISEASE AND SEVERE HYPOTHYROIDISM. Heart Rhythm.. 2023;20(5):S540$39$YR$$F$Y$$$20240701$$HP$US$US
240333781$24033378$1$I$$20230626$20240701$20240701$PER$$US-UCBSA-2023032030$UCB$Ahmad R, Naftalovich R, Tewfik G, Eloy JD, Rodriguez-Correa DT. Near?miss hypoglycemia-reflections on perioperative glucose management guidelines in diabetics. BMC Anesthesiology. 2023;23(1):1-5$36$YR$$F$Y$$$20240701$$HP$US$US
240333791$24033379$1$I$$20230705$20240701$20240701$PER$$US-UCBSA-2023034289$UCB$Lane OF, Jahangiri Y, Slater WA.. Endovascular Treatment of Acute Obstructive Shock Associated with Inferior Vena Cava Filter Thrombosis. Journal of Vascular and Interventional Radiology. 2023;34(7):1272-75$64$YR$$F$Y$$$20240701$$HP$US$US
240333802$24033380$2$F$20230926$20240702$20240701$20240709$PER$$US-JAZZ PHARMACEUTICALS-2023-US-021771$JAZZ$$43$YR$$F$Y$$$20240708$$HP$US$US
240333811$24033381$1$I$$20240625$20240701$20240701$PER$$US-JNJFOC-20240667449$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$US$US
240333821$24033382$1$I$$20240625$20240701$20240701$EXP$$US-GSK-US2024079163$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240701$$HP$US$US
240333832$24033383$2$F$$20240313$20240701$20240710$PER$$US-ROCHE-3526672$ROCHE$$27$YR$A$M$Y$$$20240701$$HP$US$US
240333841$24033384$1$I$$20230522$20240701$20240701$PER$$US-UCBSA-2023026088$UCB$Jahromi B, Knezevic NN. Neuromuscular Block Monitoring in Patients With Facial Rejuvenation: A Case Report. International Anesthesia Research Society. 2020;14(13):1-3$33$YR$$F$Y$$$20240701$$MD$US$US
240333851$24033385$1$I$$20230612$20240701$20240701$PER$$US-UCBSA-2023029439$UCB$Dong E, Fellin R, Ramzy D, Chung JS, Arabia FA, Chan A et al. Role of Methadone in Extracorporeal Membrane Oxygenation: Two Case Reports. Journal of Extra-Corporeal Technology. 2018;50(4):252-5$28$YR$$F$Y$$$20240701$$HP$US$US
240333862$24033386$2$F$$20240209$20240701$20240710$PER$$US-ROCHE-3508480$ROCHE$$19$YR$A$M$Y$50.9$KG$20240701$$CN$US$US
240333872$24033387$2$F$$20240701$20240701$20240711$EXP$$DK-PADAGIS-2024PAD01063$PADAGIS$Ravn C D, Bendix M, Lyhne S. Acute pancreatitis in an ulcerative colitis patient treated with vedolizumab and budesonide. Danish Medical Weekly. 2024;186(22):V01240025$$$$$Y$$$20240711$$HP$DK$DK
240333881$24033388$1$I$$20230605$20240701$20240701$PER$$US-UCBSA-2023028263$UCB$DeLeon AM, Lu S, Gaston I, Samworth AG, Lopez C, Farrer J. Midazolam for the Successful Treatment of Refractory Spinal-Anesthesia-Associated Hypothermia After Cesarean Delivery. Cureus. 2023;15(5):e39492$42$YR$$F$Y$63.8$KG$20240701$$HP$US$US
240333891$24033389$1$I$$20230704$20240701$20240701$PER$$US-UCBSA-2023034132$UCB$Nguyen JK. Homeward. Palliative Medicine Reports. 2022;3(1):36-38$17$YR$$M$Y$95.254$KG$20240701$$PH$US$US
240333901$24033390$1$I$$20230706$20240701$20240701$PER$$US-UCBSA-2023034889$UCB$$$$$F$Y$$$20240701$$HP$US$US
240333911$24033391$1$I$$20230711$20240701$20240701$PER$$US-UCBSA-2023035476$UCB$Vanderhoef K, Proudford C, Amoni I, Jimenez C, Strutt J, Segura B, at el. The Pediatric Emergency Department Nurse and Gastrostomy Tube Replacement: How Safe Is it?. Pediatric Emergency Care. 2023;39(6):428-431$$$C$$Y$$$20240701$$MD$US$US
240333921$24033392$1$I$$20230717$20240701$20240701$PER$$US-UCBSA-2023036390$UCB$Snehal I, Lorenzen G, Sharma A. Seizure and Other Catastrophes due to Bupropion Overdose: Recent Case Report and Review of Published Cases. Innovations in Clinical Neuroscience. 2023;20(4-6):49-52$50$YR$$F$Y$$$20240701$$MD$US$US
240333931$24033393$1$I$$20230704$20240701$20240701$PER$$US-UCBSA-2023034153$UCB$Kumar P, Gordon BM, Kheiwa A, Abudayyeh I. A case report of percutaneous MitraClip implantation in an adult with a double-outlet right ventricle. European Heart Journal - Case Reports. 2023;7(6):1-5$20$YR$$M$Y$$$20240701$$HP$US$US
240333941$24033394$1$I$$20230711$20240701$20240701$PER$$US-UCBSA-2023035730$UCB$Stampfl M, Tillman D, Borelli N, Bandara T, Cathers A. Rapid Sequence Intubation Using the SEADUC Manual Suction Unit in a Contaminated Airway. Air Medical Journal. 2023;42(4):296-9$75$YR$$F$Y$70$KG$20240701$$MD$US$US
240333951$24033395$1$I$$20230724$20240701$20240701$PER$$US-UCBSA-2023037643$UCB$Quinonez ZA, Brandford E, Char D.. Case Report: Parental Separation by Proxy Using Video Conference Between Patient and Parent for Induction of Anesthesia. A and A Practice. 2023;17(7):1-3$$$$F$Y$$$20240701$$MD$US$US
240333961$24033396$1$I$$20240607$20240701$20240701$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002757$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
240333971$24033397$1$I$20240201$20240617$20240701$20240701$EXP$$DE-MELINTA THERAPEUTICS, LLC-DE-MLNT-24-00326$Unknown Manufacturer$$$$$$Y$$$20240701$$MD$DE$DE
240333982$24033398$2$F$$20240626$20240701$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031449$AUROBINDO$Leleu X, Hulin C, Lambert J, Bobin A., Perrot A, Karlin L, et al. Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial. Nature Medicine. 2024$$$E$$Y$$$20240704$$MD$FR$FR
240333991$24033399$1$I$$20231005$20240701$20240701$PER$$US-UCBSA-2023048925$UCB$$$$$$Y$$$20240701$$HP$US$US
240334001$24033400$1$I$$20231002$20240701$20240701$PER$$US-UCBSA-2023048041$UCB$Wilson PR, Bridges KH, Wilson SH.. Particulate Gastric Contents in Patients Prescribed Glucagon-Like Peptide 1 Receptor Agonists After Appropriate Perioperative Fasting: A Report of 2 Cases. A and A Practice. 2023;17(8):E01712$55$YR$$F$Y$$$20240701$$MD$US$US
240334011$24033401$1$I$$20230728$20240701$20240701$PER$$US-UCBSA-2023039254$UCB$$$$$M$Y$$$20240701$$CN$US$US
240334021$24033402$1$I$20230101$20230802$20240701$20240701$PER$$US-UCBSA-2023039293$UCB$$$$$M$Y$$$20240701$$HP$US$US
240334031$24033403$1$I$$20230810$20240701$20240701$PER$$US-UCBSA-2023040551$UCB$$$$$$Y$$$20240701$$HP$US$US
240334041$24033404$1$I$$20230810$20240701$20240701$PER$$US-UCBSA-2023040550$UCB$$$$$$Y$$$20240701$$HP$US$US
240334051$24033405$1$I$$20230816$20240701$20240701$PER$$US-UCBSA-2023042415$UCB$$$$$$Y$$$20240701$$CN$US$US
240334061$24033406$1$I$$20230919$20240701$20240701$PER$$US-UCBSA-2023045972$UCB$Aizenberg A, Smelski G, Shirazi FM, Larsen J. Serotonergic toxidrome after insufflation of an MDMA precursor. Clinical Toxicology. 2023;61(S2):175$17$YR$$M$Y$$$20240701$$HP$US$US
240334071$24033407$1$I$$20230801$20240701$20240701$PER$$US-UCBSA-2023038780$UCB$Chen KM, Hasoon J, Nguyen A. Anesthetic Considerations for Cardiac Tamponade after Internal Jugular Central Line Placement during Trauma Resuscitation: A Case Report. Vascular Specialist International.. 2023;39:1-5$22$YR$$M$Y$$$20240701$$HP$US$US
240334081$24033408$1$I$$20230807$20240701$20240701$PER$$US-UCBSA-2023039825$UCB$Omar HR, Fairbairn J, Abdelmalak HD, Delibasic M, Camporesi EM. Postoperative takotsubo cardiomyopathy: an illustration of the electrocardiographic features that raise suspicion for takotsubo. European Heart Journal: Acute Cardiovascular Care. 2018;7(3):230-5$59$YR$$M$Y$$$20240701$$HP$US$US
240334091$24033409$1$I$$20230814$20240701$20240701$PER$$US-UCBSA-2023040705$UCB$Scott Z, Zhou C, Tracy E, ElMallah MK, Yousef S.. Congenital lobar emphysema in monozygotic twins. Respiratory Medicine Case Reports. 2023;43:1-5$2$MON$$M$Y$$$20240701$$HP$US$US
240334102$24033410$2$F$20240614$20240710$20240701$20240716$PER$$US-AMGEN-USASP2024127318$AMGEN$$77$YR$E$F$Y$$$20240716$$CN$US$US
240334111$24033411$1$I$$20230918$20240701$20240701$PER$$US-UCBSA-2023046147$UCB$Duron S, Dominguez M, Calleo V. Systemic lidocaine toxicity secondary to topical application in a pediatric patient. Clinical Toxicology. 2023;61 (2):168-9$4$YR$$F$Y$$$20240701$$HP$US$US
240334121$24033412$1$I$$20230904$20240701$20240701$PER$$US-UCBSA-2023043982$UCB$Mallaro HL, Rosenthal LJ. DRESS syndrome: quetiapine associated case report and literature review. International Clinical Psychopharmacology. 2023;38(5):356-60$33$YR$$F$Y$$$20240701$$MD$US$US
240334131$24033413$1$I$$20240618$20240701$20240701$EXP$$JP-AMGEN-JPNSP2024127755$AMGEN$$$$$$Y$$$20240701$$MD$JP$JP
240334141$24033414$1$I$20240623$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127280$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240334151$24033415$1$I$$20231009$20240701$20240701$PER$$US-UCBSA-2023049084$UCB$Arian M, Stoever J. Phenobarbital: The ultimate antitussive. Chest. 2023;164(4):1993A$45$YR$$M$Y$$$20240701$$HP$US$US
240334161$24033416$1$I$$20230911$20240701$20240701$PER$$US-UCBSA-2023044984$UCB$Akkanti B, Zwischenberger J, Warner MT, Dinh K, Hussain R, Kazzaz F et al.. COVID-19 and Blood Clots: A Report of Massive Pulmonary Embolism in COVID-19 Patient Supported on Veno-Venous ECMO and the Utility of Thrombolysis. The Journal of ExtraCorporeal Technology. 2022;54(3):235?8$53$YR$$F$Y$$$20240701$$MD$US$US
240334171$24033417$1$I$$20240624$20240701$20240701$EXP$$US-AMGEN-USASP2024125190$AMGEN$Qassab O. A.; Ali A.; Aglan A.. Amiodarone-induced Acute Respiratory Distress Syndrome After Atrial Fibrillation Catheter Ablation and Watchman Device Implant. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A2003$70$YR$E$F$Y$$$20240701$$HP$US$US
240334181$24033418$1$I$$20240620$20240701$20240701$PER$$US-BAUSCHBL-2024BNL028972$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240701$$CN$US$US
240334191$24033419$1$I$$20240620$20240701$20240701$EXP$US-MLMSERVICE-20240613-PI099952-00312-1$US-RDY-SPO/USA/24/0009135$DR REDDYS$Santosh N, Savani S, Iskapalli S. Beefing Up! Fulminant Liver Failure Secondary to Anabolic Steroid Use. American Journal of Respiratory and Critical Care Medicine. 2024:209. DOI: 10.1164/ajrccm conference.2024.209.1_MeetingAbstracts.A5688.$30$YR$A$M$Y$$$20240701$$MD$US$US
240334211$24033421$1$I$20240624$20240625$20240701$20240701$EXP$GB-MHRA-TPP11078819C11285570YC1719247254927$GB-RDY-SPO/GBR/24/0009281$DR REDDYS$$82$YR$E$F$Y$56$KG$20240701$$HP$GB$GB
240334222$24033422$2$F$$20240405$20240701$20240710$PER$$SK-ROCHE-3374880$ROCHE$$30$YR$A$F$Y$$$20240701$$MD$SK$SK
240334231$24033423$1$I$20240620$20240625$20240701$20240701$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2158722$JIANGSU HANSOH PHARMACEUTICAL$$69$YR$$M$Y$47$KG$20240701$$MD$CN$CN
240334241$24033424$1$I$20240404$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031432$AUROBINDO$$77$YR$$M$Y$79$KG$20240701$$MD$FR$FR
240334251$24033425$1$I$$20231107$20240701$20240701$PER$$US-UCBSA-2023053174$UCB$Kalra D.. Asynchronous burst-suppression pattern in eeg after traumatic brain injury (TBI). Journal of Clinical Neurophysiology. 2023;40(6):E62-3$34$YR$$M$Y$$$20240701$$MD$US$US
240334261$24033426$1$I$$20231120$20240701$20240701$PER$$US-UCBSA-2023055490$UCB$Gruzmark F, Shaikh N, Rainey SC, Hanson KA. Safety of Non-Operating Room Anesthesia With Propofol Sedation in Three Pediatric Patients With Central Sleep Apnea. Journal of Pediatric Pharmacology and Therapeutics. 2023;28(6):568-72$9$MON$$F$Y$7.7$KG$20240701$$HP$US$US
240334271$24033427$1$I$$20231120$20240701$20240701$PER$$US-UCBSA-2023055489$UCB$Gruzmark F, Shaikh N, Rainey SC, Hanson KA. Safety of Non-Operating Room Anesthesia With Propofol Sedation in Three Pediatric Patients With Central Sleep Apnea. Journal of Pediatric Pharmacology and Therapeutics. 2023;28(6):568-72$11$MON$$F$Y$8.7$KG$20240701$$HP$US$US
240334281$24033428$1$I$$20231016$20240701$20240701$PER$$US-UCBSA-2023050028$UCB$$$$$F$Y$$$20240701$$CN$US$US
240334291$24033429$1$I$$20231030$20240701$20240701$PER$$US-UCBSA-2023052549$UCB$$6$DEC$$F$Y$$$20240701$$CN$US$US
240334301$24033430$1$I$$20231009$20240701$20240701$PER$$US-UCBSA-2023049211$UCB$Zolezi S, Akhlaq H, Farhat F, Imburgio S, Odak M, Udongwo N, et al. Polyuria In The ICU Setting: Is Dexmedetomidine To Blame?. Chest. 2023;164(4):A2382-3$56$YR$$M$Y$$$20240701$$HP$US$US
240334311$24033431$1$I$$20231011$20240701$20240701$PER$$US-UCBSA-2023049194$UCB$Naveed H, Shyamkumar S, Ike C, Babu Kesavan R, Sarva S. Don^t meth with drugs: a rare presentation of methamphetamine-induced hypokalemic periodic paralysis. Chest. 2023;164(4):A2187-8$31$YR$$M$Y$$$20240701$$HP$US$US
240334321$24033432$1$I$$20231016$20240701$20240701$PER$$US-UCBSA-2023049824$UCB$Roberts J, Afifi S.. Spontaneous Dual Papillary Muscle Rupture in a Postpartum Patient with Ehlers?Danlos Syndrome. Journal of Cardiothoracic and Vascular Anesthesia. 2023;37(11):2299-304$28$YR$$F$Y$$$20240701$$MD$US$US
240334332$24033433$2$F$$20240716$20240701$20240725$EXP$$JP-AMGEN-JPNSP2024126159$AMGEN$$$$$$Y$$$20240725$$PH$JP$JP
240334341$24033434$1$I$$20240305$20240701$20240701$PER$$GB-ROCHE-3521983$ROCHE$$$$T$M$Y$$$20240701$$CN$GB$GB
240334351$24033435$1$I$20240618$20240625$20240701$20240701$PER$$MX-REGENERON PHARMACEUTICALS, INC.-2024-091419$REGENERON$$64$YR$$F$Y$$$20240701$$CN$MX$MX
240334361$24033436$1$I$$20231011$20240701$20240701$PER$$US-UCBSA-2023049240$UCB$Malik M, Demand A. The pressing issue: a case of nontraumatic elevated intracranial pressure due to cerebral amyloid angiopathy-related inflammation (CAA-RI). Chest. 2023;164(4):2088A-9$69$YR$$F$Y$$$20240701$$HP$US$US
240334371$24033437$1$I$$20231017$20240701$20240701$PER$$US-UCBSA-2023050332$UCB$Cohen S, Patel SJ, Grosh T, Augoustides JG, Spelde AE, Vernick W et al.. Surgical Placement of Axillary Impella 5.5 With Regional Anesthesia and Monitored Anesthesia Care. Journal of Cardiothoracic and Vascular Anesthesia. 2023;37(11):2350-60$47$YR$$M$Y$$$20240701$$MD$US$US
240334381$24033438$1$I$$20231011$20240701$20240701$PER$$US-UCBSA-2023049226$UCB$Napoles R, Cabrera R, Schreiber M, Danckers M, Heller D.. The double-edged sword: status epilepticus in a sickle cell patient with moyamoya syndrome and metastatic breast cancer. Chest. 2023;164(4):2885a-86a$36$YR$$F$Y$$$20240701$$HP$US$US
240334391$24033439$1$I$$20231017$20240701$20240701$PER$$US-UCBSA-2023050331$UCB$Cohen S, Patel SJ, Grosh T, Augoustides JG, Spelde AE, Vernick W et al.. Surgical Placement of Axillary Impella 5.5 With Regional Anesthesia and Monitored Anesthesia Care. Journal of Cardiothoracic and Vascular Anesthesia. 2023;37(11):2350-60$54$YR$$M$Y$$$20240701$$MD$US$US
240334401$24033440$1$I$$20240620$20240701$20240701$PER$$US-JNJFOC-20240655640$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240334411$24033441$1$I$$20231017$20240701$20240701$PER$$US-UCBSA-2023050330$UCB$Cohen S, Patel SJ, Grosh T, Augoustides JG, Spelde AE, Vernick W et al. Surgical Placement of Axillary Impella 5.5 With Regional Anesthesia and Monitored Anesthesia Care. Journal of Cardiothoracic and Vascular Anesthesia. 2023;37(11):2350-60$58$YR$$M$Y$$$20240701$$MD$US$US
240334421$24033442$1$I$$20240626$20240701$20240701$EXP$$US-ESPERIONTHERAPEUTICS-2024USA00986$ESPERION THERAPEUTICS$$72$YR$$F$Y$$$20240701$$MD$US$US
240334431$24033443$1$I$$20240620$20240701$20240701$PER$$US-IGSA-BIG0029594$GRIFOLS$$$$$F$Y$64.399$KG$20240701$$CN$US$US
240334441$24033444$1$I$$20240125$20240701$20240701$PER$$US-UCBSA-2024004370$UCB$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al. 2022 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023;61(10):717-939$16$MON$$F$Y$$$20240701$$MD$US$US
240334451$24033445$1$I$20240628$20240628$20240701$20240701$EXP$$GB-ABBVIE-5820672$ABBVIE$$36$YR$$F$Y$106$KG$20240701$$MD$GB$GB
240334461$24033446$1$I$$20231208$20240701$20240701$PER$$US-UCBSA-2023058609$UCB$$$$$F$Y$$$20240701$$CN$US$US
240334471$24033447$1$I$$20231217$20240701$20240701$PER$$US-UCBSA-2023059849$UCB$Dunlay M, Gu C, Adamo D, Welch B, Packard A, Atwell T.. Case series: The use of spermatic cord block in maximising patient comfort during ultrasound-guided percutaneous core-needle biopsy of the testicle. Australasian Journal of Ultrasound in Medicine. 2023;26(4):267-71$74$YR$$M$Y$$$20240701$$HP$US$US
240334481$24033448$1$I$$20231217$20240701$20240701$PER$$US-UCBSA-2023059850$UCB$Dunlay M, Gu C, Adamo D, Welch B, Packard A, Atwell T.. Case series: The use of spermatic cord block in maximising patient comfort during ultrasound-guided percutaneous core-needle biopsy of the testicle. Australasian Journal of Ultrasound in Medicine. 2023;26(4):267-71$67$YR$$M$Y$$$20240701$$HP$US$US
240334491$24033449$1$I$$20231217$20240701$20240701$PER$$US-UCBSA-2023059845$UCB$Dunlay M, Gu C, Adamo D, Welch B, Packard A, Atwell T.. Case series: The use of spermatic cord block in maximising patient comfort during ultrasound-guided percutaneous core-needle biopsy of the testicle. Australasian Journal of Ultrasound in Medicine. 2023;26(4):267-71$78$YR$$M$Y$$$20240701$$HP$US$US
240334501$24033450$1$I$$20240108$20240701$20240701$PER$$US-UCBSA-2024001381$UCB$Catalano TD, Orza D, Orza FM. Repeat, Bilateral Femoral Nerve Blocks with Liposomal Bupivacaine for Analgesia in a Patient with Calciphylaxis: A Case Report. A and A Practice. 2023;17(12):1-3$39$YR$$F$Y$$$20240701$$MD$US$US
240334511$24033451$1$I$$20240122$20240701$20240701$PER$$US-UCBSA-2024003482$UCB$Weyhaupt M, Hardcastle S, Jesse N, Almeida M, Ward HB. Diagnosis and Management of Perimenstrual Cycloid Motility Psychosis. Harvard Review of Psychiatry. 2024;32(1):33-9$23$YR$$F$Y$$$20240701$$MD$US$US
240334521$24033452$1$I$$20240108$20240701$20240701$PER$$US-UCBSA-2024001383$UCB$Stephenson S, Gambill M, Summers M. Emergent percutaneous closure of sub-annular aortic root pseudoaneurysm in the setting of composite graft dehiscence. European Heart Journal-Case Reports. 2023;7(12):1-5$68$YR$$M$Y$$$20240701$$MD$US$US
240334531$24033453$1$I$$20240115$20240701$20240701$PER$$US-UCBSA-2024003034$UCB$Olix DJ, Carollo DS, Ural KG.. Dexmedetomidine Used to Maintain Spontaneous Ventilation in a Patient With Anterior Mediastinal Mass and Superior Vena Cava Syndrome. Ochsner Journal. 2023;23(4):363-66$49$YR$$F$Y$$$20240701$$MD$US$US
240334541$24033454$1$I$$20231212$20240701$20240701$PER$$US-UCBSA-2023058993$UCB$Penumalee L, Dalton A. Anesthetic management of a patient with severe Pulmonary arterial hypertension for incarcerated umbilical Hernia repair. Journal of Investigative Medicine. 2023;71(7):33-4$66$YR$$F$Y$$$20240701$$HP$US$US
240334551$24033455$1$I$$20231219$20240701$20240701$PER$$US-UCBSA-2023060033$UCB$Arora H, Bode A, Avula S, Naik R, Palleti S, Chandramohan D.. Unilateral foot drop due to prone positioning in COVID-19: A case report. Clinical Case Reports. 2023;11(12):1-4$46$YR$$M$Y$$$20240701$$HP$US$US
240334561$24033456$1$I$$20231211$20240701$20240701$PER$$US-UCBSA-2023059013$UCB$Roy S, Rajan S. REVISTING PROPOFOL INFUSION SYNDROME: EARLY DIAGNOSIS LEADING TO BETTER SURVIVAL AND OUTCOME. Journal of Investigative Medicine. 2023;71(7):239-40$49$YR$$F$Y$$$20240701$$HP$US$US
240334571$24033457$1$I$$20240125$20240701$20240701$PER$$US-UCBSA-2024004371$UCB$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al. 2022 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023;61(10):717-939$3$YR$$M$Y$$$20240701$$MD$US$US
240334581$24033458$1$I$$20231218$20240701$20240701$PER$$US-UCBSA-2023060041$UCB$Thomas C, Tobes D, Trela K, Montes M, Cuppini C, Petty K, et al.. A Case Report of Percutaneous Right Ventricular Assist Device Utilization After Cesarean Delivery in a Patient With Severe Pulmonary Arterial Hypertension. A and A Practice. 2023;17(11):e01728$31$YR$$F$Y$$$20240701$$MD$US$US
240334591$24033459$1$I$$20240205$20240701$20240701$PER$$US-UCBSA-2024006228$UCB$Nawabi A, Sullivan P, De Ruyter M, Pichoff A, King CD, Nawabi P. Surgical approach for kidney transplantation under spinal anesthesia. Journal of Surgical Case Reports. 2020;12:1-2$65$YR$$F$Y$$$20240701$$HP$US$US
240334601$24033460$1$I$$20240212$20240701$20240701$PER$$US-UCBSA-2024007245$UCB$Ernzen J, Pergjika A. Catatonia vs Down Syndrome Regression Disorder: A Case Report on Acute Management for an Adolescent with DS. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64(Supplement):S8-9$14$YR$$F$Y$$$20240701$$HP$US$US
240334611$24033461$1$I$$20240213$20240701$20240701$PER$$US-UCBSA-2024007491$UCB$Maule G, Creamer C, Elsadek R, Abuassi M, Zajecka A, Obeidat O et al. Pseudohypoxic brain swelling following elective lumbar laminectomy: A rare case report and review of literature. Radiology case reports. 2024;19 (4):1351-55$73$YR$$F$Y$$$20240701$$MD$US$US
240334621$24033462$1$I$$20240220$20240701$20240701$PER$$US-UCBSA-2024009118$UCB$Brown JE, Aldred B, Boulter T, Sullivan R, Ver Hoeve J, Pattnaik BR, et al. A case report of retinal dystrophy in patients with PACS1 syndrome. Ophthalmic Genetics. 2024;45(1):103-7$$$$M$Y$$$20240701$$HP$US$US
240334631$24033463$1$I$$20240212$20240701$20240701$PER$$US-UCBSA-2024007377$UCB$Gunasekaran K., Amoah K., Rajasurya V., Buscher GM. Stroke in a young COVID-19 patient. QJM: An International Journal of Medicine. 2020;113(8):573-4$40$YR$$F$Y$$$20240701$$MD$US$US
240334641$24033464$1$I$$20240214$20240701$20240701$PER$$US-UCBSA-2024007006$UCB$$$$$F$Y$$$20240701$$MD$US$US
240334651$24033465$1$I$$20240226$20240701$20240701$PER$$US-UCBSA-2024009749$UCB$Nguyen R, Murra A, Capdeville M.. Chronic Thromboembolic Pulmonary Hypertension Due to a Rare Anterior Mediastinal Venous Malformation. Journal of Cardiothoracic and Vascular Anesthesia. 2024;38(2):552-7$21$YR$$F$Y$$$20240701$$MD$US$US
240334661$24033466$1$I$$20240304$20240701$20240701$PER$$US-UCBSA-2024011064$UCB$Sivakumar S, Young MJ, Popilevsky L. New-Onset Intermittent Deceleration-Dependent Left Bundle Branch Block Following Induction of General Anesthesia in a Healthy Patient: A Case Report. Cureus. 2024;16(2):1-7$46$YR$$M$Y$$$20240701$$HP$US$US
240334671$24033467$1$I$$20240318$20240701$20240701$PER$$US-UCBSA-2024014178$UCB$$9$YR$$M$Y$$$20240701$$CN$US$US
240334681$24033468$1$I$$20240619$20240701$20240701$PER$$US-TEVA-VS-3211821$TEVA$$$$$M$Y$$$20240701$$CN$US$US
240334691$24033469$1$I$$20240326$20240701$20240701$PER$$US-UCBSA-2024014378$UCB$$$$$M$Y$$$20240701$$MD$US$US
240334702$24033470$2$F$$20240624$20240701$20240701$PER$$US-GILEAD-2024-0678441$GILEAD$$$$A$F$Y$$$20240701$$CN$US$US
240334711$24033471$1$I$$20240129$20240701$20240701$PER$$US-UCBSA-2024004777$UCB$Goodman M, Garcia MR, Wang H, Borja MJ, Miller C, Segal D. A Severe Case of Streptococcus pneumoniae Meningoencephalitis in an Infant Resulting in Fatal Strokes. Child Neurology Open. 2024;11:1-4$6$MON$$M$Y$$$20240701$$MD$US$US
240334721$24033472$1$I$$20240125$20240701$20240701$PER$$US-UCBSA-2024004368$UCB$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al. 2022 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023;61(10):717-939$39$YR$$M$Y$$$20240701$$MD$US$US
240334731$24033473$1$I$$20240205$20240701$20240701$PER$$US-UCBSA-2024006249$UCB$Alzghoul H, Kadri F, Ismail MF, Youssef R, Shamaileh M, Al-Assi AR, et al. Paraneoplastic NMDA encephalitis, a case report and an extensive review of available literature. Radiology Case Reports. 2024;19(4):1371-85$20$YR$$F$Y$$$20240701$$MD$US$US
240334741$24033474$1$I$$20240326$20240701$20240701$PER$$US-UCBSA-2024015116$UCB$Brozyna J, Griffin B, Fancher W, Grisanti K. Hidden trigger: A case of perioperative anaphylaxis after chlorhexidine coated central venous line placement. Medically Challenging Case Abstracts/Annals of Allergy, Asthma and Immunology. 2023;131(5):S118-9$45$YR$$M$Y$$$20240701$$HP$US$US
240334751$24033475$1$I$$20240220$20240701$20240701$PER$$US-UCBSA-2024008721$UCB$Kerbage J, Dairo OO, Ketchum L, Smith C, Tobias JD. Pulseless Electrical Activity and Perioperative Cardiac Arrest Due to Undiagnosed and Asymptomatic Hypothyroidism During Outpatient Surgery in an Adolescent. Cardiology Research. 2023;14(6):468-71$18$YR$$F$Y$$$20240701$$HP$US$US
240334761$24033476$1$I$$20240307$20240701$20240701$PER$$US-AMGEN-USASP2024129313$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240334772$24033477$2$F$20240601$20240816$20240701$20240827$PER$$US-BAUSCHBL-2024BNL028976$BAUSCH AND LOMB$$$$$F$Y$$$20240827$$CN$US$US
240334781$24033478$1$I$$20240212$20240701$20240701$PER$$US-UCBSA-2024005644$UCB$Williams S, Coulter A. Use of Intravenous Valproic Acid Loading in the Emergency Department for Acute Mania: Case Report and Literature Review. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64(S):S73$42$YR$$M$Y$$$20240701$$HP$US$US
240334791$24033479$1$I$$20240226$20240701$20240701$PER$$US-UCBSA-2024009663$UCB$Natteru PA, Jayaram S, Sanchez O, Leon K, Mishra A, Nobleza CO. Abdominal Compartment Syndrome with Super-K (Ketamine) for Super-R(efractory) Status Epilepticus: A Case Report. Clinical EEG and Neuroscience. 2024;55(2):230-4$74$YR$$M$Y$$$20240701$$HP$US$US
240334803$24033480$3$F$$20240822$20240701$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-031363$AUROBINDO$Riedhammer C, Dull J, Kestler C, Kadel S, Franz J, Weis P, et al.. Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma. Annals of Hematology. 2024;103(4):1327-1332$58$YR$$F$Y$$$20240903$$MD$DE$DE
240334811$24033481$1$I$$20240402$20240701$20240701$PER$$US-UCBSA-2024016177$UCB$Nasser JJ, Cossogue AS, Saracco JA. Rare case report of a 14 year old female with a painful benign spindle cell neoplasm of fibroma within the tendon sheath of the hallux. Foot and Ankle Surgery: Techniques, Reports and Cases. 2024;4(2)$14$YR$$F$Y$50.3$KG$20240701$$MD$US$US
240334821$24033482$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024125503$AMGEN$$$$$M$Y$$$20240701$$CN$US$US
240334831$24033483$1$I$$20240510$20240701$20240701$PER$$US-AMGEN-USASP2024129334$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240334841$24033484$1$I$$20230902$20240701$20240701$PER$$US-AMGEN-USASP2023235022$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240334851$24033485$1$I$$20240619$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05545$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240334861$24033486$1$I$$20240325$20240701$20240701$PER$$US-UCBSA-2024014805$UCB$Jagadish S, Calhoun AR, Ganganna ST. Recurrent super-refractory status epilepticus and stroke like episode in a patient with Behr syndrome secondary to biallelic variants in OPA1 gene. Epilepsy and Behavior Reports. 2024;25:1-6$7$YR$$M$Y$$$20240701$$HP$US$US
240334871$24033487$1$I$20230101$20240611$20240701$20240701$PER$$US-JNJFOC-20240633539$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240701$$CN$US$US
240334881$24033488$1$I$$20240627$20240701$20240701$PER$$US-JNJFOC-20240675435$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$US$US
240334891$24033489$1$I$$20240318$20240701$20240701$PER$$US-UCBSA-2024013752$UCB$Vikash F, Vikash S, Ho S, Kotler D, Patel S.. Intensive Care Unit-Related Cholangiopathy-Induced Biliary Cast Syndrome Without Liver Transplantation: A Rare Entity. ACG Case Reports Journal. 2024;11(2):1-5$41$YR$$M$Y$$$20240701$$MD$US$US
240334902$24033490$2$F$$20240801$20240701$20240805$PER$$US-JNJFOC-20240633198$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$HP$US$US
240334912$24033491$2$F$20240706$20240708$20240701$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002761$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240730$$CN$US$US
240334921$24033492$1$I$$20240625$20240701$20240701$PER$$US-HALEON-2183810$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240334931$24033493$1$I$$20240506$20240701$20240701$PER$$US-UCBSA-2024022953$UCB$$$$$F$Y$$$20240701$$MD$US$US
240334941$24033494$1$I$$20240520$20240701$20240701$PER$$US-UCBSA-2024020857$UCB$$$$$F$Y$$$20240701$$CN$US$US
240334951$24033495$1$I$$20240423$20240701$20240701$PER$$US-UCBSA-2024020552$UCB$Rivero A, Torp K, Klingbeil R, Kusumoto F. Virtual Reality as an Anesthetic Alternative for Ablation of Noninducible Ventricular Arrhythmia. Journal of Cardiothoracic and Vascular Anesthesia. 2024;38(5):1198-1202$60$YR$$F$Y$78$KG$20240701$$MD$US$US
240334961$24033496$1$I$$20240513$20240701$20240701$PER$$US-UCBSA-2024023915$UCB$Saber M, Zichichi A, Ammar M. Serotonin syndrome due to kratom and antidepressant interaction: a case study. Critical Care Medicine. 2024;52(1):S642$28$YR$$M$Y$$$20240701$$HP$US$US
240334971$24033497$1$I$$20240507$20240701$20240701$PER$$US-UCBSA-2024022612$UCB$Edinoff AN, Hathaway DB, Martinez Garza D, Rosen JH, Suzuki J. The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case report. American Journal on Addictions. 2024;33(3):351-3$51$YR$$M$Y$$$20240701$$MD$US$US
240334981$24033498$1$I$$20240513$20240701$20240701$PER$$US-UCBSA-2024024449$UCB$Kaufman R, Fidahussein S. Wooden chest syndrome: an important consideration in mechanically ventilated ICU patients. Critical Care Medicine. 2024;52(1):S573$60$YR$$F$Y$$$20240701$$HP$US$US
240334991$24033499$1$I$$20240627$20240701$20240701$EXP$GB-MHRA-30687788$GB-ORGANON-O2406GBR002541$ORGANON$$80$YR$$F$Y$$$20240701$$PH$GB$GB
240335001$24033500$1$I$$20240422$20240701$20240701$PER$$US-UCBSA-2024020129$UCB$Scheiber CJ, Teeter EG, Smeltz AM. An Intracardiac Shunt in a Patient Undergoing Left Ventricular Assist Device Implantation. Journal of Cardiothoracic and Vascular Anesthesia. 2024;38(5):1260-4$52$YR$$M$Y$$$20240701$$MD$US$US
240335011$24033501$1$I$20210101$20240501$20240701$20240701$PER$$US-UCBSA-2024021771$UCB$$$$$F$Y$64.41$KG$20240701$$MD$US$US
240335021$24033502$1$I$$20240416$20240701$20240701$PER$$US-UCBSA-2024019039$UCB$Yan BW, Yip D, Mallidi J, Goldschlager N. Dynamic ?spiked helmet sign?: Further evidence for prolonged QT. Journal of Electrocardiology. 2024;84:91-4$69$YR$$F$Y$$$20240701$$MD$US$US
240335031$24033503$1$I$$20240503$20240701$20240701$PER$$US-UCBSA-2024022872$UCB$$$$$F$Y$$$20240701$$CN$US$US
240335041$24033504$1$I$20240606$20240607$20240701$20240701$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002762$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240701$$CN$US$US
240335061$24033506$1$I$20240318$20240623$20240701$20240701$EXP$$GB-AstraZeneca-2024A144185$ASTRAZENECA$$80$YR$$M$Y$96$KG$20240701$$MD$GB$
240335072$24033507$2$F$$20240629$20240701$20240701$30DAY$$US-SANDOZ INC.-SDZ2024US061578$SANDOZ$$$$$M$Y$$$20240701$$HP$US$US
240335081$24033508$1$I$$20240408$20240701$20240701$PER$$US-UCBSA-2024017134$UCB$Hodgson JA, Rivera-Rodriguez H, Wu P, Udani J, Weiss J.. Point-of-Care Ultrasound Aids in the Management of Patient Taking Semaglutide Before Surgery: A Case Report. A and A Practice. 2024;18(3):1-3$61$YR$$F$Y$103$KG$20240701$$MD$US$US
240335091$24033509$1$I$$20240626$20240701$20240701$30DAY$$US-SANDOZ INC.-SDZ2024US061288$SANDOZ$$$$$M$Y$$$20240701$$CN$US$US
240335102$24033510$2$F$$20240819$20240701$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US060465$SANDOZ$$$$$$Y$$$20240821$$CN$US$US
240335121$24033512$1$I$$20240628$20240701$20240701$EXP$$FR-SANDOZ INC.-SDZ2024FR061536$SANDOZ$$86$YR$$M$Y$$$20240701$$MD$FR$FR
240335132$24033513$2$F$$20240627$20240701$20240705$EXP$$US-SANDOZ INC.-SDZ2024US061539$SANDOZ$$$$$$Y$145.45$KG$20240705$$MD$US$US
240335143$24033514$3$F$20240628$20240806$20240701$20240808$EXP$$US-SANDOZ INC.-SDZ2024US061628$SANDOZ$$$$$M$Y$$$20240808$$CN$US$US
240335152$24033515$2$F$20240101$20240401$20240701$20240710$PER$$PY-ROCHE-3497958$ROCHE$$7$YR$C$M$Y$14.7$KG$20240701$$CN$PY$PY
240335164$24033516$4$F$20240101$20240906$20240701$20240919$PER$$US-BAUSCHBL-2024BNL029000$BAUSCH AND LOMB$$97$YR$$F$Y$56.69$KG$20240919$$CN$US$US
240335171$24033517$1$I$20230701$20240628$20240701$20240701$EXP$$PT-SANDOZ INC.-SDZ2024PT057526$SANDOZ$$63$YR$$M$Y$$$20240701$$MD$PT$PT
240335181$24033518$1$I$$20240626$20240701$20240701$30DAY$$US-SANDOZ INC.-SDZ2023US002065$SANDOZ$$$$$M$Y$$$20240701$$CN$US$US
240335191$24033519$1$I$$20240305$20240701$20240701$PER$$US-ROCHE-3521501$ROCHE$$$$C$M$Y$20$KG$20240701$$HP$US$US
240335202$24033520$2$F$$20240223$20240701$20240710$PER$$ES-ROCHE-3495311$ROCHE$$43$YR$A$F$Y$$$20240701$$MD$ES$ES
240335212$24033521$2$F$20240601$20240719$20240701$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002748$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240813$$CN$US$US
240335222$24033522$2$F$20201110$20240828$20240701$20240909$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05631$HIKMA$$64$YR$$F$Y$$$20240909$$CN$US$US
240335231$24033523$1$I$$20240621$20240701$20240701$PER$$US-BAUSCHBL-2024BNL029037$BAUSCH AND LOMB$$$$$F$Y$$$20240701$$CN$US$US
240335241$24033524$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432125$ACCORD$Elsayed M. An Interesting Case of Drug-Induced Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Pulmonary and Renal Involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5780.DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5780$75$YR$E$M$Y$$$20240701$$MD$US$US
240335251$24033525$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432108$ACCORD$Lam E, Santos C, Patrawalla A. A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5651. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5651.$32$YR$A$F$Y$$$20240701$$MD$US$US
240335261$24033526$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432103$ACCORD$Khawam S, Goudie M, Hartfield R, Hassan S, Padder F. A Case of Trazadone and Omeprazole Associated Wenckebach Phenomenon Disguised as Second-degree Mobitz Type 2 AV Block. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5664.$26$YR$A$F$Y$$$20240701$$MD$US$US
240335271$24033527$1$I$$20240626$20240701$20240701$EXP$$JP-GILEAD-2024-0677708$GILEAD$$8$DEC$E$M$Y$$$20240701$$PH$JP$JP
240335281$24033528$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432109$ACCORD$Patel D, Patel D, Chittal A, Malik K, Disilvio B. A Tail of Caution: Pioglitazone Induced Recurrent Pleural Effusion. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2015. Doi: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2015.$68$YR$E$F$Y$$$20240701$$MD$US$US
240335292$24033529$2$F$$20240621$20240701$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05555$LUPIN$$$$$$Y$$$20240704$$HP$US$US
240335301$24033530$1$I$$20240612$20240701$20240701$PER$$US-JNJFOC-20240634046$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240335311$24033531$1$I$$20240623$20240701$20240701$PER$$US-JNJFOC-20240665974$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240335321$24033532$1$I$$20240618$20240701$20240701$PER$$US-JNJFOC-20240650067$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240335332$24033533$2$F$$20240628$20240701$20240703$PER$$US-JNJFOC-20240634156$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240335341$24033534$1$I$$20240325$20240701$20240701$PER$$US-ROCHE-3532985$ROCHE$$2$YR$C$F$Y$11.8$KG$20240701$$CN$US$US
240335352$24033535$2$F$20240622$20240805$20240701$20240807$PER$$US-AMGEN-USASP2024126620$AMGEN$$62$YR$A$M$Y$$$20240807$$CN$US$US
240335361$24033536$1$I$$20240620$20240701$20240701$PER$$US-TAKEDA-2024TUS061977$TAKEDA$$$$$F$Y$$$20240701$$CN$US$US
240335371$24033537$1$I$20240305$20240409$20240701$20240701$PER$$AT-ROCHE-3545560$ROCHE$$1$YR$I$F$Y$6.5$KG$20240701$$MD$AT$AT
240335381$24033538$1$I$20240601$20240622$20240701$20240701$PER$$US-BAUSCHBL-2024BNL029085$BAUSCH AND LOMB$$$$$M$Y$$$20240701$$CN$US$US
240335391$24033539$1$I$$20240627$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104083$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240701$$CN$US$US
240335412$24033541$2$F$20240129$20240301$20240701$20240710$PER$$AR-ROCHE-3505740$ROCHE$$1$YR$I$F$Y$$$20240701$$CN$AR$AR
240335421$24033542$1$I$$20240220$20240701$20240701$PER$$JP-ROCHE-3520392$ROCHE$$6$DEC$A$M$Y$$$20240701$$MD$JP$JP
240335431$24033543$1$I$$20240627$20240701$20240701$EXP$GB-MHRA-WEBRADR-202406271458475810-KHQWP$GB-TAKEDA-2024TUS064715$TAKEDA$$23$YR$$F$Y$$$20240701$$HP$GB$GB
240335441$24033544$1$I$20231211$20240207$20240701$20240701$PER$$US-ROCHE-3508247$ROCHE$$$$C$F$Y$$$20240701$$CN$US$US
240335451$24033545$1$I$$20240220$20240701$20240701$PER$$US-ROCHE-3513558$ROCHE$$18$YR$A$F$Y$89.7$KG$20240701$$CN$US$US
240335461$24033546$1$I$20240601$20240627$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103893$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$81$KG$20240701$$CN$US$US
240335471$24033547$1$I$20240101$20240625$20240701$20240701$EXP$$US-TAKEDA-US201920233$TAKEDA$$33$YR$$F$Y$$$20240701$$HP$US$US
240335481$24033548$1$I$$20240321$20240701$20240701$PER$$FR-ROCHE-3533400$ROCHE$$11$YR$C$F$Y$$$20240701$$PH$FR$FR
240335492$24033549$2$F$$20240219$20240701$20240710$PER$$US-ROCHE-3509388$ROCHE$$13$YR$T$F$Y$19.87$KG$20240701$$CN$US$US
240335501$24033550$1$I$20240601$20240624$20240701$20240701$PER$$US-BAUSCHBL-2024BNL029086$BAUSCH AND LOMB$$$$$F$Y$$$20240701$$CN$US$US
240335512$24033551$2$F$20240626$20240722$20240701$20240724$PER$$US-AMGEN-USASP2024127127$AMGEN$$84$YR$E$F$Y$$$20240724$$CN$US$US
240335521$24033552$1$I$$20240626$20240701$20240701$EXP$$CA-SANDOZ INC.-SDZ2023CA076612$SANDOZ$$44$YR$$F$Y$70$KG$20240701$$HP$CA$CA
240335541$24033554$1$I$20240624$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024126682$AMGEN$$78$YR$E$F$Y$$$20240701$$CN$US$US
240335551$24033555$1$I$20240622$20240625$20240701$20240701$EXP$$US-GILEAD-2024-0678731$GILEAD$$40$YR$A$$Y$$$20240701$$CN$US$US
240335561$24033556$1$I$20240322$20240322$20240701$20240701$PER$$US-ROCHE-3533007$ROCHE$$10$YR$C$F$Y$27$KG$20240701$$CN$US$US
240335571$24033557$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126016$AMGEN$Wang T.M.; Sorathia S.; Arockiam A.D.; et al.. Catastrophic antiphospholipid syndrome: challenging case and importance of multidisciplinary evaluation and management. Clinical Case Reports. 2024;12 (6):1-8$20$YR$A$M$Y$$$20240701$$HP$US$US
240335581$24033558$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184484$Haleon PLC$$66$YR$$F$Y$$$20240701$$CN$US$US
240335593$24033559$3$F$$20240703$20240701$20240711$EXP$$GB-CELLTRION INC.-2024GB015556$CELLTRION$$$$$$Y$$$20240711$$CN$GB$GB
240335601$24033560$1$I$20240101$20240628$20240701$20240701$EXP$$US-UCBSA-2024025913$UCB$$$$$F$Y$$$20240701$$CN$US$US
240335611$24033561$1$I$$20240626$20240701$20240701$PER$$US-TAKEDA-2024TUS065023$TAKEDA$$19$YR$$M$Y$$$20240701$$HP$US$US
240335621$24033562$1$I$20240613$20240626$20240701$20240701$EXP$$TR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036857$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$66.1$KG$20240701$$MD$TR$TR
240335641$24033564$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104343$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240701$$HP$US$US
240335651$24033565$1$I$$20240624$20240701$20240701$EXP$$ZA-JNJFOC-20240663161$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$ZA$ZA
240335662$24033566$2$F$$20240703$20240701$20240712$EXP$$ES-TEVA-VS-3212906$TEVA$Aviles-Prieto J, Caro-Magdaleno M, Rodriguez-de-la-Rua-Franch E. Peripheral Ulcerative Keratopathy following Systemic Treatment with Bortezomib: A Case Report. Ocular-Immunol-Inflamm 2024; 32 (4): 470-472.; Aviles-Prieto J, Caro-Magdaleno M, Rodriguez-de-la-Rua-Franch E. Peripheral Ulcerative Keratopathy following Systemic Treatment with Bortezomib: A Case Report. Ocular-Immunol-Inflamm 2024; 32 (4): 470-472.; Aviles-Prieto J, Caro-Magdaleno M, Rodriguez-de-la-Rua-Franch E. Peripheral Ulcerat...$60$YR$$M$Y$$$20240712$$MD$ES$ES
240335671$24033567$1$I$$20240627$20240701$20240701$EXP$$PL-BAUSCHBL-2024BNL029325$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240701$$MD$PL$PL
240335681$24033568$1$I$$20240219$20240701$20240701$PER$$DE-ROCHE-3514962$ROCHE$$47$YR$A$F$Y$$$20240701$$HP$DE$DE
240335691$24033569$1$I$$20240618$20240701$20240701$EXP$$US-CIPLA LTD.-2024US06733$CIPLA$Buleza N.B, Khawam S, Midani A, Kreidy  M.. Ouch my chest hurts! paraganglioma induced hypertensive crisis and stroke. Am J Respir Crit Care Med. 2024;209:A7029$$$$$Y$$$20240701$$HP$US$US
240335701$24033570$1$I$$20240617$20240701$20240701$PER$$US-AstraZeneca-2024A140210$ASTRAZENECA$$$$$$Y$$$20240701$$CN$US$
240335712$24033571$2$F$20240501$20240722$20240701$20240724$EXP$$JP-EXELIXIS-CABO-24078942$EXELIXIS$$8$DEC$$M$Y$$$20240723$$MD$JP$JP
240335721$24033572$1$I$$20240624$20240701$20240701$EXP$$JP-EXELIXIS-CABO-24078902$EXELIXIS$$$$$M$Y$$$20240701$$MD$JP$JP
240335731$24033573$1$I$$20240618$20240701$20240701$EXP$$US-CIPLA LTD.-2024US06648$CIPLA$Goldberg E, Syed A, Desai S, Franco R, Ali Z.. Diffuse alveolar hemorrhage secondary to Hydralazine-induced vasculitis causing pulmonary-renal syndrome. Am J Respir Crit Care Med. 2024;209:A2007$$$$$Y$$$20240701$$HP$US$US
240335741$24033574$1$I$$20240618$20240701$20240701$EXP$$US-CIPLA LTD.-2024US06687$CIPLA$Laughter MR, Orlow SJ, Tegla CA, Pawar S, Moshiri AS. Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C. JAAD. 2024;49:28 to 31$$$$$Y$$$20240701$$MD$US$US
240335751$24033575$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104464$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240701$$CN$US$US
240335761$24033576$1$I$20240624$20240624$20240701$20240701$EXP$$US-AMGEN-USASP2024125633$AMGEN$$54$YR$A$F$Y$$$20240701$$CN$US$US
240335771$24033577$1$I$20240626$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024127765$AMGEN$$63$YR$A$F$Y$$$20240701$$CN$US$US
240335781$24033578$1$I$$20240219$20240701$20240701$PER$$US-ROCHE-3512649$ROCHE$$18$YR$A$F$Y$$$20240701$$CN$US$US
240335791$24033579$1$I$$20240621$20240701$20240701$EXP$$DE-ADVANZ PHARMA-202406005229$ADVANZ PHARMA$$$$$$Y$$$20240701$$PH$DE$DE
240335801$24033580$1$I$$20240618$20240701$20240701$EXP$$US-CIPLA LTD.-2024US06715$CIPLA$Peters JD, Shastri D, Hajjar S, York J, Erpenwar S, Vanlandingham A.. A rare case of Hydralazine-induced diffuse alveolar hemorrhage.. Am J Respir Crit Care Med. 2024;209: A2021$$$$$Y$$$20240701$$HP$US$US
240335812$24033581$2$F$20240210$20240217$20240701$20240710$PER$$US-ROCHE-3511861$ROCHE$$42$YR$A$F$Y$$$20240701$$CN$US$US
240335821$24033582$1$I$$20240214$20240701$20240701$PER$$BR-ROCHE-3491184$ROCHE$$11$MON$I$F$Y$9.15$KG$20240701$$HP$BR$BR
240335831$24033583$1$I$$20240418$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05956$HIKMA$$51$YR$$F$Y$$$20240701$$MD$US$US
240335841$24033584$1$I$20240304$20240621$20240701$20240701$EXP$$GB-AUROBINDO-AUR-APL-2024-031236$AUROBINDO$$$$$F$Y$$$20240701$$PH$GB$GB
240335851$24033585$1$I$$20240621$20240701$20240701$30DAY$$US-GSK-US2024078064$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240335862$24033586$2$F$$20240718$20240701$20240727$30DAY$$US-GSK-US2024077688$GLAXOSMITHKLINE$$$$$F$Y$$$20240727$$MD$US$US
240335871$24033587$1$I$$20240621$20240701$20240701$30DAY$$US-GSK-US2024AMR078466$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240335881$24033588$1$I$$20240312$20240701$20240701$PER$$US-ROCHE-3525914$ROCHE$$$$E$F$Y$$$20240701$$HP$US$US
240335892$24033589$2$F$$20240709$20240701$20240711$EXP$$SI-BAUSCH-BL-2024-009993$BAUSCH AND LOMB$Trampuz B. Elektrolitne motnje na urgenci-Klinicni primeri in urgentno zdravljenje. Urgentna Medicina-Izbrana Poglavja. 2024;142-146.$75$YR$$M$Y$$$20240711$$MD$SI$SI
240335901$24033590$1$I$20240613$20240627$20240701$20240701$EXP$FR-AFSSAPS-BX2024001270$FR-BAUSCH-BL-2024-010051$BAUSCH AND LOMB$$36$YR$$M$Y$123$KG$20240701$$PH$FR$FR
240335911$24033591$1$I$$20240627$20240701$20240701$EXP$$US-BAUSCH-BL-2024-010031$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240701$$CN$US$US
240335921$24033592$1$I$$20240626$20240701$20240701$EXP$$CA-BAUSCH-BL-2024-009942$BAUSCH AND LOMB$$37$YR$$F$Y$$$20240701$$CN$CA$CA
240335931$24033593$1$I$$20240627$20240701$20240701$EXP$$US-BAUSCH-BL-2024-010020$BAUSCH AND LOMB$$80$YR$$M$Y$$$20240701$$CN$US$US
240335942$24033594$2$F$$20240719$20240701$20240723$EXP$$PL-BAUSCH-BL-2024-010001$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240723$$MD$PL$PL
240335953$24033595$3$F$$20240905$20240701$20240917$EXP$$PT-AUROBINDO-AUR-APL-2024-031794$AUROBINDO$Coimbra. M, De Sousa. A. S, Semedo. E. Sindrome de Horner e Simpatectomia do Membro Superior Ipsilateral apos Bloqueio Epidural Lombar.. REVISTA DA SOCIEDADE PORTUGUESA DE ANESTESIOLOGIA.. 2024;33 (Supp 1):43$29$YR$$F$Y$$$20240917$$HP$PT$PT
240335961$24033596$1$I$$20240408$20240701$20240701$PER$$IN-ROCHE-3545323$ROCHE$$1$YR$I$F$Y$$$20240701$$CN$IN$IN
240335971$24033597$1$I$20240621$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024129454$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240335981$24033598$1$I$20240523$20240625$20240701$20240701$EXP$$US-GILEAD-2024-0678720$GILEAD$$67$YR$E$F$Y$$$20240701$$CN$US$US
240335992$24033599$2$F$20231025$20240628$20240701$20240704$EXP$$US-BAUSCHBL-2024BNL029122$BAUSCH AND LOMB$$2$MON$$F$Y$$$20240704$$CN$US$US
240336001$24033600$1$I$20240616$20240625$20240701$20240701$EXP$$US-ARGENX-2024-ARGX-US004888$ARGENX BVBA$$$$$$Y$$$20240701$$CN$US$US
240336011$24033601$1$I$20240614$20240626$20240701$20240701$EXP$$US-TAKEDA-2024TUS015918$TAKEDA$$58$YR$$F$Y$105$KG$20240701$$CN$US$US
240336021$24033602$1$I$20130305$20240424$20240701$20240701$EXP$$US-BEH-2013036768$CSL BEHRING$$21$YR$A$M$Y$106.6$KG$20240701$$MD$US$US
240336041$24033604$1$I$20240322$20240621$20240701$20240701$EXP$$US-GILEAD-2024-0665733$GILEAD$$85$YR$E$F$Y$$$20240701$$HP$US$US
240336052$24033605$2$F$20230711$20240318$20240701$20240710$PER$$DE-ROCHE-3463669$ROCHE$$24$YR$A$M$Y$64$KG$20240701$$MD$DE$DE
240336061$24033606$1$I$20090710$20240624$20240701$20240701$PER$$US-JNJFOC-20240666469$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240701$$HP$US$US
240336071$24033607$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05489$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240336081$24033608$1$I$$20240320$20240701$20240701$PER$$US-ROCHE-3531236$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240336091$24033609$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104511$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240701$$CN$US$US
240336102$24033610$2$F$$20240626$20240701$20240705$PER$$US-AMGEN-USASP2024126515$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240336111$24033611$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104421$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$84.37$KG$20240701$$CN$US$US
240336131$24033613$1$I$20240621$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024129465$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240336141$24033614$1$I$$20240623$20240701$20240701$EXP$$US-GTI-000249$Granulation Technology, INC$$75$YR$E$F$Y$$$20240625$$MD$US$US
240336162$24033616$2$F$20240613$20240903$20240701$20240924$30DAY$$US-BECTON DICKINSON-US-BD-24-000387$BECTON DICKINSON$$$$$$Y$$$20240924$$CN$US$US
240336171$24033617$1$I$$20240624$20240701$20240701$EXP$$CN-SA-2024SA188005$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240701$$MD$CN$CN
240336181$24033618$1$I$20240603$20240621$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031345$AUROBINDO$$82$YR$$M$Y$$$20240701$$MD$FR$FR
240336192$24033619$2$F$$20240813$20240701$20240909$30DAY$$US-BECTON DICKINSON-US-BD-24-000388$BECTON DICKINSON$$$$$$Y$$$20240909$$CN$US$US
240336201$24033620$1$I$20240501$20240625$20240701$20240701$EXP$$CA-JNJFOC-20240669041$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240701$$HP$CA$CA
240336212$24033621$2$F$20240524$20240627$20240701$20240707$PER$$US-JNJFOC-20240680393$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240707$$MD$US$US
240336221$24033622$1$I$$20240620$20240701$20240701$PER$$US-JNJFOC-20240680115$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240701$$CN$US$US
240336231$24033623$1$I$$20240625$20240701$20240701$PER$$US-LEO Pharma-371577$LEO PHARM$$42$YR$$M$Y$$$20240701$$CN$US$US
240336242$24033624$2$F$20240612$20240717$20240701$20240809$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000386$BECTON DICKINSON$$$$$$Y$$$20240809$$CN$GB$GB
240336251$24033625$1$I$20240514$20240626$20240701$20240701$EXP$$US-TAKEDA-2024TUS009694$TAKEDA$$50$YR$$F$Y$$$20240701$$CN$US$US
240336263$24033626$3$F$20240604$20240708$20240701$20240712$EXP$$IE-ABBVIE-5820912$ABBVIE$$59$YR$$F$Y$$$20240712$$HP$IE$IE
240336271$24033627$1$I$$20240620$20240701$20240701$EXP$$US-AUROBINDO-AUR-APL-2024-031135$AUROBINDO$Elkhapery A, Vallabhajosyula S, Niu C, Taifour H, O^Connor K.. An Unintentional Second Chance: Co-poisoning With Insulin Glargine and Carvidolol.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5660$54$YR$$M$Y$$$20240701$$MD$US$US
240336282$24033628$2$F$20240601$20240702$20240701$20240708$EXP$$JP-EXELIXIS-CABO-24078853$EXELIXIS$$6$DEC$$M$Y$$$20240708$$MD$JP$JP
240336291$24033629$1$I$20240526$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A147727$ASTRAZENECA$$$$$F$Y$$$20240701$$CN$US$
240336301$24033630$1$I$20240621$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024129466$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240336311$24033631$1$I$$20240626$20240701$20240701$EXP$$JP-009507513-2406JPN004045J$MERCK$$55$YR$$M$Y$$$20240701$$MD$JP$JP
240336321$24033632$1$I$$20240622$20240701$20240701$EXP$$AU-TAKEDA-2024TUS065109$TAKEDA$$$$$M$Y$83.2$KG$20240701$$MD$AU$AU
240336331$24033633$1$I$20220711$20240624$20240701$20240701$EXP$$US-RDY-CLI/USA/23/0178436$DR REDDYS$$20$YR$A$F$Y$$$20240701$$CN$US$US
240336341$24033634$1$I$20240612$20240621$20240701$20240701$PER$$US-RDY-SPO/USA/24/0009137$DR REDDYS$$66$YR$E$M$Y$$$20240701$$MD$US$US
240336351$24033635$1$I$$20240626$20240701$20240701$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-090179$REGENERON$$$$$M$Y$$$20240701$$HP$US$US
240336371$24033637$1$I$20240201$20240304$20240701$20240701$PER$$US-AJANTA-2024AJA00041$AJANTA PHARMA$$37$YR$A$F$Y$135$KG$20240701$$CN$US$US
240336382$24033638$2$F$20240620$20240722$20240701$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036838$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$146$KG$20240723$$MD$US$US
240336391$24033639$1$I$20240621$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024129469$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240336411$24033641$1$I$20230101$20240626$20240701$20240701$EXP$$US-ABBVIE-5818904$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240336421$24033642$1$I$$20240622$20240701$20240701$PER$$US-ABBVIE-5816185$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240336431$24033643$1$I$20240605$20240627$20240701$20240701$EXP$$US-ABBVIE-5820942$ABBVIE$$77$YR$$F$Y$$$20240701$$CN$US$US
240336441$24033644$1$I$20231001$20240621$20240701$20240701$EXP$GB-MHRA-MED-202406211105419530-SVCRT$GB-AMGEN-GBRSP2024125670$AMGEN$$10$YR$C$F$Y$46$KG$20240701$$HP$GB$GB
240336451$24033645$1$I$$20240625$20240701$20240701$PER$$US-JNJFOC-20240667267$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$US$US
240336461$24033646$1$I$$20240621$20240701$20240701$EXP$$CA-TAKEDA-2024TUS063135$TAKEDA$$$$$F$Y$$$20240701$$CN$CA$CA
240336471$24033647$1$I$$20240625$20240701$20240701$EXP$$CA-TAKEDA-2024TUS064095$TAKEDA$$$$$M$Y$$$20240701$$MD$CA$CA
240336482$24033648$2$F$20240601$20240712$20240701$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002752$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240805$$CN$US$US
240336491$24033649$1$I$20230530$20240628$20240701$20240701$EXP$$GB-ABBVIE-5769848$ABBVIE$$$$C$F$Y$12$KG$20240701$$MD$GB$GB
240336502$24033650$2$F$20230101$20240429$20240701$20240710$PER$$US-ROCHE-3544673$ROCHE$$11$YR$C$M$Y$43.4$KG$20240701$$HP$US$US
240336513$24033651$3$F$20240312$20240312$20240701$20240710$PER$$US-ROCHE-3526274$ROCHE$$$$$F$Y$41.41$KG$20240701$$CN$US$US
240336522$24033652$2$F$$20240719$20240701$20240725$EXP$$JP-AMGEN-JPNSP2024125328$AMGEN$$62$YR$A$F$Y$$$20240725$$MD$JP$JP
240336532$24033653$2$F$20240606$20240709$20240701$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002742$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240731$$HP$US$US
240336541$24033654$1$I$20240621$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024129477$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240336551$24033655$1$I$20240621$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024129472$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240336561$24033656$1$I$20240622$20240622$20240701$20240701$EXP$$GB-AUROBINDO-AUR-APL-2024-031366$AUROBINDO$$64$YR$$M$Y$77$KG$20240701$$CN$GB$GB
240336573$24033657$3$F$20240601$20240813$20240701$20240820$EXP$$CA-JNJFOC-20240665475$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240820$$HP$CA$CA
240336581$24033658$1$I$$20240620$20240701$20240701$EXP$$GB-JNJFOC-20240662514$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240701$$CN$GB$GB
240336591$24033659$1$I$$20240620$20240701$20240701$PER$$US-JNJFOC-20240680370$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240701$$PH$US$US
240336601$24033660$1$I$$20240626$20240701$20240701$EXP$$HU-Bion-013334$BIONPHARMA$$$$$$Y$$$20240701$$HP$HU$HU
240336611$24033661$1$I$$20240626$20240701$20240701$EXP$$US-Bion-013322$BIONPHARMA$$50$YR$A$M$Y$$$20240701$$HP$US$US
240336621$24033662$1$I$$20240626$20240701$20240701$EXP$$US-Bion-013328$BIONPHARMA$$52$YR$A$M$Y$$$20240701$$HP$US$US
240336631$24033663$1$I$$20240626$20240701$20240701$EXP$$PL-Bion-013341$BIONPHARMA$$53$YR$A$F$Y$$$20240701$$HP$PL$US
240336642$24033664$2$F$$20240805$20240701$20240817$EXP$$US-AUROBINDO-AUR-APL-2024-032079$AUROBINDO$$$$$F$Y$$$20240817$$CN$US$US
240336651$24033665$1$I$$20240626$20240701$20240701$EXP$$US-Bion-013333$BIONPHARMA$$77$YR$E$F$Y$$$20240701$$HP$US$US
240336661$24033666$1$I$$20240626$20240701$20240701$EXP$$US-TAKEDA-2024TUS061663$TAKEDA$$$$$M$Y$10.66$KG$20240701$$HP$US$US
240336672$24033667$2$F$$20240628$20240701$20240703$PER$$US-ABBVIE-5815034$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240336681$24033668$1$I$$20240626$20240701$20240701$EXP$$US-Bion-013336$BIONPHARMA$$87$YR$E$F$Y$$$20240701$$HP$US$US
240336701$24033670$1$I$$20240627$20240701$20240701$EXP$$US-Bion-013347$BIONPHARMA$$3$YR$$F$Y$$$20240701$$HP$US$US
240336711$24033671$1$I$20240611$20240626$20240701$20240701$EXP$$US-TAKEDA-2022TUS057829$TAKEDA$$55$YR$$F$Y$108$KG$20240701$$HP$US$US
240336721$24033672$1$I$$20240622$20240701$20240701$PER$$US-AMGEN-USASP2024124466$AMGEN$$50$YR$A$F$Y$$$20240701$$HP$US$US
240336731$24033673$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024126637$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240336741$24033674$1$I$20240507$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024128437$AMGEN$$64$YR$A$M$Y$$$20240701$$HP$US$US
240336751$24033675$1$I$20240619$20240619$20240701$20240701$PER$$US-TEVA-VS-3213134$TEVA$$27$YR$$F$Y$$$20240701$$HP$US$US
240336761$24033676$1$I$$20240618$20240701$20240701$EXP$$VN-TAKEDA-2024TUS064485$TAKEDA$$55$YR$$M$Y$$$20240701$$MD$VN$VN
240336771$24033677$1$I$20231120$20240216$20240701$20240701$PER$$AT-ROCHE-3494579$ROCHE$$17$YR$T$M$Y$73$KG$20240701$$HP$AT$AT
240336781$24033678$1$I$20240618$20240624$20240701$20240701$EXP$$US-TAKEDA-2024TUS063198$TAKEDA$$59$YR$$M$Y$$$20240701$$MD$US$US
240336791$24033679$1$I$20240101$20240627$20240701$20240701$EXP$$MX-ABBVIE-5821083$ABBVIE$$$$$M$Y$59$KG$20240701$$CN$MX$MX
240336801$24033680$1$I$20230523$20240625$20240701$20240701$EXP$$CN-AMGEN-CHNSP2024126913$AMGEN$$56$YR$A$F$Y$$$20240701$$HP$CN$CN
240336813$24033681$3$F$20240612$20240917$20240701$20240920$EXP$$US-TAKEDA-2024TUS065016$TAKEDA$$67$YR$$M$Y$77$KG$20240920$$CN$US$US
240336821$24033682$1$I$$20240619$20240701$20240701$EXP$$DE-TAKEDA-2024TUS064651$TAKEDA$$$$$$Y$$$20240701$$MD$DE$DE
240336831$24033683$1$I$$20240625$20240701$20240701$EXP$$US-AMGEN-USASP2024126498$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240336841$24033684$1$I$$20230131$20240701$20240701$PER$$US-AMGEN-USASP2023234978$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240336851$24033685$1$I$$20240622$20240701$20240701$PER$$US-AMGEN-USASP2024124497$AMGEN$Pradeep R.; Hanafi Z.; Cole K. T.. Organizing the Haziness: A Case of Cryptogenic Organizing Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A2046$70$YR$E$M$Y$$$20240701$$HP$US$US
240336861$24033686$1$I$20240528$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031685$AUROBINDO$$60$YR$$M$Y$$$20240701$$MD$FR$FR
240336871$24033687$1$I$$20240304$20240701$20240701$PER$$US-ROCHE-3520505$ROCHE$$7$MON$I$$Y$$$20240701$$CN$US$US
240336881$24033688$1$I$20240501$20240621$20240701$20240701$EXP$$FR-AstraZeneca-2024A149568$ASTRAZENECA$$77$YR$$F$Y$$$20240701$$MD$FR$
240336891$24033689$1$I$$20240625$20240701$20240701$EXP$$US-TAKEDA-2024TUS065125$TAKEDA$$$$$M$Y$$$20240701$$CN$US$US
240336901$24033690$1$I$$20240624$20240701$20240701$PER$$BE-AMGEN-USASP2024127578$AMGEN$Blein C.; Barion F.; Ostrovskaya O. et al.. REAL-WORLD TREATMENT PATTERNS IN ADULTS WITH PEMPHIGUS VULGARIS IN THE UNITED STATES. Value in Health. 2024;27 (6):S164$$$$$Y$$$20240701$$HP$BE$US
240336912$24033691$2$F$20240619$20240703$20240701$20240713$PER$$US-AMGEN-USASP2024126875$AMGEN$$68$YR$E$F$Y$$$20240713$$MD$US$US
240336921$24033692$1$I$20240515$20240624$20240701$20240701$EXP$$PT-AUROBINDO-AUR-APL-2024-031581$AUROBINDO$$8$YR$$F$Y$$$20240701$$CN$PT$PT
240336931$24033693$1$I$$20240626$20240701$20240701$EXP$$CH-JAZZ PHARMACEUTICALS-2024-CH-009902$JAZZ$$70$YR$$M$Y$95$KG$20240701$$HP$CH$CH
240336941$24033694$1$I$20201221$20240625$20240701$20240701$EXP$$JP-009507513-2406JPN003571J$MERCK$$76$YR$$F$Y$51$KG$20240701$$PH$JP$JP
240336952$24033695$2$F$20240614$20240711$20240701$20240722$30DAY$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-097645$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240722$$HP$CA$CA
240336961$24033696$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104340$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$CN$US$US
240336971$24033697$1$I$20201231$20240621$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210103106$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$71.21$KG$20240701$$MD$US$US
240336981$24033698$1$I$$20240623$20240701$20240701$EXP$$US-AUROBINDO-AUR-APL-2024-032090$AUROBINDO$$$$$F$Y$$$20240701$$CN$US$US
240336991$24033699$1$I$20240101$20240626$20240701$20240701$PER$$US-ORGANON-O2406USA002695$ORGANON$$$$$$Y$$$20240701$$CN$US$US
240337002$24033700$2$F$$20240723$20240701$20240725$EXP$$US-TAKEDA-2024TUS064317$TAKEDA$$$$$M$Y$$$20240725$$MD$US$US
240337011$24033701$1$I$$20240625$20240701$20240701$EXP$$US-TAKEDA-2024TUS064152$TAKEDA$$$$$$Y$$$20240701$$MD$US$US
240337021$24033702$1$I$20230901$20240624$20240701$20240701$EXP$$US-TAKEDA-2024TUS063126$TAKEDA$$67$YR$$F$Y$$$20240701$$CN$US$US
240337036$24033703$6$F$20240901$20240927$20240701$20240930$EXP$$US-GILEAD-2024-0678752$GILEAD$$53$YR$A$F$Y$74.4$KG$20240930$$CN$US$US
240337041$24033704$1$I$20240603$20240625$20240701$20240701$EXP$$TR-JNJFOC-20240672358$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240701$$MD$TR$TR
240337051$24033705$1$I$20240527$20240624$20240701$20240701$EXP$$CN-JNJFOC-20240665759$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240701$$HP$CN$CN
240337061$24033706$1$I$$20240227$20240701$20240701$PER$$US-ROCHE-3517528$ROCHE$$7$MON$I$M$Y$$$20240701$$CN$US$US
240337071$24033707$1$I$$20240214$20240701$20240701$PER$$US-ROCHE-3510764$ROCHE$$36$YR$A$F$Y$134$KG$20240701$$CN$US$US
240337083$24033708$3$F$$20240320$20240701$20240710$PER$$US-ROCHE-3527573$ROCHE$$$$N$F$Y$$$20240701$$CN$US$US
240337091$24033709$1$I$20230501$20231031$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01162$TARO$$$$$$Y$$$20240701$$CN$US$US
240337101$24033710$1$I$20240621$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127637$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240337111$24033711$1$I$$20240625$20240701$20240701$EXP$$US-AMGEN-USASP2024128052$AMGEN$Kodati S.; Nguyen N. V.; Oyeniran E. et al.. Ultrawide-field fluorescein angiography features in patients with anterior uveitis. Eye. 2024;38 (9):1742-1747$$$$$Y$$$20240701$$HP$US$US
240337121$24033712$1$I$20240624$20240626$20240701$20240701$EXP$GB-MHRA-MED-202406251655192960-LVTRK$GB-GILEAD-2024-0678779$GILEAD$$$$$F$Y$$$20240701$$PH$GB$GB
240337131$24033713$1$I$$20240624$20240701$20240701$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000810$ARBOR$$50$YR$$F$Y$$$20240701$$CN$US$US
240337141$24033714$1$I$20240607$20240701$20240701$20240701$EXP$FR-AFSSAPS-NY2024000731$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036915$BOEHRINGER INGELHEIM$$88$YR$E$F$Y$64.9$KG$20240701$$PH$FR$FR
240337151$24033715$1$I$$20240619$20240701$20240701$EXP$$CN-PDX-000357$PHARMADAX$Lei M, Cao Y, Yuan M, Xiong J, He H. Case report: A case of bradycardia triggered by diarrhea. Front Med (Lausanne). 2024 May 30;11:1405494. doi: 10.3389/fmed.2024.1405494.$92$YR$E$M$Y$$$20240701$$HP$CN$CN
240337161$24033716$1$I$20231208$20240626$20240701$20240701$EXP$$CA-TAKEDA-2024TUS064768$TAKEDA$$24$YR$$M$Y$$$20240701$$MD$CA$CA
240337171$24033717$1$I$20240528$20240621$20240701$20240701$EXP$ES-AEMPS-1533882$ES-TEVA-VS-3213462$TEVA$$73$YR$$M$Y$$$20240701$$PH$ES$ES
240337181$24033718$1$I$20231225$20240308$20240701$20240701$PER$$US-ROCHE-3487644$ROCHE$$1$YR$I$M$Y$7.79$KG$20240701$$CN$US$US
240337193$24033719$3$F$$20240801$20240701$20240808$EXP$$JP-GSK-JP2024JPN078319$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$PH$JP$JP
240337201$24033720$1$I$20240624$20240626$20240701$20240701$30DAY$$US-GSK-US2024AMR080036$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240337211$24033721$1$I$20200101$20240620$20240701$20240701$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000796$AZURITY PHARMACEUTICALS$Meier M., Linn B.S.. Record setting temperatures in the setting of sars-cov-2 suggests dexmedetomidine drug-induced fever: a case report. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-5$51$YR$$M$Y$$$20240701$$PH$US$US
240337221$24033722$1$I$20220321$20240226$20240701$20240701$PER$$DE-ROCHE-3269985$ROCHE$$44$YR$A$F$Y$65$KG$20240701$$MD$DE$DE
240337231$24033723$1$I$$20240220$20240701$20240701$PER$$CA-ROCHE-3513372$ROCHE$$$$$$Y$$$20240701$$MD$CA$CA
240337241$24033724$1$I$$20240614$20240701$20240701$PER$$US-JNJFOC-20240642030$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240337254$24033725$4$F$20231030$20240516$20240701$20240710$PER$$CN-ROCHE-3519654$ROCHE$$14$MON$I$$Y$$$20240701$$MD$CN$CN
240337261$24033726$1$I$$20240604$20240701$20240701$PER$$US-JNJFOC-20240609308$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240337272$24033727$2$F$$20240709$20240701$20240722$PER$$US-JNJFOC-20240679639$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$PH$US$US
240337281$24033728$1$I$20230501$20240621$20240701$20240701$EXP$$US-AMGEN-USASP2024123972$AMGEN$Virk S. T.; Niranjan S.; Patel D. et. al.. Rising From the Shadows: A Case of Delayed Organizing Pneumonia in Granulomatosis With Polyangiitis Post-mild COVID-19. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A2053$66$YR$E$M$Y$$$20240701$$HP$US$US
240337292$24033729$2$F$20240622$20240801$20240701$20240808$30DAY$$US-AMGEN-USASL2024126605$AMGEN$$68$YR$E$F$Y$$$20240807$$HP$US$US
240337301$24033730$1$I$$20240620$20240701$20240701$EXP$$US-AMGEN-USASP2024122667$AMGEN$Rahman O.; Javed F.; Iqbal M. et al.. Progressive Refractory Interstitial Lung Disease Due to Recurrent Aspiration in Bulimia Nervosa. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A2048$44$YR$A$F$Y$$$20240701$$HP$US$US
240337311$24033731$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05496$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240337322$24033732$2$F$20240612$20240701$20240701$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202406019834$ELI LILLY AND CO$$88$YR$E$M$Y$$$20240704$$CN$US$US
240337331$24033733$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019409$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240701$$CN$US$US
240337341$24033734$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019534$ELI LILLY AND CO$$$$A$F$Y$$$20240701$$CN$US$US
240337351$24033735$1$I$20240601$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000098$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240701$$CN$US$US
240337361$24033736$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019320$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240701$$CN$US$US
240337371$24033737$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019232$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240701$$CN$US$US
240337381$24033738$1$I$20240627$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019136$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240701$$CN$US$US
240337391$24033739$1$I$20240601$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018185$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240701$$CN$US$US
240337401$24033740$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019112$ELI LILLY AND CO$$49$YR$A$$Y$$$20240701$$CN$US$US
240337411$24033741$1$I$20240618$20240621$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018060$ELI LILLY AND CO$$79$YR$E$M$Y$122$KG$20240701$$CN$US$US
240337421$24033742$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019115$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240701$$HP$US$US
240337431$24033743$1$I$$20240619$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202309015295$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240701$$CN$US$US
240337441$24033744$1$I$20240624$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019752$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240337451$24033745$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104360$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240701$$CN$US$US
240337461$24033746$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104432$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$70.31$KG$20240701$$CN$US$US
240337471$24033747$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104440$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240701$$CN$US$US
240337482$24033748$2$F$20240529$20240719$20240701$20240724$EXP$$US-BEH-2024174170$CSL BEHRING$$20$YR$A$F$Y$$$20240724$$HP$US$US
240337491$24033749$1$I$$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031534$AUROBINDO$$28$YR$$F$Y$66$KG$20240701$$MD$FR$FR
240337501$24033750$1$I$20240608$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031486$AUROBINDO$$83$YR$$M$Y$$$20240701$$PH$FR$FR
240337511$24033751$1$I$$20240617$20240701$20240701$PER$$US-APOTEX-2024AP007489$APOTEX$$$$E$F$Y$$$20240701$$CN$US$US
240337523$24033752$3$F$20240606$20240703$20240701$20240709$PER$$US-AMGEN-USASP2024127303$AMGEN$$65$YR$E$F$Y$$$20240709$$HP$US$US
240337531$24033753$1$I$$20240625$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102670$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$95$KG$20240701$$PH$US$US
240337541$24033754$1$I$$20230303$20240701$20240701$PER$$US-AMGEN-USASP2023234977$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240337562$24033756$2$F$$20240710$20240701$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-030186$AUROBINDO$Sinha A, Cantrell S, Kozman DM, Jelovsek JE. Ectopic Prostatic Tissue in Female Urethral Diverticulum. Obstet Gynecol. 2024$53$YR$$F$Y$$$20240720$$MD$US$US
240337571$24033757$1$I$$20240613$20240701$20240701$PER$$US-JNJFOC-20240636698$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240337581$24033758$1$I$$20240618$20240701$20240701$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05443$LUPIN$Benandi K, Sieving D, Wolf K. A rare case of meloxicam-induced pseudoporphyria. Dermatology Online Journal. 2024;30(2):19:1-3$55$YR$$F$Y$$$20240701$$HP$US$US
240337591$24033759$1$I$20240522$20240624$20240701$20240701$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-091320$REGENERON$$70$YR$$M$Y$$$20240701$$MD$DE$DE
240337601$24033760$1$I$$20240625$20240701$20240701$PER$$US-JNJFOC-20240669715$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240337611$24033761$1$I$$20240628$20240701$20240701$PER$$US-AstraZeneca-2024A150218$ASTRAZENECA$$$$$M$Y$$$20240701$$MD$US$
240337621$24033762$1$I$20240623$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A147901$ASTRAZENECA$$$$$M$Y$$$20240701$$CN$US$
240337631$24033763$1$I$20240626$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A148243$ASTRAZENECA$$26255$DY$$F$Y$$$20240701$$MD$US$
240337641$24033764$1$I$$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A148128$ASTRAZENECA$$$$$F$Y$$$20240701$$CN$US$
240337651$24033765$1$I$20240205$20240623$20240701$20240701$EXP$$US-AstraZeneca-2024A144352$ASTRAZENECA$$30572$DY$$M$Y$72.6$KG$20240701$$CN$US$
240337662$24033766$2$F$20220706$20240627$20240701$20240705$EXP$$ES-AUROBINDO-AUR-APL-2024-031552$AUROBINDO$$55$YR$$F$Y$$$20240705$$MD$ES$ES
240337671$24033767$1$I$$20240626$20240701$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-103495$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$PH$JP$JP
240337682$24033768$2$F$$20240702$20240701$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-103532$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$PH$JP$JP
240337691$24033769$1$I$$20240617$20240701$20240701$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2017-US-002642$IPCA$Takehide Umeda , Taro Minami , Eleanor M. Summerhill,et al. Metformin Associated Lactic Acidosis. American Journal of Respiratory and Critical Care Medicine. 2017;195:A3776$$$$$Y$$$20240701$$HP$US$US
240337711$24033771$1$I$$20240621$20240701$20240701$EXP$$US-AMGEN-USASP2024123975$AMGEN$Mak K.; Gandhi R.; Zaidan M. F.. Rituximab for Rapidly Progressive MDA5 Dermatomyositis-Associated Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A1986$47$YR$A$M$Y$$$20240701$$HP$US$US
240337721$24033772$1$I$20240619$20240620$20240701$20240701$PER$$US-TEVA-VS-3212146$TEVA$$74$YR$$F$Y$$$20240701$$CN$US$US
240337731$24033773$1$I$$20240628$20240701$20240701$EXP$$LB-BRISTOL-MYERS SQUIBB COMPANY-2024-104204$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240701$$MD$LB$LB
240337741$24033774$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104341$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240701$$HP$US$US
240337751$24033775$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104424$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240701$$CN$US$US
240337763$24033776$3$F$$20240729$20240701$20240808$EXP$$HU-AUROBINDO-AUR-APL-2024-031456$AUROBINDO$Lakatos V, Gopcsa L, Balogh A, Fabian J. T-cell prolymphocytic leukemia treatment and transplantation - two case presentations. Hematologia - Transzfuziologia. 2024;1$52$YR$$M$Y$$$20240808$$HP$HU$HU
240337771$24033777$1$I$20240405$20240621$20240701$20240701$EXP$FR-AFSSAPS-BS2024000354$FR-TEVA-VS-3213460$TEVA$$78$YR$$M$Y$91.6$KG$20240701$$MD$FR$FR
240337782$24033778$2$F$$20240808$20240701$20240818$EXP$$US-GSK-US2024078071$GLAXOSMITHKLINE$$$$$$Y$$$20240818$$HP$US$US
240337791$24033779$1$I$$20240402$20240701$20240701$PER$$US-AMGEN-USASP2024127978$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240337801$24033780$1$I$$20240626$20240701$20240701$EXP$$DE-AMGEN-DEUSP2024126600$AMGEN$$66$YR$E$F$Y$$$20240701$$MD$DE$DE
240337811$24033781$1$I$$20231206$20240701$20240701$PER$$US-AMGEN-USASP2023234990$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240337822$24033782$2$F$$20240723$20240701$20240729$30DAY$$US-AMGEN-USASL2024122938$AMGEN$$$$$$Y$$$20240729$$HP$US$US
240337831$24033783$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104373$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240701$$CN$US$US
240337841$24033784$1$I$20180720$20240624$20240701$20240701$EXP$$ES-AUROBINDO-AUR-APL-2024-031452$AUROBINDO$$88$YR$$F$Y$$$20240701$$MD$ES$ES
240337851$24033785$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104521$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240701$$CN$US$US
240337861$24033786$1$I$$20240620$20240701$20240701$EXP$$US-APOTEX-2024AP007758$APOTEX$Gupta UD, Chowdhury T, Niriyan J, Bellamkonda A, Aryal B, Al-Ghuraibawi M. Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care. American Journal of Respiratory and Critical Care Medicine. 2024;209$43$YR$$F$Y$$$20240701$$HP$US$US
240337871$24033787$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104486$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$47.63$KG$20240701$$CN$US$US
240337882$24033788$2$F$$20240906$20240701$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104352$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240910$$CN$US$US
240337892$24033789$2$F$$20240723$20240701$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002747$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
240337901$24033790$1$I$20240602$20240620$20240701$20240701$EXP$$US-BEH-2024174489$CSL BEHRING$$45$YR$A$M$Y$$$20240701$$HP$US$US
240337911$24033791$1$I$20230101$20240625$20240701$20240701$EXP$$VN-AMGEN-VNMSP2024126053$AMGEN$$66$YR$E$F$Y$$$20240701$$MD$VN$VN
240337922$24033792$2$F$20240618$20240707$20240701$20240710$30DAY$$US-AMGEN-USASP2024125002$AMGEN$$$$$F$Y$$$20240710$$HP$US$US
240337931$24033793$1$I$$20230602$20240701$20240701$PER$$US-AMGEN-USASP2023235055$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240337941$24033794$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127391$AMGEN$$$$A$F$Y$$$20240701$$MD$US$US
240337952$24033795$2$F$$20240703$20240701$20240712$EXP$$GB-TEVA-VS-3214906$TEVA$Bateman DN. Quinine overdose: Not quite gin and tonic. J-R-Coll-Physicians-Edinb 2023; 53 (1): 71-73.; Bateman DN. Quinine overdose: Not quite gin and tonic. J-R-Coll-Physicians-Edinb 2023; 53 (1): 71-73.$$$$M$Y$$$20240712$$HP$GB$GB
240337961$24033796$1$I$$20240626$20240701$20240701$EXP$$US-JNJFOC-20240675363$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$US$US
240337971$24033797$1$I$$20240616$20240701$20240701$PER$$US-JNJFOC-20240644783$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240337981$24033798$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104384$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$69.85$KG$20240701$$CN$US$US
240338001$24033800$1$I$$20230515$20240701$20240701$PER$$US-AMGEN-USASP2023235058$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240338012$24033801$2$F$$20240930$20240701$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-103872$BRISTOL MYERS SQUIBB$$74$YR$E$$Y$$$20240930$$MD$JP$JP
240338021$24033802$1$I$20240605$20240605$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-091708$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240701$$HP$US$US
240338032$24033803$2$F$$20240808$20240701$20240818$30DAY$$US-GSK-US2024078065$GLAXOSMITHKLINE$$$$$F$Y$94.6$KG$20240818$$MD$US$US
240338041$24033804$1$I$$20240418$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05865$HIKMA$Hoyt D, Hughes J, Liu J, Ayyad H.. Hoyt D, Hughes J, Liu J, Ayyad H. Primary central nervous system post-transplantation lymphoproliferative disorder: A case report and systematic review of imaging findigs.. Radiology Case Reports. 2024;19(6):2168-2182$$$$$Y$$$20240701$$MD$US$US
240338051$24033805$1$I$$20240619$20240701$20240701$PER$$US-JNJFOC-20240655838$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240338061$24033806$1$I$20240610$20240617$20240701$20240701$PER$$US-JNJFOC-20240656705$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$HP$US$US
240338071$24033807$1$I$$20240619$20240701$20240701$PER$$US-JNJFOC-20240652237$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240338082$24033808$2$F$$20240730$20240701$20240812$30DAY$$DE-JNJFOC-20240675284$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$PH$DE$DE
240338091$24033809$1$I$20240417$20240618$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-05615$HIKMA$$41$YR$$M$Y$$$20240701$$MD$US$US
240338102$24033810$2$F$$20240619$20240701$20240702$EXP$$US-JNJFOC-20240656219$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240338111$24033811$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018949$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240701$$CN$US$US
240338121$24033812$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019635$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240701$$CN$US$US
240338131$24033813$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019848$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240701$$CN$US$US
240338141$24033814$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019001$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240701$$CN$US$US
240338151$24033815$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019841$ELI LILLY AND CO$$$$A$M$Y$$$20240701$$CN$US$US
240338161$24033816$1$I$$20240212$20240701$20240701$PER$$US-AMGEN-USASP2024129613$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240338172$24033817$2$F$$20240715$20240701$20240723$EXP$$AT-AMGEN-AUTSP2024125889$AMGEN$Worel, N.. SERIOUS ADVERSE EVENTS OR REACTIONS IN RELATED DONORS AFTER HPC DONATION. A REPORT FROM THE EBMT DONOR OUTCOME REGISTRY. Bone Marrow Transplantation. 2023;58:142-143$$$$$Y$$$20240723$$MD$AT$AT
240338182$24033818$2$F$20231025$20240626$20240701$20240704$EXP$$IT-CELLTRION INC.-2024IT015498$CELLTRION$$$$$$Y$$$20240704$$MD$IT$IT
240338191$24033819$1$I$$20240626$20240701$20240701$PER$$US-TAKEDA-2024TUS065126$TAKEDA$$$$E$F$Y$$$20240701$$CN$US$US
240338211$24033821$1$I$$20240622$20240701$20240701$PER$$US-ABBVIE-5816248$ABBVIE$$$$$$Y$$$20240701$$CN$US$US
240338221$24033822$1$I$$20240621$20240701$20240701$PER$$US-ABBVIE-5814150$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240338241$24033824$1$I$$20240123$20240701$20240701$PER$$US-AMGEN-USASP2024129673$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240338251$24033825$1$I$$20230523$20240701$20240701$PER$$US-AMGEN-USASP2023235059$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240338261$24033826$1$I$20240605$20240625$20240701$20240701$EXP$$US-ABBVIE-5817751$ABBVIE$$44$YR$$M$Y$$$20240701$$CN$US$US
240338271$24033827$1$I$$20240624$20240701$20240701$PER$$US-AMGEN-USASP2024126285$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240338281$24033828$1$I$20240620$20240624$20240701$20240701$EXP$GB-MHRA-TPP39180069C16170615YC1718900973583$GB-STRIDES ARCOLAB LIMITED-2024SP007598$STRIDES$$8$YR$$M$Y$18$KG$20240701$$HP$GB$GB
240338293$24033829$3$F$$20240905$20240701$20240913$EXP$$US-BEH-2024174614$CSL BEHRING$$27$YR$A$F$Y$61.224$KG$20240913$$CN$US$US
240338301$24033830$1$I$$20240624$20240701$20240701$EXP$$JP-ASTELLAS-2024JP004441$ASTELLAS$$71$YR$$M$Y$$$20240701$$MD$JP$JP
240338311$24033831$1$I$$20240626$20240701$20240701$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-102842$BRISTOL MYERS SQUIBB$Pichon S, Lacombe C, Aigrain P, Lemarchant B, Levy C. A rare case of immune checkpoint inhibitor-induced meningoradiculitis with vocal cord diplegia. Acta Neurologica Belgica. 2024 Jun 18;doi:10.1007/s13760-024-02590-1.$66$YR$E$M$Y$$$20240701$$HP$FR$FR
240338321$24033832$1$I$$20240624$20240701$20240701$EXP$$FI-STRIDES ARCOLAB LIMITED-2024SP007740$STRIDES$Rokkanen R, Aarnivala H, Pokka T, Niinimaki R.. Chemotherapy-related toxicities follow a typical pattern in children treated for acute lymphoblastic leukaemia. Acta-Paediatr. 2024;113(5):1103-1111$$$C$$Y$$$20240701$$HP$FI$FI
240338331$24033833$1$I$$20240627$20240701$20240701$EXP$$DE-UCBSA-2024033005$UCB$$$$$F$Y$$$20240701$$MD$DE$DE
240338341$24033834$1$I$$20240620$20240701$20240701$EXP$$CA-BAXTER-2024BAX020592$BAXTER$$43$YR$$F$Y$$$20240701$$HP$CA$CA
240338352$24033835$2$F$$20240627$20240701$20240703$PER$$US-ABBVIE-5821971$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240338361$24033836$1$I$$20240625$20240701$20240701$EXP$$US-GSK-US2024079186$GLAXOSMITHKLINE$$$$E$F$Y$$$20240701$$MD$US$US
240338372$24033837$2$F$20240610$20240826$20240701$20240904$EXP$$JP-ASTELLAS-2024JP004480$ASTELLAS$$5$DEC$A$M$Y$$$20240904$$MD$JP$JP
240338381$24033838$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5819680$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240338392$24033839$2$F$$20240820$20240701$20240829$EXP$GB-MHRA-MED-202406200035020410-NFZCY$GB-TEVA-VS-3212047$TEVA$$$$$M$Y$36$KG$20240829$$CN$GB$GB
240338402$24033840$2$F$20240618$20240726$20240701$20240803$EXP$$CO-JNJFOC-20240671063$JOHNSON AND JOHNSON$$82$YR$E$M$Y$47$KG$20240803$$HP$CO$CO
240338411$24033841$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104505$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240701$$HP$US$US
240338421$24033842$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104519$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240701$$HP$US$US
240338431$24033843$1$I$20240618$20240625$20240701$20240701$EXP$FR-AFSSAPS-PV2024000573$FR-BEH-2024174580$CSL BEHRING$$63$YR$A$M$Y$49.4$KG$20240701$$MD$FR$FR
240338441$24033844$1$I$$20240624$20240701$20240701$EXP$$IT-AUROBINDO-AUR-APL-2024-031587$AUROBINDO$$16$YR$$F$Y$$$20240701$$PH$IT$IT
240338452$24033845$2$F$$20240712$20240701$20240721$EXP$$CA-BAXTER-2024BAX020462$BAXTER$$48$YR$$F$Y$68$KG$20240721$$HP$CA$CA
240338461$24033846$1$I$20240501$20240627$20240701$20240701$EXP$$US-UCBSA-2024032998$UCB$$22$YR$$F$Y$$$20240701$$HP$US$US
240338471$24033847$1$I$$20240507$20240701$20240701$PER$$US-AMGEN-USASP2024129720$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240338481$24033848$1$I$$20240618$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003814$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240627$$HP$US$US
240338492$24033849$2$F$20240621$20240628$20240701$20240702$EXP$$US-MYLANLABS-2024M1058368$MYLAN$$61$YR$$F$Y$$$20240702$$HP$US$US
240338501$24033850$1$I$$20240620$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003866$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240628$$HP$US$US
240338511$24033851$1$I$$20240621$20240701$20240701$30DAY$$US-GSK-US2024078031$GLAXOSMITHKLINE$$2$DEC$$$Y$$$20240701$$PH$US$US
240338521$24033852$1$I$$20240617$20240701$20240701$EXP$$AT-MIRUM PHARMACEUTICALS INTERNATIONAL B.V.-AT-MIR-24-00369$Unknown Manufacturer$$8$YR$$F$Y$$$20240701$$MD$AT$AT
240338531$24033853$1$I$$20240617$20240701$20240701$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001567$IPCA$J. Ouyang ,S. Sasidharan , T. Jatoi, et.al. How high can anion gaps be in patients with metabolic acidosis? A case report. Am J Respir Crit Care Med. 2024;209:A3409$$$$$Y$$$20240701$$HP$US$US
240338542$24033854$2$F$20240613$20240813$20240701$20240816$EXP$$FR-AstraZeneca-2024A148993$ASTRAZENECA$$23821$DY$$M$Y$95$KG$20240816$$MD$FR$
240338551$24033855$1$I$$20240620$20240701$20240701$EXP$$JP-Unichem Pharmaceuticals (USA) Inc-UCM202406-000819$UNICHEM$$26$YR$A$M$Y$$$20240701$$$COUNTRY NOT SPECIFIED$
240338561$24033856$1$I$$20240621$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003899$STEMLINE THERAPEUTICS$$82$YR$E$F$Y$$$20240627$$CN$US$US
240338571$24033857$1$I$$20240620$20240701$20240701$EXP$$IN-Unichem Pharmaceuticals (USA) Inc-UCM202406-000816$UNICHEM$$$$$M$Y$$$20240701$$HP$IN$
240338581$24033858$1$I$$20240620$20240701$20240701$EXP$$JP-Unichem Pharmaceuticals (USA) Inc-UCM202406-000820$UNICHEM$$61$YR$A$M$Y$$$20240701$$$COUNTRY NOT SPECIFIED$
240338591$24033859$1$I$$20240620$20240701$20240701$EXP$$IT-Unichem Pharmaceuticals (USA) Inc-UCM202406-000815$UNICHEM$$66$YR$E$F$Y$$$20240701$$HP$IT$
240338601$24033860$1$I$20240621$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024129482$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240338611$24033861$1$I$$20240620$20240701$20240701$EXP$$JP-Unichem Pharmaceuticals (USA) Inc-UCM202406-000830$UNICHEM$$38$YR$A$M$Y$$$20240701$$$COUNTRY NOT SPECIFIED$
240338621$24033862$1$I$$20240620$20240701$20240701$EXP$$JP-Unichem Pharmaceuticals (USA) Inc-UCM202406-000829$UNICHEM$$31$YR$A$M$Y$$$20240701$$$COUNTRY NOT SPECIFIED$
240338631$24033863$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126539$AMGEN$Khattri S.; Hren M. G.; Guenin S.. Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease. Journal of the American Academy of Dermatology. 2024;91(1):138-140$23$YR$A$$Y$$$20240701$$MD$US$US
240338641$24033864$1$I$$20240518$20240701$20240701$PER$$US-AMGEN-USASP2024129630$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240338651$24033865$1$I$$20230814$20240701$20240701$PER$$US-AMGEN-USASP2023235083$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240338661$24033866$1$I$$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024128599$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240338672$24033867$2$F$$20240910$20240701$20240913$EXP$$JP-SA-2024SA137460$SANOFI AVENTIS$Yoshimatsu N, Kitamura T, Hori R.. 73. A case of marked increase in eosinophils during post-operative dupilumab therapy for eosinophilic sinusitis.. Practica Oto-Rhino-Laryngologica, Suppl.. 2024;UNK:90$60$YR$A$F$Y$$$20240913$$MD$JP$JP
240338681$24033868$1$I$20231214$20240624$20240701$20240701$EXP$GB-MHRA-MED-202406231507348940-RLZHG$GB-SA-2024SA186372$SANOFI AVENTIS$$34$YR$A$F$Y$59$KG$20240701$$CN$GB$GB
240338693$24033869$3$F$20231028$20240717$20240701$20240726$EXP$$ES-AUROBINDO-AUR-APL-2024-031679$AUROBINDO$$68$YR$$F$Y$50.1$KG$20240726$$MD$ES$ES
240338711$24033871$1$I$20240501$20240528$20240701$20240701$EXP$$US-PYROS PHARMACEUTICALS, INC-2024-PYROS-US000024$Pyros Pharmaceuticals$$0$YR$$M$Y$8.163$KG$20240628$$PH$US$US
240338731$24033873$1$I$20240529$20240530$20240701$20240701$PER$$US-PYROS PHARMACEUTICALS, INC-2024-PYROS-US000028$Pyros Pharmaceuticals$$0$YR$$M$Y$8.029$KG$20240628$$CN$US$US
240338741$24033874$1$I$$20240629$20240701$20240701$PER$$US-JNJFOC-20240700663$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240338752$24033875$2$F$$20240628$20240701$20240705$EXP$$GB-TAKEDA-2024TUS063633$TAKEDA$$$$$F$Y$$$20240705$$CN$GB$GB
240338771$24033877$1$I$20240501$20240529$20240701$20240701$EXP$$US-PYROS PHARMACEUTICALS, INC-2024-PYROS-US000020$Pyros Pharmaceuticals$$2$YR$$M$Y$12.1$KG$20240628$$MD$US$US
240338781$24033878$1$I$$20240625$20240701$20240701$EXP$$US-JNJFOC-20240667604$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240701$$MD$US$US
240338791$24033879$1$I$20230525$20240625$20240701$20240701$EXP$$CN-SA-2024SA190699$SANOFI AVENTIS$Li J.. Two cases of coronary spasm caused by tegafur, gimeracil and oteracil porassium combined with oxaliplatin in elderly patients with gastric cancer.. Pract Geriatr.. 2024;38(6):646-9.$61$YR$A$M$Y$$$20240701$$HP$CN$CN
240338801$24033880$1$I$20240501$20240626$20240701$20240701$EXP$GB-MHRA-MED-202406261024182640-VNTQL$GB-SA-2024SA191198$SANOFI AVENTIS$$$$$F$Y$$$20240701$$PH$GB$GB
240338811$24033881$1$I$$20240624$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003928$STEMLINE THERAPEUTICS$$86$YR$E$F$Y$$$20240627$$HP$US$US
240338821$24033882$1$I$$20240624$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003927$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240627$$CN$US$US
240338831$24033883$1$I$$20240627$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103946$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240701$$HP$US$US
240338844$24033884$4$F$20220101$20240916$20240701$20240919$EXP$$US-ABBVIE-5673691$ABBVIE$$$$$M$Y$69.853$KG$20240919$$CN$US$US
240338851$24033885$1$I$20240619$20240626$20240701$20240701$PER$$US-ABBVIE-5819974$ABBVIE$$26$YR$$F$Y$$$20240701$$HP$US$US
240338861$24033886$1$I$20240614$20240625$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003945$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240627$$CN$US$US
240338871$24033887$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5773633$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240338881$24033888$1$I$20230724$20240618$20240701$20240701$EXP$$CA-APOTEX-2024AP005644$APOTEX$$75$YR$E$M$Y$$$20240701$$PH$CA$CA
240338895$24033889$5$F$$20240722$20240701$20240726$EXP$$FR-MYLANLABS-2024M1058613$MYLAN$Chappuy M, Merah I, Ragonnet D, Ternay J-D and Rolland B. Lyon resource center for drug addictions (CERLAM). Le Courrier des addictions. 2024;20(2):24-27.$45$YR$$M$Y$$$20240726$$PH$FR$FR
240338901$24033890$1$I$20240601$20240620$20240701$20240701$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108150$ZYDUS PHARM$$$$$$Y$$$20240701$$CN$US$US
240338911$24033891$1$I$20240225$20240617$20240701$20240701$EXP$FR-AFSSAPS-LL2024001130$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108760$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$FR$FR
240338921$24033892$1$I$$20240617$20240701$20240701$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108631$ZYDUS PHARM$Baral A, Isaac E, Parajuli P, Kaiser A.. Primary spontaneous bacterial peritonitis caused by haemophilus influenzae. Gastroenterology. 2024;166 (Suppl.)(5):S-1571$$$$$Y$$$20240701$$HP$US$US
240338931$24033893$1$I$20240424$20240617$20240701$20240701$EXP$FR-AFSSAPS-TS2024000687$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108725$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$FR$FR
240338941$24033894$1$I$20240414$20240617$20240701$20240701$EXP$FR-AFSSAPS-TO2024000752$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108730$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$FR$FR
240338951$24033895$1$I$20230423$20240617$20240701$20240701$EXP$FR-AFSSAPS-AM2024000449$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108360$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$FR$FR
240338961$24033896$1$I$20210906$20240617$20240701$20240701$EXP$FR-AFSSAPS-PV2024000526$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108723$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$FR$FR
240338971$24033897$1$I$20240511$20240617$20240701$20240701$EXP$FR-AFSSAPS-AM2024000499$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108742$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$FR$FR
240338981$24033898$1$I$20240409$20240617$20240701$20240701$EXP$ES-AEMPS-1535398$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-108714$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$ES$ES
240338991$24033899$1$I$$20240618$20240701$20240701$EXP$$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-108773$ZYDUS PHARM$Aviles-Prieto J, Caro-Magdaleno M, Rodriguez-de-la-Rua-Franch E.. Peripheral Ulcerative Keratopathy following Systemic Treatment with Bortezomib: A Case Report.. Ocular Immunology and Inflammation. 2024;Vol. 32, No. 4:470-472$$$$$Y$$$20240701$$MD$ES$ES
240339001$24033900$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184473$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240339011$24033901$1$I$$20240627$20240701$20240701$PER$$US-JNJFOC-20240674960$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$PH$US$US
240339021$24033902$1$I$20240601$20240627$20240701$20240701$PER$$US-JNJFOC-20240674701$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20240701$$CN$US$US
240339031$24033903$1$I$20240607$20240617$20240701$20240701$EXP$ES-AEMPS-1535504$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-108712$ZYDUS PHARM$$$$$$Y$$$20240701$$PH$ES$ES
240339041$24033904$1$I$$20240625$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003941$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240627$$CN$US$US
240339051$24033905$1$I$$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017453$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240701$$CN$US$US
240339061$24033906$1$I$$20240624$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019167$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240339073$24033907$3$F$$20240819$20240701$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104620$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240822$$CN$US$US
240339081$24033908$1$I$20240622$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103774$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240701$$HP$US$US
240339091$24033909$1$I$$20240626$20240701$20240701$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-103833$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240701$$MD$DE$DE
240339101$24033910$1$I$$20240625$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003946$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240627$$CN$US$US
240339111$24033911$1$I$20240101$20240624$20240701$20240701$EXP$$US-ABBVIE-5815557$ABBVIE$$56$YR$$F$Y$$$20240701$$CN$US$US
240339121$24033912$1$I$$20240624$20240701$20240701$PER$$US-TAKEDA-2024TUS063459$TAKEDA$$$$$M$Y$$$20240701$$MD$US$US
240339131$24033913$1$I$$20240621$20240701$20240701$EXP$$JP-EMD Serono-2024034281$EMD SERONO INC$$79$YR$E$M$Y$$$20240701$$MD$JP$JP
240339142$24033914$2$F$$20240801$20240701$20240805$EXP$$JP-ABBVIE-5817101$ABBVIE$$60$YR$$F$Y$$$20240805$$MD$JP$JP
240339151$24033915$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104662$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240701$$CN$US$US
240339161$24033916$1$I$$20240625$20240701$20240701$EXP$$US-ABBVIE-5817658$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240339171$24033917$1$I$$20240625$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003948$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240628$$CN$US$US
240339181$24033918$1$I$20240623$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127263$AMGEN$$60$YR$A$F$Y$$$20240701$$CN$US$US
240339192$24033919$2$F$$20240709$20240701$20240722$EXP$$JP-UCBSA-2024032247$UCB$$50$YR$$F$Y$$$20240722$$PH$JP$JP
240339201$24033920$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024125696$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240339222$24033922$2$F$20240626$20240723$20240701$20240731$EXP$$US-Stemline Therapeutics, Inc.-2024ST003971$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240726$$CN$US$US
240339231$24033923$1$I$$20240303$20240701$20240701$PER$$EG-ROCHE-3522970$ROCHE$$$$A$$Y$70$KG$20240701$$CN$EG$EG
240339242$24033924$2$F$20240302$20240402$20240701$20240710$PER$$SA-ROCHE-3540496$ROCHE$$37$YR$A$F$Y$47$KG$20240701$$CN$SA$SA
240339251$24033925$1$I$$20240325$20240701$20240701$PER$$GB-ROCHE-3187389$ROCHE$$$$A$F$Y$$$20240701$$CN$GB$GB
240339263$24033926$3$F$$20240910$20240701$20240917$EXP$$ZA-TAKEDA-2024TUS064478$TAKEDA$$$$$M$Y$$$20240917$$CN$ZA$ZA
240339271$24033927$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5819821$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240339281$24033928$1$I$20240601$20240626$20240701$20240701$EXP$$US-ABBVIE-5819853$ABBVIE$$78$YR$$F$Y$$$20240701$$CN$US$US
240339291$24033929$1$I$$20240412$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-05867$HIKMA$Drittel D, Deyar D, Boxer E, Al Hennawi H, Mack M. Drittel D, Deyar D, Boxer E, Al Hennawi H, Mack M. The curious case of Kounis syndrome: Exploring clinical manifestations and management in the presence of nonobstructive coronary arteries. Global cardiology science and practice. 2024;(2)$41$YR$$M$Y$$$20240701$$MD$US$US
240339301$24033930$1$I$$20240624$20240701$20240701$EXP$$GB-TEVA-VS-3214905$TEVA$Bateman DN. Quinine overdose: Not quite gin and tonic. J-R-Coll-Physicians-Edinb 2023; 53 (1): 71-73.$$$$$Y$$$20240701$$HP$GB$GB
240339311$24033931$1$I$$20240626$20240701$20240701$EXP$$BY-JNJFOC-20240675642$JOHNSON AND JOHNSON$$74$YR$E$M$Y$42$KG$20240701$$MD$BY$BY
240339321$24033932$1$I$$20240628$20240701$20240701$PER$$US-BAUSCH-BL-2024-010096$BAUSCH AND LOMB$$$$$M$Y$57.204$KG$20240701$$CN$US$US
240339331$24033933$1$I$20230823$20240628$20240701$20240701$EXP$$PL-BAUSCH-BL-2024-010090$BAUSCH AND LOMB$$62$YR$$$Y$$$20240701$$MD$PL$PL
240339342$24033934$2$F$$20240420$20240701$20240710$PER$$CA-ROCHE-3551132$ROCHE$$$$C$M$Y$$$20240701$$CN$CA$CA
240339351$24033935$1$I$$20240619$20240701$20240701$EXP$$US-BAUSCH-BL-2024-010070$BAUSCH AND LOMB$UNKNOWN. Saffran et al., Conjugated Linoleic Acid-induced Hepatotoxicity Requiring Liver Transplant. Journal of Clinical and Exper-imental Hepatology. doi:https://doi.org/10.1016/ j.jceh.2024.101408$42$YR$$F$Y$$$20240701$$MD$US$US
240339361$24033936$1$I$$20240626$20240701$20240701$PER$$US-BAUSCH-BL-2024-009990$BAUSCH AND LOMB$$$$$F$Y$$$20240701$$CN$US$US
240339372$24033937$2$F$$20240731$20240701$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104690$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$113.85$KG$20240801$$CN$US$US
240339381$24033938$1$I$$20240229$20240701$20240701$PER$$EG-ROCHE-3520673$ROCHE$$3$YR$C$F$Y$10.2$KG$20240701$$CN$EG$EG
240339392$24033939$2$F$20240215$20240306$20240701$20240710$PER$$US-ROCHE-3522150$ROCHE$$12$YR$T$M$Y$$$20240701$$CN$US$US
240339411$24033941$1$I$$20240619$20240701$20240701$PER$$US-SA-2024SA185356$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240701$$MD$US$US
240339422$24033942$2$F$$20240805$20240701$20240808$EXP$$US-ABBVIE-5819560$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
240339431$24033943$1$I$$20240624$20240701$20240701$EXP$$JP-ASTELLAS-2021JP009839$ASTELLAS$$68$YR$$F$Y$38$KG$20240701$$CN$JP$JP
240339441$24033944$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186415$SANOFI AVENTIS$$$$$F$Y$$$20240701$$CN$US$US
240339452$24033945$2$F$20240101$20240628$20240701$20240712$PER$$US-SA-2024SA186953$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240712$$MD$US$US
240339461$24033946$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186955$SANOFI AVENTIS$$6$YR$C$F$Y$15.42$KG$20240701$$CN$US$US
240339471$24033947$1$I$20240101$20240619$20240701$20240701$PER$$US-SA-2024SA187710$SANOFI AVENTIS$$41$YR$A$F$Y$103$KG$20240701$$MD$US$US
240339481$24033948$1$I$20240617$20240619$20240701$20240701$PER$$US-SA-2024SA187806$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240701$$MD$US$US
240339491$24033949$1$I$20240601$20240620$20240701$20240701$PER$$US-SA-2024SA186641$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240701$$MD$US$US
240339501$24033950$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186532$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240701$$MD$US$US
240339511$24033951$1$I$20240101$20240620$20240701$20240701$PER$$US-SA-2024SA186308$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240701$$MD$US$US
240339521$24033952$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5820833$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240339531$24033953$1$I$$20240625$20240701$20240701$30DAY$$US-GSK-US2024079143$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240701$$CN$US$US
240339541$24033954$1$I$$20240621$20240701$20240701$EXP$$US-GSK-US2024AMR079938$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$US$US
240339551$24033955$1$I$$20240621$20240701$20240701$30DAY$$US-GSK-US2024077734$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240339561$24033956$1$I$20230626$20240621$20240701$20240701$EXP$$US-GSK-US2024078084$GLAXOSMITHKLINE$$88$YR$$M$Y$$$20240701$$PH$US$US
240339571$24033957$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA190562$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$CN$US$US
240339581$24033958$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA190948$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240701$$MD$US$US
240339591$24033959$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA191301$SANOFI AVENTIS$$$$T$M$Y$$$20240701$$MD$US$US
240339601$24033960$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA189234$SANOFI AVENTIS$$$$C$M$Y$$$20240701$$MD$US$US
240339611$24033961$1$I$20240625$20240625$20240701$20240701$PER$$US-SA-2024SA190781$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240701$$MD$US$US
240339621$24033962$1$I$20240101$20240620$20240701$20240701$PER$$US-SA-2024SA186605$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240701$$MD$US$US
240339631$24033963$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA190856$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240701$$CN$US$US
240339641$24033964$1$I$20240601$20240621$20240701$20240701$PER$$US-SA-2024SA177935$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240701$$PH$US$US
240339652$24033965$2$F$20240101$20240812$20240701$20240821$PER$$US-SA-2024SA190904$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240821$$MD$US$US
240339661$24033966$1$I$20220601$20240624$20240701$20240701$PER$$US-SA-2024SA190908$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240701$$MD$US$US
240339671$24033967$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA027484$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240701$$MD$US$US
240339681$24033968$1$I$20240501$20240621$20240701$20240701$PER$$US-SA-2024SA192264$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240701$$MD$US$US
240339694$24033969$4$F$20240101$20240827$20240701$20240911$PER$$US-SA-2024SA188883$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240911$$MD$US$US
240339701$24033970$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186261$SANOFI AVENTIS$$$$$$Y$$$20240701$$MD$US$US
240339711$24033971$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA189353$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240701$$MD$US$US
240339722$24033972$2$F$20230101$20240626$20240701$20240705$PER$$US-SA-2024SA189855$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240705$$MD$US$US
240339731$24033973$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA189219$SANOFI AVENTIS$$$$E$F$Y$73$KG$20240701$$MD$US$US
240339741$24033974$1$I$20240101$20240621$20240701$20240701$PER$$US-SA-2024SA189151$SANOFI AVENTIS$$49$YR$A$F$Y$53.52$KG$20240701$$MD$US$US
240339751$24033975$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA190185$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240701$$MD$US$US
240339761$24033976$1$I$20230508$20240212$20240701$20240701$PER$$DE-ROCHE-3436210$ROCHE$$1$YR$I$M$Y$13.6$KG$20240701$$MD$DE$DE
240339771$24033977$1$I$20240601$20240626$20240701$20240701$EXP$$US-ABBVIE-5819845$ABBVIE$$69$YR$$F$Y$$$20240701$$CN$US$US
240339781$24033978$1$I$20231228$20240624$20240701$20240701$PER$$US-AstraZeneca-2024A150165$ASTRAZENECA$$61$YR$$F$Y$$$20240701$$CN$US$
240339791$24033979$1$I$20240612$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A148004$ASTRAZENECA$$27530$DY$$F$Y$$$20240701$$MD$US$
240339801$24033980$1$I$20240501$20240624$20240701$20240701$PER$$US-SA-2024SA190315$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240701$$MD$US$US
240339811$24033981$1$I$$20240626$20240701$20240701$EXP$$AU-TAKEDA-2024TUS064235$TAKEDA$$$$$M$Y$$$20240701$$CN$AU$AU
240339821$24033982$1$I$20240101$20240624$20240701$20240701$PER$$US-SA-2024SA190939$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240701$$MD$US$US
240339831$24033983$1$I$20240601$20240624$20240701$20240701$PER$$US-SA-2024SA191408$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240701$$CN$US$US
240339841$24033984$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA189571$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240701$$CN$US$US
240339851$24033985$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA190359$SANOFI AVENTIS$$$$A$$Y$$$20240701$$MD$US$US
240339861$24033986$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA188605$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240701$$MD$US$US
240339871$24033987$1$I$20240627$20240627$20240701$20240701$PER$$US-JNJFOC-20240675165$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$US$US
240339891$24033989$1$I$$20240617$20240701$20240701$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000910$ALEMBIC$Hussain M, Tiwana HZJ, Sivanandham R, Barsoum A, Bagheri S, Hussain S et al. Aripiprazole-Induced Diabetic Ketoacidosis and Hypertriglyceridemia Triggering Concurrent Pancreatitis: A Case Report. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240701$$HP$US$US
240339901$24033990$1$I$$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024128609$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240339911$24033991$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190944$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$MD$US$US
240339921$24033992$1$I$$20240625$20240701$20240701$EXP$$US-AMGEN-USASP2024125831$AMGEN$Melman Y.F.. Incessant Atrial Tachycardia From the Left Atrial Appendage Treated With Appendage Ligation. JACC: Case Reports. 2024;29 (13):1-4$46$YR$A$M$Y$$$20240701$$MD$US$US
240339931$24033993$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA190928$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240701$$MD$US$US
240339941$24033994$1$I$$20240617$20240701$20240701$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000912$ALEMBIC$Oomrigar SC, Fernandez J, Rivera Ortiz C, Rajen H, Toll A, Perez Colome E et al. The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240701$$HP$US$US
240339951$24033995$1$I$$20240618$20240701$20240701$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000924$ALEMBIC$Rodriguez C, Yosry N, Qaiser S, Luzuriaga A, Adelizzi A. BRASH: A Deadly Acronym. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240701$$HP$US$US
240339961$24033996$1$I$$20240618$20240701$20240701$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000919$ALEMBIC$Abdelal Q, Isern S, Najjar N. Azith and the Myth. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240701$$HP$US$US
240339972$24033997$2$F$$20240903$20240701$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104710$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$57.2$KG$20240904$$CN$US$US
240339982$24033998$2$F$20240420$20240424$20240701$20240710$PER$$US-ROCHE-3553358$ROCHE$$24$YR$A$F$Y$$$20240701$$CN$US$US
240339992$24033999$2$F$$20240712$20240701$20240717$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-090093$REGENERON$$$$$F$Y$$$20240717$$CN$US$US
240340003$24034000$3$F$20240101$20240226$20240701$20240710$PER$$US-ROCHE-3516197$ROCHE$$5$YR$C$F$Y$$$20240701$$CN$US$US
240340011$24034001$1$I$$20240626$20240701$20240701$EXP$$US-SANDOZ INC.-SDZ2024US061602$SANDOZ$$74$YR$$F$Y$$$20240701$$CN$US$US
240340021$24034002$1$I$20240301$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031487$AUROBINDO$$19$YR$$M$Y$$$20240701$$HP$FR$FR
240340031$24034003$1$I$$20240402$20240701$20240701$PER$$JP-ROCHE-3509876$ROCHE$$5$DEC$A$F$Y$$$20240701$$PH$JP$JP
240340041$24034004$1$I$20240622$20240628$20240701$20240701$30DAY$$US-SANDOZ INC.-SDZ2024US061560$SANDOZ$$$$$F$Y$$$20240701$$CN$US$US
240340051$24034005$1$I$$20240424$20240701$20240701$PER$$US-ROCHE-3552269$ROCHE$$35$YR$A$M$Y$39.9$KG$20240701$$MD$US$US
240340061$24034006$1$I$20240614$20240625$20240701$20240701$EXP$$CN-ORGANON-O2406CHN002480$ORGANON$$71$YR$$F$Y$59$KG$20240701$$HP$CN$CN
240340072$24034007$2$F$20240520$20240705$20240701$20240708$EXP$$FR-SANDOZ INC.-SDZ2024FR061484$SANDOZ$$58$YR$$F$Y$90$KG$20240708$$PH$FR$FR
240340081$24034008$1$I$20240203$20240403$20240701$20240701$PER$$DE-ROCHE-3356941$ROCHE$$9$YR$C$M$Y$27$KG$20240701$$MD$DE$DE
240340091$24034009$1$I$20220108$20240621$20240701$20240701$EXP$FR-AFSSAPS-AM2024000358$FR-EMD Serono-2024023739$EMD SERONO INC$$33$YR$A$F$Y$70$KG$20240701$$CN$FR$FR
240340101$24034010$1$I$20240618$20240621$20240701$20240701$PER$$US-SA-2024SA188891$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240701$$MD$US$US
240340111$24034011$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA187304$SANOFI AVENTIS$$90$YR$E$M$Y$$$20240701$$CN$US$US
240340121$24034012$1$I$20240601$20240624$20240701$20240701$PER$$US-SA-2024SA190933$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240701$$MD$US$US
240340131$24034013$1$I$20240601$20240622$20240701$20240701$PER$$US-SA-2024SA188912$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240701$$MD$US$US
240340141$24034014$1$I$20220228$20240620$20240701$20240701$EXP$$AU-JNJFOC-20240662192$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240701$$MD$AU$AU
240340152$24034015$2$F$$20240709$20240701$20240718$PER$$US-SA-2024SA188908$SANOFI AVENTIS$$$$E$F$Y$$$20240718$$MD$US$US
240340161$24034016$1$I$20240601$20240620$20240701$20240701$PER$$US-SA-2024SA186452$SANOFI AVENTIS$$$$A$M$Y$$$20240701$$HP$US$US
240340171$24034017$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA188231$SANOFI AVENTIS$$$$A$M$Y$86.18$KG$20240701$$MD$US$US
240340181$24034018$1$I$20240501$20240620$20240701$20240701$PER$$US-SA-2024SA186487$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240701$$MD$US$US
240340191$24034019$1$I$20240101$20240625$20240701$20240701$PER$$US-SA-2024SA191259$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240701$$MD$US$US
240340202$24034020$2$F$20240101$20240716$20240701$20240724$PER$$US-SA-2024SA189221$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240724$$MD$US$US
240340213$24034021$3$F$20240101$20240729$20240701$20240806$PER$$US-SA-2024SA190750$SANOFI AVENTIS$$61$YR$A$F$Y$98.8$KG$20240806$$MD$US$US
240340221$24034022$1$I$$20240624$20240701$20240701$PER$$US-JNJFOC-20240662816$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$US$US
240340231$24034023$1$I$20240101$20240619$20240701$20240701$PER$$US-SA-2024SA186225$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240701$$MD$US$US
240340241$24034024$1$I$$20240626$20240701$20240701$EXP$$CA-SANDOZ INC.-SDZ2023CA076613$SANDOZ$$44$YR$$F$Y$70$KG$20240701$$HP$CA$CA
240340251$24034025$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA191029$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$CN$US$US
240340261$24034026$1$I$$20240418$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05952$HIKMA$Bangolo AI, Yelton-Torres K, Mahajan A, Patel V, Sajjad L, Ansong PO, Kashyap M, Batura U, Ravulapalli M, Perrera A, Weissman S.. Bangolo AI, Yelton-Torres K, Mahajan A, Patel V, Sajjad L, Ansong PO, Kashyap M, Batura U, Ravulapalli M, Perrera A, Weissman S. Case of Diltiazem-Induced Pustular Rash in an 83-Year-Old Female. Case Reports in Dermatological Medicine. 2024;9547206$83$YR$$F$Y$$$20240701$$MD$US$US
240340271$24034027$1$I$20240429$20240624$20240701$20240701$EXP$$ES-AUROBINDO-AUR-APL-2024-031562$AUROBINDO$$83$YR$$M$Y$80$KG$20240701$$PH$ES$ES
240340281$24034028$1$I$$20240629$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104598$BRISTOL MYERS SQUIBB$$96$YR$E$M$Y$82.1$KG$20240701$$CN$US$US
240340301$24034030$1$I$20240601$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104621$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240701$$HP$US$US
240340311$24034031$1$I$20240401$20240625$20240701$20240701$EXP$$AU-AMGEN-AUSSP2024125771$AMGEN$$77$YR$E$F$Y$$$20240701$$CN$AU$AU
240340321$24034032$1$I$$20230828$20240701$20240701$PER$$US-AMGEN-USASP2023235068$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240340331$24034033$1$I$$20240617$20240701$20240701$EXP$$AU-LUPIN HEALTHCARE (UK) LIMITED-2024-05450$LUPIN$$49$YR$$F$Y$$$20240701$$CN$AU$AU
240340341$24034034$1$I$20221101$20240624$20240701$20240701$EXP$$BG-CHEPLA-2024008028$CHEPLAPHARM$Vasilev P, Karaivanov M, Dimitrov D, Troyanova P, Yordanova I. Advanced Squamous Cell Carcinoma Of The Skin Induced By Long-Term Hydroxyurea Treatment In A Patient With Essential Thrombocythemia. Acta Medica Bulgarica. 2024;51(2):49-52.$70$YR$$F$Y$$$20240701$$HP$COUNTRY NOT SPECIFIED$BG
240340351$24034035$1$I$$20240622$20240701$20240701$EXP$$CA-TOLMAR, INC.-24CA050466$TOLMAR$$$$$M$Y$$$20240701$$CN$CA$CA
240340361$24034036$1$I$$20240618$20240701$20240701$EXP$$IN-ROCHE-10000010351$ROCHE$$58$YR$A$F$Y$$$20240701$$MD$IN$IN
240340371$24034037$1$I$20240527$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031514$AUROBINDO$$62$YR$$F$Y$76$KG$20240701$$MD$FR$FR
240340381$24034038$1$I$$20230501$20240701$20240701$PER$$US-AMGEN-USASP2023234985$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240340391$24034039$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA191194$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$MD$US$US
240340401$24034040$1$I$20220210$20240320$20240701$20240701$PER$$DE-ROCHE-3181713$ROCHE$$23$YR$A$F$Y$40$KG$20240701$$MD$DE$DE
240340411$24034041$1$I$20240611$20240625$20240701$20240701$EXP$$TW-TAKEDA-2024TUS064293$TAKEDA$$67$YR$$M$Y$$$20240701$$CN$TW$TW
240340423$24034042$3$F$$20240314$20240701$20240710$PER$$SI-ROCHE-3527602$ROCHE$$$$A$F$Y$$$20240701$$MD$SI$SI
240340431$24034043$1$I$$20240618$20240701$20240701$EXP$$US-MYLANLABS-2024M1057221$MYLAN$Simmer P, Ghandi P, Gulati S. Hot and bothered: a rare case of dyskinesia hyperpyrexia syndrome. Crit-Care-Med 2024; 52 (1): S289 abstr. 632.$53$YR$$F$Y$$$20240701$$HP$US$US
240340442$24034044$2$F$20240508$20240910$20240701$20240913$EXP$$CA-MYLANLABS-2024M1056770$MYLAN$$79$YR$$F$Y$$$20240913$$PH$CA$CA
240340451$24034045$1$I$$20240619$20240701$20240701$EXP$$US-EMD Serono-2024034669$EMD SERONO INC$Scher MS, Agarwal S, Venkatesen C. Clinical decisions in fetal-neonatal neurology I. reproductive and pregnancy health influence the neural exposome over multiple generations. Seminars in Fetal and Neonatal Medicine. 2024 Feb 01;29(1): 1-11. doi:https://doi.org/10.1016/j.siny.2024.101521.$$$N$M$Y$1$KG$20240701$$MD$US$US
240340461$24034046$1$I$20240601$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000010$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240340471$24034047$1$I$$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000178$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240701$$CN$US$US
240340481$24034048$1$I$20240527$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019223$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240701$$CN$US$US
240340491$24034049$1$I$20240627$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000076$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240701$$CN$US$US
240340501$24034050$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019761$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240701$$CN$US$US
240340511$24034051$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019416$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240701$$CN$US$US
240340521$24034052$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019580$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240701$$CN$US$US
240340531$24034053$1$I$20240601$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019531$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240701$$CN$US$US
240340541$24034054$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019283$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240701$$MD$US$US
240340551$24034055$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019562$ELI LILLY AND CO$$$$A$F$Y$$$20240701$$CN$US$US
240340561$24034056$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019023$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240701$$CN$US$US
240340571$24034057$1$I$$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019528$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240340581$24034058$1$I$20240601$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019392$ELI LILLY AND CO$$60$YR$A$$Y$$$20240701$$CN$US$US
240340591$24034059$1$I$20240601$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406016161$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240701$$CN$US$US
240340601$24034060$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019619$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240701$$CN$US$US
240340611$24034061$1$I$$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000057$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240340621$24034062$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019304$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240340631$24034063$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019037$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240701$$CN$US$US
240340641$24034064$1$I$20240619$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019379$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240701$$CN$US$US
240340651$24034065$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019279$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240701$$CN$US$US
240340661$24034066$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019482$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240701$$CN$US$US
240340671$24034067$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019673$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240701$$HP$US$US
240340681$24034068$1$I$$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000073$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240701$$CN$US$US
240340692$24034069$2$F$20240627$20240729$20240701$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202406019860$ELI LILLY AND CO$$88$YR$E$M$Y$$$20240801$$CN$US$US
240340701$24034070$1$I$20240301$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019374$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240701$$CN$US$US
240340711$24034071$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019097$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240701$$CN$US$US
240340722$24034072$2$F$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127288$AMGEN$Kaffenberger B.H; Lee B.R; Brostek A.R. No impact of immunomodulatory treatments on SARSCoV-2 (COVID-19) vaccine outcomes- A cross-sectional analysis of biologic and small molecule inhibitors used for psoriasis and hidradenitis suppurativa patients from the Epic Cosmos database. Journal of the American Academy of Dermatology. 2024;91 (1):100-102$$$$$Y$$$20240701$$MD$US$US
240340731$24034073$1$I$$20240625$20240701$20240701$EXP$$CA-ABBVIE-5818962$ABBVIE$$$$E$F$Y$$$20240701$$CN$CA$CA
240340741$24034074$1$I$$20240417$20240701$20240701$PER$$DK-ROCHE-3549846$ROCHE$$$$$$Y$$$20240701$$HP$DK$DK
240340751$24034075$1$I$20240625$20240626$20240701$20240701$PER$$US-BAYER-2024A092501$BAYER$$$$$$Y$$$20240701$$CN$US$US
240340761$24034076$1$I$20240329$20240402$20240701$20240701$PER$$US-ROCHE-3538395$ROCHE$$8$DY$N$M$Y$2.77$KG$20240701$$CN$US$US
240340772$24034077$2$F$20240403$20240403$20240701$20240710$PER$$CN-ROCHE-3537771$ROCHE$$$$A$M$Y$$$20240701$$MD$CN$CN
240340781$24034078$1$I$20240612$20240624$20240701$20240701$PER$$US-ABBVIE-5817115$ABBVIE$$51$YR$$F$Y$$$20240701$$CN$US$US
240340791$24034079$1$I$$20230512$20240701$20240701$PER$$US-AMGEN-USASP2023235057$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240340801$24034080$1$I$20231010$20240502$20240701$20240701$PER$$DE-ROCHE-3558020$ROCHE$$34$YR$A$F$Y$90$KG$20240701$$MD$DE$DE
240340811$24034081$1$I$$20230808$20240701$20240701$PER$$US-AMGEN-USASP2023235074$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240340821$24034082$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024128726$AMGEN$$$$$M$Y$$$20240701$$CN$US$US
240340831$24034083$1$I$20240622$20240625$20240701$20240701$PER$$US-BAYER-2024A092032$BAYER$$59$YR$A$F$Y$$$20240701$$CN$US$US
240340841$24034084$1$I$$20231103$20240701$20240701$PER$$US-AMGEN-USASP2023235024$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240340851$24034085$1$I$$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A148095$ASTRAZENECA$$$$$F$Y$$$20240701$$CN$US$
240340861$24034086$1$I$20240622$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A148113$ASTRAZENECA$$30351$DY$$F$Y$$$20240701$$MD$US$
240340871$24034087$1$I$$20240619$20240701$20240701$PER$$US-TEVA-VS-3212299$TEVA$$$$$$Y$$$20240701$$PH$US$US
240340881$24034088$1$I$$20240415$20240701$20240701$PER$$US-ROCHE-3546569$ROCHE$$50$YR$A$F$Y$68.04$KG$20240701$$CN$US$US
240340891$24034089$1$I$$20240619$20240701$20240701$EXP$$US-EMD Serono-2024033611$EMD SERONO INC$Scher MS, Agarwal S, Venkatesen C. Clinical decisions in fetal-neonatal neurology I. reproductive and pregnancy health influence the neural exposome over multiple generations. Seminars in Fetal and Neonatal Medicine. 2024 Feb 01;29(1): 1-11. doi:https://doi.org/10.1016/j.siny.2024.101521.$24$YR$A$F$Y$$$20240701$$MD$US$US
240340901$24034090$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184558$Haleon PLC$$$$$M$Y$$$20240701$$CN$US$US
240340911$24034091$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432114$ACCORD$Pierce V, Bollavaram V, Ali A. A case of long QT syndrome masquerading as epilepsy. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1699. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1699.$43$YR$A$F$Y$$$20240701$$MD$US$US
240340921$24034092$1$I$$20240423$20240701$20240701$PER$$US-ROCHE-3551723$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240340931$24034093$1$I$20220726$20240307$20240701$20240701$PER$$JP-ROCHE-3156077$ROCHE$$19$YR$A$M$Y$21$KG$20240701$$PH$JP$JP
240340941$24034094$1$I$$20240625$20240701$20240701$EXP$$US-BAYER-2024A092433$BAYER$$$$$$Y$$$20240701$$CN$US$US
240340952$24034095$2$F$20240625$20240701$20240701$20240703$PER$$US-AMGEN-USASP2024127792$AMGEN$$21$YR$A$F$Y$$$20240703$$CN$US$US
240340962$24034096$2$F$20240101$20240626$20240701$20240712$EXP$$US-AMGEN-USASP2024127415$AMGEN$$61$YR$A$F$Y$$$20240712$$CN$US$US
240340971$24034097$1$I$20240619$20240624$20240701$20240701$PER$$US-Vifor (International) Inc.-VIT-2024-05682$VIFOR$$35$YR$$$Y$75.9$KG$20240701$$HP$US$US
240340981$24034098$1$I$$20240307$20240701$20240701$PER$$US-ROCHE-3523740$ROCHE$$$$A$F$Y$$$20240701$$CN$US$US
240340992$24034099$2$F$$20240807$20240701$20240816$EXP$$IT-009507513-2407ITA000093$MERCK$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. European Journal of Haematology. 2024;113 (1):90-8$11$YR$$M$Y$$$20240816$$HP$IT$IT
240341001$24034100$1$I$$20240620$20240701$20240701$EXP$$CA-TAKEDA-2022TUS048276$TAKEDA$$$$$F$Y$$$20240701$$CN$CA$CA
240341012$24034101$2$F$20240601$20240622$20240701$20240814$EXP$$US-SA-2024SA189254$SANOFI AVENTIS$$84$YR$E$M$Y$84.36$KG$20240814$$HP$US$US
240341021$24034102$1$I$$20240625$20240701$20240701$PER$$US-ABBVIE-5821275$ABBVIE$$$$$F$Y$$$20240701$$HP$US$US
240341032$24034103$2$F$20240508$20240716$20240701$20240726$30DAY$$US-JNJFOC-20240526911$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240726$$HP$US$US
240341044$24034104$4$F$20231218$20240311$20240701$20240710$PER$$ZA-ROCHE-3508688$ROCHE$$$$$M$Y$70$KG$20240701$$CN$ZA$ZA
240341051$24034105$1$I$20240101$20240621$20240701$20240701$PER$$US-SA-2024SA189005$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240701$$MD$US$US
240341061$24034106$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186320$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240701$$MD$US$US
240341071$24034107$1$I$20210702$20240218$20240701$20240701$EXP$GB-MHRA-MED-202402151236563720-VYJMN$GB-TEVA-VS-3160741$TEVA$$61$YR$$F$Y$$$20240701$$MD$GB$GB
240341082$24034108$2$F$$20240725$20240701$20240730$PER$$US-AMGEN-USASP2024127534$AMGEN$$53$YR$A$F$Y$$$20240730$$MD$US$US
240341091$24034109$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05493$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240341101$24034110$1$I$$20240417$20240701$20240701$PER$$US-ROCHE-3548350$ROCHE$$54$YR$A$F$Y$$$20240701$$CN$US$US
240341111$24034111$1$I$$20240419$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05967$HIKMA$Martin S, Kaushik S, Bajantri B. Martin S, Kaushik S, Bajantri B. Pulmonary alveolar proteinosis following severe COVID - 19 infection: A case report.. Respiratory Medicine Case Reports. 2024;49:102017$67$YR$$M$Y$$$20240701$$MD$US$US
240341121$24034112$1$I$$20240422$20240701$20240701$PER$$CA-ROCHE-3551657$ROCHE$$$$$$Y$$$20240701$$CN$CA$CA
240341131$24034113$1$I$$20240619$20240701$20240701$EXP$$CZ-EMD Serono-2024033861$EMD SERONO INC$Oulehle K. Malnutrition in patients with chronic kidney disease. Postgradual Nephrology. 2024;22(2): 13-16.$74$YR$E$M$Y$$$20240701$$MD$CZ$CZ
240341151$24034115$1$I$20240601$20240620$20240701$20240701$PER$$US-SA-2024SA186513$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240701$$MD$US$US
240341161$24034116$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186390$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240701$$MD$US$US
240341171$24034117$1$I$$20240620$20240701$20240701$EXP$$IT-009507513-2407ITA000094$MERCK$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. European Journal of Haematology. 2024;113 (1):90-8$1$YR$$F$Y$$$20240701$$HP$IT$IT
240341183$24034118$3$F$$20240807$20240701$20240816$EXP$$IT-009507513-2407ITA000098$MERCK$Fati F, Zambaiti E, Petris MG, Virgone C, Dall^ Igna P, Putti MC, et al.. Surgical treatment of invasive fungal infection in pediatric oncology. European Journal of Haematology. 2024;113 (1):90-8$9$YR$$F$Y$$$20240816$$HP$IT$IT
240341193$24034119$3$F$$20240807$20240701$20240812$EXP$$IT-009507513-2406ITA010266$MERCK$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology. European Journal of Haematology. 2024;113(1):90-8$16$YR$$M$Y$$$20240812$$HP$IT$IT
240341201$24034120$1$I$20230126$20240617$20240701$20240701$EXP$$CN-TEYRO-2024-TY-000220$Teyro Labs$Shan J, Liu Z, Chen S, Du C, Li B, Ruan L, et al..Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.BMC Med.2024;22:234$67$YR$E$M$Y$$$20240701$$HP$CN$CN
240341211$24034121$1$I$$20240621$20240701$20240701$EXP$$DE-JNJFOC-20240662995$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$MD$DE$DE
240341221$24034122$1$I$$20240624$20240701$20240701$PER$$US-JNJFOC-20240665664$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240341231$24034123$1$I$20180104$20240620$20240701$20240701$EXP$$AU-JNJFOC-20240656938$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$AU$AU
240341242$24034124$2$F$$20240413$20240701$20240710$PER$$US-ROCHE-3546636$ROCHE$$$$A$M$Y$$$20240701$$CN$US$US
240341251$24034125$1$I$20240101$20240620$20240701$20240701$PER$$US-SA-2024SA185888$SANOFI AVENTIS$$$$$F$Y$$$20240701$$MD$US$US
240341262$24034126$2$F$20240623$20240822$20240701$20240906$PER$$US-SA-2024SA188717$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240906$$CN$US$US
240341271$24034127$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA187077$SANOFI AVENTIS$$$$$F$Y$$$20240701$$HP$US$US
240341281$24034128$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA185851$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240701$$MD$US$US
240341293$24034129$3$F$20240621$20240916$20240701$20240918$PER$$US-SA-2024SA189294$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240918$$HP$US$US
240341301$24034130$1$I$20240401$20240620$20240701$20240701$PER$$US-SA-2024SA186518$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240701$$MD$US$US
240341311$24034131$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA187894$SANOFI AVENTIS$$$$C$F$Y$$$20240701$$MD$US$US
240341322$24034132$2$F$$20240809$20240701$20240816$PER$$US-SA-2024SA189191$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240817$$MD$US$US
240341331$24034133$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA188811$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$MD$US$US
240341343$24034134$3$F$20240621$20240625$20240701$20240704$PER$$US-SA-2024SA188826$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240704$$MD$US$US
240341351$24034135$1$I$20230101$20240625$20240701$20240701$PER$$US-SA-2024SA191377$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240701$$MD$US$US
240341361$24034136$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA188511$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240701$$HP$US$US
240341371$24034137$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104149$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240701$$CN$US$US
240341382$24034138$2$F$$20240223$20240701$20240710$PER$$DE-ROCHE-3511638$ROCHE$$$$A$F$Y$82$KG$20240701$$CN$DE$DE
240341391$24034139$1$I$$20240617$20240701$20240701$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-13709$ALKEM$Ferreira SDC, Vasconcelos JRO, Rezende REF, Aprile LRO, Troncon LEA.. Guillain-Barre Syndrome in a Patient Receiving Anti-Tumor Necrosis Factor for Crohn Disease: Coincidence or Consequence?. American Journal of Case Reports. 2024;25:e943709$45$YR$$F$Y$$$20240701$$HP$BR$BR
240341401$24034140$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13690$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$84$YR$$M$Y$$$20240701$$HP$CN$CN
240341411$24034141$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13638$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$38$YR$$M$Y$$$20240701$$HP$CN$CN
240341421$24034142$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13687$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$48$YR$$M$Y$$$20240701$$HP$CN$CN
240341431$24034143$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13689$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$56$YR$$F$Y$$$20240701$$HP$CN$CN
240341441$24034144$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13630$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$40$YR$$M$Y$$$20240701$$HP$CN$CN
240341451$24034145$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13640$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$19$YR$$M$Y$$$20240701$$HP$CN$CN
240341461$24034146$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13792$ALKEM$Lu L, Lou Y, Tan H.. Chemotherapy-induced fulminant acute pancreatitis in pancreatic carcinoma: A case report. Oncol Lett. 2014;8(3):1143-1146$$$$$Y$$$20240701$$HP$CN$CN
240341471$24034147$1$I$$20240617$20240701$20240701$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-13972$ALKEM$Eswarappa M, Ravi V, Mysorekar V. Renal cortical necrosis in a renal transplant recipient. Indian J Nephrol. 2013;23:238-9$$$$$Y$$$20240701$$HP$IN$IN
240341481$24034148$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13633$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$51$YR$$F$Y$$$20240701$$HP$CN$CN
240341491$24034149$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13642$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$22$YR$$M$Y$$$20240701$$HP$CN$CN
240341501$24034150$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13683$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$19$YR$$M$Y$$$20240701$$HP$CN$CN
240341511$24034151$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13688$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$34$YR$$F$Y$$$20240701$$HP$CN$CN
240341521$24034152$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13684$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$39$YR$$M$Y$$$20240701$$HP$CN$CN
240341531$24034153$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13685$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$71$YR$$F$Y$$$20240701$$HP$CN$CN
240341541$24034154$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13635$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$37$YR$$F$Y$$$20240701$$HP$CN$CN
240341551$24034155$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13647$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$62$YR$$M$Y$$$20240701$$HP$CN$CN
240341561$24034156$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13691$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$63$YR$$M$Y$$$20240701$$HP$CN$CN
240341571$24034157$1$I$$20240617$20240701$20240701$EXP$$RO-ALKEM LABORATORIES LIMITED-RO-ALKEM-2024-13789$ALKEM$Gurzu S, Jung I, Comsulea M, Kadar Z, Azamfirei L, Molnar C.. Lethal cardiotoxicity, steatohepatitis, chronic pancreatitis, and acute enteritis induced by capecitabine and oxaliplatin in a 36-year-old woman.. Diagn Pathol. 2013;8:150$36$YR$$F$Y$$$20240701$$HP$RO$RO
240341581$24034158$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13039$ALKEM$Wu J, Zhou Y. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$17$YR$$M$Y$$$20240701$$HP$CN$CN
240341591$24034159$1$I$$20240617$20240701$20240701$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13692$ALKEM$Wu J, Zhou Y.. Case analysis of hepatotoxicity caused by vancomycin. Journal of Medical Case Reports. 2024;18:267$72$YR$$M$Y$$$20240701$$HP$CN$CN
240341601$24034160$1$I$$20240617$20240701$20240701$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-14001$ALKEM$Bhaskaran D, Thomas S, Scaria LM. Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications. Indian Journal of Pediatrics. 2024;unk:unk$26$MON$$F$Y$$$20240701$$HP$IN$IN
240341611$24034161$1$I$$20240617$20240701$20240701$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-14003$ALKEM$Bhaskaran D, Thomas S, Scaria LM. Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications. Indian Journal of Pediatrics. 2024;unk:unk$30$MON$$M$Y$$$20240701$$HP$IN$IN
240341621$24034162$1$I$20100415$20240617$20240701$20240701$EXP$DE-TEVA-297455GER$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-13389$ALKEM$Unknown. Arzneimittelkommission der deutschen Aerzteschaft. ^Aus der UAW-Datenbank^. Agranulozytose nach Metamizol - sehr selten, aber haeufiger als gedacht. Dtsch Aerztebl. 2011;108(33):A1758-A1759$41$YR$$F$Y$72$KG$20240701$$HP$DE$DE
240341631$24034163$1$I$$20240617$20240701$20240701$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-13722$ALKEM$Giorgetti A, Perdekamp MG, Franchetti G, Pircher R, Pollak S, Pelotti S,  Auwarter V.. Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities. International Journal of Legal Medicine. 2024;Unk:Unk$31$YR$$M$Y$$$20240701$$HP$IT$IT
240341641$24034164$1$I$$20240122$20240701$20240701$PER$$US-AMGEN-USASP2024127635$AMGEN$$$$$$Y$$$20240701$$MD$US$US
240341661$24034166$1$I$20240621$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A148216$ASTRAZENECA$$29001$DY$$$Y$$$20240701$$MD$US$
240341671$24034167$1$I$$20240617$20240701$20240701$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-13721$ALKEM$Giorgetti A, Grobe Perdekamp M, Franchetti G, Pircher R, Pollak S, Pelotti S, Auwarter V. Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities. International Journal of Legal Medicine. 2024;unk:unk$31$YR$$M$Y$$$20240701$$HP$IT$IT
240341681$24034168$1$I$20200716$20240621$20240701$20240701$EXP$PL-URPL-1-1543-2020$PL-TEVA-VS-3213554$TEVA$$$$$$Y$$$20240701$$MD$PL$PL
240341691$24034169$1$I$20240620$20240621$20240701$20240701$EXP$$US-BAYER-2024A091877$BAYER$$71$YR$E$F$Y$$$20240701$$CN$US$US
240341701$24034170$1$I$20220617$20240628$20240701$20240701$EXP$ES-AEMPS-1536216$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-103874$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240701$$MD$ES$ES
240341711$24034171$1$I$$20240617$20240701$20240701$EXP$$US-ENDO USA, INC.-2024-002714$ENDO$$$$$M$Y$$$20240701$$CN$US$US
240341721$24034172$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184483$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240341731$24034173$1$I$20240620$20240624$20240701$20240701$EXP$$GB-AMGEN-GBRSP2024125902$AMGEN$$74$YR$E$M$Y$$$20240701$$CN$GB$GB
240341741$24034174$1$I$20230301$20240617$20240701$20240701$EXP$$CN-TEYRO-2024-TY-000219$Teyro Labs$Shan J, Liu Z, Chen S, Du C, Li B, Ruan L, et al..Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.BMC Med.2024;22:234$65$YR$E$M$Y$$$20240701$$HP$CN$CN
240341751$24034175$1$I$$20230105$20240701$20240701$PER$$US-AMGEN-USASP2023235008$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240341762$24034176$2$F$20240101$20240708$20240701$20240714$PER$$US-AMGEN-USASP2024126526$AMGEN$$70$YR$E$F$Y$$$20240714$$CN$US$US
240341773$24034177$3$F$20240101$20240813$20240701$20240817$PER$$US-AMGEN-USASP2024125093$AMGEN$$61$YR$A$M$Y$$$20240817$$HP$US$US
240341781$24034178$1$I$$20230920$20240701$20240701$PER$$US-AMGEN-USASP2023235070$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240341792$24034179$2$F$20240622$20240710$20240701$20240714$30DAY$$US-AMGEN-USASP2024125096$AMGEN$$$$$$Y$$$20240714$$PH$US$US
240341801$24034180$1$I$$20231226$20240701$20240701$PER$$US-AMGEN-USASP2023235073$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240341811$24034181$1$I$20240625$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126476$AMGEN$$84$YR$E$F$Y$$$20240701$$CN$US$US
240341821$24034182$1$I$$20240622$20240701$20240701$EXP$$BR-AMGEN-BRASP2024124526$AMGEN$Nobre L.; Rosas C.; Kalichsztein B. et al.. Recurrent Pulmonary Hemorrhage in a Young Adult. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A7055$48$YR$A$F$Y$$$20240701$$HP$BR$BR
240341832$24034183$2$F$$20240807$20240701$20240812$EXP$$IT-009507513-2407ITA000099$MERCK$Fati F, Zambaiti E, Petris MG, Virgone C, Dall^ Igna P, Putti MC, et al. Surgical treatment of invasive fungal infection in pediatric oncology. European Journal of Haematology. 2024;113 (1):90-8$9$YR$$F$Y$$$20240812$$HP$IT$IT
240341841$24034184$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA188347$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$MD$US$US
240341853$24034185$3$F$20240101$20240730$20240701$20240812$PER$$US-SA-2024SA188357$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240812$$MD$US$US
240341861$24034186$1$I$20240401$20240620$20240701$20240701$PER$$US-SA-2024SA186520$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240701$$MD$US$US
240341871$24034187$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA187939$SANOFI AVENTIS$$$$C$M$Y$$$20240701$$MD$US$US
240341881$24034188$1$I$20240501$20240621$20240701$20240701$PER$$US-SA-2024SA187928$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240701$$MD$US$US
240341891$24034189$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA187844$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240701$$PH$US$US
240341903$24034190$3$F$20240619$20240916$20240701$20240924$PER$$US-SA-2024SA189163$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240924$$HP$US$US
240341912$24034191$2$F$20240101$20240814$20240701$20240828$PER$$US-SA-2024SA190831$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240828$$MD$US$US
240341921$24034192$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA187935$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240701$$MD$US$US
240341932$24034193$2$F$20240101$20240814$20240701$20240828$PER$$US-SA-2024SA190823$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240828$$MD$US$US
240341941$24034194$1$I$$20240620$20240701$20240701$EXP$$AU-JNJFOC-20240656829$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240701$$CN$AU$AU
240341951$24034195$1$I$$20240622$20240701$20240701$PER$$US-SA-2024SA189059$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240701$$CN$US$US
240341961$24034196$1$I$20240523$20240617$20240701$20240701$EXP$ES-AEMPS-1535538$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-108713$ZYDUS PHARM$$$$$$Y$$$20240701$$PH$ES$ES
240341971$24034197$1$I$20220507$20240624$20240701$20240701$EXP$$GB-ADVANZ PHARMA-202406005264$ADVANZ PHARMA$$$$$$Y$$$20240701$$PH$GB$GB
240341981$24034198$1$I$20240331$20240617$20240701$20240701$EXP$ES-AEMPS-1533750$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-108635$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$ES$ES
240341991$24034199$1$I$20240205$20240617$20240701$20240701$EXP$FR-AFSSAPS-PP2024000622$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108658$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$FR$FR
240342001$24034200$1$I$20230801$20240617$20240701$20240701$EXP$FR-AFSSAPS-TS2024000697$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108726$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$FR$FR
240342011$24034201$1$I$20240502$20240617$20240701$20240701$EXP$FR-AFSSAPS-NC2024000691$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108737$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$FR$FR
240342021$24034202$1$I$20240219$20240617$20240701$20240701$EXP$FR-AFSSAPS-PA2024001246$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108735$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$FR$FR
240342031$24034203$1$I$20240603$20240617$20240701$20240701$EXP$FR-AFSSAPS-RN2024000649$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108724$ZYDUS PHARM$$$$$$Y$$$20240701$$PH$FR$FR
240342041$24034204$1$I$20240504$20240617$20240701$20240701$EXP$FR-AFSSAPS-RN2024000660$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108741$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$FR$FR
240342051$24034205$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104254$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$CN$US$US
240342061$24034206$1$I$20230801$20240624$20240701$20240701$EXP$$US-UCBSA-2024032525$UCB$$0$YR$$M$Y$4.1$KG$20240701$$CN$US$US
240342071$24034207$1$I$20230925$20240628$20240701$20240701$EXP$$DK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035333$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$$$20240701$$MD$DK$DK
240342081$24034208$1$I$$20240625$20240701$20240701$EXP$$CN-ASTELLAS-2024US018228$ASTELLAS$Wang J, Liu X, Zhong Z, Li Y. Anesthesia management for liver cancer resection in 1 patient with coronary heart disease after renal transplantation. Perioperative Safety and Quality Assurance. 2024;6(3):165-7$52$YR$$M$Y$$$20240701$$HP$CN$CN
240342091$24034209$1$I$$20240621$20240701$20240701$EXP$$US-BAYER-2024A094240$BAYER$Ramkissoon R.; Wong Kee Song L.M.; Coelho-Prabhu N.. The Bleeding Sunflower Polyp: A Rare Sequelae of Over-the-Scope Clip Placement. American Journal of Gastroenterology. 2024;119:6:1015$84$YR$E$F$Y$$$20240701$$MD$US$US
240342101$24034210$1$I$$20240617$20240701$20240701$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001577$IPCA$E. K Hourigan, M. Rattan and M. L. Olsen. The right side of cardiogenic shock: A case of beta-blocker induced cardiogenic shock in a female with suspected pulmonary hypertension. Am J Respir Crit Care Med. 2024;209:A1595$$$$$Y$$$20240701$$HP$US$US
240342111$24034211$1$I$$20240620$20240701$20240701$EXP$$US-MACLEODS PHARMA-MAC2021031142$MACLEODS$$$$$$Y$$$20240701$$MD$US$US
240342121$24034212$1$I$$20240618$20240701$20240701$EXP$$US-MACLEODS PHARMA-MAC2024047846$MACLEODS$$$$$$Y$$$20240701$$CN$US$US
240342131$24034213$1$I$$20240620$20240701$20240701$EXP$$TW-MACLEODS PHARMA-MAC2024047877$MACLEODS$Shen YC, Wu JC, Lin TT, Chang KC, Su JJ, Juang JM..Case Report: Lacosamide unmasking SCN5A-associated Brugada syndrome in a young female with epilepsy.Frontiers in Cardiovascular Medicine.31-MAY-2024;11:1406614$$$$$Y$$$20240701$$HP$TW$TW
240342141$24034214$1$I$$20240618$20240701$20240701$EXP$$AU-MACLEODS PHARMA-MAC2016002401$MACLEODS$Shah S, Jeremiah C, Johnson D, Baker S.Risedronate as an intra-abdominal sepsis mimic: a case report..Archives of Osteoporosis.2015;10(1):213$$$$$Y$$$20240701$$MD$AU$AU
240342151$24034215$1$I$20240620$20240620$20240701$20240701$EXP$GB-MHRA-MED-202406200901269310-JHSWK$GB-MACLEODS PHARMA-MAC2024047873$MACLEODS$$$$$$Y$$$20240701$$CN$GB$GB
240342162$24034216$2$F$$20240703$20240701$20240715$EXP$$CN-MACLEODS PHARMA-MAC2024047869$MACLEODS$$$$$$Y$$$20240715$$PH$CN$CN
240342171$24034217$1$I$20240615$20240619$20240701$20240701$EXP$GB-MHRA-MED-202406191238381050-GCQDR$GB-MACLEODS PHARMA-MAC2024047865$MACLEODS$$$$$$Y$$$20240701$$PH$GB$GB
240342182$24034218$2$F$$20240627$20240701$20240709$EXP$$IR-MACLEODS PHARMA-MAC2024047868$MACLEODS$Lotfollahi L, Golmohammadi M, Gharehbagh FJ, Darazam IA..Self-induced Anuria with Diclofenac: An Interesting Case of Quadruple Whammy Acute Kidney Injury..International Journal of Medical Toxicology and Forensic Medicine..2024;14(2):E43065$$$$$Y$$$20240709$$MD$IR$IR
240342191$24034219$1$I$$20240619$20240701$20240701$EXP$$PT-MACLEODS PHARMA-MAC2024047866$MACLEODS$Sousa BS, de Sa ZC, Ramos J..Decoding the enigma: Valproate encephalopathy in a bipolar affective disorder without hyperammonemia.Bipolar disorders.2024;00:1-3$$$$$Y$$$20240701$$MD$PT$PT
240342201$24034220$1$I$$20240619$20240701$20240701$EXP$$US-MACLEODS PHARMA-MAC2024047867$MACLEODS$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM..Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients..Archives of Dermatological Research.2024;316(6):279$$$$$Y$$$20240701$$MD$US$US
240342211$24034221$1$I$$20230826$20240701$20240701$PER$$US-AMGEN-USASP2023234994$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240342223$24034222$3$F$$20240730$20240701$20240801$PER$$US-HALEON-2184442$Haleon PLC$$12$YR$$F$Y$$$20240801$$CN$US$US
240342231$24034223$1$I$$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024128621$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240342243$24034224$3$F$20240101$20240708$20240701$20240709$PER$$US-AMGEN-USASP2024127114$AMGEN$$71$YR$E$F$Y$$$20240709$$CN$US$US
240342252$24034225$2$F$20240619$20240709$20240701$20240709$EXP$$ZA-BAYER-2024A094111$BAYER$$$$$F$Y$$$20240709$$MD$ZA$ZA
240342261$24034226$1$I$20200705$20240620$20240701$20240701$EXP$$AU-JNJFOC-20240656793$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$AU$AU
240342271$24034227$1$I$20240622$20240626$20240701$20240701$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-12830$IPSEN$$57$YR$A$F$Y$$$20240701$$CN$CA$CA
240342281$24034228$1$I$$20240620$20240701$20240701$EXP$$DE-JNJFOC-20240678222$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240701$$MD$DE$DE
240342291$24034229$1$I$20230227$20240617$20240701$20240701$EXP$$CN-TEYRO-2024-TY-000215$Teyro Labs$Shan J, Liu Z, Chen S, Du C, Li B, Ruan L, et al..Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.BMC Med.2024;22:234$69$YR$E$M$Y$$$20240701$$HP$CN$CN
240342301$24034230$1$I$20240511$20240621$20240701$20240701$EXP$FR-AFSSAPS-AN2024000751$FR-TEVA-VS-3213480$TEVA$$37$YR$$M$Y$$$20240701$$MD$FR$FR
240342311$24034231$1$I$$20230717$20240701$20240701$PER$$US-AMGEN-USASP2023235081$AMGEN$$$$$$Y$$$20240701$$MD$US$US
240342321$24034232$1$I$$20230515$20240701$20240701$PER$$US-AMGEN-USASP2023235085$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240342331$24034233$1$I$$20231023$20240701$20240701$PER$$US-AMGEN-USASP2023235078$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240342341$24034234$1$I$20230901$20240618$20240701$20240701$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000095-2024$QILU PHARMACEUTICAL$Xiao M Tong W Xiao X Pu X Yi F.Systemic metastases in large cell neuroendocrine prostate cancer: a rare case report and literature review.Frontiers in Oncology.15-MAY-2024;14:1-9$65$YR$A$M$Y$$$20240627$$HP$CN$CN
240342351$24034235$1$I$20240620$20240620$20240701$20240701$PER$$US-CHATTEMPRD-2024OHG021863$CHATTEM$$$$$F$Y$$$20240701$$CN$US$US
240342361$24034236$1$I$20240601$20240620$20240701$20240701$PER$$US-CHATTEMPRD-2024OHG021696$CHATTEM$$$$$F$Y$$$20240701$$CN$US$US
240342381$24034238$1$I$$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024128007$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240342391$24034239$1$I$20230828$20240624$20240701$20240701$EXP$$ES-AMGEN-ESPSP2024124930$AMGEN$$72$YR$E$F$Y$$$20240701$$MD$ES$ES
240342401$24034240$1$I$20240606$20240621$20240701$20240701$PER$$US-ABBVIE-5812620$ABBVIE$$$$A$F$Y$$$20240701$$HP$US$US
240342411$24034241$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA187433$SANOFI AVENTIS$$$$$F$Y$$$20240701$$CN$US$US
240342422$24034242$2$F$$20240717$20240701$20240726$PER$$US-SA-2024SA187415$SANOFI AVENTIS$$65$YR$E$F$Y$86.168$KG$20240726$$CN$US$US
240342431$24034243$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA188364$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240701$$MD$US$US
240342441$24034244$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186914$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240701$$MD$US$US
240342453$24034245$3$F$20240101$20240806$20240701$20240814$PER$$US-SA-2024SA190548$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240814$$MD$US$US
240342462$24034246$2$F$20240101$20240709$20240701$20240718$PER$$US-SA-2024SA188799$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240718$$MD$US$US
240342481$24034248$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA187270$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240701$$CN$US$US
240342491$24034249$1$I$20240101$20240625$20240701$20240701$PER$$US-SA-2024SA192733$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240701$$MD$US$US
240342501$24034250$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA188053$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240701$$HP$US$US
240342512$24034251$2$F$$20240701$20240701$20240708$30DAY$$US-GSK-US2024078077$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$CN$US$US
240342521$24034252$1$I$$20240621$20240701$20240701$PER$$US-CHATTEMPRD-2024OHG022094$CHATTEM$$59$YR$A$F$Y$$$20240701$$CN$US$US
240342532$24034253$2$F$20240620$20240723$20240701$20240731$PER$$US-CHATTEMPRD-2024OHG021698$CHATTEM$$68$YR$E$F$Y$$$20240731$$CN$US$US
240342541$24034254$1$I$$20240605$20240701$20240701$PER$$US-JNJFOC-20240617042$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240342551$24034255$1$I$20240616$20240617$20240701$20240701$PER$$US-JNJFOC-20240645508$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240701$$CN$US$US
240342562$24034256$2$F$$20240702$20240701$20240704$PER$$US-AstraZeneca-2024A140198$ASTRAZENECA$$$$$F$Y$$$20240704$$CN$US$
240342571$24034257$1$I$$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A147700$ASTRAZENECA$$$$$F$Y$$$20240701$$CN$US$
240342581$24034258$1$I$$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104193$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240701$$CN$US$US
240342591$24034259$1$I$20240626$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104760$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240701$$HP$US$US
240342601$24034260$1$I$$20230621$20240701$20240701$PER$$US-AMGEN-USASP2023235063$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240342611$24034261$1$I$20230101$20240625$20240701$20240701$EXP$$PL-ABBVIE-5817815$ABBVIE$$$$$M$Y$$$20240701$$MD$PL$PL
240342621$24034262$1$I$$20240620$20240701$20240701$EXP$$US-MYLANLABS-2024M1058132$MYLAN$Saleh Z, Kanaan J. A Combination of Tezepelumab and Omalizumab for Severe Persistent Asthma. Am-J-Respir-Crit-Care-Med 2024; 209 A5302.$59$YR$$F$Y$$$20240701$$HP$US$US
240342631$24034263$1$I$$20240622$20240701$20240701$PER$$US-CHATTEMPRD-2024OHG021880$CHATTEM$$$$$F$Y$$$20240701$$CN$US$US
240342641$24034264$1$I$20220704$20240617$20240701$20240701$EXP$$CN-TEYRO-2024-TY-000218$Teyro Labs$Shan J, Liu Z, Chen S, Du C, Li B, Ruan L, et al..Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.BMC Med.2024;22:234$54$YR$A$M$Y$$$20240701$$HP$CN$CN
240342651$24034265$1$I$20240612$20240626$20240701$20240701$EXP$$CA-TAKEDA-2024TUS064548$TAKEDA$$31$YR$$F$Y$$$20240701$$CN$CA$CA
240342661$24034266$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186475$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240701$$CN$US$US
240342671$24034267$1$I$20240501$20240620$20240701$20240701$PER$$US-SA-2024SA186522$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240701$$MD$US$US
240342681$24034268$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186480$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240701$$PH$US$US
240342692$24034269$2$F$20240101$20240814$20240701$20240828$PER$$US-SA-2024SA186514$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240828$$MD$US$US
240342701$24034270$1$I$20240101$20240620$20240701$20240701$PER$$US-SA-2024SA186571$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240701$$MD$US$US
240342711$24034271$1$I$20240601$20240620$20240701$20240701$PER$$US-SA-2024SA186617$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240701$$MD$US$US
240342721$24034272$1$I$$20240624$20240701$20240701$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004744$BIOCON$$$$$$Y$$$20240701$$CN$CA$CA
240342731$24034273$1$I$$20240624$20240701$20240701$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004733$BIOCON$$$$$$Y$$$20240701$$CN$CA$CA
240342752$24034275$2$F$$20240723$20240701$20240802$30DAY$$US-GSK-US2024AMR079011$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
240342761$24034276$1$I$$20240621$20240701$20240701$EXP$$US-GSK-US2024077993$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$MD$US$US
240342771$24034277$1$I$$20240619$20240701$20240701$EXP$$CH-SCIEGENP-2024SCLIT00320$SCIEGEN$Nzomessi D, et al.Combined lactic acidosis and ketoacidosis in a female  diabetic patient with severe heart failure.Cardiovascular Endocrinology and Metabolism .sep-2023;12 (3):1-3$58$YR$A$F$Y$$$20240701$$MD$CH$CH
240342781$24034278$1$I$$20240623$20240701$20240701$PER$$US-CHATTEMPRD-2024OHG021883$CHATTEM$$$$$$Y$$$20240701$$CN$US$US
240342792$24034279$2$F$20240607$20240703$20240701$20240708$PER$$US-BAYER-2024A093375$BAYER$$47$YR$A$F$Y$$$20240708$$HP$US$US
240342801$24034280$1$I$20220625$20240617$20240701$20240701$EXP$$CN-TEYRO-2024-TY-000214$Teyro Labs$Shan J, Liu Z, Chen S, Du C, Li B, Ruan L, et al..Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.BMC Med.2024;22:234$67$YR$E$M$Y$$$20240701$$HP$CN$CN
240342811$24034281$1$I$$20240624$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101828$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$61.69$KG$20240701$$PH$US$US
240342821$24034282$1$I$$20240619$20240701$20240701$PER$$US-MSNLABS-2024MSNSPO01356$MSN LABORATORIES$$$$$$Y$$$20240701$$CN$US$US
240342831$24034283$1$I$20210322$20240625$20240701$20240701$EXP$$CA-TAKEDA-2021TUS019618$TAKEDA$$26$YR$$F$Y$$$20240701$$MD$CA$CA
240342841$24034284$1$I$$20240619$20240701$20240701$EXP$$US-MYLANLABS-2024M1057376$MYLAN$Lee M, Channick J, Chan V. Methimazole-Induced Hypothyroidism Presenting as Recurrent Thoracic Cavity Effusions and Ascites. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A1942.$62$YR$$F$Y$$$20240701$$HP$US$US
240342851$24034285$1$I$$20240619$20240701$20240701$EXP$$US-MYLANLABS-2024M1057274$MYLAN$Raymond-Forde S, Olexsey K. A Rare but Potentially Fatal Reaction in Plain Sight: Trimethoprim- Sulfamethoxazole Induced Acute Lung Injury. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$26$YR$$F$Y$$$20240701$$HP$US$US
240342861$24034286$1$I$$20240620$20240701$20240701$EXP$$US-MYLANLABS-2024M1058119$MYLAN$Ravi S, Upadhyay H. Thrombotic Enigma: A 38-year-old^s Maze of Clots. Am-J-Respir-Crit-Care-Med 2024; 209.$38$YR$$M$Y$$$20240701$$HP$US$US
240342871$24034287$1$I$$20240620$20240701$20240701$EXP$$US-MYLANLABS-2024M1058155$MYLAN$Kruttiventi S, Olcott J, Doubledee B. Ditch the Itch: Propofol in the Management of Cholestatic Pruritus. Clin-Pediatr-Phila 2023; 0 (0):.$17$YR$$F$Y$$$20240701$$MD$US$US
240342881$24034288$1$I$$20240619$20240701$20240701$EXP$$US-MYLANLABS-2024M1057695$MYLAN$Abdulelah M, McGee WT. Diagnostic Ambiguity in Brain Death. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$40$YR$$M$Y$$$20240701$$HP$US$US
240342891$24034289$1$I$$20240619$20240701$20240701$EXP$$US-MYLANLABS-2024M1057643$MYLAN$Rainone M, Ngo D, Baird JH, Budde LE, Htut M, Aldoss I, et al. Interferon-gamma blockade in CAR T-cell therapy-associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis. Blood-Adv 2023; 7 (4): 533-536.$19$YR$$M$Y$$$20240701$$HP$US$US
240342901$24034290$1$I$$20240620$20240701$20240701$EXP$$US-MYLANLABS-2024M1058129$MYLAN$Aribindi K, Arif MZ, Quon SM, Inaty H. From the Pipes to the Pleural Space: A Rare Case of a Cryptococcal Effusion. Am-J-Respir-Crit-Care-Med 2024; 209.$54$YR$$F$Y$$$20240701$$HP$US$US
240342911$24034291$1$I$$20240620$20240701$20240701$EXP$$IT-MYLANLABS-2024M1058086$MYLAN$Zelin E, Mazzoletti V, Bazzacco G, Toffoli L, Conforti C, Di Meo N, et al. Omalizumab for isolated idiopathic angioedema: A case report and short literature review. [Review]. J-Dtsch-Dermatol-Ges 2024; 22 (5): 707-709.$46$YR$$F$Y$$$20240701$$HP$IT$IT
240342921$24034292$1$I$$20240620$20240701$20240701$EXP$$US-MYLANLABS-2024M1058128$MYLAN$Sompalli S, Foray N, Sreedhar R. A Rare Case of Non-traumatic Splenic Rupture Following Portal Vein Thrombosis. Am-J-Respir-Crit-Care-Med 2024; 209.$53$YR$$F$Y$$$20240701$$HP$US$US
240342933$24034293$3$F$20240101$20240806$20240701$20240809$PER$$US-CHATTEMPRD-2024OHG021948$CHATTEM$$71$YR$E$F$Y$$$20240809$$CN$US$US
240342941$24034294$1$I$20240323$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406271040542900-VDNJS$GB-ORGANON-O2406GBR002732$ORGANON$$$$$M$Y$78$KG$20240701$$CN$GB$US
240342951$24034295$1$I$$20240618$20240701$20240701$EXP$$US-MYLANLABS-2024M1057267$MYLAN$Alam S, Cheungpasitporn W, Kukla A. Unraveling powassan encephalitis after a kidney-pancreas transplant: Case report and implication. Am-J-Kidney-Dis 2024; 83 (Suppl. 2) (4): S140 abstr. 457.$57$YR$$F$Y$$$20240701$$HP$US$US
240342961$24034296$1$I$$20240618$20240701$20240701$EXP$$US-MYLANLABS-2024M1057244$MYLAN$Haghparast P, Nadybal M, Yuan C. Treatment-Resistant Priapism in a 61-Year-Old Male After Combined Use of Trazodone, Quetiapine, and Fluoxetine. J-Clin-Psychopharmacol 2024; 44 (3): 316-317.$61$YR$$M$Y$$$20240701$$PH$US$US
240342971$24034297$1$I$$20231113$20240701$20240701$PER$$US-AMGEN-USASP2023235053$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240342981$24034298$1$I$$20230322$20240701$20240701$PER$$US-AMGEN-USASP2023235095$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240342991$24034299$1$I$$20240618$20240701$20240701$EXP$$US-ENDO USA, INC.-2024-002708$ENDO$Lam E, Santos C, Patrawalla AS.. A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5651$32$YR$$F$Y$$$20240701$$HP$US$US
240343001$24034300$1$I$20240512$20240621$20240701$20240701$EXP$$AU-EXELIXIS-CABO-22055271$EXELIXIS$$58$YR$$F$Y$$$20240701$$MD$AU$AU
240343012$24034301$2$F$20220922$20240731$20240701$20240809$EXP$$CZ-EXELIXIS-CABO-24078980$EXELIXIS$SRSENOV? J. Srsenova J.. Cabozantinib in 1st line treatment of generalized clear cell renal carcinoma  Current topics in oncology. Cabozantinib in 1st line treatment of generalized clear cell renal carcinoma.. 2024;10-11$76$YR$$M$Y$70$KG$20240809$$MD$CZ$CZ
240343021$24034302$1$I$$20240617$20240701$20240701$EXP$$GB-TEYRO-2024-TY-000207$Teyro Labs$Millen GC, Lawford A, Duncan C, Jenkinson H, Veal GJ, Barnett S. .Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom..Br J Cancer.2024$10$DY$N$$Y$$$20240701$$HP$GB$GB
240343043$24034304$3$F$20240515$20240726$20240701$20240807$30DAY$$FR-JNJFOC-20240619348$JOHNSON AND JOHNSON$$63$YR$A$M$Y$88$KG$20240807$$CN$FR$FR
240343051$24034305$1$I$$20240620$20240701$20240701$EXP$$AU-JNJFOC-20240656532$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$AU$AU
240343061$24034306$1$I$20240601$20240618$20240701$20240701$PER$$US-JNJFOC-20240646975$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240701$$CN$US$US
240343071$24034307$1$I$$20240627$20240701$20240701$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036884$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240701$$HP$US$US
240343081$24034308$1$I$20210204$20240625$20240701$20240701$PER$$US-BAYER-2024A092167$BAYER$$24$YR$A$F$Y$$$20240701$$CN$US$US
240343091$24034309$1$I$$20230315$20240701$20240701$PER$$US-AMGEN-USASP2023235093$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240343101$24034310$1$I$20240530$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031515$AUROBINDO$$47$YR$$F$Y$$$20240701$$MD$FR$FR
240343111$24034311$1$I$$20230523$20240701$20240701$PER$$US-AMGEN-USASP2023235061$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240343122$24034312$2$F$20240624$20240703$20240701$20240708$PER$$US-AMGEN-USASP2024126562$AMGEN$$65$YR$E$M$Y$$$20240708$$CN$US$US
240343131$24034313$1$I$20230609$20240617$20240701$20240701$EXP$$CN-TEYRO-2024-TY-000217$Teyro Labs$Shan J, Liu Z, Chen S, Du C, Li B, Ruan L, et al..Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.BMC Med.2024;22:234$59$YR$A$M$Y$$$20240701$$HP$CN$CN
240343152$24034315$2$F$$20240724$20240701$20240726$EXP$$CA-TAKEDA-2024TUS064122$TAKEDA$$$$$M$Y$$$20240726$$MD$CA$CA
240343161$24034316$1$I$$20240622$20240701$20240701$EXP$$US-MYLANLABS-2024M1058816$MYLAN$Grossman J, Amdo TD, Mercado JM, Moreira A, Adelman MH. Case Report: Subtle Perilymphatic Sarcoidosis Mimicking Miliary Tuberculosis. Am-J-Respir-Crit-Care-Med 2024; 209.$4$DEC$$M$Y$$$20240701$$HP$US$US
240343173$24034317$3$F$20240101$20240722$20240701$20240801$EXP$$US-INSMED, INC.-2024-02332-US$INSMED$$$$$F$Y$$$20240801$$CN$US$US
240343181$24034318$1$I$$20240622$20240701$20240701$EXP$$US-MYLANLABS-2024M1059128$MYLAN$Zemel MC, Hughes A, Wong WW. A Tale of Two Chest Tubes, Marijuana Versus Sarcoid. Am-J-Respir-Crit-Care-Med 2024; 209.$27$YR$$M$Y$$$20240701$$HP$US$US
240343191$24034319$1$I$20240625$20240625$20240701$20240701$PER$$US-BAYER-2024A092848$BAYER$$20$YR$A$F$Y$$$20240701$$MD$US$US
240343201$24034320$1$I$$20240626$20240701$20240701$EXP$$ZA-AstraZeneca-2024A149269$ASTRAZENECA$$76$YR$$F$Y$$$20240701$$CN$ZA$
240343211$24034321$1$I$$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031788$AUROBINDO$Leleu X, Hulin C, Lambert J, Bobin A, Perrot A, Karlin L, et al.. Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 benefit trial.. Nature Medicine. 2024$$$E$$Y$$$20240701$$MD$FR$FR
240343221$24034322$1$I$$20240624$20240701$20240701$PER$$US-BAYER-2024A090929$BAYER$$28$YR$A$F$Y$$$20240701$$HP$US$US
240343231$24034323$1$I$20240416$20240620$20240701$20240701$EXP$GB-MHRA-MED-202406201533404010-TSHDG$GB-Accord-431914$ACCORD$$25$YR$A$M$Y$78$KG$20240701$$CN$GB$GB
240343241$24034324$1$I$$20240620$20240701$20240701$EXP$GB-MHRA-MED-202406191030491720-RQHBZ$GB-Accord-431921$ACCORD$$$$$F$Y$$$20240701$$MD$GB$GB
240343251$24034325$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432121$ACCORD$Pandhair O. Confoundingly Persistent Pneumonia in a Heart Transplant Patient. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2442. Doi: 10.1164/ajrccm-conference.2024.209.$67$YR$E$M$Y$$$20240701$$MD$US$US
240343261$24034326$1$I$20230101$20240620$20240701$20240701$EXP$$SK-Accord-432338$ACCORD$Drahokoupilova M. Significance of primary tumor location in treatment decisions in patients with metastatic colorectal cancer without RAS mutation - a systematic review. Commentary on the study. PHARMACOTHERAPY. 2024;14(1):25-31.$38$YR$A$M$Y$$$20240701$$MD$SK$SK
240343271$24034327$1$I$20240620$20240620$20240701$20240701$EXP$GB-MHRA-TPP39180069C16170615YC1718900973583$GB-Accord-431711$ACCORD$$8$YR$C$M$Y$18$KG$20240701$$HP$GB$GB
240343281$24034328$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432135$ACCORD$Dhaliwal K, Patel N, Aulakh B. Toxic Megacolon: A Rare Adverse Effect of Etoposide Chemotherapy. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5663.$59$YR$A$M$Y$$$20240701$$MD$US$US
240343291$24034329$1$I$$20240620$20240701$20240701$EXP$AU-TGA-802781$AU-Accord-431505$ACCORD$$$$$M$Y$$$20240701$$HP$AU$AU
240343301$24034330$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432113$ACCORD$Prabhu S, Malempati S, Markowitz D. Amlodipine: Not an Ace in the Hole. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1361. DOI:10.1164/ajrccm-conference.2024.209.$56$YR$A$M$Y$$$20240701$$MD$US$US
240343311$24034331$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432117$ACCORD$Sasidharan S, Jatoi T, Milla C, Mallappallil M, Agarwal S, Puri I. Triple whammy of Amlodipine, Carvedilol and Diphenhydramine overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5669. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5669.$27$YR$A$F$Y$$$20240701$$MD$US$US
240343322$24034332$2$F$$20240702$20240701$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05537$LUPIN$$$$$$Y$$$20240724$$CN$US$US
240343331$24034333$1$I$20230301$20240617$20240701$20240701$EXP$$CN-TEYRO-2024-TY-000222$Teyro Labs$Shan J, Liu Z, Chen S, Du C, Li B, Ruan L, et al..Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.BMC Med.2024;22:234$67$YR$E$M$Y$$$20240701$$HP$CN$CN
240343343$24034334$3$F$$20240327$20240701$20240710$PER$$US-ROCHE-3535452$ROCHE$$12$DY$N$M$Y$2.96$KG$20240701$$CN$US$US
240343361$24034336$1$I$$20240322$20240701$20240701$PER$$CA-ROCHE-3532564$ROCHE$$$$$$Y$$$20240701$$MD$CA$CA
240343371$24034337$1$I$$20240327$20240701$20240701$PER$$US-ROCHE-3534864$ROCHE$$14$MON$I$M$Y$9.52$KG$20240701$$CN$US$US
240343382$24034338$2$F$20230801$20240424$20240701$20240710$PER$$GB-ROCHE-3548547$ROCHE$$36$YR$A$F$Y$$$20240701$$HP$GB$GB
240343391$24034339$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA188977$SANOFI AVENTIS$$$$A$F$Y$129$KG$20240701$$MD$US$US
240343401$24034340$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190789$SANOFI AVENTIS$$$$$M$Y$$$20240701$$PH$US$US
240343411$24034341$1$I$$20240621$20240701$20240701$PER$$US-BAYER-2024A091312$BAYER$$$$$F$Y$$$20240701$$CN$US$US
240343422$24034342$2$F$$20240710$20240701$20240712$EXP$$JP-UCBSA-2024032483$UCB$Uda T, Kawashima T, Tagami Y, Shuto F, Hamaguchi H, Hiramoto M, et al. A Case of Non-Lesional Focal Epilepsy with Ictal Asystole.. Program/Abstract of the 20th Kinki Regional Meeting of The Japan Epilepsy Societ. 2024;23$54$YR$$M$Y$$$20240712$$MD$JP$JP
240343431$24034343$1$I$20240401$20240404$20240701$20240701$PER$$CA-ROCHE-3540655$ROCHE$$55$YR$A$M$Y$$$20240701$$CN$CA$CA
240343441$24034344$1$I$$20240402$20240701$20240701$PER$$FR-ROCHE-3540569$ROCHE$$16$YR$T$M$Y$$$20240701$$HP$FR$FR
240343451$24034345$1$I$$20231010$20240701$20240701$PER$$US-AMGEN-USASP2023235071$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240343462$24034346$2$F$20240101$20240702$20240701$20240705$PER$$US-ABBVIE-5820752$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240343471$24034347$1$I$20240626$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127437$AMGEN$$56$YR$A$M$Y$$$20240701$$CN$US$US
240343481$24034348$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432128$ACCORD$Lakhani M, Azulay H. From Rashes to Ruin: The Methotrexate Misadventure. American Journal of Respiratory and Critical Care Medicine. 2024;209.$43$YR$A$M$Y$$$20240701$$MD$US$US
240343491$24034349$1$I$$20240620$20240701$20240701$EXP$$US-MYLANLABS-2024M1058106$MYLAN$Brown AF, Fowler CM. Diffuse Interstitial Lung Disease With Organizing Pneumonia in 12-year- Old Female With TNFRSF13B Monoallelic Common Variable Immunodeficiency. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$12$YR$$F$Y$$$20240701$$HP$US$US
240343501$24034350$1$I$$20240620$20240701$20240701$EXP$$US-MYLANLABS-2024M1058148$MYLAN$Magro CM, Kalomeris T, Shreve CR, Geyer JT, Patel SS. Subcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administration. Leuk-Lymphoma 2024; 65 (5): 638-646.$61$YR$$F$Y$$$20240701$$HP$US$US
240343511$24034351$1$I$20060423$20240626$20240701$20240701$EXP$$ES-PFIZER INC-HQWYE336410AUG06$PFIZER$$74$YR$$M$Y$$$20240701$$HP$ES$ES
240343531$24034353$1$I$$20240618$20240701$20240701$EXP$$NG-PFIZER INC-202400197112$PFIZER$Charles, U.. Visual and endocrine outcome following surgery for pituitary adenoma in a tertiary hospital, North Central Nigeria. British Journal of Neurosurgery. 2024;38(3):639-642$$$A$$Y$$$20240701$$HP$NG$NG
240343541$24034354$1$I$$20240626$20240701$20240701$EXP$$US-PFIZER INC-202400203366$PFIZER$O^halloran, K.. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6(1):10.1093/noajnl/vdae070$119$MON$$M$Y$$$20240701$$MD$US$US
240343552$24034355$2$F$20240623$20240627$20240701$20240703$PER$$US-JNJFOC-20240676057$JOHNSON AND JOHNSON$$92$YR$E$F$Y$$$20240703$$CN$US$US
240343561$24034356$1$I$$20240625$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103293$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240701$$CN$US$US
240343571$24034357$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104358$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$77.11$KG$20240701$$CN$US$US
240343581$24034358$1$I$20230601$20240623$20240701$20240701$EXP$$US-CELLTRION INC.-2024US008165$CELLTRION$$$$$$Y$$$20240701$$CN$US$US
240343591$24034359$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104607$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240701$$CN$US$US
240343601$24034360$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104774$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240701$$CN$US$US
240343611$24034361$1$I$$20240621$20240701$20240701$EXP$GB-MHRA-MED-202406201600553000-JBGTP$GB-MSNLABS-2024MSNSPO01425$MSN LABORATORIES$$$$$$Y$$$20240701$$HP$GB$GB
240343621$24034362$1$I$20220801$20240617$20240701$20240701$EXP$$CN-TEYRO-2024-TY-000221$Teyro Labs$Shan J, Liu Z, Chen S, Du C, Li B, Ruan L, et al..Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.BMC Med.2024;22:234$64$YR$A$M$Y$$$20240701$$HP$CN$CN
240343661$24034366$1$I$20220620$20240327$20240701$20240701$PER$$JP-ROCHE-3393526$ROCHE$$52$YR$A$M$Y$$$20240701$$MD$JP$JP
240343671$24034367$1$I$20200828$20240624$20240701$20240701$EXP$$CA-MYLANLABS-2020337315$MYLAN$$47$YR$$M$Y$$$20240701$$CN$CA$CA
240343691$24034369$1$I$$20240623$20240701$20240701$EXP$GB-MHRA-MED-202406230715043650-LSZJH$GB-862174955-ML2024-03638$MICRO LABS$$$$$F$Y$60$KG$20240701$$CN$GB$GB
240343701$24034370$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186665$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240701$$MD$US$US
240343711$24034371$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA190976$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240701$$HP$US$US
240343721$24034372$1$I$$20240617$20240701$20240701$PER$$US-SA-2024SA185546$SANOFI AVENTIS$$$$A$M$Y$92$KG$20240701$$MD$US$US
240343731$24034373$1$I$20240615$20240618$20240701$20240701$EXP$GB-MHRA-MED-202406171146230370-MZGPH$GB-862174955-ML2024-03667$Unknown Manufacturer$$72$YR$E$$Y$$$20240701$$CN$GB$GB
240343751$24034375$1$I$$20240131$20240701$20240701$PER$$US-AMGEN-USASP2024129680$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240343761$24034376$1$I$$20240627$20240701$20240701$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036860$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240701$$HP$US$US
240343773$24034377$3$F$20240314$20240320$20240701$20240710$PER$$CA-ROCHE-3530958$ROCHE$$60$YR$A$M$Y$$$20240701$$CN$CA$CA
240343782$24034378$2$F$$20240629$20240701$20240702$PER$$US-BIOVITRUM-2024-US-009267$BIOVITRUM$$80$YR$$M$Y$$$20240702$$CN$US$US
240343801$24034380$1$I$$20240625$20240701$20240701$EXP$$CA-TAKEDA-2024TUS064131$TAKEDA$$$$$F$Y$$$20240701$$MD$CA$CA
240343811$24034381$1$I$$20240628$20240701$20240701$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036877$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240701$$MD$US$US
240343823$24034382$3$F$20230725$20240606$20240701$20240701$PER$$CN-ROCHE-3532270$ROCHE$$1$MON$I$$Y$$$20240701$$MD$CN$CN
240343831$24034383$1$I$$20240617$20240701$20240701$EXP$$GB-TEYRO-2024-TY-000208$Teyro Labs$Millen GC, Lawford A, Duncan C, Jenkinson H, Veal GJ, Barnett S. .Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom..Br J Cancer.2024$4$WK$I$$Y$$$20240701$$HP$GB$GB
240343841$24034384$1$I$20210401$20240412$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05974$HIKMA$Ambat J, Patel S, Pathak PR, Antony M, Basu AK, Sto Domingo FG, et al. Ambat J, Patel S, Pathak PR, Antony M, Basu AK, Sto Domingo FG, Vu PQ. Apixaban-Induced Spontaneous Hemorrhagic Cardiac Tamponade. Cureus. 2024;16(3):e55476$72$YR$$F$Y$$$20240701$$MD$US$US
240343852$24034385$2$F$$20240722$20240701$20240726$30DAY$$JP-MYLANLABS-2024M1057305$MYLAN$$$$$$Y$$$20240726$$HP$JP$JP
240343864$24034386$4$F$$20240829$20240701$20240906$EXP$$CA-MYLANLABS-2023M1097920$BIOCON$$$$$$Y$$$20240906$$MD$CA$CA
240343871$24034387$1$I$$20240620$20240701$20240701$EXP$GB-MHRA-MED-202406201416257800-LTHCY$GB-Accord-431739$ACCORD$$$$$M$Y$72$KG$20240701$$CN$GB$GB
240343881$24034388$1$I$$20240620$20240701$20240701$EXP$GB-MHRA-MED-202406201846177150-WKSDF$GB-Accord-431913$ACCORD$$24$YR$A$$Y$$$20240701$$CN$GB$GB
240343891$24034389$1$I$$20240620$20240701$20240701$EXP$PL-URPL-DML-MLP.4401.1.4887.2021$PL-Accord-432293$ACCORD$$71$YR$E$F$Y$48$KG$20240701$$MD$PL$PL
240343901$24034390$1$I$$20240619$20240701$20240701$EXP$AU-TGA-802913$AU-Accord-431673$ACCORD$$$$$M$Y$$$20240701$$HP$AU$AU
240343911$24034391$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432119$ACCORD$Beesley S, Lanspa M. Calcium Channel Overdose and Insulin Therapy Dosing. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7313$28$YR$A$M$Y$$$20240701$$MD$US$US
240343922$24034392$2$F$$20240705$20240701$20240717$EXP$$US-Accord-432132$ACCORD$Rozenbaum Lerner G, Villamizar JP, Pelaez A, Salgado JC. Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3531. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A3531$68$YR$E$M$Y$84$KG$20240717$$MD$US$US
240343931$24034393$1$I$$20240619$20240701$20240701$EXP$AU-TGA-798173$AU-Accord-432019$ACCORD$$$$$F$Y$$$20240701$$HP$AU$AU
240343941$24034394$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019238$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240343952$24034395$2$F$$20240819$20240701$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202406017503$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240828$$CN$US$US
240343961$24034396$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432129$ACCORD$Hashmi N, Basaleli C, Gupta S, John G, Birnbaum B, Kim U, et al. Acute Eosinophilic Pneumonia in the Setting of Intramuscular Progesterone Usage. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6397.$33$YR$A$F$Y$$$20240701$$MD$US$US
240343971$24034397$1$I$$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000116$ELI LILLY AND CO$$44$YR$A$$Y$$$20240701$$CN$US$US
240343981$24034398$1$I$$20240619$20240701$20240701$EXP$CA-MHPD-E2B_06991903$CA-Accord-431621$ACCORD$$78$YR$E$M$Y$78$KG$20240701$$HP$CA$CA
240343991$24034399$1$I$20240601$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000279$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240701$$CN$US$US
240344001$24034400$1$I$$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000162$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240344011$24034401$1$I$$20240521$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000216$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240344021$24034402$1$I$$20240621$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406016048$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240701$$CN$US$US
240344031$24034403$1$I$20240626$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019240$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240701$$CN$US$US
240344041$24034404$1$I$$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000114$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240701$$CN$US$US
240344062$24034406$2$F$20240515$20240703$20240701$20240705$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-103342$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240705$$HP$FR$FR
240344071$24034407$1$I$$20240401$20240701$20240701$PER$$US-ROCHE-3539361$ROCHE$$23$YR$A$F$Y$$$20240701$$CN$US$US
240344082$24034408$2$F$$20240724$20240701$20240805$30DAY$$US-JNJFOC-20240675169$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$PH$US$US
240344091$24034409$1$I$$20240624$20240701$20240701$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000946$ALEMBIC$Gutierrez L, Patel D, Ramanujam D, Patel D, Modugula S, Disilvio B. et.al. The Downside of Your Uppers: Venlafaxine-induced Hypertriglyceridemia Causing Acute Pancreatitis.. American Journal of Respiratory and Critical Care Medicine. 2024;A5693:209$$$$$Y$$$20240701$$MD$US$US
240344101$24034410$1$I$20240606$20240628$20240701$20240701$EXP$$CN-BAYER-2024A094615$BAYER$$46$YR$A$F$Y$70$KG$20240701$$HP$CN$CN
240344112$24034411$2$F$20240601$20240910$20240701$20240913$EXP$$FR-ARGENX-2024-ARGX-FR005016$ARGENX BVBA$$$$$$Y$$$20240913$$MD$FR$FR
240344121$24034412$1$I$20220501$20240617$20240701$20240701$EXP$$CN-TEYRO-2024-TY-000216$Teyro Labs$Shan J, Liu Z, Chen S, Du C, Li B, Ruan L, et al..Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.BMC Med.2024;22:234$66$YR$E$M$Y$$$20240701$$HP$CN$CN
240344134$24034413$4$F$$20240510$20240701$20240710$PER$$US-ROCHE-3545633$ROCHE$$15$YR$T$M$Y$54.2$KG$20240701$$CN$US$US
240344141$24034414$1$I$$20240611$20240701$20240701$PER$$US-AstraZeneca-2024A138553$ASTRAZENECA$$$$A$F$Y$$$20240701$$CN$US$
240344153$24034415$3$F$20240301$20240801$20240701$20240814$EXP$$US-BEH-2024174650$CSL BEHRING$$41$YR$A$M$Y$$$20240814$$CN$US$US
240344161$24034416$1$I$$20240619$20240701$20240701$EXP$$US-PFIZER INC-202400203049$PFIZER$Monday, K.. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. The American journal of forensic medicine and pathology. 2024;10.1097/PAF.0000000000000943$$$C$$Y$$$20240701$$MD$US$US
240344171$24034417$1$I$$20240619$20240701$20240701$EXP$$US-PFIZER INC-202400203054$PFIZER$Monday, K.. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. The American journal of forensic medicine and pathology. 2024;10.1097/PAF.0000000000000943$$$C$$Y$$$20240701$$MD$US$US
240344181$24034418$1$I$$20240619$20240701$20240701$EXP$$US-PFIZER INC-202400203051$PFIZER$Monday, K.. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. The American journal of forensic medicine and pathology. 2024;10.1097/PAF.0000000000000943$$$C$$Y$$$20240701$$MD$US$US
240344191$24034419$1$I$$20240619$20240701$20240701$EXP$$US-PFIZER INC-202400203055$PFIZER$Monday, K.. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. The American journal of forensic medicine and pathology. 2024;10.1097/PAF.0000000000000943$$$C$$Y$$$20240701$$MD$US$US
240344201$24034420$1$I$$20240619$20240701$20240701$EXP$$US-PFIZER INC-202400203056$PFIZER$Monday, K.. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. The American journal of forensic medicine and pathology. 2024;10.1097/PAF.0000000000000943$$$C$$Y$$$20240701$$MD$US$US
240344211$24034421$1$I$$20240619$20240701$20240701$EXP$$US-PFIZER INC-202400202925$PFIZER$Monday, K.. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. The American journal of forensic medicine and pathology. 2024;10.1097/PAF.0000000000000943$$$C$$Y$$$20240701$$MD$US$US
240344221$24034422$1$I$$20240619$20240701$20240701$EXP$$US-PFIZER INC-202400203050$PFIZER$Monday, K.. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. The American journal of forensic medicine and pathology. 2024;10.1097/PAF.0000000000000943$$$C$$Y$$$20240701$$MD$US$US
240344231$24034423$1$I$$20240619$20240701$20240701$EXP$$US-PFIZER INC-202400203053$PFIZER$Monday, K.. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. The American journal of forensic medicine and pathology. 2024;10.1097/PAF.0000000000000943$$$C$$Y$$$20240701$$MD$US$US
240344241$24034424$1$I$$20240619$20240701$20240701$EXP$$US-PFIZER INC-202400201058$PFIZER$Monday, K.. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. The American journal of forensic medicine and pathology. 2024;10.1097/PAF.0000000000000943$$$C$$Y$$$20240701$$MD$US$US
240344251$24034425$1$I$$20240619$20240701$20240701$EXP$$US-PFIZER INC-202400203058$PFIZER$Monday, K.. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. The American journal of forensic medicine and pathology. 2024;10.1097/PAF.0000000000000943$$$C$$Y$$$20240701$$MD$US$US
240344261$24034426$1$I$$20240619$20240701$20240701$EXP$$US-PFIZER INC-202400203057$PFIZER$Monday, K.. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. The American journal of forensic medicine and pathology. 2024;10.1097/PAF.0000000000000943$$$C$$Y$$$20240701$$MD$US$US
240344271$24034427$1$I$$20240619$20240701$20240701$EXP$$US-PFIZER INC-202400203052$PFIZER$Monday, K.. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. The American journal of forensic medicine and pathology. 2024;10.1097/PAF.0000000000000943$$$C$$Y$$$20240701$$MD$US$US
240344281$24034428$1$I$$20240621$20240701$20240701$30DAY$$US-GSK-US2024078117$GLAXOSMITHKLINE$$$$A$M$Y$$$20240701$$CN$US$US
240344295$24034429$5$F$20240304$20240321$20240701$20240710$PER$$BD-ROCHE-3524650$ROCHE$$2$YR$C$F$Y$$$20240701$$CN$BD$BD
240344301$24034430$1$I$20220101$20240617$20240701$20240701$EXP$$CN-TEYRO-2024-TY-000213$Teyro Labs$Shan J, Liu Z, Chen S, Du C, Li B, Ruan L, et al..Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.BMC Med.2024;22:234$69$YR$E$M$Y$$$20240701$$HP$CN$CN
240344311$24034431$1$I$$20240624$20240701$20240701$EXP$$JP-009507513-2406JPN003532J$MERCK$$$$$F$Y$$$20240701$$HP$JP$JP
240344322$24034432$2$F$20240622$20240627$20240701$20240702$EXP$$US-BAYER-2024A094488$BAYER$$65$YR$E$F$Y$45.351$KG$20240702$$CN$US$US
240344359$24034435$9$F$20210803$20240819$20240701$20240828$EXP$$CA-CELLTRION INC.-2021CA019540$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
240344361$24034436$1$I$$20240228$20240701$20240701$PER$$KR-ROCHE-3519232$ROCHE$$42$YR$A$F$Y$$$20240701$$CN$KR$KR
240344371$24034437$1$I$$20240402$20240701$20240701$PER$$US-ROCHE-3538535$ROCHE$$$$$M$Y$$$20240701$$CN$US$US
240344381$24034438$1$I$20221209$20240618$20240701$20240701$EXP$$US-Emmaus Medical, Inc.-EMM202406-000289$EMMAUS LIFE SCIENCES$$12$YR$T$F$Y$57.8$KG$20240701$$CN$US$
240344391$24034439$1$I$20170101$20240625$20240701$20240701$EXP$$US-SA-2024SA190221$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240701$$MD$US$US
240344402$24034440$2$F$$20240624$20240701$20240708$EXP$$CA-PFIZER INC-2019259826$MYLAN$$71$YR$$M$Y$$$20240708$$HP$CA$CA
240344411$24034441$1$I$20240319$20240624$20240701$20240701$EXP$$ES-AUROBINDO-AUR-APL-2024-031526$AUROBINDO$$89$YR$$F$Y$$$20240701$$MD$ES$ES
240344421$24034442$1$I$$20240625$20240701$20240701$EXP$$US-Navinta LLC-000505$NAVINTA LLC$US-Navinta LLC-000505-01_Initial Source Document$49$YR$A$F$Y$$$20240701$$MD$US$
240344431$24034443$1$I$20230601$20240404$20240701$20240701$PER$$JP-ROCHE-3548389$ROCHE$$39$YR$A$F$Y$$$20240701$$MD$JP$JP
240344442$24034444$2$F$$20240802$20240701$20240810$PER$$US-ABBVIE-5815595$ABBVIE$$37$YR$$F$Y$80.7$KG$20240810$$CN$US$US
240344511$24034451$1$I$20240620$20240624$20240701$20240701$PER$$US-ALXN-202406USA001494US$ALEXION PHARMACEUTICALS$$61$YR$$F$Y$$$20240701$$MD$US$US
240344531$24034453$1$I$$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031492$AUROBINDO$$26$YR$$M$Y$$$20240701$$PH$FR$FR
240344541$24034454$1$I$20240101$20240624$20240701$20240701$PER$$US-AMGEN-USASP2024125163$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240344552$24034455$2$F$20240626$20240626$20240701$20240705$PER$$US-AMGEN-USASP2024126543$AMGEN$$74$YR$E$F$Y$$$20240705$$CN$US$US
240344582$24034458$2$F$$20240724$20240701$20240802$30DAY$$US-GSK-US2024079835$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
240344601$24034460$1$I$20240109$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031496$AUROBINDO$$25$YR$$M$Y$$$20240701$$PH$FR$FR
240344615$24034461$5$F$$20240515$20240701$20240710$PER$$IT-ROCHE-3538929$ROCHE$$22$YR$A$F$Y$$$20240701$$PH$IT$IT
240344621$24034462$1$I$20240101$20240625$20240701$20240701$PER$$US-INSUD PHARMA-2406US05115$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240344631$24034463$1$I$20240501$20240624$20240701$20240701$PER$$US-INSUD PHARMA-2406US05094$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240344641$24034464$1$I$20240601$20240625$20240701$20240701$PER$$US-INSUD PHARMA-2406US05114$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240344651$24034465$1$I$20240501$20240626$20240701$20240701$PER$$US-INSUD PHARMA-2406US05116$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240344661$24034466$1$I$$20240620$20240701$20240701$EXP$$US-INSUD PHARMA-2406US05071$INSUD PHARMA$Kamel A, Helliwell A, Blundin MF. A Rare Case or Anabolic Testosterone Induced Acute Lung Injury With Pulmonary Eosinophilia. Am J Respir Crit Care Med. 2024;209:A6001$$$$$Y$$$20240701$$HP$US$US
240344673$24034467$3$F$20240620$20240826$20240701$20240912$EXP$$ZA-AMAROX PHARMA-HET2024ZA02021$HETERO$$53$YR$$F$Y$56$KG$20240904$$HP$ZA$ZA
240344681$24034468$1$I$20240101$20240627$20240701$20240701$EXP$$NO-UCBSA-2024033037$UCB$$$$$$Y$$$20240701$$MD$NO$NO
240344694$24034469$4$F$20240407$20240430$20240701$20240710$PER$$CH-ROCHE-3546630$ROCHE$$40$YR$A$F$Y$$$20240701$$HP$CH$CH
240344701$24034470$1$I$$20240313$20240701$20240701$PER$$AE-ROCHE-3528212$ROCHE$$$$$F$Y$$$20240701$$MD$AE$AE
240344711$24034471$1$I$$20240617$20240701$20240701$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001588$IPCA$Elizabeth S. Mikhail, Matthew Jankowski, Dheeraj Alexander et al.. Survival and vision restoration following severe metformin-associated metabolic acidosis with transient blindness: A case report and review of the literature. Journal of Community Hospital Internal Medicine Perspectives. 2024;14(Iss.2):96-99$$$$$Y$$$20240701$$HP$US$US
240344724$24034472$4$F$20240101$20240913$20240701$20240923$EXP$$CO-SA-2024SA177888$SANOFI AVENTIS$$32$YR$A$M$Y$66$KG$20240923$$CN$CO$CO
240344732$24034473$2$F$$20240620$20240701$20240923$PER$$US-BAYER-2024A089468$BAYER$$54$YR$A$F$Y$$$20240923$$CN$US$US
240344741$24034474$1$I$20231002$20240426$20240701$20240701$PER$$AT-ROCHE-3453028$ROCHE$$6$YR$C$F$Y$15.9$KG$20240701$$MD$AT$AT
240344751$24034475$1$I$$20240624$20240701$20240701$EXP$$GB-AUROBINDO-AUR-APL-2024-031505$AUROBINDO$$$$$M$Y$$$20240701$$CN$GB$GB
240344761$24034476$1$I$20240321$20240624$20240701$20240701$EXP$DE-AMK-276407$DE-ABBVIE-5817506$ABBVIE$$33$YR$$M$Y$75$KG$20240701$$PH$DE$DE
240344773$24034477$3$F$$20240715$20240701$20240715$EXP$$CA-BAYER-2024A093663$BAYER$$$$$F$Y$$$20240715$$HP$CA$CA
240344781$24034478$1$I$$20240624$20240701$20240701$30DAY$$US-GSK-US2024078625$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240344791$24034479$1$I$$20240118$20240701$20240701$PER$$US-AMGEN-USASP2024129638$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240344802$24034480$2$F$20230606$20240502$20240701$20240710$PER$$SA-ROCHE-3375801$ROCHE$$7$YR$C$M$Y$19.5$KG$20240701$$CN$SA$SA
240344811$24034481$1$I$$20240621$20240701$20240701$PER$$US-ABBVIE-5812624$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240344821$24034482$1$I$$20240622$20240701$20240701$PER$$US-SA-2024SA189025$SANOFI AVENTIS$$$$A$M$Y$$$20240701$$MD$US$US
240344831$24034483$1$I$20240619$20240625$20240701$20240701$PER$$US-SA-2024SA190779$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240701$$CN$US$US
240344841$24034484$1$I$20240601$20240621$20240701$20240701$PER$$US-ABBVIE-5814937$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240344852$24034485$2$F$$20240325$20240701$20240710$PER$$PL-ROCHE-3535765$ROCHE$$$$$F$Y$$$20240701$$MD$PL$PL
240344861$24034486$1$I$$20240619$20240701$20240701$EXP$$CA-APOTEX-2024AP007539$APOTEX$$$$A$F$Y$$$20240701$$MD$CA$CA
240344871$24034487$1$I$$20240603$20240701$20240701$PER$$US-AstraZeneca-2024A133875$ASTRAZENECA$$69$YR$$F$Y$$$20240701$$HP$US$
240344882$24034488$2$F$20240522$20240710$20240701$20240713$PER$$US-ALXN-202406USA001493US$ALEXION PHARMACEUTICALS$$83$YR$$F$Y$$$20240713$$CN$US$US
240344891$24034489$1$I$20230923$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031509$AUROBINDO$$66$YR$$M$Y$67$KG$20240701$$MD$FR$FR
240344911$24034491$1$I$$20240625$20240701$20240701$EXP$$US-PFIZER INC-PV202400083878$PFIZER$ROSENBLATT, R.. CARDIOPULMONARY ARREST AFTER RETROBULAR BLOCK. AMERICAN JOURNAL OF OPHTHALMOLOGY. 1980$61$YR$$F$Y$$$20240701$$MD$US$US
240344921$24034492$1$I$$20240627$20240701$20240701$EXP$$US-PFIZER INC-PV202400085245$PFIZER$Arjomand, A.. A case of Scedosporium prolificans pulmonary infection in a patient with acute myeloid leukemia.. Respiratory Medicine Case Reports. 2024;51:10.1016/j.rmcr.2024.102071$63$YR$$F$Y$$$20240701$$HP$US$US
240344931$24034493$1$I$20240625$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024128471$AMGEN$$57$YR$A$F$Y$$$20240701$$PH$US$US
240344941$24034494$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127372$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240344951$24034495$1$I$$20230512$20240701$20240701$PER$$US-AMGEN-USASP2023235054$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240344961$24034496$1$I$$20231023$20240701$20240701$PER$$US-AMGEN-USASP2023235077$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240344971$24034497$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024125900$AMGEN$Khattri S.; Hren M. G.; Guenin S.. Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease. Journal of the American Academy of Dermatology. 2024;91(1):138-140$64$YR$A$$Y$$$20240701$$MD$US$US
240344981$24034498$1$I$$20240624$20240701$20240701$EXP$$JP-009507513-2406JPN003538J$MERCK$$9$DEC$$M$Y$$$20240701$$MD$JP$JP
240345004$24034500$4$F$20240312$20240312$20240701$20240710$PER$$US-ROCHE-3526497$ROCHE$$54$YR$A$F$Y$81.65$KG$20240701$$CN$US$US
240345013$24034501$3$F$20231211$20240801$20240701$20240805$EXP$$NZ-MYLANLABS-2024M1058189$MYLAN$$49$YR$$F$Y$112.8$KG$20240805$$CN$NZ$NZ
240345021$24034502$1$I$$20240625$20240701$20240701$EXP$$ZA-JNJFOC-20240665954$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$ZA$ZA
240345031$24034503$1$I$20210101$20240620$20240701$20240701$EXP$$AU-JNJFOC-20240656430$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$MD$AU$AU
240345041$24034504$1$I$20240507$20240624$20240701$20240701$PER$$US-SA-2024SA190918$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$HP$US$US
240345051$24034505$1$I$$20240617$20240701$20240701$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001591$IPCA$Harpreet K. Rai, Pranavkumar Patel and Kalpana Reddy. A case report on metformin-associated lactic acidosis. Cureus. 2020;12(8):1-5$$$$$Y$$$20240701$$HP$US$US
240345066$24034506$6$F$20240101$20240905$20240701$20240917$EXP$$US-INSMED, INC.-2024-02182-US$INSMED$$$$$F$Y$$$20240917$$CN$US$US
240345071$24034507$1$I$20231030$20240624$20240701$20240701$EXP$$US-UCBSA-2024032354$UCB$$0$YR$$M$Y$2.693$KG$20240701$$CN$US$US
240345081$24034508$1$I$$20240617$20240701$20240701$EXP$$CH-SEBELA IRELAND LIMITED-2024SEB00047$SEBELA$Cammann V.L, Tresch A, Himmelmann A, Sommerstein R, Bachli E. Fatal Hemophagocytic Lymphohistiocytosis triggered by Epstein-Barr Virus in a patient with immunosuppression. Swiss Med. Wkly. 2024;154:110S-111S$43$YR$$M$Y$$$20240701$$HP$CH$CH
240345091$24034509$1$I$20240623$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127278$AMGEN$$64$YR$A$F$Y$$$20240701$$CN$US$US
240345101$24034510$1$I$$20240624$20240701$20240701$EXP$$US-MYLANLABS-2024M1037468$MYLAN$$$$$M$Y$76.2$KG$20240701$$CN$US$US
240345111$24034511$1$I$$20240624$20240701$20240701$EXP$$CZ-TAKEDA-2024TUS063721$TAKEDA$$$$$M$Y$$$20240701$$CN$CZ$CZ
240345121$24034512$1$I$$20240619$20240701$20240701$EXP$AU-TGA-802623$AU-Accord-431997$ACCORD$$$$$F$Y$$$20240701$$HP$AU$AU
240345131$24034513$1$I$$20240619$20240701$20240701$EXP$CA-MHPD-001083174$CA-Accord-431737$ACCORD$$62$YR$A$M$Y$$$20240701$$HP$CA$CA
240345141$24034514$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432140$ACCORD$Rodriguez C, Yosry N, Qaiser S, Luzuriaga A, Adelizzi A. BRASH: A Deadly Acronym. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1596. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1596.$84$YR$E$F$Y$$$20240701$$MD$US$US
240345151$24034515$1$I$$20240620$20240701$20240701$EXP$$TW-Accord-431963$ACCORD$Shen YC, Wu JC, Lin TT, Chang KC, Su JJ, Juang JJ. Case Report: Lacosamide unmasking SCN5A-associated Brugada syndrome in a young female with epilepsy. Front Cardiovasc Med. 2024 May 31;11:1406614. doi: 10.3389/fcvm.2024.1406614.$33$YR$A$F$Y$$$20240701$$HP$TW$TW
240345161$24034516$1$I$$20240619$20240701$20240701$EXP$AU-TGA-803309$AU-Accord-431268$ACCORD$$$$$M$Y$$$20240701$$HP$AU$AU
240345171$24034517$1$I$$20240613$20240701$20240701$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06010$NEUROCRINE BIOSCIENCES$$70$YR$$F$Y$$$20240701$$HP$US$US
240345181$24034518$1$I$20240613$20240620$20240701$20240701$EXP$CN-HENLIUS-24CN015543$CN-Accord-433056$ACCORD$$45$YR$A$F$Y$55$KG$20240701$$MD$CN$CN
240345191$24034519$1$I$$20240620$20240701$20240701$EXP$$SG-Accord-431981$ACCORD$Wong J, Samol J, Chai G. Who^s to Blame? A Case of Drug-Induced Pneumonitis With Multiple Potential Culprits. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2006.$62$YR$A$M$Y$$$20240701$$MD$SG$SG
240345201$24034520$1$I$$20240620$20240701$20240701$EXP$$US-Accord-432138$ACCORD$Huang L, Ellis TJ, Bagavathy K. The Unfortunate Trifecta: Tuberculosis, EBV, and CMV Induced Hemophagocytic Lymphohistiocytosis. American Journal of Respiratory and Critical Care Medicine . 2024;209:A7416. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A7416.$52$YR$A$M$Y$$$20240701$$MD$US$US
240345221$24034522$1$I$20240315$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031532$AUROBINDO$$79$YR$$M$Y$82$KG$20240701$$PH$FR$FR
240345231$24034523$1$I$$20240617$20240701$20240701$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001592$IPCA$Joshua Santoli, Jamie Lee Aldakkou, Hossein Tohidi et al.. Metformin-associated lactic acidosis: A case report. HCA Healthcare Journal of Medicine. 2023;4(2):215-218$$$$$Y$$$20240701$$MD$US$US
240345251$24034525$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104391$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240701$$CN$US$US
240345261$24034526$1$I$$20240425$20240701$20240701$PER$$FR-ROCHE-3555187$ROCHE$$$$$$Y$$$20240701$$PH$FR$FR
240345271$24034527$1$I$20140101$20240622$20240701$20240701$PER$$US-ABBVIE-5816123$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240345281$24034528$1$I$$20240620$20240701$20240701$PER$$US-009507513-2406USA007393$MERCK$Chaturvedi M., Rowe A., Saleeb P., Robinett K.S.. Respiratory Conundrum: Concurrent Mycobacterium Abscessus and Aspergillus-related Pulmonary Disease in a Patient With Long-term Asthma. American Journal of Respiratory and Critical Care Medicine. 2024$25$YR$$F$Y$$$20240701$$HP$US$US
240345291$24034529$1$I$$20240621$20240701$20240701$EXP$$US-GSK-US2024AMR080590$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240345301$24034530$1$I$$20240419$20240701$20240701$PER$$FR-ROCHE-3552454$ROCHE$$$$A$$Y$$$20240701$$CN$FR$FR
240345312$24034531$2$F$$20240701$20240701$20240703$EXP$$DK-BAYER-2024A094559$BAYER$$$$$F$Y$$$20240703$$CN$DK$DK
240345322$24034532$2$F$20231101$20240311$20240701$20240710$PER$$AT-ROCHE-3525189$ROCHE$$8$YR$C$M$Y$28$KG$20240701$$MD$AT$AT
240345331$24034533$1$I$$20240624$20240701$20240701$PER$$US-ALXN-202406USA001496US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
240345342$24034534$2$F$$20240805$20240701$20240806$PER$$US-ALXN-202406USA001510US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240345351$24034535$1$I$$20240624$20240701$20240701$EXP$$TR-CHEPLA-2024008202$CHEPLAPHARM$Alp A, Rollas T, Eroglu EO, Yildiz MI, Yagcioglu AEA, Ulug BD. Catatonia Due to Lithium Neurotoxicity: A Case Report. Turkish Journal of Psychiatry. 2024;35(2):150-155. https://doi.org/10.5080/u27074.$60$YR$$F$Y$$$20240701$$HP$COUNTRY NOT SPECIFIED$TR
240345361$24034536$1$I$$20240627$20240701$20240701$EXP$$US-GILEAD-2024-0678947$GILEAD$$$$$F$Y$$$20240701$$MD$US$US
240345371$24034537$1$I$$20240617$20240701$20240701$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00497$UPSHER-SMITH$Santosh N, Savani S, Iskapalli S. Beefing Up! Fulminant Liver Failure Secondary to Anabolic Steroid Use. Am. J. Respir. Crit. Care Med. 2024;209$30$YR$$M$Y$$$20240701$$HP$US$US
240345381$24034538$1$I$$20240201$20240701$20240701$PER$$US-AMGEN-USASP2024129701$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240345391$24034539$1$I$20240524$20240605$20240701$20240701$EXP$$GB-MYLANLABS-2024M1060981$MYLAN$$66$YR$$M$Y$110$KG$20240701$$MD$GB$GB
240345401$24034540$1$I$$20240627$20240701$20240701$EXP$$CO-GSK-CO2024AMR080723$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$CO$CO
240345411$24034541$1$I$$20240621$20240701$20240701$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024078086$VIIV$$$$$$Y$$$20240701$$CN$US$US
240345421$24034542$1$I$$20240403$20240701$20240701$PER$$US-HALEON-2166682$Haleon PLC$$$$$$Y$$$20240420$$CN$US$US
240345431$24034543$1$I$$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103640$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$56.5$KG$20240701$$PH$US$US
240345441$24034544$1$I$$20240408$20240701$20240701$PER$$US-HALEON-2168053$Haleon PLC$$$$$M$Y$$$20240420$$CN$US$US
240345591$24034559$1$I$20240101$20240411$20240701$20240701$PER$$US-HALEON-2168322$Haleon PLC$$$$$$Y$$$20240420$$CN$US$US
240345602$24034560$2$F$$20240618$20240701$20240701$EXP$$US-ROCHE-10000006438$ROCHE$$$$E$F$Y$$$20240701$$CN$US$US
240345611$24034561$1$I$20240101$20240621$20240701$20240701$EXP$$FR-JNJFOC-20240657137$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240701$$MD$FR$FR
240345621$24034562$1$I$20130107$20240626$20240701$20240701$EXP$$US-BAYER-2024A093485$BAYER$$71$YR$E$F$Y$$$20240701$$CN$US$US
240345631$24034563$1$I$20240611$20240612$20240701$20240701$EXP$$GB-MYLANLABS-2024M1060926$MYLAN$$79$YR$$F$Y$89$KG$20240701$$MD$GB$GB
240345641$24034564$1$I$20240101$20240617$20240701$20240701$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000133$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240701$$CN$US$US
240345651$24034565$1$I$$20240618$20240701$20240701$EXP$$JP-Axellia-005253$XELLIA PHARMACEUTICALS$Miyazawa M, Yanagi M, Chiba T, Kido H, Matsuo T, Nishitani M et al. Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease. Internal Medicine. 2024;63(11):1563-68$53$YR$A$F$Y$$$20240701$$MD$JP$JP
240345661$24034566$1$I$$20240212$20240701$20240701$PER$$US-AMGEN-USASP2024129619$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240345671$24034567$1$I$20240620$20240625$20240701$20240701$EXP$$US-AMGEN-USASP2024125993$AMGEN$$79$YR$E$F$Y$$$20240701$$CN$US$US
240345682$24034568$2$F$20240611$20240725$20240701$20240803$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02270$AMNEAL$$19$YR$$F$Y$$$20240803$$MD$US$US
240345691$24034569$1$I$$20240619$20240701$20240701$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02321$AMNEAL$Fitzgerald T, Arroyo Morr MA.. Vaping-Associated Lung Injury from Oxycodone-Acetaminophen Inhalation. Am J Respir Crit Care Med. 2024;209$17$YR$$M$Y$$$20240701$$HP$US$US
240345701$24034570$1$I$$20240620$20240701$20240701$EXP$$IN-ROCHE-10000011575$ROCHE$$$$E$F$Y$$$20240701$$MD$IN$IN
240345711$24034571$1$I$$20240417$20240701$20240701$PER$$US-HALEON-2169354$Haleon PLC$$58$YR$$F$Y$$$20240420$$CN$US$US
240345723$24034572$3$F$$20240708$20240701$20240717$EXP$$US-ALCON LABORATORIES-ALC2024US003056$ALCON$$$$$F$Y$$$20240717$$CN$US$US
240345731$24034573$1$I$$20240430$20240701$20240701$PER$$US-ROCHE-3557020$ROCHE$$3$YR$C$M$Y$16.2$KG$20240701$$CN$US$US
240345742$24034574$2$F$$20240707$20240701$20240708$EXP$$CA-BAYER-2024A093382$BAYER$$$$$F$Y$$$20240708$$MD$CA$CA
240345751$24034575$1$I$$20240502$20240701$20240701$PER$$US-ROCHE-3557544$ROCHE$$$$N$M$Y$4$KG$20240701$$CN$US$US
240345761$24034576$1$I$$20240429$20240701$20240701$PER$$CH-ROCHE-3557416$ROCHE$$$$$F$Y$$$20240701$$CN$CH$CH
240345772$24034577$2$F$$20240823$20240701$20240830$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-05338$LUPIN$$48$YR$$M$Y$$$20240830$$CN$AU$AU
240345781$24034578$1$I$$20240617$20240701$20240701$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001621$IPCA$Selin Sendil, Keerthi Yarlagadda, Halimat Lawal et al.. Metformin associated lactic acidosis in the intensive care unit: A rare condition mimicking sepsis. Cureus. 2020;12(7):1-8$$$$$Y$$$20240701$$HP$US$US
240345811$24034581$1$I$20240620$20240701$20240701$20240701$EXP$DK-DKMA-30734025$DK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036933$BOEHRINGER INGELHEIM$$60$YR$A$M$Y$60$KG$20240701$$MD$DK$DK
240345821$24034582$1$I$$20240626$20240701$20240701$PER$$US-JNJFOC-20240673722$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240345832$24034583$2$F$$20240801$20240701$20240802$PER$$US-HALEON-2184456$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
240345851$24034585$1$I$20240423$20240624$20240701$20240701$EXP$$US-JNJFOC-20240669437$JOHNSON AND JOHNSON$$1$YR$$M$Y$$$20240701$$HP$US$US
240345861$24034586$1$I$$20240620$20240701$20240701$EXP$GB-MHRA-MED-202406201546147400-PDJYC$GB-TORRENT-00036867$TORRENT$$$$$F$Y$$$20240701$$PH$GB$GB
240345873$24034587$3$F$$20240627$20240701$20240708$EXP$$IN-TORRENT-00003560$TORRENT$$25$YR$A$M$Y$$$20240708$$MD$IN$IN
240345881$24034588$1$I$20240617$20240620$20240701$20240701$EXP$GB-MHRA-MED-202406201037076990-DHWYS$GB-TORRENT-00036870$TORRENT$$60$YR$A$M$Y$81$KG$20240701$$HP$GB$GB
240345911$24034591$1$I$$20240621$20240701$20240701$EXP$$CA-APOTEX-2024AP002380$APOTEX$$85$YR$$F$Y$86$KG$20240701$$MD$CA$CA
240345932$24034593$2$F$$20240620$20240701$20240829$EXP$$US-TORRENT-00013647$TORRENT$$59$YR$A$M$Y$$$20240829$$HP$US$US
240345951$24034595$1$I$$20240620$20240701$20240701$EXP$$US-TORRENT-00013648$TORRENT$$28$YR$A$F$Y$$$20240701$$MD$US$US
240345961$24034596$1$I$$20240620$20240701$20240701$EXP$$US-TORRENT-00013649$TORRENT$$26$YR$A$F$Y$$$20240701$$MD$US$US
240345971$24034597$1$I$$20240620$20240701$20240701$EXP$$US-TORRENT-00013650$TORRENT$$45$YR$A$F$Y$$$20240701$$MD$US$US
240345981$24034598$1$I$$20240620$20240701$20240701$EXP$$US-TORRENT-00013651$TORRENT$$43$YR$A$F$Y$$$20240701$$MD$US$US
240346011$24034601$1$I$$20240626$20240701$20240701$PER$$US-ABBVIE-5820088$ABBVIE$$$$$$Y$$$20240701$$HP$US$US
240346021$24034602$1$I$$20240523$20240701$20240701$PER$$US-ROCHE-3415194$ROCHE$$16$MON$I$M$Y$11.79$KG$20240701$$CN$US$US
240346031$24034603$1$I$$20240619$20240701$20240701$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02344$AMNEAL$Oomrigar S.C, Fernandez J, Rivera Ortiz C, Rajen H, Toll A, et al.. The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death. Am J Respir Crit Care Med. 2024;209:A5653$$$$F$Y$$$20240701$$HP$US$US
240346041$24034604$1$I$20231221$20240624$20240701$20240701$EXP$$JP-BAYER-2024A093006$BAYER$$60$YR$A$M$Y$$$20240701$$MD$JP$JP
240346051$24034605$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019310$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240701$$CN$US$US
240346061$24034606$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019425$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240701$$CN$US$US
240346071$24034607$1$I$20240628$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000166$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240701$$CN$US$US
240346081$24034608$1$I$$20240619$20240701$20240701$EXP$$CA-ADVANZ PHARMA-202406005349$ADVANZ PHARMA$$$$$$Y$$$20240701$$HP$CA$CA
240346091$24034609$1$I$$20240524$20240701$20240701$PER$$US-ROCHE-3570702$ROCHE$$53$YR$A$F$Y$$$20240701$$CN$US$US
240346101$24034610$1$I$$20240508$20240701$20240701$PER$$US-ROCHE-3560776$ROCHE$$2$YR$C$F$Y$$$20240701$$CN$US$US
240346113$24034611$3$F$$20240517$20240701$20240710$PER$$AR-ROCHE-3567154$ROCHE$$41$YR$A$M$Y$77$KG$20240701$$CN$AR$AR
240346121$24034612$1$I$$20240508$20240701$20240701$PER$$US-ROCHE-3560750$ROCHE$$36$YR$A$F$Y$$$20240701$$CN$US$US
240346131$24034613$1$I$$20240503$20240701$20240701$PER$$FR-ROCHE-3560490$ROCHE$$35$YR$A$F$Y$$$20240701$$PH$FR$FR
240346141$24034614$1$I$20240510$20240524$20240701$20240701$PER$$AR-ROCHE-3572028$ROCHE$$25$YR$A$F$Y$65$KG$20240701$$CN$AR$AR
240346151$24034615$1$I$20211121$20240528$20240701$20240701$PER$$DE-ROCHE-3174954$ROCHE$$9$YR$C$F$Y$72.8$KG$20240701$$MD$DE$DE
240346162$24034616$2$F$$20240408$20240701$20240710$PER$$GB-ROCHE-3339944$ROCHE$$$$A$F$Y$$$20240701$$CN$GB$GB
240346171$24034617$1$I$20240514$20240528$20240701$20240701$PER$$DE-ROCHE-3572768$ROCHE$$11$YR$C$F$Y$50$KG$20240701$$MD$DE$DE
240346181$24034618$1$I$$20240618$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000893$Steriscience PTE$Karczewski D, Backer H, Andronic O, Bedi A, Adelhoefer S, Mullner M, et al.. Serratia marcescens prosthetic joint infection: two case reports and a review of the literature.. J-Med-Case-Rep. 2023;17 (1)$82$YR$$F$Y$$$20240701$$HP$US$US
240346191$24034619$1$I$20240601$20240620$20240701$20240701$PER$$US-SA-2024SA186952$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240701$$MD$US$US
240346201$24034620$1$I$20240621$20240624$20240701$20240701$PER$$US-SA-2024SA190553$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240701$$MD$US$US
240346211$24034621$1$I$$20240620$20240701$20240701$EXP$$AU-JNJFOC-20240656369$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20240701$$HP$AU$AU
240346221$24034622$1$I$$20240618$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000894$Steriscience PTE$Brown ID, Pariser RJ. Generalized Hailey-Hailey disease associated with c.2395C}T mutation in the ATP2C1 gene, and fatal outcome.. Dermatol-Online-J. 2024;30 (2)$55$YR$$F$Y$$$20240701$$HP$US$US
240346231$24034623$1$I$$20240529$20240701$20240701$PER$$AU-ROCHE-3574357$ROCHE$$$$$$Y$$$20240701$$MD$AU$AU
240346242$24034624$2$F$20240401$20240531$20240701$20240710$PER$$AR-ROCHE-3571404$ROCHE$$42$YR$A$F$Y$56$KG$20240701$$CN$AR$AR
240346251$24034625$1$I$20240423$20240510$20240701$20240701$PER$$DE-ROCHE-3562685$ROCHE$$6$YR$C$M$Y$20$KG$20240701$$MD$DE$DE
240346261$24034626$1$I$$20240621$20240701$20240701$EXP$$AU-CELLTRION INC.-2024AU015755$CELLTRION$$$$$$Y$$$20240701$$MD$AU$AU
240346272$24034627$2$F$$20240821$20240701$20240905$EXP$$US-UCBSA-2024032205$UCB$$$$$F$Y$$$20240905$$CN$US$US
240346281$24034628$1$I$20240601$20240621$20240701$20240701$EXP$$US-VIIV HEALTHCARE LIMITED-US2024072517$VIIV$$38$YR$$M$Y$$$20240701$$PH$US$US
240346291$24034629$1$I$$20240624$20240701$20240701$EXP$$US-CHEPLA-2024008078$CHEPLAPHARM$Ghabra S, Desale S, Sugarbaker H. Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years. Diseases Of The Colon and Rectum. 2023;66(10):1329-1338. DOI:10.1097/DCR.0000000000002448.$31$YR$$M$Y$$$20240701$$HP$COUNTRY NOT SPECIFIED$US
240346391$24034639$1$I$$20230720$20240701$20240701$PER$$US-AMGEN-USASP2023235027$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240346404$24034640$4$F$20240428$20240430$20240701$20240710$PER$$BR-ROCHE-3556128$ROCHE$$12$YR$T$F$Y$$$20240701$$CN$BR$BR
240346412$24034641$2$F$$20240419$20240701$20240710$PER$$JP-ROCHE-3563960$ROCHE$$6$YR$C$F$Y$$$20240701$$MD$JP$JP
240346422$24034642$2$F$20240401$20240528$20240701$20240710$PER$$BG-ROCHE-3562993$ROCHE$$35$YR$A$F$Y$$$20240701$$MD$BG$BG
240346436$24034643$6$F$$20240610$20240701$20240710$PER$$BE-ROCHE-3563670$ROCHE$$$$$F$Y$$$20240701$$CN$BE$BE
240346441$24034644$1$I$$20240613$20240701$20240701$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06012$NEUROCRINE BIOSCIENCES$$61$YR$$F$Y$$$20240701$$HP$US$US
240346451$24034645$1$I$20240409$20240628$20240701$20240701$EXP$FR-AFSSAPS-PP2024000677$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-104183$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$69$KG$20240701$$MD$FR$FR
240346461$24034646$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104744$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240701$$HP$US$US
240346471$24034647$1$I$20240622$20240625$20240701$20240701$EXP$$US-BAYER-2024A093419$BAYER$$63$YR$A$F$Y$55.057$KG$20240701$$CN$US$US
240346481$24034648$1$I$$20240509$20240701$20240701$PER$$GB-ROCHE-3019952$ROCHE$$$$A$F$Y$$$20240701$$PH$GB$GB
240346491$24034649$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104765$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240701$$HP$US$US
240346501$24034650$1$I$$20240620$20240701$20240701$EXP$US-MLMSERVICE-20240613-PI099524-00218-1$US-RDY-SPO/USA/24/0009174$DR REDDYS$Tajfiroozeh D, Silva R, Otsuka KN, Wai A. A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2289. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2289.$15$YR$T$M$Y$$$20240701$$MD$US$US
240346513$24034651$3$F$20220101$20240916$20240701$20240925$EXP$$US-INSMED-2022-02555-USAA$INSMED$$$$$M$Y$$$20240925$$CN$US$US
240346521$24034652$1$I$20240228$20240510$20240701$20240701$PER$$DE-ROCHE-3562896$ROCHE$$15$YR$T$F$Y$80$KG$20240701$$MD$DE$DE
240346531$24034653$1$I$20240618$20240701$20240701$20240701$EXP$SE-SEMPA-2024-005164$SE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036957$BOEHRINGER INGELHEIM$$61$YR$A$F$Y$$$20240701$$MD$SE$SE
240346541$24034654$1$I$$20240529$20240701$20240701$PER$$AU-ROCHE-3574473$ROCHE$$$$$$Y$$$20240701$$MD$AU$AU
240346551$24034655$1$I$$20240520$20240701$20240701$PER$$JP-ROCHE-3575254$ROCHE$$$$C$F$Y$$$20240701$$MD$JP$JP
240346561$24034656$1$I$$20240510$20240701$20240701$PER$$US-ROCHE-3562880$ROCHE$$40$YR$A$F$Y$$$20240701$$CN$US$US
240346571$24034657$1$I$20240508$20240510$20240701$20240701$PER$$US-ROCHE-3562588$ROCHE$$2$YR$C$M$Y$5.75$KG$20240701$$CN$US$US
240346581$24034658$1$I$$20240510$20240701$20240701$PER$$US-ROCHE-3562865$ROCHE$$43$YR$A$F$Y$$$20240701$$CN$US$US
240346591$24034659$1$I$$20240528$20240701$20240701$PER$$AU-ROCHE-3574328$ROCHE$$$$$$Y$$$20240701$$MD$AU$AU
240346601$24034660$1$I$$20240624$20240701$20240701$EXP$$IN-JNJFOC-20240670466$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$IN$IN
240346611$24034661$1$I$$20240624$20240701$20240701$EXP$$CA-CHEPLA-2024008099$CHEPLAPHARM$Houlton R, Al-Shamsi F, Ho J, Leligdowicz A, Bosma K J. Acute Monocytic Leukemia Presenting With Acute Respiratory Distress Syndrome (ARDS) and Multisystem Organ Failure. American Journal of Respiratory and Critical Care Medicine.2024;209.DOI: 10.1164/ajrccm-conference.2024.209.1.$28$YR$$M$Y$$$20240701$$HP$COUNTRY NOT SPECIFIED$CA
240346631$24034663$1$I$20230120$20240621$20240701$20240701$EXP$FR-AFSSAPS-MA2024000846$FR-TEVA-VS-3213353$TEVA$$53$YR$$F$Y$58$KG$20240701$$PH$FR$FR
240346641$24034664$1$I$$20240511$20240701$20240701$PER$$US-ROCHE-3563435$ROCHE$$13$YR$T$F$Y$$$20240701$$CN$US$US
240346653$24034665$3$F$$20240502$20240701$20240710$PER$$GB-ROCHE-3558109$ROCHE$$$$$M$Y$$$20240701$$MD$GB$GB
240346662$24034666$2$F$$20240805$20240701$20240806$PER$$US-ALXN-202406USA001513US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240346672$24034667$2$F$$20240502$20240701$20240710$PER$$AT-ROCHE-3558172$ROCHE$$7$YR$C$M$Y$26.3$KG$20240701$$MD$AT$AT
240346681$24034668$1$I$$20240515$20240701$20240701$PER$$CA-ROCHE-3566364$ROCHE$$$$$$Y$$$20240701$$CN$CA$CA
240346692$24034669$2$F$20240520$20240530$20240701$20240710$PER$$US-ROCHE-3573858$ROCHE$$42$YR$A$F$Y$$$20240701$$CN$US$US
240346701$24034670$1$I$20240425$20240425$20240701$20240701$PER$$JP-ROCHE-3563409$ROCHE$$32$YR$A$M$Y$89$KG$20240701$$MD$JP$JP
240346712$24034671$2$F$20220901$20240311$20240701$20240710$PER$$DE-ROCHE-3313094$ROCHE$$12$YR$T$M$Y$42$KG$20240701$$MD$DE$DE
240346722$24034672$2$F$20240518$20240522$20240701$20240710$PER$$AR-ROCHE-3568748$ROCHE$$30$YR$A$F$Y$53$KG$20240701$$CN$AR$AR
240346732$24034673$2$F$$20240430$20240701$20240710$PER$$US-ROCHE-3364580$ROCHE$$3$YR$C$F$Y$9.56$KG$20240701$$CN$US$US
240346741$24034674$1$I$$20240624$20240701$20240701$EXP$$US-AUROBINDO-AUR-APL-2024-031725$AUROBINDO$Nauka P, Konstantinidis I.. Does Occam^s Razor Even Apply in Severely Immunosuppressed Patients? A Case of a Patient With HIV/AIDS With Opportunistic Infections, Diffuse Large B-Cell Lymphoma, and Secondary Hemophagocytic Lymphohistiocytosis. Am-J-Respir-Crit-Care-Med. 2024$58$YR$$M$Y$$$20240701$$HP$US$US
240346752$24034675$2$F$20240412$20240412$20240701$20240710$PER$$JP-ROCHE-3562405$ROCHE$$12$YR$T$F$Y$$$20240701$$MD$JP$JP
240346764$24034676$4$F$20240329$20240408$20240701$20240710$PER$$AR-ROCHE-3544706$ROCHE$$30$YR$A$F$Y$53.7$KG$20240701$$CN$AR$AR
240346771$24034677$1$I$20240624$20240627$20240701$20240701$EXP$$CA-TAKEDA-2024TUS065244$TAKEDA$$74$YR$$M$Y$$$20240701$$MD$CA$CA
240346781$24034678$1$I$$20240620$20240701$20240701$EXP$$CA-TAKEDA-2024TUS064420$TAKEDA$$$$$F$Y$$$20240701$$CN$CA$CA
240346792$24034679$2$F$$20240730$20240701$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101738$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240806$$CN$US$US
240346801$24034680$1$I$$20240311$20240701$20240701$PER$$US-AMGEN-USASP2024129622$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240346811$24034681$1$I$$20240618$20240701$20240701$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02353$AMNEAL$Hussain M, Tiwana HZ, Sivanandham R, Barsoum A, Bagheri S, et al.. Aripiprazole-lnduced diabetic ketoacidosis and hypertriglyceridemia triggering concurrent pancreatitis: a case report. Am J Respir Crit Care Med. 2024;209$35$YR$$M$Y$$$20240701$$HP$US$US
240346822$24034682$2$F$20240501$20240529$20240701$20240710$PER$$US-ROCHE-3573038$ROCHE$$55$YR$A$M$Y$170.1$KG$20240701$$HP$US$US
240346832$24034683$2$F$$20240606$20240701$20240701$PER$$DE-ROCHE-3579912$ROCHE$$8$YR$C$F$Y$$$20240701$$CN$DE$DE
240346841$24034684$1$I$$20240624$20240701$20240701$EXP$$IR-CHEPLA-2024008121$CHEPLAPHARM$Farrokhnia M, Baniasad A, Mehdiabadi FM. Co- infection of coronavirus disease 19 and cytomegalovirus in a kidney transplant recipient. Clinical case reports.2023;11:e7046. DOI:10.1002/ccr3.7046.$43$YR$$F$Y$$$20240701$$HP$COUNTRY NOT SPECIFIED$IR
240346851$24034685$1$I$$20240625$20240701$20240701$EXP$$US-BAYER-2024A093113$BAYER$$$$$$Y$$$20240701$$HP$US$US
240346881$24034688$1$I$$20240624$20240701$20240701$EXP$$CA-JNJFOC-20240666612$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$PH$CA$CA
240346891$24034689$1$I$$20240625$20240701$20240701$PER$$US-JNJFOC-20240666756$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$PH$US$US
240346902$24034690$2$F$$20240705$20240701$20240711$EXP$$CA-TAKEDA-2024TUS064688$TAKEDA$$$$$M$Y$$$20240711$$CN$CA$CA
240346941$24034694$1$I$20240201$20240513$20240701$20240701$PER$$US-ROCHE-3563102$ROCHE$$19$YR$A$F$Y$22.7$KG$20240701$$CN$US$US
240346952$24034695$2$F$20211207$20240318$20240701$20240710$PER$$JP-ROCHE-3247600$ROCHE$$23$YR$A$M$Y$20.1$KG$20240701$$MD$JP$JP
240346963$24034696$3$F$$20240627$20240701$20240705$PER$$US-ROCHE-3568356$ROCHE$$5$YR$C$F$Y$16.4$KG$20240705$$CN$US$US
240346973$24034697$3$F$$20240430$20240701$20240710$PER$$US-ROCHE-3562059$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240346982$24034698$2$F$20240606$20240606$20240701$20240701$PER$$CL-ROCHE-3579130$ROCHE$$19$YR$A$F$Y$32$KG$20240701$$CN$CL$CL
240346991$24034699$1$I$20240401$20240620$20240701$20240701$PER$$US-SA-2024SA186950$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240701$$MD$US$US
240347001$24034700$1$I$20240617$20240620$20240701$20240701$PER$$US-SA-2024SA186192$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240701$$CN$US$US
240347011$24034701$1$I$20230501$20240619$20240701$20240701$EXP$$CA-CARA THERAPEUTICS, INC.-2024-00189-CA$CARA THERAPEUTICS$$$$$M$Y$$$20240701$$MD$CA$CA
240347021$24034702$1$I$$20240521$20240701$20240701$PER$$DE-ROCHE-3569435$ROCHE$$$$C$M$Y$$$20240701$$CN$DE$DE
240347032$24034703$2$F$$20240607$20240701$20240710$PER$$US-ROCHE-3426427$ROCHE$$6$YR$C$F$Y$19.05$KG$20240701$$PH$US$US
240347042$24034704$2$F$$20240724$20240701$20240731$EXP$$CA-GSK-CA2024AMR078892$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$CA$CA
240347051$24034705$1$I$$20240619$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000909$Steriscience PTE$Hossain S, Bahadur SA. Stenotrophomonas Maltophilia, Pandoraea Species, and Aspergillus Niger Co-infection in a Patient With Acute Respiratory Failure.. Am-J-Respir-Crit-Care-Med. 2024;209$74$YR$$M$Y$$$20240701$$HP$US$US
240347061$24034706$1$I$$20240618$20240701$20240701$EXP$$PT-STERISCIENCE B.V.-2024-ST-000896$Steriscience PTE$Moutinho-Pereira S, Beires F, dos Santos J, Relvas M, Ramos LC, Ramos SC, et al.. Febrile ulceronecrotic Mucha-Habermann disease-a case and treatment review.. Dermatol-Online-J. 2024;30 (2)$23$YR$$M$Y$$$20240701$$HP$PT$PT
240347071$24034707$1$I$$20240619$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000899$Steriscience PTE$Venkat Ramanan S, Ghazal F, Addanki PR, Perez MF. Thyroid Tempest: Unravelling a Rare Case of Amiodarone-Induced Thyroid Storm. Am-J-Respir-Crit-Care-Med. 2024;209 (0):A3400 (plus Poster)$74$YR$$F$Y$$$20240701$$HP$US$US
240347081$24034708$1$I$$20240619$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000911$Steriscience PTE$Amir-Kabirian B, Iversen E, Garcia K. Central Venous Trouble: Central Line Causing Arrhythmia.. Am-J-Respir-Crit-Care-Med. 2024;209$74$YR$$F$Y$$$20240701$$HP$US$US
240347091$24034709$1$I$$20240619$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000926$Steriscience PTE$Abbas K, Wazirali M, Areti S, Schilz RJ. A Case of a Patient With IgE Mediated Idiopathic Chronic Urticaria and Angioedema Resulting in 74 Lifetime Intubations and Multiple Procedural Complications.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$45$YR$$F$Y$$$20240701$$HP$US$US
240347104$24034710$4$F$20231201$20240326$20240701$20240710$PER$$CA-ROCHE-3521070$ROCHE$$20$YR$A$M$Y$$$20240701$$CN$CA$CA
240347113$24034711$3$F$20210101$20240911$20240701$20240919$EXP$$US-BAUSCHBL-2024BNL028576$BAUSCH AND LOMB$$78$YR$$F$Y$54$KG$20240919$$CN$US$US
240347121$24034712$1$I$$20240516$20240701$20240701$PER$$OM-ROCHE-3567455$ROCHE$$$$$$Y$$$20240701$$PH$OM$OM
240347133$24034713$3$F$$20240416$20240701$20240710$PER$$IE-ROCHE-3549925$ROCHE$$$$$$Y$$$20240701$$MD$IE$IE
240347141$24034714$1$I$$20240619$20240701$20240701$EXP$$CN-STERISCIENCE B.V.-2024-ST-000913$Steriscience PTE$Liu Z, Chen Y, Huang A, Li G.. Pneumocystis jirovecii infection during immune checkpoint inhibitor therapy: a report of two cases and review of literature. [Chinese].. Anti-Tumor-Pharm. 2023;13 (1):127-132.$52$YR$$F$Y$$$20240701$$HP$CN$CN
240347151$24034715$1$I$$20240619$20240701$20240701$EXP$$US-STERISCIENCE B.V.-2024-ST-000907$Steriscience PTE$Sherman M, Holden K, Sweeney R, Dumont TL, Appiah-Kubi E.. A Case of Babesiosis Induced Sepsis Hemophagocytic Lymphohistiocytosis Overlap Syndrome in Pennsylvania.. Am-J-Respir-Crit-Care-Med. 2024;209:abstr. A7336.$74$YR$$F$Y$$$20240701$$HP$US$US
240347163$24034716$3$F$$20240521$20240701$20240710$PER$$AU-ROCHE-3567502$ROCHE$$64$YR$A$F$Y$$$20240701$$CN$AU$AU
240347171$24034717$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MIDB-b13c9216-0236-4bf2-b228-6b20ef976515$GB-HALEON-2184397$Haleon PLC$$74$YR$$M$Y$$$20240701$$PH$GB$GB
240347182$24034718$2$F$20240626$20240627$20240701$20240702$EXP$$CA-PFIZER INC-202300349194$PFIZER$$51$YR$$F$Y$$$20240702$$MD$CA$CA
240347191$24034719$1$I$$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024128439$AMGEN$$63$YR$A$F$Y$$$20240701$$HP$US$US
240347203$24034720$3$F$20231215$20240717$20240701$20240722$EXP$$CA-PFIZER INC-202300396978$PFIZER$$63$YR$$F$Y$$$20240722$$MD$CA$CA
240347212$24034721$2$F$20240101$20240704$20240701$20240704$EXP$$CA-PFIZER INC-202300328758$PFIZER$$63$YR$$F$Y$$$20240704$$HP$CA$CA
240347222$24034722$2$F$$20240624$20240701$20240701$EXP$$US-PFIZER INC-PV202400083201$PFIZER$Taylor, J.. Early Surgical Excision of Necrotic Tissue Following Unintentional Dermal Injection of Extended-Release Buprenorphine. Journal of addiction medicine. 2024;10.1097/ADM.0000000000001327$33$YR$$M$Y$$$20240701$$MD$US$US
240347232$24034723$2$F$$20240517$20240701$20240710$PER$$US-ROCHE-3566434$ROCHE$$18$YR$A$F$Y$18.14$KG$20240701$$CN$US$US
240347241$24034724$1$I$$20240516$20240701$20240701$PER$$CA-ROCHE-3566403$ROCHE$$$$$$Y$$$20240701$$CN$CA$CA
240347251$24034725$1$I$20240501$20240624$20240701$20240701$EXP$$FR-AUROBINDO-AUR-APL-2024-031539$AUROBINDO$$72$YR$$M$Y$87$KG$20240701$$MD$FR$FR
240347272$24034727$2$F$$20240525$20240701$20240710$PER$$EG-ROCHE-3565551$ROCHE$$7$YR$C$M$Y$26$KG$20240701$$CN$EG$EG
240347281$24034728$1$I$20240222$20240513$20240701$20240701$PER$$AT-ROCHE-3564713$ROCHE$$46$YR$A$F$Y$72$KG$20240701$$MD$AT$AT
240347292$24034729$2$F$$20240520$20240701$20240710$PER$$US-ROCHE-3564109$ROCHE$$31$YR$A$F$Y$$$20240701$$HP$US$US
240347301$24034730$1$I$20240616$20240620$20240701$20240701$PER$$US-SA-2024SA186923$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240701$$MD$US$US
240347321$24034732$1$I$$20240626$20240701$20240701$PER$$US-ROCHE-10000004893$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
240347331$24034733$1$I$20231207$20240701$20240701$20240701$EXP$FR-AFSSAPS-BR2024000525$FR-BAYER-2024A094673$BAYER$$53$YR$A$F$Y$$$20240701$$MD$FR$FR
240347341$24034734$1$I$$20240617$20240701$20240701$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02360$AMNEAL$Tajfiroozeh D, Silva R, Otsuka KN, Wai A. A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis. Am J Resp Crit Care Med. 2024;209$15$YR$$M$Y$$$20240701$$HP$US$US
240347351$24034735$1$I$20240523$20240619$20240701$20240701$PER$$US-ROCHE-3570326$ROCHE$$76$YR$E$F$Y$$$20240701$$CN$US$US
240347362$24034736$2$F$20240501$20240515$20240701$20240701$PER$$CN-ROCHE-3565126$ROCHE$$$$C$F$Y$$$20240701$$MD$CN$CN
240347372$24034737$2$F$$20240429$20240701$20240710$PER$$GB-ROCHE-3376293$ROCHE$$$$C$F$Y$$$20240701$$HP$GB$GB
240347382$24034738$2$F$$20240513$20240701$20240710$PER$$FR-ROCHE-3564673$ROCHE$$$$$$Y$$$20240701$$PH$FR$FR
240347392$24034739$2$F$20240530$20240722$20240701$20240731$EXP$IT-MINISAL02-989488$IT-TEVA-VS-3213474$TEVA$$73$YR$$M$Y$73$KG$20240731$$MD$IT$IT
240347401$24034740$1$I$20240101$20240625$20240701$20240701$PER$$US-JNJFOC-20240667278$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240701$$CN$US$US
240347411$24034741$1$I$$20240626$20240701$20240701$EXP$$US-JNJFOC-20240675380$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$US$US
240347421$24034742$1$I$20240426$20240620$20240701$20240701$EXP$$US-JNJFOC-20240656109$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240701$$HP$US$US
240347441$24034744$1$I$$20240624$20240701$20240701$PER$$US-ALXN-202406USA001497US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240701$$CN$US$US
240347451$24034745$1$I$20240622$20240627$20240701$20240701$EXP$$CN-GILEAD-2024-0678970$GILEAD$$55$YR$A$F$Y$51$KG$20240701$$HP$CN$CN
240347461$24034746$1$I$$20240515$20240701$20240701$PER$$US-ROCHE-3564901$ROCHE$$26$YR$A$M$Y$70.31$KG$20240701$$CN$US$US
240347471$24034747$1$I$$20240618$20240701$20240701$PER$$US-ROCHE-10000006158$ROCHE$$73$YR$E$M$Y$$$20240701$$MD$US$US
240347483$24034748$3$F$$20240524$20240701$20240710$PER$$KR-ROCHE-3559386$ROCHE$$26$YR$A$F$Y$$$20240701$$CN$KR$KR
240347492$24034749$2$F$$20240514$20240701$20240710$PER$$US-ROCHE-3565232$ROCHE$$2$YR$C$M$Y$7.79$KG$20240701$$CN$US$US
240347502$24034750$2$F$$20240511$20240701$20240710$PER$$BE-ROCHE-3565444$ROCHE$$$$$$Y$$$20240701$$CN$BE$BE
240347535$24034753$5$F$20230216$20240514$20240701$20240710$PER$$SA-ROCHE-3293265$ROCHE$$30$YR$A$M$Y$55$KG$20240701$$CN$SA$SA
240347541$24034754$1$I$$20240625$20240701$20240701$EXP$$US-BAYER-2024A091749$BAYER$$80$YR$E$M$Y$$$20240701$$CN$US$US
240347551$24034755$1$I$$20240618$20240701$20240701$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202406019456$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240701$$CN$DE$DE
240347561$24034756$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019239$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240701$$CN$US$US
240347571$24034757$1$I$$20240620$20240701$20240701$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406019872$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240701$$CN$DE$JP
240347582$24034758$2$F$20240501$20240625$20240701$20240706$EXP$$HK-ELI_LILLY_AND_COMPANY-HK202406015574$ELI LILLY AND CO$$48$YR$A$$Y$$$20240706$$CN$HK$HK
240347591$24034759$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019162$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240701$$HP$US$US
240347601$24034760$1$I$20240527$20240619$20240701$20240701$EXP$FR-AFSSAPS-LM2024000339$FR-ELI_LILLY_AND_COMPANY-FR202406013245$ELI LILLY AND CO$$32$YR$A$M$Y$72$KG$20240701$$CN$FR$FR
240347612$24034761$2$F$20240401$20240710$20240701$20240723$EXP$PT-INFARMED-F202406-385$PT-ELI_LILLY_AND_COMPANY-PT202406014062$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240723$$CN$PT$PT
240347622$24034762$2$F$20240623$20240625$20240701$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018062$ELI LILLY AND CO$$49$YR$A$M$Y$90.703$KG$20240703$$CN$US$US
240347631$24034763$1$I$20230123$20240619$20240701$20240701$EXP$FR-AFSSAPS-MA2024000862$FR-ELI_LILLY_AND_COMPANY-FR202406019307$ELI LILLY AND CO$$82$YR$E$M$Y$80$KG$20240701$$CN$DE$FR
240347641$24034764$1$I$20240314$20240619$20240701$20240701$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406013810$ELI LILLY AND CO$$76$YR$E$M$Y$54.8$KG$20240701$$CN$JP$JP
240347651$24034765$1$I$20240401$20240624$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406016720$ELI LILLY AND CO$$55$YR$A$$Y$$$20240701$$CN$US$US
240347661$24034766$1$I$20240601$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000183$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240701$$CN$US$US
240347671$24034767$1$I$$20240620$20240701$20240701$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406018384$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240701$$CN$DE$JP
240347681$24034768$1$I$$20240625$20240701$20240701$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202406017934$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240701$$CN$BR$BR
240347691$24034769$1$I$$20240625$20240701$20240701$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202405008606$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$BR$BR
240347701$24034770$1$I$$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202304003285$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240701$$CN$US$US
240347711$24034771$1$I$20220813$20240620$20240701$20240701$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406019869$ELI LILLY AND CO$$86$YR$E$M$Y$$$20240701$$CN$JP$JP
240347721$24034772$1$I$20240626$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019367$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240701$$CN$US$US
240347731$24034773$1$I$20240607$20240625$20240701$20240701$EXP$$PA-TERSERA THERAPEUTICS LLC-2024TRS003305$TERSERA THERAPEUTICS$$$$$$Y$$$20240701$$CN$PA$PA
240347742$24034774$2$F$20230101$20240410$20240701$20240710$PER$$DE-ROCHE-3546352$ROCHE$$$$$F$Y$$$20240701$$CN$DE$DE
240347752$24034775$2$F$20240515$20240606$20240701$20240710$PER$$US-ROCHE-3565639$ROCHE$$50$YR$A$M$Y$72.6$KG$20240701$$CN$US$US
240347762$24034776$2$F$$20240515$20240701$20240710$PER$$US-ROCHE-3564847$ROCHE$$$$A$M$Y$$$20240701$$CN$US$US
240347771$24034777$1$I$$20240620$20240701$20240701$PER$$US-ROCHE-10000005618$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
240347782$24034778$2$F$$20240516$20240701$20240710$PER$$GB-ROCHE-3567055$ROCHE$$$$A$F$Y$$$20240701$$CN$GB$GB
240347791$24034779$1$I$$20240515$20240701$20240701$PER$$PT-ROCHE-3566295$ROCHE$$7$YR$C$$Y$$$20240701$$MD$PT$PT
240347801$24034780$1$I$$20240516$20240701$20240701$PER$$CA-ROCHE-3566408$ROCHE$$$$$$Y$$$20240701$$CN$CA$CA
240347813$24034781$3$F$$20240320$20240701$20240710$PER$$US-ROCHE-2846786$ROCHE$$4$YR$C$M$Y$15.7$KG$20240701$$HP$US$US
240347822$24034782$2$F$$20240729$20240701$20240807$30DAY$$CA-JNJFOC-20240672026$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$CA$CA
240347832$24034783$2$F$$20240712$20240701$20240722$EXP$$LB-AMGEN-LBNSP2024124915$AMGEN$$$$$F$Y$$$20240722$$MD$LB$LB
240347841$24034784$1$I$$20240624$20240701$20240701$EXP$$AU-CHEPLA-2024008188$CHEPLAPHARM$Draper L, Vikas A, Das S, Yadav S, Walker F and Bandilovska I. Electroconvulsive Therapy in Transgender and Gender Diverse Population: A Case Report and Review of Literature. Case Reports in Psychiatry. 2024;2024:1-5. DOI:10.1155/2024/5552781.$25$YR$$$Y$$$20240701$$HP$COUNTRY NOT SPECIFIED$AU
240347851$24034785$1$I$$20230520$20240701$20240701$PER$$US-AMGEN-USASP2023235160$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240347861$24034786$1$I$20240101$20240625$20240701$20240701$PER$$US-SA-2024SA190322$SANOFI AVENTIS$$$$A$M$Y$$$20240701$$MD$US$US
240347872$24034787$2$F$20240601$20240710$20240701$20240801$PER$$US-SA-2024SA186896$SANOFI AVENTIS$$33$YR$A$F$Y$57.6$KG$20240719$$HP$US$US
240347882$24034788$2$F$20190924$20240729$20240701$20240801$EXP$$CA-TAKEDA-2020TUS029872$TAKEDA$$62$YR$$F$Y$$$20240801$$MD$CA$CA
240347893$24034789$3$F$$20240417$20240701$20240710$PER$$JP-ROCHE-3563205$ROCHE$$43$YR$A$M$Y$$$20240701$$PH$JP$JP
240347901$24034790$1$I$$20240516$20240701$20240701$PER$$CA-ROCHE-3566404$ROCHE$$$$$$Y$$$20240701$$CN$CA$CA
240347911$24034791$1$I$20230718$20240625$20240701$20240701$EXP$$CA-TAKEDA-2024TUS064239$TAKEDA$$26$YR$$F$Y$$$20240701$$CN$CA$CA
240347921$24034792$1$I$20240624$20240625$20240701$20240701$EXP$$CN-BAYER-2024A091892$BAYER$$71$YR$E$M$Y$62$KG$20240701$$HP$CN$CN
240347932$24034793$2$F$20210901$20240729$20240701$20240801$EXP$GB-MHRA-DEFECT-202406141542258880-KFMDN$GB-ORGANON-O2406GBR002605$ORGANON$$$$$F$Y$$$20240801$$HP$GB$GB
240347941$24034794$1$I$$20240626$20240701$20240701$EXP$$US-ORGANON-O2406USA002506$ORGANON$$$$$F$Y$$$20240701$$MD$US$US
240347953$24034795$3$F$20240124$20240916$20240701$20240924$EXP$$DE-CELLTRION INC.-2024DE015524$CELLTRION$$$$$$Y$$$20240924$$MD$DE$DE
240347962$24034796$2$F$$20240813$20240701$20240819$EXP$$CA-TAKEDA-2024TUS061068$TAKEDA$$$$$F$Y$$$20240819$$CN$CA$CA
240347971$24034797$1$I$20240619$20240620$20240701$20240701$EXP$$IN-ROCHE-10000011508$ROCHE$$62$YR$A$M$Y$$$20240701$$CN$IN$IN
240347982$24034798$2$F$20240413$20240722$20240701$20240802$EXP$$CA-BEH-2024174717$CSL BEHRING$$56$YR$A$F$Y$52$KG$20240802$$HP$CA$CA
240347991$24034799$1$I$20230102$20240603$20240701$20240701$PER$$DE-ROCHE-3420555$ROCHE$$44$YR$A$M$Y$63.8$KG$20240701$$MD$DE$DE
240348002$24034800$2$F$$20240530$20240701$20240710$PER$$GB-ROCHE-3167884$ROCHE$$53$YR$A$F$Y$$$20240701$$CN$GB$GB
240348011$24034801$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127378$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240348022$24034802$2$F$$20240408$20240701$20240710$PER$$US-ROCHE-3542612$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
240348031$24034803$1$I$$20240524$20240701$20240701$PER$$TW-ROCHE-3571653$ROCHE$$$$$$Y$$$20240701$$MD$TW$TW
240348041$24034804$1$I$$20230627$20240701$20240701$PER$$US-AMGEN-USASP2023235116$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240348056$24034805$6$F$$20240815$20240701$20240820$PER$$US-ROCHE-10000009584$ROCHE$$$$A$F$Y$$$20240820$$CN$US$US
240348061$24034806$1$I$$20240628$20240701$20240701$EXP$$CN-AstraZeneca-2024A149822$ASTRAZENECA$$$$$F$Y$$$20240701$$CN$CN$
240348071$24034807$1$I$$20240624$20240701$20240701$EXP$$AU-RDY-SPO/AUS/24/0009372$DR REDDYS$$53$YR$A$F$Y$$$20240701$$HP$AU$AU
240348083$24034808$3$F$$20240801$20240701$20240805$PER$$US-ALXN-202406USA001575US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240348092$24034809$2$F$20240520$20240620$20240701$20240709$EXP$$US-ROCHE-10000008073$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
240348101$24034810$1$I$20240601$20240624$20240701$20240701$EXP$$US-ALXN-202406USA001551US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
240348121$24034812$1$I$20220617$20240618$20240701$20240701$PER$$KR-VIVUS LLC-2024V1000813$VIVUS$$59$YR$E$F$Y$$$20240628$$MD$KR$KR
240348131$24034813$1$I$$20240624$20240701$20240701$EXP$$CA-AstraZeneca-2024A149756$ASTRAZENECA$$53$YR$$M$Y$$$20240701$$MD$CA$
240348161$24034816$1$I$20240530$20240626$20240701$20240701$EXP$$NL-AUROBINDO-AUR-APL-2024-031886$AUROBINDO$$83$YR$$F$Y$$$20240701$$CN$NL$NL
240348171$24034817$1$I$20240601$20240625$20240701$20240701$EXP$$US-JNJFOC-20240668681$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240701$$HP$US$US
240348215$24034821$5$F$20210704$20240918$20240701$20240926$EXP$$ES-PFIZER INC-2021SGN03700$PFIZER$$49$YR$$F$Y$56.3$KG$20240926$$MD$ES$ES
240348222$24034822$2$F$20240428$20240703$20240701$20240712$EXP$$TW-009507513-2406TWN009471$MERCK$$86$YR$$M$Y$83.5$KG$20240712$$HP$TW$TW
240348241$24034824$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184574$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240348251$24034825$1$I$$20240617$20240701$20240701$PER$$US-ROCHE-10000001919$ROCHE$Kingbemi W, Akingbemi W, Kurtz G, Yegya-Raman N, Plastaras J, Schuster S, et al. Stereotactic radiotherapy and CART for treatment of secondary CNS lymphoma. Leukemia and Lymphoma. 2024;65 (6):860-3. doi:10.1080/10428194.2024.2322033.$78$YR$E$M$Y$$$20240701$$HP$US$US
240348261$24034826$1$I$$20240620$20240701$20240701$EXP$$US-JNJFOC-20240659239$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$US$US
240348272$24034827$2$F$$20240730$20240701$20240805$30DAY$$JP-JNJFOC-20240671957$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$PH$JP$JP
240348281$24034828$1$I$20240617$20240624$20240701$20240701$EXP$$CN-SA-2024SA191423$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240701$$HP$CN$CN
240348311$24034831$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA190709$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240701$$MD$US$US
240348321$24034832$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA191254$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240701$$MD$US$US
240348334$24034833$4$F$20010725$20240920$20240701$20240930$EXP$$US-BAUSCHBL-BL-2021-027512$BAUSCH AND LOMB$$53$YR$$F$Y$61.2$KG$20240930$$CN$US$US
240348342$24034834$2$F$$20240711$20240701$20240718$PER$$US-SA-2024SA186210$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240718$$MD$US$US
240348351$24034835$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA192266$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240701$$MD$US$US
240348361$24034836$1$I$20240101$20240624$20240701$20240701$PER$$US-SA-2024SA190312$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240701$$MD$US$US
240348371$24034837$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190287$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240701$$MD$US$US
240348381$24034838$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA190930$SANOFI AVENTIS$$$$E$F$Y$$$20240701$$MD$US$US
240348394$24034839$4$F$$20240719$20240701$20240724$EXP$GB-MHRA-MED-202406271102593100-MTLRW$GB-ORGANON-O2406GBR002682$ORGANON$$37$YR$$$Y$$$20240724$$CN$GB$GB
240348401$24034840$1$I$$20240621$20240701$20240701$EXP$$US-EMD Serono-2024034338$EMD SERONO INC$$55$YR$A$F$Y$107$KG$20240701$$MD$US$US
240348411$24034841$1$I$20230622$20240621$20240701$20240701$EXP$$JP-ARGENX-2023-ARGX-JP003927AA$ARGENX BVBA$$$$$$Y$$$20240701$$CN$JP$JP
240348424$24034842$4$F$20230209$20240725$20240701$20240730$EXP$$US-ROCHE-10000009262$ROCHE$$14$YR$T$F$Y$50.1$KG$20240730$$CN$US$US
240348431$24034843$1$I$$20240624$20240701$20240701$EXP$$JP-PFIZER INC-PV202400083088$PFIZER$Toyama, K.. A case of a patient with depression having a history of atrial fibrillation and cardiac failure who orally overdosed on amiodarone, rivaroxaban, and bisoprolol. Okinawa Medical Journal. 2024;63(1):51$49$YR$$M$Y$$$20240701$$HP$JP$JP
240348441$24034844$1$I$$20240624$20240701$20240701$EXP$$JP-PFIZER INC-PV202400083216$PFIZER$Eguchi, M.. A case of pancytopenia and multiple peptic ulcers with folate deficiency during oral MTX. The 253rd Hokuriku Regional Meeting of The Japanese Society of Internal Medicine. 2024;253rd$8$DEC$$F$Y$$$20240701$$HP$JP$JP
240348451$24034845$1$I$$20240624$20240701$20240701$EXP$$JP-PFIZER INC-PV202400083090$PFIZER$Koyasu, S.. SMARCA4-Deficient Poorly Differentiated Adenocarcinoma of the Gallbladder. Clinical Nuclear Medicine. 2024;49(7):688-689$64$YR$$F$Y$$$20240701$$MD$JP$JP
240348461$24034846$1$I$20190501$20240624$20240701$20240701$EXP$$ES-PFIZER INC-202400200418$PFIZER$Lassaletta, A.. Continuous response despite reduced dose of trametinib as single agent in an adolescent with a relapsed disseminated pediatric low-grade glioma KIAA1549-BRAF fusion positive: a case report and review of the literature.. Frontiers in Oncology. 2024;14(1381354):10.3389/fonc.2024.1381354$18$YR$$M$Y$$$20240701$$MD$ES$ES
240348481$24034848$1$I$$20240624$20240701$20240701$EXP$$US-GSK-US2024078554$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240348492$24034849$2$F$$20240626$20240701$20240701$EXP$$ES-PFIZER INC-202400200626$PFIZER$Silvia Garcia, R.. Molecular characterization and drug sensitivity of a gastric FGFR2-TACC2 and a pancreatic KRASp.G12C primary culture.. Cancer-Research. 2024;Mar 22;84(6)$$$$$Y$$$20240701$$MD$ES$ES
240348502$24034850$2$F$$20240628$20240701$20240704$EXP$$US-ABBVIE-5818931$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240348512$24034851$2$F$$20240807$20240701$20240812$EXP$$MY-BRISTOL-MYERS SQUIBB COMPANY-2024-103252$BRISTOL MYERS SQUIBB$$75$YR$E$$Y$$$20240812$$MD$MY$MY
240348521$24034852$1$I$$20240624$20240701$20240701$PER$$US-ALXN-202406USA001522US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
240348533$24034853$3$F$20240622$20240717$20240701$20240731$EXP$$JP-ALXN-202406JPN001570JP$ALEXION PHARMACEUTICALS$$41$YR$$M$Y$$$20240731$$MD$JP$JP
240348542$24034854$2$F$20230101$20240627$20240701$20240702$EXP$$CN-PFIZER INC-202400201940$PFIZER$Xu, H.. Atypical BCR-ABL1 transcript in mixed phenotype acute leukemia with bone marrow necrosis. Molecular Carcinogenesis. 2024;1-7$62$YR$$M$Y$$$20240702$$MD$CN$CN
240348551$24034855$1$I$$20231004$20240701$20240701$PER$$US-AMGEN-USASP2023235148$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240348561$24034856$1$I$$20240626$20240701$20240701$PER$$US-JNJFOC-20240675519$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240348571$24034857$1$I$$20240619$20240701$20240701$PER$$US-JNJFOC-20240651226$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240348582$24034858$2$F$20240101$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104835$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240701$$PH$US$US
240348591$24034859$1$I$$20240627$20240701$20240701$EXP$GB-MHRA-MED-202406270931160880-FDJCM$GB-DSJP-DSE-2024-129521$DAIICHI$$$$$F$Y$$$20240701$$PH$GB$GB
240348601$24034860$1$I$20230914$20240626$20240701$20240701$EXP$$BY-JNJFOC-20240676051$JOHNSON AND JOHNSON$$66$YR$E$M$Y$56.7$KG$20240701$$MD$BY$BY
240348611$24034861$1$I$20240414$20240617$20240701$20240701$EXP$ES-AEMPS-1535351$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-108710$ZYDUS PHARM$$$$$$Y$$$20240701$$MD$ES$ES
240348631$24034863$1$I$$20240624$20240701$20240701$EXP$$CA-MYLANLABS-2024M1058448$MYLAN$$7$YR$$F$Y$$$20240701$$HP$CA$CA
240348711$24034871$1$I$$20221214$20240701$20240701$PER$$US-AMGEN-USASP2022230351$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240348722$24034872$2$F$$20240815$20240701$20240821$EXP$$CA-PFIZER INC-PV202400084754$PFIZER$Amatto, L.. Montelukast as a Rescue and Premedication for Rituximab Infusion Reactions. The Journal of rheumatology. 2024;51(8):837$40$YR$$F$Y$$$20240821$$MD$CA$CA
240348732$24034873$2$F$$20240627$20240701$20240702$EXP$$JP-PFIZER INC-PV202400083977$PFIZER$Oshima, S.. Cutaneous involvement in diffuse large B-cell lymphoma. Oxford Medical Case Reports. 2024;2024 (6):266-267$85$YR$$M$Y$$$20240702$$HP$JP$JP
240348741$24034874$1$I$$20240627$20240701$20240701$EXP$$US-ABBVIE-5821366$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240348754$24034875$4$F$20240812$20240919$20240701$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202407000358$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240924$$CN$US$US
240348761$24034876$1$I$$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000181$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240701$$CN$US$US
240348773$24034877$3$F$20240619$20240725$20240701$20240807$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202406019566$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240807$$CN$DE$MX
240348781$24034878$1$I$20240626$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018816$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240701$$CN$US$US
240348791$24034879$1$I$$20240627$20240701$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019625$ELI LILLY AND CO$$87$YR$E$M$Y$$$20240701$$CN$US$US
240348801$24034880$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019028$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240701$$CN$US$US
240348811$24034881$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019843$ELI LILLY AND CO$$$$A$M$Y$$$20240701$$CN$US$US
240348821$24034882$1$I$$20240624$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017403$ELI LILLY AND CO$$$$$$Y$$$20240701$$HP$US$US
240348833$24034883$3$F$$20240723$20240701$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202406003049$ELI LILLY AND CO$$53$YR$A$F$Y$52.154$KG$20240729$$CN$US$US
240348841$24034884$1$I$20240627$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019293$ELI LILLY AND CO$$73$YR$E$$Y$$$20240701$$CN$US$US
240348851$24034885$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019336$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240701$$CN$US$US
240348861$24034886$1$I$20240624$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019331$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240701$$PH$US$US
240348871$24034887$1$I$20230101$20240624$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406016312$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240701$$CN$US$US
240348881$24034888$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019090$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240701$$CN$US$US
240348891$24034889$1$I$$20240625$20240701$20240701$EXP$$US-TEVA-VS-3214750$TEVA$$65$YR$$F$Y$$$20240701$$PH$US$US
240348901$24034890$1$I$20240601$20240626$20240701$20240701$EXP$FR-AFSSAPS-LL2024001183$FR-REGENERON PHARMACEUTICALS, INC.-2024-091698$REGENERON$$48$YR$$M$Y$$$20240701$$MD$FR$FR
240348911$24034891$1$I$20240621$20240621$20240701$20240701$PER$$US-BAYER-2024A090767$BAYER$$22$YR$A$F$Y$$$20240701$$MD$US$US
240348921$24034892$1$I$$20240626$20240701$20240701$PER$$US-JNJFOC-20240675497$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240701$$CN$US$US
240348933$24034893$3$F$$20240719$20240701$20240724$EXP$$JP-JNJFOC-20240700384$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$PH$JP$JP
240348941$24034894$1$I$$20240627$20240701$20240701$EXP$$PL-BAUSCHBL-2024BNL029300$BAUSCH AND LOMB$$90$YR$$$Y$$$20240701$$MD$PL$PL
240348951$24034895$1$I$20240501$20240617$20240701$20240701$EXP$FR-AFSSAPS-NY2024000676$FR-OCTA-HAPL01124$OCTAPHARMA$$52$YR$A$F$Y$$$20240701$$MD$EU$EU
240348961$24034896$1$I$20240614$20240624$20240701$20240701$EXP$$CN-009507513-2406CHN009198$MERCK$$64$YR$$M$Y$65$KG$20240701$$HP$CN$CN
240348971$24034897$1$I$$20240618$20240701$20240701$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05562$LUPIN$Haghparast P, Nadybal M, Yuan C. Treatment-Resistant Priapism in a 61-year-old male after combined use of Trazodone, Quetiapine, and Fluoxetine. Journal of Clinical Psychopharmacology. 2024;44 (3):316-317$61$YR$$M$Y$$$20240701$$PH$US$US
240348981$24034898$1$I$$20240618$20240701$20240701$EXP$$IE-ORPHALAN-IE-ORP-24-00104$ORPHALAN$$$$$$Y$$$20240701$$PH$IE$IE
240348991$24034899$1$I$$20240624$20240701$20240701$EXP$$US-MYLANLABS-2024M1060840$MYLAN$Son MP, Noh J, Hosea S. A Breath of Hope Turns to Heartbreak: Cardiac Arrest From Aerosolized Epinephrine Overuse for Undiagnosed Allergic Bronchopulmonary Aspergillosis. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$66$YR$$F$Y$$$20240701$$HP$US$US
240349001$24034900$1$I$$20240624$20240701$20240701$EXP$$US-MYLANLABS-2024M1060849$MYLAN$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant 2023; 23 (7): 1048-1057.$7$DEC$$M$Y$$$20240701$$HP$US$US
240349031$24034903$1$I$$20240624$20240701$20240701$EXP$$US-MYLANLABS-2024M1060856$MYLAN$Cooper J, Patel K, Richardson C. A Case of Severe Herpes Simplex Virus Pneumonitis. Am-J-Respir-Crit-Care-Med 2024; 209 A3584.$71$YR$$F$Y$$$20240701$$HP$US$US
240349041$24034904$1$I$20240401$20240619$20240701$20240701$EXP$$BR-ORPHALAN-BR-ORP-24-00105$ORPHALAN$$$$$$Y$$$20240701$$MD$BR$BR
240349052$24034905$2$F$$20240814$20240701$20240829$EXP$$ES-ORPHALAN-ES-ORP-24-00107$ORPHALAN$$$$$$Y$$$20240829$$MD$ES$ES
240349093$24034909$3$F$20220801$20240705$20240701$20240710$EXP$$GB-PFIZER INC-202400201326$PFIZER$Urquhart, D.. Reversible deafness related to long-term daily Azithromycin treatment in a child with cystic fibrosis. Pediatric Pulmonology. 2024;1-3$12$YR$$M$Y$31.8$KG$20240710$$MD$GB$GB
240349111$24034911$1$I$$20240625$20240701$20240701$EXP$$SG-PFIZER INC-PV202400084721$PFIZER$Guo, W.. Rapidly progressive glomerulonephritis with anti-neutrophil cytoplasmic antibodies, in a patient on golimumab. Nephrology Dialysis Transplantation. 2024;39(Supple 1):i2068-i2069$73$YR$$F$Y$$$20240701$$HP$SG$SG
240349121$24034912$1$I$20240410$20240618$20240701$20240701$EXP$DE-PEI-CADR2024327412$DE-OCTA-GAM20724$OCTAPHARMA$$82$YR$E$M$Y$75$KG$20240701$$MD$EU$EU
240349131$24034913$1$I$20240419$20240625$20240701$20240701$EXP$$AT-BIOGEN-2024BI01259087$BIOGEN$$29$YR$$F$Y$$$20240630$$MD$AT$AT
240349191$24034919$1$I$$20240624$20240701$20240701$PER$$US-BIOGEN-2024BI01270959$BIOGEN$$$$$M$Y$$$20240701$$CN$US$US
240349201$24034920$1$I$20141011$20240626$20240701$20240701$EXP$$US-BIOGEN-2014BI109751$BIOGEN$$44$YR$$F$Y$$$20240630$$CN$US$US
240349212$24034921$2$F$$20240628$20240701$20240704$EXP$$CA-BIOGEN-2024BI01271254$BIOGEN$$$$$F$Y$$$20240704$$CN$CA$CA
240349222$24034922$2$F$20240501$20240716$20240701$20240722$EXP$$US-BIOGEN-2024BI01271610$BIOGEN$$81$YR$$F$Y$$$20240722$$CN$US$US
240349232$24034923$2$F$$20240809$20240701$20240813$PER$$US-BIOGEN-2024BI01270886$BIOGEN$$$$$M$Y$$$20240813$$CN$US$US
240349241$24034924$1$I$20240601$20240624$20240701$20240701$PER$$US-BIOGEN-2024BI01270882$BIOGEN$$58$YR$$F$Y$$$20240701$$CN$US$US
240349251$24034925$1$I$$20240624$20240701$20240701$EXP$$BG-BIOGEN-2024BI01270855$BIOGEN$$$$$F$Y$$$20240701$$CN$BG$BG
240349261$24034926$1$I$$20240624$20240701$20240701$PER$$US-BIOGEN-2024BI01271013$BIOGEN$$$$$$Y$$$20240701$$HP$US$US
240349274$24034927$4$F$20230101$20240828$20240701$20240902$PER$$US-BIOGEN-2024BI01270970$BIOGEN$$$$$F$Y$$$20240902$$CN$US$US
240349281$24034928$1$I$$20240626$20240701$20240701$EXP$$US-BIOGEN-2024BI01271522$BIOGEN$$$$$F$Y$$$20240630$$HP$US$US
240349291$24034929$1$I$20240620$20240625$20240701$20240701$EXP$$US-BIOGEN-2024BI01271321$BIOGEN$$30$YR$$F$Y$$$20240701$$HP$US$US
240349301$24034930$1$I$20240530$20240625$20240701$20240701$EXP$$CA-BIOGEN-2024BI01271457$BIOGEN$$66$YR$$M$Y$$$20240701$$PH$CA$CA
240349311$24034931$1$I$$20240624$20240701$20240701$PER$$US-BIOGEN-2024BI01270939$BIOGEN$$$$$$Y$$$20240701$$CN$US$US
240349321$24034932$1$I$20240614$20240624$20240701$20240701$PER$$US-BIOGEN-2024BI01270957$BIOGEN$$67$YR$$F$Y$$$20240701$$CN$US$US
240349332$24034933$2$F$$20240627$20240701$20240815$EXP$$US-BIOGEN-2024BI01270431$BIOGEN$$$$$M$Y$$$20240815$$CN$US$US
240349342$24034934$2$F$20240601$20240627$20240701$20240704$PER$$US-BIOGEN-2024BI01270389$BIOGEN$$54$YR$$F$Y$$$20240704$$CN$US$US
240349351$24034935$1$I$$20240624$20240701$20240701$PER$$US-BIOGEN-2024BI01270960$BIOGEN$$$$$M$Y$$$20240701$$CN$US$US
240349381$24034938$1$I$$20240621$20240701$20240701$EXP$$US-ORPHALAN-US-ORP-24-00106$ORPHALAN$$$$$$Y$$$20240701$$CN$US$US
240349393$24034939$3$F$$20240702$20240701$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-104377$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240710$$MD$JP$JP
240349401$24034940$1$I$$20240626$20240701$20240701$EXP$$US-BIOGEN-2024BI01269786$BIOGEN$$$$$F$Y$$$20240701$$HP$US$US
240349412$24034941$2$F$20220101$20240808$20240701$20240814$EXP$$BR-BIOGEN-2024BI01271458$BIOGEN$$$$$F$Y$80$KG$20240814$$HP$BR$BR
240349424$24034942$4$F$20240101$20240822$20240701$20240829$PER$$US-BIOGEN-2024BI01269372$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
240349431$24034943$1$I$20240621$20240626$20240701$20240701$EXP$$CA-BIOGEN-2024BI01271462$BIOGEN$$72$YR$$F$Y$$$20240701$$HP$CA$CA
240349441$24034944$1$I$$20240624$20240701$20240701$PER$$US-ALXN-202406USA001586US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
240349452$24034945$2$F$$20240725$20240701$20240729$PER$$US-BIOVITRUM-2024-US-009278$BIOVITRUM$$80$YR$$F$Y$$$20240729$$CN$US$US
240349461$24034946$1$I$$20240624$20240701$20240701$PER$$US-ALXN-202406USA001571US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
240349475$24034947$5$F$20240101$20240812$20240701$20240814$PER$$US-Eisai-EC-2024-168077$EISAI$$78$YR$E$M$Y$$$20240814$$CN$US$US
240349482$24034948$2$F$20230101$20240708$20240701$20240718$EXP$$DE-ROVI-20230626$ROVIPHARM SAS$$20$YR$A$M$Y$$$20240718$$MD$DE$DE
240349491$24034949$1$I$$20240624$20240701$20240701$EXP$$CA-GENMAB-2024-02279$GENMAB$$81$YR$$M$Y$$$20240701$$MD$CA$CA
240349501$24034950$1$I$$20230803$20240701$20240701$PER$$US-AMGEN-USASP2023235199$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240349511$24034951$1$I$$20240501$20240701$20240701$PER$$US-AMGEN-USASP2024129692$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240349521$24034952$1$I$$20240624$20240701$20240701$EXP$$US-MYLANLABS-2024M1058577$MYLAN$Rallabhandi S, Keelapandal Ganesh M, Kaufmann B. Cardiac Arrest: A Rare Complication of Chest Tube Placement. Am-J-Respir-Crit-Care-Med 2024; 209 A3644.$74$YR$$F$Y$$$20240701$$HP$US$US
240349531$24034953$1$I$$20240624$20240701$20240701$EXP$$IT-MYLANLABS-2024M1060012$MYLAN$Zarkovic Gjurin S, Pang J, Vrckovnik M, Hanna R. Efficacy of 1064 nm Photobiomodulation Dosimetry Delivered with a Collimated Flat-Top Handpiece in the Management of Peripheral Facial Paralysis in Patients Unresponsive to Standard Treatment Care: A Case Series. J-Clin-Med 2023; 12 (19): 1-19.$52$YR$$M$Y$$$20240701$$HP$IT$IT
240349541$24034954$1$I$20240101$20240622$20240701$20240701$PER$$US-SA-2024SA190444$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240701$$MD$US$US
240349552$24034955$2$F$20190101$20240702$20240701$20240711$PER$$US-SA-2024SA186666$SANOFI AVENTIS$$65$YR$E$F$Y$79$KG$20240711$$CN$US$US
240349561$24034956$1$I$$20240624$20240701$20240701$EXP$$BE-MYLANLABS-2024M1058812$MYLAN$Hendrickx T, Peetermans M, D^hoore A, Claes K, Van Hootegem A, Sabino J. STEC colitis mimicking acute severe colitis with life-threatening consequences: a case report. Acta-Gastroenterol-Belg 2024; 87 (1): 37-39.$18$YR$$M$Y$$$20240701$$MD$BE$BE
240349571$24034957$1$I$20240101$20240626$20240701$20240701$EXP$$US-JNJFOC-20240674491$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240701$$HP$US$US
240349582$24034958$2$F$$20240704$20240701$20240713$EXP$$KZ-JNJFOC-20240658017$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240713$$CN$KZ$KZ
240349591$24034959$1$I$20240601$20240625$20240701$20240701$PER$$US-SA-2024SA190940$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240701$$MD$US$US
240349601$24034960$1$I$20240526$20240624$20240701$20240701$EXP$$CN-SA-2024SA192160$SANOFI AVENTIS$$54$YR$A$F$Y$45$KG$20240701$$HP$CN$CN
240349611$24034961$1$I$$20240624$20240701$20240701$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004728$BIOCON$$$$$$Y$$$20240701$$CN$CA$CA
240349622$24034962$2$F$$20240724$20240701$20240726$EXP$$US-INCYTE CORPORATION-2024IN006636$INCYTE$$$$$$Y$$$20240726$$CN$US$US
240349631$24034963$1$I$20210101$20240627$20240701$20240701$EXP$$SE-UCBSA-2024033040$UCB$$$$N$$Y$$$20240701$$MD$SE$SE
240349641$24034964$1$I$$20240624$20240701$20240701$EXP$$US-BAYER-2024A090839$BAYER$$85$YR$E$M$Y$$$20240701$$CN$US$US
240349722$24034972$2$F$$20240626$20240701$20240705$PER$$US-PFM-2024-03650$PIERRE FABRE MEDICAMENT$Calderon Barahona GM, Ali R, Ortega Giron C, Ng W, Bobrysheva H, Calderon Martinez E et al. Beta-Blocked: A Severe Propranolol Overdose Case Report. American Journal of Respiratory and Critical Care Medicine. 2024;209$25$YR$$F$Y$$$20240705$$MD$US$US
240349731$24034973$1$I$$20240617$20240701$20240701$PER$$US-PFM-2024-03614$PIERRE FABRE MEDICAMENT$Mansour C ,Harris S, Kutsche WS, Lasevski N, Wilson MA. An unusual mechanism for cardiac arrest secondary to thyroid storm. Am J Respir Crit Care Med. 2024$53$YR$$F$Y$$$20240701$$HP$US$US
240349742$24034974$2$F$20240601$20240719$20240701$20240724$EXP$$DE-SANDOZ INC.-SDZ2024DE061557$SANDOZ$$9$YR$$F$Y$20.8$KG$20240724$$MD$DE$DE
240349751$24034975$1$I$$20240627$20240701$20240701$EXP$$CA-SANDOZ INC.-SDZ2024CA061612$SANDOZ$$$$$M$Y$83.9$KG$20240701$$MD$CA$CA
240349763$24034976$3$F$$20240820$20240701$20240829$EXP$$JP-SANDOZ INC.-SDZ2024JP061702$SANDOZ$Koizumi G, Hayashi A, Takigawa A, Yamada R, Murata T, Shimizu K et al. Novel histopathological findings of micro bone fragments and epithelial response in the oral mucosa in bisphosphonate related osteonecrosis of the jaw. JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS. 2024;12:1-8$54$YR$$M$Y$$$20240829$$HP$JP$JP
240349773$24034977$3$F$20240506$20240730$20240701$20240731$EXP$$ES-SANDOZ INC.-SDZ2024ES061443$SANDOZ$$67$YR$$F$Y$69.1$KG$20240731$$HP$ES$ES
240349783$24034978$3$F$$20240916$20240701$20240919$30DAY$$CO-PFIZER INC-202400198578$PFIZER$$12$YR$$M$Y$$$20240919$$CN$CO$CO
240349791$24034979$1$I$$20240628$20240701$20240701$EXP$$US-PFIZER INC-202400203281$PFIZER$$60$YR$$F$Y$$$20240701$$MD$US$US
240349803$24034980$3$F$20240601$20240919$20240701$20240924$30DAY$$AR-PFIZER INC-202400196890$PFIZER$$9$YR$$F$Y$$$20240924$$CN$AR$AR
240349811$24034981$1$I$20230101$20240627$20240701$20240701$EXP$$US-PFIZER INC-PV202400085803$PFIZER$$68$YR$$F$Y$$$20240701$$HP$US$US
240349822$24034982$2$F$20240601$20240916$20240701$20240918$EXP$$AR-PFIZER INC-202400201666$PFIZER$$$$A$F$Y$$$20240918$$CN$AR$AR
240349842$24034984$2$F$$20240628$20240701$20240701$EXP$$GB-PFIZER INC-202400202549$PFIZER$Gan, Y.. THE DIVERSITY OF CARDIAC MANIFESTATIONS IN RHEUMATOLOGICAL DISORDERS: HIGHLIGHTS ON IMMUNOSUPPRESSION AND CARDIAC COMPLICATIONS. Heart. 2024;110(Suppl 3):A33-4$30$YR$$F$Y$$$20240701$$HP$GB$GB
240349852$24034985$2$F$20220523$20240705$20240701$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-039110$JAZZ$$23$YR$$M$Y$$$20240710$$HP$US$US
240349861$24034986$1$I$20240601$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104790$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240701$$PH$US$US
240349871$24034987$1$I$$20231222$20240701$20240701$PER$$US-AMGEN-USASP2023235191$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240349883$24034988$3$F$$20240730$20240701$20240801$PER$$US-AMGEN-USASP2024128576$AMGEN$$$$$F$Y$$$20240801$$PH$US$US
240349891$24034989$1$I$20240626$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024129897$AMGEN$$76$YR$E$F$Y$$$20240701$$CN$US$US
240349902$24034990$2$F$$20240816$20240701$20240821$EXP$$US-009507513-2406USA008791$MERCK$$$$$$Y$$$20240821$$HP$US$US
240349911$24034991$1$I$$20240620$20240701$20240701$PER$$US-INCYTE CORPORATION-2024IN006627$INCYTE$$$$$$Y$$$20240701$$CN$US$US
240349921$24034992$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190958$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240701$$MD$US$US
240349934$24034993$4$F$$20240717$20240701$20240722$EXP$$JP-SA-2024SA191821$SANOFI AVENTIS$$74$YR$E$M$Y$61$KG$20240722$$HP$JP$JP
240349942$24034994$2$F$20240601$20240807$20240701$20240814$PER$$US-SA-2024SA190956$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240814$$MD$US$US
240349951$24034995$1$I$$20240627$20240701$20240701$PER$$US-GILEAD-2024-0678905$GILEAD$$50$YR$A$F$Y$$$20240701$$MD$US$US
240349963$24034996$3$F$20240624$20240916$20240701$20240918$EXP$$US-SA-2024SA189241$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240918$$HP$US$US
240349971$24034997$1$I$$20240620$20240701$20240701$PER$$US-INCYTE CORPORATION-2024IN006626$INCYTE$$$$$$Y$$$20240701$$CN$US$US
240349981$24034998$1$I$20240508$20240617$20240701$20240701$EXP$PT-INFARMED-E202406-189$PT-COLLEGIUM PHARMACEUTICAL, INC.-20240600469$COLLEGIUM PHARMACEUTICAL$$68$YR$$M$Y$92$KG$20240701$$MD$PT$PT
240349991$24034999$1$I$$20240624$20240701$20240701$EXP$$US-MYLANLABS-2024M1059389$MYLAN$Kim D, Vyas H, Hochfeld U, Zolotov E, Omidvari K. Mechanical Cardioversion of Refractory Atrial Flutter to Sinus Rhythm During Bronchoscopy. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$64$YR$$F$Y$$$20240701$$HP$US$US
240350001$24035000$1$I$20240325$20240619$20240701$20240701$EXP$ES-AEMPS-1534470$ES-COLLEGIUM PHARMACEUTICAL, INC.-20240600474$COLLEGIUM PHARMACEUTICAL$$58$YR$$F$Y$$$20240701$$MD$ES$ES
240350011$24035001$1$I$$20240624$20240701$20240701$EXP$$GB-MYLANLABS-2024M1058633$MYLAN$Buckens G, Mahir G, Bapat A. 58 Antifungal resistance, a hot topic. A case report in co-infection of Mycobacterium avium-intracellulare and chronic cavitary pulmonary aspergillosis. Clin-Infect-Pract 2023; 20 (Suppl. 1) 23 abstr. 58.$53$YR$$M$Y$$$20240701$$HP$GB$GB
240350022$24035002$2$F$20240329$20240722$20240701$20240725$EXP$$GR-MYLANLABS-2024M1060968$MYLAN$$53$YR$$M$Y$$$20240725$$MD$GR$GR
240350032$24035003$2$F$$20240724$20240701$20240727$PER$$US-AstraZeneca-2024A140287$ASTRAZENECA$$$$$M$Y$$$20240727$$CN$US$
240350043$24035004$3$F$20240101$20240718$20240701$20240723$EXP$$US-ABBVIE-5815893$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
240350051$24035005$1$I$$20240624$20240701$20240701$EXP$$US-MYLANLABS-2024M1059336$MYLAN$Blankenship S, Lodh A, Minish-Pron JM, Morris PE. Catastrophic Antiphospholipid Syndrome as a Cause for Multi-System Organ Failure and Death. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A3546.$19$YR$$F$Y$$$20240701$$HP$US$US
240350061$24035006$1$I$$20240624$20240701$20240701$EXP$$GB-MYLANLABS-2024M1060168$MYLAN$Hutton D, Kameda-Smith M, Afshari FT, Elawadly A, Hogg F, Mehta S, et al. Intracranial invasive group A streptococcus: a neurosurgical emergency in children. J-Neurosurg-Pediatr 2023; 32 (4): 478-487.$5$YR$$F$Y$$$20240701$$HP$GB$GB
240350073$24035007$3$F$$20240709$20240701$20240723$30DAY$$BE-JNJFOC-20240666584$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$PH$BE$BE
240350081$24035008$1$I$$20240625$20240701$20240701$PER$$US-JNJFOC-20240667359$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$US$US
240350091$24035009$1$I$20240621$20240625$20240701$20240701$PER$$US-JNJFOC-20240669074$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240701$$CN$US$US
240350101$24035010$1$I$$20240624$20240701$20240701$PER$$US-JNJFOC-20240671186$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$HP$US$US
240350111$24035011$1$I$$20240627$20240701$20240701$EXP$$NO-UCBSA-2024033038$UCB$$$$$F$Y$$$20240701$$MD$NO$NO
240350122$24035012$2$F$20240418$20240712$20240701$20240718$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003579$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240718$$MD$IT$IT
240350131$24035013$1$I$$20240624$20240701$20240701$PER$$US-ALXN-202406USA001578US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
240350144$24035014$4$F$$20240903$20240701$20240906$EXP$$US-ABBVIE-5817752$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
240350161$24035016$1$I$$20240621$20240701$20240701$PER$$US-INCYTE CORPORATION-2024IN006710$INCYTE$$$$$$Y$$$20240701$$PH$US$US
240350172$24035017$2$F$20240306$20240717$20240701$20240722$EXP$$JP-OTSUKA-2024_018269$OTSUKA$$62$YR$$M$Y$72$KG$20240722$$MD$JP$JP
240350181$24035018$1$I$20240604$20240627$20240701$20240701$PER$$TH-Eisai-EC-2024-168346$EISAI$$75$YR$E$M$Y$$$20240701$$CN$TH$TH
240350191$24035019$1$I$$20240624$20240701$20240701$EXP$$IR-MYLANLABS-2024M1060867$MYLAN$Shahbazi F,  Shojaei L. Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases. Curr-Drug-Saf 2024;.$52$YR$$F$Y$$$20240701$$HP$IR$IR
240350201$24035020$1$I$20240101$20240625$20240701$20240701$PER$$US-SA-2024SA190828$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240701$$MD$US$US
240350211$24035021$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA187325$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240701$$CN$US$US
240350221$24035022$1$I$20240601$20240625$20240701$20240701$PER$$US-SA-2024SA192102$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240701$$MD$US$US
240350231$24035023$1$I$$20240625$20240701$20240701$EXP$NO-NOMAADVRE-RELISN-2024-00104$NO-SA-2024SA188564$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240701$$MD$NO$NO
240350241$24035024$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126389$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240350251$24035025$1$I$$20240412$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05954$HIKMA$Dernbach MR, Carpenter JE, Shah N, Carter GB.. Dernbach MR, Carpenter JE, Shah N, Carter GB. Black Cohosh Interactions with Prescription Medications Associated with Serotonin Toxicity and Rhabdomyolysis: A Case Report. The Journal of emergency medicine.. 2024;5:53:1$55$YR$$F$Y$$$20240701$$MD$US$US
240350261$24035026$1$I$$20240617$20240701$20240701$EXP$$ES-EPICPHARMA-ES-2024EPCLIT00768$EPIC PHARM$Marc Soriano.Amiodarone triggered Kounis syndrome complicated by refractory cardiac arrest rescued with VA-ECMO.Clinical Case Reports.19-JUL-2023;12 (NO 5):1$60$YR$A$M$Y$$$20240701$$HP$ES$ES
240350271$24035027$1$I$$20240624$20240701$20240701$EXP$$US-TAKEDA-2023TUS123838$TAKEDA$$$$$F$Y$$$20240701$$CN$US$US
240350281$24035028$1$I$$20240626$20240701$20240701$PER$$US-JNJFOC-20240671454$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240350291$24035029$1$I$$20240618$20240701$20240701$EXP$$US-ENDO USA, INC.-2024-002710$ENDO$Grabie Y, Acharya S, Rudman J, Rotblat D, El-Hage H, Chalhoub MN. Beyond the High - A Ketamine Induced Hematologic Crisis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5661$40$YR$$M$Y$$$20240701$$HP$US$US
240350301$24035030$1$I$20240520$20240618$20240701$20240701$PER$$US-JNJFOC-20240647304$JOHNSON AND JOHNSON$$2$YR$C$M$Y$$$20240701$$HP$US$US
240350311$24035031$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018186$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240701$$CN$US$US
240350321$24035032$1$I$20240601$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019406$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240701$$CN$US$US
240350331$24035033$1$I$20240319$20240626$20240701$20240701$EXP$$US-TAKEDA-2024TUS038010$TAKEDA$$79$YR$$F$Y$49$KG$20240701$$HP$US$US
240350341$24035034$1$I$20240601$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019679$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240350351$24035035$1$I$20240627$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019460$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240701$$CN$US$US
240350361$24035036$1$I$$20240621$20240701$20240701$30DAY$$US-GSK-US2024AMR078455$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240350371$24035037$1$I$20240301$20240621$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406015540$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240701$$CN$US$US
240350381$24035038$1$I$20240229$20240621$20240701$20240701$EXP$ES-AEMPS-1534685$ES-TEVA-VS-3213187$TEVA$$71$YR$$M$Y$59.5$KG$20240701$$MD$ES$ES
240350392$24035039$2$F$$20240627$20240701$20240702$EXP$$DE-UCBSA-2024033029$UCB$$$$N$$Y$$$20240702$$MD$DE$DE
240350401$24035040$1$I$$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018079$ELI LILLY AND CO$$$$A$F$Y$$$20240701$$CN$US$US
240350414$24035041$4$F$20240625$20240723$20240701$20240729$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003611$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240729$$MD$US$US
240350421$24035042$1$I$$20240627$20240701$20240701$EXP$$US-BIOVITRUM-2024-US-009239$BIOVITRUM$$80$YR$$F$Y$$$20240701$$CN$US$US
240350431$24035043$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184603$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240350451$24035045$1$I$$20230829$20240701$20240701$PER$$US-AMGEN-USASP2023235127$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240350461$24035046$1$I$$20240128$20240701$20240701$PER$$US-AMGEN-USASP2024129790$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240350471$24035047$1$I$$20230615$20240701$20240701$PER$$US-AMGEN-USASP2023235091$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240350481$24035048$1$I$$20240622$20240701$20240701$EXP$$US-AMGEN-USASP2024124801$AMGEN$Temme A.L.; Watson M.; Kannappan A.. Rituximab Alone: A Rare Case of Pneumocystis Jiroveci Pneumonia in a Patient on Rituximab Monotherapy. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A2371$74$YR$E$F$Y$$$20240701$$HP$US$US
240350491$24035049$1$I$$20240621$20240701$20240701$30DAY$$US-GSK-US2024AMR078270$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240350501$24035050$1$I$$20240626$20240701$20240701$PER$$US-SA-2024SA191168$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240701$$HP$US$US
240350511$24035051$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA188922$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240701$$CN$US$US
240350522$24035052$2$F$20240624$20240705$20240701$20240715$PER$$US-SA-2024SA188650$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240715$$CN$US$US
240350531$24035053$1$I$$20240625$20240701$20240701$EXP$$CH-GILEAD-2024-0678682$GILEAD$$$$A$$Y$$$20240701$$CN$CH$CH
240350541$24035054$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA191222$SANOFI AVENTIS$$$$A$M$Y$$$20240701$$MD$US$US
240350552$24035055$2$F$20240601$20240726$20240701$20240729$EXP$$CY-ASTELLAS-2024US018444$ASTELLAS$$70$YR$$M$Y$$$20240729$$MD$CY$CY
240350561$24035056$1$I$$20240624$20240701$20240701$PER$$US-AMGEN-USASP2024127128$AMGEN$Kuranz S.. TIME TO TREATMENT INITIATION BY DIAGNOSTIC AND TREATMENT PATTERNS AMONG SARCOIDOSIS PATIENTS IN A REAL-WORLD HYBRID CLAIMS DATABASE. Value in Health. 2024;27 (6):S229-S230$$$$$Y$$$20240701$$HP$US$US
240350571$24035057$1$I$20240625$20240626$20240701$20240701$EXP$$AT-TAKEDA-2024TUS064938$TAKEDA$$1$YR$$F$Y$$$20240701$$CN$AT$AT
240350583$24035058$3$F$20240520$20240708$20240701$20240712$EXP$FR-AFSSAPS-AN2024000826$FR-OTSUKA-2024_018365$OTSUKA$$58$YR$$F$Y$90$KG$20240712$$PH$FR$FR
240350591$24035059$1$I$$20240626$20240701$20240701$EXP$$SD-PFIZER INC-PV202400084810$PFIZER$Michele, C.. Enoximone as a therapeutic option in status asthmaticus: a case report. European Heart Journal. 2024;26 (Suppl 2):ii78$58$YR$$M$Y$80$KG$20240701$$HP$SD$SD
240350601$24035060$1$I$$20240627$20240701$20240701$EXP$$JP-PFIZER INC-PV202400085162$PFIZER$Azuma, S.. The fatal case of ^Pigmentibacter^ bacteremia following aspiration pneumonia in elderly patient. Journal of Infection and Chemotherapy. 2024;30(8):806-811$95$YR$$M$Y$60.3$KG$20240701$$HP$JP$JP
240350611$24035061$1$I$$20240626$20240701$20240701$EXP$$JP-PFIZER INC-2019056754$PFIZER$Sasaki, K.. Two cases of multiple solar keratoses and spinocellular carcinoma in patients under long-term oral treatment with voriconazole. The Japanese Journal of Dermatology. 2019;129(1):54$8$DEC$$M$Y$$$20240701$$MD$JP$JP
240350622$24035062$2$F$20170101$20240628$20240701$20240703$EXP$$CN-PFIZER INC-202400202554$PFIZER$Chen, H.. Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report. Transplantation proceedings. 2024;1-4$57$YR$$F$Y$$$20240703$$MD$CN$CN
240350631$24035063$1$I$$20240622$20240701$20240701$EXP$$BR-AMGEN-BRASP2024124816$AMGEN$Medeiros Da Nobrega D.; Arai Seque C.; Oenning L. et al.. Rapid desensitization in a patient with pemphigus vulgaris and rituximab-induced anaphylaxis. International Journal of Dermatology. 2024;1-2$53$YR$A$M$Y$$$20240701$$HP$BR$BR
240350643$24035064$3$F$$20240710$20240701$20240716$EXP$$FR-PFIZER INC-202400202324$PFIZER$Belmin, J.. Amyloidosis of the heart is an underdiagnosed disease in geriatric medicine.. Geriatrics Review. 49 (5):293-8$86$YR$$M$Y$$$20240716$$MD$FR$FR
240350673$24035067$3$F$20240501$20240920$20240701$20240930$EXP$$US-BEH-2024174417$CSL BEHRING$$22$YR$A$F$Y$59$KG$20240930$$CN$US$US
240350682$24035068$2$F$$20240805$20240701$20240806$PER$$US-ALXN-202406USA001596US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240350691$24035069$1$I$$20240624$20240701$20240701$PER$$US-ALXN-202406USA001637US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
240350701$24035070$1$I$$20240624$20240701$20240701$PER$$US-ALXN-A202213918$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240701$$CN$US$US
240350711$24035071$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024127550$AMGEN$Geskin L.J.; Gordon E.R.; Chen C. et al.. Retrospective analysis of multiple myeloma drug use in cutaneous toxicity of monoclonal gammopathy of undetermined significance. Journal of the American Academy of Dermatology. 2024;91 (1):129-130$$$$$Y$$$20240701$$MD$US$US
240350722$24035072$2$F$20240624$20240805$20240701$20240807$PER$$US-AMGEN-USASP2024126162$AMGEN$$55$YR$A$M$Y$$$20240807$$CN$US$US
240350731$24035073$1$I$20240510$20240523$20240701$20240701$PER$$US-ROCHE-3569681$ROCHE$$$$C$M$Y$7.79$KG$20240701$$CN$US$US
240350742$24035074$2$F$20240101$20240523$20240701$20240701$PER$$US-ROCHE-3570667$ROCHE$$36$YR$A$F$Y$$$20240701$$CN$US$US
240350751$24035075$1$I$$20240626$20240701$20240701$EXP$$IE-MYLANLABS-2024M1060987$MYLAN$$$$$F$Y$$$20240701$$PH$IE$IE
240350761$24035076$1$I$$20240626$20240701$20240701$EXP$$GB-MYLANLABS-2024M1060928$MYLAN$$$$$M$Y$$$20240701$$PH$GB$GB
240350772$24035077$2$F$$20240708$20240701$20240711$EXP$$GB-MYLANLABS-2024M1060973$MYLAN$$$$$M$Y$$$20240711$$HP$GB$GB
240350781$24035078$1$I$$20240626$20240701$20240701$EXP$$AR-MYLANLABS-2024M1061222$MYLAN$$$$$F$Y$$$20240701$$MD$AR$AR
240350791$24035079$1$I$20240601$20240626$20240701$20240701$EXP$$AU-MYLANLABS-2024M1060816$MYLAN$$46$YR$$M$Y$$$20240701$$HP$AU$AU
240350812$24035081$2$F$$20240712$20240701$20240721$EXP$$GB-MYLANLABS-2024M1061011$MYLAN$$$$$M$Y$$$20240719$$PH$GB$GB
240350824$24035082$4$F$20231031$20240822$20240701$20240826$EXP$$AU-MYLANLABS-2024M1060991$MYLAN$$16$YR$$F$Y$$$20240826$$HP$AU$AU
240350831$24035083$1$I$20240615$20240626$20240701$20240701$EXP$$AU-MYLANLABS-2024M1060881$MYLAN$$53$YR$$M$Y$$$20240701$$HP$AU$AU
240350841$24035084$1$I$$20240617$20240701$20240701$EXP$$US-EPICPHARMA-US-2024EPCLIT00766$EPIC PHARM$Alsalama F.Ventricular arrhythmias, antiarrhythmic therapy and thyroidal illness in advanced heart failure: a case report and review of the literature.Drugs and Therapy Perspectives.JAN-2023;39:147-155$21$YR$A$M$Y$$$20240701$$HP$US$US
240350851$24035085$1$I$$20240527$20240701$20240701$PER$$PY-ROCHE-3468712$ROCHE$$$$$$Y$$$20240701$$MD$PY$PY
240350861$24035086$1$I$20220201$20240523$20240701$20240701$PER$$DE-ROCHE-3176403$ROCHE$$47$YR$A$F$Y$30$KG$20240701$$MD$DE$DE
240350872$24035087$2$F$20190525$20240702$20240701$20240706$EXP$$TW-009507513-2406TWN009299$MERCK$$51$YR$$M$Y$$$20240706$$MD$TW$TW
240350881$24035088$1$I$20240501$20240625$20240701$20240701$PER$$JP-Eisai-EC-2024-168942$EISAI$$$$$M$Y$$$20240701$$MD$JP$JP
240350892$24035089$2$F$$20240626$20240701$20240711$EXP$$US-INCYTE CORPORATION-2024IN006853$INCYTE$$$$$$Y$$$20240711$$PH$US$US
240350901$24035090$1$I$20240416$20240514$20240701$20240701$PER$$JP-ROCHE-3571490$ROCHE$$2$DEC$A$F$Y$$$20240701$$MD$JP$JP
240350911$24035091$1$I$$20240529$20240701$20240701$PER$$AU-ROCHE-3574475$ROCHE$$$$$$Y$$$20240701$$MD$AU$AU
240350923$24035092$3$F$20240517$20240517$20240701$20240710$PER$$US-ROCHE-3567297$ROCHE$$1$YR$I$F$Y$8.6$KG$20240701$$CN$US$US
240350942$24035094$2$F$$20240311$20240701$20240710$PER$$DE-ROCHE-3525824$ROCHE$$43$YR$A$F$Y$43$KG$20240701$$CN$DE$DE
240350951$24035095$1$I$$20240621$20240701$20240701$30DAY$$US-GSK-US2024078070$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240350961$24035096$1$I$$20240621$20240701$20240701$EXP$$US-GSK-US2024078654$GLAXOSMITHKLINE$$$$$F$Y$$$20240701$$CN$US$US
240350971$24035097$1$I$$20240626$20240701$20240701$EXP$$US-GSK-US2024079877$GLAXOSMITHKLINE$$$$$M$Y$$$20240701$$HP$US$US
240350981$24035098$1$I$$20240626$20240701$20240701$EXP$$GB-MYLANLABS-2024M1030439$MYLAN$$$$$M$Y$$$20240701$$MD$GB$GB
240350991$24035099$1$I$$20240625$20240701$20240701$EXP$$CA-TAKEDA-2022TUS069819$TAKEDA$$$$$F$Y$$$20240701$$MD$CA$CA
240351002$24035100$2$F$20240601$20240729$20240701$20240806$EXP$$US-BAYER-2024A086190$BAYER$$67$YR$E$M$Y$$$20240806$$CN$US$US
240351011$24035101$1$I$$20240625$20240701$20240701$EXP$$BR-JNJFOC-20240671327$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$BR$BR
240351021$24035102$1$I$$20240626$20240701$20240701$PER$$US-JNJFOC-20240671246$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$MD$US$US
240351032$24035103$2$F$20240406$20240729$20240701$20240729$PER$$US-JNJFOC-20240673937$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$HP$US$US
240351041$24035104$1$I$20240101$20240628$20240701$20240701$PER$$US-JNJFOC-20240677880$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240701$$CN$US$US
240351051$24035105$1$I$20240517$20240604$20240701$20240701$PER$DE-AMK-276007$DE-ROCHE-3576196$ROCHE$$30$YR$A$F$Y$$$20240701$$PH$DE$DE
240351061$24035106$1$I$20230215$20240604$20240701$20240701$PER$$DE-ROCHE-3370326$ROCHE$$6$YR$C$F$Y$15$KG$20240701$$MD$DE$DE
240351073$24035107$3$F$20240322$20240704$20240701$20240709$EXP$$DE-PFIZER INC-202400199448$PFIZER$$72$YR$$F$Y$$$20240709$$HP$DE$DE
240351091$24035109$1$I$$20240528$20240701$20240701$PER$$FR-ROCHE-3572856$ROCHE$$41$YR$A$M$Y$$$20240701$$PH$FR$FR
240351131$24035113$1$I$$20240627$20240701$20240701$EXP$$US-UCBSA-2024032984$UCB$$$$$M$Y$$$20240701$$HP$US$US
240351141$24035114$1$I$$20240419$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05983$HIKMA$Afroze T, Dharmarpandi G, Mohammed B, Patel D, Roy A, Khan I, et al.. Afroze T, Dharmarpandi G, Mohammed B, Patel D, Roy A, Khan I, et al. Severe hyponatremia in an elderly patient due to syndrome of inappropriate antidiuretic hormone secretion: can chronic opioid pump be the culprit?. American Journal of the Medical Sciences.. 2024;367(S1):42-43$84$YR$$F$Y$$$20240701$$MD$US$US
240351151$24035115$1$I$20231021$20240626$20240701$20240701$EXP$$RU-ABBVIE-5820591$ABBVIE$$86$YR$$F$Y$75$KG$20240701$$MD$RU$RU
240351162$24035116$2$F$20230305$20240624$20240701$20240702$EXP$$BR-AstraZeneca-2024A147897$ASTRAZENECA$$64$YR$$M$Y$$$20240702$$MD$BR$
240351171$24035117$1$I$$20240628$20240701$20240701$EXP$$CN-AstraZeneca-2024A149854$ASTRAZENECA$$$$$M$Y$$$20240701$$CN$CN$
240351182$24035118$2$F$$20240607$20240701$20240701$PER$$DE-ROCHE-3579908$ROCHE$$15$YR$T$F$Y$$$20240701$$CN$DE$DE
240351191$24035119$1$I$20240625$20240628$20240701$20240701$EXP$$CN-AstraZeneca-2024A149845$ASTRAZENECA$$19178$DY$$M$Y$$$20240701$$MD$CN$
240351201$24035120$1$I$$20240606$20240701$20240701$PER$$CA-ROCHE-3578534$ROCHE$$$$C$M$Y$$$20240701$$CN$CA$CA
240351212$24035121$2$F$$20240605$20240701$20240701$PER$$KR-ROCHE-3578793$ROCHE$$40$YR$A$M$Y$$$20240701$$CN$KR$KR
240351222$24035122$2$F$20230105$20240702$20240701$20240704$EXP$$TW-009507513-2406TWN009282$MERCK$$60$YR$$F$Y$$$20240704$$MD$TW$TW
240351231$24035123$1$I$$20240410$20240701$20240701$PER$$US-AMGEN-USASP2024128396$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240351241$24035124$1$I$$20230814$20240701$20240701$PER$$US-AMGEN-USASP2023235118$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240351251$24035125$1$I$$20240205$20240701$20240701$PER$$US-AMGEN-USASP2024129836$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240351261$24035126$1$I$$20240617$20240701$20240701$EXP$$US-PURACAP-US-2024EPCLIT00764$PURACAP$April Slamowitz.Prolonged ECMO requirement for an adolescent with amlodipine overdose..Critical Care Medicine.JAN-2024;52(1):S719$17$YR$T$F$Y$$$20240701$$HP$US$US
240351271$24035127$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024127569$AMGEN$Geskin L.J.; Gordon E.R.; Chen C. et al.. Retrospective analysis of multiple myeloma drug use in cutaneous toxicity of monoclonal gammopathy of undetermined significance. Journal of the American Academy of Dermatology. 2024;91 (1):129-130$$$$$Y$$$20240701$$MD$US$US
240351283$24035128$3$F$20240723$20240723$20240701$20240730$EXP$$CA-TAKEDA-2024TUS064621$TAKEDA$$30$YR$$F$Y$$$20240730$$CN$CA$CA
240351291$24035129$1$I$$20240626$20240701$20240701$EXP$$GB-MYLANLABS-2024M1051825$MYLAN$$$$$M$Y$$$20240701$$HP$GB$GB
240351304$24035130$4$F$20240601$20240726$20240701$20240905$EXP$$CO-BAYER-2024A093253$BAYER$$77$YR$E$F$Y$$$20240905$$CN$CO$CO
240351311$24035131$1$I$20240201$20240626$20240701$20240701$EXP$GB-MHRA-MED-202406251436015840-SWCZQ$GB-MYLANLABS-2024M1058276$MYLAN$$67$YR$$M$Y$98$KG$20240701$$CN$GB$GB
240351321$24035132$1$I$20240609$20240609$20240701$20240701$PER$$US-CSL-2024-005606$CSL Plasma$$58$YR$$M$Y$$$20240701$$HP$US$US
240351332$24035133$2$F$$20240627$20240701$20240704$PER$$US-JNJFOC-20240676370$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240351342$24035134$2$F$20240617$20240625$20240701$20240702$EXP$$CN-JNJFOC-20240676106$JOHNSON AND JOHNSON$$1$DY$N$M$Y$1.1$KG$20240702$$HP$CN$CN
240351352$24035135$2$F$$20240705$20240701$20240711$EXP$$JP-JNJFOC-20240700691$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240711$$MD$JP$JP
240351361$24035136$1$I$$20240626$20240701$20240701$PER$$US-JNJFOC-20240671119$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$US$US
240351372$24035137$2$F$$20240705$20240701$20240711$EXP$$US-JNJFOC-20240659393$JOHNSON AND JOHNSON$$$$$M$Y$56.4$KG$20240711$$HP$US$US
240351381$24035138$1$I$$20240618$20240701$20240701$PER$$AU-LUPIN PHARMACEUTICALS INC.-2024-05505$LUPIN$$$$$$Y$$$20240701$$HP$AU$US
240351391$24035139$1$I$$20240416$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05955$HIKMA$$72$YR$$F$Y$$$20240701$$MD$US$US
240351401$24035140$1$I$$20240625$20240701$20240701$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-102716$BRISTOL MYERS SQUIBB$Hunter-Dickson M, Athavale A, Ly T, Ritchie AG. Apixaban induced acute interstitial nephritis: a case report and literature review. Annals of Case Reports and Clinical Studies. 2023 Mar 03;2(2):1-7.$83$YR$E$F$Y$$$20240701$$HP$AU$AU
240351411$24035141$1$I$$20240626$20240701$20240701$EXP$$JP-009507513-2406JPN003981J$MERCK$$66$YR$$F$Y$$$20240701$$MD$JP$JP
240351451$24035145$1$I$20230916$20240627$20240701$20240701$PER$$CN-Eisai-EC-2024-169126$EISAI$$42$YR$A$F$Y$61$KG$20240701$$HP$CN$CN
240351461$24035146$1$I$$20240625$20240701$20240701$EXP$$US-PFIZER INC-PV202400084664$PFIZER$$21$YR$$M$Y$$$20240701$$MD$US$US
240351471$24035147$1$I$20231229$20240625$20240701$20240701$EXP$FR-AFSSAPS-GR2024000755$FR-PFIZER INC-202400200439$PFIZER$$69$YR$$F$Y$78$KG$20240701$$PH$FR$FR
240351481$24035148$1$I$$20240625$20240701$20240701$EXP$$GB-PFIZER INC-202400200558$PFIZER$$78$YR$$F$Y$$$20240701$$PH$GB$GB
240351491$24035149$1$I$$20240625$20240701$20240701$EXP$$US-PFIZER INC-PV202400084365$PFIZER$$14$YR$$M$Y$$$20240701$$MD$US$US
240351501$24035150$1$I$$20240624$20240701$20240701$EXP$$BR-PFIZER INC-202400202486$PFIZER$$68$YR$$F$Y$88$KG$20240701$$CN$BR$BR
240351512$24035151$2$F$$20240626$20240701$20240704$PER$$US-AMGEN-USASP2024128992$AMGEN$$$$A$$Y$$$20240704$$MD$US$US
240351521$24035152$1$I$$20240617$20240701$20240701$PER$$US-ROCHE-10000007856$ROCHE$Strizki JM, Diamond TL, Teal VL, Gilbert CL, Wang W, Stauffer N, Haber B. Cytomegalovirus antiviral resistance among participants in the phase 3 trial of letermovir vs valganciclovir prophylaxis in kidney transplant recipients. J Infect Dis. 2024 Jun 10:jiae287. doi: 10.1093/infdis/jiae287. Epub ahead of print. PMID: 38853607.$72$YR$E$F$Y$$$20240701$$HP$US$US
240351541$24035154$1$I$$20240624$20240701$20240701$EXP$$CA-PFIZER INC-202400071852$PFIZER$$34$YR$$F$Y$$$20240701$$CN$CA$CA
240351552$24035155$2$F$$20240628$20240701$20240716$PER$$US-HALEON-2184569$Haleon PLC$$$$$M$Y$$$20240716$$CN$US$US
240351562$24035156$2$F$20240101$20240722$20240701$20240903$PER$$US-Merz Pharmaceuticals GmbH-24-02288$MERZ$$47$YR$$F$Y$52.2$KG$20240904$$HP$US$US
240351581$24035158$1$I$$20240626$20240701$20240701$PER$$US-Merz Pharmaceuticals GmbH-24-02269$MERZ$$30$YR$A$F$Y$$$20240701$$HP$US$US
240351591$24035159$1$I$$20240611$20240701$20240701$30DAY$$US-JNJFOC-20240655945$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$PH$US$US
240351601$24035160$1$I$20240510$20240624$20240701$20240701$EXP$FR-AFSSAPS-TO2024000922$FR-EMD Serono-2024034308$EMD SERONO INC$$67$YR$E$F$Y$$$20240701$$MD$FR$FR
240351611$24035161$1$I$20240619$20240625$20240701$20240701$PER$$US-ABBVIE-5819491$ABBVIE$$61$YR$$F$Y$$$20240701$$CN$US$US
240351621$24035162$1$I$20240601$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104630$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240701$$HP$US$US
240351644$24035164$4$F$$20240815$20240701$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05511$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240351652$24035165$2$F$20240401$20240701$20240701$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05546$LUPIN$$$$$$Y$$$20240718$$CN$US$US
240351671$24035167$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA191294$SANOFI AVENTIS$$$$A$F$Y$124$KG$20240701$$MD$US$US
240351711$24035171$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190535$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240701$$MD$US$US
240351721$24035172$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA188603$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240701$$MD$US$US
240351731$24035173$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA190382$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240701$$MD$US$US
240351751$24035175$1$I$$20240625$20240701$20240701$EXP$$US-GILEAD-2024-0678573$GILEAD$$$$A$F$Y$$$20240701$$HP$US$US
240351761$24035176$1$I$$20240626$20240701$20240701$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003602$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240701$$CN$US$US
240351771$24035177$1$I$$20240625$20240701$20240701$EXP$$MY-MYLANLABS-2024M1058283$MYLAN$$34$YR$$F$Y$$$20240701$$PH$MY$MY
240351781$24035178$1$I$20240417$20240625$20240701$20240701$EXP$$UA-MYLANLABS-2024M1058595$MYLAN$$45$YR$$M$Y$$$20240701$$HP$UA$UA
240351791$24035179$1$I$$20240625$20240701$20240701$EXP$$MY-MYLANLABS-2024M1058291$MYLAN$$28$YR$$F$Y$$$20240701$$PH$MY$MY
240351802$24035180$2$F$20240625$20240814$20240701$20240819$EXP$$NL-MYLANLABS-2024M1057961$MYLAN$$72$YR$$F$Y$$$20240819$$HP$NL$NL
240351812$24035181$2$F$$20240910$20240701$20240912$EXP$$US-MYLANLABS-2024M1060737$MYLAN$$$$$F$Y$113$KG$20240912$$HP$US$US
240351821$24035182$1$I$20231201$20240625$20240701$20240701$EXP$$PT-MYLANLABS-2024M1057796$MYLAN$Pereira da Costa R, Sapinho G, Bandeira M, Infante J, Marques T, Santos CM, et al. VEXAS syndrome: an atypical indolent presentation as sacroiliitis with molecular response to azacitidine.. Frontiers in Immunology. 2024;15:1-6$74$YR$$M$Y$$$20240701$$HP$PT$PT
240351831$24035183$1$I$20240624$20240625$20240701$20240701$EXP$$US-MYLANLABS-2024M1060803$MYLAN$$68$YR$$$Y$$$20240701$$PH$US$US
240351841$24035184$1$I$20240621$20240625$20240701$20240701$EXP$$US-MYLANLABS-2024M1058418$MYLAN$$44$YR$$M$Y$$$20240701$$HP$US$US
240351851$24035185$1$I$20240617$20240625$20240701$20240701$EXP$$US-MYLANLABS-2024M1058414$MYLAN$$33$YR$$M$Y$$$20240701$$HP$US$US
240351861$24035186$1$I$$20240625$20240701$20240701$EXP$$TR-MYLANLABS-2024M1060116$MYLAN$Kara G. Facial edema due to low dose of vortioxetine: A case report. Psychiatr-Clin-Psychopharmacolog 2019; 29 132-133.$34$YR$$F$Y$$$20240701$$HP$TR$TR
240351872$24035187$2$F$$20240805$20240701$20240807$EXP$$GB-MYLANLABS-2024M1060889$MYLAN$$$$$M$Y$$$20240807$$PH$GB$GB
240351881$24035188$1$I$$20240625$20240701$20240701$EXP$$MY-MYLANLABS-2024M1058160$MYLAN$$67$YR$$F$Y$$$20240701$$HP$MY$MY
240351891$24035189$1$I$20240619$20240625$20240701$20240701$EXP$$CN-MYLANLABS-2024M1058556$MYLAN$$60$YR$$M$Y$85$KG$20240701$$HP$CN$CN
240351901$24035190$1$I$$20240625$20240701$20240701$EXP$$FR-MYLANLABS-2024M1058210$MYLAN$A. Mezzetta, F. Delmarre, M. Gominet, M. Cabon, W. Car?, M. Antoine, D. Andriamanantena, P.L. Conan.. Uveitis, arthritis, eosinophilia, cutaneous rash: exceptional observation of a DRESS mimicking sarcoidosis.. La Revue de m?decine interne. 2024;45:A230$47$YR$$M$Y$$$20240701$$MD$FR$FR
240351911$24035191$1$I$$20240624$20240701$20240701$PER$$US-MYLANLABS-2024M1058307$MYLAN$$$$$F$Y$$$20240701$$CN$US$US
240351922$24035192$2$F$$20240705$20240701$20240717$EXP$$PL-MYLANLABS-2024M1060711$MYLAN$Krawczyk M, Chajec J, Paluch Z, Michalczyk J, Mi?osz A, Szczukocka M. Pneumothorax as a complication of respiratory failure - two case reports and literature review. JOURNAL OF PRE-CLINICAL AND CLINICAL RESEARCH. 2024;18(2):139?146$28$YR$$M$Y$$$20240717$$MD$PL$PL
240351931$24035193$1$I$$20240624$20240701$20240701$PER$$US-ALXN-202406USA001546US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
240351941$24035194$1$I$$20240621$20240701$20240701$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000072$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240701$$CN$US$US
240351962$24035196$2$F$$20240805$20240701$20240806$PER$$US-ALXN-202406USA001548US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240351971$24035197$1$I$20240405$20240625$20240701$20240701$EXP$$CN-MYLANLABS-2024M1058542$MYLAN$$19$YR$$M$Y$102.5$KG$20240701$$HP$CN$CN
240351981$24035198$1$I$$20240412$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05927$HIKMA$Quinn J, Krakowski JC.. Quinn J, Krakowski JC. Dexmedetomidine for Preventing Sleep Disturbance after Ambulatory Anesthesia: A Case Report.. AandA practice.. 2024;18(4)::e01776$24$YR$$M$Y$64$KG$20240701$$MD$US$US
240351991$24035199$1$I$$20230314$20240701$20240701$PER$$US-AMGEN-USASP2023235121$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240352001$24035200$1$I$$20230314$20240701$20240701$PER$$US-AMGEN-USASP2023235152$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240352011$24035201$1$I$$20240625$20240701$20240701$EXP$$US-Waylis Therapeutics LLC-ATNAHS20240601849$Waylis$Pattupara A, Nguyen D, Gaikwad M, Gnirke M, Yarra S, Su M, et al. Breaking the Spell: A Rare Case of Prolonged Benzodiazepine Elimination. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5703. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5703.$67$YR$E$M$Y$$$20240701$$MD$US$US
240352021$24035202$1$I$20240101$20240621$20240701$20240701$EXP$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000073$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240701$$CN$US$US
240352033$24035203$3$F$20240724$20240827$20240701$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104748$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$62.6$KG$20240828$$CN$US$US
240352041$24035204$1$I$$20240628$20240701$20240701$EXP$$NL-TAKEDA-2024TUS065270$TAKEDA$$10$YR$$F$Y$$$20240701$$HP$NL$NL
240352051$24035205$1$I$20230801$20231130$20240701$20240701$EXP$IT-MINISAL02-955088$IT-TEVA-VS-3146536$TEVA$$37$YR$$F$Y$$$20240701$$MD$IT$IT
240352061$24035206$1$I$$20240624$20240701$20240701$PER$$US-BIOGEN-2020BI00909983$BIOGEN$$$$$F$Y$$$20240701$$CN$US$US
240352071$24035207$1$I$$20240626$20240701$20240701$PER$$US-BIOGEN-2022BI01116720$BIOGEN$$$$$F$Y$$$20240701$$CN$US$US
240352082$24035208$2$F$20090101$20240805$20240701$20240811$EXP$GB-SANDOZ-SDZ2023GB003000$GB-RDY-SPO/UKI/23/0171891$DR REDDYS$$37$YR$A$M$Y$$$20240811$$HP$GB$GB
240352101$24035210$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126881$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240352111$24035211$1$I$20240601$20240620$20240701$20240701$EXP$$RO-AMGEN-ROUSP2024126462$AMGEN$$65$YR$E$M$Y$$$20240701$$MD$RO$RO
240352121$24035212$1$I$20240401$20240616$20240701$20240701$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454003$RANBAXY$$$$$F$Y$55$KG$20240701$$CN$GB$GB
240352131$24035213$1$I$20240612$20240616$20240701$20240701$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454035$RANBAXY$$29$YR$$F$Y$80$KG$20240701$$PH$GB$GB
240352141$24035214$1$I$20240614$20240616$20240701$20240701$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454223$RANBAXY$$24$YR$$M$Y$100$KG$20240701$$CN$GB$GB
240352151$24035215$1$I$20240601$20240616$20240701$20240701$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453998$RANBAXY$$$$$F$Y$$$20240701$$CN$GB$GB
240352221$24035222$1$I$20230201$20240626$20240701$20240701$EXP$$PR-ABBVIE-5819217$ABBVIE$$61$YR$$F$Y$70$KG$20240701$$CN$PR$PR
240352241$24035224$1$I$20221116$20240621$20240701$20240701$EXP$$MY-PFIZER INC-PV202400082354$PFIZER$$81$YR$$F$Y$47.9$KG$20240701$$MD$MY$MY
240352271$24035227$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186235$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240701$$HP$US$US
240352291$24035229$1$I$$20240626$20240701$20240701$EXP$$US-MYLANLABS-2024M1060766$MYLAN$$$$$M$Y$$$20240701$$PH$US$US
240352301$24035230$1$I$$20240626$20240701$20240701$EXP$$US-MYLANLABS-2024M1060758$MYLAN$$$$$M$Y$$$20240701$$MD$US$US
240352312$24035231$2$F$$20240729$20240701$20240731$EXP$$US-MYLANLABS-2024M1060765$MYLAN$$$$$M$Y$90$KG$20240731$$HP$US$US
240352321$24035232$1$I$20240502$20240626$20240701$20240701$EXP$$US-MYLANLABS-2024M1060828$MYLAN$$33$YR$$$Y$$$20240701$$HP$US$US
240352331$24035233$1$I$$20240624$20240701$20240701$PER$$US-ALXN-202406USA001511US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240701$$CN$US$US
240352341$24035234$1$I$20240624$20240625$20240701$20240701$PER$$US-BAYER-2024A092646$BAYER$$$$$F$Y$$$20240701$$CN$US$US
240352351$24035235$1$I$20230904$20240619$20240701$20240701$EXP$$JP-UCBSA-2024032025$UCB$$0$YR$$M$Y$1.5$KG$20240701$$PH$JP$JP
240352361$24035236$1$I$$20240624$20240701$20240701$EXP$$US-TEVA-VS-3214132$TEVA$Eshghabadi MA, Javaheri S, Aboelnasr A. LONG-TERM BUPRENORPHINE USE AND PREVALENCE OF SLEEP APNEA: A CASE SERIES. Sleep 2024; 47 (Suppl. 1) A499-A500 abstr. 1166.$66$YR$$M$Y$$$20240701$$HP$US$US
240352371$24035237$1$I$$20240617$20240701$20240701$EXP$$US-EPICPHARMA-US-2024EPCLIT00763$EPIC PHARM$Anab Rehan Taseer.Midodrine-Induced Urinary Retention as A Cause of Acute Kidney Injury in Cirrhosis: Not Always Hepatorenal but The Failed Therapy for It.American Journal of Kidney Diseases.APR-2024;83:S4-S5$66$YR$E$M$Y$$$20240701$$HP$US$US
240352381$24035238$1$I$$20221220$20240701$20240701$PER$$US-AMGEN-USASP2022230354$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240352391$24035239$1$I$$20230223$20240701$20240701$PER$$US-AMGEN-USASP2023235103$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240352401$24035240$1$I$$20240205$20240701$20240701$PER$$US-AMGEN-USASP2024129832$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240352411$24035241$1$I$$20230821$20240701$20240701$PER$$US-AMGEN-USASP2023235117$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240352421$24035242$1$I$$20240620$20240701$20240701$EXP$$CO-AMGEN-COLSP2024127543$AMGEN$$65$YR$E$F$Y$$$20240701$$HP$CO$CO
240352435$24035243$5$F$$20240917$20240701$20240923$30DAY$$GR-PFIZER INC-202400200669$PFIZER$$15$YR$$M$Y$44$KG$20240923$$CN$GR$GR
240352447$24035244$7$F$20240619$20240823$20240701$20240828$30DAY$$GR-PFIZER INC-PV202400081375$PFIZER$$5$YR$$M$Y$14.3$KG$20240828$$CN$GR$GR
240352452$24035245$2$F$$20240703$20240701$20240712$EXP$$US-TEVA-VS-3214131$TEVA$Eshghabadi MA, Javaheri S, Aboelnasr A. LONG-TERM BUPRENORPHINE USE AND PREVALENCE OF SLEEP APNEA: A CASE SERIES. Sleep 2024; 47 (Suppl. 1) A499-A500 abstr. 1166.; Eshghabadi MA, Javaheri S, Aboelnasr A. LONG-TERM BUPRENORPHINE USE AND PREVALENCE OF SLEEP APNEA: A CASE SERIES. Sleep 2024; 47 (Suppl. 1) A499-A500 abstr. 1166.$46$YR$$M$Y$$$20240712$$HP$US$US
240352461$24035246$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184588$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240352473$24035247$3$F$$20240729$20240701$20240807$30DAY$$AR-JNJFOC-20240654356$JOHNSON AND JOHNSON$$77$YR$E$F$Y$90$KG$20240808$$CN$AR$AR
240352481$24035248$1$I$$20240612$20240701$20240701$EXP$$IN-ROCHE-10000004233$ROCHE$$$$E$M$Y$$$20240701$$CN$IN$IN
240352492$24035249$2$F$$20240730$20240701$20240812$EXP$$US-UCBSA-2024033127$UCB$$$$$F$Y$$$20240812$$HP$US$US
240352501$24035250$1$I$20200921$20240625$20240701$20240701$EXP$$CA-TAKEDA-2020TUS044721$TAKEDA$$79$YR$$F$Y$$$20240701$$MD$CA$CA
240352511$24035251$1$I$$20240617$20240701$20240701$30DAY$$GB-PFIZER INC-202400202408$PFIZER$$$$$$Y$$$20240701$$CN$GB$GB
240352522$24035252$2$F$$20240627$20240701$20240705$EXP$NZ-MLMSERVICE-20240614-PI093910-00123-1$NZ-SA-2024SA186331$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240705$$MD$NZ$NZ
240352551$24035255$1$I$20240518$20240625$20240701$20240701$EXP$FR-AFSSAPS-PO2024000626$FR-SA-2024SA188574$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240701$$MD$FR$FR
240352562$24035256$2$F$20240607$20240722$20240701$20240802$EXP$$US-BAYER-2024A092634$BAYER$$71$YR$E$M$Y$80.726$KG$20240802$$CN$US$US
240352573$24035257$3$F$$20240911$20240701$20240913$30DAY$$US-PFIZER INC-202400199072$PFIZER$$14$YR$$F$Y$$$20240913$$CN$US$US
240352581$24035258$1$I$$20240628$20240701$20240701$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037005$BOEHRINGER INGELHEIM$$$$$$Y$$$20240701$$CN$US$US
240352591$24035259$1$I$$20240626$20240701$20240701$EXP$$US-MYLANLABS-2024M1060875$MYLAN$$$$$M$Y$$$20240701$$MD$US$US
240352601$24035260$1$I$20240626$20240626$20240701$20240701$EXP$$US-MYLANLABS-2024M1060872$MYLAN$$72$YR$$M$Y$$$20240701$$CN$US$US
240352611$24035261$1$I$20240101$20240625$20240701$20240701$PER$$US-SA-2024SA191962$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240701$$MD$US$US
240352621$24035262$1$I$$20240626$20240701$20240701$EXP$$US-MYLANLABS-2024M1060855$MYLAN$$$$$M$Y$$$20240701$$CN$US$US
240352631$24035263$1$I$$20240626$20240701$20240701$EXP$$US-MYLANLABS-2024M1061028$MYLAN$$$$$F$Y$$$20240701$$HP$US$US
240352641$24035264$1$I$$20240626$20240701$20240701$PER$$US-ABBVIE-5819674$ABBVIE$$$$$$Y$$$20240701$$HP$US$US
240352651$24035265$1$I$$20240627$20240701$20240701$PER$$US-TAKEDA-2024TUS065067$TAKEDA$$$$$M$Y$$$20240701$$PH$US$US
240352661$24035266$1$I$$20240617$20240701$20240701$EXP$$IN-EPICPHARMA-IN-2024EPCLIT00767$EPIC PHARM$V Verma.Nicolau syndrome postintramuscular diclofenac injection: preventable iatrogenic error or an unfortunate sequalae?.International Journal of Dermatology.MAR-2024;63:396-398$18$YR$T$F$Y$$$20240701$$HP$IN$IN
240352672$24035267$2$F$$20240621$20240701$20240926$EXP$$ES-ROCHE-10000008078$ROCHE$Marta V, Labrador Andujar N, Rubio Salvador A, Ana Rosa C, Diaz Paniagua L. Pharmacological approach for the management of adrenocortical carcinoma: A case report. European Journal of Clinical Pharmacy. 2016;18 (3):199-201.$16$YR$T$F$Y$$$20240926$$HP$ES$ES
240352681$24035268$1$I$$20240625$20240701$20240701$PER$$US-ABBVIE-5818467$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240352691$24035269$1$I$20240616$20240623$20240701$20240701$EXP$$CN-GE HEALTHCARE-2024CSU007095$GE HEALTHCARE$$70$YR$$M$Y$71$KG$20240701$$HP$CN$CN
240352701$24035270$1$I$$20240627$20240701$20240701$EXP$$DE-JNJFOC-20240676725$JOHNSON AND JOHNSON$$$$$M$Y$3.94$KG$20240701$$MD$DE$DE
240352711$24035271$1$I$$20240626$20240701$20240701$EXP$GB-MHRA-MIDB-f8ca1eaa-219a-4293-926a-248086ad3141$GB-MYLANLABS-2024M1058638$MYLAN$$56$YR$$$Y$$$20240701$$PH$GB$GB
240352721$24035272$1$I$20240628$20240628$20240701$20240701$PER$$US-JNJFOC-20240677017$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240701$$CN$US$US
240352731$24035273$1$I$20230701$20240620$20240701$20240701$EXP$$BR-AstraZeneca-2023A172649$ASTRAZENECA$$644$MON$$F$Y$48$KG$20240701$$CN$BR$
240352741$24035274$1$I$$20240620$20240701$20240701$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406015197$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$JP$JP
240352751$24035275$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000038$ELI LILLY AND CO$$87$YR$E$F$Y$$$20240701$$CN$US$US
240352761$24035276$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019446$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240701$$CN$US$US
240352771$24035277$1$I$$20240619$20240701$20240701$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202406014864$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240701$$CN$FR$FR
240352781$24035278$1$I$20240604$20240621$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406015558$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240701$$CN$US$US
240352791$24035279$1$I$$20240619$20240701$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202406013732$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240352801$24035280$1$I$20240601$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000112$ELI LILLY AND CO$$$$$M$Y$$$20240701$$CN$US$US
240352811$24035281$1$I$$20240619$20240701$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202406013484$ELI LILLY AND CO$$$$A$F$Y$$$20240701$$CN$US$US
240352821$24035282$1$I$$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000125$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240701$$CN$US$US
240352831$24035283$1$I$$20240619$20240701$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017040$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240352841$24035284$1$I$$20240619$20240701$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014083$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240701$$CN$US$US
240352851$24035285$1$I$20240628$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000129$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240701$$CN$US$US
240352861$24035286$1$I$$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000071$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240701$$CN$US$US
240352871$24035287$1$I$$20240619$20240701$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014277$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240352881$24035288$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019399$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240701$$CN$US$US
240352891$24035289$1$I$20240627$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000036$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240352905$24035290$5$F$20240620$20240906$20240701$20240911$30DAY$$GR-PFIZER INC-202400198637$PFIZER$$13$YR$$F$Y$35$KG$20240911$$CN$GR$GR
240352913$24035291$3$F$20240622$20240819$20240701$20240828$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406016105$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240828$$CN$JP$JP
240352932$24035293$2$F$$20240828$20240701$20240830$30DAY$$GB-PFIZER INC-PV202400081468$PFIZER$$2$YR$$M$Y$$$20240830$$CN$GB$GB
240352951$24035295$1$I$20240623$20240628$20240701$20240701$EXP$$CN-BAYER-2024A094646$BAYER$$82$YR$E$M$Y$65$KG$20240701$$HP$CN$CN
240352963$24035296$3$F$$20240621$20240701$20240705$EXP$$RU-ROCHE-10000009810$ROCHE$$62$YR$A$F$Y$$$20240705$$MD$RU$RU
240352972$24035297$2$F$$20240701$20240701$20240713$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091996$GLENMARK$Jumaili WA, Gburi NA, Chaudhary N, Brown K, Jain S.. Two Cases of Montelukast-Associated Psychosis in Children.. The primary care companion for CNS disorders.. 2024;26:3:23cr03694$$$$$Y$$$20240713$$MD$US$US
240353002$24035300$2$F$20240601$20240705$20240701$20240712$EXP$$US-009507513-2406USA007587$MERCK$$77$YR$$F$Y$$$20240712$$CN$US$US
240353011$24035301$1$I$$20240621$20240701$20240701$PER$$US-ALXN-202406USA001793US$ALEXION PHARMACEUTICALS$$$$$M$Y$59$KG$20240701$$CN$US$US
240353021$24035302$1$I$$20240617$20240701$20240701$PER$$US-COSETTE-CP2024US000137$COSETTE PHARMACEUTICALS$$59$YR$A$F$Y$180$KG$20240701$$CN$US$US
240353031$24035303$1$I$20240617$20240628$20240701$20240701$EXP$$CN-BAYER-2024A094597$BAYER$$29$YR$A$F$Y$$$20240701$$HP$CN$CN
240353041$24035304$1$I$20240222$20240627$20240701$20240701$EXP$$IN-GSK-IN2024APC023635$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$IN$IN
240353052$24035305$2$F$$20240621$20240701$20240703$EXP$$ES-UCBSA-2024032570$UCB$$44$YR$$F$Y$$$20240703$$MD$ES$ES
240353061$24035306$1$I$$20240620$20240701$20240701$EXP$$IN-ROCHE-10000011984$ROCHE$$50$YR$A$F$Y$$$20240701$$CN$IN$IN
240353071$24035307$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190959$SANOFI AVENTIS$$$$C$M$Y$$$20240701$$MD$US$US
240353081$24035308$1$I$20240401$20240624$20240701$20240701$PER$$US-SA-2024SA189085$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240701$$MD$US$US
240353091$24035309$1$I$20240601$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127431$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240353111$24035311$1$I$$20240625$20240701$20240701$PER$$US-PFIZER INC-PV202400084217$PFIZER$$17$YR$$M$Y$$$20240701$$MD$US$US
240353131$24035313$1$I$20240528$20240625$20240701$20240701$PER$$US-PFIZER INC-202400201771$PFIZER$$33$YR$$F$Y$$$20240701$$HP$US$US
240353141$24035314$1$I$$20240625$20240701$20240701$PER$$US-PFIZER INC-PV202400083802$PFIZER$$68$YR$$F$Y$$$20240701$$CN$US$US
240353151$24035315$1$I$$20240626$20240701$20240701$PER$$US-PFIZER INC-PV202400084796$PFIZER$$30$YR$$F$Y$$$20240701$$HP$US$US
240353171$24035317$1$I$$20240625$20240701$20240701$PER$$US-PFIZER INC-PV202400084249$PFIZER$$21$YR$$M$Y$$$20240701$$MD$US$US
240353181$24035318$1$I$20240522$20240626$20240701$20240701$PER$$US-PFIZER INC-202400202108$PFIZER$$$$A$F$Y$$$20240701$$PH$US$US
240353191$24035319$1$I$$20240626$20240701$20240701$PER$$US-PFIZER INC-PV202400084539$PFIZER$$80$YR$$F$Y$$$20240701$$HP$US$US
240353201$24035320$1$I$$20240625$20240701$20240701$PER$$US-PFIZER INC-PV202400084666$PFIZER$$20$YR$$F$Y$$$20240701$$MD$US$US
240353211$24035321$1$I$$20240626$20240701$20240701$PER$$US-PFIZER INC-PV202400085054$PFIZER$$$$$$Y$$$20240701$$CN$US$US
240353221$24035322$1$I$20240625$20240625$20240701$20240701$PER$$US-PFIZER INC-PV202400084102$PFIZER$$58$YR$$M$Y$$$20240701$$HP$US$US
240353231$24035323$1$I$$20240625$20240701$20240701$PER$$US-PFIZER INC-202400201650$PFIZER$$79$YR$$F$Y$$$20240701$$PH$US$US
240353255$24035325$5$F$$20240820$20240701$20240822$PER$$US-PFIZER INC-202400201685$PFIZER$$79$YR$$F$Y$$$20240822$$CN$US$US
240353271$24035327$1$I$$20240624$20240701$20240701$PER$$DE-PFIZER INC-202400199652$PFIZER$$$$$F$Y$$$20240701$$PH$DE$DE
240353282$24035328$2$F$$20240716$20240701$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097942$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240827$$MD$US$US
240353292$24035329$2$F$20240601$20240925$20240701$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104649$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240927$$HP$US$US
240353301$24035330$1$I$$20240624$20240701$20240701$EXP$$US-BEH-2024174647$CSL BEHRING$$$$A$M$Y$$$20240701$$HP$US$US
240353311$24035331$1$I$20240608$20240625$20240701$20240701$EXP$$CN-OTSUKA-2024_018228$OTSUKA$$84$YR$$F$Y$47$KG$20240701$$MD$CN$CN
240353321$24035332$1$I$$20240624$20240701$20240701$EXP$$US-TEVA-VS-3214134$TEVA$Eshghabadi MA, Javaheri S, Aboelnasr A. LONG-TERM BUPRENORPHINE USE AND PREVALENCE OF SLEEP APNEA: A CASE SERIES. Sleep 2024; 47 (Suppl. 1) A499-A500 abstr. 1166.$68$YR$$M$Y$$$20240701$$HP$US$US
240353341$24035334$1$I$20240626$20240626$20240701$20240701$EXP$$US-MYLANLABS-2024M1060963$MYLAN$$31$YR$$M$Y$$$20240701$$MD$US$US
240353351$24035335$1$I$20240615$20240626$20240701$20240701$EXP$$US-MYLANLABS-2024M1060898$MYLAN$$34$YR$$M$Y$$$20240701$$HP$US$US
240353361$24035336$1$I$20240617$20240626$20240701$20240701$EXP$$US-MYLANLABS-2024M1061398$MYLAN$$64$YR$$M$Y$$$20240701$$HP$US$US
240353371$24035337$1$I$20240626$20240626$20240701$20240701$EXP$$US-MYLANLABS-2024M1060954$MYLAN$$38$YR$$M$Y$$$20240701$$HP$US$US
240353381$24035338$1$I$20240509$20240626$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003083$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240628$$CN$US$US
240353391$24035339$1$I$$20240626$20240701$20240701$PER$$US-ABBVIE-5819656$ABBVIE$$$$$$Y$$$20240701$$HP$US$US
240353401$24035340$1$I$20230101$20240624$20240701$20240701$EXP$$JP-009507513-2406JPN003528J$MERCK$$71$YR$$M$Y$$$20240701$$PH$JP$JP
240353411$24035341$1$I$$20240627$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003553$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240628$$CN$US$US
240353423$24035342$3$F$20210701$20240717$20240701$20240725$EXP$$DE-OTSUKA-2023_032642$OTSUKA$$34$YR$$F$Y$$$20240725$$MD$DE$DE
240353431$24035343$1$I$$20240626$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003977$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240628$$CN$US$US
240353441$24035344$1$I$$20240307$20240701$20240701$PER$$US-AMGEN-USASP2024129821$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240353451$24035345$1$I$20240511$20240617$20240701$20240701$PER$$US-COSETTE-CP2024US000138$COSETTE PHARMACEUTICALS$$45$YR$A$F$Y$$$20240701$$CN$US$US
240353465$24035346$5$F$20240621$20240805$20240701$20240809$30DAY$$US-JNJFOC-20240675376$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240809$$CN$US$US
240353471$24035347$1$I$$20240627$20240701$20240701$EXP$$BR-ROCHE-10000011333$ROCHE$$67$YR$E$$Y$$$20240701$$MD$BR$BR
240353498$24035349$8$F$$20240924$20240701$20240927$30DAY$$US-PFIZER INC-202400200073$PFIZER$$13$YR$$M$Y$43.54$KG$20240927$$CN$US$US
240353505$24035350$5$F$20240601$20240827$20240701$20240829$30DAY$$US-PFIZER INC-202400200004$PFIZER$$10$YR$$F$Y$$$20240829$$CN$US$US
240353513$24035351$3$F$20240601$20240911$20240701$20240913$30DAY$$US-PFIZER INC-202400199966$PFIZER$$16$YR$$M$Y$$$20240913$$CN$US$US
240353522$24035352$2$F$20231222$20240715$20240701$20240719$EXP$$US-OTSUKA-2024_002350$OTSUKA$$43$YR$$F$Y$$$20240719$$MD$US$US
240353531$24035353$1$I$20240412$20240626$20240701$20240701$EXP$GB-MHRA-MED-202406251510244500-ZDPTF$GB-MYLANLABS-2024M1058233$MYLAN$$58$YR$$F$Y$93$KG$20240701$$PH$GB$GB
240353542$24035354$2$F$$20240807$20240701$20240812$EXP$$GB-MYLANLABS-2024M1061016$MYLAN$$$$$F$Y$$$20240812$$MD$GB$GB
240353561$24035356$1$I$$20240629$20240701$20240701$PER$$US-HALEON-2184576$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240353573$24035357$3$F$$20240821$20240701$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097949$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240828$$HP$US$US
240353581$24035358$1$I$20240415$20240627$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003995$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240628$$CN$US$US
240353591$24035359$1$I$20240310$20240624$20240701$20240701$EXP$$CN-ROCHE-10000008056$ROCHE$$66$YR$E$M$Y$75$KG$20240701$$HP$CN$CN
240353602$24035360$2$F$20240409$20240729$20240701$20240803$EXP$$BR-ROCHE-10000002042$ROCHE$$78$YR$E$M$Y$78.4$KG$20240803$$HP$BR$BR
240353611$24035361$1$I$20240625$20240625$20240701$20240701$EXP$$US-Stemline Therapeutics, Inc.-2024ST003944$STEMLINE THERAPEUTICS$$85$YR$E$F$Y$$$20240628$$CN$US$US
240353651$24035365$1$I$20240101$20240624$20240701$20240701$PER$$US-ALXN-202406USA001515US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
240353661$24035366$1$I$20240527$20240627$20240701$20240701$EXP$$CN-BAYER-2024A093751$BAYER$$75$YR$E$F$Y$77$KG$20240701$$HP$CN$CN
240353671$24035367$1$I$$20230922$20240701$20240701$PER$$US-AMGEN-USASP2023235136$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240353681$24035368$1$I$20240625$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127553$AMGEN$$72$YR$E$M$Y$$$20240701$$CN$US$US
240353692$24035369$2$F$$20240903$20240701$20240906$PER$$US-ROCHE-10000012374$ROCHE$$75$YR$E$F$Y$$$20240906$$CN$US$US
240353702$24035370$2$F$$20240701$20240701$20240713$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091997$GLENMARK$Jumaili WA, Gburi NA, Chaudhary N, Brown K, Jain S.. Two Cases of Montelukast-Associated Psychosis in Children. The primary care companion for CNS disorders. 2024;26(3):23cr03694$$$$$Y$$$20240713$$MD$US$US
240353711$24035371$1$I$$20240627$20240701$20240701$EXP$$GB-MYLANLABS-2024M1061212$MYLAN$$$$$M$Y$$$20240701$$PH$GB$GB
240353721$24035372$1$I$$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A147870$ASTRAZENECA$$$$$F$Y$$$20240701$$CN$US$
240353732$24035373$2$F$$20240620$20240701$20240702$PER$$US-AstraZeneca-2024A143494$ASTRAZENECA$$$$$$Y$$$20240702$$CN$US$
240353741$24035374$1$I$$20240625$20240701$20240701$EXP$$JP-AstraZeneca-2024A147511$ASTRAZENECA$Watanabe T, Hirama T, Akiba M, Watanabe T, Watanabe Y, Oishi H. COVID-19 pneumonia in lung transplant recipients: understanding risk factors and treatment outcomes in Japan. Clinical and Experimental Medicine 2024;24(1):Art Nr 123 .$53$YR$$M$Y$$$20240701$$HP$JP$
240353751$24035375$1$I$20240613$20240624$20240701$20240701$EXP$$CN-JNJFOC-20240666639$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240701$$HP$CN$CN
240353763$24035376$3$F$$20240628$20240701$20240709$30DAY$$BR-JNJFOC-20240647184$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$BR$BR
240353771$24035377$1$I$$20240624$20240701$20240701$PER$$US-ROCHE-10000012601$ROCHE$$79$YR$E$M$Y$$$20240701$$CN$US$US
240353791$24035379$1$I$$20240624$20240701$20240701$EXP$$IN-TAKEDA-2023TUS107909$TAKEDA$$$$$F$Y$$$20240701$$MD$IN$IN
240353801$24035380$1$I$20240619$20240625$20240701$20240701$EXP$$CN-009507513-2406CHN010065$MERCK$$40$YR$$M$Y$55$KG$20240701$$HP$CN$CN
240353812$24035381$2$F$20240610$20240624$20240701$20240913$EXP$CN-91110000556821568D-2024DRL001181$CN-RDY-SPO/CHN/24/0009330$DR REDDYS$$72$YR$E$M$Y$66$KG$20240913$$HP$CN$CN
240353823$24035382$3$F$20240101$20240710$20240701$20240717$PER$$US-SA-2024SA190193$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240717$$MD$US$US
240353831$24035383$1$I$$20240628$20240701$20240701$PER$$US-BIOVITRUM-2024-US-009287$BIOVITRUM$$81$YR$$M$Y$$$20240701$$CN$US$US
240353842$24035384$2$F$$20240625$20240701$20240711$PER$$US-ROCHE-10000012902$ROCHE$$52$YR$A$M$Y$$$20240711$$HP$US$US
240353861$24035386$1$I$$20240620$20240701$20240701$EXP$$US-BEH-2024174508$CSL BEHRING$$62$YR$A$M$Y$$$20240701$$HP$US$US
240353871$24035387$1$I$$20240625$20240701$20240701$PER$$US-ROCHE-10000012998$ROCHE$$$$$$Y$$$20240701$$PH$US$US
240353881$24035388$1$I$$20240620$20240701$20240701$EXP$$US-ROCHE-10000008611$ROCHE$$$$$$Y$$$20240701$$MD$US$US
240353893$24035389$3$F$20230510$20240730$20240701$20240807$EXP$$CZ-EXELIXIS-CABO-24078981$EXELIXIS$SPISAROVA M. Immune-mediated encephalopathy in a patient with mRCC treated with combination of nivolumab + cabozantinib. Current topics in oncology (through the eyes of Czech doctors). 2024;9: 16-17.. 2024;9:16-17$71$YR$$M$Y$$$20240807$$MD$CZ$CZ
240353901$24035390$1$I$$20240620$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05761$HIKMA$Elsayed M.. Elsayed M. An Interesting Case of Drug-Induced Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Pulmonary and Renal Involvement.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5780$75$YR$$M$Y$$$20240701$$MD$US$US
240353911$24035391$1$I$$20240628$20240701$20240701$PER$$US-BIOVITRUM-2024-US-009291$BIOVITRUM$$76$YR$$M$Y$$$20240701$$CN$US$US
240353921$24035392$1$I$20231201$20240627$20240701$20240701$EXP$$CA-GSK-CA2024020518$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$CA$CA
240353931$24035393$1$I$$20240620$20240701$20240701$EXP$GB-MYLANLABS-2024M1054527$GB-JUBILANT PHARMA LTD-2024GB000862$JUBILANT$$$$A$F$Y$$$20240701$$MD$GB$GB
240353941$24035394$1$I$$20240624$20240701$20240701$EXP$$GB-JUBILANT CADISTA PHARMACEUTICALS-2024GB000869$JUBILANT$Roche-Kelly E, Fang C, Lewis D, Kane P, Goonasekera CD. Citalopram induced ventricular tachycardia under general anesthesia. Saudi J Anaesth. 2018;12:496-8.$65$YR$$F$Y$55$KG$20240701$$HP$GB$GB
240353951$24035395$1$I$20210101$20240620$20240701$20240701$EXP$JP-MLMSERVICE-20240620-PI098421-00125-2$JP-JUBILANT PHARMA LTD-2024JP000845$JUBILANT$Higaki Y, Ito Y.. Risedronate-Induced Chronic Drug Fever in a Case of Parkinson^s Disease.. Cureus. 2024;16(5):e60117$82$YR$$F$Y$$$20240701$$MD$JP$JP
240353962$24035396$2$F$$20240604$20240701$20240710$PER$$BR-ROCHE-3579163$ROCHE$$$$$M$Y$$$20240701$$CN$BR$BR
240353972$24035397$2$F$20230311$20240606$20240701$20240710$PER$$CN-ROCHE-3578635$ROCHE$$3$YR$C$$Y$$$20240701$$MD$CN$CN
240353982$24035398$2$F$$20240607$20240701$20240710$PER$$FR-ROCHE-3579917$ROCHE$$19$YR$A$F$Y$$$20240701$$PH$FR$FR
240353992$24035399$2$F$$20240604$20240701$20240710$PER$$DE-ROCHE-3578777$ROCHE$$39$YR$A$F$Y$$$20240701$$CN$DE$DE
240354003$24035400$3$F$20240602$20240719$20240701$20240722$PER$$US-ROCHE-3579309$ROCHE$$$$$F$Y$$$20240722$$CN$US$US
240354011$24035401$1$I$20240624$20240627$20240701$20240701$EXP$GB-MHRA-MED-202406270853023080-WKPFJ$GB-MYLANLABS-2024M1060852$MYLAN$$44$YR$$F$Y$$$20240701$$HP$GB$GB
240354021$24035402$1$I$20240615$20240627$20240701$20240701$EXP$GB-MHRA-MED-202406261715230780-NLDBV$GB-MYLANLABS-2024M1059853$MYLAN$$40$YR$$M$Y$85$KG$20240701$$CN$GB$GB
240354032$24035403$2$F$$20240718$20240701$20240723$EXP$GB-MHRA-MED-202406271102593100-MTLRW$GB-MYLANLABS-2024M1060933$MYLAN$$37$YR$$$Y$$$20240723$$CN$GB$GB
240354041$24035404$1$I$20240501$20240625$20240701$20240701$PER$$US-INSUD PHARMA-2406US05092$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240354051$24035405$1$I$20230101$20240626$20240701$20240701$EXP$GB-MHRA-MED-202406260954239370-ZNFCY$GB-REGENERON PHARMACEUTICALS, INC.-2024-091699$REGENERON$$66$YR$$F$Y$$$20240701$$PH$GB$GB
240354062$24035406$2$F$$20240605$20240701$20240710$PER$$SE-ROCHE-3579030$ROCHE$$$$$$Y$$$20240701$$HP$SE$SE
240354074$24035407$4$F$$20240607$20240701$20240710$PER$$US-ROCHE-3578832$ROCHE$$13$YR$T$F$Y$$$20240701$$CN$US$US
240354082$24035408$2$F$$20240605$20240701$20240710$PER$$RU-ROCHE-3578960$ROCHE$$34$YR$A$F$Y$$$20240701$$MD$RU$RU
240354092$24035409$2$F$$20240610$20240701$20240710$PER$$DE-ROCHE-3580041$ROCHE$$74$YR$E$M$Y$$$20240701$$CN$DE$DE
240354102$24035410$2$F$20240603$20240923$20240701$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100996$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240924$$CN$US$US
240354112$24035411$2$F$20240601$20240716$20240701$20240718$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-104815$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240718$$CN$PR$PR
240354123$24035412$3$F$$20240723$20240701$20240725$30DAY$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101218$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240725$$CN$US$US
240354131$24035413$1$I$20240620$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104559$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240701$$CN$US$US
240354142$24035414$2$F$$20240606$20240701$20240710$PER$$GB-ROCHE-3579788$ROCHE$$$$$$Y$$$20240701$$HP$GB$GB
240354152$24035415$2$F$$20240610$20240701$20240710$PER$$RO-ROCHE-3580175$ROCHE$$$$$F$Y$16$KG$20240701$$CN$RO$RO
240354162$24035416$2$F$$20240606$20240701$20240710$PER$$DE-ROCHE-3579856$ROCHE$$39$YR$A$F$Y$$$20240701$$CN$DE$DE
240354171$24035417$1$I$20240601$20240626$20240701$20240701$EXP$$DE-ABBVIE-5819480$ABBVIE$$69$YR$$M$Y$$$20240701$$CN$DE$DE
240354181$24035418$1$I$20240622$20240625$20240701$20240701$PER$$US-Millicent Holdings Ltd.-MILL20241000$MILLICENT HOLDINGS$$$$$F$Y$$$20240701$$CN$US$US
240354191$24035419$1$I$20240512$20240619$20240701$20240701$EXP$$CN-ROCHE-10000004339$ROCHE$$68$YR$E$M$Y$58$KG$20240701$$HP$CN$CN
240354202$24035420$2$F$20240501$20240705$20240701$20240721$EXP$$US-OTTER-US-2024AST000252$Unknown Manufacturer$$59$YR$$M$Y$$$20240719$$CN$US$US
240354212$24035421$2$F$$20240628$20240701$20240705$EXP$ES-AEMPS-1536790$ES-OTSUKA-2024_018099$OTSUKA$$$$A$M$Y$80$KG$20240705$$CN$ES$ES
240354231$24035423$1$I$$20240625$20240701$20240701$EXP$$US-ABBVIE-5817653$ABBVIE$$$$$$Y$$$20240701$$CN$US$US
240354241$24035424$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184533$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240354252$24035425$2$F$20231227$20231229$20240701$20240911$EXP$GB-MHRA-EMIS-4621-a926e401-432f-4378-bbf1-0ab414249ebf$GB-TEVA-VS-3146529$TEVA$$64$YR$$F$Y$112.5$KG$20240911$$HP$GB$GB
240354281$24035428$1$I$$20240620$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05925$HIKMA$Prabhu S, Malempati S, Markowitz D.. Prabhu S, Malempati S, Markowitz D. Amlodipine: Not an Ace in the Hole.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A1361.$56$YR$$M$Y$$$20240701$$MD$US$US
240354292$24035429$2$F$20231103$20240624$20240701$20240703$EXP$$CN-UCBSA-2024033197$UCB$$0$YR$$M$Y$2.92$KG$20240703$$CN$CN$CN
240354301$24035430$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-202400202690$PFIZER$$29$YR$$F$Y$$$20240701$$MD$US$US
240354312$24035431$2$F$20210101$20240729$20240701$20240805$EXP$$US-JAZZ PHARMACEUTICALS-2021-US-017304$JAZZ$$$$$F$Y$$$20240805$$MD$US$US
240354321$24035432$1$I$$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203553$PFIZER$$40$YR$$M$Y$$$20240701$$HP$US$US
240354332$24035433$2$F$$20240701$20240701$20240702$PER$$US-PFIZER INC-PV202400085537$PFIZER$$56$YR$$F$Y$$$20240702$$PH$US$US
240354351$24035435$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400085221$PFIZER$$$$A$$Y$$$20240701$$CN$US$US
240354361$24035436$1$I$$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203391$PFIZER$$16$YR$$F$Y$$$20240701$$MD$US$US
240354371$24035437$1$I$$20240626$20240701$20240701$PER$$US-PFIZER INC-PV202400084807$PFIZER$$88$YR$$M$Y$$$20240701$$MD$US$US
240354382$24035438$2$F$$20240708$20240701$20240710$PER$$US-PFIZER INC-202400203447$PFIZER$$$$$M$Y$$$20240710$$CN$US$US
240354391$24035439$1$I$20240601$20240629$20240701$20240701$PER$$US-PFIZER INC-202400203480$PFIZER$$81$YR$$F$Y$$$20240701$$CN$US$US
240354412$24035441$2$F$$20240626$20240701$20240705$EXP$$US-PFIZER INC-202400202345$PFIZER$$42$YR$$F$Y$$$20240705$$MD$US$US
240354422$24035442$2$F$$20240704$20240701$20240710$PER$$US-PFIZER INC-202400203024$PFIZER$$75$YR$$F$Y$72.57$KG$20240710$$HP$US$US
240354431$24035443$1$I$20210101$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400085441$PFIZER$$73$YR$$F$Y$$$20240701$$HP$US$US
240354441$24035444$1$I$20240601$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203184$PFIZER$$$$$F$Y$$$20240701$$CN$US$US
240354451$24035445$1$I$20240101$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400085420$PFIZER$$43$YR$$F$Y$$$20240701$$HP$US$US
240354461$24035446$1$I$$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203286$PFIZER$$$$A$F$Y$$$20240701$$MD$US$US
240354472$24035447$2$F$20240901$20240909$20240701$20240911$PER$$US-PFIZER INC-PV202400085376$PFIZER$$83$YR$$F$Y$$$20240911$$HP$US$US
240354486$24035448$6$F$20240627$20240822$20240701$20240828$PER$$US-PFIZER INC-202400203388$PFIZER$$$$E$F$Y$68.934$KG$20240828$$CN$US$US
240354491$24035449$1$I$$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203584$PFIZER$$$$$$Y$$$20240701$$HP$US$US
240354501$24035450$1$I$$20240626$20240701$20240701$PER$$US-PFIZER INC-PV202400084862$PFIZER$$$$$F$Y$$$20240701$$CN$US$US
240354511$24035451$1$I$20240617$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203748$PFIZER$$65$YR$$M$Y$$$20240701$$CN$US$US
240354521$24035452$1$I$$20240628$20240701$20240701$PER$$US-PFIZER INC-PV202400086040$PFIZER$$60$YR$$$Y$$$20240701$$HP$US$US
240354531$24035453$1$I$20240627$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203200$PFIZER$$$$A$M$Y$$$20240701$$CN$US$US
240354542$24035454$2$F$$20240702$20240701$20240703$PER$$US-PFIZER INC-202400203214$PFIZER$$$$$$Y$$$20240703$$MD$US$US
240354551$24035455$1$I$$20240626$20240701$20240701$PER$$US-PFIZER INC-202400202713$PFIZER$$74$YR$$F$Y$$$20240701$$HP$US$US
240354571$24035457$1$I$$20240626$20240701$20240701$PER$$JP-PFIZER INC-202400201184$PFIZER$$$$$$Y$$$20240701$$PH$JP$JP
240354581$24035458$1$I$20240601$20240626$20240701$20240701$PER$$US-PFIZER INC-202400202780$PFIZER$$61$YR$$F$Y$$$20240701$$HP$US$US
240354592$24035459$2$F$$20240628$20240701$20240701$PER$$US-PFIZER INC-PV202400085381$PFIZER$$$$$F$Y$$$20240701$$MD$US$US
240354601$24035460$1$I$$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203248$PFIZER$$45$YR$$F$Y$$$20240701$$PH$US$US
240354611$24035461$1$I$$20240628$20240701$20240701$PER$$US-PFIZER INC-PV202400085869$PFIZER$$$$$$Y$$$20240701$$HP$US$US
240354624$24035462$4$F$$20240801$20240701$20240805$PER$$US-PFIZER INC-PV202400085740$PFIZER$$94$YR$$F$Y$$$20240805$$HP$US$US
240354631$24035463$1$I$20240620$20240626$20240701$20240701$PER$$US-PFIZER INC-202400203146$PFIZER$$69$YR$$F$Y$$$20240701$$HP$US$US
240354641$24035464$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-202400203174$PFIZER$$3$DEC$$M$Y$$$20240701$$HP$US$US
240354651$24035465$1$I$$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203373$PFIZER$$60$YR$$M$Y$$$20240701$$HP$US$US
240354661$24035466$1$I$20240628$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203636$PFIZER$$$$$M$Y$$$20240701$$CN$US$US
240354671$24035467$1$I$20240620$20240624$20240701$20240701$EXP$$CN-JNJFOC-20240666644$JOHNSON AND JOHNSON$$60$YR$A$F$Y$69$KG$20240701$$HP$CN$CN
240354681$24035468$1$I$20240527$20240620$20240701$20240701$EXP$$CA-JNJFOC-20221263008$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240701$$CN$CA$CA
240354691$24035469$1$I$20230531$20240625$20240701$20240701$EXP$ES-AEMPS-1535306$ES-SA-2024SA189517$SANOFI AVENTIS$$69$YR$E$M$Y$98$KG$20240701$$PH$ES$ES
240354701$24035470$1$I$20240101$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102980$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240701$$CN$US$US
240354711$24035471$1$I$$20240629$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104618$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$83.01$KG$20240701$$CN$US$US
240354721$24035472$1$I$20210101$20240626$20240701$20240701$PER$$US-PFIZER INC-PV202400077537$PFIZER$$70$YR$$F$Y$$$20240701$$HP$US$US
240354732$24035473$2$F$20220523$20240731$20240701$20240731$PER$$US-PFIZER INC-202300444594$PFIZER$$8$YR$$M$Y$17.7$KG$20240731$$MD$US$US
240354741$24035474$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-202400202710$PFIZER$$44$YR$$F$Y$77.11$KG$20240701$$CN$US$US
240354751$24035475$1$I$$20240624$20240701$20240701$PER$$US-ABBVIE-5816234$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240354762$24035476$2$F$$20240729$20240701$20240730$EXP$$US-ROCHE-10000008222$ROCHE$$$$A$F$Y$$$20240730$$CN$US$US
240354771$24035477$1$I$20240601$20240611$20240701$20240701$EXP$$PT-TRAVERE-2024TVT00649$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240701$$MD$PT$PT
240354791$24035479$1$I$$20240627$20240701$20240701$PER$$US-SA-2024SA191684$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$HP$US$US
240354801$24035480$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA185624$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240701$$CN$US$US
240354821$24035482$1$I$$20240619$20240701$20240701$EXP$$US-RDY-LIT/USA/24/0009165$DR REDDYS$Allie GD, Mehta A, Boucekkine H, Saggar R. Clinically Significant Pulmonary Invasion in Multiple Myeloma - Associated Amyloid Light Chain Amyloidosis. American Journal of Respiratory and Critical Care Medicine. 2024 May;209:$77$YR$E$F$Y$$$20240701$$HP$US$US
240354831$24035483$1$I$20240101$20240621$20240701$20240701$PER$$US-SA-2024SA189091$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240701$$MD$US$US
240354841$24035484$1$I$$20240621$20240701$20240701$PER$$US-SA-2024SA189099$SANOFI AVENTIS$$$$A$F$Y$99$KG$20240701$$MD$US$US
240354851$24035485$1$I$20240319$20240624$20240701$20240701$PER$$US-SA-2024SA190430$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240701$$MD$US$US
240354881$24035488$1$I$20240628$20240628$20240701$20240701$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036994$BOEHRINGER INGELHEIM$$$$$$Y$$$20240701$$CN$US$US
240354891$24035489$1$I$$20240604$20240701$20240701$30DAY$$US-VEROBIOTECH-2024USVEROSPO00126$VERO BIOTECH$$$$A$M$Y$$$20240701$$HP$US$US
240354903$24035490$3$F$$20240826$20240701$20240903$EXP$$CA-OTSUKA-2024_018107$OTSUKA$$$$$M$Y$$$20240903$$HP$CA$CA
240354931$24035493$1$I$$20240627$20240701$20240701$EXP$$US-MYLANLABS-2024M1060896$MYLAN$$$$$F$Y$$$20240701$$HP$US$US
240354941$24035494$1$I$$20240627$20240701$20240701$EXP$$US-MYLANLABS-2024M1060916$MYLAN$$$$$M$Y$$$20240701$$PH$US$US
240354951$24035495$1$I$20240524$20240627$20240701$20240701$EXP$$GB-MYLANLABS-2024M1049884$MYLAN$$$$$F$Y$$$20240701$$CN$GB$GB
240354961$24035496$1$I$$20240626$20240701$20240701$PER$$US-ABBVIE-5817984$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240354971$24035497$1$I$$20240604$20240701$20240701$30DAY$$US-JNJFOC-20240608130$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240354982$24035498$2$F$$20240701$20240701$20240703$EXP$$BY-JNJFOC-20240674223$JOHNSON AND JOHNSON$$79$YR$E$F$Y$67.1$KG$20240703$$MD$BY$BY
240354991$24035499$1$I$$20240630$20240701$20240701$PER$$US-JNJFOC-20240701075$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240355001$24035500$1$I$$20240626$20240701$20240701$EXP$$SG-JNJFOC-20240673472$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$HP$SG$SG
240355011$24035501$1$I$$20240625$20240701$20240701$EXP$$JP-AstraZeneca-2024A147582$ASTRAZENECA$Watanabe T, Hirama T, Akiba M, Watanabe T, Watanabe Y, Oishi H. COVID-19 pneumonia in lung transplant recipients: understanding risk factors and treatment outcomes in Japan. Clinical and Experimental Medicine 2024;24(1):Art Nr 123 .$57$YR$$F$Y$$$20240701$$HP$JP$
240355023$24035502$3$F$20240111$20240819$20240701$20240821$EXP$$JP-PFIZER INC-PV202400022300$PFIZER$$85$YR$$M$Y$48.3$KG$20240821$$MD$JP$JP
240355031$24035503$1$I$20240602$20240625$20240701$20240701$EXP$ES-AEMPS-1536359$ES-PFIZER INC-202400200336$PFIZER$$6$YR$$F$Y$23$KG$20240701$$MD$ES$ES
240355041$24035504$1$I$$20240626$20240701$20240701$EXP$$US-PFIZER INC-PV202400084511$PFIZER$$14$YR$$M$Y$$$20240701$$PH$US$US
240355051$24035505$1$I$$20240626$20240701$20240701$EXP$$US-PFIZER INC-PV202400084644$PFIZER$$75$YR$$M$Y$$$20240701$$CN$US$US
240355062$24035506$2$F$20240625$20240712$20240701$20240716$EXP$$BR-PFIZER INC-202400201704$PFIZER$$43$YR$$M$Y$83$KG$20240716$$CN$BR$BR
240355071$24035507$1$I$20240612$20240626$20240701$20240701$EXP$$US-PFIZER INC-202400062097$PFIZER$$62$YR$$M$Y$82.1$KG$20240701$$CN$US$US
240355081$24035508$1$I$$20240625$20240701$20240701$EXP$$CA-PFIZER INC-PV202400084849$PFIZER$$$$A$F$Y$$$20240701$$MD$CA$CA
240355091$24035509$1$I$$20240626$20240701$20240701$EXP$$PR-PFIZER INC-202300360897$PFIZER$$63$YR$$F$Y$$$20240701$$HP$PR$PR
240355101$24035510$1$I$20231201$20240626$20240701$20240701$EXP$$DE-PFIZER INC-PV202400085323$PFIZER$$46$YR$$F$Y$$$20240701$$MD$DE$DE
240355112$24035511$2$F$20240101$20240702$20240701$20240703$EXP$$US-PFIZER INC-202400075943$PFIZER$$80$YR$$F$Y$$$20240703$$HP$US$US
240355121$24035512$1$I$20240619$20240626$20240701$20240701$EXP$IT-MINISAL02-992046$IT-PFIZER INC-202400201229$PFIZER$$61$YR$$F$Y$45$KG$20240701$$MD$IT$IT
240355134$24035513$4$F$20240619$20240821$20240701$20240822$EXP$$DE-PFIZER INC-PV202400083979$PFIZER$$81$YR$$F$Y$70$KG$20240822$$MD$DE$DE
240355141$24035514$1$I$20240624$20240625$20240701$20240701$EXP$$US-PFIZER INC-202400201235$PFIZER$$65$YR$$F$Y$69.388$KG$20240701$$HP$US$US
240355151$24035515$1$I$20230820$20240626$20240701$20240701$EXP$ES-AEMPS-1420524$ES-PFIZER INC-202400201537$PFIZER$$57$YR$$F$Y$72$KG$20240701$$CN$ES$ES
240355162$24035516$2$F$20230101$20240824$20240701$20240826$EXP$$IN-PFIZER INC-PV202400083904$PFIZER$$57$YR$$M$Y$$$20240826$$CN$IN$IN
240355171$24035517$1$I$20240626$20240626$20240701$20240701$EXP$$IE-PFIZER INC-PV202400084638$PFIZER$$64$YR$$F$Y$$$20240701$$CN$IE$IE
240355181$24035518$1$I$$20240626$20240701$20240701$EXP$$CZ-PFIZER INC-202400202343$PFIZER$$$$A$F$Y$$$20240701$$MD$CZ$CZ
240355191$24035519$1$I$$20240604$20240701$20240701$30DAY$$US-VEROBIOTECH-2024USVEROSPO00127$VERO BIOTECH$$$$$$Y$$$20240701$$HP$US$US
240355201$24035520$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASL2024127017$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240355222$24035522$2$F$$20240723$20240701$20240724$EXP$$NZ-MYLANLABS-2024M1061406$MYLAN$$$$$M$Y$$$20240724$$CN$NZ$NZ
240355231$24035523$1$I$20240621$20240627$20240701$20240701$EXP$$US-MYLANLABS-2024M1061254$MYLAN$$72$YR$$F$Y$$$20240701$$HP$US$US
240355241$24035524$1$I$$20240624$20240701$20240701$PER$$US-ALXN-202406USA001525US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240701$$CN$US$US
240355251$24035525$1$I$20240622$20240624$20240701$20240701$PER$$US-ALXN-202406USA001554US$ALEXION PHARMACEUTICALS$$82$YR$$F$Y$$$20240701$$CN$US$US
240355261$24035526$1$I$$20240621$20240701$20240701$PER$$US-GILEAD-2024-0678375$GILEAD$$51$YR$A$M$Y$$$20240701$$HP$US$US
240355271$24035527$1$I$$20240625$20240701$20240701$EXP$$US-SA-2024SA189580$SANOFI AVENTIS$$$$$$Y$$$20240701$$MD$US$US
240355282$24035528$2$F$20240621$20240917$20240701$20240920$EXP$$JP-BAYER-2024A093612$BAYER$$75$YR$E$M$Y$$$20240920$$MD$JP$JP
240355291$24035529$1$I$$20240617$20240701$20240701$PER$$US-SA-2024SA189540$SANOFI AVENTIS$$$$$F$Y$$$20240701$$CN$US$US
240355301$24035530$1$I$20231101$20240628$20240701$20240701$EXP$$DE-TAKEDA-2024TUS065200$TAKEDA$$59$YR$$F$Y$$$20240701$$HP$DE$DE
240355311$24035531$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA192395$SANOFI AVENTIS$$$$A$F$Y$72.4$KG$20240701$$MD$US$US
240355321$24035532$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA190307$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240701$$MD$US$US
240355331$24035533$1$I$20240101$20240625$20240701$20240701$EXP$$CA-OTSUKA-2024_018242$OTSUKA$$$$$M$Y$$$20240701$$CN$CA$CA
240355341$24035534$1$I$$20231004$20240701$20240701$PER$$US-AMGEN-USASP2023235125$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240355351$24035535$1$I$$20240617$20240701$20240701$PER$$US-ALKERMES INC.-ALK-2024-001683$ALKERMES$$$$$F$Y$$$20240701$$HP$US$US
240355361$24035536$1$I$$20240629$20240701$20240701$EXP$GB-MHRA-MED-202406291156204580-GSRWB$GB-MYLANLABS-2024M1061442$MYLAN$$25$YR$$M$Y$88$KG$20240701$$CN$GB$GB
240355371$24035537$1$I$$20240629$20240701$20240701$EXP$GB-MHRA-MED-202406291148076400-HYSNB$GB-MYLANLABS-2024M1061434$MYLAN$$$$$M$Y$78$KG$20240701$$CN$GB$GB
240355381$24035538$1$I$$20240603$20240701$20240701$30DAY$$US-VEROBIOTECH-2024USVEROSPO00128$VERO BIOTECH$$$$$$Y$$$20240701$$HP$US$US
240355391$24035539$1$I$$20240629$20240701$20240701$EXP$GB-MHRA-MED-202406291146576770-GMFCW$GB-MYLANLABS-2024M1061444$MYLAN$$$$$$Y$78$KG$20240701$$CN$GB$GB
240355401$24035540$1$I$$20240629$20240701$20240701$EXP$GB-MHRA-MED-202406291145190840-GJMRH$GB-MYLANLABS-2024M1061431$MYLAN$$$$$M$Y$$$20240701$$CN$GB$GB
240355413$24035541$3$F$20240101$20240823$20240701$20240823$EXP$$CA-PFIZER INC-202400202764$PFIZER$$54$YR$$M$Y$$$20240823$$HP$CA$CA
240355434$24035543$4$F$$20240904$20240701$20240909$30DAY$$US-PFIZER INC-PV202400073164$PFIZER$$9$YR$$M$Y$21.77$KG$20240909$$MD$US$US
240355444$24035544$4$F$20240601$20240821$20240701$20240826$30DAY$$US-PFIZER INC-202400200948$PFIZER$$13$YR$$M$Y$$$20240826$$HP$US$US
240355452$24035545$2$F$20240101$20240825$20240701$20240826$EXP$$CA-PFIZER INC-202200539444$PFIZER$$53$YR$$M$Y$$$20240826$$HP$CA$CA
240355471$24035547$1$I$20240329$20240621$20240701$20240701$EXP$FR-AFSSAPS-AM2024000509$FR-TEVA-VS-3213485$TEVA$$52$YR$$F$Y$55$KG$20240701$$MD$FR$FR
240355491$24035549$1$I$20240601$20240625$20240701$20240701$PER$$US-INSUD PHARMA-2406US05091$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240355501$24035550$1$I$$20240624$20240701$20240701$PER$$US-TAKEDA-2024TUS062934$TAKEDA$$$$$M$Y$110$KG$20240701$$HP$US$US
240355511$24035551$1$I$$20240626$20240701$20240701$EXP$$US-INCYTE CORPORATION-2024IN006911$INCYTE$$$$$$Y$$$20240701$$CN$US$US
240355522$24035552$2$F$$20240704$20240701$20240711$EXP$$CN-VIIV HEALTHCARE LIMITED-CN2024APC078316$VIIV$$$$$$Y$$$20240711$$MD$CN$CN
240355533$24035553$3$F$20240501$20240628$20240701$20240909$EXP$$US-ABBVIE-5821412$ABBVIE$$50$YR$$F$Y$$$20240909$$HP$US$US
240355541$24035554$1$I$20240530$20240626$20240701$20240701$EXP$$US-ABBVIE-5801393$ABBVIE$$53$YR$$F$Y$$$20240701$$CN$US$US
240355551$24035555$1$I$20240403$20240626$20240701$20240701$EXP$$IL-AMERICAN REGENT INC-2024002477$AMERICAN REGENT$$$$$$Y$$$20240701$$PH$IL$IL
240355561$24035556$1$I$20240329$20240628$20240701$20240701$PER$$US-BIOVITRUM-2024-US-009312$BIOVITRUM$$42$YR$$F$Y$$$20240701$$CN$US$US
240355574$24035557$4$F$20240601$20240906$20240701$20240911$EXP$$US-PFIZER INC-202400201793$PFIZER$$61$YR$$F$Y$55.34$KG$20240911$$HP$US$US
240355582$24035558$2$F$$20240731$20240701$20240731$30DAY$$US-PFIZER INC-202400191319$PFIZER$$10$YR$$M$Y$$$20240731$$CN$US$US
240355591$24035559$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281502574640-CFGVW$GB-MYLANLABS-2024M1061427$MYLAN$$$$$$Y$$$20240701$$CN$GB$GB
240355602$24035560$2$F$$20240709$20240701$20240715$EXP$$US-PFIZER INC-202300347346$PFIZER$$63$YR$$M$Y$$$20240715$$CN$US$US
240355621$24035562$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281434234840-MKDNF$GB-MYLANLABS-2024M1061450$MYLAN$$$$$$Y$$$20240701$$CN$GB$GB
240355631$24035563$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281042408830-QRLPK$GB-MYLANLABS-2024M1061412$MYLAN$$$$$$Y$$$20240701$$CN$GB$GB
240355641$24035564$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281435349850-RDTKB$GB-MYLANLABS-2024M1061429$MYLAN$$$$$$Y$$$20240701$$CN$GB$GB
240355651$24035565$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281503492060-NTSCD$GB-MYLANLABS-2024M1061422$MYLAN$$$$$$Y$$$20240701$$CN$GB$GB
240355662$24035566$2$F$20240323$20240708$20240701$20240709$EXP$GB-MHRA-MED-202406281038502460-PFVRS$GB-MYLANLABS-2024M1061414$MYLAN$$$$$$Y$$$20240709$$CN$GB$GB
240355671$24035567$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281433366540-CNLMB$GB-MYLANLABS-2024M1061432$MYLAN$$$$$$Y$$$20240701$$CN$GB$GB
240355681$24035568$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281423510310-QYSNJ$GB-MYLANLABS-2024M1061416$MYLAN$$$$$$Y$$$20240701$$CN$GB$GB
240355691$24035569$1$I$20240611$20240626$20240701$20240701$EXP$$CA-TAKEDA-2023TUS029505$TAKEDA$$37$YR$$F$Y$$$20240701$$CN$CA$CA
240355701$24035570$1$I$$20240622$20240701$20240701$EXP$$US-AMGEN-USASP2024124520$AMGEN$Amengual J. E.; Tiger Y. R.; Jain S. et al.. Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma. Leukemia + Lymphoma. 2024;65 (6):736-745$$$$$Y$$$20240701$$HP$US$US
240355731$24035573$1$I$$20240621$20240701$20240701$EXP$$US-AMGEN-USASP2024124035$AMGEN$Hinds D.; Keehan L.; Fischer A. J. et al.. Bi-allelic LAMP3 Variants in Three Children With Interstitial Lung Disease: Evidence of a Novel Disease-gene Association. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7155$16$MON$I$F$Y$$$20240701$$HP$US$US
240355743$24035574$3$F$20240617$20240715$20240701$20240723$EXP$$IT-AMERICAN REGENT INC-2024002494$AMERICAN REGENT$$77$YR$$F$Y$75$KG$20240723$$MD$IT$IT
240355751$24035575$1$I$$20240627$20240701$20240701$EXP$$US-INCYTE CORPORATION-2024IN006906$INCYTE$$$$$$Y$$$20240701$$PH$US$US
240355761$24035576$1$I$$20240621$20240701$20240701$EXP$$US-TAKEDA-2024TUS062512$TAKEDA$Hussain SA, Faisal H, Dy GK. Prolonged disease control despite alk inhibitor discontinuation in advanced alk-positive nsclc. European Journal Of Case Reports In Internal Medicine. 2024;11$65$YR$$M$Y$$$20240701$$MD$US$US
240355772$24035577$2$F$$20240806$20240701$20240812$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024EME078728$VIIV$$$$$$Y$$$20240812$$HP$GB$GB
240355781$24035578$1$I$$20240627$20240701$20240701$EXP$$US-INCYTE CORPORATION-2024IN006902$INCYTE$$$$$$Y$$$20240701$$CN$US$US
240355792$24035579$2$F$$20240806$20240701$20240812$EXP$$GB-GSK-GB2024EME078728$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$HP$GB$GB
240355801$24035580$1$I$20240623$20240627$20240701$20240701$EXP$$US-ABBVIE-5821624$ABBVIE$$73$YR$$M$Y$$$20240701$$CN$US$US
240355811$24035581$1$I$$20240625$20240701$20240701$EXP$$US-AMGEN-USASP2024126060$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240355822$24035582$2$F$20240625$20240626$20240701$20240704$PER$$US-AMGEN-USASP2024126541$AMGEN$$67$YR$E$M$Y$$$20240704$$CN$US$US
240355831$24035583$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5821672$ABBVIE$$75$YR$$M$Y$$$20240701$$CN$US$US
240355842$24035584$2$F$$20240708$20240701$20240711$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-10909$IPSEN$$$$$M$Y$$$20240711$$MD$CA$CA
240355851$24035585$1$I$$20240624$20240701$20240701$EXP$$JP-EMD Serono-2024031835$EMD SERONO INC$$7$DEC$E$M$Y$$$20240701$$MD$JP$JP
240355861$24035586$1$I$20240505$20240625$20240701$20240701$EXP$$US-ORGANON-O2406USA002445$ORGANON$$79$YR$$M$Y$$$20240701$$CN$US$US
240355871$24035587$1$I$20231027$20240620$20240701$20240701$EXP$$FR-AstraZeneca-2024A149750$ASTRAZENECA$$3$DY$$M$Y$4.6$KG$20240701$$MD$FR$
240355883$24035588$3$F$20240101$20240731$20240701$20240802$PER$$US-Eisai-EC-2024-168925$EISAI$$73$YR$E$M$Y$47.8$KG$20240802$$CN$US$US
240355893$24035589$3$F$20240613$20240708$20240701$20240718$EXP$$GB-MYLANLABS-2024M1061236$MYLAN$$47$YR$$M$Y$86.9$KG$20240718$$HP$GB$GB
240355901$24035590$1$I$$20240522$20240701$20240701$PER$$US-PFIZER INC-PV202400085105$PFIZER$$60$YR$$F$Y$$$20240701$$CN$US$US
240355911$24035591$1$I$$20240619$20240701$20240701$EXP$$US-RDY-LIT/USA/24/0009324$DR REDDYS$Giles C, Sriram I, Curran M, Weinman J, Galambos C, Deterding RR. Atypical Granulomatosis With Polyangiitis With Severe Rapidly Progressive Obstructive Lung Disease Requiring Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 2024;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2278.$17$YR$T$M$Y$$$20240701$$HP$US$US
240355921$24035592$1$I$20231205$20240616$20240701$20240701$EXP$GB-MHRA-MED-202406161405460800-ZCSFV$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-05771$HIKMA$$75$YR$$F$Y$59$KG$20240701$$CN$GB$GB
240355931$24035593$1$I$20240601$20240627$20240701$20240701$EXP$$US-INCYTE CORPORATION-2024IN006890$INCYTE$$$$$$Y$$$20240701$$CN$US$US
240355941$24035594$1$I$20240624$20240624$20240701$20240701$EXP$$US-GSK-US2024078522$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$US$US
240355951$24035595$1$I$$20240625$20240701$20240701$EXP$$KR-009507513-2406KOR009184$MERCK$$$$$F$Y$$$20240701$$CN$KR$KR
240355961$24035596$1$I$20221023$20240112$20240701$20240701$EXP$GB-MHRA-MED-202401111625417770-WKVHJ$GB-TEVA-VS-3146733$TEVA$$34$YR$$M$Y$100$KG$20240701$$MD$GB$GB
240355982$24035598$2$F$20240621$20240627$20240701$20240709$EXP$$US-JNJFOC-20240665492$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240709$$CN$US$US
240355991$24035599$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281413365890-NGPDS$GB-MYLANLABS-2024M1061231$MYLAN$$$$$$Y$$$20240701$$CN$GB$GB
240356001$24035600$1$I$20240323$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281053549520-RCDFK$GB-MYLANLABS-2024M1061130$MYLAN$$$$$$Y$$$20240701$$CN$GB$GB
240356011$24035601$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281412107900-RNBWT$GB-MYLANLABS-2024M1061229$MYLAN$$$$$$Y$$$20240701$$CN$GB$GB
240356021$24035602$1$I$20240612$20240627$20240701$20240701$EXP$$US-PFIZER INC-202400203358$PFIZER$$86$YR$$F$Y$$$20240701$$HP$US$US
240356031$24035603$1$I$20240521$20240627$20240701$20240701$EXP$$CN-PFIZER INC-PV202400084939$PFIZER$$47$YR$$F$Y$48$KG$20240701$$HP$CN$CN
240356041$24035604$1$I$$20240627$20240701$20240701$EXP$$US-PFIZER INC-PV202400085036$PFIZER$$24$YR$$M$Y$$$20240701$$MD$US$US
240356051$24035605$1$I$20240614$20240626$20240701$20240701$EXP$$CN-PFIZER INC-PV202400084343$PFIZER$$62$YR$$F$Y$57$KG$20240701$$HP$CN$CN
240356061$24035606$1$I$20231101$20240626$20240701$20240701$EXP$$MX-PFIZER INC-PV202400085436$PFIZER$$69$YR$$F$Y$$$20240701$$CN$MX$MX
240356071$24035607$1$I$$20240626$20240701$20240701$EXP$$GB-PFIZER INC-202400201553$PFIZER$$77$YR$$F$Y$69$KG$20240701$$HP$GB$GB
240356081$24035608$1$I$20211001$20240626$20240701$20240701$EXP$$DE-PFIZER INC-PV202400085122$PFIZER$$73$YR$$F$Y$$$20240701$$MD$DE$DE
240356091$24035609$1$I$20231102$20240627$20240701$20240701$EXP$SE-SEMPA-2024-002382$SE-PFIZER INC-202400202084$PFIZER$$42$YR$$F$Y$54$KG$20240701$$CN$SE$SE
240356101$24035610$1$I$20230201$20240626$20240701$20240701$EXP$$CN-PFIZER INC-PV202400084275$PFIZER$$81$YR$$M$Y$65$KG$20240701$$HP$CN$CN
240356111$24035611$1$I$$20240627$20240701$20240701$EXP$GB-MHRA-MED-202406271315112260-KRYCJ$GB-PFIZER INC-202400202406$PFIZER$$$$$F$Y$$$20240701$$HP$GB$GB
240356131$24035613$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103957$BRISTOL MYERS SQUIBB$$64$YR$E$F$Y$87.09$KG$20240701$$PH$US$US
240356141$24035614$1$I$20210101$20240625$20240701$20240701$EXP$FR-AFSSAPS-LM2024000344$FR-SA-2024SA188218$SANOFI AVENTIS$$64$YR$A$F$Y$95$KG$20240701$$MD$FR$FR
240356151$24035615$1$I$$20240619$20240701$20240701$EXP$$US-BAYER-2024A093106$BAYER$Alghizzawi M.; Sabobeh T.; Aboudara M.. Pulmonary Vein Injury Complicating Watchman Device Implantation for Stroke Prophylaxis: A Rare Complication. American Journal of Respiratory and Critical Care Medicine. 2024;209$90$YR$E$F$Y$$$20240701$$HP$US$US
240356161$24035616$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126525$AMGEN$Khattri S.; Hren M. G.; Guenin S.. Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease. Journal of the American Academy of Dermatology. 2024;91(1):138-140$23$YR$A$$Y$$$20240701$$MD$US$US
240356171$24035617$1$I$$20230303$20240701$20240701$PER$$US-AMGEN-USASP2023235195$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240356181$24035618$1$I$$20240621$20240701$20240701$EXP$$US-MYLANLABS-2024M1058606$MYLAN$Chang J-H, Kudose S, Droubi S, Verduzco HA, Awori J, Ratner LE, et al. Four Cases of Kidney Transplants With Donor HCV-Derived Immune Complex Glomerulonephritis. Kidney-Int-Rep 2024; 9 (6): 1903-1907.$50$YR$$M$Y$75$KG$20240701$$HP$US$US
240356191$24035619$1$I$$20240622$20240701$20240701$PER$$US-SA-2024SA187831$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240701$$MD$US$US
240356211$24035621$1$I$20240601$20240620$20240701$20240701$PER$$US-SA-2024SA186897$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240701$$MD$US$US
240356221$24035622$1$I$20240601$20240620$20240701$20240701$PER$$US-SA-2024SA186899$SANOFI AVENTIS$$9$MON$I$F$Y$$$20240701$$MD$US$US
240356231$24035623$1$I$$20240618$20240701$20240701$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05617$LUPIN$$$$$$Y$$$20240701$$CN$US$US
240356241$24035624$1$I$$20240625$20240701$20240701$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003590$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240701$$CN$US$US
240356251$24035625$1$I$$20240624$20240701$20240701$EXP$$US-INSUD PHARMA-2406US05090$INSUD PHARMA$Holbert K. Mulitorgan Failure From Heat Stroke in a Person Taking Glycopyrrolate. Am J Respir Crit Care Med. 2024;209:A7329$$$$$Y$$$20240701$$HP$US$US
240356261$24035626$1$I$20240301$20240625$20240701$20240701$EXP$$US-OTSUKA-2024_006221$OTSUKA$$$$$F$Y$$$20240701$$CN$US$US
240356291$24035629$1$I$20240414$20240625$20240701$20240701$EXP$FR-AFSSAPS-LY2024000895$FR-MYLANLABS-2024M1057943$MYLAN$$60$YR$$M$Y$66$KG$20240701$$PH$FR$FR
240356302$24035630$2$F$20230601$20240724$20240701$20240730$EXP$$PT-MYLANLABS-2024M1058602$MYLAN$Salvado J, Cimadeira F, Inez R, Meireles C, Afonso R, Ribeiro N, Santos C.. Pretomanid Active Pharmacovigilance Program.. arsylvt$51$YR$$F$Y$55$KG$20240730$$HP$PT$PT
240356311$24035631$1$I$$20240622$20240701$20240701$EXP$$US-MYLANLABS-2024M1057554$MYLAN$$$$$$Y$$$20240701$$CN$US$US
240356321$24035632$1$I$20240518$20240625$20240701$20240701$EXP$FR-AFSSAPS-PO2024000626$FR-MYLANLABS-2024M1057938$MYLAN$$78$YR$$M$Y$$$20240701$$MD$FR$FR
240356331$24035633$1$I$20240101$20240626$20240701$20240701$PER$$US-PFIZER INC-PV202400056262$PFIZER$$59$YR$$F$Y$$$20240701$$HP$US$US
240356342$24035634$2$F$20240624$20240630$20240701$20240703$PER$$US-PFIZER INC-202400202657$PFIZER$$58$YR$$M$Y$$$20240703$$CN$US$US
240356352$24035635$2$F$20240626$20240719$20240701$20240722$PER$$US-PFIZER INC-202400202168$PFIZER$$48$YR$$F$Y$93.878$KG$20240722$$CN$US$US
240356362$24035636$2$F$20240101$20240723$20240701$20240726$PER$$US-PFIZER INC-202400202777$PFIZER$$71$YR$$F$Y$$$20240726$$HP$US$US
240356371$24035637$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400084908$PFIZER$$27$YR$$M$Y$$$20240701$$MD$US$US
240356383$24035638$3$F$$20240709$20240701$20240712$PER$$US-PFIZER INC-202400203375$PFIZER$$$$$M$Y$$$20240712$$CN$US$US
240356391$24035639$1$I$20220302$20240621$20240701$20240701$EXP$IT-MINISAL02-990341$IT-TEVA-VS-3213471$TEVA$$71$YR$$M$Y$65$KG$20240701$$MD$IT$IT
240356412$24035641$2$F$20230101$20240925$20240701$20240927$EXP$$US-PFIZER INC-202400202634$PFIZER$$82$YR$$M$Y$$$20240927$$HP$US$US
240356421$24035642$1$I$20231001$20240626$20240701$20240701$PER$$US-PFIZER INC-202400202630$PFIZER$$43$YR$$F$Y$$$20240701$$HP$US$US
240356431$24035643$1$I$$20230523$20240701$20240701$PER$$US-AMGEN-USASP2023235101$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240356444$24035644$4$F$20240529$20240826$20240701$20240829$EXP$$DE-JNJFOC-20240700330$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240829$$HP$DE$DE
240356451$24035645$1$I$20240627$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203247$PFIZER$$$$$F$Y$$$20240701$$CN$US$US
240356461$24035646$1$I$$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203234$PFIZER$$67$YR$$F$Y$$$20240701$$CN$US$US
240356471$24035647$1$I$$20240604$20240701$20240701$30DAY$$US-JNJFOC-20240611794$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240701$$CN$US$US
240356485$24035648$5$F$20240101$20240718$20240701$20240723$PER$$US-PFIZER INC-202400203374$PFIZER$$81$YR$$F$Y$$$20240723$$CN$US$US
240356492$24035649$2$F$$20240716$20240701$20240720$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010048$JAZZ$$$$$M$Y$$$20240720$$HP$US$US
240356501$24035650$1$I$$20240628$20240701$20240701$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037003$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240701$$CN$US$US
240356516$24035651$6$F$20240301$20240919$20240701$20240930$EXP$$US-JNJFOC-20240512545$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240930$$HP$US$US
240356521$24035652$1$I$$20240621$20240701$20240701$EXP$$US-BAYER-2024A091933$BAYER$Abramovitz Fouks A.; Yaghi S.; Selim M.H.; Goekcal E.; Das A.S.; Rotschild O.; Silverman S.B.; Singhal A.B.; Kapur S.; Greenberg S.M.; Gurol M.E.. Left atrial appendage closure in patients with atrial fibrillation and acute ischaemic stroke despite anticoagulation. Stroke and Vascular Neurology. 2024$$$$$Y$$$20240701$$MD$US$US
240356531$24035653$1$I$$20240620$20240701$20240701$PER$$US-MYLANLABS-2024M1057917$MYLAN$$$$$$Y$$$20240701$$CN$US$US
240356542$24035654$2$F$$20240627$20240701$20240709$PER$$US-MYLANLABS-2024M1057913$MYLAN$$$$$F$Y$$$20240709$$MD$US$US
240356551$24035655$1$I$20240101$20240625$20240701$20240701$PER$$US-INSUD PHARMA-2406US05089$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240356561$24035656$1$I$$20240621$20240701$20240701$EXP$$US-INDIVIOR US-INDV-145697-2024$RECKITT BENCKISER$$$$$$Y$$$20240701$$CN$US$US
240356573$24035657$3$F$20240705$20240710$20240701$20240715$PER$$US-AMGEN-USASP2024128751$AMGEN$$60$YR$A$M$Y$$$20240715$$CN$US$US
240356582$24035658$2$F$20240626$20240701$20240701$20240703$PER$$US-AMGEN-USASP2024128995$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240356591$24035659$1$I$$20240624$20240701$20240701$EXP$$US-AMGEN-USASP2024124829$AMGEN$Giles C.; Sriram I.; Curran M. et al.. Atypical Granulomatosis With Polyangiitis With Severe Rapidly Progressive Obstructive Lung Disease Requiring Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A2278-A2278$$$$M$Y$$$20240701$$HP$US$US
240356602$24035660$2$F$20240601$20240823$20240701$20240823$EXP$$CA-PFIZER INC-202400086305$PFIZER$$31$YR$$F$Y$$$20240823$$MD$CA$CA
240356611$24035661$1$I$20240527$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019171$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240356621$24035662$1$I$20240625$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019100$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240701$$CN$US$US
240356631$24035663$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019142$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240356641$24035664$1$I$20240625$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018234$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240356651$24035665$1$I$$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017311$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240701$$CN$US$US
240356661$24035666$1$I$$20240626$20240701$20240701$EXP$$US-OTSUKA-2024_018287$OTSUKA$$$$$F$Y$$$20240701$$HP$US$US
240356681$24035668$1$I$$20240619$20240701$20240701$EXP$$US-APOTEX-2024AP007697$APOTEX$Fiter RJ, Tong T.. Covid Confusion: A Case of Paxlovid Induced Carbamazepine Toxicity. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-4$52$YR$$F$Y$$$20240701$$HP$US$US
240356691$24035669$1$I$$20240619$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05901$HIKMA$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM.. Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316(6):279$63$YR$$F$Y$$$20240701$$MD$US$US
240356721$24035672$1$I$$20240618$20240701$20240701$EXP$$US-SPECGX-T202401390$SPECGX$Al-Shokri S, Shimizu S, Warren EL, Kourouni I. Pneumocystis jirovecii pneumonia in an immunocompetent patient with inhalation injury, a case report with literature review. American Journal of Respiratory and Critical Care Medicine. 2024;209$57$YR$$M$Y$$$20240701$$HP$US$US
240356731$24035673$1$I$$20240618$20240701$20240701$EXP$$US-SPECGX-T202401395$SPECGX$Khan A, Murag S, Chinchilla D. When time is of the essence: Fatal delay in diagnosis and surgical management of pulmonary mucormycosis in a renal transplant patient. American Journal of Respiratory and Critical Care Medicine. 2024;209$67$YR$$M$Y$$$20240701$$HP$US$US
240356741$24035674$1$I$$20240628$20240701$20240701$PER$$US-PFIZER INC-202400203386$PFIZER$$$$$F$Y$$$20240701$$MD$US$US
240356752$24035675$2$F$$20240823$20240701$20240823$EXP$$CA-PFIZER INC-202400201775$PFIZER$$48$YR$$F$Y$$$20240823$$MD$CA$CA
240356761$24035676$1$I$20240101$20240624$20240701$20240701$PER$$US-INSUD PHARMA-2406US05088$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240356771$24035677$1$I$20240526$20240626$20240701$20240701$EXP$$US-OTSUKA-2024_018289$OTSUKA$$101$YR$$F$Y$$$20240701$$HP$US$US
240356781$24035678$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126494$AMGEN$Khattri S.; Hren M. G.; Guenin S.. Use of dual biologic therapy targeting the Th2 and Thl7 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease. Journal of the American Academy of Dermatology. 2024;91 (1):138-140$50$YR$A$$Y$$$20240701$$MD$US$US
240356792$24035679$2$F$20240601$20240827$20240701$20240909$EXP$$BR-BAYER-2024A091597$BAYER$$56$YR$A$M$Y$$$20240909$$CN$BR$BR
240356801$24035680$1$I$20240101$20240625$20240701$20240701$EXP$$US-ABBVIE-5713421$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240356811$24035681$1$I$$20240625$20240701$20240701$PER$$US-LEO Pharma-371551$LEO PHARM$$31$YR$$F$Y$$$20240701$$PH$US$US
240356822$24035682$2$F$20240101$20240801$20240701$20240806$EXP$$CO-ABBVIE-5820988$ABBVIE$$$$$M$Y$67$KG$20240806$$CN$CO$CO
240356831$24035683$1$I$20240617$20240620$20240701$20240701$PER$$US-SA-2024SA186860$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240701$$HP$US$US
240356841$24035684$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186770$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240701$$CN$US$US
240356861$24035686$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103616$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240701$$CN$US$US
240356871$24035687$1$I$$20230712$20240701$20240701$PER$$US-AMGEN-USASP2023235076$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240356881$24035688$1$I$$20230912$20240701$20240701$PER$$US-AMGEN-USASP2023235138$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240356891$24035689$1$I$$20231113$20240701$20240701$PER$$US-AMGEN-USASP2023235170$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240356911$24035691$1$I$20240623$20240627$20240701$20240701$EXP$GB-MHRA-MED-202406261932142240-RJMPD$GB-009507513-2406GBR009569$MERCK$$142$DY$$F$Y$70$KG$20240701$$CN$GB$GB
240356921$24035692$1$I$$20240625$20240701$20240701$PER$$US-JNJFOC-20240669349$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240356932$24035693$2$F$$20240621$20240701$20240710$EXP$$KR-PFIZER INC-202400197084$PFIZER$$5$DEC$$M$Y$$$20240710$$CN$KR$KR
240356947$24035694$7$F$20240314$20240808$20240701$20240813$30DAY$$GR-PFIZER INC-PV202400079542$PFIZER$$44$YR$$F$Y$125$KG$20240813$$MD$GR$GR
240356956$24035695$6$F$20240101$20240723$20240701$20240730$30DAY$$GR-PFIZER INC-202400195856$PFIZER$$68$YR$$M$Y$88$KG$20240730$$MD$GR$GR
240356962$24035696$2$F$20240622$20240711$20240701$20240718$PER$$US-BIOGEN-2024BI01270920$BIOGEN$$64$YR$$F$Y$$$20240718$$CN$US$US
240356971$24035697$1$I$$20240624$20240701$20240701$EXP$$AU-RDY-SPO/AUS/24/0009352$DR REDDYS$$26$YR$A$F$Y$$$20240701$$CN$AU$AU
240356981$24035698$1$I$20240624$20240627$20240701$20240701$EXP$$CA-ABBVIE-5821676$ABBVIE$$61$YR$$F$Y$$$20240701$$CN$CA$CA
240356993$24035699$3$F$$20240629$20240701$20240816$PER$$US-LUNDBECK-DKLU3078474$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
240357006$24035700$6$F$$20240911$20240701$20240918$EXP$$CA-GSK-CA2024078609$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$CA$CA
240357011$24035701$1$I$$20240621$20240701$20240701$EXP$$US-GSK-US2024078075$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$US$US
240357021$24035702$1$I$$20231212$20240701$20240701$PER$$US-AMGEN-USASP2023235030$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240357031$24035703$1$I$$20240621$20240701$20240701$EXP$$SG-JNJFOC-20240664786$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$HP$SG$SG
240357041$24035704$1$I$$20240626$20240701$20240701$PER$$US-SA-2024SA191602$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240701$$MD$US$US
240357051$24035705$1$I$$20240619$20240701$20240701$EXP$$US-APOTEX-2024AP007710$APOTEX$Holtzapple Z, Campbell A, Katterle K, Patel R, Salih A, Abrahamian A, Safi F.. Carfizomib Induced Pulmonary Hemorrhage and Acute Renal Failure in the Setting of Relapsed Multiple Myeloma. American Journal of Respiratory and Critical Care Medicine. 2024;209$60$YR$$F$Y$$$20240701$$HP$US$US
240357061$24035706$1$I$$20240417$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05957$HIKMA$Belinschi V, Iheagwara C, Muhanna A.. Belinschi V, Iheagwara C, Muhanna A. Once-Weekly Liposomal Amphotericin B Use for Maintenance and Consolidation Phase Treatment of Cryptococcal Meningitis in Patients With AIDS.. Cureus. 2024;16(3):e55824:6$47$YR$$M$Y$$$20240701$$MD$US$US
240357071$24035707$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104780$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240701$$CN$US$US
240357082$24035708$2$F$20240627$20240717$20240701$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104709$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$78.02$KG$20240719$$CN$US$US
240357093$24035709$3$F$$20240923$20240701$20240926$30DAY$$US-PFIZER INC-202400199075$PFIZER$$$$$M$Y$$$20240926$$CN$US$US
240357101$24035710$1$I$$20240625$20240701$20240701$30DAY$$FR-PFIZER INC-PV202400083483$PFIZER$$5$YR$$M$Y$$$20240701$$CN$FR$FR
240357116$24035711$6$F$$20240826$20240701$20240829$30DAY$$US-PFIZER INC-PV202400081892$PFIZER$$$$$F$Y$$$20240829$$CN$US$US
240357122$24035712$2$F$20240620$20240731$20240701$20240731$30DAY$$US-PFIZER INC-PV202400082876$PFIZER$$67$YR$$F$Y$$$20240731$$HP$US$US
240357131$24035713$1$I$20230701$20230731$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00825$TARO$$$$$$Y$$$20240701$$CN$US$US
240357141$24035714$1$I$$20230731$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00830$TARO$$$$$$Y$$$20240701$$CN$US$US
240357151$24035715$1$I$$20230810$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00866$TARO$$$$$$Y$$$20240701$$CN$US$US
240357161$24035716$1$I$20230528$20230608$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00625$TARO$$$$$$Y$$$20240701$$CN$US$US
240357171$24035717$1$I$20230912$20230912$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00989$TARO$$$$$F$Y$$$20240701$$CN$US$US
240357181$24035718$1$I$$20231208$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01309$TARO$$$$$$Y$$$20240701$$CN$US$US
240357191$24035719$1$I$20240304$20240305$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00310$TARO$$$$$$Y$$$20240701$$CN$US$US
240357201$24035720$1$I$20240304$20240305$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00311$TARO$$$$$$Y$$$20240701$$CN$US$US
240357211$24035721$1$I$$20230815$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00874$TARO$$$$$F$Y$$$20240701$$CN$US$US
240357221$24035722$1$I$$20230818$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00876$TARO$$$$$$Y$$$20240701$$CN$US$US
240357231$24035723$1$I$$20230815$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00911$TARO$$$$$$Y$$$20240701$$CN$US$US
240357241$24035724$1$I$$20230928$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01023$TARO$$$$$$Y$$$20240701$$CN$US$US
240357251$24035725$1$I$$20230929$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01124$TARO$$$$$$Y$$$20240701$$CN$US$US
240357261$24035726$1$I$$20231026$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01125$TARO$$$$$$Y$$$20240701$$CN$US$US
240357271$24035727$1$I$$20231026$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01126$TARO$$$$$M$Y$$$20240701$$CN$US$US
240357281$24035728$1$I$$20231010$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01128$TARO$$$$$$Y$$$20240701$$CN$US$US
240357291$24035729$1$I$$20231209$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01318$TARO$$$$$$Y$$$20240701$$CN$US$US
240357301$24035730$1$I$$20240219$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00098$TARO$$$$$$Y$$$20240701$$CN$US$US
240357311$24035731$1$I$20240101$20240129$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00126$TARO$$$$$$Y$$$20240701$$CN$US$US
240357321$24035732$1$I$20240129$20240129$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00127$TARO$$$$$$Y$$$20240701$$CN$US$US
240357331$24035733$1$I$$20240219$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00237$TARO$$$$$$Y$$$20240701$$CN$US$US
240357361$24035736$1$I$20240505$20240621$20240701$20240701$EXP$$US-VIIV HEALTHCARE LIMITED-US2024077682$VIIV$$54$YR$$F$Y$$$20240701$$HP$US$US
240357373$24035737$3$F$$20240702$20240701$20240710$PER$$US-ROCHE-10000012518$ROCHE$$45$YR$A$F$Y$$$20240709$$CN$US$US
240357381$24035738$1$I$$20240624$20240701$20240701$EXP$$US-SA-2024SA188599$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240701$$CN$US$US
240357391$24035739$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281040200250-ZJMNR$GB-ORGANON-O2406GBR002773$ORGANON$$$$$$Y$$$20240701$$CN$GB$GB
240357401$24035740$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281143566360-GQMFV$GB-ORGANON-O2407GBR000022$ORGANON$$$$$$Y$$$20240701$$CN$GB$GB
240357411$24035741$1$I$$20240624$20240701$20240701$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004732$BIOCON$$$$$$Y$$$20240701$$CN$CA$CA
240357421$24035742$1$I$$20240611$20240701$20240701$PER$$US-AstraZeneca-2024A136258$ASTRAZENECA$$$$$M$Y$$$20240701$$CN$US$
240357431$24035743$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184570$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240357442$24035744$2$F$$20240715$20240701$20240721$EXP$GB-GERMAN-LIT/GBR/24/0009394$GB-RDY-LIT/GBR/24/0009394$DR REDDYS$Buckens G, Mahir G, Bapat A. 58 Antifungal resistance, a hot topic. A case report in co-infection of Mycobacterium avium-intracellulare and chronic cavitary pulmonary aspergillosis. Clinical Infection in Practice. 2023;20: doi:10.1016/j.clinpr.2023.100313.$53$YR$A$M$Y$$$20240722$$HP$GB$GB
240357452$24035745$2$F$$20240702$20240701$20240705$EXP$$AU-ABBVIE-5818641$ABBVIE$$$$$$Y$$$20240705$$HP$AU$AU
240357461$24035746$1$I$20240616$20240624$20240701$20240701$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0600986$MYOVANT SCIENCES$$90$YR$$M$Y$$$20240701$$CN$US$US
240357471$24035747$1$I$20240601$20240626$20240701$20240701$EXP$$CA-MYOVANT SCIENCES GMBH-2024MYSCI0601104$MYOVANT SCIENCES$$$$$F$Y$$$20240701$$MD$CA$CA
240357481$24035748$1$I$20240601$20240625$20240701$20240701$PER$$US-MYLANLABS-2024M1058426$MYLAN$$51$YR$$F$Y$$$20240701$$CN$US$US
240357491$24035749$1$I$20240527$20240621$20240701$20240701$EXP$$SG-JNJFOC-20240662363$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240701$$HP$SG$SG
240357502$24035750$2$F$20240601$20240820$20240701$20240830$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0600926$SUNOVION$$$$$$Y$$$20240830$$CN$US$US
240357511$24035751$1$I$$20240628$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104769$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240701$$CN$US$US
240357532$24035753$2$F$$20240701$20240701$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104821$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240702$$HP$US$US
240357543$24035754$3$F$20220101$20240716$20240701$20240718$EXP$$CL-PFIZER INC-PV202400084855$PFIZER$$78$YR$$F$Y$41$KG$20240718$$CN$CL$CL
240357551$24035755$1$I$20240502$20240627$20240701$20240701$EXP$FR-AFSSAPS-PB2024000702$FR-PFIZER INC-202400202126$PFIZER$$76$YR$$M$Y$78$KG$20240701$$MD$FR$FR
240357561$24035756$1$I$20240527$20240630$20240701$20240701$EXP$$KW-PFIZER INC-PV202400086010$PFIZER$$45$YR$$F$Y$$$20240701$$MD$KW$KW
240357571$24035757$1$I$$20240627$20240701$20240701$EXP$$US-PFIZER INC-PV202300023995$PFIZER$$80$YR$$M$Y$$$20240701$$HP$US$US
240357581$24035758$1$I$20240622$20240627$20240701$20240701$EXP$$MY-PFIZER INC-PV202400086039$PFIZER$$88$YR$$F$Y$$$20240701$$CN$MY$MY
240357601$24035760$1$I$$20231010$20240701$20240701$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01127$TARO$$$$$$Y$$$20240701$$CN$US$US
240357611$24035761$1$I$20240622$20240624$20240701$20240701$PER$$US-MYLANLABS-2024M1058023$MYLAN$$76$YR$$F$Y$70.76$KG$20240701$$CN$US$US
240357663$24035766$3$F$$20240903$20240701$20240911$EXP$$IN-VANTIVE-2024VAN018037$Vantive US Healthcare$$60$YR$$M$Y$$$20240911$$CN$IN$IN
240357672$24035767$2$F$20240622$20240627$20240701$20240704$EXP$$IN-VANTIVE-2024VAN017995$Vantive US Healthcare$$26$YR$$F$Y$$$20240704$$CN$IN$IN
240357681$24035768$1$I$$20240621$20240701$20240701$EXP$$CA-TEVA-VS-3213045$TEVA$$58$YR$$M$Y$$$20240701$$HP$CA$CA
240357701$24035770$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406280855400820-VQTNC$GB-ORGANON-O2406GBR002730$ORGANON$$$$$M$Y$$$20240701$$CN$GB$GB
240357712$24035771$2$F$20240625$20240625$20240701$20240702$30DAY$$US-PFIZER INC-PV202400083784$PFIZER$$34$YR$$F$Y$$$20240702$$CN$US$US
240357732$24035773$2$F$20240622$20240722$20240701$20240725$30DAY$$US-PFIZER INC-PV202400083860$PFIZER$$40$YR$$F$Y$68.934$KG$20240725$$CN$US$US
240357744$24035774$4$F$20200101$20240926$20240701$20240926$EXP$$GB-PFIZER INC-202400202365$PFIZER$$$$$$Y$$$20240926$$MD$GB$GB
240357762$24035776$2$F$$20240731$20240701$20240731$30DAY$$FR-PFIZER INC-202400199485$PFIZER$$60$YR$$F$Y$$$20240731$$PH$FR$FR
240357775$24035777$5$F$$20240903$20240701$20240905$30DAY$$KR-PFIZER INC-202400202312$PFIZER$$12$YR$$$Y$$$20240905$$CN$KR$KR
240357781$24035778$1$I$$20240617$20240701$20240701$PER$$US-ROCHE-10000000910$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
240357791$24035779$1$I$$20240624$20240701$20240701$PER$$US-MYLANLABS-2024M1060753$MYLAN$$$$$M$Y$$$20240701$$HP$US$US
240357801$24035780$1$I$$20240417$20240701$20240701$EXP$$US-CIPLA LTD.-2024US05691$CIPLA$Curtis TM, Sady KM, Randall JT, Kervin P, Mosher DM, Dailey MW. 18-month-old with lethargy and accelerated idioventricular rhythm in prehospital setting: A case report.. Prehospital emergency care. 2024;1 to 4$$$$$Y$$$20240701$$MD$US$US
240357811$24035781$1$I$$20240625$20240701$20240701$EXP$$AU-TAKEDA-2024TUS063240$TAKEDA$$40$YR$$F$Y$$$20240701$$HP$AU$AU
240357822$24035782$2$F$$20240626$20240701$20240703$EXP$$EC-ROCHE-10000007764$ROCHE$$$$$$Y$$$20240703$$CN$EC$EC
240357831$24035783$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA185610$SANOFI AVENTIS$$$$E$F$Y$$$20240701$$HP$US$US
240357841$24035784$1$I$20240527$20240624$20240701$20240701$EXP$FR-AFSSAPS-MA2024001063$FR-SA-2024SA186488$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240701$$MD$FR$FR
240357851$24035785$1$I$20240610$20240621$20240701$20240701$PER$$US-SA-2024SA188792$SANOFI AVENTIS$$16$YR$T$M$Y$73$KG$20240701$$MD$US$US
240357861$24035786$1$I$$20240626$20240701$20240701$PER$$US-ABBVIE-5819659$ABBVIE$$$$$$Y$$$20240701$$HP$US$US
240357873$24035787$3$F$20240116$20240904$20240701$20240912$EXP$$DE-SERB S.A.S.-2158724$LABORATOIRES SERB$$40$YR$$M$Y$$$20240912$$MD$DE$DE
240357881$24035788$1$I$$20240617$20240701$20240701$EXP$$CN-CorePharma LLC-2158739$COREPHARMA$Source document (Full text)$70$YR$$M$Y$$$20240701$$$CN$CN
240357892$24035789$2$F$$20240822$20240701$20240826$30DAY$$FR-ABBVIE-5818672$ABBVIE$$$$$$Y$$$20240826$$HP$FR$FR
240357901$24035790$1$I$$20240617$20240701$20240701$EXP$$US-CorePharma LLC-2158733$COREPHARMA$Source document (Full text)$17$YR$$F$Y$$$20240701$$$US$US
240357911$24035791$1$I$$20240617$20240701$20240701$EXP$$US-CorePharma LLC-2158731$COREPHARMA$Source document$26$YR$$F$Y$$$20240701$$$US$US
240357931$24035793$1$I$$20240617$20240701$20240701$EXP$$ZA-CorePharma LLC-2158735$COREPHARMA$Source document (Full text)$3$DEC$$M$Y$$$20240701$$$ZA$ZA
240357941$24035794$1$I$$20240624$20240701$20240701$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004735$BIOCON$$$$$$Y$$$20240701$$CN$CA$CA
240357951$24035795$1$I$20240501$20240624$20240701$20240701$PER$$US-ROCHE-10000011365$ROCHE$$21$YR$A$M$Y$$$20240701$$CN$US$US
240357961$24035796$1$I$20240625$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024126468$AMGEN$$75$YR$E$F$Y$$$20240701$$HP$US$US
240357971$24035797$1$I$$20240624$20240701$20240701$EXP$$JP-ALXN-202406JPN001481JP$ALEXION PHARMACEUTICALS$$49$YR$$M$Y$$$20240701$$MD$JP$JP
240357981$24035798$1$I$$20240626$20240701$20240701$EXP$$KR-AstraZeneca-2024A150454$ASTRAZENECA$$$$$M$Y$$$20240701$$CN$KR$
240357994$24035799$4$F$20210621$20240805$20240701$20240813$EXP$$US-ROCHE-10000012816$ROCHE$$13$YR$T$M$Y$$$20240813$$CN$US$US
240358021$24035802$1$I$$20240618$20240701$20240701$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05577$LUPIN$$$$$$Y$$$20240701$$HP$US$US
240358033$24035803$3$F$$20240702$20240701$20240709$PER$$US-ROCHE-10000011053$ROCHE$$$$$$Y$$$20240709$$CN$US$US
240358041$24035804$1$I$20240601$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024128189$AMGEN$$67$YR$E$M$Y$$$20240701$$PH$US$US
240358051$24035805$1$I$20240530$20240624$20240701$20240701$EXP$$CN-JNJFOC-20240666099$JOHNSON AND JOHNSON$$75$YR$E$M$Y$64$KG$20240701$$HP$CN$CN
240358062$24035806$2$F$$20240709$20240701$20240720$30DAY$$US-JNJFOC-20240642934$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$MD$US$US
240358071$24035807$1$I$20240501$20240624$20240701$20240701$EXP$$CN-JNJFOC-20240677135$JOHNSON AND JOHNSON$$76$YR$E$M$Y$69$KG$20240701$$HP$CN$CN
240358081$24035808$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA191178$SANOFI AVENTIS$$$$A$M$Y$117.91$KG$20240701$$MD$US$US
240358092$24035809$2$F$20240222$20240908$20240701$20240909$EXP$$CN-PFIZER INC-PV202400027253$PFIZER$$29$YR$$M$Y$$$20240909$$CN$CN$CN
240358111$24035811$1$I$20240601$20240627$20240701$20240701$PER$$US-MYLANLABS-2024M1060754$MYLAN$$60$YR$$M$Y$$$20240701$$CN$US$US
240358123$24035812$3$F$20240601$20240805$20240701$20240807$EXP$$US-KYOWAKIRIN-2024KK015653$KYOWA$$$$$$Y$$$20240807$$HP$US$US
240358133$24035813$3$F$20230525$20240813$20240701$20240820$EXP$$CO-GSK-CO2024AMR079421$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$CO$CO
240358141$24035814$1$I$$20240624$20240701$20240701$EXP$$IN-JNJFOC-20240670418$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$IN$IN
240358151$24035815$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281145082300-JSMBZ$GB-ORGANON-O2407GBR000011$ORGANON$$$$$$Y$$$20240701$$CN$GB$GB
240358161$24035816$1$I$$20240627$20240701$20240701$EXP$$US-ABBVIE-5821679$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240358172$24035817$2$F$20240620$20240627$20240701$20240703$EXP$$FR-Eisai-EC-2024-169038$EISAI$$$$$F$Y$77$KG$20240703$$MD$FR$FR
240358241$24035824$1$I$$20240619$20240701$20240701$EXP$$US-RDY-LIT/USA/24/0009224$DR REDDYS$Khan A, Murag S, Chinchilla D. When Time Is of the Essence: Fatal Delay in Diagnosis and Surgical Management of Pulmonary Mucormycosis in a Renal Transplant Patient. American Journal of Respiratory and Critical Care Medicine. 2024 May;209:$67$YR$E$M$Y$$$20240701$$HP$US$US
240358252$24035825$2$F$$20240715$20240701$20240717$PER$$NVSC2024US136134$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
240358261$24035826$1$I$$20240628$20240701$20240701$PER$$NVSC2024US136204$NOVARTIS$$$$$$Y$$$20240701$$PH$US$US
240358272$24035827$2$F$$20240627$20240701$20240702$PER$$NVSC2024US135654$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240358281$24035828$1$I$$20240626$20240701$20240701$PER$$NVSC2024US135828$NOVARTIS$$45$YR$$M$Y$150$KG$20240701$$CN$US$US
240358291$24035829$1$I$$20240625$20240701$20240701$EXP$$NVSC2024US134508$NOVARTIS$$77$YR$$M$Y$$$20240701$$HP$US$US
240358301$24035830$1$I$20240606$20240626$20240701$20240701$EXP$$NVSC2024CN135272$NOVARTIS$$57$YR$$M$Y$$$20240701$$HP$CN$CN
240358312$24035831$2$F$$20240628$20240701$20240702$PER$$NVSC2024US135780$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240358321$24035832$1$I$$20240626$20240701$20240701$EXP$$NVSC2024CA134572$NOVARTIS$$$$$F$Y$$$20240701$$MD$CA$CA
240358331$24035833$1$I$$20240623$20240701$20240701$EXP$$NVSC2024IL133197$NOVARTIS$$58$YR$$M$Y$$$20240701$$HP$IL$IL
240358342$24035834$2$F$$20240906$20240701$20240912$EXP$$NVSC2024CN135239$NOVARTIS$Liu K, Sun J. Behcet?s-like disease induced by secukinumab in a patient with psoriasis: a case report and literature review. JOURNAL OF DERMATOLOGICAL TREATMENT. 2024;35 (1):1-5$28$YR$$F$Y$$$20240912$$HP$CN$CN
240358351$24035835$1$I$$20240625$20240701$20240701$PER$$US-MYLANLABS-2024M1060703$MYLAN$$$$$F$Y$$$20240701$$CN$US$US
240358361$24035836$1$I$20240601$20240628$20240701$20240701$PER$$US-MYLANLABS-2024M1061157$MYLAN$$60$YR$$F$Y$$$20240701$$CN$US$US
240358381$24035838$1$I$$20240624$20240701$20240701$EXP$$NVSC2024US134240$NOVARTIS$Gans A, Taylor J, Goel NN. A Case of Drug-Induced Stevens-Johnson Syndrome With Primarily Visceral Involvement. AM-J-RESPIR-CRIT-CARE-MED. 2024;209:A5678$76$YR$$F$Y$$$20240701$$HP$US$US
240358392$24035839$2$F$20240619$20240830$20240701$20240902$EXP$$NVSC2024US135025$NOVARTIS$$61$YR$$F$Y$$$20240902$$CN$US$US
240358401$24035840$1$I$$20240627$20240701$20240701$EXP$$NVSC2024US135320$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
240358411$24035841$1$I$$20240627$20240701$20240701$EXP$$NVSC2024US135126$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
240358421$24035842$1$I$$20240624$20240701$20240701$EXP$$NVSC2024SI131234$NOVARTIS$Vajdic TB. Electrolyte disorders in the emergency department - clinical cases and emergency treatment. EMERGENCY MEDICINE SELECTED TOPICS. 2024;30:142-6$75$YR$$M$Y$$$20240701$$HP$SI$SI
240358431$24035843$1$I$$20240624$20240701$20240701$EXP$$NVSC2024US133506$NOVARTIS$$47$YR$$F$Y$$$20240701$$MD$CH$US
240358441$24035844$1$I$20240602$20240625$20240701$20240701$EXP$$NVSC2024CN135153$NOVARTIS$$67$YR$$M$Y$65$KG$20240701$$HP$CN$CN
240358452$24035845$2$F$$20240826$20240701$20240827$EXP$$NVSC2024BR134744$NOVARTIS$$$$$$Y$$$20240827$$MD$BR$BR
240358461$24035846$1$I$$20240626$20240701$20240701$EXP$$NVSC2024CL135411$NOVARTIS$$$$$M$Y$$$20240701$$MD$CL$CL
240358471$24035847$1$I$$20240625$20240701$20240701$EXP$$NVSC2024CA133080$NOVARTIS$$22$YR$$F$Y$$$20240701$$CN$CA$CA
240358481$24035848$1$I$20240618$20240624$20240701$20240701$EXP$$NVSC2024CN134835$NOVARTIS$$78$YR$$M$Y$50$KG$20240701$$HP$CN$CN
240358491$24035849$1$I$20240501$20240514$20240701$20240701$PER$$US-LUNDBECK-DKLU3078117$LUNDBECK$$$$$$Y$$$20240701$$CN$US$US
240358501$24035850$1$I$$20230612$20240701$20240701$PER$$US-AMGEN-USASP2023235137$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240358511$24035851$1$I$$20230418$20240701$20240701$PER$$US-AMGEN-USASP2023235097$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240358521$24035852$1$I$$20240102$20240701$20240701$PER$$US-AMGEN-USASP2024129652$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240358531$24035853$1$I$$20230726$20240701$20240701$PER$$US-AMGEN-USASP2023235130$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240358541$24035854$1$I$20240623$20240624$20240701$20240701$PER$$US-ALXN-202406USA001552US$ALEXION PHARMACEUTICALS$$49$YR$$F$Y$$$20240701$$CN$US$US
240358551$24035855$1$I$$20240625$20240701$20240701$EXP$$NVSJ2024JP007652$NOVARTIS$$$$$$Y$$$20240701$$MD$JP$JP
240358581$24035858$1$I$$20240628$20240701$20240701$EXP$$NVSC2024ZA135235$NOVARTIS$$$$$$Y$$$20240701$$CN$ZA$ZA
240358594$24035859$4$F$20240601$20240722$20240701$20240726$EXP$$NVSC2024CA134660$NOVARTIS$$69$YR$$F$Y$69$KG$20240726$$MD$CA$CA
240358601$24035860$1$I$20240601$20240624$20240701$20240701$EXP$$NVSC2024RU133529$NOVARTIS$$86$YR$$M$Y$$$20240701$$CN$RU$RU
240358613$24035861$3$F$$20240712$20240701$20240716$PER$$NVSC2024US135987$NOVARTIS$$$$$F$Y$124$KG$20240716$$MD$US$US
240358634$24035863$4$F$20240614$20240903$20240701$20240911$EXP$$NVSC2024US131945$NOVARTIS$$51$YR$$F$Y$$$20240911$$CN$US$US
240358641$24035864$1$I$20210101$20240623$20240701$20240701$EXP$$NVSC2024IL133294$NOVARTIS$$53$YR$$F$Y$$$20240701$$MD$IL$IL
240358652$24035865$2$F$20211201$20240705$20240701$20240708$EXP$$NVSC2024HU134308$NOVARTIS$Bodor A, Benczuz B. Club of Broken-Hearted Women: myth orreality? MINOCA -Takotsubo cardiomyopathy- case study.. LAM. 2024;34(4):205-11$40$YR$$F$Y$$$20240708$$HP$HU$HU
240358661$24035866$1$I$$20240419$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05862$HIKMA$Anderson A, Bourgeois C, Rogers L, Sanne S. Anderson A, Bourgeois C, Rogers L, Sanne S. Methotrexate toxicity in an unusual presentation.. American Journal of the Medical Sciences. 2024;367(Suppl 1):S43$65$YR$$F$Y$$$20240701$$MD$US$US
240358671$24035867$1$I$$20240627$20240701$20240701$EXP$$NVSC2024US135237$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
240358685$24035868$5$F$20170101$20240814$20240701$20240819$EXP$$NVSC2024AR135336$NOVARTIS$$$$$F$Y$$$20240819$$CN$AR$AR
240358691$24035869$1$I$20240402$20240627$20240701$20240701$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-115266$DAIICHI$$65$YR$$M$Y$$$20240701$$MD$US$US
240358701$24035870$1$I$$20240624$20240701$20240701$EXP$$NVSC2024CN135075$NOVARTIS$Zhu Y, Shen W, Zhang Y. Effects of sacubitril valsartan combined with Songling Xuemaikang capsules  for elderly patients with hypertension and chronic heart failure. CHINESE REMEDIES + CLINICS. 2024;24(7):421-7$$$$$Y$$$20240701$$HP$CN$CN
240358714$24035871$4$F$$20240830$20240701$20240903$PER$$NVSC2024US135548$NOVARTIS$$$$$M$Y$$$20240903$$CN$US$US
240358721$24035872$1$I$$20240620$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05830$HIKMA$Hashmi N, Basaleli C, Gupta S, John G, Birnbaum B, Kim U, et al.. Hashmi N, Basaleli C, Gupta S, John G, Birnbaum B, Kim U, et al. Acute Eosinophilic Pneumonia in the Setting of Intramuscular Progesterone Usage.. American Journal of Respiratory and Critical Care Medicine. 2024;209: A6397$33$YR$$F$Y$$$20240701$$MD$US$US
240358731$24035873$1$I$$20240628$20240701$20240701$PER$$NVSC2024US136009$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
240358741$24035874$1$I$$20240627$20240701$20240701$PER$$NVSC2024US135630$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
240358751$24035875$1$I$$20240625$20240701$20240701$EXP$$NVSC2024CA132946$NOVARTIS$$40$YR$$F$Y$$$20240701$$PH$CA$CA
240358761$24035876$1$I$$20240626$20240701$20240701$EXP$$NVSC2024CN135220$NOVARTIS$$$$A$$Y$$$20240701$$CN$CN$CN
240358771$24035877$1$I$$20240624$20240701$20240701$EXP$$NVSC2024US132572$NOVARTIS$$72$YR$$M$Y$$$20240701$$MD$US$US
240358782$24035878$2$F$$20240815$20240701$20240815$PER$$NVSC2024US135598$NOVARTIS$$65$YR$$M$Y$$$20240815$$HP$US$US
240358792$24035879$2$F$$20240626$20240701$20240702$EXP$PT-EMA-DD-20240612-7482645-081752$NVSC2024PT134339$NOVARTIS$$$$E$$Y$$$20240702$$CN$PT$PT
240358801$24035880$1$I$20240614$20240619$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406013501$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240701$$CN$US$US
240358811$24035881$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019420$ELI LILLY AND CO$$$$A$F$Y$$$20240701$$CN$US$US
240358821$24035882$1$I$$20240626$20240701$20240701$PER$$NVSC2024US135622$NOVARTIS$$$$$F$Y$$$20240701$$HP$US$US
240358833$24035883$3$F$20240101$20240802$20240701$20240809$EXP$$JP-ABBVIE-5821646$ABBVIE$$59$YR$$M$Y$60$KG$20240809$$MD$JP$JP
240358841$24035884$1$I$$20240626$20240701$20240701$PER$$NVSC2024US134109$NOVARTIS$$$$$$Y$$$20240701$$CN$US$US
240358851$24035885$1$I$20240627$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000011$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240701$$CN$US$US
240358861$24035886$1$I$20150904$20240610$20240701$20240701$EXP$$NVSC2024CA132992$NOVARTIS$$59$YR$$M$Y$89.9$KG$20240701$$CN$CA$CA
240358872$24035887$2$F$20240101$20240708$20240701$20240710$EXP$$NVSC2024ES110948$NOVARTIS$$72$YR$$F$Y$$$20240710$$HP$ES$ES
240358881$24035888$1$I$20240415$20240628$20240701$20240701$EXP$PT-INFARMED-T202406-83$NVSC2024PT135180$NOVARTIS$$51$YR$$F$Y$63$KG$20240701$$PH$PT$PT
240358891$24035889$1$I$$20240628$20240701$20240701$PER$$NVSC2024US136152$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
240358901$24035890$1$I$$20240624$20240701$20240701$EXP$$NVSC2024US132363$NOVARTIS$$$$$M$Y$$$20240701$$MD$US$US
240358912$24035891$2$F$20240623$20240814$20240701$20240821$EXP$$NVSC2024DE134376$NOVARTIS$$$$A$F$Y$$$20240821$$CN$DE$DE
240358921$24035892$1$I$$20240627$20240701$20240701$EXP$$NVSC2024US134929$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
240358931$24035893$1$I$$20240625$20240701$20240701$EXP$$FR-MYLANLABS-2024M1057945$MYLAN$$$$$F$Y$$$20240701$$CN$FR$FR
240358941$24035894$1$I$$20240625$20240701$20240701$EXP$$FR-MYLANLABS-2024M1061489$MYLAN$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$47$YR$$M$Y$$$20240701$$HP$FR$FR
240358951$24035895$1$I$$20240624$20240701$20240701$PER$$US-LUNDBECK-DKLU4000957$LUNDBECK$$$$$$Y$$$20240701$$CN$US$US
240358961$24035896$1$I$$20240626$20240701$20240701$PER$$NVSC2024US135620$NOVARTIS$$$$$F$Y$$$20240701$$HP$US$US
240358971$24035897$1$I$$20240625$20240701$20240701$EXP$$PL-MYLANLABS-2024M1058604$MYLAN$Mekarska, M. Intracranial abscess as a complication of acute bacterial sinusitis of odontogenic origin - a case report. POLSKI PRZEGLAD OTORYNOLARYNGOLOGICZNY. 2023;4:51-56$26$YR$$M$Y$$$20240701$$MD$PL$PL
240358981$24035898$1$I$$20240625$20240701$20240701$EXP$$FR-MYLANLABS-2024M1061401$MYLAN$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$43$YR$$M$Y$$$20240701$$HP$FR$FR
240358991$24035899$1$I$$20240625$20240701$20240701$EXP$$FR-MYLANLABS-2024M1061510$MYLAN$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. J-Clin-Immunol 2023; 43 (3): 647-652.$3$YR$$M$Y$$$20240701$$HP$FR$FR
240359001$24035900$1$I$$20240625$20240701$20240701$EXP$$FR-MYLANLABS-2024M1061500$MYLAN$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$33$YR$$M$Y$$$20240701$$HP$FR$FR
240359011$24035901$1$I$$20240625$20240701$20240701$EXP$$FR-MYLANLABS-2024M1061507$MYLAN$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$49$YR$$M$Y$$$20240701$$HP$FR$FR
240359021$24035902$1$I$$20240624$20240701$20240701$EXP$$NVSC2024CN135105$NOVARTIS$Liu Y, Shen Y, Qiu L, Liu X. Prescription review strategy and case analysis of medical damage related to ADR. CHINESE JOURNAL OF HOSPITAL PHARMACY. 1-8$$$$$Y$$$20240701$$HP$CN$CN
240359032$24035903$2$F$$20240628$20240701$20240702$PER$$NVSC2024US135783$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240359041$24035904$1$I$$20240626$20240701$20240701$EXP$$NVSC2024CN135209$NOVARTIS$$$$A$$Y$$$20240701$$CN$CN$CN
240359061$24035906$1$I$$20240627$20240701$20240701$EXP$$NVSC2024US134987$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
240359071$24035907$1$I$$20240625$20240701$20240701$EXP$$NVSC2024CN134833$NOVARTIS$$50$YR$$M$Y$$$20240701$$CN$CN$CN
240359082$24035908$2$F$$20240826$20240701$20240902$PER$$NVSC2024US132566$NOVARTIS$$$$A$F$Y$124$KG$20240902$$CN$US$US
240359091$24035909$1$I$$20240628$20240701$20240701$PER$$NVSC2024US136203$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
240359101$24035910$1$I$$20240625$20240701$20240701$EXP$$IT-MYLANLABS-2024M1057863$MYLAN$Alessandro Perna, Mariarosaria Campise, Carlo Maria Alferi, Anna Regalia, Donata Cresseri, Maria Teresa Gandolfo, Giuseppe Castellano.. Kidney transplantation in patients with ANCA?associated vasculitisis associated with a high incidence of post?transplant cancer.. Journal of nephrology. 2024;4:9$57$YR$$F$Y$$$20240701$$MD$IT$IT
240359111$24035911$1$I$$20240628$20240701$20240701$EXP$$NVSC2024GB135593$NOVARTIS$$62$YR$$F$Y$$$20240701$$HP$GB$GB
240359121$24035912$1$I$20240219$20240627$20240701$20240701$EXP$$NVSC2024US135834$NOVARTIS$$57$YR$$M$Y$$$20240701$$CN$US$US
240359131$24035913$1$I$$20240618$20240701$20240701$EXP$$NVSC2024CH130708$NOVARTIS$Kolev M, Sarbu A-C, Moller B, Maurer B, Kollert F, Semmo N. Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis - a case series. JOURNAL OF TRANSLATIONAL AUTOIMMUNITY. 2023;6:1-8$37$YR$$M$Y$$$20240701$$HP$CH$CH
240359143$24035914$3$F$20240307$20240709$20240701$20240905$EXP$$NVSC2024HU132990$NOVARTIS$$63$DY$$M$Y$4.68$KG$20240905$$MD$HU$HU
240359151$24035915$1$I$$20240620$20240701$20240701$EXP$$US-MYLANLABS-2024M1058168$MYLAN$Abdalla AA, Ali RF, Zamora-Martinez AC, Wesselius LJ. Vexas Syndrome Presenting as Recurrent Relapses of Organizing Pneumonia- A Case Series. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A5321.$69$YR$$M$Y$$$20240701$$HP$US$US
240359171$24035917$1$I$$20240630$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104537$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$90.26$KG$20240701$$CN$US$US
240359183$24035918$3$F$20240701$20240819$20240701$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104558$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$107.5$KG$20240820$$HP$US$US
240359191$24035919$1$I$$20240630$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104520$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$98.43$KG$20240701$$CN$US$US
240359202$24035920$2$F$20240622$20240729$20240701$20240802$PER$$NVSC2024US136158$NOVARTIS$$69$YR$$F$Y$$$20240802$$HP$US$US
240359211$24035921$1$I$20240401$20240624$20240701$20240701$EXP$$NVSC2024PL125269$NOVARTIS$$73$YR$$F$Y$$$20240701$$CN$PL$PL
240359221$24035922$1$I$20240315$20240625$20240701$20240701$EXP$$NVSC2024FR135365$NOVARTIS$$$$A$F$Y$82$KG$20240701$$MD$FR$FR
240359231$24035923$1$I$20240501$20240624$20240701$20240701$EXP$$NVSC2024BR134642$NOVARTIS$$45$YR$$F$Y$66$KG$20240701$$CN$BR$BR
240359243$24035924$3$F$20240605$20240807$20240701$20240812$EXP$$NVSC2024BR134678$NOVARTIS$$84$YR$$M$Y$64$KG$20240812$$CN$BR$BR
240359251$24035925$1$I$$20240627$20240701$20240701$PER$$NVSC2024US135318$NOVARTIS$$$$$$Y$$$20240701$$CN$US$US
240359261$24035926$1$I$$20240626$20240701$20240701$PER$$NVSC2024US134341$NOVARTIS$$$$$$Y$$$20240701$$CN$US$US
240359272$24035927$2$F$20240326$20240904$20240701$20240905$EXP$$NVSC2024CA135752$NOVARTIS$$33$YR$$F$Y$$$20240905$$MD$CA$CA
240359281$24035928$1$I$20240623$20240626$20240701$20240701$PER$$US-JNJFOC-20240672088$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240701$$CN$US$US
240359291$24035929$1$I$20240513$20240628$20240701$20240701$EXP$$NVSC2024AZ120268$NOVARTIS$$5$YR$$F$Y$$$20240701$$HP$AZ$AZ
240359302$24035930$2$F$$20240628$20240701$20240704$EXP$$JP-JNJFOC-20240677326$JOHNSON AND JOHNSON$Toyama K, Yasuhara Y, Asada H, Ishiki T, Kochihira T, Shinjo O, et al. 37 A case of a depressed patient with a history of atrial fibrillation and heart failure who overdosed on amiodarone, rivaroxaban, and bisoprolol. Okinawa Medical Journal. 2024;63(1):51$49$YR$A$M$Y$$$20240704$$MD$JP$JP
240359311$24035931$1$I$$20240624$20240701$20240701$EXP$$NVSC2024US134515$NOVARTIS$Hodson EL, Kranyak A, Salem I, Buckey JC. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases.. JOURNAL OF TISSUE VIABILITY. 2024$54$YR$$F$Y$$$20240701$$HP$US$US
240359321$24035932$1$I$$20240624$20240701$20240701$EXP$$NVSC2024DE131101$NOVARTIS$Hansel A, Oms E, Tronnier M. Drug reaction with eosinophilia and systemic symptoms (DRESS): a hypersensitivity reaction with various symptoms.. DERMATOLOGIE. 2024$47$YR$$F$Y$$$20240701$$HP$DE$DE
240359331$24035933$1$I$20240616$20240628$20240701$20240701$EXP$$US-ABBVIE-5821474$ABBVIE$$80$YR$$F$Y$$$20240701$$CN$US$US
240359341$24035934$1$I$20240104$20240112$20240701$20240701$EXP$GB-MHRA-MED-202401111501317780-KRCMN$GB-TEVA-VS-3146819$TEVA$$$$$M$Y$$$20240701$$MD$GB$GB
240359351$24035935$1$I$$20240627$20240701$20240701$PER$$US-MYLANLABS-2024M1061348$MYLAN$$$$$F$Y$$$20240701$$MD$US$US
240359372$24035937$2$F$$20240711$20240701$20240713$PER$$NVSC2024US135623$NOVARTIS$$$$$F$Y$$$20240713$$HP$US$US
240359381$24035938$1$I$20240101$20240520$20240701$20240701$PER$$US-ROCHE-10000009007$ROCHE$$3$DEC$A$M$Y$$$20240701$$MD$US$US
240359391$24035939$1$I$$20240621$20240701$20240701$EXP$$DE-AMGEN-DEUSP2024129662$AMGEN$Kloehn J. Salvage Treatment of Progressive Severe Chronic Graft-versus-host disease by Immune Ablation and Stem Cell Rescue In 2 Pediatric Patients. Bone Marrow Transplantation. 2023;58 (Suppl 1):579$16$YR$T$M$Y$$$20240701$$HP$DE$DE
240359402$24035940$2$F$20240514$20240724$20240701$20240903$PER$$US-LUNDBECK-DKLU3078084$LUNDBECK$$$$$$Y$$$20240903$$CN$US$US
240359411$24035941$1$I$20240601$20240625$20240701$20240701$EXP$$US-SA-2024SA190239$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240701$$MD$US$US
240359421$24035942$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024126603$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240359431$24035943$1$I$20161215$20240624$20240701$20240701$EXP$AT-BASGAGES-184867$AT-GSK-AT2018117044$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$AT$AT
240359441$24035944$1$I$$20240625$20240701$20240701$PER$$US-MYLANLABS-2024M1060720$MYLAN$$$$$F$Y$$$20240701$$CN$US$US
240359451$24035945$1$I$20240101$20240621$20240701$20240701$PER$$US-SA-2024SA187135$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240701$$CN$US$US
240359461$24035946$1$I$$20240618$20240701$20240701$PER$$US-ALKERMES INC.-ALK-2024-001693$ALKERMES$$38$YR$$M$Y$$$20240701$$MD$US$US
240359471$24035947$1$I$$20230814$20240701$20240701$PER$$US-AMGEN-USASP2023235122$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240359481$24035948$1$I$$20230609$20240701$20240701$PER$$US-AMGEN-USASP2023235141$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240359492$24035949$2$F$$20240624$20240701$20240705$EXP$$US-JNJFOC-20240654834$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$PH$US$US
240359503$24035950$3$F$20240327$20240818$20240701$20240823$PER$$US-JNJFOC-20240654384$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240823$$HP$US$US
240359511$24035951$1$I$$20240624$20240701$20240701$EXP$$US-JNJFOC-20240666838$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$US$US
240359522$24035952$2$F$20240617$20240701$20240701$20240708$EXP$$US-LUNDBECK-DKLU4000916$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240359532$24035953$2$F$20240620$20240708$20240701$20240711$EXP$$CA-PFIZER INC-202400203132$PFIZER$$58$YR$$F$Y$$$20240711$$HP$CA$CA
240359551$24035955$1$I$$20240626$20240701$20240701$PER$$US-ABBVIE-5820505$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240359561$24035956$1$I$$20240624$20240701$20240701$EXP$$US-AMGEN-USASP2024125331$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240359572$24035957$2$F$$20240809$20240701$20240814$EXP$$US-SANDOZ INC.-SDZ2024US061518$SANDOZ$$$$$F$Y$$$20240814$$CN$US$US
240359581$24035958$1$I$20240118$20240628$20240701$20240701$EXP$FR-AFSSAPS-TO2024001132$FR-SANDOZ INC.-SDZ2024FR061541$SANDOZ$$63$YR$$F$Y$$$20240701$$PH$FR$FR
240359591$24035959$1$I$$20240624$20240701$20240701$PER$$US-VERTEX PHARMACEUTICALS-2024-010715$VERTEX$$25$YR$$$Y$$$20240701$$CN$US$US
240359601$24035960$1$I$$20240625$20240701$20240701$PER$$US-VERTEX PHARMACEUTICALS-2024-010757$VERTEX$$$$$M$Y$$$20240701$$MD$US$US
240359611$24035961$1$I$$20240625$20240701$20240701$EXP$FR-AFSSAPS-RS2024000588$FR-VERTEX PHARMACEUTICALS-2024-010672$VERTEX$$20$YR$$M$Y$47$KG$20240701$$MD$FR$FR
240359621$24035962$1$I$$20240624$20240701$20240701$EXP$$IT-VERTEX PHARMACEUTICALS-2024-010636$VERTEX$Dacco V, Rosazza C, Mariani A, Rizza C, Ingianni N, Nazzari E, et al.. Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor treatment in children aged 6-11 years with cystic fibrosis in a real-world setting. Pediatr Pulmonol. 2024$$$C$$Y$$$20240701$$HP$IT$IT
240359631$24035963$1$I$$20240626$20240701$20240701$PER$$US-VERTEX PHARMACEUTICALS-2024-010813$VERTEX$$57$YR$$M$Y$$$20240701$$HP$US$US
240359641$24035964$1$I$20240101$20240624$20240701$20240701$EXP$$GB-VERTEX PHARMACEUTICALS-2024-010725$VERTEX$$21$YR$$M$Y$$$20240701$$CN$GB$GB
240359651$24035965$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103992$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240701$$CN$US$US
240359661$24035966$1$I$$20240628$20240701$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-104493$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$MD$JP$JP
240359671$24035967$1$I$$20240617$20240701$20240701$PER$$US-ROCHE-10000006149$ROCHE$$$$$M$Y$$$20240701$$CN$US$US
240359681$24035968$1$I$$20240624$20240701$20240701$PER$$US-VERTEX PHARMACEUTICALS-2020-009923$VERTEX$$$$$M$Y$$$20240701$$CN$US$US
240359692$24035969$2$F$$20240703$20240701$20240712$EXP$$US-TEVA-VS-3213879$TEVA$Mavroudis CD, O^Connor MJ, Wittlieb-Weber C, Edelson JB, Edwards JJ, Berger JH, et al. Hybrid stage 1 palliation with simultaneous off-pump ventricular assist device placement in neonates with high-risk single ventricle anatomy: Initial experience. JTCVS-Tech 2024; 24 (0): 164-168.; Mavroudis CD, O^Connor MJ, Wittlieb-Weber C, Edelson JB, Edwards JJ, Berger JH, et al. Hybrid stage 1 palliation with simultaneous off-pump ventricular assist device placement in neonates with high-risk single ven...$5$DY$$M$Y$$$20240712$$MD$US$US
240359701$24035970$1$I$$20240618$20240701$20240701$PER$$US-ALKERMES INC.-ALK-2024-001694$ALKERMES$$54$YR$$M$Y$$$20240701$$MD$US$US
240359711$24035971$1$I$20240514$20240514$20240701$20240701$PER$$US-LUNDBECK-DKLU3078103$LUNDBECK$$$$$$Y$$$20240701$$HP$US$US
240359741$24035974$1$I$20240401$20240624$20240701$20240701$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-12829$IPSEN$$25$YR$A$F$Y$$$20240701$$HP$US$US
240359751$24035975$1$I$$20240625$20240701$20240701$EXP$$US-MYLANLABS-2024M1061068$MYLAN$$$$$F$Y$$$20240701$$CN$US$US
240359761$24035976$1$I$$20240514$20240701$20240701$PER$$US-LUNDBECK-DKLU3078158$LUNDBECK$$$$$$Y$$$20240701$$CN$US$US
240359771$24035977$1$I$$20230824$20240701$20240701$PER$$US-AMGEN-USASP2023235115$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240359781$24035978$1$I$$20240625$20240701$20240701$PER$$US-JNJFOC-20240673810$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240359791$24035979$1$I$$20240619$20240701$20240701$EXP$$US-RDY-LIT/USA/24/0009237$DR REDDYS$Seibert KE, Bailey MJ, Pruitt DL, Dejesus MS, Toste PA, Hammond TC. Spontaneous Tension Hemopneumothorax After Weight Training. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A4825.$33$YR$A$M$Y$$$20240701$$HP$US$US
240359801$24035980$1$I$20240620$20240620$20240701$20240701$PER$$US-SA-2024SA185616$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240701$$CN$US$US
240359811$24035981$1$I$20231115$20240625$20240701$20240701$EXP$$MY-JNJFOC-20231141576$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$MD$MY$MY
240359821$24035982$1$I$$20240629$20240701$20240701$PER$$US-HALEON-2184589$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240359831$24035983$1$I$$20240214$20240701$20240701$PER$$US-AMGEN-USASP2024129750$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240359841$24035984$1$I$$20240627$20240701$20240701$PER$$US-ABBVIE-5821132$ABBVIE$$$$$$Y$$$20240701$$HP$US$US
240359851$24035985$1$I$$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A148517$ASTRAZENECA$$$$$M$Y$$$20240701$$CN$US$
240359862$24035986$2$F$$20240815$20240701$20240816$EXP$$US-AstraZeneca-2024A150376$ASTRAZENECA$Stanek K., Hussain M. T., Spaulding A. C., Borkar S., Shaikh M. E.. Improving Patient Safety Through Proper Ordering and Administration of Andexanet Alfa. Mayo Clinic Proceedings: Innovations, Quality + Outcomes 2024;8(4):407-414.$74$YR$$M$Y$$$20240816$$MD$US$
240359871$24035987$1$I$20240430$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A147993$ASTRAZENECA$$$$$M$Y$$$20240701$$CN$US$
240359881$24035988$1$I$20240626$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018409$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240701$$PH$US$US
240359891$24035989$1$I$20240601$20240627$20240701$20240701$EXP$$US-ABBVIE-5821324$ABBVIE$$74$YR$$M$Y$$$20240701$$CN$US$US
240359901$24035990$1$I$20240601$20240627$20240701$20240701$EXP$$DE-JNJFOC-20240700597$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240701$$CN$DE$DE
240359911$24035991$1$I$$20240617$20240701$20240701$PER$$US-JNJFOC-20240648436$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240701$$CN$US$US
240359922$24035992$2$F$$20240702$20240701$20240708$PER$$US-ALXN-202406USA001555US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
240359931$24035993$1$I$$20240627$20240701$20240701$EXP$$AE-TAKEDA-2024TUS064946$TAKEDA$$$$$$Y$$$20240701$$CN$AE$AE
240359944$24035994$4$F$$20240724$20240701$20240729$EXP$$US-MYLANLABS-2024M1060735$MYLAN$$$$$F$Y$$$20240729$$PH$US$US
240359981$24035998$1$I$20240501$20240626$20240701$20240701$EXP$$US-UCBSA-2024033130$UCB$$55$YR$$F$Y$$$20240701$$HP$US$US
240359991$24035999$1$I$20240601$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024127588$AMGEN$$$$$M$Y$$$20240701$$CN$US$US
240360001$24036000$1$I$$20240528$20240701$20240701$PER$$US-AMGEN-USASP2024129735$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240360011$24036001$1$I$$20231109$20240701$20240701$PER$$US-AMGEN-USASP2023235177$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240360021$24036002$1$I$$20230419$20240701$20240701$PER$$US-AMGEN-USASP2023235100$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240360031$24036003$1$I$$20230824$20240701$20240701$PER$$US-AMGEN-USASP2023235124$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240360041$24036004$1$I$$20230609$20240701$20240701$PER$$US-AMGEN-USASP2023235108$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240360051$24036005$1$I$$20240621$20240701$20240701$EXP$$US-BAYER-2024A090987$BAYER$$52$YR$A$M$Y$$$20240701$$CN$US$US
240360061$24036006$1$I$20190101$20240625$20240701$20240701$EXP$SE-SEMPA-2024-005025$SE-MYLANLABS-2024M1058208$MYLAN$$$$$F$Y$$$20240701$$CN$SE$SE
240360071$24036007$1$I$20240616$20240625$20240701$20240701$EXP$IT-MINISAL02-991614$IT-MYLANLABS-2024M1058362$MYLAN$$62$YR$$M$Y$95$KG$20240701$$HP$IT$IT
240360081$24036008$1$I$$20240625$20240701$20240701$EXP$$GR-MYLANLABS-2024M1058200$MYLAN$Theofilogiannakos, S. A 30-year-old pregnant woman with a history of lymphoblastic lymphoma 12 years ago who was successfully treated with chemotherapy develops acute heart failure immediately after childbirth. How do we manage the incident?. Hippocratic days of cardiology, presentation. 2024$30$YR$$F$Y$$$20240701$$MD$GR$GR
240360101$24036010$1$I$$20240625$20240701$20240701$EXP$$CA-MYLANLABS-2024M1060716$MYLAN$$38$YR$$F$Y$$$20240701$$CN$CA$CA
240360111$24036011$1$I$$20240625$20240701$20240701$EXP$$CA-MYLANLABS-2024M1060732$MYLAN$$$$$F$Y$$$20240701$$HP$CA$CA
240360121$24036012$1$I$20221101$20231229$20240701$20240701$EXP$GB-MHRA-MED-202312290010238750-JYFNH$GB-TEVA-VS-3146506$TEVA$$23$YR$$M$Y$110$KG$20240701$$CN$GB$GB
240360131$24036013$1$I$$20240619$20240701$20240701$EXP$$US-FreseniusKabi-FK202410069$FRESENIUS KABI$Hossain S, Patten E. Daptomycin-induced Lung Injury. American Journal of Respiratory and Critical Care Medicine. 2024 May;(0):$55$YR$A$M$Y$$$20240701$$HP$US$US
240360141$24036014$1$I$20240603$20240625$20240701$20240701$EXP$$CN-FreseniusKabi-FK202410101$FRESENIUS KABI$$34$YR$A$M$Y$80$KG$20240701$$HP$CN$CN
240360151$24036015$1$I$20240401$20240622$20240701$20240701$PER$$US-SA-2024SA122030$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240701$$MD$US$US
240360172$24036017$2$F$$20240906$20240701$20240911$EXP$$CA-AMGEN-CANSP2024127572$AMGEN$$$$A$F$Y$$$20240911$$HP$CA$CA
240360181$24036018$1$I$$20240623$20240701$20240701$EXP$$IL-TEVA-VS-3214995$TEVA$$83$YR$$F$Y$$$20240701$$HP$IL$IL
240360191$24036019$1$I$$20240625$20240701$20240701$EXP$$FR-MYLANLABS-2024M1061403$MYLAN$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$33$YR$$M$Y$$$20240701$$HP$FR$FR
240360201$24036020$1$I$$20240626$20240701$20240701$PER$$US-ABBVIE-5819700$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240360242$24036024$2$F$$20240627$20240701$20240705$EXP$$US-ROCHE-10000012095$ROCHE$$49$YR$A$F$Y$$$20240705$$MD$US$US
240360251$24036025$1$I$$20240628$20240701$20240701$PER$$US-BAYER-2024A094461$BAYER$$43$YR$A$F$Y$$$20240701$$HP$US$US
240360271$24036027$1$I$$20240624$20240701$20240701$30DAY$$US-PFIZER INC-PV202400083475$PFIZER$$$$$$Y$$$20240701$$PH$US$US
240360281$24036028$1$I$20240617$20240620$20240701$20240701$EXP$$CO-ROCHE-10000006127$ROCHE$$52$YR$A$F$Y$$$20240701$$CN$CO$CO
240360293$24036029$3$F$$20240927$20240701$20240930$30DAY$$FR-PFIZER INC-202400201626$PFIZER$$45$YR$$F$Y$$$20240930$$PH$FR$FR
240360301$24036030$1$I$$20240625$20240701$20240701$EXP$$FR-MYLANLABS-2024M1061482$MYLAN$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$26$YR$$M$Y$$$20240701$$HP$FR$FR
240360322$24036032$2$F$20240701$20240722$20240701$20240729$EXP$$GB-GSK-GB2024EME080062$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$GB$GB
240360331$24036033$1$I$$20240617$20240701$20240701$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091836$GLENMARK$Huang L, Ellis TJ, Bagavathy K.. The Unfortunate Trifecta: Tuberculosis, EBV, and CMV Induced Hemophagocytic Lymphohistiocytosis.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7416$$$$$Y$$$20240701$$MD$US$US
240360342$24036034$2$F$20240626$20240701$20240701$20240703$EXP$$US-TAKEDA-2024TUS014125$TAKEDA$$37$YR$$M$Y$$$20240703$$MD$US$US
240360351$24036035$1$I$$20240508$20240701$20240701$PER$$US-AMGEN-USASP2024129870$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240360361$24036036$1$I$$20240616$20240701$20240701$EXP$$GR-ROCHE-10000012666$ROCHE$Dimou M, Bitsanis A, Chatzidimitriou C, Et al.. The Combination Of Venetoclax - Obinutuzumab As 1st Line Treatment In Patients With Chronic Lymphocytic Leukemia - Daily Clinical Practice Data - A Site^s Experience. Haema. 2022;13 (1):390-2.$$$$$Y$$$20240701$$MD$GR$GR
240360392$24036039$2$F$20240412$20240702$20240701$20240709$EXP$$FR-ABBVIE-5815553$ABBVIE$$37$YR$$F$Y$93$KG$20240709$$MD$FR$FR
240360401$24036040$1$I$20240624$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126058$AMGEN$$65$YR$E$F$Y$$$20240701$$CN$US$US
240360421$24036042$1$I$$20240621$20240701$20240701$EXP$$US-AstraZeneca-2024A149129$ASTRAZENECA$$$$$F$Y$$$20240701$$CN$US$
240360431$24036043$1$I$$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A147787$ASTRAZENECA$$$$$F$Y$$$20240701$$CN$US$
240360441$24036044$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190743$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240701$$CN$US$US
240360471$24036047$1$I$20240625$20240625$20240701$20240701$EXP$$US-ABBVIE-5817604$ABBVIE$$44$YR$$M$Y$$$20240701$$CN$US$US
240360481$24036048$1$I$$20240624$20240701$20240701$EXP$$BR-GSK-BR2024AMR078813$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$BR$BR
240360491$24036049$1$I$$20240619$20240701$20240701$EXP$$US-RDY-LIT/USA/24/0009291$DR REDDYS$Levan SR, Perez A, Kleinhenz M. Burkholderia Cepacia Mediastinitis in a Patient With Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 209:$31$YR$A$F$Y$$$20240701$$HP$US$US
240360501$24036050$1$I$20240531$20240625$20240701$20240701$EXP$$EE-GSK-EE2024EME069749$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$EE$EE
240360511$24036051$1$I$$20240617$20240701$20240701$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091838$GLENMARK$Patel KH, Halicki J, Dachert S, Mamary A.. Large Pericardial Cyst in a Lung Transplant Patient.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A1688$$$$$Y$$$20240701$$MD$US$US
240360521$24036052$1$I$$20240620$20240701$20240701$EXP$$US-FreseniusKabi-FK202410063$FRESENIUS KABI$Alsheimer K, Lantry J, Shah H, Lamichhane B, Burgei W. Genitourinary Tuberculosis Resulting in Hydronephrosis.. American Journal of Respiratory and Critical Care Medicine.. 2024 May;209: doi:https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2354?download=true.$$$$M$Y$$$20240701$$HP$US$US
240360531$24036053$1$I$20140101$20240701$20240701$20240701$EXP$$GB-JNJFOC-20240700610$JOHNSON AND JOHNSON$$$$A$M$Y$73$KG$20240701$$CN$GB$GB
240360543$24036054$3$F$20240601$20240709$20240701$20240711$EXP$$HU-ABBVIE-5819366$ABBVIE$$88$YR$$F$Y$$$20240711$$CN$HU$HU
240360552$24036055$2$F$$20240723$20240701$20240726$PER$$US-ROCHE-10000012716$ROCHE$$58$YR$A$F$Y$$$20240726$$CN$US$US
240360561$24036056$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184575$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240360572$24036057$2$F$$20240709$20240701$20240715$EXP$$US-TAKEDA-2024TUS065599$TAKEDA$$$$$F$Y$$$20240715$$MD$US$US
240360581$24036058$1$I$$20240626$20240701$20240701$PER$$US-ROCHE-3579797$ROCHE$$$$A$M$Y$$$20240701$$CN$US$US
240360591$24036059$1$I$$20240626$20240701$20240701$PER$$US-ABBVIE-5820075$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240360602$24036060$2$F$20231213$20240711$20240701$20240717$EXP$$IT-BAUSCH-BL-2024-010088$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240717$$HP$IT$IT
240360611$24036061$1$I$20240625$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017117$ELI LILLY AND CO$$86$YR$E$M$Y$$$20240701$$CN$US$US
240360621$24036062$1$I$20240527$20240624$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009656$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240360633$24036063$3$F$20240625$20240911$20240701$20240913$30DAY$$CO-PFIZER INC-PV202400084771$PFIZER$$15$YR$$M$Y$$$20240913$$CN$CO$CO
240360643$24036064$3$F$20240626$20240919$20240701$20240923$30DAY$$GT-PFIZER INC-202400202374$PFIZER$$$$C$F$Y$$$20240923$$CN$GT$GT
240360651$24036065$1$I$$20240625$20240701$20240701$30DAY$$CO-PFIZER INC-PV202400084140$PFIZER$$8$YR$$M$Y$$$20240701$$CN$CO$CO
240360662$24036066$2$F$$20240802$20240701$20240806$30DAY$$IT-PFIZER INC-202400197550$PFIZER$$65$YR$$F$Y$$$20240806$$CN$IT$IT
240360673$24036067$3$F$20240615$20240926$20240701$20240930$30DAY$$US-PFIZER INC-202400196451$PFIZER$$4$YR$$M$Y$$$20240930$$CN$US$US
240360703$24036070$3$F$$20240908$20240701$20240909$30DAY$$CO-PFIZER INC-PV202400084072$PFIZER$$9$YR$$F$Y$$$20240909$$MD$CO$CO
240360711$24036071$1$I$$20240624$20240701$20240701$EXP$$AR-GSK-AR2024AMR078968$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$AR$AR
240360721$24036072$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA187559$SANOFI AVENTIS$$$$C$F$Y$$$20240701$$MD$US$US
240360731$24036073$1$I$$20240617$20240701$20240701$PER$$US-JNJFOC-20240646394$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240701$$HP$US$US
240360741$24036074$1$I$$20240626$20240701$20240701$PER$$US-JNJFOC-20240674006$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$HP$US$US
240360753$24036075$3$F$20240607$20240717$20240701$20240730$30DAY$$CA-JNJFOC-20240638015$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240730$$HP$CA$CA
240360761$24036076$1$I$$20240621$20240701$20240701$PER$$US-SA-2023SA297769$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240701$$MD$US$US
240360771$24036077$1$I$$20240627$20240701$20240701$PER$$US-JNJFOC-20240675281$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$US$US
240360781$24036078$1$I$20240618$20240628$20240701$20240701$EXP$$US-JNJFOC-20240678248$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240701$$CN$US$US
240360792$24036079$2$F$20240229$20240722$20240701$20240724$EXP$$US-TAKEDA-2023TUS078061$TAKEDA$$67$YR$$F$Y$$$20240724$$CN$US$US
240360801$24036080$1$I$20230710$20240321$20240701$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-046017$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$50$KG$20240701$$MD$JP$JP
240360812$24036081$2$F$20240619$20240823$20240701$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102832$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$50.8$KG$20240902$$HP$US$US
240360821$24036082$1$I$$20240621$20240701$20240701$EXP$$CA-TEVA-VS-3213016$TEVA$$44$YR$$F$Y$63$KG$20240701$$PH$CA$CA
240360841$24036084$1$I$$20240621$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100355$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$84.37$KG$20240701$$HP$US$US
240360851$24036085$1$I$20240101$20240626$20240701$20240701$EXP$$US-ABBVIE-5818906$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240360861$24036086$1$I$$20240624$20240701$20240701$PER$$US-ABBVIE-5816175$ABBVIE$$$$A$M$Y$$$20240701$$CN$US$US
240360871$24036087$1$I$$20240627$20240701$20240701$PER$$US-ABBVIE-5821691$ABBVIE$$$$$$Y$$$20240701$$CN$US$US
240360882$24036088$2$F$$20240722$20240701$20240726$EXP$$US-TAKEDA-2024TUS063334$TAKEDA$$$$$F$Y$$$20240726$$CN$US$US
240360891$24036089$1$I$20240619$20240624$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009658$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240360941$24036094$1$I$$20240628$20240701$20240701$EXP$$TR-ANIPHARMA-2024-TR-000056$ANI$Alp A, Rollas T, Eroglu EO, et al.Catatonia due to lithium neurotoxicity: a case report..Turk Psikiyatri Dergisi.2024;35(2):150-155.$60$YR$$F$Y$$$20240701$$MD$TR$TR
240360951$24036095$1$I$$20240628$20240701$20240701$EXP$$US-PFIZER INC-202400203484$PFIZER$$$$E$M$Y$$$20240701$$HP$US$US
240360961$24036096$1$I$20240425$20240627$20240701$20240701$EXP$$CN-PFIZER INC-PV202400084978$PFIZER$$58$YR$$F$Y$59$KG$20240701$$HP$CN$CN
240360981$24036098$1$I$20230622$20240628$20240701$20240701$EXP$$AR-PFIZER INC-202400204241$PFIZER$$67$YR$$F$Y$$$20240701$$CN$AR$AR
240360992$24036099$2$F$20220821$20240805$20240701$20240819$EXP$$ES-Rigel Pharmaceuticals, Inc.-20240600050$RIGEL PHARMACEUTICALS$Tom?s Jos? Gonz?lez-L?pez. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. American Society of Hematology. 2024;143:doi:10.1182/blood.2024024250$81$YR$$M$Y$$$20240819$$MD$ES$ES
240361002$24036100$2$F$20230321$20240722$20240701$20240805$EXP$$ES-RIGEL-20240600051$RIGEL PHARMACEUTICALS$Gonzalez-Lopez T.J., Bermejo N., Cardesa-Cabrera R., Mart??nez V., Aguilar-Monserrate G., Perez Segura G., et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Blood. 2024$84$YR$$M$Y$$$20240805$$MD$ES$ES
240361011$24036101$1$I$20230801$20240624$20240701$20240701$EXP$$US-ORGANON-O2406USA002418$ORGANON$$$$$F$Y$$$20240701$$CN$US$US
240361024$24036102$4$F$20240214$20240925$20240701$20240927$EXP$$FR-PFIZER INC-202400202156$PFIZER$$73$YR$$F$Y$87$KG$20240927$$MD$FR$FR
240361031$24036103$1$I$$20240624$20240701$20240701$EXP$$ZA-GSK-ZA2024EME081517$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$ZA$ZA
240361041$24036104$1$I$$20240624$20240701$20240701$EXP$$ZA-VIIV HEALTHCARE LIMITED-ZA2024EME081517$VIIV$$$$$$Y$$$20240701$$MD$ZA$ZA
240361051$24036105$1$I$$20240625$20240701$20240701$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-102595$BRISTOL MYERS SQUIBB$$83$YR$E$$Y$$$20240701$$MD$CH$CH
240361061$24036106$1$I$20240606$20240627$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104487$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240701$$PH$US$US
240361071$24036107$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104767$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240701$$HP$US$US
240361082$24036108$2$F$$20240701$20240701$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104665$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$104.78$KG$20240703$$HP$US$US
240361101$24036110$1$I$$20240624$20240701$20240701$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-102845$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240701$$MD$ES$ES
240361112$24036111$2$F$20240101$20240701$20240701$20240709$EXP$$US-RIGEL PHARMACEUTICALS, INC.-2024FOS000666$RIGEL PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
240361121$24036112$1$I$$20240617$20240701$20240701$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091796$GLENMARK$Wong C, Malik M, Abu-Hashish H, Ang G, Galperin I. Hydralazine to Pulmonary Hemorrhage: A Case of Drug Induced Vasculitis. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240701$$HP$US$US
240361132$24036113$2$F$$20240624$20240701$20240821$PER$$US-CHIESI-2024CHF03832$CHIESI$$15$YR$$F$Y$$$20240821$$CN$US$US
240361143$24036114$3$F$20240610$20240726$20240701$20240805$30DAY$$FI-JNJFOC-20240632243$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240805$$PH$FI$FI
240361151$24036115$1$I$$20240628$20240701$20240701$PER$$US-JNJFOC-20240679682$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$MD$US$US
240361161$24036116$1$I$20240510$20240621$20240701$20240701$EXP$$SG-JNJFOC-20240662305$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240701$$HP$SG$SG
240361171$24036117$1$I$20240401$20240620$20240701$20240701$EXP$$US-Rigel Pharmaceuticals, Inc.-20240600056$RIGEL PHARMACEUTICALS$$79$YR$$M$Y$$$20240701$$CN$US$US
240361181$24036118$1$I$20240501$20240624$20240701$20240701$PER$$US-BIOGEN-2024BI01266106$BIOGEN$$37$YR$$F$Y$$$20240701$$CN$US$US
240361191$24036119$1$I$$20240625$20240701$20240701$PER$$US-ABBVIE-5817556$ABBVIE$$$$$F$Y$$$20240701$$HP$US$US
240361201$24036120$1$I$$20240624$20240701$20240701$PER$$US-BIOGEN-2024BI01270889$BIOGEN$$$$$$Y$$$20240701$$CN$US$US
240361211$24036121$1$I$$20240624$20240701$20240701$PER$$US-BIOGEN-2024BI01270951$BIOGEN$$$$$F$Y$$$20240701$$CN$US$US
240361221$24036122$1$I$$20240623$20240701$20240701$PER$$US-MYLANLABS-2024M1057978$MYLAN$$$$$F$Y$$$20240701$$MD$US$US
240361231$24036123$1$I$$20240617$20240701$20240701$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091920$GLENMARK$Kim AH, Taha W, Prudenti J.. A critical case of hydralazine-induced vasculitis presenting with pulmonary renal syndrome. American journal of respiratory and critical care medicine. 2024;209:A7071$$$$$Y$$$20240701$$HP$US$US
240361241$24036124$1$I$20240524$20240627$20240701$20240701$EXP$$CN-AstraZeneca-2024A149868$ASTRAZENECA$$12275$DY$$F$Y$$$20240701$$MD$CN$
240361251$24036125$1$I$20240523$20240624$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009664$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240361261$24036126$1$I$20230817$20240626$20240701$20240701$EXP$$DK-AstraZeneca-2024A147258$ASTRAZENECA$$92$YR$$F$Y$58$KG$20240701$$MD$DK$
240361271$24036127$1$I$20050303$20240624$20240701$20240701$EXP$$ES-AstraZeneca-2024A142219$ASTRAZENECA$$21$YR$$F$Y$50$KG$20240701$$MD$ES$
240361281$24036128$1$I$$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A147825$ASTRAZENECA$$$$$F$Y$$$20240701$$CN$US$
240361292$24036129$2$F$20240625$20240703$20240701$20240712$EXP$$DE-TG THERAPEUTICS INC.-TGT003737$TG THERAPEUTICS$$$$$$Y$$$20240712$$HP$DE$DE
240361302$24036130$2$F$$20240703$20240701$20240711$EXP$$GB-AstraZeneca-2024A150790$ASTRAZENECA$$$$E$M$Y$$$20240711$$MD$GB$
240361334$24036133$4$F$$20240903$20240701$20240905$30DAY$$US-PFIZER INC-202400201895$PFIZER$$7$YR$$M$Y$$$20240905$$CN$US$US
240361342$24036134$2$F$$20240916$20240701$20240919$30DAY$$CO-PFIZER INC-202400201731$PFIZER$$$$$M$Y$$$20240919$$CN$CO$CO
240361353$24036135$3$F$$20240802$20240701$20240802$30DAY$$US-PFIZER INC-202400201858$PFIZER$$15$YR$$M$Y$68.04$KG$20240802$$CN$US$US
240361362$24036136$2$F$20240619$20240622$20240701$20240705$EXP$$CN-SA-2024SA188450$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240705$$HP$CN$CN
240361371$24036137$1$I$$20240624$20240701$20240701$EXP$$DE-TAKEDA-2024TUS063367$TAKEDA$$$$$M$Y$$$20240701$$PH$DE$DE
240361381$24036138$1$I$$20240627$20240701$20240701$30DAY$$US-GSK-US2024080333$GLAXOSMITHKLINE$$$$$M$Y$$$20240701$$CN$US$US
240361391$24036139$1$I$20240503$20240621$20240701$20240701$EXP$$SG-JNJFOC-20240662019$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240701$$HP$SG$SG
240361412$24036141$2$F$20220602$20240720$20240701$20240724$EXP$$CA-GSK-CA2022AMR089718$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$CA$CA
240361421$24036142$1$I$$20240621$20240701$20240701$PER$$US-JNJFOC-20240658070$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$HP$US$US
240361431$24036143$1$I$20200224$20240621$20240701$20240701$EXP$PL-URPL-1-1183-2020$PL-TEVA-VS-3213111$TEVA$$19$YR$$M$Y$67$KG$20240701$$MD$PL$PL
240361441$24036144$1$I$20240101$20240627$20240701$20240701$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037042$BOEHRINGER INGELHEIM$$84$YR$E$F$Y$$$20240701$$CN$US$US
240361451$24036145$1$I$20240625$20240627$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104518$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240701$$CN$US$US
240361461$24036146$1$I$$20240627$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103667$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240701$$CN$US$US
240361471$24036147$1$I$$20240617$20240701$20240701$EXP$$IN-ROCHE-10000004828$ROCHE$$$$E$M$Y$$$20240701$$CN$IN$IN
240361481$24036148$1$I$$20240617$20240701$20240701$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091993$GLENMARK$Peters JD, Shastri D, Hajjar S, York J, Erpenwar S, Vanlandingham A.. A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240701$$HP$US$US
240361491$24036149$1$I$$20240622$20240701$20240701$PER$$US-SA-2024SA189586$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240701$$MD$US$US
240361501$24036150$1$I$$20231212$20240701$20240701$PER$$US-AMGEN-USASP2023235017$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240361511$24036151$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184567$Haleon PLC$$$$$F$Y$$$20240701$$CN$US$US
240361521$24036152$1$I$20230108$20240626$20240701$20240701$EXP$$AU-OTSUKA-2024_018234$OTSUKA$$96$YR$$$Y$$$20240701$$HP$AU$AU
240361531$24036153$1$I$20240509$20240624$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009676$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240361541$24036154$1$I$20240606$20240621$20240701$20240701$EXP$$CN-TAKEDA-2024TUS063243$TAKEDA$$79$YR$$M$Y$45$KG$20240701$$HP$CN$CN
240361551$24036155$1$I$$20240621$20240701$20240701$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0600928$MYOVANT SCIENCES$$$$$M$Y$$$20240701$$HP$US$US
240361572$24036157$2$F$$20240813$20240701$20240820$EXP$$CA-GSK-CA2024078597$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$MD$CA$CA
240361591$24036159$1$I$20240607$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104909$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240701$$PH$US$US
240361601$24036160$1$I$20240101$20240624$20240701$20240701$EXP$$FR-FreseniusKabi-FK202409916$FRESENIUS KABI$$75$YR$E$M$Y$$$20240701$$MD$FR$FR
240361611$24036161$1$I$20240615$20240624$20240701$20240701$EXP$$DE-FreseniusKabi-FK202409941$FRESENIUS KABI$$$$E$F$Y$49.7$KG$20240701$$MD$DE$DE
240361623$24036162$3$F$$20240702$20240701$20240704$PER$$US-HALEON-2184577$Haleon PLC$$62$YR$$M$Y$$$20240704$$CN$US$US
240361631$24036163$1$I$20220101$20240624$20240701$20240701$EXP$$US-RDY-CLI/USA/23/0177077$DR REDDYS$$27$YR$A$F$Y$$$20240701$$MD$US$US
240361641$24036164$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184594$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240361651$24036165$1$I$$20240617$20240701$20240701$EXP$$US-RIGEL-20240600029$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240701$$HP$US$US
240361662$24036166$2$F$20240501$20240719$20240701$20240723$EXP$$US-UCBSA-2024033125$UCB$$62$YR$$F$Y$$$20240723$$HP$US$US
240361672$24036167$2$F$20240101$20240904$20240701$20240913$EXP$$US-UCBSA-2024033126$UCB$$$$$F$Y$$$20240913$$MD$US$US
240361682$24036168$2$F$$20240702$20240701$20240729$EXP$$US-APELLIS-2024-APL-0000352$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
240361691$24036169$1$I$20240616$20240624$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009677$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240361702$24036170$2$F$20240601$20240726$20240701$20240729$PER$$US-AMGEN-USASP2024127465$AMGEN$$75$YR$E$F$Y$$$20240729$$HP$US$US
240361711$24036171$1$I$$20240528$20240701$20240701$PER$$US-AMGEN-USASP2024129817$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240361724$24036172$4$F$20240101$20240901$20240701$20240905$EXP$$US-009507513-2406USA007415$MERCK$$$$$F$Y$66.667$KG$20240905$$HP$US$US
240361731$24036173$1$I$$20240530$20240701$20240701$PER$$US-AMGEN-USASP2024129813$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240361741$24036174$1$I$$20231126$20240701$20240701$PER$$US-AMGEN-USASP2023235184$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240361751$24036175$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA191565$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240701$$MD$US$US
240361762$24036176$2$F$20240501$20240813$20240701$20240826$PER$$US-SA-2024SA182184$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240826$$MD$US$US
240361771$24036177$1$I$$20240617$20240701$20240701$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091923$GLENMARK$Singh N, Ramonell RP, Cody B, Dunlap DG.. A Growing Concern: Solitary Pulmonary Nodule Caused by Pneumocystis Jirovecci in an Immunocompromised Patient. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2381$$$$$Y$$$20240701$$HP$US$US
240361791$24036179$1$I$$20231218$20240701$20240701$PER$$US-AMGEN-USASP2023235132$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240361801$24036180$1$I$$20240627$20240701$20240701$EXP$$NVSC2024US135022$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
240361822$24036182$2$F$20240301$20240826$20240701$20240829$EXP$$US-OTSUKA-2024_017757$OTSUKA$$63$YR$$M$Y$69.4$KG$20240829$$CN$US$US
240361831$24036183$1$I$20240101$20240627$20240701$20240701$EXP$$US-ABBVIE-5821486$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240361841$24036184$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184568$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240361851$24036185$1$I$$20240625$20240701$20240701$EXP$$ES-Rigel Pharmaceuticals, Inc.-20240600079$RIGEL PHARMACEUTICALS$Tom?s Jos? Gonzalez-Lopez. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. American Society of Hematology. 2024;143:doi:10.1182/blood.2024024250$65$YR$$F$Y$$$20240701$$MD$ES$ES
240361861$24036186$1$I$$20240626$20240701$20240701$PER$$US-TAKEDA-2024TUS064706$TAKEDA$$$$$F$Y$$$20240701$$MD$US$US
240361871$24036187$1$I$$20240626$20240701$20240701$EXP$$CA-TAKEDA-2023TUS104749$TAKEDA$$$$$M$Y$$$20240701$$CN$CA$CA
240361881$24036188$1$I$20240401$20240626$20240701$20240701$EXP$$ZA-AstraZeneca-2024A147831$ASTRAZENECA$$79$YR$$F$Y$$$20240701$$CN$ZA$
240361893$24036189$3$F$$20240711$20240701$20240719$EXP$$CA-AstraZeneca-2024A149161$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$CA$
240361901$24036190$1$I$$20240627$20240701$20240701$EXP$$AU-MYLANLABS-2024M1050328$MYLAN$$$$$F$Y$$$20240701$$MD$AU$AU
240361911$24036191$1$I$20240628$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104908$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240701$$PH$US$US
240361921$24036192$1$I$20240528$20240624$20240701$20240701$EXP$FR-AFSSAPS-PB2024000700$FR-FreseniusKabi-FK202410023$FRESENIUS KABI$$60$YR$A$M$Y$$$20240701$$MD$FR$FR
240361931$24036193$1$I$$20240626$20240701$20240701$EXP$$IN-MYLANLABS-2024M1061423$MYLAN$Edison DC, Philip J, Mallhi RS, Basnotra R, Pynadath V, Sane K. Severe amlodipine toxicity: A medical dilemma managed with therapeutic plasma exchange. Transfus-Apheresis-Sci 2024; 63 (4).$$$$M$Y$$$20240701$$HP$IN$IN
240361941$24036194$1$I$$20240626$20240701$20240701$EXP$$AU-MYLANLABS-2024M1061404$MYLAN$Gerostamoulos D, Glowacki L, Pricone M, Crump K, Rago MD, Joubert S, et al. Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMe. J-Anal-Toxicol 2022; 47 (2): 191-196.$$$$M$Y$$$20240701$$HP$AU$AU
240361951$24036195$1$I$$20240619$20240701$20240701$EXP$$US-RDY-LIT/USA/24/0009293$DR REDDYS$McFarland BJ, Luo A, McFarland BJ. Male breast cancer: Report of two cases with bloody nipple discharge. Radiology Case Reports. 18(9): 3323-3330. doi:10.1016/j.radcr.2023.07.001.$70$YR$E$M$Y$$$20240701$$MD$US$US
240361961$24036196$1$I$$20240625$20240701$20240701$EXP$GB-MHRA-MED-202406242311213390-ZCTFL$GB-RDY-SPO/GBR/24/0009275$DR REDDYS$$$$$F$Y$60$KG$20240701$$CN$GB$GB
240361971$24036197$1$I$$20240619$20240701$20240701$PER$$US-RDY-LIT/USA/24/0009238$DR REDDYS$Bains SS, Mccormick C, Brixey A, Vranas KC, Kim S. A Case of Acute Eosinophilic Pneumonia Secondary to Daptomycin. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: A2001. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2001.$75$YR$E$M$Y$$$20240701$$HP$US$US
240361981$24036198$1$I$$20240620$20240701$20240701$EXP$$US-RDY-LIT/USA/24/0009315$DR REDDYS$Aribindi K, Arif MZ, Quon SM, Inaty H. From the Pipes to the Pleural Space: A Rare Case of a Cryptococcal Effusion. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6007.$54$YR$A$F$Y$$$20240701$$HP$US$US
240361991$24036199$1$I$$20240627$20240701$20240701$EXP$$US-BAYER-2024A093276$BAYER$$$$$$Y$$$20240701$$CN$US$US
240362001$24036200$1$I$20240616$20240625$20240701$20240701$EXP$$CN-JNJFOC-20240676127$JOHNSON AND JOHNSON$$1$YR$I$M$Y$10$KG$20240701$$HP$CN$CN
240362011$24036201$1$I$$20240617$20240701$20240701$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091825$GLENMARK$Hoerle R, Qiao X.. Lipid Emulsion Therapy in Lidocaine Anesthetic Systemic Toxicity (LAST). American Journal of Respiratory and Critical Care Medicine.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5683$$$$$Y$$$20240701$$MD$US$US
240362021$24036202$1$I$$20240619$20240701$20240701$EXP$$US-RDY-LIT/USA/24/0009294$DR REDDYS$Barrows C, Horton M, Allaham A, Israel HP. A Case of Acute Hypoxic Respiratory Failure After Administration of Rituximab. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6326.$61$YR$A$M$Y$$$20240701$$HP$US$US
240362042$24036204$2$F$20240101$20240705$20240701$20240710$EXP$$AT-AMERICAN REGENT INC-2024002509$AMERICAN REGENT$$30$YR$$F$Y$$$20240710$$MD$AT$AT
240362051$24036205$1$I$$20240626$20240701$20240701$PER$$US-ABBVIE-5820788$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240362061$24036206$1$I$$20240627$20240701$20240701$PER$$US-GILEAD-2024-0678956$GILEAD$$$$$F$Y$$$20240701$$PH$US$US
240362073$24036207$3$F$20230101$20240705$20240701$20240712$EXP$$JP-OTSUKA-2024_016129$OTSUKA$$59$YR$$M$Y$$$20240712$$MD$JP$JP
240362081$24036208$1$I$20240626$20240627$20240701$20240701$EXP$$US-PFIZER INC-PV202400085455$PFIZER$$91$YR$$M$Y$$$20240701$$HP$US$US
240362091$24036209$1$I$20231201$20240625$20240701$20240701$EXP$FR-AFSSAPS-TO2024001026$FR-MYLANLABS-2024M1057896$MYLAN$$64$YR$$M$Y$$$20240701$$MD$FR$FR
240362101$24036210$1$I$$20240628$20240701$20240701$EXP$$AR-PFIZER INC-PV202400086142$PFIZER$$$$$F$Y$$$20240701$$MD$AR$AR
240362112$24036211$2$F$20240101$20240628$20240701$20240702$EXP$$US-PFIZER INC-202400202752$PFIZER$$48$YR$$F$Y$$$20240702$$HP$US$US
240362124$24036212$4$F$$20240711$20240701$20240715$EXP$$NVSC2024US136345$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240362132$24036213$2$F$20220701$20240702$20240701$20240704$EXP$$ES-PFIZER INC-202400201523$PFIZER$$55$YR$$F$Y$$$20240704$$MD$ES$ES
240362151$24036215$1$I$$20230530$20240701$20240701$PER$$US-AMGEN-USASP2023235079$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240362162$24036216$2$F$$20240701$20240701$20240702$EXP$$US-ABBVIE-5821673$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240362171$24036217$1$I$20240101$20240625$20240701$20240701$PER$$US-SA-2024SA190357$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240701$$CN$US$US
240362181$24036218$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190285$SANOFI AVENTIS$$$$E$M$Y$97.9$KG$20240701$$MD$US$US
240362191$24036219$1$I$$20230524$20240701$20240701$PER$$US-AMGEN-USASP2023235133$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240362201$24036220$1$I$20200225$20240621$20240701$20240701$EXP$PL-URPL-1-2677-2020$PL-TEVA-VS-3213125$TEVA$$62$YR$$M$Y$70$KG$20240701$$MD$PL$PL
240362211$24036221$1$I$$20240626$20240701$20240701$PER$$US-GILEAD-2024-0678781$GILEAD$$43$YR$A$F$Y$$$20240701$$PH$US$US
240362221$24036222$1$I$$20240618$20240701$20240701$PER$$US-ROCHE-10000006184$ROCHE$$82$YR$E$M$Y$$$20240701$$MD$US$US
240362231$24036223$1$I$$20171018$20240701$20240701$EXP$$JP-TAKEDA-SH201715412$TAKEDA$$9$YR$$M$Y$$$20240701$$MD$JP$JP
240362241$24036224$1$I$$20230724$20240701$20240701$PER$$US-AMGEN-USASP2023235113$AMGEN$$$$$$Y$$$20240701$$MD$US$US
240362251$24036225$1$I$$20230309$20240701$20240701$EXP$$US-NOVOPROD-1245850$NOVO NORDISK$$$$A$M$Y$$$20240701$$CN$US$US
240362261$24036226$1$I$$20230518$20240701$20240701$EXP$$US-NOVOPROD-1172464$NOVO NORDISK$$78$YR$$$Y$$$20240701$$CN$US$US
240362271$24036227$1$I$$20230622$20240701$20240701$EXP$$US-NOVOPROD-1185444$NOVO NORDISK$$$$$$Y$$$20240701$$CN$US$US
240362281$24036228$1$I$$20240617$20240701$20240701$EXP$$US-NOVOPROD-1246131$NOVO NORDISK$H. Patel Et al.,. Plastic Surgery Gone Wrong: Catastrophic Post-operative Hemorrhagic Shock Due to Newly Acquired Factor VIII Inhibitor. American Thoracic Society. 2024;209$73$YR$$F$Y$$$20240701$$HP$US$US
240362291$24036229$1$I$$20230907$20240701$20240701$EXP$$US-NOVOPROD-1245694$NOVO NORDISK$$$$$M$Y$$$20240701$$CN$US$US
240362303$24036230$3$F$$20240715$20240701$20240730$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091831$GLENMARK$Mikhail E, Alexander D, Jankowski M, Pandya D, Kunadi A. Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A3410$$$$$Y$$$20240730$$MD$US$US
240362311$24036231$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400085058$PFIZER$$45$YR$$F$Y$$$20240701$$MD$US$US
240362321$24036232$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-202400202811$PFIZER$$$$$$Y$$$20240701$$CN$US$US
240362331$24036233$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400085261$PFIZER$$43$YR$$F$Y$$$20240701$$CN$US$US
240362341$24036234$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400085064$PFIZER$$42$YR$$F$Y$$$20240701$$HP$US$US
240362351$24036235$1$I$20240604$20240627$20240701$20240701$PER$$US-PFIZER INC-202400202778$PFIZER$$47$YR$$F$Y$$$20240701$$HP$US$US
240362372$24036237$2$F$$20240909$20240701$20240912$PER$$US-PFIZER INC-202400202783$PFIZER$$64$YR$$F$Y$$$20240912$$HP$US$US
240362382$24036238$2$F$$20240801$20240701$20240801$30DAY$$US-PFIZER INC-202400200749$PFIZER$$10$YR$$M$Y$$$20240801$$CN$US$US
240362401$24036240$1$I$20240623$20240625$20240701$20240701$PER$$US-PFIZER INC-202400200721$PFIZER$$38$YR$$F$Y$$$20240701$$PH$US$US
240362411$24036241$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400085207$PFIZER$$81$YR$$$Y$$$20240701$$CN$US$US
240362421$24036242$1$I$20240625$20240627$20240701$20240701$PER$$US-PFIZER INC-202400202490$PFIZER$$47$YR$$F$Y$$$20240701$$CN$US$US
240362431$24036243$1$I$20240601$20240627$20240701$20240701$PER$$US-PFIZER INC-202400203152$PFIZER$$$$A$F$Y$$$20240701$$HP$US$US
240362443$24036244$3$F$20240625$20240903$20240701$20240904$30DAY$$CL-PFIZER INC-PV202400084770$PFIZER$$12$YR$$F$Y$$$20240904$$CN$CL$CL
240362451$24036245$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-202400202625$PFIZER$$$$$F$Y$$$20240701$$HP$US$US
240362461$24036246$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400085422$PFIZER$$61$YR$$F$Y$$$20240701$$HP$US$US
240362472$24036247$2$F$$20240628$20240701$20240702$PER$$US-PFIZER INC-202400203354$PFIZER$$$$$F$Y$$$20240702$$CN$US$US
240362482$24036248$2$F$$20240801$20240701$20240801$PER$$US-PFIZER INC-202400202652$PFIZER$$44$YR$$F$Y$77.11$KG$20240801$$CN$US$US
240362491$24036249$1$I$20240627$20240627$20240701$20240701$PER$$US-PFIZER INC-202400202808$PFIZER$$55$YR$$M$Y$$$20240701$$CN$US$US
240362501$24036250$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400085066$PFIZER$$33$YR$$M$Y$$$20240701$$MD$US$US
240362522$24036252$2$F$$20240919$20240701$20240924$30DAY$$US-PFIZER INC-202400197731$PFIZER$$1$YR$$M$Y$$$20240924$$CN$US$US
240362531$24036253$1$I$20240619$20240628$20240701$20240701$PER$$US-PFIZER INC-PV202400085825$PFIZER$$64$YR$$F$Y$$$20240701$$HP$US$US
240362542$24036254$2$F$$20240718$20240701$20240722$PER$$US-PFIZER INC-PV202400085872$PFIZER$$54$YR$$F$Y$$$20240722$$HP$US$US
240362551$24036255$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400084918$PFIZER$$30$YR$$M$Y$$$20240701$$MD$US$US
240362561$24036256$1$I$$20240627$20240701$20240701$PER$$PR-PFIZER INC-202400202446$PFIZER$$67$YR$$M$Y$$$20240701$$MD$PR$PR
240362571$24036257$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400085177$PFIZER$$$$$$Y$$$20240701$$CN$US$US
240362581$24036258$1$I$20240401$20240627$20240701$20240701$PER$$US-PFIZER INC-202400203459$PFIZER$$61$YR$$F$Y$$$20240701$$HP$US$US
240362591$24036259$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-202400202392$PFIZER$$66$YR$$F$Y$$$20240701$$CN$US$US
240362612$24036261$2$F$20240624$20240722$20240701$20240723$PER$$US-PFIZER INC-202400202751$PFIZER$$51$YR$$F$Y$68.04$KG$20240723$$CN$US$US
240362623$24036262$3$F$20240626$20240822$20240701$20240822$PER$$US-PFIZER INC-202400202597$PFIZER$$58$YR$$M$Y$130$KG$20240822$$PH$US$US
240362631$24036263$1$I$20240101$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400085281$PFIZER$$64$YR$$F$Y$$$20240701$$CN$US$US
240362641$24036264$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400084913$PFIZER$$29$YR$$M$Y$$$20240701$$MD$US$US
240362652$24036265$2$F$$20240701$20240701$20240703$PER$$US-PFIZER INC-PV202400085178$PFIZER$$70$YR$$F$Y$$$20240703$$PH$US$US
240362661$24036266$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-202400202655$PFIZER$$$$$$Y$$$20240701$$CN$US$US
240362671$24036267$1$I$20240601$20240627$20240701$20240701$PER$$US-PFIZER INC-202400203233$PFIZER$$57$YR$$M$Y$$$20240701$$HP$US$US
240362681$24036268$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-202400202444$PFIZER$$38$YR$$M$Y$$$20240701$$CN$US$US
240362691$24036269$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-PV202400084791$PFIZER$$68$YR$$$Y$$$20240701$$MD$US$US
240362701$24036270$1$I$$20240630$20240701$20240701$EXP$$US-ANIPHARMA-2024-US-036251$ANI$Lakhani DA, Deng F.A young man with amnesia after drug overdose..European Journal of Internal Medicine.2024;122117-118.$29$YR$$M$Y$$$20240701$$HP$US$US
240362711$24036271$1$I$20240602$20240624$20240701$20240701$EXP$ES-AEMPS-1536359$ES-FreseniusKabi-FK202409924$FRESENIUS KABI$$6$YR$C$F$Y$23$KG$20240701$$MD$ES$ES
240362721$24036272$1$I$20240614$20240614$20240701$20240701$PER$$US-CSL-2024-005815$CSL Plasma$$26$YR$$F$Y$$$20240701$$HP$US$US
240362731$24036273$1$I$20230309$20240624$20240701$20240701$EXP$ES-AEMPS-1536113$ES-FreseniusKabi-FK202409925$FRESENIUS KABI$$74$YR$E$M$Y$84$KG$20240701$$PH$ES$ES
240362741$24036274$1$I$$20240621$20240701$20240701$PER$$DE-Eisai-EC-2024-168731$EISAI$$$$$F$Y$$$20240701$$MD$DE$DE
240362753$24036275$3$F$$20240729$20240701$20240805$EXP$CA-GSK-CA2024079179$CA-GSK-CA2023171043$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$CA$CA
240362761$24036276$1$I$$20240625$20240701$20240701$EXP$$AR-GSK-AR2024AMR080007$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$AR$AR
240362771$24036277$1$I$20221111$20240627$20240701$20240701$EXP$$ES-ALXN-202406GLO001839SE$ALEXION PHARMACEUTICALS$$49$YR$$F$Y$54$KG$20240701$$MD$ES$SE
240362781$24036278$1$I$20231023$20240625$20240701$20240701$EXP$$US-RDY-CLI/USA/23/0183297$DR REDDYS$$41$YR$A$F$Y$$$20240701$$CN$US$US
240362791$24036279$1$I$$20240619$20240701$20240701$PER$$US-RDY-LIT/USA/24/0009323$DR REDDYS$Holtzapple Z, Campbell A, Katterle K, Patel R, Salih A, Abraha A. Carfizomib Induced Pulmonary Hemorrhage and Acute Renal Failure in the Setting of Relapsed Multiple Myeloma. American Journal of Respiratory and Critical Care Medicine. 2024;209: A6383. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6383.$60$YR$A$F$Y$$$20240701$$HP$US$US
240362801$24036280$1$I$$20240620$20240701$20240701$EXP$$US-RDY-LIT/USA/24/0009318$DR REDDYS$Adegoke T, Subramanian S, Daunis D, Bick S, Ward HB. A Case of Treatment-Resistant Depression Complicated by Traumatic Brain Injury and Seizure: Implications for Interventional Treatment and Psychiatric Training. Harvard Review of Psychiatry. 2024 May 06;32(3): 117-125. doi:10.1097/HRP.0000000000000394.$45$YR$A$M$Y$$$20240701$$MD$US$US
240362811$24036281$1$I$20240621$20240626$20240701$20240701$EXP$$GB-TAKEDA-2023TUS107267$TAKEDA$$75$YR$$F$Y$$$20240701$$CN$GB$GB
240362821$24036282$1$I$$20240619$20240701$20240701$EXP$$US-RDY-LIT/USA/24/0009241$DR REDDYS$Huang J, Shehzad D, Ahmed I, Yu JC. Recognizing Veno-occlusive Disease After Inotuzumab Treatment: An Urgent Call to Physicians in Non-Transplant Centers. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: A5656.$47$YR$A$F$Y$$$20240701$$HP$US$US
240362831$24036283$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184460$Haleon PLC$$$$$M$Y$$$20240701$$CN$US$US
240362841$24036284$1$I$$20240617$20240701$20240701$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091844$GLENMARK$Renzetti M, Potnis K, Vemmou E, Hansen B, Lin D, Yaggi H. Salty, Sweet, and Severe: A Case of Linagliptin-induced Severe Hyponatremia.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A7036$$$$$Y$$$20240701$$MD$US$US
240362852$24036285$2$F$20221026$20240821$20240701$20240827$EXP$$CA-TAKEDA-2022TUS089401$TAKEDA$$82$YR$$F$Y$$$20240827$$MD$CA$CA
240362861$24036286$1$I$$20240625$20240701$20240701$EXP$$ES-Rigel Pharmaceuticals, Inc.-20240600073$RIGEL PHARMACEUTICALS$Tom?s Jos? Gonz?lez-L?pez. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. American Society of Hematology. 2024;143:doi:10.1182/blood.2024024250$75$YR$$M$Y$$$20240701$$MD$ES$ES
240362891$24036289$1$I$20240520$20240701$20240701$20240701$EXP$FR-AFSSAPS-SE2024000517$NVSC2024FR136070$NOVARTIS$$80$YR$$F$Y$58$KG$20240701$$MD$FR$FR
240362901$24036290$1$I$20240625$20240701$20240701$20240701$EXP$ES-AEMPS-1541378$NVSC2024ES136082$NOVARTIS$$68$YR$$M$Y$$$20240701$$PH$ES$ES
240362913$24036291$3$F$20240626$20240729$20240701$20240802$EXP$$FR-AstraZeneca-2024A149820$ASTRAZENECA$$26295$DY$$M$Y$66$KG$20240802$$MD$FR$
240362921$24036292$1$I$$20240621$20240701$20240701$EXP$$AU-AstraZeneca-2024A150519$ASTRAZENECA$$$$$$Y$$$20240701$$MD$AU$
240362931$24036293$1$I$$20240223$20240701$20240701$PER$$US-AMGEN-USASP2024129710$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240362942$24036294$2$F$$20240626$20240701$20240703$PER$$US-AMGEN-USASP2024126724$AMGEN$$$$$F$Y$$$20240703$$HP$US$US
240362951$24036295$1$I$$20240624$20240701$20240701$PER$$US-MYLANLABS-2024M1058483$MYLAN$$$$$F$Y$68$KG$20240701$$MD$US$US
240362961$24036296$1$I$$20240626$20240701$20240701$PER$$US-AMX-008108$AMYLYX PHARMACEUTICALS$$$$A$M$Y$$$20240701$$CN$US$US
240362971$24036297$1$I$$20240617$20240701$20240701$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091853$GLENMARK$Saad E, Abdulrahman A, Faris M.. Hemodialysis Reversed Bradyarrhythmia and Sinus Nodal Dysfunction From Acute Lithium Toxicity. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240701$$HP$US$US
240362981$24036298$1$I$$20240628$20240701$20240701$PER$$US-JNJFOC-20240678826$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240701$$CN$US$US
240362991$24036299$1$I$$20240628$20240701$20240701$PER$$US-JNJFOC-20240678754$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240363021$24036302$1$I$$20240624$20240701$20240701$EXP$$CA-DSJP-DSJ-2024-129723$DAIICHI$$$$$F$Y$$$20240701$$MD$CA$CA
240363031$24036303$1$I$20240222$20240624$20240701$20240701$EXP$$NVSC2024TH132218$NOVARTIS$$68$YR$$F$Y$$$20240701$$MD$TH$TH
240363041$24036304$1$I$20200709$20240621$20240701$20240701$EXP$PL-URPL-1-3193-2020$PL-TEVA-VS-3212996$TEVA$$34$YR$$M$Y$78$KG$20240701$$MD$PL$PL
240363051$24036305$1$I$$20240624$20240701$20240701$EXP$$US-ABBVIE-5815388$ABBVIE$$$$$$Y$$$20240701$$CN$US$US
240363061$24036306$1$I$20240610$20240628$20240701$20240701$EXP$HR-HALMED-300085687$HR-SANDOZ INC.-SDZ2024HR061483$SANDOZ$$68$YR$$M$Y$53.5$KG$20240701$$MD$HR$HR
240363072$24036307$2$F$$20240704$20240701$20240711$EXP$$CO-SANDOZ INC.-NVSC2023CO140034$SANDOZ$$$$$F$Y$57$KG$20240711$$CN$CO$CO
240363081$24036308$1$I$20220101$20240628$20240701$20240701$EXP$$US-SANDOZ INC.-NVSC2023US092175$SANDOZ$$$$$M$Y$$$20240701$$CN$US$US
240363091$24036309$1$I$20210101$20240621$20240701$20240701$EXP$$DE-SANDOZ INC.-SDZ2024DE061707$SANDOZ$$72$YR$$F$Y$$$20240701$$MD$DE$DE
240363101$24036310$1$I$$20240621$20240701$20240701$EXP$$DE-SANDOZ INC.-SDZ2024DE061330$SANDOZ$$29$YR$$M$Y$$$20240701$$HP$DE$DE
240363111$24036311$1$I$20230323$20240624$20240701$20240701$EXP$$IN-SANDOZ INC.-SDZ2024IN060649$SANDOZ$$21$YR$$M$Y$$$20240701$$CN$IN$IN
240363121$24036312$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281035540500-DRMKH$GB-SANDOZ INC.-SDZ2024GB061663$SANDOZ$$$$$F$Y$$$20240701$$CN$GB$GB
240363131$24036313$1$I$$20240627$20240701$20240701$EXP$$US-SANDOZ INC.-SDZ2024US061749$SANDOZ$$$$$F$Y$$$20240701$$HP$US$US
240363142$24036314$2$F$$20240719$20240701$20240722$30DAY$$US-SANDOZ INC.-SDZ2024US061758$SANDOZ$$73$YR$$F$Y$78$KG$20240722$$HP$US$US
240363151$24036315$1$I$20200209$20240701$20240701$20240701$EXP$$PL-SANDOZ INC.-SDZ2024PL061728$SANDOZ$$49$YR$$$Y$65$KG$20240701$$MD$PL$PL
240363161$24036316$1$I$$20240627$20240701$20240701$EXP$$US-SANDOZ INC.-SDZ2024US061700$SANDOZ$$$$$M$Y$$$20240701$$CN$US$US
240363171$24036317$1$I$20200122$20240627$20240701$20240701$EXP$$DE-SANDOZ INC.-NVSC2020DE023904$SANDOZ$$61$YR$$F$Y$53$KG$20240701$$MD$DE$DE
240363181$24036318$1$I$$20240624$20240701$20240701$EXP$$CA-DSJP-DSJ-2024-129725$DAIICHI$$39$YR$$F$Y$$$20240701$$HP$CA$CA
240363191$24036319$1$I$$20240624$20240701$20240701$EXP$$CA-DSJP-DSJ-2024-129705AA$DAIICHI$$$$$F$Y$$$20240701$$MD$CA$CA
240363202$24036320$2$F$$20240703$20240701$20240709$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-129757$DAIICHI$$$$$F$Y$$$20240709$$CN$US$US
240363211$24036321$1$I$$20240624$20240701$20240701$EXP$$CA-DSJP-DSJ-2024-129716AA$DAIICHI$$41$YR$$F$Y$86$KG$20240701$$PH$CA$CA
240363221$24036322$1$I$20230213$20240619$20240701$20240701$EXP$$AU-SANDOZ INC.-SDZ2024AU061403$SANDOZ$$72$YR$$M$Y$$$20240701$$MD$AU$AU
240363231$24036323$1$I$$20240628$20240701$20240701$EXP$$US-TAKEDA-2024TUS065321$TAKEDA$$$$$M$Y$$$20240701$$CN$US$US
240363243$24036324$3$F$20240621$20240711$20240701$20240716$PER$$US-AMGEN-USASP2024124275$AMGEN$$46$YR$A$F$Y$57.2$KG$20240716$$PH$US$US
240363251$24036325$1$I$$20240629$20240701$20240701$PER$$US-HALEON-2184597$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240363262$24036326$2$F$$20240911$20240701$20240920$PER$$US-SA-2024SA184245$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240920$$MD$US$US
240363271$24036327$1$I$$20240625$20240701$20240701$EXP$$MY-FreseniusKabi-FK202410058$FRESENIUS KABI$$42$YR$A$F$Y$$$20240701$$PH$MY$MY
240363281$24036328$1$I$20240110$20240625$20240701$20240701$EXP$$FI-FreseniusKabi-FK202410029$FRESENIUS KABI$$80$YR$E$F$Y$$$20240701$$MD$FI$FI
240363291$24036329$1$I$$20240617$20240701$20240701$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091915$GLENMARK$Sasidharan S., Jatoi T., Milla C., Mallappallil M., Agarwal S., Puri I.. Triple Whammy of Amlodipine, Carvedilol and Diphenhydramine Overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240701$$HP$US$US
240363301$24036330$1$I$20231201$20240624$20240701$20240701$EXP$FR-AFSSAPS-TO2024001026$FR-FreseniusKabi-FK202409972$FRESENIUS KABI$$64$YR$A$M$Y$$$20240701$$MD$FR$FR
240363311$24036331$1$I$20240523$20240621$20240701$20240701$PER$$US-BAYER-2024A090582$BAYER$$33$YR$A$F$Y$$$20240701$$PH$US$US
240363322$24036332$2$F$20240101$20240829$20240701$20240904$PER$$US-BIOGEN-2024BI01270872$BIOGEN$$$$$F$Y$$$20240904$$CN$US$US
240363331$24036333$1$I$20240101$20240621$20240701$20240701$PER$$US-BIOGEN-2024BI01270742$BIOGEN$$$$$F$Y$$$20240701$$CN$US$US
240363371$24036337$1$I$$20240624$20240701$20240701$EXP$$NVSC2024GB135330$NOVARTIS$Fenech M, Ajanaku A, McCormick A, Coupland SE, Krishna Y, Sultan Z et al. Orbital Kimura disease: maintenance therapy using mycophenolate mofetil. ORBIT. 2024;1-8$55$YR$$M$Y$$$20240701$$HP$GB$GB
240363381$24036338$1$I$$20240627$20240701$20240701$EXP$$KR-DSJP-DSJ-2024-129510$DAIICHI$$$$$F$Y$$$20240701$$HP$KR$KR
240363391$24036339$1$I$$20240624$20240701$20240701$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-129763$DAIICHI$$61$YR$$F$Y$98$KG$20240701$$CN$CA$CA
240363411$24036341$1$I$$20240624$20240701$20240701$EXP$$CA-DSJP-DSJ-2024-129765$DAIICHI$$$$$F$Y$$$20240701$$MD$CA$CA
240363422$24036342$2$F$20240101$20240711$20240701$20240716$PER$$US-ABBVIE-5821684$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240363431$24036343$1$I$20240620$20240626$20240701$20240701$EXP$$US-GILEAD-2024-0678868$GILEAD$$34$YR$A$F$Y$$$20240701$$CN$US$US
240363441$24036344$1$I$$20240626$20240701$20240701$PER$$US-GILEAD-2024-0678869$GILEAD$$46$YR$A$M$Y$$$20240701$$HP$US$US
240363455$24036345$5$F$20240625$20240905$20240701$20240911$EXP$$NVSC2024IL134085$NOVARTIS$$72$YR$$F$Y$$$20240911$$HP$IL$IL
240363463$24036346$3$F$$20240906$20240701$20240909$PER$$NVSC2024US136308$NOVARTIS$$$$$$Y$$$20240909$$MD$US$US
240363471$24036347$1$I$$20240624$20240701$20240701$EXP$$CA-GSK-CA2023042542$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$HP$CA$CA
240363481$24036348$1$I$20240525$20240621$20240701$20240701$EXP$IT-MINISAL02-990428$IT-TEVA-VS-3213347$TEVA$$65$YR$$F$Y$$$20240701$$MD$IT$IT
240363491$24036349$1$I$$20240624$20240701$20240701$EXP$$CA-GSK-CA2024AMR079058$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$CA$CA
240363501$24036350$1$I$20240622$20240626$20240701$20240701$PER$$US-JNJFOC-20240671955$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240701$$CN$US$US
240363512$24036351$2$F$20240601$20240903$20240701$20240911$PER$$US-JNJFOC-20240654802$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20240911$$CN$US$US
240363522$24036352$2$F$20240615$20240726$20240701$20240730$PER$$US-JNJFOC-20240671232$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240731$$CN$US$US
240363532$24036353$2$F$20240624$20240731$20240701$20240809$30DAY$$US-AMGEN-USASP2024125080$AMGEN$$$$$F$Y$$$20240808$$PH$US$US
240363541$24036354$1$I$$20240624$20240701$20240701$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-129766$DAIICHI$$71$YR$$F$Y$$$20240701$$PH$CA$CA
240363551$24036355$1$I$20240627$20240627$20240701$20240701$PER$$NVSC2024US136331$NOVARTIS$$$$$$Y$$$20240701$$HP$US$US
240363562$24036356$2$F$$20240703$20240701$20240705$EXP$$NVSC2024BD135836$NOVARTIS$$27$YR$$M$Y$54$KG$20240705$$CN$BD$BD
240363571$24036357$1$I$20240622$20240626$20240701$20240701$EXP$$US-AMGEN-USASL2024127254$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240363581$24036358$1$I$$20240617$20240701$20240701$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091914$GLENMARK$Narayanan LS, Lindgren B.. Severe Diabetic Ketoacidosis Resulting in Refractory Shock and Stress Cardiomyopathy.. American Journal of Respiratory and Critical Care Medicine.. 2024$$$$$Y$$$20240701$$HP$US$US
240363591$24036359$1$I$$20240625$20240701$20240701$EXP$$MY-FreseniusKabi-FK202409905$FRESENIUS KABI$$58$YR$A$M$Y$$$20240701$$HP$MY$MY
240363601$24036360$1$I$20231002$20240626$20240701$20240701$EXP$IT-MINISAL02-991619$IT-FreseniusKabi-FK202410094$FRESENIUS KABI$$38$YR$A$F$Y$55$KG$20240701$$MD$IT$IT
240363611$24036361$1$I$20240627$20240627$20240701$20240701$EXP$$US-MYLANLABS-2024M1061282$MYLAN$$44$YR$$M$Y$$$20240701$$HP$US$US
240363622$24036362$2$F$20240514$20240628$20240701$20240702$EXP$$CN-AstraZeneca-2024A148762$ASTRAZENECA$$123$MON$$F$Y$$$20240702$$MD$CN$
240363631$24036363$1$I$$20240624$20240701$20240701$EXP$$GB-MYLANLABS-2024M1059597$MYLAN$Gent DG, Ali N, Olsson-Brown A, Lip GYH, Wright DJ, Dobson R. Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights. Case-Rep-Oncol 2022; 15 (3): 950-959.$50$YR$$M$Y$$$20240701$$HP$GB$GB
240363641$24036364$1$I$20240614$20240621$20240701$20240701$EXP$$GB-AstraZeneca-2024A149963$ASTRAZENECA$$63$YR$$F$Y$92$KG$20240701$$MD$GB$
240363651$24036365$1$I$20240608$20240628$20240701$20240701$EXP$$IT-AstraZeneca-2024A149411$ASTRAZENECA$$55$YR$$M$Y$90$KG$20240701$$MD$IT$
240363661$24036366$1$I$20240625$20240627$20240701$20240701$EXP$$CN-AstraZeneca-2024A149786$ASTRAZENECA$$59$YR$$M$Y$60$KG$20240701$$MD$CN$
240363672$24036367$2$F$20240101$20240719$20240701$20240729$PER$$US-SA-2024SA193208$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240729$$MD$US$US
240363681$24036368$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA170785$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240701$$MD$US$US
240363691$24036369$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190964$SANOFI AVENTIS$$$$$F$Y$$$20240701$$MD$US$US
240363702$24036370$2$F$$20240714$20240701$20240719$EXP$$CA-OTSUKA-2024_018150$OTSUKA$$$$$F$Y$$$20240719$$HP$CA$CA
240363711$24036371$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184503$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240363721$24036372$1$I$$20230512$20240701$20240701$PER$$US-AMGEN-USASP2023235104$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240363731$24036373$1$I$20240520$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024126889$AMGEN$$67$YR$E$$Y$$$20240701$$HP$US$US
240363743$24036374$3$F$20240521$20240802$20240701$20240808$EXP$$GB-MYLANLABS-2024M1061261$MYLAN$$40$YR$$M$Y$$$20240808$$MD$GB$GB
240363751$24036375$1$I$$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018910$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240701$$CN$US$US
240363762$24036376$2$F$$20240819$20240701$20240822$30DAY$$US-ELI_LILLY_AND_COMPANY-US202406014406$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240822$$HP$US$US
240363771$24036377$1$I$$20240624$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019836$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240701$$CN$US$US
240363781$24036378$1$I$20240627$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000247$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240701$$CN$US$US
240363792$24036379$2$F$20240624$20240914$20240701$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202406018937$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240918$$CN$US$US
240363801$24036380$1$I$20240314$20240621$20240701$20240701$EXP$$US-AMGEN-USASP2024123735$AMGEN$Pariser R.J.; Brown I.D.. Generalized Hailey-Hailey disease associated with c.2395C}T mutation in the ATF`2C1 gene, and fatal outcome. Dermatology Online Journal. 2024;30(2)$55$YR$A$F$Y$$$20240701$$MD$US$US
240363812$24036381$2$F$20240628$20240703$20240701$20240705$EXP$$ES-GILEAD-2024-0678997$GILEAD$$69$YR$E$F$Y$$$20240705$$MD$ES$ES
240363822$24036382$2$F$20240603$20240702$20240701$20240705$EXP$FR-AFSSAPS-LY2024000906$FR-PFIZER INC-202400203729$PFIZER$$55$YR$$F$Y$58.6$KG$20240705$$PH$FR$FR
240363832$24036383$2$F$$20240729$20240701$20240806$EXP$$US-ZENPEP LLC-2024AIMT00995$AIMMUNE$$$$$$Y$$$20240806$$CN$US$US
240363841$24036384$1$I$$20240626$20240701$20240701$EXP$$US-SA-2024SA192251$SANOFI AVENTIS$$60$YR$A$M$Y$81.64$KG$20240701$$MD$US$US
240363853$24036385$3$F$20240101$20240701$20240701$20240705$EXP$$NVSC2024DE135344$NOVARTIS$$80$YR$$M$Y$74$KG$20240705$$CN$DE$DE
240363871$24036387$1$I$$20240624$20240701$20240701$EXP$FR-AFSSAPS-PB2024000677$FR-BAXTER-2024BAX020487$BAXTER$$62$YR$$F$Y$$$20240701$$MD$FR$FR
240363881$24036388$1$I$$20240624$20240701$20240701$EXP$$CA-TEVA-VS-3214057$TEVA$$78$YR$$M$Y$$$20240701$$MD$CA$CA
240363891$24036389$1$I$20240624$20240624$20240701$20240701$EXP$$DE-BAXTER-2024BAX020548$BAXTER$$66$YR$$F$Y$$$20240701$$HP$DE$DE
240363901$24036390$1$I$20230718$20240621$20240701$20240701$EXP$$CZ-BAXTER-2023BAX028423$BAXTER$$76$YR$$M$Y$85$KG$20240701$$MD$CZ$CZ
240363911$24036391$1$I$$20240328$20240701$20240701$PER$$US-AMGEN-USASP2024129746$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240363933$24036393$3$F$20240617$20240716$20240701$20240723$EXP$$CA-JNJFOC-20240648733$JOHNSON AND JOHNSON$$49$YR$A$F$Y$99$KG$20240722$$CN$CA$CA
240363941$24036394$1$I$$20240627$20240701$20240701$PER$$US-JNJFOC-20240674252$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240363951$24036395$1$I$$20240620$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05828$HIKMA$Alsheimer K, Burgei JW, Lantry J, Shah H, Lamichhane B.. Alsheimer K, Burgei JW, Lantry J, Shah H, Lamichhane B. Genitourinary Tuberculosis Resulting in Hydronephrosis. American Journal of Respiratory and Critical Care Medicine. 2024;209: A2354$$$$M$Y$$$20240701$$MD$US$US
240363972$24036397$2$F$$20240709$20240701$20240718$EXP$$CA-BAXTER-2024BAX020671$BAXTER$$$$$$Y$$$20240718$$MD$CA$CA
240363981$24036398$1$I$$20240620$20240701$20240701$EXP$$US-JNJFOC-20240659204$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$MD$US$US
240364011$24036401$1$I$20240315$20240321$20240701$20240701$PER$$US-NORIDC PHARMA, INC-2024US001057$PAREXEL$$$$$$Y$$$20240628$$CN$US$US
240364051$24036405$1$I$20230508$20240621$20240701$20240701$EXP$$US-BAXTER-2023BAX024433$BAXTER$$68$YR$$M$Y$74.8$KG$20240701$$HP$US$US
240364101$24036410$1$I$20240618$20240626$20240701$20240701$EXP$$NVSC2024CN135111$NOVARTIS$$65$YR$$M$Y$75$KG$20240701$$HP$CN$CN
240364111$24036411$1$I$$20240625$20240701$20240701$PER$$US-ABBVIE-5819745$ABBVIE$$$$$F$Y$$$20240701$$HP$US$US
240364131$24036413$1$I$$20240621$20240701$20240701$EXP$$GB-TEVA-VS-3199916$TEVA$$$$$M$Y$$$20240701$$MD$GB$GB
240364141$24036414$1$I$$20240619$20240701$20240701$EXP$$SK-ABBVIE-5817872$ABBVIE$$68$YR$$F$Y$$$20240701$$MD$SK$SK
240364152$24036415$2$F$$20240822$20240701$20240829$30DAY$$DK-MYLANLABS-2024M1060707$MYLAN$$$$$$Y$$$20240829$$CN$DK$DK
240364161$24036416$1$I$$20240624$20240701$20240701$PER$$US-ABBVIE-5816160$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240364171$24036417$1$I$$20240621$20240701$20240701$EXP$$CA-APOTEX-2024AP007654$APOTEX$$27$YR$$F$Y$$$20240701$$HP$CA$CA
240364181$24036418$1$I$$20240624$20240701$20240701$EXP$$CA-GSK-CA2024AMR079281$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$HP$CA$CA
240364191$24036419$1$I$20240621$20240624$20240701$20240701$EXP$$US-FreseniusKabi-FK202409983$FRESENIUS KABI$$57$YR$A$F$Y$95.25$KG$20240701$$CN$US$US
240364202$24036420$2$F$20240618$20240801$20240701$20240806$30DAY$$US-AMGEN-USASP2024125326$AMGEN$$62$YR$A$F$Y$80$KG$20240806$$PH$US$US
240364221$24036422$1$I$20240529$20240617$20240701$20240701$PER$$US-JNJFOC-20240648301$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$CN$US$US
240364231$24036423$1$I$20240612$20240617$20240701$20240701$PER$$US-JNJFOC-20240648140$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$HP$US$US
240364244$24036424$4$F$20240626$20240729$20240701$20240807$30DAY$$US-JNJFOC-20240675038$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240807$$PH$US$US
240364251$24036425$1$I$20240101$20240621$20240701$20240701$PER$$US-ABBVIE-5816814$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240364261$24036426$1$I$$20230516$20240701$20240701$PER$$US-AMGEN-USASP2023235096$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240364271$24036427$1$I$$20240623$20240701$20240701$EXP$$JP-AstraZeneca-2024A148269$ASTRAZENECA$$62$YR$$M$Y$$$20240701$$MD$JP$
240364281$24036428$1$I$20240101$20240625$20240701$20240701$EXP$$US-AMGEN-USASP2024126231$AMGEN$$73$YR$E$F$Y$$$20240701$$HP$US$US
240364296$24036429$6$F$$20240823$20240701$20240828$EXP$$US-TAKEDA-2024TUS064070$TAKEDA$$$$$M$Y$$$20240828$$CN$US$US
240364301$24036430$1$I$20240612$20240625$20240701$20240701$EXP$$IT-AstraZeneca-2024A149968$ASTRAZENECA$$83$YR$$M$Y$$$20240701$$MD$IT$
240364312$24036431$2$F$20240609$20240625$20240701$20240704$PER$$US-SA-2024SA186209$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240704$$CN$US$US
240364321$24036432$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA187173$SANOFI AVENTIS$$$$A$M$Y$$$20240701$$MD$US$US
240364331$24036433$1$I$20240601$20240620$20240701$20240701$PER$$US-SA-2024SA187197$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240701$$MD$US$US
240364341$24036434$1$I$20240523$20240620$20240701$20240701$PER$$US-ROCHE-3570229$ROCHE$$29$YR$A$F$Y$68.04$KG$20240701$$CN$US$US
240364353$24036435$3$F$$20240924$20240701$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104827$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$82.1$KG$20240924$$CN$US$US
240364361$24036436$1$I$20240630$20240701$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105023$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240701$$HP$US$US
240364371$24036437$1$I$20230124$20240625$20240701$20240701$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-075549$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240701$$MD$JP$JP
240364382$24036438$2$F$$20240926$20240701$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-103987$BRISTOL MYERS SQUIBB$$57$YR$A$$Y$$$20240926$$MD$JP$JP
240364391$24036439$1$I$$20240626$20240701$20240701$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-103797$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240701$$MD$AU$AU
240364402$24036440$2$F$20240514$20240701$20240701$20240708$EXP$$AR-BIOMARINAP-AR-2024-158867$BIOMARIN$$$$$$Y$$$20240708$$CN$AR$AR
240364411$24036441$1$I$20240625$20240626$20240701$20240701$PER$$US-GILEAD-2024-0678789$GILEAD$$24$YR$A$M$Y$$$20240701$$CN$US$US
240364422$24036442$2$F$$20240703$20240701$20240704$PER$$NVSC2024US136357$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
240364434$24036443$4$F$20240522$20240725$20240701$20240807$30DAY$$US-JNJFOC-20240676469$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
240364443$24036444$3$F$$20240730$20240701$20240801$EXP$$BR-GENMAB-2024-02284$GENMAB$$$$$F$Y$$$20240801$$HP$BR$BR
240364453$24036445$3$F$$20240829$20240701$20240906$EXP$$FR-INCYTE CORPORATION-2024IN006934$INCYTE$$$$$$Y$$$20240906$$PH$FR$FR
240364461$24036446$1$I$20240609$20240627$20240701$20240701$PER$$US-ABBVIE-5820507$ABBVIE$$$$$F$Y$$$20240701$$MD$US$US
240364471$24036447$1$I$20240101$20240621$20240701$20240701$PER$$US-SA-2024SA187936$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240701$$CN$US$US
240364483$24036448$3$F$20240621$20240718$20240701$20240812$EXP$$UA-BAYER-2024A094585$BAYER$$47$YR$A$M$Y$$$20240812$$HP$UA$UA
240364491$24036449$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45913$$FDA-CTU$$49$YR$$F$N$$$20240701$N$CN$US$
240364521$24036452$1$I$20240601$20240627$20240701$20240701$EXP$$TH-INCYTE CORPORATION-2024IN006925$INCYTE$$$$$$Y$$$20240701$$MD$TH$TH
240364532$24036453$2$F$$20240717$20240701$20240727$PER$$US-RDY-SPO/USA/24/0009085$DR REDDYS$$$$$M$Y$$$20240727$$CN$US$US
240364541$24036454$1$I$20240625$20240625$20240701$20240701$PER$$US-RDY-SPO/USA/24/0009408$DR REDDYS$$22$YR$A$M$Y$$$20240701$$MD$US$US
240364551$24036455$1$I$$20240625$20240701$20240701$PER$$US-RDY-SPO/USA/24/0009406$DR REDDYS$$25$YR$A$$Y$$$20240701$$MD$US$US
240364562$24036456$2$F$$20240705$20240701$20240712$PER$$US-RDY-SPO/USA/24/0009337$DR REDDYS$$$$$M$Y$$$20240712$$MD$US$US
240364571$24036457$1$I$$20240626$20240701$20240701$EXP$$NVSC2024US134695$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
240364581$24036458$1$I$20240621$20240624$20240701$20240701$DIR$FDA-CDER-CTU-2024-45786$$FDA-CTU$$20$YR$$M$N$$$20240624$N$HP$US$
240364611$24036461$1$I$$20240619$20240701$20240701$EXP$$DE-ACRAF SpA-2024-034920$SK LIFE SCIENCE$$$$$$Y$$$20240701$$MD$DE$DE
240364621$24036462$1$I$$20240623$20240701$20240701$EXP$$US-AMGEN-USASP2024124567$AMGEN$Keelapandal Ganesh M.; Gao L.; Rallabhandi H. et al.. A Rare Mimic of Non-resolving Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A6569$60$YR$A$M$Y$$$20240701$$HP$US$US
240364631$24036463$1$I$$20240628$20240701$20240701$DIR$FDA-CDER-CTU-2024-45868$$FDA-CTU$$$$$F$N$$$20240628$N$HP$US$
240364651$24036465$1$I$$20240528$20240701$20240701$DIR$FDA-CDER-CTU-2024-45950$$FDA-CTU$$$$$M$N$$$20240528$N$HP$US$
240364661$24036466$1$I$$20240622$20240701$20240701$EXP$$US-AMGEN-USASP2024124535$AMGEN$Amengual J. E.; Tiger Y. R.; Jain S. et.al. Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma. Leukemia + Lymphoma. 2024;65 (6):736-745$44$YR$A$M$Y$$$20240701$$HP$US$US
240364671$24036467$1$I$$20240622$20240701$20240701$EXP$$US-AMGEN-USASP2024124347$AMGEN$Adams E. W.; Madison J.; Bielick Kotkowski C. et. al.. Nocardiosis With Rapid Radiographic Progression. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A2416-A2416$85$YR$E$M$Y$$$20240701$$HP$US$US
240364682$24036468$2$F$20240101$20240711$20240701$20240723$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-000284$SK LIFE SCIENCE$$$$$$Y$$$20240723$$HP$CA$CA
240364691$24036469$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019462$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240701$$CN$US$US
240364701$24036470$1$I$$20240624$20240701$20240701$EXP$$CA-TEVA-VS-3214097$TEVA$$68$YR$$$Y$$$20240701$$MD$CA$CA
240364711$24036471$1$I$20240619$20240619$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406013639$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240364721$24036472$1$I$$20240628$20240701$20240701$EXP$$TW-PERRIGO-24TW006177$PERRIGO$Chang-Chieh L, Shen-Han C, Yu-Han F, Chi-Ta H. Eczema herpeticum in an immunocompetent man. Diagnostic Microbiology and Infectious Disease. 2024;110(1):116304. DOI: 10.1016/j.diagmicrobio.2024.116304.$40$YR$$M$Y$$$20240701$$MD$TW$TW
240364732$24036473$2$F$$20240623$20240701$20240709$EXP$$NVSC2024TH131229$NOVARTIS$$73$YR$$F$Y$$$20240709$$MD$TH$TH
240364741$24036474$1$I$$20240613$20240701$20240701$PER$$US-INCYTE CORPORATION-2024IN006380$INCYTE$$$$$$Y$$$20240701$$CN$US$US
240364751$24036475$1$I$20240525$20240627$20240701$20240701$EXP$$NVSC2024CN136257$NOVARTIS$$61$YR$$M$Y$63$KG$20240701$$HP$CN$CN
240364762$24036476$2$F$20240622$20240820$20240701$20240826$30DAY$$US-AMGEN-USASP2024125003$AMGEN$$58$YR$A$F$Y$$$20240826$$CN$US$US
240364771$24036477$1$I$$20240624$20240701$20240701$PER$$US-AMGEN-USASP2024125034$AMGEN$Wazirali M.; Abbas K.; Malik M.. A Case of Yellow Nail Syndrome With Recurrent Pleural Effusion Treated With Indwelling Plural Catheters and Vitamin E. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1906$64$YR$A$M$Y$$$20240701$$HP$US$US
240364783$24036478$3$F$$20240905$20240701$20240917$PER$$US-INCYTE CORPORATION-2024IN006360$INCYTE$$$$$$Y$$$20240917$$CN$US$US
240364791$24036479$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024126228$AMGEN$Aman L.; Patel A. R.; Brown W.. A Critical Case of Thrombotic Thrombocytopenic Purpura Occurring Secondary to Atypical Gastroenteritis. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A3539$50$YR$A$M$Y$$$20240701$$HP$US$US
240364801$24036480$1$I$20240618$20240624$20240701$20240701$PER$$US-AMGEN-USASP2024125172$AMGEN$$32$YR$A$F$Y$$$20240701$$CN$US$US
240364812$24036481$2$F$20240101$20240701$20240701$20240704$PER$$US-AMGEN-USASP2024126829$AMGEN$$76$YR$E$F$Y$$$20240704$$CN$US$US
240364821$24036482$1$I$$20240701$20240701$20240701$EXP$$CZ-TAKEDA-2024TUS065616$TAKEDA$$$$C$M$Y$$$20240701$$HP$CZ$CZ
240364831$24036483$1$I$$20240624$20240701$20240701$EXP$$US-AMGEN-USASP2024125996$AMGEN$Kharal A.; Saleem E.; Heugel M. et al.. Temporal Lobe Involvement In Cerebral Amyloid Angiopathy Related Inflammation Is Associated With Relapse Of Inflammation And Rapidly Progressive Cognitive Decline. Stroke. 2023;54 (SUPPL1)$$$$$Y$$$20240701$$HP$US$US
240364841$24036484$1$I$$20240628$20240701$20240701$PER$$NVSC2024US136213$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
240364851$24036485$1$I$$20240624$20240701$20240701$PER$$US-AMGEN-USASP2024125044$AMGEN$Tomaras M.C; Douglas L.M; Schmidt R.M. et al.. Refractory chronic spontaneous urticaria after heterologous COVID-19 booster vaccination. Dermatology Online Journal. 2024;30 (2):1-7$55$YR$A$M$Y$$$20240701$$HP$US$US
240364861$24036486$1$I$$20240624$20240701$20240701$EXP$$NVSC2024US133503$NOVARTIS$$65$YR$$F$Y$$$20240701$$HP$US$US
240364871$24036487$1$I$20230104$20240626$20240701$20240701$EXP$FR-AFSSAPS-LL2024001158$FR-OTSUKA-2024_017607$OTSUKA$$11$YR$$M$Y$$$20240701$$CN$FR$FR
240364881$24036488$1$I$20240601$20240613$20240701$20240701$PER$$US-JNJFOC-20240636820$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240701$$CN$US$US
240364897$24036489$7$F$20240626$20240822$20240701$20240906$EXP$$CA-AstraZeneca-2024A149455$ASTRAZENECA$$15294$DY$$F$Y$$$20240906$$CN$CA$
240364902$24036490$2$F$$20240815$20240701$20240816$EXP$$US-AstraZeneca-2024A150330$ASTRAZENECA$Stanek K., Hussain M. T., Spaulding A. C., Borkar S., Shaikh M. E.. Improving Patient Safety Through Proper Ordering and Administration of Andexanet Alfa. Mayo Clinic Proceedings: Innovations, Quality + Outcomes 2024;8(4):407-414.$80$YR$$M$Y$$$20240816$$MD$US$
240364921$24036492$1$I$20231101$20240627$20240701$20240701$EXP$$MX-ABBVIE-5603313$ABBVIE$$39$YR$$M$Y$68$KG$20240701$$CN$MX$MX
240364931$24036493$1$I$20240601$20240624$20240701$20240701$PER$$US-SA-2024SA191072$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240701$$MD$US$US
240364941$24036494$1$I$20231001$20240626$20240701$20240701$PER$$US-SA-2024SA193217$SANOFI AVENTIS$$35$YR$A$M$Y$63.5$KG$20240701$$MD$US$US
240364951$24036495$1$I$20200222$20240621$20240701$20240701$EXP$PL-URPL-1-1186-2020$PL-TEVA-VS-3213025$TEVA$$80$YR$$M$Y$80$KG$20240701$$MD$PL$PL
240364962$24036496$2$F$20180501$20240704$20240701$20240712$EXP$$JP-TAKEDA-2024TUS064599$TAKEDA$$32$YR$$M$Y$$$20240712$$MD$JP$JP
240364971$24036497$1$I$20240624$20240624$20240701$20240701$PER$$US-RDY-SPO/USA/24/0009288$DR REDDYS$$18$YR$A$F$Y$$$20240701$$HP$US$US
240364981$24036498$1$I$$20240627$20240701$20240701$EXP$$US-KYOWAKIRIN-2024KK015802$KYOWA$$$$$$Y$$$20240701$$HP$US$US
240364991$24036499$1$I$$20230509$20240701$20240701$PER$$US-AMGEN-USASP2023235062$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240365003$24036500$3$F$20240601$20240722$20240701$20240807$30DAY$$US-AMGEN-USASP2024125008$AMGEN$$47$YR$A$M$Y$222.6$KG$20240806$$PH$US$US
240365011$24036501$1$I$$20240612$20240701$20240701$PER$$US-INCYTE CORPORATION-2024IN006328$INCYTE$$$$$$Y$$$20240701$$CN$US$US
240365021$24036502$1$I$20240503$20240628$20240701$20240701$DIR$FDA-CDER-CTU-2024-45880$$FDA-CTU$$57$YR$$F$N$$$20240628$N$HP$US$
240365041$24036504$1$I$$20240627$20240701$20240701$DIR$FDA-CDER-CTU-2024-45883$$FDA-CTU$$$$$F$N$$$20240627$N$HP$US$
240365071$24036507$1$I$$20240620$20240701$20240701$EXP$$FR-JNJFOC-20240662606$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$MD$FR$FR
240365081$24036508$1$I$20240101$20240625$20240701$20240701$DIR$FDA-CDER-CTU-2024-45940$$FDA-CTU$$92$YR$$F$N$116$LBS$20240625$N$$US$
240365101$24036510$1$I$$20240624$20240701$20240701$EXP$$CA-DSJP-DSJ-2024-129768$DAIICHI$$74$YR$$F$Y$$$20240701$$MD$CA$CA
240365111$24036511$1$I$$20240624$20240701$20240701$EXP$$NVSC2024US133508$NOVARTIS$$47$YR$$F$Y$$$20240701$$HP$US$US
240365121$24036512$1$I$$20240627$20240701$20240701$PER$$US-ABBVIE-5820506$ABBVIE$$52$YR$$F$Y$$$20240701$$HP$US$US
240365131$24036513$1$I$20240401$20240625$20240701$20240701$PER$$US-ABBVIE-5816931$ABBVIE$$$$A$$Y$$$20240701$$MD$US$US
240365141$24036514$1$I$$20240612$20240701$20240701$PER$$US-INCYTE CORPORATION-2024IN006324$INCYTE$$$$$$Y$$$20240701$$CN$US$US
240365151$24036515$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA190967$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240701$$MD$US$US
240365161$24036516$1$I$20240611$20240612$20240701$20240701$PER$$US-INCYTE CORPORATION-2024IN006321$INCYTE$$$$$$Y$$$20240701$$PH$US$US
240365181$24036518$1$I$$20240626$20240701$20240701$EXP$$US-AMGEN-USASP2024127179$AMGEN$$70$YR$E$F$Y$$$20240701$$MD$US$US
240365191$24036519$1$I$$20240624$20240701$20240701$EXP$$US-GSK-US2024AMR079026$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$MD$US$US
240365212$24036521$2$F$$20240910$20240701$20240920$EXP$$US-MALLINCKRODT-MNK202403997$MALLINCKRODT$$$$$F$Y$$$20240920$$CN$US$US
240365222$24036522$2$F$$20240808$20240701$20240816$EXP$$US-MALLINCKRODT-MNK202403996$MALLINCKRODT$$45$YR$A$M$Y$$$20240816$$CN$US$US
240365231$24036523$1$I$$20240618$20240701$20240701$EXP$$US-MALLINCKRODT-MNK202404003$MALLINCKRODT$$$$$M$Y$$$20240701$$HP$US$US
240365251$24036525$1$I$$20240628$20240701$20240701$PER$$NVSC2024US135775$NOVARTIS$$$$$$Y$$$20240701$$CN$US$US
240365261$24036526$1$I$$20240612$20240701$20240701$PER$$US-INCYTE CORPORATION-2024IN006316$INCYTE$$$$$$Y$$$20240701$$HP$US$US
240365271$24036527$1$I$20240614$20240626$20240701$20240701$EXP$$HU-BAYER-2024A088401$BAYER$$45$YR$A$F$Y$$$20240701$$CN$HU$HU
240365286$24036528$6$F$20240101$20240913$20240701$20240918$EXP$$US-KARYOPHARM-2024KPT001181$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240918$$CN$US$US
240365291$24036529$1$I$20240520$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45964$$FDA-CTU$$35$YR$$M$N$$$20240701$N$HP$US$
240365301$24036530$1$I$20240613$20240628$20240701$20240701$EXP$$US-ABBVIE-5820956$ABBVIE$$84$YR$$F$Y$68$KG$20240701$$CN$US$US
240365311$24036531$1$I$$20240628$20240701$20240701$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037046$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240701$$CN$US$US
240365321$24036532$1$I$20240101$20240625$20240701$20240701$PER$$US-KARYOPHARM-2024KPT001222$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240701$$CN$US$US
240365332$24036533$2$F$$20240916$20240701$20240919$PER$$US-PFIZER INC-202400202719$PFIZER$$13$YR$$F$Y$$$20240919$$CN$US$US
240365342$24036534$2$F$20240620$20240702$20240701$20240708$PER$$US-AMGEN-USASP2024125079$AMGEN$$64$YR$A$F$Y$$$20240708$$HP$US$US
240365351$24036535$1$I$$20240624$20240701$20240701$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-090140$REGENERON$Betts C., Maxwell M., Floyd M., Pawlowski J. A. Neoadjuvant Cemiplimab Followed by Radiation for Locally Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: A Case Report. Advances in Radiation Oncology. 2024;9$60$YR$$F$Y$$$20240701$$MD$US$US
240365361$24036536$1$I$20230516$20240624$20240701$20240701$EXP$$US-GSK-US2024AMR079581$GLAXOSMITHKLINE$$$$$$Y$$$20240701$$CN$US$US
240365371$24036537$1$I$$20240623$20240701$20240701$PER$$NVSC2024US131373$NOVARTIS$$$$$$Y$$$20240701$$CN$US$US
240365381$24036538$1$I$$20240628$20240701$20240701$PER$$US-HALEON-2184609$Haleon PLC$$$$$$Y$$$20240701$$CN$US$US
240365392$24036539$2$F$$20240703$20240701$20240715$EXP$$NZ-ABBVIE-5822314$ABBVIE$Medicine-induced hyponatraemia: increased risks in older people. Prescriber Update. 2024;45(2):34-36.$$$$$Y$$$20240715$$HP$NZ$NZ
240365402$24036540$2$F$20240101$20240625$20240701$20240805$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003124$CURRAX PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$CA$CA
240365411$24036541$1$I$20240201$20240625$20240701$20240701$EXP$$SI-MYLANLABS-2024M1057878$MYLAN$$$$E$M$Y$$$20240701$$MD$SI$SI
240365421$24036542$1$I$20240322$20240625$20240701$20240701$EXP$FR-AFSSAPS-AN2024000814$FR-MYLANLABS-2024M1057892$MYLAN$$37$YR$$M$Y$193$KG$20240701$$MD$FR$FR
240365431$24036543$1$I$20240529$20240625$20240701$20240701$EXP$IT-MINISAL02-991415$IT-MYLANLABS-2024M1057880$MYLAN$$89$YR$$F$Y$$$20240701$$PH$IT$IT
240365441$24036544$1$I$20240124$20240625$20240701$20240701$EXP$FR-AFSSAPS-ST2024001089$FR-MYLANLABS-2024M1057909$MYLAN$$69$YR$$M$Y$$$20240701$$MD$FR$FR
240365461$24036546$1$I$$20240625$20240701$20240701$EXP$IT-MINISAL02-991417$IT-MYLANLABS-2024M1057912$MYLAN$$83$YR$$F$Y$$$20240701$$MD$IT$IT
240365474$24036547$4$F$$20240717$20240701$20240723$EXP$$RO-MYLANLABS-2024M1057874$MYLAN$Mihaila ZA, Branea OE, Branea IA, Lazar Aq. Acute muscle toxicity following an olanzapine overdose: a case report. Acta Medica Marisiensis. 2024;70 (Supp. 2):42$31$YR$$F$Y$$$20240723$$HP$RO$RO
240365481$24036548$1$I$$20240625$20240701$20240701$EXP$$CZ-MYLANLABS-2024M1052748$MYLAN$Bloomfield M, A Klocperk, H Schneiderova, E Hlavackova, M Turnovec, L Tichy etal.. Newborn screening brings progress in the diagnosis of severe congenital immune disorders.. CESKO-SLOVENSKA PEDIATRIE. 2024;79(3):136-141$10$WK$$M$Y$$$20240701$$MD$CZ$CZ
240365491$24036549$1$I$20240419$20240625$20240701$20240701$EXP$FR-AFSSAPS-TO2024000758$FR-MYLANLABS-2024M1057916$MYLAN$$65$YR$$M$Y$98$KG$20240701$$PH$FR$FR
240365502$24036550$2$F$20240401$20240628$20240701$20240701$PER$$US-JNJFOC-20240678824$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240701$$HP$US$US
240365513$24036551$3$F$$20240711$20240701$20240717$EXP$$FR-MYLANLABS-2024M1057934$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
240365521$24036552$1$I$$20240624$20240701$20240701$EXP$$CA-DSJP-DSJ-2024-129770AA$DAIICHI$$$$$F$Y$$$20240701$$MD$CA$CA
240365541$24036554$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45926$$FDA-CTU$$62$YR$$F$N$145$LBS$20240701$N$$US$
240365571$24036557$1$I$20240620$20240628$20240701$20240701$DIR$FDA-CDER-CTU-2024-45853$$FDA-CTU$$34$YR$$F$N$$$20240628$N$HP$US$
240365591$24036559$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45866$$FDA-CTU$$58$YR$$F$N$$$20240701$N$$US$
240365638$24036563$8$F$20240621$20240826$20240701$20240902$PER$$US-AMGEN-USASP2024125212$AMGEN$$$$$F$Y$$$20240902$$HP$US$US
240365641$24036564$1$I$20240521$20240627$20240701$20240701$EXP$FR-AFSSAPS-NC2024000728$FR-JNJFOC-20240700705$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240701$$PH$FR$FR
240365652$24036565$2$F$20230220$20240704$20240701$20240709$EXP$$CN-TAKEDA-2024TUS063752$TAKEDA$$51$YR$$M$Y$65$KG$20240709$$MD$CN$CN
240365661$24036566$1$I$$20240624$20240701$20240701$EXP$$CA-DSJP-DSJ-2024-129772AA$DAIICHI$$$$$F$Y$$$20240701$$CN$CA$CA
240365671$24036567$1$I$20240621$20240621$20240701$20240701$PER$$US-CSL-2024-005981$CSL Plasma$$21$YR$$F$Y$$$20240701$$HP$US$US
240365681$24036568$1$I$$20240625$20240701$20240701$EXP$$US-AMERICAN REGENT INC-2024002459$AMERICAN REGENT$Wu YF, Skinner L, Lewis J, Khodadoust MS, Kim YH, Kwong BY, et al.. Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell Transplantation. Cancer Investigation. 2023;41(3):263-270$37$YR$$M$Y$$$20240701$$HP$US$US
240365691$24036569$1$I$20240613$20240627$20240701$20240701$EXP$$CN-ASTELLAS-2024US018392$ASTELLAS$$84$YR$$M$Y$65$KG$20240701$$CN$CN$CN
240365701$24036570$1$I$20230101$20240627$20240701$20240701$EXP$$HN-MYLANLABS-2024M1061324$MYLAN$$$$$M$Y$73.48$KG$20240701$$CN$HN$HN
240365712$24036571$2$F$20240101$20240707$20240701$20240716$EXP$$DE-BAYER-2024A089857$BAYER$$37$YR$A$F$Y$$$20240716$$MD$DE$DE
240365722$24036572$2$F$20240623$20240712$20240701$20240726$EXP$$CN-PFIZER INC-PV202400084958$PFIZER$$62$YR$$M$Y$75$KG$20240726$$HP$CN$CN
240365733$24036573$3$F$$20240917$20240701$20240930$PER$$US-TRAVERE-2024TVT00559$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
240365741$24036574$1$I$$20240624$20240701$20240701$EXP$$AU-RDY-SPO/AUS/24/0009344$DR REDDYS$$$$$M$Y$$$20240701$$CN$AU$AU
240365751$24036575$1$I$$20240624$20240701$20240701$EXP$$CA-TEVA-VS-3214199$TEVA$$39$YR$$M$Y$91$KG$20240701$$HP$CA$CA
240365761$24036576$1$I$$20240627$20240701$20240701$EXP$$FR-MYLANLABS-2024M1059230$MYLAN$Leleu X, Hulin C, Lambert J, Bobin A, Perrot A, Karlin L et al.. Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 benefit trial. Nature Medicine. 2024$$$E$$Y$$$20240701$$MD$FR$FR
240365771$24036577$1$I$$20240627$20240701$20240701$EXP$$FR-MYLANLABS-2024M1058703$MYLAN$Leleu X, Hulin C, Lambert J, Bobin A, Perrot A, Karlin L et al. Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial. Nature Medicine. 2024$$$E$$Y$$$20240701$$MD$FR$FR
240365841$24036584$1$I$$20240628$20240701$20240701$DIR$FDA-CDER-CTU-2024-45867$$FDA-CTU$$$$$M$N$$$20240628$N$HP$US$
240365861$24036586$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45863$$FDA-CTU$$47$YR$$F$N$$$20240701$N$$US$
240365871$24036587$1$I$$20240626$20240701$20240701$DIR$FDA-CDER-CTU-2024-45864$$FDA-CTU$$$$$F$N$$$20240626$N$HP$US$
240365881$24036588$1$I$$20240628$20240701$20240701$PER$$US-JNJFOC-20240679664$JOHNSON AND JOHNSON$$$$$F$Y$$$20240701$$CN$US$US
240365891$24036589$1$I$$20240622$20240701$20240701$EXP$$AT-JNJFOC-20240661815$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$CN$AT$AT
240365912$24036591$2$F$$20240709$20240701$20240715$EXP$$NVSC2024US132357$NOVARTIS$$$$$M$Y$$$20240715$$MD$US$US
240365921$24036592$1$I$$20240625$20240701$20240701$PER$$US-ABBVIE-5820339$ABBVIE$$$$$F$Y$$$20240701$$HP$US$US
240365931$24036593$1$I$$20240628$20240701$20240701$EXP$$US-SANDOZ INC.-SDZ2024US061741$SANDOZ$$$$$M$Y$$$20240701$$MD$US$US
240365943$24036594$3$F$20240526$20240801$20240701$20240808$EXP$$JP-SANDOZ INC.-SDZ2024JP061508$SANDOZ$$91$YR$$F$Y$$$20240808$$MD$JP$JP
240365951$24036595$1$I$$20240628$20240701$20240701$EXP$GB-MHRA-30896414$GB-SANDOZ INC.-SDZ2024GB061676$SANDOZ$$8$YR$$M$Y$$$20240701$$CN$GB$GB
240365962$24036596$2$F$20240319$20240906$20240701$20240909$EXP$$US-SANDOZ INC.-SDZ2024US061460$SANDOZ$$$$$$Y$$$20240909$$HP$US$US
240365971$24036597$1$I$20231101$20240627$20240701$20240701$EXP$$CA-SANDOZ INC.-NVSC2022CA181190$SANDOZ$$77$YR$$F$Y$$$20240701$$CN$CA$CA
240365981$24036598$1$I$$20240626$20240701$20240701$30DAY$$US-SANDOZ INC.-SDZ2024US061187$SANDOZ$$$$$F$Y$$$20240701$$CN$US$US
240365991$24036599$1$I$$20240626$20240701$20240701$EXP$$US-SANDOZ INC.-SDZ2024US061279$SANDOZ$$$$$F$Y$$$20240701$$CN$US$US
240366001$24036600$1$I$20240610$20240628$20240701$20240701$EXP$FR-AFSSAPS-MP2024001013$FR-SANDOZ INC.-SDZ2024FR061476$SANDOZ$$8$YR$$F$Y$37.9$KG$20240701$$MD$FR$FR
240366011$24036601$1$I$20240102$20240701$20240701$20240701$EXP$DK-DKMA-30734094$DK-SANDOZ INC.-SDZ2024DK061785$SANDOZ$$66$YR$$M$Y$84$KG$20240701$$MD$DK$DK
240366021$24036602$1$I$$20240624$20240701$20240701$PER$$US-ABBVIE-5816690$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240366032$24036603$2$F$20230923$20240627$20240701$20240708$EXP$FR-AFSSAPS-PC2023000877$FR-MYLANLABS-2024M1058648$MYLAN$$66$YR$$M$Y$67$KG$20240708$$MD$FR$FR
240366042$24036604$2$F$20240525$20240724$20240701$20240801$EXP$$US-VIVUS LLC-2024V1000781$VIVUS$$25$YR$A$F$Y$$$20240731$$MD$US$US
240366051$24036605$1$I$$20240624$20240701$20240701$EXP$$GB-TAKEDA-2024TUS064875$TAKEDA$$$$$F$Y$$$20240701$$MD$GB$GB
240366061$24036606$1$I$$20240624$20240701$20240701$EXP$$US-AMGEN-USASP2024125463$AMGEN$Schroff P.; Maddipati V.; Obi O.N.. An Ode to a Node-Lymphoma Masquerading as Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A5919$39$YR$A$M$Y$$$20240701$$HP$US$US
240366071$24036607$1$I$$20240622$20240701$20240701$EXP$$US-MYLANLABS-2024M1059284$MYLAN$Puri A, Iusim S. Dust to Dawn: A Case of Complicated Silicosis With Progressive Massive Pulmonary Fibrosis. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A5983.$57$YR$$M$Y$$$20240701$$HP$US$US
240366082$24036608$2$F$20240601$20240712$20240701$20240805$PER$$US-KARYOPHARM-2024KPT001226$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240805$$CN$US$US
240366092$24036609$2$F$20240610$20240624$20240701$20240704$EXP$$CN-DSJP-DSJ-2024-129024$DAIICHI$$33$YR$$F$Y$50$KG$20240704$$HP$CN$CN
240366102$24036610$2$F$20190104$20240625$20240701$20240703$EXP$$NVSC2024DE135503$NOVARTIS$$51$YR$$M$Y$125$KG$20240703$$MD$DE$DE
240366111$24036611$1$I$$20240626$20240701$20240701$PER$$US-DSJP-DSU-2024-129720$DAIICHI$$$$$F$Y$$$20240701$$HP$US$US
240366121$24036612$1$I$$20240617$20240701$20240701$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2158749$BRECKENRIDGE$$$$$$Y$$$20240701$$$ES$A1
240366141$24036614$1$I$20231028$20240626$20240701$20240701$EXP$$US-AstraZeneca-2024A149768$ASTRAZENECA$$70$YR$$M$Y$115.2$KG$20240701$$HP$US$
240366151$24036615$1$I$20240627$20240628$20240701$20240701$EXP$$US-TAKEDA-2024TUS007650$TAKEDA$$85$YR$$M$Y$$$20240701$$CN$US$US
240366161$24036616$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA186080$SANOFI AVENTIS$$$$A$F$Y$$$20240701$$CN$US$US
240366171$24036617$1$I$20240201$20240626$20240701$20240701$PER$$US-SA-2024SA193206$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240701$$MD$US$US
240366181$24036618$1$I$20240201$20240620$20240701$20240701$PER$$US-SA-2024SA185681$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240701$$MD$US$US
240366191$24036619$1$I$$20230414$20240701$20240701$PER$$US-AMGEN-USASP2023235172$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240366202$24036620$2$F$$20240708$20240701$20240709$PER$$US-AMGEN-USASP2024127371$AMGEN$$$$$M$Y$$$20240709$$CN$US$US
240366211$24036621$1$I$$20240625$20240701$20240701$EXP$$US-FreseniusKabi-FK202410169$FRESENIUS KABI$Alsakha A, Marraffa JM. Ifosfamide neurotoxicity treated with methylene blue complicated by serotonin toxicity. American Journal of Respiratory and Critical Care Medicine. 2023 May 16;61: 106-106. doi:https://doi.org/10.1080/15563650.2023.2192024.$54$YR$A$F$Y$$$20240701$$HP$US$US
240366222$24036622$2$F$20240429$20240621$20240701$20240708$PER$$AU-Eisai-EC-2024-168899$EISAI$$72$YR$E$M$Y$$$20240708$$MD$AU$AU
240366231$24036623$1$I$$20230512$20240701$20240701$PER$$US-AMGEN-USASP2023235064$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240366241$24036624$1$I$$20240627$20240701$20240701$PER$$US-AMGEN-USASP2024129427$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240366251$24036625$1$I$$20240621$20240701$20240701$EXP$US-MLMSERVICE-20240614-PI101107-00312-1$US-RDY-SPO/USA/24/0009207$DR REDDYS$Sinha A, Cantrell S, Kozman DM, Jelovsek JE. Ectopic Prostatic Tissue in Female Urethral Diverticulum. Obstetrics and gynecology. 2024. DOI:10.1097/AOG.0000000000005638$$$$F$Y$$$20240701$$MD$US$US
240366261$24036626$1$I$20201221$20240624$20240701$20240701$EXP$$DE-RDY-SPO/DEU/24/0008757$DR REDDYS$$54$YR$A$F$Y$91$KG$20240701$$MD$DE$DE
240366271$24036627$1$I$$20240625$20240701$20240701$EXP$$US-AMGEN-USASP2024127228$AMGEN$Yilmaz S.; Prien C.; Lavryk O. et al.. Maternal and Fetal Outcomes After IBD Surgery During Pregnancy. American Journal of Gastroenterology. 2022;117:S31$20$YR$A$F$Y$$$20240701$$HP$US$US
240366281$24036628$1$I$$20240625$20240701$20240701$EXP$$US-AMGEN-USASP2024127215$AMGEN$Yilmaz S.; Prien C.; Lavryk O. et al.. Maternal and Fetal Outcomes After IBD Surgery During Pregnancy. American Journal of Gastroenterology. 2022;117:S31$$$I$$Y$3.7$KG$20240701$$HP$US$US
240366291$24036629$1$I$$20240625$20240701$20240701$PER$$US-AMGEN-USASP2024125853$AMGEN$Khattri S.; Hren M. G.; Guenin S.. Use of dual biologic therapy targeting the Th2 and Thl7 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease. Journal of the American Academy of Dermatology. 2024;91(1):138-140$38$YR$A$F$Y$$$20240701$$MD$US$US
240366301$24036630$1$I$$20240624$20240701$20240701$EXP$$IT-MYLANLABS-2024M1061004$MYLAN$Roccatello D, Baffa A, Naretto C, Barreca A, Cravero R, Roscini E, et al. Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy. Clin-Kidney-J 2023; 16 (8): 1258-1264.$26$YR$$F$Y$$$20240701$$HP$IT$IT
240366311$24036631$1$I$20240622$20240626$20240701$20240701$EXP$$AU-PFIZER INC-202400201798$PFIZER$$$$E$M$Y$$$20240701$$MD$AU$AU
240366331$24036633$1$I$20240407$20240701$20240701$20240701$EXP$FR-AFSSAPS-NC2024000778$NVSC2024FR136111$NOVARTIS$$52$YR$$F$Y$66.5$KG$20240701$$MD$FR$FR
240366341$24036634$1$I$$20240625$20240701$20240701$PER$$US-ABBVIE-5817373$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240366351$24036635$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019044$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240701$$HP$US$US
240366361$24036636$1$I$20240627$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000202$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240701$$CN$US$US
240366371$24036637$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019114$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$US$US
240366381$24036638$1$I$$20240620$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406015353$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240366391$24036639$1$I$20240605$20240624$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017147$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240701$$CN$US$US
240366401$24036640$1$I$20240601$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018802$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240366411$24036641$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000039$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240701$$CN$US$US
240366421$24036642$1$I$20240627$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000564$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240701$$CN$US$US
240366432$24036643$2$F$$20240719$20240701$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202406019196$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
240366441$24036644$1$I$20191114$20240624$20240701$20240701$EXP$$CA-TAKEDA-2024TUS024700$TAKEDA$$67$YR$$F$Y$$$20240701$$HP$CA$CA
240366451$24036645$1$I$$20240625$20240701$20240701$EXP$$CN-009507513-2406CHN009825$MERCK$$40$YR$$F$Y$$$20240701$$MD$CN$CN
240366461$24036646$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45870$$FDA-CTU$$72$YR$$F$N$$$20240701$N$$US$
240366481$24036648$1$I$$20240627$20240701$20240701$EXP$$CA-PFIZER INC-202400203164$PFIZER$$75$YR$$F$Y$$$20240701$$MD$CA$CA
240366491$24036649$1$I$20240101$20240625$20240701$20240701$EXP$$US-ABBVIE-5819852$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240366501$24036650$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45872$$FDA-CTU$$76$YR$$F$N$$$20240701$N$$US$
240366521$24036652$1$I$20221101$20240623$20240701$20240701$EXP$$NVSC2024BG134371$NOVARTIS$$70$YR$$F$Y$$$20240701$$MD$BG$BG
240366531$24036653$1$I$$20240625$20240701$20240701$EXP$$US-AMGEN-USASP2024127202$AMGEN$Yilmaz S.; Prien C.; Lavryk O. et al.. Maternal and Fetal Outcomes After IBD Surgery During Pregnancy. American Journal of Gastroenterology. 2022;117:S31$28$YR$A$F$Y$$$20240701$$HP$US$US
240366541$24036654$1$I$$20240624$20240701$20240701$EXP$$CA-TEVA-VS-3214048$TEVA$$68$YR$$M$Y$$$20240701$$HP$CA$CA
240366552$24036655$2$F$20240410$20240619$20240701$20240906$EXP$$US-FARMAPROD-202405-1864$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240904$$CN$US$US
240366561$24036656$1$I$$20240620$20240701$20240701$PER$$US-SA-2024SA188830$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240701$$CN$US$US
240366572$24036657$2$F$20240601$20240917$20240701$20240927$EXP$$US-FARMAPROD-202406-2324$DOMPE FARMACEUTICI$$79$YR$E$F$Y$47.9$KG$20240927$$MD$US$US
240366582$24036658$2$F$20240609$20240624$20240701$20240708$EXP$CN-91110000556821568D-2024DRL001183$CN-RDY-SPO/CHN/24/0009332$DR REDDYS$$75$YR$E$M$Y$57$KG$20240708$$HP$CN$CN
240366613$24036661$3$F$20240618$20240802$20240701$20240806$PER$$US-AMGEN-USASP2024128752$AMGEN$$71$YR$E$M$Y$$$20240806$$MD$US$US
240366622$24036662$2$F$20240430$20240807$20240701$20240808$PER$$NVSC2024US136372$NOVARTIS$$63$YR$$F$Y$$$20240809$$HP$US$US
240366631$24036663$1$I$$20240625$20240701$20240701$5DAY$$US-ASTELLAS-2024US018276$ASTELLAS$$$$$$Y$$$20240701$$CN$US$US
240366641$24036664$1$I$$20240626$20240701$20240701$EXP$$DE-ABBVIE-5820668$ABBVIE$$$$$F$Y$$$20240701$$CN$DE$DE
240366661$24036666$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45892$$FDA-CTU$$67$YR$$F$N$272$LBS$20240701$N$$US$
240366671$24036667$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45893$$FDA-CTU$$75$YR$$F$N$$$20240701$N$$US$
240366681$24036668$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45884$$FDA-CTU$$47$YR$$F$N$$$20240701$N$$US$
240366692$24036669$2$F$20240601$20240624$20240701$20240702$EXP$$DE-AstraZeneca-2024A145556$ASTRAZENECA$$$$E$M$Y$$$20240702$$CN$DE$
240366701$24036670$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45882$$FDA-CTU$$65$YR$$F$N$$$20240701$N$$US$
240366712$24036671$2$F$20240616$20240830$20240701$20240904$EXP$$IT-INCYTE CORPORATION-2024IN006593$INCYTE$$$$$$Y$$$20240904$$MD$IT$IT
240366722$24036672$2$F$20240529$20240711$20240701$20240716$PER$$US-JNJFOC-20240613219$JOHNSON AND JOHNSON$$74$YR$$F$Y$$$20240716$$CN$US$US
240366731$24036673$1$I$$20240624$20240701$20240701$EXP$$NVSC2024IN134275$NOVARTIS$$63$YR$$M$Y$$$20240701$$CN$IN$IN
240366741$24036674$1$I$$20240624$20240701$20240701$EXP$$CA-TEVA-VS-3214034$TEVA$$62$YR$$F$Y$$$20240701$$MD$CA$CA
240366751$24036675$1$I$20230915$20240624$20240701$20240701$PER$$US-SA-2024SA188087$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240701$$MD$US$US
240366772$24036677$2$F$20240626$20240710$20240701$20240715$PER$$US-AMGEN-USASP2024127377$AMGEN$$85$YR$E$F$Y$$$20240715$$PH$US$US
240366781$24036678$1$I$$20240627$20240701$20240701$PER$$US-MYLANLABS-2024M1061175$MYLAN$$$$$F$Y$$$20240701$$CN$US$US
240366791$24036679$1$I$$20240624$20240701$20240701$EXP$$CA-TEVA-VS-3214187$TEVA$$69$YR$$F$Y$$$20240701$$HP$CA$CA
240366801$24036680$1$I$$20240624$20240701$20240701$EXP$$CA-TEVA-VS-3214180$TEVA$$70$YR$$F$Y$$$20240701$$CN$CA$CA
240366812$24036681$2$F$$20240807$20240701$20240807$30DAY$$CL-PFIZER INC-PV202400083544$PFIZER$$12$YR$$M$Y$$$20240807$$CN$CL$CL
240366824$24036682$4$F$$20240924$20240701$20240926$30DAY$$US-PFIZER INC-202400195606$PFIZER$$14$YR$$M$Y$$$20240926$$CN$US$US
240366831$24036683$1$I$20240601$20240602$20240701$20240701$PER$$US-SCIEGENP-2024SCSPO00299$SCIEGEN$$85$YR$E$F$Y$$$20240701$$CN$US$US
240366841$24036684$1$I$$20240625$20240701$20240701$EXP$$PT-MYLANLABS-2024M1058304$MYLAN$Hemolysis and thrombocytopenia after levetiracetam: when the patient gives us a card$$$$$Y$$$20240701$$HP$PT$PT
240366851$24036685$1$I$$20240625$20240701$20240701$EXP$$DE-MYLANLABS-2022M1030067$MYLAN$Bonnet U, Kanti AK, Scherbaum N, Specka M.. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study.. J-Psychoactive Drugs.. 2022;55 (1):102-111.$46$YR$$M$Y$$$20240701$$HP$DE$DE
240366861$24036686$1$I$$20240625$20240701$20240701$EXP$$NL-MYLANLABS-2024M1058248$MYLAN$De Jonge, M.. Travelling ticks: further spread of a rare virus in the Netherlands. Journal of Neurology and Neurosurgery. 2024;125 (4):39-44$63$YR$$F$Y$$$20240701$$MD$NL$NL
240366871$24036687$1$I$$20240625$20240701$20240701$EXP$$DE-MYLANLABS-2022M1031052$MYLAN$Bonnet U, Kanti AK, Scherbaum N, Specka M.. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study.. J-Psychoactive Drugs.. 2023;55 (1):102-111$49$YR$$M$Y$$$20240701$$HP$DE$DE
240366881$24036688$1$I$$20240620$20240701$20240701$EXP$$US-MYLANLABS-2024M1057830$MYLAN$Deiss T, Harper A, Sanne S, Imsais W. Delayed clostridium difficile diagnosis in a patient with chronic constipation and diarrhea. Am-J-Med-Sci 2024; 367 (Suppl. 1) S47-S48 abstr. 80.$77$YR$$F$Y$$$20240701$$HP$US$US
240366891$24036689$1$I$20240612$20240625$20240701$20240701$EXP$IT-MINISAL02-991523$IT-MYLANLABS-2024M1058037$MYLAN$$34$YR$$F$Y$65$KG$20240701$$MD$IT$IT
240366901$24036690$1$I$20230726$20240625$20240701$20240701$EXP$$PL-MYLANLABS-2024M1058178$MYLAN$$70$YR$$F$Y$108$KG$20240701$$HP$PL$PL
240366911$24036691$1$I$$20240625$20240701$20240701$EXP$$FR-MYLANLABS-2024M1061461$MYLAN$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. J-Clin-Immunol 2023; 43 (3): 647-652.$30$YR$$M$Y$$$20240701$$HP$FR$FR
240366921$24036692$1$I$$20240625$20240701$20240701$EXP$$DE-MYLANLABS-2022M1030007$MYLAN$Bonnet U, Kanti AK, Scherbaum N, Specka M.. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study.. J Psychoactive Drugs.. 2022;55 (1):102-111$34$YR$$M$Y$$$20240701$$HP$DE$DE
240366931$24036693$1$I$20231201$20240625$20240701$20240701$EXP$FR-AFSSAPS-NT2024000640$FR-MYLANLABS-2024M1058005$MYLAN$$72$YR$$M$Y$$$20240701$$MD$FR$FR
240366951$24036695$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45894$$FDA-CTU$$60$YR$$F$N$$$20240701$N$$US$
240366961$24036696$1$I$20240508$20240626$20240701$20240701$DIR$FDA-CDER-CTU-2024-45885$$FDA-CTU$$83$YR$$F$N$$$20240626$N$HP$US$
240366971$24036697$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45895$$FDA-CTU$$74$YR$$F$N$127$LBS$20240701$N$$US$
240366981$24036698$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45906$$FDA-CTU$$79$YR$$F$N$170$LBS$20240701$N$$US$
240366991$24036699$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45907$$FDA-CTU$$51$YR$$F$N$223$LBS$20240701$N$$US$
240367001$24036700$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45908$$FDA-CTU$$54$YR$$M$N$$$20240701$N$$US$
240367011$24036701$1$I$20240101$20240621$20240701$20240701$EXP$$US-Eisai-EC-2024-169248$EISAI$$73$YR$E$F$Y$68.95$KG$20240701$$CN$US$US
240367022$24036702$2$F$20240613$20240708$20240701$20240712$EXP$$US-APELLIS-2024-APL-0000314$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240712$$CN$US$US
240367033$24036703$3$F$20240619$20240708$20240701$20240712$PER$$JP-BRACCO-2024JP03729$BRACCO$$50$YR$$M$Y$$$20240712$$MD$JP$JP
240367041$24036704$1$I$20240614$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45896$$FDA-CTU$$39$YR$$M$N$$$20240701$N$HP$US$
240367051$24036705$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127148$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240367061$24036706$1$I$$20240619$20240701$20240701$PER$$US-TAKEDA-2024TUS061250$TAKEDA$$$$$$Y$$$20240701$$HP$US$US
240367071$24036707$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45899$$FDA-CTU$$54$YR$$F$N$257$LBS$20240701$N$$US$
240367081$24036708$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45901$$FDA-CTU$$56$YR$$F$N$$$20240701$N$$US$
240367091$24036709$1$I$$20240625$20240701$20240701$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202406019516$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240701$$CN$MX$MX
240367102$24036710$2$F$$20240914$20240701$20240926$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202406014171$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240926$$CN$ES$ES
240367111$24036711$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45902$$FDA-CTU$$94$YR$$M$N$$$20240701$N$$US$
240367121$24036712$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45903$$FDA-CTU$$74$YR$$M$N$188$LBS$20240701$N$$US$
240367131$24036713$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45904$$FDA-CTU$$46$YR$$F$N$$$20240701$N$$US$
240367141$24036714$1$I$$20240619$20240701$20240701$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202406013801$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$MX$MX
240367153$24036715$3$F$20240327$20240731$20240701$20240806$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406014681$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240806$$CN$JP$JP
240367161$24036716$1$I$$20240618$20240701$20240701$EXP$$NO-ELI_LILLY_AND_COMPANY-NO202406018785$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240701$$HP$NO$NO
240367171$24036717$1$I$$20240619$20240701$20240701$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406016444$ELI LILLY AND CO$Hoshino Y, et al..A case of advanced hepatocellular carcinoma with rapidly increasing AFP and significant response to ramucirumab as third-line drug therapy.Tottori Red Cross Hospital Medical Journal 2023;32:20-25.$83$YR$E$M$Y$65$KG$20240701$$MD$JP$JP
240367181$24036718$1$I$$20240619$20240701$20240701$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202406013792$ELI LILLY AND CO$$$$$F$Y$$$20240701$$CN$MX$MX
240367191$24036719$1$I$$20240618$20240701$20240701$EXP$$SG-ELI_LILLY_AND_COMPANY-SG202406018875$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240701$$HP$SG$SG
240367201$24036720$1$I$$20240619$20240701$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014756$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240701$$CN$US$US
240367211$24036721$1$I$$20240619$20240701$20240701$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014023$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240701$$CN$US$US
240367221$24036722$1$I$$20240620$20240701$20240701$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202406014650$ELI LILLY AND CO$$$$$M$Y$$$20240701$$CN$ES$ES
240367232$24036723$2$F$$20240624$20240701$20240705$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202406017878$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$BR$BR
240367241$24036724$1$I$$20240628$20240701$20240701$EXP$$US-009507513-2407USA000267$MERCK$$$$$F$Y$$$20240701$$CN$US$US
240367261$24036726$1$I$20240601$20240628$20240701$20240701$EXP$$RU-AMERICAN REGENT INC-2024002510$AMERICAN REGENT$$7$DEC$$F$Y$120$KG$20240701$$MD$RU$RU
240367271$24036727$1$I$$20240626$20240701$20240701$EXP$$GB-TAKEDA-2023TUS073340$TAKEDA$$$$$M$Y$$$20240701$$CN$GB$GB
240367281$24036728$1$I$20240607$20240621$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100287$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240701$$CN$US$US
240367291$24036729$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104538$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$66.22$KG$20240701$$HP$US$US
240367302$24036730$2$F$20240520$20240712$20240701$20240716$EXP$$FR-PURDUE-USA-2024-0310494$PURDUE$$90$YR$$F$Y$$$20240716$$PH$FR$FR
240367312$24036731$2$F$$20240930$20240701$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104363$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240930$$CN$US$US
240367322$24036732$2$F$$20240930$20240701$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103205$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$54$KG$20240930$$HP$US$US
240367331$24036733$1$I$20240618$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104550$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$92.53$KG$20240701$$CN$US$US
240367342$24036734$2$F$20240601$20240717$20240701$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104544$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$94.35$KG$20240725$$CN$US$US
240367351$24036735$1$I$$20240701$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105015$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240701$$CN$US$US
240367361$24036736$1$I$20240501$20240625$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104926$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240701$$HP$US$US
240367373$24036737$3$F$20240612$20240920$20240701$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102144$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$106.59$KG$20240925$$CN$US$US
240367381$24036738$1$I$$20240625$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104786$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240701$$MD$US$US
240367392$24036739$2$F$$20240814$20240701$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104576$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$104.78$KG$20240822$$CN$US$US
240367401$24036740$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104332$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$103.96$KG$20240701$$HP$US$US
240367411$24036741$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103777$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$52.16$KG$20240701$$MD$US$US
240367421$24036742$1$I$$20240625$20240701$20240701$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-102997$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240701$$CN$GB$GB
240367443$24036744$3$F$20240502$20240701$20240701$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104943$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240717$$CN$US$US
240367453$24036745$3$F$20240101$20240731$20240701$20240808$EXP$$JP-BAUSCH-BL-2024-010072$BAUSCH AND LOMB$$57$YR$$M$Y$$$20240808$$MD$JP$JP
240367461$24036746$1$I$20240418$20240625$20240701$20240701$EXP$FR-AFSSAPS-TS2024000703$FR-009507513-2406FRA008964$MERCK$$63$YR$$F$Y$$$20240701$$MD$FR$FR
240367472$24036747$2$F$$20240628$20240701$20240704$PER$$NVSC2024US136391$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
240367482$24036748$2$F$$20240814$20240701$20240814$PER$$NVSC2024US136293$NOVARTIS$$$$$$Y$$$20240814$$PH$US$US
240367491$24036749$1$I$$20240623$20240701$20240701$PER$$US-MYLANLABS-2024M1057891$MYLAN$$$$$F$Y$$$20240701$$CN$US$US
240367501$24036750$1$I$$20240627$20240701$20240701$PER$$US-TAKEDA-2024TUS065146$TAKEDA$$75$YR$$M$Y$$$20240701$$CN$US$US
240367511$24036751$1$I$$20240619$20240701$20240701$EXP$$US-NORTHSTAR RX LLC-US-2024NSR000008$NORTHSTAR$Calderon Barahona GM, Ali R, Ortega Giron C, Ng W, Bobrysheva H, Calderon Martinez E, et al.,. Beta-Blocked: A Severe Propranolol Overdose Case Report. American Thoracic Society 2024 International Conference. 2024;209$25$YR$$F$Y$$$20240701$$HP$US$US
240367521$24036752$1$I$20240615$20240618$20240701$20240701$PER$$US-AstraZeneca-2024A141382$ASTRAZENECA$$26145$DY$$M$Y$$$20240701$$CN$US$
240367532$24036753$2$F$$20240912$20240701$20240913$PER$$NVSC2024US131218$NOVARTIS$$$$$M$Y$$$20240913$$CN$US$US
240367541$24036754$1$I$20240112$20240626$20240701$20240701$EXP$IT-MINISAL02-991677$IT-FreseniusKabi-FK202410102$FRESENIUS KABI$$58$YR$A$F$Y$$$20240701$$MD$IT$IT
240367551$24036755$1$I$20240601$20240627$20240701$20240701$EXP$GB-MHRA-MED-202406261625494370-HVWBP$GB-FreseniusKabi-FK202410201$FRESENIUS KABI$$$$$F$Y$$$20240701$$PH$GB$GB
240367561$24036756$1$I$$20240628$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104822$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240701$$HP$US$US
240367571$24036757$1$I$$20240626$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103595$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240701$$HP$US$US
240367581$24036758$1$I$$20240627$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104730$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240701$$CN$US$US
240367591$24036759$1$I$20230101$20240624$20240701$20240701$EXP$$ES-FreseniusKabi-FK202409928$FRESENIUS KABI$$$$A$F$Y$$$20240701$$MD$ES$ES
240367601$24036760$1$I$$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104869$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240701$$CN$US$US
240367611$24036761$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104452$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$79.83$KG$20240701$$CN$US$US
240367621$24036762$1$I$20231016$20240627$20240701$20240701$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-104671$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240701$$MD$CH$CH
240367631$24036763$1$I$$20240626$20240701$20240701$EXP$$AU-TAKEDA-2024TUS065050$TAKEDA$$72$YR$$M$Y$$$20240701$$HP$AU$AU
240367644$24036764$4$F$20240513$20240625$20240701$20240716$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036984$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240716$$MD$JP$JP
240367652$24036765$2$F$$20240716$20240701$20240726$PER$$US-APELLIS-APL-2024-004370$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$US$US
240367661$24036766$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45916$$FDA-CTU$$78$YR$$F$N$85.73$KG$20240701$N$$US$
240367671$24036767$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45905$$FDA-CTU$$69$YR$$F$N$65.32$KG$20240701$N$$US$
240367681$24036768$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45914$$FDA-CTU$$39$YR$$F$N$$$20240701$N$$US$
240367691$24036769$1$I$20240601$20240601$20240701$20240701$DIR$FDA-CDER-CTU-2024-45915$$FDA-CTU$$62$YR$$F$N$$$20240601$N$HP$US$
240367701$24036770$1$I$20240601$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45917$$FDA-CTU$$80$YR$$M$N$$$20240701$N$HP$US$
240367711$24036771$1$I$20240617$20240629$20240701$20240701$DIR$FDA-CDER-CTU-2024-45918$$FDA-CTU$$37$YR$$M$N$$$20240629$N$HP$US$
240367721$24036772$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45943$$FDA-CTU$$70$YR$$F$N$75.75$KG$20240701$N$$US$
240367731$24036773$1$I$$20240630$20240701$20240701$DIR$FDA-CDER-CTU-2024-45921$$FDA-CTU$$$$$F$N$$$20240630$N$HP$US$
240367741$24036774$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45929$$FDA-CTU$$47$YR$$F$N$81.19$KG$20240701$N$$US$
240367751$24036775$1$I$20240401$20240621$20240701$20240701$EXP$GB-MHRA-MED-202406201716065620-QTRFG$GB-BAUSCH-BL-2024-010093$BAUSCH AND LOMB$$$$$F$Y$$$20240701$$CN$GB$GB
240367761$24036776$1$I$$20240625$20240701$20240701$EXP$$CN-OTSUKA-2024_018204$OTSUKA$Jiang C, Huang J, Shao J, Yang T, Zhao Y, Huang M, et al.. T-Cell Posttransplant Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Systemic Review. Cell Transplantation. 2024;33:1-9$55$YR$$F$Y$$$20240701$$HP$CN$CN
240367771$24036777$1$I$$20240625$20240701$20240701$EXP$$CN-OTSUKA-2024_018208$OTSUKA$Jiang C, Huang J, Shao J, Yang T, Zhao Y, Huang M et al.. T-Cell Posttransplant Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Systemic Review. Cell Transplantation. 2024;33:1-9$23$YR$$F$Y$$$20240701$$HP$CN$CN
240367781$24036778$1$I$$20240418$20240701$20240701$EXP$$US-SINTETICA US LLC-US-SIN-2024-00006$Sintetica$Olivet MM, McCowan H, Boyce Sawyer S.. Anaphylaxis in the Setting of Poly-I-Lactic Acid and Lidocaine Without Epinephrine Injection.. Dermatol Surg.. 2024;50(4):395-6$62$YR$$F$Y$$$20240429$$$US$US
240367792$24036779$2$F$20200101$20240703$20240701$20240706$PER$$US-ABBVIE-5820489$ABBVIE$$$$$F$Y$53$KG$20240706$$CN$US$US
240367801$24036780$1$I$$20240624$20240701$20240701$PER$$US-ABBVIE-5816319$ABBVIE$$$$$$Y$$$20240701$$CN$US$US
240367812$24036781$2$F$$20240719$20240701$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104947$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240724$$HP$US$US
240367821$24036782$1$I$$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103384$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$63.5$KG$20240701$$CN$US$US
240367831$24036783$1$I$20240614$20240627$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104859$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$79.38$KG$20240701$$HP$US$US
240367841$24036784$1$I$20240531$20240628$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104584$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$75.3$KG$20240701$$HP$US$US
240367851$24036785$1$I$$20240626$20240701$20240701$EXP$$NVSC2024US134310$NOVARTIS$$67$YR$$F$Y$$$20240701$$MD$US$US
240367861$24036786$1$I$20240520$20240625$20240701$20240701$EXP$FR-AFSSAPS-AVLL2024000148$FR-MYLANLABS-2024M1057841$MYLAN$$16$YR$$F$Y$$$20240701$$MD$FR$FR
240367871$24036787$1$I$$20240620$20240701$20240701$EXP$$US-MYLANLABS-2024M1058163$MYLAN$Abdalla AA, Ali RF, Zamora-Martinez AC, Wesselius LJ. Vexas Syndrome Presenting as Recurrent Relapses of Organizing Pneumonia- A Case Series. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A5321.$70$YR$$M$Y$$$20240701$$HP$US$US
240367881$24036788$1$I$20240501$20240627$20240701$20240701$EXP$$US-ABBVIE-5821463$ABBVIE$$63$YR$$M$Y$$$20240701$$CN$US$US
240367892$24036789$2$F$$20240717$20240701$20240806$PER$$US-009507513-2406USA005537$MERCK$$81$YR$$F$Y$$$20240806$$CN$US$US
240367901$24036790$1$I$$20240624$20240701$20240701$PER$$US-ABBVIE-5816117$ABBVIE$$$$A$F$Y$$$20240701$$CN$US$US
240367911$24036791$1$I$20240501$20240621$20240701$20240701$PER$$CN-Eisai-EC-2024-168720$EISAI$$69$YR$E$M$Y$75.3$KG$20240701$$HP$CN$CN
240367921$24036792$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105004$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240701$$CN$US$US
240367931$24036793$1$I$20240401$20240625$20240701$20240701$PER$$US-ABBVIE-5816921$ABBVIE$$$$C$$Y$$$20240701$$MD$US$US
240367951$24036795$1$I$$20240619$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406013593$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240367961$24036796$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45933$$FDA-CTU$$74$YR$$F$N$$$20240701$N$$US$
240367971$24036797$1$I$20240609$20240629$20240701$20240701$DIR$FDA-CDER-CTU-2024-45942$$FDA-CTU$$60$YR$$F$N$$$20240629$N$HP$US$
240367981$24036798$1$I$20240622$20240625$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406017702$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240701$$CN$US$US
240367991$24036799$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45936$$FDA-CTU$$33$YR$$F$N$113.4$KG$20240701$N$$US$
240368001$24036800$1$I$20240607$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45939$$FDA-CTU$$72$YR$$M$N$$$20240701$N$$US$
240368011$24036801$1$I$20240701$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45949$$FDA-CTU$$86$YR$$M$N$$$20240701$N$HP$US$
240368032$24036803$2$F$20240624$20240701$20240701$20240705$EXP$$US-KYOWAKIRIN-2024KK015867$KYOWA$$$$$$Y$$$20240705$$HP$US$US
240368041$24036804$1$I$$20240620$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05825$HIKMA$Tajfiroozeh D, Silva R, Otsuka KN, Wai A.. Tajfiroozeh D, Silva R, Otsuka KN, Wai A. A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis. American Journal of Respiratory and Critical Care Medicine. 2024;209: A2289$15$YR$$M$Y$$$20240701$$MD$US$US
240368051$24036805$1$I$20240626$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024128537$AMGEN$$61$YR$A$M$Y$$$20240701$$CN$US$US
240368063$24036806$3$F$20240101$20240805$20240701$20240807$EXP$$US-SANDOZ INC.-SDZ2024US061736$SANDOZ$$56$YR$$F$Y$$$20240807$$CN$US$US
240368071$24036807$1$I$20240615$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45959$$FDA-CTU$$54$YR$$F$N$$$20240701$N$PH$US$
240368081$24036808$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45960$$FDA-CTU$$62$YR$$F$N$$$20240701$N$$US$
240368091$24036809$1$I$$20240625$20240701$20240701$EXP$$CA-SANDOZ INC.-NVSC2023CA145244$SANDOZ$$80$YR$$M$Y$$$20240701$$CN$CA$CA
240368101$24036810$1$I$$20240624$20240701$20240701$PER$$NVSC2024US133575$NOVARTIS$$$$$F$Y$$$20240701$$CN$US$US
240368111$24036811$1$I$20240614$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102756$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240701$$CN$US$US
240368122$24036812$2$F$$20240719$20240701$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104436$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$72.57$KG$20240801$$CN$US$US
240368132$24036813$2$F$20240621$20240626$20240701$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104079$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240710$$CN$US$US
240368141$24036814$1$I$20240614$20240628$20240701$20240701$EXP$$CN-SANDOZ INC.-SDZ2024CN061753$SANDOZ$$58$YR$$F$Y$50$KG$20240701$$HP$CN$CN
240368161$24036816$1$I$$20240627$20240701$20240701$EXP$$US-TAKEDA-2024TUS065132$TAKEDA$$$$$M$Y$$$20240701$$CN$US$US
240368171$24036817$1$I$$20240620$20240701$20240701$EXP$US-AstraZeneca-2024A101105$US-RDY-SPO/USA/24/0009105$DR REDDYS$Khawam S, Goudie M, Hartfield R, Hassan S, Padder F. A Case of Trazadone and Omeprazole Associated Wenckebach Phenomenon Disguised as Second-degree Mobitz Type 2 AV Block. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5664. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5664.$26$YR$A$F$Y$$$20240701$$MD$US$US
240368181$24036818$1$I$$20240625$20240701$20240701$EXP$$NVSC2024CA132965$NOVARTIS$$45$YR$$F$Y$$$20240701$$HP$CA$CA
240368193$24036819$3$F$$20240812$20240701$20240814$PER$$NVSC2024US135746$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
240368201$24036820$1$I$20240611$20240627$20240701$20240701$EXP$FR-AFSSAPS-PB2024000699$FR-MYLANLABS-2024M1058813$MYLAN$$60$YR$$M$Y$66.3$KG$20240701$$MD$FR$FR
240368212$24036821$2$F$20240110$20240715$20240701$20240719$EXP$$ES-MYLANLABS-2024M1058919$MYLAN$$64$YR$$F$Y$100$KG$20240719$$MD$ES$ES
240368221$24036822$1$I$$20240627$20240701$20240701$EXP$$US-PFIZER INC-PV202400085044$PFIZER$$27$YR$$M$Y$$$20240701$$MD$US$US
240368232$24036823$2$F$20240507$20240816$20240701$20240819$EXP$DE-PEI-CADR2024328024$DE-PFIZER INC-202400202938$PFIZER$$82$YR$$F$Y$65$KG$20240819$$CN$DE$DE
240368241$24036824$1$I$20240617$20240627$20240701$20240701$EXP$$CN-PFIZER INC-PV202400084962$PFIZER$$75$YR$$M$Y$75$KG$20240701$$HP$CN$CN
240368251$24036825$1$I$$20240627$20240701$20240701$EXP$$DZ-PFIZER INC-202400202463$PFIZER$$$$$F$Y$$$20240701$$MD$DZ$DZ
240368261$24036826$1$I$20240417$20240627$20240701$20240701$EXP$FR-AFSSAPS-DJ2024000806$FR-PFIZER INC-202400202155$PFIZER$$37$YR$$M$Y$92$KG$20240701$$MD$FR$FR
240368271$24036827$1$I$$20240627$20240701$20240701$EXP$$US-PFIZER INC-202400202708$PFIZER$$57$YR$$F$Y$$$20240701$$CN$US$US
240368281$24036828$1$I$$20240627$20240701$20240701$EXP$$DE-PFIZER INC-202400202889$PFIZER$$69$YR$$M$Y$$$20240701$$PH$DE$DE
240368291$24036829$1$I$$20240627$20240701$20240701$EXP$$US-PFIZER INC-PV202400085051$PFIZER$$31$YR$$F$Y$$$20240701$$MD$US$US
240368312$24036831$2$F$$20240710$20240701$20240715$EXP$$US-PFIZER INC-202300291399$PFIZER$$18$YR$$M$Y$$$20240715$$HP$US$US
240368321$24036832$1$I$20240601$20240627$20240701$20240701$EXP$$CN-PFIZER INC-PV202400084668$PFIZER$$91$YR$$M$Y$$$20240701$$CN$CN$CN
240368331$24036833$1$I$$20240627$20240701$20240701$EXP$$CL-PFIZER INC-PV202400085379$PFIZER$$55$YR$$F$Y$$$20240701$$CN$CL$CL
240368341$24036834$1$I$$20240627$20240701$20240701$EXP$$US-PFIZER INC-PV202400085132$PFIZER$$32$YR$$M$Y$$$20240701$$MD$US$US
240368351$24036835$1$I$20240615$20240627$20240701$20240701$EXP$$CN-PFIZER INC-PV202400084930$PFIZER$$42$YR$$F$Y$59.5$KG$20240701$$HP$CN$CN
240368361$24036836$1$I$20240215$20240629$20240701$20240701$EXP$$IN-PFIZER INC-PV202400086072$PFIZER$$62$YR$$M$Y$$$20240701$$CN$IN$IN
240368373$24036837$3$F$20240627$20240920$20240701$20240925$EXP$$US-PFIZER INC-202400202586$PFIZER$$64$YR$$F$Y$78.5$KG$20240925$$PH$US$US
240368381$24036838$1$I$20240601$20240627$20240701$20240701$EXP$$CO-PFIZER INC-202400202515$PFIZER$$$$$F$Y$$$20240701$$MD$CO$CO
240368391$24036839$1$I$20240501$20240626$20240701$20240701$EXP$$CA-PFIZER INC-202400202332$PFIZER$$67$YR$$M$Y$$$20240701$$HP$CA$CA
240368402$24036840$2$F$20240529$20240819$20240701$20240820$EXP$FR-AFSSAPS-TO2024001163$FR-PFIZER INC-202400202850$PFIZER$$72$YR$$M$Y$85$KG$20240820$$PH$FR$FR
240368412$24036841$2$F$$20240628$20240701$20240702$EXP$$US-PFIZER INC-PV202400085528$PFIZER$$80$YR$$F$Y$$$20240702$$CN$US$US
240368421$24036842$1$I$20240118$20240627$20240701$20240701$EXP$FR-AFSSAPS-TO2024001132$FR-PFIZER INC-202400202154$PFIZER$$63$YR$$F$Y$$$20240701$$PH$FR$FR
240368431$24036843$1$I$20240619$20240628$20240701$20240701$EXP$GB-MHRA-MED-202406281353263660-DVMHW$GB-PFIZER INC-202400203357$PFIZER$$$$$F$Y$$$20240701$$HP$GB$GB
240368441$24036844$1$I$20240618$20240619$20240701$20240701$PER$$US-BAYER-2024A090828$BAYER$$29$YR$A$F$Y$$$20240701$$MD$US$US
240368451$24036845$1$I$$20240624$20240701$20240701$EXP$$NVSC2024BR135897$NOVARTIS$$$$$F$Y$$$20240701$$CN$BR$BR
240368461$24036846$1$I$$20240627$20240701$20240701$EXP$$FR-MYLANLABS-2024M1059494$MYLAN$Leleu X, Hulin C, Lambert J, Bobin A, Perrot A, Karlin L et al... Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 benefit trial. Nature Medicine. 2024$$$E$$Y$$$20240701$$MD$FR$FR
240368471$24036847$1$I$$20240627$20240701$20240701$EXP$$FR-MYLANLABS-2024M1060427$MYLAN$Leleu X, Hulin C, Lambert J, Bobin A, Perrot A, Karlin L, et al. Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 benefit trial. Nature Medicine. 2024$$$E$$Y$$$20240701$$MD$FR$FR
240368481$24036848$1$I$$20240629$20240701$20240701$30DAY$$US-SANDOZ INC.-SDZ2023US001868$SANDOZ$$$$$M$Y$$$20240701$$CN$US$US
240368491$24036849$1$I$$20240701$20240701$20240701$EXP$$US-SANDOZ INC.-SDZ2024US061896$SANDOZ$$$$$M$Y$$$20240701$$CN$US$US
240368511$24036851$1$I$20240627$20240627$20240701$20240701$PER$$JP-PFIZER INC-202400202237$PFIZER$$$$$$Y$$$20240701$$PH$JP$JP
240368522$24036852$2$F$20240620$20240724$20240701$20240726$PER$$US-PFIZER INC-202400203303$PFIZER$$84$YR$$F$Y$$$20240726$$CN$US$US
240368532$24036853$2$F$20240607$20240708$20240701$20240711$EXP$$US-MYLANLABS-2024M1056899$MYLAN$$0$YR$$M$Y$2.52$KG$20240711$$HP$US$US
240368541$24036854$1$I$20240101$20240626$20240701$20240701$PER$$US-JNJFOC-20240673526$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240701$$CN$US$US
240368554$24036855$4$F$20240627$20240731$20240701$20240808$30DAY$$US-JNJFOC-20240675250$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240808$$CN$US$US
240368562$24036856$2$F$20240618$20240816$20240701$20240819$EXP$$CN-Eisai-EC-2024-169021$EISAI$$67$YR$E$F$Y$50$KG$20240819$$HP$CN$CN
240368571$24036857$1$I$20240601$20240627$20240701$20240701$PER$$US-Eisai-EC-2024-169041$EISAI$$$$$$Y$$$20240701$$MD$US$US
240368581$24036858$1$I$20231026$20240628$20240701$20240701$EXP$FR-AFSSAPS-GR2024000785$FR-PFIZER INC-202400202957$PFIZER$$54$YR$$F$Y$$$20240701$$PH$FR$FR
240368591$24036859$1$I$$20240628$20240701$20240701$EXP$$JP-PFIZER INC-202400203084$PFIZER$$$$$$Y$$$20240701$$PH$JP$JP
240368614$24036861$4$F$20240628$20240731$20240701$20240814$PER$$US-Calliditas-2024CAL01152$CALLIDITAS THERAPEUTICS$$64$YR$A$M$Y$113.4$KG$20240813$$CN$US$US
240368621$24036862$1$I$20240627$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000235$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240701$$CN$US$US
240368631$24036863$1$I$$20240610$20240701$20240701$PER$$US-BEH-2024173888$CSL BEHRING$$$$A$F$Y$$$20240701$$HP$US$US
240368641$24036864$1$I$20240220$20240625$20240701$20240701$EXP$IT-MINISAL02-991505$IT-MYLANLABS-2024M1057918$MYLAN$$68$YR$$M$Y$$$20240701$$PH$IT$IT
240368654$24036865$4$F$$20240924$20240701$20240927$EXP$$PT-MYLANLABS-2024M1058075$MYLAN$Maia S, Xavier B, Sa M, Antunes E, Morais D, Sampaio J.. Negative Pressure Pulmonary Edema:  An Unexpected Intercurrence.. Journal of the portuguese society of anesthesiology. 2024;33(S1):49$19$YR$$M$Y$$$20240927$$HP$PT$PT
240368662$24036866$2$F$$20240930$20240701$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103173$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$96.16$KG$20240930$$HP$US$US
240368671$24036867$1$I$$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104936$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240701$$HP$US$US
240368681$24036868$1$I$20240618$20240628$20240701$20240701$EXP$$US-KYOWAKIRIN-2024KK015882$KYOWA$$$$$$Y$$$20240701$$HP$US$US
240368691$24036869$1$I$20240411$20240625$20240701$20240701$EXP$FR-AFSSAPS-AVLL2024000144$FR-MYLANLABS-2024M1057920$MYLAN$$14$YR$$F$Y$$$20240701$$MD$FR$FR
240368701$24036870$1$I$20240523$20240625$20240701$20240701$EXP$$ES-MYLANLABS-2024M1057926$MYLAN$$64$YR$$M$Y$59.2$KG$20240701$$MD$ES$ES
240368711$24036871$1$I$20180301$20240604$20240701$20240701$EXP$$US-SA-2024SA189077$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240701$$MD$US$US
240368721$24036872$1$I$20240101$20240624$20240701$20240701$PER$$US-INSUD PHARMA-2406US05076$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240368731$24036873$1$I$$20240627$20240701$20240701$EXP$$US-PURDUE-USA-2024-0310519$PURDUE$$11$YR$$M$Y$$$20240701$$CN$US$US
240368741$24036874$1$I$20160101$20240627$20240701$20240701$EXP$$US-PURDUE-USA-2024-0310520$PURDUE$$5$DY$$F$Y$$$20240701$$CN$US$US
240368751$24036875$1$I$$20240627$20240701$20240701$EXP$$US-PURDUE-USA-2024-0310518$PURDUE$$$$$M$Y$$$20240701$$CN$US$US
240368761$24036876$1$I$20230406$20240626$20240701$20240701$EXP$$NVSC2023HU084642$NOVARTIS$$70$YR$$F$Y$$$20240701$$HP$HU$HU
240368773$24036877$3$F$20240613$20240801$20240701$20240815$PER$$US-ROCHE-10000006727$ROCHE$$$$A$F$Y$$$20240815$$CN$US$US
240368791$24036879$1$I$20240622$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127386$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240368802$24036880$2$F$20240211$20240618$20240701$20240709$EXP$$US-ROCHE-3513466$ROCHE$$53$YR$A$F$Y$$$20240705$$CN$US$US
240368811$24036881$1$I$20240601$20240624$20240701$20240701$PER$$US-INSUD PHARMA-2406US05074$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240368821$24036882$1$I$20240101$20240624$20240701$20240701$PER$$US-INSUD PHARMA-2406US05075$INSUD PHARMA$$$$$F$Y$$$20240701$$CN$US$US
240368834$24036883$4$F$20240617$20240917$20240701$20240927$EXP$$US-TRAVERE-2024TVT00624$TRAVERE THERAPEUTICS$$55$YR$A$M$Y$$$20240927$$CN$US$US
240368841$24036884$1$I$$20240628$20240701$20240701$PER$$JP-Eisai-EC-2023-145715$EISAI$$55$YR$A$F$Y$$$20240701$$MD$JP$JP
240368852$24036885$2$F$$20240828$20240701$20240828$30DAY$$SE-PFIZER INC-202400198837$PFIZER$$$$$F$Y$$$20240828$$CN$SE$SE
240368862$24036886$2$F$$20240716$20240701$20240724$PER$$US-AstraZeneca-2024A129623$ASTRAZENECA$$$$$M$Y$$$20240724$$MD$US$
240368872$24036887$2$F$20230101$20240719$20240701$20240722$PER$$US-AstraZeneca-2024A139849$ASTRAZENECA$$79$YR$$M$Y$$$20240722$$CN$US$
240368881$24036888$1$I$$20240627$20240701$20240701$PER$$US-PURDUE PHARMA-USA-2024-0310521$PURDUE$$35$YR$$M$Y$$$20240701$$CN$US$US
240368891$24036889$1$I$20240628$20240701$20240701$20240701$PER$$US-PURDUE PHARMA-USA-2024-0310523$PURDUE$$44$YR$$F$Y$72.57$KG$20240701$$CN$US$US
240368901$24036890$1$I$20191223$20240627$20240701$20240701$PER$$US-PURDUE-USA-2024-0310517$PURDUE$$30$YR$$F$Y$$$20240701$$CN$US$US
240368911$24036891$1$I$20150601$20240627$20240701$20240701$PER$$US-PURDUE PHARMA-USA-2024-0310522$PURDUE$$21$YR$$M$Y$$$20240701$$CN$US$US
240368922$24036892$2$F$20240626$20240628$20240701$20240702$PER$$US-PURDUE-USA-2024-0310488$PURDUE$$73$YR$$F$Y$$$20240702$$CN$US$US
240368931$24036893$1$I$$20240627$20240701$20240701$PER$$US-PURDUE PHARMA-USA-2024-0310516$PURDUE$$$$$M$Y$$$20240701$$CN$US$US
240368942$24036894$2$F$$20240701$20240701$20240703$PER$$US-PURDUE PHARMA-USA-2024-0310524$PURDUE$$$$$F$Y$$$20240703$$HP$US$US
240368951$24036895$1$I$20240627$20240627$20240701$20240701$EXP$$US-GILEAD-2024-0678895$GILEAD$$80$YR$E$F$Y$$$20240701$$HP$US$US
240368961$24036896$1$I$20210101$20240621$20240701$20240701$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-101429$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240701$$MD$DE$DE
240368971$24036897$1$I$$20240626$20240701$20240701$EXP$$PL-INCYTE CORPORATION-2024IN006877$INCYTE$$$$$$Y$$$20240701$$MD$PL$PL
240368981$24036898$1$I$$20240625$20240701$20240701$EXP$$CN-OTSUKA-2024_018209$OTSUKA$Jiang C, Huang J, Shao J, Yang T, Zhao Y, Huang M et al.. T-Cell Posttransplant Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Systemic Review. Cell Transplantation. 2024;33:1-9$16$YR$$M$Y$$$20240701$$HP$CN$CN
240368991$24036899$1$I$$20240626$20240701$20240701$EXP$$JP-009507513-2406JPN004046J$MERCK$$52$YR$$M$Y$$$20240701$$MD$JP$JP
240369002$24036900$2$F$20200120$20240901$20240701$20240903$EXP$$DE-BAUSCH-BL-2024-010086$BAUSCH AND LOMB$$73$YR$$F$Y$82$KG$20240903$$MD$DE$DE
240369011$24036901$1$I$20240624$20240628$20240701$20240701$EXP$$US-BAUSCH-BL-2024-010112$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240701$$CN$US$US
240369021$24036902$1$I$20230101$20240629$20240701$20240701$EXP$$PL-BAUSCH-BL-2024-010109$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240701$$MD$PL$PL
240369032$24036903$2$F$$20240729$20240701$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104675$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240731$$CN$US$US
240369041$24036904$1$I$20240501$20240629$20240701$20240701$EXP$FR-AFSSAPS-AVNT2024000484$FR-BAUSCH-BL-2024-010107$BAUSCH AND LOMB$$59$YR$$M$Y$$$20240701$$PH$FR$FR
240369071$24036907$1$I$$20240626$20240701$20240701$PER$$US-FreseniusKabi-FK202410135$FRESENIUS KABI$$52$YR$A$F$Y$70$KG$20240701$$PH$US$US
240369081$24036908$1$I$$20240624$20240701$20240701$EXP$$US-TRAVERE-2024TVT00634$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240701$$CN$US$US
240369092$24036909$2$F$20240101$20240821$20240701$20240827$EXP$$JP-DSJP-DSJ-2024-119877$DAIICHI$$9$DEC$$M$Y$$$20240827$$MD$JP$JP
240369101$24036910$1$I$$20240625$20240701$20240701$EXP$$US-JNJFOC-20240667499$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$HP$US$US
240369112$24036911$2$F$20221201$20240717$20240701$20240719$EXP$$ES-DSJP-DSE-2024-129539$DAIICHI$$82$YR$$F$Y$$$20240719$$MD$ES$ES
240369123$24036912$3$F$20220801$20240823$20240701$20240829$EXP$$ES-DSJP-DSE-2024-129536$DAIICHI$$86$YR$$F$Y$$$20240829$$MD$ES$ES
240369131$24036913$1$I$20240601$20240623$20240701$20240701$PER$$US-INSUD PHARMA-2406US05069$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240369141$24036914$1$I$20240601$20240623$20240701$20240701$PER$$US-INSUD PHARMA-2406US05067$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240369152$24036915$2$F$$20240722$20240701$20240726$EXP$$ES-DSJP-DSE-2024-129528$DAIICHI$$75$YR$$F$Y$50$KG$20240726$$MD$ES$ES
240369161$24036916$1$I$$20240627$20240701$20240701$PER$$US-PFIZER INC-202400203463$PFIZER$$61$YR$$F$Y$$$20240701$$HP$US$US
240369171$24036917$1$I$$20240628$20240701$20240701$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-104929$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$68.04$KG$20240701$$CN$PR$PR
240369182$24036918$2$F$$20240626$20240701$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102919$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240702$$CN$US$US
240369191$24036919$1$I$20240601$20240626$20240701$20240701$EXP$IT-MINISAL02-991839$IT-ABBVIE-5821653$ABBVIE$$65$YR$$F$Y$89$KG$20240701$$MD$IT$IT
240369201$24036920$1$I$20240601$20240622$20240701$20240701$PER$$US-INSUD PHARMA-2406US05066$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240369211$24036921$1$I$20240619$20240625$20240701$20240701$EXP$$CN-FreseniusKabi-FK202410060$FRESENIUS KABI$$56$YR$A$F$Y$53$KG$20240701$$HP$CN$CN
240369221$24036922$1$I$20240423$20240627$20240701$20240701$PER$$US-FreseniusKabi-FK202410141$FRESENIUS KABI$$19$YR$A$F$Y$54.7$KG$20240701$$MD$US$US
240369231$24036923$1$I$$20240628$20240701$20240701$EXP$$US-Taiho Oncology Inc-2024-005094$TAIHO ONCOLOGY INC$$81$YR$E$M$Y$79.38$KG$20240701$$HP$US$US
240369241$24036924$1$I$$20240626$20240701$20240701$EXP$$ES-DSJP-DSE-2024-129509$DAIICHI$$$$E$F$Y$$$20240701$$MD$ES$ES
240369251$24036925$1$I$$20240620$20240701$20240701$EXP$$US-RDY-LIT/USA/24/0009313$DR REDDYS$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. Rheumatology. 2024 May;63(5): 1291-1296. doi:10.1093/rheumatology/kead372.$68$YR$E$M$Y$$$20240701$$HP$US$US
240369261$24036926$1$I$20240626$20240626$20240701$20240701$EXP$GB-MHRA-MED-202406261038209360-BZGKJ$GB-DSJP-DSE-2024-129453$DAIICHI$$65$YR$$F$Y$90$KG$20240701$$CN$GB$GB
240369274$24036927$4$F$20221201$20240905$20240701$20240910$EXP$$ES-DAIICHI SANKYO, INC.-DSE-2024-129526$DAIICHI$$70$YR$$F$Y$$$20240910$$MD$ES$ES
240369303$24036930$3$F$20240619$20240628$20240701$20240710$PER$$US-AMGEN-USASP2024127917$AMGEN$$83$YR$E$F$Y$$$20240709$$CN$US$US
240369312$24036931$2$F$20240624$20240802$20240701$20240807$PER$$US-AMGEN-USASP2024126691$AMGEN$$73$YR$E$F$Y$$$20240806$$CN$US$US
240369321$24036932$1$I$$20240621$20240701$20240701$PER$$US-BIOMARINAP-US-2024-158775$BIOMARIN$$$$$$Y$$$20240701$$CN$US$US
240369331$24036933$1$I$20240601$20240622$20240701$20240701$PER$$US-INSUD PHARMA-2406US05041$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240369351$24036935$1$I$20240601$20240621$20240701$20240701$PER$$US-INSUD PHARMA-2406US05040$INSUD PHARMA$$$$$$Y$$$20240701$$CN$US$US
240369361$24036936$1$I$$20240624$20240701$20240701$PER$$US-BIOMARINAP-US-2024-158759$BIOMARIN$$$$$$Y$$$20240701$$CN$US$US
240369371$24036937$1$I$20240506$20240624$20240701$20240701$EXP$ES-AEMPS-1535895$ES-TEVA-VS-3213827$TEVA$$20$MON$$M$Y$$$20240701$$PH$ES$ES
240369381$24036938$1$I$20240403$20240612$20240701$20240701$PER$$US-APELLIS-APL-2024-004401$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240701$$CN$US$US
240369392$24036939$2$F$$20240930$20240701$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104782$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240930$$PH$US$US
240369402$24036940$2$F$$20240628$20240701$20240707$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104789$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$74.84$KG$20240707$$MD$US$US
240369413$24036941$3$F$20231031$20240710$20240701$20240807$EXP$$US-AstraZeneca-2024A148989$ASTRAZENECA$$23103$DY$$$Y$$$20240807$$MD$US$
240369424$24036942$4$F$20240601$20240911$20240701$20240917$PER$$US-KARYOPHARM-2024KPT001182$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240917$$CN$US$US
240369431$24036943$1$I$$20240625$20240701$20240701$PER$$US-JNJFOC-20240670698$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$MD$US$US
240369452$24036945$2$F$$20240626$20240701$20240705$PER$$US-AMGEN-USASP2024126704$AMGEN$$$$$F$Y$$$20240704$$HP$US$US
240369461$24036946$1$I$$20240626$20240701$20240701$PER$$US-AMGEN-USASP2024127943$AMGEN$$$$$F$Y$$$20240701$$HP$US$US
240369472$24036947$2$F$20240601$20240809$20240701$20240816$PER$$IT-KARYOPHARM-2024KPT001214$KARYOPHARM THERAPEUTICS$$65$YR$$M$Y$$$20240816$$MD$IT$IT
240369481$24036948$1$I$$20240626$20240701$20240701$EXP$$US-Taiho Oncology Inc-2024-006254$TAIHO ONCOLOGY INC$$$$E$M$Y$90.76$KG$20240701$$CN$US$US
240369491$24036949$1$I$$20240626$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103059$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240701$$HP$US$US
240369501$24036950$1$I$$20240627$20240701$20240701$PER$$US-JNJFOC-20240675013$JOHNSON AND JOHNSON$$$$$$Y$$$20240701$$HP$US$US
240369512$24036951$2$F$20240604$20240722$20240701$20240725$EXP$FR-AFSSAPS-BR2024000498$FR-MYLANLABS-2024M1058642$MYLAN$$55$YR$$F$Y$81.3$KG$20240725$$MD$FR$FR
240369531$24036953$1$I$20240626$20240627$20240701$20240701$EXP$$US-MYLANLABS-2024M1061322$MYLAN$$73$YR$$F$Y$$$20240701$$HP$US$US
240369541$24036954$1$I$20240603$20240627$20240701$20240701$EXP$$US-MYLANLABS-2024M1061260$MYLAN$$21$YR$$F$Y$$$20240701$$PH$US$US
240369552$24036955$2$F$20220706$20240702$20240701$20240709$EXP$$ES-MYLANLABS-2024M1060679$MYLAN$$55$YR$$F$Y$$$20240709$$MD$ES$ES
240369561$24036956$1$I$20240301$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019722$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240701$$CN$US$US
240369571$24036957$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018897$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240701$$CN$US$US
240369581$24036958$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019601$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240701$$CN$US$US
240369591$24036959$1$I$20240625$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018866$ELI LILLY AND CO$$47$YR$A$$Y$$$20240701$$CN$US$US
240369601$24036960$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018801$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240369611$24036961$1$I$$20240614$20240701$20240701$PER$$US-Covis Pharma GmbH-2024COV00777$COVIS PHARMA$$$$$F$Y$$$20240701$$CN$US$US
240369621$24036962$1$I$$20240624$20240701$20240701$PER$$US-BIOMARINAP-US-2024-158797$BIOMARIN$$$$$$Y$$$20240701$$CN$US$US
240369631$24036963$1$I$$20240622$20240701$20240701$EXP$$IL-AMGEN-ISRSP2024124395$AMGEN$Amer R.; Mavris N.; Jaouni T. et al.. Subretinal Fibrosis Developing 10 Years After First Presentation with Chronic Ocular Sarcoidosis in a Child. Ocular immunology and inflammation. 2024;1-4$12$YR$T$F$Y$$$20240701$$MD$IL$IL
240369641$24036964$1$I$20240201$20240618$20240701$20240701$PER$$US-Covis Pharma GmbH-2024COV00789$COVIS PHARMA$$53$YR$A$F$Y$$$20240701$$CN$US$US
240369651$24036965$1$I$$20240617$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03730$HIKMA$$$$$$Y$$$20240701$$CN$US$US
240369662$24036966$2$F$20240119$20240625$20240701$20240703$PER$$JP-Eisai-EC-2024-168943$EISAI$$72$YR$E$F$Y$$$20240703$$PH$JP$JP
240369671$24036967$1$I$$20240701$20240701$20240701$EXP$$HU-SANDOZ INC.-SDZ2024HU061757$SANDOZ$$68$YR$$M$Y$$$20240701$$HP$HU$HU
240369681$24036968$1$I$20240530$20240617$20240701$20240701$EXP$$CN-AstraZeneca-2024A143916$ASTRAZENECA$$27222$DY$$F$Y$80$KG$20240701$$MD$CN$
240369691$24036969$1$I$$20240628$20240701$20240701$PER$$NVSC2024US136387$NOVARTIS$$7$YR$$M$Y$$$20240701$$CN$US$US
240369701$24036970$1$I$$20240620$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05746$HIKMA$Kiley K, Melnychuk E.. Kiley KD, Melnychuk E. A Controversial Topic: PJP Prophylaxis in Patients With Long-Term Immunologic Agents +/- Steroids.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A3572$30$YR$$F$Y$42$KG$20240701$$MD$US$US
240369721$24036972$1$I$20240415$20240625$20240701$20240701$EXP$$CN-009507513-2406CHN009981$MERCK$$51$YR$$F$Y$$$20240701$$HP$CN$CN
240369741$24036974$1$I$$20240620$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05753$HIKMA$Raymond-Forde S, Raymond-Forde S, Godfrey A, Alexander K.. Raymond-Forde S, Raymond-Forde S, Godfrey AM, Alexander KR. The Gift of a Heart, With Strings Attached: A Case of Strongyloides Stercoralis Hyperinfection Syndrome With Fulminant Respiratory Failure.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1134$43$YR$$F$Y$$$20240701$$MD$US$US
240369752$24036975$2$F$20240618$20240628$20240701$20240705$PER$$US-ALXN-202406USA001594US$ALEXION PHARMACEUTICALS$$35$YR$$F$Y$$$20240705$$CN$US$US
240369761$24036976$1$I$$20240412$20240701$20240701$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00348$UPSHER-SMITH$$$$$M$Y$$$20240701$$CN$US$US
240369772$24036977$2$F$20240627$20240709$20240701$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103966$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$HP$US$US
240369781$24036978$1$I$$20240620$20240701$20240701$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05755$HIKMA$enkat Ramanan S, Ghazal F, Addanki P, Perez M.. Venkat Ramanan S, Ghazal F, Addanki P, Perez M. Thyroid Tempest: Unravelling a Rare Case of Amiodarone-Induced Thyroid Storm.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3400$74$YR$$F$Y$$$20240701$$MD$US$US
240369791$24036979$1$I$$20240314$20240701$20240701$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00257$UPSHER-SMITH$$$$$F$Y$$$20240701$$CN$US$US
240369801$24036980$1$I$$20240430$20240701$20240701$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00378$UPSHER-SMITH$$49$YR$$M$Y$99.773$KG$20240701$$CN$US$US
240369811$24036981$1$I$20240101$20240531$20240701$20240701$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00454$UPSHER-SMITH$$$$$F$Y$$$20240701$$CN$US$US
240369822$24036982$2$F$20240501$20240910$20240701$20240925$EXP$$US-RADIUS HEALTH INC.-2024US003844$RADIUS PHARM$$81$YR$$F$Y$$$20240925$$CN$US$US
240369832$24036983$2$F$$20240712$20240701$20240725$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI06403$NEUROCRINE BIOSCIENCES$$73$YR$$F$Y$$$20240725$$MD$JP$JP
240369841$24036984$1$I$$20240620$20240701$20240701$EXP$$US-ALSI-2024000188$AIRGAS$$74$YR$$M$Y$$$20240701$$MD$US$US
240369851$24036985$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019038$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240701$$CN$US$US
240369861$24036986$1$I$$20240628$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202407000734$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240701$$CN$US$US
240369871$24036987$1$I$$20240626$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406018899$ELI LILLY AND CO$$45$YR$A$$Y$$$20240701$$CN$US$US
240369881$24036988$1$I$20240101$20240613$20240701$20240701$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00493$UPSHER-SMITH$$$$$F$Y$$$20240701$$CN$US$US
240369891$24036989$1$I$$20240621$20240701$20240701$EXP$$US-RADIUS HEALTH INC.-2024US004556$RADIUS PHARM$$$$$F$Y$$$20240701$$CN$US$US
240369901$24036990$1$I$20240501$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104904$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240701$$HP$US$US
240369911$24036991$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104843$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$86.18$KG$20240701$$CN$US$US
240369922$24036992$2$F$20240625$20240719$20240701$20240725$EXP$$JP-ABBVIE-5818387$ABBVIE$$81$YR$$M$Y$55$KG$20240725$$MD$JP$JP
240369932$24036993$2$F$$20240906$20240701$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104763$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240909$$CN$US$US
240369941$24036994$1$I$$20240626$20240701$20240701$PER$$US-GILEAD-2024-0678736$GILEAD$$50$YR$A$M$Y$$$20240701$$HP$US$US
240369951$24036995$1$I$20230704$20240625$20240701$20240701$EXP$$NVSC2023DE272736$NOVARTIS$$$$A$F$Y$62$KG$20240702$$MD$DE$DE
240369961$24036996$1$I$$20240625$20240701$20240701$PER$$US-TPU-TPU-2024-00370$TEIKOKU$$$$$M$Y$$$20240701$$CN$US$US
240369971$24036997$1$I$20230815$20240601$20240701$20240701$EXP$$JP-AstraZeneca-2023A256185$ASTRAZENECA$$84$YR$$M$Y$$$20240701$$MD$JP$
240369981$24036998$1$I$$20240626$20240701$20240701$PER$$US-GILEAD-2024-0678747$GILEAD$$$$$F$Y$$$20240701$$HP$US$US
240369992$24036999$2$F$20240423$20240715$20240701$20240722$EXP$$CA-LUNDBECK-DKLU3077438$LUNDBECK$$$$$$Y$$$20240722$$CN$CA$CA
240370002$24037000$2$F$20240601$20240710$20240701$20240715$EXP$$JP-BIOMARINAP-JP-2024-158903$BIOMARIN$$$$$$Y$$$20240715$$CN$JP$JP
240370022$24037002$2$F$20240610$20240719$20240701$20240730$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI06419$NEUROCRINE BIOSCIENCES$$10$DEC$$F$Y$$$20240730$$MD$JP$JP
240370032$24037003$2$F$20240501$20240801$20240701$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104933$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240806$$HP$US$US
240370042$24037004$2$F$20230701$20240628$20240701$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010029$JAZZ$$36$YR$$F$Y$$$20240703$$CN$US$US
240370051$24037005$1$I$$20240514$20240701$20240701$PER$$US-LUNDBECK-DKLU3078157$LUNDBECK$$$$$$Y$$$20240701$$HP$US$US
240370062$24037006$2$F$$20240722$20240701$20240727$EXP$$NVSC2024IL130900$NOVARTIS$$36$YR$$F$Y$$$20240727$$HP$IL$IL
240370071$24037007$1$I$20240501$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019245$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240701$$CN$US$US
240370081$24037008$1$I$$20240626$20240701$20240701$EXP$$JP-009507513-2406JPN003971J$MERCK$$34$YR$$F$Y$$$20240701$$MD$JP$JP
240370094$24037009$4$F$20230101$20240820$20240701$20240826$EXP$$NVSC2024CN135482$NOVARTIS$$$$$M$Y$$$20240826$$CN$CN$CN
240370101$24037010$1$I$$20240624$20240701$20240701$PER$$US-ALXN-202406USA001506US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240701$$CN$US$US
240370111$24037011$1$I$$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019265$ELI LILLY AND CO$$$$$$Y$$$20240701$$CN$US$US
240370121$24037012$1$I$20240601$20240627$20240701$20240701$PER$$US-ELI_LILLY_AND_COMPANY-US202406019254$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240701$$HP$US$US
240370131$24037013$1$I$$20240628$20240701$20240701$PER$$US-BIOMARINAP-US-2024-158877$BIOMARIN$$$$$$Y$$$20240701$$CN$US$US
240370142$24037014$2$F$$20240627$20240701$20240701$PER$$US-BIOMARINAP-US-2024-158862$BIOMARIN$$$$$$Y$$$20240701$$CN$US$US
240370152$24037015$2$F$20240626$20240627$20240701$20240701$PER$$US-BIOMARINAP-US-2024-158853$BIOMARIN$$$$$$Y$$$20240701$$CN$US$US
240370162$24037016$2$F$$20240627$20240701$20240701$PER$$US-BIOMARINAP-US-2024-158871$BIOMARIN$$$$$$Y$$$20240701$$CN$US$US
240370172$24037017$2$F$20240601$20240705$20240701$20240711$PER$$US-ALXN-202406USA001509US$ALEXION PHARMACEUTICALS$$33$YR$$M$Y$$$20240711$$CN$US$US
240370182$24037018$2$F$$20240806$20240701$20240807$PER$$US-ALXN-202406USA001518US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240370191$24037019$1$I$$20240619$20240701$20240701$PER$$US-TEVA-VS-3211993$TEVA$$61$YR$$F$Y$$$20240701$$CN$US$US
240370201$24037020$1$I$20240627$20240628$20240701$20240701$PER$$US-BIOMARINAP-US-2024-158882$BIOMARIN$$$$$$Y$$$20240701$$CN$US$US
240370211$24037021$1$I$$20240628$20240701$20240701$PER$$US-BIOMARINAP-US-2024-158894$BIOMARIN$$$$$$Y$$$20240701$$CN$US$US
240370221$24037022$1$I$$20240624$20240701$20240701$PER$$US-ALXN-202406USA001519US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240701$$HP$US$US
240370231$24037023$1$I$20240627$20240627$20240701$20240701$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000074$Unknown Manufacturer$$$$$$Y$$$20240701$$CN$US$US
240370242$24037024$2$F$$20240805$20240701$20240806$PER$$US-ALXN-202406USA001537US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240370252$24037025$2$F$$20240805$20240701$20240806$PER$$US-ALXN-202406USA001523US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240370261$24037026$1$I$$20240510$20240701$20240701$PER$$US-AMGEN-HZN-2024-005491$AMGEN$$$$$$Y$$$20240701$$MD$US$US
240370271$24037027$1$I$$20240510$20240701$20240701$PER$$US-AMGEN-HZN-2024-005469$AMGEN$$$$E$M$Y$$$20240701$$PH$US$US
240370281$24037028$1$I$$20240626$20240701$20240701$30DAY$$US-SANDOZ INC.-SDZ2024US061229$SANDOZ$$$$$M$Y$$$20240701$$CN$US$US
240370291$24037029$1$I$20240507$20240507$20240701$20240701$PER$$US-AMGEN-HZN-2024-005340$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240370311$24037031$1$I$$20240620$20240701$20240701$PER$$US-JNJFOC-20240679637$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240701$$PH$US$US
240370321$24037032$1$I$$20240320$20240701$20240701$PER$$US-AMGEN-HZN-2024-003534$AMGEN$$$$$M$Y$$$20240701$$MD$US$US
240370333$24037033$3$F$20240101$20240801$20240701$20240805$PER$$US-ALXN-202406USA001572US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240370341$24037034$1$I$20240101$20240628$20240701$20240701$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036835$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240701$$CN$US$US
240370351$24037035$1$I$$20240620$20240701$20240701$PER$$US-JNJFOC-20240679638$JOHNSON AND JOHNSON$$$$$M$Y$$$20240701$$PH$US$US
240370362$24037036$2$F$$20240805$20240701$20240806$PER$$US-ALXN-202406USA001671US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$CN$US$US
240370382$24037038$2$F$$20240628$20240701$20240710$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI06416$NEUROCRINE BIOSCIENCES$$60$YR$$M$Y$$$20240710$$PH$JP$JP
240370391$24037039$1$I$$20230828$20240701$20240701$PER$$US-AMGEN-USASP2023235147$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240370401$24037040$1$I$$20240625$20240701$20240701$PER$$US-SA-2024SA192082$SANOFI AVENTIS$$$$A$M$Y$$$20240702$$HP$US$US
240370412$24037041$2$F$20240618$20240701$20240701$20240709$PER$$US-SA-2024SA187495$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240709$$MD$US$US
240370421$24037042$1$I$$20240220$20240701$20240701$PER$$US-AMGEN-USASP2024129764$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240370431$24037043$1$I$$20240625$20240701$20240701$PER$$NVSC2024US134243$NOVARTIS$$52$YR$$$Y$$$20240702$$CN$US$US
240370461$24037046$1$I$$20240626$20240701$20240701$EXP$$JP-009507513-2406JPN004048J$MERCK$$70$YR$$M$Y$$$20240701$$MD$JP$JP
240370471$24037047$1$I$20230801$20240621$20240701$20240701$PER$$US-JNJFOC-20240665845$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240702$$MD$US$US
240370482$24037048$2$F$20220601$20240724$20240701$20240729$EXP$$JP-SA-2024SA187029$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240730$$MD$JP$JP
240370492$24037049$2$F$$20240926$20240701$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-104129$BRISTOL MYERS SQUIBB$$72$YR$E$$Y$$$20240926$$MD$JP$JP
240370511$24037051$1$I$$20240701$20240701$20240701$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037087$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240702$$CN$US$US
240370521$24037052$1$I$20240623$20240624$20240701$20240701$PER$$US-JNJFOC-20240662844$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240702$$HP$US$US
240370531$24037053$1$I$20231101$20240624$20240701$20240701$EXP$$CA-JNJFOC-20231160798$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240702$$HP$CA$CA
240370543$24037054$3$F$20240609$20240903$20240701$20240911$EXP$$US-JNJFOC-20240614873$JOHNSON AND JOHNSON$$42$YR$A$F$Y$55.3$KG$20240912$$HP$US$US
240370572$24037057$2$F$20240423$20240722$20240701$20240725$EXP$$NVSJ2024JP007703$NOVARTIS$$62$YR$$F$Y$$$20240726$$MD$JP$JP
240370581$24037058$1$I$20240612$20240628$20240701$20240701$EXP$ES-AEMPS-1535805$ES-JNJFOC-20240701294$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240702$$HP$ES$ES
240370592$24037059$2$F$$20240703$20240701$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202406014279$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240711$$CN$US$US
240370622$24037062$2$F$20240501$20240710$20240701$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103307$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240711$$HP$US$US
240370632$24037063$2$F$$20240625$20240701$20240918$EXP$$US-EXELAPHARMA-2024EXLA00013$EXELA PHARMA SCIENCES$$$$$$Y$$$20240918$$HP$US$US
240370651$24037065$1$I$20240528$20240625$20240701$20240701$EXP$$US-ABBVIE-5817438$ABBVIE$$87$YR$$F$Y$$$20240701$$CN$US$US
240370661$24037066$1$I$$20240625$20240701$20240701$EXP$$US-SANDOZ INC.-SDZ2024US061130$SANDOZ$$67$YR$$M$Y$$$20240701$$CN$US$US
240370671$24037067$1$I$$20240626$20240701$20240701$EXP$$DE-JNJFOC-20240675248$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$MD$DE$DE
240370681$24037068$1$I$20230101$20240626$20240701$20240701$EXP$$CA-ABBVIE-5819542$ABBVIE$$73$YR$$M$Y$56$KG$20240701$$CN$CA$CA
240370691$24037069$1$I$$20240627$20240701$20240701$EXP$$US-ABBVIE-5821372$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240370701$24037070$1$I$20240511$20240625$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009756$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240370721$24037072$1$I$$20240625$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102461$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$68.04$KG$20240702$$CN$US$US
240370743$24037074$3$F$20240615$20240731$20240701$20240802$PER$$US-JNJFOC-20240644194$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240802$$CN$US$US
240370761$24037076$1$I$$20240628$20240701$20240701$EXP$$JP-TAKEDA-2024TJP009786$TAKEDA$Yuto Fujimura, Akiko Mastuo, Yusuke Takaki, Takeru Kasahara, Keisuke Ohta, Daisuke Naito, et al.. A case of drug-induced cardiomyopathy due to a proteasome inhibitor. The 136th Kinki Regional Scientific Meeting of the Japanese Circulation Society. 2023;58$69$YR$$M$Y$$$20240701$$MD$JP$JP
240370772$24037077$2$F$$20240902$20240701$20240905$EXP$$JP-SA-2024SA187343$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240905$$MD$JP$JP
240370781$24037078$1$I$$20240617$20240701$20240701$EXP$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240600480$COLLEGIUM PHARMACEUTICAL$A. Carranza Morales, J. A. Blanco Jimenez, A. Madhavan. A Painful Case of Asthma. Am J Respir Crit Care Med. 2024;209:A5999$43$YR$$F$Y$$$20240701$$HP$US$US
240370791$24037079$1$I$20240530$20240625$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009821$BEIGENE$$$$$$Y$$$20240701$$MD$CN$CN
240370802$24037080$2$F$$20240703$20240701$20240704$PER$$NVSC2024US136424$NOVARTIS$$$$$$Y$$$20240705$$HP$US$US
240370821$24037082$1$I$$20240621$20240701$20240701$EXP$$US-JNJFOC-20240662147$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$US$US
240370831$24037083$1$I$20240529$20240624$20240701$20240701$EXP$DK-DKMA-30731941$DK-TEVA-VS-3213907$TEVA$$99$YR$$F$Y$$$20240701$$MD$DK$DK
240370841$24037084$1$I$20240625$20240626$20240701$20240701$PER$$US-BIOGEN-2024BI01271653$BIOGEN$$28$YR$$F$Y$$$20240701$$CN$US$US
240370851$24037085$1$I$$20240619$20240701$20240701$EXP$$US-ABBVIE-5821685$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240370861$24037086$1$I$20230101$20240701$20240701$20240701$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037124$BOEHRINGER INGELHEIM$$$$$$Y$$$20240702$$CN$US$US
240370871$24037087$1$I$$20240627$20240701$20240701$EXP$$US-ABBVIE-5819246$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240370882$24037088$2$F$20240226$20240701$20240701$20240707$EXP$$KR-ABBVIE-5817124$ABBVIE$$50$YR$$M$Y$81$KG$20240707$$MD$KR$KR
240370892$24037089$2$F$20231009$20240728$20240701$20240730$EXP$$CA-ABBVIE-5821750$ABBVIE$$$$A$M$Y$$$20240730$$CN$CA$CA
240370901$24037090$1$I$$20240626$20240701$20240701$PER$$US-ABBVIE-5819906$ABBVIE$$$$$$Y$$$20240701$$HP$US$US
240370911$24037091$1$I$$20240624$20240701$20240701$PER$$NVSC2024US136314$NOVARTIS$$72$YR$$M$Y$$$20240702$$MD$US$US
240370922$24037092$2$F$$20240628$20240701$20240705$EXP$$AU-AstraZeneca-2024A148698$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$AU$
240370933$24037093$3$F$$20240816$20240701$20240906$PER$$US-AstraZeneca-2024A147661$ASTRAZENECA$$$$$$Y$$$20240906$$CN$US$
240370941$24037094$1$I$20240601$20240624$20240701$20240701$EXP$IT-MINISAL02-989795$IT-TEVA-VS-3213841$TEVA$$67$YR$$M$Y$$$20240701$$MD$IT$IT
240370951$24037095$1$I$20240506$20240625$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009772$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240370961$24037096$1$I$20240619$20240624$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009678$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240370971$24037097$1$I$$20240628$20240701$20240701$EXP$$US-ABBVIE-5821659$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240370981$24037098$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5819851$ABBVIE$$$$$M$Y$$$20240701$$CN$US$US
240370992$24037099$2$F$$20240805$20240701$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-102765$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240815$$MD$JP$JP
240371001$24037100$1$I$20240507$20240627$20240701$20240701$EXP$$US-ABBVIE-5821267$ABBVIE$$60$YR$$F$Y$$$20240701$$CN$US$US
240371011$24037101$1$I$20240601$20240627$20240701$20240701$EXP$$US-ABBVIE-5821459$ABBVIE$$$$A$M$Y$$$20240701$$HP$US$US
240371021$24037102$1$I$20240611$20240624$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009682$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240371032$24037103$2$F$20240620$20240709$20240701$20240715$30DAY$$US-AMGEN-USASP2024124501$AMGEN$$66$YR$E$F$Y$67.71$KG$20240715$$PH$US$US
240371042$24037104$2$F$20240528$20240812$20240701$20240813$EXP$FR-AFSSAPS-BX2024001295$FR-JNJFOC-20240676238$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240813$$PH$FR$FR
240371051$24037105$1$I$20240617$20240626$20240701$20240701$PER$$US-ABBVIE-5819673$ABBVIE$$66$YR$$F$Y$84$KG$20240701$$CN$US$US
240371061$24037106$1$I$20230725$20240626$20240701$20240701$30DAY$$TR-SANDOZ INC.-SDZ2023TR015656$SANDOZ$$14$YR$$M$Y$45$KG$20240701$$CN$TR$TR
240371071$24037107$1$I$20240607$20240611$20240701$20240701$30DAY$$CL-JNJFOC-20240631584$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$CL$CL
240371081$24037108$1$I$20240403$20240625$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009766$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240371091$24037109$1$I$$20240624$20240701$20240701$PER$$US-ABBVIE-5818364$ABBVIE$$$$A$M$Y$$$20240701$$CN$US$US
240371101$24037110$1$I$$20240624$20240701$20240701$PER$$US-ABBVIE-5817157$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240371112$24037111$2$F$$20240919$20240701$20240924$EXP$$JP-TAKEDA-2024TJP009778$TAKEDA$$3$DEC$$F$Y$$$20240924$$MD$JP$JP
240371121$24037112$1$I$$20240625$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102700$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240702$$HP$US$US
240371131$24037113$1$I$$20230727$20240701$20240701$PER$$US-AMGEN-USASP2023235021$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240371142$24037114$2$F$$20240725$20240701$20240729$EXP$$JP-TAKEDA-2024TJP009825$TAKEDA$$59$YR$$M$Y$$$20240729$$MD$JP$JP
240371161$24037116$1$I$$20240628$20240701$20240701$EXP$$US-ABBVIE-5821681$ABBVIE$$$$$M$Y$$$20240701$$HP$US$US
240371172$24037117$2$F$20240101$20240723$20240701$20240730$30DAY$$CL-JNJFOC-20240651096$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240730$$CN$CL$CL
240371181$24037118$1$I$$20240109$20240701$20240701$PER$$US-AMGEN-USASP2024129409$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240371192$24037119$2$F$$20240624$20240701$20240703$EXP$$US-ABBVIE-5814565$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240371201$24037120$1$I$$20240625$20240701$20240701$PER$$NVSC2024US133908$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240371211$24037121$1$I$$20240627$20240701$20240701$EXP$$US-ABBVIE-5821801$ABBVIE$$$$$F$Y$$$20240701$$HP$US$US
240371231$24037123$1$I$20240424$20240624$20240701$20240701$EXP$FR-AFSSAPS-LL2024001126$FR-TEVA-VS-3213139$TEVA$$81$YR$$F$Y$$$20240701$$MD$FR$FR
240371241$24037124$1$I$20240616$20240625$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009754$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240371251$24037125$1$I$20240613$20240625$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009750$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240371261$24037126$1$I$20240520$20240625$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009758$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240371271$24037127$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104898$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240702$$CN$US$US
240371282$24037128$2$F$$20240809$20240701$20240815$EXP$$CA-ABBVIE-5821747$ABBVIE$$87$YR$$M$Y$$$20240815$$HP$CA$CA
240371291$24037129$1$I$20240601$20240624$20240701$20240701$PER$$US-BAUSCHBL-2024BNL029121$BAUSCH AND LOMB$$55$YR$$M$Y$$$20240702$$MD$US$US
240371301$24037130$1$I$$20240623$20240701$20240701$PER$$US-BAUSCHBL-2024BNL029088$BAUSCH AND LOMB$$$$$F$Y$$$20240702$$CN$US$US
240371311$24037131$1$I$$20240624$20240701$20240701$PER$$US-BAUSCHBL-2024BNL029126$BAUSCH AND LOMB$$$$$F$Y$$$20240702$$CN$US$US
240371331$24037133$1$I$20240506$20240627$20240701$20240701$EXP$$US-ABBVIE-5821265$ABBVIE$$72$YR$$F$Y$$$20240701$$CN$US$US
240371341$24037134$1$I$20240501$20240627$20240701$20240701$EXP$$US-ABBVIE-5821708$ABBVIE$$79$YR$$M$Y$$$20240701$$CN$US$US
240371351$24037135$1$I$$20240621$20240701$20240701$PER$$US-ABBVIE-5813052$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240371361$24037136$1$I$$20240624$20240701$20240701$PER$$US-BAUSCHBL-2024BNL029095$BAUSCH AND LOMB$$78$YR$$F$Y$49.89$KG$20240702$$CN$US$US
240371371$24037137$1$I$$20240627$20240701$20240701$EXP$$US-SANDOZ INC.-SDZ2024US061551$SANDOZ$$$$$F$Y$$$20240701$$CN$US$US
240371381$24037138$1$I$$20240624$20240701$20240701$PER$$US-ABBVIE-5817238$ABBVIE$$$$$$Y$$$20240701$$PH$US$US
240371391$24037139$1$I$20230823$20240628$20240701$20240701$EXP$$PL-BAUSCHBL-2024BNL029330$BAUSCH AND LOMB$$62$YR$$$Y$$$20240702$$MD$PL$PL
240371401$24037140$1$I$20240415$20240628$20240701$20240701$EXP$$PL-BAUSCHBL-2024BNL029328$BAUSCH AND LOMB$$69$YR$$$Y$$$20240702$$MD$PL$PL
240371411$24037141$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104442$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240702$$CN$US$US
240371422$24037142$2$F$20210101$20240822$20240701$20240823$EXP$$US-TAKEDA-2021TUS035100$TAKEDA$$60$YR$$F$Y$$$20240823$$HP$US$US
240371431$24037143$1$I$20231213$20240628$20240701$20240701$EXP$$IT-BAUSCHBL-2024BNL029331$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240702$$HP$IT$IT
240371441$24037144$1$I$20230801$20240627$20240701$20240701$PER$$US-ABBVIE-5820428$ABBVIE$$69$YR$$F$Y$61$KG$20240701$$CN$US$US
240371451$24037145$1$I$20240507$20240625$20240701$20240701$EXP$$CN-BEIGENE-BGN-2024-009767$BEIGENE$$$$$$Y$$$20240701$$HP$CN$CN
240371461$24037146$1$I$$20240626$20240701$20240701$EXP$$CH-NOVITIUMPHARMA-2024CHNVP01126$NOVITIUM PHARMA$L. Gambini.Hypercalcemia due to severe Amiodarone-induced Thyrotoxicosis - A case report.Swiss Medical Weekly.21-MAY-2024;154(5):113S$60$YR$A$M$Y$$$20240702$$HP$CH$CH
240371481$24037148$1$I$20230501$20230601$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393673$RANBAXY$$35$YR$A$F$Y$$$20240702$$CN$US$US
240371491$24037149$1$I$$20230601$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393670$RANBAXY$$$$$M$Y$$$20240702$$CN$US$US
240371501$24037150$1$I$20230525$20230602$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393700$RANBAXY$$15$YR$T$M$Y$$$20240702$$CN$US$US
240371522$24037152$2$F$20240101$20240717$20240701$20240723$PER$$US-009507513-2406USA010054$MERCK$$$$$F$Y$96$KG$20240723$$HP$US$US
240371531$24037153$1$I$20240617$20240630$20240701$20240701$EXP$$CN-ABBVIE-5821742$ABBVIE$$76$YR$$F$Y$45$KG$20240701$$MD$CN$CN
240371541$24037154$1$I$$20240624$20240701$20240701$EXP$$CA-CELLTRION INC.-2024CA015340$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
240371551$24037155$1$I$$20240626$20240701$20240701$EXP$$US-BIOGEN-2024BI01257856$BIOGEN$$$$$F$Y$$$20240701$$CN$US$US
240371561$24037156$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104625$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240702$$CN$US$US
240371571$24037157$1$I$20240604$20240628$20240701$20240701$EXP$FR-AFSSAPS-LY2024000860$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-104281$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$62$KG$20240702$$PH$FR$FR
240371583$24037158$3$F$20240101$20240716$20240701$20240723$EXP$$US-BIOGEN-2024BI01270305$BIOGEN$$$$$F$Y$$$20240723$$CN$US$US
240371592$24037159$2$F$20230706$20240920$20240701$20240924$EXP$$US-TAKEDA-2024TUS065339$TAKEDA$$76$YR$$M$Y$$$20240924$$HP$US$US
240371602$24037160$2$F$$20240626$20240701$20240701$EXP$$US-ROCHE-10000012175$ROCHE$$$$E$M$Y$79.37$KG$20240702$$HP$US$US
240371611$24037161$1$I$20231219$20240618$20240701$20240701$EXP$$JP-AMGEN-JPNNI2024129222$AMGEN$$73$YR$E$F$Y$55.5$KG$20240701$$MD$JP$JP
240371621$24037162$1$I$$20240701$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105089$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240702$$HP$US$US
240371631$24037163$1$I$20240628$20240630$20240701$20240701$EXP$$CN-ABBVIE-5822211$ABBVIE$$74$YR$$F$Y$70$KG$20240701$$MD$CN$CN
240371641$24037164$1$I$$20240624$20240701$20240701$EXP$$US-BIOGEN-2024BI01270982$BIOGEN$$$$$F$Y$$$20240701$$CN$US$US
240371652$24037165$2$F$$20240620$20240701$20240703$PER$$US-ROCHE-10000010404$ROCHE$$$$E$M$Y$$$20240703$$PH$US$US
240371661$24037166$1$I$$20240617$20240701$20240701$EXP$$US-CIPLA LTD.-2024US06607$CIPLA$Oomrigar SC, Fernandez J, Ortiz CR, Rajen H, Toll A, Perez Colome E et al.. The highest form of flattery: Bupropion overdose mimicking brain death. Am J Respir Crit Care Med. 2024;209:A5653$$$$$Y$$$20240702$$HP$US$US
240371671$24037167$1$I$20240301$20240627$20240701$20240701$EXP$$CA-ABBVIE-5820562$ABBVIE$$$$E$M$Y$$$20240701$$CN$CA$CA
240371681$24037168$1$I$20230628$20230703$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399551$RANBAXY$$17$YR$T$$Y$$$20240702$$CN$US$US
240371691$24037169$1$I$$20230714$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400171$RANBAXY$$$$$M$Y$$$20240702$$CN$US$US
240371701$24037170$1$I$20230601$20230712$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401427$RANBAXY$$16$YR$T$F$Y$$$20240702$$CN$US$US
240371711$24037171$1$I$$20230712$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401437$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240371721$24037172$1$I$20230702$20230708$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400750$RANBAXY$$35$YR$A$F$Y$$$20240702$$MD$US$US
240371731$24037173$1$I$$20230620$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396359$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240371741$24037174$1$I$20230601$20230706$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400298$RANBAXY$$19$YR$A$F$Y$$$20240702$$CN$US$US
240371751$24037175$1$I$20230508$20230613$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395449$RANBAXY$$53$YR$A$M$Y$$$20240702$$MD$US$US
240371771$24037177$1$I$$20230707$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400691$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240371781$24037178$1$I$$20240701$20240701$20240701$PER$$US-JNJFOC-20240700653$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240702$$CN$US$US
240371792$24037179$2$F$$20240702$20240701$20240702$PER$$US-JNJFOC-20240667493$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240371802$24037180$2$F$20231201$20240624$20240701$20240702$EXP$$BR-JNJFOC-20240667593$JOHNSON AND JOHNSON$$15$YR$T$F$Y$31$KG$20240702$$CN$BR$BR
240371811$24037181$1$I$$20240617$20240701$20240701$EXP$$US-CIPLA LTD.-2024US06596$CIPLA$$$$$$Y$$$20240702$$CN$US$US
240371821$24037182$1$I$$20240627$20240701$20240701$EXP$$US-BIOGEN-2024BI01271726$BIOGEN$$$$$M$Y$$$20240701$$CN$US$US
240371831$24037183$1$I$20230718$20230720$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402519$RANBAXY$$20$YR$A$M$Y$$$20240702$$CN$US$US
240371841$24037184$1$I$$20230717$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402062$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240371851$24037185$1$I$20230712$20230712$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401440$RANBAXY$$14$YR$T$F$Y$$$20240702$$CN$US$US
240371861$24037186$1$I$20230721$20230722$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402497$RANBAXY$$16$YR$T$$Y$$$20240702$$CN$US$US
240371871$24037187$1$I$20240425$20240501$20240701$20240701$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445619$RANBAXY$$12$YR$C$F$Y$$$20240702$$CN$US$US
240371881$24037188$1$I$20240101$20240701$20240701$20240701$PER$$US-JNJFOC-20240700629$JOHNSON AND JOHNSON$$53$YR$A$F$Y$77.1$KG$20240702$$CN$US$US
240371891$24037189$1$I$$20240618$20240701$20240701$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001990$Alvotech$$26$YR$$F$Y$$$20240702$$PH$CA$CA
240371901$24037190$1$I$20230101$20240617$20240701$20240701$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-000580$Alvotech$$22$YR$$F$Y$105$KG$20240702$$CN$CA$CA
240371911$24037191$1$I$20240624$20240624$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101434$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240702$$HP$US$US
240371921$24037192$1$I$$20240627$20240701$20240701$EXP$$US-ABBVIE-5821584$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240371931$24037193$1$I$20240620$20240701$20240701$20240701$EXP$BG-BDA-27784$BG-JNJFOC-20240701085$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240702$$MD$BG$BG
240371941$24037194$1$I$20230101$20240627$20240701$20240701$EXP$$JP-ASTELLAS-2024JP004493$ASTELLAS$$9$DEC$$M$Y$$$20240702$$MD$JP$JP
240371961$24037196$1$I$$20240619$20240701$20240701$PER$$US-ROCHE-10000007178$ROCHE$$58$YR$A$F$Y$$$20240702$$CN$US$US
240371971$24037197$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5821573$ABBVIE$$$$$$Y$$$20240701$$MD$US$US
240371981$24037198$1$I$$20240627$20240701$20240701$EXP$$US-ABBVIE-5821386$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240371992$24037199$2$F$$20240701$20240701$20240702$PER$$NVSC2024US136423$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240372001$24037200$1$I$20240101$20240626$20240701$20240701$EXP$$US-ABBVIE-5819882$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240372011$24037201$1$I$$20240626$20240701$20240701$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01132$NOVITIUM PHARMA$A. Tammaro.Bullous pemphigoid associated with pleural mesothelioma: a controversial etiology. Were the bullous lesions induced by pembrolizumab or related to malignancy?.Journal Of Applied Cosmetology.24-DEC-2022;40(2):176-179$72$YR$E$M$Y$$$20240702$$HP$IT$IT
240372021$24037202$1$I$$20240626$20240701$20240701$EXP$$US-ABBVIE-5819519$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240372031$24037203$1$I$20240101$20240626$20240701$20240701$EXP$$US-ABBVIE-5820014$ABBVIE$$$$$F$Y$$$20240701$$CN$US$US
240372043$24037204$3$F$20240601$20240705$20240701$20240709$EXP$$US-ABBVIE-5821851$ABBVIE$$86$YR$$M$Y$65$KG$20240709$$HP$US$US
240372051$24037205$1$I$$20240628$20240701$20240701$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104642$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$58.06$KG$20240702$$CN$US$US
240372061$24037206$1$I$$20240628$20240701$20240701$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105019$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240702$$CN$US$US
240372081$24037208$1$I$$20240625$20240701$20240701$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036131$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240702$$CN$US$US
240372091$24037209$1$I$20240601$20240626$20240701$20240701$EXP$$US-ABBVIE-5819602$ABBVIE$$68$YR$$M$Y$$$20240701$$CN$US$US
240372101$24037210$1$I$$20240624$20240701$20240701$PER$$US-SA-2024SA191296$SANOFI AVENTIS$$$$A$F$Y$68.027$KG$20240702$$MD$US$US
240372111$24037211$1$I$20240501$20240624$20240701$20240701$PER$$US-SA-2024SA189030$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240702$$MD$US$US
240372121$24037212$1$I$$20240627$20240701$20240701$EXP$$GB-ABBVIE-5820453$ABBVIE$$$$E$F$Y$$$20240701$$CN$GB$GB
240372131$24037213$1$I$20240501$20240627$20240701$20240701$EXP$$CA-ABBVIE-5820220$ABBVIE$$77$YR$$M$Y$$$20240701$$CN$CA$CA
240372142$24037214$2$F$$20240712$20240701$20240716$EXP$$CA-ABBVIE-5820632$ABBVIE$$$$A$F$Y$$$20240716$$MD$CA$CA
240372151$24037215$1$I$20240101$20240626$20240701$20240701$EXP$$US-ABBVIE-5819665$ABBVIE$$$$$$Y$$$20240701$$MD$US$US
240372163$24037216$3$F$20210101$20240718$20240701$20240722$EXP$$JP-SA-2024SA189698$SANOFI AVENTIS$$$$$F$Y$$$20240723$$MD$JP$JP
240372171$24037217$1$I$20210916$20240624$20240701$20240701$EXP$$DE-CELLTRION INC.-2024DE015497$CELLTRION$$$$$$Y$$$20240702$$MD$DE$DE
240372181$24037218$1$I$$20240626$20240701$20240701$EXP$$CA-ABBVIE-5822467$ABBVIE$$$$$F$Y$$$20240701$$CN$CA$CA
240372192$24037219$2$F$$20240625$20240701$20240702$EXP$$JP-BEH-2024174529$CSL BEHRING$$$$$$Y$$$20240702$$MD$JP$JP
240372202$24037220$2$F$20240605$20240715$20240701$20240718$30DAY$$CA-JNJFOC-20240613747$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$PH$CA$CA
240372221$24037222$1$I$$20240626$20240701$20240701$PER$$US-ABBVIE-5820235$ABBVIE$$$$$$Y$$$20240701$$HP$US$US
240372231$24037223$1$I$$20240623$20240701$20240701$EXP$$US-JNJFOC-20240662361$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
240372242$24037224$2$F$20240601$20240702$20240701$20240703$EXP$$US-ABBVIE-5821658$ABBVIE$$29$YR$$F$Y$$$20240703$$CN$US$US
240372253$24037225$3$F$20240601$20240718$20240702$20240723$EXP$$FR-ABBVIE-5796397$ABBVIE$$88$YR$$F$Y$$$20240723$$CN$FR$FR
240372261$24037226$1$I$$20240626$20240702$20240702$EXP$$US-NOVITIUMPHARMA-2024USNVP01125$NOVITIUM PHARMA$K. Alsheimer.Genitourinary Tuberculosis Resulting in Hydronephrosis.American Journal of Respiratory and Critical Care Medicine.19-MAY-2024;209:A2354$$$$M$Y$$$20240702$$HP$US$US
240372271$24037227$1$I$20240515$20240626$20240702$20240702$EXP$$DE-ABBVIE-5821352$ABBVIE$$80$YR$$M$Y$$$20240702$$MD$DE$DE
240372281$24037228$1$I$$20240628$20240702$20240702$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037137$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240702$$CN$US$US
240372291$24037229$1$I$20240624$20240624$20240702$20240702$PER$$US-AMGEN-USASP2024125048$AMGEN$$80$YR$E$F$Y$$$20240701$$CN$US$US
240372301$24037230$1$I$$20240621$20240702$20240702$EXP$$GR-ROCHE-10000003599$ROCHE$Koutroulos V, Mittas I, Malkots B, Chalikias G, Tziakas D. Acute myocardial infarction mimicking acute gastroenteritis. Hippocratic days of cardiology. 2024 May 17;$38$YR$A$M$Y$$$20240702$$MD$GR$GR
240372312$24037231$2$F$20231126$20240708$20240702$20240722$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-001344$Alvotech$$35$YR$$F$Y$$$20240719$$CN$CA$CA
240372321$24037232$1$I$$20240619$20240702$20240702$EXP$$SG-ALVOTECHPMS-2024-ALVOTECHPMS-001975$Alvotech$Literature Reference: Shah JM, Fong W, De Silva DA. NeuroBehcet^s-related intracranial hypertension without cerebral venous thrombosis: case report and review of literature. BMC Neurol. 2024 Jun 14;24(1):203. doi: 10.1186/s12883-024-03708-x.$28$YR$$F$Y$$$20240702$$HP$SG$
240372331$24037233$1$I$$20240626$20240702$20240702$EXP$$CA-ABBVIE-5820059$ABBVIE$$$$E$M$Y$$$20240702$$HP$CA$CA
240372341$24037234$1$I$20240624$20240627$20240702$20240702$EXP$$US-ABBVIE-5819478$ABBVIE$$73$YR$$F$Y$42$KG$20240702$$CN$US$US
240372351$24037235$1$I$$20240630$20240702$20240702$EXP$GB-MHRA-MED-202406301455300240-QMJZC$GB-GSK-GB2024081227$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$GB$GB
240372362$24037236$2$F$20240618$20240724$20240702$20240726$PER$$US-JNJFOC-20240655203$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240726$$PH$US$US
240372371$24037237$1$I$$20240619$20240702$20240702$EXP$$IL-ALVOTECHPMS-2024-ALVOTECHPMS-001974$Alvotech$Mavris N, Jaouni T, Amer R. Subretinal Fibrosis Developing 10 Years After First Presentation with Chronic Ocular Sarcoidosis in a Child. Ocul Immunol Inflamm. 2024 Jun 12:1-4. doi: 10.1080/09273948.2024.2363481.$12$YR$$F$Y$$$20240702$$MD$IL$
240372381$24037238$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5819026$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240372391$24037239$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5819850$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240372401$24037240$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821364$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240372411$24037241$1$I$20240622$20240627$20240702$20240702$EXP$$US-ABBVIE-5821457$ABBVIE$$60$YR$$F$Y$$$20240702$$CN$US$US
240372421$24037242$1$I$$20240627$20240702$20240702$EXP$$IT-GENMAB-2024-02288$GENMAB$$$$$F$Y$$$20240702$$MD$IT$IT
240372431$24037243$1$I$$20240627$20240702$20240702$EXP$$ZA-AstraZeneca-2024A148890$ASTRAZENECA$$86$YR$$F$Y$$$20240702$$CN$ZA$
240372441$24037244$1$I$$20240603$20240702$20240702$PER$$US-AstraZeneca-2024A129165$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240372452$24037245$2$F$$20240712$20240702$20240716$EXP$$BG-ABBVIE-5821175$ABBVIE$$63$YR$$M$Y$$$20240716$$CN$BG$BG
240372461$24037246$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105080$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240702$$CN$US$US
240372471$24037247$1$I$$20240403$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000111$ARCUTIS$$$$$$Y$$$20240701$$MD$US$US
240372481$24037248$1$I$$20240429$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000124$ARCUTIS$$$$$$Y$$$20240701$$MD$US$US
240372491$24037249$1$I$$20240429$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000137$ARCUTIS$$$$$$Y$$$20240701$$CN$US$US
240372501$24037250$1$I$$20240430$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000138$ARCUTIS$$$$$M$Y$$$20240701$$HP$US$US
240372511$24037251$1$I$$20240430$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000139$ARCUTIS$$$$$F$Y$$$20240701$$HP$US$US
240372521$24037252$1$I$$20240506$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000144$ARCUTIS$$$$$M$Y$$$20240701$$MD$US$US
240372531$24037253$1$I$$20240508$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000147$ARCUTIS$$$$$$Y$$$20240701$$MD$US$US
240372541$24037254$1$I$20240301$20240404$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000113$ARCUTIS$$$$$$Y$$$20240701$$CN$US$US
240372552$24037255$2$F$$20240711$20240702$20240714$EXP$DE-EMA-DD-20240611-7482643-125415$DE-DEXPHARM-2024-2079$DEXCEL$$49$YR$A$F$Y$61$KG$20240714$$HP$DE$DE
240372561$24037256$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432104$ACCORD$Hourigan E, Rattan M, Olsen M. The Right Side of Cardiogenic Shock: A Case of Beta-Blocker Induced Cardiogenic Shock in a Female With Suspected Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1595. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1595.$41$YR$A$F$Y$$$20240701$$MD$US$US
240372572$24037257$2$F$20240616$20240704$20240702$20240716$EXP$ES-AEMPS-1537503$ES-Accord-432071$ACCORD$$85$YR$E$M$Y$85$KG$20240716$$HP$ES$ES
240372581$24037258$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432115$ACCORD$Simone C, Axelband J. Levetiracetam-associated rhabdomyolysis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5704. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5704.$20$YR$A$M$Y$$$20240701$$MD$US$US
240372591$24037259$1$I$$20240619$20240702$20240702$EXP$AU-TGA-802781$AU-Accord-431994$ACCORD$$$$$M$Y$$$20240701$$HP$AU$AU
240372601$24037260$1$I$20240604$20240620$20240702$20240702$EXP$GB-MHRA-MED-202406201708236010-CLRMD$GB-Accord-431911$ACCORD$$24$YR$A$M$Y$82$KG$20240701$$CN$GB$GB
240372611$24037261$1$I$20240101$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104975$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$91.63$KG$20240702$$CN$US$US
240372621$24037262$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432120$ACCORD$Ozogbo S, Pupillo S. A Rare Presentation of Large B-cell Lymphoma With Anterior Mediastinal Mass in a 24-yearold Female. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6518.$24$YR$A$F$Y$$$20240701$$MD$US$US
240372631$24037263$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5819705$ABBVIE$$$$$$Y$$$20240702$$MD$US$US
240372641$24037264$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432124$ACCORD$Crawford M, Trinh J, Chaudhary S. A Case Report of Statin-induced Necrotizing Autoimmune Myopathy With Extramuscular Involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209.$75$YR$E$F$Y$$$20240701$$MD$US$US
240372651$24037265$1$I$$20240624$20240702$20240702$PER$$US-ABBVIE-5818479$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240372661$24037266$1$I$$20240619$20240702$20240702$EXP$AU-TGA-802819$AU-Accord-431870$ACCORD$$$$$M$Y$$$20240701$$HP$AU$
240372671$24037267$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432126$ACCORD$Gans A, Taylor J, Goel NN. A Case of Drug-Induced Stevens-Johnson Syndrome With Primarily Visceral Involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5678.$76$YR$E$F$Y$$$20240701$$MD$US$US
240372681$24037268$1$I$$20231121$20240702$20240702$PER$$US-AMGEN-USASP2023235028$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240372692$24037269$2$F$20240313$20240708$20240702$20240716$30DAY$$US-AMGEN-USASP2024125214$AMGEN$$$$$F$Y$$$20240716$$HP$US$US
240372702$24037270$2$F$$20240827$20240702$20240828$EXP$$TH-ROCHE-10000003560$ROCHE$$$$$F$Y$$$20240828$$MD$TH$TH
240372712$24037271$2$F$20240611$20240729$20240702$20240805$EXP$$US-GENMAB-2024-02199$GENMAB$$49$YR$$M$Y$73.2$KG$20240804$$HP$US$US
240372722$24037272$2$F$$20240710$20240702$20240712$PER$$US-AMGEN-USASP2024126319$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240372731$24037273$1$I$20240615$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024125501$AMGEN$$84$YR$E$F$Y$$$20240701$$CN$US$US
240372741$24037274$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821313$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240372751$24037275$1$I$20240209$20240627$20240702$20240702$EXP$$US-ABBVIE-5821476$ABBVIE$$35$YR$$M$Y$$$20240702$$CN$US$US
240372761$24037276$1$I$20240620$20240627$20240702$20240702$EXP$$US-ABBVIE-5821488$ABBVIE$$49$YR$$M$Y$$$20240702$$CN$US$US
240372771$24037277$1$I$20240529$20240627$20240702$20240702$EXP$$US-ABBVIE-5821697$ABBVIE$$42$YR$$M$Y$$$20240702$$CN$US$US
240372781$24037278$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA191610$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240702$$MD$US$US
240372791$24037279$1$I$20240605$20240625$20240702$20240702$PER$$US-SA-2024SA190821$SANOFI AVENTIS$$20$MON$I$F$Y$$$20240702$$HP$US$US
240372802$24037280$2$F$$20240625$20240702$20240705$EXP$$NL-ABBVIE-5819518$ABBVIE$$$$A$M$Y$$$20240705$$CN$NL$NL
240372812$24037281$2$F$20240101$20240803$20240702$20240812$PER$$US-SA-2024SA185320$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240812$$MD$US$US
240372821$24037282$1$I$20240601$20240619$20240702$20240702$PER$$US-SA-2024SA184882$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240702$$MD$US$US
240372832$24037283$2$F$20240301$20240624$20240702$20240812$PER$$US-SA-2024SA190443$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240812$$MD$US$US
240372841$24037284$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA190949$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240702$$MD$US$US
240372852$24037285$2$F$20240101$20240916$20240702$20240923$PER$$US-SA-2024SA189756$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240923$$MD$US$US
240372861$24037286$1$I$$20240619$20240702$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014347$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240702$$CN$US$US
240372871$24037287$1$I$$20240619$20240702$20240702$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202406013363$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$DE$DE
240372883$24037288$3$F$20240612$20240716$20240702$20240720$EXP$$US-ABBVIE-5821406$ABBVIE$$58$YR$$M$Y$84$KG$20240720$$CN$US$US
240372891$24037289$1$I$$20240509$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000148$ARCUTIS$$$$$$Y$$$20240701$$MD$US$US
240372901$24037290$1$I$$20240515$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000160$ARCUTIS$$$$$$Y$$$20240701$$CN$US$US
240372911$24037291$1$I$$20240517$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000166$ARCUTIS$$$$$$Y$$$20240701$$CN$US$US
240372921$24037292$1$I$$20240522$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000171$ARCUTIS$$$$$$Y$$$20240701$$MD$US$US
240372931$24037293$1$I$$20240523$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000175$ARCUTIS$$$$$M$Y$$$20240701$$MD$US$US
240372941$24037294$1$I$$20240530$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000183$ARCUTIS$$$$$$Y$$$20240701$$MD$US$US
240372951$24037295$1$I$$20240604$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000188$ARCUTIS$$$$$M$Y$$$20240701$$MD$US$US
240372961$24037296$1$I$$20240611$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000203$ARCUTIS$$$$$$Y$$$20240701$$MD$US$US
240372971$24037297$1$I$$20240319$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000080$ARCUTIS$$$$$$Y$$$20240701$$$US$US
240372981$24037298$1$I$20240101$20240619$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000086$ARCUTIS$$50$YR$$M$Y$$$20240701$$CN$US$US
240372991$24037299$1$I$$20240325$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000087$ARCUTIS$$$$$$Y$$$20240701$$MD$US$US
240373001$24037300$1$I$20240301$20240326$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000088$ARCUTIS$$$$$$Y$$$20240701$$CN$US$US
240373011$24037301$1$I$20240301$20240325$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000090$ARCUTIS$$$$$$Y$$$20240701$$HP$US$US
240373021$24037302$1$I$20240101$20240401$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000104$ARCUTIS$$$$$$Y$$$20240701$$CN$US$US
240373031$24037303$1$I$$20240402$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000107$ARCUTIS$$$$$$Y$$$20240701$$MD$US$US
240373041$24037304$1$I$20240601$20240627$20240702$20240702$EXP$$US-ABBVIE-5821535$ABBVIE$$24$YR$$F$Y$$$20240702$$CN$US$US
240373051$24037305$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5821576$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240373062$24037306$2$F$$20240712$20240702$20240716$EXP$$JP-SAKK-2024SA190992AA$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240716$$MD$JP$JP
240373071$24037307$1$I$20240601$20240624$20240702$20240702$PER$$US-ABBVIE-5817932$ABBVIE$$57$YR$$$Y$$$20240702$$CN$US$US
240373081$24037308$1$I$$20240320$20240702$20240702$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000081$ARCUTIS$$$$$$Y$$$20240701$$CN$US$US
240373092$24037309$2$F$20240625$20240701$20240702$20240704$EXP$$US-ABBVIE-5819596$ABBVIE$$49$YR$$F$Y$141$KG$20240704$$HP$US$US
240373101$24037310$1$I$$20240620$20240702$20240702$EXP$GB-MHRA-MED-202406202200481960-CMGSV$GB-NOVOPROD-1245759$NOVO NORDISK$$$$$F$Y$81$KG$20240702$$CN$GB$GB
240373111$24037311$1$I$$20240627$20240702$20240702$EXP$$CA-ABBVIE-5820989$ABBVIE$$$$A$F$Y$$$20240702$$HP$CA$CA
240373121$24037312$1$I$20230601$20240625$20240702$20240702$EXP$$US-ROCHE-10000012343$ROCHE$$82$YR$E$M$Y$$$20240702$$HP$US$US
240373131$24037313$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5819841$ABBVIE$$$$$$Y$$$20240702$$MD$US$US
240373143$24037314$3$F$20240624$20240711$20240702$20240716$EXP$$PT-ABBVIE-5818888$ABBVIE$$85$YR$$F$Y$$$20240716$$MD$PT$PT
240373154$24037315$4$F$20240307$20240923$20240702$20240926$EXP$$DE-009507513-2406DEU009706$MERCK$$70$YR$$M$Y$$$20240926$$MD$DE$DE
240373163$24037316$3$F$20230829$20240703$20240702$20240710$EXP$$JP-ABBVIE-5821660$ABBVIE$$64$YR$$F$Y$66$KG$20240710$$MD$JP$JP
240373171$24037317$1$I$$20240620$20240702$20240702$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001991$Alvotech$$$$$F$Y$$$20240702$$CN$CA$CA
240373191$24037319$1$I$$20230106$20240702$20240702$PER$$US-AMGEN-USASP2023235291$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240373201$24037320$1$I$$20240620$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05857$HIKMA$Shivarajpur A, Valentin R.. Shivarajpur A, Valentin R. Intramuscular Progesterone: A Cause of Acute Eosinophilic Pneumonitis.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A2002$$$$$Y$$$20240702$$MD$US$US
240373212$24037321$2$F$20221020$20240627$20240702$20240705$EXP$$FR-CELLTRION INC.-2024FR015493$CELLTRION$$$$$$Y$$$20240705$$MD$FR$FR
240373221$24037322$1$I$$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024128379$AMGEN$$$$$$Y$$$20240701$$MD$US$US
240373231$24037323$1$I$$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024129643$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240373241$24037324$1$I$$20240624$20240702$20240702$30DAY$$US-GSK-US2024AMR079008$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
240373252$24037325$2$F$$20240627$20240702$20240704$PER$$US-ABBVIE-5822007$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240373261$24037326$1$I$$20240623$20240702$20240702$EXP$$IT-JNJFOC-20240667918$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$IT$IT
240373271$24037327$1$I$20240601$20240625$20240702$20240702$EXP$$US-ABBVIE-5810517$ABBVIE$$61$YR$$M$Y$$$20240702$$CN$US$US
240373285$24037328$5$F$20240625$20240807$20240702$20240813$PER$$US-ROCHE-10000011552$ROCHE$$62$YR$A$F$Y$$$20240813$$CN$US$US
240373292$24037329$2$F$20240101$20240925$20240702$20240930$EXP$$US-ABBVIE-5820919$ABBVIE$$$$$F$Y$$$20240929$$CN$US$US
240373301$24037330$1$I$$20240618$20240702$20240702$EXP$$US-ABBVIE-5810717$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240373312$24037331$2$F$20240101$20240716$20240702$20240722$EXP$$CA-ABBVIE-5819985$ABBVIE$$80$YR$$M$Y$$$20240722$$CN$CA$CA
240373321$24037332$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5818903$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240373331$24037333$1$I$$20240624$20240702$20240702$PER$$US-ALXN-202406USA001581US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
240373342$24037334$2$F$$20240627$20240702$20240705$EXP$IR-STRIDES ARCOLAB LIMITED-2024SP007347$IR-STRIDES ARCOLAB LIMITED-2024SP007347$STRIDES$Lotfollahi L, Golmohammadi M, Javandoust Gharehbagh F, Alavi Darazam I.. Self-induced Anuria with Diclofenac: An Interesting Case of ^Quadruple Whammy^ Acute Kidney Injury. .. International Journal of Medical Toxicology and Forensic Medicine. 2024;14 (2):E43065$66$YR$$F$Y$$$20240705$$MD$IR$IR
240373351$24037335$1$I$$20240622$20240702$20240702$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007704$STRIDES$Puri A, Iusim S.. Dust to Dawn: A Case of Complicated Silicosis With Progressive Massive Pulmonary Fibrosis.. Am-J-Respir-Crit-Care-Med. 2024;209 (0):abstr. A5983$57$YR$$M$Y$$$20240702$$HP$US$US
240373361$24037336$1$I$$20240625$20240702$20240702$EXP$$US-ABBVIE-5818640$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240373371$24037337$1$I$$20240624$20240702$20240702$EXP$$US-JNJFOC-20240663741$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240373381$24037338$1$I$$20240624$20240702$20240702$EXP$$US-JNJFOC-20240665925$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240373391$24037339$1$I$$20240622$20240702$20240702$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007708$STRIDES$Rahman M, Liu Z, Bellas KJ, Monegro AF.. A Case of Asymptomatic ^Limited^ Scleroderma Causing Interstitial Lung Disease.. Am-J-Respir-Crit-Care-Med. 2024;209:abstr. P065$$$$$Y$$$20240702$$HP$US$US
240373402$24037340$2$F$20240101$20240701$20240702$20240705$EXP$$US-ABBVIE-5816514$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240373412$24037341$2$F$20230408$20240911$20240702$20240918$EXP$$US-ABBVIE-5819597$ABBVIE$$51$YR$$F$Y$158$KG$20240918$$CN$US$US
240373421$24037342$1$I$$20240620$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05855$HIKMA$Carranza Morales A, Blanco Jimenez J, Madhavan A.. Carranza Morales A, Blanco Jimenez J, Madhavan A. A Painful Case of Asthma.. American Journal of Respiratory and Critical Care Medicine.. 2024;A5999:209$$$$$Y$$$20240702$$MD$US$US
240373431$24037343$1$I$$20240622$20240702$20240702$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007684$STRIDES$Grossman J, Amdo TD, Mercado JM, Moreira A, Adelman MH.. Case Report: Subtle Perilymphatic Sarcoidosis Mimicking Miliary Tuberculosis.. Am-J-Respir-Crit-Care-Med. 2024;209$4$DEC$$M$Y$$$20240702$$HP$US$US
240373441$24037344$1$I$$20240624$20240702$20240702$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007744$STRIDES$Hammond TC, Channick CL, Favano T, Purbhoo M, Exley MA, Vandiver MS, et al.. Persistent SARS-CoV-2 Viremia, COVID-19 Associated Acute Respiratory Distress Syndrome, Severe Coagulopathy and Massive Hemoptysis in a Renal Transplant Patient on Veno-Venous Extracorporeal Membrane Oxygenation.. Am-J-Respir-Crit-Care-Med. 2024;209 plus Poster$$$$$Y$$$20240702$$HP$US$US
240373451$24037345$1$I$20240601$20240626$20240702$20240702$EXP$$US-ABBVIE-5819523$ABBVIE$$48$YR$$F$Y$$$20240702$$CN$US$US
240373461$24037346$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5819867$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240373471$24037347$1$I$$20240624$20240702$20240702$EXP$$US-TAKEDA-2024TUS036524$TAKEDA$$$$$F$Y$$$20240702$$CN$US$US
240373481$24037348$1$I$20230501$20240628$20240702$20240702$EXP$$BR-ABBVIE-5821106$ABBVIE$$81$YR$$M$Y$78$KG$20240702$$CN$BR$BR
240373491$24037349$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000010295$ROCHE$$$$$F$Y$$$20240702$$CN$US$US
240373501$24037350$1$I$$20230223$20240702$20240702$PER$$US-AMGEN-USASP2023235035$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240373511$24037351$1$I$$20240624$20240702$20240702$EXP$$US-AMGEN-USASP2024125168$AMGEN$Novoa F. J.; Cheema S.; Conner S.. A Case of Symptomatic Hypercalcemia Secondary to Histoplasmosis. American Journal of Respiratory and Critical Care Medicine. 2024;209(1):A6332-A6332$57$YR$A$F$Y$$$20240701$$HP$US$US
240373521$24037352$1$I$$20240625$20240702$20240702$PER$$US-ROCHE-10000012671$ROCHE$$$$$$Y$$$20240702$$HP$US$US
240373531$24037353$1$I$$20240624$20240702$20240702$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007722$STRIDES$Hodson EL, Kranyak A, Salem I, Buckey JC.. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases.. J-Tissue-Viability. 2024$$$$$Y$$$20240702$$HP$US$US
240373541$24037354$1$I$$20240625$20240702$20240702$PER$$US-ROCHE-10000013100$ROCHE$$$$A$M$Y$$$20240702$$HP$US$US
240373552$24037355$2$F$20230101$20240704$20240702$20240709$EXP$$BR-ABBVIE-5819465$ABBVIE$$$$$F$Y$$$20240709$$CN$BR$BR
240373561$24037356$1$I$20240528$20240626$20240702$20240702$EXP$FR-AFSSAPS-MP2024001037$FR-ABBVIE-5816360$ABBVIE$$70$YR$$M$Y$$$20240702$$PH$FR$FR
240373571$24037357$1$I$$20240621$20240702$20240702$PER$$US-ABBVIE-5814519$ABBVIE$$$$A$F$Y$$$20240702$$CN$US$US
240373581$24037358$1$I$$20240626$20240702$20240702$PER$$US-ABBVIE-5819708$ABBVIE$$$$$$Y$$$20240702$$HP$US$US
240373591$24037359$1$I$20240514$20240618$20240702$20240702$PER$$US-ROCHE-10000005532$ROCHE$$29$YR$A$M$Y$$$20240702$$CN$US$US
240373601$24037360$1$I$$20240623$20240702$20240702$PER$$US-BIOGEN-2024BI01270953$BIOGEN$$$$$F$Y$$$20240702$$HP$US$US
240373612$24037361$2$F$20150101$20240702$20240702$20240716$EXP$$US-ROCHE-3266520$ROCHE$$82$YR$E$M$Y$89.36$KG$20240716$$CN$US$US
240373621$24037362$1$I$20240508$20240628$20240702$20240702$EXP$$US-ABBVIE-5821786$ABBVIE$$78$YR$$M$Y$$$20240702$$CN$US$US
240373631$24037363$1$I$$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127384$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240373641$24037364$1$I$$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024125923$AMGEN$Khattri S. Use of dual biologic therapy targeting the Th2 and Thl7 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease. Journal of the American Academy of Dermatology. 2024;91(1):138-140$58$YR$A$$Y$$$20240701$$MD$US$US
240373651$24037365$1$I$$20240624$20240702$20240702$EXP$$FI-STRIDES ARCOLAB LIMITED-2024SP007735$STRIDES$Rokkanen R, Aarnivala H, Pokka T, Niinimaki R.. Chemotherapy-related toxicities follow a typical pattern in children treated for acute lymphoblastic leukaemia. Acta-Paediatr. 2024;113(5):1103-1111$$$C$$Y$$$20240702$$HP$FI$FI
240373661$24037366$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000012684$ROCHE$$$$T$M$Y$$$20240702$$CN$US$US
240373671$24037367$1$I$20231101$20240626$20240702$20240702$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02377$AMNEAL$$81$YR$$M$Y$$$20240702$$CN$US$US
240373681$24037368$1$I$$20240624$20240702$20240702$EXP$$FI-STRIDES ARCOLAB LIMITED-2024SP007737$STRIDES$Rokkanen R, Aarnivala H, Pokka T, Niinimaki R.. Chemotherapy-related toxicities follow a typical pattern in children treated for acute lymphoblastic leukaemia. Acta-Paediatr. 2024;113(5):1103-1111$$$C$$Y$$$20240702$$HP$FI$FI
240373691$24037369$1$I$$20240625$20240702$20240702$EXP$$MY-ABBVIE-5822478$ABBVIE$$33$YR$$F$Y$$$20240702$$HP$MY$MY
240373701$24037370$1$I$20240609$20240627$20240702$20240702$PER$$US-ABBVIE-5820450$ABBVIE$$$$$F$Y$$$20240702$$MD$US$US
240373711$24037371$1$I$20240101$20240625$20240702$20240702$EXP$$JP-GENMAB-2024-00502AA$GENMAB$$79$YR$$F$Y$50$KG$20240702$$MD$JP$JP
240373721$24037372$1$I$20240609$20240618$20240702$20240702$EXP$$GB-CIPLA LTD.-2024GB06587$CIPLA$$$$$$Y$$$20240702$$CN$GB$GB
240373731$24037373$1$I$$20240625$20240702$20240702$PER$$US-ROCHE-10000012817$ROCHE$$$$A$M$Y$$$20240702$$CN$US$US
240373741$24037374$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000012539$ROCHE$$$$A$M$Y$$$20240702$$CN$US$US
240373751$24037375$1$I$$20240624$20240702$20240702$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP007738$STRIDES$Galli E, Metafuni E, Gandi C, Limongiello MA, Giammarco S, Mattozzi A, et al.. Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy.. Eur-J-Haematol. 2024;112 (4):577-584$$$$$Y$$$20240702$$HP$IT$IT
240373762$24037376$2$F$$20240808$20240702$20240820$EXP$$US-NOVOPROD-1243722$NOVO NORDISK$$86$YR$$F$Y$$$20240820$$CN$US$US
240373771$24037377$1$I$20110101$20240621$20240702$20240702$EXP$$US-NOVOPROD-1243725$NOVO NORDISK$$$$A$F$Y$$$20240702$$CN$US$US
240373781$24037378$1$I$$20240621$20240702$20240702$EXP$$CN-NOVOPROD-1244155$NOVO NORDISK$$66$YR$$M$Y$70$KG$20240702$$CN$CN$CN
240373792$24037379$2$F$20240620$20240802$20240702$20240813$EXP$$US-NOVOPROD-1244513$NOVO NORDISK$$68$YR$$F$Y$$$20240813$$CN$US$US
240373801$24037380$1$I$20240525$20240621$20240702$20240702$EXP$ES-AEMPS-1531863$ES-NOVOPROD-1244500$NOVO NORDISK$$85$YR$$M$Y$81$KG$20240702$$MD$ES$ES
240373811$24037381$1$I$$20240621$20240702$20240702$EXP$$CN-NOVOPROD-1244187$NOVO NORDISK$$64$YR$$F$Y$48$KG$20240702$$CN$CN$CN
240373821$24037382$1$I$$20240621$20240702$20240702$EXP$$EG-NOVOPROD-1236000$NOVO NORDISK$$$$$F$Y$$$20240702$$CN$EG$EG
240373832$24037383$2$F$20240613$20240812$20240702$20240821$EXP$$CO-NOVOPROD-1244765$NOVO NORDISK$$74$YR$$F$Y$90$KG$20240821$$CN$CO$CO
240373841$24037384$1$I$20230301$20240621$20240702$20240702$EXP$FR-AFSSAPS-LL2024001163$FR-NOVOPROD-1243091$NOVO NORDISK$$55$YR$$M$Y$$$20240702$$MD$FR$FR
240373851$24037385$1$I$$20240624$20240702$20240702$EXP$$BE-JNJFOC-20240666222$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240702$$HP$BE$BE
240373863$24037386$3$F$$20240717$20240702$20240726$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05845$HIKMA$Pokhriyal SC, Tan EF, Bhatt PK, Khan AA, Pasha MN, Pierre L, Idris H.. Pokhriyal SC, Tan EF, Bhatt PK, Khan AA, Pasha MN, Pierre L et al. Assay Interference Causing Persistently Elevated Vancomycin Levels Leading to Treatment Failure and Fatal Outcome.. Cureus. 2024;e61943:16(6)$$$$$Y$$$20240726$$MD$US$US
240373871$24037387$1$I$$20240426$20240702$20240702$PER$$US-AMGEN-USASP2024129539$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240373881$24037388$1$I$$20240625$20240702$20240702$EXP$$CA-ABBVIE-5819626$ABBVIE$$32$YR$$F$Y$$$20240702$$HP$CA$CA
240373891$24037389$1$I$20240625$20240625$20240702$20240702$EXP$$CA-ABBVIE-5822477$ABBVIE$$71$YR$$F$Y$$$20240702$$HP$CA$CA
240373901$24037390$1$I$$20240618$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06673$CIPLA$Patel D, Zafar P, Nasrullah A, Patel D, Holden K, Balaan MR.. Community acquired pneumonia or Hydralazine-induced vasculitis- A clinical dilemma. Am J Respir Crit Care Med. 2024;209:A2014$$$$$Y$$$20240702$$HP$US$US
240373911$24037391$1$I$$20240625$20240702$20240702$EXP$$US-JNJFOC-20240667204$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$US$US
240373931$24037393$1$I$20240328$20240624$20240702$20240702$EXP$$RU-JNJFOC-20240664912$JOHNSON AND JOHNSON$$41$YR$A$M$Y$55$KG$20240702$$MD$RU$RU
240373943$24037394$3$F$20240601$20240620$20240702$20240711$EXP$$US-AMGEN-USASP2024120607$AMGEN$$$$$F$Y$$$20240710$$MD$US$US
240373951$24037395$1$I$$20240417$20240702$20240702$PER$$US-AMGEN-USASP2024129792$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240373961$24037396$1$I$$20240622$20240702$20240702$EXP$$US-CORIUM, LLC-2024COR000135$CORIUM$$$$$M$Y$$$20240701$$CN$US$US
240373972$24037397$2$F$$20240701$20240702$20240708$EXP$$US-AMGEN-USASP2024126536$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240373982$24037398$2$F$20240402$20240718$20240702$20240720$EXP$$US-TAKEDA-2024TUS041977$TAKEDA$$66$YR$$F$Y$$$20240720$$HP$US$US
240373992$24037399$2$F$$20240705$20240702$20240716$EXP$$US-009507513-2406USA007917$MERCK$$60$YR$$M$Y$86$KG$20240716$$CN$US$US
240374001$24037400$1$I$20240617$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105054$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$38.56$KG$20240702$$CN$US$US
240374011$24037401$1$I$20240628$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104586$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240702$$HP$US$US
240374022$24037402$2$F$20240624$20240624$20240702$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102011$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$89.81$KG$20240709$$HP$US$US
240374031$24037403$1$I$$20240622$20240702$20240702$PER$$US-AMGEN-USASP2024124572$AMGEN$Leung J.; Fu J.; Sia T. et. al.. Clinical and histologic remission achieved with upadacitinib in a patient with refractory eosinophilic gastritis and duodenitis. Journal of Allergy and Clinical Immunology: In Practice. 2024;12 (6):1649-1651$59$YR$A$F$Y$$$20240701$$MD$US$US
240374041$24037404$1$I$20210423$20240626$20240702$20240702$EXP$$US-ABBVIE-5819603$ABBVIE$$65$YR$$M$Y$85$KG$20240702$$MD$US$US
240374051$24037405$1$I$$20240618$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06609$CIPLA$Mansfield PK, Moody R, Li Y, Heinecke G. A rare case of lichen planus pemphigoides with palmoplantar hyperkeratotic plaques. JAAD Case Reports. 2024;49:14 to 6$$$$$Y$$$20240702$$MD$US$US
240374061$24037406$1$I$$20240701$20240702$20240702$PER$$NVSC2024US136427$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240374073$24037407$3$F$$20240903$20240702$20240910$EXP$JP-MMM-QJ6R0GKZ$JP-GSK-JP2024078971$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$JP$JP
240374083$24037408$3$F$$20240801$20240702$20240811$PER$$US-AMGEN-USASP2024126588$AMGEN$$57$YR$A$F$Y$$$20240811$$CN$US$US
240374091$24037409$1$I$$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128212$AMGEN$$$$$F$Y$$$20240701$$HP$US$US
240374101$24037410$1$I$20240624$20240624$20240702$20240702$PER$$US-ABBVIE-5817616$ABBVIE$$42$YR$$M$Y$$$20240702$$CN$US$US
240374111$24037411$1$I$20240610$20240625$20240702$20240702$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02368$AMNEAL$$81$YR$$F$Y$$$20240702$$CN$US$US
240374121$24037412$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104968$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240702$$CN$US$US
240374131$24037413$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187437$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240702$$MD$US$US
240374141$24037414$1$I$20240301$20240620$20240702$20240702$PER$$US-SA-2024SA187865$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240702$$HP$US$US
240374152$24037415$2$F$20240101$20240816$20240702$20240829$PER$$US-SA-2024SA191370$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240829$$MD$US$US
240374161$24037416$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA191562$SANOFI AVENTIS$$$$A$$Y$$$20240702$$HP$US$US
240374171$24037417$1$I$20240624$20240625$20240702$20240702$PER$$US-SA-2024SA188630$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240702$$HP$US$US
240374183$24037418$3$F$$20240820$20240702$20240829$PER$$US-SA-2024SA189385$SANOFI AVENTIS$$76$YR$E$F$Y$165$KG$20240829$$MD$US$US
240374191$24037419$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187950$SANOFI AVENTIS$$$$E$F$Y$102$KG$20240702$$MD$US$US
240374203$24037420$3$F$20240501$20240820$20240702$20240827$EXP$$CO-GSK-CO2024AMR080015$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$CO$CO
240374211$24037421$1$I$$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024127893$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240374221$24037422$1$I$20240101$20240627$20240702$20240702$EXP$$US-ABBVIE-5821316$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240374231$24037423$1$I$20240101$20240626$20240702$20240702$EXP$$IL-JNJFOC-20240700784$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240702$$HP$IL$IL
240374242$24037424$2$F$$20240702$20240702$20240710$EXP$$CA-JNJFOC-20240671082$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240710$$HP$CA$CA
240374251$24037425$1$I$20240619$20240620$20240702$20240702$PER$$US-JNJFOC-20240655212$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240702$$PH$US$US
240374264$24037426$4$F$$20240622$20240702$20240709$EXP$$US-ROCHE-10000006853$ROCHE$$$$$$Y$$$20240702$$CN$US$US
240374271$24037427$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821612$ABBVIE$$$$$M$Y$$$20240702$$HP$US$US
240374282$24037428$2$F$20240601$20240730$20240702$20240808$PER$$US-SA-2024SA191251$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240808$$CN$US$US
240374291$24037429$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA190838$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240702$$MD$US$US
240374302$24037430$2$F$20240613$20240710$20240702$20240809$PER$$FR-TOLMAR, INC.-24FR050216$TOLMAR$$69$YR$$M$Y$$$20240809$$PH$FR$FR
240374313$24037431$3$F$20240613$20240830$20240702$20240924$PER$$FR-TOLMAR, INC.-24FR050215$TOLMAR$$79$YR$$M$Y$$$20240923$$HP$FR$FR
240374323$24037432$3$F$20240614$20240710$20240702$20240809$PER$$FR-TOLMAR, INC.-24FR050223$TOLMAR$$75$YR$$M$Y$$$20240809$$PH$FR$FR
240374332$24037433$2$F$20240614$20240710$20240702$20240809$PER$$FR-TOLMAR, INC.-24FR050224$TOLMAR$$76$YR$$M$Y$$$20240809$$PH$FR$FR
240374342$24037434$2$F$20240613$20240711$20240702$20240809$PER$$FR-TOLMAR, INC.-24FR050269$TOLMAR$$$$E$M$Y$$$20240809$$PH$FR$FR
240374351$24037435$1$I$20240612$20240612$20240702$20240702$PER$$TR-TOLMAR, INC.-24TR050139$TOLMAR$$83$YR$$M$Y$$$20240702$$HP$TR$TR
240374361$24037436$1$I$20240429$20240612$20240702$20240702$PER$$NL-TOLMAR, INC.-24NL050163$TOLMAR$$64$YR$$M$Y$$$20240702$$CN$NL$NL
240374371$24037437$1$I$$20240613$20240702$20240702$PER$$PA-TOLMAR, INC.-24PA050205$TOLMAR$$$$$M$Y$$$20240702$$CN$PA$PA
240374381$24037438$1$I$20240609$20240612$20240702$20240702$PER$$TR-TOLMAR, INC.-24TR050146$TOLMAR$$81$YR$$M$Y$$$20240702$$HP$TR$TR
240374391$24037439$1$I$20240613$20240613$20240702$20240702$PER$$TR-TOLMAR, INC.-24TR050210$TOLMAR$$85$YR$$M$Y$$$20240702$$HP$TR$TR
240374401$24037440$1$I$$20240628$20240702$20240702$PER$$US-HALEON-2184634$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240374411$24037441$1$I$20240101$20240625$20240702$20240702$PER$$US-SA-2024SA190259$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240702$$CN$US$US
240374421$24037442$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA191095$SANOFI AVENTIS$$$$$M$Y$$$20240702$$CN$US$US
240374431$24037443$1$I$$20240626$20240702$20240702$PER$$US-SA-2024SA191353$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240702$$MD$US$US
240374441$24037444$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5819619$ABBVIE$$$$$F$Y$$$20240702$$HP$US$US
240374451$24037445$1$I$$20240624$20240702$20240702$PER$$US-ALXN-202406USA001542US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
240374461$24037446$1$I$20240601$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105066$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240702$$HP$US$US
240374471$24037447$1$I$20240301$20240617$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099295$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$98.88$KG$20240702$$CN$US$US
240374481$24037448$1$I$$20240624$20240702$20240702$EXP$$CN-MSNLABS-2024MSNLIT01452$MSN LABORATORIES$Wu J, Zhou Y.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.2024;18:267$$$$$Y$$$20240702$$HP$CN$CN
240374491$24037449$1$I$$20240619$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06694$CIPLA$Nguyen NV, Shantha J, Kim L, Collins LF, Ofotokun I, Fernandes A et al.. Retinopathy associated with Ritonavir treatment for HIV infection: A case series reappraisal in the COVID-19 era. Journal of vitreoretinal diseases. 2024;8(1):111 to 116$$$$$Y$$$20240702$$HP$US$US
240374501$24037450$1$I$20240505$20240621$20240702$20240702$EXP$$US-CIPLA LTD.-2024US04795$CIPLA$$$$$$Y$$$20240702$$CN$US$US
240374511$24037451$1$I$20201103$20240626$20240702$20240702$EXP$PL-URPL-1-3882-2020$PL-HALEON-2184341$Haleon PLC$$18$YR$$M$Y$66$KG$20240701$$MD$PL$PL
240374521$24037452$1$I$$20240626$20240702$20240702$EXP$$CA-ABBVIE-5822474$ABBVIE$$$$$M$Y$$$20240702$$HP$CA$CA
240374531$24037453$1$I$$20240620$20240702$20240702$PER$$US-JNJFOC-20240679641$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$PH$US$US
240374541$24037454$1$I$20240601$20240625$20240702$20240702$EXP$$AR-JNJFOC-20240673623$JOHNSON AND JOHNSON$$56$YR$A$F$Y$160$KG$20240702$$CN$AR$AR
240374551$24037455$1$I$$20230512$20240702$20240702$PER$$US-AMGEN-USASP2023235287$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240374561$24037456$1$I$20240630$20240701$20240702$20240702$EXP$GB-MHRA-MED-202407010701487260-WFGHL$GB-JNJFOC-20240700456$JOHNSON AND JOHNSON$$41$YR$A$$Y$$$20240702$$CN$GB$GB
240374572$24037457$2$F$20240528$20240906$20240702$20240921$PER$$US-JNJFOC-20240679635$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240921$$PH$US$US
240374581$24037458$1$I$20240601$20240624$20240702$20240702$PER$$US-ABBVIE-5817343$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240374591$24037459$1$I$$20240620$20240702$20240702$PER$$US-JNJFOC-20240679640$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240702$$PH$US$US
240374601$24037460$1$I$$20240620$20240702$20240702$PER$$US-ROCHE-10000009085$ROCHE$$$$A$F$Y$$$20240702$$CN$US$US
240374611$24037461$1$I$$20240626$20240702$20240702$EXP$$CA-ABBVIE-5818724$ABBVIE$$67$YR$$F$Y$57$KG$20240702$$CN$CA$CA
240374622$24037462$2$F$20190101$20240828$20240702$20240906$EXP$$BR-CHEPLA-2024006420$CHEPLAPHARM$$$$A$F$Y$95$KG$20240906$$CN$COUNTRY NOT SPECIFIED$BR
240374631$24037463$1$I$20240510$20240627$20240702$20240702$EXP$$US-ABBVIE-5821458$ABBVIE$$73$YR$$M$Y$$$20240702$$CN$US$US
240374641$24037464$1$I$20240614$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024126502$AMGEN$$60$YR$A$M$Y$$$20240701$$CN$US$US
240374661$24037466$1$I$$20240624$20240702$20240702$EXP$$FI-STRIDES ARCOLAB LIMITED-2024SP007741$STRIDES$Rokkanen R, Aarnivala H, Pokka T, Niinimaki R.. Chemotherapy-related toxicities follow a typical pattern in children treated for acute lymphoblastic leukaemia. Acta-Paediatr. 2024;113(5):1103-1111$$$C$M$Y$$$20240702$$HP$FI$FI
240374671$24037467$1$I$$20230821$20240702$20240702$PER$$US-AMGEN-USASP2023235161$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240374681$24037468$1$I$$20240624$20240702$20240702$EXP$$FI-STRIDES ARCOLAB LIMITED-2024SP007742$STRIDES$Rokkanen R, Aarnivala H, Pokka T, Niinimaki R.. Chemotherapy-related toxicities follow a typical pattern in children treated for acute lymphoblastic leukaemia. Acta-Paediatr. 2024;113(5):1103-1111$$$C$$Y$$$20240702$$HP$FI$FI
240374691$24037469$1$I$$20240624$20240702$20240702$EXP$$BR-JNJFOC-20240674852$JOHNSON AND JOHNSON$$74$YR$E$F$Y$82$KG$20240702$$CN$BR$BR
240374701$24037470$1$I$$20221220$20240702$20240702$PER$$US-AMGEN-USASP2022230348$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240374711$24037471$1$I$$20240618$20240702$20240702$PER$$US-ROCHE-10000006787$ROCHE$$$$$$Y$$$20240702$$MD$US$US
240374721$24037472$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000568$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240702$$CN$US$US
240374732$24037473$2$F$20240601$20240808$20240702$20240820$PER$$US-APOTEX-2024AP007320$APOTEX$$$$$F$Y$$$20240820$$CN$US$US
240374741$24037474$1$I$20240101$20240627$20240702$20240702$PER$$US-ABBVIE-5821137$ABBVIE$$$$$$Y$$$20240702$$MD$US$US
240374751$24037475$1$I$$20240624$20240702$20240702$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007743$STRIDES$Woods L, Tomasco O, Ghamande SA.. Influenza Induced MIS-A With Refractory Shock in a Patient With Preexisting Pituitary Hypophysitis.. Am-J-Respir-Crit-Care-Med. 2024;209$39$YR$$F$Y$$$20240702$$HP$US$US
240374761$24037476$1$I$$20240627$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104078$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240702$$HP$US$US
240374771$24037477$1$I$20240601$20240627$20240702$20240702$EXP$$IT-ABBVIE-5820426$ABBVIE$$76$YR$$M$Y$$$20240702$$HP$IT$IT
240374781$24037478$1$I$20240601$20240626$20240702$20240702$EXP$$US-ABBVIE-5820052$ABBVIE$$58$YR$$F$Y$$$20240702$$CN$US$US
240374792$24037479$2$F$20240624$20240711$20240702$20240722$PER$$US-SA-2024SA188726$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240722$$PH$US$US
240374801$24037480$1$I$20240101$20240625$20240702$20240702$PER$$US-SA-2024SA193222$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240702$$MD$US$US
240374811$24037481$1$I$20240612$20240628$20240702$20240702$EXP$$CN-ABBVIE-5819733$ABBVIE$$65$YR$$F$Y$50$KG$20240702$$MD$CN$CN
240374822$24037482$2$F$20090101$20240819$20240702$20240826$EXP$GB-MHRA-MED-202302181721584740-KVQSW$XI-CHEPLA-2023011625$CHEPLAPHARM$$37$YR$$M$Y$$$20240826$$HP$COUNTRY NOT SPECIFIED$GB
240374842$24037484$2$F$$20240723$20240702$20240802$30DAY$$US-GSK-US2024078667$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$CN$US$US
240374851$24037485$1$I$$20240625$20240702$20240702$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00597$CATALYST PHARMA$$$$$F$Y$102.95$KG$20240702$$CN$US$US
240374871$24037487$1$I$20240501$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024127164$AMGEN$$79$YR$E$F$Y$$$20240701$$CN$US$US
240374881$24037488$1$I$$20240628$20240702$20240702$PER$$NVSC2024US136402$NOVARTIS$$$$$F$Y$$$20240702$$HP$US$US
240374892$24037489$2$F$20240101$20240814$20240702$20240826$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00598$CATALYST PHARMA$$$$$M$Y$54.49$KG$20240826$$CN$US$US
240374901$24037490$1$I$$20240624$20240702$20240702$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP007749$STRIDES$Varol F, Can YY, Kilic A, Kotcioglu AC, Durak C, Altas U, et al.. Evaluation of Intoxication Cases Followed up in Pediatric Intensive Care Unit During COVID-19 Pandemic with Social Restrictions.. Guncel-Pediatr. 2022;20 (3):258-265$163$MON$$F$Y$$$20240702$$MD$TR$TR
240374914$24037491$4$F$$20240711$20240702$20240721$EXP$IR-STRIDES ARCOLAB LIMITED-2024SP007748$IR-STRIDES ARCOLAB LIMITED-2024SP007748$STRIDES$Shahbazi F,  Shojaei L.. Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases.. Current drug safety.. 2024$52$YR$$F$Y$75$KG$20240719$$PH$IR$IR
240374921$24037492$1$I$$20240624$20240702$20240702$EXP$$CN-CHEPLA-2024008161$CHEPLAPHARM$Liu J, fang L, Qi S, Song Y and Han L. Occult extracranial malignancy after complete remission of pineal mixed germ cell tumors: a rare case report and literature review. BMC Pediatrics. 2023;23:447. DOI:10.1186/s12887-023-04213-9.$12$YR$$M$Y$$$20240702$$HP$COUNTRY NOT SPECIFIED$CN
240374931$24037493$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA187722$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240702$$MD$US$US
240374941$24037494$1$I$20240615$20240621$20240702$20240702$EXP$CN-NMPA-4313821030234202400099$CN-NOVOPROD-1245286$NOVO NORDISK$$65$YR$$M$Y$72.8$KG$20240702$$HP$CN$CN
240374951$24037495$1$I$$20240621$20240702$20240702$EXP$$US-NOVOPROD-1245479$NOVO NORDISK$$44$YR$$M$Y$$$20240702$$MD$US$US
240374961$24037496$1$I$$20240621$20240702$20240702$EXP$$US-NOVOPROD-1245666$NOVO NORDISK$$$$$F$Y$$$20240702$$CN$US$US
240374971$24037497$1$I$20090101$20240621$20240702$20240702$EXP$$US-NOVOPROD-1244840$NOVO NORDISK$$54$YR$$M$Y$$$20240702$$CN$US$US
240374981$24037498$1$I$$20240621$20240702$20240702$EXP$$US-NOVOPROD-1245618$NOVO NORDISK$$$$$M$Y$$$20240702$$CN$US$US
240374991$24037499$1$I$$20240622$20240702$20240702$EXP$$US-NOVOPROD-1246485$NOVO NORDISK$$$$$F$Y$$$20240702$$CN$US$US
240375001$24037500$1$I$$20240621$20240702$20240702$EXP$$US-NOVOPROD-1244856$NOVO NORDISK$$$$$M$Y$$$20240702$$MD$US$US
240375021$24037502$1$I$$20240626$20240702$20240702$PER$$US-SA-2024SA192485$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$MD$US$US
240375031$24037503$1$I$20240601$20240624$20240702$20240702$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00596$CATALYST PHARMA$$79$YR$$M$Y$77.551$KG$20240702$$CN$US$US
240375041$24037504$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821373$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240375051$24037505$1$I$20240626$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127167$AMGEN$$56$YR$A$F$Y$$$20240701$$CN$US$US
240375061$24037506$1$I$$20240624$20240702$20240702$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP007752$STRIDES$Varol F, Can YY, Kilic A, Kotcioglu AC, Durak C, Altas U, et al.. Evaluation of Intoxication Cases Followed up in Pediatric Intensive Care Unit During COVID-19 Pandemic with Social Restrictions.. Guncel-Pediatr. 2022;20 (3):258-265$214$MON$$M$Y$$$20240702$$MD$TR$TR
240375071$24037507$1$I$$20240619$20240702$20240702$EXP$$US-ENDO USA, INC.-2024-002757$ENDO$$$$$$Y$$$20240702$$MD$US$US
240375081$24037508$1$I$$20240624$20240702$20240702$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024EME078463$VIIV$$$$$$Y$$$20240702$$HP$GB$GB
240375091$24037509$1$I$$20240624$20240702$20240702$EXP$$GB-GSK-GB2024EME078463$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$GB$GB
240375112$24037511$2$F$20240626$20240724$20240702$20240727$EXP$$US-ABBVIE-5821345$ABBVIE$$73$YR$$M$Y$109$KG$20240727$$CN$US$US
240375121$24037512$1$I$20240101$20240623$20240702$20240702$EXP$$US-NOVOPROD-1246381$NOVO NORDISK$$$$$F$Y$$$20240702$$CN$US$US
240375131$24037513$1$I$20240620$20240621$20240702$20240702$EXP$GB-MHRA-MED-202406211157217990-NWTMP$GB-NOVOPROD-1245212$NOVO NORDISK$$57$YR$$F$Y$111$KG$20240702$$MD$GB$GB
240375141$24037514$1$I$$20240621$20240702$20240702$EXP$$US-NOVOPROD-1245219$NOVO NORDISK$$$$$F$Y$$$20240702$$CN$US$US
240375151$24037515$1$I$$20240624$20240702$20240702$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP007710$STRIDES$Ge T, Xie X, Liu J.. A rare case of pheochromocytoma in a pregnant woman presenting with chest pain: extraordinary management.. BMC-Cardiovasc-Disord. 2024;24$$$$$Y$$$20240702$$HP$CN$CN
240375161$24037516$1$I$20240610$20240622$20240702$20240702$EXP$$TR-NOVOPROD-1245280$NOVO NORDISK$$713$MON$$F$Y$74$KG$20240702$$CN$TR$TR
240375171$24037517$1$I$$20240621$20240702$20240702$EXP$$US-NOVOPROD-1245088$NOVO NORDISK$$$$$M$Y$$$20240702$$MD$US$US
240375181$24037518$1$I$$20240621$20240702$20240702$EXP$$US-NOVOPROD-1245190$NOVO NORDISK$$$$$M$Y$$$20240702$$CN$US$US
240375191$24037519$1$I$20240301$20240621$20240702$20240702$EXP$GB-MHRA-MED-202406210935082280-NJCFV$GB-NOVOPROD-1245203$NOVO NORDISK$$46$YR$$M$Y$84$KG$20240702$$MD$GB$GB
240375201$24037520$1$I$20240517$20240623$20240702$20240702$EXP$CN-NMPA-5117241016613202400256$CN-NOVOPROD-1245282$NOVO NORDISK$$76$YR$$F$Y$39$KG$20240702$$HP$CN$CN
240375211$24037521$1$I$20240601$20240621$20240702$20240702$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001992$Alvotech$$20$YR$$F$Y$$$20240702$$CN$CA$CA
240375221$24037522$1$I$$20240630$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105046$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240702$$HP$US$US
240375232$24037523$2$F$$20240729$20240702$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-104647$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$PH$JP$JP
240375241$24037524$1$I$$20240620$20240702$20240702$PER$$US-ROCHE-10000011320$ROCHE$$81$YR$E$M$Y$$$20240702$$HP$US$US
240375252$24037525$2$F$20240617$20240627$20240702$20240706$EXP$$JP-ROCHE-10000008275$ROCHE$$8$DEC$E$M$Y$$$20240706$$MD$JP$JP
240375261$24037526$1$I$$20240627$20240702$20240702$EXP$$CA-ABBVIE-5820928$ABBVIE$$$$$M$Y$$$20240702$$CN$CA$CA
240375271$24037527$1$I$20240101$20240627$20240702$20240702$EXP$$US-ABBVIE-5821302$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240375281$24037528$1$I$$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128442$AMGEN$$$$A$$Y$$$20240701$$CN$US$US
240375291$24037529$1$I$20240417$20240625$20240702$20240702$EXP$$CN-TAKEDA-2024TUS064881$TAKEDA$$47$YR$$M$Y$$$20240702$$HP$CN$CN
240375301$24037530$1$I$$20240624$20240702$20240702$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP007715$STRIDES$Puttaswamy R, Govindanayka P.. Case Report of Methotrexate Induced Pneumonitis.. Am-J-Respir-Crit-Care-Med. 2024;209 abstr:A52$45$YR$$F$Y$$$20240702$$HP$IN$IN
240375311$24037531$1$I$20240620$20240627$20240702$20240702$EXP$$US-ABBVIE-5821555$ABBVIE$$24$YR$$M$Y$$$20240702$$CN$US$US
240375321$24037532$1$I$20240101$20240627$20240702$20240702$EXP$$US-ABBVIE-5821483$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240375332$24037533$2$F$20240704$20240708$20240702$20240713$EXP$$US-ABBVIE-5821565$ABBVIE$$66$YR$$M$Y$104$KG$20240713$$CN$US$US
240375341$24037534$1$I$20240201$20240627$20240702$20240702$EXP$$CA-ABBVIE-5821103$ABBVIE$$78$YR$$F$Y$$$20240702$$CN$CA$CA
240375351$24037535$1$I$20240201$20240623$20240702$20240702$EXP$$IL-CELLTRION INC.-2024IL015569$CELLTRION$$$$$$Y$$$20240702$$CN$IL$IL
240375361$24037536$1$I$20240614$20240621$20240702$20240702$EXP$$CN-TAKEDA-2024TUS064880$TAKEDA$$65$YR$$M$Y$65$KG$20240702$$HP$CN$CN
240375372$24037537$2$F$20240101$20240708$20240702$20240712$EXP$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000792$PAREXEL$$$$$F$Y$67.574$KG$20240712$$CN$US$US
240375381$24037538$1$I$20211101$20240624$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105008$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240702$$CN$US$US
240375391$24037539$1$I$20230701$20240624$20240702$20240702$EXP$$CA-GSK-CA2023102913$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$CA$CA
240375404$24037540$4$F$20240101$20240730$20240702$20240806$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010733$UNITED THERAPEUTICS$$$$$M$Y$75.283$KG$20240806$$$US$US
240375411$24037541$1$I$$20240620$20240702$20240702$EXP$$US-862174955-ML2024-03628$Unknown Manufacturer$Crawford M, Trinh J, Chaudhary S. A Case Report of Statin-induced Necrotizing Autoimmune Myopathy With Extramuscular Involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209.$75$YR$E$F$Y$$$20240702$$MD$US$US
240375421$24037542$1$I$$20240620$20240702$20240702$EXP$$US-862174955-ML2024-03633$Unknown Manufacturer$Renzetti M, Potnis K, Vemmou E, Hansen B, Lin D, Yaggi H. Salty, Sweet, and Severe: A Case of Linagliptin-induced Severe Hyponatremia. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7036. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A7036.$76$YR$E$F$Y$$$20240702$$MD$US$US
240375431$24037543$1$I$$20240620$20240702$20240702$EXP$$US-862174955-ML2024-03636$Unknown Manufacturer$Gupta UD, Chowdhury T, Niriyan J, Bellamkonda A, Aryal B, Al-Ghuraibawi M. Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care. American Journal of Respiratory and Critical Care Medicine. 2024:209.$43$YR$A$F$Y$$$20240702$$MD$US$US
240375441$24037544$1$I$$20240620$20240702$20240702$EXP$$US-862174955-ML2024-03635$Unknown Manufacturer$Vincent J, Greenberg J, Sanghani S, Finneran K, Nguyen N. Profound Lactic Acidosis and Shock in a Patient Taking Metformin. American Journal of Respiratory and Critical Care Medicine. 2024:209$52$YR$A$F$Y$$$20240702$$MD$US$US
240375451$24037545$1$I$20240522$20240626$20240702$20240702$EXP$$US-ABBVIE-5819811$ABBVIE$$60$YR$$F$Y$$$20240702$$CN$US$US
240375461$24037546$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821308$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240375471$24037547$1$I$$20240620$20240702$20240702$EXP$$US-862174955-ML2024-03629$Unknown Manufacturer$Pierce V, Bollavaram V, Ali A. A case of long QT syndrome masquerading as epilepsy. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1699. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1699.$43$YR$A$F$Y$$$20240702$$MD$US$US
240375481$24037548$1$I$$20240620$20240702$20240702$EXP$$US-862174955-ML2024-03632$Unknown Manufacturer$Simone C, Axelband J. Levetiracetam-associated rhabdomyolysis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5704. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5704.$20$YR$A$M$Y$$$20240702$$MD$US$US
240375492$24037549$2$F$20240101$20240624$20240702$20240703$PER$$US-SA-2024SA190753$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240703$$MD$US$US
240375502$24037550$2$F$20240601$20240709$20240702$20240718$PER$$US-SA-2024SA193454$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240718$$MD$US$US
240375511$24037551$1$I$20240601$20240625$20240702$20240702$PER$$US-SA-2024SA191451$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240702$$MD$US$US
240375521$24037552$1$I$20240101$20240625$20240702$20240702$PER$$US-SA-2024SA192800$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240702$$MD$US$US
240375531$24037553$1$I$$20240624$20240702$20240702$EXP$$JP-TAKEDA-2024TUS065720$TAKEDA$$73$YR$$M$Y$$$20240702$$MD$JP$JP
240375541$24037554$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821389$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240375571$24037557$1$I$20240101$20240628$20240702$20240702$EXP$$FR-AstraZeneca-2024A149434$ASTRAZENECA$$57$YR$$F$Y$$$20240702$$MD$FR$
240375581$24037558$1$I$$20240617$20240702$20240702$EXP$$US-HALEON-2182670$Haleon PLC$$47$YR$$F$Y$$$20240624$$HP$US$US
240375591$24037559$1$I$$20240622$20240702$20240702$EXP$$US-GSK-US2024AMR078926$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
240375601$24037560$1$I$20240626$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127581$AMGEN$$66$YR$E$F$Y$$$20240701$$CN$US$US
240375611$24037561$1$I$$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128264$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240375621$24037562$1$I$$20230201$20240702$20240702$PER$$US-AMGEN-USASP2023235245$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240375631$24037563$1$I$20240625$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127996$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240375641$24037564$1$I$20230101$20240627$20240702$20240702$EXP$$US-CHATTEMPRD-2024OHG022492$CHATTEM$$76$YR$E$M$Y$$$20240702$$LW$US$US
240375651$24037565$1$I$$20240627$20240702$20240702$PER$$NVSC2024US135583$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240375661$24037566$1$I$$20240627$20240702$20240702$PER$$US-MTPC-MTDA2024-0013593$Unknown Manufacturer$$$$A$$Y$$$20240702$$MD$US$US
240375671$24037567$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000174$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240702$$CN$US$US
240375681$24037568$1$I$$20240626$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000644$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240702$$CN$US$US
240375691$24037569$1$I$20240617$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000084$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240702$$CN$US$US
240375702$24037570$2$F$$20240628$20240702$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000126$ELI LILLY AND CO$$$$A$F$Y$$$20240703$$CN$US$US
240375711$24037571$1$I$20240628$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000079$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240702$$CN$US$US
240375721$24037572$1$I$20240601$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000361$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240702$$CN$US$US
240375731$24037573$1$I$$20240625$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406018600$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240702$$CN$US$US
240375742$24037574$2$F$20230405$20240715$20240702$20240724$EXP$$CA-VANTIVE-2024VAN017843$Vantive US Healthcare$$73$YR$$M$Y$$$20240724$$CN$CA$CA
240375751$24037575$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5822394$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240375771$24037577$1$I$$20240628$20240702$20240702$EXP$$AR-ABBVIE-5821351$ABBVIE$$$$$M$Y$$$20240702$$CN$AR$AR
240375781$24037578$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821907$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240375801$24037580$1$I$$20240624$20240702$20240702$EXP$$US-NOVOPROD-1245235$NOVO NORDISK$$$$$M$Y$$$20240702$$CN$US$US
240375811$24037581$1$I$20231031$20240624$20240702$20240702$EXP$$PK-NOVOPROD-1244665$NOVO NORDISK$$8$YR$$M$Y$60$KG$20240702$$MD$PK$PK
240375821$24037582$1$I$$20240624$20240702$20240702$EXP$$ES-NOVOPROD-1244815$NOVO NORDISK$$$$$M$Y$$$20240702$$MD$ES$ES
240375831$24037583$1$I$$20240624$20240702$20240702$EXP$$GB-NOVOPROD-1244808$NOVO NORDISK$$$$$M$Y$$$20240702$$HP$GB$GB
240375841$24037584$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821538$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240375851$24037585$1$I$20240621$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127352$AMGEN$$54$YR$A$F$Y$$$20240701$$MD$US$US
240375861$24037586$1$I$$20231020$20240702$20240702$PER$$US-AMGEN-USASP2023235156$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240375871$24037587$1$I$$20230221$20240702$20240702$PER$$US-AMGEN-USASP2023235025$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240375881$24037588$1$I$$20240413$20240702$20240702$PER$$US-AMGEN-USASP2024129889$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240375891$24037589$1$I$$20240624$20240702$20240702$EXP$$NVSC2024US134041$NOVARTIS$$47$YR$$F$Y$$$20240702$$CN$US$US
240375902$24037590$2$F$$20240723$20240702$20240801$30DAY$$US-GSK-US2024AMR080216$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
240375911$24037591$1$I$$20240620$20240702$20240702$EXP$$CA-APOTEX-2024AP007600$APOTEX$$$$$F$Y$$$20240702$$HP$CA$CA
240375921$24037592$1$I$20230101$20240627$20240702$20240702$EXP$$PR-ABBVIE-5820967$ABBVIE$$$$$F$Y$73$KG$20240702$$CN$PR$PR
240375931$24037593$1$I$$20240625$20240702$20240702$EXP$$GB-JNJFOC-20240675534$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$HP$GB$GB
240375941$24037594$1$I$20240612$20240625$20240702$20240702$EXP$$CA-JNJFOC-20240668450$JOHNSON AND JOHNSON$$56$YR$A$M$Y$83$KG$20240702$$HP$CA$CA
240375952$24037595$2$F$20240601$20240829$20240702$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105203$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240906$$CN$US$US
240375961$24037596$1$I$$20240618$20240702$20240702$EXP$$US-GRAVITIPHARMA-GRA-2406-US-LIT-0184$GRAVITI PHARMACEUTICALS$Pepper E, Pittman L.Treatment of idiopathic anaphylaxis with dupilumab: a case report.Allergy, Asthma and Clinical Immunology.2023;19:82:1 to 4$28$YR$A$F$Y$$$20240702$$HP$US$US
240375971$24037597$1$I$20240520$20240626$20240702$20240702$EXP$GB-MHRA-MED-202406260704069060-QSVBG$GB-UCBSA-2024032643$UCB$$31$YR$$M$Y$85$KG$20240702$$MD$GB$GB
240375982$24037598$2$F$20240301$20240710$20240702$20240711$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-014096$BOEHRINGER INGELHEIM$$57$YR$A$$Y$$$20240711$$CN$FR$FR
240375991$24037599$1$I$$20240627$20240702$20240702$PER$$NVSC2024US136338$NOVARTIS$$$$$F$Y$$$20240702$$HP$US$US
240376001$24037600$1$I$$20231023$20240702$20240702$PER$$US-AMGEN-USASP2023235164$AMGEN$$$$$$Y$$$20240701$$MD$US$US
240376011$24037601$1$I$20240601$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128545$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240376021$24037602$1$I$$20240620$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05822$HIKMA$Ries R, Cho YD, Deitchman AR.. Ries R, Cho YD, Deitchman AR. Elevated Inflammation Sepsis Phenotype as a Potential Risk Factor for Propofol Related Infusion Syndrome: A Case Report.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A1608$$$$$Y$$$20240702$$MD$US$US
240376041$24037604$1$I$20240603$20240624$20240702$20240702$EXP$$CN-BEIGENE-BGN-2024-009668$BEIGENE$$$$$$Y$$$20240702$$HP$CN$CN
240376052$24037605$2$F$$20240723$20240702$20240729$EXP$$HU-HALEON-2184370$Haleon PLC$$$$$M$Y$$$20240729$$CN$HU$HU
240376061$24037606$1$I$$20231003$20240702$20240702$PER$$US-AMGEN-USASP2023235214$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240376072$24037607$2$F$$20240715$20240702$20240722$EXP$$CA-HALEON-2183230$Haleon PLC$$44$YR$$F$Y$$$20240719$$HP$CA$CA
240376081$24037608$1$I$$20240627$20240702$20240702$EXP$$RU-ROCHE-10000012397$ROCHE$$$$A$M$Y$$$20240702$$MD$RU$RU
240376092$24037609$2$F$20240410$20240704$20240702$20240708$EXP$$NVSC2024CA124474$NOVARTIS$$65$YR$$F$Y$$$20240708$$MD$CA$CA
240376101$24037610$1$I$$20240627$20240702$20240702$PER$$NVSC2024US135656$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240376111$24037611$1$I$$20240626$20240702$20240702$PER$$US-TAKEDA-2024TUS064965$TAKEDA$$$$$$Y$$$20240702$$PH$US$US
240376121$24037612$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA191186$SANOFI AVENTIS$$$$E$M$Y$93.44$KG$20240702$$MD$US$US
240376131$24037613$1$I$20240317$20240322$20240702$20240702$EXP$$CN-HALEON-CNCH2024APC015874$Haleon PLC$$55$YR$$M$Y$81$KG$20240701$$HP$CN$CN
240376141$24037614$1$I$$20240229$20240702$20240702$PER$$US-AMGEN-USASP2024129859$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240376151$24037615$1$I$20200805$20240625$20240702$20240702$EXP$$ES-CELLTRION INC.-2024ES015658$CELLTRION$Tabernero, J.. A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial.. Cancer Research Communications.. 2024;4(1):28-37$$$$$Y$$$20240702$$HP$ES$ES
240376163$24037616$3$F$20240626$20240809$20240702$20240812$PER$$US-AMGEN-USASP2024129522$AMGEN$$63$YR$A$M$Y$$$20240812$$CN$US$US
240376172$24037617$2$F$20240611$20240709$20240702$20240723$EXP$$CN-AMGEN-CHNSP2024128043$AMGEN$$3$YR$C$M$Y$11.6$KG$20240722$$MD$CN$CN
240376181$24037618$1$I$$20240624$20240702$20240702$PER$$US-ALXN-202406USA001512US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
240376191$24037619$1$I$$20240625$20240702$20240702$EXP$$US-GSK-US2024AMR080619$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$MD$US$US
240376201$24037620$1$I$$20240624$20240702$20240702$EXP$$US-ROCHE-10000008077$ROCHE$$57$YR$A$F$Y$$$20240702$$CN$US$US
240376212$24037621$2$F$20240617$20240708$20240702$20240715$EXP$$US-JNJFOC-20240587231$JOHNSON AND JOHNSON$$71$YR$E$F$Y$60.5$KG$20240715$$HP$US$US
240376222$24037622$2$F$$20240624$20240702$20240702$EXP$$RO-AstraZeneca-2024A148062$ASTRAZENECA$$34$YR$$M$Y$$$20240702$$CN$RO$
240376231$24037623$1$I$20240101$20240626$20240702$20240702$EXP$$FR-ABBVIE-5820828$ABBVIE$$69$YR$$M$Y$$$20240702$$CN$FR$FR
240376241$24037624$1$I$$20240620$20240702$20240702$PER$$US-RDY-LIT/USA/24/0009312$DR REDDYS$Zaidi W, Saeed AI, Lundquist N, Nelson AR, Razia D, Lee R, et al. Bronchoscopic Debridement of Endobronchial Rhizopus With 1.1 Mm Cryoprobe in Lung Transplant Recipient. American Journal of Respiratory and Critical Care Medicine. 2024 May;209(0): doi:10.1164/ajrccm-conference.2024.209.1.$67$YR$E$M$Y$$$20240702$$HP$US$US
240376251$24037625$1$I$$20240620$20240702$20240702$EXP$$US-RDY-LIT/USA/24/0009316$DR REDDYS$Gilani S, Rifai Z, Singanallur P, Song M. Prolonged COVID-19 Pneumonia in a Patient on Obinutuzumab for Treatment of Follicular Lymphoma. American Journal of Respiratory and Critical Care Medicine. 2024;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5676.$62$YR$A$M$Y$$$20240702$$HP$US$US
240376261$24037626$1$I$$20240621$20240702$20240702$EXP$$US-RDY-LIT/USA/24/0009379$DR REDDYS$Chang J, Kudose S, Droubi S, Verduzco HA, Awori J, Ratner LE, et al. Four Cases of Kidney Transplants With Donor HCV-Derived Immune Complex Glomerulonephritis. Kidney International Reports. 2024;9(6): 1903-1907. doi:10.1016/j.ekir.2024.04.010.$50$YR$A$M$Y$75$KG$20240702$$HP$US$US
240376272$24037627$2$F$$20240626$20240702$20240703$EXP$$US-ROCHE-10000011622$ROCHE$$60$YR$A$M$Y$$$20240703$$CN$US$US
240376281$24037628$1$I$$20240621$20240702$20240702$EXP$$US-RDY-LIT/USA/24/0009377$DR REDDYS$Yasmin M, Rojas LJ, Marshall SH, Hujer AM, Cmolik A, Marshall E, et al. Characterization of a Novel Pathogen in Immunocompromised Patients: Elizabethkingia anophelis-Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and beta-lactamase Inhibitors. Open Forum Infectious Diseases. 2023;10(2): doi:10.1093/ofid/ofad014.$60$YR$A$F$Y$$$20240702$$MD$US$US
240376291$24037629$1$I$20240601$20240627$20240702$20240702$EXP$$US-ABBVIE-5821417$ABBVIE$$15$YR$$M$Y$$$20240702$$CN$US$US
240376303$24037630$3$F$20240101$20240828$20240702$20240927$PER$$US-SA-2024SA187533$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240927$$MD$US$US
240376311$24037631$1$I$20240501$20240620$20240702$20240702$PER$$US-SA-2024SA189408$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240702$$MD$US$US
240376321$24037632$1$I$$20240620$20240702$20240702$EXP$$US-RDY-LIT/USA/24/0009314$DR REDDYS$Riha EN, Kim A, Tang J, Kesavan R, Girgawy E, Sarva S. Catching Flights and Malaria. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5545.$69$YR$E$F$Y$$$20240702$$HP$US$US
240376331$24037633$1$I$20240601$20240626$20240702$20240702$EXP$FR-AFSSAPS-TS2024000708$FR-SA-2024SA190244$SANOFI AVENTIS$$40$YR$A$M$Y$62$KG$20240702$$MD$FR$FR
240376341$24037634$1$I$$20240626$20240702$20240702$EXP$$GB-ROCHE-10000012412$ROCHE$$$$$$Y$$$20240702$$MD$GB$GB
240376351$24037635$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000462$ELI LILLY AND CO$$$$$M$Y$$$20240702$$CN$US$US
240376363$24037636$3$F$$20240722$20240702$20240904$EXP$$PA-ROCHE-10000002053$ROCHE$$$$$$Y$$$20240904$$MD$PA$PA
240376371$24037637$1$I$20240101$20240626$20240702$20240702$PER$$US-ABBVIE-5820411$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240376382$24037638$2$F$$20240701$20240702$20240705$EXP$$US-HALEON-2184480$Haleon PLC$$$$$F$Y$$$20240704$$CN$US$US
240376391$24037639$1$I$$20231117$20240702$20240702$PER$$US-AMGEN-USASP2023235129$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240376401$24037640$1$I$$20240508$20240702$20240702$PER$$US-AMGEN-USASP2024129990$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240376411$24037641$1$I$$20240627$20240702$20240702$EXP$$GB-AMGEN-GBRSP2024129517$AMGEN$$74$YR$E$M$Y$$$20240701$$CN$GB$GB
240376421$24037642$1$I$20240621$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024127692$AMGEN$$56$YR$A$M$Y$$$20240701$$CN$US$US
240376431$24037643$1$I$20240101$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128206$AMGEN$$40$YR$A$F$Y$$$20240701$$PH$US$US
240376441$24037644$1$I$20240101$20240620$20240702$20240702$PER$$US-SA-2024SA188385$SANOFI AVENTIS$$$$A$F$Y$96.1$KG$20240702$$MD$US$US
240376451$24037645$1$I$20240611$20240625$20240702$20240702$EXP$IT-MINISAL02-991376$IT-SA-2024SA190217$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240702$$MD$IT$IT
240376461$24037646$1$I$20240501$20240621$20240702$20240702$PER$$US-SA-2024SA187160$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240702$$MD$US$US
240376471$24037647$1$I$20240501$20240620$20240702$20240702$PER$$US-SA-2024SA187938$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$MD$US$US
240376482$24037648$2$F$20240621$20240711$20240702$20240717$EXP$$JP-ABBVIE-5822470$ABBVIE$$80$YR$$M$Y$$$20240717$$MD$JP$JP
240376492$24037649$2$F$$20240722$20240702$20240731$EXP$$CA-APOTEX-2024AP007619$APOTEX$$52$YR$$F$Y$$$20240731$$HP$CA$CA
240376511$24037651$1$I$$20231018$20240702$20240702$PER$$US-AMGEN-USASP2023235232$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240376521$24037652$1$I$$20230829$20240702$20240702$PER$$US-AMGEN-USASP2023235337$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240376531$24037653$1$I$20240626$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127357$AMGEN$$46$YR$A$F$Y$$$20240701$$CN$US$US
240376541$24037654$1$I$20240625$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024127713$AMGEN$$67$YR$E$F$Y$$$20240701$$HP$US$US
240376553$24037655$3$F$$20240828$20240702$20240905$PER$$US-ALXN-202406USA001500US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
240376561$24037656$1$I$20240605$20240624$20240702$20240702$EXP$$CA-CELLTRION INC.-2024CA015783$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
240376571$24037657$1$I$$20240626$20240702$20240702$EXP$$US-ABBVIE-5819808$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240376581$24037658$1$I$20240503$20240628$20240702$20240702$EXP$$GB-ABBVIE-5821173$ABBVIE$$$$E$F$Y$$$20240702$$CN$GB$GB
240376591$24037659$1$I$$20240620$20240702$20240702$PER$$US-ROCHE-10000009875$ROCHE$$$$$F$Y$$$20240702$$PH$US$US
240376602$24037660$2$F$$20240622$20240702$20240702$EXP$$US-ROCHE-10000009847$ROCHE$$$$$$Y$$$20240702$$HP$US$US
240376611$24037661$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5819027$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240376621$24037662$1$I$$20240622$20240702$20240702$PER$$US-ROCHE-10000009966$ROCHE$$$$$$Y$$$20240702$$CN$US$US
240376632$24037663$2$F$$20240701$20240702$20240702$PER$$US-JNJFOC-20240700755$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240376642$24037664$2$F$$20240626$20240702$20240712$EXP$$JP-009507513-2406JPN004173J$MERCK$Kuroda J, Ono T, Ogiri M, Hatta K, Aiura K, Shimizu S. P31-9 A Case with Multiple Bilateral Lung Metastases and Lumbar Spine Metastases After Chemoradiotherapy for Oesophageal Carcinoma Stage 4. The 78th Annual Meeting of The Japan Esophageal Society. 322$6$DEC$$M$Y$$$20240712$$MD$JP$JP
240376651$24037665$1$I$20220628$20230918$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409768$RANBAXY$$3$YR$C$F$Y$$$20240702$$MD$US$US
240376672$24037667$2$F$$20240704$20240702$20240713$EXP$$AU-TEVA-VS-3215050$TEVA$Draper L, Vikas A, Das S, Yadav S, Walker F, Bandilovska I. Electroconvulsive Therapy in Transgender and Gender Diverse Population: A Case Report and Review of Literature. Case-Rep-Psychiatry 2024; 2024 (0):.; Draper L, Vikas A, Das S, Yadav S, Walker F, Bandilovska I. Electroconvulsive Therapy in Transgender and Gender Diverse Population: A Case Report and Review of Literature. Case-Rep-Psychiatry 2024; 2024 (0):.$25$YR$$F$Y$$$20240713$$HP$AU$AU
240376681$24037668$1$I$$20230921$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410099$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240376691$24037669$1$I$20230501$20230921$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409950$RANBAXY$$15$YR$T$$Y$$$20240702$$CN$US$US
240376701$24037670$1$I$20230919$20230919$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409621$RANBAXY$$25$YR$A$F$Y$$$20240702$$HP$US$US
240376711$24037671$1$I$20230701$20230915$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410026$RANBAXY$$32$YR$A$F$Y$$$20240702$$CN$US$US
240376721$24037672$1$I$20240601$20240624$20240702$20240702$PER$$US-SA-2024SA191690$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240702$$MD$US$US
240376735$24037673$5$F$20240611$20240904$20240702$20240925$EXP$$US-SA-2024SA191326$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240925$$MD$US$US
240376741$24037674$1$I$20240101$20240625$20240702$20240702$PER$$US-SA-2024SA193121$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240702$$MD$US$US
240376751$24037675$1$I$20221018$20240625$20240702$20240702$EXP$$FR-CELLTRION INC.-2024FR015641$CELLTRION$$$$$$Y$$$20240702$$PH$FR$FR
240376761$24037676$1$I$$20240624$20240702$20240702$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP007682$STRIDES$Mizutani N, Kenzaka T.. Antimicrobial-associated encephalopathy due to ampicillin.. Clin-Case-Rep. 2024;12 (4)$84$YR$$M$Y$$$20240702$$HP$JP$JP
240376771$24037677$1$I$$20240624$20240702$20240702$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP007687$STRIDES$Zarkovic Gjurin S, Pang J, Vrckovnik M, Hanna R.. Efficacy of 1064 nm Photobiomodulation Dosimetry Delivered with a Collimated Flat-Top Handpiece in the Management of Peripheral Facial Paralysis in Patients Unresponsive to Standard Treatment Care: A Case Series.. J-Clin-Med. 2023;12 (19):1-19$52$YR$$M$Y$$$20240702$$HP$IT$IT
240376781$24037678$1$I$$20240624$20240702$20240702$PER$$US-JNJFOC-20240664124$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240376792$24037679$2$F$20220801$20240828$20240702$20240906$EXP$$JP-JNJFOC-20240673791$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240907$$MD$JP$JP
240376801$24037680$1$I$$20240624$20240702$20240702$EXP$$FI-STRIDES ARCOLAB LIMITED-2024SP007689$STRIDES$Rokkanen R, Aarnivala H, Pokka T, Niinimaki R.. Chemotherapy-related toxicities follow a typical pattern in children treated for acute lymphoblastic leukaemia. Acta-Paediatr. 2024;113(5):1103-1111$$$C$$Y$$$20240702$$HP$FI$FI
240376811$24037681$1$I$$20230502$20240702$20240702$PER$$US-AMGEN-USASP2023235265$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240376821$24037682$1$I$$20230922$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410429$RANBAXY$$$$A$F$Y$$$20240702$$CN$US$US
240376831$24037683$1$I$$20240624$20240702$20240702$EXP$$FI-STRIDES ARCOLAB LIMITED-2024SP007690$STRIDES$Rokkanen R, Aarnivala H, Pokka T, Niinimaki R.. Chemotherapy-related toxicities follow a typical pattern in children treated for acute lymphoblastic leukaemia. Acta-Paediatr. 2024;113(5):1103-1111$$$C$$Y$$$20240702$$HP$FI$FI
240376841$24037684$1$I$$20240624$20240702$20240702$EXP$$FI-STRIDES ARCOLAB LIMITED-2024SP007691$STRIDES$Rokkanen R, Aarnivala H, Pokka T, Niinimaki R.. Chemotherapy-related toxicities follow a typical pattern in children treated for acute lymphoblastic leukaemia. Acta-Paediatr. 2024;113(5):1103-1111$$$C$$Y$$$20240702$$HP$FI$FI
240376851$24037685$1$I$20230731$20240624$20240702$20240702$EXP$$JP-009507513-2406JPN001587J$MERCK$$63$YR$$M$Y$$$20240702$$MD$JP$JP
240376861$24037686$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821765$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240376871$24037687$1$I$$20240627$20240702$20240702$EXP$$DE-UCBSA-2024033030$UCB$$$$$F$Y$$$20240702$$MD$DE$DE
240376881$24037688$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA189649$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240702$$CN$US$US
240376892$24037689$2$F$$20240620$20240702$20240704$PER$$US-ROCHE-10000013387$ROCHE$$$$A$M$Y$$$20240704$$HP$US$US
240376902$24037690$2$F$20240101$20240731$20240702$20240809$PER$$US-SA-2024SA187625$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240809$$MD$US$US
240376911$24037691$1$I$$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024126587$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240376921$24037692$1$I$$20240219$20240702$20240702$PER$$US-AMGEN-USASP2024129982$AMGEN$$$$$$Y$$$20240701$$PH$US$US
240376931$24037693$1$I$20240401$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000266$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$US$US
240376941$24037694$1$I$20240626$20240626$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019529$ELI LILLY AND CO$$$$A$M$Y$$$20240702$$CN$US$US
240376951$24037695$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019455$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240702$$CN$US$US
240376961$24037696$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000032$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$US$US
240376971$24037697$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000451$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240702$$CN$US$US
240376981$24037698$1$I$20240625$20240625$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000061$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240702$$CN$US$US
240376991$24037699$1$I$20230801$20240622$20240702$20240702$EXP$$CN-BEIGENE-BGN-2024-009618$BEIGENE$Tingsu, Xingbao Luan, Yan lu, Yang Xu. Drug eruption and cutaneous metastasis in a patient with ALK-negative anaplastic large T-cell lymphoma after tislelizumab. Australasian College of Dermatologists. 2024;00:1-3$$$$$Y$$$20240702$$MD$CN$CN
240377001$24037700$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105091$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240702$$CN$US$US
240377011$24037701$1$I$$20240625$20240702$20240702$EXP$$GB-JNJFOC-20240675821$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240702$$CN$GB$GB
240377021$24037702$1$I$20200730$20200825$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-259906$RANBAXY$$18$YR$A$M$Y$$$20240702$$MD$US$US
240377031$24037703$1$I$$20200902$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-260680$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377041$24037704$1$I$20200101$20200831$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-260199$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240377051$24037705$1$I$20200911$20201015$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-264771$RANBAXY$$17$YR$T$M$Y$$$20240702$$MD$US$US
240377061$24037706$1$I$$20201006$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-264176$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377071$24037707$1$I$20200901$20201029$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-263130$RANBAXY$$13$YR$T$F$Y$$$20240702$$HP$US$US
240377081$24037708$1$I$20200101$20201130$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-270534$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
240377091$24037709$1$I$$20200828$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-260175$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377101$24037710$1$I$20200101$20200925$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-263131$RANBAXY$$$$A$M$Y$$$20240702$$HP$US$US
240377111$24037711$1$I$$20191030$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-227118$RANBAXY$Malone C. Isotretinoin induced granulomatosis with polyangitis. J Hosp Med. 2018;13(Suppl. 1)(4):no pagination (405)$14$YR$$M$Y$$$20240702$$MD$US$US
240377121$24037712$1$I$20200101$20201112$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-268803$RANBAXY$$$$C$F$Y$$$20240702$$HP$US$US
240377131$24037713$1$I$20201216$20201223$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-273977$RANBAXY$$19$YR$A$M$Y$$$20240702$$HP$US$US
240377141$24037714$1$I$20200101$20201204$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-263793$RANBAXY$$$$A$M$Y$$$20240702$$CN$US$US
240377151$24037715$1$I$$20240620$20240702$20240702$EXP$$US-APOTEX-2024AP007703$APOTEX$Gilani S, Rifai Z, Singanallur P, Song M.. Prolonged COVID-19 Pneumonia in a Patient on Obinutuzumab for Treatment of Follicular Lymphoma. American Journal of Respiratory and Critical Care Medicine. 2024;209 (0):1-3$62$YR$$M$Y$$$20240702$$HP$US$US
240377161$24037716$1$I$$20150223$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2015US-94198$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377171$24037717$1$I$$20201117$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-269161$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377181$24037718$1$I$$20201029$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-266693$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377191$24037719$1$I$20200901$20210430$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-264947$RANBAXY$$16$YR$T$M$Y$$$20240702$$MD$US$US
240377201$24037720$1$I$20200101$20201117$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-269153$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240377211$24037721$1$I$$20201020$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-265225$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240377221$24037722$1$I$$20201217$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-273595$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377231$24037723$1$I$$20210118$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-278541$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377241$24037724$1$I$20200101$20201221$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-273881$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377251$24037725$1$I$20201022$20210125$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-273213$RANBAXY$$34$YR$A$F$Y$$$20240702$$HP$US$US
240377261$24037726$1$I$$20201224$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-274007$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377271$24037727$1$I$$20210118$20240702$20240702$PER$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-278788$RANBAXY$Horwitz J, Huang A, McAuley D, Jansen GH, Johnston D. Embryonal Tumor With Multilayered Rosettes of the Parietooccipital Region: A Case Report. J Pediatr Hematol Oncol. 2021;1-5$2$YR$$F$Y$$$20240702$$HP$CA$US
240377281$24037728$1$I$20201201$20201221$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-273882$RANBAXY$$14$YR$T$M$Y$$$20240702$$HP$US$US
240377291$24037729$1$I$20200101$20201230$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-274776$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240377301$24037730$1$I$$20210115$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-278071$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377311$24037731$1$I$20200101$20201207$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-271731$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377321$24037732$1$I$20201009$20201026$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-263127$RANBAXY$$18$YR$A$M$Y$$$20240702$$HP$US$US
240377332$24037733$2$F$20240101$20240802$20240702$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-019791$UNITED THERAPEUTICS$$$$$F$Y$106.58$KG$20240807$$$US$US
240377341$24037734$1$I$$20141021$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2014US-87200$RANBAXY$$$$$M$Y$$$20240702$$MD$US$US
240377351$24037735$1$I$$20200911$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-261427$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377361$24037736$1$I$20200101$20201110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-268355$RANBAXY$$$$T$M$Y$$$20240702$$HP$US$US
240377371$24037737$1$I$$20210108$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-276922$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377381$24037738$1$I$20200101$20201219$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-273009$RANBAXY$$$$T$M$Y$$$20240702$$HP$US$US
240377391$24037739$1$I$20200101$20210212$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-267034$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
240377401$24037740$1$I$20210101$20210225$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-285192$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240377411$24037741$1$I$20210101$20210216$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-283803$RANBAXY$$$$T$M$Y$$$20240702$$HP$US$US
240377421$24037742$1$I$$20210202$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-280148$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377431$24037743$1$I$$20210209$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-280857$RANBAXY$Tkachenko E,Singer S,Sharma P,Barbieri J,Mostaghimi A. US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated With Isotretinoin. JAMA Dermatol.. 2019;Oct;155(10):1-9$$$$F$Y$$$20240702$$HP$US$US
240377441$24037744$1$I$$20210212$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-283159$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377451$24037745$1$I$$20210209$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-280876$RANBAXY$Tkachenko E,Singer S,Sharma P,Barbieri J,Mostaghimi A. US Food and Drug Administration Reports of Pregnancy andPregnancy-Related Adverse Events Associated With Isotretinoin. JAMA Dermatol.. 2019;Oct;155(10):1-9$$$$F$Y$$$20240702$$HP$US$US
240377461$24037746$1$I$$20210208$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-279349$RANBAXY$Esaa F, Shah PR, Dolohanty LB. Metastatic squamous cell carcinoma arising in the setting of folliculitis decalvans. Dermatol Online J. 2019;April;25(4): 15:1-2$45$YR$$M$Y$$$20240702$$HP$US$US
240377471$24037747$1$I$20210101$20210225$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-285194$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
240377481$24037748$1$I$20210101$20210202$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-280150$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240377491$24037749$1$I$$20210312$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-286948$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377501$24037750$1$I$20210101$20210730$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-285405$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240377511$24037751$1$I$$20210212$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-283160$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377521$24037752$1$I$$20210415$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-293733$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377531$24037753$1$I$$20210322$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-287875$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377541$24037754$1$I$$20210513$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-298291$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377551$24037755$1$I$$20210716$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-298189$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377561$24037756$1$I$$20210318$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-285643$RANBAXY$Della Porta AL, Saikaly SK,  Nyinawinyange D, D Benedetto A. Isotretinoin-induced inflammation of the urethral meatus. Dermatol Ther. 2021;18 Feb:e14898$27$YR$$M$Y$$$20240702$$HP$US$US
240377571$24037757$1$I$20210101$20210308$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-286181$RANBAXY$$$$A$M$Y$$$20240702$$HP$US$US
240377581$24037758$1$I$$20210324$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-288582$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377591$24037759$1$I$20210101$20210303$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-286144$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377601$24037760$1$I$$20210504$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-296904$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377611$24037761$1$I$20210101$20210621$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-301803$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240377621$24037762$1$I$20210101$20210706$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-294014$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
240377631$24037763$1$I$$20210730$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-285743$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377641$24037764$1$I$$20210401$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-243216$RANBAXY$Herold M, Nielson C, Longo MI. Isotretinoin and candida immunotherapy for recalcitrant warts in solid organ transplant recipients. Dermatologic Therapy. 2019;32:1-3$40$YR$$M$Y$$$20240702$$HP$US$US
240377651$24037765$1$I$20210101$20210525$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-299099$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240377661$24037766$1$I$20210101$20210608$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-300481$RANBAXY$$$$T$M$Y$$$20240702$$HP$US$US
240377671$24037767$1$I$20210101$20210303$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-286141$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240377681$24037768$1$I$$20210427$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-119435$RANBAXY$Tintle SJ, Harper JC, Webster GF, Kim GK, Thiboutot DM. Safe use of therapeutic-dose oral isotretinoin in patientswith a history of pseudotumor cerebri. JAMA Dermatol. 2016;152(5):582-584$$$T$F$Y$$$20240702$$MD$US$US
240377691$24037769$1$I$$20210621$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-301971$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377701$24037770$1$I$$20210329$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-289779$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377711$24037771$1$I$20210101$20230906$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-298965$RANBAXY$$$$A$M$Y$$$20240702$$HP$US$US
240377721$24037772$1$I$20210101$20210607$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-300585$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377731$24037773$1$I$$20210322$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-287877$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377741$24037774$1$I$20210101$20210524$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-299081$RANBAXY$$$$T$F$Y$$$20240702$$CN$US$US
240377751$24037775$1$I$$20210518$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-298492$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377761$24037776$1$I$$20210730$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-296898$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377771$24037777$1$I$$20210125$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-285197$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377781$24037778$1$I$20210101$20210730$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-285415$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
240377791$24037779$1$I$20210101$20210604$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-300087$RANBAXY$$$$T$M$Y$$$20240702$$HP$US$US
240377801$24037780$1$I$$20210401$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-291161$RANBAXY$London NJS, Kaiser RS, Khan MA, Alshareef RA, Khuthaila M, Shahlaee A  et al. Determining the effect of low-dose isotretinoin on proliferative vitreoretinopathy: the DELIVER trial. Br J Ophthalmol. 2019;103:1306-1313$$$$$Y$$$20240702$$HP$US$US
240377811$24037781$1$I$$20210526$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-299124$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240377821$24037782$1$I$20210101$20210802$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-299089$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
240377831$24037783$1$I$$20210517$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-298339$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240377841$24037784$1$I$20210101$20210311$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-286246$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240377851$24037785$1$I$20210101$20210621$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-301851$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240377861$24037786$1$I$$20210209$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-280879$RANBAXY$Tkachenko E,Singer S,Sharma P,Barbieri J,Mostaghimi A. US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated With Isotretinoin. JAMA Dermatol.. 2019;Oct; 155(10):1-9$$$$F$Y$$$20240702$$HP$US$US
240377871$24037787$1$I$20210101$20210324$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-288588$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240377881$24037788$1$I$$20210415$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-293723$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240377891$24037789$1$I$$20210429$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-295871$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377901$24037790$1$I$20210101$20210610$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-300792$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240377911$24037791$1$I$$20210209$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-280877$RANBAXY$Tkachenko E,Singer S,Sharma P,Barbieri J,Mostaghimi A. US Food and Drug Administration Reports of Pregnancy andPregnancy-Related Adverse Events Associated With Isotretinoin. JAMA Dermatol.. 2019;Oct; 155(10):1-9$$$$F$Y$$$20240702$$HP$US$US
240377921$24037792$1$I$20210101$20210315$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-287058$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240377931$24037793$1$I$$20210209$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-280878$RANBAXY$Tkachenko E,Singer S,Sharma P,Barbieri J,Mostaghimi A. US Food and Drug Administration Reports of Pregnancy andPregnancy-Related Adverse Events Associated With Isotretinoin. JAMA Dermatol.. 2019;Oct;155(10):1-9$$$$F$Y$$$20240702$$HP$US$US
240377942$24037794$2$F$$20240808$20240702$20240816$EXP$$US-AstraZeneca-2024A145727$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
240377952$24037795$2$F$$20240703$20240702$20240707$EXP$$NVSJ2024JP007656$NOVARTIS$$$$E$M$Y$$$20240708$$MD$JP$JP
240377962$24037796$2$F$$20240712$20240702$20240717$EXP$$JP-SAKK-2024SA173470AA$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240718$$MD$JP$JP
240377971$24037797$1$I$$20240617$20240702$20240702$EXP$$US-HALEON-2182679$Haleon PLC$$$$$F$Y$$$20240626$$HP$US$US
240377981$24037798$1$I$20240101$20240627$20240702$20240702$EXP$$US-ABBVIE-5821562$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240377991$24037799$1$I$20240101$20240621$20240702$20240702$PER$$US-SA-2024SA187919$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240702$$MD$US$US
240378001$24037800$1$I$$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024129074$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240378011$24037801$1$I$$20240625$20240702$20240702$EXP$$CA-CELLTRION INC.-2024CA015440$CELLTRION$$$$$$Y$$$20240702$$CN$CA$CA
240378022$24037802$2$F$20240515$20240701$20240702$20240705$EXP$$US-INTERCEPT-PM2024001288$INTERCEPT PHARMACEUTICALS$$86$YR$$F$Y$$$20240705$$CN$US$US
240378032$24037803$2$F$$20240628$20240702$20240704$EXP$$US-INTERCEPT-PM2024001296$INTERCEPT PHARMACEUTICALS$$$$$F$Y$67.12$KG$20240704$$CN$US$US
240378041$24037804$1$I$$20210712$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-304468$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378051$24037805$1$I$$20210727$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-307178$RANBAXY$Suh S, Nguyen C, Zhao L, Atanaskova Mesinkovska N. The role of platelet-rich plasma therapy inrefractory folliculitis decalvans. JAAD Case Rep. 2021;12:85-87$$$$M$Y$$$20240702$$HP$US$US
240378061$24037806$1$I$20210729$20210812$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-307858$RANBAXY$$16$YR$T$F$Y$$$20240702$$CN$US$US
240378071$24037807$1$I$$20210820$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-309102$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378081$24037808$1$I$20210101$20210729$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-306391$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240378091$24037809$1$I$20210830$20210830$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-309892$RANBAXY$$18$YR$A$$Y$$$20240702$$MD$US$US
240378101$24037810$1$I$$20210923$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-312635$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378111$24037811$1$I$$20210917$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-312171$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378121$24037812$1$I$$20240617$20240702$20240702$EXP$$CA-ROCHE-10000006002$ROCHE$$65$YR$E$F$Y$$$20240702$$MD$CA$CA
240378131$24037813$1$I$$20210819$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-308807$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240378141$24037814$1$I$20240616$20240624$20240702$20240702$EXP$$CN-AMGEN-CHNSP2024126128$AMGEN$$67$YR$E$F$Y$46$KG$20240701$$HP$CN$CN
240378151$24037815$1$I$$20210716$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-305281$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378161$24037816$1$I$$20210823$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-309123$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240378171$24037817$1$I$20210101$20210722$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-305732$RANBAXY$$$$A$M$Y$$$20240702$$HP$US$US
240378181$24037818$1$I$20210101$20210805$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-307119$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240378191$24037819$1$I$20210101$20210805$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-304188$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
240378201$24037820$1$I$$20210804$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-306983$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378211$24037821$1$I$20210101$20210810$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-307739$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240378221$24037822$1$I$$20211004$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-313879$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240378231$24037823$1$I$20210713$20210713$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-304548$RANBAXY$$14$YR$T$F$Y$$$20240702$$HP$US$US
240378241$24037824$1$I$20210101$20210701$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-304071$RANBAXY$$$$T$M$Y$$$20240702$$HP$US$US
240378251$24037825$1$I$$20210728$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-306464$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378261$24037826$1$I$$20211005$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-314205$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378271$24037827$1$I$20210101$20210802$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-307081$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378281$24037828$1$I$$20211011$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-314283$RANBAXY$Pona A, Cardenas-de la Garza JA, Haidari W, Cline A, Feldman SR, Taylor SL. Abnormal liver function tests in acne patients receiving isotretinoin. J Dermatolog Treat. 2021;32(4):469-472$$$$M$Y$$$20240702$$HP$US$US
240378291$24037829$1$I$20210101$20210916$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-311844$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
240378301$24037830$1$I$$20211012$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-314629$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240378311$24037831$1$I$$20210818$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-308796$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240378321$24037832$1$I$$20210922$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-312582$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378331$24037833$1$I$$20210810$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-307088$RANBAXY$$$$$M$Y$$$20240702$$MD$US$US
240378341$24037834$1$I$20211004$20211004$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-313880$RANBAXY$$60$YR$A$$Y$$$20240702$$MD$US$US
240378351$24037835$1$I$$20210913$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-311438$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240378361$24037836$1$I$$20210831$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-309930$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240378371$24037837$1$I$$20210909$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-311099$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240378381$24037838$1$I$$20210927$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-313244$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378391$24037839$1$I$$20210913$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-311419$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240378401$24037840$1$I$$20210811$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-307853$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240378411$24037841$1$I$$20210920$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-312240$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240378421$24037842$1$I$$20210924$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-312974$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378431$24037843$1$I$20210713$20210713$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-304544$RANBAXY$$16$YR$T$F$Y$$$20240702$$HP$US$US
240378441$24037844$1$I$20210812$20210812$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-308125$RANBAXY$$18$YR$A$$Y$$$20240702$$HP$US$US
240378451$24037845$1$I$$20211011$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-315214$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378461$24037846$1$I$$20210729$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-306403$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378471$24037847$1$I$$20240624$20240702$20240702$EXP$$US-INTERCEPT-PM2024001291$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240702$$HP$US$US
240378481$24037848$1$I$$20211014$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-315310$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378491$24037849$1$I$$20211014$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-315306$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378501$24037850$1$I$20170101$20211025$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2017US-138117$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
240378511$24037851$1$I$$20211208$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-320769$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378521$24037852$1$I$$20211209$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-320812$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378531$24037853$1$I$20210101$20211029$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-316667$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378541$24037854$1$I$$20211013$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-315086$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378551$24037855$1$I$20210101$20211108$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-317535$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240378561$24037856$1$I$20210101$20211122$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-318777$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240378571$24037857$1$I$20210101$20211102$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-317066$RANBAXY$$$$A$M$Y$$$20240702$$HP$US$US
240378581$24037858$1$I$20210101$20211116$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-318412$RANBAXY$$$$A$M$Y$$$20240702$$HP$US$US
240378591$24037859$1$I$$20220117$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-324714$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378601$24037860$1$I$$20220103$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323289$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240378611$24037861$1$I$$20220120$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-325164$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240378621$24037862$1$I$$20220317$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-326031$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378631$24037863$1$I$20240316$20240617$20240702$20240702$EXP$FR-AFSSAPS-NY2024000657$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108688$ZYDUS PHARM$$$$$$Y$$$20240702$$MD$FR$FR
240378641$24037864$1$I$$20211217$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-321961$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240378651$24037865$1$I$20240505$20240624$20240702$20240702$EXP$ES-AEMPS-1538238$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109009$ZYDUS PHARM$$$$$$Y$$$20240702$$PH$ES$ES
240378661$24037866$1$I$$20240621$20240702$20240702$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108886$ZYDUS PHARM$$$$$$Y$$$20240702$$HP$US$US
240378671$24037867$1$I$$20220110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323818$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240378681$24037868$1$I$$20211025$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-316072$RANBAXY$$$$$M$Y$$$20240702$$MD$US$US
240378691$24037869$1$I$$20211206$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-320397$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378701$24037870$1$I$20211101$20220111$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323783$RANBAXY$$17$YR$T$F$Y$$$20240702$$CN$US$US
240378711$24037871$1$I$20220214$20220214$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-327378$RANBAXY$$16$YR$T$$Y$$$20240702$$CN$US$US
240378721$24037872$1$I$$20211227$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-322543$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378731$24037873$1$I$$20220323$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-331838$RANBAXY$Kirchner A, Hoyer S. A detailed regimen of isotretinoin for the successful treatment of severe keratosis pilaris. Clin Exp Dermatol. 2022;47(3):619-621$16$YR$$F$Y$$$20240702$$HP$US$US
240378741$24037874$1$I$20220201$20220415$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-329396$RANBAXY$$38$YR$$$Y$$$20240702$$HP$US$US
240378751$24037875$1$I$20211216$20220104$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323401$RANBAXY$$17$YR$T$$Y$$$20240702$$CN$US$US
240378761$24037876$1$I$20211201$20220331$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-322227$RANBAXY$$41$YR$A$F$Y$$$20240702$$CN$US$US
240378771$24037877$1$I$$20211206$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-320368$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240378781$24037878$1$I$$20211217$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-321964$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240378791$24037879$1$I$$20211227$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-322546$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378801$24037880$1$I$$20220221$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-328186$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240378811$24037881$1$I$$20220106$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323571$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378821$24037882$1$I$$20220329$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-332561$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240378831$24037883$1$I$$20220104$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323309$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240378841$24037884$1$I$$20220316$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-326029$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378851$24037885$1$I$$20211015$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-315355$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240378861$24037886$1$I$20211201$20220107$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323375$RANBAXY$$21$YR$A$F$Y$$$20240702$$CN$US$US
240378871$24037887$1$I$$20211108$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-318044$RANBAXY$Alexanian C, Liakos W, Toussi A, Kao J, Cheng MY, Wang EA, et al. Immune profiling of lupus miliaris disseminatus faciei and successful management with anti-tumour necrosis factor therapy. Clin Exp Dermatol. 2021;46(5):910-914$20$YR$$M$Y$$$20240702$$HP$US$US
240378881$24037888$1$I$$20211229$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-322541$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378891$24037889$1$I$20211223$20220111$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323758$RANBAXY$$24$YR$A$F$Y$$$20240702$$CN$US$US
240378901$24037890$1$I$$20220106$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323551$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378911$24037891$1$I$$20211230$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-322961$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378921$24037892$1$I$$20220104$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323284$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378931$24037893$1$I$$20220401$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-328345$RANBAXY$$$$T$$Y$$$20240702$$CN$US$US
240378941$24037894$1$I$$20220126$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-325603$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240378951$24037895$1$I$$20220325$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-332098$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240378961$24037896$1$I$20210218$20211104$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-317114$RANBAXY$$42$YR$A$F$Y$$$20240702$$HP$US$US
240378971$24037897$1$I$$20220317$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-331065$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240378981$24037898$1$I$$20220323$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-331735$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240378991$24037899$1$I$$20220120$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-325166$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379001$24037900$1$I$20220104$20220104$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323365$RANBAXY$$14$YR$T$F$Y$$$20240702$$CN$US$US
240379011$24037901$1$I$$20220328$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-332428$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240379021$24037902$1$I$20210101$20211123$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-319017$RANBAXY$$$$A$M$Y$$$20240702$$HP$US$US
240379031$24037903$1$I$$20220307$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-329934$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379041$24037904$1$I$$20220209$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-327104$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240379051$24037905$1$I$$20211219$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-317645$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379061$24037906$1$I$$20220207$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-326202$RANBAXY$$$$C$F$Y$$$20240702$$HP$US$US
240379071$24037907$1$I$$20220304$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-329798$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379081$24037908$1$I$20200205$20210712$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-255396$RANBAXY$$14$YR$T$M$Y$$$20240702$$CN$US$US
240379091$24037909$1$I$$20220329$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-332446$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379101$24037910$1$I$$20220117$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-324791$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379111$24037911$1$I$$20220117$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-324717$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379121$24037912$1$I$$20220324$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-331733$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379131$24037913$1$I$$20220228$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-329190$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240379141$24037914$1$I$$20210401$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-291159$RANBAXY$London NJS, Kaiser RS, Khan MA, Alshareef RA, Khuthaila M, Shahlaee A  et al. Determining the effect of low-dose isotretinoin on proliferative vitreoretinopathy: the DELIVER trial. Br J Ophthalmol. 2019;103:1306-1313$$$$$Y$$$20240702$$HP$US$US
240379151$24037915$1$I$$20220105$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323313$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379161$24037916$1$I$$20220217$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-327760$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240379171$24037917$1$I$$20220307$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-329927$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379181$24037918$1$I$20210101$20210315$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-287064$RANBAXY$$$$A$M$Y$$$20240702$$HP$US$US
240379191$24037919$1$I$$20220224$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-328678$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379201$24037920$1$I$$20220111$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323781$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240379211$24037921$1$I$$20220323$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-327238$RANBAXY$$$$T$M$Y$$$20240702$$CN$US$US
240379221$24037922$1$I$20211217$20220111$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323766$RANBAXY$$24$YR$A$F$Y$$$20240702$$CN$US$US
240379231$24037923$1$I$$20220217$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-327758$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379241$24037924$1$I$20211231$20220104$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323399$RANBAXY$$20$YR$A$$Y$$$20240702$$CN$US$US
240379251$24037925$1$I$$20220203$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-326178$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240379261$24037926$1$I$$20220322$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-331692$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379271$24037927$1$I$$20240625$20240702$20240702$EXP$$CA-ROCHE-10000011502$ROCHE$$$$$M$Y$$$20240702$$HP$CA$CA
240379281$24037928$1$I$$20220429$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-336013$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240379291$24037929$1$I$$20220329$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-332563$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379301$24037930$1$I$$20220330$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-332565$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379311$24037931$1$I$$20220413$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-333981$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379321$24037932$1$I$20220203$20220505$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-336728$RANBAXY$$38$YR$A$F$Y$$$20240702$$MD$US$US
240379331$24037933$1$I$20220101$20220413$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-333997$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240379341$24037934$1$I$$20220404$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-333068$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379351$24037935$1$I$$20220505$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-336673$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379361$24037936$1$I$$20220512$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-337283$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379371$24037937$1$I$$20220518$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-337987$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379381$24037938$1$I$$20220519$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-338212$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379391$24037939$1$I$$20220512$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-337439$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379401$24037940$1$I$$20220614$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-341587$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379411$24037941$1$I$20220501$20220524$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-338908$RANBAXY$$20$YR$A$M$Y$$$20240702$$HP$US$US
240379421$24037942$1$I$20220531$20220531$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-339991$RANBAXY$$32$YR$A$F$Y$$$20240702$$CN$US$US
240379431$24037943$1$I$$20220707$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-344005$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379441$24037944$1$I$20220201$20220629$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343340$RANBAXY$$21$YR$A$F$Y$$$20240702$$HP$US$US
240379451$24037945$1$I$$20220427$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-335738$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379461$24037946$1$I$$20220608$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-341081$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379471$24037947$1$I$$20220705$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343887$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379481$24037948$1$I$$20220614$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-341592$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379491$24037949$1$I$$20230825$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-344995$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379501$24037950$1$I$$20220606$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-340744$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379511$24037951$1$I$$20220606$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-340655$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240379521$24037952$1$I$$20220706$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343969$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379531$24037953$1$I$$20220331$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-332761$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240379541$24037954$1$I$$20220620$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-342800$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379551$24037955$1$I$$20220707$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-344012$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379561$24037956$1$I$$20220411$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-333832$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379571$24037957$1$I$$20220512$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-337370$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379581$24037958$1$I$$20220627$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343250$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379591$24037959$1$I$$20220414$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-333950$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240379601$24037960$1$I$$20220630$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343728$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379611$24037961$1$I$$20220627$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343018$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379621$24037962$1$I$$20220503$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-336488$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379631$24037963$1$I$$20220609$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-341158$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379641$24037964$1$I$$20220707$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-344032$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379651$24037965$1$I$$20220531$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-339948$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379661$24037966$1$I$$20220616$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-342129$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240379671$24037967$1$I$$20220601$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-340280$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379681$24037968$1$I$$20220718$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-345384$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379691$24037969$1$I$$20220520$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-338893$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379701$24037970$1$I$$20220701$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343861$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379711$24037971$1$I$$20240627$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104243$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240702$$CN$US$US
240379732$24037973$2$F$$20240806$20240702$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102325$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240808$$CN$US$US
240379751$24037975$1$I$20240504$20240629$20240702$20240702$EXP$$CN-BEIGENE-BGN-2024-010091$BEIGENE$$$$$$Y$$$20240702$$HP$CN$CN
240379761$24037976$1$I$$20240626$20240702$20240702$EXP$$JP-VANTIVE-2024VAN017612$Vantive US Healthcare$$$$$M$Y$$$20240702$$MD$JP$JP
240379771$24037977$1$I$$20220812$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-349510$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379781$24037978$1$I$$20220809$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-348863$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379791$24037979$1$I$$20230704$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-347774$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379801$24037980$1$I$$20240627$20240702$20240702$PER$$US-TAKEDA-2024TUS064413$TAKEDA$$24$YR$$F$Y$$$20240702$$CN$US$US
240379811$24037981$1$I$$20220912$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-354419$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379821$24037982$1$I$20221121$20221128$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-366579$RANBAXY$$15$YR$T$$Y$$$20240702$$HP$US$US
240379831$24037983$1$I$$20230704$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-360581$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379841$24037984$1$I$$20221110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365785$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$12$YR$$M$Y$$$20240702$$MD$US$US
240379851$24037985$1$I$$20221104$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-362810$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379861$24037986$1$I$$20220809$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-348866$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379871$24037987$1$I$$20220831$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-353481$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379881$24037988$1$I$$20220817$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-351641$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379891$24037989$1$I$$20221115$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-366514$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240379901$24037990$1$I$$20220726$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-346884$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379911$24037991$1$I$$20220921$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-357581$RANBAXY$Gupta R, Craddock M F. Successful treatment of a child with MEK inhibitor-induced acneiform eruption with low-dose isotretinoin. Pediatric Dermatology. 2022;39:646 - 647$11$YR$$F$Y$$$20240702$$HP$US$US
240379921$24037992$1$I$$20220825$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-352825$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240379931$24037993$1$I$$20220818$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-352918$RANBAXY$Johnson H, Ranum A, Mansh M, Farah RS, Pearson DR. Falsification of At-Home Isotretinoin Pregnancy Testing During theCOVID-19 Pandemic: A Case Series and Proposal of Mitigation Strategies. JAAD Case Rep. 2022;Aug 11;:Online ahead of print$$$$F$Y$$$20240702$$HP$US$US
240379941$24037994$1$I$$20220725$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-346850$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240379951$24037995$1$I$$20220810$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-348832$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379961$24037996$1$I$$20220817$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-351677$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379971$24037997$1$I$$20220803$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-347898$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240379981$24037998$1$I$20220504$20220722$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-346086$RANBAXY$-. -. -. --;-:-$32$YR$A$M$Y$82.5$KG$20240702$$MD$US$US
240379991$24037999$1$I$$20221110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365792$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$16$YR$$M$Y$$$20240702$$MD$US$US
240380001$24038000$1$I$$20220909$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-354747$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380011$24038001$1$I$$20220829$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-353176$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380021$24038002$1$I$$20220726$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-346887$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380031$24038003$1$I$$20220915$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-356023$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380041$24038004$1$I$$20221110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365783$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$16$YR$$M$Y$$$20240702$$MD$US$US
240380051$24038005$1$I$$20221109$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-363738$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380061$24038006$1$I$$20221123$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-366563$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380071$24038007$1$I$$20220823$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-352372$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380081$24038008$1$I$$20221004$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-358047$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380091$24038009$1$I$$20221013$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-359627$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380101$24038010$1$I$$20220822$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-352297$RANBAXY$$$$$M$Y$$$20240702$$CN$US$US
240380111$24038011$1$I$$20221110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365794$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$14$YR$$M$Y$$$20240702$$MD$US$US
240380121$24038012$1$I$$20210920$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-312318$RANBAXY$$$$$M$Y$$$20240702$$CN$US$US
240380131$24038013$1$I$$20221110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365779$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$13$YR$$F$Y$$$20240702$$MD$US$US
240380141$24038014$1$I$$20221115$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-364371$RANBAXY$$$$$M$Y$$$20240702$$MD$US$US
240380151$24038015$1$I$$20220824$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-352497$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380161$24038016$1$I$$20221122$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365933$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380171$24038017$1$I$$20221110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365796$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$18$YR$$M$Y$$$20240702$$MD$US$US
240380181$24038018$1$I$$20221110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365793$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$14$YR$$M$Y$$$20240702$$MD$US$US
240380191$24038019$1$I$$20221024$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-361084$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380201$24038020$1$I$$20221017$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-359913$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380211$24038021$1$I$$20221110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365786$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$16$YR$$M$Y$$$20240702$$MD$US$US
240380221$24038022$1$I$$20221102$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-362461$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380231$24038023$1$I$$20220719$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-345746$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380241$24038024$1$I$$20221110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365789$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$13$YR$$M$Y$$$20240702$$MD$US$US
240380251$24038025$1$I$$20221121$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365520$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380261$24038026$1$I$$20220822$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-352280$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380271$24038027$1$I$$20221130$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-367022$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380281$24038028$1$I$$20220923$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-356527$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240380291$24038029$1$I$$20220927$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-356920$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380301$24038030$1$I$$20221122$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-366020$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380311$24038031$1$I$20220914$20220928$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-357254$RANBAXY$$36$YR$A$$Y$$$20240702$$CN$US$US
240380321$24038032$1$I$$20220803$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-347964$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380331$24038033$1$I$$20221130$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-367029$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380341$24038034$1$I$$20221206$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-368128$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380351$24038035$1$I$$20221216$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-369771$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380361$24038036$1$I$$20221215$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-369397$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380371$24038037$1$I$$20230330$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384061$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380381$24038038$1$I$20230113$20230221$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382436$RANBAXY$$18$YR$A$F$Y$$$20240702$$HP$US$US
240380391$24038039$1$I$$20221110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365791$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$15$YR$$M$Y$$$20240702$$MD$US$US
240380401$24038040$1$I$$20221204$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-367779$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380411$24038041$1$I$$20230310$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382546$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380421$24038042$1$I$$20230821$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383163$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240380431$24038043$1$I$$20240627$20240702$20240702$PER$$US-TAKEDA-2024TUS065236$TAKEDA$$$$$M$Y$$$20240702$$CN$US$US
240380441$24038044$1$I$$20230407$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384793$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380451$24038045$1$I$$20230414$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385518$RANBAXY$$$$A$$Y$$$20240702$$HP$US$US
240380461$24038046$1$I$$20230419$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386187$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380471$24038047$1$I$$20230322$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383261$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240380481$24038048$1$I$$20230315$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382515$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240380491$24038049$1$I$$20230214$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-379473$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380501$24038050$1$I$$20230220$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383927$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380511$24038051$1$I$$20230314$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382439$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380521$24038052$1$I$$20230112$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-374259$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380531$24038053$1$I$20220509$20230125$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-375926$RANBAXY$$26$YR$A$$Y$$$20240702$$HP$US$US
240380541$24038054$1$I$$20230125$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-376338$RANBAXY$Duvalyan A, Cha A, Goodarzian F, Arkader A, Villablanca JG, Marachelian A. Premature epiphyseal growth plate arrest after isotretinoin therapy for high-risk neuroblastoma: A case series and review of the literature. Pediatr Blood Cancer. 2020;67(8):e28236(1-9)$10$YR$$M$Y$$$20240702$$HP$US$US
240380551$24038055$1$I$$20230502$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387571$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380561$24038056$1$I$20220926$20230128$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-376377$RANBAXY$$19$YR$A$$Y$$$20240702$$CN$US$US
240380571$24038057$1$I$$20221213$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-368962$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380581$24038058$1$I$$20230313$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382390$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380591$24038059$1$I$$20230125$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-375925$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240380601$24038060$1$I$$20221220$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-370064$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380611$24038061$1$I$$20230124$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-376796$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240380621$24038062$1$I$$20230419$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386160$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380631$24038063$1$I$20220901$20230109$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-374002$RANBAXY$$44$YR$A$F$Y$$$20240702$$CN$US$US
240380641$24038064$1$I$$20221209$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-368638$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380651$24038065$1$I$20221219$20230120$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-375568$RANBAXY$$1$YR$I$$Y$$$20240702$$CN$US$US
240380661$24038066$1$I$$20230322$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383274$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240380671$24038067$1$I$20230317$20230323$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383120$RANBAXY$$16$YR$T$F$Y$$$20240702$$CN$US$US
240380681$24038068$1$I$$20230117$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-375129$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240380691$24038069$1$I$$20230504$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387867$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380701$24038070$1$I$$20230403$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384739$RANBAXY$Yildirim AM, Lemons N, Yousaf A, Zinn ZA. The Safety of Isotretinoin Treatment in Patients with Peanut Allergies. J Clin Aesthet Dermatol. 2022;Dec;15(12):49-51$14$YR$$M$Y$$$20240702$$HP$US$US
240380711$24038071$1$I$$20230414$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385387$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240380721$24038072$1$I$20230323$20230420$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386377$RANBAXY$$16$YR$T$F$Y$$$20240702$$CN$US$US
240380731$24038073$1$I$$20230403$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384783$RANBAXY$Yildirim AM, Lemons N, Yousaf A, Zinn ZA. The Safety of Isotretinoin Treatment in Patients with Peanut Allergies. J Clin Aesthet Dermatol. 2022;Dec;15(12):49-51$28$YR$$F$Y$$$20240702$$HP$US$US
240380741$24038074$1$I$$20230123$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-375896$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240380751$24038075$1$I$$20230120$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-375571$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380761$24038076$1$I$$20230428$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386162$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380771$24038077$1$I$$20230505$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388042$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240380781$24038078$1$I$$20230125$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-376151$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380791$24038079$1$I$$20221201$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-367216$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380801$24038080$1$I$20230327$20230414$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385512$RANBAXY$$16$YR$T$$Y$$$20240702$$HP$US$US
240380811$24038081$1$I$$20230419$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386138$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380821$24038082$1$I$$20230510$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388445$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380831$24038083$1$I$$20230428$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387326$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380841$24038084$1$I$$20230405$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381736$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380851$24038085$1$I$$20230321$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382956$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240380861$24038086$1$I$$20230316$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381741$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380871$24038087$1$I$$20230403$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384455$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380881$24038088$1$I$20230201$20230324$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383291$RANBAXY$$33$YR$A$F$Y$$$20240702$$MD$US$US
240380891$24038089$1$I$20230801$20240620$20240702$20240702$PER$$US-TEVA-VS-3213688$TEVA$$75$YR$$F$Y$$$20240702$$PH$US$US
240380901$24038090$1$I$$20230130$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-376614$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380911$24038091$1$I$$20230509$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388268$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240380921$24038092$1$I$$20230403$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384781$RANBAXY$Yildirim AM, Lemons N, Yousaf A, Zinn ZA. The Safety of Isotretinoin Treatment in Patients with Peanut Allergies. J Clin Aesthet Dermatol. 2022;Dec;15(12):49-51$18$YR$$F$Y$$$20240702$$HP$US$US
240380931$24038093$1$I$20210101$20211123$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-319016$RANBAXY$$$$T$M$Y$$$20240702$$HP$US$US
240380941$24038094$1$I$$20230220$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383782$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240380951$24038095$1$I$$20220318$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-331171$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240380961$24038096$1$I$$20230327$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383485$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240380971$24038097$1$I$$20230206$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-377778$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240380981$24038098$1$I$$20220111$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323719$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240380991$24038099$1$I$$20230818$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388615$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381001$24038100$1$I$$20230413$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385239$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240381011$24038101$1$I$$20230414$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385513$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381021$24038102$1$I$$20230510$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388444$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381031$24038103$1$I$$20230417$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385695$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381041$24038104$1$I$$20220215$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-327599$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240381051$24038105$1$I$$20230223$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382548$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381061$24038106$1$I$20230301$20230406$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384651$RANBAXY$$21$YR$A$F$Y$$$20240702$$CN$US$US
240381071$24038107$1$I$20230403$20230427$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387002$RANBAXY$$15$YR$T$$Y$$$20240702$$HP$US$US
240381081$24038108$1$I$$20230425$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386904$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381091$24038109$1$I$$20211102$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-317076$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240381101$24038110$1$I$$20220131$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-325887$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381111$24038111$1$I$$20230818$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381476$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240381121$24038112$1$I$$20230223$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382547$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381131$24038113$1$I$20230120$20230330$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384055$RANBAXY$$13$YR$T$$Y$$$20240702$$MD$US$US
240381141$24038114$1$I$$20230404$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384460$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240381151$24038115$1$I$$20230309$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382538$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240381161$24038116$1$I$$20230510$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388434$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381171$24038117$1$I$20220102$20220316$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-326012$RANBAXY$$15$YR$T$$Y$$$20240702$$MD$US$US
240381181$24038118$1$I$$20230510$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388441$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381191$24038119$1$I$$20220321$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-331363$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381201$24038120$1$I$$20230329$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383908$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240381211$24038121$1$I$$20211202$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-320344$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240381221$24038122$1$I$20220202$20220316$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-326139$RANBAXY$$16$YR$T$F$Y$$$20240702$$HP$US$US
240381231$24038123$1$I$$20230418$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385875$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381241$24038124$1$I$20220201$20220415$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-329399$RANBAXY$$23$YR$A$$Y$$$20240702$$HP$US$US
240381251$24038125$1$I$$20220323$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-331728$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381261$24038126$1$I$$20211203$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-320049$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240381271$24038127$1$I$$20220204$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-326145$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240381281$24038128$1$I$20220108$20220113$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323984$RANBAXY$$15$YR$T$$Y$$$20240702$$CN$US$US
240381291$24038129$1$I$$20220328$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-332421$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240381301$24038130$1$I$20220102$20220104$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323307$RANBAXY$$14$YR$T$F$Y$$$20240702$$CN$US$US
240381311$24038131$1$I$$20230426$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386955$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381321$24038132$1$I$20220214$20220214$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-327380$RANBAXY$$21$YR$A$F$Y$$$20240702$$HP$US$US
240381331$24038133$1$I$20220104$20220111$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323773$RANBAXY$$14$YR$T$F$Y$$$20240702$$CN$US$US
240381341$24038134$1$I$$20220106$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-323553$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381351$24038135$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000010427$ROCHE$$$$A$F$Y$$$20240702$$CN$US$US
240381363$24038136$3$F$$20240916$20240702$20240920$EXP$$NVSC2024DE134981$NOVARTIS$$$$$F$Y$$$20240920$$CN$DE$DE
240381371$24038137$1$I$$20230516$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389107$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381381$24038138$1$I$$20230524$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392191$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381391$24038139$1$I$$20230526$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392790$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240381401$24038140$1$I$$20230526$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392482$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381411$24038141$1$I$$20230530$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392529$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381421$24038142$1$I$$20230512$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388680$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381431$24038143$1$I$$20230616$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396265$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381441$24038144$1$I$$20230608$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394997$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240381451$24038145$1$I$$20230613$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395728$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240381461$24038146$1$I$$20230602$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395053$RANBAXY$Ghadimi TR, Martinez MJ, Rieder EA. Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series. J Drugs Dermatol. 2023;Apr;22(4):423-424$15$YR$$M$Y$$$20240702$$HP$US$US
240381471$24038147$1$I$$20230608$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390935$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381481$24038148$1$I$$20230518$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389646$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381491$24038149$1$I$$20230706$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400283$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381501$24038150$1$I$$20230614$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394946$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240381511$24038151$1$I$$20230629$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-398357$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381521$24038152$1$I$$20230621$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392798$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240381531$24038153$1$I$20230526$20230526$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392792$RANBAXY$$14$YR$T$F$Y$$$20240702$$HP$US$US
240381541$24038154$1$I$20230522$20230613$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392225$RANBAXY$$23$YR$A$F$Y$$$20240702$$HP$US$US
240381551$24038155$1$I$$20230621$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397220$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240381561$24038156$1$I$$20230602$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395059$RANBAXY$Ghadimi TR, Martinez MJ, Rieder EA. Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series. J Drugs Dermatol. 2023;Apr;22(4):423-424$18$YR$$M$Y$$$20240702$$HP$US$US
240381571$24038157$1$I$$20220715$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-345300$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381581$24038158$1$I$$20230630$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-398467$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381591$24038159$1$I$$20230706$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400296$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240381601$24038160$1$I$$20230602$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395058$RANBAXY$Ghadimi TR, Martinez M, Rieder E. Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series. J Drugs Dermatol. 2023;Apr;22(4):423-424$23$YR$$F$Y$$$20240702$$HP$US$US
240381611$24038161$1$I$$20230818$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389659$RANBAXY$$$$A$$Y$$$20240702$$HP$US$US
240381621$24038162$1$I$$20230626$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397830$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240381631$24038163$1$I$20230705$20230705$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400270$RANBAXY$$56$YR$A$$Y$$$20240702$$MD$US$US
240381641$24038164$1$I$$20230531$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392824$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381651$24038165$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031792$AUROBINDO$Cheema M, Mustafa S, Nawaz M, Siddiqui S, Iftikhar A. Heart Block Is a Rare Complication of Mitral Valve Endocarditis: Awareness Is a Key. Am-J-Respir-Crit-Care-Med. 2024;209:A1637$58$YR$$M$Y$$$20240702$$HP$US$US
240381661$24038166$1$I$$20230707$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400659$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240381671$24038167$1$I$$20230621$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397157$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381681$24038168$1$I$$20230511$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-388625$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381691$24038169$1$I$20230523$20230523$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392256$RANBAXY$$16$YR$T$F$Y$$$20240702$$CN$US$US
240381701$24038170$1$I$$20220711$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-344702$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240381711$24038171$1$I$$20230628$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397868$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381721$24038172$1$I$$20230607$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394685$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240381731$24038173$1$I$20220620$20220706$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343892$RANBAXY$$16$YR$T$F$Y$$$20240702$$CN$US$US
240381741$24038174$1$I$$20230703$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399620$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240381751$24038175$1$I$$20220701$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343877$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381761$24038176$1$I$$20220713$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-344828$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381771$24038177$1$I$$20220518$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-338093$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240381781$24038178$1$I$$20220713$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-344824$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381791$24038179$1$I$$20230602$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395052$RANBAXY$Ghadimi TR, Martinez MJ, Rieder EA. Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series. J Drugs Dermatol. 2023;22(4):423-424$15$YR$$M$Y$$$20240702$$HP$US$US
240381801$24038180$1$I$$20220701$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343653$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381811$24038181$1$I$$20220523$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-338555$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381821$24038182$1$I$$20240624$20240702$20240702$PER$$US-JNJFOC-20240666553$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$HP$US$US
240381832$24038183$2$F$20240624$20240903$20240702$20240905$EXP$$CA-JNJFOC-20240669330$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240905$$HP$CA$CA
240381841$24038184$1$I$$20240625$20240702$20240702$EXP$$BR-JNJFOC-20240677661$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$BR$BR
240381851$24038185$1$I$20240102$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031475$AUROBINDO$$69$YR$$F$Y$78$KG$20240702$$PH$FR$FR
240381861$24038186$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821591$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240381872$24038187$2$F$20240626$20240627$20240702$20240702$EXP$$US-ROCHE-10000013254$ROCHE$$$$$M$Y$$$20240702$$CN$US$US
240381881$24038188$1$I$$20240624$20240702$20240702$EXP$$PL-AUROBINDO-AUR-APL-2024-031680$AUROBINDO$$85$YR$$F$Y$64$KG$20240702$$MD$PL$PL
240381891$24038189$1$I$$20240622$20240702$20240702$EXP$$EC-ROCHE-10000007737$ROCHE$$$$$$Y$$$20240702$$CN$EC$EC
240381901$24038190$1$I$20180101$20240624$20240702$20240702$EXP$$BR-ROCHE-10000008907$ROCHE$$29$YR$A$M$Y$$$20240702$$MD$BR$BR
240381911$24038191$1$I$$20240625$20240702$20240702$PER$$US-SA-2023SA378487$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240702$$MD$US$US
240381921$24038192$1$I$20230623$20230714$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401641$RANBAXY$$15$YR$T$$Y$$$20240702$$CN$US$US
240381931$24038193$1$I$$20230712$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399622$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240381941$24038194$1$I$$20230712$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400786$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240381951$24038195$1$I$$20230712$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400765$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240381961$24038196$1$I$$20230707$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400737$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240381971$24038197$1$I$$20230720$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402503$RANBAXY$$$$A$F$Y$$$20240702$$CN$US$US
240381981$24038198$1$I$20230619$20230720$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402522$RANBAXY$$19$YR$A$F$Y$$$20240702$$HP$US$US
240381991$24038199$1$I$$20230714$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401639$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240382001$24038200$1$I$$20230728$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403740$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240382011$24038201$1$I$20230101$20230725$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403093$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240382021$24038202$1$I$$20230719$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402627$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240382031$24038203$1$I$20230710$20230721$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402848$RANBAXY$$28$YR$A$$Y$$$20240702$$CN$US$US
240382041$24038204$1$I$$20230719$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402625$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240382051$24038205$1$I$$20230816$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406300$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240382061$24038206$1$I$20230701$20230731$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404248$RANBAXY$$22$YR$A$$Y$$$20240702$$MD$US$US
240382071$24038207$1$I$$20230720$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402521$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240382081$24038208$1$I$$20230721$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402847$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240382091$24038209$1$I$20230707$20230726$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403276$RANBAXY$$22$YR$A$$Y$$$20240702$$CN$US$US
240382101$24038210$1$I$$20240625$20240702$20240702$EXP$$RO-CELLTRION INC.-2024RO015619$CELLTRION$$$$$$Y$$$20240702$$MD$RO$RO
240382111$24038211$1$I$20230701$20230803$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404309$RANBAXY$$19$YR$A$$Y$$$20240702$$HP$US$US
240382121$24038212$1$I$$20230720$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402726$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240382131$24038213$1$I$20230301$20230914$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409129$RANBAXY$$16$YR$T$F$Y$$$20240702$$HP$US$US
240382141$24038214$1$I$$20230727$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403157$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240382151$24038215$1$I$20230729$20230729$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403735$RANBAXY$$18$YR$A$F$Y$$$20240702$$MD$US$US
240382161$24038216$1$I$$20220728$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-347050$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240382171$24038217$1$I$20230101$20230831$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407388$RANBAXY$$$$A$M$Y$$$20240702$$HP$US$US
240382181$24038218$1$I$20230801$20230908$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408453$RANBAXY$$17$YR$T$F$Y$$$20240702$$CN$US$US
240382191$24038219$1$I$$20221026$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-361200$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240382201$24038220$1$I$$20221104$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-362821$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240382211$24038221$1$I$$20230807$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405353$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240382221$24038222$1$I$$20230920$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409988$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240382231$24038223$1$I$20230905$20230908$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408371$RANBAXY$$24$YR$A$F$Y$$$20240702$$CN$US$US
240382241$24038224$1$I$$20230724$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402970$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240382251$24038225$1$I$20230914$20230915$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409189$RANBAXY$$$$A$F$Y$$$20240702$$CN$US$US
240382261$24038226$1$I$$20230822$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407025$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240382271$24038227$1$I$$20230821$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407050$RANBAXY$$$$C$F$Y$$$20240702$$CN$US$US
240382281$24038228$1$I$$20230828$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405226$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240382291$24038229$1$I$$20220919$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-356340$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240382301$24038230$1$I$20230720$20230720$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402842$RANBAXY$$16$YR$T$$Y$$$20240702$$HP$US$US
240382311$24038231$1$I$$20230918$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409770$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240382321$24038232$1$I$$20221110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365795$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$15$YR$$M$Y$$$20240702$$MD$US$US
240382331$24038233$1$I$20130719$20230724$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402984$RANBAXY$$14$YR$T$F$Y$$$20240702$$CN$US$US
240382341$24038234$1$I$$20230807$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404874$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240382351$24038235$1$I$$20230727$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403192$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240382361$24038236$1$I$$20230801$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404261$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240382371$24038237$1$I$$20230717$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402060$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240382381$24038238$1$I$$20230828$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407386$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240382391$24038239$1$I$20230911$20230915$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409191$RANBAXY$$36$YR$A$F$Y$$$20240702$$CN$US$US
240382401$24038240$1$I$$20230724$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402971$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240382411$24038241$1$I$$20230810$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405879$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240382421$24038242$1$I$$20230804$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404425$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240382431$24038243$1$I$$20221028$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-361840$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240382441$24038244$1$I$20230815$20230905$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408600$RANBAXY$$15$YR$T$F$Y$$$20240702$$CN$US$US
240382451$24038245$1$I$20230728$20230731$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404241$RANBAXY$$46$YR$A$$Y$$$20240702$$CN$US$US
240382461$24038246$1$I$$20230913$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408836$RANBAXY$$$$A$$Y$$$20240702$$HP$US$US
240382473$24038247$3$F$$20240916$20240702$20240920$EXP$$PT-SANDOZ INC.-NVSC2022PT089970$SANDOZ$$61$YR$$$Y$$$20240920$$MD$PT$PT
240382481$24038248$1$I$$20230821$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406999$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240382492$24038249$2$F$$20240624$20240702$20240705$PER$$US-ROCHE-3571261$ROCHE$$57$YR$A$F$Y$$$20240705$$CN$US$US
240382501$24038250$1$I$20230901$20230907$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408919$RANBAXY$$14$YR$T$F$Y$$$20240702$$HP$US$US
240382511$24038251$1$I$20230101$20230831$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406259$RANBAXY$$$$A$$Y$$$20240702$$CN$US$US
240382521$24038252$1$I$20220928$20230814$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406161$RANBAXY$$15$YR$T$F$Y$$$20240702$$CN$US$US
240382531$24038253$1$I$$20230920$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409929$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240382541$24038254$1$I$$20221007$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-358163$RANBAXY$$$$$M$Y$$$20240702$$MD$US$US
240382551$24038255$1$I$20230727$20230810$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405731$RANBAXY$$15$YR$T$$Y$$$20240702$$CN$US$US
240382561$24038256$1$I$$20230718$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402467$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240382571$24038257$1$I$20230101$20230824$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407408$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
240382581$24038258$1$I$$20240619$20240702$20240702$EXP$$US-STERISCIENCE B.V.-2024-ST-000925$Steriscience PTE$Simpson M, Awuah KB, Patel D, Ogline O, Pratapneni S, Disilvio BE.. Early Extra Corporeal Membrane Oxygenation (ECMO) and Esophagogastroduodenoscopy (EGD) Implementation: A Timely Intervention in a Patient With Extended-Release Bupropion Overdose. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$41$YR$$M$Y$$$20240702$$HP$US$US
240382591$24038259$1$I$$20240618$20240702$20240702$EXP$$US-STERISCIENCE B.V.-2024-ST-000900$Steriscience PTE$Nwodim O, Karsalia R, Heslin ME, Lieberman AE, Wang SZ, Kalanuria AA, et al.. Opioid-related xylazine toxicity manifesting as myonecrosis, rhabdomyolysis, multifocal ischemic cerebral infarcts, and cerebral edema.. J-Am-Coll-Emerg-Physicians-Open. 2024;5$27$YR$$F$Y$$$20240702$$MD$US$US
240382601$24038260$1$I$$20240618$20240702$20240702$EXP$$US-STERISCIENCE B.V.-2024-ST-000901$Steriscience PTE$Alam S, Cheungpasitporn W, Kukla A.. UNRAVELING POWASSAN ENCEPHALITIS AFTER A KIDNEY-PANCREAS TRANSPLANT: CASE REPORT AND IMPLICATION. Am-J-Kidney-Dis. 2024;83 (Suppl 2)(4):S140 abstr. 457.$57$YR$$F$Y$$$20240702$$HP$US$US
240382611$24038261$1$I$$20240619$20240702$20240702$EXP$$US-STERISCIENCE B.V.-2024-ST-000903$Steriscience PTE$Yosry N, Chajkowski A, Rodriguez C, Medik Y, Lali M, Qaiser S, et al.. A Rare Cause of Rhabdomyolysis and Acute Renal Failure: Legionnaires Disease.. Am-J-Respir-Crit-Care-Med. 2024;209(plus Poste)$55$YR$$M$Y$$$20240702$$HP$US$US
240382621$24038262$1$I$$20240619$20240702$20240702$EXP$$US-STERISCIENCE B.V.-2024-ST-000917$Steriscience PTE$Wazirali M, Georg M, Malik M.. Relapsing Cryptogenic Organizing Pneumonia: What Comes After Steroids?.. Am-J-Respir-Crit-Care-Med. 2024;209:A2066$71$YR$$M$Y$$$20240702$$HP$US$US
240382631$24038263$1$I$$20240619$20240702$20240702$EXP$$JP-STERISCIENCE B.V.-2024-ST-000912$Steriscience PTE$Furukawa K, Haruki K, Kasahara M, Taniai T, Ikegami T.. Dual Antibody Treatment for Simultaneous Acute Cellular Rejection and Antibody-Mediated Rejection After Liver Transplantation: A Case Report.. Transplant-Proc. 2023;55 (8):1938-1942$40$YR$$M$Y$$$20240702$$MD$JP$JP
240382641$24038264$1$I$$20240619$20240702$20240702$EXP$$US-STERISCIENCE B.V.-2024-ST-000874$Steriscience PTE$Xiong J, Embry E, Prasad S, Singh K, Singh M.. Mycoplasma Pneumonia Induced Acute Respiratory Distress Syndrome in Pregnancy.. Am-J-Respir-Crit-Care-Med. 2024;209$38$YR$$F$Y$$$20240702$$HP$US$US
240382651$24038265$1$I$$20231129$20240702$20240702$PER$$US-AMGEN-USASP2023235088$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240382661$24038266$1$I$$20240619$20240702$20240702$EXP$$US-STERISCIENCE B.V.-2024-ST-000921$Steriscience PTE$Hossain S, Bahadur SA. Stenotrophomonas Maltophilia, Pandoraea Species, and Aspergillus Niger Co-infection in a Patient With Acute Respiratory Failure.. Am-J-Respir-Crit-Care-Med. 2024;209$74$YR$$M$Y$$$20240702$$HP$US$US
240382671$24038267$1$I$20240624$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127319$AMGEN$$67$YR$E$F$Y$$$20240701$$CN$US$US
240382681$24038268$1$I$20240626$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024126624$AMGEN$$78$YR$E$$Y$$$20240701$$CN$US$US
240382691$24038269$1$I$20230922$20230929$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411768$RANBAXY$$19$YR$A$F$Y$$$20240702$$CN$US$US
240382701$24038270$1$I$$20230927$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410324$RANBAXY$$$$T$M$Y$$$20240702$$HP$US$US
240382711$24038271$1$I$$20231009$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413255$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240382721$24038272$1$I$$20230925$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410075$RANBAXY$$$$T$$Y$$$20240702$$HP$US$US
240382731$24038273$1$I$$20230927$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411425$RANBAXY$$$$T$$Y$$$20240702$$CN$US$US
240382741$24038274$1$I$$20230923$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410447$RANBAXY$$$$T$F$Y$$$20240702$$PH$US$US
240382751$24038275$1$I$20230927$20231003$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-412075$RANBAXY$$34$YR$A$$Y$$$20240702$$HP$US$US
240382761$24038276$1$I$$20230928$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411553$RANBAXY$$$$A$M$Y$$$20240702$$CN$US$US
240382771$24038277$1$I$$20230925$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411430$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240382781$24038278$1$I$20231013$20231013$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413840$RANBAXY$$18$YR$A$$Y$$$20240702$$MD$US$US
240382791$24038279$1$I$20230929$20230929$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411772$RANBAXY$$20$YR$A$$Y$$$20240702$$CN$US$US
240382801$24038280$1$I$$20231019$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415445$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
240382811$24038281$1$I$$20231221$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-426399$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
240382821$24038282$1$I$20231017$20231017$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415048$RANBAXY$$16$YR$T$$Y$$$20240702$$MD$US$US
240382831$24038283$1$I$20230928$20230928$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411560$RANBAXY$$13$YR$T$F$Y$$$20240702$$CN$US$US
240382841$24038284$1$I$$20231006$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413218$RANBAXY$$$$T$$Y$$$20240702$$CN$US$US
240382851$24038285$1$I$20230531$20230925$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411429$RANBAXY$$34$YR$A$F$Y$77.098$KG$20240702$$CN$US$US
240382861$24038286$1$I$$20230920$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409986$RANBAXY$$$$T$M$Y$$$20240702$$HP$US$US
240382871$24038287$1$I$$20231107$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417834$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240382881$24038288$1$I$20230929$20230929$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411773$RANBAXY$$17$YR$T$M$Y$$$20240702$$HP$US$US
240382891$24038289$1$I$20230823$20231011$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413753$RANBAXY$$21$YR$A$F$Y$$$20240702$$MD$US$US
240382901$24038290$1$I$20231229$20231230$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-426369$RANBAXY$$19$YR$A$M$Y$$$20240702$$CN$US$US
240382911$24038291$1$I$$20231204$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424405$RANBAXY$$$$T$$Y$$$20240702$$MD$US$US
240382921$24038292$1$I$$20231110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419072$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240382931$24038293$1$I$$20231019$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415447$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240382941$24038294$1$I$$20231030$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417009$RANBAXY$$$$A$$Y$$$20240702$$HP$US$US
240382951$24038295$1$I$$20231121$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421445$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240382961$24038296$1$I$$20240202$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-431364$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240382971$24038297$1$I$20230928$20230928$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411536$RANBAXY$$22$YR$A$F$Y$$$20240702$$HP$US$US
240382981$24038298$1$I$20221001$20230927$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411661$RANBAXY$$15$YR$T$$Y$$$20240702$$HP$US$US
240382991$24038299$1$I$20231109$20240124$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430156$RANBAXY$$25$YR$A$F$Y$$$20240702$$HP$US$US
240383001$24038300$1$I$$20231004$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-412473$RANBAXY$$$$A$M$Y$$$20240702$$HP$US$US
240383011$24038301$1$I$$20231019$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415457$RANBAXY$$$$A$$Y$$$20240702$$CN$US$US
240383021$24038302$1$I$$20240104$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-426906$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240383031$24038303$1$I$$20231011$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413856$RANBAXY$$$$T$M$Y$$$20240702$$MD$US$US
240383041$24038304$1$I$20231202$20231202$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424230$RANBAXY$$32$YR$A$F$Y$$$20240702$$CN$US$US
240383051$24038305$1$I$$20231205$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420869$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240383061$24038306$1$I$$20240103$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-426889$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240383071$24038307$1$I$$20230109$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-373994$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240383081$24038308$1$I$20231017$20231019$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415419$RANBAXY$$18$YR$A$$Y$$$20240702$$HP$US$US
240383091$24038309$1$I$$20240131$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-431368$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240383101$24038310$1$I$$20240201$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430614$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240383111$24038311$1$I$$20240115$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428877$RANBAXY$$$$A$$Y$$$20240702$$HP$US$US
240383121$24038312$1$I$$20240105$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-427632$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240383131$24038313$1$I$$20240131$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-431369$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240383141$24038314$1$I$$20231201$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424227$RANBAXY$$$$T$M$Y$$$20240702$$CN$US$US
240383161$24038316$1$I$$20231013$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413513$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240383171$24038317$1$I$$20231016$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-414964$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240383181$24038318$1$I$$20240125$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430313$RANBAXY$$$$$$Y$$$20240702$$PH$US$US
240383191$24038319$1$I$$20231208$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425117$RANBAXY$$$$T$$Y$$$20240702$$MD$US$US
240383201$24038320$1$I$$20231003$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-412472$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240383211$24038321$1$I$$20230112$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-374182$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240383221$24038322$1$I$20240117$20240117$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429141$RANBAXY$$16$YR$T$F$Y$$$20240702$$CN$US$US
240383231$24038323$1$I$$20231215$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425650$RANBAXY$$36$YR$$F$Y$$$20240702$$CN$US$US
240383241$24038324$1$I$$20231215$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425500$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240383251$24038325$1$I$20240129$20240129$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430742$RANBAXY$$15$YR$T$$Y$$$20240702$$CN$US$US
240383261$24038326$1$I$$20230321$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382831$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240383271$24038327$1$I$$20240129$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430740$RANBAXY$$$$$M$Y$$$20240702$$CN$US$US
240383281$24038328$1$I$$20231222$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425997$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240383291$24038329$1$I$$20231110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419395$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240383301$24038330$1$I$$20240115$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428876$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240383311$24038331$1$I$$20231226$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-426153$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240383321$24038332$1$I$$20230109$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-374032$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240383331$24038333$1$I$$20240123$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429536$RANBAXY$$22$YR$$F$Y$$$20240702$$CN$US$US
240383341$24038334$1$I$$20221229$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-371737$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240383351$24038335$1$I$$20231120$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421234$RANBAXY$$$$A$M$Y$$$20240702$$CN$US$US
240383361$24038336$1$I$$20230320$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382934$RANBAXY$$$$$M$Y$$$20240702$$MD$US$US
240383371$24038337$1$I$$20240116$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429334$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240383381$24038338$1$I$$20240102$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-426887$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240383391$24038339$1$I$20220101$20230104$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-372761$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240383401$24038340$1$I$$20230112$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-374203$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240383411$24038341$1$I$$20230403$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384782$RANBAXY$Yildirim AM, Lemons N, Yousaf A, Zinn ZA. The Safety of Isotretinoin Treatment in Patients with Peanut Allergies. J Clin Aesthet Dermatol. 2022;Dec;15(12):49-51$21$YR$$M$Y$$$20240702$$HP$US$US
240383421$24038342$1$I$$20230111$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-373877$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240383431$24038343$1$I$$20240111$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428698$RANBAXY$$16$YR$$M$Y$$$20240702$$HP$US$US
240383441$24038344$1$I$$20230329$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383931$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240383451$24038345$1$I$$20230405$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384578$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240383461$24038346$1$I$$20230414$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385516$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240383471$24038347$1$I$$20231220$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425958$RANBAXY$$$$A$$Y$$$20240702$$HP$US$US
240383481$24038348$1$I$20240115$20240127$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430735$RANBAXY$$32$YR$A$$Y$$$20240702$$CN$US$US
240383491$24038349$1$I$$20230313$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382385$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240383501$24038350$1$I$$20230424$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386664$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240383511$24038351$1$I$$20231108$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417835$RANBAXY$$$$A$F$Y$$$20240702$$CN$US$US
240383521$24038352$1$I$20240125$20240126$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430605$RANBAXY$$27$YR$A$F$Y$$$20240702$$HP$US$US
240383531$24038353$1$I$$20230606$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394581$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240383541$24038354$1$I$20230522$20230522$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392229$RANBAXY$$20$YR$A$$Y$$$20240702$$HP$US$US
240383551$24038355$1$I$$20230202$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-377306$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240383561$24038356$1$I$$20230623$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397231$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240383571$24038357$1$I$$20230630$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-398386$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240383581$24038358$1$I$$20230630$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-398472$RANBAXY$$$$A$F$Y$$$20240702$$CN$US$US
240383591$24038359$1$I$$20230612$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395718$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240383601$24038360$1$I$$20230602$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395060$RANBAXY$Ghadimi TR, Martinez MJ. Rieder EA. Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series. J Drugs Dermatol. 2023;Apr;22(4):423-424$18$YR$$M$Y$$$20240702$$HP$US$US
240383611$24038361$1$I$$20230602$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395056$RANBAXY$Ghadimi TR, Martinez MJ, Rieder EA. Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series. J Drugs Dermatol. 2023;Apr;22(4):423-424$27$YR$$M$Y$$$20240702$$HP$US$US
240383621$24038362$1$I$$20230607$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394689$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240383631$24038363$1$I$20230523$20230523$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392220$RANBAXY$$19$YR$A$F$Y$$$20240702$$HP$US$US
240383641$24038364$1$I$$20230612$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395790$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240383651$24038365$1$I$$20230601$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393681$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240383661$24038366$1$I$$20240322$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438098$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
240383671$24038367$1$I$$20230525$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392784$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240383681$24038368$1$I$20240101$20240304$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436694$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240383691$24038369$1$I$$20240220$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434284$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240383701$24038370$1$I$$20240321$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439775$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240383711$24038371$1$I$$20240301$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436562$RANBAXY$$$$$M$Y$$$20240702$$CN$US$US
240383721$24038372$1$I$20240201$20240327$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440390$RANBAXY$$17$YR$T$F$Y$$$20240702$$MD$US$US
240383731$24038373$1$I$$20240226$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433540$RANBAXY$$$$$M$Y$$$20240702$$CN$US$US
240383741$24038374$1$I$$20240223$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434006$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240383751$24038375$1$I$$20240304$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436690$RANBAXY$$$$T$$Y$$$20240702$$CN$US$US
240383761$24038376$1$I$$20240212$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433011$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
240383771$24038377$1$I$$20240212$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432966$RANBAXY$$$$A$$Y$$$20240702$$HP$US$US
240383781$24038378$1$I$$20240405$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441393$RANBAXY$$$$T$F$Y$$$20240702$$CN$US$US
240383791$24038379$1$I$$20240307$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-437568$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240383801$24038380$1$I$$20240219$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434122$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240383811$24038381$1$I$$20240322$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-437787$RANBAXY$$15$YR$$M$Y$$$20240702$$CN$US$US
240383821$24038382$1$I$$20240213$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432961$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240383831$24038383$1$I$$20240306$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-437275$RANBAXY$$$$T$M$Y$$$20240702$$MD$US$US
240383841$24038384$1$I$$20240212$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433007$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240383851$24038385$1$I$$20240212$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432964$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240383861$24038386$1$I$$20240306$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-435972$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240383871$24038387$1$I$20240101$20240326$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439358$RANBAXY$$$$C$M$Y$$$20240702$$HP$US$US
240383881$24038388$1$I$20220501$20240312$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-437070$RANBAXY$$48$YR$A$M$Y$$$20240702$$MD$US$US
240383891$24038389$1$I$$20240326$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440430$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240383901$24038390$1$I$$20240318$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439102$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240383911$24038391$1$I$$20240321$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439888$RANBAXY$$$$T$$Y$$$20240702$$MD$US$US
240383921$24038392$1$I$$20240305$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-437237$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240383931$24038393$1$I$$20240207$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432237$RANBAXY$$$$T$$Y$$$20240702$$HP$US$US
240383941$24038394$1$I$$20240219$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434120$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240383951$24038395$1$I$$20240219$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434123$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
240383961$24038396$1$I$$20240221$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433400$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240383971$24038397$1$I$$20240223$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-435011$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240383981$24038398$1$I$20231201$20240224$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434297$RANBAXY$$15$YR$T$$Y$$$20240702$$CN$US$US
240383991$24038399$1$I$20240101$20240404$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436394$RANBAXY$$$$T$$Y$$$20240702$$HP$US$US
240384001$24038400$1$I$$20240320$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439583$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240384011$24038401$1$I$20240101$20240320$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439591$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240384021$24038402$1$I$$20240318$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439356$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240384031$24038403$1$I$$20240220$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434275$RANBAXY$$14$YR$$F$Y$$$20240702$$MD$US$US
240384041$24038404$1$I$$20240219$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433999$RANBAXY$$$$A$F$Y$$$20240702$$CN$US$US
240384051$24038405$1$I$$20240220$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433659$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240384061$24038406$1$I$$20240222$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434707$RANBAXY$$$$C$$Y$$$20240702$$CN$US$US
240384071$24038407$1$I$$20240401$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441134$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240384081$24038408$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000175$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240702$$CN$US$US
240384094$24038409$4$F$20240601$20240730$20240702$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407000347$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240805$$CN$US$US
240384101$24038410$1$I$20240628$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000569$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240702$$CN$US$US
240384111$24038411$1$I$$20240620$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406015691$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240702$$CN$US$US
240384121$24038412$1$I$$20240625$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406018267$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$US$US
240384131$24038413$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019748$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240702$$CN$US$US
240384141$24038414$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000180$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240702$$CN$US$US
240384152$24038415$2$F$$20240704$20240702$20240712$EXP$$US-TEVA-VS-3214642$TEVA$Abdalla JA, Wyatt T, Ghanem A. Brugada Syndrome Discovered After Cardiac Arrest. Am-J-Respir-Crit-Care-Med 2024; 209.; Abdalla JA, Wyatt T, Ghanem A. Brugada Syndrome Discovered After Cardiac Arrest. Am-J-Respir-Crit-Care-Med 2024; 209.$23$YR$$M$Y$$$20240712$$HP$US$US
240384161$24038416$1$I$$20240611$20240702$20240702$PER$$US-TAKEDA-2024TUS065762$TAKEDA$$$$$$Y$$$20240702$$CN$US$US
240384171$24038417$1$I$20240101$20240611$20240702$20240702$PER$$US-TAKEDA-2024TUS065753$TAKEDA$$$$$$Y$$$20240702$$CN$US$US
240384181$24038418$1$I$$20240628$20240702$20240702$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-104467$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240702$$MD$CA$CA
240384191$24038419$1$I$$20230727$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403836$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240384201$24038420$1$I$20230731$20230911$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408551$RANBAXY$$33$YR$A$F$Y$$$20240702$$MD$US$US
240384211$24038421$1$I$$20230919$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409608$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240384221$24038422$1$I$$20230823$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407389$RANBAXY$$$$A$$Y$$$20240702$$CN$US$US
240384231$24038423$1$I$$20230824$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407407$RANBAXY$$$$A$$Y$$$20240702$$HP$US$US
240384241$24038424$1$I$$20230918$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409613$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
240384251$24038425$1$I$20240429$20240509$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447208$RANBAXY$$16$YR$T$M$Y$$$20240702$$CN$US$US
240384261$24038426$1$I$$20230918$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409774$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240384271$24038427$1$I$$20240501$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446304$RANBAXY$$$$T$$Y$$$20240702$$CN$US$US
240384281$24038428$1$I$$20240403$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441432$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240384291$24038429$1$I$$20240404$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441638$RANBAXY$$$$T$$Y$$$20240702$$HP$US$US
240384301$24038430$1$I$20240101$20240411$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442488$RANBAXY$$$$T$$Y$$$20240702$$MD$US$US
240384311$24038431$1$I$$20240422$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-444054$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240384321$24038432$1$I$$20240408$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441382$RANBAXY$$$$A$F$Y$$$20240702$$CN$US$US
240384331$24038433$1$I$20240705$20240514$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447985$RANBAXY$$33$YR$A$F$Y$$$20240702$$HP$US$US
240384341$24038434$1$I$$20240416$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-443163$RANBAXY$$$$E$$Y$$$20240702$$MD$US$US
240384351$24038435$1$I$$20240514$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447986$RANBAXY$$$$A$F$Y$$$20240702$$PH$US$US
240384361$24038436$1$I$20240430$20240430$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446098$RANBAXY$$15$YR$T$F$Y$$$20240702$$MD$US$US
240384371$24038437$1$I$$20240523$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449727$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
240384381$24038438$1$I$$20240425$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445011$RANBAXY$$$$$M$Y$$$20240702$$PH$US$US
240384391$24038439$1$I$20230608$20230720$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402525$RANBAXY$$65$YR$E$$Y$$$20240702$$CN$US$US
240384401$24038440$1$I$$20230912$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408750$RANBAXY$$$$A$M$Y$$$20240702$$HP$US$US
240384411$24038441$1$I$$20240502$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445594$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240384421$24038442$1$I$$20230810$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405747$RANBAXY$$$$$M$Y$$$20240702$$HP$US$US
240384431$24038443$1$I$20240511$20240515$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448187$RANBAXY$$28$YR$A$F$Y$$$20240702$$CN$US$US
240384441$24038444$1$I$$20240529$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450130$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240384451$24038445$1$I$$20240501$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445629$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240384461$24038446$1$I$20240426$20240509$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447205$RANBAXY$$27$YR$A$F$Y$$$20240702$$HP$US$US
240384471$24038447$1$I$$20240419$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-443837$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240384481$24038448$1$I$$20240508$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446595$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240384491$24038449$1$I$$20230719$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402630$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240384501$24038450$1$I$20240301$20240610$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452128$RANBAXY$$15$YR$T$F$Y$$$20240702$$HP$US$US
240384511$24038451$1$I$$20240606$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451433$RANBAXY$$$$$F$Y$$$20240702$$CN$US$US
240384521$24038452$1$I$$20230815$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402064$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240384531$24038453$1$I$$20240503$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445869$RANBAXY$$$$E$$Y$$$20240702$$HP$US$US
240384541$24038454$1$I$$20240408$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442046$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240384551$24038455$1$I$$20240425$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445009$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240384561$24038456$1$I$$20240429$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445451$RANBAXY$$$$A$$Y$$$20240702$$CN$US$US
240384571$24038457$1$I$$20240422$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-444044$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240384581$24038458$1$I$$20240524$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448864$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
240384591$24038459$1$I$20240426$20240502$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445606$RANBAXY$$20$YR$A$F$Y$$$20240702$$CN$US$US
240384601$24038460$1$I$$20240614$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452236$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240384611$24038461$1$I$20241010$20240417$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-443338$RANBAXY$$16$YR$T$$Y$$$20240702$$CN$US$US
240384621$24038462$1$I$20240511$20240511$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447418$RANBAXY$$17$YR$T$F$Y$$$20240702$$PH$US$US
240384631$24038463$1$I$$20240528$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449960$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240384641$24038464$1$I$$20240510$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447440$RANBAXY$$$$A$$Y$$$20240702$$CN$US$US
240384651$24038465$1$I$$20240516$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446332$RANBAXY$$$$A$F$Y$$$20240702$$CN$US$US
240384661$24038466$1$I$$20240412$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442553$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240384671$24038467$1$I$$20240520$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448189$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240384681$24038468$1$I$20240520$20240520$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447777$RANBAXY$$39$YR$A$F$Y$$$20240702$$HP$US$US
240384691$24038469$1$I$$20240603$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451056$RANBAXY$$$$A$$Y$$$20240702$$HP$US$US
240384701$24038470$1$I$20240327$20240607$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450762$RANBAXY$$17$YR$T$F$Y$$$20240702$$HP$US$US
240384711$24038471$1$I$20240514$20240514$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447987$RANBAXY$$17$YR$T$F$Y$$$20240702$$CN$US$US
240384721$24038472$1$I$$20240619$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453418$RANBAXY$$$$T$M$Y$$$20240702$$CN$US$US
240384731$24038473$1$I$$20240425$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445008$RANBAXY$$$$A$$Y$$$20240702$$HP$US$US
240384741$24038474$1$I$$20240510$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447439$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240384751$24038475$1$I$$20240509$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446599$RANBAXY$$21$YR$$F$Y$$$20240702$$MD$US$US
240384761$24038476$1$I$$20240610$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452218$RANBAXY$$$$T$$Y$$$20240702$$MD$US$US
240384771$24038477$1$I$$20240603$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450763$RANBAXY$$$$A$$Y$$$20240702$$PH$US$US
240384781$24038478$1$I$20240418$20240523$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449631$RANBAXY$$30$YR$A$F$Y$$$20240702$$MD$US$US
240384791$24038479$1$I$20240424$20240426$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445179$RANBAXY$$15$YR$T$$Y$$$20240702$$HP$US$US
240384801$24038480$1$I$$20240530$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450369$RANBAXY$$$$T$M$Y$$$20240702$$MD$US$US
240384811$24038481$1$I$20240429$20240509$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447203$RANBAXY$$16$YR$T$M$Y$$$20240702$$PH$US$US
240384821$24038482$1$I$20240401$20240401$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441158$RANBAXY$$20$YR$A$M$Y$$$20240702$$CN$US$US
240384831$24038483$1$I$$20240604$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451323$RANBAXY$$$$A$$Y$$$20240702$$CN$US$US
240384841$24038484$1$I$$20240509$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446643$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240384851$24038485$1$I$$20240605$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451331$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240384861$24038486$1$I$20230101$20231006$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-412923$RANBAXY$$$$T$M$Y$$$20240702$$CN$US$US
240384871$24038487$1$I$$20240515$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448191$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240384881$24038488$1$I$$20240109$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428363$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
240384891$24038489$1$I$$20231118$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420855$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240384901$24038490$1$I$$20231002$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-412161$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240384911$24038491$1$I$$20211202$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-320055$RANBAXY$$$$$F$Y$$$20240702$$HP$US$US
240384921$24038492$1$I$20220322$20220323$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-331729$RANBAXY$$20$YR$A$M$Y$$$20240702$$HP$US$US
240384931$24038493$1$I$$20231117$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420852$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240384941$24038494$1$I$20231202$20231202$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422947$RANBAXY$$28$YR$A$F$Y$$$20240702$$CN$US$US
240384951$24038495$1$I$$20231108$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419768$RANBAXY$Guenin S, Lebwohl M. Bexarotene use in refractory Darier^s disease. Int J Dermatol. 2023;62(11):e587-e589$30$YR$$M$Y$$$20240702$$HP$US$US
240384961$24038496$1$I$20220225$20220225$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-328465$RANBAXY$$48$YR$A$$Y$$$20240702$$HP$US$US
240384971$24038497$1$I$20231218$20231218$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425543$RANBAXY$$13$YR$T$$Y$$$20240702$$HP$US$US
240384981$24038498$1$I$$20231218$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425539$RANBAXY$$$$A$$Y$$$20240702$$HP$US$US
240384991$24038499$1$I$$20231110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419073$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240385001$24038500$1$I$$20240207$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432238$RANBAXY$$$$T$$Y$$$20240702$$HP$US$US
240385011$24038501$1$I$20231001$20231019$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-414372$RANBAXY$$21$YR$A$$Y$$$20240702$$CN$US$US
240385021$24038502$1$I$$20231103$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417844$RANBAXY$$$$A$$Y$$$20240702$$MD$US$US
240385031$24038503$1$I$$20231006$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413251$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240385041$24038504$1$I$20240506$20240625$20240702$20240702$EXP$$CN-BEIGENE-BGN-2024-009773$BEIGENE$$$$$$Y$$$20240702$$HP$CN$CN
240385051$24038505$1$I$$20231031$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417663$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
240385061$24038506$1$I$20231221$20240213$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-431520$RANBAXY$$22$YR$A$M$Y$$$20240702$$MD$US$US
240385071$24038507$1$I$$20231128$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-423288$RANBAXY$$48$YR$$F$Y$$$20240702$$MD$US$US
240385081$24038508$1$I$$20231219$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425957$RANBAXY$$$$T$F$Y$$$20240702$$MD$US$US
240385091$24038509$1$I$$20240118$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428790$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
240385101$24038510$1$I$20231003$20231017$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413734$RANBAXY$$47$YR$A$F$Y$$$20240702$$MD$US$US
240385111$24038511$1$I$$20240207$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432240$RANBAXY$$$$T$F$Y$$$20240702$$HP$US$US
240385121$24038512$1$I$$20240129$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430739$RANBAXY$$$$$M$Y$$$20240702$$CN$US$US
240385131$24038513$1$I$$20231221$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425476$RANBAXY$$$$T$M$Y$$$20240702$$HP$US$US
240385141$24038514$1$I$$20240113$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-426885$RANBAXY$$$$T$F$Y$$$20240702$$CN$US$US
240385151$24038515$1$I$20230101$20231201$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422923$RANBAXY$$$$T$$Y$$$20240702$$MD$US$US
240385161$24038516$1$I$$20240118$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429344$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240385171$24038517$1$I$$20231129$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422133$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240385181$24038518$1$I$$20240117$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429137$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240385191$24038519$1$I$20240101$20240624$20240702$20240702$EXP$$US-JNJFOC-20240663519$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240385201$24038520$1$I$$20240619$20240702$20240702$PER$$US-JNJFOC-20240653764$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240702$$CN$US$US
240385211$24038521$1$I$20220310$20220526$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-339121$RANBAXY$$15$YR$T$M$Y$$$20240702$$MD$US$US
240385221$24038522$1$I$20240520$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031530$AUROBINDO$$12$YR$$M$Y$$$20240702$$PH$FR$FR
240385231$24038523$1$I$$20240617$20240702$20240702$EXP$$CA-ROCHE-10000013189$ROCHE$$$$A$F$Y$$$20240702$$CN$CA$CA
240385241$24038524$1$I$20240603$20240625$20240702$20240702$PER$$US-JNJFOC-20240671059$JOHNSON AND JOHNSON$$65$YR$E$M$Y$65.3$KG$20240702$$CN$US$US
240385251$24038525$1$I$$20240620$20240702$20240702$EXP$$US-APOTEX-2024AP007749$APOTEX$Hong A, Durant CE, Watson RL, Betancourt J, Eng KJ. Recurrent Hypoxia With Feeding: Uncovering the Hidden Fistula. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-3$77$YR$$M$Y$$$20240702$$HP$US$US
240385261$24038526$1$I$20240501$20240619$20240702$20240702$EXP$$US-ROCHE-10000010146$ROCHE$$73$YR$E$M$Y$$$20240702$$CN$US$US
240385271$24038527$1$I$20240521$20240625$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102444$BRISTOL MYERS SQUIBB$$8$YR$C$F$Y$$$20240702$$HP$US$US
240385282$24038528$2$F$20240104$20240801$20240702$20240807$EXP$$NVSC2024AT134390$NOVARTIS$$62$YR$$M$Y$$$20240808$$MD$AT$AT
240385292$24038529$2$F$20240101$20240619$20240702$20240917$PER$$US-TEVA-VS-3212800$TEVA$$73$YR$$F$Y$$$20240917$$CN$US$US
240385301$24038530$1$I$20211205$20240624$20240702$20240702$PER$$US-BIOGEN-2024BI01271389$BIOGEN$$66$YR$$F$Y$$$20240702$$CN$US$US
240385311$24038531$1$I$$20240625$20240702$20240702$PER$$US-BIOGEN-2024BI01271102$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
240385322$24038532$2$F$$20240709$20240702$20240715$PER$$US-BIOGEN-2024BI01271101$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240385331$24038533$1$I$20240301$20240625$20240702$20240702$PER$$US-BIOGEN-2024BI01255619$BIOGEN$$24$YR$$F$Y$$$20240702$$CN$US$US
240385341$24038534$1$I$$20221107$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-363081$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240385351$24038535$1$I$$20221114$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-364160$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240385361$24038536$1$I$$20221110$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365787$RANBAXY$Alazawi S, Hendriksz T. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review. J Osteopath Med. 2022;122(1):45-53$16$YR$$M$Y$$$20240702$$MD$US$US
240385371$24038537$1$I$20220920$20220926$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-356807$RANBAXY$$16$YR$T$F$Y$$$20240702$$MD$US$US
240385381$24038538$1$I$$20220908$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-354594$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240385391$24038539$1$I$$20240403$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441460$RANBAXY$$$$A$F$Y$$$20240702$$HP$US$US
240385401$24038540$1$I$20240522$20240522$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449407$RANBAXY$$15$YR$T$$Y$$$20240702$$MD$US$US
240385411$24038541$1$I$$20240430$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445404$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240385421$24038542$1$I$$20240618$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453772$RANBAXY$Holt S, Saju S, Miller R.. A case of darier disease with perioral cutaneous cobblestoning treated with dupilumab. JAAD Case Rep. 2024;49 (0):68-70$53$YR$$M$Y$$$20240702$$HP$US$US
240385431$24038543$1$I$$20230123$20240702$20240702$PER$$US-AMGEN-USASP2023235146$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240385441$24038544$1$I$$20221220$20240702$20240702$PER$$US-AMGEN-USASP2022230345$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240385452$24038545$2$F$20240625$20240826$20240702$20240827$PER$$US-AMGEN-USASP2024128417$AMGEN$$64$YR$A$M$Y$$$20240827$$CN$US$US
240385461$24038546$1$I$$20240414$20240702$20240702$PER$$US-AMGEN-USASP2024129547$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240385471$24038547$1$I$$20230729$20240702$20240702$PER$$US-AMGEN-USASP2023235023$AMGEN$$$$$$Y$$$20240701$$CN$US$US
240385481$24038548$1$I$20240401$20240607$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451613$RANBAXY$$27$YR$A$F$Y$$$20240702$$HP$US$US
240385491$24038549$1$I$$20240506$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446297$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240385501$24038550$1$I$$20240507$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446720$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240385511$24038551$1$I$$20240412$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442552$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240385521$24038552$1$I$20240411$20240412$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442612$RANBAXY$$20$YR$A$F$Y$$$20240702$$CN$US$US
240385531$24038553$1$I$$20240430$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445403$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240385541$24038554$1$I$20240429$20240503$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445609$RANBAXY$$21$YR$A$F$Y$$$20240702$$HP$US$US
240385551$24038555$1$I$$20240513$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447781$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240385561$24038556$1$I$20240401$20240503$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445611$RANBAXY$$14$YR$T$$Y$$$20240702$$CN$US$US
240385571$24038557$1$I$$20240611$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452353$RANBAXY$$$$A$F$Y$$$20240702$$MD$US$US
240385581$24038558$1$I$20240101$20240614$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452785$RANBAXY$$$$A$M$Y$$$20240702$$MD$US$US
240385591$24038559$1$I$20240101$20240605$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451628$RANBAXY$$$$A$$Y$$$20240702$$HP$US$US
240385601$24038560$1$I$$20230502$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-386378$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240385611$24038561$1$I$$20230309$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382544$RANBAXY$$$$$F$Y$$$20240702$$MD$US$US
240385621$24038562$1$I$$20230130$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-376622$RANBAXY$$$$$$Y$$$20240702$$CN$US$US
240385631$24038563$1$I$20230210$20230213$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-379412$RANBAXY$$13$YR$T$F$Y$$$20240702$$CN$US$US
240385641$24038564$1$I$$20230327$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383439$RANBAXY$$$$$$Y$$$20240702$$MD$US$US
240385651$24038565$1$I$$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024128146$AMGEN$$$$$$Y$$$20240701$$HP$US$US
240385662$24038566$2$F$20240621$20240729$20240702$20240805$30DAY$$US-AMGEN-USASP2024126964$AMGEN$$45$YR$A$F$Y$90.6$KG$20240805$$PH$US$US
240385671$24038567$1$I$20240625$20240625$20240702$20240702$EXP$$US-AMGEN-USASP2024126070$AMGEN$$72$YR$E$F$Y$$$20240701$$CN$US$US
240385681$24038568$1$I$20240627$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406292309212590-HVMJD$GB-GSK-GB2024081135$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$GB$GB
240385691$24038569$1$I$20240626$20240626$20240702$20240702$PER$$US-JNJFOC-20240671503$JOHNSON AND JOHNSON$$28$YR$A$$Y$$$20240702$$CN$US$US
240385701$24038570$1$I$$20240618$20240702$20240702$EXP$$IN-ROCHE-3537976$ROCHE$$60$YR$A$M$Y$$$20240702$$MD$IN$IN
240385711$24038571$1$I$20240618$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127337$AMGEN$$$$C$$Y$$$20240701$$PH$US$US
240385721$24038572$1$I$$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128567$AMGEN$$$$$F$Y$$$20240701$$CN$US$US
240385731$24038573$1$I$$20240618$20240702$20240702$PER$$US-APOTEX-2024AP007558$APOTEX$Eid JJ, Stelzer JW, Rodner CM.. Severe Carpal Tunnel Syndrome in a Pediatric Patient With a History of Congenital Adrenal Hyperplasia. Journal of Hand Surgery Global Online. 2024;6 (3):435-437$17$YR$$F$Y$$$20240702$$HP$US$US
240385741$24038574$1$I$$20240619$20240702$20240702$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000932$ALEMBIC$Holbert K. Multiorgan Failure From Heat Stroke in a Person Taking Glycopyrrolate. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240702$$HP$US$US
240385751$24038575$1$I$$20240625$20240702$20240702$PER$$NVSC2024US133337$NOVARTIS$$24$YR$$F$Y$$$20240702$$CN$US$US
240385761$24038576$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA186239$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240702$$MD$US$US
240385772$24038577$2$F$20240403$20240803$20240702$20240807$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000936$ALEMBIC$$$$$$Y$$$20240807$$CN$US$US
240385782$24038578$2$F$20240101$20240716$20240702$20240725$PER$$US-SA-2024SA188047$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240725$$MD$US$US
240385791$24038579$1$I$$20240626$20240702$20240702$PER$$US-SA-2024SA192223$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240702$$MD$US$US
240385801$24038580$1$I$20230829$20240103$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408345$RANBAXY$$16$YR$T$F$Y$$$20240702$$HP$US$US
240385811$24038581$1$I$$20230921$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409311$RANBAXY$$$$T$M$Y$$$20240702$$CN$US$US
240385821$24038582$1$I$20240209$20240624$20240702$20240702$EXP$$DE-AUROBINDO-AUR-APL-2024-031431$AUROBINDO$$57$YR$$M$Y$73.6$KG$20240702$$MD$DE$DE
240385831$24038583$1$I$20240301$20240627$20240702$20240702$EXP$$US-UCBSA-2024014513$UCB$$30$YR$$F$Y$$$20240702$$CN$US$US
240385841$24038584$1$I$20230405$20240620$20240702$20240702$EXP$$US-RDY-SPO/USA/23/0163766$DR REDDYS$$33$YR$A$F$Y$45.72$KG$20240702$$MD$US$US
240385851$24038585$1$I$$20240620$20240702$20240702$EXP$US-MLMSERVICE-20240613-PI100267-00190-1$US-RDY-SPO/USA/24/0009157$DR REDDYS$Pitter D, Hanley S, Eisa H, Nene Y, Zhou X. Unexpected Seizure Activity in the Setting of Lamotrigine Toxicity. Cureus. 2024;16(5):e60094. DOI: 10.7759/cureus.60094.$28$YR$A$F$Y$$$20240702$$MD$US$US
240385861$24038586$1$I$20240211$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031434$AUROBINDO$$33$YR$$M$Y$81$KG$20240702$$MD$FR$FR
240385872$24038587$2$F$20240528$20240627$20240702$20240709$PER$$US-ROCHE-3573671$ROCHE$$$$$M$Y$$$20240705$$CN$US$US
240385882$24038588$2$F$$20240722$20240702$20240727$PER$$US-AMGEN-USASP2024127707$AMGEN$$$$$M$Y$$$20240727$$CN$US$US
240385891$24038589$1$I$$20240617$20240702$20240702$EXP$GB-ABBVIE-5800975$GB-ROCHE-10000003208$ROCHE$$$$$F$Y$$$20240702$$HP$GB$GB
240385903$24038590$3$F$20240606$20240726$20240702$20240729$PER$$US-AMGEN-USASP2024127675$AMGEN$$68$YR$E$F$Y$$$20240729$$CN$US$US
240385911$24038591$1$I$20240613$20240624$20240702$20240702$EXP$$IT-AUROBINDO-AUR-APL-2024-031469$AUROBINDO$$57$YR$$F$Y$$$20240702$$PH$IT$IT
240385921$24038592$1$I$$20240618$20240702$20240702$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091749$GLENMARK$Bury K, Citriniti V, Bahrampour S, Bajaj S, Ferguson JF.. Understanding the Risk Factors and Pathogenesis of Disseminated Nocardiosis in Immunocompromised Patients.. Cureus.. 2024;16 (5):e59838$$$$$Y$$$20240702$$MD$US$US
240385931$24038593$1$I$$20240626$20240702$20240702$EXP$$IR-Bion-013327$BIONPHARMA$$66$YR$E$F$Y$$$20240702$$HP$IR$IR
240385941$24038594$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000258$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240702$$CN$US$US
240385951$24038595$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019450$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240702$$CN$US$US
240385961$24038596$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000254$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240702$$CN$US$US
240385971$24038597$1$I$$20240625$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019837$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240702$$CN$US$US
240385981$24038598$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000196$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$US$US
240385991$24038599$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000484$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240702$$CN$US$US
240386001$24038600$1$I$$20240626$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019550$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$US$US
240386011$24038601$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000080$ELI LILLY AND CO$$$$$$Y$$$20240702$$PH$US$US
240386021$24038602$1$I$20240627$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000142$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240702$$CN$US$US
240386031$24038603$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406016258$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$US$US
240386041$24038604$1$I$$20240626$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000643$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240702$$CN$US$US
240386051$24038605$1$I$20240628$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000435$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240702$$CN$US$US
240386061$24038606$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000158$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240702$$CN$US$US
240386071$24038607$1$I$20240614$20240618$20240702$20240702$PER$$US-ROCHE-10000006068$ROCHE$$$$$$Y$$$20240702$$HP$US$US
240386101$24038610$1$I$$20240620$20240702$20240702$EXP$$US-CHATTEMPRD-2024OHG022190$CHATTEM$Sasidharan S, Jatoi T, Milla C, Mallappallil M, Agarwal S, Puri I. Triple whammy of Amlodipine, Carvedilol and Diphenhydramine overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5669. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5669.$27$YR$A$F$Y$$$20240702$$MD$US$US
240386112$24038611$2$F$20240604$20240715$20240702$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-031437$AUROBINDO$$55$YR$$F$Y$81.3$KG$20240724$$MD$FR$FR
240386141$24038614$1$I$$20240628$20240702$20240702$EXP$$GB-UCBSA-2024033196$UCB$$$$$F$Y$$$20240702$$CN$GB$GB
240386151$24038615$1$I$$20240618$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06671$CIPLA$Devault KF, Mudrakola HV. Hydralazine induced pleuropericarditis with bilateral eosinophilic pleural effusions. Am J Respir Crit Care Med. 2024;209:A2029$$$$$Y$$$20240702$$HP$US$US
240386161$24038616$1$I$$20240621$20240702$20240702$PER$$US-ROCHE-10000012544$ROCHE$$80$YR$E$F$Y$515.28$KG$20240702$$HP$US$US
240386172$24038617$2$F$20201110$20240828$20240702$20240909$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05648$HIKMA$$64$YR$$F$Y$$$20240909$$CN$US$US
240386181$24038618$1$I$$20230612$20240702$20240702$PER$$US-AMGEN-USASP2023235274$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240386192$24038619$2$F$$20240711$20240702$20240712$PER$$US-AMGEN-USASP2024128465$AMGEN$$66$YR$E$F$Y$$$20240712$$HP$US$US
240386201$24038620$1$I$$20240621$20240702$20240702$PER$$US-ROCHE-10000012083$ROCHE$$$$$$Y$$$20240702$$CN$US$US
240386211$24038621$1$I$20230124$20240625$20240702$20240702$EXP$GB-MHRA-MED-202406241411204870-RSVBM$GB-ROCHE-10000009967$ROCHE$$$$$M$Y$$$20240702$$MD$GB$GB
240386221$24038622$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007662$APOTEX$$82$YR$$F$Y$$$20240702$$HP$CA$CA
240386231$24038623$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000011111$ROCHE$$$$E$F$Y$68.03$KG$20240702$$MD$US$US
240386241$24038624$1$I$20240524$20240624$20240702$20240702$EXP$$ES-AUROBINDO-AUR-APL-2024-031444$AUROBINDO$$67$YR$$F$Y$$$20240702$$MD$ES$ES
240386252$24038625$2$F$20220320$20240801$20240702$20240805$EXP$JP-intagehealthcare-A3270S010810$JP-TAKEDA-SH202212387$TAKEDA$$14$YR$$F$Y$54$KG$20240804$$MD$JP$JP
240386261$24038626$1$I$$20240620$20240702$20240702$EXP$$US-CHATTEMPRD-2024OHG022191$CHATTEM$Hoerle R, Qiao X. A Last Resort: Lipid Emulsion Therapy in Lidocaine Anesthetic Systemic Toxicity (LAST). American Journal of Respiratory and Critical Care Medicine. 2024;209:A5683. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5683.$81$YR$E$F$Y$65$KG$20240702$$MD$US$US
240386271$24038627$1$I$$20240628$20240702$20240702$PER$$US-HALEON-2184459$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240386281$24038628$1$I$$20240628$20240702$20240702$PER$$US-HALEON-2184561$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240386292$24038629$2$F$$20240704$20240702$20240712$EXP$$US-TEVA-VS-3214629$TEVA$Raymond-Forde S, Olexsey K. A Rare but Potentially Fatal Reaction in Plain Sight: Trimethoprim- Sulfamethoxazole Induced Acute Lung Injury. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Raymond-Forde S, Olexsey K. A Rare but Potentially Fatal Reaction in Plain Sight: Trimethoprim- Sulfamethoxazole Induced Acute Lung Injury. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$34$YR$$M$Y$$$20240712$$HP$US$US
240386301$24038630$1$I$$20240625$20240702$20240702$EXP$$FR-JNJFOC-20240701339$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240702$$CN$FR$FR
240386311$24038631$1$I$20240501$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031481$AUROBINDO$$63$YR$$F$Y$87$KG$20240702$$MD$FR$FR
240386322$24038632$2$F$$20240710$20240702$20240723$30DAY$$US-JNJFOC-20240653666$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$HP$US$US
240386331$24038633$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5816778$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240386341$24038634$1$I$20240617$20240618$20240702$20240702$EXP$$US-MDD US Operations-MDD202406-002192$MDD OPERATIONS$$$$$M$Y$$$20240702$$CN$US$
240386351$24038635$1$I$$20240624$20240702$20240702$EXP$$US-TEVA-VS-3214628$TEVA$Raymond-Forde S, Olexsey K. A Rare but Potentially Fatal Reaction in Plain Sight: Trimethoprim- Sulfamethoxazole Induced Acute Lung Injury. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$26$YR$$F$Y$$$20240702$$HP$US$US
240386361$24038636$1$I$20231101$20240628$20240702$20240702$EXP$$US-UCBSA-2024033234$UCB$$28$YR$$F$Y$$$20240702$$HP$US$US
240386371$24038637$1$I$$20240628$20240702$20240702$EXP$$JP-TAKEDA-2024TJP009829$TAKEDA$$34$YR$$M$Y$$$20240702$$MD$JP$JP
240386381$24038638$1$I$20240613$20240628$20240702$20240702$EXP$$US-TAKEDA-2022TUS049441$TAKEDA$$34$YR$$M$Y$$$20240702$$CN$US$US
240386391$24038639$1$I$$20240626$20240702$20240702$EXP$$ES-Bion-013340$BIONPHARMA$$54$YR$A$F$Y$$$20240702$$HP$ES$ES
240386401$24038640$1$I$20240319$20240624$20240702$20240702$EXP$$ES-AUROBINDO-AUR-APL-2024-031425$AUROBINDO$$57$YR$$M$Y$$$20240702$$MD$ES$ES
240386412$24038641$2$F$$20240708$20240702$20240716$PER$$US-APOTEX-2024AP007759$APOTEX$Zaidi W, Saeed AI, Lundquist N, Nelson AR, Razia D, Lee R, et al.. Bronchoscopic Debridement of Endobronchial Rhizopus With 1.1 Mm Cryoprobe in Lung Transplant Recipient. American Journal of Respiratory and Critical Care Medicine. 2024;209 (0):1-4$67$YR$$M$Y$$$20240716$$HP$US$US
240386421$24038642$1$I$$20240618$20240702$20240702$PER$$US-APOTEX-2024AP007567$APOTEX$$$$E$F$Y$$$20240702$$CN$US$US
240386432$24038643$2$F$20240626$20240717$20240702$20240722$EXP$$CA-UCBSA-2024033061$UCB$$44$YR$$M$Y$$$20240722$$CN$CA$CA
240386442$24038644$2$F$$20240708$20240702$20240708$PER$$US-JNJFOC-20240701097$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240708$$HP$US$US
240386451$24038645$1$I$20240625$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024128618$AMGEN$$75$YR$E$M$Y$$$20240702$$CN$US$US
240386461$24038646$1$I$20240610$20240625$20240702$20240702$EXP$IT-MINISAL02-991612$IT-AMGEN-ITASP2024125557$AMGEN$$54$YR$A$F$Y$$$20240702$$MD$IT$IT
240386471$24038647$1$I$$20240628$20240702$20240702$EXP$$JP-TAKEDA-2024TJP009853$TAKEDA$$67$YR$$F$Y$$$20240702$$MD$JP$JP
240386481$24038648$1$I$$20240628$20240702$20240702$EXP$$JP-TAKEDA-2024TJP009855$TAKEDA$$69$YR$$F$Y$$$20240702$$MD$JP$JP
240386491$24038649$1$I$20240601$20240626$20240702$20240702$EXP$$IT-ABBVIE-5818632$ABBVIE$$74$YR$$F$Y$$$20240702$$CN$IT$IT
240386503$24038650$3$F$20240301$20240708$20240702$20240712$EXP$$PT-AMGEN-PRTNI2024113982$AMGEN$$77$YR$E$F$Y$$$20240712$$PH$PT$PT
240386511$24038651$1$I$$20240628$20240702$20240702$EXP$$JP-TAKEDA-2024TJP009857$TAKEDA$$45$YR$$F$Y$$$20240702$$MD$JP$JP
240386521$24038652$1$I$20170825$20170926$20240702$20240702$EXP$$JP-TAKEDA-SH201712956$TAKEDA$$16$YR$$M$Y$50$KG$20240702$$MD$JP$JP
240386531$24038653$1$I$$20240624$20240702$20240702$EXP$$US-ROCHE-10000008335$ROCHE$Granger E, Groover M, Harwood C, Proby C, Karn E, Murad F, et al. Cutaneous squamous cell carcinoma tumor accrual rates in immunosuppressed patients with autoimmune and inflammatory conditions: A retrospective cohort study. J.Am.Acad.Dermatol. 2024;90 (4):731-8. doi:10.1016/j.jaad.2023.11.039.$$$$$Y$$$20240702$$HP$US$US
240386551$24038655$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000013026$ROCHE$$73$YR$E$F$Y$$$20240702$$MD$US$US
240386561$24038656$1$I$20240101$20240619$20240702$20240702$PER$$US-APOTEX-2024AP007554$APOTEX$$$$$M$Y$$$20240702$$CN$US$US
240386571$24038657$1$I$20231101$20240626$20240702$20240702$EXP$$US-ABBVIE-5819830$ABBVIE$$70$YR$$F$Y$$$20240702$$CN$US$US
240386581$24038658$1$I$$20240110$20240702$20240702$EXP$GB-MHRA-MED-202401091004224670-FVLJM$GB-TEVA-VS-3146467$TEVA$$$$$M$Y$$$20240702$$HP$GB$GB
240386591$24038659$1$I$$20240628$20240702$20240702$EXP$$JP-TAKEDA-2024TJP009860$TAKEDA$$57$YR$$F$Y$$$20240702$$MD$JP$JP
240386601$24038660$1$I$20231208$20240612$20240702$20240702$EXP$$DE-ROCHE-10000013469$ROCHE$$44$YR$A$M$Y$$$20240702$$MD$DE$DE
240386612$24038661$2$F$$20240704$20240702$20240712$EXP$$ES-AUROBINDO-AUR-APL-2024-031565$AUROBINDO$Marc R R, Santiago C A, Jordi C P and Maria L O S,. Visceral coloration due to the blue of postmortem methylene Postmortem visceral staining due to methylene blue. Magazine Spanish Legal Medicine. 3$41$YR$$F$Y$$$20240712$$MD$ES$ES
240386622$24038662$2$F$20231122$20240806$20240702$20240808$EXP$$CA-JNJFOC-20231152730$JOHNSON AND JOHNSON$$14$YR$T$M$Y$69.3$KG$20240809$$HP$CA$CA
240386633$24038663$3$F$20240706$20240904$20240702$20240916$EXP$$CA-UCBSA-2024001651$UCB$$29$YR$$F$Y$$$20240916$$CN$CA$CA
240386641$24038664$1$I$$20240326$20240702$20240702$PER$$US-AMGEN-USASP2024129777$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240386651$24038665$1$I$$20230621$20240702$20240702$PER$$US-AMGEN-USASP2023235275$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240386661$24038666$1$I$20231109$20240404$20240702$20240702$EXP$IT-MINISAL02-975020$IT-TEVA-VS-3180356$TEVA$$66$YR$$F$Y$$$20240702$$MD$IT$IT
240386691$24038669$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A145686$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240386701$24038670$1$I$$20240624$20240702$20240702$EXP$$ES-AstraZeneca-2024A149191$ASTRAZENECA$$$$$F$Y$$$20240702$$MD$ES$
240386711$24038671$1$I$$20240615$20240702$20240702$PER$$US-AstraZeneca-2024A140578$ASTRAZENECA$$$$$$Y$$$20240702$$CN$US$
240386723$24038672$3$F$$20240912$20240702$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105222$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240913$$CN$US$US
240386732$24038673$2$F$$20240705$20240702$20240715$EXP$$US-GRAVITIPHARMA-GRA-2406-US-LIT-0185$GRAVITI PHARMACEUTICALS$Jumaili WA, Gburi NA, Chaudhary N, Brown K, Jain S..Two Cases of Montelukast-Associated Psychosis in Children.Prim-Care-Companion-CNS-Disord.2024;26:3$11$YR$C$M$Y$$$20240715$$MD$US$US
240386741$24038674$1$I$20180815$20240623$20240702$20240702$EXP$$US-SA-2024SA187830$SANOFI AVENTIS$$22$YR$A$F$Y$53.07$KG$20240702$$HP$US$US
240386753$24038675$3$F$20240306$20240704$20240702$20240712$EXP$$DE-AUROBINDO-AUR-APL-2024-019846$AUROBINDO$$64$YR$$M$Y$92$KG$20240712$$MD$DE$DE
240386761$24038676$1$I$20240628$20240628$20240702$20240702$PER$$NVSC2024US136385$NOVARTIS$$70$YR$$$Y$$$20240702$$CN$US$US
240386771$24038677$1$I$20240624$20240627$20240702$20240702$EXP$$RU-ABBVIE-5822453$ABBVIE$$$$$F$Y$$$20240702$$CN$RU$RU
240386781$24038678$1$I$$20240628$20240702$20240702$PER$$US-GILEAD-2024-0679056$GILEAD$$$$$$Y$$$20240702$$CN$US$US
240386801$24038680$1$I$20240626$20240627$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104164$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240702$$PH$US$US
240386811$24038681$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031640$AUROBINDO$Qazi ZA, Ward M, Sithamraju A, Demars B, Bates T, Calick D, et al. A Rare Cause of Acute Hypoxic Respiratory Failure After ST-Elevation Myocardial Infarction. Am-J-Respir-Crit-Care-Med. 2024;209:A3650$77$YR$$F$Y$$$20240702$$HP$US$US
240386821$24038682$1$I$20240619$20240619$20240702$20240702$EXP$$GB-ROCHE-10000007898$ROCHE$$38$YR$A$M$Y$$$20240702$$HP$GB$GB
240386832$24038683$2$F$$20240905$20240702$20240912$EXP$$US-ABBVIE-5821590$ABBVIE$$$$$F$Y$52$KG$20240912$$CN$US$US
240386841$24038684$1$I$$20240625$20240702$20240702$PER$$US-UNITED THERAPEUTICS-UNT-2024-016473$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240702$$$US$US
240386852$24038685$2$F$20240519$20240711$20240702$20240717$EXP$$JP-GENMAB-2024-01855AA$GENMAB$$82$YR$$F$Y$48$KG$20240717$$MD$JP$JP
240386861$24038686$1$I$$20240627$20240702$20240702$EXP$$AT-UCBSA-2024033024$UCB$$$$$F$Y$$$20240702$$MD$AT$AT
240386882$24038688$2$F$20240501$20240715$20240702$20240722$PER$$US-ALXN-202406USA001545US$ALEXION PHARMACEUTICALS$$69$YR$$M$Y$$$20240722$$CN$US$US
240386891$24038689$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007656$APOTEX$$6$YR$$M$Y$35$KG$20240702$$CN$CA$CA
240386901$24038690$1$I$20231220$20240625$20240702$20240702$EXP$$IT-CELLTRION INC.-2024IT015609$CELLTRION$$$$$$Y$$$20240702$$MD$IT$IT
240386911$24038691$1$I$$20240627$20240702$20240702$EXP$$FI-UCBSA-2024033026$UCB$$$$$F$Y$$$20240702$$MD$FI$FI
240386921$24038692$1$I$$20230104$20240702$20240702$PER$$US-AMGEN-USASP2023235090$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240386931$24038693$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821405$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240386941$24038694$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821692$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240386951$24038695$1$I$$20240628$20240702$20240702$EXP$$JP-TAKEDA-2024TJP009861$TAKEDA$$60$YR$$F$Y$$$20240702$$MD$JP$JP
240386961$24038696$1$I$$20230720$20240702$20240702$PER$$US-AMGEN-USASP2023235069$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240386972$24038697$2$F$20240627$20240712$20240702$20240715$PER$$US-AMGEN-USASP2024128494$AMGEN$$67$YR$E$F$Y$$$20240715$$PH$US$US
240386982$24038698$2$F$20240625$20240809$20240702$20240813$PER$$US-AMGEN-USASP2024126602$AMGEN$$56$YR$A$F$Y$$$20240813$$CN$US$US
240386991$24038699$1$I$$20240618$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-05618$HIKMA$$$$$$Y$$$20240702$$CN$US$US
240387002$24038700$2$F$20240601$20240702$20240702$20240705$EXP$$US-ABBVIE-5821776$ABBVIE$$79$YR$$M$Y$79.378$KG$20240705$$CN$US$US
240387011$24038701$1$I$20240101$20240628$20240702$20240702$EXP$$AU-ABBVIE-5820247$ABBVIE$$$$$M$Y$$$20240702$$CN$AU$US
240387021$24038702$1$I$$20240628$20240702$20240702$EXP$$JP-TAKEDA-2024TJP009867$TAKEDA$$69$YR$$F$Y$$$20240702$$MD$JP$JP
240387032$24038703$2$F$20230726$20240624$20240702$20240710$EXP$$PL-AstraZeneca-2024A144826$ASTRAZENECA$$70$YR$$F$Y$108$KG$20240710$$MD$PL$
240387041$24038704$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000200$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240702$$CN$US$US
240387051$24038705$1$I$20240101$20240627$20240702$20240702$EXP$$DE-UCBSA-2024033027$UCB$$$$$F$Y$$$20240702$$MD$DE$DE
240387061$24038706$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000029$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$US$US
240387071$24038707$1$I$20240625$20240625$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406018366$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240702$$CN$US$US
240387081$24038708$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000213$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240702$$CN$US$US
240387091$24038709$1$I$20240626$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000598$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240702$$CN$US$US
240387101$24038710$1$I$$20240618$20240702$20240702$EXP$$US-ENDO USA, INC.-2024-002704$ENDO$Fitzgerald T, Arroyo Morr MA.. Vaping-Associated Lung Injury From Oxycodone-Acetaminophen Inhalation. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6172$17$YR$$M$Y$$$20240702$$HP$US$US
240387111$24038711$1$I$20240607$20240610$20240702$20240702$PER$$US-GLK-002350$GLAUKOS$$$$$$Y$$$20240702$$CN$US$US
240387135$24038713$5$F$$20240906$20240702$20240913$EXP$$CA-JNJFOC-20240501390$JOHNSON AND JOHNSON$$65$YR$E$M$Y$56$KG$20240913$$HP$CA$CA
240387141$24038714$1$I$20170917$20171108$20240702$20240702$EXP$$JP-TAKEDA-SH201714268$TAKEDA$$13$YR$$M$Y$46.95$KG$20240702$$MD$JP$JP
240387154$24038715$4$F$20240101$20240808$20240702$20240822$EXP$$PL-UCBSA-2024033315$UCB$$$$$F$Y$67$KG$20240822$$CN$PL$PL
240387161$24038716$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5818733$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240387171$24038717$1$I$20240101$20240620$20240702$20240702$EXP$$US-ENDO USA, INC.-2024-002735$ENDO$$$$$$Y$$$20240702$$HP$US$US
240387181$24038718$1$I$$20240624$20240702$20240702$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010058$JAZZ$$17$YR$$$Y$$$20240702$$MD$JP$JP
240387193$24038719$3$F$20240610$20240626$20240702$20240709$EXP$$CA-ROCHE-10000012184$ROCHE$$30$YR$A$M$Y$$$20240709$$CN$CA$CA
240387201$24038720$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105312$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240702$$CN$US$US
240387211$24038721$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105188$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240702$$HP$US$US
240387221$24038722$1$I$$20240628$20240702$20240702$EXP$$JP-TAKEDA-2024TJP009862$TAKEDA$$78$YR$$M$Y$$$20240702$$MD$JP$JP
240387232$24038723$2$F$20231215$20240705$20240702$20240716$EXP$$JP-UCBSA-2024032457$UCB$$4$DEC$$F$Y$$$20240716$$MD$JP$JP
240387252$24038725$2$F$$20240715$20240702$20240723$EXP$$CA-APOTEX-2024AP007598$APOTEX$$74$YR$$M$Y$$$20240723$$MD$CA$CA
240387261$24038726$1$I$$20240618$20240702$20240702$PER$$US-JNJFOC-20240665523$JOHNSON AND JOHNSON$$2$YR$C$M$Y$$$20240702$$HP$US$US
240387271$24038727$1$I$20230101$20240624$20240702$20240702$PER$$US-JNJFOC-20240671183$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240702$$HP$US$US
240387281$24038728$1$I$$20240624$20240702$20240702$EXP$$US-HALEON-2183938$Haleon PLC$$18$YR$$M$Y$$$20240627$$HP$US$US
240387291$24038729$1$I$$20240628$20240702$20240702$PER$$US-JNJFOC-20240677948$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
240387302$24038730$2$F$20230923$20240712$20240702$20240725$EXP$DK-DKMA-30732125$DK-ROCHE-10000012747$ROCHE$$57$YR$A$F$Y$60$KG$20240725$$CN$DK$DK
240387311$24038731$1$I$$20240619$20240702$20240702$PER$$US-CHATTEMPRD-2024OHG022359$CHATTEM$$$$$$Y$$$20240702$$CN$US$US
240387321$24038732$1$I$$20221219$20240702$20240702$PER$$US-AMGEN-USASP2022230355$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240387331$24038733$1$I$20240101$20240623$20240702$20240702$EXP$$IL-TEVA-VS-3214113$TEVA$$79$YR$$F$Y$$$20240702$$PH$IL$IL
240387341$24038734$1$I$$20230730$20240702$20240702$PER$$US-AMGEN-USASP2023235094$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240387352$24038735$2$F$$20240429$20240702$20240726$EXP$$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-05978$HIKMA$Chew Sue Mei S, Pritchard N, Grayton H, Simonicova I, Park S, Adler A. Chew Sue Mei S, Pritchard N, Grayton H, Simonicova I, Park S, Adler A. Diabetes mellitus in Kabuki syndrome 1 on a background of post-transplant diabetes mellitus.. Endocrinology, Diabetes and Metabolism Case Reports.. 2024;2024(1)$2$DEC$$F$Y$$$20240726$$HP$GB$GB
240387362$24038736$2$F$20240101$20240708$20240702$20240715$EXP$$FR-TEVA-VS-3214003$TEVA$$79$YR$$F$Y$$$20240715$$CN$FR$FR
240387371$24038737$1$I$20240501$20240626$20240702$20240702$EXP$$US-ABBVIE-5819814$ABBVIE$$80$YR$$M$Y$$$20240702$$CN$US$US
240387381$24038738$1$I$20231204$20240620$20240702$20240702$EXP$$BR-SA-2024SA188529$SANOFI AVENTIS$$35$YR$A$F$Y$75$KG$20240702$$PH$BR$BR
240387401$24038740$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5820062$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240387411$24038741$1$I$20240517$20240621$20240702$20240702$EXP$$CN-SA-2024SA188472$SANOFI AVENTIS$$1$DY$N$M$Y$$$20240702$$HP$CN$CN
240387422$24038742$2$F$20240501$20240904$20240702$20240913$EXP$$US-TEVA-VS-3214556$TEVA$$20$YR$$M$Y$$$20240913$$HP$US$US
240387433$24038743$3$F$20231208$20240828$20240702$20240907$EXP$$BE-CELLTRION INC.-2024BE015527$CELLTRION$$$$$$Y$$$20240907$$PH$BE$BE
240387443$24038744$3$F$$20240911$20240702$20240920$EXP$$FR-CELLTRION INC.-2024FR015622$CELLTRION$$$$$$Y$$$20240920$$PH$FR$FR
240387451$24038745$1$I$$20240626$20240702$20240702$EXP$$US-GSK-US2024080221$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$US$US
240387461$24038746$1$I$20240626$20240626$20240702$20240702$EXP$$FR-ABBVIE-5820960$ABBVIE$$75$YR$$F$Y$$$20240702$$CN$FR$FR
240387471$24038747$1$I$$20240625$20240702$20240702$PER$$US-CHATTEMPRD-2024OHG022198$CHATTEM$$$$$F$Y$$$20240702$$CN$US$US
240387481$24038748$1$I$$20240629$20240702$20240702$PER$$NVSC2024US136404$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
240387491$24038749$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821581$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240387501$24038750$1$I$$20240109$20240702$20240702$PER$$US-AMGEN-USASP2024129635$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240387511$24038751$1$I$$20240529$20240702$20240702$PER$$US-AMGEN-USASP2024129908$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240387521$24038752$1$I$20240627$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024129277$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240387531$24038753$1$I$$20240126$20240702$20240702$PER$$US-AMGEN-USASP2024127940$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240387563$24038756$3$F$$20240912$20240702$20240924$EXP$$CA-APOTEX-2024AP007595$APOTEX$$54$YR$$F$Y$$$20240924$$HP$CA$CA
240387571$24038757$1$I$20240501$20240625$20240702$20240702$EXP$$JP-ORGANON-O2406JPN000022$ORGANON$$59$YR$$F$Y$$$20240702$$MD$JP$JP
240387581$24038758$1$I$$20240625$20240702$20240702$EXP$$EG-EMD Serono-2024034764$EMD SERONO INC$$$$N$M$Y$$$20240702$$CN$EG$EG
240387591$24038759$1$I$20240620$20240626$20240702$20240702$PER$$US-ABBVIE-5819514$ABBVIE$$46$YR$$F$Y$$$20240702$$MD$US$US
240387601$24038760$1$I$$20240627$20240702$20240702$EXP$$IL-UCBSA-2024033041$UCB$$$$$F$Y$$$20240702$$MD$IL$IL
240387612$24038761$2$F$20240312$20240722$20240702$20240729$EXP$FR-AFSSAPS-PB2024000686$FR-SA-2024SA192072$SANOFI AVENTIS$$49$YR$A$M$Y$82$KG$20240729$$CN$FR$FR
240387621$24038762$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105243$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240702$$HP$US$US
240387631$24038763$1$I$$20240625$20240702$20240702$EXP$$US-TAKEDA-2023TUS115401$TAKEDA$$$$$M$Y$$$20240702$$CN$US$US
240387641$24038764$1$I$$20240627$20240702$20240702$PER$$US-ABBVIE-5820911$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240387651$24038765$1$I$20240510$20240625$20240702$20240702$EXP$$GR-CELLTRION INC.-2024GR015687$CELLTRION$$$$$$Y$$$20240702$$MD$GR$GR
240387662$24038766$2$F$20240626$20240709$20240702$20240712$PER$$US-ALXN-202406USA001556US$ALEXION PHARMACEUTICALS$$68$YR$$F$Y$$$20240712$$CN$US$US
240387671$24038767$1$I$20240624$20240626$20240702$20240702$EXP$$SG-VANTIVE-2024VAN017996$Vantive US Healthcare$$76$YR$$F$Y$$$20240702$$CN$SG$SG
240387681$24038768$1$I$$20240624$20240702$20240702$EXP$$IN-VANTIVE-2024VAN018008$Vantive US Healthcare$$43$YR$$F$Y$$$20240702$$CN$IN$IN
240387691$24038769$1$I$$20240617$20240702$20240702$PER$$US-JNJFOC-20240665858$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240387701$24038770$1$I$$20240626$20240702$20240702$EXP$$CA-JNJFOC-20240673216$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$HP$CA$CA
240387711$24038771$1$I$$20240628$20240702$20240702$EXP$$HK-GSK-HK2024GSK081522$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$HK$HK
240387721$24038772$1$I$$20240628$20240702$20240702$EXP$$IT-ADIENNEP-2024AD000430$ADIENNE PHARMA + BIOTECH$Trotta GE, Ciangola G, Cerroni I, Mezzanotte V, Nunzi A, Anemona L et al. Fatal acute graft-versus-host disease in Sezary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation. Curr Res Transl Med. 2024;72(3):103452. DOI: 10.1016/j.retram.2024.103452$$$A$M$Y$$$20240701$$MD$IT$
240387732$24038773$2$F$$20240826$20240702$20240905$EXP$$JP-ROCHE-10000011833$ROCHE$$$$E$M$Y$$$20240905$$MD$JP$JP
240387741$24038774$1$I$$20240701$20240702$20240702$EXP$$GB-BIOVITRUM-2024-GB-009030$BIOVITRUM$$72$YR$$F$Y$$$20240702$$CN$GB$GB
240387752$24038775$2$F$$20240913$20240702$20240913$PER$$NVSC2024US136368$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
240387761$24038776$1$I$$20240625$20240702$20240702$PER$$NVSC2024US133928$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
240387772$24038777$2$F$20240616$20240920$20240702$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202407000571$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240926$$CN$US$US
240387782$24038778$2$F$20240619$20240730$20240702$20240801$PER$$US-AMGEN-USASP2024127409$AMGEN$$78$YR$E$F$Y$$$20240801$$CN$US$US
240387791$24038779$1$I$20240625$20240625$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000097$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240702$$CN$US$US
240387801$24038780$1$I$20240601$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000970$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240702$$CN$US$US
240387811$24038781$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000525$ELI LILLY AND CO$$$$A$F$Y$$$20240702$$CN$US$US
240387821$24038782$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000118$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$US$US
240387831$24038783$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019859$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$US$US
240387841$24038784$1$I$20240621$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000405$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$US$US
240387851$24038785$1$I$$20240625$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406018565$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240702$$CN$US$US
240387861$24038786$1$I$20240501$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019644$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240702$$CN$US$US
240387871$24038787$1$I$$20230419$20240702$20240702$PER$$US-AMGEN-USASP2023235210$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240387881$24038788$1$I$20240625$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127249$AMGEN$$$$$M$Y$$$20240702$$CN$US$US
240387891$24038789$1$I$20230101$20240625$20240702$20240702$EXP$$BR-JNJFOC-20240671281$JOHNSON AND JOHNSON$$72$YR$E$F$Y$54$KG$20240702$$CN$BR$BR
240387902$24038790$2$F$20240101$20240704$20240702$20240708$PER$$US-AMGEN-USASP2024127772$AMGEN$$67$YR$E$F$Y$$$20240708$$CN$US$US
240387911$24038791$1$I$$20240701$20240702$20240702$EXP$$SG-HALEON-2184414$Haleon PLC$$$$$M$Y$$$20240702$$HP$SG$SG
240387922$24038792$2$F$$20240729$20240702$20240730$PER$$US-JNJFOC-20240645224$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240730$$CN$US$US
240387931$24038793$1$I$20230801$20240624$20240702$20240702$EXP$FR-AFSSAPS-TS2024000697$FR-TEVA-VS-3213852$TEVA$$61$YR$$M$Y$$$20240702$$MD$FR$FR
240387942$24038794$2$F$$20240715$20240702$20240723$EXP$$US-GSK-US2024080423$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$HP$US$US
240387951$24038795$1$I$20221107$20240624$20240702$20240702$PER$$US-JNJFOC-20240669377$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240702$$HP$US$US
240387961$24038796$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5818449$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240387972$24038797$2$F$20240626$20240723$20240702$20240728$EXP$$JP-AMGEN-JPNSP2024126975$AMGEN$$$$$$Y$$$20240728$$PH$JP$JP
240387981$24038798$1$I$$20240620$20240702$20240702$PER$$US-TEVA-VS-3212987$TEVA$$79$YR$$F$Y$$$20240702$$CN$US$US
240387991$24038799$1$I$$20240617$20240702$20240702$EXP$$IN-ROCHE-10000007873$ROCHE$$68$YR$E$M$Y$$$20240702$$CN$IN$IN
240388001$24038800$1$I$$20240627$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103543$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$85.73$KG$20240702$$CN$US$US
240388011$24038801$1$I$20100111$20240621$20240702$20240702$EXP$$CN-ROCHE-10000007527$ROCHE$$61$YR$A$M$Y$51$KG$20240702$$HP$CN$CN
240388022$24038802$2$F$$20240805$20240702$20240806$PER$$US-ALXN-202406USA001579US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240388031$24038803$1$I$$20240624$20240702$20240702$PER$$US-ALXN-202406USA001584US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
240388041$24038804$1$I$$20240628$20240702$20240702$PER$$US-HALEON-2184477$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240388051$24038805$1$I$$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024128161$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240388061$24038806$1$I$$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024127530$AMGEN$Geskin, J. L.. Retrospective analysis of multiple myeloma drug use in cutaneous toxicity of monoclonal gammopathy of undetermined significance. Journal of the American Academy of Dermatology. 2024;91 (1):129-130$$$$$Y$$$20240702$$MD$US$US
240388071$24038807$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821854$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240388081$24038808$1$I$$20240626$20240702$20240702$EXP$$CO-JNJFOC-20240674951$JOHNSON AND JOHNSON$$32$YR$A$F$Y$60$KG$20240702$$HP$CO$CO
240388091$24038809$1$I$$20240624$20240702$20240702$EXP$$US-GSK-US2024078560$GLAXOSMITHKLINE$$$$$M$Y$$$20240702$$MD$US$US
240388102$24038810$2$F$$20240705$20240702$20240718$EXP$$US-GRAVITIPHARMA-GRA-2406-US-LIT-0186$GRAVITI PHARMACEUTICALS$Jumaili WA, Gburi NA, Chaudhary N, Brown K, Jain S..Two Cases of Montelukast-Associated Psychosis in Children.Prim-Care-Companion-CNS-Disord.2024;26:3$15$YR$T$F$Y$$$20240718$$MD$US$US
240388112$24038811$2$F$20240618$20240710$20240702$20240717$EXP$$US-ROCHE-10000011987$ROCHE$$25$YR$A$M$Y$121.11$KG$20240717$$CN$US$US
240388121$24038812$1$I$20211119$20240627$20240702$20240702$EXP$$CA-TAKEDA-2018TUS032126$TAKEDA$$25$YR$$M$Y$$$20240702$$MD$CA$CA
240388132$24038813$2$F$20240626$20240724$20240702$20240727$PER$$US-AMGEN-USASP2024127776$AMGEN$$23$YR$A$F$Y$$$20240727$$CN$US$US
240388142$24038814$2$F$$20240724$20240702$20240730$EXP$$JP-AMGEN-JPNSP2024125004$AMGEN$$62$YR$A$F$Y$$$20240730$$PH$JP$JP
240388151$24038815$1$I$$20231220$20240702$20240702$PER$$US-AMGEN-USASP2023235189$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240388161$24038816$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5816729$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240388172$24038817$2$F$$20240910$20240702$20240913$EXP$$US-TAKEDA-2024TUS064232$TAKEDA$$$$$F$Y$$$20240913$$CN$US$US
240388181$24038818$1$I$20240625$20240627$20240702$20240702$EXP$$US-ABBVIE-5820986$ABBVIE$$53$YR$$M$Y$$$20240702$$CN$US$US
240388191$24038819$1$I$$20240625$20240702$20240702$EXP$$US-GSK-US2024AMR080079$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
240388201$24038820$1$I$20240516$20240624$20240702$20240702$30DAY$$US-GSK-US2024078688$GLAXOSMITHKLINE$$45$YR$$F$Y$$$20240702$$CN$US$US
240388212$24038821$2$F$$20240701$20240702$20240703$PER$$US-JNJFOC-20240700866$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240388221$24038822$1$I$20231212$20240624$20240702$20240702$EXP$$CN-UCBSA-2023060167$UCB$$37$YR$$F$Y$70$KG$20240702$$MD$CN$CN
240388234$24038823$4$F$20240510$20240910$20240702$20240918$PER$$US-JNJFOC-20240645058$JOHNSON AND JOHNSON$$68$YR$E$F$Y$72.2$KG$20240918$$HP$US$US
240388241$24038824$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-032006$AUROBINDO$$$$$$Y$$$20240702$$HP$US$US
240388251$24038825$1$I$$20240619$20240702$20240702$EXP$$IN-ROCHE-10000010623$ROCHE$$43$YR$A$F$Y$$$20240702$$CN$IN$IN
240388261$24038826$1$I$$20240617$20240702$20240702$EXP$$AU-TEVA-VS-3211462$TEVA$$49$YR$$M$Y$$$20240702$$HP$AU$AU
240388271$24038827$1$I$$20240627$20240702$20240702$EXP$$GB-ABBVIE-5820527$ABBVIE$$$$A$F$Y$$$20240702$$CN$GB$GB
240388281$24038828$1$I$$20240627$20240702$20240702$PER$$US-ROCHE-10000013404$ROCHE$$$$E$M$Y$$$20240702$$CN$US$US
240388292$24038829$2$F$20230101$20240817$20240702$20240822$EXP$$US-ROCHE-10000008113$ROCHE$$60$YR$A$F$Y$80.74$KG$20240822$$CN$US$US
240388302$24038830$2$F$$20240704$20240702$20240712$EXP$$US-TEVA-VS-3213888$TEVA$Jenkins CN, Badri NW, Blasko BJ. Case Study of Biatrial Thrombus: Found Down With Atrial Fibrillation. J-Emerg-Med 2023; 64 (6): 714-717.; Jenkins CN, Badri NW, Blasko BJ. Case Study of Biatrial Thrombus: Found Down With Atrial Fibrillation. J-Emerg-Med 2023; 64 (6): 714-717.$75$YR$$M$Y$$$20240712$$MD$US$US
240388321$24038832$1$I$$20240405$20240702$20240702$PER$$US-AMGEN-USASP2024127972$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240388331$24038833$1$I$20240612$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128188$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240388341$24038834$1$I$$20230727$20240702$20240702$PER$$US-AMGEN-USASP2023235257$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240388351$24038835$1$I$$20240214$20240702$20240702$PER$$US-AMGEN-USASP2024129951$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240388361$24038836$1$I$20240523$20240626$20240702$20240702$EXP$PT-INFARMED-F202406-420$PT-AMGEN-PRTSP2024128574$AMGEN$$41$YR$A$F$Y$$$20240702$$PH$PT$PT
240388373$24038837$3$F$20240601$20240813$20240702$20240827$EXP$$US-UCBSA-2024033077$UCB$$86$YR$$F$Y$$$20240827$$CN$US$US
240388391$24038839$1$I$20240501$20240620$20240702$20240702$PER$$US-TEVA-VS-3213615$TEVA$$26$YR$$F$Y$65.77$KG$20240702$$CN$US$US
240388402$24038840$2$F$20240523$20240711$20240702$20240717$30DAY$$JP-JNJFOC-20240631982$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240717$$PH$JP$JP
240388411$24038841$1$I$$20230515$20240702$20240702$PER$$US-AMGEN-USASP2023235249$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240388421$24038842$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031816$AUROBINDO$Rose K, Rubin R, Zacharias W. Disseminated Blastomycosis Complicated by Multiorgan Failure Driven by Cytokine Release Syndrome in a Patient With Poorly Controlled Diabetes Mellitus.. Am-JRespir-Crit-Care-Med. 2024;209:A3588$37$YR$$F$Y$$$20240702$$HP$US$US
240388431$24038843$1$I$20240518$20240625$20240702$20240702$EXP$FR-AFSSAPS-PO2024000626$FR-EMD Serono-2024034482$EMD SERONO INC$$78$YR$E$M$Y$$$20240702$$MD$FR$FR
240388441$24038844$1$I$$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024127586$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240388451$24038845$1$I$$20240628$20240702$20240702$PER$$NVSC2024US136375$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
240388461$24038846$1$I$20230907$20240618$20240702$20240702$EXP$EU-AFSSAPS-AVLY2024000058$EU-ETHYPHARM-2024001627$ETHYPHARM$$$$$$Y$$$20240701$$MD$EU$
240388471$24038847$1$I$$20240624$20240702$20240702$EXP$$DE-BAUSCH-BL-2024-010057$BAUSCH AND LOMB$$$$A$F$Y$$$20240702$$CN$DE$DE
240388482$24038848$2$F$20180703$20240712$20240702$20240715$EXP$$IT-BAUSCH-BL-2024-010089$BAUSCH AND LOMB$$65$YR$$$Y$$$20240715$$MD$IT$IT
240388491$24038849$1$I$20240603$20240627$20240702$20240702$EXP$$US-BAUSCH-BL-2024-010043$BAUSCH AND LOMB$$52$YR$$M$Y$$$20240702$$CN$US$US
240388501$24038850$1$I$20240601$20240626$20240702$20240702$EXP$$US-BAUSCH-BL-2024-010030$BAUSCH AND LOMB$$$$$F$Y$$$20240702$$MD$US$US
240388511$24038851$1$I$20240701$20240628$20240702$20240702$EXP$$JP-TAKEDA-2024TJP009870$TAKEDA$$8$DEC$$M$Y$$$20240702$$MD$JP$JP
240388522$24038852$2$F$$20240712$20240702$20240717$EXP$$PL-BAUSCH-BL-2024-010000$BAUSCH AND LOMB$$90$YR$$$Y$$$20240717$$MD$PL$PL
240388531$24038853$1$I$$20240626$20240702$20240702$EXP$$US-BAUSCH-BL-2023-016182$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240702$$CN$US$US
240388542$24038854$2$F$20240124$20240629$20240702$20240918$EXP$FR-AFSSAPS-TS2024000740$FR-BAUSCH-BL-2024-010105$BAUSCH AND LOMB$$50$YR$$F$Y$60$KG$20240918$$MD$FR$FR
240388551$24038855$1$I$$20240216$20240702$20240702$PER$$US-AMGEN-USASP2024129926$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240388562$24038856$2$F$20240101$20240723$20240702$20240726$PER$$US-AMGEN-USASP2024128353$AMGEN$$61$YR$A$M$Y$$$20240726$$HP$US$US
240388573$24038857$3$F$20231211$20240826$20240702$20240908$EXP$$CA-ABBVIE-5819912$ABBVIE$$$$E$M$Y$$$20240908$$CN$CA$CA
240388581$24038858$1$I$20240507$20240625$20240702$20240702$EXP$$CN-BEIGENE-BGN-2024-009764$BEIGENE$$$$$$Y$$$20240702$$HP$CN$CN
240388591$24038859$1$I$20240501$20240619$20240702$20240702$EXP$$US-ADVANZ PHARMA-202404005266$ADVANZ PHARMA$$$$$$Y$$$20240702$$CN$US$US
240388601$24038860$1$I$$20240619$20240702$20240702$PER$$US-APOTEX-2024AP007614$APOTEX$Alpert M, Chu DC. Solving a Paradox: Use of Biologic Monotherapy in an Unusual Case of Asthma With Paradoxical Bronchospasm. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-3$24$YR$$F$Y$$$20240702$$HP$US$US
240388611$24038861$1$I$$20240629$20240702$20240702$PER$$US-HALEON-2184735$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240388621$24038862$1$I$20230511$20240620$20240702$20240702$EXP$$ES-CIPLA LTD.-2024ES06613$CIPLA$$$$$$Y$$$20240702$$MD$ES$ES
240388631$24038863$1$I$20240330$20240625$20240702$20240702$EXP$FR-AFSSAPS-NT2024000690$FR-EMD Serono-2024034645$EMD SERONO INC$$74$YR$E$F$Y$77$KG$20240702$$MD$FR$FR
240388642$24038864$2$F$$20240625$20240702$20240705$EXP$$NVSC2023CA251403$NOVARTIS$$70$YR$$F$Y$$$20240705$$CN$CA$CA
240388652$24038865$2$F$$20240814$20240702$20240823$EXP$$US-ROCHE-10000006288$ROCHE$$41$YR$A$M$Y$$$20240823$$CN$US$US
240388662$24038866$2$F$$20240624$20240702$20240704$PER$$US-ROCHE-10000011263$ROCHE$$$$A$F$Y$$$20240704$$HP$US$US
240388671$24038867$1$I$20240417$20240625$20240702$20240702$EXP$FR-AFSSAPS-DJ2024000806$FR-RDY-SPO/FRA/24/0009271$DR REDDYS$$37$YR$A$M$Y$92$KG$20240702$$MD$FR$FR
240388681$24038868$1$I$20240625$20240627$20240702$20240702$EXP$$US-ABBVIE-5821551$ABBVIE$$84$YR$$M$Y$$$20240702$$CN$US$US
240388691$24038869$1$I$$20240628$20240702$20240702$EXP$$JP-TAKEDA-2024TJP009859$TAKEDA$$55$YR$$F$Y$$$20240702$$MD$JP$JP
240388701$24038870$1$I$20231211$20240628$20240702$20240702$EXP$$NP-TAKEDA-2024TUS065554$TAKEDA$$57$YR$$M$Y$$$20240702$$CN$NP$NP
240388711$24038871$1$I$$20240626$20240702$20240702$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13039$IPSEN$$$$$$Y$$$20240702$$HP$US$US
240388721$24038872$1$I$$20240626$20240702$20240702$EXP$$NVSJ2024JP007658$NOVARTIS$$$$$$Y$$$20240702$$MD$JP$JP
240388733$24038873$3$F$$20240703$20240702$20240710$EXP$$ES-ROCHE-10000002832$ROCHE$$47$YR$A$F$Y$$$20240710$$MD$ES$ES
240388741$24038874$1$I$$20240628$20240702$20240702$EXP$$KE-TAKEDA-2024TUS065631$TAKEDA$$$$$F$Y$$$20240702$$CN$KE$KE
240388751$24038875$1$I$$20240624$20240702$20240702$30DAY$$US-GSK-US2024078657$GLAXOSMITHKLINE$$$$A$F$Y$$$20240702$$CN$US$US
240388761$24038876$1$I$$20240618$20240702$20240702$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-13989$ALKEM$Cornejo-Uixeda S, Escoin-P?rez C, Hernandez-Lorente E.. Capecitabine-induced pancreatitis. Med Clin (Barc). 2018;150(11):e37-e38$69$YR$$M$Y$$$20240702$$HP$ES$ES
240388771$24038877$1$I$20240627$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024127700$AMGEN$$$$$F$Y$$$20240702$$CN$US$US
240388781$24038878$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031737$AUROBINDO$Hossain S, Bahadur SA. Aspergillus Niger Co-infection in a Patient With Acute Respiratory Failure. Am-J-Respir-Crit-Care-Med. 2024$74$YR$$M$Y$$$20240702$$HP$US$US
240388792$24038879$2$F$$20240711$20240702$20240717$PER$$US-AstraZeneca-2024A143513$ASTRAZENECA$$$$$$Y$$$20240717$$CN$US$
240388801$24038880$1$I$20240510$20240606$20240702$20240702$PER$$US-AstraZeneca-2024A136154$ASTRAZENECA$$18623$DY$$F$Y$$$20240702$$CN$US$
240388811$24038881$1$I$20130224$20240618$20240702$20240702$EXP$DE-DCGMA-13160251$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-13398$ALKEM$$30$YR$$M$Y$70$KG$20240702$$MD$DE$DE
240388821$24038882$1$I$$20240606$20240702$20240702$PER$$US-AstraZeneca-2024A132709$ASTRAZENECA$$$$$F$Y$$$20240702$$PH$US$
240388831$24038883$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000100$ELI LILLY AND CO$$20$YR$A$M$Y$$$20240702$$CN$US$US
240388841$24038884$1$I$20240627$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000068$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240702$$CN$US$US
240388851$24038885$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001037$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240702$$CN$US$US
240388861$24038886$1$I$20240617$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000135$ELI LILLY AND CO$$$$$M$Y$$$20240702$$CN$US$US
240388871$24038887$1$I$$20240628$20240702$20240702$EXP$$US-GILEAD-2024-0679060$GILEAD$$$$A$M$Y$$$20240702$$CN$US$US
240388881$24038888$1$I$20240628$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000134$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240702$$CN$US$US
240388891$24038889$1$I$$20240626$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019840$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240702$$CN$US$US
240388902$24038890$2$F$$20240625$20240702$20240711$PER$$US-ROCHE-10000013482$ROCHE$$$$A$F$Y$$$20240711$$MD$US$US
240388911$24038891$1$I$$20240628$20240702$20240702$PER$$US-ABBVIE-5822310$ABBVIE$$$$$$Y$$$20240702$$HP$US$US
240388921$24038892$1$I$$20240625$20240702$20240702$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-105115$BRISTOL MYERS SQUIBB$Lim MS, Mohamed M. Retrospective study of clinical settings, indications and consequences of measurement of direct oral anticoagulant plasma levels in Northern Tasmania, Australia. Internal Medicine Journal. 2024 Jun 01;54(6):932-40. doi:10.1111/imj.16329.$$$$$Y$$$20240702$$HP$AU$AU
240388932$24038893$2$F$$20240702$20240702$20240712$PER$$US-HALEON-2184732$Haleon PLC$$76$YR$$F$Y$$$20240712$$CN$US$US
240388941$24038894$1$I$$20240627$20240702$20240702$EXP$$US-BIOGEN-2024BI01271814$BIOGEN$$$$$F$Y$58.566$KG$20240702$$MD$US$US
240388951$24038895$1$I$$20240629$20240702$20240702$PER$$US-HALEON-2184722$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240388961$24038896$1$I$$20240618$20240702$20240702$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091786$GLENMARK$Dinh A, Savoy JM, Kontoyiannis DP, Takahashi K, Issa GC, Kantarjian HM, et al.. Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer. 2024;130:1964-1971$$$$$Y$$$20240702$$PH$US$US
240388971$24038897$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031787$AUROBINDO$Boulter JH, Stiefel MF, Ben-Aire E, Schuette AJ. Thrombectomy and stenting of pseudoaneurysm from transcarotid artery revascularization. Surgical Neurology International. 2024;15:127$64$YR$$M$Y$$$20240702$$HP$US$US
240388981$24038898$1$I$$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031418$AUROBINDO$Leleu X, Hulin C, Lambert J, Bobin A, Perrot A, Karlin L et al.. Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 benefit trial.. Nature Medicine.. 2024$$$E$$Y$$$20240702$$MD$FR$FR
240388991$24038899$1$I$$20240701$20240702$20240702$EXP$$GB-UCBSA-2024033298$UCB$$$$$F$Y$$$20240702$$CN$GB$GB
240389001$24038900$1$I$20190308$20240624$20240702$20240702$EXP$CN-UCBSA-2024032701$CN-UCBSA-2024032701$UCB$$50$YR$$F$Y$55$KG$20240702$$HP$CN$CN
240389011$24038901$1$I$$20240619$20240702$20240702$PER$$US-APOTEX-2024AP007629$APOTEX$Feghali E, Beavers C, Feghali E, Harb A, Hassan Z. When Cement Meets Asbestos: A Multifaceted Approach to Dyspnea and Chest Pain in an 81-year-old. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-3$81$YR$$M$Y$$$20240702$$HP$US$US
240389021$24038902$1$I$20240101$20240617$20240702$20240702$EXP$IT-MINISAL02-989867$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-05689$HIKMA$$$$$$Y$$$20240702$$MD$IT$IT
240389031$24038903$1$I$20240614$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031400$AUROBINDO$$92$YR$$F$Y$50$KG$20240702$$HP$FR$FR
240389041$24038904$1$I$$20240619$20240702$20240702$PER$$US-TEVA-VS-3212033$TEVA$$$$$F$Y$$$20240702$$CN$US$US
240389051$24038905$1$I$20220301$20240620$20240702$20240702$PER$$US-APOTEX-2024AP007760$APOTEX$Beale P, Hourigan EK, Collins J.. Recurrent Pleural Effusions and Evidence of Pulmonary Arterial Hypertension on Bosutinib in a CML Patient Previously Treated With Dasatinib Therapy. American Journal of Respiratory and Critical Care Medicine. 2024;209 (0):1-4$45$YR$$M$Y$$$20240702$$HP$US$US
240389061$24038906$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007653$APOTEX$$86$YR$$M$Y$$$20240702$$PH$CA$CA
240389071$24038907$1$I$$20240627$20240702$20240702$EXP$$US-GILEAD-2024-0679012$GILEAD$$$$E$F$Y$$$20240702$$CN$US$US
240389081$24038908$1$I$$20240620$20240702$20240702$EXP$$PA-ROCHE-3579841$ROCHE$$66$YR$E$F$Y$63.5$KG$20240702$$CN$PA$PA
240389092$24038909$2$F$$20240807$20240702$20240818$EXP$$IN-ROCHE-10000004453$ROCHE$$$$E$M$Y$$$20240819$$CN$IN$IN
240389101$24038910$1$I$$20240625$20240702$20240702$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-105116$BRISTOL MYERS SQUIBB$Lim MS, Mohamed M. Retrospective study of clinical settings, indications and consequences of measurement of direct oral anticoagulant plasma levels in Northern Tasmania, Australia. Internal Medicine Journal. 2024 Jun 01;54(6):932-40. doi:10.1111/imj.16329.$$$$$Y$$$20240702$$HP$AU$AU
240389113$24038911$3$F$$20240826$20240702$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105182$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240828$$CN$US$US
240389131$24038913$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007666$APOTEX$$77$YR$$M$Y$65.76$KG$20240702$$HP$CA$CA
240389141$24038914$1$I$$20240625$20240702$20240702$EXP$$FR-JNJFOC-20240674189$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$MD$FR$FR
240389153$24038915$3$F$$20240705$20240702$20240712$EXP$$CH-ROCHE-10000004278$ROCHE$Gieriet N, Keerl C, Wertli M, Diomande I, Leo C. A case of drug induced non-cirrhotic portal hypertension [Abstract number: P115]. Swiss Medical Weekly. 2024-May;154(Sup276:92S. doi:10.57187/s.3896.$26$YR$A$F$Y$$$20240712$$HP$CH$CH
240389161$24038916$1$I$$20230313$20240702$20240702$PER$$US-AMGEN-USASP2023235020$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240389171$24038917$1$I$$20230607$20240702$20240702$PER$$US-AMGEN-USASP2023235251$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240389181$24038918$1$I$$20230727$20240702$20240702$PER$$US-AMGEN-USASP2023235262$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240389191$24038919$1$I$20231126$20240625$20240702$20240702$EXP$$NL-CELLTRION INC.-2024NL015643$CELLTRION$$$$$$Y$$$20240702$$MD$NL$NL
240389201$24038920$1$I$$20240624$20240702$20240702$EXP$$KR-UCBSA-2024032415$UCB$Park JS, Chung JH, Kim NS, Jung HS, Seo YH, Gong HY, et al. Emergency cesarean section of a patient with refractory status epilepticus A case report of challenges during anesthesia. Medicine (United States). 2024;103(18):1-3$$$N$$Y$$$20240702$$MD$KR$KR
240389211$24038921$1$I$$20240628$20240702$20240702$EXP$$FR-GILEAD-2024-0679005$GILEAD$$$$$F$Y$$$20240702$$PH$FR$FR
240389221$24038922$1$I$20240420$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031520$AUROBINDO$$72$YR$$M$Y$$$20240702$$PH$FR$FR
240389231$24038923$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031723$AUROBINDO$Xiong J, Embry E, Prasad S, Singh K, Singh M. Mycoplasma Pneumonia Induced Acute Respiratory Distress Syndrome in Pregnancy. Am-J-Respir-Crit-Care-Med. 2024$38$YR$$F$Y$$$20240702$$HP$US$US
240389241$24038924$1$I$$20240626$20240702$20240702$PER$$NVSC2024US134656$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240389251$24038925$1$I$$20230512$20240702$20240702$PER$$US-AMGEN-USASP2023235330$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240389261$24038926$1$I$$20230501$20240702$20240702$PER$$US-AMGEN-USASP2023235241$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240389271$24038927$1$I$$20230202$20240702$20240702$PER$$US-AMGEN-USASP2023235284$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240389281$24038928$1$I$$20230124$20240702$20240702$PER$$US-AMGEN-USASP2023235243$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240389291$24038929$1$I$$20240628$20240702$20240702$EXP$$JP-TAKEDA-2024TJP009822$TAKEDA$$$$$$Y$$$20240702$$MD$JP$JP
240389301$24038930$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031771$AUROBINDO$Ahoussougbemey Mele A, Mahmood R, Ogbuagu H, Fombi J.. Management of Hyperlipidemia Induced by Primary Biliary Cholangitis. Am-J-Gastroenterol. 2022;117 (Suppl. 12):S3$46$YR$$F$Y$$$20240702$$HP$US$US
240389311$24038931$1$I$20240601$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105231$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$52.62$KG$20240702$$HP$US$US
240389322$24038932$2$F$20240313$20240716$20240702$20240723$EXP$$FR-BIOGEN-2024BI01271654$BIOGEN$$10$YR$$M$Y$$$20240723$$MD$FR$FR
240389331$24038933$1$I$$20240625$20240702$20240702$30DAY$$US-GSK-US2024079220$GLAXOSMITHKLINE$$$$$M$Y$$$20240702$$CN$US$US
240389342$24038934$2$F$20240610$20240705$20240702$20240715$EXP$$ES-TAKEDA-2024TUS065215$TAKEDA$$82$YR$$M$Y$$$20240715$$MD$ES$ES
240389351$24038935$1$I$20240531$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031485$AUROBINDO$$66$YR$$F$Y$70$KG$20240702$$MD$FR$FR
240389361$24038936$1$I$20240101$20240627$20240702$20240702$PER$$US-JNJFOC-20240674134$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240702$$CN$US$US
240389371$24038937$1$I$$20240625$20240702$20240702$PER$$US-JNJFOC-20240672958$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$HP$US$US
240389381$24038938$1$I$20240201$20240624$20240702$20240702$EXP$$GB-AUROBINDO-AUR-APL-2024-031489$AUROBINDO$$43$YR$$M$Y$102$KG$20240702$$CN$GB$GB
240389391$24038939$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281140265240-PFTZY$GB-ORGANON-O2406GBR002768$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240389401$24038940$1$I$20220101$20230109$20240702$20240702$EXP$$US-RECORDATI RARE DISEASE INC.-2022007253$RECORDATI$$$$$$Y$$$20240702$$CN$US$US
240389411$24038941$1$I$20240101$20240614$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA049816$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240389422$24038942$2$F$$20240820$20240702$20240909$PER$$CA-TOLMAR, INC.-24CA049780$TOLMAR$$$$$M$Y$$$20240906$$CN$CA$CA
240389431$24038943$1$I$$20240614$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA049822$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240389441$24038944$1$I$20240101$20240614$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA049960$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240389451$24038945$1$I$20240501$20240613$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA049953$TOLMAR$$64$YR$$M$Y$$$20240702$$CN$CA$CA
240389461$24038946$1$I$$20240614$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA049965$TOLMAR$$$$$M$Y$$$20240702$$PH$CA$CA
240389471$24038947$1$I$20240606$20240614$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA050054$TOLMAR$$69$YR$$M$Y$$$20240702$$CN$CA$CA
240389481$24038948$1$I$$20240613$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA050049$TOLMAR$$$$$M$Y$$$20240702$$MD$CA$CA
240389491$24038949$1$I$20230101$20240612$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA049990$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240389501$24038950$1$I$$20240612$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA050185$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240389512$24038951$2$F$20240603$20240724$20240702$20240819$PER$$CA-TOLMAR, INC.-24CA050171$TOLMAR$$63$YR$$M$Y$$$20240819$$HP$CA$CA
240389521$24038952$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007674$APOTEX$$69$YR$$F$Y$$$20240702$$CN$CA$CA
240389531$24038953$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281141493050-NJBWG$GB-ORGANON-O2407GBR000021$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240389541$24038954$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5819578$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240389551$24038955$1$I$$20240626$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103467$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240702$$CN$US$US
240389581$24038958$1$I$$20240625$20240702$20240702$PER$US-MLMSERVICE-20240619-PI101873-00108-3$US-RDY-SPO/USA/24/0009384$DR REDDYS$Leung JG, Allen ND, Markota M. A case series of clozapine titrations affected by inflammatory processes. Schizophrenia Research. 2024;268:94-7. DOI:10.1016/j.schres.2023.08.007.$38$YR$A$F$Y$$$20240702$$PH$US$US
240389591$24038959$1$I$$20230615$20240702$20240702$PER$$US-AMGEN-USASP2023235329$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240389601$24038960$1$I$$20240209$20240702$20240702$PER$$US-AMGEN-USASP2024129944$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240389611$24038961$1$I$$20230512$20240702$20240702$PER$$US-AMGEN-USASP2023235106$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240389622$24038962$2$F$$20240826$20240702$20240830$EXP$$US-ABBVIE-5821460$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
240389632$24038963$2$F$$20240627$20240702$20240704$PER$$US-AMGEN-USASP2024128150$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240389641$24038964$1$I$20240510$20240624$20240702$20240702$EXP$$ES-AUROBINDO-AUR-APL-2024-031422$AUROBINDO$$75$YR$$M$Y$$$20240702$$MD$ES$ES
240389651$24038965$1$I$20230101$20240627$20240702$20240702$EXP$$DE-EMD Serono-2024035263$EMD SERONO INC$$57$YR$A$F$Y$$$20240702$$CN$DE$DE
240389661$24038966$1$I$$20240625$20240702$20240702$EXP$$FR-CELLTRION INC.-2024FR015674$CELLTRION$$$$$$Y$$$20240702$$PH$FR$FR
240389671$24038967$1$I$$20240624$20240702$20240702$EXP$$US-CELLTRION INC.-2024US015732$CELLTRION$Barnaba Durairaj MV, Caraway H, Buresh R, Sampath R, Waghchoure S.. Rapidly Progressing Secondary Organizing Pneumonia Due to Underlying Immunosuppression With Rituximab in SARS-CoV-2 Patients. Cureus. 2024;16(5):e60328$$$$$Y$$$20240702$$HP$US$US
240389681$24038968$1$I$$20240624$20240702$20240702$EXP$$AU-TOLMAR, INC.-24AU050403$TOLMAR$$$$$M$Y$$$20240702$$CN$AU$AU
240389691$24038969$1$I$$20240621$20240702$20240702$PER$$US-JNJFOC-20240660102$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$MD$US$US
240389701$24038970$1$I$$20240624$20240702$20240702$EXP$$CA-TOLMAR, INC.-24CA050475$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240389711$24038971$1$I$$20240624$20240702$20240702$EXP$$CA-TOLMAR, INC.-24CA050461$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240389721$24038972$1$I$$20240624$20240702$20240702$EXP$$US-TOLMAR, INC.-24US050433$TOLMAR$$$$$M$Y$68.027$KG$20240702$$HP$US$US
240389731$24038973$1$I$20240628$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000655$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240702$$CN$US$US
240389741$24038974$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000602$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$US$US
240389751$24038975$1$I$20240501$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019376$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240702$$CN$US$US
240389761$24038976$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000458$ELI LILLY AND CO$$40$YR$A$$Y$$$20240702$$CN$US$US
240389771$24038977$1$I$20240624$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000197$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240702$$CN$US$US
240389781$24038978$1$I$20240627$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000075$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240702$$CN$US$US
240389791$24038979$1$I$20230101$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000248$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240702$$CN$US$US
240389811$24038981$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000360$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240702$$CN$US$US
240389821$24038982$1$I$$20240619$20240702$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05553$LUPIN$$$$$$Y$$$20240702$$CN$US$US
240389831$24038983$1$I$$20230511$20240702$20240702$PER$$US-AMGEN-USASP2023235084$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240389841$24038984$1$I$$20230125$20240702$20240702$PER$$US-AMGEN-USASP2023235075$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240389851$24038985$1$I$$20240624$20240702$20240702$EXP$$US-APOTEX-2024AP007790$APOTEX$Prabhu S, Malempati S, Markowitz D. Amlodipine: Not an Ace in the Hole. American Journal of Respiratory and Critical Care Medicine. 2024;209 (0):1-3$56$YR$$M$Y$$$20240702$$HP$US$US
240389861$24038986$1$I$20240101$20240626$20240702$20240702$EXP$$US-009507513-2406USA009677$MERCK$$$$$F$Y$$$20240702$$HP$US$US
240389871$24038987$1$I$20240522$20240625$20240702$20240702$EXP$$US-AMGEN-USASP2024126346$AMGEN$$60$YR$A$F$Y$$$20240702$$HP$US$US
240389881$24038988$1$I$$20240620$20240702$20240702$EXP$$US-STERISCIENCE B.V.-2024-ST-000932$Steriscience PTE$Hurera A, Ain N, Agarwal B.. A Case of Infective Endocarditis Complicated by Intracardiac Fistula and Systemic Embolization.. Am-J-Respir-Crit-Care-Med. 2024;209(0):abstr. A1646.$29$YR$$M$Y$$$20240702$$HP$US$US
240389891$24038989$1$I$$20240624$20240702$20240702$EXP$$CN-AUROBINDO-AUR-APL-2024-031541$AUROBINDO$Lei M, Cao Y, Yuan M, Xiong J, He H.. A case of bradycardia triggered by diarrhea.. Frontiers in medicine.. 2024;11:1405494$92$YR$$M$Y$$$20240702$$MD$CN$CN
240389901$24038990$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031694$AUROBINDO$De Allie G, Mehta A, Boucekkine H, Saggar R, Neville TH, Fishbein G.. Clinically Significant Pulmonary Invasion in Multiple Myeloma - Associated Amyloid Light Chain Amyloidosis. Am-JRespir-Crit-Care-Med. 2024$77$YR$$F$Y$$$20240702$$HP$US$US
240389911$24038991$1$I$20240611$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031394$AUROBINDO$$60$YR$$M$Y$66.3$KG$20240702$$MD$FR$FR
240389932$24038993$2$F$$20240708$20240702$20240711$EXP$GB-MHRA-MED-202406281144360370-LSKWG$GB-ORGANON-O2407GBR000014$ORGANON$$$$$$Y$$$20240711$$CN$GB$GB
240389941$24038994$1$I$20240612$20240625$20240702$20240702$EXP$$CN-ROCHE-10000009448$ROCHE$$58$YR$A$F$Y$56$KG$20240702$$HP$CN$CN
240389951$24038995$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031721$AUROBINDO$Yosry N, Chajkowski A, Rodriguez C, Medik Y, Lali M, Qaiser S, et al.. A Rare Cause of Rhabdomyolysis and Acute Renal Failure: Legionnaires Disease.. Am-J-Respir-Crit-Care-Med. 2024$55$YR$$M$Y$$$20240702$$HP$US$US
240389961$24038996$1$I$20240101$20240624$20240702$20240702$EXP$$CA-CELLTRION INC.-2024CA012430$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
240389971$24038997$1$I$$20240619$20240702$20240702$PER$$US-APOTEX-2024AP007689$APOTEX$Aslam S, Basaraba I, Icard BL. A Rare Case of Pulmonary Mucoepidermoid Carcinoma Manifesting as Recurrent Post-obstructive Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6565$27$YR$$M$Y$$$20240702$$HP$US$US
240389981$24038998$1$I$20240410$20240624$20240702$20240702$EXP$$ES-AUROBINDO-AUR-APL-2024-031419$AUROBINDO$$56$YR$$F$Y$$$20240702$$MD$ES$ES
240389991$24038999$1$I$$20240620$20240702$20240702$PER$$US-TEVA-VS-3213144$TEVA$$$$$$Y$$$20240702$$CN$US$US
240390001$24039000$1$I$$20231124$20240702$20240702$PER$$US-AMGEN-USASP2023235010$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240390011$24039001$1$I$$20230726$20240702$20240702$PER$$US-AMGEN-USASP2023235278$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240390022$24039002$2$F$$20240904$20240702$20240924$PER$$AU-TOLMAR, INC.-24AU050011$TOLMAR$$$$$M$Y$$$20240923$$CN$AU$AU
240390032$24039003$2$F$$20240904$20240702$20240924$PER$$AU-TOLMAR, INC.-24AU050040$TOLMAR$$$$$M$Y$$$20240923$$CN$AU$AU
240390042$24039004$2$F$$20240819$20240702$20240827$EXP$$AU-TOLMAR, INC.-24AU050014$TOLMAR$$$$$M$Y$$$20240827$$HP$AU$AU
240390051$24039005$1$I$$20240617$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06663$CIPLA$Simpson M, Awuah KB, Patel D, Ogline O, Pratapneni S, Disilvio BE.. Early extra corporeal membrane oxygenation (ECMO) and esophagogastroduodenoscopy (EGD) implementation: A timely intervention in a patient with extended-release Bupropion overdose. Am J Respir Crit Care Med. 2024;209:A5672:A5672$$$$$Y$$$20240702$$HP$US$US
240390062$24039006$2$F$20240606$20240711$20240702$20240731$PER$$AU-TOLMAR, INC.-24AU050041$TOLMAR$$69$YR$$M$Y$$$20240731$$HP$AU$AU
240390071$24039007$1$I$$20240607$20240702$20240702$PER$$AU-TOLMAR, INC.-24AU050045$TOLMAR$$$$$M$Y$$$20240702$$CN$AU$AU
240390082$24039008$2$F$$20240711$20240702$20240731$PER$$AU-TOLMAR, INC.-24AU050099$TOLMAR$$$$$$Y$$$20240731$$HP$AU$AU
240390091$24039009$1$I$$20240620$20240702$20240702$PER$$US-TEVA-VS-3214407$TEVA$$$$$$Y$$$20240702$$HP$US$US
240390102$24039010$2$F$$20240604$20240702$20240718$PER$$BR-TOLMAR, INC.-24BR050365$TOLMAR$$$$$F$Y$$$20240718$$CN$BR$BR
240390112$24039011$2$F$$20240703$20240702$20240705$PER$$US-AMGEN-USASP2024128960$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240390121$24039012$1$I$20240616$20240620$20240702$20240702$PER$$US-AstraZeneca-2024A143243$ASTRAZENECA$$75$YR$$F$Y$$$20240702$$CN$US$
240390131$24039013$1$I$20220101$20240627$20240702$20240702$EXP$$US-ABBVIE-5820885$ABBVIE$$38$YR$$F$Y$$$20240702$$CN$US$US
240390141$24039014$1$I$20240601$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105393$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240702$$CN$US$US
240390151$24039015$1$I$$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024129217$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240390161$24039016$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007677$APOTEX$$69$YR$$F$Y$$$20240702$$HP$CA$CA
240390171$24039017$1$I$$20240619$20240702$20240702$PER$$US-APOTEX-2024AP007699$APOTEX$Sarantopoulos N, Wiltchik E, Thakkar V, Klein W.. Fluconazole Associated DRESS Syndrome in Patient With Coccidioidomycosis Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-4$59$YR$$M$Y$$$20240702$$HP$US$US
240390182$24039018$2$F$$20240618$20240702$20240806$EXP$$BR-JNJFOC-20240654717$JOHNSON AND JOHNSON$$75$YR$E$M$Y$64$KG$20240806$$CN$BR$BR
240390191$24039019$1$I$$20240624$20240702$20240702$PER$$US-JNJFOC-20240671153$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240702$$HP$US$US
240390202$24039020$2$F$20240627$20240805$20240702$20240807$PER$$US-JNJFOC-20240676779$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240808$$HP$US$US
240390211$24039021$1$I$20240101$20240621$20240702$20240702$EXP$$US-JNJFOC-20240664111$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240702$$HP$US$US
240390221$24039022$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000012756$ROCHE$$66$YR$E$F$Y$$$20240702$$MD$US$US
240390231$24039023$1$I$20201028$20240624$20240702$20240702$EXP$$PL-AUROBINDO-AUR-APL-2024-031578$AUROBINDO$$29$YR$$M$Y$80$KG$20240702$$MD$PL$PL
240390241$24039024$1$I$$20240628$20240702$20240702$EXP$$FR-TAKEDA-2024TUS057834$TAKEDA$$$$$M$Y$$$20240702$$PH$FR$FR
240390251$24039025$1$I$20240501$20240624$20240702$20240702$PER$$US-ABBVIE-5817014$ABBVIE$$28$YR$$F$Y$$$20240702$$HP$US$US
240390261$24039026$1$I$20240618$20240621$20240702$20240702$EXP$$KZ-Merck Healthcare KGaA-2024034506$MERCK KGAA$$$$$F$Y$$$20240627$$HP$KZ$KZ
240390271$24039027$1$I$20220101$20220203$20240702$20240702$EXP$$US-RECORDATI RARE DISEASE INC.-2022007334$RECORDATI$$$$$$Y$$$20240702$$CN$US$US
240390281$24039028$1$I$$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031440$AUROBINDO$Leleu X, Hulin C, Lambert J, Bobin A, Perrot A, Karlin L et al. Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 benefit trial. Nature Medicine. 2024$$$E$$Y$$$20240702$$MD$FR$FR
240390293$24039029$3$F$20210824$20240911$20240702$20240919$EXP$$CA-CELLTRION INC.-2023CA005456$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
240390301$24039030$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007664$APOTEX$$79$YR$$F$Y$$$20240702$$HP$CA$CA
240390311$24039031$1$I$$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031410$AUROBINDO$Leleu X, Hulin C, Lambert J, Bobin A, Perrot A, Karlin L et al... Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.. Nature Medicine. 2024$$$E$$Y$$$20240702$$MD$FR$FR
240390321$24039032$1$I$20240216$20240620$20240702$20240702$EXP$PL-URPL-DML-MLP.4401.1.132.2024$PL-Merck Healthcare KGaA-2024033828$MERCK KGAA$$14$YR$T$F$Y$42$KG$20240627$$MD$PL$PL
240390331$24039033$1$I$$20240624$20240702$20240702$PER$$US-ABBVIE-5818061$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240390341$24039034$1$I$$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031812$AUROBINDO$Leleu X, Hulin C, Lambert J, Bobin A, Perrot A, Karlin L et al.. Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.. Nature Medicine. 2024$$$E$$Y$$$20240702$$MD$FR$FR
240390351$24039035$1$I$20240101$20240624$20240702$20240702$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-082566$REGENERON$$82$YR$$M$Y$$$20240702$$CN$US$US
240390361$24039036$1$I$20240401$20240624$20240702$20240702$EXP$$US-TEVA-VS-3213093$TEVA$$82$YR$$M$Y$$$20240702$$CN$US$US
240390371$24039037$1$I$$20240629$20240702$20240702$PER$$NVSC2024US136382$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240390383$24039038$3$F$20240601$20240717$20240702$20240723$EXP$$JP-009507513-2406JPN003946J$MERCK$$82$YR$$M$Y$$$20240723$$PH$JP$JP
240390391$24039039$1$I$20231224$20240614$20240702$20240702$EXP$$US-ROCHE-10000006391$ROCHE$$81$YR$E$M$Y$68.03$KG$20240702$$HP$US$US
240390401$24039040$1$I$$20230804$20240702$20240702$PER$$US-AMGEN-USASP2023235145$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240390411$24039041$1$I$20240624$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127549$AMGEN$$34$YR$A$F$Y$$$20240702$$CN$US$US
240390421$24039042$1$I$20240601$20240613$20240702$20240702$EXP$$IT-ROCHE-10000012587$ROCHE$$49$YR$A$M$Y$$$20240702$$MD$IT$IT
240390431$24039043$1$I$20240620$20240627$20240702$20240702$EXP$$US-AMGEN-USASP2024127870$AMGEN$$81$YR$E$F$Y$$$20240702$$CN$US$US
240390441$24039044$1$I$$20240626$20240702$20240702$PER$$US-ABBVIE-5818430$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240390451$24039045$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001112$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240702$$CN$US$US
240390461$24039046$1$I$$20240617$20240702$20240702$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108629$ZYDUS PHARM$Duke JD, Reisenauer J.. EP14.03-04 Rare but Aggressive: A Case of Primary Pulmonary Synovial Sarcoma.. J-Thorac-Oncol. 2023;18 (Suppl.)(11):S722$$$$$Y$$$20240702$$HP$US$US
240390471$24039047$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019488$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240702$$CN$US$US
240390481$24039048$1$I$$20240627$20240702$20240702$EXP$GB-MHRA-30950590$GB-TEVA-VS-3214829$TEVA$$83$YR$$F$Y$$$20240702$$PH$GB$GB
240390492$24039049$2$F$$20240710$20240702$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407000439$ELI LILLY AND CO$$$$$F$Y$$$20240712$$CN$US$US
240390501$24039050$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105100$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240702$$CN$US$US
240390511$24039051$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105065$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240702$$HP$US$US
240390521$24039052$1$I$$20240625$20240702$20240702$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-102112$BRISTOL MYERS SQUIBB$Lim MS, Mohamed M. Retrospective study of clinical settings, indications and consequences of measurement of direct oral anticoagulant plasma levels in Northern Tasmania, Australia. Internal Medicine Journal. 2024 Jun 01;54(6):932-40. doi:10.1111/imj.16329.$$$$$Y$$$20240702$$HP$AU$AU
240390531$24039053$1$I$$20240630$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105226$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240702$$CN$US$US
240390541$24039054$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05567$LUPIN$Ruff K, Wikenheiser-Brokamp KA, Critser P, Hirsch R, Burg G, Hayes D, et al. Pulmonary capillary hemangiomatosis: a rare disorder with a nonspecific presentation. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2327$9$YR$$F$Y$$$20240702$$HP$US$US
240390552$24039055$2$F$$20240805$20240702$20240812$EXP$$GB-AMGEN-GBRSL2024110590$AMGEN$$$$$F$Y$$$20240812$$CN$GB$GB
240390562$24039056$2$F$$20240826$20240702$20240904$30DAY$$US-GSK-US2024079848$GLAXOSMITHKLINE$$$$$M$Y$$$20240904$$CN$US$US
240390571$24039057$1$I$$20240620$20240702$20240702$EXP$$US-APOTEX-2024AP007794$APOTEX$Puri C, Khan AA, Sher N.. A Case of Emphysematous Gastritis With Septic Shock and Clostridioides Difficile. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1630$72$YR$$F$Y$$$20240702$$HP$US$US
240390581$24039058$1$I$20220714$20240620$20240702$20240702$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-12488$IPSEN$$50$YR$A$F$Y$88$KG$20240702$$CN$US$US
240390591$24039059$1$I$$20240624$20240702$20240702$EXP$$US-CELLTRION INC.-2024US015736$CELLTRION$Barnaba Durairaj MV, Caraway H, Buresh R, Sampath R, Waghchoure S.. Rapidly Progressing Secondary Organizing Pneumonia Due to Underlying Immunosuppression With Rituximab in SARS-CoV-2 Patients. Cureus. 2024;16(5):e60328$$$$$Y$$$20240702$$HP$US$US
240390602$24039060$2$F$$20240625$20240702$20240711$PER$$US-ROCHE-10000013122$ROCHE$$63$YR$A$M$Y$$$20240711$$CN$US$US
240390611$24039061$1$I$$20240614$20240702$20240702$PER$$US-AstraZeneca-2024A151404$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240390621$24039062$1$I$20240301$20240626$20240702$20240702$EXP$$US-AstraZeneca-2024A119146$ASTRAZENECA$$976$MON$$M$Y$91.6$KG$20240702$$MD$US$
240390631$24039063$1$I$$20240117$20240702$20240702$PER$$US-AMGEN-USASP2024130073$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240390642$24039064$2$F$$20240626$20240702$20240708$EXP$$JP-AMGEN-JPNSP2024127015$AMGEN$$$$$F$Y$$$20240707$$PH$JP$JP
240390651$24039065$1$I$$20240619$20240702$20240702$PER$$US-APOTEX-2024AP007717$APOTEX$Khalil H, Ernst EB, Fitzpatrick N.. The Worst Cough in History. American Journal of Respiratory and Critical Care Medicine. 2024;209$76$YR$$M$Y$$$20240702$$HP$US$US
240390661$24039066$1$I$$20240627$20240702$20240702$EXP$GB-MHRA-MIDB- 3328e1f3-2748-45ca-9d59-b678ef86a431$GB-TEVA-VS-3214801$TEVA$$83$YR$$$Y$$$20240702$$PH$GB$GB
240390671$24039067$1$I$$20240627$20240702$20240702$EXP$GB-MHRA-30708036$GB-TEVA-VS-3214848$TEVA$$8$MON$$$Y$$$20240702$$PH$GB$GB
240390681$24039068$1$I$$20240629$20240702$20240702$PER$$US-HALEON-2184728$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240390692$24039069$2$F$$20240627$20240702$20240705$PER$$US-AMGEN-USASP2024128905$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240390701$24039070$1$I$$20240624$20240702$20240702$PER$$US-ALXN-A202303240$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240702$$MD$US$US
240390711$24039071$1$I$$20240625$20240702$20240702$PER$$PR-ABBVIE-5817186$ABBVIE$$55$YR$$M$Y$$$20240702$$MD$PR$PR
240390732$24039073$2$F$20240218$20240807$20240702$20240813$EXP$$NVSC2024DE134403$NOVARTIS$$$$$F$Y$$$20240813$$CN$DE$DE
240390741$24039074$1$I$$20240624$20240702$20240702$PER$$US-ABBVIE-5818214$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240390761$24039076$1$I$$20240621$20240702$20240702$PER$$US-JNJFOC-20240700997$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240390771$24039077$1$I$$20240626$20240702$20240702$PER$$US-JNJFOC-20240672138$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240390782$24039078$2$F$20230101$20240702$20240702$20240708$EXP$$US-BIOGEN-2024BI01271454$BIOGEN$$$$$M$Y$$$20240708$$CN$US$US
240390791$24039079$1$I$20220101$20220228$20240702$20240702$EXP$$US-RECORDATI RARE DISEASE INC.-2022007335$RECORDATI$$$$$$Y$$$20240702$$CN$US$US
240390801$24039080$1$I$20240305$20240626$20240702$20240702$EXP$GB-MHRA-MED-202406252015368400-KZMWC$GB-TEVA-VS-3214025$TEVA$$37$YR$$F$Y$72$KG$20240702$$CN$GB$GB
240390811$24039081$1$I$$20240624$20240702$20240702$EXP$$CA-APOTEX-2024AP007719$APOTEX$$50$YR$$M$Y$$$20240702$$PH$CA$CA
240390821$24039082$1$I$$20240617$20240702$20240702$EXP$$IN-ROCHE-10000005290$ROCHE$$70$YR$E$M$Y$$$20240702$$CN$IN$IN
240390831$24039083$1$I$$20240624$20240702$20240702$EXP$$US-TEVA-VS-3214133$TEVA$Eshghabadi MA, Javaheri S, Aboelnasr A. LONG-TERM BUPRENORPHINE USE AND PREVALENCE OF SLEEP APNEA: A CASE SERIES. Sleep 2024; 47 (Suppl. 1) A499-A500 abstr. 1166.$28$YR$$M$Y$$$20240702$$HP$US$US
240390841$24039084$1$I$$20240627$20240702$20240702$PER$$US-ABBVIE-5821261$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240390851$24039085$1$I$$20240627$20240702$20240702$EXP$$US-GSK-US2024AMR081245$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$MD$US$US
240390861$24039086$1$I$20240617$20240624$20240702$20240702$EXP$ES-AEMPS-1538287$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109011$ZYDUS PHARM$$$$$$Y$$$20240702$$PH$ES$ES
240390871$24039087$1$I$20231120$20240624$20240702$20240702$EXP$$CA-CELLTRION INC.-2023CA023259$CELLTRION$$$$$$Y$$$20240702$$MD$CA$CA
240390881$24039088$1$I$$20240618$20240702$20240702$EXP$$BR-CADILA HEALTHCARE LIMITED-BR-ZYDUS-108788$ZYDUS PHARM$de Almeida FranzoiAE, Ferreira EL, Wollmann GM, de Araujo MeskauMP, Tensini TS.. Acute generalized pustulosis secondary to lamotrigine: from clinical to anatomopathological description.. Acta-Neurol-Belg. 2024;124(2):701-703$$$$$Y$$$20240702$$HP$BR$BR
240390891$24039089$1$I$20240330$20240624$20240702$20240702$EXP$FR-AFSSAPS-NT2024000690$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108960$ZYDUS PHARM$$$$$$Y$$$20240702$$MD$FR$FR
240390903$24039090$3$F$20190101$20240718$20240702$20240720$PER$$US-AMGEN-USASP2024128114$AMGEN$$60$YR$A$F$Y$$$20240720$$MD$US$US
240390912$24039091$2$F$20240601$20240724$20240702$20240726$PER$$US-AMGEN-USASP2024129177$AMGEN$$85$YR$E$F$Y$$$20240726$$CN$US$US
240390921$24039092$1$I$$20240618$20240702$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05497$LUPIN$$$$$$Y$$$20240702$$CN$US$US
240390931$24039093$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031382$AUROBINDO$Anand Ashwin Patel,  Madero-Marroquin R, DuVall AS, Saygin C, Wang P, Gurbuxani S et al. Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitor. Br J Haematol. 2024;204(4):1238?1242$34$YR$$M$Y$$$20240702$$HP$US$US
240390941$24039094$1$I$$20240623$20240702$20240702$EXP$$US-SERVIER-S24007846$SERVIER$Schwartz M., Gutman J., McMahon M., Amaya M., Pollyea D., Witkowski M. et al.. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. Blood. 2023;142:5898-5900$$$$$Y$$$20240702$$MD$US$US
240390951$24039095$1$I$$20240625$20240702$20240702$PER$$US-JNJFOC-20240666704$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240390961$24039096$1$I$$20240620$20240702$20240702$EXP$$US-APOTEX-2024AP007685$APOTEX$Sasidharan S; Jatoi T; Milla C; Mallappallil M; Agarwal S; Puri I. Triple Whammy of Amlodipine, Carvedilol and Diphenhydramine Overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-3$27$YR$$F$Y$$$20240702$$HP$US$US
240390971$24039097$1$I$20210101$20210701$20240702$20240702$EXP$$US-RECORDATI RARE DISEASE INC.-2021005905$RECORDATI$$$$$$Y$$$20240702$$CN$US$US
240390981$24039098$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821519$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240390992$24039099$2$F$20240408$20240705$20240702$20240709$EXP$$US-ABBVIE-5821456$ABBVIE$$59$YR$$M$Y$$$20240709$$CN$US$US
240391001$24039100$1$I$$20230612$20240702$20240702$PER$$US-AMGEN-USASP2023235296$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240391011$24039101$1$I$$20230807$20240702$20240702$PER$$US-AMGEN-USASP2023235277$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240391021$24039102$1$I$$20230717$20240702$20240702$PER$$US-AMGEN-USASP2023235323$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240391031$24039103$1$I$20240417$20240625$20240702$20240702$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-023112$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240702$$CN$US$US
240391041$24039104$1$I$$20240625$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105274$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240702$$CN$US$US
240391051$24039105$1$I$$20240627$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104456$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240702$$CN$US$US
240391061$24039106$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031758$AUROBINDO$Corey KB, Koo G, Stone CA, Kroop SF, Fissell WH, elizabeth P.J, et al.. A case of coronavirus disease 2019 messenger RNA vaccine tolerance and immune response despite presence of anti-polyethylene glycol antibodies.. Ann-Allergy-Asthma-Immunol. 2022;129(2):246-248$60$YR$$F$Y$$$20240702$$MD$US$US
240391071$24039107$1$I$20240625$20240626$20240702$20240702$EXP$$GB-TEVA-VS-3214202$TEVA$$39$YR$$F$Y$$$20240702$$HP$GB$GB
240391081$24039108$1$I$$20240620$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05856$HIKMA$Hoerle R, Qiao X. Hoerle R, Qiao X. A Last Resort: Lipid Emulsion Therapy in Lidocaine Anesthetic Systemic Toxicity (LAST).. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5683$81$YR$$F$Y$65$KG$20240702$$MD$US$US
240391091$24039109$1$I$20220201$20240626$20240702$20240702$EXP$$US-JAZZ-2022-US-005343$JAZZ$$46$YR$$F$Y$$$20240702$$CN$US$US
240391101$24039110$1$I$20240609$20240619$20240702$20240702$EXP$GB-MHRA-MED-202406181227426580-QYJNB$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13828$ALKEM$$25$YR$$M$Y$78$KG$20240702$$CN$GB$GB
240391113$24039111$3$F$$20240705$20240702$20240718$EXP$IR-MLMSERVICE-20240611-PI092975-00145-2$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-13847$ALKEM$Shahbazi F, Shojaei L. Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases. Current drug safety. 2024;unk:unk$49$YR$$M$Y$85$KG$20240718$$PH$IR$IR
240391123$24039112$3$F$$20240705$20240702$20240718$EXP$IR-MLMSERVICE-20240611-PI092975-00202-1$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-13849$ALKEM$Shahbazi F, Shojaei L.. Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases. Current drug safety. 2024;unk:unk$52$YR$$F$Y$75$KG$20240718$$PH$IR$IR
240391141$24039114$1$I$$20240619$20240702$20240702$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-13801$ALKEM$$55$YR$$M$Y$$$20240702$$HP$AU$AU
240391152$24039115$2$F$$20240904$20240702$20240905$EXP$$NVSC2024IE134598$NOVARTIS$$$$$M$Y$$$20240905$$MD$IE$IE
240391171$24039117$1$I$$20240619$20240702$20240702$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-13808$ALKEM$$53$YR$$M$Y$$$20240702$$HP$AU$AU
240391181$24039118$1$I$20240615$20240619$20240702$20240702$EXP$GB-MHRA-MED-202406171146230370-MZGPH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13944$ALKEM$$72$YR$$$Y$$$20240702$$CN$GB$GB
240391192$24039119$2$F$20190101$20240621$20240702$20240708$EXP$$US-ROCHE-10000008459$ROCHE$$53$YR$A$F$Y$104.33$KG$20240708$$CN$US$US
240391201$24039120$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031716$AUROBINDO$Keegan K, Ruff K, Burg G, Berklite LE, Deutsch G, Wikenheiser-Brokamp KA, et al. Surfactant Function Disorders: Genetics Is Just the Tip of the Iceberg. Am-J-Respir-Crit-Care-Med. 2024;209:A2305$3$YR$$F$Y$$$20240702$$HP$US$US
240391211$24039121$1$I$$20240619$20240702$20240702$EXP$PS-MLMSERVICE-20240613-PI097278-00030-1$PS-ALKEM LABORATORIES LIMITED-PS-ALKEM-2024-13951$ALKEM$Maqboul I, Daraghmeh L, Eleiwi MR, Qasrawi H, Akkawi M, AwadGhanem A. Atraumatic splenic rupture after administering aspirin, clopidogrel, and heparin to a patient with unstable angina: A case report. SAGE Open Med Case Rep. 2024;12:1-5$49$YR$$M$Y$$$20240702$$MD$PS$PS
240391221$24039122$1$I$$20240701$20240702$20240702$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037138$BOEHRINGER INGELHEIM$$$$$$Y$$$20240702$$CN$US$US
240391231$24039123$1$I$20210731$20240626$20240702$20240702$EXP$$CO-TAKEDA-2021TUS051594$TAKEDA$$47$YR$$F$Y$72$KG$20240702$$CN$CO$CO
240391241$24039124$1$I$$20240626$20240702$20240702$EXP$$NL-AMGEN-NLDSP2024127041$AMGEN$Ploumen R.W.; Claassens E.; Kooreman L.F. et al.. Surgical outcomes and prognosis of HER2+ invasive breast cancer patients with a DCIS component treated with breast-conserving surgery after neoadjuvant systemic therapy. European Journal of Surgical Oncology. 2024;50 (9):1-9$$$$$Y$$$20240702$$HP$NL$NL
240391251$24039125$1$I$$20240622$20240702$20240702$EXP$$US-AMGEN-USASP2024125339$AMGEN$Yasir M.; Gelaye A. E.. Rare Case of Resistant Aspergillus Niger Invasive Pulmonary Aspergillosis. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A3586$70$YR$E$F$Y$$$20240702$$HP$US$US
240391261$24039126$1$I$$20240628$20240702$20240702$PER$$US-BIOVITRUM-2024-US-009296$BIOVITRUM$$80$YR$$M$Y$$$20240702$$CN$US$US
240391271$24039127$1$I$$20240627$20240702$20240702$PER$$US-AstraZeneca-2024A150136$ASTRAZENECA$$$$$F$Y$$$20240702$$MD$US$
240391281$24039128$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A147035$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240391291$24039129$1$I$20240601$20240619$20240702$20240702$PER$$US-AstraZeneca-2024A151549$ASTRAZENECA$$$$$$Y$$$20240702$$CN$US$
240391301$24039130$1$I$$20240621$20240702$20240702$EXP$$US-NOVAST LABORATORIES INC.-2024NOV000261$NOVAST$Al-Moussally F, Tien JJ, Rajagopalan K, Boterosuarez C, Crouse R.. Euglycemic Ketoacidosis and Lactic Acidosis Associated With Metformin Toxicity.. Cureus. 2024;16(5)$67$YR$$F$Y$$$20240702$$HP$US$US
240391311$24039131$1$I$$20240624$20240702$20240702$EXP$$AT-AstraZeneca-2024A149196$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$AT$
240391321$24039132$1$I$$20240619$20240702$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04972$LUPIN$$$$$$Y$$$20240702$$CN$US$US
240391331$24039133$1$I$$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A149162$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240391341$24039134$1$I$20240610$20240618$20240702$20240702$EXP$$CN-Techdow-J2024HPR000382$SHENZHEN TECHDOW PHARMACEUTICAL$$72$YR$E$M$Y$51.5$KG$20240702$$MD$CN$CN
240391352$24039135$2$F$20240626$20240815$20240702$20240821$EXP$$CA-TAKEDA-2022TUS086259$TAKEDA$$51$YR$$M$Y$$$20240821$$CN$CA$CA
240391361$24039136$1$I$20240101$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031435$AUROBINDO$$17$YR$$F$Y$51$KG$20240702$$MD$FR$FR
240391382$24039138$2$F$20240101$20240628$20240702$20240704$EXP$$CA-ABBVIE-5821821$ABBVIE$$67$YR$$M$Y$$$20240704$$CN$CA$CA
240391391$24039139$1$I$20240628$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000171$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240702$$CN$US$US
240391401$24039140$1$I$20240628$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000614$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240702$$CN$US$US
240391411$24039141$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000282$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240702$$CN$US$US
240391421$24039142$1$I$20240630$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001048$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240702$$CN$US$US
240391431$24039143$1$I$20240625$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000131$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240702$$CN$US$US
240391441$24039144$1$I$20240628$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000433$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240702$$CN$US$US
240391451$24039145$1$I$20240608$20240625$20240702$20240702$PER$$US-ABBVIE-5817673$ABBVIE$$40$YR$$F$Y$$$20240702$$CN$US$US
240391461$24039146$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821841$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240391471$24039147$1$I$20240513$20240624$20240702$20240702$EXP$$GB-AUROBINDO-AUR-APL-2024-031476$AUROBINDO$$69$YR$$M$Y$67$KG$20240702$$MD$GB$GB
240391483$24039148$3$F$20240101$20240822$20240702$20240830$EXP$$CA-CELLTRION INC.-2024CA015862$CELLTRION$$$$$$Y$$$20240830$$CN$CA$CA
240391491$24039149$1$I$20240601$20240627$20240702$20240702$EXP$$US-ABBVIE-5821496$ABBVIE$$59$YR$$F$Y$$$20240702$$CN$US$US
240391503$24039150$3$F$20240501$20240705$20240702$20240716$EXP$$TW-ROCHE-10000009891$ROCHE$$82$YR$E$F$Y$40$KG$20240716$$MD$TW$TW
240391511$24039151$1$I$20240620$20240627$20240702$20240702$PER$$NVSC2024US135027$NOVARTIS$$70$YR$$M$Y$$$20240702$$HP$US$US
240391522$24039152$2$F$$20240628$20240702$20240725$PER$$US-HALEON-2184627$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
240391534$24039153$4$F$$20240710$20240702$20240723$EXP$$CZ-AUROBINDO-AUR-APL-2024-031830$AUROBINDO$Oulehle K, Vachek J. Malnutrice u pacientu s chronickym onemocnenim ledvin (Malnutrition in patients with chronic  kidney disease). Postgradualni nefrologie. 2024;22(2):13-16$74$YR$$M$Y$$$20240719$$MD$CZ$CZ
240391542$24039154$2$F$20240618$20240712$20240702$20240725$EXP$$US-VANTIVE-2024VAN017941$Vantive US Healthcare$$71$YR$$M$Y$$$20240725$$HP$US$US
240391552$24039155$2$F$$20240807$20240702$20240814$EXP$$US-VANTIVE-2024BAX010026$Vantive US Healthcare$$$$$F$Y$$$20240814$$HP$US$US
240391561$24039156$1$I$$20240621$20240702$20240702$EXP$$CO-NOVAST LABORATORIES INC.-2024NOV000262$NOVAST$Nati-Castillo HA, Aristizabal-Colorado D, Lopez Ordonez C, Egas Proano D, Ortiz-Prado E, Izquierdo-Condoy JS. Takotsubo syndrome as an acute cardiac complication following combined chemotherapy. Int J Cardiol Cardiovasc Risk Prev. 2024;22$61$YR$$F$Y$$$20240702$$HP$CO$CO
240391571$24039157$1$I$$20240620$20240702$20240702$EXP$AU-TGA-802864$AU-Accord-431498$ACCORD$$$$$M$Y$$$20240702$$HP$AU$AU
240391581$24039158$1$I$20240618$20240621$20240702$20240702$EXP$GB-MHRA-MED-202406211747088400-SPBLF$GB-Accord-432174$ACCORD$$33$YR$A$F$Y$$$20240702$$CN$GB$GB
240391591$24039159$1$I$20240614$20240621$20240702$20240702$EXP$CN-HENLIUS-24CN015547$CN-Accord-433063$ACCORD$$71$YR$E$F$Y$66$KG$20240702$$MD$CN$CN
240391602$24039160$2$F$20221101$20240628$20240702$20240709$EXP$$CO-Accord-432343$ACCORD$Mejia-Salgado G, Cardozo-Perez C, Cifuentes-Gonzalez C, Duran-Merino C, de-la-Torre A. Coinfection Suspicion is Imperative in Immunosuppressed Patients with Suspected Infectious Uveitis and Inadequate Treatment Response: A Case Report. Ocul Immunol Inflamm. 2024 Jun 18:1-5.$70$YR$E$F$Y$$$20240709$$MD$CO$CO
240391611$24039161$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821561$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240391621$24039162$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031707$AUROBINDO$Samuels S, Arunthamakun J, Gilge JL.. AS BELOW, SO ABOVE - NOT YOUR TYPICAL CAVOTRICUSPID ISTHMUS ATRIAL FLUTTER ABLATION. J-Am-Coll-Cardiol. 2024;83 (Suppl. 2)13:2899$48$YR$$M$Y$$$20240702$$HP$US$US
240391631$24039163$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432116$ACCORD$Landis AR, Minish J, Zouk AN. A Case of Kaposi Sarcoma masquerading as bilateral pleural effusions in a patient with orthotopic heart transplant. American Journal of Respiratory and Critical Care Medicine. 2024:209. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1941.$58$YR$A$M$Y$$$20240702$$MD$US$US
240391641$24039164$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432111$ACCORD$Alsheimer K, Burgei JW, Lantry J, Shah H, Lamichhane B. Genitourinary Tuberculosis Resulting in Hydronephrosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2354. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2354.$$$$M$Y$$$20240702$$MD$US$US
240391661$24039166$1$I$20240614$20240626$20240702$20240702$EXP$$US-ABBVIE-5819598$ABBVIE$$66$YR$$F$Y$81.646$KG$20240702$$CN$US$PR
240391671$24039167$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-032126$AUROBINDO$Anthony O, Avalos Sugastti E, Nananamibia d. Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab. BMJ Case Rep. 2024$$$A$M$Y$$$20240702$$HP$US$US
240391681$24039168$1$I$$20240625$20240702$20240702$PER$$US-JNJFOC-20240668022$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$MD$US$US
240391691$24039169$1$I$20240603$20240629$20240702$20240702$EXP$$US-TAKEDA-2024TUS065609$TAKEDA$$76$YR$$M$Y$$$20240702$$CN$US$US
240391701$24039170$1$I$$20240628$20240702$20240702$EXP$$JP-TAKEDA-2023TJP007079$TAKEDA$$76$YR$$F$Y$$$20240702$$MD$JP$JP
240391711$24039171$1$I$20240528$20240624$20240702$20240702$EXP$$CA-TAKEDA-2024TUS056552$TAKEDA$$74$YR$$F$Y$$$20240702$$CN$CA$CA
240391723$24039172$3$F$$20240823$20240702$20240827$PER$$US-AMGEN-USASP2024128761$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
240391731$24039173$1$I$$20230825$20240702$20240702$PER$$US-AMGEN-USASP2023235143$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240391741$24039174$1$I$20240520$20240620$20240702$20240702$EXP$$CO-TERSERA THERAPEUTICS LLC-2024TRS003301$TERSERA THERAPEUTICS$$$$$$Y$$$20240702$$CN$CO$CO
240391752$24039175$2$F$20240704$20240704$20240702$20240710$EXP$$CA-TAKEDA-2022TUS099236$TAKEDA$$65$YR$$F$Y$$$20240710$$CN$CA$CA
240391761$24039176$1$I$20240506$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031430$AUROBINDO$$87$YR$$M$Y$79$KG$20240702$$PH$FR$FR
240391771$24039177$1$I$20240205$20240624$20240702$20240702$EXP$FR-AFSSAPS-BR2024000487$FR-AMGEN-FRASP2024124967$AMGEN$$42$YR$A$M$Y$95$KG$20240702$$CN$FR$FR
240391781$24039178$1$I$$20240621$20240702$20240702$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000263$NOVAST$Lei M, Cao Y, Yuan M, Xiong J, He H.. Case report: A case of bradycardia triggered by diarrhea.. Front. Med.. 2024;11$92$YR$$M$Y$$$20240702$$HP$CN$CN
240391791$24039179$1$I$$20240626$20240702$20240702$EXP$DE-EMBRYOTOX-202301664$DE-RDY-SPO/DEU/24/0009339$DR REDDYS$$$$A$F$Y$73$KG$20240702$$MD$DE$DE
240391802$24039180$2$F$$20240815$20240702$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104192$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240816$$PH$US$US
240391811$24039181$1$I$20240404$20240624$20240702$20240702$EXP$$RU-HETERO-HET2024RU02005$HETERO$$$$$F$Y$37$KG$20240702$$MD$RU$RU
240391822$24039182$2$F$20240624$20240827$20240702$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102679$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240906$$CN$US$US
240391831$24039183$1$I$20240615$20240627$20240702$20240702$EXP$GB-MHRA-MED-202406261715230780-NLDBV$GB-TEVA-VS-3214611$TEVA$$40$YR$$M$Y$85$KG$20240702$$CN$GB$GB
240391841$24039184$1$I$20240101$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128461$AMGEN$$30$YR$A$F$Y$$$20240702$$HP$US$US
240391851$24039185$1$I$$20230116$20240702$20240702$PER$$US-AMGEN-USASP2023235282$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240391861$24039186$1$I$20210101$20240626$20240702$20240702$EXP$$US-ABBVIE-5812783$ABBVIE$$$$$F$Y$71.667$KG$20240702$$CN$US$US
240391872$24039187$2$F$20240628$20240809$20240702$20240819$30DAY$$US-GSK-US2024081045$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240819$$CN$US$US
240391881$24039188$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821569$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240391891$24039189$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821705$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240391902$24039190$2$F$20240619$20240709$20240702$20240711$EXP$$DE-ABBVIE-5818439$ABBVIE$$62$YR$$F$Y$79$KG$20240711$$MD$DE$DE
240391911$24039191$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5819896$ABBVIE$$$$$F$Y$$$20240702$$HP$US$US
240391921$24039192$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821811$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240391931$24039193$1$I$20240613$20240628$20240702$20240702$EXP$$CN-ABBVIE-5821819$ABBVIE$$80$YR$$F$Y$56$KG$20240702$$MD$CN$CN
240391941$24039194$1$I$$20240625$20240702$20240702$EXP$$CA-TAKEDA-2023TUS041964$TAKEDA$$$$$M$Y$$$20240702$$CN$CA$CA
240391952$24039195$2$F$20240101$20240719$20240702$20240724$EXP$$CA-ABBVIE-5820203$ABBVIE$$36$YR$$F$Y$$$20240724$$CN$CA$CA
240391962$24039196$2$F$$20240705$20240702$20240708$EXP$$CA-ABBVIE-5820166$ABBVIE$$$$E$F$Y$$$20240708$$CN$CA$CA
240391971$24039197$1$I$20240501$20240624$20240702$20240702$EXP$$CA-CELLTRION INC.-2024CA015779$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
240391981$24039198$1$I$$20240701$20240702$20240702$EXP$$US-TAKEDA-2024TUS063123$TAKEDA$$$$$F$Y$$$20240702$$CN$US$US
240391992$24039199$2$F$20200101$20240710$20240702$20240715$EXP$$US-ABBVIE-5819955$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240392001$24039200$1$I$$20230214$20240702$20240702$EXP$$US-RECORDATI-2023000861$RECORDATI$$$$$$Y$$$20240702$$HP$US$US
240392011$24039201$1$I$$20240628$20240702$20240702$EXP$$GB-UCBSA-2024033274$UCB$$$$A$F$Y$$$20240702$$CN$GB$GB
240392021$24039202$1$I$$20230607$20240702$20240702$PER$$US-AMGEN-USASP2023235051$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240392034$24039203$4$F$20240504$20240709$20240702$20240715$PER$$US-AMGEN-USASP2024127504$AMGEN$$65$YR$E$F$Y$$$20240715$$PH$US$US
240392043$24039204$3$F$20240419$20240814$20240702$20240822$EXP$FR-AFSSAPS-BX2024001179$FR-TEVA-VS-3213845$TEVA$$63$YR$$F$Y$$$20240822$$PH$FR$FR
240392051$24039205$1$I$20200101$20240619$20240702$20240702$EXP$GB-MHRA-MED-202406190948417390-QSLZT$GB-LUPIN PHARMACEUTICALS INC.-2024-05462$LUPIN$$$$$$Y$$$20240702$$MD$GB$GB
240392061$24039206$1$I$20240101$20240628$20240702$20240702$EXP$$DE-TAKEDA-2024TUS065204$TAKEDA$$59$YR$$F$Y$$$20240702$$HP$DE$DE
240392074$24039207$4$F$$20240822$20240702$20240827$EXP$$CH-TAKEDA-2024TUS064321$TAKEDA$$59$YR$$F$Y$$$20240827$$HP$CH$CH
240392081$24039208$1$I$$20240627$20240702$20240702$PER$$NVSC2024US135644$NOVARTIS$$$$$M$Y$$$20240702$$HP$US$US
240392092$24039209$2$F$20240613$20240729$20240702$20240802$EXP$FR-AFSSAPS-TO2024001123$FR-UCBSA-2024033252$UCB$$58$YR$$M$Y$100$KG$20240802$$MD$FR$FR
240392101$24039210$1$I$$20240628$20240702$20240702$EXP$$GB-TAKEDA-2023TUS101607$TAKEDA$$$$$M$Y$$$20240702$$CN$GB$GB
240392113$24039211$3$F$20240101$20240914$20240702$20240923$EXP$$CA-CELLTRION INC.-2024CA005498$CELLTRION$$$$$$Y$$$20240923$$PH$CA$CA
240392122$24039212$2$F$$20240906$20240702$20240912$EXP$$BR-TAKEDA-2024TUS065510$TAKEDA$$$$$F$Y$13$KG$20240912$$CN$BR$BR
240392131$24039213$1$I$20240124$20240625$20240702$20240702$EXP$$FR-CELLTRION INC.-2024FR015631$CELLTRION$$$$$$Y$$$20240702$$MD$FR$FR
240392141$24039214$1$I$$20240621$20240702$20240702$EXP$$IN-ROCHE-10000008224$ROCHE$$$$E$M$Y$$$20240702$$CN$IN$IN
240392151$24039215$1$I$20240625$20240626$20240702$20240702$30DAY$$US-GSK-US2024079681$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240702$$CN$US$US
240392161$24039216$1$I$$20240621$20240702$20240702$EXP$$US-GSK-US2024AMR080025$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$MD$US$US
240392181$24039218$1$I$$20240412$20240702$20240702$PER$$US-AMGEN-USASP2024129669$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240392191$24039219$1$I$20240627$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128683$AMGEN$$62$YR$A$F$Y$$$20240702$$CN$US$US
240392201$24039220$1$I$20240627$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128070$AMGEN$$36$YR$A$M$Y$$$20240702$$MD$US$US
240392211$24039221$1$I$$20231205$20240702$20240702$PER$$US-AMGEN-USASP2023235012$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240392221$24039222$1$I$$20230823$20240702$20240702$PER$$US-AMGEN-USASP2023235271$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240392234$24039223$4$F$20240610$20240829$20240702$20240904$PER$$US-AMGEN-USASP2024128514$AMGEN$$71$YR$E$F$Y$$$20240904$$CN$US$US
240392241$24039224$1$I$20240627$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128512$AMGEN$$71$YR$E$F$Y$$$20240702$$CN$US$US
240392251$24039225$1$I$20240101$20240627$20240702$20240702$EXP$$US-ORGANON-O2407USA000081$ORGANON$$$$$F$Y$$$20240702$$CN$US$US
240392262$24039226$2$F$$20240709$20240702$20240710$EXP$GB-MHRA-MED-202406281431213880-YGRFD$GB-ORGANON-O2407GBR000010$ORGANON$$$$$$Y$$$20240710$$CN$GB$GB
240392271$24039227$1$I$20240612$20240618$20240702$20240702$PER$$US-ABBVIE-5822641$ABBVIE$$5$YR$$F$Y$$$20240702$$CN$US$US
240392281$24039228$1$I$20240429$20240625$20240702$20240702$EXP$$CN-BEIGENE-BGN-2024-009753$BEIGENE$$$$$$Y$$$20240702$$HP$CN$CN
240392291$24039229$1$I$20240607$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A149106$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240392302$24039230$2$F$20240101$20240627$20240702$20240704$PER$$US-ABBVIE-5822495$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240392312$24039231$2$F$20240517$20240702$20240702$20240708$EXP$$CA-TAKEDA-2024TUS063640$TAKEDA$$25$YR$$F$Y$$$20240708$$MD$CA$CA
240392321$24039232$1$I$20240628$20240628$20240702$20240702$PER$$US-AMGEN-USASP2024129229$AMGEN$$$$$F$Y$$$20240702$$HP$US$US
240392335$24039233$5$F$20240101$20240912$20240702$20240920$EXP$$CA-CELLTRION INC.-2024CA015792$CELLTRION$$$$$$Y$$$20240920$$CN$CA$CA
240392341$24039234$1$I$20191119$20240624$20240702$20240702$EXP$$CA-TAKEDA-2024TUS024729$TAKEDA$$20$YR$$F$Y$$$20240702$$HP$CA$CA
240392351$24039235$1$I$$20240628$20240702$20240702$PER$$US-AMGEN-USASP2024129265$AMGEN$$31$YR$A$M$Y$$$20240702$$CN$US$US
240392363$24039236$3$F$20240626$20240820$20240702$20240823$PER$$US-AMGEN-USASP2024128984$AMGEN$$71$YR$E$F$Y$$$20240822$$CN$US$US
240392372$24039237$2$F$20240607$20240724$20240702$20240730$PER$$US-AMGEN-USASP2024127447$AMGEN$$75$YR$E$F$Y$$$20240729$$CN$US$US
240392382$24039238$2$F$$20240805$20240702$20240806$PER$$US-ALXN-202406USA001620US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240392393$24039239$3$F$20240101$20240712$20240702$20240722$EXP$$CA-CELLTRION INC.-2024CA015905$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
240392401$24039240$1$I$$20240621$20240702$20240702$EXP$$US-AMGEN-USASP2024124016$AMGEN$Mak K.; Gandhi R.; Zaidan M. F.. Rituximab for Rapidly Progressive MDA5 Dermatomyositis-Associated Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A1986$41$YR$A$F$Y$$$20240702$$HP$US$US
240392411$24039241$1$I$20240630$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001018$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240702$$CN$US$US
240392421$24039242$1$I$$20240626$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406018529$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240702$$CN$US$US
240392431$24039243$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001041$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240702$$CN$US$US
240392441$24039244$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000518$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240702$$CN$US$US
240392451$24039245$1$I$20240601$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000091$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240702$$CN$US$US
240392461$24039246$1$I$$20240627$20240702$20240702$EXP$$US-JNJFOC-20240675006$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240392471$24039247$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05590$LUPIN$Raymond-Forde S, Olexsey K. A Rare but potentially fatal reaction in plain sight: Trimethoprim- Sulfamethoxazole induced acute lung injury. American Journal of Respiratory and Critical Care Medicine. 2024;209$26$YR$$F$Y$$$20240702$$HP$US$US
240392481$24039248$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031885$AUROBINDO$Hussain M, Lam J, Sivanandham R, Barsoum A, Bagheri S, Hussain S, et al.. AripiprazoleInduced Diabetic Ketoacidosis and Hypertriglyceridemia Triggering Concurrent Pancreatitis: A Case Report.. Am-J-Respir-Crit-Care-Med. 2024$35$YR$$M$Y$$$20240702$$HP$US$US
240392492$24039249$2$F$$20240913$20240702$20240920$EXP$$GB-TAKEDA-2024TUS030652$TAKEDA$$$$$M$Y$$$20240920$$CN$GB$GB
240392501$24039250$1$I$$20240630$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104925$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$75.75$KG$20240702$$CN$US$US
240392512$24039251$2$F$$20240814$20240702$20240819$EXP$$NVSC2024CH135499$NOVARTIS$$$$$F$Y$$$20240819$$HP$CH$CH
240392522$24039252$2$F$$20240628$20240702$20240704$PER$$NVSC2024US136752$NOVARTIS$$$$$F$Y$$$20240704$$MD$US$US
240392532$24039253$2$F$$20240905$20240702$20240911$EXP$$US-TAKEDA-2024TUS063828$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
240392541$24039254$1$I$$20230922$20240702$20240702$PER$$US-AMGEN-USASP2023235167$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240392553$24039255$3$F$20240625$20240904$20240702$20240906$EXP$$JP-AMGEN-JPNSP2024127013$AMGEN$$$$E$F$Y$$$20240906$$CN$JP$JP
240392561$24039256$1$I$20240614$20240628$20240702$20240702$EXP$$GB-TAKEDA-2024TUS065951$TAKEDA$$51$YR$$M$Y$$$20240702$$CN$US$GB
240392571$24039257$1$I$$20240701$20240702$20240702$30DAY$$US-SANDOZ INC.-SDZ2024US062005$SANDOZ$$$$$M$Y$$$20240702$$CN$US$US
240392581$24039258$1$I$20240215$20240701$20240702$20240702$EXP$FR-AFSSAPS-LY2024000867$FR-SANDOZ INC.-SDZ2024FR061812$SANDOZ$$67$YR$$F$Y$50$KG$20240702$$PH$FR$FR
240392591$24039259$1$I$$20240625$20240702$20240702$EXP$$VN-SANDOZ INC.-SDZ2024VN061709$SANDOZ$$74$YR$$F$Y$$$20240702$$MD$VN$VN
240392601$24039260$1$I$$20240626$20240702$20240702$EXP$$JP-SANDOZ INC.-SDZ2024JP061440$SANDOZ$Ueki Y, Ohshima S, Yokoyama Y, Takahashi T, Shodo R, Yamazaki K et al.. Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma. International Journal of Clinical Oncology. 2024;29(1):20-26$$$$$Y$$$20240702$$MD$JP$JP
240392612$24039261$2$F$$20240703$20240702$20240711$EXP$$DE-SANDOZ INC.-PHHY2011DE17401$SANDOZ$Pfersdorff M, Spes J, Kraus MR. 17-year-old patient with neutropenia and fever during therapy with analgesics.. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. 2011;136 (8)$17$YR$$M$Y$68$KG$20240711$$MD$DE$DE
240392621$24039262$1$I$$20240625$20240702$20240702$EXP$$US-SANDOZ INC.-SDZ2024US061859$SANDOZ$$51$YR$$F$Y$$$20240702$$HP$US$US
240392631$24039263$1$I$$20240628$20240702$20240702$EXP$$AU-SANDOZ INC.-SDZ2024AU061800$SANDOZ$$$$$$Y$$$20240702$$PH$AU$AU
240392641$24039264$1$I$$20240624$20240702$20240702$EXP$$CA-APOTEX-2024AP007738$APOTEX$$21$YR$$F$Y$$$20240702$$HP$CA$CA
240392651$24039265$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281422291500-CTQJK$GB-TEVA-VS-3215583$TEVA$$$$$$Y$$$20240702$$CN$GB$GB
240392662$24039266$2$F$20240101$20240709$20240702$20240716$EXP$$CA-SANDOZ INC.-SDZ2024CA061078$SANDOZ$$$$$F$Y$$$20240716$$CN$CA$CA
240392671$24039267$1$I$$20240626$20240702$20240702$30DAY$$FR-SANDOZ INC.-SDZ2024FR061982$SANDOZ$$9$YR$$F$Y$$$20240702$$CN$FR$FR
240392682$24039268$2$F$20240507$20240820$20240702$20240822$EXP$$DE-SANDOZ INC.-SDZ2024DE059047$SANDOZ$$64$YR$$F$Y$53$KG$20240822$$HP$DE$DE
240392692$24039269$2$F$20200910$20231128$20240702$20240704$EXP$$DE-SANDOZ INC.-NVSC2021DE035702$SANDOZ$$$$E$F$Y$$$20240704$$MD$DE$DE
240392711$24039271$1$I$$20240627$20240702$20240702$EXP$$IN-SANDOZ INC.-SDZ2024IN061918$SANDOZ$$$$$F$Y$$$20240702$$CN$IN$IN
240392721$24039272$1$I$20231224$20240701$20240702$20240702$EXP$FR-AFSSAPS-AVNY2024000190$FR-SANDOZ INC.-SDZ2024FR061970$SANDOZ$$34$YR$$M$Y$69$KG$20240702$$MD$FR$FR
240392733$24039273$3$F$$20240705$20240702$20240711$PER$$US-ROCHE-10000008015$ROCHE$$$$$M$Y$$$20240711$$CN$US$US
240392741$24039274$1$I$$20240628$20240702$20240702$PER$$US-ABBVIE-5821718$ABBVIE$$$$$$Y$$$20240702$$HP$US$US
240392751$24039275$1$I$20240601$20240626$20240702$20240702$PER$$US-JNJFOC-20240676505$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
240392761$24039276$1$I$$20240627$20240702$20240702$EXP$$CA-JNJFOC-20240263351$JOHNSON AND JOHNSON$$44$YR$A$M$Y$81$KG$20240702$$HP$CA$CA
240392771$24039277$1$I$20240426$20240626$20240702$20240702$EXP$$CA-TAKEDA-2024TUS026213$TAKEDA$$68$YR$$F$Y$$$20240702$$CN$CA$CA
240392781$24039278$1$I$20240625$20240626$20240702$20240702$PER$$US-ROCHE-10000011713$ROCHE$$$$$$Y$$$20240702$$PH$US$US
240392792$24039279$2$F$20240601$20240722$20240702$20240730$30DAY$$US-AMGEN-USASL2024126869$AMGEN$$$$$$Y$$$20240729$$PH$US$US
240392801$24039280$1$I$20240627$20240628$20240702$20240702$PER$$US-AMGEN-USASP2024128706$AMGEN$$59$YR$A$F$Y$$$20240702$$CN$US$US
240392811$24039281$1$I$$20240625$20240702$20240702$EXP$$GB-AMGEN-GBRNI2024129084$AMGEN$$43$YR$A$F$Y$$$20240702$$CN$GB$GB
240392821$24039282$1$I$$20240622$20240702$20240702$EXP$$US-AMGEN-USASP2024124587$AMGEN$Glick M. R.; Callahan S. J.; Scholand M.. Rapid Antibody Depletion: A Novel Therapeutic Approach for Acute Exacerbation of Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A3745-A3745$$$$$Y$$$20240702$$HP$US$US
240392832$24039283$2$F$20240616$20240809$20240702$20240813$PER$$US-AMGEN-USASP2024127563$AMGEN$$63$YR$A$F$Y$$$20240813$$CN$US$US
240392842$24039284$2$F$$20240627$20240702$20240705$PER$$US-AMGEN-USASP2024128431$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240392852$24039285$2$F$20240524$20240812$20240702$20240816$EXP$$CO-AMGEN-COLSL2024127281$AMGEN$$87$YR$E$F$Y$$$20240816$$CN$CO$CO
240392861$24039286$1$I$20240622$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127403$AMGEN$$77$YR$E$F$Y$$$20240702$$CN$US$US
240392872$24039287$2$F$$20240724$20240702$20240731$EXP$$JP-AMGEN-JPNSP2024129310$AMGEN$$$$$$Y$$$20240731$$PH$JP$JP
240392882$24039288$2$F$$20240710$20240702$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104804$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240715$$CN$US$US
240392891$24039289$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105288$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$51.71$KG$20240702$$CN$US$US
240392901$24039290$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05604$LUPIN$Bjork ST, Chen E. Nephrotoxicity as a complication of inhaled tobramycin for pseudomonas pneumonia: A case series. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7429:1$74$YR$$F$Y$$$20240702$$HP$US$US
240392912$24039291$2$F$$20240719$20240702$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05055$LUPIN$$$$$$Y$$$20240813$$CN$US$US
240392922$24039292$2$F$$20240702$20240702$20240716$EXP$$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001558$IPCA$$$$$$Y$$$20240716$$CN$GB$GB
240392932$24039293$2$F$20240617$20240819$20240702$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103781$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$75.3$KG$20240822$$PH$US$US
240392941$24039294$1$I$20240605$20240626$20240702$20240702$EXP$$CA-TAKEDA-2024TUS064551$TAKEDA$$64$YR$$F$Y$$$20240702$$CN$CA$CA
240392951$24039295$1$I$20240613$20240626$20240702$20240702$PER$$US-ABBVIE-5818043$ABBVIE$$63$YR$$F$Y$39$KG$20240702$$CN$US$US
240392961$24039296$1$I$20230101$20230615$20240702$20240702$EXP$$US-RECORDATI RARE DISEASE INC.-2023004035$RECORDATI$$$$$$Y$$$20240702$$CN$US$US
240392971$24039297$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281041575460-KYCFR$GB-TEVA-VS-3215637$TEVA$$$$$$Y$$$20240702$$CN$GB$GB
240392981$24039298$1$I$$20240627$20240702$20240702$EXP$$ES-UCBSA-2024033009$UCB$$$$$$Y$$$20240702$$MD$ES$ES
240392991$24039299$1$I$$20240627$20240702$20240702$EXP$$SG-AstraZeneca-2024A148891$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$SG$
240393001$24039300$1$I$20240627$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A149347$ASTRAZENECA$$$$$F$Y$$$20240702$$MD$US$
240393011$24039301$1$I$$20240627$20240702$20240702$PER$$US-TAKEDA-2024TUS065284$TAKEDA$$$$$F$Y$$$20240702$$CN$US$US
240393021$24039302$1$I$20231123$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128371$AMGEN$$85$YR$E$F$Y$$$20240702$$CN$US$US
240393032$24039303$2$F$20240515$20240628$20240702$20240704$PER$$US-AMGEN-USASP2024128633$AMGEN$$63$YR$A$F$Y$$$20240704$$HP$US$US
240393041$24039304$1$I$$20240626$20240702$20240702$EXP$$US-JNJFOC-20240673101$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$US$US
240393051$24039305$1$I$$20240626$20240702$20240702$EXP$$US-ABBVIE-5820365$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240393061$24039306$1$I$20240101$20240626$20240702$20240702$PER$$US-ABBVIE-5819025$ABBVIE$$61$YR$$F$Y$$$20240702$$CN$US$US
240393072$24039307$2$F$$20240805$20240702$20240806$PER$$US-ALXN-202406USA001589US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240393082$24039308$2$F$$20240805$20240702$20240806$PER$$US-ALXN-202406USA001587US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$CN$US$US
240393094$24039309$4$F$$20240903$20240702$20240905$EXP$$PY-ABBVIE-5822689$ABBVIE$$33$YR$$F$Y$$$20240905$$MD$PY$PY
240393101$24039310$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007683$APOTEX$$75$YR$$F$Y$$$20240702$$CN$CA$CA
240393112$24039311$2$F$20221103$20240806$20240702$20240815$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-22-022797$AKEBIA THERAPEUTICS$$$$$$Y$$$20240815$$MD$JP$JP
240393121$24039312$1$I$$20240628$20240702$20240702$PER$$US-TAKEDA-2024TUS065509$TAKEDA$$$$$F$Y$$$20240702$$CN$US$US
240393131$24039313$1$I$$20240625$20240702$20240702$EXP$$US-UCBSA-2024033351$UCB$$$$$F$Y$$$20240702$$HP$US$US
240393141$24039314$1$I$20240620$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024125563$AMGEN$$54$YR$A$F$Y$$$20240702$$PH$US$US
240393151$24039315$1$I$$20240624$20240702$20240702$PER$$US-AMGEN-USASP2024126353$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240393161$24039316$1$I$$20230717$20240702$20240702$PER$$US-AMGEN-USASP2023235324$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240393171$24039317$1$I$$20240626$20240702$20240702$EXP$$US-GILEAD-2024-0674937$GILEAD$$$$A$M$Y$$$20240702$$CN$US$US
240393181$24039318$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031396$AUROBINDO$Collen LV, Mitchell PD, Fox VL, Grover AS.. Pancreatitis-Associated Medication Use in Hospitalized Pediatric and Young Adult Patients with Acute Pancreatitis.. J-Pediatr-Gastroenterol-Nutr. 2023;77(2):260-266$$$$$Y$$$20240702$$HP$US$US
240393192$24039319$2$F$20240526$20240722$20240702$20240729$EXP$$US-GSK-US2024080397$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$HP$US$US
240393202$24039320$2$F$20240621$20240715$20240702$20240719$PER$$US-AMGEN-USASP2024129388$AMGEN$$62$YR$A$M$Y$$$20240719$$CN$US$US
240393212$24039321$2$F$$20240814$20240702$20240826$30DAY$$US-GSK-US2024080440$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
240393231$24039323$1$I$$20240624$20240702$20240702$EXP$$NL-AMGEN-NLDSP2024128565$AMGEN$de Bruijn, A.; De Bruijn A.; Van Der Sangenc M. J. et al.. Oncologic outcomes of de-escalating axillary treatment in clinically node-positive breast cancer patients treated with neoadjuvant systemic therapy - A two center cohort study. European Journal of Surgical Oncology. 2024;50 (9):1-7$$$$$Y$$$20240702$$HP$NL$NL
240393241$24039324$1$I$20240618$20240627$20240702$20240702$PER$$US-JNJFOC-20240674881$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240702$$HP$US$US
240393251$24039325$1$I$$20240619$20240702$20240702$PER$$US-ROCHE-10000012917$ROCHE$$81$YR$E$F$Y$$$20240702$$HP$US$US
240393261$24039326$1$I$$20240626$20240702$20240702$PER$$US-ABBVIE-5818433$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240393271$24039327$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105321$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$79.38$KG$20240702$$CN$US$US
240393281$24039328$1$I$$20240619$20240702$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05554$LUPIN$$$$$$Y$$$20240702$$CN$US$US
240393291$24039329$1$I$20170101$20240628$20240702$20240702$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037047$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$$$20240702$$CN$BR$BR
240393301$24039330$1$I$20240625$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104842$BRISTOL MYERS SQUIBB$$82$YR$E$$Y$$$20240702$$PH$US$US
240393311$24039331$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105365$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240702$$CN$US$US
240393322$24039332$2$F$$20240702$20240702$20240711$EXP$$BR-CELLTRION INC.-2024BR015660$CELLTRION$$$$$$Y$$$20240711$$CN$BR$BR
240393331$24039333$1$I$$20240621$20240702$20240702$PER$$US-APOTEX-2024AP007763$APOTEX$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allergy, Asthma + Clinical Immunology. 2023;19 (1)(78):1-6$58$YR$$F$Y$$$20240702$$HP$US$US
240393341$24039334$1$I$20240101$20240618$20240702$20240702$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00501$UPSHER-SMITH$$$$$$Y$$$20240702$$HP$US$US
240393351$24039335$1$I$20231101$20240603$20240702$20240702$EXP$$US-GSK-US2024080913$GLAXOSMITHKLINE$$33$YR$$F$Y$$$20240702$$HP$US$US
240393361$24039336$1$I$20231020$20240624$20240702$20240702$EXP$$CA-CELLTRION INC.-2023CA017312$CELLTRION$$$$$$Y$$$20240702$$MD$CA$CA
240393371$24039337$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05524$LUPIN$Crawford M, Trinh J, Chaudhary S. A case report of statin-induced necrotizing autoimmune myopathy With extramuscular involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209$75$YR$$F$Y$$$20240702$$HP$US$US
240393386$24039338$6$F$20240101$20240813$20240702$20240821$EXP$$CA-CELLTRION INC.-2024CA007916$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
240393391$24039339$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000023$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240702$$CN$US$US
240393401$24039340$1$I$20240630$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000954$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240702$$CN$US$US
240393411$24039341$1$I$$20240626$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406018220$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240702$$CN$US$US
240393421$24039342$1$I$20240601$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000444$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240702$$CN$US$US
240393431$24039343$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000309$ELI LILLY AND CO$$$$$$Y$$$20240702$$HP$US$US
240393441$24039344$1$I$20240621$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024129337$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240393451$24039345$1$I$20240620$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127155$AMGEN$$62$YR$A$F$Y$$$20240702$$CN$US$US
240393471$24039347$1$I$$20240627$20240702$20240702$EXP$$US-JNJFOC-20240674795$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
240393484$24039348$4$F$20240625$20240917$20240702$20240926$EXP$$CA-CELLTRION INC.-2024CA015953$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
240393491$24039349$1$I$20221216$20240627$20240702$20240702$EXP$FR-AFSSAPS-AM2024000521$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-102988$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$90$KG$20240702$$PH$FR$FR
240393501$24039350$1$I$$20240624$20240702$20240702$EXP$$US-BEH-2024174732$CSL BEHRING$$$$A$F$Y$$$20240702$$CN$US$US
240393511$24039351$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281402147980-LZGDH$GB-TEVA-VS-3215523$TEVA$$$$$$Y$$$20240702$$CN$GB$GB
240393521$24039352$1$I$$20240621$20240702$20240702$PER$$US-APOTEX-2024AP007762$APOTEX$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allergy, Asthma + Clinical Immunology. 2023;19 (1)(78):1-6$39$YR$$M$Y$$$20240702$$HP$US$US
240393531$24039353$1$I$20161118$20240625$20240702$20240702$PER$$US-BIOGEN-2016BI00330099$BIOGEN$$74$YR$$F$Y$$$20240702$$CN$US$US
240393541$24039354$1$I$$20240626$20240702$20240702$PER$$US-ABBVIE-5817960$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240393552$24039355$2$F$$20240627$20240702$20240704$EXP$$DE-JNJFOC-20240674868$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$MD$DE$DE
240393561$24039356$1$I$20230101$20240624$20240702$20240702$EXP$$JP-JNJFOC-20231055548$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240702$$HP$JP$JP
240393581$24039358$1$I$20240625$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A149039$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240393591$24039359$1$I$$20240623$20240702$20240702$PER$$US-AMGEN-USASP2024124556$AMGEN$Lau C.; Whiting T.; Uppalapu S.. The Bleed That Will Not Stop - Acquired Coagulopathy Due to Combined Factor VIII Deficiency and Inhibitor. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A3553$63$YR$A$M$Y$$$20240702$$HP$US$US
240393601$24039360$1$I$$20230201$20240702$20240702$PER$$US-AMGEN-USASP2023235289$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240393611$24039361$1$I$$20240625$20240702$20240702$PER$$US-AMGEN-USASP2023234951$AMGEN$Khattri S.; Hren M. G.; Guenin S.. Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease. Journal of the American Academy of Dermatolog. 2024;91(1):138-140$44$YR$A$$Y$$$20240702$$MD$US$US
240393621$24039362$1$I$$20230810$20240702$20240702$PER$$US-AMGEN-USASP2023235325$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240393631$24039363$1$I$20240310$20240624$20240702$20240702$EXP$$GB-AstraZeneca-2024A145210$ASTRAZENECA$$$$$M$Y$$$20240702$$MD$GB$
240393641$24039364$1$I$$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024128476$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240393651$24039365$1$I$20240626$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024129271$AMGEN$$52$YR$A$M$Y$$$20240702$$CN$US$US
240393661$24039366$1$I$20231114$20240627$20240702$20240702$EXP$$IT-AMGEN-ITASP2024127659$AMGEN$$59$YR$A$M$Y$$$20240702$$HP$IT$IT
240393671$24039367$1$I$$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024125922$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240393681$24039368$1$I$$20230712$20240702$20240702$PER$$US-AMGEN-USASP2023235331$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240393693$24039369$3$F$20240101$20240821$20240702$20240916$EXP$$JP-AstraZeneca-2024A148795$ASTRAZENECA$$61$YR$$M$Y$$$20240916$$MD$JP$
240393702$24039370$2$F$20240626$20240626$20240702$20240715$PER$$US-GILEAD-2024-0678762$GILEAD$$$$$F$Y$$$20240715$$HP$US$US
240393711$24039371$1$I$20240427$20240624$20240702$20240702$EXP$$CN-AstraZeneca-2024A148091$ASTRAZENECA$$79$YR$$F$Y$$$20240702$$MD$CN$
240393721$24039372$1$I$$20240619$20240702$20240702$EXP$$IN-ROCHE-10000008267$ROCHE$$$$A$M$Y$$$20240702$$CN$IN$IN
240393732$24039373$2$F$$20240619$20240702$20240704$EXP$$IE-ROCHE-10000012807$ROCHE$$$$$M$Y$$$20240704$$CN$IE$IE
240393741$24039374$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05650$LUPIN$Simpson M, Awuah KB, Patel D, Ogline O, Pratapneni S, Disilvio BE. Early extra corporeal membrane oxygenation (ECMO) and esophagogastroduodenoscopy (EGD) Implementation: A timely intervention in a patient with extended-release Bupropion overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5672$41$YR$$M$Y$$$20240702$$HP$US$US
240393751$24039375$1$I$20240402$20240617$20240702$20240702$EXP$FR-AFSSAPS-GR2024000720$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108684$ZYDUS PHARM$$$$$$Y$$$20240702$$MD$FR$FR
240393761$24039376$1$I$$20240628$20240702$20240702$EXP$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452207$CZ-GSK-CZ2024080990$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$MD$CZ$CZ
240393771$24039377$1$I$$20240628$20240702$20240702$EXP$$US-KYOWAKIRIN-2024KK015840$KYOWA$$$$$$Y$$$20240702$$HP$US$US
240393781$24039378$1$I$$20230717$20240702$20240702$PER$$US-AMGEN-USASP2023235213$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240393791$24039379$1$I$$20240701$20240702$20240702$EXP$$NVSC2024US136446$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240393802$24039380$2$F$20240401$20240701$20240702$20240704$EXP$IT-MINISAL02-992169$NVSC2024IT134950$NOVARTIS$$33$YR$$F$Y$$$20240704$$MD$IT$IT
240393811$24039381$1$I$$20240627$20240702$20240702$EXP$$NVSC2024US135208$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240393831$24039383$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007650$APOTEX$$72$YR$$F$Y$$$20240702$$MD$CA$CA
240393851$24039385$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05596$LUPIN$Williams HL, Baxter C, Alnijoumi M. Management of catamenial pneumothorax. American Journal of Respiratory and Critical Care Medicine. 2024;209$41$YR$$F$Y$$$20240702$$HP$US$US
240393861$24039386$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821593$ABBVIE$$$$$M$Y$$$20240702$$PH$US$US
240393871$24039387$1$I$20220101$20240628$20240702$20240702$EXP$$US-UCBSA-2024033309$UCB$$$$$M$Y$$$20240702$$HP$US$US
240393882$24039388$2$F$$20240726$20240702$20240805$EXP$$CA-APOTEX-2024AP007604$APOTEX$$60$YR$$F$Y$$$20240805$$HP$CA$CA
240393891$24039389$1$I$20240607$20240701$20240702$20240702$EXP$BE-FAMHP-DHH-N2024-122286$BE-UCBSA-2024033231$UCB$$23$YR$$F$Y$97$KG$20240702$$CN$BE$BE
240393901$24039390$1$I$$20240625$20240702$20240702$EXP$$US-JNJFOC-20240666811$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240393912$24039391$2$F$20240508$20240626$20240702$20240806$EXP$$DE-JNJFOC-20240701407$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240806$$HP$DE$DE
240393921$24039392$1$I$$20240626$20240702$20240702$PER$$US-JNJFOC-20240671690$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
240393931$24039393$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821850$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240393941$24039394$1$I$20240411$20240624$20240702$20240702$30DAY$$US-GSK-US2024078542$GLAXOSMITHKLINE$$51$YR$$M$Y$$$20240702$$HP$US$US
240393951$24039395$1$I$$20240626$20240702$20240702$EXP$$US-GSK-US2024079728$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$MD$US$US
240393961$24039396$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA188394$SANOFI AVENTIS$$$$A$F$Y$56.6$KG$20240702$$MD$US$US
240393971$24039397$1$I$20240607$20240607$20240702$20240702$PER$$US-SA-2024SA186656$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240702$$MD$US$US
240393981$24039398$1$I$20240101$20240620$20240702$20240702$PER$$US-SA-2024SA189006$SANOFI AVENTIS$$$$A$M$Y$$$20240702$$MD$US$US
240393991$24039399$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187892$SANOFI AVENTIS$$$$$$Y$$$20240702$$HP$US$US
240394001$24039400$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187326$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$MD$US$US
240394011$24039401$1$I$20240101$20240620$20240702$20240702$PER$$US-SA-2024SA187829$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240702$$MD$US$US
240394021$24039402$1$I$$20240610$20240702$20240702$PER$$US-SA-2024SA188202$SANOFI AVENTIS$$$$T$F$Y$58$KG$20240702$$MD$US$US
240394031$24039403$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187728$SANOFI AVENTIS$$$$T$M$Y$55$KG$20240702$$MD$US$US
240394041$24039404$1$I$$20230712$20240702$20240702$PER$$US-AMGEN-USASP2023235193$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240394051$24039405$1$I$20231226$20240624$20240702$20240702$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02346$AMNEAL$$76$YR$$M$Y$$$20240702$$CN$US$US
240394061$24039406$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA185965$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240702$$CN$US$US
240394071$24039407$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA189200$SANOFI AVENTIS$$$$$M$Y$99$KG$20240702$$HP$US$US
240394082$24039408$2$F$$20240627$20240702$20240706$PER$$US-SA-2024SA186445$SANOFI AVENTIS$$$$A$F$Y$$$20240706$$CN$US$US
240394091$24039409$1$I$20240620$20240620$20240702$20240702$PER$$US-SA-2024SA188280$SANOFI AVENTIS$$4$YR$C$M$Y$13.69$KG$20240702$$MD$US$US
240394103$24039410$3$F$20240601$20240627$20240702$20240704$PER$$US-SA-2024SA187102$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240704$$MD$US$US
240394111$24039411$1$I$20240101$20240620$20240702$20240702$PER$$US-SA-2024SA188266$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240702$$MD$US$US
240394121$24039412$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA188342$SANOFI AVENTIS$$$$A$M$Y$77$KG$20240702$$MD$US$US
240394131$24039413$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA189440$SANOFI AVENTIS$$$$A$F$Y$104.32$KG$20240702$$MD$US$US
240394141$24039414$1$I$20240101$20240621$20240702$20240702$PER$$US-SA-2024SA187854$SANOFI AVENTIS$$48$YR$A$F$Y$71.21$KG$20240702$$MD$US$US
240394151$24039415$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA186779$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240702$$MD$US$US
240394161$24039416$1$I$20240620$20240620$20240702$20240702$PER$$US-SA-2024SA186951$SANOFI AVENTIS$$$$$M$Y$$$20240702$$MD$US$US
240394171$24039417$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA187303$SANOFI AVENTIS$$$$$F$Y$$$20240702$$HP$US$US
240394181$24039418$1$I$20240530$20240621$20240702$20240702$EXP$$AU-BEH-2024174633$CSL BEHRING$$73$YR$E$F$Y$$$20240702$$HP$AU$AU
240394191$24039419$1$I$20240621$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024129338$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240394201$24039420$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104643$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240702$$HP$US$US
240394231$24039423$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104805$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240702$$CN$US$US
240394241$24039424$1$I$20220101$20240628$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105044$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240702$$CN$US$US
240394252$24039425$2$F$20240601$20240712$20240702$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099910$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$75.3$KG$20240716$$PH$US$US
240394261$24039426$1$I$20240510$20240624$20240702$20240702$PER$$US-SA-2024SA192210$SANOFI AVENTIS$$14$YR$T$F$Y$45$KG$20240702$$MD$US$US
240394273$24039427$3$F$20240101$20240820$20240702$20240913$PER$$US-SA-2024SA190199$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240913$$CN$US$US
240394281$24039428$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA187961$SANOFI AVENTIS$$$$E$F$Y$$$20240702$$MD$US$US
240394291$24039429$1$I$$20240623$20240702$20240702$PER$$US-SA-2024SA189558$SANOFI AVENTIS$$$$$M$Y$$$20240702$$CN$US$US
240394301$24039430$1$I$20240620$20240621$20240702$20240702$PER$$US-SA-2024SA189551$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240702$$CN$US$US
240394311$24039431$1$I$20240615$20240623$20240702$20240702$PER$$US-SA-2024SA189552$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240702$$HP$US$US
240394321$24039432$1$I$$20240626$20240702$20240702$PER$$US-SA-2024SA192384$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$MD$US$US
240394331$24039433$1$I$$20240626$20240702$20240702$PER$$US-SA-2024SA192231$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240702$$CN$US$US
240394341$24039434$1$I$20240101$20240626$20240702$20240702$PER$$US-SA-2024SA192451$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240702$$CN$US$US
240394352$24039435$2$F$$20240705$20240702$20240717$PER$$US-SA-2024SA187750$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240717$$MD$US$US
240394362$24039436$2$F$20240101$20240725$20240702$20240803$PER$$US-SA-2024SA187411$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240803$$CN$US$US
240394372$24039437$2$F$20240101$20240701$20240702$20240710$PER$$US-SA-2024SA193621$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240710$$MD$US$US
240394381$24039438$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA191226$SANOFI AVENTIS$$59$YR$A$F$Y$72$KG$20240702$$MD$US$US
240394391$24039439$1$I$20240101$20240621$20240702$20240702$PER$$US-SA-2024SA187770$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240702$$MD$US$US
240394402$24039440$2$F$20240101$20240721$20240702$20240731$PER$$US-SA-2024SA193219$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240731$$MD$US$US
240394411$24039441$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA191975$SANOFI AVENTIS$$$$A$M$Y$$$20240702$$CN$US$US
240394421$24039442$1$I$20240101$20240624$20240702$20240702$PER$$US-SA-2024SA188324$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240702$$CN$US$US
240394431$24039443$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA193631$SANOFI AVENTIS$$$$A$F$Y$47$KG$20240702$$MD$US$US
240394441$24039444$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA191853$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240702$$MD$US$US
240394451$24039445$1$I$20240101$20240624$20240702$20240702$PER$$US-SA-2024SA191379$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240702$$MD$US$US
240394461$24039446$1$I$20240620$20240626$20240702$20240702$PER$$US-SA-2024SA192004$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240702$$CN$US$US
240394471$24039447$1$I$20240101$20240624$20240702$20240702$PER$$US-SA-2024SA189844$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240702$$CN$US$US
240394491$24039449$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA107326$SANOFI AVENTIS$$$$T$M$Y$$$20240702$$MD$US$US
240394501$24039450$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA191283$SANOFI AVENTIS$$51$YR$A$M$Y$81$KG$20240702$$MD$US$US
240394511$24039451$1$I$20240101$20240625$20240702$20240702$PER$$US-SA-2024SA192311$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240702$$MD$US$US
240394521$24039452$1$I$20240101$20240624$20240702$20240702$PER$$US-SA-2024SA191224$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240702$$MD$US$US
240394531$24039453$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA191284$SANOFI AVENTIS$$6$YR$C$M$Y$24.9$KG$20240702$$MD$US$US
240394542$24039454$2$F$20240101$20240820$20240702$20240829$PER$$US-SA-2024SA192950$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240829$$MD$US$US
240394551$24039455$1$I$$20240628$20240702$20240702$EXP$$DE-009507513-2407DEU000084$MERCK$$59$YR$$M$Y$$$20240702$$MD$DE$DE
240394561$24039456$1$I$$20240625$20240702$20240702$PER$$US-BIOGEN-2024BI01271164$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
240394572$24039457$2$F$20240428$20240716$20240702$20240722$PER$$US-BIOGEN-2024BI01265376$BIOGEN$$53$YR$$F$Y$$$20240722$$CN$US$US
240394581$24039458$1$I$20230101$20240625$20240702$20240702$PER$$US-BIOGEN-2024BI01271157$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
240394591$24039459$1$I$$20240625$20240702$20240702$PER$$US-BIOGEN-2024BI01271115$BIOGEN$$$$$M$Y$$$20240702$$CN$US$US
240394601$24039460$1$I$$20240622$20240702$20240702$PER$$US-ABBVIE-5815440$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240394611$24039461$1$I$$20230927$20240702$20240702$PER$$US-AMGEN-USASP2023235158$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240394621$24039462$1$I$$20240625$20240702$20240702$EXP$$CA-GSK-CA2024068835$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$MD$CA$CA
240394631$24039463$1$I$$20231109$20240702$20240702$PER$$US-AMGEN-USASP2023235157$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240394643$24039464$3$F$20240625$20240805$20240702$20240809$30DAY$$US-AMGEN-USASP2024126821$AMGEN$$73$YR$E$F$Y$9$KG$20240808$$PH$US$US
240394653$24039465$3$F$$20240726$20240702$20240801$EXP$$JP-ASTELLAS-2024JP004498$ASTELLAS$$46$YR$$M$Y$$$20240801$$MD$JP$JP
240394661$24039466$1$I$$20231103$20240702$20240702$PER$$US-AMGEN-USASP2023235339$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240394672$24039467$2$F$20240624$20240708$20240702$20240716$30DAY$$US-AMGEN-USASP2024127491$AMGEN$$52$YR$A$F$Y$135.6$KG$20240716$$HP$US$US
240394682$24039468$2$F$20240101$20240828$20240702$20240905$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05617$HIKMA$$$$$F$Y$83.5$KG$20240905$$CN$US$US
240394691$24039469$1$I$20240101$20240628$20240702$20240702$PER$$US-AMGEN-USASP2024129045$AMGEN$$75$YR$E$F$Y$$$20240702$$HP$US$US
240394701$24039470$1$I$20240612$20240627$20240702$20240702$EXP$$JP-ASTELLAS-2024JP004476$ASTELLAS$$81$YR$$M$Y$$$20240702$$PH$JP$JP
240394712$24039471$2$F$20230510$20240711$20240702$20240712$EXP$$FR-JNJFOC-20240438003$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240712$$MD$FR$FR
240394721$24039472$1$I$$20240624$20240702$20240702$EXP$$JP-JNJFOC-20240703482$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240702$$MD$JP$JP
240394732$24039473$2$F$$20240701$20240702$20240704$EXP$$JP-ROCHE-10000009435$ROCHE$$6$DEC$A$F$Y$$$20240704$$PH$JP$JP
240394742$24039474$2$F$20240213$20240703$20240702$20240708$EXP$IT-MINISAL02-991298$IT-GILEAD-2024-0678401$GILEAD$$47$YR$A$F$Y$$$20240708$$MD$IT$IT
240394752$24039475$2$F$20240224$20240821$20240702$20240828$EXP$$CA-CELLTRION INC.-2024CA001278$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
240394761$24039476$1$I$20240626$20240626$20240702$20240702$PER$$US-PCCINC-2024-PPL-000493$PIRAMAL$$$$$$Y$$$20240702$$HP$US$US
240394781$24039478$1$I$$20230626$20240702$20240702$PER$$US-AMGEN-USASP2023235114$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240394791$24039479$1$I$20240601$20240619$20240702$20240702$EXP$$JP-ROCHE-10000009062$ROCHE$$9$DEC$E$M$Y$$$20240702$$CN$JP$JP
240394802$24039480$2$F$20240501$20240813$20240702$20240820$EXP$$US-AstraZeneca-2024A145807$ASTRAZENECA$$921$MON$$M$Y$$$20240820$$CN$US$
240394811$24039481$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A145669$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240394821$24039482$1$I$$20240620$20240702$20240702$PER$$US-AstraZeneca-2024A143257$ASTRAZENECA$$$$$$Y$$$20240702$$CN$US$
240394851$24039485$1$I$20240619$20240619$20240702$20240702$PER$$US-JNJFOC-20240650937$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240702$$CN$US$US
240394861$24039486$1$I$20240101$20240626$20240702$20240702$EXP$$CA-JNJFOC-20240673146$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240702$$HP$CA$CA
240394882$24039488$2$F$20240101$20240621$20240702$20240725$PER$$US-SA-2024SA187899$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240725$$MD$US$US
240394891$24039489$1$I$$20240624$20240702$20240702$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02384$AMNEAL$$$$$F$Y$$$20240702$$HP$US$US
240394901$24039490$1$I$20240101$20240620$20240702$20240702$PER$$US-SA-2024SA184154$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240702$$MD$US$US
240394915$24039491$5$F$20240601$20240919$20240702$20240927$PER$$US-GSK-US2024AMR080054$GLAXOSMITHKLINE$$75$YR$$F$Y$62$KG$20240927$$CN$US$US
240394921$24039492$1$I$20240625$20240701$20240702$20240702$EXP$GB-MHRA-MED-202407011500448070-RNYHF$GB-GSK-GB2024081623$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$PH$GB$GB
240394931$24039493$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105368$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240702$$CN$US$US
240394941$24039494$1$I$20240628$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000271$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240702$$CN$US$US
240394951$24039495$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105036$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240702$$CN$US$US
240394961$24039496$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105017$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240702$$CN$US$US
240394971$24039497$1$I$20240612$20240701$20240702$20240702$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-105181$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240702$$CN$PR$PR
240394981$24039498$1$I$$20240626$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103357$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240702$$CN$US$US
240395001$24039500$1$I$20240626$20240626$20240702$20240702$PER$$US-PCCINC-2024-PPL-000494$PIRAMAL$$$$$$Y$$$20240702$$HP$US$US
240395012$24039501$2$F$20240827$20240827$20240702$20240902$PER$$US-SA-2024SA190045$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240902$$CN$US$US
240395021$24039502$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA192319$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240702$$MD$US$US
240395031$24039503$1$I$20240101$20240625$20240702$20240702$PER$$US-SA-2024SA190674$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240702$$MD$US$US
240395041$24039504$1$I$20240101$20240626$20240702$20240702$PER$$US-SA-2024SA191700$SANOFI AVENTIS$$$$A$M$Y$$$20240702$$MD$US$US
240395051$24039505$1$I$20240101$20240625$20240702$20240702$PER$$US-SA-2024SA193789$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240702$$CN$US$US
240395061$24039506$1$I$20240529$20240626$20240702$20240702$PER$$US-SA-2024SA192050$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240702$$MD$US$US
240395072$24039507$2$F$$20240901$20240702$20240916$PER$$US-SA-2024SA192597$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$MD$US$US
240395082$24039508$2$F$$20240708$20240702$20240709$PER$$US-TAKEDA-2024TUS065913$TAKEDA$$$$$M$Y$88.45$KG$20240709$$HP$US$US
240395091$24039509$1$I$$20240625$20240702$20240702$EXP$$DE-AMGEN-DEUSP2024125962$AMGEN$Patrick-pascal S.; Englbrecht M.; Risser L .M . et al.. Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database. Frontiers in Immunology. 2024;15:1-9$$$$$Y$$$20240702$$HP$DE$DE
240395101$24039510$1$I$$20240619$20240702$20240702$EXP$$US-VIRTUS PHARMACEUTICALS, LLC-2024VTS00014$VIRTUS PHARMACEUTICALS$Hashmi N, Basaleli C, Gupta S. et.al. Acute Eosinophilic Pneumonia in the Setting of Intramuscular Progesterone Usage. Am. J. Respir. Crit. Care Med. 2024;209:A6397$33$YR$$F$Y$$$20240702$$HP$US$US
240395111$24039511$1$I$$20240619$20240702$20240702$EXP$$US-VIRTUS PHARMACEUTICALS, LLC-2024VTS00013$VIRTUS PHARMACEUTICALS$Shivarajpur A, Valentin R.G. Intramuscular Progesterone: A Cause of Acute Eosinophilic Pneumonitis. Am. J. Respir. Crit. Care Med. 2024;209:A2002$35$YR$$F$Y$$$20240702$$HP$US$US
240395122$24039512$2$F$20240626$20240723$20240702$20240729$30DAY$$US-AMGEN-USASP2024127457$AMGEN$$$$$F$Y$$$20240729$$PH$US$US
240395132$24039513$2$F$20240601$20240710$20240702$20240715$EXP$$JP-ASTELLAS-2024JP004467$ASTELLAS$$$$$M$Y$$$20240715$$MD$JP$JP
240395141$24039514$1$I$20240301$20240619$20240702$20240702$PER$$US-TEVA-VS-3212125$TEVA$$23$YR$$F$Y$54.43$KG$20240702$$CN$US$US
240395152$24039515$2$F$20240101$20240701$20240702$20240705$EXP$$US-AMGEN-USASP2024129366$AMGEN$$64$YR$A$F$Y$$$20240705$$CN$US$US
240395161$24039516$1$I$$20230703$20240702$20240702$PER$$US-AMGEN-USASP2023235111$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240395171$24039517$1$I$$20240109$20240702$20240702$PER$$US-AMGEN-USASP2024129827$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240395181$24039518$1$I$$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127592$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240395191$24039519$1$I$$20230526$20240702$20240702$PER$$US-AMGEN-USASP2023235041$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240395202$24039520$2$F$$20240625$20240702$20240704$EXP$$DE-SA-2024SA191344$SANOFI AVENTIS$$$$$M$Y$$$20240704$$MD$DE$DE
240395211$24039521$1$I$$20240624$20240702$20240702$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00504$UPSHER-SMITH$$$$$F$Y$9.3$KG$20240702$$PH$US$US
240395231$24039523$1$I$20240525$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024126469$AMGEN$$75$YR$E$M$Y$$$20240702$$HP$US$US
240395241$24039524$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007655$APOTEX$$6$YR$$M$Y$35$KG$20240702$$CN$CA$CA
240395253$24039525$3$F$$20240809$20240702$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05495$LUPIN$$$$$$Y$$$20240829$$CN$US$US
240395261$24039526$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05630$LUPIN$Sherman M, Holden K, Sweeney R, Dumont TL, Appiah-kubi E. A case of Babesiosis induced sepsis hemophagocytic lymphohistiocytosis overlap syndrome in Pennsylvania. American Journal of Respiratory and Critical Care Medicine. 2024;209$74$YR$$F$Y$$$20240702$$HP$US$US
240395271$24039527$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5816740$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240395282$24039528$2$F$20240201$20240827$20240702$20240906$EXP$$US-ASTELLAS-2024US014828$ASTELLAS$$78$YR$E$M$Y$$$20240906$$CN$US$US
240395291$24039529$1$I$$20240626$20240702$20240702$EXP$$ES-ASTELLAS-2024US018402$ASTELLAS$$76$YR$$F$Y$$$20240702$$CN$ES$ES
240395301$24039530$1$I$$20240624$20240702$20240702$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004730$BIOCON$$$$$$Y$$$20240702$$CN$CA$CA
240395311$24039531$1$I$20230101$20240627$20240702$20240702$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037035$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240702$$CN$US$US
240395321$24039532$1$I$$20230512$20240702$20240702$PER$$US-AMGEN-USASP2023235192$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240395331$24039533$1$I$$20240625$20240702$20240702$EXP$$US-ASTELLAS-2024US018196$ASTELLAS$$72$YR$$M$Y$$$20240702$$CN$US$US
240395341$24039534$1$I$$20240628$20240702$20240702$EXP$$US-UCBSA-2024033300$UCB$$$$$F$Y$$$20240702$$HP$US$US
240395352$24039535$2$F$$20240723$20240702$20240730$EXP$$US-BANNER LIFE SCIENCES-USBAN24000092$BANNER$$$$$$Y$$$20240730$$CN$US$US
240395362$24039536$2$F$20240620$20240705$20240702$20240710$EXP$$JP-GSK-JP2024081289$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$JP$JP
240395373$24039537$3$F$$20240806$20240702$20240813$EXP$$US-GSK-US2024079115$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
240395381$24039538$1$I$20240502$20240624$20240702$20240702$EXP$$US-GSK-US2024078649$GLAXOSMITHKLINE$$82$YR$$M$Y$$$20240702$$CN$US$US
240395391$24039539$1$I$$20230912$20240702$20240702$PER$$US-AMGEN-USASP2023235338$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240395401$24039540$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105522$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240702$$CN$US$US
240395411$24039541$1$I$$20240624$20240702$20240702$PER$$US-APOTEX-2024AP007791$APOTEX$Durand PH, Stratulat E, Jansen D, Weir ID.. Systemic Lupus Erythematosus Presenting as Acute Lupus Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-2$50$YR$$F$Y$$$20240702$$HP$US$US
240395421$24039542$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281504408720-TKDCS$GB-ORGANON-O2407GBR000085$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240395431$24039543$1$I$$20240624$20240702$20240702$EXP$$DE-ROCHE-10000008519$ROCHE$Mengoni M, Mengoni M, Braun A, Aghayev A, Tuting T, Surov A. Comprehensive analysis of body composition features in melanoma patients treated with tyrosine kinase inhibitors. JDDG - Journal of the German Society of Dermatology. 2024-Jun;22 (6):783-791. doi:10.1111/ddg.15402.$$$$$Y$$$20240702$$HP$DE$DE
240395441$24039544$1$I$$20240621$20240702$20240702$PER$$US-ROCHE-3550765$ROCHE$$64$YR$A$M$Y$$$20240702$$CN$US$US
240395451$24039545$1$I$$20240626$20240702$20240702$PER$$US-SA-2024SA193233$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240702$$MD$US$US
240395461$24039546$1$I$20240101$20240626$20240702$20240702$PER$$US-SA-2024SA192362$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240702$$MD$US$US
240395471$24039547$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA193109$SANOFI AVENTIS$$$$E$M$Y$$$20240702$$MD$US$US
240395481$24039548$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA189284$SANOFI AVENTIS$$$$A$$Y$$$20240702$$MD$US$US
240395491$24039549$1$I$$20240626$20240702$20240702$PER$$US-SA-2024SA191953$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240702$$CN$US$US
240395502$24039550$2$F$20240624$20240821$20240702$20240919$PER$$US-SA-2024SA193089$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240919$$MD$US$US
240395511$24039551$1$I$$20240627$20240702$20240702$PER$$US-SA-2024SA193774$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240702$$CN$US$US
240395521$24039552$1$I$20240618$20240618$20240702$20240702$EXP$$CA-ROCHE-10000012570$ROCHE$$43$YR$A$F$Y$$$20240702$$CN$CA$CA
240395531$24039553$1$I$$20240620$20240702$20240702$PER$$US-ROCHE-3557287$ROCHE$$$$E$F$Y$$$20240702$$CN$US$US
240395541$24039554$1$I$$20230729$20240702$20240702$PER$$US-AMGEN-USASP2023235218$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240395553$24039555$3$F$$20240624$20240702$20240723$EXP$$SK-ASTELLAS-2024EU004467$ASTELLAS$Blichova T, Beliancinova M, Kleinova P, Vnucak M, Granak K, Dedinska I. Immunosuppression and kidney transplant - salvation or achilles^ heel?. Interna medicina. 2024;S1:14-5$33$YR$$F$Y$$$20240723$$CN$SK$SK
240395561$24039556$1$I$20231001$20240625$20240702$20240702$EXP$$US-AMGEN-USASP2024127505$AMGEN$$74$YR$E$F$Y$4$KG$20240702$$CN$US$US
240395571$24039557$1$I$$20240625$20240702$20240702$EXP$$JP-AMGEN-JPNSP2024127111$AMGEN$$$$$M$Y$$$20240702$$PH$JP$JP
240395581$24039558$1$I$$20230915$20240702$20240702$PER$$US-AMGEN-USASP2023235327$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240395591$24039559$1$I$$20240624$20240702$20240702$EXP$$ES-ASTELLAS-2024US018069$ASTELLAS$$65$YR$$M$Y$$$20240702$$CN$ES$ES
240395601$24039560$1$I$$20240626$20240702$20240702$EXP$$US-JNJFOC-20240673210$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240395611$24039561$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104527$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240702$$HP$US$US
240395622$24039562$2$F$$20240828$20240702$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104361$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$56.7$KG$20240830$$CN$US$US
240395631$24039563$1$I$$20240629$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104836$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240702$$CN$US$US
240395641$24039564$1$I$20240624$20240627$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103541$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$75.3$KG$20240702$$CN$US$US
240395652$24039565$2$F$20240630$20240705$20240702$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105173$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240708$$HP$US$US
240395661$24039566$1$I$$20240624$20240702$20240702$EXP$$US-ASTELLAS-2024EU006431$ASTELLAS$$$$$M$Y$$$20240702$$CN$US$US
240395671$24039567$1$I$$20240625$20240702$20240702$PER$$US-LEO Pharma-371548$LEO PHARM$$43$YR$$M$Y$$$20240701$$PH$US$US
240395681$24039568$1$I$$20240624$20240702$20240702$EXP$$CN-AMGEN-CHNSP2024125971$AMGEN$Guo X. Role of recombinant human granulocyte colony-stimulating factor in development of cancer-associated venous thromboembolism in lung cancer patients who undergo chemotherapy. Frontiers in Immunology. 2024;15$$$$$Y$$$20240702$$HP$CN$CN
240395692$24039569$2$F$$20240704$20240702$20240715$EXP$$BR-SA-2024SA188545$SANOFI AVENTIS$$$$$F$Y$$$20240715$$CN$BR$BR
240395701$24039570$1$I$$20240619$20240702$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05612$LUPIN$$$$$$Y$$$20240702$$HP$US$US
240395711$24039571$1$I$20240606$20240619$20240702$20240702$EXP$$CN-ROCHE-10000004040$ROCHE$$71$YR$E$F$Y$50$KG$20240702$$HP$CN$CN
240395721$24039572$1$I$$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A149261$ASTRAZENECA$$$$$F$Y$$$20240702$$MD$US$
240395731$24039573$1$I$$20240621$20240702$20240702$EXP$$CN-ROCHE-10000006379$ROCHE$$67$YR$E$F$Y$$$20240702$$CN$CN$CN
240395741$24039574$1$I$$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A148761$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240395751$24039575$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A150570$ASTRAZENECA$$$$$M$Y$$$20240702$$MD$US$
240395761$24039576$1$I$$20240624$20240702$20240702$EXP$$JP-ASTELLAS-2024JP004443$ASTELLAS$Yoshitani S, Kaneda K, Nishida M, Komura K, Moriwaki S, Fukunaga A. A case of urothelial carcinoma with successful continuation of enfortumab vedotin without dose reduction despite grade 3 diffuse erythema with fever. European journal of dermatology. 2024;34(2):214-6$71$YR$$M$Y$$$20240702$$MD$JP$JP
240395771$24039577$1$I$$20240624$20240702$20240702$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007753$STRIDES$Hirt PA, Gonzalez AM, Acosta AS, Price A, Elgart GW, Nousari CH, et al.. Cutaneous Mycobacterium avium-intracellulare infection masquerading as sarcoidosis.. Pediatr-Dermatol. 2024;41 (3):497-500.$$$$$Y$$$20240702$$MD$US$US
240395781$24039578$1$I$$20240624$20240702$20240702$PER$$US-AstraZeneca-2024A145780$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240395791$24039579$1$I$20240614$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A149002$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240395801$24039580$1$I$$20240628$20240702$20240702$PER$$US-HALEON-2184656$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240395811$24039581$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05569$LUPIN$Ghose M, Anwar M, Rajamohan A, Vangala A, Roy P, Weiner SM. Vancomycin induced anaphylaxis presenting with cardiac arrest: Judicious use of antibiotic in low risk procedures. American Journal of Respiratory and Critical Care Medicine. 2024;209$74$YR$$F$Y$$$20240702$$HP$US$US
240395821$24039582$1$I$20240520$20240701$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105291$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240702$$CN$US$US
240395831$24039583$1$I$$20240625$20240702$20240702$PER$$US-ALXN-202406USA001590US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
240395841$24039584$1$I$$20230824$20240702$20240702$PER$$US-AMGEN-USASP2023235326$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240395851$24039585$1$I$$20221214$20240702$20240702$PER$$US-AMGEN-USASP2022230352$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240395862$24039586$2$F$$20240910$20240702$20240912$EXP$$US-JNJFOC-20240667532$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
240395871$24039587$1$I$$20240630$20240702$20240702$PER$$US-JNJFOC-20240703817$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240395881$24039588$1$I$20240401$20240625$20240702$20240702$EXP$$US-AMGEN-HZN-2024-004767$AMGEN$$71$YR$E$F$Y$$$20240702$$HP$US$US
240395892$24039589$2$F$$20240913$20240702$20240926$EXP$$US-ALVOGEN-2024094953$ALVOGEN$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Medicine Pathology. 2024;45 (3):193-197. doi:10.1097/PAF.0000000000000943$4$YR$$M$Y$$$20240926$$MD$US$US
240395901$24039590$1$I$$20230906$20240702$20240702$PER$$US-AMGEN-USASP2023235159$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240395912$24039591$2$F$20240626$20240802$20240702$20240806$PER$$US-AMGEN-USASP2024128147$AMGEN$$76$YR$E$M$Y$$$20240806$$CN$US$US
240395921$24039592$1$I$$20240624$20240702$20240702$EXP$AU-AUS-SPO/AUS/24/0009354$AU-RDY-SPO/AUS/24/0009354$DR REDDYS$$83$YR$E$F$Y$$$20240702$$CN$AU$AU
240395941$24039594$1$I$$20240628$20240702$20240702$PER$$NVSC2024US136384$NOVARTIS$$$$$$Y$$$20240702$$MD$US$US
240395952$24039595$2$F$$20240913$20240702$20240926$EXP$$US-ALVOGEN-2024094952$ALVOGEN$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Medicine Pathology. 2024;45 (3):193-197. doi:10.1097/PAF.0000000000000943$17$YR$$M$Y$$$20240926$$MD$US$US
240395961$24039596$1$I$20220101$20240621$20240702$20240702$PER$$US-SA-2024SA187583$SANOFI AVENTIS$$$$$F$Y$$$20240702$$CN$US$US
240395971$24039597$1$I$20240601$20240625$20240702$20240702$PER$$US-SA-2024SA191884$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240702$$PH$US$US
240395981$24039598$1$I$$20240621$20240702$20240702$PER$$US-APOTEX-2024AP007747$APOTEX$Faryad S, Tran J, Prasad B.. VAGAL NERVE STIMULATOR-INDUCED SLEEP DISORDERED BREATHING. Sleep. 2024;47 (Suppl. 1):A522-A523$40$YR$$F$Y$$$20240702$$HP$US$US
240395991$24039599$1$I$$20240624$20240702$20240702$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP007734$STRIDES$Furmanczyk-Zawiska A, Bullo-Piontecka B, Komorniczak M, Debska-Slizien A, Augustyniak-Bartosik H, Durlik M.. Antiphospholipid Syndrome in Renal Allograft Recipients-A Long-Term Multicenter Analysis.. J-Clin-Med. 2023;12 (2)$31$YR$$M$Y$$$20240702$$HP$PL$PL
240396001$24039600$1$I$$20240624$20240702$20240702$EXP$$US-JNJFOC-20240668752$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
240396021$24039602$1$I$20240301$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000077$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240702$$CN$US$US
240396031$24039603$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000966$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240702$$CN$US$US
240396041$24039604$1$I$20240601$20240624$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019145$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$US$US
240396051$24039605$1$I$20240620$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024126451$AMGEN$$77$YR$E$F$Y$$$20240702$$CN$US$US
240396061$24039606$1$I$20240626$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128620$AMGEN$$71$YR$E$M$Y$$$20240702$$CN$US$US
240396071$24039607$1$I$20240621$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024130040$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240396081$24039608$1$I$$20240624$20240702$20240702$EXP$$NVSC2024CN134222$NOVARTIS$Cao Q, Huang Z, Liang H, Hu X, Wang L, Yang Y. Case report: Adult NTRK-rearranged spindle cell neoplasms with TPM3-NTRK1 fusion in the pelvic. FRONT-ONCOL. 2024;14:1-6$50$YR$$$Y$$$20240702$$HP$CN$CN
240396091$24039609$1$I$$20240625$20240702$20240702$EXP$$NVSC2024US133209$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240396101$24039610$1$I$$20240620$20240702$20240702$PER$$US-TEVA-VS-3214389$TEVA$$$$$$Y$$$20240702$$CN$US$US
240396111$24039611$1$I$20240626$20240626$20240702$20240702$PER$$US-PCCINC-2024-PPL-000495$PIRAMAL$$$$$$Y$$$20240702$$HP$US$US
240396121$24039612$1$I$20240101$20240628$20240702$20240702$EXP$$JP-ASTELLAS-2023JP013938$ASTELLAS$$8$DEC$$M$Y$$$20240702$$HP$JP$JP
240396131$24039613$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105390$BRISTOL MYERS SQUIBB$$24$YR$A$F$Y$$$20240702$$HP$US$US
240396141$24039614$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105406$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240702$$CN$US$US
240396151$24039615$1$I$$20240627$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104148$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240702$$CN$US$US
240396162$24039616$2$F$$20240711$20240702$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104350$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240715$$HP$US$US
240396171$24039617$1$I$$20240625$20240702$20240702$EXP$$IN-VANTIVE-2024VAN018017$Vantive US Healthcare$$62$YR$$M$Y$$$20240702$$CN$IN$IN
240396181$24039618$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821891$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240396192$24039619$2$F$$20240913$20240702$20240926$EXP$$US-ALVOGEN-2024094951$ALVOGEN$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Medicine Pathology. 2024 Sep;45 (3):193?197. doi:10.1097/PAF.0000000000000943$17$YR$$M$Y$$$20240926$$MD$US$US
240396201$24039620$1$I$$20240624$20240702$20240702$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP007739$STRIDES$Furmanczyk-Zawiska A, Bullo-Piontecka B, Komorniczak M, Debska-Slizien A, Augustyniak-Bartosik H, Durlik M.. Antiphospholipid Syndrome in Renal Allograft Recipients-A Long-Term Multicenter Analysis.. J-Clin-Med. 2023;12 (2)$47$YR$$F$Y$$$20240702$$HP$PL$PL
240396211$24039621$1$I$$20240611$20240702$20240702$PER$$US-BEH-2024173955$CSL BEHRING$$$$A$F$Y$$$20240702$$HP$US$US
240396221$24039622$1$I$$20240626$20240702$20240702$PER$$NVSC2024US134727$NOVARTIS$$35$YR$$F$Y$$$20240702$$CN$US$US
240396232$24039623$2$F$20220803$20240710$20240702$20240717$EXP$$US-ROCHE-10000012052$ROCHE$$59$YR$A$F$Y$$$20240717$$CN$US$US
240396242$24039624$2$F$$20240711$20240702$20240720$EXP$$RO-AUROBINDO-AUR-APL-2024-031593$AUROBINDO$Niamat SadaPM, Niamat SapanaPM, Pepparelli A, Tilinca MC, Varga B. DIABETES DIAGNOSTIC PUZZLE: UNDERSTANDING DIABETES CLASSIFICATION CHALLENGES. Acta Marisiensis - Seria Medica. 2024;70:Supplement 3$29$YR$$F$Y$$$20240720$$MD$RO$RO
240396251$24039625$1$I$$20240624$20240702$20240702$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP007696$STRIDES$Wang T, Yang J, Yang F, Cheng Y, Huang Z, Li B, et al.. The association between HLA-B variants and amoxicillin-induced severe cutaneous adverse reactions in Chinese han population. Front-Pharmacol. 2024;15 (0)$60$YR$$M$Y$$$20240702$$HP$CN$CN
240396261$24039626$1$I$$20240624$20240702$20240702$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP007723$STRIDES$Emami AH, Alizadehasl A, Sayad M, Shavandi F, Firoozbakhsh P, Meshgi S, et al.. Diagnosis and management of cancer therapy-related myocarditis in a young female: A case report and review of literature.. BMC-Cardiovasc-Disord. 2024;24(1):1-5$18$YR$$F$Y$$$20240702$$HP$IR$IR
240396273$24039627$3$F$20181228$20240716$20240702$20240718$EXP$$CA-TAKEDA-2024TUS065660$TAKEDA$$43$YR$$F$Y$$$20240718$$MD$CA$CA
240396283$24039628$3$F$20240401$20240819$20240702$20240826$EXP$$CA-GSK-CA2024017799$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$HP$CA$CA
240396291$24039629$1$I$$20240626$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102973$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$128$KG$20240702$$PH$US$US
240396301$24039630$1$I$20240607$20240628$20240702$20240702$EXP$$US-ABBVIE-5821825$ABBVIE$$67$YR$$M$Y$$$20240702$$CN$US$US
240396311$24039631$1$I$$20240626$20240702$20240702$EXP$$US-JNJFOC-20240671962$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240396321$24039632$1$I$$20240625$20240702$20240702$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037186$BOEHRINGER INGELHEIM$$34$YR$A$F$Y$$$20240702$$CN$US$US
240396331$24039633$1$I$$20240618$20240702$20240702$EXP$$KR-VISIOX-2024VSX00055$Visiox$$$$A$F$Y$$$20240702$$CN$KR$KR
240396351$24039635$1$I$20240617$20240624$20240702$20240702$PER$$US-ALXN-202406USA001529US$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240702$$CN$US$US
240396361$24039636$1$I$$20230927$20240702$20240702$PER$$US-AMGEN-USASP2023235328$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240396372$24039637$2$F$$20240913$20240702$20240927$EXP$$US-ALVOGEN-2024094949$ALVOGEN$Monday K, Shattuck B, Barba K, Carolyn H. Revercomb CH. Fentanyl Deaths in Infants and Children A Case Series and Literature Review. Am J Forensic Med Pathol. 2024 Sep;45 (3):193?197. doi:10.1097/PAF.0000000000000943$15$YR$$M$Y$$$20240927$$MD$US$US
240396381$24039638$1$I$20240627$20240628$20240702$20240702$EXP$$CA-ABBVIE-5821712$ABBVIE$$$$A$F$Y$36$KG$20240702$$CN$CA$CA
240396391$24039639$1$I$$20231017$20240702$20240702$PER$$US-AMGEN-USASP2023235135$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240396401$24039640$1$I$$20230927$20240702$20240702$PER$$US-AMGEN-USASP2023235391$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240396411$24039641$1$I$$20240625$20240702$20240702$EXP$$US-NOVITIUMPHARMA-2024USNVP01100$NOVITIUM PHARMA$Kailyn Valido.Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach.JAAD Case Reports.08-APR-2024;48:49-53$52$YR$A$F$Y$$$20240702$$HP$US$US
240396421$24039642$1$I$$20240619$20240702$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05615$LUPIN$$$$$$Y$$$20240702$$PH$US$US
240396431$24039643$1$I$20240101$20240628$20240702$20240702$EXP$$US-ABBVIE-5821959$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240396441$24039644$1$I$20240531$20240627$20240702$20240702$EXP$FR-AFSSAPS-SE2024000507$FR-SA-2024SA192075$SANOFI AVENTIS$$66$YR$E$F$Y$70$KG$20240702$$MD$FR$FR
240396461$24039646$1$I$20240101$20240620$20240702$20240702$PER$$US-SA-2024SA188350$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240702$$MD$US$US
240396471$24039647$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA186689$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240702$$MD$US$US
240396481$24039648$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA189590$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240702$$CN$US$US
240396491$24039649$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA188384$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240702$$MD$US$US
240396502$24039650$2$F$$20240708$20240702$20240716$PER$$US-SA-2024SA186652$SANOFI AVENTIS$$62$YR$A$F$Y$86$KG$20240716$$MD$US$US
240396512$24039651$2$F$$20240718$20240702$20240728$PER$$US-SA-2024SA193243$SANOFI AVENTIS$$$$E$M$Y$$$20240729$$MD$US$US
240396521$24039652$1$I$20240101$20240621$20240702$20240702$PER$$US-SA-2024SA188379$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240702$$MD$US$US
240396531$24039653$1$I$20240501$20240621$20240702$20240702$PER$$US-SA-2024SA188380$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240702$$MD$US$US
240396542$24039654$2$F$$20240812$20240702$20240820$PER$$US-SA-2024SA186843$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240820$$CN$US$US
240396551$24039655$1$I$20240101$20240620$20240702$20240702$PER$$US-SA-2024SA188389$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240702$$MD$US$US
240396562$24039656$2$F$$20240827$20240702$20240910$PER$$US-SA-2024SA187947$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240910$$MD$US$US
240396572$24039657$2$F$$20240719$20240702$20240729$PER$$US-SA-2024SA188025$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240729$$CN$US$US
240396582$24039658$2$F$$20240913$20240702$20240927$EXP$$US-ALVOGEN-2024094948$ALVOGEN$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Med Pathol. 2024;45 (3):193?197. doi:10.1097/PAF.0000000000000943$13$YR$$F$Y$$$20240927$$MD$US$US
240396591$24039659$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A145770$ASTRAZENECA$$$$$M$Y$90.7$KG$20240702$$CN$US$
240396601$24039660$1$I$20240517$20240627$20240702$20240702$EXP$$ID-AstraZeneca-2024A149737$ASTRAZENECA$$25486$DY$$M$Y$$$20240702$$CN$ID$
240396611$24039661$1$I$20240522$20240620$20240702$20240702$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00873$AIMMUNE$$$$$$Y$$$20240702$$HP$US$US
240396621$24039662$1$I$20240518$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A147594$ASTRAZENECA$$$$$$Y$$$20240702$$CN$US$
240396631$24039663$1$I$$20230627$20240702$20240702$PER$$US-AMGEN-USASP2023235207$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240396641$24039664$1$I$$20240628$20240702$20240702$PER$$US-GILEAD-2024-0679097$GILEAD$$$$$M$Y$$$20240702$$CN$US$US
240396651$24039665$1$I$$20240618$20240702$20240702$EXP$$IE-ROCHE-10000013349$ROCHE$$$$$M$Y$$$20240702$$CN$IE$IE
240396663$24039666$3$F$20240613$20240717$20240702$20240724$PER$$US-AMGEN-USASP2024125062$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
240396671$24039667$1$I$$20240624$20240702$20240702$EXP$$JP-AMGEN-JPNSP2024128627$AMGEN$Fujii S,; Osawa T.; Hirate T. et al.. Establishment of Blinatumomab Home Administration Transition Program Using CADD-Legacy Pump. JPN J Cancer Chemother. 2024;51 (5):535-539$14$YR$T$F$Y$46.9$KG$20240702$$HP$JP$JP
240396681$24039668$1$I$$20240624$20240702$20240702$EXP$$US-AMGEN-USASP2024125344$AMGEN$Martinino A.; Di Cocco P.; Bencini G. et al.. Clinical outcomes of intestinal transplant recipients receiving maintenance basiliximab, sublingual tacrolimus and prednisone: A case series. Human Immunology. 2024;85 (3):1-4$$$$$Y$$$20240702$$HP$US$US
240396691$24039669$1$I$$20240624$20240702$20240702$EXP$$US-AMGEN-USASP2024125357$AMGEN$Martinino A.; Di Cocco P.; Bencini G. et al.. Clinical outcomes of intestinal transplant recipients receiving maintenance basiliximab, sublingual tacrolimus and prednisone: A case series. Human Immunology. 2024;85 (3):1-4$$$$$Y$$$20240702$$HP$US$US
240396701$24039670$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105284$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$$$20240702$$HP$US$US
240396711$24039671$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105069$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240702$$CN$US$US
240396721$24039672$1$I$$20240625$20240702$20240702$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-101929$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240702$$MD$DE$DE
240396732$24039673$2$F$20231227$20240730$20240702$20240807$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-280165$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240807$$CN$CA$CA
240396742$24039674$2$F$$20240913$20240702$20240927$EXP$$US-ALVOGEN-2024094946$ALVOGEN$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Med Pathol. 2024 Sep;45 (3):193?197. doi:10.1097/PAF.0000000000000943$11$MON$$M$Y$$$20240927$$MD$US$US
240396751$24039675$1$I$$20240627$20240702$20240702$EXP$$GB-SA-2024SA192799$SANOFI AVENTIS$$$$E$F$Y$$$20240702$$CN$GB$GB
240396761$24039676$1$I$20030101$20240621$20240702$20240702$PER$$US-SA-2024SA187502$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240702$$CN$US$US
240396771$24039677$1$I$20231215$20240628$20240702$20240702$EXP$$CA-BIOGEN-2024BI01271901$BIOGEN$$67$YR$$F$Y$$$20240702$$PH$CA$CA
240396781$24039678$1$I$$20240628$20240702$20240702$PER$$NVSC2024US136311$NOVARTIS$$$$$M$Y$$$20240702$$HP$US$US
240396791$24039679$1$I$$20240624$20240702$20240702$PER$$US-ABBVIE-5817120$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240396801$24039680$1$I$$20240617$20240702$20240702$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454193$RANBAXY$Hsieh T-Y, Su T-Y, Hung K-Y, Hsu M-S, Lin Y-J, Kuo H-C, et al. Feasibility of ketogenic diet therapy variants for refractory epilepsy in neonates to infants under 2 years old. Epilepsy Behav. 2023;146$$$$M$Y$$$20240702$$HP$TW$TW
240396811$24039681$1$I$20240318$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453698$RANBAXY$$88$YR$$F$Y$70$KG$20240702$$MD$FR$FR
240396821$24039682$1$I$$20240617$20240702$20240702$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454202$RANBAXY$Iha T, Watanabe A, Saeki M, Itoh A, Kashiwabara Y, Fujiwara A, et al.. Combined sepsis- and renal dysfunction-induced hypoglycaemia in an older patient taking cibenzoline. Clin Case Rep. 2024;12 (6):1-6$86$YR$$F$Y$44.6$KG$20240702$$HP$JP$JP
240396831$24039683$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454029$RANBAXY$Mei M, Fang M, Mao Y, Chen H, Huang L. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy. Open Med. 2023;18 (1):20230664/1-8$64$YR$$$Y$$$20240702$$HP$CN$CN
240396841$24039684$1$I$$20240617$20240702$20240702$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454212$RANBAXY$Yazaki T, Kimoto M, Minagawa A, Maruno T, Yamanaka M, Sonehara K, et al. Simultaneous Acquisition of T790M Mutation and SCLC Transformation during Targeted Therapy in EGFR-Mutated Lung Adenocarcinoma: A Rare Case Report. Am J  Case Rep. 2024;25 (0):e943466$66$YR$$M$Y$$$20240702$$HP$JP$JP
240396851$24039685$1$I$20240203$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454022$RANBAXY$$82$YR$$M$Y$109.7$KG$20240702$$MD$FR$FR
240396861$24039686$1$I$$20240617$20240702$20240702$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454197$RANBAXY$Hsieh T-Y, Su T-Y, Hung K-Y, Hsu M-S, Lin Y-J, Kuo H-C, et al. Feasibility of ketogenic diet therapy variants for refractory epilepsy in neonates to infants under 2 years old. Epilepsy Behav. 2023;146$$$$F$Y$$$20240702$$HP$TW$TW
240396871$24039687$1$I$$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453588$RANBAXY$Solignac M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, Laurent A, Foray AP, et al.. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study. J Autoimmun. 2024;147(0):103248;1-10$$$C$F$Y$$$20240702$$HP$FR$FR
240396881$24039688$1$I$$20240617$20240702$20240702$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453624$RANBAXY$Yang T-M, Fang Y-H, Lin C-M, Chen M-F, Lin C-L. Spheroids Generated from Malignant Pleural Effusion as a Tool to Predict the Response of Non-Small Cell Lung Cancer to Treatment. Diagnostics Basel. 2024;14:1-12$53$YR$$M$Y$$$20240702$$HP$TW$TW
240396891$24039689$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454041$RANBAXY$Mei M, Fang M, Mao Y, Chen H, Huang L. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy. Open Med. 2023;18 (1):20230664/1-8$53$YR$$$Y$$$20240702$$HP$CN$CN
240396901$24039690$1$I$$20240617$20240702$20240702$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454224$RANBAXY$Matsushima S, Kobayashi R, Sano H, Hori D, Yanagi M, Goto J, et al. Colorectal signet-ring cell carcinoma treated with FOLFOX plus panitumumab. Pediatr Int. 1900;64 (1):1-2$13$YR$$M$Y$$$20240702$$HP$JP$JP
240396911$24039691$1$I$$20240617$20240702$20240702$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454171$RANBAXY$Hsieh T-Y, Su T-Y, Hung K-Y, Hsu M-S, Lin Y-J, Kuo H-C, et al. Feasibility of ketogenic diet therapy variants for refractory epilepsy in neonates to infants under 2 years old. Epilepsy Behav. 2023;146$$$$M$Y$$$20240702$$HP$TW$TW
240396921$24039692$1$I$$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453609$RANBAXY$Solignac M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, Laurent A, Foray A-P, et al. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study. J Autoimmun. 2024;147(0):103248;1-10$$$C$F$Y$$$20240702$$HP$FR$FR
240396931$24039693$1$I$20231215$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453758$RANBAXY$$56$YR$$M$Y$55.2$KG$20240702$$MD$FR$FR
240396941$24039694$1$I$$20240617$20240702$20240702$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454199$RANBAXY$Murakami M, Hirahata K, Fujimori N, Yamamoto T, Oda Y, Kozono S, et al. Two cases of pancreatic neuroendocrine tumors with ectopic ACTH syndrome during their disease course. Clin J Gastroenterol. 2024;17 (2):363-370$55$YR$$F$Y$$$20240702$$HP$JP$JP
240396951$24039695$1$I$20240201$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454233$RANBAXY$$81$YR$$M$Y$92$KG$20240702$$MD$FR$FR
240396961$24039696$1$I$$20240617$20240702$20240702$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454195$RANBAXY$Hsieh T-Y, Su T-Y, Hung K-Y, Hsu M-S, Lin Y-J, Kuo H-C, et al. Feasibility of ketogenic diet therapy variants for refractory epilepsy in neonates to infants under 2 years old. Epilepsy Behav. 2023;146$$$$F$Y$$$20240702$$HP$TW$TW
240396971$24039697$1$I$$20240617$20240702$20240702$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453630$RANBAXY$Yang T-M, Fang Y-H, Lin C-M, Chen M-F, Lin C-L. Spheroids Generated from Malignant Pleural Effusion as a Tool to Predict the Response of Non-Small Cell Lung Cancer to Treatment. Diagnostics (Basel). 2024;14(998):1-12$$$E$F$Y$$$20240702$$HP$TW$TW
240396981$24039698$1$I$$20240617$20240702$20240702$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454176$RANBAXY$Hsieh T-Y, Su T-Y, Hung K-Y, Hsu M-S, Lin Y-J, Kuo H-C, et al. Feasibility of ketogenic diet therapy variants for refractory epilepsy in neonates to infants under 2 years old. Epilepsy Behav. 2023;146:109315$$$$M$Y$$$20240702$$HP$TW$TW
240396991$24039699$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453815$RANBAXY$Zhu X, Weng R, Huang Y, Xu Y, Yang J, He T. Canakinumab in the treatment of systemic juvenile idiopathic arthritis: a retrospective single center study in China. Front Pediatr. 2024;Mar;12 (0):1349907/1-7$$$C$$Y$$$20240702$$HP$CN$CN
240397001$24039700$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453607$RANBAXY$Yang TM, Fang YH, Lin CM, Chen MF, Lin CL. Spheroids Generated from Malignant Pleural Effusion as a Tool to Predict the Response of Non-Small Cell Lung Cancer to Treatment. Diagnostics Basel. 2024;14:1-12$61$YR$$M$Y$$$20240702$$HP$CN$TW
240397011$24039701$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454030$RANBAXY$Mei M, Fang M, Mao Y, Chen H, Huang L. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy. Open Med. 2023;18 (1):20230664/1-8$63$YR$$$Y$$$20240702$$HP$CN$CN
240397021$24039702$1$I$20240601$20240617$20240702$20240702$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453937$RANBAXY$$68$YR$$M$Y$$$20240702$$HP$DE$DE
240397031$24039703$1$I$$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453591$RANBAXY$Solignac M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, Laurent A, Foray AP, et al.. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study. J Autoimmun. 2024;147(0):103248;1-10$$$T$F$Y$$$20240702$$HP$FR$FR
240397041$24039704$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453918$RANBAXY$Mei M, Fang M, Mao Y, Chen H, Huang L. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy. Open Med. 2023;18 (1):20230664/1-8$58$YR$$$Y$$$20240702$$HP$CN$CN
240397051$24039705$1$I$$20240617$20240702$20240702$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453616$RANBAXY$Belani N, Liang K, Fradley M, Judd J, Borghaei H. How to Treat EGFR-Mutated Non-Small Cell Lung Cancer. JACC CardioOncol. 2023;5 (4):542-545$4$DEC$$F$Y$$$20240702$$MD$US$US
240397061$24039706$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453812$RANBAXY$Zhu X, Weng R, Huang Y, Xu Y, Yang J, He T. Canakinumab in the treatment of systemic juvenile idiopathic arthritis: a retrospective single center study in China. Front Pediatr. 2024;Mar;12 (0):1349907/1-7$$$C$$Y$$$20240702$$HP$CN$CN
240397071$24039707$1$I$20230201$20240617$20240702$20240702$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453584$RANBAXY$$63$YR$$M$Y$$$20240702$$MD$ES$ES
240397081$24039708$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453813$RANBAXY$Zhu X, Weng R, Huang Y, Xu Y, Yang J, He T. Canakinumab in the treatment of systemic juvenile idiopathic arthritis: a retrospective single center study in China. Front Pediatr. 2024;Mar;12 (0):1349907/1-7$$$C$$Y$$$20240702$$HP$CN$CN
240397091$24039709$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453926$RANBAXY$Mei M, Fang M, Mao Y, Chen H, Huang L. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy. Open Med. 2023;18 (1):20230664/1-8$67$YR$$$Y$$$20240702$$HP$CN$CN
240397101$24039710$1$I$$20240617$20240702$20240702$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-444183$RANBAXY$$$$A$F$Y$$$20240702$$CN$IT$IT
240397111$24039711$1$I$$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453604$RANBAXY$Solignac M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, Laurent A, Foray A-P, et al. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study. J Autoimmun. 2024;147(0):103248;1-10$$$T$F$Y$$$20240702$$HP$FR$FR
240397122$24039712$2$F$$20240619$20240702$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454170$RANBAXY$$77$YR$$F$Y$$$20240704$$MD$IT$IT
240397131$24039713$1$I$$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453594$RANBAXY$Solignac M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, Laurent A, Foray AP, et al.. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study. J Autoimmun. 2024;147(0):103248;1-10$$$$F$Y$$$20240702$$HP$FR$FR
240397141$24039714$1$I$$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453585$RANBAXY$Solignac M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, Laurent A, Foray AP, et al.. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study. J Autoimmun. 2024;147(0):103248;1-10$$$C$M$Y$$$20240702$$HP$FR$FR
240397151$24039715$1$I$$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453586$RANBAXY$Solignac M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, Laurent A, Foray AP, et al.. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study. J Autoimmun. 2024;147(0):103248;1-10$$$T$F$Y$$$20240702$$HP$FR$FR
240397161$24039716$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453638$RANBAXY$Zhu X, Weng R, Huang Y, Xu Y, Yang J, He T. Canakinumab in the treatment of systemic juvenile idiopathic arthritis: a retrospective single center study in China. Front Pediatr. 2024;Mar; 12:1349907(1-7)$$$$$Y$$$20240702$$HP$CN$CN
240397171$24039717$1$I$$20240617$20240702$20240702$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453751$RANBAXY$Gupta A, Jatwani K, Gupta K, Qiu J, Dy GK. Loss of Rb1 Associated With the Onset of Acquired Resistance to Trastuzumab Deruxtecan in TP53-/HER2-Mutated Non-Small-Cell Lung Cancer: Case Series. JCO Precis Oncol. 2023;7:1-5$57$YR$$F$Y$$$20240702$$MD$US$US
240397181$24039718$1$I$$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453593$RANBAXY$Solignac M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, Laurent A, Foray AP, et al. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study. J Autoimmun. 2024;147(0):103248;1-10$$$$F$Y$$$20240702$$HP$FR$FR
240397191$24039719$1$I$$20240617$20240702$20240702$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453781$RANBAXY$Caria J, Vara-Luiz F, Maia I, Joosten A, Val-Flores L, Pinheiro H, et al. Fatal Case of Progressive Mpox in a Patient with AIDS-Viral Enteropathy and  Malabsorption Demanding the Use of Full Parenteral ARV and Endovenous Cidofovir. Infect Dis Rep. 2023;15(2):171-179$23$YR$$M$Y$65$KG$20240702$$HP$PT$PT
240397201$24039720$1$I$$20240617$20240702$20240702$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453808$RANBAXY$Turcu C, Grama A, Pop TL. Diagnostic and management difficulties in Alagille syndrome -  case report. Pediatru ro. 2024;73 (1):32-35$2$YR$$M$Y$$$20240702$$HP$RO$RO
240397211$24039721$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453817$RANBAXY$Zhu X, Weng R, Huang Y, Xu Y, Yang J, He T. Canakinumab in the treatment of systemic juvenile idiopathic arthritis: a retrospective single center study in China. Front Pediatr. 2024;Mar;12 (0):1349907/1-7$$$C$$Y$$$20240702$$HP$CN$CN
240397221$24039722$1$I$$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453592$RANBAXY$Solignac M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, Laurent A, Foray AP, et al.. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study. J Autoimmun. 2024;147(0):103248(1-10)$$$C$M$Y$$$20240702$$HP$FR$FR
240397231$24039723$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454017$RANBAXY$Mei M, Fang M, Mao Y, Chen H, Huang L. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy. Open Med. 2023;18 (1):20230664/1-8$69$YR$$$Y$$$20240702$$HP$CN$CN
240397241$24039724$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453818$RANBAXY$Zhu X, Weng R, Huang Y, Xu Y, Yang J, He T. Canakinumab in the treatment of systemic juvenile idiopathic arthritis: a retrospective single center study in China. Front Pediatr. 2024;Mar;12 (0):1349907/1-7$$$C$$Y$$$20240702$$HP$CN$CN
240397251$24039725$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453816$RANBAXY$Zhu X, Weng R, Huang Y, Xu Y, Yang J, He T. Canakinumab in the treatment of systemic juvenile idiopathic arthritis: a retrospective single center study in China. Front Pediatr. 2024;Mar;12 (0):1349907/1-7$$$C$$Y$$$20240702$$HP$CN$CN
240397261$24039726$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453794$RANBAXY$Wang C, Zhou F, Zhang L, Liu T, Nan Y, Liu Y. Long-term efficacy and safety of programmed death-1 (PD-1) antibody alone in relapsed/refractory human immunodeficiency virus-associated Hodgkin lymphoma. eJHaem. 2022;3 (3):924-926$26$YR$$M$Y$$$20240702$$HP$CN$CN
240397271$24039727$1$I$$20240617$20240702$20240702$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454191$RANBAXY$Hsieh T-Y, Su T-Y, Hung K-Y, Hsu M-S, Lin Y-J, Kuo H-C, et al. Feasibility of ketogenic diet therapy variants for refractory epilepsy in neonates to infants under 2 years old. Epilepsy Behav. 2023;146:109315$$$$M$Y$$$20240702$$HP$TW$TW
240397281$24039728$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454028$RANBAXY$Mei M, Fang M, Mao Y, Chen H, Huang L. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy. Open Med. 2023;18 (1):20230664/1-8$64$YR$$$Y$$$20240702$$HP$CN$CN
240397291$24039729$1$I$$20240617$20240702$20240702$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454168$RANBAXY$Hsieh T-Y, Su T-Y, Hung K-Y, Hsu M-S, Lin Y-J, Kuo H-C, et al. Feasibility of ketogenic diet therapy variants for refractory epilepsy in neonates to infants under 2 years old. Epilepsy Behav. 2023;146$$$$M$Y$$$20240702$$HP$TW$TW
240397301$24039730$1$I$$20240617$20240702$20240702$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453619$RANBAXY$Alp A, Rollas T, Eroglu EO, Yildiz MI, Yagcioglu AEA, Ulug BD. Catatonia Due to Lithium Neurotoxicity: A Case Report. Turk Psikiyatri Dergisi. 2024;35 (2):150-155/1-6$60$YR$$F$Y$$$20240702$$HP$TR$TR
240397311$24039731$1$I$$20240617$20240702$20240702$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453628$RANBAXY$Yang T-M, Fang Y-H, Lin C-M, Chen M-F, Lin C-L. Spheroids Generated from Malignant Pleural Effusion as a Tool to Predict the Response of Non-Small Cell Lung Cancer to Treatment. Diagnostics (Basel). 2024;14(998):1-12$$$E$F$Y$$$20240702$$HP$TW$TW
240397321$24039732$1$I$20240601$20240621$20240702$20240702$EXP$$DE-ALVOGEN-2024094976$ALVOGEN$$$$$F$Y$$$20240702$$CN$DE$DE
240397331$24039733$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453814$RANBAXY$Zhu X, Weng R, Huang Y, Xu Y, Yang J, He T. Canakinumab in the treatment of systemic juvenile idiopathic arthritis: a retrospective single center study in China. Front Pediatr. 2024;Mar;12 (0):1349907/1-7$$$C$$Y$$$20240702$$HP$CN$CN
240397341$24039734$1$I$$20240613$20240702$20240702$EXP$$IT-ROCHE-10000013313$ROCHE$$$$$$Y$$$20240702$$HP$IT$IT
240397351$24039735$1$I$$20240628$20240702$20240702$EXP$$CA-JNJFOC-20240700595$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$CA$CA
240397372$24039737$2$F$20240101$20240803$20240702$20240810$EXP$$CA-CELLTRION INC.-2024CA014013$CELLTRION$$$$$$Y$$$20240810$$HP$CA$CA
240397382$24039738$2$F$20220101$20240710$20240702$20240715$EXP$$US-BIOGEN-2024BI01270338$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240397391$24039739$1$I$20240524$20240627$20240702$20240702$EXP$$US-BIOGEN-2024BI01271619$BIOGEN$$82$YR$$F$Y$$$20240702$$HP$US$US
240397401$24039740$1$I$$20240621$20240702$20240702$EXP$GB-MHRA-MED-202406211412527020-WBJTK$GB-TORRENT-00036881$TORRENT$$$$$$Y$$$20240702$$PH$GB$GB
240397411$24039741$1$I$$20240622$20240702$20240702$EXP$GB-MHRA-MED-202406221952301500-ZQMSR$GB-TORRENT-00036893$TORRENT$$$$$$Y$$$20240702$$CN$GB$GB
240397421$24039742$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5819934$ABBVIE$$$$$$Y$$$20240702$$MD$US$US
240397432$24039743$2$F$20240619$20240625$20240702$20240807$EXP$IT-MINISAL02-991751$IT-BEH-2024174589$CSL BEHRING$$88$YR$E$M$Y$70$KG$20240807$$MD$IT$IT
240397441$24039744$1$I$$20240617$20240702$20240702$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453576$RANBAXY$Kadokawa Y, Inoue S, Tatsumi A, Uchida M, Fujita K, Takagi M, et al. Efficacy and safety of mycophenolate mofetil in treating immune-related hepatitis induced by immune checkpoint inhibitor use: A retrospective study. JGH Open. 2023;7 (2):87-97$50$YR$$M$Y$$$20240702$$HP$JP$JP
240397451$24039745$1$I$$20240617$20240702$20240702$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453578$RANBAXY$Kadokawa Y, Inoue S, Tatsumi A, Uchida M Fujita K, Takagi M, et al. Efficacy and safety of mycophenolate mofetil in treating immune-related hepatitis induced by immune checkpoint inhibitor use: A retrospective study. JGH Open. 2023;7 (2):87-97$72$YR$$M$Y$$$20240702$$HP$JP$JP
240397463$24039746$3$F$$20240704$20240702$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453560$RANBAXY$Hoang S, Pujar T, Bellorin-Font E, Edwards JC, Miyata KN. A case of ifosfamide-induced acute kidney injury, Fanconi syndrome, and nephrogenic diabetes insipidus. CEN Case Rep. 2024;13 (3):194-198$54$YR$$M$Y$$$20240719$$HP$US$US
240397471$24039747$1$I$$20240617$20240702$20240702$EXP$$HU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453545$RANBAXY$Cegledi A, Batai A, Dolgos J, Fekete M, Gopcsa L, Kiraly V, et al. Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol. Pathol Oncol Res. 2024;30 (0):1611720 (1-8)$68$YR$$M$Y$$$20240702$$HP$HU$HU
240397481$24039748$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453544$RANBAXY$Fan Z, Khizar H, Lu J, Wang A, Xun T, Zhang X, et al. From pill to pain: Alendronate-induced esophageal injury-A case report and review. JGH Open. 2024;8 (6):e13080$62$YR$$$Y$$$20240702$$HP$CN$CN
240397491$24039749$1$I$$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453570$RANBAXY$Solignac M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, Laurent A, Foray AP, et al.. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study. J Autoimmun. 2024;147(0):103248;1-10$$$C$M$Y$$$20240702$$HP$FR$FR
240397501$24039750$1$I$$20240617$20240702$20240702$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454237$RANBAXY$Matsuura M, Yorozu K, Nagao S, Kurokawa S, Tamate M, Akimoto T, et al. Therapeutic efficacy of a four-year treatment with eribulin in a patient with uterine leiomyosarcoma: A case report. Gynecol Oncol Rep. 2023;47$31$YR$$F$Y$$$20240702$$HP$JP$JP
240397511$24039751$1$I$$20240617$20240702$20240702$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453548$RANBAXY$Tan CR, Derkach A, Nemirovsky D, Ciardiello A, Diamond B, Hultcrantz M, et al. Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma. Blood Can J. 2023;13:112$$$$$Y$$$20240702$$HP$US$US
240397521$24039752$1$I$20240529$20240617$20240702$20240702$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454361$RANBAXY$$$$$M$Y$$$20240702$$HP$GB$GB
240397531$24039753$1$I$20231123$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454421$RANBAXY$$78$YR$$F$Y$99$KG$20240702$$PH$FR$FR
240397541$24039754$1$I$$20240617$20240702$20240702$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454355$RANBAXY$$$$$$Y$$$20240702$$PH$GB$GB
240397551$24039755$1$I$$20240617$20240702$20240702$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453540$RANBAXY$Suwalski P, Wilke F, Fairweather D, Landmesser U, Heidecker B. Application of magnetocardiography for myocarditis assessment in a testosterone-substituted female-to-male individual. Am Heart J Plus. 2024;43 (0):100412$38$YR$$$Y$$$20240702$$HP$DE$DE
240397561$24039756$1$I$$20240617$20240702$20240702$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452986$RANBAXY$Yu J, Sim DW. A Case of Angioedema to Oral Doxycycline and Cross-Reactivity to Minocycline. Ann Pharmacother. 2024;0 (0):no pagination$28$YR$$F$Y$$$20240702$$MD$KR$KR
240397571$24039757$1$I$$20240617$20240702$20240702$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453140$RANBAXY$$$$E$M$Y$60$KG$20240702$$HP$CN$CN
240397581$24039758$1$I$20231025$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454317$RANBAXY$$70$YR$$F$Y$75$KG$20240702$$MD$FR$FR
240397591$24039759$1$I$$20240617$20240702$20240702$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453137$RANBAXY$$$$E$M$Y$$$20240702$$CN$US$US
240397601$24039760$1$I$20190331$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454236$RANBAXY$$77$YR$$M$Y$72$KG$20240702$$HP$FR$FR
240397611$24039761$1$I$$20240617$20240702$20240702$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454245$RANBAXY$$77$YR$$M$Y$74$KG$20240702$$CN$NL$NL
240397621$24039762$1$I$$20240617$20240702$20240702$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453559$RANBAXY$Kanbour S, Balaji A,Maragakis N, Stanley Clarke N, Mathioudakis N. Concurrent diagnoses of treatment-induced neuropathy of diabetes and restless leg syndrome. J Clin Transl Endocrinol Case Rep. 2023;28:1-4/100143$36$YR$$M$Y$$$20240702$$HP$US$US
240397631$24039763$1$I$20240126$20240617$20240702$20240702$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454587$RANBAXY$$36$YR$$F$Y$61$KG$20240702$$MD$ES$ES
240397642$24039764$2$F$20240207$20240729$20240702$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454375$RANBAXY$$54$YR$$F$Y$75$KG$20240813$$MD$FR$FR
240397651$24039765$1$I$$20240617$20240702$20240702$EXP$IT-EMA-DD-20240405-7482701-094818$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454249$RANBAXY$$63$YR$$M$Y$$$20240702$$HP$IT$IT
240397661$24039766$1$I$$20240617$20240702$20240702$EXP$$DZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454322$RANBAXY$Mansour S, Mekaouche FZN, Amrani A, Charif FZ, Haouatti F, Betaouaf H, et al.. From pharmacovigilance to pharmaceutical care: About a case of urticaria and angioedema.. Rev Fr Allergol. 2023;63 (7):no pagination$22$YR$$F$Y$50$KG$20240702$$HP$DZ$DZ
240397681$24039768$1$I$$20240617$20240702$20240702$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454173$RANBAXY$Hsieh T-Y, Su T-Y, Hung K-Y, Hsu M-S, Lin Y-J, Kuo H-C, et al. Feasibility of ketogenic diet therapy variants for refractory epilepsy in neonates to infants under 2 years old. Epilepsy Behav. 2023;146:109315$$$$F$Y$$$20240702$$HP$TW$TW
240397691$24039769$1$I$20240213$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454583$RANBAXY$$68$YR$$F$Y$65$KG$20240702$$PH$FR$FR
240397702$24039770$2$F$$20240702$20240702$20240717$EXP$$MX-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453113$RANBAXY$Garcia-Uribe PA, Preciado M.. Crystalline keratopathy secondary to the use of ciprofloxacin after cataract surgery with confirmation by histopathological study: A case report and review of the literature. Arch Soc Esp Oftalmol. 2024;JUN 99 (6):229-231$75$YR$$M$Y$$$20240717$$HP$MX$MX
240397711$24039771$1$I$$20240617$20240702$20240702$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454490$RANBAXY$$$$$$Y$$$20240702$$PH$GB$GB
240397721$24039772$1$I$$20240617$20240702$20240702$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453558$RANBAXY$Faress F, Moossavi SZ, Owliaey H, Soltani S, Marashi SM. Successful Treatment of Acute Respiratory Distress Syndrome Following Cardiopulmonary Resuscitation in the Context of Aluminum Phosphide Poisoning: A Case Report. J Crit Intensive Care. 2024;May; 15(1):49-54$19$YR$$F$Y$$$20240702$$MD$IR$IR
240397731$24039773$1$I$20240304$20240617$20240702$20240702$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454291$RANBAXY$$89$YR$$F$Y$$$20240702$$MD$ES$ES
240397741$24039774$1$I$$20240617$20240702$20240702$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453511$RANBAXY$Russwurm M, Maier- Giebing T, Kortus- Goetze B, Russ P, Groene H-J, Hoyer JD. Efficacy of Double Membrane Filtration Immunoadsorption in Severe C1q-Binding Donor-Specific Antibody-Positive Acute Humoral Kidney Allograft Rejection: A Case Series. Blood Purif. 2023;52(5):428-436$62$YR$$F$Y$$$20240702$$HP$DE$DE
240397751$24039775$1$I$$20240617$20240702$20240702$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453386$RANBAXY$Singh S, Khatavkar S, Yerramshetty M. Anaesthetic Management of Paediatric Patient with Klippel-Trenaunay Syndrome undergoing Excision of Scalp Cyst: A Case Report. J Clin Diagnostic Res. 2024;18 (5):UD01-UD03 (1-3)$10$YR$$F$Y$20$KG$20240702$$HP$IN$IN
240397761$24039776$1$I$$20240617$20240702$20240702$EXP$$SI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450951$RANBAXY$Trsinar M. ANTIDEPRESSANT INDUCED SEXUAL DYSFUNCTION-CLINICAL CASE. Farm Vestn. 2023;74:136-140$$$$M$Y$$$20240702$$HP$SI$SI
240397771$24039777$1$I$$20240617$20240702$20240702$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453769$RANBAXY$Hirsch TI, Friedman R, Granoff M, Tsai LL, Critchlow JF, Sharma R, et al. Omental vascularized lymph node transplant for the treatment of breast lymphedema: A case report. Microsurgery. 2023;43 (4):387-391$48$YR$$F$Y$$$20240702$$MD$US$US
240397781$24039778$1$I$$20240617$20240702$20240702$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453535$RANBAXY$Manzotti C, Castellani M, Murgo A, Basilisco G. Duodenojejunal inflammation causing chronic vomiting in adult-onset still^s diseasse. BMJ Case Rep. 2023;16 (2):e252345(1-4)$$$$F$Y$$$20240702$$HP$IT$IT
240397791$24039779$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821580$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240397801$24039780$1$I$$20240619$20240702$20240702$PER$$US-JNJFOC-20240650840$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240702$$CN$US$US
240397811$24039781$1$I$$20240617$20240702$20240702$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454543$RANBAXY$Fernandez Martinez V, Garcia-Avello F-C, Valencia Soto CM, Barbadillo Villanueva S, Ochagavia Sufrategui M, Rioja Carrera M, et al. Pembrolizumab-induced agranulocytosis. J Oncol Pharm Pract. 2024;30(4):767-771$68$YR$$M$Y$$$20240702$$HP$ES$ES
240397821$24039782$1$I$$20240625$20240702$20240702$EXP$$US-GSK-US2024079040$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$US$US
240397831$24039783$1$I$$20240617$20240702$20240702$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454487$RANBAXY$Lee M-J, Kao H-F. Promising response with PI3K inhibitor for a patient with heavily pretreated PIK3CA mutation head-And-neck cancer. J Cancer Res. 2023;10(2):75-77$51$YR$$M$Y$$$20240702$$HP$TW$TW
240397841$24039784$1$I$$20240627$20240702$20240702$PER$$US-JNJFOC-20240675068$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240397851$24039785$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001045$ELI LILLY AND CO$$$$$M$Y$$$20240702$$CN$US$US
240397861$24039786$1$I$20240601$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000222$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240702$$CN$US$US
240397871$24039787$1$I$20240611$20240620$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406014484$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$US$US
240397881$24039788$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000901$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240702$$CN$US$US
240397891$24039789$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105253$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240702$$CN$US$US
240397901$24039790$1$I$$20240626$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103466$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240702$$CN$US$US
240397911$24039791$1$I$20240621$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024130007$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240397921$24039792$1$I$$20240128$20240702$20240702$PER$$US-AMGEN-USASP2024129793$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240397941$24039794$1$I$$20240621$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05786$HIKMA$$$$$$Y$$$20240702$$CN$US$US
240397951$24039795$1$I$20240621$20240624$20240702$20240702$PER$$US-AMX-004216$AMYLYX PHARMACEUTICALS$$69$YR$$F$Y$$$20240702$$CN$US$US
240397961$24039796$1$I$$20240625$20240702$20240702$EXP$$JP-UCBSA-2024032958$UCB$$$$$$Y$$$20240702$$MD$JP$JP
240397971$24039797$1$I$20240624$20240624$20240702$20240702$PER$$US-BAYER-2024A092470$BAYER$$$$$$Y$$$20240702$$CN$US$US
240397991$24039799$1$I$$20230131$20240702$20240702$PER$$US-AMGEN-USASP2023235294$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240398001$24039800$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5822494$ABBVIE$$$$$$Y$$$20240702$$HP$US$US
240398012$24039801$2$F$20230915$20240712$20240702$20240715$EXP$$JP-EMD Serono-2024035412$EMD SERONO INC$$66$YR$E$M$Y$59$KG$20240715$$HP$JP$JP
240398021$24039802$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031626$AUROBINDO$Zhang R, Polenakovik H, Barreras Beltran IA, Waalkes A, Salipante SJ, Xu L, et al.. Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated with Dalbavancin: Case Report and Isolate Characterization.. Clinical Infectious Diseases. 2022;75(9):1641-1644$63$YR$$M$Y$$$20240702$$HP$US$US
240398031$24039803$1$I$$20240620$20240702$20240702$EXP$$CA-APOTEX-2024AP007590$APOTEX$$32$YR$$F$Y$$$20240702$$HP$CA$CA
240398041$24039804$1$I$20230101$20240625$20240702$20240702$EXP$$SG-AMGEN-SGPSP2024089880$AMGEN$$$$$$Y$$$20240702$$PH$SG$SG
240398051$24039805$1$I$$20240626$20240702$20240702$EXP$$US-ABBVIE-5819873$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240398061$24039806$1$I$$20240626$20240702$20240702$EXP$$FR-TAKEDA-2024TUS064243$TAKEDA$$$$$$Y$$$20240702$$PH$FR$FR
240398071$24039807$1$I$$20240628$20240702$20240702$PER$$US-BAYER-2024A094724$BAYER$$$$$M$Y$$$20240702$$CN$US$US
240398081$24039808$1$I$20230801$20240625$20240702$20240702$EXP$$CA-GSK-CA2023113924$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$MD$CA$CA
240398091$24039809$1$I$20240101$20240625$20240702$20240702$PER$$US-SA-2024SA192651$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240702$$MD$US$US
240398102$24039810$2$F$20240101$20240717$20240702$20240726$PER$$US-SA-2024SA186461$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240726$$MD$US$US
240398111$24039811$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281412466070-YKBNQ$GB-ORGANON-O2407GBR000046$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240398121$24039812$1$I$20240109$20240625$20240702$20240702$EXP$$JP-EXELIXIS-CABO-24073477$EXELIXIS$$39$YR$$F$Y$$$20240702$$MD$JP$JP
240398131$24039813$1$I$$20240630$20240702$20240702$PER$$US-BAYER-2024A094608$BAYER$$$$$$Y$$$20240702$$CN$US$US
240398141$24039814$1$I$20240101$20240617$20240702$20240702$EXP$IT-MINISAL02-989796$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-05677$HIKMA$$66$YR$$F$Y$$$20240702$$MD$IT$IT
240398151$24039815$1$I$$20240625$20240702$20240702$EXP$$CA-APOTEX-2024AP007769$APOTEX$$40$YR$$F$Y$$$20240702$$HP$CA$CA
240398161$24039816$1$I$$20240624$20240702$20240702$EXP$$JP-EMD Serono-2024034959$EMD SERONO INC$$8$DEC$E$F$Y$65$KG$20240702$$MD$JP$JP
240398172$24039817$2$F$20211021$20240820$20240702$20240821$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-160153$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$79$KG$20240821$$CN$ES$ES
240398181$24039818$1$I$$20240627$20240702$20240702$PER$$US-ROCHE-10000011267$ROCHE$Yossef S, English J. Attenuation of disease process following treatment with low-dose naltrexone in patients with frontal fibrosing alopecia and lichen planopilaris: A retrospective study. Journal of the American Academy of Dermatology. 2024-Jul;91 (1):141-2. doi:10.1016/j.jaad.2024.03.010.$$$$$Y$$$20240702$$HP$US$US
240398192$24039819$2$F$$20240807$20240702$20240813$EXP$$US-TAKEDA-2024TUS065123$TAKEDA$$$$$$Y$59$KG$20240813$$CN$US$US
240398201$24039820$1$I$$20240617$20240702$20240702$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-13939$ALKEM$$$$$F$Y$68.481$KG$20240702$$CN$US$US
240398212$24039821$2$F$$20240701$20240702$20240726$PER$$US-BAYER-2024A094905$BAYER$$$$$F$Y$$$20240726$$CN$US$US
240398221$24039822$1$I$$20240626$20240702$20240702$EXP$$US-ABBVIE-5821449$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240398231$24039823$1$I$$20240624$20240702$20240702$PER$$US-ABBVIE-5817691$ABBVIE$$$$$F$Y$54$KG$20240702$$CN$US$US
240398243$24039824$3$F$$20240909$20240702$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105385$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240910$$HP$US$US
240398251$24039825$1$I$$20240620$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101616$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240702$$MD$US$US
240398262$24039826$2$F$$20240705$20240702$20240706$EXP$$DE-ABBVIE-5820408$ABBVIE$$$$$M$Y$$$20240706$$CN$DE$DE
240398271$24039827$1$I$20240417$20240628$20240702$20240702$EXP$ES-AEMPS-1540720$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-104269$BRISTOL MYERS SQUIBB$$65$YR$A$M$Y$78$KG$20240702$$PH$ES$ES
240398281$24039828$1$I$$20230911$20240702$20240702$PER$$US-AMGEN-USASP2023235225$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240398291$24039829$1$I$$20240626$20240702$20240702$30DAY$$US-GSK-US2024079852$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
240398301$24039830$1$I$$20240627$20240702$20240702$EXP$$CA-ABBVIE-5753439$ABBVIE$$$$E$F$Y$$$20240702$$CN$CA$CA
240398311$24039831$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5807517$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240398321$24039832$1$I$20240603$20240621$20240702$20240702$EXP$$CN-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000157-2024$QILU PHARMACEUTICAL$$34$YR$A$M$Y$60$KG$20240702$$HP$CN$CN
240398331$24039833$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031802$AUROBINDO$Werenski 15No. 1H, Ford K, Casey D, Glass C, Schoeneck J. Abscess pulsatility: a sonographic sign of osteomyelitis. Ultrasound-J (The Ultrasound Journal). 2023;15No. 1:41$68$YR$$F$Y$$$20240702$$HP$US$US
240398342$24039834$2$F$$20240703$20240702$20240709$PER$$US-MSNLABS-2024MSNSPO01357$MSN LABORATORIES$$$$$$Y$$$20240709$$CN$US$US
240398351$24039835$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821293$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240398361$24039836$1$I$$20240701$20240702$20240702$PER$$US-BAYER-2024A094961$BAYER$$$$$F$Y$$$20240702$$CN$US$US
240398371$24039837$1$I$$20240620$20240702$20240702$EXP$$CA-APOTEX-2024AP007591$APOTEX$$38$YR$$F$Y$73$KG$20240702$$HP$CA$CA
240398381$24039838$1$I$$20240620$20240702$20240702$EXP$$US-MYLANLABS-2024M1058146$MYLAN$Gupta UD, Chowdhury T, Niriyan J, Bellamkonda A, Aryal B, Al-Ghuraibawi M. Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$43$YR$$F$Y$$$20240702$$HP$US$US
240398391$24039839$1$I$$20240619$20240702$20240702$EXP$$US-MYLANLABS-2024M1057242$MYLAN$Venkat Ramanan S, Ghazal F, Addanki PR, Perez MF. Thyroid Tempest: Unravelling a Rare Case of Amiodarone-Induced Thyroid Storm. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A3400 (plus Poster).$74$YR$$F$Y$$$20240702$$HP$US$US
240398402$24039840$2$F$20220401$20240703$20240702$20240708$EXP$$JP-SA-2024SA188928$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240709$$MD$JP$JP
240398412$24039841$2$F$20240620$20240705$20240702$20240710$EXP$$IN-ROCHE-3551393$ROCHE$$76$YR$E$M$Y$$$20240710$$CN$IN$IN
240398421$24039842$1$I$$20240701$20240702$20240702$PER$$US-BAYER-2024A095066$BAYER$$$$E$F$Y$$$20240702$$CN$US$US
240398431$24039843$1$I$20231001$20240628$20240702$20240702$EXP$$PR-ABBVIE-5821077$ABBVIE$$65$YR$$F$Y$73$KG$20240702$$CN$PR$PR
240398441$24039844$1$I$$20230414$20240702$20240702$PER$$US-AMGEN-USASP2023235065$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240398451$24039845$1$I$$20230626$20240702$20240702$PER$$US-AMGEN-USASP2023235319$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240398461$24039846$1$I$20240625$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127187$AMGEN$$89$YR$E$M$Y$$$20240702$$CN$US$US
240398472$24039847$2$F$20240501$20240718$20240702$20240726$30DAY$$US-GSK-US2024079009$GLAXOSMITHKLINE$$56$YR$$F$Y$59$KG$20240726$$MD$US$US
240398481$24039848$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46038$$FDA-CTU$$71$YR$$M$N$$$20240701$N$$US$
240398503$24039850$3$F$20240601$20240905$20240702$20240912$EXP$$JP-ASTELLAS-2024JP004451$ASTELLAS$$8$DEC$E$M$Y$$$20240912$$MD$JP$JP
240398511$24039851$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281432464540-VLDZP$GB-ORGANON-O2407GBR000088$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240398521$24039852$1$I$20240601$20240625$20240702$20240702$30DAY$$US-GSK-US2024079087$GLAXOSMITHKLINE$$65$YR$$M$Y$$$20240702$$CN$US$US
240398532$24039853$2$F$20240624$20240815$20240702$20240829$EXP$$US-BEH-2024174592$CSL BEHRING$$27$YR$A$F$Y$95.238$KG$20240829$$MD$US$US
240398541$24039854$1$I$20240601$20240625$20240702$20240702$EXP$$BR-JNJFOC-20240673755$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240702$$MD$BR$BR
240398551$24039855$1$I$20240628$20240628$20240702$20240702$EXP$$US-ABBVIE-5822121$ABBVIE$$75$YR$$F$Y$$$20240702$$CN$US$US
240398561$24039856$1$I$20240331$20240610$20240702$20240702$EXP$$IN-ROCHE-10000002224$ROCHE$$77$YR$E$F$Y$$$20240702$$CN$IN$IN
240398581$24039858$1$I$20231204$20240612$20240702$20240702$EXP$$DE-ROCHE-10000012171$ROCHE$$37$YR$A$M$Y$$$20240702$$MD$DE$DE
240398591$24039859$1$I$$20240626$20240702$20240702$PER$$US-SA-2024SA191958$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$MD$US$US
240398601$24039860$1$I$20240201$20240625$20240702$20240702$PER$$US-SA-2024SA191420$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240702$$MD$US$US
240398611$24039861$1$I$20181001$20240624$20240702$20240702$PER$$US-SA-2022SA334067$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240702$$MD$US$US
240398621$24039862$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA187999$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240702$$MD$US$US
240398631$24039863$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187608$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$MD$US$US
240398641$24039864$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187601$SANOFI AVENTIS$$$$A$$Y$$$20240702$$MD$US$US
240398651$24039865$1$I$$20240624$20240702$20240702$EXP$$ZA-AstraZeneca-2024A146182$ASTRAZENECA$$39$YR$$F$Y$$$20240702$$CN$ZA$
240398661$24039866$1$I$20240601$20240627$20240702$20240702$EXP$$US-ABBVIE-5821350$ABBVIE$$74$YR$$M$Y$$$20240702$$CN$US$US
240398672$24039867$2$F$20240529$20240708$20240702$20240726$EXP$$ZA-ROCHE-10000011839$ROCHE$$45$YR$A$F$Y$$$20240726$$CN$ZA$ZA
240398681$24039868$1$I$$20240701$20240702$20240702$PER$$US-BAYER-2024A094966$BAYER$$$$$F$Y$$$20240702$$CN$US$US
240398691$24039869$1$I$20240623$20240624$20240702$20240702$EXP$$CO-AstraZeneca-2024A148365$ASTRAZENECA$$24175$DY$$M$Y$63$KG$20240702$$CN$CO$
240398701$24039870$1$I$20240620$20240624$20240702$20240702$EXP$$CO-AstraZeneca-2024A148226$ASTRAZENECA$$23857$DY$$F$Y$$$20240702$$CN$CO$
240398711$24039871$1$I$$20240624$20240702$20240702$EXP$$ZA-AstraZeneca-2024A145862$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$ZA$
240398722$24039872$2$F$20240601$20240718$20240702$20240730$EXP$$JP-ASTELLAS-2024JP004494$ASTELLAS$$$$E$M$Y$$$20240730$$MD$JP$JP
240398731$24039873$1$I$$20240627$20240702$20240702$30DAY$$US-GSK-US2024080327$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
240398741$24039874$1$I$$20240629$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000913$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240702$$CN$US$US
240398751$24039875$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001104$ELI LILLY AND CO$$$$$M$Y$$$20240702$$CN$US$US
240398761$24039876$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000511$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240702$$CN$US$US
240398772$24039877$2$F$20240629$20240807$20240702$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000936$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240816$$CN$US$US
240398781$24039878$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000147$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240702$$CN$US$US
240398791$24039879$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019830$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$US$US
240398801$24039880$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000208$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240702$$CN$US$US
240398811$24039881$1$I$20240601$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000481$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240702$$CN$US$US
240398821$24039882$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019177$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240702$$CN$US$US
240398831$24039883$1$I$$20240625$20240702$20240702$EXP$$NVSC2024US135923$NOVARTIS$$50$YR$$F$Y$$$20240702$$CN$US$US
240398841$24039884$1$I$$20240627$20240702$20240702$EXP$$NVSC2024US135042$NOVARTIS$$$$$M$Y$$$20240702$$MD$US$US
240398851$24039885$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105016$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240702$$HP$US$US
240398861$24039886$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821932$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240398881$24039888$1$I$$20240701$20240702$20240702$PER$$US-BAYER-2024A094970$BAYER$$50$YR$A$F$Y$$$20240702$$MD$US$US
240398891$24039889$1$I$$20240628$20240702$20240702$EXP$$US-JNJFOC-20240677519$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240398901$24039890$1$I$$20240619$20240702$20240702$EXP$$US-SEBELA IRELAND LIMITED-2024SEB00048$SEBELA$Sasidharan S, Ouyang J, Jatoi T, Mallappallil M, Puri I, Agarwal S. Myxedema Coma Triggering BRASH Syndrome. Am. J. Respir. Crit. Care Med.. 2024;209:A1597$56$YR$$F$Y$$$20240702$$HP$US$US
240398911$24039891$1$I$20230101$20240624$20240702$20240702$EXP$$US-JAZZ-2022-US-009157$JAZZ$$$$$F$Y$$$20240702$$HP$US$US
240398921$24039892$1$I$$20230419$20240702$20240702$PER$$US-AMGEN-USASP2023235144$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240398931$24039893$1$I$$20230807$20240702$20240702$PER$$US-AMGEN-USASP2024129917$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240398941$24039894$1$I$$20230825$20240702$20240702$PER$$US-AMGEN-USASP2023235280$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240398951$24039895$1$I$$20240628$20240701$20240701$DIR$FDA-CDER-CTU-2024-46031$$FDA-CTU$$$$$F$N$$$20240628$N$HP$US$
240398961$24039896$1$I$$20240629$20240702$20240702$EXP$$NVSC2024US136523$NOVARTIS$$$$$M$Y$$$20240702$$CN$US$US
240398971$24039897$1$I$20231201$20240627$20240702$20240702$EXP$$US-ABBVIE-5764008$ABBVIE$$45$YR$$F$Y$81$KG$20240702$$CN$US$US
240398981$24039898$1$I$20230201$20240625$20240702$20240702$PER$$US-SA-2024SA191015$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$MD$US$US
240398991$24039899$1$I$20240610$20240701$20240702$20240702$EXP$$SG-HALEON-2184412$Haleon PLC$$40$YR$$F$Y$$$20240702$$HP$SG$SG
240399001$24039900$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46063$$FDA-CTU$$72$YR$$M$N$$$20240701$N$$US$
240399012$24039901$2$F$$20240702$20240702$20240708$EXP$$GB-ASPEN-GLO2024GB004251$ASPEN$$$$$$Y$$$20240708$$CN$GB$GB
240399021$24039902$1$I$20231026$20240701$20240702$20240702$PER$$US-BAYER-2024A094960$BAYER$$36$YR$A$F$Y$$$20240702$$MD$US$US
240399032$24039903$2$F$$20240820$20240702$20240902$EXP$$JP-SMPA-2024SMP009702$SUNOVION$Aratake et al.. A pharmacokinetic study of antipsychotics during pregnancy in a patient with schizophrenia whose psychiatric symptoms worsened due to pregnancy. Psychiatria et Neurologia Japonica. 2024;(??):3-O20-4$$$$$Y$$$20240902$$CN$JP$JP
240399041$24039904$1$I$20240626$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46074$$FDA-CTU$$46$YR$$F$N$$$20240701$Y$PH$US$
240399051$24039905$1$I$$20240624$20240702$20240702$EXP$$US-AMAROX PHARMA-HET2024US02040$HETERO$Hussain M, Tiwana HZ, Sivanandham R, Barsoum A, Bagheri S, Hussain S, Lam J, Adial A.. Aripiprazole-Induced Diabetic Ketoacidosis and Hypertriglyceridemia Triggering Concurrent Pancreatitis: A Case Report. American Thoracic Society. 2024;209:A5680$35$YR$$M$Y$$$20240702$$HP$US$US
240399061$24039906$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105416$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240702$$MD$US$US
240399071$24039907$1$I$20240515$20240626$20240702$20240702$EXP$FR-AFSSAPS-NT2024000680$FR-HALEON-2184110$Haleon PLC$$100$YR$$F$Y$64$KG$20240702$$HP$FR$FR
240399081$24039908$1$I$$20240624$20240702$20240702$EXP$23889794$US-NPI-000035$NIVAGEN PHARMACEUTICALS$$$$$$Y$$$20240627$$CN$US$US
240399091$24039909$1$I$$20230614$20240702$20240702$PER$$US-AMGEN-USASP2023235154$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240399101$24039910$1$I$$20221220$20240702$20240702$PER$$US-AMGEN-USASP2022230353$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240399111$24039911$1$I$$20230503$20240702$20240702$PER$$US-AMGEN-USASP2023235240$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240399121$24039912$1$I$$20240624$20240702$20240702$EXP$$FR-TAKEDA-2024TUS064879$TAKEDA$$40$YR$$M$Y$$$20240702$$CN$FR$FR
240399141$24039914$1$I$$20240628$20240702$20240702$EXP$$US-CHATTEMPRD-2024OHG022640$CHATTEM$$$$$M$Y$$$20240702$$LW$US$US
240399152$24039915$2$F$$20230907$20240702$20240709$PER$$US-AMGEN-USASP2023235042$AMGEN$$$$$$Y$$$20240708$$MD$US$US
240399161$24039916$1$I$$20230717$20240702$20240702$PER$$US-AMGEN-USASP2023235109$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240399183$24039918$3$F$20240701$20240821$20240702$20240827$EXP$$CA-JNJFOC-20240675631$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240827$$HP$CA$CA
240399192$24039919$2$F$$20240729$20240702$20240802$EXP$$JP-AMGEN-JPNSP2024125129$AMGEN$$$$E$$Y$$$20240802$$MD$JP$JP
240399201$24039920$1$I$20080101$20240624$20240702$20240702$EXP$$US-JNJFOC-20240666374$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20240702$$HP$US$US
240399211$24039921$1$I$20240323$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281053549520-RCDFK$GB-ORGANON-O2407GBR000040$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240399221$24039922$1$I$20240323$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281137402150-JMBTC$GB-ORGANON-O2407GBR000018$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240399231$24039923$1$I$$20240419$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05984$HIKMA$Alexander MR, Aday AW, Lewis J, Deyholos CJ, Luther JM.. Alexander MR, Aday AW, Lewis J, Deyholos CJ, Luther JM. Flow Disturbances: Competing Interests in a Case of Hypertensive Emergency.. Hypertension. 2024;81(4):676-681$$$$$Y$$$20240702$$MD$US$US
240399241$24039924$1$I$20240301$20240620$20240702$20240702$EXP$$ES-TAKEDA-2024TUS065217$TAKEDA$$88$YR$$M$Y$$$20240702$$MD$ES$ES
240399251$24039925$1$I$20240616$20240620$20240702$20240702$EXP$$PK-ROCHE-10000010881$ROCHE$$53$YR$A$M$Y$$$20240702$$CN$PK$PK
240399261$24039926$1$I$$20240628$20240702$20240702$PER$$US-BAYER-2024A094954$BAYER$$42$YR$A$F$Y$$$20240702$$HP$US$US
240399271$24039927$1$I$$20240624$20240702$20240702$PER$$US-ABBVIE-5817617$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240399281$24039928$1$I$20231115$20240626$20240702$20240702$EXP$$CH-ASTELLAS-2024US018574$ASTELLAS$$63$YR$$F$Y$$$20240702$$CN$CH$CH
240399291$24039929$1$I$$20240625$20240702$20240702$PER$$US-ROCHE-10000013380$ROCHE$$$$$F$Y$$$20240702$$HP$US$US
240399301$24039930$1$I$20240420$20240701$20240702$20240702$EXP$MT-ADM-03062024$MT-UCBSA-2024033243$UCB$$26$YR$$M$Y$90$KG$20240702$$CN$MT$MT
240399312$24039931$2$F$$20240812$20240702$20240813$PER$$US-ROCHE-10000013637$ROCHE$$34$YR$A$M$Y$$$20240813$$HP$US$US
240399321$24039932$1$I$$20240626$20240702$20240702$PER$$US-ROCHE-10000013339$ROCHE$$$$$$Y$$$20240702$$CN$US$US
240399332$24039933$2$F$20240601$20240718$20240702$20240722$PER$$US-BAYER-2024A092182$BAYER$$$$$F$Y$$$20240722$$CN$US$US
240399342$24039934$2$F$20240605$20240905$20240702$20240913$EXP$$US-TAKEDA-2024TUS024560$TAKEDA$$63$YR$$F$Y$$$20240913$$MD$US$US
240399351$24039935$1$I$$20240625$20240702$20240702$EXP$$CA-CELLTRION INC.-2024CA015441$CELLTRION$$$$$$Y$$$20240702$$HP$CA$CA
240399361$24039936$1$I$20240417$20240624$20240702$20240702$EXP$$JP-009507513-2406JPN003385J$MERCK$$77$YR$$M$Y$48$KG$20240702$$PH$JP$JP
240399371$24039937$1$I$20240618$20240624$20240702$20240702$EXP$$CN-ROCHE-10000008158$ROCHE$$57$YR$A$M$Y$68$KG$20240702$$HP$CN$CN
240399381$24039938$1$I$20240607$20240624$20240702$20240702$EXP$$US-BEH-2024174731$CSL BEHRING$$18$YR$A$M$Y$$$20240702$$HP$US$US
240399391$24039939$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137013$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
240399401$24039940$1$I$$20240624$20240702$20240702$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007731$STRIDES$Cooper J, Patel K, Richardson C.. A Case of Severe Herpes Simplex Virus Pneumonitis.. Am-J-Respir-Crit-Care-Med. 2024;209:A3584$$$$$Y$$$20240702$$HP$US$US
240399411$24039941$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46027$$FDA-CTU$$55$YR$$F$N$$$20240701$N$$US$
240399421$24039942$1$I$$20240627$20240702$20240702$EXP$$CA-TAKEDA-2024TUS065264$TAKEDA$$$$$F$Y$$$20240702$$CN$CA$CA
240399431$24039943$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46056$$FDA-CTU$$59$YR$$M$N$$$20240701$N$$US$
240399441$24039944$1$I$$20240628$20240701$20240701$DIR$FDA-CDER-CTU-2024-46055$$FDA-CTU$$59$YR$$M$N$$$20240628$N$HP$US$
240399451$24039945$1$I$$20240629$20240701$20240701$DIR$FDA-CDER-CTU-2024-46051$$FDA-CTU$$$$$F$N$$$20240629$N$HP$US$
240399461$24039946$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46071$$FDA-CTU$$45$YR$$M$N$$$20240701$N$$US$
240399471$24039947$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46030$$FDA-CTU$$32$YR$$F$N$$$20240701$N$$US$
240399481$24039948$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46080$$FDA-CTU$$42$YR$$F$N$$$20240701$N$$US$
240399491$24039949$1$I$20240625$20240629$20240701$20240701$DIR$FDA-CDER-CTU-2024-46059$$FDA-CTU$$38$YR$$M$N$$$20240629$N$HP$US$
240399501$24039950$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46062$$FDA-CTU$$61$YR$$F$N$$$20240701$N$$US$
240399511$24039951$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46033$$FDA-CTU$$67$YR$$F$N$$$20240701$N$$US$
240399521$24039952$1$I$$20240619$20240702$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05551$LUPIN$$$$$$Y$$$20240702$$CN$US$US
240399531$24039953$1$I$$20240624$20240702$20240702$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007692$STRIDES$Pimentel MA, Kim DH, Walker LW, Noelck MB, Perelygina L, Kripps KA, et al.. Rubella virus-associated necrotizing granulomatous inflammation with extensive eyelid, ocular, and orbital involvement.. Pediatr-Dermatol. 2023;40:1107-1111$$$$$Y$$$20240702$$MD$US$US
240399561$24039956$1$I$20240626$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128199$AMGEN$$66$YR$E$F$Y$$$20240702$$CN$US$US
240399571$24039957$1$I$$20230814$20240702$20240702$PER$$US-AMGEN-USASP2023235238$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240399591$24039959$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46029$$FDA-CTU$$74$YR$$F$N$81.65$KG$20240701$N$$US$
240399601$24039960$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46053$$FDA-CTU$$66$YR$$F$N$$$20240701$N$HP$US$
240399612$24039961$2$F$20240628$20240813$20240702$20240814$PER$$US-AMGEN-USASP2024129227$AMGEN$$70$YR$E$F$Y$$$20240814$$HP$US$US
240399621$24039962$1$I$$20240619$20240702$20240702$EXP$$CA-APOTEX-2024AP007546$APOTEX$$89$YR$$M$Y$91$KG$20240702$$PH$CA$CA
240399631$24039963$1$I$$20240627$20240702$20240702$EXP$$GB-GILEAD-2024-0678765$GILEAD$$$$A$$Y$$$20240702$$HP$GB$GB
240399651$24039965$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821856$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240399661$24039966$1$I$$20240617$20240702$20240702$EXP$$US-PROCTER+GAMBLE-PH24005153$PROCTER AND GAMBLE$Sasidharan S., Jatoi T., Milla C., Mallappallil M., Agarwal S., Puri I.. Triple Whammy of Amlodipine, Carvedilol and Diphenhydramine Overdose. Am J Respir Crit Care Med. 2024;209:A5669$27$YR$$F$Y$$$20240702$$HP$US$US
240399672$24039967$2$F$$20240701$20240702$20240707$EXP$$NVSC2024FR135182$NOVARTIS$$49$YR$$F$Y$$$20240708$$MD$FR$FR
240399681$24039968$1$I$20240323$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281136243400-GYCWK$GB-ORGANON-O2406GBR002766$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240399691$24039969$1$I$20240618$20240621$20240702$20240702$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024078061$VIIV$$36$YR$$M$Y$$$20240702$$HP$US$US
240399711$24039971$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821861$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240399722$24039972$2$F$$20240716$20240702$20240723$PER$$US-AstraZeneca-2024A146050$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
240399731$24039973$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821797$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240399742$24039974$2$F$$20240704$20240702$20240709$EXP$$GB-MYLANLABS-2024M1060860$MYLAN$$$$$M$Y$$$20240709$$HP$GB$GB
240399751$24039975$1$I$$20240626$20240702$20240702$EXP$$US-MYLANLABS-2024M1061711$MYLAN$$$$$M$Y$$$20240702$$CN$US$US
240399761$24039976$1$I$$20231111$20240702$20240702$PER$$US-AMGEN-USASP2023235212$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240399771$24039977$1$I$$20240624$20240702$20240702$PER$$US-AMGEN-USASP2024128217$AMGEN$Shakir M.; Zaidi S. H.; Basit S. A. et al.. Blood and Crescents With Atypical Anti Neutrophil Cytoplasmic Antibody: An Unusual Presentation of Pulmonary Renal Syndrome. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A5336-A5336$60$YR$A$F$Y$$$20240702$$HP$US$US
240399781$24039978$1$I$$20240303$20240702$20240702$PER$$US-AMGEN-USASP2024129761$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240399791$24039979$1$I$$20240621$20240702$20240702$EXP$$CA-AMGEN-CANSP2024125456$AMGEN$$$$$$Y$$$20240702$$MD$CA$CA
240399801$24039980$1$I$$20230901$20240702$20240702$PER$$US-AMGEN-USASP2023235102$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240399812$24039981$2$F$20240501$20240822$20240702$20240830$EXP$$US-ABBVIE-5780563$ABBVIE$$48$YR$$M$Y$$$20240828$$CN$US$US
240399822$24039982$2$F$$20240625$20240702$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05780$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240399831$24039983$1$I$20240612$20240621$20240702$20240702$EXP$FR-AFSSAPS-NT2024000735$FR-Accord-432047$ACCORD$$43$YR$A$M$Y$$$20240702$$MD$FR$FR
240399841$24039984$1$I$20240519$20240621$20240702$20240702$EXP$GB-MHRA-MED-202406211630171300-RVHCP$GB-Accord-432175$ACCORD$$36$YR$A$F$Y$$$20240702$$CN$GB$GB
240399851$24039985$1$I$20230101$20240621$20240702$20240702$EXP$$CH-Accord-432364$ACCORD$Eberle C, Schob T, Schoenborn V, Hofer Strebel S, Cusini A. Challenging diagnosis and treatment: A case report of a patient with chronic Q-fever. Swiss Medical Weekly. 2024;154(Supplement 276):107S. DOI:10.57187/s.3896.$68$YR$E$M$Y$$$20240702$$MD$CH$CH
240399861$24039986$1$I$20170101$20240620$20240702$20240702$EXP$$CN-Accord-432763$ACCORD$Fan TY, Yan Y, Lu Q, Li J, Chen H. Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report. Transplant Proc. 2024 Jun 14:S0041-1345(24)00283-5.$57$YR$A$F$Y$$$20240702$$HP$CN$CN
240399872$24039987$2$F$20191101$20240705$20240702$20240715$EXP$$IT-Accord-432564$ACCORD$Rivoli G, Bartalucci G, Laurino M, Coviello E, Beltrami G, Coniglio ML, et al. POLIGENIC PREDISPOSITION TO LATE ONSET SEVERE HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH MDS. Haematologica 2021; 106 (Suppl. 3) 174 abstr. D149.$64$YR$A$M$Y$$$20240715$$MD$IT$IT
240399881$24039988$1$I$20240607$20240621$20240702$20240702$EXP$FR-AFSSAPS-MP2024001041$FR-Accord-432327$ACCORD$$82$YR$E$M$Y$85$KG$20240702$$PH$FR$FR
240399891$24039989$1$I$20240301$20240622$20240702$20240702$EXP$DE-BFARM-24004450$DE-Accord-432631$ACCORD$$72$YR$E$F$Y$54$KG$20240702$$MD$DE$DE
240399901$24039990$1$I$20230101$20240621$20240702$20240702$EXP$$CZ-Accord-429429$ACCORD$Skopal D, Belada D. Treatment of 1st line nodal TFH lymphoma, angioimmunoblastic subtype. FARMAKOTERAPIE. 2024;(Supplementum 6 - Ext 1/2):15-16.$60$YR$A$F$Y$$$20240702$$MD$CZ$CZ
240399911$24039991$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432130$ACCORD$Tajfiroozeh D, Silva R, Otsuka KN, Wai A. A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2289. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2289.$15$YR$T$M$Y$$$20240702$$MD$US$US
240399921$24039992$1$I$20240501$20240622$20240702$20240702$EXP$FR-AFSSAPS-PV2024000566$FR-Accord-432516$ACCORD$$63$YR$A$F$Y$87$KG$20240702$$MD$FR$FR
240399931$24039993$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432127$ACCORD$Ravi S, Ravi SN, Ballam Nagaraj N, Upadhyay H. Acute Respiratory Compromise in the Context of COVID-19 and Gemcitabine. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5539. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5539.$48$YR$A$F$Y$$$20240702$$MD$US$US
240399941$24039994$1$I$$20240620$20240702$20240702$EXP$AU-TGA-802913$AU-Accord-431488$ACCORD$$$$$M$Y$$$20240702$$CN$AU$AU
240399951$24039995$1$I$$20240626$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406018493$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240702$$CN$US$US
240399962$24039996$2$F$$20240628$20240702$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407000746$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240704$$CN$US$US
240399971$24039997$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000124$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240702$$CN$US$US
240399981$24039998$1$I$20240628$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000466$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240702$$CN$US$US
240399991$24039999$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000085$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240702$$CN$US$US
240400002$24040000$2$F$$20240626$20240702$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202406019151$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240704$$CN$US$US
240400012$24040001$2$F$$20240705$20240702$20240706$PER$$US-BAYER-2024A093517$BAYER$$32$YR$A$F$Y$$$20240706$$HP$US$US
240400021$24040002$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031897$AUROBINDO$Hawco C, Nguyen A, Hernandez L, Pendlebury D, Sakr L.. Delayed Diagnosis of Hemophagocytic Lymphohistiocytosis Leading to Multiorgan System Failure. Am-J-Respir-Crit-Care-Med. 2024;209:abstr. A3536$50$YR$$M$Y$$$20240702$$HP$US$US
240400032$24040003$2$F$$20240710$20240702$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-104546$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240718$$PH$JP$JP
240400041$24040004$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104580$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240702$$HP$US$US
240400051$24040005$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104646$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240702$$HP$US$US
240400061$24040006$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104979$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240702$$CN$US$US
240400072$24040007$2$F$20240612$20240801$20240702$20240828$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000389$BECTON DICKINSON$$$$$$Y$$$20240828$$CN$GB$GB
240400081$24040008$1$I$$20240625$20240702$20240702$EXP$$US-GSK-US2024079153$GLAXOSMITHKLINE$$$$$M$Y$$$20240702$$HP$US$US
240400091$24040009$1$I$$20240624$20240702$20240702$EXP$$PT-AUROBINDO-AUR-APL-2024-031657$AUROBINDO$Lu J.. Rescue of immediate post-transcarotid artery revascularization carotid stent thrombosis due to clopidogrel resistance using flow-reversal and aspiration thrombectomy.. Journal of Vascular Surgery Cases, Innovations and Techniques. 2023;9(2):1-5$84$YR$$M$Y$$$20240702$$MD$PT$US
240400102$24040010$2$F$20240612$20240801$20240702$20240828$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000390$BECTON DICKINSON$$$$$$Y$$$20240828$$CN$GB$GB
240400111$24040011$1$I$20231211$20240625$20240702$20240702$EXP$$CA-GSK-CA2023AMR076062$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$CA$CA
240400122$24040012$2$F$20240612$20240801$20240702$20240828$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000391$BECTON DICKINSON$$$$$$Y$$$20240828$$CN$GB$GB
240400131$24040013$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA190796$SANOFI AVENTIS$$$$$$Y$$$20240702$$PH$US$US
240400141$24040014$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-032255$AUROBINDO$$28$YR$$M$Y$$$20240702$$PH$US$US
240400151$24040015$1$I$20240621$20240625$20240702$20240702$PER$$US-BAYER-2024A092668$BAYER$$$$$F$Y$$$20240702$$MD$US$US
240400161$24040016$1$I$20240401$20240620$20240702$20240702$PER$$US-SA-2024SA188345$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240702$$MD$US$US
240400171$24040017$1$I$$20240621$20240702$20240702$EXP$$CH-Accord-432365$ACCORD$Ballmer A, Loretz L, Henzen C, Ulmer T, Van Veelen N. Small tablet, large effect: Statin-induced rhabdomyolysis. Swiss Medical Weekly. 2024;154(Supplement 276):40S$48$YR$A$M$Y$$$20240702$$MD$CH$CH
240400182$24040018$2$F$20191008$20240903$20240702$20240909$EXP$$JP-GILEAD-2020-0475382$GILEAD$$40$YR$A$M$Y$$$20240909$$MD$JP$JP
240400191$24040019$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031776$AUROBINDO$Vagedes R, Nurse D, Latifi M. Lazarus Response^ Upon Initiation of Targeted Oncogenic Therapy for Acute Respiratory Failure in Rapidly Progressive ALK-Positive Pulmonary Adenocarcinoma. AmJ-Respir-Crit-Care-Med. 2024;209:A6571$53$YR$$F$Y$$$20240702$$HP$US$US
240400201$24040020$1$I$$20240626$20240702$20240702$EXP$$US-MYLANLABS-2024M1061595$MYLAN$Malik H, Hong J, Tomcho JC, Iturrizaga JC. Challenges in managing ACS in a patient with AML. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 4382.$65$YR$$M$Y$$$20240702$$HP$US$US
240400213$24040021$3$F$20240621$20240916$20240702$20240918$PER$$US-SA-2024SA189072$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240918$$HP$US$US
240400223$24040022$3$F$20240601$20240710$20240702$20240718$PER$$US-SA-2024SA189754$SANOFI AVENTIS$$47$YR$A$M$Y$88.4$KG$20240718$$MD$US$US
240400231$24040023$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031424$AUROBINDO$Pham LL, Landeen C.. New Onset Refractory Status Epilepticus in Prion Disease. Am-J-RespirCrit-Care-Med. 2024;209:A5614$60$YR$$F$Y$$$20240702$$HP$US$US
240400241$24040024$1$I$20240501$20240627$20240702$20240702$PER$$US-SA-2024SA192658$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240702$$CN$US$US
240400251$24040025$1$I$$20240618$20240702$20240702$PER$$US-ABBVIE-5819520$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240400261$24040026$1$I$20240624$20240625$20240702$20240702$PER$$US-BAYER-2024A092830$BAYER$$43$YR$A$F$Y$$$20240702$$HP$US$US
240400271$24040027$1$I$20240101$20240625$20240702$20240702$EXP$MY-UCBSA-2024033371$MY-UCBSA-2024033371$UCB$$18$YR$$M$Y$$$20240702$$PH$MY$MY
240400281$24040028$1$I$$20240625$20240702$20240702$EXP$$US-AMGEN-USASP2024125582$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240400291$24040029$1$I$20240621$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128250$AMGEN$$73$YR$E$M$Y$$$20240702$$CN$US$US
240400302$24040030$2$F$$20240702$20240702$20240703$PER$$US-HALEON-2184831$Haleon PLC$$56$YR$$F$Y$$$20240703$$CN$US$US
240400311$24040031$1$I$$20240624$20240702$20240702$EXP$$JP-AMGEN-JPNSP2024128796$AMGEN$Fujii S,; Osawa T.; Hirate T. et al.. Establishment of Blinatumomab Home Administration Transition Program Using CADD-Legacyg Pump. JPN J Cancer Chemother. 2024;51 (5):535-539$8$YR$C$M$Y$28.2$KG$20240702$$HP$JP$JP
240400321$24040032$1$I$$20240617$20240702$20240702$EXP$$US-ENDO USA, INC.-2024-002713$ENDO$$$$$F$Y$$$20240702$$CN$US$US
240400331$24040033$1$I$$20230811$20240702$20240702$PER$$US-AMGEN-USASP2023235202$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240400341$24040034$1$I$$20230720$20240702$20240702$PER$$US-AMGEN-USASP2023235283$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240400351$24040035$1$I$$20240628$20240702$20240702$PER$$NVSC2024US136878$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240400371$24040037$1$I$$20240630$20240701$20240701$DIR$FDA-CDER-CTU-2024-46075$$FDA-CTU$$$$$F$N$$$20240630$N$HP$US$
240400383$24040038$3$F$$20240808$20240702$20240813$EXP$$CA-APOTEX-2024AP006928$APOTEX$$$$T$F$Y$$$20240813$$MD$CA$CA
240400401$24040040$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46026$$FDA-CTU$$56$YR$$F$N$$$20240701$N$$US$
240400411$24040041$1$I$20240513$20240622$20240702$20240702$EXP$FR-AFSSAPS-MA2024001032$FR-Accord-432172$ACCORD$$12$YR$T$M$Y$$$20240702$$MD$FR$FR
240400421$24040042$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432143$ACCORD$Raymond-Forde S, Raymond-Forde S, Godfrey AM, Alexander KR. The Gift of a Heart, With Strings Attached: A Case of Strongyloides Stercoralis Hyperinfection Syndrome With Fulminant Respiratory Failure. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1134$43$YR$A$F$Y$$$20240702$$MD$US$US
240400431$24040043$1$I$20231101$20240622$20240702$20240702$EXP$FR-AFSSAPS-PB2024000675$FR-Accord-432520$ACCORD$$58$YR$A$F$Y$78$KG$20240702$$PH$FR$FR
240400441$24040044$1$I$20240522$20240621$20240702$20240702$EXP$FR-AFSSAPS-NC2024000730$FR-Accord-432355$ACCORD$$77$YR$E$M$Y$94$KG$20240702$$PH$FR$FR
240400451$24040045$1$I$$20240626$20240702$20240702$EXP$$CO-TAKEDA-2024TUS064461$TAKEDA$$$$$F$Y$60$KG$20240702$$HP$CO$CO
240400461$24040046$1$I$20240301$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453658$RANBAXY$$83$YR$$M$Y$67$KG$20240702$$PH$FR$FR
240400471$24040047$1$I$20231128$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454178$RANBAXY$$57$YR$$F$Y$$$20240702$$PH$FR$FR
240400481$24040048$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-032067$AUROBINDO$$64$YR$$F$Y$$$20240702$$HP$US$US
240400492$24040049$2$F$$20240628$20240702$20240712$EXP$$SI-TAKEDA-2024TUS065368$TAKEDA$$57$YR$$M$Y$$$20240712$$CN$SI$SI
240400502$24040050$2$F$$20240625$20240702$20240710$PER$$US-EMD Serono-2024034786$EMD SERONO INC$$30$YR$A$F$Y$$$20240710$$CN$US$US
240400511$24040051$1$I$$20240625$20240702$20240702$EXP$$FR-MYLANLABS-2024M1061409$MYLAN$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$38$YR$$M$Y$$$20240702$$HP$FR$FR
240400521$24040052$1$I$$20240625$20240702$20240702$EXP$$FR-MYLANLABS-2024M1061486$MYLAN$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$44$YR$$M$Y$$$20240702$$HP$FR$FR
240400531$24040053$1$I$20230201$20230223$20240702$20240702$EXP$$US-RECORDATI-2023001056$RECORDATI$$$$$$Y$$$20240702$$CN$US$US
240400541$24040054$1$I$$20240625$20240702$20240702$EXP$$FR-MYLANLABS-2024M1061452$MYLAN$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$55$YR$$M$Y$$$20240702$$HP$FR$FR
240400551$24040055$1$I$$20240622$20240702$20240702$EXP$$EC-ROCHE-10000007748$ROCHE$$$$$$Y$$$20240702$$CN$EC$EC
240400563$24040056$3$F$$20240805$20240702$20240807$30DAY$$IT-JNJFOC-20240678704$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$IT$IT
240400571$24040057$1$I$20240628$20240701$20240702$20240702$PER$$US-JNJFOC-20240702795$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240702$$CN$US$US
240400582$24040058$2$F$20240110$20240710$20240702$20240723$EXP$$ES-AUROBINDO-AUR-APL-2024-031443$AUROBINDO$$64$YR$$F$Y$100$KG$20240719$$MD$ES$ES
240400591$24040059$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031666$AUROBINDO$Ji SH, Imtiaz A, Sanekommu H, Clemetson E, Lipschutz J, Marlys M, et al.. Case Report of Fatal Skin Sparing Laryngeal Zoster in Post-acute COVID-19 Syndrome. Am-J-Respir-Crit-Care-Med. 2024;209:A3565$87$YR$$F$Y$$$20240702$$HP$US$US
240400601$24040060$1$I$$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024129384$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240400611$24040061$1$I$$20240627$20240702$20240702$EXP$$US-AMGEN-USASP2024128088$AMGEN$Short N.J.; Jabbour E.; Nasr L.F. et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$$$Y$$$20240702$$HP$US$US
240400621$24040062$1$I$$20240701$20240702$20240702$EXP$$NVSC2024US136513$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240400641$24040064$1$I$20240624$20240625$20240702$20240702$PER$$US-ABBVIE-5817935$ABBVIE$$70$YR$$M$Y$$$20240702$$CN$US$US
240400651$24040065$1$I$$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A148733$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240400661$24040066$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031778$AUROBINDO$Mavroudis CD, O^Connor MJ, Wittlieb-Weber C, Edelson JB, Edwards JJ, Berger JH, et al. Hybrid stage 1 palliation with simultaneous off-pump ventricular assist device Initial experience. Initial experience.  placement in neonates with high-risk single ventricle anatomy. JTCVS-Tech. 2024;24:164-168$5$DY$$M$Y$2.7$KG$20240702$$MD$US$US
240400671$24040067$1$I$$20231025$20240702$20240702$PER$$US-AMGEN-USASP2023235215$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240400701$24040070$1$I$$20240622$20240702$20240702$EXP$$EC-ROCHE-10000007747$ROCHE$$$$$$Y$$$20240702$$CN$EC$EC
240400713$24040071$3$F$20240620$20240716$20240702$20240723$PER$$US-ALXN-202406USA001598US$ALEXION PHARMACEUTICALS$$55$YR$$F$Y$$$20240723$$CN$US$US
240400722$24040072$2$F$20221103$20240702$20240702$20240708$EXP$$CN-TAKEDA-2024TUS065626$TAKEDA$$58$YR$$M$Y$$$20240708$$HP$CN$CN
240400731$24040073$1$I$$20240625$20240702$20240702$EXP$$US-MYLANLABS-2024M1061026$MYLAN$Shapoo N, Poor A, Trenard N. Lost in the Mix: A Challenging Diagnosis of Myxedema Coma in an Elderly Patient. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A3392.$86$YR$$M$Y$$$20240702$$HP$US$US
240400741$24040074$1$I$$20240625$20240702$20240702$EXP$$US-MYLANLABS-2024M1061030$MYLAN$Singh KB, Kumar S, Almalouf P. From the Sea to the ICU: The Unexpected Journey of Vibrio Vulnificus Compartment Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209.$59$YR$$M$Y$$$20240702$$HP$US$US
240400752$24040075$2$F$20240615$20240729$20240702$20240809$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000217$THERATECHNOLOGIES$$$$$$Y$$$20240809$$CN$US$US
240400761$24040076$1$I$$20240625$20240702$20240702$EXP$$US-MYLANLABS-2024M1060982$MYLAN$Pattupara A, Nguyen D, Gaikwad M, Gnirke M, Yarra S, Su M, et al. Breaking the Spell: A Rare Case of Prolonged Benzodiazepine Elimination. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A5703.$67$YR$$M$Y$$$20240702$$HP$US$US
240400772$24040077$2$F$$20240625$20240702$20240708$EXP$$US-MYLANLABS-2024M1061459$MYLAN$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series. Pediatr-Nephrol 2024; 0 (0).$15$YR$$M$Y$$$20240708$$HP$US$US
240400783$24040078$3$F$$20240906$20240702$20240906$EXP$$NVSC2024AT136493$NOVARTIS$$26$YR$$F$Y$$$20240906$$MD$AT$AT
240400792$24040079$2$F$$20240704$20240702$20240712$EXP$$US-TEVA-VS-3214630$TEVA$El-Atoum M, Hargarten JC, Park Y-D, Ssebambulidde K, Ding L, Chittiboina P, et al. Persistent neurological symptoms and elevated intracranial pressures in a previously healthy host with cryptococcal meningitis. BMC-Infect-Dis 2023; 23 (1): no pagination.; El-Atoum M, Hargarten JC, Park Y-D, Ssebambulidde K, Ding L, Chittiboina P, et al. Persistent neurological symptoms and elevated intracranial pressures in a previously healthy host with cryptococcal meningitis. BMC-Infect-Dis 2023; 23 (1): n...$55$YR$$M$Y$$$20240712$$HP$US$US
240400801$24040080$1$I$$20240701$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105034$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240702$$MD$US$US
240400811$24040081$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104773$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240702$$HP$US$US
240400821$24040082$1$I$20240508$20240702$20240702$20240702$DIR$708835$$FDA-CTU$$24$YR$$M$N$121.05$KG$20240702$N$CN$US$
240400832$24040083$2$F$$20240626$20240702$20240711$PER$$US-ROCHE-10000014194$ROCHE$$25$YR$A$F$Y$$$20240711$$HP$US$US
240400841$24040084$1$I$$20240626$20240702$20240702$EXP$$AU-JNJFOC-20240677101$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$AU$AU
240400851$24040085$1$I$$20240627$20240702$20240702$EXP$$ES-JNJFOC-20240549990$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$PH$ES$ES
240400861$24040086$1$I$20180101$20240624$20240702$20240702$EXP$$NL-AUROBINDO-AUR-APL-2024-031605$AUROBINDO$van Weringh G, van Koolwijk L, Haan LD, Touw DJ, de Koning MB. Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/norclozapine ratio after switching valproic acid to carbamazepine: a case report. Therap-Adv-Psychopharmacol. 2024;14:1-8$39$YR$$M$Y$65.9$KG$20240702$$HP$NL$NL
240400891$24040089$1$I$20240518$20240621$20240701$20240701$DIR$FDA-CDER-CTU-2024-46061$$FDA-CTU$$64$YR$$F$N$$$20240621$N$HP$US$
240400901$24040090$1$I$20210101$20240625$20240702$20240702$PER$$US-SA-2024SA193740$SANOFI AVENTIS$$48$YR$A$M$Y$68$KG$20240702$$MD$US$US
240400911$24040091$1$I$20240101$20240625$20240702$20240702$PER$$US-SA-2024SA190929$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240702$$CN$US$US
240400921$24040092$1$I$$20240626$20240701$20240701$DIR$FDA-CDER-CTU-2024-46050$$FDA-CTU$$$$$F$N$$$20240626$N$HP$US$
240400931$24040093$1$I$$20240627$20240701$20240701$DIR$FDA-CDER-CTU-2024-46066$$FDA-CTU$$$$$M$N$$$20240627$N$HP$US$
240400941$24040094$1$I$$20240621$20240701$20240701$DIR$FDA-CDER-CTU-2024-46039$$FDA-CTU$$$$$F$N$$$20240621$N$HP$US$
240400951$24040095$1$I$20240601$20240625$20240702$20240702$EXP$$GB-MYLANLABS-2024M1052222$MYLAN$$$$$M$Y$$$20240702$$PH$GB$GB
240400961$24040096$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46047$$FDA-CTU$$$$$F$N$$$20240701$N$HP$US$
240400971$24040097$1$I$20240513$20240625$20240702$20240702$EXP$FR-AFSSAPS-AVPA2024000584$FR-MYLANLABS-2024M1057941$MYLAN$$14$YR$$M$Y$$$20240702$$MD$FR$FR
240400981$24040098$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432122$ACCORD$Shivarajpur A, Valentin R. Intramuscular Progesterone: A Cause of Acute Eosinophilic Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 2024:209:A2002.$35$YR$A$F$Y$$$20240702$$MD$US$US
240400991$24040099$1$I$20240613$20240622$20240702$20240702$EXP$IT-MINISAL02-991854$IT-Accord-432642$ACCORD$$57$YR$A$F$Y$$$20240702$$PH$IT$IT
240401001$24040100$1$I$20240527$20240621$20240702$20240702$EXP$FR-AFSSAPS-LM2024000348$FR-Accord-432041$ACCORD$$65$YR$E$M$Y$71.5$KG$20240702$$PH$FR$FR
240401011$24040101$1$I$$20240620$20240702$20240702$EXP$$BD-Accord-432353$ACCORD$Bari A, Begum NAS, Nobi F, Rashid HU, Akhter N, Islam S. Varicella zoster virus and cytomegalovirus coinfection in a live related kidney transplant recipient: A case report. Clin Case Rep. 2024 Jun 16;12(6):e9089.$32$YR$A$F$Y$$$20240702$$HP$BD$BD
240401021$24040102$1$I$$20230920$20240702$20240702$PER$$US-AMGEN-USASP2023235307$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240401031$24040103$1$I$$20230706$20240702$20240702$PER$$US-AMGEN-USASP2023235389$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240401041$24040104$1$I$20240628$20240628$20240702$20240702$PER$$US-AMGEN-USASP2024129312$AMGEN$$65$YR$E$F$Y$$$20240702$$CN$US$US
240401051$24040105$1$I$$20231024$20240702$20240702$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66527$HIKMA$$23$YR$$F$Y$$$20240701$$MD$US$US
240401061$24040106$1$I$20210912$20231013$20240702$20240702$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66113$HIKMA$$$$$$Y$$$20240701$$MD$US$US
240401071$24040107$1$I$$20231219$20240702$20240702$PER$$US-HIKMA PHARMACEUTICALS-US-H14001-23-68626$HIKMA$$54$YR$$M$Y$$$20240701$$MD$US$US
240401081$24040108$1$I$20240301$20240626$20240702$20240702$EXP$IT-MINISAL02-991753$IT-BIOGEN-2024BI01271642$BIOGEN$$62$YR$$M$Y$74$KG$20240702$$MD$IT$IT
240401092$24040109$2$F$20240101$20240918$20240702$20240924$EXP$$US-ABBVIE-5821713$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
240401101$24040110$1$I$$20240321$20240702$20240702$PER$$US-HIKMA PHARMACEUTICALS-US-H14001-24-02737$HIKMA$$$$$$Y$$$20240701$$MD$US$US
240401111$24040111$1$I$20240420$20240426$20240702$20240702$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03636$HIKMA$$$$$$Y$$$20240701$$HP$US$US
240401121$24040112$1$I$20240623$20240624$20240702$20240702$EXP$$US-BAYER-2024A091274$BAYER$$20$YR$A$M$Y$$$20240702$$CN$US$US
240401131$24040113$1$I$20240621$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024130014$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240401141$24040114$1$I$$20240214$20240702$20240702$PER$$US-AMGEN-USASP2024130002$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240401151$24040115$1$I$20240626$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024128632$AMGEN$$61$YR$A$F$Y$$$20240702$$CN$US$US
240401162$24040116$2$F$20240601$20240826$20240702$20240829$EXP$$AU-AMERICAN REGENT INC-2024002476$AMERICAN REGENT$$15$YR$$M$Y$$$20240829$$HP$AU$AU
240401174$24040117$4$F$$20240905$20240702$20240909$PER$$US-ROCHE-10000010181$ROCHE$$$$A$F$Y$45.36$KG$20240909$$CN$US$US
240401181$24040118$1$I$$20240621$20240702$20240702$EXP$$US-ASTELLAS-2024EU006344$ASTELLAS$Pearson BG, Walker DH, Lea AS, Khalife W, Kislingbury KK, Lick SD, et al.. Early, rapidly progressive vasculopathy in a transplanted heart: A possible complication of COVID-19. Cardiovascular Pathology. 2024;72:1-6$45$YR$$M$Y$$$20240702$$HP$US$US
240401191$24040119$1$I$$20240626$20240702$20240702$PER$$NVSC2024US135368$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240401201$24040120$1$I$$20240626$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102719$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240702$$CN$US$US
240401211$24040121$1$I$20240419$20240621$20240702$20240702$EXP$$FR-ASTELLAS-2024US018629$ASTELLAS$$67$YR$$M$Y$$$20240702$$CN$NL$FR
240401221$24040122$1$I$$20240627$20240702$20240702$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-13149$IPSEN$$$$$M$Y$$$20240702$$CN$GB$GB
240401231$24040123$1$I$$20240628$20240702$20240702$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024EME081424$VIIV$$$$$$Y$$$20240702$$HP$GB$GB
240401241$24040124$1$I$20240329$20240625$20240702$20240702$EXP$FR-AFSSAPS-NC2024000679$FR-MYLANLABS-2024M1058142$MYLAN$$69$YR$$M$Y$$$20240702$$MD$FR$FR
240401251$24040125$1$I$20240602$20240626$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103818$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$71.22$KG$20240702$$PH$US$US
240401262$24040126$2$F$20230901$20240725$20240702$20240726$PER$$US-ROCHE-10000012777$ROCHE$$34$YR$A$M$Y$$$20240726$$CN$US$US
240401272$24040127$2$F$$20240626$20240702$20240704$PER$$US-ROCHE-10000014159$ROCHE$$$$A$F$Y$$$20240704$$CN$US$US
240401281$24040128$1$I$$20240618$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06735$CIPLA$Wang Q, Tang Z, See X, Yang A.. Atypical presentation of pulmonary-renal syndrome (PRS) caused by hydralazine-induced antineutrophil cytoplasmic antibody vasculitis/lupus overlap: A case report. Am J Respir Crit Care Med. 2024;209:A5356$$$$$Y$$$20240702$$HP$US$US
240401301$24040130$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000012534$ROCHE$$56$YR$A$M$Y$$$20240702$$CN$US$US
240401311$24040131$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000013237$ROCHE$$$$A$F$Y$$$20240702$$CN$US$US
240401321$24040132$1$I$$20231220$20240702$20240702$PER$$US-AMGEN-USASP2023235190$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240401331$24040133$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000013355$ROCHE$$$$A$F$Y$$$20240702$$CN$US$US
240401342$24040134$2$F$20230918$20240822$20240702$20240829$EXP$$PT-ASTELLAS-2023US030531$ASTELLAS$$72$YR$E$M$Y$$$20240827$$MD$PT$PT
240401351$24040135$1$I$$20240627$20240702$20240702$EXP$$NVSC2024DE135166$NOVARTIS$$53$YR$$F$Y$$$20240702$$MD$DE$DE
240401361$24040136$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821528$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240401371$24040137$1$I$$20240625$20240702$20240702$EXP$$US-MYLANLABS-2024M1061437$MYLAN$Calderon Barahona GM, Ali R, Ortega Giron C, Ng W, Bobrysheva H, Calderon Martinez E, et al. Beta-Blocked: A Severe Propranolol Overdose Case Report. Am-J-Respir-Crit-Care-Med 2024; 209.$25$YR$$F$Y$$$20240702$$HP$US$US
240401381$24040138$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031768$AUROBINDO$Levan SR, Perez A, Kleinhenz M. Burkholderia Cepacia Mediastinitis in a Patient With Cystic Fibrosis. Am-J-Respir-Crit-Care-Med. 2024;209:A5854$31$YR$$F$Y$$$20240702$$HP$US$US
240401391$24040139$1$I$$20240625$20240702$20240702$EXP$$US-MYLANLABS-2024M1061463$MYLAN$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch-Dermatol-Res 2024; 316 (6):.$63$YR$$F$Y$$$20240702$$HP$US$US
240401401$24040140$1$I$$20240624$20240702$20240702$EXP$$FR-AstraZeneca-2024A150462$ASTRAZENECA$$75$YR$$F$Y$$$20240702$$MD$FR$
240401411$24040141$1$I$$20240626$20240702$20240702$EXP$$US-MYLANLABS-2024M1061826$MYLAN$Vallabhajosyula S, Ukrani H, Wersinger D, Malik H, Obaji A. Fighting the Recovering Heart While Drowning in Volume: Role of VA-V ECMO Configuration in Migrating Mixing Cloud Effect. Am-J-Respir-Crit-Care-Med 2024; 209 A5582.$43$YR$$F$Y$$$20240702$$HP$US$US
240401422$24040142$2$F$20240616$20240730$20240702$20240806$PER$$US-ROCHE-10000007355$ROCHE$$$$$M$Y$$$20240806$$CN$US$US
240401431$24040143$1$I$$20240125$20240702$20240702$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429173$RANBAXY$$$$$$Y$$$20240702$$HP$US$US
240401441$24040144$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821493$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240401462$24040146$2$F$$20240708$20240702$20240711$PER$$US-ROCHE-10000012953$ROCHE$$$$E$M$Y$$$20240711$$CN$US$US
240401471$24040147$1$I$$20240627$20240702$20240702$PER$$US-ABBVIE-5820982$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240401481$24040148$1$I$20240625$20240625$20240702$20240702$EXP$$JP-ASTELLAS-2024JP004387$ASTELLAS$$7$DEC$$M$Y$$$20240702$$MD$JP$JP
240401491$24040149$1$I$$20240626$20240702$20240702$EXP$$GB-JNJFOC-20240675830$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240702$$CN$GB$GB
240401501$24040150$1$I$$20240626$20240702$20240702$EXP$$CA-JNJFOC-20240674865$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240702$$HP$CA$CA
240401511$24040151$1$I$$20240628$20240702$20240702$EXP$$US-GSK-US2024081173$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
240401522$24040152$2$F$$20240704$20240702$20240715$PER$$CA-USP-004881$USPHARMA$$$$$M$Y$$$20240715$$CN$CA$CA
240401531$24040153$1$I$$20240629$20240702$20240702$EXP$$NVSJ2024JP007806$NOVARTIS$$62$YR$$M$Y$$$20240702$$MD$JP$JP
240401541$24040154$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821515$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240401551$24040155$1$I$20240509$20240628$20240702$20240702$EXP$GB-MHRA-MIDB-41044ecb-1347-4981-ac26-69141f820ea3$NVSC2024GB136529$NOVARTIS$$59$YR$$F$Y$$$20240702$$HP$GB$GB
240401561$24040156$1$I$$20240628$20240702$20240702$EXP$$AU-TEVA-VS-3215532$TEVA$$$$$F$Y$$$20240702$$MD$AU$AU
240401573$24040157$3$F$20240621$20240801$20240702$20240803$PER$$US-ROCHE-10000012824$ROCHE$$28$YR$A$F$Y$$$20240803$$CN$US$US
240401581$24040158$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46072$$FDA-CTU$$69$YR$$F$N$$$20240701$N$$US$
240401591$24040159$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46070$$FDA-CTU$$60$YR$$F$N$$$20240701$N$$US$
240401601$24040160$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45962$$FDA-CTU$$58$YR$$M$N$$$20240701$N$$US$
240401611$24040161$1$I$20240626$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46081$$FDA-CTU$$$$$F$N$$$20240701$N$CN$US$
240401651$24040165$1$I$$20231102$20240702$20240702$PER$$US-AMGEN-USASP2023235219$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240401661$24040166$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5818292$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240401671$24040167$1$I$$20240623$20240702$20240702$EXP$$LT-NATCOUSA-2024-NATCOUSA-000214$NATCO PHARMA$Sirvys A, Baranauskas A, Budrys P. A Rare Encounter: Unstable Vasospastic Angina Induced by Thyrotoxicosis. J Clin Med. 2024 May 27;13(11):3130. doi: 10.3390/jcm13113130. PMID: 38892840; PMCID: PMC11172422.$62$YR$$F$Y$$$20240702$$HP$LT$
240401681$24040168$1$I$20240618$20240618$20240702$20240702$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-00129$IPSEN$$73$YR$E$F$Y$$$20240702$$HP$US$US
240401694$24040169$4$F$20240620$20240911$20240702$20240913$PER$$US-ROCHE-10000013148$ROCHE$$82$YR$E$F$Y$$$20240913$$CN$US$US
240401711$24040171$1$I$$20240626$20240702$20240702$PER$$US-PFIZER INC-PV202400084688$PFIZER$$33$YR$$F$Y$$$20240702$$CN$US$US
240401721$24040172$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-202400202814$PFIZER$$$$A$$Y$$$20240702$$MD$US$US
240401732$24040173$2$F$$20240703$20240702$20240708$EXP$$AU-MYLANLABS-2024M1061475$MYLAN$$$$$F$Y$$$20240708$$PH$AU$AU
240401741$24040174$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406280003484410-MPGTC$GB-MYLANLABS-2024M1061402$MYLAN$$$$$F$Y$$$20240702$$CN$GB$GB
240401751$24040175$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5816739$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240401762$24040176$2$F$20220816$20240710$20240702$20240711$EXP$$JP-EMD Serono-2024035480$EMD SERONO INC$$6$DEC$A$F$Y$70$KG$20240711$$MD$JP$JP
240401771$24040177$1$I$$20240623$20240702$20240702$EXP$$US-SERVIER-S24007850$SERVIER$Schwartz M., Gutman J., McMahon M., Amaya M., Pollyea D., Witkowski M. et al.. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. Blood. 2023;142:5898-5900$$$$$Y$$$20240702$$MD$US$US
240401781$24040178$1$I$20240101$20240627$20240702$20240702$EXP$$US-ABBVIE-5821297$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240401791$24040179$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5820937$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240401812$24040181$2$F$20240621$20240626$20240702$20240823$PER$$US-ROCHE-10000011586$ROCHE$$40$YR$A$F$Y$100.7$KG$20240823$$HP$US$US
240401821$24040182$1$I$$20231017$20240702$20240702$PER$$US-AMGEN-USASP2023235309$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240401831$24040183$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05522$LUPIN$Lam E, Santos C, Patrawalla AS. A case of critical Bupropion, olanzapine, and oxcarbazepine overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209$32$YR$$F$Y$$$20240702$$MD$US$US
240401852$24040185$2$F$$20240731$20240702$20240802$30DAY$$JP-JNJFOC-20240674638$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$HP$JP$JP
240401861$24040186$1$I$$20240626$20240702$20240702$EXP$$US-GSK-US2024079693$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$MD$US$US
240401872$24040187$2$F$20240201$20240722$20240702$20240731$30DAY$$US-GSK-US2024081198$GLAXOSMITHKLINE$$28$YR$$F$Y$$$20240731$$MD$US$US
240401881$24040188$1$I$$20240627$20240702$20240702$EXP$$US-JNJFOC-20240674121$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240702$$CN$US$US
240401891$24040189$1$I$$20240701$20240701$20240701$DIR$708672$$FDA-CTU$$$$$UNK$N$$$20240701$N$CN$US$
240401903$24040190$3$F$$20240814$20240702$20240819$EXP$$GB-MYLANLABS-2024M1061213$MYLAN$$44$YR$$F$Y$71$KG$20240819$$HP$GB$GB
240401911$24040191$1$I$20240626$20240627$20240702$20240702$EXP$$GB-MYLANLABS-2024M1061216$MYLAN$$$$$M$Y$$$20240702$$PH$GB$GB
240401921$24040192$1$I$$20240627$20240702$20240702$EXP$$GB-MYLANLABS-2024M1061053$MYLAN$$$$$F$Y$$$20240702$$HP$GB$GB
240401934$24040193$4$F$$20240626$20240702$20240708$EXP$$US-ROCHE-10000013458$ROCHE$$$$$$Y$$$20240708$$MD$US$
240401941$24040194$1$I$20240624$20240701$20240701$20240701$DIR$708695$$FDA-CTU$$67$YR$$M$N$$$20240701$N$$US$
240401951$24040195$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821792$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240401961$24040196$1$I$$20240701$20240702$20240702$PER$$US-BAYER-2024A094959$BAYER$$$$$F$Y$$$20240702$$CN$US$US
240401972$24040197$2$F$$20240718$20240702$20240724$EXP$$US-BEH-2024173645$CSL BEHRING$$$$$M$Y$$$20240724$$MD$US$US
240401981$24040198$1$I$$20221220$20240702$20240702$PER$$US-AMGEN-USASP2022230346$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240401991$24040199$1$I$$20231227$20240702$20240702$PER$$US-AMGEN-USASP2023235092$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240402001$24040200$1$I$$20231202$20240702$20240702$PER$$US-AMGEN-USASP2023235187$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240402011$24040201$1$I$20240501$20240621$20240702$20240702$EXP$GB-MHRA-MED-202406211806513460-WFPTY$GB-SA-2024SA186561$SANOFI AVENTIS$$$$A$$Y$$$20240702$$MD$GB$GB
240402021$24040202$1$I$20240624$20240627$20240702$20240702$EXP$GB-MHRA-MED-202406270853023080-WKPFJ$GB-BIOGEN-2024BI01271701$BIOGEN$$44$YR$$F$Y$$$20240702$$HP$GB$GB
240402041$24040204$1$I$$20240625$20240702$20240702$PER$$US-BIOGEN-2024BI01271160$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
240402051$24040205$1$I$20240416$20240625$20240702$20240702$EXP$$CN-ROCHE-10000009530$ROCHE$$68$YR$E$F$Y$$$20240702$$MD$CN$CN
240402061$24040206$1$I$$20240625$20240702$20240702$PER$$US-BIOGEN-2024BI01271135$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
240402071$24040207$1$I$$20240624$20240702$20240702$PER$$US-TEVA-VS-3214721$TEVA$$$$$$Y$$$20240702$$CN$US$US
240402081$24040208$1$I$$20240627$20240702$20240702$EXP$$CA-ABBVIE-5821259$ABBVIE$$$$A$F$Y$$$20240702$$CN$CA$CA
240402092$24040209$2$F$$20240705$20240702$20240712$EXP$$CO-SA-2024SA190775$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240712$$MD$CO$CO
240402111$24040211$1$I$$20240607$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA049625$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240402121$24040212$1$I$$20240606$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA049608$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240402131$24040213$1$I$20240518$20240607$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA049593$TOLMAR$$87$YR$$M$Y$$$20240702$$CN$CA$CA
240402142$24040214$2$F$$20240702$20240702$20240723$PER$$CA-TOLMAR, INC.-24CA049626$TOLMAR$$$$$M$Y$$$20240723$$CN$CA$CA
240402151$24040215$1$I$$20240607$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA049689$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240402161$24040216$1$I$$20240606$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA049718$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240402171$24040217$1$I$$20240605$20240702$20240702$PER$$US-TOLMAR, INC.-24US049670$TOLMAR$$$$$$Y$$$20240702$$CN$US$US
240402181$24040218$1$I$$20240607$20240702$20240702$PER$$US-TOLMAR, INC.-24US049746$TOLMAR$$$$$$Y$$$20240702$$MD$US$US
240402192$24040219$2$F$$20240628$20240702$20240705$EXP$$US-ABBVIE-5821717$ABBVIE$$56$YR$$M$Y$$$20240705$$CN$US$US
240402203$24040220$3$F$$20240712$20240702$20240813$PER$$US-TOLMAR, INC.-24US049859$TOLMAR$$$$$M$Y$$$20240813$$HP$US$US
240402211$24040221$1$I$20240603$20240605$20240702$20240702$PER$$US-TOLMAR, INC.-24US049935$TOLMAR$$71$YR$$M$Y$$$20240702$$HP$US$US
240402222$24040222$2$F$20240515$20240722$20240702$20240816$PER$$US-TOLMAR, INC.-24US049954$TOLMAR$$64$YR$$M$Y$$$20240816$$PH$US$US
240402231$24040223$1$I$20240530$20240607$20240702$20240702$PER$$US-TOLMAR, INC.-24US049955$TOLMAR$$59$YR$$M$Y$$$20240702$$HP$US$US
240402241$24040224$1$I$20240606$20240622$20240702$20240702$EXP$FR-AFSSAPS-CN2024000564$FR-Accord-432215$ACCORD$$74$YR$E$M$Y$96.5$KG$20240702$$MD$FR$FR
240402251$24040225$1$I$$20240622$20240702$20240702$EXP$AU-TGA-802443$AU-Accord-431836$ACCORD$$$$$$Y$$$20240702$$HP$AU$AU
240402261$24040226$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA188363$SANOFI AVENTIS$$$$A$M$Y$$$20240702$$MD$US$US
240402272$24040227$2$F$20240601$20240731$20240702$20240809$PER$$US-SA-2024SA193284$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240809$$MD$US$US
240402281$24040228$1$I$20240201$20240625$20240702$20240702$PER$$US-SA-2024SA191309$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240702$$MD$US$US
240402292$24040229$2$F$20240604$20240730$20240702$20240808$PER$$US-SA-2024SA194118$SANOFI AVENTIS$$72$YR$E$M$Y$108.84$KG$20240808$$CN$US$US
240402301$24040230$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187906$SANOFI AVENTIS$$$$A$$Y$$$20240702$$HP$US$US
240402311$24040231$1$I$$20240626$20240702$20240702$PER$$US-SA-2024SA192240$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240702$$CN$US$US
240402321$24040232$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA086197$SANOFI AVENTIS$$$$E$M$Y$98.866$KG$20240702$$MD$US$US
240402331$24040233$1$I$20240522$20240627$20240702$20240702$EXP$$IE-SA-2024SA191828$SANOFI AVENTIS$$16$MON$I$M$Y$10$KG$20240702$$MD$IE$IE
240402341$24040234$1$I$$20240628$20240702$20240702$PER$$US-ABBVIE-5822277$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240402351$24040235$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05626$LUPIN$Renzetti M, Potnis K, Vemmou E, Hansen B, Lin D, Yaggi HK. Salty, sweet, and severe: A case of linagliptin-induced severe hyponatremia. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7036$76$YR$$F$Y$$$20240702$$HP$US$US
240402362$24040236$2$F$20240701$20240724$20240702$20240802$30DAY$$US-GSK-US2024073094$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240802$$CN$US$US
240402371$24040237$1$I$$20240626$20240702$20240702$PER$$US-BAYER-2024A092727$BAYER$$$$A$F$Y$$$20240702$$MD$US$US
240402381$24040238$1$I$$20240627$20240702$20240702$EXP$$US-JNJFOC-20240674944$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240702$$PH$US$US
240402391$24040239$1$I$$20240622$20240702$20240702$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024078449$VIIV$$$$$M$Y$$$20240702$$CN$US$US
240402401$24040240$1$I$20240515$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281019467880-WQTRJ$GB-ORGANON-O2407GBR000001$ORGANON$$59$YR$$M$Y$104$KG$20240702$$PH$GB$GB
240402411$24040241$1$I$$20240624$20240702$20240702$EXP$$US-OTSUKA-2024_018057$OTSUKA$Lima R.,Osborne R.,Wermuth M.. Pediatric Brexpiprazole Ingestion Presenting With Prolonged Sedation and Delayed Symptoms. Journal of Medical Toxicology. 2024;20(2):133-134$22$MON$$F$Y$$$20240702$$HP$US$US
240402431$24040243$1$I$20240516$20240625$20240702$20240702$PER$$US-BAYER-2024A092841$BAYER$$40$YR$A$F$Y$$$20240702$$MD$US$US
240402441$24040244$1$I$20240601$20240625$20240702$20240702$EXP$FR-AFSSAPS-PB2024000677$FR-SA-2024SA188292$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240702$$MD$FR$FR
240402451$24040245$1$I$$20240624$20240702$20240702$EXP$$JP-AstraZeneca-2023A262004$ASTRAZENECA$$$$$$Y$$$20240702$$MD$JP$
240402461$24040246$1$I$20240318$20240624$20240702$20240702$EXP$$CA-AstraZeneca-2024A143588$ASTRAZENECA$$22501$DY$$F$Y$$$20240702$$CN$CA$
240402471$24040247$1$I$20240620$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A147361$ASTRAZENECA$$77$YR$$F$Y$$$20240702$$CN$US$
240402481$24040248$1$I$20240615$20240624$20240702$20240702$EXP$$FR-AUROBINDO-AUR-APL-2024-031479$AUROBINDO$$29$YR$$M$Y$$$20240702$$MD$FR$FR
240402492$24040249$2$F$$20240628$20240702$20240712$PER$$US-SA-2024SA194289$SANOFI AVENTIS$$4$YR$C$M$Y$11.294$KG$20240712$$MD$US$US
240402511$24040251$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA188507$SANOFI AVENTIS$$$$A$M$Y$$$20240702$$CN$US$US
240402521$24040252$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432131$ACCORD$Patel K, Halicki J, Dachert S, Mamary A. Large Pericardial Cyst in a Lung Transplant Patient. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1688. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1688$74$YR$E$M$Y$$$20240702$$MD$US$US
240402531$24040253$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432112$ACCORD$Puri C, Khan AA, Sher N. A Case of Emphysematous Gastritis With Septic Shock and Clostridioides Difficile. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1630. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1630$72$YR$E$F$Y$$$20240702$$MD$US$US
240402541$24040254$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432107$ACCORD$lmazan E, Ellaicy O, Carter D, Kaleka K, Faruqi M. Another Case of the Blues, Methylene Blue as Adjunctive Therapy in Calcium-channel Blocker Induced Vasoplegia. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5655. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5655$65$YR$E$F$Y$$$20240702$$MD$US$US
240402551$24040255$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432141$ACCORD$Ayat P, Valdes Bracamontes MD, Khudyakov A, Al Ajam MR. Wherever You Go, Cryptococcus Is There: A Case Series. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6327. DOI:10.1164/ajrcc-conference.2024.209.$73$YR$E$$Y$$$20240702$$MD$US$US
240402561$24040256$1$I$$20240620$20240702$20240702$EXP$$JP-Accord-431959$ACCORD$Kawai F, Watanabe S, Ebihara H, Shimizu N, Oshima S, Okai H, et al. Recurrent reactive hypoglycemia due to clozapine-induced glucose intolerance: A case report. PCN Rep. 2023 Dec 21;2(4):e162. doi: 10.1002/pcn5.162.$50$YR$A$M$Y$76.7$KG$20240702$$MD$JP$JP
240402571$24040257$1$I$$20240620$20240702$20240702$EXP$$US-Accord-432144$ACCORD$Nunez Cuello L, Perozo M, Cedeno H, Shah P. Indomethacin-induced Angioedema: A Rare and Challenging Case. American Journal of Respiratory and Critical Care Medicine. 2024;209.$68$YR$E$M$Y$$$20240702$$MD$US$US
240402581$24040258$1$I$$20240626$20240702$20240702$EXP$$US-PFIZER INC-202400203365$PFIZER$O^halloran, K.. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6(1):10.1093/noajnl/vdae070$53$MON$$F$Y$$$20240702$$MD$US$US
240402591$24040259$1$I$$20240626$20240702$20240702$EXP$$US-PFIZER INC-202400203368$PFIZER$O Halloran, K.. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6(1):10.1093/noajnl/vdae070$65$MON$$F$Y$$$20240702$$MD$US$US
240402601$24040260$1$I$$20240626$20240702$20240702$EXP$$US-PFIZER INC-202400203370$PFIZER$O^Halloran, K.. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6(1):10.1093/noajnl/vdae070$36$MON$$F$Y$$$20240702$$MD$US$US
240402611$24040261$1$I$$20240625$20240702$20240702$EXP$$CA-APOTEX-2024AP007772$APOTEX$$50$YR$$F$Y$$$20240702$$HP$CA$CA
240402621$24040262$1$I$20240418$20240701$20240701$20240701$DIR$708678$$FDA-CTU$$85$YR$$M$N$65.7$KG$20240701$N$HP$US$
240402631$24040263$1$I$20240603$20240626$20240701$20240701$DIR$FDA-CDER-CTU-2024-46034$$FDA-CTU$$71$YR$$F$N$$$20240626$N$HP$US$
240402651$24040265$1$I$20240422$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46064$$FDA-CTU$$65$YR$$F$N$$$20240701$Y$PH$US$
240402661$24040266$1$I$20240605$20240701$20240701$20240701$DIR$708690$$FDA-CTU$$55$YR$$F$N$90$KG$20240701$Y$CN$US$
240402681$24040268$1$I$$20240625$20240702$20240702$PER$$US-BAYER-2024A092872$BAYER$$$$$M$Y$$$20240702$$HP$US$US
240402691$24040269$1$I$$20240625$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000326$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240702$$CN$US$US
240402701$24040270$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001219$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240702$$CN$US$US
240402711$24040271$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000189$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240702$$CN$US$US
240402721$24040272$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000020$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$US$US
240402731$24040273$1$I$20240628$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000971$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240702$$CN$US$US
240402741$24040274$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000283$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240702$$CN$US$US
240402751$24040275$1$I$20240501$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001122$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240702$$CN$US$US
240402761$24040276$1$I$$20230926$20240702$20240702$PER$$US-AMGEN-USASP2023235316$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240402771$24040277$1$I$20240625$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128275$AMGEN$$32$YR$A$F$Y$$$20240702$$PH$US$US
240402781$24040278$1$I$$20231103$20240702$20240702$PER$$US-AMGEN-USASP2023235222$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240402791$24040279$1$I$20220701$20240626$20240702$20240702$EXP$$NVSJ2022JP097448$NOVARTIS$$15$YR$$F$Y$56.7$KG$20240702$$MD$JP$JP
240402801$24040280$1$I$20220201$20240626$20240702$20240702$EXP$$NVSJ2022JP098532$NOVARTIS$$4$YR$$F$Y$19.8$KG$20240702$$MD$JP$JP
240402811$24040281$1$I$20240622$20240624$20240702$20240702$EXP$$JP-009507513-2406JPN003350J$MERCK$$6$DEC$$M$Y$$$20240702$$PH$JP$JP
240402821$24040282$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104622$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240702$$CN$US$US
240402851$24040285$1$I$20240627$20240627$20240702$20240702$EXP$$US-MYLANLABS-2024M1061339$MYLAN$$25$YR$$M$Y$$$20240702$$HP$US$US
240402861$24040286$1$I$20240626$20240627$20240702$20240702$EXP$$US-MYLANLABS-2024M1061306$MYLAN$$73$YR$$F$Y$$$20240702$$HP$US$US
240402871$24040287$1$I$20240625$20240627$20240702$20240702$EXP$$US-MYLANLABS-2024M1061270$MYLAN$$53$YR$$F$Y$$$20240702$$PH$US$US
240402881$24040288$1$I$20240626$20240627$20240702$20240702$EXP$$US-MYLANLABS-2024M1061504$MYLAN$$37$YR$$F$Y$$$20240702$$HP$US$US
240402891$24040289$1$I$20240624$20240627$20240702$20240702$EXP$$US-MYLANLABS-2024M1061343$MYLAN$$25$YR$$F$Y$$$20240702$$HP$US$US
240402901$24040290$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187103$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240702$$HP$US$US
240402912$24040291$2$F$20240901$20240919$20240702$20240930$PER$$US-SA-2024SA187532$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240930$$MD$US$US
240402921$24040292$1$I$20240601$20240620$20240702$20240702$PER$$US-SA-2024SA188208$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240702$$MD$US$US
240402931$24040293$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821820$ABBVIE$$$$$F$Y$$$20240702$$HP$US$US
240402941$24040294$1$I$$20240626$20240702$20240702$PER$$US-ABBVIE-5821866$ABBVIE$$$$$$Y$$$20240702$$HP$US$US
240402951$24040295$1$I$20240601$20240626$20240702$20240702$EXP$$CA-JNJFOC-20240673999$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20240702$$HP$CA$CA
240402967$24040296$7$F$20240501$20240917$20240702$20240923$EXP$$JP-JNJFOC-20240569430$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240923$$HP$JP$JP
240402971$24040297$1$I$$20240621$20240702$20240702$EXP$$US-Accord-432618$ACCORD$$$$$F$Y$$$20240702$$HP$US$US
240402981$24040298$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45971$$FDA-CTU$$74$YR$$M$N$$$20240701$N$$US$
240402991$24040299$1$I$20240606$20240621$20240702$20240702$EXP$PT-INFARMED-F202406-330$PT-Accord-432331$ACCORD$$53$YR$A$F$Y$83$KG$20240702$$HP$PT$PT
240403001$24040300$1$I$20240529$20240620$20240702$20240702$EXP$IT-MINISAL02-991415$IT-Accord-431922$ACCORD$$89$YR$E$F$Y$$$20240702$$PH$IT$IT
240403011$24040301$1$I$20230101$20240622$20240702$20240702$EXP$$CN-Accord-432340$ACCORD$Liu J, Jiang Y, Yuan D, Zhang Z, Liu X, Zhao W et. al Atypical BCR-ABL1 transcript in mixed phenotype acute leukemia with bone marrow necrosis. Mol Carcinog. 2024 Jun 11.$62$YR$A$M$Y$$$20240702$$HP$CN$CN
240403021$24040302$1$I$20240409$20240621$20240702$20240702$EXP$FR-AFSSAPS-LL2024001148$FR-Accord-432401$ACCORD$$77$YR$E$F$Y$47$KG$20240702$$PH$FR$FR
240403031$24040303$1$I$20240210$20240621$20240702$20240702$EXP$FR-AFSSAPS-PA2024001296$FR-Accord-432360$ACCORD$$71$YR$E$M$Y$72$KG$20240702$$PH$FR$FR
240403041$24040304$1$I$20230322$20240621$20240702$20240702$EXP$IT-MINISAL02-985546$IT-Accord-427615$ACCORD$$66$YR$E$M$Y$73$KG$20240702$$PH$IT$IT
240403051$24040305$1$I$20240605$20240621$20240702$20240702$EXP$GB-MHRA-MED-202406212349030260-THQVZ$GB-Accord-432187$ACCORD$$47$YR$A$F$Y$95$KG$20240702$$CN$GB$GB
240403061$24040306$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46040$$FDA-CTU$$55$YR$$M$N$$$20240701$N$HP$US$
240403071$24040307$1$I$20240501$20240621$20240702$20240702$EXP$GB-MHRA-MED-202406211806513460-WFPTY$GB-Accord-432219$ACCORD$$$$$$Y$$$20240702$$MD$GB$GB
240403081$24040308$1$I$$20240626$20240702$20240702$EXP$$US-ABBVIE-5818730$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240403091$24040309$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031589$AUROBINDO$Schultz L, Davis KL, Walkush A, Baggott C, Erickson C, Ramakrishna S, etal. Role of peripheral blood MRD and 18FFDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD. Journal for ImmunoTherapy of Cancer. 2023;11:e004851$$$$F$Y$$$20240702$$MD$US$US
240403101$24040310$1$I$20231014$20240621$20240702$20240702$EXP$GB-MHRA-MED-202406211105419530-SVCRT$GB-Accord-432166$ACCORD$$10$YR$C$F$Y$46$KG$20240702$$HP$GB$GB
240403111$24040311$1$I$20240622$20240630$20240702$20240702$PER$$US-HALEON-2184740$Haleon PLC$$79$YR$$M$Y$$$20240702$$CN$US$US
240403121$24040312$1$I$$20240627$20240702$20240702$PER$$US-SA-2024SA192766$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240702$$CN$US$US
240403131$24040313$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA192792$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240702$$MD$US$US
240403141$24040314$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA188173$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240702$$MD$US$US
240403151$24040315$1$I$$20240627$20240702$20240702$PER$$US-SA-2024SA193455$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240702$$MD$US$US
240403161$24040316$1$I$$20231204$20240702$20240702$PER$$US-AMGEN-USASP2023235131$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240403171$24040317$1$I$$20231113$20240702$20240702$PER$$US-AMGEN-USASP2023235286$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240403181$24040318$1$I$$20231109$20240702$20240702$PER$$US-AMGEN-USASP2023235180$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240403191$24040319$1$I$20240603$20240627$20240701$20240701$DIR$FDA-CDER-CTU-2024-46076$$FDA-CTU$$55$YR$$M$N$$$20240627$N$HP$US$
240403201$24040320$1$I$20240610$20240625$20240702$20240702$PER$$US-BIOGEN-2024BI01271192$BIOGEN$$65$YR$$F$Y$$$20240702$$CN$US$US
240403211$24040321$1$I$$20240625$20240702$20240702$PER$$US-BIOGEN-2024BI01271184$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
240403221$24040322$1$I$20240404$20240701$20240701$20240701$DIR$708747$$FDA-CTU$$62$YR$$M$N$150.75$KG$20240701$Y$CN$US$
240403231$24040323$1$I$$20240617$20240702$20240702$PER$$US-TEVA-VS-3211530$TEVA$$$$$M$Y$$$20240702$$CN$US$US
240403241$24040324$1$I$$20240624$20240702$20240702$EXP$$US-AUROBINDO-AUR-APL-2024-031494$AUROBINDO$Mir MJ, Herndon NE, Wagle Shukla A, Wheeler-Hegland K, McFarland NR.. The Vocal Flutter of Multiple System Atrophy: A Parkinsonian-Type Phenomenon?. Mov-Disord-Clin-Pract. 2024;11(4):403-410$62$YR$$M$Y$$$20240702$$HP$US$US
240403252$24040325$2$F$20220309$20240815$20240702$20240820$EXP$$CA-TAKEDA-2021TUS058479$TAKEDA$$54$YR$$M$Y$$$20240820$$HP$CA$CA
240403261$24040326$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05602$LUPIN$Hua S, Gohil AA. It^s not always the liver: Rifampin-induced lupus pericarditis with tamponade. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5679$63$YR$$M$Y$$$20240702$$HP$US$US
240403271$24040327$1$I$$20240627$20240702$20240702$30DAY$$US-SANDOZ INC.-SDZ2023US011302$SANDOZ$$$$$F$Y$$$20240702$$CN$US$US
240403281$24040328$1$I$20240617$20240618$20240702$20240702$EXP$$CA-ROCHE-10000002488$ROCHE$$69$YR$E$F$Y$$$20240702$$CN$CA$CA
240403291$24040329$1$I$$20240623$20240702$20240702$EXP$$DE-SANDOZ INC.-SDZ2024DE061594$SANDOZ$$$$I$$Y$$$20240702$$HP$DE$DE
240403311$24040331$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46054$$FDA-CTU$$80$YR$$M$N$$$20240701$N$$US$
240403321$24040332$1$I$$20240626$20240702$20240702$EXP$$CA-SANDOZ INC.-NVSC2022CA042179$SANDOZ$$$$$F$Y$$$20240702$$CN$CA$CA
240403331$24040333$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5820074$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240403341$24040334$1$I$20240601$20240627$20240702$20240702$EXP$$JP-GENMAB-2024-02230$GENMAB$$$$$F$Y$$$20240702$$PH$JP$JP
240403351$24040335$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5821683$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240403361$24040336$1$I$20240626$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105187$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240702$$HP$US$US
240403401$24040340$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281446000970-SKTYP$GB-ORGANON-O2407GBR000029$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240403411$24040341$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281423510310-QYSNJ$GB-ORGANON-O2407GBR000003$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240403431$24040343$1$I$$20240627$20240702$20240702$PER$$US-JNJFOC-20240674952$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
240403441$24040344$1$I$20240630$20240701$20240701$20240701$DIR$708801$$FDA-CTU$$73$YR$$F$N$77.4$KG$20240701$N$CN$US$
240403452$24040345$2$F$$20240802$20240702$20240806$EXP$$JP-OTSUKA-2024_018359$OTSUKA$$50$YR$$M$Y$$$20240806$$PH$JP$JP
240403461$24040346$1$I$$20240411$20240702$20240702$PER$$US-AMGEN-USASP2024129628$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240403471$24040347$1$I$$20240305$20240702$20240702$PER$$US-AMGEN-USASP2024130425$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240403481$24040348$1$I$20240626$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128299$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240403491$24040349$1$I$20240126$20240618$20240702$20240702$EXP$$US-COOPERSURGICAL, INC.-2024CPS001944$COOPERSURGICAL$$$$$F$Y$$$20240702$$LW$US$US
240403501$24040350$1$I$$20240624$20240702$20240702$EXP$$US-MYLANLABS-2024M1060221$MYLAN$Geller A, Martinez Manzano J, Benzaquen S. An Exudative Enigma: Recurrent Pleural Effusions Following Drug-Eluting Bead Transarterial Chemoembolization With Percutaneous Ethanol Injection for Palliative Treatment of Hepatocellular Carcinoma. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$64$YR$$M$Y$$$20240702$$HP$US$US
240403511$24040351$1$I$$20240624$20240702$20240702$EXP$$US-MYLANLABS-2024M1059908$MYLAN$Pandey M, Vallapu Reddy T, Khattri B, Hemmige A, Pujar S, Aashish A. Pneumocystis Pneumonia in a Patient With Prolonged Steroid Therapy. Am-J-Respir-Crit-Care-Med 2024; 209.$65$YR$$M$Y$$$20240702$$HP$US$US
240403521$24040352$1$I$20240101$20240619$20240702$20240702$EXP$$US-COOPERSURGICAL, INC.-2024CPS001879$COOPERSURGICAL$$$$$F$Y$74.83$KG$20240702$$CN$US$US
240403531$24040353$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46025$$FDA-CTU$$80$YR$$F$N$71$KG$20240701$N$PH$US$
240403541$24040354$1$I$$20240624$20240702$20240702$EXP$$US-MYLANLABS-2024M1060324$MYLAN$Yegudkin I, Feng L, Manzouri S, Funnamark R, Ciurczak N, McKenzie ME, et al. Neurogenic Pulmonary Edema in the Setting of Intracerebral Hemorrhage: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A1157.$40$YR$$M$Y$$$20240702$$HP$US$US
240403551$24040355$1$I$$20240624$20240702$20240702$EXP$$AU-MYLANLABS-2024M1061501$MYLAN$Suraya H. Kamsani, Melissa E. Middeldorp, Glenda Chiang, Maria Stefil, Shaun Evans, Mau T. Nguyen, Elnaz Shahmohamadi, Jessica Qingying Zhang, Kurt C. Roberts-Thomson, Mehrdad Emami, Glenn D. Young. Safety of outpatient commencement of sotalol. Heart rhythm O2. 2024;5:6:341-350$78$YR$$F$Y$$$20240702$$MD$AU$AU
240403561$24040356$1$I$$20240624$20240702$20240702$EXP$$US-MYLANLABS-2024M1060853$MYLAN$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant 2023; 23 (7): 1048-1057.$6$DEC$$F$Y$$$20240702$$HP$US$US
240403571$24040357$1$I$$20240624$20240702$20240702$EXP$$GB-MYLANLABS-2024M1061009$MYLAN$Fenech M, Ajanaku A, McCormick A, Coupland SE, Krishna Y, Sultan Z, et al. Orbital Kimura disease: maintenance therapy using mycophenolate mofetil. Orbit 2024; 1-8.$55$YR$$M$Y$$$20240702$$HP$GB$GB
240403581$24040358$1$I$$20240624$20240702$20240702$EXP$$GB-MYLANLABS-2024M1060685$MYLAN$Gent DG, Ali N, Olsson-Brown A, Lip GYH, Wright DJ, Dobson R. Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights. Case-Rep-Oncol 2022; 15 (3): 950-959.$46$YR$$F$Y$$$20240702$$HP$GB$GB
240403591$24040359$1$I$$20240624$20240702$20240702$EXP$$US-MYLANLABS-2024M1060837$MYLAN$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant 2023; 23 (7): 1048-1057.$7$DEC$$F$Y$$$20240702$$HP$US$US
240403601$24040360$1$I$$20240624$20240702$20240702$EXP$$US-MYLANLABS-2024M1060117$MYLAN$Gans A, Taylor J, Goel NN. A Case of Drug-Induced Stevens-Johnson Syndrome With Primarily Visceral Involvement. Am-J-Respir-Crit-Care-Med 2024; 209 A5678.$76$YR$$F$Y$$$20240702$$HP$US$US
240403611$24040361$1$I$$20240624$20240702$20240702$EXP$$US-MYLANLABS-2024M1061477$MYLAN$Okura M, Sheikhan N, Thind GS. First Case of Elizabethkingia Lung Infection Strikes Central Valley California. Am-J-Respir-Crit-Care-Med 2024; 209 A6009 (plus Poster).$24$YR$$F$Y$$$20240702$$HP$US$US
240403621$24040362$1$I$$20240624$20240702$20240702$EXP$$US-MYLANLABS-2024M1060924$MYLAN$Kanack AJ, Schaefer JK, Sridharan M, Splinter NP, Kohlhagen MC, Singh B, et al. Monoclonal gammopathy of thrombotic/thrombocytopenic significance. Blood 2023; 141 (14): 1772-1776.$$$$M$Y$$$20240702$$HP$US$US
240403631$24040363$1$I$$20240624$20240702$20240702$EXP$$US-MYLANLABS-2024M1060429$MYLAN$Chowdhury T, Mainali A, Uprety N, Bisural R, Adhikari S, Gousy N, et al. The Deadly Duel: Legionnaires Disease and Multiple Myeloma: A Case of Fatal Pulmonary Renal Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209 A3608 (plus Poster).$57$YR$$M$Y$$$20240702$$HP$US$US
240403641$24040364$1$I$$20240626$20240702$20240702$EXP$$GR-EMD Serono-2024035159$EMD SERONO INC$$$$$F$Y$$$20240702$$MD$GR$GR
240403651$24040365$1$I$20240608$20240701$20240701$20240701$DIR$708725$$FDA-CTU$$38$YR$$F$N$49.5$KG$20240701$Y$CN$US$
240403662$24040366$2$F$$20240702$20240702$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05613$HIKMA$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL.. Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: A case series.. Pediatric nephrology. 2024$6$YR$$F$Y$24.5$KG$20240716$$MD$US$US
240403671$24040367$1$I$20240619$20240621$20240702$20240702$EXP$$BR-BAXTER-2024BAX020717$BAXTER$$42$YR$$F$Y$61.5$KG$20240702$$CN$BR$BR
240403683$24040368$3$F$20240515$20240710$20240702$20240720$EXP$$BR-BAXTER-2024BAX020719$BAXTER$$32$YR$$F$Y$63.8$KG$20240720$$CN$BR$BR
240403691$24040369$1$I$$20240621$20240702$20240702$EXP$$US-BAXTER-2024BAX020395$BAXTER$$$$$$Y$$$20240702$$CN$US$US
240403701$24040370$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007671$APOTEX$$65$YR$$F$Y$$$20240702$$HP$CA$CA
240403712$24040371$2$F$20220101$20240703$20240702$20240715$EXP$$US-ROCHE-3546865$ROCHE$$78$YR$E$F$Y$59.42$KG$20240715$$CN$US$US
240403721$24040372$1$I$$20240624$20240702$20240702$PER$$NVSC2024US132293$NOVARTIS$$26$YR$$M$Y$140.59$KG$20240702$$CN$US$US
240403731$24040373$1$I$$20240628$20240702$20240702$PER$$NVSC2024US136341$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240403742$24040374$2$F$$20240717$20240702$20240718$EXP$$CH-PFIZER INC-PV202400085468$PFIZER$Thurner, A.. Think atypical!. Swiss Medical Weekly. 2024;154(Supple 277):25S$7$YR$$M$Y$$$20240718$$HP$CH$CH
240403753$24040375$3$F$$20240703$20240702$20240709$EXP$$JP-PFIZER INC-PV202400085173$PFIZER$Furukawa, S.. A Case of Consciousness Disorder Due to Hyperammonemia Induced by Modified FOLFOX6 for Multiple Liver Metastasis from Rectal Cancer. Gan to kagaku ryoho. Cancer + chemotherapy. 2024;51(5):567-570$74$YR$$M$Y$61$KG$20240709$$HP$JP$JP
240403761$24040376$1$I$$20240626$20240702$20240702$EXP$$US-PFIZER INC-202400203364$PFIZER$O^halloran, K.. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6(1):10.1093/noajnl/vdae070$69$MON$$F$Y$$$20240702$$MD$US$US
240403771$24040377$1$I$$20240621$20240702$20240702$EXP$$CA-BAXTER-2024BAX020675$BAXTER$$$$$F$Y$$$20240702$$HP$CA$CA
240403781$24040378$1$I$20240409$20240624$20240702$20240702$EXP$FR-AFSSAPS-LL2024001148$FR-BAXTER-2024BAX020524$BAXTER$$77$YR$$F$Y$47$KG$20240702$$PH$FR$FR
240403791$24040379$1$I$$20240621$20240702$20240702$EXP$$TW-ROCHE-10000007770$ROCHE$$44$YR$A$F$Y$$$20240702$$MD$TW$TW
240403802$24040380$2$F$20240617$20240724$20240702$20240801$EXP$$JP-009507513-2406JPN003364J$MERCK$$7$DEC$$M$Y$$$20240801$$MD$JP$JP
240403811$24040381$1$I$20240320$20240624$20240702$20240702$EXP$CN-NMPACDR-3501111002373202400232$CN-BAXTER-2024BAX020645$BAXTER$$52$YR$$M$Y$$$20240702$$MD$CN$CN
240403821$24040382$1$I$20240316$20240624$20240702$20240702$EXP$ES-AEMPS-1537426$ES-BAXTER-2024BAX020520$BAXTER$$77$YR$$F$Y$45.5$KG$20240702$$MD$ES$ES
240403831$24040383$1$I$20240604$20240626$20240702$20240702$EXP$$CN-BAXTER-2024BAX019867$BAXTER$$57$YR$$M$Y$42$KG$20240702$$MD$CN$CN
240403841$24040384$1$I$20240123$20240618$20240702$20240702$EXP$$FR-CIPLA LTD.-2024FR06578$CIPLA$$$$$$Y$$$20240702$$PH$FR$FR
240403852$24040385$2$F$$20240802$20240702$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105404$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$67.59$KG$20240805$$HP$US$US
240403861$24040386$1$I$$20240625$20240702$20240702$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-105117$BRISTOL MYERS SQUIBB$Lim MS, Mohamed M. Retrospective study of clinical settings, indications and consequences of measurement of direct oral anticoagulant plasma levels in Northern Tasmania, Australia. Internal Medicine Journal. 2024 Jun 01;54(6):932-40. doi:10.1111/imj.16329.$$$$$Y$$$20240702$$HP$AU$AU
240403871$24040387$1$I$$20240701$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105300$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$61.23$KG$20240702$$MD$US$US
240403891$24040389$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105326$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240702$$HP$US$US
240403901$24040390$1$I$20240624$20240625$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102584$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240702$$PH$US$US
240403911$24040391$1$I$20240520$20240701$20240702$20240702$EXP$FR-AFSSAPS-SE2024000517$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-105042$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$58$KG$20240702$$MD$FR$FR
240403931$24040393$1$I$$20240701$20240701$20240701$DIR$708817$$FDA-CTU$$45$YR$$F$N$58.5$KG$20240701$N$CN$US$
240403942$24040394$2$F$$20240719$20240702$20240729$EXP$$US-GSK-US2024AMR081439$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
240403951$24040395$1$I$20240610$20240625$20240702$20240702$EXP$$CN-GSK-CN2024APC079283$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$CN$CN
240403961$24040396$1$I$$20240621$20240702$20240702$EXP$CH-MLMSERVICE-20240614-PI100540-00190-1$CH-JUBILANT CADISTA PHARMACEUTICALS-2024CH000878$JUBILANT$Vukovic J, Nikolaou A, Terrier J, Samer C.. Lamotrigine-induced Severe Drug Reaction with Eosinophilia Systemic Symptoms (DRESS) in a child. Swiss Medical Weekly. 2024;154(Supp 276):137S$9$YR$$F$Y$$$20240702$$MD$CH$CH
240403971$24040397$1$I$$20240624$20240702$20240702$EXP$CN-MLMSERVICE-20240617-PI101855-00050-1$CN-JUBILANT CADISTA PHARMACEUTICALS-2024CN000866$JUBILANT$Lei M, Cao Y, Yuan M, Xiong J, He H.. Case report: A case of bradycardia triggered by diarrhea. Frontiers in medicine. 2024;11$92$YR$$M$Y$$$20240702$$MD$CN$CN
240403981$24040398$1$I$$20240618$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06672$CIPLA$Kim AH, Taha W, Prudenti J.. A critical case of Hydralazine-induced vasculitis presenting with pulmonary renal syndrome. Am J Respir Crit Care Med. 2024;209; A7071$$$$$Y$$$20240702$$HP$US$US
240403992$24040399$2$F$$20240715$20240702$20240724$EXP$$US-GILEAD-2024-0673800$GILEAD$$$$C$F$Y$16.4$KG$20240724$$HP$US$US
240404002$24040400$2$F$$20240726$20240702$20240731$30DAY$$FR-JNJFOC-20240674488$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$PH$FR$FR
240404011$24040401$1$I$$20240618$20240702$20240702$EXP$$JP-AptaPharma Inc.-2158764$APTAPHARMA$Source document (Abstract)$$$$M$Y$$$20240702$$$JP$JP
240404021$24040402$1$I$$20230511$20240702$20240702$PER$$US-AMGEN-USASP2023235126$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240404031$24040403$1$I$$20240110$20240702$20240702$PER$$US-AMGEN-USASP2024130080$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240404041$24040404$1$I$$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024128612$AMGEN$$65$YR$E$F$Y$$$20240702$$MD$US$US
240404051$24040405$1$I$20240621$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024130104$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240404065$24040406$5$F$20240626$20240719$20240702$20240726$PER$$US-AMGEN-USASP2024127313$AMGEN$$71$YR$E$M$Y$$$20240726$$MD$US$US
240404071$24040407$1$I$20240621$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127455$AMGEN$$69$YR$E$F$Y$$$20240702$$MD$US$US
240404081$24040408$1$I$$20240625$20240702$20240702$EXP$$US-AMGEN-USASP2024127535$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240404091$24040409$1$I$$20240625$20240702$20240702$PER$$US-AstraZeneca-2024A146863$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240404101$24040410$1$I$20240601$20240621$20240702$20240702$30DAY$$DE-UCBSA-2024032360$UCB$$70$YR$$M$Y$$$20240702$$PH$DE$DE
240404111$24040411$1$I$$20240619$20240702$20240702$PER$$US-MSNLABS-2024MSNSPO01358$MSN LABORATORIES$$$$$$Y$$$20240702$$CN$US$US
240404122$24040412$2$F$$20240711$20240702$20240717$EXP$$JP-OTSUKA-2024_018402$OTSUKA$$$$$$Y$$$20240717$$PH$JP$JP
240404131$24040413$1$I$$20240628$20240702$20240702$EXP$$US-SANDOZ INC.-SDZ2024US061755$SANDOZ$$$$$$Y$$$20240702$$HP$US$US
240404141$24040414$1$I$20230601$20230630$20240702$20240702$PER$$US-PERRIGO-23US007681$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404151$24040415$1$I$20230627$20230627$20240702$20240702$PER$$US-PERRIGO-23US007406$PERRIGO$$65$YR$$F$Y$$$20240702$$CN$US$US
240404161$24040416$1$I$20230601$20230628$20240702$20240702$PER$$US-PERRIGO-23US007706$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404171$24040417$1$I$20230801$20230809$20240702$20240702$PER$$US-PERRIGO-23US009171$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404181$24040418$1$I$20230601$20230621$20240702$20240702$PER$$US-PERRIGO-23US007418$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404191$24040419$1$I$20230618$20230619$20240702$20240702$PER$$US-PERRIGO-23US008019$PERRIGO$$50$YR$$F$Y$50.794$KG$20240702$$CN$US$US
240404201$24040420$1$I$20230611$20230612$20240702$20240702$PER$$US-PERRIGO-23US006893$PERRIGO$$62$YR$$F$Y$88.435$KG$20240702$$CN$US$US
240404211$24040421$1$I$20230901$20230911$20240702$20240702$PER$$US-PERRIGO-23US010937$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404221$24040422$1$I$20230812$20230816$20240702$20240702$PER$$US-PERRIGO-23US009238$PERRIGO$$27$YR$$F$Y$62.132$KG$20240702$$CN$US$US
240404231$24040423$1$I$20230609$20230609$20240702$20240702$PER$$US-PERRIGO-23US006882$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404241$24040424$1$I$20230622$20230622$20240702$20240702$PER$$US-PERRIGO-23US007420$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404251$24040425$1$I$20230601$20230619$20240702$20240702$PER$$US-PERRIGO-23US007517$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404261$24040426$1$I$20240617$20240627$20240702$20240702$EXP$$US-MYLANLABS-2024M1061345$MYLAN$$36$YR$$F$Y$$$20240702$$HP$US$US
240404271$24040427$1$I$20231115$20240701$20240701$20240701$DIR$708796$$FDA-CTU$$74$YR$$F$N$84.6$KG$20240701$N$CN$US$
240404281$24040428$1$I$$20240701$20240701$20240701$DIR$708673$$FDA-CTU$$$$$UNK$N$$$20240701$N$CN$US$
240404292$24040429$2$F$20240624$20240801$20240702$20240805$EXP$$US-MYLANLABS-2024M1061327$MYLAN$$68$YR$$F$Y$$$20240805$$CN$US$US
240404301$24040430$1$I$$20240627$20240702$20240702$EXP$$US-MYLANLABS-2024M1061319$MYLAN$$$$$M$Y$$$20240702$$HP$US$US
240404312$24040431$2$F$20190101$20240805$20240702$20240808$EXP$$US-JNJFOC-20240675054$JOHNSON AND JOHNSON$$97$YR$E$$Y$$$20240808$$CN$US$US
240404321$24040432$1$I$$20240627$20240702$20240702$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-020029$UNITED THERAPEUTICS$$69$YR$$F$Y$$$20240702$$$JP$JP
240404331$24040433$1$I$20240622$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128337$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240404341$24040434$1$I$20240601$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024126351$AMGEN$$73$YR$E$F$Y$$$20240702$$CN$US$US
240404351$24040435$1$I$$20240620$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05962$HIKMA$Gans A, Taylor J, Goel N.. Gans A, Taylor J, Goel NN. A Case of Drug-Induced Stevens-Johnson Syndrome With Primarily Visceral Involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5678$76$YR$$F$Y$$$20240702$$MD$US$US
240404361$24040436$1$I$20230901$20230911$20240702$20240702$PER$$US-PERRIGO-23US010964$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404371$24040437$1$I$$20231110$20240702$20240702$PER$$US-PERRIGO-23US013152$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404381$24040438$1$I$$20231112$20240702$20240702$PER$$US-PERRIGO-23US013198$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404391$24040439$1$I$$20231117$20240702$20240702$PER$$US-PERRIGO-23US013323$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404401$24040440$1$I$20240625$20240701$20240701$20240701$DIR$708707$$FDA-CTU$$58$YR$$F$N$$$20240701$N$$US$
240404411$24040441$1$I$20231115$20231115$20240702$20240702$PER$$US-PERRIGO-23US013186$PERRIGO$$23$YR$$F$Y$90.703$KG$20240702$$CN$US$US
240404421$24040442$1$I$$20231027$20240702$20240702$PER$$US-PERRIGO-23US012595$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404431$24040443$1$I$20231101$20231108$20240702$20240702$PER$$US-PERRIGO-23US012952$PERRIGO$$71$YR$$F$Y$61.678$KG$20240702$$CN$US$US
240404441$24040444$1$I$20230901$20230929$20240702$20240702$PER$$US-PERRIGO-23US011591$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404451$24040445$1$I$20231019$20231026$20240702$20240702$PER$$US-PERRIGO-23US012493$PERRIGO$$71$YR$$F$Y$81.633$KG$20240702$$CN$US$US
240404461$24040446$1$I$20231001$20231024$20240702$20240702$PER$$US-PERRIGO-23US012413$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404471$24040447$1$I$$20231113$20240702$20240702$PER$$US-PERRIGO-23US013444$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404481$24040448$1$I$$20231027$20240702$20240702$PER$$US-PERRIGO-23US012598$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404491$24040449$1$I$20231001$20231031$20240702$20240702$PER$$US-PERRIGO-23US012707$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404501$24040450$1$I$$20231122$20240702$20240702$PER$$US-PERRIGO-23US013627$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404511$24040451$1$I$$20231114$20240702$20240702$PER$$US-PERRIGO-23US013445$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404521$24040452$1$I$20230301$20240627$20240702$20240702$EXP$$NVSC2024RO135360$NOVARTIS$$2$YR$$F$Y$$$20240702$$MD$RO$RO
240404531$24040453$1$I$20230901$20231003$20240702$20240702$PER$$US-PERRIGO-23US011667$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404541$24040454$1$I$$20240624$20240702$20240702$EXP$$US-CELLTRION INC.-2024US015735$CELLTRION$Durairaj MVB, Caraway H, Buresh R, Sampath R, Waghchoure S.. Rapidly Progressing Secondary Organizing Pneumonia Due to Underlying Immunosuppression With Rituximab in SARS-CoV-2 Patients. Cureus. 2024;16(5)$$$$$Y$$$20240702$$HP$US$US
240404551$24040455$1$I$$20231215$20240702$20240702$PER$$US-PERRIGO-23US014674$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404561$24040456$1$I$20240601$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000152$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240702$$CN$US$US
240404571$24040457$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000067$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$US$US
240404581$24040458$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05455$LUPIN$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316(6):1-5$49$YR$$F$Y$$$20240702$$HP$US$US
240404591$24040459$1$I$20240105$20240110$20240702$20240702$PER$$US-PERRIGO-24US000318$PERRIGO$$60$YR$$F$Y$88.435$KG$20240702$$CN$US$US
240404601$24040460$1$I$$20231125$20240702$20240702$PER$$US-PERRIGO-23US013914$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404611$24040461$1$I$$20240110$20240702$20240702$PER$$US-PERRIGO-24US000319$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404621$24040462$1$I$$20231211$20240702$20240702$PER$$US-PERRIGO-23US014183$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404631$24040463$1$I$$20231215$20240702$20240702$PER$$US-PERRIGO-23US014684$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404641$24040464$1$I$$20240112$20240702$20240702$PER$$US-PERRIGO-24US000502$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404651$24040465$1$I$$20240117$20240702$20240702$PER$$US-PERRIGO-24US000763$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404661$24040466$1$I$$20240118$20240702$20240702$PER$$US-PERRIGO-24US000628$PERRIGO$$$$$F$Y$52.608$KG$20240702$$CN$US$US
240404671$24040467$1$I$20240105$20240109$20240702$20240702$PER$$US-PERRIGO-24US000258$PERRIGO$$35$YR$$F$Y$77.098$KG$20240702$$CN$US$US
240404681$24040468$1$I$$20240618$20240702$20240702$EXP$$JP-Guardian Drug Company-2158765$GUARDIAN PHARMACEUTICALS$Source document (Full text)$$$$M$Y$$$20240702$$$JP$JP
240404691$24040469$1$I$$20240626$20240702$20240702$EXP$$CA-SANDOZ INC.-SDZ2023CA076609$SANDOZ$$44$YR$$F$Y$70$KG$20240702$$HP$CA$CA
240404701$24040470$1$I$$20240626$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102994$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240702$$CN$US$US
240404711$24040471$1$I$$20240626$20240702$20240702$EXP$$US-ASTELLAS-2024US018638$ASTELLAS$$89$YR$$M$Y$$$20240702$$CN$US$US
240404721$24040472$1$I$$20240625$20240702$20240702$EXP$$US-LUOXIN-LUX-2024-US-LIT-00024$LUOXIN AUROVITAS PHARMA(CHENGDU)$Tan E, Pokhriyal SC, Khan A, Pasha M, Idris H.Assay Interference Causing Persistently Elevated Vancomycin Levels Ultimately Leading to Treatment Failure and Fatal Outcome.Am-J-Respir-Crit-Care-Med.MAY-2024;209:A5673-A5673$69$YR$A$F$Y$$$20240702$$HP$US$US
240404731$24040473$1$I$$20240629$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105586$BRISTOL MYERS SQUIBB$$$$T$F$Y$$$20240702$$HP$US$US
240404741$24040474$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105504$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$78.93$KG$20240702$$CN$US$US
240404751$24040475$1$I$$20240119$20240702$20240702$PER$$US-PERRIGO-24US000790$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404771$24040477$1$I$$20240512$20240702$20240702$PER$$US-PERRIGO-24US004687$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404781$24040478$1$I$$20240526$20240702$20240702$PER$$US-PERRIGO-24US005155$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404791$24040479$1$I$20240213$20240213$20240702$20240702$PER$$US-PERRIGO-24US001843$PERRIGO$$41$YR$$F$Y$72.562$KG$20240702$$CN$US$US
240404801$24040480$1$I$$20240303$20240702$20240702$PER$$US-PERRIGO-24US002364$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404811$24040481$1$I$20240315$20240319$20240702$20240702$PER$$US-PERRIGO-24US002833$PERRIGO$$21$YR$$F$Y$72.562$KG$20240702$$CN$US$US
240404821$24040482$1$I$20240217$20240218$20240702$20240702$PER$$US-PERRIGO-24US001881$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404831$24040483$1$I$20240327$20240402$20240702$20240702$PER$$US-PERRIGO-24US003337$PERRIGO$$77$YR$$F$Y$61.224$KG$20240702$$CN$US$US
240404841$24040484$1$I$20240228$20240229$20240702$20240702$PER$$US-PERRIGO-24US002199$PERRIGO$$62$YR$$F$Y$46.712$KG$20240702$$CN$US$US
240404851$24040485$1$I$20240226$20240226$20240702$20240702$PER$$US-PERRIGO-24US002083$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404861$24040486$1$I$20240509$20240510$20240702$20240702$PER$$US-PERRIGO-24US004676$PERRIGO$$62$YR$$F$Y$$$20240702$$CN$US$US
240404871$24040487$1$I$20240225$20240226$20240702$20240702$PER$$US-PERRIGO-24US002091$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404881$24040488$1$I$$20240130$20240702$20240702$PER$$US-PERRIGO-24US001449$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404891$24040489$1$I$$20240509$20240702$20240702$PER$$US-PERRIGO-24US004627$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404901$24040490$1$I$$20240124$20240702$20240702$PER$$US-PERRIGO-24US001064$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404911$24040491$1$I$$20240125$20240702$20240702$PER$$US-PERRIGO-24US001084$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404921$24040492$1$I$20240304$20240304$20240702$20240702$PER$$US-PERRIGO-24US002311$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404931$24040493$1$I$$20240120$20240702$20240702$PER$$US-PERRIGO-24US000799$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404941$24040494$1$I$$20240325$20240702$20240702$PER$$US-PERRIGO-24US003126$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404951$24040495$1$I$20240201$20240214$20240702$20240702$PER$$US-PERRIGO-24US001699$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240404971$24040497$1$I$$20240625$20240702$20240702$PER$$US-ROCHE-10000014065$ROCHE$$7$YR$C$M$Y$$$20240702$$HP$US$US
240404981$24040498$1$I$$20240627$20240702$20240702$EXP$$MX-GILEAD-2024-0678834$GILEAD$$$$$$Y$$$20240702$$HP$MX$MX
240404991$24040499$1$I$$20240424$20240702$20240702$PER$$US-PERRIGO-24US005872$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240405001$24040500$1$I$$20240530$20240702$20240702$PER$$US-PERRIGO-24US005344$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240405011$24040501$1$I$20240520$20240526$20240702$20240702$PER$$US-PERRIGO-24US005175$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240405021$24040502$1$I$$20240527$20240702$20240702$PER$$US-PERRIGO-24US005177$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240405031$24040503$1$I$$20240627$20240702$20240702$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-12340$IPSEN$$$$$F$Y$$$20240702$$HP$US$US
240405041$24040504$1$I$$20240619$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05897$HIKMA$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.. Archives of Dermatological Research. 2024;316(6):279$69$YR$$M$Y$$$20240702$$MD$US$US
240405051$24040505$1$I$20240628$20240701$20240701$20240701$DIR$708675$$FDA-CTU$$19$YR$$F$N$67.5$KG$20240701$Y$HP$US$
240405061$24040506$1$I$20240625$20240701$20240701$20240701$DIR$708704$$FDA-CTU$$30$YR$$F$N$$$20240701$N$$US$
240405071$24040507$1$I$20240624$20240701$20240701$20240701$DIR$708703$$FDA-CTU$$45$YR$$F$N$$$20240701$N$$US$
240405091$24040509$1$I$20240625$20240701$20240701$20240701$DIR$708708$$FDA-CTU$$35$YR$$F$N$$$20240701$N$$US$
240405101$24040510$1$I$20240612$20240701$20240701$20240701$DIR$708701$$FDA-CTU$$21$YR$$F$N$$$20240701$N$$US$
240405111$24040511$1$I$20240621$20240701$20240701$20240701$DIR$708702$$FDA-CTU$$37$YR$$F$N$$$20240701$N$$US$
240405121$24040512$1$I$20240611$20240701$20240701$20240701$DIR$708698$$FDA-CTU$$57$YR$$M$N$$$20240701$N$$US$
240405141$24040514$1$I$$20231208$20240702$20240702$PER$$US-AMGEN-USASP2023235272$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240405152$24040515$2$F$20240101$20240824$20240702$20240826$EXP$$CA-PFIZER INC-202400204125$PFIZER$$42$YR$$F$Y$$$20240826$$HP$CA$CA
240405162$24040516$2$F$$20240701$20240702$20240705$EXP$$MY-PFIZER INC-202400203625$PFIZER$Ng, K.. Unravelling lung adenocarcinoma in an immunocompetent patient with endobronchial aspergilloma: A case report. Respirology case reports. 2024;12(6):10.1002/rcr2.1409$73$YR$$M$Y$$$20240705$$MD$MY$MY
240405172$24040517$2$F$20240621$20240826$20240702$20240828$EXP$$ES-PFIZER INC-PV202400086650$PFIZER$$61$YR$$F$Y$80$KG$20240828$$MD$ES$ES
240405182$24040518$2$F$$20240628$20240702$20240712$EXP$$CN-PFIZER INC-202400203724$PFIZER$Liu, S.. Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia. Oncotarget. 2017;8(23):37761-37772$$$$$Y$$$20240712$$HP$CN$CN
240405201$24040520$1$I$$20240628$20240702$20240702$EXP$$US-PFIZER INC-202400203310$PFIZER$$56$YR$$F$Y$$$20240702$$CN$US$US
240405211$24040521$1$I$$20240701$20240701$20240701$DIR$708735$$FDA-CTU$$$$$UNK$N$$$20240701$N$CN$US$
240405221$24040522$1$I$$20240627$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085113$PFIZER$Lin, D.. CLINICAL EFFICACY OF RITUXIMAB COMBINED WITH CHOP REGIMEN SEQUENTIAL OR NON-SEQUENTIAL LOCAL RADIOTHERAPY IN PATIENTS WITH STAGE IIIIV DIFFUSE LARGE B-CELL LYMPHOMA.. Acta-Med-Mediter. 2023;39(1):17-22$$$$$Y$$$20240702$$HP$CN$CN
240405231$24040523$1$I$20240430$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46067$$FDA-CTU$$99$YR$$F$N$$$20240701$N$PH$US$
240405241$24040524$1$I$20231201$20240628$20240702$20240702$EXP$FR-AFSSAPS-LY2024000922$FR-PFIZER INC-202400202856$PFIZER$$73$YR$$F$Y$76$KG$20240702$$PH$FR$FR
240405251$24040525$1$I$$20240701$20240702$20240702$EXP$$US-PFIZER INC-202400204585$PFIZER$$61$YR$$F$Y$$$20240702$$CN$US$US
240405261$24040526$1$I$$20240628$20240702$20240702$EXP$$GB-PFIZER INC-PV202400086084$PFIZER$$64$YR$$F$Y$$$20240702$$CN$GB$GB
240405271$24040527$1$I$$20240701$20240701$20240701$DIR$708789$$FDA-CTU$$$$$UNK$N$$$20240701$$CN$US$
240405281$24040528$1$I$$20240628$20240701$20240701$DIR$FDA-CDER-CTU-2024-46068$$FDA-CTU$$$$$F$N$$$20240628$N$HP$US$
240405301$24040530$1$I$$20240621$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006866$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240405312$24040531$2$F$$20240701$20240702$20240704$EXP$$BD-PFIZER INC-202400203662$PFIZER$Islam, S.. Varicella zoster virus and cytomegalovirus coinfection in a live related kidney transplant recipient: A case report. Clinical case reports. 2024;12(6):e9089$32$YR$$F$Y$$$20240704$$MD$BD$BD
240405321$24040532$1$I$$20240622$20240702$20240702$EXP$$EC-ROCHE-10000007745$ROCHE$$$$$$Y$$$20240702$$CN$EC$EC
240405333$24040533$3$F$20240501$20240722$20240702$20240725$PER$$US-AMGEN-USASP2024128717$AMGEN$$54$YR$A$F$Y$$$20240725$$MD$US$US
240405341$24040534$1$I$$20240619$20240702$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05549$LUPIN$$$$$$Y$$$20240702$$CN$US$US
240405351$24040535$1$I$20220601$20240628$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105370$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240702$$CN$US$US
240405362$24040536$2$F$$20240730$20240702$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099113$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240808$$HP$US$US
240405371$24040537$1$I$$20240627$20240702$20240702$EXP$$US-MYLANLABS-2024M1061470$MYLAN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.$70$YR$$M$Y$$$20240702$$HP$US$US
240405381$24040538$1$I$$20240627$20240702$20240702$EXP$$ES-MYLANLABS-2024M1058867$MYLAN$Marc R R, Santiago C A, Jordi C P and Maria L O S. Visceral coloration due to the blue of postmortem methylene, postmortem visceral staining due to methylene blue. Magazine Spanish Legal Medicine. 3$18$YR$$M$Y$$$20240702$$MD$ES$ES
240405392$24040539$2$F$$20240709$20240702$20240712$EXP$$ES-MYLANLABS-2024M1058809$MYLAN$Marc R R, Santiago C A, Jordi C P and Maria L O S. Visceral coloration due to the blue of postmortem methylene Postmortem visceral staining due to methylene blue. Magazine Spanish Legal Medicine. page (3)$41$YR$$F$Y$$$20240712$$MD$ES$ES
240405402$24040540$2$F$20230101$20240723$20240702$20240802$EXP$$US-INSMED, INC.-2023-02588-US$INSMED$$$$$F$Y$$$20240802$$CN$US$US
240405411$24040541$1$I$$20240627$20240702$20240702$EXP$$US-MYLANLABS-2024M1061474$MYLAN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.$61$YR$$M$Y$$$20240702$$HP$US$US
240405421$24040542$1$I$$20240627$20240702$20240702$PER$$US-TAKEDA-2024TUS065857$TAKEDA$$$$$F$Y$$$20240702$$CN$US$US
240405443$24040544$3$F$$20240916$20240702$20240925$PER$$US-GSK-US2024AMR080064$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
240405453$24040545$3$F$20240101$20240717$20240702$20240722$EXP$$US-SA-2024SA194211$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240722$$MD$US$US
240405461$24040546$1$I$20240101$20240620$20240702$20240702$PER$$US-SA-2024SA187788$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240702$$MD$US$US
240405471$24040547$1$I$20240101$20240623$20240702$20240702$PER$$US-SA-2024SA189086$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240702$$MD$US$US
240405481$24040548$1$I$20240601$20240624$20240702$20240702$EXP$DE-CADRBFARM-2024328702$DE-TEVA-VS-3213383$TEVA$$28$YR$$F$Y$65$KG$20240702$$CN$DE$DE
240405491$24040549$1$I$$20230710$20240702$20240702$PER$$US-AMGEN-USASP2023235203$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240405501$24040550$1$I$$20230612$20240702$20240702$PER$$US-AMGEN-USASP2023235239$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240405523$24040552$3$F$$20240911$20240702$20240916$30DAY$$US-PFIZER INC-202400201222$PFIZER$$15$YR$$M$Y$$$20240916$$CN$US$US
240405532$24040553$2$F$20240101$20240703$20240702$20240704$EXP$$CA-PFIZER INC-202400202443$PFIZER$$84$YR$$M$Y$$$20240704$$HP$CA$CA
240405541$24040554$1$I$$20240626$20240702$20240702$EXP$$DE-MYLANLABS-2024M1060670$MYLAN$Bonnet U, Kanti AK, Scherbaum N, Specka M.. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment ? A Pilot Study.. Journal of Psychoactive Drugs.. 2023;55 (1):102-111$20$YR$$M$Y$$$20240702$$HP$DE$DE
240405562$24040556$2$F$$20240802$20240702$20240802$30DAY$$US-PFIZER INC-202400200221$PFIZER$$13$YR$$M$Y$$$20240802$$CN$US$US
240405572$24040557$2$F$$20240801$20240702$20240801$30DAY$$US-PFIZER INC-202400200961$PFIZER$$15$YR$$M$Y$$$20240801$$CN$US$US
240405584$24040558$4$F$20240625$20240925$20240702$20240930$30DAY$$US-PFIZER INC-202400202060$PFIZER$$14$YR$$M$Y$$$20240930$$CN$US$US
240405591$24040559$1$I$20240601$20240628$20240702$20240702$EXP$$CA-PFIZER INC-202400203345$PFIZER$$91$YR$$M$Y$$$20240702$$PH$CA$CA
240405611$24040561$1$I$$20240628$20240702$20240702$EXP$$US-PFIZER INC-PV202400085527$PFIZER$$89$YR$$M$Y$$$20240702$$CN$US$US
240405631$24040563$1$I$$20240620$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06674$CIPLA$Puthumana RM, Mintz J, Perez M, Gaddipati S, Gorman D. Too much of a good thing: A case of beta blocker and Warfarin toxicity. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5692:1 to 3$$$$$Y$$$20240702$$MD$US$US
240405641$24040564$1$I$20200601$20240619$20240702$20240702$EXP$$GB-CIPLA LTD.-2024GB06660$CIPLA$$$$$$Y$$$20240702$$CN$GB$GB
240405651$24040565$1$I$$20240620$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06675$CIPLA$Demars B., Bates T., Ward M., Qazi Z., Karki P., Calick D., et all.. A case of sarcomatoid carcinoma presenting in the setting of Anastrozole use. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6590$$$$$Y$$$20240702$$MD$US$US
240405661$24040566$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05603$LUPIN$Hossain S, Bahadur SA. Stenotrophomonas Maltophilia, Pandoraea Species, and Aspergillus Niger Co-infection in a patient with acute respiratory failure. American Journal of Respiratory and Critical Care Medicine. 2024;209$74$YR$$M$Y$$$20240702$$HP$US$US
240405671$24040567$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A147502$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240405681$24040568$1$I$20240401$20240624$20240702$20240702$EXP$$DE-AstraZeneca-2024A130144$ASTRAZENECA$$$$$M$Y$$$20240702$$MD$DE$
240405691$24040569$1$I$20240224$20240617$20240702$20240702$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454255$RANBAXY$$71$YR$$M$Y$$$20240702$$MD$FR$FR
240405701$24040570$1$I$$20240628$20240702$20240702$PER$$US-BIOVITRUM-2024-US-009307$BIOVITRUM$$59$YR$$F$Y$$$20240702$$CN$US$US
240405711$24040571$1$I$$20240619$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06768$CIPLA$Dave J, Goldner B. Extra pleural hematoma vs hemothorax: A unique case of ambiguous CT findings. Am J Respir Crit Care Med. 2024;209:A1934$$$$$Y$$$20240702$$HP$US$US
240405721$24040572$1$I$$20240619$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06678$CIPLA$Nguyen NV, Kim L, Collins LF, Ofotokun I, Fernandes A, Yeh S et al. Retinopathy associated with Ritonavir treatment for HIV infection: a case series reappraisal in the COVID-19 era.. Journal of vitreoretinal diseases. 2024;8(1):111 to 116$$$$$Y$$$20240702$$HP$US$US
240405751$24040575$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007676$APOTEX$$60$YR$$F$Y$$$20240702$$HP$CA$CA
240405767$24040576$7$F$20240627$20240823$20240702$20240902$PER$$US-JNJFOC-20240678836$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240903$$HP$US$US
240405771$24040577$1$I$20240101$20240627$20240702$20240702$EXP$$US-ABBVIE-5822210$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240405781$24040578$1$I$20240613$20240625$20240702$20240702$PER$$US-BAYER-2024A092879$BAYER$$31$YR$A$F$Y$$$20240702$$MD$US$US
240405792$24040579$2$F$20240601$20240717$20240702$20240722$EXP$$US-SA-2024SA190915$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240722$$MD$US$US
240405801$24040580$1$I$$20240619$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06693$CIPLA$Nguyen NV, Kim L, Collins LF, Ofotokun I, Fernandes A, Yeh S. Retinopathy associated with Ritonavir treatment for HIV Infection: a case series reappraisal in the COVID-19 era. Journal of vitreoretinal diseases. 2024;8(1):111-6$$$$$Y$$$20240702$$HP$US$US
240405811$24040581$1$I$$20240621$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006694$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240405821$24040582$1$I$$20240617$20240702$20240702$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009348$JAZZ$$$$$M$Y$$$20240702$$CN$US$US
240405832$24040583$2$F$20240626$20240710$20240702$20240711$EXP$$US-UCBSA-2024033328$UCB$$30$YR$$M$Y$$$20240711$$CN$US$US
240405841$24040584$1$I$$20240618$20240702$20240702$EXP$$US-Changzhou Pharmaceutical Factory-2158767$CHANGZHOU PHARMACEUTICAL FACTORY$Source document (Full text)$71$YR$$F$Y$$$20240702$$MD$US$US
240405852$24040585$2$F$20240101$20240716$20240702$20240722$EXP$$US-SA-2024SA191566$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240719$$CN$US$US
240405861$24040586$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46046$$FDA-CTU$$83$YR$$F$N$$$20240701$N$$US$
240405873$24040587$3$F$$20240913$20240702$20240919$30DAY$$US-PFIZER INC-202400202717$PFIZER$$15$YR$$M$Y$$$20240919$$CN$US$US
240405884$24040588$4$F$20240601$20240922$20240702$20240925$30DAY$$US-PFIZER INC-202400201987$PFIZER$$15$YR$$M$Y$$$20240925$$CN$US$US
240405891$24040589$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46065$$FDA-CTU$$94$YR$$F$N$$$20240701$N$$US$
240405901$24040590$1$I$20240621$20240701$20240701$20240701$DIR$708751$$FDA-CTU$$62$YR$$M$N$78.5$KG$20240701$Y$HP$US$
240405912$24040591$2$F$$20240822$20240702$20240822$EXP$$US-PFIZER INC-PV202400085549$PFIZER$$8$YR$$M$Y$$$20240822$$HP$US$US
240405923$24040592$3$F$$20240719$20240702$20240725$30DAY$$TR-PFIZER INC-PV202400079198$PFIZER$$$$$$Y$$$20240725$$PH$TR$TR
240405931$24040593$1$I$$20240620$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-05869$HIKMA$Ozogbo S, Pupillo S.. Ozogbo S, Pupillo S. A Rare Presentation of Large B-cell Lymphoma With Anterior Mediastinal Mass in a 24-yearold Female. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6518$24$YR$$F$Y$$$20240702$$MD$US$US
240405954$24040595$4$F$$20240925$20240702$20240930$30DAY$$US-PFIZER INC-202400203246$PFIZER$$11$YR$$F$Y$$$20240930$$CN$US$US
240405974$24040597$4$F$$20240918$20240702$20240923$30DAY$$HR-PFIZER INC-PV202400084779$PFIZER$$$$$$Y$$$20240923$$PH$HR$HR
240406001$24040600$1$I$20240628$20240701$20240701$20240701$DIR$708744$$FDA-CTU$$38$YR$$F$N$$$20240701$Y$HP$US$
240406011$24040601$1$I$20240627$20240701$20240701$20240701$DIR$708758$$FDA-CTU$$10$YR$$M$N$44.3$KG$20240701$Y$PH$US$
240406031$24040603$1$I$$20240626$20240702$20240702$EXP$$US-BAUSCHBL-2024BNL029284$BAUSCH AND LOMB$$78$YR$$M$Y$$$20240702$$CN$US$US
240406041$24040604$1$I$$20240625$20240702$20240702$PER$$US-ROCHE-10000012524$ROCHE$$$$A$M$Y$$$20240702$$CN$US$US
240406051$24040605$1$I$20240621$20240625$20240702$20240702$PER$$US-BAYER-2024A092941$BAYER$$$$$F$Y$$$20240702$$MD$US$US
240406061$24040606$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA191414$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240702$$MD$US$US
240406071$24040607$1$I$20240501$20240621$20240702$20240702$PER$$US-SA-2024SA187873$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240702$$MD$US$US
240406081$24040608$1$I$$20240626$20240702$20240702$EXP$$PT-BAYER-2024A094572$BAYER$Bento T, Santos Miranda M, Landeiro R.. PULMONARY EMBOLISM IN A YOUNG ADULT: THE IMPORTANCE OF RISK FACTORS. RH. 2024;101:32-6.$45$YR$A$F$Y$$$20240702$$HP$PT$PT
240406091$24040609$1$I$$20240625$20240702$20240702$PER$$US-BAYER-2024A093147$BAYER$$$$$F$Y$$$20240702$$HP$US$US
240406101$24040610$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137019$NOVARTIS$$$$$M$Y$$$20240702$$CN$US$US
240406112$24040611$2$F$20240610$20240710$20240702$20240716$PER$$US-INCYTE CORPORATION-2024IN006577$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240406121$24040612$1$I$$20240701$20240702$20240702$EXP$DE-SANDOZ-SDZ2024DE060245$DE-UCBSA-2024033225$UCB$$$$$F$Y$$$20240702$$CN$DE$DE
240406141$24040614$1$I$$20240621$20240702$20240702$EXP$$NO-ORGANON-O2406NOR002540$ORGANON$Sande L O, Moloklinikken, Gjesdal K.. THE ECG COLUMN. heart forum. 2024;37:42-3$69$YR$$F$Y$$$20240702$$HP$NO$NO
240406151$24040615$1$I$$20240624$20240702$20240702$PER$$US-BIOVITRUM-2024-US-009264$BIOVITRUM$$$$$M$Y$$$20240702$$CN$US$US
240406161$24040616$1$I$20190211$20240628$20240702$20240702$EXP$$PL-BAUSCHBL-2024BNL029329$BAUSCH AND LOMB$$62$YR$$$Y$$$20240702$$MD$PL$PL
240406171$24040617$1$I$20240603$20240624$20240702$20240702$EXP$FR-AFSSAPS-RN2024000649$FR-TEVA-VS-3213145$TEVA$$74$YR$$M$Y$90$KG$20240702$$PH$FR$FR
240406181$24040618$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281413365890-NGPDS$GB-ORGANON-O2407GBR000004$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240406191$24040619$1$I$20240606$20240701$20240702$20240702$EXP$GB-MHRA-MED-202406281442381420-RNWGQ$GB-MYLANLABS-2024M1061708$MYLAN$$83$YR$$$Y$$$20240702$$PH$GB$GB
240406201$24040620$1$I$20240604$20240701$20240701$20240701$DIR$708737$$FDA-CTU$$65$YR$$F$N$62.3$KG$20240701$N$HP$US$
240406221$24040622$1$I$20240625$20240701$20240702$20240702$EXP$GB-MHRA-MED-202407011500448070-RNYHF$GB-MYLANLABS-2024M1061815$MYLAN$$73$YR$$F$Y$$$20240702$$PH$GB$GB
240406241$24040624$1$I$20240521$20240625$20240702$20240702$PER$$US-BAYER-2024A093262$BAYER$$23$YR$A$F$Y$$$20240702$$MD$US$US
240406251$24040625$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA186006$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240702$$CN$US$US
240406261$24040626$1$I$$20240702$20240702$20240702$PER$$US-HALEON-2184863$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240406271$24040627$1$I$20240601$20240620$20240702$20240702$PER$$US-SA-2024SA189490$SANOFI AVENTIS$$76$YR$E$F$Y$56.7$KG$20240702$$MD$US$US
240406281$24040628$1$I$$20240619$20240702$20240702$EXP$$US-TEVA-VS-3215597$TEVA$$62$YR$$F$Y$$$20240702$$HP$US$US
240406291$24040629$1$I$$20230621$20240702$20240702$PER$$US-AMGEN-USASP2023235209$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240406301$24040630$1$I$$20231116$20240702$20240702$PER$$US-AMGEN-USASP2023235312$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240406311$24040631$1$I$$20240630$20240702$20240702$EXP$$PL-BAUSCHBL-2024BNL029353$BAUSCH AND LOMB$Sirek S, Woszczek D, Szklarek E, Wilczynski T, Wygl?dowska-Promienska D. Central decompressive vitrectomy with cataract phacoemulsification and implantation of an artificial intraocular lens in the left eye. Case report of a 51-year-old woman suffering from angle closure glaucoma.. Ophthalmology. 2024;XXVII:179-182.$51$YR$$F$Y$$$20240702$$MD$PL$PL
240406322$24040632$2$F$20220101$20240718$20240702$20240801$EXP$$JP-EAGLE PHARMACEUTICALS, INC.-JP-2024EAG000170$EAGLE$$73$YR$$F$Y$$$20240801$$MD$JP$JP
240406331$24040633$1$I$$20240624$20240702$20240702$PER$$US-BAYER-2024A090989$BAYER$$31$YR$A$F$Y$$$20240702$$MD$US$US
240406343$24040634$3$F$$20240816$20240702$20240824$EXP$$US-ALXN-202406USA001964US$ALEXION PHARMACEUTICALS$$$$$M$Y$64.853$KG$20240824$$HP$US$US
240406351$24040635$1$I$20240531$20240701$20240702$20240702$EXP$NO-NOMAADVRE-RELISV-2024-00108$NO-BRISTOL-MYERS SQUIBB COMPANY-2024-104797$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240702$$MD$NO$NO
240406361$24040636$1$I$$20240619$20240702$20240702$PER$$US-MYLANLABS-2024M1057122$MYLAN$$$$$$Y$$$20240702$$CN$US$US
240406371$24040637$1$I$$20240624$20240702$20240702$PER$$US-ABBVIE-5816516$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240406382$24040638$2$F$$20240703$20240702$20240726$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-12455$IPSEN$$$$$M$Y$$$20240726$$MD$US$US
240406393$24040639$3$F$$20240718$20240702$20240920$PER$$US-BRAEBURN-US-BRA-24-000512$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$MD$US$US
240406402$24040640$2$F$20240101$20240709$20240702$20240723$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01021$INTRA-CELLULAR THERAPIES$$3$DEC$$F$Y$$$20240723$$CN$US$US
240406411$24040641$1$I$$20240624$20240702$20240702$PER$$US-BAYER-2024A091366$BAYER$$$$$F$Y$$$20240702$$CN$US$US
240406421$24040642$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA187898$SANOFI AVENTIS$$$$C$F$Y$$$20240702$$CN$US$US
240406432$24040643$2$F$$20240625$20240702$20240724$EXP$$DE-UCBSA-2024033019$UCB$$17$YR$$F$Y$$$20240724$$MD$DE$DE
240406441$24040644$1$I$$20240621$20240702$20240702$PER$$US-MYLANLABS-2024M1057413$MYLAN$$$$$F$Y$$$20240702$$CN$US$US
240406452$24040645$2$F$$20240905$20240702$20240910$PER$$US-BAUSCHBL-2024BNL029131$BAUSCH AND LOMB$$$$$F$Y$$$20240910$$CN$US$US
240406461$24040646$1$I$$20240620$20240702$20240702$PER$$US-BAYER-2024A089533$BAYER$$$$$F$Y$$$20240702$$CN$US$US
240406471$24040647$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3213992$TEVA$$54$YR$$M$Y$112$KG$20240702$$HP$CA$CA
240406481$24040648$1$I$20240601$20240627$20240702$20240702$EXP$DK-DKMA-30733128$DK-009507513-2406DNK009894$MERCK$$76$YR$$M$Y$$$20240702$$MD$DK$DK
240406491$24040649$1$I$20230101$20240607$20240702$20240702$PER$$US-009507513-2406USA003255$MERCK$$$$$F$Y$$$20240702$$CN$US$US
240406504$24040650$4$F$20240627$20240922$20240702$20240925$30DAY$$US-PFIZER INC-202400202706$PFIZER$$51$YR$$M$Y$$$20240925$$CN$US$US
240406543$24040654$3$F$$20240916$20240702$20240919$30DAY$$US-PFIZER INC-202400202727$PFIZER$$7$YR$$M$Y$$$20240919$$CN$US$US
240406554$24040655$4$F$$20240912$20240702$20240913$30DAY$$US-PFIZER INC-202400202610$PFIZER$$10$YR$$M$Y$$$20240913$$CN$US$US
240406563$24040656$3$F$$20240913$20240702$20240918$30DAY$$US-PFIZER INC-202400202998$PFIZER$$11$YR$$M$Y$$$20240918$$CN$US$US
240406592$24040659$2$F$20240601$20240716$20240702$20240718$30DAY$$US-PFIZER INC-202400201844$PFIZER$$89$YR$$M$Y$54.43$KG$20240718$$CN$US$US
240406605$24040660$5$F$$20240821$20240702$20240827$30DAY$$US-PFIZER INC-202400203466$PFIZER$$14$YR$$M$Y$$$20240827$$CN$US$US
240406611$24040661$1$I$$20240624$20240702$20240702$EXP$$ZA-AstraZeneca-2024A145843$ASTRAZENECA$$24837$DY$$F$Y$$$20240702$$CN$ZA$
240406621$24040662$1$I$20240621$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A146098$ASTRAZENECA$$21860$DY$$F$Y$74.4$KG$20240702$$CN$US$
240406631$24040663$1$I$20240101$20240625$20240702$20240702$EXP$$US-UCBSA-2024026944$UCB$$$$$F$Y$$$20240702$$CN$US$US
240406641$24040664$1$I$$20240124$20240702$20240702$PER$$US-AMGEN-USASP2024130018$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240406651$24040665$1$I$$20240627$20240702$20240702$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036864$BOEHRINGER INGELHEIM$$$$$$Y$$$20240702$$HP$US$US
240406661$24040666$1$I$$20240625$20240702$20240702$EXP$$IL-AstraZeneca-2024A151141$ASTRAZENECA$$78$YR$$F$Y$$$20240702$$MD$IL$
240406671$24040667$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05586$LUPIN$Keegan K, Ruff K, Burg G, Berklite LE, Deutsch G, Wikenheiser-Brokamp KA, et al. Surfactant function disorders: Genetics is just the tip of the iceberg. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2305$3$YR$$F$Y$$$20240702$$HP$US$US
240406681$24040668$1$I$$20240621$20240702$20240702$EXP$$US-Zhejiang Yongtai pharmaceuticals Co..,Ltd.-2158768$ZHEJIANG YONGTAI$Source document (Full text)$71$YR$$F$Y$$$20240702$$MD$US$US
240406692$24040669$2$F$20240423$20240715$20240702$20240724$EXP$FR-AFSSAPS-BX2024001177$FR-TEVA-VS-3213132$TEVA$$68$YR$$F$Y$$$20240724$$PH$FR$FR
240406701$24040670$1$I$20240531$20240701$20240701$20240701$DIR$708753$$FDA-CTU$$57$YR$$F$N$47$KG$20240701$N$CN$US$
240406711$24040671$1$I$$20240701$20240701$20240701$DIR$708733$$FDA-CTU$$$$$UNK$N$$$20240701$N$CN$US$
240406721$24040672$1$I$20240522$20240701$20240701$20240701$DIR$708810$$FDA-CTU$$58$YR$$F$N$$$20240701$N$CN$US$
240406731$24040673$1$I$$20240620$20240702$20240702$EXP$$IT-AMNEAL PHARMACEUTICALS-2024-AMRX-02374$AMNEAL$Costantini I, Mantelli G, Carollo M, Losso L, Morando E, et al.. Not only Van Gogh: a case of BRASH syndrome with concomitant digoxin toxicity. J Med Case Rep. 2024;18(1)$66$YR$$F$Y$$$20240702$$HP$IT$IT
240406741$24040674$1$I$$20240620$20240702$20240702$PER$US-MLMSERVICE-20240615-PI097400-00150-2$US-RDY-SPO/USA/24/0009095$DR REDDYS$Sarantopoulos N, Wiltchik E, Thakkar V, Klein W. Fluconazole associated DRESS syndrome in patient with Coccidioidomycosis pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1357. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1357.$59$YR$A$M$Y$$$20240702$$HP$US$US
240406751$24040675$1$I$20240628$20240701$20240701$20240701$DIR$708802$$FDA-CTU$$68$YR$$M$N$87$KG$20240701$N$HP$US$
240406761$24040676$1$I$20240628$20240701$20240701$20240701$DIR$708682$$FDA-CTU$$$$$UNK$N$$$20240701$N$CN$US$
240406771$24040677$1$I$$20240701$20240701$20240701$DIR$708782$$FDA-CTU$$$$$UNK$N$$$20240701$$CN$US$
240406782$24040678$2$F$$20240808$20240702$20240813$EXP$$NVSC2024US127076$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
240406791$24040679$1$I$$20240619$20240702$20240702$EXP$$NVSJ2023JP018010$NOVARTIS$$67$YR$$M$Y$$$20240620$$MD$JP$JP
240406801$24040680$1$I$$20240621$20240702$20240702$PER$$US-BAYER-2024A090498$BAYER$$$$$F$Y$$$20240702$$CN$US$US
240406811$24040681$1$I$20240627$20240701$20240702$20240702$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037292$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240702$$CN$US$US
240406821$24040682$1$I$20240501$20240620$20240702$20240702$EXP$$NVSC2024MX135779$NOVARTIS$$39$YR$$M$Y$$$20240702$$CN$MX$MX
240406831$24040683$1$I$$20240626$20240702$20240702$EXP$$SI-009507513-2406SVN009876$MERCK$Ocepek A. Colitis due to cancer treatment with immune check-point inhibitors - review of literature and presentation of clinical cases. Radiology and Oncology. 2024;58 (2):179-185$75$YR$$M$Y$$$20240702$$HP$SI$SI
240406841$24040684$1$I$$20240617$20240702$20240702$30DAY$$US-JNJFOC-20240643529$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240406852$24040685$2$F$$20240702$20240702$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05612$HIKMA$$$$$$Y$$$20240716$$MD$US$US
240406861$24040686$1$I$20240620$20240624$20240702$20240702$EXP$$US-ALXN-202406USA001852US$ALEXION PHARMACEUTICALS$$76$YR$$M$Y$$$20240702$$CN$US$US
240406871$24040687$1$I$20240101$20240625$20240702$20240702$PER$$US-MYLANLABS-2024M1060767$MYLAN$$43$YR$$F$Y$$$20240702$$CN$US$US
240406881$24040688$1$I$20240622$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128247$AMGEN$$83$YR$E$M$Y$$$20240702$$CN$US$US
240406901$24040690$1$I$20230223$20240603$20240702$20240702$EXP$FR-AFSSAPS-TO2024000894$FR-PFIZER INC-202400185164$PFIZER$$9$YR$$M$Y$25$KG$20240702$$MD$FR$FR
240406911$24040691$1$I$$20230714$20240702$20240702$PER$$US-AMGEN-USASP2023235204$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240406921$24040692$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105467$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$107.05$KG$20240702$$CN$US$US
240406931$24040693$1$I$$20240626$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103241$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240702$$HP$US$US
240406941$24040694$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105358$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$74.39$KG$20240702$$CN$US$US
240406951$24040695$1$I$20240627$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128636$AMGEN$$81$YR$E$F$Y$$$20240702$$HP$US$US
240406961$24040696$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105453$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240702$$HP$US$US
240406971$24040697$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105546$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240702$$CN$US$US
240406981$24040698$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105606$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$63.5$KG$20240702$$CN$US$US
240406991$24040699$1$I$20240624$20240624$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102611$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$148.78$KG$20240702$$CN$US$US
240407001$24040700$1$I$$20240617$20240702$20240702$PER$$US-BAYER-2024A087695$BAYER$$23$YR$A$F$Y$$$20240702$$CN$US$US
240407012$24040701$2$F$$20240906$20240702$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105593$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240916$$CN$US$US
240407021$24040702$1$I$20240101$20240625$20240702$20240702$PER$$US-SA-2024SA192296$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240702$$MD$US$US
240407031$24040703$1$I$20240601$20240620$20240702$20240702$PER$$US-SA-2024SA189142$SANOFI AVENTIS$$47$YR$A$F$Y$52.2$KG$20240702$$MD$US$US
240407041$24040704$1$I$20240501$20240625$20240702$20240702$PER$$US-SA-2024SA192958$SANOFI AVENTIS$$40$YR$A$F$Y$86$KG$20240702$$MD$US$US
240407051$24040705$1$I$$20240627$20240702$20240702$EXP$FR-AFSSAPS-AM2024000522$FR-SA-2024SA192135$SANOFI AVENTIS$$69$YR$E$M$Y$84$KG$20240702$$MD$FR$FR
240407073$24040707$3$F$20240601$20240823$20240702$20240827$EXP$$CA-JNJFOC-20240679078$JOHNSON AND JOHNSON$$16$YR$T$M$Y$42$KG$20240827$$HP$CA$CA
240407082$24040708$2$F$20240401$20240710$20240702$20240724$EXP$$JP-AMGEN-JPNSP2024127925$AMGEN$$76$YR$E$M$Y$$$20240723$$MD$JP$JP
240407091$24040709$1$I$20240101$20240625$20240702$20240702$EXP$$US-TEVA-VS-3214589$TEVA$$17$YR$$F$Y$$$20240702$$HP$US$US
240407101$24040710$1$I$$20240627$20240702$20240702$PER$$US-MYLANLABS-2024M1061329$MYLAN$$$$$M$Y$$$20240702$$MD$US$US
240407111$24040711$1$I$20240101$20240625$20240702$20240702$PER$$US-TEVA-VS-3213753$TEVA$$$$$$Y$$$20240702$$CN$US$US
240407122$24040712$2$F$$20240624$20240702$20240710$EXP$$JP-009507513-2406JPN003535J$MERCK$Suzuki K, Fukazawa E, Yamamoto Y, Fujita Y, Shiratori K, Shibata T, et al.. C-03 A case of suspected immune-related adverse event (irAE) meningitis induced by pembrolizumab in a patient with postoperative recurrence of lung adenocarcinoma. Joint Meeting of the 143rd Tokai Branch Meeting of the Japanese Society for Tube. 28$8$DEC$$M$Y$$$20240710$$MD$JP$JP
240407131$24040713$1$I$20240624$20240627$20240702$20240702$EXP$$JP-GEHPL-2024JSU007271AA$GE HEALTHCARE$$8$DEC$$M$Y$$$20240702$$CN$JP$JP
240407141$24040714$1$I$20240523$20240617$20240702$20240702$EXP$$CA-ROCHE-10000013118$ROCHE$$62$YR$A$M$Y$103$KG$20240702$$HP$CA$CA
240407151$24040715$1$I$20240621$20240624$20240702$20240702$EXP$$CN-GE HEALTHCARE-2024CSU007097$GE HEALTHCARE$$21$YR$$M$Y$105$KG$20240702$$HP$CN$CN
240407161$24040716$1$I$$20240618$20240702$20240702$EXP$$US-ENDO USA, INC.-2024-002683$ENDO$Teplitsky E, Khedekar M, Cookman C.. A Case of Dexlansoprazole Induced Lupus Presenting With Pericardial and Pleural Effusions. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1926$75$YR$$F$Y$$$20240702$$HP$US$US
240407171$24040717$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05457$LUPIN$Ebong IL, Delgado A, Aranda SS, Shonibare OO, Aryal S, Karki B, et al. Idiopathic intracranial hypertension in an adolescent with recent human immunodeficiency virus (HIV) diagnosis: A challenging etiological dilemma. Cureus. 2024;16(5):e60001:1-6$15$YR$$F$Y$$$20240702$$MD$US$US
240407181$24040718$1$I$$20240620$20240702$20240702$PER$US-MLMSERVICE-20240613-PI099876-00306-1$US-RDY-SPO/USA/24/0009079$DR REDDYS$Deanda S, Razia D, Zaidi W, Lee R, Arjuna A. post-transplant lymphoproliferative disorder: A nodular area that kept growing. American Journal of Respiratory and Critical Care Medicine. 2024:209. DOI: 10.1164/ajrccm-conference.2024:209.1_MeetingAbstracts.A5942.$82$YR$E$F$Y$$$20240702$$MD$US$US
240407191$24040719$1$I$20240625$20240625$20240702$20240702$PER$$US-BRACCO-2024US03772$BRACCO$$80$YR$$M$Y$$$20240702$$MD$US$US
240407201$24040720$1$I$$20240619$20240702$20240702$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02413$AMNEAL$Blohm JE, Choi HJ, Jakharia K.. No-lax-zone: Side Effects That Can Steal Your Breath Away. Am J Respir Crit Care Med. 2024;209$24$YR$$M$Y$$$20240702$$HP$US$US
240407211$24040721$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000010869$ROCHE$Kathuria N, Lopez L, Raman S, Ye H, Anaokar J, Sisk A, et al. ALK Inhibition With Alectinib for Refractory Metastatic Renal Cell Carcinoma With ALK Rearrangement: A Rare Case Report and Literature Review. JCO precision oncology. 2024-Jun;8:e2400154. doi:10.1200/PO.24.00154.$64$YR$A$M$Y$$$20240702$$HP$US$US
240407221$24040722$1$I$$20240201$20240702$20240702$PER$$US-AMGEN-USASP2024129512$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240407231$24040723$1$I$$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128619$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240407241$24040724$1$I$$20240228$20240702$20240702$PER$$US-AMGEN-USASP2024129492$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240407251$24040725$1$I$$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024127057$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240407262$24040726$2$F$20240618$20240723$20240702$20240806$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0601138$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
240407281$24040728$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281434234840-MKDNF$GB-ORGANON-O2407GBR000124$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240407291$24040729$1$I$$20240619$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05898$HIKMA$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM.. Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.. Arch. Dermatol. Res. 2024;316(6):279$26$YR$$F$Y$$$20240702$$MD$US$US
240407301$24040730$1$I$$20240628$20240702$20240702$EXP$$US-GILEAD-2024-0679101$GILEAD$$76$YR$E$M$Y$$$20240702$$HP$US$US
240407313$24040731$3$F$20240101$20240628$20240702$20240820$EXP$$HU-ABBVIE-5821358$ABBVIE$$60$YR$$F$Y$$$20240820$$MD$HU$HU
240407323$24040732$3$F$$20240722$20240702$20240724$PER$$US-HALEON-2184554$Haleon PLC$$59$YR$$F$Y$$$20240724$$CN$US$US
240407331$24040733$1$I$20230409$20240701$20240701$20240701$DIR$708741$$FDA-CTU$$63$YR$$M$N$91.8$KG$20240701$N$CN$US$
240407341$24040734$1$I$$20240624$20240702$20240702$EXP$$US-MYLANLABS-2024M1058435$MYLAN$$$$$$Y$$$20240702$$CN$US$US
240407351$24040735$1$I$20240101$20240618$20240702$20240702$EXP$$US-INSMED, INC.-2024-01904-US$INSMED$$$$$M$Y$$$20240702$$CN$US$US
240407363$24040736$3$F$20240101$20240806$20240702$20240821$EXP$$US-INSMED, INC.-2024-01289-US$INSMED$$$$$F$Y$$$20240821$$CN$US$US
240407371$24040737$1$I$$20240627$20240702$20240702$EXP$$CA-JNJFOC-20240675904$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240702$$HP$CA$CA
240407381$24040738$1$I$20240620$20240701$20240702$20240702$EXP$$CN-ROCHE-10000013522$ROCHE$$56$YR$A$F$Y$64$KG$20240702$$HP$CN$CN
240407391$24040739$1$I$$20240624$20240702$20240702$EXP$$ZA-AstraZeneca-2024A147130$ASTRAZENECA$$67$YR$$M$Y$$$20240702$$CN$ZA$
240407401$24040740$1$I$$20240701$20240701$20240701$DIR$708706$$FDA-CTU$$52$YR$$M$N$78.75$KG$20240701$N$CN$US$
240407411$24040741$1$I$20240629$20240701$20240701$20240701$DIR$708807$$FDA-CTU$$52$YR$$F$N$99$KG$20240701$N$CN$US$
240407421$24040742$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46069$$FDA-CTU$$62$YR$$F$N$$$20240701$N$PH$US$
240407431$24040743$1$I$20231101$20240624$20240702$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-105197$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240702$$PH$JP$JP
240407441$24040744$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105437$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$95.71$KG$20240702$$HP$US$US
240407451$24040745$1$I$20240604$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A149572$ASTRAZENECA$$$$$F$Y$$$20240702$$MD$US$
240407462$24040746$2$F$20240101$20240710$20240702$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105636$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$79.38$KG$20240714$$CN$US$US
240407472$24040747$2$F$$20240730$20240702$20240802$EXP$$JP-BAYER-2024A093323$BAYER$$66$YR$E$F$Y$$$20240802$$MD$JP$JP
240407481$24040748$1$I$$20240628$20240702$20240702$PER$$US-AMGEN-USASP2024129340$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240407491$24040749$1$I$$20240416$20240702$20240702$PER$$US-AMGEN-USASP2024129961$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240407501$24040750$1$I$20080101$20240625$20240702$20240702$EXP$$CN-SA-2024SA190264$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240702$$CN$CN$CN
240407511$24040751$1$I$$20240624$20240702$20240702$PER$$US-MYLANLABS-2024M1058480$MYLAN$$$$$$Y$$$20240702$$CN$US$US
240407521$24040752$1$I$$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024126158$AMGEN$Lavin L.; Chefitz G.; Patel D. et al.. Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect. JAAD Case Reports. 2024;49:40-43$74$YR$E$F$Y$$$20240702$$HP$US$US
240407532$24040753$2$F$$20240718$20240702$20240723$EXP$$JP-JNJFOC-20240703010$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$MD$JP$JP
240407551$24040755$1$I$20240515$20240627$20240702$20240702$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0601222$MYOVANT SCIENCES$$87$YR$$M$Y$$$20240702$$CN$US$US
240407571$24040757$1$I$20240628$20240701$20240702$20240702$EXP$$US-TAKEDA-2024TUS066164$TAKEDA$$51$YR$$F$Y$$$20240702$$CN$US$US
240407581$24040758$1$I$20240625$20240626$20240701$20240701$DIR$FDA-CDER-CTU-2024-46060$$FDA-CTU$$44$YR$$F$N$$$20240626$N$PH$US$
240407591$24040759$1$I$$20240627$20240702$20240702$EXP$$US-GILEAD-2024-0679049$GILEAD$$$$A$F$Y$$$20240702$$CN$US$US
240407601$24040760$1$I$$20230724$20240702$20240702$PER$$US-AMGEN-USASP2023235281$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240407612$24040761$2$F$20240614$20240817$20240702$20240826$EXP$$CA-CELLTRION INC.-2024CA015795$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
240407621$24040762$1$I$$20240630$20240701$20240701$DIR$FDA-CDER-CTU-2024-46044$$FDA-CTU$$$$$F$N$$$20240630$N$HP$US$
240407632$24040763$2$F$20240627$20240704$20240702$20240708$PER$$US-AMGEN-USASP2024129624$AMGEN$$16$YR$T$$Y$$$20240708$$CN$US$US
240407672$24040767$2$F$20240629$20240718$20240702$20240724$EXP$$AE-TAKEDA-2024TUS066187$TAKEDA$$$$$$Y$$$20240724$$MD$AE$AE
240407682$24040768$2$F$$20240729$20240702$20240807$EXP$$JP-ABBVIE-5822670$ABBVIE$$$$$$Y$$$20240807$$MD$JP$JP
240407691$24040769$1$I$$20240619$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-05902$HIKMA$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316(6):279$49$YR$$F$Y$$$20240702$$MD$US$US
240407701$24040770$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187738$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240702$$MD$US$US
240407711$24040771$1$I$$20240621$20240702$20240702$EXP$$IN-ROCHE-10000008361$ROCHE$$59$YR$A$F$Y$$$20240702$$HP$IN$IN
240407722$24040772$2$F$20240501$20240903$20240702$20240914$PER$$US-SA-2024SA192217$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240914$$MD$US$US
240407731$24040773$1$I$20240528$20240624$20240702$20240702$EXP$$CN-SA-2024SA189730$SANOFI AVENTIS$$59$YR$A$F$Y$53$KG$20240702$$HP$CN$CN
240407741$24040774$1$I$$20240617$20240702$20240702$EXP$$RU-MELINTA THERAPEUTICS, LLC-RU-MLNT-24-00324$Unknown Manufacturer$Ignatova GL, Antonov VN, Zakharova IA.. Clinical case of indacaterol/glycopyrronium bromide prescription in a patient with severe COPD and concomitant pathology.. Meditsinskiy Sovet. 2024;18(9):27-3$$$$$Y$$$20240702$$HP$RU$RU
240407752$24040775$2$F$20240618$20240812$20240702$20240816$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-009710$JAZZ$$$$$$Y$$$20240816$$MD$IT$IT
240407761$24040776$1$I$20231214$20240208$20240702$20240702$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000067$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240702$$MD$US$US
240407771$24040777$1$I$20240609$20240627$20240702$20240702$EXP$$US-GILEAD-2024-0679051$GILEAD$$75$YR$E$M$Y$$$20240702$$CN$US$US
240407781$24040778$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05565$LUPIN$Hamad HM, Miett T, Kopec S.. Statin and Fenofibrate-Induced rhabdomyolysis in liver transplant; A case of multiple organ dysfunction. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5694$49$YR$$M$Y$$$20240702$$HP$US$US
240407791$24040779$1$I$$20240625$20240702$20240702$PER$$US-ALXN-202406USA001698US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
240407801$24040780$1$I$$20240629$20240702$20240702$PER$$US-HALEON-2184761$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240407823$24040782$3$F$$20240723$20240702$20240730$EXP$$US-TAKEDA-2024TUS065874$TAKEDA$$$$$F$Y$$$20240730$$CN$US$US
240407833$24040783$3$F$20240624$20240916$20240702$20240924$EXP$$US-JNJFOC-20240675416$JOHNSON AND JOHNSON$$57$YR$A$M$Y$202$KG$20240924$$CN$US$US
240407841$24040784$1$I$20160808$20240626$20240702$20240702$EXP$$CA-TAKEDA-2021TUS034834$TAKEDA$$24$YR$$F$Y$$$20240702$$HP$CA$CA
240407852$24040785$2$F$20180316$20240916$20240702$20240923$EXP$$CA-TAKEDA-2018TUS003558$TAKEDA$$54$YR$$F$Y$$$20240923$$CN$CA$CA
240407861$24040786$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2023AP017760$APOTEX$$68$YR$$M$Y$$$20240702$$HP$CA$CA
240407871$24040787$1$I$$20240617$20240702$20240702$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091827$GLENMARK$Singh M, Kuo J, Raza A.. Lamotrigine induced drug reaction with eosinophilia with systemic symptoms (dress)with hhv-6 reactivation causing severe encephalitis and status epilepticus.. American journal of respiratory and critical care medicine.. 2024;209:A1358$$$$$Y$$$20240702$$MD$US$US
240407882$24040788$2$F$$20240913$20240702$20240917$EXP$$US-PFIZER INC-PV202400085571$PFIZER$$60$YR$$$Y$$$20240917$$CN$US$US
240407898$24040789$8$F$20240707$20240823$20240702$20240828$30DAY$$US-PFIZER INC-PV202400084662$PFIZER$$62$YR$$M$Y$74.84$KG$20240828$$CN$US$US
240407911$24040791$1$I$20240629$20240701$20240701$20240701$DIR$708754$$FDA-CTU$$66$YR$$F$N$74.3$KG$20240701$N$PH$US$
240407921$24040792$1$I$$20240701$20240701$20240701$DIR$708770$$FDA-CTU$$$$$UNK$N$$$20240701$N$CN$US$
240407931$24040793$1$I$$20240628$20240702$20240702$PER$$US-GILEAD-2024-0679077$GILEAD$$41$YR$A$M$Y$$$20240702$$CN$US$US
240407941$24040794$1$I$20240630$20240701$20240701$20240701$DIR$708759$$FDA-CTU$$29$YR$$F$N$54$KG$20240701$N$CN$US$
240407951$24040795$1$I$20240701$20240701$20240701$20240701$DIR$708812$$FDA-CTU$$39$YR$$F$N$96.75$KG$20240701$N$CN$US$
240407971$24040797$1$I$$20240629$20240701$20240701$DIR$FDA-CDER-CTU-2024-46036$$FDA-CTU$$$$$F$N$$$20240629$N$HP$US$
240407981$24040798$1$I$20240601$20240626$20240702$20240702$PER$$US-MYLANLABS-2024M1060503$MYLAN$$60$YR$$F$Y$54.43$KG$20240702$$CN$US$US
240407991$24040799$1$I$$20240627$20240702$20240702$EXP$$CA-TAKEDA-2024TUS065307$TAKEDA$$$$$F$Y$$$20240702$$CN$CA$CA
240408002$24040800$2$F$20240522$20240710$20240702$20240715$PER$$US-AMGEN-USASP2024125007$AMGEN$$$$$$Y$$$20240715$$HP$US$US
240408012$24040801$2$F$$20240628$20240702$20240704$PER$$US-AMGEN-USASP2024129353$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240408021$24040802$1$I$20240613$20240701$20240701$20240701$DIR$708767$$FDA-CTU$$74$YR$$F$N$82.1$KG$20240701$N$HP$US$
240408031$24040803$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46052$$FDA-CTU$$60$YR$$F$N$$$20240701$N$$US$
240408041$24040804$1$I$$20240701$20240701$20240701$DIR$708700$$FDA-CTU$$$$$UNK$N$$$20240701$$CN$US$
240408051$24040805$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-45963$$FDA-CTU$$58$YR$$M$N$$$20240701$N$$US$
240408061$24040806$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46049$$FDA-CTU$$29$YR$$F$N$122.47$KG$20240701$N$$US$
240408071$24040807$1$I$20240501$20240701$20240701$20240701$DIR$708797$$FDA-CTU$$37$YR$$F$N$51.75$KG$20240701$N$CN$US$
240408081$24040808$1$I$20231215$20240701$20240701$20240701$DIR$708804$$FDA-CTU$$73$YR$$F$N$155.25$KG$20240701$N$CN$US$
240408091$24040809$1$I$$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46058$$FDA-CTU$$53$YR$$M$N$$$20240701$N$$US$
240408111$24040811$1$I$$20240628$20240701$20240701$DIR$FDA-CDER-CTU-2024-46073$$FDA-CTU$$$$$F$N$$$20240628$N$HP$US$
240408122$24040812$2$F$20240525$20240731$20240702$20240813$EXP$$US-UCBSA-2024033287$UCB$$50$YR$$F$Y$69.841$KG$20240813$$HP$US$US
240408131$24040813$1$I$$20240610$20240702$20240702$EXP$$FR-ROCHE-10000013091$ROCHE$$$$$$Y$$$20240702$$PH$FR$FR
240408152$24040815$2$F$$20240830$20240702$20240830$EXP$$NVSC2024US134583$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
240408161$24040816$1$I$20240624$20240627$20240702$20240702$PER$$NVSC2024US135188$NOVARTIS$$70$YR$$$Y$$$20240702$$CN$US$US
240408172$24040817$2$F$$20240821$20240702$20240828$PER$$US-ROCHE-10000014105$ROCHE$$13$YR$T$F$Y$$$20240828$$MD$US$US
240408181$24040818$1$I$$20240628$20240702$20240702$PER$$US-BIOGEN-2024BI01271099$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
240408192$24040819$2$F$$20240717$20240702$20240722$EXP$$US-ROCHE-10000009843$ROCHE$$78$YR$E$F$Y$$$20240722$$MD$US$US
240408201$24040820$1$I$$20240514$20240702$20240702$PER$$US-AMGEN-USASP2024130008$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240408211$24040821$1$I$$20230731$20240702$20240702$PER$$US-AMGEN-USASP2023235107$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240408221$24040822$1$I$$20240625$20240702$20240702$EXP$$AU-ROCHE-10000011147$ROCHE$Reporter known to authority ,  Unknown. Unknown.$67$YR$E$$Y$$$20240702$$HP$AU$AU
240408231$24040823$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104808$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240702$$HP$US$US
240408252$24040825$2$F$20240611$20240627$20240702$20240705$EXP$$JP-ROCHE-10000008391$ROCHE$$76$YR$E$M$Y$$$20240706$$MD$JP$JP
240408262$24040826$2$F$20240101$20240802$20240702$20240815$EXP$ES-ABBVIE-5764286$ES-ACORDA-ACO_177467_2024$ACORDA$$$$$$Y$$$20240815$$CN$ES$ES
240408272$24040827$2$F$20240601$20240624$20240702$20240709$EXP$$US-Eisai-EC-2024-169257$EISAI$$75$YR$E$M$Y$$$20240709$$CN$US$US
240408281$24040828$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA188128$SANOFI AVENTIS$$$$A$F$Y$45.351$KG$20240702$$MD$US$US
240408291$24040829$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA188188$SANOFI AVENTIS$$$$T$F$Y$83.91$KG$20240702$$MD$US$US
240408301$24040830$1$I$20240618$20240701$20240702$20240702$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037143$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240702$$CN$US$US
240408311$24040831$1$I$$20240617$20240702$20240702$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091834$GLENMARK$Gupta UD, Chowdhury T, Niriyan J, Bellamkonda A, Aryal B, Al-Ghuraibawi M. Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care.. American Journal of Respiratory and Critical Care Medicine.. 2024;209$$$$$Y$$$20240702$$MD$US$US
240408323$24040832$3$F$$20240807$20240702$20240808$EXP$$CA-BAYER-2024A094992$BAYER$$$$$F$Y$$$20240808$$HP$CA$CA
240408333$24040833$3$F$$20240829$20240702$20240903$EXP$$CA-TAKEDA-2024TUS065373$TAKEDA$$$$$F$Y$$$20240903$$CN$CA$CA
240408341$24040834$1$I$20221025$20240626$20240702$20240702$EXP$SE-SEMPA-2022-022772$SE-TAKEDA-2024TUS063673$TAKEDA$$31$YR$$F$Y$$$20240702$$HP$SE$SE
240408351$24040835$1$I$$20240625$20240702$20240702$EXP$$CA-JNJFOC-20240671627$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240702$$PH$CA$CA
240408361$24040836$1$I$20240621$20240627$20240702$20240702$PER$$US-MYLANLABS-2024M1061141$MYLAN$$62$YR$$F$Y$$$20240702$$CN$US$US
240408371$24040837$1$I$20240528$20240626$20240702$20240702$EXP$$CN-DSJP-DSJ-2024-129409$DAIICHI$$60$YR$$M$Y$72$KG$20240702$$HP$CN$CN
240408382$24040838$2$F$20240101$20240703$20240702$20240708$EXP$$GB-DSJP-DSE-2024-121393$DAIICHI$$58$YR$$F$Y$72.8$KG$20240708$$HP$GB$GB
240408392$24040839$2$F$$20240627$20240702$20240702$EXP$$US-GILEAD-2024-0679025$GILEAD$$$$$F$Y$$$20240702$$HP$US$US
240408401$24040840$1$I$$20240628$20240702$20240702$EXP$$US-INCYTE CORPORATION-2024IN006922$INCYTE$$$$$$Y$$$20240702$$MD$US$US
240408411$24040841$1$I$$20240627$20240702$20240702$EXP$$US-INCYTE CORPORATION-2024IN006910$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240408421$24040842$1$I$20240601$20240618$20240702$20240702$PER$$US-GRANULES-US-2024GRASPO00242$GRANULES INDIA$$$$$F$Y$$$20240702$$CN$US$US
240408431$24040843$1$I$$20240623$20240702$20240702$EXP$$US-Prasco Laboratories-PRAS20241003$PRASCO$Barnett B, Koons C, Van den Eynde V, Gillman P, Bodkin J. Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine. Journal of Psychoactive Drugs. 2024 JUN 21;1-7. doi:10.1080/02791072.2024.2368617$42$YR$A$M$Y$$$20240702$$HP$US$US
240408441$24040844$1$I$20240601$20240621$20240702$20240702$PER$$US-SA-2024SA188213$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240702$$MD$US$US
240408451$24040845$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA191893$SANOFI AVENTIS$$$$E$M$Y$122$KG$20240702$$MD$US$US
240408461$24040846$1$I$20240601$20240620$20240702$20240702$PER$$US-SA-2024SA188224$SANOFI AVENTIS$$53$YR$A$F$Y$113.3$KG$20240702$$MD$US$US
240408471$24040847$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA188275$SANOFI AVENTIS$$$$T$F$Y$54.4$KG$20240702$$MD$US$US
240408481$24040848$1$I$$20240627$20240702$20240702$EXP$$US-INCYTE CORPORATION-2024IN006904$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240408501$24040850$1$I$$20240625$20240702$20240702$PER$$US-JNJFOC-20240675211$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240408511$24040851$1$I$$20240619$20240702$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05548$LUPIN$$$$$$Y$$$20240702$$CN$US$US
240408521$24040852$1$I$20240101$20240626$20240702$20240702$EXP$$NVSC2024DE135501$NOVARTIS$$$$A$F$Y$$$20240702$$CN$DE$DE
240408531$24040853$1$I$$20240625$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006795$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240408551$24040855$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3214224$TEVA$$61$YR$$M$Y$$$20240702$$HP$CA$CA
240408561$24040856$1$I$20240601$20240629$20240701$20240701$DIR$FDA-CDER-CTU-2024-46024$$FDA-CTU$$74$YR$$F$N$$$20240629$N$HP$US$
240408571$24040857$1$I$20240629$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46045$$FDA-CTU$$65$YR$$M$N$$$20240701$N$HP$US$
240408581$24040858$1$I$$20240627$20240702$20240702$EXP$$CA-PFIZER INC-202400202436$PFIZER$$80$YR$$F$Y$$$20240702$$MD$CA$CA
240408591$24040859$1$I$$20240617$20240702$20240702$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091846$GLENMARK$Raymond-Forde S, Raymond-Forde S, Godfrey AM, Alexander KR.. The Gift of a Heart, With Strings Attached: A Case of Strongyloides Stercoralis Hyperinfection Syndrome With Fulminant Respiratory Failure.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A1134$$$$$Y$$$20240702$$MD$US$US
240408601$24040860$1$I$$20240626$20240702$20240702$PER$$US-HALEON-2184158$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240408611$24040861$1$I$20240627$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128801$AMGEN$$75$YR$E$M$Y$$$20240702$$CN$US$US
240408621$24040862$1$I$$20230125$20240702$20240702$PER$$US-AMGEN-USASP2023235229$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240408631$24040863$1$I$20240621$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024129213$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240408641$24040864$1$I$20240614$20240628$20240702$20240702$EXP$$DE-ABBVIE-5821755$ABBVIE$$43$YR$$M$Y$97$KG$20240702$$MD$DE$DE
240408651$24040865$1$I$20240627$20240628$20240702$20240702$EXP$$US-MYLANLABS-2024M1061702$MYLAN$$42$YR$$M$Y$$$20240702$$HP$US$US
240408661$24040866$1$I$20240627$20240628$20240702$20240702$EXP$$US-MYLANLABS-2024M1061679$MYLAN$$31$YR$$M$Y$$$20240702$$HP$US$US
240408671$24040867$1$I$20240323$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281137402150-JMBTC$GB-MYLANLABS-2024M1061532$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240408681$24040868$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281446000970-SKTYP$GB-MYLANLABS-2024M1061606$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240408692$24040869$2$F$$20240708$20240702$20240711$EXP$GB-MHRA-MED-202406281431213880-YGRFD$GB-MYLANLABS-2024M1061565$MYLAN$$$$$$Y$$$20240711$$CN$GB$GB
240408701$24040870$1$I$$20240628$20240702$20240702$EXP$$US-MYLANLABS-2024M1061691$MYLAN$$$$$F$Y$$$20240702$$CN$US$US
240408711$24040871$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281437236830-WVLTH$GB-MYLANLABS-2024M1061751$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240408721$24040872$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281435011580-DLRNY$GB-MYLANLABS-2024M1061546$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240408731$24040873$1$I$20240617$20240628$20240702$20240702$EXP$$US-MYLANLABS-2024M1061456$MYLAN$$72$YR$$M$Y$$$20240702$$PH$US$US
240408741$24040874$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281412466070-YKBNQ$GB-MYLANLABS-2024M1061541$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240408752$24040875$2$F$$20240813$20240702$20240819$EXP$$US-MYLANLABS-2024M1061448$MYLAN$$$$$M$Y$107.95$KG$20240819$$PH$US$US
240408761$24040876$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281040200250-ZJMNR$GB-MYLANLABS-2024M1061542$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240408771$24040877$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281419074630-BMTGL$GB-MYLANLABS-2024M1061650$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240408781$24040878$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281456410520-PYKZQ$GB-MYLANLABS-2024M1061754$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240408791$24040879$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406291149288680-KLQWZ$GB-MYLANLABS-2024M1061445$MYLAN$$$$$M$Y$78$KG$20240702$$CN$GB$GB
240408801$24040880$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281432464540-VLDZP$GB-MYLANLABS-2024M1061552$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240408811$24040881$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406251045593230-ZSKLH$GB-MYLANLABS-2024M1061405$MYLAN$$$$$F$Y$$$20240702$$CN$GB$GB
240408822$24040882$2$F$$20240708$20240702$20240711$EXP$GB-MHRA-MED-202406281442341590-SCYTR$GB-MYLANLABS-2024M1061584$MYLAN$$$$$$Y$$$20240711$$CN$GB$GB
240408831$24040883$1$I$$20240628$20240702$20240702$EXP$$US-MYLANLABS-2024M1061502$MYLAN$$$$$F$Y$$$20240702$$CN$US$US
240408841$24040884$1$I$$20240628$20240702$20240702$EXP$$US-MYLANLABS-2024M1061561$MYLAN$$$$$F$Y$$$20240702$$CN$US$US
240408851$24040885$1$I$20240513$20240628$20240702$20240702$EXP$$GB-MYLANLABS-2024M1061278$MYLAN$$63$YR$$F$Y$83$KG$20240702$$CN$GB$GB
240408862$24040886$2$F$$20240708$20240702$20240711$EXP$GB-MHRA-MED-202406281439120430-SHLWN$GB-MYLANLABS-2024M1061568$MYLAN$$$$$$Y$$$20240711$$CN$GB$GB
240408871$24040887$1$I$20210401$20240625$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006788$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240408881$24040888$1$I$20230101$20240626$20240702$20240702$EXP$$US-ABBVIE-5552933$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240408891$24040889$1$I$20240602$20240627$20240702$20240702$EXP$$GB-AstraZeneca-2024A148649$ASTRAZENECA$$81$YR$$M$Y$$$20240702$$MD$GB$
240408901$24040890$1$I$$20240621$20240702$20240702$PER$$US-RDY-LIT/USA/24/0009158$DR REDDYS$Faryad S, Tran J, Prasad B. VAGAL NERVE STIMULATOR-INDUCED SLEEP DISORDERED BREATHING. Sleep. 2024;47: A522-A523. doi:10.1093/sleep/zsae067.01225.$40$YR$A$F$Y$$$20240702$$HP$US$US
240408911$24040891$1$I$$20240621$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05814$HIKMA$$$$$M$Y$$$20240702$$HP$US$US
240408922$24040892$2$F$20240624$20240805$20240702$20240806$PER$$US-ALXN-202406USA001627US$ALEXION PHARMACEUTICALS$$14$YR$$F$Y$$$20240806$$CN$US$US
240408931$24040893$1$I$$20240620$20240702$20240702$PER$$US-AstraZeneca-2024A143720$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240408941$24040894$1$I$$20240603$20240702$20240702$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000111$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240702$$MD$US$US
240408951$24040895$1$I$$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A149970$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240408961$24040896$1$I$$20240625$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006778$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240408971$24040897$1$I$$20240620$20240702$20240702$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-027666$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240702$$HP$JP$JP
240408991$24040899$1$I$$20240620$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05751$HIKMA$Landis AR, Minish J, Zouk AN.. Landis AR, Minish J, Zouk AN. A Case of Kaposi Sarcoma masquerading as bilateral pleural effusions in a patient with orthotopic heart transplant.. American Journal of Respiratory and Critical Care Medicine. 2024;209:/$58$YR$$M$Y$$$20240702$$MD$US$US
240409001$24040900$1$I$$20240618$20240702$20240702$PER$$US-GRANULES-US-2024GRASPO00243$GRANULES INDIA$$$$$$Y$$$20240702$$CN$US$US
240409011$24040901$1$I$$20240619$20240702$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05116$LUPIN$$$$$$Y$$$20240702$$PH$US$US
240409021$24040902$1$I$20240101$20240606$20240702$20240702$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000116$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240702$$CN$US$US
240409034$24040903$4$F$20240617$20240718$20240702$20240730$30DAY$$US-JNJFOC-20240647835$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240730$$CN$US$US
240409041$24040904$1$I$$20240620$20240702$20240702$EXP$$JP-ROCHE-10000009015$ROCHE$$$$$M$Y$$$20240702$$MD$JP$JP
240409051$24040905$1$I$$20240628$20240702$20240702$PER$$NVSC2024US136761$NOVARTIS$$51$YR$$F$Y$$$20240702$$CN$US$US
240409062$24040906$2$F$20231229$20240702$20240702$20240730$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000120$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240730$$CN$US$US
240409073$24040907$3$F$20240101$20240821$20240702$20240828$EXP$$CA-CELLTRION INC.-2024CA015952$CELLTRION$$$$$$Y$$$20240828$$CN$CA$CA
240409081$24040908$1$I$$20240617$20240702$20240702$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091991$GLENMARK$Radhakrishnan S, Safdar H, Gubeladze T, Reed M.. An Unusual Presentation of Mycobacterium Fortuitum With Classical Findings of Pleuroparenchymal Fibroelastosis on Imaging. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240702$$HP$US$US
240409093$24040909$3$F$$20240801$20240702$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103932$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240805$$CN$US$US
240409101$24040910$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104952$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240702$$CN$US$US
240409111$24040911$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105503$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$62.6$KG$20240702$$CN$US$US
240409121$24040912$1$I$$20240701$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105398$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240702$$HP$US$US
240409131$24040913$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105466$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240702$$CN$US$US
240409141$24040914$1$I$$20240618$20240702$20240702$EXP$$US-ADMA BIOLOGICS INC.-US-2024ADM000094$ADMA BIOLOGICS$Ali R., Mirza T.M., Malik M., Golubykh K., Kovalenko I., Bobrysheva H. et al.. Guillain-Barre Syndrome With Concurrent Implantable Cardioverter- Defibrillator Related Endocarditis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1643$57$YR$$M$Y$$$20240702$$HP$US$US
240409152$24040915$2$F$$20240722$20240702$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105352$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240725$$HP$US$US
240409161$24040916$1$I$$20240618$20240702$20240702$EXP$$US-ADMA BIOLOGICS INC.-US-2024ADM000093$ADMA BIOLOGICS$Ali R., Mirza T.M., Malik M., Golubykh K., Kovalenko I., Bobrysheva H. et al.. Guillain-Barre Syndrome With Concurrent Implantable Cardioverter- Defibrillator Related Endocarditis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1643$57$YR$$M$Y$$$20240702$$HP$US$US
240409172$24040917$2$F$$20240704$20240702$20240712$EXP$$US-TEVA-VS-3213886$TEVA$Sohn A, Sanchez G, Mantopoulos D. Partial thickness subfoveal hole in a patient treated with tamoxifen: a case report and review of the literature. [Review]. J-Med-Case-Rep 2022; 16 (1): 1-5.; Sohn A, Sanchez G, Mantopoulos D. Partial thickness subfoveal hole in a patient treated with tamoxifen: a case report and review of the literature. [Review]. J-Med-Case-Rep 2022; 16 (1): 1-5.; Sohn A, Sanchez G, Mantopoulos D. Partial thickness subfoveal hole in a patient treated with tamoxifen: a case ...$76$YR$$F$Y$$$20240712$$HP$US$US
240409182$24040918$2$F$20240526$20240621$20240702$20240709$EXP$$CN-SA-2024SA189277$SANOFI AVENTIS$$62$YR$A$M$Y$58$KG$20240709$$HP$CN$CN
240409191$24040919$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3213948$TEVA$$56$YR$$F$Y$$$20240702$$HP$CA$CA
240409201$24040920$1$I$$20240627$20240702$20240702$EXP$$US-MYLANLABS-2024M1061279$MYLAN$$$$$M$Y$$$20240702$$HP$US$US
240409211$24040921$1$I$20240618$20240624$20240702$20240702$EXP$$US-Vifor (International) Inc.-VIT-2024-05728$VIFOR$$69$YR$$F$Y$119$KG$20240702$$HP$US$US
240409221$24040922$1$I$20240627$20240627$20240702$20240702$EXP$$US-MYLANLABS-2024M1061264$MYLAN$$20$YR$$M$Y$$$20240702$$CN$US$US
240409241$24040924$1$I$20240522$20240621$20240702$20240702$EXP$GB-MHRA-MED-202406210859273550-PQDVB$GB-NOVOPROD-1245215$NOVO NORDISK$$43$YR$$F$Y$$$20240702$$MD$GB$GB
240409251$24040925$1$I$20240614$20240621$20240702$20240702$EXP$GB-MHRA-MED-202406210739203770-PDQWY$GB-NOVOPROD-1245211$NOVO NORDISK$$46$YR$$F$Y$72$KG$20240702$$CN$GB$GB
240409261$24040926$1$I$$20240520$20240702$20240702$PER$$US-AMGEN-USASP2024130026$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240409272$24040927$2$F$$20240723$20240702$20240727$PER$$US-AMGEN-USASP2024128813$AMGEN$$61$YR$A$M$Y$$$20240727$$PH$US$US
240409281$24040928$1$I$$20230502$20240702$20240702$PER$$US-AMGEN-USASP2023235299$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240409291$24040929$1$I$$20230918$20240702$20240702$PER$$US-AMGEN-USASP2023235279$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240409302$24040930$2$F$20240624$20240724$20240702$20240729$PER$$US-JNJFOC-20240663775$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240729$$PH$US$US
240409311$24040931$1$I$20240623$20240624$20240702$20240702$PER$$US-SA-2024SA189013$SANOFI AVENTIS$$$$$F$Y$$$20240702$$MD$US$US
240409321$24040932$1$I$20240101$20240621$20240702$20240702$PER$$US-SA-2024SA187492$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240702$$MD$US$US
240409332$24040933$2$F$$20240625$20240702$20240703$EXP$$DE-AstraZeneca-2024A147592$ASTRAZENECA$$$$E$M$Y$$$20240703$$MD$DE$
240409341$24040934$1$I$20220801$20240625$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006783$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240409352$24040935$2$F$20231130$20240711$20240702$20240719$EXP$$JP-BAUSCH-BL-2024-010153$BAUSCH AND LOMB$$60$YR$$F$Y$$$20240719$$MD$JP$JP
240409361$24040936$1$I$20240521$20240627$20240702$20240702$EXP$$US-SERVIER-S24006857$SERVIER$$$$$$Y$$$20240702$$CN$US$US
240409371$24040937$1$I$$20240617$20240702$20240702$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091992$GLENMARK$Raymond-Forde S, Olexsey K.. A Rare but Potentially Fatal Reaction in Plain Sight: Trimethoprim- Sulfamethoxazole Induced Acute Lung Injury.. American Journal of Respiratory and Critical Care Medicine.. 2024;209$$$$$Y$$$20240702$$HP$US$US
240409381$24040938$1$I$$20240701$20240701$20240701$DIR$708710$$FDA-CTU$$$$$UNK$N$$$20240701$N$$US$
240409391$24040939$1$I$20240101$20240611$20240702$20240702$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000124$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240702$$CN$US$US
240409401$24040940$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105264$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240702$$CN$US$US
240409413$24040941$3$F$20240101$20240821$20240702$20240828$EXP$$CA-CELLTRION INC.-2024CA015954$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
240409421$24040942$1$I$$20240623$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05951$HIKMA$Saleh T, Kamau E, Rathe JA.. Saleh T, Kamau E, Rathe JA. New and old lessons from a devastating case of neonatal E coli meningitis. BMC Pediatrics. 2024;24:339$3$MON$$M$Y$$$20240702$$MD$US$US
240409432$24040943$2$F$20240628$20240703$20240702$20240704$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037150$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240705$$CN$US$US
240409441$24040944$1$I$20240601$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024127573$AMGEN$$25$YR$A$$Y$$$20240702$$HP$US$US
240409451$24040945$1$I$$20231126$20240702$20240702$PER$$US-AMGEN-USASP2023235304$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240409461$24040946$1$I$$20230822$20240702$20240702$PER$$US-AMGEN-USASP2023235043$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240409471$24040947$1$I$$20240624$20240702$20240702$EXP$$AU-RDY-SPO/AUS/24/0009370$DR REDDYS$$58$YR$A$M$Y$$$20240702$$CN$AU$AU
240409481$24040948$1$I$20240429$20240626$20240702$20240702$EXP$$NVSC2024CA095526$NOVARTIS$$68$YR$$M$Y$$$20240702$$HP$CA$CA
240409491$24040949$1$I$$20240621$20240702$20240702$PER$$US-RDY-LIT/USA/24/0009381$DR REDDYS$Ozogbo S, Pupillo S. A Rare Presentation of Large Bcell Lymphoma With Anterior Mediastinal Mass in a 24-yearold Female. American Journal of Respiratory and Critical Care Medicine. 2024;209: doi:10.1164/ajrccmconference. 2024.209.1_MeetingAbstracts.A6518.$24$YR$A$F$Y$$$20240702$$HP$US$US
240409501$24040950$1$I$$20240624$20240702$20240702$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004729$BIOCON$$$$$$Y$$$20240702$$CN$CA$CA
240409511$24040951$1$I$$20240624$20240702$20240702$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004734$BIOCON$$$$$$Y$$$20240702$$MD$CA$CA
240409521$24040952$1$I$$20240624$20240702$20240702$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004736$BIOCON$$$$$$Y$$$20240702$$CN$CA$CA
240409531$24040953$1$I$$20240624$20240702$20240702$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004740$BIOCON$$$$$$Y$$$20240702$$CN$CA$CA
240409541$24040954$1$I$$20240627$20240702$20240702$EXP$$ES-ORGANON-O2407ESP000139$ORGANON$$$$$F$Y$$$20240702$$MD$ES$ES
240409551$24040955$1$I$$20240701$20240702$20240702$PER$$US-HALEON-2184818$Haleon PLC$$81$YR$$F$Y$$$20240702$$CN$US$US
240409561$24040956$1$I$$20240625$20240702$20240702$EXP$$US-GSK-US2024AMR080018$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$US$US
240409571$24040957$1$I$20231014$20240624$20240702$20240702$EXP$GB-MHRA-MED-202406211105419530-SVCRT$GB-BIOCON BIOLOGICS LIMITED-BBL2024004717$BIOCON$$$$$$Y$$$20240702$$HP$GB$GB
240409581$24040958$1$I$$20240624$20240702$20240702$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004721$BIOCON$$$$$$Y$$$20240702$$HP$CA$CA
240409591$24040959$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA188595$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240702$$MD$US$US
240409601$24040960$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA190961$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240702$$MD$US$US
240409611$24040961$1$I$20240601$20240624$20240702$20240702$PER$$US-SA-2024SA188988$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240702$$CN$US$US
240409621$24040962$1$I$20240101$20240621$20240702$20240702$PER$$US-SA-2024SA188995$SANOFI AVENTIS$$47$YR$A$M$Y$131.5$KG$20240702$$MD$US$US
240409631$24040963$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA187709$SANOFI AVENTIS$$$$$$Y$$$20240702$$PH$US$US
240409641$24040964$1$I$$20240627$20240702$20240702$EXP$$BR-JNJFOC-20240704394$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$HP$BR$BR
240409651$24040965$1$I$$20240617$20240702$20240702$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091998$GLENMARK$Pollack ED, Richardson C, Powell B, Patel K.. Meningoencephalitis With Transverse Myelitis in a Patient With West Nile Virus - Clinical Insights and Awareness. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240702$$HP$US$US
240409661$24040966$1$I$20240627$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000922$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240702$$CN$US$US
240409671$24040967$1$I$20240627$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000291$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240702$$CN$US$US
240409681$24040968$1$I$$20240626$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406018150$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$US$US
240409692$24040969$2$F$20240501$20240807$20240702$20240813$EXP$$US-ABBVIE-5822667$ABBVIE$$64$YR$$F$Y$$$20240813$$CN$US$US
240409701$24040970$1$I$$20240628$20240702$20240702$PER$$US-JNJFOC-20240677382$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240702$$CN$US$US
240409711$24040971$1$I$$20240626$20240702$20240702$PER$$US-JNJFOC-20240674564$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240409721$24040972$1$I$20211201$20240624$20240702$20240702$PER$$PR-JNJFOC-20240664581$JOHNSON AND JOHNSON$$59$YR$A$M$Y$84.37$KG$20240702$$CN$PR$PR
240409731$24040973$1$I$$20240604$20240702$20240702$PER$$US-AMGEN-USASP2024130766$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240409742$24040974$2$F$20240617$20240705$20240702$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05638$LUPIN$$$$$$Y$$$20240801$$CN$US$US
240409751$24040975$1$I$$20230414$20240702$20240702$PER$$US-AMGEN-USASP2023235149$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240409761$24040976$1$I$$20240626$20240702$20240702$PER$$NVSC2024US135037$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
240409772$24040977$2$F$$20240712$20240702$20240715$EXP$$BG-ABBVIE-5820954$ABBVIE$$71$YR$$M$Y$$$20240715$$CN$BG$BG
240409782$24040978$2$F$20240627$20240628$20240702$20240702$PER$$US-JNJFOC-20240675142$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$US$US
240409792$24040979$2$F$20240201$20240801$20240702$20240805$EXP$$JP-ABBVIE-5819883$ABBVIE$$80$YR$$F$Y$58$KG$20240804$$MD$JP$JP
240409801$24040980$1$I$$20240617$20240702$20240702$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092000$GLENMARK$Gupta A., Wojnowski K, Gurung P.. Mucormycosis - A rare etiology of empyema nessisitans. American journal of respiratory and critical care medicine. 2024;209$$$$$Y$$$20240702$$HP$US$US
240409811$24040981$1$I$$20240628$20240702$20240702$EXP$$US-AstraZeneca-2024A149952$ASTRAZENECA$$$$$M$Y$$$20240702$$MD$US$
240409821$24040982$1$I$20240613$20240627$20240702$20240702$EXP$$ID-AstraZeneca-2024A149746$ASTRAZENECA$$29442$DY$$F$Y$$$20240702$$CN$ID$
240409831$24040983$1$I$20240529$20240628$20240702$20240702$EXP$$AE-AstraZeneca-2024A150640$ASTRAZENECA$$49$YR$$M$Y$75$KG$20240702$$MD$AE$
240409841$24040984$1$I$$20240617$20240702$20240702$EXP$$IN-ROCHE-10000013845$ROCHE$$$$A$M$Y$$$20240702$$CN$IN$IN
240409851$24040985$1$I$$20240628$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104801$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240702$$CN$US$US
240409862$24040986$2$F$$20240723$20240702$20240723$PER$$US-ALXN-202406USA000454US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
240409871$24040987$1$I$$20240624$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006752$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240409885$24040988$5$F$20240627$20240925$20240702$20240927$EXP$$AR-MYLANLABS-2024M1061513$MYLAN$$61$YR$$F$Y$$$20240927$$CN$AR$AR
240409891$24040989$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA192645$SANOFI AVENTIS$$$$A$F$Y$50.8$KG$20240702$$MD$US$US
240409901$24040990$1$I$$20240617$20240702$20240702$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092001$GLENMARK$Ingram A., Rode S., Safdar H., Alnijoumi M.. Pneumomediastinum in the Setting of Invasive Pulmonary Aspergillosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6337$$$$$Y$$$20240702$$HP$US$US
240409911$24040991$1$I$$20240621$20240702$20240702$PER$$US-RDY-LIT/USA/24/0009387$DR REDDYS$Manjunath J, Liao V, Kambala A, Bao A, Kollhoff AL, Ma EZ, et al. . Immune stimulus exposure as a trigger for the development of chronic pruritus and circulating blood type 2 inflammation. JAAD International. 2024;16: 97-102. doi:10.1016/j.jdin.2024.03.022.$54$YR$A$M$Y$$$20240702$$HP$US$US
240409921$24040992$1$I$$20240627$20240702$20240702$EXP$$NVSC2024GB135803$NOVARTIS$$$$$M$Y$$$20240702$$CN$GB$GB
240409931$24040993$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05594$LUPIN$Santosh N, Savani S, Iskapalli S. Beefing Up! Fulminant liver failure secondary to anabolic steroid use. American Journal of Respiratory and Critical Care Medicine. 2024;209$30$YR$$M$Y$$$20240702$$HP$US$US
240409941$24040994$1$I$20240523$20240701$20240701$20240701$DIR$708692$$FDA-CTU$$64$YR$$F$N$$$20240701$$CN$US$
240409951$24040995$1$I$20240603$20240624$20240701$20240701$DIR$FDA-CDER-CTU-2024-45862$$FDA-CTU$$38$YR$$F$N$$$20240624$N$HP$US$
240409961$24040996$1$I$$20230612$20240702$20240702$PER$$US-AMGEN-USASP2023235252$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240409971$24040997$1$I$$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127396$AMGEN$$$$$F$Y$$$20240702$$HP$US$US
240409981$24040998$1$I$$20240528$20240702$20240702$PER$$US-AMGEN-USASP2024130089$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240409991$24040999$1$I$20240625$20240628$20240702$20240702$PER$$US-AMGEN-USASP2024129407$AMGEN$$64$YR$A$F$Y$$$20240702$$CN$US$US
240410001$24041000$1$I$$20230202$20240702$20240702$PER$$US-AMGEN-USASP2023235153$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240410021$24041002$1$I$$20240624$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006746$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240410032$24041003$2$F$20240618$20240628$20240702$20240811$EXP$$PY-JNJFOC-20240704054$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240812$$CN$PY$PY
240410041$24041004$1$I$20240101$20240628$20240702$20240702$EXP$$US-UCBSA-2024025904$UCB$$$$$M$Y$$$20240702$$HP$US$US
240410052$24041005$2$F$$20240715$20240702$20240716$PER$$US-JNJFOC-20240650488$JOHNSON AND JOHNSON$$12$YR$T$M$Y$38.59$KG$20240716$$CN$US$US
240410061$24041006$1$I$20240627$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105348$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$104.33$KG$20240702$$HP$US$US
240410071$24041007$1$I$20240601$20240701$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105361$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240702$$HP$US$US
240410081$24041008$1$I$$20230828$20240702$20240702$PER$$US-AMGEN-USASP2023235206$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240410091$24041009$1$I$$20240627$20240702$20240702$EXP$$BR-BIOVITRUM-2024-BR-009345$BIOVITRUM$$$$I$M$Y$$$20240702$$CN$BR$BR
240410101$24041010$1$I$20240101$20240625$20240702$20240702$EXP$$US-SA-2024SA192574$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240702$$MD$US$US
240410112$24041011$2$F$$20240704$20240702$20240712$EXP$$US-TEVA-VS-3214061$TEVA$Ji SH, Imtiaz A, Sanekommu H, Clemetson E, Lipschutz J, Marlys M, et al. A Case Report of Fatal Skin Sparing Laryngeal Zoster in Post-acute COVID-19 Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Ji SH, Imtiaz A, Sanekommu H, Clemetson E, Lipschutz J, Marlys M, et al. A Case Report of Fatal Skin Sparing Laryngeal Zoster in Post-acute COVID-19 Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$87$YR$$F$Y$$$20240712$$HP$US$US
240410121$24041012$1$I$$20240619$20240702$20240702$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-05651$LUPIN$Chiu SM, Siranart N, Lesmana E, Simadibrata D. Interstitial pneumonia with autoimmune features mimicking paradoxical responses in a patient under treatment for tuberculosis: A case report. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2080$25$YR$$M$Y$$$20240702$$HP$IN$IN
240410131$24041013$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA186536$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240702$$MD$US$US
240410141$24041014$1$I$20240524$20240624$20240702$20240702$PER$$US-SA-2024SA192086$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240702$$MD$US$US
240410151$24041015$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA189002$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240702$$MD$US$US
240410161$24041016$1$I$20240626$20240626$20240702$20240702$PER$$US-SA-2024SA192375$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240702$$MD$US$US
240410171$24041017$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187505$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240702$$MD$US$US
240410182$24041018$2$F$$20240709$20240702$20240715$PER$$US-JNJFOC-20240666656$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240716$$CN$US$US
240410191$24041019$1$I$20240611$20240617$20240702$20240702$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000126$Unknown Manufacturer$$$$$$Y$$$20240702$$CN$US$US
240410211$24041021$1$I$20240615$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46079$$FDA-CTU$$41$YR$$F$N$77.1$KG$20240701$N$HP$US$
240410221$24041022$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3213981$TEVA$$65$YR$$M$Y$$$20240702$$HP$CA$CA
240410231$24041023$1$I$$20240618$20240702$20240702$EXP$$SK-LEADINGPHARMA-SK-2024LEALIT00250$LEADING PHARMA$Adela Penesova.5-Fluorouracil Induced Hypertriglyceridemia During the Colorectal Cancer Treatment in a Patient With Multifactorial Chylomicronemia Syndrome: A Case Report.Clinical Therapeutics.MAY-2024;46 (2024):429-432$47$YR$A$F$Y$$$20240702$$MD$SK$SK
240410242$24041024$2$F$$20240814$20240702$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105079$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$76.2$KG$20240822$$CN$US$US
240410251$24041025$1$I$20240401$20240627$20240702$20240702$EXP$$BE-UCBSA-2024033060$UCB$$53$YR$$M$Y$$$20240702$$MD$BE$BE
240410261$24041026$1$I$20240625$20240701$20240702$20240702$EXP$$US-BAYER-2024A095086$BAYER$$87$YR$E$F$Y$$$20240702$$CN$US$US
240410272$24041027$2$F$20220101$20240724$20240702$20240802$PER$$US-SA-2024SA188990$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240802$$MD$US$US
240410281$24041028$1$I$20240501$20240623$20240702$20240702$PER$$US-SA-2024SA189409$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240702$$MD$US$US
240410291$24041029$1$I$$20240627$20240702$20240702$EXP$$NVSC2024US136452$NOVARTIS$$$$$F$Y$$$20240702$$HP$US$US
240410303$24041030$3$F$20220101$20240802$20240702$20240805$EXP$$NVSC2024SK135121$NOVARTIS$Sykora T. Autologna transplantacia perifernych krvotvornych buniek ako liecba sclerosis multiplex u deti [Autologous transplantation of peripheral hematopoietic cells as a treatment for multiple sclerosis in children]. PEDIATRICIAN PRACTICE. 2023;24(S2):13-4$17$YR$$F$Y$$$20240805$$HP$SK$SK
240410321$24041032$1$I$$20240626$20240702$20240702$PER$$US-SA-2024SA191126$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240702$$CN$US$US
240410332$24041033$2$F$20191106$20240828$20240702$20240907$EXP$$JP-JNJFOC-20240700674$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240907$$MD$JP$JP
240410341$24041034$1$I$20240617$20240626$20240702$20240702$EXP$$US-ABBVIE-5819024$ABBVIE$$63$YR$$F$Y$$$20240702$$CN$US$US
240410351$24041035$1$I$20240620$20240625$20240702$20240702$PER$$US-ABBVIE-5819474$ABBVIE$$23$YR$$F$Y$104$KG$20240702$$CN$US$US
240410361$24041036$1$I$$20230807$20240702$20240702$PER$$US-AMGEN-USASP2023235300$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240410371$24041037$1$I$20240501$20240627$20240702$20240702$EXP$$BR-PFIZER INC-PV202400085417$PFIZER$$43$YR$$M$Y$$$20240702$$MD$BR$BR
240410381$24041038$1$I$20240525$20240621$20240702$20240702$EXP$$DE-LEADIANT BIOSCIENCES, INC.-2024LBI000227$SIGMA TAU$$87$YR$$M$Y$70$KG$20240702$$HP$DE$DE
240410391$24041039$1$I$$20240627$20240702$20240702$EXP$$US-PFIZER INC-PV202400085220$PFIZER$$34$YR$$F$Y$$$20240702$$MD$US$US
240410401$24041040$1$I$$20240627$20240702$20240702$EXP$$US-PFIZER INC-PV202400085167$PFIZER$$25$YR$$F$Y$$$20240702$$MD$US$US
240410411$24041041$1$I$20240627$20240627$20240702$20240702$EXP$$US-PFIZER INC-202400202587$PFIZER$$$$$F$Y$$$20240702$$PH$US$US
240410421$24041042$1$I$20240416$20240628$20240702$20240702$EXP$ES-AEMPS-1539461$ES-PFIZER INC-202400202877$PFIZER$$71$YR$$F$Y$$$20240702$$MD$ES$ES
240410434$24041043$4$F$$20240809$20240702$20240925$30DAY$$FR-PFIZER INC-202400203362$PFIZER$$$$E$$Y$$$20240925$$HP$FR$FR
240410441$24041044$1$I$$20240628$20240702$20240702$EXP$$JP-PFIZER INC-202400202620$PFIZER$$61$YR$$M$Y$$$20240702$$PH$JP$JP
240410453$24041045$3$F$20240621$20240802$20240702$20240805$30DAY$$AR-PFIZER INC-202400199784$PFIZER$$14$YR$$M$Y$$$20240805$$CN$AR$AR
240410461$24041046$1$I$$20240627$20240702$20240702$EXP$$ID-PFIZER INC-PV202400084690$PFIZER$$50$YR$$F$Y$$$20240702$$HP$ID$ID
240410482$24041048$2$F$$20240703$20240702$20240708$30DAY$$KR-PFIZER INC-PV202400085049$PFIZER$$$$$$Y$$$20240708$$CN$KR$KR
240410491$24041049$1$I$20240531$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085662$PFIZER$$11$YR$$F$Y$32.9$KG$20240702$$HP$CN$CN
240410501$24041050$1$I$20240601$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406261542006860-VQRJN$GB-PFIZER INC-202400203175$PFIZER$$29$YR$$F$Y$$$20240702$$CN$GB$GB
240410514$24041051$4$F$20240601$20240910$20240702$20240912$30DAY$$CO-PFIZER INC-202400195959$PFIZER$$13$YR$$F$Y$$$20240912$$CN$CO$CO
240410521$24041052$1$I$$20240627$20240702$20240702$EXP$$US-PFIZER INC-PV202400084899$PFIZER$$16$YR$$M$Y$$$20240702$$MD$US$US
240410533$24041053$3$F$20240617$20240911$20240702$20240912$30DAY$$CL-PFIZER INC-PV202400070572$PFIZER$$12$YR$$F$Y$$$20240912$$CN$CL$CL
240410541$24041054$1$I$20240614$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085637$PFIZER$$6$YR$$M$Y$23.7$KG$20240702$$HP$CN$CN
240410551$24041055$1$I$$20240627$20240702$20240702$EXP$$US-PFIZER INC-PV202400085191$PFIZER$$42$YR$$M$Y$$$20240702$$MD$US$US
240410561$24041056$1$I$20240401$20240627$20240702$20240702$EXP$$IN-PFIZER INC-PV202300003928$PFIZER$$51$YR$$F$Y$35.6$KG$20240702$$CN$IN$IN
240410573$24041057$3$F$$20240916$20240702$20240919$30DAY$$PR-PFIZER INC-202400201874$PFIZER$$14$YR$$M$Y$$$20240919$$CN$PR$PR
240410581$24041058$1$I$20240301$20240630$20240702$20240702$EXP$GB-MHRA-MED-202406301141315600-HTYCV$GB-PFIZER INC-202400203427$PFIZER$$$$$F$Y$50$KG$20240702$$CN$GB$GB
240410591$24041059$1$I$20240501$20240627$20240702$20240702$EXP$$JP-PFIZER INC-PV202400078177$PFIZER$$8$DEC$$M$Y$$$20240702$$MD$JP$JP
240410601$24041060$1$I$$20240627$20240702$20240702$EXP$$CA-PFIZER INC-202400202513$PFIZER$$30$YR$$F$Y$$$20240702$$PH$CA$CA
240410611$24041061$1$I$$20240627$20240702$20240702$EXP$$US-PFIZER INC-PV202400085211$PFIZER$$34$YR$$M$Y$$$20240702$$MD$US$US
240410625$24041062$5$F$20240626$20240918$20240702$20240923$30DAY$$KR-PFIZER INC-PV202400085072$PFIZER$$10$YR$$$Y$$$20240923$$CN$KR$KR
240410631$24041063$1$I$$20240624$20240702$20240702$EXP$$ZA-AstraZeneca-2024A145842$ASTRAZENECA$$39$YR$$F$Y$$$20240702$$CN$ZA$
240410642$24041064$2$F$20240228$20240702$20240702$20240710$EXP$$JP-AstraZeneca-2024A148788$ASTRAZENECA$$50$YR$$F$Y$$$20240710$$MD$JP$
240410652$24041065$2$F$20240501$20240729$20240702$20240731$EXP$$US-PFIZER INC-202400101666$PFIZER$$82$YR$$F$Y$$$20240731$$HP$US$US
240410661$24041066$1$I$$20240629$20240702$20240702$PER$$US-HALEON-2184721$Haleon PLC$$$$$F$Y$$$20240702$$CN$US$US
240410671$24041067$1$I$$20230224$20240702$20240702$PER$$US-AMGEN-USASP2023235169$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240410682$24041068$2$F$20240501$20240903$20240702$20240910$EXP$$JP-AMGEN-JPNSP2024127544$AMGEN$$98$YR$E$M$Y$$$20240910$$MD$JP$JP
240410691$24041069$1$I$$20230327$20240702$20240702$PER$$US-AMGEN-USASP2023235080$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240410701$24041070$1$I$20180510$20240628$20240702$20240702$EXP$$FR-SERVIER-S21005539$SERVIER$$$$$$Y$$$20240702$$MD$FR$FR
240410711$24041071$1$I$20240628$20240701$20240701$20240701$DIR$708687$$FDA-CTU$$$$$UNK$N$$$20240701$N$CN$US$
240410721$24041072$1$I$20230618$20240701$20240701$20240701$DIR$708776$$FDA-CTU$$77$YR$$F$N$77.4$KG$20240701$N$CN$US$
240410731$24041073$1$I$$20240618$20240702$20240702$EXP$$CN-LEADINGPHARMA-CN-2024LEALIT00257$LEADING PHARMA$Zheng-Quan Feng.Cetuximab combined with chemotherapy for simultaneous esophageal squamous cell carcinoma and colon adenocarcinoma: A case report.World Journal of Clinical Cases.26-MAY-2024;12:2649-2654 (No. 15)$64$YR$A$M$Y$$$20240702$$MD$CN$CN
240410741$24041074$1$I$20240529$20240620$20240702$20240702$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406019390$ELI LILLY AND CO$$61$YR$A$M$Y$63$KG$20240702$$CN$DE$CN
240410762$24041076$2$F$20240404$20240628$20240702$20240711$EXP$FR-AFSSAPS-TO2024001135$FR-ELI_LILLY_AND_COMPANY-FR202406016054$ELI LILLY AND CO$$77$YR$E$M$Y$79$KG$20240711$$CN$FR$FR
240410781$24041078$1$I$20180101$20240620$20240702$20240702$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202406013747$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240702$$CN$AU$AU
240410791$24041079$1$I$20240411$20240620$20240702$20240702$EXP$FR-AFSSAPS-AVLL2024000144$FR-ELI_LILLY_AND_COMPANY-FR202406015067$ELI LILLY AND CO$$14$YR$T$F$Y$$$20240702$$CN$FR$FR
240410801$24041080$1$I$$20240620$20240702$20240702$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202406014892$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$AU$AU
240410811$24041081$1$I$$20240626$20240702$20240702$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406019195$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240702$$CN$JP$JP
240410821$24041082$1$I$20240619$20240628$20240702$20240702$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407000475$ELI LILLY AND CO$$62$YR$A$F$Y$64$KG$20240702$$CN$CN$CN
240410831$24041083$1$I$$20240627$20240702$20240702$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202406018645$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$KR$KR
240410842$24041084$2$F$20240527$20240723$20240702$20240805$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406016134$ELI LILLY AND CO$$70$YR$E$M$Y$42.5$KG$20240805$$CN$JP$JP
240410851$24041085$1$I$20090303$20240620$20240702$20240702$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202406013984$ELI LILLY AND CO$$18$YR$A$M$Y$$$20240702$$CN$AU$AU
240410864$24041086$4$F$20240620$20240925$20240702$20240926$30DAY$$AR-PFIZER INC-202400197683$PFIZER$$45$YR$$F$Y$$$20240926$$HP$AR$AR
240410891$24041089$1$I$20240625$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281408542860-LBSYV$GB-PFIZER INC-202400203359$PFIZER$$30$YR$$F$Y$$$20240702$$HP$GB$GB
240410901$24041090$1$I$20240401$20240620$20240702$20240702$PER$$US-COSETTE-CP2024US000143$COSETTE PHARMACEUTICALS$$38$YR$A$F$Y$179$KG$20240702$$CN$US$US
240410911$24041091$1$I$$20240604$20240702$20240702$30DAY$$US-VEROBIOTECH-2024USVEROSPO00130$VERO BIOTECH$$$$$$Y$$$20240702$$HP$US$US
240410921$24041092$1$I$$20240624$20240702$20240702$EXP$$CA-CELLTRION INC.-2024CA015544$CELLTRION$$$$$$Y$$$20240702$$CN$CA$CA
240410931$24041093$1$I$$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024129365$AMGEN$$$$$F$Y$$$20240702$$CN$US$US
240410941$24041094$1$I$$20230829$20240702$20240702$PER$$US-AMGEN-USASP2023235175$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240410951$24041095$1$I$$20240620$20240702$20240702$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05824$HIKMA$Talon A, Gao YA, Murray C, Shamsid-Deen N, Puebla Neira DA.. Talon A, Gao YA, Murray C, Shamsid-Deen N, Puebla Neira DA. Factitious Elevation of Plasma Free Hemoglobin in a Patient Undergoing VV-ECMO With Hypertriglyceridemia.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1700:/$49$YR$$M$Y$$$20240702$$MD$US$US
240410961$24041096$1$I$20240611$20240701$20240702$20240702$EXP$$CN-BAYER-2024A095165$BAYER$$70$YR$E$F$Y$$$20240702$$HP$CN$CN
240410971$24041097$1$I$$20240619$20240702$20240702$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05552$LUPIN$$$$$$Y$$$20240702$$CN$US$US
240410992$24041099$2$F$$20240910$20240702$20240925$EXP$$CA-HLS-202401558$HLS THERAPEUTICS$$57$YR$A$M$Y$$$20240925$$HP$CA$CA
240411001$24041100$1$I$$20240618$20240702$20240702$EXP$$US-LEADINGPHARMA-US-2024LEALIT00251$LEADING PHARMA$MM Olivet.Anaphylaxis in the Setting of Poly- l -Lactic Acid and Lidocaine Without Epinephrine Injection.Dermatologic Surgery.APR-2024;50 (No.4):395-396$62$YR$E$F$Y$$$20240702$$HP$US$US
240411014$24041101$4$F$20240101$20240911$20240702$20240925$EXP$$CA-UCBSA-2023020641$UCB$$$$$F$Y$$$20240925$$CN$CA$CA
240411021$24041102$1$I$$20240627$20240702$20240702$PER$$US-JNJFOC-20240675059$JOHNSON AND JOHNSON$$88$YR$E$M$Y$$$20240702$$CN$US$US
240411043$24041104$3$F$$20240801$20240702$20240805$EXP$$GB-JNJFOC-20240704234$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240806$$CN$GB$GB
240411051$24041105$1$I$$20240625$20240702$20240702$PER$$US-JNJFOC-20240670122$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$HP$US$US
240411061$24041106$1$I$$20240604$20240702$20240702$30DAY$$US-VEROBIOTECH-2024USVEROSPO00131$VERO BIOTECH$$$$I$$Y$$$20240702$$HP$US$US
240411071$24041107$1$I$$20240617$20240702$20240702$PER$$US-BAYER-2024A087705$BAYER$$23$YR$A$F$Y$$$20240702$$CN$US$US
240411081$24041108$1$I$$20240626$20240702$20240702$PER$$US-ALXN-202406USA001764US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
240411091$24041109$1$I$$20240629$20240702$20240702$PER$$NVSC2024US136786$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
240411122$24041112$2$F$$20240905$20240702$20240906$EXP$$NVSC2024US136471$NOVARTIS$$$$I$M$Y$$$20240906$$MD$US$US
240411131$24041113$1$I$20240622$20240701$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105526$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$99.79$KG$20240702$$HP$US$US
240411141$24041114$1$I$20240601$20240624$20240702$20240702$EXP$$JP-009507513-2406JPN003522J$MERCK$$74$YR$$M$Y$$$20240702$$MD$JP$JP
240411161$24041116$1$I$20240630$20240701$20240702$20240702$DIR$FDA-CDER-CTU-2024-46077$$FDA-CTU$$67$YR$$M$N$81.8$KG$20240701$N$$US$
240411171$24041117$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46159$$FDA-CTU$$83$YR$$M$N$226$LBS$20240702$N$$US$
240411191$24041119$1$I$20240608$20240627$20240702$20240702$DIR$FDA-CDER-CTU-2024-46082$$FDA-CTU$$18$YR$$F$N$79.8$KG$20240627$N$$US$
240411211$24041121$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46163$$FDA-CTU$$68$YR$$F$N$$$20240702$N$$US$
240411221$24041122$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46158$$FDA-CTU$$44$YR$$F$N$201$LBS$20240702$N$$US$
240411231$24041123$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46177$$FDA-CTU$$68$YR$$F$N$162$LBS$20240702$N$$US$
240411241$24041124$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46175$$FDA-CTU$$68$YR$$F$N$$$20240702$N$$US$
240411261$24041126$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5818631$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240411271$24041127$1$I$20240627$20240701$20240701$20240701$DIR$708674$$FDA-CTU$$43$YR$$F$N$64.35$KG$20240701$N$CN$US$
240411282$24041128$2$F$20240101$20240711$20240702$20240718$EXP$$US-AMGEN-USASP2024127238$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
240411291$24041129$1$I$$20240622$20240702$20240702$EXP$$US-AMGEN-USASP2024124539$AMGEN$Amengual J. E.; Tiger Y. R.; Jain S. et al.. Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma. Leukemia + Lymphoma. 2024;65 (6):736-745$89$YR$E$F$Y$$$20240702$$HP$US$US
240411301$24041130$1$I$$20231025$20240702$20240702$PER$$US-AMGEN-USASP2023235393$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240411311$24041131$1$I$20240626$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128780$AMGEN$$$$$F$Y$$$20240702$$CN$US$US
240411322$24041132$2$F$20240101$20240701$20240702$20240704$EXP$$US-AMGEN-USASP2024127705$AMGEN$$$$E$F$Y$$$20240704$$CN$US$US
240411331$24041133$1$I$$20240625$20240702$20240702$EXP$$US-AMGEN-USASP2024126254$AMGEN$Castellino S. M.; Pei Q.; Parsons S. K. et al.. Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin^s Lymphoma. The New England  journal of medicine. 2024;387 (18):1649-1660$$$$$Y$$$20240702$$MD$US$US
240411342$24041134$2$F$$20240909$20240702$20240911$PER$$US-AMGEN-USASP2024129942$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
240411351$24041135$1$I$$20230912$20240702$20240702$PER$$US-AMGEN-USASP2023235315$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240411361$24041136$1$I$$20240626$20240702$20240702$PER$$US-JNJFOC-20240676512$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240411371$24041137$1$I$20211101$20240617$20240702$20240702$EXP$$CA-ROCHE-10000012284$ROCHE$$$$$$Y$$$20240702$$CN$CA$CA
240411381$24041138$1$I$$20240624$20240702$20240702$EXP$$US-AMGEN-USASP2024125063$AMGEN$Ji S. H.; Imtiaz A.; Sanekommu A. et.al. A Case Report of Fatal Skin Sparing Laryngeal Zoster in Post-acute COVID-19 Syndrome. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A3565$87$YR$E$F$Y$$$20240702$$HP$US$US
240411391$24041139$1$I$$20240624$20240702$20240702$EXP$GB-MHRA-MED-202406220013389710-QTKVS$GB-BAXTER-2024BAX020417$BAXTER$$$$$M$Y$$$20240702$$CN$GB$GB
240411401$24041140$1$I$20240608$20240624$20240702$20240702$PER$$US-009507513-2406USA008832$MERCK$$75$YR$$M$Y$$$20240702$$CN$US$US
240411411$24041141$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281443140430-YKFLG$GB-MYLANLABS-2024M1061624$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240411431$24041143$1$I$20240117$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281626497690-MPKWV$GB-MYLANLABS-2024M1061587$MYLAN$$52$YR$$F$Y$$$20240702$$MD$GB$GB
240411441$24041144$1$I$20240630$20240701$20240701$20240701$DIR$708683$$FDA-CTU$$20$YR$$F$N$59.4$KG$20240701$N$CN$US$
240411451$24041145$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281457303540-MZPCV$GB-MYLANLABS-2024M1061578$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240411462$24041146$2$F$$20240708$20240702$20240712$EXP$GB-MHRA-MED-202406281441057610-CBYGW$GB-MYLANLABS-2024M1061745$MYLAN$$$$$$Y$$$20240712$$CN$GB$GB
240411471$24041147$1$I$20240323$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281122461890-DVTGF$GB-MYLANLABS-2024M1061535$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240411481$24041148$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-30930544$GB-MYLANLABS-2024M1061272$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240411491$24041149$1$I$$20240624$20240702$20240702$EXP$$AU-MYLANLABS-2024M1061495$MYLAN$Suraya H. Kamsani,Melissa E. Middeldorp, Glenda Chiang, Maria Stefil, Shaun Evans,Mau T. Nguyen, Elnaz Shahmohamadi, Jessica Qingying Zhang, Kurt C. Roberts-Thomson.et.al. Safety of outpatient commencement of sotalol. Heart Rhythm O2. 2024;5:6:341-350$53$YR$$M$Y$$$20240702$$MD$AU$AU
240411501$24041150$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281437578480-ZYWPV$GB-MYLANLABS-2024M1061749$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240411511$24041151$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281432034530-LJZCK$GB-MYLANLABS-2024M1061574$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240411521$24041152$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281440345420-HKJBF$GB-MYLANLABS-2024M1061569$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240411533$24041153$3$F$$20240930$20240702$20240930$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-104478$BRISTOL MYERS SQUIBB$$57$YR$E$M$Y$$$20240930$$MD$AT$AT
240411541$24041154$1$I$$20240624$20240702$20240702$EXP$$AU-MYLANLABS-2024M1061492$MYLAN$Kamsani SH, Middeldorp ME, Chiang G, Stefil M, Evans S, Nguyen MT.et.al. Safety of outpatient commencement of sotalol. Heart Rhythm O2. 2024;5:6:341-350$65$YR$$M$Y$$$20240702$$MD$AU$AU
240411551$24041155$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104693$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$86.2$KG$20240702$$PH$US$US
240411561$24041156$1$I$$20240626$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103081$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240702$$HP$US$US
240411573$24041157$3$F$20240101$20240827$20240702$20240903$EXP$$US-OTSUKA-2024_017435$OTSUKA$$$$$F$Y$61.23$KG$20240903$$CN$US$US
240411581$24041158$1$I$$20240628$20240702$20240702$PER$$NVSC2024US137133$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
240411591$24041159$1$I$20240529$20240701$20240702$20240702$PER$$US-BAYER-2024A095188$BAYER$$72$YR$E$M$Y$$$20240702$$HP$US$US
240411602$24041160$2$F$20240621$20240702$20240702$20240708$EXP$IT-MINISAL02-992219$IT-BAYER-2024A095332$BAYER$$61$YR$A$M$Y$79$KG$20240708$$MD$IT$IT
240411611$24041161$1$I$20240101$20240620$20240702$20240702$PER$$US-SA-2024SA188337$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240702$$MD$US$US
240411621$24041162$1$I$20240601$20240620$20240702$20240702$PER$$US-SA-2024SA188333$SANOFI AVENTIS$$17$YR$T$F$Y$63.5$KG$20240702$$MD$US$US
240411631$24041163$1$I$20240621$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024128737$AMGEN$$78$YR$E$F$Y$$$20240702$$CN$US$US
240411641$24041164$1$I$$20231204$20240702$20240702$PER$$US-AMGEN-USASP2023235321$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240411651$24041165$1$I$$20240624$20240702$20240702$EXP$$CN-AstraZeneca-2024A147352$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$CN$
240411662$24041166$2$F$20240501$20240710$20240702$20240715$EXP$$JP-AstraZeneca-2024A148774$ASTRAZENECA$$76$YR$$M$Y$64$KG$20240715$$MD$JP$
240411671$24041167$1$I$20240613$20240627$20240702$20240702$EXP$$ID-AstraZeneca-2024A149744$ASTRAZENECA$$16910$DY$$M$Y$$$20240702$$CN$ID$
240411681$24041168$1$I$20240225$20240628$20240702$20240702$EXP$$US-ABBVIE-5822375$ABBVIE$$76$YR$$F$Y$$$20240702$$CN$US$US
240411691$24041169$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105413$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240702$$HP$US$US
240411701$24041170$1$I$$20240626$20240702$20240702$PER$$US-BAYER-2024A092862$BAYER$$$$$F$Y$$$20240702$$CN$US$US
240411721$24041172$1$I$$20240627$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103866$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240702$$HP$US$US
240411731$24041173$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105542$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240702$$CN$US$US
240411741$24041174$1$I$20240416$20240628$20240702$20240702$EXP$FR-AFSSAPS-CN2024000636$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-104657$BRISTOL MYERS SQUIBB$$68$YR$A$M$Y$90.5$KG$20240702$$MD$FR$FR
240411751$24041175$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5822366$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240411761$24041176$1$I$20240620$20240621$20240702$20240702$EXP$$CA-ROCHE-10000009127$ROCHE$$27$YR$A$F$Y$$$20240702$$CN$CA$CA
240411771$24041177$1$I$$20240626$20240702$20240702$EXP$$SI-PERRIGO-24SI006172$PERRIGO$Trampuz BV. ELECTROLYTE DISORDERS IN THE EMERGENCY DEPARTMENT - CLINICAL CASES AND EMERGENCY TREATMENT. Urgentna Medicina - Izbrana Poglavja. 2024:142-6.$$$$M$Y$$$20240702$$MD$SI$SI
240411781$24041178$1$I$20220101$20240627$20240702$20240702$PER$$US-ABBVIE-5823306$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240411791$24041179$1$I$20240623$20240624$20240702$20240702$PER$$US-SA-2024SA188649$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240702$$CN$US$US
240411801$24041180$1$I$20240619$20240620$20240702$20240702$PER$$US-SA-2024SA188791$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240702$$MD$US$US
240411811$24041181$1$I$$20240626$20240702$20240702$EXP$$NVSC2024BR135660$NOVARTIS$$$$$F$Y$$$20240702$$CN$BR$BR
240411821$24041182$1$I$20240412$20240626$20240702$20240702$EXP$GB-MHRA-MED-202406251510244500-ZDPTF$GB-TEVA-VS-3213959$TEVA$$58$YR$$F$Y$93$KG$20240702$$PH$GB$GB
240411831$24041183$1$I$$20240620$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05517$LUPIN$Singh M, Kuo J, Raza A. Lamotrigine induced drug reaction with eosinophilia with systemic symptoms (dress) with hhv-6 reactivation causing severe encephalitis and status epilepticus. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1358$18$YR$$F$Y$$$20240702$$MD$US$US
240411841$24041184$1$I$20231022$20240404$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003960$SAREPTA THERAPEUTICS$$15$YR$$M$Y$38.549$KG$20240702$$HP$US$US
240411851$24041185$1$I$20240215$20240321$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004493$SAREPTA THERAPEUTICS$$22$YR$$M$Y$$$20240702$$HP$US$US
240411861$24041186$1$I$20240301$20240503$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004510$SAREPTA THERAPEUTICS$$9$YR$$M$Y$$$20240702$$HP$US$US
240411871$24041187$1$I$20240412$20240530$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004556$SAREPTA THERAPEUTICS$$11$YR$$M$Y$42.3$KG$20240702$$HP$US$US
240411881$24041188$1$I$20240209$20240509$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004367$SAREPTA THERAPEUTICS$$10$YR$$M$Y$42.3$KG$20240702$$HP$US$US
240411891$24041189$1$I$20240131$20240321$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004490$SAREPTA THERAPEUTICS$$22$YR$$M$Y$$$20240702$$HP$US$US
240411901$24041190$1$I$$20240430$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004446$SAREPTA THERAPEUTICS$$$$$M$Y$30$KG$20240702$$HP$US$US
240411911$24041191$1$I$20240320$20240321$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004487$SAREPTA THERAPEUTICS$$13$YR$$$Y$$$20240702$$HP$US$US
240411921$24041192$1$I$$20240626$20240702$20240702$EXP$GB-MHRA-30687788$GB-TEVA-VS-3214261$TEVA$$80$YR$$F$Y$$$20240702$$PH$GB$GB
240411931$24041193$1$I$20240307$20240401$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004455$SAREPTA THERAPEUTICS$$13$YR$$M$Y$21$KG$20240702$$HP$US$US
240411941$24041194$1$I$20240301$20240514$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004509$SAREPTA THERAPEUTICS$$11$YR$$M$Y$42.3$KG$20240702$$HP$US$US
240411951$24041195$1$I$20240625$20240626$20240702$20240702$EXP$$GB-TEVA-VS-3214271$TEVA$$75$YR$$M$Y$99$KG$20240702$$MD$GB$GB
240411961$24041196$1$I$20240623$20240626$20240702$20240702$EXP$$GB-TEVA-VS-3214044$TEVA$$79$YR$$M$Y$$$20240702$$MD$GB$GB
240411971$24041197$1$I$$20240605$20240702$20240702$PER$$US-TOLMAR, INC.-24US049973$TOLMAR$$$$$M$Y$$$20240628$$HP$US$US
240411982$24041198$2$F$20240521$20240722$20240702$20240816$PER$$US-TOLMAR, INC.-24US049956$TOLMAR$$65$YR$$M$Y$$$20240816$$PH$US$US
240411991$24041199$1$I$20240529$20240605$20240702$20240702$PER$$US-TOLMAR, INC.-24US049980$TOLMAR$$85$YR$$M$Y$$$20240628$$PH$US$US
240412002$24041200$2$F$20240524$20240715$20240702$20240807$PER$$US-TOLMAR, INC.-24US049978$TOLMAR$$67$YR$$M$Y$$$20240807$$HP$US$US
240412012$24041201$2$F$20240603$20240715$20240702$20240807$PER$$US-TOLMAR, INC.-24US049981$TOLMAR$$67$YR$$M$Y$$$20240807$$HP$US$US
240412021$24041202$1$I$20240524$20240605$20240702$20240702$PER$$US-TOLMAR, INC.-24US049986$TOLMAR$$63$YR$$M$Y$$$20240628$$HP$US$US
240412032$24041203$2$F$20240604$20240715$20240702$20240807$PER$$US-TOLMAR, INC.-24US050001$TOLMAR$$$$$$Y$$$20240807$$HP$US$US
240412041$24041204$1$I$$20240618$20240702$20240702$EXP$$US-GLANDPHARMA-US-2024GLNLIT00395$GLAND PHARMA$Helene Puzio.A Remission of Hypocalcemia in Idiopathic Hypoparathyroidism.Journal of the Endocrine Society.DEC-2022;6 (1):A213$24$YR$A$M$Y$$$20240702$$MD$US$US
240412052$24041205$2$F$20240603$20240715$20240702$20240809$PER$$US-TOLMAR, INC.-24US050020$TOLMAR$$$$$$Y$$$20240809$$HP$US$US
240412062$24041206$2$F$20240606$20240715$20240702$20240809$PER$$US-TOLMAR, INC.-24US050007$TOLMAR$$85$YR$$M$Y$$$20240809$$HP$US$US
240412072$24041207$2$F$20240606$20240715$20240702$20240809$PER$$US-TOLMAR, INC.-24US050029$TOLMAR$$84$YR$$M$Y$$$20240809$$HP$US$US
240412081$24041208$1$I$20240604$20240607$20240702$20240702$PER$$US-TOLMAR, INC.-24US050052$TOLMAR$$85$YR$$M$Y$$$20240628$$PH$US$US
240412091$24041209$1$I$$20240607$20240702$20240702$PER$$US-TOLMAR, INC.-24US050072$TOLMAR$$$$$$Y$$$20240628$$CN$US$US
240412101$24041210$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281436108240-JYFTK$GB-ORGANON-O2407GBR000056$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240412111$24041211$1$I$20240629$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001021$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240702$$CN$US$US
240412121$24041212$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000087$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240702$$CN$US$US
240412131$24041213$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001016$ELI LILLY AND CO$$$$$M$Y$$$20240702$$CN$US$US
240412141$24041214$1$I$20240423$20240509$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004639$SAREPTA THERAPEUTICS$$19$YR$$M$Y$$$20240702$$HP$US$US
240412151$24041215$1$I$20240509$20240513$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004651$SAREPTA THERAPEUTICS$$8$YR$$M$Y$$$20240702$$HP$US$US
240412161$24041216$1$I$$20240503$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004619$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240412171$24041217$1$I$$20240418$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004564$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240412181$24041218$1$I$$20240513$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004643$SAREPTA THERAPEUTICS$$$$$M$Y$48.53$KG$20240702$$HP$US$US
240412191$24041219$1$I$20240501$20240513$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004652$SAREPTA THERAPEUTICS$$3$YR$$M$Y$$$20240702$$HP$US$US
240412204$24041220$4$F$20240418$20240903$20240702$20240910$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004569$SAREPTA THERAPEUTICS$$11$YR$$M$Y$46.259$KG$20240910$$HP$US$US
240412211$24041221$1$I$$20240507$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004603$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240412221$24041222$1$I$20240514$20240605$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004659$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240702$$HP$US$US
240412231$24041223$1$I$20240510$20240529$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004636$SAREPTA THERAPEUTICS$$10$YR$$M$Y$19.84$KG$20240702$$HP$US$US
240412241$24041224$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3214014$TEVA$$63$YR$$M$Y$$$20240702$$HP$CA$CA
240412251$24041225$1$I$20240621$20240621$20240702$20240702$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001382$SK LIFE SCIENCE$$$$$$Y$$$20240702$$CN$US$US
240412262$24041226$2$F$20240101$20240828$20240702$20240910$EXP$$IT-ACRAF SpA-2024-033586$SK LIFE SCIENCE$$$$$$Y$$$20240910$$MD$IT$IT
240412271$24041227$1$I$20230401$20240626$20240702$20240702$EXP$GB-MHRA-MED-202406260140244870-RZGDF$GB-TEVA-VS-3214095$TEVA$$$$$F$Y$$$20240702$$CN$GB$GB
240412281$24041228$1$I$20240101$20240627$20240702$20240702$PER$$US-JNJFOC-20240675429$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$MD$US$US
240412292$24041229$2$F$20240101$20240731$20240702$20240809$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004687$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240809$$CN$US$US
240412301$24041230$1$I$20240518$20240518$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004670$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240702$$HP$US$US
240412311$24041231$1$I$20240507$20240528$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004698$SAREPTA THERAPEUTICS$$23$YR$$M$Y$43$KG$20240702$$HP$US$US
240412321$24041232$1$I$20240621$20240625$20240702$20240702$PER$$US-BAYER-2024A092733$BAYER$$23$YR$A$F$Y$$$20240702$$HP$US$US
240412332$24041233$2$F$$20240708$20240702$20240711$EXP$$NVSC2024CA135423$NOVARTIS$$$$$$Y$$$20240711$$MD$CA$CA
240412343$24041234$3$F$$20240808$20240702$20240812$EXP$$NVSC2024MX136016$NOVARTIS$$$$$M$Y$71$KG$20240812$$CN$MX$MX
240412351$24041235$1$I$20240531$20240619$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004731$SAREPTA THERAPEUTICS$$16$YR$$M$Y$39.4$KG$20240702$$HP$US$US
240412361$24041236$1$I$20240101$20240612$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004755$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240412371$24041237$1$I$20240613$20240614$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004758$SAREPTA THERAPEUTICS$$16$YR$$M$Y$$$20240702$$HP$US$US
240412381$24041238$1$I$20240101$20240607$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004738$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240412391$24041239$1$I$20240617$20240617$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004765$SAREPTA THERAPEUTICS$$13$YR$$M$Y$44.5$KG$20240702$$HP$US$US
240412401$24041240$1$I$20240601$20240612$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004753$SAREPTA THERAPEUTICS$$2$YR$$M$Y$$$20240702$$HP$US$US
240412411$24041241$1$I$20240608$20240626$20240702$20240702$EXP$$US-OTSUKA-2024_017810$OTSUKA$$$$$F$Y$$$20240702$$CN$US$US
240412422$24041242$2$F$$20240702$20240702$20240710$EXP$$CA-ROCHE-10000011557$ROCHE$$$$A$F$Y$$$20240710$$CN$CA$CA
240412431$24041243$1$I$20240531$20240624$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004751$SAREPTA THERAPEUTICS$$17$YR$$M$Y$78$KG$20240702$$HP$US$US
240412441$24041244$1$I$20240101$20240625$20240702$20240702$EXP$$CN-SA-2024SA191459$SANOFI AVENTIS$$77$YR$E$M$Y$60$KG$20240702$$HP$CN$CN
240412451$24041245$1$I$20240101$20240618$20240702$20240702$EXP$$US-SCPHARMACEUTICALS-2024-SCPH-US000369$PAREXEL$$$$$$Y$$$20240702$$CN$US$US
240412462$24041246$2$F$$20240702$20240702$20240708$EXP$$CN-GILEAD-2024-0678846$GILEAD$Renjie C, Sheng C, Song C, Bin L, Nianqiao G, Gang C, et al.. Therapeitic effect of direct antiviral drugs on donor-derived hepatitis C infection after kidney transplantation. Prac J Organ Transplant(Electronic version). 2024;12(3):UNK. doi:10.3969/j.issn.2095-5332.2024.03.006$$$A$$Y$$$20240708$$HP$CN$CN
240412472$24041247$2$F$20240501$20240726$20240702$20240730$EXP$$US-UCBSA-2024033385$UCB$$59$YR$$F$Y$$$20240730$$HP$US$US
240412501$24041250$1$I$20240101$20240625$20240702$20240702$PER$$US-BIOGEN-2024BI01255156$BIOGEN$$$$$M$Y$$$20240702$$CN$US$US
240412511$24041251$1$I$20240601$20240624$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004790$SAREPTA THERAPEUTICS$$25$YR$$M$Y$$$20240702$$HP$US$US
240412521$24041252$1$I$20240612$20240614$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004767$SAREPTA THERAPEUTICS$$12$YR$$M$Y$$$20240702$$HP$US$US
240412531$24041253$1$I$20240613$20240617$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004766$SAREPTA THERAPEUTICS$$11$YR$$M$Y$15.51$KG$20240702$$HP$US$US
240412541$24041254$1$I$$20240626$20240702$20240702$PER$$US-ABBVIE-5817992$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240412551$24041255$1$I$$20240625$20240702$20240702$EXP$$DE-INDIVIOR UK LIMITED-INDV-145801-2024$RECKITT BENCKISER$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$39$YR$$F$Y$$$20240702$$HP$DE$DE
240412561$24041256$1$I$$20231003$20240702$20240702$PER$$US-AMGEN-USASP2023235196$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240412571$24041257$1$I$$20231109$20240702$20240702$PER$$US-AMGEN-USASP2023235302$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240412581$24041258$1$I$20240628$20240701$20240702$20240702$DIR$FDA-CDER-CTU-2024-46152$$FDA-CTU$$86$YR$$F$N$$$20240701$N$HP$US$
240412591$24041259$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46186$$FDA-CTU$$58$YR$$F$N$$$20240702$N$$US$
240412611$24041261$1$I$$20240620$20240702$20240702$PER$$US-JNJFOC-20240656205$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$US$US
240412622$24041262$2$F$20240101$20240731$20240702$20240814$EXP$$US-UCBSA-2024033316$UCB$$$$$M$Y$$$20240814$$CN$US$US
240412631$24041263$1$I$20240606$20240623$20240702$20240702$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018750$UNITED THERAPEUTICS$$86$YR$$M$Y$97.052$KG$20240702$$$US$US
240412641$24041264$1$I$$20240628$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105063$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$$$20240702$$CN$US$US
240412651$24041265$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA188978$SANOFI AVENTIS$$$$C$M$Y$$$20240702$$MD$US$US
240412661$24041266$1$I$20240618$20240625$20240702$20240702$PER$$US-SA-2024SA192323$SANOFI AVENTIS$$55$YR$A$F$Y$50.8$KG$20240702$$MD$US$US
240412671$24041267$1$I$20240101$20240625$20240702$20240702$PER$$US-SA-2024SA193137$SANOFI AVENTIS$$$$A$F$Y$78$KG$20240702$$MD$US$US
240412691$24041269$1$I$20240601$20240624$20240702$20240702$PER$$US-SA-2024SA188636$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240702$$MD$US$US
240412706$24041270$6$F$20240101$20240906$20240702$20240916$PER$$US-SA-2024SA187554$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240916$$MD$US$US
240412711$24041271$1$I$20240220$20240620$20240702$20240702$PER$$US-SA-2024SA187991$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240702$$MD$US$US
240412722$24041272$2$F$20240101$20240816$20240702$20240903$PER$$US-SA-2024SA188961$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240903$$MD$US$US
240412731$24041273$1$I$20240621$20240621$20240702$20240702$PER$$US-SA-2024SA187526$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240702$$HP$US$US
240412741$24041274$1$I$20240101$20240627$20240702$20240702$PER$$US-SA-2024SA192649$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$CN$US$US
240412751$24041275$1$I$$20240701$20240702$20240702$PER$$US-HALEON-2184886$Haleon PLC$$$$$M$Y$$$20240702$$CN$US$US
240412765$24041276$5$F$20240101$20240816$20240702$20240820$EXP$$JP-OTSUKA-2024_018358$OTSUKA$$68$YR$$F$Y$$$20240820$$PH$JP$JP
240412771$24041277$1$I$20240601$20240630$20240702$20240702$EXP$GB-MHRA-MED-202406302122384370-FQNTR$GB-TAKEDA-2024TUS065501$TAKEDA$$$$$F$Y$$$20240702$$HP$GB$GB
240412781$24041278$1$I$20230622$20230725$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003506$SAREPTA THERAPEUTICS$$11$YR$$M$Y$27.5$KG$20240702$$HP$US$US
240412791$24041279$1$I$$20240620$20240702$20240702$EXP$$US-SCIEGENP-2024SCLIT00321$SCIEGEN$Pitter D, Hanley S, Eisa H, et al..Unexpected Seizure Activity in the Setting of Lamotrigine Toxicity.Cureus.11-May-2024;16 (5)$28$YR$A$F$Y$$$20240702$$HP$US$US
240412801$24041280$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281041575460-KYCFR$GB-ORGANON-O2407GBR000049$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240412821$24041282$1$I$$20201002$20240702$20240702$PER$$US-CHATTEMPRD-2020SA273501$CHATTEM$$$$$M$Y$$$20240702$$CN$US$US
240412832$24041283$2$F$20231201$20240628$20240702$20240725$PER$$US-ORGANON-O2407USA000054$ORGANON$$18$YR$$F$Y$55.329$KG$20240725$$CN$US$US
240412841$24041284$1$I$20240512$20240515$20240702$20240702$PER$$US-PERRIGO-24US004879$PERRIGO$$7$YR$$F$Y$$$20240702$$CN$US$US
240412851$24041285$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5817351$ABBVIE$$$$$F$Y$100$KG$20240702$$CN$US$US
240412861$24041286$1$I$20230928$20230928$20240702$20240702$PER$$US-PERRIGO-23US011497$PERRIGO$$7$YR$$$Y$$$20240702$$CN$US$US
240412871$24041287$1$I$20240512$20240521$20240702$20240702$PER$$US-PERRIGO-24US004998$PERRIGO$$9$YR$$F$Y$$$20240702$$CN$US$US
240412881$24041288$1$I$20220307$20220314$20240702$20240702$PER$$US-PERRIGO-22US017009$PERRIGO$$68$YR$$F$Y$$$20240702$$CN$US$US
240412891$24041289$1$I$$20240618$20240702$20240702$EXP$$US-GLANDPHARMA-US-2024GLNLIT00393$GLAND PHARMA$Spencer Wilhelm.Toxicity to Recovery, Acute Right Ventricular Failure and Oxy Right Ventricular Assist Device.ASAIO Journal.APR-2024;70:73$20$YR$A$M$Y$$$20240702$$MD$US$US
240412903$24041290$3$F$$20240802$20240702$20240815$PER$$US-AstraZeneca-2024A142178$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
240412911$24041291$1$I$$20240627$20240702$20240702$PER$$US-AstraZeneca-2024A149399$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240412921$24041292$1$I$$20240627$20240702$20240702$EXP$$CA-TAKEDA-2024TUS062616$TAKEDA$$$$$F$Y$$$20240702$$CN$CA$CA
240412931$24041293$1$I$20240101$20240624$20240702$20240702$30DAY$$US-GSK-US2024078568$GLAXOSMITHKLINE$$19$YR$$F$Y$88.45$KG$20240702$$PH$US$US
240412961$24041296$1$I$$20240625$20240702$20240702$EXP$$ES-CELLTRION INC.-2024ES015676$CELLTRION$$$$$$Y$$$20240702$$CN$ES$ES
240412971$24041297$1$I$20230629$20230630$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003566$SAREPTA THERAPEUTICS$$18$YR$$M$Y$$$20240702$$HP$US$US
240412981$24041298$1$I$$20230712$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003578$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240412991$24041299$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A146169$ASTRAZENECA$$$$$F$Y$126$KG$20240702$$CN$US$
240413001$24041300$1$I$20230704$20230720$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003579$SAREPTA THERAPEUTICS$$21$YR$$M$Y$64.86$KG$20240702$$HP$US$US
240413011$24041301$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46191$$FDA-CTU$$78$YR$$F$N$$$20240702$N$$US$
240413021$24041302$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46151$$FDA-CTU$$47$YR$$F$N$117$LBS$20240702$N$$US$
240413031$24041303$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46173$$FDA-CTU$$62$YR$$F$N$121$LBS$20240702$N$$US$
240413041$24041304$1$I$20230602$20230720$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003583$SAREPTA THERAPEUTICS$$8$YR$$M$Y$38.56$KG$20240702$$HP$US$US
240413051$24041305$1$I$20230630$20230714$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003576$SAREPTA THERAPEUTICS$$23$YR$$M$Y$50.8$KG$20240702$$HP$US$US
240413061$24041306$1$I$20230630$20230726$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003570$SAREPTA THERAPEUTICS$$7$YR$$M$Y$34.83$KG$20240702$$HP$US$US
240413071$24041307$1$I$20230703$20230703$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003577$SAREPTA THERAPEUTICS$$9$YR$$M$Y$$$20240702$$HP$US$US
240413081$24041308$1$I$20240622$20240624$20240702$20240702$EXP$$CO-BIOVITRUM-2024-CO-009350$BIOVITRUM$$86$DY$$F$Y$2.7$KG$20240702$$CN$CO$CO
240413091$24041309$1$I$20230621$20230712$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003553$SAREPTA THERAPEUTICS$$12$YR$$M$Y$69.49$KG$20240702$$HP$US$US
240413101$24041310$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46180$$FDA-CTU$$53$YR$$F$N$$$20240702$N$$US$
240413111$24041311$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46174$$FDA-CTU$$60$YR$$F$N$$$20240702$N$HP$US$
240413131$24041313$1$I$$20230718$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003555$SAREPTA THERAPEUTICS$$$$$M$Y$45.351$KG$20240702$$HP$US$US
240413141$24041314$1$I$20230622$20230713$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003559$SAREPTA THERAPEUTICS$$17$YR$$M$Y$63.492$KG$20240702$$HP$US$US
240413151$24041315$1$I$20240617$20240624$20240702$20240702$EXP$$CA-TAKEDA-2024TUS053315$TAKEDA$$72$YR$$F$Y$$$20240702$$MD$CA$CA
240413161$24041316$1$I$20230628$20230805$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003585$SAREPTA THERAPEUTICS$$13$YR$$M$Y$86.168$KG$20240702$$HP$US$US
240413171$24041317$1$I$$20240625$20240702$20240702$PER$$US-AGIOS-2406US03809$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
240413181$24041318$1$I$$20240626$20240702$20240702$PER$$US-AGIOS-2406US03810$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
240413191$24041319$1$I$20230630$20230726$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003584$SAREPTA THERAPEUTICS$$8$YR$$M$Y$38.56$KG$20240702$$HP$US$US
240413201$24041320$1$I$20230717$20230801$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003611$SAREPTA THERAPEUTICS$$6$YR$$M$Y$19.048$KG$20240702$$HP$US$US
240413211$24041321$1$I$20230705$20230731$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003586$SAREPTA THERAPEUTICS$$8$YR$$M$Y$$$20240702$$CN$US$US
240413221$24041322$1$I$20230125$20230829$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003607$SAREPTA THERAPEUTICS$$19$YR$$M$Y$32.6$KG$20240702$$HP$US$US
240413231$24041323$1$I$20211101$20230714$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003606$SAREPTA THERAPEUTICS$$17$YR$$M$Y$32.6$KG$20240702$$HP$US$US
240413241$24041324$1$I$20230708$20231002$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003597$SAREPTA THERAPEUTICS$$20$YR$$M$Y$$$20240702$$HP$US$US
240413251$24041325$1$I$20240520$20240624$20240702$20240702$EXP$$CO-BIOVITRUM-2024-CO-009355$BIOVITRUM$$45$DY$$F$Y$$$20240702$$CN$CO$CO
240413261$24041326$1$I$20210217$20230808$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003605$SAREPTA THERAPEUTICS$$17$YR$$M$Y$32.6$KG$20240702$$HP$US$US
240413271$24041327$1$I$20240101$20240626$20240702$20240702$EXP$$NL-BIOVITRUM-2024-NL-009356$BIOVITRUM$$0$YR$$M$Y$4.8$KG$20240702$$HP$NL$NL
240413281$24041328$1$I$$20240625$20240702$20240702$PER$$US-BIOGEN-2024BI01271190$BIOGEN$$$$$M$Y$$$20240702$$HP$US$US
240413291$24041329$1$I$$20240619$20240702$20240702$EXP$$JP-SPECGX-T202401442$SPECGX$$6$DEC$$M$Y$$$20240702$$MD$JP$JP
240413301$24041330$1$I$20230616$20230802$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003604$SAREPTA THERAPEUTICS$$17$YR$$M$Y$97.7$KG$20240702$$HP$US$US
240413311$24041331$1$I$20230719$20230804$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003617$SAREPTA THERAPEUTICS$$23$YR$$M$Y$108.86$KG$20240702$$HP$US$US
240413321$24041332$1$I$20230711$20230816$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003601$SAREPTA THERAPEUTICS$$13$YR$$M$Y$62$KG$20240702$$HP$US$US
240413333$24041333$3$F$20240401$20240716$20240702$20240717$EXP$$IT-BIOVITRUM-2024-IT-009351$BIOVITRUM$$78$YR$$F$Y$$$20240717$$MD$IT$IT
240413342$24041334$2$F$$20240704$20240702$20240713$EXP$$US-TEVA-VS-3214636$TEVA$Deng X, Jung D. A Late, Unusual Presentation of Chronic Eosinophilic Pneumonia Requiring Anti-IL5 Therapy. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).; Deng X, Jung D. A Late, Unusual Presentation of Chronic Eosinophilic Pneumonia Requiring Anti-IL5 Therapy. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$88$YR$$F$Y$$$20240713$$HP$US$US
240413361$24041336$1$I$20230714$20230817$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003616$SAREPTA THERAPEUTICS$$11$YR$$M$Y$36.74$KG$20240702$$HP$US$US
240413371$24041337$1$I$20230719$20230802$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003619$SAREPTA THERAPEUTICS$$23$YR$$M$Y$37.4$KG$20240702$$HP$US$US
240413382$24041338$2$F$$20240621$20240702$20240705$EXP$$NO-ROCHE-10000012999$ROCHE$$40$YR$A$M$Y$$$20240705$$MD$NO$NO
240413391$24041339$1$I$20240627$20240627$20240702$20240702$PER$$US-JNJFOC-20240674803$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240702$$HP$US$US
240413403$24041340$3$F$$20240820$20240702$20240827$EXP$$CA-ROCHE-10000008046$ROCHE$$65$YR$E$F$Y$$$20240827$$HP$CA$CA
240413412$24041341$2$F$20240520$20240710$20240702$20240717$PER$$US-BAYER-2024A092966$BAYER$$23$YR$A$F$Y$66.22$KG$20240717$$MD$US$US
240413421$24041342$1$I$$20240624$20240702$20240702$EXP$$US-TEVA-VS-3214037$TEVA$Whyte MP, McAlister WH, Dhiman V, Gopinathan NR, Bhadada SK. Drug-induced osteopetrosis. Bone 2023; 173.$13$YR$$M$Y$$$20240702$$HP$US$US
240413431$24041343$1$I$20230712$20230725$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003640$SAREPTA THERAPEUTICS$$10$YR$$M$Y$23.04$KG$20240702$$HP$US$US
240413441$24041344$1$I$20230706$20230724$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003649$SAREPTA THERAPEUTICS$$16$YR$$M$Y$$$20240702$$HP$US$US
240413451$24041345$1$I$20230712$20231018$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003623$SAREPTA THERAPEUTICS$$14$YR$$M$Y$64.853$KG$20240702$$HP$US$US
240413461$24041346$1$I$20230619$20231025$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003622$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240702$$HP$US$US
240413471$24041347$1$I$20230719$20230726$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003644$SAREPTA THERAPEUTICS$$19$YR$$M$Y$35.6$KG$20240702$$HP$US$US
240413481$24041348$1$I$$20240624$20240702$20240702$EXP$$US-TEVA-VS-3214038$TEVA$Whyte MP, McAlister WH, Dhiman V, Gopinathan NR, Bhadada SK. Drug-induced osteopetrosis. Bone 2023; 173.$6$YR$$M$Y$22$KG$20240702$$HP$US$US
240413491$24041349$1$I$20230717$20230804$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003638$SAREPTA THERAPEUTICS$$14$YR$$M$Y$51$KG$20240702$$HP$US$US
240413503$24041350$3$F$20240530$20240723$20240702$20240728$PER$$US-AMGEN-USASP2024127758$AMGEN$$74$YR$E$F$Y$79.38$KG$20240728$$HP$US$US
240413511$24041351$1$I$20230717$20230815$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003639$SAREPTA THERAPEUTICS$$10$YR$$M$Y$30.295$KG$20240702$$HP$US$US
240413521$24041352$1$I$20230701$20230730$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003662$SAREPTA THERAPEUTICS$$27$YR$$M$Y$$$20240702$$CN$US$US
240413531$24041353$1$I$20230721$20230731$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003663$SAREPTA THERAPEUTICS$$24$YR$$M$Y$$$20240702$$HP$US$US
240413541$24041354$1$I$20230728$20231011$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003664$SAREPTA THERAPEUTICS$$28$YR$$M$Y$28.571$KG$20240702$$HP$US$US
240413551$24041355$1$I$20230705$20230920$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003680$SAREPTA THERAPEUTICS$$25$YR$$M$Y$46.712$KG$20240702$$HP$US$US
240413561$24041356$1$I$20230725$20230731$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003652$SAREPTA THERAPEUTICS$$13$YR$$M$Y$$$20240702$$HP$US$US
240413571$24041357$1$I$20230802$20230825$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003684$SAREPTA THERAPEUTICS$$17$YR$$M$Y$66.22$KG$20240702$$HP$US$US
240413581$24041358$1$I$20230804$20230817$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003678$SAREPTA THERAPEUTICS$$23$YR$$M$Y$53$KG$20240702$$HP$US$US
240413591$24041359$1$I$20230727$20230811$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003654$SAREPTA THERAPEUTICS$$17$YR$$M$Y$68.027$KG$20240702$$HP$US$US
240413601$24041360$1$I$20230801$20230811$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003668$SAREPTA THERAPEUTICS$$13$YR$$M$Y$62$KG$20240702$$HP$US$US
240413621$24041362$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46179$$FDA-CTU$$36$YR$$F$N$$$20240702$N$$US$
240413631$24041363$1$I$20220101$20240625$20240702$20240702$EXP$$CA-UCBSA-2024032449$UCB$$$$$F$Y$$$20240702$$CN$CA$CA
240413641$24041364$1$I$$20240626$20240702$20240702$PER$$US-SA-2024SA192242$SANOFI AVENTIS$$$$C$M$Y$$$20240702$$HP$US$US
240413661$24041366$1$I$20240617$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46176$$FDA-CTU$$76$YR$$F$N$$$20240702$Y$PH$US$
240413671$24041367$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3214172$TEVA$$38$YR$$F$Y$73$KG$20240702$$HP$CA$CA
240413681$24041368$1$I$20240101$20240626$20240702$20240702$PER$$US-SA-2024SA192978$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240702$$MD$US$US
240413691$24041369$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46164$$FDA-CTU$$35$YR$$M$N$$$20240702$N$$US$
240413701$24041370$1$I$$20240701$20240701$20240701$DIR$708676$$FDA-CTU$$$$$UNK$N$$$20240701$N$CN$US$
240413731$24041373$1$I$20230801$20231121$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003687$SAREPTA THERAPEUTICS$$23$YR$$M$Y$43$KG$20240702$$HP$US$US
240413751$24041375$1$I$20240618$20240701$20240702$20240702$DIR$FDA-CDER-CTU-2024-46182$$FDA-CTU$$78$YR$$M$N$$$20240701$N$HP$US$
240413761$24041376$1$I$$20240618$20240702$20240702$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00407$GLAND PHARMA$Zheng-Qian Li.Difficult airway due to cervical haemorrhage caused by spontaneous rupture of a parathyroid adenoma: A case report..World Journal of Clinical Cases.16-FEB-2023;11(5):1217-1223$64$YR$A$F$Y$75$KG$20240702$$MD$CN$CN
240413771$24041377$1$I$20240405$20240701$20240702$20240702$EXP$ES-AEMPS-1540641$ES-ABBVIE-5822977$ABBVIE$$3$YR$$F$Y$16$KG$20240702$$PH$ES$ES
240413781$24041378$1$I$20230701$20231003$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003707$SAREPTA THERAPEUTICS$$12$YR$$M$Y$55.782$KG$20240702$$HP$US$US
240413791$24041379$1$I$20230804$20230809$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003702$SAREPTA THERAPEUTICS$$18$YR$$M$Y$$$20240702$$HP$US$US
240413801$24041380$1$I$20230814$20230831$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003713$SAREPTA THERAPEUTICS$$24$YR$$M$Y$128.97$KG$20240702$$HP$US$US
240413811$24041381$1$I$20230801$20230818$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003725$SAREPTA THERAPEUTICS$$21$YR$$M$Y$$$20240702$$HP$US$US
240413821$24041382$1$I$20230811$20240215$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003699$SAREPTA THERAPEUTICS$$24$YR$$M$Y$45.351$KG$20240702$$HP$US$US
240413831$24041383$1$I$20230726$20230922$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003708$SAREPTA THERAPEUTICS$$13$YR$$M$Y$22.857$KG$20240702$$HP$US$US
240413851$24041385$1$I$20230818$20230907$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003726$SAREPTA THERAPEUTICS$$19$YR$$M$Y$41.1$KG$20240702$$HP$US$US
240413861$24041386$1$I$$20231002$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003722$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240413871$24041387$1$I$$20230811$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003698$SAREPTA THERAPEUTICS$$$$$M$Y$135.3$KG$20240702$$HP$US$US
240413881$24041388$1$I$20230809$20230815$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003714$SAREPTA THERAPEUTICS$$19$YR$$M$Y$61.678$KG$20240702$$HP$US$US
240413891$24041389$1$I$$20240624$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006737$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240413902$24041390$2$F$20240628$20240702$20240702$20240706$PER$$US-AMGEN-USASP2024129642$AMGEN$$70$YR$E$F$Y$$$20240706$$CN$US$US
240413912$24041391$2$F$20240618$20240624$20240702$20240826$EXP$CN-NMPACDR-3701051014824202400114$CN-BAXTER-2024BAX020640$BAXTER$$46$YR$$F$Y$75$KG$20240826$$MD$CN$CN
240413921$24041392$1$I$20240612$20240624$20240702$20240702$EXP$CN-NMPACDR-4510011028128202400484$CN-BAXTER-2024BAX020636$BAXTER$$60$YR$$F$Y$41$KG$20240702$$MD$CN$CN
240413931$24041393$1$I$20240612$20240624$20240702$20240702$EXP$SE-SEMPA-2024-004936$SE-BAXTER-2024BAX020523$BAXTER$$61$YR$$F$Y$53$KG$20240702$$MD$SE$SE
240413951$24041395$1$I$20240323$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281122461890-DVTGF$GB-ORGANON-O2407GBR000005$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240413962$24041396$2$F$$20240919$20240702$20240923$EXP$$CN-ORGANON-O2406CHN002346$ORGANON$$$$$F$Y$$$20240923$$CN$CN$CN
240413971$24041397$1$I$$20240624$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006732$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240413984$24041398$4$F$20240101$20240829$20240702$20240904$30DAY$$US-PFIZER INC-202400201349$PFIZER$$19$YR$$M$Y$$$20240904$$CN$US$US
240413991$24041399$1$I$20240601$20240625$20240702$20240702$EXP$$GB-JNJFOC-20240672562$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240702$$CN$GB$GB
240414001$24041400$1$I$$20240627$20240702$20240702$PER$$US-JNJFOC-20240675189$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240414011$24041401$1$I$20230802$20230825$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003744$SAREPTA THERAPEUTICS$$16$YR$$M$Y$72.286$KG$20240702$$HP$US$US
240414021$24041402$1$I$$20230929$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003730$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240414031$24041403$1$I$20230829$20230915$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003757$SAREPTA THERAPEUTICS$$5$YR$$M$Y$20.5$KG$20240702$$HP$US$US
240414041$24041404$1$I$$20230908$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003778$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$MD$US$US
240414051$24041405$1$I$20230824$20231116$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003759$SAREPTA THERAPEUTICS$$9$YR$$M$Y$21.315$KG$20240702$$HP$US$US
240414061$24041406$1$I$20230816$20230823$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003742$SAREPTA THERAPEUTICS$$6$YR$$M$Y$$$20240702$$HP$US$US
240414071$24041407$1$I$20230825$20230831$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003760$SAREPTA THERAPEUTICS$$19$YR$$M$Y$$$20240702$$HP$US$US
240414081$24041408$1$I$20230804$20230915$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003729$SAREPTA THERAPEUTICS$$25$YR$$M$Y$38.549$KG$20240702$$HP$US$US
240414091$24041409$1$I$20230829$20231102$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003754$SAREPTA THERAPEUTICS$$12$YR$$M$Y$$$20240702$$HP$US$US
240414101$24041410$1$I$20240101$20240628$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104966$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240702$$CN$US$US
240414111$24041411$1$I$20230818$20230922$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003772$SAREPTA THERAPEUTICS$$21$YR$$M$Y$37.642$KG$20240702$$HP$US$US
240414121$24041412$1$I$20240601$20240624$20240702$20240702$PER$$US-SA-2024SA188955$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240702$$MD$US$US
240414131$24041413$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA188567$SANOFI AVENTIS$$$$T$F$Y$182.98$KG$20240702$$MD$US$US
240414141$24041414$1$I$20240501$20240621$20240702$20240702$PER$$US-SA-2024SA188923$SANOFI AVENTIS$$50$YR$A$F$Y$120$KG$20240702$$MD$US$US
240414151$24041415$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187630$SANOFI AVENTIS$$46$YR$A$F$Y$63.502$KG$20240702$$MD$US$US
240414161$24041416$1$I$20240601$20240620$20240702$20240702$PER$$US-SA-2024SA188910$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240702$$MD$US$US
240414171$24041417$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5816764$ABBVIE$$68$YR$$M$Y$$$20240702$$CN$US$US
240414181$24041418$1$I$$20240618$20240702$20240702$EXP$$US-GLANDPHARMA-US-2024GLNLIT00400$GLAND PHARMA$$79$YR$E$F$Y$$$20240702$$HP$US$US
240414203$24041420$3$F$$20240701$20240702$20240712$PER$$US-ROCHE-10000012715$ROCHE$$$$C$M$Y$$$20240712$$MD$US$US
240414211$24041421$1$I$20230911$20230913$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003798$SAREPTA THERAPEUTICS$$14$YR$$M$Y$$$20240702$$HP$US$US
240414221$24041422$1$I$20230906$20230912$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003794$SAREPTA THERAPEUTICS$$16$YR$$M$Y$$$20240702$$HP$US$US
240414231$24041423$1$I$20230906$20230915$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003804$SAREPTA THERAPEUTICS$$17$YR$$M$Y$$$20240702$$HP$US$US
240414241$24041424$1$I$20230901$20231226$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003803$SAREPTA THERAPEUTICS$$19$YR$$M$Y$41.1$KG$20240702$$HP$US$US
240414251$24041425$1$I$20230914$20230929$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003801$SAREPTA THERAPEUTICS$$16$YR$$M$Y$69.85$KG$20240702$$HP$US$US
240414261$24041426$1$I$20230915$20231005$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003808$SAREPTA THERAPEUTICS$$19$YR$$M$Y$53.2$KG$20240702$$HP$US$US
240414271$24041427$1$I$20230917$20231212$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003815$SAREPTA THERAPEUTICS$$14$YR$$M$Y$60.7$KG$20240702$$HP$US$US
240414281$24041428$1$I$20230915$20231005$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003809$SAREPTA THERAPEUTICS$$28$YR$$M$Y$45.9$KG$20240702$$HP$US$US
240414291$24041429$1$I$20230912$20231009$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003807$SAREPTA THERAPEUTICS$$11$YR$$M$Y$82.993$KG$20240702$$HP$US$US
240414301$24041430$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3214278$TEVA$$52$YR$$F$Y$70$KG$20240702$$HP$CA$CA
240414311$24041431$1$I$20230303$20231005$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003816$SAREPTA THERAPEUTICS$$13$YR$$M$Y$28.5$KG$20240702$$HP$US$US
240414321$24041432$1$I$20240624$20240624$20240702$20240702$EXP$$US-ALXN-202406USA001672US$ALEXION PHARMACEUTICALS$$76$YR$$M$Y$68.038$KG$20240702$$HP$US$US
240414332$24041433$2$F$$20240805$20240702$20240806$PER$$US-ALXN-202406USA001574US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240414341$24041434$1$I$20240601$20240626$20240702$20240702$EXP$$US-OTSUKA-2024_017811$OTSUKA$$45$YR$$F$Y$$$20240702$$HP$US$US
240414352$24041435$2$F$20240601$20240709$20240702$20240712$EXP$$AU-NALPROPION PHARMACEUTICALS INC.-AU-2024CUR003145$CURRAX PHARMACEUTICALS$$36$YR$$F$Y$$$20240712$$CN$AU$AU
240414361$24041436$1$I$$20240628$20240702$20240702$EXP$$AU-MYLANLABS-2024M1061503$MYLAN$$$$$F$Y$$$20240702$$HP$AU$AU
240414371$24041437$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281418165880-YWTHP$GB-MYLANLABS-2024M1061544$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240414381$24041438$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281425089800-RYTVB$GB-MYLANLABS-2024M1061564$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240414391$24041439$1$I$20240323$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281136243400-GYCWK$GB-MYLANLABS-2024M1061534$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240414401$24041440$1$I$$20240206$20240702$20240702$EXP$GB-MHRA-MED-202402051505582400-YZHLF$GB-TEVA-VS-3154108$TEVA$$$$$F$Y$$$20240702$$HP$GB$GB
240414411$24041441$1$I$20230707$20231006$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003818$SAREPTA THERAPEUTICS$$13$YR$$M$Y$28.5$KG$20240702$$HP$US$US
240414421$24041442$1$I$20230901$20231212$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003846$SAREPTA THERAPEUTICS$$23$YR$$M$Y$53$KG$20240702$$HP$US$US
240414431$24041443$1$I$20230920$20231009$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003824$SAREPTA THERAPEUTICS$$13$YR$$M$Y$$$20240702$$HP$US$US
240414441$24041444$1$I$20230901$20230925$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003835$SAREPTA THERAPEUTICS$$6$YR$$M$Y$$$20240702$$HP$US$US
240414451$24041445$1$I$20230922$20230925$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003836$SAREPTA THERAPEUTICS$$22$YR$$M$Y$$$20240702$$HP$US$US
240414461$24041446$1$I$20230923$20231006$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003828$SAREPTA THERAPEUTICS$$23$YR$$M$Y$56$KG$20240702$$HP$US$US
240414471$24041447$1$I$20230928$20231012$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003844$SAREPTA THERAPEUTICS$$17$YR$$M$Y$68.027$KG$20240702$$HP$US$US
240414481$24041448$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-PV202400085079$PFIZER$$31$YR$$M$Y$$$20240702$$MD$US$US
240414491$24041449$1$I$$20240628$20240702$20240702$PER$$US-PFIZER INC-202400204321$PFIZER$$67$YR$$F$Y$$$20240702$$CN$US$US
240414501$24041450$1$I$20240626$20240628$20240702$20240702$PER$$US-PFIZER INC-202400204298$PFIZER$$33$YR$$M$Y$$$20240702$$CN$US$US
240414512$24041451$2$F$$20240702$20240702$20240703$PER$$US-PFIZER INC-202400203745$PFIZER$$67$YR$$F$Y$$$20240703$$CN$US$US
240414523$24041452$3$F$20240719$20240808$20240702$20240813$PER$$US-PFIZER INC-PV202400085863$PFIZER$$67$YR$$M$Y$$$20240813$$HP$US$US
240414531$24041453$1$I$$20240620$20240702$20240702$PER$$US-PFIZER INC-202400201795$PFIZER$$77$YR$$M$Y$87.982$KG$20240702$$MD$US$US
240414541$24041454$1$I$$20230922$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003826$SAREPTA THERAPEUTICS$$$$$M$Y$62.6$KG$20240702$$HP$US$US
240414551$24041455$1$I$$20230928$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003845$SAREPTA THERAPEUTICS$$$$$M$Y$36.29$KG$20240702$$HP$US$US
240414561$24041456$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-PV202400084901$PFIZER$$20$YR$$M$Y$$$20240702$$MD$US$US
240414572$24041457$2$F$$20240722$20240702$20240724$PER$$US-PFIZER INC-202400199824$PFIZER$$77$YR$$M$Y$$$20240724$$CN$US$US
240414581$24041458$1$I$$20240603$20240702$20240702$PER$$US-PFIZER INC-PV202400086212$PFIZER$$73$YR$$F$Y$$$20240702$$CN$US$US
240414591$24041459$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-PV202400085039$PFIZER$$29$YR$$F$Y$$$20240702$$MD$US$US
240414601$24041460$1$I$$20240628$20240702$20240702$PER$$US-PFIZER INC-PV202400086291$PFIZER$$45$YR$$F$Y$$$20240702$$CN$US$US
240414611$24041461$1$I$$20240212$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003849$SAREPTA THERAPEUTICS$$$$$M$Y$41.1$KG$20240702$$HP$US$US
240414621$24041462$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-202400202769$PFIZER$$$$$$Y$$$20240702$$CN$US$US
240414632$24041463$2$F$20181101$20240708$20240702$20240709$PER$$US-PFIZER INC-202400203899$PFIZER$$$$$F$Y$$$20240709$$CN$US$US
240414641$24041464$1$I$$20240626$20240702$20240702$PER$$US-PFIZER INC-PV202400084867$PFIZER$$29$YR$$F$Y$$$20240702$$HP$US$US
240414652$24041465$2$F$$20240801$20240702$20240801$PER$$US-PFIZER INC-PV202400085805$PFIZER$$67$YR$$M$Y$$$20240801$$CN$US$US
240414661$24041466$1$I$$20240628$20240702$20240702$PER$$US-PFIZER INC-202400204277$PFIZER$$34$YR$$M$Y$$$20240702$$HP$US$US
240414671$24041467$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-PV202400085146$PFIZER$$15$YR$$M$Y$$$20240702$$MD$US$US
240414682$24041468$2$F$$20240821$20240702$20240827$PER$$US-PFIZER INC-PV202400084830$PFIZER$$58$YR$$F$Y$$$20240827$$HP$US$US
240414691$24041469$1$I$$20240626$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006856$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240414701$24041470$1$I$$20240628$20240702$20240702$PER$$US-PFIZER INC-202400203299$PFIZER$$73$YR$$F$Y$70.76$KG$20240702$$CN$US$US
240414711$24041471$1$I$20240101$20240628$20240702$20240702$PER$$US-PFIZER INC-PV202400085885$PFIZER$$50$YR$$F$Y$$$20240702$$HP$US$US
240414721$24041472$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-PV202400085202$PFIZER$$34$YR$$M$Y$$$20240702$$MD$US$US
240414731$24041473$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-PV202400085159$PFIZER$$19$YR$$M$Y$$$20240702$$MD$US$US
240414741$24041474$1$I$$20240628$20240702$20240702$PER$$US-PFIZER INC-PV202400084422$PFIZER$$83$YR$$M$Y$$$20240702$$CN$US$US
240414753$24041475$3$F$20240601$20240707$20240702$20240710$PER$$US-PFIZER INC-202400204363$PFIZER$$41$YR$$F$Y$$$20240710$$CN$US$US
240414761$24041476$1$I$$20240628$20240702$20240702$PER$$US-PFIZER INC-PV202400085626$PFIZER$$83$YR$$F$Y$$$20240702$$HP$US$US
240414771$24041477$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-PV202400085063$PFIZER$$27$YR$$F$Y$$$20240702$$MD$US$US
240414781$24041478$1$I$$20240628$20240702$20240702$PER$$US-PFIZER INC-202400203372$PFIZER$$27$YR$$F$Y$$$20240702$$CN$US$US
240414791$24041479$1$I$20240101$20240627$20240702$20240702$PER$$US-PFIZER INC-202400203676$PFIZER$$63$YR$$F$Y$$$20240702$$HP$US$US
240414801$24041480$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-PV202400085043$PFIZER$$30$YR$$F$Y$$$20240702$$MD$US$US
240414811$24041481$1$I$20240601$20240627$20240702$20240702$PER$$US-PFIZER INC-202400203042$PFIZER$$$$$$Y$$$20240702$$CN$US$US
240414823$24041482$3$F$$20240805$20240702$20240808$EXP$$US-PFIZER INC-PV202400085133$PFIZER$$65$YR$$M$Y$$$20240808$$HP$US$US
240414832$24041483$2$F$$20240725$20240702$20240730$PER$$US-PFIZER INC-202400203254$PFIZER$$70$YR$$F$Y$$$20240730$$CN$US$US
240414842$24041484$2$F$$20240906$20240702$20240910$PER$$US-PFIZER INC-PV202300012810$PFIZER$$37$YR$$F$Y$$$20240910$$HP$US$US
240414851$24041485$1$I$$20240628$20240702$20240702$PER$$US-PFIZER INC-202400203955$PFIZER$$56$YR$$F$Y$$$20240702$$HP$US$US
240414862$24041486$2$F$20240101$20240701$20240702$20240703$PER$$US-PFIZER INC-202400202735$PFIZER$$54$YR$$F$Y$$$20240703$$MD$US$US
240414873$24041487$3$F$$20240903$20240702$20240911$EXP$$US-PFIZER INC-202400203779$PFIZER$$63$YR$$M$Y$$$20240910$$MD$US$US
240414881$24041488$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-PV202400085204$PFIZER$$14$YR$$F$Y$$$20240702$$MD$US$US
240414891$24041489$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-PV202400085140$PFIZER$$21$YR$$M$Y$$$20240702$$MD$US$US
240414901$24041490$1$I$20240625$20240627$20240702$20240702$PER$$US-PFIZER INC-202400107724$PFIZER$$47$YR$$F$Y$106.59$KG$20240702$$CN$US$US
240414911$24041491$1$I$$20240627$20240702$20240702$PER$$US-PFIZER INC-202400202429$PFIZER$$53$YR$$F$Y$$$20240702$$MD$US$US
240414922$24041492$2$F$$20240814$20240702$20240819$PER$$US-PFIZER INC-202400203342$PFIZER$$79$YR$$F$Y$$$20240819$$CN$US$US
240414932$24041493$2$F$$20240808$20240702$20240814$PER$$US-PFIZER INC-PV202400086110$PFIZER$$65$YR$$F$Y$$$20240814$$HP$US$US
240414941$24041494$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A146189$ASTRAZENECA$$$$$F$Y$83.9$KG$20240702$$CN$US$
240414951$24041495$1$I$$20240610$20240702$20240702$PER$$US-AstraZeneca-2024A101875$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240414961$24041496$1$I$20240501$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105460$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240702$$HP$US$US
240414971$24041497$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105376$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240702$$CN$US$US
240414981$24041498$1$I$$20240626$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103339$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240702$$CN$US$US
240414991$24041499$1$I$$20231010$20240702$20240702$PER$$US-AMGEN-USASP2023235067$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240415002$24041500$2$F$20240624$20240625$20240702$20240702$EXP$$US-AMGEN-USASP2024126013$AMGEN$$$$A$F$Y$$$20240702$$PH$US$US
240415011$24041501$1$I$$20240629$20240702$20240702$PER$$US-AMGEN-USASP2024129830$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240415021$24041502$1$I$$20230113$20240702$20240702$PER$$US-AMGEN-USASP2023235320$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240415031$24041503$1$I$20240101$20240628$20240702$20240702$PER$$US-Eisai-EC-2024-167501$EISAI$$81$YR$E$F$Y$$$20240702$$CN$US$US
240415041$24041504$1$I$$20240621$20240702$20240702$PER$$US-SA-2023SA042471$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240702$$MD$US$US
240415051$24041505$1$I$20231003$20231006$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003885$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240702$$HP$US$US
240415061$24041506$1$I$20231004$20231020$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003868$SAREPTA THERAPEUTICS$$23$YR$$M$Y$33.11$KG$20240702$$HP$US$US
240415071$24041507$1$I$20231003$20231006$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003886$SAREPTA THERAPEUTICS$$14$YR$$M$Y$$$20240702$$HP$US$US
240415091$24041509$1$I$$20231019$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003875$SAREPTA THERAPEUTICS$$$$$M$Y$56.19$KG$20240702$$HP$US$US
240415101$24041510$1$I$20230928$20231002$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003864$SAREPTA THERAPEUTICS$$18$YR$$M$Y$$$20240702$$HP$US$US
240415111$24041511$1$I$20231001$20231030$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003881$SAREPTA THERAPEUTICS$$28$YR$$M$Y$45.9$KG$20240702$$HP$US$US
240415121$24041512$1$I$20231006$20231006$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003887$SAREPTA THERAPEUTICS$$22$YR$$M$Y$$$20240702$$HP$US$US
240415131$24041513$1$I$20231005$20231006$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003888$SAREPTA THERAPEUTICS$$20$YR$$M$Y$$$20240702$$HP$US$US
240415141$24041514$1$I$$20231003$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003874$SAREPTA THERAPEUTICS$$$$$M$Y$94.3$KG$20240702$$HP$US$US
240415151$24041515$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281402147980-LZGDH$GB-MYLANLABS-2024M1061742$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240415162$24041516$2$F$$20240617$20240702$20240702$EXP$$US-ROCHE-10000001761$ROCHE$Laughter M, Tegla C, Pawar S, Moshiri A. Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C. JAAD Case Reports. 2024;49:28-31. doi:10.1016/j.jdcr.2024.04.039.$37$YR$A$M$Y$$$20240702$$MD$US$US
240415171$24041517$1$I$20231002$20231204$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003861$SAREPTA THERAPEUTICS$$16$YR$$M$Y$45.1$KG$20240702$$HP$US$US
240415181$24041518$1$I$$20240628$20240702$20240702$PER$$US-TAKEDA-2024TUS066037$TAKEDA$$$$$$Y$$$20240702$$PH$US$US
240415191$24041519$1$I$20240628$20240701$20240702$20240702$PER$$US-BAYER-2024A095235$BAYER$$84$YR$E$F$Y$$$20240702$$CN$US$US
240415201$24041520$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46162$$FDA-CTU$$28$YR$$M$N$61.23$KG$20240702$N$HP$US$
240415211$24041521$1$I$$20230630$20240702$20240702$DIR$FDA-CDER-CTU-2024-46189$$FDA-CTU$$$$$M$N$$$20230630$N$HP$US$
240415221$24041522$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46181$$FDA-CTU$$70$YR$$F$N$$$20240702$N$$US$
240415231$24041523$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46149$$FDA-CTU$$59$YR$$F$N$77.11$KG$20240702$N$$US$
240415251$24041525$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46192$$FDA-CTU$$65$YR$$F$N$108.86$KG$20240702$N$$US$
240415261$24041526$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46193$$FDA-CTU$$65$YR$$F$N$108.86$KG$20240702$N$$US$
240415281$24041528$1$I$20240617$20240701$20240701$20240701$DIR$708686$$FDA-CTU$$86$YR$$M$N$103.5$KG$20240701$N$$US$
240415291$24041529$1$I$20240611$20240701$20240701$20240701$DIR$708756$$FDA-CTU$$56$YR$$M$N$87.7$KG$20240701$N$HP$US$
240415301$24041530$1$I$20231010$20231026$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003898$SAREPTA THERAPEUTICS$$13$YR$$M$Y$28.5$KG$20240702$$HP$US$US
240415312$24041531$2$F$20240301$20240702$20240702$20240705$EXP$$NVSC2024DE135700$NOVARTIS$$$$E$M$Y$80$KG$20240705$$HP$DE$DE
240415321$24041532$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281421048380-HJCMP$GB-ORGANON-O2407GBR000090$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240415331$24041533$1$I$20231010$20231031$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003908$SAREPTA THERAPEUTICS$$10$YR$$M$Y$24.04$KG$20240702$$HP$US$US
240415342$24041534$2$F$20240201$20240708$20240702$20240710$EXP$$US-INCYTE CORPORATION-2024IN006834$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240415351$24041535$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281042408830-QRLPK$GB-ORGANON-O2407GBR000064$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240415361$24041536$1$I$20231014$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128472$AMGEN$$48$YR$A$M$Y$$$20240702$$HP$US$US
240415375$24041537$5$F$$20240923$20240702$20240930$EXP$$CA-GSK-CA2023AMR053261$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$CA$CA
240415381$24041538$1$I$$20240127$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003913$SAREPTA THERAPEUTICS$$$$$M$Y$61.224$KG$20240702$$HP$US$US
240415391$24041539$1$I$20231019$20231110$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003943$SAREPTA THERAPEUTICS$$8$YR$$M$Y$26.304$KG$20240702$$HP$US$US
240415401$24041540$1$I$20231010$20231108$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003934$SAREPTA THERAPEUTICS$$11$YR$$M$Y$44.036$KG$20240702$$HP$US$US
240415411$24041541$1$I$20231011$20231213$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003946$SAREPTA THERAPEUTICS$$13$YR$$M$Y$$$20240702$$HP$US$US
240415421$24041542$1$I$20230101$20231114$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003953$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240415431$24041543$1$I$20231010$20231018$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003951$SAREPTA THERAPEUTICS$$17$YR$$M$Y$$$20240702$$CN$US$US
240415441$24041544$1$I$20231013$20231107$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003949$SAREPTA THERAPEUTICS$$21$YR$$M$Y$37.642$KG$20240702$$HP$US$US
240415451$24041545$1$I$20231008$20231012$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003918$SAREPTA THERAPEUTICS$$3$YR$$M$Y$$$20240702$$HP$US$US
240415461$24041546$1$I$20240501$20240626$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006832$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240415471$24041547$1$I$$20240626$20240702$20240702$EXP$$AU-OTSUKA AUSTRALIA PHARMACEUTICALS PTY LTD-2024_018334$OTSUKA$$78$YR$$$Y$$$20240702$$HP$AU$AU
240415481$24041548$1$I$20240101$20240626$20240702$20240702$EXP$$AU-OTSUKA-2024_018221$OTSUKA$$84$YR$$$Y$$$20240702$$HP$AU$AU
240415492$24041549$2$F$20240611$20240702$20240702$20240708$EXP$$BR-BAYER-2024A092608$BAYER$$67$YR$E$M$Y$$$20240708$$CN$BR$BR
240415501$24041550$1$I$20231024$20231024$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003965$SAREPTA THERAPEUTICS$$16$YR$$M$Y$$$20240702$$HP$US$US
240415511$24041551$1$I$20231019$20231113$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003973$SAREPTA THERAPEUTICS$$23$YR$$M$Y$40.3$KG$20240702$$HP$US$US
240415521$24041552$1$I$20231019$20231116$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003969$SAREPTA THERAPEUTICS$$8$YR$$M$Y$27.574$KG$20240702$$HP$US$US
240415531$24041553$1$I$20231021$20231215$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003971$SAREPTA THERAPEUTICS$$23$YR$$M$Y$53.061$KG$20240702$$HP$US$US
240415541$24041554$1$I$20231018$20231119$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003972$SAREPTA THERAPEUTICS$$26$YR$$M$Y$$$20240702$$HP$US$US
240415551$24041555$1$I$$20231113$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003957$SAREPTA THERAPEUTICS$$$$$M$Y$97$KG$20240702$$HP$US$US
240415561$24041556$1$I$20231019$20231110$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003970$SAREPTA THERAPEUTICS$$18$YR$$M$Y$26.7$KG$20240702$$HP$US$US
240415571$24041557$1$I$20231021$20231023$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003958$SAREPTA THERAPEUTICS$$10$YR$$M$Y$$$20240702$$HP$US$US
240415581$24041558$1$I$$20240626$20240702$20240702$EXP$$AU-OTSUKA-2024_018361$OTSUKA$$$$$$Y$$$20240702$$HP$AU$AU
240415601$24041560$1$I$$20240625$20240702$20240702$PER$$US-VERTEX PHARMACEUTICALS-2024-010699$VERTEX$$45$YR$$F$Y$$$20240702$$CN$US$US
240415611$24041561$1$I$20230101$20240618$20240702$20240702$PER$$US-VERTEX PHARMACEUTICALS-2024-009131$VERTEX$$$$$M$Y$$$20240702$$HP$US$US
240415621$24041562$1$I$$20240627$20240702$20240702$EXP$$US-VERTEX PHARMACEUTICALS-2024-010838$VERTEX$$20$YR$$F$Y$$$20240702$$CN$US$US
240415631$24041563$1$I$20230101$20240624$20240702$20240702$EXP$FR-AFSSAPS-TS2024000702$FR-VERTEX PHARMACEUTICALS-2024-010608$VERTEX$$$$N$F$Y$$$20240702$$MD$FR$FR
240415641$24041564$1$I$$20240624$20240702$20240702$PER$$US-VERTEX PHARMACEUTICALS-2024-010689$VERTEX$$$$$$Y$$$20240702$$CN$US$US
240415652$24041565$2$F$20240624$20240725$20240702$20240802$PER$$US-SA-2020SA376589$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240802$$CN$US$US
240415661$24041566$1$I$$20240618$20240702$20240702$PER$$US-ALKERMES INC.-ALK-2024-001715$ALKERMES$$$$$M$Y$$$20240702$$HP$US$US
240415671$24041567$1$I$20231018$20231113$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003980$SAREPTA THERAPEUTICS$$4$YR$$M$Y$16.1$KG$20240702$$HP$US$US
240415681$24041568$1$I$20231030$20231117$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003984$SAREPTA THERAPEUTICS$$16$YR$$M$Y$45.1$KG$20240702$$HP$US$US
240415696$24041569$6$F$20240617$20240823$20240702$20240828$PER$$US-ALXN-202406USA001503US$ALEXION PHARMACEUTICALS$$30$YR$$F$Y$65.76$KG$20240828$$CN$US$US
240415701$24041570$1$I$20230925$20240624$20240702$20240702$PER$$US-ALXN-A202312653$ALEXION PHARMACEUTICALS$$36$YR$$F$Y$$$20240702$$CN$US$US
240415711$24041571$1$I$20231110$20231204$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004028$SAREPTA THERAPEUTICS$$5$YR$$M$Y$24.036$KG$20240702$$HP$US$US
240415721$24041572$1$I$20231027$20240117$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003989$SAREPTA THERAPEUTICS$$22$YR$$M$Y$55$KG$20240702$$HP$US$US
240415731$24041573$1$I$20231124$20231213$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004063$SAREPTA THERAPEUTICS$$11$YR$$M$Y$51.7$KG$20240702$$HP$US$US
240415741$24041574$1$I$20231027$20231116$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003987$SAREPTA THERAPEUTICS$$18$YR$$M$Y$$$20240702$$HP$US$US
240415751$24041575$1$I$20231114$20231211$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004046$SAREPTA THERAPEUTICS$$11$YR$$M$Y$44.036$KG$20240702$$HP$US$US
240415761$24041576$1$I$20231025$20231205$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003995$SAREPTA THERAPEUTICS$$28$YR$$M$Y$45.9$KG$20240702$$HP$US$US
240415771$24041577$1$I$20231025$20231113$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003985$SAREPTA THERAPEUTICS$$11$YR$$M$Y$33.56$KG$20240702$$HP$US$US
240415781$24041578$1$I$$20231121$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004059$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240415791$24041579$1$I$20231016$20231111$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004029$SAREPTA THERAPEUTICS$$28$YR$$M$Y$$$20240702$$CN$US$US
240415811$24041581$1$I$$20231031$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003992$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$CN$US$US
240415821$24041582$1$I$20240101$20240620$20240702$20240702$EXP$$US-TEVA-VS-3213050$TEVA$$$$T$M$Y$$$20240702$$HP$US$US
240415831$24041583$1$I$$20240626$20240702$20240702$EXP$$AU-OTSUKA-2024_018342$OTSUKA$$84$YR$$F$Y$$$20240702$$HP$AU$AU
240415841$24041584$1$I$20240101$20240626$20240702$20240702$EXP$$AU-OTSUKA-2024_018258$OTSUKA$$82$YR$$$Y$$$20240702$$HP$AU$AU
240415851$24041585$1$I$20240106$20240117$20240702$20240702$EXP$GB-MHRA-MED-202401161707555950-GBRTH$GB-TEVA-VS-3147244$TEVA$$30$YR$$F$Y$90$KG$20240702$$CN$GB$GB
240415871$24041587$1$I$20240613$20240627$20240702$20240702$EXP$$US-ABBVIE-5821687$ABBVIE$$79$YR$$F$Y$$$20240702$$CN$US$US
240415881$24041588$1$I$$20231201$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004097$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$PH$US$US
240415891$24041589$1$I$20231006$20240617$20240702$20240702$EXP$$CN-ROCHE-3489251$ROCHE$$41$YR$A$M$Y$$$20240702$$MD$CN$CN
240415901$24041590$1$I$20231113$20231229$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004102$SAREPTA THERAPEUTICS$$16$YR$$M$Y$45.1$KG$20240702$$HP$US$US
240415911$24041591$1$I$$20231215$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004067$SAREPTA THERAPEUTICS$$$$$M$Y$22.68$KG$20240702$$HP$US$US
240415921$24041592$1$I$20231201$20231201$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004098$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240415931$24041593$1$I$20231121$20231124$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004066$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240702$$HP$US$US
240415941$24041594$1$I$$20231124$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004069$SAREPTA THERAPEUTICS$$$$$M$Y$15.42$KG$20240702$$HP$US$US
240415951$24041595$1$I$20230922$20231201$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004095$SAREPTA THERAPEUTICS$$23$YR$$M$Y$40.3$KG$20240702$$HP$US$US
240415961$24041596$1$I$20231129$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004085$SAREPTA THERAPEUTICS$$8$YR$$M$Y$34.6$KG$20240702$$HP$US$US
240415972$24041597$2$F$20240101$20240724$20240702$20240730$EXP$$US-ABBVIE-5821369$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
240415991$24041599$1$I$20231101$20240417$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004092$SAREPTA THERAPEUTICS$$15$YR$$M$Y$60.4$KG$20240702$$HP$US$US
240416001$24041600$1$I$20221207$20240626$20240702$20240702$EXP$$AU-OTSUKA-2024_018239$OTSUKA$$74$YR$$$Y$$$20240702$$HP$AU$AU
240416012$24041601$2$F$20240206$20240807$20240702$20240816$EXP$$CA-JNJFOC-20240546032$JOHNSON AND JOHNSON$$64$YR$A$F$Y$71$KG$20240816$$HP$CA$CA
240416021$24041602$1$I$20231124$20231213$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004074$SAREPTA THERAPEUTICS$$17$YR$$M$Y$51$KG$20240702$$HP$US$US
240416041$24041604$1$I$$20240619$20240702$20240702$PER$$US-ROCHE-10000011751$ROCHE$$$$$$Y$$$20240702$$CN$US$US
240416051$24041605$1$I$20240628$20240701$20240701$20240701$DIR$708685$$FDA-CTU$$$$$UNK$N$$$20240701$N$CN$US$
240416061$24041606$1$I$$20240625$20240702$20240702$EXP$$NVSC2024AE135356$NOVARTIS$$$$$M$Y$$$20240702$$CN$AE$AE
240416071$24041607$1$I$20231201$20240123$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004103$SAREPTA THERAPEUTICS$$15$YR$$M$Y$$$20240702$$HP$US$US
240416081$24041608$1$I$20231207$20240222$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004121$SAREPTA THERAPEUTICS$$20$YR$$M$Y$$$20240702$$HP$US$US
240416091$24041609$1$I$20231209$20240310$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004119$SAREPTA THERAPEUTICS$$1$YR$$M$Y$10.431$KG$20240702$$CN$US$US
240416101$24041610$1$I$$20231221$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004116$SAREPTA THERAPEUTICS$$$$$M$Y$28.5$KG$20240702$$HP$US$US
240416111$24041611$1$I$20231201$20240125$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004123$SAREPTA THERAPEUTICS$$16$YR$$M$Y$$$20240702$$HP$US$US
240416121$24041612$1$I$$20240307$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004114$SAREPTA THERAPEUTICS$$$$$M$Y$40.37$KG$20240702$$PH$US$US
240416131$24041613$1$I$20230515$20231229$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004135$SAREPTA THERAPEUTICS$$16$YR$$M$Y$40.3$KG$20240702$$HP$US$US
240416141$24041614$1$I$20230314$20231222$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004134$SAREPTA THERAPEUTICS$$16$YR$$M$Y$40.3$KG$20240702$$HP$US$US
240416151$24041615$1$I$20231114$20231229$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004133$SAREPTA THERAPEUTICS$$17$YR$$M$Y$88$KG$20240702$$HP$US$US
240416161$24041616$1$I$20230101$20231205$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004104$SAREPTA THERAPEUTICS$$$$$M$Y$42.177$KG$20240702$$HP$US$US
240416171$24041617$1$I$$20240626$20240702$20240702$EXP$$AU-OTSUKA-2024_018237$OTSUKA$$88$YR$$$Y$$$20240702$$HP$AU$AU
240416181$24041618$1$I$20230518$20240626$20240702$20240702$EXP$$AU-OTSUKA-2024_018226$OTSUKA$$88$YR$$$Y$$$20240702$$HP$AU$AU
240416192$24041619$2$F$20220101$20240710$20240702$20240722$EXP$$ES-UCBSA-2024030765$UCB$$67$YR$$F$Y$$$20240723$$CN$ES$ES
240416201$24041620$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5819134$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240416211$24041621$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281423022780-LSYQG$GB-ORGANON-O2407GBR000002$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240416221$24041622$1$I$20230706$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004136$SAREPTA THERAPEUTICS$$16$YR$$M$Y$40.3$KG$20240702$$HP$US$US
240416231$24041623$1$I$20230921$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004138$SAREPTA THERAPEUTICS$$16$YR$$M$Y$40.3$KG$20240702$$HP$US$US
240416241$24041624$1$I$20230803$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004137$SAREPTA THERAPEUTICS$$16$YR$$M$Y$40.3$KG$20240702$$HP$US$US
240416251$24041625$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000406$ELI LILLY AND CO$$$$$M$Y$$$20240702$$CN$US$US
240416261$24041626$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000337$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240702$$CN$US$US
240416271$24041627$1$I$$20240620$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406015407$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240702$$CN$US$US
240416281$24041628$1$I$20240613$20240620$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406014728$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$US$US
240416301$24041630$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5819315$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240416311$24041631$1$I$20240623$20240624$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406016307$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240702$$CN$US$US
240416321$24041632$1$I$20230819$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004144$SAREPTA THERAPEUTICS$$18$YR$$M$Y$26.7$KG$20240702$$HP$US$US
240416331$24041633$1$I$20231123$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004141$SAREPTA THERAPEUTICS$$8$YR$$M$Y$27.574$KG$20240702$$HP$US$US
240416341$24041634$1$I$20231123$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004148$SAREPTA THERAPEUTICS$$16$YR$$M$Y$40.3$KG$20240702$$HP$US$US
240416351$24041635$1$I$20230314$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004140$SAREPTA THERAPEUTICS$$17$YR$$M$Y$26.7$KG$20240702$$HP$US$US
240416361$24041636$1$I$20240630$20240701$20240701$20240701$DIR$708738$$FDA-CTU$$29$YR$$F$N$54.45$KG$20240701$N$CN$US$
240416371$24041637$1$I$20231123$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004145$SAREPTA THERAPEUTICS$$18$YR$$M$Y$26.7$KG$20240702$$HP$US$US
240416381$24041638$1$I$20230622$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004143$SAREPTA THERAPEUTICS$$18$YR$$M$Y$26.7$KG$20240702$$HP$US$US
240416391$24041639$1$I$20230515$20231222$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004142$SAREPTA THERAPEUTICS$$18$YR$$M$Y$26.7$KG$20240702$$HP$US$US
240416401$24041640$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281502574640-CFGVW$GB-ORGANON-O2407GBR000070$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240416411$24041641$1$I$20240622$20240625$20240702$20240702$EXP$$CN-AMGEN-CHNSP2024127335$AMGEN$$8$YR$C$F$Y$$$20240702$$HP$CN$CN
240416421$24041642$1$I$20220226$20240626$20240702$20240702$EXP$$US-GILEAD-2024-0678721$GILEAD$$36$YR$A$F$Y$$$20240702$$PH$US$US
240416431$24041643$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A145981$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240416441$24041644$1$I$$20240624$20240702$20240702$EXP$$ES-AstraZeneca-2024A146845$ASTRAZENECA$$55$YR$$M$Y$$$20240702$$MD$ES$
240416451$24041645$1$I$$20231219$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004167$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240416461$24041646$1$I$20230515$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004150$SAREPTA THERAPEUTICS$$8$YR$$M$Y$60.8$KG$20240702$$HP$US$US
240416471$24041647$1$I$20230627$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004151$SAREPTA THERAPEUTICS$$8$YR$$M$Y$60.8$KG$20240702$$HP$US$US
240416481$24041648$1$I$20230819$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004175$SAREPTA THERAPEUTICS$$8$YR$$M$Y$60.8$KG$20240702$$HP$US$US
240416491$24041649$1$I$20231208$20231226$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004177$SAREPTA THERAPEUTICS$$9$YR$$M$Y$45.1$KG$20240702$$HP$US$US
240416501$24041650$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A145785$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240416511$24041651$1$I$20230314$20231214$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004149$SAREPTA THERAPEUTICS$$8$YR$$M$Y$60.8$KG$20240702$$HP$US$US
240416521$24041652$1$I$20231213$20240224$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004166$SAREPTA THERAPEUTICS$$28$YR$$M$Y$45.9$KG$20240702$$HP$US$US
240416531$24041653$1$I$20231208$20240123$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004153$SAREPTA THERAPEUTICS$$21$YR$$M$Y$32.653$KG$20240702$$HP$US$US
240416541$24041654$1$I$20231010$20231215$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004154$SAREPTA THERAPEUTICS$$11$YR$$M$Y$36.74$KG$20240702$$HP$US$US
240416551$24041655$1$I$20231113$20231219$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004162$SAREPTA THERAPEUTICS$$11$YR$$M$Y$36.74$KG$20240702$$HP$US$US
240416561$24041656$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105626$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240702$$HP$US$US
240416571$24041657$1$I$$20240618$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098951$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240702$$CN$US$US
240416591$24041659$1$I$20240401$20240701$20240702$20240702$EXP$$NVSC2024FR136283$NOVARTIS$$56$YR$$F$Y$$$20240702$$CN$FR$FR
240416601$24041660$1$I$20231228$20240123$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004190$SAREPTA THERAPEUTICS$$16$YR$$M$Y$$$20240702$$HP$US$US
240416611$24041661$1$I$20231222$20231222$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004179$SAREPTA THERAPEUTICS$$22$YR$$M$Y$$$20240702$$HP$US$US
240416621$24041662$1$I$20231228$20240111$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004191$SAREPTA THERAPEUTICS$$17$YR$$M$Y$40.3$KG$20240702$$HP$US$US
240416631$24041663$1$I$20231228$20240109$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004189$SAREPTA THERAPEUTICS$$11$YR$$M$Y$51.7$KG$20240702$$HP$US$US
240416641$24041664$1$I$20231205$20240221$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004186$SAREPTA THERAPEUTICS$$11$YR$$M$Y$36.74$KG$20240702$$HP$US$US
240416651$24041665$1$I$$20230518$20240702$20240702$PER$$US-AMGEN-USASP2023235253$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240416661$24041666$1$I$20231226$20240130$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004197$SAREPTA THERAPEUTICS$$13$YR$$M$Y$$$20240702$$HP$US$US
240416681$24041668$1$I$20231228$20240108$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004193$SAREPTA THERAPEUTICS$$8$YR$$M$Y$60.8$KG$20240702$$HP$US$US
240416691$24041669$1$I$20231228$20240108$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004192$SAREPTA THERAPEUTICS$$18$YR$$M$Y$26.7$KG$20240702$$HP$US$US
240416701$24041670$1$I$20231222$20240108$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004178$SAREPTA THERAPEUTICS$$9$YR$$$Y$45.1$KG$20240702$$HP$US$US
240416711$24041671$1$I$20231227$20240102$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004207$SAREPTA THERAPEUTICS$$15$YR$$M$Y$$$20240702$$HP$US$US
240416721$24041672$1$I$20240601$20240620$20240702$20240702$PER$$US-TEVA-VS-3213152$TEVA$$75$YR$$F$Y$$$20240702$$PH$US$US
240416731$24041673$1$I$20240101$20240620$20240702$20240702$PER$$US-MYLANLABS-2024M1056852$MYLAN$$$$$M$Y$61.23$KG$20240702$$CN$US$US
240416741$24041674$1$I$$20240627$20240702$20240702$EXP$$US-BAYER-2024A094815$BAYER$$62$YR$A$M$Y$97.052$KG$20240702$$HP$US$US
240416752$24041675$2$F$$20240704$20240702$20240713$EXP$$US-TEVA-VS-3214032$TEVA$Gatts JE, Rush MC, Check JF, Samelak DM, McLean TW. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age. Pediatr-Dermatol 2022; 39 (3): 389-393.; Gatts JE, Rush MC, Check JF, Samelak DM, McLean TW. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age. Pediatr-Dermatol 2022; 39 (3): 389-393.; Gatts JE, Rush MC, Check JF, Samelak DM, McLean TW. Safety of propranolol for infantile hemangioma in infants less than fiv...$$$I$F$Y$$$20240713$$MD$US$US
240416764$24041676$4$F$20240301$20240917$20240702$20240923$EXP$$US-VIIV HEALTHCARE LIMITED-US2024080435$VIIV$$$$$$Y$$$20240923$$HP$US$US
240416771$24041677$1$I$20231213$20240104$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004217$SAREPTA THERAPEUTICS$$17$YR$$M$Y$$$20240702$$HP$US$US
240416781$24041678$1$I$20240104$20240207$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004223$SAREPTA THERAPEUTICS$$3$YR$$M$Y$15.4$KG$20240702$$HP$US$US
240416791$24041679$1$I$$20240105$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004227$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240416801$24041680$1$I$20240104$20240119$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004228$SAREPTA THERAPEUTICS$$11$YR$$M$Y$61.3$KG$20240702$$HP$US$US
240416811$24041681$1$I$20231230$20240121$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004214$SAREPTA THERAPEUTICS$$12$YR$$M$Y$61.224$KG$20240702$$HP$US$US
240416821$24041682$1$I$20240102$20240118$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004215$SAREPTA THERAPEUTICS$$12$YR$$M$Y$35$KG$20240702$$HP$US$US
240416831$24041683$1$I$20240103$20240104$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004210$SAREPTA THERAPEUTICS$$24$YR$$M$Y$83.46$KG$20240702$$HP$US$US
240416841$24041684$1$I$20240106$20240208$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004240$SAREPTA THERAPEUTICS$$15$YR$$M$Y$36.7$KG$20240702$$HP$US$US
240416851$24041685$1$I$20231124$20240118$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004221$SAREPTA THERAPEUTICS$$26$YR$$M$Y$38.549$KG$20240702$$HP$US$US
240416861$24041686$1$I$$20240501$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004242$SAREPTA THERAPEUTICS$$$$$M$Y$54.7$KG$20240702$$HP$US$US
240416871$24041687$1$I$20240101$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104579$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240702$$CN$US$US
240416881$24041688$1$I$20240601$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104548$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240702$$CN$US$US
240416892$24041689$2$F$20240623$20240702$20240702$20240729$EXP$$US-CHIESI-2024CHF03862$CHIESI$$60$YR$$M$Y$$$20240729$$CN$US$US
240416901$24041690$1$I$20240601$20240624$20240702$20240702$EXP$$SE-ABBVIE-5822552$ABBVIE$$$$$F$Y$$$20240702$$CN$SE$SE
240416911$24041691$1$I$$20240626$20240702$20240702$EXP$US-MLMSERVICE-20240619-PI106775-00175-1$US-RDY-SPO/USA/24/0009409$DR REDDYS$Ali F, Arshad K, Latif R, Farooq A, Nanjundappa A. Spontaneous spinal epidural hematoma following IV heparin and catheter-directed thrombolysis for deep vein thrombosis. Journal of Vascular Surgery Cases, Innovations and Techniques. 2024;10(4). DOI: 10.1016/j.jvscit.2024.101541.$65$YR$E$M$Y$$$20240702$$MD$US$US
240416922$24041692$2$F$$20240903$20240702$20240928$PER$$US-SA-2024SA192261$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240928$$HP$US$US
240416931$24041693$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA192017$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240702$$MD$US$US
240416941$24041694$1$I$20240525$20240627$20240702$20240702$EXP$ES-AEMPS-1540602$ES-RDY-SPO/ESP/24/0009399$DR REDDYS$$78$YR$E$M$Y$$$20240702$$MD$ES$ES
240416952$24041695$2$F$20240626$20240701$20240702$20240805$EXP$$JP-BAYER-2024A092630$BAYER$$70$YR$E$M$Y$$$20240805$$PH$JP$JP
240416961$24041696$1$I$20240116$20240211$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004275$SAREPTA THERAPEUTICS$$9$YR$$M$Y$48.073$KG$20240702$$HP$US$US
240416971$24041697$1$I$20240111$20240122$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004253$SAREPTA THERAPEUTICS$$17$YR$$M$Y$40.3$KG$20240702$$HP$US$US
240416981$24041698$1$I$20240103$20240202$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004250$SAREPTA THERAPEUTICS$$18$YR$$M$Y$68.027$KG$20240702$$HP$US$US
240416991$24041699$1$I$20240102$20240123$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004259$SAREPTA THERAPEUTICS$$10$YR$$M$Y$27.22$KG$20240702$$HP$US$US
240417011$24041701$1$I$20240108$20240112$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004257$SAREPTA THERAPEUTICS$$14$YR$$M$Y$$$20240702$$HP$US$US
240417021$24041702$1$I$20240108$20240112$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004258$SAREPTA THERAPEUTICS$$15$YR$$M$Y$$$20240702$$HP$US$US
240417031$24041703$1$I$20240101$20240328$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004245$SAREPTA THERAPEUTICS$$20$YR$$M$Y$53.3$KG$20240702$$HP$US$US
240417041$24041704$1$I$20240115$20240209$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004265$SAREPTA THERAPEUTICS$$11$YR$$M$Y$46.259$KG$20240702$$HP$US$US
240417051$24041705$1$I$20240106$20240122$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004246$SAREPTA THERAPEUTICS$$10$YR$$M$Y$19.84$KG$20240702$$HP$US$US
240417061$24041706$1$I$20240102$20240124$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004247$SAREPTA THERAPEUTICS$$13$YR$$M$Y$28.9$KG$20240702$$HP$US$US
240417072$24041707$2$F$$20240704$20240702$20240711$EXP$$JP-MALLINCKRODT-MNK202404216$MALLINCKRODT$$50$YR$A$M$Y$$$20240711$$MD$JP$JP
240417081$24041708$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3214236$TEVA$$58$YR$$M$Y$$$20240702$$MD$CA$CA
240417101$24041710$1$I$20231123$20240627$20240702$20240702$EXP$$JP-009507513-2406JPN003941J$MERCK$$56$YR$$F$Y$50$KG$20240702$$PH$JP$JP
240417112$24041711$2$F$$20240814$20240702$20240814$PER$$NVSC2024US136745$NOVARTIS$$$$$F$Y$$$20240814$$MD$US$US
240417121$24041712$1$I$20240111$20240116$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004278$SAREPTA THERAPEUTICS$$20$YR$$M$Y$$$20240702$$HP$US$US
240417131$24041713$1$I$$20240624$20240702$20240702$30DAY$$US-GSK-US2024078682$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
240417141$24041714$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281438310700-KPJBZ$GB-ORGANON-O2407GBR000123$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240417152$24041715$2$F$$20240708$20240702$20240709$EXP$GB-MHRA-MED-202406281442341590-SCYTR$GB-ORGANON-O2407GBR000094$ORGANON$$$$$$Y$$$20240709$$CN$GB$GB
240417161$24041716$1$I$20240601$20240625$20240702$20240702$EXP$$US-UCBSA-2024032494$UCB$$60$YR$$F$Y$$$20240702$$HP$US$US
240417171$24041717$1$I$20240120$20240127$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004298$SAREPTA THERAPEUTICS$$12$YR$$M$Y$61.224$KG$20240702$$HP$US$US
240417181$24041718$1$I$20240105$20240226$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004282$SAREPTA THERAPEUTICS$$14$YR$$M$Y$$$20240702$$HP$US$US
240417191$24041719$1$I$20240117$20240202$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004289$SAREPTA THERAPEUTICS$$32$YR$$M$Y$52.154$KG$20240702$$HP$US$US
240417201$24041720$1$I$20240130$20240208$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004302$SAREPTA THERAPEUTICS$$22$YR$$M$Y$68.04$KG$20240702$$HP$US$US
240417211$24041721$1$I$20240111$20240202$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004327$SAREPTA THERAPEUTICS$$14$YR$$M$Y$51$KG$20240702$$HP$US$US
240417221$24041722$1$I$20240111$20240202$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004326$SAREPTA THERAPEUTICS$$11$YR$$M$Y$34.2$KG$20240702$$HP$US$US
240417231$24041723$1$I$20240101$20240229$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004291$SAREPTA THERAPEUTICS$$12$YR$$M$Y$$$20240702$$CN$US$US
240417241$24041724$1$I$20240110$20240212$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004303$SAREPTA THERAPEUTICS$$16$YR$$M$Y$78.02$KG$20240702$$HP$US$US
240417251$24041725$1$I$$20240626$20240702$20240702$EXP$$JP-009507513-2406JPN004186J$MERCK$Takahashi T, Sato Y, Wakata A, Nagaki Y, Sasamori R, Sasaki Y, et al.. p11-10 A Case of irAE cholangitis sclerosing after Administration of Pembrolizumab for Recurrent Lymph-node-metastasis After Surgery for Thoracic oesophageal carcinoma. The 78th Annual Meeting of The Japan Esophageal Society. 223$74$YR$$M$Y$$$20240702$$HP$JP$JP
240417261$24041726$1$I$20240202$20240229$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004317$SAREPTA THERAPEUTICS$$26$YR$$M$Y$38.549$KG$20240702$$HP$US$US
240417271$24041727$1$I$20240425$20240627$20240702$20240702$EXP$$CN-JNJFOC-20240703574$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240702$$HP$CN$CN
240417281$24041728$1$I$$20240620$20240702$20240702$PER$$US-JNJFOC-20240679636$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$US$US
240417311$24041731$1$I$20240617$20240701$20240701$20240701$DIR$708798$$FDA-CTU$$71$YR$$F$N$81.45$KG$20240701$N$CN$US$
240417321$24041732$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46194$$FDA-CTU$$65$YR$$F$N$$$20240702$N$$US$
240417331$24041733$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46204$$FDA-CTU$$70$YR$$M$N$114.76$KG$20240702$N$$US$
240417361$24041736$1$I$20240524$20240701$20240701$20240701$DIR$708745$$FDA-CTU$$55$YR$$F$N$66.6$KG$20240701$N$CN$US$
240417371$24041737$1$I$$20240701$20240702$20240702$EXP$$US-TAKEDA-US202000406$TAKEDA$$$$$F$Y$$$20240702$$HP$US$US
240417381$24041738$1$I$$20240629$20240702$20240702$PER$$NVSC2024US137028$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240417391$24041739$1$I$20240207$20240223$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004356$SAREPTA THERAPEUTICS$$23$YR$$M$Y$43$KG$20240702$$HP$US$US
240417401$24041740$1$I$20240206$20240207$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004344$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240702$$HP$US$US
240417411$24041741$1$I$20240206$20240209$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004354$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240702$$HP$US$US
240417421$24041742$1$I$20240207$20240220$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004349$SAREPTA THERAPEUTICS$$16$YR$$M$Y$88.45$KG$20240702$$HP$US$US
240417431$24041743$1$I$20240201$20240215$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004368$SAREPTA THERAPEUTICS$$13$YR$$M$Y$$$20240702$$HP$US$US
240417441$24041744$1$I$$20240215$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004373$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240417451$24041745$1$I$20240212$20240224$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004382$SAREPTA THERAPEUTICS$$29$YR$$M$Y$$$20240702$$HP$US$US
240417461$24041746$1$I$20240111$20240202$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004329$SAREPTA THERAPEUTICS$$16$YR$$M$Y$45.1$KG$20240702$$HP$US$US
240417471$24041747$1$I$20240214$20240226$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004371$SAREPTA THERAPEUTICS$$18$YR$$M$Y$68.027$KG$20240702$$HP$US$US
240417481$24041748$1$I$20240125$20240202$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004328$SAREPTA THERAPEUTICS$$14$YR$$M$Y$51$KG$20240702$$HP$US$US
240417491$24041749$1$I$20240613$20240613$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA050198$TOLMAR$$80$YR$$M$Y$$$20240702$$CN$CA$CA
240417501$24041750$1$I$$20240612$20240702$20240702$PER$$CA-TOLMAR, INC.-24CA050187$TOLMAR$$$$$M$Y$$$20240702$$CN$CA$CA
240417521$24041752$1$I$20240216$20240325$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004387$SAREPTA THERAPEUTICS$$9$YR$$M$Y$33$KG$20240702$$HP$US$US
240417531$24041753$1$I$20240215$20240311$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004410$SAREPTA THERAPEUTICS$$11$YR$$M$Y$34.2$KG$20240702$$HP$US$US
240417541$24041754$1$I$20240215$20240227$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004414$SAREPTA THERAPEUTICS$$16$YR$$M$Y$45.1$KG$20240702$$HP$US$US
240417551$24041755$1$I$20240215$20240227$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004415$SAREPTA THERAPEUTICS$$14$YR$$M$Y$51$KG$20240702$$HP$US$US
240417562$24041756$2$F$20240628$20240628$20240702$20240704$PER$$US-AMGEN-USASP2024129649$AMGEN$$78$YR$E$F$Y$$$20240704$$CN$US$US
240417571$24041757$1$I$$20240219$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004386$SAREPTA THERAPEUTICS$$$$$M$Y$64.6$KG$20240702$$HP$US$US
240417581$24041758$1$I$$20230915$20240702$20240702$PER$$US-AMGEN-USASP2023235285$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240417591$24041759$1$I$20230101$20240628$20240702$20240702$EXP$$US-UCBSA-2024033304$UCB$$57$YR$$F$Y$$$20240702$$HP$US$US
240417611$24041761$1$I$20240305$20240306$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004441$SAREPTA THERAPEUTICS$$13$YR$$M$Y$$$20240702$$HP$US$US
240417621$24041762$1$I$20201221$20240403$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004427$SAREPTA THERAPEUTICS$$13$YR$$M$Y$60.4$KG$20240702$$HP$US$US
240417631$24041763$1$I$$20240405$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004434$SAREPTA THERAPEUTICS$$$$$M$Y$28.4$KG$20240702$$HP$US$US
240417641$24041764$1$I$20240601$20240621$20240702$20240702$EXP$$JP-ROCHE-10000012137$ROCHE$$89$YR$E$F$Y$$$20240702$$MD$JP$JP
240417651$24041765$1$I$20240301$20240325$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004431$SAREPTA THERAPEUTICS$$13$YR$$M$Y$48.526$KG$20240702$$HP$US$US
240417661$24041766$1$I$20240311$20240402$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004453$SAREPTA THERAPEUTICS$$13$YR$$M$Y$45.36$KG$20240702$$HP$US$US
240417671$24041767$1$I$20240227$20240229$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004422$SAREPTA THERAPEUTICS$$8$YR$$M$Y$34.6$KG$20240702$$HP$US$US
240417681$24041768$1$I$$20240313$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004464$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240417691$24041769$1$I$$20240328$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004457$SAREPTA THERAPEUTICS$$$$$M$Y$58.06$KG$20240702$$HP$US$US
240417701$24041770$1$I$20240113$20240312$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004456$SAREPTA THERAPEUTICS$$23$YR$$M$Y$58.06$KG$20240702$$HP$US$US
240417721$24041772$1$I$$20240307$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004448$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240702$$HP$US$US
240417731$24041773$1$I$20240301$20240523$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004468$SAREPTA THERAPEUTICS$$22$YR$$M$Y$$$20240702$$HP$US$US
240417741$24041774$1$I$$20240701$20240702$20240702$EXP$$CN-TAKEDA-2024TUS066102$TAKEDA$$$$$M$Y$$$20240702$$CN$CN$CN
240417751$24041775$1$I$20240601$20240626$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102948$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240702$$CN$US$US
240417761$24041776$1$I$20240226$20240321$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004494$SAREPTA THERAPEUTICS$$22$YR$$M$Y$$$20240702$$HP$US$US
240417771$24041777$1$I$$20240628$20240702$20240702$EXP$$US-KYOWAKIRIN-2024KK015833$KYOWA$$$$$$Y$$$20240702$$HP$US$US
240417781$24041778$1$I$20240322$20240411$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004484$SAREPTA THERAPEUTICS$$9$YR$$M$Y$34.37$KG$20240702$$HP$US$US
240417791$24041779$1$I$20240328$20240424$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004520$SAREPTA THERAPEUTICS$$21$YR$$M$Y$71.3$KG$20240702$$HP$US$US
240417801$24041780$1$I$20240301$20240520$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004508$SAREPTA THERAPEUTICS$$13$YR$$M$Y$52.6$KG$20240702$$HP$US$US
240417811$24041781$1$I$20240616$20240619$20240702$20240702$PER$$US-AstraZeneca-2024A151569$ASTRAZENECA$$48$YR$$F$Y$$$20240702$$CN$US$
240417821$24041782$1$I$20240314$20240508$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004529$SAREPTA THERAPEUTICS$$19$YR$$M$Y$63.447$KG$20240702$$HP$US$US
240417831$24041783$1$I$20240322$20240422$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004575$SAREPTA THERAPEUTICS$$20$YR$$M$Y$105.69$KG$20240702$$HP$US$US
240417841$24041784$1$I$20240405$20240514$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004533$SAREPTA THERAPEUTICS$$14$YR$$M$Y$28.4$KG$20240702$$HP$US$US
240417851$24041785$1$I$20240123$20240508$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004633$SAREPTA THERAPEUTICS$$25$YR$$M$Y$21.497$KG$20240702$$HP$US$US
240417861$24041786$1$I$20240410$20240424$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004555$SAREPTA THERAPEUTICS$$12$YR$$M$Y$69.388$KG$20240702$$HP$US$US
240417871$24041787$1$I$20240101$20240523$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004627$SAREPTA THERAPEUTICS$$$$$M$Y$112$KG$20240702$$HP$US$US
240417881$24041788$1$I$20240405$20240505$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004554$SAREPTA THERAPEUTICS$$29$YR$$M$Y$$$20240702$$HP$US$US
240417891$24041789$1$I$20240502$20240514$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004620$SAREPTA THERAPEUTICS$$16$YR$$M$Y$45.1$KG$20240702$$HP$US$US
240417901$24041790$1$I$20240502$20240516$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004622$SAREPTA THERAPEUTICS$$14$YR$$M$Y$51$KG$20240702$$HP$US$US
240417911$24041791$1$I$20240502$20240516$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004621$SAREPTA THERAPEUTICS$$11$YR$$M$Y$34.2$KG$20240702$$HP$US$US
240417921$24041792$1$I$$20240617$20240702$20240702$PER$$US-ROCHE-10000002247$ROCHE$Temme A, Watson M, Kannappan A. Rituximab Alone: A Rare Case of Pneumocystis Jiroveci Pneumonia in a Patient on Rituximab Monotherapy. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:$74$YR$E$F$Y$$$20240702$$HP$US$US
240417931$24041793$1$I$20240101$20240626$20240702$20240702$PER$$US-SA-2024SA193049$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240702$$MD$US$US
240417942$24041794$2$F$20240615$20240903$20240702$20240912$PER$$US-SA-2024SA187497$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240912$$MD$US$US
240417951$24041795$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187730$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240702$$CN$US$US
240417961$24041796$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA191439$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$HP$US$US
240417971$24041797$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5819153$ABBVIE$$$$$$Y$$$20240702$$MD$US$US
240417981$24041798$1$I$$20240627$20240702$20240702$EXP$$PH-OTSUKA-2024_012086$OTSUKA$$$$$F$Y$$$20240702$$CN$PH$PH
240417991$24041799$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001174$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240702$$CN$US$US
240418001$24041800$1$I$20240630$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000932$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240702$$CN$US$US
240418011$24041801$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3214156$TEVA$$53$YR$$F$Y$$$20240702$$MD$CA$CA
240418031$24041803$1$I$$20240701$20240702$20240702$EXP$$CA-ORGANON-O2407CAN000136$ORGANON$$65$YR$$F$Y$$$20240702$$MD$CA$CA
240418041$24041804$1$I$20240522$20240531$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004709$SAREPTA THERAPEUTICS$$20$YR$$M$Y$58.06$KG$20240702$$HP$US$US
240418057$24041805$7$F$20240308$20240829$20240702$20240902$EXP$$CN-ORGANON-O2406CHN001608$ORGANON$$28$YR$$F$Y$60$KG$20240902$$MD$CN$CN
240418061$24041806$1$I$20240521$20240604$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004678$SAREPTA THERAPEUTICS$$18$YR$$M$Y$68.027$KG$20240702$$HP$US$US
240418072$24041807$2$F$$20240726$20240702$20240730$30DAY$$US-MYLANLABS-2024M1061132$MYLAN$$$$$M$Y$58.97$KG$20240730$$CN$US$US
240418081$24041808$1$I$$20240626$20240702$20240702$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003618$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240702$$HP$US$US
240418091$24041809$1$I$20240601$20240628$20240702$20240702$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003663$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240702$$CN$US$US
240418101$24041810$1$I$20240610$20240611$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004743$SAREPTA THERAPEUTICS$$19$YR$$M$Y$29$KG$20240702$$HP$US$US
240418111$24041811$1$I$20240517$20240611$20240702$20240702$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004668$SAREPTA THERAPEUTICS$$18$YR$$M$Y$100.5$KG$20240702$$PH$US$US
240418122$24041812$2$F$$20240711$20240702$20240722$PER$$US-JNJFOC-20240675291$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$HP$US$US
240418131$24041813$1$I$20240529$20240622$20240702$20240702$EXP$GB-MHRA-MED-202406220956578000-QDZSP$GB-009507513-2406GBR007900$MERCK$$35$YR$$M$Y$110$KG$20240702$$MD$GB$GB
240418141$24041814$1$I$$20240625$20240702$20240702$PER$$US-ALXN-202406USA001658US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
240418151$24041815$1$I$20240628$20240628$20240702$20240702$PER$$US-AMGEN-USASP2024130127$AMGEN$$79$YR$E$M$Y$$$20240702$$CN$US$US
240418161$24041816$1$I$$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024128455$AMGEN$$$$A$M$Y$$$20240702$$CN$US$US
240418171$24041817$1$I$20240626$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024127560$AMGEN$$62$YR$A$F$Y$$$20240702$$CN$US$US
240418181$24041818$1$I$$20240629$20240702$20240702$EXP$$US-TAKEDA-2024TUS065372$TAKEDA$$$$$$Y$$$20240702$$CN$US$US
240418191$24041819$1$I$$20240626$20240702$20240702$EXP$$AT-TAKEDA-2024TUS065832$TAKEDA$$75$YR$$M$Y$$$20240702$$HP$AT$AT
240418201$24041820$1$I$20240609$20240621$20240702$20240702$EXP$CN-NMPACDR-3311241044692202400007$CN-BAXTER-2024BAX020565$BAXTER$$61$YR$$M$Y$64$KG$20240702$$MD$CN$CN
240418211$24041821$1$I$20240527$20240624$20240702$20240702$EXP$CN-NMPACDR-2102011010991202400047$CN-BAXTER-2024BAX020657$BAXTER$$52$YR$$F$Y$85$KG$20240702$$MD$CN$CN
240418221$24041822$1$I$20230120$20240624$20240702$20240702$EXP$ES-AEMPS-1538133$ES-BAXTER-2024BAX020493$BAXTER$$79$YR$$F$Y$$$20240702$$MD$ES$ES
240418241$24041824$1$I$$20240701$20240701$20240701$DIR$708768$$FDA-CTU$$$$$UNK$N$$$20240701$N$CN$US$
240418251$24041825$1$I$$20240613$20240702$20240702$PER$$US-Nobelpharma America, LLC-NPA-2024-01056$NOBELPHARMA$$$$$M$Y$$$20240702$$HP$US$US
240418261$24041826$1$I$$20240617$20240702$20240702$EXP$2024-CA-000408$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000251$ASSERTIO THERAPEUTICS$$32$YR$$F$Y$$$20240702$$CN$CA$CA
240418271$24041827$1$I$$20240627$20240702$20240702$EXP$$NVSC2024GB135396$NOVARTIS$$$$$F$Y$$$20240702$$HP$GB$GB
240418283$24041828$3$F$$20240920$20240702$20240930$PER$$US-TRAVERE-2024TVT00622$TRAVERE THERAPEUTICS$$41$YR$A$M$Y$$$20240930$$CN$US$US
240418311$24041831$1$I$20231122$20240625$20240702$20240702$EXP$FR-AFSSAPS-AVNY2024000165$FR-INDIVIOR UK LIMITED-INDV-145752-2024$RECKITT BENCKISER$$$$$$Y$$$20240702$$MD$FR$FR
240418321$24041832$1$I$$20240628$20240702$20240702$PER$$US-BAYER-2024A094811$BAYER$$$$$$Y$$$20240702$$CN$US$US
240418331$24041833$1$I$20240529$20240623$20240702$20240702$EXP$$AU-TAKEDA-2024TUS065381$TAKEDA$$88$YR$$M$Y$$$20240702$$MD$AU$AU
240418341$24041834$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281411346130-TDLKP$GB-ORGANON-O2407GBR000106$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240418351$24041835$1$I$20240405$20240619$20240702$20240702$PER$$US-Nobelpharma America, LLC-NPA-2024-01094$NOBELPHARMA$$5$YR$C$M$Y$$$20240702$$PH$US$US
240418362$24041836$2$F$$20240816$20240702$20240826$PER$$US-ROCHE-10000007305$ROCHE$$61$YR$A$F$Y$$$20240826$$CN$US$US
240418371$24041837$1$I$$20240627$20240702$20240702$EXP$$US-PFIZER INC-PV202400085134$PFIZER$$56$YR$$M$Y$$$20240702$$MD$US$US
240418381$24041838$1$I$20240522$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085671$PFIZER$$65$YR$$M$Y$75$KG$20240702$$HP$CN$CN
240418391$24041839$1$I$20240401$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085715$PFIZER$$12$YR$$M$Y$35$KG$20240702$$HP$CN$CN
240418401$24041840$1$I$20240101$20240627$20240702$20240702$EXP$$GR-PFIZER INC-202400202111$PFIZER$$21$YR$$$Y$$$20240702$$MD$GR$GR
240418411$24041841$1$I$20240625$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085643$PFIZER$$89$YR$$M$Y$$$20240702$$HP$CN$CN
240418421$24041842$1$I$20240609$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085725$PFIZER$$30$YR$$M$Y$52$KG$20240702$$HP$CN$CN
240418431$24041843$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A146099$ASTRAZENECA$$$$$M$Y$$$20240702$$MD$US$
240418451$24041845$1$I$20240627$20240701$20240701$20240701$DIR$708794$$FDA-CTU$$$$$UNK$N$$$20240701$N$HP$US$
240418461$24041846$1$I$20240622$20240701$20240701$20240701$DIR$708771$$FDA-CTU$$77$YR$$F$N$97.52$KG$20240701$N$HP$US$
240418471$24041847$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46209$$FDA-CTU$$69$YR$$M$N$87.09$KG$20240702$N$$US$
240418481$24041848$1$I$20240628$20240701$20240701$20240701$DIR$708760$$FDA-CTU$$77$YR$$F$N$71.99$KG$20240701$N$HP$US$
240418492$24041849$2$F$$20240702$20240702$20240703$PER$$US-JNJFOC-20240674015$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$MD$US$US
240418501$24041850$1$I$$20240620$20240702$20240702$EXP$$US-SOCIETAL CDMO GAINESVILLE, LLC-SOC-2024-000017$RECRO PHARMA$Vallabhajosyula S, et al.. Fighting the Recovering Heart While Drowning in Volume: Role of VA-V ECMO Configuration in Migrating Mixing Cloud Effect. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5582-A5582$43$YR$$F$Y$$$20240702$$MD$US$US
240418511$24041851$1$I$$20240628$20240702$20240702$PER$$US-AMGEN-USASP2024129648$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240418521$24041852$1$I$20240605$20240701$20240702$20240702$EXP$$FR-PURDUE-USA-2024-0310538$PURDUE$$70$YR$$F$Y$58$KG$20240702$$MD$FR$FR
240418531$24041853$1$I$$20240628$20240702$20240702$EXP$$US-PURDUE PHARMA-USA-2024-0310487$PURDUE$$27$YR$$M$Y$$$20240702$$CN$US$US
240418541$24041854$1$I$20240620$20240627$20240702$20240702$EXP$$CN-PURDUE-USA-2024-0310542$PURDUE$$54$YR$$F$Y$44.5$KG$20240702$$HP$CN$CN
240418551$24041855$1$I$$20240701$20240702$20240702$EXP$$FR-PURDUE-USA-2024-0310543$PURDUE$$28$YR$$F$Y$66$KG$20240702$$MD$FR$FR
240418561$24041856$1$I$$20240625$20240702$20240702$EXP$$US-UCBSA-2024033270$UCB$$$$C$M$Y$$$20240702$$CN$US$US
240418571$24041857$1$I$$20240603$20240702$20240702$PER$$US-009507513-2406USA001138$MERCK$$$$$F$Y$$$20240702$$CN$US$US
240418581$24041858$1$I$20100701$20240625$20240702$20240702$EXP$$NVSC2023PL175494$NOVARTIS$Razik M, Rozwadowska P, Koclega A, Helbig G. Double malignancy and double transplant-a bumpy road to success. MEDICINA. 2023;59:1209, 1-7$35$YR$$F$Y$$$20240702$$HP$PL$PL
240418591$24041859$1$I$$20240626$20240702$20240702$EXP$$DE-MYLANLABS-2024M1061170$MYLAN$Bonnet U, Kanti AK, Scherbaum N, Specka M.. The role of gabapentinoids in the substance use pattern of adult Germans seeking inpatient detoxification treatment- A Pilot Study. Journal of Psychoactive Drugs. 2023;55(1):102-11$29$YR$$M$Y$$$20240702$$HP$DE$DE
240418611$24041861$1$I$20240622$20240701$20240701$20240701$DIR$708786$$FDA-CTU$$52$YR$$F$N$64.8$KG$20240701$N$HP$US$
240418621$24041862$1$I$20240627$20240701$20240701$20240701$DIR$708809$$FDA-CTU$$19$YR$$M$N$65.25$KG$20240701$N$CN$US$
240418631$24041863$1$I$20240625$20240701$20240701$20240701$DIR$708785$$FDA-CTU$$78$YR$$F$N$76.5$KG$20240701$Y$CN$US$
240418641$24041864$1$I$20240701$20240701$20240701$20240701$DIR$708722$$FDA-CTU$$40$YR$$F$N$$$20240701$N$CN$US$
240418651$24041865$1$I$$20240624$20240702$20240702$EXP$$US-TEVA-VS-3214036$TEVA$Whyte MP, McAlister WH, Dhiman V, Gopinathan NR, Bhadada SK. Drug-induced osteopetrosis. Bone 2023; 173.$4$YR$$F$Y$$$20240702$$HP$US$US
240418662$24041866$2$F$$20240705$20240702$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05556$LUPIN$$$$$$Y$$$20240801$$CN$US$US
240418671$24041867$1$I$20231101$20240626$20240702$20240702$EXP$DE-EMBRYOTOX-202303590$DE-RDY-SPO/DEU/24/0009338$DR REDDYS$$$$$M$Y$2.59$KG$20240702$$MD$DE$DE
240418682$24041868$2$F$20240628$20240702$20240702$20240704$PER$$US-JNJFOC-20240678998$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$CN$US$US
240418691$24041869$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3214651$TEVA$$$$$F$Y$$$20240702$$CN$CA$CA
240418701$24041870$1$I$20240701$20240701$20240701$20240701$DIR$708709$$FDA-CTU$$59$YR$$M$N$94.5$KG$20240701$Y$CN$US$
240418711$24041871$1$I$$20240701$20240701$20240701$DIR$708712$$FDA-CTU$$$$$F$N$$$20240701$N$$US$
240418721$24041872$1$I$$20240619$20240702$20240702$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06212$NEUROCRINE BIOSCIENCES$$71$YR$$M$Y$$$20240702$$HP$US$US
240418731$24041873$1$I$$20240618$20240702$20240702$EXP$$CA-HLS-202401572$HLS THERAPEUTICS$$$$A$M$Y$$$20240702$$HP$CA$CA
240418741$24041874$1$I$$20240624$20240702$20240702$EXP$$CA-DSJP-DSJ-2024-129786$DAIICHI$$$$$F$Y$$$20240702$$CN$CA$CA
240418751$24041875$1$I$20240614$20240628$20240702$20240702$EXP$$CN-BAYER-2024A094735$BAYER$$45$YR$A$M$Y$$$20240702$$HP$CN$CN
240418761$24041876$1$I$$20240701$20240702$20240702$PER$$US-HALEON-2184838$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240418772$24041877$2$F$$20240704$20240702$20240712$EXP$$US-TEVA-VS-3214035$TEVA$Whyte MP, McAlister WH, Dhiman V, Gopinathan NR, Bhadada SK. Drug-induced osteopetrosis. Bone 2023; 173.; Whyte MP, McAlister WH, Dhiman V, Gopinathan NR, Bhadada SK. Drug-induced osteopetrosis. Bone 2023; 173.$7$YR$$F$Y$$$20240712$$HP$US$US
240418782$24041878$2$F$20240101$20240722$20240702$20240806$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00853$AVADEL CNS PHARMA$$$$$F$Y$68.027$KG$20240806$$CN$US$US
240418792$24041879$2$F$$20240708$20240702$20240710$EXP$$NVSC2024US136449$NOVARTIS$$$$$F$Y$$$20240710$$HP$US$US
240418802$24041880$2$F$20240621$20240723$20240702$20240731$PER$$US-JNJFOC-20240658899$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240731$$CN$US$US
240418811$24041881$1$I$$20231210$20240702$20240702$EXP$GB-MHRA-MED-202312081354135660-FCJPR$GB-TEVA-VS-3146310$TEVA$$83$YR$$F$Y$$$20240702$$HP$GB$GB
240418822$24041882$2$F$$20240708$20240702$20240712$EXP$$FR-MYLANLABS-2024M1060974$MYLAN$Belmin J, Broussier A, Boureau A-S, Donal E, Hanon O, Paccalin M et al.. Cardiac amyloidosis, an underdiagnosed disease in geriatrics. Revue du g?riatrie. 2024;49 (5):293-298$86$YR$$M$Y$$$20240712$$MD$FR$FR
240418832$24041883$2$F$$20240731$20240702$20240802$PER$$US-AMGEN-USASP2024129455$AMGEN$$71$YR$E$F$Y$$$20240802$$HP$US$US
240418841$24041884$1$I$$20240628$20240702$20240702$EXP$PL-URPL-DML-MLP.4401.1.3347.2021$PL-MYLANLABS-2024M1060978$MYLAN$$24$YR$$F$Y$40$KG$20240702$$MD$PL$PL
240418851$24041885$1$I$$20240624$20240702$20240702$EXP$$GB-AstraZeneca-2024A145706$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$GB$
240418861$24041886$1$I$$20240628$20240702$20240702$EXP$$PT-MYLANLABS-2024M1061138$MYLAN$$$$E$$Y$$$20240702$$HP$PT$PT
240418881$24041888$1$I$20240620$20240620$20240702$20240702$PER$$US-TEVA-VS-3212150$TEVA$$69$YR$$F$Y$$$20240702$$CN$US$US
240418891$24041889$1$I$$20240620$20240702$20240702$EXP$$FR-JNJFOC-20240658674$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$MD$FR$FR
240418901$24041890$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05632$LUPIN$Sarantopoulos N, Wiltchik E, Thakkar V, Klein W. Fluconazole associated DRESS syndrome in patient with coccidioidomycosis pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024;209: A1357:1$59$YR$$M$Y$$$20240702$$HP$US$US
240418911$24041891$1$I$$20240621$20240702$20240702$EXP$$US-JNJFOC-20240676957$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$MD$US$US
240418923$24041892$3$F$20240621$20240905$20240702$20240916$30DAY$$US-GSK-US2024081062$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240916$$PH$US$US
240418932$24041893$2$F$20240801$20240812$20240702$20240820$EXP$$CA-GSK-CA2023079716$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$CA$CA
240418942$24041894$2$F$20240601$20240822$20240702$20240901$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104687$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240902$$PH$US$US
240418951$24041895$1$I$20240401$20240626$20240702$20240702$EXP$DE-EMBRYOTOX-202306375$DE-RDY-SPO/DEU/24/0009341$DR REDDYS$$1$DY$N$F$Y$3.18$KG$20240702$$MD$DE$DE
240418961$24041896$1$I$$20240625$20240702$20240702$PER$$US-ABBVIE-5818746$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240418971$24041897$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281145082300-JSMBZ$GB-MYLANLABS-2024M1061525$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240418981$24041898$1$I$20240618$20240618$20240702$20240702$PER$$US-ROCHE-10000011364$ROCHE$$$$$F$Y$$$20240702$$PH$US$US
240418991$24041899$1$I$20191119$20240618$20240702$20240702$EXP$$CA-HLS-202000802$HLS THERAPEUTICS$$47$YR$A$F$Y$$$20240702$$HP$CA$CA
240419001$24041900$1$I$20240701$20240701$20240701$20240701$DIR$708742$$FDA-CTU$$42$YR$$F$N$$$20240701$N$HP$US$
240419011$24041901$1$I$20240701$20240701$20240701$20240701$DIR$708740$$FDA-CTU$$42$YR$$F$N$$$20240701$N$$US$
240419021$24041902$1$I$$20240625$20240702$20240702$PER$$US-INCYTE CORPORATION-2024IN006789$INCYTE$$$$$$Y$$$20240702$$CN$US$US
240419032$24041903$2$F$20240601$20240702$20240702$20240705$EXP$$US-KARYOPHARM-2024KPT001220$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240705$$CN$US$US
240419041$24041904$1$I$20240624$20240625$20240702$20240702$PER$$CN-BRACCO-2024CN03816$BRACCO$$80$YR$$F$Y$$$20240702$$HP$CN$CN
240419051$24041905$1$I$$20240701$20240702$20240702$EXP$GB-MHRA-MED-202406281336531360-CFMRD$GB-ORGANON-O2407GBR000159$ORGANON$$$$$F$Y$$$20240702$$CN$GB$GB
240419061$24041906$1$I$$20240624$20240702$20240702$PER$$US-MYLANLABS-2024M1061049$MYLAN$$$$$$Y$$$20240702$$CN$US$US
240419072$24041907$2$F$$20240807$20240702$20240813$EXP$$NVSC2024TR135327$NOVARTIS$$43$YR$$M$Y$$$20240813$$CN$TR$TR
240419081$24041908$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05628$LUPIN$Hourigan EK, Rattan M, Olsen ML. The right side of cardiogenic shock: A case of beta-blocker induced cardiogenic shock in a female with suspected pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine. 2024;209$41$YR$$F$Y$$$20240702$$HP$US$US
240419091$24041909$1$I$$20240629$20240702$20240702$PER$$NVSC2024US136767$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240419101$24041910$1$I$$20240628$20240702$20240702$PER$$US-JNJFOC-20240676922$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240419111$24041911$1$I$$20240701$20240702$20240702$EXP$$CA-ORGANON-O2407CAN000128$ORGANON$$$$$F$Y$$$20240702$$HP$CA$CA
240419121$24041912$1$I$$20240617$20240702$20240702$EXP$$US-GENERICUS, INC.-2024GNR00005$GENERICUS$Bjork S.T, Chen E. Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series. Am. J. Respir. Crit. Care Med. 2024;209$76$YR$$F$Y$$$20240702$$HP$US$US
240419131$24041913$1$I$$20240617$20240702$20240702$EXP$$US-GENERICUS, INC.-2024GNR00004$GENERICUS$Bjork S.T, Chen E. Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series. Am. J. Respir. Crit. Care Med. 2024;209$74$YR$$F$Y$$$20240702$$HP$US$US
240419141$24041914$1$I$$20240620$20240702$20240702$EXP$$US-BAYER-2024A091273$BAYER$$$$$M$Y$$$20240702$$LW$US$US
240419154$24041915$4$F$20240418$20240723$20240702$20240726$EXP$$NVSC2024MX088583$NOVARTIS$$69$YR$$M$Y$65$KG$20240726$$CN$MX$MX
240419161$24041916$1$I$20240528$20240603$20240702$20240702$EXP$$US-ALXN-202406USA000101US$ALEXION PHARMACEUTICALS$$74$YR$$F$Y$$$20240611$$PH$US$US
240419171$24041917$1$I$$20240625$20240702$20240702$EXP$$FR-GSK-FR2024EME080989$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$MD$FR$FR
240419181$24041918$1$I$$20240625$20240702$20240702$EXP$$US-FreseniusKabi-FK202410123$FRESENIUS KABI$$32$YR$$F$Y$73.9$KG$20240702$$PH$US$US
240419192$24041919$2$F$20240612$20240703$20240702$20240712$EXP$$CA-JNJFOC-20240673787$JOHNSON AND JOHNSON$$10$YR$C$F$Y$28$KG$20240712$$HP$CA$CA
240419211$24041921$1$I$$20240627$20240702$20240702$EXP$$US-GSK-US2024080214$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
240419222$24041922$2$F$20240625$20240723$20240702$20240730$EXP$$CA-GSK-CA2024029735$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$CA$CA
240419231$24041923$1$I$$20240622$20240702$20240702$EXP$$US-FreseniusKabi-FK202410183$FRESENIUS KABI$Gualano FM, Carter CL, Hassoun P, Hanson D. Embryonal tumor with multilayered rosettes: Post-treatment maturation and implications for future therapy. Cancer Reports. 2023 May;6(5): 1-7. doi:http://doi.org/10.1002/cnr2.1812.$5$MON$I$F$Y$$$20240702$$HP$US$US
240419241$24041924$1$I$20240529$20240701$20240702$20240702$EXP$$US-Eisai-EC-2024-168726$EISAI$$60$YR$A$M$Y$75$KG$20240702$$CN$US$US
240419251$24041925$1$I$$20240627$20240702$20240702$PER$$NVSC2024US135505$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240419261$24041926$1$I$20240101$20240702$20240702$20240702$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037305$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240702$$MD$FR$FR
240419271$24041927$1$I$20240120$20240701$20240702$20240702$EXP$FR-AFSSAPS-PC2024000492$FR-BAYER-2024A094696$BAYER$$28$YR$A$F$Y$$$20240702$$CN$FR$FR
240419281$24041928$1$I$$20240701$20240702$20240702$PER$$US-HALEON-2184860$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240419291$24041929$1$I$$20240621$20240702$20240702$EXP$$US-MYLANLABS-2024M1057500$MYLAN$$$$$F$Y$$$20240702$$HP$US$US
240419301$24041930$1$I$$20240624$20240702$20240702$EXP$$CA-DSJP-DSJ-2024-129778$DAIICHI$$$$$F$Y$$$20240702$$HP$CA$CA
240419312$24041931$2$F$$20240716$20240702$20240718$EXP$$IT-AstraZeneca-2024A149753$ASTRAZENECA$Sorvillo G, Olivieri F, Rainone A, Quercia E, Violante A, Mazza A. A VERY COMPLEX CLINICAL CASE OF ACUTE CORONARY SYNDROME COMPLICATED BY THROMBOSIS AND INTRACRANIAL HAEMORRHAGE. European Heart Journal Supplements 2024;26(Suppl. 2):ii127.$62$YR$$F$Y$$$20240718$$MD$IT$
240419321$24041932$1$I$20240401$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A146114$ASTRAZENECA$$$$$$Y$$$20240702$$CN$US$
240419331$24041933$1$I$20240606$20240628$20240702$20240702$EXP$$IN-AstraZeneca-2024A151148$ASTRAZENECA$$19880$DY$$F$Y$$$20240702$$CN$IN$
240419341$24041934$1$I$$20240624$20240702$20240702$EXP$$RU-AstraZeneca-2024A149006$ASTRAZENECA$Budkovaya MA, Rebrova SA. Chronic rhinosinusitis with nasal polyps as the first stage in the development of eosinophilic granulomatosis with polyangiitis. Russian Rhinology 2024;32(2):157-166.$37$YR$$M$Y$$$20240702$$MD$RU$
240419351$24041935$1$I$$20240701$20240702$20240702$EXP$$CA-ORGANON-O2407CAN000141$ORGANON$$65$YR$$F$Y$$$20240702$$HP$CA$CA
240419361$24041936$1$I$20240621$20240624$20240702$20240702$EXP$$JP-AstraZeneca-2024A148756$ASTRAZENECA$$$$$F$Y$$$20240702$$PH$JP$
240419372$24041937$2$F$20240614$20240801$20240702$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202406014753$ELI LILLY AND CO$$38$YR$A$M$Y$106$KG$20240812$$CN$US$US
240419381$24041938$1$I$20240101$20240624$20240702$20240702$EXP$$JP-AstraZeneca-2024A140771$ASTRAZENECA$$90$YR$$F$Y$$$20240702$$MD$JP$
240419391$24041939$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001432$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240702$$CN$US$US
240419401$24041940$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000857$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$US$US
240419411$24041941$1$I$$20240619$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000194$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240702$$CN$US$US
240419422$24041942$2$F$20230401$20240823$20240702$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202407000305$ELI LILLY AND CO$$34$YR$A$F$Y$72.562$KG$20240904$$CN$US$US
240419431$24041943$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000999$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240702$$CN$US$US
240419441$24041944$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000897$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240702$$CN$US$US
240419452$24041945$2$F$$20240906$20240702$20240906$EXP$$NVSC2024US135324$NOVARTIS$$$$$F$Y$$$20240906$$HP$US$US
240419464$24041946$4$F$$20240819$20240702$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202407000978$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240827$$CN$US$US
240419471$24041947$1$I$$20240626$20240702$20240702$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-104381$BRISTOL MYERS SQUIBB$Corgibet F. Therapeutic in private practice brest (France), 15th provincial national dermatology days, march 2024. Dermatomag. 2024 Apr 01;2:69-74.$$$$F$Y$$$20240702$$HP$FR$FR
240419483$24041948$3$F$20240620$20240730$20240702$20240801$PER$$US-JNJFOC-20240671979$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240801$$CN$US$US
240419491$24041949$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105454$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240702$$CN$US$US
240419502$24041950$2$F$20240626$20240730$20240702$20240801$PER$$US-JNJFOC-20240671895$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$US$US
240419511$24041951$1$I$$20240626$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105655$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240702$$CN$US$US
240419521$24041952$1$I$$20240625$20240702$20240702$EXP$$CA-GSK-CA2024079748$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$CA$CA
240419531$24041953$1$I$20240101$20240626$20240702$20240702$EXP$$GB-SA-2024SA190749$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240702$$MD$GB$GB
240419542$24041954$2$F$$20240910$20240702$20240912$PER$$NVSC2024US136771$NOVARTIS$$$$$M$Y$$$20240912$$MD$US$US
240419551$24041955$1$I$20240318$20240626$20240702$20240702$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0601144$MYOVANT SCIENCES$$74$YR$$M$Y$$$20240702$$CN$US$US
240419562$24041956$2$F$$20240704$20240702$20240713$EXP$$SE-TEVA-VS-3215031$TEVA$Fink K, Gorczyca A, Alping P, Englund S, Farmand S, Langer-Gould AM, et al. Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study. Mult-Scler-J 2023; 29 (6): 731-740.; Fink K, Gorczyca A, Alping P, Englund S, Farmand S, Langer-Gould AM, et al. Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study. Mult-Scler-J 2023;...$$$$$Y$$$20240713$$HP$SE$SE
240419572$24041957$2$F$$20240626$20240702$20240708$EXP$$ES-MYLANLABS-2024M1058295$MYLAN$$80$YR$$M$Y$$$20240708$$CN$ES$ES
240419583$24041958$3$F$$20240823$20240702$20240904$PER$$US-INCYTE CORPORATION-2024IN006796$INCYTE$$$$$$Y$$$20240904$$HP$US$US
240419591$24041959$1$I$20240508$20240625$20240702$20240702$EXP$$US-TAKEDA-2024TUS045696$TAKEDA$$61$YR$$F$Y$$$20240702$$CN$US$US
240419601$24041960$1$I$$20240626$20240702$20240702$PER$$US-JNJFOC-20240673993$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$MD$US$US
240419612$24041961$2$F$20230901$20240802$20240702$20240822$PER$$US-TEVA-VS-3213168$TEVA$$48$YR$$M$Y$$$20240822$$PH$US$US
240419621$24041962$1$I$20190101$20240624$20240702$20240702$EXP$$AT-FreseniusKabi-FK202410041$FRESENIUS KABI$$46$YR$A$F$Y$$$20240702$$MD$AT$AT
240419631$24041963$1$I$20230101$20240624$20240702$20240702$EXP$$SI-FreseniusKabi-FK202410043$FRESENIUS KABI$$$$E$M$Y$$$20240702$$MD$SI$SI
240419641$24041964$1$I$$20240625$20240702$20240702$EXP$$HU-FreseniusKabi-FK202410018$FRESENIUS KABI$$46$YR$A$M$Y$$$20240702$$MD$HU$HU
240419651$24041965$1$I$20240614$20240624$20240702$20240702$EXP$AT-BASGAGES-2024-004469$AT-FreseniusKabi-FK202410040$FRESENIUS KABI$$8$YR$C$M$Y$18.9$KG$20240702$$PH$AT$AT
240419661$24041966$1$I$$20240628$20240702$20240702$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-104529$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240702$$MD$DE$DE
240419672$24041967$2$F$20240624$20240809$20240702$20240817$30DAY$$US-GSK-US2024078670$GLAXOSMITHKLINE$$68$YR$$M$Y$$$20240817$$CN$US$US
240419682$24041968$2$F$$20240703$20240702$20240709$EXP$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-04992$IT-RDY-SPO/ITA/24/0009298$DR REDDYS$Rubino R, Trizzino M, Pipito L, Sucato G, Santoro M, Maugeri R, et al.. Rubino R, Trizzino M, Pipito L, Sucato G, Santoro M, Maugeri R,Iacopino DG, Giammanco MG, Siragusa S, Cascio A. A difficult case of ventriculitis in a 40-year-old woman with acute myeloid leukemia. Antibiotics.. 2024;13(5):432. doi:10.3390/antibiotics13050432$40$YR$A$F$Y$$$20240709$$MD$IT$IT
240419691$24041969$1$I$$20240617$20240702$20240702$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000254$ASSERTIO THERAPEUTICS$$43$YR$$M$Y$$$20240702$$MD$CA$CA
240419701$24041970$1$I$$20240701$20240702$20240702$PER$$US-HALEON-2184749$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240419721$24041972$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3214018$TEVA$$52$YR$$M$Y$$$20240702$$HP$CA$CA
240419741$24041974$1$I$$20240628$20240702$20240702$EXP$$BR-ABBVIE-5820932$ABBVIE$$$$$F$Y$$$20240702$$CN$BR$BR
240419751$24041975$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406291149288680-KLQWZ$GB-ORGANON-O2407GBR000062$ORGANON$$$$$M$Y$78$KG$20240702$$CN$GB$GB
240419761$24041976$1$I$$20240626$20240702$20240702$EXP$$US-PERRIGO-24US006175$PERRIGO$Postoll-Downs MA, Ozguc F, Vasudevan J, Stawinski PM, Wright R. Breaking Patterns: A Case of Dieulafoy Lesion in a Young Patient Without Comorbid Conditions. Cureus. 2024;16(5):e60513. DOI: 10.7759/cureus.60513.$18$YR$$M$Y$$$20240702$$MD$US$US
240419781$24041978$1$I$$20240628$20240702$20240702$EXP$$US-KYOWAKIRIN-2024KK015841$KYOWA$$$$$$Y$$$20240702$$HP$US$US
240419791$24041979$1$I$$20240619$20240702$20240702$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05456$LUPIN$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: A unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316:279:1-5$63$YR$$F$Y$$$20240702$$HP$US$US
240419801$24041980$1$I$$20240617$20240702$20240702$EXP$$IT-PIERREL S.P.A.-2024PIR00031$PIERREL$Gabrieli A, Barberi C, Compostella C, Azzolini M, Butturini A, Larger G et al. Local Anesthetic Systemic Toxicity Joint Management in the Prehospital Environment: A Case Report. Air Medical Journal. 2024;43(3):256-258$89$YR$$F$Y$$$20240702$$HP$IT$IT
240419811$24041981$1$I$$20240617$20240702$20240702$EXP$$US-PARI RESPIRATORY EQUIPMENT, INC.-2024PAR00050$PARI RESPIRATORY EQUIPMENT$Bjork S.T, Chen E. Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series. Am. J. Respir. Crit. Care Med. 2024;209$74$YR$$F$Y$$$20240702$$HP$US$US
240419821$24041982$1$I$$20240617$20240702$20240702$EXP$$US-PARI RESPIRATORY EQUIPMENT, INC.-2024PAR00051$PARI RESPIRATORY EQUIPMENT$Bjork S.T, Chen E. Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series. . Am. J. Respir. Crit. Care Med. 2024;209$76$YR$$F$Y$$$20240702$$HP$US$US
240419831$24041983$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46210$$FDA-CTU$$61$YR$$F$N$81.65$KG$20240702$N$$US$
240419841$24041984$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46211$$FDA-CTU$$73$YR$$M$N$$$20240702$N$$US$
240419851$24041985$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46212$$FDA-CTU$$43$YR$$M$N$$$20240702$N$$US$
240419862$24041986$2$F$20190916$20240703$20240702$20240708$EXP$$CA-TAKEDA-2023TUS108304$TAKEDA$$66$YR$$M$Y$$$20240708$$CN$CA$CA
240419874$24041987$4$F$20240530$20240723$20240702$20240807$30DAY$$US-JNJFOC-20240662795$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240807$$PH$US$US
240419883$24041988$3$F$$20240806$20240702$20240815$PER$$US-JAZZ PHARMACEUTICALS-2023-US-007353$JAZZ$$$$$F$Y$$$20240814$$MD$US$US
240419891$24041989$1$I$20190625$20240626$20240702$20240702$EXP$$US-JAZZ-2022-US-009119$JAZZ$$26$YR$$F$Y$$$20240702$$MD$US$US
240419901$24041990$1$I$$20240624$20240702$20240702$EXP$$ZA-AstraZeneca-2024A146634$ASTRAZENECA$$51$YR$$F$Y$$$20240702$$CN$ZA$
240419911$24041991$1$I$20240101$20240623$20240702$20240702$EXP$$US-PERRIGO-24US006050$PERRIGO$$$$$F$Y$$$20240702$$CN$US$US
240419921$24041992$1$I$20230801$20240624$20240702$20240702$EXP$$ZA-AstraZeneca-2024A146673$ASTRAZENECA$$61$YR$$M$Y$$$20240702$$CN$ZA$
240419931$24041993$1$I$$20240621$20240702$20240702$EXP$$TN-PERRIGO-24TN006048$PERRIGO$$53$YR$$F$Y$$$20240702$$MD$TN$TN
240419941$24041994$1$I$$20240621$20240702$20240702$EXP$$TN-PERRIGO-24TN006061$PERRIGO$$37$YR$$M$Y$$$20240702$$MD$TN$TN
240419951$24041995$1$I$$20240621$20240702$20240702$EXP$$TN-PERRIGO-24TN006060$PERRIGO$$50$YR$$F$Y$$$20240702$$MD$TN$TN
240419961$24041996$1$I$$20240618$20240702$20240702$EXP$001053739$CA-ICU MEDICAL, INC.-ICU2024CA00016$ICU MEDICAL$$79$YR$$F$Y$100$KG$20240702$$HP$CA$CA
240419971$24041997$1$I$$20240627$20240702$20240702$PER$$US-FreseniusKabi-FK202410199$FRESENIUS KABI$$$$$F$Y$$$20240702$$HP$US$US
240419981$24041998$1$I$20240624$20240625$20240702$20240702$EXP$$CN-FreseniusKabi-FK202410108$FRESENIUS KABI$$74$YR$E$M$Y$$$20240702$$HP$CN$CN
240419991$24041999$1$I$20240610$20240626$20240702$20240702$PER$$US-FreseniusKabi-FK202410134$FRESENIUS KABI$$65$YR$E$M$Y$127$KG$20240702$$CN$US$US
240420002$24042000$2$F$20240618$20240704$20240702$20240715$EXP$$HR-GUERBET / LLC-HR-20240004$GUERBET$$48$YR$A$M$Y$95$KG$20240715$$HP$HR$HR
240420012$24042001$2$F$$20240710$20240702$20240712$PER$$US-Taiho Oncology Inc-2024-006342$TAIHO ONCOLOGY INC$$81$YR$E$M$Y$$$20240712$$HP$US$US
240420021$24042002$1$I$$20240626$20240702$20240702$PER$$US-FreseniusKabi-FK202410138$FRESENIUS KABI$$67$YR$E$F$Y$50$KG$20240702$$PH$US$US
240420032$24042003$2$F$20240623$20240628$20240702$20240815$PER$$US-TRAVERE-2024TVT00635$TRAVERE THERAPEUTICS$$65$YR$E$F$Y$$$20240815$$CN$US$US
240420051$24042005$1$I$20220101$20240626$20240702$20240702$EXP$FR-AFSSAPS-AVMP2024000181$FR-MYLANLABS-2024M1058382$MYLAN$$23$YR$$F$Y$$$20240702$$MD$FR$FR
240420061$24042006$1$I$$20240627$20240702$20240702$EXP$$US-JNJFOC-20240674232$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
240420071$24042007$1$I$$20240621$20240702$20240702$EXP$$CA-APOTEX-2024AP007688$APOTEX$$83$YR$$M$Y$85$KG$20240702$$PH$CA$CA
240420081$24042008$1$I$$20240630$20240702$20240702$PER$$NVSC2024US136785$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240420091$24042009$1$I$$20240625$20240702$20240702$EXP$$NVSC2024US135867$NOVARTIS$$68$YR$$F$Y$$$20240702$$CN$US$US
240420101$24042010$1$I$$20240628$20240702$20240702$EXP$$US-KYOWAKIRIN-2024KK015900$KYOWA$$$$$$Y$$$20240702$$HP$US$US
240420111$24042011$1$I$$20240626$20240702$20240702$EXP$$DE-AMGEN-DEUSP2024127269$AMGEN$Schmidt W.F.; Ahlgrim C.. Clinical importance of distinguishing true anemia from dilutional pseudo-anemia: Consequences of a 3-year follow-up volume assessment in a heart failure patient. Clinical Case Reports. 2024;12 (6):1-6$78$YR$E$M$Y$95$KG$20240702$$HP$DE$DE
240420121$24042012$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406281437236830-WVLTH$GB-ORGANON-O2407GBR000032$ORGANON$$$$$$Y$$$20240702$$CN$GB$GB
240420131$24042013$1$I$$20240618$20240702$20240702$EXP$E2B_06858011$CA-ICU MEDICAL, INC.-ICU2024CA00014$ICU MEDICAL$$$$$M$Y$$$20240702$$HP$CA$CA
240420141$24042014$1$I$$20240624$20240702$20240702$EXP$$US-AMGEN-USASP2024124821$AMGEN$Wireko F.H.; Ryu J.H.. Lung Transplant for Acute Exacerbation in Interstitial Pneumonia With Autoimmune Features (IPAF). American Journal of Respiratory and Critical Care Medicine. 2024;209(1):A5934$63$YR$A$M$Y$$$20240702$$HP$US$US
240420151$24042015$1$I$20240626$20240627$20240702$20240702$EXP$$US-TG THERAPEUTICS INC.-TGT003750$TG THERAPEUTICS$$$$$$Y$$$20240702$$CN$US$US
240420163$24042016$3$F$$20240903$20240702$20240911$EXP$$US-SA-2024SA176605$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240911$$MD$US$US
240420171$24042017$1$I$$20240624$20240702$20240702$EXP$$US-AMGEN-USASP2024125531$AMGEN$Deng X; Jung D. A Late, Unusual Presentation of Chronic Eosinophilic Pneumonia Requiring Anti-IL5 Therapy. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A6374$88$YR$E$F$Y$$$20240702$$HP$US$US
240420181$24042018$1$I$20230829$20240624$20240702$20240702$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-104111$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240702$$MD$DE$DE
240420192$24042019$2$F$$20240624$20240702$20240702$30DAY$$US-SANDOZ INC.-SDZ2024US061936$SANDOZ$$$$$F$Y$$$20240702$$CN$US$US
240420201$24042020$1$I$20240101$20240625$20240702$20240702$EXP$$CL-SANDOZ INC.-SDZ2024CL061374$SANDOZ$$58$YR$$F$Y$$$20240702$$CN$CL$CL
240420213$24042021$3$F$20240401$20240827$20240702$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA037740$SANDOZ$$61$YR$$F$Y$$$20240830$$CN$CA$CA
240420221$24042022$1$I$$20240626$20240702$20240702$EXP$$US-SANDOZ INC.-SDZ2024US061467$SANDOZ$$$$E$F$Y$$$20240702$$MD$US$US
240420231$24042023$1$I$20240501$20240701$20240702$20240702$EXP$$FR-SANDOZ INC.-SDZ2024FR061916$SANDOZ$$51$YR$$F$Y$$$20240702$$MD$FR$FR
240420241$24042024$1$I$20240415$20240701$20240702$20240702$EXP$FR-AFSSAPS-PC2024000499$FR-SANDOZ INC.-SDZ2024FR061983$SANDOZ$$63$YR$$M$Y$86$KG$20240702$$MD$FR$FR
240420251$24042025$1$I$20240622$20240701$20240702$20240702$EXP$FR-AFSSAPS-PB2024000740$FR-SANDOZ INC.-SDZ2024FR061874$SANDOZ$$22$YR$$F$Y$76.5$KG$20240702$$MD$FR$FR
240420261$24042026$1$I$20240101$20240623$20240702$20240702$PER$$US-SA-2024SA189592$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240702$$MD$US$US
240420271$24042027$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46218$$FDA-CTU$$87$YR$$F$N$$$20240702$N$$US$
240420281$24042028$1$I$$20240701$20240701$20240701$DIR$708731$$FDA-CTU$$$$$UNK$N$$$20240701$N$CN$US$
240420311$24042031$1$I$20240101$20240621$20240702$20240702$PER$$US-SA-2024SA188349$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240702$$MD$US$US
240420321$24042032$1$I$20240501$20240624$20240702$20240702$PER$$US-SA-2024SA189788$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240702$$MD$US$US
240420331$24042033$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46219$$FDA-CTU$$70$YR$$M$N$$$20240702$N$$US$
240420341$24042034$1$I$20240627$20240701$20240701$20240701$DIR$708783$$FDA-CTU$$65$YR$$F$N$48.15$KG$20240701$N$CN$US$
240420361$24042036$1$I$20240701$20240701$20240701$20240701$DIR$708689$$FDA-CTU$$55$YR$$F$N$$$20240701$N$$US$
240420381$24042038$1$I$20240628$20240628$20240702$20240702$PER$$US-JNJFOC-20240677440$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240702$$CN$US$US
240420391$24042039$1$I$20240628$20240701$20240701$20240701$DIR$708680$$FDA-CTU$$69$YR$$F$N$$$20240701$N$HP$US$
240420401$24042040$1$I$$20240621$20240702$20240702$EXP$$US-MYLANLABS-2024M1041239$MYLAN$$$$$M$Y$2.02$KG$20240702$$HP$US$US
240420411$24042041$1$I$20240619$20240701$20240701$20240701$DIR$708724$$FDA-CTU$$61$YR$$M$N$$$20240701$N$HP$US$
240420421$24042042$1$I$20240629$20240701$20240701$20240701$DIR$708763$$FDA-CTU$$21$YR$$F$N$50.4$KG$20240701$N$CN$US$
240420441$24042044$1$I$20240601$20240701$20240701$20240701$DIR$708671$$FDA-CTU$$35$YR$$M$N$103.5$KG$20240701$N$CN$US$
240420451$24042045$1$I$20240602$20240701$20240701$20240701$DIR$708739$$FDA-CTU$$44$YR$$F$N$108$KG$20240701$N$CN$US$
240420461$24042046$1$I$20240628$20240701$20240701$20240701$DIR$708719$$FDA-CTU$$67$YR$$F$N$74.25$KG$20240701$N$CN$US$
240420472$24042047$2$F$$20240814$20240702$20240814$PER$$NVSC2024US136986$NOVARTIS$$$$$M$Y$$$20240814$$HP$US$US
240420481$24042048$1$I$$20240626$20240702$20240702$EXP$$US-Sprout Pharmaceuticals, Inc.-2024SP000201$SPROUT PHARMACEUTICALS$$$$A$F$Y$$$20240701$$CN$US$US
240420492$24042049$2$F$$20240911$20240702$20240920$PER$$US-TAKEDA-2024TUS066219$TAKEDA$$$$$$Y$$$20240920$$CN$US$US
240420504$24042050$4$F$20240622$20240708$20240702$20240712$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000124$Unknown Manufacturer$$$$$$Y$$$20240712$$MD$FR$FR
240420511$24042051$1$I$20240616$20240628$20240702$20240702$EXP$$AU-MYLANLABS-2024M1061480$MYLAN$$29$YR$$F$Y$$$20240702$$HP$AU$AU
240420521$24042052$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281143566360-GQMFV$GB-MYLANLABS-2024M1061518$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240420531$24042053$1$I$$20240625$20240702$20240702$EXP$$US-TRAVERE-2024TVT00641$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240702$$CN$US$US
240420542$24042054$2$F$$20240708$20240702$20240709$EXP$GB-MHRA-MED-202406281144360370-LSKWG$GB-MYLANLABS-2024M1061538$MYLAN$$$$$M$Y$$$20240709$$CN$GB$GB
240420551$24042055$1$I$$20240624$20240702$20240702$EXP$$US-AMGEN-USASP2024129244$AMGEN$Baskaran N.; Sharma P.; Tahir M. et al.. A case of ocular diffuse large B-cell lymphoma unveiled. Journal of Surgical Case Reports. 2024;6:1-3$74$YR$E$M$Y$$$20240702$$HP$US$US
240420563$24042056$3$F$20240420$20240718$20240702$20240729$EXP$$DE-JNJFOC-20240606981$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240729$$PH$DE$DE
240420571$24042057$1$I$20240531$20240603$20240702$20240702$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000444$PAREXEL$$$$$$Y$$$20240702$$PH$US$US
240420581$24042058$1$I$20240622$20240627$20240702$20240702$EXP$$US-VANTIVE-2024VAN017972$Vantive US Healthcare$$54$YR$$F$Y$$$20240702$$CN$US$US
240420591$24042059$1$I$$20240628$20240702$20240702$PER$$US-AMGEN-USASP2024128681$AMGEN$$$$A$F$Y$$$20240702$$CN$US$US
240420601$24042060$1$I$20240616$20240627$20240702$20240702$EXP$$ZA-AstraZeneca-2024A149802$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$ZA$
240420621$24042062$1$I$$20240626$20240702$20240702$EXP$$CA-GSK-CA2024AMR081468$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$CA$CA
240420631$24042063$1$I$$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A149275$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240420641$24042064$1$I$20240613$20240624$20240702$20240702$EXP$$CN-AstraZeneca-2024A147689$ASTRAZENECA$$19095$DY$$F$Y$61$KG$20240702$$MD$CN$
240420651$24042065$1$I$$20240624$20240702$20240702$EXP$$JP-AstraZeneca-2024A148793$ASTRAZENECA$$$$$M$Y$$$20240702$$PH$JP$
240420662$24042066$2$F$$20240704$20240702$20240712$EXP$$CA-AstraZeneca-2024A147615$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$CA$
240420671$24042067$1$I$20240512$20240629$20240702$20240702$EXP$$CN-AstraZeneca-2024A151098$ASTRAZENECA$$24338$DY$$M$Y$56$KG$20240702$$MD$CN$
240420681$24042068$1$I$$20240624$20240702$20240702$EXP$$FR-EMD Serono-2024035761$EMD SERONO INC$$$$$F$Y$$$20240702$$MD$FR$FR
240420693$24042069$3$F$20221231$20240717$20240702$20240731$EXP$$IN-CIPLA LTD.-2024IN06839$CIPLA$Edison DC, Philip J, Mallhi RS, Basnotra R, Pynadath V, Sane K. Severe Amlodipine toxicity: A medical dilemma managed with therapeutic plasma exchange.. Transfusion and apheresis science.. 2024;63 (4):103958$$$$$Y$$$20240731$$MD$IN$IN
240420702$24042070$2$F$20230101$20240711$20240702$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103160$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$82$KG$20240716$$CN$US$US
240420711$24042071$1$I$20230701$20240625$20240702$20240702$EXP$$CN-SA-2024SA190653$SANOFI AVENTIS$Li J.. Two cases of coronary spasm caused by tegafur, gimeracil and oteracil porassium combined with oxaliplatin in elderly patients with gastric cancer. Pract Geriatr. 2024;38:646-9$73$YR$E$M$Y$$$20240702$$HP$CN$CN
240420721$24042072$1$I$$20240620$20240702$20240702$EXP$$US-CIPLA LTD.-2024US06786$CIPLA$Rodriguez C, Yosry N, Qaiser S, Luzuriaga A, Adelizzi A.. BRASH: A deadly acronym.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1596$$$$$Y$$$20240702$$MD$US$US
240420732$24042073$2$F$$20240815$20240702$20240815$PER$$NVSC2024US137072$NOVARTIS$$$$$M$Y$$$20240815$$CN$US$US
240420741$24042074$1$I$$20230829$20240702$20240702$PER$$US-AMGEN-USASP2023235387$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240420751$24042075$1$I$$20240624$20240702$20240702$EXP$$FR-AMGEN-FRASP2024125167$AMGEN$Moranne O.; Cauchy L.; Mousty E. et. al.. Successful pregnancy after 10 consecutive failures in a liver transplant patient with advanced kidney failure. Journal of Nephrology. 2024;37:747-751$$$$M$Y$8.3$KG$20240702$$HP$FR$FR
240420762$24042076$2$F$20230310$20240703$20240702$20240708$EXP$$CA-TAKEDA-2024TUS052769$TAKEDA$$52$YR$$M$Y$$$20240708$$CN$CA$CA
240420771$24042077$1$I$20240601$20240627$20240702$20240702$EXP$$DE-BAYER-2024A093412$BAYER$$57$YR$A$M$Y$$$20240702$$MD$DE$DE
240420801$24042080$1$I$20240524$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46228$$FDA-CTU$$55$YR$$F$N$$$20240702$Y$PH$US$
240420813$24042081$3$F$$20240918$20240702$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099489$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240918$$MD$JP$JP
240420822$24042082$2$F$$20240730$20240702$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105759$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240802$$CN$US$US
240420832$24042083$2$F$$20240730$20240702$20240809$EXP$$IE-TEVA-VS-3215339$TEVA$Cronin C, McLaughlin R, Lane L, Brett FM, Jansen M, Bermingham N, et al. Case report: BRAF-inhibitor therapy in BRAF-mutated primary CNS tumours including one case of BRAF-mutated Rosai-Dorfman disease. Front-Med 2022; 9.; Cronin C, McLaughlin R, Lane L, Brett FM, Jansen M, Bermingham N, et al. Case report: BRAF-inhibitor therapy in BRAF-mutated primary CNS tumours including one case of BRAF-mutated Rosai-Dorfman disease. Front-Med 2022; 9.$12$YR$$M$Y$$$20240809$$HP$IE$IE
240420852$24042085$2$F$20240101$20240828$20240702$20240913$EXP$$NL-ABBVIE-5819382$ABBVIE$$$$E$M$Y$$$20240913$$CN$NL$NL
240420861$24042086$1$I$$20240625$20240702$20240702$EXP$$US-AMGEN-USASP2024127221$AMGEN$Yilmaz S.; Prien C.; Lavryk O. et al.. Maternal and Fetal Outcomes After IBD Surgery During Pregnancy. American Journal of Gastroenterology. 2022;117:S31$$$A$F$Y$$$20240702$$HP$US$US
240420871$24042087$1$I$20070701$20240625$20240702$20240702$EXP$$PHBS2009IT00799$NOVARTIS$Brizzi MP, Sculli C, Ragni F, Porpilia F, Tampellini M, Gorzegno G. Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma. ANNALS OF ONCOLOGY. 2009;20 (2):1-2$69$YR$$F$Y$$$20240702$$HP$IT$IT
240420881$24042088$1$I$20240601$20240628$20240702$20240702$PER$$NVSC2024US136799$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240420891$24042089$1$I$20100101$20240621$20240702$20240702$EXP$$US-JNJFOC-20240472193$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$LW$US$US
240420901$24042090$1$I$20240610$20240625$20240702$20240702$EXP$$CO-JNJFOC-20240671790$JOHNSON AND JOHNSON$$51$YR$A$M$Y$90$KG$20240702$$HP$CO$CO
240420911$24042091$1$I$$20240627$20240702$20240702$EXP$$US-GSK-US2024080369$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
240420921$24042092$1$I$20230401$20240627$20240702$20240702$EXP$$US-ABBVIE-5806996$ABBVIE$$75$YR$$F$Y$73$KG$20240702$$CN$US$US
240420931$24042093$1$I$$20240625$20240702$20240702$EXP$$ES-Rigel Pharmaceuticals, Inc.-20240600074$RIGEL PHARMACEUTICALS$Tom?s Jos? Gonzalez-Lopez. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. American Society of Hematology. 2024;143:doi:10.1182/blood.2024024250$82$YR$$F$Y$$$20240702$$MD$ES$ES
240420941$24042094$1$I$20230101$20240626$20240702$20240702$EXP$$US-ABBVIE-5819231$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240420951$24042095$1$I$20240601$20240625$20240702$20240702$PER$$US-SA-2024SA192444$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240702$$PH$US$US
240420962$24042096$2$F$20240601$20240829$20240702$20240918$PER$$US-SA-2024SA189480$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240918$$MD$US$US
240420971$24042097$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA188353$SANOFI AVENTIS$$$$A$F$Y$85.714$KG$20240702$$MD$US$US
240420981$24042098$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA190803$SANOFI AVENTIS$$$$A$M$Y$$$20240702$$MD$US$US
240420991$24042099$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA189796$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$MD$US$US
240421002$24042100$2$F$20240101$20240820$20240702$20240828$EXP$$IT-BIOMARINAP-IT-2024-158905$BIOMARIN$$$$$$Y$$$20240828$$CN$US$IT
240421012$24042101$2$F$20240601$20240723$20240702$20240801$PER$$US-SA-2024SA188969$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240801$$MD$US$US
240421021$24042102$1$I$$20240701$20240702$20240702$PER$$US-JNJFOC-20240702055$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240421031$24042103$1$I$$20240626$20240702$20240702$PER$$US-SA-2024SA192475$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240702$$CN$US$US
240421042$24042104$2$F$20240101$20240808$20240702$20240813$EXP$$US-SA-2024SA192692$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240813$$CN$US$US
240421052$24042105$2$F$20240411$20240819$20240702$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006573$JAZZ$$27$YR$$F$Y$$$20240822$$CN$US$US
240421061$24042106$1$I$$20240619$20240702$20240702$EXP$$CA-GSK-CA2024AMR071075$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$MD$CA$CA
240421071$24042107$1$I$20240430$20240617$20240702$20240702$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000533$PAREXEL$$$$$$Y$$$20240702$$HP$CN$CN
240421082$24042108$2$F$20230408$20240911$20240702$20240919$EXP$$US-ABBVIE-5819564$ABBVIE$$51$YR$$F$Y$158$KG$20240919$$CN$US$US
240421092$24042109$2$F$20210316$20240708$20240702$20240721$EXP$$JP-AMRYT PHARMACEUTICALS DAC-AEGR005146$AEGERION$$$$$$Y$$$20240719$$MD$JP$JP
240421101$24042110$1$I$$20230829$20240702$20240702$PER$$US-AMGEN-USASP2023235345$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240421111$24042111$1$I$$20240701$20240702$20240702$PER$$US-AMGEN-USASP2024130768$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240421121$24042112$1$I$$20240628$20240702$20240702$EXP$$GB-MYLANLABS-2024M1061508$MYLAN$$$$$M$Y$$$20240702$$HP$GB$GB
240421131$24042113$1$I$$20240624$20240702$20240702$EXP$$VN-AstraZeneca-2024A146763$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$VN$
240421141$24042114$1$I$20221028$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A146664$ASTRAZENECA$$40$YR$$M$Y$95.3$KG$20240702$$HP$US$
240421151$24042115$1$I$20161101$20240619$20240702$20240702$EXP$GB-MHRA-MED-202406191327139100-PSBVR$GB-GLENMARK PHARMACEUTICALS-2024GMK091781$GLENMARK$$$$$$Y$$$20240702$$CN$GB$GB
240421171$24042117$1$I$20230626$20240624$20240702$20240702$EXP$$GB-AstraZeneca-2024A145239$ASTRAZENECA$$72$YR$$F$Y$$$20240702$$MD$GB$
240421181$24042118$1$I$20240101$20240628$20240702$20240702$EXP$$US-ABBVIE-5822002$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240421191$24042119$1$I$20240621$20240625$20240702$20240702$EXP$$US-TRAVERE-2024TVT00644$TRAVERE THERAPEUTICS$$54$YR$A$M$Y$$$20240702$$CN$US$US
240421202$24042120$2$F$20240101$20240718$20240702$20240722$EXP$$CA-ABBVIE-5821775$ABBVIE$$$$A$F$Y$$$20240722$$CN$CA$CA
240421211$24042121$1$I$$20240620$20240702$20240702$PER$$US-TEVA-VS-3213198$TEVA$$76$YR$$F$Y$57.15$KG$20240702$$CN$US$US
240421222$24042122$2$F$20240505$20240709$20240702$20240715$EXP$ES-AEMPS-1538238$ES-MYLANLABS-2024M1058383$MYLAN$$90$YR$$M$Y$$$20240715$$PH$ES$ES
240421231$24042123$1$I$$20240625$20240702$20240702$EXP$$US-AMGEN-USASP2024125558$AMGEN$$$$$M$Y$$$20240702$$CN$US$US
240421241$24042124$1$I$$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024126981$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240421251$24042125$1$I$$20231116$20240702$20240702$PER$$US-AMGEN-USASP2023235394$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240421261$24042126$1$I$20240624$20240628$20240702$20240702$PER$$US-JNJFOC-20240677953$JOHNSON AND JOHNSON$$32$YR$A$$Y$$$20240702$$HP$US$US
240421271$24042127$1$I$$20240701$20240702$20240702$PER$$US-JNJFOC-20240702285$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$CN$US$US
240421282$24042128$2$F$20240617$20240628$20240702$20240705$EXP$$US-GSK-US2024079184$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$US$US
240421291$24042129$1$I$20231005$20240625$20240702$20240702$EXP$$CA-GSK-CA2024079685$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$CA$CA
240421301$24042130$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5822031$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240421311$24042131$1$I$$20240628$20240702$20240702$EXP$$CL-PFIZER INC-PV202400086155$PFIZER$$62$YR$$F$Y$$$20240702$$CN$CL$CL
240421321$24042132$1$I$20231210$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085721$PFIZER$$12$YR$$F$Y$32$KG$20240702$$HP$CN$CN
240421331$24042133$1$I$20240610$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085699$PFIZER$$14$YR$$F$Y$21$KG$20240702$$HP$CN$CN
240421341$24042134$1$I$20240607$20240628$20240702$20240702$EXP$BE-FAMHP-DHH-N2024-122286$BE-PFIZER INC-202400202881$PFIZER$$23$YR$$F$Y$97$KG$20240702$$CN$BE$BE
240421351$24042135$1$I$20240522$20240628$20240702$20240702$EXP$$US-PFIZER INC-202400203939$PFIZER$$86$YR$$F$Y$45.36$KG$20240702$$CN$US$US
240421361$24042136$1$I$20240614$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085620$PFIZER$$69$YR$$F$Y$$$20240702$$HP$CN$CN
240421371$24042137$1$I$20240618$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085644$PFIZER$$45$YR$$M$Y$60$KG$20240702$$HP$CN$CN
240421381$24042138$1$I$20240613$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085711$PFIZER$$66$YR$$F$Y$60$KG$20240702$$HP$CN$CN
240421391$24042139$1$I$20190101$20240628$20240702$20240702$EXP$$CA-PFIZER INC-2019275806$PFIZER$$78$YR$$F$Y$$$20240702$$MD$CA$CA
240421401$24042140$1$I$20240611$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085693$PFIZER$$6$YR$$F$Y$26$KG$20240702$$HP$CN$CN
240421412$24042141$2$F$20240712$20240718$20240702$20240724$EXP$$BR-PFIZER INC-202400203381$PFIZER$$75$YR$$F$Y$46.8$KG$20240724$$PH$BR$BR
240421421$24042142$1$I$20030101$20240628$20240702$20240702$EXP$NO-NOMAADVRE-PASRAPP-2024-Vdk4p4$NO-PFIZER INC-202400203255$PFIZER$$47$YR$$F$Y$83$KG$20240702$$CN$NO$NO
240421434$24042143$4$F$20240525$20240722$20240702$20240726$EXP$$CA-PFIZER INC-202400194060$PFIZER$$94$YR$$M$Y$$$20240726$$PH$CA$CA
240421441$24042144$1$I$$20240628$20240702$20240702$EXP$$CN-PFIZER INC-202400203983$PFIZER$$$$C$F$Y$$$20240702$$HP$CN$CN
240421451$24042145$1$I$$20240628$20240702$20240702$EXP$$US-PFIZER INC-PV202400085838$PFIZER$$$$$M$Y$$$20240702$$MD$US$US
240421461$24042146$1$I$20240628$20240628$20240702$20240702$EXP$$US-PFIZER INC-202400203934$PFIZER$$62$YR$$M$Y$$$20240702$$CN$US$US
240421471$24042147$1$I$$20240701$20240702$20240702$PER$$US-ABBVIE-5823008$ABBVIE$$$$$F$Y$$$20240702$$MD$US$US
240421483$24042148$3$F$$20240822$20240702$20240828$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001304$BLUEPRINT MEDICINES$$$$$M$Y$$$20240828$$CN$US$US
240421491$24042149$1$I$$20240629$20240702$20240702$EXP$GB-MHRA-MED-202406290959216370-ZTQWJ$GB-ORGANON-O2407GBR000127$ORGANON$$$$$M$Y$$$20240702$$CN$GB$GB
240421501$24042150$1$I$$20240624$20240702$20240702$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001302$BLUEPRINT MEDICINES$$$$$$Y$$$20240702$$CN$US$US
240421511$24042151$1$I$$20240624$20240702$20240702$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001307$BLUEPRINT MEDICINES$$$$$F$Y$$$20240702$$CN$US$US
240421521$24042152$1$I$20240401$20240628$20240702$20240702$EXP$$US-ABBVIE-5821696$ABBVIE$$65$YR$$F$Y$$$20240702$$CN$US$US
240421541$24042154$1$I$20240601$20240701$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105558$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240702$$CN$US$US
240421551$24042155$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105774$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240702$$CN$US$US
240421561$24042156$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105440$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240702$$CN$US$US
240421572$24042157$2$F$20240628$20240807$20240702$20240807$PER$$US-JNJFOC-20240677068$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
240421581$24042158$1$I$20240529$20240627$20240702$20240702$EXP$$TW-JNJFOC-20240676416$JOHNSON AND JOHNSON$$79$YR$E$$Y$$$20240702$$MD$TW$TW
240421591$24042159$1$I$$20240625$20240702$20240702$EXP$$US-GSK-US2024079061$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$US$US
240421601$24042160$1$I$20191101$20240625$20240702$20240702$EXP$$CN-PFIZER INC-PV202400083978$PFIZER$Lu, C.. Guillain-Barr Syndrome Caused by Cytomegalovirus after Multiple Myeloma Treatment. Clinical Laboratory. 2024;70(6):1175-1177$50$YR$$F$Y$$$20240702$$HP$CN$CN
240421611$24042161$1$I$20210101$20240625$20240702$20240702$EXP$$US-PFIZER INC-202400047290$PFIZER$Chirravur, P.. Unsung oral toxicities of antibody drug conjugate. Oral Oncology. 2024;150(106692):10.1016/j.oraloncology.2024.10$57$YR$$F$Y$$$20240702$$MD$US$US
240421621$24042162$1$I$$20240620$20240702$20240702$EXP$$US-FARMAPROD-202406-2345$DOMPE FARMACEUTICI$$$$E$M$Y$62.28$KG$20240702$$CN$US$US
240421632$24042163$2$F$20240618$20240806$20240702$20240807$PER$$US-ALXN-202406USA001745US$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240807$$CN$US$US
240421642$24042164$2$F$$20240705$20240702$20240709$EXP$$US-PFIZER INC-K201100487$PFIZER$Singleton, R.. Iatrogenic cerebral venous sinus occlusion with flowable topical hemostatic matrix: Clinical article.. Journal of Neurosurgery. 2011;115(3):576-583$40$YR$$F$Y$$$20240709$$MD$US$US
240421652$24042165$2$F$$20240706$20240702$20240716$EXP$$US-TEVA-VS-3215513$TEVA$Wordekemper B, Clifton B, Deibert CM. Cryoablation of the penile nerves for chronic penile pain. Int-J-Impot-Res 2023; 35 (5): 415-418.; Wordekemper B, Clifton B, Deibert CM. Cryoablation of the penile nerves for chronic penile pain. Int-J-Impot-Res 2023; 35 (5): 415-418.$39$YR$$M$Y$$$20240716$$HP$US$US
240421661$24042166$1$I$20240627$20240627$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103962$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240702$$CN$US$US
240421671$24042167$1$I$20240101$20240627$20240702$20240702$PER$$US-SA-2024SA192737$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240702$$MD$US$US
240421681$24042168$1$I$$20240628$20240702$20240702$EXP$$US-GSK-US2024081161$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$HP$US$US
240421691$24042169$1$I$$20240701$20240702$20240702$PER$$US-AMGEN-USASP2024130763$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240421701$24042170$1$I$$20230920$20240702$20240702$PER$$US-AMGEN-USASP2023235349$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240421715$24042171$5$F$$20240807$20240702$20240814$PER$$US-JNJFOC-20240665413$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$US$US
240421721$24042172$1$I$$20240628$20240702$20240702$PER$$US-JNJFOC-20240677687$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240421731$24042173$1$I$20240513$20240617$20240702$20240702$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000532$PAREXEL$$$$$$Y$$$20240702$$HP$CN$CN
240421741$24042174$1$I$$20240629$20240702$20240702$EXP$$US-AstraZeneca-2024A150720$ASTRAZENECA$Hidalgo, J ; Rao, A ; Luzuriaga, A ; Pava De Los Rios, J; Parikh, M. Emphysematous Cystitis In A Female With Heart Failure Treated With Dapagliflozin. 2024 Annual Meeting of the Endocrine Society (ENDO) 2024;$60$YR$$F$Y$$$20240702$$MD$US$
240421761$24042176$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019646$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240702$$CN$US$US
240421771$24042177$1$I$$20240620$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406014532$ELI LILLY AND CO$$$$E$F$Y$$$20240702$$CN$US$US
240421781$24042178$1$I$$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A149769$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240421791$24042179$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46235$$FDA-CTU$$52$YR$$F$N$82.1$KG$20240702$N$$US$
240421812$24042181$2$F$$20240821$20240702$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105596$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240826$$CN$US$US
240421822$24042182$2$F$$20240722$20240702$20240724$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-105506$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$77.11$KG$20240724$$HP$PR$PR
240421844$24042184$4$F$20240101$20240822$20240702$20240905$PER$$US-SA-2024SA192781$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240905$$MD$US$US
240421851$24042185$1$I$20240529$20240617$20240702$20240702$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000527$PAREXEL$$$$$$Y$$$20240702$$HP$CN$CN
240421861$24042186$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5822076$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240421871$24042187$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821958$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240421881$24042188$1$I$20240518$20240628$20240702$20240702$EXP$FR-AFSSAPS-RN2024000697$FR-PFIZER INC-202400202968$PFIZER$$69$YR$$M$Y$$$20240702$$MD$FR$FR
240421891$24042189$1$I$$20240628$20240702$20240702$EXP$$AT-PFIZER INC-PV202400086026$PFIZER$$$$$F$Y$$$20240702$$MD$AT$AT
240421902$24042190$2$F$20231110$20240813$20240702$20240816$EXP$$PL-PFIZER INC-202400202991$PFIZER$$74$YR$$M$Y$76$KG$20240816$$MD$PL$PL
240421911$24042191$1$I$$20240628$20240702$20240702$EXP$$CN-PFIZER INC-202400202890$PFIZER$$$$$$Y$$$20240702$$MD$CN$CN
240421921$24042192$1$I$20240603$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085684$PFIZER$$62$YR$$M$Y$57$KG$20240702$$HP$CN$CN
240421932$24042193$2$F$20240330$20240913$20240702$20240918$EXP$$IN-PFIZER INC-202400204423$PFIZER$$76$YR$$M$Y$112$KG$20240918$$CN$IN$US
240421941$24042194$1$I$20240522$20240620$20240702$20240702$EXP$FR-AFSSAPS-GR2024000730$FR-MYLANLABS-2024M1056415$MYLAN$$50$YR$$F$Y$49.5$KG$20240702$$PH$FR$FR
240421951$24042195$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281436108240-JYFTK$GB-MYLANLABS-2024M1061586$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240421961$24042196$1$I$20240323$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406271040542900-VDNJS$GB-MYLANLABS-2024M1061527$MYLAN$$$$$M$Y$78$KG$20240702$$CN$GB$GB
240421982$24042198$2$F$$20240730$20240702$20240802$PER$$US-ROCHE-10000008402$ROCHE$$$$A$F$Y$$$20240802$$CN$US$US
240421991$24042199$1$I$$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024128340$AMGEN$$70$YR$E$F$Y$$$20240702$$CN$US$US
240422001$24042200$1$I$$20230127$20240702$20240702$PER$$US-AMGEN-USASP2023235099$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240422023$24042202$3$F$20240510$20240716$20240702$20240723$PER$$US-ROCHE-10000013670$ROCHE$$26$YR$A$M$Y$$$20240723$$CN$US$US
240422031$24042203$1$I$20240619$20240627$20240702$20240702$PER$$US-ROCHE-10000013405$ROCHE$$39$YR$A$M$Y$$$20240702$$CN$US$US
240422041$24042204$1$I$$20240627$20240702$20240702$EXP$$US-TAKEDA-2024TUS012760$TAKEDA$$$$$M$Y$$$20240702$$MD$US$US
240422051$24042205$1$I$$20240620$20240702$20240702$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091824$GLENMARK$Khanal B, Bartosek N, Calvo Ayala E.. A Rare Cause of Acute Respiratory Distress Syndrome (ARDS) in Young Patients.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A1141$$$$$Y$$$20240702$$MD$US$US
240422061$24042206$1$I$20240614$20240628$20240702$20240702$EXP$$NVSC2024CN137052$NOVARTIS$$82$YR$$M$Y$65$KG$20240702$$HP$CN$CN
240422072$24042207$2$F$20240506$20240620$20240702$20240704$PER$$US-ROCHE-RCA5207657$ROCHE$$1$YR$I$M$Y$$$20240704$$CN$US$US
240422081$24042208$1$I$$20240624$20240702$20240702$EXP$$US-MYLANLABS-2024M1059443$MYLAN$Salman A, Jabra E, Paul V. From Epi Rush to Multi-Organ Crush: A Case of Epinephrine Overdose and Organ Dysfunction. Am-J-Respir-Crit-Care-Med 2024; 209 A3659.$62$YR$$M$Y$$$20240702$$HP$US$US
240422091$24042209$1$I$20240501$20240624$20240702$20240702$EXP$$CL-JNJFOC-20240670038$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240702$$CN$CL$CL
240422101$24042210$1$I$$20240625$20240702$20240702$EXP$$CA-APOTEX-2024AP007766$APOTEX$$57$YR$$F$Y$$$20240702$$HP$CA$CA
240422111$24042211$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000012967$ROCHE$$$$A$M$Y$$$20240702$$CN$US$US
240422121$24042212$1$I$$20240624$20240702$20240702$PER$$US-ROCHE-10000013187$ROCHE$$$$A$M$Y$$$20240702$$CN$US$US
240422131$24042213$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46244$$FDA-CTU$$67$YR$$F$N$71.67$KG$20240702$N$$US$
240422141$24042214$1$I$$20240625$20240702$20240702$PER$$US-ROCHE-10000013152$ROCHE$$$$A$M$Y$$$20240702$$CN$US$US
240422151$24042215$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46233$$FDA-CTU$$52$YR$$F$N$74.39$KG$20240702$N$$US$
240422162$24042216$2$F$$20240708$20240702$20240709$EXP$GB-MHRA-MED-202406281439120430-SHLWN$GB-ORGANON-O2407GBR000083$ORGANON$$$$$$Y$$$20240709$$CN$GB$GB
240422171$24042217$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46243$$FDA-CTU$$65$YR$$F$N$$$20240702$N$$US$
240422181$24042218$1$I$20240619$20240619$20240702$20240702$EXP$$US-3M-2024-US-035937$Solventum$$$$$M$Y$$$20240702$$CN$US$US
240422191$24042219$1$I$$20240626$20240702$20240702$EXP$FR-AFSSAPS-AVNT2024000409$FR-MYLANLABS-2024M1058311$MYLAN$$26$YR$$M$Y$$$20240702$$PH$FR$FR
240422202$24042220$2$F$$20240723$20240702$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105721$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$67$KG$20240805$$CN$US$US
240422211$24042221$1$I$$20240701$20240702$20240702$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-105576$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240702$$MD$GB$GB
240422221$24042222$1$I$$20240628$20240702$20240702$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-105659$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240702$$PH$CA$CA
240422232$24042223$2$F$$20240821$20240702$20240826$EXP$$CA-TAKEDA-2024TUS064909$TAKEDA$$$$$F$Y$$$20240826$$MD$CA$CA
240422242$24042224$2$F$20240624$20240724$20240702$20240729$PER$$US-JNJFOC-20240663762$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240729$$PH$US$US
240422251$24042225$1$I$20230803$20240626$20240702$20240702$EXP$$CA-TAKEDA-2024TUS056320$TAKEDA$$68$YR$$F$Y$$$20240702$$CN$CA$CA
240422261$24042226$1$I$20240628$20240628$20240702$20240702$PER$$US-JNJFOC-20240677484$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240702$$CN$US$US
240422271$24042227$1$I$$20230920$20240702$20240702$PER$$US-AMGEN-USASP2023235350$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240422291$24042229$1$I$$20240701$20240702$20240702$DIR$FDA-CDER-CTU-2024-46247$$FDA-CTU$$$$$F$N$$$20240701$N$HP$US$
240422301$24042230$1$I$$20240625$20240702$20240702$EXP$$US-MYLANLABS-2024M1060909$MYLAN$Guzman A. Should Severe Hypertriglyceridemia Also Be Considered as a Contraindication for Use of Glucagon like Peptide 1 (GLP-1) Agonists?. J-Endocr-Soc 2020; 4 (Suppl.) A122.$46$YR$$M$Y$$$20240702$$MD$US$US
240422311$24042231$1$I$20240527$20240626$20240702$20240702$EXP$FR-AFSSAPS-LM2024000348$FR-MYLANLABS-2024M1058324$MYLAN$$65$YR$$M$Y$71.5$KG$20240702$$PH$FR$FR
240422321$24042232$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A146086$ASTRAZENECA$$$$$F$Y$45.4$KG$20240702$$CN$US$
240422331$24042233$1$I$$20240627$20240702$20240702$EXP$$DE-AstraZeneca-2024A149508$ASTRAZENECA$$$$$F$Y$$$20240702$$PH$DE$
240422341$24042234$1$I$$20240624$20240702$20240702$EXP$$JP-AstraZeneca-2024A149288$ASTRAZENECA$$45$YR$$F$Y$$$20240702$$MD$JP$
240422351$24042235$1$I$$20240624$20240702$20240702$EXP$$JP-AstraZeneca-2024A148769$ASTRAZENECA$$88$YR$$M$Y$$$20240702$$PH$JP$
240422361$24042236$1$I$$20240624$20240702$20240702$EXP$$FR-AstraZeneca-2024A149218$ASTRAZENECA$$$$$M$Y$$$20240702$$MD$FR$
240422372$24042237$2$F$$20240808$20240702$20240816$EXP$$US-AstraZeneca-2024A145581$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
240422381$24042238$1$I$$20240628$20240702$20240702$EXP$$US-TRAVERE-2024TVT00660$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240702$$CN$US$US
240422391$24042239$1$I$$20240627$20240702$20240702$EXP$$FR-AstraZeneca-2024A149941$ASTRAZENECA$$84$YR$$M$Y$$$20240702$$MD$FR$
240422411$24042241$1$I$20240101$20240626$20240702$20240702$PER$$US-TAKEDA-2024TUS065068$TAKEDA$$34$YR$$F$Y$79.38$KG$20240702$$MD$US$US
240422422$24042242$2$F$20240621$20240719$20240702$20240723$PER$$US-JNJFOC-20240664011$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240723$$CN$US$US
240422431$24042243$1$I$$20240627$20240702$20240702$EXP$$CA-JNJFOC-20240676887$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240702$$HP$CA$CA
240422441$24042244$1$I$$20230112$20240702$20240702$PER$$US-AMGEN-USASP2023235002$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240422452$24042245$2$F$$20240708$20240702$20240711$EXP$GB-MHRA-MED-202406281141054980-NZHDV$GB-ORGANON-O2407GBR000104$ORGANON$$$$$$Y$$$20240711$$CN$GB$GB
240422463$24042246$3$F$20200301$20240808$20240702$20240814$EXP$$NVSC2020CO298069$NOVARTIS$$77$YR$$F$Y$46$KG$20240814$$CN$CO$CO
240422471$24042247$1$I$$20240627$20240702$20240702$EXP$$CN-Ipsen Biopharmaceuticals, Inc.-2024-12996$IPSEN$RU-AO C, QI-SHUANG C, ZI-XUAN C, F-H Y, X-Y C, H-Y T. Retrospective cohort study of Qi Zhen Yi Liu Formula and somatostatin analogues in advanced pancreatic neuroendocrine tumors. Journal of China-Japan Friendship Hospital. 2024 Jun;38(3): 139-143. doi:10.3969/j.issn.1001-0025.2024.03.003.$$$$$Y$$$20240702$$HP$CN$CN
240422482$24042248$2$F$20240101$20240703$20240702$20240704$EXP$IT-MINISAL02-992855$NVSC2024IT136323$NOVARTIS$$39$YR$$F$Y$54$KG$20240704$$MD$IT$IT
240422491$24042249$1$I$$20240628$20240702$20240702$30DAY$$US-GSK-US2024081068$GLAXOSMITHKLINE$$$$$F$Y$$$20240702$$CN$US$US
240422501$24042250$1$I$$20240622$20240702$20240702$EXP$$US-JNJFOC-20240666253$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240422511$24042251$1$I$20240401$20240628$20240702$20240702$EXP$FR-AFSSAPS-SE2024000479$FR-MYLANLABS-2024M1060971$MYLAN$$35$YR$$M$Y$59$KG$20240702$$MD$FR$FR
240422521$24042252$1$I$20231201$20240628$20240702$20240702$EXP$DK-DKMA-30729591$DK-MYLANLABS-2024M1060957$MYLAN$$39$YR$$F$Y$141$KG$20240702$$MD$DK$DK
240422542$24042254$2$F$20240621$20240705$20240702$20240711$30DAY$$US-AMGEN-USASP2024124057$AMGEN$$39$YR$A$F$Y$$$20240711$$CN$US$US
240422551$24042255$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46248$$FDA-CTU$$60$YR$$F$N$$$20240702$N$$US$
240422561$24042256$1$I$$20240701$20240702$20240702$DIR$FDA-CDER-CTU-2024-46249$$FDA-CTU$$$$$M$N$$$20240701$N$HP$US$
240422571$24042257$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46252$$FDA-CTU$$48$YR$$F$N$83.01$KG$20240702$N$$US$
240422581$24042258$1$I$$20240612$20240702$20240702$EXP$$PL-BEH-2024173673$CSL BEHRING$Zdziarski P, Gamian A.,. Role of B Cells beyond Antibodies in HBV-Induced Oncogenesis, Fulminant Cancer in Common Variable Immunodeficiency-Clinical and Immunotransplant Implications with a Review of the Literature. Diseases. 2024;12(5)$28$YR$A$M$Y$$$20240702$$MD$PL$PL
240422592$24042259$2$F$$20240630$20240702$20240705$PER$$NVSC2024US136783$NOVARTIS$$$$$$Y$$$20240705$$CN$US$US
240422601$24042260$1$I$20240501$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105280$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240702$$HP$US$US
240422611$24042261$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105306$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$77.56$KG$20240702$$CN$US$US
240422621$24042262$1$I$$20240625$20240702$20240702$EXP$$IE-TAKEDA-2024TUS065274$TAKEDA$Kelly P, Lemmens R, Weimar C, Walsh C, Purroy F, Barber M, et al. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (convince): a randomised controlled trial. The Lancet. 2024$$$$$Y$$$20240702$$MD$IE$IE
240422631$24042263$1$I$$20240628$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104806$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$43.54$KG$20240702$$PH$US$US
240422641$24042264$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821980$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240422651$24042265$1$I$$20240625$20240702$20240702$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003591$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240702$$CN$US$US
240422661$24042266$1$I$$20240628$20240702$20240702$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003650$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240702$$CN$US$US
240422673$24042267$3$F$20240601$20240906$20240702$20240912$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003614$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240912$$CN$US$US
240422681$24042268$1$I$20221201$20240628$20240702$20240702$EXP$$MX-ABBVIE-4267071$ABBVIE$$68$YR$$M$Y$72$KG$20240702$$CN$MX$MX
240422692$24042269$2$F$$20240708$20240702$20240716$PER$$US-SA-2024SA191642$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240716$$MD$US$US
240422701$24042270$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA187852$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240702$$MD$US$US
240422712$24042271$2$F$$20240626$20240702$20240703$PER$$US-SA-2024SA192773$SANOFI AVENTIS$$$$E$F$Y$54$KG$20240703$$MD$US$US
240422721$24042272$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA192357$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$MD$US$US
240422731$24042273$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46260$$FDA-CTU$$83$YR$$F$N$$$20240702$N$$US$
240422741$24042274$1$I$20240501$20240620$20240702$20240702$PER$$US-SA-2024SA188127$SANOFI AVENTIS$$14$YR$T$F$Y$58.9$KG$20240702$$MD$US$US
240422751$24042275$1$I$$20240622$20240702$20240702$EXP$$US-JNJFOC-20240665516$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240422761$24042276$1$I$20240519$20240625$20240702$20240702$EXP$$CA-JNJFOC-20240580366$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240702$$HP$CA$CA
240422771$24042277$1$I$$20240621$20240702$20240702$EXP$$VN-ORGANON-O2407VNM000061$ORGANON$Hung TP .. AMYLOIDOSIS WITH LIGHT CHAIN DEPOSITION CARDIOMYOPATHY: A CLINICAL CASE.. VIETNAM MEDICAL JOURNAL.. 2024;2:192-6$77$YR$$F$Y$$$20240702$$HP$VN$VN
240422792$24042279$2$F$20240612$20240712$20240702$20240717$EXP$$NL-PFIZER INC-PV202400084061$PFIZER$$68$YR$$M$Y$$$20240717$$CN$NL$NL
240422801$24042280$1$I$$20240701$20240702$20240702$EXP$$US-PFIZER INC-PV202400086507$PFIZER$$65$YR$$F$Y$$$20240702$$CN$US$US
240422821$24042282$1$I$$20240624$20240702$20240702$EXP$$US-PFIZER INC-202300235610$PFIZER$$63$YR$$F$Y$$$20240702$$CN$US$US
240422832$24042283$2$F$20240520$20240723$20240702$20240726$EXP$$US-PFIZER INC-2024SGN06260$PFIZER$$35$YR$$F$Y$$$20240726$$CN$US$US
240422842$24042284$2$F$$20240731$20240702$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105607$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$126.1$KG$20240812$$CN$US$US
240422851$24042285$1$I$$20240624$20240702$20240702$EXP$$ZA-AstraZeneca-2024A146666$ASTRAZENECA$$86$YR$$F$Y$$$20240702$$CN$ZA$
240422861$24042286$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A150390$ASTRAZENECA$$$$$$Y$$$20240702$$CN$US$
240422881$24042288$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A145865$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240422895$24042289$5$F$$20240805$20240702$20240813$EXP$$CA-AstraZeneca-2024A150423$ASTRAZENECA$$42$YR$$F$Y$$$20240813$$CN$CA$
240422901$24042290$1$I$20240430$20240627$20240702$20240702$EXP$$DE-AstraZeneca-2024A119232$ASTRAZENECA$$80$YR$$M$Y$$$20240702$$MD$DE$
240422913$24042291$3$F$20240507$20240815$20240702$20240821$PER$$US-AMGEN-USASP2024127938$AMGEN$$65$YR$E$F$Y$$$20240821$$PH$US$US
240422921$24042292$1$I$20231001$20240624$20240702$20240702$EXP$$FR-AstraZeneca-2024A148927$ASTRAZENECA$$$$A$F$Y$$$20240702$$MD$FR$
240422931$24042293$1$I$$20240626$20240702$20240702$EXP$$US-Covis Pharma GmbH-2024COV00819$COVIS PHARMA$Ekladious F, Saul D. A case of severe anaphylactic reaction after administration of diagnostic-dose ferumoxytol in a pediatric patient. Pediatr Radiol. 2024 JUN 22;. doi:10.1007/s00247-024-05970-0$4$YR$C$F$Y$$$20240702$$MD$US$US
240422941$24042294$1$I$20240526$20240624$20240702$20240702$EXP$$NO-AstraZeneca-2024A151265$ASTRAZENECA$$26$YR$$F$Y$$$20240702$$MD$NO$
240422951$24042295$1$I$$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A148953$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240422961$24042296$1$I$$20240624$20240702$20240702$EXP$$JP-AstraZeneca-2024A148843$ASTRAZENECA$$$$E$$Y$$$20240702$$MD$JP$
240422971$24042297$1$I$20240610$20240701$20240702$20240702$PER$$US-BAYER-2024A095151$BAYER$$35$YR$A$F$Y$$$20240702$$HP$US$US
240422981$24042298$1$I$$20240624$20240702$20240702$EXP$$US-ABBVIE-5816462$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240423001$24042300$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821949$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240423011$24042301$1$I$$20231017$20240702$20240702$PER$$US-AMGEN-USASP2023235351$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240423021$24042302$1$I$$20240701$20240702$20240702$PER$$US-AMGEN-USASP2024130755$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240423031$24042303$1$I$$20240701$20240702$20240702$30DAY$$US-SANDOZ INC.-SDZ2023US003980$SANDOZ$$$$$F$Y$$$20240702$$CN$US$US
240423044$24042304$4$F$$20240728$20240702$20240808$EXP$$IN-SANDOZ INC.-SDZ2024IN060624$SANDOZ$$$$$M$Y$$$20240808$$CN$IN$IN
240423051$24042305$1$I$$20240624$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101859$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240702$$CN$US$US
240423061$24042306$1$I$20240604$20240701$20240702$20240702$EXP$$GB-SANDOZ INC.-SDZ2024GB062088$SANDOZ$$33$YR$$M$Y$53$KG$20240702$$HP$GB$GB
240423071$24042307$1$I$20240513$20240701$20240702$20240702$EXP$FR-AFSSAPS-PC2024000498$FR-SANDOZ INC.-SDZ2024FR061778$SANDOZ$$49$YR$$F$Y$$$20240702$$PH$FR$FR
240423081$24042308$1$I$20240612$20240628$20240702$20240702$EXP$$NVSC2024CN137168$NOVARTIS$$59$YR$$M$Y$55$KG$20240702$$HP$CN$CN
240423092$24042309$2$F$20240606$20240923$20240702$20240925$EXP$FR-AFSSAPS-TO2024001192$FR-ABBVIE-5821956$ABBVIE$$83$YR$$M$Y$$$20240925$$PH$FR$FR
240423101$24042310$1$I$20240613$20240630$20240702$20240702$EXP$$CN-ABBVIE-5821709$ABBVIE$$64$YR$$M$Y$$$20240702$$MD$CN$CN
240423111$24042311$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821746$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240423121$24042312$1$I$$20240623$20240702$20240702$EXP$$SA-JNJFOC-20240669135$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$SA$SA
240423131$24042313$1$I$$20240627$20240702$20240702$EXP$$FR-JNJFOC-20240676816$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$PH$FR$FR
240423142$24042314$2$F$20240626$20240705$20240702$20240710$30DAY$$FR-SANDOZ INC.-SDZ2024FR061975$SANDOZ$$8$YR$$M$Y$$$20240710$$CN$FR$FR
240423152$24042315$2$F$$20240702$20240702$20240709$EXP$$SK-SANDOZ INC.-SDZ2024SK061929$SANDOZ$$72$YR$$F$Y$70$KG$20240709$$PH$SK$SK
240423161$24042316$1$I$20230101$20240628$20240702$20240702$EXP$$TW-SANDOZ INC.-SDZ2024TW061444$SANDOZ$$42$YR$$$Y$$$20240702$$HP$TW$TW
240423171$24042317$1$I$20240401$20240701$20240702$20240702$EXP$$DE-SANDOZ INC.-SDZ2024DE061908$SANDOZ$$1$DY$$F$Y$3.18$KG$20240702$$MD$DE$DE
240423181$24042318$1$I$$20240701$20240702$20240702$30DAY$$US-SANDOZ INC.-SDZ2024CA030436$SANDOZ$$$$$$Y$$$20240702$$CN$US$CA
240423191$24042319$1$I$20210811$20240701$20240702$20240702$EXP$$DE-SANDOZ INC.-NVSC2022DE112538$SANDOZ$$$$A$F$Y$90$KG$20240702$$MD$DE$DE
240423201$24042320$1$I$20240501$20240627$20240702$20240702$EXP$$CL-SANDOZ INC.-SDZ2024CL062037$SANDOZ$$45$YR$$F$Y$$$20240702$$CN$CL$CL
240423211$24042321$1$I$$20240628$20240702$20240702$EXP$$US-SANDOZ INC.-NVSC2021US206984$SANDOZ$$$$$F$Y$58.957$KG$20240702$$CN$US$US
240423221$24042322$1$I$$20240626$20240702$20240702$EXP$$US-SANDOZ INC.-SDZ2024US061337$SANDOZ$$$$$F$Y$$$20240702$$PH$US$US
240423232$24042323$2$F$20240620$20240701$20240702$20240709$EXP$GB-MHRA-MED-202407010811065940-JBQDH$GB-SANDOZ INC.-SDZ2024GB062095$SANDOZ$$69$YR$$M$Y$96$KG$20240709$$CN$GB$GB
240423243$24042324$3$F$20240831$20240903$20240702$20240911$EXP$$US-SANDOZ INC.-SDZ2024US062084$SANDOZ$$40$YR$$M$Y$65.76$KG$20240911$$PH$US$US
240423251$24042325$1$I$$20240628$20240702$20240702$30DAY$$US-SANDOZ INC.-SDZ2024US061756$SANDOZ$$$$$$Y$$$20240702$$HP$US$US
240423267$24042326$7$F$20231018$20240927$20240702$20240930$EXP$$DE-SANDOZ INC.-SDZ2024DE061978$SANDOZ$$70$YR$$M$Y$$$20240930$$HP$DE$DE
240423282$24042328$2$F$20200120$20240902$20240702$20240903$EXP$$DE-SANDOZ INC.-SDZ2024DE061986$SANDOZ$$8$DEC$$F$Y$82$KG$20240903$$MD$DE$DE
240423291$24042329$1$I$20240517$20240701$20240702$20240702$EXP$HR-HALMED-300085743$HR-SANDOZ INC.-SDZ2024HR061931$SANDOZ$$65$YR$$M$Y$$$20240702$$MD$HR$HR
240423301$24042330$1$I$20240701$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001108$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240702$$PH$US$US
240423311$24042331$1$I$20231201$20240627$20240702$20240702$EXP$$US-ABBVIE-5736424$ABBVIE$$64$YR$$F$Y$$$20240702$$CN$US$US
240423321$24042332$1$I$20240601$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000741$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$US$US
240423341$24042334$1$I$$20240628$20240702$20240702$EXP$$CO-ROCHE-10000013462$ROCHE$$73$YR$E$F$Y$$$20240702$$CN$CO$CO
240423351$24042335$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105191$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$105.69$KG$20240702$$CN$US$US
240423361$24042336$1$I$20240101$20240621$20240702$20240702$PER$$US-ALKERMES INC.-ALK-2024-001729$ALKERMES$$$$$F$Y$$$20240702$$HP$US$US
240423371$24042337$1$I$20240601$20240628$20240702$20240702$EXP$$US-ABBVIE-5821848$ABBVIE$$$$A$M$Y$$$20240702$$MD$US$US
240423384$24042338$4$F$20230906$20240826$20240702$20240828$EXP$CZ-ASPEN-GLO2024CZ003730$CZ-SANDOZ INC.-SDZ2024CZ061906$SANDOZ$$41$YR$$F$Y$$$20240828$$MD$CZ$CZ
240423391$24042339$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5821455$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240423401$24042340$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA188230$SANOFI AVENTIS$$$$$$Y$$$20240702$$HP$US$US
240423411$24042341$1$I$20240101$20240621$20240702$20240702$PER$$US-SA-2024SA188305$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240702$$MD$US$US
240423421$24042342$1$I$$20240628$20240702$20240702$PER$$US-ABBVIE-5823417$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240423431$24042343$1$I$20240621$20240624$20240702$20240702$PER$$US-ALXN-202406USA001499US$ALEXION PHARMACEUTICALS$$9$YR$$F$Y$$$20240702$$CN$US$US
240423441$24042344$1$I$$20240624$20240702$20240702$EXP$$CA-BAXTER-2024BAX020759$BAXTER$$31$YR$$M$Y$$$20240702$$CN$CA$CA
240423451$24042345$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137274$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240423461$24042346$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A149947$ASTRAZENECA$$$$$M$Y$$$20240702$$CN$US$
240423481$24042348$1$I$20240101$20240628$20240702$20240702$EXP$$US-BAUSCH-BL-2024-010083$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240702$$CN$US$US
240423491$24042349$1$I$20240628$20240628$20240702$20240702$PER$$US-BAUSCH-BL-2024-010071$BAUSCH AND LOMB$$$$A$F$Y$$$20240702$$CN$US$US
240423503$24042350$3$F$20240625$20240709$20240702$20240725$30DAY$$US-AMGEN-USASP2024127012$AMGEN$$80$YR$E$F$Y$73.66$KG$20240724$$HP$US$US
240423511$24042351$1$I$20240101$20240621$20240702$20240702$PER$$US-SA-2024SA187858$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240702$$MD$US$US
240423521$24042352$1$I$$20240701$20240702$20240702$EXP$$IE-SANDOZ INC.-PHHY2018IE008708$SANDOZ$$$$N$F$Y$1.5$KG$20240702$$MD$IE$IE
240423531$24042353$1$I$20240503$20240630$20240702$20240702$EXP$FR-AFSSAPS-AN2024000803$FR-BAUSCH-BL-2024-010144$BAUSCH AND LOMB$$66$YR$$F$Y$65$KG$20240702$$PH$FR$FR
240423541$24042354$1$I$20240501$20240620$20240702$20240702$PER$$US-SA-2024SA187257$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240702$$MD$US$US
240423551$24042355$1$I$$20240620$20240702$20240702$PER$$US-SA-2024SA188138$SANOFI AVENTIS$$$$C$F$Y$18.1$KG$20240702$$MD$US$US
240423561$24042356$1$I$$20240621$20240702$20240702$PER$$US-SA-2024SA187117$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240702$$MD$US$US
240423573$24042357$3$F$$20240807$20240702$20240811$EXP$$US-SA-2024SA187237$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240811$$CN$US$US
240423581$24042358$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-30919045$GB-MYLANLABS-2024M1061269$MYLAN$$$$$F$Y$$$20240702$$CN$GB$GB
240423591$24042359$1$I$20240701$20240701$20240702$20240702$PER$$US-JNJFOC-20240702468$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240702$$CN$US$US
240423601$24042360$1$I$$20240617$20240702$20240702$EXP$$JP-JNJFOC-20240656220$JOHNSON AND JOHNSON$Yasumasa NAKATA, et. al. Department of Hematology, Tokyo Medical and Dental University Hospital. A case of liver disorder due to multiple azole antimycotic drugs followed by successful continuous treatment with ISAVUCONAZOLE. Medical Mycology Update Tokyo Program/Abstracts. Proceedings of the 43rd Meeting of Medical Mycology Update Tokyo;2024.6.15;Shinjuku-ku Tokyo:2024.p.67$41$YR$A$F$Y$$$20240702$$MD$JP$JP
240423611$24042361$1$I$20231201$20240630$20240702$20240702$EXP$$PL-BAUSCH-BL-2024-010140$BAUSCH AND LOMB$$6$DEC$$M$Y$$$20240702$$MD$PL$PL
240423621$24042362$1$I$20240525$20240629$20240702$20240702$EXP$FR-AFSSAPS-TS2024000745$FR-BAUSCH-BL-2024-010103$BAUSCH AND LOMB$$49$YR$$F$Y$89$KG$20240702$$MD$FR$FR
240423631$24042363$1$I$$20240625$20240702$20240702$PER$$US-JNJFOC-20240672454$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$PH$US$US
240423641$24042364$1$I$$20240630$20240702$20240702$EXP$$HU-BAUSCH-BL-2024-010142$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240702$$MD$HU$HU
240423652$24042365$2$F$20230901$20240702$20240702$20240707$EXP$$US-ABBVIE-5821885$ABBVIE$$65$YR$$M$Y$72.574$KG$20240707$$CN$US$US
240423662$24042366$2$F$$20240715$20240702$20240806$PER$$US-KARYOPHARM-2024KPT001192$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240806$$CN$US$US
240423672$24042367$2$F$20230118$20240711$20240702$20240712$EXP$$JP-EMD Serono-2024035462$EMD SERONO INC$$73$YR$E$M$Y$68$KG$20240712$$MD$JP$JP
240423691$24042369$1$I$20240521$20240629$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085750$PFIZER$$80$YR$$M$Y$78$KG$20240702$$HP$CN$CN
240423701$24042370$1$I$20240616$20240630$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085789$PFIZER$$35$YR$$F$Y$68$KG$20240702$$HP$CN$CN
240423721$24042372$1$I$20240513$20240630$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085790$PFIZER$$87$YR$$M$Y$$$20240702$$HP$CN$CN
240423732$24042373$2$F$20240301$20240701$20240702$20240705$EXP$$US-ABBVIE-5821886$ABBVIE$$76$YR$$F$Y$$$20240705$$CN$US$US
240423741$24042374$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5822309$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240423751$24042375$1$I$20240419$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46266$$FDA-CTU$$72$YR$$F$N$136.6$LBS$20240701$N$HP$US$
240423761$24042376$1$I$20240701$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105811$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240702$$CN$US$US
240423774$24042377$4$F$20180101$20240710$20240702$20240717$EXP$$AT-BAUSCH-BL-2024-010154$BAUSCH AND LOMB$Scherr S, Ksiazek S, Schwarz C, Saemann M. SGLT2 Inhibitor Use for Treatment of Hypocitraturia in a Distal Renal Tubular Acidosis. Kidney Med. 2024 MAY 16;6(7):1-3. doi:10.1016/ j.xkme.2024.100839$47$YR$$M$Y$$$20240717$$MD$AT$AT
240423791$24042379$1$I$20231220$20240629$20240702$20240702$EXP$FR-AFSSAPS-AVMA2024000261$FR-BAUSCH-BL-2024-010106$BAUSCH AND LOMB$$55$YR$$M$Y$$$20240702$$PH$FR$FR
240423801$24042380$1$I$$20240627$20240702$20240702$EXP$$NVSC2024US134946$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
240423811$24042381$1$I$20240101$20240628$20240702$20240702$EXP$$US-ABBVIE-5822352$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240423821$24042382$1$I$$20240630$20240702$20240702$PER$$NVSC2024US136995$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240423831$24042383$1$I$$20230330$20240702$20240702$PER$$US-AMGEN-USASP2023235399$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240423841$24042384$1$I$$20240625$20240702$20240702$PER$$US-AMGEN-USASP2024127251$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240423852$24042385$2$F$20240628$20240814$20240702$20240817$PER$$US-AMGEN-USASP2024129355$AMGEN$$66$YR$E$F$Y$$$20240817$$CN$US$US
240423863$24042386$3$F$20240627$20240805$20240702$20240809$PER$$US-AMGEN-USASP2024128593$AMGEN$$55$YR$A$F$Y$118.82$KG$20240809$$HP$US$US
240423873$24042387$3$F$20240621$20240916$20240702$20240923$PER$$US-SA-2024SA190495$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240923$$HP$US$US
240423882$24042388$2$F$$20240702$20240702$20240705$EXP$$US-BAUSCH-BL-2024-010156$BAUSCH AND LOMB$Reinsch N, Haq E, Ramakrishna K, Craft L. Cardiovascular Collapse Requiring Veno-Arterial Extracorporeal Membrane Oxygenation and Lidocaine: A Case of Massive Bupropion Overdose.. Cureus. 2024;16 (6):1-5. doi:10.7759/cureus.62873$18$YR$$F$Y$$$20240705$$HP$US$US
240423892$24042389$2$F$$20240702$20240702$20240710$PER$$US-ROCHE-10000009559$ROCHE$$$$$F$Y$$$20240710$$CN$US$US
240423902$24042390$2$F$20240619$20240712$20240702$20240717$EXP$$US-LANTHEUS-LMI-2024-00796$LANTHEUS MEDICAL IMAGING$$24$YR$$M$Y$75$KG$20240717$$MD$US$US
240423911$24042391$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821688$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240423922$24042392$2$F$20240101$20240701$20240702$20240705$EXP$$US-ABBVIE-5821732$ABBVIE$$49$YR$$M$Y$68.038$KG$20240705$$CN$US$US
240423931$24042393$1$I$20240517$20240621$20240702$20240702$EXP$$US-BEH-2024173002$CSL BEHRING$$71$YR$E$F$Y$68.027$KG$20240702$$HP$US$US
240423941$24042394$1$I$$20240625$20240702$20240702$PER$$NVSC2024US132562$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240423952$24042395$2$F$$20240720$20240702$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102366$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$62.6$KG$20240814$$CN$US$US
240423961$24042396$1$I$20240605$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128368$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240423981$24042398$1$I$$20240701$20240702$20240702$PER$$US-JNJFOC-20240700518$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$US$US
240423991$24042399$1$I$$20240624$20240702$20240702$EXP$$US-AstraZeneca-2024A145671$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240424001$24042400$1$I$20240627$20240628$20240702$20240702$PER$$US-AMGEN-USASP2024128902$AMGEN$$82$YR$E$F$Y$$$20240702$$CN$US$US
240424012$24042401$2$F$20231206$20240702$20240702$20240705$EXP$$JP-AstraZeneca-2024A129677$ASTRAZENECA$$19964$DY$$M$Y$48$KG$20240705$$MD$JP$
240424021$24042402$1$I$$20240617$20240702$20240702$EXP$$US-ROCHE-10000002801$ROCHE$Wei R, Wu Y, Jiang S, Zhang A, Zhang L, Liu L, et al. Efficacy and safety of Orelabrutinib-based regimens in diffuse large B-cell lymphoma: a single-center retrospective analysis.. Clin.Exp.Med. 2023;23 (8):4609-21.$$$$$Y$$$20240702$$MD$US$US
240424032$24042403$2$F$20240601$20240711$20240702$20240716$EXP$$GR-ABBVIE-5819037$ABBVIE$$86$YR$$M$Y$60$KG$20240716$$CN$GR$GR
240424041$24042404$1$I$20210928$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46229$$FDA-CTU$$21$YR$$F$N$220$LBS$20240701$N$$US$
240424051$24042405$1$I$20240520$20240701$20240701$20240701$DIR$FDA-CDER-CTU-2024-46238$$FDA-CTU$$75$YR$$F$N$$$20240701$N$HP$US$
240424071$24042407$1$I$20240401$20240628$20240702$20240702$EXP$$PR-ABBVIE-5820994$ABBVIE$$62$YR$$F$Y$122$KG$20240702$$CN$PR$PR
240424081$24042408$1$I$20240224$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105553$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240702$$CN$US$US
240424097$24042409$7$F$20240101$20240913$20240702$20240920$EXP$$NL-ABBVIE-5820875$ABBVIE$$$$E$F$Y$$$20240920$$HP$NL$NL
240424101$24042410$1$I$20240601$20240625$20240702$20240702$EXP$$AT-ABBVIE-5817608$ABBVIE$$27$YR$$M$Y$$$20240702$$CN$AT$AT
240424111$24042411$1$I$20240529$20240628$20240702$20240702$EXP$$NVSC2024CN137170$NOVARTIS$$65$YR$$F$Y$$$20240702$$HP$CN$CN
240424122$24042412$2$F$20191001$20240703$20240702$20240708$EXP$$NVSC2024BR050832$NOVARTIS$$63$YR$$F$Y$75$KG$20240708$$CN$BR$BR
240424132$24042413$2$F$$20240705$20240702$20240710$PER$$NVSC2024US134931$NOVARTIS$$$$$$Y$$$20240710$$CN$US$US
240424141$24042414$1$I$$20240626$20240702$20240702$EXP$$US-ABBVIE-5819881$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240424151$24042415$1$I$$20240623$20240702$20240702$EXP$$US-JNJFOC-20240668872$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$CN$US$US
240424161$24042416$1$I$$20240620$20240702$20240702$EXP$$IT-JNJFOC-20240656193$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$MD$IT$IT
240424171$24042417$1$I$$20240701$20240702$20240702$PER$$NVSC2024US136991$NOVARTIS$$$$$F$Y$$$20240702$$MD$US$US
240424181$24042418$1$I$20240620$20240624$20240702$20240702$PER$$US-ABBVIE-5816653$ABBVIE$$25$YR$$F$Y$86$KG$20240702$$CN$US$US
240424211$24042421$1$I$$20230307$20240702$20240702$EXP$$NVSC2023CA280772$NOVARTIS$$44$YR$$F$Y$70$KG$20240702$$HP$CA$CA
240424221$24042422$1$I$20240501$20240627$20240702$20240702$EXP$$US-ABBVIE-5821548$ABBVIE$$60$YR$$F$Y$$$20240702$$CN$US$US
240424231$24042423$1$I$$20240630$20240702$20240702$PER$$NVSC2024US137192$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
240424241$24042424$1$I$$20240625$20240702$20240702$EXP$$IE-TAKEDA-2024TUS066050$TAKEDA$Kelly P, Lemmens R, Weimar C, Walsh C, Purroy F, Barber M, et al. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (convince): a randomised controlled trial. The Lancet. 2024$$$$$Y$$$20240702$$MD$IE$IE
240424251$24042425$1$I$$20240625$20240702$20240702$EXP$$IE-TAKEDA-2024TUS066048$TAKEDA$Kelly P, Lemmens R, Weimar C, Walsh C, Purroy F, Barber M, et al. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (convince): a randomised controlled trial. The Lancet. 2024$$$$$Y$$$20240702$$MD$IE$IE
240424271$24042427$1$I$$20240629$20240702$20240702$PER$$US-PFIZER INC-202400204218$PFIZER$$$$T$F$Y$$$20240702$$CN$US$US
240424282$24042428$2$F$$20240703$20240702$20240703$PER$$US-PFIZER INC-202400203503$PFIZER$$$$$$Y$$$20240703$$CN$US$US
240424291$24042429$1$I$20240618$20240628$20240702$20240702$PER$$US-PFIZER INC-202400204309$PFIZER$$61$YR$$F$Y$$$20240702$$HP$US$US
240424301$24042430$1$I$20240630$20240630$20240702$20240702$PER$$US-PFIZER INC-202400204431$PFIZER$$56$YR$$F$Y$$$20240702$$CN$US$US
240424311$24042431$1$I$$20240626$20240702$20240702$PER$$US-PFIZER INC-PV202400084588$PFIZER$$77$YR$$F$Y$$$20240702$$HP$US$US
240424321$24042432$1$I$$20240628$20240702$20240702$PER$$US-PFIZER INC-PV202400085912$PFIZER$$23$YR$$F$Y$$$20240702$$CN$US$US
240424331$24042433$1$I$20240630$20240630$20240702$20240702$PER$$US-PFIZER INC-202400204325$PFIZER$$59$YR$$F$Y$$$20240702$$CN$US$US
240424343$24042434$3$F$20240601$20240716$20240702$20240722$PER$$US-PFIZER INC-202400204421$PFIZER$$61$YR$$F$Y$77.098$KG$20240722$$CN$US$US
240424351$24042435$1$I$20240630$20240630$20240702$20240702$PER$$US-PFIZER INC-202400204424$PFIZER$$65$YR$$M$Y$$$20240702$$CN$US$US
240424361$24042436$1$I$20240620$20240629$20240702$20240702$PER$$US-PFIZER INC-202400204396$PFIZER$$74$YR$$F$Y$$$20240702$$CN$US$US
240424372$24042437$2$F$$20240701$20240702$20240704$PER$$US-PFIZER INC-PV202400085807$PFIZER$$45$YR$$F$Y$$$20240704$$HP$US$US
240424381$24042438$1$I$$20240701$20240702$20240702$PER$$US-PFIZER INC-202400204530$PFIZER$$78$YR$$F$Y$$$20240702$$CN$US$US
240424395$24042439$5$F$$20240917$20240702$20240919$PER$$US-PFIZER INC-202400203325$PFIZER$$66$YR$$M$Y$$$20240919$$CN$US$US
240424401$24042440$1$I$20240627$20240629$20240702$20240702$PER$$US-PFIZER INC-202400204348$PFIZER$$56$YR$$F$Y$$$20240702$$CN$US$US
240424413$24042441$3$F$20240513$20240808$20240702$20240815$PER$$US-PFIZER INC-202400203974$PFIZER$$74$YR$$F$Y$81.633$KG$20240815$$CN$US$US
240424421$24042442$1$I$$20240628$20240702$20240702$PER$$US-PFIZER INC-202400204495$PFIZER$$61$YR$$M$Y$$$20240702$$HP$US$US
240424432$24042443$2$F$$20240704$20240702$20240704$PER$$US-PFIZER INC-202400204454$PFIZER$$47$YR$$F$Y$$$20240704$$MD$US$US
240424442$24042444$2$F$20240626$20240701$20240702$20240703$PER$$US-PFIZER INC-202400204316$PFIZER$$87$YR$$M$Y$$$20240703$$MD$US$US
240424451$24042445$1$I$20240629$20240701$20240702$20240702$PER$$US-PFIZER INC-PV202400086482$PFIZER$$$$$F$Y$$$20240702$$CN$US$US
240424461$24042446$1$I$$20240628$20240702$20240702$PER$$US-PFIZER INC-202400191495$PFIZER$$47$YR$$M$Y$$$20240702$$CN$US$US
240424471$24042447$1$I$$20240529$20240702$20240702$PER$$US-PFIZER INC-PV202400070820$PFIZER$$12$YR$$$Y$$$20240702$$CN$US$US
240424481$24042448$1$I$20240627$20240629$20240702$20240702$PER$$US-PFIZER INC-202400204402$PFIZER$$66$YR$$F$Y$$$20240702$$HP$US$US
240424491$24042449$1$I$$20240701$20240702$20240702$PER$$US-PFIZER INC-PV202300151724$PFIZER$$77$YR$$F$Y$$$20240702$$CN$US$US
240424501$24042450$1$I$20200101$20240628$20240702$20240702$PER$$US-PFIZER INC-PV202400085953$PFIZER$$$$$$Y$$$20240702$$CN$US$US
240424512$24042451$2$F$20240626$20240722$20240702$20240724$PER$$US-PFIZER INC-202400204408$PFIZER$$71$YR$$F$Y$43.084$KG$20240724$$CN$US$US
240424522$24042452$2$F$$20240716$20240702$20240718$PER$$US-PFIZER INC-202400203605$PFIZER$$81$YR$$F$Y$74.84$KG$20240718$$CN$US$US
240424533$24042453$3$F$$20240913$20240702$20240916$PER$$US-PFIZER INC-202400199068$PFIZER$$66$YR$$F$Y$$$20240916$$CN$US$US
240424542$24042454$2$F$20240628$20240715$20240702$20240718$PER$$US-PFIZER INC-202400204335$PFIZER$$68$YR$$M$Y$115.65$KG$20240718$$MD$US$US
240424553$24042455$3$F$$20240807$20240702$20240813$EXP$$US-PFIZER INC-202400204472$PFIZER$$81$YR$$F$Y$$$20240813$$CN$US$US
240424561$24042456$1$I$20240627$20240629$20240702$20240702$PER$$US-PFIZER INC-202400204297$PFIZER$$68$YR$$M$Y$$$20240702$$CN$US$US
240424572$24042457$2$F$20240101$20240701$20240702$20240703$PER$$US-PFIZER INC-202400204531$PFIZER$$$$$F$Y$$$20240703$$CN$US$US
240424581$24042458$1$I$$20240630$20240702$20240702$PER$$US-PFIZER INC-202400204323$PFIZER$$79$YR$$M$Y$$$20240702$$CN$US$US
240424591$24042459$1$I$$20240628$20240702$20240702$PER$$US-PFIZER INC-PV202400085899$PFIZER$$67$YR$$F$Y$$$20240702$$CN$US$US
240424601$24042460$1$I$20240629$20240629$20240702$20240702$PER$$US-PFIZER INC-202400204331$PFIZER$$45$YR$$F$Y$$$20240702$$CN$US$US
240424611$24042461$1$I$20240101$20240628$20240702$20240702$PER$$US-PFIZER INC-202400203470$PFIZER$$71$YR$$M$Y$85.73$KG$20240702$$PH$US$US
240424622$24042462$2$F$20240628$20240708$20240702$20240710$PER$$US-PFIZER INC-202400204310$PFIZER$$43$YR$$F$Y$$$20240710$$CN$US$US
240424631$24042463$1$I$20240630$20240630$20240702$20240702$PER$$US-PFIZER INC-202400204440$PFIZER$$33$YR$$F$Y$$$20240702$$CN$US$US
240424641$24042464$1$I$$20240629$20240702$20240702$PER$$US-PFIZER INC-PV202400085497$PFIZER$$68$YR$$$Y$$$20240702$$CN$US$US
240424652$24042465$2$F$20240629$20240710$20240702$20240711$PER$$US-PFIZER INC-202400204447$PFIZER$$76$YR$$M$Y$81.633$KG$20240711$$CN$US$US
240424663$24042466$3$F$$20240716$20240702$20240718$PER$$US-PFIZER INC-PV202400085844$PFIZER$$75$YR$$F$Y$$$20240718$$CN$US$US
240424671$24042467$1$I$20240601$20240628$20240702$20240702$EXP$$US-ABBVIE-5821852$ABBVIE$$39$YR$$F$Y$$$20240702$$CN$US$US
240424682$24042468$2$F$20240623$20240627$20240702$20240719$EXP$$US-ABBVIE-5821518$ABBVIE$$44$YR$$M$Y$$$20240719$$CN$US$US
240424691$24042469$1$I$20240131$20240621$20240702$20240702$PER$$US-SA-2024SA187629$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240702$$MD$US$US
240424701$24042470$1$I$$20240627$20240702$20240702$EXP$$US-SA-2024SA194062$SANOFI AVENTIS$$$$E$F$Y$68.03$KG$20240702$$MD$US$US
240424711$24042471$1$I$20240101$20240623$20240702$20240702$PER$$US-SA-2024SA190851$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240702$$MD$US$US
240424721$24042472$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137286$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240424731$24042473$1$I$20240323$20240625$20240702$20240702$EXP$$US-MYLANLABS-2024M1060747$MYLAN$$81$YR$$F$Y$$$20240702$$CN$US$US
240424742$24042474$2$F$$20240730$20240702$20240805$PER$$US-JNJFOC-20240702398$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
240424753$24042475$3$F$20240614$20240725$20240702$20240731$EXP$$US-APELLIS-2024-APL-0000320$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
240424762$24042476$2$F$20240629$20240704$20240702$20240705$EXP$$NVSC2024SK137137$NOVARTIS$$$$A$M$Y$$$20240705$$MD$SK$SK
240424771$24042477$1$I$$20230330$20240702$20240702$PER$$US-AMGEN-USASP2023235405$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240424781$24042478$1$I$$20230109$20240702$20240702$PER$$US-AMGEN-USASP2023235407$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240424791$24042479$1$I$20240628$20240628$20240702$20240702$EXP$$US-MYLANLABS-2024M1061686$MYLAN$$36$YR$$M$Y$$$20240702$$PH$US$US
240424801$24042480$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281441485000-MGTNK$GB-MYLANLABS-2024M1061562$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240424812$24042481$2$F$20240430$20240708$20240702$20240711$EXP$FR-AFSSAPS-AN2024000825$FR-MYLANLABS-2024M1061025$MYLAN$$77$YR$$M$Y$$$20240711$$PH$FR$FR
240424822$24042482$2$F$20240520$20240705$20240702$20240709$EXP$FR-AFSSAPS-AN2024000826$FR-MYLANLABS-2024M1060918$MYLAN$$58$YR$$F$Y$90$KG$20240709$$PH$FR$FR
240424831$24042483$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281436490710-YBJTK$GB-MYLANLABS-2024M1061750$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240424841$24042484$1$I$$20240630$20240702$20240702$PER$$NVSC2024US136751$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240424851$24042485$1$I$$20240627$20240702$20240702$PER$$US-BAYER-2024A093529$BAYER$$58$YR$A$F$Y$$$20240702$$HP$US$US
240424861$24042486$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105796$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$88.45$KG$20240702$$CN$US$US
240424871$24042487$1$I$$20240628$20240702$20240702$PER$$US-BIOGEN-2024BI01271826$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
240424882$24042488$2$F$20240101$20240718$20240702$20240802$EXP$$US-COOPERSURGICAL, INC.-2024CPS001930$COOPERSURGICAL$$$$$F$Y$51.247$KG$20240802$$CN$US$US
240424911$24042491$1$I$20220701$20240321$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2022ICT01425$INTRA-CELLULAR THERAPIES$$21$YR$$M$Y$77.098$KG$20240702$$HP$US$US
240424921$24042492$1$I$$20240321$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00486$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240424931$24042493$1$I$$20240325$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00489$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240424941$24042494$1$I$$20240325$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00492$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240424951$24042495$1$I$$20240325$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00494$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240424961$24042496$1$I$20240301$20240326$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00500$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$CN$US$US
240424971$24042497$1$I$$20240326$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00501$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240424981$24042498$1$I$20240201$20240320$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00468$INTRA-CELLULAR THERAPIES$$36$YR$$M$Y$$$20240702$$HP$US$US
240424991$24042499$1$I$$20240325$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00496$INTRA-CELLULAR THERAPIES$$21$YR$$F$Y$$$20240702$$HP$US$US
240425001$24042500$1$I$$20240326$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00498$INTRA-CELLULAR THERAPIES$$3$DEC$$F$Y$$$20240702$$HP$US$US
240425011$24042501$1$I$20240301$20240321$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00469$INTRA-CELLULAR THERAPIES$$$$E$F$Y$$$20240702$$CN$US$US
240425021$24042502$1$I$$20240325$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00485$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$CN$US$US
240425031$24042503$1$I$$20240322$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00488$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$MD$US$US
240425041$24042504$1$I$$20240325$20240702$20240702$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00491$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240425051$24042505$1$I$$20240325$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00493$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425061$24042506$1$I$$20240325$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00495$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$MD$US$US
240425071$24042507$1$I$$20240326$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00497$INTRA-CELLULAR THERAPIES$$52$YR$$F$Y$$$20240702$$HP$US$US
240425081$24042508$1$I$$20240326$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00499$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240425091$24042509$1$I$$20240329$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00520$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240425101$24042510$1$I$20240101$20240322$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00478$INTRA-CELLULAR THERAPIES$$29$YR$$M$Y$81.633$KG$20240702$$HP$US$US
240425111$24042511$1$I$20240105$20240328$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00519$INTRA-CELLULAR THERAPIES$$33$YR$$F$Y$81.633$KG$20240702$$HP$US$US
240425121$24042512$1$I$$20240328$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00521$INTRA-CELLULAR THERAPIES$$55$YR$$F$Y$$$20240702$$MD$US$US
240425131$24042513$1$I$$20240328$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00525$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240425141$24042514$1$I$$20240328$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00527$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$MD$US$US
240425151$24042515$1$I$$20240328$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00528$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$MD$US$US
240425161$24042516$1$I$$20240328$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00530$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425171$24042517$1$I$$20240401$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00534$INTRA-CELLULAR THERAPIES$$62$YR$$M$Y$$$20240702$$MD$US$US
240425181$24042518$1$I$$20240401$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00537$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$MD$US$US
240425191$24042519$1$I$$20240401$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00538$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425201$24042520$1$I$20230101$20240321$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00474$INTRA-CELLULAR THERAPIES$$$$$F$Y$67.12$KG$20240702$$HP$US$US
240425211$24042521$1$I$$20240326$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00502$INTRA-CELLULAR THERAPIES$$3$DEC$$F$Y$$$20240702$$HP$US$US
240425221$24042522$1$I$$20240326$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00503$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240425231$24042523$1$I$$20240326$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00504$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240425241$24042524$1$I$$20240326$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00505$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240425251$24042525$1$I$20240201$20240327$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00509$INTRA-CELLULAR THERAPIES$$35$YR$$M$Y$$$20240702$$CN$US$US
240425261$24042526$1$I$20240301$20240327$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00515$INTRA-CELLULAR THERAPIES$$4$DEC$$F$Y$$$20240702$$HP$US$US
240425271$24042527$1$I$$20240327$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00516$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240425281$24042528$1$I$$20240327$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00517$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240425291$24042529$1$I$$20240327$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00518$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425301$24042530$1$I$$20240401$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00539$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240425311$24042531$1$I$$20240402$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00543$INTRA-CELLULAR THERAPIES$$19$YR$$F$Y$$$20240702$$HP$US$US
240425321$24042532$1$I$$20240402$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00544$INTRA-CELLULAR THERAPIES$$20$YR$$F$Y$$$20240702$$HP$US$US
240425331$24042533$1$I$$20240402$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00546$INTRA-CELLULAR THERAPIES$$26$YR$$F$Y$$$20240702$$HP$US$US
240425341$24042534$1$I$$20240402$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00547$INTRA-CELLULAR THERAPIES$$4$DEC$$M$Y$$$20240702$$HP$US$US
240425351$24042535$1$I$$20240401$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00548$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$MD$US$US
240425361$24042536$1$I$$20240403$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00550$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$MD$US$US
240425371$24042537$1$I$$20240403$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00551$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425381$24042538$1$I$$20240403$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00552$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425391$24042539$1$I$$20240403$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00553$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425401$24042540$1$I$20240301$20240404$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00556$INTRA-CELLULAR THERAPIES$$30$YR$$F$Y$$$20240702$$HP$US$US
240425411$24042541$1$I$20240401$20240403$20240702$20240702$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00554$INTRA-CELLULAR THERAPIES$$33$YR$$F$Y$$$20240702$$HP$US$US
240425421$24042542$1$I$20240208$20240405$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00558$INTRA-CELLULAR THERAPIES$$71$YR$$F$Y$50.794$KG$20240702$$CN$US$US
240425431$24042543$1$I$$20240404$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00559$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$MD$US$US
240425441$24042544$1$I$20240101$20240403$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00560$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425451$24042545$1$I$20240301$20240403$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00561$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$CN$US$US
240425461$24042546$1$I$20240101$20240404$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00563$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425471$24042547$1$I$$20240404$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00566$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240425481$24042548$1$I$20240101$20240404$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00567$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240425491$24042549$1$I$20240101$20240404$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00569$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425501$24042550$1$I$$20240404$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00570$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425511$24042551$1$I$$20240404$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00571$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240425521$24042552$1$I$$20240404$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00572$INTRA-CELLULAR THERAPIES$$28$YR$$F$Y$$$20240702$$HP$US$US
240425531$24042553$1$I$20230101$20240408$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00574$INTRA-CELLULAR THERAPIES$$34$YR$$F$Y$$$20240702$$HP$US$US
240425541$24042554$1$I$$20240409$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00577$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240425551$24042555$1$I$$20240408$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00583$INTRA-CELLULAR THERAPIES$$40$YR$$M$Y$$$20240702$$MD$US$US
240425561$24042556$1$I$$20240409$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00584$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425571$24042557$1$I$$20240409$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00585$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425581$24042558$1$I$$20240408$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00586$INTRA-CELLULAR THERAPIES$$3$DEC$$F$Y$$$20240702$$HP$US$US
240425591$24042559$1$I$$20240408$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00587$INTRA-CELLULAR THERAPIES$$4$DEC$$F$Y$$$20240702$$HP$US$US
240425601$24042560$1$I$20240101$20240412$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00614$INTRA-CELLULAR THERAPIES$$$$$F$Y$48.98$KG$20240702$$CN$US$US
240425611$24042561$1$I$20240201$20240412$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00615$INTRA-CELLULAR THERAPIES$$51$YR$$F$Y$$$20240702$$HP$US$US
240425621$24042562$1$I$$20240411$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00608$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$MD$US$US
240425631$24042563$1$I$$20240408$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00588$INTRA-CELLULAR THERAPIES$$6$DEC$$F$Y$$$20240702$$HP$US$US
240425641$24042564$1$I$$20240410$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00592$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$MD$US$US
240425651$24042565$1$I$$20240409$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00594$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425661$24042566$1$I$$20240410$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00595$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$MD$US$US
240425671$24042567$1$I$$20240410$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00596$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240425681$24042568$1$I$$20240410$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00601$INTRA-CELLULAR THERAPIES$$6$DEC$$M$Y$$$20240702$$MD$US$US
240425691$24042569$1$I$$20240411$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00604$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240425701$24042570$1$I$20240101$20240411$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00606$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$MD$US$US
240425711$24042571$1$I$$20240411$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00607$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$MD$US$US
240425721$24042572$1$I$$20240417$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00637$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$MD$US$US
240425731$24042573$1$I$$20240416$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00638$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240425741$24042574$1$I$$20240417$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00639$INTRA-CELLULAR THERAPIES$$55$YR$$M$Y$$$20240702$$HP$US$US
240425751$24042575$1$I$20240101$20240412$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00621$INTRA-CELLULAR THERAPIES$$7$DEC$$F$Y$$$20240702$$HP$US$US
240425761$24042576$1$I$$20240416$20240702$20240702$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00624$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240425771$24042577$1$I$$20240416$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00630$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240425781$24042578$1$I$$20240416$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00634$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425791$24042579$1$I$20240101$20240417$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00640$INTRA-CELLULAR THERAPIES$$5$DEC$$F$Y$$$20240702$$MD$US$US
240425801$24042580$1$I$$20240417$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00641$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425811$24042581$1$I$$20240417$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00642$INTRA-CELLULAR THERAPIES$$37$YR$$F$Y$$$20240702$$HP$US$US
240425821$24042582$1$I$$20240416$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00643$INTRA-CELLULAR THERAPIES$$60$YR$$F$Y$$$20240702$$HP$US$US
240425831$24042583$1$I$$20240418$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00649$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240425841$24042584$1$I$$20240417$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00650$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240425851$24042585$1$I$20240101$20240422$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00655$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$CN$US$US
240425861$24042586$1$I$$20240421$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00659$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$CN$US$US
240425871$24042587$1$I$$20240419$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00662$INTRA-CELLULAR THERAPIES$$19$YR$$F$Y$$$20240702$$MD$US$US
240425891$24042589$1$I$$20240606$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00974$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240425901$24042590$1$I$$20240611$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00990$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240425911$24042591$1$I$$20240618$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01025$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425921$24042592$1$I$$20240611$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00981$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$PH$US$US
240425931$24042593$1$I$$20240611$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00983$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425941$24042594$1$I$$20240611$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00985$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240425951$24042595$1$I$$20240613$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01001$INTRA-CELLULAR THERAPIES$$35$YR$$M$Y$$$20240702$$HP$US$US
240425961$24042596$1$I$20240101$20240617$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01022$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240425971$24042597$1$I$$20240613$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01004$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425981$24042598$1$I$$20240606$20240702$20240702$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00963$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240425991$24042599$1$I$$20240611$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00987$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240426001$24042600$1$I$20240101$20240417$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00629$INTRA-CELLULAR THERAPIES$$$$$M$Y$96.599$KG$20240702$$CN$US$US
240426011$24042601$1$I$$20240613$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01006$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426021$24042602$1$I$$20240610$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00978$INTRA-CELLULAR THERAPIES$$38$YR$$M$Y$$$20240702$$HP$US$US
240426031$24042603$1$I$$20240618$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01024$INTRA-CELLULAR THERAPIES$$4$DEC$$F$Y$$$20240702$$HP$US$US
240426051$24042605$1$I$$20240611$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00979$INTRA-CELLULAR THERAPIES$$$$$M$Y$78.471$KG$20240702$$CN$US$US
240426061$24042606$1$I$20240601$20240612$20240702$20240702$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00988$INTRA-CELLULAR THERAPIES$$5$DEC$$M$Y$$$20240702$$MD$US$US
240426071$24042607$1$I$20240101$20240612$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00989$INTRA-CELLULAR THERAPIES$$28$YR$$F$Y$$$20240702$$HP$US$US
240426081$24042608$1$I$20240501$20240612$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00991$INTRA-CELLULAR THERAPIES$$36$YR$$F$Y$68.027$KG$20240702$$CN$US$US
240426101$24042610$1$I$20240101$20240610$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00961$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$CN$US$US
240426111$24042611$1$I$$20240613$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00994$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$MD$US$US
240426121$24042612$1$I$$20240606$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00970$INTRA-CELLULAR THERAPIES$$5$DEC$$F$Y$$$20240702$$HP$US$US
240426131$24042613$1$I$$20240613$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01007$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426141$24042614$1$I$$20240611$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00984$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$MD$US$US
240426151$24042615$1$I$20240501$20240606$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00960$INTRA-CELLULAR THERAPIES$$21$YR$$F$Y$$$20240702$$HP$US$US
240426161$24042616$1$I$$20240607$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00973$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240426171$24042617$1$I$$20240611$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00986$INTRA-CELLULAR THERAPIES$$67$YR$$F$Y$$$20240702$$MD$US$US
240426181$24042618$1$I$20240601$20240617$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01019$INTRA-CELLULAR THERAPIES$$27$YR$$F$Y$$$20240702$$HP$US$US
240426191$24042619$1$I$20220101$20240614$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01010$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$CN$US$US
240426201$24042620$1$I$$20240614$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01012$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426211$24042621$1$I$$20240510$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00801$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$MD$US$US
240426221$24042622$1$I$$20240507$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00803$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240426231$24042623$1$I$20240301$20240425$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00711$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426241$24042624$1$I$$20240506$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00791$INTRA-CELLULAR THERAPIES$$25$YR$$M$Y$$$20240702$$HP$US$US
240426251$24042625$1$I$$20240507$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00774$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240426261$24042626$1$I$$20240509$20240702$20240702$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00808$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240426271$24042627$1$I$20240101$20240607$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00966$INTRA-CELLULAR THERAPIES$$34$YR$$F$Y$90.703$KG$20240702$$CN$US$US
240426281$24042628$1$I$20240101$20240610$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00968$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240426291$24042629$1$I$$20240606$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00969$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426301$24042630$1$I$$20240613$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01003$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426321$24042632$1$I$$20240507$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00787$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426331$24042633$1$I$$20240509$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00789$INTRA-CELLULAR THERAPIES$$72$YR$$F$Y$$$20240702$$HP$US$US
240426341$24042634$1$I$$20240510$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00793$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426351$24042635$1$I$$20240514$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00832$INTRA-CELLULAR THERAPIES$$40$YR$$F$Y$$$20240702$$HP$US$US
240426361$24042636$1$I$20240501$20240515$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00835$INTRA-CELLULAR THERAPIES$$27$YR$$F$Y$$$20240702$$HP$US$US
240426371$24042637$1$I$$20240515$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00837$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240426381$24042638$1$I$$20240515$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00838$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240426391$24042639$1$I$20240516$20240516$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00848$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$CN$US$US
240426401$24042640$1$I$20240401$20240422$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00669$INTRA-CELLULAR THERAPIES$$33$YR$$F$Y$$$20240702$$HP$US$US
240426411$24042641$1$I$$20240508$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00775$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240426421$24042642$1$I$$20240423$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00671$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426431$24042643$1$I$$20240520$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00856$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$CN$US$US
240426441$24042644$1$I$20240501$20240520$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00858$INTRA-CELLULAR THERAPIES$$33$YR$$F$Y$$$20240702$$CN$US$US
240426451$24042645$1$I$$20240516$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00855$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$MD$US$US
240426461$24042646$1$I$$20240515$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00836$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$MD$US$US
240426471$24042647$1$I$20240101$20240503$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00762$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240426491$24042649$1$I$$20240509$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00783$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240426501$24042650$1$I$20240101$20240508$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00786$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$MD$US$US
240426511$24042651$1$I$$20240516$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00860$INTRA-CELLULAR THERAPIES$$65$YR$$M$Y$$$20240702$$MD$US$US
240426521$24042652$1$I$$20240430$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00737$INTRA-CELLULAR THERAPIES$$56$YR$$F$Y$$$20240702$$HP$US$US
240426531$24042653$1$I$$20240502$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00741$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240426541$24042654$1$I$20240101$20240517$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00861$INTRA-CELLULAR THERAPIES$$21$YR$$F$Y$78.458$KG$20240702$$HP$US$US
240426551$24042655$1$I$$20240520$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00862$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426561$24042656$1$I$$20240424$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00705$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426571$24042657$1$I$20240101$20240425$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00713$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240426581$24042658$1$I$20240401$20240425$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00699$INTRA-CELLULAR THERAPIES$$32$YR$$F$Y$$$20240702$$HP$US$US
240426591$24042659$1$I$$20240422$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00698$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$PH$US$US
240426601$24042660$1$I$$20240516$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00859$INTRA-CELLULAR THERAPIES$$6$DEC$$F$Y$$$20240702$$HP$US$US
240426611$24042661$1$I$$20240510$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00826$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240426621$24042662$1$I$$20240423$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00686$INTRA-CELLULAR THERAPIES$$37$YR$$F$Y$$$20240702$$HP$US$US
240426631$24042663$1$I$$20240423$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00683$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240426641$24042664$1$I$$20240424$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00688$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240426651$24042665$1$I$20240101$20240521$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00865$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$CN$US$US
240426661$24042666$1$I$$20240521$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00866$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240426671$24042667$1$I$20230713$20240424$20240702$20240702$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00692$INTRA-CELLULAR THERAPIES$$23$YR$$F$Y$$$20240702$$HP$US$US
240426681$24042668$1$I$$20240422$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00667$INTRA-CELLULAR THERAPIES$$3$DEC$$F$Y$$$20240702$$HP$US$US
240426691$24042669$1$I$$20240423$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00670$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$MD$US$US
240426701$24042670$1$I$20240521$20240521$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00867$INTRA-CELLULAR THERAPIES$$35$YR$$F$Y$84.368$KG$20240702$$CN$US$US
240426711$24042671$1$I$$20240514$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00843$INTRA-CELLULAR THERAPIES$$5$DEC$$F$Y$$$20240702$$HP$US$US
240426721$24042672$1$I$$20240422$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00668$INTRA-CELLULAR THERAPIES$$4$DEC$$F$Y$$$20240702$$HP$US$US
240426731$24042673$1$I$$20240423$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00665$INTRA-CELLULAR THERAPIES$$37$YR$$F$Y$$$20240702$$CN$US$US
240426741$24042674$1$I$$20240423$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00672$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$MD$US$US
240426751$24042675$1$I$$20240501$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00739$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240426761$24042676$1$I$$20240430$20240702$20240702$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00734$INTRA-CELLULAR THERAPIES$$5$DEC$$F$Y$$$20240702$$HP$US$US
240426771$24042677$1$I$$20240513$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00824$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240426781$24042678$1$I$20240401$20240430$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00735$INTRA-CELLULAR THERAPIES$$3$DEC$$F$Y$$$20240702$$HP$US$US
240426791$24042679$1$I$20240503$20240513$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00830$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426801$24042680$1$I$20240501$20240514$20240702$20240702$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00831$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240426811$24042681$1$I$$20240505$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00771$INTRA-CELLULAR THERAPIES$$40$YR$$F$Y$$$20240702$$HP$US$US
240426821$24042682$1$I$$20240505$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00770$INTRA-CELLULAR THERAPIES$$34$YR$$M$Y$$$20240702$$HP$US$US
240426831$24042683$1$I$20240101$20240503$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00777$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$MD$US$US
240426841$24042684$1$I$$20240505$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00778$INTRA-CELLULAR THERAPIES$$80$YR$$F$Y$$$20240702$$MD$US$US
240426851$24042685$1$I$$20240506$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00779$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240426861$24042686$1$I$20240401$20240426$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00714$INTRA-CELLULAR THERAPIES$$20$YR$$M$Y$76.644$KG$20240702$$HP$US$US
240426871$24042687$1$I$$20240423$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00694$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240426891$24042689$1$I$20240201$20240514$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00842$INTRA-CELLULAR THERAPIES$$51$YR$$F$Y$97.37$KG$20240702$$HP$US$US
240426903$24042690$3$F$20240501$20240826$20240702$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104577$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240902$$CN$US$US
240426911$24042691$1$I$20240101$20240628$20240702$20240702$EXP$$US-ABBVIE-5821874$ABBVIE$$69$YR$$M$Y$$$20240702$$CN$US$US
240426922$24042692$2$F$20231211$20240709$20240702$20240718$EXP$$NVSC2024IL134569$NOVARTIS$$$$$$Y$$$20240718$$MD$IL$IL
240426943$24042694$3$F$20240617$20240911$20240702$20240912$30DAY$$CL-PFIZER INC-PV202400080848$PFIZER$$9$YR$$F$Y$$$20240912$$CN$CL$CL
240426958$24042695$8$F$20240101$20240921$20240702$20240926$30DAY$$US-PFIZER INC-202400201868$PFIZER$$12$YR$$M$Y$$$20240926$$MD$US$US
240426973$24042697$3$F$$20240823$20240702$20240828$30DAY$$US-PFIZER INC-202400197045$PFIZER$$12$YR$$F$Y$31.75$KG$20240828$$CN$US$US
240426981$24042698$1$I$$20240627$20240702$20240702$30DAY$$FR-PFIZER INC-PV202400084868$PFIZER$$4$YR$$$Y$$$20240702$$MD$FR$FR
240426991$24042699$1$I$$20240627$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103441$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240702$$CN$US$US
240427001$24042700$1$I$$20240702$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105797$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240702$$HP$US$US
240427011$24042701$1$I$$20240529$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00913$INTRA-CELLULAR THERAPIES$$55$YR$$M$Y$$$20240702$$MD$US$US
240427021$24042702$1$I$$20240528$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00920$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240427031$24042703$1$I$$20240425$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00707$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$MD$US$US
240427041$24042704$1$I$$20240604$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00946$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240427051$24042705$1$I$$20240528$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00903$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240427061$24042706$1$I$$20240605$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00952$INTRA-CELLULAR THERAPIES$$72$YR$$M$Y$$$20240702$$HP$US$US
240427071$24042707$1$I$$20240605$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00951$INTRA-CELLULAR THERAPIES$$48$YR$$M$Y$$$20240702$$MD$US$US
240427081$24042708$1$I$$20240605$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00939$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$CN$US$US
240427091$24042709$1$I$$20240510$20240702$20240702$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00811$INTRA-CELLULAR THERAPIES$$50$YR$$M$Y$$$20240702$$MD$US$US
240427101$24042710$1$I$20240101$20240523$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00896$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240427111$24042711$1$I$$20240530$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00925$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240427121$24042712$1$I$20240101$20240604$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00937$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$CN$US$US
240427131$24042713$1$I$$20240506$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00792$INTRA-CELLULAR THERAPIES$$6$DEC$$F$Y$$$20240702$$HP$US$US
240427141$24042714$1$I$20240101$20240423$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00696$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$MD$US$US
240427151$24042715$1$I$$20240506$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00790$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$MD$US$US
240427161$24042716$1$I$$20240509$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00816$INTRA-CELLULAR THERAPIES$$4$DEC$$F$Y$$$20240702$$MD$US$US
240427171$24042717$1$I$$20240514$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00844$INTRA-CELLULAR THERAPIES$$7$DEC$$F$Y$$$20240702$$HP$US$US
240427181$24042718$1$I$$20240510$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00812$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240427191$24042719$1$I$$20240513$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00845$INTRA-CELLULAR THERAPIES$$30$YR$$F$Y$$$20240702$$HP$US$US
240427201$24042720$1$I$$20240513$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00846$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240427211$24042721$1$I$$20240514$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00847$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$MD$US$US
240427221$24042722$1$I$$20240528$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00906$INTRA-CELLULAR THERAPIES$$32$YR$$F$Y$$$20240702$$HP$US$US
240427231$24042723$1$I$$20240506$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00773$INTRA-CELLULAR THERAPIES$$50$YR$$F$Y$$$20240702$$HP$US$US
240427241$24042724$1$I$20240526$20240527$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00904$INTRA-CELLULAR THERAPIES$$36$YR$$F$Y$$$20240702$$MD$US$US
240427251$24042725$1$I$$20240422$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00690$INTRA-CELLULAR THERAPIES$$38$YR$$F$Y$$$20240702$$HP$US$US
240427261$24042726$1$I$$20240516$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00852$INTRA-CELLULAR THERAPIES$$78$YR$$F$Y$$$20240702$$HP$US$US
240427271$24042727$1$I$$20240422$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00664$INTRA-CELLULAR THERAPIES$$60$YR$$F$Y$$$20240702$$MD$US$US
240427281$24042728$1$I$$20240529$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00914$INTRA-CELLULAR THERAPIES$$52$YR$$F$Y$$$20240702$$MD$US$US
240427291$24042729$1$I$$20240531$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00928$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240427301$24042730$1$I$$20240522$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00886$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240427311$24042731$1$I$$20240530$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00922$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$MD$US$US
240427321$24042732$1$I$$20240505$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00768$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$MD$US$US
240427331$24042733$1$I$$20240507$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00806$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240427341$24042734$1$I$$20240523$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00889$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240427351$24042735$1$I$$20240530$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00917$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240427361$24042736$1$I$20240101$20240530$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00918$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240427371$24042737$1$I$20240527$20240529$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00912$INTRA-CELLULAR THERAPIES$$25$YR$$F$Y$72.562$KG$20240702$$HP$US$US
240427381$24042738$1$I$$20240524$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00901$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240427391$24042739$1$I$$20240530$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00923$INTRA-CELLULAR THERAPIES$$57$YR$$M$Y$$$20240702$$HP$US$US
240427401$24042740$1$I$$20240523$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00897$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240427411$24042741$1$I$$20240524$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00900$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240427421$24042742$1$I$20240101$20240516$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00872$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$MD$US$US
240427431$24042743$1$I$$20240522$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00877$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240427441$24042744$1$I$$20240522$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00878$INTRA-CELLULAR THERAPIES$$7$DEC$$F$Y$$$20240702$$MD$US$US
240427451$24042745$1$I$20240101$20240523$20240702$20240702$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00882$INTRA-CELLULAR THERAPIES$$5$DEC$$F$Y$$$20240702$$HP$US$US
240427461$24042746$1$I$20240101$20240523$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00884$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$CN$US$US
240427471$24042747$1$I$20230101$20240424$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00695$INTRA-CELLULAR THERAPIES$$3$DEC$$F$Y$$$20240702$$MD$US$US
240427481$24042748$1$I$$20240516$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00853$INTRA-CELLULAR THERAPIES$$41$YR$$F$Y$$$20240702$$HP$US$US
240427491$24042749$1$I$$20240507$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00804$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240427501$24042750$1$I$$20240507$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00805$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240427511$24042751$1$I$20240501$20240531$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00931$INTRA-CELLULAR THERAPIES$$33$YR$$F$Y$$$20240702$$HP$US$US
240427521$24042752$1$I$$20240530$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00926$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240427531$24042753$1$I$$20240528$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00910$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240427541$24042754$1$I$$20240524$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00898$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$HP$US$US
240427551$24042755$1$I$20240501$20240529$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00916$INTRA-CELLULAR THERAPIES$$50$YR$$F$Y$$$20240702$$CN$US$US
240427571$24042757$1$I$20240509$20240617$20240702$20240702$EXP$$CN-EAGLE PHARMACEUTICALS, INC.-CN-2024EAG000168$EAGLE$$52$YR$$M$Y$$$20240702$$HP$CN$CN
240427583$24042758$3$F$20240401$20240709$20240702$20240720$EXP$$NVSC2024CO101941$NOVARTIS$$69$YR$$F$Y$44$KG$20240719$$CN$CO$CO
240427591$24042759$1$I$$20240701$20240702$20240702$EXP$$US-KYOWAKIRIN-2024KK015984$KYOWA$$$$$$Y$$$20240702$$HP$US$US
240427601$24042760$1$I$20240612$20240624$20240702$20240702$EXP$$CN-AstraZeneca-2024A147649$ASTRAZENECA$$64$YR$$F$Y$55$KG$20240702$$MD$CN$
240427611$24042761$1$I$$20240701$20240702$20240702$PER$$US-PFIZER INC-202400204649$PFIZER$$$$$$Y$$$20240702$$CN$US$US
240427621$24042762$1$I$$20240701$20240702$20240702$PER$$US-PFIZER INC-202400204584$PFIZER$$49$YR$$F$Y$$$20240702$$PH$US$US
240427632$24042763$2$F$20240629$20240701$20240702$20240704$PER$$US-PFIZER INC-202400204312$PFIZER$$79$YR$$M$Y$95.25$KG$20240704$$CN$US$US
240427641$24042764$1$I$$20240701$20240702$20240702$PER$$US-PFIZER INC-202400204398$PFIZER$$67$YR$$F$Y$$$20240702$$CN$US$US
240427651$24042765$1$I$$20240701$20240702$20240702$PER$$US-PFIZER INC-202400204551$PFIZER$$77$YR$$M$Y$$$20240702$$HP$US$US
240427661$24042766$1$I$$20240701$20240702$20240702$PER$$US-PFIZER INC-202400204923$PFIZER$$52$YR$$F$Y$$$20240702$$HP$US$US
240427691$24042769$1$I$$20240701$20240702$20240702$PER$$US-PFIZER INC-202400204406$PFIZER$$$$$$Y$$$20240702$$MD$US$US
240427703$24042770$3$F$$20240822$20240702$20240822$PER$$US-PFIZER INC-PV202400085997$PFIZER$$87$YR$$F$Y$$$20240822$$CN$US$US
240427711$24042771$1$I$$20240701$20240702$20240702$PER$$US-PFIZER INC-202400204550$PFIZER$$77$YR$$M$Y$$$20240702$$HP$US$US
240427722$24042772$2$F$20240511$20240913$20240702$20240917$PER$$IN-PFIZER INC-202400204430$PFIZER$$59$YR$$M$Y$$$20240917$$CN$IN$US
240427734$24042773$4$F$$20240801$20240702$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-097627$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240808$$PH$JP$JP
240427751$24042775$1$I$$20240627$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103729$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240702$$HP$US$US
240427761$24042776$1$I$20240101$20240523$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00891$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240427771$24042777$1$I$$20240604$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00945$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240427781$24042778$1$I$$20240528$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00907$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240427791$24042779$1$I$$20240528$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00908$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240427811$24042781$1$I$$20240521$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00871$INTRA-CELLULAR THERAPIES$$57$YR$$M$Y$$$20240702$$HP$US$US
240427821$24042782$1$I$20240101$20240514$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00834$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240427831$24042783$1$I$$20240520$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00863$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$MD$US$US
240427841$24042784$1$I$20240420$20240426$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00715$INTRA-CELLULAR THERAPIES$$50$YR$$M$Y$$$20240702$$HP$US$US
240427851$24042785$1$I$$20240520$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00868$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240427861$24042786$1$I$20240415$20240430$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00722$INTRA-CELLULAR THERAPIES$$23$YR$$M$Y$$$20240702$$CN$US$US
240427871$24042787$1$I$$20240515$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00849$INTRA-CELLULAR THERAPIES$$25$YR$$F$Y$$$20240702$$HP$US$US
240427881$24042788$1$I$$20240522$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00890$INTRA-CELLULAR THERAPIES$$21$YR$$F$Y$$$20240702$$HP$US$US
240427891$24042789$1$I$$20240430$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00718$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$MD$US$US
240427901$24042790$1$I$20240401$20240501$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00725$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$CN$US$US
240427911$24042791$1$I$$20240501$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00727$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$CN$US$US
240427921$24042792$1$I$$20240501$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00728$INTRA-CELLULAR THERAPIES$$40$YR$$M$Y$$$20240702$$HP$US$US
240427931$24042793$1$I$20240501$20240502$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00746$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$CN$US$US
240427941$24042794$1$I$$20240528$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00905$INTRA-CELLULAR THERAPIES$$6$DEC$$F$Y$$$20240702$$HP$US$US
240427951$24042795$1$I$$20240528$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00911$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240702$$MD$US$US
240427961$24042796$1$I$$20240529$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00919$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$HP$US$US
240427971$24042797$1$I$$20240429$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00721$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$MD$US$US
240427981$24042798$1$I$$20240430$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00738$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240427991$24042799$1$I$$20240502$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00755$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240702$$HP$US$US
240428001$24042800$1$I$$20240520$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00869$INTRA-CELLULAR THERAPIES$$70$YR$$F$Y$$$20240702$$HP$US$US
240428011$24042801$1$I$$20240522$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00879$INTRA-CELLULAR THERAPIES$$51$YR$$M$Y$$$20240702$$HP$US$US
240428021$24042802$1$I$$20240501$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00754$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240428031$24042803$1$I$20240401$20240430$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00733$INTRA-CELLULAR THERAPIES$$49$YR$$F$Y$$$20240702$$HP$US$US
240428041$24042804$1$I$$20240507$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00766$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240428051$24042805$1$I$$20240509$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00788$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240428061$24042806$1$I$$20240510$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00800$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240702$$HP$US$US
240428071$24042807$1$I$20240501$20240606$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00949$INTRA-CELLULAR THERAPIES$$50$YR$$F$Y$$$20240702$$HP$US$US
240428081$24042808$1$I$$20240606$20240702$20240702$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00955$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240428091$24042809$1$I$$20240507$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00807$INTRA-CELLULAR THERAPIES$$3$DEC$$F$Y$$$20240702$$HP$US$US
240428101$24042810$1$I$20240101$20240501$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00753$INTRA-CELLULAR THERAPIES$$5$DEC$$M$Y$$$20240702$$HP$US$US
240428111$24042811$1$I$$20240422$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00666$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240428121$24042812$1$I$$20240510$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00799$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$MD$US$US
240428131$24042813$1$I$$20240509$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00802$INTRA-CELLULAR THERAPIES$$5$DEC$$M$Y$$$20240702$$HP$US$US
240428141$24042814$1$I$$20240523$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00888$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240428151$24042815$1$I$$20240506$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00764$INTRA-CELLULAR THERAPIES$$47$YR$$F$Y$$$20240702$$MD$US$US
240428161$24042816$1$I$$20240507$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00767$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240428171$24042817$1$I$$20240522$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00899$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240702$$MD$US$US
240428181$24042818$1$I$$20240627$20240702$20240702$EXP$$CA-ABBVIE-5820163$ABBVIE$$$$E$F$Y$$$20240702$$CN$CA$CA
240428191$24042819$1$I$$20230707$20240702$20240702$PER$$US-AMGEN-USASP2023235404$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240428201$24042820$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137289$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240428211$24042821$1$I$$20240625$20240702$20240702$PER$$NVSC2024US133387$NOVARTIS$$$$$$Y$$$20240702$$CN$US$US
240428221$24042822$1$I$$20240626$20240702$20240702$EXP$FR-AFSSAPS-AVNT2024000470$FR-MYLANLABS-2024M1058389$MYLAN$$47$YR$$F$Y$$$20240702$$MD$FR$FR
240428231$24042823$1$I$20240601$20240626$20240702$20240702$EXP$FR-AFSSAPS-TS2024000708$FR-MYLANLABS-2024M1058335$MYLAN$$40$YR$$M$Y$62$KG$20240702$$MD$FR$FR
240428242$24042824$2$F$20240612$20240918$20240702$20240924$EXP$FR-AFSSAPS-LL2024001174$FR-MYLANLABS-2024M1058315$MYLAN$$50$YR$$M$Y$79.4$KG$20240924$$MD$FR$FR
240428261$24042826$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821853$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240428271$24042827$1$I$20240301$20240626$20240702$20240702$EXP$FR-AFSSAPS-AVMP2024000183$FR-MYLANLABS-2024M1058312$MYLAN$$16$YR$$M$Y$$$20240702$$MD$FR$FR
240428281$24042828$1$I$20240601$20240621$20240702$20240702$EXP$$JP-EAGLE PHARMACEUTICALS, INC.-JP-2024EAG000169$EAGLE$$$$E$F$Y$$$20240702$$MD$JP$JP
240428291$24042829$1$I$20240605$20240619$20240702$20240702$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-12514$IPSEN$$59$YR$A$M$Y$83$KG$20240702$$CN$US$US
240428303$24042830$3$F$20240602$20240617$20240702$20240716$PER$$US-TRAVERE-2024TVT00574$TRAVERE THERAPEUTICS$$38$YR$A$F$Y$$$20240716$$CN$US$US
240428311$24042831$1$I$20230101$20240701$20240702$20240702$PER$$US-PURDUE PHARMA-USA-2024-0310539$PURDUE$$$$$F$Y$$$20240702$$CN$US$US
240428321$24042832$1$I$$20240630$20240702$20240702$PER$$US-PURDUE PHARMA-USA-2024-0310545$PURDUE$$$$$M$Y$$$20240702$$CN$US$US
240428331$24042833$1$I$20240601$20240701$20240702$20240702$PER$$US-PURDUE PHARMA-USA-2024-0310525$PURDUE$$$$$F$Y$$$20240702$$CN$US$US
240428341$24042834$1$I$20240509$20240628$20240702$20240702$EXP$GB-MHRA-MIDB-41044ecb-1347-4981-ac26-69141f820ea3$GB-MYLANLABS-2024M1061522$MYLAN$$59$YR$$F$Y$$$20240702$$HP$GB$GB
240428352$24042835$2$F$20240624$20240628$20240702$20240708$EXP$$US-MYLANLABS-2024M1061710$MYLAN$$70$YR$$F$Y$$$20240708$$HP$US$US
240428361$24042836$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281444339100-ZPDRB$GB-MYLANLABS-2024M1061748$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240428371$24042837$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281422291500-CTQJK$GB-MYLANLABS-2024M1061738$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240428381$24042838$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MED-202406281504408720-TKDCS$GB-MYLANLABS-2024M1061581$MYLAN$$$$$$Y$$$20240702$$CN$GB$GB
240428391$24042839$1$I$$20240701$20240702$20240702$EXP$$NP-PFIZER INC-PV202400086060$PFIZER$$57$YR$$M$Y$$$20240702$$MD$NP$NP
240428402$24042840$2$F$20240101$20240707$20240702$20240708$EXP$$US-PFIZER INC-PV202400086463$PFIZER$$40$YR$$F$Y$$$20240708$$HP$US$US
240428411$24042841$1$I$$20240701$20240702$20240702$EXP$$NP-PFIZER INC-PV202400086070$PFIZER$$54$YR$$M$Y$$$20240702$$MD$NP$NP
240428421$24042842$1$I$$20240620$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406014708$ELI LILLY AND CO$$48$YR$A$$Y$$$20240702$$LW$US$US
240428431$24042843$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000387$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240702$$CN$US$US
240428442$24042844$2$F$$20240613$20240702$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105550$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240705$$CN$US$US
240428452$24042845$2$F$$20240729$20240702$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105009$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240731$$CN$US$US
240428462$24042846$2$F$$20240627$20240702$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105806$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240711$$HP$US$US
240428472$24042847$2$F$$20240819$20240702$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105737$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240820$$HP$US$US
240428481$24042848$1$I$$20240622$20240702$20240702$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-101695$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240702$$MD$IT$IT
240428491$24042849$1$I$20240501$20240628$20240702$20240702$EXP$$US-ABBVIE-5822324$ABBVIE$$75$YR$$F$Y$$$20240702$$HP$US$US
240428501$24042850$1$I$$20240624$20240702$20240702$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010130$JAZZ$$62$YR$$M$Y$$$20240702$$MD$JP$JP
240428511$24042851$1$I$20240101$20240629$20240702$20240702$EXP$$ZA-ABBVIE-5822687$ABBVIE$$$$$F$Y$$$20240702$$MD$ZA$ZA
240428521$24042852$1$I$20240625$20240628$20240702$20240702$PER$$US-JNJFOC-20240677498$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240702$$HP$US$US
240428531$24042853$1$I$$20240624$20240702$20240702$EXP$$BR-AstraZeneca-2024A148144$ASTRAZENECA$$51$YR$$F$Y$$$20240702$$MD$BR$
240428541$24042854$1$I$20240312$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105449$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$65.77$KG$20240702$$CN$US$US
240428551$24042855$1$I$$20230707$20240702$20240702$PER$$US-AMGEN-USASP2023235406$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240428581$24042858$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3214383$TEVA$$16$YR$$M$Y$75$KG$20240702$$HP$CA$CA
240428593$24042859$3$F$20240101$20240911$20240702$20240918$PER$$US-ABBVIE-5817818$ABBVIE$$$$$F$Y$56$KG$20240918$$CN$US$US
240428612$24042861$2$F$20240101$20240702$20240702$20240706$PER$$US-JNJFOC-20240701934$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240706$$HP$US$US
240428621$24042862$1$I$$20240621$20240702$20240702$PER$$US-JNJFOC-20240700943$JOHNSON AND JOHNSON$$$$$M$Y$$$20240702$$PH$US$US
240428631$24042863$1$I$$20240624$20240702$20240702$EXP$$CA-TEVA-VS-3214021$TEVA$$43$YR$$F$Y$$$20240702$$HP$CA$CA
240428654$24042865$4$F$$20240726$20240702$20240805$EXP$$FI-MYLANLABS-2024M1061246$MYLAN$Helin H, Huovinen S, Uusitalo T. Autoimmune myopathy is a rare muscle disease associated with statin therapy. Local Literature Review finding-Duodecim. 2024;140(13-14):1143-1147$60$YR$$M$Y$$$20240805$$MD$FI$FI
240428661$24042866$1$I$$20240626$20240702$20240702$EXP$$DE-MYLANLABS-2024M1058636$MYLAN$Bonnet U, Kanti AK, Scherbaum N, Specka M.. The role of gabapentinoids in the substance use pattern of adult germans seeking inpatient detoxification treatment- A Pilot Study. Journal of Psychoactive Drugs. 2023;55(1):102-11$34$YR$$M$Y$$$20240702$$HP$DE$DE
240428671$24042867$1$I$20240524$20240625$20240702$20240702$EXP$$GB-009507513-2407GBR000350$MERCK$$$$$M$Y$$$20240702$$MD$GB$GB
240428681$24042868$1$I$20230221$20240701$20240702$20240702$EXP$$DE-SANDOZ INC.-NVSC2023DE110605$SANDOZ$$55$YR$$F$Y$$$20240702$$MD$DE$DE
240428701$24042870$1$I$$20240630$20240702$20240702$EXP$$US-SANDOZ INC.-SDZ2024US062171$SANDOZ$$$$$$Y$$$20240702$$CN$US$US
240428711$24042871$1$I$$20240630$20240702$20240702$EXP$$IL-SANDOZ INC.-SDZ2024IL062128$SANDOZ$$51$YR$$$Y$$$20240702$$MD$IL$IL
240428723$24042872$3$F$20240614$20240819$20240702$20240820$EXP$$AU-SANDOZ INC.-SDZ2023AU051122$SANDOZ$$54$YR$$F$Y$58.3$KG$20240820$$MD$AU$AU
240428731$24042873$1$I$20231101$20240701$20240702$20240702$EXP$$DE-SANDOZ INC.-SDZ2024DE061907$SANDOZ$$$$$M$Y$2.59$KG$20240702$$MD$DE$DE
240428744$24042874$4$F$$20240730$20240702$20240801$EXP$$IT-SANDOZ INC.-SDZ2024IT062125$SANDOZ$$35$YR$$F$Y$$$20240801$$MD$IT$IT
240428752$24042875$2$F$20240118$20240710$20240702$20240711$EXP$FR-AFSSAPS-AVMA2024000256$FR-SANDOZ INC.-SDZ2024FR061956$SANDOZ$$60$YR$$F$Y$$$20240711$$PH$FR$FR
240428761$24042876$1$I$$20240628$20240702$20240702$EXP$$GB-SANDOZ INC.-SDZ2024GB062010$SANDOZ$$$$$F$Y$$$20240702$$HP$GB$GB
240428771$24042877$1$I$$20240701$20240702$20240702$EXP$$GB-SANDOZ INC.-SDZ2024GB062104$SANDOZ$$$$$F$Y$$$20240702$$CN$GB$GB
240428781$24042878$1$I$$20240624$20240702$20240702$EXP$$BR-SANDOZ INC.-SDZ2024BR062150$SANDOZ$$$$$F$Y$$$20240702$$CN$BR$BR
240428791$24042879$1$I$20231222$20240701$20240702$20240702$EXP$$PL-SANDOZ INC.-SDZ2024PL061951$SANDOZ$$74$YR$$M$Y$76$KG$20240702$$MD$PL$PL
240428801$24042880$1$I$20240502$20240701$20240702$20240702$EXP$$DE-SANDOZ INC.-SDZ2024DE048384$SANDOZ$$45$YR$$F$Y$86$KG$20240702$$MD$DE$DE
240428812$24042881$2$F$20240618$20240704$20240702$20240705$EXP$$NL-SANDOZ INC.-SDZ2024NL061940$SANDOZ$$49$YR$$M$Y$130$KG$20240705$$MD$NL$NL
240428821$24042882$1$I$20240227$20240624$20240702$20240702$EXP$$AU-ABBVIE-5822506$ABBVIE$$20$YR$$F$Y$$$20240702$$PH$AU$AU
240428834$24042883$4$F$20240212$20240806$20240702$20240809$EXP$$NP-PFIZER INC-PV202400086056$PFIZER$$62$YR$$F$Y$$$20240809$$MD$NP$NP
240428841$24042884$1$I$$20240624$20240702$20240702$EXP$$CA-SANDOZ INC.-NVSC2022CA147979$SANDOZ$$$$$F$Y$$$20240702$$CN$CA$CA
240428851$24042885$1$I$$20240701$20240702$20240702$EXP$$US-PFIZER INC-202400204377$PFIZER$$64$YR$$F$Y$$$20240702$$CN$US$US
240428861$24042886$1$I$20240218$20240701$20240702$20240702$EXP$$CN-PFIZER INC-PV202400086428$PFIZER$$75$YR$$M$Y$72$KG$20240702$$HP$CN$CN
240428872$24042887$2$F$20240601$20240713$20240702$20240716$EXP$$IT-PFIZER INC-202400203135$PFIZER$$77$YR$$F$Y$60$KG$20240716$$MD$IT$IT
240428881$24042888$1$I$20240609$20240701$20240702$20240702$EXP$$NP-PFIZER INC-PV202400086067$PFIZER$$71$YR$$M$Y$$$20240702$$MD$NP$NP
240428893$24042889$3$F$20240430$20240722$20240702$20240723$EXP$FR-AFSSAPS-AN2024000825$FR-PFIZER INC-202400202151$PFIZER$$77$YR$$M$Y$$$20240723$$PH$FR$FR
240428901$24042890$1$I$20240421$20240701$20240702$20240702$EXP$ES-AEMPS-1540864$ES-PFIZER INC-202400203938$PFIZER$$72$YR$$M$Y$88$KG$20240702$$HP$ES$ES
240428912$24042891$2$F$$20240924$20240702$20240927$EXP$$US-PFIZER INC-PV202400085538$PFIZER$$68$YR$$F$Y$$$20240927$$CN$US$US
240428921$24042892$1$I$$20240701$20240702$20240702$EXP$$CA-PFIZER INC-202400204270$PFIZER$$6$YR$$M$Y$20$KG$20240702$$PH$CA$CA
240428931$24042893$1$I$$20240701$20240702$20240702$EXP$$JP-PFIZER INC-PV202400086432$PFIZER$$$$$F$Y$$$20240702$$MD$JP$JP
240428943$24042894$3$F$$20240814$20240702$20240814$PER$$NVSC2024US137291$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
240428951$24042895$1$I$20240608$20240701$20240702$20240702$EXP$FR-AFSSAPS-RN2024000722$FR-PFIZER INC-202400203873$PFIZER$$45$YR$$M$Y$67$KG$20240702$$MD$FR$FR
240428961$24042896$1$I$$20240701$20240702$20240702$EXP$$NP-PFIZER INC-PV202400086057$PFIZER$$75$YR$$F$Y$$$20240702$$MD$NP$NP
240428971$24042897$1$I$20240626$20240701$20240702$20240702$EXP$$PE-PFIZER INC-PV202400086711$PFIZER$$$$A$F$Y$$$20240702$$CN$PE$PE
240428981$24042898$1$I$$20240701$20240702$20240702$EXP$$CA-PFIZER INC-202400204282$PFIZER$$3$YR$$F$Y$16$KG$20240702$$PH$CA$CA
240428991$24042899$1$I$20240613$20240626$20240702$20240702$EXP$$VN-BAYER-2024A094521$BAYER$$66$YR$E$F$Y$$$20240702$$HP$VN$VN
240429001$24042900$1$I$$20240628$20240702$20240702$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-104890$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240702$$PH$CA$CA
240429011$24042901$1$I$20240606$20240627$20240702$20240702$EXP$FR-AFSSAPS-NC2024000738$FR-009507513-2406FRA010086$MERCK$$75$YR$$F$Y$$$20240702$$MD$FR$FR
240429021$24042902$1$I$$20240626$20240702$20240702$EXP$$US-ASTELLAS-2024US018298$ASTELLAS$$$$$F$Y$$$20240702$$CN$US$US
240429041$24042904$1$I$$20240626$20240702$20240702$EXP$$CO-ASTELLAS-2024US018415$ASTELLAS$$72$YR$$M$Y$$$20240702$$CN$CO$CO
240429051$24042905$1$I$20240616$20240621$20240702$20240702$EXP$$CN-BEH-2024174742$CSL BEHRING$$47$YR$A$F$Y$75$KG$20240702$$CN$CN$CN
240429061$24042906$1$I$20231101$20240625$20240702$20240702$EXP$$US-UNITED THERAPEUTICS-UNT-2023-032328$UNITED THERAPEUTICS$$45$YR$$F$Y$53.968$KG$20240702$$$US$US
240429071$24042907$1$I$$20240617$20240702$20240702$EXP$$US-CMP PHARMA-2024CMP00035$CMP PHARMA$Beesley S, Lanspa M.J. Calcium Channel Overdose and Insulin Therapy Dosing. Am. J. Respir. Crit. Care Med. 2024;209$28$YR$$M$Y$$$20240702$$HP$US$US
240429082$24042908$2$F$$20240912$20240702$20240912$PER$$NVSC2024US137292$NOVARTIS$$$$$F$Y$$$20240912$$MD$US$US
240429091$24042909$1$I$$20240702$20240702$20240702$PER$$NVSC2024US137302$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240429108$24042910$8$F$20231101$20240828$20240702$20240918$EXP$$NVSC2024MX136897$NOVARTIS$$52$YR$$F$Y$75$KG$20240918$$CN$MX$MX
240429111$24042911$1$I$$20240617$20240702$20240702$EXP$$US-CMP PHARMA-2024CMP00037$CMP PHARMA$Sasidharan S, Jatoi T, Milla C, Mallappallil M, Agarwal S, Puri I. Triple Whammy of Amlodipine, Carvedilol and Diphenhydramine Overdose. Am. J. Respir. Crit. Care Med. 2024;209$27$YR$$F$Y$$$20240702$$HP$US$US
240429121$24042912$1$I$$20240617$20240702$20240702$EXP$$US-CMP PHARMA-2024CMP00036$CMP PHARMA$Almazan E.P, Ellaicy O, Carter D.J., Kaleka K, Faruqi M. Another Case of the Blues, Methylene Blue as Adjunctive Therapy in Calcium-channel Blocker Induced Vasoplegia. Am. J. Respir. Crit. Care Med. 2024;209$65$YR$$F$Y$$$20240702$$HP$US$US
240429131$24042913$1$I$$20240627$20240702$20240702$EXP$$US-AstraZeneca-2024A151473$ASTRAZENECA$$$$$F$Y$$$20240702$$CN$US$
240429161$24042916$1$I$20240528$20240620$20240702$20240702$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406015701$ELI LILLY AND CO$$47$YR$A$F$Y$50.7$KG$20240702$$CN$CN$CN
240429172$24042917$2$F$$20240709$20240702$20240718$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014806$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240718$$CN$US$US
240429182$24042918$2$F$20240603$20240719$20240702$20240731$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202406016102$ELI LILLY AND CO$$37$YR$A$F$Y$66.7$KG$20240731$$HP$CA$CA
240429192$24042919$2$F$20240627$20240628$20240702$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000885$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240705$$CN$US$US
240429201$24042920$1$I$$20240627$20240702$20240702$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202406019134$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240702$$CN$AU$AU
240429211$24042921$1$I$20240614$20240621$20240702$20240702$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406019558$ELI LILLY AND CO$$51$YR$A$M$Y$70$KG$20240702$$CN$DE$CN
240429221$24042922$1$I$20240320$20240620$20240702$20240702$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202406014114$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240702$$CN$IT$IT
240429231$24042923$1$I$20240609$20240620$20240702$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014614$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$US$US
240429251$24042925$1$I$$20240620$20240702$20240702$PER$$US-TEVA-VS-3212950$TEVA$$$$E$M$Y$$$20240702$$HP$US$US
240429261$24042926$1$I$$20240626$20240702$20240702$PER$$US-ABBVIE-5819258$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240429271$24042927$1$I$$20240619$20240702$20240702$PER$$US-ALKERMES INC.-ALK-2024-001708$ALKERMES$$$$$F$Y$$$20240702$$HP$US$US
240429281$24042928$1$I$20240401$20240607$20240702$20240702$EXP$$US-009507513-2406USA003152$MERCK$$$$$M$Y$$$20240702$$MD$US$US
240429291$24042929$1$I$20240401$20240627$20240702$20240702$PER$$US-009507513-2406USA010035$MERCK$$$$A$M$Y$$$20240702$$CN$US$US
240429311$24042931$1$I$$20230815$20240702$20240702$PER$$US-AMGEN-USASP2023235395$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240429321$24042932$1$I$$20240621$20240702$20240702$PER$$US-MYLANLABS-2024M1057417$MYLAN$$$$$F$Y$$$20240702$$CN$US$US
240429331$24042933$1$I$$20240624$20240702$20240702$EXP$$US-MYLANLABS-2024M1060814$MYLAN$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant 2023; 23 (7): 1048-1057.$7$DEC$$M$Y$$$20240702$$HP$US$US
240429341$24042934$1$I$$20240627$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104186$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240702$$CN$US$US
240429351$24042935$1$I$$20240627$20240702$20240702$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-105516$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240702$$MD$ES$ES
240429363$24042936$3$F$20240605$20240709$20240702$20240716$EXP$$NVSC2024RU134536$NOVARTIS$$48$YR$$F$Y$53$KG$20240716$$CN$RU$RU
240429371$24042937$1$I$20240618$20240628$20240702$20240702$EXP$$NVSC2024CN137047$NOVARTIS$$81$YR$$F$Y$49$KG$20240702$$HP$CN$CN
240429381$24042938$1$I$20240101$20240624$20240702$20240702$PER$$US-MYLANLABS-2024M1060521$MYLAN$$$$$M$Y$78.47$KG$20240702$$CN$US$US
240429392$24042939$2$F$20230929$20240904$20240702$20240905$EXP$$NVSC2023CA213974$NOVARTIS$$$$A$M$Y$$$20240905$$HP$CA$CA
240429401$24042940$1$I$$20240626$20240702$20240702$EXP$$NVSC2024PL136217$NOVARTIS$Majowicz D, Kostrzewa K, Gromek T, Sokolowska B, Hus M. Haemophagocytic lymphohistiocytosis: case series. Serum ferritin level as an indicator of treatment effectiveness.. HEMATOLOGY IN CLINICAL PRACTICE. 2022;13(3-4):130-7$31$YR$$M$Y$$$20240702$$HP$PL$PL
240429412$24042941$2$F$$20240724$20240702$20240801$PER$$US-ALXN-202406USA001558US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$HP$US$US
240429421$24042942$1$I$$20240606$20240702$20240702$EXP$$US-MYLANLABS-2024M1061670$MYLAN$$$$$F$Y$$$20240702$$MD$US$US
240429431$24042943$1$I$20240618$20240621$20240702$20240702$PER$$US-JNJFOC-20240704441$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240702$$HP$US$US
240429441$24042944$1$I$20211225$20240701$20240702$20240702$EXP$$PL-PFIZER INC-202400204098$PFIZER$$$$$M$Y$62$KG$20240702$$MD$PL$PL
240429452$24042945$2$F$20240613$20240813$20240702$20240820$EXP$FR-AFSSAPS-TO2024001173$FR-ABBVIE-5822476$ABBVIE$$70$YR$$M$Y$61$KG$20240820$$MD$FR$FR
240429461$24042946$1$I$20240414$20240620$20240702$20240702$PER$$US-SA-2024SA187155$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240702$$MD$US$US
240429471$24042947$1$I$$20240625$20240702$20240702$PER$$US-SA-2024SA191965$SANOFI AVENTIS$$$$A$F$Y$$$20240702$$MD$US$US
240429511$24042951$1$I$20240613$20240626$20240702$20240702$EXP$IT-MINISAL02-991854$IT-MYLANLABS-2024M1058516$MYLAN$$57$YR$$F$Y$$$20240702$$PH$IT$IT
240429521$24042952$1$I$20240517$20240626$20240702$20240702$EXP$FR-AFSSAPS-AN2024000798$FR-MYLANLABS-2024M1058599$MYLAN$$69$YR$$F$Y$68$KG$20240702$$PH$FR$FR
240429531$24042953$1$I$20240115$20240626$20240702$20240702$EXP$FR-AFSSAPS-TO2024001144$FR-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2406FR05065$INSUD PHARMA$$24$YR$$F$Y$50$KG$20240702$$PH$FR$FR
240429541$24042954$1$I$20240619$20240625$20240702$20240702$EXP$$US-GSK-US2024079211$GLAXOSMITHKLINE$$$$$$Y$$$20240702$$CN$US$US
240429551$24042955$1$I$20240515$20240627$20240702$20240702$EXP$$US-AMERICAN REGENT INC-2024002100$AMERICAN REGENT$$40$YR$$F$Y$$$20240702$$HP$US$US
240429561$24042956$1$I$20220301$20240626$20240702$20240702$EXP$$BG-MYLANLABS-2024M1060775$MYLAN$$74$YR$$F$Y$$$20240702$$MD$BG$BG
240429571$24042957$1$I$20240617$20240626$20240702$20240702$EXP$ES-AEMPS-1538287$ES-MYLANLABS-2024M1058420$MYLAN$$44$YR$$M$Y$$$20240702$$PH$ES$ES
240429581$24042958$1$I$20240609$20240626$20240702$20240702$EXP$IT-MINISAL02-991717$IT-MYLANLABS-2024M1058513$MYLAN$$40$YR$$F$Y$$$20240702$$MD$IT$IT
240429591$24042959$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-30950847$GB-PURDUE-USA-2024-0310530$PURDUE$$66$YR$$$Y$$$20240702$$PH$GB$GB
240429601$24042960$1$I$$20240628$20240702$20240702$EXP$$GB-PURDUE-USA-2024-0310537$PURDUE$$63$YR$$$Y$$$20240702$$PH$GB$GB
240429611$24042961$1$I$$20240110$20240702$20240702$PER$$US-AMGEN-USASP2024130780$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240429621$24042962$1$I$$20240626$20240702$20240702$EXP$$CA-BAUSCH-BL-2024-009998$BAUSCH AND LOMB$$$$$M$Y$$$20240702$$MD$CA$CA
240429632$24042963$2$F$$20240813$20240702$20240819$EXP$$HU-SANDOZ INC.-SDZ2024HU062080$SANDOZ$$68$YR$$M$Y$$$20240819$$HP$HU$HU
240429641$24042964$1$I$$20240628$20240702$20240702$EXP$$US-SANDOZ INC.-SDZ2024US061900$SANDOZ$$$$$F$Y$$$20240702$$CN$US$US
240429651$24042965$1$I$20151129$20240628$20240702$20240702$EXP$$US-PURDUE PHARMA-USA-2024-0310546$PURDUE$$48$YR$$M$Y$$$20240702$$CN$US$US
240429661$24042966$1$I$20240312$20240701$20240702$20240702$EXP$FR-AFSSAPS-AVMA2024000276$FR-SANDOZ INC.-SDZ2024FR061948$SANDOZ$$26$YR$$M$Y$$$20240702$$PH$FR$FR
240429671$24042967$1$I$20240124$20240626$20240702$20240702$EXP$ES-AEMPS-1538274$ES-MYLANLABS-2024M1058387$MYLAN$$76$YR$$F$Y$$$20240702$$PH$ES$ES
240429681$24042968$1$I$$20240701$20240702$20240702$30DAY$$US-SANDOZ INC.-SDZ2023US008346$SANDOZ$$$$$F$Y$$$20240702$$PH$US$US
240429701$24042970$1$I$20240523$20240626$20240702$20240702$EXP$FR-AFSSAPS-LL2024001177$FR-MYLANLABS-2024M1058263$MYLAN$$46$YR$$M$Y$$$20240702$$MD$FR$FR
240429711$24042971$1$I$$20240605$20240702$20240702$PER$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00962$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240702$$HP$US$US
240429733$24042973$3$F$20240522$20240902$20240702$20240906$EXP$FR-AFSSAPS-LL2024001106$FR-009507513-2406FRA009778$MERCK$$72$YR$$F$Y$80$KG$20240906$$MD$FR$FR
240429742$24042974$2$F$$20240729$20240702$20240731$PER$$NVSC2024US137307$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
240429752$24042975$2$F$$20240715$20240702$20240722$PER$$US-JNJFOC-20240667913$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$CN$US$US
240429762$24042976$2$F$$20240821$20240702$20240821$PER$$NVSC2024US137240$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
240429771$24042977$1$I$20240627$20240627$20240702$20240702$EXP$$DE-INCYTE CORPORATION-2024IN006923$INCYTE$$$$$$Y$$$20240702$$MD$DE$DE
240429791$24042979$1$I$$20240701$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105422$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240702$$HP$US$US
240429801$24042980$1$I$20230401$20240627$20240702$20240702$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-129731$DAIICHI$$$$$F$Y$$$20240702$$CN$US$US
240429812$24042981$2$F$$20240815$20240702$20240820$EXP$$NVSC2024MX137222$NOVARTIS$$$$$M$Y$$$20240820$$MD$MX$MX
240429822$24042982$2$F$20240522$20240628$20240702$20240705$EXP$$NVSC2024CN137153$NOVARTIS$$28$YR$$M$Y$55$KG$20240705$$HP$CN$CN
240429881$24042988$1$I$20240401$20240621$20240702$20240702$PER$$US-SA-2024SA189158$SANOFI AVENTIS$$32$YR$A$F$Y$91.625$KG$20240702$$MD$US$US
240429891$24042989$1$I$$20240626$20240702$20240702$EXP$$DE-MYLANLABS-2024M1058332$MYLAN$Bonnet U, Kanti AK, Scherbaum N, Specka M.. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment ? A Pilot Study.. Journal of psychoactive drugs. 2023;55 (1):102-111$34$YR$$M$Y$$$20240702$$HP$DE$DE
240429901$24042990$1$I$20240701$20240701$20240702$20240702$PER$$NVSC2024US137283$NOVARTIS$$49$YR$$$Y$$$20240702$$CN$US$US
240429921$24042992$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000072$ELI LILLY AND CO$$66$YR$E$$Y$$$20240702$$CN$US$US
240429931$24042993$1$I$$20240625$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406018059$ELI LILLY AND CO$$$$$M$Y$$$20240702$$CN$US$US
240429951$24042995$1$I$$20240613$20240702$20240702$PER$$US-009507513-2406USA004878$MERCK$$$$$F$Y$$$20240702$$CN$US$US
240429961$24042996$1$I$$20240701$20240702$20240702$EXP$$CA-ORGANON-O2407CAN000105$ORGANON$$57$YR$$F$Y$$$20240702$$HP$CA$CA
240429971$24042997$1$I$$20240624$20240702$20240702$PER$$US-SA-2024SA188796$SANOFI AVENTIS$$$$A$M$Y$$$20240702$$MD$US$US
240429981$24042998$1$I$$20240627$20240702$20240702$PER$$US-SA-2024SA192984$SANOFI AVENTIS$$$$C$M$Y$$$20240702$$MD$US$US
240429991$24042999$1$I$$20240624$20240702$20240702$EXP$$NZ-AstraZeneca-2024A151056$ASTRAZENECA$$66$YR$$F$Y$$$20240702$$CN$NZ$
240430012$24043001$2$F$20240229$20240624$20240702$20240709$EXP$BE-FAMHP-DHH-N2024-122275$BE-MYLANLABS-2024M1057779$MYLAN$$$$E$M$Y$56$KG$20240709$$MD$BE$BE
240430022$24043002$2$F$20240101$20240723$20240702$20240806$PER$$US-ALKERMES INC.-ALK-2024-001681$ALKERMES$$$$$F$Y$81.633$KG$20240806$$CN$US$US
240430031$24043003$1$I$$20240617$20240702$20240702$EXP$$US-JOURNEY MEDICAL CORPORATION-2024JNY00126$JOURNEY MEDICAL CORPORATION$Holbert K. Multiorgan Failure From Heat Stroke in a Person Taking Glycopyrrolate. . Am. J. Respir. Crit. Care Med. 2024;209$24$YR$$M$Y$$$20240702$$HP$US$US
240430041$24043004$1$I$$20240626$20240702$20240702$EXP$$SI-MYLANLABS-2024M1058467$MYLAN$Vajdic Trampuz B.. Acute hyponatremia in a marathon runner.. Emergency medicine:International symposium on emergency medicine:selected topics. 2024;146$$$$M$Y$$$20240702$$MD$SI$SI
240430051$24043005$1$I$$20240626$20240702$20240702$EXP$$DE-MYLANLABS-2024M1058366$MYLAN$Hansel A, Oms E, Tronnier M.. Drug reaction with eosinophilia and systemic symptoms (DRESS): a hypersensitivity reaction with various symptoms.. Dermatologie. 2024$47$YR$$F$Y$$$20240702$$HP$DE$DE
240430073$24043007$3$F$20240605$20240925$20240702$20240930$EXP$$JP-PFIZER INC-PV202400074412$PFIZER$$77$YR$$F$Y$47.7$KG$20240930$$MD$JP$JP
240430081$24043008$1$I$$20240628$20240702$20240702$PER$$US-JNJFOC-20240677580$JOHNSON AND JOHNSON$$$$$$Y$$$20240702$$HP$US$US
240430091$24043009$1$I$20240618$20240618$20240702$20240702$PER$$US-009507513-2406USA006399$MERCK$$51$YR$$$Y$$$20240702$$CN$US$US
240430101$24043010$1$I$20240629$20240630$20240702$20240702$PER$$US-JNJFOC-20240700129$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240702$$CN$US$US
240430111$24043011$1$I$$20240701$20240702$20240702$PER$$US-HALEON-2184861$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240430121$24043012$1$I$20240610$20240626$20240702$20240702$EXP$$US-Eisai-EC-2024-168288$EISAI$$66$YR$E$M$Y$67.2$KG$20240702$$MD$US$US
240430131$24043013$1$I$20240621$20240624$20240702$20240702$PER$$US-SA-2024SA189587$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240702$$CN$US$US
240430142$24043014$2$F$20240607$20240819$20240702$20240823$EXP$$EG-Taiho Oncology Inc-2024-006500$TAIHO ONCOLOGY INC$$59$YR$A$F$Y$57$KG$20240823$$CN$EG$EG
240430161$24043016$1$I$$20240627$20240702$20240702$PER$$US-SA-2024SA193107$SANOFI AVENTIS$$$$A$M$Y$$$20240702$$MD$US$US
240430172$24043017$2$F$20240101$20240814$20240702$20240821$PER$$US-Eisai-EC-2024-169364$EISAI$$69$YR$E$M$Y$$$20240821$$CN$US$US
240430181$24043018$1$I$$20240620$20240702$20240702$PER$$US-ALKERMES INC.-ALK-2024-001724$ALKERMES$$$$$M$Y$$$20240702$$$US$US
240430191$24043019$1$I$$20240701$20240702$20240702$PER$$US-BIOMARINAP-US-2024-158944$BIOMARIN$$$$$$Y$$$20240702$$CN$US$US
240430201$24043020$1$I$$20240625$20240702$20240702$EXP$$NVSC2024DE136049$NOVARTIS$$$$A$M$Y$$$20240702$$CN$DE$DE
240430211$24043021$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001390$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240702$$CN$US$US
240430221$24043022$1$I$20240618$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000168$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240702$$CN$US$US
240430231$24043023$1$I$20240611$20240621$20240702$20240702$PER$$US-ALKERMES INC.-ALK-2024-001742$ALKERMES$$40$YR$$F$Y$99.773$KG$20240702$$MD$US$US
240430241$24043024$1$I$20240401$20240701$20240702$20240702$EXP$$US-Eisai-EC-2024-169330$EISAI$$58$YR$A$M$Y$65.76$KG$20240702$$CN$US$US
240430251$24043025$1$I$20240601$20240624$20240702$20240702$PER$$US-SA-2024SA192209$SANOFI AVENTIS$$30$YR$A$M$Y$108.86$KG$20240702$$MD$US$US
240430261$24043026$1$I$20240101$20240626$20240702$20240702$EXP$$CN-009507513-2407CHN000090$MERCK$$64$YR$$M$Y$70$KG$20240702$$HP$CN$CN
240430271$24043027$1$I$20240620$20240701$20240702$20240702$EXP$$NVSC2024US136596$NOVARTIS$$60$YR$$F$Y$$$20240702$$CN$US$US
240430281$24043028$1$I$20240624$20240624$20240702$20240702$EXP$$IN-AstraZeneca-2024A147671$ASTRAZENECA$$23911$DY$$M$Y$64.9$KG$20240702$$CN$IN$
240430291$24043029$1$I$$20240209$20240702$20240702$PER$$US-AMGEN-USASP2024130790$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240430302$24043030$2$F$$20240828$20240702$20240829$EXP$$NVSC2024BR136694$NOVARTIS$$55$YR$$F$Y$$$20240829$$MD$BR$BR
240430311$24043031$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137288$NOVARTIS$$$$$F$Y$$$20240702$$CN$US$US
240430321$24043032$1$I$20240606$20240606$20240702$20240702$EXP$$AU-GE HEALTHCARE-2024CSU006315$GE HEALTHCARE$$54$YR$$F$Y$70$KG$20240702$$HP$AU$AU
240430331$24043033$1$I$20240412$20240412$20240702$20240702$PER$$US-GE HEALTHCARE-2024CSU003852$GE HEALTHCARE$$50$YR$$F$Y$73.5$KG$20240702$$HP$US$US
240430341$24043034$1$I$20240615$20240701$20240702$20240702$EXP$GB-MHRA-MED-202406290731408350-JDBNM$GB-SANDOZ INC.-SDZ2024GB062107$SANDOZ$$77$YR$$M$Y$90$KG$20240702$$CN$GB$GB
240430351$24043035$1$I$$20240626$20240702$20240702$EXP$$US-SANDOZ INC.-SDZ2024US062198$SANDOZ$$$$$$Y$$$20240702$$PH$US$US
240430361$24043036$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137310$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240430371$24043037$1$I$$20240625$20240702$20240702$PER$$US-ALXN-202406USA001611US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240702$$CN$US$US
240430411$24043041$1$I$20240326$20240626$20240702$20240702$EXP$$SG-LUNDBECK-DKLU4001005$LUNDBECK$$$$$$Y$$$20240702$$CN$SG$SG
240430421$24043042$1$I$20240101$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024127289$AMGEN$$45$YR$A$M$Y$$$20240702$$CN$US$US
240430431$24043043$1$I$$20240702$20240702$20240702$PER$$NVSC2024US137309$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240430441$24043044$1$I$20240528$20240628$20240702$20240702$EXP$$NVSC2024CN137174$NOVARTIS$$66$YR$$F$Y$54$KG$20240702$$HP$CN$CN
240430452$24043045$2$F$$20240717$20240702$20240722$PER$$US-PFIZER INC-202400204494$PFIZER$$78$YR$$F$Y$$$20240722$$CN$US$US
240430461$24043046$1$I$$20240701$20240702$20240702$PER$$US-PFIZER INC-202400204687$PFIZER$$$$$F$Y$$$20240702$$HP$US$US
240430471$24043047$1$I$20240101$20240624$20240702$20240702$PER$$US-SA-2024SA191835$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240702$$MD$US$US
240430491$24043049$1$I$20240607$20240627$20240702$20240702$EXP$FR-AFSSAPS-MP2024001041$FR-009507513-2406FRA010094$MERCK$$82$YR$$M$Y$85$KG$20240702$$PH$FR$FR
240430502$24043050$2$F$$20240625$20240702$20240711$PER$$US-ALXN-202406USA001604US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240430521$24043052$1$I$$20240520$20240702$20240702$PER$$US-FMCRTG-FMC-2405-000612$FRESENIUS MEDICAL CARE$$54$YR$A$F$Y$$$20240702$$CN$US$US
240430531$24043053$1$I$20240617$20240618$20240702$20240702$EXP$$US-FMCRTG-FMC-2406-000741$FRESENIUS MEDICAL CARE$$51$YR$A$F$Y$$$20240702$$HP$US$US
240430541$24043054$1$I$20240601$20240618$20240702$20240702$EXP$$US-FMCRTG-FMC-2406-000744$FRESENIUS MEDICAL CARE$$63$YR$A$M$Y$$$20240702$$HP$US$US
240430551$24043055$1$I$$20240602$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000712$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240702$$CN$US$US
240430561$24043056$1$I$$20240526$20240702$20240702$PER$$US-FMCRTG-FMC-2405-000639$FRESENIUS MEDICAL CARE$$$$$$Y$$$20240702$$HP$US$US
240430571$24043057$1$I$20240620$20240620$20240702$20240702$EXP$$US-FMCRTG-FMC-2406-000748$FRESENIUS MEDICAL CARE$$40$YR$A$F$Y$80.5$KG$20240702$$HP$US$US
240430581$24043058$1$I$20240610$20240610$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000723$FRESENIUS MEDICAL CARE$$72$YR$E$M$Y$88$KG$20240702$$HP$US$US
240430591$24043059$1$I$$20240606$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000694$FRESENIUS MEDICAL CARE$$57$YR$A$M$Y$$$20240702$$HP$US$US
240430601$24043060$1$I$$20240609$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000714$FRESENIUS MEDICAL CARE$$36$YR$A$M$Y$80$KG$20240702$$HP$US$US
240430611$24043061$1$I$$20240607$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000689$FRESENIUS MEDICAL CARE$$51$YR$A$F$Y$89$KG$20240702$$HP$US$US
240430621$24043062$1$I$$20240604$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000681$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240702$$HP$US$US
240430631$24043063$1$I$$20240604$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000683$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240702$$CN$US$US
240430641$24043064$1$I$20240523$20240607$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000701$FRESENIUS MEDICAL CARE$$76$YR$E$M$Y$92$KG$20240702$$HP$US$US
240430651$24043065$1$I$20240606$20240609$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000698$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240702$$HP$US$US
240430661$24043066$1$I$$20240604$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000675$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240702$$HP$US$US
240430671$24043067$1$I$20240506$20240605$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000685$FRESENIUS MEDICAL CARE$$71$YR$E$M$Y$78$KG$20240702$$HP$US$US
240430681$24043068$1$I$$20240606$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000688$FRESENIUS MEDICAL CARE$$73$YR$E$F$Y$$$20240702$$HP$US$US
240430691$24043069$1$I$20240517$20240611$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000715$FRESENIUS MEDICAL CARE$$65$YR$E$F$Y$92.3$KG$20240702$$HP$US$US
240430701$24043070$1$I$20240606$20240606$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000691$FRESENIUS MEDICAL CARE$$35$YR$A$M$Y$$$20240702$$HP$US$US
240430711$24043071$1$I$$20240606$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000686$FRESENIUS MEDICAL CARE$$68$YR$E$F$Y$$$20240702$$HP$US$US
240430721$24043072$1$I$20240527$20240603$20240702$20240702$PER$$US-FMCRTG-FMC-2406-000676$FRESENIUS MEDICAL CARE$$82$YR$E$M$Y$66$KG$20240702$$HP$US$US
240430731$24043073$1$I$$20240626$20240702$20240702$EXP$$NVSC2024ZA133588$NOVARTIS$$37$YR$$F$Y$$$20240702$$HP$ZA$ZA
240430741$24043074$1$I$$20240626$20240702$20240702$EXP$$NL-SA-2024SA192237$SANOFI AVENTIS$Broijl A, Roeloffzen W, Dimopoulos MA, Rosinol L, Van Der Klift M, Bertuglia G et al.. Isatuximab-carfilzomib-lenalidomide-dexamethasone vs carfilzomib-lenalidomide-dexamethasone as pre-transplant induction and post-transplant consolidation in newly diagnosed multiple myeloma patients: results of the phase iii randomized emn24 iskia trial.. Haematologica. 2024;109(Suppl 2):18-9$$$$$Y$$$20240702$$HP$NL$NL
240430751$24043075$1$I$$20240625$20240702$20240702$EXP$$US-009507513-2406USA009181$MERCK$Berry J, Leelatian N, Harmsen H.. Unmasking of neuromuscular paraneoplastic syndrome by pembrolizumab leading to rapid respiratory failure and death. Journal of Neuropathology and Experimental Neurology. 2024;83 (6):495$69$YR$$M$Y$$$20240702$$HP$US$US
240430761$24043076$1$I$$20240619$20240702$20240702$PER$$US-TEVA-VS-3212473$TEVA$$70$YR$$F$Y$$$20240702$$CN$US$US
240430772$24043077$2$F$20240301$20240830$20240702$20240830$PER$$NVSC2024US134570$NOVARTIS$$55$YR$$M$Y$$$20240830$$MD$US$US
240430793$24043079$3$F$$20240712$20240702$20240823$PER$$US-LUNDBECK-DKLU3078331$LUNDBECK$$$$$$Y$$$20240823$$CN$US$US
240430801$24043080$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137312$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240430812$24043081$2$F$20240515$20240730$20240702$20240809$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000224$THERATECHNOLOGIES$$$$$$Y$$$20240809$$CN$US$US
240430821$24043082$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137313$NOVARTIS$$$$$$Y$$$20240702$$HP$US$US
240430831$24043083$1$I$$20240627$20240702$20240702$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036869$BOEHRINGER INGELHEIM$$$$$$Y$$$20240702$$CN$US$US
240430841$24043084$1$I$$20240628$20240702$20240702$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010054$JAZZ$$$$$F$Y$$$20240702$$CN$US$US
240430851$24043085$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000325$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$US$US
240430861$24043086$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000307$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240702$$CN$US$US
240430871$24043087$1$I$20240627$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000018$ELI LILLY AND CO$$$$$$Y$$$20240702$$CN$US$US
240430881$24043088$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019063$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240702$$CN$US$US
240430891$24043089$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000559$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240702$$CN$US$US
240430911$24043091$1$I$$20240627$20240702$20240702$PER$$US-ABBVIE-5820392$ABBVIE$$$$$$Y$$$20240702$$MD$US$US
240430921$24043092$1$I$20240101$20240619$20240702$20240702$EXP$$AU-009507513-2406AUS006903$MERCK$$97$YR$$M$Y$$$20240702$$PH$AU$AU
240430934$24043093$4$F$20240701$20240822$20240702$20240827$EXP$$NVSC2024US137311$NOVARTIS$$63$YR$$F$Y$$$20240827$$HP$US$US
240430942$24043094$2$F$20240617$20240710$20240702$20240715$EXP$$NVSC2024MX135868$NOVARTIS$$71$YR$$F$Y$$$20240715$$CN$MX$MX
240430952$24043095$2$F$20240418$20240719$20240702$20240903$PER$$US-LUNDBECK-DKLU3078101$LUNDBECK$$$$$$Y$$$20240903$$CN$US$US
240430961$24043096$1$I$$20240625$20240702$20240702$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06389$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240702$$HP$US$US
240430971$24043097$1$I$$20240514$20240702$20240702$PER$$US-LUNDBECK-DKLU3078151$LUNDBECK$$$$$$Y$$$20240702$$CN$US$US
240430981$24043098$1$I$$20240515$20240702$20240702$PER$$US-LUNDBECK-DKLU3078182$LUNDBECK$$$$$$Y$$$20240702$$CN$US$US
240430993$24043099$3$F$$20240703$20240702$20240708$PER$$US-PFIZER INC-PV202400085809$PFIZER$$20$YR$$M$Y$$$20240708$$HP$US$US
240431011$24043101$1$I$$20240520$20240702$20240702$EXP$$US-APELLIS-2024-APL-0000185$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240612$$CN$US$US
240431024$24043102$4$F$$20240920$20240702$20240924$PER$$NVSC2024US137064$NOVARTIS$$$$$F$Y$$$20240924$$HP$US$US
240431032$24043103$2$F$$20240626$20240702$20240904$EXP$$CA-LUNDBECK-DKLU4001003$LUNDBECK$$$$$$Y$$$20240904$$HP$CA$CA
240431041$24043104$1$I$$20240625$20240702$20240702$PER$$US-009507513-2406USA009173$MERCK$Zahid A, Tummala S. Cerebral clues: serum neurofilament light chain (sNfL) as a novel biomarker for immune check point inhibitor (ICI) mediated seronegative encephalitis. Oxford Medical Case Reports. 2024;6:242-244$71$YR$$M$Y$$$20240702$$HP$US$US
240431051$24043105$1$I$20240101$20240624$20240702$20240702$PER$$US-UNITED THERAPEUTICS-UNT-2024-019242$UNITED THERAPEUTICS$$$$$$Y$82.54$KG$20240702$$$US$US
240431061$24043106$1$I$20240601$20240624$20240702$20240702$PER$$US-UNITED THERAPEUTICS-UNT-2024-018560$UNITED THERAPEUTICS$$86$YR$$M$Y$108.84$KG$20240702$$$US$US
240431075$24043107$5$F$20240101$20240717$20240702$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016178$UNITED THERAPEUTICS$$$$$F$Y$51.701$KG$20240725$$$US$US
240431081$24043108$1$I$20240101$20240625$20240702$20240702$EXP$$US-009507513-2406USA009176$MERCK$$$$$F$Y$$$20240702$$HP$US$US
240431091$24043109$1$I$20240701$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001175$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240702$$CN$US$US
240431112$24043111$2$F$$20240628$20240702$20240703$EXP$$ES-TAKEDA-2024TUS066034$TAKEDA$$$$$F$Y$$$20240703$$CN$ES$ES
240431132$24043113$2$F$20240501$20240726$20240702$20240802$PER$$US-JNJFOC-20240701112$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240802$$CN$US$US
240431142$24043114$2$F$20240624$20240806$20240702$20240807$PER$$US-ALXN-202406USA001615US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240431151$24043115$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137116$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240431161$24043116$1$I$20240628$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000338$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240702$$CN$US$US
240431171$24043117$1$I$$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000324$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240702$$CN$US$US
240431181$24043118$1$I$20240101$20240626$20240702$20240702$PER$$US-UNITED THERAPEUTICS-UNT-2024-017536$UNITED THERAPEUTICS$$$$$F$Y$85.261$KG$20240702$$$US$US
240431191$24043119$1$I$20240101$20240626$20240702$20240702$PER$$US-UNITED THERAPEUTICS-UNT-2024-019832$UNITED THERAPEUTICS$$$$$F$Y$119.27$KG$20240702$$$US$US
240431202$24043120$2$F$$20240801$20240702$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-016749$UNITED THERAPEUTICS$$$$$M$Y$68.027$KG$20240807$$$US$US
240431221$24043122$1$I$$20240612$20240702$20240702$PER$$US-009507513-2406USA004232$MERCK$Vergidis P., Sendi P., Alkhateeb HB., Nguyen MH.. How do I manage refractory invasive pulmonary aspergillosis. Clinical Microbiology and Infection. 2024;30 (6):755-61$77$YR$$M$Y$$$20240702$$HP$US$US
240431241$24043124$1$I$$20240625$20240702$20240702$PER$$US-ALXN-202406USA001597US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240702$$CN$US$US
240431251$24043125$1$I$20240401$20240626$20240702$20240702$EXP$$US-LUNDBECK-DKLU3076645$LUNDBECK$$$$$$Y$$$20240702$$HP$US$US
240431273$24043127$3$F$20240101$20240712$20240702$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-019969$UNITED THERAPEUTICS$$$$$F$Y$64.399$KG$20240718$$$US$US
240431282$24043128$2$F$20240101$20240712$20240702$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-019944$UNITED THERAPEUTICS$$$$$M$Y$102.04$KG$20240718$$$US$US
240431292$24043129$2$F$20240101$20240703$20240702$20240712$PER$$US-UNITED THERAPEUTICS-UNT-2024-019516$UNITED THERAPEUTICS$$$$$M$Y$70.748$KG$20240712$$$US$US
240431312$24043131$2$F$20240620$20240802$20240702$20240809$PER$$US-ALXN-202406USA001544US$ALEXION PHARMACEUTICALS$$57$YR$$M$Y$$$20240809$$CN$US$US
240431321$24043132$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137106$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240431331$24043133$1$I$20240101$20240627$20240702$20240702$EXP$$NVSC2024GR134293$NOVARTIS$$21$YR$$$Y$$$20240703$$MD$GR$GR
240431352$24043135$2$F$20240625$20240719$20240702$20240726$PER$$US-ALXN-202406USA001609US$ALEXION PHARMACEUTICALS$$68$YR$$M$Y$$$20240726$$CN$US$US
240431361$24043136$1$I$20240603$20240701$20240702$20240702$EXP$FR-AFSSAPS-PP2024000704$NVSC2024FR136538$NOVARTIS$$84$YR$$M$Y$65.3$KG$20240703$$PH$FR$FR
240431371$24043137$1$I$$20240621$20240702$20240702$EXP$$US-PHARMING-PHAUS2024000521$PHARMING GROUP$$$$$$Y$$$20240702$$CN$US$US
240431381$24043138$1$I$$20240514$20240702$20240702$PER$$US-LUNDBECK-DKLU3078111$LUNDBECK$$$$$$Y$$$20240702$$HP$US$US
240431391$24043139$1$I$$20240626$20240702$20240702$PER$$US-ABBVIE-5820360$ABBVIE$$$$$$Y$$$20240702$$MD$US$US
240431401$24043140$1$I$$20240627$20240702$20240702$EXP$$FR-AMGEN-FRASP2024128820$AMGEN$$$$$F$Y$$$20240702$$PH$FR$FR
240431411$24043141$1$I$$20240624$20240702$20240702$EXP$$IT-LUNDBECK-DKLU4001014$LUNDBECK$Iodice A, Marchi? G, Asta F, Rocchetti K, Rosati A.. Vigabatrin-associated hyperkinetic movements in two children with epileptic spasms: Case reports and video phenomenology description. Seizure. 2024;120:12-4$$$$$Y$$$20240702$$HP$IT$IT
240431421$24043142$1$I$$20240621$20240702$20240702$PER$$US-BIOMARINAP-US-2024-158806$BIOMARIN$$$$$$Y$$$20240702$$CN$US$US
240431431$24043143$1$I$$20240702$20240702$20240702$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037337$BOEHRINGER INGELHEIM$$$$$$Y$$$20240702$$PH$US$US
240431441$24043144$1$I$$20240514$20240702$20240702$PER$$US-LUNDBECK-DKLU3078085$LUNDBECK$$$$$$Y$$$20240702$$CN$US$US
240431452$24043145$2$F$$20240905$20240702$20240906$EXP$$NVSC2024CA131668$NOVARTIS$$39$YR$$F$Y$$$20240906$$CN$CA$CA
240431461$24043146$1$I$20240306$20240701$20240702$20240702$EXP$DK-DKMA-30729615$DK-JNJFOC-20240704983$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240702$$MD$DK$DK
240431472$24043147$2$F$$20240709$20240702$20240717$PER$$US-BIOMARINAP-US-2024-158801$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
240431482$24043148$2$F$20240619$20240729$20240702$20240812$PER$$US-ALKERMES INC.-ALK-2024-001714$ALKERMES$$23$YR$$M$Y$90.249$KG$20240812$$HP$US$US
240431491$24043149$1$I$20240619$20240628$20240702$20240702$EXP$$BR-JNJFOC-20240705020$JOHNSON AND JOHNSON$$$$$F$Y$$$20240702$$CN$BR$BR
240431502$24043150$2$F$$20240828$20240702$20240830$EXP$$NVSC2024UA135263$NOVARTIS$$44$YR$$F$Y$$$20240830$$MD$UA$UA
240431511$24043151$1$I$20240301$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000697$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240702$$CN$US$US
240431521$24043152$1$I$$20240626$20240702$20240702$PER$$US-BIOMARINAP-US-2024-158860$BIOMARIN$$$$$$Y$$$20240702$$CN$US$US
240431531$24043153$1$I$20240601$20240626$20240702$20240702$EXP$$US-BIOGEN-2024BI01271467$BIOGEN$$$$$F$Y$$$20240702$$HP$US$US
240431541$24043154$1$I$$20240626$20240702$20240702$EXP$$US-BIOGEN-2024BI01271464$BIOGEN$$$$$F$Y$$$20240702$$CN$US$US
240431561$24043156$1$I$20240626$20240627$20240702$20240702$EXP$$NVSC2024ZA135367$NOVARTIS$$44$YR$$F$Y$$$20240703$$CN$ZA$ZA
240431571$24043157$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5820881$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240431581$24043158$1$I$20230101$20240627$20240702$20240702$EXP$$CA-ABBVIE-5821075$ABBVIE$$$$A$M$Y$$$20240702$$CN$CA$CA
240431591$24043159$1$I$20240101$20240628$20240702$20240702$EXP$$SI-ABBVIE-5821068$ABBVIE$$$$$M$Y$$$20240702$$HP$SI$SI
240431602$24043160$2$F$$20240911$20240702$20240917$EXP$$US-ABBVIE-5822016$ABBVIE$$$$$F$Y$104$KG$20240917$$CN$US$US
240431611$24043161$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5822353$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240431622$24043162$2$F$20231127$20240724$20240702$20240731$EXP$$US-ABBVIE-5817811$ABBVIE$$56$YR$$F$Y$68$KG$20240731$$CN$US$US
240431631$24043163$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821941$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240431641$24043164$1$I$20240101$20240628$20240702$20240702$EXP$$US-ABBVIE-5821968$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240431652$24043165$2$F$20240626$20240829$20240702$20240829$EXP$$NVSC2024US136268$NOVARTIS$$35$YR$$F$Y$$$20240829$$HP$US$US
240431662$24043166$2$F$20240101$20240919$20240702$20240921$EXP$$AR-ABBVIE-5822682$ABBVIE$$$$$M$Y$$$20240921$$CN$AR$AR
240431671$24043167$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001166$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240702$$CN$US$US
240431681$24043168$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821734$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240431691$24043169$1$I$20240101$20240628$20240702$20240702$EXP$$US-ABBVIE-5821739$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240431702$24043170$2$F$20240601$20240822$20240702$20240831$EXP$$US-IOVANCE BIOTHERAPEUTICS, INC-2024IOV000036$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240831$$MD$US$US
240431711$24043171$1$I$$20240627$20240702$20240702$PER$$NVSC2024US135658$NOVARTIS$$$$$M$Y$$$20240703$$HP$US$US
240431722$24043172$2$F$20240201$20240920$20240702$20240927$EXP$$US-ABBVIE-5821545$ABBVIE$$68$YR$$M$Y$$$20240927$$CN$US$US
240431741$24043174$1$I$20240401$20240619$20240702$20240702$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06252$NEUROCRINE BIOSCIENCES$$71$YR$$F$Y$$$20240703$$CN$US$US
240431751$24043175$1$I$$20240626$20240702$20240702$PER$$US-ABBVIE-5817988$ABBVIE$$$$$M$Y$$$20240702$$MD$US$US
240431763$24043176$3$F$20240201$20240724$20240702$20240729$EXP$$US-ABBVIE-5822359$ABBVIE$$39$YR$$F$Y$$$20240729$$CN$US$US
240431773$24043177$3$F$20230101$20240703$20240702$20240705$EXP$$US-ABBVIE-5823248$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240431781$24043178$1$I$$20240627$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406019794$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240702$$CN$US$US
240431791$24043179$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137318$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240431801$24043180$1$I$20240626$20240627$20240702$20240702$PER$$US-BIOGEN-2024BI01271725$BIOGEN$$30$YR$$M$Y$$$20240702$$CN$US$US
240431811$24043181$1$I$20240401$20240701$20240702$20240702$EXP$IT-MINISAL02-992928$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-105600$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240703$$MD$IT$IT
240431821$24043182$1$I$$20240624$20240702$20240702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-104984$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240703$$MD$JP$JP
240431833$24043183$3$F$$20240921$20240702$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105482$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$92.53$KG$20240923$$CN$US$US
240431841$24043184$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105552$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$PH$US$US
240431861$24043186$1$I$$20240627$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104430$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$PH$US$US
240431871$24043187$1$I$$20240702$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105856$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240703$$CN$US$US
240431884$24043188$4$F$20240601$20240823$20240702$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102947$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$68.04$KG$20240903$$CN$US$US
240431891$24043189$1$I$$20240628$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105724$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240703$$HP$US$US
240431901$24043190$1$I$$20240701$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105436$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$103.87$KG$20240703$$CN$US$US
240431911$24043191$1$I$20231029$20240701$20240702$20240702$EXP$$NVSC2024IN137131$NOVARTIS$$54$YR$$M$Y$$$20240703$$CN$IN$IN
240431921$24043192$1$I$20240302$20240628$20240702$20240702$EXP$$NVSC2024NP136304$NOVARTIS$$89$YR$$F$Y$$$20240703$$MD$NP$NP
240431931$24043193$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137314$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240431951$24043195$1$I$20240610$20240625$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202406017406$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240702$$CN$US$US
240431961$24043196$1$I$$20240627$20240702$20240702$30DAY$$US-SANDOZ INC.-SDZ2023US001765$SANDOZ$$$$$M$Y$$$20240702$$HP$US$US
240431983$24043198$3$F$20240101$20240802$20240702$20240806$PER$$US-AMGEN-USASP2024129406$AMGEN$$40$YR$A$F$Y$$$20240806$$HP$US$US
240431991$24043199$1$I$$20240702$20240702$20240702$PER$$NVSC2024US137330$NOVARTIS$$$$$$Y$$$20240703$$MD$US$US
240432002$24043200$2$F$20200615$20240703$20240702$20240706$EXP$$US-009507513-2407TWN000933$MERCK$$68$YR$$M$Y$$$20240706$$MD$TW$TW
240432012$24043201$2$F$$20240723$20240702$20240725$30DAY$$EG-SANDOZ INC.-SDZ2023EG026868$SANDOZ$$$$$M$Y$27$KG$20240725$$CN$EG$EG
240432031$24043203$1$I$$20240702$20240702$20240702$PER$$NVSC2024US137327$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240432042$24043204$2$F$20240531$20240822$20240702$20240828$EXP$$DE-ORGANON-O2407DEU000172$ORGANON$$26$YR$$F$Y$$$20240828$$MD$DE$DE
240432051$24043205$1$I$20240624$20240628$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407000277$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240702$$CN$US$US
240432063$24043206$3$F$20240627$20240919$20240702$20240920$PER$$US-AMGEN-USASP2024129113$AMGEN$$53$YR$A$M$Y$$$20240920$$CN$US$US
240432071$24043207$1$I$$20240620$20240702$20240702$PER$$US-JNJFOC-20240662574$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$US$US
240432082$24043208$2$F$20240601$20240711$20240702$20240723$30DAY$$AR-JNJFOC-20240704857$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$CN$AR$AR
240432091$24043209$1$I$20220101$20240629$20240702$20240702$EXP$$US-ABBVIE-5823438$ABBVIE$$78$YR$$M$Y$$$20240702$$CN$US$US
240432101$24043210$1$I$$20240626$20240702$20240702$PER$$US-AMGEN-USASP2024128309$AMGEN$$$$E$F$Y$$$20240702$$MD$US$US
240432111$24043211$1$I$$20240628$20240702$20240702$PER$$US-JNJFOC-20240677776$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$US$US
240432121$24043212$1$I$20240601$20240628$20240702$20240702$PER$$US-AMGEN-USASP2024129225$AMGEN$$81$YR$E$F$Y$$$20240702$$CN$US$US
240432131$24043213$1$I$20240101$20240628$20240702$20240702$EXP$$US-ABBVIE-5822735$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240432142$24043214$2$F$20240507$20240724$20240702$20240730$EXP$$GB-ABBVIE-5820600$ABBVIE$$25$YR$$F$Y$$$20240730$$HP$GB$GB
240432152$24043215$2$F$20240531$20240702$20240702$20240704$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037409$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240704$$HP$CO$CO
240432161$24043216$1$I$20240626$20240628$20240702$20240702$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037410$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240703$$HP$CO$CO
240432171$24043217$1$I$$20240623$20240702$20240702$EXP$$US-JNJFOC-20240662292$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240703$$MD$US$US
240432181$24043218$1$I$20230201$20240626$20240702$20240702$EXP$$PR-ABBVIE-5817827$ABBVIE$$61$YR$$F$Y$70.76$KG$20240702$$CN$PR$PR
240432191$24043219$1$I$20240201$20240626$20240702$20240702$EXP$$US-ABBVIE-5819825$ABBVIE$$72$YR$$F$Y$$$20240702$$CN$US$US
240432202$24043220$2$F$$20240708$20240702$20240717$EXP$$JP-JNJFOC-20240701095$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$MD$JP$JP
240432211$24043221$1$I$20231201$20240628$20240702$20240702$PER$$US-JNJFOC-20240677672$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$PH$US$US
240432222$24043222$2$F$20240626$20240705$20240702$20240708$EXP$$AR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037379$BOEHRINGER INGELHEIM$$88$YR$E$M$Y$73$KG$20240709$$CN$AR$AR
240432231$24043223$1$I$20240601$20240628$20240702$20240702$EXP$$US-ABBVIE-5821778$ABBVIE$$55$YR$$F$Y$$$20240702$$CN$US$US
240432241$24043224$1$I$$20240629$20240702$20240702$EXP$$US-ABBVIE-5821800$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240432251$24043225$1$I$$20240630$20240702$20240702$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037064$BOEHRINGER INGELHEIM$$$$$$Y$$$20240703$$CN$US$US
240432261$24043226$1$I$$20240628$20240702$20240702$EXP$$CA-ABBVIE-5821894$ABBVIE$$$$A$M$Y$$$20240702$$CN$CA$CA
240432273$24043227$3$F$20221201$20240730$20240702$20240807$EXP$$JP-SA-2024SA188418$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240807$$MD$JP$JP
240432281$24043228$1$I$$20240701$20240702$20240702$EXP$$NVSJ2024JP007844$NOVARTIS$$$$E$M$Y$$$20240703$$MD$JP$JP
240432291$24043229$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821902$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240432301$24043230$1$I$20240609$20240621$20240702$20240702$PER$$US-BEH-2024173922$CSL BEHRING$$50$YR$A$M$Y$$$20240702$$CN$US$US
240432311$24043231$1$I$$20240630$20240702$20240702$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037062$BOEHRINGER INGELHEIM$$$$$$Y$$$20240703$$CN$US$US
240432325$24043232$5$F$20210723$20240712$20240702$20240726$EXP$$US-ABBVIE-5819904$ABBVIE$$73$YR$$F$Y$$$20240726$$CN$US$US
240432331$24043233$1$I$$20240627$20240702$20240702$EXP$$ES-BEIGENE-BGN-2024-009888$BEIGENE$$$$$$Y$$$20240702$$HP$ES$ES
240432341$24043234$1$I$$20240629$20240702$20240702$EXP$$MX-ABBVIE-5822769$ABBVIE$$$$$M$Y$$$20240702$$CN$MX$MX
240432351$24043235$1$I$20240424$20240626$20240702$20240702$EXP$$US-ABBVIE-5822723$ABBVIE$$63$YR$$F$Y$$$20240702$$CN$US$US
240432361$24043236$1$I$20240601$20240627$20240702$20240702$EXP$$GB-ABBVIE-5820576$ABBVIE$$27$YR$$F$Y$$$20240702$$CN$GB$GB
240432371$24043237$1$I$20240612$20240624$20240702$20240702$EXP$$US-BEH-2024174644$CSL BEHRING$$7$YR$C$F$Y$$$20240702$$CN$US$US
240432381$24043238$1$I$$20240630$20240702$20240702$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037057$BOEHRINGER INGELHEIM$$$$$$Y$$$20240703$$CN$US$US
240432391$24043239$1$I$$20240630$20240702$20240702$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037060$BOEHRINGER INGELHEIM$$$$$$Y$$$20240703$$CN$US$US
240432401$24043240$1$I$$20240701$20240702$20240702$PER$$NVSC2024US137328$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240432411$24043241$1$I$$20240626$20240702$20240702$EXP$$NVSJ2024JP007675$NOVARTIS$$82$YR$$M$Y$$$20240703$$PH$JP$JP
240432421$24043242$1$I$20240101$20240701$20240702$20240702$EXP$$US-ABBVIE-5822776$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240432431$24043243$1$I$20240508$20240628$20240702$20240702$EXP$$US-ABBVIE-5821707$ABBVIE$$70$YR$$M$Y$$$20240702$$CN$US$US
240432441$24043244$1$I$20240430$20240630$20240702$20240702$EXP$$IL-ABBVIE-5822340$ABBVIE$$53$YR$$M$Y$$$20240702$$CN$IL$IL
240432452$24043245$2$F$20240626$20240813$20240702$20240814$PER$$US-AMGEN-USASP2024129423$AMGEN$$63$YR$A$M$Y$$$20240814$$CN$US$US
240432471$24043247$1$I$$20240628$20240702$20240702$EXP$GB-MHRA-MIDB-c805fb18-2563-49a6-9b74-1f1baeb8bc45$GB-ABBVIE-5820671$ABBVIE$$25$YR$$F$Y$$$20240702$$PH$GB$GB
240432481$24043248$1$I$$20240627$20240702$20240702$EXP$$CA-BEIGENE-BGN-2024-009913$BEIGENE$$$$$$Y$$$20240702$$HP$CA$CA
240432492$24043249$2$F$20240627$20240710$20240702$20240712$PER$$US-AMGEN-USASP2024129448$AMGEN$$68$YR$E$M$Y$$$20240712$$CN$US$US
240432502$24043250$2$F$20240617$20240723$20240702$20240725$PER$$US-JNJFOC-20240643372$JOHNSON AND JOHNSON$$44$YR$A$$Y$$$20240725$$CN$US$US
240432511$24043251$1$I$20230914$20240628$20240702$20240702$EXP$IE-HPRA-2024-113765$IE-PFIZER INC-202400205008$PFIZER$$45$YR$$F$Y$65$KG$20240702$$CN$IE$IE
240432521$24043252$1$I$20240628$20240628$20240702$20240702$EXP$$JP-PFIZER INC-202400203094$PFIZER$$47$YR$$F$Y$$$20240702$$PH$JP$JP
240432531$24043253$1$I$20240123$20240628$20240702$20240702$EXP$$CA-PFIZER INC-202300349438$PFIZER$$62$YR$$M$Y$81$KG$20240702$$PH$CA$CA
240432541$24043254$1$I$$20240701$20240702$20240702$EXP$$CA-PFIZER INC-202400204329$PFIZER$$16$YR$$F$Y$$$20240702$$PH$CA$CA
240432552$24043255$2$F$20190101$20240628$20240702$20240704$PER$$US-ABBVIE-5819378$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240432561$24043256$1$I$20240607$20240628$20240702$20240702$EXP$$CN-PFIZER INC-PV202400085694$PFIZER$$5$YR$$M$Y$16$KG$20240702$$HP$CN$CN
240432571$24043257$1$I$$20240701$20240702$20240702$EXP$$GB-PFIZER INC-202400204407$PFIZER$$15$YR$$F$Y$$$20240702$$HP$GB$GB
240432581$24043258$1$I$20240630$20240630$20240702$20240702$EXP$$GR-PFIZER INC-PV202400085962$PFIZER$$85$YR$$M$Y$$$20240702$$CN$GR$GR
240432591$24043259$1$I$20240301$20240625$20240702$20240702$EXP$$US-009507513-2406USA008680$MERCK$$77$YR$$F$Y$$$20240702$$CN$US$US
240432611$24043261$1$I$20240618$20240627$20240702$20240702$EXP$$CN-PFIZER INC-PV202400084999$PFIZER$$47$YR$$F$Y$50$KG$20240702$$HP$CN$CN
240432621$24043262$1$I$$20240626$20240702$20240702$PER$$US-JNJFOC-20240673744$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240703$$LW$US$US
240432631$24043263$1$I$$20230731$20240702$20240702$PER$$US-AMGEN-USASP2023235258$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240432642$24043264$2$F$20240501$20240716$20240702$20240729$30DAY$$US-JNJFOC-20240623007$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240729$$PH$US$US
240432652$24043265$2$F$$20240628$20240702$20240704$PER$$US-AMGEN-USASP2024129634$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240432671$24043267$1$I$20240101$20240625$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102724$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$64$KG$20240703$$PH$US$US
240432681$24043268$1$I$20240627$20240627$20240702$20240702$PER$$US-AMGEN-USASP2024128228$AMGEN$$66$YR$E$F$Y$$$20240702$$CN$US$US
240432691$24043269$1$I$$20240612$20240702$20240702$PER$$US-009507513-2406USA004555$MERCK$$$$$F$Y$$$20240702$$MD$US$US
240432701$24043270$1$I$$20240626$20240702$20240702$PER$$US-ABBVIE-5820367$ABBVIE$$$$$$Y$$$20240702$$CN$US$US
240432711$24043271$1$I$$20240628$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104838$BRISTOL MYERS SQUIBB$$100$YR$E$M$Y$$$20240703$$CN$US$US
240432721$24043272$1$I$20230101$20240627$20240702$20240702$EXP$$GB-BIOGEN-2024BI01271820$BIOGEN$$51$YR$$F$Y$$$20240702$$CN$GB$GB
240432732$24043273$2$F$20240101$20240910$20240702$20240917$EXP$$US-ABBVIE-5717386$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
240432741$24043274$1$I$20231201$20240628$20240702$20240702$EXP$$US-ABBVIE-5823240$ABBVIE$$81$YR$$F$Y$$$20240702$$CN$US$US
240432752$24043275$2$F$20211017$20240712$20240702$20240717$EXP$$EG-BIOGEN-2023BI01204006$BIOGEN$$39$YR$$F$Y$70$KG$20240717$$CN$EG$EG
240432762$24043276$2$F$$20240726$20240702$20240805$EXP$$US-BIOGEN-2024BI01271849$BIOGEN$$$$$F$Y$$$20240804$$HP$US$US
240432772$24043277$2$F$$20240726$20240702$20240806$EXP$$US-BEH-2024174851$CSL BEHRING$$47$YR$A$F$Y$82.54$KG$20240806$$CN$US$US
240432781$24043278$1$I$$20240701$20240702$20240702$PER$$US-ELI_LILLY_AND_COMPANY-US202407001352$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240702$$CN$US$US
240432791$24043279$1$I$20240101$20240626$20240702$20240702$EXP$$US-ABBVIE-5818867$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240432801$24043280$1$I$$20240627$20240702$20240702$EXP$$NVSJ2024JP006865$NOVARTIS$$$$A$M$Y$$$20240703$$MD$JP$JP
240432814$24043281$4$F$20240628$20240719$20240702$20240725$PER$$US-AMGEN-USASP2024129081$AMGEN$$74$YR$E$M$Y$$$20240725$$CN$US$US
240432821$24043282$1$I$$20240702$20240702$20240702$PER$$NVSC2024US137393$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240432831$24043283$1$I$20230101$20240701$20240702$20240702$EXP$$US-TAKEDA-2024TUS066193$TAKEDA$$$$$M$Y$$$20240702$$CN$US$US
240432844$24043284$4$F$20240619$20240822$20240702$20240828$EXP$$CA-TAKEDA-2024TUS062513$TAKEDA$$82$YR$$F$Y$$$20240828$$MD$CA$CA
240432851$24043285$1$I$20210101$20240701$20240702$20240702$EXP$$RU-ABBVIE-5822219$ABBVIE$$39$YR$$M$Y$67$KG$20240702$$MD$RU$RU
240432881$24043288$1$I$$20230828$20240702$20240702$PER$$US-AMGEN-USASP2023235142$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240432891$24043289$1$I$20231201$20240625$20240702$20240702$EXP$$US-ABBVIE-5817400$ABBVIE$$60$YR$$F$Y$$$20240702$$CN$US$US
240432903$24043290$3$F$20240615$20240802$20240702$20240806$EXP$IT-MINISAL02-991755$IT-PURDUE-USA-2024-0310527$PURDUE$$56$YR$$F$Y$$$20240806$$MD$IT$IT
240432911$24043291$1$I$$20240622$20240702$20240702$EXP$$US-RDY-LIT/USA/24/0009431$DR REDDYS$Gualano FM, Hassoun P, Carter CL, Hanson D. Embryonal tumor with multilayered rosettes: Post-treatment maturation and implications for future  therapy. Cancer Reports. 2023;6(5): 1-7. doi:10.1002/cnr2.1812.$5$MON$I$F$Y$$$20240703$$HP$US$US
240432921$24043292$1$I$20240201$20240627$20240702$20240702$EXP$$US-ABBVIE-5821507$ABBVIE$$30$YR$$M$Y$$$20240702$$CN$US$US
240432931$24043293$1$I$20230401$20240625$20240702$20240702$EXP$$US-ABBVIE-5816815$ABBVIE$$39$YR$$F$Y$$$20240702$$CN$US$US
240432941$24043294$1$I$20240101$20240627$20240702$20240702$EXP$$US-ABBVIE-5819484$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240432951$24043295$1$I$20240624$20240701$20240702$20240702$EXP$$AE-ABBVIE-5823218$ABBVIE$$83$YR$$F$Y$$$20240702$$CN$AE$AE
240432961$24043296$1$I$20240605$20240626$20240702$20240702$EXP$$US-ABBVIE-5822760$ABBVIE$$76$YR$$F$Y$$$20240702$$CN$US$US
240432971$24043297$1$I$20240324$20240627$20240702$20240702$EXP$$US-ABBVIE-5823221$ABBVIE$$82$YR$$F$Y$$$20240702$$CN$US$US
240432981$24043298$1$I$$20240621$20240702$20240702$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101130$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$HP$US$US
240432991$24043299$1$I$$20240628$20240702$20240702$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-104551$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240703$$MD$BR$BR
240433001$24043300$1$I$$20240625$20240702$20240702$PER$$US-ALXN-202406USA001639US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240703$$CN$US$US
240433012$24043301$2$F$$20240809$20240702$20240815$EXP$$CA-TAKEDA-2024TUS001191$TAKEDA$$$$$F$Y$$$20240815$$CN$CA$CA
240433021$24043302$1$I$20240626$20240627$20240702$20240702$EXP$$US-ABBVIE-5822934$ABBVIE$$78$YR$$F$Y$$$20240702$$CN$US$US
240433031$24043303$1$I$20240614$20240701$20240702$20240702$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010113$JAZZ$$12$YR$$$Y$$$20240702$$CN$US$US
240433045$24043304$5$F$20240623$20240909$20240702$20240918$EXP$$GR-CELLTRION INC.-2024GR015703$CELLTRION$$$$$$Y$$$20240918$$CN$GR$GR
240433051$24043305$1$I$$20240626$20240702$20240702$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-015243$JAZZ$$$$$F$Y$$$20240702$$CN$US$US
240433061$24043306$1$I$$20240625$20240702$20240702$PER$$US-BAUSCHBL-2024BNL029241$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240703$$MD$US$US
240433071$24043307$1$I$20240617$20240626$20240702$20240702$EXP$$US-ABBVIE-5822751$ABBVIE$$85$YR$$M$Y$$$20240702$$CN$US$US
240433081$24043308$1$I$$20240628$20240702$20240702$EXP$$US-ABBVIE-5821964$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240433092$24043309$2$F$$20240702$20240702$20240709$PER$$US-BAUSCHBL-2024BNL029265$BAUSCH AND LOMB$$$$$F$Y$$$20240710$$MD$US$US
240433101$24043310$1$I$20240501$20240620$20240702$20240702$PER$$US-TEVA-VS-3213563$TEVA$$26$YR$$M$Y$$$20240702$$CN$US$US
240433111$24043311$1$I$20240501$20240624$20240702$20240702$EXP$$US-JNJFOC-20240555408$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240703$$CN$US$US
240433121$24043312$1$I$$20240628$20240702$20240702$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010114$JAZZ$$$$$M$Y$$$20240702$$CN$US$US
240433131$24043313$1$I$20231215$20240624$20240702$20240702$EXP$$CA-JNJFOC-20240103478$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240703$$CN$CA$CA
240433141$24043314$1$I$$20240627$20240702$20240702$EXP$$US-ABBVIE-5821582$ABBVIE$$$$$M$Y$$$20240702$$CN$US$US
240433151$24043315$1$I$$20240621$20240702$20240702$EXP$$US-JNJFOC-20240666027$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$MD$US$US
240433161$24043316$1$I$$20240626$20240702$20240702$EXP$$US-ABBVIE-5819513$ABBVIE$$$$$F$Y$$$20240702$$CN$US$US
240433171$24043317$1$I$20240301$20240627$20240702$20240702$EXP$$JP-009507513-2403JPN003327J$MERCK$$70$YR$$M$Y$$$20240702$$MD$JP$JP
240433181$24043318$1$I$$20240702$20240702$20240702$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037471$BOEHRINGER INGELHEIM$$$$$$Y$$$20240703$$CN$US$US
240433192$24043319$2$F$20240401$20240709$20240702$20240719$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202406014684$ELI LILLY AND CO$$79$YR$E$M$Y$90$KG$20240719$$CN$DE$DE
240433202$24043320$2$F$$20240628$20240702$20240705$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202406018884$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240705$$MD$IT$IT
240433211$24043321$1$I$20140101$20240620$20240702$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015209$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240702$$CN$US$US
240433221$24043322$1$I$20240618$20240619$20240702$20240702$EXP$GB-MHRA-MED-202406191441402090-HKGJC$GB-ELI_LILLY_AND_COMPANY-GB202406013355$ELI LILLY AND CO$$40$YR$A$F$Y$113$KG$20240702$$CN$GB$GB
240433231$24043323$1$I$20240606$20240620$20240702$20240702$EXP$FR-AFSSAPS-NT2024000725$FR-ELI_LILLY_AND_COMPANY-FR202406015070$ELI LILLY AND CO$$71$YR$E$F$Y$58$KG$20240702$$CN$FR$FR
240433241$24043324$1$I$$20240620$20240702$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015212$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240702$$CN$US$US
240433251$24043325$1$I$$20240626$20240702$20240702$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406018039$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240702$$CN$JP$JP
240433261$24043326$1$I$$20240626$20240702$20240702$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202406017876$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240702$$CN$GB$GB
240433271$24043327$1$I$$20240621$20240702$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202406016037$ELI LILLY AND CO$$87$YR$E$F$Y$$$20240702$$CN$US$US
240433281$24043328$1$I$$20240626$20240702$20240702$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202407000329$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240702$$HP$TW$TW
240433291$24043329$1$I$$20240620$20240702$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014834$ELI LILLY AND CO$$$$A$F$Y$$$20240702$$CN$US$US
240433301$24043330$1$I$$20240620$20240702$20240702$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202406015851$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240702$$CN$TW$TW
240433311$24043331$1$I$20240319$20240620$20240702$20240702$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202406015176$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240702$$CN$AU$AU
240433321$24043332$1$I$$20240620$20240702$20240702$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202406014931$ELI LILLY AND CO$$$$$F$Y$$$20240702$$CN$BR$BR
240433331$24043333$1$I$$20240620$20240702$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014879$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240702$$CN$US$US
240433341$24043334$1$I$$20240626$20240702$20240702$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202407000339$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240702$$HP$TW$TW
240433351$24043335$1$I$20240610$20240620$20240702$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015302$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240702$$CN$US$US
240433361$24043336$1$I$20240603$20240620$20240702$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014889$ELI LILLY AND CO$$$$A$M$Y$$$20240702$$CN$US$US
240433371$24043337$1$I$20240620$20240620$20240702$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014486$ELI LILLY AND CO$$$$A$F$Y$$$20240702$$CN$US$US
240433381$24043338$1$I$20240530$20240620$20240702$20240702$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015229$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240702$$CN$US$US
240433391$24043339$1$I$20240601$20240619$20240702$20240702$EXP$GB-MHRA-MED-202406191919252060-JKYND$GB-ELI_LILLY_AND_COMPANY-GB202406014074$ELI LILLY AND CO$$33$YR$A$F$Y$88$KG$20240702$$CN$GB$GB
240433403$24043340$3$F$20240423$20240724$20240702$20240731$EXP$FR-AFSSAPS-DJ2024000804$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-103048$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$67$KG$20240731$$MD$FR$FR
240433412$24043341$2$F$$20240805$20240702$20240806$PER$$US-ALXN-202406USA001625US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240433421$24043342$1$I$$20240619$20240702$20240702$EXP$$CA-ROCHE-10000013917$ROCHE$$$$A$M$Y$$$20240703$$CN$CA$CA
240433431$24043343$1$I$$20240626$20240702$20240702$PER$$US-JNJFOC-20240674351$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$US$US
240433441$24043344$1$I$20240613$20240621$20240702$20240702$PER$$US-JNJFOC-20240657898$JOHNSON AND JOHNSON$$47$YR$A$F$Y$51.4$KG$20240703$$CN$US$US
240433451$24043345$1$I$$20240626$20240702$20240702$EXP$$CA-ABBVIE-5819028$ABBVIE$$$$A$M$Y$$$20240702$$CN$CA$CA
240433461$24043346$1$I$$20230925$20240702$20240702$PER$$US-AMGEN-USASP2023235368$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240433471$24043347$1$I$20240629$20240701$20240702$20240702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105813$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240703$$CN$US$US
240433481$24043348$1$I$20240101$20240702$20240702$20240702$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037473$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240703$$CN$US$US
240433492$24043349$2$F$$20240702$20240702$20240704$PER$$NVSC2024US137384$NOVARTIS$$$$$F$Y$$$20240704$$HP$US$US
240433501$24043350$1$I$$20240619$20240702$20240702$EXP$$JP-AMGEN-JPNSP2024129965$AMGEN$$$$$$Y$$$20240702$$CN$JP$JP
240433511$24043351$1$I$20240612$20240625$20240702$20240702$EXP$$JP-SA-2024SA187471$SANOFI AVENTIS$$85$YR$E$M$Y$57$KG$20240703$$HP$JP$JP
240433521$24043352$1$I$20210329$20240618$20240702$20240702$EXP$$CA-ROCHE-2800521$ROCHE$$36$YR$A$F$Y$$$20240703$$HP$CA$CA
240433531$24043353$1$I$20240415$20240702$20240702$20240702$EXP$FR-AFSSAPS-PC2024000499$FR-TAKEDA-2024TUS066169$TAKEDA$$63$YR$$M$Y$86$KG$20240702$$HP$FR$FR
240433541$24043354$1$I$$20240620$20240702$20240702$EXP$$US-JNJFOC-20240700742$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$MD$US$US
240433551$24043355$1$I$$20240627$20240703$20240703$EXP$$US-ABBVIE-5821589$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240433563$24043356$3$F$20231202$20240716$20240703$20240724$EXP$$US-ABBVIE-5820005$ABBVIE$$72$YR$$F$Y$54$KG$20240724$$HP$US$US
240433571$24043357$1$I$20240628$20240628$20240703$20240703$EXP$$US-ABBVIE-5823749$ABBVIE$$85$YR$$M$Y$$$20240703$$CN$US$US
240433581$24043358$1$I$$20240627$20240703$20240703$EXP$$VN-AstraZeneca-2024A150056$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$VN$
240433591$24043359$1$I$$20240627$20240703$20240703$EXP$$US-NOVITIUMPHARMA-2024USNVP01142$NOVITIUM PHARMA$Pham LL.New Onset Refractory Status Epilepticus in Prion Disease.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;209:A5614$60$YR$A$F$Y$$$20240703$$HP$US$US
240433601$24043360$1$I$20240601$20240628$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104799$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240703$$PH$US$US
240433611$24043361$1$I$$20240626$20240703$20240703$PER$$US-BAUSCHBL-2024BNL029262$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240703$$CN$US$US
240433621$24043362$1$I$$20240628$20240703$20240703$PER$$US-ABBVIE-5822123$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240433635$24043363$5$F$20240620$20240815$20240703$20240817$30DAY$$US-JNJFOC-20240658706$JOHNSON AND JOHNSON$$20$YR$A$M$Y$59.928$KG$20240817$$CN$US$US
240433641$24043364$1$I$20240401$20240628$20240703$20240703$EXP$DE-EMBRYOTOX-202306375$DE-GSK-DE2024081006$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$DE$DE
240433651$24043365$1$I$$20240628$20240703$20240703$PER$$US-ABBVIE-5822019$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240433661$24043366$1$I$20240101$20240625$20240703$20240703$EXP$$US-AMGEN-USASP2024127348$AMGEN$$$$A$F$Y$$$20240702$$HP$US$US
240433671$24043367$1$I$20240101$20240702$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037468$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240703$$HP$US$US
240433681$24043368$1$I$20240611$20240625$20240703$20240703$EXP$$CN-AMGEN-CHNSP2024127950$AMGEN$$65$YR$E$M$Y$52.5$KG$20240702$$HP$CN$CN
240433691$24043369$1$I$20220101$20240625$20240703$20240703$EXP$$CH-ABBVIE-5817640$ABBVIE$$32$YR$$M$Y$118$KG$20240703$$MD$CH$CH
240433701$24043370$1$I$$20240701$20240703$20240703$PER$$US-JNJFOC-20240701115$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240433712$24043371$2$F$$20240722$20240703$20240729$EXP$$EG-AMGEN-EGYSP2024128342$AMGEN$$$$$F$Y$$$20240729$$CN$EG$EG
240433723$24043372$3$F$$20240717$20240703$20240720$PER$$NVSC2024US137123$NOVARTIS$$$$$$Y$$$20240720$$HP$US$US
240433731$24043373$1$I$$20240620$20240703$20240703$PER$$US-ROCHE-10000009757$ROCHE$$79$YR$E$F$Y$$$20240703$$MD$US$US
240433743$24043374$3$F$20240501$20240729$20240703$20240801$30DAY$$US-AMGEN-USASP2024127406$AMGEN$$28$YR$A$M$Y$131.1$KG$20240801$$PH$US$US
240433754$24043375$4$F$$20240910$20240703$20240919$PER$$US-ROCHE-10000013240$ROCHE$$37$YR$A$F$Y$$$20240919$$CN$US$US
240433761$24043376$1$I$$20240623$20240703$20240703$EXP$$US-ABBVIE-5823149$ABBVIE$Davis F, Murray D, Markantonis J, Hoppenot R, Jo J, McCormick-Baw C, et al. Intracranial Cerebral Mucormycosis Infection in the Context of Immunosuppression: Comparison of Ischemic vs. Hemorrhagic Complications. J Neuropathol Exp Neurol. 2024;83(6):467-468.$75$YR$$M$Y$$$20240703$$HP$US$US
240433782$24043378$2$F$20240401$20240805$20240703$20240812$EXP$$US-SANDOZ INC.-SDZ2024US062220$SANDOZ$$60$YR$$F$Y$108.59$KG$20240812$$CN$US$US
240433801$24043380$1$I$$20240626$20240703$20240703$EXP$$JP-GSK-JP2024JPN079902$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$PH$JP$JP
240433811$24043381$1$I$19401213$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406260840319370-DWYJQ$GB-GSK-GB2024081120$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$GB$GB
240433821$24043382$1$I$$20240626$20240703$20240703$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024EME079586$VIIV$$$$$$Y$$$20240703$$MD$GB$GB
240433831$24043383$1$I$20090827$20240621$20240703$20240703$EXP$$GB-ROCHE-10000011919$ROCHE$$69$YR$E$F$Y$46$KG$20240703$$HP$GB$GB
240433841$24043384$1$I$$20240627$20240703$20240703$EXP$$BE-ABBVIE-5823049$ABBVIE$$$$$F$Y$$$20240703$$MD$BE$BE
240433851$24043385$1$I$$20240628$20240703$20240703$EXP$$CA-ABBVIE-5821869$ABBVIE$$$$A$F$Y$$$20240703$$MD$CA$CA
240433861$24043386$1$I$$20240626$20240703$20240703$PER$$PR-JNJFOC-20240672435$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240703$$MD$PR$PR
240433871$24043387$1$I$$20240620$20240703$20240703$PER$$US-JNJFOC-20240658283$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$CN$US$US
240433881$24043388$1$I$$20240627$20240703$20240703$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01143$NOVITIUM PHARMA$Jiayao Wu.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.04-JUN-2024;NA:1-14$19$YR$A$M$Y$$$20240703$$HP$CN$CN
240433891$24043389$1$I$$20240524$20240703$20240703$EXP$$SA-ALXN-202405MES002353SA$ALEXION PHARMACEUTICALS$$$$I$M$Y$$$20240703$$MD$SA$SA
240433901$24043390$1$I$$20231113$20240703$20240703$PER$$US-AMGEN-USASP2023235340$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240433912$24043391$2$F$20210801$20240625$20240703$20240709$EXP$$DE-ABBVIE-5819335$ABBVIE$$61$YR$$M$Y$107$KG$20240709$$MD$DE$DE
240433921$24043392$1$I$20240101$20240627$20240703$20240703$EXP$$CO-ABBVIE-5822639$ABBVIE$$$$$F$Y$$$20240703$$CN$CO$CO
240433932$24043393$2$F$20230525$20240729$20240703$20240812$EXP$DE-EMA-2024611-AUTODUP-1718134334534$DE-ROCHE-10000009009$ROCHE$$44$YR$A$F$Y$111$KG$20240812$$MD$DE$DE
240433941$24043394$1$I$$20240625$20240703$20240703$PER$$US-AstraZeneca-2024A147118$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240433951$24043395$1$I$$20230828$20240703$20240703$PER$$US-AMGEN-USASP2023235263$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240433961$24043396$1$I$$20230825$20240703$20240703$PER$$US-AMGEN-USASP2023235268$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240433971$24043397$1$I$$20240620$20240703$20240703$EXP$$JP-STERISCIENCE B.V.-2024-ST-000938$Steriscience PTE$Imanishi T, Kawabata K, Kanno C, Kanno M, Shimizu M.. A 26 week preterm infant delivered by a mother on extracorporeal membrane oxygenation for COVID-19.. Pediatr-Int. 2022;64 (1):e15229$$$N$M$Y$3.806$KG$20240703$$MD$JP$JP
240433981$24043398$1$I$$20240626$20240703$20240703$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036646$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240703$$HP$CA$CA
240433993$24043399$3$F$$20240716$20240703$20240726$EXP$$CA-BAUSCHBL-2024BNL017087$BAUSCH AND LOMB$$52$YR$$F$Y$50$KG$20240726$$HP$CA$CA
240434001$24043400$1$I$$20240625$20240703$20240703$PER$$US-JNJFOC-20240666911$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$US$US
240434011$24043401$1$I$$20240624$20240703$20240703$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007829$STRIDES$Poondru S, Joseph A, Harding JC, Sundaramoorthi H, Mehta-Shah N, Green P, et al.. Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy.. Case-Rep-Oncol. 2022;15 (3):918-926$$$$$Y$$$20240703$$HP$US$US
240434021$24043402$1$I$$20240701$20240703$20240703$PER$$US-JNJFOC-20240703829$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240434031$24043403$1$I$20240701$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105847$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240703$$MD$US$US
240434042$24043404$2$F$20240601$20240628$20240703$20240704$PER$$US-AMGEN-USASP2024128859$AMGEN$$$$E$F$Y$$$20240704$$HP$US$US
240434051$24043405$1$I$$20240620$20240703$20240703$EXP$$US-STERISCIENCE B.V.-2024-ST-000936$Steriscience PTE$Braat J, Shacker M, Arjuna A.. Atypical Presentation of Central Serous Chorioretinopathy (CSCR) After Lung Transplantation.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$7$DEC$$F$Y$$$20240703$$HP$US$US
240434061$24043406$1$I$$20240628$20240703$20240703$EXP$$CA-ABBVIE-5821727$ABBVIE$$$$A$F$Y$$$20240703$$CN$CA$CA
240434071$24043407$1$I$20240624$20240628$20240703$20240703$EXP$$US-ABBVIE-5822767$ABBVIE$$64$YR$$M$Y$$$20240703$$CN$US$US
240434081$24043408$1$I$$20240625$20240703$20240703$EXP$$US-ROCHE-10000013413$ROCHE$$$$A$F$Y$$$20240703$$HP$US$US
240434091$24043409$1$I$20240527$20240626$20240703$20240703$EXP$$CA-ABBVIE-5823580$ABBVIE$$82$YR$$M$Y$$$20240703$$PH$CA$CA
240434101$24043410$1$I$$20240627$20240703$20240703$EXP$$US-ABBVIE-5821721$ABBVIE$$$$$M$Y$$$20240703$$HP$US$US
240434111$24043411$1$I$$20240625$20240703$20240703$PER$$US-AMGEN-USASP2024128560$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240434123$24043412$3$F$$20240801$20240703$20240809$EXP$$JP-AMGEN-JPNSP2024127850$AMGEN$$68$YR$E$M$Y$$$20240809$$MD$JP$JP
240434131$24043413$1$I$$20240624$20240703$20240703$EXP$$BR-JNJFOC-20240671911$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240703$$MD$BR$BR
240434141$24043414$1$I$$20240618$20240703$20240703$EXP$$US-CIPLA LTD.-2024US06492$CIPLA$$$$$$Y$$$20240703$$HP$US$US
240434151$24043415$1$I$$20240629$20240703$20240703$PER$$US-HALEON-2184572$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240434171$24043417$1$I$$20240627$20240703$20240703$EXP$$AU-GSK-AU2024080478$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$AU$AU
240434181$24043418$1$I$$20240624$20240703$20240703$EXP$$US-TAKEDA-US201916388$TAKEDA$$$$$F$Y$43.08$KG$20240703$$HP$US$US
240434191$24043419$1$I$20171010$20240701$20240703$20240703$EXP$FR-AFSSAPS-ST2024001110$FR-GSK-FR2024081550$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$FR$FR
240434201$24043420$1$I$20240621$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129341$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240434211$24043421$1$I$20100520$20240621$20240703$20240703$EXP$$TW-ROCHE-10000007772$ROCHE$$57$YR$A$M$Y$54$KG$20240703$$CN$TW$TW
240434221$24043422$1$I$20240401$20240702$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037508$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240703$$CN$US$US
240434231$24043423$1$I$$20240625$20240703$20240703$EXP$$FR-CELLTRION INC.-2023FR025579$CELLTRION$Delarbre D, Junca-Laplace C, Otto MP, Antoine C, Defuentes G.. Disseminated tuberculosis after anti-TNF alpha treatment: Do not blindly trust the IGRA test.. Enfermedades Infecciosas y Microbiologia Clinica. 2023$$$$$Y$$$20240703$$MD$FR$FR
240434241$24043424$1$I$$20240625$20240703$20240703$EXP$$GB-ROCHE-10000012882$ROCHE$$$$A$F$Y$$$20240703$$MD$GB$GB
240434251$24043425$1$I$$20240627$20240703$20240703$EXP$$US-GSK-US2024080320$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$HP$US$US
240434261$24043426$1$I$20230101$20240620$20240703$20240703$PER$$US-TEVA-VS-3213085$TEVA$$53$YR$$F$Y$$$20240703$$CN$US$US
240434271$24043427$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031784$AUROBINDO$Federman M, Dragomer D, Grant S, Reemtsen B, Biniwale R.. Use of bivalirudin for anticoagulation during implantation of total artificial heart. J-Extra-Corpor-Technol. 2014;46(2):170-172$19$YR$$M$Y$$$20240703$$MD$US$US
240434281$24043428$1$I$$20231207$20240703$20240703$PER$$US-AMGEN-USASP2023235370$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240434291$24043429$1$I$20240619$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-030154$AUROBINDO$$26$YR$$M$Y$$$20240703$$MD$US$US
240434301$24043430$1$I$20221215$20240620$20240703$20240703$EXP$$CA-ROCHE-10000014215$ROCHE$$47$YR$A$M$Y$$$20240703$$HP$CA$CA
240434312$24043431$2$F$$20240921$20240703$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-032093$AUROBINDO$$67$YR$$M$Y$$$20240927$$PH$US$US
240434321$24043432$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031614$AUROBINDO$Durugu SR, Rajeshkumar Chitra S, Sekaran S, Naro GR. Rare Presentation of Daptomycin induced Eosinophilic Pneumonia in a Patient With Klinefelter^s Syndrome. Am-J-Respir-Crit-CareMed. 2024;209:A2030$46$YR$$M$Y$$$20240703$$HP$US$US
240434331$24043433$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031807$AUROBINDO$Ryan A, Jones M, Broadwell M. Cold and Confused: A Case of Suspected Adrenal Insufficiency After COVID-19. Am-J-Respir-Crit-Care-Med. 2024;209:A3390$92$YR$$F$Y$$$20240703$$HP$US$US
240434344$24043434$4$F$20240627$20240813$20240703$20240822$30DAY$$US-JNJFOC-20240675032$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240822$$CN$US$US
240434352$24043435$2$F$$20240801$20240703$20240801$PER$$US-ALXN-202406USA001602US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
240434361$24043436$1$I$$20240624$20240703$20240703$EXP$$IT-AUROBINDO-AUR-APL-2024-031780$AUROBINDO$Pietrantonio F, Lordi M, Vinci F, Alessi E, Pascucci M, Castelli MD, et al.. Leptomeningeal carcinomatosis, an emerging disease in internal medicine departments with a generally poor prognosis: two case reports.. Italian Journal of Medicine. 2024;volume 18:1727$61$YR$$F$Y$$$20240703$$HP$IT$IT
240434371$24043437$1$I$$20230419$20240703$20240703$PER$$US-AMGEN-USASP2023235409$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240434381$24043438$1$I$$20230309$20240703$20240703$PER$$US-AMGEN-USASP2023235402$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240434391$24043439$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031804$AUROBINDO$Herron E, Powell D, Florell SR, Hansen C.. Drug-induced dermatomyositis following COVID-19 vaccination.. Dermatology Online Journal |. 2024;Volume 30 (2):No. 2$53$YR$$M$Y$$$20240703$$HP$US$US
240434401$24043440$1$I$20210216$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-032487$AUROBINDO$Zhang R, Polenakovik H, Barreras Beltran IA, Waalkes A, Salipante SJ, Xu L, et al.. Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated with Dalbavancin: Case Report and Isolate Characterization.. Clinical Infectious Diseases. 2022;75(9):1641-1644$63$YR$$M$Y$$$20240703$$HP$US$US
240434422$24043442$2$F$$20240701$20240703$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407000895$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240704$$CN$US$US
240434431$24043443$1$I$$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406015667$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240703$$CN$US$US
240434441$24043444$1$I$20240614$20240620$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406014602$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240703$$CN$US$US
240434455$24043445$5$F$$20240826$20240703$20240831$EXP$$PT-CELLTRION INC.-2024PT015808$CELLTRION$$$$$$Y$$$20240831$$HP$PT$PT
240434461$24043446$1$I$20240427$20240624$20240703$20240703$EXP$$IT-AUROBINDO-AUR-APL-2024-031409$AUROBINDO$$80$YR$$M$Y$$$20240703$$MD$IT$IT
240434471$24043447$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031863$AUROBINDO$Agudelo Higuita NI, Yuen C.. Hemophagocytic Lymphohistiocytosis Secondary to Ehrlichia Chaffeensis in Adults. Am-J-Med-Sci. 2021;361(2):269- 273$62$YR$$F$Y$$$20240703$$HP$US$US
240434481$24043448$1$I$$20240624$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031568$AUROBINDO$$74$YR$$F$Y$$$20240703$$MD$FR$FR
240434491$24043449$1$I$$20240624$20240703$20240703$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP007808$STRIDES$Fore R, Liozon E, Dumonteil S, Sene T, Heron E, Lacombe V, et al.. BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score analysis.. Joint-Bone-Spine. 2023;91 (1)$$$$$Y$$$20240703$$HP$FR$FR
240434501$24043450$1$I$$20240624$20240703$20240703$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP007809$STRIDES$Fore R, Liozon E, Dumonteil S, Sene T, Heron E, Lacombe V, et al.. BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score analysis.. Joint-Bone-Spine. 2023;91 (1)$$$$$Y$$$20240703$$HP$FR$FR
240434522$24043452$2$F$$20240823$20240703$20240903$EXP$$GB-AUROBINDO-AUR-APL-2024-032757$AUROBINDO$$$$$M$Y$$$20240903$$MD$GB$GB
240434531$24043453$1$I$20240621$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024128230$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240434541$24043454$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129142$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240434551$24043455$1$I$$20240308$20240703$20240703$PER$$US-AMGEN-USASP2024130450$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240434561$24043456$1$I$$20240629$20240703$20240703$PER$$US-JNJFOC-20240701026$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240434571$24043457$1$I$$20240624$20240703$20240703$EXP$$CO-STRIDES ARCOLAB LIMITED-2024SP007822$STRIDES$Corredor-Orlandelli D, Borda C, Sierra JS, Fernandez-Avila DG.. SILICOSIS-ASSOCIATED FIVE-DISEASE MULTIPLE AUTOIMMUNE SYNDROME WITH SEVERAL PULMONARY COMPLICATIONS: A CASE REPORT AND LITERATURE REVIEW.. Revmatologiia. 2024;31 (4)::123-128.$47$YR$$M$Y$$$20240703$$HP$CO$CO
240434581$24043458$1$I$$20240628$20240703$20240703$EXP$$GB-JNJFOC-20240704556$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$HP$GB$GB
240434591$24043459$1$I$20240622$20240627$20240703$20240703$EXP$$US-AstraZeneca-2024A148721$ASTRAZENECA$$51$YR$$F$Y$46.3$KG$20240703$$CN$US$
240434602$24043460$2$F$20231201$20240708$20240703$20240715$PER$$US-SA-2024SA193415$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240715$$MD$US$US
240434611$24043461$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA193523$SANOFI AVENTIS$$$$E$F$Y$$$20240703$$MD$US$US
240434621$24043462$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA192968$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
240434631$24043463$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA192922$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240703$$MD$US$US
240434641$24043464$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA193084$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240703$$MD$US$US
240434651$24043465$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA192383$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
240434661$24043466$1$I$$20240625$20240703$20240703$PER$$US-SA-2024SA192389$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
240434674$24043467$4$F$20230101$20240730$20240703$20240808$PER$$US-SA-2024SA192607$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240808$$MD$US$US
240434681$24043468$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031391$AUROBINDO$Ruff K, Wikenheiser-Brokamp KA, Critser P, Hirsch R, Burg G, Hayes D, et al.. Pulmonary Capillary Hemangiomatosis: A Rare Disorder With a Nonspecific Presentation.. Am-J-Respir-Crit-Care-Med. 2024;2 0 9:A2 3 2 7$9$YR$$F$Y$$$20240703$$HP$US$US
240434691$24043469$1$I$$20240624$20240703$20240703$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP007761$STRIDES$Roccatello D, Baffa A, Naretto C, Barreca A, Cravero R, Roscini E, et al.. Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy. Clin-Kidney-J. 2023;16 (8):1258-1264$32$YR$$M$Y$$$20240703$$HP$IT$IT
240434701$24043470$1$I$20240620$20240626$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103367$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$79.1$KG$20240703$$PH$US$US
240434711$24043471$1$I$$20240620$20240703$20240703$EXP$$IE-MACLEODS PHARMA-MAC2024047893$MACLEODS$S. Temperley T, Temperley HC, O^Sullivan NJ, Corr A, Brennan I, Kelly ME, et al..Tracheoesophageal fistula development following radiotherapy and tyrosine kinase inhibitors  in a patient with advanced follicular thyroid carcinoma: A case-based review..Irish Journal of Medical Science..2024;193(3):1143-1147$$$$$Y$$$20240702$$MD$IE$IE
240434721$24043472$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047895$MACLEODS$Renzetti M, Potnis K, Vemmou E, Hansen B, Lin D, Yaggi H..Salty, Sweet, and Severe: A Case of Linagliptin-induced Severe Hyponatremia..American Journal of Respiratory and Critical Care Medicine.2024;209:A7036$$$$$Y$$$20240702$$MD$US$US
240434732$24043473$2$F$20230101$20240626$20240703$20240705$EXP$CN-MLMSERVICE-20240617-PI103879-00232-1$CN-STRIDES ARCOLAB LIMITED-2024SP007781$STRIDES$Cheng Y, Ting-Ting L, Li-Tao G.. Chronic inflammatory demyelinating polyneuropathy with pulmonary nocardiosis: A case report.. Medicine. 2024;103(24):1-7.$65$YR$$M$Y$$$20240705$$MD$CN$CN
240434741$24043474$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047896$MACLEODS$Vincent J, Greenberg J, Sanghani S, Finneran K, Nguyen N..Profound Lactic Acidosis and Shock in a Patient Taking Metformin..American Journal of Respiratory and Critical Care Medicine.2024;209$$$$$Y$$$20240702$$MD$US$US
240434751$24043475$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047894$MACLEODS$Hoerle R, Qiao X..A Last Resort: Lipid Emulsion Therapy in Lidocaine Anesthetic Systemic Toxicity (LAST). InC44. TOXIDROMES AND ADVERSE MEDICATION REACTIONS IN THE ICU.American Journal of Respiratory and Critical Care Medicine.MAY 2024;209:A5683$81$YR$E$F$Y$65$KG$20240702$$MD$US$US
240434761$24043476$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047897$MACLEODS$Lam E, Santos C, Patrawalla A..A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose.. A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose.2024;209:A5651$$$$$Y$$$20240702$$MD$US$US
240434771$24043477$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047882$MACLEODS$lmazan E, Ellaicy O, Carter D, Kaleka K, Faruqi M..Methylene Blue as Adjunctive Therapy in Calcium-channel Blocker Induced Vasoplegia..American Journal of Respiratory and Critical Care Medicine.2024;209:A5655$$$$$Y$$$20240702$$MD$US$US
240434781$24043478$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047905$MACLEODS$Gupta UD, Chowdhury T, Niriyan J, Bellamkonda A, Aryal B, Al-Ghuraibawi M..Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care.Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care.2024;209$$$$$Y$$$20240702$$MD$US$US
240434791$24043479$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047902$MACLEODS$Gutierrez L, Patel D, Ramanujam D, Patel D, Modugula S, Disilvio B..The Downside of Your  Uppers: Venlafaxine-induced Hypertriglyceridemia Causing Acute Pancreatitis..American  Journal of Respiratory and Critical Care Medicine..2024;209:A5693$$$$$Y$$$20240702$$MD$US$US
240434801$24043480$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047898$MACLEODS$Patel D, Patel D, Chittal A, Malik K, Disilvio B..A Tail of Caution: Pioglitazone Induced Recurrent Pleural Effusion.American Journal of Respiratory and Critical Care Medicine.2024;209:A2015$68$YR$E$F$Y$$$20240702$$MD$US$US
240434811$24043481$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047900$MACLEODS$Barrows C, Horton M, Allaham A, Israel HP..A Case of Acute Hypoxic Respiratory Failure After Administration of Rituximab.American Journal of Respiratory and Critical Care Medicine.2024;209:A6326$61$YR$A$M$Y$$$20240702$$MD$US$US
240434823$24043482$3$F$$20240715$20240703$20240726$EXP$$US-MACLEODS PHARMA-MAC2024047904$MACLEODS$Mikhail E, Alexander D, Jankowski M, Pandya D, Kunadi A..Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature..American Journal of Respiratory and Critical Care Medicine..2024;209:A3410$$$$$Y$$$20240726$$MD$US$US
240434831$24043483$1$I$$20240620$20240703$20240703$EXP$$JP-MACLEODS PHARMA-MAC2024047901$MACLEODS$Inoue F, Okazaki Y, Ichiba T, Chiba T, Namera A.Giant T waves and QT interval prolongation associated with guanfacine toxicity.Clinical Toxicology.2024;62(4):269-71$$$$$Y$$$20240702$$MD$JP$JP
240434841$24043484$1$I$20240604$20240701$20240703$20240703$EXP$$CN-ROCHE-10000013843$ROCHE$$46$YR$A$M$Y$75$KG$20240703$$HP$CN$CN
240434851$24043485$1$I$20240501$20240625$20240703$20240703$PER$$US-SA-2024SA193360$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240703$$MD$US$US
240434861$24043486$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA181684$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240703$$HP$US$US
240434873$24043487$3$F$20240502$20240619$20240703$20240708$EXP$$TW-ROCHE-10000009533$ROCHE$$36$YR$A$F$Y$45$KG$20240708$$MD$TW$TW
240434881$24043488$1$I$$20240624$20240703$20240703$PER$$US-CHATTEMPRD-2024OHG022608$CHATTEM$$$$A$$Y$$$20240703$$CN$US$US
240434892$24043489$2$F$20240101$20240702$20240703$20240711$PER$$US-SA-2024SA193562$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240711$$MD$US$US
240434903$24043490$3$F$20240101$20240807$20240703$20240815$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00343$MIRUM PHARMACEUTICALS$$$$$M$Y$12.7$KG$20240815$$CN$US$US
240434912$24043491$2$F$$20240708$20240703$20240718$PER$$US-APOTEX-2024AP007319$APOTEX$$$$$F$Y$$$20240718$$CN$US$US
240434921$24043492$1$I$$20240619$20240703$20240703$EXP$$GB-CIPLA LTD.-2024GB06646$CIPLA$$$$$$Y$$$20240703$$CN$GB$GB
240434933$24043493$3$F$20240101$20240819$20240703$20240826$PER$$US-SA-2024SA189819$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240826$$MD$US$US
240434946$24043494$6$F$20240610$20240820$20240703$20240826$EXP$$AR-JNJFOC-20240671374$JOHNSON AND JOHNSON$$22$YR$A$F$Y$37$KG$20240826$$CN$AR$AR
240434951$24043495$1$I$$20240620$20240703$20240703$PER$$US-JNJFOC-20240654720$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$CN$US$US
240434961$24043496$1$I$$20240624$20240703$20240703$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP007763$STRIDES$Roccatello D, Baffa A, Naretto C, Barreca A, Cravero R, Roscini E, et al.. Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy.. Clin-Kidney-J. 2023;16 (8):1258-1264.$26$YR$$F$Y$$$20240703$$HP$IT$IT
240434971$24043497$1$I$20240610$20240618$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100890$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$59.87$KG$20240703$$HP$US$US
240434981$24043498$1$I$20240621$20240630$20240703$20240703$EXP$$CN-ABBVIE-5821896$ABBVIE$$42$YR$$M$Y$65$KG$20240703$$MD$CN$CN
240434991$24043499$1$I$20240101$20240630$20240703$20240703$EXP$$IL-ABBVIE-5822212$ABBVIE$$72$YR$$M$Y$$$20240703$$MD$IL$IL
240435001$24043500$1$I$$20231025$20240703$20240703$PER$$US-AMGEN-USASP2023235231$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240435012$24043501$2$F$$20240706$20240703$20240709$PER$$US-ABBVIE-5823211$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240435021$24043502$1$I$20240314$20240625$20240703$20240703$EXP$$GB-AUROBINDO-AUR-APL-2024-031571$AUROBINDO$$22$YR$$F$Y$53$KG$20240703$$CN$GB$GB
240435031$24043503$1$I$$20230731$20240703$20240703$PER$$US-AMGEN-USASP2023235440$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240435041$24043504$1$I$20240628$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024129249$AMGEN$$71$YR$E$F$Y$$$20240702$$CN$US$US
240435051$24043505$1$I$$20231202$20240703$20240703$PER$$US-AMGEN-USASP2023235267$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240435062$24043506$2$F$20231201$20240819$20240703$20240828$PER$$US-SA-2024SA189439$SANOFI AVENTIS$$48$YR$A$F$Y$76.2$KG$20240828$$MD$US$US
240435071$24043507$1$I$$20240627$20240703$20240703$EXP$$DK-AstraZeneca-2024A148390$ASTRAZENECA$$70$YR$$M$Y$$$20240703$$MD$DK$
240435081$24043508$1$I$20240101$20240625$20240703$20240703$PER$$US-SA-2024SA193540$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240703$$MD$US$US
240435091$24043509$1$I$20240101$20240626$20240703$20240703$PER$$US-SA-2024SA192569$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240703$$MD$US$US
240435102$24043510$2$F$20240522$20240813$20240703$20240815$EXP$$FR-ABBVIE-5823389$ABBVIE$$29$YR$$F$Y$50$KG$20240815$$MD$FR$FR
240435122$24043512$2$F$20240607$20240808$20240703$20240815$EXP$$US-GSK-US2024079200$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$HP$US$US
240435131$24043513$1$I$$20240626$20240703$20240703$30DAY$$US-GSK-US2024AMR081030$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240435141$24043514$1$I$$20240621$20240703$20240703$EXP$$US-NOVOPROD-1247517$NOVO NORDISK$$$$$M$Y$$$20240703$$CN$US$US
240435151$24043515$1$I$$20240623$20240703$20240703$EXP$$US-NOVOPROD-1245217$NOVO NORDISK$$39$YR$$$Y$$$20240703$$CN$US$US
240435161$24043516$1$I$$20240624$20240703$20240703$EXP$$US-NOVOPROD-1245132$NOVO NORDISK$$$$$M$Y$$$20240703$$CN$US$US
240435171$24043517$1$I$20231201$20240624$20240703$20240703$EXP$$EG-NOVOPROD-1244945$NOVO NORDISK$$906$MON$$M$Y$$$20240703$$CN$EG$EG
240435181$24043518$1$I$20230131$20240623$20240703$20240703$EXP$$US-NOVOPROD-1245511$NOVO NORDISK$$$$$F$Y$$$20240703$$MD$US$US
240435192$24043519$2$F$20240123$20240708$20240703$20240718$EXP$$IL-NOVOPROD-1244539$NOVO NORDISK$$$$$F$Y$72$KG$20240718$$CN$IL$IL
240435201$24043520$1$I$$20240624$20240703$20240703$PER$$US-JNJFOC-20240666799$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240703$$CN$US$US
240435211$24043521$1$I$20240625$20240625$20240703$20240703$EXP$$US-JNJFOC-20240670625$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240703$$MD$US$US
240435221$24043522$1$I$20240619$20240626$20240703$20240703$PER$$US-ABBVIE-5820349$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240435231$24043523$1$I$20240610$20240628$20240703$20240703$EXP$$US-ABBVIE-5821877$ABBVIE$$43$YR$$F$Y$$$20240703$$CN$US$US
240435241$24043524$1$I$$20240624$20240703$20240703$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP007766$STRIDES$Fenech M, Ajanaku A, McCormick A, Coupland SE, Krishna Y, Sultan Z, et al.. Orbital Kimura disease: maintenance therapy using mycophenolate mofetil. Orbit. 2024;1-8$55$YR$$M$Y$$$20240703$$HP$GB$GB
240435251$24043525$1$I$$20240624$20240703$20240703$EXP$$US-CHEPLA-2024008144$CHEPLAPHARM$Huang L, Ellis TJ, Bagavathy K. The Unfortunate Trifecta: Tuberculosis, EBV, and CMV Induced Hemophagocytic Lymphohistiocytosis. Am J Respir Crit Care Med 2024;209.$52$YR$$M$Y$$$20240702$$HP$COUNTRY NOT SPECIFIED$US
240435261$24043526$1$I$$20240620$20240703$20240703$PER$$US-TEVA-VS-3212954$TEVA$$25$YR$$F$Y$$$20240703$$CN$US$US
240435272$24043527$2$F$20240301$20240809$20240703$20240820$EXP$$US-NOVOPROD-1246448$NOVO NORDISK$$54$YR$$F$Y$109.7$KG$20240820$$MD$US$US
240435281$24043528$1$I$$20240624$20240703$20240703$EXP$$US-NOVOPROD-1245816$NOVO NORDISK$$$$$F$Y$$$20240703$$CN$US$US
240435291$24043529$1$I$$20240624$20240703$20240703$EXP$$US-NOVOPROD-1245595$NOVO NORDISK$$$$$F$Y$$$20240703$$MD$US$US
240435301$24043530$1$I$20240218$20240624$20240703$20240703$EXP$DK-DKMA-30729426$DK-NOVOPROD-1245749$NOVO NORDISK$$57$YR$$F$Y$110$KG$20240703$$MD$DK$DK
240435311$24043531$1$I$$20240613$20240703$20240703$30DAY$$US-NOVOPROD-1246015$NOVO NORDISK$$$$$$Y$$$20240703$$CN$US$US
240435321$24043532$1$I$$20240624$20240703$20240703$EXP$$US-NOVOPROD-1246482$NOVO NORDISK$$$$$F$Y$$$20240703$$CN$US$US
240435331$24043533$1$I$$20240624$20240703$20240703$EXP$$US-NOVOPROD-1246113$NOVO NORDISK$$$$$$Y$$$20240703$$HP$US$US
240435343$24043534$3$F$$20240813$20240703$20240821$30DAY$$LB-NOVOPROD-1243993$NOVO NORDISK$$$$A$F$Y$$$20240821$$MD$LB$LB
240435351$24043535$1$I$20240626$20240624$20240703$20240703$EXP$$US-NOVOPROD-1246478$NOVO NORDISK$$69$YR$$M$Y$$$20240703$$CN$US$US
240435362$24043536$2$F$20240201$20240808$20240703$20240820$EXP$$CA-NOVOPROD-1246623$NOVO NORDISK$$78$YR$$M$Y$$$20240820$$CN$CA$CA
240435371$24043537$1$I$20240616$20240624$20240703$20240703$EXP$DE-CADRBFARM-2024328877$DE-NOVOPROD-1245741$NOVO NORDISK$$70$YR$$M$Y$$$20240703$$MD$DE$DE
240435381$24043538$1$I$$20240701$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062227$SANDOZ$$$$$$Y$$$20240703$$CN$US$US
240435392$24043539$2$F$$20240920$20240703$20240924$EXP$$US-SANDOZ INC.-SDZ2023US001049$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
240435401$24043540$1$I$20240613$20240625$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062237$SANDOZ$$$$$$Y$$$20240703$$PH$US$US
240435412$24043541$2$F$$20240703$20240703$20240711$EXP$$IE-CELLTRION INC.-2024IE015745$CELLTRION$Cunneen B, Hussein H, OSullivan J, Yearoo I.. Calcific constrictive pericarditis following tumour necrosis factor-alpha inhibition.. European heart journal. 2024;8(2)$$$$$Y$$$20240711$$HP$IE$IE
240435421$24043542$1$I$20240509$20240625$20240703$20240703$EXP$$CN-JNJFOC-20240670349$JOHNSON AND JOHNSON$$58$YR$A$F$Y$39$KG$20240703$$HP$CN$CN
240435431$24043543$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129467$AMGEN$Lund T. C.; Gupta A. O.; Furcich J. W. et al.. Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy. Journal of neuroimmunology. 2024;393:1-12$9$YR$C$M$Y$$$20240702$$HP$US$US
240435441$24043544$1$I$$20240625$20240703$20240703$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP007804$STRIDES$Jabiry-Zieniewicz Z, Stelmach DA, Jasak K, Knap-Wielgus W, Szumska A, Raszeja-Wyszomirska J, et al.. Pregnancies in Women After Liver Transplant due to Wilson^s Disease-Case Series.. Transplant-Proc. 2024;56 (4):919-922$29$YR$$F$Y$$$20240703$$HP$PL$PL
240435451$24043545$1$I$$20240626$20240703$20240703$30DAY$$US-GSK-US2024AMR081228$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240435461$24043546$1$I$20240227$20240624$20240703$20240703$EXP$$CN-UCBSA-2024032672$UCB$$$$N$$Y$$$20240703$$CN$CN$CN
240435471$24043547$1$I$$20240624$20240703$20240703$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001997$Alvotech$$39$YR$$F$Y$$$20240703$$CN$CA$CA
240435481$24043548$1$I$$20240625$20240703$20240703$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP007805$STRIDES$Jabiry-Zieniewicz Z, Stelmach DA, Jasak K, Knap-Wielgus W, Szumska A, Raszeja-Wyszomirska J, et al.. Pregnancies in Women After Liver Transplant due to Wilson^s Disease-Case Series.. Transplant-Proc. 2024;56 (4):919-922$$$$$Y$$$20240703$$HP$PL$PL
240435491$24043549$1$I$$20240625$20240703$20240703$EXP$$SA-STRIDES ARCOLAB LIMITED-2024SP007765$STRIDES$Zafar A.. Case Report: Non-convulsive seizure following traumatic brain injury - a significant occurrence that needs to be considered due to potential long-term sequelae.. F1000Res. 2023;12$13$YR$$F$Y$$$20240703$$HP$SA$SA
240435501$24043550$1$I$$20240502$20240703$20240703$PER$$US-AMGEN-USASP2024130429$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240435511$24043551$1$I$$20240626$20240703$20240703$EXP$$CH-AMGEN-CHESP2024126951$AMGEN$$$$E$F$Y$$$20240702$$MD$CH$CH
240435521$24043552$1$I$20240624$20240701$20240703$20240703$EXP$$GB-HALEON-2184617$Haleon PLC$$63$YR$$F$Y$57$KG$20240702$$PH$GB$GB
240435531$24043553$1$I$20240627$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024129168$AMGEN$$74$YR$E$F$Y$$$20240702$$CN$US$US
240435541$24043554$1$I$$20240624$20240703$20240703$EXP$$US-AMAROX PHARMA-HET2024US02007$HETERO$$$$$M$Y$$$20240703$$CN$US$US
240435551$24043555$1$I$20240625$20240625$20240703$20240703$EXP$$US-VIIV HEALTHCARE LIMITED-US2024079747$VIIV$$32$YR$$M$Y$$$20240703$$CN$US$US
240435562$24043556$2$F$20230105$20240722$20240703$20240726$EXP$$JP-GSK-JP2024081693$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$MD$JP$JP
240435571$24043557$1$I$20240506$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130074$AMGEN$$64$YR$A$M$Y$$$20240702$$HP$US$US
240435581$24043558$1$I$20240625$20240628$20240703$20240703$EXP$GB-MHRA-TPP37044927C16176816YC1719306210825$GB-STRIDES ARCOLAB LIMITED-2024SP007827$STRIDES$$39$YR$$F$Y$$$20240703$$HP$GB$GB
240435591$24043559$1$I$20240617$20240624$20240703$20240703$EXP$$CA-JNJFOC-20240522981$JOHNSON AND JOHNSON$$18$YR$$M$Y$61$KG$20240703$$HP$CA$CA
240435601$24043560$1$I$20230101$20240627$20240703$20240703$EXP$$US-BEIGENE-BGN-2024-009893$BEIGENE$$$$$$Y$$$20240703$$CN$US$US
240435612$24043561$2$F$20190101$20240628$20240703$20240703$PER$$US-ABBVIE-5818524$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240435621$24043562$1$I$20240601$20240626$20240703$20240703$PER$$US-SA-2024SA193330$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240703$$MD$US$US
240435631$24043563$1$I$20240101$20240621$20240703$20240703$PER$$US-SA-2024SA189434$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240703$$MD$US$US
240435642$24043564$2$F$20240501$20240912$20240703$20240922$PER$$US-SA-2024SA186886$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240922$$MD$US$US
240435651$24043565$1$I$$20240205$20240703$20240703$PER$$US-AMGEN-USASP2024129962$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240435671$24043567$1$I$20240518$20240528$20240703$20240703$PER$$US-AMGEN-USASP2024131056$AMGEN$$76$YR$E$M$Y$$$20240702$$CN$US$US
240435681$24043568$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129474$AMGEN$Lund T. C.; Gupta A. O.; Furcich J. W. et al. Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy. Journal of neuroimmunology. 2024;393:1-12$6$YR$C$M$Y$$$20240702$$HP$US$US
240435691$24043569$1$I$20230601$20240701$20240703$20240703$EXP$FR-AFSSAPS-2024054487$FR-UCBSA-2024033233$UCB$$84$YR$$F$Y$$$20240703$$PH$FR$FR
240435702$24043570$2$F$$20240916$20240703$20240925$PER$$US-GSK-US2024AMR080045$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
240435712$24043571$2$F$$20240814$20240703$20240824$30DAY$$US-GSK-US2024080408$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
240435721$24043572$1$I$$20240625$20240703$20240703$PER$$US-ABBVIE-5818666$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240435731$24043573$1$I$$20240626$20240703$20240703$EXP$$CA-HALEON-2183924$Haleon PLC$$44$YR$$F$Y$60$KG$20240702$$HP$CA$CA
240435741$24043574$1$I$$20240702$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037519$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$$$20240703$$CN$US$US
240435751$24043575$1$I$$20240630$20240703$20240703$EXP$$US-HALEON-2184587$Haleon PLC$$$$$$Y$$$20240702$$CN$US$US
240435761$24043576$1$I$20240625$20240701$20240703$20240703$EXP$$CN-ROCHE-10000013925$ROCHE$$57$YR$A$F$Y$59.5$KG$20240703$$HP$CN$CN
240435772$24043577$2$F$20240101$20240716$20240703$20240723$EXP$$HN-BIOGEN-2024BI01272007$BIOGEN$$$$$F$Y$72.6$KG$20240723$$CN$HN$HN
240435781$24043578$1$I$$20240219$20240703$20240703$PER$$US-AMGEN-USASP2024129921$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240435791$24043579$1$I$$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024130837$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240435801$24043580$1$I$20240627$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024129095$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240435811$24043581$1$I$20240621$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024129350$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240435821$24043582$1$I$$20240610$20240703$20240703$30DAY$$CA-JNJFOC-20240616280$JOHNSON AND JOHNSON$$58$YR$A$M$Y$61$KG$20240703$$HP$CA$CA
240435831$24043583$1$I$20230901$20240625$20240703$20240703$EXP$$FR-CELLTRION INC.-2024FR015632$CELLTRION$$$$$$Y$$$20240703$$PH$FR$FR
240435841$24043584$1$I$$20240625$20240703$20240703$EXP$$CA-TOLMAR, INC.-24CA050470$TOLMAR$$$$$M$Y$$$20240703$$PH$CA$CA
240435851$24043585$1$I$$20240625$20240703$20240703$EXP$$CA-TOLMAR, INC.-24CA050497$TOLMAR$$$$$M$Y$$$20240703$$CN$CA$CA
240435867$24043586$7$F$20200721$20240814$20240703$20240822$EXP$$IT-TOLMAR, INC.-24IT050457$TOLMAR$$35$YR$$F$Y$58$KG$20240822$$MD$IT$IT
240435871$24043587$1$I$20240626$20240701$20240703$20240703$EXP$$CN-ROCHE-10000013884$ROCHE$$61$YR$A$F$Y$59$KG$20240703$$HP$CN$CN
240435881$24043588$1$I$$20240627$20240703$20240703$30DAY$$US-GSK-US2024080426$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240435891$24043589$1$I$$20240627$20240703$20240703$EXP$$ES-HALEON-2184334$Haleon PLC$Neutropenia Febril. REVISTA DE SA?DE AMATO LUSITANO 2017, 4? CMBI - 46. 2017 DEC;.; Rodriguez B, Almeida H, Belhassen M, Per Ez ML, Madruga I. Febrile neutropenia$81$YR$$F$Y$$$20240702$$MD$ES$ES
240435901$24043590$1$I$20240615$20240701$20240703$20240703$EXP$$CN-ROCHE-10000014053$ROCHE$$36$YR$A$F$Y$$$20240703$$HP$CN$CN
240435911$24043591$1$I$$20240604$20240703$20240703$PER$$US-JNJFOC-20240609586$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240435921$24043592$1$I$20240323$20240701$20240703$20240703$EXP$$AU-JAZZ PHARMACEUTICALS-2024-AU-010120$JAZZ$$28$YR$$M$Y$$$20240702$$HP$AU$AU
240435931$24043593$1$I$$20230710$20240703$20240703$PER$$US-AMGEN-USASP2023235365$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240435942$24043594$2$F$20240622$20240702$20240703$20240715$PER$$US-AMGEN-USASP2024128172$AMGEN$$50$YR$A$F$Y$$$20240715$$CN$US$US
240435951$24043595$1$I$$20240628$20240703$20240703$30DAY$$US-GSK-US2024081050$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240435961$24043596$1$I$$20240701$20240703$20240703$PER$$US-HALEON-2184755$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240435971$24043597$1$I$$20240628$20240703$20240703$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037422$BOEHRINGER INGELHEIM$$84$YR$E$M$Y$$$20240703$$HP$CO$CO
240435981$24043598$1$I$20240101$20240627$20240703$20240703$PER$$US-ABBVIE-5820286$ABBVIE$$$$$$Y$$$20240703$$PH$US$US
240435991$24043599$1$I$$20240404$20240703$20240703$PER$$US-AMGEN-USASP2024130459$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240436001$24043600$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137276$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240436011$24043601$1$I$$20240624$20240703$20240703$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002001$Alvotech$$39$YR$$M$Y$$$20240703$$MD$CA$CA
240436021$24043602$1$I$$20240702$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105794$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240703$$HP$US$US
240436042$24043604$2$F$$20240912$20240703$20240924$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001999$Alvotech$$$$$F$Y$$$20240924$$CN$CA$CA
240436051$24043605$1$I$$20240627$20240703$20240703$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-000345$Alvotech$$35$YR$$M$Y$$$20240703$$CN$CA$CA
240436061$24043606$1$I$$20240627$20240703$20240703$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-001171$Alvotech$$70$YR$$F$Y$$$20240703$$PH$CA$CA
240436073$24043607$3$F$20240614$20240712$20240703$20240720$EXP$$ES-GRUNENTHAL-2024-122202$AVERITAS$$64$YR$$F$Y$$$20240719$$HP$ES$ES
240436082$24043608$2$F$$20240816$20240703$20240821$PER$$NVSC2024US133264$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
240436091$24043609$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA192191$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240703$$MD$US$US
240436111$24043611$1$I$$20240614$20240703$20240703$PER$$US-JNJFOC-20240641834$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240436121$24043612$1$I$$20240604$20240703$20240703$PER$$US-JNJFOC-20240609713$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240436131$24043613$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105873$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240703$$CN$US$US
240436141$24043614$1$I$$20240619$20240703$20240703$EXP$$US-APOTEX-2024AP007636$APOTEX$Ries R, Cho YD, Deitchman AR.. Elevated Inflammation Sepsis Phenotype as a Potential Risk Factor for Propofol Related Infusion Syndrome: A Case Report. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-3$32$YR$$F$Y$$$20240703$$HP$US$US
240436152$24043615$2$F$20240627$20240802$20240703$20240806$PER$$US-AMGEN-USASP2024128782$AMGEN$$72$YR$E$F$Y$$$20240806$$CN$US$US
240436161$24043616$1$I$20240628$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024128770$AMGEN$$$$$F$Y$$$20240702$$CN$US$US
240436171$24043617$1$I$20240628$20240628$20240703$20240703$30DAY$$US-GSK-US2024081194$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240703$$CN$US$US
240436181$24043618$1$I$20231108$20240628$20240703$20240703$30DAY$$US-GSK-US2024081158$GLAXOSMITHKLINE$$32$YR$$F$Y$58.97$KG$20240703$$CN$US$US
240436191$24043619$1$I$$20240624$20240703$20240703$PER$$US-JNJFOC-20240663656$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240703$$CN$US$US
240436203$24043620$3$F$20240623$20240822$20240703$20240904$PER$$US-AstraZeneca-2024A145637$ASTRAZENECA$$24666$DY$$M$Y$$$20240904$$CN$US$
240436211$24043621$1$I$$20240630$20240703$20240703$EXP$$US-JNJFOC-20240703554$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240436221$24043622$1$I$$20240624$20240703$20240703$EXP$$US-APOTEX-2024AP007779$APOTEX$Holbert K.. Multiorgan Failure From Heat Stroke in a Person Taking Glycopyrrolate. American Journal of Respiratory and Critical Care Medicine. 2024;209$24$YR$$M$Y$$$20240703$$HP$US$US
240436231$24043623$1$I$$20240624$20240703$20240703$EXP$$US-HETERO-HET2024US02044$HETERO$Kim AH, Taha W, Prudenti J.. A Critical Case of Hydralazine-induced Vasculitis Presenting With Pulmonary Renal Syndrome. American Thoracic Society.. 2024;A7071$72$YR$$M$Y$$$20240703$$HP$US$US
240436241$24043624$1$I$$20240624$20240703$20240703$EXP$$FR-CELLTRION INC.-2024FR015757$CELLTRION$$$$$$Y$$$20240703$$PH$FR$FR
240436251$24043625$1$I$20240615$20240626$20240703$20240703$EXP$$CN-HALEON-2184063$Haleon PLC$$36$YR$$M$Y$70$KG$20240703$$HP$CN$CN
240436262$24043626$2$F$20240501$20240626$20240703$20240704$EXP$$US-ABBVIE-5819879$ABBVIE$$82$YR$$M$Y$59.9$KG$20240704$$CN$US$US
240436271$24043627$1$I$$20240624$20240703$20240703$PER$$US-JNJFOC-20240663691$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240436281$24043628$1$I$20240501$20240627$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103933$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240703$$HP$US$US
240436291$24043629$1$I$$20231019$20240703$20240703$PER$$US-AMGEN-USASP2023235408$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240436302$24043630$2$F$20240622$20240823$20240703$20240827$PER$$US-AMGEN-USASP2024131171$AMGEN$$67$YR$E$F$Y$$$20240827$$CN$US$US
240436311$24043631$1$I$20230801$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024129531$AMGEN$$60$YR$A$F$Y$$$20240702$$CN$US$US
240436321$24043632$1$I$20240622$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024128154$AMGEN$$78$YR$E$F$Y$$$20240702$$CN$US$US
240436333$24043633$3$F$20240609$20240628$20240703$20240709$EXP$$US-ROCHE-10000002795$ROCHE$$9$YR$C$M$Y$35.4$KG$20240705$$CN$US$US
240436341$24043634$1$I$20240221$20240622$20240703$20240703$EXP$FR-AFSSAPS-TO2024000809$FR-Accord-432168$ACCORD$$85$YR$E$M$Y$80.8$KG$20240703$$PH$FR$FR
240436351$24043635$1$I$20240326$20240620$20240703$20240703$EXP$ES-AEMPS-1535348$ES-HIKMA PHARMACEUTICALS USA INC.-ES-H14001-24-05887$HIKMA$$58$YR$$F$Y$$$20240703$$MD$ES$ES
240436361$24043636$1$I$$20240623$20240703$20240703$PER$$US-APOTEX-2024AP007782$APOTEX$Rao M, Casias M, Abidi MZ.. Disseminated Scedosporium infection in the early post-kidney transplant period. Transplant Infectious Disease. 2024;26 (2):el4232$63$YR$$F$Y$$$20240703$$HP$US$US
240436371$24043637$1$I$$20240417$20240703$20240703$PER$$US-AMGEN-USASP2024130702$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240436381$24043638$1$I$$20240623$20240703$20240703$PER$$US-ROCHE-10000010395$ROCHE$$4$YR$C$M$Y$$$20240703$$CN$US$US
240436391$24043639$1$I$20240101$20240621$20240703$20240703$PER$$US-Encube-000796$ENCUBE ETHICALS$$53$YR$A$F$Y$$$20240703$$CN$US$
240436401$24043640$1$I$$20240701$20240703$20240703$EXP$$US-JNJFOC-20240702183$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$MD$US$US
240436411$24043641$1$I$$20240628$20240703$20240703$PER$$US-GILEAD-2024-0679083$GILEAD$$$$$M$Y$$$20240702$$CN$US$US
240436422$24043642$2$F$$20240724$20240703$20240726$EXP$$JP-BEH-2024174609$CSL BEHRING$$$$$$Y$$$20240726$$MD$JP$JP
240436431$24043643$1$I$20240601$20240628$20240703$20240703$EXP$$US-UCBSA-2024033416$UCB$$43$YR$$F$Y$$$20240703$$HP$US$US
240436441$24043644$1$I$20240625$20240625$20240703$20240703$PER$$US-ALXN-202406USA001648US$ALEXION PHARMACEUTICALS$$57$YR$$F$Y$$$20240703$$CN$US$US
240436451$24043645$1$I$$20240627$20240703$20240703$PER$$US-ROCHE-10000014555$ROCHE$$$$C$M$Y$$$20240703$$CN$US$US
240436461$24043646$1$I$20240601$20240622$20240703$20240703$EXP$$CN-AUROBINDO-AUR-APL-2024-032798$AUROBINDO$$58$YR$$M$Y$68$KG$20240703$$HP$CN$CN
240436471$24043647$1$I$$20240628$20240703$20240703$EXP$$US-Bion-013354$BIONPHARMA$$79$YR$E$F$Y$$$20240703$$HP$US$US
240436481$24043648$1$I$$20240627$20240703$20240703$EXP$$CH-Bion-013343$BIONPHARMA$$41$YR$A$M$Y$$$20240703$$HP$CH$CH
240436491$24043649$1$I$$20240625$20240703$20240703$EXP$$PL-NOVITIUMPHARMA-2024PLNVP01106$NOVITIUM PHARMA$Lucjan Slawinski.Primary pulmonary Hodgkin^s lymphoma mimicking granulomatosis with polyangiitis - a case report of diagnostic and therapeutic dilemmas.Contemporary Oncology.20-AUG-2023;27(2):113-117$53$YR$A$F$Y$$$20240703$$HP$PL$PL
240436501$24043650$1$I$20240531$20240622$20240703$20240703$EXP$$CN-AUROBINDO-AUR-APL-2024-032797$AUROBINDO$$35$YR$$M$Y$59$KG$20240703$$HP$CN$CN
240436512$24043651$2$F$20240101$20240711$20240703$20240718$PER$$US-BIOGEN-2024BI01261589$BIOGEN$$$$$F$Y$$$20240718$$CN$US$US
240436521$24043652$1$I$20240612$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024129170$AMGEN$$70$YR$E$F$Y$$$20240702$$CN$US$US
240436533$24043653$3$F$20240626$20240911$20240703$20240923$EXP$$FR-BIOGEN-2024BI01271842$BIOGEN$$59$YR$$M$Y$63$KG$20240923$$MD$FR$FR
240436542$24043654$2$F$$20240712$20240703$20240719$PER$$US-AstraZeneca-2024A136025$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
240436551$24043655$1$I$$20240620$20240703$20240703$PER$$US-AstraZeneca-2024A143495$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240436561$24043656$1$I$$20240617$20240703$20240703$EXP$$CA-TEVA-201907_00006337$TEVA$$6$YR$$M$Y$$$20240703$$HP$CA$CA
240436573$24043657$3$F$20231218$20240910$20240703$20240916$EXP$FR-AFSSAPS-AVMA2024000264$FR-JNJFOC-20240701547$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240917$$PH$FR$FR
240436581$24043658$1$I$$20240507$20240703$20240703$EXP$$CA-TEVA-VS-3207659$TEVA$$61$YR$$F$Y$70$KG$20240703$$MD$CA$CA
240436591$24043659$1$I$$20240626$20240703$20240703$PER$$US-BIOGEN-2020BI00905567$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
240436601$24043660$1$I$$20240502$20240703$20240703$PER$$US-ROCHE-10000014312$ROCHE$$$$$$Y$$$20240703$$CN$US$US
240436611$24043661$1$I$20240510$20240625$20240703$20240703$EXP$SE-SEMPA-2024-004790$SE-EMD Serono-2024034503$EMD SERONO INC$$32$YR$A$F$Y$$$20240703$$MD$SE$SE
240436621$24043662$1$I$$20240626$20240703$20240703$EXP$$NL-EMD Serono-2024034093$EMD SERONO INC$$62$YR$A$F$Y$$$20240703$$CN$NL$NL
240436631$24043663$1$I$$20240328$20240703$20240703$PER$$US-AMGEN-USASP2024131034$AMGEN$$$$$$Y$$$20240702$$PH$US$US
240436641$24043664$1$I$20240610$20240618$20240703$20240703$EXP$GB-MHRA-MED-202406180842487090-NPMFW$GB-TEVA-VS-3211279$TEVA$$80$YR$$F$Y$$$20240703$$HP$GB$GB
240436662$24043666$2$F$$20240802$20240703$20240802$PER$$US-ALXN-202406USA001797US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$HP$US$US
240436672$24043667$2$F$20240601$20240625$20240703$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019441$UNITED THERAPEUTICS$$49$YR$$M$Y$90.703$KG$20240705$$$US$US
240436681$24043668$1$I$$20240626$20240703$20240703$EXP$$NL-CELLTRION INC.-2024NL015806$CELLTRION$$$$$$Y$$$20240703$$MD$NL$NL
240436692$24043669$2$F$20240613$20240718$20240703$20240726$EXP$$CN-HETERO-HET2024CN01984$HETERO$$78$YR$$M$Y$$$20240726$$HP$CN$CN
240436701$24043670$1$I$20240523$20240628$20240703$20240703$EXP$ES-AEMPS-1534242$ES-HALEON-2184744$Haleon PLC$$48$YR$$M$Y$$$20240703$$MD$ES$ES
240436712$24043671$2$F$$20240726$20240703$20240803$EXP$$CA-TEVA-VS-3212611$TEVA$$53$YR$$M$Y$$$20240803$$CN$CA$CA
240436721$24043672$1$I$$20240620$20240703$20240703$PER$$US-ROCHE-10000013169$ROCHE$$$$$$Y$$$20240703$$MD$US$US
240436731$24043673$1$I$$20240625$20240703$20240703$EXP$$ES-ESPERIONTHERAPEUTICS-2024ESP01006$ESPERION THERAPEUTICS$$$$$$Y$$$20240703$$MD$ES$ES
240436741$24043674$1$I$$20240626$20240703$20240703$EXP$$US-ROCHE-10000013615$ROCHE$$$$E$M$Y$$$20240703$$CN$US$US
240436752$24043675$2$F$20080501$20240627$20240703$20240703$EXP$$US-BIOGEN-2013BI032874$BIOGEN$$51$YR$$F$Y$$$20240703$$CN$US$US
240436761$24043676$1$I$20240623$20240625$20240703$20240703$EXP$$BR-JNJFOC-20240676457$JOHNSON AND JOHNSON$$34$YR$A$M$Y$57$KG$20240703$$CN$BR$BR
240436771$24043677$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05816$HIKMA$Cardona Quinones RA, Salem Hernandez SA, Sekimitsu S, Antongiorgi Torres J, Yerstein O, Safar LT. Cardona Quinones RA, Salem Hernandez SA, Sekimitsu S, Antongiorgi Torres J, Yerstein O, Safar LT. A neuropsychiatric case of delayed post-hypoxic leukoencephalopathy from opioid intoxication resulting in Anton-Babinski syndrome and quadriplegia. Neurocase. 2023;29(5):160-6$26$YR$$M$Y$$$20240703$$MD$US$US
240436781$24043678$1$I$$20240624$20240703$20240703$PER$$US-JNJFOC-20240664446$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$US$US
240436791$24043679$1$I$$20240624$20240703$20240703$PER$$US-JNJFOC-20240664180$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240436801$24043680$1$I$$20240701$20240703$20240703$PER$$US-JNJFOC-20240706839$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240436811$24043681$1$I$$20240625$20240703$20240703$EXP$$ES-AUROBINDO-AUR-APL-2024-031643$AUROBINDO$Gabald?n Torres L.. Abcesos cerebrales en el contexto de endocarditis con cultivos negativos.. Neurorecordings.. 2024$52$YR$$M$Y$$$20240703$$HP$ES$ES
240436821$24043682$1$I$20140101$20240627$20240703$20240703$EXP$$US-BIOGEN-2024BI01271807$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
240436832$24043683$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3214096$TEVA$Collen LV, Mitchell PD, Fox VL, Grover AS. Pancreatitis-Associated Medication Use in Hospitalized Pediatric and Young Adult Patients with Acute Pancreatitis. J-Pediatr-Gastroenterol-Nutr 2023; 77 (2): 260-266.; Collen LV, Mitchell PD, Fox VL, Grover AS. Pancreatitis-Associated Medication Use in Hospitalized Pediatric and Young Adult Patients with Acute Pancreatitis. J-Pediatr-Gastroenterol-Nutr 2023; 77 (2): 260-266.$$$$$Y$$$20240717$$MD$US$US
240436841$24043684$1$I$$20240626$20240703$20240703$PER$$US-EMD Serono-2024035186$EMD SERONO INC$$$$A$F$Y$$$20240703$$HP$US$US
240436851$24043685$1$I$$20240620$20240703$20240703$EXP$$CA-TEVA-VS-3212615$TEVA$$40$YR$$F$Y$96$KG$20240703$$HP$CA$CA
240436862$24043686$2$F$20240528$20240808$20240703$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-031659$AUROBINDO$$50$YR$$M$Y$$$20240818$$PH$FR$FR
240436871$24043687$1$I$$20240628$20240703$20240703$EXP$$CA-JNJFOC-20240417594$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240703$$HP$CA$CA
240436881$24043688$1$I$20240620$20240624$20240703$20240703$30DAY$$US-GSK-US2024078604$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240436891$24043689$1$I$$20230919$20240703$20240703$PER$$US-AMGEN-USASP2023235254$AMGEN$$$$$$Y$$$20240702$$HP$US$US
240436901$24043690$1$I$$20230530$20240703$20240703$PER$$US-AMGEN-USASP2023235056$AMGEN$$$$$$Y$$$20240702$$CN$US$US
240436911$24043691$1$I$$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024128788$AMGEN$$$$$F$Y$$$20240702$$CN$US$US
240436921$24043692$1$I$$20240630$20240703$20240703$PER$$US-AMGEN-USASP2024130116$AMGEN$$$$$$Y$$$20240702$$MD$US$US
240436931$24043693$1$I$20240625$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024128288$AMGEN$$71$YR$E$F$Y$$$20240702$$CN$US$US
240436941$24043694$1$I$20240423$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031727$AUROBINDO$$57$YR$$M$Y$$$20240703$$MD$FR$FR
240436951$24043695$1$I$$20240618$20240703$20240703$EXP$$US-ROCHE-10000010185$ROCHE$$75$YR$E$F$Y$$$20240703$$MD$US$US
240436961$24043696$1$I$$20240628$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037165$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240703$$CN$US$US
240436971$24043697$1$I$$20240624$20240703$20240703$PER$$US-APOTEX-2024AP007788$APOTEX$Kumari R, Singla T, Perswani P, Ghosh S.. A Curious Case of Pleural Effusion. American Journal of Respiratory and Critical Care Medicine. 2024;209 (0):1-3$79$YR$$F$Y$$$20240703$$HP$US$US
240436981$24043698$1$I$$20240620$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05643$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240436991$24043699$1$I$20240623$20240628$20240703$20240703$EXP$$US-JNJFOC-20240703221$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240703$$CN$US$US
240437001$24043700$1$I$20240228$20240624$20240703$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-103026$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$58.9$KG$20240703$$PH$JP$JP
240437012$24043701$2$F$$20240703$20240703$20240709$EXP$$US-JNJFOC-20240701391$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$HP$US$US
240437021$24043702$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05870$HIKMA$Cardona Quinones RA, Salem Hernandez SA, Sekimitsu S, Antongiorgi Torres J, Yerstein O, Safar LT. Cardona Quinones RA, Salem Hernandez SA, Sekimitsu S, Antongiorgi Torres J, Yerstein O, Safar LT. A neuropsychiatric case of delayed post-hypoxic leukoencephalopathy from opioid intoxication resulting in Anton-Babinski syndrome and quadriplegia.. Neurocase. 2023;29(5):160-166$26$YR$$M$Y$$$20240703$$MD$US$US
240437031$24043703$1$I$$20240630$20240703$20240703$PER$$US-HALEON-2184882$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240437041$24043704$1$I$$20240624$20240703$20240703$EXP$$US-HETERO-HET2024US02043$HETERO$Wong C, Malik M, Abu-Hashish H, Ang G, Galperin I.. Hydralazine to Pulmonary Hemorrhage: A Case of Drug Induced Vasculitis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2031$85$YR$$M$Y$$$20240703$$HP$US$US
240437052$24043705$2$F$20240605$20240709$20240703$20240717$EXP$$US-ZENPEP LLC-2024AIMT01001$AIMMUNE$$$$$$Y$$$20240717$$HP$US$US
240437061$24043706$1$I$$20240628$20240703$20240703$EXP$$US-BIOGEN-2024BI01270559$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
240437071$24043707$1$I$$20240624$20240703$20240703$EXP$$US-TEVA-VS-3214146$TEVA$Collen LV, Mitchell PD, Fox VL, Grover AS. Pancreatitis-Associated Medication Use in Hospitalized Pediatric and Young Adult Patients with Acute Pancreatitis. J-Pediatr-Gastroenterol-Nutr 2023; 77 (2): 260-266.$$$$$Y$$$20240703$$MD$US$US
240437081$24043708$1$I$$20240628$20240703$20240703$EXP$$CA-HALEON-2184665$Haleon PLC$$13$MON$$M$Y$1$KG$20240703$$PH$CA$CA
240437092$24043709$2$F$20240601$20240702$20240703$20240704$PER$$US-ABBVIE-5820872$ABBVIE$$9$YR$$M$Y$$$20240704$$CN$US$US
240437101$24043710$1$I$$20240619$20240703$20240703$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05649$LUPIN$Almazan EP, Ellaicy O, Carter DJ, Kaleka K, Faruqi M. Another case of the blues, methylene blue as adjunctive therapy in calcium-channel blocker induced vasoplegia. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5655$65$YR$$F$Y$$$20240703$$HP$US$US
240437111$24043711$1$I$$20240625$20240703$20240703$EXP$$US-JNJFOC-20240700587$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240437121$24043712$1$I$$20240701$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062217$SANDOZ$$$$$F$Y$$$20240703$$LW$US$US
240437133$24043713$3$F$$20240821$20240703$20240826$30DAY$$US-SANDOZ INC.-SDZ2024US061971$SANDOZ$$$$$$Y$$$20240826$$CN$US$US
240437141$24043714$1$I$$20240701$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US062138$SANDOZ$$$$$F$Y$$$20240703$$CN$US$US
240437151$24043715$1$I$$20240701$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US062135$SANDOZ$$$$$F$Y$$$20240703$$CN$US$US
240437161$24043716$1$I$$20240701$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2023US002044$SANDOZ$$$$$F$Y$$$20240703$$CN$US$US
240437171$24043717$1$I$20240601$20240626$20240703$20240703$EXP$$CA-JNJFOC-20240676241$JOHNSON AND JOHNSON$$14$YR$T$M$Y$102$KG$20240703$$PH$CA$CA
240437181$24043718$1$I$$20240625$20240703$20240703$30DAY$$US-GSK-US2024079141$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240437194$24043719$4$F$$20240819$20240703$20240829$30DAY$$US-GSK-US2024AMR079987$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$PH$US$US
240437201$24043720$1$I$$20240701$20240703$20240703$EXP$GB-MHRA-MED-202406191521210010-ZJBRL$GB-SANDOZ INC.-SDZ2024GB062122$SANDOZ$$$$$F$Y$$$20240703$$PH$GB$GB
240437211$24043721$1$I$$20240620$20240703$20240703$EXP$$CA-TEVA-VS-3212692$TEVA$$43$YR$$F$Y$96$KG$20240703$$HP$CA$CA
240437221$24043722$1$I$20240401$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031733$AUROBINDO$$41$YR$$M$Y$$$20240703$$PH$FR$FR
240437231$24043723$1$I$20221215$20240625$20240703$20240703$EXP$$FR-CELLTRION INC.-2024FR015636$CELLTRION$$$$$$Y$$$20240703$$MD$FR$FR
240437241$24043724$1$I$$20240628$20240703$20240703$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036856$BOEHRINGER INGELHEIM$$$$$$Y$$$20240703$$MD$CN$CN
240437251$24043725$1$I$$20240625$20240703$20240703$EXP$$EC-AstraZeneca-2024A149799$ASTRAZENECA$$22065$DY$$F$Y$$$20240703$$CN$EC$
240437261$24043726$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A148097$ASTRAZENECA$$$$$M$Y$$$20240703$$CN$US$
240437282$24043728$2$F$$20240624$20240703$20240709$PER$$US-ROCHE-10000012713$ROCHE$$44$YR$A$F$Y$$$20240705$$MD$US$US
240437291$24043729$1$I$20240614$20240628$20240703$20240703$30DAY$$US-GSK-US2024081154$GLAXOSMITHKLINE$$6$DEC$$F$Y$$$20240703$$HP$US$US
240437301$24043730$1$I$$20240625$20240703$20240703$EXP$$US-AMGEN-USASP2024125320$AMGEN$Tedeschi S.K.; Hayashi K.; Rosenthal A. et al.. Fractures in Patients With Acute Calcium Pyrophosphate Crystal Arthritis Versus Matched Comparators in a Large Cohort Study. Arthritis + Rheumatology. 2024;76 (6):936-941$$$$$Y$$$20240703$$MD$US$US
240437312$24043731$2$F$20240627$20240807$20240703$20240810$PER$$US-AMGEN-USASP2024129012$AMGEN$$69$YR$E$F$Y$$$20240809$$CN$US$US
240437322$24043732$2$F$20240628$20240712$20240703$20240715$PER$$US-AMGEN-USASP2024130019$AMGEN$$59$YR$A$F$Y$$$20240715$$HP$US$US
240437331$24043733$1$I$$20240624$20240703$20240703$EXP$$JP-ROCHE-10000011956$ROCHE$$7$DEC$E$F$Y$$$20240703$$MD$JP$JP
240437341$24043734$1$I$$20240619$20240703$20240703$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05633$LUPIN$Elkhapery A, Vallabhajosyula S, Niu C, Taifour H, O^Connor K. An unintentional second chance: Co-poisoning with insulin glargine and Carvedilol. American Journal of Respiratory and Critical Care Medicine. 2024;209$54$YR$$M$Y$$$20240703$$HP$US$US
240437351$24043735$1$I$20240520$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031668$AUROBINDO$$58$YR$$F$Y$90$KG$20240703$$PH$FR$FR
240437361$24043736$1$I$$20240626$20240703$20240703$PER$$US-ABBVIE-5820857$ABBVIE$$$$$$Y$$$20240703$$HP$US$US
240437371$24043737$1$I$$20240626$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406019122$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240703$$CN$US$US
240437381$24043738$1$I$$20240624$20240703$20240703$PER$$US-HETERO-HET2024US02012$HETERO$$$$$F$Y$61.23$KG$20240703$$CN$US$US
240437391$24043739$1$I$20240608$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001360$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240703$$CN$US$US
240437401$24043740$1$I$$20240627$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001581$ELI LILLY AND CO$$$$$$Y$$$20240703$$CN$US$US
240437411$24043741$1$I$$20240627$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406019135$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$US$US
240437421$24043742$1$I$$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000759$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$US$US
240437431$24043743$1$I$20240501$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000276$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240703$$CN$US$US
240437441$24043744$1$I$$20240625$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000886$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240703$$CN$US$US
240437451$24043745$1$I$20240630$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001208$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240703$$CN$US$US
240437461$24043746$1$I$20170101$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000422$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240703$$CN$US$US
240437471$24043747$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001677$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240703$$CN$US$US
240437481$24043748$1$I$$20240613$20240703$20240703$EXP$$CH-ROCHE-10000001123$ROCHE$$$$E$$Y$$$20240703$$MD$CH$CH
240437491$24043749$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001363$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240703$$CN$US$US
240437501$24043750$1$I$20240601$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001393$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$US$US
240437511$24043751$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001316$ELI LILLY AND CO$$$$$$Y$$$20240703$$CN$US$US
240437521$24043752$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000911$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240703$$CN$US$US
240437531$24043753$1$I$20240623$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001043$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240703$$CN$US$US
240437541$24043754$1$I$$20240627$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001544$ELI LILLY AND CO$$$$A$F$Y$$$20240703$$CN$US$US
240437552$24043755$2$F$$20240912$20240703$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202407000967$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240918$$MD$US$US
240437561$24043756$1$I$20240628$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000747$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240703$$CN$US$US
240437571$24043757$1$I$20240623$20240625$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406018388$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240703$$CN$US$US
240437581$24043758$1$I$20240628$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001202$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240703$$CN$US$US
240437591$24043759$1$I$20240630$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000996$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240703$$CN$US$US
240437601$24043760$1$I$20240610$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000969$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240703$$CN$US$US
240437611$24043761$1$I$20240101$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001382$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240703$$CN$US$US
240437621$24043762$1$I$20240501$20240627$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406019166$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240703$$CN$US$US
240437631$24043763$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001195$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240703$$CN$US$US
240437641$24043764$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000951$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240703$$CN$US$US
240437651$24043765$1$I$$20240625$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406019706$ELI LILLY AND CO$$$$$$Y$$$20240703$$CN$US$US
240437661$24043766$1$I$20240618$20240621$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406015784$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240703$$CN$US$US
240437671$24043767$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001072$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240703$$CN$US$US
240437681$24043768$1$I$20240603$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001009$ELI LILLY AND CO$$$$$M$Y$$$20240703$$CN$US$US
240437691$24043769$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001015$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240703$$CN$US$US
240437701$24043770$1$I$20240623$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001038$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240703$$CN$US$US
240437711$24043771$1$I$$20240624$20240703$20240703$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000569$DECIPHERA PHARMACEUTICALS$$65$YR$A$M$Y$$$20240703$$CN$US$US
240437724$24043772$4$F$20230510$20240730$20240703$20240809$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-105329$BRISTOL MYERS SQUIBB$Spisarova M. Immune-mediated encephalopathy in a patient with mRCC treated with combination of nivolumab + cabozantinib. Current Topics in Oncology (Through the Eyes of Czech Doctors). 2024;9:16-7.$71$YR$E$M$Y$$$20240809$$MD$CZ$CZ
240437734$24043773$4$F$$20240814$20240703$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105644$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240820$$HP$US$US
240437742$24043774$2$F$20240703$20240712$20240703$20240725$PER$$US-AMGEN-USASP2024131028$AMGEN$$75$YR$E$M$Y$$$20240725$$CN$US$US
240437751$24043775$1$I$20240625$20240625$20240703$20240703$EXP$$GB-AUROBINDO-AUR-APL-2024-031624$AUROBINDO$$79$YR$$F$Y$$$20240703$$MD$GB$GB
240437762$24043776$2$F$$20240705$20240703$20240710$EXP$$GB-EMD Serono-2024035779$EMD SERONO INC$$$$A$M$Y$$$20240710$$HP$GB$GB
240437771$24043777$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05833$HIKMA$Blohm JE, Choi H, Jakharia K. Blohm JE, Choi H, Jakharia K. No-lax-zone: Side Effects That Can Steal Your Breath Away. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2038$24$YR$$M$Y$$$20240703$$MD$US$US
240437781$24043778$1$I$20240503$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031743$AUROBINDO$$85$YR$$F$Y$$$20240703$$MD$FR$FR
240437791$24043779$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5823455$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240437802$24043780$2$F$20220901$20240712$20240703$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-031683$AUROBINDO$Antonelli JP, Quach M, Mahajan A, Pleva J, Ma VT. Rapid Life-Saving Response to Anti-PD-1 in a Solid Organ Transplant Recipient with Metastatic Cutaneous Squamous Cell Carcinoma: A Case Report and Review. Journal of Immunotherapy. 2024;47(6):216-9$5$DEC$$M$Y$$$20240723$$MD$US$US
240437811$24043781$1$I$20240227$20240624$20240703$20240703$EXP$$CN-UCBSA-2024032674$UCB$$$$N$$Y$$$20240703$$MD$CN$CN
240437821$24043782$1$I$20240506$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031674$AUROBINDO$$2$YR$$M$Y$13.3$KG$20240703$$MD$FR$FR
240437831$24043783$1$I$20231104$20240617$20240703$20240703$EXP$FR-AFSSAPS-TO2024000985$FR-TEVA-VS-3211485$TEVA$$92$YR$$F$Y$87.2$KG$20240703$$PH$FR$FR
240437841$24043784$1$I$$20230929$20240703$20240703$PER$$US-AMGEN-USASP2023235139$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240437851$24043785$1$I$$20230206$20240703$20240703$PER$$US-AMGEN-USASP2023235442$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240437861$24043786$1$I$$20240624$20240703$20240703$PER$$US-RDY-SPO/USA/24/0009287$DR REDDYS$$60$YR$A$M$Y$$$20240703$$MD$US$US
240437871$24043787$1$I$$20240624$20240703$20240703$PER$US-MLMSERVICE-20240617-PI102761-00123-1$US-RDY-SPO/USA/24/0009273$DR REDDYS$Crawford M, Mayo T. Scalp cooling success in a Black woman. JAAD Case Reports. 2024;49:82-4. DOI: 10.1016/j.jdcr.2024.05.008.$65$YR$E$F$Y$$$20240703$$MD$US$US
240437881$24043788$1$I$20240621$20240625$20240703$20240703$PER$$US-RDY-CLI/USA/24/0009412$DR REDDYS$$29$YR$A$M$Y$$$20240703$$HP$US$US
240437891$24043789$1$I$$20240621$20240703$20240703$PER$$US-RDY-LIT/USA/24/0009392$DR REDDYS$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allergy, Asthma and Clinical Immunology. 2023;19: doi:10.1186/s13223-023-00820-4.$58$YR$A$F$Y$$$20240703$$HP$US$US
240437901$24043790$1$I$$20240621$20240703$20240703$PER$$US-RDY-LIT/USA/24/0009390$DR REDDYS$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allergy, Asthma and Clinical Immunology. 2023;19: doi:10.1186/s13223-023-00820-4.$41$YR$A$F$Y$$$20240703$$HP$US$US
240437911$24043791$1$I$$20240621$20240703$20240703$PER$$US-RDY-LIT/USA/24/0009391$DR REDDYS$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allergy, Asthma and Clinical Immunology. 2023;19: doi:10.1186/s13223-023-00820-4.$39$YR$A$M$Y$$$20240703$$HP$US$US
240437921$24043792$1$I$20240619$20240625$20240703$20240703$PER$$US-RDY-SPO/USA/24/0009357$DR REDDYS$$24$YR$A$F$Y$$$20240703$$CN$US$US
240437931$24043793$1$I$$20240622$20240703$20240703$EXP$$US-AMGEN-USASP2024124445$AMGEN$Virk S. T.; Niranjan S.; Pate D. et al.. Breathing Battles: The Ongoing Struggle of Recurrent Covid-19-related Respiratory Failure in a Patient With Hashimoto^s Encephalopathy Under Intermittent Immunosuppression. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A5589-A5589$42$YR$A$F$Y$$$20240703$$HP$US$US
240437942$24043794$2$F$20240608$20240711$20240703$20240716$PER$$US-AMGEN-USASP2024129415$AMGEN$$84$YR$E$F$Y$$$20240716$$HP$US$US
240437951$24043795$1$I$$20240626$20240703$20240703$EXP$$US-JNJFOC-20240675345$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$CN$US$US
240437961$24043796$1$I$$20240626$20240703$20240703$EXP$$BR-JNJFOC-20240676436$JOHNSON AND JOHNSON$$59$YR$A$F$Y$42$KG$20240703$$CN$BR$BR
240437981$24043798$1$I$20231103$20240624$20240703$20240703$EXP$$CN-UCBSA-2023054641$UCB$$30$YR$$F$Y$60$KG$20240703$$MD$CN$CN
240438001$24043800$1$I$$20240625$20240703$20240703$EXP$$GB-AUROBINDO-AUR-APL-2024-031690$AUROBINDO$$$$$M$Y$$$20240703$$CN$GB$GB
240438011$24043801$1$I$20240624$20240625$20240703$20240703$EXP$$GB-AUROBINDO-AUR-APL-2024-031649$AUROBINDO$$82$YR$$F$Y$56$KG$20240703$$HP$GB$GB
240438021$24043802$1$I$20220810$20240625$20240703$20240703$EXP$$FR-CELLTRION INC.-2024FR015661$CELLTRION$$$$$$Y$$$20240703$$MD$FR$FR
240438031$24043803$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5819445$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240438061$24043806$1$I$$20240628$20240703$20240703$PER$$NVSC2024US137065$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240438071$24043807$1$I$20240617$20240619$20240703$20240703$EXP$$IL-ROCHE-10000005172$ROCHE$$48$YR$A$F$Y$$$20240703$$CN$IL$IL
240438081$24043808$1$I$$20230726$20240703$20240703$PER$$US-AMGEN-USASP2023235360$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240438091$24043809$1$I$$20230920$20240703$20240703$PER$$US-AMGEN-USASP2023235416$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240438102$24043810$2$F$$20240726$20240703$20240808$EXP$$JP-AMGEN-JPNSP2024127847$AMGEN$$$$$$Y$$$20240807$$PH$JP$JP
240438115$24043811$5$F$20240617$20240905$20240703$20240918$EXP$$US-AUROBINDO-AUR-APL-2024-032385$AUROBINDO$$77$YR$$M$Y$64.4$KG$20240918$$MD$US$US
240438121$24043812$1$I$$20240626$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103377$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240703$$CN$US$US
240438132$24043813$2$F$20240613$20240723$20240703$20240724$PER$$US-JNJFOC-20240651128$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
240438142$24043814$2$F$20240621$20240724$20240703$20240726$PER$$US-JNJFOC-20240659000$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$HP$US$US
240438151$24043815$1$I$$20240620$20240703$20240703$PER$$US-TEVA-VS-3213783$TEVA$$62$YR$$F$Y$62.14$KG$20240703$$CN$US$US
240438172$24043817$2$F$$20240625$20240703$20240902$EXP$$GB-AUROBINDO-AUR-APL-2024-031670$AUROBINDO$$$$$F$Y$67$KG$20240902$$CN$GB$GB
240438181$24043818$1$I$$20240630$20240703$20240703$EXP$$PT-HALEON-2184663$Haleon PLC$$$$$M$Y$$$20240703$$CN$PT$PT
240438191$24043819$1$I$20240101$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031720$AUROBINDO$$24$YR$$F$Y$67$KG$20240703$$MD$FR$FR
240438202$24043820$2$F$20240101$20240628$20240703$20240704$PER$$US-ABBVIE-5821240$ABBVIE$$$$$F$Y$81$KG$20240704$$CN$US$US
240438213$24043821$3$F$$20240902$20240703$20240903$PER$$NVSC2024US137403$NOVARTIS$$$$$$Y$$$20240903$$CN$US$US
240438221$24043822$1$I$20210101$20240625$20240703$20240703$EXP$$DK-AUROBINDO-AUR-APL-2024-031704$AUROBINDO$$8$DEC$$F$Y$$$20240703$$MD$DK$DK
240438231$24043823$1$I$20240625$20240626$20240703$20240703$PER$$US-ABBVIE-5819818$ABBVIE$$55$YR$$F$Y$$$20240703$$CN$US$US
240438241$24043824$1$I$$20240624$20240703$20240703$PER$$US-ABBVIE-5816386$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240438251$24043825$1$I$20240625$20240627$20240703$20240703$EXP$$US-VIIV HEALTHCARE LIMITED-US2024080296$VIIV$$44$YR$$M$Y$$$20240703$$CN$US$US
240438261$24043826$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047891$MACLEODS$Crawford M, Trinh J, Chaudhary S..A Case Report of Statin-induced Necrotizing Autoimmune Myopathy With Extramuscular Involvement..American Journal of Respiratory and Critical Care Medicine.2024;209$$$$$Y$$$20240703$$MD$US$US
240438271$24043827$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047883$MACLEODS$Prabhu S, Malempati S, Markowitz D..Amlodipine: Not an Ace in the Hole.American Journal of Respiratory and Critical Care Medicine.2024;209:A1361$56$YR$A$M$Y$$$20240703$$MD$US$US
240438281$24043828$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047888$MACLEODS$Beesley S, Lanspa M..Calcium Channel Overdose and Insulin Therapy Dosing.American Journal of Respiratory and Critical Care Medicine.2024;209:A7313$28$YR$A$M$Y$$$20240703$$MD$US$US
240438301$24043830$1$I$20240101$20240626$20240703$20240703$EXP$FR-AFSSAPS-RS2024000589$FR-CHEPLA-2024008097$CHEPLAPHARM$$73$YR$$M$Y$64$KG$20240703$$MD$COUNTRY NOT SPECIFIED$FR
240438311$24043831$1$I$$20240620$20240703$20240703$EXP$$US-MACLEODS PHARMA-MAC2024047884$MACLEODS$Sasidharan S, Jatoi T, Milla C, Mallappallil M, Agarwal S, Puri I..Triple whammy of Amlodipine, Carvedilol and Diphenhydramine overdose.American Journal of Respiratory and Critical Care Medicine.2024;209:A5669$$$$$Y$$$20240703$$MD$US$US
240438321$24043832$1$I$20220901$20240626$20240703$20240703$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00358$VELOXIS PHARMACEUTICALS$Antonelli JP, Quach M, Mahajan A, Pleva J, Ma VT.. Rapid life-saving response to anti-PD-1 in a solid organ transplant recipient with metastatic cutaneous squamous cell carcinoma: A case report and review.. Journal of immunotherapy. 2024;47(6):216-9$5$DEC$$M$Y$$$20240703$$MD$US$US
240438331$24043833$1$I$20240516$20240619$20240703$20240703$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001036$AKEBIA THERAPEUTICS$$81$YR$$M$Y$$$20240703$$MD$JP$JP
240438341$24043834$1$I$20240613$20240620$20240703$20240703$EXP$$IN-ROCHE-3404727$ROCHE$$52$YR$A$M$Y$$$20240703$$MD$IN$IN
240438351$24043835$1$I$$20240129$20240703$20240703$PER$$US-AMGEN-USASP2024130485$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240438361$24043836$1$I$$20230710$20240703$20240703$PER$$US-AMGEN-USASP2023235087$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240438371$24043837$1$I$$20240628$20240703$20240703$PER$$US-AMGEN-USASL2024129741$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240438381$24043838$1$I$$20240619$20240703$20240703$PER$$US-ROCHE-10000009088$ROCHE$$$$$$Y$$$20240703$$CN$US$US
240438391$24043839$1$I$$20240627$20240703$20240703$EXP$$US-CHATTEMPRD-2024OHG022636$CHATTEM$$$$E$F$Y$$$20240703$$LW$US$US
240438405$24043840$5$F$20240101$20240821$20240703$20240830$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000540$DECIPHERA PHARMACEUTICALS$$62$YR$A$M$Y$$$20240830$$CN$US$US
240438411$24043841$1$I$20240605$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031748$AUROBINDO$$6$DY$$M$Y$0.7$KG$20240703$$MD$FR$FR
240438421$24043842$1$I$20240615$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024128289$AMGEN$$59$YR$A$F$Y$$$20240703$$HP$US$US
240438433$24043843$3$F$$20240628$20240703$20240708$PER$$NVSC2024US137012$NOVARTIS$$$$$$Y$$$20240708$$CN$US$US
240438452$24043845$2$F$$20240703$20240703$20240708$PER$$US-JNJFOC-20240675106$JOHNSON AND JOHNSON$$$$$M$Y$$$20240708$$MD$US$US
240438461$24043846$1$I$20160509$20240625$20240703$20240703$EXP$$JP-JNJFOC-A-CH2016-136600$JOHNSON AND JOHNSON$$73$YR$E$F$Y$55.8$KG$20240703$$MD$JP$JP
240438471$24043847$1$I$$20240628$20240703$20240703$PER$$US-JNJFOC-20240677210$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240703$$HP$US$US
240438481$24043848$1$I$$20240625$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031943$AUROBINDO$Pando C, Beran B, Briggs M. 9605 Endometrial Ablation for Abnormal Uterine Bleeding in the Setting of Severe Thrombocytopenia.. J-Minim-Invasive-Gynecol. 2023;30 (Suppl.):S76-S77$44$YR$$F$Y$$$20240703$$HP$US$US
240438491$24043849$1$I$$20240624$20240703$20240703$PER$$US-ABBVIE-5816716$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240438501$24043850$1$I$20240401$20240630$20240703$20240703$EXP$$JP-TAKEDA-2024TJP009831$TAKEDA$$10$YR$$M$Y$33.8$KG$20240703$$MD$JP$JP
240438511$24043851$1$I$$20240701$20240703$20240703$PER$$US-ABBVIE-5824161$ABBVIE$$$$E$$Y$$$20240703$$CN$US$US
240438521$24043852$1$I$20240510$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105842$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240703$$CN$US$US
240438531$24043853$1$I$20240501$20240701$20240703$20240703$PER$FR-AFSSAPS-MP2024001046$FR-IDORSIA-008186-2024-FR$IDORSIA PHARMACEUTICALS$$28$YR$$$Y$64.5$KG$20240703$$PH$FR$FR
240438541$24043854$1$I$20180525$20240625$20240703$20240703$EXP$$GB-AUROBINDO-AUR-APL-2024-031667$AUROBINDO$$34$YR$$F$Y$60$KG$20240703$$MD$GB$GB
240438551$24043855$1$I$$20240626$20240703$20240703$PER$GB-MEN-2024-101644$GB-MEN-2024-101644$MENARINI$$$$$F$Y$$$20240703$$HP$GB$GB
240438564$24043856$4$F$20240616$20240807$20240703$20240812$PER$$US-ROCHE-10000008321$ROCHE$$84$YR$E$F$Y$$$20240812$$CN$US$US
240438571$24043857$1$I$$20240626$20240703$20240703$PER$GB-MEN-2024-101945$GB-MEN-2024-101945$MENARINI$$$$$M$Y$69$KG$20240703$$PH$GB$GB
240438581$24043858$1$I$$20230929$20240703$20240703$PER$$US-AMGEN-USASP2023235224$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240438591$24043859$1$I$$20231009$20240703$20240703$PER$$US-AMGEN-USASP2023235261$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240438602$24043860$2$F$$20240626$20240703$20240707$PER$$US-AMGEN-USASP2024127985$AMGEN$$$$A$$Y$$$20240707$$PH$US$US
240438611$24043861$1$I$20230601$20240625$20240703$20240703$EXP$$DE-AUROBINDO-AUR-APL-2024-031628$AUROBINDO$$$$$F$Y$2.94$KG$20240703$$MD$DE$DE
240438621$24043862$1$I$20240605$20240619$20240703$20240703$EXP$$JP-AMGEN-JPNSP2024114670$AMGEN$$5$DEC$A$F$Y$$$20240703$$PH$JP$JP
240438631$24043863$1$I$20240603$20240701$20240703$20240703$EXP$$CN-ROCHE-10000014035$ROCHE$$65$YR$E$M$Y$53.6$KG$20240703$$HP$CN$CN
240438642$24043864$2$F$$20240717$20240703$20240728$PER$$US-LUPIN HEALTHCARE (UK) LIMITED-2024-05494$LUPIN$$$$$$Y$$$20240728$$CN$US$US
240438651$24043865$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105880$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$87.09$KG$20240703$$CN$US$US
240438661$24043866$1$I$$20240624$20240703$20240703$PER$$US-ROCHE-10000012509$ROCHE$$$$E$F$Y$$$20240703$$CN$US$US
240438671$24043867$1$I$$20230519$20240703$20240703$PER$$US-AMGEN-USASP2023235151$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240438691$24043869$1$I$$20240701$20240703$20240703$PER$$US-JNJFOC-20240704247$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240438702$24043870$2$F$20240301$20240628$20240703$20240703$PER$$US-JNJFOC-20240667404$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240703$$CN$US$US
240438712$24043871$2$F$20240626$20240709$20240703$20240730$PER$$US-AMGEN-USASP2024129143$AMGEN$$67$YR$E$F$Y$$$20240730$$CN$US$US
240438721$24043872$1$I$$20230815$20240703$20240703$PER$$US-AMGEN-USASP2023235220$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240438731$24043873$1$I$20240628$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024129548$AMGEN$$83$YR$E$F$Y$$$20240703$$CN$US$US
240438741$24043874$1$I$$20240625$20240703$20240703$30DAY$$US-GSK-US2024AMR079901$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240438752$24043875$2$F$$20240625$20240703$20240724$EXP$$DE-UCBSA-2024033044$UCB$$17$YR$$F$Y$$$20240724$$MD$DE$DE
240438761$24043876$1$I$$20240701$20240703$20240703$PER$$US-HALEON-2184835$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240438772$24043877$2$F$$20240712$20240703$20240716$PER$$US-HALEON-2184962$Haleon PLC$$$$$$Y$$$20240716$$CN$US$US
240438782$24043878$2$F$$20240711$20240703$20240722$EXP$$IE-CELLTRION INC.-2024IE015749$CELLTRION$Cunneen B.; Hussein H.; Osullivan J. et al.. Calcific constrictive pericarditis following tumour necrosis factor-alpha inhibition.. European Heart Journal - Case Reports. 2024;8 (2):1-5$$$$$Y$$$20240722$$MD$IE$IE
240438791$24043879$1$I$20240621$20240621$20240703$20240703$PER$$US-TEVA-VS-3215340$TEVA$$$$$F$Y$$$20240703$$CN$US$US
240438801$24043880$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129600$AMGEN$Shahriari N. Upadacitinib for the treatment of psoriasiform and spongiotic dermatitis: A multicenter case series. JAAD Case Reports. 2024;49:106-109$28$YR$A$F$Y$$$20240703$$MD$US$US
240438811$24043881$1$I$$20230823$20240703$20240703$PER$$US-AMGEN-USASP2023235363$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240438821$24043882$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105963$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$112.04$KG$20240703$$CN$US$US
240438831$24043883$1$I$$20240623$20240703$20240703$EXP$$US-CBL-002676$CONCORD BIOTECH$Ocon A, Avalos Sugastti E, Duffy N. Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab. BMJ Case Rep. 2024 Jun 18;17(6):e258487. doi: 10.1136/bcr-2023-258487.$$$$M$Y$$$20240703$$MD$US$US
240438841$24043884$1$I$$20240618$20240703$20240703$EXP$BE-FAMHP-DHH-N2024-122221$BE-TEVA-VS-3211812$TEVA$$67$YR$$M$Y$100$KG$20240703$$CN$BE$BE
240438851$24043885$1$I$$20240620$20240703$20240703$PER$$US-APOTEX-2024AP007702$APOTEX$Adegoke T, Subramanian S, Daunis D, Bick S, Ward HB. A Case of Treatment Resistant Depression Complicated by Traumatic Brain Injury and Seizure: Implications for Interventional Treatment and Psychiatric Training. Harvard Review of Psychiatry. 2024;32(3):117-125$45$YR$$M$Y$$$20240703$$MD$US$US
240438861$24043886$1$I$20240501$20240603$20240703$20240703$PER$$MT-MEN-2024-098666$MENARINI$$73$YR$$M$Y$$$20240703$$HP$MT$MT
240438871$24043887$1$I$$20240623$20240703$20240703$EXP$$US-CBL-002675$CONCORD BIOTECH$Abdelrahim M, Esmail A, Divatia MK, Xu J, Kodali S, Victor DW, et al. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. J Clin Med. 2024 May 24;13(11):3068. doi: 10.3390/jcm13113068.$64$YR$A$M$Y$$$20240703$$HP$US$US
240438881$24043888$1$I$$20240623$20240703$20240703$EXP$$US-CBL-002677$CONCORD BIOTECH$Abdelrahim M, Esmail A, Divatia MK, Xu J, Kodali S, Victor DW, et al. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. J Clin Med. 2024 May 24;13(11):3068. doi: 10.3390/jcm13113068.$58$YR$A$M$Y$$$20240703$$HP$US$US
240438891$24043889$1$I$$20240623$20240703$20240703$EXP$$US-CBL-002678$CONCORD BIOTECH$Abdelrahim M, Esmail A, Divatia MK, Xu J, Kodali S, Victor DW, et al. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. J Clin Med. 2024 May 24;13(11):3068. doi: 10.3390/jcm13113068.$68$YR$E$M$Y$$$20240703$$HP$US$US
240438901$24043890$1$I$$20240624$20240703$20240703$EXP$$JP-PBT-009466$PANACEA BIOTEC$Ota H, Igarashi T, Matsui R, Takeshita H, Hashimoto K, Miyao M, et al. Use of tocilizumab to treat arthritis associated with mixed connective tissue disease complicated by ovarian teratoma: a case report. J Nippon Med Sch. 2024 Jun 18. doi: 10.1272/jnms.JNMS.2025_92-303.$10$YR$C$F$Y$$$20240703$$HP$JP$JP
240438911$24043891$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137475$NOVARTIS$$$$$$Y$$$20240703$$MD$US$US
240438921$24043892$1$I$$20240624$20240703$20240703$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024078618$VIIV$$$$$M$Y$$$20240703$$CN$US$US
240438931$24043893$1$I$20231206$20240626$20240703$20240703$EXP$$BY-JNJFOC-20240676420$JOHNSON AND JOHNSON$$74$YR$E$M$Y$44$KG$20240703$$MD$BY$BY
240438942$24043894$2$F$20240616$20240703$20240703$20240704$EXP$$DE-JNJFOC-20240701017$JOHNSON AND JOHNSON$$20$YR$A$F$Y$60$KG$20240704$$PH$DE$DE
240438951$24043895$1$I$$20230928$20240703$20240703$PER$$US-AMGEN-USASP2023235205$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240438961$24043896$1$I$20240628$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024129148$AMGEN$$66$YR$E$F$Y$$$20240703$$CN$US$US
240438972$24043897$2$F$20240519$20240813$20240703$20240816$EXP$$US-AstraZeneca-2024A150061$ASTRAZENECA$$23438$DY$$F$Y$$$20240816$$HP$US$
240438981$24043898$1$I$$20240626$20240703$20240703$PER$$US-ABBVIE-5820451$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240438992$24043899$2$F$20220101$20240821$20240703$20240829$EXP$$CA-CELLTRION INC.-2022CA017193$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
240439001$24043900$1$I$20240604$20240626$20240703$20240703$PER$$US-ABBVIE-5819856$ABBVIE$$59$YR$$M$Y$$$20240703$$CN$US$US
240439011$24043901$1$I$20240601$20240627$20240703$20240703$EXP$$CN-ABBVIE-5822637$ABBVIE$$91$YR$$M$Y$$$20240703$$CN$CN$CN
240439021$24043902$1$I$$20240620$20240703$20240703$PER$$US-APOTEX-2024AP007705$APOTEX$Kruttiventi S, Olcott J, Doubledee B. Ditch the Itch: Propofol in the Management of Cholestatic Pruritus. Clinical Pediatrics. 2024;63 (4):580-583$17$YR$$F$Y$$$20240703$$MD$US$US
240439032$24043903$2$F$$20240723$20240703$20240802$30DAY$$US-GSK-US2024078684$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$HP$US$US
240439041$24043904$1$I$$20231116$20240703$20240703$PER$$US-AMGEN-USASP2023235357$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240439051$24043905$1$I$20240701$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130478$AMGEN$$84$YR$E$F$Y$$$20240703$$CN$US$US
240439061$24043906$1$I$20240610$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031665$AUROBINDO$$8$YR$$F$Y$37.9$KG$20240703$$MD$FR$FR
240439071$24043907$1$I$$20240628$20240703$20240703$EXP$$US-ABBVIE-5821771$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240439081$24043908$1$I$$20240628$20240703$20240703$EXP$$US-ABBVIE-5821700$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240439091$24043909$1$I$$20240628$20240703$20240703$EXP$$DE-ABBVIE-5823439$ABBVIE$$$$$F$Y$$$20240703$$HP$DE$DE
240439101$24043910$1$I$20240401$20240627$20240703$20240703$EXP$SE-SEMPA-2024-005178$SE-ABBVIE-5817958$ABBVIE$$26$YR$$F$Y$100$KG$20240703$$MD$SE$SE
240439111$24043911$1$I$$20221230$20240703$20240703$PER$$US-AMGEN-USASP2022230356$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240439121$24043912$1$I$20240412$20240619$20240703$20240703$EXP$$JP-ROCHE-10000001881$ROCHE$$71$YR$E$F$Y$45$KG$20240703$$MD$JP$JP
240439131$24043913$1$I$$20240620$20240703$20240703$PER$$US-APOTEX-2024AP007709$APOTEX$Phekoo A, Turk M, Torain J, Cate J, Java A, Sparks MA.. USE OF ECULIZUMAB DURING PREGNANCY IN A PATIENT WITH C3GN. American Journal of Kidney Diseases. 2024;83(4)(Suppl. 2):S44$24$YR$$F$Y$$$20240703$$HP$US$US
240439141$24043914$1$I$20240419$20240617$20240703$20240703$EXP$FR-AFSSAPS-LL2024001014$FR-TEVA-VS-3211735$TEVA$$93$YR$$M$Y$77.4$KG$20240703$$PH$FR$FR
240439161$24043916$1$I$$20240626$20240703$20240703$EXP$$US-JNJFOC-20240672425$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240703$$HP$US$US
240439171$24043917$1$I$$20240611$20240703$20240703$PER$$TR-MEN-2024-099547$MENARINI$$$$E$M$Y$$$20240703$$MD$TR$TR
240439181$24043918$1$I$$20240630$20240703$20240703$PER$$NVSC2024US137122$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240439191$24043919$1$I$20230101$20240618$20240703$20240703$EXP$FR-AFSSAPS-NC2024000685$FR-TEVA-VS-3211915$TEVA$$20$YR$$F$Y$55.8$KG$20240703$$MD$FR$FR
240439201$24043920$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137285$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240439211$24043921$1$I$$20240625$20240703$20240703$EXP$$CA-INTERCEPT-PM2024001314$INTERCEPT PHARMACEUTICALS$$55$YR$$F$Y$$$20240703$$CN$CA$CA
240439231$24043923$1$I$$20240621$20240703$20240703$EXP$$CA-INTERCEPT-PM2024001313$INTERCEPT PHARMACEUTICALS$$72$YR$$F$Y$$$20240703$$CN$CA$CA
240439241$24043924$1$I$$20240620$20240703$20240703$EXP$$GB-INTERCEPT-PM2024001310$INTERCEPT PHARMACEUTICALS$$$$E$F$Y$$$20240703$$CN$GB$GB
240439252$24043925$2$F$20231201$20240731$20240703$20240813$EXP$$GB-INTERCEPT-PM2024000051$INTERCEPT PHARMACEUTICALS$$$$E$F$Y$$$20240813$$HP$GB$GB
240439271$24043927$1$I$$20240702$20240703$20240703$PER$$US-HALEON-2184949$Haleon PLC$$$$$F$Y$$$20240703$$CN$US$US
240439283$24043928$3$F$$20240521$20240703$20240731$PER$$MT-MEN-2024-096690$MENARINI$$73$YR$$M$Y$$$20240731$$HP$MT$MT
240439304$24043930$4$F$20240601$20240826$20240703$20240904$EXP$$US-DELCATH SYSTEMS-DELC-000002$DELCATH SYSTEMS$$50$YR$$M$Y$105$KG$20240904$$MD$US$US
240439313$24043931$3$F$$20240911$20240703$20240919$EXP$$CA-JNJFOC-20240673333$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$HP$CA$CA
240439322$24043932$2$F$$20240627$20240703$20240703$EXP$$US-AMGEN-USASP2024129814$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240439331$24043933$1$I$20240101$20240619$20240703$20240703$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000493$DECIPHERA PHARMACEUTICALS$$85$YR$E$M$Y$$$20240703$$CN$US$US
240439341$24043934$1$I$$20240624$20240703$20240703$EXP$$US-AMGEN-USASP2024126017$AMGEN$Shaker N; musa R. B.; Tynski Z. et al.. Delayed Diagnosis of SMARCA4-Deficient Undifferentiated Tumor in a Heavy Smoker Male Patient: Discovered Through Bone Sampling, with Extensive Distant Metastases and Concurrent Granulomatous Disease, Leading to Patient Fatalityand Concurrent Granulomatous Disease, Leading to Patient Fatality. International Journal of Surgical Pathology. 2024;1-6$69$YR$E$M$Y$$$20240703$$MD$US$US
240439351$24043935$1$I$20240628$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024129221$AMGEN$$82$YR$E$F$Y$$$20240703$$CN$US$US
240439361$24043936$1$I$$20231113$20240703$20240703$PER$$US-AMGEN-USASP2023235356$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240439371$24043937$1$I$20230101$20240625$20240703$20240703$EXP$$CA-CELLTRION INC.-2023CA021788$CELLTRION$$$$$$Y$$$20240703$$MD$CA$CA
240439381$24043938$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05873$HIKMA$Pattupara A, Nguyen D, Gaikwad M, Gnirke M, Yarra S, Su M, et al.. Pattupara A, Nguyen D, Gaikwad M, Gnirke M, Yarra S, Su M, et al. Breaking the Spell: A Rare Case of Prolonged Benzodiazepine Elimination.. American Journal of Respiratory and Critical Care Medicine. 2024;209$67$YR$$M$Y$$$20240703$$MD$US$US
240439391$24043939$1$I$$20240625$20240703$20240703$EXP$$US-SA-2024SA190695$SANOFI AVENTIS$$$$E$M$Y$$$20240703$$CN$US$US
240439401$24043940$1$I$20240101$20240701$20240703$20240703$EXP$$US-UCBSA-2024033388$UCB$$$$$F$Y$$$20240703$$CN$US$US
240439411$24043941$1$I$$20240627$20240703$20240703$PER$$US-JNJFOC-20240674376$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$US$US
240439431$24043943$1$I$20240625$20240625$20240703$20240703$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000571$DECIPHERA PHARMACEUTICALS$$83$YR$E$M$Y$$$20240703$$CN$US$US
240439441$24043944$1$I$20240628$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001084$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240703$$CN$US$US
240439451$24043945$1$I$20240630$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001233$ELI LILLY AND CO$$69$YR$E$$Y$$$20240703$$CN$US$US
240439461$24043946$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000910$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240703$$CN$US$US
240439471$24043947$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001087$ELI LILLY AND CO$$89$YR$E$M$Y$$$20240703$$CN$US$US
240439481$24043948$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001375$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240703$$CN$US$US
240439491$24043949$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001080$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240703$$CN$US$US
240439501$24043950$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000923$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240703$$CN$US$US
240439511$24043951$1$I$$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000366$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240703$$CN$US$US
240439521$24043952$1$I$20240520$20240625$20240703$20240703$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000568$DECIPHERA PHARMACEUTICALS$$71$YR$E$M$Y$$$20240703$$CN$US$US
240439531$24043953$1$I$$20240622$20240703$20240703$PER$$US-TEVA-VS-3213942$TEVA$$$$$M$Y$$$20240703$$CN$US$US
240439541$24043954$1$I$$20240627$20240703$20240703$EXP$$US-TAKEDA-2024TUS065657$TAKEDA$$$$$M$Y$72$KG$20240703$$HP$US$US
240439552$24043955$2$F$20240604$20240709$20240703$20240712$PER$$US-AMGEN-USASP2024130968$AMGEN$$80$YR$E$F$Y$$$20240712$$CN$US$US
240439561$24043956$1$I$$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024128747$AMGEN$$56$YR$A$F$Y$97.7$KG$20240703$$PH$US$US
240439572$24043957$2$F$20240303$20240809$20240703$20240822$EXP$$JP-AMGEN-JPNSP2024099712$AMGEN$$71$YR$E$M$Y$$$20240822$$MD$JP$JP
240439581$24043958$1$I$20230101$20240625$20240703$20240703$EXP$$US-THE RITEDOSE CORPORATION-2024RIT000087$THE RITEDOSE CORP$$$$$$Y$$$20240702$$CN$US$US
240439592$24043959$2$F$$20240801$20240703$20240809$EXP$$JP-ROCHE-10000011003$ROCHE$$7$DEC$A$$Y$$$20240810$$MD$JP$JP
240439601$24043960$1$I$20240601$20240627$20240703$20240703$EXP$$US-ABBVIE-5821355$ABBVIE$$58$YR$$F$Y$$$20240703$$CN$US$US
240439611$24043961$1$I$$20240618$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05510$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240439621$24043962$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105951$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240703$$HP$US$US
240439631$24043963$1$I$$20240627$20240703$20240703$EXP$$US-ABBVIE-5821418$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240439641$24043964$1$I$$20240627$20240703$20240703$EXP$$US-ABBVIE-5821719$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240439651$24043965$1$I$20240101$20240628$20240703$20240703$EXP$$US-ABBVIE-5822261$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240439661$24043966$1$I$$20240621$20240703$20240703$EXP$$PL-ROCHE-10000012982$ROCHE$$$$$$Y$$$20240703$$HP$PL$PL
240439672$24043967$2$F$$20240627$20240703$20240703$EXP$$US-AMGEN-USASP2024129157$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240439682$24043968$2$F$20240223$20240708$20240703$20240715$EXP$$CA-SA-2024SA067131$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240715$$MD$CA$CA
240439691$24043969$1$I$20240621$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024130006$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240439701$24043970$1$I$20240201$20240628$20240703$20240703$EXP$$US-ABBVIE-5821735$ABBVIE$$55$YR$$M$Y$$$20240703$$CN$US$US
240439711$24043971$1$I$$20240624$20240703$20240703$EXP$US-MLMSERVICE-20240613-PI097527-00246-1$US-CHEPLA-2024008172$CHEPLAPHARM$Lam E, Santos C, Patrawalla AS. A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5651. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5651.$32$YR$$F$Y$$$20240703$$MD$COUNTRY NOT SPECIFIED$US
240439721$24043972$1$I$$20240610$20240703$20240703$PER$$US-JNJFOC-20240626359$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$CN$US$US
240439733$24043973$3$F$$20240711$20240703$20240717$EXP$$CA-ABBVIE-5821738$ABBVIE$$$$A$F$Y$$$20240717$$CN$CA$CA
240439741$24043974$1$I$20240101$20240628$20240703$20240703$EXP$$CA-ABBVIE-5821840$ABBVIE$$82$YR$$F$Y$$$20240703$$CN$CA$CA
240439751$24043975$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5822096$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240439761$24043976$1$I$20240201$20240628$20240703$20240703$EXP$$JP-009507513-2402JPN001709J$MERCK$$7$DEC$$M$Y$$$20240703$$MD$JP$JP
240439771$24043977$1$I$20230418$20240627$20240703$20240703$EXP$$ES-ABBVIE-5823602$ABBVIE$$$$$$Y$$$20240703$$MD$ES$ES
240439781$24043978$1$I$20240101$20240628$20240703$20240703$EXP$$US-ABBVIE-5821978$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240439801$24043980$1$I$20240623$20240623$20240703$20240703$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000561$DECIPHERA PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
240439811$24043981$1$I$$20240628$20240703$20240703$EXP$$US-TAKEDA-2022TUS021227$TAKEDA$$$$$F$Y$57$KG$20240703$$HP$US$US
240439821$24043982$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5820753$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240439831$24043983$1$I$20240314$20240618$20240703$20240703$EXP$FR-AFSSAPS-NY2024000640$FR-TEVA-VS-3211977$TEVA$$74$YR$$F$Y$$$20240703$$PH$FR$FR
240439842$24043984$2$F$20240218$20240730$20240703$20240812$EXP$$JP-AMGEN-JPNSP2024104797$AMGEN$$54$YR$A$M$Y$$$20240812$$MD$JP$JP
240439851$24043985$1$I$20240201$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024128814$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240439861$24043986$1$I$$20231109$20240703$20240703$PER$$US-AMGEN-USASP2023235353$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240439872$24043987$2$F$$20240710$20240703$20240712$EXP$$US-BAUSCH-BL-2024-010201$BAUSCH AND LOMB$$59$YR$$M$Y$$$20240712$$HP$US$US
240439881$24043988$1$I$$20240618$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05453$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240439892$24043989$2$F$20240101$20240710$20240703$20240716$PER$$US-ABBVIE-5823601$ABBVIE$$$$$F$Y$59$KG$20240716$$CN$US$US
240439901$24043990$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105860$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$75.75$KG$20240703$$CN$US$US
240439913$24043991$3$F$$20240619$20240703$20240709$EXP$$RU-ROCHE-10000009585$ROCHE$$59$YR$A$F$Y$$$20240701$$HP$RU$RU
240439922$24043992$2$F$$20240805$20240703$20240807$30DAY$$TR-JNJFOC-20240678377$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$TR$TR
240439934$24043993$4$F$20240626$20240813$20240703$20240823$30DAY$$US-JNJFOC-20240675240$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240823$$HP$US$US
240439941$24043994$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024128363$AMGEN$$31$YR$A$$Y$$$20240703$$MD$US$US
240439961$24043996$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001081$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240703$$CN$US$US
240439971$24043997$1$I$20240701$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000937$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240703$$CN$US$US
240439981$24043998$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001265$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240703$$CN$US$US
240439991$24043999$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001600$ELI LILLY AND CO$$$$$F$Y$$$20240703$$PH$US$US
240440001$24044000$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000920$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240703$$CN$US$US
240440011$24044001$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001551$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240703$$CN$US$US
240440021$24044002$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001154$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$US$US
240440031$24044003$1$I$20240701$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001017$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240703$$CN$US$US
240440041$24044004$1$I$20240621$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001062$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240703$$CN$US$US
240440051$24044005$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001014$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240703$$CN$US$US
240440061$24044006$1$I$20240601$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001132$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240703$$CN$US$US
240440071$24044007$1$I$20240630$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001353$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240703$$CN$US$US
240440081$24044008$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001205$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240703$$CN$US$US
240440091$24044009$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000995$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240703$$CN$US$US
240440101$24044010$1$I$$20240626$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406018415$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240703$$CN$US$US
240440111$24044011$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001206$ELI LILLY AND CO$$42$YR$A$$Y$$$20240703$$CN$US$US
240440121$24044012$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001197$ELI LILLY AND CO$$$$$$Y$$$20240703$$MD$US$US
240440131$24044013$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000934$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240703$$CN$US$US
240440141$24044014$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001046$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240703$$CN$US$US
240440151$24044015$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105915$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$58.97$KG$20240703$$CN$US$US
240440161$24044016$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105882$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$73.94$KG$20240703$$CN$US$US
240440172$24044017$2$F$$20240820$20240703$20240827$PER$$US-EMD Serono-2024035168$EMD SERONO INC$$62$YR$A$F$Y$$$20240827$$CN$US$US
240440181$24044018$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024128502$AMGEN$$69$YR$E$M$Y$$$20240703$$MD$US$US
240440191$24044019$1$I$$20231108$20240703$20240703$PER$$US-AMGEN-USASP2023235358$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240440201$24044020$1$I$$20240626$20240703$20240703$EXP$$US-NOVITIUMPHARMA-2024USNVP01148$NOVITIUM PHARMA$$$$$$Y$$$20240703$$CN$US$US
240440211$24044021$1$I$20240625$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024128721$AMGEN$$49$YR$A$F$Y$84.7$KG$20240703$$CN$US$US
240440233$24044023$3$F$$20240919$20240703$20240926$30DAY$$PT-JNJFOC-20240675831$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$PT$PT
240440251$24044025$1$I$$20240702$20240703$20240703$EXP$$US-GILEAD-2024-0679353$GILEAD$$$$$$Y$$$20240703$$LW$US$US
240440261$24044026$1$I$$20240619$20240703$20240703$PER$$US-ROCHE-10000013116$ROCHE$$$$$$Y$$$20240703$$CN$US$US
240440271$24044027$1$I$$20240628$20240703$20240703$EXP$$US-TAKEDA-2024TUS066149$TAKEDA$$$$$F$Y$$$20240703$$MD$US$US
240440281$24044028$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05813$HIKMA$Hammond TC, Channick CL, Favano T, Purbhoo M, Exley MA, Vandiver MS, et al.. Hammond TC, Channick CL, Favano T, Purbhoo M, Exley MA, Vandiver MS, et al. Persistent SARS-CoV-2 Viremia, COVID-19 Associated Acute Respiratory Distress Syndrome, Severe Coagulopathy and Massive Hemoptysis in a Renal Transplant Patient on Veno-Venous Extracorporeal Membrane Oxygenation.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5563$$$$$Y$$$20240703$$MD$US$US
240440291$24044029$1$I$$20240626$20240703$20240703$PER$$US-ABBVIE-5819332$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240440301$24044030$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05805$HIKMA$Shakir M, Nawaz M, Abdul Basit S, Jethani K, Zaidi S, Patel N.. Shakir M, Nawaz M, Abdul Basit S, Jethani K, Zaidi S, Patel N. Spontaneous Pulmonary Hematoma on Heparin Infusion With Rapid Progression.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5767$$$$$Y$$$20240703$$MD$US$US
240440311$24044031$1$I$$20240625$20240703$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-015754$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240703$$$US$US
240440321$24044032$1$I$$20240625$20240703$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-019840$UNITED THERAPEUTICS$$$$$F$Y$126.53$KG$20240703$$$US$US
240440331$24044033$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281412107900-RNBWT$GB-ORGANON-O2407GBR000036$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240440342$24044034$2$F$$20240621$20240703$20240705$PER$$US-ROCHE-10000012688$ROCHE$$$$$F$Y$$$20240705$$MD$US$US
240440351$24044035$1$I$$20240620$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05640$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240440361$24044036$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05815$HIKMA$Barrows C, Horton M, Allaham A, Israel HP. Barrows C, Horton M, Allaham A, Israel HP. A Case of Acute Hypoxic Respiratory Failure After Administration of Rituximab. nd Critical Care Medicine.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6326$$$$$Y$$$20240703$$MD$US$US
240440371$24044037$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106019$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240703$$CN$US$US
240440381$24044038$1$I$$20240620$20240703$20240703$EXP$$BR-BEH-2024174528$CSL BEHRING$$$$$$Y$$$20240703$$CN$BR$BR
240440391$24044039$1$I$$20240627$20240703$20240703$EXP$$US-AMGEN-USASP2024129475$AMGEN$Lund T. C.; Gupta A. O.; Furcich J. W. et al.. Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy. Journal of neuroimmunology. 2024;393:1-12$10$YR$C$M$Y$$$20240703$$HP$US$US
240440403$24044040$3$F$20240618$20240820$20240703$20240823$EXP$$JP-GSK-JP2024079570$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$JP$JP
240440412$24044041$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3214245$TEVA$Antony MA, Gundlapally S, Joglekar M, Fritz BN, Patel S, Verma V, et al. Clinical Implications Due To Long-term Delayed Diagnosis Of Macroprolactinemia. J-Endocr-Soc 2023; 7 (Suppl. 1) A667-A668 abstr. FRI313.; Antony MA, Gundlapally S, Joglekar M, Fritz BN, Patel S, Verma V, et al. Clinical Implications Due To Long-term Delayed Diagnosis Of Macroprolactinemia. J-Endocr-Soc 2023; 7 (Suppl. 1) A667-A668 abstr. FRI313.$74$YR$$M$Y$$$20240717$$MD$US$US
240440421$24044042$1$I$20240501$20240701$20240703$20240703$EXP$FR-AFSSAPS-MP2024001070$FR-JNJFOC-20240701429$JOHNSON AND JOHNSON$$43$YR$A$M$Y$78$KG$20240703$$PH$FR$FR
240440431$24044043$1$I$20240627$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024127789$AMGEN$$$$$M$Y$$$20240703$$CN$US$US
240440441$24044044$1$I$$20231109$20240703$20240703$PER$$US-AMGEN-USASP2023235352$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240440451$24044045$1$I$$20240620$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05578$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240440461$24044046$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5822104$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240440471$24044047$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05806$HIKMA$Wireko F, Ryu JH.. Wireko F, Ryu JH. Lung Transplant for Acute Exacerbation in Interstitial Pneumonia With Autoimmune Features (IPAF).. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5934$$$$$Y$$$20240703$$MD$US$US
240440481$24044048$1$I$$20240620$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05392$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240440491$24044049$1$I$$20240621$20240703$20240703$EXP$$JP-STERISCIENCE B.V.-2024-ST-000939$Steriscience PTE$Takanosu T, Izawa Y, Yonekawa C, Mato T. Clostridium perfringens-induced liver abscess with severe haemolysis.. BMJ-Case-Rep. 2024;17 (5)$8$DEC$$M$Y$$$20240703$$HP$JP$JP
240440502$24044050$2$F$20240625$20240729$20240703$20240806$EXP$$CO-JNJFOC-20240674978$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240806$$HP$CO$CO
240440511$24044051$1$I$20240101$20240627$20240703$20240703$EXP$$CA-ABBVIE-5729714$ABBVIE$$48$YR$$F$Y$$$20240703$$CN$CA$CA
240440521$24044052$1$I$20240612$20240619$20240703$20240703$EXP$GB-MHRA-MED-202406191703450180-QSYBJ$GB-USV-002519$USV PRIVATE$$35$YR$A$F$Y$65$KG$20240703$$CN$GB$GB
240440531$24044053$1$I$20230501$20240619$20240703$20240703$EXP$$XI-TEVA-VS-3212733$TEVA$$88$YR$$F$Y$88$KG$20240703$$MD$GB$GB
240440541$24044054$1$I$$20240619$20240703$20240703$EXP$$US-Axellia-005254$XELLIA PHARMACEUTICALS$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316(6):279.$63$YR$A$F$Y$$$20240703$$MD$US$US
240440551$24044055$1$I$$20240619$20240703$20240703$EXP$$JP-USV-002516$USV PRIVATE$Koizumi G, Hayashi A, Takigawa A, Yamada R, Murata T, Shimizu K, et al. Novel Histopathological Findings of Micro Bone Fragments and Epithelial Response in the Oral Mucosa in Bisphosphonate-Related Osteonecrosis of the Jaw. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-8.$53$YR$A$M$Y$$$20240703$$MD$JP$JP
240440561$24044056$1$I$$20240624$20240703$20240703$EXP$$JP-VANTIVE-2024VAN017191$Vantive US Healthcare$$$$$M$Y$$$20240703$$MD$JP$JP
240440571$24044057$1$I$20240408$20240501$20240703$20240703$PER$$US-Indoco-000545$INDOCO$$37$YR$A$F$Y$$$20240703$$CN$US$US
240440581$24044058$1$I$20240522$20240625$20240703$20240703$EXP$$JP-VANTIVE-2024VAN017566$Vantive US Healthcare$$$$$F$Y$$$20240703$$CN$JP$JP
240440591$24044059$1$I$20210501$20240625$20240703$20240703$EXP$$RO-CELLTRION INC.-2024RO015714$CELLTRION$$$$$$Y$$$20240703$$MD$RO$RO
240440602$24044060$2$F$$20240724$20240703$20240805$30DAY$$US-GSK-US2024081054$GLAXOSMITHKLINE$$$$$F$Y$$$20240804$$CN$US$US
240440611$24044061$1$I$20220101$20240620$20240703$20240703$EXP$SE-SEMPA-2024-002002$SE-TEVA-VS-3213128$TEVA$$23$YR$$F$Y$55$KG$20240703$$CN$SE$SE
240440624$24044062$4$F$20240628$20240730$20240703$20240808$30DAY$$US-JNJFOC-20240678210$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240808$$PH$US$US
240440632$24044063$2$F$20240101$20240709$20240703$20240712$EXP$$CA-UCBSA-2024033523$UCB$$$$$M$Y$$$20240712$$CN$CA$CA
240440641$24044064$1$I$20240201$20240620$20240703$20240703$EXP$$DE-TEVA-VS-3213182$TEVA$$$$$M$Y$2.6$KG$20240703$$MD$DE$DE
240440651$24044065$1$I$20240629$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000940$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240703$$CN$US$US
240440661$24044066$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001244$ELI LILLY AND CO$$87$YR$E$M$Y$$$20240703$$CN$US$US
240440671$24044067$1$I$20240628$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001563$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240703$$CN$US$US
240440681$24044068$1$I$20240701$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001121$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240703$$CN$US$US
240440691$24044069$1$I$20240502$20240620$20240703$20240703$EXP$DE-AMK-276229$DE-TEVA-VS-3213282$TEVA$$65$YR$$M$Y$$$20240703$$PH$DE$DE
240440701$24044070$1$I$$20231109$20240703$20240703$PER$$US-AMGEN-USASP2023235422$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240440712$24044071$2$F$20240501$20240828$20240703$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105982$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$65.77$KG$20240902$$CN$US$US
240440722$24044072$2$F$20240620$20240702$20240703$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105756$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$58.97$KG$20240711$$HP$US$US
240440732$24044073$2$F$$20240730$20240703$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105975$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240801$$CN$US$US
240440742$24044074$2$F$$20241001$20240703$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105616$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$79.83$KG$20241001$$HP$US$US
240440751$24044075$1$I$20240101$20240620$20240703$20240703$EXP$$US-TEVA-VS-3213141$TEVA$$53$YR$$F$Y$$$20240703$$PH$US$US
240440761$24044076$1$I$20240409$20240618$20240703$20240703$EXP$FR-AFSSAPS-BX2024001158$FR-TEVA-VS-3211836$TEVA$$51$YR$$F$Y$$$20240703$$HP$FR$FR
240440771$24044077$1$I$$20240621$20240703$20240703$PER$$US-TEVA-VS-3213100$TEVA$$$$$$Y$$$20240703$$CN$US$US
240440781$24044078$1$I$20190101$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406191030491720-RQHBZ$GB-LUPIN PHARMACEUTICALS INC.-2024-05527$LUPIN$$$$$$Y$$$20240703$$MD$GB$GB
240440792$24044079$2$F$20240101$20240709$20240703$20240714$EXP$$US-ABBVIE-5822208$ABBVIE$$$$$F$Y$$$20240714$$CN$US$US
240440801$24044080$1$I$$20240628$20240703$20240703$EXP$JP-MMM-RKBJ9XPI$JP-GSK-JP2024080724$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$JP$JP
240440812$24044081$2$F$$20240628$20240703$20240706$PER$$US-ABBVIE-5821512$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240440822$24044082$2$F$$20240903$20240703$20240905$EXP$$US-JNJFOC-20240668753$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$HP$US$US
240440831$24044083$1$I$$20231012$20240703$20240703$PER$$US-AMGEN-USASP2023235310$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240440841$24044084$1$I$$20231010$20240703$20240703$PER$$US-AMGEN-USASP2023235434$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240440861$24044086$1$I$$20230314$20240703$20240703$PER$$US-AMGEN-USASP2023235376$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240440872$24044087$2$F$$20240627$20240703$20240705$EXP$$US-ROCHE-10000013403$ROCHE$$$$$$Y$$$20240705$$CN$US$US
240440881$24044088$1$I$$20240623$20240703$20240703$PER$$US-ROCHE-10000011597$ROCHE$$$$$$Y$$$20240703$$CN$US$US
240440891$24044089$1$I$20240507$20240627$20240703$20240703$EXP$$CN-BEIGENE-BGN-2024-009974$BEIGENE$$$$$$Y$$$20240703$$HP$CN$CN
240440901$24044090$1$I$20240227$20240624$20240703$20240703$EXP$$CN-UCBSA-2024020543$UCB$$28$YR$$F$Y$$$20240703$$MD$CN$CN
240440911$24044091$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05854$HIKMA$Rubannelsonkumar C, Hornak J.. Rubannelsonkumar C, Hornak J. Treatment of Mucormycosis Infection With Combination Therapy Using Echinocandin and Amphotericin B.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2389$$$$$Y$$$20240703$$MD$US$US
240440922$24044092$2$F$20190729$20240828$20240703$20240902$PER$$US-GILEAD-2024-0679354$GILEAD$$40$YR$A$M$Y$$$20240902$$LW$US$US
240440931$24044093$1$I$$20240628$20240703$20240703$EXP$$US-ABBVIE-5821574$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240440941$24044094$1$I$$20240624$20240703$20240703$EXP$$US-AMGEN-USASP2024124984$AMGEN$Bugayong M.; Singh M.; Kwentoh I. et.al.. A Fatal Mimic- A Case of Hemophagocytic Lymphohistiocytosis (IHLH)/Macrophage Activation Syndrome (MAS). American Journal of Respiratory and Critical Care Medicine. 2024;209(1):A3534$25$YR$A$F$Y$$$20240703$$HP$US$US
240440951$24044095$1$I$$20240702$20240703$20240703$EXP$$GB-TEVA-VS-3216270$TEVA$$84$YR$$F$Y$$$20240703$$CN$GB$GB
240440961$24044096$1$I$$20240626$20240703$20240703$PER$$US-ROCHE-10000014384$ROCHE$$75$YR$E$F$Y$$$20240703$$CN$US$US
240440971$24044097$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05818$HIKMA$Huang L, Ellis TJ, Bagavathy K.. Huang L, Ellis TJ, Bagavathy K. The Unfortunate Trifecta: Tuberculosis, EBV, and CMV Induced Hemophagocytic Lymphohistiocytosis.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7416$$$$$Y$$$20240703$$MD$US$US
240440981$24044098$1$I$20200601$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406192136501430-MVPZQ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13857$ALKEM$$38$YR$$M$Y$68$KG$20240703$$CN$GB$GB
240440991$24044099$1$I$20240323$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406192051505820-QMVBS$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13855$ALKEM$$$$$M$Y$78$KG$20240703$$CN$GB$GB
240441001$24044100$1$I$$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406192122039270-KNLMW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13856$ALKEM$$$$$M$Y$$$20240703$$CN$GB$GB
240441011$24044101$1$I$20240323$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406192152345820-JNHDY$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13858$ALKEM$$24$YR$$M$Y$78$KG$20240703$$CN$GB$GB
240441022$24044102$2$F$$20240628$20240703$20240711$EXP$IN-MLMSERVICE-20240612-PI096128-00275-1$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-13838$ALKEM$Bedi GN, Acharya S, Kumar S, Mapari SA, Sawant R.. Central Pontine Myelinolysis: A Rare and Life-Threatening Adverse Effect of Clobazam and Quetiapine. Cureus. 2024;16(5):e60007$69$YR$$M$Y$$$20240711$$MD$IN$IN
240441031$24044103$1$I$20230301$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406191943386520-JSQZC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13877$ALKEM$$25$YR$$M$Y$68$KG$20240703$$CN$GB$GB
240441041$24044104$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281414490710-DZNCP$GB-ORGANON-O2407GBR000068$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240441051$24044105$1$I$20161101$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406191327139100-PSBVR$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13842$ALKEM$$$$$F$Y$82$KG$20240703$$CN$GB$GB
240441062$24044106$2$F$$20240628$20240703$20240711$EXP$US-MLMSERVICE-20240612-PI096223-00030-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-13836$ALKEM$Raza HS, Love JS, Mikolajczyk AE.. Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding. ACG Case Reports Journal. 2024;11(6):e01378$38$YR$$M$Y$$$20240711$$MD$US$US
240441072$24044107$2$F$$20240628$20240703$20240711$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-13954$ALKEM$Kobylianskii J, Austin E, Kumachev A, Wu PE.. A 53-year-old woman with a suspected drug overdose. Canadian Medical Association Journal. 2022;194(5):E163-E166$53$YR$$F$Y$$$20240711$$MD$CA$CA
240441081$24044108$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406291156204580-GSRWB$GB-ORGANON-O2407GBR000034$ORGANON$$25$YR$$M$Y$88$KG$20240703$$CN$GB$GB
240441092$24044109$2$F$$20240806$20240703$20240813$EXP$$JP-GSK-JP2024JPN079325$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$PH$JP$JP
240441101$24044110$1$I$20240501$20240701$20240703$20240703$EXP$FR-AFSSAPS-RS2024000636$FR-GSK-FR2024081640$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$FR$FR
240441111$24044111$1$I$$20240628$20240703$20240703$EXP$$JP-TAKEDA-2023TJP002782$TAKEDA$$76$YR$$M$Y$$$20240703$$MD$JP$JP
240441121$24044112$1$I$20240401$20240701$20240703$20240703$EXP$DE-LUNDBECK-DKLU3076711$DE-GSK-DE2024081638$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$DE$DE
240441131$24044113$1$I$20240518$20240701$20240703$20240703$EXP$$FR-GILEAD-2024-0679157$GILEAD$$40$YR$A$M$Y$$$20240703$$PH$FR$FR
240441141$24044114$1$I$$20240627$20240703$20240703$EXP$$US-BEIGENE-BGN-2024-009907$BEIGENE$$$$$$Y$$$20240703$$CN$US$US
240441152$24044115$2$F$20240201$20240726$20240703$20240801$EXP$$JP-ABBVIE-5823332$ABBVIE$$88$YR$$F$Y$$$20240801$$HP$JP$JP
240441171$24044117$1$I$20240624$20240625$20240703$20240703$EXP$$US-AMGEN-USASP2024126369$AMGEN$$78$YR$E$M$Y$$$20240703$$CN$US$US
240441181$24044118$1$I$$20240627$20240703$20240703$PER$$US-ROCHE-10000014553$ROCHE$$17$YR$T$F$Y$$$20240703$$CN$US$US
240441191$24044119$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05858$HIKMA$Nunez Cuello L, Perozo M, Cedeno H, Shah P.. Nunez Cuello L, Perozo M, Cedeno H, Shah P. Indomethacin-induced Angioedema: A Rare and Challenging Case.. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240703$$MD$US$US
240441201$24044120$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05883$HIKMA$Patel S, Prajapati V, Patel P.. Patel S, Prajapati V, Patel P. Culture Negative Infective Endocarditis Secondary to Septic Emboli of Lung.. American Journal of Respiratory and Critical Care Med. 2024;209:2414$32$YR$$F$Y$$$20240703$$MD$US$US
240441211$24044121$1$I$$20240625$20240703$20240703$PER$$US-ALXN-202406USA001653US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
240441221$24044122$1$I$$20240701$20240703$20240703$EXP$GB-MHRA-MED-202407012134569120-BSNPD$GB-GSK-GB2024081660$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$GB$GB
240441231$24044123$1$I$20240604$20240625$20240703$20240703$EXP$$US-SA-2024SA192158$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240703$$MD$US$US
240441241$24044124$1$I$$20240628$20240703$20240703$EXP$$US-ABBVIE-5821812$ABBVIE$$$$$F$Y$$$20240703$$HP$US$US
240441251$24044125$1$I$20240522$20240619$20240703$20240703$EXP$FR-AFSSAPS-AN2024000781$FR-TEVA-VS-3212325$TEVA$$59$YR$$M$Y$$$20240703$$PH$FR$FR
240441261$24044126$1$I$$20240627$20240703$20240703$EXP$$CA-BEIGENE-BGN-2024-009905$BEIGENE$$$$$$Y$$$20240703$$HP$CA$CA
240441272$24044127$2$F$20240601$20240822$20240703$20240901$PER$$US-AstraZeneca-2024A145890$ASTRAZENECA$$674$MON$$M$Y$$$20240901$$CN$US$
240441281$24044128$1$I$$20240625$20240703$20240703$EXP$$CA-AstraZeneca-2024A147319$ASTRAZENECA$$$$$M$Y$$$20240703$$HP$CA$
240441292$24044129$2$F$20240702$20240923$20240703$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105868$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240924$$CN$US$US
240441303$24044130$3$F$$20240826$20240703$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106118$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240829$$CN$US$US
240441316$24044131$6$F$20240626$20240909$20240703$20240920$EXP$$NL-BEH-2024174719$CSL BEHRING$$15$YR$T$M$Y$65$KG$20240920$$PH$NL$NL
240441322$24044132$2$F$$20240725$20240703$20240727$PER$$US-JNJFOC-20240676879$JOHNSON AND JOHNSON$$$$$M$Y$$$20240727$$HP$US$US
240441331$24044133$1$I$$20240628$20240703$20240703$EXP$$RU-ABBVIE-5822505$ABBVIE$$$$$M$Y$$$20240703$$MD$RU$RU
240441341$24044134$1$I$$20240624$20240703$20240703$EXP$$BR-JNJFOC-20240674981$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240703$$MD$BR$BR
240441351$24044135$1$I$$20240628$20240703$20240703$30DAY$$US-GSK-US2024081076$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240441361$24044136$1$I$20230923$20240627$20240703$20240703$EXP$FR-AFSSAPS-PC2023000877$FR-SA-2024SA192745$SANOFI AVENTIS$$66$YR$E$M$Y$67$KG$20240703$$MD$FR$FR
240441371$24044137$1$I$20240501$20240702$20240703$20240703$EXP$FR-AFSSAPS-AVNT2024000484$FR-ORGANON-O2407FRA000221$ORGANON$$59$YR$$M$Y$$$20240703$$PH$FR$FR
240441392$24044139$2$F$20231218$20240808$20240703$20240814$EXP$$JP-009507513-2403JPN001108J$MERCK$$76$YR$$M$Y$$$20240814$$PH$JP$JP
240441402$24044140$2$F$20240101$20240826$20240703$20240829$EXP$$CA-ABBVIE-5821572$ABBVIE$$60$YR$$F$Y$$$20240829$$CN$CA$CA
240441411$24044141$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001118$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240703$$CN$US$US
240441422$24044142$2$F$20240501$20240807$20240703$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202407000186$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240811$$CN$US$US
240441431$24044143$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281437578480-ZYWPV$GB-ORGANON-O2407GBR000060$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240441441$24044144$1$I$20240601$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001077$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240703$$CN$US$US
240441451$24044145$1$I$$20240627$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406019478$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240703$$CN$US$US
240441461$24044146$1$I$$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000748$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240703$$CN$US$US
240441471$24044147$1$I$20240601$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000938$ELI LILLY AND CO$$51$YR$A$$Y$$$20240703$$CN$US$US
240441481$24044148$1$I$$20240625$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000512$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240703$$CN$US$US
240441491$24044149$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001096$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240703$$CN$US$US
240441501$24044150$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001083$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$US$US
240441511$24044151$1$I$20240601$20240628$20240703$20240703$EXP$$US-ABBVIE-5821838$ABBVIE$$76$YR$$M$Y$$$20240703$$CN$US$US
240441521$24044152$1$I$$20240701$20240703$20240703$PER$$US-MTPC-MTDA2024-0013739$Unknown Manufacturer$$$$A$F$Y$$$20240703$$HP$US$US
240441531$24044153$1$I$$20230310$20240703$20240703$PER$$US-AMGEN-USASP2023235441$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240441541$24044154$1$I$20230718$20240625$20240703$20240703$EXP$$JP-MTPC-MTPC2023-0018831$Unknown Manufacturer$$5$DEC$$M$Y$$$20240703$$PH$JP$JP
240441561$24044156$1$I$$20230613$20240703$20240703$PER$$US-AMGEN-USASP2023235248$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240441571$24044157$1$I$20240627$20240701$20240703$20240703$EXP$$CZ-GILEAD-2024-0678794$GILEAD$$$$$F$Y$$$20240703$$MD$CZ$CZ
240441581$24044158$1$I$$20231207$20240703$20240703$EXP$GB-MHRA-WEBRADR-202312061055022030-LSCWT$GB-TEVA-VS-3146281$TEVA$$$$$F$Y$$$20240703$$HP$GB$GB
240441591$24044159$1$I$20240626$20240626$20240703$20240703$PER$$US-ABBVIE-5820830$ABBVIE$$$$A$F$Y$$$20240703$$CN$US$US
240441601$24044160$1$I$$20240621$20240703$20240703$PER$$US-ROCHE-10000009298$ROCHE$$$$$$Y$$$20240703$$PH$US$US
240441611$24044161$1$I$$20240603$20240703$20240703$PER$$US-JNJFOC-20240606276$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240441621$24044162$1$I$20140101$20240627$20240703$20240703$EXP$$AU-BEIGENE-BGN-2024-009891$BEIGENE$$$$$$Y$$$20240703$$HP$AU$AU
240441632$24044163$2$F$$20240704$20240703$20240718$EXP$$AU-CIPLA LTD.-2024AU06437$CIPLA$$$$$$Y$$$20240718$$CN$AU$AU
240441641$24044164$1$I$20231221$20240624$20240703$20240703$EXP$$EG-ROCHE-10000012117$ROCHE$$37$YR$A$M$Y$55$KG$20240703$$CN$EG$EG
240441652$24044165$2$F$$20240802$20240703$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105895$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$52.62$KG$20240802$$CN$US$US
240441661$24044166$1$I$20231101$20240627$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103726$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240703$$HP$US$US
240441672$24044167$2$F$20240627$20240703$20240703$20240708$PER$$US-AMGEN-USASP2024128304$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240441682$24044168$2$F$20240527$20240704$20240703$20240712$EXP$$DE-CELLTRION INC.-2024DE015443$CELLTRION$$$$$$Y$$$20240712$$HP$DE$DE
240441692$24044169$2$F$$20240807$20240703$20240816$EXP$$SA-EMD Serono-2024034649$EMD SERONO INC$$22$YR$A$F$Y$$$20240816$$MD$SA$SA
240441701$24044170$1$I$$20240624$20240703$20240703$PER$$US-ROCHE-10000011896$ROCHE$$$$$$Y$$$20240703$$CN$US$US
240441711$24044171$1$I$$20240628$20240703$20240703$PER$$US-HALEON-2185008$Haleon PLC$$$$$F$Y$$$20240703$$CN$US$US
240441722$24044172$2$F$20240625$20240723$20240703$20240729$PER$$US-ROCHE-10000012791$ROCHE$$83$YR$E$F$Y$$$20240729$$CN$US$US
240441731$24044173$1$I$$20240626$20240703$20240703$EXP$$CA-ABBVIE-5818670$ABBVIE$$20$YR$$F$Y$$$20240703$$CN$CA$CA
240441741$24044174$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281435349850-RDTKB$GB-ORGANON-O2407GBR000108$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240441751$24044175$1$I$$20240624$20240703$20240703$EXP$$US-APOTEX-2024AP007781$APOTEX$Hammond TC, Channick CL, Favano T, Purbhoo M, Exley MA, Vandiver MS, et al.. Persistent SARS-CoV-2 Viremia, COVID-19 Associated Acute Respiratory Distress Syndrome, Severe Coagulopathy and Massive Hemoptysis in a Renal Transplant Patient on Veno-Venous Extracorporeal Membrane Oxygenation.. American Journal of Respiratory and Critical Care Medicine. 2024;209$26$YR$$M$Y$$$20240703$$HP$US$US
240441762$24044176$2$F$$20240820$20240703$20240822$EXP$$US-GSK-US2024079676$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
240441773$24044177$3$F$$20240711$20240703$20240715$30DAY$$US-GSK-US2024081169$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
240441782$24044178$2$F$20240101$20240711$20240703$20240725$EXP$$US-INSMED, INC.-2024-00640-US$INSMED$$$$$F$Y$$$20240725$$CN$US$US
240441801$24044180$1$I$$20230509$20240703$20240703$PER$$US-AMGEN-USASP2023235348$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240441811$24044181$1$I$20240101$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024127754$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240441823$24044182$3$F$20240529$20240808$20240703$20240809$PER$$US-JNJFOC-20240676768$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$HP$US$US
240441831$24044183$1$I$$20240702$20240703$20240703$PER$$US-JNJFOC-20240705252$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$PH$US$US
240441841$24044184$1$I$$20240627$20240703$20240703$PER$$US-JNJFOC-20240675082$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240703$$HP$US$US
240441851$24044185$1$I$$20240628$20240703$20240703$EXP$$US-JNJFOC-20240678040$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240441861$24044186$1$I$20240107$20240624$20240703$20240703$EXP$$US-JNJFOC-20240672738$JOHNSON AND JOHNSON$$0$YR$$M$Y$$$20240703$$HP$US$US
240441871$24044187$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105969$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240703$$HP$US$US
240441891$24044189$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105829$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240703$$CN$US$US
240441902$24044190$2$F$$20240628$20240703$20240712$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-19728$SAMSUNG BIOEPIS$$82$YR$E$M$Y$$$20240712$$CN$CA$CA
240441911$24044191$1$I$$20240701$20240703$20240703$EXP$$US-GILEAD-2024-0679191$GILEAD$$$$E$F$Y$$$20240703$$CN$US$US
240441921$24044192$1$I$$20240624$20240703$20240703$PER$$US-ABBVIE-5817499$ABBVIE$$$$$M$Y$$$20240703$$MD$US$US
240441931$24044193$1$I$20110101$20240625$20240703$20240703$EXP$$RS-CHEPLA-2024008133$CHEPLAPHARM$Colovic N, Ljubicic J, Kostic D, Barac A, Jurisic V. Disseminated cerebral cryptococcosis after silent West Nile virus infection in a patient with polycythemia vera: A case report and review of the literature. Sage Open Medical Case Reports.2024;12:1?5.doi: 10.1177/2050313X241262145.$43$YR$$M$Y$$$20240703$$HP$COUNTRY NOT SPECIFIED$RS
240441941$24044194$1$I$20240624$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406270316543460-WQYKC$GB-GILEAD-2024-0678994$GILEAD$$18$YR$A$M$Y$93$KG$20240703$$CN$GB$GB
240441951$24044195$1$I$$20231128$20240703$20240703$PER$$US-AMGEN-USASP2023234999$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240441962$24044196$2$F$20230705$20240711$20240703$20240715$EXP$$CA-TAKEDA-2022TUS032243$TAKEDA$$37$YR$$F$Y$$$20240715$$CN$CA$CA
240441971$24044197$1$I$20240612$20240701$20240703$20240703$PER$$US-BIOVITRUM-2024-US-009367$BIOVITRUM$$30$YR$$F$Y$$$20240703$$CN$US$US
240441981$24044198$1$I$$20240620$20240703$20240703$EXP$$CN-INGENUS PHARMACEUTICALS, LLC-2024INF000031$INGENUS$Chu S, Bai J, Wang X, Zhang L, Li L. Acute Promyelocytic Leukemia With Long and Short Isoforms of PML::RARA Fusion Transcripts Complicated by Abdominal Distension and Acute Edematous Pancreatitis During Induction Treatment: A Case Report.. Cureus.. 2024;16(5)$70$YR$$M$Y$$$20240703$$HP$CN$CN
240441991$24044199$1$I$20220916$20240619$20240703$20240703$EXP$$JP-ROCHE-10000010413$ROCHE$$70$YR$E$F$Y$$$20240703$$MD$JP$JP
240442011$24044201$1$I$20240520$20240628$20240703$20240703$EXP$$US-ABBVIE-5822308$ABBVIE$$70$YR$$M$Y$$$20240703$$CN$US$US
240442032$24044203$2$F$20240601$20240701$20240703$20240710$EXP$$IL-UNITED THERAPEUTICS-UNT-2024-019504$UNITED THERAPEUTICS$$83$YR$$M$Y$$$20240710$$$IL$IL
240442041$24044204$1$I$20240624$20240624$20240703$20240703$EXP$$US-VANTIVE-2024VAN017945$Vantive US Healthcare$$48$YR$$M$Y$$$20240703$$CN$US$US
240442051$24044205$1$I$20240621$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024130001$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240442061$24044206$1$I$$20240628$20240703$20240703$EXP$$US-GILEAD-2024-0679085$GILEAD$$23$YR$A$F$Y$$$20240703$$CN$US$US
240442072$24044207$2$F$$20240625$20240703$20240705$EXP$$AU-CELLTRION INC.-2024AU015939$CELLTRION$$$$$$Y$$$20240705$$MD$AU$AU
240442081$24044208$1$I$$20240627$20240703$20240703$EXP$$ZA-ABBVIE-5822520$ABBVIE$$77$DY$$F$Y$$$20240703$$CN$ZA$ZA
240442091$24044209$1$I$$20240701$20240703$20240703$EXP$$CA-ORGANON-O2407CAN000154$ORGANON$$65$YR$$F$Y$$$20240703$$HP$CA$CA
240442101$24044210$1$I$20240122$20240627$20240703$20240703$PER$$US-009507513-2406USA009758$MERCK$$$$$M$Y$104.76$KG$20240703$$CN$US$US
240442111$24044211$1$I$$20240624$20240703$20240703$EXP$$US-APOTEX-2024AP007792$APOTEX$Hodson EL, Kranyak A, Salem I, Buckey Jr JC. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases. Journal of Tissue Viability. 2024;1-3$54$YR$$F$Y$$$20240703$$HP$US$US
240442121$24044212$1$I$$20231010$20240703$20240703$PER$$US-AMGEN-USASP2023235390$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240442131$24044213$1$I$$20230711$20240703$20240703$PER$$US-AMGEN-USASP2023235155$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240442141$24044214$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05823$HIKMA$Seetharaman K, Clarke J, Achamallah N, Fried J.. Seetharaman K, Clarke J, Achamallah N, Fried J. Fentanyl Induced Chest Wall Rigidity Syndrome. American Journal of Respiratory and Critical Care Medicine.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1150$$$$$Y$$$20240703$$MD$US$US
240442151$24044215$1$I$20240619$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024130029$AMGEN$$75$YR$E$M$Y$$$20240703$$CN$US$US
240442161$24044216$1$I$$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024129497$AMGEN$$$$A$F$Y$$$20240703$$MD$US$US
240442171$24044217$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001256$ELI LILLY AND CO$$$$$M$Y$$$20240703$$CN$US$US
240442181$24044218$1$I$20240629$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001356$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240703$$CN$US$US
240442191$24044219$1$I$20240101$20240628$20240703$20240703$EXP$$CA-JNJFOC-20240678536$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240703$$HP$CA$CA
240442201$24044220$1$I$20180525$20240625$20240703$20240703$EXP$$GB-JNJFOC-20240669990$JOHNSON AND JOHNSON$$34$YR$A$F$Y$60$KG$20240703$$MD$GB$GB
240442211$24044221$1$I$20240630$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001010$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240703$$CN$US$US
240442221$24044222$1$I$20240701$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001101$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240703$$CN$US$US
240442231$24044223$1$I$$20240624$20240703$20240703$EXP$$CA-JNJFOC-20240674682$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$CA$CA
240442241$24044224$1$I$20230428$20240625$20240703$20240703$EXP$$FR-CELLTRION INC.-2024FR015717$CELLTRION$$$$$$Y$$$20240703$$HP$FR$FR
240442251$24044225$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105780$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240703$$HP$US$US
240442261$24044226$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105917$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240703$$CN$US$US
240442271$24044227$1$I$$20240702$20240703$20240703$PER$$US-HALEON-2184947$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240442281$24044228$1$I$20240620$20240628$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105109$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$83.46$KG$20240703$$HP$US$US
240442301$24044230$1$I$20230901$20240628$20240703$20240703$EXP$$US-ABBVIE-5403364$ABBVIE$$64$YR$$F$Y$$$20240703$$CN$US$US
240442311$24044231$1$I$20231121$20240627$20240703$20240703$EXP$$US-ABBVIE-5821568$ABBVIE$$70$YR$$M$Y$$$20240703$$CN$US$US
240442321$24044232$1$I$$20240621$20240703$20240703$EXP$$US-STERISCIENCE B.V.-2024-ST-000931$Steriscience PTE$Huff RR, Jose A, Taillon J.. Unlikely Friends: Coinfection of a Malignant Cavitary Lesion With Aspergillus and Actinomyces.. Am-J-Respir-Crit-Care-Med. 2024;209 (0):A2379$58$YR$$M$Y$$$20240703$$HP$US$US
240442332$24044233$2$F$$20240703$20240703$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105908$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$52$KG$20240704$$PH$US$US
240442341$24044234$1$I$20240601$20240627$20240703$20240703$PER$$US-ABBVIE-5821526$ABBVIE$$18$YR$$F$Y$$$20240703$$MD$US$US
240442352$24044235$2$F$20240919$20240919$20240703$20240919$EXP$$KR-GILEAD-2024-0679221$GILEAD$$$$$F$Y$$$20240919$$CN$KR$KR
240442362$24044236$2$F$20230203$20240807$20240703$20240814$EXP$$JP-GSK-JP2024081692$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$JP$JP
240442371$24044237$1$I$$20240628$20240703$20240703$EXP$$ZA-AstraZeneca-2024A149843$ASTRAZENECA$$24471$DY$$M$Y$$$20240703$$CN$ZA$
240442381$24044238$1$I$$20240625$20240703$20240703$PER$$US-AstraZeneca-2024A147237$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240442391$24044239$1$I$$20240626$20240703$20240703$EXP$$CA-JNJFOC-20240700249$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$HP$CA$CA
240442401$24044240$1$I$$20240621$20240703$20240703$EXP$$IN-ROCHE-10000010565$ROCHE$$28$YR$A$M$Y$$$20240703$$MD$IN$IN
240442412$24044241$2$F$20240101$20240701$20240703$20240708$PER$$US-ABBVIE-5823583$ABBVIE$$$$$$Y$$$20240708$$HP$US$US
240442422$24044242$2$F$20240625$20240709$20240703$20240715$EXP$$US-JNJFOC-20240670695$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240715$$HP$US$US
240442431$24044243$1$I$20240618$20240618$20240703$20240703$PER$$US-ROCHE-10000006966$ROCHE$$$$$$Y$$$20240703$$HP$US$US
240442441$24044244$1$I$$20240618$20240703$20240703$PER$$US-ROCHE-10000012043$ROCHE$$$$$F$Y$$$20240703$$CN$US$US
240442453$24044245$3$F$20240101$20240719$20240703$20240805$PER$$US-APOTEX-2024AP007665$APOTEX$$$$$M$Y$$$20240805$$CN$US$US
240442461$24044246$1$I$$20240625$20240703$20240703$PER$$US-AMGEN-USASP2024126463$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240442471$24044247$1$I$20240524$20240701$20240703$20240703$EXP$$JP-GILEAD-2024-0679048$GILEAD$$75$YR$E$M$Y$67$KG$20240703$$PH$JP$JP
240442481$24044248$1$I$$20240628$20240703$20240703$EXP$$US-ABBVIE-5822258$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240442491$24044249$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281451164270-FJGCR$GB-ORGANON-O2407GBR000113$ORGANON$$$$$M$Y$$$20240703$$CN$GB$GB
240442502$24044250$2$F$20230501$20240903$20240703$20240910$EXP$$IN-GSK-IN2023APC091032$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$IN$IN
240442511$24044251$1$I$20230501$20240618$20240703$20240703$EXP$$US-ROCHE-10000005809$ROCHE$$56$YR$A$F$Y$66.22$KG$20240703$$CN$US$US
240442521$24044252$1$I$$20240621$20240703$20240703$EXP$$HU-STERISCIENCE B.V.-2023-ST-002401$Steriscience PTE$Pasztor-Bazso V, Kelemen A, Varga A, Farkas M, Puskas N, Kassa C et al.. First Hungarian report of Geotrichum capitatum/Saprochaete capitata infection in an immunocompromised child.. Orvosi Hetilap (Medical Jounal). 2023;164(26):1034-1038$18$MON$$F$Y$$$20240703$$HP$HU$HU
240442531$24044253$1$I$$20240624$20240703$20240703$EXP$$CA-TAKEDA-2024TUS060897$TAKEDA$$$$$M$Y$$$20240703$$CN$CA$CA
240442542$24044254$2$F$20190101$20240702$20240703$20240706$EXP$$US-ABBVIE-5822225$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240442553$24044255$3$F$$20240814$20240703$20240815$EXP$$CA-TAKEDA-2024TUS065290$TAKEDA$$$$$M$Y$$$20240815$$CN$CA$CA
240442562$24044256$2$F$$20240702$20240703$20240705$PER$$US-JNJFOC-20240703911$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240442572$24044257$2$F$$20240702$20240703$20240704$PER$$US-JNJFOC-20240703876$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240442582$24044258$2$F$$20240627$20240703$20240718$PER$$US-JNJFOC-20240700476$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
240442591$24044259$1$I$$20240702$20240703$20240703$PER$$US-JNJFOC-20240703573$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240442602$24044260$2$F$$20240702$20240703$20240704$PER$$US-JNJFOC-20240704351$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240442611$24044261$1$I$$20240625$20240703$20240703$PER$$US-JNJFOC-20240673902$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240442631$24044263$1$I$$20230512$20240703$20240703$PER$$US-AMGEN-USASP2023235417$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240442641$24044264$1$I$20240621$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024130090$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240442651$24044265$1$I$$20231012$20240703$20240703$PER$$US-AMGEN-USASP2023235292$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240442661$24044266$1$I$$20240524$20240703$20240703$PER$$US-AMGEN-USASP2024130712$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240442672$24044267$2$F$20240626$20240903$20240703$20240904$PER$$US-AMGEN-USASP2024129100$AMGEN$$36$YR$A$M$Y$$$20240904$$PH$US$US
240442681$24044268$1$I$20231201$20240122$20240703$20240703$EXP$$GB-AMGEN-GBRSP2024130066$AMGEN$$83$YR$E$F$Y$$$20240703$$HP$GB$GB
240442693$24044269$3$F$20220606$20240920$20240703$20240930$EXP$$CA-TAKEDA-2024TUS066420$TAKEDA$$73$YR$$M$Y$$$20240930$$CN$CA$CA
240442701$24044270$1$I$$20240626$20240703$20240703$EXP$$BE-EMD Serono-2024035216$EMD SERONO INC$$$$$M$Y$$$20240703$$MD$BE$BE
240442722$24044272$2$F$$20240704$20240703$20240708$PER$$US-JNJFOC-20240700942$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$CN$US$US
240442731$24044273$1$I$$20240626$20240703$20240703$EXP$$US-JNJFOC-20240671820$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240703$$PH$US$US
240442751$24044275$1$I$20240501$20240627$20240703$20240703$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010003$JAZZ$$32$YR$$F$Y$$$20240703$$CN$US$US
240442761$24044276$1$I$$20240701$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062219$SANDOZ$Yu, Evan Y, Ferrario. Pembrolizumab plus Abiraterone Acetate and Prednisone in Patientswith Chemotherapy-na?ve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D. European urology oncology.. 2024$$$$$Y$$$20240703$$HP$US$US
240442771$24044277$1$I$$20240630$20240703$20240703$EXP$$GB-SANDOZ INC.-SDZ2024GB062119$SANDOZ$$$$$F$Y$$$20240703$$PH$GB$GB
240442781$24044278$1$I$$20240702$20240703$20240703$EXP$GR-EMA-DD-20240628-7482650-080155$GR-SANDOZ INC.-SDZ2024GR062184$SANDOZ$$74$YR$$F$Y$$$20240703$$MD$GR$GR
240442791$24044279$1$I$$20240626$20240703$20240703$EXP$$JP-SANDOZ INC.-SDZ2024JP061431$SANDOZ$Aramachi  Y. A Case of Death Due to Haemophagocytic Syndrome after Umbilical Cord Blood Transplantation for Recurrent and Refractory Malignant Lymphoma. Asahikawa City Hospital Medical Journal. 2023;55(1):17-18$6$DEC$$M$Y$58$KG$20240703$$MD$JP$JP
240442801$24044280$1$I$$20240701$20240703$20240703$PER$$US-ABBVIE-5823665$ABBVIE$$$$E$$Y$$$20240703$$CN$US$US
240442811$24044281$1$I$$20240625$20240703$20240703$EXP$$IN-ROCHE-10000011416$ROCHE$$$$A$F$Y$$$20240703$$CN$IN$IN
240442821$24044282$1$I$$20240619$20240703$20240703$PER$$US-ROCHE-10000013154$ROCHE$$$$$F$Y$$$20240703$$PH$US$US
240442831$24044283$1$I$$20230816$20240703$20240703$PER$$US-AMGEN-USASP2023235072$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240442842$24044284$2$F$20240101$20240627$20240703$20240706$PER$$US-AMGEN-USASP2024128349$AMGEN$$69$YR$E$M$Y$$$20240706$$CN$US$US
240442854$24044285$4$F$20240624$20240821$20240703$20240827$EXP$$CA-TAKEDA-2024TUS065235$TAKEDA$$37$YR$$M$Y$$$20240827$$CN$CA$CA
240442863$24044286$3$F$20200717$20240918$20240703$20240925$EXP$$CA-TAKEDA-2020TUS033992$TAKEDA$$8$YR$$F$Y$$$20240925$$HP$CA$CA
240442872$24044287$2$F$$20240704$20240703$20240709$PER$$US-AstraZeneca-2024A145956$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240442891$24044289$1$I$20240519$20240628$20240703$20240703$EXP$$US-AstraZeneca-2024A149912$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240442901$24044290$1$I$20220201$20240625$20240703$20240703$EXP$$CA-UCBSA-2024033543$UCB$$0$YR$$F$Y$$$20240703$$CN$CA$CA
240442911$24044291$1$I$$20240621$20240703$20240703$PER$$US-TEVA-VS-3213031$TEVA$$$$$M$Y$$$20240703$$CN$US$US
240442922$24044292$2$F$20240612$20240705$20240703$20240712$EXP$$DE-AstraZeneca-2024A146363$ASTRAZENECA$$82$YR$$M$Y$$$20240712$$MD$DE$
240442931$24044293$1$I$$20240701$20240703$20240703$EXP$$CA-ORGANON-O2407CAN000133$ORGANON$$65$YR$$F$Y$$$20240703$$HP$CA$CA
240442941$24044294$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000961$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240703$$CN$US$US
240442951$24044295$1$I$20240630$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001277$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240703$$CN$US$US
240442963$24044296$3$F$20240601$20240715$20240703$20240725$EXP$$US-ELI_LILLY_AND_COMPANY-US202407001102$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240725$$CN$US$US
240442971$24044297$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001290$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240703$$CN$US$US
240442981$24044298$1$I$20240228$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105979$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$76$KG$20240703$$PH$US$US
240442991$24044299$1$I$20220419$20240618$20240703$20240703$EXP$$CA-GSK-CA2022076063$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CA$CA
240443001$24044300$1$I$20240624$20240626$20240703$20240703$EXP$$FI-JNJFOC-20240672319$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240703$$HP$FI$FI
240443023$24044302$3$F$20240623$20240812$20240703$20240826$30DAY$$US-JNJFOC-20240678018$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240827$$CN$US$US
240443031$24044303$1$I$$20230912$20240703$20240703$PER$$US-AMGEN-USASP2023235347$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240443041$24044304$1$I$$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024128322$AMGEN$$22$MON$I$F$Y$$$20240703$$HP$US$US
240443051$24044305$1$I$$20240628$20240703$20240703$EXP$$PE-ABBVIE-5822133$ABBVIE$Mamani Maquera DJ, Pantoja Davalos N. Ghost cell glaucoma: Clinic case. RFMH. 2023;23(1):121-5.$49$YR$$M$Y$$$20240703$$MD$PE$PE
240443071$24044307$1$I$20240626$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129470$AMGEN$$59$YR$A$F$Y$$$20240703$$CN$US$US
240443091$24044309$1$I$20240115$20240627$20240703$20240703$EXP$$US-TAKEDA-2024TUS008867$TAKEDA$$79$YR$$F$Y$$$20240703$$MD$US$US
240443101$24044310$1$I$$20240621$20240703$20240703$EXP$$EG-TAKEDA-2024TUS065825$TAKEDA$$$$A$F$Y$$$20240703$$MD$EG$EG
240443112$24044311$2$F$20231213$20240702$20240703$20240708$EXP$$US-TAKEDA-2023TUS122748$TAKEDA$$80$YR$$F$Y$$$20240708$$PH$US$US
240443122$24044312$2$F$20240611$20240711$20240703$20240712$EXP$$US-SANDOZ INC.-SDZ2024US062185$SANDOZ$$13$YR$$M$Y$$$20240712$$CN$US$US
240443131$24044313$1$I$$20240701$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062242$SANDOZ$$$$$M$Y$$$20240703$$HP$US$US
240443141$24044314$1$I$$20240702$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062395$SANDOZ$$$$$F$Y$$$20240703$$HP$US$US
240443151$24044315$1$I$$20240625$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062272$SANDOZ$$$$$$Y$$$20240703$$HP$US$US
240443161$24044316$1$I$20240628$20240629$20240703$20240703$30DAY$$FR-SANDOZ INC.-SDZ2024FR062331$SANDOZ$$13$YR$$$Y$$$20240703$$PH$FR$FR
240443172$24044317$2$F$20230502$20240716$20240703$20240723$EXP$$DE-SANDOZ INC.-SDZ2024DE062213$SANDOZ$$$$E$F$Y$80$KG$20240723$$MD$DE$DE
240443181$24044318$1$I$$20240619$20240703$20240703$EXP$$CA-GSK-CA2024077137$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CA$CA
240443191$24044319$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031703$AUROBINDO$Lodh A, Blankenship S, Minish-Pron JM, Solomon GM. Cyclophosphamide in the Treatment of Shrinking Lung Syndrome. Am-J-Respir-Crit-Care-Med. 2024;209:A1985$46$YR$$F$Y$$$20240703$$HP$US$US
240443211$24044321$1$I$$20240126$20240703$20240703$PER$$US-ROCHE-3244614$ROCHE$$68$YR$E$F$Y$$$20240703$$PH$US$US
240443222$24044322$2$F$$20240307$20240703$20240703$PER$$US-ROCHE-2790665$ROCHE$$61$YR$A$M$Y$$$20240703$$MD$US$US
240443241$24044324$1$I$20240101$20240621$20240703$20240703$PER$$US-TEVA-VS-3213020$TEVA$$46$YR$$F$Y$$$20240703$$CN$US$US
240443252$24044325$2$F$$20240910$20240703$20240912$PER$$US-JNJFOC-20240670876$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
240443262$24044326$2$F$$20240701$20240703$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062203$SANDOZ$$$$$$Y$$$20240705$$LW$US$US
240443281$24044328$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031805$AUROBINDO$Pysick H, Bowmaster S, Gehlbach BK, Doerschug KC. Gasping, Bradypnea, and Obtundation: An Unusual Case of Respiratory Failure From Seizures. Am-J-Respir-Crit-Care-Med. 2024;209:A4580$21$YR$$M$Y$$$20240703$$HP$US$US
240443291$24044329$1$I$$20240701$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US062292$SANDOZ$$$$$M$Y$$$20240703$$CN$US$US
240443301$24044330$1$I$$20240628$20240703$20240703$30DAY$$FR-SANDOZ INC.-SDZ2024FR032897$SANDOZ$$$$C$M$Y$$$20240703$$PH$FR$FR
240443311$24044331$1$I$$20240628$20240703$20240703$PER$$US-TAKEDA-2024TUS066011$TAKEDA$$$$$$Y$$$20240703$$CN$US$US
240443321$24044332$1$I$20240626$20240626$20240703$20240703$PER$$US-JNJFOC-20240672553$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240703$$CN$US$US
240443331$24044333$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031416$AUROBINDO$Khan M, Farmer MS.. Ticking All the Boxes: Case of Anaplasmosis With Acute Respiratory Distress Syndrome and Multi-Organ Failure. Am-J-Respir-Crit-Care-Med. 2024;209:A3557$79$YR$$F$Y$$$20240703$$HP$US$US
240443341$24044334$1$I$20240101$20240701$20240703$20240703$EXP$$US-UCBSA-2024033467$UCB$$$$$F$Y$$$20240703$$CN$US$US
240443351$24044335$1$I$20240614$20240620$20240703$20240703$EXP$$RU-ROCHE-10000009983$ROCHE$$56$YR$A$F$Y$$$20240703$$MD$RU$RU
240443361$24044336$1$I$$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105772$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240703$$CN$US$US
240443371$24044337$1$I$20230701$20240701$20240703$20240703$EXP$$US-TAKEDA-2023TUS087597$TAKEDA$$4$YR$$F$Y$$$20240703$$MD$US$US
240443381$24044338$1$I$$20240624$20240703$20240703$EXP$$PL-AUROBINDO-AUR-APL-2024-031755$AUROBINDO$Braun M, Solek JM, Milkowska-Dymanowska J, Jesionek-Kupnicka D, Gora-Tybor J, Mikulski D, et al. Primary pulmonary Hodgkin^s lymphoma mimicking granulomatosis with polyangiitis - a case report of diagnostic and therapeutic dilemmas. Wspolczesna-Onkol. 2023;27(2):113-117$53$YR$$F$Y$$$20240703$$HP$PL$PL
240443391$24044339$1$I$$20240619$20240703$20240703$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2020AMR255553$VIIV$$$$$$Y$$$20240703$$MD$CA$CA
240443401$24044340$1$I$$20240628$20240703$20240703$EXP$$CZ-TAKEDA-2022TUS055542$TAKEDA$$52$YR$$F$Y$$$20240703$$HP$CZ$CZ
240443412$24044341$2$F$20170101$20240925$20240703$20240930$EXP$$US-ROCHE-10000012489$ROCHE$$51$YR$A$M$Y$123.83$KG$20240929$$CN$US$US
240443424$24044342$4$F$20240320$20240904$20240703$20240911$EXP$$CA-GSK-CA2022129922$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$MD$CA$CA
240443432$24044343$2$F$20240101$20240905$20240703$20240911$EXP$$US-ABBVIE-5822946$ABBVIE$$$$$M$Y$111$KG$20240911$$CN$US$US
240443441$24044344$1$I$$20240619$20240703$20240703$PER$$US-ROCHE-10000008768$ROCHE$$$$$$Y$$$20240703$$MD$US$US
240443451$24044345$1$I$20160401$20240625$20240703$20240703$EXP$$US-AMGEN-USASP2024127968$AMGEN$$83$YR$E$M$Y$$$20240703$$CN$US$US
240443461$24044346$1$I$$20231121$20240703$20240703$PER$$US-AMGEN-USASP2023235334$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240443472$24044347$2$F$$20240620$20240703$20240709$EXP$$US-ROCHE-10000009770$ROCHE$$$$$M$Y$$$20240701$$HP$US$US
240443481$24044348$1$I$20230101$20240629$20240703$20240703$EXP$$PL-BAUSCHBL-2024BNL029334$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240703$$MD$PL$PL
240443491$24044349$1$I$$20240628$20240703$20240703$PER$$US-JNJFOC-20240676999$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240443501$24044350$1$I$$20240624$20240703$20240703$EXP$$US-JNJFOC-20240665355$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240443511$24044351$1$I$$20230123$20240703$20240703$PER$$US-AMGEN-USASP2023235005$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240443521$24044352$1$I$20240621$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024130424$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240443531$24044353$1$I$20231201$20240630$20240703$20240703$EXP$$PL-BAUSCHBL-2024BNL029398$BAUSCH AND LOMB$$6$DEC$$M$Y$$$20240703$$MD$PL$PL
240443541$24044354$1$I$$20240630$20240703$20240703$EXP$$HU-BAUSCHBL-2024BNL029394$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240703$$MD$HU$HU
240443551$24044355$1$I$$20240630$20240703$20240703$EXP$$PL-BAUSCHBL-2024BNL029396$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240703$$MD$PL$PL
240443561$24044356$1$I$$20240624$20240703$20240703$PER$$US-APOTEX-2024AP007756$APOTEX$$$$$$Y$$$20240703$$CN$US$US
240443571$24044357$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05839$HIKMA$Behbahani-Nejad N, Palepu R, Kotha A, Nayef H.. Behbahani-Nejad N, Palepu R, Kotha A, Nayef HA. Fentanyl-Induced Wooden Chest Syndrome. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5674$30$YR$$F$Y$$$20240703$$MD$US$US
240443581$24044358$1$I$$20240630$20240703$20240703$EXP$$AU-BAUSCHBL-2024BNL029424$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240703$$CN$AU$AU
240443591$24044359$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105940$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240703$$HP$US$US
240443603$24044360$3$F$20240701$20240806$20240703$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106109$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240812$$HP$US$US
240443611$24044361$1$I$$20240626$20240703$20240703$PER$$US-JNJFOC-20240672799$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$MD$US$US
240443621$24044362$1$I$$20240625$20240703$20240703$PER$$US-JNJFOC-20240673320$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240443631$24044363$1$I$20240626$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024128207$AMGEN$$75$YR$E$F$Y$$$20240703$$CN$US$US
240443641$24044364$1$I$$20231115$20240703$20240703$PER$$US-AMGEN-USASP2023235385$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240443651$24044365$1$I$$20231024$20240703$20240703$PER$$US-AMGEN-USASP2023235264$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240443662$24044366$2$F$20240628$20240806$20240703$20240808$PER$$US-AMGEN-USASP2024128944$AMGEN$$67$YR$E$M$Y$$$20240808$$HP$US$US
240443671$24044367$1$I$$20240630$20240703$20240703$EXP$$AU-BAUSCHBL-2024BNL029428$BAUSCH AND LOMB$$$$$M$Y$$$20240703$$CN$AU$AU
240443681$24044368$1$I$20240601$20240626$20240703$20240703$EXP$$DE-ABBVIE-5823972$ABBVIE$$49$YR$$M$Y$80$KG$20240703$$HP$DE$DE
240443691$24044369$1$I$$20240630$20240703$20240703$EXP$$AU-BAUSCHBL-2024BNL029429$BAUSCH AND LOMB$$59$YR$$M$Y$$$20240703$$CN$AU$AU
240443701$24044370$1$I$20230929$20240625$20240703$20240703$EXP$$IT-AUROBINDO-AUR-APL-2023-076797$AUROBINDO$$76$YR$$F$Y$$$20240703$$CN$IT$IT
240443711$24044371$1$I$20240101$20240624$20240703$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019541$UNITED THERAPEUTICS$$$$$F$Y$73.469$KG$20240703$$$US$US
240443722$24044372$2$F$$20240806$20240703$20240806$PER$$US-ALXN-202407USA000064US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240443741$24044374$1$I$20240401$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001145$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240703$$CN$US$US
240443761$24044376$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001049$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240703$$CN$US$US
240443771$24044377$1$I$20210101$20240625$20240703$20240703$EXP$$US-SA-2024SA191550$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240703$$MD$US$US
240443782$24044378$2$F$20240323$20240708$20240703$20240709$EXP$GB-MHRA-MED-202406281038502460-PFVRS$GB-ORGANON-O2407GBR000041$ORGANON$$$$$$Y$$$20240709$$CN$GB$GB
240443792$24044379$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3214509$TEVA$Hawco C, Nguyen A, Hernandez L, Pendlebury D, Sakr L. Delayed Diagnosis of Hemophagocytic Lymphohistiocytosis Leading to Multiorgan System Failure. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A3536.; Hawco C, Nguyen A, Hernandez L, Pendlebury D, Sakr L. Delayed Diagnosis of Hemophagocytic Lymphohistiocytosis Leading to Multiorgan System Failure. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A3536.$50$YR$$M$Y$$$20240717$$HP$US$US
240443801$24044380$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001150$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$US$US
240443812$24044381$2$F$$20240715$20240703$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407001904$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240717$$CN$US$US
240443821$24044382$1$I$$20240627$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000456$ELI LILLY AND CO$$$$$$Y$$$20240703$$CN$US$US
240443831$24044383$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001141$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240703$$CN$US$US
240443841$24044384$1$I$20240630$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001074$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240703$$CN$US$US
240443851$24044385$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000983$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240703$$CN$US$US
240443861$24044386$1$I$$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001836$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240703$$CN$US$US
240443871$24044387$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001307$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240703$$CN$US$US
240443881$24044388$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001186$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240703$$CN$US$US
240443892$24044389$2$F$$20240628$20240703$20240708$EXP$$IN-VANTIVE-2024VAN018014$Vantive US Healthcare$$43$YR$$M$Y$$$20240708$$CN$IN$IN
240443901$24044390$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031412$AUROBINDO$Hirsch TI, Friedman R, Granoff M, Tsai LL, Critchlow JF, Sharma R, et al.. Omental vascularized lymph node transplant for the treatment of breast lymphedema: A case report.. Microsurgery. 2023;43(4):387-391$48$YR$$F$Y$$$20240703$$MD$US$US
240443911$24044391$1$I$20240428$20240701$20240703$20240703$EXP$CH-SM-2024-13187$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-105495$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$66$KG$20240703$$MD$CH$CH
240443924$24044392$4$F$20240622$20240805$20240703$20240806$PER$$US-JNJFOC-20240676914$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240806$$CN$US$US
240443931$24044393$1$I$20240601$20240621$20240703$20240703$PER$$US-TEVA-VS-3213600$TEVA$$47$YR$$F$Y$$$20240703$$CN$US$US
240443941$24044394$1$I$20221028$20240626$20240703$20240703$EXP$$FR-CELLTRION INC.-2024FR015725$CELLTRION$$$$$$Y$$$20240703$$MD$FR$FR
240443951$24044395$1$I$$20230802$20240703$20240703$PER$$US-GILEAD-2024-0679189$GILEAD$$$$$F$Y$$$20240703$$HP$US$US
240443961$24044396$1$I$$20240701$20240703$20240703$EXP$$US-UCBSA-2024033389$UCB$$$$$F$Y$$$20240703$$CN$US$US
240443971$24044397$1$I$$20231207$20240703$20240703$PER$$US-AMGEN-USASP2023235140$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240443981$24044398$1$I$20230729$20240625$20240703$20240703$EXP$FR-AFSSAPS-GR2024000758$FR-AMGEN-FRASP2024125543$AMGEN$$64$YR$A$F$Y$$$20240703$$MD$FR$FR
240443991$24044399$1$I$20240101$20240627$20240703$20240703$EXP$$JP-AMGEN-JPNSP2024127521$AMGEN$$76$YR$E$F$Y$$$20240703$$HP$JP$JP
240444001$24044400$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031406$AUROBINDO$Gosmanov AR, Green M, Gerges AK, Ziganshina AP, Roy MP. Unilateral adrenalectomy as a treatment option in a patient with recurrent Cushing^s disease. Oxf-Med-Case-Reports. 2023;2023(8):301-304$51$YR$$F$Y$$$20240703$$HP$US$US
240444011$24044401$1$I$$20240625$20240703$20240703$EXP$$US-SA-2024SA192549$SANOFI AVENTIS$$$$A$F$Y$74.84$KG$20240703$$MD$US$US
240444022$24044402$2$F$20240101$20240722$20240703$20240726$EXP$$US-SA-2024SA191752$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240726$$CN$US$US
240444031$24044403$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031757$AUROBINDO$Belani N, Liang K, Fradley M, Judd J, Borghaei H. How to Treat EGFR-Mutated Non-Small Cell Lung Cancer. JACC-CardioOncol. 2023;5(4):542-545$5$DEC$$F$Y$$$20240703$$MD$US$US
240444042$24044404$2$F$$20240823$20240703$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05679$LUPIN$$$$$$Y$$$20240906$$CN$US$US
240444051$24044405$1$I$20231201$20240620$20240703$20240703$EXP$$US-ZENPEP LLC-2024AIMT01007$AIMMUNE$$$$$$Y$$$20240703$$MD$US$US
240444061$24044406$1$I$$20240510$20240703$20240703$PER$$US-AMGEN-USASP2024129540$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240444071$24044407$1$I$20240620$20240626$20240703$20240703$EXP$$US-ABBVIE-5817685$ABBVIE$$79$YR$$F$Y$72$KG$20240703$$CN$US$US
240444081$24044408$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024128367$AMGEN$$67$YR$E$F$Y$$$20240703$$HP$US$US
240444091$24044409$1$I$$20231202$20240703$20240703$PER$$US-AMGEN-USASP2023235105$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240444101$24044410$1$I$$20240117$20240703$20240703$PER$$US-AMGEN-USASP2024129914$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240444111$24044411$1$I$$20240401$20240703$20240703$PER$$US-AMGEN-USASP2024130759$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240444121$24044412$1$I$$20230321$20240703$20240703$PER$$US-AMGEN-USASP2023235128$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240444131$24044413$1$I$$20231126$20240703$20240703$PER$$US-AMGEN-USASP2023235186$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240444141$24044414$1$I$$20231230$20240703$20240703$PER$$US-AMGEN-USASP2023235120$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240444151$24044415$1$I$$20240624$20240703$20240703$EXP$$US-HETERO-HET2024US02045$HETERO$Wang Q, Tang Z, See X, Yang A. Atypical Presentation of Pulmonary-Renal Syndrome (PRS) Caused by Hydralazine-induced Antineutrophil Cytoplasmic Antibody Vasculitis/Lupus Overlap: A Case Report. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5356$74$YR$$F$Y$$$20240703$$HP$US$US
240444161$24044416$1$I$20240204$20240618$20240703$20240703$EXP$$US-ENDO USA, INC.-2024-002711$ENDO$$68$YR$$M$Y$$$20240703$$HP$US$US
240444171$24044417$1$I$$20240620$20240703$20240703$EXP$$CA-GILEAD-2024-0677939$GILEAD$$81$YR$E$F$Y$$$20240703$$CN$CA$CA
240444181$24044418$1$I$$20240701$20240703$20240703$PER$$US-TAKEDA-2024TUS066667$TAKEDA$$$$$M$Y$$$20240703$$CN$US$US
240444191$24044419$1$I$20240601$20240701$20240703$20240703$EXP$$US-TAKEDA-2024TUS066152$TAKEDA$$$$$F$Y$$$20240703$$CN$US$US
240444202$24044420$2$F$$20240729$20240703$20240806$EXP$$US-AstraZeneca-2024A146678$ASTRAZENECA$$66$YR$$F$Y$$$20240806$$CN$US$
240444211$24044421$1$I$20240601$20240618$20240703$20240703$PER$$US-AstraZeneca-2024A141336$ASTRAZENECA$$927$MON$$F$Y$$$20240703$$CN$US$
240444221$24044422$1$I$$20240628$20240703$20240703$EXP$$US-AstraZeneca-2024A149879$ASTRAZENECA$$$$$M$Y$$$20240703$$MD$US$
240444231$24044423$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281435011580-DLRNY$GB-ORGANON-O2407GBR000047$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240444241$24044424$1$I$20240611$20240611$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA050169$TOLMAR$$87$YR$$M$Y$$$20240701$$CN$CA$CA
240444251$24044425$1$I$20240129$20240129$20240703$20240703$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00430$AMNEAL$$$$$$Y$$$20240703$$CN$US$US
240444262$24044426$2$F$$20240702$20240703$20240710$EXP$$GB-TEVA-VS-3212753$TEVA$$$$E$M$Y$$$20240710$$CN$GB$GB
240444271$24044427$1$I$20231201$20231218$20240703$20240703$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04448$AMNEAL$$47$YR$$M$Y$92.971$KG$20240703$$CN$US$US
240444282$24044428$2$F$20240512$20240809$20240703$20240815$EXP$$US-ROCHE-10000014063$ROCHE$$58$YR$A$F$Y$$$20240815$$MD$US$US
240444291$24044429$1$I$20240415$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105777$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240703$$CN$US$US
240444301$24044430$1$I$$20240618$20240703$20240703$EXP$$CA-ROCHE-10000012894$ROCHE$$$$A$M$Y$77.11$KG$20240703$$CN$CA$CA
240444311$24044431$1$I$$20240702$20240703$20240703$EXP$$US-GILEAD-2024-0679355$GILEAD$$$$$$Y$$$20240703$$LW$US$US
240444321$24044432$1$I$20240612$20240624$20240703$20240703$EXP$$GB-TEVA-VS-3213095$TEVA$$32$YR$$$Y$88$KG$20240703$$CN$GB$GB
240444332$24044433$2$F$20240617$20240709$20240703$20240720$EXP$$GB-TEVA-VS-3212868$TEVA$$66$YR$$F$Y$79$KG$20240720$$MD$GB$GB
240444341$24044434$1$I$$20240619$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05454$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240444351$24044435$1$I$$20230615$20240703$20240703$PER$$US-AMGEN-USASP2023235208$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240444361$24044436$1$I$$20240626$20240703$20240703$EXP$$CO-ABBVIE-5824131$ABBVIE$$$$$$Y$$$20240703$$HP$CO$CO
240444372$24044437$2$F$20240626$20240701$20240703$20240710$PER$$US-JNJFOC-20240701223$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240710$$CN$US$US
240444381$24044438$1$I$20240307$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031734$AUROBINDO$$27$YR$$M$Y$$$20240703$$PH$FR$FR
240444392$24044439$2$F$20240430$20240719$20240703$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-031711$AUROBINDO$$77$YR$$M$Y$$$20240730$$PH$FR$FR
240444401$24044440$1$I$20240101$20240626$20240703$20240703$EXP$$US-SA-2024SA193051$SANOFI AVENTIS$$72$YR$E$M$Y$105.22$KG$20240703$$MD$US$US
240444413$24044441$3$F$20220916$20240823$20240703$20240906$EXP$$GB-SA-2024SA191405$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$MD$GB$GB
240444422$24044442$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3214505$TEVA$Kim AH, Taha W, Prudenti J. A Critical Case of Hydralazine-induced Vasculitis Presenting With Pulmonary Renal Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209.; Kim AH, Taha W, Prudenti J. A Critical Case of Hydralazine-induced Vasculitis Presenting With Pulmonary Renal Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209.$72$YR$$M$Y$$$20240717$$HP$US$US
240444431$24044443$1$I$$20240624$20240703$20240703$PER$$US-APOTEX-2024AP007795$APOTEX$Carter M, Kumar S, Almalouf P. When Abdominal Pain and Pseudo-stemi Unleash Paroxysmal Granulomatosis. American Journal of Respiratory and Critical Care Medicine. 2024;209$30$YR$$M$Y$$$20240703$$HP$US$US
240444441$24044444$1$I$$20240620$20240703$20240703$EXP$$US-CIPLA LTD.-2024US06767$CIPLA$Pierce V, Bollavaram V, Ali A.. A case of long QT syndrome masquerading as epilepsy.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A1699$$$$$Y$$$20240703$$MD$US$US
240444451$24044445$1$I$$20240620$20240703$20240703$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05687$LUPIN$Lam C, Kioka M. A critical confluence: Acute pulmonary embolism complicating systemic sclerosis- associated pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2211:1-2$58$YR$$F$Y$$$20240703$$HP$US$US
240444461$24044446$1$I$20240621$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024130430$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240444471$24044447$1$I$$20240621$20240703$20240703$EXP$$CA-AMGEN-CANCT2019103802$AMGEN$$48$YR$A$F$Y$$$20240703$$CN$CA$CA
240444481$24044448$1$I$$20240207$20240703$20240703$PER$$US-AMGEN-USASP2024129773$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240444491$24044449$1$I$$20240109$20240703$20240703$PER$$US-AMGEN-USASP2024129543$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240444501$24044450$1$I$20220101$20240701$20240703$20240703$EXP$$US-ABBVIE-5822661$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240444511$24044451$1$I$$20240627$20240703$20240703$PER$$US-GILEAD-2024-0679102$GILEAD$$60$YR$A$F$Y$$$20240703$$HP$US$US
240444521$24044452$1$I$$20240620$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05581$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240444531$24044453$1$I$$20240620$20240703$20240703$EXP$$US-GRAVITIPHARMA-GRA-2406-US-LIT-0198$GRAVITI PHARMACEUTICALS$Idowu D, Ezema K, Corcoran J, Farkas A.The predictive value of heart rate in determining clinical course after a  bupropion overdose.Clinical Toxicology.22-MAY-2024;NA:1-7$63$YR$A$M$Y$$$20240703$$HP$US$US
240444542$24044454$2$F$$20240711$20240703$20240720$EXP$$GB-CELLTRION INC.-2024GB015780$CELLTRION$$$$$$Y$$$20240720$$CN$GB$GB
240444551$24044455$1$I$$20240628$20240703$20240703$PER$$US-HALEON-2184655$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240444562$24044456$2$F$20240601$20240822$20240703$20240911$PER$$US-APOTEX-2024AP007805$APOTEX$$72$YR$E$M$Y$$$20240911$$CN$US$US
240444571$24044457$1$I$$20240626$20240703$20240703$EXP$$US-NOVITIUMPHARMA-2024USNVP01135$NOVITIUM PHARMA$A. A. Abdalla.Vexas Syndrome Presenting as Recurrent Relapses of Organizing Pneumonia- A Case Series.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;209:A5321$69$YR$E$M$Y$$$20240703$$HP$US$US
240444581$24044458$1$I$$20240628$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105973$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$MD$US$US
240444601$24044460$1$I$$20240626$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104668$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$PH$US$US
240444611$24044461$1$I$$20240622$20240703$20240703$PER$$US-JNJFOC-20240665550$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240444621$24044462$1$I$$20240620$20240703$20240703$EXP$$US-Axellia-005257$XELLIA PHARMACEUTICALS$Ghose M, Anwar M, Rajamohan A, Vangala A, Roy P, Weiner SM. Vancomycin Induced Anaphylaxis Presenting With Cardiac Arrest: Judicious Use of Antibiotic in Low Risk Procedures. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5700.$74$YR$E$F$Y$$$20240703$$MD$US$US
240444631$24044463$1$I$$20240625$20240703$20240703$PER$$US-JNJFOC-20240701244$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240444642$24044464$2$F$20240101$20240809$20240703$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-018698$UNITED THERAPEUTICS$$$$$F$Y$76.19$KG$20240816$$$US$US
240444653$24044465$3$F$20180125$20240829$20240703$20240902$EXP$$US-GILEAD-2024-0679359$GILEAD$$55$YR$A$$Y$$$20240902$$LW$US$US
240444672$24044467$2$F$$20240709$20240703$20240715$EXP$$GB-Orion Corporation ORION PHARMA-24_00030580$ORION$Berman G, Kashipazb R. Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Polymyalgia Rheumatica Presenting with Double Vision. Neuro-Ophthalmology. 2024 JUN 17;1-9.$78$YR$E$F$Y$$$20240715$$MD$GB$
240444681$24044468$1$I$$20240328$20240703$20240703$PER$$US-AMGEN-USASP2024129615$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240444691$24044469$1$I$$20240325$20240703$20240703$PER$$US-AMGEN-USASP2024129712$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240444701$24044470$1$I$20240601$20240628$20240703$20240703$EXP$$US-AstraZeneca-2024A150227$ASTRAZENECA$$857$MON$$F$Y$$$20240703$$PH$US$
240444711$24044471$1$I$$20240625$20240703$20240703$PER$$US-AstraZeneca-2024A151385$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240444721$24044472$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A147110$ASTRAZENECA$$$$$M$Y$57.2$KG$20240703$$CN$US$
240444731$24044473$1$I$$20240625$20240703$20240703$EXP$$ZA-AstraZeneca-2024A146841$ASTRAZENECA$$42$YR$$F$Y$$$20240703$$CN$ZA$
240444741$24044474$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A147039$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240444751$24044475$1$I$$20240628$20240703$20240703$EXP$$US-BIOGEN-2024BI01262566$BIOGEN$$$$$M$Y$$$20240703$$CN$US$US
240444762$24044476$2$F$$20240702$20240703$20240704$EXP$$US-BIOGEN-2024BI01272032$BIOGEN$$$$$F$Y$$$20240704$$MD$US$US
240444772$24044477$2$F$$20240625$20240703$20240910$EXP$$BR-AstraZeneca-2024A150126$ASTRAZENECA$$57$YR$$M$Y$$$20240910$$CN$BR$
240444781$24044478$1$I$20240601$20240628$20240703$20240703$EXP$$US-BIOGEN-2024BI01271744$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
240444791$24044479$1$I$$20240620$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05593$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240444801$24044480$1$I$$20240626$20240703$20240703$EXP$$US-GILEAD-2024-0678942$GILEAD$$$$$$Y$$$20240703$$CN$US$US
240444814$24044481$4$F$20240101$20240907$20240703$20240912$EXP$$US-ABBVIE-5823400$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
240444821$24044482$1$I$$20240620$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05653$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240444832$24044483$2$F$$20240716$20240703$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-032641$JAZZ$$$$$M$Y$$$20240722$$CN$US$US
240444841$24044484$1$I$20240614$20240624$20240703$20240703$EXP$$CN-EMD Serono-2024034805$EMD SERONO INC$$38$YR$A$F$Y$58$KG$20240703$$HP$CN$CN
240444853$24044485$3$F$20240601$20240802$20240703$20240809$EXP$$US-ALXN-202406USA001770US$ALEXION PHARMACEUTICALS$$39$YR$$F$Y$$$20240809$$CN$US$US
240444861$24044486$1$I$$20240305$20240703$20240703$PER$$US-AMGEN-USASP2024129778$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240444871$24044487$1$I$$20240521$20240703$20240703$PER$$US-AMGEN-USASP2024129727$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240444892$24044489$2$F$$20240724$20240703$20240808$PER$$US-APOTEX-2024AP007755$APOTEX$$$$$$Y$$$20240808$$CN$US$US
240444902$24044490$2$F$20240101$20240718$20240703$20240724$EXP$$US-BIOGEN-2024BI01271831$BIOGEN$$$$$F$Y$$$20240724$$CN$US$US
240444911$24044491$1$I$20240101$20240625$20240703$20240703$EXP$$CA-CELLTRION INC.-2024CA011607$CELLTRION$$$$$$Y$$$20240703$$MD$CA$CA
240444921$24044492$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281503492060-NTSCD$GB-ORGANON-O2407GBR000067$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240444931$24044493$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105823$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$83$KG$20240703$$PH$US$US
240444941$24044494$1$I$$20240621$20240703$20240703$EXP$$JP-ROCHE-10000009721$ROCHE$$8$DEC$E$M$Y$$$20240703$$MD$JP$JP
240444951$24044495$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106039$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240703$$HP$US$US
240444961$24044496$1$I$$20240620$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05695$LUPIN$$$$$F$Y$$$20240703$$CN$US$US
240444971$24044497$1$I$$20240626$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105415$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$70.5$KG$20240703$$MD$US$US
240444981$24044498$1$I$$20240624$20240703$20240703$PER$$US-JNJFOC-20240669428$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240444991$24044499$1$I$20240622$20240630$20240703$20240703$EXP$$CN-JNJFOC-20240706551$JOHNSON AND JOHNSON$$71$YR$E$M$Y$75$KG$20240703$$HP$CN$CN
240445003$24044500$3$F$20240501$20240710$20240703$20240716$30DAY$$US-AMGEN-USASP2024127481$AMGEN$$54$YR$A$F$Y$113.3$KG$20240716$$PH$US$US
240445011$24044501$1$I$20231201$20240627$20240703$20240703$EXP$$US-GSK-US2024080285$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240703$$CN$US$US
240445022$24044502$2$F$20130806$20240829$20240703$20240902$PER$$US-GILEAD-2024-0679338$GILEAD$$40$YR$A$M$Y$$$20240902$$LW$US$US
240445031$24044503$1$I$$20240624$20240703$20240703$EXP$$US-GSK-US2024078529$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240445042$24044504$2$F$$20240705$20240703$20240718$EXP$$PK-ROCHE-10000012993$ROCHE$$34$YR$A$M$Y$$$20240718$$CN$PK$PK
240445051$24044505$1$I$$20240621$20240703$20240703$EXP$GB-MHRA-MED-202406201606106590-GDWLJ$GB-MSNLABS-2024MSNSPO01424$MSN LABORATORIES$$$$$$Y$$$20240703$$HP$GB$GB
240445061$24044506$1$I$$20240620$20240703$20240703$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05521$LUPIN$Nunez Cuello L, Perozo M, Cedeno H, Shah P. Indomethacin-induced angioedema: A rare and challenging case. American Journal of Respiratory and Critical Care Medicine. 2024;209$68$YR$$M$Y$$$20240703$$MD$US$US
240445071$24044507$1$I$$20240618$20240703$20240703$EXP$$CN-RISINGPHARMA-CN-2024RISLIT00216$RISING PHARMACEUTICALS$Haili Xin.Pregabalin-induced rhabdomyolysis: a case series and literature analysis.Journal of International Medical Research.JUN-2024;52 (6):1-7$$$E$F$Y$$$20240703$$HP$CN$CN
240445081$24044508$1$I$$20240624$20240703$20240703$PER$$US-TEVA-VS-3214342$TEVA$$$$A$M$Y$$$20240703$$HP$US$US
240445092$24044509$2$F$20240626$20240716$20240703$20240723$EXP$$AR-TAKEDA-2024TUS066201$TAKEDA$$3$YR$$M$Y$$$20240723$$HP$AR$AR
240445101$24044510$1$I$$20240620$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05620$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240445111$24044511$1$I$$20240621$20240703$20240703$EXP$GB-MHRA-MED-202406201519038770-CMGDY$GB-MSNLABS-2024MSNSPO01423$MSN LABORATORIES$$$$$$Y$$$20240703$$HP$GB$GB
240445131$24044513$1$I$$20240625$20240703$20240703$EXP$$US-GSK-US2024079060$GLAXOSMITHKLINE$$$$$M$Y$$$20240703$$CN$US$US
240445143$24044514$3$F$20240601$20240820$20240703$20240827$EXP$$CA-GSK-CA2024081175$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$CA$CA
240445151$24044515$1$I$$20240521$20240703$20240703$PER$$US-AMGEN-USASP2024129721$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240445161$24044516$1$I$$20240109$20240703$20240703$PER$$US-AMGEN-USASP2024130684$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240445171$24044517$1$I$20240627$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129509$AMGEN$$77$YR$E$F$Y$$$20240703$$PH$US$US
240445181$24044518$1$I$20240625$20240626$20240703$20240703$EXP$$US-AMGEN-USASP2024127099$AMGEN$$47$YR$A$M$Y$$$20240703$$CN$US$US
240445191$24044519$1$I$$20240625$20240703$20240703$EXP$$CN-AstraZeneca-2024A149795$ASTRAZENECA$$$$$$Y$$$20240703$$MD$CN$
240445201$24044520$1$I$$20240627$20240703$20240703$EXP$$CO-AMGEN-COLSL2024129028$AMGEN$$$$A$F$Y$$$20240703$$CN$CO$CO
240445211$24044521$1$I$$20240628$20240703$20240703$EXP$$ZA-AstraZeneca-2024A150129$ASTRAZENECA$$18627$DY$$M$Y$$$20240703$$CN$ZA$
240445221$24044522$1$I$$20240621$20240703$20240703$PER$$US-AstraZeneca-2024A144599$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240445231$24044523$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281440345420-HKJBF$GB-ORGANON-O2407GBR000151$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240445241$24044524$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281417420110-KQVHC$GB-ORGANON-O2407GBR000120$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240445251$24044525$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001873$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240703$$CN$US$US
240445261$24044526$1$I$$20240627$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000026$ELI LILLY AND CO$$$$A$F$Y$$$20240703$$CN$US$US
240445271$24044527$1$I$$20240620$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406014664$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240703$$CN$US$US
240445286$24044528$6$F$20240515$20240805$20240703$20240814$EXP$$JP-ABBVIE-5819281$ABBVIE$$64$YR$$M$Y$67$KG$20240814$$MD$JP$JP
240445291$24044529$1$I$$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001728$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$US$US
240445301$24044530$1$I$20240101$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001384$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240703$$CN$US$US
240445312$24044531$2$F$$20240712$20240703$20240724$PER$$US-MSNLABS-2024MSNSPO01397$MSN LABORATORIES$$$$$$Y$$$20240724$$CN$US$US
240445321$24044532$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105887$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$70.76$KG$20240703$$CN$US$US
240445331$24044533$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106096$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240703$$CN$US$US
240445341$24044534$1$I$$20240625$20240703$20240703$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108947$ZYDUS PHARM$$$$$$Y$$$20240703$$CN$US$US
240445351$24044535$1$I$$20240627$20240703$20240703$EXP$GB-MHRA-MED-202406271643381660-MBKHG$GB-009507513-2407GBR000134$MERCK$$$$$$Y$$$20240703$$MD$GB$GB
240445364$24044536$4$F$$20240725$20240703$20240805$30DAY$$US-JNJFOC-20240666555$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$HP$US$US
240445372$24044537$2$F$20240627$20240703$20240703$20240709$EXP$$JP-JNJFOC-20240703635$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$PH$JP$JP
240445381$24044538$1$I$$20231127$20240703$20240703$PER$$US-AMGEN-USASP2023235244$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240445391$24044539$1$I$$20240626$20240703$20240703$EXP$$US-NOVITIUMPHARMA-2024USNVP01122$NOVITIUM PHARMA$A. A. Abdalla.Vexas Syndrome Presenting as Recurrent Relapses of Organizing Pneumonia- A Case Series.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;209:A5321$70$YR$E$M$Y$$$20240703$$HP$US$US
240445401$24044540$1$I$20240619$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024131195$AMGEN$$74$YR$E$M$Y$$$20240703$$CN$US$US
240445411$24044541$1$I$20240501$20240625$20240703$20240703$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001305$BLUEPRINT MEDICINES$$40$YR$A$F$Y$$$20240703$$CN$US$US
240445423$24044542$3$F$20190925$20240828$20240703$20240830$EXP$$US-GILEAD-2024-0679363$GILEAD$$48$YR$A$M$Y$$$20240830$$LW$US$US
240445431$24044543$1$I$20240620$20240624$20240703$20240703$30DAY$$US-GSK-US2024078638$GLAXOSMITHKLINE$$62$YR$$M$Y$$$20240703$$CN$US$US
240445451$24044545$1$I$$20240620$20240703$20240703$EXP$$US-ADVANZ PHARMA-202406005204$ADVANZ PHARMA$$$$$$Y$$$20240703$$MD$US$US
240445462$24044546$2$F$20240614$20240716$20240703$20240805$PER$$US-TEVA-VS-3213613$TEVA$$36$YR$$F$Y$60.33$KG$20240805$$CN$US$US
240445471$24044547$1$I$$20240624$20240703$20240703$PER$$US-JNJFOC-20240665665$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240703$$CN$US$US
240445481$24044548$1$I$$20230619$20240703$20240703$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02361$AMNEAL$$50$YR$$M$Y$$$20240703$$HP$US$US
240445491$24044549$1$I$$20230821$20240703$20240703$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03203$AMNEAL$$$$$$Y$$$20240703$$HP$US$US
240445501$24044550$1$I$20230419$20230616$20240703$20240703$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02135$AMNEAL$$77$YR$$F$Y$68.027$KG$20240703$$CN$US$US
240445511$24044551$1$I$20240618$20240618$20240703$20240703$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01032$AVADEL CNS PHARMA$$42$YR$$F$Y$$$20240703$$CN$US$US
240445521$24044552$1$I$$20240618$20240703$20240703$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT00997$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240703$$HP$US$US
240445531$24044553$1$I$$20240627$20240703$20240703$EXP$$GB-TAKEDA-2024TUS066139$TAKEDA$$$$$F$Y$$$20240703$$CN$GB$GB
240445542$24044554$2$F$$20240731$20240703$20240810$EXP$$GB-TAKEDA-2024TUS040124$TAKEDA$$$$$F$Y$$$20240810$$CN$GB$GB
240445551$24044555$1$I$20240623$20240627$20240703$20240703$EXP$$US-TAKEDA-2024TUS065351$TAKEDA$$51$YR$$F$Y$$$20240703$$MD$US$US
240445561$24044556$1$I$20240612$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031722$AUROBINDO$$76$YR$$F$Y$$$20240703$$MD$FR$FR
240445571$24044557$1$I$20240222$20240628$20240703$20240703$PER$$US-BIOGEN-2024BI01252763$BIOGEN$$67$YR$$F$Y$$$20240703$$CN$US$US
240445581$24044558$1$I$20220101$20240628$20240703$20240703$EXP$$US-BIOGEN-2024BI01271887$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
240445592$24044559$2$F$20240613$20240711$20240703$20240715$PER$$US-AMGEN-USASP2024127118$AMGEN$$22$YR$A$$Y$$$20240715$$PH$US$US
240445611$24044561$1$I$20240624$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129252$AMGEN$$82$YR$E$F$Y$$$20240703$$CN$US$US
240445621$24044562$1$I$$20230714$20240703$20240703$PER$$US-AMGEN-USASP2023235427$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240445631$24044563$1$I$$20240623$20240703$20240703$EXP$GB-MHRA-MED-202406230715043650-LSZJH$GB-TORRENT-00036895$TORRENT$$$$$F$Y$60$KG$20240703$$CN$GB$GB
240445642$24044564$2$F$20240531$20240819$20240703$20240829$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-105776$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$62$KG$20240829$$MD$FR$FR
240445651$24044565$1$I$$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105802$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240703$$CN$US$US
240445661$24044566$1$I$$20240625$20240703$20240703$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007836$STRIDES$Yasir M, Gelaye AE.. Rare Case of Resistant Aspergillus Niger Invasive Pulmonary Aspergillosis.. Am-J-Respir-Crit-Care-Med. 2024;209:A3586$$$$$Y$$$20240703$$HP$US$US
240445681$24044568$1$I$$20240625$20240703$20240703$EXP$$DE-AUROBINDO-AUR-APL-2024-031632$AUROBINDO$$$$E$$Y$$$20240703$$MD$DE$DE
240445692$24044569$2$F$$20240708$20240703$20240718$EXP$$US-TEVA-VS-3214525$TEVA$Ries R, Cho YD, Deitchman AR. Elevated Inflammation Sepsis Phenotype as a Potential Risk Factor for Propofol Related Infusion Syndrome: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A1608.; Ries R, Cho YD, Deitchman AR. Elevated Inflammation Sepsis Phenotype as a Potential Risk Factor for Propofol Related Infusion Syndrome: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A1608.$32$YR$$F$Y$$$20240718$$HP$US$US
240445701$24044570$1$I$$20240626$20240703$20240703$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01114$NOVITIUM PHARMA$Fan X.An immunocompetent patient with primary cutaneous aspergillosis caused by Aspergillus fumigatus.Chinese Journal of Clinical Infectious Diseases.2021;14(5):389-391$68$YR$A$M$Y$$$20240703$$HP$CN$CN
240445711$24044571$1$I$$20240628$20240703$20240703$EXP$$US-AstraZeneca-2024A150245$ASTRAZENECA$$$$$F$Y$$$20240703$$HP$US$
240445721$24044572$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A148263$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240445731$24044573$1$I$$20240625$20240703$20240703$EXP$$ZA-AstraZeneca-2024A146929$ASTRAZENECA$$70$YR$$F$Y$$$20240703$$CN$ZA$
240445741$24044574$1$I$$20240701$20240703$20240703$EXP$$US-TAKEDA-2024TUS050140$TAKEDA$$$$$M$Y$$$20240703$$HP$US$US
240445751$24044575$1$I$$20240702$20240703$20240703$EXP$$US-GILEAD-2024-0679342$GILEAD$$$$$$Y$$$20240703$$LW$US$US
240445761$24044576$1$I$$20240625$20240703$20240703$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-007134$JAZZ$$$$$F$Y$$$20240703$$HP$US$US
240445781$24044578$1$I$20240201$20240625$20240703$20240703$EXP$$US-GSK-US2024079158$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240703$$CN$US$US
240445791$24044579$1$I$$20240625$20240703$20240703$30DAY$$US-GSK-US2024AMR080785$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240445801$24044580$1$I$$20240620$20240703$20240703$EXP$$US-CIPLA LTD.-2024US06468$CIPLA$Hamad HM, Miett T, Kopec S.. Statin and Fenofibrate-Induced rhabdomyolysis in liver transplant; A case of multiple organ dysfunction. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5694$$$$$Y$$$20240703$$MD$US$US
240445811$24044581$1$I$$20240626$20240703$20240703$PER$$US-ABBVIE-5819252$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240445821$24044582$1$I$$20240624$20240703$20240703$EXP$$HU-TEVA-VS-3215414$TEVA$Cegledi A, Batai A, Dolgos J, Fekete M, Gopcsa L, Kiraly V, et al. Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol. Pathol-Oncol-Res 2024; 30.$$$$$Y$$$20240703$$HP$HU$HU
240445831$24044583$1$I$20240622$20240702$20240703$20240703$EXP$FR-AFSSAPS-PB2024000740$FR-ORGANON-O2407FRA000212$ORGANON$$22$YR$$F$Y$76.5$KG$20240703$$MD$FR$FR
240445841$24044584$1$I$$20240624$20240703$20240703$EXP$$US-ROCHE-10000012479$ROCHE$$50$YR$A$M$Y$$$20240703$$MD$US$US
240445851$24044585$1$I$20240628$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001255$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240703$$CN$US$US
240445861$24044586$1$I$20240627$20240628$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105060$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240703$$HP$US$US
240445871$24044587$1$I$20240624$20240702$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105854$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$74.84$KG$20240703$$MD$US$US
240445881$24044588$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406290956091950-BTVGZ$GB-ORGANON-O2407GBR000149$ORGANON$$$$$M$Y$$$20240703$$CN$GB$GB
240445892$24044589$2$F$20240629$20240703$20240703$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407001161$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240709$$CN$US$US
240445902$24044590$2$F$$20240820$20240703$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105136$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240822$$CN$US$US
240445911$24044591$1$I$$20230726$20240703$20240703$PER$$US-AMGEN-USASP2023235382$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240445921$24044592$1$I$$20230731$20240703$20240703$PER$$US-AMGEN-USASP2023235036$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240445931$24044593$1$I$$20240624$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101410$BRISTOL MYERS SQUIBB$Zahid A, Tummala S. Cerebral clues: serum neurofilament light chain (sNfL) as a novel biomarker for immune check point inhibitor (ICI) mediated seronegative encephalitis. Oxford Medical Case Reports. 2024 Jun 01;2024(6):242-4. doi:10.1093/omcr/omae058.$62$YR$A$F$Y$$$20240703$$HP$US$US
240445941$24044594$1$I$$20240623$20240703$20240703$EXP$$US-JNJFOC-20240668789$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240445951$24044595$1$I$20240401$20240619$20240703$20240703$EXP$FR-AFSSAPS-BR2024000472$FR-TEVA-VS-3212684$TEVA$$59$YR$$M$Y$100$KG$20240703$$MD$FR$FR
240445961$24044596$1$I$$20240628$20240703$20240703$EXP$$US-GSK-US2024081206$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240445971$24044597$1$I$$20240701$20240703$20240703$EXP$$JP-GSK-JP2024082417$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$JP$JP
240445982$24044598$2$F$$20240627$20240703$20240710$EXP$$US-ADVANZ PHARMA-202406005282$ADVANZ PHARMA$$$$$$Y$$$20240710$$MD$US$US
240445991$24044599$1$I$$20240621$20240703$20240703$EXP$$PL-ROCHE-10000012884$ROCHE$$71$YR$E$M$Y$$$20240703$$HP$PL$PL
240446001$24044600$1$I$$20240624$20240703$20240703$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004716$BIOCON$$$$$$Y$$$20240703$$HP$CA$CA
240446041$24044604$1$I$$20240624$20240703$20240703$EXP$$US-AMGEN-USASP2024126256$AMGEN$Qazilbash:M.. Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma over Three Decades. Transplantation and Cellular Therapy. 2024$$$$$Y$$$20240703$$MD$US$US
240446051$24044605$1$I$$20231003$20240703$20240703$PER$$US-AMGEN-USASP2023235297$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240446061$24044606$1$I$20240627$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024128738$AMGEN$$69$YR$E$F$Y$$$20240703$$HP$US$US
240446071$24044607$1$I$$20240701$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US062254$SANDOZ$$$$$F$Y$$$20240703$$CN$US$US
240446081$24044608$1$I$$20240701$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US062289$SANDOZ$$$$$M$Y$$$20240703$$CN$US$US
240446091$24044609$1$I$20220516$20240627$20240703$20240703$EXP$$CA-SANDOZ INC.-NVSC2021CA257615$SANDOZ$$30$YR$$F$Y$69.9$KG$20240703$$HP$CA$CA
240446101$24044610$1$I$20220706$20240621$20240703$20240703$30DAY$$CA-SANDOZ INC.-NVSC2022CA155568$SANDOZ$$70$YR$$F$Y$$$20240703$$CN$CA$CA
240446111$24044611$1$I$$20240625$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2023US076619$SANDOZ$Annunzio K., Cackovic M., Bond D., Sawalha Y., Voorhees T.J., Hanel W.,. Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy. Blood Adv. 2023;7 (10):2241-2244$$$I$$Y$2.59$KG$20240703$$MD$US$US
240446121$24044612$1$I$20240419$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105161$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240703$$CN$US$US
240446131$24044613$1$I$$20240626$20240703$20240703$EXP$$US-NOVITIUMPHARMA-2024USNVP01145$NOVITIUM PHARMA$Katrina A Williamson.Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease.Rheumatology.19-JUL-2023;63:1291-1296$42$YR$A$M$Y$$$20240703$$HP$US$US
240446141$24044614$1$I$$20240625$20240703$20240703$PER$$US-ALXN-202406USA001613US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
240446151$24044615$1$I$$20240626$20240703$20240703$EXP$$US-TAKEDA-2024TUS065494$TAKEDA$$$$$F$Y$$$20240703$$CN$US$US
240446161$24044616$1$I$$20240620$20240703$20240703$PER$$US-TAKEDA-2024TUS061637$TAKEDA$$$$$$Y$$$20240703$$CN$US$US
240446171$24044617$1$I$$20240626$20240703$20240703$PER$$CA-IGSA-BIG0029601$GRIFOLS$$$$$M$Y$$$20240703$$HP$CA$CA
240446181$24044618$1$I$$20240624$20240703$20240703$EXP$$US-RDY-LIT/USA/24/0009393$DR REDDYS$Holbert K. Multiorgan Failure From Heat Stroke in a Person Taking Glycopyrrolate. American Journal of Respiratory and Critical Care Medicine. 209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A7329.$24$YR$A$M$Y$$$20240703$$HP$US$US
240446191$24044619$1$I$20240515$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406281019467880-WQTRJ$GB-862174955-ML2024-03694$Unknown Manufacturer$$59$YR$A$M$Y$104$KG$20240703$$PH$GB$GB
240446201$24044620$1$I$$20240625$20240703$20240703$EXP$$IT-862174955-ML2024-03678$Unknown Manufacturer$Vischini G, La Manna G, Speciale S, Przygocka A, Martano L, Baraldi O. Lessons for the clinical nephrologist: acute kidney injury during therapy with apixaban. Journal of Nephrology. 2023 Dec 06;37: 511-513. doi:10.1007/s40620-023-01781-y.$81$YR$E$M$Y$$$20240703$$HP$IT$IT
240446212$24044621$2$F$$20240715$20240703$20240725$EXP$$US-862174955-ML2024-03634$Unknown Manufacturer$Mikhail E, Alexander D, Jankowski M, Pandya D, Kunadi A. Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3410. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A3410.$72$YR$E$F$Y$$$20240725$$MD$US$US
240446221$24044622$1$I$$20240624$20240703$20240703$EXP$$US-862174955-ML2024-03668$Unknown Manufacturer$$$$$F$Y$$$20240703$$CN$US$US
240446232$24044623$2$F$$20240806$20240703$20240814$EXP$$US-862174955-ML2024-03600$MICRO LABS$$$$$F$Y$$$20240814$$PH$US$US
240446241$24044624$1$I$20240201$20240626$20240703$20240703$EXP$GB-MHRA-MED-202406251436015840-SWCZQ$GB-862174955-ML2024-03671$Unknown Manufacturer$$67$YR$E$M$Y$98$KG$20240703$$CN$GB$GB
240446251$24044625$1$I$20240601$20240628$20240703$20240703$EXP$$DE-ABBVIE-5823432$ABBVIE$$19$YR$$M$Y$$$20240703$$CN$DE$DE
240446271$24044627$1$I$20240412$20240619$20240703$20240703$EXP$FR-AFSSAPS-PP2024000628$FR-TEVA-VS-3212774$TEVA$$37$YR$$F$Y$95.6$KG$20240703$$MD$FR$FR
240446281$24044628$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5819446$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240446291$24044629$1$I$$20240627$20240703$20240703$EXP$$US-ABBVIE-5821539$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240446302$24044630$2$F$$20240813$20240703$20240821$EXP$$US-AstraZeneca-2024A147403$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
240446331$24044633$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5820475$ABBVIE$$$$$$Y$$$20240703$$MD$US$US
240446341$24044634$1$I$20240112$20240627$20240703$20240703$EXP$FR-AFSSAPS-TO2024001131$FR-ASTELLAS-2024EU006419$ASTELLAS$$73$YR$$F$Y$$$20240703$$CN$FR$FR
240446351$24044635$1$I$20240114$20240625$20240703$20240703$EXP$GB-MHRA-MED-202406241314554680-YRBMQ$GB-TORRENT-00036903$TORRENT$$21$YR$A$M$Y$86$KG$20240703$$CN$GB$GB
240446361$24044636$1$I$$20240628$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062278$SANDOZ$$$$$$Y$$$20240703$$HP$US$US
240446372$24044637$2$F$$20240701$20240703$20240704$EXP$$US-SANDOZ INC.-SDZ2024US062301$SANDOZ$$$$$$Y$$$20240704$$CN$US$US
240446382$24044638$2$F$20240630$20240702$20240703$20240704$30DAY$$FR-SANDOZ INC.-SDZ2024FR062317$SANDOZ$$36$YR$$M$Y$$$20240704$$PH$FR$FR
240446391$24044639$1$I$20220301$20240701$20240703$20240703$EXP$$DE-SANDOZ INC.-SDZ2024DE061941$SANDOZ$$72$YR$$F$Y$$$20240703$$MD$DE$DE
240446401$24044640$1$I$$20240628$20240703$20240703$30DAY$$FR-SANDOZ INC.-SDZ2023FR074827$SANDOZ$$9$YR$$M$Y$$$20240703$$CN$FR$FR
240446411$24044641$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105206$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240703$$CN$US$US
240446421$24044642$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105960$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240703$$HP$US$US
240446431$24044643$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106068$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240703$$CN$US$US
240446441$24044644$1$I$$20240627$20240703$20240703$EXP$$US-ABBVIE-5821577$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240446451$24044645$1$I$$20240625$20240703$20240703$PER$$US-ABBVIE-5816776$ABBVIE$$60$YR$$F$Y$$$20240703$$CN$US$US
240446462$24044646$2$F$$20240708$20240703$20240710$EXP$GB-MHRA-MED-202406281415559760-KVNGH$GB-ORGANON-O2407GBR000135$ORGANON$$$$$$Y$$$20240710$$CN$GB$GB
240446471$24044647$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281422291500-CTQJK$GB-ORGANON-O2407GBR000086$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240446481$24044648$1$I$20240520$20240627$20240703$20240703$EXP$$CN-JNJFOC-20240700617$JOHNSON AND JOHNSON$$$$N$F$Y$1.2$KG$20240703$$HP$CN$CN
240446492$24044649$2$F$20191008$20240830$20240703$20240903$PER$$US-GILEAD-2024-0679346$GILEAD$$46$YR$A$M$Y$$$20240903$$LW$US$US
240446501$24044650$1$I$$20230811$20240703$20240703$PER$$US-AMGEN-USASP2023235383$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240446511$24044651$1$I$$20231129$20240703$20240703$PER$$US-AMGEN-USASP2023235045$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240446522$24044652$2$F$$20240905$20240703$20240915$30DAY$$US-GSK-US2024AMR081283$GLAXOSMITHKLINE$$$$$F$Y$$$20240915$$CN$US$US
240446531$24044653$1$I$$20240628$20240703$20240703$EXP$$US-JNJFOC-20240677891$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$CN$US$US
240446541$24044654$1$I$$20240626$20240703$20240703$EXP$$US-NOVITIUMPHARMA-2024USNVP01144$NOVITIUM PHARMA$Katrina A Williamson.Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease.Rheumatology.19-JUL-2023;63:1291-1296$68$YR$E$M$Y$$$20240703$$HP$US$US
240446553$24044655$3$F$$20240627$20240703$20240718$EXP$$TR-ASTELLAS-2024US018538$ASTELLAS$$$$E$$Y$$$20240718$$CN$TR$TR
240446561$24044656$1$I$20230501$20240627$20240703$20240703$EXP$$AU-ASTELLAS-2024US018540$ASTELLAS$$78$YR$$M$Y$$$20240703$$CN$AU$AU
240446572$24044657$2$F$$20230824$20240703$20240917$PER$$US-HALEON-2185033$Haleon PLC$$$$$$Y$$$20240917$$CN$US$US
240446582$24044658$2$F$$20240911$20240703$20240913$EXP$$US-ABBVIE-5823593$ABBVIE$$$$$M$Y$95$KG$20240913$$CN$US$US
240446591$24044659$1$I$$20240319$20240703$20240703$PER$$US-AMGEN-USASP2024130630$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240446601$24044660$1$I$20240621$20240624$20240703$20240703$EXP$$US-ABBVIE-5823748$ABBVIE$$82$YR$$M$Y$$$20240703$$CN$US$US
240446611$24044661$1$I$20190801$20240624$20240703$20240703$EXP$$DE-UCBSA-2024032909$UCB$$33$YR$$F$Y$$$20240703$$MD$DE$DE
240446622$24044662$2$F$20230401$20240709$20240703$20240711$EXP$$CN-ASTELLAS-2024US018589$ASTELLAS$$9$YR$$F$Y$27$KG$20240711$$CN$CH$CN
240446631$24044663$1$I$$20240613$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105075$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240703$$CN$US$US
240446641$24044664$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106058$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240703$$HP$US$US
240446652$24044665$2$F$20240101$20240729$20240703$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106027$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240731$$HP$US$US
240446664$24044666$4$F$20240906$20240912$20240703$20240919$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001308$BLUEPRINT MEDICINES$$60$YR$A$M$Y$$$20240919$$CN$US$US
240446691$24044669$1$I$$20240628$20240703$20240703$EXP$$US-ABBVIE-5821991$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240446701$24044670$1$I$20240621$20240628$20240703$20240703$EXP$$US-ABBVIE-5822291$ABBVIE$$64$YR$$M$Y$$$20240703$$CN$US$US
240446711$24044671$1$I$$20240630$20240703$20240703$EXP$$AU-ABBVIE-5823359$ABBVIE$$$$$M$Y$$$20240703$$CN$AU$AU
240446721$24044672$1$I$20240101$20240606$20240703$20240703$EXP$$JP-AMGEN-JPNSP2024077514$AMGEN$$$$$M$Y$$$20240703$$PH$JP$JP
240446741$24044674$1$I$$20240626$20240703$20240703$EXP$$US-NOVITIUMPHARMA-2024USNVP01128$NOVITIUM PHARMA$X. Deng.A Late, Unusual Presentation of Chronic Eosinophilic Pneumonia Requiring Anti-IL5 Therapy.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;209:A6374$88$YR$E$F$Y$$$20240703$$HP$US$US
240446752$24044675$2$F$20240628$20240701$20240703$20240704$EXP$$US-ABBVIE-5823260$ABBVIE$$63$YR$$F$Y$$$20240704$$CN$US$US
240446761$24044676$1$I$20240101$20240423$20240703$20240703$EXP$$US-PROCTER+GAMBLE-PH24004925$PROCTER AND GAMBLE$$18$YR$$M$Y$$$20240703$$MD$US$US
240446771$24044677$1$I$20240521$20240702$20240703$20240703$EXP$FR-AFSSAPS-TS2024000748$FR-ORGANON-O2407FRA000243$ORGANON$$68$YR$$M$Y$$$20240703$$MD$FR$FR
240446782$24044678$2$F$$20240730$20240703$20240806$30DAY$$FR-JNJFOC-20240703245$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$FR$FR
240446792$24044679$2$F$20220131$20240907$20240703$20240911$EXP$$US-GILEAD-2024-0679347$GILEAD$$53$YR$A$M$Y$$$20240911$$LW$US$US
240446801$24044680$1$I$20151201$20240627$20240703$20240703$EXP$$JP-JNJFOC-20161105730$JOHNSON AND JOHNSON$Miura T. A case of rheumatoid arthritis (RA) accompanied by inflammatory aortic aneurysm during treatment for RA. 31st Annual Meeting of the Japanese Society for Clinical Rheumatology and Related Research 29-Oct-2016:172.$6$DEC$A$F$Y$$$20240703$$MD$JP$JP
240446811$24044681$1$I$$20230926$20240703$20240703$PER$$US-AMGEN-USASP2023235379$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240446821$24044682$1$I$$20240628$20240703$20240703$EXP$$CH-AMGEN-CHESP2024129286$AMGEN$$72$YR$E$F$Y$$$20240703$$MD$CH$CH
240446831$24044683$1$I$$20240701$20240703$20240703$PER$$US-HALEON-2184715$Haleon PLC$$58$YR$$F$Y$$$20240703$$CN$US$US
240446851$24044685$1$I$20240530$20240621$20240703$20240703$EXP$$JP-ROCHE-10000012707$ROCHE$$78$YR$E$M$Y$$$20240703$$PH$JP$JP
240446861$24044686$1$I$20230511$20240626$20240703$20240703$EXP$ES-AEMPS-1393984$ES-CHEPLA-2024008096$CHEPLAPHARM$$49$YR$$F$Y$46.9$KG$20240703$$MD$COUNTRY NOT SPECIFIED$ES
240446871$24044687$1$I$$20240626$20240703$20240703$30DAY$$US-GSK-US2024079780$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240446881$24044688$1$I$$20240624$20240703$20240703$30DAY$$US-GSK-US2024AMR079943$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240446891$24044689$1$I$$20240625$20240703$20240703$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004787$BIOCON$$$$$$Y$$$20240703$$HP$CA$CA
240446901$24044690$1$I$$20240620$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-05785$HIKMA$Rubannelsonkumar C, Hornak J.. Rubannelsonkumar C, Hornak J. Treatment of Mucormycosis Infection With Combination Therapy Using Echinocandin and Amphotericin B. American Journal of Respiratory and Critical Care Medicine. 2024;209: A2389:/$46$YR$$M$Y$$$20240703$$MD$US$US
240446911$24044691$1$I$$20240625$20240703$20240703$EXP$$ZA-AstraZeneca-2024A149256$ASTRAZENECA$$64$YR$$F$Y$$$20240703$$CN$ZA$
240446922$24044692$2$F$$20240802$20240703$20240812$PER$$US-AstraZeneca-2024A147425$ASTRAZENECA$$$$$$Y$$$20240812$$CN$US$
240446931$24044693$1$I$20240426$20240701$20240703$20240703$EXP$$US-AstraZeneca-2024A151094$ASTRAZENECA$$$$$M$Y$$$20240703$$CN$US$
240446941$24044694$1$I$$20240628$20240703$20240703$EXP$$CA-AstraZeneca-2024A149813$ASTRAZENECA$$$$$F$Y$$$20240703$$PH$CA$
240446951$24044695$1$I$$20240625$20240703$20240703$PER$$US-ALXN-202406USA001635US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240703$$CN$US$US
240446961$24044696$1$I$20240525$20240619$20240703$20240703$EXP$FR-AFSSAPS-AVLY2024000050$FR-TEVA-VS-3212889$TEVA$$24$YR$$M$Y$$$20240703$$MD$FR$FR
240446971$24044697$1$I$$20230518$20240703$20240703$PER$$US-AMGEN-USASP2023235049$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240446984$24044698$4$F$$20240702$20240703$20240712$EXP$$US-ROCHE-10000013257$ROCHE$$59$YR$A$M$Y$$$20240712$$PH$US$US
240446992$24044699$2$F$$20240708$20240703$20240716$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001309$BLUEPRINT MEDICINES$$$$$M$Y$$$20240716$$CN$US$US
240447001$24044700$1$I$$20240625$20240703$20240703$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001312$BLUEPRINT MEDICINES$$$$$F$Y$$$20240703$$CN$US$US
240447011$24044701$1$I$$20240626$20240703$20240703$EXP$$US-JNJFOC-20240675583$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240447021$24044702$1$I$$20240625$20240703$20240703$EXP$$GB-AUROBINDO-AUR-APL-2024-032201$AUROBINDO$Cooray S, Price-Kuehne F, Hong Y, Omoyinmi E, Burleigh A, Gilmour KC, et al.. Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4.. Frontiers in Immunology. 2023$$$N$F$Y$$$20240703$$HP$GB$GB
240447031$24044703$1$I$$20240617$20240703$20240703$EXP$$DE-TEVA-VS-3213307$TEVA$$$$A$$Y$$$20240703$$CN$DE$DE
240447042$24044704$2$F$$20240826$20240703$20240827$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037457$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240827$$CN$US$US
240447051$24044705$1$I$$20240627$20240703$20240703$EXP$$RU-TEVA-VS-3215566$TEVA$$$$A$F$Y$$$20240703$$MD$RU$RU
240447091$24044709$1$I$$20240702$20240703$20240703$PER$$US-HALEON-2184951$Haleon PLC$$72$YR$$F$Y$$$20240703$$CN$US$US
240447101$24044710$1$I$20240101$20240626$20240703$20240703$EXP$$US-SA-2024SA192301$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240703$$MD$US$US
240447122$24044712$2$F$20240601$20240826$20240703$20240906$EXP$$JP-ASTELLAS-2024JP004588$ASTELLAS$$7$DEC$E$$Y$$$20240906$$MD$JP$JP
240447132$24044713$2$F$$20240703$20240703$20240709$EXP$$DE-SA-2024SA193414$SANOFI AVENTIS$Solimani F, Nast A, Dilling A, Pahl S, Graf B, Gabner J, et al.. Fatal course of cutaneous mucormycosis in an immunosuppressed patient.. JDDG - Journal of the German Society of Dermatology.. 2024;22(6):850-2$41$YR$A$F$Y$$$20240709$$MD$DE$DE
240447141$24044714$1$I$20240629$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130522$AMGEN$$83$YR$E$M$Y$$$20240703$$CN$US$US
240447151$24044715$1$I$20240101$20240626$20240703$20240703$EXP$$US-SA-2024SA192376$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240703$$MD$US$US
240447161$24044716$1$I$20240206$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106247$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240703$$MD$US$US
240447171$24044717$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106099$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240703$$CN$US$US
240447191$24044719$1$I$20240601$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106035$BRISTOL MYERS SQUIBB$$31$YR$A$M$Y$$$20240703$$HP$US$US
240447202$24044720$2$F$20240401$20240801$20240703$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105865$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$92.99$KG$20240805$$CN$US$US
240447211$24044721$1$I$20240601$20240626$20240703$20240703$EXP$$US-SA-2024SA192407$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240703$$MD$US$US
240447222$24044722$2$F$20240217$20240722$20240703$20240727$EXP$ES-AEMPS-1538159$ES-SA-2024SA192738$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240727$$PH$ES$ES
240447231$24044723$1$I$20240101$20240626$20240703$20240703$EXP$$US-SA-2024SA192400$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240703$$MD$US$US
240447241$24044724$1$I$20240101$20240626$20240703$20240703$EXP$$US-SA-2024SA192837$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240703$$MD$US$US
240447251$24044725$1$I$20240626$20240701$20240703$20240703$PER$$US-JNJFOC-20240703694$JOHNSON AND JOHNSON$$38$YR$A$$Y$$$20240703$$HP$US$US
240447261$24044726$1$I$20240613$20240621$20240703$20240703$PER$$US-009507513-2406USA008335$MERCK$$85$YR$$M$Y$$$20240703$$CN$US$US
240447281$24044728$1$I$$20240624$20240703$20240703$EXP$FR-AFSSAPS-PO2024000633$FR-BAXTER-2024BAX020484$BAXTER$$55$YR$$F$Y$98$KG$20240703$$MD$FR$FR
240447291$24044729$1$I$$20240624$20240703$20240703$EXP$$CA-BAXTER-2024BAX020762$BAXTER$$$$$$Y$$$20240703$$HP$CA$CA
240447301$24044730$1$I$20240504$20240625$20240703$20240703$EXP$CN-NMPACDR-4301011002666202400338$CN-BAXTER-2024BAX020735$BAXTER$$53$YR$$F$Y$60$KG$20240703$$MD$CN$CN
240447312$24044731$2$F$20221101$20240724$20240703$20240731$EXP$$CA-GSK-CA2022175801$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$CA$CA
240447321$24044732$1$I$$20240628$20240703$20240703$30DAY$$US-GSK-US2024081046$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240447333$24044733$3$F$20160101$20240924$20240703$20240925$PER$$US-GILEAD-2024-0679348$GILEAD$$26$YR$A$M$Y$$$20240925$$LW$US$US
240447341$24044734$1$I$20240415$20240621$20240703$20240703$EXP$GB-MHRA-MED-202406211125572580-JLBMY$GB-Accord-432179$ACCORD$$46$YR$A$M$Y$75$KG$20240703$$PH$GB$GB
240447352$24044735$2$F$20110103$20240704$20240703$20240709$EXP$$BR-ROCHE-10000011359$ROCHE$$59$YR$A$M$Y$$$20240709$$HP$BR$BR
240447361$24044736$1$I$$20240627$20240703$20240703$EXP$$ES-UCBSA-2024033039$UCB$$$$$F$Y$$$20240703$$MD$ES$ES
240447371$24044737$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106093$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$89.36$KG$20240703$$CN$US$US
240447383$24044738$3$F$$20240723$20240703$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106069$BRISTOL MYERS SQUIBB$$83$YR$E$$Y$52$KG$20240801$$PH$JP$JP
240447391$24044739$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105988$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240703$$HP$US$US
240447401$24044740$1$I$$20240625$20240703$20240703$EXP$$US-VIVUS LLC-2024V1000816$VIVUS$$$$A$F$Y$$$20240701$$CN$US$US
240447412$24044741$2$F$$20240712$20240703$20240713$PER$$US-AMGEN-USASP2024130103$AMGEN$$$$$F$Y$$$20240713$$CN$US$US
240447421$24044742$1$I$$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031738$AUROBINDO$$34$YR$$M$Y$$$20240703$$PH$FR$FR
240447431$24044743$1$I$20240605$20240619$20240703$20240703$EXP$$JP-AMGEN-JPNSP2024116336$AMGEN$$59$YR$A$F$Y$$$20240703$$MD$JP$JP
240447443$24044744$3$F$20240327$20240729$20240703$20240801$30DAY$$BR-AMGEN-BRASP2024127153$AMGEN$$$$$$Y$$$20240801$$PH$BR$BR
240447452$24044745$2$F$20240316$20240709$20240703$20240716$PER$$US-AMGEN-USASP2024128090$AMGEN$$48$YR$A$M$Y$$$20240716$$PH$US$US
240447461$24044746$1$I$$20221229$20240703$20240703$PER$$US-AMGEN-USASP2022230358$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240447471$24044747$1$I$$20231016$20240703$20240703$PER$$US-AMGEN-USASP2023235322$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240447491$24044749$1$I$$20240620$20240703$20240703$EXP$$US-RDY-LIT/USA/24/0009172$DR REDDYS$Sasidharan S, Jatoi T, Milla C, Mallappallil M, Agarwal S, Puri I. Triple Whammy of Amlodipine, Carvedilol and Diphenhydramine Overdose. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: A5669. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5669.$27$YR$A$F$Y$$$20240703$$HP$US$US
240447501$24044750$1$I$$20240610$20240703$20240703$PER$$US-JNJFOC-20240629002$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240447512$24044751$2$F$20230605$20240702$20240703$20240710$EXP$$GB-AUROBINDO-AUR-APL-2023-064187$AUROBINDO$$63$YR$$M$Y$80.5$KG$20240710$$MD$GB$GB
240447521$24044752$1$I$$20240625$20240703$20240703$EXP$$ZA-AstraZeneca-2024A148138$ASTRAZENECA$$72$YR$$M$Y$$$20240703$$CN$ZA$
240447531$24044753$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A146986$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240447542$24044754$2$F$20240601$20240725$20240703$20240801$EXP$$JP-ROCHE-10000011932$ROCHE$$5$DEC$A$M$Y$$$20240801$$MD$JP$JP
240447551$24044755$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A148266$ASTRAZENECA$$$$$F$Y$79.8$KG$20240703$$CN$US$
240447561$24044756$1$I$$20240627$20240703$20240703$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01140$NOVITIUM PHARMA$Anna Gardin.The importance of MRI in the acute phase of herpes encephalitis mimicking an acute ischemic stroke. Neurological Sciences.31-JUL-2023;44:4563-4567$80$YR$E$M$Y$$$20240703$$HP$IT$IT
240447581$24044758$1$I$$20240701$20240703$20240703$PER$$US-HALEON-2184953$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240447591$24044759$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281432034530-LJZCK$GB-ORGANON-O2407GBR000076$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240447601$24044760$1$I$$20230717$20240703$20240703$PER$$US-AMGEN-USASP2023235047$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240447611$24044761$1$I$$20230714$20240703$20240703$PER$$US-AMGEN-USASP2023235359$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240447621$24044762$1$I$$20240402$20240703$20240703$PER$$US-AMGEN-USASP2024130625$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240447631$24044763$1$I$$20240402$20240703$20240703$PER$$US-AMGEN-USASP2024129956$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240447641$24044764$1$I$$20240626$20240703$20240703$EXP$$CA-AMGEN-CANSP2024127976$AMGEN$$$$$$Y$$$20240703$$PH$CA$CA
240447651$24044765$1$I$$20231101$20240703$20240703$PER$$US-AMGEN-USASP2023235311$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240447662$24044766$2$F$20240522$20240708$20240703$20240712$PER$$US-AMGEN-USASP2024126920$AMGEN$$47$YR$A$F$Y$101$KG$20240712$$PH$US$US
240447681$24044768$1$I$$20240624$20240703$20240703$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001314$BLUEPRINT MEDICINES$$$$$M$Y$$$20240703$$CN$US$US
240447691$24044769$1$I$20230527$20240627$20240703$20240703$EXP$$CO-UCBSA-2024033582$UCB$$35$YR$$F$Y$61$KG$20240703$$CN$CO$CO
240447701$24044770$1$I$20240622$20240622$20240703$20240703$EXP$GB-MHRA-MED-202406221105535250-JMHBS$GB-TORRENT-00036911$TORRENT$$64$YR$A$M$Y$77$KG$20240703$$CN$GB$GB
240447712$24044771$2$F$$20240708$20240703$20240718$EXP$$TH-TEVA-VS-3215421$TEVA$Sirikul W, Buawangpong N, Pruksakorn D, Charoentum C, Teeyakasem P, Koonrungsesomboon N. The Survival Outcomes, Prognostic Factors and Adverse Events following Systemic Chemotherapy Treatment in Bone Sarcomas: A Retrospective Observational Study from the Experience of the Cancer Referral Center in Northern Thailand. Cancers 2023; 15 (7):.; Sirikul W, Buawangpong N, Pruksakorn D, Charoentum C, Teeyakasem P, Koonrungsesomboon N. The Survival Outcomes, Prognostic Factors and Adverse Events follo...$58$YR$$M$Y$$$20240718$$HP$TH$TH
240447721$24044772$1$I$$20240624$20240703$20240703$EXP$$US-MYLANLABS-2024M1060220$MYLAN$Bhatia S, Jamil A, Sharif M, Skenderi S. Cardiovascular Collapse Shortly After Beta Blockers in Atrial Fibrillationcomplicated Thyroid Storm. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.$49$YR$$M$Y$$$20240703$$HP$US$US
240447741$24044774$1$I$$20240626$20240703$20240703$PER$$US-ABBVIE-5820425$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240447751$24044775$1$I$$20240620$20240703$20240703$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05642$LUPIN$$$$$$Y$$$20240703$$CN$US$US
240447761$24044776$1$I$$20240624$20240703$20240703$EXP$DE-BFARM-24004314$DE-TEVA-VS-3213857$TEVA$$$$$F$Y$$$20240703$$CN$DE$DE
240447771$24044777$1$I$$20240621$20240703$20240703$PER$$US-GILEAD-2024-0678374$GILEAD$$51$YR$A$M$Y$$$20240703$$HP$US$US
240447791$24044779$1$I$20231121$20240627$20240703$20240703$EXP$$DE-TAKEDA-2024TUS066242$TAKEDA$$58$YR$$F$Y$64$KG$20240703$$MD$DE$DE
240447801$24044780$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453279$RANBAXY$$$$A$F$Y$$$20240703$$HP$US$US
240447811$24044781$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453173$RANBAXY$Chen S, Kavanagh A, Zarick C. Steroid-Induced Avascular Necrosis in the Foot and Ankle-Pathophysiology, Surgical, and Nonsurgical Therapies: Case Study and Literature Review. Foot Ankle Spec. 2024;17 (2):168-176$41$YR$$F$Y$$$20240703$$HP$US$US
240447821$24044782$1$I$$20240618$20240703$20240703$EXP$$HK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453924$RANBAXY$Leung EKH, Kan AKC, Lau J, Wong CH, Loong CHN, Cheung SCW, et al. Atypical metatarsal fracture in a Chinese postmenopausal woman with osteoporosis on long-term denosumab: a case report. Hong Kong Med J. 2024;30:1-3$69$YR$$F$Y$54$KG$20240703$$HP$HK$HK
240447832$24044783$2$F$20170101$20240702$20240703$20240717$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447438$RANBAXY$Senol B, Ekinci RN, Goka E. First manic episode induced by abrupt discontinuation of sertraline in apatient with OCD: A case report. Bipolar Disord. 2024;0 (0):no pagination$29$YR$$F$Y$$$20240717$$HP$TR$TR
240447841$24044784$1$I$$20240618$20240703$20240703$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450364$RANBAXY$Rui M, Zhu Z. Fulminant type 1 diabetes mellitus caused by tirelizumab. [Chinese]. ADRJ. 2023;Jan; 25(1):53-55$73$YR$$M$Y$$$20240703$$HP$CN$CN
240447851$24044785$1$I$20230803$20240618$20240703$20240703$EXP$$AR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454258$RANBAXY$$75$YR$E$M$Y$$$20240703$$CN$AR$AR
240447861$24044786$1$I$$20240618$20240703$20240703$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453727$RANBAXY$Giorgetti A, Grosse Perdekamp M, Franchetti G, Pircher R, Pollak S, Pelotti S, et al. Intoxications involving methoxyacetylfentanyl and U?47700: a study of 3 polydrug fatalities. Int J Legal Med. 2024;0 (0):1-11$31$YR$$M$Y$$$20240703$$HP$IT$IT
240447872$24044787$2$F$$20240731$20240703$20240814$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452939$RANBAXY$Randi BA,  Oliveira VFD ,  Rapozo MM ,  Higashino HR ,  Del Negro GMB ,  Magri MMC , et al. Fatal hepatic mucormycosis in an allogeneic hematopoietic-stem cell transplanted patient: Case report of a rare presentation and review of the literature. J Infect Chemother. 2024;Jun 13:38879078/35/58$36$YR$$M$Y$$$20240814$$HP$BR$BR
240447881$24044788$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453771$RANBAXY$Gosmanov AR, Green M, Gerges AK, Ziganshina AP, Roy MP. Unilateral adrenalectomy as a treatment option in a patient with recurrent Cushing^s disease. Oxf Med Case Reports. 2023;8:301-304$51$YR$$F$Y$$$20240703$$HP$US$US
240447891$24044789$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453782$RANBAXY$Tomaras MC, Douglas LM, Schmidt RM, Bloomquist MS, Diwan AH, Kim SJ. Refractory chronic spontaneous urticaria after heterologous COVID-19 booster vaccination. Dermatology Online Journal. 2024;30 (2):1-7$55$YR$$M$Y$$$20240703$$HP$US$US
240447901$24044790$1$I$$20240618$20240703$20240703$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453994$RANBAXY$Taida T, Kato J, Ishikawa K, Akizue N, Ohta Y, Okimoto K, et al. Severe ulcerative colitis induced by COVID?19 vaccination. Clin J Gastroenterol. 2024;17 (3):447-450$37$YR$$F$Y$$$20240703$$HP$JP$JP
240447911$24044791$1$I$$20240618$20240703$20240703$EXP$$SI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453950$RANBAXY$Pavlin T, Blatnik A, Seruga B. Challenges in the management of operable triple-negative breast cancer in a survivor of the B-cell acute lymphoblastic leukemia: a case report. Front Oncol. 2024;14 (0):1-6$40$YR$$F$Y$$$20240703$$HP$SI$SI
240447921$24044792$1$I$$20240618$20240703$20240703$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454097$RANBAXY$Mikolajczak A, Bokiniec R, Sienicka A, Pisula A, Romejko-Wolniewicz E. Adverse outcome of T3-predominant maternal Grave^s disease during pregnancy in the mother and the offspring. Endokrynol Pol. 2023;74 (3):340-341$29$YR$$F$Y$$$20240703$$HP$PL$PL
240447931$24044793$1$I$$20240618$20240703$20240703$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454109$RANBAXY$Mikolajczak A, Bokiniec R, Sienicka A, Pisula A, Romejko- Wolniewicz E. Adverse outcome of T3-predominant maternal Grave?s disease during pregnancy in the mother and the offspring. Endokrynol Pol. 2023;74 (3):340-341$$$N$F$Y$2.78$KG$20240703$$HP$PL$PL
240447941$24044794$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453775$RANBAXY$Lavin L, Chefitz G, Patel D, Baek WK, Khattri S. Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: an unusual adverse effect. JAAD Case Rep. 2024;49 (0):40-43$74$YR$$F$Y$$$20240703$$HP$US$US
240447951$24044795$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454144$RANBAXY$Karczewski D, Backer H, Andronic O, Bedi A, Adelhoefer S, Mullner M, et al. Serratia marcescens prosthetic joint infection: two case reports and a review of the literatureSerratia marcescens prosthetic joint infection: two case reports and a review of the literature. J Med Case Rep. 2023;17(1):294(1-12)$72$YR$$F$Y$$$20240703$$HP$US$US
240447961$24044796$1$I$$20240627$20240702$20240702$DIR$FDA-CDER-CTU-2024-46314$$FDA-CTU$$$$$M$N$$$20240627$N$HP$US$
240447971$24044797$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454142$RANBAXY$Lu J. Rescue of immediate post-transcarotid artery revascularization carotid stent thrombosis due to clopidogrel resistance using flow-reversal and aspiration thrombectomy. J Vasc Surg Cases Innov Tech. 2023;9(2):1-5$84$YR$$M$Y$$$20240703$$MD$US$US
240447982$24044798$2$F$$20240715$20240703$20240730$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454078$RANBAXY$Moutinho-Pereira S, Beires F, dos Santos J, Relvas M, Ramos LC, Ramos SC, et al. Febrile ulceronecrotic Mucha-Habermann disease-a case and treatment review. Dermatol Online J. 2024;MAR/APR; 30 (2):8/1-10$23$YR$$M$Y$$$20240730$$HP$PT$PT
240447991$24044799$1$I$20240401$20240618$20240703$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454471$RANBAXY$$41$YR$$M$Y$83$KG$20240703$$CN$GB$GB
240448001$24044800$1$I$$20240618$20240703$20240703$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454167$RANBAXY$Dixit A, Kumar A, Trivedi S, Joshi D. Perampanel?induced erectile dysfunction. Neurol Sci. 2024;45:1787-1788$42$YR$$M$Y$$$20240703$$HP$IN$IN
240448011$24044801$1$I$$20240618$20240703$20240703$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454514$RANBAXY$Giorgetti A, Grosse Perdekamp M, Franchetti G, Pircher R, Pollak S, Pelotti S. Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities. Int J Legal Med. 2024;0(0):no pagination$20$YR$$M$Y$$$20240703$$HP$IT$IT
240448021$24044802$1$I$$20240620$20240703$20240703$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05654$LUPIN$Aljbour Almajali D, Cherabuddi MR, Ayyad A, Fram F, Abu Sayf A. Brivaracetam-related neurological decline in a patient with complex medical history. American Journal of Respiratory and Critical Care Medicine. 2024;209$68$YR$$F$Y$$$20240703$$HP$US$US
240448031$24044803$1$I$$20240618$20240703$20240703$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454272$RANBAXY$Zuniga D, Stumpf MAM, Monteiro ALS, Glezer A. Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review. J Endocrinol Invest. 2024;47:1295-1303$27$YR$$M$Y$$$20240703$$HP$BR$BR
240448041$24044804$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454161$RANBAXY$Nwodim O, Karsalia R, Heslin ME, Lieberman AE, Wang SZ, Kalanuria AA, et al.. Opioid-related xylazine toxicity manifesting as myonecrosis, rhabdomyolysis, multifocal ischemic cerebral infarcts, and cerebral edema. J Am Coll Emerg Physicians Open. 2024;5 (3):1-4 e13187$27$YR$$F$Y$$$20240703$$MD$US$US
240448051$24044805$1$I$20240625$20240627$20240702$20240702$DIR$FDA-CDER-CTU-2024-46301$$FDA-CTU$$41$YR$$F$N$$$20240627$N$HP$US$
240448062$24044806$2$F$$20240625$20240703$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454156$RANBAXY$Haghparast P, Nadybal M, Yuan C. Treatment-Resistant Priapism in a 61-Year-Old Male After Combined Use of Trazodone, Quetiapine, and Fluoxetine. J Clin Psychopharmacol. 2024;MAY/JUN; 44 (3):316-317$61$YR$$M$Y$$$20240710$$HP$US$US
240448071$24044807$1$I$$20240618$20240703$20240703$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449606$RANBAXY$Wenqi Lu, Li J, Kuang W. Dramatic toothache related to venlafaxine: a case report. Psychogeriatrics. 2024;May 21; 0 (0):no pagination$68$YR$$F$Y$$$20240703$$HP$CN$CN
240448082$24044808$2$F$$20240704$20240703$20240720$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453774$RANBAXY$Hartinger JM, Bobek DL. How to prevent polypharmacy. Czech J Med. 2024;163:3-8$76$YR$$M$Y$$$20240719$$PH$CZ$CZ
240448091$24044809$1$I$$20240618$20240703$20240703$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454278$RANBAXY$Lefeuvre S, Richeval C, Lelong  J, Venisse N, Humbert L, Brunet B. N-ethylhexedrone: a very long and bad trip! A Case series. J Anal Toxicol. 2024;-:-$33$YR$$M$Y$$$20240703$$HP$FR$FR
240448102$24044810$2$F$$20240620$20240703$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454344$RANBAXY$Preskorn SH, Masolak DD. Cerebral Anoxia in an 18-year-old Patient Being Treated for Major Depressive Disorder: How Forensic Detective Work Uses Medical Knowledge Including Clinical Pharmacology to Solve Cases. J Psychiatr Pract. 2024;30 (3):212-219$18$YR$$M$Y$$$20240705$$MD$US$US
240448113$24044811$3$F$$20240718$20240703$20240802$EXP$$HN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454086$RANBAXY$Zaldivar GJ, Zamora KM, Zcoa AE. Antineutrophil cytoplasmic antibodies-positive vasculitis induced by propylthiouracil in patient with hyperthyroidism. Rev Argent Endocrinol Metab. 2022;59 (1):18-22$41$YR$$F$Y$$$20240802$$HP$HN$HN
240448121$24044812$1$I$$20240618$20240703$20240703$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452921$RANBAXY$Khadela A ,  Dave B , Premal  Y, Patel N , Sadhwani D. The Phenytoin Ataxia Enigma Unveiled ^^A Case Report^^. J Pharm Pract. 2024;Jun 13::8-9/14/38871356$16$YR$$M$Y$$$20240703$$HP$IN$IN
240448131$24044813$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453780$RANBAXY$Schultz L, Davis KL, Walkush A, Baggott C, Erickson C, Ramakrishna S, et al. Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD. J Immunother Cancer. 2023;11 (2):1-4 (e004851)$$$$F$Y$$$20240703$$HP$US$US
240448141$24044814$1$I$$20240618$20240703$20240703$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453735$RANBAXY$Giorgetti A, Grosse Perdekamp M, Franchetti G, Pircher R, Pollak S, Pelotti S, et al. Intoxications involving methoxyacetylfentanyl and U?47700: a study of 3 polydrug fatalities. Int J Legal Med. 2024;0 (0):1-11$31$YR$$M$Y$$$20240703$$HP$IT$IT
240448151$24044815$1$I$$20240618$20240703$20240703$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454133$RANBAXY$Zarras C, Iosifidis E, Simitsopoulou M, Pappa S, Kontou A, Roilides E, et al. Neonatal Bloodstream Infection with Ceftazidime-Avibactam-Resistant blaKPC-2-Producing Klebsiella pneumoniae Carrying blaVEB-25. Antibiotics (Basel). 2023;12 (8):1290 (1-11)$$$N$$Y$$$20240703$$HP$GR$GR
240448161$24044816$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453785$RANBAXY$Eid JJ, Stelzer JW, Rodner CM. Severe Carpal Tunnel Syndrome in a Pediatric Patient With a History of Congenital Adrenal Hyperplasia. J Hand Surg Glob Online. 2024;6 (3):430-432$17$YR$$F$Y$$$20240703$$HP$US$US
240448171$24044817$1$I$$20240618$20240703$20240703$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454125$RANBAXY$Xiang X, Lin W, Guan X, Zhou B, Yuan Y, Silva D, et al. Corneal ulcer development due to sintilimab-anlotinib combination therapy-induced dry eye: a case report. Transl Cancer Res. 2024;13(5):2571-2579$65$YR$$F$Y$$$20240703$$HP$CN$CN
240448181$24044818$1$I$$20240618$20240703$20240703$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453922$RANBAXY$Tanaka T, Sato H, Kimura S, Kasai K, Umehara T. An Autopsy Case of Dextromethorphan Poisoning. J UOEH. 2024;46 (2):221-226$2$DEC$$F$Y$57.2$KG$20240703$$HP$JP$JP
240448191$24044819$1$I$$20240618$20240703$20240703$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453997$RANBAXY$Kumagai K, Baba T, Fukushima T, Tabata E, Nakazawa A, Hagiwara E, et al. A case of sialadenitis observed as an irAE of atezolizumab: A case report. Respirat Med Case Report. 2024;50(0):102068/1-4$73$YR$$F$Y$$$20240703$$HP$JP$JP
240448201$24044820$1$I$$20240618$20240703$20240703$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453940$RANBAXY$Cronin C, McLaughlin R, Lane L, Brett FM, Jansen M, Bermingham N, et al. Case report: BRAF-inhibitor therapy in BRAF-mutated primary CNS tumours including one case of BRAF-mutated Rosai-Dorfman disease. Front Med. 2022;9:1070828 (1-8)$18$YR$$M$Y$$$20240703$$HP$IE$IE
240448211$24044821$1$I$$20240624$20240703$20240703$EXP$$TH-TEVA-VS-3215420$TEVA$Sirikul W, Buawangpong N, Pruksakorn D, Charoentum C, Teeyakasem P, Koonrungsesomboon N. The Survival Outcomes, Prognostic Factors and Adverse Events following Systemic Chemotherapy Treatment in Bone Sarcomas: A Retrospective Observational Study from the Experience of the Cancer Referral Center in Northern Thailand. Cancers 2023; 15 (7):.; Sirikul W, Buawangpong N, Pruksakorn D, Charoentum C, Teeyakasem P, Koonrungsesomboon N. The Survival Outcomes, Prognostic Factors and Adverse Events follo...$45$YR$$F$Y$$$20240703$$HP$TH$TH
240448221$24044822$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454160$RANBAXY$Valido K, Patel V, Murphy MJ, Junejo MH, Patel DK, Deutsch A, et al. Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach. JAAD Case Rep. 2024;48:49-53$52$YR$$F$Y$$$20240703$$MD$US$US
240448231$24044823$1$I$$20240618$20240703$20240703$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454582$RANBAXY$Kashif S, Al-Mani SY, Almani NY. A rare psoriasis drug eruption induced by levetiracetam: a case study from Saudi Arabia. Int J Pharmacol. 2024;20 (4):704-708$40$YR$$F$Y$$$20240703$$HP$SA$SA
240448241$24044824$1$I$20240618$20240618$20240703$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454650$RANBAXY$$49$YR$$F$Y$114$KG$20240703$$MD$GB$GB
240448251$24044825$1$I$$20240618$20240703$20240703$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454727$RANBAXY$Lee JJ, Choi YJ, Byun JY, Choi YW, Roh JY, Choi HY. Nontuberculous mycobacterial infection in a sporotricoid distribution in Korea: a case report. EWHA Med J. 2024;47 (2):1-4$77$YR$$F$Y$$$20240703$$HP$KR$KR
240448261$24044826$1$I$20240608$20240618$20240703$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454612$RANBAXY$$55$YR$$M$Y$86$KG$20240703$$MD$GB$GB
240448271$24044827$1$I$$20240618$20240703$20240703$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454606$RANBAXY$$$$$F$Y$$$20240703$$CN$GB$GB
240448281$24044828$1$I$$20240618$20240703$20240703$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454551$RANBAXY$Pinto MYP, Neelankavil S.. Gallbladder agenesis diagnosed during pregnancy- Case report and a literature review. Int J Surg Case Rep. 2023;105:no pagination$31$YR$$F$Y$$$20240703$$HP$AU$AU
240448291$24044829$1$I$$20240626$20240703$20240703$EXP$$GB-009507513-1812GBR000280$MERCK$$$$E$F$Y$$$20240703$$CN$GB$GB
240448302$24044830$2$F$20240423$20240819$20240703$20240826$PER$$US-AMGEN-USASP2024128124$AMGEN$$35$YR$A$F$Y$$$20240826$$PH$US$US
240448311$24044831$1$I$$20240626$20240703$20240703$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036269$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240703$$HP$CA$CA
240448321$24044832$1$I$$20240702$20240703$20240703$EXP$$US-TAKEDA-2024TUS066586$TAKEDA$$$$$M$Y$$$20240703$$CN$US$US
240448331$24044833$1$I$$20240626$20240703$20240703$PER$$US-CHATTEMPRD-2024OHG022569$CHATTEM$$$$$F$Y$$$20240703$$CN$US$US
240448351$24044835$1$I$20230702$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46349$$FDA-CTU$$32$YR$$F$N$$$20240702$Y$PH$US$
240448361$24044836$1$I$$20240625$20240703$20240703$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004785$BIOCON$$$$$$Y$$$20240703$$HP$CA$CA
240448371$24044837$1$I$$20240614$20240703$20240703$30DAY$$US-BECTON DICKINSON-US-BD-24-000394$BECTON DICKINSON$$$$$$Y$$$20240703$$CN$US$US
240448392$24044839$2$F$$20240625$20240703$20240709$PER$$US-ROCHE-10000013738$ROCHE$$21$YR$A$F$Y$$$20240705$$CN$US$US
240448402$24044840$2$F$$20240724$20240703$20240816$30DAY$$US-BECTON DICKINSON-US-BD-24-000406$BECTON DICKINSON$$$$$M$Y$$$20240816$$HP$US$US
240448411$24044841$1$I$$20240628$20240703$20240703$EXP$GB-MHRA-30919072$GB-MYLANLABS-2024M1061263$MYLAN$$$$$$Y$$$20240703$$CN$GB$GB
240448422$24044842$2$F$$20240619$20240703$20240704$EXP$$US-MYLANLABS-2024M1057368$MYLAN$Tatapudi S, Sarva ST, Jayaraman G, Krupa MS, Bhimaraj A, Kesavan RB. Silicone Heart: Unraveling Cardiac Sarcoidosis in a 42-Year-Old Female. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$42$YR$$F$Y$$$20240704$$HP$US$US
240448431$24044843$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281418165880-YWTHP$GB-ORGANON-O2407GBR000065$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240448441$24044844$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281433366540-CNLMB$GB-ORGANON-O2407GBR000121$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240448451$24044845$1$I$20240627$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129886$AMGEN$$$$A$$Y$$$20240703$$MD$US$US
240448461$24044846$1$I$$20240122$20240703$20240703$PER$$US-AMGEN-USASP2024130871$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240448472$24044847$2$F$20240401$20240708$20240703$20240716$PER$$US-AMGEN-USASP2024128095$AMGEN$$59$YR$A$F$Y$$$20240716$$PH$US$US
240448481$24044848$1$I$$20240122$20240703$20240703$PER$$US-AMGEN-USASP2024130901$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240448492$24044849$2$F$20240301$20240814$20240703$20240822$EXP$$CA-CELLTRION INC.-2024CA010314$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
240448501$24044850$1$I$$20240618$20240703$20240703$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453879$RANBAXY$Pietrantonio F, Lordi M, Vinci F, Alessi E, Pascucci M, Castelli MD, et al. Leptomeningeal carcinomatosis, an emerging disease in internal medicine departments with a generally poor prognosis: two case reports. Italian J Med. 2024;18 (2):1727$58$YR$$F$Y$$$20240703$$HP$IT$IT
240448511$24044851$1$I$$20240618$20240703$20240703$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453962$RANBAXY$Jiang X, Aljbri A, Liu J, Shang L, Tian Y, Shao H. Hepatic arterial infusion chemotherapy with implantable arterial access port for advanced-stage hepatocellular carcinoma: a case report. Front. Oncol. 2024;14:1401882$64$YR$$M$Y$$$20240703$$HP$CN$CN
240448521$24044852$1$I$$20240618$20240703$20240703$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454080$RANBAXY$Liu Y, Cheng Y, Wen Y, Li C, Chen G, Li M. A case report of youth-onset lipoprotein glomerulopathy with APOE Chicago mutation. BMC Nephrol. 2024;25 (1):87;1-5$26$YR$$M$Y$$$20240703$$HP$CN$CN
240448531$24044853$1$I$$20240618$20240703$20240703$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454293$RANBAXY$Lefeuvre S, Richeval C, Lelong  J, Venisse N, Humbert L, Brunet B. N-ethylhexedrone: a very long and bad trip! A Case series. J Anal Toxicol. 2024;-:-$30$YR$$M$Y$$$20240703$$HP$FR$FR
240448542$24044854$2$F$$20240702$20240703$20240717$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454390$RANBAXY$Lotfollahi L, Golmohammadi M, Gharehbagh FJ, Darazam IA. Self-induced Anuria with Diclofenac: An Interesting Case of Quadruple Whammy Acute Kidney Injury. Int J Med Toxicol Forensic Med. 2024;14(2):no pagination/E43065$66$YR$$F$Y$$$20240717$$HP$IR$IR
240448552$24044855$2$F$$20240702$20240703$20240717$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454153$RANBAXY$Hamimed M, Devillier R, Weiller PJ, Marin C, Schiano JM, Belmecheri N, et al. Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?. Cancer Chemother Pharmacol. 2023;93 (6):627-632$53$YR$$M$Y$$$20240717$$HP$FR$FR
240448561$24044856$1$I$$20240618$20240703$20240703$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454068$RANBAXY$Ballesteros A, Rosero AS, Inchausti F, Manrique E, Saiz H, Carlos C,et al. Clinical case: Phelan-McDermid and pharmacological management. Eur Psychiatry. 2017;41(Suppl.):S430/EV0081$13$YR$$F$Y$$$20240703$$HP$ES$ES
240448571$24044857$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454150$RANBAXY$Valido K, Patel V, Murphy MJ, Junejo MH, Patel DK, Deutsch A, et al. The Vocal Flutter of Multiple System Atrophy: A Parkinsonian-Type Phenomenon?. JAAD Case Rep. 2024;Feb; 48 (0):49-53$62$YR$$M$Y$$$20240703$$MD$US$US
240448581$24044858$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454515$RANBAXY$Valido K, Patel V, Murphy MJ, Junejo MH, Patel DK, Deutsch A, et al. The Vocal Flutter of Multiple System Atrophy: A Parkinsonian-Type Phenomenon?. JAAD Case Rep. 2024;Feb; 48 (0):49-53$66$YR$$M$Y$$$20240703$$MD$US$US
240448591$24044859$1$I$$20240618$20240703$20240703$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453944$RANBAXY$Cronin C, McLaughlin R, Lane L, Brett FM, Jansen M, Bermingham N, et al. Case report: BRAF-inhibitor therapy in BRAF-mutated primary CNS tumours including one case of BRAF-mutated Rosai-Dorfman disease. Front Med. 2022;9:1070828 (1-8)$21$YR$$F$Y$$$20240703$$HP$IE$IE
240448601$24044860$1$I$$20240618$20240703$20240703$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454562$RANBAXY$Tauber J, Ritterband DC, Kang JJ. Corneal Complications Related to Dupilumab Use. Eye Contact Lens. 2024;50:270-273$43$YR$$F$Y$$$20240703$$MD$US$US
240448613$24044861$3$F$20220330$20240830$20240703$20240905$EXP$$JP-ASTELLAS-2024JP004519$ASTELLAS$$83$YR$E$F$Y$47$KG$20240905$$MD$JP$JP
240448621$24044862$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281457303540-MZPCV$GB-ORGANON-O2407GBR000126$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240448631$24044863$1$I$$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024128939$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240448642$24044864$2$F$20210803$20240829$20240703$20240902$PER$$US-GILEAD-2024-0679388$GILEAD$$56$YR$A$F$Y$$$20240902$$LW$US$US
240448651$24044865$1$I$20240531$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46388$$FDA-CTU$$61$YR$$F$N$$$20240702$Y$PH$US$
240448661$24044866$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281432323530-HKSTC$GB-ORGANON-O2407GBR000087$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240448671$24044867$1$I$20240626$20240626$20240703$20240703$PER$$US-ABBVIE-5819860$ABBVIE$$75$YR$$F$Y$$$20240703$$CN$US$US
240448682$24044868$2$F$20240621$20240702$20240703$20240708$EXP$$GB-MYLANLABS-2024M1061515$MYLAN$$$$$M$Y$$$20240708$$PH$GB$GB
240448691$24044869$1$I$$20240613$20240703$20240703$PER$$US-JNJFOC-20240646470$JOHNSON AND JOHNSON$$$$$M$Y$84.1$KG$20240703$$CN$US$US
240448701$24044870$1$I$20240430$20240627$20240703$20240703$EXP$$CN-JNJFOC-20240673459$JOHNSON AND JOHNSON$$31$YR$A$F$Y$48$KG$20240703$$HP$CN$CN
240448712$24044871$2$F$$20240805$20240703$20240806$PER$$US-ALXN-202406USA001638US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240448731$24044873$1$I$$20240619$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05843$HIKMA$Lin C, Cavanaugh N, Subramani S, Singhal A, Hanada S.. Lin C, Cavanaugh N, Subramani S, Singhal A, Hanada S. Interpretation of chest fluoroscopy: the risk of misdiagnosing atelectasis as pneumothorax due to greyscale inversion.. Anaesthesia Reports. 2024;12(1):e12307:4 pgs$52$YR$$M$Y$112$KG$20240703$$MD$US$US
240448741$24044874$1$I$20240521$20240620$20240703$20240703$EXP$PT-INFARMED-T202406-26$PT-TEVA-VS-3212848$TEVA$$57$YR$$M$Y$85$KG$20240703$$PH$PT$PT
240448752$24044875$2$F$$20240702$20240703$20240705$PER$$US-AMGEN-USASP2024129924$AMGEN$$$$$F$Y$$$20240705$$PH$US$US
240448761$24044876$1$I$20230101$20240701$20240703$20240703$EXP$DE-PEI-CADR2024328755$DE-UCBSA-2024033237$UCB$$53$YR$$F$Y$73$KG$20240703$$CN$DE$DE
240448772$24044877$2$F$$20240712$20240703$20240719$PER$$US-AstraZeneca-2024A141482$ASTRAZENECA$$66$YR$$M$Y$$$20240719$$HP$US$
240448781$24044878$1$I$$20240625$20240703$20240703$EXP$$GR-AstraZeneca-2024A150265$ASTRAZENECA$$$$$M$Y$$$20240703$$PH$GR$
240448792$24044879$2$F$20240516$20240729$20240703$20240801$EXP$$US-UCBSA-2024033559$UCB$$70$YR$$F$Y$54.422$KG$20240801$$CN$US$US
240448801$24044880$1$I$$20240624$20240703$20240703$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001299$BLUEPRINT MEDICINES$$$$$M$Y$$$20240703$$CN$US$US
240448823$24044882$3$F$20210101$20240719$20240703$20240726$EXP$$FR-SA-2024SA188664$SANOFI AVENTIS$$50$YR$A$F$Y$64$KG$20240726$$MD$FR$FR
240448831$24044883$1$I$$20240625$20240703$20240703$EXP$$RU-ROCHE-10000011631$ROCHE$$$$C$M$Y$$$20240703$$MD$RU$RU
240448841$24044884$1$I$$20240627$20240703$20240703$PER$$US-ROCHE-10000014849$ROCHE$$75$YR$E$F$Y$$$20240703$$CN$US$US
240448851$24044885$1$I$$20240626$20240703$20240703$EXP$$US-MYLANLABS-2024M1061604$MYLAN$Puri C, Khan AA, Sher N. A Case of Emphysematous Gastritis With Septic Shock and Clostridioides Difficile. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$72$YR$$F$Y$$$20240703$$HP$US$US
240448861$24044886$1$I$$20240620$20240703$20240703$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05572$LUPIN$Sasidharan S, Jatoi T, Milla C, Mallappallil M, Agarwal S, Puri I. Triple whammy of amlodipine, carvedilol and diphenhydramine overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5669$27$YR$$F$Y$$$20240703$$HP$US$US
240448871$24044887$1$I$$20240626$20240703$20240703$EXP$$US-MYLANLABS-2024M1061816$MYLAN$Mak K, Maleckar S, Strek ME, Adegunsoye AO, Lee CT. Improvement in Pulmonary Function in a Patient With ILD Following Semaglutide Therapy. Am-J-Respir-Crit-Care-Med 2024; 209 (0).$65$YR$$F$Y$$$20240703$$HP$US$US
240448881$24044888$1$I$$20240108$20240703$20240703$PER$$US-BAYER-2024A095439$BAYER$$$$$F$Y$$$20240703$$MD$US$US
240448891$24044889$1$I$$20240619$20240703$20240703$EXP$$IL-ROCHE-10000008419$ROCHE$$$$A$F$Y$$$20240703$$CN$IL$IL
240448901$24044890$1$I$$20240620$20240703$20240703$PER$$US-RDY-CLI/USA/24/0008979$DR REDDYS$$8$YR$C$M$Y$34.29$KG$20240703$$CN$US$US
240448911$24044891$1$I$20240129$20240627$20240703$20240703$EXP$$US-UCBSA-2024005011$UCB$$39$YR$$M$Y$$$20240703$$CN$US$US
240448921$24044892$1$I$$20240702$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037506$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240703$$CN$US$US
240448931$24044893$1$I$20240102$20240622$20240703$20240703$EXP$FR-AFSSAPS-2024053490$FR-Accord-432628$ACCORD$$69$YR$E$F$Y$78$KG$20240703$$PH$FR$FR
240448941$24044894$1$I$$20240622$20240703$20240703$EXP$PL-URPL-DML-MLP.4401.1.4907.2021$PL-Accord-432315$ACCORD$$85$YR$E$F$Y$64$KG$20240703$$MD$PL$PL
240448951$24044895$1$I$20240201$20240624$20240703$20240703$EXP$IT-MINISAL02-992123$IT-Accord-432640$ACCORD$$69$YR$E$M$Y$$$20240703$$MD$IT$IT
240448961$24044896$1$I$20201221$20240624$20240703$20240703$EXP$DE-EMA-2024614-AUTODUP-1718393267765$DE-Accord-431386$ACCORD$$54$YR$A$F$Y$91$KG$20240703$$MD$DE$DE
240448971$24044897$1$I$$20240623$20240703$20240703$EXP$$JP-Accord-432547$ACCORD$Yamaguchi T, Shimizu J, Shigematsu F, Watanabe N, Hasegawa T, Horio Y, et al. Atezolizumab and nintedanib in patients with non-small cell lung cancer and interstitial lung disease. J Thorac Dis. 2024 May 31;16(5):3371-3380.$78$YR$E$M$Y$$$20240703$$MD$JP$JP
240448981$24044898$1$I$20240408$20240625$20240703$20240703$EXP$SE-SEMPA-2024-005083$SE-Accord-432900$ACCORD$$57$YR$A$F$Y$$$20240703$$MD$SE$SE
240448991$24044899$1$I$$20240624$20240703$20240703$EXP$GB-MHRA-MED-202406232331342190-RKDPY$GB-Accord-432535$ACCORD$$$$$F$Y$80$KG$20240703$$CN$GB$GB
240449002$24044900$2$F$20230101$20240702$20240703$20240712$EXP$$CN-Accord-432526$ACCORD$Peng M, Lin T, Song Z, Huang T, Pan X. High dose tacrolimus-induced acute pancreatitis after kidney transplantation: a case report. Pancreas. 2024 Jun 24.$31$YR$A$M$Y$$$20240712$$MD$CN$CN
240449011$24044901$1$I$$20230825$20240703$20240703$PER$$US-AMGEN-USASP2023235369$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240449021$24044902$1$I$$20240626$20240703$20240703$PER$$US-AMGEN-USASL2024127448$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240449033$24044903$3$F$20240403$20240819$20240703$20240829$PER$$US-AMGEN-USASP2024128048$AMGEN$$$$$F$Y$$$20240828$$PH$US$US
240449041$24044904$1$I$$20240124$20240703$20240703$PER$$US-AMGEN-USASP2024130598$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240449061$24044906$1$I$$20240702$20240703$20240703$PER$$US-HALEON-2185027$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240449072$24044907$2$F$$20240925$20240703$20240930$EXP$$US-SA-2024SA191112$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240930$$MD$US$US
240449081$24044908$1$I$$20240624$20240703$20240703$EXP$$US-ASPIRO-ASP2024US02048$ASPIRO PHARMA$Ghose. M, Anwar.M, Rajamohan. A, Vangala. A, Roy. P, Weiner. SM, et., al.. Vancomycin Induced Anaphylaxis Presenting With Cardiac Arrest: Judicious Use of Antibiotic in Low Risk Procedures. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5700$74$YR$$F$Y$$$20240703$$HP$US$US
240449091$24044909$1$I$$20240622$20240703$20240703$EXP$$RU-MACLEODS PHARMA-MAC2024047916$MACLEODS$$$$$F$Y$$$20240703$$HP$RU$RU
240449101$24044910$1$I$$20240627$20240703$20240703$EXP$$CA-TAKEDA-2022TUS046324$TAKEDA$$$$$M$Y$$$20240703$$MD$CA$CA
240449111$24044911$1$I$20240201$20240701$20240703$20240703$EXP$DE-BFARM-24004558$DE-UCBSA-2024033236$UCB$$$$$F$Y$3.58$KG$20240703$$MD$DE$DE
240449121$24044912$1$I$$20240621$20240703$20240703$EXP$$CH-MACLEODS PHARMA-MAC2024047907$MACLEODS$Ballmer A, Loretz L, Henzen C, Ulmer T, Van Veelen N..Small tablet, large effect: Statin-induced rhabdomyolysis.Swiss Medical Weekly.2024;154(Supplement 276):40S$48$YR$A$M$Y$$$20240703$$MD$CH$CH
240449131$24044913$1$I$$20240621$20240703$20240703$EXP$$EG-MACLEODS PHARMA-MAC2024047912$MACLEODS$Hussien R.Tramadol Intoxication in an 8-Months-Old Infant through Breastfeeding: A Case ReportJournal of Clinical Toxicology .Journal of Clinical Toxicology .2017;7(1):1-3$$$$$Y$$$20240703$$HP$EG$EG
240449141$24044914$1$I$$20240621$20240703$20240703$EXP$$CA-MACLEODS PHARMA-MAC2024047909$MACLEODS$Mijovic H, Grant C, Couturier J..Severe bradycardia following initiation of low-dose olanzapine in a patient with anorexia nervosa. Paediatrics and Child Health..Paediatrics and Child Health.2016;21(5):e60$$$$$Y$$$20240703$$MD$CA$CA
240449151$24044915$1$I$$20240621$20240703$20240703$EXP$$GB-MACLEODS PHARMA-MAC2024047924$MACLEODS$$$$$M$Y$$$20240703$$CN$GB$GB
240449161$24044916$1$I$20240622$20240622$20240703$20240703$EXP$GB-MHRA-MED-202406221105535250-JMHBS$GB-MACLEODS PHARMA-MAC2024047946$MACLEODS$$$$$$Y$$$20240703$$CN$GB$GB
240449171$24044917$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105901$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$92.08$KG$20240703$$CN$US$US
240449192$24044919$2$F$$20240702$20240703$20240705$PER$$US-TAKEDA-2024TUS066311$TAKEDA$$$$$F$Y$$$20240705$$CN$US$US
240449201$24044920$1$I$$20240620$20240703$20240703$EXP$$ZA-MACLEODS PHARMA-MAC2024047962$MACLEODS$$$$$$Y$$$20240703$$CN$ZA$ZA
240449212$24044921$2$F$20240625$20240710$20240703$20240715$PER$$US-AMGEN-USASP2024130526$AMGEN$$75$YR$E$M$Y$$$20240714$$CN$US$US
240449221$24044922$1$I$$20231206$20240703$20240703$PER$$US-AMGEN-USASP2023235451$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240449231$24044923$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129179$AMGEN$$$$$M$Y$$$20240703$$CN$US$US
240449241$24044924$1$I$$20240625$20240703$20240703$PER$$US-ROCHE-10000014698$ROCHE$$$$$$Y$$$20240703$$CN$US$US
240449251$24044925$1$I$$20240628$20240703$20240703$EXP$$CA-ABBVIE-5821763$ABBVIE$$$$A$M$Y$$$20240703$$MD$CA$CA
240449264$24044926$4$F$20190101$20240802$20240703$20240806$PER$$US-AMGEN-USASP2024130337$AMGEN$$55$YR$A$F$Y$$$20240806$$MD$US$US
240449281$24044928$1$I$$20240624$20240703$20240703$EXP$$US-JNJFOC-20240672651$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$CN$US$US
240449291$24044929$1$I$20230707$20230726$20240703$20240703$PER$$US-CPL-003572$CADILA$$78$YR$E$F$Y$$$20240703$$CN$US$US
240449301$24044930$1$I$$20240702$20240703$20240703$EXP$$AT-ABBVIE-5823714$ABBVIE$$29$YR$$M$Y$$$20240703$$CN$AT$AT
240449311$24044931$1$I$$20240624$20240703$20240703$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010057$JAZZ$$60$YR$$M$Y$$$20240703$$MD$JP$JP
240449322$24044932$2$F$20240101$20240704$20240703$20240708$EXP$$GB-UCBSA-2024033302$UCB$$$$$F$Y$$$20240708$$CN$GB$GB
240449331$24044933$1$I$$20240624$20240703$20240703$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP007852$STRIDES$Mimura Y, Kojima K, Fujikawa A, Okada S, Fujimori A, Kuma A, et al.. A case of TAFRO syndrome after vaccination, successfully treated with cyclosporine.. BMC-Nephrol. 2024;25 (1):1-12$$$$F$Y$$$20240703$$HP$JP$JP
240449351$24044935$1$I$20240605$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46376$$FDA-CTU$$39$YR$$M$N$$$20240702$Y$PH$US$
240449361$24044936$1$I$20240621$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46390$$FDA-CTU$$66$YR$$F$N$$$20240702$Y$PH$US$
240449381$24044938$1$I$20240428$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46316$$FDA-CTU$$80$YR$$F$N$$$20240702$Y$$US$
240449391$24044939$1$I$20240625$20240625$20240703$20240703$PER$$US-ABBVIE-5821613$ABBVIE$$39$YR$$F$Y$$$20240703$$CN$US$US
240449401$24044940$1$I$$20240626$20240703$20240703$EXP$$IL-MYLANLABS-2024M1061594$MYLAN$Levy DM, Arush OB, Carmi L, Wetzler AJ, Zohar J. Off-label higher doses of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Safety and tolerability. Compr-Psychiatry 2024; 133 1-6.$$$A$$Y$$$20240703$$HP$IL$IL
240449411$24044941$1$I$$20240626$20240703$20240703$EXP$$TR-MYLANLABS-2024M1061597$MYLAN$Gungor ES, Durmaz O. A case of psoriasis following clozapine treatment: Considerations for immunopsychiatry. Indian-J-Psychiatry 2024; 66 (4): 407-408.$47$YR$$F$Y$$$20240703$$HP$TR$TR
240449421$24044942$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46334$$FDA-CTU$$77$YR$$F$N$60.33$KG$20240702$N$HP$US$
240449431$24044943$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46300$$FDA-CTU$$57$YR$$M$N$$$20240702$N$HP$US$
240449441$24044944$1$I$$20240626$20240703$20240703$EXP$$IT-MYLANLABS-2024M1061596$MYLAN$Megna M, De Lucia M, Fornaro L, Tommasino N, Castiglione F, Cacciapuoti S, et al. Asymptomatic microscopic colitis induced by secukinumab. JAAD-Case-Rep 2024; 48 11-13.$58$YR$$M$Y$$$20240703$$MD$IT$IT
240449461$24044946$1$I$$20240626$20240703$20240703$EXP$$GB-MYLANLABS-2024M1061893$MYLAN$Abada M. Conversion disorder after general anaesthesia for cystoscopy: A case report. Saudi-J-Anaesth 2024; 18 (3): 445-446.$62$YR$$F$Y$$$20240703$$HP$GB$GB
240449472$24044947$2$F$$20240714$20240703$20240723$EXP$$US-ASPIRO-ASP2024US02046$ASPIRO PHARMA$Tan EF, Pokhriyal SC, Khan AA, Pasha M, Idris H. Assay Interference Causing Persistently Elevated Vancomycin Levels Ultimately Leading to Treatment Failure and Fatal Outcome. InA52. CASE REPORTS IN DRUG-INDUCED LUNG DISEASE. 2024;209:A5673$69$YR$$F$Y$170$KG$20240723$$HP$US$US
240449481$24044948$1$I$$20240624$20240703$20240703$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP007828$STRIDES$Arakawa N, Shiota Y, Onizawa F, Miyata F, Miyoshi A, Akaba T, et al.. Autoimmune pulmonary alveolar proteinosis during the treatment of nonspecific interstitial pneumonia complicated by clinically amyopathic dermatomyositis: A case report.. Respirol-Case-Rep. 2024;12 (6):1-4$46$YR$$M$Y$$$20240703$$HP$JP$JP
240449491$24044949$1$I$$20240205$20240703$20240703$PER$$US-AMGEN-USASP2024130160$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240449501$24044950$1$I$$20230823$20240703$20240703$PER$$US-AMGEN-USASP2023235060$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240449513$24044951$3$F$$20240912$20240703$20240920$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001051$AKEBIA THERAPEUTICS$Shinnosuke Fukushima (Okayama University Graduate School of Medicine (Department of General Medicine)) et al.. Calcium polystyrene sulfonate-induced rectal ulcer causing E. coli native-valve infective endocarditis. Clinical Journal of Gastroenterology. 2024;17:472-476$66$YR$$M$Y$$$20240920$$MD$JP$JP
240449521$24044952$1$I$$20240530$20240703$20240703$PER$$US-AMGEN-USASP2024130415$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240449531$24044953$1$I$20240601$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130594$AMGEN$$59$YR$A$M$Y$$$20240703$$CN$US$US
240449541$24044954$1$I$$20240619$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05784$HIKMA$Lin C, Cavanaugh N, Subramani S, Singhal A, Hanada S.. Lin C, Cavanaugh N, Subramani S, Singhal A, Hanada S. Interpretation of chest fluoroscopy: the risk of misdiagnosing atelectasis as pneumothorax due to greyscale inversion.. Anaesthesia Reports.. 2024;12(1):e12307$52$YR$$M$Y$112$KG$20240703$$MD$US$US
240449551$24044955$1$I$$20240701$20240703$20240703$EXP$$US-UCBSA-2024033349$UCB$$$$$F$Y$$$20240703$$CN$US$US
240449561$24044956$1$I$$20240619$20240703$20240703$EXP$$PH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454826$RANBAXY$Batara JMF, Apor ADAO, Mojica CV, Mondia MWL. Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: A retrospective analysis. Neurooncol Adv. 2022;4(1):1-9$70$YR$$M$Y$$$20240703$$HP$PH$PH
240449571$24044957$1$I$$20240619$20240703$20240703$EXP$$PH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454821$RANBAXY$Batara JMF, Apor ADAO, Mojica CV, Mondia MWL. Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: A retrospective analysis. Neurooncol Adv. 2022;4(1):1-9$32$YR$$M$Y$$$20240703$$HP$PH$PH
240449581$24044958$1$I$$20240619$20240703$20240703$EXP$$PH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454771$RANBAXY$Batara JMF, Apor ADAO, Mojica CV, Mondia MWL. Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: A retrospective analysis. Neurooncol Adv. 2022;4(1):1-9$40$YR$$M$Y$$$20240703$$HP$PH$PH
240449591$24044959$1$I$$20240619$20240703$20240703$EXP$$PH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454823$RANBAXY$Batara JMF, Apor ADAO, Mojica CV, Mondia MWL. Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: A retrospective analysis. Neurooncol Adv. 2022;4(1):1-9$64$YR$$M$Y$$$20240703$$HP$PH$PH
240449601$24044960$1$I$$20240619$20240703$20240703$EXP$$PH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454825$RANBAXY$Batara JMF, Apor ADAO, Mojica CV, Mondia MWL. Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: A retrospective analysis. Neurooncol Adv. 2022;4(1):1-9$65$YR$$M$Y$$$20240703$$HP$PH$PH
240449611$24044961$1$I$$20240619$20240703$20240703$EXP$$PH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454818$RANBAXY$Batara JMF, Apor ADAO, Mojica CV, Mondia MWL. Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: A retrospective analysis. Neurooncol Adv. 2022;4(1):1-9$71$YR$$M$Y$$$20240703$$HP$PH$PH
240449621$24044962$1$I$$20240626$20240703$20240703$EXP$$US-SA-2024SA193065$SANOFI AVENTIS$$2$YR$C$M$Y$13$KG$20240703$$MD$US$US
240449632$24044963$2$F$20210705$20240830$20240703$20240903$PER$$US-GILEAD-2024-0679390$GILEAD$$44$YR$A$M$Y$$$20240903$$LW$US$US
240449641$24044964$1$I$20240628$20240628$20240703$20240703$EXP$$US-GILEAD-2024-0679078$GILEAD$$42$YR$A$F$Y$$$20240703$$CN$US$US
240449652$24044965$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3214027$TEVA$Ghabra S, Desale S, Sugarbaker PH. Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years. Dis-Colon-Rectum 2023; 66 (10): 1329-1338.; Ghabra S, Desale S, Sugarbaker PH. Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years. Dis-Colon-Rectum 2023; 66 (10): 1329-1338.; Ghabra S, Desale S, Sugarbaker PH. Clinical and Histopathologic Features of 35 Patients Treated for...$54$YR$$M$Y$$$20240717$$MD$US$US
240449661$24044966$1$I$20240515$20240624$20240703$20240703$EXP$$JP-ROCHE-10000007015$ROCHE$$8$DEC$E$M$Y$50.2$KG$20240703$$PH$JP$JP
240449672$24044967$2$F$$20240806$20240703$20240813$EXP$$IN-VANTIVE-2024VAN018068$Vantive US Healthcare$$70$YR$$M$Y$$$20240813$$CN$IN$IN
240449692$24044969$2$F$$20240712$20240703$20240722$EXP$$IN-VANTIVE-2024VAN018054$Vantive US Healthcare$$55$YR$$M$Y$$$20240722$$CN$IN$IN
240449701$24044970$1$I$$20240627$20240703$20240703$EXP$$CL-VANTIVE-2024VAN016999$Vantive US Healthcare$$82$YR$$M$Y$$$20240703$$HP$CL$CL
240449712$24044971$2$F$20240217$20240228$20240703$20240703$PER$$US-CPL-004024$CADILA$$$$$F$Y$$$20240703$$CN$US$US
240449723$24044972$3$F$20231101$20231121$20240703$20240703$PER$$US-CPL-003831$CADILA$$82$YR$E$F$Y$$$20240703$$CN$US$US
240449731$24044973$1$I$20240101$20240626$20240703$20240703$EXP$$CN-JNJFOC-20240673900$JOHNSON AND JOHNSON$$73$YR$E$F$Y$45$KG$20240703$$HP$CN$CN
240449741$24044974$1$I$$20240624$20240703$20240703$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP007832$STRIDES$Oguni K, Fukushima S, Otsuka Y, Soejima Y, Kawaguchi M, Sazumi Y, et al.. Disseminated septic arthritis caused by Ureaplasma urealyticum in an immunocompromised patient with hypogammaglobulinemia after rituximab therapy.. Infection. 2024;52 (3)$23$YR$$F$Y$$$20240703$$HP$JP$JP
240449753$24044975$3$F$20240611$20240806$20240703$20240812$30DAY$$US-JNJFOC-20240664586$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20240812$$CN$US$US
240449763$24044976$3$F$$20240714$20240703$20240727$EXP$$US-Axellia-005256$XELLIA PHARMACEUTICALS$Pokhriyal SC, Tan EF, Bhatt PK, Khan AA, Pasha MN, Pierre L et al. Assay Interference Causing Persistently Elevated Vancomycin Levels Leading to Treatment Failure and Fatal Outcome. Cureus. 2024;16(6):e61943$69$YR$E$F$Y$150.59$KG$20240727$$MD$US$US
240449771$24044977$1$I$$20240619$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05836$HIKMA$Lavin L, Chefitz G, Patel D, Baek WK, Khattri S.. Lavin L, Chefitz G, Patel D, Baek WK, Khattri S. Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect.. JAAD Case Reports. 2024;49:40-44$$$$F$Y$$$20240703$$MD$US$US
240449784$24044978$4$F$20240529$20240924$20240703$20240927$EXP$$AR-MYLANLABS-2024M1050240$MYLAN$$35$YR$$F$Y$$$20240927$$CN$AR$AR
240449801$24044980$1$I$$20240620$20240703$20240703$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05684$LUPIN$Ampaw NA, Saad eldin M, Zhang R. A fatal case of cerebral herniation due to elevated ICP in a relapsed case of Cryptococal meningitis. American Journal of Respiratory and Critical Care Medicine. 2024;209$34$YR$$M$Y$$$20240703$$HP$US$US
240449812$24044981$2$F$$20240626$20240703$20240708$EXP$IT-STRIDES ARCOLAB LIMITED-2024SP007838$IT-STRIDES ARCOLAB LIMITED-2024SP007838$STRIDES$Costantini I, Mantelli G, Carollo M, Losso L, Morando E, Bacchion M, et al.. Not only Van Gogh: a case of BRASH syndrome with concomitant digoxin toxicity.. Journal of Medical Case Reports. 2024;18 (1):273.$66$YR$$F$Y$$$20240708$$MD$IT$IT
240449821$24044982$1$I$$20240701$20240703$20240703$EXP$$US-ABBVIE-5823750$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240449831$24044983$1$I$$20240624$20240703$20240703$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP007839$STRIDES$Zhang X, Xu L, Pan E, Sun X, Ding X.. Partial remission with sintilimab monotherapy in a patient carrying a CD274 amplification in refractory diffuse large B-cell lymphoma: A case report.. Oncol-Lett. 2024;27 (6)$60$YR$$M$Y$$$20240703$$MD$CN$CN
240449841$24044984$1$I$$20240625$20240703$20240703$PER$$US-AstraZeneca-2024A146812$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240449852$24044985$2$F$20240625$20240821$20240703$20240829$EXP$$US-AstraZeneca-2024A146941$ASTRAZENECA$$29044$DY$$F$Y$$$20240829$$CN$US$
240449861$24044986$1$I$$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024128742$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240449881$24044988$1$I$$20240628$20240703$20240703$EXP$$US-SA-2024SA194620$SANOFI AVENTIS$$$$E$F$Y$$$20240703$$MD$US$US
240449892$24044989$2$F$$20240624$20240703$20240705$PER$$US-ROCHE-10000011113$ROCHE$$$$$F$Y$$$20240705$$HP$US$US
240449901$24044990$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406291352445690-FRSGZ$GB-ORGANON-O2407GBR000129$ORGANON$$$$$M$Y$$$20240703$$CN$GB$GB
240449911$24044991$1$I$$20240625$20240703$20240703$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004791$BIOCON$$$$$$Y$$$20240703$$HP$CA$CA
240449921$24044992$1$I$$20240624$20240703$20240703$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007802$STRIDES$Alexander G, Moore SA, Lenert PS.. Eosinophilic granulomatosis with polyangiitis and its association with montelukast: a case-based review. [Review].. Clin-Rheumatol. 2024;43 (6):2153-2165$21$YR$$M$Y$$$20240703$$HP$US$US
240449931$24044993$1$I$$20240607$20240703$20240703$PER$$US-LEX-000332$LEXICON PHARMACEUTICALS$$62$YR$$M$Y$$$20240703$$CN$US$US
240449942$24044994$2$F$20240425$20240726$20240703$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106033$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240730$$HP$US$US
240449952$24044995$2$F$$20240903$20240703$20240906$EXP$$JP-VIATRISJAPAN-2024M1058605AA$MYLAN$Kanno T, Yukawa T, Otsubo S, Yamagiwa T. A case of Kounis syndrome with midventricular obstructive hypertrophic cardiomyopathy with apical aneurysm. Journal of Japanese Association for Acute Medicine. 2024;35(6):216-221$45$YR$$F$Y$$$20240906$$MD$JP$JP
240449962$24044996$2$F$20240601$20240703$20240703$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106003$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240704$$PH$US$US
240449971$24044997$1$I$20240618$20240627$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104024$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240703$$CN$US$US
240449981$24044998$1$I$$20240624$20240703$20240703$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007789$STRIDES$Alexander G, Moore SA, Lenert PS.. Eosinophilic granulomatosis with polyangiitis and its association with montelukast: a case-based review. [Review].. Clin-Rheumatol. 2024;43 (6):2153-2165$44$YR$$F$Y$$$20240703$$HP$US$US
240449991$24044999$1$I$$20240622$20240703$20240703$EXP$GB-MHRA-MED-202406211602178080-BSMDG$GB-MSNLABS-2024MSNSPO01446$MSN LABORATORIES$$$$$$Y$$$20240703$$HP$GB$GB
240450001$24045000$1$I$20230301$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031730$AUROBINDO$$42$YR$$M$Y$$$20240703$$MD$FR$FR
240450011$24045001$1$I$$20240625$20240703$20240703$PER$$US-ROCHE-10000013239$ROCHE$$80$YR$E$F$Y$$$20240703$$CN$US$US
240450031$24045003$1$I$20240519$20240624$20240703$20240703$EXP$ES-AEMPS-1538969$ES-Accord-432641$ACCORD$$$$E$M$Y$$$20240703$$HP$ES$ES
240450041$24045004$1$I$$20240622$20240703$20240703$EXP$AU-TGA-800850$AU-Accord-431858$ACCORD$$72$YR$$F$Y$$$20240703$$HP$AU$AU
240450052$24045005$2$F$20240627$20240806$20240703$20240808$PER$$US-AMGEN-USASP2024129632$AMGEN$$77$YR$E$M$Y$$$20240808$$CN$US$US
240450061$24045006$1$I$$20240622$20240703$20240703$EXP$AU-TGA-799616$AU-Accord-431882$ACCORD$$70$YR$E$F$Y$$$20240703$$HP$AU$AU
240450071$24045007$1$I$20240329$20240404$20240703$20240703$PER$$US-CPL-004143$CADILA$$76$YR$E$F$Y$$$20240703$$CN$US$US
240450081$24045008$1$I$$20240623$20240703$20240703$EXP$GB-MHRA-MED-202406230715043650-LSZJH$GB-Accord-432070$ACCORD$$$$$F$Y$60$KG$20240703$$CN$GB$GB
240450091$24045009$1$I$$20230901$20240703$20240703$PER$$US-AMGEN-USASP2023235447$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240450101$24045010$1$I$$20240205$20240703$20240703$PER$$US-AMGEN-USASP2024129851$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240450111$24045011$1$I$$20240206$20240703$20240703$PER$$US-AMGEN-USASP2024129110$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240450121$24045012$1$I$$20230530$20240703$20240703$PER$$US-AMGEN-USASP2023235052$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240450131$24045013$1$I$$20240701$20240703$20240703$EXP$$US-ABBVIE-5823318$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240450141$24045014$1$I$$20240624$20240703$20240703$EXP$CN-MLMSERVICE-20240617-PI101855-00050-1$CN-STRIDES ARCOLAB LIMITED-2024SP007757$STRIDES$Lei M, Cao Y, Yuan M, Xiong J, He H.. Case report: A case of bradycardia triggered by diarrhea.. Frontiers in medicine.. 2024;11:1405494$92$YR$$M$Y$$$20240703$$MD$CN$CN
240450151$24045015$1$I$$20240625$20240703$20240703$EXP$$IL-STRIDES ARCOLAB LIMITED-2024SP007811$STRIDES$Rahamimov R, Telem S, Davidovichi B, Bielopolski D, Steinmetz T, Nesher E, et al.. The association between hydrochlorothiazide use and non-melanoma skin cancer in kidney transplant recipients.  ;. Clin-Kidney-J. 2024;17 (5)$$$A$$Y$$$20240703$$HP$IL$IL
240450161$24045016$1$I$20240604$20240625$20240703$20240703$EXP$$TW-JNJFOC-20240665742$JOHNSON AND JOHNSON$$47$YR$A$F$Y$58$KG$20240703$$CN$TW$TW
240450171$24045017$1$I$20230721$20240626$20240703$20240703$EXP$$TW-AMGEN-TWNSP2024127182$AMGEN$Liu Y.; Chen Y.;  Chang C. et al.. Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with Pemigatinib- A case report and review of the literature. Neuro-Oncology Advances. 2024;6 (1):1-6$53$YR$A$M$Y$$$20240703$$MD$TW$TW
240450181$24045018$1$I$$20240613$20240703$20240703$EXP$$US-ROCHE-10000003695$ROCHE$$29$YR$A$M$Y$$$20240703$$CN$US$US
240450191$24045019$1$I$$20240627$20240703$20240703$EXP$$US-MYLANLABS-2024M1061435$MYLAN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.$68$YR$$M$Y$$$20240703$$HP$US$US
240450201$24045020$1$I$$20240627$20240703$20240703$EXP$$US-MYLANLABS-2024M1061540$MYLAN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.$26$YR$$M$Y$$$20240703$$HP$US$US
240450213$24045021$3$F$20231209$20240815$20240703$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-031661$AUROBINDO$$73$YR$$F$Y$$$20240828$$HP$GB$GB
240450221$24045022$1$I$$20240627$20240703$20240703$EXP$$US-MYLANLABS-2024M1061473$MYLAN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.$59$YR$$F$Y$$$20240703$$HP$US$US
240450231$24045023$1$I$$20240627$20240703$20240703$EXP$$US-MYLANLABS-2024M1061426$MYLAN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.$72$YR$$F$Y$$$20240703$$HP$US$US
240450241$24045024$1$I$$20240625$20240703$20240703$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP007823$STRIDES$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al.. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome.. J-Clin-Immunol. 2023;43 (3):647-652$4$YR$$F$Y$$$20240703$$HP$FR$FR
240450252$24045025$2$F$20240601$20240705$20240703$20240710$EXP$$PT-GILEAD-2024-0678998$GILEAD$$52$YR$A$F$Y$$$20240710$$MD$PT$PT
240450261$24045026$1$I$$20240625$20240703$20240703$EXP$$US-AMGEN-USASP2024127103$AMGEN$Kingsmore K.M.; Zent J.; Lipsky P.E.. Clinical management of lupus in the United States: A claims-based analysis. Seminars in Arthritis and Rheumatism. 2024;68:1-15$$$$$Y$$$20240703$$HP$US$US
240450271$24045027$1$I$$20240628$20240703$20240703$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2024081082$VIIV$$$$$$Y$$$20240703$$CN$CA$CA
240450281$24045028$1$I$$20240624$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-032879$AUROBINDO$$81$YR$$M$Y$$$20240703$$MD$US$US
240450291$24045029$1$I$$20240625$20240703$20240703$PER$$US-LNK INTERNATIONAL, INC.-2158779$LNK INTERNATIONAL$$$$$F$Y$$$20240703$$$US$US
240450301$24045030$1$I$$20240625$20240703$20240703$EXP$$US-KOANAAP-SML-US-2024-00614$Unknown Manufacturer$Belani N, Liang K, Judd J, Borghaei H. How to Treat EGFR-Mutated Non-Small Cell Lung Cancer. JACC: CardioOncology. 2023 Apr 10;5(4): 542-545. doi:10.1016/j.jaccao.2023.04.005.$6$DEC$A$F$Y$$$20240703$$MD$US$US
240450311$24045031$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46335$$FDA-CTU$$85$YR$$F$N$$$20240702$N$$US$
240450321$24045032$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46302$$FDA-CTU$$68$YR$$F$N$73.48$KG$20240702$N$$US$
240450342$24045034$2$F$$20240705$20240703$20240709$PER$$US-HALEON-2184346$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240450351$24045035$1$I$$20221219$20240703$20240703$PER$$US-AMGEN-USASP2022230357$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240450361$24045036$1$I$$20230918$20240703$20240703$PER$$US-AMGEN-USASP2023235418$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240450371$24045037$1$I$$20240701$20240703$20240703$EXP$$GB-Karo Pharma-2158785$Karo Pharma$$32$YR$$F$Y$155$KG$20240703$$$GB$GB
240450381$24045038$1$I$$20240223$20240703$20240703$PER$$US-Stallergenes SAS-2158776$STALLERGENES$$10$YR$$M$Y$$$20240703$$$US$US
240450391$24045039$1$I$$20240628$20240703$20240703$PER$$US-Mission Pharmacal Company-2158790$MISSION$$88$YR$$M$Y$$$20240703$$$US$US
240450401$24045040$1$I$$20240702$20240703$20240703$PER$$US-Mission Pharmacal Company-2158791$MISSION$$63$YR$$M$Y$$$20240703$$$US$US
240450411$24045041$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106198$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240703$$CN$US$US
240450421$24045042$1$I$$20240627$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105747$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240703$$CN$US$US
240450442$24045044$2$F$19980101$20240704$20240703$20240711$EXP$$JP-TEVA-VS-3215487$TEVA$$84$YR$$M$Y$$$20240711$$PH$JP$JP
240450451$24045045$1$I$$20240626$20240703$20240703$PER$$US-ABBVIE-5819862$ABBVIE$$$$$F$Y$86$KG$20240703$$CN$US$US
240450461$24045046$1$I$$20240620$20240703$20240703$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2158788$BRECKENRIDGE$$$$$F$Y$$$20240703$$$ES$A1
240450471$24045047$1$I$$20240627$20240703$20240703$EXP$$US-MYLANLABS-2024M1061469$MYLAN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.$67$YR$$M$Y$$$20240703$$HP$US$US
240450481$24045048$1$I$$20240620$20240703$20240703$EXP$$CN-Caplin Steriles Limited-2158800$CAPLIN POINT LABORATORIES$Wu W, Xia C, Gan L, Liao S and Yan Y (2024)?Etomidate-induced hypokalemia in electronic?cigarette users: two case reports and?literature review.?Front. Endocrinol. 15:1321610.?doi: 10.3389/fendo.2024.1321610$32$YR$$M$Y$$$20240703$$$CN$CN
240450491$24045049$1$I$20220401$20240614$20240703$20240703$EXP$$FR-Provepharm-2158778$PROVEPHARM$$50$YR$$F$Y$$$20240703$$MD$FR$FR
240450501$24045050$1$I$$20240621$20240703$20240703$PER$$US-Mission Pharmacal Company-2158771$MISSION$$57$YR$$F$Y$$$20240703$$$US$US
240450511$24045051$1$I$20240618$20240624$20240703$20240703$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158795$JIANGSU HENGRUI MEDICINE$$54$YR$$M$Y$$$20240703$$MD$CN$CN
240450521$24045052$1$I$20240511$20240625$20240703$20240703$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158796$JIANGSU HENGRUI MEDICINE$$45$YR$$F$Y$54$KG$20240703$$MD$CN$CN
240450531$24045053$1$I$$20240619$20240703$20240703$EXP$$US-SIGA Technologies, Inc.-2158777$SIGA TECHNOLOGIES$publication$33$YR$$M$Y$$$20240703$$MD$US$US
240450541$24045054$1$I$$20240702$20240703$20240703$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037565$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240703$$MD$DE$DE
240450553$24045055$3$F$$20240717$20240703$20240730$30DAY$$GB-JNJFOC-20240702953$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240730$$CN$GB$GB
240450561$24045056$1$I$20240609$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031749$AUROBINDO$$77$YR$$F$Y$69$KG$20240703$$MD$FR$FR
240450571$24045057$1$I$20240616$20240703$20240703$20240703$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2158462$JIANGSU HANSOH PHARMACEUTICAL$$75$YR$$M$Y$60$KG$20240703$$MD$CN$CN
240450581$24045058$1$I$$20240623$20240703$20240703$EXP$$IN-Oxford Pharmaceuticals, LLC-2158799$OXFORD PHARMACEUTICALS$Source document$25$YR$$M$Y$$$20240703$$MD$IN$IN
240450591$24045059$1$I$$20240620$20240703$20240703$EXP$$CN-Caplin Steriles Limited-2158798$CAPLIN POINT LABORATORIES$Wu W, Xia C, Gan L, Liao S and Yan Y (2024)?Etomidate-induced hypokalemia in electronic?cigarette users: two case reports and?literature review.?Front. Endocrinol. 15:1321610.?doi: 10.3389/fendo.2024.1321610$29$YR$$M$Y$$$20240703$$$CN$CN
240450602$24045060$2$F$20210225$20240830$20240703$20240902$PER$$US-GILEAD-2024-0679391$GILEAD$$39$YR$A$F$Y$$$20240902$$LW$US$US
240450612$24045061$2$F$$20240708$20240703$20240718$EXP$$NL-TEVA-VS-3215042$TEVA$Van Der Meer PB, Dirven L, Fiocco M, Vos MJ, Kouwenhoven MCM, Van Den Bent MJ, et al. Effectiveness of Antiseizure Medication Triple Therapy in Patients with Glioma with Refractory Epilepsy: An Observational Cohort Study. Neurology 2023; 100 (14): E1488-E1496.; Van Der Meer PB, Dirven L, Fiocco M, Vos MJ, Kouwenhoven MCM, Van Den Bent MJ, et al. Effectiveness of Antiseizure Medication Triple Therapy in Patients with Glioma with Refractory Epilepsy: An Observational Cohort Study. Neurology 202...$$$$$Y$$$20240718$$MD$NL$NL
240450621$24045062$1$I$$20240619$20240703$20240703$EXP$$US-Breckenridge Pharmaceutical, Inc.-2158792$BRECKENRIDGE$Literature Article$66$YR$$M$Y$$$20240703$$$IN$US
240450631$24045063$1$I$20240613$20240614$20240703$20240703$PER$$US-Kindeva Drug Delivery L.P.-2158802$KINDEVA DRUG DELIVERY$$77$YR$$F$Y$$$20240703$$$US$US
240450641$24045064$1$I$$20240621$20240703$20240703$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2158789$BRECKENRIDGE$$$$$M$Y$$$20240703$$$ES$A1
240450651$24045065$1$I$$20240621$20240703$20240703$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2158786$BRECKENRIDGE$$$$$$Y$$$20240703$$$ES$A1
240450661$24045066$1$I$$20240625$20240703$20240703$EXP$$US-VIIV HEALTHCARE LIMITED-US2024079128$VIIV$$$$$F$Y$$$20240703$$HP$US$US
240450671$24045067$1$I$$20240625$20240703$20240703$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001310$BLUEPRINT MEDICINES$$$$$F$Y$$$20240703$$CN$US$US
240450691$24045069$1$I$20240501$20240627$20240703$20240703$EXP$$CA-Orion Corporation ORION PHARMA-24_00030595$ORION$$67$YR$E$M$Y$$$20240703$$HP$CA$
240450701$24045070$1$I$$20240618$20240703$20240703$EXP$$US-WES Pharma Inc-2158770$WES PHARMA$Source document (Full text)$29$YR$$M$Y$$$20240703$$$US$US
240450712$24045071$2$F$$20240904$20240703$20240913$EXP$$AU-ROCHE-10000012530$ROCHE$$48$YR$A$M$Y$$$20240913$$CN$AU$AU
240450731$24045073$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106209$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$106.59$KG$20240703$$CN$US$US
240450741$24045074$1$I$$20240702$20240703$20240703$PER$$US-HALEON-2185010$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240450751$24045075$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105981$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240703$$MD$US$US
240450761$24045076$1$I$$20240701$20240703$20240703$PER$$US-ABBVIE-5824587$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240450771$24045077$1$I$20230607$20240621$20240703$20240703$EXP$$US-COOPERSURGICAL, INC.-2024CPS001973$COOPERSURGICAL$$$$$F$Y$$$20240703$$LW$US$US
240450781$24045078$1$I$20210915$20240620$20240703$20240703$EXP$$US-COOPERSURGICAL, INC.-2024CPS001979$COOPERSURGICAL$$31$YR$$F$Y$57.143$KG$20240703$$LW$US$US
240450791$24045079$1$I$20230201$20240627$20240703$20240703$EXP$$HN-MYLANLABS-2024M1061276$MYLAN$$54$YR$$M$Y$71.21$KG$20240703$$CN$HN$HN
240450801$24045080$1$I$$20240627$20240703$20240703$EXP$$DE-MYLANLABS-2024M1060908$MYLAN$$$$$F$Y$$$20240703$$MD$DE$DE
240450821$24045082$1$I$20240619$20240628$20240703$20240703$EXP$$CN-ABBVIE-5822981$ABBVIE$$70$YR$$F$Y$$$20240703$$HP$CN$CN
240450831$24045083$1$I$20240530$20240621$20240703$20240703$PER$$US-JNJFOC-20240658457$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240703$$MD$US$US
240450841$24045084$1$I$$20240628$20240703$20240703$EXP$$US-JNJFOC-20240700430$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$HP$US$US
240450851$24045085$1$I$$20231114$20240703$20240703$PER$$US-AMGEN-USASP2023235428$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240450861$24045086$1$I$20240409$20240625$20240703$20240703$EXP$$CL-AstraZeneca-2024A150331$ASTRAZENECA$$63$YR$$F$Y$74$KG$20240703$$CN$CL$
240450871$24045087$1$I$20240624$20240625$20240703$20240703$EXP$$GB-AUROBINDO-AUR-APL-2024-031656$AUROBINDO$$73$YR$$F$Y$75$KG$20240703$$MD$GB$GB
240450881$24045088$1$I$20240612$20240618$20240703$20240703$EXP$$US-ACORDA-ACO_177412_2024$ACORDA$$76$YR$$M$Y$$$20240703$$CN$US$US
240450891$24045089$1$I$$20230928$20240703$20240703$PER$$US-AMGEN-USASP2023235293$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240450902$24045090$2$F$20230210$20240903$20240703$20240904$PER$$US-GILEAD-2024-0679349$GILEAD$$51$YR$A$M$Y$$$20240904$$LW$US$US
240450911$24045091$1$I$$20240624$20240703$20240703$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108913$ZYDUS PHARM$Lam E, Santos C, Patrawalla AS.. A Case of critical bupropion, olanzapine, and oxcarbazepine overdose.. Am-J-Respir-Crit-Care-Med. 2024;209 abstr. A5651$$$$$Y$$$20240703$$HP$US$US
240450921$24045092$1$I$20240621$20240628$20240703$20240703$EXP$$US-UCBSA-2024033303$UCB$$51$YR$$F$Y$$$20240703$$CN$US$US
240450931$24045093$1$I$20240626$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024129367$AMGEN$$$$A$M$Y$$$20240703$$CN$US$US
240450942$24045094$2$F$20230101$20240826$20240703$20240903$EXP$$US-AMGEN-USASP2024127612$AMGEN$$62$YR$A$M$Y$$$20240903$$LW$US$US
240450951$24045095$1$I$$20231114$20240703$20240703$PER$$US-AMGEN-USASP2023235398$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240450961$24045096$1$I$$20231013$20240703$20240703$PER$$US-AMGEN-USASP2023235431$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240450972$24045097$2$F$20240630$20240701$20240703$20240730$PER$$US-AMGEN-USASP2024130603$AMGEN$$63$YR$A$M$Y$$$20240729$$CN$US$US
240450981$24045098$1$I$$20231115$20240703$20240703$PER$$US-AMGEN-USASP2023235420$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240450991$24045099$1$I$$20240118$20240703$20240703$PER$$US-BAYER-2024A095441$BAYER$$$$$F$Y$$$20240703$$CN$US$US
240451002$24045100$2$F$20230701$20240726$20240703$20240805$EXP$$US-MYLANLABS-2024M1061289$MYLAN$$13$YR$$F$Y$$$20240805$$HP$US$US
240451011$24045101$1$I$20240701$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105565$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$54.88$KG$20240703$$CN$US$US
240451021$24045102$1$I$$20240628$20240703$20240703$EXP$$US-ABBVIE-5820927$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240451031$24045103$1$I$$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024128108$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240451044$24045104$4$F$$20240701$20240703$20240711$EXP$$US-GILEAD-2024-0679173$GILEAD$$68$YR$E$M$Y$$$20240711$$CN$US$US
240451052$24045105$2$F$20240701$20240805$20240703$20240806$PER$$US-JNJFOC-20240702469$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240806$$PH$US$US
240451062$24045106$2$F$20210310$20240705$20240703$20240711$EXP$$AR-MYLANLABS-2024M1061927$MYLAN$$13$YR$$M$Y$$$20240711$$CN$AR$AR
240451071$24045107$1$I$20240620$20240629$20240703$20240703$EXP$$US-MYLANLABS-2024M1061719$MYLAN$$64$YR$$F$Y$$$20240703$$PH$US$US
240451081$24045108$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46401$$FDA-CTU$$$$$$N$$$20240702$N$CN$US$
240451091$24045109$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46400$$FDA-CTU$$$$$$N$$$20240702$N$CN$US$
240451102$24045110$2$F$$20240702$20240703$20240705$30DAY$$US-GSK-US2024080223$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240451113$24045111$3$F$$20240819$20240703$20240829$30DAY$$US-GSK-US2024081136$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$HP$US$US
240451121$24045112$1$I$$20240628$20240703$20240703$EXP$$US-GSK-US2024AMR082125$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$HP$US$US
240451131$24045113$1$I$$20240627$20240703$20240703$EXP$$US-GSK-US2024AMR081445$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240451141$24045114$1$I$$20240702$20240703$20240703$EXP$$CA-PFIZER INC-202400205227$PFIZER$$42$YR$$F$Y$$$20240703$$HP$CA$CA
240451151$24045115$1$I$20220809$20240701$20240703$20240703$30DAY$$US-SANDOZ INC.-NVSC2022US182616$SANDOZ$$6$YR$$M$Y$$$20240703$$CN$US$US
240451161$24045116$1$I$20231101$20240627$20240703$20240703$EXP$$GB-SANDOZ INC.-SDZ2024GB062018$SANDOZ$$67$YR$$F$Y$$$20240703$$CN$GB$GB
240451171$24045117$1$I$20240225$20240624$20240703$20240703$EXP$FR-AFSSAPS-DJ2024000690$FR-009507513-2406FRA008390$MERCK$$67$YR$$F$Y$$$20240703$$MD$FR$FR
240451182$24045118$2$F$20240716$20240731$20240703$20240801$30DAY$$US-SANDOZ INC.-SDZ2024US062425$SANDOZ$$33$YR$$M$Y$$$20240801$$HP$US$US
240451191$24045119$1$I$$20240702$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2023US003693$SANDOZ$$$$$M$Y$$$20240703$$CN$US$US
240451211$24045121$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281419074630-BMTGL$GB-ORGANON-O2407GBR000115$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240451221$24045122$1$I$$20240628$20240703$20240703$EXP$$GR-MYLANLABS-2024M1061888$MYLAN$Fountoulaki M, Kapetanakis EI, Kouna N, Papagiannis N, Sidiropoulou T. Hemodynamic instability caused by pneumorrachis and pneumomediastinum following epidural analgesia: a case report. J-Med-Case-Rep 2024; 18 (1): 263.$78$YR$$M$Y$$$20240703$$HP$GR$GR
240451232$24045123$2$F$$20240625$20240703$20240712$PER$$US-TEVA-VS-3213101$TEVA$$$$$$Y$$$20240712$$CN$US$US
240451241$24045124$1$I$20240615$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031606$AUROBINDO$$83$YR$$F$Y$79$KG$20240703$$PH$FR$FR
240451251$24045125$1$I$20230101$20240625$20240703$20240703$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001311$BLUEPRINT MEDICINES$$66$YR$E$M$Y$$$20240703$$CN$US$US
240451262$24045126$2$F$$20240702$20240703$20240705$PER$$US-ROCHE-10000007908$ROCHE$$$$A$M$Y$$$20240705$$CN$US$US
240451273$24045127$3$F$20240621$20240715$20240703$20240722$EXP$$PL-GILEAD-2024-0678672$GILEAD$$50$YR$A$F$Y$$$20240722$$MD$PL$PL
240451281$24045128$1$I$20240525$20240621$20240703$20240703$EXP$$US-RIGEL-20240600082$RIGEL PHARMACEUTICALS$$78$YR$$F$Y$94.982$KG$20240703$$CN$US$US
240451291$24045129$1$I$$20240625$20240703$20240703$EXP$$US-ALXN-202406USA001622US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240703$$HP$US$US
240451301$24045130$1$I$$20240620$20240703$20240703$PER$$US-ALKERMES INC.-ALK-2024-001739$ALKERMES$$$$$F$Y$$$20240703$$CN$US$US
240451311$24045131$1$I$$20240315$20240703$20240703$PER$$US-BAYER-2024A095474$BAYER$$$$$F$Y$$$20240703$$CN$US$US
240451321$24045132$1$I$$20231220$20240703$20240703$PER$$US-AMGEN-USASP2023235373$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240451334$24045133$4$F$20240101$20240816$20240703$20240821$EXP$$US-Rigel Pharmaceuticals, Inc.-20240600063$RIGEL PHARMACEUTICALS$$$$$F$Y$119.29$KG$20240821$$MD$US$US
240451343$24045134$3$F$20240101$20240815$20240703$20240822$EXP$$US-RIGEL-20240600083$RIGEL PHARMACEUTICALS$$$$$M$Y$102.06$KG$20240822$$CN$US$US
240451351$24045135$1$I$$20231130$20240703$20240703$PER$$US-AMGEN-USASP2023235211$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240451361$24045136$1$I$20230101$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024129670$AMGEN$$$$$F$Y$$$20240703$$PH$US$US
240451371$24045137$1$I$$20240617$20240703$20240703$PER$$US-AMGEN-USASP2024123738$AMGEN$Modi P.; Falde S.; Specks U. et al.. Avacopan for Treatment of MPO-ANCA Associated Vasculitis Presenting as Diffuse Alveolar Hemorrhage and Glomerulonephritis. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A5782$69$YR$E$F$Y$$$20240703$$HP$US$US
240451381$24045138$1$I$$20240620$20240703$20240703$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091899$GLENMARK$$$$$$Y$$$20240703$$CN$US$US
240451392$24045139$2$F$20170206$20240913$20240703$20240917$PER$$US-GILEAD-2024-0679368$GILEAD$$58$YR$A$M$Y$$$20240917$$LW$US$US
240451401$24045140$1$I$$20240701$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037131$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240703$$MD$US$US
240451411$24045141$1$I$20240101$20240703$20240703$20240703$EXP$FR-AFSSAPS-NY2024000728$FR-JNJFOC-20240707613$JOHNSON AND JOHNSON$$45$YR$A$F$Y$52$KG$20240703$$MD$FR$FR
240451421$24045142$1$I$20230823$20240621$20240703$20240703$EXP$FR-AFSSAPS-MP2024000786$FR-BAYER-2024A089762$BAYER$$9$MON$I$M$Y$$$20240703$$MD$FR$FR
240451431$24045143$1$I$$20240624$20240703$20240703$EXP$$RU-ROCHE-10000010812$ROCHE$$66$YR$E$F$Y$$$20240703$$MD$RU$RU
240451441$24045144$1$I$20240626$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129199$AMGEN$$81$YR$E$F$Y$$$20240703$$CN$US$US
240451451$24045145$1$I$20240622$20240627$20240703$20240703$PER$$US-ABBVIE-5822490$ABBVIE$$42$YR$$F$Y$$$20240703$$MD$US$US
240451471$24045147$1$I$$20240702$20240703$20240703$EXP$$US-GILEAD-2024-0679350$GILEAD$$$$$$Y$$$20240703$$LW$US$US
240451481$24045148$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A147306$ASTRAZENECA$$$$$$Y$$$20240703$$CN$US$
240451491$24045149$1$I$20240611$20240625$20240703$20240703$EXP$$CN-AstraZeneca-2024A149236$ASTRAZENECA$$24044$DY$$F$Y$40$KG$20240703$$MD$CN$
240451502$24045150$2$F$20240619$20240703$20240703$20240711$EXP$$JP-AstraZeneca-2024A148737$ASTRAZENECA$$76$YR$$F$Y$$$20240711$$MD$JP$
240451511$24045151$1$I$20240602$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A150031$ASTRAZENECA$$25462$DY$$F$Y$$$20240703$$CN$US$
240451521$24045152$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A147011$ASTRAZENECA$$$$$$Y$$$20240703$$CN$US$
240451531$24045153$1$I$20240625$20240625$20240703$20240703$EXP$$GB-AstraZeneca-2024A146624$ASTRAZENECA$$79$YR$$F$Y$$$20240703$$MD$GB$
240451541$24045154$1$I$$20240625$20240703$20240703$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR080011$VIIV$$$$$$Y$$$20240703$$MD$US$US
240451551$24045155$1$I$20231018$20240625$20240703$20240703$EXP$$JP-ROCHE-3459992$ROCHE$$8$DEC$E$M$Y$43.7$KG$20240703$$MD$JP$JP
240451561$24045156$1$I$$20240625$20240703$20240703$30DAY$$US-GSK-US2024079209$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240451571$24045157$1$I$20240301$20240625$20240703$20240703$EXP$$US-GSK-US2024079173$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240703$$CN$US$US
240451582$24045158$2$F$$20240723$20240703$20240802$30DAY$$US-GSK-US2024AMR079284$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
240451592$24045159$2$F$20230101$20240725$20240703$20240730$EXP$$CA-UCBSA-2023039093$UCB$$$$$F$Y$$$20240730$$CN$CA$CA
240451602$24045160$2$F$20240216$20240806$20240703$20240808$EXP$$US-OTSUKA-2024_015337$OTSUKA$$78$YR$$F$Y$54.42$KG$20240808$$HP$US$US
240451631$24045163$1$I$20200209$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406291153551960-YVRTB$GB-ORGANON-O2407GBR000112$ORGANON$$24$YR$$M$Y$65$KG$20240703$$CN$GB$GB
240451641$24045164$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406291146576770-GMFCW$GB-ORGANON-O2407GBR000125$ORGANON$$$$$$Y$78$KG$20240703$$CN$GB$GB
240451651$24045165$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281443140430-YKFLG$GB-ORGANON-O2407GBR000148$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240451661$24045166$1$I$20240625$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130627$AMGEN$$65$YR$E$M$Y$$$20240703$$CN$US$US
240451672$24045167$2$F$$20240802$20240703$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106100$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240805$$CN$US$US
240451681$24045168$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106046$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240703$$HP$US$US
240451701$24045170$1$I$20240627$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106083$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240703$$HP$US$US
240451711$24045171$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106079$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240703$$CN$US$US
240451722$24045172$2$F$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106169$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240703$$CN$US$US
240451732$24045173$2$F$$20240703$20240703$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05070$LUPIN$$$$$F$Y$$$20240728$$HP$US$US
240451741$24045174$1$I$20230714$20240621$20240703$20240703$EXP$$US-COOPERSURGICAL, INC.-2024CPS001969$COOPERSURGICAL$$$$$F$Y$$$20240703$$LW$US$US
240451752$24045175$2$F$20200101$20240709$20240703$20240724$EXP$$US-COOPERSURGICAL, INC.-2024CPS001970$COOPERSURGICAL$$$$$F$Y$67.12$KG$20240724$$CN$US$US
240451761$24045176$1$I$20240507$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031744$AUROBINDO$$78$YR$$F$Y$$$20240703$$MD$FR$FR
240451771$24045177$1$I$$20240624$20240703$20240703$PER$$US-TEVA-VS-3213965$TEVA$Stanford S, Kharel Z, Hemminger L, Schmidt T, Hardy S, Zittel J, et al. Excellent Response to Trastuzumab Deruxtecan in HER-2 Low Leptomeningeal Breast Cancer and Diagnostic and Monitoring Utility of CNSide Assay. Cancer-Res 2024; 84 (Suppl.) (9): abstr. PO4-20-11.$72$YR$$F$Y$$$20240703$$HP$US$US
240451791$24045179$1$I$20240101$20240701$20240703$20240703$PER$$US-JNJFOC-20240702788$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$US$US
240451801$24045180$1$I$$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406281438310700-KPJBZ$GB-MYLANLABS-2024M1061554$MYLAN$$$$$$Y$$$20240703$$CN$GB$GB
240451811$24045181$1$I$$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406281421048380-HJCMP$GB-MYLANLABS-2024M1061555$MYLAN$$$$$$Y$$$20240703$$CN$GB$GB
240451821$24045182$1$I$$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406281423022780-LSYQG$GB-MYLANLABS-2024M1061736$MYLAN$$$$$$Y$$$20240703$$CN$GB$GB
240451831$24045183$1$I$$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406281414140760-PYGTQ$GB-MYLANLABS-2024M1061559$MYLAN$$$$$$Y$$$20240703$$CN$GB$GB
240451841$24045184$1$I$$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406281417420110-KQVHC$GB-MYLANLABS-2024M1061575$MYLAN$$$$$$Y$$$20240703$$CN$GB$GB
240451851$24045185$1$I$$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406281459532020-PFYZC$GB-MYLANLABS-2024M1061744$MYLAN$$$$$M$Y$$$20240703$$CN$GB$GB
240451861$24045186$1$I$$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406281432323530-HKSTC$GB-MYLANLABS-2024M1061560$MYLAN$$$$$$Y$$$20240703$$CN$GB$GB
240451872$24045187$2$F$$20240708$20240703$20240711$EXP$GB-MHRA-MED-202406281415559760-KVNGH$GB-MYLANLABS-2024M1061547$MYLAN$$$$$$Y$$$20240711$$CN$GB$GB
240451881$24045188$1$I$20240613$20240619$20240703$20240703$EXP$$US-ACORDA-ACO_177414_2024$ACORDA$$79$YR$$F$Y$$$20240703$$CN$US$US
240451891$24045189$1$I$$20231214$20240703$20240703$PER$$US-AMGEN-USASP2023235430$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240451901$24045190$1$I$$20240701$20240703$20240703$EXP$$US-PFIZER INC-PV202400086572$PFIZER$Lizarraga, K.. Fulminant mononeuritis multiplex triggered by rituximab in IGM-K gammopathy. Annals of Neurology. 2014;76 (SUPPL. 18):S79$62$YR$$F$Y$$$20240703$$HP$US$US
240451913$24045191$3$F$$20240708$20240703$20240715$EXP$$IN-PFIZER INC-PV202400086789$PFIZER$Jose, A.. ^A boat in the stormy sea^: A case report on systemic steroid induced Delirium and relapse of Psychosis in a patient with Pemphigus vulgaris. Indian Journal of Psychiatry. 2024;66(Suppl 1):S183$61$YR$$M$Y$$$20240715$$HP$IN$IN
240451922$24045192$2$F$$20240702$20240703$20240705$EXP$$BE-PFIZER INC-202400204528$PFIZER$Inthasot, S.. Fever of unknown origin revealing testicular nocardiosis: a case report and literature review. BMC infectious diseases. 2024;24(1):614$75$YR$$M$Y$$$20240705$$MD$BE$BE
240451932$24045193$2$F$$20240701$20240703$20240705$EXP$$US-PFIZER INC-PV202400086725$PFIZER$Boateng, W.. Rituximab-Induced Colitis and Esophagitis in a Patient With Granulomatosis With Polyangiitis. Cureus. 2023;15(4):10.7759/cureus.38207$44$YR$$F$Y$$$20240705$$HP$US$US
240451941$24045194$1$I$$20240628$20240703$20240703$EXP$$IT-PFIZER INC-202400202246$PFIZER$Assanto, G.. BRENTUXIMAB VEDOTIN (BV)+AVD IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA: AN ITALIAN REAL-LIFE MULTICENTRIC STUDY. HemaSphere. 2024;8:(S1):1957-1958$$$E$$Y$$$20240703$$HP$IT$IT
240451952$24045195$2$F$20150722$20240911$20240703$20240916$EXP$$US-GILEAD-2024-0679369$GILEAD$$39$YR$A$M$Y$$$20240916$$LW$US$US
240451962$24045196$2$F$$20240701$20240703$20240709$EXP$$US-PFIZER INC-202400202053$PFIZER$Arshad, K.. Spontaneous spinal epidural hematoma following IV heparin and catheter-directed thrombolysis for deep vein thrombosis. Journal of Vascular Surgery Cases, Innovations and Techniques. 2024;10(4):10.1016/j.jvscit.2024.101541$65$YR$$M$Y$$$20240709$$MD$US$US
240451971$24045197$1$I$$20240625$20240703$20240703$EXP$$US-SPECGX-T202401295$SPECGX$$$$$F$Y$$$20240703$$CN$US$US
240451981$24045198$1$I$$20240627$20240703$20240703$EXP$RO-PFIZER INC-202400196631$RO-TAKEDA-2024TUS064518$TAKEDA$$38$YR$$M$Y$$$20240703$$HP$RO$RO
240451991$24045199$1$I$$20240528$20240703$20240703$EXP$$US-TDD-202400001$Unknown Manufacturer$$76$YR$E$F$Y$$$20240703$$HP$US$US
240452001$24045200$1$I$$20240701$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037119$BOEHRINGER INGELHEIM$$$$$$Y$$$20240703$$CN$US$US
240452011$24045201$1$I$$20240627$20240703$20240703$PER$$US-ROCHE-10000014860$ROCHE$$69$YR$E$F$Y$$$20240703$$HP$US$US
240452021$24045202$1$I$20240618$20240621$20240703$20240703$EXP$$CN-BBU-2024000156$BIOGEN$$80$YR$$F$Y$60$KG$20240703$$MD$CN$CN
240452042$24045204$2$F$$20240708$20240703$20240712$EXP$$US-PFIZER INC-PV202400085963$PFIZER$Xu, E.. Intrathecal Methotrexate-Induced Lumbosacral Polyradiculopathy: A Case Report. Pain Medicine Case Reports. 2024;8(1):31-35$69$YR$$F$Y$$$20240712$$MD$US$US
240452051$24045205$1$I$$20240626$20240703$20240703$EXP$$AU-ABBVIE-5823266$ABBVIE$$$$$M$Y$$$20240703$$HP$AU$AU
240452061$24045206$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024128200$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240452071$24045207$1$I$$20240224$20240703$20240703$PER$$US-AMGEN-USASP2024131064$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240452081$24045208$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46366$$FDA-CTU$$30$YR$$F$N$$$20240702$N$$US$
240452091$24045209$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46313$$FDA-CTU$$67$YR$$F$N$$$20240702$N$$US$
240452101$24045210$1$I$20240620$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46306$$FDA-CTU$$73$YR$$M$N$$$20240702$N$$US$
240452111$24045211$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024033783$EMD SERONO INC$$$$A$F$Y$$$20240703$$HP$US$US
240452121$24045212$1$I$20240626$20240626$20240703$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-019846$UNITED THERAPEUTICS$$74$YR$$F$Y$81.633$KG$20240703$$$US$US
240452131$24045213$1$I$$20240625$20240703$20240703$EXP$$GR-JNJFOC-20240675236$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240703$$MD$GR$GR
240452141$24045214$1$I$20240627$20240628$20240703$20240703$EXP$$US-MYLANLABS-2024M1061539$MYLAN$$20$YR$$M$Y$$$20240703$$HP$US$US
240452151$24045215$1$I$20240621$20240628$20240703$20240703$EXP$$US-MYLANLABS-2024M1061706$MYLAN$$28$YR$$M$Y$$$20240703$$HP$US$US
240452163$24045216$3$F$20240101$20240909$20240703$20240917$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019042$UNITED THERAPEUTICS$$$$$M$Y$71.655$KG$20240917$$$US$US
240452171$24045217$1$I$20240628$20240628$20240703$20240703$EXP$$US-MYLANLABS-2024M1061609$MYLAN$$70$YR$$F$Y$$$20240703$$HP$US$US
240452182$24045218$2$F$$20240704$20240703$20240709$EXP$$CA-GSK-CA2023141205$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$CA$CA
240452192$24045219$2$F$20230105$20240703$20240703$20240710$EXP$$CA-GSK-CA2023001915$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$HP$CA$CA
240452203$24045220$3$F$$20240727$20240703$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05614$LUPIN$$$$$$Y$$$20240818$$CN$US$US
240452211$24045221$1$I$$20240702$20240703$20240703$EXP$$US-GILEAD-2024-0679351$GILEAD$$$$$$Y$$$20240703$$LW$US$US
240452223$24045222$3$F$20240101$20240830$20240703$20240903$EXP$$HR-ABBVIE-5823338$ABBVIE$$$$$F$Y$$$20240903$$HP$HR$HR
240452231$24045223$1$I$$20240625$20240703$20240703$EXP$$JP-TEVA-VS-3215380$TEVA$$72$YR$$M$Y$$$20240703$$MD$JP$JP
240452241$24045224$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281425089800-RYTVB$GB-ORGANON-O2407GBR000075$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240452251$24045225$1$I$20240301$20240625$20240703$20240703$30DAY$$US-GSK-US2024079146$GLAXOSMITHKLINE$$84$YR$$M$Y$$$20240703$$CN$US$US
240452262$24045226$2$F$20240101$20240701$20240703$20240709$EXP$$BR-SA-2024SA191830$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240709$$CN$BR$BR
240452271$24045227$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024033787$EMD SERONO INC$$$$A$F$Y$$$20240703$$HP$US$US
240452281$24045228$1$I$$20240624$20240703$20240703$EXP$$JP-EMD Serono-2024034914$EMD SERONO INC$$67$YR$E$M$Y$82$KG$20240703$$MD$JP$JP
240452291$24045229$1$I$20240621$20240626$20240703$20240703$EXP$$ES-TEVA-VS-3215439$TEVA$$76$YR$$F$Y$$$20240703$$CN$ES$ES
240452301$24045230$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281436490710-YBJTK$GB-ORGANON-O2407GBR000110$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240452311$24045231$1$I$20240420$20240624$20240703$20240703$EXP$FR-AFSSAPS-LM2024000330$FR-SA-2024SA192975$SANOFI AVENTIS$$63$YR$A$F$Y$76$KG$20240703$$PH$FR$FR
240452321$24045232$1$I$20240606$20240624$20240703$20240703$EXP$$CN-BAYER-2024A091309$BAYER$$43$YR$A$F$Y$56$KG$20240703$$HP$CN$CN
240452331$24045233$1$I$20240102$20240626$20240703$20240703$EXP$$US-SA-2024SA193395$SANOFI AVENTIS$$86$YR$E$M$Y$68.038$KG$20240703$$MD$US$US
240452341$24045234$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46271$$FDA-CTU$$25$YR$$F$N$86.18$KG$20240702$Y$CN$US$
240452361$24045236$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46345$$FDA-CTU$$54$YR$$F$N$$$20240702$N$$US$
240452371$24045237$1$I$20240630$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46395$$FDA-CTU$$70$YR$$M$N$$$20240702$N$HP$US$
240452381$24045238$1$I$20240609$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46362$$FDA-CTU$$61$YR$$F$N$$$20240702$N$$US$
240452391$24045239$1$I$20240630$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46397$$FDA-CTU$$70$YR$$M$N$$$20240702$N$HP$US$
240452411$24045241$1$I$20240627$20240628$20240703$20240703$EXP$$US-MYLANLABS-2024M1061900$MYLAN$$68$YR$$F$Y$$$20240703$$HP$US$US
240452421$24045242$1$I$$20240628$20240703$20240703$EXP$$GB-MYLANLABS-2024M1061316$MYLAN$$73$YR$$$Y$$$20240703$$PH$GB$GB
240452432$24045243$2$F$$20240806$20240703$20240812$EXP$$GB-MYLANLABS-2024M1061505$MYLAN$$$$$F$Y$$$20240812$$PH$GB$GB
240452444$24045244$4$F$20240101$20240826$20240703$20240829$EXP$$US-AMGEN-USASP2024127518$AMGEN$$44$YR$A$M$Y$$$20240828$$CN$US$US
240452452$24045245$2$F$$20240828$20240703$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05506$LUPIN$$$$$$Y$$$20240918$$CN$US$US
240452461$24045246$1$I$$20240627$20240703$20240703$EXP$$AR-TEVA-VS-3143619$TEVA$$$$$M$Y$$$20240703$$CN$AR$AR
240452501$24045250$1$I$20240629$20240701$20240703$20240703$EXP$$US-TAKEDA-2024TUS066473$TAKEDA$$93$YR$$M$Y$$$20240703$$CN$US$US
240452513$24045251$3$F$20240705$20240918$20240703$20240926$EXP$$CA-TAKEDA-2024TUS065601$TAKEDA$$29$YR$$M$Y$$$20240926$$CN$CA$CA
240452521$24045252$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46318$$FDA-CTU$$31$YR$$F$N$114.76$KG$20240702$N$$US$
240452532$24045253$2$F$20240214$20240712$20240703$20240717$EXP$$CA-TAKEDA-2024TUS063232$TAKEDA$$69$YR$$F$Y$$$20240717$$CN$CA$CA
240452541$24045254$1$I$20240601$20240629$20240702$20240702$DIR$FDA-CDER-CTU-2024-46312$$FDA-CTU$$80$YR$$F$N$$$20240629$N$HP$US$
240452551$24045255$1$I$$20240626$20240703$20240703$EXP$$CA-TAKEDA-2024TUS063665$TAKEDA$$$$$M$Y$$$20240703$$MD$CA$CA
240452562$24045256$2$F$$20240816$20240703$20240821$PER$$US-PFIZER INC-PV202400086510$PFIZER$$81$YR$$F$Y$$$20240821$$CN$US$US
240452572$24045257$2$F$$20240708$20240703$20240710$PER$$US-PFIZER INC-202400201162$PFIZER$$71$YR$$F$Y$$$20240710$$CN$US$US
240452581$24045258$1$I$20240501$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205217$PFIZER$$78$YR$$F$Y$49.887$KG$20240703$$CN$US$US
240452594$24045259$4$F$20240624$20240730$20240703$20240805$PER$$US-PFIZER INC-PV202400086999$PFIZER$$63$YR$$F$Y$51.247$KG$20240805$$CN$US$US
240452601$24045260$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-202400204619$PFIZER$$51$YR$$F$Y$$$20240703$$CN$US$US
240452611$24045261$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-PV202400086579$PFIZER$$54$YR$$F$Y$$$20240703$$HP$US$US
240452621$24045262$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-202400205196$PFIZER$$73$YR$$F$Y$$$20240703$$CN$US$US
240452631$24045263$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-PV202400086660$PFIZER$$72$YR$$F$Y$$$20240703$$HP$US$US
240452641$24045264$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205255$PFIZER$$71$YR$$F$Y$$$20240703$$CN$US$US
240452651$24045265$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46396$$FDA-CTU$$$$$$N$$$20240702$Y$CN$US$
240452662$24045266$2$F$$20240829$20240703$20240904$PER$$US-PFIZER INC-202400204283$PFIZER$$68$YR$$M$Y$$$20240904$$HP$US$US
240452671$24045267$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-202400205359$PFIZER$$85$YR$$F$Y$$$20240703$$HP$US$US
240452682$24045268$2$F$20240507$20240702$20240703$20240703$PER$$US-PFIZER INC-202400204662$PFIZER$$$$A$F$Y$$$20240703$$MD$US$US
240452691$24045269$1$I$20200815$20240701$20240703$20240703$PER$$US-PFIZER INC-202400205191$PFIZER$$76$YR$$F$Y$$$20240703$$HP$US$US
240452702$24045270$2$F$20240401$20240717$20240703$20240723$PER$$US-PFIZER INC-202400205185$PFIZER$$64$YR$$F$Y$122.47$KG$20240723$$HP$US$US
240452711$24045271$1$I$$20240628$20240703$20240703$PER$$US-PFIZER INC-202400204503$PFIZER$$60$YR$$F$Y$$$20240703$$HP$US$US
240452722$24045272$2$F$$20240709$20240703$20240711$PER$$US-PFIZER INC-202400204442$PFIZER$$77$YR$$F$Y$$$20240711$$CN$US$US
240452731$24045273$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-202400204401$PFIZER$$$$A$$Y$$$20240703$$MD$US$US
240452741$24045274$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-202400204955$PFIZER$$60$YR$$F$Y$$$20240703$$CN$US$US
240452752$24045275$2$F$$20240807$20240703$20240807$PER$$US-PFIZER INC-PV202400048679$PFIZER$$9$YR$$M$Y$25.3$KG$20240807$$MD$US$US
240452763$24045276$3$F$20190601$20240829$20240703$20240902$PER$$US-GILEAD-2024-0679371$GILEAD$$55$YR$A$M$Y$$$20240902$$LW$US$US
240452771$24045277$1$I$$20240627$20240703$20240703$PER$$US-ROCHE-10000012115$ROCHE$$$$$$Y$$$20240703$$HP$US$US
240452781$24045278$1$I$20240624$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46406$$FDA-CTU$$46$YR$$F$N$$$20240702$N$MD$US$
240452791$24045279$1$I$$20240625$20240703$20240703$PER$$US-ROCHE-10000014493$ROCHE$$$$$$Y$$$20240703$$CN$US$US
240452801$24045280$1$I$$20240621$20240703$20240703$PER$$US-B.Braun Medical Inc.-2158803$B BRAUN$$28$YR$$F$Y$$$20240703$$$US$US
240452811$24045281$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106177$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240703$$HP$US$US
240452831$24045283$1$I$$20240626$20240703$20240703$EXP$$IL-MYLANLABS-2024M1061619$MYLAN$Levy DM, Arush OB, Carmi L, Wetzler AJ, Zohar J. Off-label higher doses of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Safety and tolerability. Compr-Psychiatry 2024; 133 1-6.$18$YR$$$Y$$$20240703$$HP$IL$IL
240452841$24045284$1$I$20210623$20240629$20240703$20240703$EXP$$CA-TAKEDA-2024TUS066635$TAKEDA$$61$YR$$F$Y$$$20240703$$CN$CA$CA
240452852$24045285$2$F$$20240825$20240703$20240826$PER$$US-PFIZER INC-PV202300101918$PFIZER$$16$YR$$M$Y$$$20240826$$MD$US$US
240452861$24045286$1$I$$20240625$20240703$20240703$30DAY$$US-GSK-US2024079216$GLAXOSMITHKLINE$$$$$M$Y$$$20240703$$CN$US$US
240452871$24045287$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A146696$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240452881$24045288$1$I$20170101$20240620$20240703$20240703$EXP$FR-AFSSAPS-AVCN2024000439$FR-TEVA-VS-3213421$TEVA$$45$YR$$M$Y$$$20240703$$MD$FR$FR
240452891$24045289$1$I$$20240624$20240703$20240703$EXP$GB-MHRA-MED-202406220013389710-QTKVS$GB-Accord-432417$ACCORD$$$$$M$Y$$$20240703$$CN$GB$GB
240452901$24045290$1$I$20240604$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46336$$FDA-CTU$$64$YR$$M$N$$$20240702$Y$PH$US$
240452912$24045291$2$F$20180101$20240702$20240703$20240706$PER$$US-ABBVIE-5822402$ABBVIE$$$$$F$Y$70$KG$20240706$$CN$US$US
240452921$24045292$1$I$$20240627$20240703$20240703$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037244$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240703$$MD$JP$JP
240452942$24045294$2$F$20230101$20240702$20240703$20240708$EXP$$US-ABBVIE-5821814$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240452951$24045295$1$I$$20240628$20240703$20240703$EXP$$CA-TAKEDA-2024TUS066480$TAKEDA$$$$$F$Y$$$20240703$$CN$CA$CA
240452961$24045296$1$I$$20240701$20240702$20240702$DIR$FDA-CDER-CTU-2024-46339$$FDA-CTU$$$$$M$N$$$20240701$N$HP$US$
240452972$24045297$2$F$20220630$20240722$20240703$20240730$EXP$$JP-CHEPLA-2024008154$CHEPLAPHARM$Minemura T, et al. A case of acute myeloid leukemia (AML-cuplike) with FLT3-ITD and NPM1 mutations diagnosed based on morphological findings. The 253rd Hokuriku Regional Meeting of the Japanese Society of Internal Medicine.$63$YR$$F$Y$$$20240730$$MD$COUNTRY NOT SPECIFIED$JP
240452981$24045298$1$I$$20240624$20240703$20240703$EXP$$FI-NORDICGR-056533$NORDIC PHARMA$$$$$M$Y$$$20240701$$MD$FI$FI
240452991$24045299$1$I$20190701$20240624$20240703$20240703$EXP$$NL-NORDICGR-056524$NORDIC PHARMA$$27$YR$$M$Y$$$20240701$$HP$NL$NL
240453001$24045300$1$I$$20240624$20240703$20240703$EXP$$PT-NORDICGR-056531$NORDIC PHARMA$Nogueira J, Parente AR, Mendes A et al. Tongue hematoma with necrosis. Cureus 13(1): e12741. https://doi.org/10.7759/cureus.12741; Nogueira J, Mendes A, Lavadinho I, Parente A. Tongue Hematoma With Necrosis.. Cureus. 2021;13:E12741--. doi:10.7759/cureus.12741$9$DEC$$F$Y$$$20240701$$MD$PT$PT
240453011$24045301$1$I$20200101$20240624$20240703$20240703$EXP$$NL-NORDICGR-056523$NORDIC PHARMA$$59$YR$$F$Y$$$20240701$$MD$NL$NL
240453022$24045302$2$F$$20240708$20240703$20240722$EXP$$NL-NORDICGR-056525$NORDIC PHARMA$$22$YR$$M$Y$$$20240722$$MD$NL$NL
240453031$24045303$1$I$20190101$20240624$20240703$20240703$EXP$$NL-NORDICGR-056527$NORDIC PHARMA$$$$A$F$Y$$$20240701$$MD$NL$NL
240453041$24045304$1$I$$20240624$20240703$20240703$EXP$$IE-NORDICGR-056514$NORDIC PHARMA$Leel U, Zanib A, Ahmed A, Milos A, Varghese S. Disseminated Herpes Zoster infection in an Immunosuppressed patient with neurological complication. Ir Med J. 2024 Mar 21;117(3):936.$67$YR$$F$Y$$$20240703$$HP$IE$IE
240453051$24045305$1$I$20231201$20240624$20240703$20240703$EXP$FR-AFSSAPS-LL2024000723$FR-NORDICGR-056453$NORDIC PHARMA$$56$YR$$F$Y$83$KG$20240702$$PH$FR$FR
240453061$24045306$1$I$20240530$20240622$20240703$20240703$EXP$FR-AFSSAPS-LL2024001165$FR-Accord-432648$ACCORD$$47$YR$A$F$Y$$$20240703$$MD$FR$FR
240453071$24045307$1$I$20200701$20240619$20240703$20240703$EXP$$GB-ALIMERA SCIENCES INC.-GB-A16013-24-000439$ALIMERA$$63$YR$$M$Y$$$20240703$$MD$GB$GB
240453081$24045308$1$I$$20240626$20240703$20240703$PER$$US-JNJFOC-20240676599$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240453091$24045309$1$I$$20230710$20240703$20240703$PER$$US-AMGEN-USASP2023235048$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240453102$24045310$2$F$20240626$20240710$20240703$20240712$PER$$US-AMGEN-USASP2024128181$AMGEN$$69$YR$E$M$Y$$$20240711$$PH$US$US
240453112$24045311$2$F$20201101$20240828$20240703$20240905$EXP$$US-AMGEN-USASP2024127652$AMGEN$$56$YR$A$M$Y$$$20240905$$LW$US$US
240453123$24045312$3$F$$20240822$20240703$20240830$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-12885$IPSEN$$$$$M$Y$$$20240830$$CN$GB$GB
240453131$24045313$1$I$20240101$20240528$20240703$20240703$EXP$$US-TDD-202400002$Unknown Manufacturer$$52$YR$A$F$Y$$$20240703$$MD$US$US
240453141$24045314$1$I$$20240625$20240703$20240703$EXP$$US-LUOXIN-LUX-2024-US-LIT-00023$LUOXIN AUROVITAS PHARMA(CHENGDU)$Pysick H, Bowmaster S, Gehlbach BK, Doerschug KC.Gasping, Bradypnea, and Obtundation: An Unusual Case of Respiratory Failure From Seizures.Am J Respir Crit Care Med.2024;209:A4580$21$YR$A$M$Y$$$20240703$$HP$US$US
240453151$24045315$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105311$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240703$$HP$US$US
240453161$24045316$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105491$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240703$$CN$US$US
240453171$24045317$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105082$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$73.48$KG$20240703$$CN$US$US
240453181$24045318$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-PV202400086472$PFIZER$$61$YR$$M$Y$$$20240703$$HP$US$US
240453192$24045319$2$F$20240702$20240807$20240703$20240808$PER$$US-PFIZER INC-202400205361$PFIZER$$70$YR$$F$Y$$$20240808$$CN$US$US
240453201$24045320$1$I$20240627$20240628$20240703$20240703$PER$$US-PFIZER INC-202400203684$PFIZER$$51$YR$$F$Y$$$20240703$$CN$US$US
240453211$24045321$1$I$20240630$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205189$PFIZER$$59$YR$$F$Y$$$20240703$$CN$US$US
240453221$24045322$1$I$20240630$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205139$PFIZER$$70$YR$$F$Y$$$20240703$$CN$US$US
240453231$24045323$1$I$20240601$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205112$PFIZER$$25$YR$$F$Y$$$20240703$$CN$US$US
240453241$24045324$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-PV202400086487$PFIZER$$64$YR$$F$Y$$$20240703$$HP$US$US
240453254$24045325$4$F$$20240724$20240703$20240731$PER$$US-PFIZER INC-202400205370$PFIZER$$51$YR$$F$Y$$$20240731$$CN$US$US
240453261$24045326$1$I$20240628$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205730$PFIZER$$45$YR$$F$Y$$$20240703$$CN$US$US
240453271$24045327$1$I$20240628$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205663$PFIZER$$66$YR$$M$Y$$$20240703$$CN$US$US
240453281$24045328$1$I$20240701$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205124$PFIZER$$77$YR$$F$Y$68.95$KG$20240703$$CN$US$US
240453291$24045329$1$I$20240601$20240628$20240703$20240703$PER$$US-PFIZER INC-202400204692$PFIZER$$72$YR$$F$Y$$$20240703$$HP$US$US
240453312$24045331$2$F$20240630$20240801$20240703$20240805$PER$$US-PFIZER INC-202400204393$PFIZER$$79$YR$$M$Y$81.65$KG$20240805$$MD$US$US
240453321$24045332$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-PV202400086699$PFIZER$$68$YR$$M$Y$$$20240703$$HP$US$US
240453331$24045333$1$I$$20240628$20240703$20240703$PER$$US-PFIZER INC-202400203717$PFIZER$$$$$F$Y$$$20240703$$HP$US$US
240453341$24045334$1$I$$20240628$20240703$20240703$EXP$$US-TAKEDA-2024TUS066123$TAKEDA$$$$$M$Y$61$KG$20240703$$MD$US$US
240453351$24045335$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281459532020-PFYZC$GB-ORGANON-O2407GBR000063$ORGANON$$$$$M$Y$$$20240703$$CN$GB$GB
240453361$24045336$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406291145190840-GJMRH$GB-ORGANON-O2407GBR000114$ORGANON$$$$$M$Y$$$20240703$$CN$GB$GB
240453373$24045337$3$F$20240503$20240806$20240703$20240812$EXP$$CA-TAKEDA-2024TUS043986$TAKEDA$$14$YR$$M$Y$$$20240812$$CN$CA$CA
240453381$24045338$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406291352445690-FRSGZ$GB-MYLANLABS-2024M1061490$MYLAN$$$$$M$Y$$$20240703$$CN$GB$GB
240453391$24045339$1$I$$20240625$20240703$20240703$EXP$$US-MYLANLABS-2024M1061549$MYLAN$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch-Dermatol-Res 2024; 316 (6).$49$YR$$F$Y$$$20240703$$HP$US$US
240453401$24045340$1$I$$20240624$20240703$20240703$EXP$$IT-MYLANLABS-2024M1061045$MYLAN$Costantini I, Mantelli G, Carollo M, Losso L, Morando E, Bacchion M, et al. Not only Van Gogh: a case of BRASH syndrome with concomitant digoxin toxicity. J-Med-Case-Rep 2024; 18 (1): 273.$66$YR$$F$Y$$$20240703$$HP$IT$IT
240453421$24045342$1$I$$20240624$20240703$20240703$EXP$$US-MYLANLABS-2024M1060848$MYLAN$Pimentel MA, Kim DH, Walker LW, Noelck MB, Perelygina L, Kripps KA, et al. Rubella virus-associated necrotizing granulomatous inflammation with extensive eyelid, ocular, and orbital involvement. Pediatr-Dermatol 2023; 40 1107-1111.$4$YR$$F$Y$$$20240703$$MD$US$US
240453441$24045344$1$I$$20240624$20240703$20240703$EXP$$US-MYLANLABS-2024M1060843$MYLAN$Lord ML, Rana D, Hossain S, Chang C, Palli V. A Fatal Case of Lyme Myocarditis With Babesia Co-infection. Am-J-Respir-Crit-Care-Med 2024; 209.$79$YR$$F$Y$$$20240703$$HP$US$US
240453451$24045345$1$I$$20240624$20240703$20240703$EXP$$IT-MYLANLABS-2024M1061000$MYLAN$Roccatello D, Baffa A, Naretto C, Barreca A, Cravero R, Roscini E, et al. Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy. Clin-Kidney-J 2023; 16 (8): 1258-1264.$32$YR$$M$Y$$$20240703$$HP$IT$IT
240453461$24045346$1$I$$20240625$20240703$20240703$EXP$$JP-MYLANLABS-2024M1061380$MYLAN$Watanabe M, Takao C, Maeda C, Nayanar G, Tominaga R, Kimura Y, et al. The effective perospirone augmentation with clonazepam for treatment-resistant burning mouth syndrome: A case report. Neuropsychopharmacol-Rep 2024; 44 (2): 464-467.. 2024;44 (2):464-467$51$YR$$F$Y$$$20240703$$HP$JP$JP
240453471$24045347$1$I$$20240624$20240703$20240703$EXP$$IN-MYLANLABS-2024M1061494$MYLAN$Fernandes G, Patil M, Harinkhede N, Khumanthem G, Rojekar A. Renal allograft failure resulting from diffuse cortical necrosis. Indian-J-Pathol-Microbiol 2024; 1-4.$28$YR$$F$Y$$$20240703$$MD$IN$IN
240453481$24045348$1$I$$20240625$20240703$20240703$EXP$$US-MYLANLABS-2024M1061413$MYLAN$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch-Dermatol-Res 2024; 316 (6):.$26$YR$$F$Y$$$20240703$$HP$US$US
240453491$24045349$1$I$$20240625$20240703$20240703$EXP$$JP-MYLANLABS-2024M1061389$MYLAN$Tanabe M, Koba Y, Yaguchi T, Watanabe M. Detection of Schizophyllum commune in SARS-CoV-2 Pneumonia. Intern-Med 2024; 63 (7): 1037-1038.. 2024;63 (7):1037-1038$72$YR$$M$Y$$$20240703$$MD$JP$JP
240453501$24045350$1$I$$20240624$20240703$20240703$EXP$$JP-MYLANLABS-2024M1061366$MYLAN$Oguni K, Fukushima S, Otsuka Y, Soejima Y, Kawaguchi M, Sazumi Y, et al. Disseminated septic arthritis caused by Ureaplasma urealyticum in an immunocompromised patient with hypogammaglobulinemia after rituximab therapy. Infection 2024; 52 (3):.. 2024;52 (3)$23$YR$$F$Y$$$20240703$$HP$JP$JP
240453511$24045351$1$I$$20240624$20240703$20240703$EXP$$US-MYLANLABS-2024M1061457$MYLAN$Alexander G, Moore SA, Lenert PS. Eosinophilic granulomatosis with polyangiitis and its association with montelukast: a case-based review. [Review]. Clin-Rheumatol 2024; 43 (6): 2153-2165.$21$YR$$M$Y$$$20240703$$HP$US$US
240453521$24045352$1$I$$20240624$20240703$20240703$EXP$$US-MYLANLABS-2024M1061451$MYLAN$Alexander G, Moore SA, Lenert PS. Eosinophilic granulomatosis with polyangiitis and its association with montelukast: a case-based review. [Review]. Clin-Rheumatol 2024; 43 (6): 2153-2165.$44$YR$$F$Y$$$20240703$$HP$US$US
240453531$24045353$1$I$$20240624$20240703$20240703$EXP$$US-MYLANLABS-2024M1060808$MYLAN$Patel P, Turbin RE, Husain S, Wang S. Neurosyphilis Mimicking Connective Tissue Disease. BMJ-Case-Rep 2023; 16 (9).$7$DEC$$M$Y$$$20240703$$HP$US$US
240453541$24045354$1$I$20180621$20240627$20240703$20240703$EXP$$CA-TAKEDA-2017TUS021929$TAKEDA$$28$YR$$M$Y$$$20240703$$HP$CA$CA
240453553$24045355$3$F$20240504$20240816$20240703$20240827$PER$$US-AMGEN-USASP2024128144$AMGEN$$63$YR$A$F$Y$$$20240827$$PH$US$US
240453562$24045356$2$F$20240626$20240711$20240703$20240716$PER$$US-AMGEN-USASP2024129514$AMGEN$$75$YR$E$F$Y$$$20240716$$CN$US$US
240453581$24045358$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024033790$EMD SERONO INC$$$$A$F$Y$$$20240703$$HP$US$US
240453591$24045359$1$I$20240605$20240628$20240703$20240703$EXP$ES-AEMPS-1539336$ES-009507513-2407ESP000156$MERCK$$13$YR$$M$Y$$$20240703$$PH$ES$ES
240453602$24045360$2$F$20121029$20240828$20240703$20240830$PER$$US-GILEAD-2024-0679400$GILEAD$$46$YR$A$M$Y$$$20240830$$LW$US$US
240453611$24045361$1$I$$20240619$20240703$20240703$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05835$HIKMA$Raza HS, Love JS, Mikolajczyk AE. Raza HS, Love JS, Mikolajczyk AE. Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding.. ACG case reports journal. 2024;11(6):e01378$38$YR$$M$Y$$$20240703$$MD$US$US
240453641$24045364$1$I$20240621$20240630$20240703$20240703$EXP$$US-MYLANLABS-2024M1061855$MYLAN$$59$YR$$F$Y$$$20240703$$HP$US$US
240453651$24045365$1$I$20090206$20240626$20240703$20240703$EXP$DE-PVZIBE-JENA-10070$DE-CHEPLA-1100016609$CHEPLAPHARM$$66$YR$$F$Y$70$KG$20240703$$MD$COUNTRY NOT SPECIFIED$DE
240453662$24045366$2$F$$20240702$20240703$20240708$EXP$$CH-BAUSCH-BL-2024-010188$BAUSCH AND LOMB$Galland-Decker C, Kraege V, Sartori C. Central nervous system manifestations due to iatrogenic adrenal insufficiency in a Ewing sarcoma patient. World Journal of Emergency Medicine. 2019;10(2):119.-121. doi:10.5847/wjem.j.1920-8642.2019.02.010.$20$YR$$M$Y$$$20240708$$HP$CH$CH
240453671$24045367$1$I$$20240702$20240703$20240703$PER$$US-HALEON-2184978$Haleon PLC$$77$YR$$$Y$$$20240703$$CN$US$US
240453682$24045368$2$F$20231001$20240812$20240703$20240905$EXP$FR-AFSSAPS-SE2024000497$FR-Ipsen Biopharmaceuticals, Inc.-2024-12344$IPSEN$$89$YR$E$M$Y$$$20240905$$MD$FR$FR
240453691$24045369$1$I$20240301$20240619$20240703$20240703$EXP$IT-MINISAL02-989932$IT-TEVA-VS-3212425$TEVA$$72$YR$$M$Y$72$KG$20240703$$PH$IT$IT
240453701$24045370$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106166$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240703$$CN$US$US
240453711$24045371$1$I$$20240625$20240703$20240703$EXP$$CA-TAKEDA-2021TUS044714$TAKEDA$$$$$F$Y$$$20240703$$MD$CA$CA
240453721$24045372$1$I$$20240625$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031947$AUROBINDO$El-Atoum M, Hargarten JC, Park Y-D, Ssebambulidde K, Ding L, Chittiboina P, et al. Persistent neurological symptoms and elevated intracranial pressures in a previously healthy host with cryptococcal meningitis. BMC-Infect-Dis. 2023;23(1):407$55$YR$$M$Y$$$20240703$$HP$US$US
240453732$24045373$2$F$$20240705$20240703$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105157$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240705$$CN$US$US
240453741$24045374$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105846$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$103.87$KG$20240703$$CN$US$US
240453751$24045375$1$I$20240312$20240619$20240703$20240703$EXP$FR-AFSSAPS-AN2024000780$FR-TEVA-VS-3212828$TEVA$$54$YR$$M$Y$$$20240703$$PH$FR$FR
240453761$24045376$1$I$$20240620$20240703$20240703$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01037$INTRA-CELLULAR THERAPIES$$35$YR$$F$Y$$$20240703$$HP$US$US
240453781$24045378$1$I$$20240625$20240703$20240703$EXP$$US-AUROBINDO-AUR-APL-2024-031960$AUROBINDO$Olmsted A, DeSimone A, Lopez-Pastrana J, Becker M.. Fetal demise and Wernicke?Korsakof  syndrome in a patient with hyperemesis  gravidarum: a case report.. J-Med-Case-Rep. 2023;17:1$33$YR$$F$Y$$$20240703$$HP$US$US
240453791$24045379$1$I$20230925$20240618$20240703$20240703$EXP$FR-AFSSAPS-LM2024000317$FR-TEVA-VS-3211990$TEVA$$42$YR$$F$Y$83$KG$20240703$$MD$FR$FR
240453802$24045380$2$F$20240614$20240719$20240703$20240723$EXP$$IT-REGENERON PHARMACEUTICALS, INC.-2024-089195$REGENERON$$72$YR$$M$Y$$$20240723$$MD$IT$IT
240453815$24045381$5$F$20240101$20240813$20240703$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-019671$UNITED THERAPEUTICS$$$$$F$Y$$$20240817$$$US$US
240453821$24045382$1$I$20240624$20240625$20240703$20240703$EXP$$DE-TEVA-VS-3214859$TEVA$$60$YR$$F$Y$$$20240703$$CN$DE$DE
240453831$24045383$1$I$20240101$20240626$20240703$20240703$EXP$$US-TEVA-VS-3215525$TEVA$$$$$M$Y$$$20240703$$CN$US$US
240453841$24045384$1$I$20240625$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46385$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240453852$24045385$2$F$$20240626$20240703$20240709$PER$$US-ALXN-202406USA001791US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240453862$24045386$2$F$20240420$20240709$20240703$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-032386$AUROBINDO$$46$YR$$F$Y$$$20240717$$MD$US$US
240453872$24045387$2$F$20230101$20240715$20240703$20240723$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019305$VALIDUS$$$$$$Y$$$20240723$$MD$US$US
240453881$24045388$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46321$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240453891$24045389$1$I$$20240626$20240703$20240703$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019302$VALIDUS$$$$$$Y$$$20240703$$CN$US$US
240453901$24045390$1$I$$20240624$20240703$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-005611$UNITED THERAPEUTICS$$$$$F$Y$106.58$KG$20240703$$$US$US
240453911$24045391$1$I$20240425$20240701$20240703$20240703$EXP$GB-MHRA-30958493$GB-MYLANLABS-2024M1061810$MYLAN$$74$YR$$F$Y$$$20240703$$PH$GB$GB
240453924$24045392$4$F$$20240904$20240703$20240911$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003680$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240911$$HP$US$US
240453931$24045393$1$I$$20240702$20240703$20240703$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037317$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240703$$MD$US$US
240453942$24045394$2$F$20180422$20240828$20240703$20240830$PER$$US-GILEAD-2024-0679370$GILEAD$$51$YR$A$M$Y$$$20240830$$LW$US$US
240453961$24045396$1$I$20240521$20240702$20240703$20240703$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-093001$REGENERON$$$$$M$Y$$$20240703$$CN$CA$CA
240453971$24045397$1$I$20240618$20240627$20240703$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-019822$UNITED THERAPEUTICS$$62$YR$$M$Y$$$20240703$$$US$US
240453985$24045398$5$F$20240506$20240709$20240703$20240718$30DAY$$US-ALKERMES INC.-ALK-2024-001745$ALKERMES$$49$YR$$M$Y$$$20240718$$PH$US$US
240453991$24045399$1$I$$20240625$20240703$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-019842$UNITED THERAPEUTICS$$$$$F$Y$99.773$KG$20240703$$$US$US
240454001$24045400$1$I$$20230720$20240703$20240703$PER$$US-AMGEN-USASP2023235475$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240454012$24045401$2$F$20240501$20240529$20240703$20240712$30DAY$$US-UCBSA-2024027233$UCB$$58$YR$$F$Y$$$20240712$$CN$US$US
240454022$24045402$2$F$$20240618$20240703$20240719$EXP$$US-TEVA-VS-3212072$TEVA$$53$YR$$F$Y$70.3$KG$20240719$$CN$US$US
240454031$24045403$1$I$20190401$20240625$20240703$20240703$EXP$$FR-AUROBINDO-AUR-APL-2024-031750$AUROBINDO$$64$YR$$M$Y$$$20240703$$MD$FR$FR
240454042$24045404$2$F$$20240708$20240703$20240709$EXP$GB-MHRA-MED-202406281441057610-CBYGW$GB-ORGANON-O2407GBR000037$ORGANON$$$$$$Y$$$20240709$$CN$GB$GB
240454052$24045405$2$F$$20240701$20240703$20240712$PER$$US-ROCHE-10000013448$ROCHE$$$$A$F$Y$$$20240712$$CN$US$US
240454062$24045406$2$F$20240101$20240701$20240703$20240710$EXP$$GB-MYLANLABS-2024M1061823$MYLAN$$88$YR$$M$Y$$$20240710$$MD$GB$GB
240454072$24045407$2$F$20201006$20240703$20240703$20240708$EXP$$DE-MYLANLABS-2021M1042458$MYLAN$$$$E$F$Y$78$KG$20240708$$HP$DE$DE
240454082$24045408$2$F$$20240703$20240703$20240709$EXP$$US-GSK-US2024081667$GLAXOSMITHKLINE$$$$$F$Y$$$20240709$$CN$US$US
240454091$24045409$1$I$20240228$20240627$20240703$20240703$EXP$$RU-REGENERON PHARMACEUTICALS, INC.-2024-092666$REGENERON$$37$YR$$M$Y$$$20240703$$HP$RU$RU
240454101$24045410$1$I$20240618$20240624$20240703$20240703$EXP$$JP-NEBO-662966$PHARMACOSMOS$$49$YR$$F$Y$$$20240703$$MD$JP$JP
240454113$24045411$3$F$20240624$20240701$20240703$20240913$EXP$$JP-ROCHE-10000011812$ROCHE$$80$YR$E$M$Y$$$20240913$$PH$JP$JP
240454121$24045412$1$I$20190211$20240628$20240703$20240703$EXP$$PL-BAUSCH-BL-2024-010091$BAUSCH AND LOMB$$62$YR$$$Y$$$20240703$$MD$PL$PL
240454132$24045413$2$F$$20240710$20240703$20240715$EXP$$JP-009507513-2406JPN003989J$MERCK$$69$YR$$M$Y$$$20240715$$PH$JP$JP
240454141$24045414$1$I$$20240628$20240703$20240703$EXP$$AU-JAZZ PHARMACEUTICALS-2024-AU-010026$JAZZ$$$$$M$Y$$$20240703$$HP$AU$AU
240454151$24045415$1$I$$20240701$20240703$20240703$EXP$$CA-BAUSCH-BL-2024-010181$BAUSCH AND LOMB$$$$$$Y$$$20240703$$HP$CA$CA
240454161$24045416$1$I$$20231013$20240703$20240703$PER$$US-AMGEN-USASP2023235188$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240454171$24045417$1$I$$20240702$20240703$20240703$EXP$$US-BAUSCH-BL-2024-010205$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240703$$HP$US$US
240454183$24045418$3$F$20240621$20240627$20240703$20240704$PER$$US-JNJFOC-20240659111$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240704$$CN$US$US
240454193$24045419$3$F$$20240807$20240703$20240812$PER$$US-ROCHE-10000012368$ROCHE$$$$A$M$Y$$$20240812$$CN$US$US
240454201$24045420$1$I$20240601$20240624$20240703$20240703$PER$$US-JNJFOC-20240665991$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240703$$CN$US$US
240454221$24045422$1$I$$20240701$20240703$20240703$PER$$US-ABBVIE-5822745$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240454231$24045423$1$I$$20240702$20240702$20240702$DIR$708820$$FDA-CTU$$$$$M$N$103.5$KG$20240702$Y$CN$US$
240454241$24045424$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46304$$FDA-CTU$$53$YR$$F$N$$$20240702$N$$US$
240454271$24045427$1$I$$20240624$20240703$20240703$EXP$$FR-EXELIXIS-CABO-24078997$EXELIXIS$$$$$M$Y$$$20240703$$MD$FR$FR
240454281$24045428$1$I$$20240621$20240703$20240703$EXP$$KR-TEVA-VS-3213775$TEVA$$76$YR$$M$Y$$$20240703$$CN$KR$KR
240454292$24045429$2$F$20240513$20240702$20240703$20240710$EXP$FR-AFSSAPS-LL2024001083$FR-TEVA-VS-3211540$TEVA$$21$YR$$F$Y$$$20240710$$MD$FR$FR
240454322$24045432$2$F$$20240814$20240703$20240820$EXP$$AU-JAZZ PHARMACEUTICALS-2024-AU-010144$JAZZ$$$$$M$Y$$$20240820$$MD$AU$AU
240454334$24045433$4$F$20221201$20240904$20240703$20240906$EXP$$CA-GSK-CA2023093856$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$CA$CA
240454341$24045434$1$I$20231001$20240618$20240703$20240703$EXP$FR-AFSSAPS-MP2024000683$FR-TEVA-VS-3194536$TEVA$$11$YR$$M$Y$$$20240703$$MD$FR$FR
240454351$24045435$1$I$20220507$20240624$20240703$20240703$EXP$$GB-TEVA-VS-3213437$TEVA$$61$YR$$F$Y$$$20240703$$PH$GB$GB
240454364$24045436$4$F$20240623$20240808$20240703$20240814$EXP$$US-Eisai-EC-2024-169276$EISAI$$68$YR$E$M$Y$72.25$KG$20240814$$MD$US$US
240454371$24045437$1$I$20240506$20240624$20240703$20240703$EXP$IT-MINISAL02-990541$IT-TEVA-VS-3213835$TEVA$$64$YR$$M$Y$$$20240703$$MD$IT$IT
240454391$24045439$1$I$$20240627$20240703$20240703$EXP$$US-MYLANLABS-2024M1062179$MYLAN$Habib A, Butt K, Ibrahim R, Shaaban A, Lee HS. BRASH syndrome: A rare but reversible cause of sinus node dysfunction. HeartRhythm-Case-Rep 2024; 10 (6): 398-401.$57$YR$$F$Y$$$20240703$$MD$US$US
240454401$24045440$1$I$$20240702$20240703$20240703$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037357$BOEHRINGER INGELHEIM$Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 Annual Report of the American Association of Poison Control Centers??? National Poison Data System (NPDS): 34th Annual Report. Clinical Toxicoogy, DOI: 10.1080/15563650.2017.1388087 2017; :1-181.$60$YR$A$M$Y$$$20240703$$MD$US$US
240454411$24045441$1$I$20240228$20240624$20240703$20240703$EXP$FR-AFSSAPS-ST2024001072$FR-TEVA-VS-3213847$TEVA$$28$YR$$M$Y$75$KG$20240703$$MD$FR$FR
240454421$24045442$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024033793$EMD SERONO INC$$$$A$F$Y$$$20240703$$HP$US$US
240454431$24045443$1$I$20220806$20240626$20240703$20240703$EXP$$US-BAYER-2024A092477$BAYER$$25$YR$A$F$Y$$$20240703$$CN$US$US
240454442$24045444$2$F$$20240802$20240703$20240802$PER$$US-ALXN-202406USA001902US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
240454451$24045445$1$I$$20240625$20240703$20240703$EXP$$IN-ROCHE-10000011421$ROCHE$$$$E$M$Y$$$20240703$$CN$IN$IN
240454463$24045446$3$F$20150101$20240910$20240703$20240912$PER$$US-GILEAD-2024-0679411$GILEAD$$38$YR$A$F$Y$$$20240912$$LW$US$US
240454471$24045447$1$I$$20240624$20240703$20240703$EXP$$US-MYLANLABS-2024M1058399$MYLAN$$67$YR$$F$Y$$$20240703$$CN$US$US
240454481$24045448$1$I$20240521$20240625$20240703$20240703$EXP$IT-MINISAL02-990874$IT-TEVA-VS-3214481$TEVA$$74$YR$$F$Y$$$20240703$$MD$IT$IT
240454503$24045450$3$F$20161102$20240829$20240703$20240830$EXP$$US-GILEAD-2024-0679374$GILEAD$$53$YR$A$M$Y$$$20240830$$LW$US$US
240454511$24045451$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001838$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240703$$CN$US$US
240454521$24045452$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001151$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240703$$CN$US$US
240454531$24045453$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001025$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240703$$CN$US$US
240454541$24045454$1$I$20240630$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001997$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240703$$CN$US$US
240454551$24045455$1$I$20240627$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001088$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$US$US
240454561$24045456$1$I$20240628$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001147$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240703$$CN$US$US
240454571$24045457$1$I$$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000863$ELI LILLY AND CO$$$$A$M$Y$$$20240703$$CN$US$US
240454581$24045458$1$I$$20240626$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406018587$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240703$$CN$US$US
240454591$24045459$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000997$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240703$$CN$US$US
240454601$24045460$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001311$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240703$$CN$US$US
240454611$24045461$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001606$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240703$$CN$US$US
240454621$24045462$1$I$20240501$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001159$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240703$$CN$US$US
240454631$24045463$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001968$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240703$$CN$US$US
240454641$24045464$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001408$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$US$US
240454652$24045465$2$F$20240701$20240702$20240703$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001896$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240704$$CN$US$US
240454661$24045466$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001237$ELI LILLY AND CO$$$$$M$Y$$$20240703$$CN$US$US
240454671$24045467$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001068$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240703$$CN$US$US
240454681$24045468$1$I$20240701$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407002111$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240703$$CN$US$US
240454692$24045469$2$F$20240624$20240715$20240703$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407001339$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$US$US
240454701$24045470$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001178$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240703$$CN$US$US
240454711$24045471$1$I$$20240627$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406019388$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240703$$CN$US$US
240454722$24045472$2$F$20240630$20240701$20240703$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407000977$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240705$$CN$US$US
240454731$24045473$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407002097$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240703$$CN$US$US
240454741$24045474$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001512$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240703$$CN$US$US
240454751$24045475$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407002045$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240703$$CN$US$US
240454761$24045476$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407002130$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240703$$CN$US$US
240454771$24045477$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001981$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240703$$CN$US$US
240454781$24045478$1$I$20240301$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001050$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240703$$CN$US$US
240454801$24045480$1$I$$20240611$20240703$20240703$PER$$US-JNJFOC-20240630683$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240454812$24045481$2$F$$20240726$20240703$20240808$30DAY$$FR-JNJFOC-20240678453$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$PH$FR$FR
240454821$24045482$1$I$$20240624$20240703$20240703$EXP$$US-JNJFOC-20240701978$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$MD$US$US
240454831$24045483$1$I$20240101$20240701$20240703$20240703$EXP$$US-PFIZER INC-2020328081$PFIZER$$69$YR$$F$Y$$$20240703$$CN$US$US
240454841$24045484$1$I$$20240625$20240703$20240703$EXP$$DE-JNJFOC-20240670000$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240703$$HP$DE$DE
240454853$24045485$3$F$20240604$20240702$20240703$20240703$EXP$$US-PFIZER INC-PV202400086469$PFIZER$$80$YR$$F$Y$$$20240703$$HP$US$US
240454862$24045486$2$F$20190101$20240703$20240703$20240704$EXP$$US-PFIZER INC-PV202400087034$PFIZER$$57$YR$$F$Y$$$20240704$$HP$US$US
240454871$24045487$1$I$$20240701$20240702$20240702$DIR$FDA-CDER-CTU-2024-46305$$FDA-CTU$$$$$F$N$$$20240701$N$HP$US$
240454881$24045488$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46307$$FDA-CTU$$60$YR$$F$N$$$20240702$N$$US$
240454891$24045489$1$I$$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024128731$AMGEN$$85$YR$E$F$Y$$$20240703$$CN$US$US
240454901$24045490$1$I$20240101$20240627$20240703$20240703$EXP$$US-AMGEN-USASP2024127833$AMGEN$$29$YR$A$M$Y$$$20240703$$CN$US$US
240454911$24045491$1$I$$20231228$20240703$20240703$PER$$US-AMGEN-USASP2023235425$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240454921$24045492$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46308$$FDA-CTU$$61$YR$$F$N$130.63$KG$20240702$N$$US$
240454931$24045493$1$I$20240616$20240701$20240702$20240702$DIR$FDA-CDER-CTU-2024-46309$$FDA-CTU$$54$YR$$F$N$$$20240701$N$HP$US$
240454941$24045494$1$I$$20230828$20240703$20240703$PER$$US-AMGEN-USASP2023235354$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240454961$24045496$1$I$20240307$20240618$20240703$20240703$EXP$FR-AFSSAPS-PP2024000620$FR-TEVA-VS-3211987$TEVA$$52$YR$$F$Y$76$KG$20240703$$MD$FR$FR
240454971$24045497$1$I$20240223$20240702$20240703$20240703$EXP$$ES-ROCHE-10000001826$ROCHE$$45$YR$A$M$Y$$$20240703$$MD$ES$ES
240454986$24045498$6$F$20240101$20240815$20240703$20240826$EXP$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000579$DECIPHERA PHARMACEUTICALS$$59$YR$A$M$Y$$$20240826$$HP$US$US
240454992$24045499$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3214163$TEVA$Karczewski D, Backer H, Andronic O, Bedi A, Adelhoefer S, Mullner M, et al. Serratia marcescens prosthetic joint infection: two case reports and a review of the literature. J-Med-Case-Rep 2023; 17 (1):.; Karczewski D, Backer H, Andronic O, Bedi A, Adelhoefer S, Mullner M, et al. Serratia marcescens prosthetic joint infection: two case reports and a review of the literature. J-Med-Case-Rep 2023; 17 (1):.$72$YR$$F$Y$$$20240717$$HP$US$US
240455001$24045500$1$I$20240514$20240627$20240703$20240703$EXP$$US-ROCHE-10000015225$ROCHE$$68$YR$E$F$Y$$$20240703$$CN$US$US
240455011$24045501$1$I$$20230823$20240703$20240703$PER$$US-AMGEN-USASP2023235066$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240455021$24045502$1$I$20240528$20240628$20240703$20240703$EXP$$US-ABBVIE-5821982$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240455031$24045503$1$I$$20240621$20240703$20240703$30DAY$$US-JNJFOC-20240678101$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$PH$US$US
240455061$24045506$1$I$$20240624$20240703$20240703$PER$$US-PFM-2024-03712$PIERRE FABRE MEDICAMENT$Edminster S, Ji J,  Zhou S, Schmidt R, Rebhun C, Chang J et al. Aggressive Periorbital Epithelioid Hemangioma with GATA6:FOXO1 Fusion and Low-level  KRAS Mutation$15$YR$$M$Y$$$20240703$$HP$US$US
240455071$24045507$1$I$$20240701$20240703$20240703$EXP$$US-PFIZER INC-2020092257$PFIZER$$83$YR$$M$Y$68.04$KG$20240703$$CN$US$US
240455082$24045508$2$F$$20240807$20240703$20240812$EXP$$US-PFIZER INC-PV202400085268$PFIZER$$83$YR$$M$Y$$$20240812$$HP$US$US
240455093$24045509$3$F$$20240903$20240703$20240905$30DAY$$JO-PFIZER INC-202400193822$PFIZER$$$$$$Y$$$20240905$$CN$JO$JO
240455101$24045510$1$I$20240601$20240701$20240703$20240703$EXP$$US-PFIZER INC-PV202400086710$PFIZER$$65$YR$$F$Y$$$20240703$$HP$US$US
240455114$24045511$4$F$20240601$20240822$20240703$20240828$EXP$$US-PFIZER INC-202400204877$PFIZER$$64$YR$$F$Y$74.4$KG$20240828$$HP$US$US
240455124$24045512$4$F$$20240903$20240703$20240905$30DAY$$JO-PFIZER INC-202400193821$PFIZER$$$$$$Y$$$20240905$$CN$JO$JO
240455131$24045513$1$I$20240701$20240701$20240703$20240703$EXP$$US-PFIZER INC-202400204650$PFIZER$$77$YR$$M$Y$$$20240703$$CN$US$US
240455141$24045514$1$I$$20240702$20240703$20240703$EXP$$US-PFIZER INC-PV202200119772$PFIZER$$88$YR$$M$Y$$$20240703$$CN$US$US
240455153$24045515$3$F$20240601$20240911$20240703$20240916$EXP$$CA-PFIZER INC-202400203239$PFIZER$$77$YR$$M$Y$$$20240916$$MD$CA$CA
240455162$24045516$2$F$20240101$20240824$20240703$20240826$EXP$$CA-PFIZER INC-202300312862$PFIZER$$54$YR$$F$Y$128$KG$20240826$$MD$CA$CA
240455171$24045517$1$I$20240503$20240627$20240703$20240703$EXP$$DE-BAYER-2024A066784$BAYER$$81$YR$E$M$Y$$$20240703$$CN$DE$DE
240455181$24045518$1$I$$20240621$20240703$20240703$EXP$$US-MYLANLABS-2024M1058643$MYLAN$$$$$M$Y$101.15$KG$20240703$$CN$US$US
240455193$24045519$3$F$$20240903$20240703$20240905$30DAY$$JO-PFIZER INC-202400193823$PFIZER$$$$$$Y$$$20240905$$CN$JO$JO
240455205$24045520$5$F$$20240903$20240703$20240905$30DAY$$JO-PFIZER INC-202400193791$PFIZER$$$$$$Y$$$20240905$$CN$JO$JO
240455221$24045522$1$I$20240606$20240611$20240703$20240703$EXP$$IN-ROCHE-10000003762$ROCHE$$55$YR$A$F$Y$$$20240703$$CN$IN$IN
240455231$24045523$1$I$$20240624$20240703$20240703$EXP$$US-RDY-LIT/USA/24/0009432$DR REDDYS$Alghizzawi M, Alsakarneh S, Fouad J, Sallam Y, Fahel A, Sabobeh T. Monomicrobial Clostridium Difficile Bacteremia: An Exceptionally Rare Presentation of Bowel Ischemia. American Journal of Respiratory and Critical Care Medicine. 2024;209: A1657. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1657.$34$YR$A$M$Y$$$20240703$$HP$US$US
240455241$24045524$1$I$20240503$20240701$20240703$20240703$EXP$$US-ABBVIE-5823377$ABBVIE$$81$YR$$M$Y$$$20240703$$CN$US$US
240455251$24045525$1$I$$20240628$20240703$20240703$PER$$US-Merz Pharmaceuticals GmbH-24-02323$MERZ$$$$$$Y$$$20240703$$HP$US$US
240455261$24045526$1$I$20240618$20240620$20240703$20240703$EXP$$US-INSMED, INC.-2024-00491-US$INSMED$$93$YR$$F$Y$$$20240703$$CN$US$US
240455271$24045527$1$I$$20231016$20240703$20240703$PER$$US-AMGEN-USASP2023235298$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240455291$24045529$1$I$20240519$20240620$20240703$20240703$EXP$ES-AEMPS-1534656$ES-TEVA-VS-3213387$TEVA$$77$YR$$M$Y$$$20240703$$MD$ES$ES
240455302$24045530$2$F$20240101$20240701$20240703$20240903$PER$$US-Merz Pharmaceuticals GmbH-24-02326$MERZ$$$$$F$Y$$$20240904$$HP$US$US
240455312$24045531$2$F$20240625$20240716$20240703$20240723$PER$$US-MYLANLABS-2024M1060524$MYLAN$$75$YR$$F$Y$$$20240723$$CN$US$US
240455332$24045533$2$F$$20240703$20240703$20240708$EXP$GB-MHRA-MED-202406291157398850-KGTCR$GB-MYLANLABS-2024M1062033$MYLAN$$30$YR$$M$Y$$$20240708$$CN$GB$GB
240455341$24045534$1$I$20240701$20240702$20240703$20240703$EXP$GB-MHRA-MED-202407021200033630-CDZPF$GB-MYLANLABS-2024M1062085$MYLAN$$55$YR$$F$Y$$$20240703$$HP$GB$GB
240455351$24045535$1$I$$20240625$20240703$20240703$EXP$$US-MYLANLABS-2024M1060845$MYLAN$Alsakha A, Marraffa JM. Ifosfamide neurotoxicity treated with methylene blue complicated by serotonin toxicity. Clin-Toxicol-(Phila) 2023; 61 106-107 abstr. 223.$54$YR$$F$Y$$$20240703$$HP$US$US
240455371$24045537$1$I$$20240611$20240703$20240703$EXP$$IN-ROCHE-10000003419$ROCHE$$47$YR$A$F$Y$$$20240703$$CN$IN$IN
240455381$24045538$1$I$$20240621$20240703$20240703$30DAY$$US-JNJFOC-20240676292$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$US$US
240455391$24045539$1$I$$20240625$20240703$20240703$EXP$$US-KOANAAP-SML-US-2024-00617$Unknown Manufacturer$R V, D N, M L. ^Lazarus Response^ Upon Initiation of Targeted Oncogenic Therapy for Acute Respiratory Failure in Rapidly Progressive ALK-Positive Pulmonary Adenocarcinoma. Am-J-Respir-Crit-Care-Med. 2024;$53$YR$A$F$Y$$$20240703$$MD$US$US
240455401$24045540$1$I$$20240625$20240703$20240703$EXP$$US-KOANAAP-SML-US-2024-00616$Unknown Manufacturer$Wu YF, Skinner L, Lewis J, Khodadoust MS, Kim YH, Kwong BY. Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell Transplantation. Cancer-Invest. 2023 Jan 31;263-270. doi:10.1080/07357907.2021.1919696.$37$YR$A$M$Y$$$20240703$$MD$US$US
240455411$24045541$1$I$20190426$20240626$20240703$20240703$PER$$US-009507513-2406USA009231$MERCK$$$$$M$Y$$$20240703$$CN$US$US
240455421$24045542$1$I$$20240626$20240703$20240703$PER$$US-BIOGEN-2024BI01271406$BIOGEN$$$$$M$Y$$$20240703$$CN$US$US
240455431$24045543$1$I$$20240628$20240703$20240703$PER$$US-ABBVIE-5823783$ABBVIE$$$$$$Y$$$20240703$$HP$US$US
240455442$24045544$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3214175$TEVA$Clos ALT, Mittelman A. Man with recurrent rash. J-Am-Coll-Emerg-Physicians-Open 2023; 4 (2): 1-2.; Clos ALT, Mittelman A. Man with recurrent rash. J-Am-Coll-Emerg-Physicians-Open 2023; 4 (2): 1-2.$33$YR$$M$Y$$$20240717$$MD$US$US
240455451$24045545$1$I$20240611$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130723$AMGEN$$86$YR$E$F$Y$$$20240703$$MD$US$US
240455461$24045546$1$I$20240628$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024131223$AMGEN$$74$YR$E$M$Y$$$20240703$$CN$US$US
240455471$24045547$1$I$$20240702$20240703$20240703$PER$$US-HALEON-2185022$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240455483$24045548$3$F$20220706$20240829$20240703$20240830$EXP$$US-GILEAD-2024-0679395$GILEAD$$51$YR$A$M$Y$$$20240830$$LW$US$US
240455492$24045549$2$F$20150619$20240924$20240703$20240926$PER$$US-GILEAD-2024-0679377$GILEAD$$49$YR$A$F$Y$$$20240926$$LW$US$US
240455501$24045550$1$I$$20240628$20240703$20240703$EXP$$JP-EMD Serono-2024035758$EMD SERONO INC$$64$YR$A$M$Y$$$20240703$$MD$JP$JP
240455511$24045551$1$I$20240620$20240624$20240703$20240703$EXP$$IL-ROCHE-10000014391$ROCHE$$60$YR$A$F$Y$$$20240703$$CN$IL$IL
240455521$24045552$1$I$20240412$20240618$20240703$20240703$EXP$FR-AFSSAPS-NY2024000637$FR-TEVA-VS-3212142$TEVA$$78$YR$$M$Y$$$20240703$$MD$FR$FR
240455531$24045553$1$I$20240618$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46355$$FDA-CTU$$71$YR$$F$N$$$20240702$Y$PH$US$
240455543$24045554$3$F$$20240726$20240703$20240807$30DAY$$CA-JNJFOC-20240665546$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240807$$CN$CA$CA
240455551$24045555$1$I$20240101$20240702$20240703$20240703$EXP$$US-UCBSA-2024033510$UCB$$$$$F$Y$$$20240703$$CN$US$US
240455561$24045556$1$I$20240618$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46371$$FDA-CTU$$71$YR$$F$N$$$20240702$Y$HP$US$
240455571$24045557$1$I$20240610$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46320$$FDA-CTU$$77$YR$$M$N$$$20240702$Y$PH$US$
240455581$24045558$1$I$20240627$20240628$20240703$20240703$EXP$$FR-UCBSA-2024033572$UCB$$$$$F$Y$$$20240703$$MD$FR$FR
240455591$24045559$1$I$$20240628$20240703$20240703$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010097$JAZZ$$$$$M$Y$41$KG$20240703$$MD$US$US
240455601$24045560$1$I$$20240627$20240703$20240703$EXP$$US-BAYER-2024A093283$BAYER$$$$$$Y$$$20240703$$CN$US$US
240455613$24045561$3$F$$20240916$20240703$20240920$EXP$$PL-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00251$VELOXIS PHARMACEUTICALS$Pempkowiak M, Chamienia A, Debska-Slizieh A and Rutkowski B. Progressive multifocal leukoencellhalopathy in a kidney transplant recipient case report and review of the literature. Renal disease and forum. 2024;17 (1):25-32$48$YR$$F$Y$$$20240920$$MD$PL$PL
240455621$24045562$1$I$$20240620$20240703$20240703$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05689$LUPIN$Singh N, Ramonell RP, Cody B, Dunlap DG. A growing concern: Solitary pulmonary nodule caused by Pneumocystis jirovecci in an immunocompromised patient. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2381$71$YR$$M$Y$$$20240703$$HP$US$US
240455631$24045563$1$I$20240530$20240621$20240703$20240703$EXP$GB-MHRA-MED-202406211000315570-CSBDQ$GB-TEVA-VS-3212589$TEVA$$58$YR$$M$Y$$$20240703$$PH$GB$GB
240455642$24045564$2$F$20240627$20240719$20240703$20240726$PER$$US-AMGEN-USASP2024128588$AMGEN$$23$YR$A$M$Y$$$20240726$$PH$US$US
240455651$24045565$1$I$$20240625$20240703$20240703$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001317$BLUEPRINT MEDICINES$$$$$M$Y$$$20240703$$CN$US$US
240455661$24045566$1$I$$20240618$20240703$20240703$EXP$$US-ENDO USA, INC.-2024-002715$ENDO$$$$$M$Y$$$20240703$$CN$US$US
240455672$24045567$2$F$$20240722$20240703$20240729$EXP$$GB-AMGEN-GBRSL2024121290$AMGEN$$57$YR$A$F$Y$$$20240729$$CN$GB$GB
240455681$24045568$1$I$20240601$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130511$AMGEN$$81$YR$E$$Y$$$20240703$$CN$US$US
240455691$24045569$1$I$$20240618$20240703$20240703$EXP$$US-TRIGEN LABORATORIES-2024ALO00299$Unknown Manufacturer$A. J. Chaudhary, M. Z. Khan, A. Sohail, S. M. H. Zaidi, E. Denha, D. Venkat. Acute onset nitrofurantoin-induced autoimmune hepatitis after urinary tract infection treatment. Clin Case Rep.. 2024;12:e9050$84$YR$$F$Y$$$20240703$$HP$US$US
240455701$24045570$1$I$20240401$20240624$20240703$20240703$EXP$SE-SEMPA-2024-004854$SE-TEVA-VS-3213846$TEVA$$75$YR$$M$Y$$$20240703$$MD$SE$SE
240455712$24045571$2$F$20240621$20240710$20240703$20240716$PER$$US-BIOGEN-2024BI01271328$BIOGEN$$44$YR$$F$Y$$$20240716$$CN$US$US
240455721$24045572$1$I$$20240626$20240703$20240703$PER$$US-BIOGEN-2024BI01271361$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
240455731$24045573$1$I$20240607$20240613$20240703$20240703$PER$$US-BAYER-2024A094047$BAYER$$41$YR$A$F$Y$$$20240703$$CN$US$US
240455741$24045574$1$I$$20240103$20240703$20240703$PER$$US-AMGEN-USASP2024129920$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240455782$24045578$2$F$$20240627$20240703$20240709$EXP$$US-ROCHE-10000011436$ROCHE$$72$YR$E$F$Y$$$20240708$$CN$US$US
240455791$24045579$1$I$20231125$20240626$20240703$20240703$EXP$$FR-AstraZeneca-2024A152154$ASTRAZENECA$$2$WK$$F$Y$3.7$KG$20240703$$MD$FR$
240455803$24045580$3$F$$20240802$20240703$20240809$EXP$$CA-AstraZeneca-2024A148350$ASTRAZENECA$$$$$F$Y$$$20240809$$MD$CA$
240455811$24045581$1$I$20230703$20240702$20240702$20240702$DIR$708829$$FDA-CTU$$53$YR$$F$N$$$20240702$N$PH$US$
240455821$24045582$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46382$$FDA-CTU$$82$YR$$M$N$$$20240702$N$$US$
240455831$24045583$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001388$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240703$$CN$US$US
240455841$24045584$1$I$$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406201444405110-YQJGC$GB-ELI_LILLY_AND_COMPANY-GB202406014120$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$GB$GB
240455851$24045585$1$I$20240101$20240620$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015116$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240703$$CN$US$US
240455861$24045586$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001380$ELI LILLY AND CO$$$$$M$Y$$$20240703$$CN$US$US
240455871$24045587$1$I$$20240621$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015422$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240703$$CN$US$US
240455881$24045588$1$I$20221201$20240620$20240703$20240703$EXP$$SE-ELI_LILLY_AND_COMPANY-SE202406015061$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240703$$CN$SE$SE
240455901$24045590$1$I$$20240626$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406019031$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240703$$CN$US$US
240455911$24045591$1$I$$20240621$20240703$20240703$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202406010126$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$BR$BR
240455921$24045592$1$I$$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406202312564760-MNGWQ$GB-ELI_LILLY_AND_COMPANY-GB202406014881$ELI LILLY AND CO$$$$$F$Y$117$KG$20240703$$CN$GB$GB
240455931$24045593$1$I$20240629$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001258$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240703$$CN$US$US
240455941$24045594$1$I$$20240621$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015287$ELI LILLY AND CO$$$$$F$Y$$$20240703$$HP$US$US
240455951$24045595$1$I$$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406201426399860-STKMD$GB-ELI_LILLY_AND_COMPANY-GB202406014194$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$GB$GB
240455961$24045596$1$I$20080201$20240625$20240703$20240703$EXP$$JP-JNJFOC-20240707599$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240703$$MD$JP$JP
240455971$24045597$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106175$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240703$$CN$US$US
240455982$24045598$2$F$$20240705$20240703$20240724$EXP$$MX-JNJFOC-20240658962$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$60$KG$20240724$$HP$MX$MX
240456002$24045600$2$F$$20240729$20240703$20240801$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003686$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
240456011$24045601$1$I$20240601$20240627$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103854$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240703$$CN$US$US
240456021$24045602$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024033797$EMD SERONO INC$$$$A$F$Y$$$20240703$$HP$US$US
240456032$24045603$2$F$$20240710$20240703$20240712$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010150$JAZZ$$$$$M$Y$$$20240711$$HP$US$US
240456041$24045604$1$I$20240501$20240627$20240703$20240703$EXP$$JP-009507513-2406JPN003996J$MERCK$$$$$F$Y$$$20240703$$MD$JP$JP
240456071$24045607$1$I$$20240625$20240703$20240703$PER$$US-AMGEN-USASP2024126601$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240456082$24045608$2$F$$20240701$20240703$20240708$EXP$$US-BAUSCHBL-2024BNL029305$BAUSCH AND LOMB$$$$$F$Y$$$20240708$$HP$US$US
240456091$24045609$1$I$$20240628$20240703$20240703$EXP$$AT-BAUSCHBL-2024BNL029332$BAUSCH AND LOMB$$$$$$Y$$$20240703$$CN$AT$AT
240456101$24045610$1$I$$20240624$20240703$20240703$EXP$$US-TEVA-VS-3214216$TEVA$Balasubramanian P, Moreau C, Ahmad T, Inzucchi SE. Extreme High Insulin Requirements in Two Non- Diabetic Patients Following Cardiac Transplantation. J-Endocr-Soc 2021; 5 (Suppl. 1) A383.$49$YR$$M$Y$$$20240703$$MD$US$US
240456112$24045611$2$F$20160526$20240831$20240703$20240903$PER$$US-GILEAD-2024-0679399$GILEAD$$52$YR$A$M$Y$$$20240903$$LW$US$US
240456121$24045612$1$I$$20230713$20240703$20240703$PER$$US-AMGEN-USASP2023235372$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240456131$24045613$1$I$$20230628$20240703$20240703$PER$$US-AMGEN-USASP2023235412$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240456141$24045614$1$I$$20230601$20240703$20240703$PER$$US-AMGEN-USASP2023235295$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240456151$24045615$1$I$20230101$20240611$20240703$20240703$PER$$BR-TOLMAR, INC.-24BR050147$TOLMAR$$$$$M$Y$$$20240703$$CN$BR$BR
240456161$24045616$1$I$$20240611$20240703$20240703$PER$$AU-TOLMAR, INC.-24AU050145$TOLMAR$$$$$M$Y$$$20240703$$CN$AU$AU
240456171$24045617$1$I$20240531$20240619$20240703$20240703$EXP$IT-MINISAL02-989902$IT-TEVA-VS-3212894$TEVA$$65$YR$$F$Y$55$KG$20240703$$MD$IT$IT
240456181$24045618$1$I$$20240611$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA049707$TOLMAR$$$$$M$Y$$$20240703$$CN$CA$CA
240456192$24045619$2$F$20240603$20240905$20240703$20240924$PER$$CA-TOLMAR, INC.-24CA049923$TOLMAR$$90$YR$$M$Y$$$20240924$$CN$CA$CA
240456201$24045620$1$I$20240502$20240611$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA049895$TOLMAR$$79$YR$$M$Y$$$20240703$$CN$CA$CA
240456211$24045621$1$I$$20230831$20240703$20240703$PER$$US-AMGEN-USASP2023235313$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240456221$24045622$1$I$$20230823$20240703$20240703$PER$$US-AMGEN-USASP2023235378$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240456231$24045623$1$I$$20231017$20240703$20240703$PER$$US-AMGEN-USASP2023235216$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240456241$24045624$1$I$$20240103$20240703$20240703$PER$$US-AMGEN-USASP2024130393$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240456251$24045625$1$I$20240625$20240628$20240703$20240703$EXP$$US-BAYER-2024A094908$BAYER$$64$YR$A$F$Y$$$20240703$$CN$US$US
240456261$24045626$1$I$20240501$20240701$20240703$20240703$PER$$US-Eisai-EC-2024-169258$EISAI$$77$YR$E$F$Y$$$20240703$$CN$US$US
240456271$24045627$1$I$$20240628$20240703$20240703$PER$$US-ABBVIE-5823110$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240456281$24045628$1$I$$20240625$20240703$20240703$PER$$US-MYLANLABS-2024M1060715$MYLAN$$$$$F$Y$$$20240703$$CN$US$US
240456291$24045629$1$I$$20240702$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US062443$SANDOZ$$$$$$Y$$$20240703$$CN$US$US
240456301$24045630$1$I$$20240625$20240703$20240703$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004789$BIOCON$$$$$$Y$$$20240703$$HP$CA$CA
240456321$24045632$1$I$$20240620$20240703$20240703$EXP$$CA-B.Braun Medical Inc.-2158804$B BRAUN$$38$YR$$F$Y$$$20240703$$$CA$CA
240456331$24045633$1$I$$20240626$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2023US002069$SANDOZ$$$$$M$Y$$$20240703$$CN$US$US
240456341$24045634$1$I$$20240625$20240703$20240703$PER$$US-MYLANLABS-2024M1061349$MYLAN$$$$$F$Y$$$20240703$$CN$US$US
240456351$24045635$1$I$$20240702$20240703$20240703$EXP$$DE-SANDOZ INC.-SDZ2024DE062160$SANDOZ$$49$YR$$$Y$$$20240703$$MD$DE$DE
240456361$24045636$1$I$20230807$20240629$20240703$20240703$EXP$$AU-TAKEDA-2023TUS077737$TAKEDA$$33$YR$$F$Y$$$20240703$$CN$AU$AU
240456373$24045637$3$F$20240625$20240716$20240703$20240720$EXP$$PH-TAKEDA-2024TUS064411$TAKEDA$$78$YR$$F$Y$$$20240720$$CN$PH$PH
240456381$24045638$1$I$20240701$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46310$$FDA-CTU$$22$YR$$F$N$$$20240702$N$HP$US$
240456391$24045639$1$I$$20240702$20240702$20240702$DIR$708838$$FDA-CTU$$$$$UNK$N$$$20240702$N$CN$US$
240456401$24045640$1$I$20230815$20240702$20240702$20240702$DIR$708830$$FDA-CTU$$64$YR$$F$N$$$20240702$N$PH$US$
240456411$24045641$1$I$20240617$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46389$$FDA-CTU$$75$YR$$F$N$$$20240702$N$$US$
240456421$24045642$1$I$$20240702$20240702$20240702$DIR$708831$$FDA-CTU$$54$YR$$M$N$$$20240702$N$PH$US$
240456431$24045643$1$I$20240616$20240702$20240702$20240702$DIR$708832$$FDA-CTU$$59$YR$$M$N$$$20240702$N$PH$US$
240456441$24045644$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46333$$FDA-CTU$$53$YR$$M$N$$$20240702$N$$US$
240456451$24045645$1$I$$20240620$20240703$20240703$EXP$$CA-TEVA-VS-3213239$TEVA$$40$YR$$F$Y$$$20240703$$HP$CA$CA
240456461$24045646$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46327$$FDA-CTU$$63$YR$$M$N$$$20240702$N$$US$
240456471$24045647$1$I$$20240702$20240702$20240702$DIR$708837$$FDA-CTU$$$$$UNK$N$$$20240702$N$CN$US$
240456481$24045648$1$I$$20240702$20240702$20240702$DIR$708848$$FDA-CTU$$$$$UNK$N$$$20240702$N$CN$US$
240456491$24045649$1$I$20231113$20240701$20240702$20240702$DIR$FDA-CDER-CTU-2024-46358$$FDA-CTU$$43$YR$$F$N$$$20240701$N$$US$
240456501$24045650$1$I$20240610$20240702$20240702$20240702$DIR$708842$$FDA-CTU$$36$YR$$M$N$85$KG$20240702$N$PH$US$
240456511$24045651$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46337$$FDA-CTU$$83$YR$$F$N$$$20240702$N$$US$
240456521$24045652$1$I$20240701$20240702$20240702$20240702$DIR$708844$$FDA-CTU$$39$YR$$F$N$64$KG$20240702$N$HP$US$
240456531$24045653$1$I$$20240701$20240702$20240702$DIR$FDA-CDER-CTU-2024-46303$$FDA-CTU$$$$$F$N$$$20240701$N$HP$US$
240456541$24045654$1$I$20240419$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46338$$FDA-CTU$$48$YR$$F$N$$$20240702$N$$US$
240456551$24045655$1$I$$20240702$20240702$20240702$DIR$FDA-CDER-CTU-2024-46311$$FDA-CTU$$62$YR$$F$N$$$20240702$N$HP$US$
240456561$24045656$1$I$$20240628$20240703$20240703$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006181$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
240456572$24045657$2$F$$20240708$20240703$20240718$EXP$$JP-TEVA-VS-3214538$TEVA$Yazaki T, Kimoto M, Minagawa A, Maruno T, Yamanaka M, Sonehara K, et al. Simultaneous Acquisition of T790M Mutation and SCLC Transformation during Targeted Therapy in EGFR-Mutated Lung Adenocarcinoma: A Rare Case Report. Am-J-Case-Rep 2024; 25.; Yazaki T, Kimoto M, Minagawa A, Maruno T, Yamanaka M, Sonehara K, et al. Simultaneous Acquisition of T790M Mutation and SCLC Transformation during Targeted Therapy in EGFR-Mutated Lung Adenocarcinoma: A Rare Case Report. Am-J-Case-Rep 2024; 25.$66$YR$$M$Y$$$20240718$$HP$JP$JP
240456581$24045658$1$I$20230101$20240628$20240703$20240703$EXP$$JP-SANDOZ INC.-SDZ2024JP062093$SANDOZ$$$$$F$Y$$$20240703$$CN$JP$JP
240456601$24045660$1$I$$20240530$20240703$20240703$PER$$US-AMGEN-USASP2024129890$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240456611$24045661$1$I$$20230803$20240703$20240703$PER$$US-AMGEN-USASP2023235458$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240456621$24045662$1$I$20240118$20240626$20240703$20240703$PER$FR-AFSSAPS-AVMA2024000256$FR-Atnahs Limited-ATNAHS20240601842$Atnahs Healthcare$$60$YR$A$F$Y$$$20240702$$PH$FR$FR
240456631$24045663$1$I$$20240625$20240703$20240703$PER$$US-ALXN-202406USA001664US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
240456642$24045664$2$F$$20240719$20240703$20240725$EXP$$US-TAKEDA-2024TUS061481$TAKEDA$$$$$F$Y$$$20240725$$CN$US$US
240456651$24045665$1$I$$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024131155$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240456661$24045666$1$I$$20240219$20240703$20240703$PER$$US-AMGEN-USASP2024131590$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240456671$24045667$1$I$$20240626$20240703$20240703$PER$$US-JNJFOC-20240671521$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$HP$US$US
240456681$24045668$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106345$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240703$$CN$US$US
240456691$24045669$1$I$20240422$20240626$20240703$20240703$EXP$$US-JNJFOC-20240671749$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240703$$HP$US$US
240456701$24045670$1$I$20240610$20240701$20240703$20240703$EXP$FR-AFSSAPS-AN2024000823$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-103394$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$75.2$KG$20240703$$MD$FR$FR
240456722$24045672$2$F$20240101$20240807$20240703$20240809$EXP$$US-KARYOPHARM-2024KPT001177$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240809$$CN$US$US
240456731$24045673$1$I$$20240626$20240703$20240703$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006160$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
240456752$24045675$2$F$20210104$20240830$20240703$20240903$PER$$US-GILEAD-2024-0679404$GILEAD$$29$YR$A$F$Y$$$20240903$$LW$US$US
240456761$24045676$1$I$20240616$20240626$20240703$20240703$EXP$$CN-SA-2024SA194232$SANOFI AVENTIS$$81$YR$E$F$Y$65$KG$20240703$$HP$CN$CN
240456771$24045677$1$I$20240601$20240626$20240703$20240703$EXP$$US-SA-2024SA193125$SANOFI AVENTIS$$$$A$M$Y$$$20240703$$HP$US$US
240456782$24045678$2$F$20240530$20240628$20240703$20240705$EXP$$AR-SA-2024SA185160$SANOFI AVENTIS$$7$MON$I$M$Y$10$KG$20240705$$PH$AR$AR
240456792$24045679$2$F$20240303$20240723$20240703$20240729$EXP$FR-AFSSAPS-AVMA2024000266$FR-Waylis Therapeutics LLC-ATNAHS20240601858$Waylis$$44$YR$A$F$Y$$$20240729$$PH$FR$FR
240456802$24045680$2$F$20220601$20240806$20240703$20240809$EXP$$AT-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00359$VELOXIS PHARMACEUTICALS$Sommer L, Weber S, Listabarth S, Trojer A, Groemer M, Konig D.. Clozapine therapy for loss of efficacy of antipsychotic treatment after liver transplantation. Immunosuppression with tacrolimus as a complicating factor. Psychopraxis. Neurop. 2024;27:159-62$50$YR$$M$Y$$$20240809$$HP$AT$AT
240456811$24045681$1$I$$20240626$20240703$20240703$EXP$$US-SA-2024SA193430$SANOFI AVENTIS$$$$A$F$Y$47.619$KG$20240703$$MD$US$US
240456821$24045682$1$I$20240101$20240626$20240703$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-019855$UNITED THERAPEUTICS$$$$$F$Y$76.644$KG$20240703$$$US$US
240456833$24045683$3$F$20151011$20240829$20240703$20240902$EXP$$US-GILEAD-2024-0679379$GILEAD$$47$YR$A$M$Y$$$20240902$$LW$US$US
240456842$24045684$2$F$$20240708$20240703$20240718$EXP$$JP-TEVA-VS-3213947$TEVA$Shimizu M, Nishimura K, Iwata N, Yasumi T, Umebayashi H, Nakagishi Y, et al. Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan. Int-J-Rheum-Diseases 2023; 26 (5): 938-945.; Shimizu M, Nishimura K, Iwata N, Yasumi T, Umebayashi H, Nakagishi Y, et al. Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan. Int-J-Rheum-Diseases 2023; 26 (5): 938-945.$$$$$Y$$$20240718$$HP$JP$JP
240456852$24045685$2$F$$20240628$20240703$20240722$PER$$US-MYLANLABS-2024M1061180$MYLAN$$$$$$Y$$$20240722$$CN$US$US
240456861$24045686$1$I$20240601$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105396$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240703$$CN$US$US
240456871$24045687$1$I$$20240626$20240703$20240703$EXP$$BR-TAKEDA-2024TUS066032$TAKEDA$$18$YR$$M$Y$$$20240703$$CN$BR$BR
240456881$24045688$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106218$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240703$$CN$US$US
240456891$24045689$1$I$$20240702$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037433$BOEHRINGER INGELHEIM$$$$$$Y$$$20240703$$CN$US$US
240456902$24045690$2$F$20240327$20240718$20240703$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-010541$UNITED THERAPEUTICS$$63$YR$$F$Y$102.04$KG$20240725$$$US$US
240456911$24045691$1$I$20010101$20240624$20240703$20240703$EXP$$US-ABBVIE-5815760$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240456921$24045692$1$I$20240218$20240627$20240703$20240703$EXP$FR-AFSSAPS-AVMA2024000267$FR-Waylis Therapeutics LLC-ATNAHS20240601857$Waylis$$26$YR$A$M$Y$$$20240703$$PH$FR$FR
240456932$24045693$2$F$20240101$20240709$20240703$20240712$EXP$$US-AMGEN-USASL2024129687$AMGEN$$68$YR$E$F$Y$$$20240712$$CN$US$US
240456941$24045694$1$I$$20231202$20240703$20240703$PER$$US-AMGEN-USASP2023235432$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240456951$24045695$1$I$$20240108$20240703$20240703$PER$$US-AMGEN-USASP2024131730$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240456964$24045696$4$F$20240601$20240904$20240703$20240913$PER$$US-UNITED THERAPEUTICS-UNT-2024-017822$UNITED THERAPEUTICS$$75$YR$$M$Y$80.408$KG$20240913$$$US$US
240456971$24045697$1$I$$20240629$20240703$20240703$PER$$US-HALEON-2184734$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240456981$24045698$1$I$$20240625$20240703$20240703$PER$$US-ALXN-202406USA001748US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240703$$CN$US$US
240456991$24045699$1$I$20240528$20240625$20240703$20240703$EXP$FR-AFSSAPS-PV2024000545$FR-TEVA-VS-3214555$TEVA$$68$YR$$F$Y$70$KG$20240703$$MD$FR$FR
240457001$24045700$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407002034$ELI LILLY AND CO$$$$$M$Y$$$20240703$$CN$US$US
240457023$24045702$3$F$20220412$20240628$20240703$20240708$EXP$$JP-BAYER-2022A067506$BAYER$$58$YR$A$M$Y$$$20240708$$MD$JP$JP
240457031$24045703$1$I$$20240626$20240703$20240703$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202406018597$ELI LILLY AND CO$$$$$M$Y$$$20240703$$MD$GB$GB
240457041$24045704$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001103$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240703$$CN$US$US
240457052$24045705$2$F$$20240705$20240703$20240716$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406016114$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240716$$PH$JP$JP
240457061$24045706$1$I$$20230310$20240703$20240703$PER$$US-AMGEN-USASP2023235437$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240457071$24045707$1$I$20240618$20240625$20240703$20240703$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406019876$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240703$$CN$JP$JP
240457092$24045709$2$F$$20240708$20240703$20240717$EXP$$TR-TEVA-VS-3211503$TEVA$Senol B, Ekinci RN, Goka E. First manic episode induced by abrupt discontinuation of sertraline in a patient with OCD: A case report. Bipolar-Disord 2024; 1-3.; Senol B, Ekinci RN, Goka E. First manic episode induced by abrupt discontinuation of sertraline in a patient with OCD: A case report. Bipolar-Disord 2024; 1-3.$$$$F$Y$$$20240717$$HP$TR$TR
240457101$24045710$1$I$20240425$20240618$20240703$20240703$EXP$FR-AFSSAPS-PP2024000626$FR-TEVA-VS-3211986$TEVA$$72$YR$$F$Y$$$20240703$$MD$FR$FR
240457111$24045711$1$I$20240101$20240702$20240703$20240703$EXP$$US-UCBSA-2024033528$UCB$$$$$M$Y$$$20240703$$CN$US$US
240457121$24045712$1$I$20231205$20240701$20240703$20240703$EXP$SE-SEMPA-2024-003622$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-104783$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240703$$MD$SE$SE
240457131$24045713$1$I$$20240629$20240703$20240703$PER$$US-UNITED THERAPEUTICS-UNT-2024-020168$UNITED THERAPEUTICS$$$$$F$Y$65.306$KG$20240703$$$US$US
240457141$24045714$1$I$$20240628$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104460$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240703$$CN$US$US
240457162$24045716$2$F$$20240625$20240703$20240709$EXP$$EC-ROCHE-10000007754$ROCHE$$$$$$Y$$$20240704$$CN$EC$EC
240457171$24045717$1$I$$20240626$20240703$20240703$EXP$$JP-EMD Serono-2024035226$EMD SERONO INC$$75$YR$E$M$Y$$$20240703$$MD$JP$JP
240457181$24045718$1$I$20220408$20240701$20240703$20240703$EXP$GB-MHRA-MED-202406302340231520-PFTLK$GB-JNJFOC-20240700906$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$GB$GB
240457193$24045719$3$F$20240101$20240802$20240703$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-020010$UNITED THERAPEUTICS$$$$$M$Y$82.54$KG$20240807$$$US$US
240457202$24045720$2$F$$20240709$20240703$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-020017$UNITED THERAPEUTICS$$$$$F$Y$66.485$KG$20240713$$$US$US
240457213$24045721$3$F$20210204$20240830$20240703$20240903$PER$$US-GILEAD-2024-0679412$GILEAD$$70$YR$E$M$Y$$$20240903$$LW$US$US
240457223$24045722$3$F$$20240708$20240703$20240718$EXP$$US-TEVA-VS-3212155$TEVA$Adams PE, Ehyayee V, Ahmed A. A Case of CD4+T-Cell Lymphoma with Gamma-Delta Phenotype, Incidentally Manifesting in a Wound Debridement Sample. Am-J-Dermatopathol 2024; 46 (6): 383-385.; Adams PE, Ehyayee V, Ahmed A. A Case of CD4+T-Cell Lymphoma with Gamma-Delta Phenotype, Incidentally Manifesting in a Wound Debridement Sample. Am-J-Dermatopathol 2024; 46 (6): 383-385.; Adams PE, Ehyayee V, Ahmed A. A Case of CD4+T-Cell Lymphoma with Gamma-Delta Phenotype, Incidentally Manifesting in a Wound...$85$YR$$M$Y$$$20240718$$HP$US$US
240457231$24045723$1$I$$20240628$20240703$20240703$PER$$NVSC2024US136348$NOVARTIS$$$$$M$Y$$$20240703$$CN$US$US
240457241$24045724$1$I$$20240628$20240703$20240703$EXP$$NVSJ2024JP007783$NOVARTIS$$61$YR$$F$Y$$$20240703$$PH$JP$JP
240457251$24045725$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137678$NOVARTIS$$11$YR$$$Y$$$20240703$$CN$US$US
240457262$24045726$2$F$$20240702$20240703$20240704$PER$$NVSC2024US137023$NOVARTIS$$$$$M$Y$$$20240704$$CN$US$US
240457271$24045727$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137687$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240457281$24045728$1$I$$20240628$20240703$20240703$EXP$$NVSC2024US136347$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240457291$24045729$1$I$$20240702$20240703$20240703$EXP$$NVSC2024US137800$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240457301$24045730$1$I$$20240626$20240703$20240703$EXP$$NVSJ2024JP007689$NOVARTIS$$$$A$M$Y$$$20240703$$CN$JP$JP
240457311$24045731$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137319$NOVARTIS$$$$$F$Y$$$20240703$$HP$US$US
240457322$24045732$2$F$$20240918$20240703$20240919$PER$$NVSC2024US137974$NOVARTIS$$$$$M$Y$$$20240919$$MD$US$US
240457331$24045733$1$I$$20240702$20240703$20240703$PER$$NVSC2024US137826$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240457341$24045734$1$I$20240219$20240702$20240702$20240702$DIR$708851$$FDA-CTU$$43$YR$$F$N$79.2$KG$20240702$Y$$US$
240457351$24045735$1$I$$20240627$20240703$20240703$EXP$$NVSC2024HR136144$NOVARTIS$$$$$F$Y$$$20240703$$HP$HR$HR
240457361$24045736$1$I$20240601$20240701$20240703$20240703$PER$$NVSC2024US137549$NOVARTIS$$$$$M$Y$$$20240703$$HP$US$US
240457371$24045737$1$I$$20240702$20240703$20240703$EXP$$CA-PFIZER INC-202400205294$PFIZER$$19$YR$$F$Y$$$20240703$$HP$CA$CA
240457391$24045739$1$I$20230520$20240628$20240703$20240703$EXP$ES-AEMPS-1539406$NVSC2024ES135513$NOVARTIS$$64$YR$$F$Y$$$20240703$$MD$ES$ES
240457401$24045740$1$I$20240327$20240625$20240703$20240703$EXP$IT-MINISAL02-990895$IT-TEVA-VS-3214317$TEVA$$53$YR$$F$Y$60$KG$20240703$$MD$IT$IT
240457411$24045741$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137092$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240457421$24045742$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137603$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240457432$24045743$2$F$$20240830$20240703$20240902$EXP$$NVSC2024GB136484$NOVARTIS$$$$A$F$Y$$$20240902$$CN$GB$GB
240457441$24045744$1$I$$20240702$20240702$20240702$DIR$708850$$FDA-CTU$$$$$UNK$N$$$20240702$N$CN$US$
240457451$24045745$1$I$$20240626$20240703$20240703$PER$$NVSC2024US134994$NOVARTIS$$45$YR$$M$Y$$$20240703$$CN$US$US
240457461$24045746$1$I$$20240702$20240702$20240702$DIR$708852$$FDA-CTU$$$$$UNK$N$$$20240702$N$CN$US$
240457472$24045747$2$F$20240601$20240624$20240703$20240708$PER$$US-JNJFOC-20240668871$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240708$$CN$US$US
240457481$24045748$1$I$20240701$20240702$20240702$20240702$DIR$708847$$FDA-CTU$$72$YR$$M$N$88.2$KG$20240702$N$$US$
240457491$24045749$1$I$$20240702$20240702$20240702$DIR$708854$$FDA-CTU$$$$$UNK$N$$$20240702$N$CN$US$
240457501$24045750$1$I$20240610$20240627$20240703$20240703$EXP$$NVSC2024CN136260$NOVARTIS$$54$YR$$M$Y$85$KG$20240703$$HP$CN$CN
240457511$24045751$1$I$$20240702$20240702$20240702$DIR$708821$$FDA-CTU$$$$$M$N$$$20240702$$CN$US$
240457521$24045752$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137667$NOVARTIS$$$$$M$Y$$$20240703$$CN$US$US
240457532$24045753$2$F$20240601$20240703$20240703$20240710$PER$$US-JNJFOC-20240705512$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240710$$CN$US$US
240457542$24045754$2$F$$20240705$20240703$20240708$PER$$NVSC2024US137646$NOVARTIS$$75$YR$$M$Y$$$20240708$$CN$US$US
240457552$24045755$2$F$$20240725$20240703$20240731$PER$$NVSC2024US136262$NOVARTIS$$$$$$Y$$$20240731$$CN$US$US
240457561$24045756$1$I$20230124$20240625$20240703$20240703$EXP$$NVSC2024DE135519$NOVARTIS$$57$YR$$M$Y$72$KG$20240703$$MD$DE$DE
240457572$24045757$2$F$20240620$20240701$20240703$20240705$EXP$IT-MINISAL02-992367$NVSC2024IT136326$NOVARTIS$$36$YR$$F$Y$$$20240705$$MD$IT$IT
240457583$24045758$3$F$20240101$20240904$20240703$20240905$EXP$$NVSC2024IE135590$NOVARTIS$$$$$M$Y$$$20240905$$MD$IE$IE
240457591$24045759$1$I$$20240617$20240703$20240703$EXP$$TR-TEVA-VS-3211411$TEVA$Gultekin N. THE ASSOCIATION OF INFECTIVE ENDOCARDITIS AND LEGIONELLA PNEUMONIA IN A PATIENT. E-J-Cardiovasc-Med 2019; 7 (Suppl.) (1): 616.$$$$M$Y$$$20240703$$HP$TR$TR
240457601$24045760$1$I$20240401$20240626$20240703$20240703$EXP$$NVSC2024US134530$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240457611$24045761$1$I$$20240628$20240703$20240703$PER$$NVSC2024US135597$NOVARTIS$$$$$F$Y$$$20240703$$MD$US$US
240457624$24045762$4$F$20240628$20240815$20240703$20240819$PER$$NVSC2024US137610$NOVARTIS$$37$YR$$M$Y$$$20240819$$CN$US$US
240457632$24045763$2$F$$20240801$20240703$20240808$EXP$$NVSC2024CN137094$NOVARTIS$$$$$F$Y$$$20240808$$CN$CN$CN
240457642$24045764$2$F$$20240906$20240703$20240906$PER$$NVSC2024US137048$NOVARTIS$$$$$M$Y$$$20240906$$HP$US$US
240457652$24045765$2$F$$20240904$20240703$20240905$PER$$NVSC2024US136758$NOVARTIS$$$$$M$Y$$$20240905$$HP$US$US
240457661$24045766$1$I$20230101$20240701$20240703$20240703$EXP$FR-AFSSAPS-PC2024000541$NVSC2024FR137248$NOVARTIS$$62$YR$$F$Y$$$20240703$$MD$FR$FR
240457671$24045767$1$I$$20240626$20240703$20240703$30DAY$$US-GSK-US2024079682$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240457682$24045768$2$F$$20240703$20240703$20240712$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024078689$VIIV$$$$$M$Y$$$20240712$$HP$US$US
240457691$24045769$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106131$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240703$$CN$US$US
240457701$24045770$1$I$20240628$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106240$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240703$$PH$US$US
240457711$24045771$1$I$20240623$20240628$20240703$20240703$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-105986$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$50$KG$20240703$$CN$CN$CN
240457721$24045772$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137595$NOVARTIS$$$$$$Y$85$KG$20240703$$CN$US$US
240457733$24045773$3$F$20240626$20240626$20240703$20240710$EXP$$NVSC2024DE134315$NOVARTIS$$$$A$F$Y$$$20240710$$CN$DE$DE
240457742$24045774$2$F$$20240830$20240703$20240903$EXP$$NVSC2024US135605$NOVARTIS$$37$YR$$F$Y$$$20240903$$CN$US$US
240457751$24045775$1$I$$20240701$20240703$20240703$PER$$NVSC2024US136912$NOVARTIS$$$$$F$Y$$$20240703$$HP$US$US
240457764$24045776$4$F$$20240904$20240703$20240910$EXP$$NVSC2024US101239$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
240457771$24045777$1$I$$20240626$20240703$20240703$EXP$$NVSC2024MX135697$NOVARTIS$$$$$F$Y$$$20240703$$CN$MX$MX
240457781$24045778$1$I$$20240618$20240703$20240703$EXP$$US-GLANDPHARMA-US-2024GLNLIT00408$GLAND PHARMA$F Alsalama.Ventricular arrhythmias, antiarrhythmic therapy and thyroidal illness in advanced heart failure: a case report and review of the literature.Drugs and Therapy Perspectives.JAN-2023;39 (No.4):147-155$21$YR$A$M$Y$$$20240703$$HP$US$US
240457791$24045779$1$I$20240621$20240628$20240703$20240703$EXP$$NVSC2024CN137156$NOVARTIS$$77$YR$$M$Y$75$KG$20240703$$HP$CN$CN
240457801$24045780$1$I$20201201$20240626$20240703$20240703$EXP$$NVSC2024US135317$NOVARTIS$$$$$M$Y$$$20240703$$CN$US$US
240457813$24045781$3$F$20240701$20240718$20240703$20240725$PER$$JP-Eisai-EC-2024-169386$EISAI$$57$YR$A$F$Y$50$KG$20240725$$PH$JP$JP
240457821$24045782$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137568$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240457831$24045783$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137753$NOVARTIS$$47$YR$$$Y$$$20240703$$CN$US$US
240457841$24045784$1$I$20240513$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406141736543970-ZDBRJ$NVSC2024GB137104$NOVARTIS$$63$YR$$F$Y$83$KG$20240703$$CN$GB$GB
240457852$24045785$2$F$$20240627$20240703$20240712$EXP$$NVSC2024CA137242$NOVARTIS$$27$YR$$F$Y$$$20240712$$MD$CA$CA
240457862$24045786$2$F$$20240821$20240703$20240826$EXP$$NVSC2024EG133550$NOVARTIS$$$$$F$Y$$$20240826$$CN$EG$EG
240457881$24045788$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137677$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240457891$24045789$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137113$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240457901$24045790$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137691$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240457911$24045791$1$I$20240510$20240625$20240703$20240703$EXP$ES-AEMPS-1534175$ES-TEVA-VS-3214152$TEVA$$89$YR$$F$Y$63$KG$20240703$$MD$ES$ES
240457922$24045792$2$F$$20240815$20240703$20240815$PER$$NVSC2024US137756$NOVARTIS$$$$$M$Y$$$20240815$$CN$US$US
240457931$24045793$1$I$$20240630$20240703$20240703$PER$$NVSC2024US136931$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240457941$24045794$1$I$$20231020$20240703$20240703$PER$$US-AMGEN-USASP2023235400$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240457951$24045795$1$I$$20240109$20240703$20240703$PER$$US-AMGEN-USASP2024129892$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240457962$24045796$2$F$20240615$20240628$20240703$20240708$PER$$US-AMGEN-USASP2024129907$AMGEN$$54$YR$A$M$Y$$$20240708$$HP$US$US
240457971$24045797$1$I$$20240627$20240703$20240703$EXP$$AU-GILEAD-2024-0679303$GILEAD$$$$E$M$Y$$$20240703$$MD$AU$AU
240457982$24045798$2$F$$20240904$20240703$20240906$EXP$$NVSC2024US136207$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
240457991$24045799$1$I$$20240702$20240703$20240703$PER$$NVSC2024US137999$NOVARTIS$$$$$M$Y$$$20240703$$CN$US$US
240458001$24045800$1$I$$20240701$20240703$20240703$EXP$$NVSC2024US137347$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240458012$24045801$2$F$20240618$20240816$20240703$20240819$PER$$NVSC2024US137735$NOVARTIS$$$$$F$Y$$$20240819$$HP$US$US
240458031$24045803$1$I$$20240628$20240703$20240703$PER$$NVSC2024US136754$NOVARTIS$$44$YR$$M$Y$$$20240703$$CN$US$US
240458041$24045804$1$I$$20240627$20240703$20240703$EXP$$NVSC2024PT137444$NOVARTIS$$$$$$Y$$$20240703$$HP$PT$PT
240458051$24045805$1$I$$20240702$20240703$20240703$PER$$NVSC2024US137510$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240458061$24045806$1$I$$20240626$20240703$20240703$EXP$$NVSC2024EG134478$NOVARTIS$$$$$M$Y$57$KG$20240703$$CN$EG$EG
240458071$24045807$1$I$$20240628$20240703$20240703$EXP$$GB-MYLANLABS-2024M1061506$MYLAN$$$$$F$Y$$$20240703$$CN$GB$GB
240458081$24045808$1$I$20240601$20240627$20240703$20240703$PER$$US-MYLANLABS-2024M1061734$MYLAN$$60$YR$$F$Y$72.57$KG$20240703$$CN$US$US
240458091$24045809$1$I$20240422$20240702$20240702$20240702$DIR$708853$$FDA-CTU$$43$YR$$F$N$67.5$KG$20240702$N$CN$US$
240458101$24045810$1$I$$20240702$20240702$20240702$DIR$708855$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240458111$24045811$1$I$20240410$20240628$20240703$20240703$EXP$$NVSC2024IN105654$NOVARTIS$$55$YR$$F$Y$$$20240703$$CN$IN$IN
240458121$24045812$1$I$20240101$20240702$20240703$20240703$EXP$$US-UCBSA-2024033527$UCB$$$$$F$Y$$$20240703$$CN$US$US
240458131$24045813$1$I$20231001$20240701$20240703$20240703$PER$$NVSC2024US137392$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240458141$24045814$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137468$NOVARTIS$$25$YR$$M$Y$$$20240703$$CN$US$US
240458151$24045815$1$I$20240626$20240702$20240702$20240702$DIR$708859$$FDA-CTU$$37$YR$$F$N$80.1$KG$20240702$Y$HP$US$
240458182$24045818$2$F$$20230727$20240703$20240913$PER$$US-HALEON-2185117$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
240458203$24045820$3$F$20240101$20240723$20240703$20240801$PER$$US-AMGEN-USASP2024126737$AMGEN$$72$YR$E$M$Y$$$20240801$$HP$US$US
240458211$24045821$1$I$$20230824$20240703$20240703$PER$$US-AMGEN-USASP2023235362$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240458222$24045822$2$F$$20240703$20240703$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05641$LUPIN$$$$$$Y$$$20240729$$CN$US$US
240458231$24045823$1$I$20240701$20240701$20240703$20240703$PER$$NVSC2024US137730$NOVARTIS$$54$YR$$M$Y$$$20240703$$CN$US$US
240458242$24045824$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3212413$TEVA$Alhatemi R, Alsudani H, Tripathee S. #1702691 Bilateral Adrenal Hemorrhage with Adrenal Insufficiency in Coronavirus 2019. Endocr-Pract 2024; 30 (Suppl.) (5): S6 abstr. 1702691.; Alhatemi R, Alsudani H, Tripathee S. #1702691 Bilateral Adrenal Hemorrhage with Adrenal Insufficiency in Coronavirus 2019. Endocr-Pract 2024; 30 (Suppl.) (5): S6 abstr. 1702691.$71$YR$$F$Y$$$20240717$$MD$US$US
240458252$24045825$2$F$$20240709$20240703$20240725$PER$$US-GLANDPHARMA-US-2024GLNSPO00424$GLAND PHARMA$$31$YR$A$M$Y$$$20240725$$PH$US$US
240458262$24045826$2$F$20180821$20240829$20240703$20240903$PER$$US-GILEAD-2024-0679383$GILEAD$$34$YR$A$F$Y$$$20240903$$LW$US$US
240458271$24045827$1$I$20240405$20240624$20240703$20240703$PER$$US-TRIS PHARMA, INC.-24US011557$TRIS PHARM$$$$$$Y$$$20240703$$CN$US$US
240458281$24045828$1$I$$20240604$20240703$20240703$PER$$US-009507513-2406USA001295$MERCK$Jafry R, Khan H, Jones J.. A Case of Multifocal Ductal Breast Carcinoma with Extension into Lobules and Concurrent Primary Colon Adenocarcinoma. Cancer Research. 2024;84 (9)$52$YR$$F$Y$$$20240703$$HP$US$US
240458291$24045829$1$I$$20240628$20240703$20240703$EXP$$US-AstraZeneca-2024A150647$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240458301$24045830$1$I$$20240628$20240703$20240703$EXP$$TW-AstraZeneca-2024A149834$ASTRAZENECA$$$$$M$Y$$$20240703$$MD$TW$
240458311$24045831$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106132$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240703$$CN$US$US
240458322$24045832$2$F$$20240823$20240703$20240826$EXP$$NVSC2024BR135663$NOVARTIS$$$$$M$Y$$$20240826$$CN$BR$BR
240458333$24045833$3$F$20240101$20240621$20240703$20240820$EXP$$US-ROCHE-10000006552$ROCHE$$54$YR$A$F$Y$$$20240820$$CN$US$US
240458342$24045834$2$F$$20240708$20240703$20240716$EXP$$US-TEVA-VS-3212411$TEVA$Fu K, White K, Ramaniuk A, Kollu V, Urbine D. Manifestations and Management of Trimethoprim/ Sulfamethoxazole-Resistant Nocardia otitidiscaviarum Infection. Emerging-Infect-Dis 2023; 29 (6): 1266-1267.; Fu K, White K, Ramaniuk A, Kollu V, Urbine D. Manifestations and Management of Trimethoprim/ Sulfamethoxazole-Resistant Nocardia otitidiscaviarum Infection. Emerging-Infect-Dis 2023; 29 (6): 1266-1267.$73$YR$$M$Y$$$20240716$$HP$US$US
240458351$24045835$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137536$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240458361$24045836$1$I$$20240628$20240703$20240703$PER$$US-ABBVIE-5823572$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240458371$24045837$1$I$$20240621$20240703$20240703$EXP$$CA-TEVA-VS-3213030$TEVA$$46$YR$$M$Y$$$20240703$$HP$CA$CA
240458391$24045839$1$I$$20240620$20240703$20240703$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091828$GLENMARK$Landis AR, Minish J, Zouk AN.. A Case of Kaposi Sarcoma masquerading as bilateral pleural effusions in a patient with orthotopic heart transplant.. American Journal of Respiratory and Critical Care Medicine.. 2024;209$$$$$Y$$$20240703$$MD$US$US
240458401$24045840$1$I$20220909$20240626$20240703$20240703$EXP$$ES-CELLTRION INC.-2024ES015759$CELLTRION$$$$$$Y$$$20240703$$MD$ES$ES
240458411$24045841$1$I$20240401$20240624$20240703$20240703$PER$$US-ABBVIE-5817193$ABBVIE$$63$YR$$F$Y$$$20240703$$MD$US$US
240458421$24045842$1$I$$20230307$20240703$20240703$EXP$$NVSC2023CA280773$NOVARTIS$$44$YR$$F$Y$70$KG$20240703$$HP$CA$CA
240458431$24045843$1$I$$20230307$20240703$20240703$EXP$$NVSC2023CA280780$NOVARTIS$$44$YR$$F$Y$70$KG$20240703$$HP$CA$CA
240458441$24045844$1$I$$20240618$20240703$20240703$PER$$US-APOTEX-2024AP007786$APOTEX$Preskorn SH, Masolak DD. Cerebral Anoxia in an 18-year-old Patient Being Treated for Major Depressive Disorder: How Forensic Detective Work Uses Medical Knowledge Including Clinical Pharmacology to Solve Cases. Journal of Psychiatric Practice. 2024;30 (3):212-219$18$YR$$M$Y$$$20240703$$MD$US$US
240458461$24045846$1$I$$20240625$20240703$20240703$EXP$$JP-UCBSA-2024032953$UCB$$15$YR$$$Y$$$20240703$$MD$JP$JP
240458472$24045847$2$F$20230607$20240708$20240703$20240711$EXP$$US-UCBSA-2023029162$UCB$$23$YR$$M$Y$104.4$KG$20240711$$CN$US$US
240458481$24045848$1$I$20240618$20240702$20240702$20240702$DIR$708845$$FDA-CTU$$59$YR$$F$N$$$20240702$N$PH$US$
240458491$24045849$1$I$$20240109$20240703$20240703$PER$$US-AMGEN-USASP2024130874$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240458501$24045850$1$I$20240701$20240702$20240702$20240702$DIR$708860$$FDA-CTU$$$$$F$N$72.4$KG$20240702$N$PH$US$
240458511$24045851$1$I$$20240311$20240703$20240703$PER$$US-AMGEN-USASP2024131735$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240458522$24045852$2$F$20230101$20240701$20240703$20240709$EXP$$IT-INDIVIOR US-INDV-145815-2024$RECKITT BENCKISER$$$$$$Y$$$20240709$$CN$IT$IT
240458531$24045853$1$I$20240618$20240702$20240702$20240702$DIR$708874$$FDA-CTU$$73$YR$$M$N$$$20240702$N$PH$US$
240458541$24045854$1$I$20240601$20240702$20240702$20240702$DIR$708865$$FDA-CTU$$51$YR$$F$N$$$20240702$N$PH$US$
240458551$24045855$1$I$$20240622$20240703$20240703$EXP$$EC-ROCHE-10000007759$ROCHE$$$$$$Y$$$20240703$$CN$EC$EC
240458561$24045856$1$I$$20240620$20240703$20240703$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091830$GLENMARK$Pandhair O.. Confoundingly Persistent Pneumonia in a Heart Transplant Patient.. American Journal of Respiratory and Critical Care Medicine.. 2023;209:A2442$$$$$Y$$$20240703$$MD$US$US
240458571$24045857$1$I$20240621$20240627$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406019128$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240703$$CN$US$US
240458581$24045858$1$I$20240626$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000628$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240703$$CN$US$US
240458591$24045859$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001993$ELI LILLY AND CO$$$$$M$Y$$$20240703$$CN$US$US
240458601$24045860$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407002039$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240703$$CN$US$US
240458611$24045861$1$I$20240630$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001915$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240703$$CN$US$US
240458621$24045862$1$I$$20240625$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406017462$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240703$$CN$US$US
240458641$24045864$1$I$20240501$20240628$20240703$20240703$EXP$$CN-BAYER-2024A095719$BAYER$$29$YR$A$F$Y$47$KG$20240703$$HP$CN$CN
240458651$24045865$1$I$$20231020$20240703$20240703$PER$$US-AMGEN-USASP2023235288$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240458661$24045866$1$I$$20240202$20240703$20240703$PER$$US-AMGEN-USASP2024131591$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240458671$24045867$1$I$20221012$20240612$20240703$20240703$EXP$$DE-ROCHE-10000008058$ROCHE$$33$YR$A$F$Y$$$20240703$$MD$DE$DE
240458682$24045868$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3212512$TEVA$Baral A, Isaac E, Parajuli P, Kaiser A. PRIMARY SPONTANEOUS BACTERIAL PERITONITIS CAUSED BY HAEMOPHILUS INFLUENZAE. Gastroenterology 2024; 166 (Suppl.) (5): S-1571.; Baral A, Isaac E, Parajuli P, Kaiser A. PRIMARY SPONTANEOUS BACTERIAL PERITONITIS CAUSED BY HAEMOPHILUS INFLUENZAE. Gastroenterology 2024; 166 (Suppl.) (5): S-1571.$68$YR$$M$Y$$$20240717$$HP$US$US
240458695$24045869$5$F$20240101$20240828$20240703$20240903$EXP$$US-KARYOPHARM-2024KPT001246$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
240458703$24045870$3$F$$20240814$20240703$20240820$EXP$$CN-ROCHE-10000010191$ROCHE$$$$$M$Y$$$20240820$$MD$CN$CN
240458712$24045871$2$F$$20240729$20240703$20240801$PER$$NVSC2024US136356$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
240458721$24045872$1$I$20240619$20240628$20240703$20240703$EXP$$PH-AstraZeneca-2024A150114$ASTRAZENECA$$28158$DY$$M$Y$$$20240703$$CN$PH$
240458731$24045873$1$I$$20240625$20240703$20240703$EXP$$DE-AstraZeneca-2024A147560$ASTRAZENECA$$$$$F$Y$$$20240703$$PH$DE$
240458741$24045874$1$I$$20240624$20240703$20240703$EXP$$BR-PFIZER INC-202400204343$PFIZER$$30$YR$$M$Y$$$20240703$$MD$BR$BR
240458751$24045875$1$I$$20240320$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004872$JAZZ$Chrepa V, Villasenor S, Mauney A, Kotsakis G, Macpherson L et al. Cannabidiol as an Alternative Analgesic for Acute Dental Pain. Journal of dental research. 2023$34$YR$$F$Y$$$20240703$$HP$US$US
240458761$24045876$1$I$$20230731$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-016402$JAZZ$Beaudreault CP, Spirollari E, Naftchi AF, Sukul V, Das A, Vazquez S, Wolf SM, McGoldrick PE,. Safety of vagus nerve stimulation and responsive neurostimulation used in combination for. Journal of Neurosurgery: Pediatrics. 2023;31:6:565-573$13$YR$$M$Y$$$20240703$$HP$US$US
240458771$24045877$1$I$$20240325$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005181$JAZZ$Stephanie B, Michael C, Sreenath T.G.. Safety and tolerance of the ketogenic diet in patients with Zellweger Syndrome. Epilepsy and Behavior Reports. 2024;26$11$YR$$M$Y$$$20240703$$HP$US$US
240458781$24045878$1$I$$20231113$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-023098$JAZZ$Esteban D, Perry SM. Long term Seizure Freedom in Dravet Syndrome Using Fenufluramine Monotherapy. Journal of Child Neurology. 2023;38 (8-9)$6$MON$$M$Y$$$20240703$$HP$US$US
240458791$24045879$1$I$$20240320$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004877$JAZZ$Chrepa V, Villasenor S, Mauney A, Kotsakis G, Macpherson L et al. Cannabidiol as an Alternative Analgesic for Acute Dental Pain. Journal of dental research. 2023;1-8$68$YR$$M$Y$$$20240703$$HP$US$US
240458801$24045880$1$I$$20240325$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005180$JAZZ$Ward S.K, Wadley A, Tsai C.H, Benke P.J, Emrick L et al. De novo missense variants in ZBTB47 are associated with developmental delays, hypotonia, seizures, gait abnormalities,and variable movement abnormalities. American Journal of Medical Genetics. 2023;194A:17-30$5$YR$$F$Y$$$20240703$$HP$US$US
240458811$24045881$1$I$$20240320$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004865$JAZZ$Chrepa V., Villasenor S., Mauney A., Kotsakis G., Macpherson L.. Cannabidiol as an alternative analgesic for acute dental pain. Journal of dental research. 2023;1-8$32$YR$$M$Y$$$20240703$$MD$US$US
240458821$24045882$1$I$$20231211$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-024586$JAZZ$Layton L, Mauricio B, Adithya S, Lawrence H, Dennis D et all. Transfrontal Approach to the Amygdala for Ablation With Laser Interstitial Thermal Therapy An Epilepsy Case Report. Operative Neurosurgery. 2023;24:E381$70$YR$$F$Y$$$20240703$$MD$US$US
240458831$24045883$1$I$$20240527$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008192$JAZZ$Bonda D, Kelly K A, Boop S, Feroze A H, Randle S C, Bindschadler M, et al. Deep Brain Stimulation of Bilateral Centromedian Thalamic Nuclei in Pediatric Patients with Lennox Gastaut Syndrome: An Institutional Experience. World Neurosurgery. 2024;185:e631-e639$19$YR$$F$Y$$$20240703$$HP$US$US
240458841$24045884$1$I$$20231113$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-023096$JAZZ$Rosario S, Riel Romero. A Rare Case of a UBA5 Related Disorder Early Infantile Epileptic Encephalopathy Type 44 Clinical Findings and Course. Journal of Child Neurology. 2023;38:8-9:565-566$5$YR$$M$Y$$$20240703$$HP$US$US
240458851$24045885$1$I$$20240110$20240703$20240703$PER$$US-AMGEN-USASP2024129850$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240458862$24045886$2$F$20240620$20240626$20240703$20240708$EXP$$CN-JNJFOC-20240674316$JOHNSON AND JOHNSON$$47$YR$A$M$Y$65.2$KG$20240708$$HP$CN$CN
240458871$24045887$1$I$$20240628$20240703$20240703$EXP$$US-LEX-000366$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
240458881$24045888$1$I$$20240627$20240703$20240703$PER$$US-MYLANLABS-2024M1061202$MYLAN$$$$$F$Y$$$20240703$$CN$US$US
240458891$24045889$1$I$$20240626$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104270$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$80.29$KG$20240703$$MD$US$US
240458901$24045890$1$I$$20240619$20240703$20240703$EXP$$US-NORTHSTAR RX LLC-US-2024NSR000009$NORTHSTAR$Gans A, Taylor J, Goel NN.,. A Case of Drug-Induced Stevens-Johnson Syndrome With Primarily Visceral Involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209$76$YR$$F$Y$$$20240703$$HP$US$US
240458911$24045891$1$I$$20240702$20240702$20240702$DIR$708868$$FDA-CTU$$$$$UNK$N$$$20240702$N$CN$US$
240458931$24045893$1$I$$20240523$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008070$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240458941$24045894$1$I$$20240606$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008801$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240458951$24045895$1$I$$20240702$20240702$20240702$DIR$708867$$FDA-CTU$$$$$UNK$N$$$20240702$N$CN$US$
240458961$24045896$1$I$$20240614$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009430$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240458971$24045897$1$I$$20240607$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008855$JAZZ$$$$$F$Y$$$20240703$$CN$US$US
240458981$24045898$1$I$20240522$20240524$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008166$JAZZ$$20$YR$$F$Y$$$20240703$$CN$US$US
240458991$24045899$1$I$20240617$20240620$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009521$JAZZ$$3$YR$$F$Y$$$20240703$$CN$US$US
240459001$24045900$1$I$$20240618$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009371$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240459011$24045901$1$I$20240615$20240620$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009537$JAZZ$$14$YR$$M$Y$$$20240703$$HP$US$US
240459021$24045902$1$I$$20240530$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008380$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240459031$24045903$1$I$$20240612$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009177$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240459042$24045904$2$F$$20240613$20240703$20240712$PER$$US-ROCHE-RCA5211988$ROCHE$$$$A$F$Y$$$20240712$$CN$US$US
240459051$24045905$1$I$20240628$20240702$20240702$20240702$DIR$708833$$FDA-CTU$$44$YR$$F$N$67.5$KG$20240702$N$CN$US$
240459061$24045906$1$I$20150814$20240622$20240702$20240702$DIR$FDA-CDER-CTU-2024-46324$$FDA-CTU$$65$YR$$F$N$51.71$KG$20240622$N$CN$US$
240459071$24045907$1$I$20190801$20240702$20240702$20240702$DIR$708873$$FDA-CTU$$21$YR$$F$N$$$20240702$$CN$US$
240459083$24045908$3$F$20200401$20240828$20240703$20240830$EXP$$US-GILEAD-2024-0679414$GILEAD$$31$YR$A$F$Y$$$20240830$$LW$US$US
240459101$24045910$1$I$$20240510$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007356$JAZZ$$$$$F$Y$$$20240703$$MD$US$US
240459111$24045911$1$I$$20240522$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007718$JAZZ$$$$$F$Y$$$20240703$$CN$US$US
240459121$24045912$1$I$$20240501$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006919$JAZZ$$$$$$Y$$$20240703$$PH$US$US
240459131$24045913$1$I$$20240412$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005780$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240459141$24045914$1$I$$20240513$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007437$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240459151$24045915$1$I$$20240416$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006185$JAZZ$$$$$$Y$$$20240703$$CN$US$US
240459161$24045916$1$I$$20240429$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006186$JAZZ$$$$$M$Y$$$20240703$$HP$US$US
240459171$24045917$1$I$$20240503$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007029$JAZZ$$20$YR$$F$Y$$$20240703$$CN$US$US
240459181$24045918$1$I$$20240406$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005783$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240459191$24045919$1$I$$20240405$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005698$JAZZ$$$$$F$Y$$$20240703$$CN$US$US
240459201$24045920$1$I$$20240627$20240703$20240703$PER$$US-GILEAD-2024-0678915$GILEAD$$$$E$F$Y$$$20240703$$PH$US$US
240459221$24045922$1$I$$20240628$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104469$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240703$$HP$US$US
240459231$24045923$1$I$$20240628$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104651$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240703$$HP$US$US
240459241$24045924$1$I$$20240315$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004578$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240459251$24045925$1$I$$20240401$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005501$JAZZ$$$$$M$Y$$$20240703$$PH$US$US
240459261$24045926$1$I$$20240401$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005437$JAZZ$$$$$M$Y$$$20240703$$PH$US$US
240459271$24045927$1$I$$20240321$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004892$JAZZ$$15$YR$$M$Y$44$KG$20240703$$PH$US$US
240459281$24045928$1$I$$20240325$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005041$JAZZ$$$$$F$Y$$$20240703$$PH$US$US
240459291$24045929$1$I$20220901$20240417$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004501$JAZZ$$3$YR$$F$Y$35$KG$20240703$$MD$US$US
240459301$24045930$1$I$$20240315$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004569$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240459311$24045931$1$I$$20240315$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004585$JAZZ$$12$YR$$F$Y$$$20240703$$CN$US$US
240459321$24045932$1$I$20240301$20240327$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005353$JAZZ$$18$MON$$M$Y$$$20240703$$MD$US$US
240459331$24045933$1$I$$20240321$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004847$JAZZ$$$$C$F$Y$$$20240703$$MD$US$US
240459341$24045934$1$I$$20240620$20240703$20240703$PER$$US-JNJFOC-20240660061$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$HP$US$US
240459351$24045935$1$I$$20240701$20240703$20240703$PER$$US-HALEON-2184846$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240459361$24045936$1$I$$20240617$20240703$20240703$EXP$$SE-TEVA-VS-3212513$TEVA$Maria E, Berg S. Severe calcinosis in NXP2-positive juvenile dermatomyositis despite intensive anti-inflammatory treatment - a case report. Pediatr-Rheumatol 2023; 21 (Suppl. 2) abstr. P447.$8$YR$$F$Y$$$20240703$$HP$SE$SE
240459381$24045938$1$I$$20240222$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-003254$JAZZ$$$$A$M$Y$$$20240703$$HP$US$US
240459391$24045939$1$I$$20240306$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004106$JAZZ$$$$$F$Y$$$20240703$$HP$US$US
240459401$24045940$1$I$$20240227$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-003565$JAZZ$$$$$M$Y$17.551$KG$20240703$$CN$US$US
240459411$24045941$1$I$$20240630$20240703$20240703$EXP$$NVSC2024US137235$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240459421$24045942$1$I$$20240222$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-003268$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240459431$24045943$1$I$$20240229$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-003695$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240459441$24045944$1$I$$20240306$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004032$JAZZ$$$$$M$Y$$$20240703$$HP$US$US
240459451$24045945$1$I$$20240308$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004201$JAZZ$$$$$F$Y$$$20240703$$CN$US$US
240459461$24045946$1$I$$20240223$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-003486$JAZZ$$$$$F$Y$$$20240703$$CN$US$US
240459471$24045947$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129035$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240459481$24045948$1$I$$20240207$20240703$20240703$PER$$US-AMGEN-USASP2024131722$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240459491$24045949$1$I$$20240701$20240703$20240703$EXP$$PH-GILEAD-2024-0679279$GILEAD$Mejos J, Darunday G., Polito E. and Maguad R.. Hepatitis-B virus related membranous nephropathy presenting as nephrotic syndrome treated with tenofovir. Nephrology Dialysis Transplantation. 2024;39(1):i2066-i2067$32$YR$A$M$Y$$$20240703$$HP$PH$PH
240459502$24045950$2$F$20240520$20240702$20240703$20240717$PER$$US-ROCHE-RCA5209301$ROCHE$$79$YR$E$F$Y$$$20240717$$CN$US$US
240459511$24045951$1$I$$20240301$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-003235$JAZZ$$$$$M$Y$$$20240703$$HP$US$US
240459521$24045952$1$I$$20240221$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-003174$JAZZ$$$$$M$Y$$$20240703$$MD$US$US
240459531$24045953$1$I$$20240412$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-003055$JAZZ$$23$YR$$F$Y$$$20240703$$MD$US$US
240459541$24045954$1$I$$20240214$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-002784$JAZZ$$$$A$F$Y$$$20240703$$HP$US$US
240459551$24045955$1$I$$20240702$20240702$20240702$DIR$708876$$FDA-CTU$$$$$UNK$N$$$20240702$$CN$US$
240459561$24045956$1$I$20240604$20240625$20240703$20240703$EXP$IT-MINISAL02-989520$IT-TEVA-VS-3214487$TEVA$$54$YR$$M$Y$82$KG$20240703$$MD$IT$IT
240459571$24045957$1$I$$20240702$20240703$20240703$EXP$$NVSC2024US137516$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240459581$24045958$1$I$20240524$20240619$20240703$20240703$EXP$FR-AFSSAPS-RN2024000653$FR-TEVA-VS-3212693$TEVA$$66$YR$$F$Y$$$20240703$$MD$FR$FR
240459591$24045959$1$I$$20240118$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-001189$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240459601$24045960$1$I$$20240213$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-002731$JAZZ$$4$YR$$F$Y$$$20240703$$CN$US$US
240459611$24045961$1$I$$20240209$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-002513$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240459621$24045962$1$I$$20240213$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-002691$JAZZ$$$$$F$Y$$$20240703$$CN$US$US
240459631$24045963$1$I$$20240624$20240703$20240703$EXP$$IT-TEVA-VS-3215423$TEVA$Giorgetti A, Grosse Perdekamp M, Franchetti G, Pircher R, Pollak S, Pelotti S, et al. Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities. Int-J-Legal-Med 2024;.$20$YR$$M$Y$$$20240703$$HP$IT$IT
240459641$24045964$1$I$$20240622$20240702$20240702$DIR$FDA-CDER-CTU-2024-46323$$FDA-CTU$$$$$$N$$$20240622$N$$US$
240459651$24045965$1$I$$20240212$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-002608$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240459661$24045966$1$I$$20240209$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-002520$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240459671$24045967$1$I$$20240214$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-002782$JAZZ$$$$A$F$Y$$$20240703$$HP$US$US
240459681$24045968$1$I$$20240701$20240703$20240703$PER$$US-MYLANLABS-2024M1061989$MYLAN$$$$$F$Y$$$20240703$$HP$US$US
240459691$24045969$1$I$$20240624$20240703$20240703$EXP$$US-MYLANLABS-2024M1060851$MYLAN$Hammond TC, Channick CL, Favano T, Purbhoo M, Exley MA, Vandiver MS, et al. Persistent SARS-CoV-2 Viremia, COVID-19 Associated Acute Respiratory Distress Syndrome, Severe Coagulopathy and Massive Hemoptysis in a Renal Transplant Patient on Veno-Venous Extracorporeal Membrane Oxygenation. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$26$YR$$M$Y$$$20240703$$HP$US$US
240459701$24045970$1$I$$20240626$20240703$20240703$EXP$$US-ALKERMES INC.-ALK-2024-001774$ALKERMES$$$$$F$Y$$$20240703$$HP$US$US
240459712$24045971$2$F$$20240708$20240703$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05621$LUPIN$$$$$$Y$$$20240806$$CN$US$US
240459721$24045972$1$I$$20240702$20240702$20240702$DIR$708877$$FDA-CTU$$$$$UNK$N$$$20240702$$CN$US$
240459731$24045973$1$I$20240101$20240627$20240703$20240703$EXP$$US-ALKERMES INC.-ALK-2024-001772$ALKERMES$$$$$F$Y$$$20240703$$MD$US$US
240459741$24045974$1$I$$20240610$20240703$20240703$PER$$US-AstraZeneca-2024A139718$ASTRAZENECA$$68$YR$$F$Y$$$20240703$$HP$US$
240459761$24045976$1$I$20240517$20240628$20240703$20240703$EXP$$US-AstraZeneca-2024A149811$ASTRAZENECA$$$$$M$Y$$$20240703$$HP$US$
240459792$24045979$2$F$$20240808$20240703$20240811$PER$$US-AstraZeneca-2024A145092$ASTRAZENECA$$$$$F$Y$$$20240811$$CN$US$
240459801$24045980$1$I$$20240702$20240703$20240703$PER$$US-JNJFOC-20240705558$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$CN$US$US
240459813$24045981$3$F$$20240729$20240703$20240805$EXP$$CA-JNJFOC-20240673768$JOHNSON AND JOHNSON$$6$MON$I$M$Y$$$20240805$$CN$CA$CA
240459821$24045982$1$I$20240504$20240628$20240703$20240703$EXP$$CN-JNJFOC-20240677318$JOHNSON AND JOHNSON$$27$YR$A$F$Y$72$KG$20240703$$HP$CN$CN
240459841$24045984$1$I$20231124$20240624$20240703$20240703$EXP$$KR-JNJFOC-20240664894$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$HP$KR$KR
240459862$24045986$2$F$20240101$20240708$20240703$20240710$EXP$$US-UCBSA-2024024290$UCB$$$$$F$Y$$$20240710$$CN$US$US
240459871$24045987$1$I$$20240619$20240703$20240703$EXP$$US-NORTHSTAR RX LLC-US-2024NSR000010$NORTHSTAR$Elsayed M. An interesting case of drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis with pulmonary and renal involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209$75$YR$$M$Y$$$20240703$$HP$US$US
240459881$24045988$1$I$$20231206$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-024329$JAZZ$$$$$F$Y$$$20240703$$HP$US$US
240459891$24045989$1$I$$20231213$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-024719$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240459901$24045990$1$I$$20240108$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-000345$JAZZ$$$$$$Y$$$20240703$$PH$US$US
240459911$24045991$1$I$$20240104$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-000185$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240459921$24045992$1$I$$20240102$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-000028$JAZZ$$$$$$Y$$$20240703$$PH$US$US
240459931$24045993$1$I$$20240112$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-000682$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240459941$24045994$1$I$$20240109$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-000097$JAZZ$$$$$$Y$$$20240703$$PH$US$US
240459951$24045995$1$I$$20240112$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2024-US-000721$JAZZ$$$$$F$Y$$$20240703$$PH$US$US
240459961$24045996$1$I$$20231208$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-024494$JAZZ$$$$$M$Y$$$20240703$$MD$US$US
240459971$24045997$1$I$$20240627$20240703$20240703$EXP$$US-OTSUKA-2024_018444$OTSUKA$$$$$F$Y$$$20240703$$HP$US$US
240459981$24045998$1$I$20240627$20240701$20240703$20240703$EXP$$CN-BAYER-2024A095875$BAYER$$58$YR$A$M$Y$55$KG$20240703$$HP$CN$CN
240459991$24045999$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137557$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240460001$24046000$1$I$$20240620$20240703$20240703$EXP$$CA-B.Braun Medical Inc.-2158806$B BRAUN$$71$YR$$F$Y$69$KG$20240703$$$CA$CA
240460011$24046001$1$I$20240620$20240701$20240703$20240703$EXP$GB-MHRA-MED-202407010811065940-JBQDH$GB-MYLANLABS-2024M1061839$MYLAN$$69$YR$$M$Y$96$KG$20240703$$CN$GB$GB
240460021$24046002$1$I$$20240702$20240703$20240703$EXP$$GB-SANDOZ INC.-SDZ2024GB062438$SANDOZ$$49$YR$$F$Y$53$KG$20240703$$MD$GB$GB
240460031$24046003$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106264$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240703$$CN$US$US
240460041$24046004$1$I$$20240621$20240703$20240703$EXP$$US-INCYTE CORPORATION-2024IN006744$INCYTE$$$$$$Y$$$20240703$$MD$US$US
240460052$24046005$2$F$20240601$20240708$20240703$20240802$30DAY$$US-JNJFOC-20240702764$JOHNSON AND JOHNSON$$19$YR$A$F$Y$$$20240802$$CN$US$US
240460062$24046006$2$F$20240101$20240801$20240703$20240807$EXP$$JP-009507513-2406JPN004157J$MERCK$$8$DEC$$$Y$$$20240807$$MD$JP$JP
240460071$24046007$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406291148076400-HYSNB$GB-ORGANON-O2407GBR000071$ORGANON$$$$$M$Y$78$KG$20240703$$CN$GB$GB
240460082$24046008$2$F$20240101$20240628$20240703$20240809$PER$$US-KARYOPHARM-2024KPT001146$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240809$$CN$US$US
240460091$24046009$1$I$20231108$20231206$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-023019$JAZZ$$8$YR$$F$Y$$$20240703$$CN$US$US
240460101$24046010$1$I$$20231122$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-023459$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240460111$24046011$1$I$$20231205$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-024312$JAZZ$$$$$$Y$$$20240703$$CN$US$US
240460121$24046012$1$I$$20231204$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-024318$JAZZ$$5$YR$$F$Y$$$20240703$$MD$US$US
240460131$24046013$1$I$$20231106$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-022446$JAZZ$$$$$F$Y$$$20240703$$CN$US$US
240460141$24046014$1$I$20231205$20231205$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-024306$JAZZ$$$$$$Y$$$20240703$$CN$US$US
240460151$24046015$1$I$$20231025$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-021686$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240460161$24046016$1$I$20231020$20231025$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-021938$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240460171$24046017$1$I$$20231108$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-022676$JAZZ$$$$$M$Y$$$20240703$$PH$US$US
240460181$24046018$1$I$$20231107$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-022543$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240460191$24046019$1$I$$20240701$20240703$20240703$PER$$US-DSJP-DSU-2024-130003$DAIICHI$$$$$F$Y$$$20240703$$CN$US$US
240460201$24046020$1$I$20240620$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024127746$AMGEN$$78$YR$E$M$Y$$$20240703$$CN$US$US
240460211$24046021$1$I$$20240111$20240703$20240703$PER$$US-AMGEN-USASP2024130618$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240460221$24046022$1$I$$20230823$20240703$20240703$PER$$US-AMGEN-USASP2023235396$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240460231$24046023$1$I$20240201$20240626$20240703$20240703$EXP$$NVSC2024BG136196$NOVARTIS$$57$YR$$F$Y$$$20240703$$MD$BG$BG
240460241$24046024$1$I$20240523$20240701$20240703$20240703$EXP$DK-DKMA-30732260$NVSC2024DK136943$NOVARTIS$$1$DY$$M$Y$$$20240703$$MD$DK$DK
240460251$24046025$1$I$$20231006$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-020644$JAZZ$$$$$F$Y$$$20240703$$CN$US$US
240460261$24046026$1$I$$20230925$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-019986$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240460271$24046027$1$I$$20230930$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-020330$JAZZ$$$$C$$Y$$$20240703$$HP$US$US
240460281$24046028$1$I$$20231011$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-020862$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240460291$24046029$1$I$$20230929$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-020285$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240460301$24046030$1$I$$20230919$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-019680$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240460311$24046031$1$I$$20230919$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-019615$JAZZ$$8$YR$$F$Y$$$20240703$$MD$US$US
240460321$24046032$1$I$$20240628$20240703$20240703$EXP$$JP-BAYER-2024A064222$BAYER$$88$YR$E$M$Y$$$20240703$$MD$JP$JP
240460331$24046033$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-202400100553$PFIZER$$36$YR$$F$Y$$$20240703$$CN$US$US
240460341$24046034$1$I$$20240627$20240703$20240703$PER$$US-PFIZER INC-202400204775$PFIZER$$52$YR$$F$Y$$$20240703$$HP$US$US
240460351$24046035$1$I$20240101$20240701$20240703$20240703$PER$$US-PFIZER INC-202400204961$PFIZER$$61$YR$$M$Y$$$20240703$$CN$US$US
240460362$24046036$2$F$$20240703$20240703$20240704$PER$$US-PFIZER INC-202400202522$PFIZER$$$$$$Y$$$20240704$$HP$US$US
240460372$24046037$2$F$$20240816$20240703$20240821$PER$$US-PFIZER INC-202400204875$PFIZER$$$$A$$Y$$$20240821$$PH$US$US
240460381$24046038$1$I$20240601$20240628$20240703$20240703$PER$$US-PFIZER INC-202400204128$PFIZER$$29$YR$$M$Y$$$20240703$$MD$US$US
240460391$24046039$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-202400204394$PFIZER$$$$A$F$Y$$$20240703$$MD$US$US
240460401$24046040$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-PV202400086755$PFIZER$$62$YR$$F$Y$$$20240703$$CN$US$US
240460411$24046041$1$I$$20240627$20240703$20240703$PER$$US-PFIZER INC-PV202400084892$PFIZER$$21$YR$$F$Y$$$20240703$$MD$US$US
240460421$24046042$1$I$$20240629$20240703$20240703$PER$$US-PFIZER INC-PV202400086680$PFIZER$$$$$$Y$$$20240703$$CN$US$US
240460431$24046043$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-PV202400086767$PFIZER$$44$YR$$F$Y$$$20240703$$CN$US$US
240460441$24046044$1$I$20240630$20240630$20240703$20240703$PER$$US-PFIZER INC-202400204911$PFIZER$$19$YR$$F$Y$$$20240703$$CN$US$US
240460451$24046045$1$I$$20240627$20240703$20240703$PER$$US-PFIZER INC-PV202400085150$PFIZER$$12$YR$$M$Y$$$20240703$$MD$US$US
240460461$24046046$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-202400204639$PFIZER$$$$$$Y$$$20240703$$CN$US$US
240460472$24046047$2$F$$20240703$20240703$20240708$PER$$US-PFIZER INC-PV202400086197$PFIZER$$$$$$Y$$$20240708$$LW$US$US
240460481$24046048$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-202400204400$PFIZER$$53$YR$$F$Y$$$20240703$$CN$US$US
240460491$24046049$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-202400204444$PFIZER$$$$$F$Y$$$20240703$$MD$US$US
240460503$24046050$3$F$$20240705$20240703$20240712$PER$$US-PFIZER INC-202400203106$PFIZER$$$$$F$Y$$$20240712$$CN$US$US
240460512$24046051$2$F$20230928$20240806$20240703$20240814$EXP$$US-PFIZER INC-2018319923$PFIZER$$77$YR$$F$Y$68$KG$20240814$$MD$US$US
240460524$24046052$4$F$20200701$20240912$20240703$20240916$PER$$US-PFIZER INC-PV202400086199$PFIZER$$67$YR$$F$Y$$$20240916$$LW$US$US
240460532$24046053$2$F$$20240703$20240703$20240708$PER$$US-PFIZER INC-202400205360$PFIZER$$63$YR$$F$Y$$$20240708$$CN$US$US
240460541$24046054$1$I$20240101$20240701$20240703$20240703$PER$$US-PFIZER INC-PV202400086740$PFIZER$$4$DEC$$F$Y$$$20240703$$MD$US$US
240460551$24046055$1$I$$20240628$20240703$20240703$PER$$US-PFIZER INC-PV202400086231$PFIZER$$85$YR$$F$Y$$$20240703$$MD$US$US
240460561$24046056$1$I$$20230915$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-019434$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240460571$24046057$1$I$20240519$20240625$20240703$20240703$EXP$ES-AEMPS-1536019$ES-TEVA-VS-3214138$TEVA$$76$YR$$F$Y$44.2$KG$20240703$$MD$ES$ES
240460581$24046058$1$I$$20230907$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-018843$JAZZ$$$$$$Y$$$20240703$$CN$US$US
240460591$24046059$1$I$$20230918$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-019511$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240460601$24046060$1$I$$20230828$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-018192$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240460611$24046061$1$I$$20230914$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-019340$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240460621$24046062$1$I$$20230831$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-018461$JAZZ$$$$$F$Y$$$20240703$$MD$US$US
240460631$24046063$1$I$$20230919$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-019599$JAZZ$$$$$F$Y$$$20240703$$HP$US$US
240460641$24046064$1$I$$20230828$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-018181$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240460651$24046065$1$I$$20230918$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-019525$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240460661$24046066$1$I$$20230904$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-018605$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240460671$24046067$1$I$$20240628$20240703$20240703$PER$$US-JNJFOC-20240700995$JOHNSON AND JOHNSON$$62$YR$A$M$Y$113.5$KG$20240703$$CN$US$US
240460691$24046069$1$I$20240101$20240627$20240703$20240703$EXP$$US-ABBVIE-5821340$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240460701$24046070$1$I$$20240328$20240703$20240703$PER$$US-AMGEN-USASP2024131546$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240460711$24046071$1$I$$20240701$20240703$20240703$EXP$$US-TAKEDA-2024TUS066970$TAKEDA$$$$$M$Y$$$20240703$$MD$US$US
240460721$24046072$1$I$$20230831$20240703$20240703$PER$$US-AMGEN-USASP2023235526$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240460751$24046075$1$I$20240604$20240702$20240702$20240702$DIR$708885$$FDA-CTU$$55$YR$$F$N$$$20240702$N$HP$US$
240460761$24046076$1$I$20240630$20240702$20240702$20240702$DIR$708886$$FDA-CTU$$81$YR$$M$N$$$20240702$$CN$US$
240460781$24046078$1$I$20240606$20240702$20240702$20240702$DIR$708888$$FDA-CTU$$$$$UNK$N$$$20240702$N$PH$US$
240460791$24046079$1$I$20240625$20240702$20240702$20240702$DIR$708929$$FDA-CTU$$50$YR$$M$N$86$KG$20240702$Y$HP$US$
240460801$24046080$1$I$$20240702$20240702$20240702$DIR$708883$$FDA-CTU$$65$YR$$M$N$$$20240702$N$PH$US$
240460811$24046081$1$I$$20240702$20240702$20240702$DIR$708945$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240460821$24046082$1$I$20240702$20240702$20240702$20240702$DIR$708917$$FDA-CTU$$84$YR$$F$N$$$20240702$N$HP$US$
240460841$24046084$1$I$$20240625$20240703$20240703$30DAY$$US-GSK-US2024079080$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240460851$24046085$1$I$$20230829$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017330$JAZZ$$4$YR$$M$Y$$$20240703$$HP$US$US
240460861$24046086$1$I$$20230818$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017603$JAZZ$$$$$$Y$$$20240703$$PH$US$US
240460871$24046087$1$I$20240101$20240627$20240703$20240703$EXP$$CN-ABBVIE-5819973$ABBVIE$$$$$F$Y$64$KG$20240703$$MD$CN$CN
240460881$24046088$1$I$$20230815$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017325$JAZZ$$$$$F$Y$$$20240703$$CN$US$US
240460891$24046089$1$I$$20230817$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017597$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240460901$24046090$1$I$$20230817$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017543$JAZZ$$$$$$Y$$$20240703$$PH$US$US
240460911$24046091$1$I$$20230817$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017552$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240460921$24046092$1$I$$20230823$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017993$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240460931$24046093$1$I$$20230811$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017254$JAZZ$$$$$$Y$$$20240703$$CN$US$US
240460941$24046094$1$I$$20231020$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017879$JAZZ$$$$$F$Y$$$20240703$$MD$US$US
240460951$24046095$1$I$$20230815$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017419$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240460961$24046096$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5823286$ABBVIE$$$$$$Y$56$KG$20240703$$HP$US$US
240460971$24046097$1$I$20201126$20240618$20240703$20240703$EXP$PL-URPL-1-3426-2020$PL-TEVA-VS-3212202$TEVA$$76$YR$$$Y$75$KG$20240703$$MD$PL$PL
240460981$24046098$1$I$20240621$20240628$20240703$20240703$EXP$$US-OTSUKA-2024_012741$OTSUKA$$48$YR$$F$Y$$$20240703$$HP$US$US
240460993$24046099$3$F$20210101$20240903$20240703$20240905$PER$$US-GILEAD-2024-0679415$GILEAD$$42$YR$A$F$Y$$$20240905$$LW$US$US
240461011$24046101$1$I$20240607$20240702$20240703$20240703$EXP$GB-MHRA-MED-202407021624232570-SZQVP$GB-ABBVIE-5824096$ABBVIE$$75$YR$$F$Y$62$KG$20240703$$PH$GB$GB
240461022$24046102$2$F$20240504$20240805$20240703$20240815$EXP$$JP-009507513-2405JPN000546J$MERCK$$73$YR$$F$Y$$$20240815$$MD$JP$JP
240461031$24046103$1$I$$20240701$20240703$20240703$EXP$$AU-MYLANLABS-2024M1061931$MYLAN$$$$$M$Y$$$20240703$$PH$AU$AU
240461044$24046104$4$F$20240627$20240912$20240703$20240916$30DAY$$US-PFIZER INC-202400203665$PFIZER$$13$YR$$M$Y$$$20240916$$CN$US$US
240461052$24046105$2$F$$20240809$20240703$20240809$30DAY$$GB-PFIZER INC-202400204939$PFIZER$$$$$$Y$$$20240809$$CN$GB$GB
240461073$24046107$3$F$$20240911$20240703$20240913$30DAY$$CO-PFIZER INC-202400195170$PFIZER$$12$YR$$F$Y$$$20240913$$CN$CO$CO
240461081$24046108$1$I$$20240625$20240703$20240703$EXP$$BR-PFIZER INC-202400187711$PFIZER$$69$YR$$F$Y$56$KG$20240703$$CN$BR$BR
240461111$24046111$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5823410$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240461121$24046112$1$I$$20230811$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017167$JAZZ$$$$$F$Y$$$20240703$$CN$US$US
240461131$24046113$1$I$$20230725$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-015951$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240461141$24046114$1$I$$20230726$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-016079$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240461151$24046115$1$I$$20230811$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017173$JAZZ$$$$$$Y$$$20240703$$HP$US$US
240461161$24046116$1$I$$20230807$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-016901$JAZZ$$$$$M$Y$$$20240703$$HP$US$US
240461171$24046117$1$I$$20230811$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017168$JAZZ$$$$$F$Y$$$20240703$$HP$US$US
240461181$24046118$1$I$$20230726$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-016081$JAZZ$$$$A$M$Y$$$20240703$$CN$US$US
240461191$24046119$1$I$$20230731$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-016311$JAZZ$$$$A$F$Y$$$20240703$$CN$US$US
240461201$24046120$1$I$20230101$20230811$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-017241$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240461211$24046121$1$I$$20230721$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-015700$JAZZ$$$$$$Y$$$20240703$$PH$US$US
240461221$24046122$1$I$$20240627$20240703$20240703$EXP$$JP-OTSUKA-2024_018539$OTSUKA$$$$$$Y$$$20240703$$PH$JP$JP
240461232$24046123$2$F$$20240712$20240703$20240715$PER$$US-VEROBIOTECH-2024USVEROSPO00129$VERO BIOTECH$$$$A$$Y$$$20240715$$HP$US$US
240461241$24046124$1$I$20240526$20240626$20240703$20240703$EXP$$CN-BEIGENE-BGN-2024-009854$BEIGENE$$$$$$Y$$$20240703$$HP$CN$CN
240461261$24046126$1$I$$20240702$20240703$20240703$PER$$US-JNJFOC-20240705260$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$CN$US$US
240461271$24046127$1$I$20240626$20240626$20240703$20240703$EXP$$NVSC2024US135033$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240461281$24046128$1$I$20230126$20240603$20240702$20240702$DIR$FDA-CDER-CTU-2024-46326$$FDA-CTU$$50$YR$$M$N$104.33$KG$20240603$N$CN$US$
240461291$24046129$1$I$$20240702$20240703$20240703$PER$$US-JNJFOC-20240704161$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240461301$24046130$1$I$$20240701$20240703$20240703$EXP$FR-AFSSAPS-MP2024001059$NVSC2024FR136924$NOVARTIS$$$$N$F$Y$2.36$KG$20240703$$MD$FR$FR
240461313$24046131$3$F$$20240916$20240703$20240919$30DAY$$US-PFIZER INC-202400202930$PFIZER$$$$$$Y$$$20240919$$CN$US$US
240461331$24046133$1$I$20210101$20240612$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211007408$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240703$$HP$US$US
240461343$24046134$3$F$20230804$20240726$20240703$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-061886$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240801$$MD$JP$JP
240461351$24046135$1$I$$20240624$20240703$20240703$30DAY$$US-GSK-US2024078660$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240461361$24046136$1$I$$20240621$20240703$20240703$PER$$US-BAYER-2024A094237$BAYER$Iwamoto S.J.; Rothman M.S.; T^sjoen G.; Defreyne J.. Approach to the Patient: Hormonal Therapy in Transgender Adults With Complex Medical Histories. Journal of Clinical Endocrinology and Metabolism. 2024;109:2:592-602$58$YR$A$F$Y$$$20240703$$HP$US$US
240461371$24046137$1$I$$20230627$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-013863$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240461381$24046138$1$I$$20230705$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-014457$JAZZ$$$$$M$Y$$$20240703$$MD$US$US
240461391$24046139$1$I$$20230630$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-014174$JAZZ$$$$$M$Y$$$20240703$$CN$US$US
240461401$24046140$1$I$20231227$20240618$20240703$20240703$EXP$$DE-ROCHE-10000014950$ROCHE$$45$YR$A$M$Y$100$KG$20240703$$MD$DE$DE
240461411$24046141$1$I$$20230720$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-015588$JAZZ$$22$YR$$M$Y$$$20240703$$CN$US$US
240461421$24046142$1$I$$20240611$20240703$20240703$PER$$US-JAZZ PHARMACEUTICALS-2023-US-005516$JAZZ$$$$$$Y$$$20240703$$MD$US$US
240461432$24046143$2$F$20240601$20240708$20240703$20240711$EXP$PT-INFARMED-J202406-345$PT-EMD Serono-2024033999$EMD SERONO INC$$41$YR$A$F$Y$56$KG$20240711$$CN$PT$PT
240461441$24046144$1$I$$20240701$20240703$20240703$30DAY$$US-GSK-US2024081631$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240461451$24046145$1$I$$20240625$20240703$20240703$30DAY$$US-GSK-US2024079192$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240461461$24046146$1$I$20240105$20240702$20240703$20240703$EXP$$US-TAKEDA-2024TUS066723$TAKEDA$$65$YR$$F$Y$$$20240703$$HP$US$US
240461483$24046148$3$F$$20240903$20240703$20240905$30DAY$$JO-PFIZER INC-202400193824$PFIZER$$$$$$Y$$$20240905$$CN$JO$JO
240461491$24046149$1$I$20240321$20240626$20240703$20240703$EXP$$CN-BEIGENE-BGN-2024-009861$BEIGENE$$$$$$Y$$$20240703$$HP$CN$CN
240461502$24046150$2$F$$20240804$20240703$20240805$30DAY$$US-PFIZER INC-202400202791$PFIZER$$$$$$Y$$$20240805$$CN$US$US
240461521$24046152$1$I$20240701$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46444$$FDA-CTU$$94$YR$$M$N$$$20240703$N$$US$
240461533$24046153$3$F$$20240912$20240703$20240916$30DAY$$US-PFIZER INC-202400202932$PFIZER$$6$YR$$M$Y$$$20240916$$CN$US$US
240461552$24046155$2$F$20240621$20240825$20240703$20240826$30DAY$$CO-PFIZER INC-202400199625$PFIZER$$13$YR$$F$Y$$$20240826$$CN$CO$CO
240461563$24046156$3$F$$20240922$20240703$20240925$30DAY$$US-PFIZER INC-202400202027$PFIZER$$20$YR$$F$Y$72.57$KG$20240925$$CN$US$US
240461573$24046157$3$F$20240625$20240911$20240703$20240913$30DAY$$US-PFIZER INC-202400202728$PFIZER$$13$YR$$M$Y$$$20240913$$CN$US$US
240461585$24046158$5$F$$20240905$20240703$20240910$30DAY$$US-PFIZER INC-202400203722$PFIZER$$13$YR$$M$Y$32.66$KG$20240910$$CN$US$US
240461593$24046159$3$F$$20240911$20240703$20240912$30DAY$$US-PFIZER INC-202400202951$PFIZER$$11$YR$$F$Y$$$20240912$$CN$US$US
240461601$24046160$1$I$20200611$20240701$20240703$20240703$EXP$PL-URPL-1-2333-2020$PL-HALEON-2184857$Haleon PLC$$22$YR$$F$Y$$$20240703$$MD$PL$PL
240461611$24046161$1$I$20240528$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024129626$AMGEN$$$$$F$Y$$$20240703$$PH$US$US
240461621$24046162$1$I$$20240620$20240703$20240703$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091826$GLENMARK$Prabhu S, Malempati S, Markowitz D.. Amlodipine: Not an Ace in the Hole.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A1361$$$$$Y$$$20240703$$MD$US$US
240461631$24046163$1$I$20240628$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024128605$AMGEN$$76$YR$E$M$Y$$$20240703$$CN$US$US
240461641$24046164$1$I$20240330$20240627$20240703$20240703$EXP$FR-AFSSAPS-PO2024000698$FR-009507513-2406FRA010216$MERCK$$58$YR$$F$Y$58$KG$20240703$$MD$FR$FR
240461651$24046165$1$I$$20240625$20240703$20240703$PER$$US-ALXN-202406USA001631US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240703$$CN$US$US
240461662$24046166$2$F$$20240805$20240703$20240806$PER$$US-ALXN-202406USA001707US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240461673$24046167$3$F$20240604$20240920$20240703$20240926$30DAY$$GB-PFIZER INC-202400196777$PFIZER$$$$$$Y$$$20240926$$CN$GB$GB
240461681$24046168$1$I$$20240702$20240703$20240703$EXP$$ES-TAKEDA-2024TUS066765$TAKEDA$$66$YR$$M$Y$$$20240703$$HP$ES$ES
240461691$24046169$1$I$$20240627$20240703$20240703$EXP$$ID-MYLANLABS-2024M1061483$MYLAN$Triono A, Herini ES, Gunadi. Genetic exploration of Dravet syndrome: two case report. J-Med-Case-Rep 2024; 18 (1):.$3$MON$$F$Y$$$20240703$$HP$ID$ID
240461704$24046170$4$F$$20240919$20240703$20240924$30DAY$$US-PFIZER INC-202400202975$PFIZER$$12$YR$$F$Y$63.5$KG$20240924$$CN$US$US
240461725$24046172$5$F$20240620$20240904$20240703$20240906$EXP$$CA-TAKEDA-2024TUS065314$TAKEDA$$30$YR$$M$Y$$$20240906$$CN$CA$CA
240461732$24046173$2$F$20240724$20240724$20240703$20240729$EXP$$CA-TAKEDA-2024TUS058078$TAKEDA$$72$YR$$F$Y$$$20240729$$CN$CA$CA
240461741$24046174$1$I$20240601$20240625$20240703$20240703$EXP$$BR-JNJFOC-20240676332$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$BR$BR
240461751$24046175$1$I$20240624$20240628$20240703$20240703$EXP$$CA-TAKEDA-2024TUS065782$TAKEDA$$79$YR$$M$Y$$$20240703$$CN$CA$CA
240461761$24046176$1$I$$20240607$20240703$20240703$PER$$US-VEROBIOTECH-2024USVEROSPO00132$VERO BIOTECH$$$$$$Y$$$20240703$$HP$US$US
240461772$24046177$2$F$20240615$20240618$20240703$20240712$EXP$$CA-ROCHE-10000012983$ROCHE$$30$YR$A$F$Y$$$20240712$$CN$CA$CA
240461781$24046178$1$I$20240101$20240621$20240703$20240703$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00507$UPSHER-SMITH$$$$$F$Y$$$20240703$$HP$US$US
240461791$24046179$1$I$20240620$20240620$20240703$20240703$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00505$UPSHER-SMITH$$24$YR$$F$Y$$$20240703$$HP$US$US
240461802$24046180$2$F$20240329$20240731$20240703$20240809$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00506$PARATEK PHARMACEUTICALS$$75$YR$$M$Y$$$20240809$$CN$US$US
240461822$24046182$2$F$20240101$20240705$20240703$20240712$EXP$$US-SA-2024SA194227$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240712$$CN$US$US
240461831$24046183$1$I$$20240629$20240703$20240703$EXP$$CA-TAKEDA-2024TUS066769$TAKEDA$$$$$M$Y$$$20240703$$CN$CA$CA
240461841$24046184$1$I$20240601$20240624$20240703$20240703$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00501$PARATEK PHARMACEUTICALS$$$$E$M$Y$$$20240703$$CN$US$US
240461851$24046185$1$I$20240502$20240628$20240703$20240703$EXP$FR-AFSSAPS-NC2024000691$FR-HALEON-2184508$Haleon PLC$$15$YR$$F$Y$50$KG$20240703$$MD$FR$FR
240461861$24046186$1$I$$20240626$20240703$20240703$EXP$$US-TAKEDA-2024TUS065456$TAKEDA$$$$$$Y$$$20240703$$CN$US$US
240461872$24046187$2$F$20240505$20240708$20240703$20240715$EXP$ES-AEMPS-1538238$ES-SA-2024SA195530$SANOFI AVENTIS$$90$YR$E$M$Y$$$20240715$$CN$ES$ES
240461892$24046189$2$F$20240627$20240715$20240703$20240718$EXP$$CA-UCBSA-2024033578$UCB$$57$YR$$F$Y$$$20240718$$CN$CA$CA
240461901$24046190$1$I$20240301$20240627$20240703$20240703$PER$$US-ABBVIE-5823547$ABBVIE$$50$YR$$F$Y$$$20240703$$MD$US$US
240461911$24046191$1$I$$20240604$20240703$20240703$PER$$US-VEROBIOTECH-2024USVEROSPO00133$VERO BIOTECH$$$$$$Y$$$20240703$$HP$US$US
240461921$24046192$1$I$20240624$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001149$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240703$$CN$US$US
240461931$24046193$1$I$$20240702$20240703$20240703$EXP$$NVSC2024US137300$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240461942$24046194$2$F$20210701$20240711$20240703$20240712$EXP$$NVSC2024DE137920$NOVARTIS$$70$YR$$M$Y$$$20240712$$MD$DE$DE
240461951$24046195$1$I$$20240628$20240703$20240703$EXP$$US-JNJFOC-20240704659$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240461961$24046196$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106176$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240703$$CN$US$US
240461971$24046197$1$I$$20240624$20240703$20240703$EXP$$US-TEVA-VS-3213927$TEVA$$$$E$F$Y$$$20240703$$CN$US$US
240461981$24046198$1$I$$20240624$20240703$20240703$EXP$$US-EMD Serono-2024034708$EMD SERONO INC$$$$A$F$Y$$$20240703$$CN$US$US
240461991$24046199$1$I$$20240629$20240703$20240703$PER$$US-ABBVIE-5824369$ABBVIE$$$$$F$Y$$$20240703$$HP$US$US
240462001$24046200$1$I$$20240626$20240703$20240703$EXP$GB-MHRA-MIDB-f8ca1eaa-219a-4293-926a-248086ad3141$GB-RDY-SPO/GBR/24/0009353$DR REDDYS$$56$YR$A$$Y$$$20240703$$PH$GB$GB
240462011$24046201$1$I$20240101$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024127087$AMGEN$$28$YR$A$F$Y$$$20240703$$HP$US$US
240462021$24046202$1$I$$20231101$20240703$20240703$PER$$US-AMGEN-USASP2023235201$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240462032$24046203$2$F$20240101$20240801$20240703$20240806$PER$$US-JNJFOC-20240638033$JOHNSON AND JOHNSON$$75$YR$E$M$Y$72.186$KG$20240806$$CN$US$US
240462051$24046205$1$I$$20240211$20240703$20240703$PER$$US-ABBVIE-5824683$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240462061$24046206$1$I$$20240701$20240703$20240703$EXP$$CA-ORGANON-O2407CAN000131$ORGANON$$60$YR$$F$Y$$$20240703$$HP$CA$CA
240462073$24046207$3$F$20231226$20240722$20240703$20240729$EXP$FR-AFSSAPS-NT2024000734$FR-009507513-2406FRA009983$MERCK$$45$YR$$F$Y$54$KG$20240729$$MD$FR$FR
240462081$24046208$1$I$$20240620$20240703$20240703$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091835$GLENMARK$Hennen MA, Zhang V, Opler DJ.. An unwelcome side-effect of trazodone use in a trans-male.. Psychiatry and Clinical Neurosciences.. 2024;78 (6):376$$$$$Y$$$20240703$$MD$US$US
240462092$24046209$2$F$20240505$20240808$20240703$20240809$EXP$$JP-BAYER-2024A082270$BAYER$$65$YR$E$F$Y$$$20240809$$MD$JP$JP
240462101$24046210$1$I$20240610$20240621$20240703$20240703$EXP$$CN-Bio-Thera Solutions, Ltd.-2158807$BIOTHERA PHARMACEUTICALS$$67$YR$$F$Y$64$KG$20240703$$$CN$CN
240462111$24046211$1$I$$20240626$20240703$20240703$PER$$US-ABBVIE-5817987$ABBVIE$$$$$$Y$100.69$KG$20240703$$CN$US$US
240462121$24046212$1$I$$20240626$20240703$20240703$EXP$$US-MYLANLABS-2024M1061813$MYLAN$Koga S, Pai E, Banihashemi A. Diffuse lymphocytic encephalomyelitis with stiffperson- like syndrome in multiple myeloma after Teclistamab treatment. J-Neuropathol-Exp-Neurol 2024; 83 (6): 457-458 abstr. 5.$45$YR$$M$Y$$$20240703$$HP$US$US
240462131$24046213$1$I$$20240628$20240703$20240703$EXP$$GB-MYLANLABS-2024M1061614$MYLAN$$$$$M$Y$$$20240703$$HP$GB$GB
240462143$24046214$3$F$20190101$20240831$20240703$20240902$EXP$$US-GILEAD-2024-0679417$GILEAD$$56$YR$A$M$Y$$$20240902$$LW$US$US
240462152$24046215$2$F$20240628$20240802$20240703$20240802$PER$$US-ALXN-202406USA001896US$ALEXION PHARMACEUTICALS$$65$YR$$F$Y$$$20240802$$CN$US$US
240462162$24046216$2$F$$20240805$20240703$20240806$PER$$US-ALXN-202406USA001621US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240462171$24046217$1$I$$20240627$20240703$20240703$EXP$$US-Amarin Pharma, Inc-2024AMR000329$AMARIN$$$$$F$Y$$$20240703$$CN$US$US
240462181$24046218$1$I$$20240628$20240703$20240703$EXP$$CN-PFIZER INC-PV202400085988$PFIZER$Li, M.. Treatment experience for different risk groups of Kaposiform hemangioendothelioma. Frontiers in Oncology. 2024;14:10.3389/fonc.2024.1336763$$$I$$Y$$$20240703$$HP$CN$CN
240462191$24046219$1$I$$20240628$20240703$20240703$EXP$$CN-PFIZER INC-202400204060$PFIZER$Li, M.. Treatment experience for different risk groups of Kaposiform hemangioendothelioma. Frontiers in Oncology. 2024;14:10.3389/fonc.2024.1336763$$$I$$Y$$$20240703$$HP$CN$CN
240462201$24046220$1$I$20240201$20240624$20240703$20240703$EXP$$SI-FreseniusKabi-FK202410042$FRESENIUS KABI$$$$E$M$Y$$$20240703$$MD$SI$SI
240462211$24046221$1$I$20240628$20240628$20240703$20240703$EXP$$GB-FreseniusKabi-FK202410342$FRESENIUS KABI$$36$YR$A$F$Y$106$KG$20240703$$MD$GB$GB
240462221$24046222$1$I$$20240624$20240703$20240703$PER$$US-ABBVIE-5814942$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240462237$24046223$7$F$20240701$20240829$20240703$20240902$PER$$US-JNJFOC-20240705712$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240902$$PH$US$US
240462242$24046224$2$F$20240624$20240812$20240703$20240813$EXP$$US-UCBSA-2024033597$UCB$$71$YR$$F$Y$$$20240813$$CN$US$US
240462252$24046225$2$F$20240524$20240904$20240703$20240905$PER$$NVSC2024US135504$NOVARTIS$$51$YR$$F$Y$109$KG$20240905$$PH$US$US
240462261$24046226$1$I$$20240618$20240703$20240703$EXP$GB-MHRA-MED-202406181730532200-SNRZV$GB-TEVA-VS-3211720$TEVA$$$$$F$Y$$$20240703$$HP$GB$GB
240462271$24046227$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5823112$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240462281$24046228$1$I$$20240117$20240703$20240703$PER$$US-AMGEN-USASP2024130873$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240462291$24046229$1$I$$20240429$20240703$20240703$EXP$$US-AMGEN-USASP2024127547$AMGEN$Coyne W, D.. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the Dialysis Patients^ Response to IV Iron with Elevated Ferritin (DRIVE) study. Journal of the American Society of Nephrology: JASN. 2007;18 (3):975-984$$$$$Y$$$20240703$$MD$US$US
240462301$24046230$1$I$20240621$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024128137$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240462312$24046231$2$F$20240601$20240805$20240703$20240809$PER$$US-AMGEN-USASP2024126485$AMGEN$$81$YR$E$M$Y$$$20240809$$CN$US$US
240462321$24046232$1$I$$20240116$20240703$20240703$PER$$US-AMGEN-USASP2024129808$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240462331$24046233$1$I$$20240618$20240703$20240703$EXP$GB-MHRA-MED-202406181554333930-FTYZR$GB-TEVA-VS-3211781$TEVA$$$$$M$Y$$$20240703$$PH$GB$GB
240462341$24046234$1$I$$20240620$20240703$20240703$EXP$$CA-TEVA-VS-3213196$TEVA$$40$YR$$F$Y$$$20240703$$HP$CA$CA
240462351$24046235$1$I$$20240624$20240703$20240703$EXP$$HU-AMGEN-HUNSP2024125090$AMGEN$Cegledi A.; Batai A.; Dolgos J. et al.. Case Report: Effective management of adalimumab induced acquired hemophilia A with the CyDRI protocol. Pathology + Oncology Research. 2024;30:1-8$68$YR$E$M$Y$$$20240703$$HP$HU$HU
240462361$24046236$1$I$20240101$20240610$20240703$20240703$PER$$US-KARYOPHARM-2024KPT001173$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240703$$PH$US$US
240462383$24046238$3$F$20240524$20240912$20240703$20240920$EXP$$CA-Amarin Pharma, Inc-2024AMR000323$AMARIN$$66$YR$E$F$Y$$$20240920$$CN$CA$CA
240462391$24046239$1$I$$20240619$20240703$20240703$EXP$$GB-TEVA-VS-3211956$TEVA$$68$YR$$M$Y$$$20240703$$MD$GB$GB
240462401$24046240$1$I$20240612$20240625$20240703$20240703$EXP$$CN-AstraZeneca-2024A150075$ASTRAZENECA$$65$YR$$M$Y$75$KG$20240703$$MD$CN$
240462411$24046241$1$I$$20240626$20240703$20240703$PER$$US-TAKEDA-2024TUS064809$TAKEDA$$$$$M$Y$34$KG$20240703$$HP$US$US
240462421$24046242$1$I$$20240701$20240703$20240703$EXP$$CA-PFIZER INC-202400204300$PFIZER$$15$YR$$F$Y$$$20240703$$PH$CA$CA
240462431$24046243$1$I$$20240701$20240703$20240703$EXP$$CA-PFIZER INC-202400204445$PFIZER$$14$YR$$M$Y$70$KG$20240703$$HP$CA$CA
240462441$24046244$1$I$20240623$20240628$20240703$20240703$EXP$$CN-PFIZER INC-PV202400085657$PFIZER$$52$YR$$F$Y$47.7$KG$20240703$$HP$CN$CN
240462451$24046245$1$I$20240401$20240625$20240703$20240703$EXP$FR-AFSSAPS-PO2024000633$FR-PFIZER INC-202400199402$PFIZER$$55$YR$$F$Y$98$KG$20240703$$MD$FR$FR
240462461$24046246$1$I$$20240701$20240703$20240703$EXP$$CA-PFIZER INC-202400204418$PFIZER$$22$YR$$M$Y$105$KG$20240703$$HP$CA$CA
240462471$24046247$1$I$$20240701$20240703$20240703$EXP$$CA-PFIZER INC-202400204410$PFIZER$$6$YR$$M$Y$27$KG$20240703$$HP$CA$CA
240462481$24046248$1$I$20240628$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46330$$FDA-CTU$$54$YR$$F$N$131.7$KG$20240702$N$$US$
240462491$24046249$1$I$20240519$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46394$$FDA-CTU$$64$YR$$F$N$70.8$KG$20240702$N$$US$
240462501$24046250$1$I$20240615$20240628$20240703$20240703$EXP$$CN-PFIZER INC-PV202400085618$PFIZER$$4$YR$$F$Y$17$KG$20240703$$HP$CN$CN
240462511$24046251$1$I$20240624$20240625$20240703$20240703$DIR$FDA-CDER-CTU-2024-46391$$FDA-CTU$$71$YR$$F$N$162.6$KG$20240625$N$$US$
240462521$24046252$1$I$20220716$20240626$20240703$20240703$DIR$FDA-CDER-CTU-2024-46328$$FDA-CTU$$64$YR$$F$N$107.5$KG$20240626$N$$US$
240462531$24046253$1$I$20240201$20240701$20240703$20240703$EXP$FR-AFSSAPS-MA2024001109$FR-PFIZER INC-202400203980$PFIZER$$48$YR$$M$Y$$$20240703$$PH$FR$FR
240462541$24046254$1$I$20240627$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46331$$FDA-CTU$$68$YR$$M$N$77.6$KG$20240702$N$$US$
240462551$24046255$1$I$20240622$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46452$$FDA-CTU$$90$YR$$M$N$$$20240702$N$HP$US$
240462561$24046256$1$I$$20240701$20240703$20240703$EXP$$BE-PFIZER INC-202400203903$PFIZER$$32$YR$$M$Y$$$20240703$$MD$BE$BE
240462571$24046257$1$I$20240617$20240701$20240703$20240703$DIR$FDA-CDER-CTU-2024-46393$$FDA-CTU$$18$YR$$M$N$53.5$KG$20240701$N$$US$
240462581$24046258$1$I$$20240701$20240703$20240703$EXP$$CA-PFIZER INC-202400204289$PFIZER$$15$YR$$M$Y$62$KG$20240703$$PH$CA$CA
240462591$24046259$1$I$20240601$20240701$20240703$20240703$EXP$FR-AFSSAPS-RN2024000723$FR-PFIZER INC-202400203981$PFIZER$$62$YR$$M$Y$$$20240703$$PH$FR$FR
240462601$24046260$1$I$20240612$20240628$20240703$20240703$EXP$$CN-PFIZER INC-PV202400085664$PFIZER$$23$YR$$M$Y$52$KG$20240703$$HP$CN$CN
240462611$24046261$1$I$20230707$20240625$20240703$20240703$DIR$FDA-CDER-CTU-2024-46329$$FDA-CTU$$31$YR$$F$N$140$KG$20240625$N$$US$
240462621$24046262$1$I$20240427$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46332$$FDA-CTU$$$$$M$N$76$KG$20240702$N$$US$
240462641$24046264$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46445$$FDA-CTU$$64$YR$$F$N$188$LBS$20240703$N$$US$
240462651$24046265$1$I$$20240627$20240703$20240703$EXP$$US-PFIZER INC-PV202400085031$PFIZER$$29$YR$$F$Y$$$20240703$$MD$US$US
240462661$24046266$1$I$$20240628$20240703$20240703$EXP$$US-PFIZER INC-202400203469$PFIZER$$58$YR$$F$Y$$$20240703$$CN$US$US
240462671$24046267$1$I$20240601$20240628$20240703$20240703$EXP$$CN-PFIZER INC-PV202400085682$PFIZER$$8$YR$$M$Y$24$KG$20240703$$HP$CN$CN
240462681$24046268$1$I$$20240701$20240703$20240703$EXP$$CA-PFIZER INC-202400204318$PFIZER$$14$YR$$M$Y$$$20240703$$PH$CA$CA
240462691$24046269$1$I$20240531$20240701$20240703$20240703$EXP$$JP-PFIZER INC-PV202400086468$PFIZER$$85$YR$$M$Y$$$20240703$$PH$JP$JP
240462701$24046270$1$I$20240509$20240701$20240703$20240703$EXP$FR-AFSSAPS-PP2024000695$FR-PFIZER INC-202400203886$PFIZER$$80$YR$$M$Y$68$KG$20240703$$MD$FR$FR
240462711$24046271$1$I$$20240627$20240703$20240703$EXP$$ID-PFIZER INC-PV202400084689$PFIZER$$28$YR$$M$Y$$$20240703$$HP$ID$ID
240462721$24046272$1$I$$20240701$20240703$20240703$EXP$$CA-PFIZER INC-202400204426$PFIZER$$3$YR$$F$Y$11$KG$20240703$$HP$CA$CA
240462731$24046273$1$I$$20240701$20240703$20240703$EXP$$JP-PFIZER INC-PV202400086813$PFIZER$$84$YR$$M$Y$$$20240703$$MD$JP$JP
240462743$24046274$3$F$20240201$20240806$20240703$20240808$EXP$$US-PFIZER INC-202400204382$PFIZER$$21$YR$$F$Y$58.957$KG$20240808$$CN$US$US
240462752$24046275$2$F$$20240829$20240703$20240829$EXP$$AU-PFIZER INC-PV202400086263$PFIZER$$39$YR$$M$Y$79$KG$20240829$$MD$AU$AU
240462761$24046276$1$I$$20240627$20240703$20240703$EXP$$US-PFIZER INC-PV202400084925$PFIZER$$28$YR$$M$Y$$$20240703$$MD$US$US
240462771$24046277$1$I$20240619$20240701$20240703$20240703$EXP$$CN-PFIZER INC-PV202400086370$PFIZER$$71$YR$$F$Y$64$KG$20240703$$HP$CN$CN
240462781$24046278$1$I$$20240701$20240703$20240703$EXP$$CA-PFIZER INC-202400204420$PFIZER$$13$YR$$M$Y$44$KG$20240703$$HP$CA$CA
240462791$24046279$1$I$$20240619$20240703$20240703$EXP$$GB-TEVA-VS-3211875$TEVA$$$$E$F$Y$$$20240703$$CN$GB$GB
240462801$24046280$1$I$$20240625$20240703$20240703$PER$$US-JNJFOC-20240670739$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240462813$24046281$3$F$$20240718$20240703$20240722$PER$$US-JNJFOC-20240704664$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240723$$CN$US$US
240462822$24046282$2$F$20240420$20240812$20240703$20240816$EXP$HR-HALMED-300085798$HR-UCBSA-2024033253$UCB$$4$YR$$M$Y$20$KG$20240816$$CN$HR$HR
240462832$24046283$2$F$$20240820$20240703$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106214$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240822$$CN$US$US
240462841$24046284$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024127775$AMGEN$$$$$M$Y$$$20240703$$CN$US$US
240462851$24046285$1$I$$20240625$20240703$20240703$EXP$$DE-AMGEN-DEUSP2024129716$AMGEN$Schulz N.; Dischereit G.; Henke L. et al.. Prevalence and effects of Vitamin D receptor polymorphism on bone mineral density and metabolism in patients with systemic sclerosis- a preliminary study. Clinical and Experimental Medicine. 2024;24 (1):1-9$$$$$Y$$$20240703$$HP$DE$DE
240462861$24046286$1$I$$20240626$20240703$20240703$EXP$$BR-GSK-BR2023AMR017973$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$BR$BR
240462874$24046287$4$F$20240605$20240723$20240703$20240805$PER$$US-ROCHE-3578601$ROCHE$$29$YR$A$M$Y$$$20240806$$CN$US$US
240462881$24046288$1$I$$20240624$20240703$20240703$EXP$$FR-AMGEN-FRASP2024125135$AMGEN$Moranne O.; Cauchy L.; Mousty E. et. al.. Successful pregnancy after 10 consecutive failures in a liver transplant patient with advanced kidney failure. Journal of Nephrology. 2024;37:747-751$39$YR$A$F$Y$$$20240703$$HP$FR$FR
240462891$24046289$1$I$$20240701$20240703$20240703$EXP$$ES-AMGEN-ESPSP2024130716$AMGEN$Jimenez E.M; Sanjuan J.B; Casado E. et al.. ERCOS multicenter Spanish study:clinical profile of patients with chronic kidney disease G3a-G5D and osteoporosis. Nephrology Dialysis Transplantation. 2024;39 (SUPPL_1):i2353$$$$$Y$$$20240703$$HP$ES$ES
240462901$24046290$1$I$20240323$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406201846177150-WKSDF$GB-TEVA-VS-3212375$TEVA$$24$YR$$$Y$$$20240703$$CN$GB$GB
240462911$24046291$1$I$$20240619$20240703$20240703$EXP$$GB-TEVA-VS-3211919$TEVA$$67$YR$$M$Y$$$20240703$$MD$GB$GB
240462921$24046292$1$I$20231101$20240619$20240703$20240703$EXP$$BR-TEVA-VS-3212801$TEVA$$43$YR$$M$Y$$$20240703$$CN$BR$BR
240462931$24046293$1$I$20240614$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406201851208190-PLTDB$GB-TEVA-VS-3212376$TEVA$$63$YR$$F$Y$91$KG$20240703$$HP$GB$GB
240462941$24046294$1$I$20240626$20240627$20240703$20240703$PER$$US-ABBVIE-5821371$ABBVIE$$63$YR$$F$Y$$$20240703$$CN$US$US
240462951$24046295$1$I$20240630$20240701$20240703$20240703$EXP$$NVSC2024US137346$NOVARTIS$$74$YR$$M$Y$$$20240703$$HP$US$US
240462961$24046296$1$I$20230112$20240628$20240703$20240703$EXP$$NVSC2023RU020811$NOVARTIS$$35$YR$$F$Y$58$KG$20240703$$MD$RU$RU
240462971$24046297$1$I$20240628$20240628$20240703$20240703$EXP$$NVSC2024US136137$NOVARTIS$$37$YR$$M$Y$$$20240703$$PH$US$US
240462981$24046298$1$I$20240401$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406201716065620-QTRFG$GB-TEVA-VS-3212351$TEVA$$$$$F$Y$$$20240703$$CN$GB$GB
240462991$24046299$1$I$$20240702$20240703$20240703$EXP$$NVSC2024US137845$NOVARTIS$$$$$F$Y$$$20240703$$HP$US$US
240463002$24046300$2$F$20230101$20240828$20240703$20240903$EXP$$CA-PFIZER INC-202400205078$PFIZER$$92$YR$$F$Y$53$KG$20240903$$HP$CA$CA
240463011$24046301$1$I$$20240702$20240703$20240703$EXP$$CA-PFIZER INC-202400205092$PFIZER$$82$YR$$F$Y$$$20240703$$PH$CA$CA
240463021$24046302$1$I$$20240702$20240703$20240703$EXP$$CA-PFIZER INC-202400205154$PFIZER$$82$YR$$M$Y$$$20240703$$HP$CA$CA
240463031$24046303$1$I$$20240702$20240703$20240703$EXP$$CA-PFIZER INC-202400205104$PFIZER$$34$YR$$M$Y$55$KG$20240703$$HP$CA$CA
240463041$24046304$1$I$$20240702$20240703$20240703$EXP$$CA-PFIZER INC-202400205068$PFIZER$$66$YR$$M$Y$$$20240703$$HP$CA$CA
240463051$24046305$1$I$$20240702$20240703$20240703$EXP$$CA-PFIZER INC-202400205136$PFIZER$$89$YR$$M$Y$74$KG$20240703$$HP$CA$CA
240463061$24046306$1$I$$20240702$20240703$20240703$EXP$$CA-PFIZER INC-202400205087$PFIZER$$91$YR$$M$Y$83$KG$20240703$$HP$CA$CA
240463071$24046307$1$I$$20240625$20240703$20240703$EXP$$US-HETERO-HET2024US01756$HETERO$$$$$$Y$$$20240703$$CN$US$US
240463081$24046308$1$I$$20240624$20240703$20240703$EXP$$CN-BEIGENE-BGN-2024-009723$BEIGENE$Zhou Y, Xue H, Lu C, Zhang Y, Wu Q, Zhang J et al. Treatment of Tislelizumab-Induced Toxic Epidermal Necrolysis and Agranulocytosis: A Case Report and Literature Review. Current Drug Safety. 2024;1-5$$$$$Y$$$20240703$$MD$CN$CN
240463091$24046309$1$I$20231019$20240624$20240703$20240703$PER$$US-BAYER-2024A090981$BAYER$$33$YR$A$F$Y$$$20240703$$HP$US$US
240463101$24046310$1$I$20240701$20240701$20240703$20240703$PER$$US-JNJFOC-20240702797$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240703$$CN$US$US
240463111$24046311$1$I$$20240701$20240703$20240703$EXP$$AT-FreseniusKabi-FK202410311$FRESENIUS KABI$$$$E$M$Y$$$20240703$$MD$AT$AT
240463121$24046312$1$I$$20240701$20240703$20240703$PER$$US-JNJFOC-20240701590$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$US$US
240463131$24046313$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46462$$FDA-CTU$$76$YR$$M$N$$$20240703$N$HP$US$
240463141$24046314$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46475$$FDA-CTU$$49$YR$$F$N$213$LBS$20240703$N$$US$
240463151$24046315$1$I$20240618$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46392$$FDA-CTU$$77$YR$$F$N$103.4$KG$20240702$N$$US$
240463161$24046316$1$I$20240406$20240701$20240703$20240703$EXP$DE-PEI-CADR2024328984$DE-JNJFOC-20240700950$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240703$$MD$DE$DE
240463171$24046317$1$I$$20240701$20240703$20240703$PER$$US-JNJFOC-20240705824$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240703$$MD$US$US
240463183$24046318$3$F$20151215$20240831$20240703$20240903$PER$$US-GILEAD-2024-0679416$GILEAD$$43$YR$A$M$Y$$$20240903$$LW$US$US
240463191$24046319$1$I$20030101$20240625$20240703$20240703$EXP$IT-MINISAL02-990316$IT-TEVA-VS-3214336$TEVA$$20$YR$$M$Y$72$KG$20240703$$CN$IT$IT
240463203$24046320$3$F$$20240708$20240703$20240711$EXP$$US-KYOWAKIRIN-2024KK015997$KYOWA$$$$$$Y$$$20240711$$HP$US$US
240463221$24046322$1$I$20240613$20240626$20240703$20240703$EXP$$CA-GSK-CA2024079797$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CA$CA
240463232$24046323$2$F$$20240708$20240703$20240718$EXP$$MA-TEVA-VS-3215180$TEVA$Rkain M, Bouhmidi M, Hamam  A, Elouali A, Chariba S, Kamaoui I et al. Wilson?Disease in Children in the Eastern Region of Morocco: Analysis of 24 Cases. Cureus. 2024; 16(5): e60023, 1-10.$$$$$Y$$$20240718$$HP$MA$MA
240463241$24046324$1$I$$20240701$20240703$20240703$EXP$GB-MHRA-MED-202406281336531360-CFMRD$GB-MYLANLABS-2024M1061830$MYLAN$$$$$F$Y$$$20240703$$CN$GB$GB
240463251$24046325$1$I$$20240624$20240703$20240703$PER$$US-BAYER-2024A091880$BAYER$Huff R.R.; Jose A.; Karpinska-Leydier K.; Theriault K.; Kapadia S.. Kartagener^s Syndrome With Situs Inversus Total Is: Breaking the Vicious Cycle. American Journal of Respiratory and Critical Care Medicine (2024) 209, American. 2024;209$71$YR$E$F$Y$$$20240703$$MD$US$US
240463261$24046326$1$I$20230901$20240621$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406015389$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240703$$CN$US$US
240463272$24046327$2$F$$20240812$20240703$20240812$EXP$$GB-JNJFOC-20240705434$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$HP$GB$GB
240463285$24046328$5$F$20230921$20240821$20240703$20240830$EXP$ES-AEMPS-1532996$ES-TEVA-VS-3212656$TEVA$$83$YR$$F$Y$$$20240830$$MD$ES$ES
240463291$24046329$1$I$$20240306$20240703$20240703$PER$$US-AMGEN-USASP2024129867$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240463301$24046330$1$I$$20231106$20240703$20240703$PER$$US-AMGEN-USASP2023235194$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240463321$24046332$1$I$$20240702$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037476$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240703$$CN$US$US
240463331$24046333$1$I$20240630$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130651$AMGEN$$86$YR$E$F$Y$$$20240703$$CN$US$US
240463342$24046334$2$F$$20240703$20240703$20240710$EXP$$SA-GSK-SA2024EME082022$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$SA$SA
240463362$24046336$2$F$20230801$20240917$20240703$20240927$EXP$$FR-TEVA-VS-3214352$TEVA$$44$YR$$F$Y$$$20240927$$CN$FR$FR
240463385$24046338$5$F$20240625$20240906$20240703$20240913$30DAY$$GR-PFIZER INC-PV202400084695$PFIZER$$16$YR$$M$Y$$$20240913$$CN$GR$GR
240463401$24046340$1$I$20230822$20240625$20240703$20240703$EXP$ES-AEMPS-1526749$ES-TEVA-VS-3214256$TEVA$$58$YR$$F$Y$52.3$KG$20240703$$MD$ES$ES
240463411$24046341$1$I$$20240702$20240703$20240703$EXP$$TW-PFIZER INC-202400204710$PFIZER$$$$$$Y$$$20240703$$PH$TW$TW
240463421$24046342$1$I$$20240627$20240703$20240703$EXP$$AU-BAYER-2024A093944$BAYER$$59$YR$A$M$Y$$$20240703$$MD$AU$AU
240463432$24046343$2$F$$20240725$20240703$20240801$EXP$$BR-TAKEDA-2024TUS064884$TAKEDA$$$$$$Y$$$20240801$$CN$BR$BR
240463441$24046344$1$I$20231101$20240624$20240703$20240703$PER$$US-MYLANLABS-2024M1060435$MYLAN$$$$$M$Y$$$20240703$$CN$US$US
240463451$24046345$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105876$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240703$$HP$US$US
240463472$24046347$2$F$$20240706$20240703$20240709$EXP$$NVSC2024EG137371$NOVARTIS$$$$$F$Y$70$KG$20240709$$CN$EG$EG
240463482$24046348$2$F$$20240725$20240703$20240805$PER$$US-BAYER-2024A096102$BAYER$$64$YR$A$M$Y$$$20240805$$CN$US$US
240463492$24046349$2$F$20240622$20240722$20240703$20240730$PER$$BE-Blueprint Medicines Corporation-SO-BE-2024-001325$BLUEPRINT MEDICINES$$71$YR$E$M$Y$$$20240730$$$COUNTRY NOT SPECIFIED$BE
240463501$24046350$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46429$$FDA-CTU$$29$YR$$F$N$$$20240703$N$$US$
240463511$24046351$1$I$$20240619$20240703$20240703$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-14289$SAMSUNG BIOEPIS$$55$YR$A$F$Y$71$KG$20240703$$CN$CA$CA
240463541$24046354$1$I$20240618$20240628$20240703$20240703$EXP$$PR-ABBVIE-5821072$ABBVIE$$53$YR$$F$Y$63$KG$20240703$$CN$PR$PR
240463551$24046355$1$I$20240618$20240701$20240703$20240703$EXP$$NL-FreseniusKabi-FK202410318$FRESENIUS KABI$$49$YR$A$M$Y$130$KG$20240703$$MD$NL$NL
240463561$24046356$1$I$20240518$20240628$20240703$20240703$EXP$$US-PERRIGO-24US006195$PERRIGO$$76$YR$$M$Y$$$20240703$$CN$US$US
240463571$24046357$1$I$20240601$20240626$20240703$20240703$EXP$$CO-JNJFOC-20240674838$JOHNSON AND JOHNSON$$60$YR$A$M$Y$58$KG$20240703$$HP$CO$CO
240463581$24046358$1$I$$20240703$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037658$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240703$$CN$US$US
240463591$24046359$1$I$$20240623$20240703$20240703$EXP$$US-RDY-LIT/USA/24/0009395$DR REDDYS$Rao M, Casias M, Abidi MZ. Disseminated Scedosporium infection in the early post-kidney transplant period. Transplant Infectious Disease. 2024;26(2): doi:10.1111/tid.14232.$63$YR$A$F$Y$$$20240703$$HP$US$US
240463621$24046362$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46465$$FDA-CTU$$80$YR$$F$N$$$20240703$N$$US$
240463641$24046364$1$I$20231101$20240628$20240703$20240703$EXP$$AT-ABBVIE-5823608$ABBVIE$$39$YR$$F$Y$$$20240703$$CN$AT$AT
240463651$24046365$1$I$$20240625$20240703$20240703$EXP$$DE-CELLTRION INC.-2023DE023832$CELLTRION$$$$$$Y$$$20240703$$MD$DE$DE
240463661$24046366$1$I$$20240627$20240703$20240703$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001334$BLUEPRINT MEDICINES$$$$$$Y$$$20240703$$MD$US$US
240463671$24046367$1$I$$20240701$20240703$20240703$EXP$$AU-MYLANLABS-2024M1061940$MYLAN$$$$$M$Y$$$20240703$$HP$AU$AU
240463681$24046368$1$I$$20231121$20240703$20240703$PER$$US-AMGEN-USASP2023235364$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240463691$24046369$1$I$$20231011$20240703$20240703$PER$$US-AMGEN-USASP2023235401$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240463701$24046370$1$I$$20240621$20240703$20240703$EXP$$CA-TEVA-VS-3213146$TEVA$$61$YR$$M$Y$$$20240703$$HP$CA$CA
240463713$24046371$3$F$20090914$20240831$20240703$20240903$EXP$$US-GILEAD-2024-0679419$GILEAD$$56$YR$A$F$Y$$$20240903$$LW$US$US
240463721$24046372$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46466$$FDA-CTU$$62$YR$$M$N$$$20240703$N$$US$
240463741$24046374$1$I$20240623$20240624$20240703$20240703$PER$$US-JNJFOC-20240664603$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240463771$24046377$1$I$$20240624$20240703$20240703$PER$$US-BAYER-2024A092102$BAYER$$$$$F$Y$$$20240703$$CN$US$US
240463801$24046380$1$I$$20240625$20240703$20240703$PER$$US-BIOGEN-2024BI01270441$BIOGEN$$$$$M$Y$$$20240703$$HP$US$US
240463811$24046381$1$I$$20240618$20240703$20240703$PER$$NVSC2024US137914$NOVARTIS$$$$$M$Y$$$20240703$$CN$US$US
240463822$24046382$2$F$$20240806$20240703$20240813$PER$$US-ALXN-202406USA001773US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
240463831$24046383$1$I$$20240624$20240703$20240703$PER$$US-MYLANLABS-2024M1058434$MYLAN$$$$$$Y$$$20240703$$CN$US$US
240463841$24046384$1$I$$20240625$20240703$20240703$EXP$$CA-APOTEX-2024AP007775$APOTEX$$79$YR$$F$Y$$$20240703$$PH$CA$CA
240463852$24046385$2$F$$20240725$20240703$20240730$EXP$$IE-MYLANLABS-2024M1061844$MYLAN$$$$$M$Y$$$20240730$$HP$IE$IE
240463861$24046386$1$I$20240627$20240629$20240703$20240703$EXP$$US-MYLANLABS-2024M1061866$MYLAN$$42$YR$$F$Y$$$20240703$$HP$US$US
240463871$24046387$1$I$20240101$20240628$20240703$20240703$EXP$$CN-PFIZER INC-PV202400085804$PFIZER$$74$YR$$M$Y$$$20240703$$CN$CN$CN
240463881$24046388$1$I$20240624$20240625$20240703$20240703$PER$$US-BAYER-2024A092484$BAYER$$7$YR$C$F$Y$$$20240703$$CN$US$US
240463892$24046389$2$F$$20240719$20240703$20240724$EXP$$JP-JNJFOC-20240706065$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$MD$JP$JP
240463901$24046390$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105958$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240703$$CN$US$US
240463911$24046391$1$I$$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105013$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240703$$MD$US$US
240463923$24046392$3$F$20240423$20240729$20240703$20240730$EXP$FR-AFSSAPS-DJ2024000804$FR-JNJFOC-20240701508$JOHNSON AND JOHNSON$$68$YR$E$F$Y$67$KG$20240730$$MD$FR$FR
240463936$24046393$6$F$20240704$20240918$20240703$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106267$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240919$$CN$US$US
240463942$24046394$2$F$$20240716$20240703$20240724$PER$$US-HETERO-HET2024US02025$HETERO$$$$$M$Y$$$20240724$$PH$US$US
240463951$24046395$1$I$20240524$20240619$20240703$20240703$EXP$$DE-PHOTOCURE ASA-PHCDE2024000006$PHOTOCURE$$71$YR$$M$Y$87$KG$20240703$$MD$DE$DE
240463961$24046396$1$I$20240617$20240625$20240703$20240703$PER$$US-BAYER-2024A092677$BAYER$$24$YR$A$F$Y$$$20240703$$MD$US$US
240463972$24046397$2$F$$20240807$20240703$20240809$EXP$$NVSC2024GB134780$NOVARTIS$$16$MON$$F$Y$8.2$KG$20240809$$CN$GB$GB
240463983$24046398$3$F$20080927$20240829$20240703$20240902$PER$$US-GILEAD-2024-0679420$GILEAD$$35$YR$A$F$Y$$$20240902$$LW$US$US
240463991$24046399$1$I$20240515$20240630$20240703$20240703$EXP$$AU-GILEAD-2024-0679105$GILEAD$$69$YR$E$M$Y$$$20240703$$CN$AU$AU
240464001$24046400$1$I$$20240625$20240703$20240703$EXP$$RO-AstraZeneca-2024A147822$ASTRAZENECA$$$$$M$Y$$$20240703$$CN$RO$
240464011$24046401$1$I$$20240625$20240703$20240703$EXP$$ZA-AstraZeneca-2024A147086$ASTRAZENECA$$80$YR$$F$Y$$$20240703$$CN$ZA$
240464021$24046402$1$I$$20240626$20240703$20240703$PER$$US-TEVA-VS-3214182$TEVA$$$$$$Y$$$20240703$$HP$US$US
240464032$24046403$2$F$$20240923$20240703$20240927$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02367$AMNEAL$$$$$F$Y$$$20240927$$CN$US$US
240464042$24046404$2$F$20240101$20240731$20240703$20240805$PER$$US-AMGEN-USASP2024130914$AMGEN$$64$YR$A$M$Y$$$20240805$$PH$US$US
240464051$24046405$1$I$20240528$20240627$20240703$20240703$EXP$FR-AFSSAPS-PB2024000700$FR-MYLANLABS-2024M1060693$MYLAN$$60$YR$$M$Y$$$20240703$$MD$FR$FR
240464062$24046406$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3214076$TEVA$Tan CR, Derkach A, Nemirovsky D, Ciardiello A, Diamond B, Hultcrantz M, et al. Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma. Blood-Can-J 2023; 13 (1): 1-8.; Tan CR, Derkach A, Nemirovsky D, Ciardiello A, Diamond B, Hultcrantz M, et al. Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multi...$$$$$Y$$$20240717$$HP$US$US
240464071$24046407$1$I$20240624$20240625$20240703$20240703$PER$$US-BAYER-2024A092825$BAYER$$25$YR$A$F$Y$$$20240703$$MD$US$US
240464081$24046408$1$I$20240607$20240628$20240703$20240703$EXP$$US-ORGANON-O2407USA000146$ORGANON$$19$YR$$F$Y$$$20240703$$CN$US$US
240464091$24046409$1$I$20240101$20240621$20240703$20240703$PER$$US-SA-2024SA187937$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240703$$MD$US$US
240464101$24046410$1$I$20240101$20240621$20240703$20240703$PER$$US-SA-2024SA188086$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240703$$MD$US$US
240464111$24046411$1$I$20240601$20240621$20240703$20240703$PER$$US-SA-2024SA190937$SANOFI AVENTIS$$48$YR$A$F$Y$63$KG$20240703$$MD$US$US
240464121$24046412$1$I$20240621$20240621$20240703$20240703$PER$$US-SA-2024SA188236$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240703$$MD$US$US
240464131$24046413$1$I$20240101$20240621$20240703$20240703$PER$$US-SA-2024SA190510$SANOFI AVENTIS$$52$YR$A$F$Y$72.5$KG$20240703$$MD$US$US
240464141$24046414$1$I$$20240620$20240703$20240703$PER$$US-SA-2024SA091162$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240703$$MD$US$US
240464151$24046415$1$I$20240101$20240621$20240703$20240703$PER$$US-SA-2024SA190389$SANOFI AVENTIS$$25$YR$A$M$Y$75.283$KG$20240703$$MD$US$US
240464161$24046416$1$I$20240601$20240621$20240703$20240703$PER$$US-SA-2023SA368497$SANOFI AVENTIS$$56$YR$A$F$Y$113.39$KG$20240703$$MD$US$US
240464181$24046418$1$I$20240101$20240620$20240703$20240703$PER$$US-SA-2024SA189579$SANOFI AVENTIS$$46$YR$A$F$Y$95$KG$20240703$$MD$US$US
240464191$24046419$1$I$20240625$20240701$20240703$20240703$DIR$FDA-CDER-CTU-2024-46480$$FDA-CTU$$40$YR$$F$N$$$20240701$N$HP$US$
240464211$24046421$1$I$$20240620$20240703$20240703$PER$$US-SA-2024SA186867$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240703$$CN$US$US
240464221$24046422$1$I$$20240621$20240703$20240703$PER$$US-SA-2024SA189417$SANOFI AVENTIS$$$$A$F$Y$48.9$KG$20240703$$MD$US$US
240464251$24046425$1$I$20230101$20240621$20240703$20240703$PER$$US-SA-2024SA188905$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240703$$MD$US$US
240464262$24046426$2$F$$20240621$20240703$20240705$PER$$US-SA-2024SA195792$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240705$$CN$US$US
240464271$24046427$1$I$20240614$20240621$20240703$20240703$PER$$US-SA-2024SA190602$SANOFI AVENTIS$$51$YR$A$M$Y$83$KG$20240703$$MD$US$US
240464281$24046428$1$I$$20240621$20240703$20240703$PER$$US-SA-2024SA190704$SANOFI AVENTIS$$$$C$F$Y$20.181$KG$20240703$$MD$US$US
240464291$24046429$1$I$$20240621$20240703$20240703$PER$$US-SA-2024SA189562$SANOFI AVENTIS$$$$C$M$Y$46.9$KG$20240703$$MD$US$US
240464301$24046430$1$I$$20240620$20240703$20240703$PER$$US-SA-2024SA187965$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240703$$MD$US$US
240464312$24046431$2$F$$20240106$20240703$20240913$PER$$US-HALEON-2185114$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
240464321$24046432$1$I$20240101$20240621$20240703$20240703$PER$$US-SA-2024SA167560$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240703$$MD$US$US
240464342$24046434$2$F$20230501$20240626$20240703$20240705$PER$$US-SA-2024SA188263$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240705$$MD$US$US
240464351$24046435$1$I$20231201$20240621$20240703$20240703$PER$$US-SA-2024SA188913$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240703$$MD$US$US
240464361$24046436$1$I$20240601$20240621$20240703$20240703$PER$$US-SA-2024SA189209$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240703$$MD$US$US
240464371$24046437$1$I$$20240621$20240703$20240703$PER$$US-SA-2024SA190736$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240703$$MD$US$US
240464381$24046438$1$I$20240615$20240701$20240703$20240703$EXP$GB-MHRA-MED-202406290731408350-JDBNM$GB-ORGANON-O2407GBR000165$ORGANON$$77$YR$$M$Y$90$KG$20240703$$CN$GB$GB
240464391$24046439$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281444339100-ZPDRB$GB-ORGANON-O2407GBR000069$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240464402$24046440$2$F$20240620$20240731$20240703$20240809$PER$$US-SA-2024SA189466$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240809$$MD$US$US
240464411$24046441$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA189954$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240703$$MD$US$US
240464422$24046442$2$F$20240620$20240703$20240703$20240712$PER$$US-SA-2024SA188800$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240712$$CN$US$US
240464432$24046443$2$F$20240101$20240718$20240703$20240727$PER$$US-SA-2024SA189930$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240727$$MD$US$US
240464441$24046444$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA189585$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240703$$MD$US$US
240464451$24046445$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA189514$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240703$$MD$US$US
240464461$24046446$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA192092$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240703$$MD$US$US
240464472$24046447$2$F$20240101$20240923$20240703$20240926$PER$$US-SA-2024SA157253$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240926$$MD$US$US
240464481$24046448$1$I$$20240622$20240703$20240703$PER$$US-SA-2024SA189038$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
240464491$24046449$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA190971$SANOFI AVENTIS$$$$A$M$Y$$$20240703$$MD$US$US
240464501$24046450$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA189419$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240703$$MD$US$US
240464521$24046452$1$I$20240201$20240626$20240703$20240703$PER$$US-SA-2024SA193569$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240703$$MD$US$US
240464532$24046453$2$F$20240601$20240627$20240703$20240708$PER$$US-SA-2024SA189889$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240708$$MD$US$US
240464541$24046454$1$I$20230101$20240621$20240703$20240703$PER$$US-SA-2024SA188312$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240703$$MD$US$US
240464551$24046455$1$I$20240601$20240624$20240703$20240703$PER$$US-SA-2023SA221597$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240703$$MD$US$US
240464561$24046456$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA188911$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240703$$MD$US$US
240464581$24046458$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA188882$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240703$$MD$US$US
240464592$24046459$2$F$$20240716$20240703$20240724$PER$$US-SA-2024SA190934$SANOFI AVENTIS$$15$YR$T$M$Y$70.3$KG$20240724$$MD$US$US
240464601$24046460$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA190526$SANOFI AVENTIS$$$$$$Y$$$20240703$$MD$US$US
240464611$24046461$1$I$$20240625$20240703$20240703$PER$$US-SA-2024SA192791$SANOFI AVENTIS$$$$$M$Y$$$20240703$$HP$US$US
240464622$24046462$2$F$$20240730$20240703$20240808$PER$$US-SA-2024SA190932$SANOFI AVENTIS$$$$A$F$Y$93.4$KG$20240808$$MD$US$US
240464631$24046463$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA190146$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240703$$CN$US$US
240464641$24046464$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA191332$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240703$$MD$US$US
240464651$24046465$1$I$20240601$20240624$20240703$20240703$PER$$US-SA-2024SA189317$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240703$$MD$US$US
240464663$24046466$3$F$20240913$20240913$20240703$20240923$PER$$US-SA-2024SA188855$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240923$$MD$US$US
240464671$24046467$1$I$20240614$20240626$20240703$20240703$PER$$US-SA-2024SA193574$SANOFI AVENTIS$$26$YR$A$F$Y$68$KG$20240703$$MD$US$US
240464681$24046468$1$I$$20240627$20240703$20240703$PER$$US-ALXN-202406USA001910US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240703$$HP$US$US
240464691$24046469$1$I$20231001$20240626$20240703$20240703$PER$$US-SA-2024SA193585$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240703$$MD$US$US
240464703$24046470$3$F$20240101$20240814$20240703$20240828$PER$$US-SA-2024SA193048$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240828$$MD$US$US
240464711$24046471$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA194152$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240703$$MD$US$US
240464722$24046472$2$F$$20240718$20240703$20240729$PER$$US-SA-2024SA193485$SANOFI AVENTIS$$$$E$F$Y$$$20240729$$MD$US$US
240464731$24046473$1$I$$20240625$20240703$20240703$PER$$US-SA-2024SA192817$SANOFI AVENTIS$$$$E$M$Y$$$20240703$$MD$US$US
240464751$24046475$1$I$20240401$20240624$20240703$20240703$PER$$US-SA-2024SA189896$SANOFI AVENTIS$$49$YR$A$F$Y$73$KG$20240703$$MD$US$US
240464763$24046476$3$F$20240101$20240826$20240703$20240910$PER$$US-SA-2024SA189791$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240910$$MD$US$US
240464771$24046477$1$I$20221127$20240624$20240703$20240703$PER$$US-SA-2022SA467862$SANOFI AVENTIS$$34$YR$A$F$Y$104.32$KG$20240703$$MD$US$US
240464781$24046478$1$I$20231201$20240624$20240703$20240703$PER$$US-SA-2024SA190402$SANOFI AVENTIS$$5$YR$C$F$Y$23.81$KG$20240703$$MD$US$US
240464791$24046479$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA191271$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240703$$MD$US$US
240464801$24046480$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA191266$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240703$$MD$US$US
240464812$24046481$2$F$20240101$20240731$20240703$20240809$PER$$US-SA-2024SA194872$SANOFI AVENTIS$$71$YR$E$F$Y$65.77$KG$20240809$$MD$US$US
240464832$24046483$2$F$20240625$20240626$20240703$20240703$PER$$US-SA-2024SA195076$SANOFI AVENTIS$$47$YR$A$F$Y$75.374$KG$20240703$$MD$US$US
240464841$24046484$1$I$20240621$20240625$20240703$20240703$PER$$US-SA-2024SA189826$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240703$$CN$US$US
240464852$24046485$2$F$$20240723$20240703$20240801$PER$$US-SA-2024SA116656$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240801$$MD$US$US
240464862$24046486$2$F$$20240626$20240703$20240705$PER$$US-SA-2024SA192044$SANOFI AVENTIS$$$$T$F$Y$58.05$KG$20240705$$MD$US$US
240464871$24046487$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA190298$SANOFI AVENTIS$$$$A$F$Y$80$KG$20240703$$MD$US$US
240464881$24046488$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA190539$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240703$$MD$US$US
240464892$24046489$2$F$20240201$20240826$20240703$20240909$PER$$US-SA-2024SA193461$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240909$$MD$US$US
240464902$24046490$2$F$20240101$20240822$20240703$20240916$PER$$US-SA-2024SA195227$SANOFI AVENTIS$$70$YR$E$F$Y$81$KG$20240916$$MD$US$US
240464911$24046491$1$I$20240620$20240628$20240703$20240703$EXP$$CN-MYLANLABS-2024M1061846$MYLAN$$55$YR$$F$Y$62$KG$20240703$$HP$CN$CN
240464921$24046492$1$I$20240501$20240624$20240703$20240703$PER$$US-SA-2024SA191242$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240703$$MD$US$US
240464931$24046493$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA192248$SANOFI AVENTIS$$$$A$M$Y$83.9$KG$20240703$$MD$US$US
240464941$24046494$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA190540$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240703$$MD$US$US
240464951$24046495$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA195235$SANOFI AVENTIS$$$$A$F$Y$99.79$KG$20240703$$MD$US$US
240464961$24046496$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA191351$SANOFI AVENTIS$$$$C$F$Y$$$20240703$$MD$US$US
240464971$24046497$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA189133$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240703$$CN$US$US
240464981$24046498$1$I$20240601$20240624$20240703$20240703$PER$$US-SA-2024SA189789$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240703$$MD$US$US
240464991$24046499$1$I$20231107$20240624$20240703$20240703$PER$$US-SA-2024SA189596$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240703$$MD$US$US
240465001$24046500$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA191130$SANOFI AVENTIS$$$$A$F$Y$97.5$KG$20240703$$MD$US$US
240465011$24046501$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA191278$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240703$$MD$US$US
240465021$24046502$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA193527$SANOFI AVENTIS$$$$A$M$Y$77.11$KG$20240703$$MD$US$US
240465031$24046503$1$I$$20231023$20240703$20240703$PER$$US-AMGEN-USASP2023235515$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240465051$24046505$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA188755$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240703$$MD$US$US
240465061$24046506$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA190396$SANOFI AVENTIS$$57$YR$A$F$Y$73.48$KG$20240703$$MD$US$US
240465071$24046507$1$I$$20240625$20240703$20240703$PER$$US-SA-2021SA169477$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
240465081$24046508$1$I$20240101$20240626$20240703$20240703$PER$$US-SA-2024SA193738$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240703$$CN$US$US
240465091$24046509$1$I$$20240625$20240703$20240703$PER$$US-SA-2024SA193236$SANOFI AVENTIS$$57$YR$A$F$Y$99.7$KG$20240703$$MD$US$US
240465101$24046510$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA195536$SANOFI AVENTIS$$$$E$F$Y$78.4$KG$20240703$$MD$US$US
240465111$24046511$1$I$20240101$20240626$20240703$20240703$PER$$US-SA-2024SA193709$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240703$$MD$US$US
240465121$24046512$1$I$20240101$20240625$20240703$20240703$PER$$US-SA-2024SA191456$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240703$$MD$US$US
240465131$24046513$1$I$$20240625$20240703$20240703$PER$$US-SA-2024SA191181$SANOFI AVENTIS$$$$$F$Y$$$20240703$$CN$US$US
240465141$24046514$1$I$20240619$20240624$20240703$20240703$PER$$US-SA-2024SA190893$SANOFI AVENTIS$$6$YR$C$F$Y$22.22$KG$20240703$$MD$US$US
240465151$24046515$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA189598$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240703$$MD$US$US
240465161$24046516$1$I$20240201$20240624$20240703$20240703$PER$$US-SA-2024SA190356$SANOFI AVENTIS$$28$YR$A$M$Y$86.18$KG$20240703$$MD$US$US
240465171$24046517$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA189584$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240703$$MD$US$US
240465181$24046518$1$I$20230801$20240624$20240703$20240703$PER$$US-SA-2024SA190517$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240703$$MD$US$US
240465191$24046519$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA190552$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240703$$MD$US$US
240465201$24046520$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA189770$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240703$$MD$US$US
240465211$24046521$1$I$20240601$20240624$20240703$20240703$PER$$US-SA-2024SA191608$SANOFI AVENTIS$$16$YR$T$M$Y$72$KG$20240703$$MD$US$US
240465221$24046522$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA190938$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240703$$MD$US$US
240465232$24046523$2$F$$20240910$20240703$20240925$PER$$US-SA-2024SA189581$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240925$$MD$US$US
240465241$24046524$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA192577$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240703$$HP$US$US
240465251$24046525$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA189583$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240703$$MD$US$US
240465261$24046526$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA189609$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240703$$MD$US$US
240465273$24046527$3$F$20240101$20240913$20240703$20240924$PER$$US-SA-2024SA191579$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240924$$MD$US$US
240465281$24046528$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA192537$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240703$$MD$US$US
240465291$24046529$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA193313$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
240465301$24046530$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA193144$SANOFI AVENTIS$$54$YR$A$F$Y$91.8$KG$20240703$$MD$US$US
240465311$24046531$1$I$20240601$20240626$20240703$20240703$PER$$US-SA-2024SA193138$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240703$$MD$US$US
240465321$24046532$1$I$20230101$20240626$20240703$20240703$PER$$US-SA-2024SA195210$SANOFI AVENTIS$$61$YR$A$F$Y$74.38$KG$20240703$$MD$US$US
240465331$24046533$1$I$20240622$20240624$20240703$20240703$PER$$US-SA-2024SA189322$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240703$$MD$US$US
240465341$24046534$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA191263$SANOFI AVENTIS$$$$E$F$Y$72.12$KG$20240703$$MD$US$US
240465351$24046535$1$I$20240625$20240625$20240703$20240703$PER$$US-SA-2024SA190015$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240703$$CN$US$US
240465362$24046536$2$F$$20240731$20240703$20240809$PER$$US-SA-2024SA190525$SANOFI AVENTIS$$58$YR$A$F$Y$135$KG$20240809$$MD$US$US
240465371$24046537$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA192249$SANOFI AVENTIS$$$$A$F$Y$74.8$KG$20240703$$MD$US$US
240465381$24046538$1$I$20210401$20240624$20240703$20240703$PER$$US-SA-2024SA191805$SANOFI AVENTIS$$$$A$M$Y$$$20240703$$MD$US$US
240465391$24046539$1$I$20240501$20240624$20240703$20240703$PER$$US-SA-2024SA192208$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240703$$MD$US$US
240465402$24046540$2$F$20240101$20240904$20240703$20240912$PER$$US-SA-2024SA188907$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240912$$MD$US$US
240465413$24046541$3$F$20240101$20240805$20240703$20240810$PER$$US-SA-2024SA190777$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240810$$CN$US$US
240465421$24046542$1$I$20240601$20240624$20240703$20240703$PER$$US-SA-2024SA191890$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240703$$MD$US$US
240465432$24046543$2$F$20240101$20240724$20240703$20240801$PER$$US-SA-2024SA189769$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240801$$MD$US$US
240465441$24046544$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA191583$SANOFI AVENTIS$$12$YR$T$M$Y$90$KG$20240703$$MD$US$US
240465451$24046545$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA189881$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240703$$CN$US$US
240465462$24046546$2$F$$20240715$20240703$20240723$PER$$US-SA-2024SA191328$SANOFI AVENTIS$$$$A$F$Y$70.748$KG$20240723$$MD$US$US
240465472$24046547$2$F$$20240718$20240703$20240727$PER$$US-SA-2024SA073956$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240727$$MD$US$US
240465491$24046549$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA191589$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240703$$MD$US$US
240465501$24046550$1$I$20240619$20240626$20240703$20240703$PER$$US-BAYER-2024A092505$BAYER$$64$YR$A$M$Y$$$20240703$$CN$US$US
240465511$24046551$1$I$$20240626$20240703$20240703$PER$$US-AGIOS-2406US03814$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
240465521$24046552$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA190655$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240703$$MD$US$US
240465532$24046553$2$F$20240101$20240916$20240703$20240923$PER$$US-SA-2024SA193694$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240923$$MD$US$US
240465543$24046554$3$F$20240101$20240826$20240703$20240909$PER$$US-SA-2024SA190565$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240909$$MD$US$US
240465551$24046555$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA193539$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
240465561$24046556$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA190714$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240703$$MD$US$US
240465571$24046557$1$I$20240611$20240624$20240703$20240703$PER$$US-SA-2024SA193577$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240703$$CN$US$US
240465581$24046558$1$I$$20240625$20240703$20240703$PER$$US-SA-2024SA190567$SANOFI AVENTIS$$$$$F$Y$$$20240703$$CN$US$US
240465591$24046559$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA194819$SANOFI AVENTIS$$$$A$F$Y$87$KG$20240703$$MD$US$US
240465603$24046560$3$F$20240101$20240826$20240703$20240920$PER$$US-SA-2024SA193027$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240920$$CN$US$US
240465611$24046561$1$I$20240601$20240624$20240703$20240703$PER$$US-SA-2024SA191849$SANOFI AVENTIS$$15$YR$T$M$Y$59.42$KG$20240703$$MD$US$US
240465621$24046562$1$I$20240601$20240624$20240703$20240703$PER$$US-SA-2024SA190555$SANOFI AVENTIS$$87$YR$E$F$Y$68.038$KG$20240703$$MD$US$US
240465631$24046563$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA189399$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
240465641$24046564$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA189530$SANOFI AVENTIS$$$$$F$Y$$$20240703$$CN$US$US
240465651$24046565$1$I$20240607$20240624$20240703$20240703$PER$$US-SA-2024SA190952$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240703$$MD$US$US
240465661$24046566$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA190675$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240703$$MD$US$US
240465671$24046567$1$I$$20240625$20240703$20240703$PER$$US-SA-2024SA189733$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240703$$CN$US$US
240465681$24046568$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA193310$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240703$$MD$US$US
240465692$24046569$2$F$20240601$20240716$20240703$20240724$PER$$US-SA-2024SA189339$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240724$$CN$US$US
240465701$24046570$1$I$20240101$20240626$20240703$20240703$PER$$US-SA-2024SA194221$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240703$$MD$US$US
240465715$24046571$5$F$$20240729$20240703$20240807$30DAY$$MX-JNJFOC-20240654487$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$MX$MX
240465721$24046572$1$I$20230101$20240627$20240703$20240703$EXP$$CO-JNJFOC-20240676819$JOHNSON AND JOHNSON$$48$YR$A$M$Y$63$KG$20240703$$HP$CO$CO
240465732$24046573$2$F$20240618$20240822$20240703$20240905$PER$$US-SA-2024SA193590$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240905$$MD$US$US
240465761$24046576$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46486$$FDA-CTU$$29$YR$$F$N$$$20240703$N$$US$
240465771$24046577$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA191777$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240703$$CN$US$US
240465781$24046578$1$I$$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105848$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240703$$CN$US$US
240465791$24046579$1$I$20240101$20240626$20240703$20240703$PER$$US-SA-2024SA193533$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240703$$MD$US$US
240465801$24046580$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46487$$FDA-CTU$$75$YR$$M$N$136.08$KG$20240703$N$$US$
240465811$24046581$1$I$20240624$20240701$20240703$20240703$EXP$$SG-FreseniusKabi-FK202410246$FRESENIUS KABI$$25$YR$A$F$Y$$$20240703$$HP$SG$SG
240465822$24046582$2$F$20240101$20240729$20240703$20240807$PER$$US-SA-2024SA190791$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240807$$MD$US$US
240465831$24046583$1$I$20240101$20240625$20240703$20240703$PER$$US-SA-2024SA193226$SANOFI AVENTIS$$55$YR$A$F$Y$112.7$KG$20240703$$MD$US$US
240465841$24046584$1$I$20240401$20240701$20240703$20240703$EXP$FR-AFSSAPS-SE2024000479$FR-FreseniusKabi-FK202410394$FRESENIUS KABI$$35$YR$A$M$Y$59$KG$20240703$$MD$FR$FR
240465851$24046585$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA192192$SANOFI AVENTIS$$$$A$F$Y$59.42$KG$20240703$$MD$US$US
240465871$24046587$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA191593$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240703$$MD$US$US
240465882$24046588$2$F$$20240809$20240703$20240820$PER$$US-SA-2024SA189975$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240820$$CN$US$US
240465892$24046589$2$F$20240710$20240724$20240703$20240801$PER$$US-SA-2024SA193482$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240801$$MD$US$US
240465901$24046590$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA190970$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
240465913$24046591$3$F$20240506$20240902$20240703$20240909$EXP$$ES-FreseniusKabi-FK202410369$FRESENIUS KABI$$67$YR$E$F$Y$69.1$KG$20240909$$MD$ES$ES
240465921$24046592$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA105854$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240703$$MD$US$US
240465931$24046593$1$I$20240301$20240624$20240703$20240703$PER$$US-SA-2024SA189800$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240703$$MD$US$US
240465942$24046594$2$F$20240601$20240715$20240703$20240718$PER$$TH-Eisai-EC-2024-169393$EISAI$$72$YR$E$F$Y$$$20240718$$MD$TH$TH
240465951$24046595$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA190747$SANOFI AVENTIS$$10$YR$C$M$Y$38.1$KG$20240703$$MD$US$US
240465961$24046596$1$I$20240601$20240627$20240703$20240703$PER$$US-SA-2024SA193545$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240703$$HP$US$US
240465973$24046597$3$F$20240101$20240708$20240703$20240722$PER$$US-SA-2024SA191807$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240720$$MD$US$US
240465981$24046598$1$I$$20240627$20240703$20240703$EXP$$AT-MYLANLABS-2024M1060011$MYLAN$$75$YR$$M$Y$$$20240703$$MD$AT$AT
240465991$24046599$1$I$20240601$20240627$20240703$20240703$PER$$US-SA-2024SA193492$SANOFI AVENTIS$$$$$F$Y$$$20240703$$HP$US$US
240466001$24046600$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA193176$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240703$$MD$US$US
240466012$24046601$2$F$20240623$20240822$20240703$20240830$PER$$US-SA-2024SA193761$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240830$$CN$US$US
240466021$24046602$1$I$20240101$20240626$20240703$20240703$PER$$US-SA-2024SA193401$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240703$$MD$US$US
240466031$24046603$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA193791$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240703$$MD$US$US
240466041$24046604$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA194319$SANOFI AVENTIS$$$$E$F$Y$87$KG$20240703$$MD$US$US
240466051$24046605$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA193655$SANOFI AVENTIS$$$$E$F$Y$$$20240703$$CN$US$US
240466061$24046606$1$I$20240501$20240624$20240703$20240703$PER$$US-SA-2024SA190950$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240703$$MD$US$US
240466071$24046607$1$I$20240101$20240626$20240703$20240703$PER$$US-SA-2024SA192565$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240703$$MD$US$US
240466081$24046608$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA193726$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240703$$CN$US$US
240466091$24046609$1$I$20240101$20240627$20240703$20240703$PER$$US-SA-2024SA193535$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240703$$MD$US$US
240466101$24046610$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA191357$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240703$$MD$US$US
240466111$24046611$1$I$20240601$20240624$20240703$20240703$PER$$US-SA-2024SA190630$SANOFI AVENTIS$$54$YR$A$M$Y$115.66$KG$20240703$$MD$US$US
240466121$24046612$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA195704$SANOFI AVENTIS$$$$E$M$Y$$$20240703$$MD$US$US
240466131$24046613$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA192653$SANOFI AVENTIS$$$$$F$Y$$$20240703$$HP$US$US
240466141$24046614$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA188917$SANOFI AVENTIS$$$$A$$Y$$$20240703$$MD$US$US
240466151$24046615$1$I$20240601$20240624$20240703$20240703$PER$$US-SA-2024SA191576$SANOFI AVENTIS$$57$YR$A$F$Y$81.646$KG$20240703$$MD$US$US
240466161$24046616$1$I$20240101$20240627$20240703$20240703$PER$$US-SA-2024SA194213$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240703$$MD$US$US
240466171$24046617$1$I$20240301$20240625$20240703$20240703$PER$$US-SA-2024SA190669$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240703$$MD$US$US
240466181$24046618$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA192426$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240703$$CN$US$US
240466191$24046619$1$I$20240625$20240626$20240703$20240703$PER$$US-SA-2024SA193402$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240703$$HP$US$US
240466202$24046620$2$F$$20240702$20240703$20240711$PER$$US-SA-2024SA192532$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240711$$CN$US$US
240466212$24046621$2$F$20240627$20240627$20240703$20240709$PER$$US-SA-2024SA192508$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240709$$MD$US$US
240466221$24046622$1$I$$20240625$20240703$20240703$PER$$US-SA-2024SA106389$SANOFI AVENTIS$$$$E$F$Y$$$20240703$$MD$US$US
240466234$24046623$4$F$$20240711$20240703$20240718$PER$$US-SA-2024SA193025$SANOFI AVENTIS$$24$YR$A$M$Y$113$KG$20240718$$MD$US$US
240466241$24046624$1$I$$20240625$20240703$20240703$PER$$US-SA-2024SA190656$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240703$$MD$US$US
240466251$24046625$1$I$20240601$20240627$20240703$20240703$PER$$US-SA-2024SA193399$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240703$$MD$US$US
240466261$24046626$1$I$20240101$20240627$20240703$20240703$PER$$US-SA-2024SA193080$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240703$$CN$US$US
240466272$24046627$2$F$$20240719$20240703$20240724$EXP$$US-ABBVIE-5822635$ABBVIE$$$$$F$Y$$$20240724$$MD$US$US
240466281$24046628$1$I$$20240622$20240703$20240703$PER$$US-AMGEN-USASP2024124581$AMGEN$Glick M.; Callahan S. J.; Scholand M. et. al. Rapid Antibody Depletion: A Novel Therapeutic Approach for Acute Exacerbation of Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A3745$$$$$Y$$$20240703$$HP$US$US
240466291$24046629$1$I$$20240524$20240703$20240703$PER$$US-AMGEN-USASP2024130113$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240466331$24046633$1$I$$20240625$20240703$20240703$30DAY$$US-GSK-US2024079202$GLAXOSMITHKLINE$$$$$M$Y$$$20240703$$CN$US$US
240466343$24046634$3$F$20240501$20240911$20240703$20240923$PER$$US-GSK-US2024081196$GLAXOSMITHKLINE$$90$YR$$F$Y$$$20240923$$CN$US$US
240466351$24046635$1$I$$20240628$20240703$20240703$PER$$US-SA-2024SA194111$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240703$$CN$US$US
240466362$24046636$2$F$20240626$20240828$20240703$20240906$PER$$US-SA-2024SA194562$SANOFI AVENTIS$$53$YR$A$F$Y$95.2$KG$20240906$$MD$US$US
240466371$24046637$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46488$$FDA-CTU$$84$YR$$F$N$$$20240703$N$$US$
240466391$24046639$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA193807$SANOFI AVENTIS$$$$A$M$Y$$$20240703$$MD$US$US
240466401$24046640$1$I$20231002$20240627$20240703$20240703$PER$$US-SA-2024SA193801$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240703$$MD$US$US
240466411$24046641$1$I$20240531$20240628$20240703$20240703$PER$$US-SA-2024SA195518$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240703$$MD$US$US
240466421$24046642$1$I$$20240628$20240703$20240703$PER$$US-SA-2024SA194253$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240703$$HP$US$US
240466431$24046643$1$I$$20240628$20240703$20240703$PER$$US-SA-2024SA195430$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$CN$US$US
240466441$24046644$1$I$20240101$20240627$20240703$20240703$PER$$US-SA-2024SA193022$SANOFI AVENTIS$$47$YR$A$F$Y$77.11$KG$20240703$$MD$US$US
240466451$24046645$1$I$20240628$20240628$20240703$20240703$PER$$US-SA-2024SA194115$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240703$$CN$US$US
240466461$24046646$1$I$$20240628$20240703$20240703$PER$$US-SA-2024SA194888$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240703$$CN$US$US
240466476$24046647$6$F$$20240809$20240703$20240819$PER$$US-SA-2024SA195417$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240819$$CN$US$US
240466481$24046648$1$I$20240201$20240628$20240703$20240703$PER$$US-SA-2024SA195353$SANOFI AVENTIS$$13$YR$T$M$Y$52.472$KG$20240703$$HP$US$US
240466491$24046649$1$I$20240625$20240626$20240703$20240703$PER$$US-BAYER-2024A092717$BAYER$$17$YR$T$F$Y$$$20240703$$CN$US$US
240466502$24046650$2$F$20240628$20240628$20240703$20240708$PER$$US-SA-2024SA194529$SANOFI AVENTIS$$42$YR$A$F$Y$127$KG$20240708$$MD$US$US
240466513$24046651$3$F$20240101$20240823$20240703$20240917$PER$$US-SA-2024SA194700$SANOFI AVENTIS$$78$YR$E$M$Y$72.57$KG$20240918$$MD$US$US
240466521$24046652$1$I$$20240628$20240703$20240703$PER$$US-SA-2024SA194635$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240703$$CN$US$US
240466531$24046653$1$I$$20240626$20240703$20240703$EXP$$US-ABBVIE-5819444$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240466543$24046654$3$F$$20240718$20240703$20240723$EXP$$US-TAKEDA-2024TUS065757$TAKEDA$$$$$M$Y$$$20240723$$MD$US$US
240466564$24046656$4$F$20210101$20240711$20240703$20240721$EXP$$CZ-BAXTER-2024BAX020679$BAXTER$Tuskova L..CHEPA treatment of ALK-positive anaplastic large T-cell lymphoma complicated by microangiopathy and peripheral neuropathy.FARMAKOTERAPIE 2024;20 (Suppl 6):1-36.$39$YR$$F$Y$$$20240721$$$COUNTRY NOT SPECIFIED$CZ
240466572$24046657$2$F$$20240715$20240703$20240724$EXP$$CZ-BAXTER-2024BAX020695$BAXTER$$49$YR$$F$Y$$$20240724$$MD$CZ$CZ
240466581$24046658$1$I$20240621$20240624$20240703$20240703$EXP$CN-NMPACDR-3704011509867202400583$CN-BAXTER-2024BAX020654$BAXTER$$39$YR$$F$Y$46$KG$20240703$$MD$CN$CN
240466591$24046659$1$I$20240603$20240625$20240703$20240703$EXP$CN-NMPACDR-3401011543495202400196$CN-BAXTER-2024BAX020729$BAXTER$$45$YR$$F$Y$62$KG$20240703$$MD$CN$CN
240466611$24046661$1$I$20240507$20240617$20240703$20240703$PER$$US-JNJFOC-20240648276$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$CN$US$US
240466623$24046662$3$F$$20240729$20240703$20240806$30DAY$$CL-JNJFOC-20240654456$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240806$$CN$CL$CL
240466632$24046663$2$F$20240628$20240801$20240703$20240805$EXP$$US-BIOVITRUM-2024-US-009321$BIOVITRUM$$62$YR$$F$Y$$$20240805$$CN$US$US
240466643$24046664$3$F$20240601$20240712$20240703$20240718$EXP$$CA-JNJFOC-20240676192$JOHNSON AND JOHNSON$$60$YR$A$F$Y$55$KG$20240718$$HP$CA$CA
240466651$24046665$1$I$$20240627$20240703$20240703$PER$$US-ALXN-202406USA001912US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240703$$HP$US$US
240466661$24046666$1$I$20240601$20240701$20240703$20240703$EXP$$US-ORGANON-O2407USA000177$ORGANON$$$$$M$Y$$$20240703$$CN$US$US
240466671$24046667$1$I$20240627$20240628$20240703$20240703$PER$$US-BIOGEN-2024BI01271737$BIOGEN$$12$YR$$M$Y$$$20240703$$CN$US$US
240466681$24046668$1$I$20200101$20240610$20240703$20240703$PER$$US-BIOGEN-2024BI01272051$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
240466691$24046669$1$I$$20240626$20240703$20240703$EXP$$BR-BIOMARINAP-BR-2024-158873$BIOMARIN$$$$$$Y$$$20240703$$CN$BR$BR
240466705$24046670$5$F$20240628$20240716$20240703$20240912$EXP$$FR-BIOVITRUM-2024-FR-009329$BIOVITRUM$$21$MON$$M$Y$10$KG$20240912$$MD$FR$FR
240466711$24046671$1$I$20240501$20240626$20240703$20240703$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000538$PAREXEL$$$$$$Y$$$20240703$$HP$CN$CN
240466721$24046672$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137575$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240466731$24046673$1$I$$20240701$20240703$20240703$EXP$$US-KYOWAKIRIN-2024KK015946$KYOWA$$$$$$Y$$$20240703$$HP$US$US
240466741$24046674$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46490$$FDA-CTU$$43$YR$$M$N$88.45$KG$20240703$N$HP$US$
240466752$24046675$2$F$$20240808$20240703$20240813$EXP$$US-AstraZeneca-2024A147188$ASTRAZENECA$$$$$$Y$$$20240813$$HP$US$
240466761$24046676$1$I$$20240625$20240703$20240703$EXP$$CN-AstraZeneca-2024A149805$ASTRAZENECA$$$$$$Y$$$20240703$$MD$CN$
240466781$24046678$1$I$$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46425$$FDA-CTU$$$$$M$N$$$20240702$N$HP$US$
240466791$24046679$1$I$$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46437$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240466801$24046680$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46451$$FDA-CTU$$65$YR$$F$N$$$20240703$N$$US$
240466811$24046681$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46430$$FDA-CTU$$62$YR$$M$N$$$20240703$N$$US$
240466821$24046682$1$I$$20240618$20240703$20240703$EXP$$US-ENDO USA, INC.-2024-002712$ENDO$Saliba F, Mina J, Aoun L, Khattar G, Sanayeh EB, Jdaidani J et al.. Ketamine Induced Acute Systolic Heart Failure. European Journal of Case Reports in Internal Medicine. 2024;11(6)$14$YR$$F$Y$$$20240703$$HP$US$US
240466831$24046683$1$I$20240519$20240702$20240703$20240703$EXP$$JP-BAYER-2024A095265$BAYER$$73$YR$E$M$Y$$$20240703$$PH$JP$JP
240466841$24046684$1$I$20240630$20240630$20240703$20240703$PER$$US-JNJFOC-20240679855$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240703$$CN$US$US
240466851$24046685$1$I$20230726$20240624$20240703$20240703$EXP$$PL-FreseniusKabi-FK202409854$FRESENIUS KABI$$70$YR$E$F$Y$108$KG$20240703$$HP$PL$PL
240466871$24046687$1$I$20240616$20240628$20240703$20240703$EXP$$CN-FreseniusKabi-FK202410257$FRESENIUS KABI$$37$YR$A$F$Y$52$KG$20240703$$HP$CN$CN
240466881$24046688$1$I$20240630$20240701$20240703$20240703$EXP$$CN-TAKEDA-2024TUS066314$TAKEDA$$62$YR$$M$Y$$$20240703$$CN$CN$CN
240466891$24046689$1$I$20240529$20240626$20240703$20240703$PER$$US-BAYER-2024A092844$BAYER$$24$YR$A$F$Y$$$20240703$$HP$US$US
240466903$24046690$3$F$20240828$20240918$20240703$20240923$EXP$$NVSC2024CO136570$NOVARTIS$$71$YR$$F$Y$53$KG$20240923$$HP$CO$CO
240466912$24046691$2$F$20240601$20240905$20240703$20240909$PER$$US-AMGEN-USASP2024130359$AMGEN$$78$YR$E$F$Y$$$20240909$$MD$US$US
240466921$24046692$1$I$$20240701$20240703$20240703$EXP$$US-GSK-US2024081645$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$HP$US$US
240466934$24046693$4$F$20240729$20240819$20240703$20240828$EXP$$US-GSK-US2024081618$GLAXOSMITHKLINE$$64$YR$$M$Y$$$20240828$$MD$US$US
240466941$24046694$1$I$20240601$20240701$20240703$20240703$EXP$$US-GSK-US2024081620$GLAXOSMITHKLINE$$73$YR$$M$Y$$$20240703$$MD$US$US
240466961$24046696$1$I$20240330$20240619$20240703$20240703$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000540$PAREXEL$$56$YR$$M$Y$$$20240703$$MD$CN$CN
240466971$24046697$1$I$$20240624$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006743$INCYTE$$$$$$Y$$$20240703$$CN$US$US
240466981$24046698$1$I$20240408$20240702$20240703$20240703$EXP$FR-AFSSAPS-PP2024000684$FR-VIIV HEALTHCARE LIMITED-FR2024082099$VIIV$$$$$$Y$$$20240703$$PH$FR$FR
240466991$24046699$1$I$$20240621$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406016313$ELI LILLY AND CO$$62$YR$A$$Y$$$20240703$$LW$US$US
240467001$24046700$1$I$20240601$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001936$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240703$$CN$US$US
240467011$24046701$1$I$20240606$20240621$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406015267$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240703$$CN$US$US
240467021$24046702$1$I$$20240627$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000670$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240703$$CN$US$US
240467031$24046703$1$I$$20240627$20240703$20240703$EXP$$CA-TAKEDA-2024TUS065629$TAKEDA$$$$$M$Y$$$20240703$$CN$CA$CA
240467041$24046704$1$I$$20240703$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106381$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240703$$CN$US$US
240467051$24046705$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106007$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240703$$CN$US$US
240467061$24046706$1$I$$20240627$20240703$20240703$PER$$US-BAYER-2024A093336$BAYER$$76$YR$E$F$Y$$$20240703$$CN$US$US
240467071$24046707$1$I$$20240626$20240703$20240703$PER$$US-VERTEX PHARMACEUTICALS-2024-010863$VERTEX$$8$YR$$F$Y$$$20240703$$HP$US$US
240467081$24046708$1$I$20240101$20240627$20240703$20240703$EXP$$GB-VERTEX PHARMACEUTICALS-2024-010836$VERTEX$$$$$M$Y$$$20240703$$CN$GB$GB
240467091$24046709$1$I$20240615$20240628$20240703$20240703$EXP$$GB-VERTEX PHARMACEUTICALS-2024-010348$VERTEX$$$$A$M$Y$$$20240703$$CN$GB$GB
240467101$24046710$1$I$20240605$20240627$20240703$20240703$EXP$$RO-VERTEX PHARMACEUTICALS-2024-010156$VERTEX$$12$YR$$M$Y$40$KG$20240703$$MD$RO$RO
240467111$24046711$1$I$$20240627$20240703$20240703$EXP$$GB-VERTEX PHARMACEUTICALS-2024-010865$VERTEX$$$$A$F$Y$$$20240703$$CN$GB$GB
240467121$24046712$1$I$$20240626$20240703$20240703$PER$$US-VERTEX PHARMACEUTICALS-2024-010910$VERTEX$$$$$M$Y$$$20240703$$CN$US$US
240467131$24046713$1$I$$20240628$20240703$20240703$PER$$NVSC2024US137955$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240467151$24046715$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46426$$FDA-CTU$$82$YR$$M$N$$$20240703$N$$US$
240467161$24046716$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46463$$FDA-CTU$$74$YR$$M$N$$$20240703$N$HP$US$
240467171$24046717$1$I$20220101$20240619$20240703$20240703$EXP$$US-Axsome Therapeutics, Inc.-AXS202406-000890$AXSOME THERAPEUTICS$$59$YR$A$F$Y$$$20240703$$CN$US$
240467181$24046718$1$I$20240101$20240701$20240703$20240703$EXP$$US-TAKEDA-2024TUS066180$TAKEDA$$$$$F$Y$$$20240703$$CN$US$US
240467191$24046719$1$I$$20240626$20240703$20240703$EXP$$IL-ABBVIE-5824385$ABBVIE$$66$YR$$$Y$$$20240703$$MD$IL$IL
240467201$24046720$1$I$20240601$20240703$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106360$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240703$$HP$US$US
240467211$24046721$1$I$$20240701$20240703$20240703$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-105652$BRISTOL MYERS SQUIBB$Karhan O, Sezgin Y, Ileri S, Tunc S. Mesenteric panniculitis as a side effect of nivolumab in a patient with larnyngeal cancer. Nigerian Journal of Clinical Practice. 2024 Jun 29;27(6):800-3.doi:10.4103/njcp.njcp_655_23.$56$YR$A$M$Y$$$20240703$$HP$TR$TR
240467223$24046722$3$F$$20240812$20240703$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106237$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240813$$CN$US$US
240467231$24046723$1$I$$20240619$20240703$20240703$EXP$$CH-CMP PHARMA-2024CMP00034$CMP PHARMA$Ballmer A, Loretz L, Henzen C, Ulmer T, Van Veelen N. Small tablet, large effect: Statin-induced rhabdomyolysis. Swiss Med. Wkly. 2024;154:40S$48$YR$$M$Y$$$20240703$$HP$CH$CH
240467241$24046724$1$I$$20240619$20240703$20240703$EXP$$CN-CMP PHARMA-2024CMP00033$CMP PHARMA$Meixian Lei. Case report: A case of bradycardia triggered by diarrhea. Front. Med.. 2024;(11)$92$YR$$M$Y$$$20240703$$HP$CN$CN
240467252$24046725$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3214088$TEVA$Lu J. Rescue of immediate post-transcarotid artery revascularization carotid stent thrombosis due to clopidogrel resistance using flow-reversal and aspiration thrombectomy. J-Vasc-Surg-Cases-Innov-Tech 2023; 9 (2): 1-5.; Lu J. Rescue of immediate post-transcarotid artery revascularization carotid stent thrombosis due to clopidogrel resistance using flow-reversal and aspiration thrombectomy. J-Vasc-Surg-Cases-Innov-Tech 2023; 9 (2): 1-5.$84$YR$$M$Y$$$20240717$$MD$US$US
240467261$24046726$1$I$$20240620$20240703$20240703$PER$US-MLMSERVICE-20240613-PI097662-00198-1$US-RDY-SPO/USA/24/0009082$DR REDDYS$Aslam S, Basaraba I, Icard BL. A Rare Case of Pulmonary Mucoepidermoid Carcinoma Manifesting as Recurrent Post-obstructive Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6565. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6565.$27$YR$A$M$Y$$$20240703$$MD$US$US
240467271$24046727$1$I$$20240620$20240703$20240703$PER$US-MLMSERVICE-20240613-PI097050-00099-1$US-RDY-SPO/USA/24/0009113$DR REDDYS$Radhakrishnan S, Safdar H, Gubeladze T, Reed M. An Unusual Presentation of Mycobacterium Fortuitum With Classical Findings of Pleuroparenchymal Fibroelastosis on Imaging. American Journal of Respiratory and Critical Care Medicine. 2024;209.$86$YR$E$M$Y$$$20240703$$MD$US$US
240467281$24046728$1$I$$20231220$20240703$20240703$PER$$US-AMGEN-USASP2023235524$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240467291$24046729$1$I$$20240620$20240703$20240703$PER$US-MLMSERVICE-20240613-PI097412-00150-1$US-RDY-SPO/USA/24/0009096$DR REDDYS$Veerabattini N, Christensen B, Arcega R, Honsberg A. Challenges in Diagnosing and Managing Concurrent Silicosis and Coccidioidomycosis With Hypersensitivity Symptoms: A Case Report. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6006. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6006$33$YR$A$M$Y$$$20240703$$MD$US$US
240467301$24046730$1$I$$20240118$20240703$20240703$PER$$US-AMGEN-USASP2024129943$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240467311$24046731$1$I$$20230424$20240703$20240703$PER$$US-AMGEN-USASP2023235110$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240467321$24046732$1$I$20240621$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024130421$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240467331$24046733$1$I$$20230921$20240703$20240703$PER$$US-AMGEN-USASP2023235498$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240467341$24046734$1$I$20240620$20240625$20240703$20240703$EXP$$US-JNJFOC-20240668748$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$MD$US$US
240467352$24046735$2$F$$20240701$20240703$20240705$PER$$US-JNJFOC-20240702612$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$CN$US$US
240467361$24046736$1$I$$20240625$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006803$INCYTE$$$$$$Y$$$20240703$$CN$US$US
240467371$24046737$1$I$$20240627$20240703$20240703$EXP$$RU-ABBVIE-5824674$ABBVIE$$$$$$Y$$$20240703$$MD$RU$RU
240467381$24046738$1$I$$20240625$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006806$INCYTE$$$$$$Y$$$20240703$$PH$US$US
240467391$24046739$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46492$$FDA-CTU$$76$YR$$F$N$68.04$KG$20240703$N$$US$
240467411$24046741$1$I$$20240620$20240703$20240703$EXP$$JP-B.Braun Medical Inc.-2158811$B BRAUN$Literature Article$66$YR$$M$Y$$$20240703$$$JP$JP
240467433$24046743$3$F$20240101$20240814$20240703$20240821$EXP$$US-SA-2024SA194622$SANOFI AVENTIS$$68$YR$E$F$Y$56.24$KG$20240821$$MD$US$US
240467451$24046745$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A149887$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240467471$24046747$1$I$$20240628$20240703$20240703$PER$$US-ABBVIE-5822503$ABBVIE$$$$E$$Y$$$20240703$$CN$US$US
240467481$24046748$1$I$$20231111$20240703$20240703$PER$$US-AMGEN-USASP2023235165$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240467491$24046749$1$I$20240520$20240627$20240703$20240703$PER$$US-BAYER-2024A093486$BAYER$$39$YR$A$F$Y$$$20240703$$CN$US$US
240467501$24046750$1$I$$20240627$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103488$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$60.33$KG$20240703$$PH$US$US
240467511$24046751$1$I$20230101$20240701$20240703$20240703$EXP$$US-ABBVIE-5822694$ABBVIE$$$$$F$Y$45$KG$20240703$$CN$US$US
240467521$24046752$1$I$$20240628$20240703$20240703$EXP$$US-INCYTE CORPORATION-2024IN006931$INCYTE$$$$$$Y$$$20240703$$MD$US$US
240467531$24046753$1$I$20240101$20240628$20240703$20240703$EXP$$NVSC2024DE136202$NOVARTIS$$87$YR$$F$Y$$$20240703$$CN$DE$DE
240467542$24046754$2$F$20230922$20240816$20240703$20240822$EXP$$JP-009507513-2310JPN003557J$MERCK$$67$YR$$F$Y$$$20240822$$MD$JP$JP
240467553$24046755$3$F$$20240723$20240703$20240802$30DAY$$FR-JNJFOC-20240652505$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$PH$FR$FR
240467561$24046756$1$I$20240501$20240628$20240703$20240703$EXP$$US-SA-2024SA195119$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240703$$MD$US$US
240467572$24046757$2$F$20240625$20240712$20240703$20240717$EXP$$US-SA-2024SA195833$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240717$$MD$US$US
240467581$24046758$1$I$$20240627$20240703$20240703$PER$$US-BAYER-2024A093499$BAYER$$$$$F$Y$$$20240703$$HP$US$US
240467592$24046759$2$F$20240601$20240814$20240703$20240819$EXP$$NVSC2024US095166$NOVARTIS$$73$YR$$F$Y$$$20240819$$CN$US$US
240467601$24046760$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137670$NOVARTIS$$81$YR$$F$Y$$$20240703$$MD$US$US
240467613$24046761$3$F$$20240705$20240703$20240710$EXP$$NVSC2024DE136266$NOVARTIS$$$$E$F$Y$$$20240710$$PH$DE$DE
240467621$24046762$1$I$$20240620$20240703$20240703$EXP$$US-B.Braun Medical Inc.-2158812$B BRAUN$Literature Article$71$YR$$M$Y$$$20240703$$$US$US
240467631$24046763$1$I$$20240702$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106313$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240703$$CN$US$US
240467641$24046764$1$I$20240528$20240627$20240703$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099890$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240703$$PH$JP$JP
240467651$24046765$1$I$20240702$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105957$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$85$KG$20240703$$CN$US$US
240467691$24046769$1$I$$20240624$20240703$20240703$EXP$$US-RDY-LIT/USA/24/0009435$DR REDDYS$Prabhu S, Malempati S, Markowitz D. Amlodipine: Not an Ace in the Hole. American Journal of Respiratory and Critical Care Medicine. 2024;209(0): doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1361.$56$YR$A$M$Y$$$20240703$$HP$US$US
240467701$24046770$1$I$$20240620$20240703$20240703$PER$US-MLMSERVICE-20240613-PI097691-00135-2$US-RDY-SPO/USA/24/0009083$DR REDDYS$Ghose M, Anwar M, Rajamohan A, Vangala A, Roy P, Weiner SM. Vancomycin Induced Anaphylaxis Presenting With Cardiac Arrest: Judicious Use of Antibiotic in Low Risk Procedures. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5700. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5700.$$$$F$Y$$$20240703$$MD$US$US
240467711$24046771$1$I$$20240620$20240703$20240703$PER$US-MLMSERVICE-20240613-PI098343-00129-1$US-RDY-SPO/USA/24/0009102$DR REDDYS$Gondal MUR, Rovenstine L, Ansari F, Kiyani Z, Jyothi Ramachandran Nair DP, Khan T, et al. Navigating a complex case of Mycobacterium xenopi in a patient with blue rubber bleb nevus syndrome. European Journal of Case Reports in Internal Medicine. 2024;11(6). DOI:10.12890/2024_004530.$$$$F$Y$$$20240703$$MD$US$US
240467721$24046772$1$I$20240627$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024128787$AMGEN$$65$YR$E$$Y$$$20240703$$CN$US$US
240467731$24046773$1$I$$20240122$20240703$20240703$PER$$US-AMGEN-USASP2024129945$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240467751$24046775$1$I$20240101$20240627$20240703$20240703$PER$$US-BAYER-2024A094342$BAYER$$31$YR$A$F$Y$$$20240703$$CN$US$US
240467761$24046776$1$I$20240201$20240627$20240703$20240703$EXP$$US-RADIUS HEALTH, INC.-2024US004527$RADIUS PHARM$$83$YR$$F$Y$$$20240703$$CN$US$US
240467771$24046777$1$I$20240601$20240625$20240703$20240703$EXP$$CN-SPECGX-T202401439$SPECGX$$65$YR$$F$Y$48$KG$20240703$$CN$CN$CN
240467781$24046778$1$I$20240628$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001251$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240703$$CN$US$US
240467791$24046779$1$I$20240530$20240625$20240703$20240703$EXP$SE-SEMPA-2024-004961$SE-TEVA-VS-3214455$TEVA$$75$YR$$F$Y$69$KG$20240703$$MD$SE$SE
240467801$24046780$1$I$$20240627$20240703$20240703$PER$$US-BAYER-2024A094495$BAYER$$$$$F$Y$$$20240703$$HP$US$US
240467811$24046781$1$I$$20230516$20240703$20240703$PER$$US-AMGEN-USASP2023235183$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240467821$24046782$1$I$$20240626$20240703$20240703$EXP$$US-VIIV HEALTHCARE LIMITED-US2024079879$VIIV$$$$$$Y$$$20240703$$CN$US$US
240467832$24046783$2$F$20240215$20240701$20240703$20240705$EXP$$DE-009507513-2407DEU000689$MERCK$$64$YR$$M$Y$$$20240705$$MD$DE$DE
240467841$24046784$1$I$$20240702$20240703$20240703$PER$$US-BAYER-2024A095495$BAYER$$$$$M$Y$$$20240703$$CN$US$US
240467861$24046786$1$I$$20240625$20240703$20240703$EXP$$ZA-AstraZeneca-2024A147255$ASTRAZENECA$$61$YR$$F$Y$$$20240703$$CN$ZA$
240467871$24046787$1$I$$20240629$20240703$20240703$EXP$GB-MHRA-MED-202406281414140760-PYGTQ$GB-ORGANON-O2407GBR000027$ORGANON$$$$$$Y$$$20240703$$CN$GB$GB
240467881$24046788$1$I$20240514$20240625$20240703$20240703$EXP$$CN-AstraZeneca-2024A150283$ASTRAZENECA$$23771$DY$$F$Y$67$KG$20240703$$MD$CN$
240467891$24046789$1$I$$20240625$20240703$20240703$EXP$$JP-AstraZeneca-2024A149328$ASTRAZENECA$Satsusa N, et al.. C-04 A case of squamous cell carcinoma presenting with fever suspected to be due to cytokine release syndrome during combination therapy with durvalumab and tremelimumab.. The 143rd Tokai Branch Meeting of the Japanese Society for Tuberculosis and Nontuberculous Mycobasteriosis, 2024;28-..$60$YR$$M$Y$$$20240703$$MD$JP$
240467901$24046790$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A150606$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240467911$24046791$1$I$$20240625$20240703$20240703$EXP$$JP-AstraZeneca-2024A149042$ASTRAZENECA$Honda Y, et al.. B-10 A case of cytomegalovirus pneumonia developed 5 months after discontinuation of long-term oral steroids.. The 143rd Tokai Branch Academic Meeting of the Japanese Society for Tuberculosis and Nontuberculous Mycobacteriosis, 2024;$83$YR$$M$Y$$$20240703$$MD$JP$
240467921$24046792$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A147452$ASTRAZENECA$$$$$M$Y$$$20240703$$MD$US$
240467941$24046794$1$I$$20240628$20240703$20240703$EXP$$US-KYOWAKIRIN-2024KK015969$KYOWA$$$$$$Y$$$20240703$$PH$US$US
240467951$24046795$1$I$$20240618$20240703$20240703$PER$$US-FreseniusKabi-FK202409731$FRESENIUS KABI$$55$YR$A$F$Y$52.16$KG$20240703$$HP$US$US
240467962$24046796$2$F$20240527$20240906$20240703$20240912$EXP$$TW-FreseniusKabi-FK202409834$FRESENIUS KABI$$49$YR$A$F$Y$61.7$KG$20240912$$MD$TW$TW
240467971$24046797$1$I$20220121$20240701$20240703$20240703$EXP$$AT-FreseniusKabi-FK202410313$FRESENIUS KABI$$84$YR$E$M$Y$$$20240703$$MD$AT$AT
240467981$24046798$1$I$20240606$20240626$20240703$20240703$PER$$US-RDY-SPO/USA/24/0009493$DR REDDYS$$27$YR$A$F$Y$$$20240703$$MD$US$US
240467991$24046799$1$I$$20240625$20240703$20240703$PER$$US-RDY-SPO/USA/24/0009494$DR REDDYS$$20$YR$C$F$Y$$$20240703$$MD$US$US
240468001$24046800$1$I$$20240625$20240703$20240703$PER$$US-RDY-SPO/USA/24/0009495$DR REDDYS$$16$YR$C$$Y$$$20240703$$MD$US$US
240468011$24046801$1$I$20240623$20240628$20240703$20240703$EXP$$CL-JNJFOC-20240702586$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240703$$CN$CL$CL
240468021$24046802$1$I$$20240620$20240703$20240703$EXP$$US-B.Braun Medical Inc.-2158814$B BRAUN$Literature Article$68$YR$$M$Y$$$20240703$$$US$US
240468041$24046804$1$I$$20240702$20240703$20240703$PER$$US-BAYER-2024A095582$BAYER$$$$$F$Y$$$20240703$$CN$US$US
240468062$24046806$2$F$20240507$20240815$20240703$20240822$EXP$$DE-AMGEN-DEUSP2024128622$AMGEN$$82$YR$E$F$Y$65$KG$20240822$$MD$DE$DE
240468071$24046807$1$I$$20240226$20240703$20240703$PER$$US-AMGEN-USASP2024129985$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240468081$24046808$1$I$$20231115$20240703$20240703$PER$$US-AMGEN-USASP2023235227$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240468092$24046809$2$F$20230731$20240705$20240703$20240710$EXP$ES-AEMPS-1431855$ES-GILEAD-2024-0679154$GILEAD$$51$YR$A$M$Y$79$KG$20240710$$PH$ES$ES
240468102$24046810$2$F$20230101$20240904$20240703$20240913$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000135$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240913$$HP$US$US
240468111$24046811$1$I$$20240624$20240703$20240703$PER$$US-Calliditas-2024CAL01164$CALLIDITAS THERAPEUTICS$$36$YR$A$M$Y$86.2$KG$20240703$$CN$US$US
240468122$24046812$2$F$20240709$20240709$20240703$20240716$EXP$$CA-GSK-CA2024001688$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$HP$CA$CA
240468131$24046813$1$I$$20240628$20240703$20240703$EXP$$JP-009507513-2406JPN004242J$MERCK$$$$$F$Y$$$20240703$$MD$JP$JP
240468141$24046814$1$I$$20240702$20240703$20240703$PER$$US-BAYER-2024A095622$BAYER$$$$$F$Y$$$20240703$$CN$US$US
240468151$24046815$1$I$$20240626$20240703$20240703$EXP$$CA-GSK-CA2024079768$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CA$CA
240468162$24046816$2$F$$20240712$20240703$20240725$EXP$$US-ALXN-202406USA001711US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240719$$MD$US$US
240468171$24046817$1$I$$20240325$20240703$20240703$PER$$US-AMGEN-USASP2024131603$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240468181$24046818$1$I$20240618$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024129782$AMGEN$$85$YR$E$M$Y$$$20240703$$CN$US$US
240468201$24046820$1$I$20240601$20240701$20240703$20240703$EXP$$US-KYOWAKIRIN-2024KK015994$KYOWA$$$$$$Y$$$20240703$$HP$US$US
240468211$24046821$1$I$20240507$20240628$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105035$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240703$$CN$US$US
240468221$24046822$1$I$$20240702$20240703$20240703$PER$$US-BAYER-2024A095811$BAYER$$93$YR$E$F$Y$$$20240703$$CN$US$US
240468232$24046823$2$F$20240627$20240723$20240703$20240802$PER$$US-JNJFOC-20240676682$JOHNSON AND JOHNSON$$25$YR$A$M$Y$104.42$KG$20240802$$HP$US$US
240468251$24046825$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-PV202400086848$PFIZER$$$$$$Y$$$20240703$$CN$US$US
240468261$24046826$1$I$20240101$20240702$20240703$20240703$PER$$US-PFIZER INC-202400185553$PFIZER$$45$YR$$F$Y$86.18$KG$20240703$$CN$US$US
240468271$24046827$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-PV202400087043$PFIZER$$87$YR$$F$Y$$$20240703$$CN$US$US
240468281$24046828$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-PV202400086876$PFIZER$$33$YR$$M$Y$$$20240703$$MD$US$US
240468291$24046829$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-PV202400086986$PFIZER$$18$YR$$F$Y$$$20240703$$HP$US$US
240468301$24046830$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-PV202400086884$PFIZER$$37$YR$$M$Y$$$20240703$$MD$US$US
240468311$24046831$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-PV202400086865$PFIZER$$27$YR$$M$Y$$$20240703$$MD$US$US
240468322$24046832$2$F$20240401$20240710$20240703$20240715$PER$$US-PFIZER INC-202400204507$PFIZER$$37$YR$$F$Y$$$20240715$$CN$US$US
240468331$24046833$1$I$$20240702$20240703$20240703$EXP$$CA-PFIZER INC-202400205286$PFIZER$$10$YR$$M$Y$$$20240703$$HP$CA$CA
240468341$24046834$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-PV202400087189$PFIZER$$42$YR$$F$Y$$$20240703$$HP$US$US
240468351$24046835$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-PV202400086868$PFIZER$$18$YR$$F$Y$$$20240703$$MD$US$US
240468361$24046836$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-202400204274$PFIZER$$$$$F$Y$$$20240703$$HP$US$US
240468372$24046837$2$F$20240613$20240708$20240703$20240710$PER$$US-PFIZER INC-PV202400087222$PFIZER$$67$YR$$F$Y$53.515$KG$20240710$$MD$US$US
240468381$24046838$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-PV202400086845$PFIZER$$67$YR$$F$Y$$$20240703$$CN$US$US
240468392$24046839$2$F$$20240703$20240703$20240703$PER$$US-PFIZER INC-PV202400085835$PFIZER$$59$YR$$F$Y$$$20240703$$HP$US$US
240468411$24046841$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-PV202400087020$PFIZER$$52$YR$$F$Y$$$20240703$$HP$US$US
240468421$24046842$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205395$PFIZER$$43$YR$$F$Y$$$20240703$$CN$US$US
240468431$24046843$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024130419$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240468441$24046844$1$I$20240701$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130457$AMGEN$$45$YR$A$F$Y$$$20240703$$CN$US$US
240468453$24046845$3$F$20240701$20240828$20240703$20240829$PER$$US-AMGEN-USASP2024130644$AMGEN$$60$YR$A$M$Y$$$20240829$$CN$US$US
240468461$24046846$1$I$$20240123$20240703$20240703$PER$$US-AMGEN-USASP2024129916$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240468471$24046847$1$I$$20240416$20240703$20240703$PER$$US-AMGEN-USASP2024131621$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240468481$24046848$1$I$$20240622$20240703$20240703$EXP$$EC-ROCHE-10000007742$ROCHE$$$$$$Y$$$20240703$$CN$EC$EC
240468491$24046849$1$I$$20240628$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105011$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240703$$CN$US$US
240468501$24046850$1$I$$20240628$20240703$20240703$PER$$US-RDY-SPO/USA/24/0009507$DR REDDYS$$39$YR$A$F$Y$$$20240703$$CN$US$US
240468511$24046851$1$I$$20240626$20240703$20240703$PER$$US-RDY-SPO/USA/24/0009475$DR REDDYS$$34$YR$A$$Y$$$20240703$$MD$US$US
240468532$24046853$2$F$20240616$20240902$20240703$20240906$PER$$JP-Eisai-EC-2024-169406$EISAI$$70$YR$E$F$Y$45$KG$20240906$$MD$JP$JP
240468541$24046854$1$I$$20240627$20240703$20240703$PER$$US-RDY-SPO/USA/24/0009512$DR REDDYS$$33$YR$A$F$Y$$$20240703$$MD$US$US
240468551$24046855$1$I$$20240626$20240703$20240703$PER$$US-RDY-SPO/USA/24/0009473$DR REDDYS$$40$YR$A$$Y$$$20240703$$MD$US$US
240468561$24046856$1$I$$20240627$20240703$20240703$PER$US-MLMSERVICE-20240620-PI107543-00246-4$US-RDY-SPO/USA/24/0009467$DR REDDYS$Calabrese L, Frase R, Ghaloo M. Complete remission of depression and anxiety using a ketogenic diet: case series. Frontiers in nutrition. 2024;11:1396685. DOI: 10.3389/fnut.2024.1396685.$$$$M$Y$$$20240703$$MD$US$US
240468571$24046857$1$I$$20240625$20240703$20240703$EXP$$US-SPECGX-T202401457$SPECGX$Kalsoom S, Khan M, Zaman MA, Vitellas M. A silent inferior wall ST segment elevation myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(1)$36$YR$$M$Y$$$20240703$$HP$US$US
240468581$24046858$1$I$$20240605$20240703$20240703$PER$$US-009507513-2406USA003254$MERCK$Nassief G, Butt O.H., Zhou A.Y., Ansstas G. Poly (ADP-Ribose) Polymerase inhibitors (PARPi) therapy response in an acral melanoma patient with EMSY gene amplification. JAAD Case Reports. 2024;48:59-61$88$YR$$M$Y$$$20240703$$HP$US$US
240468591$24046859$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138159$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240468601$24046860$1$I$20240601$20240701$20240703$20240703$PER$$US-JNJFOC-20240701775$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240703$$CN$US$US
240468611$24046861$1$I$$20240622$20240703$20240703$EXP$$EC-ROCHE-10000007736$ROCHE$$$$$$Y$$$20240703$$CN$EC$EC
240468621$24046862$1$I$$20240702$20240703$20240703$PER$$US-HALEON-2185077$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240468631$24046863$1$I$$20240628$20240703$20240703$EXP$$US-AstraZeneca-2024A150287$ASTRAZENECA$$$$$F$Y$52.2$KG$20240703$$MD$US$
240468641$24046864$1$I$$20240626$20240703$20240703$EXP$$CA-GSK-CA2024GSK081425$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CA$CA
240468651$24046865$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A147485$ASTRAZENECA$Shi M., Yuan J.. Pseudo-Richter Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma After Temporary Acalabrutinib Interruption. Mayo Clinic Proceedings 2024;99(6):867-868.$$$E$M$Y$$$20240703$$MD$US$
240468661$24046866$1$I$$20240625$20240703$20240703$EXP$$BR-AstraZeneca-2024A150115$ASTRAZENECA$$68$YR$$M$Y$$$20240703$$MD$BR$
240468671$24046867$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A147409$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240468683$24046868$3$F$20240624$20240813$20240703$20240820$EXP$$CO-GSK-CO2024AMR080671$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$CO$CO
240468691$24046869$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A146773$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240468701$24046870$1$I$20240531$20240628$20240703$20240703$EXP$$FR-AstraZeneca-2024A149384$ASTRAZENECA$$26$YR$$F$Y$100$KG$20240703$$MD$FR$
240468712$24046871$2$F$$20240802$20240703$20240806$PER$$US-ALXN-202406USA001771US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240468721$24046872$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001309$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240703$$CN$US$US
240468731$24046873$1$I$$20240627$20240703$20240703$EXP$$US-ABBVIE-5820936$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240468751$24046875$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137584$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240468761$24046876$1$I$20240101$20240627$20240703$20240703$EXP$$US-ABBVIE-5823291$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240468771$24046877$1$I$20240501$20240628$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105039$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$99.79$KG$20240703$$CN$US$US
240468781$24046878$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106439$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240703$$CN$US$US
240468791$24046879$1$I$20230101$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105434$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240703$$HP$US$US
240468802$24046880$2$F$$20240827$20240703$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106174$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240830$$CN$US$US
240468812$24046881$2$F$20240601$20240729$20240703$20240808$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00698$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240808$$CN$US$US
240468821$24046882$1$I$$20240626$20240703$20240703$EXP$$JP-009507513-2406JPN004044J$MERCK$$78$YR$$M$Y$$$20240703$$MD$JP$JP
240468841$24046884$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5821357$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240468854$24046885$4$F$$20240909$20240703$20240910$EXP$$JP-JNJFOC-20240700392$JOHNSON AND JOHNSON$Katayama Y, Katayama Y. AL amyloidosis in the era of Dara-CyBorD therapy.$71$YR$E$M$Y$$$20240910$$MD$JP$JP
240468861$24046886$1$I$20240521$20240702$20240703$20240703$EXP$FR-AFSSAPS-TS2024000748$FR-JNJFOC-20240704788$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240703$$MD$FR$FR
240468871$24046887$1$I$20240123$20240619$20240703$20240703$EXP$FR-AFSSAPS-RE2024000562$FR-TEVA-VS-3212780$TEVA$$75$YR$$M$Y$79$KG$20240703$$MD$FR$FR
240468881$24046888$1$I$$20240626$20240703$20240703$EXP$$CA-GSK-CA2024AMR080226$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CA$CA
240468902$24046890$2$F$20240628$20240709$20240703$20240711$30DAY$$AR-PFIZER INC-202400204209$PFIZER$$14$YR$$M$Y$$$20240711$$CN$AR$AR
240468921$24046892$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46404$$FDA-CTU$$41$YR$$F$N$95.25$KG$20240703$N$$US$
240468935$24046893$5$F$$20240911$20240703$20240913$30DAY$$US-PFIZER INC-202400202803$PFIZER$$10$YR$$F$Y$45.36$KG$20240913$$CN$US$US
240468941$24046894$1$I$$20240623$20240703$20240703$PER$$US-TEVA-VS-3213890$TEVA$$$$A$M$Y$$$20240703$$HP$US$US
240468951$24046895$1$I$$20240516$20240703$20240703$PER$$US-AMGEN-USASP2024129995$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240468962$24046896$2$F$$20240122$20240703$20240913$PER$$US-HALEON-2185073$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
240468971$24046897$1$I$20240620$20240701$20240701$20240701$DIR$708788$$FDA-CTU$$21$YR$$F$N$54$KG$20240701$Y$CN$US$
240468983$24046898$3$F$20240617$20240718$20240703$20240725$30DAY$$ES-JNJFOC-20240650768$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240725$$CN$ES$ES
240468991$24046899$1$I$$20240628$20240703$20240703$EXP$$CA-TAKEDA-2024TUS066866$TAKEDA$$$$$F$Y$$$20240703$$CN$CA$CA
240469001$24046900$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138163$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240469021$24046902$1$I$$20240701$20240703$20240703$EXP$$JP-PFIZER INC-202400204736$PFIZER$$62$YR$$M$Y$$$20240703$$MD$JP$JP
240469041$24046904$1$I$20240526$20240701$20240703$20240703$EXP$ES-AEMPS-1537060$ES-PFIZER INC-202400203942$PFIZER$$20$YR$$F$Y$$$20240703$$HP$ES$ES
240469051$24046905$1$I$$20240701$20240703$20240703$EXP$$MA-PFIZER INC-PV202400087283$PFIZER$$$$$M$Y$$$20240703$$CN$MA$MA
240469061$24046906$1$I$$20240701$20240703$20240703$EXP$$US-PFIZER INC-PV202400086452$PFIZER$$77$YR$$F$Y$$$20240703$$CN$US$US
240469071$24046907$1$I$20240521$20240701$20240703$20240703$EXP$$CN-PFIZER INC-PV202400086332$PFIZER$$57$YR$$M$Y$$$20240703$$HP$CN$CN
240469084$24046908$4$F$20240101$20240729$20240703$20240730$EXP$$JP-PFIZER INC-PV202400082124$PFIZER$$$$T$M$Y$$$20240730$$PH$JP$JP
240469091$24046909$1$I$$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46439$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240469111$24046911$1$I$$20240701$20240703$20240703$EXP$$MA-PFIZER INC-PV202400087285$PFIZER$$$$$F$Y$$$20240703$$CN$MA$MA
240469122$24046912$2$F$20230424$20240806$20240703$20240808$EXP$$PL-PFIZER INC-202400203973$PFIZER$$72$YR$$M$Y$$$20240808$$MD$PL$PL
240469131$24046913$1$I$20240513$20240701$20240703$20240703$EXP$FR-AFSSAPS-PC2024000498$FR-PFIZER INC-202400204017$PFIZER$$49$YR$$F$Y$$$20240703$$PH$FR$FR
240469141$24046914$1$I$20240601$20240701$20240703$20240703$EXP$$US-PFIZER INC-202400204596$PFIZER$$40$YR$$M$Y$$$20240703$$CN$US$US
240469151$24046915$1$I$20240603$20240701$20240703$20240703$EXP$FR-AFSSAPS-PP2024000704$FR-PFIZER INC-202400203986$PFIZER$$84$YR$$M$Y$65.3$KG$20240703$$PH$FR$FR
240469161$24046916$1$I$$20240701$20240703$20240703$EXP$$HR-PFIZER INC-202400203965$PFIZER$$56$YR$$F$Y$$$20240703$$HP$HR$HR
240469171$24046917$1$I$$20240701$20240703$20240703$EXP$$CA-PFIZER INC-202400204346$PFIZER$$$$$$Y$$$20240703$$MD$CA$CA
240469181$24046918$1$I$$20240701$20240703$20240703$EXP$$ES-PFIZER INC-202400204808$PFIZER$$61$YR$$F$Y$$$20240703$$MD$ES$ES
240469191$24046919$1$I$20240618$20240701$20240703$20240703$EXP$$CN-PFIZER INC-PV202400086324$PFIZER$$50$YR$$M$Y$73$KG$20240703$$HP$CN$CN
240469202$24046920$2$F$20240608$20240717$20240703$20240722$EXP$$US-PFIZER INC-202400204485$PFIZER$$65$YR$$M$Y$$$20240722$$HP$US$US
240469214$24046921$4$F$$20240901$20240703$20240903$30DAY$$AU-PFIZER INC-202400203496$PFIZER$$$$$F$Y$$$20240903$$CN$AU$AU
240469231$24046923$1$I$$20240701$20240703$20240703$EXP$$US-PFIZER INC-PV202400086283$PFIZER$$2$YR$$M$Y$$$20240703$$MD$US$US
240469241$24046924$1$I$20240217$20240618$20240703$20240703$EXP$$CA-TEVA-VS-3212017$TEVA$$57$YR$$F$Y$63.5$KG$20240703$$CN$CA$CA
240469254$24046925$4$F$$20240924$20240703$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106153$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240925$$HP$US$US
240469271$24046927$1$I$20240629$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46509$$FDA-CTU$$70$YR$$M$N$$$20240703$N$$US$
240469281$24046928$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46498$$FDA-CTU$$56$YR$$F$N$134.26$KG$20240703$N$$US$
240469291$24046929$1$I$20230919$20240702$20240702$20240702$DIR$708960$$FDA-CTU$$13$YR$$F$N$68.4$KG$20240702$Y$MD$US$
240469301$24046930$1$I$20240618$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46496$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240469311$24046931$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46494$$FDA-CTU$$50$YR$$M$N$$$20240703$N$$US$
240469331$24046933$1$I$20240618$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46495$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240469341$24046934$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46517$$FDA-CTU$$64$YR$$F$N$$$20240703$N$$US$
240469351$24046935$1$I$$20240702$20240702$20240702$DIR$708915$$FDA-CTU$$$$$UNK$N$$$20240702$$CN$US$
240469361$24046936$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46500$$FDA-CTU$$82$YR$$F$N$$$20240703$N$$US$
240469371$24046937$1$I$$20240702$20240702$20240702$DIR$708941$$FDA-CTU$$$$$UNK$N$$$20240702$$CN$US$
240469381$24046938$1$I$20240601$20240626$20240703$20240703$EXP$$AU-Blueprint Medicines Corporation-SO-AU-2024-001324$BLUEPRINT MEDICINES$$$$$M$Y$$$20240703$$PH$AU$AU
240469392$24046939$2$F$$20240730$20240703$20240802$PER$$US-JNJFOC-20240667507$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$CN$US$US
240469411$24046941$1$I$20240401$20240627$20240703$20240703$EXP$DK-DKMA-30733315$DK-MYLANLABS-2024M1060780$MYLAN$$65$YR$$F$Y$$$20240703$$HP$DK$DK
240469421$24046942$1$I$20240702$20240702$20240702$20240702$DIR$708954$$FDA-CTU$$52$YR$$M$N$112.95$KG$20240702$N$MD$US$
240469431$24046943$1$I$20240501$20240627$20240703$20240703$EXP$FR-AFSSAPS-PV2024000566$FR-MYLANLABS-2024M1060682$MYLAN$$63$YR$$F$Y$87$KG$20240703$$MD$FR$FR
240469441$24046944$1$I$$20240129$20240703$20240703$PER$$US-AMGEN-USASP2024130870$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240469451$24046945$1$I$$20231120$20240703$20240703$PER$$US-AMGEN-USASP2023235123$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240469461$24046946$1$I$$20231018$20240703$20240703$PER$$US-AMGEN-USASP2023235273$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240469471$24046947$1$I$20240626$20240628$20240703$20240703$EXP$$US-SA-2024SA195402$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240703$$MD$US$US
240469482$24046948$2$F$$20240708$20240703$20240717$EXP$$JP-TEVA-VS-3214321$TEVA$Kumagai K, Baba T, Fukushima T, Tabata E, Nakazawa A, Hagiwara E, et al. A case of sialadenitis observed as an irAE of atezolizumab: A case report. Respirat-Med-Case-Report 2024; 50 102068.; Kumagai K, Baba T, Fukushima T, Tabata E, Nakazawa A, Hagiwara E, et al. A case of sialadenitis observed as an irAE of atezolizumab: A case report. Respirat-Med-Case-Report 2024; 50 102068.; Kumagai K, Baba T, Fukushima T, Tabata E, Nakazawa A, Hagiwara E, et al. A case of sialadenitis observed as an irAE...$73$YR$$F$Y$$$20240717$$HP$JP$JP
240469491$24046949$1$I$20240101$20240628$20240703$20240703$EXP$$US-SA-2024SA195819$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
240469501$24046950$1$I$20240101$20240628$20240703$20240703$EXP$$US-SA-2024SA195823$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240703$$MD$US$US
240469511$24046951$1$I$20230901$20240628$20240703$20240703$EXP$$AU-SA-2024SA194451$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240703$$CN$AU$AU
240469521$24046952$1$I$20240501$20240627$20240703$20240703$EXP$$NVSC2024DE135376$NOVARTIS$$$$E$M$Y$$$20240703$$PH$DE$DE
240469531$24046953$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138088$NOVARTIS$$$$$F$Y$$$20240703$$HP$US$US
240469541$24046954$1$I$20240509$20240625$20240703$20240703$EXP$DE-CADRBFARM-2024328722$DE-TEVA-VS-3214458$TEVA$$63$YR$$F$Y$125$KG$20240703$$PH$DE$DE
240469551$24046955$1$I$20240627$20240629$20240703$20240703$EXP$$CN-BAYER-2024A094708$BAYER$$57$YR$A$F$Y$70$KG$20240703$$HP$CN$CN
240469561$24046956$1$I$20240408$20240625$20240703$20240703$EXP$IT-MINISAL02-990911$IT-TEVA-VS-3213809$TEVA$$80$YR$$F$Y$54$KG$20240703$$MD$IT$IT
240469571$24046957$1$I$20230830$20240627$20240703$20240703$EXP$$DE-MYLANLABS-2023M1103059$MYLAN$$91$YR$$M$Y$94$KG$20240703$$HP$DE$DE
240469581$24046958$1$I$20240626$20240629$20240703$20240703$EXP$$US-MYLANLABS-2024M1061722$MYLAN$$37$YR$$M$Y$$$20240703$$HP$US$US
240469591$24046959$1$I$20240501$20240702$20240703$20240703$EXP$$US-KYOWAKIRIN-2024KK015996$KYOWA$$$$$$Y$$$20240703$$PH$US$US
240469601$24046960$1$I$20210101$20240628$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036944$BOEHRINGER INGELHEIM$$55$YR$A$F$Y$$$20240703$$CN$US$US
240469611$24046961$1$I$$20240624$20240703$20240703$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010135$JAZZ$$$$A$M$Y$$$20240703$$MD$JP$JP
240469621$24046962$1$I$$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024130063$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240469631$24046963$1$I$$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130648$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240469641$24046964$1$I$$20240628$20240703$20240703$EXP$$US-AMGEN-USASP2024129623$AMGEN$$$$$F$Y$$$20240703$$MD$US$US
240469651$24046965$1$I$20130224$20240625$20240703$20240703$EXP$$DE-TEVA-405233GER$TEVA$$30$YR$$M$Y$70$KG$20240703$$MD$DE$DE
240469662$24046966$2$F$$20240729$20240703$20240806$EXP$$ES-AstraZeneca-2024A152487$ASTRAZENECA$$$$$F$Y$$$20240806$$MD$ES$
240469671$24046967$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A147396$ASTRAZENECA$$$$$M$Y$$$20240703$$CN$US$
240469682$24046968$2$F$$20240625$20240703$20240729$EXP$$US-AstraZeneca-2024A147059$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
240469693$24046969$3$F$$20240724$20240703$20240802$EXP$$EG-TAKEDA-2024TUS065291$TAKEDA$$$$$M$Y$$$20240802$$MD$EG$EG
240469702$24046970$2$F$$20240701$20240703$20240704$PER$$NVSC2024US137084$NOVARTIS$$44$YR$$M$Y$$$20240704$$CN$US$US
240469711$24046971$1$I$$20240627$20240703$20240703$EXP$$CO-VANTIVE-2024VAN017716$Vantive US Healthcare$$$$$M$Y$68$KG$20240703$$HP$CO$CO
240469721$24046972$1$I$$20240622$20240703$20240703$PER$$US-TEVA-VS-3213463$TEVA$$79$YR$$M$Y$$$20240703$$HP$US$US
240469731$24046973$1$I$20240601$20240625$20240703$20240703$EXP$$US-BAYER-2024A092607$BAYER$$$$$M$Y$$$20240703$$MD$US$US
240469741$24046974$1$I$20240501$20240620$20240703$20240703$PER$$US-SA-2024SA109740$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240703$$MD$US$US
240469751$24046975$1$I$20240101$20240620$20240703$20240703$PER$$US-SA-2024SA189367$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240703$$MD$US$US
240469761$24046976$1$I$20240201$20240621$20240703$20240703$PER$$US-SA-2024SA060617$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240703$$CN$US$US
240469771$24046977$1$I$20240501$20240620$20240703$20240703$PER$$US-SA-2024SA188362$SANOFI AVENTIS$$35$YR$A$M$Y$73.923$KG$20240703$$MD$US$US
240469781$24046978$1$I$20240101$20240620$20240703$20240703$PER$$US-SA-2024SA188329$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240703$$MD$US$US
240469792$24046979$2$F$20240101$20240904$20240703$20240913$PER$$US-SA-2024SA190338$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240913$$MD$US$US
240469801$24046980$1$I$$20240610$20240703$20240703$PER$$US-LEX-000337$LEXICON PHARMACEUTICALS$$76$YR$$F$Y$$$20240703$$HP$US$US
240469811$24046981$1$I$$20240627$20240703$20240703$EXP$$CY-MYLANLABS-2024M1058868$MYLAN$Sotiriadou M. A 69-year-old patient with hypertension, suffering from multiple myeloma and to be treated with Carfilzomib due to disease progression, is referred to the Cardio-oncology clinic for evaluation. How do we manage this case?. Hippocrates Cardiology Days. 2024$69$YR$$M$Y$$$20240703$$HP$CY$CY
240469821$24046982$1$I$20240618$20240618$20240703$20240703$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00496$Phathom Pharmaceuticals$$64$YR$$M$Y$$$20240703$$MD$JP$JP
240469831$24046983$1$I$$20240607$20240703$20240703$PER$$US-LEX-000333$LEXICON PHARMACEUTICALS$$75$YR$$F$Y$$$20240703$$CN$US$US
240469841$24046984$1$I$20240101$20240701$20240703$20240703$PER$$US-JNJFOC-20240702129$JOHNSON AND JOHNSON$$91$YR$E$M$Y$$$20240703$$CN$US$US
240469851$24046985$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA194489$SANOFI AVENTIS$$$$T$F$Y$$$20240703$$MD$US$US
240469861$24046986$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA189098$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240703$$MD$US$US
240469871$24046987$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA036284$SANOFI AVENTIS$$$$T$M$Y$$$20240703$$MD$US$US
240469891$24046989$1$I$20240614$20240624$20240703$20240703$PER$$US-SA-2024SA189359$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240703$$MD$US$US
240469902$24046990$2$F$20240101$20240808$20240703$20240816$PER$$US-SA-2024SA190326$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240816$$MD$US$US
240469911$24046991$1$I$20230101$20240624$20240703$20240703$PER$$US-SA-2024SA188914$SANOFI AVENTIS$$11$YR$C$$Y$$$20240703$$HP$US$US
240469921$24046992$1$I$$20240626$20240703$20240703$PER$$US-SA-2024SA194207$SANOFI AVENTIS$$$$E$F$Y$95$KG$20240703$$MD$US$US
240469931$24046993$1$I$20240623$20240624$20240703$20240703$PER$$US-SA-2024SA189287$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240703$$CN$US$US
240469941$24046994$1$I$20240601$20240626$20240703$20240703$PER$$US-SA-2024SA195092$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240703$$MD$US$US
240469951$24046995$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA189253$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240703$$MD$US$US
240469961$24046996$1$I$20240201$20240625$20240703$20240703$PER$$US-SA-2024SA193583$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240703$$MD$US$US
240469971$24046997$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA190022$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240703$$MD$US$US
240469981$24046998$1$I$$20230714$20240703$20240703$PER$$US-AMGEN-USASP2023235436$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240469991$24046999$1$I$$20240625$20240703$20240703$PER$$US-SA-2024SA189918$SANOFI AVENTIS$$$$$F$Y$$$20240703$$HP$US$US
240470001$24047000$1$I$20240601$20240624$20240703$20240703$PER$$US-SA-2024SA189917$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240703$$MD$US$US
240470021$24047002$1$I$20240702$20240702$20240702$20240702$DIR$708947$$FDA-CTU$$31$YR$$F$N$76.5$KG$20240702$N$CN$US$
240470031$24047003$1$I$20240301$20240624$20240703$20240703$PER$$US-SA-2024SA193781$SANOFI AVENTIS$$36$YR$A$M$Y$94.8$KG$20240703$$MD$US$US
240470041$24047004$1$I$$20240702$20240703$20240703$PER$$US-HALEON-2185127$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240470051$24047005$1$I$$20240618$20240703$20240703$PER$$US-SA-2024SA190941$SANOFI AVENTIS$$$$$F$Y$$$20240703$$CN$US$US
240470061$24047006$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA190013$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240703$$MD$US$US
240470071$24047007$1$I$$20240702$20240702$20240702$DIR$708932$$FDA-CTU$$$$$UNK$N$$$20240702$N$CN$US$
240470081$24047008$1$I$20240601$20240626$20240703$20240703$PER$$US-SA-2024SA192229$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240703$$CN$US$US
240470101$24047010$1$I$$20240628$20240703$20240703$EXP$$CA-GSK-CA2023111253$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$CA$CA
240470111$24047011$1$I$20240603$20240626$20240703$20240703$EXP$$US-GSK-US2024079875$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$US$US
240470121$24047012$1$I$20240626$20240627$20240703$20240703$PER$$IL-Blueprint Medicines Corporation-SP-IL-2024-001321$BLUEPRINT MEDICINES$$69$YR$E$M$Y$$$20240703$$MD$IL$IL
240470131$24047013$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA190624$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240703$$MD$US$US
240470142$24047014$2$F$20240101$20240708$20240703$20240717$PER$$US-SA-2024SA193553$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240717$$MD$US$US
240470151$24047015$1$I$$20240628$20240703$20240703$PER$$US-SA-2024SA195195$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240703$$CN$US$US
240470161$24047016$1$I$$20240628$20240703$20240703$PER$$US-SA-2024SA195892$SANOFI AVENTIS$$$$E$M$Y$$$20240703$$MD$US$US
240470171$24047017$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA192606$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240703$$CN$US$US
240470182$24047018$2$F$20240101$20240719$20240703$20240724$PER$$US-SA-2024SA194058$SANOFI AVENTIS$$44$YR$A$F$Y$56.699$KG$20240724$$MD$US$US
240470191$24047019$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA189172$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240703$$CN$US$US
240470201$24047020$1$I$20230101$20240624$20240703$20240703$PER$$US-SA-2024SA193320$SANOFI AVENTIS$$$$A$F$Y$$$20240703$$MD$US$US
240470211$24047021$1$I$20240627$20240627$20240703$20240703$PER$$US-SA-2024SA194280$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240703$$MD$US$US
240470221$24047022$1$I$$20240628$20240703$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-105322$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240703$$MD$JP$JP
240470231$24047023$1$I$20230701$20240626$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006837$INCYTE$$$$$$Y$$$20240703$$CN$US$US
240470241$24047024$1$I$$20240626$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006836$INCYTE$$$$$$Y$$$20240703$$CN$US$US
240470251$24047025$1$I$20200101$20240624$20240703$20240703$PER$$US-SA-2024SA188601$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240703$$MD$US$US
240470262$24047026$2$F$20240110$20240909$20240703$20240913$EXP$$IT-INCYTE CORPORATION-2024IN005406$INCYTE$$$$$$Y$$$20240913$$MD$IT$IT
240470273$24047027$3$F$20230901$20240803$20240703$20240808$PER$$US-SA-2023SA338517$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240808$$CN$US$US
240470281$24047028$1$I$20240601$20240625$20240703$20240703$PER$$US-BEH-2024174648$CSL BEHRING$$19$YR$$F$Y$87.982$KG$20240703$$HP$US$US
240470291$24047029$1$I$$20240626$20240703$20240703$PER$$US-BEH-2024174901$CSL BEHRING$$$$$M$Y$$$20240703$$CN$US$US
240470301$24047030$1$I$20240628$20240702$20240703$20240703$EXP$$CN-ROCHE-10000015089$ROCHE$$40$YR$A$M$Y$60$KG$20240703$$HP$CN$CN
240470312$24047031$2$F$$20240704$20240703$20240710$EXP$$TW-009507513-2406TWN010024$MERCK$$50$YR$$M$Y$$$20240710$$MD$TW$TW
240470331$24047033$1$I$$20240627$20240703$20240703$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001333$BLUEPRINT MEDICINES$$$$$M$Y$$$20240703$$CN$US$US
240470341$24047034$1$I$20240108$20240701$20240703$20240703$EXP$FR-AFSSAPS-AM2024000535$NVSC2024FR136581$NOVARTIS$$49$YR$$F$Y$56$KG$20240703$$MD$FR$FR
240470351$24047035$1$I$20240623$20240624$20240703$20240703$PER$$US-SA-2024SA188483$SANOFI AVENTIS$$$$$F$Y$$$20240703$$CN$US$US
240470361$24047036$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137114$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240470371$24047037$1$I$20230101$20240627$20240703$20240703$EXP$$DE-MYLANLABS-2024M1060671$MYLAN$$82$YR$$M$Y$$$20240703$$CN$DE$DE
240470381$24047038$1$I$$20240626$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006846$INCYTE$$$$$$Y$$$20240703$$CN$US$US
240470391$24047039$1$I$$20240628$20240703$20240703$PER$$US-ABBVIE-5825012$ABBVIE$$$$$F$Y$$$20240703$$HP$US$US
240470401$24047040$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5822869$ABBVIE$$10$YR$$M$Y$$$20240703$$HP$US$US
240470412$24047041$2$F$$20240716$20240703$20240723$PER$$US-INCYTE CORPORATION-2024IN006851$INCYTE$$$$$$Y$$$20240723$$CN$US$US
240470421$24047042$1$I$$20240627$20240703$20240703$EXP$$US-KYOWAKIRIN-2024KK015903$KYOWA$$$$$$Y$$$20240703$$HP$US$US
240470431$24047043$1$I$$20240623$20240703$20240703$PER$$US-TEVA-VS-3213679$TEVA$$69$YR$$M$Y$$$20240703$$HP$US$US
240470441$24047044$1$I$20240701$20240701$20240703$20240703$PER$$US-JNJFOC-20240703066$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$HP$US$US
240470452$24047045$2$F$20240618$20240701$20240703$20240705$EXP$$US-BAYER-2024A095105$BAYER$$34$YR$A$M$Y$$$20240705$$CN$US$US
240470462$24047046$2$F$$20240612$20240703$20240704$PER$$NVSC2024US137941$NOVARTIS$$$$$F$Y$$$20240704$$HP$US$US
240470471$24047047$1$I$$20240628$20240703$20240703$PER$$US-ABBVIE-5822502$ABBVIE$$$$E$$Y$$$20240703$$CN$US$US
240470491$24047049$1$I$20240109$20240627$20240703$20240703$EXP$FR-AFSSAPS-AVMA2024000244$FR-MYLANLABS-2024M1060777$MYLAN$$25$YR$$M$Y$$$20240703$$PH$FR$FR
240470501$24047050$1$I$20240629$20240702$20240702$20240702$DIR$708951$$FDA-CTU$$78$YR$$UNK$N$$$20240702$N$HP$US$
240470511$24047051$1$I$20240618$20240702$20240702$20240702$DIR$708904$$FDA-CTU$$23$YR$$F$N$$$20240702$N$PH$US$
240470521$24047052$1$I$20240626$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46499$$FDA-CTU$$60$YR$$F$N$$$20240703$N$HP$US$
240470531$24047053$1$I$20240605$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46477$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240470541$24047054$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46438$$FDA-CTU$$70$YR$$F$N$$$20240703$N$$US$
240470551$24047055$1$I$20240627$20240702$20240702$20240702$DIR$708958$$FDA-CTU$$77$YR$$F$N$79.2$KG$20240702$N$CN$US$
240470561$24047056$1$I$20240403$20240624$20240703$20240703$EXP$FR-AFSSAPS-DJ2024000701$FR-009507513-2406FRA008185$MERCK$$27$YR$$F$Y$41$KG$20240703$$MD$FR$FR
240470571$24047057$1$I$20240626$20240627$20240703$20240703$EXP$$US-GSK-US2024080416$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$CN$US$US
240470582$24047058$2$F$$20240730$20240703$20240806$EXP$$CA-GSK-CA2023096137$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$CA$CA
240470591$24047059$1$I$$20240626$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006863$INCYTE$$$$$$Y$$$20240703$$PH$US$US
240470603$24047060$3$F$20080801$20240829$20240703$20240902$PER$$US-GILEAD-2024-0679352$GILEAD$$62$YR$A$M$Y$$$20240902$$LW$US$US
240470611$24047061$1$I$$20240621$20240703$20240703$EXP$$CA-TEVA-VS-3213107$TEVA$$61$YR$$M$Y$$$20240703$$CN$CA$CA
240470621$24047062$1$I$$20240628$20240703$20240703$EXP$$NVSC2024PT136697$NOVARTIS$$$$$F$Y$$$20240703$$MD$PT$PT
240470651$24047065$1$I$$20240629$20240703$20240703$EXP$$NVSC2024US136553$NOVARTIS$$9$YR$$F$Y$$$20240703$$MD$US$US
240470661$24047066$1$I$$20230828$20240703$20240703$PER$$US-AMGEN-USASP2023235290$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240470671$24047067$1$I$20240517$20240627$20240703$20240703$EXP$FR-AFSSAPS-AN2024000798$FR-BAYER-2024A093252$BAYER$$69$YR$E$F$Y$68$KG$20240703$$PH$FR$FR
240470681$24047068$1$I$$20240216$20240703$20240703$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-01650$HIKMA$$65$YR$$F$Y$$$20240703$$PH$US$US
240470691$24047069$1$I$$20230926$20240703$20240703$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65757$HIKMA$$$$$F$Y$$$20240703$$PH$US$US
240470701$24047070$1$I$$20240524$20240703$20240703$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-04899$HIKMA$$49$YR$$F$Y$$$20240703$$PH$US$US
240470711$24047071$1$I$$20230630$20240703$20240703$PER$$US-HIKMA PHARMACEUTICALS-US-H14001-23-01758$HIKMA$$64$YR$$M$Y$$$20240703$$PH$US$US
240470731$24047073$1$I$20230117$20240627$20240703$20240703$PER$$US-JNJFOC-20240701046$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240703$$PH$US$US
240470741$24047074$1$I$$20240624$20240703$20240703$PER$$US-ROCHE-10000014172$ROCHE$$45$YR$A$F$Y$$$20240703$$CN$US$US
240470751$24047075$1$I$$20240627$20240703$20240703$EXP$$US-AMGEN-USASP2024129481$AMGEN$Lund T. C.; Gupta A. O.; Furcich J. W. et al.. Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy. Journal of neuroimmunology. 2024;393:1-12$8$YR$C$M$Y$$$20240703$$HP$US$US
240470771$24047077$1$I$20240630$20240701$20240703$20240703$EXP$$US-BAYER-2024A095914$BAYER$$74$YR$E$M$Y$95.238$KG$20240703$$CN$US$US
240470781$24047078$1$I$$20240627$20240703$20240703$EXP$$US-AMGEN-USASP2024128111$AMGEN$Rahman O.; Aftab S.; Carroll J. et al.. Acute Respiratory Distress Syndrome From Transfusion Transmitted Babesiosis in a Trauma Patient With Systemic Lupus Erythematosus. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A1144$25$YR$A$F$Y$$$20240703$$HP$US$US
240470791$24047079$1$I$$20240702$20240702$20240702$DIR$708898$$FDA-CTU$$$$$UNK$N$$$20240702$$CN$US$
240470801$24047080$1$I$$20240625$20240703$20240703$EXP$$US-AMGEN-USASP2024126055$AMGEN$Gul M. H.; Taylor  K.; Bailey K. L et.al. An Unexpected Cause of Acute Liver Failure. American journal of respiratory and Critical care Medicine. 2024;209 (1):A1723-A1723$81$YR$E$M$Y$$$20240703$$HP$US$US
240470811$24047081$1$I$$20240624$20240703$20240703$PER$$US-AMGEN-USASP2024128597$AMGEN$Abdelrahim M.; Esmail A.; Divatia M.K. et al.. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. Journal of Clinical Medicine. 2024;13 (11):3068$61$YR$A$M$Y$$$20240703$$HP$US$US
240470821$24047082$1$I$$20240623$20240703$20240703$EXP$$US-AMGEN-USASP2024124270$AMGEN$Wu Y.; Tsai T.; Somers A.. A Rare Pulmonary Manifestation of Erdheim-Chester Disease. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A6391$71$YR$E$M$Y$$$20240703$$HP$US$US
240470831$24047083$1$I$20240526$20240702$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106356$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240703$$CN$US$US
240470841$24047084$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46476$$FDA-CTU$$43$YR$$M$N$$$20240703$N$$US$
240470851$24047085$1$I$20240629$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46523$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240470872$24047087$2$F$20240621$20240826$20240703$20240911$EXP$$US-RADIUS HEALTH, INC.-2024US004664$RADIUS PHARM$$73$YR$$F$Y$$$20240911$$CN$US$US
240470881$24047088$1$I$$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46520$$FDA-CTU$$$$$M$N$$$20240702$N$HP$US$
240470891$24047089$1$I$20240615$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46519$$FDA-CTU$$60$YR$$M$N$$$20240702$N$HP$US$
240470902$24047090$2$F$20240701$20240715$20240703$20240716$PER$$US-JNJFOC-20240701528$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240716$$HP$US$US
240470911$24047091$1$I$$20240627$20240703$20240703$PER$$US-ROCHE-10000013248$ROCHE$$$$$$Y$$$20240703$$PH$US$US
240470921$24047092$1$I$$20240624$20240703$20240703$EXP$$US-MYLANLABS-2024M1058521$MYLAN$$$$$M$Y$$$20240703$$CN$US$US
240470931$24047093$1$I$$20240619$20240703$20240703$EXP$$US-CIDARA THERAPEUTICS, INC-2024-RZ-0023-US$CIDARA THERAPEUTICS$$$$A$M$Y$$$20240703$$MD$US$US
240470941$24047094$1$I$20240612$20240627$20240703$20240703$EXP$$CN-ALCON LABORATORIES-ALC2024CN003172$ALCON$$49$YR$$M$Y$61$KG$20240703$$HP$CN$CN
240470952$24047095$2$F$$20240918$20240703$20240923$PER$$US-PFIZER INC-202400205163$PFIZER$$63$YR$$F$Y$76.1$KG$20240923$$PH$US$US
240470961$24047096$1$I$20240301$20240617$20240703$20240703$PER$$US-PFIZER INC-202400195953$PFIZER$$68$YR$$F$Y$98.8$KG$20240703$$CN$US$US
240470972$24047097$2$F$$20240730$20240703$20240802$PER$$US-PFIZER INC-202400204399$PFIZER$$65$YR$$F$Y$$$20240802$$PH$US$US
240470981$24047098$1$I$$20240703$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106444$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240703$$HP$US$US
240470992$24047099$2$F$20240101$20240820$20240703$20240823$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-104189$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240823$$MD$FR$FR
240471001$24047100$1$I$$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106303$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240703$$CN$US$US
240471011$24047101$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5822858$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240471031$24047103$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46501$$FDA-CTU$$71$YR$$F$N$66.68$KG$20240703$N$$US$
240471041$24047104$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46485$$FDA-CTU$$52$YR$$$N$$$20240703$N$CN$US$
240471061$24047106$1$I$$20240702$20240702$20240702$DIR$708942$$FDA-CTU$$$$$UNK$N$$$20240702$$CN$US$
240471071$24047107$1$I$20240524$20240702$20240702$20240702$DIR$708937$$FDA-CTU$$67$YR$$F$N$$$20240702$N$CN$US$
240471081$24047108$1$I$20240618$20240702$20240702$20240702$DIR$708936$$FDA-CTU$$68$YR$$F$N$87.75$KG$20240702$Y$CN$US$
240471091$24047109$1$I$20240502$20240702$20240702$20240702$DIR$708921$$FDA-CTU$$84$YR$$F$N$84.8$KG$20240702$N$PH$US$
240471101$24047110$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA193472$SANOFI AVENTIS$$15$YR$T$M$Y$45.7$KG$20240703$$MD$US$US
240471111$24047111$1$I$$20240621$20240703$20240703$PER$$US-SA-2024SA189186$SANOFI AVENTIS$$$$A$M$Y$75.737$KG$20240703$$MD$US$US
240471123$24047112$3$F$20240610$20240904$20240703$20240925$PER$$US-SA-2024SA189487$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240925$$MD$US$US
240471131$24047113$1$I$$20240621$20240703$20240703$PER$$US-SA-2024SA189016$SANOFI AVENTIS$$$$E$M$Y$79.832$KG$20240703$$MD$US$US
240471141$24047114$1$I$$20240628$20240703$20240703$PER$$US-ABBVIE-5823795$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240471151$24047115$1$I$20240618$20240701$20240703$20240703$EXP$$CN-ROCHE-10000013830$ROCHE$$10$YR$C$F$Y$49$KG$20240703$$HP$CN$CN
240471161$24047116$1$I$$20240624$20240703$20240703$EXP$$US-RDY-LIT/USA/24/0009440$DR REDDYS$Okura M, Sheikhan N, Thind GS. First Case of Elizabethkingia Lung Infection Strikes Central Valley California. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6009.$24$YR$A$F$Y$$$20240703$$HP$US$US
240471171$24047117$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137702$NOVARTIS$$$$$M$Y$$$20240703$$CN$US$US
240471181$24047118$1$I$$20240628$20240703$20240703$PER$$US-HALEON-2184825$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240471193$24047119$3$F$$20240917$20240703$20240924$EXP$$US-BAYER-2024A093772$BAYER$$62$YR$A$M$Y$$$20240924$$CN$US$US
240471201$24047120$1$I$20240517$20240702$20240702$20240702$DIR$708916$$FDA-CTU$$89$YR$$F$N$50.4$KG$20240702$N$CN$US$
240471221$24047122$1$I$$20230905$20240703$20240703$PER$$US-AMGEN-USASP2023235256$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240471231$24047123$1$I$20240702$20240702$20240702$20240702$DIR$708957$$FDA-CTU$$28$YR$$F$N$$$20240702$N$CN$US$
240471241$24047124$1$I$$20240702$20240702$20240702$DIR$708899$$FDA-CTU$$20$YR$$F$N$$$20240702$N$PH$US$
240471255$24047125$5$F$20231101$20240917$20240703$20240924$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2023CUR004827$CURRAX PHARMACEUTICALS$$57$YR$$F$Y$$$20240924$$CN$CA$CA
240471261$24047126$1$I$20230509$20240702$20240702$20240702$DIR$708901$$FDA-CTU$$74$YR$$F$N$56.25$KG$20240702$N$CN$US$
240471271$24047127$1$I$20240609$20240702$20240702$20240702$DIR$708944$$FDA-CTU$$93$YR$$F$N$$$20240702$N$CN$US$
240471281$24047128$1$I$20240627$20240628$20240703$20240703$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0600018$MYOVANT SCIENCES$$83$YR$$M$Y$$$20240703$$CN$US$US
240471311$24047131$1$I$20240501$20240702$20240703$20240703$PER$$US-BAYER-2024A095620$BAYER$$95$YR$E$M$Y$$$20240703$$CN$US$US
240471321$24047132$1$I$20240703$20240703$20240703$20240703$EXP$GB-MHRA-MED-202407030833047240-QRVZH$GB-MYLANLABS-2024M1062299$MYLAN$$55$YR$$M$Y$80$KG$20240703$$MD$GB$GB
240471331$24047133$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205654$PFIZER$$$$$$Y$$$20240703$$MD$US$US
240471341$24047134$1$I$$20240701$20240703$20240703$PER$$US-PFIZER INC-202400204674$PFIZER$$$$$F$Y$$$20240703$$CN$US$US
240471351$24047135$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205397$PFIZER$$64$YR$$F$Y$$$20240703$$MD$US$US
240471362$24047136$2$F$$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205652$PFIZER$$$$$$Y$$$20240703$$MD$US$US
240471373$24047137$3$F$20240601$20240823$20240703$20240827$EXP$$US-PFIZER INC-202400205262$PFIZER$$81$YR$$F$Y$52.16$KG$20240827$$CN$US$US
240471381$24047138$1$I$$20240702$20240703$20240703$PER$$US-PFIZER INC-202400205655$PFIZER$$$$$$Y$$$20240703$$MD$US$US
240471393$24047139$3$F$20240101$20240814$20240703$20240819$PER$$US-PFIZER INC-202400205380$PFIZER$$70$YR$$F$Y$89.36$KG$20240819$$CN$US$US
240471401$24047140$1$I$20240601$20240701$20240703$20240703$PER$$US-PFIZER INC-202400205138$PFIZER$$$$$$Y$$$20240703$$HP$US$US
240471411$24047141$1$I$20240627$20240628$20240703$20240703$EXP$$AU-SA-2024SA193930$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240703$$MD$AU$AU
240471421$24047142$1$I$$20240624$20240703$20240703$PER$$US-ROCHE-10000013208$ROCHE$$71$YR$E$F$Y$$$20240703$$CN$US$US
240471441$24047144$1$I$20240601$20240702$20240703$20240703$PER$$US-BAYER-2024A095655$BAYER$$54$YR$A$F$Y$$$20240703$$MD$US$US
240471451$24047145$1$I$$20230916$20240703$20240703$PER$$US-AMGEN-USASP2023235230$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240471461$24047146$1$I$$20240702$20240703$20240703$PER$$US-HALEON-2185085$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240471471$24047147$1$I$$20240617$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006471$INCYTE$$$$$$Y$$$20240703$$CN$US$US
240471481$24047148$1$I$20240623$20240625$20240703$20240703$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-12894$IPSEN$$43$YR$A$M$Y$84.5$KG$20240703$$CN$US$US
240471491$24047149$1$I$$20240625$20240703$20240703$PER$$US-ROCHE-10000012788$ROCHE$$$$N$M$Y$$$20240703$$CN$US$US
240471501$24047150$1$I$20220615$20240628$20240703$20240703$EXP$$JP-BAYER-2024A070787$BAYER$$84$YR$E$M$Y$$$20240703$$MD$JP$JP
240471511$24047151$1$I$$20240702$20240703$20240703$PER$$NVSC2024US137872$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240471521$24047152$1$I$$20240701$20240703$20240703$PER$$NVSC2024US137525$NOVARTIS$$$$$M$Y$$$20240703$$HP$US$US
240471531$24047153$1$I$20240601$20240702$20240703$20240703$EXP$$NVSC2024RO138016$NOVARTIS$$$$E$M$Y$$$20240703$$MD$RO$RO
240471541$24047154$1$I$$20240618$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006523$INCYTE$$$$$$Y$$$20240703$$CN$US$US
240471552$24047155$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3214063$TEVA$Keegan K, Ruff K, Burg G, Berklite LE, Deutsch G, Wikenheiser-Brokamp KA, et al. Surfactant Function Disorders: Genetics Is Just the Tip of the Iceberg. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).; Keegan K, Ruff K, Burg G, Berklite LE, Deutsch G, Wikenheiser-Brokamp KA, et al. Surfactant Function Disorders: Genetics Is Just the Tip of the Iceberg. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$3$YR$$F$Y$$$20240717$$HP$US$US
240471561$24047156$1$I$$20240702$20240703$20240703$EXP$$DE-ABBVIE-5823000$ABBVIE$$55$YR$$F$Y$$$20240703$$MD$DE$DE
240471571$24047157$1$I$20240624$20240701$20240703$20240703$PER$$US-JNJFOC-20240702316$JOHNSON AND JOHNSON$$37$YR$A$M$Y$93.07$KG$20240703$$HP$US$US
240471582$24047158$2$F$20240617$20240903$20240703$20240905$PER$$US-BAYER-2024A094024$BAYER$$45$YR$A$F$Y$$$20240905$$MD$US$US
240471591$24047159$1$I$$20240624$20240703$20240703$EXP$$JP-ABBVIE-5815170$ABBVIE$$59$YR$$F$Y$$$20240703$$MD$JP$JP
240471601$24047160$1$I$$20240626$20240703$20240703$PER$$US-ROCHE-10000014620$ROCHE$$$$A$M$Y$$$20240703$$CN$US$US
240471611$24047161$1$I$20240531$20240605$20240703$20240703$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000445$PAREXEL$$$$$$Y$$$20240703$$PH$US$US
240471622$24047162$2$F$20230101$20240821$20240703$20240906$EXP$$NL-ABBVIE-5511283$ABBVIE$$$$E$M$Y$$$20240906$$CN$NL$NL
240471632$24047163$2$F$$20240916$20240703$20240918$30DAY$$CO-PFIZER INC-202400204206$PFIZER$$9$YR$$F$Y$$$20240918$$CN$CO$CO
240471641$24047164$1$I$$20240628$20240703$20240703$EXP$$US-AstraZeneca-2024A149848$ASTRAZENECA$$$$$M$Y$$$20240703$$CN$US$
240471651$24047165$1$I$$20240624$20240703$20240703$EXP$$CN-BEIGENE-BGN-2024-009722$BEIGENE$Wang WH, Chen H, Ju WD, Yang WH, Ding GM, Wang L. A rare case of Richter transformation with breast involvement: A case report and literature review. Open Life Sci. 2024;19(1):20220889$$$$$Y$$$20240703$$MD$CN$CN
240471661$24047166$1$I$$20240628$20240703$20240703$EXP$$US-AstraZeneca-2024A149772$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240471671$24047167$1$I$$20240624$20240703$20240703$EXP$$US-MYLANLABS-2024M1058461$MYLAN$$$$$F$Y$$$20240703$$CN$US$US
240471682$24047168$2$F$20240101$20240905$20240703$20240918$EXP$$US-UCBSA-2024025222$UCB$$$$$M$Y$35.4$KG$20240918$$CN$US$US
240471692$24047169$2$F$20230307$20240801$20240703$20240809$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003712$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240809$$MD$JP$JP
240471702$24047170$2$F$$20240703$20240703$20240710$PER$$US-ROCHE-10000014827$ROCHE$$22$YR$A$F$Y$$$20240710$$CN$US$US
240471711$24047171$1$I$$20240626$20240703$20240703$PER$$US-ROCHE-10000014744$ROCHE$$$$$$Y$$$20240703$$HP$US$US
240471722$24047172$2$F$$20240719$20240703$20240731$30DAY$$GB-JNJFOC-20240640311$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$GB$GB
240471732$24047173$2$F$20240601$20240708$20240703$20240710$PER$$US-BAUSCH-BL-2024-010111$BAUSCH AND LOMB$$38$YR$$F$Y$$$20240710$$CN$US$US
240471741$24047174$1$I$$20240702$20240702$20240702$DIR$708878$$FDA-CTU$$$$$UNK$N$$$20240702$$CN$US$
240471761$24047176$1$I$20230711$20240702$20240702$20240702$DIR$708892$$FDA-CTU$$34$YR$$F$N$99$KG$20240702$N$CN$US$
240471771$24047177$1$I$20240702$20240702$20240702$20240702$DIR$708927$$FDA-CTU$$78$YR$$F$N$$$20240702$N$$US$
240471781$24047178$1$I$$20240625$20240703$20240703$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004747$BIOCON$$$$$$Y$$$20240703$$HP$CA$CA
240471791$24047179$1$I$$20240702$20240702$20240702$DIR$708926$$FDA-CTU$$$$$UNK$N$$$20240702$N$CN$US$
240471801$24047180$1$I$$20240624$20240703$20240703$EXP$$US-MYLANLABS-2024M1058491$MYLAN$$$$$$Y$$$20240703$$CN$US$US
240471811$24047181$1$I$$20240627$20240703$20240703$EXP$$US-MYLANLABS-2024M1061150$MYLAN$$38$YR$$F$Y$$$20240703$$HP$US$US
240471821$24047182$1$I$20240701$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130552$AMGEN$$65$YR$E$M$Y$$$20240703$$CN$US$US
240471831$24047183$1$I$$20240620$20240703$20240703$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091829$GLENMARK$Pitter D, Hanley S, Eisa H, Nene Y, Zhou X.. Unexpected Seizure Activity in the Setting of Lamotrigine Toxicity.. Cureus. 2024;16(5):e60094$$$$$Y$$$20240703$$MD$US$US
240471841$24047184$1$I$$20240625$20240703$20240703$PER$$US-AMGEN-USASP2024130046$AMGEN$$$$A$M$Y$$$20240703$$CN$US$US
240471852$24047185$2$F$$20240907$20240703$20240918$PER$$US-INCYTE CORPORATION-2024IN006901$INCYTE$$$$$$Y$$$20240918$$CN$US$US
240471862$24047186$2$F$$20240715$20240703$20240717$PER$$US-ROCHE-10000015027$ROCHE$$$$A$M$Y$$$20240717$$CN$US$US
240471881$24047188$1$I$$20240626$20240703$20240703$PER$$US-ROCHE-10000014953$ROCHE$$$$E$F$Y$$$20240703$$CN$US$US
240471892$24047189$2$F$$20240724$20240703$20240731$EXP$$US-Calliditas-2024CAL01187$CALLIDITAS THERAPEUTICS$$40$YR$A$F$Y$$$20240731$$CN$US$US
240471901$24047190$1$I$20230101$20240626$20240703$20240703$EXP$$US-ABBVIE-5821400$ABBVIE$$53$YR$$F$Y$$$20240703$$CN$US$US
240471911$24047191$1$I$$20240626$20240703$20240703$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024079794$VIIV$$$$$$Y$$$20240703$$HP$US$US
240471921$24047192$1$I$20240618$20240628$20240703$20240703$EXP$$US-ABBVIE-5822295$ABBVIE$$83$YR$$M$Y$100$KG$20240703$$CN$US$US
240471931$24047193$1$I$20240101$20240628$20240703$20240703$EXP$$US-ABBVIE-5787289$ABBVIE$$$$$F$Y$84$KG$20240703$$CN$US$US
240471941$24047194$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105994$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240703$$HP$US$US
240471961$24047196$1$I$20240601$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106262$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$111.13$KG$20240703$$CN$US$US
240471971$24047197$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106249$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240703$$CN$US$US
240471982$24047198$2$F$$20240829$20240703$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105748$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240902$$CN$US$US
240471991$24047199$1$I$20240701$20240702$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106144$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240703$$PH$US$US
240472002$24047200$2$F$20190101$20240905$20240703$20240911$EXP$$US-ABBVIE-5821967$ABBVIE$$$$$F$Y$72.5$KG$20240911$$CN$US$US
240472021$24047202$1$I$$20231123$20240703$20240703$PER$$US-AMGEN-USASP2023235217$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240472031$24047203$1$I$20240619$20240625$20240703$20240703$EXP$$US-OTSUKA-2024_018112$OTSUKA$$64$YR$$F$Y$79.38$KG$20240703$$CN$US$US
240472041$24047204$1$I$$20231220$20240703$20240703$PER$$US-AMGEN-USASP2023235374$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240472051$24047205$1$I$$20240115$20240703$20240703$PER$$US-AMGEN-USASP2024130985$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240472061$24047206$1$I$20240627$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024130021$AMGEN$$63$YR$A$M$Y$$$20240703$$CN$US$US
240472071$24047207$1$I$$20240116$20240703$20240703$PER$$US-AMGEN-USASP2024129898$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240472081$24047208$1$I$20240301$20240626$20240703$20240703$EXP$$ZA-AMGEN-ZAFSL2024127939$AMGEN$$60$YR$A$F$Y$$$20240703$$CN$ZA$ZA
240472101$24047210$1$I$$20240621$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105925$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240703$$HP$US$US
240472112$24047211$2$F$$20240628$20240703$20240705$EXP$$BE-ABBVIE-5823356$ABBVIE$$$$A$M$Y$$$20240705$$CN$BE$BE
240472121$24047212$1$I$$20240703$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106408$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240703$$HP$US$US
240472131$24047213$1$I$20240101$20240626$20240703$20240703$EXP$$CA-ABBVIE-5751872$ABBVIE$$60$YR$$F$Y$$$20240703$$CN$CA$CA
240472141$24047214$1$I$$20240625$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158850$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240472151$24047215$1$I$20230524$20240701$20240703$20240703$EXP$$DE-ABBVIE-5823908$ABBVIE$$76$YR$$F$Y$62$KG$20240703$$CN$DE$DE
240472161$24047216$1$I$20240507$20240625$20240703$20240703$PER$$CN-Eisai-EC-2024-169440$EISAI$$54$YR$A$M$Y$61.5$KG$20240703$$HP$CN$CN
240472172$24047217$2$F$$20230724$20240703$20240704$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-63857$HIKMA$$$$$$Y$$$20240704$$HP$US$US
240472182$24047218$2$F$$20230817$20240703$20240704$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64575$HIKMA$$$$$$Y$$$20240704$$$US$US
240472192$24047219$2$F$$20230803$20240703$20240704$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64123$HIKMA$$$$$$Y$$$20240704$$MD$US$US
240472202$24047220$2$F$20120921$20230911$20240703$20240704$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65316$HIKMA$$58$YR$$F$Y$$$20240704$$MD$US$US
240472212$24047221$2$F$$20230615$20240703$20240704$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-02206$HIKMA$$$$$M$Y$$$20240704$$CN$US$US
240472221$24047222$1$I$$20240624$20240703$20240703$EXP$$JP-TEVA-VS-3214347$TEVA$Kadokawa Y, Inoue S, Tatsumi A, Uchida M, Fujita K, Takagi M, et al. Efficacy and safety of mycophenolate mofetil in treating immune-related hepatitis induced by immune checkpoint inhibitor use: A retrospective study. JGH-Open 2023; 7 (2): 87-97.$72$YR$$M$Y$$$20240703$$HP$JP$JP
240472231$24047223$1$I$$20231120$20240703$20240703$PER$$US-AMGEN-USASP2023235242$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240472241$24047224$1$I$$20240628$20240703$20240703$PER$$US-ABBVIE-5824040$ABBVIE$$$$$$Y$$$20240703$$HP$US$US
240472251$24047225$1$I$$20240701$20240703$20240703$EXP$$US-KYOWAKIRIN-2024KK015956$KYOWA$$$$$$Y$$$20240703$$MD$US$US
240472262$24047226$2$F$$20240708$20240703$20240722$EXP$$US-TEVA-VS-3214404$TEVA$Zeineddine MA, Kuzmishin GB, Ackerman A, Garrow A. Daptomycin-Induced Eosinophilic Pneumonia (DIEP). Am-J-Respir-Crit-Care-Med 2024; 209 A2023 abstr. A52.; Zeineddine MA, Kuzmishin GB, Ackerman A, Garrow A. Daptomycin-Induced Eosinophilic Pneumonia (DIEP). Am-J-Respir-Crit-Care-Med 2024; 209 A2023 abstr. A52.$60$YR$$M$Y$$$20240722$$HP$US$US
240472271$24047227$1$I$$20240624$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406016377$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240703$$CN$US$US
240472281$24047228$1$I$20240621$20240621$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015599$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240703$$CN$US$US
240472291$24047229$1$I$$20240619$20240703$20240703$EXP$$JP-GRANULES-JP-2024GRALIT00249$GRANULES INDIA$Hiramatsu Y.Hypothermia, bradycardia and hypotension during glucocorticoid or cyclosporine A therapy in a boy with Kikuchi-Fujimoto disease.Modern Rheumatology Case Reports : no pagination.MAY-2024$$$$M$Y$$$20240703$$HP$JP$JP
240472301$24047230$1$I$20220101$20240624$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406016255$ELI LILLY AND CO$$92$YR$E$F$Y$$$20240703$$CN$US$US
240472311$24047231$1$I$20220101$20240624$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406016984$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240703$$CN$US$US
240472322$24047232$2$F$20230301$20240626$20240703$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015371$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240708$$CN$US$US
240472331$24047233$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46483$$FDA-CTU$$88$YR$$F$N$$$20240703$N$$US$
240472341$24047234$1$I$20240501$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46484$$FDA-CTU$$52$YR$$F$N$$$20240702$N$HP$US$
240472371$24047237$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46493$$FDA-CTU$$70$YR$$F$N$162$LBS$20240703$N$$US$
240472381$24047238$1$I$20240610$20240702$20240702$20240702$DIR$708907$$FDA-CTU$$69$YR$$M$N$114.3$KG$20240702$N$CN$US$
240472391$24047239$1$I$$20240625$20240703$20240703$EXP$$MX-AstraZeneca-2024A148768$ASTRAZENECA$$$$T$M$Y$$$20240703$$MD$MX$
240472401$24047240$1$I$20240101$20240628$20240703$20240703$EXP$$US-SA-2024SA042505$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240703$$MD$US$US
240472411$24047241$1$I$$20240528$20240703$20240703$EXP$$JP-AstraZeneca-2024A110185$ASTRAZENECA$Saito W.. [O -1038] A case report of CRRT with suspected circuit clotting due to andexanet alfa administration and a study of its relationship. The 69th Annual Meeting of the Japanese Society for Dialysis Theapy 2024;$50$YR$$M$Y$$$20240703$$MD$JP$
240472421$24047242$1$I$20230601$20240624$20240703$20240703$EXP$$JP-AstraZeneca-2024A148584$ASTRAZENECA$Aihara R., Umemura K., Katada Y., Nakagawa S., Kobayashi T., Hatano E., Date H., Nagao M., Terada T.. Investigation of severe acute respiratory syndrome coronavirus 2 infection status in solid organ transplant recipients treated with tixagevimab/cilgavimab. Journal of Infection and Chemotherapy 2024;$55$YR$$F$Y$$$20240703$$HP$JP$
240472431$24047243$1$I$20230501$20240624$20240703$20240703$EXP$$JP-AstraZeneca-2024A149540$ASTRAZENECA$Aihara R., Umemura K., Katada Y., Nakagawa S., Kobayashi T., Hatano E., Date H., Nagao M., Terada T.. Investigation of severe acute respiratory syndrome coronavirus 2 infection status in solid organ transplant recipients treated with tixagevimab/cilgavimab. Journal of Infection and Chemotherapy 2024;$27$YR$$M$Y$$$20240703$$HP$JP$
240472451$24047245$1$I$20230701$20240624$20240703$20240703$EXP$$JP-AstraZeneca-2024A149549$ASTRAZENECA$Aihara R., Umemura K., Katada Y., Nakagawa S., Kobayashi T., Hatano E., Date H., Nagao M., Terada T.. Investigation of severe acute respiratory syndrome coronavirus 2 infection status in solid organ transplant recipients treated with tixagevimab/cilgavimab. Journal of Infection and Chemotherapy 2024;$44$YR$$F$Y$$$20240703$$HP$JP$
240472462$24047246$2$F$20240101$20240717$20240703$20240726$PER$$US-SA-2024SA192018$SANOFI AVENTIS$$84$YR$E$F$Y$67$KG$20240726$$MD$US$US
240472471$24047247$1$I$$20240621$20240703$20240703$PER$$US-SA-2024SA188949$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240703$$MD$US$US
240472481$24047248$1$I$$20240621$20240703$20240703$EXP$$CA-TEVA-VS-3213140$TEVA$$57$YR$$F$Y$$$20240703$$HP$CA$CA
240472491$24047249$1$I$20240630$20240701$20240703$20240703$PER$$US-BAYER-2024A095113$BAYER$$63$YR$A$M$Y$$$20240703$$CN$US$US
240472501$24047250$1$I$$20240628$20240703$20240703$EXP$$AR-PERRIGO-24AR006178$PERRIGO$Cervantes JG, Gasque RA, Lenz ME, Barbero M, Navarro L, Roca I, et al. Liver transplantation as treatment for acetaminophen poisoning. Medicina. 2024;84(3):588-91.$28$YR$$F$Y$$$20240703$$MD$AR$AR
240472511$24047251$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138098$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240472522$24047252$2$F$20240701$20240717$20240703$20240722$PER$$US-AMGEN-USASP2024130892$AMGEN$$69$YR$E$M$Y$$$20240722$$CN$US$US
240472531$24047253$1$I$20240513$20240627$20240703$20240703$EXP$FR-AFSSAPS-MA2024001032$FR-MYLANLABS-2024M1060498$MYLAN$$12$YR$$M$Y$$$20240703$$MD$FR$FR
240472541$24047254$1$I$20140101$20240701$20240703$20240703$EXP$$GB-TEVA-VS-3215846$TEVA$$$$A$M$Y$73$KG$20240703$$CN$GB$GB
240472551$24047255$1$I$20240401$20240607$20240703$20240703$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00631$BIOCRYST PHARMACEUTICALS$$$$$M$Y$$$20240703$$MD$US$US
240472561$24047256$1$I$20240605$20240628$20240703$20240703$EXP$$PL-JNJFOC-20240707471$JOHNSON AND JOHNSON$$75$YR$E$F$Y$105$KG$20240703$$HP$PL$PL
240472571$24047257$1$I$$20240609$20240703$20240703$PER$$US-JNJFOC-20240626061$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$CN$US$US
240472581$24047258$1$I$$20240701$20240703$20240703$PER$$US-JNJFOC-20240702269$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$MD$US$US
240472591$24047259$1$I$20240415$20240702$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106323$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240703$$HP$US$US
240472601$24047260$1$I$$20240701$20240703$20240703$PER$$US-JNJFOC-20240704681$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$MD$US$US
240472611$24047261$1$I$20210801$20240628$20240703$20240703$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-106256$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240703$$MD$DE$DE
240472621$24047262$1$I$$20240619$20240703$20240703$EXP$$DE-GRANULES-DE-2024GRALIT00246$GRANULES INDIA$Klara Kristin Bruning.Acute kidney injury in lamotrigine-induced DRESS syndrome.Pediatric Nephrology.01-MAY-2024;1-3$17$YR$T$F$Y$$$20240703$$HP$DE$DE
240472631$24047263$1$I$20240620$20240701$20240703$20240703$PER$$US-PFIZER INC-202400204560$PFIZER$$69$YR$$F$Y$68.04$KG$20240703$$CN$US$US
240472642$24047264$2$F$$20240801$20240703$20240806$PER$$US-PFIZER INC-202400204574$PFIZER$$87$YR$$M$Y$78.93$KG$20240806$$PH$US$US
240472651$24047265$1$I$20240630$20240630$20240703$20240703$PER$$US-PFIZER INC-202400204314$PFIZER$$70$YR$$M$Y$$$20240703$$CN$US$US
240472661$24047266$1$I$20240628$20240628$20240703$20240703$PER$$US-PFIZER INC-202400204290$PFIZER$$50$YR$$M$Y$$$20240703$$CN$US$US
240472671$24047267$1$I$$20240702$20240702$20240702$DIR$708924$$FDA-CTU$$$$$UNK$N$$$20240702$$CN$US$
240472681$24047268$1$I$20240630$20240702$20240702$20240702$DIR$708935$$FDA-CTU$$69$YR$$F$N$52.2$KG$20240702$N$HP$US$
240472691$24047269$1$I$20240101$20240701$20240703$20240703$PER$$US-PFIZER INC-202400204429$PFIZER$$82$YR$$M$Y$$$20240703$$CN$US$US
240472701$24047270$1$I$20240101$20240701$20240703$20240703$PER$$US-PFIZER INC-202400205356$PFIZER$$61$YR$$F$Y$$$20240703$$HP$US$US
240472721$24047272$1$I$20240619$20240627$20240703$20240703$EXP$FR-AFSSAPS-TO2024001184$FR-RDY-SPO/FRA/24/0009363$DR REDDYS$$33$YR$A$F$Y$51$KG$20240703$$MD$FR$FR
240472732$24047273$2$F$20240601$20240731$20240703$20240807$EXP$$US-AMERICAN REGENT INC-2024002526$AMERICAN REGENT$$17$YR$$$Y$$$20240807$$PH$US$US
240472741$24047274$1$I$$20240626$20240703$20240703$PER$$US-BAYER-2024A092543$BAYER$$38$YR$A$F$Y$$$20240703$$HP$US$US
240472751$24047275$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024034126$EMD SERONO INC$$39$YR$A$F$Y$$$20240703$$CN$US$US
240472802$24047280$2$F$$20240124$20240703$20240916$PER$$US-HALEON-2185108$Haleon PLC$$$$$$Y$$$20240916$$CN$US$US
240472811$24047281$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024034130$EMD SERONO INC$$38$YR$A$F$Y$$$20240703$$CN$US$US
240472821$24047282$1$I$20231219$20240702$20240702$20240702$DIR$708890$$FDA-CTU$$12$YR$$F$N$72$KG$20240702$N$MD$US$
240472831$24047283$1$I$$20240702$20240702$20240702$DIR$708910$$FDA-CTU$$$$$UNK$N$$$20240702$$CN$US$
240472851$24047285$1$I$$20240703$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106445$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240703$$HP$US$US
240472861$24047286$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46533$$FDA-CTU$$$$$M$N$$$20240703$N$HP$US$
240472871$24047287$1$I$$20240627$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103509$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$47$KG$20240703$$PH$US$US
240472881$24047288$1$I$20211201$20240626$20240703$20240703$PER$$US-BAYER-2024A092609$BAYER$$30$YR$A$F$Y$$$20240703$$HP$US$US
240472892$24047289$2$F$20240101$20240724$20240703$20240802$PER$$US-SA-2024SA192431$SANOFI AVENTIS$$79$YR$E$F$Y$90.7$KG$20240802$$MD$US$US
240472901$24047290$1$I$$20240702$20240702$20240702$DIR$708893$$FDA-CTU$$69$YR$$F$N$$$20240702$N$PH$US$
240472922$24047292$2$F$$20240712$20240703$20240716$EXP$$US-BIOMARINAP-US-2024-158863$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240472931$24047293$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA192246$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240703$$MD$US$US
240472943$24047294$3$F$$20240906$20240703$20240910$EXP$$NVSC2024HU136772$NOVARTIS$$49$YR$$F$Y$$$20240910$$MD$HU$HU
240472951$24047295$1$I$20240701$20240701$20240703$20240703$PER$$NVSC2024US137618$NOVARTIS$$63$YR$$F$Y$$$20240703$$CN$US$US
240472962$24047296$2$F$$20240806$20240703$20240809$EXP$$US-TAKEDA-2024TUS064780$TAKEDA$$$$$M$Y$$$20240809$$CN$US$US
240472971$24047297$1$I$$20240702$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062397$SANDOZ$$$$$$Y$$$20240703$$CN$US$US
240472981$24047298$1$I$$20240618$20240703$20240703$EXP$$CH-SANDOZ INC.-SDZ2024CH061942$SANDOZ$Kolev M, Sarbu A-C, Moller B, Maurer B, Kollert F, Semmo N. Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis - a case series. JOURNAL OF TRANSLATIONAL AUTOIMMUNITY. 2023;6:1-8. doi:10.1016/j.jtauto.2023.100189$37$YR$$M$Y$$$20240703$$HP$CH$CH
240472991$24047299$1$I$$20240702$20240703$20240703$EXP$$GB-SANDOZ INC.-SDZ2024GB062413$SANDOZ$$65$YR$$F$Y$88$KG$20240703$$PH$GB$GB
240473001$24047300$1$I$20240611$20240702$20240703$20240703$EXP$FR-AFSSAPS-AN2024000845$FR-SANDOZ INC.-SDZ2024FR062149$SANDOZ$$73$YR$$M$Y$$$20240703$$MD$FR$FR
240473012$24047301$2$F$$20240710$20240703$20240715$EXP$$DE-SANDOZ INC.-SDZ2024DE058863$SANDOZ$$$$E$M$Y$70$KG$20240715$$CN$DE$DE
240473031$24047303$1$I$20230823$20240702$20240702$20240702$DIR$708864$$FDA-CTU$$42$YR$$UNK$N$$$20240702$N$$US$
240473041$24047304$1$I$20240618$20240702$20240702$20240702$DIR$708902$$FDA-CTU$$87$YR$$F$N$81.3$KG$20240702$N$PH$US$
240473051$24047305$1$I$$20240702$20240702$20240702$DIR$708922$$FDA-CTU$$$$$UNK$N$$$20240702$$CN$US$
240473061$24047306$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46502$$FDA-CTU$$66$YR$$M$N$$$20240703$N$HP$US$
240473071$24047307$1$I$20240314$20240702$20240702$20240702$DIR$708928$$FDA-CTU$$39$YR$$F$N$63$KG$20240702$N$CN$US$
240473081$24047308$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46506$$FDA-CTU$$45$YR$$F$N$199$LBS$20240703$N$$US$
240473091$24047309$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46516$$FDA-CTU$$59$YR$$F$N$$$20240703$N$$US$
240473101$24047310$1$I$20240623$20240702$20240702$20240702$DIR$708863$$FDA-CTU$$35$YR$$F$N$130.05$KG$20240702$N$CN$US$
240473111$24047311$1$I$$20240702$20240702$20240702$DIR$708911$$FDA-CTU$$$$$UNK$N$$$20240702$$CN$US$
240473121$24047312$1$I$20240702$20240702$20240702$20240702$DIR$708903$$FDA-CTU$$69$YR$$F$N$108$KG$20240702$N$HP$US$
240473141$24047314$1$I$20240215$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46525$$FDA-CTU$$73$YR$$M$N$265$LBS$20240703$Y$CN$US$
240473171$24047317$1$I$20240615$20240627$20240703$20240703$EXP$$BR-TAKEDA-2024TUS066972$TAKEDA$$$$$F$Y$$$20240703$$CN$BR$BR
240473181$24047318$1$I$20240521$20240626$20240703$20240703$PER$$US-BAYER-2024A092744$BAYER$$37$YR$A$F$Y$$$20240703$$HP$US$US
240473191$24047319$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024034132$EMD SERONO INC$$36$YR$A$F$Y$$$20240703$$HP$US$US
240473202$24047320$2$F$20240601$20240731$20240703$20240802$EXP$$US-AMERICAN REGENT INC-2024002527$AMERICAN REGENT$$14$YR$$$Y$$$20240802$$PH$US$US
240473211$24047321$1$I$20240701$20240701$20240703$20240703$EXP$$US-TAKEDA-2024TUS056210$TAKEDA$$71$YR$$F$Y$$$20240703$$CN$US$US
240473221$24047322$1$I$$20240222$20240703$20240703$PER$$US-AMGEN-USASP2024129888$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240473231$24047323$1$I$$20240620$20240703$20240703$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091833$GLENMARK$Vallabhajosyula S, Ukrani H, Wersinger D, Malik H, Obaji A.. Fighting the Recovering Heart While Drowning in Volume: Role of VA-V ECMO Configuration in Migrating Mixing Cloud Effect.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A5582$$$$$Y$$$20240703$$MD$US$US
240473242$24047324$2$F$20240101$20240913$20240703$20240917$EXP$$US-PFIZER INC-PV202400057766$PFIZER$$22$YR$$M$Y$$$20240917$$HP$US$US
240473251$24047325$1$I$$20240701$20240703$20240703$EXP$$IN-PFIZER INC-PV202400087047$PFIZER$$$$$F$Y$$$20240703$$MD$IN$IN
240473261$24047326$1$I$20210101$20240619$20240703$20240703$EXP$$BR-GRANULES-BR-2024GRALIT00245$GRANULES INDIA$AE de Almeida Franzoi.Acute generalized pustulosis secondary to lamotrigine: from clinical to anatomopathological description.Acta Neurologica Belgica.APR-2024;124:701-703$65$YR$A$F$Y$$$20240703$$HP$BR$BR
240473271$24047327$1$I$20240625$20240626$20240703$20240703$PER$$US-BAYER-2024A092850$BAYER$$17$YR$T$F$Y$$$20240703$$CN$US$US
240473281$24047328$1$I$$20240624$20240703$20240703$PER$$US-BAYER-2024A092404$BAYER$$$$$F$Y$$$20240703$$CN$US$US
240473291$24047329$1$I$20240515$20240702$20240703$20240703$EXP$$US-TAKEDA-2024TUS067167$TAKEDA$$70$YR$$F$Y$$$20240703$$CN$US$US
240473301$24047330$1$I$$20240701$20240703$20240703$EXP$$CA-PFIZER INC-202400204448$PFIZER$$10$YR$$M$Y$44$KG$20240703$$HP$CA$CA
240473311$24047331$1$I$20240222$20240625$20240703$20240703$EXP$$JP-009507513-2402JPN004210J$MERCK$$7$DEC$$M$Y$$$20240703$$MD$JP$JP
240473321$24047332$1$I$$20240625$20240703$20240703$EXP$$CN-AstraZeneca-2024A147934$ASTRAZENECA$$$$$M$Y$$$20240703$$MD$CN$
240473331$24047333$1$I$$20240625$20240703$20240703$EXP$$ZA-AstraZeneca-2024A146807$ASTRAZENECA$$18627$DY$$F$Y$$$20240703$$CN$ZA$
240473341$24047334$1$I$$20240625$20240703$20240703$EXP$$ZA-AstraZeneca-2024A148131$ASTRAZENECA$$81$YR$$F$Y$$$20240703$$CN$ZA$
240473351$24047335$1$I$$20240625$20240703$20240703$EXP$$US-MYLANLABS-2024M1062005$MYLAN$$$$$F$Y$$$20240703$$CN$US$US
240473361$24047336$1$I$20220801$20240628$20240703$20240703$EXP$$CA-ABBVIE-4247584$ABBVIE$$80$YR$$M$Y$$$20240703$$HP$CA$CA
240473372$24047337$2$F$20240624$20240725$20240703$20240802$EXP$$JP-AstraZeneca-2024A149554$ASTRAZENECA$$42$YR$$F$Y$47$KG$20240802$$MD$JP$
240473381$24047338$1$I$$20240624$20240703$20240703$EXP$$ES-AMGEN-ESPSP2023069387$AMGEN$Fernandez-crehuet P.; Haselgruber S.; Padial-gomez A. et al.. Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study. Springer Healthcare. 2023;13 (4):1029-1038$$$$$Y$$$20240703$$HP$ES$ES
240473391$24047339$1$I$20240623$20240625$20240703$20240703$PER$$US-SA-2024SA191682$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240703$$MD$US$US
240473401$24047340$1$I$20240620$20240624$20240703$20240703$EXP$$CN-SA-2024SA193220$SANOFI AVENTIS$$62$YR$A$F$Y$67$KG$20240703$$HP$CN$CN
240473411$24047341$1$I$$20240625$20240703$20240703$EXP$$US-RDY-LIT/USA/24/0009488$DR REDDYS$Singh KB, Kumar S, Almalouf P. From the Sea to the ICU: The Unexpected Journey of Vibrio Vulnificus Compartment Syndrome. American Journal of Respiratory and Critical Care Medicine. 2024;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1683?role=tab.$59$YR$A$M$Y$$$20240703$$HP$US$US
240473431$24047343$1$I$$20240702$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US062429$SANDOZ$$$$$M$Y$$$20240703$$HP$US$US
240473442$24047344$2$F$20240101$20240708$20240703$20240717$EXP$$US-SANDOZ INC.-SDZ2024US062190$SANDOZ$$$$$F$Y$67.57$KG$20240717$$CN$US$US
240473451$24047345$1$I$20220901$20240625$20240703$20240703$EXP$US-MLMSERVICE-20240619-PI103555-00232-1$US-RDY-SPO/USA/24/0009345$DR REDDYS$Antonelli JP, Quach M, Mahajan A, Pleva J, Ma VT. Rapid Life-Saving Response to Anti-PD-1 in a Solid Organ Transplant Recipient with Metastatic Cutaneous Squamous Cell Carcinoma: A Case Report and Review. Journal of Immunotherapy. 2024;47(6):216-9. DOI: 10.1097/CJI.0000000000000514.$5$DEC$A$M$Y$$$20240703$$MD$US$US
240473461$24047346$1$I$20240517$20240702$20240703$20240703$EXP$FR-AFSSAPS-LM2024000370$FR-SANDOZ INC.-SDZ2024FR062255$SANDOZ$$89$YR$$F$Y$77.8$KG$20240703$$MD$FR$FR
240473471$24047347$1$I$$20240702$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062299$SANDOZ$Chaudhary AJ, Joyce KM, Haq K, Qureshi MH, Donthireddy V. Non-alcoholic Wernicke^s Encephalopathy Masquerading As CNS Relapse of Acute Myeloid Leukemia.. Cereus. 2024;16(5):1-5$20$YR$$M$Y$$$20240703$$HP$US$US
240473481$24047348$1$I$$20240624$20240703$20240703$EXP$$CA-BAXTER-2024BAX020760$BAXTER$$26$YR$$F$Y$63$KG$20240703$$HP$CA$CA
240473501$24047350$1$I$$20240626$20240703$20240703$EXP$$GB-ROCHE-10000014793$ROCHE$$$$$F$Y$$$20240703$$HP$GB$GB
240473511$24047351$1$I$20240620$20240627$20240703$20240703$PER$$US-BAYER-2024A093263$BAYER$$32$YR$A$F$Y$$$20240703$$MD$US$US
240473521$24047352$1$I$20240612$20240612$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA050203$TOLMAR$$66$YR$$M$Y$$$20240703$$CN$CA$CA
240473531$24047353$1$I$20240613$20240613$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA050217$TOLMAR$$75$YR$$M$Y$$$20240703$$CN$CA$CA
240473541$24047354$1$I$$20240613$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA050199$TOLMAR$$$$$M$Y$$$20240703$$CN$CA$CA
240473552$24047355$2$F$20240614$20240709$20240703$20240730$PER$$CA-TOLMAR, INC.-24CA050221$TOLMAR$$83$YR$$M$Y$$$20240730$$HP$CA$CA
240473562$24047356$2$F$$20240704$20240703$20240731$PER$$CA-TOLMAR, INC.-24CA050225$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
240473571$24047357$1$I$20240301$20240614$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA050228$TOLMAR$$73$YR$$M$Y$$$20240703$$CN$CA$CA
240473581$24047358$1$I$20240604$20240614$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA050229$TOLMAR$$75$YR$$M$Y$$$20240703$$CN$CA$CA
240473591$24047359$1$I$20240101$20240614$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA050230$TOLMAR$$$$$M$Y$$$20240703$$CN$CA$CA
240473601$24047360$1$I$$20240614$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA050231$TOLMAR$$$$$M$Y$$$20240703$$CN$CA$CA
240473611$24047361$1$I$20240612$20240614$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA050233$TOLMAR$$77$YR$$M$Y$$$20240703$$CN$CA$CA
240473621$24047362$1$I$20240614$20240614$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA050235$TOLMAR$$65$YR$$M$Y$$$20240703$$CN$CA$CA
240473631$24047363$1$I$$20240614$20240703$20240703$PER$$CA-TOLMAR, INC.-24CA050238$TOLMAR$$$$$M$Y$$$20240703$$CN$CA$CA
240473641$24047364$1$I$20240501$20240627$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006899$INCYTE$$$$$$Y$$$20240703$$CN$US$US
240473651$24047365$1$I$20240301$20240627$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006888$INCYTE$$$$$$Y$$$20240703$$CN$US$US
240473671$24047367$1$I$20240626$20240627$20240703$20240703$PER$$US-BAYER-2024A093324$BAYER$$75$YR$E$F$Y$$$20240703$$CN$US$US
240473681$24047368$1$I$$20240621$20240703$20240703$PER$$US-ROCHE-10000009561$ROCHE$$$$$M$Y$$$20240703$$CN$US$US
240473703$24047370$3$F$20240608$20240717$20240703$20240722$EXP$$NVSC2024BR137554$NOVARTIS$$16$YR$$M$Y$41.9$KG$20240722$$MD$BR$BR
240473721$24047372$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-129968$DAIICHI$$$$$F$Y$89$KG$20240703$$CN$CA$CA
240473731$24047373$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024034913$EMD SERONO INC$$$$$F$Y$$$20240703$$HP$US$US
240473742$24047374$2$F$20210914$20240718$20240703$20240722$EXP$$DK-SANDOZ INC.-NVSC2021DK247848$SANDOZ$$62$YR$$F$Y$68.9$KG$20240722$$MD$DK$DK
240473751$24047375$1$I$$20240624$20240703$20240703$EXP$$US-AMAROX PHARMA-HET2024US02073$HETERO$Haghparast P, Nadybal M, Yuan C.. Treatment-Resistant Priapism in a 61-Year-Old Male After Combined Use of Trazodone, Quetiapine, and Fluoxetine. Journal of Clinical Psychopharmacology.. 2024;44(3):316-317$61$YR$$M$Y$$$20240703$$HP$US$US
240473762$24047376$2$F$$20240704$20240703$20240710$EXP$$FR-GILEAD-2024-0679463$GILEAD$$72$YR$E$F$Y$$$20240710$$HP$FR$FR
240473771$24047377$1$I$$20240626$20240703$20240703$PER$$US-BAYER-2024A093611$BAYER$$$$$M$Y$$$20240703$$CN$US$US
240473781$24047378$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024034125$EMD SERONO INC$$39$YR$A$F$Y$$$20240703$$CN$US$US
240473791$24047379$1$I$20240625$20240627$20240703$20240703$PER$$US-ABBVIE-5821558$ABBVIE$$63$YR$$F$Y$$$20240703$$CN$US$US
240473802$24047380$2$F$$20240705$20240703$20240710$EXP$$ES-MYLANLABS-2024M1060669$MYLAN$Silvia Garcia, R, Nikolaeva EM, Mosquera JG, Ibanez MG, Roman R, Rodr?guez S. Molecular characterization and drug sensitivity of a gastric FGFR2-TACC2 and a pancreatic KRASp.G12C primary culture. Cancer-Research. 2024;84(6)$$$$$Y$$$20240710$$MD$ES$ES
240473812$24047381$2$F$$20240716$20240703$20240723$EXP$$RO-MYLANLABS-2024M1061002$MYLAN$Niamat SadaPM, Niamat SapanaPM, Pepparelli A, Tilinca MC, Varga B.. Diabetes diagnostic puzzle: understanding diabetes classification challenges. Acta Marisiensis - Seria Medica. 2024;70 (Suppl. 3):205$29$YR$$F$Y$$$20240723$$MD$RO$RO
240473821$24047382$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-130030$DAIICHI$$78$YR$$F$Y$$$20240703$$HP$CA$CA
240473831$24047383$1$I$20240101$20240624$20240703$20240703$PER$$US-SA-2024SA193021$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240703$$MD$US$US
240473841$24047384$1$I$$20240625$20240703$20240703$PER$$US-SA-2024SA191762$SANOFI AVENTIS$$$$$F$Y$$$20240703$$HP$US$US
240473851$24047385$1$I$20240101$20240626$20240703$20240703$PER$$US-SA-2024SA194200$SANOFI AVENTIS$$40$YR$A$F$Y$89$KG$20240703$$MD$US$US
240473861$24047386$1$I$20240101$20240703$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037678$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240703$$CN$US$US
240473871$24047387$1$I$20240521$20240701$20240703$20240703$EXP$IT-MINISAL02-992625$NVSC2024IT136789$NOVARTIS$$74$YR$$F$Y$55$KG$20240703$$MD$IT$IT
240473883$24047388$3$F$20240626$20240919$20240703$20240926$EXP$$CA-HLS-202401630$HLS THERAPEUTICS$$75$YR$E$F$Y$$$20240926$$PH$CA$CA
240473891$24047389$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024034127$EMD SERONO INC$$40$YR$A$F$Y$$$20240703$$CN$US$US
240473901$24047390$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5823406$ABBVIE$$$$$M$Y$$$20240703$$HP$US$US
240473911$24047391$1$I$$20240420$20240703$20240703$PER$$US-AMGEN-USASP2024129978$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240473921$24047392$1$I$20240404$20240627$20240703$20240703$EXP$FR-AFSSAPS-TO2024001135$FR-MYLANLABS-2024M1060776$MYLAN$$77$YR$$M$Y$79$KG$20240703$$MD$FR$FR
240473931$24047393$1$I$$20240109$20240703$20240703$PER$$US-AMGEN-USASP2024130145$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240473941$24047394$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024034128$EMD SERONO INC$$42$YR$A$F$Y$$$20240703$$CN$US$US
240473951$24047395$1$I$20240528$20240625$20240703$20240703$EXP$$CN-AstraZeneca-2024A149317$ASTRAZENECA$$19153$DY$$F$Y$62$KG$20240703$$MD$CN$
240473961$24047396$1$I$20240101$20240628$20240703$20240703$EXP$$SE-AstraZeneca-2024A151139$ASTRAZENECA$$56$YR$$M$Y$$$20240703$$MD$SE$
240473971$24047397$1$I$$20240614$20240703$20240703$EXP$$FR-AstraZeneca-2024A142140$ASTRAZENECA$$$$$$Y$$$20240703$$MD$FR$
240473981$24047398$1$I$$20240628$20240703$20240703$EXP$$US-AstraZeneca-2024A151279$ASTRAZENECA$$$$$F$Y$$$20240703$$CN$US$
240473992$24047399$2$F$$20240815$20240703$20240823$EXP$$TR-AstraZeneca-2024A147839$ASTRAZENECA$$58$YR$$M$Y$$$20240823$$MD$TR$
240474001$24047400$1$I$$20240625$20240703$20240703$EXP$$CN-AstraZeneca-2024A147919$ASTRAZENECA$$$$$M$Y$$$20240703$$CN$CN$
240474011$24047401$1$I$$20240625$20240703$20240703$EXP$$IL-AstraZeneca-2024A150860$ASTRAZENECA$$84$YR$$M$Y$$$20240703$$MD$IL$
240474021$24047402$1$I$$20240625$20240703$20240703$PER$$US-SA-2024SA190924$SANOFI AVENTIS$$$$$$Y$$$20240703$$MD$US$US
240474032$24047403$2$F$$20240627$20240703$20240718$EXP$$JP-AstraZeneca-2024A148754$ASTRAZENECA$$70$YR$$M$Y$$$20240718$$MD$JP$
240474043$24047404$3$F$20240618$20240812$20240703$20240823$PER$$US-ROCHE-10000009604$ROCHE$$16$YR$T$M$Y$65.77$KG$20240823$$CN$US$US
240474051$24047405$1$I$20240520$20240627$20240703$20240703$EXP$FR-AFSSAPS-NT2024000749$FR-MYLANLABS-2024M1060689$MYLAN$$12$YR$$M$Y$$$20240703$$PH$FR$FR
240474061$24047406$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024034129$EMD SERONO INC$$37$YR$A$F$Y$$$20240703$$CN$US$US
240474071$24047407$1$I$$20240621$20240703$20240703$PER$$US-ROCHE-10000012495$ROCHE$$$$E$M$Y$$$20240703$$CN$US$US
240474081$24047408$1$I$20240515$20240618$20240703$20240703$EXP$FR-AFSSAPS-NT2024000680$FR-TEVA-VS-3212223$TEVA$$100$YR$$F$Y$64$KG$20240703$$HP$FR$FR
240474091$24047409$1$I$$20240621$20240703$20240703$EXP$$GB-TEVA-VS-3212529$TEVA$$$$$M$Y$$$20240703$$CN$GB$GB
240474102$24047410$2$F$$20240709$20240703$20240821$PER$$US-LUNDBECK-DKLU3078181$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
240474113$24047411$3$F$20240101$20240907$20240703$20240912$PER$$US-ALXN-A202300149$ALEXION PHARMACEUTICALS$$44$YR$$F$Y$$$20240912$$CN$US$US
240474121$24047412$1$I$$20240626$20240703$20240703$EXP$$US-GSK-US2024AMR081248$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$US$US
240474131$24047413$1$I$$20240626$20240703$20240703$30DAY$$US-GSK-US2024079847$GLAXOSMITHKLINE$$$$$F$Y$$$20240703$$CN$US$US
240474153$24047415$3$F$20240619$20240725$20240703$20240731$PER$$US-APELLIS-2024-APL-0000347$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
240474161$24047416$1$I$20240701$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130568$AMGEN$$77$YR$E$F$Y$$$20240703$$CN$US$US
240474171$24047417$1$I$20240614$20240627$20240703$20240703$EXP$FR-AFSSAPS-SE2024000492$FR-MYLANLABS-2024M1060495$MYLAN$$92$YR$$F$Y$50$KG$20240703$$HP$FR$FR
240474181$24047418$1$I$$20240624$20240703$20240703$EXP$$AU-RDY-SPO/AUS/24/0009704$DR REDDYS$$53$YR$A$F$Y$$$20240703$$CN$AU$AU
240474192$24047419$2$F$$20240709$20240703$20240715$EXP$$IT-MYLANLABS-2024M1060686$MYLAN$$16$YR$$F$Y$$$20240715$$PH$IT$IT
240474201$24047420$1$I$$20240621$20240703$20240703$EXP$$CA-TEVA-VS-3213138$TEVA$$57$YR$$F$Y$$$20240703$$HP$CA$CA
240474221$24047422$1$I$$20240515$20240703$20240703$PER$$US-LUNDBECK-DKLU3078112$LUNDBECK$$$$$$Y$$$20240703$$HP$US$US
240474231$24047423$1$I$$20240619$20240703$20240703$PER$$US-EMD Serono-2024034131$EMD SERONO INC$$35$YR$A$F$Y$$$20240703$$CN$US$US
240474242$24047424$2$F$20240409$20240716$20240703$20240726$EXP$$ES-TEVA-VS-3184056$TEVA$$66$YR$$F$Y$$$20240726$$CN$ES$ES
240474253$24047425$3$F$20240209$20240903$20240703$20240904$EXP$$US-BAYER-2024A095204$BAYER$$23$YR$A$M$Y$$$20240904$$CN$US$US
240474261$24047426$1$I$$20240124$20240703$20240703$PER$$US-AMGEN-USASP2024129139$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240474271$24047427$1$I$20240628$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130988$AMGEN$$81$YR$E$F$Y$$$20240703$$CN$US$US
240474281$24047428$1$I$$20230223$20240703$20240703$PER$$US-AMGEN-USASP2023235355$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240474292$24047429$2$F$20220130$20240828$20240703$20240904$EXP$$US-AMGEN-USASP2024127639$AMGEN$$49$YR$A$M$Y$$$20240904$$LW$US$US
240474302$24047430$2$F$20220101$20240826$20240703$20240902$EXP$$US-AMGEN-USASP2024127646$AMGEN$$57$YR$A$F$Y$$$20240902$$LW$US$US
240474311$24047431$1$I$20220615$20240624$20240703$20240703$EXP$$US-KYOWAKIRIN-2024KK015189$KYOWA$$$$$$Y$$$20240703$$HP$US$US
240474321$24047432$1$I$$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105878$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240703$$HP$US$US
240474331$24047433$1$I$20240701$20240702$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106396$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240703$$CN$US$US
240474341$24047434$1$I$$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106327$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240703$$CN$US$US
240474351$24047435$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106225$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240703$$CN$US$US
240474361$24047436$1$I$$20240515$20240703$20240703$PER$$US-LUNDBECK-DKLU3078134$LUNDBECK$$$$$$Y$$$20240703$$HP$US$US
240474371$24047437$1$I$$20240603$20240703$20240703$PER$$US-AstraZeneca-2024A129292$ASTRAZENECA$$$$$M$Y$$$20240703$$CN$US$
240474382$24047438$2$F$20240501$20240729$20240703$20240805$EXP$$ZA-ABBVIE-5823549$ABBVIE$$56$YR$$F$Y$$$20240804$$CN$ZA$ZA
240474391$24047439$1$I$20240609$20240628$20240703$20240703$EXP$$CN-AstraZeneca-2024A152520$ASTRAZENECA$$22666$DY$$M$Y$60$KG$20240703$$MD$CN$
240474402$24047440$2$F$20230530$20240705$20240703$20240711$EXP$$JP-AstraZeneca-2024A121013$ASTRAZENECA$$73$YR$$M$Y$75$KG$20240711$$MD$JP$
240474411$24047441$1$I$20240509$20240625$20240703$20240703$EXP$$JP-AstraZeneca-2024A135826$ASTRAZENECA$$66$YR$$F$Y$$$20240703$$MD$JP$
240474422$24047442$2$F$20240214$20240730$20240703$20240802$EXP$$JP-AstraZeneca-2024A150702$ASTRAZENECA$$75$YR$$F$Y$45$KG$20240802$$MD$JP$
240474431$24047443$1$I$20240701$20240701$20240703$20240703$PER$$US-AstraZeneca-2024A151854$ASTRAZENECA$$41$YR$$F$Y$68$KG$20240703$$HP$US$
240474441$24047444$1$I$20240612$20240625$20240703$20240703$EXP$$CN-AstraZeneca-2024A148692$ASTRAZENECA$$17196$DY$$F$Y$67$KG$20240703$$MD$CN$
240474451$24047445$1$I$$20240701$20240703$20240703$PER$$US-AstraZeneca-2024A152006$ASTRAZENECA$$$$$$Y$$$20240703$$CN$US$
240474471$24047447$1$I$20240101$20240627$20240703$20240703$EXP$$GB-JNJFOC-20240675543$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$PH$GB$GB
240474481$24047448$1$I$$20240620$20240703$20240703$EXP$$US-ROCHE-10000008999$ROCHE$$$$A$M$Y$$$20240703$$CN$US$US
240474491$24047449$1$I$20201126$20240625$20240703$20240703$EXP$PL-URPL-1-3374-2020$PL-TEVA-VS-3214489$TEVA$$76$YR$$M$Y$71$KG$20240703$$MD$PL$PL
240474501$24047450$1$I$20161215$20240627$20240703$20240703$EXP$AT-BASGAGES-184869$AT-MYLANLABS-2018M1096820$MYLAN$$28$YR$$F$Y$65$KG$20240703$$MD$AT$AT
240474511$24047451$1$I$$20240627$20240703$20240703$EXP$$US-ABBVIE-5821296$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240474521$24047452$1$I$$20240620$20240703$20240703$EXP$$GB-TEVA-VS-3212378$TEVA$$$$E$F$Y$$$20240703$$CN$GB$GB
240474532$24047453$2$F$$20240902$20240703$20240903$EXP$$NVSC2024BE137519$NOVARTIS$$$$$M$Y$$$20240903$$MD$BE$BE
240474541$24047454$1$I$20240616$20240620$20240703$20240703$EXP$GB-MHRA-MED-202406201748323780-WFMQL$GB-TEVA-VS-3212370$TEVA$$76$YR$$F$Y$75$KG$20240703$$PH$GB$GB
240474561$24047456$1$I$$20240624$20240703$20240703$EXP$$PS-JNJFOC-20240665663$JOHNSON AND JOHNSON$$19$YR$A$F$Y$$$20240703$$MD$PS$PS
240474571$24047457$1$I$$20240627$20240703$20240703$EXP$$FR-MYLANLABS-2024M1060722$MYLAN$$$$$F$Y$$$20240703$$CN$FR$FR
240474592$24047459$2$F$$20240702$20240703$20240711$EXP$$US-APELLIS-2024-APL-0000386$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$MD$US$US
240474601$24047460$1$I$$20230527$20240703$20240703$PER$$US-AMGEN-USASP2023235197$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240474612$24047461$2$F$20240607$20240716$20240703$20240723$PER$$US-AMGEN-USASP2024128165$AMGEN$$68$YR$E$M$Y$$$20240722$$PH$US$US
240474621$24047462$1$I$20240626$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130626$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240474631$24047463$1$I$$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130848$AMGEN$$$$A$F$Y$$$20240703$$CN$US$US
240474651$24047465$1$I$$20240702$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106331$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240703$$CN$US$US
240474671$24047467$1$I$20240229$20240618$20240703$20240703$EXP$FR-AFSSAPS-TO2024001028$FR-TEVA-VS-3212220$TEVA$$$$$$Y$$$20240703$$MD$FR$FR
240474681$24047468$1$I$20240510$20240510$20240703$20240703$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000062$UROGEN PHARMA$$$$$$Y$$$20240704$$PH$US$US
240474691$24047469$1$I$20240401$20240514$20240703$20240703$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000061$UROGEN PHARMA$$$$$$Y$$$20240704$$HP$US$US
240474701$24047470$1$I$20240101$20240508$20240703$20240703$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000059$UROGEN PHARMA$$$$$$Y$$$20240704$$MD$US$US
240474711$24047471$1$I$$20231027$20240703$20240703$PER$$US-IMP-2023000334$Harrow Health$$$$$M$Y$$$20240703$$CN$US$US
240474721$24047472$1$I$$20240701$20240703$20240703$PER$$US-ROCHE-10000015121$ROCHE$$$$$F$Y$$$20240703$$CN$US$US
240474731$24047473$1$I$$20240625$20240703$20240703$EXP$GB-MHRA-MED-202406240939544720-VTGJN$GB-TEVA-VS-3213509$TEVA$$$$$F$Y$67$KG$20240703$$CN$GB$GB
240474741$24047474$1$I$$20240625$20240703$20240703$EXP$$GB-TEVA-VS-3213662$TEVA$$53$YR$$F$Y$81$KG$20240703$$MD$GB$GB
240474751$24047475$1$I$20240622$20240624$20240703$20240703$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019518$UNITED THERAPEUTICS$$68$YR$$F$Y$82.54$KG$20240703$$$US$US
240474761$24047476$1$I$$20240701$20240703$20240703$EXP$$US-ABBVIE-5824003$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240474771$24047477$1$I$$20240703$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106426$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240703$$HP$US$US
240474781$24047478$1$I$20240614$20240620$20240703$20240703$EXP$$US-BATHANDBODY-2024-US-034619$Bath and Body Works$$46$YR$$F$Y$53.52$KG$20240703$$CN$US$US
240474791$24047479$1$I$$20240514$20240703$20240703$PER$$US-Eisai-EC-2024-166031$EISAI$$$$$M$Y$$$20240703$$MD$US$US
240474801$24047480$1$I$20220913$20240627$20240703$20240703$PER$$CN-Eisai-EC-2024-169134$EISAI$$51$YR$A$F$Y$62$KG$20240703$$HP$CN$CN
240474811$24047481$1$I$20230904$20240627$20240703$20240703$PER$$CN-Eisai-EC-2024-169125$EISAI$$41$YR$A$F$Y$50$KG$20240703$$HP$CN$CN
240474821$24047482$1$I$$20240621$20240703$20240703$EXP$$CA-TEVA-VS-3213203$TEVA$$53$YR$$M$Y$$$20240703$$CN$CA$CA
240474831$24047483$1$I$$20240624$20240703$20240703$EXP$$US-ABBVIE-5815729$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240474842$24047484$2$F$20240601$20240703$20240703$20240709$EXP$FR-AFSSAPS-BR2024000514$FR-MYLANLABS-2024M1060493$MYLAN$$61$YR$$M$Y$$$20240709$$MD$FR$FR
240474851$24047485$1$I$20240501$20240627$20240703$20240703$EXP$FR-AFSSAPS-SE2024000510$FR-MYLANLABS-2024M1060518$MYLAN$$72$YR$$M$Y$87$KG$20240703$$MD$FR$FR
240474861$24047486$1$I$$20240626$20240703$20240703$EXP$$DE-TAKEDA-2024TUS066044$TAKEDA$$$$$M$Y$$$20240703$$CN$DE$DE
240474872$24047487$2$F$20230101$20240730$20240703$20240801$EXP$$DK-DSJP-DSE-2024-126792$DAIICHI$$$$$F$Y$58$KG$20240801$$MD$DK$DK
240474881$24047488$1$I$$20240626$20240703$20240703$EXP$$US-AstraZeneca-2024A151817$ASTRAZENECA$Papsun D.M, Chan-Hosokawal A, Lamb M.E, Logan B.. Increasing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017 to 2021.. Journal of Analytical Toxicology 2023;47(8):668-679.$27$YR$$M$Y$$$20240703$$HP$US$
240474891$24047489$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407002047$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240703$$CN$US$US
240474901$24047490$1$I$$20240627$20240703$20240703$PER$$NVSC2024US135179$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240474912$24047491$2$F$$20240701$20240703$20240708$PER$$NVSC2024US138084$NOVARTIS$$$$$$Y$$$20240708$$CN$US$US
240474921$24047492$1$I$20240701$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130740$AMGEN$$68$YR$E$F$Y$$$20240703$$CN$US$US
240474931$24047493$1$I$20240404$20240702$20240703$20240703$PER$$US-AMGEN-USASP2024131618$AMGEN$$69$YR$E$M$Y$$$20240703$$PH$US$US
240474941$24047494$1$I$$20240617$20240703$20240703$EXP$$US-CHIESI-2024CHF03633$CHIESI$Saleh.Z, Kanaan J. A Combination of Tezepelumab and Omalizumab for Severe Persistent Asthma. Am J Respir Crit Care Med. 2024;209:A5302$59$YR$$F$Y$$$20240703$$HP$US$US
240474951$24047495$1$I$$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106411$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240703$$CN$US$US
240474961$24047496$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106475$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240703$$CN$US$US
240474972$24047497$2$F$$20240731$20240703$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104217$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$145.15$KG$20240806$$CN$US$US
240474981$24047498$1$I$$20240628$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104405$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240703$$PH$US$US
240474991$24047499$1$I$20231001$20240627$20240703$20240703$EXP$$US-AMGEN-USASP2024127584$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240475002$24047500$2$F$$20240723$20240703$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106440$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240726$$CN$US$US
240475012$24047501$2$F$$20240726$20240703$20240801$EXP$$AU-BAYER-2024A090423$BAYER$$77$YR$E$M$Y$$$20240801$$MD$AU$AU
240475022$24047502$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3212443$TEVA$Patel D, Patel D, Chittal A, Malik KJ, Disilvio BE. A ^tail^ of caution: pioglitazone induced recurrent pleural effusion. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2015.; Patel D, Patel D, Chittal A, Malik KJ, Disilvio BE. A ^tail^ of caution: pioglitazone induced recurrent pleural effusion. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2015$68$YR$$F$Y$$$20240717$$HP$US$US
240475031$24047503$1$I$$20240626$20240703$20240703$PER$$US-BIOGEN-2024BI01271539$BIOGEN$$$$$M$Y$$$20240703$$CN$US$US
240475041$24047504$1$I$20231003$20240626$20240703$20240703$PER$$US-BIOGEN-2023BI01229821$BIOGEN$$66$YR$$M$Y$$$20240703$$CN$US$US
240475051$24047505$1$I$20240203$20240619$20240703$20240703$EXP$FR-AFSSAPS-RE2024000561$FR-TEVA-VS-3212421$TEVA$$75$YR$$M$Y$79$KG$20240703$$MD$FR$FR
240475062$24047506$2$F$$20240729$20240703$20240801$PER$$US-AMGEN-USASP2024128343$AMGEN$$$$$$Y$$$20240801$$PH$US$US
240475071$24047507$1$I$$20240624$20240703$20240703$PER$$US-JNJFOC-20240665617$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240703$$CN$US$US
240475081$24047508$1$I$$20240701$20240703$20240703$PER$$US-JNJFOC-20240702750$JOHNSON AND JOHNSON$$$$$F$Y$$$20240703$$CN$US$US
240475091$24047509$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA060662$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240703$$MD$US$US
240475102$24047510$2$F$20191001$20240703$20240703$20240712$PER$$US-SA-2024SA192858$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240712$$MD$US$US
240475111$24047511$1$I$$20240624$20240703$20240703$PER$$US-SA-2024SA189334$SANOFI AVENTIS$$$$$F$Y$$$20240703$$CN$US$US
240475123$24047512$3$F$20231209$20240815$20240703$20240825$EXP$$GB-TEVA-VS-3213593$TEVA$$73$YR$$F$Y$$$20240825$$CN$GB$GB
240475133$24047513$3$F$20240629$20240823$20240703$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010121$JAZZ$$26$YR$$F$Y$37$KG$20240826$$MD$US$US
240475141$24047514$1$I$20210901$20240627$20240703$20240703$EXP$GB-MHRA-MED-202406271311088880-LFQDK$GB-TEVA-VS-3214986$TEVA$$$$$F$Y$$$20240703$$MD$GB$GB
240475151$24047515$1$I$$20240701$20240703$20240703$EXP$$CA-Taiho Oncology Inc-2024-006537$TAIHO ONCOLOGY INC$$36$YR$A$M$Y$93$KG$20240703$$HP$CA$CA
240475161$24047516$1$I$20240509$20240517$20240703$20240703$PER$$US-Eisai-EC-2024-166028$EISAI$$$$E$M$Y$$$20240703$$CN$US$US
240475171$24047517$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138196$NOVARTIS$$$$$$Y$$$20240703$$MD$US$US
240475181$24047518$1$I$20240528$20240621$20240703$20240703$EXP$$PK-ROCHE-10000013581$ROCHE$$46$YR$A$F$Y$$$20240703$$MD$PK$PK
240475191$24047519$1$I$20240531$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406281130392760-JHGPF$GB-TEVA-VS-3215564$TEVA$$45$YR$$F$Y$59$KG$20240703$$PH$GB$GB
240475201$24047520$1$I$$20240626$20240703$20240703$PER$$US-BIOGEN-2024BI01271397$BIOGEN$$$$$F$Y$$$20240703$$CN$US$US
240475211$24047521$1$I$20191014$20240627$20240703$20240703$PER$$US-BIOGEN-2019BI00794133$BIOGEN$$52$YR$$M$Y$$$20240703$$CN$US$US
240475221$24047522$1$I$20240101$20240626$20240703$20240703$PER$$US-BIOGEN-2024BI01271402$BIOGEN$$$$$M$Y$$$20240703$$CN$US$US
240475231$24047523$1$I$$20240626$20240703$20240703$PER$$US-BIOGEN-2024BI01254378$BIOGEN$$$$$M$Y$$$20240703$$CN$US$US
240475241$24047524$1$I$$20240629$20240703$20240703$PER$$US-ABBVIE-5824461$ABBVIE$$$$$$Y$$$20240703$$CN$US$US
240475251$24047525$1$I$$20240605$20240703$20240703$PER$$US-SCIEGENP-2024SCSPO00307$SCIEGEN$$$$$F$Y$$$20240703$$CN$US$US
240475261$24047526$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106455$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240703$$CN$US$US
240475271$24047527$1$I$$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106328$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240703$$MD$US$US
240475281$24047528$1$I$20200602$20240625$20240703$20240703$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-103937$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$67$KG$20240703$$MD$KR$KR
240475291$24047529$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105836$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240703$$CN$US$US
240475301$24047530$1$I$$20240702$20240703$20240703$PER$$US-BAYER-2024A096160$BAYER$$$$$$Y$$$20240703$$CN$US$US
240475311$24047531$1$I$20240619$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106435$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240703$$CN$US$US
240475321$24047532$1$I$$20240626$20240703$20240703$EXP$$BR-TAKEDA-2024TUS066177$TAKEDA$$18$YR$$F$Y$$$20240703$$CN$BR$BR
240475331$24047533$1$I$20240628$20240701$20240703$20240703$EXP$$IT-TAKEDA-2024TUS066857$TAKEDA$$$$$F$Y$$$20240703$$CN$IT$IT
240475341$24047534$1$I$$20240628$20240703$20240703$PER$$NVSC2024US136699$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240475351$24047535$1$I$$20240624$20240703$20240703$EXP$$US-ALKERMES INC.-ALK-2024-001759$ALKERMES$$$$$F$Y$$$20240703$$CN$US$US
240475361$24047536$1$I$$20240627$20240703$20240703$EXP$$FR-009507513-2407FRA000551$MERCK$$$$$F$Y$$$20240703$$PH$FR$FR
240475373$24047537$3$F$$20240708$20240703$20240717$EXP$$GB-TEVA-VS-3212842$TEVA$Lionel S, Slonim LB, Hannah G, Potter V, Avenoso D. Very late onset post transplantation lymphoproliferative disorder (PTLD) after haematopoietic stem cell transplant (HCT)  a clinical case. Mediterranean Journal of Hematology and Infectious Diseases. 2024,16(1):e2024048.; Lionel S, Slonim LB, Hannah G, Potter V, Avenoso D.. Very late onset post-transplantation lymphoproliferative disorder (PTLD) after haematopoietic stem cell transplant (HCT) - a clinical case.. Mediterr. J. Hematol. Infect....$$$A$M$Y$$$20240717$$HP$GB$GB
240475381$24047538$1$I$20240618$20240624$20240703$20240703$EXP$$JP-009507513-2406JPN003388J$MERCK$$7$DEC$$M$Y$$$20240703$$MD$JP$JP
240475391$24047539$1$I$$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406280855400820-VQTNC$GB-TEVA-VS-3215625$TEVA$$$$$M$Y$$$20240703$$CN$GB$GB
240475402$24047540$2$F$20240408$20240624$20240703$20240704$EXP$IT-MINISAL02-990796$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06016$HIKMA$$68$YR$$M$Y$$$20240704$$MD$IT$IT
240475422$24047542$2$F$20240101$20240621$20240703$20240709$PER$$US-JNJFOC-20240662810$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240709$$CN$US$US
240475432$24047543$2$F$20240528$20240808$20240703$20240815$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037187$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$47.4$KG$20240815$$MD$JP$JP
240475441$24047544$1$I$20240529$20240607$20240703$20240703$PER$$US-Eisai-EC-2024-167788$EISAI$$78$YR$E$F$Y$$$20240703$$MD$US$US
240475454$24047545$4$F$20240528$20240821$20240703$20240828$PER$$JP-Eisai-EC-2024-169297$EISAI$$52$YR$A$F$Y$$$20240828$$MD$JP$JP
240475461$24047546$1$I$20240528$20240529$20240703$20240703$PER$$US-Eisai-EC-2024-166777$EISAI$$77$YR$E$M$Y$$$20240703$$HP$US$US
240475471$24047547$1$I$20190101$20240626$20240703$20240703$EXP$$BR-TAKEDA-2024TUS066128$TAKEDA$$57$YR$$F$Y$$$20240703$$MD$BR$BR
240475491$24047549$1$I$20231019$20240626$20240703$20240703$EXP$$AU-TAKEDA-2024TUS064845$TAKEDA$$43$YR$$F$Y$$$20240703$$HP$AU$AU
240475501$24047550$1$I$20240405$20240619$20240703$20240703$EXP$SE-SEMPA-2024-004802$SE-TEVA-VS-3212755$TEVA$$79$YR$$M$Y$$$20240703$$MD$SE$SE
240475511$24047551$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138204$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240475522$24047552$2$F$20221101$20240701$20240703$20240710$EXP$IT-MINISAL02-989737$IT-TEVA-VS-3212722$TEVA$$79$YR$$M$Y$$$20240710$$PH$IT$IT
240475533$24047553$3$F$$20240726$20240703$20240807$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407000837$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240807$$CN$JP$JP
240475541$24047554$1$I$20230206$20240701$20240703$20240703$EXP$$NL-ELI_LILLY_AND_COMPANY-NL202407002143$ELI LILLY AND CO$$75$YR$E$$Y$$$20240703$$HP$NL$NL
240475551$24047555$1$I$20170101$20240620$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406014527$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240703$$CN$US$US
240475561$24047556$1$I$20240614$20240624$20240703$20240703$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407001248$ELI LILLY AND CO$$50$YR$A$M$Y$51$KG$20240703$$CN$DE$CN
240475571$24047557$1$I$$20240621$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015303$ELI LILLY AND CO$$$$$$Y$$$20240703$$CN$US$US
240475581$24047558$1$I$20231201$20240626$20240703$20240703$EXP$$SK-ELI_LILLY_AND_COMPANY-SK202407000320$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240703$$CN$SK$SK
240475591$24047559$1$I$$20240625$20240703$20240703$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202406017745$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240703$$CN$DE$DE
240475601$24047560$1$I$$20240622$20240703$20240703$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202406015533$ELI LILLY AND CO$$$$$F$Y$$$20240703$$CN$DE$DE
240475612$24047561$2$F$$20240628$20240703$20240708$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406019030$ELI LILLY AND CO$$$$$$Y$$$20240708$$MD$JP$JP
240475625$24047562$5$F$20240620$20240904$20240703$20240910$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406016139$ELI LILLY AND CO$$68$YR$E$M$Y$74.3$KG$20240910$$MD$JP$JP
240475631$24047563$1$I$$20240621$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015232$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240703$$CN$US$US
240475641$24047564$1$I$20240501$20240625$20240703$20240703$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202406017197$ELI LILLY AND CO$$$$$M$Y$$$20240703$$CN$AU$AU
240475651$24047565$1$I$20240620$20240621$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015683$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240703$$CN$US$US
240475661$24047566$1$I$20240601$20240621$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202406016117$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240703$$CN$US$US
240475672$24047567$2$F$20240210$20240718$20240703$20240729$EXP$$NL-ELI_LILLY_AND_COMPANY-NL202406015921$ELI LILLY AND CO$$$$A$F$Y$67.5$KG$20240729$$CN$NL$NL
240475681$24047568$1$I$$20240627$20240703$20240703$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000855$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240703$$HP$US$US
240475691$24047569$1$I$20240604$20240625$20240703$20240703$EXP$IT-MINISAL02-991503$IT-ELI_LILLY_AND_COMPANY-IT202407001413$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240703$$CN$DE$IT
240475701$24047570$1$I$$20240621$20240703$20240703$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202406018420$ELI LILLY AND CO$$$$$F$Y$$$20240703$$MD$IN$IN
240475711$24047571$1$I$20240601$20240627$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103947$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240703$$CN$US$US
240475721$24047572$1$I$$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106316$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240703$$CN$US$US
240475731$24047573$1$I$20240521$20240626$20240703$20240703$EXP$$CA-HLS-202401601$HLS THERAPEUTICS$$17$YR$T$M$Y$$$20240703$$MD$CA$CA
240475751$24047575$1$I$$20240624$20240703$20240703$EXP$$JP-TAKEDA-2024TUS067144$TAKEDA$$69$YR$$M$Y$$$20240703$$PH$JP$JP
240475761$24047576$1$I$20240323$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406271040542900-VDNJS$GB-TEVA-VS-3215629$TEVA$$$$$M$Y$78$KG$20240703$$CN$GB$GB
240475773$24047577$3$F$20240614$20240709$20240703$20240716$EXP$$NVSC2024FR137387$NOVARTIS$$71$YR$$M$Y$63$KG$20240716$$MD$FR$FR
240475782$24047578$2$F$20221219$20240729$20240703$20240731$EXP$$JP-DSJP-DSJ-2023-107763$DAIICHI$$92$YR$$M$Y$60$KG$20240731$$MD$JP$JP
240475791$24047579$1$I$20201201$20240626$20240703$20240703$EXP$$NVSC2024US135484$NOVARTIS$$$$$M$Y$102.2$KG$20240703$$CN$US$US
240475811$24047581$1$I$$20240626$20240703$20240703$EXP$$GB-AMGEN-GBRSP2024127085$AMGEN$Norton B.C.; Papaefthymiou A.; Telese A. et al.. Role of oesophageal balloon cryoablation in combination with personalised immunotherapy to achieve luminal control in metastatic oesophageal cancer: a case report. Frontline Gastroenterology. 2024;15 (4):336-339$39$YR$A$M$Y$$$20240703$$MD$GB$GB
240475824$24047582$4$F$$20240807$20240703$20240807$PER$$US-JNJFOC-20240678194$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
240475831$24047583$1$I$20240621$20240629$20240703$20240703$PER$$CN-Eisai-EC-2024-169270$EISAI$$67$YR$E$M$Y$50$KG$20240703$$HP$CN$CN
240475841$24047584$1$I$20240620$20240626$20240703$20240703$PER$$CN-Eisai-EC-2024-169020$EISAI$$47$YR$A$F$Y$50$KG$20240703$$HP$CN$CN
240475851$24047585$1$I$20240305$20240629$20240703$20240703$PER$$CN-Eisai-EC-2024-169267$EISAI$$70$YR$E$M$Y$62$KG$20240703$$HP$CN$CN
240475861$24047586$1$I$20230509$20240625$20240703$20240703$EXP$ES-AEMPS-1536583$ES-TEVA-VS-3214144$TEVA$$27$YR$$M$Y$$$20240703$$PH$ES$ES
240475881$24047588$1$I$20240113$20240625$20240703$20240703$EXP$IT-MINISAL02-990949$IT-TEVA-VS-3214324$TEVA$$78$YR$$M$Y$$$20240703$$MD$IT$IT
240475893$24047589$3$F$20230526$20240724$20240703$20240730$EXP$FR-AFSSAPS-TO2024000120$FR-009507513-2401FRA016329$MERCK$$75$YR$$M$Y$$$20240730$$PH$FR$FR
240475901$24047590$1$I$20240510$20240627$20240703$20240703$EXP$FR-AFSSAPS-PA2024001286$FR-MYLANLABS-2024M1060491$MYLAN$$39$YR$$F$Y$110$KG$20240703$$PH$FR$FR
240475912$24047591$2$F$20231028$20240708$20240703$20240712$EXP$FR-AFSSAPS-PA2024001282$FR-MYLANLABS-2024M1060677$MYLAN$$58$YR$$F$Y$92$KG$20240712$$CN$FR$FR
240475921$24047592$1$I$20240301$20240628$20240703$20240703$EXP$HR-HALMED-300085695$HR-TAKEDA-2024TUS065138$TAKEDA$$40$YR$$M$Y$$$20240703$$HP$HR$HR
240475931$24047593$1$I$$20240625$20240703$20240703$EXP$$US-AstraZeneca-2024A147501$ASTRAZENECA$$$$$F$Y$53.1$KG$20240703$$CN$US$
240475941$24047594$1$I$20240625$20240628$20240703$20240703$EXP$$US-AstraZeneca-2024A150499$ASTRAZENECA$$$$E$$Y$$$20240703$$CN$US$
240475953$24047595$3$F$$20240903$20240703$20240912$EXP$$CA-ABBVIE-5824116$ABBVIE$$$$$M$Y$$$20240912$$HP$CA$CA
240475961$24047596$1$I$20240527$20240627$20240703$20240703$EXP$FR-AFSSAPS-PA2024001273$FR-MYLANLABS-2024M1060509$MYLAN$$62$YR$$F$Y$76$KG$20240703$$MD$FR$FR
240475972$24047597$2$F$20240128$20240827$20240703$20240903$EXP$$DE-ABBVIE-5824115$ABBVIE$$62$YR$$M$Y$$$20240903$$HP$DE$DE
240475981$24047598$1$I$20240221$20240627$20240703$20240703$EXP$FR-AFSSAPS-TO2024000809$FR-MYLANLABS-2024M1060904$MYLAN$$85$YR$$M$Y$80.8$KG$20240703$$PH$FR$FR
240475992$24047599$2$F$$20240808$20240703$20240809$PER$$NVSC2024US138187$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
240476001$24047600$1$I$$20240701$20240703$20240703$EXP$$IT-PURDUE-GBR-2019-0069002$PURDUE$Rizzo G, Bussolin L, Genitori L, Zicca A, Messeri A, Lenge M et al.. The use of opioids in children receiving intrathecal baclofen therapy. Child^s nevrous system. 2019;35:1213-8$15$YR$$M$Y$30.7$KG$20240703$$HP$IT$IT
240476011$24047601$1$I$20240601$20240701$20240703$20240703$EXP$$DE-ABBVIE-5823999$ABBVIE$$48$YR$$M$Y$$$20240703$$CN$DE$DE
240476022$24047602$2$F$20240601$20240724$20240703$20240726$EXP$$IN-PFIZER INC-PV202400086657$PFIZER$$55$YR$$$Y$$$20240726$$CN$IN$IN
240476031$24047603$1$I$20240101$20240625$20240703$20240703$EXP$FR-AFSSAPS-SE2024000490$FR-TEVA-VS-3214560$TEVA$$84$YR$$F$Y$80$KG$20240703$$PH$FR$FR
240476041$24047604$1$I$20240221$20240702$20240703$20240703$EXP$FR-AFSSAPS-NC2024000770$FR-PFIZER INC-202400204868$PFIZER$$32$YR$$F$Y$66$KG$20240703$$MD$FR$FR
240476051$24047605$1$I$20240614$20240702$20240703$20240703$EXP$PT-INFARMED-R202406-496$PT-PFIZER INC-202400204815$PFIZER$$30$YR$$F$Y$$$20240703$$MD$PT$PT
240476061$24047606$1$I$20240619$20240702$20240703$20240703$EXP$$CN-PFIZER INC-PV202400086958$PFIZER$$20$YR$$M$Y$70$KG$20240703$$HP$CN$CN
240476071$24047607$1$I$20240617$20240701$20240703$20240703$EXP$CZ-CZSUKL-24001842$CZ-PFIZER INC-202400203851$PFIZER$$83$YR$$F$Y$70$KG$20240703$$MD$CZ$CZ
240476081$24047608$1$I$$20240702$20240703$20240703$EXP$$US-PFIZER INC-202400205335$PFIZER$$77$YR$$M$Y$$$20240703$$HP$US$US
240476091$24047609$1$I$$20240702$20240703$20240703$EXP$$US-PFIZER INC-PV202400087105$PFIZER$$73$YR$$$Y$$$20240703$$CN$US$US
240476101$24047610$1$I$$20240702$20240703$20240703$EXP$$US-PFIZER INC-202400205520$PFIZER$$80$YR$$F$Y$$$20240703$$CN$US$US
240476111$24047611$1$I$20240701$20240702$20240703$20240703$EXP$$CN-PFIZER INC-PV202400086606$PFIZER$$51$YR$$M$Y$$$20240703$$MD$CN$CN
240476121$24047612$1$I$$20240702$20240703$20240703$EXP$$KR-PFIZER INC-PV202400086816$PFIZER$$$$$$Y$$$20240703$$CN$KR$KR
240476131$24047613$1$I$20240101$20240701$20240703$20240703$EXP$$US-PFIZER INC-PV202400086743$PFIZER$$4$DEC$$F$Y$$$20240703$$MD$US$US
240476143$24047614$3$F$20240101$20240917$20240703$20240919$EXP$$US-PFIZER INC-PV202400087125$PFIZER$$61$YR$$F$Y$77.098$KG$20240919$$CN$US$US
240476152$24047615$2$F$$20240805$20240703$20240806$EXP$$CA-PFIZER INC-202400205198$PFIZER$$34$YR$$F$Y$62$KG$20240806$$PH$CA$CA
240476161$24047616$1$I$$20240702$20240703$20240703$EXP$$CA-PFIZER INC-202400205186$PFIZER$$19$YR$$M$Y$98$KG$20240703$$HP$CA$CA
240476171$24047617$1$I$$20240702$20240703$20240703$EXP$$CA-PFIZER INC-202400205223$PFIZER$$52$YR$$F$Y$$$20240703$$MD$CA$CA
240476181$24047618$1$I$$20240702$20240703$20240703$EXP$$JP-PFIZER INC-PV202400086832$PFIZER$$55$YR$$$Y$$$20240703$$MD$JP$JP
240476191$24047619$1$I$20240411$20240701$20240703$20240703$EXP$CH-SM-2024-13238$CH-PFIZER INC-202400204234$PFIZER$$77$YR$$F$Y$$$20240703$$HP$CH$CH
240476211$24047621$1$I$20240601$20240702$20240703$20240703$EXP$$US-PFIZER INC-202400205167$PFIZER$$52$YR$$F$Y$55.79$KG$20240703$$CN$US$US
240476223$24047622$3$F$20240409$20240816$20240703$20240821$EXP$$JP-PFIZER INC-PV202400086817$PFIZER$$79$YR$$M$Y$$$20240821$$PH$JP$JP
240476231$24047623$1$I$20240508$20240702$20240703$20240703$EXP$$CN-PFIZER INC-PV202400086954$PFIZER$$24$YR$$F$Y$80$KG$20240703$$HP$CN$CN
240476243$24047624$3$F$20240101$20240827$20240703$20240828$EXP$$CN-PFIZER INC-PV202400081750$PFIZER$$64$YR$$F$Y$$$20240828$$MD$CN$CN
240476251$24047625$1$I$20240501$20240701$20240703$20240703$EXP$FR-AFSSAPS-PB2024000736$FR-PFIZER INC-202400204001$PFIZER$$38$YR$$F$Y$$$20240703$$MD$FR$FR
240476262$24047626$2$F$20221225$20240812$20240703$20240814$EXP$$PL-PFIZER INC-202400204811$PFIZER$$67$YR$$F$Y$$$20240814$$MD$PL$PL
240476271$24047627$1$I$$20240627$20240703$20240703$EXP$$US-ABBVIE-5822780$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240476311$24047631$1$I$20240626$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024128405$AMGEN$$81$YR$E$M$Y$$$20240703$$CN$US$US
240476321$24047632$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106185$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240703$$CN$US$US
240476331$24047633$1$I$20240624$20240701$20240703$20240703$EXP$$US-Taiho Oncology Inc-2024-006518$TAIHO ONCOLOGY INC$$87$YR$E$M$Y$$$20240703$$CN$US$US
240476341$24047634$1$I$20240407$20240701$20240703$20240703$PER$FR-AFSSAPS-NC2024000778$FR-Eisai-EC-2024-169190$EISAI$$52$YR$A$F$Y$66.5$KG$20240703$$MD$FR$FR
240476352$24047635$2$F$20220711$20240627$20240703$20240710$PER$$CN-Eisai-EC-2024-169129$EISAI$$61$YR$A$M$Y$65$KG$20240710$$MD$CN$CN
240476381$24047638$1$I$$20240627$20240703$20240703$PER$$JP-Eisai-EC-2024-169052$EISAI$$$$$F$Y$$$20240703$$MD$JP$JP
240476391$24047639$1$I$20240516$20240517$20240703$20240703$PER$$US-Eisai-EC-2024-166027$EISAI$$72$YR$E$F$Y$$$20240703$$CN$US$US
240476401$24047640$1$I$$20240627$20240703$20240703$PER$$JP-Eisai-EC-2024-169059$EISAI$$$$E$$Y$$$20240703$$MD$JP$JP
240476413$24047641$3$F$20240616$20240827$20240703$20240904$PER$$US-RDY-CLI/USA/24/0009516$DR REDDYS$$19$YR$A$F$Y$$$20240904$$HP$US$US
240476421$24047642$1$I$$20240702$20240703$20240703$PER$$NVSC2024US137879$NOVARTIS$$$$$$Y$$$20240703$$CN$US$US
240476442$24047644$2$F$20240212$20240826$20240703$20240829$EXP$$SA-SANDOZ INC.-SDZ2024SA028108$SANDOZ$$23$YR$$M$Y$$$20240829$$CN$SA$SA
240476451$24047645$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-130028$DAIICHI$$$$$F$Y$42$KG$20240703$$MD$CA$CA
240476461$24047646$1$I$20240628$20240628$20240703$20240703$PER$$US-ABBVIE-5821319$ABBVIE$$82$YR$$F$Y$83.007$KG$20240703$$CN$US$US
240476471$24047647$1$I$20240615$20240627$20240703$20240703$EXP$FR-AFSSAPS-PB2024000704$FR-MYLANLABS-2024M1060863$MYLAN$$29$YR$$M$Y$$$20240703$$MD$FR$FR
240476482$24047648$2$F$20240601$20240705$20240703$20240710$PER$$US-PFIZER INC-PV202400086184$PFIZER$$64$YR$$M$Y$$$20240710$$HP$US$US
240476493$24047649$3$F$20220101$20240628$20240703$20240710$PER$$US-PFIZER INC-202400202470$PFIZER$$73$YR$$F$Y$54.43$KG$20240710$$CN$US$US
240476501$24047650$1$I$$20240626$20240703$20240703$PER$$US-ALXN-202406USA001659US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
240476512$24047651$2$F$$20240801$20240703$20240806$PER$$US-PFIZER INC-202400204918$PFIZER$$54$YR$$M$Y$79.38$KG$20240806$$PH$US$US
240476521$24047652$1$I$$20240625$20240703$20240703$PER$$NVSC2024US132367$NOVARTIS$$$$$F$Y$$$20240703$$CN$US$US
240476531$24047653$1$I$20240401$20240620$20240703$20240703$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI04214$NEUROCRINE BIOSCIENCES$$59$YR$$M$Y$$$20240703$$MD$US$US
240476551$24047655$1$I$$20240627$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158870$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240476561$24047656$1$I$20240628$20240702$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US062481$SANDOZ$$54$YR$$F$Y$$$20240703$$HP$US$US
240476574$24047657$4$F$20240201$20240820$20240703$20240902$EXP$$AR-SANDOZ INC.-SDZ2024AR026339$SANDOZ$$60$YR$$F$Y$$$20240902$$CN$AR$AR
240476581$24047658$1$I$20240101$20240627$20240703$20240703$EXP$$GR-SANDOZ INC.-SDZ2024GR062406$SANDOZ$$21$YR$$$Y$$$20240703$$MD$GR$GR
240476591$24047659$1$I$20231201$20240628$20240703$20240703$EXP$$US-ABBVIE-5821920$ABBVIE$$66$YR$$M$Y$$$20240703$$CN$US$US
240476601$24047660$1$I$$20240701$20240703$20240703$EXP$$US-ABBVIE-5823361$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240476621$24047662$1$I$20240619$20240625$20240703$20240703$EXP$$CN-AstraZeneca-2024A148680$ASTRAZENECA$$25691$DY$$M$Y$78$KG$20240703$$MD$CN$
240476631$24047663$1$I$20240505$20240627$20240703$20240703$EXP$ES-AEMPS-1539069$ES-MYLANLABS-2024M1060719$MYLAN$$73$YR$$F$Y$$$20240703$$MD$ES$ES
240476641$24047664$1$I$20231112$20240624$20240703$20240703$EXP$GB-MHRA-MED-202406231830427040-HGDSW$GB-TEVA-VS-3213071$TEVA$$33$YR$$F$Y$84$KG$20240703$$CN$GB$GB
240476652$24047665$2$F$20240619$20240717$20240703$20240723$EXP$$DE-009507513-2406DEU010006$MERCK$$55$YR$$F$Y$63$KG$20240723$$MD$DE$DE
240476661$24047666$1$I$20240606$20240625$20240703$20240703$EXP$$CN-AstraZeneca-2024A148669$ASTRAZENECA$$20016$DY$$M$Y$78$KG$20240703$$MD$CN$
240476682$24047668$2$F$$20240705$20240703$20240711$EXP$$FR-MYLANLABS-2024M1060838$MYLAN$G. Drevin, N. Picard, A. Baudriller, Pena-Martin M, Ferec S, Leuger L, Briet M, Abbara Cet al.. Tramadol intoxication in children: An emerging issue. Therapie. 2024;S0040-5957:24)00067-2$5$YR$$M$Y$$$20240711$$HP$FR$FR
240476691$24047669$1$I$$20240617$20240703$20240703$PER$$US-APELLIS-2024-APL-0000348$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240703$$CN$US$US
240476701$24047670$1$I$20220729$20240627$20240703$20240703$PER$$CN-Eisai-EC-2024-169143$EISAI$$65$YR$E$F$Y$47$KG$20240703$$HP$CN$CN
240476711$24047671$1$I$$20240625$20240703$20240703$PER$$JP-Eisai-EC-2024-169072$EISAI$$$$A$M$Y$$$20240703$$MD$JP$JP
240476721$24047672$1$I$$20240627$20240703$20240703$EXP$$AU-GILEAD-2024-0678793$GILEAD$$$$E$M$Y$$$20240703$$CN$AU$AU
240476731$24047673$1$I$20240610$20240624$20240703$20240703$EXP$GB-MHRA-MED-202406231945493330-VCGQN$GB-TEVA-VS-3213083$TEVA$$43$YR$$F$Y$100$KG$20240703$$CN$GB$GB
240476741$24047674$1$I$$20240621$20240703$20240703$EXP$$CA-TEVA-VS-3213040$TEVA$$65$YR$$F$Y$$$20240703$$HP$CA$CA
240476761$24047676$1$I$$20240515$20240703$20240703$PER$$US-LUNDBECK-DKLU3078113$LUNDBECK$$$$$$Y$$$20240703$$HP$US$US
240476781$24047678$1$I$20240405$20240630$20240703$20240703$EXP$GB-MHRA-MED-202406301116153080-MDTRN$GB-MYLANLABS-2024M1061725$MYLAN$$$$$$Y$$$20240703$$CN$GB$GB
240476791$24047679$1$I$20240628$20240628$20240703$20240703$EXP$$US-MYLANLABS-2024M1062200$MYLAN$$30$YR$$F$Y$$$20240703$$HP$US$US
240476801$24047680$1$I$$20240515$20240703$20240703$PER$$US-LUNDBECK-DKLU3078187$LUNDBECK$$$$$$Y$$$20240703$$HP$US$US
240476811$24047681$1$I$20240628$20240701$20240703$20240703$EXP$$US-ABBVIE-5823355$ABBVIE$$85$YR$$M$Y$$$20240703$$CN$US$US
240476822$24047682$2$F$20230101$20240627$20240703$20240711$EXP$$BR-ALXN-202406SAM000980BR$ALEXION PHARMACEUTICALS$$39$YR$$F$Y$75$KG$20240711$$CN$BR$BR
240476833$24047683$3$F$20240101$20240805$20240703$20240810$EXP$$US-ABBVIE-5821517$ABBVIE$$$$$F$Y$117.93$KG$20240810$$CN$US$US
240476841$24047684$1$I$$20240610$20240703$20240703$PER$$US-JNJFOC-20240625934$JOHNSON AND JOHNSON$$$$I$M$Y$$$20240703$$CN$US$US
240476861$24047686$1$I$$20240625$20240703$20240703$PER$$US-ALXN-202406USA001749US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
240476881$24047688$1$I$$20240626$20240703$20240703$PER$$US-ABBVIE-5819320$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240476891$24047689$1$I$20240629$20240630$20240703$20240703$EXP$$RO-ABBVIE-5823236$ABBVIE$$77$YR$$M$Y$$$20240703$$CN$RO$RO
240476912$24047691$2$F$$20240701$20240703$20240704$PER$$NVSC2024US138190$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240476923$24047692$3$F$20240619$20240724$20240703$20240730$PER$$US-JNJFOC-20240704761$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240731$$CN$US$US
240476931$24047693$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106130$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240703$$PH$US$US
240476941$24047694$1$I$$20240515$20240703$20240703$PER$$US-LUNDBECK-DKLU3078116$LUNDBECK$$$$$$Y$$$20240703$$MD$US$US
240476951$24047695$1$I$$20240626$20240703$20240703$EXP$$CN-ABBVIE-5824345$ABBVIE$$$$$$Y$$$20240703$$CN$CN$CN
240476971$24047697$1$I$$20240625$20240703$20240703$PER$GB-MHRA-MED-202406251730479200-CHFTZ$GB-Eisai-EC-2024-168875$EISAI$$$$$F$Y$$$20240703$$HP$GB$GB
240476991$24047699$1$I$20240609$20240627$20240703$20240703$PER$$CN-Eisai-EC-2024-169139$EISAI$$61$YR$A$M$Y$$$20240703$$HP$CN$CN
240477001$24047700$1$I$20240613$20240626$20240703$20240703$PER$$CN-Eisai-EC-2024-169019$EISAI$$54$YR$A$F$Y$56$KG$20240703$$HP$CN$CN
240477012$24047701$2$F$20240529$20240710$20240703$20240718$PER$$JP-Eisai-EC-2024-167828$EISAI$$$$E$F$Y$$$20240718$$MD$JP$JP
240477022$24047702$2$F$20240506$20240806$20240703$20240809$EXP$$JP-Eisai-EC-2024-168867$EISAI$$46$YR$A$M$Y$71$KG$20240809$$PH$JP$JP
240477031$24047703$1$I$20240527$20240625$20240703$20240703$PER$$CN-Eisai-EC-2024-168900$EISAI$$64$YR$A$F$Y$$$20240703$$MD$CN$CN
240477041$24047704$1$I$20240510$20240625$20240703$20240703$PER$$CN-Eisai-EC-2024-168909$EISAI$$39$YR$A$F$Y$49.5$KG$20240703$$HP$CN$CN
240477053$24047705$3$F$20240601$20240813$20240703$20240930$PER$$US-LUNDBECK-DKLU4000786$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
240477061$24047706$1$I$$20240621$20240703$20240703$EXP$$CA-TEVA-VS-3213064$TEVA$$72$YR$$M$Y$$$20240703$$MD$CA$CA
240477083$24047708$3$F$$20240802$20240703$20240809$PER$$NVSC2024US138145$NOVARTIS$$$$$$Y$$$20240809$$CN$US$US
240477091$24047709$1$I$$20240621$20240703$20240703$EXP$$BG-TEVA-VS-3213087$TEVA$$38$YR$$M$Y$$$20240703$$MD$BG$BG
240477101$24047710$1$I$$20240627$20240703$20240703$EXP$$IE-MYLANLABS-2024M1060919$MYLAN$Isa NM, Sharp M and Wilson G.. Clinical focus: Psoriatic disease management. Rheumatology. 2024;30 n?5:23-28$69$YR$$F$Y$$$20240703$$MD$IE$IE
240477112$24047711$2$F$$20240725$20240703$20240805$EXP$$SK-ELI_LILLY_AND_COMPANY-SK202406018453$ELI LILLY AND CO$$64$YR$A$M$Y$77$KG$20240805$$CN$SK$SK
240477122$24047712$2$F$$20240702$20240703$20240705$EXP$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000313$Day One Biopharmaceuticals$$$$$$Y$$$20240705$$MD$US$US
240477131$24047713$1$I$$20240702$20240703$20240703$EXP$$JP-ABBVIE-5825039$ABBVIE$$88$YR$$M$Y$$$20240703$$MD$JP$JP
240477144$24047714$4$F$20240621$20240809$20240703$20240820$EXP$$NVSC2024CA133062$NOVARTIS$$60$YR$$M$Y$$$20240820$$CN$CA$CA
240477151$24047715$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138161$NOVARTIS$$$$$F$Y$$$20240703$$HP$US$US
240477161$24047716$1$I$$20240625$20240703$20240703$PER$$US-MYLANLABS-2024M1061681$MYLAN$$$$$F$Y$58.45$KG$20240703$$CN$US$US
240477171$24047717$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-130026$DAIICHI$$74$YR$$F$Y$74$KG$20240703$$HP$CA$CA
240477181$24047718$1$I$20240617$20240627$20240703$20240703$EXP$FR-AFSSAPS-MA2024001089$FR-009507513-2406FRA009658$MERCK$$38$YR$$F$Y$$$20240703$$MD$FR$FR
240477191$24047719$1$I$20240608$20240627$20240703$20240703$EXP$$CA-ABBVIE-5821034$ABBVIE$$72$YR$$F$Y$$$20240703$$MD$CA$CA
240477202$24047720$2$F$20230325$20240716$20240703$20240718$EXP$IT-MINISAL02-992758$IT-DSJP-DSE-2024-129931$DAIICHI$$72$YR$$F$Y$52$KG$20240718$$MD$IT$IT
240477211$24047721$1$I$$20240625$20240703$20240703$PER$$NVSC2024US132485$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240477232$24047723$2$F$$20240801$20240703$20240807$PER$$NVSC2024US132370$NOVARTIS$$$$$F$Y$$$20240807$$HP$US$US
240477241$24047724$1$I$$20240701$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104990$BRISTOL MYERS SQUIBB$$4$YR$C$F$Y$$$20240703$$CN$US$US
240477253$24047725$3$F$$20240821$20240703$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106318$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240824$$CN$US$US
240477272$24047727$2$F$20240501$20240618$20240703$20240808$PER$$US-LUNDBECK-DKLU4000343$LUNDBECK$$$$$$Y$$$20240808$$CN$US$US
240477281$24047728$1$I$20240301$20240628$20240703$20240703$PER$$JP-Eisai-EC-2024-169148$EISAI$$$$$$Y$$$20240703$$PH$JP$JP
240477291$24047729$1$I$20240601$20240627$20240703$20240703$EXP$$JP-Eisai-EC-2024-169076$EISAI$$$$E$M$Y$$$20240703$$MD$JP$JP
240477301$24047730$1$I$$20240624$20240703$20240703$PER$$US-Eisai-EC-2024-168952$EISAI$$$$$$Y$$$20240703$$MD$US$US
240477311$24047731$1$I$20230807$20240627$20240703$20240703$PER$$CN-Eisai-EC-2024-169131$EISAI$$53$YR$A$F$Y$61$KG$20240703$$HP$CN$CN
240477321$24047732$1$I$20240601$20240627$20240703$20240703$PER$$US-Eisai-EC-2024-169120$EISAI$$$$E$F$Y$$$20240703$$HP$US$US
240477331$24047733$1$I$20240527$20240627$20240703$20240703$PER$$CN-Eisai-EC-2024-169140$EISAI$$40$YR$A$F$Y$58$KG$20240703$$HP$CN$CN
240477341$24047734$1$I$$20240627$20240703$20240703$EXP$$JP-Eisai-EC-2024-169057$EISAI$$$$E$F$Y$$$20240703$$MD$JP$JP
240477361$24047736$1$I$$20240624$20240703$20240703$EXP$$JP-Eisai-EC-2024-168982$EISAI$Echizen K, Hirose D. Obsessive-compulsive disorder induced by Donepezil in a patient with Alzheimer^s disease. Psychiatry Clin Neurosci Rep. 2024 Jun;(3: e217): 1-3. doi:https://doi.org/10.1002/pcn5.217.$$$E$M$Y$$$20240703$$MD$JP$JP
240477371$24047737$1$I$20230611$20240627$20240703$20240703$PER$$CN-Eisai-EC-2024-169142$EISAI$$59$YR$A$F$Y$59$KG$20240703$$HP$CN$CN
240477381$24047738$1$I$$20240620$20240703$20240703$EXP$$US-RDY-LIT/USA/24/0009342$DR REDDYS$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. Rheumatology. 2024 May;63(5): 1291-1296. doi:10.1093/rheumatology/kead372.$35$YR$A$M$Y$$$20240703$$HP$US$US
240477391$24047739$1$I$20240513$20240517$20240703$20240703$PER$$US-Eisai-EC-2024-166123$EISAI$$75$YR$E$F$Y$$$20240703$$MD$US$US
240477411$24047741$1$I$20240601$20240627$20240703$20240703$EXP$$CN-009507513-2407CHN000617$MERCK$$58$YR$$M$Y$$$20240703$$HP$CN$CN
240477431$24047743$1$I$$20240628$20240703$20240703$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037327$BOEHRINGER INGELHEIM$$$$$$Y$$$20240703$$CN$US$US
240477441$24047744$1$I$20240618$20240627$20240703$20240703$EXP$$CN-DAIICHI SANKYO, INC.-DSJ-2024-129604$DAIICHI$$50$YR$$F$Y$61$KG$20240703$$HP$CN$CN
240477451$24047745$1$I$$20240625$20240703$20240703$EXP$$CA-APELLIS-2024-APL-0000377$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240703$$HP$CA$CA
240477462$24047746$2$F$$20240702$20240703$20240715$EXP$$AU-ANIPHARMA-2024-AU-000296$ANI$$51$YR$$M$Y$$$20240715$$CN$AU$AU
240477481$24047748$1$I$20230620$20240628$20240703$20240703$EXP$GB-MHRA-MED-202406270750170050-LQRPY$GB-TEVA-VS-3215475$TEVA$$75$YR$$F$Y$50$KG$20240703$$CN$GB$GB
240477492$24047749$2$F$$20240703$20240703$20240704$PER$$NVSC2024US138146$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
240477501$24047750$1$I$$20240627$20240703$20240703$EXP$$NVSC2024RU136558$NOVARTIS$$$$$$Y$$$20240703$$MD$RU$RU
240477511$24047751$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-129781$DAIICHI$$$$$F$Y$$$20240703$$HP$CA$CA
240477541$24047754$1$I$20240510$20240627$20240703$20240703$EXP$ES-AEMPS-1538596$ES-MYLANLABS-2024M1060525$MYLAN$$75$YR$$M$Y$$$20240703$$MD$ES$ES
240477562$24047756$2$F$$20240808$20240703$20240812$EXP$$US-PFIZER INC-PV202400087203$PFIZER$$81$YR$$F$Y$$$20240812$$CN$US$US
240477571$24047757$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-129954$DAIICHI$$78$YR$$F$Y$$$20240703$$HP$CA$CA
240477581$24047758$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-129957$DAIICHI$$$$$F$Y$63$KG$20240703$$CN$CA$CA
240477591$24047759$1$I$20240614$20240701$20240703$20240703$EXP$IT-MINISAL02-992507$IT-PFIZER INC-202400204212$PFIZER$$50$YR$$F$Y$$$20240703$$PH$IT$IT
240477601$24047760$1$I$20231201$20240701$20240703$20240703$EXP$$ES-PFIZER INC-202400203910$PFIZER$$59$YR$$F$Y$$$20240703$$MD$ES$ES
240477611$24047761$1$I$20240701$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130977$AMGEN$$76$YR$E$F$Y$$$20240703$$CN$US$US
240477622$24047762$2$F$$20240708$20240703$20240717$EXP$GB-MHRA-MED-202406281439120430-SHLWN$GB-TEVA-VS-3215874$TEVA$$$$$$Y$$$20240717$$CN$GB$GB
240477631$24047763$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-129966$DAIICHI$$55$YR$$F$Y$47$KG$20240703$$CN$CA$CA
240477641$24047764$1$I$$20240626$20240703$20240703$EXP$$US-RDY-SPO/USA/24/0009490$DR REDDYS$$$$$F$Y$$$20240703$$CN$US$US
240477651$24047765$1$I$20240101$20240517$20240703$20240703$PER$$US-Eisai-EC-2024-166060$EISAI$$78$YR$E$M$Y$$$20240703$$MD$US$US
240477661$24047766$1$I$20240617$20240625$20240703$20240703$PER$$CN-Eisai-EC-2024-168905$EISAI$$56$YR$A$F$Y$50$KG$20240703$$HP$CN$CN
240477671$24047767$1$I$$20240518$20240703$20240703$PER$$US-Eisai-EC-2024-166063$EISAI$$61$YR$A$F$Y$$$20240703$$MD$US$US
240477701$24047770$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-129950$DAIICHI$$$$$F$Y$$$20240703$$MD$CA$CA
240477711$24047771$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-129942$DAIICHI$$$$$F$Y$$$20240703$$HP$CA$CA
240477721$24047772$1$I$$20240702$20240703$20240703$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037590$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240703$$MD$JP$JP
240477731$24047773$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-129934$DAIICHI$$$$$F$Y$81$KG$20240703$$HP$CA$CA
240477741$24047774$1$I$$20240703$20240703$20240703$EXP$$CA-PFIZER INC-202101546345$PFIZER$$62$YR$$F$Y$59.4$KG$20240703$$CN$CA$CA
240477751$24047775$1$I$20240617$20240628$20240703$20240703$EXP$$CN-009507513-2407CHN001072$MERCK$$64$YR$$M$Y$65$KG$20240703$$HP$CN$CN
240477761$24047776$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-129937$DAIICHI$$$$$F$Y$$$20240703$$CN$CA$CA
240477771$24047777$1$I$$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001587$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240703$$CN$US$US
240477782$24047778$2$F$$20240911$20240703$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202407000737$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240912$$MD$US$US
240477801$24047780$1$I$20240614$20240623$20240703$20240703$EXP$DK-DKMA-30732635$DK-GE HEALTHCARE-2024CSU006992$GE HEALTHCARE$$67$YR$$F$Y$$$20240703$$HP$DK$DK
240477811$24047781$1$I$$20240624$20240703$20240703$EXP$$CA-DSJP-DSJ-2024-129932$DAIICHI$$$$$F$Y$87$KG$20240703$$HP$CA$CA
240477821$24047782$1$I$$20240625$20240703$20240703$PER$$US-JNJFOC-20240708403$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$MD$US$US
240477832$24047783$2$F$$20240703$20240703$20240714$PER$$US-JNJFOC-20240708678$JOHNSON AND JOHNSON$$$$$M$Y$$$20240714$$HP$US$US
240477843$24047784$3$F$20240501$20240917$20240703$20240923$EXP$$US-PHARMING-PHAUS2024000520$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
240477853$24047785$3$F$$20240826$20240703$20240826$PER$$NVSC2024US138209$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
240477861$24047786$1$I$$20240626$20240703$20240703$PER$$NVSC2024US132500$NOVARTIS$$$$$F$Y$$$20240703$$HP$US$US
240477892$24047789$2$F$$20240808$20240703$20240812$PER$$US-AMGEN-USASP2024130156$AMGEN$$$$$$Y$$$20240811$$CN$US$US
240477911$24047791$1$I$$20240320$20240703$20240703$PER$$US-PFIZER INC-2024SGN03030$PFIZER$$$$$F$Y$$$20240703$$MD$US$US
240477932$24047793$2$F$20240717$20240801$20240703$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105821$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240807$$HP$US$US
240477941$24047794$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106216$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240703$$CN$US$US
240477951$24047795$1$I$20240601$20240624$20240703$20240703$EXP$$JP-Eisai-EC-2024-168865$EISAI$$74$YR$E$M$Y$$$20240703$$MD$JP$JP
240477961$24047796$1$I$$20240404$20240703$20240703$PER$$US-PFIZER INC-2024SGN04146$PFIZER$$$$$F$Y$$$20240703$$MD$US$US
240477971$24047797$1$I$20240626$20240626$20240703$20240703$PER$$US-RDY-SPO/USA/24/0009476$DR REDDYS$$39$YR$A$F$Y$$$20240703$$MD$US$US
240477981$24047798$1$I$20240323$20240425$20240703$20240703$PER$$US-PFIZER INC-2024SGN04318$PFIZER$$46$YR$$$Y$$$20240703$$HP$US$US
240477994$24047799$4$F$20240101$20240909$20240703$20240920$EXP$$US-MALLINCKRODT-MNK202401471$MALLINCKRODT$$59$YR$A$F$Y$$$20240920$$CN$US$US
240478002$24047800$2$F$$20240807$20240703$20240816$EXP$$US-MALLINCKRODT-MNK202403860$MALLINCKRODT$$68$YR$E$M$Y$$$20240816$$CN$US$US
240478011$24047801$1$I$$20240624$20240703$20240703$EXP$$US-MALLINCKRODT-MNK202404136$MALLINCKRODT$$48$YR$A$M$Y$$$20240703$$HP$US$US
240478021$24047802$1$I$$20240619$20240703$20240703$EXP$$US-MALLINCKRODT-MNK202404042$MALLINCKRODT$$$$$F$Y$$$20240703$$CN$US$US
240478031$24047803$1$I$$20240515$20240703$20240703$PER$$US-PFIZER INC-2024SGN05827$PFIZER$$$$$F$Y$$$20240703$$HP$US$US
240478041$24047804$1$I$$20240508$20240703$20240703$PER$$US-PFIZER INC-2024SGN05470$PFIZER$$$$$$Y$$$20240703$$MD$US$US
240478051$24047805$1$I$$20240418$20240703$20240703$PER$$US-PFIZER INC-2024SGN04735$PFIZER$$$$$F$Y$$$20240703$$MD$US$US
240478063$24047806$3$F$20240201$20240716$20240703$20240728$PER$$US-AMGEN-USASP2024128448$AMGEN$$74$YR$E$F$Y$$$20240728$$CN$US$US
240478071$24047807$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129611$AMGEN$Shahriari N.; Strober B.; Shahriari M. et al.. Upadacitinib for the treatment of psoriasiform and spongiotic dermatitis: A multicenter case series. JAAD Case Reports. 2024;49:106-109$55$YR$A$F$Y$$$20240703$$MD$US$US
240478081$24047808$1$I$$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130302$AMGEN$$$$$M$Y$$$20240703$$CN$US$US
240478091$24047809$1$I$$20240627$20240703$20240703$EXP$$JP-009507513-2311JPN002698J$MERCK$$7$DEC$$M$Y$$$20240703$$MD$JP$JP
240478101$24047810$1$I$20240501$20240515$20240703$20240703$PER$$US-LUNDBECK-DKLU3078145$LUNDBECK$$$$$$Y$$$20240703$$CN$US$US
240478111$24047811$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106197$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240703$$CN$US$US
240478151$24047815$1$I$20240614$20240627$20240703$20240703$PER$$CN-Eisai-EC-2024-169136$EISAI$$51$YR$A$F$Y$55$KG$20240703$$HP$CN$CN
240478163$24047816$3$F$$20240710$20240703$20240821$PER$$US-LUNDBECK-DKLU4000335$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
240478175$24047817$5$F$20240316$20240826$20240703$20240829$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037133$BOEHRINGER INGELHEIM$$7$DEC$$M$Y$$$20240829$$MD$US$US
240478182$24047818$2$F$20240501$20240918$20240703$20240927$EXP$$US-RADIUS HEALTH INC.-2024US004782$RADIUS PHARM$$71$YR$$F$Y$$$20240927$$CN$US$US
240478191$24047819$1$I$20230101$20240629$20240703$20240703$EXP$$IN-BIOGEN-2024BI01272005$BIOGEN$$20$YR$$F$Y$$$20240703$$CN$IN$IN
240478201$24047820$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138193$NOVARTIS$$$$$$Y$$$20240703$$MD$US$US
240478211$24047821$1$I$20240501$20240626$20240703$20240703$PER$$US-ABBVIE-5821642$ABBVIE$$34$YR$$F$Y$$$20240703$$MD$US$US
240478222$24047822$2$F$20221216$20240628$20240703$20240705$EXP$$NVSC2023RU020732$NOVARTIS$$36$YR$$F$Y$64$KG$20240705$$MD$RU$RU
240478231$24047823$1$I$$20240702$20240703$20240703$PER$$US-JNJFOC-20240706494$JOHNSON AND JOHNSON$$$$$$Y$$$20240703$$HP$US$US
240478242$24047824$2$F$20230101$20240718$20240703$20240718$PER$$US-JNJFOC-20240708834$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$93.07$KG$20240718$$HP$US$US
240478251$24047825$1$I$$20240626$20240703$20240703$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2024-080333$REGENERON$$79$YR$$F$Y$$$20240703$$MD$GB$GB
240478261$24047826$1$I$$20240628$20240703$20240703$EXP$$US-TAKEDA-2024TUS065480$TAKEDA$$53$YR$$F$Y$$$20240703$$CN$US$US
240478273$24047827$3$F$$20240802$20240703$20240807$PER$$US-AMGEN-USASP2024130933$AMGEN$$$$$M$Y$$$20240806$$PH$US$US
240478291$24047829$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106224$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240703$$HP$US$US
240478301$24047830$1$I$$20240521$20240703$20240703$PER$$US-Eisai-EC-2024-166254$EISAI$$$$$$Y$$$20240703$$HP$US$US
240478311$24047831$1$I$20240518$20240520$20240703$20240703$PER$$US-Eisai-EC-2024-166140$EISAI$$$$$M$Y$$$20240703$$HP$US$US
240478321$24047832$1$I$20240520$20240520$20240703$20240703$PER$$US-Eisai-EC-2024-166138$EISAI$$72$YR$E$F$Y$$$20240703$$PH$US$US
240478331$24047833$1$I$20230101$20240520$20240703$20240703$PER$$US-Eisai-EC-2024-166178$EISAI$$$$$F$Y$$$20240703$$CN$US$US
240478341$24047834$1$I$$20240627$20240703$20240703$PER$$US-ABBVIE-5823798$ABBVIE$$87$YR$$F$Y$$$20240703$$HP$US$US
240478351$24047835$1$I$$20240625$20240703$20240703$PER$$US-ALXN-202406USA001612US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240703$$CN$US$US
240478383$24047838$3$F$$20240726$20240703$20240731$PER$$US-APELLIS-2024-APL-0000363$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
240478391$24047839$1$I$$20240625$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006779$INCYTE$$$$$$Y$$$20240703$$CN$US$US
240478401$24047840$1$I$$20240626$20240703$20240703$PER$$US-BAUSCH-BL-2024-009967$BAUSCH AND LOMB$$45$YR$$M$Y$$$20240703$$MD$US$US
240478411$24047841$1$I$$20240627$20240703$20240703$EXP$$US-BAUSCH-BL-2024-010017$BAUSCH AND LOMB$$68$YR$$F$Y$80.358$KG$20240703$$MD$US$US
240478421$24047842$1$I$20230923$20240627$20240703$20240703$PER$$US-SA-2024SA193526$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240703$$CN$US$US
240478441$24047844$1$I$$20240628$20240703$20240703$EXP$$CZ-BAUSCH-BL-2024-010075$BAUSCH AND LOMB$Lazanska R, Kratka K, Havrda M, Rychlik I, Sykora M. Experiences with the treatment of al amyloidosis with renal impairment. Unspecified title.$63$YR$$M$Y$$$20240703$$HP$CZ$CZ
240478461$24047846$1$I$$20240627$20240703$20240703$EXP$$DE-BAUSCH-BL-2024-009974$BAUSCH AND LOMB$Kurz K, Noerenberg D, Schaich M, Bethge W, Horn H, Staiger A, Fend F, Damm F, Ott G. An aggressive mediastinal EBV-associated large B cell lymphoma. Histopathology. 2024;85:195-197. doi:10.1111/his.15183$24$YR$$F$Y$$$20240703$$HP$DE$DE
240478471$24047847$1$I$20240401$20240626$20240703$20240703$EXP$$RS-DSJP-DSE-2024-130642$DAIICHI$$89$YR$$F$Y$$$20240703$$MD$RS$RS
240478481$24047848$1$I$20200701$20240701$20240703$20240703$EXP$$PL-BAUSCH-BL-2024-010197$BAUSCH AND LOMB$$39$YR$$F$Y$60$KG$20240703$$CN$PL$PL
240478491$24047849$1$I$$20240702$20240703$20240703$PER$$US-BAUSCH-BL-2024-010206$BAUSCH AND LOMB$$58$YR$$F$Y$$$20240703$$CN$US$US
240478501$24047850$1$I$20240517$20240629$20240703$20240703$EXP$HR-HALMED-300085743$HR-BAUSCH-BL-2024-010102$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240703$$MD$HR$HR
240478532$24047853$2$F$$20240802$20240703$20240807$EXP$$JP-Eisai-EC-2024-168945$EISAI$Akihiko Matsuura. A case of undifferentiated metastasis of papillary thyroid carcinoma diagnosed by thoracoscopy under local anesthesia. Bronchology. 2024; 46: 31-3-.$69$YR$E$M$Y$$$20240807$$MD$JP$JP
240478542$24047854$2$F$$20240731$20240703$20240808$PER$$JP-Eisai-EC-2024-169077$EISAI$$$$A$F$Y$$$20240808$$MD$JP$JP
240478551$24047855$1$I$20220913$20240625$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006805$INCYTE$$$$$$Y$$$20240703$$CN$US$US
240478561$24047856$1$I$$20240515$20240703$20240703$PER$$US-LUNDBECK-DKLU3078176$LUNDBECK$$$$$$Y$$$20240703$$CN$US$US
240478571$24047857$1$I$20240211$20240627$20240703$20240703$EXP$FR-AFSSAPS-NT2024000750$FR-MYLANLABS-2024M1060684$MYLAN$$33$YR$$M$Y$81$KG$20240703$$MD$FR$FR
240478581$24047858$1$I$$20240627$20240703$20240703$EXP$$US-RADIUS HEALTH, INC.-2024US004796$RADIUS PHARM$$$$$F$Y$$$20240703$$CN$US$US
240478591$24047859$1$I$20240701$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000981$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240703$$CN$US$US
240478601$24047860$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407002032$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240703$$CN$US$US
240478611$24047861$1$I$$20240701$20240703$20240703$EXP$$US-GILEAD-2024-0679180$GILEAD$$$$$M$Y$$$20240703$$HP$US$US
240478621$24047862$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001000$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240703$$CN$US$US
240478641$24047864$1$I$$20240702$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US062471$SANDOZ$$$$$M$Y$$$20240703$$CN$US$US
240478651$24047865$1$I$20240626$20240627$20240703$20240703$30DAY$$IT-SANDOZ INC.-SDZ2024IT062055$SANDOZ$$11$YR$$M$Y$40$KG$20240703$$CN$IT$IT
240478661$24047866$1$I$$20240701$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062251$SANDOZ$$$$$F$Y$99.34$KG$20240703$$HP$US$US
240478671$24047867$1$I$$20240702$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2024US062396$SANDOZ$$$$$$Y$$$20240703$$CN$US$US
240478681$24047868$1$I$20240624$20240702$20240703$20240703$EXP$FR-AFSSAPS-SE2024000533$FR-SANDOZ INC.-SDZ2024FR062156$SANDOZ$$16$YR$$F$Y$58.3$KG$20240703$$PH$FR$FR
240478691$24047869$1$I$$20240701$20240703$20240703$PER$$US-PURDUE PHARMA-USA-2024-0310547$PURDUE$$$$$M$Y$$$20240703$$CN$US$US
240478701$24047870$1$I$$20240702$20240703$20240703$PER$$US-PURDUE-USA-2024-0310548$PURDUE$$$$$F$Y$88.45$KG$20240703$$CN$US$US
240478711$24047871$1$I$$20240628$20240703$20240703$PER$$US-PURDUE PHARMA-USA-2024-0310544$PURDUE$$$$$M$Y$$$20240703$$CN$US$US
240478721$24047872$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138202$NOVARTIS$$$$$F$Y$$$20240703$$HP$US$US
240478752$24047875$2$F$$20240809$20240703$20240811$PER$$US-JNJFOC-20240676221$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$CN$US$US
240478772$24047877$2$F$20230101$20240719$20240703$20240729$EXP$$US-RADIUS HEALTH, INC.-2024US004802$RADIUS PHARM$$$$$F$Y$$$20240729$$CN$US$US
240478781$24047878$1$I$20240416$20240701$20240703$20240703$EXP$FR-AFSSAPS-CN2024000636$FR-SANDOZ INC.-SDZ2024FR061889$SANDOZ$$68$YR$$M$Y$90.5$KG$20240703$$MD$FR$FR
240478791$24047879$1$I$$20240701$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062444$SANDOZ$$$$$M$Y$$$20240703$$CN$US$US
240478811$24047881$1$I$20240702$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106273$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$104.33$KG$20240703$$CN$US$US
240478821$24047882$1$I$20240125$20240621$20240703$20240703$EXP$$IE-AstraZeneca-2024A061371$ASTRAZENECA$$28742$DY$$F$Y$$$20240703$$HP$IE$
240478831$24047883$1$I$20240419$20240625$20240703$20240703$EXP$$JP-Eisai-EC-2024-168941$EISAI$$68$YR$E$F$Y$$$20240703$$PH$JP$JP
240478842$24047884$2$F$20240620$20240914$20240703$20240919$PER$$CN-Eisai-EC-2024-168907$EISAI$$70$YR$E$F$Y$40$KG$20240919$$MD$CN$CN
240478852$24047885$2$F$$20240717$20240703$20240723$EXP$$JP-Eisai-EC-2024-168862$EISAI$$$$$F$Y$$$20240723$$MD$JP$JP
240478861$24047886$1$I$20240611$20240625$20240703$20240703$PER$$CN-Eisai-EC-2024-168910$EISAI$$73$YR$E$F$Y$40$KG$20240703$$HP$CN$CN
240478871$24047887$1$I$20240511$20240625$20240703$20240703$PER$$CN-Eisai-EC-2024-168911$EISAI$$53$YR$A$F$Y$53$KG$20240703$$MD$CN$CN
240478881$24047888$1$I$20200821$20240625$20240703$20240703$PER$$KR-Eisai-EC-2024-168960$EISAI$$35$YR$A$F$Y$$$20240703$$HP$KR$KR
240478891$24047889$1$I$20240201$20240702$20240703$20240703$EXP$FR-AFSSAPS-MA2024000810$FR-ABBVIE-5823740$ABBVIE$$10$YR$$F$Y$$$20240703$$MD$FR$FR
240478901$24047890$1$I$$20240618$20240703$20240703$PER$$US-SA-2024SA185292$SANOFI AVENTIS$$3$YR$C$$Y$$$20240703$$CN$US$US
240478911$24047891$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138227$NOVARTIS$$$$$$Y$$$20240703$$MD$US$US
240478921$24047892$1$I$20230317$20240627$20240703$20240703$EXP$$CN-WOODWARD-2024-CN-000234$WOODWARD PHARMA SERVICES$$86$YR$$M$Y$$$20240702$$HP$CN$CN
240478931$24047893$1$I$20230830$20240627$20240703$20240703$EXP$$DE-009507513-2406DEU010038$MERCK$$47$YR$$M$Y$78.8$KG$20240703$$MD$DE$DE
240478951$24047895$1$I$20240529$20240625$20240703$20240703$PER$$JP-Eisai-EC-2024-168944$EISAI$$75$YR$E$F$Y$$$20240703$$MD$JP$JP
240478961$24047896$1$I$20240401$20240703$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037707$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240703$$CN$US$US
240478972$24047897$2$F$20240520$20240729$20240703$20240806$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-19479$SAMSUNG BIOEPIS$$31$YR$A$M$Y$72$KG$20240806$$CN$CA$CA
240478981$24047898$1$I$20240614$20240626$20240703$20240703$PER$$CN-Eisai-EC-2024-169018$EISAI$$41$YR$A$F$Y$31$KG$20240703$$MD$CN$CN
240478992$24047899$2$F$$20240716$20240703$20240725$EXP$$JP-Eisai-EC-2024-168974$EISAI$$72$YR$E$M$Y$$$20240725$$MD$JP$JP
240479001$24047900$1$I$20240518$20240626$20240703$20240703$EXP$FR-AFSSAPS-RN2024000697$FR-GE HEALTHCARE-2024CSU007167$GE HEALTHCARE$$69$YR$$M$Y$$$20240703$$HP$FR$FR
240479011$24047901$1$I$$20240619$20240703$20240703$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-19372$SAMSUNG BIOEPIS$$61$YR$A$M$Y$$$20240703$$CN$CA$CA
240479022$24047902$2$F$20240701$20240723$20240703$20240725$PER$$US-AMGEN-USASP2024130934$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
240479031$24047903$1$I$$20240624$20240703$20240703$EXP$$CA-ALXN-202406CAN001498CA$ALEXION PHARMACEUTICALS$$5$YR$$F$Y$$$20240703$$HP$CA$CA
240479051$24047905$1$I$$20240627$20240703$20240703$EXP$US-MLMSERVICE-20240620-PI107421-00034-1$US-RDY-SPO/USA/24/0009451$DR REDDYS$Martin G, Narvaez-Guerra O, Aurigemma G, Kovell L. Peripartum ventricular tachycardia and PVC-induced cardiomyopathy: Delivering optimal care when it^s time to deliver. BMJ Case Reports. 2024;17(6):e259075. DOI: 10.1136/bcr-2023-259075.$3$DEC$A$F$Y$$$20240703$$MD$US$US
240479061$24047906$1$I$$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001620$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240703$$CN$US$US
240479072$24047907$2$F$20240628$20240801$20240703$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407001267$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240805$$HP$US$US
240479081$24047908$1$I$$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001144$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240703$$CN$US$US
240479091$24047909$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406014450$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240703$$CN$US$US
240479101$24047910$1$I$20240501$20240621$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202406016440$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240703$$CN$US$US
240479111$24047911$1$I$$20240703$20240703$20240703$EXP$$US-PAIPHARMA-2024-US-036837$PHARMACEUTICAL ASSOC$Yousaf Z, Jyothi Ramachandran Nair D, Kamel A.Nystatin induced laryngeal edema - first reported case..American Journal of Respiratory and Critical Care Medicine.2024;209A1360.$64$YR$$F$Y$$$20240703$$HP$US$US
240479122$24047912$2$F$20240101$20240701$20240703$20240708$PER$$US-AMGEN-USASP2024130942$AMGEN$$80$YR$E$M$Y$$$20240707$$CN$US$US
240479131$24047913$1$I$$20240703$20240703$20240703$EXP$$US-PAIPHARMA-2024-US-036825$PHARMACEUTICAL ASSOC$Simone C, Axelband J.Levetiracetam-associated rhabdomyolysis..American Journal of Respiratory and Critical Care Medicine.2024;209A5704.$20$YR$$M$Y$$$20240703$$HP$US$US
240479141$24047914$1$I$20240618$20240627$20240703$20240703$PER$$CN-Eisai-EC-2024-169138$EISAI$$54$YR$A$F$Y$80$KG$20240703$$HP$CN$CN
240479151$24047915$1$I$$20240605$20240703$20240703$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00627$BIOCRYST PHARMACEUTICALS$$59$YR$$F$Y$$$20240703$$CN$US$US
240479161$24047916$1$I$20240402$20240627$20240703$20240703$EXP$ES-AEMPS-1540689$ES-RDY-SPO/ESP/24/0009401$DR REDDYS$$77$YR$E$M$Y$$$20240703$$MD$ES$ES
240479171$24047917$1$I$20240619$20240627$20240703$20240703$PER$$CN-Eisai-EC-2024-169141$EISAI$$61$YR$A$F$Y$$$20240703$$HP$CN$CN
240479181$24047918$1$I$20230308$20240627$20240703$20240703$PER$$CN-Eisai-EC-2024-169145$EISAI$$61$YR$A$F$Y$65$KG$20240703$$HP$CN$CN
240479193$24047919$3$F$20220401$20240718$20240703$20240913$EXP$$JP-Eisai-EC-2024-169308$EISAI$Shimoda Naohiko. Discussion from our experience with Pembrolizumab + Lenvatinib$73$YR$E$F$Y$$$20240913$$MD$JP$JP
240479201$24047920$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105790$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$68$KG$20240703$$PH$US$US
240479211$24047921$1$I$$20240624$20240703$20240703$PER$$US-EMD Serono-2024035769$EMD SERONO INC$$$$$F$Y$$$20240703$$HP$US$US
240479222$24047922$2$F$$20240704$20240703$20240710$EXP$$JP-009507513-2406JPN003959J$MERCK$$3$DEC$$M$Y$$$20240710$$MD$JP$JP
240479231$24047923$1$I$$20240703$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106465$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240703$$CN$US$US
240479241$24047924$1$I$$20240703$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106448$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240703$$HP$US$US
240479251$24047925$1$I$$20240624$20240703$20240703$EXP$$AU-RDY-SPO/AUS/24/0009346$DR REDDYS$$50$YR$A$F$Y$$$20240703$$CN$AU$AU
240479271$24047927$1$I$$20240617$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006468$INCYTE$$$$$$Y$$$20240703$$MD$US$US
240479281$24047928$1$I$$20240617$20240703$20240703$PER$$US-INCYTE CORPORATION-2024IN006476$INCYTE$$$$$$Y$$$20240703$$MD$US$US
240479291$24047929$1$I$$20240701$20240703$20240703$EXP$$CA-JAZZ PHARMACEUTICALS-2024-CA-010227$JAZZ$$76$YR$$F$Y$$$20240703$$PH$CA$CA
240479302$24047930$2$F$$20240712$20240703$20240717$PER$$NVSC2024US138266$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
240479311$24047931$1$I$20150815$20230412$20240703$20240703$EXP$$US-GSK-US2016GSK024256$GLAXOSMITHKLINE$$$$$$Y$$$20240703$$MD$US$US
240479321$24047932$1$I$20240626$20240626$20240703$20240703$PER$$US-ABBVIE-5821398$ABBVIE$$53$YR$$F$Y$$$20240703$$CN$US$US
240479331$24047933$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138268$NOVARTIS$$$$$$Y$$$20240703$$HP$US$US
240479351$24047935$1$I$20240215$20240701$20240703$20240703$EXP$FR-AFSSAPS-LY2024000867$FR-GILEAD-2024-0679163$GILEAD$$67$YR$E$F$Y$50$KG$20240703$$PH$FR$FR
240479361$24047936$1$I$$20240628$20240703$20240703$EXP$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452419$CZ-GSK-CZ2024081007$GLAXOSMITHKLINE$Mocikova H. Treatment of angioimmunoblastic lymphoma with the combination of brentuximab vedotin with cyclophosphamide, doxorubicin and prednisone. Kaczynski/clinical practice. 2024;20 (S6):1-36$$$$$Y$$$20240703$$HP$CZ$CZ
240479381$24047938$1$I$$20240625$20240703$20240703$EXP$$FR-AstraZeneca-2024A149237$ASTRAZENECA$$$$$F$Y$42$KG$20240703$$MD$FR$
240479391$24047939$1$I$$20240703$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407002438$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240703$$CN$US$US
240479401$24047940$1$I$$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000249$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240703$$CN$US$US
240479411$24047941$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001979$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240703$$CN$US$US
240479421$24047942$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407002264$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240703$$CN$US$US
240479431$24047943$1$I$20240629$20240701$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000959$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240703$$CN$US$US
240479441$24047944$1$I$20230101$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407000205$ELI LILLY AND CO$$54$YR$A$F$Y$120.18$KG$20240703$$CN$US$US
240479451$24047945$1$I$20240621$20240628$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001143$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240703$$CN$US$US
240479461$24047946$1$I$$20240702$20240703$20240703$PER$$US-ELI_LILLY_AND_COMPANY-US202407001908$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240703$$CN$US$US
240479471$24047947$1$I$$20240703$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037738$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240703$$CN$US$US
240479481$24047948$1$I$$20240626$20240703$20240703$EXP$$JP-EMD Serono-2024035883$EMD SERONO INC$$8$DEC$E$M$Y$$$20240703$$PH$JP$JP
240479511$24047951$1$I$$20240703$20240703$20240703$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037731$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240703$$MD$CA$CA
240479521$24047952$1$I$20221101$20240624$20240703$20240703$PER$$US-ABBVIE-5820256$ABBVIE$$70$YR$$F$Y$40.8$KG$20240703$$CN$US$US
240479532$24047953$2$F$20240531$20240709$20240703$20240712$EXP$$US-GE HEALTHCARE-2024CSU007325$GE HEALTHCARE$$47$YR$$F$Y$$$20240712$$HP$US$US
240479541$24047954$1$I$$20240703$20240703$20240703$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037698$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240703$$CN$US$US
240479553$24047955$3$F$20240617$20240628$20240703$20240722$30DAY$$US-JNJFOC-20240677161$JOHNSON AND JOHNSON$$$$$M$Y$$$20240721$$CN$US$US
240479561$24047956$1$I$$20240626$20240703$20240703$PER$$US-ALXN-202406USA001686US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240703$$CN$US$US
240479571$24047957$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA195242$SANOFI AVENTIS$$$$E$M$Y$104$KG$20240704$$MD$US$US
240479602$24047960$2$F$20240623$20240628$20240703$20240705$PER$$US-ALXN-202406USA001678US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
240479611$24047961$1$I$$20240701$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158911$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240479621$24047962$1$I$$20240628$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158879$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240479632$24047963$2$F$20240615$20240729$20240703$20240813$EXP$$US-SERVIER-S24007785$SERVIER$$$$$$Y$$$20240813$$MD$US$US
240479641$24047964$1$I$20240626$20240628$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158878$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240479651$24047965$1$I$20240501$20240701$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158932$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240479661$24047966$1$I$20200101$20240607$20240703$20240703$PER$$US-JNJFOC-20240622474$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240703$$CN$US$US
240479671$24047967$1$I$$20240625$20240703$20240703$EXP$$US-SABAL THERAPEUTICS LLC-2024-ATH-000016$ATHENA$Aiello?M, Roy?S, Chitty?L, et?al.. Prolonged administration of intrathecal baclofen in a patient with generalized grade 4?tetanus. Reg Anesth Pain Med. 2024;0:1-3$$$$$Y$$$20240703$$MD$US$US
240479681$24047968$1$I$20240101$20240626$20240703$20240703$EXP$$US-009507513-2406USA006670$MERCK$$$$$F$Y$81.6$KG$20240703$$PH$US$US
240479692$24047969$2$F$20240624$20240704$20240703$20240704$EXP$$DK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037611$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$65$KG$20240704$$CN$DK$DK
240479711$24047971$1$I$20240401$20240626$20240703$20240703$EXP$$JP-009507513-2404JPN001105J$MERCK$$6$DEC$$F$Y$$$20240703$$MD$JP$JP
240479721$24047972$1$I$20240613$20240619$20240703$20240703$EXP$$CA-HLS-202401580$HLS THERAPEUTICS$$34$YR$A$M$Y$$$20240703$$MD$CA$CA
240479741$24047974$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138281$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
240479761$24047976$1$I$20240625$20240626$20240703$20240703$PER$$US-ALXN-202406USA001700US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240703$$MD$US$US
240479772$24047977$2$F$$20240703$20240703$20240704$PER$$NVSC2024US138286$NOVARTIS$$$$$$Y$$$20240705$$HP$US$US
240479783$24047978$3$F$20240701$20240801$20240703$20240801$EXP$$PY-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037706$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$65$KG$20240801$$MD$PY$PY
240479791$24047979$1$I$20240617$20240624$20240703$20240703$EXP$$BR-TPU-TPU-2024-00358$TEIKOKU$$85$YR$E$F$Y$55$KG$20240703$$CN$BR$BR
240479802$24047980$2$F$$20240805$20240703$20240806$PER$$US-ALXN-202406USA001714US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240479813$24047981$3$F$20240501$20240819$20240703$20240823$PER$$US-ALXN-202406USA001705US$ALEXION PHARMACEUTICALS$$28$YR$$F$Y$104.31$KG$20240823$$CN$US$US
240479821$24047982$1$I$$20240628$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158899$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240479831$24047983$1$I$20240429$20240619$20240703$20240703$EXP$$CA-HLS-202401593$HLS THERAPEUTICS$$60$YR$A$M$Y$$$20240703$$PH$CA$CA
240479841$24047984$1$I$$20240628$20240703$20240703$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031364$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240703$$CN$JP$JP
240479851$24047985$1$I$20240601$20240627$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103944$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240703$$CN$US$US
240479862$24047986$2$F$$20240805$20240703$20240806$PER$$US-ALXN-202406USA001716US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240479873$24047987$3$F$$20240911$20240703$20240920$EXP$$CA-GILEAD-2024-0671129$GILEAD$$44$YR$A$F$Y$$$20240920$$MD$CA$CA
240479882$24047988$2$F$$20240702$20240703$20240704$PER$$NVSC2024US138250$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240479891$24047989$1$I$20240601$20240628$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158900$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240479901$24047990$1$I$$20240619$20240703$20240703$PER$$US-009507513-2406USA006855$MERCK$$$$$F$Y$$$20240703$$HP$US$US
240479911$24047991$1$I$20240625$20240626$20240703$20240703$PER$$US-AMGEN-USASP2024129231$AMGEN$$$$A$$Y$$$20240703$$HP$US$US
240479921$24047992$1$I$$20240627$20240703$20240703$PER$$US-ROCHE-10000015042$ROCHE$$9$YR$C$M$Y$$$20240703$$MD$US$US
240479931$24047993$1$I$$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129347$AMGEN$$$$$F$Y$$$20240703$$HP$US$US
240479941$24047994$1$I$$20240620$20240703$20240703$PER$$US-009507513-2406USA007403$MERCK$$$$$F$Y$$$20240703$$CN$US$US
240479951$24047995$1$I$$20240702$20240703$20240703$30DAY$$US-SANDOZ INC.-SDZ2023US008939$SANDOZ$$$$$F$Y$$$20240703$$CN$US$US
240479961$24047996$1$I$$20240628$20240703$20240703$EXP$$NVSC2024US136548$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240479971$24047997$1$I$$20240703$20240703$20240703$PER$$US-JNJFOC-20240708648$JOHNSON AND JOHNSON$$$$$M$Y$$$20240703$$CN$US$US
240479981$24047998$1$I$$20240628$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158928$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240479991$24047999$1$I$$20240701$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158934$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240480001$24048000$1$I$$20240701$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158927$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240480011$24048001$1$I$$20240702$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158945$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240480021$24048002$1$I$20240601$20240701$20240703$20240703$PER$$US-BIOMARINAP-US-2024-158921$BIOMARIN$$$$$$Y$$$20240703$$CN$US$US
240480032$24048003$2$F$20240627$20240719$20240703$20240722$PER$$US-BIOMARINAP-US-2024-158935$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
240480041$24048004$1$I$20190701$20240625$20240703$20240703$EXP$$CA-AMGEN-CANSP2024129333$AMGEN$$57$YR$A$F$Y$97.506$KG$20240703$$HP$CA$CA
240480051$24048005$1$I$20240627$20240630$20240703$20240703$EXP$$US-009507513-2407USA000873$MERCK$$79$YR$$F$Y$$$20240703$$CN$US$US
240480061$24048006$1$I$20240201$20240701$20240703$20240703$EXP$$NVSC2024DE137252$NOVARTIS$$50$YR$$F$Y$$$20240704$$MD$DE$DE
240480082$24048008$2$F$$20240611$20240703$20240703$PER$$US-ROCHE-10000012031$ROCHE$$$$$$Y$$$20240704$$CN$US$US
240480091$24048009$1$I$$20240628$20240703$20240703$EXP$$NVSJ2024JP007333$NOVARTIS$$77$YR$$M$Y$$$20240704$$PH$JP$JP
240480101$24048010$1$I$20240501$20240624$20240703$20240703$EXP$$DE-JNJFOC-20240641700$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$DE$DE
240480112$24048011$2$F$20240602$20240805$20240703$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-104658$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240814$$MD$JP$JP
240480131$24048013$1$I$20240628$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024129255$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240480141$24048014$1$I$$20240625$20240703$20240703$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP007831$STRIDES$Naghibi SM, Hosseini SH.. Improved anorgasmia following add-on lamotrigine treatment.. Trends-Pharm-Sci. 2023;9 (4):239-242$31$YR$$M$Y$$$20240704$$MD$IR$IR
240480151$24048015$1$I$$20240625$20240703$20240703$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP007834$STRIDES$Nakamura Y, Kikumoto N, Takeuchi H, Kimura T, Nakamori M, Fujiwara K.. Combination Biologic Therapy with Mepolizumab and Dupilumab for Severe Eosinophilic Granulomatosis with Polyangiitis and Chronic Rhinosinusitis with Nasal Polyp.. Yonago-Acta-Med. 2024;67 (2):157-162$6$DEC$$F$Y$$$20240704$$HP$JP$JP
240480161$24048016$1$I$20230101$20240625$20240703$20240703$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP007835$STRIDES$Gonzalez-Romero MF, Martinez-Avila JM, Moloney E, Garcia-Cabeza I.. Aversive agents: Think twice. A case report on disulfiram-induced mania.. Bipolar-Disord. 2024;26 (4):395-397$26$YR$$M$Y$67$KG$20240704$$HP$ES$ES
240480171$24048017$1$I$$20240625$20240703$20240703$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007840$STRIDES$Calderon Barahona GM, Ali R, Ortega Giron C, Ng W, Bobrysheva H, Calderon Martinez E, et al.. Beta-Blocked: A Severe Propranolol Overdose Case Report. Am-J-Respir-Crit-Care-Med. 2024;209$25$YR$$F$Y$$$20240704$$HP$US$US
240480191$24048019$1$I$$20240625$20240703$20240703$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP007837$STRIDES$Celardo G, Scaffei E, Buchignani B, Donatelli G, Costagli M, Cristofani P, et al.. Case report: Exploring chemoradiotherapy-induced leukoencephalopathy with 7T imaging and quantitative susceptibility mapping. Front-Neurol. 2024;15:1-6.$9$YR$$M$Y$$$20240704$$HP$IT$IT
240480201$24048020$1$I$$20240628$20240703$20240703$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037180$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240704$$CN$US$US
240480211$24048021$1$I$$20240625$20240703$20240703$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP007841$STRIDES$Knorr F, Schellekens KPJ, Schoot RA, Landman-Parker J, Teltschik H-M, Forster J, et al.. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma.. Haematologica. 2023;108 (5):1442-1446.$17$YR$$M$Y$$$20240704$$HP$DE$DE
240480221$24048022$1$I$$20240625$20240703$20240703$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP007842$STRIDES$Knorr F, Schellekens KPJ, Schoot RA, Landman-Parker J, Teltschik H-M, Forster J, et al.. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma.. Haematologica. 2023;108 (5):1442-1446.$11$YR$$M$Y$$$20240704$$HP$DE$DE
240480231$24048023$1$I$$20240625$20240703$20240703$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP007846$STRIDES$Jabiry-Zieniewicz Z, Stelmach DA, Jasak K, Knap-Wielgus W, Szumska A, Raszeja-Wyszomirska J, et al.. Pregnancies in Women After Liver Transplant due to Wilson^s Disease-Case Series.. Transplant-Proc. 2024;56 (4):919-922.$28$YR$$F$Y$$$20240704$$HP$PL$PL
240480241$24048024$1$I$$20240625$20240703$20240703$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP007851$STRIDES$Jabiry-Zieniewicz Z, Stelmach DA, Jasak K, Knap-Wielgus W, Szumska A, Raszeja-Wyszomirska J, et al.. Pregnancies in Women After Liver Transplant due to Wilson^s Disease-Case Series.  ;. Transplant-Proc. 2024;56 (4)::919-922.$$$$$Y$$$20240704$$HP$PL$PL
240480251$24048025$1$I$$20240618$20240703$20240703$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06192$NEUROCRINE BIOSCIENCES$$77$YR$$F$Y$$$20240704$$MD$US$US
240480262$24048026$2$F$20240101$20240826$20240703$20240829$EXP$$US-AMGEN-USASL2024128253$AMGEN$$50$YR$A$F$Y$$$20240829$$HP$US$US
240480271$24048027$1$I$$20240625$20240703$20240703$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007784$STRIDES$Grodsky JD, Doshi R, Riaz KM.. Medical management and visual rehabilitation of limbal niche dysfunction.. J-Cataract-Refract-Surg. 2020;46 (2):312-316$61$YR$$F$Y$$$20240704$$MD$US$US
240480281$24048028$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138291$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
240480291$24048029$1$I$$20240622$20240703$20240703$EXP$$CA-SANDOZ INC.-NVSC2023CA004038$SANDOZ$$$$$F$Y$$$20240703$$CN$CA$CA
240480301$24048030$1$I$$20240625$20240703$20240703$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP007787$STRIDES$Nan N, Pan L, Dong R, Song X.. Mismatch of systematic and local inflammatory activity in Takayasu arteritis with coronary involvement: A case report.. Eur-Heart-J-Case-Rep. 2023;7 (8)$31$YR$$F$Y$$$20240704$$HP$CN$CN
240480311$24048031$1$I$20240625$20240627$20240703$20240703$EXP$$US-ABBVIE-5821362$ABBVIE$$48$YR$$F$Y$$$20240703$$CN$US$US
240480321$24048032$1$I$$20240701$20240703$20240703$EXP$$US-ABBVIE-5824263$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240480331$24048033$1$I$$20230912$20240703$20240703$PER$$US-AMGEN-USASP2023235032$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240480341$24048034$1$I$$20240625$20240703$20240703$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP007792$STRIDES$Knorr F, Schellekens KPJ, Schoot RA, Landman-Parker J, Teltschik H-M, Forster J, et al.. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma.. Haematologica. 2023;108 (5):1442-1446.$6$YR$$M$Y$$$20240704$$HP$DE$DE
240480351$24048035$1$I$$20240618$20240703$20240703$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06227$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240704$$HP$US$US
240480361$24048036$1$I$20240629$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106072$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240704$$CN$US$US
240480371$24048037$1$I$$20240618$20240703$20240703$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06547$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240704$$HP$US$US
240480381$24048038$1$I$$20231010$20240703$20240703$PER$$US-AMGEN-USASP2023235134$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240480391$24048039$1$I$$20240627$20240703$20240703$EXP$$NVSC2024US127846$NOVARTIS$$$$$M$Y$$$20240704$$CN$US$US
240480401$24048040$1$I$$20230808$20240703$20240703$PER$$US-AMGEN-USASP2023235086$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240480411$24048041$1$I$$20230619$20240703$20240703$PER$$US-AMGEN-USASP2023235038$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240480421$24048042$1$I$20240101$20240703$20240703$20240703$EXP$$DE-JNJFOC-20240708674$JOHNSON AND JOHNSON$$82$YR$E$F$Y$58$KG$20240704$$MD$DE$DE
240480432$24048043$2$F$$20240708$20240703$20240709$PER$$US-JNJFOC-20240704252$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240480441$24048044$1$I$$20240702$20240703$20240703$PER$$NVSC2024US138290$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
240480451$24048045$1$I$20240601$20240625$20240703$20240703$EXP$SE-SEMPA-2024-004939$SE-TEVA-VS-3214457$TEVA$$98$YR$$F$Y$$$20240703$$MD$SE$SE
240480461$24048046$1$I$20240524$20240610$20240703$20240703$PER$$US-009507513-2406USA003390$MERCK$$72$YR$$M$Y$$$20240703$$CN$US$US
240480471$24048047$1$I$$20240701$20240703$20240703$EXP$$IT-SANDOZ INC.-NVSC2022IT145954$SANDOZ$$45$YR$$F$Y$$$20240703$$MD$IT$IT
240480481$24048048$1$I$$20240621$20240703$20240703$PER$$US-009507513-2406USA008613$MERCK$Mohammadi A., Akhondi  H., Joshi DR., Mirabbasi SA.. Rare Pathogens in Peritoneal Dialysis-Associated Peritonitis: A Comprehensive Case Study and Guideline Review. American Journal of Case Reports. 2024;25$80$YR$$F$Y$$$20240703$$HP$US$US
240480492$24048049$2$F$$20240711$20240703$20240717$EXP$$BR-009507513-2407BRA000355$MERCK$$$$$F$Y$$$20240717$$MD$BR$BR
240480501$24048050$1$I$20201201$20240621$20240703$20240703$EXP$$PL-ROCHE-10000014344$ROCHE$$49$YR$A$M$Y$$$20240704$$MD$PL$PL
240480511$24048051$1$I$$20240628$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105648$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240704$$CN$US$US
240480521$24048052$1$I$$20240628$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104240$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$CN$US$US
240480531$24048053$1$I$$20240701$20240703$20240703$EXP$$JP-TAKEDA-2024TJP009900$TAKEDA$$5$DEC$$F$Y$$$20240703$$MD$JP$JP
240480541$24048054$1$I$20240510$20240625$20240703$20240703$EXP$ES-AEMPS-1536027$ES-TEVA-VS-3214463$TEVA$$47$YR$$F$Y$$$20240703$$HP$ES$ES
240480552$24048055$2$F$20240528$20240620$20240703$20240704$EXP$$CN-ROCHE-10000008403$ROCHE$$73$YR$E$M$Y$57$KG$20240704$$HP$CN$CN
240480562$24048056$2$F$$20240716$20240703$20240722$EXP$$JP-GSK-JP2024080755$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$MD$JP$JP
240480571$24048057$1$I$$20231019$20240703$20240703$PER$$US-AMGEN-USASP2023235050$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240480582$24048058$2$F$$20240703$20240703$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105087$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240704$$CN$US$US
240480611$24048061$1$I$20240401$20240626$20240703$20240703$PER$$US-SA-2024SA193754$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240704$$PH$US$US
240480631$24048063$1$I$$20230330$20240703$20240703$PER$$US-AMGEN-USASP2023235033$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240480642$24048064$2$F$$20240718$20240703$20240729$EXP$$JP-AMGEN-JPNSP2024130549$AMGEN$$$$$$Y$$$20240729$$PH$JP$JP
240480651$24048065$1$I$$20230912$20240703$20240703$PER$$US-AMGEN-USASP2023235162$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240480661$24048066$1$I$$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106133$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$49.9$KG$20240704$$HP$US$US
240480671$24048067$1$I$20240617$20240626$20240703$20240703$EXP$$CN-BEIGENE-BGN-2024-009865$BEIGENE$$$$$$Y$$$20240703$$HP$CN$CN
240480691$24048069$1$I$20231226$20240625$20240703$20240703$EXP$NO-NOMAADVRE-RELISSO-2024-00102$NO-TEVA-VS-3214470$TEVA$$55$YR$$M$Y$$$20240703$$MD$NO$NO
240480701$24048070$1$I$$20230619$20240703$20240703$PER$$US-AMGEN-USASP2023235044$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240480711$24048071$1$I$$20240701$20240703$20240703$EXP$$US-ABBVIE-5823953$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240480721$24048072$1$I$20240612$20240626$20240703$20240703$EXP$$CN-BEIGENE-BGN-2024-009868$BEIGENE$$$$$$Y$$$20240703$$HP$CN$CN
240480731$24048073$1$I$$20240624$20240703$20240703$EXP$$CN-JNJFOC-20240708193$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$MD$CN$CN
240480742$24048074$2$F$$20240805$20240703$20240809$EXP$$JP-GSK-JP2024JPN080024$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$PH$JP$JP
240480753$24048075$3$F$$20240912$20240703$20240919$EXP$$BR-TAKEDA-2024TUS067103$TAKEDA$$$$$M$Y$$$20240919$$CN$BR$BR
240480762$24048076$2$F$20240601$20240702$20240703$20240705$PER$$US-ABBVIE-5820042$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240480771$24048077$1$I$20240601$20240624$20240703$20240703$EXP$$US-BAUSCHBL-2024BNL029164$BAUSCH AND LOMB$$90$YR$$F$Y$$$20240704$$CN$US$US
240480781$24048078$1$I$20230801$20240628$20240703$20240703$EXP$$NVSJ2024JP007801$NOVARTIS$$73$YR$$M$Y$$$20240704$$MD$JP$JP
240480791$24048079$1$I$$20240627$20240703$20240703$EXP$$CN-BEIGENE-BGN-2024-009886$BEIGENE$$$$$$Y$$$20240703$$HP$CN$CN
240480801$24048080$1$I$$20240627$20240703$20240703$EXP$$AU-BEIGENE-BGN-2024-009912$BEIGENE$$$$$$Y$$$20240703$$HP$AU$AU
240480811$24048081$1$I$20240621$20240621$20240703$20240703$PER$$US-009507513-2406USA008190$MERCK$$69$YR$$M$Y$$$20240703$$CN$US$US
240480821$24048082$1$I$$20231004$20240703$20240703$PER$$US-AMGEN-USASP2023235040$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240480831$24048083$1$I$$20240628$20240703$20240703$EXP$$US-AMGEN-USASP2024129546$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240480841$24048084$1$I$$20231114$20240703$20240703$PER$$US-AMGEN-USASP2023235269$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240480851$24048085$1$I$$20230907$20240703$20240703$PER$$US-AMGEN-USASP2023235259$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240480861$24048086$1$I$$20231024$20240703$20240703$PER$$US-AMGEN-USASP2023235246$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240480873$24048087$3$F$20240625$20240723$20240703$20240727$EXP$$IT-ABBVIE-5824712$ABBVIE$$66$YR$$F$Y$$$20240727$$MD$IT$IT
240480891$24048089$1$I$$20240627$20240703$20240703$EXP$$AU-BEIGENE-BGN-2024-009887$BEIGENE$$$$$$Y$$$20240703$$HP$AU$AU
240480902$24048090$2$F$$20240722$20240703$20240728$EXP$$JP-GSK-JP2024080748$GLAXOSMITHKLINE$$$$$$Y$$$20240728$$PH$JP$JP
240480911$24048091$1$I$$20240627$20240703$20240703$EXP$$US-ABBVIE-5821451$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240480931$24048093$1$I$$20230828$20240703$20240703$PER$$US-AMGEN-USASP2023235198$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240480941$24048094$1$I$$20240627$20240703$20240703$EXP$$IE-BEIGENE-BGN-2024-009895$BEIGENE$$$$$$Y$$$20240703$$MD$IE$IE
240480952$24048095$2$F$20240606$20240702$20240703$20240708$EXP$$US-ABBVIE-5823322$ABBVIE$$71$YR$$M$Y$$$20240708$$CN$US$US
240480961$24048096$1$I$20240213$20240625$20240703$20240703$EXP$FR-AFSSAPS-TO2024001034$FR-TEVA-VS-3214472$TEVA$$45$YR$$M$Y$$$20240703$$HP$FR$FR
240480971$24048097$1$I$20240401$20240702$20240703$20240703$EXP$$US-ABBVIE-5824979$ABBVIE$$75$YR$$M$Y$$$20240703$$CN$US$US
240480982$24048098$2$F$20230125$20240819$20240703$20240821$EXP$$NVSJ2024JP007811$NOVARTIS$$82$YR$$M$Y$$$20240822$$MD$JP$JP
240480992$24048099$2$F$20240101$20240630$20240703$20240705$EXP$$US-ABBVIE-5824675$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240481001$24048100$1$I$$20230626$20240703$20240703$PER$$US-AMGEN-USASP2023235034$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240481011$24048101$1$I$$20230803$20240703$20240703$PER$$US-AMGEN-USASP2023235098$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240481021$24048102$1$I$$20230729$20240703$20240703$PER$$US-AMGEN-USASP2023235182$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240481031$24048103$1$I$$20240627$20240703$20240703$EXP$$IE-BEIGENE-BGN-2024-009904$BEIGENE$$$$$$Y$$$20240703$$HP$IE$IE
240481041$24048104$1$I$$20240627$20240703$20240703$EXP$$CN-BEIGENE-BGN-2024-009903$BEIGENE$$$$$$Y$$$20240703$$HP$CN$CN
240481051$24048105$1$I$$20240124$20240703$20240703$PER$$US-AMGEN-USASP2024129621$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240481061$24048106$1$I$20230101$20240701$20240703$20240703$EXP$$US-ABBVIE-5729704$ABBVIE$$75$YR$$M$Y$$$20240703$$HP$US$US
240481072$24048107$2$F$20230701$20240705$20240703$20240708$EXP$$US-ABBVIE-5825036$ABBVIE$$72$YR$$F$Y$63$KG$20240708$$CN$US$US
240481081$24048108$1$I$$20240625$20240703$20240703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-104404$BRISTOL MYERS SQUIBB$Nagata Y. Impact of second primary malignancy developing after autotransplantation for multiple myeloma. Hematology. 2024; 88(4); 395-400$$$$M$Y$$$20240704$$MD$JP$JP
240481093$24048109$3$F$$20240815$20240703$20240815$PER$$NVSC2024US138197$NOVARTIS$$$$$M$Y$$$20240815$$CN$US$US
240481101$24048110$1$I$20230101$20240620$20240703$20240703$EXP$$JP-COLLEGIUM PHARMACEUTICAL, INC.-20240600494$COLLEGIUM PHARMACEUTICAL$$60$DEC$$M$Y$$$20240703$$MD$JP$JP
240481111$24048111$1$I$20240616$20240702$20240703$20240703$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105883$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$94.8$KG$20240704$$PH$US$US
240481151$24048115$1$I$$20230516$20240703$20240703$PER$$US-AMGEN-USASP2023235166$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240481162$24048116$2$F$$20240802$20240703$20240809$EXP$$NVSJ2024JP007723$NOVARTIS$$80$YR$$M$Y$$$20240809$$PH$JP$JP
240481171$24048117$1$I$$20240702$20240703$20240703$PER$$US-HALEON-2185126$Haleon PLC$$79$YR$$F$Y$$$20240703$$CN$US$US
240481181$24048118$1$I$20240611$20240624$20240703$20240703$EXP$NO-NOMAADVRE-RELISN-2024-Vdkd4e$NO-ROCHE-10000008991$ROCHE$$63$YR$A$F$Y$$$20240704$$MD$NO$NO
240481191$24048119$1$I$$20240628$20240703$20240703$PER$$US-AMGEN-USASP2024130409$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240481202$24048120$2$F$$20240705$20240703$20240711$EXP$$US-BIOGEN-2024BI01271641$BIOGEN$$$$$M$Y$$$20240711$$HP$US$US
240481213$24048121$3$F$20231010$20240710$20240703$20240716$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-106128$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$80$KG$20240716$$MD$AT$AT
240481222$24048122$2$F$$20240708$20240703$20240718$EXP$$US-TEVA-VS-3214518$TEVA$Sasidharan S, Ouyang J, Jatoi T, Mallappallil M, Puri I, Agarwal S. Myxedema Coma Triggering BRASH Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209.; Sasidharan S, Ouyang J, Jatoi T, Mallappallil M, Puri I, Agarwal S. Myxedema Coma Triggering BRASH Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209.$56$YR$$F$Y$$$20240718$$HP$US$US
240481233$24048123$3$F$20240610$20240701$20240703$20240710$EXP$$NVSC2024GB137100$NOVARTIS$$51$YR$$M$Y$$$20240710$$CN$GB$GB
240481241$24048124$1$I$20240620$20240627$20240703$20240703$EXP$$NVSJ2024JP005964$NOVARTIS$$$$$F$Y$$$20240704$$MD$JP$JP
240481252$24048125$2$F$$20240310$20240703$20240913$PER$$US-HALEON-2185049$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
240481261$24048126$1$I$$20240620$20240703$20240703$EXP$$US-BAUSCHBL-2024BNL028951$BAUSCH AND LOMB$Ghose M, Anwar M, Rajamohan A, Vangala A, Roy P, Weiner M. Vancomycin Induced Anaphylaxis Presenting With Cardiac Arrest: Judicious Use of Antibiotic in Low Risk Procedures. American Journal of Respiratory and Critical Care Medicine. 2024 MAY 01;209:1-3.$$$$F$Y$$$20240704$$MD$US$US
240481271$24048127$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA194088$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240704$$MD$US$US
240481281$24048128$1$I$20240630$20240701$20240703$20240703$PER$$US-AMGEN-USASP2024130587$AMGEN$$65$YR$E$M$Y$$$20240703$$CN$US$US
240481293$24048129$3$F$20240601$20240821$20240703$20240823$PER$$US-AMGEN-USASP2024130608$AMGEN$$75$YR$E$F$Y$$$20240823$$CN$US$US
240481312$24048131$2$F$$20240912$20240703$20240912$PER$$NVSC2024US137745$NOVARTIS$$$$$M$Y$$$20240912$$HP$US$US
240481323$24048132$3$F$20240619$20240719$20240703$20240808$PER$$US-BEH-2024174726$CSL BEHRING$$37$YR$A$F$Y$$$20240808$$CN$US$US
240481331$24048133$1$I$$20240625$20240703$20240703$EXP$$TH-JNJFOC-20240672290$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$MD$TH$TH
240481341$24048134$1$I$20240613$20240701$20240703$20240703$EXP$$DE-ABBVIE-5822727$ABBVIE$$57$YR$$F$Y$80$KG$20240703$$MD$DE$DE
240481351$24048135$1$I$20240625$20240626$20240703$20240703$PER$$US-BAUSCHBL-2024BNL029280$BAUSCH AND LOMB$$73$YR$$F$Y$56$KG$20240704$$CN$US$US
240481362$24048136$2$F$20240101$20240722$20240703$20240725$EXP$$JP-SAKK-2024SA192289AA$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240726$$MD$JP$JP
240481371$24048137$1$I$20240101$20240628$20240703$20240703$EXP$$US-ABBVIE-5821783$ABBVIE$$$$$F$Y$$$20240703$$CN$US$US
240481411$24048141$1$I$$20230915$20240703$20240703$PER$$US-AMGEN-USASP2023235178$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240481421$24048142$1$I$20240520$20240625$20240703$20240703$EXP$FR-AFSSAPS-BR2024000502$FR-TEVA-VS-3214491$TEVA$$80$YR$$F$Y$$$20240703$$MD$FR$FR
240481431$24048143$1$I$20240501$20240627$20240703$20240703$EXP$$CO-ABBVIE-5799350$ABBVIE$$71$YR$$F$Y$77$KG$20240703$$HP$CO$CO
240481442$24048144$2$F$20240623$20240827$20240703$20240903$EXP$$JP-SHIONOGI + CO. LTD-2024001498$SHIONOGI$$$$$$Y$$$20240903$$PH$JP$JP
240481451$24048145$1$I$20240622$20240628$20240703$20240703$EXP$$JP-SHIONOGI INC.-2024001497$SHIONOGI$$$$$$Y$$$20240703$$PH$JP$JP
240481462$24048146$2$F$$20240708$20240703$20240718$EXP$$US-TEVA-VS-3214519$TEVA$Kasireddy T, George A, Martin KB. A Drug Reaction Waking Up a Virus. Am-J-Respir-Crit-Care-Med 2024; 209.; Kasireddy T, George A, Martin KB. A Drug Reaction Waking Up a Virus. Am-J-Respir-Crit-Care-Med 2024; 209.$75$YR$$M$Y$$$20240718$$HP$US$US
240481472$24048147$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3214367$TEVA$Alam S, Cheungpasitporn W, Kukla A. UNRAVELING POWASSAN ENCEPHALITIS AFTER A KIDNEY-PANCREAS TRANSPLANT: CASE REPORT AND IMPLICATION. Am-J-Kidney-Dis 2024; 83 (Suppl. 2) (4): S140 abstr. 457.; Alam S, Cheungpasitporn W, Kukla A. UNRAVELING POWASSAN ENCEPHALITIS AFTER A KIDNEY-PANCREAS TRANSPLANT: CASE REPORT AND IMPLICATION. Am-J-Kidney-Dis 2024; 83 (Suppl. 2) (4): S140 abstr. 457.$57$YR$$F$Y$$$20240717$$HP$US$US
240481481$24048148$1$I$$20240626$20240703$20240703$PER$$US-BAUSCHBL-2024BNL029288$BAUSCH AND LOMB$$80$YR$$M$Y$$$20240704$$CN$US$US
240481492$24048149$2$F$20240627$20240725$20240703$20240802$PER$$US-SA-2024SA194263$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240802$$CN$US$US
240481502$24048150$2$F$20240501$20240718$20240703$20240724$EXP$$JP-SA-2024SA192281$SANOFI AVENTIS$$19$YR$A$M$Y$70$KG$20240724$$MD$JP$JP
240481511$24048151$1$I$20230616$20240619$20240703$20240703$PER$$US-009507513-2406USA006605$MERCK$$68$YR$$M$Y$$$20240703$$CN$US$US
240481521$24048152$1$I$20191119$20240624$20240703$20240703$EXP$$CA-TAKEDA-2024TUS024722$TAKEDA$$$$A$F$Y$$$20240703$$CN$CA$CA
240481531$24048153$1$I$20240615$20240628$20240703$20240703$EXP$$CA-ABBVIE-5825110$ABBVIE$$70$YR$$M$Y$$$20240703$$PH$CA$CA
240481541$24048154$1$I$20240615$20240626$20240703$20240703$EXP$$GB-JNJFOC-20240673313$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20240704$$HP$GB$GB
240481553$24048155$3$F$$20240730$20240703$20240808$30DAY$$FR-JNJFOC-20240649705$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240808$$PH$FR$FR
240481561$24048156$1$I$$20240112$20240703$20240703$PER$$US-AMGEN-USASP2024129992$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240481572$24048157$2$F$$20240712$20240703$20240719$PER$$US-AMGEN-USASP2024129993$AMGEN$$$$$$Y$$$20240719$$PH$US$US
240481583$24048158$3$F$$20240913$20240703$20240919$EXP$$US-ROCHE-10000008173$ROCHE$$$$E$F$Y$95.25$KG$20240919$$CN$US$US
240481661$24048166$1$I$20240618$20240627$20240703$20240703$EXP$$TW-PFIZER INC-PV202400084923$PFIZER$$$$E$F$Y$$$20240703$$HP$TW$TW
240481691$24048169$1$I$20240529$20240628$20240703$20240703$EXP$$CN-ABBVIE-5823638$ABBVIE$$53$YR$$F$Y$93$KG$20240703$$HP$CN$CN
240481701$24048170$1$I$20240615$20240701$20240703$20240703$EXP$IT-MINISAL02-993014$IT-ABBVIE-5822525$ABBVIE$$65$YR$$M$Y$$$20240703$$MD$IT$IT
240481711$24048171$1$I$20240305$20240625$20240703$20240703$EXP$FR-AFSSAPS-LM2024000328$FR-TEVA-VS-3214562$TEVA$$90$YR$$M$Y$$$20240703$$PH$FR$FR
240481721$24048172$1$I$$20240628$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US061737$SANDOZ$$$$$M$Y$$$20240703$$CN$US$US
240481731$24048173$1$I$$20240627$20240703$20240703$PER$$US-BAUSCHBL-2024BNL029318$BAUSCH AND LOMB$$35$YR$$F$Y$$$20240704$$CN$US$US
240481741$24048174$1$I$$20240623$20240703$20240703$EXP$GB-MHRA-MED-202406230715043650-LSZJH$GB-UCBSA-2024031907$UCB$$$$$F$Y$60$KG$20240704$$CN$GB$GB
240481751$24048175$1$I$$20240701$20240703$20240703$EXP$$US-ABBVIE-5823491$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240481761$24048176$1$I$$20240624$20240703$20240703$EXP$$US-TEVA-VS-3214183$TEVA$Jamison T, Kantarjian HM, Paul S, Cuglievan B, McCall D, Jain N, et al. ^Dose-Dense^ Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves High Rates of Rapid MRD-Negativity in Patients with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia: A Retrospective Analysis. Blood 2023; 142 (Suppl. 1) 1508.$$$$$Y$$$20240703$$HP$US$US
240481771$24048177$1$I$$20240627$20240703$20240703$PER$$US-SA-2024SA192845$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240704$$HP$US$US
240481781$24048178$1$I$20240101$20240626$20240703$20240703$PER$$US-SA-2024SA194434$SANOFI AVENTIS$$53$YR$A$F$Y$90$KG$20240704$$MD$US$US
240481791$24048179$1$I$20240521$20240621$20240703$20240703$EXP$FR-AFSSAPS-NC2024000728$FR-ELI_LILLY_AND_COMPANY-FR202406015885$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240703$$CN$FR$FR
240481802$24048180$2$F$20240622$20240628$20240703$20240711$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407000486$ELI LILLY AND CO$$61$YR$A$F$Y$52$KG$20240711$$CN$CN$CN
240481811$24048181$1$I$20230420$20240620$20240703$20240703$EXP$PT-INFARMED-E202406-437$PT-ELI_LILLY_AND_COMPANY-PT202406015064$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240703$$CN$PT$PT
240481821$24048182$1$I$20240610$20240620$20240703$20240703$EXP$ES-AEMPS-1536844$ES-ELI_LILLY_AND_COMPANY-ES202406015059$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240703$$CN$ES$ES
240481831$24048183$1$I$20240605$20240621$20240703$20240703$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406015891$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240703$$CN$CN$CN
240481842$24048184$2$F$$20240729$20240703$20240812$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202406013998$ELI LILLY AND CO$Mulchandani M, Conrad A..Extreme behavioural and psychological symptoms of dementia: a case study.BMC-Psychiatry 2024;24:.$76$YR$E$M$Y$$$20240812$$HP$AU$AU
240481851$24048185$1$I$20240510$20240624$20240703$20240703$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407000916$ELI LILLY AND CO$$68$YR$E$M$Y$51$KG$20240703$$CN$DE$JP
240481861$24048186$1$I$20240101$20240625$20240703$20240703$EXP$$DE-JNJFOC-20240618760$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$MD$DE$DE
240481872$24048187$2$F$$20240626$20240703$20240911$EXP$$US-JNJFOC-20240672403$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$HP$US$US
240481881$24048188$1$I$$20240625$20240703$20240703$EXP$$PL-JNJFOC-20240666956$JOHNSON AND JOHNSON$$68$YR$E$$Y$$$20240704$$MD$PL$PL
240481891$24048189$1$I$$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106452$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240704$$CN$US$US
240481901$24048190$1$I$20230101$20240701$20240703$20240703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106429$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$104.33$KG$20240704$$CN$US$US
240481912$24048191$2$F$20240101$20240826$20240703$20240917$PER$$US-SA-2024SA192433$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240918$$MD$US$US
240481952$24048195$2$F$20240201$20240702$20240703$20240709$EXP$$US-ABBVIE-5823807$ABBVIE$$76$YR$$M$Y$73.935$KG$20240709$$CN$US$US
240481963$24048196$3$F$20240601$20240703$20240703$20240708$PER$$US-AMGEN-USASP2024131987$AMGEN$$71$YR$E$M$Y$$$20240708$$HP$US$US
240481971$24048197$1$I$20240623$20240626$20240703$20240703$PER$$US-ROCHE-10000013446$ROCHE$$$$A$M$Y$61$KG$20240704$$HP$US$US
240481981$24048198$1$I$20240628$20240628$20240703$20240703$PER$$US-GILEAD-2024-0679038$GILEAD$$34$YR$A$F$Y$$$20240703$$HP$US$US
240481991$24048199$1$I$$20240627$20240703$20240703$EXP$$US-ABBVIE-5821560$ABBVIE$$$$$M$Y$$$20240703$$CN$US$US
240482001$24048200$1$I$20240601$20240701$20240703$20240703$EXP$$US-ABBVIE-5822746$ABBVIE$$64$YR$$F$Y$$$20240703$$CN$US$US
240482011$24048201$1$I$20240501$20240627$20240703$20240703$PER$$US-AMGEN-USASP2024129537$AMGEN$$90$YR$E$M$Y$$$20240703$$CN$US$US
240482022$24048202$2$F$20240101$20240712$20240703$20240726$PER$$US-SA-2024SA195354$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240726$$MD$US$US
240482031$24048203$1$I$20240626$20240626$20240703$20240703$EXP$$US-JNJFOC-20240675503$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240704$$MD$US$US
240482042$24048204$2$F$$20240712$20240703$20240715$30DAY$$US-ABBVIE-5823154$ABBVIE$$$$$$Y$$$20240715$$CN$US$US
240482062$24048206$2$F$20240527$20240702$20240703$20240711$EXP$$BR-CELLTRION INC.-2024BR015767$CELLTRION$$$$$$Y$$$20240711$$CN$BR$BR
240482072$24048207$2$F$$20240708$20240703$20240717$EXP$$US-TEVA-VS-3214203$TEVA$Balasubramanian P, Moreau C, Ahmad T, Inzucchi SE. Extreme High Insulin Requirements in Two Non- Diabetic Patients Following Cardiac Transplantation. J-Endocr-Soc 2021; 5 (Suppl. 1) A383.; Balasubramanian P, Moreau C, Ahmad T, Inzucchi SE. Extreme High Insulin Requirements in Two Non- Diabetic Patients Following Cardiac Transplantation. J-Endocr-Soc 2021; 5 (Suppl. 1) A383.$59$YR$$M$Y$$$20240717$$MD$US$US
240482081$24048208$1$I$$20240701$20240703$20240703$EXP$$US-SANDOZ INC.-SDZ2024US062194$SANDOZ$$$$$F$Y$$$20240703$$LW$US$US
240482091$24048209$1$I$$20240523$20240703$20240703$EXP$$RU-ROCHE-10000011305$ROCHE$$59$YR$A$$Y$$$20240704$$MD$RU$RU
240482101$24048210$1$I$$20240625$20240703$20240703$EXP$$ZA-JNJFOC-20240668504$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$MD$ZA$ZA
240482111$24048211$1$I$20240624$20240628$20240703$20240703$EXP$$CN-SANDOZ INC.-SDZ2024CN062404$SANDOZ$$8$YR$$M$Y$26$KG$20240703$$HP$CN$CN
240482121$24048212$1$I$$20240626$20240703$20240703$PER$$US-ABBVIE-5819833$ABBVIE$$$$$$Y$$$20240703$$HP$US$US
240482141$24048214$1$I$20240601$20240625$20240703$20240703$PER$$US-ABBVIE-5818692$ABBVIE$$70$YR$$F$Y$$$20240703$$HP$US$US
240482151$24048215$1$I$$20240701$20240703$20240703$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010196$JAZZ$$$$$M$Y$$$20240703$$HP$US$US
240482167$24048216$7$F$20240613$20240902$20240703$20240903$EXP$$US-ASTELLAS-2024US018377$ASTELLAS$$57$YR$A$F$Y$$$20240903$$HP$US$US
240482172$24048217$2$F$$20240627$20240703$20240718$EXP$$TR-ASTELLAS-2024US018546$ASTELLAS$$$$E$$Y$$$20240718$$CN$TR$TR
240482182$24048218$2$F$$20240730$20240703$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106091$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$MD$JP$JP
240482193$24048219$3$F$20211118$20240805$20240703$20240806$EXP$$JP-TAKEDA-2021TJP122609$TAKEDA$$56$YR$$F$Y$42.8$KG$20240806$$HP$JP$JP
240482211$24048221$1$I$$20240628$20240704$20240704$EXP$$US-ABBVIE-5821724$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240482222$24048222$2$F$$20240705$20240704$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106015$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240710$$CN$US$US
240482231$24048223$1$I$20240201$20240701$20240704$20240704$EXP$$MX-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031798$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240704$$CN$MX$MX
240482241$24048224$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA190289$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240704$$CN$US$US
240482251$24048225$1$I$$20240626$20240704$20240704$EXP$$US-ABBVIE-5818991$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240482271$24048227$1$I$$20201105$20240704$20240704$EXP$$JP-TAKEDA-SH202017142$TAKEDA$$14$YR$$F$Y$76$KG$20240704$$PH$JP$JP
240482281$24048228$1$I$20240515$20240625$20240704$20240704$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202406016845$ELI LILLY AND CO$$65$YR$E$M$Y$102$KG$20240703$$CN$GB$GB
240482294$24048229$4$F$$20240925$20240704$20240930$EXP$$US-TAKEDA-2024TUS067139$TAKEDA$$$$$F$Y$49.8$KG$20240930$$HP$US$US
240482301$24048230$1$I$20240506$20240621$20240704$20240704$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202406019526$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240703$$CN$DE$MX
240482317$24048231$7$F$20240301$20240925$20240704$20240930$EXP$$JP-JNJFOC-20240468326$JOHNSON AND JOHNSON$$75$YR$E$M$Y$65$KG$20240930$$HP$JP$JP
240482321$24048232$1$I$$20240702$20240704$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010240$JAZZ$$$$$M$Y$$$20240703$$MD$US$US
240482331$24048233$1$I$20240616$20240626$20240704$20240704$PER$$US-SA-2024SA193680$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240704$$MD$US$US
240482341$24048234$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190308$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240704$$MD$US$US
240482351$24048235$1$I$20240528$20240622$20240704$20240704$EXP$FR-AFSSAPS-PB2024000700$FR-Accord-432517$ACCORD$$60$YR$A$M$Y$$$20240703$$MD$FR$FR
240482361$24048236$1$I$20240611$20240621$20240704$20240704$EXP$CN-HENLIUS-24CN015552$CN-Accord-433310$ACCORD$$60$YR$A$F$Y$50$KG$20240703$$MD$CN$CN
240482371$24048237$1$I$$20240623$20240704$20240704$EXP$$IN-Accord-432720$ACCORD$Edison DC, Philip J, Mallhi RS, Basnotra R, Pynadath V, Sane K. Severe amlodipine toxicity: A medical dilemma managed with therapeutic plasma exchange. Transfus Apher Sci. 2024 Jun 5;63(4):103958.$25$YR$A$M$Y$$$20240703$$HP$IN$IN
240482381$24048238$1$I$20240531$20240625$20240704$20240704$EXP$FR-AFSSAPS-PC2024000524$FR-Accord-432946$ACCORD$$67$YR$E$F$Y$52$KG$20240703$$PH$FR$FR
240482391$24048239$1$I$20240616$20240702$20240704$20240704$EXP$IT-MINISAL02-992699$IT-GSK-IT2024082108$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$MD$IT$IT
240482411$24048241$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131052$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240482421$24048242$1$I$20240630$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130803$AMGEN$$77$YR$E$F$Y$$$20240703$$CN$US$US
240482433$24048243$3$F$20240101$20240812$20240704$20240821$EXP$$US-SA-2024SA195725$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240821$$MD$US$US
240482441$24048244$1$I$20240626$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024129030$AMGEN$$70$YR$E$F$Y$$$20240703$$CN$US$US
240482451$24048245$1$I$20240701$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131971$AMGEN$$69$YR$E$F$Y$$$20240703$$CN$US$US
240482461$24048246$1$I$$20240624$20240704$20240704$PER$$US-AstraZeneca-2024A145951$ASTRAZENECA$$$$$$Y$$$20240704$$CN$US$
240482471$24048247$1$I$20240426$20240701$20240704$20240704$EXP$$US-AstraZeneca-2024A151249$ASTRAZENECA$$31447$DY$$$Y$$$20240704$$CN$US$
240482483$24048248$3$F$20240624$20240705$20240704$20240707$PER$$US-JNJFOC-20240702745$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$US$US
240482491$24048249$1$I$$20240625$20240704$20240704$PER$$US-JNJFOC-20240667560$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240704$$CN$US$US
240482508$24048250$8$F$20240613$20240918$20240704$20240926$EXP$$DE-JNJFOC-20240644296$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240927$$HP$DE$DE
240482511$24048251$1$I$$20240626$20240704$20240704$PER$$US-ABBVIE-5820207$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240482522$24048252$2$F$$20240731$20240704$20240802$PER$$NVSC2024US138322$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
240482551$24048255$1$I$20240601$20240627$20240704$20240704$EXP$$US-ABBVIE-5821397$ABBVIE$$53$YR$$F$Y$$$20240704$$CN$US$US
240482572$24048257$2$F$20240501$20240712$20240704$20240717$EXP$$CO-ABBVIE-5824051$ABBVIE$$66$YR$$F$Y$74$KG$20240717$$HP$CO$CO
240482591$24048259$1$I$$20240625$20240704$20240704$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000230$EMCURE$Al-Moussally F, Tien JJ, Rajagopalan K, Boterosuarez C, Crouse R. Euglycemic Ketoacidosis and Lactic Acidosis Associated With Metformin Toxicity. Cureus. 2024;16(5):e60661$67$YR$$F$Y$$$20240704$$HP$US$US
240482601$24048260$1$I$$20240627$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007798$STRIDES$Syed MJ, Zutshi D, Muzammil SM, Mohamed W.. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care. 2024;40:976-983$61$YR$$M$Y$$$20240704$$HP$US$US
240482611$24048261$1$I$$20240627$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007795$STRIDES$Syed MJ, Zutshi D, Muzammil SM, Mohamed W.. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care. 2024;40:976-983$68$YR$$M$Y$$$20240704$$HP$US$US
240482621$24048262$1$I$20240621$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024130190$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240482631$24048263$1$I$20190101$20240628$20240704$20240704$EXP$$DE-AMGEN-DEUSP2024128648$AMGEN$$38$YR$A$M$Y$$$20240703$$MD$DE$DE
240482641$24048264$1$I$$20240622$20240704$20240704$PER$$US-AMGEN-USASP2024132035$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240482661$24048266$1$I$$20240628$20240704$20240704$PER$$US-JNJFOC-20240676514$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$HP$US$US
240482671$24048267$1$I$20240101$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130212$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240482681$24048268$1$I$$20240627$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007773$STRIDES$Syed MJ, Zutshi D, Muzammil SM, Mohamed W.. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care. 2024;40:976-983$58$YR$$M$Y$$$20240704$$HP$US$US
240482691$24048269$1$I$$20240624$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-031781$AUROBINDO$Hussain M, Tiwana HZJ, Sivanandham R, Barsoum A, Bagheri S, Hussain S, et al. Aripiprazole Induced Diabetic Ketoacidosis and Hypertriglyceridemia Triggering Concurrent Pancreatitis: A Case Report. Am-J-Respir-Crit-Care-Med. 2024$35$YR$$M$Y$$$20240704$$HP$US$US
240482701$24048270$1$I$$20240618$20240704$20240704$30DAY$$US-SANDOZ INC.-SDZ2024US062560$SANDOZ$$$$$F$Y$$$20240704$$CN$US$US
240482711$24048271$1$I$$20240702$20240704$20240704$EXP$$US-SANDOZ INC.-SDZ2023US073042$SANDOZ$$$$$F$Y$$$20240704$$CN$US$US
240482721$24048272$1$I$$20240627$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007774$STRIDES$Syed MJ, Zutshi D, Muzammil SM, Mohamed W.. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series.. Neurocrit-Care. 2024;40:976-983$72$YR$$F$Y$$$20240704$$HP$US$US
240482731$24048273$1$I$$20240620$20240704$20240704$EXP$$CA-ROCHE-10000010298$ROCHE$$65$YR$E$F$Y$$$20240704$$HP$CA$CA
240482743$24048274$3$F$$20240625$20240704$20240708$EXP$$US-JNJFOC-20240676039$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240708$$CN$US$US
240482751$24048275$1$I$$20240627$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007775$STRIDES$Syed MJ, Zutshi D, Muzammil SM, Mohamed W.. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care. 2024;40:976-983$67$YR$$M$Y$$$20240704$$HP$US$US
240482761$24048276$1$I$$20240625$20240704$20240704$EXP$$CH-ABBVIE-5824411$ABBVIE$$$$$F$Y$$$20240704$$MD$CH$CH
240482772$24048277$2$F$$20240705$20240704$20240711$EXP$$CA-ABBVIE-5823490$ABBVIE$$20$YR$$F$Y$$$20240711$$CN$CA$CA
240482781$24048278$1$I$20200831$20240626$20240704$20240704$EXP$$BE-CELLTRION INC.-2024BE015739$CELLTRION$$$$$$Y$$$20240704$$PH$BE$BE
240482791$24048279$1$I$$20240701$20240704$20240704$EXP$$US-SANDOZ INC.-SDZ2024US062565$SANDOZ$$$$$F$Y$$$20240704$$MD$US$US
240482802$24048280$2$F$20240101$20240722$20240704$20240731$PER$$US-SA-2024SA193351$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240731$$MD$US$US
240482821$24048282$1$I$20240624$20240625$20240704$20240704$PER$$US-SA-2024SA190334$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240704$$CN$US$US
240482831$24048283$1$I$20240618$20240626$20240704$20240704$EXP$$CN-EMD Serono-2024035347$EMD SERONO INC$$41$YR$A$F$Y$74$KG$20240704$$HP$CN$CN
240482842$24048284$2$F$$20240708$20240704$20240717$EXP$$GR-TEVA-VS-3214499$TEVA$$67$YR$$F$Y$$$20240717$$MD$GR$GR
240482851$24048285$1$I$20240101$20240701$20240704$20240704$EXP$$US-ABBVIE-5824900$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240482861$24048286$1$I$20240628$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129257$AMGEN$$67$YR$E$M$Y$$$20240703$$CN$US$US
240482871$24048287$1$I$$20230307$20240704$20240704$PER$$US-AMGEN-USASP2023235234$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240482881$24048288$1$I$$20231024$20240704$20240704$PER$$US-AMGEN-USASP2023234979$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240482891$24048289$1$I$$20240627$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007776$STRIDES$Syed MJ, Zutshi D, Muzammil SM, Mohamed W.. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series.. Neurocrit-Care. 2024;40:976-983$59$YR$$F$Y$$$20240704$$HP$US$US
240482901$24048290$1$I$20240101$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130532$AMGEN$$77$YR$E$F$Y$$$20240703$$PH$US$US
240482911$24048291$1$I$$20240702$20240704$20240704$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037752$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240704$$CN$US$US
240482922$24048292$2$F$20240101$20240716$20240704$20240724$PER$$US-SA-2024SA193643$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240724$$MD$US$US
240482932$24048293$2$F$$20240702$20240704$20240711$PER$$US-SA-2024SA192620$SANOFI AVENTIS$$$$$F$Y$$$20240711$$CN$US$US
240482942$24048294$2$F$$20240701$20240704$20240710$PER$$US-SA-2024SA195485$SANOFI AVENTIS$$6$YR$C$F$Y$19$KG$20240711$$MD$US$US
240482951$24048295$1$I$$20240627$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007777$STRIDES$Syed MJ, Zutshi D, Muzammil SM, Mohamed W.. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care. 2024;40:976-983$26$YR$$M$Y$$$20240704$$HP$US$US
240482981$24048298$1$I$20240225$20240625$20240704$20240704$EXP$FR-AFSSAPS-DJ2024000690$FR-TEVA-VS-3214544$TEVA$$67$YR$$F$Y$$$20240704$$MD$FR$FR
240482991$24048299$1$I$$20230620$20240704$20240704$PER$$US-AMGEN-USASP2023235046$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240483001$24048300$1$I$$20240509$20240704$20240704$PER$$US-AMGEN-USASP2024129797$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240483012$24048301$2$F$$20240702$20240704$20240712$EXP$AU-MLMSERVICE-20240620-PI108449-00270-1$AU-STRIDES ARCOLAB LIMITED-2024SP007862$STRIDES$Carrozzi A, Chu R, Nigole W, Goldman H, Hope S, Li R, et al.. A case of pneumomediastinum complicating immunotherapy associated pneumonitis.. Respirology case reports. 2024;12(6):e01406$87$YR$$M$Y$$$20240712$$MD$AU$AU
240483022$24048302$2$F$$20240717$20240704$20240724$PER$$US-ALXN-202406USA001719US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
240483031$24048303$1$I$$20240627$20240704$20240704$EXP$$US-ABBVIE-5822738$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240483042$24048304$2$F$20240621$20240828$20240704$20240902$EXP$$JP-ABBVIE-5822766$ABBVIE$$75$YR$$M$Y$$$20240902$$HP$JP$JP
240483052$24048305$2$F$20240622$20240726$20240704$20240729$EXP$$US-ABBVIE-5824299$ABBVIE$$29$YR$$F$Y$$$20240729$$CN$US$US
240483071$24048307$1$I$20240624$20240702$20240704$20240704$EXP$GB-MHRA-MED-202407020713502460-CMJHD$GB-TAKEDA-2024TUS066593$TAKEDA$$33$YR$$F$Y$103$KG$20240704$$HP$GB$GB
240483081$24048308$1$I$20240601$20240627$20240704$20240704$EXP$$US-GSK-US2024080438$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
240483091$24048309$1$I$20240606$20240627$20240704$20240704$EXP$$US-GSK-US2024080399$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
240483101$24048310$1$I$20240611$20240624$20240704$20240704$EXP$$US-ETON PHARMACEUTICALS, INC-2024ETO000148$ETON PHARMACEUTICALS$$$$$$Y$$$20240703$$CN$US$US
240483112$24048311$2$F$$20240712$20240704$20240722$EXP$BD-MLMSERVICE-20240620-PI107440-00232-1$BD-STRIDES ARCOLAB LIMITED-2024SP007863$STRIDES$Bari A, Begum NA, Nobi F, Rashid HU, Akhter N, Islam S.. Varicella zoster virus and cytomegalovirus coinfection in a live related kidney transplant recipient: A case report. Clinical case reports. 2024;12(6):e9089$32$YR$$F$Y$$$20240722$$MD$BD$BD
240483121$24048312$1$I$$20240626$20240704$20240704$EXP$US-MLMSERVICE-20240619-PI104961-00030-1$US-STRIDES ARCOLAB LIMITED-2024SP007907$STRIDES$Postoll-Downs MA, Ozguc F, Vasudevan J, Stawinski PM, Wright R.. Breaking Patterns: A Case of Dieulafoy Lesion in a Young Patient Without Comorbid Conditions.. Cureus. 2024;16(5):e60513$$$$$Y$$$20240704$$MD$US$US
240483131$24048313$1$I$20240101$20240701$20240704$20240704$EXP$$GB-ABBVIE-5824014$ABBVIE$$57$YR$$F$Y$$$20240704$$CN$GB$GB
240483141$24048314$1$I$20240101$20240701$20240704$20240704$EXP$$US-009507513-2407USA000840$MERCK$$$$$F$Y$$$20240704$$CN$US$US
240483151$24048315$1$I$20240630$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130811$AMGEN$$73$YR$E$F$Y$$$20240703$$CN$US$US
240483162$24048316$2$F$$20240909$20240704$20240912$EXP$$IL-ABBVIE-5824149$ABBVIE$$$$$M$Y$$$20240912$$CN$IL$IL
240483174$24048317$4$F$20240101$20240904$20240704$20240911$EXP$$CA-CELLTRION INC.-2024CA015936$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
240483181$24048318$1$I$$20240628$20240704$20240704$EXP$$TR-ABBVIE-5823307$ABBVIE$$$$$F$Y$$$20240704$$MD$TR$TR
240483191$24048319$1$I$$20240701$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105214$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240704$$HP$US$US
240483201$24048320$1$I$$20240702$20240704$20240704$EXP$$US-ABBVIE-5825124$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240483212$24048321$2$F$20240501$20240710$20240704$20240717$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036553$BOEHRINGER INGELHEIM$$47$YR$A$M$Y$62$KG$20240717$$HP$GB$GB
240483221$24048322$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA193014$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240704$$MD$US$US
240483232$24048323$2$F$$20240626$20240704$20240712$EXP$$US-ABBVIE-5825404$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240483241$24048324$1$I$20240509$20240627$20240704$20240704$EXP$$AU-GSK-AU2023APC112311$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$AU$AU
240483251$24048325$1$I$$20240627$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007794$STRIDES$Syed MJ, Zutshi D, Muzammil SM, Mohamed W.. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care. 2024;40:976-983$$$$$Y$$$20240704$$HP$US$US
240483263$24048326$3$F$$20240808$20240704$20240818$30DAY$$US-GSK-US2024AMR082246$GLAXOSMITHKLINE$$$$$F$Y$$$20240818$$CN$US$US
240483272$24048327$2$F$$20240819$20240704$20240826$30DAY$$US-GSK-US2024080436$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$HP$US$US
240483281$24048328$1$I$20240630$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130210$AMGEN$$55$YR$A$M$Y$$$20240703$$CN$US$US
240483292$24048329$2$F$20160101$20240723$20240704$20240801$EXP$$MX-ROCHE-10000010123$ROCHE$$58$YR$A$F$Y$61.5$KG$20240801$$CN$MX$MX
240483301$24048330$1$I$20240101$20240628$20240704$20240704$PER$$US-ABBVIE-5824413$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240483311$24048331$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002168$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240704$$CN$US$US
240483321$24048332$1$I$20240630$20240701$20240704$20240704$EXP$$CN-ABBVIE-5823459$ABBVIE$$51$YR$$F$Y$52$KG$20240704$$MD$CN$CN
240483341$24048334$1$I$$20240626$20240704$20240704$PER$$US-ROCHE-10000014263$ROCHE$$$$E$F$Y$$$20240704$$CN$US$US
240483351$24048335$1$I$$20240701$20240704$20240704$EXP$$US-ABBVIE-5823792$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240483362$24048336$2$F$20240101$20240722$20240704$20240729$PER$$US-SA-2024SA193421$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240729$$MD$US$US
240483371$24048337$1$I$20230519$20240625$20240704$20240704$EXP$$FR-CHATTEMPRD-2024OHG022774$CHATTEM$$$$$F$Y$$$20240704$$MD$FR$FR
240483381$24048338$1$I$$20240627$20240704$20240704$EXP$$US-ABBVIE-5821542$ABBVIE$$$$$F$Y$104.32$KG$20240704$$CN$US$US
240483391$24048339$1$I$$20240703$20240704$20240704$EXP$$LB-BRISTOL-MYERS SQUIBB COMPANY-2024-106526$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240704$$MD$LB$LB
240483401$24048340$1$I$20201130$20240627$20240704$20240704$EXP$DE-BoehringerIngelheim-2021-BI-082583$DE-KOANAAP-SML-DE-2021-00212$Unknown Manufacturer$$66$YR$E$M$Y$75.5$KG$20240704$$MD$DE$DE
240483412$24048341$2$F$$20240708$20240704$20240717$EXP$$JP-TEVA-VS-3214330$TEVA$Yabuki S, Hirai H, Moriya C, Kusano Y, Hasegawa T. Case report: Strong GAD antibody positivity and type 1 diabetes-HLA-susceptible haplotype-DRB1*04:05-DQB1*04:01 in a Japanese patient with immune checkpoint inhibitor-induced type 1 diabetes. Front-Endocrinol-(Lausanne) 2024; 15.; Yabuki S, Hirai H, Moriya C, Kusano Y, Hasegawa T. Case report: Strong GAD antibody positivity and type 1 diabetes-HLA-susceptible haplotype-DRB1*04:05-DQB1*04:01 in a Japanese patient with immune checkpoint inhibit...$66$YR$$M$Y$$$20240717$$HP$JP$JP
240483421$24048342$1$I$$20240627$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007797$STRIDES$Syed MJ, Zutshi D, Muzammil SM, Mohamed W.. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care. 2024;40:976-983$$$$$Y$$$20240704$$HP$US$US
240483431$24048343$1$I$$20240625$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102709$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240704$$CN$US$US
240483441$24048344$1$I$20240601$20240701$20240704$20240704$EXP$$US-ABBVIE-5824614$ABBVIE$$53$YR$$F$Y$$$20240704$$CN$US$US
240483451$24048345$1$I$20240101$20240627$20240704$20240704$EXP$$US-SA-2024SA194708$SANOFI AVENTIS$$81$YR$E$M$Y$98.88$KG$20240704$$MD$US$US
240483461$24048346$1$I$20240628$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129733$AMGEN$$75$YR$E$M$Y$$$20240703$$CN$US$US
240483473$24048347$3$F$20240101$20240903$20240704$20240916$EXP$$US-UCBSA-2024033533$UCB$$$$$F$Y$89.796$KG$20240916$$HP$US$US
240483492$24048349$2$F$$20240701$20240704$20240712$PER$$US-TAKEDA-2024TUS066946$TAKEDA$$$$$F$Y$59$KG$20240712$$HP$US$US
240483501$24048350$1$I$20240101$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106117$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240704$$HP$US$US
240483511$24048351$1$I$$20240701$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106374$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240704$$CN$US$US
240483521$24048352$1$I$20240611$20240625$20240704$20240704$EXP$$CN-SA-2024SA193932$SANOFI AVENTIS$$81$YR$E$F$Y$42$KG$20240704$$HP$CN$CN
240483532$24048353$2$F$20240207$20240626$20240704$20240704$EXP$$IT-CELLTRION INC.-2024IT015798$CELLTRION$$$$$$Y$$$20240704$$MD$IT$IT
240483541$24048354$1$I$$20240701$20240704$20240704$EXP$FI-FIMEA-202402270$FI-UCBSA-2024033247$UCB$$66$YR$$F$Y$$$20240704$$CN$FI$FI
240483551$24048355$1$I$20240101$20240701$20240704$20240704$EXP$$US-UCBSA-2024033531$UCB$$$$$M$Y$$$20240704$$HP$US$US
240483561$24048356$1$I$20240601$20240626$20240704$20240704$EXP$$JP-009507513-2406JPN003766J$MERCK$$$$E$$Y$$$20240704$$PH$JP$JP
240483571$24048357$1$I$20240520$20240625$20240704$20240704$EXP$$CN-009507513-2406CHN009968$MERCK$$83$YR$$F$Y$49.2$KG$20240704$$HP$CN$CN
240483581$24048358$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190391$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240704$$MD$US$US
240483591$24048359$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002348$ELI LILLY AND CO$$62$YR$A$$Y$$$20240704$$CN$US$US
240483601$24048360$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001458$ELI LILLY AND CO$$$$$$Y$$$20240704$$CN$US$US
240483611$24048361$1$I$$20240625$20240704$20240704$EXP$$JP-JNJFOC-20240708415$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240704$$MD$JP$JP
240483624$24048362$4$F$20240628$20240809$20240704$20240816$PER$$US-JNJFOC-20240702681$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240816$$CN$US$US
240483634$24048363$4$F$20240701$20240719$20240704$20240723$PER$$US-JNJFOC-20240702370$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240723$$HP$US$US
240483641$24048364$1$I$20240527$20240627$20240704$20240704$EXP$$US-SA-2024SA195816$SANOFI AVENTIS$$62$YR$A$F$Y$71.2$KG$20240704$$MD$US$US
240483651$24048365$1$I$$20240625$20240704$20240704$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR080317$VIIV$$$$$M$Y$$$20240704$$CN$US$US
240483661$24048366$1$I$20240621$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024130195$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240483674$24048367$4$F$20240702$20240723$20240704$20240724$PER$$US-AMGEN-USASP2024131968$AMGEN$$61$YR$A$F$Y$$$20240724$$CN$US$US
240483681$24048368$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130582$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240483701$24048370$1$I$$20240626$20240704$20240704$PER$$US-009507513-2406USA009451$MERCK$$$$$F$Y$$$20240704$$CN$US$US
240483711$24048371$1$I$$20240620$20240704$20240704$EXP$$US-GRAVITIPHARMA-GRA-2406-US-LIT-0199$GRAVITI PHARMACEUTICALS$Idowu D, Ezema K, Corcoran J, Farkas A.The predictive value of heart rate in determining clinical course after a  bupropion overdose.Clinical Toxicology.22-MAY-2024;NA:1-7$18$YR$A$F$Y$$$20240704$$HP$US$US
240483723$24048372$3$F$20240229$20240809$20240704$20240822$EXP$$JP-AMGEN-JPNSP2024106452$AMGEN$$84$YR$E$M$Y$$$20240822$$MD$JP$JP
240483742$24048374$2$F$20240627$20240805$20240704$20240806$PER$$US-JNJFOC-20240675033$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240807$$HP$US$US
240483751$24048375$1$I$20240627$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024129443$AMGEN$$76$YR$E$F$Y$$$20240703$$CN$US$US
240483762$24048376$2$F$$20240809$20240704$20240812$PER$$US-AMGEN-USASP2024131013$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
240483771$24048377$1$I$$20240625$20240704$20240704$30DAY$$US-GSK-US2024AMR080700$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
240483781$24048378$1$I$20221001$20240627$20240704$20240704$EXP$$US-GSK-US2024080352$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
240483791$24048379$1$I$20240625$20240701$20240704$20240704$EXP$$US-AstraZeneca-2024A151660$ASTRAZENECA$$25368$DY$$F$Y$$$20240704$$CN$US$
240483801$24048380$1$I$$20240627$20240704$20240704$EXP$$US-CIPLA LTD.-2024US06824$CIPLA$Sinha A, Cantrell S, Kozman DM, Jelovsek JE. Ectopic prostatic tissue in female urethral diverticulum. Obstetrics and gynecology. 2024$$$$$Y$$$20240704$$MD$US$US
240483811$24048381$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA191174$SANOFI AVENTIS$$77$YR$E$M$Y$175.2$KG$20240704$$MD$US$US
240483821$24048382$1$I$$20240627$20240704$20240704$EXP$$US-AstraZeneca-2024A148960$ASTRAZENECA$$$$$$Y$$$20240704$$CN$US$
240483831$24048383$1$I$20230612$20240701$20240704$20240704$EXP$$HR-ABBVIE-5823333$ABBVIE$$75$YR$$M$Y$$$20240704$$MD$HR$HR
240483842$24048384$2$F$$20240714$20240704$20240725$EXP$$EG-NOVOPROD-1246735$NOVO NORDISK$$$$$F$Y$63$KG$20240725$$CN$EG$EG
240483852$24048385$2$F$20240624$20240806$20240704$20240816$EXP$$US-NOVOPROD-1246290$NOVO NORDISK$$63$YR$$F$Y$$$20240816$$CN$US$US
240483862$24048386$2$F$$20240814$20240704$20240826$EXP$$IL-NOVOPROD-1234366$NOVO NORDISK$$$$A$M$Y$97$KG$20240826$$CN$IL$IL
240483871$24048387$1$I$20200101$20240624$20240704$20240704$EXP$$US-NOVOPROD-1246194$NOVO NORDISK$$$$$F$Y$$$20240704$$CN$US$US
240483881$24048388$1$I$$20240624$20240704$20240704$EXP$$US-NOVOPROD-1245778$NOVO NORDISK$$$$$M$Y$$$20240704$$CN$US$US
240483891$24048389$1$I$$20240624$20240704$20240704$EXP$$US-NOVOPROD-1246429$NOVO NORDISK$$67$YR$$F$Y$$$20240704$$MD$US$US
240483901$24048390$1$I$$20240613$20240704$20240704$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12547$ALKEM$Kuhn AK, Determan ML, Wright JA, Matey E, Leung JG.. The potential influence of estrogen-containing oral contraception on clozapine metabolism in a patient with known pharmacogenomic status. Mental Health Clinician. 2024;14(3):220-223$17$YR$$F$Y$$$20240704$$HP$US$US
240483911$24048391$1$I$$20240624$20240704$20240704$EXP$$US-NOVOPROD-1246112$NOVO NORDISK$$$$$$Y$$$20240704$$CN$US$US
240483922$24048392$2$F$20180723$20240714$20240704$20240725$EXP$$EG-NOVOPROD-1244646$NOVO NORDISK$$2$DY$$$Y$$$20240725$$CN$EG$EG
240483931$24048393$1$I$$20240624$20240704$20240704$EXP$$US-NOVOPROD-1246421$NOVO NORDISK$$$$$M$Y$$$20240704$$CN$US$US
240483941$24048394$1$I$$20240621$20240704$20240704$EXP$$US-NOVOPROD-1247844$NOVO NORDISK$$$$$F$Y$$$20240704$$CN$US$US
240483952$24048395$2$F$$20240709$20240704$20240722$EXP$$EG-NOVOPROD-1246647$NOVO NORDISK$$$$$F$Y$64$KG$20240719$$CN$EG$EG
240483961$24048396$1$I$20240301$20240624$20240704$20240704$EXP$$US-NOVOPROD-1238973$NOVO NORDISK$$79$YR$$M$Y$$$20240704$$MD$US$US
240483974$24048397$4$F$20220101$20240903$20240704$20240913$EXP$$US-NOVOPROD-1245866$NOVO NORDISK$$73$YR$$F$Y$$$20240913$$CN$US$US
240483981$24048398$1$I$$20240623$20240704$20240704$EXP$$US-NOVOPROD-1245218$NOVO NORDISK$$46$YR$$$Y$$$20240704$$CN$US$US
240483991$24048399$1$I$$20240624$20240704$20240704$EXP$$CA-NOVOPROD-1246992$NOVO NORDISK$$$$$F$Y$$$20240704$$MD$CA$CA
240484001$24048400$1$I$20210101$20240624$20240704$20240704$EXP$$TR-NOVOPROD-1246667$NOVO NORDISK$$795$MON$$M$Y$73$KG$20240704$$CN$TR$TR
240484011$24048401$1$I$20240623$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106261$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$HP$US$US
240484021$24048402$1$I$20210201$20240319$20240704$20240704$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06105$ALKEM$Dima A, Abdelsamie A, Clark-Castillo R, Webb-Wilson H, Shergill SS, Stanton B, Gaughran F, Whiskey E, Nettis MA.. Overcoming Obstacles to Clozapine Treatment: A Case of Clozapine Rechallenge in ECT-Resistant Schizophrenia With Catatonic Features. Journal of Clinical Psychopharmacology. 2024;44(2):182-185$55$YR$$M$Y$$$20240704$$MD$GB$GB
240484031$24048403$1$I$$20240626$20240704$20240704$EXP$$AU-CELLTRION INC.-2024AU015778$CELLTRION$$$$$$Y$$$20240704$$HP$AU$AU
240484041$24048404$1$I$20221122$20240626$20240704$20240704$EXP$$BE-CELLTRION INC.-2024BE015727$CELLTRION$$$$$$Y$$$20240704$$MD$BE$BE
240484051$24048405$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA195488$SANOFI AVENTIS$$$$E$M$Y$111.6$KG$20240704$$MD$US$US
240484061$24048406$1$I$$20231113$20240704$20240704$PER$$US-AMGEN-USASP2023235457$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240484071$24048407$1$I$20240601$20240630$20240704$20240704$PER$$US-AMGEN-USASP2024130543$AMGEN$$38$YR$A$M$Y$$$20240703$$HP$US$US
240484082$24048408$2$F$$20240628$20240704$20240706$EXP$$US-AMGEN-USASP2024127706$AMGEN$$$$$F$Y$$$20240706$$CN$US$US
240484091$24048409$1$I$20240314$20240621$20240704$20240704$PER$$US-ROCHE-3528346$ROCHE$$12$YR$T$F$Y$27.22$KG$20240704$$CN$US$US
240484101$24048410$1$I$$20240627$20240704$20240704$EXP$$CH-GSK-CH2024GSK081009$GLAXOSMITHKLINE$Lourenco J, Bertin L, Lacroix L. Prolonged QT interval following inhaled salbutamol administration: a case report. Swiss Medical Weekly. 2024;154(Suppl. 277):33S$$$$$Y$$$20240704$$HP$CH$CH
240484111$24048411$1$I$20240525$20240701$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106378$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240704$$MD$US$US
240484122$24048412$2$F$$20240627$20240704$20240801$EXP$$CH-GSK-CH2024GSK082297$GLAXOSMITHKLINE$Sofia P, Fortesa M. Plasmapheresis in a Pediatric Case of Multiorgan failure with Suspected DRESS or TSS. Swiss Medical Weekly. 2024;154(Suppl 277):19S$$$$$Y$$$20240801$$HP$CH$CH
240484131$24048413$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106268$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240704$$HP$US$US
240484141$24048414$1$I$$20240626$20240704$20240704$PER$$US-JNJFOC-20240672045$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$MD$US$US
240484151$24048415$1$I$$20240626$20240704$20240704$EXP$$JP-ROCHE-3575854$ROCHE$$6$DEC$A$M$Y$$$20240704$$MD$JP$JP
240484161$24048416$1$I$20201019$20240627$20240704$20240704$EXP$$CA-BIOGEN-2023BI01179080$BIOGEN$$40$YR$$M$Y$$$20240704$$HP$CA$CA
240484171$24048417$1$I$$20240125$20240704$20240704$PER$$US-AMGEN-USASP2024130917$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240484181$24048418$1$I$$20230106$20240704$20240704$PER$$US-AMGEN-USASP2023235455$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240484191$24048419$1$I$$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129861$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240484212$24048421$2$F$20220101$20240716$20240704$20240717$EXP$$NVSJ2024JP007831$NOVARTIS$$62$YR$$F$Y$$$20240718$$MD$JP$JP
240484223$24048422$3$F$20230101$20240708$20240704$20240718$EXP$$PL-AUROBINDO-AUR-APL-2024-032048$AUROBINDO$Krawczyk M, Chajec J, Paluch Z, Michalczyk J, Mi?osz A, Szczukocka M.. Pneumothorax as a complication of respiratory failure ? two case reports and literature review.. JOURNAL OF PRE-CLINICAL AND CLINICAL RESEARCH. 2024;18(2):139-146$28$YR$$M$Y$$$20240718$$HP$PL$PL
240484231$24048423$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002064$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240704$$CN$US$US
240484241$24048424$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001593$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240704$$CN$US$US
240484251$24048425$1$I$20240701$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001985$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240704$$CN$US$US
240484261$24048426$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001514$ELI LILLY AND CO$$$$$F$Y$$$20240704$$CN$US$US
240484271$24048427$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001283$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240704$$CN$US$US
240484281$24048428$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002079$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240704$$HP$US$US
240484291$24048429$1$I$$20240624$20240704$20240704$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP007819$STRIDES$Sousa BSGC, de Sa ZC, Ramos J.. Decoding the enigma: Valproate encephalopathy in a bipolar affective disorder without hyperammonemia.. Bipolar-Disord. 2024$63$YR$$F$Y$$$20240704$$HP$PT$PT
240484305$24048430$5$F$$20240808$20240704$20240809$EXP$$CN-JNJFOC-20240704235$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$CN$CN$CN
240484311$24048431$1$I$$20240625$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007760$STRIDES$Pattupara A, Nguyen D, Gaikwad M, Gnirke M, Yarra S, Su M, et al.. Breaking the Spell: A Rare Case of Prolonged Benzodiazepine Elimination.. Am-J-Respir-Crit-Care-Med. 2024;209 (0):abstr. A5703.$67$YR$$M$Y$$$20240704$$HP$US$US
240484322$24048432$2$F$$20240806$20240704$20240807$EXP$$NVSJ2024JP007753$NOVARTIS$$$$$$Y$$$20240808$$MD$JP$JP
240484331$24048433$1$I$$20240701$20240704$20240704$EXP$$US-AstraZeneca-2024A150973$ASTRAZENECA$$$$$$Y$$$20240704$$MD$US$
240484341$24048434$1$I$20240529$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131960$AMGEN$$74$YR$E$F$Y$$$20240703$$CN$US$US
240484351$24048435$1$I$$20230424$20240704$20240704$PER$$US-AMGEN-USASP2023235429$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240484362$24048436$2$F$$20240712$20240704$20240717$PER$$US-AMGEN-USASP2024129987$AMGEN$$$$$$Y$$$20240717$$PH$US$US
240484371$24048437$1$I$$20230914$20240704$20240704$PER$$US-AMGEN-USASP2023235173$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240484381$24048438$1$I$20240621$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024130417$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240484391$24048439$1$I$$20240626$20240704$20240704$EXP$$CA-CELLTRION INC.-2024CA015508$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
240484401$24048440$1$I$$20240627$20240704$20240704$EXP$$US-AstraZeneca-2024A148852$ASTRAZENECA$$$$T$M$Y$$$20240704$$CN$US$
240484411$24048441$1$I$20240613$20240625$20240704$20240704$EXP$$CN-AUROBINDO-AUR-APL-2024-032316$AUROBINDO$$18$YR$$F$Y$$$20240704$$HP$CN$CN
240484421$24048442$1$I$$20240626$20240704$20240704$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP007820$STRIDES$Edison DC, Philip J, Mallhi RS, Basnotra R, Pynadath V, Sane K.. Severe amlodipine toxicity: A medical dilemma managed with therapeutic plasma exchange.. Transfus-Apheresis-Sci. 2024;63 (4)$$$$M$Y$$$20240704$$HP$IN$IN
240484432$24048443$2$F$$20240806$20240704$20240807$PER$$US-ALXN-202406USA001735US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
240484443$24048444$3$F$20240418$20240812$20240704$20240926$EXP$FR-AFSSAPS-TO2024001122$FR-UCBSA-2024033251$UCB$$21$YR$$M$Y$60$KG$20240926$$MD$FR$FR
240484452$24048445$2$F$20170101$20240725$20240704$20240802$EXP$CN-MLMSERVICE-20240620-PI104046-00306-4$CN-STRIDES ARCOLAB LIMITED-2024SP007868$STRIDES$Fan T, Yan Y, Lu Q, Li J, Chen H.. Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report.. Transplantation proceedings.. 2024;1-4$57$YR$$F$Y$$$20240802$$MD$CN$CN
240484461$24048446$1$I$$20240625$20240704$20240704$PER$$US-009507513-2406USA009073$MERCK$Yuen CA, Bao S, Pekmezci M, Mo F, Kong XT.. Pembrolizumab in an HIV-infected patient with glioblastoma. Immunotherapy. 2024$39$YR$$M$Y$$$20240704$$HP$US$US
240484511$24048451$1$I$20240520$20240701$20240704$20240704$EXP$$JP-TAKEDA-2024TJP009892$TAKEDA$$4$DEC$$F$Y$$$20240704$$MD$JP$JP
240484521$24048452$1$I$$20240109$20240704$20240704$PER$$US-AMGEN-USASP2024129609$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240484531$24048453$1$I$20240515$20240526$20240704$20240704$PER$$US-AMGEN-USASP2024127112$AMGEN$$83$YR$E$F$Y$$$20240703$$CN$US$US
240484541$24048454$1$I$$20240626$20240704$20240704$EXP$SI-MLMSERVICE-20240624-PI109519-00030-3$SI-STRIDES ARCOLAB LIMITED-2024SP007906$STRIDES$Trampuz BV. ELECTROLYTE DISORDERS IN THE EMERGENCY DEPARTMENT - CLINICAL CASES AND EMERGENCY TREATMENT.. Urgentna Medicina - Izbrana Poglavja. 2024;142-6$$$$M$Y$$$20240704$$MD$SI$SI
240484551$24048455$1$I$20240101$20240626$20240704$20240704$PER$$US-SA-2024SA192893$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240704$$MD$US$US
240484561$24048456$1$I$20180101$20240626$20240704$20240704$EXP$CA-MLMSERVICE-20211014-3171576-1$CA-STRIDES ARCOLAB LIMITED-2024SP007908$STRIDES$Garneau B, Desharnais B, Beauchamp-Dor? A, Lavall?e C, Mireault P, Lajeunesse A.. Challenges Related to Three Cases of Fatal Intoxication to Multiple Novel Synthetic Opioids.. Journal of Analytical Toxicology. 2021;44(1):86-91$29$YR$$M$Y$89$KG$20240704$$MD$CA$CA
240484571$24048457$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA193257$SANOFI AVENTIS$$$$E$F$Y$$$20240704$$MD$US$US
240484581$24048458$1$I$20240626$20240626$20240704$20240704$PER$$US-CHATTEMPRD-2024OHG022616$CHATTEM$$$$A$F$Y$$$20240704$$CN$US$US
240484591$24048459$1$I$$20240626$20240704$20240704$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001326$BLUEPRINT MEDICINES$$$$$F$Y$$$20240704$$CN$US$US
240484601$24048460$1$I$20240627$20240627$20240704$20240704$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001327$BLUEPRINT MEDICINES$$24$YR$A$F$Y$$$20240704$$CN$US$US
240484615$24048461$5$F$20240601$20240814$20240704$20240821$EXP$$IL-Blueprint Medicines Corporation-SP-IL-2024-001322$BLUEPRINT MEDICINES$$46$YR$A$F$Y$$$20240821$$MD$IL$IL
240484623$24048462$3$F$20240601$20240910$20240704$20240918$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001329$BLUEPRINT MEDICINES$$59$YR$A$F$Y$83.99$KG$20240918$$CN$US$US
240484631$24048463$1$I$$20231127$20240704$20240704$EXP$GB-MHRA-ADR 28343694$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15023$ALKEM$$76$YR$$F$Y$$$20240704$$HP$GB$GB
240484641$24048464$1$I$$20240327$20240704$20240704$EXP$GB-MHRA-ADR 28631981$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06582$ALKEM$$31$YR$$M$Y$$$20240704$$HP$GB$GB
240484651$24048465$1$I$$20240405$20240704$20240704$EXP$GB-MHRA-ADR 28654327$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-07674$ALKEM$$$$$M$Y$$$20240704$$CN$GB$GB
240484661$24048466$1$I$$20240627$20240704$20240704$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001332$BLUEPRINT MEDICINES$$$$$F$Y$$$20240704$$CN$US$US
240484672$24048467$2$F$20240625$20240718$20240704$20240720$EXP$$TR-ABBVIE-5823818$ABBVIE$$57$YR$$M$Y$75$KG$20240720$$CN$TR$TR
240484681$24048468$1$I$$20240628$20240704$20240704$EXP$$BR-NOVOPROD-1247424$NOVO NORDISK$$$$$M$Y$$$20240704$$PH$BR$BR
240484691$24048469$1$I$20240607$20240625$20240704$20240704$EXP$GB-MHRA-MED-202406241659035480-FQWZR$GB-NOVOPROD-1245792$NOVO NORDISK$$$$$M$Y$$$20240704$$HP$GB$GB
240484703$24048470$3$F$20240622$20240815$20240704$20240822$EXP$$EG-NOVOPROD-1244634$NOVO NORDISK$$60$YR$$F$Y$90$KG$20240822$$CN$EG$EG
240484711$24048471$1$I$20230614$20240410$20240704$20240704$EXP$DE-DCGMA-23202644$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-00392$ALKEM$$60$YR$$F$Y$60$KG$20240704$$MD$DE$DE
240484721$24048472$1$I$$20240321$20240704$20240704$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-05771$ALKEM$Mohan S, Sheehan M, Tebben P, Wermers R.. Efficacy of Oral Cinacalcet in Non-PTH Nonmalignant Hypercalcemia from Excess 1,25-Dihydroxyvitamin D. JCEM Case Reports. 2024;2(3):1-4$67$YR$$M$Y$$$20240704$$MD$US$US
240484741$24048474$1$I$$20240625$20240704$20240704$EXP$$EG-NOVOPROD-1245593$NOVO NORDISK$$$$$M$Y$110$KG$20240704$$CN$EG$EG
240484751$24048475$1$I$$20240625$20240704$20240704$EXP$$US-NOVOPROD-1246175$NOVO NORDISK$$54$YR$$F$Y$$$20240704$$CN$US$US
240484763$24048476$3$F$20240701$20240729$20240704$20240731$PER$$US-AMGEN-USASP2024131925$AMGEN$$83$YR$E$M$Y$$$20240731$$CN$US$US
240484771$24048477$1$I$$20231018$20240704$20240704$PER$$US-AMGEN-USASP2023235483$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240484781$24048478$1$I$20240627$20240627$20240704$20240704$PER$$US-CHATTEMPRD-2024OHG022618$CHATTEM$$$$$$Y$$$20240704$$CN$US$US
240484792$24048479$2$F$20240101$20240701$20240704$20240722$PER$$US-CHATTEMPRD-2024OHG022837$CHATTEM$$$$$F$Y$$$20240722$$CN$US$US
240484803$24048480$3$F$20240620$20240906$20240704$20240913$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001330$BLUEPRINT MEDICINES$$89$YR$E$F$Y$$$20240913$$CN$US$US
240484811$24048481$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106655$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$59.87$KG$20240704$$PH$US$US
240484821$24048482$1$I$$20240625$20240704$20240704$EXP$$MY-ROCHE-10000013356$ROCHE$$47$YR$A$F$Y$$$20240704$$MD$MY$MY
240484831$24048483$1$I$$20240624$20240704$20240704$EXP$$CN-JNJFOC-20240671067$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$HP$CN$CN
240484841$24048484$1$I$$20240702$20240704$20240704$PER$$US-HALEON-2185115$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240484851$24048485$1$I$20240623$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129416$AMGEN$$58$YR$A$F$Y$$$20240703$$CN$US$US
240484861$24048486$1$I$$20230509$20240704$20240704$PER$$US-AMGEN-USASP2023235308$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240484871$24048487$1$I$$20240624$20240704$20240704$EXP$$JP-AMGEN-JPNSP2024129211$AMGEN$$$$$$Y$$$20240703$$PH$JP$JP
240484882$24048488$2$F$$20240715$20240704$20240724$PER$$US-AstraZeneca-2024A132617$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
240484891$24048489$1$I$$20240627$20240704$20240704$EXP$$US-AstraZeneca-2024A148730$ASTRAZENECA$$$$$F$Y$$$20240704$$CN$US$
240484901$24048490$1$I$20240628$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130148$AMGEN$$35$YR$A$F$Y$$$20240703$$CN$US$US
240484911$24048491$1$I$$20240620$20240704$20240704$PER$$US-ROCHE-10000010034$ROCHE$$58$YR$A$M$Y$$$20240704$$HP$US$US
240484921$24048492$1$I$20240301$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001935$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240704$$MD$US$US
240484931$24048493$1$I$20240629$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001297$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240704$$CN$US$US
240484941$24048494$1$I$$20240625$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-008512$UNITED THERAPEUTICS$$$$$F$Y$97.506$KG$20240704$$$US$US
240484951$24048495$1$I$$20240624$20240704$20240704$EXP$$GB-BIOCON BIOLOGICS LIMITED-BBL2024004714$BIOCON$$$$$$Y$$$20240704$$HP$GB$GB
240484961$24048496$1$I$$20240620$20240704$20240704$PER$$US-ROCHE-10000009955$ROCHE$$$$$$Y$$$20240704$$CN$US$US
240484971$24048497$1$I$$20240701$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105237$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240704$$CN$US$US
240484981$24048498$1$I$20240627$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129451$AMGEN$$45$YR$A$F$Y$$$20240703$$CN$US$US
240484992$24048499$2$F$20240613$20240624$20240704$20240708$EXP$$CN-ROCHE-10000008063$ROCHE$$78$YR$E$F$Y$49$KG$20240708$$HP$CN$CN
240485001$24048500$1$I$$20240626$20240704$20240704$EXP$$US-NOVITIUMPHARMA-2024USNVP01129$NOVITIUM PHARMA$E. Chan.The Imitation Game: Concurrent Tuberculous Myositis in a Dermatomyositis Patient.American Journal of Respiratory and Critical Care Medicine.22-MAY-2024;209:A7415$82$YR$E$F$Y$$$20240704$$HP$US$US
240485011$24048501$1$I$$20240625$20240704$20240704$PER$$US-009507513-2407USA001762$MERCK$Yuen CA, Bao S, Pekmezci M, Mo F, Kong XT.. Pembrolizumab in an HIV-infected patient with glioblastoma. Immunotherapy. 2024$39$YR$$M$Y$$$20240704$$HP$US$US
240485023$24048502$3$F$20240630$20240801$20240704$20240806$PER$$US-AMGEN-USASP2024130751$AMGEN$$66$YR$E$F$Y$$$20240806$$CN$US$US
240485032$24048503$2$F$$20240713$20240704$20240723$30DAY$$US-GSK-US2024081061$GLAXOSMITHKLINE$$$$$M$Y$$$20240723$$CN$US$US
240485042$24048504$2$F$20240527$20240715$20240704$20240724$EXP$$IT-AUROBINDO-AUR-APL-2024-031865$AUROBINDO$$67$YR$$F$Y$$$20240724$$MD$IT$IT
240485051$24048505$1$I$$20240626$20240704$20240704$EXP$$RO-CELLTRION INC.-2024RO015742$CELLTRION$$$$$$Y$$$20240704$$CN$RO$RO
240485071$24048507$1$I$$20240626$20240704$20240704$EXP$$US-TAKEDA-2024TUS062634$TAKEDA$$$$$F$Y$$$20240704$$CN$US$US
240485081$24048508$1$I$20240701$20240701$20240704$20240704$PER$$US-HALEON-2184821$Haleon PLC$$56$YR$$F$Y$$$20240704$$CN$US$US
240485093$24048509$3$F$$20240906$20240704$20240906$PER$$US-ALXN-202406USA001740US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
240485101$24048510$1$I$$20240627$20240704$20240704$EXP$$US-ALXN-202406USA001870US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240704$$CN$US$US
240485112$24048511$2$F$20221101$20240703$20240704$20240708$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-104948$BRISTOL MYERS SQUIBB$Mejia-Salgado G, Cardozo-Perez C, Cifuentes-Gonzalez C, Duran-Merino C, De-la-Torre A. Coinfection suspicion is imperative in immunosuppressed patients with suspected infectious uveitis and inadequate treatment response: a case report. Ocular Immunology and Inflammation. 2024 Jun 18;1-5. doi:10.1080/09273948.2024.2367656.$70$YR$E$F$Y$$$20240708$$MD$CO$CO
240485121$24048512$1$I$20240601$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106637$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$48$KG$20240704$$PH$US$US
240485131$24048513$1$I$20240601$20240626$20240704$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009926$JAZZ$$38$YR$$F$Y$$$20240703$$HP$US$US
240485141$24048514$1$I$$20240624$20240704$20240704$30DAY$$US-GSK-US2024AMR079979$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$PH$US$US
240485151$24048515$1$I$$20240506$20240704$20240704$PER$$US-AMGEN-USASP2024129946$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240485161$24048516$1$I$20240628$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024128749$AMGEN$$63$YR$A$F$Y$$$20240703$$CN$US$US
240485171$24048517$1$I$20240626$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129241$AMGEN$$82$YR$E$F$Y$$$20240703$$CN$US$US
240485181$24048518$1$I$20240601$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024132053$AMGEN$$71$YR$E$F$Y$$$20240703$$CN$US$US
240485191$24048519$1$I$$20230731$20240704$20240704$PER$$US-AMGEN-USASP2023235465$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240485201$24048520$1$I$$20230215$20240704$20240704$PER$$US-AMGEN-USASP2023235529$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240485211$24048521$1$I$$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024128869$AMGEN$$$$$F$Y$$$20240703$$PH$US$US
240485221$24048522$1$I$$20240311$20240704$20240704$PER$$US-AMGEN-USASP2024130128$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240485231$24048523$1$I$$20230512$20240704$20240704$PER$$US-AMGEN-USASP2023235384$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240485241$24048524$1$I$20240702$20240702$20240704$20240704$PER$$US-HALEON-2185132$Haleon PLC$$$$A$$Y$$$20240704$$CN$US$US
240485271$24048527$1$I$$20240625$20240704$20240704$EXP$$JP-ROCHE-10000013924$ROCHE$$87$YR$E$F$Y$$$20240704$$PH$JP$JP
240485294$24048529$4$F$20240626$20240806$20240704$20240813$EXP$$BR-CELLTRION INC.-2024BR015854$CELLTRION$$$$$$Y$$$20240813$$HP$BR$BR
240485304$24048530$4$F$20240620$20240925$20240704$20240928$PER$$US-ROCHE-10000015246$ROCHE$$36$YR$A$M$Y$$$20240928$$CN$US$US
240485312$24048531$2$F$$20240627$20240704$20240711$PER$$US-ROCHE-10000015264$ROCHE$$48$YR$A$F$Y$$$20240711$$MD$US$US
240485321$24048532$1$I$$20240620$20240704$20240704$PER$$US-JNJFOC-20240661863$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240485331$24048533$1$I$20220601$20240629$20240704$20240704$PER$$US-HETERO-HET2024US01722$HETERO$$$$$M$Y$$$20240704$$CN$US$US
240485341$24048534$1$I$20240201$20240314$20240704$20240704$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-104812$ZYDUS PHARM$$$$$$Y$$$20240704$$CN$US$US
240485351$24048535$1$I$$20240625$20240704$20240704$EXP$$US-GSK-US2024AMR079933$GLAXOSMITHKLINE$$$$$F$Y$61.23$KG$20240704$$CN$US$US
240485361$24048536$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001941$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240704$$CN$US$US
240485371$24048537$1$I$$20240630$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001947$ELI LILLY AND CO$$$$$$Y$$$20240704$$CN$US$US
240485381$24048538$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002254$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240704$$CN$US$US
240485391$24048539$1$I$20240626$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407000918$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240704$$CN$US$US
240485401$24048540$1$I$20240701$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002148$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240704$$CN$US$US
240485411$24048541$1$I$20240701$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002062$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240704$$CN$US$US
240485421$24048542$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002188$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240704$$CN$US$US
240485431$24048543$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002187$ELI LILLY AND CO$$$$$$Y$$$20240704$$CN$US$US
240485441$24048544$1$I$$20240626$20240704$20240704$PER$$US-AMGEN-USASP2024131560$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240485451$24048545$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001977$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240704$$CN$US$US
240485461$24048546$1$I$20240623$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002012$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240704$$CN$US$US
240485472$24048547$2$F$$20231010$20240704$20240709$PER$$US-AMGEN-USASP2023235276$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240485481$24048548$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130490$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240485491$24048549$1$I$$20231003$20240704$20240704$PER$$US-AMGEN-USASP2023235255$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240485501$24048550$1$I$$20231204$20240704$20240704$PER$$US-AMGEN-USASP2023235318$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240485511$24048551$1$I$$20230906$20240704$20240704$PER$$US-AMGEN-USASP2023235439$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240485521$24048552$1$I$$20240620$20240704$20240704$EXP$$US-CIPLA LTD.-2024US06773$CIPLA$Santosh N, Savani S, Iskapalli S. Beefing up! fulminant liver failure secondary to anabolic steroid use. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240704$$MD$US$US
240485532$24048553$2$F$20240101$20240820$20240704$20240828$EXP$$CA-CELLTRION INC.-2024CA002887$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
240485541$24048554$1$I$20231001$20240626$20240704$20240704$EXP$$US-SPECGX-T202401462$SPECGX$$62$YR$$M$Y$$$20240704$$CN$US$US
240485551$24048555$1$I$$20240620$20240704$20240704$EXP$$US-CIPLA LTD.-2024US06523$CIPLA$Prabhu S, Malempati S, Markowitz D.. Amlodipine: Not an ace in the hole. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1361$$$$$Y$$$20240704$$MD$US$US
240485561$24048556$1$I$$20240109$20240704$20240704$PER$$US-AMGEN-USASP2024129639$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240485571$24048557$1$I$20240527$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024129513$AMGEN$$57$YR$A$F$Y$$$20240703$$CN$US$US
240485581$24048558$1$I$$20240703$20240704$20240704$PER$$NVSC2024US138412$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240485591$24048559$1$I$$20240626$20240704$20240704$EXP$$US-JNJFOC-20240672479$JOHNSON AND JOHNSON$$$$A$$Y$$$20240704$$HP$US$US
240485601$24048560$1$I$20240619$20240626$20240704$20240704$EXP$$SE-DENTSPLY-2024SCDP000191$DENTSPLY$$16$YR$$M$Y$$$20240704$$HP$SE$SE
240485613$24048561$3$F$20240101$20240904$20240704$20240909$EXP$$JP-009507513-2406JPN003775J$MERCK$$6$DEC$$M$Y$$$20240909$$MD$JP$JP
240485621$24048562$1$I$$20240620$20240704$20240704$EXP$$US-CIPLA LTD.-2024US06601$CIPLA$Cuello LN, Perozo MA, Cedeno H, Shah P. Indomethacin-induced angioedema: A rare and challenging case. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1362$$$$$Y$$$20240704$$MD$US$US
240485631$24048563$1$I$$20240701$20240704$20240704$PER$$US-BIOVITRUM-2024-US-009388$BIOVITRUM$$30$YR$$$Y$$$20240704$$CN$US$US
240485641$24048564$1$I$$20240624$20240704$20240704$30DAY$$US-GSK-US2024078664$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
240485651$24048565$1$I$20210101$20240628$20240704$20240704$EXP$$US-ABBVIE-5817943$ABBVIE$$$$$F$Y$50$KG$20240704$$CN$US$US
240485692$24048569$2$F$$20240708$20240704$20240715$PER$$US-ALXN-202406USA001753US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
240485703$24048570$3$F$20240628$20240923$20240704$20240925$PER$$US-BIOVITRUM-2024-US-009415$BIOVITRUM$$76$YR$$M$Y$$$20240925$$CN$US$US
240485711$24048571$1$I$$20240627$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106486$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240704$$HP$US$US
240485722$24048572$2$F$20190601$20240731$20240704$20240806$PER$$US-BIOGEN-2024BI01271516$BIOGEN$$38$YR$$F$Y$$$20240806$$CN$US$US
240485731$24048573$1$I$20231101$20240627$20240704$20240704$PER$$US-BIOGEN-2024BI01271604$BIOGEN$$76$YR$$F$Y$$$20240704$$CN$US$US
240485751$24048575$1$I$$20230414$20240704$20240704$PER$$US-AMGEN-USASP2023235039$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240485763$24048576$3$F$20190601$20240903$20240704$20240904$PER$$US-GILEAD-2024-0679450$GILEAD$$31$YR$A$M$Y$$$20240904$$LW$US$US
240485771$24048577$1$I$$20240702$20240704$20240704$EXP$$US-ABBVIE-5823982$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240485781$24048578$1$I$$20240701$20240704$20240704$EXP$$JP-GILEAD-2024-0679072$GILEAD$$71$YR$E$F$Y$$$20240703$$PH$JP$JP
240485801$24048580$1$I$$20240624$20240704$20240704$30DAY$$US-GSK-US2024078696$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
240485821$24048582$1$I$$20240626$20240704$20240704$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP007893$STRIDES$Megna M, De Lucia M, Fornaro L, Tommasino N, Castiglione F, Cacciapuoti S, et al.. Asymptomatic microscopic colitis induced by secukinumab.. JAAD-Case-Rep. 2024;48:11-13$58$YR$$M$Y$$$20240704$$MD$IT$IT
240485831$24048583$1$I$20230127$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130544$AMGEN$$80$YR$E$M$Y$$$20240703$$CN$US$US
240485841$24048584$1$I$$20240626$20240704$20240704$EXP$GB-MLMSERVICE-20240626-PI103883-00270-1$GB-STRIDES ARCOLAB LIMITED-2024SP007861$STRIDES$Gan YL, Bashir A, Sunni N.. THE DIVERSITY OF CARDIAC MANIFESTATIONS IN RHEUMATOLOGICAL DISORDERS: HIGHLIGHTS ON IMMUNOSUPPRESSION AND CARDIAC COMPLICATIONS.. Heart. 2024;110(Suppl 3):A33-4.$30$YR$$F$Y$$$20240704$$HP$GB$GB
240485851$24048585$1$I$$20240626$20240704$20240704$PER$$US-BIOGEN-2024BI01271560$BIOGEN$$$$$F$Y$$$20240704$$MD$US$US
240485861$24048586$1$I$20240601$20240626$20240704$20240704$EXP$$US-BIOGEN-2024BI01271465$BIOGEN$$33$YR$$F$Y$$$20240704$$CN$US$US
240485876$24048587$6$F$20240430$20240826$20240704$20240830$EXP$$FR-BIOGEN-2024BI01271514$BIOGEN$$50$YR$$M$Y$99$KG$20240830$$MD$FR$FR
240485894$24048589$4$F$$20240716$20240704$20240718$EXP$$BR-JNJFOC-20240702421$JOHNSON AND JOHNSON$$49$YR$A$M$Y$60$KG$20240718$$CN$BR$BR
240485901$24048590$1$I$$20240626$20240704$20240704$EXP$$LK-STRIDES ARCOLAB LIMITED-2024SP007883$STRIDES$Dandeniya CL, Premathilake TK.. Thrombotic and immunological phenomena following COVID-19 vaccination: experience from a case series.. RMD-Open. 2023;9 (1)$32$YR$$F$Y$$$20240704$$MD$LK$LK
240485911$24048591$1$I$$20240626$20240704$20240704$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP007884$STRIDES$Majowicz D, Kostrzewa K, Gromek T, Sokolowska B, Hus M.. Haemophagocytic lymphohistiocytosis: case series. Serum ferritin level as an indicator of treatment effectiveness.. Hematol-Clinic-Pract. 2022;13:130-137$31$YR$$M$Y$$$20240704$$HP$PL$PL
240485921$24048592$1$I$20240610$20240611$20240704$20240704$PER$$TR-TOLMAR, INC.-24TR050105$TOLMAR$$67$YR$$M$Y$$$20240704$$MD$TR$TR
240485931$24048593$1$I$20240610$20240611$20240704$20240704$PER$$TR-TOLMAR, INC.-24TR050108$TOLMAR$$$$$M$Y$$$20240704$$HP$TR$TR
240485941$24048594$1$I$20240621$20240626$20240704$20240704$EXP$$US-VIIV HEALTHCARE LIMITED-US2024079697$VIIV$$34$YR$$M$Y$$$20240704$$CN$US$US
240485951$24048595$1$I$20240611$20240611$20240704$20240704$PER$$TR-TOLMAR, INC.-24TR050136$TOLMAR$$64$YR$$M$Y$$$20240704$$PH$TR$TR
240485961$24048596$1$I$$20240701$20240704$20240704$EXP$$US-HALEON-2184849$Haleon PLC$$$$$$Y$$$20240703$$CN$US$US
240485971$24048597$1$I$$20240611$20240704$20240704$PER$$US-TOLMAR, INC.-24US049885$TOLMAR$$$$$$Y$$$20240704$$CN$US$US
240485981$24048598$1$I$$20240626$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007886$STRIDES$Vallabhajosyula S, Ukrani H, Wersinger D, Malik H, Obaji A.. Fighting the Recovering Heart While Drowning in Volume: Role of VA-V ECMO Configuration in Migrating Mixing Cloud Effect.. Am-J-Respir-Crit-Care-Med. 2024;209:A5582$43$YR$$F$Y$$$20240704$$HP$US$US
240485992$24048599$2$F$20240101$20240710$20240704$20240801$PER$$US-TOLMAR, INC.-24US049753$TOLMAR$$76$YR$$M$Y$$$20240801$$CN$US$US
240486022$24048602$2$F$20240401$20240903$20240704$20240906$EXP$$US-BIOGEN-2024BI01272027$BIOGEN$$62$YR$$M$Y$$$20240906$$CN$US$US
240486042$24048604$2$F$$20240717$20240704$20240724$30DAY$$GB-JNJFOC-20240648194$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$HP$GB$GB
240486051$24048605$1$I$20240314$20240628$20240704$20240704$EXP$$CA-JNJFOC-20240514707$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240704$$HP$CA$CA
240486072$24048607$2$F$20150526$20240909$20240704$20240911$PER$$US-GILEAD-2024-0679451$GILEAD$$41$YR$A$F$Y$$$20240911$$LW$US$US
240486081$24048608$1$I$20240604$20240701$20240704$20240704$EXP$SE-SEMPA-2024-004864$SE-HALEON-2184851$Haleon PLC$$63$YR$$F$Y$$$20240703$$MD$SE$SE
240486091$24048609$1$I$20240628$20240628$20240704$20240704$EXP$$US-VANTIVE-2024VAN018048$Vantive US Healthcare$$80$YR$$M$Y$$$20240704$$CN$US$US
240486101$24048610$1$I$20240623$20240625$20240704$20240704$EXP$$JP-VANTIVE-2024VAN017903$Vantive US Healthcare$$$$$F$Y$$$20240704$$MD$JP$JP
240486111$24048611$1$I$$20240303$20240704$20240704$PER$$US-AMGEN-USASP2024131383$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240486121$24048612$1$I$$20231024$20240704$20240704$PER$$US-AMGEN-USASP2023235228$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240486131$24048613$1$I$$20240429$20240704$20240704$PER$$US-AMGEN-USASP2024129753$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240486141$24048614$1$I$$20240621$20240704$20240704$EXP$$JP-TWI PHARMACEUTICAL, INC-2024SCTW000127$TWI PHARMACEUTICALS$Sayano Oishi, Go Horie, Yoichiro Oda. A case of a 11-year-old girl with an overdose of guanfacine hydrochloride sustained-release tablets. Pediatr. of Japan. 2023;64:83-86$$$$$Y$$$20240701$$$JP$JP
240486151$24048615$1$I$$20240621$20240704$20240704$EXP$$JP-TWI PHARMACEUTICAL, INC-2024SCTW000128$TWI PHARMACEUTICALS$Atsushi Tanioka, Shinobu Yoshida, Tsuguhiro Ishikawa. A 14-year-old girl with characteristic blood pressure fluctuations after overdosing with guanfacine sustained-release drug. Journal of Japanese Society of Emergency Pediatrics. 2022;21:79-83$$$$$Y$$$20240701$$$JP$JP
240486161$24048616$1$I$$20240628$20240704$20240704$PER$$US-ABBVIE-5821214$ABBVIE$$$$$$Y$$$20240704$$HP$US$US
240486172$24048617$2$F$$20240628$20240704$20240926$PER$$US-GSK-US2024AMR081767$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
240486181$24048618$1$I$$20240629$20240704$20240704$EXP$$US-HETERO-HET2024US01774$HETERO$$83$YR$$M$Y$$$20240704$$CN$US$US
240486191$24048619$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002147$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240704$$CN$US$US
240486201$24048620$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002238$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240704$$CN$US$US
240486211$24048621$1$I$$20240621$20240704$20240704$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001605$IPCA$J. Vincent, J. Greenberg, S. Sanghani, et al. Profound lactic acidosis and shock in a patient taking metformin. Am J Respir Crit Care Med. 2024;209:A5702$$$$$Y$$$20240704$$HP$US$US
240486222$24048622$2$F$20240624$20240629$20240704$20240708$EXP$$CO-TAKEDA-2024TUS066998$TAKEDA$$77$YR$$M$Y$60$KG$20240708$$CN$CO$CO
240486231$24048623$1$I$$20240611$20240704$20240704$PER$$US-JNJFOC-20240633722$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240486243$24048624$3$F$$20240724$20240704$20240729$EXP$$DE-BIOVITRUM-2024-DE-009376$BIOVITRUM$Satirer O, Benseler SM, Kuemmerle-Deschner JB. Pregnancy outcomes of CAPS patient on IL-1 Inhibition.$$$A$F$Y$$$20240729$$MD$DE$DE
240486253$24048625$3$F$20240501$20240719$20240704$20240724$PER$$US-AstraZeneca-2024A140414$ASTRAZENECA$$974$MON$$F$Y$$$20240724$$CN$US$
240486261$24048626$1$I$$20240620$20240704$20240704$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05685$LUPIN$Gupta UD, Chowdhury T, Niriyan J, Bellamkonda A, Aryal B, Al-Ghuraibawi M. Severe metabolic acidosis attributed to metformin overdose: necessitating urgent dialysis and critical care. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3415:1-2$43$YR$$F$Y$$$20240704$$HP$US$US
240486271$24048627$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130518$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240486281$24048628$1$I$$20240109$20240704$20240704$PER$$US-AMGEN-USASP2024129765$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240486291$24048629$1$I$$20240122$20240704$20240704$PER$$US-AMGEN-USASP2024129730$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240486301$24048630$1$I$20230101$20240624$20240704$20240704$EXP$$DE-AMGEN-DEUSP2024125481$AMGEN$$$$$F$Y$$$20240703$$CN$DE$DE
240486311$24048631$1$I$$20230530$20240704$20240704$PER$$US-AMGEN-USASP2023235037$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240486321$24048632$1$I$$20230817$20240704$20240704$PER$$US-AMGEN-USASP2023235112$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240486332$24048633$2$F$20240629$20240709$20240704$20240711$PER$$US-AMGEN-USASP2024130153$AMGEN$$81$YR$E$F$Y$$$20240711$$CN$US$US
240486342$24048634$2$F$$20240703$20240704$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05583$LUPIN$$$$$$Y$$$20240725$$CN$US$US
240486351$24048635$1$I$$20240701$20240704$20240704$PER$$US-JNJFOC-20240706014$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$MD$US$US
240486361$24048636$1$I$$20240628$20240704$20240704$PER$$US-ABBVIE-5822931$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240486401$24048640$1$I$$20231206$20240704$20240704$PER$$US-AMGEN-USASP2023235392$AMGEN$$$$$$Y$$$20240703$$MD$US$US
240486411$24048641$1$I$$20240424$20240704$20240704$PER$$US-AMGEN-USASP2024129755$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240486421$24048642$1$I$$20240701$20240704$20240704$PER$$US-ROCHE-10000015219$ROCHE$Foulger L, Simmons K, Schiano M, Bush S. Rare phalanges soft tissue and bony metastasis in vulvar squamous cell carcinoma: Case report.. Gynecologic Oncology Reports. 2024;54:1-3. doi:10.1016/j.gore.2024.101435.$52$YR$A$F$Y$$$20240704$$MD$US$US
240486432$24048643$2$F$$20240913$20240704$20240927$EXP$$US-ALVOGEN-2024094950$ALVOGEN$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Medicine Pathology. 2024;45 (3):193?197. doi:10.1097/PAF.0000000000000943$17$YR$$M$Y$$$20240927$$MD$US$US
240486442$24048644$2$F$$20240828$20240704$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-020191$UNITED THERAPEUTICS$$$$$F$Y$59.864$KG$20240906$$$US$US
240486451$24048645$1$I$$20240620$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05588$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240486462$24048646$2$F$$20240709$20240704$20240724$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05523$LUPIN$Cardona Quinones RA, Salem Hernandez SA, Sekimitsu S, Antongiorgi Torres J, Yerstein O, Safar LT. A neuropsychiatric case of delayed post-hypoxic leukoencephalopathy from opioid intoxication resulting in Anton-Babinski syndrome and quadriplegia. Neurocase. 2023;29(5):160-166$26$YR$$M$Y$$$20240724$$MD$US$US
240486472$24048647$2$F$$20240707$20240704$20240722$EXP$$SA-OCTA-LIT04424$OCTAPHARMA$Hussein MRA, Babiker M, Asim S, Elsamwal M. Membranoproliferative Glomerulonephritis Type I Associated with Intravenous Immunoglobulin Administration Arising in a Child with X-Linked Agammaglobulinemia: A Case Report and a Reappraisal. Saudi J Kidney Dis Transpl. 2023 Nov 1;34(6):660-665. doi: 10.4103/sjkdt.sjkdt_133_23. Epub 2024 May 9. PMID: 38725215.$12$YR$T$M$Y$$$20240722$$MD$SA$SA
240486481$24048648$1$I$$20240622$20240704$20240704$EXP$$EC-ROCHE-10000007743$ROCHE$$$$$$Y$$$20240704$$CN$EC$EC
240486491$24048649$1$I$$20240626$20240704$20240704$PER$$US-HETERO-HET2024US02026$HETERO$$$$$F$Y$$$20240704$$CN$US$US
240486502$24048650$2$F$$20240712$20240704$20240718$EXP$$US-TAKEDA-2024TUS050513$TAKEDA$$$$$M$Y$$$20240718$$CN$US$US
240486511$24048651$1$I$$20240622$20240704$20240704$EXP$$EC-ROCHE-10000007750$ROCHE$$$$$$Y$$$20240704$$CN$EC$EC
240486521$24048652$1$I$$20240626$20240704$20240704$EXP$$JP-HALEON-2183776$Haleon PLC$$$$$$Y$$$20240703$$PH$JP$JP
240486531$24048653$1$I$$20240701$20240704$20240704$EXP$$US-ABBVIE-5824199$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240486541$24048654$1$I$20240701$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130479$AMGEN$$47$YR$A$F$Y$$$20240703$$CN$US$US
240486554$24048655$4$F$20240630$20240806$20240704$20240809$PER$$US-AMGEN-USASP2024130613$AMGEN$$69$YR$E$F$Y$$$20240808$$CN$US$US
240486561$24048656$1$I$$20231103$20240704$20240704$PER$$US-AMGEN-USASP2023235163$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240486572$24048657$2$F$20170925$20240712$20240704$20240715$EXP$$KR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036684$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$51$KG$20240715$$MD$KR$KR
240486583$24048658$3$F$$20240828$20240704$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106289$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$49.9$KG$20240903$$HP$US$US
240486594$24048659$4$F$20240101$20240807$20240704$20240820$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000539$DECIPHERA PHARMACEUTICALS$$51$YR$A$F$Y$$$20240820$$CN$US$US
240486601$24048660$1$I$$20240627$20240704$20240704$EXP$$AU-BEIGENE-BGN-2024-009932$BEIGENE$$$$$$Y$$$20240704$$HP$AU$AU
240486611$24048661$1$I$$20240627$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104660$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240704$$CN$US$US
240486621$24048662$1$I$20240615$20240619$20240704$20240704$EXP$$CN-OCTA-ALB09924$OCTAPHARMA$$$$E$F$Y$$$20240702$$HP$CN$CN
240486631$24048663$1$I$$20240701$20240704$20240704$EXP$$US-AstraZeneca-2024A150985$ASTRAZENECA$$$$$F$Y$$$20240704$$CN$US$
240486641$24048664$1$I$$20231006$20240704$20240704$PER$$US-AMGEN-USASP2023235031$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240486651$24048665$1$I$$20230717$20240704$20240704$PER$$US-AMGEN-USASP2023235477$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240486661$24048666$1$I$20240201$20240627$20240704$20240704$EXP$$US-GSK-US2024080358$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
240486671$24048667$1$I$20231226$20240621$20240704$20240704$EXP$$JP-AMGEN-JPNNI2024130482$AMGEN$$65$YR$E$M$Y$62.7$KG$20240703$$MD$JP$JP
240486681$24048668$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002242$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240704$$CN$US$US
240486691$24048669$1$I$20240701$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002088$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240704$$CN$US$US
240486701$24048670$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001891$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240704$$CN$US$US
240486711$24048671$1$I$20240601$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002443$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240704$$CN$US$US
240486721$24048672$1$I$$20240617$20240704$20240704$EXP$$CA-HALEON-2183147$Haleon PLC$$97$YR$$F$Y$$$20240703$$HP$CA$CA
240486751$24048675$1$I$20240101$20240626$20240704$20240704$EXP$$CA-CELLTRION INC.-2024CA015974$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
240486761$24048676$1$I$$20240623$20240704$20240704$EXP$$CN-Square Pharmaceuticals PLC-000033$SQUARE PHARMACEUTICALS$CN-Square Pharmaceuticals PLC-000033-01_initial Source document$17$YR$T$M$Y$$$20240703$$MD$CN$
240486771$24048677$1$I$$20240701$20240704$20240704$PER$$US-TAKEDA-2024TUS066300$TAKEDA$$$$$F$Y$$$20240704$$CN$US$US
240486782$24048678$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214506$TEVA$Xiong J, Embry E, Prasad S, Singh K, Singh M. Mycoplasma Pneumonia Induced Acute Respiratory Distress Syndrome in Pregnancy. Am-J-Respir-Crit-Care-Med 2024; 209.; Xiong J, Embry E, Prasad S, Singh K, Singh M. Mycoplasma Pneumonia Induced Acute Respiratory Distress Syndrome in Pregnancy. Am-J-Respir-Crit-Care-Med 2024; 209.$38$YR$$F$Y$$$20240720$$HP$US$US
240486803$24048680$3$F$20240425$20240719$20240704$20240726$EXP$$CN-TAKEDA-2024TUS061899$TAKEDA$$$$E$F$Y$42$KG$20240726$$MD$CN$CN
240486811$24048681$1$I$$20240626$20240704$20240704$PER$$US-SA-2024SA193667$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240704$$MD$US$US
240486822$24048682$2$F$20240101$20240702$20240704$20240711$PER$$US-SA-2024SA191243$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240711$$CN$US$US
240486831$24048683$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190321$SANOFI AVENTIS$$$$A$F$Y$124$KG$20240704$$MD$US$US
240486843$24048684$3$F$20240619$20240805$20240704$20240809$30DAY$$US-AMGEN-USASP2024128362$AMGEN$$89$YR$E$F$Y$$$20240809$$PH$US$US
240486852$24048685$2$F$$20240626$20240704$20240704$PER$$PR-ABBVIE-5819450$ABBVIE$$50$YR$$F$Y$$$20240704$$MD$PR$PR
240486861$24048686$1$I$20240601$20240701$20240704$20240704$30DAY$$US-GSK-US2024081653$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240704$$CN$US$US
240486871$24048687$1$I$$20240624$20240704$20240704$PER$$US-TEVA-VS-3214800$TEVA$$$$$$Y$$$20240704$$CN$US$US
240486881$24048688$1$I$20240416$20240620$20240704$20240704$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-18568$SAMSUNG BIOEPIS$$42$YR$A$F$Y$$$20240704$$HP$CA$CA
240486891$24048689$1$I$$20240621$20240704$20240704$EXP$CN-HENLIUS-24CN015649$CN-Accord-433516$ACCORD$$$$A$F$Y$$$20240704$$MD$CN$CN
240486901$24048690$1$I$20240620$20240624$20240704$20240704$EXP$CN-HENLIUS-24CN015582$CN-Accord-433518$ACCORD$$53$YR$A$F$Y$62$KG$20240704$$MD$CN$CN
240486911$24048691$1$I$$20240623$20240704$20240704$EXP$$IT-Accord-432774$ACCORD$Iodice A, Marchio G, Asta F, Rocchetti K, Rosati A. Vigabatrin-associated hyperkinetic movements in two children with epileptic spasms: Case reports and video phenomenology description. Seizure. 2024 Jun 4;120:12-14. doi: 10.1016/j.seizure.2024.06.003.$3$YR$C$M$Y$$$20240704$$HP$IT$IT
240486921$24048692$1$I$$20240625$20240704$20240704$EXP$CA-MHPD-E2B_07059516$CA-Accord-432539$ACCORD$$65$YR$E$M$Y$$$20240704$$HP$CA$CA
240486932$24048693$2$F$$20240723$20240704$20240726$EXP$$CA-HALEON-2183826$Haleon PLC$$53$YR$$M$Y$$$20240726$$CN$CA$CA
240486951$24048695$1$I$$20240623$20240704$20240704$EXP$$BE-Accord-432894$ACCORD$Inthasot S, Leemans S, Hing M, Vanderhulst J. Fever of unknown origin revealing testicular nocardiosis: a case report and literature review. BMC infectious diseases. 2024;24(1):614.$75$YR$E$M$Y$$$20240704$$HP$BE$BE
240486965$24048696$5$F$20240711$20240821$20240704$20240828$EXP$$CA-CELLTRION INC.-2024CA015975$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
240486972$24048697$2$F$$20240628$20240704$20240709$EXP$$GR-Accord-432536$ACCORD$Betsikos A, Mousia M, Simopoulou E, Gazouni E, Magaliou S, Paschou E, et al. Cutaneous Small-Vessel Vasculitis Induced by Escitalopram: A Case-Based Brief Review of the Literature. Cureus. 2024 Jun 20;16(6):e62776. doi: 10.7759/cureus.62776.$65$YR$E$M$Y$$$20240709$$HP$GR$GR
240486981$24048698$1$I$$20240621$20240704$20240704$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001610$IPCA$A. Gans, J. Taylor and N. N. Goel. A case of drug-induced Stevens-Johnson syndrome with primarily visceral involvement. Am J Respir Crit Care Med. 2024;209:A5678$$$$$Y$$$20240704$$HP$US$US
240486991$24048699$1$I$20240621$20240626$20240704$20240704$EXP$$US-BEH-2024174689$CSL BEHRING$$13$YR$T$M$Y$$$20240704$$HP$US$US
240487001$24048700$1$I$$20240703$20240704$20240704$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-106515$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$50.8$KG$20240704$$CN$PR$PR
240487011$24048701$1$I$20240517$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105938$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$61.69$KG$20240704$$PH$US$US
240487021$24048702$1$I$$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024130011$AMGEN$$$$$$Y$$$20240703$$PH$US$US
240487031$24048703$1$I$$20240221$20240704$20240704$PER$$US-AMGEN-USASP2024131460$AMGEN$$$$$$Y$$$20240703$$CN$US$US
240487041$24048704$1$I$$20240702$20240704$20240704$EXP$$NVSC2024NG138156$NOVARTIS$$$$$M$Y$$$20240704$$CN$NG$NG
240487051$24048705$1$I$$20240628$20240704$20240704$EXP$$JP-AMGEN-JPNSP2024131269$AMGEN$$$$$$Y$$$20240703$$PH$JP$JP
240487061$24048706$1$I$20240628$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131208$AMGEN$$79$YR$E$M$Y$$$20240703$$CN$US$US
240487073$24048707$3$F$20180726$20240829$20240704$20240902$PER$$US-GILEAD-2024-0679452$GILEAD$$56$YR$A$M$Y$$$20240902$$LW$US$US
240487081$24048708$1$I$$20240627$20240704$20240704$EXP$$US-JNJFOC-20240674879$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240704$$CN$US$US
240487091$24048709$1$I$$20240628$20240704$20240704$EXP$$GB-JNJFOC-20240650532$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240704$$CN$GB$GB
240487102$24048710$2$F$$20230515$20240704$20240814$PER$$US-AMGEN-USASP2023235377$AMGEN$$$$$$Y$$$20240814$$CN$US$US
240487111$24048711$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130164$AMGEN$$$$$F$Y$$$20240703$$CN$US$US
240487121$24048712$1$I$$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024130801$AMGEN$Li G.; Chen Y.; Peachey J.. Construction of a digital twin of chronic graft vs. host disease patients with standard of care. Bone Marrow Transplantation. 2024;1-6$$$$$Y$$$20240703$$HP$US$US
240487131$24048713$1$I$$20240624$20240704$20240704$EXP$$CA-HALEON-2183399$Haleon PLC$$97$YR$$F$Y$$$20240704$$HP$CA$CA
240487142$24048714$2$F$$20240709$20240704$20240716$EXP$$US-APOTEX-2024AP007780$APOTEX$$$$A$F$Y$$$20240716$$HP$US$US
240487151$24048715$1$I$$20240626$20240704$20240704$EXP$$JP-009507513-2406JPN004047J$MERCK$$80$YR$$M$Y$$$20240704$$MD$JP$JP
240487162$24048716$2$F$20210625$20240708$20240704$20240710$EXP$$CA-TAKEDA-2024TUS065618$TAKEDA$$66$YR$$F$Y$$$20240710$$CN$CA$CA
240487171$24048717$1$I$$20240621$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05764$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240487181$24048718$1$I$$20240624$20240704$20240704$PER$$US-TEVA-VS-3213570$TEVA$$50$YR$$M$Y$$$20240704$$HP$US$US
240487192$24048719$2$F$$20240719$20240704$20240805$PER$$US-APOTEX-2024AP007321$APOTEX$$$$$F$Y$$$20240805$$CN$US$US
240487203$24048720$3$F$$20240804$20240704$20240811$EXP$$CA-CELLTRION INC.-2024CA003298$CELLTRION$$$$$$Y$$$20240812$$CN$CA$CA
240487214$24048721$4$F$20240101$20240917$20240704$20240926$EXP$$CA-CELLTRION INC.-2024CA006427$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
240487221$24048722$1$I$20240630$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130473$AMGEN$$61$YR$A$F$Y$$$20240703$$CN$US$US
240487231$24048723$1$I$$20240624$20240704$20240704$PER$$US-TEVA-VS-3213630$TEVA$$$$$$Y$$$20240704$$CN$US$US
240487241$24048724$1$I$$20240619$20240704$20240704$PER$$US-ROCHE-10000007905$ROCHE$$7$YR$C$M$Y$$$20240704$$CN$US$US
240487251$24048725$1$I$20240101$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130705$AMGEN$$51$YR$A$F$Y$$$20240703$$PH$US$US
240487261$24048726$1$I$$20240620$20240704$20240704$EXP$$US-APOTEX-2024AP007631$APOTEX$Wu YF, Skinner L, Lewis J, Khodadoust MS, Kim YH, Kwong BY, et al.. Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell Transplantation. Cancer Investigation. 2023;41 (3):263-270$37$YR$$M$Y$$$20240704$$HP$US$US
240487271$24048727$1$I$$20240621$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05746$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240487281$24048728$1$I$20220202$20240626$20240704$20240704$EXP$$BE-CELLTRION INC.-2024BE015760$CELLTRION$$$$$$Y$$$20240704$$MD$BE$BE
240487321$24048732$1$I$20240625$20240627$20240704$20240704$EXP$ES-AEMPS-1540608$ES-HETERO-AMR2024ES02033$HETERO$$22$YR$$M$Y$$$20240704$$PH$ES$ES
240487331$24048733$1$I$$20240621$20240704$20240704$PER$$US-JNJFOC-20240662471$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240487342$24048734$2$F$$20240809$20240704$20240813$30DAY$$JP-JNJFOC-20240708196$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$MD$JP$JP
240487352$24048735$2$F$$20240903$20240704$20240905$EXP$$AT-JNJFOC-20240676140$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240906$$MD$AT$AT
240487361$24048736$1$I$$20230831$20240704$20240704$PER$$US-AMGEN-USASP2023235176$AMGEN$$$$$$Y$$$20240703$$HP$US$US
240487371$24048737$1$I$$20240624$20240704$20240704$EXP$$JP-ROCHE-10000012229$ROCHE$Ishikawa M, Naito T, Matsubara H, Yamada M, Ymamoto H, Hattori A. 03 A case of hypoadrenocorticism which developed after concomitant therapy with atezolizumab + bevacizumab for unresectable hepatocellular carcinoma. The 140th Regular Meeting of the Japanese Society of Gastroenterology Tokai Bran. 2024;83.$6$DEC$A$M$Y$$$20240704$$MD$JP$JP
240487381$24048738$1$I$$20240622$20240704$20240704$EXP$$EC-ROCHE-10000007760$ROCHE$$$$$$Y$$$20240704$$CN$EC$EC
240487394$24048739$4$F$20240101$20240903$20240704$20240909$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000575$DECIPHERA PHARMACEUTICALS$$79$YR$E$F$Y$$$20240909$$CN$US$US
240487401$24048740$1$I$20240627$20240627$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103723$BRISTOL MYERS SQUIBB$$29$YR$A$F$Y$$$20240704$$HP$US$US
240487412$24048741$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214511$TEVA$Hossain S, Bahadur SA. Stenotrophomonas Maltophilia, Pandoraea Species, and Aspergillus Niger Co-infection in a Patient With Acute Respiratory Failure. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).; Hossain S, Bahadur SA. Stenotrophomonas Maltophilia, Pandoraea Species, and Aspergillus Niger Co-infection in a Patient With Acute Respiratory Failure. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$74$YR$$M$Y$$$20240720$$HP$US$US
240487422$24048742$2$F$20240501$20240616$20240704$20240704$EXP$$CA-GSK-CA2024057833$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240704$$CN$CA$CA
240487431$24048743$1$I$20240301$20240619$20240704$20240704$EXP$$CA-GSK-CA2024076556$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$CA$CA
240487442$24048744$2$F$$20240628$20240704$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05582$LUPIN$$$$$$Y$$$20240716$$CN$US$US
240487461$24048746$1$I$$20240701$20240704$20240704$PER$$NVSC2024US138603$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240487471$24048747$1$I$20240605$20240628$20240704$20240704$EXP$$AR-JNJFOC-20240619754$JOHNSON AND JOHNSON$$62$YR$A$F$Y$54$KG$20240704$$CN$AR$AR
240487481$24048748$1$I$$20240626$20240704$20240704$EXP$$CA-JNJFOC-20240676146$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240704$$HP$CA$CA
240487492$24048749$2$F$$20240913$20240704$20240927$EXP$$US-ALVOGEN-2024094947$ALVOGEN$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Med Pathol. 2024 Sep;45 (3):193?197. doi:10.1097/PAF.0000000000000943$2$YR$$F$Y$$$20240927$$MD$US$US
240487502$24048750$2$F$20240607$20240628$20240704$20240704$EXP$$CA-JNJFOC-20240678774$JOHNSON AND JOHNSON$$16$YR$T$F$Y$49.94$KG$20240705$$HP$CA$CA
240487511$24048751$1$I$$20240701$20240704$20240704$EXP$$US-Bion-013361$BIONPHARMA$$17$YR$T$M$Y$$$20240704$$HP$US$US
240487521$24048752$1$I$$20240625$20240704$20240704$EXP$$CA-HALEON-2183798$Haleon PLC$$43$YR$$F$Y$96$KG$20240703$$HP$CA$CA
240487531$24048753$1$I$20240627$20240628$20240704$20240704$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000164$DENDREON$$$$$$Y$$$20240704$$HP$US$US
240487542$24048754$2$F$$20240712$20240704$20240716$EXP$$JP-ABBVIE-5824610$ABBVIE$$70$YR$$M$Y$$$20240716$$MD$JP$JP
240487551$24048755$1$I$$20240626$20240704$20240704$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000577$DECIPHERA PHARMACEUTICALS$$54$YR$A$M$Y$$$20240704$$HP$US$US
240487561$24048756$1$I$20240628$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001396$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240704$$CN$US$US
240487571$24048757$1$I$20240701$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001961$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240704$$CN$US$US
240487582$24048758$2$F$$20240628$20240704$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202406017515$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240711$$CN$US$US
240487591$24048759$1$I$20240702$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002003$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240704$$CN$US$US
240487601$24048760$1$I$20240602$20240626$20240704$20240704$EXP$$CA-CELLTRION INC.-2024CA013380$CELLTRION$$$$$$Y$$$20240704$$CN$CA$CA
240487611$24048761$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001634$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240704$$CN$US$US
240487622$24048762$2$F$$20240701$20240704$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407001185$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240710$$CN$US$US
240487631$24048763$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002154$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240704$$CN$US$US
240487641$24048764$1$I$$20240102$20240704$20240704$PER$$US-AMGEN-USASP2024130792$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240487651$24048765$1$I$20240602$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024129281$AMGEN$$74$YR$E$M$Y$$$20240704$$CN$US$US
240487661$24048766$1$I$$20240619$20240704$20240704$EXP$$US-GSK-US2024AMR078175$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$MD$US$US
240487672$24048767$2$F$20240516$20240830$20240704$20240912$EXP$$GB-AMGEN-GBRSP2024130514$AMGEN$$80$YR$E$M$Y$70.1$KG$20240911$$HP$GB$GB
240487681$24048768$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5820569$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240487691$24048769$1$I$20230103$20240627$20240704$20240704$EXP$$FR-CELLTRION INC.-2024FR015887$CELLTRION$$$$$$Y$$$20240704$$PH$FR$FR
240487702$24048770$2$F$$20240716$20240704$20240722$EXP$$CA-HALEON-2184347$Haleon PLC$$69$YR$$M$Y$$$20240722$$CN$CA$CA
240487712$24048771$2$F$$20240809$20240704$20240813$30DAY$$JP-JNJFOC-20240707996$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$MD$JP$JP
240487721$24048772$1$I$$20240625$20240704$20240704$EXP$$US-APOTEX-2024AP007841$APOTEX$Thompson TZ, Rearick WA, Pizzuto MF, Quinsey C, Enyart CE, Trau SP. Increasing Seizures, Encephalopathy, and Hypothermia in an 18-Year-Old Woman. PEDIATRICS. 2023;151(3):e2022057229$18$YR$$F$Y$$$20240704$$HP$US$US
240487731$24048773$1$I$20240528$20240625$20240704$20240704$EXP$$CN-HALEON-2183838$Haleon PLC$$67$YR$$F$Y$50$KG$20240703$$HP$CN$CN
240487761$24048776$1$I$$20240701$20240704$20240704$EXP$$US-Bion-013362$BIONPHARMA$$33$YR$$F$Y$$$20240704$$HP$US$US
240487771$24048777$1$I$$20240701$20240704$20240704$EXP$$US-Bion-013363$BIONPHARMA$$57$YR$A$M$Y$$$20240704$$HP$US$US
240487781$24048778$1$I$$20230627$20240704$20240704$PER$$US-AMGEN-USASP2023235423$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240487791$24048779$1$I$$20240624$20240704$20240704$EXP$$TW-AMGEN-TWNSP2024130521$AMGEN$$$$A$M$Y$$$20240704$$HP$TW$TW
240487801$24048780$1$I$$20240626$20240704$20240704$EXP$$JP-AMGEN-JPNSP2024129816$AMGEN$$4$DEC$A$M$Y$$$20240704$$MD$JP$JP
240487811$24048781$1$I$$20240219$20240704$20240704$PER$$US-AMGEN-USASP2024130546$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240487821$24048782$1$I$20240624$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130446$AMGEN$$59$YR$A$M$Y$$$20240704$$CN$US$US
240487831$24048783$1$I$$20230912$20240704$20240704$PER$$US-AMGEN-USASP2023235533$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240487842$24048784$2$F$$20240703$20240704$20240705$PER$$US-AMGEN-USASP2024132012$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240487853$24048785$3$F$20240622$20240827$20240704$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024079195$VIIV$$35$YR$$M$Y$$$20240906$$MD$US$US
240487861$24048786$1$I$$20240624$20240704$20240704$30DAY$$US-GSK-US2024AMR079539$GLAXOSMITHKLINE$$$$$M$Y$$$20240704$$CN$US$US
240487871$24048787$1$I$$20240626$20240704$20240704$EXP$$JP-EMD Serono-2024035278$EMD SERONO INC$$78$YR$E$F$Y$$$20240704$$MD$JP$JP
240487883$24048788$3$F$20240615$20240711$20240704$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-100661$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$PH$JP$JP
240487891$24048789$1$I$$20240627$20240704$20240704$EXP$$AR-EMD Serono-2024035486$EMD SERONO INC$$45$YR$A$M$Y$$$20240704$$MD$AR$AR
240487901$24048790$1$I$$20240627$20240704$20240704$EXP$$US-BEIGENE-BGN-2024-009934$BEIGENE$$$$$$Y$$$20240704$$CN$US$US
240487913$24048791$3$F$20221017$20240913$20240704$20240917$PER$$US-GILEAD-2024-0679453$GILEAD$$36$YR$A$M$Y$$$20240917$$LW$US$US
240487922$24048792$2$F$20240109$20240628$20240704$20240711$EXP$FR-AFSSAPS-ST2024001087$FR-ALVOGEN-2024094954$ALVOGEN$$78$YR$$F$Y$45.8$KG$20240711$$MD$FR$FR
240487932$24048793$2$F$20240528$20240701$20240704$20240710$EXP$$US-AstraZeneca-2024A151061$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240487941$24048794$1$I$$20240625$20240704$20240704$PER$$US-AstraZeneca-2024A147204$ASTRAZENECA$$$$$$Y$$$20240704$$CN$US$
240487951$24048795$1$I$$20240626$20240704$20240704$EXP$$NL-CELLTRION INC.-2023NL019389$CELLTRION$$$$$$Y$$$20240704$$MD$NL$NL
240487961$24048796$1$I$$20240627$20240704$20240704$EXP$$US-CHEPLA-2024008214$CHEPLAPHARM$$$$A$F$Y$$$20240704$$HP$COUNTRY NOT SPECIFIED$US
240487971$24048797$1$I$$20240628$20240704$20240704$PER$$NVSC2024US136389$NOVARTIS$$$$$M$Y$$$20240704$$CN$US$US
240487982$24048798$2$F$20230424$20240708$20240704$20240724$EXP$$JP-Merz Pharmaceuticals GmbH-24-02299$MERZ$$60$YR$$F$Y$56$KG$20240724$$MD$JP$JP
240487991$24048799$1$I$20240101$20240629$20240704$20240704$EXP$$DE-Merz Pharmaceuticals GmbH-24-02340$MERZ$$34$YR$A$F$Y$$$20240704$$CN$DE$DE
240488002$24048800$2$F$20230713$20240724$20240704$20240725$PER$$US-JNJFOC-20240666607$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$HP$US$US
240488011$24048801$1$I$$20240621$20240704$20240704$PER$$US-IDORSIA-008160-2024-US$IDORSIA PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
240488021$24048802$1$I$20240608$20240621$20240704$20240704$EXP$$CN-ROCHE-10000011469$ROCHE$$66$YR$E$F$Y$51.5$KG$20240704$$HP$CN$CN
240488041$24048804$1$I$$20240628$20240704$20240704$EXP$$US-CHATTEMPRD-2024OHG022656$CHATTEM$$$$$F$Y$$$20240704$$LW$US$US
240488051$24048805$1$I$20240625$20240627$20240704$20240704$EXP$$US-ROCHE-10000015419$ROCHE$$78$YR$E$M$Y$$$20240704$$CN$US$US
240488063$24048806$3$F$$20240703$20240704$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-031740$AUROBINDO$Belmin J, Broussier A, Boureau A-S, Donal E, Hanon O, Paccalin M et al.. L?amylose cardiaque, une maladie sous-diagnostiqu?e en g?riatrie [Cardiac amyloidosis, an underdiagnosed disease in geriatrics].. La Revue du g?riatrie.. 2024;49 (5):293-298$86$YR$$M$Y$$$20240809$$MD$FR$FR
240488071$24048807$1$I$20240628$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129796$AMGEN$$82$YR$E$F$Y$$$20240704$$HP$US$US
240488081$24048808$1$I$$20230103$20240704$20240704$PER$$US-AMGEN-USASP2023235185$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240488091$24048809$1$I$$20240625$20240704$20240704$EXP$$US-SA-2024SA193290$SANOFI AVENTIS$$$$$$Y$$$20240704$$HP$US$US
240488103$24048810$3$F$$20240805$20240704$20240809$EXP$$CA-HALEON-2184035$Haleon PLC$$$$$F$Y$$$20240809$$HP$CA$CA
240488138$24048813$8$F$20240708$20240805$20240704$20240807$EXP$$US-ROCHE-10000015128$ROCHE$$65$YR$E$F$Y$50.35$KG$20240807$$CN$US$US
240488141$24048814$1$I$$20240625$20240704$20240704$EXP$$US-SA-2024SA193270$SANOFI AVENTIS$$$$$$Y$$$20240704$$HP$US$US
240488151$24048815$1$I$$20240625$20240704$20240704$EXP$$US-SA-2024SA191173$SANOFI AVENTIS$$75$YR$E$F$Y$64$KG$20240704$$MD$US$US
240488161$24048816$1$I$20231201$20240628$20240704$20240704$EXP$$US-ABBVIE-5821955$ABBVIE$$77$YR$$F$Y$$$20240704$$CN$US$US
240488171$24048817$1$I$20240630$20240701$20240704$20240704$EXP$$US-ABBVIE-5824037$ABBVIE$$80$YR$$F$Y$$$20240704$$CN$US$US
240488181$24048818$1$I$$20240624$20240704$20240704$PER$$US-JNJFOC-20240664368$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240488191$24048819$1$I$$20240625$20240704$20240704$EXP$$PL-AUROBINDO-AUR-APL-2024-032049$AUROBINDO$Krawczyk M, Chajec J, Paluch Z, Michalczyk J, Mi?osz A, Szczukocka M. Pneumothorax as a complication of respiratory failure ? two case reports and literature review. J Pre-Clin Clin Res. 2024;18(2):139?146$41$YR$$M$Y$$$20240704$$HP$PL$PL
240488203$24048820$3$F$20221019$20240903$20240704$20240905$EXP$$US-GILEAD-2024-0679479$GILEAD$$58$YR$A$M$Y$$$20240905$$LW$US$US
240488212$24048821$2$F$$20240731$20240704$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407002167$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240804$$HP$US$US
240488222$24048822$2$F$20240601$20240718$20240704$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407002163$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240722$$CN$US$US
240488231$24048823$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002236$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240704$$CN$US$US
240488241$24048824$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001223$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240704$$CN$US$US
240488251$24048825$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002046$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240704$$CN$US$US
240488261$24048826$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001134$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240704$$CN$US$US
240488271$24048827$1$I$20240702$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002139$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240704$$CN$US$US
240488281$24048828$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002128$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240704$$CN$US$US
240488291$24048829$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001975$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240704$$CN$US$US
240488303$24048830$3$F$20240625$20240807$20240704$20240812$PER$$US-ALXN-202406USA001767US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
240488312$24048831$2$F$$20240701$20240704$20240722$EXP$$AR-HALEON-2184391$Haleon PLC$Cervantes, Jose G, Gasque, et al. [Liver transplantation as treatment for acetaminophen poisoning].. Medicina.?#PY#;84(3):588. #DOI#.; Cervantes JG, Gasque RA, Lenz ME, Barbero M, Navarro L, Roca I et.al. Liver transplantation as treatment for Paracetamol poisoning. Medicina. 2024;84:588-591.$28$YR$$F$Y$$$20240719$$HP$AR$AR
240488321$24048832$1$I$$20240625$20240704$20240704$EXP$$US-ALVOGEN-2024094979$ALVOGEN$$$$E$F$Y$$$20240704$$MD$US$US
240488331$24048833$1$I$20230301$20240701$20240704$20240704$EXP$$US-UCBSA-2024033774$UCB$$39$YR$$F$Y$$$20240704$$HP$US$US
240488351$24048835$1$I$20240628$20240628$20240704$20240704$PER$$US-ABBVIE-5822693$ABBVIE$$35$YR$$M$Y$$$20240704$$CN$US$US
240488361$24048836$1$I$$20240416$20240704$20240704$PER$$US-AMGEN-USASP2024130913$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240488371$24048837$1$I$$20240702$20240704$20240704$EXP$$US-JNJFOC-20240705276$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$HP$US$US
240488393$24048839$3$F$20240613$20240806$20240704$20240808$PER$$US-AMGEN-USASP2024131969$AMGEN$$79$YR$E$M$Y$$$20240808$$CN$US$US
240488401$24048840$1$I$$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024129463$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240488411$24048841$1$I$$20240620$20240704$20240704$EXP$$IE-ROCHE-10000014446$ROCHE$$$$$F$Y$$$20240704$$CN$IE$IE
240488421$24048842$1$I$$20230707$20240704$20240704$PER$$US-AMGEN-USASP2023235414$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240488441$24048844$1$I$$20240627$20240704$20240704$PER$$US-AstraZeneca-2024A149476$ASTRAZENECA$$$$A$F$Y$$$20240704$$MD$US$
240488452$24048845$2$F$$20240708$20240704$20240711$30DAY$$US-GSK-US2024078668$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$PH$US$US
240488461$24048846$1$I$$20240620$20240704$20240704$EXP$$US-GRAVITIPHARMA-GRA-2406-US-LIT-0227$GRAVITI PHARMACEUTICALS$Yang K, Mistry PD, Richeimer SH.Intrathecal baclofen pump in pregnancy: case report, literature review, and management considerations..Regional Anesthesia + Pain Medicine.17-MAY-2024;0:1-4$$$N$$Y$$$20240704$$HP$US$US
240488471$24048847$1$I$20240622$20240701$20240704$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106490$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240704$$MD$JP$JP
240488481$24048848$1$I$20240628$20240701$20240704$20240704$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037136$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$$$20240704$$CN$US$US
240488491$24048849$1$I$20231201$20240627$20240704$20240704$EXP$$US-SA-2024SA194428$SANOFI AVENTIS$$64$YR$A$F$Y$107$KG$20240704$$MD$US$US
240488541$24048854$1$I$$20240625$20240704$20240704$EXP$$JP-EMD Serono-2024034864$EMD SERONO INC$$81$YR$E$M$Y$$$20240704$$PH$JP$JP
240488551$24048855$1$I$20240604$20240626$20240704$20240704$PER$$US-JNJFOC-20240672805$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240704$$CN$US$US
240488567$24048856$7$F$20240612$20240722$20240704$20240801$30DAY$$AR-JNJFOC-20240646685$JOHNSON AND JOHNSON$$38$YR$A$F$Y$67$KG$20240801$$CN$AR$AR
240488571$24048857$1$I$$20240630$20240704$20240704$PER$$US-JNJFOC-20240704069$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240488581$24048858$1$I$$20240627$20240704$20240704$EXP$$GB-CELLTRION INC.-2024GB016000$CELLTRION$$$$$$Y$$$20240704$$CN$GB$GB
240488591$24048859$1$I$$20240501$20240704$20240704$PER$$US-AMGEN-USASP2024130535$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240488601$24048860$1$I$$20240626$20240704$20240704$PER$$US-ALXN-A202109313$ALEXION PHARMACEUTICALS$$$$E$F$Y$$$20240704$$CN$US$US
240488611$24048861$1$I$$20240626$20240704$20240704$PER$$US-ALXN-202406USA001776US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
240488621$24048862$1$I$$20240703$20240704$20240704$PER$$NVSC2024US138619$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
240488643$24048864$3$F$20230101$20240920$20240704$20240923$PER$$US-GILEAD-2024-0679533$GILEAD$$38$YR$A$M$Y$$$20240923$$LW$US$US
240488651$24048865$1$I$20220504$20240626$20240704$20240704$EXP$$BE-CELLTRION INC.-2024BE015726$CELLTRION$$$$$$Y$$$20240704$$PH$BE$BE
240488661$24048866$1$I$$20240626$20240704$20240704$PER$$US-JNJFOC-20240671547$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240488671$24048867$1$I$$20240620$20240704$20240704$EXP$$CN-Nexus Pharma-000288$NEXUS PHARMACEUTICALS$Chu S, Bai J, Wang X, Zhang L, Li L. Acute Promyelocytic Leukemia with Long and Short Isoforms of PML:: RARA Fusion Transcripts Complicated by Abdominal Distension and Acute Edematous Pancreatitis During Induction Treatment: A Case Report. Cureus. 2024 May 15;16(5): e60321.$70$YR$E$M$Y$$$20240704$$HP$CN$CN
240488681$24048868$1$I$$20240620$20240704$20240704$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05518$LUPIN$Simone C, Axelband J. Levetiracetam-associated rhabdomyolysis. The American Journal of Respiratory and Critical Care Medicine. 2024;209:A5704$20$YR$$M$Y$$$20240704$$MD$US$US
240488691$24048869$1$I$$20240627$20240704$20240704$EXP$$US-TAKEDA-2021TUS040958$TAKEDA$$$$$F$Y$75$KG$20240704$$HP$US$US
240488701$24048870$1$I$$20240702$20240704$20240704$EXP$$NVSC2024US138154$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
240488711$24048871$1$I$20240627$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129789$AMGEN$$56$YR$A$$Y$$$20240704$$CN$US$US
240488722$24048872$2$F$20240630$20240704$20240704$20240705$PER$$US-AMGEN-USASP2024130952$AMGEN$$81$YR$E$M$Y$$$20240704$$CN$US$US
240488732$24048873$2$F$20240627$20240627$20240704$20240814$PER$$US-AMGEN-USASP2024129031$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
240488742$24048874$2$F$20240620$20240723$20240704$20240726$PER$$US-ROCHE-10000009679$ROCHE$$$$$F$Y$$$20240726$$CN$US$US
240488762$24048876$2$F$$20240708$20240704$20240717$EXP$$JP-TEVA-VS-3213941$TEVA$Hiya S, Yoshimura H, Kawamoto M. Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD). eNeurologicalSci 2023; 31 no pagination.; Hiya S, Yoshimura H, Kawamoto M. Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD). eNeurologicalSci 2023; 31 no pagination.; Hiy...$17$YR$$F$Y$$$20240717$$HP$JP$JP
240488771$24048877$1$I$$20240626$20240704$20240704$EXP$$US-VIIV HEALTHCARE LIMITED-US2024079916$VIIV$$$$$M$Y$$$20240704$$CN$US$US
240488781$24048878$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106018$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240704$$HP$US$US
240488791$24048879$1$I$20240501$20240626$20240704$20240704$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024079721$VIIV$$31$YR$$M$Y$$$20240704$$CN$US$US
240488801$24048880$1$I$20240331$20240619$20240704$20240704$EXP$ES-AEMPS-1533750$ES-TEVA-VS-3212727$TEVA$$69$YR$$M$Y$71$KG$20240704$$MD$ES$ES
240488812$24048881$2$F$20240501$20240715$20240704$20240723$EXP$$AU-EMD Serono-2024034462$EMD SERONO INC$$38$YR$A$M$Y$$$20240723$$CN$AU$AU
240488821$24048882$1$I$$20230914$20240704$20240704$PER$$US-AMGEN-USASP2023235540$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240488837$24048883$7$F$20240605$20240903$20240704$20240910$EXP$$CA-ROCHE-10000015025$ROCHE$$58$YR$A$M$Y$$$20240910$$HP$CA$CA
240488841$24048884$1$I$20240629$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002424$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240704$$CN$US$US
240488851$24048885$1$I$20240527$20240628$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407000976$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240704$$CN$US$US
240488862$24048886$2$F$$20240705$20240704$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407001259$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240709$$CN$US$US
240488871$24048887$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001971$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240704$$CN$US$US
240488881$24048888$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002372$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240704$$CN$US$US
240488891$24048889$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002183$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240704$$CN$US$US
240488901$24048890$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001976$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240704$$HP$US$US
240488911$24048891$1$I$20240622$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002284$ELI LILLY AND CO$$$$A$F$Y$$$20240704$$CN$US$US
240488921$24048892$1$I$20240701$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002213$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240704$$HP$US$US
240488931$24048893$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002334$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240704$$CN$US$US
240488941$24048894$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001999$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240704$$CN$US$US
240488951$24048895$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002170$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240704$$CN$US$US
240488961$24048896$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001735$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240704$$HP$US$US
240488971$24048897$1$I$20240619$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202406014517$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240704$$CN$US$US
240488982$24048898$2$F$20240701$20240718$20240704$20240805$PER$$US-AMGEN-USASP2024131476$AMGEN$$$$$$Y$$$20240805$$CN$US$US
240488991$24048899$1$I$20240201$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024129893$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240489013$24048901$3$F$20140729$20240903$20240704$20240905$PER$$US-GILEAD-2024-0679534$GILEAD$$39$YR$A$M$Y$$$20240905$$LW$US$US
240489021$24048902$1$I$20240626$20240626$20240704$20240704$PER$$US-CSL-2024-006188$CSL Plasma$$34$YR$$M$Y$$$20240704$$HP$US$US
240489031$24048903$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106308$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240704$$PH$US$US
240489041$24048904$1$I$$20240624$20240704$20240704$EXP$$IN-ROCHE-10000013802$ROCHE$$57$YR$A$F$Y$$$20240704$$CN$IN$IN
240489051$24048905$1$I$20240620$20240621$20240704$20240704$EXP$$JP-ROCHE-10000012208$ROCHE$$6$DEC$A$F$Y$$$20240704$$MD$JP$JP
240489061$24048906$1$I$$20240624$20240704$20240704$EXP$$US-TEVA-VS-3214186$TEVA$Agudelo Higuita NI, Yuen C. Hemophagocytic Lymphohistiocytosis Secondary to Ehrlichia Chaffeensis in Adults: A Case Series From Oklahoma. [Review]. Am-J-Med-Sci 2021; 361 (2): 269-273.$62$YR$$F$Y$$$20240704$$MD$US$US
240489072$24048907$2$F$$20240723$20240704$20240730$PER$$US-CHATTEMPRD-2024OHG022153$CHATTEM$$70$YR$E$F$Y$72.57$KG$20240730$$CN$US$US
240489081$24048908$1$I$$20240620$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05591$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240489091$24048909$1$I$20240623$20240701$20240704$20240704$EXP$$US-TAKEDA-2024TUS041723$TAKEDA$$58$YR$$M$Y$$$20240704$$MD$US$US
240489101$24048910$1$I$20240618$20240628$20240704$20240704$EXP$$CA-JNJFOC-20240701719$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240704$$HP$CA$CA
240489111$24048911$1$I$20240501$20240626$20240704$20240704$EXP$$AR-JNJFOC-20240674963$JOHNSON AND JOHNSON$$52$YR$A$M$Y$80$KG$20240704$$CN$AR$AR
240489121$24048912$1$I$20240203$20240619$20240704$20240704$EXP$FR-AFSSAPS-PC2024000457$FR-TEVA-VS-3212420$TEVA$$25$YR$$F$Y$84$KG$20240704$$MD$FR$FR
240489131$24048913$1$I$20240101$20240628$20240704$20240704$PER$$US-CHATTEMPRD-2024OHG022574$CHATTEM$$$$$M$Y$$$20240704$$CN$US$US
240489141$24048914$1$I$$20240628$20240704$20240704$PER$$US-ABBVIE-5822982$ABBVIE$$$$A$$Y$$$20240704$$CN$US$US
240489152$24048915$2$F$$20240626$20240704$20240709$EXP$$US-ROCHE-3520936$ROCHE$$69$YR$E$M$Y$$$20240709$$CN$US$US
240489161$24048916$1$I$20240624$20240626$20240704$20240704$EXP$$CA-APOTEX-2024AP007881$APOTEX$$63$YR$A$M$Y$$$20240704$$CN$CA$CA
240489171$24048917$1$I$20231015$20240626$20240704$20240704$EXP$$NL-CELLTRION INC.-2024NL015731$CELLTRION$$$$$$Y$$$20240704$$MD$NL$NL
240489181$24048918$1$I$20240219$20240620$20240704$20240704$EXP$FR-AFSSAPS-PA2024001246$FR-TEVA-VS-3213072$TEVA$$76$YR$$F$Y$108$KG$20240704$$MD$FR$FR
240489191$24048919$1$I$20240522$20240620$20240704$20240704$EXP$SE-SEMPA-2024-004579$SE-TEVA-VS-3213308$TEVA$$76$YR$$M$Y$$$20240704$$MD$SE$SE
240489201$24048920$1$I$$20240617$20240704$20240704$EXP$$US-INFO-20240173$INFORLIFE$$70$YR$E$M$Y$$$20240619$$HP$US$US
240489211$24048921$1$I$$20240620$20240704$20240704$EXP$$US-INFO-20240187$INFORLIFE$$73$YR$E$M$Y$$$20240621$$HP$US$US
240489221$24048922$1$I$$20240628$20240704$20240704$EXP$$GR-INFO-20240194$INFORLIFE$Koliaki C, Siafarikas C, Tsakanikas A, Georgopoulou A, Mylona M. A young neutropenic patient with glycogen storage disease and diarrhea: An underlying infection or her pre-existing Crohn^s like disease? European Journal of Case Reports in Internal Medicine. 2019;6(Supplement1):411. DOI: 10.12890/2019_V6Sup1.$30$YR$A$F$Y$$$20240701$$MD$GR$
240489231$24048923$1$I$$20240626$20240704$20240704$EXP$$US-JNJFOC-20240589559$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240489241$24048924$1$I$$20240619$20240704$20240704$EXP$$US-INFO-20240177$INFORLIFE$$68$YR$E$M$Y$$$20240620$$HP$US$US
240489251$24048925$1$I$$20240617$20240704$20240704$EXP$$US-INFO-20240175$INFORLIFE$$$$$$Y$$$20240619$$HP$US$US
240489262$24048926$2$F$20160103$20240903$20240704$20240905$PER$$US-GILEAD-2024-0679535$GILEAD$$28$YR$A$F$Y$$$20240905$$LW$US$US
240489271$24048927$1$I$$20240617$20240704$20240704$EXP$$US-INFO-20240171$INFORLIFE$$62$YR$$F$Y$$$20240619$$HP$US$US
240489281$24048928$1$I$$20240628$20240704$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106171$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$CN$JP$JP
240489291$24048929$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138630$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240489302$24048930$2$F$$20240724$20240704$20240807$PER$$US-RDY-SPO/USA/24/0008980$DR REDDYS$$66$YR$E$F$Y$$$20240807$$CN$US$US
240489311$24048931$1$I$$20240621$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05743$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240489321$24048932$1$I$$20240312$20240704$20240704$PER$$US-AMGEN-USASP2024130909$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240489331$24048933$1$I$$20230823$20240704$20240704$PER$$US-AMGEN-USASP2023235424$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240489342$24048934$2$F$20240101$20240724$20240704$20240730$EXP$$AR-JNJFOC-20240701763$JOHNSON AND JOHNSON$$57$YR$A$F$Y$65$KG$20240730$$CN$AR$AR
240489351$24048935$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131000$AMGEN$$$$A$F$Y$$$20240704$$HP$US$US
240489361$24048936$1$I$$20240625$20240704$20240704$PER$$US-SMPA-2024SPA000080$SUNOVION$$$$$$Y$$$20240704$$CN$US$US
240489371$24048937$1$I$$20240627$20240704$20240704$EXP$$US-VIIV HEALTHCARE LIMITED-US2024081142$VIIV$$$$$$Y$$$20240704$$MD$US$US
240489382$24048938$2$F$$20240702$20240704$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05680$LUPIN$$$$$$Y$$$20240724$$CN$US$US
240489391$24048939$1$I$$20240610$20240704$20240704$PER$$US-JNJFOC-20240669160$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$HP$US$US
240489401$24048940$1$I$20240620$20240624$20240704$20240704$EXP$$US-VIIV HEALTHCARE LIMITED-US2024078610$VIIV$$37$YR$$M$Y$$$20240704$$CN$US$US
240489411$24048941$1$I$$20240114$20240704$20240704$PER$$US-AMGEN-USASP2024130686$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240489421$24048942$1$I$20240101$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129332$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240489431$24048943$1$I$$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024130673$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240489442$24048944$2$F$$20240626$20240704$20240705$PER$$US-SMPA-2024SPA000085$SUNOVION$$$$$$Y$$$20240705$$CN$US$US
240489451$24048945$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131400$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240489461$24048946$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138463$NOVARTIS$$$$$$Y$$$20240704$$MD$US$US
240489471$24048947$1$I$20230101$20240626$20240704$20240704$EXP$$US-JNJFOC-20240675141$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240489481$24048948$1$I$20240615$20240627$20240704$20240704$EXP$$BR-SA-2024SA196196$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$MD$BR$BR
240489492$24048949$2$F$$20240723$20240704$20240729$EXP$$US-BIOVITRUM-2024-US-009208$BIOVITRUM$$68$YR$$M$Y$89.2$KG$20240729$$HP$US$US
240489501$24048950$1$I$$20240627$20240704$20240704$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036509$BOEHRINGER INGELHEIM$Borrelli JC, Cioffi MA, Martini N, Samarneh M. Empagliflozin-associated pancreatitis in the setting of hyperglycemic hyperosmolar syndrome. Cureus. 2024 May 23;16(5): e60935. doi:dx.doi.org/10.7759/cureu s.60935.$57$YR$A$M$Y$$$20240704$$HP$US$US
240489512$24048951$2$F$$20240730$20240704$20240808$EXP$$CN-ROCHE-10000012322$ROCHE$Shao X, Li W, Hu H, Lu Y, Jiang Y, Tian Y. The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy. National Medical Journal of China. 2024-Apr-23;104 (16):1397-402. doi:10.3760/cma.j.cn112137-20230811-00206.$$$$$Y$$$20240808$$HP$CN$CN
240489521$24048952$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106553$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240704$$CN$US$US
240489531$24048953$1$I$$20240627$20240704$20240704$EXP$$US-SA-2024SA193434$SANOFI AVENTIS$$32$YR$A$M$Y$63$KG$20240704$$MD$US$US
240489542$24048954$2$F$20240101$20240719$20240704$20240724$EXP$$US-SA-2024SA173092$SANOFI AVENTIS$$85$YR$E$M$Y$72$KG$20240724$$MD$US$US
240489551$24048955$1$I$20240428$20240628$20240704$20240704$EXP$FR-AFSSAPS-TS2024000729$FR-SA-2024SA192094$SANOFI AVENTIS$$55$YR$A$M$Y$83$KG$20240704$$CN$FR$FR
240489561$24048956$1$I$$20240620$20240704$20240704$EXP$$US-ROCHE-10000010891$ROCHE$$9$YR$C$M$Y$25.85$KG$20240704$$MD$US$US
240489571$24048957$1$I$$20240620$20240704$20240704$EXP$$JP-SMPA-2024SPA000079$SUNOVION$$$$$$Y$$$20240704$$MD$BR$BR
240489582$24048958$2$F$20230714$20240708$20240704$20240710$EXP$$SA-UCBSA-2024033426$UCB$Alruwaili M, AlRuwaili R, Alshaalan ZM, Aljumah TK, Alsaidan AA, Alorayyidh MM, et al.. Levetiracetam-Induced Acute Hypersensitivity Reaction in a Previously Undiagnosed Epilepsy Elderly Woman: A Case Report. International Journal of Pharmacology. 2024;20(5):912-5$71$YR$$F$Y$$$20240710$$HP$SA$SA
240489591$24048959$1$I$$20231009$20240704$20240704$PER$$US-AMGEN-USASP2023235247$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240489601$24048960$1$I$$20240628$20240704$20240704$EXP$$US-JNJFOC-20240677839$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$HP$US$US
240489611$24048961$1$I$$20240627$20240704$20240704$PER$$US-JNJFOC-20240700902$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240704$$CN$US$US
240489622$24048962$2$F$20240301$20240624$20240704$20240708$EXP$$JP-ROCHE-10000013685$ROCHE$$79$YR$E$F$Y$39.8$KG$20240708$$PH$JP$JP
240489641$24048964$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131279$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240489653$24048965$3$F$20240101$20240815$20240704$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-017560$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240823$$$US$US
240489661$24048966$1$I$20240221$20240621$20240704$20240704$EXP$FR-AFSSAPS-TO2024001072$FR-TEVA-VS-3213329$TEVA$$77$YR$$M$Y$$$20240704$$PH$FR$FR
240489671$24048967$1$I$$20240624$20240704$20240704$EXP$GB-MHRA-MED-202406231928213080-HJRFD$GB-ALK-ABELLO A/S-2024AA002612$ALK-ABELLO$$$$$$Y$$$20240704$$CN$GB$GB
240489681$24048968$1$I$$20240702$20240704$20240704$EXP$$GB-UCBSA-2024033796$UCB$$$$$F$Y$$$20240704$$CN$GB$GB
240489693$24048969$3$F$20200515$20240911$20240704$20240913$EXP$$US-GILEAD-2024-0679536$GILEAD$$53$YR$A$M$Y$$$20240913$$LW$US$US
240489701$24048970$1$I$$20240620$20240704$20240704$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-05759$HIKMA$Simone C, Axelband J.. Simone C, Axelband J. Levetiracetam-associated rhabdomyolysis.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5704$20$YR$$M$Y$$$20240704$$MD$US$US
240489712$24048971$2$F$$20240722$20240704$20240723$PER$$NVSC2024US138623$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
240489721$24048972$1$I$20240513$20240626$20240704$20240704$EXP$$CN-ROCHE-10000010208$ROCHE$$55$YR$A$F$Y$52$KG$20240704$$HP$CN$CN
240489741$24048974$1$I$$20240702$20240704$20240704$PER$$US-JNJFOC-20240705539$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$HP$US$US
240489751$24048975$1$I$$20240620$20240704$20240704$EXP$$US-LUPIN HEALTHCARE (UK) LIMITED-2024-05520$LUPIN$Pierce V, Bollavaram V, Ali A. A case of long QT syndrome masquerading as epilepsy. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1699$43$YR$$F$Y$$$20240704$$MD$US$US
240489761$24048976$1$I$$20240626$20240704$20240704$EXP$$CN-ROCHE-10000010540$ROCHE$$55$YR$A$F$Y$60$KG$20240704$$HP$CN$CN
240489771$24048977$1$I$$20240626$20240704$20240704$30DAY$$US-GSK-US2024079868$GLAXOSMITHKLINE$$$$$M$Y$$$20240704$$CN$US$US
240489782$24048978$2$F$$20240726$20240704$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106502$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240731$$CN$US$US
240489791$24048979$1$I$$20240408$20240704$20240704$PER$$US-AMGEN-USASP2024129955$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240489801$24048980$1$I$$20240105$20240704$20240704$PER$$US-AMGEN-USASP2024130800$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240489811$24048981$1$I$$20240223$20240704$20240704$PER$$US-AMGEN-USASP2024130928$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240489824$24048982$4$F$$20240805$20240704$20240806$PER$$US-ALXN-202406USA001775US$ALEXION PHARMACEUTICALS$$$$$M$Y$117.91$KG$20240806$$CN$US$US
240489832$24048983$2$F$20230116$20240911$20240704$20240913$PER$$US-GILEAD-2024-0679537$GILEAD$$63$YR$A$M$Y$$$20240913$$LW$US$US
240489843$24048984$3$F$20240301$20240716$20240704$20240724$PER$$US-ABBVIE-5822879$ABBVIE$$63$YR$$F$Y$65.77$KG$20240724$$CN$US$US
240489855$24048985$5$F$20240101$20240828$20240704$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-019687$UNITED THERAPEUTICS$$$$$F$Y$42.63$KG$20240905$$$US$US
240489861$24048986$1$I$$20240703$20240704$20240704$EXP$$GB-SANDOZ INC.-SDZ2024GB062591$SANDOZ$$$$A$M$Y$$$20240704$$CN$GB$GB
240489871$24048987$1$I$20240101$20240626$20240704$20240704$PER$$US-SMPA-2024SPA000103$SUNOVION$$$$$$Y$$$20240704$$CN$US$US
240489881$24048988$1$I$$20240628$20240704$20240704$PER$$US-SMPA-2024SPA000094$SUNOVION$$$$$$Y$$$20240704$$CN$US$US
240489891$24048989$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001939$ELI LILLY AND CO$$53$YR$A$$Y$$$20240704$$CN$US$US
240489901$24048990$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002314$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240704$$CN$US$US
240489911$24048991$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001287$ELI LILLY AND CO$$3$YR$C$F$Y$$$20240704$$HP$US$US
240489921$24048992$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001702$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240704$$CN$US$US
240489931$24048993$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002118$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240704$$CN$US$US
240489942$24048994$2$F$20240214$20240708$20240704$20240722$EXP$FR-AFSSAPS-AN2024000610$FR-NORDICGR-056461$NORDIC PHARMA$$83$YR$$F$Y$$$20240722$$MD$FR$FR
240489951$24048995$1$I$20240111$20240624$20240704$20240704$EXP$FR-AFSSAPS-BR2024000388$FR-NORDICGR-056456$NORDIC PHARMA$$77$YR$$M$Y$$$20240704$$PH$FR$FR
240489962$24048996$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214807$TEVA$Pham LL, Landeen C. New Onset Refractory Status Epilepticus in Prion Disease. Am-J-Respir-Crit-Care-Med 2024; 209 A5614.; Pham LL, Landeen C. New Onset Refractory Status Epilepticus in Prion Disease. Am-J-Respir-Crit-Care-Med 2024; 209 A5614.$60$YR$$F$Y$$$20240720$$HP$US$US
240489971$24048997$1$I$20201201$20240621$20240704$20240704$EXP$$PL-ROCHE-10000012697$ROCHE$$49$YR$A$M$Y$$$20240704$$HP$PL$PL
240489981$24048998$1$I$20240528$20240626$20240704$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-095439$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240704$$PH$JP$JP
240489991$24048999$1$I$$20240624$20240704$20240704$30DAY$$US-JNJFOC-20240703262$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240490002$24049000$2$F$$20240708$20240704$20240710$PER$$US-JNJFOC-20240704609$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$HP$US$US
240490011$24049001$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138468$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
240490021$24049002$1$I$$20230907$20240704$20240704$PER$$US-AMGEN-USASP2023235367$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240490031$24049003$1$I$$20240112$20240704$20240704$PER$$US-AMGEN-USASP2024130020$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240490041$24049004$1$I$20240531$20240620$20240704$20240704$EXP$AT-BASGAGES-2024-004206$AT-TEVA-VS-3212994$TEVA$$49$YR$$M$Y$$$20240704$$CN$AT$AT
240490051$24049005$1$I$$20240404$20240704$20240704$PER$$US-AMGEN-USASP2024129957$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240490062$24049006$2$F$$20240801$20240704$20240813$EXP$$JP-AMGEN-JPNSP2024129322$AMGEN$$$$$$Y$$$20240813$$PH$JP$JP
240490071$24049007$1$I$20200222$20240701$20240704$20240704$EXP$PL-URPL-1-1186-2020$PL-HALEON-2185104$Haleon PLC$$80$YR$$M$Y$80$KG$20240704$$MD$PL$PL
240490082$24049008$2$F$20240229$20240702$20240704$20240711$EXP$$SE-AUROBINDO-AUR-APL-2024-031941$AUROBINDO$$40$YR$$M$Y$$$20240711$$MD$SE$SE
240490092$24049009$2$F$$20240703$20240704$20240718$EXP$$DE-002147023-PHHY2011DE17401$Haleon PLC$M, Spes J, Kraus MR, 17-year-old patient with neutropenia and fever during therapy with analgesics. Deutsche medizinische?wochenschrift, 2011; 136 (8): 365-8.; M, Spes J, Kraus MR, 17-year-old patient with neutropenia and fever during therapy with analgesics. Deutsche medizinische?wochenschrift, 2011; 136 (8): 365-8.$17$YR$$M$Y$68$KG$20240717$$MD$DE$DE
240490101$24049010$1$I$$20240625$20240704$20240704$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001316$BLUEPRINT MEDICINES$$$$$M$Y$$$20240704$$CN$US$US
240490113$24049011$3$F$20181019$20240917$20240704$20240918$PER$$US-GILEAD-2024-0679538$GILEAD$$58$YR$A$M$Y$$$20240918$$LW$US$US
240490121$24049012$1$I$$20240628$20240704$20240704$PER$$US-JNJFOC-20240676498$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240490131$24049013$1$I$20230910$20240630$20240704$20240704$EXP$$SA-GSK-SA2023EME135368$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$SA$SA
240490141$24049014$1$I$$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-032224$AUROBINDO$$$$$M$Y$$$20240704$$PH$FR$FR
240490152$24049015$2$F$20240101$20240724$20240704$20240808$PER$$US-APOTEX-2024AP007396$APOTEX$$$$$M$Y$$$20240808$$CN$US$US
240490161$24049016$1$I$20240228$20240626$20240704$20240704$EXP$$CA-TAKEDA-2024TUS057152$TAKEDA$$10$YR$$F$Y$$$20240704$$CN$CA$CA
240490171$24049017$1$I$20230401$20240626$20240704$20240704$EXP$$DE-AUROBINDO-AUR-APL-2024-031959$AUROBINDO$$$$E$$Y$$$20240704$$MD$DE$DE
240490182$24049018$2$F$$20240629$20240704$20240705$PER$$US-ROCHE-10000015612$ROCHE$$$$A$F$Y$$$20240705$$CN$US$US
240490191$24049019$1$I$$20240624$20240704$20240704$30DAY$$US-GSK-US2024078662$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
240490201$24049020$1$I$$20240627$20240704$20240704$PER$$US-LEO Pharma-371585$LEO PHARM$$54$YR$$F$Y$$$20240704$$CN$US$US
240490211$24049021$1$I$20231101$20240626$20240704$20240704$EXP$$DE-AUROBINDO-AUR-APL-2024-031921$AUROBINDO$$88$YR$$M$Y$$$20240704$$MD$DE$DE
240490221$24049022$1$I$$20240626$20240704$20240704$EXP$$CA-CELLTRION INC.-2024CA015519$CELLTRION$$$$$$Y$$$20240704$$MD$CA$CA
240490232$24049023$2$F$20240101$20240729$20240704$20240807$EXP$$US-RECORDATI-2024004964$RECORDATI$$$$$$Y$$$20240807$$CN$US$US
240490241$24049024$1$I$20240627$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024129518$AMGEN$$75$YR$E$M$Y$$$20240704$$CN$US$US
240490251$24049025$1$I$$20240417$20240704$20240704$PER$$US-AMGEN-USASP2024130642$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240490261$24049026$1$I$20231129$20240702$20240704$20240704$EXP$HR-HALMED-300063267$HR-TAKEDA-2023TUS122194$TAKEDA$$38$YR$$M$Y$$$20240704$$HP$HR$HR
240490271$24049027$1$I$$20240702$20240704$20240704$EXP$$JP-TAKEDA-2024TJP009940$TAKEDA$$$$$$Y$$$20240704$$CN$JP$JP
240490282$24049028$2$F$$20240627$20240704$20240708$EXP$$JP-ROCHE-10000014789$ROCHE$$6$DEC$A$M$Y$$$20240708$$MD$JP$JP
240490291$24049029$1$I$$20240625$20240704$20240704$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001315$BLUEPRINT MEDICINES$$$$$M$Y$$$20240704$$CN$US$US
240490301$24049030$1$I$$20240701$20240704$20240704$PER$$NVSC2024US137401$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
240490313$24049031$3$F$20240226$20240722$20240704$20240724$EXP$$CA-UCBSA-2024010348$UCB$$30$YR$$F$Y$$$20240724$$CN$CA$CA
240490322$24049032$2$F$$20240617$20240704$20240711$PER$$US-ROCHE-RCA5067762$ROCHE$$30$YR$A$F$Y$$$20240711$$CN$US$US
240490334$24049033$4$F$20240615$20240813$20240704$20240823$PER$$US-ROCHE-10000005349$ROCHE$$28$YR$A$F$Y$97.52$KG$20240823$$CN$US$US
240490341$24049034$1$I$$20240621$20240704$20240704$EXP$$IN-ROCHE-3541558$ROCHE$$66$YR$E$M$Y$$$20240704$$MD$IN$IN
240490351$24049035$1$I$$20240628$20240704$20240704$PER$$US-JNJFOC-20240704824$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$PH$US$US
240490361$24049036$1$I$20240601$20240613$20240704$20240704$PER$$US-JNJFOC-20240636863$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240490381$24049038$1$I$$20240614$20240704$20240704$PER$$US-APOTEX-2024AP007627$APOTEX$Park LK, Lim K-H, Volkman J, Abdiannia M, Johnston H, Nigogosyan Z, et al. Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study. Cancer + Metabolism. 2023;11(1)(6):1-12$$$A$$Y$$$20240704$$HP$US$US
240490391$24049039$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002727$ELI LILLY AND CO$$$$$M$Y$$$20240704$$CN$US$US
240490401$24049040$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002082$ELI LILLY AND CO$$13$YR$T$F$Y$$$20240704$$CN$US$US
240490411$24049041$1$I$20240627$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002016$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240704$$CN$US$US
240490422$24049042$2$F$$20240823$20240704$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202407002001$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240827$$CN$US$US
240490431$24049043$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001951$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240704$$CN$US$US
240490441$24049044$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001884$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240704$$CN$US$US
240490451$24049045$1$I$20240601$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002195$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240704$$CN$US$US
240490462$24049046$2$F$20240628$20240701$20240704$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407001221$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240709$$CN$US$US
240490471$24049047$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001658$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240704$$CN$US$US
240490481$24049048$1$I$20240501$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001562$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240704$$CN$US$US
240490491$24049049$1$I$20240501$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001308$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240704$$MD$US$US
240490501$24049050$1$I$20240614$20240626$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-009867$BEIGENE$$$$$$Y$$$20240704$$HP$CN$CN
240490511$24049051$1$I$$20240701$20240704$20240704$PER$$NVSC2024US137315$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240490521$24049052$1$I$20240104$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031891$AUROBINDO$$20$YR$$F$Y$37$KG$20240704$$MD$FR$FR
240490531$24049053$1$I$20240101$20240701$20240704$20240704$PER$$US-ABBVIE-5822732$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240490541$24049054$1$I$20240326$20240621$20240704$20240704$EXP$ES-AEMPS-1535348$ES-TEVA-VS-3213215$TEVA$$58$YR$$F$Y$$$20240704$$MD$ES$ES
240490551$24049055$1$I$$20240614$20240704$20240704$PER$$US-APOTEX-2024AP007628$APOTEX$Park LK, Lim K-H, Volkman J, Abdiannia M, Johnston H, Nigogosyan Z, et al. Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study. Cancer + Metabolism. 2023;11:1 (6):1-12$$$A$$Y$$$20240704$$HP$US$US
240490561$24049056$1$I$$20240626$20240704$20240704$EXP$$DE-EMD Serono-2024034996$EMD SERONO INC$$$$E$F$Y$$$20240704$$CN$DE$DE
240490571$24049057$1$I$$20240109$20240704$20240704$PER$$US-AMGEN-USASP2024129997$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240490582$24049058$2$F$20240501$20240824$20240704$20240902$EXP$$CA-CELLTRION INC.-2022CA013615$CELLTRION$$$$$$Y$$$20240902$$MD$CA$CA
240490591$24049059$1$I$$20240702$20240704$20240704$PER$$US-JNJFOC-20240708714$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$HP$US$US
240490601$24049060$1$I$$20240627$20240704$20240704$EXP$$US-JNJFOC-20240674909$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$HP$US$US
240490612$24049061$2$F$20100101$20240709$20240704$20240720$EXP$$US-ABBVIE-5824247$ABBVIE$$$$$M$Y$108.86$KG$20240720$$CN$US$US
240490621$24049062$1$I$$20240627$20240704$20240704$EXP$$AU-JNJFOC-20240678864$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$HP$AU$AU
240490642$24049064$2$F$$20240627$20240704$20240712$EXP$$US-ROCHE-10000015216$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240490651$24049065$1$I$$20240702$20240704$20240704$PER$$US-GILEAD-2024-0679341$GILEAD$$$$$$Y$$$20240704$$CN$US$US
240490661$24049066$1$I$$20240702$20240704$20240704$EXP$$US-VIIV HEALTHCARE LIMITED-US2024082221$VIIV$$$$$M$Y$$$20240704$$HP$US$US
240490672$24049067$2$F$$20240710$20240704$20240719$EXP$$US-TEVA-VS-3214405$TEVA$Kabil EW, Lunardi N, Tennant WG, Esfahani K. Serotonin Syndrome After Prolonged Remifentanil and Propofol Infusion for Craniotomy: A Case Report. A-A-Pract 2024; 18 (6):.; Kabil EW, Lunardi N, Tennant WG, Esfahani K. Serotonin Syndrome After Prolonged Remifentanil and Propofol Infusion for Craniotomy: A Case Report. A-A-Pract 2024; 18 (6):.$32$YR$$M$Y$$$20240719$$MD$US$US
240490683$24049068$3$F$20110309$20240913$20240704$20240917$PER$$US-GILEAD-2024-0679542$GILEAD$$51$YR$A$M$Y$$$20240917$$LW$US$US
240490693$24049069$3$F$20240101$20240828$20240704$20240913$PER$$US-APOTEX-2024AP007461$APOTEX$$72$YR$$M$Y$$$20240913$$CN$US$US
240490722$24049072$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214512$TEVA$Vu-Ticar N, Gupta M. Chryseobacterium: A Critical Conundrum. Am-J-Respir-Crit-Care-Med 2024; 209.; Vu-Ticar N, Gupta M. Chryseobacterium: A Critical Conundrum. Am-J-Respir-Crit-Care-Med 2024; 209.$50$YR$$F$Y$$$20240720$$HP$US$US
240490731$24049073$1$I$$20230713$20240704$20240704$PER$$US-AMGEN-USASP2023235426$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240490741$24049074$1$I$$20240627$20240704$20240704$EXP$$US-AMGEN-USASP2024129473$AMGEN$Lund T. C.; Gupta A. O.; Furcich J. W. et al.. Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy. Journal of neuroimmunology. 2024;393:1-12$9$YR$C$M$Y$$$20240704$$HP$US$US
240490751$24049075$1$I$$20240628$20240704$20240704$EXP$$IT-JNJFOC-20240679850$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$HP$IT$IT
240490761$24049076$1$I$20240101$20240627$20240704$20240704$EXP$$PT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037334$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240704$$HP$PT$PT
240490772$24049077$2$F$$20240708$20240704$20240717$EXP$$US-TEVA-VS-3213987$TEVA$Mir MJ, Herndon NE, Wagle Shukla A, Wheeler-Hegland K, McFarland NR. The Vocal Flutter of Multiple System Atrophy: A Parkinsonian-Type Phenomenon?. Mov-Disord-Clin-Pract 2024; 11 (4): 403-410.; Mir MJ, Herndon NE, Wagle Shukla A, Wheeler-Hegland K, McFarland NR. The Vocal Flutter of Multiple System Atrophy: A Parkinsonian-Type Phenomenon?. Mov-Disord-Clin-Pract 2024; 11 (4): 403-410.$62$YR$$M$Y$$$20240717$$HP$US$US
240490781$24049078$1$I$$20240627$20240704$20240704$PER$$US-JNJFOC-20240674520$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$HP$US$US
240490793$24049079$3$F$20240605$20240725$20240704$20240806$30DAY$$US-JNJFOC-20240674201$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$US$US
240490801$24049080$1$I$$20240514$20240704$20240704$PER$$US-AMGEN-USASP2024129875$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240490812$24049081$2$F$20240630$20240813$20240704$20240814$PER$$US-AMGEN-USASP2024132064$AMGEN$$75$YR$E$M$Y$$$20240814$$CN$US$US
240490821$24049082$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131403$AMGEN$$$$$F$Y$$$20240704$$HP$US$US
240490831$24049083$1$I$$20240326$20240704$20240704$PER$$US-AMGEN-USASP2024131048$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240490841$24049084$1$I$$20240626$20240704$20240704$EXP$$JP-AstraZeneca-2024A149044$ASTRAZENECA$$$$$$Y$$$20240704$$PH$JP$
240490851$24049085$1$I$$20240626$20240704$20240704$EXP$$TW-AstraZeneca-2024A149793$ASTRAZENECA$$$$$F$Y$$$20240704$$CN$TW$
240490861$24049086$1$I$$20240624$20240704$20240704$PER$$US-AstraZeneca-2024A145696$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$US$
240490871$24049087$1$I$$20240626$20240704$20240704$EXP$$JP-AstraZeneca-2024A149286$ASTRAZENECA$$$$$$Y$$$20240704$$PH$JP$
240490881$24049088$1$I$20240626$20240628$20240704$20240704$EXP$$US-Taiho Oncology Inc-2024-006522$TAIHO ONCOLOGY INC$$73$YR$E$M$Y$$$20240704$$HP$US$US
240490891$24049089$1$I$$20240624$20240704$20240704$PER$$US-ABBVIE-5817631$ABBVIE$$$$$$Y$$$20240704$$HP$US$US
240490912$24049091$2$F$20240507$20240817$20240704$20240828$EXP$$DE-AUROBINDO-AUR-APL-2024-030000$AUROBINDO$$64$YR$$F$Y$53$KG$20240828$$HP$DE$DE
240490921$24049092$1$I$20230818$20240626$20240704$20240704$PER$$US-INCYTE CORPORATION-2024IN006861$INCYTE$$$$$$Y$$$20240704$$CN$US$US
240490931$24049093$1$I$$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024130921$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240490941$24049094$1$I$$20240626$20240704$20240704$EXP$$NL-AUROBINDO-AUR-APL-2024-031979$AUROBINDO$Diercks GFH, Meijer JM, Bolling MC, Scholtens-Jaegers SMHJ, Bremer J, Horvath B.. Absence of epidermal antibodies in Stevens-Johnson syndrome/toxic epidermal necrolysis patients but beware of single positive results.. Dermatology Research and Practice.. 2024;2024:1-5.$60$YR$$F$Y$$$20240704$$HP$NL$NL
240490951$24049095$1$I$$20240626$20240704$20240704$EXP$$CA-CELLTRION INC.-2024CA015515$CELLTRION$$$$$$Y$$$20240704$$CN$CA$CA
240490961$24049096$1$I$$20240221$20240704$20240704$PER$$US-AMGEN-USASP2024130166$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240490971$24049097$1$I$20240701$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131891$AMGEN$$55$YR$A$F$Y$$$20240704$$CN$US$US
240490981$24049098$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002792$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240704$$CN$US$US
240490991$24049099$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001940$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240704$$CN$US$US
240491001$24049100$1$I$20240630$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002209$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240704$$CN$US$US
240491011$24049101$1$I$20240601$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001282$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240704$$CN$US$US
240491021$24049102$1$I$20180901$20181010$20240704$20240704$EXP$$JP-TAKEDA-SH201817397$TAKEDA$$7$YR$$M$Y$$$20240704$$MD$JP$JP
240491031$24049103$1$I$20240101$20240701$20240704$20240704$PER$$US-JNJFOC-20240702649$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240704$$CN$US$US
240491042$24049104$2$F$20240630$20240702$20240704$20240704$PER$$US-JNJFOC-20240701679$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240704$$CN$US$US
240491051$24049105$1$I$20240601$20240624$20240704$20240704$PER$$US-JNJFOC-20240662905$JOHNSON AND JOHNSON$$58$YR$A$F$Y$68.1$KG$20240704$$CN$US$US
240491061$24049106$1$I$20240628$20240628$20240704$20240704$30DAY$$US-GSK-US2024081058$GLAXOSMITHKLINE$$65$YR$$M$Y$$$20240704$$CN$US$US
240491072$24049107$2$F$20201125$20240806$20240704$20240813$EXP$$JP-EXELIXIS-CABO-24077906$EXELIXIS$$69$YR$$M$Y$$$20240812$$MD$JP$JP
240491082$24049108$2$F$$20240724$20240704$20240802$30DAY$$US-GSK-US2024081166$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$MD$US$US
240491091$24049109$1$I$20240101$20240627$20240704$20240704$PER$$US-ABBVIE-5823420$ABBVIE$$35$YR$$F$Y$$$20240704$$CN$US$US
240491102$24049110$2$F$20240604$20240724$20240704$20240801$EXP$IT-MINISAL02-990188$IT-TEVA-VS-3213278$TEVA$$74$YR$$F$Y$57$KG$20240801$$MD$IT$IT
240491111$24049111$1$I$$20240628$20240704$20240704$EXP$$US-GSK-US2024081187$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
240491121$24049112$1$I$20240622$20240702$20240704$20240704$EXP$$US-GILEAD-2024-0679284$GILEAD$$60$YR$A$F$Y$$$20240704$$CN$US$US
240491131$24049113$1$I$20240617$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024129865$AMGEN$$76$YR$E$F$Y$$$20240704$$CN$US$US
240491141$24049114$1$I$$20240425$20240704$20240704$PER$$US-AMGEN-USASP2024129999$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240491151$24049115$1$I$$20240604$20240704$20240704$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108422$ZYDUS PHARM$$$$$$Y$$$20240704$$CN$US$US
240491161$24049116$1$I$$20240325$20240704$20240704$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-105300$ZYDUS PHARM$$$$$$Y$$$20240704$$CN$US$US
240491171$24049117$1$I$$20240620$20240704$20240704$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108868$ZYDUS PHARM$Sohn A, Sanchez G, Mantopoulos D. Partial thickness subfoveal hole in a patient treated with tamoxifen: a case report and review of the literature. [Review].. J-Med-Case-Rep. 2022;16(1):1-5$$$$$Y$$$20240704$$HP$US$US
240491181$24049118$1$I$$20240314$20240704$20240704$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-104762$ZYDUS PHARM$$$$$$Y$$$20240704$$CN$US$US
240491191$24049119$1$I$20240513$20240624$20240704$20240704$EXP$ES-AEMPS-1536637$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109000$ZYDUS PHARM$$$$$$Y$$$20240704$$PH$ES$ES
240491201$24049120$1$I$$20240619$20240704$20240704$EXP$$US-LUPIN EUROPE GMBH-2024-05592$LUPIN$Hussain M, Tiwana HZJ, Sivanandham R, Barsoum A, Bagheri S, Hussain S, et al. Aripiprazole-induced diabetic ketoacidosis and hypertriglyceridemia triggering concurrent pancreatitis: a case report. Critical Care Medicine. 2024;209:A5680$35$YR$$M$Y$$$20240704$$HP$US$US
240491211$24049121$1$I$$20240626$20240704$20240704$30DAY$$US-GSK-US2024AMR080093$GLAXOSMITHKLINE$$$$$M$Y$$$20240704$$CN$US$US
240491221$24049122$1$I$$20240619$20240704$20240704$EXP$$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108796$ZYDUS PHARM$Berge M, Giraud JS, De Percin S, Puszkiel A, Thomas-Schoemann A, Blanchet B.. Pharmacokinetic drug-drug interaction between olaparib and apixaban: a case report.. Cancer-Chemother-Pharmacol. 2024;93(5):519-521$$$$$Y$$$20240704$$HP$FR$FR
240491231$24049123$1$I$20240319$20240626$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-009858$BEIGENE$$$$$$Y$$$20240704$$HP$CN$CN
240491241$24049124$1$I$$20240624$20240704$20240704$PER$$US-TEVA-VS-3213192$TEVA$$51$YR$$F$Y$$$20240704$$CN$US$US
240491251$24049125$1$I$20240201$20240701$20240704$20240704$PER$$US-JNJFOC-20240702481$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240704$$CN$US$US
240491262$24049126$2$F$20240621$20240722$20240704$20240724$PER$$US-JNJFOC-20240667363$JOHNSON AND JOHNSON$$46$YR$A$F$Y$120$KG$20240724$$HP$US$US
240491271$24049127$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105998$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240704$$CN$US$US
240491281$24049128$1$I$$20240620$20240704$20240704$EXP$$US-CIPLA LTD.-2024US06524$CIPLA$Crawford M, Trinh JM, Chaudhary S.. A case report of statin-induced necrotizing autoimmune myopathy with extramuscular involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240704$$MD$US$US
240491292$24049129$2$F$$20240708$20240704$20240715$EXP$GB-MHRA-MED-202406281144360370-LSKWG$GB-RDY-SPO/GBR/24/0009664$DR REDDYS$$$$$$Y$$$20240715$$CN$GB$GB
240491301$24049130$1$I$20240323$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281122461890-DVTGF$GB-RDY-SPO/GBR/24/0009666$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240491311$24049131$1$I$20240323$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281137402150-JMBTC$GB-RDY-SPO/GBR/24/0009634$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240491321$24049132$1$I$20240601$20240628$20240704$20240704$EXP$FR-AFSSAPS-TS2024000708$FR-CHEPLA-2024008241$CHEPLAPHARM$$40$YR$$M$Y$62$KG$20240704$$MD$COUNTRY NOT SPECIFIED$FR
240491331$24049133$1$I$20200101$20240620$20240704$20240704$EXP$$GB-ROCHE-10000004583$ROCHE$$$$$$Y$$$20240704$$PH$GB$GB
240491341$24049134$1$I$$20240626$20240704$20240704$30DAY$$US-GSK-US2024AMR080012$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
240491352$24049135$2$F$20231215$20240830$20240704$20240909$EXP$$JP-MTPC-MTPC2024-0013669$MITSUBISHI TANABE PHARMA$$56$YR$$F$Y$$$20240909$$MD$JP$JP
240491361$24049136$1$I$20240531$20240624$20240704$20240704$EXP$$US-VIIV HEALTHCARE LIMITED-US2024078532$VIIV$$63$YR$$M$Y$81.65$KG$20240704$$CN$US$US
240491371$24049137$1$I$$20240625$20240704$20240704$PER$$US-AstraZeneca-2024A147038$ASTRAZENECA$$70$YR$$F$Y$$$20240704$$PH$US$
240491385$24049138$5$F$20240628$20240828$20240704$20240904$EXP$$US-GILEAD-2024-0679255$GILEAD$$39$YR$A$F$Y$$$20240904$$HP$US$US
240491391$24049139$1$I$$20240620$20240704$20240704$EXP$$AU-CIPLA LTD.-2024AU06716$CIPLA$Dhaliwal N, Roberts DM. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clin-Toxicol-(Phila). 2024;0 (0):1 to 6$$$$$Y$$$20240704$$HP$AU$AU
240491401$24049140$1$I$$20240415$20240704$20240704$PER$$US-AMGEN-USASP2024130028$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240491412$24049141$2$F$20230921$20240710$20240704$20240715$EXP$$CO-AMGEN-COLSL2024046463$AMGEN$$58$YR$A$F$Y$$$20240715$$CN$CO$CO
240491421$24049142$1$I$$20231010$20240704$20240704$PER$$US-AMGEN-USASP2023235493$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240491435$24049143$5$F$20240322$20240913$20240704$20240917$EXP$$DE-BAUSCH-BL-2024-010087$BAUSCH AND LOMB$$72$YR$$F$Y$68$KG$20240917$$HP$DE$DE
240491441$24049144$1$I$$20240703$20240704$20240704$EXP$$PL-ADIENNEP-2024AD000483$ADIENNE PHARMA + BIOTECH$Wypyszczak K, Urbanska Z, Miarka-Walczyk K, Kolodrubiec J, Jakubowska J, Spychalska J et al. Transformation of aplastic anemia with paroxysmal nocturnal hemoglobinuria clone to childhood B-cell precursor acute lymphoblastic leukemia. Pediatr Blood Cancer. 2024;71(7):e30994. DOI: 10.1002/pbc.30994$$$T$M$Y$$$20240703$$MD$PL$
240491451$24049145$1$I$$20240627$20240704$20240704$EXP$$BE-JNJFOC-20240678528$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$BE$BE
240491461$24049146$1$I$$20240606$20240704$20240704$PER$$US-JNJFOC-20240622070$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240491471$24049147$1$I$20240501$20240626$20240704$20240704$EXP$$CN-JNJFOC-20240673913$JOHNSON AND JOHNSON$$45$YR$A$F$Y$52.5$KG$20240704$$HP$CN$CN
240491481$24049148$1$I$20220502$20240626$20240704$20240704$EXP$$BE-AUROBINDO-AUR-APL-2024-031883$AUROBINDO$$81$YR$$F$Y$57.6$KG$20240704$$HP$BE$BE
240491491$24049149$1$I$$20240628$20240704$20240704$EXP$NL-EMA-20160719-dkevhp-134157769$NL-HALEON-2184883$Haleon PLC$Oliveira dos Santos C, Zijlstra JG, Porte RJ, Kampinga GA, van Diepeningen AD, Sinha B et al. Emerging pan-resistance in Trichosporon species: A case report. BMC Infectious Diseases. 2016;16(1): Article Number 148. DOI: 10.1186/s12879-016-1477-3.; Oliveira dos Santos C, Zijlstra JG, Porte RJ, Kampinga GA, van Diepeningen AD, Sinha B et al. Emerging pan-resistance in Trichosporon species: A case report. BMC Infectious Diseases. 2016;16(1): Article Number 148. DOI: 10.1186/s12879-016-1477-3.$48$YR$$M$Y$$$20240703$$MD$NL$NL
240491503$24049150$3$F$$20240826$20240704$20240828$EXP$$NVSC2024US138475$NOVARTIS$$$$$M$Y$$$20240828$$CN$US$US
240491511$24049151$1$I$20211214$20240701$20240704$20240704$EXP$NO-NOMAADVRE-RELISSO-2024-Vzb4nj$NVSC2024NO136315$NOVARTIS$$44$YR$$F$Y$$$20240704$$MD$NO$NO
240491522$24049152$2$F$20231213$20240709$20240704$20240718$EXP$$IT-AUROBINDO-AUR-APL-2024-031916$AUROBINDO$$77$YR$$F$Y$$$20240718$$HP$IT$IT
240491532$24049153$2$F$20230605$20240625$20240704$20240709$EXP$$CA-CELLTRION INC.-2023CA011821$CELLTRION$$$$$$Y$$$20240709$$CN$CA$CA
240491541$24049154$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5821889$ABBVIE$$$$$$Y$$$20240704$$HP$US$US
240491551$24049155$1$I$$20240620$20240704$20240704$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-13986$ALKEM$$$$$M$Y$68.027$KG$20240704$$CN$US$US
240491561$24049156$1$I$$20240627$20240704$20240704$EXP$$US-BAUSCH-BL-2024-010012$BAUSCH AND LOMB$Credo R, Kesey J, Bharadia D, Griswold J, Pang A. Acute Intermittent Porphyria in a Burn Patient: Case Study and Review of the Literature. Journal of Burn Care and Research. 2024;45 (3):790-795. doi:10.1093/jbcr/irad135$60$YR$$M$Y$$$20240704$$MD$US$US
240491571$24049157$1$I$$20240702$20240704$20240704$EXP$GB-MHRA-MED-202406291157398850-KGTCR$GB-ORGANON-O2407GBR000250$ORGANON$$30$YR$$M$Y$$$20240704$$CN$GB$GB
240491581$24049158$1$I$20240518$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031894$AUROBINDO$$69$YR$$M$Y$$$20240704$$MD$FR$FR
240491591$24049159$1$I$20230301$20240620$20240704$20240704$EXP$$GB-CIPLA LTD.-2024GB06471$CIPLA$$$$$$Y$$$20240704$$CN$GB$GB
240491601$24049160$1$I$$20240702$20240704$20240704$EXP$$US-BAUSCH-BL-2024-010207$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240704$$CN$US$US
240491611$24049161$1$I$$20240703$20240704$20240704$EXP$$CA-BAUSCH-BL-2024-010256$BAUSCH AND LOMB$$$$$$Y$$$20240704$$MD$CA$CA
240491621$24049162$1$I$$20240620$20240704$20240704$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05683$LUPIN$Deka A, Joseph E, Sharma N, Berhanu T, Kaplan J. Recurrent serotonin syndrome after ketamine-assisted electroconvulsive therapy: a case report and review of the literature. Journal of Psychiatric Practice. 2024;30 (3):234-241$78$YR$$F$Y$$$20240704$$MD$US$US
240491631$24049163$1$I$$20240701$20240704$20240704$PER$$US-BAUSCH-BL-2024-010217$BAUSCH AND LOMB$$$$$F$Y$$$20240704$$CN$US$US
240491641$24049164$1$I$20240312$20240630$20240704$20240704$EXP$FR-AFSSAPS-AVMA2024000276$FR-BAUSCH-BL-2024-010151$BAUSCH AND LOMB$$26$YR$$M$Y$$$20240704$$PH$FR$FR
240491651$24049165$1$I$$20240625$20240704$20240704$EXP$$US-AMGEN-USASP2024127658$AMGEN$$$$$$Y$$$20240704$$LW$US$US
240491661$24049166$1$I$$20240306$20240704$20240704$PER$$US-AMGEN-USASP2024130628$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240491671$24049167$1$I$$20240701$20240704$20240704$EXP$$CA-BAUSCH-BL-2024-010174$BAUSCH AND LOMB$$18$YR$$F$Y$$$20240704$$HP$CA$CA
240491681$24049168$1$I$$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129900$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240491691$24049169$1$I$20240623$20240626$20240704$20240704$EXP$$GB-AUROBINDO-AUR-APL-2024-031702$AUROBINDO$$79$YR$$M$Y$$$20240704$$MD$GB$GB
240491701$24049170$1$I$$20240701$20240704$20240704$PER$$US-LEO Pharma-371673$LEO PHARM$$49$YR$$F$Y$$$20240704$$CN$US$US
240491711$24049171$1$I$20240604$20240627$20240704$20240704$EXP$ES-AEMPS-1540252$ES-AMAROX PHARMA-AMR2024ES02035$HETERO$$68$YR$$M$Y$68$KG$20240704$$HP$ES$ES
240491722$24049172$2$F$$20240708$20240704$20240717$EXP$$JP-TEVA-VS-3214029$TEVA$Kurimoto J, Takagi H, Miyata T, Kawaguchi Y, Hodai Y, Tsumura T, et al. Mineralocorticoids induce polyuria by reducing apical aquaporin-2 expression of the kidney in partial vasopressin deficiency. Ednocr-J 2023; 70 (3): 295-304.; Kurimoto J, Takagi H, Miyata T, Kawaguchi Y, Hodai Y, Tsumura T, et al. Mineralocorticoids induce polyuria by reducing apical aquaporin-2 expression of the kidney in partial vasopressin deficiency. Ednocr-J 2023; 70 (3): 295-304.$59$YR$$F$Y$$$20240717$$HP$JP$JP
240491732$24049173$2$F$$20240718$20240704$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-104592$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240726$$PH$JP$JP
240491742$24049174$2$F$$20240729$20240704$20240731$EXP$$CA-BAUSCH-BL-2024-010175$BAUSCH AND LOMB$$53$YR$$M$Y$$$20240731$$CN$CA$CA
240491751$24049175$1$I$$20240626$20240704$20240704$PER$$US-JNJFOC-20240710445$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$HP$US$US
240491761$24049176$1$I$$20240605$20240704$20240704$PER$$US-JNJFOC-20240645416$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240491773$24049177$3$F$$20240711$20240704$20240717$PER$$US-CHATTEMPRD-2024OHG022845$CHATTEM$$7$DEC$E$F$Y$$$20240717$$CN$US$US
240491781$24049178$1$I$$20240626$20240704$20240704$EXP$$DE-AUROBINDO-AUR-APL-2024-031850$AUROBINDO$$$$A$F$Y$73$KG$20240704$$MD$DE$DE
240491791$24049179$1$I$20220101$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031876$AUROBINDO$$15$YR$$F$Y$$$20240704$$MD$FR$FR
240491801$24049180$1$I$$20240626$20240704$20240704$EXP$$AU-CELLTRION INC.-2024AU015787$CELLTRION$$$$$$Y$$$20240704$$HP$AU$AU
240491811$24049181$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001931$ELI LILLY AND CO$$$$$$Y$$$20240704$$CN$US$US
240491821$24049182$1$I$$20240605$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001831$ELI LILLY AND CO$$$$$$Y$$$20240704$$CN$US$US
240491831$24049183$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001110$ELI LILLY AND CO$$$$$$Y$$$20240704$$CN$US$US
240491841$24049184$1$I$20240601$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001364$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240704$$CN$US$US
240491851$24049185$1$I$20240616$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001980$ELI LILLY AND CO$$$$$M$Y$$$20240704$$CN$US$US
240491861$24049186$1$I$20240601$20240624$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202406016855$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240704$$CN$US$US
240491871$24049187$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002114$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240704$$CN$US$US
240491881$24049188$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001733$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240704$$CN$US$US
240491891$24049189$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002259$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240704$$CN$US$US
240491901$24049190$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002851$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240704$$CN$US$US
240491911$24049191$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138244$NOVARTIS$$$$C$$Y$$$20240704$$MD$US$US
240491921$24049192$1$I$20240427$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031904$AUROBINDO$$76$YR$$M$Y$90$KG$20240704$$MD$FR$FR
240491931$24049193$1$I$$20240621$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05702$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240491942$24049194$2$F$20240701$20240710$20240704$20240713$PER$$US-AMGEN-USASP2024130919$AMGEN$$59$YR$A$F$Y$$$20240713$$CN$US$US
240491951$24049195$1$I$20240608$20240624$20240704$20240704$EXP$$CN-ROCHE-10000008146$ROCHE$$51$YR$A$F$Y$65$KG$20240704$$HP$CN$CN
240491964$24049196$4$F$20240628$20240812$20240704$20240816$PER$$US-AMGEN-USASP2024131780$AMGEN$$80$YR$E$M$Y$82.54$KG$20240816$$MD$US$US
240491971$24049197$1$I$$20230912$20240704$20240704$PER$$US-AMGEN-USASP2023235501$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240491981$24049198$1$I$$20231011$20240704$20240704$PER$$US-AMGEN-USASP2023235380$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240491991$24049199$1$I$$20240626$20240704$20240704$EXP$$US-JNJFOC-20240671885$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$MD$US$US
240492001$24049200$1$I$$20240130$20240704$20240704$PER$$US-AUROBINDO-AUR-APL-2023-078577$AUROBINDO$$64$YR$$$Y$111.13$KG$20240704$$CN$US$US
240492012$24049201$2$F$$20240722$20240704$20240728$EXP$$JP-ROCHE-10000012111$ROCHE$$64$YR$A$M$Y$$$20240728$$MD$JP$JP
240492021$24049202$1$I$$20240621$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05749$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240492031$24049203$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5823933$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240492042$24049204$2$F$20240101$20240715$20240704$20240717$EXP$$IT-ABBVIE-5820262$ABBVIE$$10$YR$$M$Y$40$KG$20240717$$MD$IT$IT
240492052$24049205$2$F$20231127$20240703$20240704$20240708$EXP$$BR-ORGANON-O2407BRA000266$ORGANON$$$$$F$Y$$$20240708$$CN$BR$BR
240492061$24049206$1$I$20240521$20240628$20240704$20240704$EXP$$CN-ABBVIE-5821748$ABBVIE$$72$YR$$M$Y$75$KG$20240704$$MD$CN$CN
240492071$24049207$1$I$$20240625$20240704$20240704$PER$$NVSC2024US138210$NOVARTIS$$45$YR$$F$Y$$$20240704$$CN$US$US
240492081$24049208$1$I$$20240627$20240704$20240704$EXP$$CR-009507513-2407CRI000468$MERCK$$$$$F$Y$$$20240704$$MD$CR$CR
240492091$24049209$1$I$$20240627$20240704$20240704$EXP$$US-LEO Pharma-371582$LEO PHARM$$24$YR$$F$Y$$$20240704$$CN$US$US
240492102$24049210$2$F$$20240724$20240704$20240727$PER$$US-AMGEN-USASP2024130880$AMGEN$$$$$$Y$$$20240727$$CN$US$US
240492112$24049211$2$F$20240701$20240807$20240704$20240809$PER$$US-AMGEN-USASP2024130920$AMGEN$$$$$M$Y$$$20240808$$CN$US$US
240492121$24049212$1$I$20240701$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130279$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240492131$24049213$1$I$$20240626$20240704$20240704$EXP$$GB-AstraZeneca-2024A148380$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$GB$
240492141$24049214$1$I$$20240111$20240704$20240704$PER$$US-AMGEN-USASP2024130970$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240492151$24049215$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5824680$ABBVIE$$$$$$Y$$$20240704$$HP$US$US
240492161$24049216$1$I$20230401$20240411$20240704$20240704$PER$$US-AUROBINDO-AUR-APL-2024-009924$AUROBINDO$$73$YR$$F$Y$$$20240704$$CN$US$US
240492171$24049217$1$I$20150613$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031888$AUROBINDO$$50$YR$$F$Y$74$KG$20240704$$PH$FR$FR
240492183$24049218$3$F$$20240805$20240704$20240815$EXP$$US-ROCHE-10000003925$ROCHE$$85$YR$E$M$Y$$$20240815$$CN$US$US
240492191$24049219$1$I$$20240701$20240704$20240704$EXP$$US-GSK-US2024081570$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
240492201$24049220$1$I$20240521$20240625$20240704$20240704$EXP$FR-AFSSAPS-LL2024001176$FR-GILEAD-2024-0678587$GILEAD$$76$YR$E$F$Y$58$KG$20240704$$MD$FR$FR
240492212$24049221$2$F$20240101$20240705$20240704$20240710$EXP$$CA-ABBVIE-5825259$ABBVIE$$54$YR$$F$Y$$$20240710$$CN$CA$CA
240492221$24049222$1$I$20240101$20240628$20240704$20240704$EXP$$US-ABBVIE-5822724$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240492231$24049223$1$I$20190101$20240628$20240704$20240704$EXP$$US-ABBVIE-5821279$ABBVIE$$$$$F$Y$62$KG$20240704$$CN$US$US
240492242$24049224$2$F$20230101$20240729$20240704$20240802$EXP$$CA-ABBVIE-5182885$ABBVIE$$$$$F$Y$72$KG$20240802$$CN$CA$CA
240492251$24049225$1$I$20200101$20240628$20240704$20240704$EXP$$US-ABBVIE-5821105$ABBVIE$$31$YR$$F$Y$62$KG$20240704$$CN$US$US
240492261$24049226$1$I$$20230714$20240704$20240704$PER$$US-AMGEN-USASP2023235466$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240492271$24049227$1$I$$20240621$20240704$20240704$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05700$LUPIN$Stone EG. Unintended adverse consequences of a clinical decision support system: two cases. Journal of the American Medical Informatics Association. 2018;25(5):564-567$63$YR$$$Y$$$20240704$$HP$US$US
240492282$24049228$2$F$$20240708$20240704$20240717$EXP$$US-TEVA-VS-3214264$TEVA$Preskorn SH, Masolak DD. Cerebral Anoxia in an 18-year-old Patient Being Treated for Major Depressive Disorder: How Forensic Detective Work Uses Medical Knowledge Including Clinical Pharmacology to Solve Cases. J-Psychiatr-Pract 2024; 30 (3): 212-219.; Preskorn SH, Masolak DD. Cerebral Anoxia in an 18-year-old Patient Being Treated for Major Depressive Disorder: How Forensic Detective Work Uses Medical Knowledge Including Clinical Pharmacology to Solve Cases. J-Psychiatr-Pract 2024; 30 (3): 2...$18$YR$$M$Y$$$20240717$$MD$US$US
240492291$24049229$1$I$20240630$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130896$AMGEN$$54$YR$A$F$Y$$$20240704$$CN$US$US
240492301$24049230$1$I$20230505$20240628$20240704$20240704$EXP$$CA-TAKEDA-2023TUS034793$TAKEDA$$41$YR$$F$Y$$$20240704$$HP$CA$CA
240492312$24049231$2$F$20240512$20240624$20240704$20240704$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-05807$HIKMA$$$$$$Y$$$20240704$$PH$EG$EG
240492323$24049232$3$F$20240501$20240918$20240704$20240925$EXP$$CA-GSK-CA2022AMR111996$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$CA$CA
240492331$24049233$1$I$$20240629$20240704$20240704$EXP$GB-MHRA-MED-202406281456410520-PYKZQ$GB-ORGANON-O2407GBR000119$ORGANON$$$$$$Y$$$20240704$$CN$GB$GB
240492341$24049234$1$I$$20240629$20240704$20240704$EXP$GB-MHRA-MED-202406281429282700-HZCNF$GB-ORGANON-O2407GBR000031$ORGANON$$$$$$Y$$$20240704$$CN$GB$GB
240492351$24049235$1$I$$20240629$20240704$20240704$EXP$GB-MHRA-MED-202406281441485000-MGTNK$GB-ORGANON-O2407GBR000038$ORGANON$$$$$$Y$$$20240704$$CN$GB$GB
240492363$24049236$3$F$20230310$20240920$20240704$20240930$EXP$$CA-CELLTRION INC.-2024CA006786$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
240492371$24049237$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131934$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240492382$24049238$2$F$20240626$20240703$20240704$20240705$PER$$US-AMGEN-USASP2024128743$AMGEN$$88$YR$E$F$Y$$$20240705$$CN$US$US
240492391$24049239$1$I$$20240625$20240704$20240704$EXP$$BR-JNJFOC-20240677359$JOHNSON AND JOHNSON$$63$YR$A$F$Y$58$KG$20240704$$CN$BR$BR
240492401$24049240$1$I$$20240628$20240704$20240704$EXP$$ES-AMGEN-ESPSP2024129117$AMGEN$Gonzalez-lopez T.; Bermejo-vega N.; Cardesa-cabrera R. et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Blood. 2024;1-29$93$YR$E$F$Y$$$20240704$$HP$ES$ES
240492413$24049241$3$F$20240728$20240911$20240704$20240919$EXP$$IL-TAKEDA-2024TUS066211$TAKEDA$$20$YR$$F$Y$$$20240919$$CN$IL$IL
240492422$24049242$2$F$20230110$20240916$20240704$20240924$EXP$$ES-CELLTRION INC.-2024ES015890$CELLTRION$$$$$$Y$$$20240924$$MD$ES$ES
240492432$24049243$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214526$TEVA$Durugu SR, Rajeshkumar Chitra S, Sekaran S, Naro GR. A Rare Presentation of Daptomycin-induced Eosinophilic Pneumonia in a Patient With Klinefelter^s Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.; Durugu SR, Rajeshkumar Chitra S, Sekaran S, Naro GR. A Rare Presentation of Daptomycin-induced Eosinophilic Pneumonia in a Patient With Klinefelter^s Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.$46$YR$$M$Y$$$20240720$$HP$US$US
240492443$24049244$3$F$20240701$20240711$20240704$20240722$EXP$$US-GSK-US2024081627$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240722$$CN$US$US
240492462$24049246$2$F$$20240628$20240704$20240704$30DAY$$US-SANDOZ INC.-SDZ2024US062240$SANDOZ$$$$$M$Y$$$20240704$$CN$US$US
240492472$24049247$2$F$20240101$20240712$20240704$20240715$EXP$$GB-SANDOZ INC.-SDZ2024GB022217$SANDOZ$$$$$M$Y$$$20240715$$CN$GB$GB
240492481$24049248$1$I$$20240628$20240704$20240704$EXP$$CA-SANDOZ INC.-NVSC2022CA296119$SANDOZ$$$$$M$Y$$$20240704$$CN$CA$CA
240492501$24049250$1$I$$20240701$20240704$20240704$EXP$$US-SANDOZ INC.-SDZ2024US062535$SANDOZ$$$$$F$Y$$$20240704$$MD$US$US
240492511$24049251$1$I$$20240628$20240704$20240704$EXP$$NVSC2024BR137857$NOVARTIS$$$$$M$Y$$$20240704$$CN$BR$BR
240492521$24049252$1$I$20240620$20240630$20240704$20240704$PER$$US-ABBVIE-5824517$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240492531$24049253$1$I$$20240625$20240704$20240704$PER$$US-AstraZeneca-2024A147321$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$US$
240492541$24049254$1$I$$20240627$20240704$20240704$EXP$$US-AstraZeneca-2024A149259$ASTRAZENECA$$$$$F$Y$$$20240704$$CN$US$
240492551$24049255$1$I$20230101$20240626$20240704$20240704$EXP$$PL-AUROBINDO-AUR-APL-2024-031983$AUROBINDO$$74$YR$$M$Y$$$20240704$$MD$PL$PL
240492562$24049256$2$F$20240701$20240806$20240704$20240807$30DAY$$IT-SANDOZ INC.-SDZ2024IT062578$SANDOZ$$74$YR$$$Y$64$KG$20240807$$CN$IT$IT
240492571$24049257$1$I$20240324$20240703$20240704$20240704$EXP$GB-MHRA-MED-202404191502598390-GLWNT$GB-SANDOZ INC.-SDZ2024GB062629$SANDOZ$$71$YR$$F$Y$$$20240704$$HP$GB$GB
240492591$24049259$1$I$$20240628$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407000105$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240704$$CN$US$US
240492602$24049260$2$F$20230101$20240702$20240704$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407002132$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240801$$CN$US$US
240492611$24049261$1$I$20240602$20240701$20240704$20240704$EXP$IT-MINISAL02-992904$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-105692$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$45$KG$20240704$$MD$IT$IT
240492621$24049262$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106517$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240704$$CN$US$US
240492631$24049263$1$I$$20240703$20240704$20240704$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-106471$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240704$$HP$PR$PR
240492641$24049264$1$I$$20240624$20240704$20240704$EXP$$US-ROCHE-10000011186$ROCHE$$77$YR$E$M$Y$$$20240704$$CN$US$US
240492652$24049265$2$F$20240611$20240716$20240704$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA062376$SANDOZ$$62$YR$$M$Y$$$20240722$$CN$CA$CA
240492662$24049266$2$F$20240501$20240624$20240704$20240704$EXP$$US-NEBO-658896$PHARMACOSMOS$$25$YR$$F$Y$83.46$KG$20240704$$HP$US$US
240492671$24049267$1$I$$20240626$20240704$20240704$PER$$US-ALXN-202406USA001676US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
240492681$24049268$1$I$$20240628$20240704$20240704$EXP$$ES-AMGEN-ESPSP2024129147$AMGEN$Gonzalez-lopez T.; Bermejo-vega N.; Cardesa-cabrera R. et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Blood. 2024;1-29$82$YR$E$F$Y$$$20240704$$HP$ES$ES
240492691$24049269$1$I$$20240626$20240704$20240704$PER$$US-ROCHE-10000015203$ROCHE$$38$YR$A$F$Y$$$20240704$$CN$US$US
240492701$24049270$1$I$$20240701$20240704$20240704$PER$$NVSC2024US137238$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240492713$24049271$3$F$$20240719$20240704$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106546$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$34.47$KG$20240722$$CN$US$US
240492721$24049272$1$I$20230901$20240620$20240704$20240704$EXP$FR-AFSSAPS-TS2024000689$FR-TEVA-VS-3213418$TEVA$$68$YR$$F$Y$$$20240704$$MD$FR$FR
240492731$24049273$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106404$BRISTOL MYERS SQUIBB$$15$YR$T$F$Y$$$20240704$$HP$US$US
240492741$24049274$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106423$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240704$$HP$US$US
240492764$24049276$4$F$$20240701$20240704$20240712$PER$$US-ROCHE-10000011142$ROCHE$$51$YR$A$F$Y$$$20240712$$CN$US$US
240492772$24049277$2$F$$20240718$20240704$20240727$EXP$$US-JNJFOC-20240667339$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240727$$HP$US$US
240492782$24049278$2$F$20240628$20240729$20240704$20240731$EXP$$US-TAKEDA-2024TUS063554$TAKEDA$$51$YR$$F$Y$$$20240731$$HP$US$US
240492791$24049279$1$I$$20240701$20240704$20240704$EXP$$DE-EMD Serono-2024035799$EMD SERONO INC$$$$A$M$Y$$$20240704$$CN$DE$DE
240492811$24049281$1$I$$20240701$20240704$20240704$EXP$$US-UCBSA-2024033390$UCB$Verma K, Hardy D.. Two Cases of Pediatric Leucine-Rich Glioma-Inactivated Protein-1 Encephalitis: Clinical Course, Challenges, and Implications. Pediatric Neurology. 2024;157:96-99$16$YR$$F$Y$$$20240704$$MD$US$US
240492822$24049282$2$F$$20240701$20240704$20240708$PER$$US-AMGEN-USASP2024131815$AMGEN$$$$$M$Y$$$20240708$$CN$US$US
240492833$24049283$3$F$20240630$20240827$20240704$20240829$PER$$US-AMGEN-USASP2024131234$AMGEN$$71$YR$E$F$Y$$$20240829$$CN$US$US
240492841$24049284$1$I$$20230830$20240704$20240704$PER$$US-AMGEN-USASP2023235332$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240492851$24049285$1$I$$20240703$20240704$20240704$PER$$NVSC2024US138816$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
240492872$24049287$2$F$20240131$20240712$20240704$20240722$EXP$$PT-CELLTRION INC.-2024PT015761$CELLTRION$$$$$$Y$$$20240722$$PH$PT$PT
240492881$24049288$1$I$20240101$20240624$20240704$20240704$EXP$$CN-SA-2024SA193624$SANOFI AVENTIS$$$$T$$Y$$$20240704$$HP$CN$CN
240492892$24049289$2$F$$20240905$20240704$20240912$EXP$GB-SEATTLE GENETICS-2024SGN06285$GB-ROCHE-10000008487$ROCHE$$42$YR$A$F$Y$$$20240912$$MD$GB$GB
240492911$24049291$1$I$$20240624$20240704$20240704$EXP$$US-ROCHE-10000014795$ROCHE$$$$A$F$Y$73.03$KG$20240704$$CN$US$US
240492921$24049292$1$I$20240615$20240626$20240704$20240704$EXP$$GB-AUROBINDO-AUR-APL-2024-031775$AUROBINDO$$30$YR$$F$Y$$$20240704$$CN$GB$GB
240492941$24049294$1$I$20240401$20240701$20240704$20240704$EXP$$US-GILEAD-2024-0679331$GILEAD$$56$YR$A$F$Y$$$20240704$$CN$US$US
240492952$24049295$2$F$$20240802$20240704$20240807$EXP$$GB-TAKEDA-2024TUS058332$TAKEDA$$$$E$F$Y$$$20240807$$MD$GB$GB
240492961$24049296$1$I$20240603$20240624$20240704$20240704$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-05809$HIKMA$$$$$$Y$$$20240704$$HP$EG$EG
240492971$24049297$1$I$20240601$20240624$20240704$20240704$PER$$US-TEVA-VS-3213521$TEVA$$$$$$Y$$$20240704$$HP$US$US
240492981$24049298$1$I$$20240628$20240704$20240704$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13180$IPSEN$$44$YR$A$F$Y$$$20240704$$CN$US$US
240492993$24049299$3$F$20240201$20240903$20240704$20240909$EXP$$CA-TAKEDA-2023TUS094108$TAKEDA$$64$YR$$F$Y$$$20240909$$HP$CA$CA
240493001$24049300$1$I$$20240629$20240704$20240704$EXP$$US-SA-2024SA195510$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240704$$MD$US$US
240493011$24049301$1$I$20240601$20240629$20240704$20240704$EXP$$US-SA-2024SA195400$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240704$$MD$US$US
240493022$24049302$2$F$20240101$20240725$20240704$20240730$EXP$$US-SA-2024SA195399$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240730$$MD$US$US
240493032$24049303$2$F$$20240927$20240704$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106549$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$119.29$KG$20240930$$CN$US$US
240493041$24049304$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106566$BRISTOL MYERS SQUIBB$$30$YR$A$M$Y$$$20240704$$CN$US$US
240493051$24049305$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106589$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240704$$HP$US$US
240493072$24049307$2$F$$20240625$20240704$20240704$PER$$US-ROCHE-10000013052$ROCHE$$$$$F$Y$$$20240704$$CN$US$US
240493081$24049308$1$I$$20240626$20240704$20240704$EXP$$CH-BEIGENE-BGN-2024-010104$BEIGENE$$$$$$Y$$$20240704$$MD$CH$CH
240493091$24049309$1$I$20230801$20240701$20240704$20240704$EXP$$NVSC2023GB175030$NOVARTIS$$$$$F$Y$$$20240704$$CN$GB$GB
240493102$24049310$2$F$$20240627$20240704$20240708$PER$$US-AMGEN-USASP2024129173$AMGEN$$$$$$Y$$$20240708$$MD$US$US
240493112$24049311$2$F$20240312$20240709$20240704$20240713$EXP$$JP-AMGEN-JPNSP2024130055$AMGEN$$80$YR$E$F$Y$39$KG$20240713$$PH$JP$JP
240493122$24049312$2$F$$20240710$20240704$20240720$EXP$$IT-TEVA-VS-3215422$TEVA$Giorgetti A, Grosse Perdekamp M, Franchetti G, Pircher R, Pollak S, Pelotti S, et al. Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities. Int-J-Legal-Med 2024;.; Giorgetti A, Grosse Perdekamp M, Franchetti G, Pircher R, Pollak S, Pelotti S, et al. Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities. Int-J-Legal-Med 2024;.$31$YR$$M$Y$$$20240720$$HP$IT$IT
240493131$24049313$1$I$$20240626$20240704$20240704$PER$$US-ROCHE-10000015345$ROCHE$$51$YR$A$F$Y$$$20240704$$MD$US$US
240493141$24049314$1$I$$20240628$20240704$20240704$PER$$US-JNJFOC-20240677510$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$HP$US$US
240493152$24049315$2$F$$20240813$20240704$20240822$30DAY$$US-GSK-US2024078656$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
240493161$24049316$1$I$$20240701$20240704$20240704$EXP$$ID-GSK-ID2024APC081510$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$MD$ID$ID
240493171$24049317$1$I$20240509$20240627$20240704$20240704$EXP$$US-GSK-US2024080241$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
240493183$24049318$3$F$20210205$20240913$20240704$20240917$PER$$US-GILEAD-2024-0679445$GILEAD$$42$YR$A$F$Y$$$20240917$$LW$US$US
240493191$24049319$1$I$20240319$20240627$20240704$20240704$EXP$$PL-UCBSA-2024029744$UCB$$30$YR$$M$Y$68$KG$20240704$$MD$PL$PL
240493201$24049320$1$I$20240528$20240628$20240704$20240704$EXP$$US-ABBVIE-5822227$ABBVIE$$27$YR$$F$Y$$$20240704$$CN$US$US
240493211$24049321$1$I$$20240628$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407000762$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240704$$CN$US$US
240493221$24049322$1$I$20240627$20240627$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407000396$ELI LILLY AND CO$$$$$$Y$$$20240704$$CN$US$US
240493231$24049323$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001801$ELI LILLY AND CO$$$$$$Y$$$20240704$$CN$US$US
240493241$24049324$1$I$20240703$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002778$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240704$$CN$US$US
240493251$24049325$1$I$20240101$20240701$20240704$20240704$EXP$$US-ABBVIE-5824602$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240493261$24049326$1$I$$20240617$20240704$20240704$EXP$$CA-GSK-CA2024AMR075314$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240704$$CN$CA$CA
240493271$24049327$1$I$$20240701$20240704$20240704$EXP$$US-ABBVIE-5824323$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240493281$24049328$1$I$$20240627$20240704$20240704$PER$$US-ROCHE-10000015393$ROCHE$$$$$$Y$$$20240704$$CN$US$US
240493291$24049329$1$I$$20240314$20240704$20240704$PER$$US-AMGEN-USASP2024130488$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240493301$24049330$1$I$20240529$20240627$20240704$20240704$EXP$$CN-SA-2024SA195006$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240704$$HP$CN$CN
240493313$24049331$3$F$20230528$20240826$20240704$20240904$30DAY$$BR-AMGEN-BRASP2024129715$AMGEN$$$$$$Y$$$20240904$$PH$BR$BR
240493322$24049332$2$F$20240101$20240705$20240704$20240710$PER$$US-AMGEN-USASP2024130076$AMGEN$$63$YR$A$M$Y$$$20240710$$CN$US$US
240493331$24049333$1$I$20240629$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130448$AMGEN$$71$YR$E$F$Y$$$20240704$$CN$US$US
240493341$24049334$1$I$$20240629$20240704$20240704$PER$$US-HALEON-2184659$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240493351$24049335$1$I$20220601$20240628$20240704$20240704$EXP$$US-ABBVIE-5821725$ABBVIE$$71$YR$$M$Y$92$KG$20240704$$CN$US$US
240493361$24049336$1$I$20240627$20240627$20240704$20240704$EXP$$US-JNJFOC-20240674744$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$MD$US$US
240493374$24049337$4$F$$20240715$20240704$20240917$EXP$$BR-CELLTRION INC.-2023BR000644$CELLTRION$$$$$$Y$$$20240917$$CN$BR$BR
240493381$24049338$1$I$$20240703$20240704$20240704$PER$$US-HALEON-2185239$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240493401$24049340$1$I$$20240625$20240704$20240704$EXP$$US-APOTEX-2024AP007848$APOTEX$Ravi S, Ravi SN, Ballam Nagaraj N, Upadhyay H.. Acute Respiratory Compromise in the Context of COVID-19 and Gemcitabine. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-4$48$YR$$F$Y$$$20240704$$HP$US$US
240493421$24049342$1$I$$20240703$20240704$20240704$EXP$$US-GILEAD-2024-0679497$GILEAD$$$$E$F$Y$$$20240704$$CN$US$US
240493432$24049343$2$F$$20240703$20240704$20240718$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-05573$LUPIN$$$$$$Y$$$20240718$$CN$IN$IN
240493442$24049344$2$F$20240616$20240718$20240704$20240726$EXP$$CN-HETERO-HET2024CN02027$HETERO$$86$YR$$M$Y$60$KG$20240726$$HP$CN$CN
240493451$24049345$1$I$$20240628$20240704$20240704$PER$$US-ABBVIE-5822501$ABBVIE$$$$E$$Y$$$20240704$$CN$US$US
240493461$24049346$1$I$20240306$20240409$20240704$20240704$EXP$GB-MHRA-ADR 28661730$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-07687$ALKEM$$25$YR$$F$Y$75$KG$20240704$$HP$GB$GB
240493471$24049347$1$I$20240328$20240420$20240704$20240704$EXP$GB-MHRA-ADR 28688383$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08798$ALKEM$$74$YR$$M$Y$70$KG$20240704$$MD$GB$GB
240493481$24049348$1$I$$20240424$20240704$20240704$EXP$GB-MHRA-ADR 28692019$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08980$ALKEM$$$$A$$Y$$$20240704$$CN$GB$GB
240493491$24049349$1$I$$20240330$20240704$20240704$EXP$GB-MHRA-ADR 28635617$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06869$ALKEM$$$$$M$Y$$$20240704$$CN$GB$GB
240493501$24049350$1$I$20240507$20240509$20240704$20240704$EXP$GB-MHRA-ADR 28728622$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10018$ALKEM$$69$YR$$M$Y$111$KG$20240704$$HP$GB$GB
240493511$24049351$1$I$20240507$20240509$20240704$20240704$EXP$GB-MHRA-ADR 28729478$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10024$ALKEM$$67$YR$$F$Y$$$20240704$$MD$GB$GB
240493521$24049352$1$I$20240412$20240416$20240704$20240704$EXP$GB-MHRA-ADR 28675833$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08213$ALKEM$$44$YR$$M$Y$95$KG$20240704$$HP$GB$GB
240493531$24049353$1$I$$20240424$20240704$20240704$EXP$GB-MHRA-ADR 28688055$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08965$ALKEM$$59$YR$$M$Y$84$KG$20240704$$MD$GB$GB
240493541$24049354$1$I$20240402$20240411$20240704$20240704$EXP$GB-MHRA-ADR 28651847$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-07856$ALKEM$$35$YR$$F$Y$56$KG$20240704$$MD$GB$GB
240493551$24049355$1$I$$20240424$20240704$20240704$EXP$GB-MHRA-ADR 28692017$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08986$ALKEM$$$$C$F$Y$$$20240704$$CN$GB$GB
240493561$24049356$1$I$20220901$20240621$20240704$20240704$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-10238$ALKEM$$38$YR$$F$Y$$$20240704$$CN$DE$DE
240493571$24049357$1$I$$20240626$20240704$20240704$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-11460$ALKEM$$65$YR$$F$Y$68$KG$20240704$$HP$DE$DE
240493581$24049358$1$I$$20240313$20240704$20240704$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-04999$ALKEM$$$$$F$Y$$$20240704$$PH$DE$DE
240493591$24049359$1$I$$20240515$20240704$20240704$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-11462$ALKEM$Luo L, Yang X.. Edema of the lips due to ibuprofen extended-release capsules. J Pharmacoepidemio. 2000;2:101-102$13$YR$$F$Y$$$20240704$$HP$CN$CN
240493601$24049360$1$I$20240413$20240417$20240704$20240704$EXP$DE-CADRBFARM-2024327399$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-08328$ALKEM$$16$YR$$M$Y$54$KG$20240704$$CN$DE$DE
240493611$24049361$1$I$$20240326$20240704$20240704$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-06476$ALKEM$$$$$M$Y$$$20240704$$CN$DE$DE
240493621$24049362$1$I$$20240425$20240704$20240704$EXP$DE-CADRBFARM-2024327591$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-09062$ALKEM$$20$YR$$M$Y$70$KG$20240704$$CN$DE$DE
240493631$24049363$1$I$$20240320$20240704$20240704$EXP$GB-MHRA-ADR 28612519$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05781$ALKEM$$$$C$F$Y$$$20240704$$CN$GB$GB
240493641$24049364$1$I$20240411$20240418$20240704$20240704$EXP$DE-CADRBFARM-2024327430$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-08461$ALKEM$$85$YR$$M$Y$75$KG$20240704$$PH$DE$DE
240493651$24049365$1$I$20240526$20240530$20240704$20240704$EXP$DE-CADRBFARM-2024328369$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-11848$ALKEM$$39$YR$$F$Y$74$KG$20240704$$CN$DE$DE
240493661$24049366$1$I$20200317$20240605$20240704$20240704$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-12361$ALKEM$$51$YR$$F$Y$$$20240704$$CN$DE$DE
240493671$24049367$1$I$20190629$20240315$20240704$20240704$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-05292$ALKEM$$52$YR$$F$Y$$$20240704$$CN$DE$DE
240493681$24049368$1$I$$20240325$20240704$20240704$EXP$GB-MHRA-ADR 28626043$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06472$ALKEM$$$$$F$Y$$$20240704$$CN$GB$GB
240493691$24049369$1$I$20240122$20240315$20240704$20240704$EXP$GB-MHRA-ADR 28603757$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05308$ALKEM$$84$YR$$F$Y$61$KG$20240704$$PH$GB$GB
240493701$24049370$1$I$$20240607$20240704$20240704$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-12545$ALKEM$$74$YR$$M$Y$$$20240704$$MD$DE$DE
240493711$24049371$1$I$$20240607$20240704$20240704$EXP$DE-SANDOZ-SDZ2024DE054962$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-12518$ALKEM$$49$YR$$F$Y$$$20240704$$HP$DE$DE
240493721$24049372$1$I$20240222$20240315$20240704$20240704$EXP$GB-MHRA-ADR 28604725$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05322$ALKEM$$67$YR$$F$Y$$$20240704$$HP$GB$GB
240493731$24049373$1$I$20240520$20240522$20240704$20240704$EXP$GB-MHRA-ADR 28756627$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-11153$ALKEM$$13$YR$$M$Y$44$KG$20240704$$MD$GB$GB
240493741$24049374$1$I$20240315$20240319$20240704$20240704$EXP$GB-MHRA-ADR 28612776$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05665$ALKEM$$46$YR$$M$Y$$$20240704$$MD$GB$GB
240493751$24049375$1$I$20240311$20240313$20240704$20240704$EXP$GB-MHRA-ADR 28598318$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05010$ALKEM$$64$YR$$M$Y$$$20240704$$MD$GB$GB
240493761$24049376$1$I$20240115$20240315$20240704$20240704$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-05289$ALKEM$$72$YR$$M$Y$$$20240704$$HP$DE$DE
240493771$24049377$1$I$$20240316$20240704$20240704$EXP$GB-MHRA-ADR 28600309$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05481$ALKEM$$51$YR$$F$Y$67$KG$20240704$$MD$GB$GB
240493781$24049378$1$I$$20240515$20240704$20240704$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-10431$ALKEM$$$$E$M$Y$$$20240704$$PH$DE$DE
240493791$24049379$1$I$20020101$20240315$20240704$20240704$EXP$GB-MHRA-ADR 28595785$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05303$ALKEM$$48$YR$$M$Y$79$KG$20240704$$CN$GB$GB
240493801$24049380$1$I$$20240424$20240704$20240704$EXP$IN-MLMSERVICE-20240409-4900393-1$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-08223$ALKEM$Yadav P, Bhatia R, Vasisht S, Sethi J.. Patch test with multiple antipyretics in a case of fixed drug eruption in a child. Contact Dermatitis. 2024;90(4):420-422$10$YR$$M$Y$$$20240704$$MD$IN$IN
240493811$24049381$1$I$$20240516$20240704$20240704$EXP$GB-MHRA-ADR 28738336$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10565$ALKEM$$17$YR$$F$Y$50$KG$20240704$$HP$GB$GB
240493821$24049382$1$I$$20240529$20240704$20240704$EXP$CZ-MLMSERVICE-20240502-PI047716-00030-1$CZ-ALKEM LABORATORIES LIMITED-CZ-ALKEM-2024-10149$ALKEM$Kobzova M, Polak P.. Suspicion of a hypervitaminosis A during acitretin therapy. Internal Medicine. 2024;70(2):120-125$90$YR$$F$Y$55$KG$20240704$$MD$CZ$CZ
240493831$24049383$1$I$20240423$20240425$20240704$20240704$EXP$GB-MHRA-ADR 28699875$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-09110$ALKEM$$41$YR$$M$Y$$$20240704$$MD$GB$GB
240493841$24049384$1$I$20240516$20240518$20240704$20240704$EXP$GB-MHRA-ADR 28752439$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10970$ALKEM$$50$YR$$F$Y$$$20240704$$HP$GB$GB
240493851$24049385$1$I$20240422$20240425$20240704$20240704$EXP$GB-MHRA-ADR 28698095$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-09105$ALKEM$$40$YR$$F$Y$66$KG$20240704$$HP$GB$GB
240493861$24049386$1$I$20240413$20240525$20240704$20240704$EXP$GB-MHRA-ADR 28763109$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-11500$ALKEM$$11$YR$$F$Y$19$KG$20240704$$MD$GB$GB
240493871$24049387$1$I$20230615$20240605$20240704$20240704$EXP$GB-MHRA-TPP15417330C9949486YC1716905825151$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-12340$ALKEM$$85$YR$$M$Y$64$KG$20240704$$HP$GB$GB
240493881$24049388$1$I$20240423$20240425$20240704$20240704$EXP$GB-MHRA-ADR 28700481$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-09106$ALKEM$$34$YR$$M$Y$$$20240704$$MD$GB$GB
240493891$24049389$1$I$$20240526$20240704$20240704$EXP$GB-MHRA-ADR 28762043$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-11521$ALKEM$$31$YR$$F$Y$60$KG$20240704$$MD$GB$GB
240493901$24049390$1$I$20240516$20240518$20240704$20240704$EXP$GB-MHRA-ADR 28751831$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10969$ALKEM$$64$YR$$M$Y$$$20240704$$MD$GB$GB
240493911$24049391$1$I$$20240313$20240704$20240704$EXP$GB-MHRA-ADR 28587084$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-04995$ALKEM$$80$YR$$F$Y$55$KG$20240704$$HP$GB$GB
240493921$24049392$1$I$20240512$20240523$20240704$20240704$EXP$GB-MHRA-ADR 28740371$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10420$ALKEM$$26$YR$$F$Y$$$20240704$$MD$GB$GB
240493931$24049393$1$I$20240509$20240511$20240704$20240704$EXP$GB-MHRA-ADR 28735988$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10233$ALKEM$$32$YR$$F$Y$52$KG$20240704$$MD$GB$GB
240493942$24049394$2$F$20240201$20240820$20240704$20240821$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-021387$BOEHRINGER INGELHEIM$$82$YR$E$M$Y$62$KG$20240821$$CN$ES$ES
240493951$24049395$1$I$20240327$20240329$20240704$20240704$EXP$GB-MHRA-ADR 28637721$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06750$ALKEM$$6$YR$$F$Y$18$KG$20240704$$MD$GB$GB
240493961$24049396$1$I$20240327$20240329$20240704$20240704$EXP$GB-MHRA-ADR 28638752$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06757$ALKEM$$15$YR$$M$Y$46$KG$20240704$$MD$GB$GB
240493971$24049397$1$I$20240328$20240420$20240704$20240704$EXP$GB-MHRA-ADR 28688389$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08799$ALKEM$$74$YR$$M$Y$$$20240704$$MD$GB$GB
240493981$24049398$1$I$20240315$20240319$20240704$20240704$EXP$GB-MHRA-ADR 28610347$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05747$ALKEM$$49$YR$$F$Y$72$KG$20240704$$MD$GB$GB
240493991$24049399$1$I$20240523$20240525$20240704$20240704$EXP$GB-MHRA-ADR 28761788$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-11556$ALKEM$$27$YR$$F$Y$71$KG$20240704$$MD$GB$GB
240494001$24049400$1$I$20240416$20240418$20240704$20240704$EXP$GB-MHRA-ADR 28681928$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08510$ALKEM$$91$YR$$F$Y$60$KG$20240704$$MD$GB$GB
240494011$24049401$1$I$20240327$20240329$20240704$20240704$EXP$GB-MHRA-ADR 28638659$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06758$ALKEM$$54$YR$$F$Y$48$KG$20240704$$MD$GB$GB
240494021$24049402$1$I$20240312$20240315$20240704$20240704$EXP$GB-MHRA-ADR 28605436$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05323$ALKEM$$58$YR$$M$Y$79$KG$20240704$$MD$GB$GB
240494031$24049403$1$I$20240313$20240417$20240704$20240704$EXP$GB-MHRA-ADR 28604977$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08360$ALKEM$$76$YR$$M$Y$91$KG$20240704$$HP$GB$GB
240494041$24049404$1$I$$20240605$20240704$20240704$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12714$ALKEM$Dwarica DS, Pickett SD, Zhao YD, Nihira MA, Quiroz LH.. Comparing Ketorolac With Ibuprofen for Postoperative Pain: A Randomized Clinical Trial. Female Pelvic Med Reconstr Surg .. 2020;26(4):233-238$$$$F$Y$$$20240704$$MD$US$US
240494051$24049405$1$I$20240402$20240411$20240704$20240704$EXP$GB-MHRA-ADR 28650943$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-07829$ALKEM$$58$YR$$F$Y$53$KG$20240704$$MD$GB$GB
240494061$24049406$1$I$$20240405$20240704$20240704$EXP$GB-MHRA-ADR 28641428$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-07431$ALKEM$$7$YR$$M$Y$20$KG$20240704$$MD$GB$GB
240494071$24049407$1$I$$20240417$20240704$20240704$EXP$GB-MHRA-ADR 28677645$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08380$ALKEM$$47$YR$$F$Y$55$KG$20240704$$CN$GB$GB
240494081$24049408$1$I$$20240323$20240704$20240704$EXP$GB-MHRA-ADR 28621880$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06464$ALKEM$$50$YR$$M$Y$93$KG$20240704$$PH$GB$GB
240494091$24049409$1$I$$20240514$20240704$20240704$EXP$$BG-ALKEM LABORATORIES LIMITED-BG-ALKEM-2024-10583$ALKEM$Kantardjiev V, Stoikova E, Broshtilova V.. Drug-induced Rowell syndrome in a male patient. Scripta Scientifica Medica. 2018;50(4):39-42$53$YR$$M$Y$$$20240704$$HP$BG$BG
240494101$24049410$1$I$$20240417$20240704$20240704$EXP$GB-MHRA-ADR 28660290$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08369$ALKEM$$63$YR$$M$Y$69$KG$20240704$$HP$GB$GB
240494111$24049411$1$I$$20240605$20240704$20240704$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-11921$ALKEM$Dwarica DS, Pickett SD, Zhao YD, Nihira MA, Quiroz LH. Comparing Ketorolac With Ibuprofen for Postoperative Pain: A Randomized Clinical Trial. Female Pelvic Medicine + Reconstructive Surgery. 2020;26(4):233-238$$$$$Y$$$20240704$$MD$US$US
240494121$24049412$1$I$$20240517$20240704$20240704$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11202$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$23$YR$$F$Y$$$20240704$$MD$BR$BR
240494131$24049413$1$I$$20240604$20240704$20240704$EXP$US-MLMSERVICE-20240520-PI065262-00029-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-11493$ALKEM$Schwedt TJ.. Posttraumatic Headache. CONTINUUM Lifelong Learning in Neurology. 2024;30(2):411-424$26$YR$$F$Y$$$20240704$$MD$US$US
240494141$24049414$1$I$$20240605$20240704$20240704$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12711$ALKEM$Dwarica DS, Pickett SD, Zhao YD, Nihira MA, Quiroz LH.. Comparing Ketorolac With Ibuprofen for Postoperative Pain: A Randomized Clinical Trial. Female Pelvic Med Reconstr Surg .. 2020;26(4):233-238$$$$F$Y$$$20240704$$MD$US$US
240494151$24049415$1$I$20240424$20240502$20240704$20240704$EXP$GB-MHRA-ADR 28715362$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-09492$ALKEM$$42$YR$$M$Y$80$KG$20240704$$MD$GB$GB
240494161$24049416$1$I$$20240529$20240704$20240704$EXP$RO-MLMSERVICE-20240513-PI058766-00030-1$RO-ALKEM LABORATORIES LIMITED-RO-ALKEM-2024-10851$ALKEM$Marghidan CS, Preda M, Popescu FD. Cofactor-associated anaphylaxis in a patient allergic to pollen and celery. Clinica Chimica Acta. 2024;558(Supple 1):119474$28$YR$$F$Y$$$20240704$$MD$RO$RO
240494171$24049417$1$I$20240514$20240516$20240704$20240704$EXP$GB-MHRA-ADR 28745404$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10571$ALKEM$$75$YR$$M$Y$82$KG$20240704$$MD$GB$GB
240494181$24049418$1$I$$20240424$20240704$20240704$EXP$GB-MHRA-ADR 28684456$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08962$ALKEM$$9$YR$$F$Y$38$KG$20240704$$PH$GB$GB
240494191$24049419$1$I$$20240517$20240704$20240704$EXP$CI-MLMSERVICE-20240430-PI045151-00030-1$CI-ALKEM LABORATORIES LIMITED-CI-ALKEM-2024-09949$ALKEM$Koffi NR, Pete Y, N Da KC, Ory OA, One JL, Ogondon B, et al. Ibuprofen Lyell^s syndrome in an eight-year-old child. Annals of burns and fire disasters. 2023;36(1):68-73$8$YR$$F$Y$$$20240704$$MD$CI$CI
240494201$24049420$1$I$$20240506$20240704$20240704$EXP$IR-MLMSERVICE-20240422-PI029201-00030-2$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-09065$ALKEM$Alhatemi AQ, Hashim HT, Al-Tarbosh MA, Abdulhussain R, Hashim AT. Single-dose ibuprofen induced Stevens-Johnson Syndrome. Clinical case reports.. 2024;12(4):e8574$45$YR$$F$Y$78$KG$20240704$$HP$IR$IR
240494211$24049421$1$I$20240415$20240417$20240704$20240704$EXP$GB-MHRA-ADR 28677738$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08325$ALKEM$$24$YR$$F$Y$50$KG$20240704$$MD$GB$GB
240494221$24049422$1$I$$20240523$20240704$20240704$EXP$GB-MHRA-ADR 28714751$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-09490$ALKEM$$42$YR$$F$Y$55$KG$20240704$$MD$GB$GB
240494231$24049423$1$I$$20240514$20240704$20240704$EXP$GB-MHRA-ADR 28734090$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10365$ALKEM$$74$YR$$M$Y$$$20240704$$PH$GB$GB
240494241$24049424$1$I$$20240612$20240704$20240704$EXP$$TN-ALKEM LABORATORIES LIMITED-TN-ALKEM-2024-13344$ALKEM$Ben Fadhel N, Chahed F, Ben Romdhane H, Chaabane A, Ben Fredj N, Aouam K. Paracetamol tolerance in patients with previous NSAID hypersensitivity: Identifying risk factors and threshold dosages. Journal of the European Academy of Dermatology + Venereology. 2024;38:e490-e492$37$YR$$$Y$$$20240704$$HP$TN$TN
240494251$24049425$1$I$$20240517$20240704$20240704$EXP$GB-MHRA-ADR 28727344$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10063$ALKEM$$42$YR$$F$Y$55$KG$20240704$$HP$GB$GB
240494261$24049426$1$I$20230413$20230530$20240704$20240704$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000074-2023$QILU PHARMACEUTICAL$$58$YR$A$F$Y$$$20240619$$PH$US$US
240494274$24049427$4$F$20240619$20240709$20240704$20240713$PER$$US-AMGEN-USASP2024128948$AMGEN$$63$YR$A$F$Y$$$20240713$$CN$US$US
240494281$24049428$1$I$$20240528$20240704$20240704$PER$$US-AMGEN-USASP2024132281$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240494291$24049429$1$I$$20230125$20240704$20240704$PER$$US-AMGEN-USASP2023235410$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240494303$24049430$3$F$20211028$20240903$20240704$20240904$EXP$$US-GILEAD-2024-0679447$GILEAD$$58$YR$A$M$Y$$$20240904$$LW$US$US
240494311$24049431$1$I$$20240612$20240704$20240704$EXP$$TN-ALKEM LABORATORIES LIMITED-TN-ALKEM-2024-13342$ALKEM$Ben Fadhel N, Chahed F, Ben Romdhane H, Chaabane A, Ben Fredj N, Aouam K. Paracetamol tolerance in patients with previous NSAID hypersensitivity: Identifying risk factors and threshold dosages. Journal of the European Academy of Dermatology + Venereology. 2024;38:e490-e492$50$YR$$F$Y$$$20240704$$HP$TN$TN
240494321$24049432$1$I$$20240517$20240704$20240704$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2020-00371$ALKEM$Sternlieb P and Robinson RM.. Stevens-Johnson syndrome plus toxic hepatitis due to Ibuprofen. N Y State J Med. 1978;78:1239-1243$44$YR$$M$Y$$$20240704$$HP$ES$ES
240494351$24049435$1$I$$20240612$20240704$20240704$EXP$$TN-ALKEM LABORATORIES LIMITED-TN-ALKEM-2024-13345$ALKEM$Ben Fadhel N, Chahed F, Ben Romdhane H, Chaabane A, Ben Fredj N, Aouam K.. Paracetamol tolerance in patients with previous NSAID hypersensitivity: Identifying risk factors and threshold dosages. Journal of the European Academy of Dermatology + Venereology. 2024;38:e490-e492$49$YR$$F$Y$$$20240704$$HP$TN$TN
240494361$24049436$1$I$$20240517$20240704$20240704$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-11160$ALKEM$Morelli MS, O^Brien FX.. Stevens-Johnson Syndrome and cholestatic hepatitis. Dig Dis Sci. 2001;46:2385-8$19$YR$$F$Y$$$20240704$$HP$US$US
240494371$24049437$1$I$$20240430$20240704$20240704$EXP$$UA-ALKEM LABORATORIES LIMITED-UA-ALKEM-2024-09576$ALKEM$Malska AA, Kurilyak OB, Kurilyak AK, Burak TV. Prematurely closed arterial duct: possible risks for the newborn. Modern Pediatric. 2023;8(136):124-130$$$$F$Y$$$20240704$$HP$UA$UA
240494381$24049438$1$I$20240625$20240626$20240704$20240704$EXP$$GB-AUROBINDO-AUR-APL-2024-031767$AUROBINDO$$39$YR$$F$Y$$$20240704$$HP$GB$GB
240494391$24049439$1$I$20240501$20240701$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105112$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240704$$HP$US$US
240494401$24049440$1$I$20240201$20240628$20240704$20240704$EXP$$US-ABBVIE-5821878$ABBVIE$$21$YR$$M$Y$$$20240704$$CN$US$US
240494411$24049441$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106633$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240704$$CN$US$US
240494421$24049442$1$I$$20240327$20240704$20240704$EXP$GB-MHRA-ADR 28628894$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06576$ALKEM$$65$YR$$F$Y$90$KG$20240704$$HP$GB$GB
240494431$24049443$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106685$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240704$$HP$US$US
240494441$24049444$1$I$$20240624$20240704$20240704$PER$$US-TEVA-VS-3213222$TEVA$$$$E$M$Y$$$20240704$$CN$US$US
240494451$24049445$1$I$20240521$20240523$20240704$20240704$EXP$GB-MHRA-ADR 28758860$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-11354$ALKEM$$37$YR$$M$Y$53$KG$20240704$$HP$GB$GB
240494461$24049446$1$I$20230419$20230530$20240704$20240704$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000075-2023$QILU PHARMACEUTICAL$$78$YR$E$M$Y$$$20240619$$PH$US$US
240494471$24049447$1$I$$20240628$20240704$20240704$EXP$$ES-AMGEN-ESPSP2024129123$AMGEN$Gonzalez-lopez T.; Bermejo-vega N.; Cardesa-cabrera R. et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Blood. 2024;1-29$88$YR$E$F$Y$$$20240704$$HP$ES$ES
240494481$24049448$1$I$$20240628$20240704$20240704$EXP$$ES-AMGEN-ESPSP2024129132$AMGEN$Gonzalez-lopez T.; Bermejo-vega N.; Cardesa-cabrera R. et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Blood. 2024;1-29$75$YR$E$M$Y$$$20240704$$HP$ES$ES
240494491$24049449$1$I$$20230727$20240704$20240704$PER$$US-AMGEN-USASP2023235520$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240494501$24049450$1$I$20240625$20240626$20240704$20240704$PER$$US-ABBVIE-5819804$ABBVIE$$32$YR$$M$Y$$$20240704$$CN$US$US
240494511$24049451$1$I$$20240430$20240704$20240704$EXP$US-MLMSERVICE-20240412-PI024421-00030-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-08795$ALKEM$Abdelsalam M, Hamaad M, Hafiz S, Khan I, Walker J.. A case of toxic epidermal necrolysis precipitated by ibuprofen and COVID-19. The American Journal of the Medical Sciences. 2024;367(S1):S1-S212$49$YR$$M$Y$$$20240704$$MD$US$US
240494521$24049452$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106505$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$119.75$KG$20240704$$CN$US$US
240494531$24049453$1$I$$20240628$20240704$20240704$PER$$US-JNJFOC-20240678117$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$HP$US$US
240494541$24049454$1$I$$20230502$20240704$20240704$PER$$US-AMGEN-USASP2023235415$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240494551$24049455$1$I$20240615$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024132073$AMGEN$$61$YR$A$F$Y$$$20240704$$CN$US$US
240494561$24049456$1$I$$20240624$20240704$20240704$EXP$$US-ROCHE-10000009303$ROCHE$Peng Y, Kumar A, Gu Z, Kosuru N, Wampfler J, Reck dos Santos P, et al. Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort. Journal of the American Academy of Dermatology. 2024;91 (1):172-5. doi:10.1016/j.jaad.2024.03.029.$$$$$Y$$$20240704$$MD$US$US
240494571$24049457$1$I$20230420$20230530$20240704$20240704$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000076-2023$QILU PHARMACEUTICAL$$77$YR$E$F$Y$$$20240620$$PH$US$US
240494581$24049458$1$I$20240308$20240625$20240704$20240704$EXP$SE-SEMPA-2024-002110$SE-TEVA-VS-3214428$TEVA$$17$YR$$F$Y$60$KG$20240704$$MD$SE$SE
240494592$24049459$2$F$$20240626$20240704$20240705$PER$$US-ROCHE-10000015220$ROCHE$$67$YR$E$F$Y$$$20240705$$HP$US$US
240494602$24049460$2$F$20240502$20240902$20240704$20240905$EXP$FR-AFSSAPS-RE2024000661$FR-ABBVIE-5823129$ABBVIE$$62$YR$$M$Y$100$KG$20240905$$MD$FR$FR
240494611$24049461$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138532$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240494621$24049462$1$I$$20240703$20240704$20240704$PER$$NVSC2024US138823$NOVARTIS$$$$$M$Y$$$20240704$$HP$US$US
240494631$24049463$1$I$$20240624$20240704$20240704$EXP$$PL-AUROBINDO-AUR-APL-2024-032026$AUROBINDO$Jerzak M, Bindas J, Szczukocka M. Diffuse alveolar haemorrhage ? case report and literature review. Journal of Pre-Clinical and Clinical Research. 2024;18 (2):147-150$36$YR$$F$Y$$$20240704$$HP$PL$PL
240494641$24049464$1$I$$20240621$20240704$20240704$PER$23821230$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000855$ALEMBIC$$$$$$Y$$$20240704$$CN$US$US
240494651$24049465$1$I$20230420$20230530$20240704$20240704$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000077-2023$QILU PHARMACEUTICAL$$69$YR$E$M$Y$$$20240619$$PH$US$US
240494661$24049466$1$I$20240101$20240625$20240704$20240704$EXP$$US-JNJFOC-20240668919$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240704$$CN$US$US
240494671$24049467$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032400$AUROBINDO$Chan E, Ngo TT, Liang L, Ling J, Horng GS.. The Imitation Game: Concurrent Tuberculous Myositis in a Dermatomyositis Patient.. Am-J-Respir-Crit-Care-Med. 2024;209:A7415$82$YR$$F$Y$$$20240704$$HP$US$US
240494692$24049469$2$F$$20240708$20240704$20240713$EXP$$US-ABBVIE-5823363$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240494701$24049470$1$I$$20240620$20240704$20240704$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05960$HIKMA$Gooding K, Salunke R, Fiscus G, Quental A, Kaur A.. Gooding K, Salunke R, Fiscus G, Quental A, Kaur A. Beating to Its Own Drum; Flecainide Toxicity and Cardiogenic Shock in a Patient With Dual-Chamber Pacemaker.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5667$76$YR$$F$Y$$$20240704$$MD$US$US
240494711$24049471$1$I$20240101$20240628$20240704$20240704$EXP$$CA-ABBVIE-5823531$ABBVIE$$$$E$F$Y$$$20240704$$MD$CA$CA
240494722$24049472$2$F$20221219$20240719$20240704$20240722$EXP$$JP-ABBVIE-5824244$ABBVIE$$64$YR$$F$Y$78$KG$20240722$$MD$JP$JP
240494731$24049473$1$I$$20240702$20240704$20240704$EXP$$US-ABBVIE-5825447$ABBVIE$$$$$M$Y$$$20240704$$HP$US$US
240494741$24049474$1$I$20240628$20240701$20240704$20240704$EXP$$US-ABBVIE-5825287$ABBVIE$$76$YR$$M$Y$$$20240704$$CN$US$US
240494751$24049475$1$I$20240124$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031907$AUROBINDO$$45$YR$$F$Y$$$20240704$$PH$FR$FR
240494761$24049476$1$I$$20240701$20240704$20240704$EXP$$GB-ABBVIE-5825453$ABBVIE$$74$YR$$F$Y$$$20240704$$CN$GB$GB
240494771$24049477$1$I$20240501$20240629$20240704$20240704$EXP$$FR-ABBVIE-5824987$ABBVIE$$78$YR$$M$Y$$$20240704$$CN$FR$FR
240494781$24049478$1$I$$20240624$20240704$20240704$30DAY$$US-GSK-US2024078559$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
240494802$24049480$2$F$$20240911$20240704$20240912$EXP$$NVSC2024CA135277$NOVARTIS$$$$$F$Y$$$20240912$$MD$CA$CA
240494811$24049481$1$I$$20240628$20240704$20240704$EXP$$NVSC2024BR122431$NOVARTIS$$$$$F$Y$$$20240704$$MD$BR$BR
240494823$24049482$3$F$$20240816$20240704$20240820$PER$$NVSC2024US138215$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
240494841$24049484$1$I$$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024130048$AMGEN$Massengill M.T.; Cubillos S.; Sheth N. et al.. Response of Diabetic Macular Edema to Anti-VEGF Medications Correlates with Improvement in Macular Vessel Architecture Measured with OCT Angiography. Ophthalmology Science. 2024;4 (4):1-10$$$$$Y$$$20240704$$MD$US$US
240494851$24049485$1$I$$20240626$20240704$20240704$EXP$$GB-AUROBINDO-AUR-APL-2024-031856$AUROBINDO$$80$YR$$F$Y$$$20240704$$PH$GB$GB
240494861$24049486$1$I$$20230809$20240704$20240704$PER$$US-AMGEN-USASP2023235361$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240494881$24049488$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001954$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240704$$CN$US$US
240494891$24049489$1$I$20240630$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002840$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240704$$CN$US$US
240494901$24049490$1$I$$20240629$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001909$ELI LILLY AND CO$$$$$$Y$$$20240704$$CN$US$US
240494911$24049491$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002030$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240704$$CN$US$US
240494921$24049492$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002720$ELI LILLY AND CO$$7$YR$C$M$Y$$$20240704$$CN$US$US
240494931$24049493$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002000$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240704$$CN$US$US
240494941$24049494$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001916$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240704$$CN$US$US
240494961$24049496$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001903$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240704$$CN$US$US
240494971$24049497$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002360$ELI LILLY AND CO$$$$$M$Y$$$20240704$$CN$US$US
240494982$24049498$2$F$$20240708$20240704$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05503$LUPIN$$$$$$Y$$$20240805$$PH$US$US
240494992$24049499$2$F$$20240708$20240704$20240717$EXP$$US-TEVA-VS-3214290$TEVA$Schultz L, Davis KL, Walkush A, Baggott C, Erickson C, Ramakrishna S, et al. Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD. J-Immunother-Cancer 2023; 11 (2):.; Schultz L, Davis KL, Walkush A, Baggott C, Erickson C, Ramakrishna S, et al. Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD. J-Immunother-Cancer 2...$$$C$F$Y$$$20240717$$MD$US$US
240495001$24049500$1$I$20240322$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031892$AUROBINDO$$56$YR$$M$Y$$$20240704$$PH$FR$FR
240495011$24049501$1$I$$20240628$20240704$20240704$PER$$US-ABBVIE-5822497$ABBVIE$$$$E$$Y$$$20240704$$CN$US$US
240495023$24049502$3$F$20150701$20240903$20240704$20240904$EXP$$US-GILEAD-2024-0679448$GILEAD$$62$YR$A$M$Y$$$20240904$$LW$US$US
240495031$24049503$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106525$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240704$$CN$US$US
240495041$24049504$1$I$$20240625$20240704$20240704$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004754$BIOCON$$$$$$Y$$$20240704$$CN$CA$CA
240495051$24049505$1$I$$20240703$20240704$20240704$PER$$US-JNJFOC-20240710060$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240704$$HP$US$US
240495061$24049506$1$I$20230421$20230530$20240704$20240704$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000078-2023$QILU PHARMACEUTICAL$$63$YR$A$M$Y$$$20240619$$PH$US$US
240495071$24049507$1$I$$20230926$20240704$20240704$PER$$US-AMGEN-USASP2023235366$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240495081$24049508$1$I$$20231102$20240704$20240704$PER$$US-AMGEN-USASP2023235446$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240495091$24049509$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131225$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240495101$24049510$1$I$20240101$20240701$20240704$20240704$EXP$$US-BIOGEN-2024BI01272139$BIOGEN$$$$$F$Y$$$20240704$$CN$US$US
240495111$24049511$1$I$20240201$20240629$20240704$20240704$EXP$$ES-BAUSCHBL-2024BNL029336$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240704$$HP$ES$ES
240495121$24049512$1$I$20231101$20240628$20240704$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-010331$JAZZ$$53$YR$$M$Y$$$20240704$$HP$US$US
240495151$24049515$1$I$$20240630$20240704$20240704$EXP$$AU-BAUSCHBL-2024BNL029420$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240704$$CN$AU$AU
240495161$24049516$1$I$$20240627$20240704$20240704$EXP$$US-GSK-US2024AMR081247$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$MD$US$US
240495171$24049517$1$I$20230501$20230530$20240704$20240704$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000079-2023$QILU PHARMACEUTICAL$$70$YR$E$F$Y$$$20240619$$PH$US$US
240495181$24049518$1$I$$20240626$20240704$20240704$EXP$$BG-AstraZeneca-2024A151470$ASTRAZENECA$$$$$M$Y$$$20240704$$MD$BG$
240495191$24049519$1$I$$20240626$20240704$20240704$EXP$$SG-AstraZeneca-2024A148475$ASTRAZENECA$$$$$F$Y$$$20240704$$MD$SG$
240495207$24049520$7$F$20240101$20240906$20240704$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-020263$UNITED THERAPEUTICS$$$$$M$Y$68.027$KG$20240914$$$US$US
240495211$24049521$1$I$$20240630$20240704$20240704$EXP$$AU-BAUSCHBL-2024BNL029421$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240704$$CN$AU$AU
240495222$24049522$2$F$20240619$20240717$20240704$20240809$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000407$BECTON DICKINSON$$$$$$Y$$$20240809$$CN$GB$GB
240495232$24049523$2$F$20240619$20240718$20240704$20240809$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000409$BECTON DICKINSON$$$$$$Y$$$20240809$$CN$GB$GB
240495242$24049524$2$F$20240619$20240718$20240704$20240809$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000408$BECTON DICKINSON$$$$$$Y$$$20240809$$CN$GB$GB
240495251$24049525$1$I$$20240625$20240704$20240704$PER$$US-APOTEX-2024AP007847$APOTEX$Le CT, Mahmoud A, Kurt O, Bangash H, Saad Eldin M, Ayaz S. Advanced Care in Rheumatoid Arthritis With Biologic Agents: The Role of Pneumocystis Jirovecii Pneumonia Prophylaxis. American Journal of Respiratory and Critical Care Medicine. 2024;209: A2388$66$YR$$F$Y$$$20240704$$HP$US$US
240495261$24049526$1$I$20240619$20240627$20240704$20240704$EXP$$CN-ROCHE-10000011690$ROCHE$$9$YR$C$M$Y$25.9$KG$20240704$$HP$CN$CN
240495271$24049527$1$I$$20240626$20240704$20240704$EXP$$ES-AUROBINDO-AUR-APL-2024-031922$AUROBINDO$$$$$M$Y$$$20240704$$CN$ES$ES
240495281$24049528$1$I$20240623$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024127992$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240495291$24049529$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106552$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$108.86$KG$20240704$$HP$US$US
240495301$24049530$1$I$$20240627$20240704$20240704$PER$$US-ROCHE-10000011733$ROCHE$$$$$$Y$$$20240704$$PH$US$US
240495311$24049531$1$I$$20240630$20240704$20240704$EXP$$AU-BAUSCHBL-2024BNL029431$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240704$$CN$AU$AU
240495321$24049532$1$I$20240525$20240621$20240704$20240704$EXP$FR-AFSSAPS-AN2024000792$FR-TEVA-VS-3213067$TEVA$$67$YR$$F$Y$$$20240704$$PH$FR$FR
240495331$24049533$1$I$20230905$20230930$20240704$20240704$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000149-2023$QILU PHARMACEUTICAL$$68$YR$E$F$Y$$$20240619$$PH$US$US
240495341$24049534$1$I$20240611$20240701$20240704$20240704$EXP$$IT-ABBVIE-5823654$ABBVIE$$62$YR$$F$Y$57$KG$20240704$$MD$IT$IT
240495352$24049535$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214520$TEVA$Wong C, Malik M, Abu-Hashish H, Ang G, Galperin I. Hydralazine to Pulmonary Hemorrhage: A Case of Drug Induced Vasculitis. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Wong C, Malik M, Abu-Hashish H, Ang G, Galperin I. Hydralazine to Pulmonary Hemorrhage: A Case of Drug Induced Vasculitis. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$85$YR$$M$Y$$$20240720$$HP$US$US
240495363$24049536$3$F$$20240628$20240704$20240709$EXP$$PL-ROCHE-10000014120$ROCHE$$$$$F$Y$$$20240709$$MD$PL$PL
240495374$24049537$4$F$20240616$20240821$20240704$20240903$EXP$$ES-AUROBINDO-AUR-APL-2024-031881$AUROBINDO$$85$YR$$M$Y$85$KG$20240903$$MD$ES$ES
240495381$24049538$1$I$20240201$20240626$20240704$20240704$EXP$$GB-AUROBINDO-AUR-APL-2024-031705$AUROBINDO$$67$YR$$M$Y$98$KG$20240704$$CN$GB$GB
240495391$24049539$1$I$20221101$20240626$20240704$20240704$EXP$GB-MHRA-MED-202406260038570290-BDSYP$GB-AMAROX PHARMA-AMR2024GB02015$HETERO$$37$YR$$F$Y$$$20240704$$CN$GB$GB
240495421$24049542$1$I$20240301$20240701$20240704$20240704$EXP$$US-ABBVIE-5824782$ABBVIE$$69$YR$$F$Y$$$20240704$$CN$US$US
240495431$24049543$1$I$$20240701$20240704$20240704$EXP$$US-ABBVIE-5824641$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240495442$24049544$2$F$$20240722$20240704$20240724$EXP$GB-JNJFOC-20240633377$GB-VIIV HEALTHCARE LIMITED-GB2024077310$VIIV$$$$$$Y$$$20240724$$HP$GB$GB
240495451$24049545$1$I$$20240702$20240704$20240704$PER$$US-TAKEDA-2024TUS067221$TAKEDA$$$$$$Y$$$20240704$$PH$US$US
240495461$24049546$1$I$20230807$20230930$20240704$20240704$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000150-2023$QILU PHARMACEUTICAL$$41$YR$A$F$Y$$$20240619$$PH$US$US
240495472$24049547$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214641$TEVA$Saracino V, Kotha A. Myxedema Coma: The Master of Disguise. Am-J-Respir-Crit-Care-Med 2024; 209.; Saracino V, Kotha A. Myxedema Coma: The Master of Disguise. Am-J-Respir-Crit-Care-Med 2024; 209.$42$YR$$M$Y$$$20240720$$HP$US$US
240495491$24049549$1$I$$20231121$20240704$20240704$PER$$US-AMGEN-USASP2023235303$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240495501$24049550$1$I$20240228$20240703$20240704$20240704$EXP$$GB-UCBSA-2024033781$UCB$$$$$$Y$$$20240704$$HP$GB$GB
240495511$24049551$1$I$$20240625$20240704$20240704$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004772$BIOCON$$$$$$Y$$$20240704$$HP$CA$CA
240495531$24049553$1$I$20230905$20230930$20240704$20240704$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000151-2023$QILU PHARMACEUTICAL$$62$YR$A$F$Y$$$20240619$$PH$US$US
240495541$24049554$1$I$$20230614$20240704$20240704$PER$$US-AMGEN-USASP2023235168$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240495553$24049555$3$F$20211129$20240903$20240704$20240904$PER$$US-GILEAD-2024-0679449$GILEAD$$41$YR$A$M$Y$$$20240904$$LW$US$US
240495561$24049556$1$I$20240627$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024129226$AMGEN$$77$YR$E$M$Y$$$20240704$$HP$US$US
240495572$24049557$2$F$20240629$20240701$20240704$20240715$PER$$US-AMGEN-USASP2024130835$AMGEN$$65$YR$E$F$Y$$$20240714$$CN$US$US
240495581$24049558$1$I$$20230725$20240704$20240704$PER$$US-AMGEN-USASP2023235089$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240495591$24049559$1$I$$20240626$20240704$20240704$EXP$$DE-AMGEN-DEUSP2024128134$AMGEN$Heyer S; Steimle-Grauer S; Schmidle P. et al. 33-year-old man with plaques and bullae. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024;22 (6):857-859$33$YR$A$M$Y$$$20240704$$MD$DE$DE
240495601$24049560$1$I$20220301$20220623$20240704$20240704$EXP$$JP-TAKEDA-SH202204514$TAKEDA$$20$YR$$M$Y$$$20240704$$MD$JP$JP
240495611$24049561$1$I$$20240528$20240704$20240704$PER$$US-AMGEN-USASP2024132291$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240495621$24049562$1$I$20230601$20230930$20240704$20240704$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000167-2023$QILU PHARMACEUTICAL$$57$YR$A$M$Y$$$20240619$$PH$US$US
240495631$24049563$1$I$$20240627$20240704$20240704$EXP$$US-ROCHE-10000015074$ROCHE$$74$YR$E$F$Y$$$20240704$$CN$US$US
240495642$24049564$2$F$20240101$20240705$20240704$20240709$EXP$$US-ABBVIE-5825895$ABBVIE$$$$$M$Y$88.9$KG$20240709$$CN$US$US
240495651$24049565$1$I$20231201$20240625$20240704$20240704$EXP$SE-SEMPA-2024-005053$SE-GSK-SE2024078988$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$MD$SE$SE
240495661$24049566$1$I$$20231025$20240704$20240704$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000184-2023$QILU PHARMACEUTICAL$$$$$F$Y$$$20240620$$PH$US$US
240495671$24049567$1$I$20240602$20240621$20240704$20240704$EXP$ES-AEMPS-1535182$ES-TEVA-VS-3213235$TEVA$$85$YR$$F$Y$$$20240704$$MD$ES$ES
240495681$24049568$1$I$20240601$20240626$20240704$20240704$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019805$UNITED THERAPEUTICS$$56$YR$$M$Y$$$20240704$$$US$US
240495691$24049569$1$I$$20231121$20240704$20240704$PER$$US-AMGEN-USASP2023235119$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240495702$24049570$2$F$20240503$20240701$20240704$20240709$EXP$FR-AFSSAPS-AM2024000500$FR-TEVA-VS-3213355$TEVA$$61$YR$$F$Y$$$20240709$$MD$FR$FR
240495711$24049571$1$I$$20240625$20240704$20240704$EXP$$US-862174955-ML2024-03701$Unknown Manufacturer$Kim JH, Shelat N, Ji CS. Apixaban and Rivaroxaban Anti-Xa Concentration Utilization in Clinical Practice. J Cardiovasc Pharmacol. 2023 Feb;81(Number 2): 165-170. doi:10.1097/FJC.0000000000001383.$76$YR$E$F$Y$$$20240704$$PH$US$US
240495721$24049572$1$I$20240608$20240627$20240704$20240704$EXP$$US-JNJFOC-20240632288$JOHNSON AND JOHNSON$$50$YR$A$M$Y$97.7$KG$20240704$$HP$US$US
240495734$24049573$4$F$20240729$20240916$20240704$20240923$EXP$$US-TAKEDA-2024TUS067413$TAKEDA$$65$YR$$F$Y$97$KG$20240923$$MD$US$US
240495741$24049574$1$I$$20240627$20240704$20240704$PER$$US-BIOGEN-2024BI01271569$BIOGEN$$$$$F$Y$$$20240704$$CN$US$US
240495751$24049575$1$I$$20240627$20240704$20240704$PER$$US-BIOGEN-2024BI01266797$BIOGEN$$$$$M$Y$$$20240704$$CN$US$US
240495761$24049576$1$I$$20240627$20240704$20240704$PER$$US-BIOGEN-2024BI01271532$BIOGEN$$$$$M$Y$73.5$KG$20240704$$MD$US$US
240495771$24049577$1$I$20240531$20240614$20240704$20240704$30DAY$$US-GSK-US2024074406$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240704$$CN$US$US
240495781$24049578$1$I$$20240628$20240704$20240704$EXP$$AU-GSK-AU2024080986$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$MD$AU$AU
240495791$24049579$1$I$$20240624$20240704$20240704$30DAY$$US-GSK-US2024079033$GLAXOSMITHKLINE$$8$DEC$$F$Y$$$20240704$$HP$US$US
240495801$24049580$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A148087$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$US$
240495811$24049581$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A149083$ASTRAZENECA$$$$$F$Y$$$20240704$$CN$US$
240495821$24049582$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A148556$ASTRAZENECA$$$$$F$Y$$$20240704$$CN$US$
240495831$24049583$1$I$$20240626$20240704$20240704$PER$$US-ALXN-202406USA001783US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
240495841$24049584$1$I$20240623$20240624$20240704$20240704$PER$$US-ROCHE-10000011050$ROCHE$$$$$$Y$$$20240704$$PH$US$US
240495851$24049585$1$I$20240626$20240627$20240704$20240704$EXP$$GB-AstraZeneca-2024A147688$ASTRAZENECA$$61$YR$$M$Y$116$KG$20240704$$MD$GB$
240495861$24049586$1$I$$20240629$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002200$ELI LILLY AND CO$$$$$$Y$$$20240704$$CN$US$US
240495871$24049587$1$I$20240622$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002116$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240704$$CN$US$US
240495881$24049588$1$I$20240628$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002632$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240704$$CN$US$US
240495891$24049589$1$I$20240701$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001938$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240704$$CN$US$US
240495901$24049590$1$I$20240702$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001923$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240704$$CN$US$US
240495911$24049591$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002295$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240704$$CN$US$US
240495921$24049592$1$I$20240703$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002637$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240704$$CN$US$US
240495942$24049594$2$F$$20240711$20240704$20240722$30DAY$$US-GSK-US2024074392$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
240495951$24049595$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002058$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240704$$CN$US$US
240495961$24049596$1$I$20240703$20240703$20240704$20240704$EXP$$US-UCBSA-2024033786$UCB$$68$YR$$$Y$$$20240704$$CN$US$US
240495983$24049598$3$F$20240610$20240812$20240704$20240813$PER$$US-ROCHE-10000014411$ROCHE$$34$YR$A$F$Y$117.03$KG$20240813$$CN$US$US
240495991$24049599$1$I$20240524$20240621$20240704$20240704$EXP$FR-AFSSAPS-AN2024000783$FR-TEVA-VS-3213478$TEVA$$74$YR$$M$Y$130$KG$20240704$$PH$FR$FR
240496004$24049600$4$F$$20240624$20240704$20240712$EXP$$JP-ROCHE-10000014218$ROCHE$Sato K, Kim I, Tanaka M, Meguro N, Den K, Sugita M. A Case of Advanced Gastric Cancer with Multiple Liver Metastases Treated with Nivolumab Monotherapy followed by Conversion Surgery as Third-Line Therapy. The 45th Annual Meeting of Japanese Research Society of Surgical Cancer Immunolo. 2024:91.$72$YR$E$M$Y$$$20240712$$MD$JP$JP
240496011$24049601$1$I$20230502$20240614$20240704$20240704$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024074364$VIIV$$50$YR$$M$Y$$$20240704$$MD$US$US
240496022$24049602$2$F$$20240701$20240704$20240711$EXP$$JP-ROCHE-10000009747$ROCHE$Maruki T, Nomoto H, Iwamoto N, Yamamoto K, Kurokawa M, Iwatsuki-Horimoto K, et al. Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for fol. Journal of Infection and Chemotherapy. 2024;30 (8):793-795. doi:10.1016/j.jiac.2024.01.008.$59$YR$A$F$Y$$$20240711$$HP$JP$JP
240496031$24049603$1$I$20240302$20240619$20240704$20240704$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454046$RANBAXY$$47$YR$$F$Y$104.6$KG$20240704$$MD$FR$FR
240496041$24049604$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452904$RANBAXY$Abdulelah M, McGee WT. Diagnostic Ambiguity in Brain Death. Am J Respir Crit Care Med. 2024;209:A7048$40$YR$$M$Y$$$20240704$$HP$US$US
240496051$24049605$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453942$RANBAXY$Mazin LN, Sofi UF. Streptococcal Toxic Shock Syndrome Masquerading as Necrotizing Fasciitis: A Case Report. Am J Respir Crit Care Med. 2024;209 (0):A1607$61$YR$$M$Y$$$20240704$$HP$US$US
240496061$24049606$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453899$RANBAXY$Khan M, Farmer MS. Ticking All the Boxes: Case of Anaplasmosis With Acute Respirator Distress Syndrome and Multi-Organ Failure. Am J Respir Crit Care Med. 2024;209 (0):A3557/B43$79$YR$$F$Y$$$20240704$$HP$US$US
240496071$24049607$1$I$20240501$20240619$20240704$20240704$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452734$RANBAXY$$70$YR$$F$Y$$$20240704$$MD$JP$JP
240496081$24049608$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453894$RANBAXY$Khalil M, Dredla B, Cheung J, Castillo P. DEXTROMETHORPHAN FOR RESTLESS LEGS SYNDROME: TESTING THE GLUTAMATE THEORY. Sleep. 2024;47(1):A302;0706;Abst zsae067.0706$45$YR$$F$Y$$$20240704$$HP$US$US
240496092$24049609$2$F$$20240626$20240704$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453290$RANBAXY$Olguner Eker O, Turan T, Sarilar AC, Danaci Sezgin SI. Postinjection Delirium/Sedation Syndrome After Paliperidone Palmitate Injection in a Bipolar Affective Disorder Patient: A Case Report. J Clin Psychopharmacol. 2024;May/Jun;44 (3):319-321$48$YR$$M$Y$$$20240711$$MD$TR$TR
240496114$24049611$4$F$20240518$20240822$20240704$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453871$RANBAXY$$61$YR$A$M$Y$71.6$KG$20240906$$MD$CN$CN
240496121$24049612$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453118$RANBAXY$Ng Z, Broussard BA. A Case of Diabetic Ketoacidosis (DKA) Secondary to Olanzapine Use. Am J Respir Crit Care Med. 2024;209(0):A3385$66$YR$$F$Y$$$20240704$$HP$US$US
240496131$24049613$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453898$RANBAXY$Raymond-Forde S, Olexsey K. A Rare but Potentially Fatal Reaction in Plain Sight: Trimethoprim-Sulfamethoxazole Induced Acute Lung Injury. Am J Respir Crit Care Med. 2024;209 (0:A2027;A52$34$YR$$M$Y$$$20240704$$HP$US$US
240496141$24049614$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453930$RANBAXY$Ruff K, Wikenheiser- Brokamp KA, Critser P, Hirsch R, Burg G, Hayes D, et al. Pulmonary Capillary Hemangiomatosis: A Rare Disorder With a Nonspecific Presentation. Am J Respir Crit Care Med. 2024;209 (0):A2327$9$YR$$F$Y$$$20240704$$HP$US$US
240496151$24049615$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453892$RANBAXY$Peters JD, Shastri D,Hajjar S, York J, ErpenwarS, Vanlandingham A. A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage. Am J Respir Crit Care Med. 2024;209 (0:A2021;A52$85$YR$$F$Y$$$20240704$$HP$US$US
240496161$24049616$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453900$RANBAXY$Lee M, Channick J, Chan V. Methimazole-Induced Hypothyroidism Presenting as Recurrent Thoracic Cavity Effusions and Ascites. Am J Respir Crit Care Med. 2024;209 (0):A1942$62$YR$$F$Y$$$20240704$$HP$US$US
240496171$24049617$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453897$RANBAXY$Georg M, Malik M, Wazirali M. Relapsing Cryptogenic Organizing Pneumonia What Comes After Steroids?. Am J Respir Crit Care Med. 2024;209 (0:A2066;A53$71$YR$$M$Y$$$20240704$$HP$US$US
240496181$24049618$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453935$RANBAXY$Goldberg E, Syed A, Desai S, Franco R, Ali Z. Diffuse Alveolar Hemorrhage Secondary to Hydralazine induced Vasculitis Causing Pulmonary-renal Syndrome. Am J Respir Crit Care Med. 2024;209 (0):no pagination (A2007)$80$YR$$F$Y$$$20240704$$HP$US$US
240496191$24049619$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453873$RANBAXY$Huang L, Ellis TJ, Bagavathy K. The unfortunate trifecta: tuberculosis, EBV, and CMV induced hemophagocytic lymphohistiocytosis. Am J Respir Crit Care Med. 2024;22 May 209 (0):1-2 (A7416)$52$YR$$M$Y$$$20240704$$HP$US$US
240496202$24049620$2$F$20240515$20240804$20240704$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449637$RANBAXY$$81$YR$E$M$Y$97$KG$20240816$$MD$CN$CN
240496211$24049621$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453881$RANBAXY$Hamad HM, Miett T, Kopec S. Statin and fenofibrate-induced rhabdomyolysis in liver transplant. Am J Respir Crit Care Med. 2024;21 May 209 (0):1 (A5694)$49$YR$$M$Y$$$20240704$$HP$US$US
240496221$24049622$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453927$RANBAXY$Chawla R, Connor L, Listur A. Unveiling Histoplasma: A Rare Culprit of Sepsis in Pancytopenic Patients With Transaminitis. Am J Respir Crit Care Med. 2024;209(0):A3570$39$YR$$M$Y$$$20240704$$HP$US$US
240496232$24049623$2$F$$20240904$20240704$20240913$PER$$US-ABBVIE-5821441$ABBVIE$$$$$M$Y$$$20240913$$MD$US$US
240496241$24049624$1$I$$20230829$20240704$20240704$PER$$US-AMGEN-USASP2023235574$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240496251$24049625$1$I$$20230829$20240704$20240704$PER$$US-AMGEN-USASP2023235413$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240496261$24049626$1$I$$20231215$20240704$20240704$PER$$US-AMGEN-USASP2023235317$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240496271$24049627$1$I$$20240625$20240704$20240704$PER$$US-AMGEN-USASP2024128553$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240496281$24049628$1$I$$20230315$20240704$20240704$PER$$US-AMGEN-USASP2023235485$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240496291$24049629$1$I$$20230503$20240704$20240704$PER$$US-AMGEN-USASP2023235467$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240496301$24049630$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454007$RANBAXY$Xiong J, Embry E, Prasad S, Singh K, Singh M. Mycoplasma Pneumonia Induced Acute Respiratory Distress Syndrome in Pregnancy. Am J Respir Crit Care Med. 2024;209 (0):A5546$38$YR$$F$Y$$$20240704$$HP$US$US
240496311$24049631$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453989$RANBAXY$Jones M, Ryan A, Haverkamp C, Broadwell M, Wilson MA. From Painkiller to Brain Thriller: The Curious Case of Fentanyl-induced Serotonin Syndrome. Am J Respir Crit Care Med. 2024;209(0):A7050$72$YR$$M$Y$$$20240704$$HP$US$US
240496321$24049632$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454049$RANBAXY$Keegan K, Ruff K, Burg G, Berklite LE, Deutsch G, Wikenheiser-Brokamp KA, et al. Surfactant Function Disorders: Genetics Is Just the Tip of the Iceberg. Am J Respir Crit Care Med. 2024;209 (0):A2305/A63$$$C$F$Y$$$20240704$$HP$US$US
240496331$24049633$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454056$RANBAXY$Durugu SR, Rajeshkumar Chitra S, Sekaran S, Naro GR. A Rare Presentation of Daptomycin-induced Eosinophilic Pneumonia in a Patient With Klinefelter^s Syndrome. Am J Respir Crit Care Med. 2024;209(0):A2030$46$YR$$M$Y$$$20240704$$HP$US$US
240496342$24049634$2$F$$20240702$20240704$20240709$EXP$GB-MHRA-MED-202407012148170490-RGMNT$GB-ORGANON-O2407GBR000189$ORGANON$$$$$F$Y$$$20240709$$CN$GB$GB
240496351$24049635$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454100$RANBAXY$Ryan A, Jones M, Broadwell M. Cold and Confused: A Case of Suspected Adrenal Insufficiency After COVID-19. Am J Respir Crit Care Med. 2024;209 (0):A3390$92$YR$$F$Y$$$20240704$$HP$US$US
240496361$24049636$1$I$20240407$20240619$20240704$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454091$RANBAXY$$87$YR$$M$Y$$$20240704$$MD$IT$IT
240496371$24049637$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454263$RANBAXY$Huff RR, Jose A, Karpinska-Leydier K, Theriault K, Kapadia S. Kartagener s Syndrome With Situs Inversus Total Is: Breaking the Vicious Cycle. Am J Respir Crit Care Med. 2024;209:A5836$71$YR$$F$Y$$$20240704$$HP$US$US
240496381$24049638$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454094$RANBAXY$Niranjan S, Rosa B, Patel D, Virk ST, Nasrullah A, Bajwa Y, et al. Rituximab Meets COVID-19: When Lung Tales Take an Unexpected Twist!. Am J Respir Crit Care Med. 2024;209 (0):A2055$63$YR$$M$Y$$$20240704$$HP$US$US
240496391$24049639$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453947$RANBAXY$McFarland BJ, Luo A, Wang X. Male breast cancer: Report of two cases with bloody nipple discharge. Radiol Case Rep. 2023;18(9):3323-3330$70$YR$$M$Y$$$20240704$$MD$US$US
240496401$24049640$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454399$RANBAXY$Wang Q, Tang Z, See X, Yang A. Atypical Presentation of Pulmonary-Renal Syndrome (PRS) Caused by Hydralazine-induced Antineutrophil Cytoplasmic Antibody Vasculitis/Lupus Overlap: A Case Report. Am J Respir Crit Care Med. 2024;209 (0):A5356/C33$74$YR$$F$Y$$$20240704$$HP$US$US
240496411$24049641$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454341$RANBAXY$Bjork ST, Chen E. Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series. Am J Respir Crit Care Med. 2024;209:A7429/D107$76$YR$$F$Y$$$20240704$$HP$US$US
240496421$24049642$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454130$RANBAXY$Nauka P, Konstantinidis I. Does Occam^s Razor Even Apply in Severely Immunosuppressed Patients? A Case of a Patient With HIV/AIDS With Opportunistic Infections, Diffuse Large B-Cell Lymphoma, and Secondary Hemophagocytic Lymphohistiocytosis. Am J Respir Crit Care Med. 2024;209(0):A3535$58$YR$$M$Y$$$20240704$$HP$US$US
240496431$24049643$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454411$RANBAXY$Hashmi N, Basaleli C, Gupta S, John G, Birnbaum B, Kim U, et al. Acute Eosinophilic Pneumonia in the Setting of Intramuscular Progesterone Usage. Am J Respir Crit Care Med. 2024;209(0):A6397$33$YR$$F$Y$$$20240704$$HP$US$US
240496441$24049644$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454377$RANBAXY$Deng X, Jung D. A Late, Unusual Presentation of Chronic Eosinophilic Pneumonia Requiring Anti-IL5 Therapy. Am J Respir Crit Care Med. 2024;209(0):A6374$88$YR$$F$Y$$$20240704$$HP$US$US
240496451$24049645$1$I$20240415$20240619$20240704$20240704$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454554$RANBAXY$$$$$M$Y$$$20240704$$MD$GB$GB
240496461$24049646$1$I$20240301$20240619$20240704$20240704$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454243$RANBAXY$$15$YR$$F$Y$$$20240704$$MD$FR$FR
240496481$24049648$1$I$$20240619$20240704$20240704$EXP$$US-SUNPHARMA-2024R1-454079AA$RANBAXY$Kim AH, Taha W, Prudenti J. A Critical Case of Hydralazine-induced Vasculitis Presenting With Pulmonary Renal Syndrome. Am J Respir Crit Care Med. 2024;209(0):A7071$72$YR$$M$Y$$$20240704$$HP$US$US
240496491$24049649$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454257$RANBAXY$Rink DE, Goodman J, Albert TJ. A Tough Pill to Swallow: A Unique Case of Foreign Body Aspiration. Am J Respir Crit Care Med. 2024;209:A5771$$$E$M$Y$$$20240704$$HP$US$US
240496502$24049650$2$F$20240614$20240628$20240704$20240712$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454261$RANBAXY$$36$YR$A$F$Y$57$KG$20240712$$PH$BR$BR
240496511$24049651$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454431$RANBAXY$Ramakrishnan S, Zhang S, Genese F. Macrobid-induced Acute Pulmonary Toxicity. Am J Respir Crit Care Med. 2024;209 (0):A6413$72$YR$$F$Y$$$20240704$$HP$US$US
240496521$24049652$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454358$RANBAXY$Ibrar M, Saber H, Iftikhar M, Shakir M, Waqas M, Chaudhary T, et al. A Rapidly Progressive Case: From Radiation Pneumonitis, to End Stage Radiation-induced Pulmonary Fibrosis in Less Than 3 Months. Am J Respir Crit Care Med. 2024;209(0):A6409/C72$70$YR$$M$Y$$$20240704$$HP$US$US
240496531$24049653$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454280$RANBAXY$Santosh N, Savani S, Iskapalli S. Beefing Up! Fulminant Liver Failure Secondary to Anabolic Steroid Use. Am J Respir Crit Care Med. 2024;209:A5688$30$YR$$M$Y$$$20240704$$HP$US$US
240496541$24049654$1$I$20240322$20240619$20240704$20240704$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454751$RANBAXY$$33$YR$$M$Y$$$20240704$$MD$FR$FR
240496551$24049655$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454340$RANBAXY$Bjork ST, Chen E. Nephrotoxicity as a complication of inhaled tobramycin for pseudomonas pneumonia: a case series. Am J Respir Crit Care Med. 2024;22 May 209 (0):A7429$74$YR$$F$Y$$$20240704$$HP$US$US
240496561$24049656$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454460$RANBAXY$Shah S, OSullivan MM. Psoriasiform Dermatitis During Dupilumab Treatment in Asthma and Allergic Bronchopulmonary Aspergillosis (ABPA). Am J Respir Crit Care Med. 2024;209 (0):A5295$68$YR$$F$Y$$$20240704$$HP$US$US
240496571$24049657$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454025$RANBAXY$Zafar P, Nasrullah A, Patel D, Holden K, Balaan MR. Community Acquired Pneumonia or Hydralazine-Induced Vasculitis - A Clinical Dilemma. Am J Respir Crit Care Med. 2024;209 (0):A2014$82$YR$$F$Y$$$20240704$$HP$US$US
240496581$24049658$1$I$$20240619$20240704$20240704$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454449$RANBAXY$Cavalcante Neto PM, Luz LC, Pereira LLS, De Souza YA, Pereira ADL, Simongini RL, et al. Non-Eosinophilic Exudative Pleural Effusion Induced by Valproic Acid. Am J Respir Crit Care Med. 2024;209 (0):A1924$55$YR$$M$Y$$$20240704$$HP$BR$BR
240496591$24049659$1$I$$20240619$20240704$20240704$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454619$RANBAXY$$63$YR$$$Y$$$20240704$$PH$GB$GB
240496601$24049660$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454247$RANBAXY$Gutierrez L, Ramanujam D, Patel D, Modugula S, Disilvio BE. The downside of your uppers: venlafaxine-induced hypertriglyceridemia causing acute pancreatitis. Am J Respir Crit Care Med. 2024;209 (0)$45$YR$$F$Y$$$20240704$$HP$US$US
240496611$24049661$1$I$20240324$20240619$20240704$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454618$RANBAXY$$48$YR$$M$Y$$$20240704$$HP$IT$IT
240496621$24049662$1$I$20240214$20240619$20240704$20240704$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454072$RANBAXY$$61$YR$$M$Y$$$20240704$$PH$ES$ES
240496632$24049663$2$F$$20240624$20240704$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454427$RANBAXY$Gunasekaran T, Gorla K, Berman J, Bhardwaj V. INHALED-SWALLOWED ALBUTEROL AS NON-ENDOSCOPIC TREATMENT FOR FOOD IMPACTION (FI) IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE). Gastrointest Endosc. 2024;99 (Suppl.) (6):AB1085/ Mo2058$$$T$$Y$$$20240709$$HP$US$US
240496642$24049664$2$F$$20240624$20240704$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454429$RANBAXY$Gunasekaran T, Gorla K, Berman J, Bhardwaj V. INHALED-SWALLOWED ALBUTEROL AS NON-ENDOSCOPIC TREATMENT FOR FOOD IMPACTION (FI) IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE). Gastrointest Endosc. 2024;99 (Suppl.) (6):AB1085(Mo2058)$$$T$$Y$$$20240709$$HP$US$US
240496651$24049665$1$I$$20240619$20240704$20240704$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454172$RANBAXY$$47$YR$$M$Y$$$20240704$$MD$GR$GR
240496662$24049666$2$F$$20240702$20240704$20240717$EXP$$SG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454395$RANBAXY$Wong J, Samol J, Chai G. Who^s to Blame? A Case of Drug-Induced Pneumonitis With Multiple Potential Culprits. Am J Respir Crit Care Med. 2024;209:A2006$62$YR$$M$Y$$$20240717$$HP$SG$SG
240496673$24049667$3$F$$20240712$20240704$20240726$EXP$$CO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454127$RANBAXY$Mejia-salgado G, Cardozo-Perez C, Cifuentes-Gonzalez C, Duran-Merino C, De-la-Torre A. Coinfection suspicion is imperative in immunosuppressed patients with suspected infectious uveitis and inadequate treatment response: a case report. Ocul Immunol Inflamm. 2024;0 (0):no pagination$70$YR$$F$Y$$$20240726$$MD$CO$CO
240496681$24049668$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454389$RANBAXY$Al Bizri L, Hernandez D, Young BP. Severe Airflow Obstruction Caused by a Rare Diagnosis: A Case of Endotracheal Plasmacytoma. Am J Respir Crit Care Med. 2024;209:A7489$57$YR$$F$Y$$$20240704$$HP$US$US
240496691$24049669$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454225$RANBAXY$Hartfield R, Khawam S, Levy JM, Hassan S, Goudie MP, Dawson MS. An Embolic Shower:A Case of Thrombotic Stroke in a Patient With Nephrotic Syndrome on Anticoagulation. Am J Respir Crit Care Med. 2022;209 (0):A5601$41$YR$$M$Y$$$20240704$$HP$US$US
240496702$24049670$2$F$20140101$20240701$20240704$20240716$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454568$RANBAXY$$$$A$M$Y$73$KG$20240716$$CN$GB$GB
240496711$24049671$1$I$20240401$20240619$20240704$20240704$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454731$RANBAXY$$58$YR$$M$Y$90.8$KG$20240704$$MD$FR$FR
240496721$24049672$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454462$RANBAXY$Alpert M, Chu DC. Solving a Paradox: Use of Biologic Monotherapy in an Unusual Case of Asthma With Paradoxical Bronchospasm. Am J Respir Crit Care Med. 2024;209 (0):A6398$24$YR$$F$Y$$$20240704$$HP$US$US
240496731$24049673$1$I$20240226$20240619$20240704$20240704$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454623$RANBAXY$$47$YR$$F$Y$$$20240704$$MD$ES$ES
240496742$24049674$2$F$$20240708$20240704$20240723$EXP$$SK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454903$RANBAXY$Horna S, Lecky P, Krivus J, et al. Mental anorexia - cold complications and nutritional support. Medical overview. 2024;73(6):218-25$20$YR$$F$Y$$$20240723$$HP$SK$SK
240496751$24049675$1$I$$20240619$20240704$20240704$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454309$RANBAXY$Bhatti A, Kalearasu A, Jayapalen V. TACHYPHYLAXIS-INDUCED MYOCARDIAL INFARCTION IN A PATIENT WITH VASOSPASTIC ANGINA. Heart. 2024;110 (Suppl.3):A80-A81 (75)$70$YR$$F$Y$$$20240704$$HP$GB$GB
240496761$24049676$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454381$RANBAXY$Barsoum A, Huang J, Kazemi M, Price J, Chakrabarty I. Hydroxychloroquine Induced Hypoglycemia. Am J Respir Crit Care Med. 2024;209(0):A1364$31$YR$$F$Y$$$20240704$$HP$US$US
240496771$24049677$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454430$RANBAXY$Xiong J, Prasad S, Embry E, Singh K, Singh M. Resistant Pneumocystis Jiroveci Pneumonia in Patients With ANCAAssociated Vasculitis. Am J Respir Crit Care Med. 2024;209 (0):A6323$68$YR$$M$Y$$$20240704$$HP$US$US
240496781$24049678$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454400$RANBAXY$Padte S, Sharma N, Plzak C, Kashyap R. Uncommon Breast Metastasis in PDL1 and EGFR-Positive Non-Small Cell Lung Cancer: A Case Report. Am J Respir Crit Care Med. 2024;209 (0):A6513/C78$$$$F$Y$$$20240704$$HP$US$US
240496791$24049679$1$I$$20240619$20240704$20240704$EXP$$US-SUNPHARMA-2024R1-454077AA$RANBAXY$Wong C, Malik M, Abu- Hashish H, Ang G, Galperin I. Hydralazine to Pulmonary Hemorrhage: A Case of Drug Induced Vasculitis. Am J Respir Crit Care Med. 2024;209:A2031 (A52)$85$YR$$M$Y$$$20240704$$HP$US$US
240496801$24049680$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454211$RANBAXY$Kaur L, Kaur R, Shakir M, Basit S, Ray B, Chaudhary T. Primary Pulmonary Carcinosarcoma with Metastasis Treated With Induction Chemotherapy. Am J Respir Crit Care Med. 2024;209 (0):A6526$56$YR$$M$Y$$$20240704$$HP$US$US
240496811$24049681$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454386$RANBAXY$Lam E, Santos C, Patrawalla AS. A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose. Am J Respir Crit Care Med. 2024;209(0):A5651$32$YR$$F$Y$$$20240704$$HP$US$US
240496821$24049682$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454214$RANBAXY$Saad E, Abdulrahman A, Faris M. Hemodialysis Reversed Bradyarrhythmia and Sinus Nodal Dysfunction From Acute Lithium Toxicity. Am J Respir Crit Care Med. 2024;209:A5666$50$YR$$M$Y$$$20240704$$HP$US$US
240496831$24049683$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454413$RANBAXY$De Allie G, Mehta A, Boucekkine H, Saggar R, Neville TH, Fishbein G. Clinically Significant Pulmonary Invasion in Multiple Myeloma - Associated Amyloid Light Chain Amyloidosis. Am J Respir Crit Care Med. 2024;209 (0):A6048$77$YR$$F$Y$$$20240704$$HP$US$US
240496841$24049684$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454482$RANBAXY$Schuster J, Georas SN. Dupilumab-Associated Sarcoidosis: Review of a Case and Consideration of Potential Mechanisms. Am J Respir Crit Care Med. 2024;209 (0):A5317$49$YR$$M$Y$$$20240704$$HP$US$US
240496851$24049685$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454624$RANBAXY$Peters AT, Case R, Kim SJ, McGregor M, Shifren A, Schroeder G, et al. Single-Agent Oral Therapy of Granulomatous- Lymphocytic Interstitial Lung Disease: A Case Series. Am J Respir Crit Care Med. 2024;209 (0):A3739$$$$$Y$$$20240704$$HP$US$US
240496861$24049686$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454660$RANBAXY$Nandavaram S. Immune Checkpoint Inhibitors in Lung Transplant World. Am J Respir Crit Care Med. 2024;209:A5697$69$YR$$M$Y$$$20240704$$HP$US$US
240496871$24049687$1$I$$20240619$20240704$20240704$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454383$RANBAXY$Marwaha AS, Cockcroft DW, Philipenko B. Psyllium Husk (Metamucil) Induced Non-atopic Perennial Asthma: A Case Report. Am J Respir Crit Care Med. 2024;209 (0):A5996$44$YR$$F$Y$$$20240704$$HP$CA$CA
240496881$24049688$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454679$RANBAXY$Phan AT, Robinson D, Nguyen S, Azhand H, Vo D. Mirtazapine-Induced Ventricular Arrhythmia. Am J Respir Crit Care Med. 2024;May;209 (0):A5701 (C44)$64$YR$$F$Y$$$20240704$$HP$US$US
240496891$24049689$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454051$RANBAXY$Devault KF, Mudrakola HV. Hydralazine Induced Pleuropericarditis With Bilateral Eosinophilic Pleural Effusions. Am J Respir Crit Care Med. 2024;209 (0):A2029/A52$81$YR$$M$Y$$$20240704$$HP$US$US
240496901$24049690$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454686$RANBAXY$Lodh A, Blankenship S, Minish-Pron J, Lalani I. Treatment of Acute Respiratory Failure Secondary to Chronic Graft Versus-Host Disease With Fluticasone, Azithromycin, Montelukast, and High-Dose Glucocorticoids. Am J Respir Crit Care Med. 2024;May;209 (0):A5898 (C52)$38$YR$$M$Y$$$20240704$$HP$US$US
240496911$24049691$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454371$RANBAXY$Cherabuddi MR, Srikanth A, Ouellette DR. Pan-positive PET-CT - Metastasis or Multisystem Sarcoidosis?. Am J Respir Crit Care Med. 2024;209 (0):A5899/C53$36$YR$$F$Y$$$20240704$$HP$US$US
240496921$24049692$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454208$RANBAXY$Alpizar-Rivas RM, Mo J, Georas SN. A Tale of Immunosuppression: Pneumocystis Jiroveci Pneumonia (PJP) in a Patient on Ruxolitinib for a Hematologic Disorder. Am J  Respir Crit Care Med. 2024;209 (0):A5675$55$YR$$F$Y$$$20240704$$HP$US$US
240496931$24049693$1$I$20230831$20240619$20240704$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454749$RANBAXY$$62$YR$$M$Y$88$KG$20240704$$HP$IT$IT
240496941$24049694$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454069$RANBAXY$Bugayong M, Singh M, Kwentoh I, Sammut A, Silverman E. A Fatal Mimic: A Case of Hemophagocytic Lymphohistiocytosis (HLH)/Macrophage Activation Syndrome (MAS). Am J Respir Crit Care Med. 2024;209 (0):A3534$25$YR$$F$Y$$$20240704$$HP$US$US
240496951$24049695$1$I$$20240619$20240704$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454437$RANBAXY$Sala A, Vitali A, Remelli F, Zurlo A, Volpato S. Delirium in hip fractured patients. J gerontol geriatr. 2023;71 (1):8-14$70$YR$$M$Y$$$20240704$$HP$IT$IT
240496961$24049696$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454466$RANBAXY$Kim J,Hanna M, Aviles D,Dietrich M, Swetland DV. A Pediatric Case of Histoplasmosis-Related Immune Reconstitution Inflammatory Syndrome. Am J Crit Care Med. 2024;209:A2256$10$YR$$M$Y$$$20240704$$HP$US$US
240496971$24049697$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454410$RANBAXY$Fomeche J, Nor M, Wang Y, Carro M, Homayounrooz F, Hastrup F. Ketamine Chronicles: A Breath of Fresh Air in Status Asthmaticus. Am J Respir Crit Care Med. 2024;209 (0):A5301$64$YR$$M$Y$$$20240704$$HP$US$US
240496981$24049698$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454454$RANBAXY$Choi J, Moizuddin M. An Unusual Case of Metabolic Acidosis - Mind the Gap!. Am J Respir Crit Care Med. 2024;209 (0):A3404$64$YR$$F$Y$$$20240704$$HP$US$US
240496991$24049699$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454335$RANBAXY$Huang J, Shehzad D, Ahmed I, Yu JC.. Recognizing Veno-occlusive Disease After Inotuzumab Treatment: An Urgent Call to Physicians in Non-Transplant Centers. Am J Respir Crit Care Med. May 21 209 (0):A5656$47$YR$$F$Y$$$20240704$$HP$US$US
240497001$24049700$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454354$RANBAXY$Almazan EP, Ellaicy O, Carter DJ, Kaleka K, Faruqi M. Another Case of the Blues, Methylene Blue as Adjunctive Therapy in Calcium-channel Blocker Induced Vasoplegia. Am J Respir Crit Care Med. 2024;209 (0):A5655/C44$65$YR$$F$Y$$$20240704$$HP$US$US
240497011$24049701$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454414$RANBAXY$Blough P, Morrison RJ, Taylor S. The Role of Plasmapheresis in Management of Thyroid Storm P. Am J Respir Crit Care Med. 2024;209 (0):A3397$53$YR$$M$Y$$$20240704$$HP$US$US
240497021$24049702$1$I$$20240619$20240704$20240704$EXP$$US-SUNPHARMA-2024R1-454417AA$RANBAXY$Hourigan EK, Rattan M, Olsen ML. The Right Side of Cardiogenic Shock: A Case of Beta-Blocker Induced Cardiogenic Shock in a Female With Suspected Pulmonary Hypertension. Am J Respir Crit Care Med. 2024;209:A1595$41$YR$$F$Y$$$20240704$$HP$US$US
240497031$24049703$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454458$RANBAXY$Pysick H, Bowmaster S, Gehlbach BK, Doerschug KC. Gasping, Bradypnea, and Obtundation: An Unusual Case of Respiratory Failure From Seizures. Am J Respir Crit Care Med. 2024;209 (0):A4580$21$YR$$M$Y$$$20240704$$HP$US$US
240497041$24049704$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454066$RANBAXY$Kiley KD, Melnychuk E. A Controversial Topic: PJP Prophylaxis in Patients With Long-Term Immunologic Agents +/- Steroids. Am J Respir Crit Care Med. 2024;209 (0):A3572$30$YR$$F$Y$42$KG$20240704$$HP$US$US
240497051$24049705$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454442$RANBAXY$Mansour C, Harris S, Kutsche WS, Lasevski N Wilson MA. An Unusual Mechanism for Cardiac Arrest Secondary to Thyroid Storm. Am J Respir Crit Care Med. 2024;209:A7331$53$YR$$F$Y$$$20240704$$HP$US$US
240497061$24049706$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454070$RANBAXY$Raymond-Forde S, Olexsey K. A Rare but Potentially Fatal Reaction in Plain Sight: Trimethoprim-Sulfamethoxazole Induced Acute Lung Injury. Am J Respir Crit Care Med. 2024;209 (0:A2027;A52$26$YR$$F$Y$$$20240704$$HP$US$US
240497071$24049707$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454445$RANBAXY$Aribindi K, Vaddadi SM, Miller J, Inaty H, Chau-Etchepare F. A Puzzling Pathology: A Rare Presentation of Lung Adenocarcinoma. Am J Respir Crit Care Med. 2024;209:A4647$44$YR$$F$Y$$$20240704$$HP$US$US
240497081$24049708$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454464$RANBAXY$Lakhani M, Azulay H. From Rashes to Ruin: The Methotrexate Misadventure. Am J Respir Crit Care Med. 2024;209 (0):A5682$43$YR$$M$Y$$$20240704$$HP$US$US
240497091$24049709$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454053$RANBAXY$Yeates AC, Monroe IA, Ahmad F. Fungal Duo: A Case of Disseminated Histoplasmosis and Pneumocystis Pneumonia Competing for the Spotlight. Am J Respir Crit Care Med. 2024;209(0):A3575$66$YR$$M$Y$$$20240704$$HP$US$US
240497101$24049710$1$I$$20240619$20240704$20240704$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454747$RANBAXY$Rubio I, de la Puente EM, Boveda O, Jimenez I, Pena I. Green neutrophilic inclusions in patient with drug intoxication: a case report. J Lab Precis Med. 2024;9:1-4$54$YR$$F$Y$$$20240704$$HP$ES$ES
240497111$24049711$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454416$RANBAXY$Ghantarchyan H, Wong W, Sond V, Phan A, Mehta A, Vo D. A Rare Case of COVID-19 Induced Immune Thrombocytopenic Purpura Resistant to Dexamethasone Therapy: A Case Report and Review of the Literature. Am J Respir Crit Care Med. 2024;209:A6757$$$$F$Y$$$20240704$$HP$US$US
240497121$24049712$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454090$RANBAXY$Ji SH, Imtiaz A, Sanekommu H, Clemetson E, Lipschutz J, Marlys M, et al. A Case Report of Fatal Skin Sparing Laryngeal Zoster in Post-acute COVID-19 Syndrome. Am J Respir Crit Care Med. 2024;209:A3565/B43$87$YR$$F$Y$$$20240704$$HP$US$US
240497133$24049713$3$F$20160801$20240712$20240704$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453862$RANBAXY$$33$YR$$M$Y$$$20240726$$CN$FR$FR
240497141$24049714$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454701$RANBAXY$Wang J, Adams C, Becker M. Post-operative Diffuse Alveolar Hemorrhage Associated With Vaping, Desflurane, and Negative Pressure Pulmonary Edema. Am J Respir Crit Care Med. 2024;209(0):A6062$30$YR$$M$Y$$$20240704$$HP$US$US
240497151$24049715$1$I$$20240619$20240704$20240704$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454788$RANBAXY$Plonski A, Plonski AF, Glowinski J. Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review. Int J Environ Res Public Health. 2023;20 (13):6256; 1-14$73$YR$$M$Y$$$20240704$$HP$PL$PL
240497161$24049716$1$I$20240331$20240619$20240704$20240704$EXP$$CA-SUNPHARMA-2022R1-368880AA$RANBAXY$$74$YR$E$M$Y$$$20240704$$CN$CA$CA
240497171$24049717$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454695$RANBAXY$Pham LL, Landeen C. New Onset Refractory Status Epilepticus in Prion Disease. Am J Respir Crit Care Med. 2024;209(0):A5614/C43$60$YR$$F$Y$$$20240704$$HP$US$US
240497191$24049719$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454716$RANBAXY$Vagedes R, Nurse D, Latifi M. ^Lazarus Response^ Upon Initiation of Targeted Oncogenic Therapy for Acute Respiratory Failure in Rapidly Progressive ALK-Positive Pulmonary Adenocarcinoma. Am J Respir Crit Care Med. 2024;209 (0):A6571$53$YR$$F$Y$$$20240704$$HP$US$US
240497201$24049720$1$I$20240222$20240619$20240704$20240704$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453647$RANBAXY$$67$YR$$M$Y$$$20240704$$PH$FR$FR
240497211$24049721$1$I$20230907$20240619$20240704$20240704$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454011$RANBAXY$$70$YR$$M$Y$$$20240704$$MD$SE$SE
240497221$24049722$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454715$RANBAXY$Yousaf Z, Jyothi Ramachandran Nair D, Kamel A. Nystatin Induced Laryngeal Edema - First Reported Case. Am J Respir Crit Care Med. 2024;209 (0):A1360$64$YR$$F$Y$$$20240704$$HP$US$US
240497231$24049723$1$I$$20240619$20240704$20240704$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454774$RANBAXY$Plonski A, Plonski AF, Glowinski J. Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review. Int J Environ Res Public Health. 2023;20 (13):6256; 1-14$45$YR$$M$Y$$$20240704$$HP$PL$PL
240497241$24049724$1$I$20240304$20240619$20240704$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453961$RANBAXY$$68$YR$$F$Y$$$20240704$$MD$IT$IT
240497251$24049725$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454702$RANBAXY$Oppegard LJ, Robinson JC, Devendra G. Case Series: Marked Attenuation of Methamphetamine-associated Pulmonary Arterial Hypertension With Methamphetamine Cessation and Pharmacologic Therapy. Am J Respir Crit Care Med. 2024;209(0):A6117$52$YR$$M$Y$$$20240704$$HP$US$US
240497261$24049726$1$I$$20240619$20240704$20240704$EXP$$PH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454833$RANBAXY$Batara JMF, Apor ADAO, Mojica CV, Mondia MWL. Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: A retrospective analysis. Neurooncol Adv. 2022;4(1):1-9$60$YR$$M$Y$$$20240704$$HP$PH$PH
240497271$24049727$1$I$$20240619$20240704$20240704$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454782$RANBAXY$Plonski A, Plonski AF, Glowinski J. Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review. Int J Environ Res Public Health. 2023;20 (13):6256; 1-14$38$YR$$M$Y$$$20240704$$HP$PL$PL
240497281$24049728$1$I$20240113$20240619$20240704$20240704$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453600$RANBAXY$$15$YR$$M$Y$55$KG$20240704$$MD$FR$FR
240497291$24049729$1$I$20220501$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454712$RANBAXY$Adams SL, Hartz W, Hutchinson CT, Gandler A. A Missed Diagnosis of Chronic Dyspnea Due to Subglottic Stenosis. Am J Respir Crit Care Med. 2024;209(0):A6387$49$YR$$F$Y$$$20240704$$HP$US$US
240497301$24049730$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454714$RANBAXY$Yosry N, Chajkowski A,Rodriguez C, Medik Y, Lali M Qaiser S, et al. A Rare Cause of Rhabdomyolysis and Acute Renal Failure: Legionnaires Disease. Am J Respir Crit Care Med. 2024;209 (0):A6011$55$YR$$M$Y$$$20240704$$HP$US$US
240497311$24049731$1$I$$20240619$20240704$20240704$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454786$RANBAXY$Plonski A, Plonski AF, Glowinski J. Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review. Int J Environ Res Public Health. 2023;20 (13):6256; 1-14$79$YR$$M$Y$$$20240704$$HP$PL$PL
240497321$24049732$1$I$$20240619$20240704$20240704$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454763$RANBAXY$Jenny K, Kaiser P, Diebold J, Baur M, Ansorge A, Berger CT et al. Malakoplakia mimicking bone invasive malignancy in an immunocompetent patient. Swiss Med Wkly. 2024;May29-31;154(S):115S/P147$65$YR$$F$Y$$$20240704$$HP$CH$CH
240497331$24049733$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454713$RANBAXY$Perez Gonzalez D, Gonzalez Marrero G, Aleman-Ortiz JR. Beware of This Cause of Post-covid Dyspnea. Am J Respir Crit Care Med. 2024;209(0):A6388$81$YR$$M$Y$$$20240704$$HP$US$US
240497342$24049734$2$F$20240114$20240729$20240704$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453981$RANBAXY$$70$YR$$M$Y$64$KG$20240813$$MD$IT$IT
240497351$24049735$1$I$20240403$20240619$20240704$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453595$RANBAXY$$51$YR$$F$Y$$$20240704$$MD$IT$IT
240497361$24049736$1$I$$20240620$20240704$20240704$EXP$$CA-UCBSA-2024033350$UCB$$$$$F$Y$$$20240704$$HP$CA$CA
240497371$24049737$1$I$20210301$20240619$20240704$20240704$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454001$RANBAXY$$79$YR$$F$Y$103$KG$20240704$$HP$DE$DE
240497381$24049738$1$I$20240219$20240619$20240704$20240704$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453946$RANBAXY$$65$YR$$M$Y$$$20240704$$MD$IT$IT
240497391$24049739$1$I$20240702$20240703$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106523$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240704$$CN$US$US
240497402$24049740$2$F$20190701$20240701$20240704$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454718$RANBAXY$Razia D, Moin A, Walia T, Arjuna A. Metastatic Large Cell Neuroendocrine Carcinoma of Unknown Primary in a Lung Transplant Recipient. Am J Respir Crit Care Med. 2024;May 21;209 (0):A5947;C54$73$YR$$M$Y$$$20240716$$HP$US$US
240497421$24049742$1$I$$20240627$20240704$20240704$PER$$US-ROCHE-10000014879$ROCHE$$$$A$F$Y$$$20240704$$CN$US$US
240497431$24049743$1$I$$20230808$20240704$20240704$PER$$US-AMGEN-USASP2023235443$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240497441$24049744$1$I$$20240628$20240704$20240704$EXP$$RU-ROCHE-10000014456$ROCHE$$$$$M$Y$$$20240704$$MD$RU$RU
240497451$24049745$1$I$$20240627$20240704$20240704$EXP$DE-EMBRYOTOX-202301664-B$DE-RDY-SPO/DEU/24/0009400$DR REDDYS$$$$$F$Y$3.41$KG$20240704$$MD$DE$DE
240497461$24049746$1$I$$20240625$20240704$20240704$PER$$US-ABBVIE-5816763$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240497472$24049747$2$F$$20240724$20240704$20240816$30DAY$$US-JNJFOC-20240708158$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$US$US
240497481$24049748$1$I$20240628$20240629$20240704$20240704$PER$$US-JNJFOC-20240700817$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240497491$24049749$1$I$20240101$20240625$20240704$20240704$EXP$$JP-ROCHE-10000011945$ROCHE$$43$YR$A$F$Y$$$20240704$$MD$JP$JP
240497503$24049750$3$F$20240418$20240722$20240704$20240723$EXP$$JP-JNJFOC-20240710475$JOHNSON AND JOHNSON$$78$YR$E$F$Y$47.5$KG$20240723$$MD$JP$JP
240497511$24049751$1$I$$20240627$20240704$20240704$PER$$US-BIOGEN-2024BI01271525$BIOGEN$$$$$F$Y$$$20240704$$CN$US$US
240497521$24049752$1$I$20240409$20240701$20240704$20240704$EXP$$DE-BIOGEN-2024BI01271999$BIOGEN$$26$YR$$F$Y$113$KG$20240704$$MD$DE$DE
240497531$24049753$1$I$$20240625$20240704$20240704$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004751$BIOCON$$$$$$Y$$$20240704$$HP$CA$CA
240497551$24049755$1$I$20240614$20240625$20240704$20240704$EXP$$IN-ROCHE-3576964$ROCHE$$47$YR$A$M$Y$63.38$KG$20240704$$CN$IN$IN
240497561$24049756$1$I$$20240627$20240704$20240704$EXP$$JP-GSK-JP2024080156$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$JP$JP
240497571$24049757$1$I$20240101$20240701$20240704$20240704$EXP$$US-ABBVIE-5825471$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240497581$24049758$1$I$20240119$20240619$20240704$20240704$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454735$RANBAXY$$66$YR$$M$Y$61$KG$20240704$$MD$FR$FR
240497591$24049759$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454085$RANBAXY$Hawco C, Nguyen A, Hernandez L, Pendlebury D, Sakr L. Delayed Diagnosis of Hemophagocytic Lymphohistiocytosis Leading to Multiorgan System Failure. Am J Respir Crit Care Med. 2024;209(0):A3536$$$A$M$Y$$$20240704$$HP$US$US
240497601$24049760$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454486$RANBAXY$Seibert KE, Bailey MJ, Pruitt DL, Dejesus MS, Toste PA, Hammond TC. Spontaneous Tension Hemopneumothorax After Weight Training. Am J Respir Crit Care Med. 2024;209 (0):A4825$33$YR$$M$Y$$$20240704$$HP$US$US
240497611$24049761$1$I$$20240619$20240704$20240704$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454221$RANBAXY$Wiseman J, Oprysko C, Shah T. A Broken Brain. Am J Respir Crit Care Med. 2024;209 (0):A5598$23$YR$$F$Y$$$20240704$$HP$CA$CA
240497622$24049762$2$F$$20240624$20240704$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454428$RANBAXY$Gunasekaran T, Gorla K, Berman J, Bhardwaj V. INHALED-SWALLOWED ALBUTEROL AS NON-ENDOSCOPIC TREATMENT FOR FOOD IMPACTION (FI) IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE). Gastrointest Endosc. 2024;99 (Suppl.) (6):AB1085(Mo2058)$$$T$$Y$$$20240709$$HP$US$US
240497631$24049763$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454450$RANBAXY$Levan SR, Perez A, Kleinhenz M. Burkholderia Cepacia Mediastinitis in a Patient With Cystic Fibrosis. Am J Respir Crit Care Med. 2024;209 (0):A5854$31$YR$$F$Y$$$20240704$$HP$US$US
240497651$24049765$1$I$20240619$20240619$20240704$20240704$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454273$RANBAXY$$$$$M$Y$$$20240704$$PH$FR$FR
240497661$24049766$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454088$RANBAXY$Qazi ZA, Ward M, Sithamraju A, Demars B, Bates T, Calick D, et al. A Rare Cause of Acute Hypoxic Respiratory Failure After ST-Elevation Myocardial Infarction. Am J Respir Crit Care Med. 2024;209 (0):A3650$77$YR$$F$Y$$$20240704$$HP$US$US
240497671$24049767$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454270$RANBAXY$Bashir Z, Marathe A, Geigel EJ. A Case of Capnothorax Following Robotic Assisted Laparoscopic Nissen Fundoplication. Am J Respir Crit Care Med. 2024;209:A5809$40$YR$$F$Y$$$20240704$$HP$US$US
240497681$24049768$1$I$20200101$20240619$20240704$20240704$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454579$RANBAXY$$$$$F$Y$$$20240704$$MD$GB$GB
240497692$24049769$2$F$$20240705$20240704$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454424$RANBAXY$Marrium A, Viswanathan S, Soundarajan R. Resistant Hypertension In Young Patient- A Case Of Conn^S Syndrome. Hypertension. 2023;80sup1:Abs P227$47$YR$$M$Y$$$20240719$$HP$US$US
240497701$24049770$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454499$RANBAXY$Razi S, Mcguire RJ, Krings JG. Use of the Anti-interleukin-5- Receptor Monoclonal Antibody, Benralizumab, for the Treatment of Allergic Bronchopulmonary Aspergillosis. Am J Respir Crit Care Med. 2024;209 (0):A5287$64$YR$$M$Y$$$20240704$$HP$US$US
240497711$24049771$1$I$$20240619$20240704$20240704$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454456$RANBAXY$Jeltsch S, Van Der Wegen M, Gerrits E. How to differentiate erythema multiforme major from Steven Jhonsons syndrome. Swiss Med Wkly. 2024;May29-31;154(S):112S-113S/P143$41$YR$$M$Y$$$20240704$$HP$CH$CH
240497721$24049772$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454503$RANBAXY$Crawford M, Trinh JM, Chaudhary S. A Case Report of Statin induced Necrotizing Autoimmune Myopathy With Extramuscular Involvement. Am J Respir Crit Care Med. 2024;May;209 (0):A1363 (A33)$75$YR$$F$Y$$$20240704$$HP$US$US
240497731$24049773$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454465$RANBAXY$Feghali E, Beavers C, Harb A, Hassan Z. When Cement Meets Asbestos: A Multifaceted Approach to Dyspnea and Chest Pain in an 81-year-old. Am J Respir Crit Care Med. 2024;209:A5979$81$YR$$M$Y$$$20240704$$HP$US$US
240497741$24049774$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454071$RANBAXY$Hill M, Warrior K. Sirolimus-Induced Thrombotic Microangiopathy in a Lung Transplant Recipient. Am J Respir Crit Care Med. 2024;209:A5937$61$YR$$F$Y$$$20240704$$HP$US$US
240497751$24049775$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454409$RANBAXY$Barrows C, Horton M, Allaham A, Israel HP. A Case of Acute Hypoxic Respiratory Failure After Administration of Rituximab. Am J Respir Crit Care Med. 2024;209 (0):A6326/C69$61$YR$$M$Y$$$20240704$$HP$US$US
240497761$24049776$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454433$RANBAXY$Sivaji S, Subramanian R, Wan X, Joshi HI. A Fatal Encounter With Blastomycosis-induced Acute Respiratory Distress Syndrome in an Immunocompetent Host. Am J Respir Crit Care Med. 2024;209:A1145$66$YR$$F$Y$$$20240704$$HP$US$US
240497772$24049777$2$F$$20240624$20240704$20240705$EXP$$BE-ROCHE-10000015449$ROCHE$$58$YR$A$$Y$$$20240705$$MD$BE$BE
240497781$24049778$1$I$$20240619$20240704$20240704$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454517$RANBAXY$Waheed H, Kable S, Butt MY, Ali SH. Mycobacterium Abscessus and Klebsiella Oxytoca Co-Infection. Am J Respir Crit Care Med. 2024;May;209 (0):A6292 (C68)$87$YR$$F$Y$$$20240704$$HP$US$US
240497791$24049779$1$I$$20240627$20240704$20240704$PER$$US-ROCHE-10000010971$ROCHE$Kroll C, Non L, Ince D, Et al.. Maribavir failure in refractory cytomegalovirus infection in a lung transplant patient on extracorporealmembrane oxygenation. Transplant Infectious Disease. 2024;26 (3):1-3. doi:10.1111/tid.14275.$59$YR$A$M$Y$$$20240704$$HP$US$US
240497801$24049780$1$I$$20240617$20240704$20240704$EXP$$US-GSK-US2024AMR076379$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
240497811$24049781$1$I$20220701$20240627$20240704$20240704$EXP$$FR-CELLTRION INC.-2024FR015944$CELLTRION$$$$$$Y$$$20240704$$MD$FR$FR
240497821$24049782$1$I$20240601$20240628$20240704$20240704$EXP$$US-ABBVIE-5824965$ABBVIE$$54$YR$$F$Y$$$20240704$$CN$US$US
240497832$24049783$2$F$$20240827$20240704$20240906$30DAY$$US-GSK-US2024075858$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
240497842$24049784$2$F$20130523$20240829$20240704$20240902$PER$$US-GILEAD-2024-0679545$GILEAD$$47$YR$A$M$Y$$$20240902$$LW$US$US
240497852$24049785$2$F$20240523$20240709$20240704$20240711$EXP$$US-BIOGEN-2024BI01271747$BIOGEN$$54$YR$$F$Y$$$20240711$$CN$US$US
240497861$24049786$1$I$20240531$20240624$20240704$20240704$EXP$HR-HALMED-300085556$HR-TEVA-VS-3213859$TEVA$$61$YR$$M$Y$110$KG$20240704$$CN$HR$HR
240497871$24049787$1$I$$20240625$20240704$20240704$EXP$$US-VIIV HEALTHCARE LIMITED-US2024079144$VIIV$$$$$M$Y$$$20240704$$CN$US$US
240497881$24049788$1$I$$20240625$20240704$20240704$EXP$$AU-ROCHE-10000008610$ROCHE$$$$$M$Y$$$20240704$$CN$AU$AU
240497892$24049789$2$F$$20240715$20240704$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106115$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240717$$MD$US$US
240497912$24049791$2$F$$20240703$20240704$20240705$PER$$US-AMGEN-USASP2024131953$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240497921$24049792$1$I$$20230126$20240704$20240704$PER$$US-AMGEN-USASP2023235478$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240497931$24049793$1$I$$20221220$20240704$20240704$PER$$US-AMGEN-USASP2022230361$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240497941$24049794$1$I$$20240416$20240704$20240704$PER$$US-AMGEN-USASP2024130171$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240497951$24049795$1$I$$20231109$20240704$20240704$PER$$US-AMGEN-USASP2023235301$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240497961$24049796$1$I$20240629$20240702$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106355$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240704$$CN$US$US
240497974$24049797$4$F$20240626$20240709$20240704$20240716$30DAY$$US-AMGEN-USASP2024128535$AMGEN$$44$YR$A$M$Y$124.7$KG$20240716$$PH$US$US
240497981$24049798$1$I$20240627$20240628$20240704$20240704$EXP$$US-AMGEN-USASP2024129399$AMGEN$$72$YR$E$F$Y$$$20240704$$CN$US$US
240497991$24049799$1$I$20240419$20240624$20240704$20240704$EXP$$US-AMGEN-USASP2024126323$AMGEN$$73$YR$E$F$Y$$$20240704$$CN$US$US
240498001$24049800$1$I$$20240624$20240704$20240704$PER$$US-TEVA-VS-3213522$TEVA$$$$$$Y$$$20240704$$HP$US$US
240498011$24049801$1$I$$20240702$20240704$20240704$EXP$$US-SANDOZ INC.-SDZ2024US062479$SANDOZ$$$$$$Y$$$20240704$$LW$US$US
240498021$24049802$1$I$$20240703$20240704$20240704$30DAY$$US-SANDOZ INC.-SDZ2024US062709$SANDOZ$$$$$M$Y$$$20240704$$HP$US$US
240498031$24049803$1$I$$20240702$20240704$20240704$EXP$GB-MHRA-MED-202407021657439190-VBJZM$GB-SANDOZ INC.-SDZ2024GB062546$SANDOZ$$$$$M$Y$$$20240704$$HP$GB$GB
240498041$24049804$1$I$$20240702$20240704$20240704$EXP$GB-MHRA-MED-202407021645515840-LWBGM$GB-SANDOZ INC.-SDZ2024GB062595$SANDOZ$$$$$F$Y$$$20240704$$HP$GB$GB
240498051$24049805$1$I$20220301$20240701$20240704$20240704$EXP$$DE-SANDOZ INC.-NVSC2022DE286118$SANDOZ$$14$YR$$M$Y$66$KG$20240704$$MD$DE$DE
240498071$24049807$1$I$20240319$20240626$20240704$20240704$EXP$$ES-AstraZeneca-2024A147439$ASTRAZENECA$$57$YR$$M$Y$$$20240704$$MD$ES$
240498082$24049808$2$F$$20240726$20240704$20240807$PER$$US-AstraZeneca-2024A144448$ASTRAZENECA$$$$$F$Y$$$20240807$$HP$US$
240498092$24049809$2$F$$20240708$20240704$20240715$EXP$GB-MHRA-MED-202406281441057610-CBYGW$GB-RDY-SPO/GBR/24/0009631$DR REDDYS$$$$$$Y$$$20240715$$CN$GB$GB
240498103$24049810$3$F$20240506$20240716$20240704$20240722$EXP$$ES-SANDOZ INC.-SDZ2024ES050704$SANDOZ$$67$YR$$F$Y$69.1$KG$20240722$$MD$ES$ES
240498111$24049811$1$I$$20240624$20240704$20240704$EXP$$US-SANDOZ INC.-NVSC2023US116532$SANDOZ$Pimentel MA, Kim DH, Walker LW, Noelck MB, Perelygina L, Kripps KA et al. . Rubella virus-associated necrotizing granulomatous inflammation with extensive eyelid, ocular, and orbital involvement. PEDIATRIC DERMATOLOGY. 2023;1-5. doi:10.1111/pde.15337$4$YR$$F$Y$$$20240704$$MD$US$US
240498121$24049812$1$I$20240621$20240629$20240704$20240704$EXP$$IN-AstraZeneca-2024A151123$ASTRAZENECA$$68$YR$$M$Y$$$20240704$$CN$IN$
240498131$24049813$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281414140760-PYGTQ$GB-RDY-SPO/GBR/24/0009653$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240498141$24049814$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281418165880-YWTHP$GB-RDY-SPO/GBR/24/0009635$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240498151$24049815$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281423022780-LSYQG$GB-RDY-SPO/GBR/24/0009548$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240498161$24049816$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281421048380-HJCMP$GB-RDY-SPO/GBR/24/0009601$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240498172$24049817$2$F$$20240906$20240704$20240909$EXP$$HR-SANDOZ INC.-SDZ2024HR061968$SANDOZ$$56$YR$$F$Y$$$20240909$$HP$HR$HR
240498181$24049818$1$I$$20240516$20240704$20240704$PER$$US-AMGEN-USASP2024129903$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240498191$24049819$1$I$$20231228$20240704$20240704$PER$$US-AMGEN-USASP2023235181$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240498201$24049820$1$I$$20230414$20240704$20240704$PER$$US-AMGEN-USASP2023235476$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240498211$24049821$1$I$20230708$20240625$20240704$20240704$EXP$$CN-AMGEN-CHNSP2024126925$AMGEN$$71$YR$E$M$Y$$$20240704$$HP$CN$CN
240498221$24049822$1$I$20160201$20240619$20240704$20240704$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-452782$RANBAXY$$17$YR$$M$Y$$$20240704$$CN$GB$GB
240498232$24049823$2$F$20240626$20240703$20240704$20240709$30DAY$$US-GSK-US2024079867$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240709$$CN$US$US
240498242$24049824$2$F$$20240719$20240704$20240729$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR080308$VIIV$$$$$$Y$$$20240729$$MD$US$US
240498252$24049825$2$F$$20240806$20240704$20240807$PER$$US-ALXN-202406USA001717US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240498262$24049826$2$F$20240604$20240628$20240704$20240704$PER$$US-ABBVIE-5822833$ABBVIE$$80$YR$$M$Y$$$20240704$$CN$US$US
240498271$24049827$1$I$20171205$20240626$20240704$20240704$EXP$$NL-AUROBINDO-AUR-APL-2018-002862$AUROBINDO$$54$YR$$M$Y$87$KG$20240704$$CN$NL$NL
240498281$24049828$1$I$$20240625$20240704$20240704$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004779$BIOCON$$$$$$Y$$$20240704$$HP$CA$CA
240498291$24049829$1$I$$20240625$20240704$20240704$EXP$$CA-APOTEX-2024AP007773$APOTEX$$70$YR$$F$Y$$$20240704$$MD$CA$CA
240498301$24049830$1$I$$20240129$20240704$20240704$PER$$US-AMGEN-USASP2024132538$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240498311$24049831$1$I$20240612$20240627$20240704$20240704$EXP$$US-AMGEN-USASL2024128066$AMGEN$$53$YR$A$M$Y$$$20240704$$CN$US$US
240498322$24049832$2$F$$20240708$20240704$20240712$PER$$US-ABBVIE-5825292$ABBVIE$$$$$M$Y$$$20240712$$HP$US$US
240498331$24049833$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002671$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240704$$CN$US$US
240498341$24049834$1$I$20240701$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002117$ELI LILLY AND CO$$$$$F$Y$$$20240704$$CN$US$US
240498351$24049835$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002109$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240704$$CN$US$US
240498361$24049836$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002182$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240704$$CN$US$US
240498371$24049837$1$I$20220101$20240626$20240704$20240704$EXP$$CA-BEH-2024174833$CSL BEHRING$$$$E$M$Y$$$20240704$$MD$CA$CA
240498382$24049838$2$F$$20240923$20240704$20240928$EXP$$DE-ROCHE-10000012541$ROCHE$$$$A$M$Y$$$20240928$$PH$DE$DE
240498391$24049839$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138191$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240498401$24049840$1$I$20240401$20240626$20240704$20240704$EXP$$DE-AUROBINDO-AUR-APL-2024-031962$AUROBINDO$$1$DY$$F$Y$3.18$KG$20240704$$MD$DE$DE
240498411$24049841$1$I$$20240625$20240704$20240704$EXP$$US-JNJFOC-20240671946$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240704$$MD$US$US
240498421$24049842$1$I$20240619$20240628$20240704$20240704$PER$$US-JNJFOC-20240677098$JOHNSON AND JOHNSON$$50$YR$A$$Y$$$20240704$$CN$US$US
240498431$24049843$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281435349850-RDTKB$GB-TEVA-VS-3216091$TEVA$$$$$$Y$$$20240704$$CN$GB$GB
240498441$24049844$1$I$$20240626$20240704$20240704$EXP$$US-ROCHE-10000011468$ROCHE$$79$YR$E$M$Y$$$20240704$$MD$US$US
240498451$24049845$1$I$20240620$20240628$20240704$20240704$EXP$$US-BIOGEN-2024BI01270821$BIOGEN$$45$YR$$M$Y$$$20240704$$CN$US$US
240498461$24049846$1$I$$20240627$20240704$20240704$EXP$$US-GSK-US2024080271$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$MD$US$US
240498481$24049848$1$I$20240530$20240627$20240704$20240704$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-12350$IPSEN$$44$YR$A$F$Y$$$20240704$$HP$US$US
240498491$24049849$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050539$TOLMAR$$$$A$M$Y$$$20240704$$HP$CA$CA
240498501$24049850$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050503$TOLMAR$$$$$M$Y$$$20240704$$CN$CA$CA
240498511$24049851$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050540$TOLMAR$$$$$M$Y$$$20240704$$CN$CA$CA
240498521$24049852$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050541$TOLMAR$$$$$M$Y$$$20240704$$CN$CA$CA
240498531$24049853$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050542$TOLMAR$$76$YR$$M$Y$$$20240704$$CN$CA$CA
240498541$24049854$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050544$TOLMAR$$$$$M$Y$$$20240704$$CN$CA$CA
240498551$24049855$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050543$TOLMAR$$96$YR$$M$Y$$$20240704$$HP$CA$CA
240498561$24049856$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050545$TOLMAR$$84$YR$$M$Y$$$20240704$$HP$CA$CA
240498571$24049857$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050548$TOLMAR$$$$$M$Y$$$20240704$$CN$CA$CA
240498581$24049858$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050549$TOLMAR$$$$E$M$Y$$$20240704$$HP$CA$CA
240498591$24049859$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050550$TOLMAR$$$$$M$Y$$$20240704$$CN$CA$CA
240498602$24049860$2$F$$20230807$20240704$20240913$PER$$US-HALEON-2185224$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
240498611$24049861$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050551$TOLMAR$$77$YR$$M$Y$$$20240704$$CN$CA$CA
240498621$24049862$1$I$$20240626$20240704$20240704$EXP$$CA-TOLMAR, INC.-24CA050554$TOLMAR$$$$$M$Y$$$20240704$$CN$CA$CA
240498632$24049863$2$F$$20240715$20240704$20240723$EXP$$CA-TOLMAR, INC.-24CA050564$TOLMAR$$$$$M$Y$$$20240723$$MD$CA$CA
240498642$24049864$2$F$20240513$20240715$20240704$20240723$PER$$CA-TOLMAR, INC.-24CA050570$TOLMAR$$79$YR$$M$Y$$$20240723$$CN$CA$CA
240498653$24049865$3$F$20240101$20240711$20240704$20240722$EXP$$US-TOLMAR, INC.-24US050502$TOLMAR$$$$$M$Y$$$20240719$$HP$US$US
240498661$24049866$1$I$20231208$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031889$AUROBINDO$$61$YR$$M$Y$86.9$KG$20240704$$MD$FR$FR
240498671$24049867$1$I$$20240620$20240704$20240704$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024078066$VIIV$$42$YR$$F$Y$$$20240704$$PH$US$US
240498681$24049868$1$I$$20240624$20240704$20240704$EXP$$JP-ROCHE-10000013604$ROCHE$Minora K, Kataoka K, Hafimoto S, Takei R, Fukihara J, Sasano H et al.. B-20 A case of phrenic nerve paralysis due to neuralgic amyotrophy that developed during treatment of interstitial pneumonia. The 143rd Tokai Branch Meeting of the Japanese Society for Tuberculosis and Nont. 2024;37$76$YR$E$M$Y$$$20240704$$MD$JP$JP
240498691$24049869$1$I$$20240203$20240704$20240704$PER$$US-AMGEN-USASP2024132527$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240498701$24049870$1$I$$20240624$20240704$20240704$PER$$US-AMGEN-USASP2024130184$AMGEN$Lowell J.A.; Sharma G.; Chua V. et al.. Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis. Digestive Diseases and Sciences. 2024;1-12$88$YR$E$F$Y$$$20240704$$HP$US$US
240498711$24049871$1$I$$20240626$20240704$20240704$EXP$$MY-AMAROX PHARMA-HET2024MY02080$HETERO$$29$YR$$M$Y$$$20240704$$PH$MY$MY
240498721$24049872$1$I$$20240701$20240704$20240704$PER$$US-ROCHE-10000016420$ROCHE$Gupta A, Furcich J, Nascene D, Kemp S, King C, Nolan E, et al. Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy. Journal of Neuroimmunology. 2024;393:1-12. doi:10.1016/j.jneuroim.2024.578395.$10$YR$C$M$Y$$$20240704$$HP$US$US
240498731$24049873$1$I$$20240701$20240704$20240704$EXP$$AU-Orion Corporation ORION PHARMA-24_00030636$ORION$$39$YR$A$M$Y$79$KG$20240704$$MD$AU$
240498741$24049874$1$I$$20240627$20240704$20240704$EXP$$US-GILEAD-2024-0678954$GILEAD$$$$A$F$Y$102.3$KG$20240704$$HP$US$US
240498754$24049875$4$F$$20240812$20240704$20240812$PER$$US-ALXN-202406USA001685US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
240498761$24049876$1$I$$20240625$20240704$20240704$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004784$BIOCON$$$$$$Y$$$20240704$$HP$CA$CA
240498781$24049878$1$I$$20240628$20240704$20240704$EXP$$ES-AMGEN-ESPSP2024129141$AMGEN$Gonzalez-lopez T.; Bermejo-vega N.; Cardesa-cabrera R. et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Blood. 2024;1-29$65$YR$E$F$Y$$$20240704$$HP$ES$ES
240498791$24049879$1$I$20230101$20240628$20240704$20240704$EXP$$DE-AMGEN-DEUSL2024129064$AMGEN$$14$YR$T$F$Y$$$20240704$$CN$DE$DE
240498801$24049880$1$I$$20230118$20240704$20240704$PER$$US-AMGEN-USASP2023235577$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240498811$24049881$1$I$$20240627$20240704$20240704$30DAY$$US-GSK-US2024080414$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$CN$US$US
240498821$24049882$1$I$$20240626$20240704$20240704$EXP$$CA-AstraZeneca-2024A148915$ASTRAZENECA$$$$$$Y$$$20240704$$CN$CA$
240498831$24049883$1$I$$20240626$20240704$20240704$EXP$$CA-AstraZeneca-2024A148614$ASTRAZENECA$$$$$F$Y$$$20240704$$CN$CA$
240498841$24049884$1$I$20240605$20240702$20240704$20240704$EXP$$US-AstraZeneca-2024A152297$ASTRAZENECA$$$$$F$Y$$$20240704$$CN$US$
240498852$24049885$2$F$20240601$20240702$20240704$20240710$PER$$US-AstraZeneca-2024A150024$ASTRAZENECA$$1040$MON$$F$Y$$$20240710$$CN$US$
240498862$24049886$2$F$20141111$20240909$20240704$20240912$PER$$US-GILEAD-2024-0679546$GILEAD$$48$YR$A$M$Y$$$20240912$$LW$US$US
240498871$24049887$1$I$$20240624$20240704$20240704$PER$$US-AMGEN-USASP2024130122$AMGEN$Lowell J.A.; Sharma G.; Chua V. et al.. Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis. Digestive Diseases and Sciences. 2024;1-12$52$YR$A$M$Y$$$20240704$$HP$US$US
240498882$24049888$2$F$$20240725$20240704$20240801$EXP$$TR-AMGEN-TURSP2024126412$AMGEN$$$$A$F$Y$$$20240801$$MD$TR$TR
240498892$24049889$2$F$20240601$20240905$20240704$20240910$PER$$US-AMGEN-USASP2024130623$AMGEN$$$$$F$Y$$$20240909$$MD$US$US
240498901$24049890$1$I$20210906$20240624$20240704$20240704$EXP$FR-AFSSAPS-PV2024000526$FR-TEVA-VS-3213854$TEVA$$52$YR$$F$Y$80$KG$20240704$$MD$FR$FR
240498911$24049891$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131860$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240498921$24049892$1$I$20240628$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130655$AMGEN$$71$YR$E$F$Y$$$20240704$$PH$US$US
240498931$24049893$1$I$20240101$20240703$20240704$20240704$EXP$$AU-UCBSA-2024033757$UCB$$$$$F$Y$$$20240704$$CN$AU$AU
240498941$24049894$1$I$$20240701$20240704$20240704$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-105770$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240704$$MD$FR$FR
240498951$24049895$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106616$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$80.29$KG$20240704$$CN$US$US
240498961$24049896$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106587$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$44.91$KG$20240704$$CN$US$US
240498971$24049897$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106661$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240704$$CN$US$US
240498981$24049898$1$I$$20240621$20240704$20240704$PER$$US-ROCHE-10000011694$ROCHE$$$$$$Y$$$20240704$$CN$US$US
240498991$24049899$1$I$$20231030$20240704$20240704$PER$$US-AMGEN-USASP2023235270$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240499002$24049900$2$F$$20240718$20240704$20240727$EXP$GB-MHRA-MED-202406271102593100-MTLRW$GB-TEVA-VS-3215009$TEVA$$37$YR$$$Y$$$20240727$$CN$GB$GB
240499011$24049901$1$I$$20240701$20240704$20240704$PER$$US-ROCHE-10000016421$ROCHE$Gupta A, Furcich J, Nascene D, Kemp S, King C, Nolan E, et al. Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy. Journal of Neuroimmunology. 2024;393:1-12. doi:10.1016/j.jneuroim.2024.578395.$6$YR$C$M$Y$$$20240704$$HP$US$US
240499022$24049902$2$F$$20240705$20240704$20240709$EXP$$TW-ASTELLAS-2024US018506$ASTELLAS$$32$YR$$F$Y$$$20240709$$CN$TW$TW
240499032$24049903$2$F$$20240627$20240704$20240718$EXP$$TR-ASTELLAS-2024US018513$ASTELLAS$$$$E$$Y$$$20240718$$CN$TR$TR
240499041$24049904$1$I$$20240702$20240704$20240704$PER$$US-HALEON-2185270$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240499051$24049905$1$I$$20240701$20240704$20240704$PER$$US-ROCHE-10000016422$ROCHE$Gupta A, Furcich J, Nascene D, Kemp S, King C, Nolan E, et al. Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy. Journal of Neuroimmunology. 2024;393:1-12. doi:10.1016/j.jneuroim.2024.578395.$9$YR$C$M$Y$$$20240704$$HP$US$US
240499061$24049906$1$I$20240630$20240701$20240704$20240704$EXP$$US-ASTELLAS-2024US018836$ASTELLAS$$79$YR$$M$Y$$$20240704$$CN$US$US
240499071$24049907$1$I$$20240626$20240704$20240704$EXP$$JP-CHEPLA-2024008270$CHEPLAPHARM$$73$YR$$M$Y$$$20240704$$PH$COUNTRY NOT SPECIFIED$JP
240499081$24049908$1$I$$20240628$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104706$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$MD$US$US
240499091$24049909$1$I$$20240121$20240704$20240704$PER$$US-AMGEN-USASP2024132245$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240499102$24049910$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214637$TEVA$Venkat Ramanan S, Ghazal F, Addanki PR, Perez MF. Thyroid Tempest: Unravelling a Rare Case of Amiodarone-Induced Thyroid Storm. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A3400 (plus Poster).; Venkat Ramanan S, Ghazal F, Addanki PR, Perez MF. Thyroid Tempest: Unravelling a Rare Case of Amiodarone-Induced Thyroid Storm. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A3400 (plus Poster).$74$YR$$F$Y$$$20240720$$HP$US$US
240499113$24049911$3$F$19990316$20240703$20240704$20240716$EXP$$SE-HALEON-2183629$Haleon PLC$$32$YR$$F$Y$75$KG$20240716$$MD$SE$SE
240499121$24049912$1$I$$20240627$20240704$20240704$PER$$US-HETERO-HET2024US01778$HETERO$$$$$F$Y$$$20240704$$CN$US$US
240499131$24049913$1$I$20220101$20240627$20240704$20240704$EXP$$CN-ASTELLAS-2024US018610$ASTELLAS$$68$YR$$M$Y$$$20240704$$HP$CN$CN
240499162$24049916$2$F$20240501$20240626$20240704$20240705$EXP$$DE-ASTELLAS-2024US018528$ASTELLAS$$8$DEC$$M$Y$$$20240705$$CN$US$DE
240499173$24049917$3$F$$20240719$20240704$20240725$EXP$$CA-TAKEDA-2024TUS067431$TAKEDA$$$$$M$Y$$$20240725$$CN$CA$CA
240499182$24049918$2$F$$20240724$20240704$20240806$30DAY$$US-JNJFOC-20240707997$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$US$US
240499191$24049919$1$I$$20240626$20240704$20240704$EXP$$PL-ASTELLAS-2024EU006416$ASTELLAS$$33$YR$$F$Y$$$20240704$$MD$PL$PL
240499211$24049921$1$I$$20240625$20240704$20240704$EXP$$US-HBP-2023US029643$HELSINN HEALTHCARE$$$$$M$Y$$$20240704$$MD$US$US
240499221$24049922$1$I$$20240627$20240704$20240704$PER$$US-HETERO-HET2024US01739$HETERO$$$$$$Y$$$20240704$$CN$US$US
240499231$24049923$1$I$20240505$20240624$20240704$20240704$EXP$$JP-TEVA-VS-3197663$TEVA$$74$YR$$M$Y$$$20240704$$PH$JP$JP
240499241$24049924$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281421048380-HJCMP$GB-TEVA-VS-3215579$TEVA$$$$$$Y$$$20240704$$CN$GB$GB
240499251$24049925$1$I$20240702$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002686$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240704$$CN$US$US
240499261$24049926$1$I$20240629$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001296$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240704$$CN$US$US
240499271$24049927$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001922$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240704$$CN$US$US
240499281$24049928$1$I$20240301$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002235$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240704$$CN$US$US
240499291$24049929$1$I$20240702$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002757$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240704$$CN$US$US
240499301$24049930$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407000989$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240704$$CN$US$US
240499311$24049931$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002687$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240704$$CN$US$US
240499321$24049932$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002688$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240704$$CN$US$US
240499331$24049933$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002848$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240704$$CN$US$US
240499341$24049934$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002293$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240704$$CN$US$US
240499351$24049935$1$I$20240629$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002119$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240704$$CN$US$US
240499361$24049936$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002419$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240704$$CN$US$US
240499371$24049937$1$I$20240703$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002868$ELI LILLY AND CO$$28$YR$A$M$Y$$$20240704$$CN$US$US
240499381$24049938$1$I$20240601$20240626$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202406019773$ELI LILLY AND CO$$$$$F$Y$$$20240704$$CN$US$US
240499391$24049939$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001991$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240704$$CN$US$US
240499401$24049940$1$I$20240623$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002421$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240704$$CN$US$US
240499411$24049941$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001002$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240704$$CN$US$US
240499422$24049942$2$F$$20240813$20240704$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202406019338$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240815$$MD$US$US
240499431$24049943$1$I$20240619$20240701$20240704$20240704$EXP$$GB-HALEON-2184658$Haleon PLC$$32$YR$$F$Y$155$KG$20240704$$CN$GB$GB
240499441$24049944$1$I$20240703$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002640$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240704$$CN$US$US
240499451$24049945$1$I$20240702$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002151$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240704$$CN$US$US
240499462$24049946$2$F$$20240708$20240704$20240717$EXP$GB-MHRA-MED-202406281141054980-NZHDV$GB-TEVA-VS-3215310$TEVA$$$$$$Y$$$20240717$$CN$GB$GB
240499471$24049947$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106106$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240704$$HP$US$US
240499481$24049948$1$I$$20240103$20240704$20240704$PER$$US-AMGEN-USASP2024132324$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240499491$24049949$1$I$$20240216$20240704$20240704$PER$$US-AMGEN-USASP2024130144$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240499501$24049950$1$I$$20240624$20240704$20240704$PER$$US-AMGEN-USASP2024130196$AMGEN$Lowell J.A.; Sharma G.; Chua V. et al.. Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis. Digestive Diseases and Sciences. 2024;1-12$27$YR$A$F$Y$$$20240704$$HP$US$US
240499511$24049951$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106804$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240704$$HP$US$US
240499521$24049952$1$I$$20240311$20240704$20240704$PER$$US-AMGEN-USASP2024130995$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240499531$24049953$1$I$$20240629$20240704$20240704$PER$$US-AMGEN-USASP2024130364$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240499541$24049954$1$I$20240101$20240617$20240704$20240704$PER$$US-AMGEN-USASP2024131250$AMGEN$$72$YR$E$F$Y$$$20240704$$CN$US$US
240499561$24049956$1$I$20240701$20240703$20240704$20240704$EXP$$US-UCBSA-2024033797$UCB$$57$YR$$F$Y$$$20240704$$CN$US$US
240499571$24049957$1$I$20230101$20240625$20240704$20240704$EXP$$JP-INSMED, INC.-2023-04408-JP$INSMED$$79$YR$$M$Y$$$20240704$$CN$JP$JP
240499583$24049958$3$F$$20240712$20240704$20240717$EXP$$NVSC2024ZA137799$NOVARTIS$$52$YR$$F$Y$$$20240717$$CN$ZA$ZA
240499591$24049959$1$I$$20240627$20240704$20240704$PER$$US-HETERO-HET2024US01715$HETERO$$$$$M$Y$$$20240704$$CN$US$US
240499603$24049960$3$F$20240521$20240722$20240704$20240728$EXP$$US-ABBVIE-5824785$ABBVIE$$58$YR$$F$Y$60$KG$20240728$$CN$US$US
240499611$24049961$1$I$$20230217$20240704$20240704$PER$$US-AMGEN-USASP2023235150$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240499621$24049962$1$I$$20240624$20240704$20240704$PER$$US-AMGEN-USASP2024130217$AMGEN$Lowell J.A.; Sharma G.; Chua V. et al.. Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis. Digestive Diseases and Sciences. 2024;1-12$68$YR$E$F$Y$$$20240704$$HP$US$US
240499642$24049964$2$F$20240501$20240806$20240704$20240809$30DAY$$US-AMGEN-USASP2024128334$AMGEN$$$$$$Y$$$20240808$$PH$US$US
240499651$24049965$1$I$$20240624$20240704$20240704$PER$$US-AMGEN-USASP2024130202$AMGEN$Lowell J.A.; Sharma G.; Chua V. et al.. Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis. Digestive Diseases and Sciences. 2024;1-12$64$YR$A$M$Y$$$20240704$$HP$US$US
240499663$24049966$3$F$20240503$20240819$20240704$20240827$PER$$US-AMGEN-USASP2024128064$AMGEN$$67$YR$E$M$Y$$$20240826$$PH$US$US
240499671$24049967$1$I$20240701$20240701$20240704$20240704$PER$$US-ABBVIE-5822722$ABBVIE$$40$YR$$F$Y$53.07$KG$20240704$$CN$US$US
240499681$24049968$1$I$$20240703$20240704$20240704$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037756$BOEHRINGER INGELHEIM$$$$$$Y$$$20240704$$HP$US$US
240499691$24049969$1$I$20240610$20240626$20240704$20240704$EXP$$JP-AstraZeneca-2024A148806$ASTRAZENECA$$70$YR$$F$Y$45$KG$20240704$$MD$JP$
240499701$24049970$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A149457$ASTRAZENECA$$77$YR$$F$Y$$$20240704$$CN$ZA$
240499711$24049971$1$I$$20240626$20240704$20240704$EXP$$AU-AstraZeneca-2024A148155$ASTRAZENECA$$$$$M$Y$$$20240704$$MD$AU$
240499721$24049972$1$I$$20240628$20240704$20240704$EXP$$IT-Stemline Therapeutics, Inc.-2024ST004008$STEMLINE THERAPEUTICS$$67$YR$E$M$Y$$$20240702$$HP$IT$IT
240499731$24049973$1$I$$20240701$20240704$20240704$EXP$$TW-ASTELLAS-2024US001992$ASTELLAS$$58$YR$$M$Y$$$20240704$$CN$TW$TW
240499741$24049974$1$I$20240603$20240624$20240704$20240704$EXP$FR-AFSSAPS-GR2024000735$FR-TEVA-VS-3213891$TEVA$$22$YR$$F$Y$114.5$KG$20240704$$PH$FR$FR
240499754$24049975$4$F$20240426$20240919$20240704$20240928$EXP$$JP-ROCHE-10000013609$ROCHE$$83$YR$E$M$Y$69$KG$20240928$$PH$JP$JP
240499761$24049976$1$I$$20240626$20240704$20240704$EXP$$US-ALXN-202406USA001780US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$MD$US$US
240499771$24049977$1$I$20230826$20240620$20240704$20240704$EXP$IT-MINISAL02-990187$IT-TEVA-VS-3212859$TEVA$$84$YR$$F$Y$$$20240704$$MD$IT$IT
240499781$24049978$1$I$$20240620$20240704$20240704$PER$$US-ROCHE-10000013142$ROCHE$$$$$$Y$$$20240704$$MD$US$US
240499791$24049979$1$I$20240604$20240628$20240704$20240704$EXP$$US-Stemline Therapeutics, Inc.-2024ST004017$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240702$$CN$US$US
240499801$24049980$1$I$$20240701$20240704$20240704$PER$$US-ABBVIE-5825706$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240499811$24049981$1$I$20240601$20240702$20240704$20240704$PER$$US-JNJFOC-20240706618$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240704$$CN$US$US
240499841$24049984$1$I$$20240624$20240704$20240704$EXP$$US-TEVA-VS-3213929$TEVA$$81$YR$$M$Y$$$20240704$$CN$US$US
240499851$24049985$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138217$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240499861$24049986$1$I$$20240628$20240704$20240704$EXP$$NVSC2024PT137299$NOVARTIS$$$$$F$Y$$$20240704$$MD$PT$PT
240499873$24049987$3$F$20240619$20240712$20240704$20240726$PER$$FR-Stemline Therapeutics, Inc.-2024ST004032$STEMLINE THERAPEUTICS$$78$YR$E$F$Y$51$KG$20240726$$MD$FR$FR
240499881$24049988$1$I$20240118$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031914$AUROBINDO$$60$YR$$F$Y$$$20240704$$PH$FR$FR
240499901$24049990$1$I$$20240614$20240704$20240704$PER$$US-IDORSIA-008123-2024-US$IDORSIA PHARMACEUTICALS$$$$$F$Y$$$20240704$$CN$US$US
240499911$24049991$1$I$$20240627$20240704$20240704$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-105598$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240704$$MD$ES$ES
240499931$24049993$1$I$20231220$20240628$20240704$20240704$EXP$$CO-UCBSA-2024033898$UCB$$69$YR$$M$Y$88$KG$20240704$$CN$CO$CO
240499941$24049994$1$I$$20240624$20240704$20240704$PER$$US-AMGEN-USASP2024130232$AMGEN$Lowell J.A.; Sharma G.; Chua V. et al.. Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis. Digestive Diseases and Sciences. 2024;1-12$21$YR$A$F$Y$$$20240704$$HP$US$US
240499951$24049995$1$I$20240531$20240626$20240704$20240704$EXP$$CA-AMGEN-CANSP2024128400$AMGEN$$$$$$Y$$$20240704$$MD$CA$CA
240499961$24049996$1$I$20240628$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129521$AMGEN$$82$YR$E$F$Y$$$20240704$$CN$US$US
240499971$24049997$1$I$$20230315$20240704$20240704$PER$$US-AMGEN-USASP2023235508$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240499981$24049998$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106786$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240704$$HP$US$US
240499991$24049999$1$I$$20240628$20240704$20240704$EXP$$US-Stemline Therapeutics, Inc.-2024ST004012$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240703$$CN$US$US
240500001$24050000$1$I$20240522$20240628$20240704$20240704$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01962$AMNEAL$$33$YR$$F$Y$$$20240704$$MD$US$US
240500021$24050002$1$I$$20240625$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007759$STRIDES$Lopez C, Smith D, Buffington C. Is Gabapentin a Safe and Effective Analgesic for Reducing Opioid Needs with Roux-en-Y Gastric Bypass (RYGB)?.. Surg-Obes-Relat-Dis. 2024;20 (Suppl.) (6):S66 abstr. A160$$$$$Y$$$20240704$$HP$US$US
240500031$24050003$1$I$$20240629$20240704$20240704$PER$$US-ABBVIE-5824194$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240500041$24050004$1$I$$20240626$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007887$STRIDES$Deanda S, Razia D, Zaidi W, Lee R, Arjuna A.. Post-transplant Lymphoproliferative Disorder: A Nodular Area That Kept Growing!.. Am-J-Respir-Crit-Care-Med. 2024;209:A5942$$$$$Y$$$20240704$$HP$US$US
240500052$24050005$2$F$20240511$20240801$20240704$20240805$EXP$$JP-ABBVIE-5824306$ABBVIE$$63$YR$$M$Y$71$KG$20240805$$MD$JP$JP
240500061$24050006$1$I$20240627$20240627$20240704$20240704$PER$$US-ALXN-202406USA001785US$ALEXION PHARMACEUTICALS$$57$YR$$$Y$$$20240704$$CN$US$US
240500071$24050007$1$I$$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031912$AUROBINDO$$49$YR$$F$Y$$$20240704$$PH$FR$FR
240500081$24050008$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281425089800-RYTVB$GB-RDY-SPO/GBR/24/0009568$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240500092$24050009$2$F$$20240708$20240704$20240715$EXP$GB-MHRA-MED-202406281439120430-SHLWN$GB-RDY-SPO/GBR/24/0009569$DR REDDYS$$$$$$Y$$$20240715$$CN$GB$GB
240500101$24050010$1$I$20240530$20240604$20240704$20240704$EXP$$US-NEBO-661054$PHARMACOSMOS$$91$YR$$F$Y$$$20240704$$HP$US$US
240500111$24050011$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281441485000-MGTNK$GB-RDY-SPO/GBR/24/0009571$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240500121$24050012$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281421496220-GBHVJ$GB-RDY-SPO/GBR/24/0009651$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240500131$24050013$1$I$$20240625$20240704$20240704$EXP$$MY-TEVA-VS-3214722$TEVA$$57$YR$$F$Y$$$20240704$$PH$MY$MY
240500141$24050014$1$I$$20240702$20240704$20240704$PER$$US-TAKEDA-2024TUS067252$TAKEDA$$$$$$Y$$$20240704$$PH$US$US
240500151$24050015$1$I$20240110$20240527$20240704$20240704$PER$$US-AUROBINDO-AUR-APL-2024-002385$AUROBINDO$$$$$F$Y$$$20240704$$CN$US$US
240500162$24050016$2$F$$20240717$20240704$20240723$EXP$$US-GSK-US2024082127$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$MD$US$US
240500172$24050017$2$F$$20240808$20240704$20240810$PER$$US-AstraZeneca-2024A145832$ASTRAZENECA$$$$$M$Y$$$20240810$$CN$US$
240500181$24050018$1$I$$20240703$20240704$20240704$EXP$GB-MHRA-DEFECT-202406221311545970-BHSNJ$GB-JNJFOC-20240708612$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$GB$GB
240500191$24050019$1$I$20211229$20240626$20240704$20240704$EXP$$ES-AUROBINDO-AUR-APL-2024-031848$AUROBINDO$$81$YR$$F$Y$$$20240704$$PH$ES$ES
240500201$24050020$1$I$$20240626$20240704$20240704$EXP$$DE-AUROBINDO-AUR-APL-2024-031796$AUROBINDO$Solimani F, Nast A, Dilling A, Pahl S, Graf B, Gabner J, et al.. Fatal course of cutaneous mucormycosis in an immunosuppressed patient.. JDDG - Journal of the German Society of Dermatology.. 2024;22(6):850-2.$41$YR$$F$Y$$$20240704$$MD$DE$DE
240500211$24050021$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A149153$ASTRAZENECA$$27759$DY$$F$Y$$$20240704$$CN$ZA$
240500221$24050022$1$I$$20240619$20240704$20240704$PER$$US-ROCHE-10000008613$ROCHE$$55$YR$A$F$Y$$$20240704$$CN$US$US
240500231$24050023$1$I$20240604$20240616$20240704$20240704$PER$$US-ROCHE-3579840$ROCHE$$53$YR$A$M$Y$$$20240704$$CN$US$US
240500241$24050024$1$I$$20240610$20240704$20240704$PER$$US-ROCHE-3562522$ROCHE$$$$$$Y$$$20240704$$MD$US$US
240500251$24050025$1$I$20230101$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031918$AUROBINDO$$58$YR$$M$Y$$$20240704$$MD$FR$FR
240500261$24050026$1$I$$20240628$20240704$20240704$PER$$US-ABBVIE-5825913$ABBVIE$$$$A$$Y$$$20240704$$CN$US$US
240500271$24050027$1$I$$20240703$20240704$20240704$PER$$US-HALEON-2185234$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240500281$24050028$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106763$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240704$$HP$US$US
240500292$24050029$2$F$$20240709$20240704$20240716$PER$$US-ABBVIE-5822729$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240500313$24050031$3$F$20240101$20240613$20240704$20240710$EXP$$FR-ROCHE-3532697$ROCHE$$$$A$F$Y$$$20240710$$MD$FR$FR
240500322$24050032$2$F$$20240807$20240704$20240812$PER$$US-AMGEN-USASP2024130299$AMGEN$$$$$M$Y$$$20240812$$PH$US$US
240500332$24050033$2$F$20240630$20240906$20240704$20240910$PER$$US-AMGEN-USASP2024130852$AMGEN$$64$YR$A$F$Y$$$20240909$$CN$US$US
240500342$24050034$2$F$20240601$20240723$20240704$20240725$PER$$US-AMGEN-USASP2024130229$AMGEN$$50$YR$$F$Y$$$20240725$$PH$US$US
240500351$24050035$1$I$$20240624$20240704$20240704$PER$$US-AMGEN-USASP2024128093$AMGEN$Akopyan K.. Novel Use of Ivabradine for Persistent Sinus Tachycardia in a Patient on Extracorporeal Life Support With Right Ventricular Dysfunction. Cureus. 2024;16(6):1-6$17$YR$T$M$Y$$$20240704$$HP$US$US
240500361$24050036$1$I$20240601$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131942$AMGEN$$74$YR$E$F$Y$$$20240704$$CN$US$US
240500371$24050037$1$I$$20240325$20240704$20240704$PER$$US-AMGEN-USASP2024132556$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240500381$24050038$1$I$$20231209$20240704$20240704$PER$$US-AMGEN-USASP2023235336$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240500391$24050039$1$I$$20240109$20240704$20240704$PER$$US-AMGEN-USASP2024129587$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240500401$24050040$1$I$$20240311$20240704$20240704$PER$$US-AMGEN-USASP2024131543$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240500411$24050041$1$I$$20240304$20240704$20240704$PER$$US-AUROBINDO-AUR-APL-2024-011611$AUROBINDO$$72$YR$$F$Y$$$20240704$$CN$US$US
240500421$24050042$1$I$$20240624$20240704$20240704$PER$$US-ABBVIE-5824686$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240500431$24050043$1$I$$20240620$20240704$20240704$EXP$$DE-TEVA-VS-3213426$TEVA$$$$A$F$Y$72$KG$20240704$$MD$DE$DE
240500441$24050044$1$I$20240208$20240625$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031731$AUROBINDO$$38$YR$$M$Y$$$20240704$$PH$FR$FR
240500451$24050045$1$I$$20240628$20240704$20240704$PER$$US-ABBVIE-5823931$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240500461$24050046$1$I$20240617$20240620$20240704$20240704$PER$$US-ROCHE-10000010067$ROCHE$$61$YR$A$F$Y$$$20240704$$CN$US$US
240500471$24050047$1$I$$20240701$20240704$20240704$EXP$IN-MLMSERVICE-20240531-PI084796-00232-1$IN-ROCHE-10000013814$ROCHE$Aggarwal J, Kumar D, Rathore V, Mehta R, Kumar A, Ravina M. Acute airway obstruction: An unusual presentation of posttransplant lymphoproliferative disorder in a renal transplant recipient. Experimental and Clinical Transplantation. 2024;22 (4):307-10. doi:10.6002/ect.2024.0061.$26$YR$A$M$Y$$$20240704$$HP$IN$IN
240500482$24050048$2$F$$20240708$20240704$20240717$EXP$$JP-TEVA-VS-3214343$TEVA$Kadokawa Y, Inoue S, Tatsumi A, Uchida M, Fujita K, Takagi M, et al. Efficacy and safety of mycophenolate mofetil in treating immune-related hepatitis induced by immune checkpoint inhibitor use: A retrospective study. JGH-Open 2023; 7 (2): 87-97.; Kadokawa Y, Inoue S, Tatsumi A, Uchida M, Fujita K, Takagi M, et al. Efficacy and safety of mycophenolate mofetil in treating immune-related hepatitis induced by immune checkpoint inhibitor use: A retrospective study. JGH-Open 2023; 7 (2): 87-97.$67$YR$$M$Y$$$20240717$$HP$JP$JP
240500492$24050049$2$F$20190128$20240829$20240704$20240903$PER$$US-GILEAD-2024-0679547$GILEAD$$32$YR$A$M$Y$$$20240903$$LW$US$US
240500502$24050050$2$F$$20240717$20240704$20240723$30DAY$$US-JNJFOC-20240707949$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$PH$US$US
240500511$24050051$1$I$$20230414$20240704$20240704$PER$$US-AMGEN-USASP2023235507$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240500522$24050052$2$F$20110107$20240621$20240704$20240712$EXP$$KR-ROCHE-10000010986$ROCHE$$57$YR$A$M$Y$68$KG$20240712$$CN$KR$KR
240500531$24050053$1$I$$20240619$20240704$20240704$EXP$$NVSC2024RU137992$NOVARTIS$Kudaeva LM, Kozhedub EE, Kupryshina VO, Aliev TZ, Troshina EA. Toxic manifestations of alpelisib in endocrinology. Description of the clinical case. PROBLEMS OF ENDOCRINOLOGY. 2024;70 (2):70-7$60$YR$$F$Y$66$KG$20240704$$HP$RU$RU
240500542$24050054$2$F$20240617$20240808$20240704$20240808$EXP$FR-AFSSAPS-SE2024000526$NVSC2024FR136298$NOVARTIS$$65$YR$$M$Y$102.4$KG$20240808$$MD$FR$FR
240500552$24050055$2$F$20240321$20240708$20240704$20240716$EXP$$NVSJ2024JP004147$NOVARTIS$$76$YR$$F$Y$39.2$KG$20240716$$MD$JP$JP
240500561$24050056$1$I$20240515$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106957$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240704$$CN$US$US
240500571$24050057$1$I$$20240109$20240704$20240704$PER$$US-AMGEN-USASP2024130787$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240500582$24050058$2$F$20240513$20240712$20240704$20240715$EXP$IT-MINISAL02-992905$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-105849$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$60$KG$20240716$$MD$IT$IT
240500591$24050059$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105875$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240704$$CN$US$US
240500601$24050060$1$I$$20240627$20240704$20240704$EXP$$NVSJ2024JP007766$NOVARTIS$$$$$$Y$$$20240704$$MD$JP$JP
240500611$24050061$1$I$20240627$20240628$20240704$20240704$EXP$$NVSC2024JP138358$NOVARTIS$$$$$M$Y$$$20240704$$CN$JP$JP
240500621$24050062$1$I$$20240626$20240704$20240704$EXP$$NVSC2024US135395$NOVARTIS$$$$$M$Y$$$20240704$$MD$US$US
240500631$24050063$1$I$20240606$20240624$20240704$20240704$EXP$$JP-EMD Serono-2024035399$EMD SERONO INC$$68$YR$E$M$Y$$$20240704$$HP$JP$JP
240500642$24050064$2$F$$20240703$20240704$20240709$EXP$$AU-ABBVIE-5824757$ABBVIE$$$$$F$Y$$$20240709$$CN$AU$AU
240500654$24050065$4$F$$20240724$20240704$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-031954$AUROBINDO$Scherlinger. M, Sztejkowski, C, Sibilia J., Danion F., Mertz P., Elodie F, et al.. Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event.. Rheumatology. 2024;63(6):e185-187$52$YR$$F$Y$$$20240805$$MD$FR$FR
240500663$24050066$3$F$20240101$20240910$20240704$20240920$EXP$$US-INSMED, INC.-2024-01839-US$INSMED$$$$$F$Y$$$20240920$$CN$US$US
240500671$24050067$1$I$$20240618$20240704$20240704$PER$$US-AUROBINDO-AUR-APL-2024-014369$AUROBINDO$$72$YR$$F$Y$$$20240704$$CN$US$US
240500681$24050068$1$I$20230310$20240624$20240704$20240704$EXP$$CN-RDY-LIT/CHN/24/0009397$DR REDDYS$Jai-Li L, Xian Y, Hong-mei Z, Li-ning Y, Yu C, Yang L. Case Analysis of a ACS Patient With in-stent Thrombosis after PCI. Strait Pharmaceutical Journal. 2024;36(5):$68$YR$E$M$Y$70$KG$20240704$$PH$CN$CN
240500691$24050069$1$I$20240530$20240625$20240704$20240704$EXP$IT-MINISAL02-991096$IT-TEVA-VS-3213829$TEVA$$84$YR$$M$Y$96$KG$20240704$$MD$IT$IT
240500701$24050070$1$I$$20240220$20240704$20240704$PER$$US-AMGEN-USASP2024130876$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240500711$24050071$1$I$20240401$20240628$20240704$20240704$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-093080$REGENERON$$80$YR$$F$Y$$$20240704$$HP$CO$CO
240500721$24050072$1$I$20240501$20240702$20240704$20240704$EXP$$DE-JNJFOC-20240704790$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$MD$DE$DE
240500731$24050073$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032638$AUROBINDO$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al.. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. Rheumatology. 2024;63(5):1291-1296$42$YR$$M$Y$$$20240704$$HP$US$US
240500741$24050074$1$I$$20240627$20240704$20240704$PER$$US-HETERO-HET2024US01754$HETERO$$$$$$Y$$$20240704$$MD$US$US
240500751$24050075$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825754$ABBVIE$$58$YR$$F$Y$$$20240704$$HP$US$US
240500761$24050076$1$I$20230101$20231130$20240704$20240704$EXP$FR-AFSSAPS-AVMP2023000390$FR-TEVA-VS-3147002$TEVA$$51$YR$$M$Y$$$20240704$$PH$FR$FR
240500771$24050077$1$I$$20240627$20240704$20240704$PER$$US-BIOGEN-2024BI01271646$BIOGEN$$$$$F$Y$$$20240704$$CN$US$US
240500782$24050078$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214527$TEVA$Santosh N, Savani S, Iskapalli S. Beefing Up! Fulminant Liver Failure Secondary to Anabolic Steroid Use. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Santosh N, Savani S, Iskapalli S. Beefing Up! Fulminant Liver Failure Secondary to Anabolic Steroid Use. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$30$YR$$M$Y$$$20240720$$HP$US$US
240500791$24050079$1$I$20240614$20240627$20240704$20240704$EXP$$JP-ROCHE-10000014641$ROCHE$$7$DEC$E$F$Y$$$20240704$$MD$JP$JP
240500803$24050080$3$F$20231201$20240731$20240704$20240806$PER$$US-BIOGEN-2023BI01231749$BIOGEN$$66$YR$$F$Y$$$20240806$$CN$US$US
240500811$24050081$1$I$20240101$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106314$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$71.67$KG$20240704$$CN$US$US
240500821$24050082$1$I$$20240702$20240704$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106689$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$PH$JP$JP
240500831$24050083$1$I$$20240628$20240704$20240704$EXP$$NVSC2024BR137928$NOVARTIS$$$$$M$Y$72$KG$20240704$$CN$BR$BR
240500841$24050084$1$I$$20240624$20240704$20240704$PER$$US-TEVA-VS-3213606$TEVA$$$$$$Y$$$20240704$$PH$US$US
240500851$24050085$1$I$20240524$20240625$20240704$20240704$EXP$FR-AFSSAPS-BX2024001248$FR-TEVA-VS-3214569$TEVA$$36$YR$$M$Y$$$20240704$$MD$FR$FR
240500861$24050086$1$I$$20240627$20240704$20240704$PER$$US-HETERO-HET2024US01736$HETERO$$$$$F$Y$$$20240704$$CN$US$US
240500881$24050088$1$I$20240601$20240627$20240704$20240704$EXP$$US-SA-2024SA194556$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240704$$MD$US$US
240500891$24050089$1$I$20240612$20240626$20240704$20240704$EXP$$AT-AstraZeneca-2024A150139$ASTRAZENECA$$$$$M$Y$$$20240704$$MD$AT$
240500902$24050090$2$F$20231222$20240812$20240704$20240822$EXP$$PL-AUROBINDO-AUR-APL-2024-031988$AUROBINDO$$74$YR$$M$Y$76$KG$20240822$$MD$PL$PL
240500912$24050091$2$F$$20240709$20240704$20240717$EXP$$JP-AstraZeneca-2024A150689$ASTRAZENECA$$$$$$Y$$$20240717$$PH$JP$
240500921$24050092$1$I$$20240620$20240704$20240704$PER$$US-ROCHE-10000006643$ROCHE$$14$YR$T$M$Y$$$20240704$$CN$US$US
240500931$24050093$1$I$20240429$20240624$20240704$20240704$EXP$ES-AEMPS-1537230$ES-Accord-432448$ACCORD$$63$YR$A$M$Y$68$KG$20240704$$MD$ES$ES
240500941$24050094$1$I$20231002$20240622$20240704$20240704$EXP$IT-MINISAL02-991619$IT-Accord-432446$ACCORD$$38$YR$A$F$Y$55$KG$20240704$$MD$IT$IT
240500951$24050095$1$I$$20240625$20240704$20240704$EXP$CA-MHPD-E2B_07062889$CA-Accord-432444$ACCORD$$63$YR$A$M$Y$$$20240704$$HP$CA$CA
240500961$24050096$1$I$20240417$20240625$20240704$20240704$EXP$FR-AFSSAPS-2024053632$FR-Accord-432659$ACCORD$$37$YR$A$M$Y$92$KG$20240704$$MD$FR$FR
240500971$24050097$1$I$20210605$20240625$20240704$20240704$EXP$DE-EMA-2024623-AUTODUP-1719171213373$DE-Accord-432876$ACCORD$$$$A$F$Y$$$20240704$$MD$DE$DE
240500982$24050098$2$F$$20240909$20240704$20240913$EXP$$CA-AstraZeneca-2024A138143$ASTRAZENECA$$$$$F$Y$$$20240913$$PH$CA$
240500991$24050099$1$I$$20240626$20240704$20240704$EXP$$IN-AstraZeneca-2024A149192$ASTRAZENECA$$59$YR$$M$Y$78$KG$20240704$$CN$IN$
240501001$24050100$1$I$$20240626$20240704$20240704$EXP$$CA-AstraZeneca-2024A148539$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$CA$
240501011$24050101$1$I$20240529$20240625$20240704$20240704$EXP$CN-HENLIUS-24CN015603$CN-Accord-433314$ACCORD$$61$YR$A$F$Y$65$KG$20240704$$MD$CN$CN
240501021$24050102$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A148912$ASTRAZENECA$$$$$F$Y$52.2$KG$20240704$$CN$US$
240501031$24050103$1$I$$20240627$20240704$20240704$EXP$$US-SA-2024SA193336$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240704$$HP$US$US
240501041$24050104$1$I$$20231215$20240704$20240704$PER$$US-AMGEN-USASP2023235494$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240501051$24050105$1$I$$20240429$20240704$20240704$PER$$US-AMGEN-USASP2024131408$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240501061$24050106$1$I$$20231212$20240704$20240704$PER$$US-AMGEN-USASP2023235532$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240501071$24050107$1$I$$20240621$20240704$20240704$EXP$$US-AMGEN-USASP2024123759$AMGEN$Acharya N.; Duong D.; Alghanim A. et al.. Precapillary Pulmonary Hypertension in Dermatomyositis: Multiple Mechanisms of Disease.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1967$54$YR$A$F$Y$$$20240704$$HP$US$US
240501081$24050108$1$I$$20230428$20240704$20240704$PER$$US-AMGEN-USASP2023235516$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240501091$24050109$1$I$20240101$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130304$AMGEN$$$$$M$Y$$$20240704$$PH$US$US
240501101$24050110$1$I$20231001$20240628$20240704$20240704$EXP$$US-LEO Pharma-371662$LEO PHARM$$71$YR$$F$Y$$$20240704$$PH$US$US
240501113$24050111$3$F$20240624$20240815$20240704$20240823$EXP$$CN-VANTIVE-2024VAN018097$Vantive US Healthcare$$58$YR$$M$Y$$$20240823$$HP$CN$CN
240501121$24050112$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032410$AUROBINDO$Hu G, Hauk PJ, Zhang N, Elsegeiny W, Guardia CM, Kullas A, et al. Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in ATG9A. Autophagy. 2023;19(2):678-691$11$YR$$M$Y$$$20240704$$HP$US$US
240501131$24050113$1$I$$20240701$20240704$20240704$EXP$$IN-VANTIVE-2024VAN018119$Vantive US Healthcare$$73$YR$$M$Y$$$20240704$$CN$IN$IN
240501141$24050114$1$I$$20240621$20240704$20240704$EXP$$IN-ROCHE-10000013326$ROCHE$$81$YR$E$F$Y$$$20240704$$CN$IN$IN
240501151$24050115$1$I$$20240701$20240704$20240704$PER$$US-ROCHE-10000014728$ROCHE$Gupta A, Furcich J, Nascene D, Kemp S, King C, Nolan E, et al. Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy. Journal of Neuroimmunology. 2024;393:1-12. doi:10.1016/j.jneuroim.2024.578395.$9$YR$C$M$Y$$$20240704$$HP$US$US
240501161$24050116$1$I$$20240621$20240704$20240704$EXP$$CA-TEVA-VS-3213055$TEVA$$62$YR$$F$Y$$$20240704$$CN$CA$CA
240501171$24050117$1$I$$20240626$20240704$20240704$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001318$BLUEPRINT MEDICINES$$$$$M$Y$$$20240704$$CN$US$US
240501181$24050118$1$I$$20240620$20240704$20240704$EXP$$TW-Indoco-000567$INDOCO$Shen YC, Wu JC, Lin TT, Chang KC, Su JJ, Juang JJ. Case Report: Lacosamide unmasking SCN5A-associated Brugada syndrome in a young female with epilepsy. Front Cardiovasc Med. 2024 May 31;11:1406614. doi: 10.3389/fcvm.2024.1406614.$33$YR$A$F$Y$$$20240704$$HP$TW$TW
240501191$24050119$1$I$$20240623$20240704$20240704$EXP$$IT-Accord-432775$ACCORD$Iodice A, Marchio G, Asta F, Rocchetti K, Rosati A. Vigabatrin-associated hyperkinetic movements in two children with epileptic spasms: Case reports and video phenomenology description. Seizure. 2024 Jun 4;120:12-14. doi: 10.1016/j.seizure.2024.06.003.$12$MON$I$M$Y$$$20240704$$HP$IT$IT
240501201$24050120$1$I$20240610$20240621$20240704$20240704$EXP$ES-AEMPS-1534295$ES-TEVA-VS-3213342$TEVA$$66$YR$$F$Y$$$20240704$$MD$ES$ES
240501212$24050121$2$F$$20240827$20240704$20240828$EXP$$US-TAKEDA-2024TUS067475$TAKEDA$$$$$F$Y$$$20240828$$CN$US$US
240501221$24050122$1$I$20240501$20240627$20240704$20240704$EXP$$PL-ASTELLAS-2024US018474$ASTELLAS$$$$E$M$Y$$$20240704$$CN$PL$PL
240501231$24050123$1$I$$20240624$20240704$20240704$EXP$$JP-STERISCIENCE B.V.-2024-ST-000943$Steriscience PTE$Mizutani N, Kenzaka T. Antimicrobial-associated encephalopathy due to ampicillin.. Clin-Case-Rep. 2024;12(4)$84$YR$$M$Y$$$20240704$$HP$JP$JP
240501243$24050124$3$F$20240626$20240716$20240704$20240726$EXP$$DE-BAXTER-2024BAX020803$BAXTER$$84$YR$$M$Y$$$20240726$$HP$DE$DE
240501251$24050125$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131239$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240501261$24050126$1$I$20240425$20240625$20240704$20240704$EXP$FR-AFSSAPS-NC2024000687$FR-TEVA-VS-3214479$TEVA$$29$YR$$F$Y$$$20240704$$PH$FR$FR
240501272$24050127$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214397$TEVA$Mansfield PK, Moody R, Li Y, Heinecke G. A rare case of lichen planus pemphigoides with palmoplantar hyperkeratotic plaques. JAAD-Case-Rep 2024; 49 14-16.; Mansfield PK, Moody R, Li Y, Heinecke G. A rare case of lichen planus pemphigoides with palmoplantar hyperkeratotic plaques. JAAD-Case-Rep 2024; 49 14-16.$64$YR$$F$Y$$$20240720$$HP$US$US
240501281$24050128$1$I$20240608$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002004$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240704$$CN$US$US
240501301$24050130$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002918$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240704$$PH$US$US
240501312$24050131$2$F$20240501$20240801$20240704$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407002055$ELI LILLY AND CO$$90$YR$E$F$Y$$$20240806$$CN$US$US
240501321$24050132$1$I$20240601$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002690$ELI LILLY AND CO$$34$YR$A$$Y$$$20240704$$CN$US$US
240501331$24050133$1$I$20240501$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002415$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240704$$CN$US$US
240501341$24050134$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002716$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240704$$CN$US$US
240501351$24050135$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002895$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240704$$CN$US$US
240501361$24050136$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002265$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240704$$CN$US$US
240501371$24050137$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002722$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240704$$CN$US$US
240501392$24050139$2$F$20230101$20240729$20240704$20240810$EXP$$US-JNJFOC-20240668988$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240810$$CN$US$US
240501401$24050140$1$I$$20240624$20240704$20240704$EXP$$JP-STERISCIENCE B.V.-2024-ST-000955$Steriscience PTE$Mori H, Shibata E, Kondo E, Sasaki N, Sawada Y, Yoshino K.. The incidence of Jarisch-Herxheimer reactions and associated risk factors in pregnant women and nonpregnant women: A retrospective chart review at a university hospital in Japan.. J-Obstet-Gynaecol-Res. 2023;49 (5):1435-1442.$37$YR$$F$Y$$$20240704$$HP$JP$JP
240501411$24050141$1$I$$20240624$20240704$20240704$EXP$$GB-RECORDATI-2024004872$RECORDATI$Allen C, Armstrong K, Game D and Kinton L. Cysteamine toxicity presenting with acute encephalopathy and spastic?tetraparesis. Pract Neurol. 2024;0:1-4$$$$$Y$$$20240704$$MD$GB$GB
240501421$24050142$1$I$20240629$20240701$20240704$20240704$PER$$US-JNJFOC-20240702318$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240704$$PH$US$US
240501431$24050143$1$I$$20240625$20240704$20240704$30DAY$$US-JNJFOC-20240707935$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240501442$24050144$2$F$$20240715$20240704$20240723$EXP$$CA-HALEON-2182910$Haleon PLC$$60$YR$$F$Y$$$20240723$$HP$CA$CA
240501451$24050145$1$I$$20240701$20240704$20240704$PER$$US-BIOVITRUM-2024-US-009409$BIOVITRUM$$$$E$M$Y$$$20240704$$CN$US$US
240501463$24050146$3$F$20240626$20240919$20240704$20240927$EXP$$US-TAKEDA-2024TUS067378$TAKEDA$$9$YR$$M$Y$$$20240927$$PH$US$US
240501481$24050148$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106550$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240704$$CN$US$US
240501491$24050149$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106707$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$MD$US$US
240501502$24050150$2$F$20150120$20240918$20240704$20240919$PER$$US-GILEAD-2024-0679482$GILEAD$$46$YR$A$M$Y$$$20240919$$LW$US$US
240501512$24050151$2$F$20240625$20240822$20240704$20240901$30DAY$$US-GSK-US2024079830$GLAXOSMITHKLINE$$38$YR$$F$Y$$$20240901$$CN$US$US
240501522$24050152$2$F$$20240717$20240704$20240723$PER$$US-ROCHE-3527529$ROCHE$$59$YR$A$F$Y$$$20240723$$CN$US$US
240501541$24050154$1$I$$20240626$20240704$20240704$EXP$$GB-TEVA-VS-3214166$TEVA$$$$A$F$Y$$$20240704$$CN$GB$GB
240501552$24050155$2$F$20240624$20240711$20240704$20240726$EXP$$ES-TEVA-VS-3215476$TEVA$$72$YR$$F$Y$$$20240726$$CN$ES$ES
240501562$24050156$2$F$$20240627$20240704$20240712$PER$$US-ROCHE-10000016306$ROCHE$$42$YR$A$F$Y$$$20240712$$HP$US$US
240501571$24050157$1$I$$20240624$20240704$20240704$EXP$$US-STERISCIENCE B.V.-2024-ST-000944$Steriscience PTE$Pintor Jimenez KA, Holland E, Sonkarley K, Ainte O, Powell C.. More Than What Meets the Eye: A Case of Fulminant Malaria in the Intensive Care Unit.. Am-J-Respir-Crit-Care-Med. 2024;209(0):A7319$62$YR$$M$Y$$$20240704$$HP$US$US
240501581$24050158$1$I$20200616$20240701$20240704$20240704$EXP$PL-URPL-1-1562-2020$NVSC2024PL136301$NOVARTIS$$73$YR$$F$Y$40$KG$20240704$$MD$PL$PL
240501601$24050160$1$I$20240610$20240702$20240704$20240704$EXP$FR-AFSSAPS-2024054962$FR-ORGANON-O2407FRA000223$ORGANON$$63$YR$$M$Y$103$KG$20240704$$MD$FR$FR
240501611$24050161$1$I$$20240702$20240704$20240704$PER$$US-BIOVITRUM-2024-US-009404$BIOVITRUM$$33$YR$$F$Y$$$20240704$$CN$US$US
240501621$24050162$1$I$$20240621$20240704$20240704$EXP$FR-AFSSAPS-LL2024001112$FR-TEVA-VS-3213458$TEVA$$57$YR$$F$Y$$$20240704$$MD$FR$FR
240501631$24050163$1$I$$20240113$20240704$20240704$PER$$US-AMGEN-USASP2024132536$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240501643$24050164$3$F$20240101$20240713$20240704$20240719$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017165$UNITED THERAPEUTICS$$$$$F$Y$83.9$KG$20240719$$PH$US$US
240501662$24050166$2$F$$20240726$20240704$20240801$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-19534$SAMSUNG BIOEPIS$$86$YR$E$F$Y$$$20240801$$CN$GB$GB
240501672$24050167$2$F$20190101$20240703$20240704$20240709$EXP$$CA-TAKEDA-2024TUS067454$TAKEDA$$$$$M$Y$$$20240709$$CN$CA$CA
240501681$24050168$1$I$20240621$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024130433$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240501691$24050169$1$I$20240628$20240627$20240704$20240704$EXP$$CA-TAKEDA-2024TUS065741$TAKEDA$$42$YR$$M$Y$$$20240704$$CN$CA$CA
240501703$24050170$3$F$20240625$20240717$20240704$20240725$PER$$US-AMGEN-USASP2024129574$AMGEN$$63$YR$A$F$Y$83.6$KG$20240724$$HP$US$US
240501713$24050171$3$F$20240628$20240820$20240704$20240823$PER$$US-AMGEN-USASP2024129787$AMGEN$$59$YR$A$F$Y$$$20240823$$HP$US$US
240501721$24050172$1$I$$20240117$20240704$20240704$PER$$US-AMGEN-USASP2024129756$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240501731$24050173$1$I$20240617$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129432$AMGEN$$$$A$F$Y$$$20240704$$HP$US$US
240501741$24050174$1$I$20230101$20240628$20240704$20240704$EXP$$US-AMGEN-USASP2024128741$AMGEN$$77$YR$E$F$Y$$$20240704$$CN$US$US
240501751$24050175$1$I$$20230905$20240704$20240704$PER$$US-AMGEN-USASP2023235403$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240501762$24050176$2$F$20240101$20240917$20240704$20240924$EXP$$US-AMGEN-USASP2024130548$AMGEN$$48$YR$A$M$Y$$$20240924$$HP$US$US
240501771$24050177$1$I$20240403$20240625$20240704$20240704$EXP$FR-AFSSAPS-DJ2024000701$FR-TEVA-VS-3214495$TEVA$$27$YR$$F$Y$41$KG$20240704$$MD$FR$FR
240501781$24050178$1$I$$20240626$20240704$20240704$EXP$$CA-CELLTRION INC.-2024CA015876$CELLTRION$$$$$$Y$$$20240704$$HP$CA$CA
240501792$24050179$2$F$20240301$20240723$20240704$20240731$EXP$$JP-ARDELYX-2024ARDX002625$ARDELYX$$64$YR$$M$Y$$$20240731$$MD$JP$JP
240501801$24050180$1$I$$20240702$20240704$20240704$PER$$US-GILEAD-2024-0679435$GILEAD$$23$YR$A$F$Y$$$20240704$$CN$US$US
240501811$24050181$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138224$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240501821$24050182$1$I$20240101$20240702$20240704$20240704$EXP$$NVSC2024RO138122$NOVARTIS$$$$E$F$Y$$$20240704$$MD$RO$RO
240501832$24050183$2$F$20240703$20240704$20240704$20240705$PER$$US-AMGEN-USASP2024132313$AMGEN$$69$YR$E$F$Y$$$20240705$$CN$US$US
240501845$24050184$5$F$$20240924$20240704$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106234$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240925$$CN$US$US
240501856$24050185$6$F$20240712$20240718$20240704$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020291$UNITED THERAPEUTICS$$71$YR$$M$Y$101.59$KG$20240726$$$US$US
240501861$24050186$1$I$$20240621$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05681$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240501871$24050187$1$I$20240301$20240703$20240704$20240704$EXP$FR-AFSSAPS-LL2024001238$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-106442$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240704$$MD$FR$FR
240501883$24050188$3$F$20240501$20240801$20240704$20240812$EXP$$JP-ARDELYX-2024ARDX004518$ARDELYX$$7$DEC$$M$Y$$$20240811$$MD$JP$JP
240501891$24050189$1$I$20240101$20240701$20240704$20240704$EXP$$US-ABBVIE-5824250$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240501901$24050190$1$I$$20240625$20240704$20240704$EXP$CA-MHPD-E2B_07058924$CA-Accord-432542$ACCORD$$77$YR$E$F$Y$$$20240704$$HP$CA$CA
240501911$24050191$1$I$$20240625$20240704$20240704$EXP$GB-MHRA-MED-202406240939544720-VTGJN$GB-Accord-432724$ACCORD$$$$$F$Y$67$KG$20240704$$CN$GB$GB
240501921$24050192$1$I$20240423$20240625$20240704$20240704$EXP$FR-AFSSAPS-AM2024000532$FR-Accord-432925$ACCORD$$57$YR$A$M$Y$$$20240704$$MD$FR$FR
240501933$24050193$3$F$20240101$20240723$20240704$20240802$EXP$$US-ARDELYX-2024ARDX004633$ARDELYX$$$$$F$Y$$$20240802$$CN$US$US
240501941$24050194$1$I$20231201$20240625$20240704$20240704$EXP$FR-AFSSAPS-BX2024001287$FR-Accord-432822$ACCORD$$66$YR$E$M$Y$94$KG$20240704$$MD$FR$FR
240501952$24050195$2$F$$20240709$20240704$20240713$EXP$$CA-ABBVIE-5825063$ABBVIE$$$$E$M$Y$$$20240713$$HP$CA$CA
240501961$24050196$1$I$20240614$20240701$20240704$20240704$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-13277$IPSEN$$68$YR$E$M$Y$$$20240704$$HP$US$US
240501971$24050197$1$I$20240423$20240704$20240704$20240704$EXP$FR-AFSSAPS-CF2024000244$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037837$BOEHRINGER INGELHEIM$$92$YR$E$M$Y$55.2$KG$20240704$$MD$FR$FR
240501983$24050198$3$F$20231027$20240826$20240704$20240904$EXP$$US-NEBO-663042$PHARMACOSMOS$$69$YR$$M$Y$121$KG$20240904$$MD$US$US
240501991$24050199$1$I$$20240701$20240704$20240704$PER$$US-ROCHE-10000016419$ROCHE$Gupta A, Furcich J, Nascene D, Kemp S, King C, Nolan E, et al. Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy. Journal of Neuroimmunology. 2024;393:1-12. doi:10.1016/j.jneuroim.2024.578395.$12$YR$T$M$Y$$$20240704$$HP$US$US
240502001$24050200$1$I$$20240626$20240704$20240704$EXP$$US-ARDELYX-2024ARDX004710$ARDELYX$$68$YR$$M$Y$$$20240704$$HP$US$US
240502014$24050201$4$F$20190925$20240916$20240704$20240919$PER$$US-GILEAD-2024-0679486$GILEAD$$50$YR$A$M$Y$$$20240919$$LW$US$US
240502031$24050203$1$I$$20240702$20240704$20240704$EXP$$GB-UCBSA-2024033798$UCB$$$$$F$Y$$$20240704$$CN$GB$GB
240502043$24050204$3$F$$20240805$20240704$20240806$PER$$US-ALXN-202406USA001786US$ALEXION PHARMACEUTICALS$$$$$M$Y$108.84$KG$20240806$$CN$US$US
240502051$24050205$1$I$$20240701$20240704$20240704$EXP$$US-ASTELLAS-2024EU006507$ASTELLAS$$$$$M$Y$$$20240704$$CN$US$US
240502066$24050206$6$F$20240711$20240903$20240704$20240911$EXP$$CA-CELLTRION INC.-2024CA016047$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
240502071$24050207$1$I$$20240630$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104872$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$CN$US$US
240502081$24050208$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106711$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$CN$US$US
240502091$24050209$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106513$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240704$$CN$US$US
240502102$24050210$2$F$$20240731$20240704$20240806$EXP$$US-ASTELLAS-2023EU005702$ASTELLAS$$$$$M$Y$$$20240806$$CN$US$US
240502121$24050212$1$I$20240517$20240621$20240704$20240704$EXP$FR-AFSSAPS-MA2024000931$FR-TEVA-VS-3213476$TEVA$$28$YR$$M$Y$$$20240704$$MD$FR$FR
240502151$24050215$1$I$20240501$20240701$20240704$20240704$EXP$FR-AFSSAPS-GR2024000801$FR-BAUSCH-BL-2024-010192$BAUSCH AND LOMB$$79$YR$$M$Y$$$20240704$$PH$FR$FR
240502161$24050216$1$I$$20240626$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007882$STRIDES$Mak K, Maleckar S, Strek ME, Adegunsoye AO, Lee CT.. Improvement in Pulmonary Function in a Patient With ILD Following Semaglutide Therapy.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$65$YR$$F$Y$$$20240704$$HP$US$US
240502171$24050217$1$I$20231223$20240702$20240704$20240704$30DAY$$GB-SANDOZ INC.-SDZ2024GB003310$SANDOZ$$42$YR$$M$Y$$$20240704$$CN$GB$GB
240502181$24050218$1$I$20210101$20240630$20240704$20240704$EXP$$EG-SANDOZ INC.-SDZ2024EG061890$SANDOZ$$$$$F$Y$85$KG$20240704$$CN$EG$EG
240502191$24050219$1$I$$20240703$20240704$20240704$PER$$US-HALEON-2185246$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240502202$24050220$2$F$$20240704$20240704$20240708$EXP$$US-SANDOZ INC.-SDZ2024US062249$SANDOZ$Reinsch N, Haq E, Ramakrishna K, Craft L.. Cardiovascular Collapse Requiring Veno-Arterial Extracorporeal Membrane Oxygenation and Lidocaine: A Case of Massive Bupropion Overdose. Cureus. 2024;16(6):e62873$18$YR$$F$Y$$$20240708$$MD$US$US
240502211$24050221$1$I$$20240109$20240704$20240704$PER$$US-AMGEN-USASP2024130784$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240502223$24050222$3$F$20240601$20240709$20240704$20240712$PER$$US-AMGEN-USASP2024130283$AMGEN$$79$YR$E$M$Y$$$20240712$$CN$US$US
240502232$24050223$2$F$20240622$20240711$20240704$20240713$PER$$US-AMGEN-USASP2024129769$AMGEN$$76$YR$E$F$Y$$$20240712$$CN$US$US
240502241$24050224$1$I$$20240627$20240704$20240704$EXP$$JP-CHEPLA-2024008294$CHEPLAPHARM$$102$YR$$F$Y$$$20240704$$PH$COUNTRY NOT SPECIFIED$JP
240502251$24050225$1$I$$20240627$20240704$20240704$EXP$$US-TEVA-VS-3215606$TEVA$$63$YR$$M$Y$$$20240704$$HP$US$US
240502261$24050226$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002950$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240704$$CN$US$US
240502271$24050227$1$I$20240601$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002161$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240704$$CN$US$US
240502281$24050228$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001893$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240704$$CN$US$US
240502292$24050229$2$F$$20240625$20240704$20240705$EXP$$AU-BEH-2024174737$CSL BEHRING$$55$YR$A$M$Y$$$20240705$$HP$AU$AU
240502301$24050230$1$I$$20240605$20240704$20240704$PER$$US-JNJFOC-20240613364$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240502311$24050231$1$I$20240501$20240627$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202406019235$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240704$$CN$US$US
240502321$24050232$1$I$20240621$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024130440$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240502331$24050233$1$I$20240619$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024128205$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240502342$24050234$2$F$20240516$20240704$20240704$20240713$EXP$IT-MINISAL02-990816$IT-TEVA-VS-3214480$TEVA$$68$YR$$F$Y$$$20240713$$MD$IT$IT
240502351$24050235$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032050$AUROBINDO$Hurera A, Ain N, Agarwal B. A Case of Infective Endocarditis Complicated by Intracardiac Fistula and Systemic Embolization. Am-J-Respir-Crit-Care-Med. 2024;209:A1646$29$YR$$M$Y$$$20240704$$HP$US$US
240502361$24050236$1$I$$20240626$20240704$20240704$EXP$QA-MLMSERVICE-20240619-PI104960-00030-1$QA-STRIDES ARCOLAB LIMITED-2024SP007904$STRIDES$Ahmed AI, Alkorbi HA, Jolo L, Al Kurbi M, Abbarh S, Danjuma M.. Infectious Mononucleosis Revealed by Non-steroidal Anti-inflammatory Drug: A First Clinical Report.. Cureus. 2024;16(5):e60329.$32$YR$$F$Y$$$20240704$$MD$QA$QA
240502371$24050237$1$I$$20240701$20240704$20240704$EXP$$NVSC2024BR138305$NOVARTIS$$$$$M$Y$$$20240704$$CN$BR$BR
240502382$24050238$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214795$TEVA$Vagedes R, Nurse D, Latifi M. ^Lazarus Response^ Upon Initiation of Targeted Oncogenic Therapy for Acute Respiratory Failure in Rapidly Progressive ALK-Positive Pulmonary Adenocarcinoma. Am-J-Respir-Crit-Care-Med 2024; 209.; Vagedes R, Nurse D, Latifi M. ^Lazarus Response^ Upon Initiation of Targeted Oncogenic Therapy for Acute Respiratory Failure in Rapidly Progressive ALK-Positive Pulmonary Adenocarcinoma. Am-J-Respir-Crit-Care-Med 2024; 209.$53$YR$$F$Y$$$20240720$$HP$US$US
240502391$24050239$1$I$$20240701$20240704$20240704$PER$$US-ROCHE-10000016418$ROCHE$Gupta A, Furcich J, Nascene D, Kemp S, King C, Nolan E, et al. Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy. Journal of Neuroimmunology. 2024;393:1-12. doi:10.1016/j.jneuroim.2024.578395.$8$YR$C$M$Y$$$20240704$$HP$US$US
240502401$24050240$1$I$$20240626$20240704$20240704$EXP$$LK-STRIDES ARCOLAB LIMITED-2024SP007891$STRIDES$Dandeniya CL, Premathilake TK.. Thrombotic and immunological phenomena following COVID-19 vaccination: experience from a case series.. RMD-Open. 2023;9(1)$56$YR$$M$Y$$$20240704$$MD$LK$LK
240502411$24050241$1$I$20240201$20240627$20240704$20240704$PER$$US-JNJFOC-20240675843$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$HP$US$US
240502421$24050242$1$I$20240601$20240702$20240704$20240704$PER$$US-JNJFOC-20240708108$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240704$$CN$US$US
240502441$24050244$1$I$$20240626$20240704$20240704$PER$$US-ALXN-202406USA001755US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
240502464$24050246$4$F$20240601$20240920$20240704$20240923$EXP$$DE-JNJFOC-20240619040$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240923$$HP$DE$DE
240502471$24050247$1$I$20201001$20240627$20240704$20240704$EXP$$US-UCBSA-2024032860$UCB$$0$YR$$M$Y$3.16$KG$20240704$$HP$US$US
240502483$24050248$3$F$$20240819$20240704$20240829$PER$$US-AstraZeneca-2024A146148$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
240502491$24050249$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-031800$AUROBINDO$Mueller SW, Molina KC, Blass B, Gibson C, Kohler AD, Krsak M et al.. Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa.. Journal of Burn Care and Research. 2024;(3):808-10$48$YR$$M$Y$$$20240704$$MD$US$US
240502502$24050250$2$F$20240101$20240710$20240704$20240718$EXP$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-01231$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$$$20240718$$CN$US$US
240502511$24050251$1$I$20240612$20240701$20240704$20240704$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-13279$IPSEN$$57$YR$A$M$Y$$$20240704$$HP$US$US
240502531$24050253$1$I$$20240626$20240704$20240704$EXP$$CN-AstraZeneca-2024A150020$ASTRAZENECA$$$$A$F$Y$64$KG$20240704$$MD$CN$
240502541$24050254$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A149060$ASTRAZENECA$$60$YR$$M$Y$$$20240704$$CN$ZA$
240502551$24050255$1$I$20230725$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031900$AUROBINDO$$55$YR$$F$Y$$$20240704$$MD$FR$FR
240502561$24050256$1$I$$20240624$20240704$20240704$PER$$US-TEVA-VS-3215119$TEVA$$68$YR$$F$Y$$$20240704$$CN$US$US
240502571$24050257$1$I$$20240702$20240704$20240704$EXP$$US-GILEAD-2024-0679548$GILEAD$$$$$$Y$$$20240704$$LW$US$US
240502581$24050258$1$I$$20240626$20240704$20240704$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP007895$STRIDES$Reid I, Sharma A, Gogbashian A, Kaur B, Fotopoulou C.. Germ cell cancer in pregnancy - Successfully treated with chemotherapy and surgery. Gynecol-Oncol-Rep. 2023;47:1-4$31$YR$$F$Y$$$20240704$$HP$GB$GB
240502591$24050259$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5821301$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240502601$24050260$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032398$AUROBINDO$Deng X, Jung D.. A Late, Unusual Presentation of Chronic Eosinophilic Pneumonia Requiring Anti-IL5 Therapy. Am-J-Respir-Crit-Care-Med. 2024$88$YR$$F$Y$$$20240704$$HP$US$US
240502611$24050261$1$I$20240101$20240624$20240704$20240704$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-12700$IPSEN$$54$YR$A$F$Y$$$20240704$$CN$US$US
240502621$24050262$1$I$20240219$20240625$20240704$20240704$EXP$FR-AFSSAPS-NT2024000294$FR-TEVA-VS-3214496$TEVA$$78$YR$$M$Y$$$20240704$$MD$FR$FR
240502631$24050263$1$I$$20240625$20240704$20240704$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004790$BIOCON$$$$$$Y$$$20240704$$MD$CA$CA
240502641$24050264$1$I$$20240624$20240704$20240704$EXP$$US-RDY-LIT/USA/24/0009396$DR REDDYS$Kumari R, Singla T, Perswani P, Ghosh S. A Curious Case of Pleural Effusion. American Journal of Respiratory and Critical Care Medicine. 209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1952.$79$YR$E$F$Y$$$20240704$$HP$US$US
240502651$24050265$1$I$20221214$20240627$20240704$20240704$EXP$$CN-TAKEDA-2024TUS065713$TAKEDA$$30$YR$$M$Y$$$20240704$$HP$CN$CN
240502661$24050266$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032388$AUROBINDO$Phekoo A, Turk M, Torain J, Cate J, Java A, Sparks MA. USE OF ECULIZUMAB DURING PREGNANCYIN A PATIENT WITH C3GN. Am-J-Kidney-Dis. 2024;83 (Suppl. 2)(4:S44$24$YR$$F$Y$$$20240704$$HP$US$US
240502671$24050267$1$I$$20240415$20240704$20240704$PER$$US-AMGEN-USASP2024131657$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240502681$24050268$1$I$$20231016$20240704$20240704$PER$$US-AMGEN-USASP2023235502$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240502691$24050269$1$I$$20240117$20240704$20240704$PER$$US-AMGEN-USASP2024131612$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240502701$24050270$1$I$$20230902$20240704$20240704$PER$$US-AMGEN-USASP2023235397$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240502711$24050271$1$I$$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129913$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240502721$24050272$1$I$$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031843$AUROBINDO$$28$YR$$M$Y$$$20240704$$CN$FR$FR
240502731$24050273$1$I$20240627$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024128910$AMGEN$$73$YR$E$F$Y$$$20240704$$CN$US$US
240502752$24050275$2$F$$20240905$20240704$20240906$EXP$$NVSC2024US136550$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
240502763$24050276$3$F$20240515$20240822$20240704$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-031880$AUROBINDO$$76$YR$$F$Y$75$KG$20240903$$MD$DE$DE
240502771$24050277$1$I$$20230828$20240704$20240704$PER$$US-AMGEN-USASP2023235462$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240502781$24050278$1$I$20240614$20240626$20240704$20240704$EXP$ES-AEMPS-1537289$ES-TEVA-VS-3214749$TEVA$$65$YR$$M$Y$$$20240704$$PH$ES$ES
240502791$24050279$1$I$$20231005$20240704$20240704$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03558$AMNEAL$$$$$F$Y$$$20240704$$MD$US$US
240502801$24050280$1$I$$20240408$20240704$20240704$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01203$AMNEAL$$$$$F$Y$$$20240704$$CN$US$US
240502811$24050281$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032406$AUROBINDO$Razi S, Mcguire RJ, Krings JG. Use of the Anti-interleukin-5-Receptor Monoclonal Antibody, Benralizumab, for the Treatment of Allergic Bronchopulmonary Aspergillosis. Am-J-Respir-Crit-CareMed. 2024;209:A5287$64$YR$$M$Y$$$20240704$$HP$US$US
240502821$24050282$1$I$$20240621$20240704$20240704$EXP$$KR-ROCHE-10000010988$ROCHE$$39$YR$A$$Y$$$20240704$$HP$KR$KR
240502832$24050283$2$F$$20240702$20240704$20240716$PER$$US-JNJFOC-20240705926$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$CN$US$US
240502841$24050284$1$I$$20240702$20240704$20240704$PER$$US-JNJFOC-20240705721$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$HP$US$US
240502852$24050285$2$F$$20240802$20240704$20240805$EXP$$SG-JNJFOC-20240670478$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240806$$CN$SG$SG
240502861$24050286$1$I$20230101$20240703$20240704$20240704$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037726$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240704$$CN$US$US
240502871$24050287$1$I$20240619$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106745$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$56.25$KG$20240704$$PH$US$US
240502881$24050288$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106681$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$78.93$KG$20240704$$CN$US$US
240502891$24050289$1$I$20240702$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106993$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240704$$MD$US$US
240502903$24050290$3$F$$20240815$20240704$20240820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-103851$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240820$$MD$JP$JP
240502912$24050291$2$F$20240601$20240911$20240704$20240912$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-106602$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240912$$CN$PR$PR
240502931$24050293$1$I$$20240626$20240704$20240704$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP007896$STRIDES$Reid I, Sharma A, Gogbashian A, Kaur B, Fotopoulou C.. Germ cell cancer in pregnancy - Successfully treated with chemotherapy and surgery. Gynecol-Oncol-Rep. 2023;47:1-4$$$$F$Y$$$20240704$$HP$GB$GB
240502941$24050294$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-031991$AUROBINDO$Zaidi W, Saeed AI, Lundquist N, Nelson AR, Razia D, Lee R, et al. Bronchoscopic Debridement of Endobronchial Rhizopus With 1.1 Mm Cryoprobe in Lung Transplant Recipient. Am-J-Respir-CritCare-Med. 2024;209:A2369$67$YR$$M$Y$$$20240704$$HP$US$US
240502951$24050295$1$I$$20240626$20240704$20240704$EXP$$US-AMGEN-USASP2024127439$AMGEN$$77$YR$E$F$Y$$$20240704$$CN$US$US
240502961$24050296$1$I$20240617$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130662$AMGEN$$77$YR$E$F$Y$$$20240704$$CN$US$US
240502971$24050297$1$I$20240701$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131608$AMGEN$$75$YR$E$F$Y$$$20240704$$CN$US$US
240502981$24050298$1$I$$20240626$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007897$STRIDES$Bergus KC, Srinivas S, Minneci PC. Site wedge resection technique for gastrostomy tube site revision: A case series.. J-Pediatr-Surg-Case-Reports. 2024;107$8$YR$$M$Y$$$20240704$$HP$US$US
240502992$24050299$2$F$20240531$20240708$20240704$20240716$EXP$$US-TEVA-VS-3215889$TEVA$$25$YR$$F$Y$$$20240716$$HP$US$US
240503001$24050300$1$I$20240528$20240626$20240704$20240704$EXP$$US-TEVA-VS-3215503$TEVA$$30$YR$$F$Y$$$20240704$$CN$US$US
240503011$24050301$1$I$20240605$20240626$20240704$20240704$EXP$$RS-TEVA-VS-3215157$TEVA$$58$YR$$F$Y$70$KG$20240704$$MD$RS$RS
240503021$24050302$1$I$$20240703$20240704$20240704$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037768$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240704$$CN$US$US
240503031$24050303$1$I$$20240625$20240704$20240704$EXP$$MY-TEVA-VS-3214736$TEVA$$57$YR$$F$Y$$$20240704$$PH$MY$MY
240503041$24050304$1$I$20240101$20240628$20240704$20240704$EXP$$US-ABBVIE-5822202$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240503052$24050305$2$F$20210101$20240703$20240704$20240712$EXP$PT-STRIDES ARCOLAB LIMITED-2024SP007888$PT-STRIDES ARCOLAB LIMITED-2024SP007888$STRIDES$Paulo N, Goncalves PL, Cerqueira A, Araujo J, Sampaio S, Vasconcelos MP.. Recurrent parvovirus B19 infection-associated pure red cell aplasia in kidney transplantation.. Nephrology Dialysis Transplantation. 2024;39(Supplement 1:i2698 abstr. 1572.$42$YR$$M$Y$$$20240712$$MD$PT$PT
240503063$24050306$3$F$20240627$20240705$20240704$20240711$PER$$US-BIOGEN-2024BI01271919$BIOGEN$$66$YR$$F$Y$$$20240711$$CN$US$US
240503071$24050307$1$I$20240624$20240702$20240704$20240704$EXP$GB-MHRA-MED-202407020836118930-PQFBJ$GB-ORGANON-O2407GBR000239$ORGANON$$29$YR$$F$Y$92$KG$20240704$$CN$GB$GB
240503081$24050308$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-031996$AUROBINDO$Huff RR, Jose A, Taillon J.. Unlikely Friends: Coinfection of a Malignant Cavitary Lesion With Aspergillus and Actinomyces.. Am-J-Respir-Crit-Care-Med. 2024;209:A2379$58$YR$$M$Y$$$20240704$$HP$US$US
240503091$24050309$1$I$$20240627$20240704$20240704$EXP$$US-JNJFOC-20240700338$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240704$$CN$US$US
240503102$24050310$2$F$$20240708$20240704$20240718$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024081168$VIIV$$$$$$Y$$$20240718$$MD$US$US
240503111$24050311$1$I$20240611$20240612$20240704$20240704$PER$$BR-TOLMAR, INC.-24BR050194$TOLMAR$$10$YR$$F$Y$$$20240704$$CN$BR$BR
240503122$24050312$2$F$20240520$20240702$20240704$20240724$PER$$BR-TOLMAR, INC.-24BR050196$TOLMAR$$81$YR$$M$Y$$$20240724$$HP$BR$BR
240503132$24050313$2$F$20240101$20240703$20240704$20240731$PER$$CA-TOLMAR, INC.-24CA049175$TOLMAR$$$$$M$Y$$$20240731$$HP$CA$CA
240503141$24050314$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106668$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240704$$HP$US$US
240503151$24050315$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106625$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240704$$CN$US$US
240503161$24050316$1$I$$20240613$20240704$20240704$PER$$CA-TOLMAR, INC.-24CA049693$TOLMAR$$$$$M$Y$$$20240704$$CN$CA$CA
240503171$24050317$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032403$AUROBINDO$Tarras ES, Sen S, Wang H, Singh I. Tumoral Pulmonary Hypertension in a Patient With Metastatic Breast Cancer: Diagnostic Opportunity of the Right Heart Catheterization. Am-J-Respir-Crit-CareMed. 2024;209:A2208$76$YR$$F$Y$$$20240704$$HP$US$US
240503181$24050318$1$I$$20240621$20240704$20240704$EXP$$US-CIPLA LTD.-2024US06930$CIPLA$O?Halloran K, Phadnis S, Friedman GK, Metrock K, Davidson TB, Robison NJ, et al. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6(1), vdae070:1 to 9$$$$$Y$$$20240704$$HP$US$US
240503191$24050319$1$I$$20240624$20240704$20240704$EXP$$BR-SAMSUNG BIOEPIS-SB-2024-20060$SAMSUNG BIOEPIS$Randi B. Fatal hepatic mucormycosis in an allogeneic hematopoietic-stem cell transplanted patient: Case report of a rare presentation and review of the literature. Journal of Infection and Chemotherapy. 2024 JUN 14;. doi:10.1016/j.jiac.2024.06.006$36$YR$A$M$Y$$$20240704$$HP$BR$BR
240503201$24050320$1$I$$20240626$20240704$20240704$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007878$STRIDES$Koga S, Pai E, Banihashemi A.. Diffuse lymphocytic encephalomyelitis with stiffperson- like syndrome in multiple myeloma after Teclistamab treatment.. J-Neuropathol-Exp-Neurol. 2024;83 (6):457-458 abstr. 5.$45$YR$$M$Y$$$20240704$$HP$US$US
240503211$24050321$1$I$$20240621$20240704$20240704$EXP$$US-CIPLA LTD.-2024US06935$CIPLA$O?halloran K, Phadnis S, Friedman GK, Metrock K, Davidson TB, Robison NJ, et al. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6(1), vdae070:1 to 9$$$$$Y$$$20240704$$HP$US$US
240503221$24050322$1$I$$20240626$20240704$20240704$EXP$$CH-STRIDES ARCOLAB LIMITED-2024SP007873$STRIDES$Bours B, Barcena C, Cairoli A, De Leval L, Schaefer N, Segot A.. Primary bone marrow lymphoma (PBML): a rare cause of chronic inflammation with diffuse bone marrow hypermetabolism.. Swiss-Med-Wkly. 2023;153 (Suppl. 274:69S-70S abstr. 279$81$YR$$F$Y$$$20240704$$HP$CH$CH
240503231$24050323$1$I$20221101$20240626$20240704$20240704$EXP$$GB-AUROBINDO-AUR-APL-2024-031815$AUROBINDO$$37$YR$$F$Y$$$20240704$$CN$GB$GB
240503242$24050324$2$F$20240404$20240813$20240704$20240819$PER$$US-AMGEN-USASP2024128110$AMGEN$$51$YR$A$F$Y$$$20240819$$PH$US$US
240503251$24050325$1$I$20240621$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024130524$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240503263$24050326$3$F$$20240704$20240704$20240715$EXP$$IT-AUROBINDO-AUR-APL-2024-031799$AUROBINDO$Costantini I, Mantelli G, Carollo M, Losso L, Morando E, Bacchion M, et al.. Not only Van Gogh: a case of BRASH syndrome with concomitant digoxin toxicity. Journal of Medical Case Reports. 2024;18 (1):273$66$YR$$F$Y$$$20240715$$MD$IT$IT
240503271$24050327$1$I$20231225$20240701$20240704$20240704$EXP$$JP-AMGEN-JPNSP2024062254$AMGEN$$$$$M$Y$$$20240704$$MD$JP$JP
240503281$24050328$1$I$$20240701$20240704$20240704$EXP$GB-MHRA-MIDB-b13c9216-0236-4bf2-b228-6b20ef976515$GB-STRIDES ARCOLAB LIMITED-2024SP007903$STRIDES$$74$YR$$M$Y$$$20240704$$PH$GB$GB
240503291$24050329$1$I$$20240701$20240704$20240704$PER$$US-ABBVIE-5825341$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240503301$24050330$1$I$$20240621$20240704$20240704$EXP$$US-CIPLA LTD.-2024US06882$CIPLA$Song E. Case report: Approaches for managing resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplantation recipients. Frontiers in Pediatrics. 2024;12:1394006:1 to 8$$$$$Y$$$20240704$$HP$US$US
240503311$24050331$1$I$20240323$20240621$20240704$20240704$EXP$$GB-CIPLA LTD.-2024GB06711$CIPLA$$$$$$Y$$$20240704$$CN$GB$GB
240503321$24050332$1$I$$20240624$20240704$20240704$EXP$$US-GRAVITIPHARMA-GRA-2406-US-LIT-0187$GRAVITI PHARMACEUTICALS$Lam E, Santos C, Patrawalla AS.A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose..Am-J-Respir-Crit-Care-Med.2024;209:A5651$32$YR$A$F$Y$$$20240704$$HP$US$US
240503331$24050333$1$I$$20240626$20240704$20240704$EXP$$IT-AUROBINDO-AUR-APL-2024-032368$AUROBINDO$Tammaro A, Adebanjo GAR, Chello C, Capalbo A, Alexander S, Trischitta G, et al.. Bullous pemphigoid associated with pleural mesothelioma: a controversial etiology. Were the bullous lesions induced by pembrolizumab or related to malignancy?. J-Appl-Cosmetol. 2022;40(2):176-179$72$YR$$M$Y$$$20240704$$HP$IT$IT
240503342$24050334$2$F$20240101$20240726$20240704$20240805$EXP$$US-JNJFOC-20240677618$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240805$$HP$US$US
240503351$24050335$1$I$$20240626$20240704$20240704$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP007879$STRIDES$Li C, Zheng X, Zhang L, Wang Y, Hu R, Cui H-Y, et al.. Obinutuzumab for the treatment of refractory PLA2R-associated membranous nephropathy: a single-center cohort study.. Nephrol-Dial-Transplant. 2024;39 (Suppl. 1).$$$$$Y$$$20240704$$HP$CN$CN
240503361$24050336$1$I$20240520$20240702$20240704$20240704$PER$$US-JNJFOC-20240706299$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240503372$24050337$2$F$20240606$20240809$20240704$20240816$EXP$GB-MHRA-TPP36064774C23315082YC1719488124401$GB-STRIDES ARCOLAB LIMITED-2024SP007867$STRIDES$$89$YR$$F$Y$55$KG$20240816$$PH$GB$GB
240503382$24050338$2$F$$20240725$20240704$20240802$30DAY$$CN-JNJFOC-20240707524$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$CN$CN
240503391$24050339$1$I$20240702$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002858$ELI LILLY AND CO$$87$YR$E$M$Y$$$20240704$$CN$US$US
240503401$24050340$1$I$20240629$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002679$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240704$$CN$US$US
240503411$24050341$1$I$20240601$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407003044$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240704$$CN$US$US
240503421$24050342$1$I$20240625$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001967$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240704$$CN$US$US
240503431$24050343$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002598$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240704$$CN$US$US
240503442$24050344$2$F$$20240705$20240704$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202406018837$ELI LILLY AND CO$$$$$M$Y$$$20240708$$CN$US$US
240503453$24050345$3$F$20190601$20240830$20240704$20240903$PER$$US-GILEAD-2024-0679549$GILEAD$$55$YR$A$M$Y$$$20240903$$LW$US$US
240503461$24050346$1$I$$20240626$20240704$20240704$EXP$$LK-STRIDES ARCOLAB LIMITED-2024SP007880$STRIDES$Dandeniya CL, Premathilake TK.. Thrombotic and immunological phenomena following COVID-19 vaccination: experience from a case series. RMD-Open. 2023;9 (1)$58$YR$$F$Y$$$20240704$$MD$LK$LK
240503471$24050347$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032042$AUROBINDO$Bolivar SA, Holman P, Eng KJ, Betancourt J.. Black Esophagus: A Case of Sevelamer Induced Esophagitis Presenting as a Gastrointestinal Bleed. Am-J-Respir-Crit-Care-Med. 2024$92$YR$$M$Y$$$20240704$$HP$US$US
240503481$24050348$1$I$$20240624$20240704$20240704$PER$$US-TEVA-VS-3214353$TEVA$$$$$$Y$$$20240704$$CN$US$US
240503491$24050349$1$I$$20231227$20240704$20240704$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04538$AMNEAL$$$$$F$Y$$$20240704$$CN$US$US
240503501$24050350$1$I$20210101$20240624$20240704$20240704$EXP$$FR-TEVA-VS-3215327$TEVA$Paradis C, Zarrouk E, de Ferrieres O, Foulgoc H, Langrand J, Lan M, et al. Fatal case of sodium fluoroacetate poisoning in two young children. Toxic-Analyt-Clinique 2023; 35 (3): 262-265.$12$MON$$F$Y$$$20240704$$HP$FR$FR
240503513$24050351$3$F$$20240812$20240704$20240819$EXP$$CA-GSK-CA2024050612$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$HP$CA$CA
240503521$24050352$1$I$20240627$20240628$20240704$20240704$EXP$$US-GSK-US2024081073$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240704$$CN$US$US
240503531$24050353$1$I$$20240626$20240704$20240704$EXP$$LK-STRIDES ARCOLAB LIMITED-2024SP007881$STRIDES$Dandeniya CL, Premathilake TK.. Thrombotic and immunological phenomena following COVID-19 vaccination: experience from a case series.. RMD-Open. 2023;9 (1)$53$YR$$F$Y$$$20240704$$MD$LK$LK
240503541$24050354$1$I$$20240627$20240704$20240704$EXP$$NVSC2024VE138315$NOVARTIS$$$$A$F$Y$$$20240704$$MD$VE$VE
240503551$24050355$1$I$20240621$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024130445$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240503561$24050356$1$I$$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024127971$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240503571$24050357$1$I$$20240621$20240704$20240704$EXP$$CA-TEVA-VS-3213135$TEVA$$65$YR$$F$Y$$$20240704$$HP$CA$CA
240503581$24050358$1$I$$20240621$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05623$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240503591$24050359$1$I$20240501$20240628$20240704$20240704$EXP$$US-ABBVIE-5771790$ABBVIE$$65$YR$$F$Y$53$KG$20240704$$CN$US$US
240503603$24050360$3$F$20200122$20240912$20240704$20240916$PER$$US-GILEAD-2024-0679477$GILEAD$$35$YR$A$M$Y$$$20240916$$LW$US$US
240503612$24050361$2$F$20210101$20240710$20240704$20240720$EXP$$FR-TEVA-VS-3215330$TEVA$Paradis C, Zarrouk E, de Ferrieres O, Foulgoc H, Langrand J, Lan M, et al. Fatal case of sodium fluoroacetate poisoning in two young children. Toxic-Analyt-Clinique 2023; 35 (3): 262-265.; Paradis C, Zarrouk E, de Ferrieres O, Foulgoc H, Langrand J, Lan M, et al. Fatal case of sodium fluoroacetate poisoning in two young children. Toxic-Analyt-Clinique 2023; 35 (3): 262-265.$11$MON$$M$Y$$$20240720$$HP$FR$FR
240503621$24050362$1$I$20240615$20240703$20240704$20240704$PER$$US-GILEAD-2024-0679446$GILEAD$$60$YR$A$M$Y$$$20240704$$CN$US$US
240503631$24050363$1$I$$20240627$20240704$20240704$PER$$US-ALXN-202406USA001830US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240704$$CN$US$US
240503642$24050364$2$F$20231112$20240701$20240704$20240730$EXP$$NVSC2023FR257664$NOVARTIS$$$$A$F$Y$69$KG$20240730$$MD$FR$FR
240503651$24050365$1$I$$20240701$20240704$20240704$PER$$NVSC2024US137676$NOVARTIS$$25$YR$$M$Y$$$20240704$$CN$US$US
240503661$24050366$1$I$$20240619$20240704$20240704$PER$$US-JNJFOC-20240652446$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240503673$24050367$3$F$20240702$20240807$20240704$20240809$30DAY$$US-JNJFOC-20240706453$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240809$$PH$US$US
240503681$24050368$1$I$$20240627$20240704$20240704$PER$$US-009507513-2407USA000261$MERCK$Vlachou E, Johnson BA, Guancial E, Lombardo KA, Hoffman-Censits J. Frontline immune checkpoint inhibitors in patients = 90 years with advanced urothelial cancer: a single center experience. The Canadian journal of urology. 2024;31(3):11875-9$98$YR$$M$Y$$$20240704$$MD$US$US
240503691$24050369$1$I$$20240621$20240704$20240704$EXP$$GB-LUPIN PHARMACEUTICALS INC.-2024-05606$LUPIN$$$$$M$Y$$$20240704$$CN$GB$GB
240503701$24050370$1$I$20231224$20240626$20240704$20240704$EXP$$FR-AUROBINDO-AUR-APL-2024-031877$AUROBINDO$$34$YR$$M$Y$69$KG$20240704$$MD$FR$FR
240503712$24050371$2$F$20240625$20240708$20240704$20240711$PER$$US-AMGEN-USASP2024129804$AMGEN$$58$YR$A$F$Y$$$20240711$$CN$US$US
240503721$24050372$1$I$$20231123$20240704$20240704$PER$$US-AMGEN-USASP2023235342$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240503731$24050373$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032383$AUROBINDO$Abdalla AA, Ali RF, Zamora-Martinez AC, Wesselius LJ. Vexas Syndrome Presenting as Recurrent Relapses of Organizing Pneumonia. Am-J-Respir-Crit-Care-Med. 2024;209:A5321$70$YR$$M$Y$$$20240704$$HP$US$US
240503741$24050374$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106838$BRISTOL MYERS SQUIBB$$68$YR$E$$Y$94.8$KG$20240704$$CN$US$US
240503751$24050375$1$I$20240626$20240626$20240704$20240704$30DAY$$US-GSK-US2024079870$GLAXOSMITHKLINE$$$$A$F$Y$$$20240704$$CN$US$US
240503762$24050376$2$F$20230101$20240726$20240704$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103161$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240802$$CN$US$US
240503772$24050377$2$F$$20240704$20240704$20240708$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR078586$VIIV$$$$A$M$Y$$$20240708$$CN$US$US
240503781$24050378$1$I$$20240627$20240704$20240704$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR081221$VIIV$$$$A$F$Y$$$20240704$$CN$US$US
240503791$24050379$1$I$$20240629$20240704$20240704$30DAY$$PR-VIIV HEALTHCARE LIMITED-PR2024081573$VIIV$$85$YR$$F$Y$$$20240704$$MD$PR$US
240503803$24050380$3$F$20240101$20240723$20240704$20240802$EXP$$US-INSMED, INC.-2024-02263-US$INSMED$$$$$M$Y$$$20240802$$CN$US$US
240503811$24050381$1$I$$20240624$20240704$20240704$EXP$$UA-TEVA-VS-3213432$TEVA$$59$YR$$F$Y$$$20240704$$MD$UA$UA
240503821$24050382$1$I$$20240625$20240704$20240704$EXP$$PL-RDY-LIT/POL/24/0009383$DR REDDYS$Wcis?o S, Bojkowska-Otr?bska K, Salamon A, Skowronek A, Kandziora K, Labuz-Roszak B. Zespo? cytotoksycznego uszkodzenia cia?a modzelowatego - opis trzech przypadkow. Polski Przegl?d Neurologiczny. 2024;20(1): 37-42. doi:10.56/ppn.97446.$48$YR$A$M$Y$$$20240704$$HP$PL$PL
240503835$24050383$5$F$20240101$20240819$20240704$20240827$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00545$MIRUM PHARMACEUTICALS$$10$MON$$F$Y$$$20240827$$HP$US$US
240503841$24050384$1$I$$20240701$20240704$20240704$EXP$$US-TAKEDA-2024TUS067147$TAKEDA$$$$$F$Y$$$20240704$$MD$US$US
240503851$24050385$1$I$20240101$20240627$20240704$20240704$PER$$US-MYLANLABS-2024M1061172$MYLAN$$$$$F$Y$63.05$KG$20240704$$CN$US$US
240503871$24050387$1$I$20240701$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131845$AMGEN$$80$YR$E$M$Y$$$20240704$$CN$US$US
240503881$24050388$1$I$20240626$20240703$20240704$20240704$EXP$IT-MINISAL02-992822$IT-JNJFOC-20240709027$JOHNSON AND JOHNSON$$58$YR$A$M$Y$90$KG$20240704$$HP$IT$IT
240503901$24050390$1$I$20240531$20240619$20240704$20240704$EXP$$JP-ROCHE-10000008172$ROCHE$$6$DEC$A$F$Y$$$20240704$$MD$JP$JP
240503921$24050392$1$I$20240401$20240701$20240704$20240704$30DAY$$US-GSK-US2024081611$GLAXOSMITHKLINE$$63$YR$$F$Y$93.89$KG$20240704$$CN$US$US
240503931$24050393$1$I$$20240627$20240704$20240704$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR081514$VIIV$$$$$$Y$$$20240704$$MD$US$US
240503941$24050394$1$I$20240604$20240701$20240704$20240704$EXP$$US-BEH-2024174875$CSL BEHRING$$43$YR$A$M$Y$$$20240704$$HP$US$US
240503951$24050395$1$I$20240301$20240628$20240704$20240704$EXP$$DE-ABBVIE-5822715$ABBVIE$$31$YR$$F$Y$$$20240704$$CN$DE$DE
240503961$24050396$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131485$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240503971$24050397$1$I$$20240621$20240704$20240704$EXP$$CA-TEVA-VS-3213131$TEVA$$65$YR$$F$Y$$$20240704$$HP$CA$CA
240503981$24050398$1$I$20240621$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024130583$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240503991$24050399$1$I$$20230804$20240704$20240704$PER$$US-AMGEN-USASP2023235484$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240504001$24050400$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130378$AMGEN$$$$$M$Y$$$20240704$$PH$US$US
240504013$24050401$3$F$20240101$20240822$20240704$20240830$EXP$$CA-CELLTRION INC.-2024CA015955$CELLTRION$$$$$$Y$$$20240830$$MD$CA$CA
240504021$24050402$1$I$$20240702$20240704$20240704$EXP$$NVSC2024AT138302$NOVARTIS$$$$E$F$Y$$$20240704$$MD$AT$AT
240504031$24050403$1$I$20240624$20240624$20240704$20240704$PER$$US-JNJFOC-20240664491$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240704$$CN$US$US
240504042$24050404$2$F$20240301$20240717$20240704$20240724$EXP$$GR-JNJFOC-20240678793$JOHNSON AND JOHNSON$$12$YR$T$F$Y$55$KG$20240724$$CN$GR$GR
240504052$24050405$2$F$$20240705$20240704$20240706$PER$$US-JNJFOC-20240707457$JOHNSON AND JOHNSON$$$$$F$Y$$$20240706$$HP$US$US
240504062$24050406$2$F$20160101$20240913$20240704$20240918$PER$$US-GILEAD-2024-0679518$GILEAD$$48$YR$A$M$Y$$$20240918$$LW$US$US
240504071$24050407$1$I$$20240624$20240704$20240704$PER$$US-TEVA-VS-3213568$TEVA$$$$A$F$Y$$$20240704$$HP$US$US
240504082$24050408$2$F$20240621$20240701$20240704$20240710$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020079$UNITED THERAPEUTICS$$41$YR$$M$Y$52.154$KG$20240710$$$US$US
240504092$24050409$2$F$$20240803$20240704$20240805$30DAY$$FR-PFIZER INC-202400202529$PFIZER$$$$$$Y$$$20240805$$HP$FR$FR
240504101$24050410$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032636$AUROBINDO$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al.. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. Rheumatology. 2024;63(5):1291-1296$35$YR$$M$Y$$$20240704$$HP$US$US
240504111$24050411$1$I$$20240627$20240704$20240704$EXP$$CN-UCBSA-2024033043$UCB$$$$$F$Y$$$20240704$$MD$CN$CN
240504121$24050412$1$I$20231014$20240627$20240704$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-105928$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$MD$JP$JP
240504131$24050413$1$I$$20240620$20240704$20240704$EXP$$AU-BRAEBURN-AU-BRA-24-000613$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240704$$HP$AU$AU
240504141$24050414$1$I$20240327$20240630$20240704$20240704$EXP$$NVSC2024IN069018$NOVARTIS$$55$YR$$F$Y$$$20240704$$CN$IN$IN
240504152$24050415$2$F$20240101$20240820$20240704$20240821$EXP$$JP-ABBVIE-5825900$ABBVIE$$70$YR$$M$Y$$$20240821$$PH$JP$JP
240504162$24050416$2$F$$20240701$20240704$20240710$EXP$$GB-AUROBINDO-AUR-APL-2024-032396$AUROBINDO$Samraj S, Olasoji K, Patel R.. Loss of control of herpes suppression following bariatric surgery.. Int J STD AIDS. 2024;1?2$42$YR$$F$Y$$$20240710$$HP$GB$GB
240504172$24050417$2$F$$20240708$20240704$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05745$LUPIN$$$$$$Y$$$20240806$$CN$US$US
240504181$24050418$1$I$20240603$20240624$20240704$20240704$30DAY$$US-GSK-US2024078206$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240704$$CN$US$US
240504191$24050419$1$I$20201127$20240701$20240704$20240704$EXP$$NVSC2024DE137246$NOVARTIS$$58$YR$$M$Y$$$20240704$$MD$DE$DE
240504201$24050420$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A148892$ASTRAZENECA$$60$YR$$F$Y$$$20240704$$CN$ZA$
240504211$24050421$1$I$$20240626$20240704$20240704$EXP$$AU-AstraZeneca-2024A148387$ASTRAZENECA$$$$$$Y$$$20240704$$MD$AU$
240504221$24050422$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A148012$ASTRAZENECA$$59$YR$$F$Y$60.3$KG$20240704$$CN$US$
240504231$24050423$1$I$$20240624$20240704$20240704$EXP$$US-TEVA-VS-3214031$TEVA$Ghabra S, Desale S, Sugarbaker PH. Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years. Dis-Colon-Rectum 2023; 66 (10): 1329-1338.; Ghabra S, Desale S, Sugarbaker PH. Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years. Dis-Colon-Rectum 2023; 66 (10): 1329-1338.$31$YR$$M$Y$$$20240704$$MD$US$US
240504241$24050424$1$I$20240625$20240625$20240704$20240704$EXP$GB-MHRA-MED-202406250919257530-VZWCK$GB-Accord-432707$ACCORD$$79$YR$E$F$Y$$$20240704$$MD$GB$GB
240504251$24050425$1$I$20240527$20240622$20240704$20240704$EXP$FR-AFSSAPS-PA2024001273$FR-Accord-432167$ACCORD$$62$YR$$F$Y$76$KG$20240704$$MD$FR$FR
240504261$24050426$1$I$$20240625$20240704$20240704$EXP$CN-HENLIUS-24CN015606$CN-Accord-433313$ACCORD$$$$A$F$Y$60$KG$20240704$$MD$CN$CN
240504271$24050427$1$I$$20240619$20240704$20240704$EXP$$CH-GRANULES-CH-2024GRALIT00251$GRANULES INDIA$Emmanuelle Massie.Combined lactic acidosis and ketoacidosis in a female  diabetic patient with severe heart failure.Cardiovascular Endocrinology + Metabolism.14-JUN-2023;12:1-3$58$YR$A$F$Y$$$20240704$$MD$CH$CH
240504281$24050428$1$I$20240127$20240625$20240704$20240704$EXP$FR-AFSSAPS-DJ2024000631$FR-TEVA-VS-3214486$TEVA$$62$YR$$M$Y$$$20240704$$MD$FR$FR
240504292$24050429$2$F$20240530$20240711$20240704$20240725$PER$$US-Calliditas-2024CAL01171$CALLIDITAS THERAPEUTICS$$53$YR$A$M$Y$$$20240724$$HP$US$US
240504301$24050430$1$I$20240101$20240703$20240704$20240704$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037765$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240704$$CN$US$US
240504321$24050432$1$I$20240601$20240624$20240704$20240704$EXP$$JP-UCBSA-2024032686$UCB$$6$DEC$$$Y$$$20240704$$MD$JP$JP
240504331$24050433$1$I$20240601$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002891$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240704$$CN$US$US
240504341$24050434$1$I$$20240626$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002836$ELI LILLY AND CO$$64$YR$A$M$Y$95.7$KG$20240704$$CN$US$US
240504351$24050435$1$I$$20240701$20240704$20240704$PER$$US-ABBVIE-5825197$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240504362$24050436$2$F$$20240802$20240704$20240806$PER$$US-ALXN-202406USA001758US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240504381$24050438$1$I$20240201$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001650$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240704$$CN$US$US
240504392$24050439$2$F$$20240802$20240704$20240815$EXP$$GB-UCBSA-2024033939$UCB$$$$$F$Y$$$20240815$$HP$GB$GB
240504401$24050440$1$I$20240620$20240626$20240704$20240704$EXP$$US-ALXN-202406USA001736US$ALEXION PHARMACEUTICALS$$76$YR$$M$Y$$$20240704$$HP$US$US
240504423$24050442$3$F$$20240621$20240704$20240709$PER$$US-ROCHE-10000012997$ROCHE$$$$E$M$Y$$$20240704$$PH$US$US
240504431$24050443$1$I$20210310$20240702$20240704$20240704$EXP$$CA-TAKEDA-2024TUS067462$TAKEDA$$61$YR$$M$Y$$$20240704$$CN$CA$CA
240504451$24050445$1$I$$20240625$20240704$20240704$EXP$CA-MHPD-E2B_07055900$CA-Accord-432541$ACCORD$$68$YR$E$$Y$$$20240704$$MD$CA$CA
240504461$24050446$1$I$20231112$20240624$20240704$20240704$EXP$GB-MHRA-MED-202406231830427040-HGDSW$GB-Accord-432291$ACCORD$$33$YR$A$F$Y$84$KG$20240704$$CN$GB$GB
240504471$24050447$1$I$$20240625$20240704$20240704$EXP$CA-MHPD-001090751$CA-Accord-432431$ACCORD$$46$YR$A$F$Y$$$20240704$$PH$CA$CA
240504481$24050448$1$I$$20230515$20240704$20240704$PER$$US-AMGEN-USASP2023235509$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240504491$24050449$1$I$20240517$20240624$20240704$20240704$EXP$$BR-Accord-431112$ACCORD$$54$YR$A$F$Y$73$KG$20240704$$PH$BR$BR
240504501$24050450$1$I$$20230310$20240704$20240704$PER$$US-AMGEN-USASP2023235511$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240504531$24050453$1$I$20220101$20240624$20240704$20240704$EXP$$CH-NORDICGR-056643$NORDIC PHARMA$Jetter A, Degrandib C, Faberb K et al. Caution with low-dose methotrexate. Bull Med Suisses. 2024;105(24):36-39. doi: 10.4414/saez.2024.1458264159; Jetter A, Degrandib C, Faberb K et al. Caution with low-dose methotrexate. Bull Med Suisses. 2024;105(24):36-39. doi: 10.4414/saez.2024.1458264159$$$E$F$Y$$$20240704$$MD$CH$CH
240504541$24050454$1$I$20220101$20240624$20240704$20240704$EXP$$CH-NORDICGR-056644$NORDIC PHARMA$Jetter A, Degrandib C, Faberb K et al. Caution with low-dose methotrexate. Bull Med Suisses. 2024;105(24):36-39. doi: 10.4414/saez.2024.1458264159; Jetter A, Degrandib C, Faberb K et al. Caution with low-dose methotrexate. Bull Med Suisses. 2024;105(24):36-39. doi: 10.4414/saez.2024.1458264159$$$E$$Y$$$20240704$$MD$CH$CH
240504551$24050455$1$I$$20231226$20240704$20240704$PER$$US-AMGEN-USASP2023235573$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240504561$24050456$1$I$20220101$20240624$20240704$20240704$EXP$$CH-NORDICGR-056642$NORDIC PHARMA$Jetter A, Degrandib C, Faberb K et al. Caution with low-dose methotrexate. Bull Med Suisses. 2024;105(24):36-39. doi: 10.4414/saez.2024.1458264159; Jetter A, Degrandib C, Faberb K et al. Caution with low-dose methotrexate. Bull Med Suisses. 2024;105(24):36-39. doi: 10.4414/saez.2024.1458264159$$$E$$Y$$$20240704$$MD$CH$CH
240504571$24050457$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130706$AMGEN$Mueller S. W.; Molina K. C.; Blass B. et al.. Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa. Journal of Burn Care and Research. 2024;45 (3):808-810$48$YR$A$M$Y$$$20240704$$HP$US$US
240504581$24050458$1$I$$20240626$20240704$20240704$PER$$US-AMGEN-USASP2024128568$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240504591$24050459$1$I$$20240626$20240704$20240704$EXP$$AT-CLINIGEN-AT-CLI-2024-010390$CLINIGEN$$$$$$Y$$$20240704$$PH$AT$AT
240504601$24050460$1$I$$20240619$20240704$20240704$EXP$$US-GRANULES-US-2024GRALIT00250$GRANULES INDIA$H Reda.Neurologic Complications of Endocrine Disorders.Continuum Lifelong Learning in Neurology .JUN-2023;29:887-902$70$YR$E$M$Y$$$20240704$$HP$US$US
240504611$24050461$1$I$$20240621$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05878$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240504621$24050462$1$I$$20240621$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05779$LUPIN$$$$$$Y$$$20240704$$HP$US$US
240504631$24050463$1$I$$20240625$20240704$20240704$30DAY$$US-GSK-US2024AMR061155$GLAXOSMITHKLINE$$$$$M$Y$$$20240704$$CN$US$US
240504641$24050464$1$I$20240628$20240703$20240704$20240704$EXP$GB-MHRA-MED-202407030306076070-MLWDZ$GB-ORGANON-O2407GBR000268$ORGANON$$31$YR$$F$Y$$$20240704$$CN$GB$GB
240504651$24050465$1$I$$20230213$20240704$20240704$PER$$US-AMGEN-USASP2023235459$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240504663$24050466$3$F$20100219$20240912$20240704$20240917$EXP$$US-GILEAD-2024-0679520$GILEAD$$40$YR$A$M$Y$$$20240917$$LW$US$US
240504671$24050467$1$I$$20240625$20240704$20240704$EXP$$CN-STERISCIENCE B.V.-2024-ST-000956$Steriscience PTE$Jin Y, Xu J, Hua Y, Zhang H, Li Y.. Challenging of ECMO application in pediatric restrictive cardiomyopathy: case report of a novel TNNI3 variant.. Front-Cardiovasc-Med. 2024;11$8$YR$$F$Y$$$20240704$$HP$CN$CN
240504681$24050468$1$I$20240228$20240627$20240704$20240704$EXP$$CA-TAKEDA-2024TUS064870$TAKEDA$$50$YR$$M$Y$83$KG$20240704$$HP$CA$CA
240504692$24050469$2$F$$20240705$20240704$20240711$EXP$$CA-TAKEDA-2024TUS067486$TAKEDA$$$$$M$Y$$$20240711$$MD$CA$CA
240504713$24050471$3$F$20100201$20240903$20240704$20240905$PER$$US-GILEAD-2024-0679552$GILEAD$$49$YR$A$M$Y$$$20240905$$LW$US$US
240504722$24050472$2$F$20240614$20240821$20240704$20240902$EXP$$US-BEH-2024174790$CSL BEHRING$$24$YR$A$F$Y$$$20240902$$HP$US$US
240504731$24050473$1$I$$20240703$20240704$20240704$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037772$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240704$$CN$US$US
240504751$24050475$1$I$$20240629$20240704$20240704$PER$$US-ABBVIE-5824388$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240504761$24050476$1$I$20240625$20240627$20240704$20240704$PER$$US-ALXN-202406USA001800US$ALEXION PHARMACEUTICALS$$62$YR$$$Y$$$20240704$$CN$US$US
240504781$24050478$1$I$$20240626$20240704$20240704$EXP$$AU-AstraZeneca-2024A149318$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$AU$
240504791$24050479$1$I$$20240702$20240704$20240704$EXP$$NVSC2024US138382$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240504801$24050480$1$I$$20240621$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05735$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240504811$24050481$1$I$$20240627$20240704$20240704$EXP$$US-GSK-US2024080911$GLAXOSMITHKLINE$$$$$F$Y$$$20240704$$HP$US$US
240504822$24050482$2$F$$20240710$20240704$20240720$EXP$$IT-TEVA-VS-3214882$TEVA$Michelerio A, Tomasini C, Fiandrino G, De Amici M, Varettoni M, Defrancesco I, et al. Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin^s B lymphoma: a single center prospective clinico-pathological study. Front-Med 2023; 10 1-10.; Michelerio A, Tomasini C, Fiandrino G, De Amici M, Varettoni M, Defrancesco I, et al. Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin^s B lymphoma:...$53$YR$$F$Y$$$20240720$$HP$IT$IT
240504832$24050483$2$F$$20240805$20240704$20240808$PER$$US-UNITED THERAPEUTICS-UNT-2024-017779$UNITED THERAPEUTICS$$$$$M$Y$10.884$KG$20240808$$$US$US
240504841$24050484$1$I$20240101$20240627$20240704$20240704$EXP$$US-ABBVIE-5825190$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240504851$24050485$1$I$$20240626$20240704$20240704$EXP$$CZ-AUROBINDO-AUR-APL-2024-031828$AUROBINDO$Mocikova H.. Treatment of angioimmunoblastic lymphoma with the combination of brentuximab vedotin with cyclophosphamide, doxorubicin and prednisone.. kaczynski/klinicka praxis.. 2024;20 (S6):1-36$71$YR$$M$Y$$$20240704$$HP$CZ$CZ
240504871$24050487$1$I$$20240701$20240704$20240704$EXP$$NVSC2024PK137924$NOVARTIS$Shah SYM, Ajmal, Nawaz D, Lodhi AU, Rehman J, Banaras F, et al.. The responsiveness of childhood/adolescent chronic myeloid leukaemia patients of pakistani origin to tyrosine kinase inhibitor. J AYUB MED COLL ABBOTTABAD. 2023;35 (2):313-5$17$YR$$M$Y$$$20240704$$HP$PK$PK
240504881$24050488$1$I$$20230127$20240704$20240704$PER$$US-AMGEN-USASP2023235438$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240504892$24050489$2$F$20240620$20240826$20240704$20240828$PER$$US-AMGEN-USASP2024130672$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
240504901$24050490$1$I$$20231130$20240704$20240704$PER$$US-AMGEN-USASP2023235570$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240504911$24050491$1$I$$20230515$20240704$20240704$PER$$US-AMGEN-USASP2023235541$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240504921$24050492$1$I$20240628$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130377$AMGEN$$78$YR$E$F$Y$$$20240704$$CN$US$US
240504941$24050494$1$I$$20240626$20240704$20240704$EXP$$DE-AUROBINDO-AUR-APL-2024-032394$AUROBINDO$Doldi F, Gessler N, Anwar O, Kahle A-K, Scherschel K, Rath B, et al.. In-hospital mortality and major complications related to radiofrequency catheter ablations of over 10 000 supraventricular arrhythmias from 2005 to 2020: individualized case analysis of multicentric administrative data.. Europace. 2023;25 (1):130-136$64$YR$$M$Y$$$20240704$$HP$DE$DE
240504951$24050495$1$I$$20240701$20240704$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008017$JAZZ$$$$$M$Y$$$20240704$$CN$US$US
240504962$24050496$2$F$$20240730$20240704$20240802$30DAY$$US-JNJFOC-20240706394$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
240504971$24050497$1$I$$20240626$20240704$20240704$PER$$US-JNJFOC-20240671158$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$MD$US$US
240504983$24050498$3$F$20240101$20240709$20240704$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-019493$UNITED THERAPEUTICS$$$$$F$Y$78.458$KG$20240718$$$US$US
240505002$24050500$2$F$20240101$20240717$20240704$20240726$EXP$$CA-CELLTRION INC.-2024CA016050$CELLTRION$$$$$$Y$$$20240726$$HP$CA$CA
240505011$24050501$1$I$20240601$20240621$20240704$20240704$EXP$$US-APOTEX-2024AP007680$APOTEX$$$$A$M$Y$$$20240704$$CN$US$US
240505021$24050502$1$I$20240629$20240630$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-020177$UNITED THERAPEUTICS$$54$YR$$F$Y$68.481$KG$20240704$$$US$US
240505031$24050503$1$I$$20240628$20240704$20240704$PER$$NVSC2024US136867$NOVARTIS$$51$YR$$$Y$$$20240704$$CN$US$US
240505041$24050504$1$I$20240401$20240702$20240704$20240704$EXP$$NVSC2024CA138329$NOVARTIS$$75$YR$$M$Y$$$20240704$$CN$CA$CA
240505051$24050505$1$I$$20230202$20240704$20240704$PER$$US-AMGEN-USASP2023235562$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240505061$24050506$1$I$$20240624$20240704$20240704$EXP$$US-AMGEN-USASP2024128236$AMGEN$Koga S.; Pai E.; Banihashemi A.. Diffuse lymphocytic encephalomyelitis with stiffperson- like syndrome in multiple myeloma after Teclistamab treatment. Journal of Neuropathology and Experimental Neurology. 2024;83 (6):457-458$45$YR$A$M$Y$$$20240704$$HP$US$US
240505071$24050507$1$I$20240601$20240620$20240704$20240704$PER$$US-GRANULES-US-2024GRASPO00248$GRANULES INDIA$$$$$F$Y$$$20240704$$CN$US$US
240505081$24050508$1$I$$20230511$20240704$20240704$PER$$US-AMGEN-USASP2023235566$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240505091$24050509$1$I$20231101$20240626$20240704$20240704$EXP$$DE-AUROBINDO-AUR-APL-2024-031835$AUROBINDO$$$$$M$Y$2.59$KG$20240704$$MD$DE$DE
240505102$24050510$2$F$20210101$20240909$20240704$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202407001128$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240920$$CN$US$US
240505111$24050511$1$I$$20240628$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-020333$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240704$$$US$US
240505121$24050512$1$I$20240703$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407003149$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240704$$CN$US$US
240505131$24050513$1$I$$20240628$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-020352$UNITED THERAPEUTICS$$$$$F$Y$48.526$KG$20240704$$$US$US
240505142$24050514$2$F$20240601$20240912$20240704$20240924$EXP$$US-BEH-2024174791$CSL BEHRING$$20$YR$A$M$Y$$$20240924$$HP$US$US
240505152$24050515$2$F$$20240706$20240704$20240802$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05755$LUPIN$$$$$$Y$$$20240802$$CN$US$US
240505171$24050517$1$I$$20240627$20240704$20240704$EXP$$NVSC2024US135703$NOVARTIS$$$$A$$Y$$$20240704$$CN$US$US
240505182$24050518$2$F$$20240919$20240704$20240926$EXP$$JP-009507513-2406JPN004003J$MERCK$$$$$F$Y$$$20240926$$MD$JP$JP
240505191$24050519$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106675$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$73.03$KG$20240704$$PH$US$US
240505201$24050520$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-031990$AUROBINDO$Zaidi W, Saeed AI, Lundquist N, Nelson AR, Razia D, Lee R, et al. Bronchoscopic Debridement of Endobronchial Rhizopus With 1.1 Mm Cryoprobe in Lung Transplant Recipient. Am-J-Respir-CritCare-Med. 2024;209:A2369$67$YR$$M$Y$$$20240704$$HP$US$US
240505211$24050521$1$I$20240101$20240605$20240704$20240704$PER$$US-009507513-2406USA001555$MERCK$$$$$F$Y$$$20240704$$CN$US$US
240505221$24050522$1$I$$20240621$20240704$20240704$EXP$$CA-TEVA-VS-3213126$TEVA$$$$$F$Y$$$20240704$$HP$CA$CA
240505233$24050523$3$F$20200104$20240830$20240704$20240903$EXP$$US-GILEAD-2024-0679553$GILEAD$$51$YR$A$M$Y$$$20240903$$LW$US$US
240505241$24050524$1$I$20110101$20240701$20240704$20240704$EXP$GB-MHRA-MED-202406291143518570-FBMQP$GB-ORGANON-O2407GBR000155$ORGANON$$$$$F$Y$$$20240704$$CN$GB$GB
240505251$24050525$1$I$20240522$20240626$20240704$20240704$EXP$FR-AFSSAPS-AN2024000797$FR-TEVA-VS-3214895$TEVA$$65$YR$$F$Y$53$KG$20240704$$MD$FR$FR
240505261$24050526$1$I$$20240620$20240704$20240704$PER$$US-EPICPHARMA-US-2024EPCSPO00774$EPIC PHARM$$$$$$Y$$$20240704$$CN$US$US
240505272$24050527$2$F$20240624$20240628$20240704$20240708$PER$$US-AMGEN-USASP2024129485$AMGEN$$$$$$Y$$$20240708$$HP$US$US
240505281$24050528$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131659$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240505301$24050530$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032404$AUROBINDO$Lam C, Kioka M. A Critical Confluence: Acute Pulmonary Embolism Complicating Systemic Sclerosis- Associated Pulmonary Arterial Hypertension. Am-J-Respir-Crit-Care-Med. 2024;209:A2211$58$YR$$F$Y$$$20240704$$HP$US$US
240505311$24050531$1$I$$20240627$20240704$20240704$EXP$$US-AMGEN-USASP2024128041$AMGEN$Chiou D.; Mooney B. H.; Shi B. et al.. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240704$$MD$US$US
240505323$24050532$3$F$20240601$20240816$20240704$20240821$PER$$US-AMGEN-USASP2024129723$AMGEN$$70$YR$E$F$Y$$$20240821$$CN$US$US
240505332$24050533$2$F$$20240709$20240704$20240712$EXP$$US-JNJFOC-20240675597$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$CN$US$US
240505341$24050534$1$I$$20240624$20240704$20240704$EXP$$US-AMGEN-USASP2024125178$AMGEN$Herron E.; Powell D.; Florell S.R. et.al.. Drug-induced dermatomyositis following COVID-19 vaccination. Dermatology Online Journal. 2024;30 (2):1-4$53$YR$A$M$Y$$$20240704$$HP$US$US
240505351$24050535$1$I$$20240626$20240704$20240704$EXP$$US-AUROBINDO-AUR-APL-2024-032044$AUROBINDO$Singla A, Vashi M.. Worsening Cavitary Lung Lesions in a Patient With Metastatic Colorectal Cancer on Stirvaga (Regorafenib). Am-J-RespirCrit-Care-Med. 2024;209:A7478$67$YR$$M$Y$$$20240704$$HP$US$US
240505362$24050536$2$F$$20240711$20240704$20240723$EXP$$CH-TEVA-VS-3215461$TEVA$Vukovic J, Nikolaou A, Terrier J, Samer C. Lamotrigine-induced Severe Drug Reaction with Eosinophilia Systemic Symptoms (DRESS) in a child. Swiss-Med-Wkly 2024; 154 (5): 137S abstr. P179.; Vukovic J, Nikolaou A, Terrier J, Samer C. Lamotrigine-induced Severe Drug Reaction with Eosinophilia Systemic Symptoms (DRESS) in a child. Swiss-Med-Wkly 2024; 154 (5): 137S abstr. P179.$9$YR$$F$Y$$$20240723$$HP$CH$CH
240505372$24050537$2$F$20230101$20240703$20240704$20240711$EXP$$US-AstraZeneca-2024A152217$ASTRAZENECA$$91$YR$$F$Y$$$20240711$$CN$US$
240505381$24050538$1$I$$20240625$20240704$20240704$EXP$$ES-RIGEL-20240600069$RIGEL PHARMACEUTICALS$Gonzalez-Lopez T.J., Bermejo N., Cardesa-Cabrera R., Mart??nez V., Aguilar-Monserrate G., P??rez Segura G., et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. American Society of Hematology. 2024;143:doi:10.1182/blood.2024024250$76$YR$$F$Y$$$20240704$$MD$ES$ES
240505391$24050539$1$I$$20240625$20240704$20240704$EXP$$ES-Rigel Pharmaceuticals, Inc.-20240600072$RIGEL PHARMACEUTICALS$Gonzalez-Lopez T.J., Bermejo N., Cardesa-Cabrera R., Mart??nez V., Aguilar-Monserrate G., Perez Segura G., et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. American Society of Hematology. 2024;143:doi:10.1182/blood.2024024250$88$YR$$F$Y$$$20240704$$MD$ES$ES
240505401$24050540$1$I$$20240625$20240704$20240704$EXP$$ES-Rigel Pharmaceuticals, Inc.-20240600071$RIGEL PHARMACEUTICALS$Gonzalez-Lopez T.J., Bermejo N., Cardesa-Cabrera R., Mart??nez V., Aguilar-Monserrate G., Perez Segura G., et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. American Society of Hematology. 2024;143:doi:10.1182/blood.2024024250$93$YR$$F$Y$$$20240704$$MD$ES$ES
240505411$24050541$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825771$ABBVIE$$41$YR$$F$Y$$$20240704$$HP$US$US
240505421$24050542$1$I$$20240625$20240704$20240704$EXP$$ES-Rigel Pharmaceuticals, Inc.-20240600070$RIGEL PHARMACEUTICALS$Gonzalez-Lopez T.J., Bermejo N., Cardesa-Cabrera R., Mart??nez V., Aguilar-Monserrate G., P??rez Segura G., et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. American Society of Hematology. 2024;143:doi:10.1182/blood.2024024250$87$YR$$M$Y$$$20240704$$MD$ES$ES
240505431$24050543$1$I$20240615$20240624$20240704$20240704$EXP$$US-Rigel Pharmaceuticals, Inc.-20240600076$RIGEL PHARMACEUTICALS$$82$YR$$F$Y$64.864$KG$20240704$$CN$US$US
240505441$24050544$1$I$20231024$20240624$20240704$20240704$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240600096$RIGEL PHARMACEUTICALS$$82$YR$$M$Y$$$20240704$$MD$JP$JP
240505473$24050547$3$F$$20240822$20240704$20240829$EXP$$US-Rigel Pharmaceuticals, Inc.-20240600091$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
240505482$24050548$2$F$20240501$20240729$20240704$20240806$EXP$$US-Rigel Pharmaceuticals, Inc.-20240600093$RIGEL PHARMACEUTICALS$$65$YR$$F$Y$$$20240806$$CN$US$US
240505493$24050549$3$F$20200101$20240913$20240704$20240918$EXP$$US-GILEAD-2024-0679521$GILEAD$$58$YR$A$M$Y$$$20240918$$LW$US$US
240505501$24050550$1$I$$20240625$20240704$20240704$EXP$$ES-Rigel Pharmaceuticals, Inc.-20240600075$RIGEL PHARMACEUTICALS$Tom?s Jos? Gonzalez-Lopez. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. American Society of Hematology. 2024;143:doi:10.1182/blood.2024024250$$$$$Y$$$20240704$$MD$ES$ES
240505511$24050551$1$I$20060101$20240621$20240704$20240704$PER$$US-TAKEDA-2024TUS062440$TAKEDA$$$$$$Y$$$20240704$$CN$US$US
240505521$24050552$1$I$20240101$20240701$20240704$20240704$PER$$US-ABBVIE-5825519$ABBVIE$$$$A$$Y$$$20240704$$MD$US$US
240505531$24050553$1$I$20240415$20240702$20240704$20240704$EXP$GB-MHRA-MED-202407021248095350-GNCRY$GB-SANDOZ INC.-SDZ2024GB062554$SANDOZ$$77$YR$$M$Y$$$20240704$$CN$GB$GB
240505541$24050554$1$I$20230712$20240703$20240704$20240704$30DAY$$US-SANDOZ INC.-SDZ2023US004459$SANDOZ$$13$YR$$M$Y$$$20240704$$CN$US$US
240505551$24050555$1$I$$20240702$20240704$20240704$EXP$GB-MHRA-MED-202407021702084410-SYWHN$GB-SANDOZ INC.-SDZ2024GB062589$SANDOZ$$$$$M$Y$$$20240704$$HP$GB$GB
240505561$24050556$1$I$$20240626$20240704$20240704$PER$$US-ABBVIE-5820864$ABBVIE$$$$A$M$Y$$$20240704$$HP$US$US
240505571$24050557$1$I$20230901$20240703$20240704$20240704$EXP$$US-ABBVIE-5825893$ABBVIE$$97$YR$$M$Y$$$20240704$$CN$US$US
240505581$24050558$1$I$$20230825$20240704$20240704$PER$$US-AMGEN-USASP2023235226$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240505592$24050559$2$F$$20240904$20240704$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05783$LUPIN$$$$$$Y$$$20240920$$PH$US$US
240505602$24050560$2$F$$20240725$20240704$20240807$30DAY$$CN-JNJFOC-20240705069$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$CN$CN
240505611$24050561$1$I$20240621$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024130878$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240505621$24050562$1$I$20240530$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130727$AMGEN$$68$YR$E$M$Y$$$20240704$$CN$US$US
240505631$24050563$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131668$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240505641$24050564$1$I$$20240627$20240704$20240704$EXP$$US-AMGEN-USASP2024128091$AMGEN$Chiou D.; Mooney B.H.; Shi B. et.al. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240704$$MD$US$US
240505651$24050565$1$I$$20240626$20240704$20240704$EXP$$US-AMGEN-USASP2024126990$AMGEN$Morris M. J.; Heller G.; Hillman D. W. et al.. Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial). Journal of Clinical Oncology. 2023;41 (18):3352-3362$$$$$Y$$$20240704$$MD$US$US
240505661$24050566$1$I$$20240627$20240704$20240704$EXP$$US-AMGEN-USASP2024128125$AMGEN$Chiou D.; Mooney B.H.; Shi B. et.al. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240704$$MD$US$US
240505671$24050567$1$I$20240425$20240701$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106456$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240704$$CN$US$US
240505681$24050568$1$I$$20240703$20240704$20240704$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037750$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240704$$CN$US$US
240505691$24050569$1$I$$20240703$20240704$20240704$EXP$NO-NOMAADVRE-PASRAPP-2024-V37gbw$NO-GSK-NO2024082350$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$NO$NO
240505703$24050570$3$F$20210101$20240717$20240704$20240801$EXP$$IE-TEVA-2022-IE-2013855$TEVA$$40$YR$$F$Y$$$20240801$$MD$IE$IE
240505712$24050571$2$F$$20240830$20240704$20240902$EXP$$NVSC2024US136972$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
240505721$24050572$1$I$$20240702$20240704$20240704$EXP$$NVSC2024CN138815$NOVARTIS$$65$YR$$M$Y$$$20240704$$CN$CN$CN
240505732$24050573$2$F$20240701$20240806$20240704$20240808$PER$$US-AMGEN-USASP2024131904$AMGEN$$63$YR$A$M$Y$$$20240808$$CN$US$US
240505741$24050574$1$I$$20240129$20240704$20240704$PER$$US-AMGEN-USASP2024132429$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240505752$24050575$2$F$20240701$20240715$20240704$20240717$PER$$US-AMGEN-USASP2024130276$AMGEN$$82$YR$E$F$Y$$$20240717$$CN$US$US
240505761$24050576$1$I$$20240627$20240704$20240704$EXP$$US-AMGEN-USASP2024128140$AMGEN$Chiou D.; Mooney B.H.; Shi B. et.al. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240704$$MD$US$US
240505771$24050577$1$I$$20240627$20240704$20240704$EXP$$US-AMGEN-USASP2024128265$AMGEN$Chiou C.; Mooney B.H.; Shi B. et.al.. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240704$$MD$US$US
240505781$24050578$1$I$$20240627$20240704$20240704$EXP$$US-AMGEN-USASP2024128237$AMGEN$Chiou D.; Mooney B.H.; Shi B. et.al.. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240704$$MD$US$US
240505791$24050579$1$I$$20240627$20240704$20240704$EXP$$US-AMGEN-USASP2024128291$AMGEN$Chiou D.; Mooney B. H.; Shi B. et al.. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240704$$MD$US$US
240505801$24050580$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138229$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240505814$24050581$4$F$20230920$20240906$20240704$20240912$EXP$$NVSC2023CA206314$NOVARTIS$$31$YR$$F$Y$$$20240912$$CN$CA$CA
240505821$24050582$1$I$$20240701$20240704$20240704$EXP$$US-UCBSA-2024033748$UCB$$$$$$Y$$$20240704$$CN$US$US
240505831$24050583$1$I$$20240701$20240704$20240704$PER$$US-ABBVIE-5825419$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240505841$24050584$1$I$$20230412$20240704$20240704$PER$$US-AMGEN-USASP2023235563$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240505851$24050585$1$I$$20240624$20240704$20240704$EXP$$US-AMGEN-USASP2024128555$AMGEN$Abdelrahim M.; Esmail A.; Divatia M.K. et al.. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. Journal of Clinical Medicine. 2024;13 (11):3068$64$YR$A$M$Y$$$20240704$$HP$US$US
240505861$24050586$1$I$$20230515$20240704$20240704$PER$$US-AMGEN-USASP2023235452$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240505871$24050587$1$I$$20240701$20240704$20240704$PER$$US-ALXN-202407USA000078US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240704$$CN$US$US
240505881$24050588$1$I$$20240627$20240704$20240704$EXP$$US-AMGEN-USASP2024128313$AMGEN$Chiou D.; Mooney B.H.; Shi B.et.al. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240704$$MD$US$US
240505891$24050589$1$I$$20240629$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001589$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240704$$CN$US$US
240505901$24050590$1$I$$20240629$20240704$20240704$EXP$$US-JNJFOC-20240703686$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240505912$24050591$2$F$20240601$20240916$20240704$20240919$EXP$$US-KYOWAKIRIN-2024KK016110$KYOWA$$$$$$Y$$$20240919$$HP$US$US
240505921$24050592$1$I$20240512$20240701$20240704$20240704$EXP$$GB-JNJFOC-20240710738$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240704$$CN$GB$GB
240505932$24050593$2$F$$20240729$20240704$20240731$30DAY$$DE-JNJFOC-20240703190$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$DE$DE
240505945$24050594$5$F$20170421$20240805$20240704$20240816$EXP$$US-TEVA-VS-3205844$TEVA$$64$YR$$M$Y$$$20240816$$LW$US$US
240505961$24050596$1$I$20240630$20240703$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106419$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240704$$HP$US$US
240505971$24050597$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138213$NOVARTIS$$52$YR$$$Y$$$20240704$$CN$US$US
240505981$24050598$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A148894$ASTRAZENECA$$69$YR$$F$Y$$$20240704$$CN$ZA$
240505991$24050599$1$I$20240319$20240624$20240704$20240704$EXP$ES-AEMPS-1538594$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109014$ZYDUS PHARM$$$$$$Y$$$20240704$$MD$ES$ES
240506003$24050600$3$F$20240608$20240708$20240704$20240710$PER$$US-AMGEN-USASP2024132307$AMGEN$$66$YR$E$F$Y$$$20240710$$CN$US$US
240506011$24050601$1$I$$20240625$20240704$20240704$EXP$$IN-AMGEN-INDSP2024125767$AMGEN$Kakkar D.. A tertiary care centre experience with Elranatamab: A report of three cases. Leukemia Research Reports. 2024;21:1-4$$$$F$Y$$$20240704$$HP$IN$IN
240506022$24050602$2$F$20220101$20240913$20240704$20240917$PER$$US-GILEAD-2024-0679527$GILEAD$$62$YR$A$M$Y$$$20240917$$LW$US$US
240506032$24050603$2$F$20210101$20240913$20240704$20240917$EXP$$US-GILEAD-2024-0679554$GILEAD$$52$YR$A$F$Y$$$20240917$$LW$US$US
240506041$24050604$1$I$20240627$20240628$20240704$20240704$PER$$US-ABBVIE-5822824$ABBVIE$$35$YR$$F$Y$$$20240704$$CN$US$US
240506051$24050605$1$I$$20240626$20240704$20240704$EXP$$US-AMGEN-USASP2024129728$AMGEN$Yuen C. A.; Bao S.; Aung M S.et.al.. Dabrafenib and steroids for the treatment of Erdheim-Chester disease with extensive CNS involvement: a case report. Personalized Medicine. 2024;21(2):71-78$44$YR$A$M$Y$$$20240704$$HP$US$US
240506061$24050606$1$I$$20240624$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05748$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240506071$24050607$1$I$$20240626$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-010009$BEIGENE$Qiuyu L, Baoguo L. Evaluation of Clinical efficacy and Safety of Tislelizumab Combined with Anlotinib in the Treatment of Patients with Head and Neck Cancer. Medical Research Journal. 2024;53(5):135-153$$$$$Y$$$20240704$$MD$CN$CN
240506081$24050608$1$I$20240101$20240626$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-019784$UNITED THERAPEUTICS$$$$$F$Y$67.12$KG$20240704$$$US$US
240506091$24050609$1$I$$20240701$20240704$20240704$EXP$$NVSC2024GB137553$NOVARTIS$$$$$F$Y$$$20240704$$CN$GB$GB
240506101$24050610$1$I$20240502$20240701$20240704$20240704$EXP$FR-AFSSAPS-BR2024000513$FR-UCBSA-2024033227$UCB$$93$YR$$M$Y$77$KG$20240704$$MD$FR$FR
240506111$24050611$1$I$$20240624$20240704$20240704$EXP$$JP-009507513-2406JPN003519J$MERCK$$$$$F$Y$$$20240704$$MD$JP$JP
240506121$24050612$1$I$$20240704$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106843$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$95.25$KG$20240704$$CN$US$US
240506131$24050613$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281435011580-DLRNY$GB-RDY-SPO/GBR/24/0009563$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240506141$24050614$1$I$$20240628$20240704$20240704$EXP$$CA-JNJFOC-20240704344$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240704$$CN$CA$CA
240506151$24050615$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281041575460-KYCFR$GB-RDY-SPO/GBR/24/0009672$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240506161$24050616$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281417043890-YNTHC$GB-RDY-SPO/GBR/24/0009559$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240506171$24050617$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281432034530-LJZCK$GB-RDY-SPO/GBR/24/0009561$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240506182$24050618$2$F$$20240708$20240704$20240715$EXP$GB-MHRA-MED-202406281415559760-KVNGH$GB-RDY-SPO/GBR/24/0009565$DR REDDYS$$$$$$Y$$$20240715$$CN$GB$GB
240506191$24050619$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281417420110-KQVHC$GB-RDY-SPO/GBR/24/0009557$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240506201$24050620$1$I$$20240621$20240704$20240704$EXP$$CA-TEVA-VS-3213142$TEVA$$65$YR$$F$Y$$$20240704$$MD$CA$CA
240506212$24050621$2$F$$20240718$20240704$20240725$EXP$GB-MHRA-MED-202406271102593100-MTLRW$GB-RDY-SPO/GBR/24/0009415$DR REDDYS$$37$YR$A$$Y$$$20240725$$CN$GB$GB
240506221$24050622$1$I$20240323$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281053549520-RCDFK$GB-RDY-SPO/GBR/24/0009670$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240506242$24050624$2$F$20211007$20240626$20240704$20240709$EXP$$CA-CELLTRION INC.-2021CA005392$CELLTRION$$$$$$Y$$$20240709$$HP$CA$CA
240506251$24050625$1$I$$20240220$20240704$20240704$PER$$US-AMGEN-USASP2024130000$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240506261$24050626$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131384$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240506271$24050627$1$I$20240701$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130769$AMGEN$$64$YR$A$F$Y$$$20240704$$CN$US$US
240506281$24050628$1$I$$20240627$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-019960$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240704$$$US$US
240506291$24050629$1$I$$20231127$20240704$20240704$PER$$US-AMGEN-USASP2023235572$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240506301$24050630$1$I$$20240202$20240704$20240704$PER$$US-AMGEN-USASP2024129819$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240506311$24050631$1$I$$20230626$20240704$20240704$PER$$US-AMGEN-USASP2023235306$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240506321$24050632$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131711$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240506331$24050633$1$I$$20240521$20240704$20240704$PER$$US-AMGEN-USASP2024129602$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240506341$24050634$1$I$20240301$20240624$20240704$20240704$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024078545$VIIV$$56$YR$$M$Y$$$20240704$$HP$US$US
240506352$24050635$2$F$20240101$20240703$20240704$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-019972$UNITED THERAPEUTICS$$$$$F$Y$47.619$KG$20240709$$$US$US
240506362$24050636$2$F$20240101$20240712$20240704$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-019999$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240717$$$US$US
240506391$24050639$1$I$20230613$20240628$20240704$20240704$EXP$$US-SA-2024SA195827$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240704$$MD$US$US
240506401$24050640$1$I$20240101$20240620$20240704$20240704$PER$$US-009507513-2406USA007061$MERCK$$83$YR$$M$Y$$$20240704$$CN$US$US
240506422$24050642$2$F$20240616$20240727$20240704$20240806$EXP$$US-BEH-2024174802$CSL BEHRING$$6$YR$C$M$Y$$$20240806$$CN$US$US
240506431$24050643$1$I$$20240629$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-019428$UNITED THERAPEUTICS$$$$$F$Y$72.109$KG$20240704$$$US$US
240506442$24050644$2$F$$20240704$20240704$20240715$EXP$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00325$Unknown Manufacturer$Simhadri KS., Chandramohan D., Singh P., Marathi R., Burton K., Vaitla P.. A Patient With Spontaneous Perinephric Hematoma: A Quiz. American Journal of Kidney Diseases. 2024;84(1):A19-A21$$$$$Y$$$20240715$$MD$US$US
240506451$24050645$1$I$$20240627$20240704$20240704$EXP$$DE-SA-2024SA180857$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240704$$MD$DE$DE
240506461$24050646$1$I$$20240703$20240704$20240704$EXP$$TN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037885$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240704$$MD$TN$TN
240506475$24050647$5$F$20240101$20240901$20240704$20240909$EXP$$US-BEH-2024174813$CSL BEHRING$$32$YR$A$F$Y$$$20240909$$HP$US$US
240506492$24050649$2$F$$20240726$20240704$20240801$EXP$$JP-009507513-2406JPN004146J$MERCK$$$$$F$Y$$$20240801$$MD$JP$JP
240506501$24050650$1$I$$20230215$20240704$20240704$PER$$US-AMGEN-USASP2023235510$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240506511$24050651$1$I$20211007$20240626$20240704$20240704$EXP$$BE-CELLTRION INC.-2024BE015741$CELLTRION$$$$$$Y$$$20240704$$PH$BE$BE
240506521$24050652$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024132286$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240506532$24050653$2$F$$20240711$20240704$20240723$EXP$$CH-TEVA-VS-3215467$TEVA$Ballmer A, Loretz L, Henzen C, Ulmer T, Van Veelen N. Small tablet, large effect: Statin-induced rhabdomyolysis. Swiss-Med-Wkly 2024; 154 (Suppl.) 40S.; Ballmer A, Loretz L, Henzen C, Ulmer T, Van Veelen N. Small tablet, large effect: Statin-induced rhabdomyolysis. Swiss-Med-Wkly 2024; 154 (Suppl.) 40S.$48$YR$$M$Y$$$20240723$$HP$CH$CH
240506541$24050654$1$I$$20240702$20240704$20240704$EXP$$NVSC2024US138005$NOVARTIS$$$$$M$Y$$$20240704$$CN$US$US
240506551$24050655$1$I$$20240701$20240704$20240704$EXP$$NVSC2024US137395$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240506562$24050656$2$F$$20240703$20240704$20240709$EXP$$FR-OTSUKA-2024_018585$OTSUKA$$57$YR$$M$Y$$$20240709$$MD$FR$FR
240506573$24050657$3$F$20240101$20240712$20240704$20240812$EXP$$CA-BEH-2024174832$CSL BEHRING$$23$YR$A$M$Y$189$KG$20240812$$CN$CA$CA
240506581$24050658$1$I$$20240629$20240704$20240704$EXP$$US-GSK-US2024AMR082042$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$MD$US$US
240506591$24050659$1$I$$20240701$20240704$20240704$EXP$$US-UCBSA-2024033728$UCB$$$$$$Y$$$20240704$$CN$US$US
240506601$24050660$1$I$20240624$20240701$20240704$20240704$EXP$$US-UCBSA-2024033568$UCB$$0$YR$$$Y$$$20240704$$CN$US$US
240506611$24050661$1$I$20240101$20240628$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-010311$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240704$$$US$US
240506621$24050662$1$I$$20240627$20240704$20240704$PER$$US-009507513-2407USA001880$MERCK$Vlachou E, Johnson BA, Guancial E, Lombardo KA, Hoffman-Censits J. Frontline immune checkpoint inhibitors in patients = 90 years with advanced urothelial cancer: a single center experience. The Canadian journal of urology. 2024;31(3):11875-9$96$YR$$M$Y$$$20240704$$MD$US$US
240506631$24050663$1$I$$20240626$20240704$20240704$PER$$US-ALXN-202406USA001772US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
240506641$24050664$1$I$$20240627$20240704$20240704$EXP$$BR-TAKEDA-2024TUS066948$TAKEDA$$$$$$Y$$$20240704$$CN$BR$BR
240506652$24050665$2$F$$20240708$20240704$20240717$EXP$$US-TEVA-VS-3214273$TEVA$Vu VA, Bhayana S, Sweiss H, Castro N, Hall R, Nelson J. Impact of Cumulative 6 mg/kg Antithymocyte Globulin on Early Posttransplant Outcomes in Kidney Transplant Recipients with Delayed Graft Function. Prog-Transplant 2024; 34 (1-2): 47-52.; Vu VA, Bhayana S, Sweiss H, Castro N, Hall R, Nelson J. Impact of Cumulative 6 mg/kg Antithymocyte Globulin on Early Posttransplant Outcomes in Kidney Transplant Recipients with Delayed Graft Function. Prog-Transplant 2024; 34 (1-2): 47-52.$$$$$Y$$$20240717$$HP$US$US
240506661$24050666$1$I$20230101$20240703$20240704$20240704$EXP$IT-MINISAL02-986506$NVSC2024IT137908$NOVARTIS$$41$YR$$F$Y$$$20240704$$CN$IT$IT
240506672$24050667$2$F$20240101$20240718$20240704$20240724$EXP$FR-AFSSAPS-AN2024000833$FR-Waylis Therapeutics LLC-ATNAHS20240601880$Waylis$$54$YR$A$M$Y$80$KG$20240724$$PH$FR$FR
240506681$24050668$1$I$20240401$20240628$20240704$20240704$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00611$CATALYST PHARMA$$63$YR$$F$Y$83.887$KG$20240704$$CN$US$US
240506691$24050669$1$I$20211224$20240626$20240704$20240704$EXP$$TW-EXELIXIS-CABO-24079086$EXELIXIS$$61$YR$$M$Y$$$20240704$$MD$TW$TW
240506701$24050670$1$I$20240630$20240703$20240704$20240704$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037770$BOEHRINGER INGELHEIM$$85$YR$E$F$Y$$$20240704$$CN$US$US
240506712$24050671$2$F$20240621$20240722$20240704$20240730$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00607$CATALYST PHARMA$$32$YR$$M$Y$93.878$KG$20240730$$CN$US$US
240506721$24050672$1$I$$20240626$20240704$20240704$EXP$$AU-CELLTRION INC.-2024AU015777$CELLTRION$$$$$$Y$$$20240704$$HP$AU$AU
240506731$24050673$1$I$20240101$20240626$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-018065$UNITED THERAPEUTICS$$$$$M$Y$116.69$KG$20240704$$$US$US
240506741$24050674$1$I$$20240621$20240704$20240704$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05714$LUPIN$Chang J-H, Kudose S, Droubi S, Verduzco HA, Awori J, Ratner LE, et al. Four cases of kidney transplants with donor HCV-derived immune complex glomerulonephritis. Kidney International Reports. 2024;9:1903-1907$60$YR$$M$Y$73$KG$20240704$$HP$US$US
240506751$24050675$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002133$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240704$$CN$US$US
240506761$24050676$1$I$20240702$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002674$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240704$$CN$US$US
240506771$24050677$1$I$20240703$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002796$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240704$$CN$US$US
240506782$24050678$2$F$$20240801$20240704$20240805$PER$$US-AMGEN-USASP2024131169$AMGEN$$52$YR$A$F$Y$$$20240805$$MD$US$US
240506791$24050679$1$I$$20240619$20240704$20240704$PER$$US-ROCHE-10000009124$ROCHE$$$$$$Y$$$20240704$$MD$US$US
240506801$24050680$1$I$$20240521$20240704$20240704$PER$$US-AMGEN-USASP2024132427$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240506811$24050681$1$I$$20240624$20240704$20240704$EXP$$IT-AMGEN-ITASP2024127106$AMGEN$Canino F. Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study. BMC Cancer. 2024;24(1):1-18$$$$$Y$$$20240704$$HP$IT$IT
240506821$24050682$1$I$$20240205$20240704$20240704$PER$$US-AMGEN-USASP2024130912$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240506831$24050683$1$I$20240628$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130645$AMGEN$$66$YR$E$M$Y$$$20240704$$CN$US$US
240506843$24050684$3$F$20240621$20240725$20240704$20240726$EXP$$US-JNJFOC-20240675003$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20240726$$HP$US$US
240506851$24050685$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138239$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240506861$24050686$1$I$20090206$20240626$20240704$20240704$EXP$DE-ROCHE-627508$DE-TEVA-VS-3215144$TEVA$$66$YR$$F$Y$70$KG$20240704$$MD$DE$DE
240506871$24050687$1$I$$20240701$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-020304$UNITED THERAPEUTICS$$$$$F$Y$64.399$KG$20240704$$$US$US
240506881$24050688$1$I$$20240703$20240704$20240704$EXP$$CL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037720$BOEHRINGER INGELHEIM$$58$YR$A$F$Y$$$20240704$$MD$CL$CL
240506891$24050689$1$I$$20240622$20240704$20240704$EXP$$EC-ROCHE-10000007763$ROCHE$$$$$$Y$$$20240704$$CN$EC$EC
240506903$24050690$3$F$$20240709$20240704$20240710$EXP$$US-PFIZER INC-PV202400087170$PFIZER$$89$YR$$F$Y$$$20240710$$CN$US$US
240506912$24050691$2$F$$20240624$20240704$20240709$EXP$$NVSC2024TH132090$NOVARTIS$$77$YR$$M$Y$$$20240709$$MD$TH$TH
240506953$24050695$3$F$20240514$20240904$20240704$20240909$EXP$$US-PFIZER INC-PV202400087103$PFIZER$$31$YR$$F$Y$$$20240909$$HP$US$US
240506961$24050696$1$I$$20240702$20240704$20240704$EXP$$TW-PFIZER INC-202400204599$PFIZER$$$$$$Y$$$20240704$$PH$TW$TW
240506973$24050697$3$F$20230909$20240901$20240704$20240903$EXP$$CA-PFIZER INC-202300282649$PFIZER$$45$YR$$M$Y$$$20240903$$MD$CA$CA
240506982$24050698$2$F$$20240824$20240704$20240826$EXP$$US-PFIZER INC-2021050131$PFIZER$$54$YR$$F$Y$$$20240826$$MD$US$US
240506993$24050699$3$F$20240510$20240912$20240704$20240917$30DAY$$CO-PFIZER INC-202400199831$PFIZER$$15$YR$$M$Y$$$20240917$$CN$CO$CO
240507001$24050700$1$I$$20231010$20240704$20240704$PER$$US-AMGEN-USASP2023235568$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240507011$24050701$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130658$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240507021$24050702$1$I$20240627$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130776$AMGEN$$54$YR$A$M$Y$$$20240704$$CN$US$US
240507031$24050703$1$I$$20240625$20240704$20240704$EXP$$US-MALLINCKRODT-MNK202404215$MALLINCKRODT$$$$$F$Y$$$20240704$$CN$US$US
240507041$24050704$1$I$$20240629$20240704$20240704$PER$$US-ABBVIE-5824474$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240507052$24050705$2$F$$20240627$20240704$20240715$EXP$$US-BEH-2024174805$CSL BEHRING$$$$A$M$Y$$$20240715$$HP$US$US
240507061$24050706$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106934$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240704$$CN$US$US
240507071$24050707$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106951$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240704$$CN$US$US
240507082$24050708$2$F$20240101$20240715$20240704$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-019866$UNITED THERAPEUTICS$$$$$M$Y$89.342$KG$20240719$$$US$US
240507091$24050709$1$I$$20240627$20240704$20240704$PER$$US-JNJFOC-20240675056$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240507101$24050710$1$I$$20240621$20240704$20240704$EXP$$CA-ROCHE-10000015098$ROCHE$$$$A$M$Y$$$20240704$$HP$CA$CA
240507111$24050711$1$I$20240624$20240701$20240704$20240704$EXP$$US-UCBSA-2024033347$UCB$$31$YR$$F$Y$$$20240704$$CN$US$US
240507121$24050712$1$I$$20231207$20240704$20240704$PER$$US-AMGEN-USASP2023235411$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240507131$24050713$1$I$$20240214$20240704$20240704$PER$$US-AMGEN-USASP2024130578$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240507141$24050714$1$I$$20240626$20240704$20240704$EXP$$PL-JNJFOC-20240677307$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240704$$MD$PL$PL
240507151$24050715$1$I$20240315$20240626$20240704$20240704$EXP$FR-AFSSAPS-TO2024001038$FR-TEVA-VS-3215201$TEVA$$80$YR$$M$Y$$$20240704$$PH$FR$FR
240507161$24050716$1$I$$20240228$20240704$20240704$PER$$US-AMGEN-USASP2024129868$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240507171$24050717$1$I$20240702$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131660$AMGEN$$40$YR$A$M$Y$$$20240704$$CN$US$US
240507181$24050718$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A148925$ASTRAZENECA$$27759$DY$$F$Y$$$20240704$$CN$ZA$
240507191$24050719$1$I$$20240628$20240704$20240704$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037201$BOEHRINGER INGELHEIM$$$$$$Y$$$20240704$$CN$US$US
240507201$24050720$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A147792$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$US$
240507211$24050721$1$I$20221022$20240627$20240704$20240704$EXP$$FR-CELLTRION INC.-2024FR015935$CELLTRION$$$$$$Y$$$20240704$$MD$FR$FR
240507221$24050722$1$I$20240513$20240702$20240704$20240704$PER$$US-PFIZER INC-202400206099$PFIZER$$70$YR$$F$Y$$$20240704$$HP$US$US
240507232$24050723$2$F$$20240703$20240704$20240708$PER$$US-PFIZER INC-202400206137$PFIZER$$$$A$F$Y$$$20240708$$PH$US$US
240507241$24050724$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-PV202400087046$PFIZER$$87$YR$$F$Y$$$20240704$$HP$US$US
240507251$24050725$1$I$20240702$20240702$20240704$20240704$PER$$US-PFIZER INC-202400205541$PFIZER$$71$YR$$M$Y$$$20240704$$CN$US$US
240507261$24050726$1$I$20230201$20240702$20240704$20240704$PER$$US-PFIZER INC-202400206175$PFIZER$$71$YR$$F$Y$$$20240704$$HP$US$US
240507271$24050727$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-PV202400086867$PFIZER$$28$YR$$M$Y$$$20240704$$MD$US$US
240507281$24050728$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-202400206015$PFIZER$$43$YR$$F$Y$$$20240704$$CN$US$US
240507291$24050729$1$I$$20240701$20240704$20240704$PER$$US-PFIZER INC-PV202400086279$PFIZER$$$$$F$Y$$$20240704$$CN$US$US
240507302$24050730$2$F$$20240731$20240704$20240805$PER$$US-PFIZER INC-202400206651$PFIZER$$21$YR$$F$Y$113.38$KG$20240805$$HP$US$US
240507311$24050731$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-PV202400087239$PFIZER$$$$A$F$Y$$$20240704$$CN$US$US
240507322$24050732$2$F$$20240820$20240704$20240823$PER$$US-PFIZER INC-202400091240$PFIZER$$60$YR$$F$Y$$$20240823$$CN$US$US
240507341$24050734$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-202400206179$PFIZER$$19$YR$$F$Y$$$20240704$$HP$US$US
240507351$24050735$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-202400205798$PFIZER$$63$YR$$F$Y$$$20240704$$MD$US$US
240507362$24050736$2$F$20240601$20240923$20240704$20240925$PER$$US-PFIZER INC-202400205706$PFIZER$$71$YR$$F$Y$$$20240925$$CN$US$US
240507371$24050737$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-PV202400086870$PFIZER$$15$YR$$M$Y$$$20240704$$MD$US$US
240507383$24050738$3$F$20240628$20240730$20240704$20240802$PER$$US-PFIZER INC-202400205402$PFIZER$$55$YR$$M$Y$77.098$KG$20240802$$CN$US$US
240507391$24050739$1$I$$20240701$20240704$20240704$PER$$US-PFIZER INC-PV202400086623$PFIZER$$21$YR$$F$Y$$$20240704$$HP$US$US
240507401$24050740$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-202400205694$PFIZER$$74$YR$$F$Y$$$20240704$$CN$US$US
240507412$24050741$2$F$$20240804$20240704$20240805$PER$$US-PFIZER INC-202400205820$PFIZER$$80$YR$$F$Y$61.224$KG$20240805$$CN$US$US
240507422$24050742$2$F$$20240913$20240704$20240918$30DAY$$US-PFIZER INC-202400199949$PFIZER$$$$$$Y$$$20240918$$HP$US$US
240507431$24050743$1$I$$20240703$20240704$20240704$PER$$US-PFIZER INC-202400206196$PFIZER$$82$YR$$F$Y$$$20240704$$CN$US$US
240507451$24050745$1$I$$20240703$20240704$20240704$PER$$US-PFIZER INC-PV202400087649$PFIZER$$35$YR$$F$Y$$$20240704$$HP$US$US
240507463$24050746$3$F$20220801$20240918$20240704$20240923$PER$$US-PFIZER INC-202400206232$PFIZER$$59$YR$$F$Y$77.11$KG$20240923$$CN$US$US
240507471$24050747$1$I$20240703$20240703$20240704$20240704$PER$$US-PFIZER INC-202400206203$PFIZER$$$$A$F$Y$$$20240704$$CN$US$US
240507481$24050748$1$I$$20240703$20240704$20240704$PER$$US-PFIZER INC-202400206215$PFIZER$$85$YR$$F$Y$$$20240704$$CN$US$US
240507493$24050749$3$F$20240701$20240711$20240704$20240712$PER$$US-PFIZER INC-202400205933$PFIZER$$$$$M$Y$$$20240712$$CN$US$US
240507501$24050750$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-PV202400086872$PFIZER$$12$YR$$M$Y$$$20240704$$MD$US$US
240507511$24050751$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-PV202400086888$PFIZER$$28$YR$$M$Y$$$20240704$$MD$US$US
240507521$24050752$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-PV202400087304$PFIZER$$78$YR$$F$Y$$$20240704$$CN$US$US
240507532$24050753$2$F$$20240913$20240704$20240918$30DAY$$US-PFIZER INC-202400199870$PFIZER$$13$YR$$M$Y$$$20240918$$CN$US$US
240507541$24050754$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-202400205519$PFIZER$$83$YR$$M$Y$$$20240704$$HP$US$US
240507553$24050755$3$F$$20240916$20240704$20240919$PER$$US-PFIZER INC-202400205201$PFIZER$$$$$F$Y$$$20240919$$MD$US$US
240507561$24050756$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-PV202400087183$PFIZER$$$$$F$Y$$$20240704$$CN$US$US
240507571$24050757$1$I$$20240703$20240704$20240704$PER$$US-PFIZER INC-PV202400087657$PFIZER$$73$YR$$F$Y$$$20240704$$HP$US$US
240507581$24050758$1$I$$20240703$20240704$20240704$PER$$US-PFIZER INC-202400206008$PFIZER$$$$$M$Y$$$20240704$$CN$US$US
240507592$24050759$2$F$$20240814$20240704$20240816$PER$$US-PFIZER INC-PV202400066110$PFIZER$$85$YR$$F$Y$57.15$KG$20240816$$CN$US$US
240507602$24050760$2$F$20240630$20240723$20240704$20240725$PER$$US-PFIZER INC-202400205355$PFIZER$$82$YR$$F$Y$61.678$KG$20240725$$CN$US$US
240507612$24050761$2$F$$20240703$20240704$20240708$PER$$US-PFIZER INC-202400205994$PFIZER$$74$YR$$F$Y$63.5$KG$20240708$$CN$US$US
240507623$24050762$3$F$$20240722$20240704$20240723$PER$$US-PFIZER INC-PV202400087455$PFIZER$$71$YR$$F$Y$$$20240723$$HP$US$US
240507631$24050763$1$I$$20240702$20240704$20240704$PER$$US-PFIZER INC-PV202400087466$PFIZER$$71$YR$$F$Y$56.236$KG$20240704$$MD$US$US
240507641$24050764$1$I$$20240623$20240704$20240704$EXP$$BR-TAKEDA-2024TUS055072$TAKEDA$$$$$M$Y$75$KG$20240704$$CN$BR$BR
240507651$24050765$1$I$$20240701$20240704$20240704$PER$$US-ABBVIE-5825644$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240507661$24050766$1$I$$20240625$20240704$20240704$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004781$BIOCON$$$$$$Y$$$20240704$$CN$CA$CA
240507681$24050768$1$I$20240601$20240620$20240704$20240704$PER$$US-JNJFOC-20240656451$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240507691$24050769$1$I$$20240703$20240704$20240704$PER$$NVSC2024US138941$NOVARTIS$$$$$M$Y$$$20240704$$HP$US$US
240507702$24050770$2$F$$20240726$20240704$20240809$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001048$AKEBIA THERAPEUTICS$$102$YR$$F$Y$$$20240809$$PH$JP$JP
240507711$24050771$1$I$$20240630$20240704$20240704$PER$$US-LEO Pharma-371658$LEO PHARM$$54$YR$$F$Y$$$20240704$$PH$US$US
240507721$24050772$1$I$20240601$20240701$20240704$20240704$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00617$CATALYST PHARMA$$64$YR$$F$Y$90.703$KG$20240704$$CN$US$US
240507732$24050773$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214515$TEVA$Khan M, Farmer MS. Ticking All the Boxes: Case of Anaplasmosis With Acute Respiratory Distress Syndrome and Multi-Organ Failure. Am-J-Respir-Crit-Care-Med 2024; 209 A3557-A3557.; Khan M, Farmer MS. Ticking All the Boxes: Case of Anaplasmosis With Acute Respiratory Distress Syndrome and Multi-Organ Failure. Am-J-Respir-Crit-Care-Med 2024; 209 A3557-A3557.$79$YR$$F$Y$$$20240720$$HP$US$US
240507741$24050774$1$I$$20240628$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-020176$UNITED THERAPEUTICS$$$$$F$Y$86.168$KG$20240704$$$US$US
240507751$24050775$1$I$$20240624$20240704$20240704$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004720$BIOCON$$$$$$Y$$$20240704$$HP$CA$CA
240507761$24050776$1$I$$20240701$20240704$20240704$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00616$CATALYST PHARMA$$$$$M$Y$95.238$KG$20240704$$CN$US$US
240507771$24050777$1$I$$20230713$20240704$20240704$PER$$US-AYTU BIOPHARMA, INC.-2023AYT000033$AYTU BIOSCIENCE$$$$$$Y$$$20240704$$CN$US$US
240507782$24050778$2$F$$20240812$20240704$20240819$EXP$$US-ROCHE-10000013280$ROCHE$$65$YR$E$F$Y$50.35$KG$20240819$$MD$US$US
240507801$24050780$1$I$20230805$20230905$20240704$20240704$PER$$US-SAGENT PHARMACEUTICALS-2023SAG000131$SAGENT$$$$$$Y$$$20240704$$PH$US$US
240507813$24050781$3$F$$20240808$20240704$20240808$30DAY$$JP-PFIZER INC-PV202400075440$PFIZER$$11$YR$$M$Y$33.75$KG$20240808$$MD$JP$JP
240507842$24050784$2$F$$20240708$20240704$20240716$EXP$$JP-JNJFOC-20240711910$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240716$$MD$JP$JP
240507852$24050785$2$F$$20240701$20240704$20240709$EXP$$NVSC2024US137867$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240507861$24050786$1$I$$20240703$20240704$20240704$PER$$NVSC2024US138955$NOVARTIS$$66$YR$$F$Y$$$20240704$$HP$US$US
240507871$24050787$1$I$$20240627$20240704$20240704$EXP$$JP-RDY-LIT/JPN/24/0009522$DR REDDYS$Takuma O. CASE REPORT A case of Bloom syndrome manifesting with therapy?related myelodysplastic syndromes harboring a novel BLM gene variant. International Journal of Hematology. 2024;119(5): 603-607.$34$YR$A$F$Y$$$20240704$$HP$JP$JP
240507883$24050788$3$F$$20240827$20240704$20240830$PER$$US-ALXN-202406USA001803US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
240507891$24050789$1$I$$20240625$20240704$20240704$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004783$BIOCON$$$$$$Y$$$20240704$$HP$CA$CA
240507902$24050790$2$F$$20240726$20240704$20240808$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001049$AKEBIA THERAPEUTICS$$96$YR$$M$Y$$$20240808$$PH$JP$JP
240507911$24050791$1$I$$20240627$20240704$20240704$PER$$US-ALXN-202406USA001828US$ALEXION PHARMACEUTICALS$$$$$F$Y$290$KG$20240704$$CN$US$US
240507921$24050792$1$I$20240603$20240627$20240704$20240704$EXP$FR-AFSSAPS-GR2024000771$FR-009507513-2406FRA009947$MERCK$$72$YR$$F$Y$70$KG$20240704$$PH$FR$FR
240507931$24050793$1$I$$20240628$20240704$20240704$EXP$$CA-TAKEDA-2023TUS092157$TAKEDA$$$$$F$Y$$$20240704$$MD$CA$CA
240507942$24050794$2$F$$20240702$20240704$20240710$EXP$$CA-TAKEDA-2024TUS067104$TAKEDA$$$$$F$Y$$$20240710$$CN$CA$CA
240507962$24050796$2$F$$20240715$20240704$20240716$PER$$US-AMGEN-USASP2024126685$AMGEN$$$$$M$Y$$$20240716$$MD$US$US
240507972$24050797$2$F$20240630$20240805$20240704$20240807$PER$$US-AMGEN-USASP2024130850$AMGEN$$69$YR$E$M$Y$$$20240807$$CN$US$US
240507981$24050798$1$I$$20240213$20240704$20240704$PER$$US-AMGEN-USASP2024131488$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240507991$24050799$1$I$$20240621$20240704$20240704$EXP$$CA-TEVA-VS-3213176$TEVA$$65$YR$$M$Y$$$20240704$$HP$CA$CA
240508002$24050800$2$F$$20240710$20240704$20240716$EXP$$US-AMGEN-USASP2024129394$AMGEN$$$$$F$Y$$$20240716$$PH$US$US
240508011$24050801$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002152$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240704$$CN$US$US
240508021$24050802$1$I$20240627$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002710$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240704$$CN$US$US
240508031$24050803$1$I$$20240626$20240704$20240704$EXP$$AU-CELLTRION INC.-2024AU015796$CELLTRION$$$$$$Y$$$20240704$$HP$AU$AU
240508042$24050804$2$F$$20240719$20240704$20240726$EXP$$BR-TAKEDA-2024TUS066024$TAKEDA$$25$YR$$M$Y$$$20240726$$CN$BR$BR
240508052$24050805$2$F$$20240726$20240704$20240809$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001050$AKEBIA THERAPEUTICS$$88$YR$$M$Y$$$20240809$$PH$JP$JP
240508071$24050807$1$I$$20240703$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106962$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240704$$CN$US$US
240508081$24050808$1$I$$20240619$20240704$20240704$EXP$$SG-ROCHE-10000003521$ROCHE$$74$YR$E$M$Y$$$20240704$$CN$SG$SG
240508091$24050809$1$I$$20240621$20240704$20240704$EXP$$IN-ROCHE-10000013700$ROCHE$$69$YR$E$M$Y$$$20240704$$CN$IN$IN
240508101$24050810$1$I$20220101$20240626$20240704$20240704$EXP$$CA-BEH-2024174828$CSL BEHRING$$47$YR$A$M$Y$$$20240704$$CN$CA$CA
240508114$24050811$4$F$$20240920$20240704$20240926$EXP$$CA-TAKEDA-2024TUS066995$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
240508122$24050812$2$F$$20240708$20240704$20240717$EXP$$US-TEVA-VS-3214281$TEVA$Tomaras MC, Douglas LM, Schmidt RM, Bloomquist MS, Diwan AH, Kim SJ. Refractory chronic spontaneous urticaria after heterologous COVID-19 booster vaccination. Dermatol-Online-J 2024; 30 (2):.; Tomaras MC, Douglas LM, Schmidt RM, Bloomquist MS, Diwan AH, Kim SJ. Refractory chronic spontaneous urticaria after heterologous COVID-19 booster vaccination. Dermatol-Online-J 2024; 30 (2):.$55$YR$$M$Y$$$20240717$$HP$US$US
240508131$24050813$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5821554$ABBVIE$$$$$M$Y$$$20240704$$HP$US$US
240508141$24050814$1$I$20240630$20240701$20240704$20240704$PER$$US-ABBVIE-5825288$ABBVIE$$7$YR$$M$Y$$$20240704$$CN$US$US
240508151$24050815$1$I$20240523$20240620$20240704$20240704$EXP$FR-AFSSAPS-LY2024000821$FR-TEVA-VS-3213292$TEVA$$38$YR$$F$Y$50$KG$20240704$$CN$FR$FR
240508161$24050816$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A149094$ASTRAZENECA$$75$YR$$F$Y$$$20240704$$CN$ZA$
240508172$24050817$2$F$20201209$20240826$20240704$20240826$PER$$NVSC2024US138992$NOVARTIS$$58$YR$$F$Y$65.5$KG$20240827$$HP$US$US
240508181$24050818$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105517$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240704$$CN$US$US
240508192$24050819$2$F$20240618$20240726$20240704$20240728$EXP$IT-MINISAL02-993380$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037851$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240728$$MD$IT$IT
240508211$24050821$1$I$20240329$20240619$20240704$20240704$EXP$$DE-ROCHE-10000015903$ROCHE$$56$YR$A$M$Y$$$20240704$$MD$DE$DE
240508221$24050822$1$I$$20240627$20240704$20240704$EXP$$US-AMGEN-USASL2024127946$AMGEN$$64$YR$A$F$Y$$$20240704$$CN$US$US
240508231$24050823$1$I$20240701$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130851$AMGEN$$74$YR$E$F$Y$$$20240704$$CN$US$US
240508241$24050824$1$I$$20240123$20240704$20240704$PER$$US-AMGEN-USASP2024131607$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240508251$24050825$1$I$$20240626$20240704$20240704$PER$$US-AMGEN-USASP2024127479$AMGEN$$$$A$F$Y$$$20240704$$CN$US$US
240508261$24050826$1$I$20231223$20240621$20240704$20240704$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-03510$SAMSUNG BIOEPIS$$43$YR$A$F$Y$55$KG$20240704$$HP$CA$CA
240508331$24050833$1$I$$20240619$20240704$20240704$EXP$$SG-ROCHE-10000014121$ROCHE$$74$YR$E$M$Y$$$20240704$$CN$SG$SG
240508342$24050834$2$F$20240621$20240709$20240704$20240710$PER$$US-AMGEN-USASP2024131705$AMGEN$$90$YR$E$F$Y$$$20240710$$CN$US$US
240508351$24050835$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106766$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$64.4$KG$20240704$$HP$US$US
240508361$24050836$1$I$$20240702$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106457$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240704$$CN$US$US
240508372$24050837$2$F$$20240704$20240704$20240712$EXP$$IT-GILEAD-2024-0679494$GILEAD$$64$YR$A$M$Y$$$20240712$$MD$IT$IT
240508381$24050838$1$I$$20240702$20240704$20240704$PER$$US-GILEAD-2024-0679456$GILEAD$$$$$$Y$$$20240704$$CN$US$US
240508391$24050839$1$I$20240122$20240704$20240704$20240704$EXP$IT-EMA-DD-20240701-7482689-073512$NVSC2024IT138710$NOVARTIS$$14$YR$$F$Y$$$20240704$$MD$IT$IT
240508404$24050840$4$F$$20240725$20240704$20240807$30DAY$$US-JNJFOC-20240666517$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
240508411$24050841$1$I$$20240605$20240704$20240704$EXP$$US-NEBO-661052$PHARMACOSMOS$$84$YR$$F$Y$$$20240704$$HP$US$US
240508421$24050842$1$I$$20240702$20240704$20240704$PER$$US-GILEAD-2024-0679340$GILEAD$$35$YR$A$M$Y$$$20240704$$CN$US$US
240508432$24050843$2$F$$20240705$20240704$20240709$EXP$$TR-GILEAD-2024-0679459$GILEAD$$$$E$F$Y$$$20240709$$HP$TR$TR
240508441$24050844$1$I$20221018$20240627$20240704$20240704$EXP$$FR-CELLTRION INC.-2024FR015942$CELLTRION$$$$$$Y$$$20240704$$PH$FR$FR
240508452$24050845$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214643$TEVA$De Allie G, Mehta A, Boucekkine H, Saggar R, Neville TH, Fishbein G. Clinically Significant Pulmonary Invasion in Multiple Myeloma - Associated Amyloid Light Chain Amyloidosis. Am-J-Respir-Crit-Care-Med 2024; 209.; De Allie G, Mehta A, Boucekkine H, Saggar R, Neville TH, Fishbein G. Clinically Significant Pulmonary Invasion in Multiple Myeloma - Associated Amyloid Light Chain Amyloidosis. Am-J-Respir-Crit-Care-Med 2024; 209.$77$YR$$F$Y$$$20240720$$HP$US$US
240508461$24050846$1$I$$20240624$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05705$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240508471$24050847$1$I$$20240626$20240704$20240704$PER$$US-ALXN-202406USA001702US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240704$$HP$US$US
240508482$24050848$2$F$20240627$20240802$20240704$20240806$PER$$US-ALXN-202406USA001796US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240508501$24050850$1$I$$20240626$20240704$20240704$EXP$$GB-JNJFOC-20240706652$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$MD$GB$GB
240508511$24050851$1$I$$20240627$20240704$20240704$EXP$$US-RDY-SPO/USA/24/0009604$DR REDDYS$$72$YR$E$M$Y$$$20240704$$MD$US$US
240508521$24050852$1$I$$20240514$20240704$20240704$PER$$US-AMGEN-USASP2024131428$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240508532$24050853$2$F$20240627$20240627$20240704$20240815$PER$$US-AMGEN-USASP2024128352$AMGEN$$74$YR$E$M$Y$$$20240814$$CN$US$US
240508552$24050855$2$F$$20240801$20240704$20240806$PER$$US-AMGEN-USASP2024131263$AMGEN$$67$YR$E$M$Y$$$20240806$$CN$US$US
240508561$24050856$1$I$$20240628$20240704$20240704$PER$$US-GILEAD-2024-0679064$GILEAD$$$$$F$Y$$$20240704$$MD$US$US
240508572$24050857$2$F$20240120$20240731$20240704$20240806$EXP$$NVSC2024CO097722$NOVARTIS$$51$YR$$F$Y$96$KG$20240806$$CN$CO$CO
240508582$24050858$2$F$20240609$20240618$20240704$20240709$EXP$$IN-ROCHE-3574366$ROCHE$$45$YR$A$M$Y$$$20240701$$CN$IN$IN
240508591$24050859$1$I$$20240626$20240704$20240704$EXP$$AU-AstraZeneca-2024A149114$ASTRAZENECA$$$$$$Y$$$20240704$$MD$AU$
240508622$24050862$2$F$20240629$20240629$20240704$20240731$EXP$$VN-AstraZeneca-2024A151653$ASTRAZENECA$$21620$DY$$F$Y$$$20240731$$MD$VN$
240508631$24050863$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A148061$ASTRAZENECA$$$$$$Y$$$20240704$$CN$US$
240508641$24050864$1$I$$20240701$20240704$20240704$EXP$$AU-ABBVIE-5826113$ABBVIE$$$$$F$Y$$$20240704$$MD$AU$AU
240508651$24050865$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A148265$ASTRAZENECA$$82$YR$$M$Y$$$20240704$$CN$ZA$
240508662$24050866$2$F$$20240710$20240704$20240719$EXP$$US-TEVA-VS-3214830$TEVA$Yousaf Z, Jyothi Ramachandran Nair D, Kamel A. Nystatin Induced Laryngeal Edema - First Reported Case. Am-J-Respir-Crit-Care-Med 2024; 209.; Yousaf Z, Jyothi Ramachandran Nair D, Kamel A. Nystatin Induced Laryngeal Edema - First Reported Case. Am-J-Respir-Crit-Care-Med 2024; 209.$64$YR$$F$Y$$$20240719$$HP$US$US
240508671$24050867$1$I$20231101$20240701$20240704$20240704$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037876$BOEHRINGER INGELHEIM$$57$YR$A$M$Y$$$20240704$$CN$US$US
240508682$24050868$2$F$20240101$20240912$20240704$20240920$EXP$$JP-AMGEN-JPNSP2024130071$AMGEN$$89$YR$E$M$Y$$$20240920$$PH$JP$JP
240508691$24050869$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825384$ABBVIE$$58$YR$$F$Y$$$20240704$$HP$US$US
240508701$24050870$1$I$$20240108$20240704$20240704$PER$$US-AMGEN-USASP2024131692$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240508711$24050871$1$I$20240628$20240628$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104593$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240704$$PH$US$US
240508721$24050872$1$I$$20240702$20240704$20240704$EXP$$NVSC2024AT138391$NOVARTIS$$$$E$F$Y$$$20240704$$MD$AT$AT
240508731$24050873$1$I$20240101$20240702$20240704$20240704$PER$$US-JNJFOC-20240706731$JOHNSON AND JOHNSON$$49$YR$A$$Y$$$20240704$$CN$US$US
240508741$24050874$1$I$$20240624$20240704$20240704$EXP$$FR-ROCHE-10000009793$ROCHE$Choquet S, Soussain C, Azar N, Morel V, Metz C, Ursu R, et al. CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network. American Journal of Hematology. 2024-Jul;99 (7):1240-9. doi:10.1002/ajh.27316.$$$$$Y$$$20240704$$HP$FR$FR
240508751$24050875$1$I$$20240702$20240704$20240704$PER$$US-HALEON-2185362$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240508761$24050876$1$I$20240518$20240629$20240704$20240704$EXP$$NVSC2024IN137765$NOVARTIS$$56$YR$$F$Y$$$20240704$$CN$IN$IN
240508771$24050877$1$I$$20240624$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05753$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240508791$24050879$1$I$20240601$20240624$20240704$20240704$EXP$PT-INFARMED-J202406-64$PT-TEVA-VS-3213834$TEVA$$59$YR$$F$Y$$$20240704$$MD$PT$PT
240508801$24050880$1$I$20201101$20240626$20240704$20240704$EXP$$ES-CELLTRION INC.-2024ES015724$CELLTRION$$$$$$Y$$$20240704$$PH$ES$ES
240508812$24050881$2$F$20240530$20240710$20240704$20240711$EXP$$US-ROCHE-10000012011$ROCHE$$78$YR$E$M$Y$$$20240711$$CN$US$US
240508831$24050883$1$I$$20240621$20240704$20240704$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00501$Phathom Pharmaceuticals$$$$$F$Y$$$20240704$$CN$JP$JP
240508841$24050884$1$I$$20240621$20240704$20240704$EXP$$BR-PHATHOM PHARMACEUTICALS INC.-2024PHT00518$Phathom Pharmaceuticals$$$$$M$Y$73$KG$20240704$$CN$BR$BR
240508851$24050885$1$I$$20240701$20240704$20240704$PER$$US-JNJFOC-20240702069$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$CN$US$US
240508861$24050886$1$I$20240401$20240628$20240704$20240704$EXP$$CO-UCBSA-2024033848$UCB$$14$YR$$M$Y$49$KG$20240704$$CN$CO$CO
240508871$24050887$1$I$$20240607$20240704$20240704$PER$$US-JNJFOC-20240622443$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240704$$CN$US$US
240508881$24050888$1$I$20200425$20240624$20240704$20240704$EXP$PL-URPL-1-1314-2020$PL-TEVA-VS-3213856$TEVA$$74$YR$$M$Y$72$KG$20240704$$MD$PL$PL
240508891$24050889$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024132320$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240508901$24050890$1$I$20240701$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131653$AMGEN$$59$YR$A$M$Y$$$20240704$$CN$US$US
240508911$24050891$1$I$$20240624$20240704$20240704$EXP$$US-AMGEN-USASP2024128589$AMGEN$Abdelrahim M.; Esmail A.; Divatia M.K. et al.. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. Journal of Clinical Medicine. 2024;13 (11):3068$58$YR$A$M$Y$$$20240704$$HP$US$US
240508922$24050892$2$F$$20240627$20240704$20240711$EXP$$HK-VISIOX-2024VSX00056$Visiox$$28$YR$$M$Y$$$20240711$$MD$HK$HK
240508931$24050893$1$I$$20240628$20240704$20240704$PER$$US-TAKEDA-2024TUS066025$TAKEDA$$$$$F$Y$$$20240704$$PH$US$US
240508941$24050894$1$I$$20240620$20240704$20240704$EXP$$US-SA-2024SA186512$SANOFI AVENTIS$$$$E$M$Y$$$20240704$$MD$US$US
240508961$24050896$1$I$$20240604$20240704$20240704$PER$$US-009507513-2406USA002559$MERCK$Otchere P, Pak S, Ulloa-Rodriguez J, Fierro M, Sharma A, Poku T, et al.. Complex decision making in a patient with lung cancer with incidentally found fast-growing atrial mass. Cardio-Oncology. 2024;10(30):1-8$72$YR$$F$Y$$$20240704$$HP$US$US
240508972$24050897$2$F$20240601$20240708$20240704$20240709$PER$$US-AMGEN-USASP2024131854$AMGEN$$75$YR$E$F$Y$$$20240709$$MD$US$US
240508981$24050898$1$I$$20231130$20240704$20240704$PER$$US-AMGEN-USASP2023235236$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240508991$24050899$1$I$$20230131$20240704$20240704$PER$$US-AMGEN-USASP2023235553$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240509014$24050901$4$F$20240701$20240924$20240704$20240926$EXP$$US-SANDOZ INC.-NVSC2022US221717$SANDOZ$$56$YR$$F$Y$70.748$KG$20240926$$CN$US$US
240509021$24050902$1$I$$20240619$20240704$20240704$EXP$$AU-ROCHE-10000016098$ROCHE$$$$$$Y$$$20240704$$MD$AU$AU
240509032$24050903$2$F$20240621$20240822$20240704$20240826$PER$$US-ROCHE-10000012732$ROCHE$$27$YR$A$F$Y$63.95$KG$20240826$$MD$US$US
240509041$24050904$1$I$20230303$20240604$20240704$20240704$PER$$US-009507513-2406USA001199$MERCK$Varanitskaya  L, Unlu S, Clemow C.. A Case Report on the Management of a Patient with Local Breast Cancer, BIA-ALCL and Radiation Induced Metastatic Angiosarcoma: A Multidisciplinary Approach. Cancer Research. 2024;84$60$YR$$F$Y$$$20240704$$MD$US$US
240509051$24050905$1$I$$20240702$20240704$20240704$PER$$US-ABBVIE-5827214$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240509062$24050906$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214680$TEVA$Dhaliwal K, Patel N, Aulakh BS. Toxic Megacolon: A Rare Adverse Effect of Etoposide Chemotherapy. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Dhaliwal K, Patel N, Aulakh BS. Toxic Megacolon: A Rare Adverse Effect of Etoposide Chemotherapy. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$59$YR$$M$Y$$$20240720$$HP$US$US
240509071$24050907$1$I$20240615$20240626$20240704$20240704$EXP$$IE-ROCHE-10000016303$ROCHE$$$$$F$Y$$$20240704$$CN$IE$IE
240509083$24050908$3$F$20240531$20240723$20240704$20240801$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004792$SAREPTA THERAPEUTICS$$6$YR$$M$Y$18.7$KG$20240801$$MD$US$US
240509134$24050913$4$F$$20240701$20240704$20240711$PER$$US-ROCHE-10000015425$ROCHE$$56$YR$A$F$Y$$$20240711$$MD$US$US
240509151$24050915$1$I$$20240622$20240704$20240704$PER$$US-ROCHE-10000013225$ROCHE$$$$$$Y$$$20240704$$CN$US$US
240509172$24050917$2$F$$20240613$20240704$20240711$PER$$US-JNJFOC-20240649313$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240509181$24050918$1$I$20240610$20240702$20240704$20240704$PER$$US-JNJFOC-20240706001$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240509192$24050919$2$F$20240624$20240708$20240704$20240711$EXP$$US-JNJFOC-20240668688$JOHNSON AND JOHNSON$$46$YR$A$F$Y$62.198$KG$20240711$$MD$US$US
240509211$24050921$1$I$$20240627$20240704$20240704$EXP$$GB-SA-2024SA194850$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240704$$MD$GB$GB
240509222$24050922$2$F$20240501$20240712$20240704$20240725$PER$$US-ALXN-202406USA001788US$ALEXION PHARMACEUTICALS$$48$YR$$F$Y$105.67$KG$20240719$$CN$US$US
240509231$24050923$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024132563$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240509241$24050924$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131186$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240509251$24050925$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131474$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240509261$24050926$1$I$$20240701$20240704$20240704$EXP$$US-UCBSA-2024033723$UCB$$$$$$Y$$$20240704$$CN$US$US
240509271$24050927$1$I$20240626$20240703$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106516$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240704$$CN$US$US
240509281$24050928$1$I$20091201$20240627$20240704$20240704$EXP$$JP-JNJFOC-20240711968$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240704$$MD$JP$JP
240509291$24050929$1$I$$20240625$20240704$20240704$EXP$$JP-AstraZeneca-2024A147545$ASTRAZENECA$Watanabe T, Hirama T, Akiba M, Watanabe T, Watanabe Y, Oishi H. COVID-19 pneumonia in lung transplant recipients: understanding risk factors and treatment outcomes in Japan. Clinical and Experimental Medicine 2024;24(1):Art nr 123.$58$YR$$M$Y$$$20240704$$HP$JP$
240509301$24050930$1$I$20240601$20240701$20240704$20240704$EXP$$US-UCBSA-2024033887$UCB$$36$YR$$F$Y$$$20240704$$HP$US$US
240509312$24050931$2$F$20240101$20240710$20240704$20240717$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036727$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$83$KG$20240717$$MD$DE$DE
240509321$24050932$1$I$$20240624$20240704$20240704$PER$$US-TEVA-VS-3214658$TEVA$$$$$M$Y$$$20240704$$CN$US$US
240509332$24050933$2$F$$20240628$20240704$20240708$EXP$$CO-AMGEN-COLSL2023022156$AMGEN$$85$YR$E$F$Y$$$20240708$$CN$CO$CO
240509342$24050934$2$F$20240612$20240829$20240704$20240902$PER$$US-AMGEN-USASP2024132310$AMGEN$$63$YR$A$M$Y$$$20240901$$CN$US$US
240509353$24050935$3$F$20170905$20240912$20240704$20240916$EXP$$US-GILEAD-2024-0679529$GILEAD$$50$YR$A$M$Y$$$20240916$$LW$US$US
240509361$24050936$1$I$$20240618$20240704$20240704$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06168$NEUROCRINE BIOSCIENCES$$60$YR$$F$Y$$$20240704$$HP$US$US
240509371$24050937$1$I$20240627$20240628$20240704$20240704$PER$$US-ABBVIE-5824664$ABBVIE$$$$A$$Y$$$20240704$$MD$US$US
240509381$24050938$1$I$20240606$20240607$20240704$20240704$PER$$US-JNJFOC-20240628944$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240509391$24050939$1$I$20240601$20240702$20240704$20240704$PER$$US-JNJFOC-20240706439$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240704$$CN$US$US
240509403$24050940$3$F$$20240711$20240704$20240719$EXP$$US-009507513-2407USA001883$MERCK$Vlachou E, Johnson BA, Guancial E, Lombardo KA, Hoffman-Censits J.. Frontline immune checkpoint inhibitors in patients = 90 years with advanced urothelial cancer: a single center experience.. The Canadian journal of urology.. 2024;31(3):11875-9$90$YR$$F$Y$$$20240719$$MD$US$US
240509411$24050941$1$I$$20240620$20240704$20240704$EXP$$MA-INGENUS PHARMACEUTICALS, LLC-2024INF000030$INGENUS$Jamal A, Draoui N, Assarrar I, Rouf S, Latrech H.. Apoplexy of a giant clival ectopic prolactinoma: A very rare case report.. Int J Surg Case Rep. 2024$45$YR$$F$Y$$$20240704$$HP$MA$MA
240509421$24050942$1$I$20240605$20240622$20240704$20240704$EXP$GB-MHRA-MED-202406212349030260-THQVZ$GB-LUPIN PHARMACEUTICALS INC.-2024-05607$LUPIN$$47$YR$$F$Y$95$KG$20240704$$CN$GB$GB
240509431$24050943$1$I$$20240701$20240704$20240704$EXP$$NVSC2024US041013$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240509441$24050944$1$I$20240624$20240625$20240704$20240704$EXP$$KR-TAKEDA-2024TUS064591$TAKEDA$$46$YR$$M$Y$98$KG$20240704$$MD$KR$KR
240509451$24050945$1$I$$20240628$20240704$20240704$EXP$$GB-TAKEDA-2024TUS067298$TAKEDA$$$$$M$Y$$$20240704$$CN$GB$GB
240509461$24050946$1$I$$20240628$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104145$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$CN$US$US
240509471$24050947$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107022$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$72.12$KG$20240704$$PH$US$US
240509481$24050948$1$I$$20240624$20240704$20240704$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-101913$BRISTOL MYERS SQUIBB$$$$$F$Y$40$KG$20240704$$HP$CA$CA
240509491$24050949$1$I$$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024128888$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240509501$24050950$1$I$$20240628$20240704$20240704$PER$$US-JNJFOC-20240700605$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240509512$24050951$2$F$$20240808$20240704$20240812$PER$$US-JNJFOC-20240706972$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$US$US
240509522$24050952$2$F$$20240708$20240704$20240715$EXP$GB-MHRA-MED-202406281141054980-NZHDV$GB-RDY-SPO/GBR/24/0009669$DR REDDYS$$$$$$Y$$$20240715$$CN$GB$GB
240509531$24050953$1$I$$20240703$20240704$20240704$PER$$US-HALEON-2185304$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240509541$24050954$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281141493050-NJBWG$GB-RDY-SPO/GBR/24/0009619$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240509551$24050955$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281042408830-QRLPK$GB-RDY-SPO/GBR/24/0009616$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240509561$24050956$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281429282700-HZCNF$GB-RDY-SPO/GBR/24/0009543$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240509571$24050957$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281423510310-QYSNJ$GB-RDY-SPO/GBR/24/0009578$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240509582$24050958$2$F$20240620$20240801$20240704$20240810$30DAY$$US-GSK-US2024079207$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240810$$CN$US$US
240509591$24050959$1$I$20240620$20240624$20240704$20240704$EXP$CN-NMPA-3201271886349202400117$CN-Ipsen Biopharmaceuticals, Inc.-2024-13298$IPSEN$$55$YR$A$M$Y$53$KG$20240704$$HP$CN$CN
240509601$24050960$1$I$$20240703$20240704$20240704$EXP$$NVSC2024US138231$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240509612$24050961$2$F$20240606$20240704$20240704$20240723$30DAY$$TR-JNJFOC-20240623327$JOHNSON AND JOHNSON$$72$YR$E$F$Y$62$KG$20240723$$PH$TR$TR
240509621$24050962$1$I$$20240626$20240704$20240704$EXP$$JP-AstraZeneca-2024A149310$ASTRAZENECA$$$$$$Y$$$20240704$$PH$JP$
240509631$24050963$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A147796$ASTRAZENECA$$$$$M$Y$$$20240704$$HP$US$
240509641$24050964$1$I$20240616$20240626$20240704$20240704$EXP$$DE-AstraZeneca-2024A153527$ASTRAZENECA$$50$YR$$F$Y$$$20240704$$MD$ES$
240509651$24050965$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A149025$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$US$
240509661$24050966$1$I$$20240628$20240704$20240704$EXP$$US-AMGEN-USASP2024129786$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240509671$24050967$1$I$20240101$20240613$20240704$20240704$PER$$US-009507513-2406USA005308$MERCK$$$$$M$Y$$$20240704$$CN$US$US
240509682$24050968$2$F$20170809$20240911$20240704$20240916$PER$$US-GILEAD-2024-0679530$GILEAD$$54$YR$A$M$Y$$$20240916$$LW$US$US
240509691$24050969$1$I$20240402$20240703$20240704$20240704$EXP$SE-SEMPA-2024-005292$SE-ABBVIE-5824663$ABBVIE$$30$YR$$F$Y$$$20240704$$MD$SE$SE
240509702$24050970$2$F$$20240702$20240704$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106158$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240710$$CN$US$US
240509711$24050971$1$I$$20230630$20240704$20240704$PER$$US-AMGEN-USASP2023235200$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240509721$24050972$1$I$20240701$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131894$AMGEN$$50$YR$A$M$Y$$$20240704$$CN$US$US
240509731$24050973$1$I$20240601$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129612$AMGEN$$80$YR$E$F$Y$$$20240704$$CN$US$US
240509741$24050974$1$I$$20240627$20240704$20240704$EXP$$NVSC2024CO137096$NOVARTIS$$70$YR$$$Y$$$20240704$$MD$CO$CO
240509752$24050975$2$F$20240624$20240624$20240704$20240917$EXP$$BR-CELLTRION INC.-2024BR015701$CELLTRION$$$$$$Y$$$20240917$$CN$BR$BR
240509761$24050976$1$I$20240101$20240625$20240704$20240704$EXP$$US-JNJFOC-20240668609$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240704$$CN$US$US
240509771$24050977$1$I$$20240702$20240704$20240704$PER$$US-JNJFOC-20240707440$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$CN$US$US
240509782$24050978$2$F$$20240712$20240704$20240715$PER$$US-PFIZER INC-PV202400087462$PFIZER$$83$YR$$F$Y$$$20240715$$HP$US$US
240509791$24050979$1$I$20240701$20240701$20240704$20240704$PER$$US-PFIZER INC-PV202400086803$PFIZER$$71$YR$$F$Y$$$20240704$$CN$US$US
240509803$24050980$3$F$20240101$20240718$20240704$20240724$PER$$US-PFIZER INC-202400205459$PFIZER$$82$YR$$F$Y$$$20240724$$HP$US$US
240509811$24050981$1$I$$20240701$20240704$20240704$PER$$US-PFIZER INC-PV202400087049$PFIZER$$62$YR$$F$Y$$$20240704$$HP$US$US
240509821$24050982$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407003235$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240704$$CN$US$US
240509831$24050983$1$I$20240618$20240618$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202406013237$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240704$$CN$US$US
240509841$24050984$1$I$$20240626$20240704$20240704$EXP$$US-TEVA-VS-3215344$TEVA$$$$A$F$Y$$$20240704$$HP$US$US
240509851$24050985$1$I$$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407003236$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240704$$CN$US$US
240509861$24050986$1$I$20190101$20240702$20240704$20240704$EXP$$US-UCBSA-2024002954$UCB$$$$$M$Y$$$20240704$$CN$US$US
240509871$24050987$1$I$20240624$20240701$20240704$20240704$PER$$US-009507513-2407USA001178$MERCK$$4$YR$$$Y$$$20240704$$HP$US$US
240509883$24050988$3$F$$20240802$20240704$20240812$EXP$$KR-EMD Serono-2024035522$EMD SERONO INC$$$$T$F$Y$$$20240812$$CN$KR$KR
240509892$24050989$2$F$20240415$20240708$20240704$20240711$EXP$$NVSC2024US105841$NOVARTIS$$69$YR$$F$Y$$$20240711$$CN$US$US
240509901$24050990$1$I$20240621$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024130494$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240509912$24050991$2$F$20240605$20240916$20240704$20240925$EXP$$US-TEVA-VS-3215500$TEVA$$13$YR$$F$Y$40.6$KG$20240925$$HP$US$US
240509922$24050992$2$F$20231201$20240913$20240704$20240913$PER$$NVSC2024US138467$NOVARTIS$$$$$F$Y$$$20240913$$MD$US$US
240509932$24050993$2$F$$20240724$20240704$20240730$PER$$US-AstraZeneca-2024A145702$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
240509941$24050994$1$I$$20240626$20240704$20240704$EXP$$GB-TEVA-VS-3214090$TEVA$$79$YR$$F$Y$66$KG$20240704$$MD$GB$GB
240509951$24050995$1$I$20240505$20240624$20240704$20240704$EXP$$EG-HIKMA PHARMACEUTICALS USA INC.-EG-H14001-24-05808$HIKMA$$$$$$Y$$$20240704$$PH$EG$EG
240509961$24050996$1$I$20240201$20240627$20240704$20240704$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036724$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240704$$CN$US$US
240509971$24050997$1$I$20240112$20240624$20240704$20240704$EXP$IT-MINISAL02-991677$IT-BAXTER-2024BAX020526$BAXTER$$58$YR$$F$Y$$$20240704$$MD$IT$IT
240509981$24050998$1$I$$20240624$20240704$20240704$EXP$$JP-BAXTER-2024BAX019812$BAXTER$$$$$F$Y$$$20240704$$HP$JP$JP
240509991$24050999$1$I$20240623$20240623$20240704$20240704$EXP$$GB-BAXTER-2024BAX020489$BAXTER$$57$YR$$M$Y$$$20240704$$HP$GB$GB
240510001$24051000$1$I$$20240624$20240704$20240704$EXP$$CA-BAXTER-2024BAX020761$BAXTER$$61$YR$$F$Y$$$20240704$$CN$CA$CA
240510021$24051002$1$I$20240702$20240702$20240704$20240704$PER$$US-JNJFOC-20240705777$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$CN$US$US
240510031$24051003$1$I$20240608$20240625$20240704$20240704$EXP$CN-NMPACDR-5201011038487202400107$CN-BAXTER-2024BAX020724$BAXTER$$16$YR$$M$Y$39$KG$20240704$$MD$CN$CN
240510041$24051004$1$I$20240419$20240628$20240704$20240704$PER$$US-ABBVIE-5824489$ABBVIE$$38$YR$$M$Y$$$20240704$$PH$US$US
240510052$24051005$2$F$20240625$20240712$20240704$20240721$EXP$$DE-BAXTER-2024BAX020776$BAXTER$$62$YR$$F$Y$$$20240721$$HP$DE$DE
240510061$24051006$1$I$20240101$20240701$20240704$20240704$PER$$US-ABBVIE-5825304$ABBVIE$$$$A$$Y$$$20240704$$MD$US$US
240510071$24051007$1$I$20240501$20240625$20240704$20240704$EXP$FR-AFSSAPS-AN2024000822$FR-BIOCON BIOLOGICS LIMITED-BBL2024004739$BIOCON$$$$$$Y$$$20240704$$MD$FR$FR
240510081$24051008$1$I$$20240625$20240704$20240704$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004805$BIOCON$$$$$$Y$$$20240704$$HP$CA$CA
240510091$24051009$1$I$20180701$20240624$20240704$20240704$PER$$US-ABBVIE-5814532$ABBVIE$$25$YR$$F$Y$$$20240704$$CN$US$US
240510101$24051010$1$I$$20240701$20240704$20240704$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-104919$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240704$$MD$DE$DE
240510111$24051011$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106424$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240704$$CN$US$US
240510123$24051012$3$F$20170829$20240911$20240704$20240916$PER$$US-GILEAD-2024-0679531$GILEAD$$61$YR$A$M$Y$$$20240916$$LW$US$US
240510131$24051013$1$I$20240702$20240703$20240704$20240704$PER$$US-PFIZER INC-202400206259$PFIZER$$72$YR$$F$Y$$$20240704$$CN$US$US
240510142$24051014$2$F$20240701$20240722$20240704$20240724$PER$$US-PFIZER INC-202400206282$PFIZER$$65$YR$$M$Y$91.6$KG$20240724$$CN$US$US
240510151$24051015$1$I$20240101$20240702$20240704$20240704$PER$$US-PFIZER INC-202400206200$PFIZER$$66$YR$$F$Y$71.67$KG$20240704$$CN$US$US
240510161$24051016$1$I$20240702$20240703$20240704$20240704$PER$$US-PFIZER INC-202400206660$PFIZER$$84$YR$$F$Y$$$20240704$$CN$US$US
240510181$24051018$1$I$$20240703$20240704$20240704$PER$$US-PFIZER INC-PV202400087634$PFIZER$$69$YR$$$Y$$$20240704$$CN$US$US
240510191$24051019$1$I$20240702$20240703$20240704$20240704$PER$$US-PFIZER INC-202400206234$PFIZER$$57$YR$$M$Y$$$20240704$$CN$US$US
240510201$24051020$1$I$$20240620$20240704$20240704$PER$$US-SA-2024SA188390$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240704$$MD$US$US
240510211$24051021$1$I$20240601$20240621$20240704$20240704$PER$$US-SA-2024SA189400$SANOFI AVENTIS$$18$YR$A$F$Y$68$KG$20240704$$MD$US$US
240510221$24051022$1$I$$20240621$20240704$20240704$PER$$US-SA-2024SA190746$SANOFI AVENTIS$$$$A$F$Y$51.7$KG$20240704$$MD$US$US
240510231$24051023$1$I$$20240621$20240704$20240704$PER$$US-SA-2024SA189316$SANOFI AVENTIS$$$$C$M$Y$$$20240704$$MD$US$US
240510241$24051024$1$I$20240101$20240621$20240704$20240704$PER$$US-SA-2024SA189102$SANOFI AVENTIS$$78$YR$E$M$Y$80.7$KG$20240704$$MD$US$US
240510251$24051025$1$I$$20240621$20240704$20240704$PER$$US-SA-2024SA189469$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$MD$US$US
240510261$24051026$1$I$20231201$20240620$20240704$20240704$PER$$US-SA-2024SA189600$SANOFI AVENTIS$$3$YR$C$F$Y$15.01$KG$20240704$$MD$US$US
240510271$24051027$1$I$20240101$20240621$20240704$20240704$PER$$US-SA-2024SA188773$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240704$$MD$US$US
240510281$24051028$1$I$20240101$20240620$20240704$20240704$PER$$US-SA-2024SA188772$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240704$$MD$US$US
240510291$24051029$1$I$20240617$20240621$20240704$20240704$PER$$US-SA-2024SA188903$SANOFI AVENTIS$$20$MON$I$F$Y$$$20240704$$MD$US$US
240510301$24051030$1$I$20240401$20240621$20240704$20240704$PER$$US-SA-2024SA189564$SANOFI AVENTIS$$$$A$F$Y$61$KG$20240704$$MD$US$US
240510311$24051031$1$I$$20240620$20240704$20240704$PER$$US-SA-2024SA189928$SANOFI AVENTIS$$$$E$M$Y$60$KG$20240704$$MD$US$US
240510321$24051032$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA193444$SANOFI AVENTIS$$51$YR$A$M$Y$135$KG$20240704$$MD$US$US
240510331$24051033$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191586$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240704$$HP$US$US
240510341$24051034$1$I$$20240620$20240704$20240704$PER$$US-SA-2024SA188787$SANOFI AVENTIS$$$$E$M$Y$69.8$KG$20240704$$MD$US$US
240510351$24051035$1$I$20230201$20240621$20240704$20240704$PER$$US-SA-2024SA191928$SANOFI AVENTIS$$18$YR$A$M$Y$84.82$KG$20240704$$MD$US$US
240510362$24051036$2$F$20240401$20240816$20240704$20240821$PER$$US-SA-2024SA189619$SANOFI AVENTIS$$38$YR$A$F$Y$76.65$KG$20240821$$MD$US$US
240510371$24051037$1$I$20231030$20240625$20240704$20240704$PER$$US-SA-2024SA191205$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240704$$MD$US$US
240510381$24051038$1$I$20240101$20240626$20240704$20240704$PER$$US-SA-2024SA193736$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240704$$MD$US$US
240510391$24051039$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA193087$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240704$$MD$US$US
240510401$24051040$1$I$$20240621$20240704$20240704$PER$$US-SA-2024SA189797$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240704$$MD$US$US
240510411$24051041$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA190972$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240704$$MD$US$US
240510421$24051042$1$I$$20240626$20240704$20240704$PER$$US-SA-2024SA194359$SANOFI AVENTIS$$$$A$M$Y$$$20240704$$MD$US$US
240510431$24051043$1$I$20240613$20240625$20240704$20240704$PER$$US-SA-2024SA192744$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240704$$MD$US$US
240510441$24051044$1$I$20240618$20240625$20240704$20240704$PER$$US-SA-2024SA192099$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240704$$MD$US$US
240510451$24051045$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA192197$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240704$$MD$US$US
240510461$24051046$1$I$20170101$20240625$20240704$20240704$PER$$US-SA-2024SA192786$SANOFI AVENTIS$$15$DY$N$F$Y$$$20240704$$HP$US$US
240510471$24051047$1$I$20240101$20240621$20240704$20240704$PER$$US-SA-2024SA188919$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240704$$MD$US$US
240510481$24051048$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192105$SANOFI AVENTIS$$$$I$M$Y$$$20240704$$MD$US$US
240510491$24051049$1$I$20240614$20240625$20240704$20240704$PER$$US-SA-2024SA192374$SANOFI AVENTIS$$55$YR$A$F$Y$103$KG$20240704$$MD$US$US
240510501$24051050$1$I$20240101$20240627$20240704$20240704$EXP$$US-ABBVIE-5823175$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240510511$24051051$1$I$$20240629$20240704$20240704$PER$$US-JNJFOC-20240700707$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240510521$24051052$1$I$$20240626$20240704$20240704$EXP$$US-ALXN-202406USA001751US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240704$$MD$US$US
240510541$24051054$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191839$SANOFI AVENTIS$$$$A$M$Y$$$20240704$$MD$US$US
240510553$24051055$3$F$$20240715$20240704$20240722$PER$$US-SA-2024SA191709$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240722$$CN$US$US
240510561$24051056$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA193671$SANOFI AVENTIS$$21$YR$A$M$Y$68.03$KG$20240704$$MD$US$US
240510571$24051057$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191148$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$MD$US$US
240510581$24051058$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190946$SANOFI AVENTIS$$$$C$F$Y$11$KG$20240704$$MD$US$US
240510591$24051059$1$I$20240516$20240625$20240704$20240704$PER$$US-SA-2024SA193266$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240704$$MD$US$US
240510601$24051060$1$I$20240501$20240625$20240704$20240704$PER$$US-SA-2024SA192412$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240704$$MD$US$US
240510611$24051061$1$I$20240401$20240625$20240704$20240704$PER$$US-SA-2024SA191662$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240704$$MD$US$US
240510621$24051062$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA189913$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240704$$MD$US$US
240510631$24051063$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192992$SANOFI AVENTIS$$$$A$M$Y$83.914$KG$20240704$$MD$US$US
240510641$24051064$1$I$20240501$20240625$20240704$20240704$PER$$US-SA-2024SA192193$SANOFI AVENTIS$$51$YR$A$F$Y$102$KG$20240704$$MD$US$US
240510651$24051065$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2022SA258086$SANOFI AVENTIS$$60$YR$A$F$Y$72$KG$20240704$$MD$US$US
240510662$24051066$2$F$$20240813$20240704$20240826$PER$$US-SA-2024SA192767$SANOFI AVENTIS$$61$YR$A$M$Y$83.9$KG$20240826$$MD$US$US
240510671$24051067$1$I$20240518$20240625$20240704$20240704$PER$$US-SA-2024SA190665$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240704$$HP$US$US
240510681$24051068$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190917$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240704$$MD$US$US
240510691$24051069$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193314$SANOFI AVENTIS$$$$C$M$Y$15.8$KG$20240704$$MD$US$US
240510701$24051070$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191244$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240704$$MD$US$US
240510712$24051071$2$F$20240101$20240814$20240704$20240828$PER$$US-SA-2024SA193489$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240828$$CN$US$US
240510721$24051072$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA192206$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240704$$MD$US$US
240510731$24051073$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA192355$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240704$$CN$US$US
240510742$24051074$2$F$20240601$20240913$20240704$20240923$PER$$US-SA-2024SA190909$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240923$$MD$US$US
240510751$24051075$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA193669$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240704$$MD$US$US
240510761$24051076$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190784$SANOFI AVENTIS$$$$E$M$Y$$$20240704$$MD$US$US
240510771$24051077$1$I$20240502$20240701$20240704$20240704$EXP$FR-AFSSAPS-MA2024001106$FR-UCBSA-2024033885$UCB$$61$YR$$F$Y$$$20240704$$MD$FR$FR
240510782$24051078$2$F$20240101$20240824$20240704$20240914$PER$$US-SA-2024SA054342$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240914$$CN$US$US
240510791$24051079$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192107$SANOFI AVENTIS$$$$T$M$Y$$$20240704$$MD$US$US
240510801$24051080$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193828$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$LW$US$US
240510811$24051081$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193232$SANOFI AVENTIS$$$$A$F$Y$56.699$KG$20240704$$MD$US$US
240510821$24051082$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193318$SANOFI AVENTIS$$$$A$M$Y$$$20240704$$MD$US$US
240510831$24051083$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA192580$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240704$$MD$US$US
240510841$24051084$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA192962$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240704$$MD$US$US
240510851$24051085$1$I$20240101$20240626$20240704$20240704$PER$$US-SA-2024SA195312$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240704$$CN$US$US
240510861$24051086$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA169345$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240704$$MD$US$US
240510871$24051087$1$I$$20240624$20240704$20240704$PER$$US-SA-2024SA189589$SANOFI AVENTIS$$$$$$Y$$$20240704$$CN$US$US
240510882$24051088$2$F$20240501$20240711$20240704$20240716$PER$$US-SA-2024SA193045$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240716$$MD$US$US
240510891$24051089$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA193556$SANOFI AVENTIS$$51$YR$A$M$Y$99.773$KG$20240704$$MD$US$US
240510901$24051090$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192204$SANOFI AVENTIS$$$$T$F$Y$$$20240704$$MD$US$US
240510912$24051091$2$F$20240101$20240906$20240704$20240914$PER$$US-SA-2024SA190294$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240914$$MD$US$US
240510921$24051092$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA192648$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240704$$MD$US$US
240510931$24051093$1$I$20240625$20240625$20240704$20240704$PER$$US-SA-2024SA189937$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240704$$CN$US$US
240510941$24051094$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA193456$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240704$$MD$US$US
240510951$24051095$1$I$20240618$20240625$20240704$20240704$PER$$US-SA-2024SA192202$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240704$$MD$US$US
240510961$24051096$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA192203$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240704$$MD$US$US
240510971$24051097$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193481$SANOFI AVENTIS$$$$A$M$Y$79.3$KG$20240704$$MD$US$US
240510981$24051098$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193340$SANOFI AVENTIS$$$$E$F$Y$66.6$KG$20240704$$HP$US$US
240510991$24051099$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA197223$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240704$$MD$US$US
240511001$24051100$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192215$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240704$$MD$US$US
240511012$24051101$2$F$20240601$20240916$20240704$20240924$PER$$US-SA-2024SA074914$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240924$$MD$US$US
240511021$24051102$1$I$20240623$20240625$20240704$20240704$PER$$US-SA-2024SA191260$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240704$$MD$US$US
240511031$24051103$1$I$20240625$20240626$20240704$20240704$PER$$US-SA-2024SA196379$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240704$$CN$US$US
240511041$24051104$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193319$SANOFI AVENTIS$$63$YR$A$F$Y$76.2$KG$20240704$$MD$US$US
240511051$24051105$1$I$20240611$20240625$20240704$20240704$PER$$US-SA-2024SA193364$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240704$$MD$US$US
240511061$24051106$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190121$SANOFI AVENTIS$$$$E$F$Y$$$20240704$$CN$US$US
240511071$24051107$1$I$$20240703$20240704$20240704$PER$$NVSC2024US139064$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
240511081$24051108$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191220$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$MD$US$US
240511091$24051109$1$I$$20240627$20240704$20240704$PER$$US-BAUSCH-BL-2024-010055$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240704$$CN$US$US
240511101$24051110$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190770$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240704$$HP$US$US
240511111$24051111$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA190914$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240704$$MD$US$US
240511122$24051112$2$F$20240622$20240628$20240704$20240710$PER$$US-SA-2024SA190920$SANOFI AVENTIS$$12$YR$T$M$Y$56.6$KG$20240710$$MD$US$US
240511131$24051113$1$I$20240501$20240625$20240704$20240704$PER$$US-SA-2024SA193830$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240704$$MD$US$US
240511141$24051114$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190942$SANOFI AVENTIS$$69$YR$E$F$Y$86.18$KG$20240704$$MD$US$US
240511152$24051115$2$F$20240101$20240723$20240704$20240801$PER$$US-SA-2024SA190677$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240801$$MD$US$US
240511161$24051116$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190533$SANOFI AVENTIS$$12$YR$T$M$Y$32$KG$20240704$$MD$US$US
240511171$24051117$1$I$20240301$20240625$20240704$20240704$PER$$US-SA-2024SA192457$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240704$$MD$US$US
240511181$24051118$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA193507$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240704$$MD$US$US
240511191$24051119$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190819$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240704$$MD$US$US
240511202$24051120$2$F$20240101$20240905$20240704$20240914$PER$$US-SA-2024SA193462$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240914$$MD$US$US
240511211$24051121$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191582$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240704$$MD$US$US
240511222$24051122$2$F$20240101$20240727$20240704$20240805$PER$$US-SA-2024SA191723$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240805$$MD$US$US
240511231$24051123$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193727$SANOFI AVENTIS$$$$C$M$Y$14$KG$20240704$$MD$US$US
240511242$24051124$2$F$20240101$20240911$20240704$20240920$PER$$US-SA-2024SA190767$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240920$$MD$US$US
240511253$24051125$3$F$20240101$20240917$20240704$20240926$PER$$US-SA-2024SA193622$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240926$$MD$US$US
240511261$24051126$1$I$$20240625$20240704$20240704$PER$$US-SA-2022SA429763$SANOFI AVENTIS$$$$E$F$Y$$$20240704$$MD$US$US
240511271$24051127$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190957$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$CN$US$US
240511281$24051128$1$I$$20240626$20240704$20240704$PER$$US-SA-2024SA192655$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240704$$CN$US$US
240511291$24051129$1$I$20240626$20240626$20240704$20240704$PER$$US-SA-2024SA193755$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240704$$MD$US$US
240511301$24051130$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192333$SANOFI AVENTIS$$$$T$F$Y$$$20240704$$MD$US$US
240511311$24051131$1$I$20240621$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024130464$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240511321$24051132$1$I$$20240203$20240704$20240704$PER$$US-AMGEN-USASP2024129713$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240511333$24051133$3$F$$20240723$20240704$20240726$PER$$US-AMGEN-USASP2024132315$AMGEN$$$$$M$Y$$$20240726$$PH$US$US
240511341$24051134$1$I$$20240701$20240704$20240704$EXP$DE-Eisai-EC-2024-168590$DE-UCBSA-2024033219$UCB$$$$$F$Y$$$20240704$$MD$DE$DE
240511351$24051135$1$I$20240101$20240624$20240704$20240704$PER$$US-TEVA-VS-3213514$TEVA$$$$$F$Y$$$20240704$$CN$US$US
240511361$24051136$1$I$20240601$20240703$20240704$20240704$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-106569$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240704$$PH$BR$BR
240511371$24051137$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190936$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240704$$MD$US$US
240511381$24051138$1$I$$20240626$20240704$20240704$PER$$US-SA-2024SA193445$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240704$$MD$US$US
240511391$24051139$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190798$SANOFI AVENTIS$$$$E$M$Y$$$20240704$$MD$US$US
240511401$24051140$1$I$20240101$20240626$20240704$20240704$PER$$US-SA-2024SA193982$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240704$$MD$US$US
240511411$24051141$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190528$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240704$$MD$US$US
240511421$24051142$1$I$$20240626$20240704$20240704$PER$$US-SA-2024SA193632$SANOFI AVENTIS$$$$A$M$Y$83.9$KG$20240704$$MD$US$US
240511431$24051143$1$I$$20240626$20240704$20240704$PER$$US-SA-2024SA193688$SANOFI AVENTIS$$$$A$M$Y$$$20240704$$MD$US$US
240511441$24051144$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA089180$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240704$$MD$US$US
240511451$24051145$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190523$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240704$$MD$US$US
240511461$24051146$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA193134$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240704$$MD$US$US
240511471$24051147$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193565$SANOFI AVENTIS$$$$A$F$Y$67$KG$20240704$$MD$US$US
240511481$24051148$1$I$20240501$20240625$20240704$20240704$PER$$US-SA-2024SA193717$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240704$$MD$US$US
240511491$24051149$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193627$SANOFI AVENTIS$$61$YR$A$F$Y$47$KG$20240704$$MD$US$US
240511501$24051150$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA145430$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240704$$MD$US$US
240511511$24051151$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193020$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240704$$MD$US$US
240511521$24051152$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190327$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240704$$MD$US$US
240511532$24051153$2$F$$20240628$20240704$20240709$EXP$$BR-GENMAB-2024-02326$GENMAB$$$$$F$Y$$$20240709$$MD$BR$BR
240511541$24051154$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281414490710-DZNCP$GB-RDY-SPO/GBR/24/0009547$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240511551$24051155$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281503492060-NTSCD$GB-RDY-SPO/GBR/24/0009553$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240511561$24051156$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281411346130-TDLKP$GB-RDY-SPO/GBR/24/0009552$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240511572$24051157$2$F$$20240708$20240704$20240717$PER$$US-SA-2024SA193695$SANOFI AVENTIS$$$$A$F$Y$58.05$KG$20240717$$MD$US$US
240511581$24051158$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA194899$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$MD$US$US
240511591$24051159$1$I$20240101$20240624$20240704$20240704$PER$$US-SA-2024SA190947$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240704$$MD$US$US
240511601$24051160$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA193681$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240704$$MD$US$US
240511611$24051161$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192860$SANOFI AVENTIS$$2$YR$C$M$Y$13.19$KG$20240704$$MD$US$US
240511621$24051162$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192822$SANOFI AVENTIS$$$$C$M$Y$46.304$KG$20240704$$MD$US$US
240511631$24051163$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192108$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240704$$MD$US$US
240511641$24051164$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA064448$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240704$$CN$US$US
240511651$24051165$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193531$SANOFI AVENTIS$$1$YR$I$F$Y$10.1$KG$20240704$$MD$US$US
240511661$24051166$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA195339$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240704$$HP$US$US
240511681$24051168$1$I$20240613$20240625$20240704$20240704$PER$$US-SA-2024SA191568$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240704$$MD$US$US
240511691$24051169$1$I$$20240625$20240704$20240704$PER$$US-SA-2020SA108124$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240704$$CN$US$US
240511701$24051170$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192935$SANOFI AVENTIS$$$$I$M$Y$15$KG$20240704$$MD$US$US
240511711$24051171$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193519$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$MD$US$US
240511721$24051172$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191211$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240704$$MD$US$US
240511731$24051173$1$I$20240501$20240627$20240704$20240704$PER$$US-SA-2024SA196157$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240704$$MD$US$US
240511743$24051174$3$F$20240617$20240830$20240704$20240927$PER$$US-SA-2024SA192593$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240927$$MD$US$US
240511751$24051175$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193678$SANOFI AVENTIS$$$$A$F$Y$86.5$KG$20240704$$MD$US$US
240511761$24051176$1$I$20240601$20240627$20240704$20240704$PER$$US-SA-2024SA194459$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240704$$MD$US$US
240511771$24051177$1$I$20240614$20240625$20240704$20240704$PER$$US-SA-2024SA192640$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240704$$MD$US$US
240511781$24051178$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA190765$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240704$$MD$US$US
240511791$24051179$1$I$20240101$20240627$20240704$20240704$PER$$US-SA-2024SA195075$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240704$$MD$US$US
240511811$24051181$1$I$20240101$20240627$20240704$20240704$PER$$US-SA-2024SA194822$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240704$$MD$US$US
240511821$24051182$1$I$20240101$20240627$20240704$20240704$PER$$US-SA-2024SA196918$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240704$$MD$US$US
240511831$24051183$1$I$20240601$20240627$20240704$20240704$PER$$US-SA-2024SA194762$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240704$$MD$US$US
240511842$24051184$2$F$20240101$20240806$20240704$20240816$PER$$US-SA-2024SA194869$SANOFI AVENTIS$$20$YR$A$F$Y$62.5$KG$20240816$$MD$US$US
240511853$24051185$3$F$20240101$20240916$20240704$20240923$PER$$US-SA-2024SA193595$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240923$$MD$US$US
240511861$24051186$1$I$20240101$20240627$20240704$20240704$PER$$US-SA-2024SA194773$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240704$$CN$US$US
240511871$24051187$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA194678$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240704$$MD$US$US
240511882$24051188$2$F$20240624$20240819$20240704$20240828$PER$$US-SA-2024SA195010$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240828$$MD$US$US
240511891$24051189$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA194968$SANOFI AVENTIS$$$$C$M$Y$38.1$KG$20240704$$MD$US$US
240511911$24051191$1$I$20240601$20240628$20240704$20240704$PER$$US-SA-2024SA195388$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240704$$MD$US$US
240511921$24051192$1$I$20240301$20240627$20240704$20240704$PER$$US-SA-2024SA193763$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240704$$MD$US$US
240511931$24051193$1$I$20240516$20240627$20240704$20240704$PER$$US-SA-2024SA195237$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240704$$MD$US$US
240511942$24051194$2$F$20240501$20240725$20240704$20240803$PER$$US-SA-2024SA194961$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240803$$MD$US$US
240511951$24051195$1$I$$20240628$20240704$20240704$PER$$US-SA-2024SA194838$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240704$$MD$US$US
240511961$24051196$1$I$$20240628$20240704$20240704$PER$$US-SA-2024SA195163$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240704$$MD$US$US
240511971$24051197$1$I$20240101$20240628$20240704$20240704$PER$$US-SA-2024SA194464$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240704$$MD$US$US
240511981$24051198$1$I$$20240628$20240704$20240704$PER$$US-SA-2024SA195130$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240704$$CN$US$US
240511991$24051199$1$I$$20240628$20240704$20240704$PER$$US-SA-2024SA195251$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$MD$US$US
240512001$24051200$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA193130$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240704$$CN$US$US
240512011$24051201$1$I$$20240628$20240704$20240704$PER$$US-SA-2024SA195088$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240704$$HP$US$US
240512021$24051202$1$I$$20240628$20240704$20240704$PER$$US-SA-2024SA194551$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240704$$CN$US$US
240512031$24051203$1$I$$20240628$20240704$20240704$PER$$US-SA-2024SA194396$SANOFI AVENTIS$$$$A$M$Y$$$20240704$$CN$US$US
240512042$24051204$2$F$20240101$20240815$20240704$20240829$PER$$US-SA-2024SA194423$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240829$$MD$US$US
240512051$24051205$1$I$20240601$20240627$20240704$20240704$PER$$US-SA-2024SA195404$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240704$$CN$US$US
240512061$24051206$1$I$20240601$20240627$20240704$20240704$PER$$US-SA-2024SA194586$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240704$$MD$US$US
240512072$24051207$2$F$$20240723$20240704$20240801$PER$$US-SA-2024SA194836$SANOFI AVENTIS$$41$YR$A$F$Y$104$KG$20240801$$MD$US$US
240512081$24051208$1$I$20240627$20240628$20240704$20240704$PER$$US-SA-2024SA194882$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240704$$CN$US$US
240512091$24051209$1$I$20240501$20240627$20240704$20240704$PER$$US-SA-2024SA195835$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240704$$MD$US$US
240512102$24051210$2$F$$20240710$20240704$20240720$EXP$$DE-TEVA-VS-3215299$TEVA$Suwalski P, Wilke F, Fairweather D, Landmesser U, Heidecker B. Application of magnetocardiography for myocarditis assessment in a testosterone-substituted female-to-male individual. Am-Heart-J-Plus 2024; 43.; Suwalski P, Wilke F, Fairweather D, Landmesser U, Heidecker B. Application of magnetocardiography for myocarditis assessment in a testosterone-substituted female-to-male individual. Am-Heart-J-Plus 2024; 43.; Suwalski P, Wilke F, Fairweather D, Landmesser U, Heidecker B. Application of m...$38$YR$$M$Y$$$20240720$$HP$DE$DE
240512111$24051211$1$I$20240417$20240627$20240704$20240704$PER$$US-SA-2024SA195013$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240704$$MD$US$US
240512121$24051212$1$I$20240618$20240629$20240704$20240704$PER$$US-SA-2024SA194745$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240704$$MD$US$US
240512131$24051213$1$I$20240101$20240627$20240704$20240704$PER$$US-SA-2024SA034865$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240704$$CN$US$US
240512154$24051215$4$F$20240615$20240806$20240704$20240814$PER$$US-SA-2024SA195432$SANOFI AVENTIS$$63$YR$A$F$Y$101$KG$20240814$$CN$US$US
240512161$24051216$1$I$20240101$20240627$20240704$20240704$PER$$US-SA-2024SA193315$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240704$$MD$US$US
240512171$24051217$1$I$20240627$20240627$20240704$20240704$PER$$US-SA-2024SA194479$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240704$$CN$US$US
240512182$24051218$2$F$20240628$20240812$20240704$20240821$PER$$US-SA-2024SA195147$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240821$$MD$US$US
240512192$24051219$2$F$20240101$20240823$20240704$20240909$PER$$US-SA-2024SA195296$SANOFI AVENTIS$$62$YR$A$F$Y$86.18$KG$20240909$$MD$US$US
240512201$24051220$1$I$20231101$20240628$20240704$20240704$PER$$US-SA-2024SA195232$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240704$$MD$US$US
240512213$24051221$3$F$20230101$20240729$20240704$20240808$PER$$US-SA-2024SA193443$SANOFI AVENTIS$$92$YR$E$F$Y$56$KG$20240808$$MD$US$US
240512221$24051222$1$I$20240101$20240628$20240704$20240704$PER$$US-SA-2024SA195189$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240704$$MD$US$US
240512231$24051223$1$I$20240501$20240628$20240704$20240704$PER$$US-SA-2024SA195326$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240704$$MD$US$US
240512241$24051224$1$I$20240627$20240628$20240704$20240704$PER$$US-SA-2024SA194350$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240704$$HP$US$US
240512251$24051225$1$I$$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130528$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240512262$24051226$2$F$$20240702$20240704$20240711$PER$$US-SA-2024SA197389$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240711$$MD$US$US
240512271$24051227$1$I$$20240629$20240704$20240704$PER$$US-SA-2024SA195036$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240704$$MD$US$US
240512281$24051228$1$I$$20240703$20240704$20240704$PER$$NVSC2024US138627$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240512291$24051229$1$I$$20240701$20240704$20240704$PER$$US-SA-2024SA196111$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240704$$CN$US$US
240512301$24051230$1$I$$20240701$20240704$20240704$PER$$US-SA-2024SA195947$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$CN$US$US
240512311$24051231$1$I$$20240701$20240704$20240704$PER$$US-SA-2024SA195960$SANOFI AVENTIS$$$$$F$Y$$$20240704$$HP$US$US
240512325$24051232$5$F$20240701$20240828$20240704$20240830$PER$$US-SA-2024SA118645$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240830$$MD$US$US
240512331$24051233$1$I$$20240630$20240704$20240704$PER$$US-SA-2024SA195234$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240704$$MD$US$US
240512341$24051234$1$I$20240101$20240701$20240704$20240704$PER$$US-SA-2024SA196176$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240704$$HP$US$US
240512352$24051235$2$F$20240627$20240705$20240704$20240713$PER$$US-SA-2024SA196529$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240713$$MD$US$US
240512361$24051236$1$I$20240101$20240701$20240704$20240704$PER$$US-SA-2024SA195805$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240704$$CN$US$US
240512371$24051237$1$I$20240101$20240701$20240704$20240704$PER$$US-SA-2024SA196141$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240704$$CN$US$US
240512381$24051238$1$I$$20240624$20240704$20240704$PER$$US-ROCHE-10000010383$ROCHE$$$$E$F$Y$$$20240704$$CN$US$US
240512391$24051239$1$I$20240601$20240701$20240704$20240704$PER$$US-SA-2024SA194685$SANOFI AVENTIS$$$$E$F$Y$$$20240704$$CN$US$US
240512401$24051240$1$I$$20240702$20240704$20240704$PER$$US-SA-2024SA196224$SANOFI AVENTIS$$$$$F$Y$$$20240704$$CN$US$US
240512411$24051241$1$I$$20240220$20240704$20240704$EXP$$US-SA-2022SA443402$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240704$$MD$US$US
240512432$24051243$2$F$$20240723$20240704$20240725$30DAY$$FR-JNJFOC-20240702882$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$FR$FR
240512441$24051244$1$I$$20240108$20240704$20240704$EXP$$US-SA-2022SA447781$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240704$$HP$US$US
240512451$24051245$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5821798$ABBVIE$$$$E$$Y$$$20240704$$HP$US$US
240512462$24051246$2$F$$20240703$20240704$20240712$EXP$$CN-SA-2024SA188747$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240712$$HP$CN$CN
240512472$24051247$2$F$20240215$20240705$20240704$20240709$EXP$FR-AFSSAPS-LY2024000867$FR-PFIZER INC-202400204007$PFIZER$$67$YR$$F$Y$50$KG$20240709$$PH$FR$FR
240512481$24051248$1$I$20240621$20240701$20240704$20240704$EXP$$CN-PFIZER INC-PV202400086336$PFIZER$$39$YR$$F$Y$46.5$KG$20240704$$HP$CN$CN
240512491$24051249$1$I$$20240628$20240704$20240704$EXP$$CN-PFIZER INC-PV202400085215$PFIZER$Wu, R.. Hyperkalemia with hyponatremia induced by the compound sulfamethoxazole combined with voriconazole: 3 case reports and analysis. Anhui Medical and Pharmaceutical Journal. 2024;28(6):1269-1272$68$YR$$M$Y$$$20240704$$HP$CN$CN
240512502$24051250$2$F$20211201$20240704$20240704$20240709$EXP$$CN-PFIZER INC-202400206153$PFIZER$Gu, B.. Weathering the storm: diagnosis and treatment of a life-threatening disseminated Nocardia otitidiscaviarum infection. Frontiers in Cellular and Infection Microbiology. 2024;14:1397847$66$YR$$M$Y$$$20240709$$MD$CN$CN
240512511$24051251$1$I$20230925$20240628$20240704$20240704$EXP$$CN-PFIZER INC-PV202400085095$PFIZER$Li, X.. Death due to severe toxic epidermal necrolysis induced by tigecycline:a case report. China Pharmacist. 2024;27(4):722-728$81$YR$$F$Y$$$20240704$$HP$CN$CN
240512522$24051252$2$F$20240101$20240816$20240704$20240821$EXP$$US-PFIZER INC-202400205151$PFIZER$$67$YR$$F$Y$$$20240821$$HP$US$US
240512531$24051253$1$I$$20240701$20240704$20240704$EXP$$CN-PFIZER INC-PV202400086488$PFIZER$Ni, X.. Heatstroke Comorbid with SARS-CoV-2 Infection: A Case Report and Literature Review. International Medical Case Reports Journal. 2024;17:555-563$52$YR$$M$Y$$$20240704$$HP$CN$CN
240512541$24051254$1$I$20240417$20240628$20240704$20240704$EXP$$JP-PFIZER INC-202400097983$PFIZER$$60$YR$$M$Y$$$20240704$$MD$JP$JP
240512551$24051255$1$I$20230101$20240701$20240704$20240704$EXP$$DE-PFIZER INC-PV202400086639$PFIZER$$3$YR$$F$Y$$$20240704$$MD$DE$DE
240512561$24051256$1$I$$20240701$20240704$20240704$EXP$$BE-PFIZER INC-202400203900$PFIZER$$$$E$M$Y$$$20240704$$MD$BE$BE
240512571$24051257$1$I$$20240701$20240704$20240704$EXP$$BE-PFIZER INC-202400203901$PFIZER$$58$YR$$F$Y$$$20240704$$MD$BE$BE
240512584$24051258$4$F$$20240919$20240704$20240923$EXP$$US-PFIZER INC-202400205248$PFIZER$$70$YR$$F$Y$$$20240923$$CN$US$US
240512592$24051259$2$F$20240101$20240903$20240704$20240905$EXP$$US-PFIZER INC-PV202400087330$PFIZER$$54$YR$$F$Y$$$20240905$$HP$US$US
240512604$24051260$4$F$20240608$20240918$20240704$20240925$EXP$$JP-PFIZER INC-202400202678$PFIZER$$43$YR$$F$Y$110$KG$20240925$$PH$JP$JP
240512612$24051261$2$F$20240619$20240913$20240704$20240917$EXP$FR-AFSSAPS-TO2024001184$FR-PFIZER INC-202400204026$PFIZER$$$$$$Y$$$20240917$$MD$FR$FR
240512621$24051262$1$I$20240701$20240701$20240704$20240704$EXP$$US-PFIZER INC-202400204894$PFIZER$$33$YR$$F$Y$$$20240704$$HP$US$US
240512631$24051263$1$I$20230122$20240628$20240704$20240704$EXP$$CN-PFIZER INC-202400205001$PFIZER$Wu, R.. Hyperkalemia with hyponatremia induced by the compound sulfamethoxazole combined with voriconazole: 3 case reports and analysis. Anhui Medical and Pharmaceutical Journal. 2024;28(6):1269-1272$82$YR$$M$Y$$$20240704$$HP$CN$CN
240512641$24051264$1$I$$20240628$20240704$20240704$EXP$$CL-PFIZER INC-PV202400086167$PFIZER$$60$YR$$F$Y$$$20240704$$CN$CL$CL
240512651$24051265$1$I$20230204$20240628$20240704$20240704$EXP$$CN-PFIZER INC-202400204999$PFIZER$Wu, R.. Hyperkalemia with hyponatremia induced by the compound sulfamethoxazole combined with voriconazole: 3 case reports and analysis. Anhui Medical and Pharmaceutical Journal. 2024;28(6):1269-1272$69$YR$$M$Y$$$20240704$$HP$CN$CN
240512661$24051266$1$I$20211119$20240628$20240704$20240704$EXP$$CN-PFIZER INC-PV202400085104$PFIZER$Wang, G,. Strategy analysis of a case of failure in the treatment of severe pneumonia with ceftazidime avibactam and aztreonam. Chinese Journal of Pharmacoepidemiology. 2024;33(3):342-348$63$YR$$M$Y$60$KG$20240704$$HP$CN$CN
240512671$24051267$1$I$$20240701$20240704$20240704$EXP$$US-PFIZER INC-202400205071$PFIZER$$83$YR$$F$Y$$$20240704$$HP$US$US
240512681$24051268$1$I$20240702$20240702$20240704$20240704$PER$$NVSC2024US138673$NOVARTIS$$67$YR$$$Y$$$20240704$$CN$US$US
240512691$24051269$1$I$$20240627$20240704$20240704$PER$$US-ROCHE-10000014759$ROCHE$$$$E$M$Y$$$20240704$$CN$US$US
240512701$24051270$1$I$20240617$20240626$20240704$20240704$EXP$$GB-AstraZeneca-2024A146734$ASTRAZENECA$$60$YR$$F$Y$160$KG$20240704$$MD$GB$
240512711$24051271$1$I$$20240701$20240704$20240704$PER$$US-ABBVIE-5825164$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240512721$24051272$1$I$$20240627$20240704$20240704$PER$$US-ROCHE-10000015143$ROCHE$$$$A$M$Y$$$20240704$$CN$US$US
240512731$24051273$1$I$20240101$20240624$20240704$20240704$PER$$US-TEVA-VS-3212981$TEVA$$36$YR$$F$Y$$$20240704$$CN$US$US
240512743$24051274$3$F$20040101$20240708$20240704$20240711$PER$$US-ABBVIE-5826202$ABBVIE$$$$$F$Y$62$KG$20240711$$CN$US$US
240512751$24051275$1$I$$20240627$20240704$20240704$PER$$US-ALXN-202406USA001817US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240704$$CN$US$US
240512763$24051276$3$F$20181107$20240911$20240704$20240913$EXP$$US-GILEAD-2024-0679532$GILEAD$$54$YR$A$M$Y$$$20240913$$LW$US$US
240512782$24051278$2$F$20220802$20240702$20240704$20240708$EXP$$CN-TAKEDA-2024TUS065760$TAKEDA$$30$YR$$M$Y$$$20240708$$HP$CN$CN
240512792$24051279$2$F$$20240719$20240704$20240723$PER$$NVSC2024US139052$NOVARTIS$$$$$$Y$$$20240723$$PH$US$US
240512801$24051280$1$I$$20240624$20240704$20240704$EXP$$NL-AMGEN-NLDSP2024127933$AMGEN$Rauwerdink P.; Van De Vlasakker C. J.; Wassenaar E. E. et al.. First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II). European Journal of Surgical Oncology. 2024;50 (9):1-10$$$$$Y$$$20240704$$HP$NL$NL
240512821$24051282$1$I$$20240627$20240704$20240704$EXP$$US-SA-2024SA194413$SANOFI AVENTIS$$$$A$F$Y$83.914$KG$20240704$$MD$US$US
240512831$24051283$1$I$$20240627$20240704$20240704$EXP$$US-AMGEN-USASP2024127529$AMGEN$$36$YR$A$M$Y$$$20240704$$CN$US$US
240512841$24051284$1$I$20240101$20240701$20240704$20240704$EXP$$NG-SA-2024SA196314$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240704$$HP$NG$NG
240512851$24051285$1$I$20240630$20240703$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106481$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240704$$HP$US$US
240512862$24051286$2$F$$20240827$20240704$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106894$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$59.87$KG$20240829$$CN$US$US
240512872$24051287$2$F$$20240708$20240704$20240717$EXP$$US-TEVA-VS-3214157$TEVA$Eller JS, White JD, Botha H. 73-Year-Old Man With Altered Mental Status and Speech Difficulties. Mayo-Clin-Proc 2023; 98 (5): 795-800.; Eller JS, White JD, Botha H. 73-Year-Old Man With Altered Mental Status and Speech Difficulties. Mayo-Clin-Proc 2023; 98 (5): 795-800.; Eller JS, White JD, Botha H. 73-Year-Old Man With Altered Mental Status and Speech Difficulties. Mayo-Clin-Proc 2023; 98 (5): 795-800.$73$YR$$M$Y$$$20240717$$HP$US$US
240512881$24051288$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107082$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240704$$CN$US$US
240512891$24051289$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281435349850-RDTKB$GB-RDY-SPO/GBR/24/0009524$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240512901$24051290$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281433366540-CNLMB$GB-RDY-SPO/GBR/24/0009627$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240512911$24051291$1$I$$20240701$20240704$20240704$PER$$NVSC2024US137732$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240512921$24051292$1$I$$20240626$20240704$20240704$PER$$US-ROCHE-10000015820$ROCHE$$34$YR$A$$Y$$$20240704$$CN$US$US
240512931$24051293$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214282$TEVA$$44$YR$$F$Y$$$20240704$$HP$CA$CA
240512941$24051294$1$I$$20230621$20240704$20240704$PER$$US-AMGEN-USASP2023235536$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240512954$24051295$4$F$$20240817$20240704$20240823$EXP$$JP-GENMAB-2023-02462$GENMAB$$64$YR$$M$Y$$$20240823$$MD$JP$JP
240512962$24051296$2$F$$20240801$20240704$20240806$30DAY$$FR-JNJFOC-20240702832$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$FR$FR
240512971$24051297$1$I$$20240626$20240704$20240704$EXP$$BR-JNJFOC-20240679074$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$MD$BR$BR
240512981$24051298$1$I$20240611$20240628$20240704$20240704$EXP$$BR-JNJFOC-20240701768$JOHNSON AND JOHNSON$$13$YR$T$F$Y$41$KG$20240704$$CN$BR$BR
240512991$24051299$1$I$20240701$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131800$AMGEN$$76$YR$E$F$Y$$$20240704$$CN$US$US
240513001$24051300$1$I$$20240624$20240704$20240704$EXP$$US-ROCHE-3545673$ROCHE$$69$YR$E$M$Y$$$20240704$$CN$US$US
240513012$24051301$2$F$20230401$20240905$20240704$20240912$EXP$$CO-GSK-CO2024AMR081785$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$CO$CO
240513031$24051303$1$I$$20240620$20240704$20240704$PER$$US-SA-2024SA187930$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240704$$MD$US$US
240513041$24051304$1$I$$20240620$20240704$20240704$PER$$US-SA-2024SA188612$SANOFI AVENTIS$$45$YR$A$M$Y$79$KG$20240704$$MD$US$US
240513051$24051305$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191279$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240704$$MD$US$US
240513062$24051306$2$F$$20240913$20240704$20240923$PER$$US-SA-2024SA192398$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240923$$MD$US$US
240513071$24051307$1$I$20240601$20240620$20240704$20240704$PER$$US-SA-2024SA189075$SANOFI AVENTIS$$61$YR$A$F$Y$76.65$KG$20240704$$MD$US$US
240513082$24051308$2$F$$20240802$20240704$20240816$PER$$US-SA-2024SA192723$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240816$$MD$US$US
240513091$24051309$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192393$SANOFI AVENTIS$$64$YR$A$M$Y$90.71$KG$20240704$$MD$US$US
240513101$24051310$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192584$SANOFI AVENTIS$$$$A$M$Y$81.64$KG$20240704$$MD$US$US
240513111$24051311$1$I$20240101$20240620$20240704$20240704$PER$$US-SA-2024SA188710$SANOFI AVENTIS$$$$A$F$Y$71$KG$20240704$$MD$US$US
240513121$24051312$1$I$20240623$20240625$20240704$20240704$PER$$US-SA-2024SA191227$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240704$$MD$US$US
240513131$24051313$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA195319$SANOFI AVENTIS$$$$A$F$Y$71.202$KG$20240704$$MD$US$US
240513141$24051314$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA195426$SANOFI AVENTIS$$$$A$F$Y$79.773$KG$20240704$$MD$US$US
240513151$24051315$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA194724$SANOFI AVENTIS$$$$A$M$Y$71$KG$20240704$$MD$US$US
240513161$24051316$1$I$$20240626$20240704$20240704$PER$$US-SA-2024SA194306$SANOFI AVENTIS$$$$A$M$Y$122.45$KG$20240704$$MD$US$US
240513171$24051317$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA189057$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240704$$HP$US$US
240513181$24051318$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA193207$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240704$$MD$US$US
240513191$24051319$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA193512$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240704$$MD$US$US
240513203$24051320$3$F$$20240730$20240704$20240807$PER$$US-SA-2024SA190921$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240807$$CN$US$US
240513211$24051321$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA192369$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240704$$CN$US$US
240513221$24051322$1$I$20240101$20240627$20240704$20240704$PER$$US-SA-2024SA194558$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240704$$MD$US$US
240513231$24051323$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191285$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240704$$MD$US$US
240513241$24051324$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192942$SANOFI AVENTIS$$25$YR$A$M$Y$88.9$KG$20240704$$MD$US$US
240513251$24051325$1$I$$20240701$20240704$20240704$PER$$US-SA-2024SA195721$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240704$$CN$US$US
240513261$24051326$1$I$$20240701$20240704$20240704$PER$$US-SA-2024SA196438$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240704$$CN$US$US
240513271$24051327$1$I$$20240628$20240704$20240704$PER$$US-SA-2024SA194735$SANOFI AVENTIS$$$$$M$Y$$$20240704$$HP$US$US
240513281$24051328$1$I$20240601$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131069$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240513291$24051329$1$I$20240101$20240627$20240704$20240704$EXP$$US-JNJFOC-20240674842$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240704$$HP$US$US
240513302$24051330$2$F$$20240708$20240704$20240717$EXP$$US-TEVA-VS-3214012$TEVA$Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk-Lymphoma 2023; 64 (2): 407-414.; Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk-Lymphoma 2023; 64 (2): 407-414.; Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial in...$$$$$Y$$$20240717$$PH$US$US
240513311$24051331$1$I$20240623$20240627$20240704$20240704$EXP$GB-MHRA-MED-202406261400387930-TMGCY$GB-JUBILANT CADISTA PHARMACEUTICALS-2024GB000885$JUBILANT$$65$YR$$M$Y$$$20240704$$HP$GB$GB
240513321$24051332$1$I$$20240624$20240704$20240704$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2024US000881$JUBILANT$Song W, Daneman L, Cohen-Oram A, Aradi S. A Case Series of Delusional Infestation in Huntington^s Disease. Journal of Huntington^s Disease. 2024;1-3$38$YR$$F$Y$$$20240704$$HP$US$US
240513331$24051333$1$I$$20240621$20240704$20240704$EXP$DE-MLMSERVICE-20240415-PI026876-00185-1$DE-JUBILANT CADISTA PHARMACEUTICALS-2024DE000879$JUBILANT$Koschitzki K, Karrer S, Berneburg M, Niebel D, Drexler K.. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema). Journal of the German Society of Dermatology.. 2024;1-4$53$YR$$M$Y$$$20240704$$MD$DE$DE
240513342$24051334$2$F$$20240709$20240704$20240717$EXP$IT-JUBILANT CADISTA PHARMACEUTICALS-2024IT000872$IT-JUBILANT CADISTA PHARMACEUTICALS-2024IT000872$JUBILANT$Costantini I, Mantelli G, Carollo M, Losso L, Morando E, Bacchion M, et al. Not only Van Gogh: a case of BRASH syndrome with concomitant digoxin toxicity. Journal of Medical Case Reports. 2024;18(1):273$66$YR$$F$Y$$$20240717$$MD$IT$IT
240513352$24051335$2$F$20240101$20240830$20240704$20240924$PER$$US-SA-2024SA188637$SANOFI AVENTIS$$60$YR$A$M$Y$124.73$KG$20240924$$MD$US$US
240513361$24051336$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191644$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$MD$US$US
240513371$24051337$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA191689$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240704$$CN$US$US
240513381$24051338$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191963$SANOFI AVENTIS$$$$T$F$Y$68.94$KG$20240704$$MD$US$US
240513391$24051339$1$I$20180101$20240626$20240704$20240704$EXP$CA-MLMSERVICE-20211014-3171576-1$CA-JUBILANT CADISTA PHARMACEUTICALS-2021CA001094$JUBILANT$Garneau B, Desharnais B, Beauchamp-Dor? A, Lavall?e C, Mireault P, Lajeunesse A. Challenges Related to Three Cases of Fatal Intoxication to Multiple Novel Synthetic Opioids. Journal of Analytical Toxicology. 2021;44(1):86-91$29$YR$$M$Y$89$KG$20240704$$MD$CA$CA
240513401$24051340$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA192566$SANOFI AVENTIS$$37$YR$A$F$Y$74.843$KG$20240704$$MD$US$US
240513411$24051341$1$I$$20240626$20240704$20240704$PER$$US-SA-2024SA194488$SANOFI AVENTIS$$45$YR$A$F$Y$113.4$KG$20240704$$MD$US$US
240513421$24051342$1$I$20240501$20240621$20240704$20240704$PER$$US-SA-2024SA190670$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240704$$MD$US$US
240513431$24051343$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A147802$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$US$
240513452$24051345$2$F$20240101$20240703$20240704$20240709$EXP$$US-ABBVIE-5824659$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240513463$24051346$3$F$20240101$20240729$20240704$20240806$EXP$$JP-GENMAB-2024-01467$GENMAB$$72$YR$$M$Y$60.4$KG$20240806$$MD$JP$JP
240513471$24051347$1$I$20240430$20240627$20240704$20240704$EXP$$CN-GSK-CN2024APC080002$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$HP$CN$CN
240513481$24051348$1$I$$20240701$20240704$20240704$EXP$$CA-JNJFOC-20240712331$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240704$$HP$CA$CA
240513493$24051349$3$F$20231214$20240823$20240704$20240828$EXP$$CA-GSK-CA2023175910$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$CA$CA
240513501$24051350$1$I$$20240520$20240704$20240704$PER$$US-AMGEN-USASP2024132424$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240513511$24051351$1$I$$20240405$20240704$20240704$PER$$US-AMGEN-USASP2024132516$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240513522$24051352$2$F$$20240709$20240704$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407002983$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240711$$CN$US$US
240513531$24051353$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002728$ELI LILLY AND CO$$$$$M$Y$$$20240704$$CN$US$US
240513551$24051355$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106122$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240704$$HP$US$US
240513561$24051356$1$I$20240701$20240701$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106246$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$67.59$KG$20240704$$PH$US$US
240513572$24051357$2$F$20240621$20240718$20240704$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101106$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240724$$PH$US$US
240513581$24051358$1$I$$20240701$20240704$20240704$PER$$NVSC2024US138387$NOVARTIS$$52$YR$$$Y$$$20240704$$CN$US$US
240513601$24051360$1$I$20240625$20240625$20240704$20240704$PER$$US-SA-2024SA192989$SANOFI AVENTIS$$$$$M$Y$$$20240704$$MD$US$US
240513611$24051361$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191389$SANOFI AVENTIS$$$$A$F$Y$147.4$KG$20240704$$MD$US$US
240513621$24051362$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191383$SANOFI AVENTIS$$$$A$M$Y$$$20240704$$MD$US$US
240513631$24051363$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191438$SANOFI AVENTIS$$13$YR$T$M$Y$63$KG$20240704$$MD$US$US
240513641$24051364$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191598$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240704$$MD$US$US
240513651$24051365$1$I$$20230612$20240704$20240704$PER$$US-AMGEN-USASP2023235548$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240513662$24051366$2$F$20240702$20240731$20240704$20240805$PER$$US-AMGEN-USASP2024132408$AMGEN$$77$YR$E$F$Y$$$20240805$$CN$US$US
240513672$24051367$2$F$20240626$20240718$20240704$20240724$PER$$US-AMGEN-USASP2024131280$AMGEN$$69$YR$E$M$Y$$$20240724$$CN$US$US
240513681$24051368$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825388$ABBVIE$$73$YR$$F$Y$$$20240704$$HP$US$US
240513691$24051369$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214241$TEVA$$97$YR$$F$Y$$$20240704$$HP$CA$CA
240513701$24051370$1$I$$20240701$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106194$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240704$$CN$US$US
240513713$24051371$3$F$$20240925$20240704$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106098$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240926$$HP$US$US
240513721$24051372$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825752$ABBVIE$$36$YR$$M$Y$$$20240704$$HP$US$US
240513732$24051373$2$F$$20240722$20240704$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107033$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$50.35$KG$20240724$$CN$US$US
240513741$24051374$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107079$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240704$$CN$US$US
240513752$24051375$2$F$20190101$20240722$20240704$20240725$EXP$$US-ABBVIE-5825882$ABBVIE$$$$$M$Y$77.11$KG$20240725$$CN$US$US
240513761$24051376$1$I$$20240624$20240704$20240704$EXP$AU-AUS-SPO/AUS/24/0009677$AU-RDY-SPO/AUS/24/0009677$DR REDDYS$$52$YR$A$F$Y$$$20240704$$HP$AU$AU
240513771$24051377$1$I$20240630$20240701$20240704$20240704$EXP$$NVSC2024CN138546$NOVARTIS$$73$YR$$M$Y$$$20240704$$HP$CN$CN
240513781$24051378$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825376$ABBVIE$$39$YR$$F$Y$$$20240704$$HP$US$US
240513791$24051379$1$I$$20240702$20240704$20240704$PER$$US-JNJFOC-20240707758$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240513801$24051380$1$I$$20240702$20240704$20240704$PER$$US-JNJFOC-20240708583$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$HP$US$US
240513812$24051381$2$F$$20240703$20240704$20240711$PER$$US-JNJFOC-20240674054$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$CN$US$US
240513822$24051382$2$F$$20240628$20240704$20240708$30DAY$$CA-JNJFOC-20240666055$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240708$$PH$CA$CA
240513841$24051384$1$I$$20240628$20240704$20240704$PER$$US-ROCHE-10000015887$ROCHE$$$$$$Y$$$20240704$$MD$US$US
240513852$24051385$2$F$20240627$20240805$20240704$20240812$PER$$US-ROCHE-10000014901$ROCHE$$52$YR$A$F$Y$105.5$KG$20240812$$HP$US$US
240513863$24051386$3$F$20230301$20240812$20240704$20240826$EXP$FR-AFSSAPS-TO2024001188$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036910$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$56$KG$20240826$$MD$FR$FR
240513871$24051387$1$I$20220101$20240702$20240704$20240704$PER$$US-PFIZER INC-202400206225$PFIZER$$90$YR$$F$Y$$$20240704$$HP$US$US
240513882$24051388$2$F$$20240731$20240704$20240805$PER$$US-PFIZER INC-PV202400086807$PFIZER$$41$YR$$F$Y$$$20240805$$HP$US$US
240513891$24051389$1$I$$20240628$20240704$20240704$PER$$US-ABBVIE-5822496$ABBVIE$$$$E$$Y$$$20240704$$CN$US$US
240513901$24051390$1$I$20240101$20240624$20240704$20240704$EXP$$CN-009507513-2406CHN010272$MERCK$$74$YR$$F$Y$57$KG$20240704$$HP$CN$CN
240513911$24051391$1$I$$20240701$20240704$20240704$EXP$$US-009507513-2407USA000758$MERCK$$$$$M$Y$$$20240704$$PH$US$US
240513921$24051392$1$I$$20240202$20240704$20240704$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-431282$RANBAXY$$$$$$Y$$$20240704$$CN$US$US
240513931$24051393$1$I$$20240627$20240704$20240704$EXP$$VN-AstraZeneca-2024A150185$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$VN$
240513942$24051394$2$F$$20240805$20240704$20240806$PER$$US-ALXN-202406USA001684US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240513951$24051395$1$I$$20240627$20240704$20240704$EXP$$JP-AMGEN-JPNSP2024129051$AMGEN$$15$YR$T$M$Y$$$20240704$$MD$JP$JP
240513961$24051396$1$I$$20240624$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05703$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240513971$24051397$1$I$20240629$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024132425$AMGEN$$68$YR$E$M$Y$$$20240704$$CN$US$US
240513981$24051398$1$I$$20240702$20240704$20240704$EXP$$KR-009507513-2407KOR001387$MERCK$$$$$M$Y$$$20240704$$CN$KR$KR
240513991$24051399$1$I$20231010$20240627$20240704$20240704$EXP$$PL-AMGEN-POLSP2024129490$AMGEN$$83$YR$E$F$Y$$$20240704$$CN$PL$PL
240514001$24051400$1$I$20240702$20240702$20240704$20240704$EXP$$NVSC2024US138118$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240514011$24051401$1$I$$20240702$20240704$20240704$EXP$$NVSC2024US138185$NOVARTIS$$$$$$Y$$$20240704$$HP$US$US
240514021$24051402$1$I$20240605$20240627$20240704$20240704$EXP$$US-GSK-US2024080413$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
240514031$24051403$1$I$20230101$20240620$20240704$20240704$PER$$US-SA-2024SA188388$SANOFI AVENTIS$$15$YR$T$M$Y$79.37$KG$20240704$$MD$US$US
240514041$24051404$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA192778$SANOFI AVENTIS$$$$$$Y$$$20240704$$MD$US$US
240514051$24051405$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA193474$SANOFI AVENTIS$$52$YR$A$M$Y$90.71$KG$20240704$$MD$US$US
240514061$24051406$1$I$$20240628$20240704$20240704$PER$$US-SA-2024SA195589$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240704$$CN$US$US
240514071$24051407$1$I$20231115$20240628$20240704$20240704$EXP$$GB-SA-2024SA015026$SANOFI AVENTIS$$77$YR$E$F$Y$57.7$KG$20240704$$HP$GB$GB
240514081$24051408$1$I$$20230828$20240704$20240704$PER$$US-AMGEN-USASP2023235567$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240514091$24051409$1$I$$20240119$20240704$20240704$PER$$US-AMGEN-USASP2024132372$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240514101$24051410$1$I$20240701$20240702$20240704$20240704$EXP$$US-VANTIVE-2024VAN018113$Vantive US Healthcare$$18$YR$$F$Y$$$20240704$$CN$US$US
240514111$24051411$1$I$20240627$20240627$20240704$20240704$EXP$$US-VANTIVE-2024VAN018021$Vantive US Healthcare$$57$YR$$M$Y$$$20240704$$CN$US$US
240514122$24051412$2$F$20240627$20240627$20240704$20240822$EXP$$US-VANTIVE-2024VAN018019$Vantive US Healthcare$$$$$$Y$$$20240822$$CN$US$US
240514132$24051413$2$F$20240627$20240711$20240704$20240715$EXP$$NVSC2024GR138183$NOVARTIS$$80$YR$$F$Y$$$20240715$$CN$GR$GR
240514143$24051414$3$F$20240615$20240906$20240704$20240909$EXP$$NVSC2024US138295$NOVARTIS$$60$YR$$M$Y$$$20240909$$CN$US$US
240514151$24051415$1$I$$20240702$20240704$20240704$PER$$US-JNJFOC-20240707640$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240514161$24051416$1$I$$20240627$20240704$20240704$PER$$US-JNJFOC-20240676421$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$MD$US$US
240514172$24051417$2$F$20231001$20240821$20240704$20240821$30DAY$$JP-PFIZER INC-PV202400075442$PFIZER$$10$YR$$F$Y$27.75$KG$20240821$$MD$JP$JP
240514181$24051418$1$I$$20240624$20240704$20240704$EXP$$US-TEVA-VS-3213989$TEVA$Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk-Lymphoma 2023; 64 (2): 407-414.; Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk-Lymphoma 2023; 64 (2): 407-414.$$$$$Y$$$20240704$$PH$US$US
240514191$24051419$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825390$ABBVIE$$39$YR$$F$Y$$$20240704$$HP$US$US
240514201$24051420$1$I$$20240624$20240704$20240704$EXP$$US-TEVA-VS-3213976$TEVA$Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk-Lymphoma 2023; 64 (2): 407-414.; Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk-Lymphoma 2023; 64 (2): 407-414.$$$$$Y$$$20240704$$PH$US$US
240514211$24051421$1$I$$20231208$20240704$20240704$PER$$US-AMGEN-USASP2023235235$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240514221$24051422$1$I$20240626$20240626$20240704$20240704$PER$$US-AMGEN-USASP2024132329$AMGEN$$83$YR$E$F$Y$$$20240704$$CN$US$US
240514231$24051423$1$I$$20240507$20240704$20240704$PER$$US-AMGEN-USASP2024131761$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240514242$24051424$2$F$$20240708$20240704$20240710$PER$$NVSC2024US139059$NOVARTIS$$76$YR$$M$Y$$$20240710$$CN$US$US
240514262$24051426$2$F$$20230716$20240704$20240917$PER$$US-HALEON-2185240$Haleon PLC$$$$$$Y$$$20240917$$CN$US$US
240514273$24051427$3$F$$20240912$20240704$20240912$EXP$$US-PFIZER INC-202400205362$PFIZER$$$$A$F$Y$76.2$KG$20240912$$CN$US$US
240514281$24051428$1$I$20240206$20240702$20240704$20240704$EXP$FR-AFSSAPS-MP2024001012$FR-PFIZER INC-202400204869$PFIZER$$54$YR$$F$Y$$$20240704$$MD$FR$FR
240514291$24051429$1$I$20240602$20240702$20240704$20240704$EXP$$CN-PFIZER INC-PV202400086890$PFIZER$$43$YR$$M$Y$$$20240704$$HP$CN$CN
240514301$24051430$1$I$$20240702$20240704$20240704$EXP$$US-PFIZER INC-PV202400087015$PFIZER$$64$YR$$F$Y$$$20240704$$CN$US$US
240514311$24051431$1$I$$20240702$20240704$20240704$EXP$$CA-PFIZER INC-202400205145$PFIZER$$48$YR$$F$Y$$$20240704$$CN$CA$CA
240514321$24051432$1$I$20240701$20240702$20240704$20240704$EXP$GB-MHRA-MED-202407021541570960-BRCNP$GB-PFIZER INC-202400205175$PFIZER$$48$YR$$F$Y$$$20240704$$HP$GB$GB
240514331$24051433$1$I$$20240701$20240704$20240704$EXP$$US-PFIZER INC-PV202400086457$PFIZER$Creamer, M.. Left Sixth Nerve Palsy and Subdural Hygroma Following Intrathecal Morphine Pump Placement: A Case Report. Pain Medicine Case Reports. 2023;7(8):385-387$59$YR$$M$Y$$$20240704$$HP$US$US
240514341$24051434$1$I$20240118$20240702$20240704$20240704$EXP$FR-AFSSAPS-RE2024000656$FR-PFIZER INC-202400204866$PFIZER$$78$YR$$F$Y$74$KG$20240704$$MD$FR$FR
240514351$24051435$1$I$$20240701$20240704$20240704$EXP$$US-PFIZER INC-202400204974$PFIZER$Holmes, B.. Numbing the Heart to Death: A Cautionary Tale About an In-Vogue Preoperative Analgesic. Circulation. 2024;149(25):2021-2025$70$YR$$F$Y$$$20240704$$MD$US$US
240514362$24051436$2$F$20240502$20240704$20240704$20240705$EXP$$US-PFIZER INC-PV202400087377$PFIZER$$79$YR$$F$Y$$$20240705$$CN$US$US
240514382$24051438$2$F$$20240702$20240704$20240708$EXP$$ES-PFIZER INC-202400205088$PFIZER$Plaza, J.. Use of isavuconazole in cryptococcal meningitis in a cirrhotic patient. Infectious Diseases and Clinical Microbiology. 2024;1-2$59$YR$$M$Y$$$20240708$$HP$ES$ES
240514391$24051439$1$I$20240603$20240702$20240704$20240704$EXP$FR-AFSSAPS-PP2024000694$FR-PFIZER INC-202400204871$PFIZER$$75$YR$$F$Y$75$KG$20240704$$MD$FR$FR
240514401$24051440$1$I$20240620$20240702$20240704$20240704$EXP$LV-SAM-2024068268$LV-PFIZER INC-202400204790$PFIZER$$40$YR$$M$Y$$$20240704$$MD$LV$LV
240514411$24051441$1$I$$20240702$20240704$20240704$EXP$$GB-PFIZER INC-PV202400087234$PFIZER$$59$YR$$M$Y$$$20240704$$CN$GB$GB
240514421$24051442$1$I$$20240701$20240704$20240704$EXP$$US-PFIZER INC-PV202400086652$PFIZER$Holmes, B.. Numbing the Heart to Death: A Cautionary Tale About an In-Vogue Preoperative Analgesic. Circulation. 2024;149(25):2021-2025$70$YR$$F$Y$$$20240704$$MD$US$US
240514431$24051443$1$I$20240617$20240702$20240704$20240704$EXP$$CN-PFIZER INC-PV202400086932$PFIZER$$23$YR$$M$Y$$$20240704$$HP$CN$CN
240514441$24051444$1$I$$20240701$20240704$20240704$EXP$$US-PFIZER INC-PV202400086431$PFIZER$Taylor, S.. Hyperfibrinolysis during the treatment of rhabdomyosarcoma. Research and Practice in Thrombosis and Haemostasis. 2024;8(4):10.1016/j.rpth.2024.102467$25$YR$$M$Y$$$20240704$$HP$US$US
240514454$24051445$4$F$$20240828$20240704$20240902$EXP$$AR-PFIZER INC-202400205900$PFIZER$$61$YR$$F$Y$$$20240902$$CN$AR$AR
240514462$24051446$2$F$20240101$20240716$20240704$20240722$EXP$$CA-PFIZER INC-202400205303$PFIZER$$91$YR$$M$Y$$$20240722$$HP$CA$CA
240514471$24051447$1$I$$20240702$20240704$20240704$EXP$$AR-PFIZER INC-202400205893$PFIZER$$89$YR$$F$Y$$$20240704$$CN$AR$AR
240514481$24051448$1$I$$20240702$20240704$20240704$EXP$$CA-PFIZER INC-202400205869$PFIZER$$42$YR$$F$Y$$$20240704$$HP$CA$CA
240514491$24051449$1$I$20230101$20240702$20240704$20240704$EXP$$CA-PFIZER INC-202300377334$PFIZER$$69$YR$$F$Y$95.1$KG$20240704$$MD$CA$CA
240514501$24051450$1$I$$20240701$20240704$20240704$EXP$$US-PFIZER INC-202400205072$PFIZER$$74$YR$$M$Y$96.16$KG$20240704$$CN$US$US
240514511$24051451$1$I$20240701$20240702$20240704$20240704$EXP$$CN-PFIZER INC-PV202400086939$PFIZER$$29$YR$$F$Y$71.2$KG$20240704$$HP$CN$CN
240514522$24051452$2$F$20210101$20240823$20240704$20240828$EXP$$JP-PFIZER INC-202400205332$PFIZER$$$$$F$Y$41$KG$20240828$$CN$JP$JP
240514532$24051453$2$F$$20240819$20240704$20240823$EXP$$JP-PFIZER INC-PV202400086829$PFIZER$$83$YR$$M$Y$$$20240823$$MD$JP$JP
240514541$24051454$1$I$20170101$20240701$20240704$20240704$EXP$$ES-PFIZER INC-202400204193$PFIZER$Tornero, C.. Terapia biol?gica con sarilumab en paciente con artritis reumatoide y afectaci?n pulmonar asociada. EXPERIENCIAS KEVZARA$63$YR$$F$Y$$$20240704$$MD$ES$ES
240514552$24051455$2$F$$20240824$20240704$20240826$EXP$$US-PFIZER INC-PV202400087050$PFIZER$$57$YR$$F$Y$$$20240826$$CN$US$US
240514561$24051456$1$I$$20240628$20240704$20240704$PER$$US-JNJFOC-20240677888$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$CN$US$US
240514571$24051457$1$I$$20240621$20240704$20240704$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05710$LUPIN$Grabie Y, Acharya S, Sadiq W, Rotblat D, Chalhoub MN. Iatrogenic bilothorax following dislodgment of cholecystostomy tube. American Journal of Respiratory and Critical Care Medicine. 2024;209$83$YR$$M$Y$$$20240704$$HP$US$US
240514581$24051458$1$I$$20240627$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-009896$BEIGENE$$$$$$Y$$$20240704$$HP$CN$CN
240514593$24051459$3$F$20220101$20240809$20240704$20240816$EXP$$MX-AstraZeneca-2024A148170$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$MX$
240514601$24051460$1$I$$20240702$20240704$20240704$EXP$$CN-TAKEDA-2024TUS067156$TAKEDA$$$$$F$Y$$$20240704$$CN$CN$CN
240514611$24051461$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA194463$SANOFI AVENTIS$$$$A$M$Y$106$KG$20240704$$MD$US$US
240514621$24051462$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA194474$SANOFI AVENTIS$$$$A$M$Y$$$20240704$$MD$US$US
240514631$24051463$1$I$$20240627$20240704$20240704$PER$$US-SA-2023SA399359$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240704$$CN$US$US
240514641$24051464$1$I$20240512$20240620$20240704$20240704$PER$$US-SA-2024SA188336$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240704$$MD$US$US
240514651$24051465$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193139$SANOFI AVENTIS$$$$C$F$Y$43$KG$20240704$$MD$US$US
240514662$24051466$2$F$$20240814$20240704$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106916$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240820$$CN$US$US
240514671$24051467$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA193328$SANOFI AVENTIS$$4$YR$C$F$Y$15$KG$20240704$$MD$US$US
240514681$24051468$1$I$$20240627$20240704$20240704$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037149$BOEHRINGER INGELHEIM$$$$$$Y$$$20240704$$PH$JP$JP
240514691$24051469$1$I$$20240622$20240704$20240704$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05867$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240514701$24051470$1$I$20240129$20240626$20240704$20240704$EXP$$JP-TAKEDA-2024TUS067360$TAKEDA$$8$DEC$$M$Y$$$20240704$$MD$JP$JP
240514711$24051471$1$I$$20240628$20240704$20240704$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037268$BOEHRINGER INGELHEIM$Anne-Catherine Neumann M. Overdosing of direct oral anticoagulants. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 2024 Jun 25;1-8.$66$YR$E$F$Y$$$20240704$$HP$DE$DE
240514721$24051472$1$I$$20230831$20240704$20240704$PER$$US-AMGEN-USASP2023235445$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240514731$24051473$1$I$20231201$20240703$20240704$20240704$EXP$$US-ABBVIE-5825887$ABBVIE$$49$YR$$F$Y$$$20240704$$CN$US$US
240514741$24051474$1$I$20240623$20240627$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-009957$BEIGENE$$$$$$Y$$$20240704$$HP$CN$CN
240514751$24051475$1$I$$20240625$20240704$20240704$PER$$US-ROCHE-10000013907$ROCHE$$$$$$Y$$$20240704$$MD$US$US
240514761$24051476$1$I$$20240628$20240704$20240704$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037281$BOEHRINGER INGELHEIM$Anne-Catherine Neumann M, Sieg N, Borrega JG, Hueser C, Caspers M, Shimabukuro-Vornhagen A. Overdosing of direct oral anticoagulants. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 2024 Jun 25;1-8. doi:10.1007/s00063-024-01154-8.$66$YR$E$F$Y$$$20240704$$HP$DE$DE
240514771$24051477$1$I$20240702$20240703$20240704$20240704$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037799$BOEHRINGER INGELHEIM$$$$$$Y$$$20240704$$MD$US$US
240514782$24051478$2$F$20240601$20240809$20240704$20240826$PER$$US-SA-2024SA193070$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240826$$CN$US$US
240514791$24051479$1$I$$20240621$20240704$20240704$PER$$US-SA-2024SA188624$SANOFI AVENTIS$$$$T$M$Y$$$20240704$$MD$US$US
240514802$24051480$2$F$20240101$20240801$20240704$20240810$PER$$US-SA-2024SA194644$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240810$$MD$US$US
240514811$24051481$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA193069$SANOFI AVENTIS$$29$YR$A$F$Y$77$KG$20240704$$MD$US$US
240514821$24051482$1$I$20220101$20240627$20240704$20240704$PER$$US-SA-2023SA205888$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240704$$MD$US$US
240514832$24051483$2$F$20240101$20240806$20240704$20240813$PER$$US-SA-2024SA193112$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240814$$MD$US$US
240514841$24051484$1$I$$20240626$20240704$20240704$PER$$US-ROCHE-10000013752$ROCHE$$38$YR$A$F$Y$$$20240704$$CN$US$US
240514851$24051485$1$I$$20240625$20240704$20240704$PER$$US-ROCHE-10000012873$ROCHE$$$$A$F$Y$$$20240704$$CN$US$US
240514861$24051486$1$I$20240517$20240627$20240704$20240704$EXP$$CN-TAKEDA-2024TUS066316$TAKEDA$$70$YR$$F$Y$78$KG$20240704$$HP$CN$CN
240514872$24051487$2$F$$20240809$20240704$20240812$EXP$$NVSC2024GB135507$NOVARTIS$$$$A$F$Y$$$20240812$$MD$GB$GB
240514881$24051488$1$I$$20240703$20240704$20240704$PER$$US-TAKEDA-2024TUS067558$TAKEDA$$$$$$Y$$$20240704$$CN$US$US
240514891$24051489$1$I$$20240430$20240704$20240704$PER$$US-TAKEDA-2024TUS067110$TAKEDA$$$$$M$Y$$$20240704$$CN$US$US
240514901$24051490$1$I$20240624$20240626$20240704$20240704$PER$$US-JNJFOC-20240672704$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240704$$CN$US$US
240514921$24051492$1$I$$20240704$20240704$20240704$PER$$US-HALEON-2185346$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240514931$24051493$1$I$$20240702$20240704$20240704$PER$$US-TAKEDA-2024TUS067471$TAKEDA$$$$$F$Y$$$20240704$$CN$US$US
240514941$24051494$1$I$$20240624$20240704$20240704$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06016$LUPIN$$$$$$Y$$$20240704$$CN$US$US
240514951$24051495$1$I$$20240702$20240704$20240704$PER$$US-ROCHE-10000014810$ROCHE$$$$$F$Y$$$20240704$$CN$US$US
240514961$24051496$1$I$$20230914$20240704$20240704$PER$$US-AMGEN-USASP2023235557$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240514972$24051497$2$F$$20240830$20240704$20240902$EXP$$NVSC2024US072792$NOVARTIS$$$$$$Y$$$20240902$$CN$US$US
240514981$24051498$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825714$ABBVIE$$33$YR$$F$Y$$$20240704$$HP$US$US
240514991$24051499$1$I$20240619$20240627$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-009963$BEIGENE$$$$$$Y$$$20240704$$HP$CN$CN
240515002$24051500$2$F$20240601$20240801$20240704$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106737$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240802$$PH$US$US
240515011$24051501$1$I$$20240628$20240704$20240704$EXP$$TW-AMGEN-TWNSP2024130355$AMGEN$$32$YR$A$M$Y$$$20240704$$HP$TW$TW
240515022$24051502$2$F$20190604$20240903$20240704$20240905$PER$$US-GILEAD-2024-0679578$GILEAD$$42$YR$A$M$Y$$$20240905$$LW$US$US
240515031$24051503$1$I$20240626$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A148851$ASTRAZENECA$$65$YR$$M$Y$$$20240704$$CN$ZA$
240515041$24051504$1$I$$20240624$20240704$20240704$EXP$AU-AUS-SPO/AUS/24/0009679$AU-RDY-SPO/AUS/24/0009679$DR REDDYS$$$$$M$Y$$$20240704$$CN$AU$AU
240515052$24051505$2$F$$20240802$20240704$20240806$PER$$US-ALXN-202406USA001807US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240515061$24051506$1$I$$20240703$20240704$20240704$PER$$US-JNJFOC-20240711306$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$CN$US$US
240515073$24051507$3$F$$20240725$20240704$20240806$30DAY$$FR-JNJFOC-20240660659$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240806$$PH$FR$FR
240515081$24051508$1$I$$20240701$20240704$20240704$EXP$$CA-JNJFOC-20240712019$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240704$$PH$CA$CA
240515091$24051509$1$I$$20240624$20240704$20240704$EXP$$US-TEVA-VS-3214007$TEVA$Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk-Lymphoma 2023; 64 (2): 407-414.; Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk-Lymphoma 2023; 64 (2): 407-414.$$$$$Y$$$20240704$$PH$US$US
240515101$24051510$1$I$20240605$20240703$20240704$20240704$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037780$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240704$$HP$SG$SG
240515111$24051511$1$I$20240601$20240627$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-009965$BEIGENE$$$$$$Y$$$20240704$$HP$CN$CN
240515122$24051512$2$F$20230101$20240704$20240704$20240710$EXP$$CO-AMGEN-COLSL2024129775$AMGEN$$70$YR$E$M$Y$$$20240710$$MD$CO$CO
240515131$24051513$1$I$20240201$20240626$20240704$20240704$EXP$GB-MHRA-MED-202406251436015840-SWCZQ$GB-TEVA-VS-3213998$TEVA$$67$YR$$M$Y$98$KG$20240704$$CN$GB$GB
240515142$24051514$2$F$$20240624$20240704$20240930$EXP$$US-TEVA-VS-3213982$TEVA$Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk-Lymphoma 2023; 64 (2): 407-414.; Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk-Lymphoma 2023; 64 (2): 407-414.$$$$$Y$$$20240930$$PH$US$US
240515151$24051515$1$I$20240601$20240629$20240704$20240704$EXP$$US-SA-2024SA195877$SANOFI AVENTIS$$93$YR$E$M$Y$$$20240704$$MD$US$US
240515161$24051516$1$I$20240617$20240620$20240704$20240704$PER$$US-SA-2024SA188360$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240704$$MD$US$US
240515172$24051517$2$F$20240601$20240626$20240704$20240709$PER$$US-SA-2024SA184073$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240709$$MD$US$US
240515181$24051518$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA195523$SANOFI AVENTIS$$$$C$M$Y$49$KG$20240704$$MD$US$US
240515191$24051519$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA194047$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240704$$MD$US$US
240515201$24051520$1$I$$20240627$20240704$20240704$EXP$$GB-JNJFOC-20240675524$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$CN$GB$GB
240515211$24051521$1$I$$20240702$20240704$20240704$PER$$US-JNJFOC-20240706516$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$CN$US$US
240515221$24051522$1$I$20240615$20240702$20240704$20240704$PER$$US-JNJFOC-20240705768$JOHNSON AND JOHNSON$$$$$M$Y$$$20240704$$CN$US$US
240515231$24051523$1$I$$20240627$20240704$20240704$PER$$US-TEVA-VS-3215393$TEVA$$$$A$F$Y$$$20240704$$MD$US$US
240515242$24051524$2$F$20240101$20240628$20240704$20240710$EXP$FR-AFSSAPS-AN2024000813$FR-Merck Healthcare KGaA-2024034500$MERCK KGAA$$62$YR$A$F$Y$$$20240708$$PH$FR$FR
240515251$24051525$1$I$$20240506$20240704$20240704$PER$$US-AMGEN-USASP2024130037$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240515261$24051526$1$I$$20240624$20240704$20240704$EXP$$AU-RDY-SPO/AUS/24/0009682$DR REDDYS$$57$YR$A$M$Y$$$20240704$$CN$AU$AU
240515272$24051527$2$F$20230901$20240704$20240704$20240708$EXP$GB-MHRA-MED-202407021235502260-VRZQL$GB-PFIZER INC-202400205834$PFIZER$$$$$M$Y$$$20240708$$MD$GB$GB
240515281$24051528$1$I$$20240703$20240704$20240704$EXP$$JP-PFIZER INC-PV202400087471$PFIZER$$9$DEC$$M$Y$$$20240704$$MD$JP$JP
240515291$24051529$1$I$$20240702$20240704$20240704$EXP$$JP-PFIZER INC-202400204802$PFIZER$$$$E$$Y$$$20240704$$MD$JP$JP
240515301$24051530$1$I$20231203$20240703$20240704$20240704$EXP$ES-AEMPS-1530421$ES-PFIZER INC-202400205649$PFIZER$$66$YR$$M$Y$$$20240704$$MD$ES$ES
240515311$24051531$1$I$$20240701$20240704$20240704$EXP$$JP-PFIZER INC-PV202400086363$PFIZER$Uemura, N.. Two cases of very preterm infants with marked myocardial thickening and circulatory failure while on steroids and insulin. The 19th Annual Meeting of the Japanese Society of Perinatal Circulation Managem. 2024;19th:54$1$DY$$$Y$$$20240704$$HP$JP$JP
240515322$24051532$2$F$20120101$20240926$20240704$20240927$PER$$US-PFIZER INC-PV202300116500$PFIZER$$43$YR$$F$Y$$$20240927$$LW$US$US
240515331$24051533$1$I$$20240703$20240704$20240704$PER$$US-PFIZER INC-202400205992$PFIZER$$$$$$Y$$$20240704$$CN$US$US
240515341$24051534$1$I$$20240701$20240704$20240704$EXP$$JP-PFIZER INC-202400205432$PFIZER$Uemura, N.. Two cases of very preterm infants with marked myocardial thickening and circulatory failure while on steroids and insulin. The 19th Annual Meeting of the Japanese Society of Perinatal Circulation Managem. 2024;19th:54$5$DY$$$Y$0.491$KG$20240704$$HP$JP$JP
240515351$24051535$1$I$20240101$20240702$20240704$20240704$PER$$US-PFIZER INC-PV202400087141$PFIZER$$61$YR$$F$Y$$$20240704$$CN$US$US
240515361$24051536$1$I$$20240703$20240704$20240704$EXP$$GB-PFIZER INC-202400205818$PFIZER$$68$YR$$F$Y$87$KG$20240704$$MD$GB$GB
240515373$24051537$3$F$$20240813$20240704$20240815$PER$$US-PFIZER INC-202400206379$PFIZER$$67$YR$$F$Y$$$20240815$$CN$US$US
240515381$24051538$1$I$$20240703$20240704$20240704$EXP$$CA-PFIZER INC-202400206045$PFIZER$$72$YR$$F$Y$88$KG$20240704$$MD$CA$CA
240515401$24051540$1$I$20231205$20240702$20240704$20240704$EXP$$GB-PFIZER INC-202400205131$PFIZER$$76$YR$$M$Y$89$KG$20240704$$HP$GB$GB
240515412$24051541$2$F$$20240703$20240704$20240708$EXP$$US-PFIZER INC-202400204246$PFIZER$Contag, C.. Q fever presenting as splenic infarct without endocarditis. IDCases. 2024;37:10.1016/j.idcr.2024.e02012$44$YR$$M$Y$$$20240708$$MD$US$US
240515432$24051543$2$F$$20240709$20240704$20240711$PER$$US-PFIZER INC-202400206307$PFIZER$$76$YR$$F$Y$$$20240711$$HP$US$US
240515441$24051544$1$I$20240101$20240703$20240704$20240704$PER$$US-PFIZER INC-202400206183$PFIZER$$$$A$M$Y$$$20240704$$CN$US$US
240515451$24051545$1$I$$20240701$20240704$20240704$PER$$US-PFIZER INC-202400204688$PFIZER$$$$$F$Y$$$20240704$$MD$US$US
240515461$24051546$1$I$$20240703$20240704$20240704$EXP$$JP-PFIZER INC-PV202400087464$PFIZER$$9$DEC$$M$Y$$$20240704$$MD$JP$JP
240515471$24051547$1$I$$20240703$20240704$20240704$PER$$US-PFIZER INC-PV202400087837$PFIZER$$$$$$Y$$$20240704$$CN$US$US
240515484$24051548$4$F$$20240911$20240704$20240913$PER$$US-PFIZER INC-PV202400087101$PFIZER$$73$YR$$F$Y$$$20240913$$CN$US$US
240515494$24051549$4$F$20240601$20240912$20240704$20240916$PER$$US-PFIZER INC-202400205760$PFIZER$$70$YR$$M$Y$89.36$KG$20240916$$CN$US$US
240515501$24051550$1$I$$20240703$20240704$20240704$PER$$US-PFIZER INC-PV202400087482$PFIZER$$73$YR$$F$Y$$$20240704$$CN$US$US
240515511$24051551$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825718$ABBVIE$$33$YR$$F$Y$$$20240704$$HP$US$US
240515522$24051552$2$F$$20240820$20240704$20240822$PER$$US-PFIZER INC-202400206277$PFIZER$$70$YR$$M$Y$$$20240822$$HP$US$US
240515531$24051553$1$I$20240616$20240702$20240704$20240704$EXP$$CN-PFIZER INC-PV202400086941$PFIZER$$4$YR$$M$Y$11.6$KG$20240704$$HP$CN$CN
240515542$24051554$2$F$$20240802$20240704$20240806$PER$$US-ALXN-202406USA001808US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240515551$24051555$1$I$20240701$20240702$20240704$20240704$PER$$US-JNJFOC-20240706133$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240704$$CN$US$US
240515563$24051556$3$F$20170110$20240903$20240704$20240905$PER$$US-GILEAD-2024-0679579$GILEAD$$45$YR$A$F$Y$$$20240905$$LW$US$US
240515571$24051557$1$I$$20240701$20240704$20240704$EXP$$IT-PFIZER INC-202400196635$PFIZER$Favi, E.. Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept. Clinical Immunology. 2024;264:10.1016/j.clim.2024.110240.$50$YR$$M$Y$$$20240704$$MD$IT$IT
240515583$24051558$3$F$20240101$20240717$20240704$20240723$EXP$$PE-JNJFOC-20240675206$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240722$$HP$PE$PE
240515593$24051559$3$F$$20240831$20240704$20240903$EXP$$US-PFIZER INC-PV202400085856$PFIZER$$1$YR$$M$Y$$$20240903$$CN$US$US
240515601$24051560$1$I$20240506$20240620$20240704$20240704$EXP$FR-AFSSAPS-TS2024000684$FR-TEVA-VS-3213174$TEVA$$81$YR$$M$Y$90$KG$20240704$$PH$FR$FR
240515611$24051561$1$I$20201201$20240621$20240704$20240704$EXP$$PL-ROCHE-10000012245$ROCHE$$49$YR$A$M$Y$$$20240704$$CN$PL$PL
240515622$24051562$2$F$20240606$20240808$20240704$20240820$30DAY$$US-AMGEN-USASP2024129239$AMGEN$$65$YR$E$M$Y$90.8$KG$20240820$$PH$US$US
240515631$24051563$1$I$20240228$20240626$20240704$20240704$EXP$IT-MINISAL02-991353$IT-TEVA-VS-3214778$TEVA$$60$YR$$F$Y$$$20240704$$MD$IT$IT
240515641$24051564$1$I$$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024128705$AMGEN$$$$A$M$Y$$$20240704$$HP$US$US
240515652$24051565$2$F$$20240722$20240704$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001339$BLUEPRINT MEDICINES$$$$$F$Y$$$20240731$$CN$US$US
240515662$24051566$2$F$$20240730$20240704$20240806$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001337$BLUEPRINT MEDICINES$$$$$F$Y$$$20240807$$CN$US$US
240515671$24051567$1$I$$20240620$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099677$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$CN$US$US
240515681$24051568$1$I$$20240627$20240704$20240704$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001336$BLUEPRINT MEDICINES$$$$$F$Y$$$20240704$$CN$US$US
240515691$24051569$1$I$$20240701$20240704$20240704$EXP$$US-TAKEDA-2024TUS066231$TAKEDA$$$$$M$Y$$$20240704$$CN$US$US
240515701$24051570$1$I$$20240701$20240704$20240704$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-093487$REGENERON$$82$YR$$F$Y$$$20240704$$PH$JP$JP
240515711$24051571$1$I$$20240605$20240704$20240704$PER$$US-BEIGENE-BGN-2024-008649$BEIGENE$Ahmad Rajeh, Sarah Ferree, Milan J. Anadkat. Radiation Recall Dermatitis With Bruton Tyrosine Kinase Inhibitor Therapy. JAMA Dermatology. 2024;160(5):577-578$$$$$Y$$$20240704$$MD$US$US
240515721$24051572$1$I$$20240702$20240704$20240704$PER$$US-JNJFOC-20240705009$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$HP$US$US
240515731$24051573$1$I$$20240628$20240704$20240704$PER$$US-ABBVIE-5823797$ABBVIE$$$$$F$Y$$$20240704$$HP$US$US
240515741$24051574$1$I$$20240624$20240704$20240704$EXP$$JP-TAKEDA-2024TUS066768$TAKEDA$$8$DEC$$F$Y$$$20240704$$MD$JP$JP
240515751$24051575$1$I$$20240426$20240704$20240704$PER$$US-AMGEN-USASP2024132423$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240515761$24051576$1$I$$20221227$20240704$20240704$PER$$US-AMGEN-USASP2022230359$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240515771$24051577$1$I$20240301$20240701$20240704$20240704$EXP$IT-MINISAL02-992778$NVSC2024IT137241$NOVARTIS$$7$MON$$M$Y$5$KG$20240704$$MD$IT$IT
240515781$24051578$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5822373$ABBVIE$$$$$$Y$$$20240704$$MD$US$US
240515791$24051579$1$I$$20240627$20240704$20240704$EXP$$FR-Merck Healthcare KGaA-2024035558$MERCK KGAA$$$$$F$Y$$$20240704$$CN$FR$FR
240515801$24051580$1$I$$20240627$20240704$20240704$EXP$$US-ROCHE-10000014770$ROCHE$$21$YR$A$F$Y$$$20240704$$HP$US$US
240515811$24051581$1$I$20240615$20240626$20240704$20240704$EXP$$FR-AstraZeneca-2024A153390$ASTRAZENECA$$29$YR$$M$Y$$$20240704$$MD$FR$
240515821$24051582$1$I$$20240701$20240704$20240704$EXP$$CA-Taiho Oncology Inc-2024-006533$TAIHO ONCOLOGY INC$$72$YR$E$M$Y$89$KG$20240704$$PH$CA$CA
240515831$24051583$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A148136$ASTRAZENECA$$21915$DY$$F$Y$$$20240704$$CN$ZA$
240515842$24051584$2$F$20240101$20240626$20240704$20240710$EXP$$FR-AstraZeneca-2024A151244$ASTRAZENECA$$41$YR$$F$Y$$$20240710$$PH$FR$
240515851$24051585$1$I$$20240626$20240704$20240704$EXP$$CN-AstraZeneca-2024A149983$ASTRAZENECA$$55$YR$$M$Y$$$20240704$$CN$CN$
240515862$24051586$2$F$$20240731$20240704$20240829$PER$$US-AstraZeneca-2024A147054$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
240515881$24051588$1$I$$20240701$20240704$20240704$PER$$US-ABBVIE-5825081$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240515891$24051589$1$I$$20240627$20240704$20240704$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202406018030$ELI LILLY AND CO$McClatchy J, Yap T, Nirenberg A, Scardamaglia L..Fixed drug eruptions - the common and novel culprits since 2000. (Review).J-Dtsch-Dermatol-Ges 2020;20(10):1289-1302.DOI:10.1111/ddg.14870$$$$$Y$$$20240704$$HP$AU$AU
240515921$24051592$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825789$ABBVIE$$24$YR$$F$Y$$$20240704$$HP$US$US
240515943$24051594$3$F$20201208$20240904$20240704$20240905$EXP$$US-GILEAD-2024-0679582$GILEAD$$50$YR$A$M$Y$$$20240905$$LW$US$US
240515951$24051595$1$I$20221201$20240701$20240704$20240704$EXP$$DE-ABBVIE-5826112$ABBVIE$$53$YR$$F$Y$85$KG$20240704$$CN$DE$DE
240515962$24051596$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214606$TEVA$Hoerle R, Qiao X. A Last Resort: Lipid Emulsion Therapy in Lidocaine Anesthetic Systemic Toxicity (LAST). Am-J-Respir-Crit-Care-Med 2024; 209 A5683 (plus Poster).; Hoerle R, Qiao X. A Last Resort: Lipid Emulsion Therapy in Lidocaine Anesthetic Systemic Toxicity (LAST). Am-J-Respir-Crit-Care-Med 2024; 209 A5683 (plus Poster).$81$YR$$F$Y$$$20240720$$HP$US$US
240515974$24051597$4$F$$20240809$20240704$20240815$EXP$$CA-TAKEDA-2024TUS054855$TAKEDA$$$$$F$Y$$$20240815$$MD$CA$CA
240515981$24051598$1$I$20240601$20240703$20240704$20240704$EXP$$AR-PFIZER INC-202400206779$PFIZER$$81$YR$$F$Y$$$20240704$$CN$AR$AR
240515991$24051599$1$I$20231101$20240703$20240704$20240704$EXP$$IN-PFIZER INC-PV202400087298$PFIZER$$39$YR$$F$Y$$$20240704$$CN$IN$IN
240516002$24051600$2$F$20240322$20240703$20240704$20240705$EXP$$US-PFIZER INC-202400206264$PFIZER$$49$YR$$F$Y$77$KG$20240705$$CN$US$US
240516011$24051601$1$I$$20240703$20240704$20240704$EXP$$CA-PFIZER INC-202400206035$PFIZER$$43$YR$$F$Y$68$KG$20240704$$HP$CA$CA
240516021$24051602$1$I$20240629$20240703$20240704$20240704$EXP$$IN-PFIZER INC-PV202400087301$PFIZER$$63$YR$$M$Y$$$20240704$$CN$IN$IN
240516031$24051603$1$I$$20240703$20240704$20240704$EXP$$US-PFIZER INC-PV202400087606$PFIZER$$$$$$Y$$$20240704$$CN$US$US
240516041$24051604$1$I$$20240703$20240704$20240704$EXP$$US-PFIZER INC-202400206399$PFIZER$$45$YR$$M$Y$$$20240704$$MD$US$US
240516051$24051605$1$I$20231201$20240703$20240704$20240704$EXP$$IN-PFIZER INC-PV202400087846$PFIZER$$46$YR$$M$Y$$$20240704$$CN$IN$IN
240516062$24051606$2$F$$20240705$20240704$20240708$EXP$$US-PFIZER INC-202400206306$PFIZER$$80$YR$$M$Y$$$20240708$$HP$US$US
240516071$24051607$1$I$20240401$20240703$20240704$20240704$EXP$$CL-PFIZER INC-PV202400087419$PFIZER$$49$YR$$F$Y$$$20240704$$CN$CL$CL
240516081$24051608$1$I$20240601$20240704$20240704$20240704$EXP$DE-CADRBFARM-2024329066$DE-PFIZER INC-202400206503$PFIZER$$89$YR$$F$Y$$$20240704$$MD$DE$DE
240516094$24051609$4$F$20220101$20240802$20240704$20240807$EXP$$CA-PFIZER INC-2019419386$PFIZER$$57$YR$$F$Y$$$20240807$$CN$CA$CA
240516102$24051610$2$F$20240101$20240722$20240704$20240726$EXP$$DE-PFIZER INC-202400205679$PFIZER$$36$YR$$F$Y$89$KG$20240726$$MD$DE$DE
240516111$24051611$1$I$$20240703$20240704$20240704$EXP$$JP-PFIZER INC-202400205447$PFIZER$$38$YR$$F$Y$$$20240704$$PH$JP$JP
240516131$24051613$1$I$$20240703$20240704$20240704$PER$$US-DSJP-DSU-2024-130707$DAIICHI$$$$$F$Y$$$20240704$$CN$US$US
240516141$24051614$1$I$20240101$20240703$20240704$20240704$EXP$$DE-PFIZER INC-202400205678$PFIZER$$36$YR$$F$Y$89$KG$20240704$$MD$DE$DE
240516152$24051615$2$F$$20240719$20240704$20240722$PER$$NVSC2024US139089$NOVARTIS$$$$$$Y$$$20240722$$MD$US$US
240516161$24051616$1$I$$20240626$20240704$20240704$EXP$$US-Blueprint Medicines Corporation-LT-US-2024-001320$BLUEPRINT MEDICINES$$$$$F$Y$$$20240704$$MD$US$US
240516171$24051617$1$I$$20240703$20240704$20240704$EXP$$CA-PURDUE-USA-2024-0310595$PURDUE$$56$YR$$F$Y$$$20240704$$PH$CA$CA
240516181$24051618$1$I$$20240624$20240704$20240704$EXP$$US-TEVA-VS-3213960$TEVA$Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk-Lymphoma 2023; 64 (2): 407-414.; Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk-Lymphoma 2023; 64 (2): 407-414.$$$$$Y$$$20240704$$PH$US$US
240516201$24051620$1$I$$20240703$20240704$20240704$EXP$$US-PURDUE PHARMA-USA-2024-0310574$PURDUE$$$$$F$Y$$$20240704$$CN$US$US
240516211$24051621$1$I$20240601$20240703$20240704$20240704$EXP$$FR-PURDUE-USA-2024-0310592$PURDUE$$20$YR$$F$Y$$$20240704$$MD$FR$FR
240516221$24051622$1$I$$20240701$20240704$20240704$EXP$CA-HEALTHCANVIG-E2B_07100892$CA-PURDUE-USA-2024-0310598$PURDUE$Watson CPN, Mackinnon SE, Dostrovsky JO, Bennett GJ, Farran RP, Carlson T. Nerve resection, crush and re-location relieve complex regional pain syndrome type II: A case report. Pain. 2014;155(6):1168-1173$19$YR$$F$Y$$$20240704$$HP$CA$CA
240516232$24051623$2$F$$20240724$20240704$20240726$PER$$NVSC2024US139087$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
240516241$24051624$1$I$$20240627$20240704$20240704$EXP$$NVSC2024GB135483$NOVARTIS$$$$A$F$Y$$$20240704$$MD$GB$GB
240516252$24051625$2$F$$20240710$20240704$20240720$EXP$$IT-TEVA-VS-3215297$TEVA$Di Lorenzo A, Rindi LV, Campogiani L, Imeneo A, Alessio G, Pace PG, et al. Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review. Chemotherapy 2024; 69 (2): 85-99.; Di Lorenzo A, Rindi LV, Campogiani L, Imeneo A, Alessio G, Pace PG, et al. Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review. Chemotherapy 2024; 69 (2): 85-99.; Di Lorenzo A, Rindi LV, Campogiani L, Imeneo A, Alessio G, Pace PG, et al. Daptomycin-Induced Eosinophilic Pneumonia:...$82$YR$$M$Y$$$20240720$$HP$IT$IT
240516262$24051626$2$F$$20240802$20240704$20240806$PER$$US-ALXN-202406USA001809US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240516271$24051627$1$I$20240101$20240630$20240704$20240704$EXP$GB-MHRA-MED-202406301724129040-CZVPQ$GB-ORGANON-O2407GBR000093$ORGANON$$33$YR$$F$Y$$$20240704$$CN$GB$GB
240516281$24051628$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024132580$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240516292$24051629$2$F$20240624$20240725$20240704$20240730$PER$$US-AMGEN-USASP2024129922$AMGEN$$73$YR$E$M$Y$$$20240730$$CN$US$US
240516301$24051630$1$I$$20240702$20240704$20240704$EXP$$NVSC2024US138271$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240516311$24051631$1$I$$20240703$20240704$20240704$PER$$NVSC2024US139048$NOVARTIS$$$$$M$Y$$$20240704$$MD$US$US
240516321$24051632$1$I$20240601$20240621$20240704$20240704$PER$$US-SA-2024SA188463$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240704$$MD$US$US
240516331$24051633$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA194853$SANOFI AVENTIS$$$$A$M$Y$82.5$KG$20240704$$MD$US$US
240516341$24051634$1$I$20240301$20240626$20240704$20240704$PER$$US-SA-2024SA197188$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240704$$MD$US$US
240516351$24051635$1$I$$20240621$20240704$20240704$PER$$US-SA-2024SA188217$SANOFI AVENTIS$$$$A$F$Y$$$20240704$$CN$US$US
240516361$24051636$1$I$20240628$20240628$20240704$20240704$PER$$US-SA-2024SA195546$SANOFI AVENTIS$$37$YR$A$F$Y$115$KG$20240704$$MD$US$US
240516371$24051637$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A149118$ASTRAZENECA$$35$YR$$F$Y$$$20240704$$CN$ZA$
240516381$24051638$1$I$$20240701$20240704$20240704$EXP$$BG-AstraZeneca-2024A150866$ASTRAZENECA$Artinyan E, Dimov N, Vaysilova M. Emphysematous Pyelonephritis in a Patient on SGLT2 Inhibitor Therapy: A Rare Clinical Case Report. Case Reports in Nephrology and Dialysis 2024;14(1):81-87.$60$YR$$M$Y$$$20240704$$MD$BG$
240516391$24051639$1$I$$20240703$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106717$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240704$$CN$US$US
240516403$24051640$3$F$20240627$20240912$20240704$20240912$PER$$US-DSJP-DSU-2024-130002$DAIICHI$$61$YR$$F$Y$71.67$KG$20240913$$PH$US$US
240516411$24051641$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A148829$ASTRAZENECA$$$$$F$Y$$$20240704$$CN$US$
240516421$24051642$1$I$20240620$20240625$20240704$20240704$EXP$CN-NMPACDR-4401041007106202400292$CN-BAXTER-2024BAX020754$BAXTER$$6$YR$$F$Y$18.2$KG$20240704$$MD$CN$CN
240516431$24051643$1$I$$20240626$20240704$20240704$30DAY$$US-GSK-US2024079836$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
240516441$24051644$1$I$$20240422$20240704$20240704$PER$$CN-VER-202400008$VERITY PHARMACEUTICALS$$15$YR$T$M$Y$69$KG$20240704$$HP$CN$CN
240516455$24051645$5$F$20200524$20240909$20240704$20240919$EXP$$IT-BAXTER-2021BAX029326$BAXTER$$62$YR$$M$Y$$$20240919$$MD$IT$IT
240516461$24051646$1$I$20240623$20240624$20240704$20240704$EXP$GB-MHRA-MED-202406241024358720-MRBQW$GB-BAXTER-2024BAX020536$BAXTER$$69$YR$$F$Y$$$20240704$$CN$GB$GB
240516472$24051647$2$F$$20240715$20240704$20240719$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-130692$DAIICHI$$$$$F$Y$$$20240719$$CN$US$US
240516491$24051649$1$I$$20240521$20240704$20240704$PER$$US-VER-202400193$VERITY PHARMACEUTICALS$$$$A$M$Y$$$20240704$$CN$US$US
240516501$24051650$1$I$$20240410$20240704$20240704$PER$$US-AMGEN-USASP2024131506$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240516514$24051651$4$F$20240101$20240807$20240704$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106988$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$$$20240809$$CN$US$US
240516521$24051652$1$I$$20240624$20240704$20240704$PER$$US-TEVA-VS-3213166$TEVA$$$$$F$Y$$$20240704$$CN$US$US
240516531$24051653$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214253$TEVA$$64$YR$$F$Y$$$20240704$$HP$CA$CA
240516546$24051654$6$F$$20240917$20240704$20240925$EXP$$PE-JNJFOC-20240552336$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240925$$CN$PE$PE
240516551$24051655$1$I$20240101$20240629$20240704$20240704$EXP$$US-SA-2024SA196799$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240704$$MD$US$US
240516563$24051656$3$F$20240525$20240805$20240704$20240814$PER$$US-SA-2024SA195778$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240814$$MD$US$US
240516571$24051657$1$I$$20240625$20240704$20240704$PER$$US-TEVA-VS-3214221$TEVA$$$$$F$Y$$$20240704$$CN$US$US
240516581$24051658$1$I$20190904$20240627$20240704$20240704$EXP$$CO-GSK-CO2024AMR025878$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$CO$CO
240516591$24051659$1$I$$20240620$20240704$20240704$EXP$$CA-HLS-202401600$HLS THERAPEUTICS$$$$A$M$Y$$$20240704$$PH$CA$CA
240516601$24051660$1$I$$20240701$20240704$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010191$JAZZ$$$$$F$Y$$$20240704$$CN$US$US
240516611$24051661$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214237$TEVA$$69$YR$$F$Y$$$20240704$$CN$CA$CA
240516621$24051662$1$I$20240601$20240628$20240704$20240704$PER$$US-SA-2024SA194455$SANOFI AVENTIS$$65$YR$E$M$Y$83.9$KG$20240704$$MD$US$US
240516631$24051663$1$I$20240625$20240627$20240704$20240704$EXP$$CO-GSK-CO2024AMR050748$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$CO$CO
240516641$24051664$1$I$20240624$20240624$20240704$20240704$PER$$US-TEVA-VS-3213073$TEVA$$61$YR$$F$Y$96.16$KG$20240704$$CN$US$US
240516651$24051665$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131268$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240516662$24051666$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214400$TEVA$Ruff K, Wikenheiser-Brokamp KA, Critser P, Hirsch R, Burg G, Hayes D, et al. Pulmonary Capillary Hemangiomatosis: A Rare Disorder With a Nonspecific Presentation. Am-J-Respir-Crit-Care-Med 2024; 209.; Ruff K, Wikenheiser-Brokamp KA, Critser P, Hirsch R, Burg G, Hayes D, et al. Pulmonary Capillary Hemangiomatosis: A Rare Disorder With a Nonspecific Presentation. Am-J-Respir-Crit-Care-Med 2024; 209.$9$YR$$F$Y$$$20240720$$HP$US$US
240516671$24051667$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107009$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240704$$CN$US$US
240516681$24051668$1$I$$20240620$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099856$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$CN$US$US
240516691$24051669$1$I$20240101$20240623$20240704$20240704$PER$$US-JNJFOC-20240669278$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240704$$CN$US$US
240516701$24051670$1$I$$20240703$20240704$20240704$PER$$US-JNJFOC-20240709984$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240704$$CN$US$US
240516711$24051671$1$I$20240620$20240628$20240704$20240704$EXP$$CN-ABBVIE-5824063$ABBVIE$$92$YR$$M$Y$$$20240704$$HP$CN$CN
240516721$24051672$1$I$20240201$20240704$20240704$20240704$EXP$FR-AFSSAPS-DJ2024000813$FR-JNJFOC-20240712125$JOHNSON AND JOHNSON$$88$YR$E$M$Y$62$KG$20240704$$MD$FR$FR
240516732$24051673$2$F$20240630$20240704$20240704$20240705$PER$$US-AMGEN-USASP2024132327$AMGEN$$73$YR$E$F$Y$$$20240705$$CN$US$US
240516742$24051674$2$F$$20240703$20240704$20240711$EXP$$IT-AstraZeneca-2024A148857$ASTRAZENECA$$$$$M$Y$$$20240711$$CN$IT$
240516751$24051675$1$I$$20240626$20240704$20240704$EXP$$MX-AstraZeneca-2024A150320$ASTRAZENECA$$$$$F$Y$$$20240704$$MD$MX$
240516762$24051676$2$F$$20240802$20240704$20240808$PER$$US-AstraZeneca-2024A150604$ASTRAZENECA$$$$$F$Y$$$20240808$$MD$US$
240516772$24051677$2$F$20240601$20240709$20240704$20240711$EXP$$US-GILEAD-2024-0679489$GILEAD$$25$YR$A$M$Y$$$20240711$$CN$US$US
240516781$24051678$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A148210$ASTRAZENECA$$84$YR$$F$Y$$$20240704$$CN$ZA$
240516791$24051679$1$I$20240501$20240620$20240704$20240704$EXP$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000219$Tarsus Pharmaceuticals$$36$YR$$F$Y$$$20240704$$PH$US$US
240516801$24051680$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214439$TEVA$$$$$F$Y$$$20240704$$HP$CA$CA
240516811$24051681$1$I$20240516$20240626$20240704$20240704$EXP$$GB-AstraZeneca-2024A147317$ASTRAZENECA$$39$YR$$F$Y$$$20240704$$MD$GB$
240516823$24051682$3$F$20240601$20240708$20240704$20240712$EXP$PT-INFARMED-J202406-345$PT-Merck Healthcare KGaA-2024033999$MERCK KGAA$$41$YR$A$F$Y$56$KG$20240711$$CN$PT$PT
240516831$24051683$1$I$20240529$20240626$20240704$20240704$EXP$$IT-AstraZeneca-2024A153670$ASTRAZENECA$$89$YR$$F$Y$$$20240704$$MD$IT$
240516843$24051684$3$F$20240101$20240709$20240704$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019511$UNITED THERAPEUTICS$$$$$F$Y$50.794$KG$20240719$$$US$US
240516851$24051685$1$I$20240604$20240625$20240704$20240704$EXP$PT-INFARMED-F202406-204$PT-TEVA-VS-3214466$TEVA$$87$YR$$F$Y$60$KG$20240704$$MD$PT$PT
240516861$24051686$1$I$$20240701$20240704$20240704$EXP$$US-009507513-2407USA000724$MERCK$$$$$F$Y$$$20240704$$MD$US$US
240516871$24051687$1$I$$20240628$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104875$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240704$$CN$US$US
240516881$24051688$1$I$$20240626$20240704$20240704$EXP$$NVSC2024RU137814$NOVARTIS$Alexeeva EI. Experience with the JAK-kinase inhibitor upadacitinib in children with rheumatic diseases. CLINICAL PRACTICE IN PEDIATRICS. 2024;19 (2):59-79$9$YR$$F$Y$$$20240704$$HP$RU$RU
240516892$24051689$2$F$$20240628$20240704$20240717$EXP$$NVSC2024RU137361$NOVARTIS$$$$A$F$Y$$$20240717$$MD$RU$RU
240516901$24051690$1$I$20240609$20240704$20240704$20240704$EXP$FR-AFSSAPS-LL2024001225$NVSC2024FR138740$NOVARTIS$$12$YR$$M$Y$$$20240704$$PH$FR$FR
240516911$24051691$1$I$20240529$20240701$20240704$20240704$EXP$FR-AFSSAPS-GR2024000792$NVSC2024FR136935$NOVARTIS$$51$YR$$F$Y$$$20240704$$PH$FR$FR
240516921$24051692$1$I$20240625$20240702$20240704$20240704$EXP$$NVSC2024US138440$NOVARTIS$$70$YR$$M$Y$$$20240704$$CN$US$US
240516931$24051693$1$I$20240601$20240627$20240704$20240704$EXP$$US-AMGEN-USASP2024129153$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240516941$24051694$1$I$$20240621$20240704$20240704$EXP$GB-MHRA-MED-202406211412527020-WBJTK$GB-GLENMARK PHARMACEUTICALS-2024GMK091864$GLENMARK$$$$$$Y$$$20240704$$PH$GB$GB
240516951$24051695$1$I$20240609$20240624$20240704$20240704$EXP$$CN-Merck Healthcare KGaA-2024034795$MERCK KGAA$$22$YR$A$F$Y$50$KG$20240701$$HP$CN$CN
240516961$24051696$1$I$$20240703$20240704$20240704$PER$$NVSC2024US138936$NOVARTIS$$$$$M$Y$$$20240704$$CN$US$US
240516972$24051697$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214369$TEVA$Valido K, Patel V, Murphy MJ, Junejo MH, Patel DK, Deutsch A, et al. Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly guided approach. JAAD-Case-Rep 2024; 48 49-53.; Valido K, Patel V, Murphy MJ, Junejo MH, Patel DK, Deutsch A, et al. Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach. JAAD-Case-Rep 2024; 48 49-53.; Valido K, Patel V, Mu...$52$YR$$F$Y$$$20240720$$HP$US$US
240516991$24051699$1$I$$20240703$20240704$20240704$PER$$US-HALEON-2185364$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240517001$24051700$1$I$20240501$20240703$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106875$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240704$$CN$US$US
240517011$24051701$1$I$$20240701$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106312$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240704$$HP$US$US
240517031$24051703$1$I$20240210$20240627$20240704$20240704$EXP$FR-AFSSAPS-PA2024001296$FR-009507513-2406FRA010008$MERCK$$71$YR$$M$Y$72$KG$20240704$$PH$FR$FR
240517041$24051704$1$I$$20240701$20240704$20240704$EXP$$US-009507513-2407USA000735$MERCK$$$$$M$Y$$$20240704$$MD$US$US
240517053$24051705$3$F$20120608$20240914$20240704$20240917$PER$$US-GILEAD-2024-0679480$GILEAD$$46$YR$A$M$Y$$$20240917$$LW$US$US
240517063$24051706$3$F$$20240801$20240704$20240805$PER$$US-ALXN-202406USA001819US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240517071$24051707$1$I$$20240702$20240704$20240704$PER$$US-HALEON-2185081$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240517082$24051708$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214649$TEVA$Al Qassab O, Ali A, Aglan A. Amiodarone-induced Acute Respiratory Distress Syndrome After Atrial Fibrillation Catheter Ablation and Watchman Device Implant. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).; Al Qassab O, Ali A, Aglan A. Amiodarone-induced Acute Respiratory Distress Syndrome After Atrial Fibrillation Catheter Ablation and Watchman Device Implant. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$70$YR$$F$Y$$$20240720$$HP$US$US
240517092$24051709$2$F$20230905$20240807$20240704$20240809$EXP$$JP-DSJP-DSJ-2023-140037$DAIICHI$Kaneko N, Numata Y, Nogawa M, Satou K, Aoki S, Koshio J, et al. A-15 A case of interstitial lung disease due to Trastuzumab Deruxtecan (T-DXd) experienced at our hospital, The 92nd Joint Hokuriku Regional Meeting on Respiratory Organs, The 104th Japanese Society for Tuberculosis and Non-tuberculous Mycobacterial Infection, The 93rd Japanese Society for Respiratory Medicine, The 78th Japanese Society for Respiratory Endoscopy, The 63rd Japanese Society for Sarcoidosis and Granulomatous Diseases.$68$YR$$F$Y$51.3$KG$20240809$$MD$JP$JP
240517104$24051710$4$F$20240601$20240802$20240704$20240809$EXP$$US-GSK-US2024AMR081685$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$US$US
240517111$24051711$1$I$$20240626$20240704$20240704$PER$$US-RDY-SPO/USA/24/0009472$DR REDDYS$$58$YR$A$$Y$$$20240704$$MD$US$US
240517121$24051712$1$I$$20240702$20240704$20240704$EXP$$NVSC2024US138470$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240517131$24051713$1$I$$20240627$20240704$20240704$PER$$US-RDY-SPO/USA/24/0009471$DR REDDYS$$$$$F$Y$$$20240704$$CN$US$US
240517141$24051714$1$I$20240601$20240703$20240704$20240704$30DAY$$US-SANDOZ INC.-SDZ2024US062699$SANDOZ$$9$YR$$M$Y$$$20240704$$CN$US$US
240517161$24051716$1$I$20240101$20240703$20240704$20240704$EXP$$US-SANDOZ INC.-SDZ2024US062449$SANDOZ$$$$$F$Y$$$20240704$$CN$US$US
240517171$24051717$1$I$$20240702$20240704$20240704$30DAY$$US-SANDOZ INC.-SDZ2024US062506$SANDOZ$$$$$F$Y$$$20240704$$HP$US$US
240517201$24051720$1$I$$20240702$20240704$20240704$EXP$$US-SANDOZ INC.-SDZ2024US062697$SANDOZ$$$$$F$Y$$$20240704$$CN$US$US
240517211$24051721$1$I$20240616$20240621$20240704$20240704$PER$$US-TEVA-VS-3213863$TEVA$$$$$F$Y$$$20240704$$CN$US$US
240517221$24051722$1$I$20221120$20240628$20240704$20240704$EXP$$CN-SANDOZ INC.-NVSC2023CN026736$SANDOZ$$68$YR$$M$Y$71.5$KG$20240704$$MD$CN$CN
240517231$24051723$1$I$20240701$20240701$20240704$20240704$EXP$$US-ABBVIE-5825017$ABBVIE$$33$YR$$F$Y$$$20240704$$CN$US$US
240517241$24051724$1$I$20240601$20240628$20240704$20240704$EXP$$US-SA-2024SA195874$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240704$$MD$US$US
240517251$24051725$1$I$$20240701$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105579$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$78.02$KG$20240704$$CN$US$US
240517262$24051726$2$F$20230202$20240703$20240704$20240710$EXP$$DE-AstraZeneca-2021A104732$ASTRAZENECA$$$$E$F$Y$67$KG$20240710$$MD$DE$
240517271$24051727$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A148906$ASTRAZENECA$$81$YR$$F$Y$$$20240704$$CN$ZA$
240517281$24051728$1$I$$20240701$20240704$20240704$EXP$$US-AstraZeneca-2024A150102$ASTRAZENECA$Zhang M.;  Truver M.T.;  Hoyer J.L.;  Chronister C.W.;  Goldberger B.A.. Presumptive identification of nitrite by Griess reagent test strips-Case reports of fatal poisoning with sodium nitrite. Journal of Analytical Toxicology 2023;47(8):746-749.$16$YR$$F$Y$$$20240704$$HP$US$
240517301$24051730$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138225$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240517312$24051731$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214709$TEVA$Fiter RJ, Tong T. Covid Confusion: A Case of Paxlovid Induced Carbamazepine Toxicity. Am-J-Respir-Crit-Care-Med 2024; 209.; Fiter RJ, Tong T. Covid Confusion: A Case of Paxlovid Induced Carbamazepine Toxicity. Am-J-Respir-Crit-Care-Med 2024; 209.$52$YR$$F$Y$$$20240720$$HP$US$US
240517321$24051732$1$I$20240301$20240701$20240704$20240704$EXP$$US-ABBVIE-5824784$ABBVIE$$90$YR$$M$Y$$$20240704$$CN$US$US
240517331$24051733$1$I$20240101$20240627$20240704$20240704$EXP$$US-AMGEN-USASP2024127771$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240517343$24051734$3$F$20240624$20240821$20240704$20240826$30DAY$$US-PFIZER INC-202400203482$PFIZER$$15$YR$$F$Y$28.12$KG$20240826$$CN$US$US
240517355$24051735$5$F$$20240904$20240704$20240906$30DAY$$US-PFIZER INC-202400204765$PFIZER$$15$YR$$M$Y$$$20240906$$MD$US$US
240517383$24051738$3$F$20240626$20240911$20240704$20240912$30DAY$$US-PFIZER INC-202400202923$PFIZER$$15$YR$$M$Y$$$20240912$$CN$US$US
240517401$24051740$1$I$20240201$20240620$20240704$20240704$EXP$$FR-AstraZeneca-2024A142897$ASTRAZENECA$$73$YR$$F$Y$37.7$KG$20240704$$MD$FR$
240517418$24051741$8$F$20240627$20240913$20240704$20240918$30DAY$$US-PFIZER INC-202400203644$PFIZER$$15$YR$$M$Y$78.02$KG$20240918$$CN$US$US
240517444$24051744$4$F$$20240924$20240704$20240927$30DAY$$US-PFIZER INC-202400203033$PFIZER$$15$YR$$M$Y$61.23$KG$20240927$$HP$US$US
240517453$24051745$3$F$$20240912$20240704$20240917$30DAY$$US-PFIZER INC-202400203654$PFIZER$$14$YR$$M$Y$$$20240917$$CN$US$US
240517475$24051747$5$F$$20240913$20240704$20240918$30DAY$$US-PFIZER INC-202400204441$PFIZER$$15$YR$$M$Y$$$20240918$$MD$US$US
240517483$24051748$3$F$$20240805$20240704$20240806$EXP$$US-ALXN-202406USA001720US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240517491$24051749$1$I$20240619$20240620$20240704$20240704$PER$$US-SA-2024SA186904$SANOFI AVENTIS$$2$YR$C$F$Y$10.6$KG$20240704$$MD$US$US
240517501$24051750$1$I$$20240624$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106791$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$95.21$KG$20240704$$HP$US$US
240517511$24051751$1$I$20231201$20240628$20240704$20240704$EXP$$AR-JNJFOC-20230872879$JOHNSON AND JOHNSON$$74$YR$E$M$Y$74$KG$20240704$$CN$AR$AR
240517521$24051752$1$I$20230709$20240628$20240704$20240704$EXP$$CN-JNJFOC-20240707358$JOHNSON AND JOHNSON$$38$DY$I$M$Y$$$20240704$$HP$CN$CN
240517532$24051753$2$F$20240624$20240717$20240704$20240723$EXP$$US-JNJFOC-20240672566$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240723$$CN$US$US
240517541$24051754$1$I$$20240621$20240704$20240704$EXP$$US-FARMAPROD-202406-2359$DOMPE FARMACEUTICI$$$$A$M$Y$88.45$KG$20240704$$CN$US$US
240517551$24051755$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825677$ABBVIE$$34$YR$$F$Y$$$20240704$$HP$US$US
240517563$24051756$3$F$20220527$20240912$20240704$20240916$PER$$US-GILEAD-2024-0679481$GILEAD$$54$YR$A$M$Y$$$20240916$$LW$US$US
240517571$24051757$1$I$$20240506$20240704$20240704$PER$$US-AMGEN-USASP2024130124$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240517581$24051758$1$I$$20240630$20240704$20240704$PER$$US-AMGEN-USASP2024130115$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240517591$24051759$1$I$$20230902$20240704$20240704$PER$$US-AMGEN-USASP2023235499$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240517601$24051760$1$I$$20230515$20240704$20240704$PER$$US-AMGEN-USASP2023235456$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240517611$24051761$1$I$20240622$20240625$20240704$20240704$PER$$US-SA-2024SA194733$SANOFI AVENTIS$$82$YR$E$F$Y$61.23$KG$20240704$$MD$US$US
240517621$24051762$1$I$$20240701$20240704$20240704$30DAY$$US-ABBVIE-5826398$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240517631$24051763$1$I$$20230712$20240704$20240704$EXP$$CA-SANDOZ INC.-NVSC2020CA259875$SANDOZ$$43$YR$$F$Y$68$KG$20240704$$MD$CA$CA
240517641$24051764$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA194932$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240704$$MD$US$US
240517653$24051765$3$F$20240101$20240726$20240704$20240805$PER$$US-SA-2024SA196446$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240805$$CN$US$US
240517661$24051766$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106917$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240704$$CN$US$US
240517671$24051767$1$I$20230301$20240513$20240704$20240704$PER$$US-AMGEN-USASP2024132043$AMGEN$$65$YR$$F$Y$$$20240704$$CN$US$US
240517681$24051768$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA194158$SANOFI AVENTIS$$60$YR$A$F$Y$99.7$KG$20240704$$MD$US$US
240517691$24051769$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214255$TEVA$$44$YR$$F$Y$$$20240704$$HP$CA$CA
240517701$24051770$1$I$$20240702$20240704$20240704$PER$$US-TAKEDA-2024TUS067448$TAKEDA$$$$$M$Y$$$20240704$$CN$US$US
240517713$24051771$3$F$20190121$20240923$20240704$20240925$PER$$US-GILEAD-2024-0679483$GILEAD$$44$YR$A$F$Y$$$20240925$$LW$US$US
240517722$24051772$2$F$$20240710$20240704$20240720$EXP$$PL-TEVA-VS-3215077$TEVA$Slawinski L, Solek JM, Milkowska-Dymanowska J, Jesionek-Kupnicka D, Gora-Tybor J, Mikulski D, et al. Primary pulmonary Hodgkin^s lymphoma mimicking granulomatosis with polyangiitis - a case report of diagnostic and therapeutic dilemmas. Wspolczesna-Onkol 2023; 27 (2): 113-117.; Slawinski L, Solek JM, Milkowska-Dymanowska J, Jesionek-Kupnicka D, Gora-Tybor J, Mikulski D, et al. Primary pulmonary Hodgkin^s lymphoma mimicking granulomatosis with polyangiitis - a case report of diagnostic and the...$53$YR$$F$Y$$$20240720$$HP$PL$PL
240517731$24051773$1$I$$20240626$20240704$20240704$EXP$$JP-ASTELLAS-2024JP004577$ASTELLAS$Matsuda Y, Masuda M, Asai M, Okamoto S, Ishihara T, Nanto K, et al.. Impact of Immunosuppressive Therapy on Lead Dislodgement After Cardiac Implantable Electronic Device Implantation. Clinical Cardiology. 2024;47(6):1-8$83$YR$$F$Y$44.7$KG$20240704$$MD$JP$JP
240517741$24051774$1$I$$20240626$20240704$20240704$EXP$$CA-ASTELLAS-2024EU006603$ASTELLAS$Luong ML, Nakamachi Y, Silveira FP, Morrissey CO, Danziger-Isakov L, Verschuuren EAM et al. Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel. Transpl Infect Dis. 2024;26(3):1-16$55$YR$$M$Y$$$20240704$$HP$CA$CA
240517751$24051775$1$I$20240625$20240627$20240704$20240704$EXP$$UA-Ipsen Biopharmaceuticals, Inc.-2024-12946$IPSEN$$43$YR$A$F$Y$$$20240704$$MD$UA$UA
240517761$24051776$1$I$20240101$20240701$20240704$20240704$PER$$US-ABBVIE-5825262$ABBVIE$$$$A$$Y$$$20240704$$MD$US$US
240517771$24051777$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-129962$DAIICHI$$45$YR$$F$Y$$$20240704$$HP$CA$CA
240517781$24051778$1$I$$20240626$20240704$20240704$EXP$$CA-ASTELLAS-2024EU006605$ASTELLAS$Luong ML, Nakamachi Y, Silveira FP, Morrissey CO, Danziger-Isakov L, Verschuuren EAM et al. Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel. Transpl Infect Dis. 2024;26(3):1-16$52$YR$$F$Y$$$20240704$$HP$CA$CA
240517791$24051779$1$I$$20240627$20240704$20240704$PER$$US-ALXN-202406USA001866US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240704$$CN$US$US
240517801$24051780$1$I$20210526$20240624$20240704$20240704$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-091993$REGENERON$Betts C, Maxwell M, Floyd M, Pawlowski J. Neoadjuvant Cemiplimab Followed by Radiation for Locally Advanced Unresectable Cutaneous Squamous Cell Carcinoma: A Case Report.. Advances in Radiation Oncology. 2024;9(8):1-6$60$YR$$F$Y$$$20240704$$HP$US$US
240517811$24051781$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825784$ABBVIE$$60$YR$$F$Y$$$20240704$$HP$US$US
240517821$24051782$1$I$$20240626$20240704$20240704$PER$$US-JNJFOC-20240672059$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240517831$24051783$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-129946$DAIICHI$$58$YR$$F$Y$$$20240704$$PH$CA$CA
240517841$24051784$1$I$$20240627$20240704$20240704$EXP$$US-VIIV HEALTHCARE LIMITED-US2024080314$VIIV$$$$$$Y$$$20240704$$MD$US$US
240517851$24051785$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-129960$DAIICHI$$80$YR$$F$Y$$$20240704$$CN$CA$CA
240517861$24051786$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825502$ABBVIE$$49$YR$$M$Y$$$20240704$$HP$US$US
240517871$24051787$1$I$$20240626$20240704$20240704$EXP$$CN-JNJFOC-20240673482$JOHNSON AND JOHNSON$$$$E$$Y$$$20240704$$HP$CN$CN
240517881$24051788$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-129949$DAIICHI$$72$YR$$F$Y$59$KG$20240704$$HP$CA$CA
240517891$24051789$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A148080$ASTRAZENECA$$$$$M$Y$$$20240704$$HP$US$
240517902$24051790$2$F$20240527$20240716$20240704$20240718$EXP$IT-MINISAL02-992166$IT-ORGANON-O2407ITA000213$ORGANON$$67$YR$$F$Y$$$20240718$$MD$IT$IT
240517914$24051791$4$F$$20240711$20240704$20240810$PER$$US-AMGEN-USASP2024129026$AMGEN$$$$$$Y$$$20240810$$PH$US$US
240517921$24051792$1$I$20240601$20240628$20240704$20240704$PER$$US-AMGEN-USASP2024129597$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240517932$24051793$2$F$20240514$20240725$20240704$20240731$EXP$$JP-DSJP-DSJ-2024-127050$DAIICHI$$43$YR$$F$Y$59.7$KG$20240731$$MD$JP$JP
240517941$24051794$1$I$$20240701$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105630$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$96$KG$20240704$$PH$US$US
240517951$24051795$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214222$TEVA$$64$YR$$F$Y$$$20240704$$PH$CA$CA
240517961$24051796$1$I$20240601$20240620$20240704$20240704$PER$$US-SA-2024SA187199$SANOFI AVENTIS$$69$YR$E$F$Y$71.214$KG$20240704$$MD$US$US
240517971$24051797$1$I$20240627$20240703$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106709$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240704$$HP$US$US
240517981$24051798$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106621$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240704$$CN$US$US
240517991$24051799$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106956$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240704$$CN$US$US
240518001$24051800$1$I$$20231115$20240704$20240704$PER$$US-AMGEN-USASP2023235497$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240518011$24051801$1$I$$20240626$20240704$20240704$EXP$$IE-TAKEDA-2024TUS066623$TAKEDA$$$$$$Y$$$20240704$$MD$IE$IE
240518031$24051803$1$I$20230801$20240702$20240704$20240704$EXP$GB-MHRA-MED-202407021100306640-MFJBG$GB-ABBVIE-5824333$ABBVIE$$32$YR$$M$Y$$$20240704$$CN$GB$GB
240518041$24051804$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214263$TEVA$$80$YR$$M$Y$$$20240704$$HP$CA$CA
240518051$24051805$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214075$TEVA$$44$YR$$F$Y$$$20240704$$HP$CA$CA
240518064$24051806$4$F$20240401$20240723$20240704$20240806$EXP$$IL-ALXN-202406EEA001629IL$ALEXION PHARMACEUTICALS$$3$YR$$F$Y$$$20240806$$MD$IL$IL
240518072$24051807$2$F$20240101$20240828$20240704$20240909$PER$$US-SA-2022SA490753$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240909$$MD$US$US
240518082$24051808$2$F$$20240723$20240704$20240729$EXP$$TH-JNJFOC-20240670044$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$MD$TH$TH
240518091$24051809$1$I$$20240701$20240704$20240704$PER$$US-ABBVIE-5824981$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240518101$24051810$1$I$20230816$20240701$20240704$20240704$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010210$JAZZ$$24$YR$$M$Y$$$20240704$$MD$US$US
240518111$24051811$1$I$$20230730$20240704$20240704$PER$$US-AMGEN-USASP2023235305$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240518121$24051812$1$I$$20240109$20240704$20240704$PER$$US-AMGEN-USASP2024132655$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240518132$24051813$2$F$20240101$20240807$20240704$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013555$UNITED THERAPEUTICS$$$$$F$Y$49.252$KG$20240810$$$US$US
240518142$24051814$2$F$20240626$20240702$20240704$20240710$PER$$US-JNJFOC-20240706291$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240710$$CN$US$US
240518152$24051815$2$F$20240301$20240809$20240704$20240813$PER$$US-JNJFOC-20240675320$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
240518161$24051816$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA131045$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240704$$CN$US$US
240518171$24051817$1$I$20240515$20240628$20240704$20240704$EXP$$CA-JNJFOC-20240424234$JOHNSON AND JOHNSON$$68$YR$E$F$Y$69.008$KG$20240704$$HP$CA$CA
240518181$24051818$1$I$$20240628$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104227$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240704$$HP$US$US
240518191$24051819$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106430$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240704$$HP$US$US
240518201$24051820$1$I$$20240702$20240704$20240704$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-107044$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240704$$CN$DE$DE
240518211$24051821$1$I$20240601$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107115$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240704$$CN$US$US
240518224$24051822$4$F$20240703$20240828$20240704$20240902$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037858$BOEHRINGER INGELHEIM$$43$YR$A$F$Y$$$20240902$$CN$US$US
240518231$24051823$1$I$$20240703$20240704$20240704$PER$$US-HALEON-2185296$Haleon PLC$$$$$M$Y$$$20240704$$CN$US$US
240518241$24051824$1$I$$20240626$20240704$20240704$EXP$$ID-AstraZeneca-2024A149837$ASTRAZENECA$$$$$$Y$$$20240704$$MD$ID$
240518251$24051825$1$I$20240523$20240701$20240704$20240704$EXP$$JP-AstraZeneca-2024A132383$ASTRAZENECA$$69$YR$$M$Y$$$20240704$$MD$JP$
240518261$24051826$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5826199$ABBVIE$$36$YR$$M$Y$$$20240704$$HP$US$US
240518272$24051827$2$F$20240703$20240704$20240704$20240705$PER$$US-AMGEN-USASP2024132543$AMGEN$$78$YR$E$M$Y$$$20240704$$CN$US$US
240518282$24051828$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214588$TEVA$Lam E, Santos C, Patrawalla AS. A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A5651.; Lam E, Santos C, Patrawalla AS. A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A5651.$32$YR$$F$Y$$$20240720$$HP$US$US
240518291$24051829$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214266$TEVA$$43$YR$$F$Y$$$20240704$$HP$CA$CA
240518301$24051830$1$I$20170101$20240626$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2017-008849$UNITED THERAPEUTICS$$$$$F$Y$98.413$KG$20240704$$$US$US
240518311$24051831$1$I$20240101$20240627$20240704$20240704$PER$$US-UNITED THERAPEUTICS-UNT-2024-019468$UNITED THERAPEUTICS$$$$$M$Y$69.388$KG$20240704$$$US$US
240518323$24051832$3$F$20240601$20240630$20240704$20240807$EXP$$IL-Ipsen Biopharmaceuticals, Inc.-2024-13172$IPSEN$$4$YR$C$M$Y$$$20240807$$MD$IL$IL
240518331$24051833$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281413365890-NGPDS$GB-RDY-SPO/GBR/24/0009607$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240518341$24051834$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281040200250-ZJMNR$GB-RDY-SPO/GBR/24/0009617$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240518351$24051835$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281143566360-GQMFV$GB-RDY-SPO/GBR/24/0009662$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240518361$24051836$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281145082300-JSMBZ$GB-RDY-SPO/GBR/24/0009637$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240518371$24051837$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214008$TEVA$$50$YR$$M$Y$$$20240704$$PH$CA$CA
240518381$24051838$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281412107900-RNBWT$GB-RDY-SPO/GBR/24/0009640$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240518401$24051840$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214223$TEVA$$$$$F$Y$$$20240704$$HP$CA$CA
240518412$24051841$2$F$$20240806$20240704$20240809$EXP$$US-PFIZER INC-202400204317$PFIZER$$$$$M$Y$$$20240809$$CN$US$US
240518421$24051842$1$I$$20240701$20240704$20240704$PER$$NVSC2024US137689$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240518432$24051843$2$F$20240701$20240830$20240704$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106611$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240906$$CN$US$US
240518441$24051844$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107075$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240704$$CN$US$US
240518451$24051845$1$I$$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106833$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240704$$CN$US$US
240518463$24051846$3$F$$20240823$20240704$20240827$EXP$$CA-SANDOZ INC.-SDZ2024CA041449$SANDOZ$$$$$M$Y$$$20240827$$MD$CA$CA
240518472$24051847$2$F$$20240711$20240704$20240712$EXP$$GB-SANDOZ INC.-NVSC2021GB185089$SANDOZ$$$$$F$Y$$$20240712$$CN$GB$GB
240518481$24051848$1$I$$20240703$20240704$20240704$30DAY$$US-SANDOZ INC.-SDZ2024US062706$SANDOZ$$$$$F$Y$$$20240704$$HP$US$US
240518491$24051849$1$I$20230801$20240702$20240704$20240704$EXP$GB-MHRA-MED-202407021100306640-MFJBG$GB-SANDOZ INC.-SDZ2024GB062577$SANDOZ$$32$YR$$M$Y$$$20240704$$CN$GB$GB
240518501$24051850$1$I$$20240629$20240704$20240704$EXP$$US-SANDOZ INC.-SDZ2024US062087$SANDOZ$$57$YR$$$Y$$$20240704$$CN$US$US
240518511$24051851$1$I$$20240703$20240704$20240704$EXP$$GB-SANDOZ INC.-SDZ2024GB062708$SANDOZ$$74$YR$$F$Y$52$KG$20240704$$MD$GB$GB
240518521$24051852$1$I$20240322$20240625$20240704$20240704$EXP$FR-AFSSAPS-NY2024000690$FR-TEVA-VS-3214478$TEVA$$58$YR$$M$Y$$$20240704$$HP$FR$FR
240518532$24051853$2$F$20240702$20240704$20240704$20240705$PER$$US-AMGEN-USASP2024132531$AMGEN$$60$YR$A$F$Y$$$20240705$$HP$US$US
240518541$24051854$1$I$$20240215$20240704$20240704$PER$$US-AMGEN-USASP2024132663$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240518551$24051855$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825765$ABBVIE$$37$YR$$F$Y$$$20240704$$HP$US$US
240518562$24051856$2$F$20240107$20240807$20240704$20240809$EXP$$JP-DSJP-DSJ-2024-118882$DAIICHI$$51$YR$$F$Y$57$KG$20240809$$MD$JP$JP
240518571$24051857$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A148846$ASTRAZENECA$$71$YR$$F$Y$$$20240704$$CN$ZA$
240518581$24051858$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A147775$ASTRAZENECA$$$$$F$Y$$$20240704$$MD$US$
240518591$24051859$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214098$TEVA$$$$$F$Y$$$20240704$$HP$CA$CA
240518601$24051860$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214043$TEVA$$47$YR$$F$Y$95$KG$20240704$$HP$CA$CA
240518611$24051861$1$I$20240618$20240630$20240704$20240704$30DAY$$US-PFIZER INC-202400204319$PFIZER$$19$YR$$$Y$$$20240704$$HP$US$US
240518621$24051862$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A148156$ASTRAZENECA$$$$$F$Y$$$20240704$$CN$US$
240518634$24051863$4$F$$20240822$20240704$20240916$PER$$US-AstraZeneca-2024A153772$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
240518642$24051864$2$F$$20240723$20240704$20240729$EXP$$CA-AstraZeneca-2024A153091$ASTRAZENECA$$53$YR$$M$Y$$$20240729$$MD$CA$
240518652$24051865$2$F$$20240814$20240704$20240831$PER$$US-AstraZeneca-2024A152825$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$US$
240518661$24051866$1$I$20240425$20240701$20240704$20240704$EXP$$GB-AstraZeneca-2024A150902$ASTRAZENECA$$74$YR$$F$Y$$$20240704$$MD$GB$
240518671$24051867$1$I$20230912$20240626$20240704$20240704$EXP$$JP-AstraZeneca-2024A149530$ASTRAZENECA$$62$YR$$M$Y$57$KG$20240704$$MD$JP$
240518684$24051868$4$F$20180718$20240722$20240704$20240807$EXP$$AU-AstraZeneca-2024A151103$ASTRAZENECA$$56$YR$$F$Y$$$20240807$$MD$AU$
240518691$24051869$1$I$$20240625$20240704$20240704$EXP$$DE-TAKEDA-2024TUS065829$TAKEDA$$59$YR$$M$Y$$$20240704$$HP$DE$DE
240518701$24051870$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825713$ABBVIE$$32$YR$$F$Y$$$20240704$$HP$US$US
240518711$24051871$1$I$20240627$20240703$20240704$20240704$PER$$US-JNJFOC-20240709048$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240704$$CN$US$US
240518721$24051872$1$I$20240702$20240703$20240704$20240704$PER$$US-JNJFOC-20240709122$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$PH$US$US
240518731$24051873$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825691$ABBVIE$$24$YR$$F$Y$$$20240704$$HP$US$US
240518742$24051874$2$F$20240701$20240722$20240704$20240723$PER$$US-JNJFOC-20240710990$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$PH$US$US
240518751$24051875$1$I$20240101$20240701$20240704$20240704$PER$$US-ABBVIE-5825534$ABBVIE$$$$$F$Y$41$KG$20240704$$CN$US$US
240518761$24051876$1$I$$20240628$20240704$20240704$EXP$$CA-Taiho Oncology Inc-2024-006559$TAIHO ONCOLOGY INC$$52$YR$A$M$Y$$$20240704$$CN$CA$CA
240518771$24051877$1$I$$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281434234840-MKDNF$GB-RDY-SPO/GBR/24/0009554$DR REDDYS$$$$$$Y$$$20240704$$CN$GB$GB
240518781$24051878$1$I$$20240623$20240704$20240704$EXP$$AU-JNJFOC-20240676342$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$HP$AU$AU
240518791$24051879$1$I$$20240703$20240704$20240704$PER$$US-HALEON-2185276$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240518802$24051880$2$F$$20240704$20240704$20240705$PER$$US-AMGEN-USASP2024132562$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240518811$24051881$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214230$TEVA$$40$YR$$F$Y$$$20240704$$HP$CA$CA
240518821$24051882$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214286$TEVA$$44$YR$$F$Y$70$KG$20240704$$HP$CA$CA
240518831$24051883$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138349$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240518841$24051884$1$I$$20240629$20240704$20240704$EXP$$US-ASTELLAS-2024EU006526$ASTELLAS$$$$$M$Y$$$20240704$$CN$US$US
240518851$24051885$1$I$$20240628$20240704$20240704$EXP$$US-ASTELLAS-2024EU006549$ASTELLAS$$$$$M$Y$$$20240704$$CN$US$US
240518861$24051886$1$I$$20240703$20240704$20240704$PER$$NVSC2024US139047$NOVARTIS$$$$$$Y$$$20240704$$MD$US$US
240518872$24051887$2$F$20240622$20240709$20240704$20240710$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-106927$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240711$$CN$PR$PR
240518881$24051888$1$I$$20240629$20240704$20240704$PER$$US-ABBVIE-5826141$ABBVIE$$$$$F$Y$$$20240704$$MD$US$US
240518891$24051889$1$I$$20240701$20240704$20240704$PER$$US-ALXN-202407USA000138US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240704$$HP$US$US
240518901$24051890$1$I$$20240628$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104771$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240704$$CN$US$US
240518911$24051891$1$I$20221101$20240626$20240704$20240704$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-103282$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$MD$CH$CH
240518921$24051892$1$I$20231026$20240702$20240704$20240704$EXP$$JP-DSJP-DSJ-2024-130277$DAIICHI$$8$DEC$$M$Y$$$20240704$$MD$JP$JP
240518931$24051893$1$I$20240323$20240620$20240704$20240704$EXP$$GB-CIPLA LTD.-2024GB05338$CIPLA$$$$$$Y$$$20240704$$CN$GB$GB
240518941$24051894$1$I$20190115$20240617$20240704$20240704$EXP$$JP-TAKEDA-2024TUS066643$TAKEDA$$72$YR$$M$Y$$$20240704$$MD$JP$JP
240518951$24051895$1$I$20240416$20240620$20240704$20240704$EXP$$GB-CIPLA LTD.-2024GB06665$CIPLA$$$$$$Y$$$20240704$$CN$GB$GB
240518961$24051896$1$I$20240323$20240620$20240704$20240704$EXP$$GB-CIPLA LTD.-2024GB06664$CIPLA$$$$$$Y$$$20240704$$CN$GB$GB
240518971$24051897$1$I$$20240626$20240704$20240704$EXP$$GB-AstraZeneca-2024A147976$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$GB$
240518981$24051898$1$I$$20240626$20240704$20240704$EXP$$BE-AstraZeneca-2024A127857$ASTRAZENECA$$$$$F$Y$$$20240704$$MD$BE$
240518992$24051899$2$F$$20240705$20240704$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002712$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240708$$CN$US$US
240519001$24051900$1$I$$20240626$20240704$20240704$EXP$$DE-TEVA-VS-3215188$TEVA$$$$E$F$Y$64$KG$20240704$$MD$DE$DE
240519011$24051901$1$I$$20240626$20240704$20240704$EXP$$ZA-AstraZeneca-2024A149482$ASTRAZENECA$$76$YR$$F$Y$$$20240704$$CN$ZA$
240519021$24051902$1$I$20240229$20240626$20240704$20240704$EXP$$BE-AstraZeneca-2024A153505$ASTRAZENECA$$$$E$M$Y$56$KG$20240704$$MD$BE$
240519031$24051903$1$I$20240630$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407003229$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240704$$CN$US$US
240519041$24051904$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191289$SANOFI AVENTIS$$$$$F$Y$$$20240704$$MD$US$US
240519052$24051905$2$F$$20240813$20240704$20240826$PER$$US-SA-2024SA191425$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240826$$MD$US$US
240519061$24051906$1$I$$20240620$20240704$20240704$EXP$$US-CIPLA LTD.-2024US06779$CIPLA$Hennen MA, Zhang V, Opler DJ. An unwelcome side-effect of trazodone use in a trans-male. Psychiatry and Clinical Neurosciences. 2024;78(6):376$$$$$Y$$$20240704$$MD$US$US
240519071$24051907$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214154$TEVA$$50$YR$$F$Y$$$20240704$$HP$CA$CA
240519081$24051908$1$I$20240605$20240702$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106493$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240704$$CN$US$US
240519112$24051911$2$F$$20240710$20240704$20240720$EXP$$CH-TEVA-VS-3215348$TEVA$Kolev M, Sarbu A-C, Moller B, Maurer B, Kollert F, Semmo N. Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis - a case series. J-Transl-Autoimmun 2023; 6.; Kolev M, Sarbu A-C, Moller B, Maurer B, Kollert F, Semmo N. Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis - a case series. J-Transl-Autoimmun 2023; 6.; Kolev M, Sarbu A-C, Moller B, Maurer B, Kollert F, Semmo N. Belimumab treatment in autoimmune hepatitis and primary biliary cholangit...$5$DEC$$F$Y$$$20240720$$HP$CH$CH
240519121$24051912$1$I$$20240701$20240704$20240704$EXP$$KR-DSJP-DSJ-2024-129944$DAIICHI$An SY, Yang Y.. Challenges associated with managing treatment complications in an older patient with cardiac amyloidosis. The Egyptian Heart Journal. 2024;76(75):1-8$83$YR$$M$Y$$$20240704$$HP$KR$KR
240519131$24051913$1$I$$20240625$20240704$20240704$PER$$US-SA-2024SA191919$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240704$$MD$US$US
240519141$24051914$1$I$$20240620$20240704$20240704$EXP$$GB-CIPLA LTD.-2024GB06661$CIPLA$$$$$$Y$$$20240704$$HP$GB$GB
240519152$24051915$2$F$20240101$20240607$20240704$20240705$PER$$US-JNJFOC-20240622233$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240519161$24051916$1$I$20240626$20240702$20240704$20240704$PER$$US-JNJFOC-20240706039$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240704$$CN$US$US
240519171$24051917$1$I$20240225$20240624$20240704$20240704$EXP$FR-AFSSAPS-LL2024001130$FR-TEVA-VS-3213378$TEVA$$78$YR$$M$Y$$$20240704$$MD$FR$FR
240519181$24051918$1$I$20240605$20240625$20240704$20240704$EXP$FR-AFSSAPS-LL2024001132$FR-TEVA-VS-3214456$TEVA$$70$YR$$F$Y$68$KG$20240704$$MD$FR$FR
240519191$24051919$1$I$20240307$20240626$20240704$20240704$EXP$SE-SEMPA-2024-004658$SE-TEVA-VS-3215231$TEVA$$47$YR$$M$Y$$$20240704$$MD$SE$SE
240519201$24051920$1$I$20240618$20240625$20240704$20240704$PER$$US-SA-2024SA191367$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240704$$MD$US$US
240519211$24051921$1$I$20240701$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024131694$AMGEN$$66$YR$E$F$Y$$$20240704$$CN$US$US
240519222$24051922$2$F$$20240718$20240704$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100097$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240722$$HP$US$US
240519231$24051923$1$I$20240301$20240702$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106950$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240704$$CN$US$US
240519242$24051924$2$F$20240601$20240802$20240704$20240816$PER$$US-SA-2024SA191321$SANOFI AVENTIS$$39$YR$A$F$Y$49.89$KG$20240816$$MD$US$US
240519251$24051925$1$I$$20240701$20240704$20240704$PER$$US-ABBVIE-5826060$ABBVIE$$$$$$Y$$$20240704$$MD$US$US
240519261$24051926$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214055$TEVA$$15$YR$$F$Y$63.503$KG$20240704$$CN$CA$CA
240519271$24051927$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214042$TEVA$$46$YR$$F$Y$$$20240704$$PH$CA$CA
240519281$24051928$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214430$TEVA$$80$YR$$M$Y$$$20240704$$HP$CA$CA
240519291$24051929$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3213994$TEVA$$41$YR$$F$Y$$$20240704$$MD$CA$CA
240519301$24051930$1$I$20240525$20240626$20240704$20240704$EXP$SE-SEMPA-2024-005021$SE-TEVA-VS-3215125$TEVA$$28$YR$$M$Y$$$20240704$$MD$SE$SE
240519311$24051931$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3213988$TEVA$$69$YR$$F$Y$$$20240704$$HP$CA$CA
240519321$24051932$1$I$20240328$20240625$20240704$20240704$EXP$FR-AFSSAPS-DJ2024000691$FR-TEVA-VS-3214477$TEVA$$67$YR$$F$Y$$$20240704$$MD$FR$FR
240519332$24051933$2$F$$20240904$20240704$20240905$EXP$$NVSC2024US137342$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
240519341$24051934$1$I$20240101$20240625$20240704$20240704$EXP$$CA-BEH-2024173548$CSL BEHRING$$74$YR$E$F$Y$64$KG$20240704$$CN$CA$CA
240519351$24051935$1$I$$20240630$20240704$20240704$PER$$US-LEO Pharma-371676$LEO PHARM$$23$YR$$F$Y$$$20240704$$PH$US$US
240519361$24051936$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3213962$TEVA$$65$YR$$F$Y$$$20240704$$HP$CA$CA
240519371$24051937$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3213972$TEVA$$59$YR$$F$Y$$$20240704$$MD$CA$CA
240519381$24051938$1$I$$20240627$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104197$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240704$$CN$US$US
240519391$24051939$1$I$20240501$20240628$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104686$BRISTOL MYERS SQUIBB$$23$YR$A$M$Y$$$20240704$$HP$US$US
240519401$24051940$1$I$20240601$20240625$20240704$20240704$PER$$US-SA-2024SA191976$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240704$$MD$US$US
240519412$24051941$2$F$$20240827$20240704$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106840$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240829$$HP$US$US
240519422$24051942$2$F$$20240906$20240704$20240909$EXP$$NVSC2024US138930$NOVARTIS$$$$$F$Y$$$20240909$$MD$US$US
240519431$24051943$1$I$$20240607$20240704$20240704$PER$$US-JNJFOC-20240622173$JOHNSON AND JOHNSON$$$$$F$Y$$$20240704$$CN$US$US
240519442$24051944$2$F$$20240710$20240704$20240715$PER$$US-ABBVIE-5823256$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240519452$24051945$2$F$20170101$20240703$20240704$20240709$EXP$$US-ABBVIE-5824204$ABBVIE$$$$$F$Y$54$KG$20240709$$CN$US$US
240519462$24051946$2$F$20240618$20240730$20240704$20240805$EXP$$BE-BEH-2024174560$CSL BEHRING$$67$YR$E$F$Y$85$KG$20240805$$HP$BE$BE
240519471$24051947$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3213999$TEVA$$75$YR$$F$Y$72$KG$20240704$$HP$CA$CA
240519481$24051948$1$I$$20240628$20240704$20240704$PER$$US-LEO Pharma-371641$LEO PHARM$$40$YR$$F$Y$$$20240704$$CN$US$US
240519491$24051949$1$I$20240625$20240625$20240704$20240704$PER$$US-SA-2024SA191827$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240704$$MD$US$US
240519502$24051950$2$F$$20240729$20240704$20240807$PER$$US-SA-2024SA191910$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240807$$MD$US$US
240519511$24051951$1$I$20240623$20240703$20240704$20240704$EXP$$NVSC2024US138873$NOVARTIS$$53$YR$$M$Y$43.54$KG$20240704$$MD$US$US
240519521$24051952$1$I$20240101$20240628$20240704$20240704$EXP$$US-ABBVIE-5821785$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240519531$24051953$1$I$$20240625$20240704$20240704$EXP$$JP-TAKEDA-2024TUS067258$TAKEDA$$56$YR$$F$Y$$$20240704$$MD$JP$JP
240519544$24051954$4$F$20230713$20240910$20240704$20240919$EXP$$JP-ABBVIE-5418328$ABBVIE$$57$YR$$M$Y$63$KG$20240919$$MD$JP$JP
240519551$24051955$1$I$$20240701$20240704$20240704$EXP$$US-ABBVIE-5824649$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240519561$24051956$1$I$$20240626$20240704$20240704$PER$$US-SA-2024SA191092$SANOFI AVENTIS$$$$E$F$Y$$$20240704$$CN$US$US
240519572$24051957$2$F$$20240703$20240704$20240705$EXP$$HU-AstraZeneca-2024A150900$ASTRAZENECA$Juhasz M, Antal B, Herczeg G, Nemes B, Fulesdi B, Vegh T. Hemorrhagic pneumonia in a kidney transplant recipient caused by stenotrophomonas maltophilia. TRANSPLANTATION PROCEEDINGS 2024;000:1-4.$73$YR$$M$Y$83$KG$20240705$$MD$HU$
240519581$24051958$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3213954$TEVA$$74$YR$$F$Y$54$KG$20240704$$HP$CA$CA
240519592$24051959$2$F$20240601$20240801$20240704$20240805$PER$$US-AMGEN-USASP2024131489$AMGEN$$82$YR$E$F$Y$$$20240805$$CN$US$US
240519602$24051960$2$F$20240503$20240705$20240704$20240711$EXP$FR-AFSSAPS-RS2024000627$FR-PFIZER INC-202400203985$PFIZER$$70$YR$$F$Y$$$20240711$$MD$FR$FR
240519611$24051961$1$I$$20240627$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407000764$ELI LILLY AND CO$$$$A$M$Y$$$20240704$$CN$US$US
240519621$24051962$1$I$20240627$20240702$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106512$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240704$$HP$US$US
240519631$24051963$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106879$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240704$$HP$US$US
240519641$24051964$1$I$20240108$20240701$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106391$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240704$$CN$US$US
240519651$24051965$1$I$$20240703$20240704$20240704$EXP$$ZA-ABBVIE-5825411$ABBVIE$$$$A$M$Y$$$20240704$$PH$ZA$ZA
240519661$24051966$1$I$20240410$20240605$20240704$20240704$PER$$JP-APELLIS-2024-APL-0000085$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240704$$CN$JP$JP
240519674$24051967$4$F$20240702$20240903$20240704$20240910$PER$$US-JNJFOC-20240705664$JOHNSON AND JOHNSON$$36$YR$A$F$Y$90.8$KG$20240910$$HP$US$US
240519691$24051969$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130184$DAIICHI$$53$YR$$F$Y$58$KG$20240704$$HP$CA$CA
240519701$24051970$1$I$20231022$20240621$20240704$20240704$EXP$FR-AFSSAPS-AN2024000752$FR-TEVA-VS-3213070$TEVA$$19$YR$$M$Y$$$20240704$$PH$FR$FR
240519711$24051971$1$I$20231101$20240625$20240704$20240704$EXP$FR-AFSSAPS-ST2024001081$FR-TEVA-VS-3213951$TEVA$$53$YR$$M$Y$$$20240704$$MD$FR$FR
240519721$24051972$1$I$$20240628$20240704$20240704$EXP$$DE-009507513-2407DEU000719$MERCK$$$$$F$Y$$$20240704$$MD$DE$DE
240519735$24051973$5$F$$20240913$20240704$20240918$30DAY$$US-PFIZER INC-202400202561$PFIZER$$4$YR$$M$Y$$$20240918$$CN$US$US
240519741$24051974$1$I$20240512$20240620$20240704$20240704$EXP$ES-AEMPS-1534464$ES-TEVA-VS-3213069$TEVA$$67$YR$$M$Y$95$KG$20240704$$MD$ES$ES
240519755$24051975$5$F$20240101$20240919$20240704$20240924$30DAY$$US-PFIZER INC-202400203258$PFIZER$$2$YR$$F$Y$10.89$KG$20240924$$MD$US$US
240519763$24051976$3$F$$20240904$20240704$20240909$30DAY$$US-PFIZER INC-202400203614$PFIZER$$2$YR$$F$Y$$$20240909$$CN$US$US
240519773$24051977$3$F$$20240913$20240704$20240924$30DAY$$US-PFIZER INC-202400204477$PFIZER$$5$YR$$M$Y$$$20240924$$CN$US$US
240519793$24051979$3$F$$20240912$20240704$20240917$30DAY$$US-PFIZER INC-202400203533$PFIZER$$2$YR$$F$Y$$$20240917$$CN$US$US
240519804$24051980$4$F$$20240916$20240704$20240919$30DAY$$US-PFIZER INC-202400203958$PFIZER$$5$YR$$F$Y$11.4$KG$20240919$$HP$US$US
240519813$24051981$3$F$$20240916$20240704$20240919$30DAY$$US-PFIZER INC-202400202886$PFIZER$$8$YR$$M$Y$$$20240919$$CN$US$US
240519821$24051982$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130144$DAIICHI$$$$$F$Y$$$20240704$$CN$CA$CA
240519834$24051983$4$F$20240627$20240827$20240704$20240830$30DAY$$US-PFIZER INC-202400203211$PFIZER$$8$YR$$M$Y$26.531$KG$20240830$$MD$US$US
240519841$24051984$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130148$DAIICHI$$$$$F$Y$$$20240704$$HP$CA$CA
240519852$24051985$2$F$$20240702$20240704$20240711$PER$$US-SA-2024SA196477$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240711$$CN$US$US
240519861$24051986$1$I$$20240703$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106522$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240704$$HP$US$US
240519881$24051988$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106839$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240704$$HP$US$US
240519892$24051989$2$F$$20240703$20240704$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107151$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240715$$CN$US$US
240519921$24051992$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130143$DAIICHI$$$$$F$Y$$$20240704$$MD$CA$CA
240519931$24051993$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138449$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240519941$24051994$1$I$20240601$20240628$20240704$20240704$EXP$$FR-ABBVIE-5824978$ABBVIE$$81$YR$$F$Y$$$20240704$$CN$FR$FR
240519971$24051997$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130140$DAIICHI$$$$$F$Y$$$20240704$$HP$CA$CA
240519981$24051998$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130142$DAIICHI$$$$$F$Y$$$20240704$$MD$CA$CA
240519991$24051999$1$I$20240703$20240703$20240704$20240704$PER$$US-AMGEN-USASP2024132369$AMGEN$$84$YR$E$F$Y$$$20240704$$CN$US$US
240520002$24052000$2$F$20240618$20240708$20240704$20240712$EXP$$CA-HLS-202401573$HLS THERAPEUTICS$$24$YR$A$F$Y$$$20240712$$HP$CA$CA
240520011$24052001$1$I$20240520$20240521$20240704$20240704$PER$$DE-APELLIS-2024-APL-0000194$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240704$$PH$DE$DE
240520022$24052002$2$F$20230101$20240705$20240704$20240714$EXP$$RS-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036840$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$$$20240714$$MD$RS$RS
240520031$24052003$1$I$$20240626$20240704$20240704$EXP$$CN-AstraZeneca-2024A148704$ASTRAZENECA$$$$$F$Y$$$20240704$$CN$CN$
240520041$24052004$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130127$DAIICHI$$$$$F$Y$$$20240704$$HP$CA$CA
240520051$24052005$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130139$DAIICHI$$$$$F$Y$$$20240704$$HP$CA$CA
240520061$24052006$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130117$DAIICHI$$48$YR$$F$Y$$$20240704$$CN$CA$CA
240520071$24052007$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130138$DAIICHI$$61$YR$$F$Y$$$20240704$$CN$CA$CA
240520081$24052008$1$I$$20240626$20240704$20240704$EXP$$GB-AstraZeneca-2024A148514$ASTRAZENECA$$$$$$Y$$$20240704$$MD$GB$
240520091$24052009$1$I$$20240701$20240704$20240704$EXP$$CN-AstraZeneca-2024A151953$ASTRAZENECA$$$$$M$Y$$$20240704$$CN$CN$
240520101$24052010$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5826029$ABBVIE$$62$YR$$F$Y$$$20240704$$HP$US$US
240520112$24052011$2$F$20221110$20240702$20240704$20240708$EXP$$CN-TAKEDA-2024TUS065770$TAKEDA$$59$YR$$M$Y$$$20240708$$HP$CN$CN
240520122$24052012$2$F$20220621$20240702$20240704$20240708$EXP$$CN-TAKEDA-2024TUS065761$TAKEDA$$22$YR$$M$Y$$$20240708$$HP$CN$CN
240520131$24052013$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130114$DAIICHI$$$$$F$Y$$$20240704$$HP$CA$CA
240520143$24052014$3$F$20240214$20240920$20240704$20240927$EXP$$CA-GSK-CA2023AMR090222$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$HP$CA$CA
240520151$24052015$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214666$TEVA$$80$YR$$M$Y$89$KG$20240704$$HP$CA$CA
240520161$24052016$1$I$20240101$20240625$20240704$20240704$PER$$US-SA-2024SA191433$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240704$$MD$US$US
240520171$24052017$1$I$$20240621$20240704$20240704$PER$$US-SA-2024SA190741$SANOFI AVENTIS$$$$E$M$Y$83.9$KG$20240704$$MD$US$US
240520181$24052018$1$I$$20240701$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106443$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240704$$CN$US$US
240520191$24052019$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214085$TEVA$$44$YR$$F$Y$$$20240704$$HP$CA$CA
240520201$24052020$1$I$20230619$20240627$20240704$20240704$EXP$$DE-ABBVIE-5383707$ABBVIE$$80$YR$$M$Y$$$20240704$$HP$DE$DE
240520211$24052021$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130076$DAIICHI$$$$$F$Y$$$20240704$$CN$CA$CA
240520221$24052022$1$I$$20240701$20240704$20240704$PER$$US-ABBVIE-5822970$ABBVIE$$$$$F$Y$61$KG$20240704$$CN$US$US
240520231$24052023$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130072$DAIICHI$$$$$F$Y$$$20240704$$MD$CA$CA
240520241$24052024$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130064$DAIICHI$$$$$F$Y$74$KG$20240704$$CN$CA$CA
240520251$24052025$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214382$TEVA$$30$YR$$M$Y$$$20240704$$HP$CA$CA
240520261$24052026$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130069$DAIICHI$$66$YR$$F$Y$82$KG$20240704$$CN$CA$CA
240520271$24052027$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130063$DAIICHI$$43$YR$$F$Y$$$20240704$$HP$CA$CA
240520281$24052028$1$I$$20240624$20240704$20240704$EXP$$CA-ALXN-202406CAN001501CA$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240704$$CN$CA$CA
240520291$24052029$1$I$20160504$20240627$20240704$20240704$PER$$US-BIOGEN-2016BI00238656$BIOGEN$$39$YR$$F$Y$$$20240704$$CN$US$US
240520302$24052030$2$F$20240624$20240702$20240704$20240709$PER$$US-BIOGEN-2024BI01271660$BIOGEN$$47$YR$$F$Y$$$20240709$$CN$US$US
240520321$24052032$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106721$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240704$$HP$US$US
240520331$24052033$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106937$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240704$$CN$US$US
240520341$24052034$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130062$DAIICHI$$$$$F$Y$$$20240704$$CN$CA$CA
240520351$24052035$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130056$DAIICHI$$$$$F$Y$$$20240704$$CN$CA$CA
240520361$24052036$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130060$DAIICHI$$$$$F$Y$47$KG$20240704$$CN$CA$CA
240520372$24052037$2$F$20230101$20240712$20240704$20240722$EXP$$JP-TAKEDA-2024TUS067366$TAKEDA$$17$YR$$F$Y$$$20240722$$MD$JP$JP
240520381$24052038$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825696$ABBVIE$$53$YR$$F$Y$$$20240704$$HP$US$US
240520401$24052040$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130017$DAIICHI$$63$YR$$F$Y$$$20240704$$CN$CA$CA
240520411$24052041$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130051$DAIICHI$$60$YR$$F$Y$$$20240704$$HP$CA$CA
240520421$24052042$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-130029$DAIICHI$$68$YR$$F$Y$$$20240704$$CN$CA$CA
240520432$24052043$2$F$$20240719$20240704$20240722$PER$$NVSC2024US139124$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
240520441$24052044$1$I$$20240702$20240704$20240704$EXP$$CL-SANDOZ INC.-SDZ2024CL062532$SANDOZ$$$$$F$Y$$$20240704$$CN$CL$CL
240520452$24052045$2$F$20240501$20240902$20240704$20240904$EXP$$AR-SANDOZ INC.-SDZ2024AR049764$SANDOZ$$56$YR$$M$Y$$$20240904$$CN$AR$AR
240520461$24052046$1$I$$20240703$20240704$20240704$EXP$$US-SANDOZ INC.-SDZ2024US062502$SANDOZ$Daniel P Weigle. Uncommon and Unfavorable: Heparin-Induced Hyperkalemia. Journal of Cardiothoracic and Vascular Anesthesia$56$YR$$M$Y$$$20240704$$HP$US$US
240520471$24052047$1$I$20240221$20240704$20240704$20240704$EXP$IT-MINISAL02-993018$IT-SANDOZ INC.-SDZ2024IT062727$SANDOZ$$71$YR$$F$Y$$$20240704$$MD$IT$IT
240520481$24052048$1$I$$20240703$20240704$20240704$EXP$$CA-SANDOZ INC.-SDZ2024CA062723$SANDOZ$$$$$F$Y$$$20240704$$MD$CA$CA
240520491$24052049$1$I$$20240624$20240704$20240704$EXP$$CA-DSJP-DSJ-2024-129967$DAIICHI$$$$$F$Y$81$KG$20240704$$HP$CA$CA
240520501$24052050$1$I$$20240626$20240704$20240704$EXP$$US-AstraZeneca-2024A148349$ASTRAZENECA$$87$YR$$M$Y$$$20240704$$MD$US$
240520521$24052052$1$I$$20240703$20240704$20240704$PER$$US-PFIZER INC-202400206130$PFIZER$$78$YR$$F$Y$58.97$KG$20240704$$CN$US$US
240520532$24052053$2$F$20240629$20240805$20240704$20240806$PER$$US-PFIZER INC-202400206415$PFIZER$$59$YR$$F$Y$73.94$KG$20240806$$CN$US$US
240520541$24052054$1$I$$20240628$20240704$20240704$PER$$US-BIOGEN-2024BI01271825$BIOGEN$$$$$$Y$$$20240704$$CN$US$US
240520551$24052055$1$I$20240101$20240627$20240704$20240704$PER$$US-009507513-2406USA010118$MERCK$$$$$F$Y$$$20240704$$CN$US$US
240520561$24052056$1$I$20240625$20240627$20240704$20240704$PER$$US-BAUSCH-BL-2024-010023$BAUSCH AND LOMB$$$$$F$Y$$$20240704$$CN$US$US
240520581$24052058$1$I$$20240703$20240704$20240704$EXP$$CA-BAUSCH-BL-2024-010238$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240704$$MD$CA$CA
240520591$24052059$1$I$$20240701$20240704$20240704$EXP$$EC-ORGANON-O2407ECU000446$ORGANON$$26$YR$$F$Y$$$20240704$$MD$EC$EC
240520601$24052060$1$I$20240529$20240625$20240704$20240704$EXP$FR-AFSSAPS-PB2024000647$FR-TEVA-VS-3214551$TEVA$$68$YR$$F$Y$46.3$KG$20240704$$PH$FR$FR
240520611$24052061$1$I$20240522$20240624$20240704$20240704$EXP$FR-AFSSAPS-GR2024000730$FR-TEVA-VS-3214440$TEVA$$50$YR$$F$Y$49.5$KG$20240704$$PH$FR$FR
240520621$24052062$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3212949$TEVA$$43$YR$$F$Y$96$KG$20240704$$HP$CA$CA
240520631$24052063$1$I$$20240624$20240704$20240704$EXP$$CA-TEVA-VS-3214639$TEVA$$$$$F$Y$97$KG$20240704$$MD$CA$CA
240520643$24052064$3$F$20240501$20240906$20240704$20240917$EXP$$JP-BAUSCH-BL-2024-009681$BAUSCH AND LOMB$$72$YR$$F$Y$55.3$KG$20240917$$PH$JP$JP
240520651$24052065$1$I$20240402$20240701$20240704$20240704$EXP$MT-ADM-03062024$MT-PFIZER INC-202400203957$PFIZER$$26$YR$$M$Y$90$KG$20240704$$CN$MT$MT
240520661$24052066$1$I$$20240620$20240704$20240704$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-05894$HIKMA$Ghose M, Anwar M, Rajamohan A, Vangala A, Roy P, Weiner SM.. Ghose M, Anwar M, Rajamohan A, Vangala A, Roy P, Weiner SM. Vancomycin Induced Anaphylaxis Presenting With Cardiac Arrest: Judicious Use of Antibiotic in Low Risk Procedures. American Journal of Respiratory and Critical Care Medicine.. 2024;A5700:209$$$$$Y$$$20240704$$MD$US$US
240520671$24052067$1$I$$20240630$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001565$ELI LILLY AND CO$$$$$F$Y$$$20240704$$CN$US$US
240520681$24052068$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002736$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240704$$CN$US$US
240520691$24052069$1$I$$20240630$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001567$ELI LILLY AND CO$$$$$F$Y$$$20240704$$HP$US$US
240520702$24052070$2$F$20200101$20240701$20240704$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407001719$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240708$$CN$US$US
240520722$24052072$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214598$TEVA$Brown ID, Pariser RJ. Generalized Hailey-Hailey disease associated with c.2395C}T mutation in the ATP2C1 gene, and fatal outcome. Dermatol-Online-J 2024; 30 (2):.; Brown ID, Pariser RJ. Generalized Hailey-Hailey disease associated with c.2395C}T mutation in the ATP2C1 gene, and fatal outcome. Dermatol-Online-J 2024; 30 (2):.; Brown ID, Pariser RJ. Generalized Hailey-Hailey disease associated with c.2395C}T mutation in the ATP2C1 gene, and fatal outcome. Dermatol-Online-J 2024; 30 (2):.$55$YR$$F$Y$$$20240720$$HP$US$US
240520731$24052073$1$I$20240601$20240628$20240704$20240704$PER$$US-BAUSCH-BL-2024-010052$BAUSCH AND LOMB$$54$YR$$F$Y$$$20240704$$CN$US$US
240520741$24052074$1$I$20240209$20240626$20240704$20240704$EXP$FR-AFSSAPS-AM2024000511$FR-TEVA-VS-3215227$TEVA$$28$YR$$F$Y$54.9$KG$20240704$$MD$FR$FR
240520751$24052075$1$I$19810101$20240626$20240704$20240704$EXP$FR-AFSSAPS-ST2024001074$FR-TEVA-VS-3215220$TEVA$$20$YR$$F$Y$$$20240704$$MD$FR$FR
240520762$24052076$2$F$$20240816$20240704$20240816$PER$$NVSC2024US139104$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
240520771$24052077$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024132518$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240520781$24052078$1$I$20240501$20240628$20240704$20240704$EXP$$JP-BAUSCH-BL-2024-009555$BAUSCH AND LOMB$$$$E$$Y$$$20240704$$MD$JP$JP
240520791$24052079$1$I$20230929$20240627$20240704$20240704$EXP$$IT-BAUSCH-BL-2023-017881$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240704$$CN$IT$IT
240520801$24052080$1$I$$20240627$20240704$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106933$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240704$$MD$JP$JP
240520811$24052081$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106603$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$64.86$KG$20240704$$HP$US$US
240520821$24052082$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106795$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$68.95$KG$20240704$$CN$US$US
240520833$24052083$3$F$$20240729$20240704$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106747$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$69.85$KG$20240730$$HP$US$US
240520841$24052084$1$I$20240608$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106694$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240704$$HP$US$US
240520861$24052086$1$I$$20240703$20240704$20240704$EXP$$CA-BAUSCH-BL-2024-010236$BAUSCH AND LOMB$$86$YR$$F$Y$$$20240704$$MD$CA$CA
240520873$24052087$3$F$20240506$20240830$20240704$20240903$EXP$$ES-BAUSCH-BL-2024-010056$BAUSCH AND LOMB$$67$YR$$F$Y$69.1$KG$20240903$$MD$ES$ES
240520881$24052088$1$I$$20240619$20240704$20240704$PER$$US-BAUSCH-BL-2024-010291$BAUSCH AND LOMB$Fram F, Abu S, Cherabuddi M, Aljbour A. Brivaracetam-Related Neurological Decline in a Patient With Complex Medical History. Am J Respir Crit Care Med. 2024;209:A5642.$68$YR$$F$Y$$$20240704$$MD$US$US
240520891$24052089$1$I$20240602$20240701$20240704$20240704$EXP$$US-BAUSCH-BL-2024-002222$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240704$$CN$US$US
240520901$24052090$1$I$$20240626$20240704$20240704$PER$$US-ALXN-202406USA001743US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
240520911$24052091$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5826206$ABBVIE$$66$YR$$F$Y$$$20240704$$HP$US$US
240520921$24052092$1$I$$20240620$20240704$20240704$EXP$$JP-SA-2024SA191681$SANOFI AVENTIS$$72$YR$E$M$Y$72$KG$20240704$$MD$JP$JP
240520932$24052093$2$F$$20240701$20240704$20240712$PER$$US-APELLIS-2024-APL-0000325$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240712$$CN$US$US
240520941$24052094$1$I$$20240621$20240704$20240704$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015610$ELI LILLY AND CO$$66$YR$E$$Y$$$20240704$$CN$US$US
240520951$24052095$1$I$$20240701$20240704$20240704$EXP$$NVSC2024US137520$NOVARTIS$$$$$M$Y$$$20240704$$HP$US$US
240520961$24052096$1$I$$20240701$20240704$20240704$PER$$US-ABBVIE-5824974$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240520972$24052097$2$F$20240601$20240703$20240704$20240710$PER$$US-PURDUE PHARMA-USA-2024-0310575$PURDUE$$59$YR$$M$Y$72.57$KG$20240708$$CN$US$US
240520982$24052098$2$F$$20240705$20240704$20240715$PER$$US-PURDUE PHARMA-USA-2024-0310576$PURDUE$$$$$F$Y$120.2$KG$20240715$$CN$US$US
240520992$24052099$2$F$$20240823$20240704$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-024178$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240826$$CN$US$US
240521001$24052100$1$I$$20240627$20240704$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106967$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240704$$MD$JP$JP
240521011$24052101$1$I$20240325$20240704$20240704$20240704$EXP$SI-JAZMP-NCPHV-2024SI0637_0637$SI-BRISTOL-MYERS SQUIBB COMPANY-2024-107045$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240704$$PH$SI$SI
240521022$24052102$2$F$$20240730$20240704$20240805$PER$$US-AMGEN-USASP2024129086$AMGEN$$$$$F$Y$$$20240804$$CN$US$US
240521034$24052103$4$F$20240626$20240909$20240704$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107056$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$92.08$KG$20240911$$CN$US$US
240521041$24052104$1$I$20221223$20240701$20240704$20240704$EXP$$IN-SANDOZ INC.-NVSC2023IN010538$SANDOZ$$49$YR$$M$Y$$$20240704$$CN$IN$IN
240521051$24052105$1$I$$20240627$20240704$20240704$PER$$US-ALXN-202406USA001856US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
240521062$24052106$2$F$$20240718$20240704$20240812$EXP$$GB-JNJFOC-20240634047$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$CN$GB$GB
240521071$24052107$1$I$20240613$20240628$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106901$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240704$$CN$US$US
240521081$24052108$1$I$$20240702$20240704$20240704$EXP$$US-SANDOZ INC.-SDZ2024US062782$SANDOZ$$$$$F$Y$$$20240704$$CN$US$US
240521092$24052109$2$F$$20240814$20240704$20240822$PER$$US-APELLIS-2024-APL-0000335$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240822$$CN$US$US
240521101$24052110$1$I$$20231013$20240704$20240704$PER$$US-AMGEN-USASP2023235223$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240521111$24052111$1$I$20240702$20240702$20240704$20240704$EXP$$US-ABBVIE-5825844$ABBVIE$$81$YR$$M$Y$$$20240704$$CN$US$US
240521122$24052112$2$F$$20240626$20240704$20240730$EXP$$US-AstraZeneca-2024A151915$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
240521131$24052113$1$I$$20240627$20240704$20240704$PER$$US-SA-2024SA163502$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240704$$MD$US$US
240521141$24052114$1$I$20240101$20240626$20240704$20240704$PER$$US-SA-2024SA194262$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240704$$MD$US$US
240521152$24052115$2$F$20240601$20240815$20240704$20240828$PER$$US-SA-2024SA193509$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240828$$HP$US$US
240521161$24052116$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106932$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240704$$HP$US$US
240521171$24052117$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106758$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240704$$HP$US$US
240521192$24052119$2$F$$20240903$20240704$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106645$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240905$$CN$US$US
240521201$24052120$1$I$$20240702$20240704$20240704$EXP$$GB-SANDOZ INC.-SDZ2024GB062369$SANDOZ$$$$N$$Y$1$KG$20240704$$MD$GB$GB
240521211$24052121$1$I$20240701$20240703$20240704$20240704$PER$$NVSC2024US138945$NOVARTIS$$77$YR$$$Y$$$20240704$$MD$US$US
240521221$24052122$1$I$20240625$20240702$20240704$20240704$EXP$$CN-PFIZER INC-PV202400086927$PFIZER$$68$YR$$F$Y$52$KG$20240704$$HP$CN$CN
240521231$24052123$1$I$20240611$20240702$20240704$20240704$EXP$$CN-PFIZER INC-PV202400086957$PFIZER$$45$YR$$F$Y$60$KG$20240704$$HP$CN$CN
240521251$24052125$1$I$20240527$20240702$20240704$20240704$EXP$$EG-PFIZER INC-PV202400086608$PFIZER$$35$YR$$F$Y$63$KG$20240704$$PH$EG$EG
240521263$24052126$3$F$20240626$20240628$20240704$20240722$PER$$US-APELLIS-2024-APL-0000388$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240722$$HP$US$US
240521271$24052127$1$I$$20240701$20240704$20240704$EXP$$IT-PFIZER INC-202400203839$PFIZER$$41$YR$$M$Y$80$KG$20240704$$MD$IT$IT
240521281$24052128$1$I$20220121$20240702$20240704$20240704$EXP$$AT-PFIZER INC-202400204828$PFIZER$$84$YR$$M$Y$$$20240704$$MD$AT$AT
240521293$24052129$3$F$20231116$20240702$20240704$20240716$EXP$$CA-BEH-2023165751$CSL BEHRING$$79$YR$E$F$Y$68$KG$20240716$$CN$CA$CA
240521302$24052130$2$F$$20240710$20240704$20240720$EXP$$US-TEVA-VS-3214738$TEVA$Tan E, Pokhriyal SC, Khan A, Pasha M, Idris H. Assay Interference Causing Persistently Elevated Vancomycin Levels Ultimately Leading to Treatment Failure and Fatal Outcome. Am-J-Respir-Crit-Care-Med 2024; 209.; Tan E, Pokhriyal SC, Khan A, Pasha M, Idris H. Assay Interference Causing Persistently Elevated Vancomycin Levels Ultimately Leading to Treatment Failure and Fatal Outcome. Am-J-Respir-Crit-Care-Med 2024; 209.$69$YR$$F$Y$$$20240720$$HP$US$US
240521311$24052131$1$I$20230101$20240701$20240704$20240704$PER$$US-ABBVIE-5825525$ABBVIE$$$$$$Y$$$20240704$$CN$US$US
240521321$24052132$1$I$$20240628$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407000696$ELI LILLY AND CO$$$$$$Y$$$20240704$$CN$US$US
240521331$24052133$1$I$20240407$20240626$20240704$20240704$EXP$$CN-AstraZeneca-2024A149996$ASTRAZENECA$$31605$DY$$F$Y$52$KG$20240704$$MD$CN$
240521341$24052134$1$I$$20240624$20240704$20240704$EXP$$CH-TEVA-VS-3215363$TEVA$Kolev M, Sarbu A-C, Moller B, Maurer B, Kollert F, Semmo N. Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis - a case series. J-Transl-Autoimmun 2023; 6.; Kolev M, Sarbu A-C, Moller B, Maurer B, Kollert F, Semmo N. Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis - a case series. J-Transl-Autoimmun 2023; 6.$$$A$M$Y$$$20240704$$HP$CH$CH
240521351$24052135$1$I$$20240704$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107077$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240704$$CN$US$US
240521361$24052136$1$I$$20240629$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106016$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$96.62$KG$20240704$$CN$US$US
240521371$24052137$1$I$20240601$20240627$20240704$20240704$PER$$US-AMGEN-USASP2024132426$AMGEN$$53$YR$A$F$Y$$$20240704$$CN$US$US
240521381$24052138$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825769$ABBVIE$$$$A$F$Y$$$20240704$$HP$US$US
240521391$24052139$1$I$20240602$20240703$20240704$20240704$EXP$GB-MHRA-MED-202407031549500560-PVHNW$GB-PFIZER INC-202400206016$PFIZER$$77$YR$$M$Y$61$KG$20240704$$PH$GB$GB
240521401$24052140$1$I$20231216$20240703$20240704$20240704$EXP$$IN-PFIZER INC-PV202400087882$PFIZER$$40$YR$$M$Y$$$20240704$$CN$IN$IN
240521421$24052142$1$I$$20240703$20240704$20240704$EXP$$US-PFIZER INC-PV202400087724$PFIZER$$81$YR$$M$Y$$$20240704$$CN$US$US
240521432$24052143$2$F$20230809$20240826$20240704$20240904$EXP$$MY-PFIZER INC-2024SGN01555$PFIZER$$24$YR$$M$Y$$$20240904$$MD$MY$MY
2405214414$24052144$14$F$20240101$20240909$20240704$20240912$EXP$$IN-PFIZER INC-PV202400086490$PFIZER$$49$YR$$F$Y$68.4$KG$20240912$$CN$IN$IN
240521461$24052146$1$I$20240601$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106912$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240704$$HP$US$US
240521471$24052147$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106631$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$77.11$KG$20240704$$HP$US$US
240521481$24052148$1$I$20240701$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001570$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240704$$CN$US$US
240521491$24052149$1$I$$20240629$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001666$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240704$$MD$US$US
240521501$24052150$1$I$20231201$20240701$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001636$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240704$$CN$US$US
240521512$24052151$2$F$$20240715$20240704$20240724$EXP$$IT-TEVA-VS-3215304$TEVA$Tammaro A, Adebanjo GAR, Chello C, Capalbo A, Alexander S, Trischitta G, et al. Bullous pemphigoid associated with pleural mesothelioma: a controversial etiology. Were the bullous lesions induced by pembrolizumab or related to malignancy?. J-Appl-Cosmetol 2022; 40 (2): 176-179.; Tammaro A, Adebanjo GAR, Chello C, Capalbo A, Alexander S, Trischitta G, et al. Bullous pemphigoid associated with pleural mesothelioma: a controversial etiology. Were the bullous lesions induced by pembrolizumab or r...$72$YR$$M$Y$$$20240724$$HP$IT$IT
240521521$24052152$1$I$20240101$20240701$20240704$20240704$EXP$$CA-ABBVIE-5824903$ABBVIE$$83$YR$$M$Y$$$20240704$$CN$CA$CA
240521531$24052153$1$I$20240101$20240701$20240704$20240704$EXP$$US-PFIZER INC-202400080089$PFIZER$$77$YR$$F$Y$$$20240704$$HP$US$US
240521551$24052155$1$I$20240627$20240627$20240704$20240704$PER$$US-ALXN-202406USA001810US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240704$$CN$US$US
240521561$24052156$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106812$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240704$$HP$US$US
240521582$24052158$2$F$20230313$20240729$20240704$20240802$EXP$$ES-PFIZER INC-202400203931$PFIZER$$62$YR$$M$Y$68.5$KG$20240802$$MD$ES$ES
240521591$24052159$1$I$20230225$20240701$20240704$20240704$EXP$IT-MINISAL02-914667$IT-PFIZER INC-202400203892$PFIZER$$15$YR$$F$Y$59$KG$20240704$$PH$IT$IT
240521601$24052160$1$I$20230413$20240701$20240704$20240704$EXP$IT-MINISAL02-929077$IT-PFIZER INC-202400203940$PFIZER$$7$YR$$F$Y$25$KG$20240704$$PH$IT$IT
240521611$24052161$1$I$$20240702$20240704$20240704$PER$$NVSC2024US137993$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240521621$24052162$1$I$$20240626$20240704$20240704$EXP$$US-BEH-2024174917$CSL BEHRING$$59$YR$A$F$Y$$$20240704$$CN$US$US
240521631$24052163$1$I$$20240702$20240704$20240704$PER$$US-009507513-2407USA001533$MERCK$Duran M, Shieh D, Choi P, He YG, Ufret RL. Atypical Central Serous Chorioretinopathy Masquerading as Vogt-Koyanagi-Harada Disease: A Case Report. Case Report Ophthalmol. 2024;15(1):441-450$30$YR$$M$Y$$$20240704$$HP$US$US
240521642$24052164$2$F$$20240702$20240704$20240709$EXP$$US-MYLANLABS-2023M1137155$MYLAN$$$$$F$Y$91.63$KG$20240709$$CN$US$US
240521652$24052165$2$F$$20240711$20240704$20240718$EXP$$JP-009507513-2406JPN004159J$MERCK$$$$$F$Y$$$20240718$$MD$JP$JP
240521661$24052166$1$I$$20240702$20240704$20240704$EXP$$NVSC2024US138330$NOVARTIS$$$$$F$Y$$$20240704$$CN$US$US
240521681$24052168$1$I$20240401$20240703$20240704$20240704$EXP$$NVSC2024BG138972$NOVARTIS$$64$YR$$F$Y$$$20240704$$MD$BG$BG
240521701$24052170$1$I$$20240619$20240704$20240704$EXP$$US-Fagron Sterile Services-2158821$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$$$$$Y$$$20240704$$PH$US$US
240521711$24052171$1$I$$20240620$20240704$20240704$EXP$$US-Fagron Sterile Services-2158829$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$$$$$Y$$$20240704$$$US$US
240521721$24052172$1$I$$20240619$20240704$20240704$EXP$$US-Fagron Sterile Services-2158826$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$26$YR$$F$Y$95.455$KG$20240704$$PH$US$US
240521731$24052173$1$I$$20240619$20240704$20240704$EXP$$US-Fagron Sterile Services-2158825$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$25$YR$$F$Y$71.364$KG$20240704$$PH$US$US
240521741$24052174$1$I$$20240619$20240704$20240704$EXP$$US-Fagron Sterile Services-2158822$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$$$$$Y$$$20240704$$PH$US$US
240521751$24052175$1$I$$20240619$20240704$20240704$EXP$$US-Fagron Sterile Services-2158823$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$18$YR$$F$Y$67.273$KG$20240704$$PH$US$US
240521761$24052176$1$I$$20240619$20240704$20240704$EXP$$US-Fagron Sterile Services-2158824$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$34$YR$$F$Y$62.727$KG$20240704$$PH$US$US
240521771$24052177$1$I$$20240619$20240704$20240704$EXP$$US-Fagron Sterile Services-2158827$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$31$YR$$F$Y$76.364$KG$20240704$$PH$US$US
240521781$24052178$1$I$$20240610$20240704$20240704$PER$$US-B.Braun Medical Inc.-2158831$B BRAUN$$65$YR$$M$Y$$$20240704$$$US$US
240521792$24052179$2$F$20240113$20240729$20240704$20240822$PER$$CA-GREER Laboratories, Inc.-2158830$GREER$$11$YR$$M$Y$37$KG$20240822$$MD$CA$CA
240521801$24052180$1$I$20240620$20240625$20240704$20240704$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158844$JIANGSU HENGRUI MEDICINE$$69$YR$$M$Y$$$20240704$$MD$CN$CN
240521811$24052181$1$I$20240605$20240625$20240704$20240704$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2158842$JIANGSU HANSOH PHARMACEUTICAL$$75$YR$$M$Y$56.7$KG$20240704$$MD$CN$CN
240521821$24052182$1$I$20240614$20240621$20240704$20240704$EXP$$US-Compliance Insight, Inc.-2158835$Compliance Insight$$63$YR$$M$Y$$$20240704$$$US$US
240521831$24052183$1$I$$20240624$20240704$20240704$EXP$$CN-B.Braun Medical Inc.-2158854$B BRAUN$$68$YR$$M$Y$70$KG$20240704$$$CN$CN
240521851$24052185$1$I$20240416$20240617$20240704$20240704$EXP$$PT-Jiangsu Hansoh Pharmaceutical Co., Ltd-2158850$JIANGSU HANSOH PHARMACEUTICAL$$47$YR$$$Y$85$KG$20240704$$MD$PT$PT
240521861$24052186$1$I$$20240627$20240704$20240704$PER$$US-ALXN-202406USA001813US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240704$$CN$US$US
240521871$24052187$1$I$20240102$20240628$20240704$20240704$EXP$FR-AFSSAPS-GR2024000755$FR-009507513-2406FRA010340$MERCK$$69$YR$$F$Y$78$KG$20240704$$PH$FR$FR
240521881$24052188$1$I$20240514$20240619$20240704$20240704$EXP$$CN-Hisun Pharmaceuticals-2158847$HISUN PHARMACEUTICALS$$56$YR$$M$Y$78$KG$20240704$$$CN$CN
240521891$24052189$1$I$$20240620$20240704$20240704$EXP$$US-Nuvo Pharmaceuticals Inc-2158855$NUVO PHARMACEUTICALS$Source document (Full text)$29$YR$$M$Y$$$20240704$$$US$US
240521901$24052190$1$I$20240618$20240624$20240704$20240704$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158846$JIANGSU HENGRUI MEDICINE$$37$YR$$F$Y$60$KG$20240704$$MD$CN$CN
240521911$24052191$1$I$20240604$20240626$20240704$20240704$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2158849$JIANGSU HANSOH PHARMACEUTICAL$$42$YR$$F$Y$55$KG$20240704$$MD$CN$CN
240521921$24052192$1$I$$20240621$20240704$20240704$EXP$$GB-B.Braun Medical Inc.-2158853$B BRAUN$$57$YR$$F$Y$58$KG$20240704$$$GB$GB
240521932$24052193$2$F$20240620$20240708$20240704$20240711$EXP$$UA-Integrated Therapeutic Solutions Inc.-2158857$Integrated Therapeutic Solutions$$62$YR$$F$Y$$$20240711$$$DE$DE
240521941$24052194$1$I$20240601$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107156$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$111.13$KG$20240704$$PH$US$US
240521951$24052195$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106674$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240704$$CN$US$US
240521971$24052197$1$I$$20240624$20240704$20240704$EXP$$US-RDY-LIT/USA/24/0009459$DR REDDYS$Chowdhury T, Mainali A, Uprety N, Bisural R, Adhikari S, Gousy N, et al. The Deadly Duel: Legionnaires Disease and Multiple Myeloma: A Case of Fatal Pulmonary Renal Syndrome. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: A3608. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A3608.$57$YR$A$M$Y$$$20240704$$HP$US$US
240521981$24052198$1$I$$20240703$20240704$20240704$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037728$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240704$$CN$US$US
240521992$24052199$2$F$$20240809$20240704$20240816$EXP$$US-ALXN-202406USA001815US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
240522001$24052200$1$I$$20240703$20240704$20240704$PER$$NVSC2024US139148$NOVARTIS$$$$$$Y$$$20240704$$CN$US$US
240522012$24052201$2$F$$20240723$20240704$20240727$PER$$US-AstraZeneca-2024A136319$ASTRAZENECA$$70$YR$$F$Y$$$20240727$$HP$US$
240522022$24052202$2$F$20240617$20240724$20240704$20240805$PER$$US-MYLANLABS-2024M1057882$MYLAN$$15$YR$$F$Y$49.89$KG$20240805$$CN$US$US
240522031$24052203$1$I$20230101$20240703$20240704$20240704$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037803$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240704$$HP$US$US
240522043$24052204$3$F$$20240816$20240704$20240822$PER$$US-ALXN-202406USA001820US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$HP$US$US
240522051$24052205$1$I$$20240627$20240704$20240704$PER$$US-ALXN-202406USA001816US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240704$$CN$US$US
240522061$24052206$1$I$$20240627$20240704$20240704$PER$$US-ALXN-202406USA001858US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
240522073$24052207$3$F$20240623$20240816$20240704$20240822$PER$$US-ALXN-202406USA001821US$ALEXION PHARMACEUTICALS$$64$YR$$M$Y$$$20240822$$CN$US$US
240522082$24052208$2$F$20240613$20240705$20240704$20240705$PER$$US-009507513-2406USA010064$MERCK$$76$YR$$F$Y$$$20240705$$HP$US$US
240522091$24052209$1$I$20240613$20240626$20240704$20240704$EXP$$CN-AstraZeneca-2024A150585$ASTRAZENECA$$70$YR$$M$Y$80$KG$20240704$$MD$CN$
240522111$24052211$1$I$$20240627$20240704$20240704$PER$$US-ALXN-202406USA001872US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240704$$HP$US$US
240522122$24052212$2$F$20230324$20240702$20240704$20240708$EXP$$CN-TAKEDA-2024TUS064939$TAKEDA$$72$YR$$M$Y$$$20240708$$HP$CN$CN
240522132$24052213$2$F$$20240802$20240704$20240806$PER$$US-ALXN-202406USA001824US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240522143$24052214$3$F$$20240724$20240704$20240801$EXP$$CA-AstraZeneca-2024A149372$ASTRAZENECA$$$$$F$Y$$$20240801$$MD$CA$
240522151$24052215$1$I$20201001$20240624$20240704$20240704$EXP$IT-MINISAL02-979917$IT-SAMSUNG BIOEPIS-SB-2024-19652$SAMSUNG BIOEPIS$$49$YR$A$F$Y$70$KG$20240704$$MD$IT$IT
240522163$24052216$3$F$20240622$20240827$20240704$20240907$PER$$US-JNJFOC-20240711303$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240907$$MD$US$US
240522182$24052218$2$F$$20240708$20240704$20240718$PER$$US-JNJFOC-20240712574$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$MD$US$US
240522192$24052219$2$F$$20240704$20240704$20240709$PER$$US-JNJFOC-20240712610$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240709$$CN$US$US
240522201$24052220$1$I$$20240629$20240704$20240704$PER$$PR-JNJFOC-20240712611$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240704$$MD$PR$US
240522211$24052221$1$I$$20240627$20240704$20240704$PER$$US-JNJFOC-20240712612$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240704$$CN$US$US
240522221$24052222$1$I$$20240627$20240704$20240704$PER$$US-ALXN-202406USA001861US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
240522231$24052223$1$I$20240125$20240620$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202406017108$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240704$$MD$US$US
240522241$24052224$1$I$20230101$20240627$20240704$20240704$PER$$US-ALXN-202406USA001876US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240704$$CN$US$US
240522251$24052225$1$I$$20240627$20240704$20240704$PER$$US-JNJFOC-20240712627$JOHNSON AND JOHNSON$$$$$$Y$$$20240704$$MD$US$US
240522261$24052226$1$I$20240301$20240624$20240704$20240704$PER$$US-JNJFOC-20240712860$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240704$$HP$US$US
240522271$24052227$1$I$$20240703$20240704$20240704$PER$$NVSC2024US139101$NOVARTIS$$$$$M$Y$$$20240705$$MD$US$US
240522281$24052228$1$I$$20240626$20240704$20240704$EXP$$NZ-AstraZeneca-2024A150176$ASTRAZENECA$$$$$F$Y$$$20240704$$MD$NZ$
240522292$24052229$2$F$$20240802$20240704$20240806$PER$$US-ALXN-202406USA001890US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240522301$24052230$1$I$20240702$20240702$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106877$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$$$20240704$$HP$US$US
240522311$24052231$1$I$20240101$20240628$20240704$20240704$PER$$US-ALXN-202406USA001911US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
240522322$24052232$2$F$$20240802$20240704$20240806$PER$$US-ALXN-202406USA001863US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240522331$24052233$1$I$$20240628$20240704$20240704$PER$$US-ALXN-202406USA001927US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240704$$CN$US$US
240522342$24052234$2$F$20240523$20240806$20240704$20240809$EXP$$CO-ABBVIE-5779519$ABBVIE$$25$YR$$M$Y$73$KG$20240809$$CN$CO$CO
240522351$24052235$1$I$$20240624$20240704$20240704$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-19251$SAMSUNG BIOEPIS$$33$YR$A$F$Y$$$20240704$$CN$GB$GB
240522361$24052236$1$I$20240201$20240624$20240704$20240704$EXP$IT-MINISAL02-980259$IT-SAMSUNG BIOEPIS-SB-2024-19608$SAMSUNG BIOEPIS$$56$YR$A$F$Y$$$20240704$$MD$IT$IT
240522372$24052237$2$F$20240624$20240809$20240704$20240815$EXP$$NVSC2024GB103418$NOVARTIS$$82$YR$$F$Y$$$20240815$$CN$GB$GB
240522381$24052238$1$I$$20240626$20240704$20240704$EXP$$US-TAKEDA-2024TUS065263$TAKEDA$$$$$F$Y$$$20240704$$CN$US$US
240522391$24052239$1$I$20210101$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131333$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240522401$24052240$1$I$$20240626$20240704$20240704$EXP$$CN-AstraZeneca-2024A131345$ASTRAZENECA$$55$YR$$M$Y$$$20240704$$CN$CN$
240522411$24052241$1$I$$20240628$20240704$20240704$PER$$US-ALXN-202406USA001922US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240704$$CN$US$US
240522423$24052242$3$F$$20240816$20240704$20240816$PER$$NVSC2024US139073$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
240522431$24052243$1$I$$20240625$20240704$20240704$PER$$US-JNJFOC-20240711035$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240704$$CN$US$US
240522441$24052244$1$I$$20240628$20240704$20240704$PER$$US-APELLIS-2024-APL-0000389$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240704$$CN$US$US
240522451$24052245$1$I$20240619$20240626$20240704$20240704$EXP$$CN-AstraZeneca-2024A149982$ASTRAZENECA$$29336$DY$$F$Y$45$KG$20240704$$MD$CN$
240522461$24052246$1$I$$20240628$20240704$20240704$PER$$US-ALXN-202406USA001919US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240704$$CN$US$US
240522471$24052247$1$I$$20240702$20240704$20240704$PER$$US-TAKEDA-2024TUS067403$TAKEDA$$$$$F$Y$$$20240704$$CN$US$US
240522481$24052248$1$I$$20240612$20240704$20240704$PER$$US-BEH-2024172424$CSL BEHRING$$11$YR$C$M$Y$$$20240704$$MD$US$US
240522491$24052249$1$I$$20240615$20240704$20240704$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06087$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240704$$MD$US$US
240522502$24052250$2$F$20231117$20240716$20240704$20240725$PER$$US-BEH-2024173965$CSL BEHRING$$69$YR$E$M$Y$$$20240725$$HP$US$US
240522513$24052251$3$F$20240529$20240904$20240704$20240924$PER$$US-BEH-2024174010$CSL BEHRING$$21$YR$A$F$Y$$$20240924$$MD$US$US
240522522$24052252$2$F$20240501$20240806$20240704$20240807$EXP$$CH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037020$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$57$KG$20240807$$MD$CH$CH
240522531$24052253$1$I$$20240628$20240704$20240704$EXP$$HU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036975$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240704$$CN$HU$HU
240522543$24052254$3$F$20240504$20240917$20240704$20240923$EXP$$US-BEH-2024173964$CSL BEHRING$$85$YR$E$F$Y$$$20240923$$HP$US$US
240522552$24052255$2$F$20240530$20240716$20240704$20240725$EXP$$US-BEH-2024173962$CSL BEHRING$$80$YR$E$F$Y$$$20240725$$HP$US$US
240522561$24052256$1$I$$20240616$20240704$20240704$PER$$US-009507513-2406USA005952$MERCK$$$$$M$Y$$$20240704$$CN$US$US
240522571$24052257$1$I$20240516$20240624$20240704$20240704$EXP$$CN-009507513-2406CHN009723$MERCK$$51$YR$$M$Y$$$20240704$$HP$CN$CN
240522581$24052258$1$I$$20240702$20240704$20240704$PER$$NVSC2024US138661$NOVARTIS$$$$$$Y$$$20240705$$CN$US$US
240522591$24052259$1$I$$20240702$20240704$20240704$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037460$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240704$$CN$US$US
240522601$24052260$1$I$$20240621$20240704$20240704$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-19930$SAMSUNG BIOEPIS$$$$$M$Y$$$20240704$$HP$CA$CA
240522611$24052261$1$I$$20240620$20240704$20240704$PER$$US-APELLIS-2024-APL-0000337$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240704$$CN$US$US
240522622$24052262$2$F$20200101$20240705$20240704$20240710$EXP$$FI-JNJFOC-20240712199$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240710$$CN$FI$FI
240522632$24052263$2$F$20240501$20240906$20240704$20240909$EXP$$NVSC2024US136841$NOVARTIS$$42$YR$$F$Y$$$20240909$$CN$US$US
240522641$24052264$1$I$$20240627$20240704$20240704$EXP$$NVSC2024BR136254$NOVARTIS$$$$$F$Y$$$20240705$$CN$BR$BR
240522652$24052265$2$F$20240521$20240719$20240704$20240801$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-15039$SAMSUNG BIOEPIS$$35$YR$A$F$Y$$$20240801$$CN$CA$CA
240522661$24052266$1$I$20240225$20240621$20240704$20240704$EXP$FR-AFSSAPS-LY2024000503$FR-SAMSUNG BIOEPIS-SB-2024-19494$SAMSUNG BIOEPIS$$76$YR$E$F$Y$49$KG$20240705$$PH$FR$FR
240522671$24052267$1$I$20231121$20240621$20240704$20240704$EXP$IT-MINISAL02-978130$IT-SAMSUNG BIOEPIS-SB-2024-19488$SAMSUNG BIOEPIS$$47$YR$A$F$Y$$$20240705$$MD$IT$IT
240522681$24052268$1$I$20230101$20240621$20240704$20240704$EXP$CZ-EMA-DD-20240402-7482705-151641$CZ-SAMSUNG BIOEPIS-SB-2024-19448$SAMSUNG BIOEPIS$Skalova A. The benefit of tucatinib in the treatment of HER2+ metastatic breast cancer. PROFI Medicina. 2023;8(11):33-37$35$YR$A$F$Y$$$20240705$$MD$CZ$CZ
240522692$24052269$2$F$20240601$20240704$20240704$20240706$PER$$US-AMGEN-USASP2024132294$AMGEN$$$$$$Y$$$20240706$$MD$US$US
240522702$24052270$2$F$20240625$20240801$20240704$20240806$EXP$$US-JNJFOC-20240675572$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240807$$MD$US$US
240522711$24052271$1$I$20240624$20240628$20240704$20240704$EXP$$JP-009507513-2406JPN004407J$MERCK$$75$YR$$M$Y$$$20240704$$MD$JP$JP
240522721$24052272$1$I$20240101$20240626$20240704$20240704$EXP$$US-JNJFOC-20240675584$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240705$$CN$US$US
240522731$24052273$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131656$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240522741$24052274$1$I$20240101$20240621$20240704$20240704$EXP$IT-MINISAL02-980592$IT-SAMSUNG BIOEPIS-SB-2024-19466$SAMSUNG BIOEPIS$$55$YR$A$F$Y$$$20240705$$MD$IT$IT
240522751$24052275$1$I$$20240621$20240704$20240704$EXP$PT-EMA-DD-20240404-7482705-101202$PT-SAMSUNG BIOEPIS-SB-2024-19450$SAMSUNG BIOEPIS$Machado M, Dias RR, Martins AL, Pedrosa S, Gon?alves A, Malheiro L, et.al. A misfortune never comes alone. European Journal of Surgical Oncology. 2024;50 (2):doi:10.101016/j.ejso.2023.107676$47$YR$A$M$Y$$$20240705$$HP$PT$PT
240522762$24052276$2$F$20240401$20240731$20240704$20240808$EXP$$JP-AMGEN-JPNSP2024132572$AMGEN$$8$DEC$E$M$Y$$$20240808$$PH$JP$JP
240522771$24052277$1$I$$20240627$20240704$20240704$EXP$$US-SANDOZ INC.-SDZ2024US062803$SANDOZ$$$$$F$Y$$$20240704$$HP$US$US
240522783$24052278$3$F$$20240917$20240704$20240924$EXP$$US-GSK-US2024081066$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$US$US
240522792$24052279$2$F$20240703$20240704$20240704$20240705$PER$$US-AMGEN-USASP2024132522$AMGEN$$54$YR$A$M$Y$$$20240705$$CN$US$US
240522801$24052280$1$I$20240702$20240703$20240704$20240704$30DAY$$US-SANDOZ INC.-SDZ2024US062786$SANDOZ$$59$YR$$$Y$$$20240704$$CN$US$US
240522811$24052281$1$I$20240401$20240628$20240704$20240704$EXP$$US-GSK-US2024081181$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$CN$US$US
240522821$24052282$1$I$$20240625$20240704$20240704$EXP$$IT-009507513-2406ITA010185$MERCK$Antonello RM, Marangoni D, Ducci F, Barbiero A, Manciulli T, Graziani L, et al. Antiviral combination regimens as rescue therapy in immunocompromised hosts with persistent COVID-19. Journal of Chemotherapy. 2024;1-5$68$YR$$M$Y$$$20240704$$HP$IT$IT
240522831$24052283$1$I$$20240701$20240704$20240704$EXP$$JP-TAKEDA-2024TJP009873$TAKEDA$$17$YR$$M$Y$$$20240704$$MD$JP$JP
240522841$24052284$1$I$$20240702$20240704$20240704$EXP$$NVSC2024US137784$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
240522851$24052285$1$I$$20240702$20240704$20240704$PER$$US-JNJFOC-20240708284$JOHNSON AND JOHNSON$$24$YR$A$F$Y$$$20240705$$CN$US$US
240522861$24052286$1$I$20240401$20240702$20240704$20240704$EXP$$US-SANDOZ INC.-SDZ2024US062434$SANDOZ$$45$YR$$M$Y$$$20240704$$CN$US$US
240522871$24052287$1$I$$20240702$20240704$20240704$EXP$$JP-ORGANON-O2407JPN000169$ORGANON$$54$YR$$F$Y$$$20240704$$PH$JP$JP
240522881$24052288$1$I$20240628$20240628$20240704$20240704$EXP$GB-MHRA-MED-202406281139505730-JFZHP$GB-JNJFOC-20240707655$JOHNSON AND JOHNSON$$7$YR$C$$Y$$$20240705$$PH$GB$GB
240522891$24052289$1$I$20240629$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130497$AMGEN$$64$YR$A$F$Y$$$20240704$$CN$US$US
240522902$24052290$2$F$$20240624$20240704$20240704$EXP$$US-ROCHE-10000012580$ROCHE$$$$E$F$Y$$$20240705$$CN$US$US
240522911$24052291$1$I$20240601$20240614$20240704$20240704$PER$$US-JNJFOC-20240639104$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240705$$CN$US$US
240522921$24052292$1$I$20191001$20240626$20240704$20240704$EXP$$UG-PRINSTON PHARMACEUTICAL INC.-2024PRN00259$PRINSTON PHARMACEUTICAL$Nambuya M, H Kizza M. A case report: recurrent anemia related to long term acyclovir use in a pregnant HIV infected Ugandan. African Health Sciences. 2024;24 (1):91-93$19$YR$$F$Y$$$20240704$$HP$UG$UG
240522933$24052293$3$F$$20240809$20240704$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-102967$BRISTOL MYERS SQUIBB$Ohsako T, Takuwa T. Case of pleural mesothelioma responding to nivolumab and ipilimumab therapy followed by salvage surgery. The 41st Annual Meeting of the Japanese Association for Chest Surgery (Abstracts). 2024;$69$YR$E$M$Y$$$20240815$$MD$JP$JP
240522941$24052294$1$I$20240605$20240626$20240704$20240704$EXP$$US-JNJFOC-20240670937$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240705$$CN$US$US
240522952$24052295$2$F$$20240722$20240704$20240725$EXP$$US-JNJFOC-20240675440$JOHNSON AND JOHNSON$$59$YR$A$F$Y$44.492$KG$20240725$$HP$US$US
240522962$24052296$2$F$20231201$20240828$20240704$20240904$EXP$$US-AMGEN-USASL2024128776$AMGEN$$47$YR$A$M$Y$$$20240904$$CN$US$US
240522972$24052297$2$F$20240703$20240704$20240704$20240705$PER$$US-AMGEN-USASP2024132509$AMGEN$$75$YR$E$M$Y$$$20240705$$CN$US$US
240522981$24052298$1$I$20240601$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002036$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240704$$CN$US$US
240522992$24052299$2$F$$20240709$20240704$20240710$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037909$BOEHRINGER INGELHEIM$$82$YR$E$M$Y$$$20240710$$MD$RU$RU
240523003$24052300$3$F$20240601$20240805$20240704$20240812$EXP$$US-SANDOZ INC.-SDZ2024US062877$SANDOZ$$56$YR$$F$Y$$$20240812$$CN$US$US
240523012$24052301$2$F$$20240703$20240704$20240708$PER$$NVSC2024US139130$NOVARTIS$$$$$F$Y$$$20240708$$CN$US$US
240523022$24052302$2$F$$20240705$20240704$20240708$EXP$$AT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037884$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240708$$CN$AT$AT
240523031$24052303$1$I$20240207$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130294$AMGEN$$83$YR$E$M$Y$$$20240704$$CN$US$US
240523041$24052304$1$I$$20231111$20240704$20240704$PER$$US-AMGEN-USASP2023235482$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240523051$24052305$1$I$$20240628$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104345$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240705$$CN$US$US
240523061$24052306$1$I$$20240625$20240704$20240704$EXP$$US-JNJFOC-20240675960$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240705$$CN$US$US
240523071$24052307$1$I$$20240702$20240704$20240704$EXP$$NVSJ2024JP007858$NOVARTIS$$80$YR$$F$Y$42.9$KG$20240705$$MD$JP$JP
240523081$24052308$1$I$$20240704$20240704$20240704$PER$$US-HALEON-2185367$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240523111$24052311$1$I$20240401$20240630$20240704$20240704$EXP$$CN-JNJFOC-20240712690$JOHNSON AND JOHNSON$$71$YR$E$M$Y$55$KG$20240705$$HP$CN$CN
240523121$24052312$1$I$20230412$20240626$20240704$20240704$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-105189$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$50.4$KG$20240705$$PH$JP$JP
240523131$24052313$1$I$$20240627$20240704$20240704$EXP$$GB-JNJFOC-20240701538$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$GB$GB
240523141$24052314$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407001932$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240704$$CN$US$US
240523161$24052316$1$I$$20240628$20240704$20240704$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037921$BOEHRINGER INGELHEIM$$55$YR$A$F$Y$$$20240705$$CN$CA$CA
240523181$24052318$1$I$$20240626$20240704$20240704$EXP$$US-JNJFOC-20240671154$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$MD$US$US
240523193$24052319$3$F$20240704$20240807$20240704$20240811$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037944$BOEHRINGER INGELHEIM$$85$YR$E$F$Y$$$20240812$$CN$CA$CA
240523201$24052320$1$I$20240101$20240629$20240704$20240704$EXP$$US-ABBVIE-5822748$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240523213$24052321$3$F$$20240724$20240704$20240727$PER$$US-JNJFOC-20240668023$JOHNSON AND JOHNSON$$$$$$Y$$$20240727$$PH$US$US
240523223$24052322$3$F$$20240831$20240704$20240906$EXP$$JP-AMGEN-JPNSP2024130363$AMGEN$Takahashi, A.. A case of disseminated trichosporonosis caused by Trichosporon mucoides. The 154th Shin-Etsu Regional Meeting of the Japanese Society of Internal Medicin. 2024;154th$8$DEC$E$F$Y$$$20240905$$MD$JP$JP
240523231$24052323$1$I$$20240702$20240704$20240704$EXP$$NVSJ2024JP007855$NOVARTIS$$66$YR$$M$Y$$$20240705$$MD$JP$JP
240523241$24052324$1$I$$20240625$20240704$20240704$EXP$$IT-009507513-2406ITA010186$MERCK$Antonello RM, Marangoni D, Ducci F, Barbiero A, Manciulli T, Graziani L, et al. Antiviral combination regimens as rescue therapy in immunocompromised hosts with persistent COVID-19. Journal of Chemotherapy. 2024;1-5$71$YR$$F$Y$$$20240704$$HP$IT$IT
240523251$24052325$1$I$20240604$20240703$20240704$20240704$EXP$$US-ABBVIE-5826180$ABBVIE$$75$YR$$M$Y$$$20240704$$HP$US$US
240523271$24052327$1$I$20240601$20240626$20240704$20240704$EXP$$US-JNJFOC-20240672518$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240705$$CN$US$US
240523282$24052328$2$F$20240703$20240711$20240704$20240726$PER$$US-AMGEN-USASP2024132301$AMGEN$$84$YR$E$F$Y$$$20240726$$CN$US$US
240523292$24052329$2$F$$20240704$20240704$20240705$PER$$US-AMGEN-USASP2024132513$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240523302$24052330$2$F$20240101$20240701$20240704$20240708$PER$$US-AMGEN-USASP2024131651$AMGEN$$64$YR$A$F$Y$$$20240708$$HP$US$US
240523311$24052331$1$I$20201201$20240621$20240704$20240704$EXP$$PL-ROCHE-10000014993$ROCHE$$$$$$Y$$$20240705$$MD$PL$PL
240523321$24052332$1$I$$20240703$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106809$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240705$$HP$US$US
240523331$24052333$1$I$$20240628$20240704$20240704$PER$$US-ABBVIE-5825093$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240523342$24052334$2$F$$20240625$20240704$20240704$EXP$$US-ROCHE-10000014439$ROCHE$$93$YR$E$$Y$$$20240705$$HP$US$US
240523351$24052335$1$I$$20240702$20240704$20240704$EXP$$GB-JNJFOC-20240711906$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240705$$CN$GB$GB
240523361$24052336$1$I$20240101$20240702$20240704$20240704$EXP$$US-ABBVIE-5825290$ABBVIE$$$$$F$Y$$$20240704$$HP$US$US
240523374$24052337$4$F$20240101$20240807$20240704$20240813$EXP$$US-ABBVIE-5825127$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
240523381$24052338$1$I$20240521$20240626$20240704$20240704$EXP$$CO-ALXN-202405SAM002328CO$ALEXION PHARMACEUTICALS$$23$YR$$F$Y$75$KG$20240705$$CN$CO$CO
240523391$24052339$1$I$$20240703$20240704$20240704$EXP$$US-SANDOZ INC.-SDZ2024US062841$SANDOZ$$$$$F$Y$$$20240704$$CN$US$US
240523402$24052340$2$F$$20240625$20240704$20240704$EXP$$US-ROCHE-10000014434$ROCHE$$93$YR$E$$Y$$$20240705$$HP$US$US
240523411$24052341$1$I$$20240626$20240704$20240704$PER$$US-ROCHE-10000015377$ROCHE$$$$$$Y$$$20240705$$CN$US$US
240523422$24052342$2$F$$20240715$20240704$20240723$PER$$US-ROCHE-10000015078$ROCHE$$$$E$F$Y$$$20240723$$HP$US$US
240523431$24052343$1$I$20240622$20240627$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-009959$BEIGENE$$$$$$Y$$$20240704$$HP$CN$CN
240523441$24052344$1$I$20240629$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130749$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240523451$24052345$1$I$20240501$20240702$20240704$20240704$EXP$$IT-ABBVIE-5825337$ABBVIE$$68$YR$$M$Y$$$20240704$$CN$IT$IT
240523462$24052346$2$F$20240625$20240716$20240704$20240718$PER$$US-AMGEN-USASP2024131053$AMGEN$$74$YR$E$F$Y$$$20240718$$PH$US$US
240523471$24052347$1$I$$20240429$20240704$20240704$EXP$$US-AMGEN-USASP2024127531$AMGEN$Coyne W, D.. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the Dialysis Patients^ Response to IV Iron with Elevated Ferritin (DRIVE) study. Journal of the American Society of Nephrology: JASN. 2007;18 (3):975-984$$$$$Y$$$20240704$$HP$US$US
240523482$24052348$2$F$$20240827$20240704$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106935$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240902$$CN$US$US
240523491$24052349$1$I$20240624$20240627$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-009958$BEIGENE$$$$$$Y$$$20240704$$HP$CN$CN
240523501$24052350$1$I$20240517$20240701$20240704$20240704$EXP$$US-BAUSCHBL-2024BNL029537$BAUSCH AND LOMB$$58$YR$$M$Y$$$20240705$$CN$US$US
240523511$24052351$1$I$20240612$20240627$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-009977$BEIGENE$$$$$$Y$$$20240704$$HP$CN$CN
240523521$24052352$1$I$$20240702$20240704$20240704$EXP$$US-ABBVIE-5825835$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240523531$24052353$1$I$$20240628$20240704$20240704$PER$$US-SA-2024SA194792$SANOFI AVENTIS$$$$E$M$Y$$$20240705$$MD$US$US
240523542$24052354$2$F$20240628$20240729$20240704$20240731$PER$$US-TAKEDA-2024TUS067397$TAKEDA$$16$YR$$M$Y$89$KG$20240731$$MD$US$US
240523551$24052355$1$I$$20240625$20240704$20240704$PER$$US-JNJFOC-20240667534$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$CN$US$US
240523561$24052356$1$I$$20240701$20240704$20240704$EXP$$NVSC2024US135189$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
240523571$24052357$1$I$$20240627$20240704$20240704$EXP$$CA-ABBVIE-5821914$ABBVIE$$$$E$M$Y$$$20240704$$CN$CA$CA
240523581$24052358$1$I$$20240603$20240704$20240704$PER$$US-AMGEN-USASP2024131611$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240523592$24052359$2$F$$20240906$20240704$20240912$EXP$$JP-BIOGEN-2024BI01271274$BIOGEN$$$$$F$Y$$$20240912$$MD$JP$JP
240523602$24052360$2$F$20240601$20240806$20240704$20240808$EXP$$NVSJ2024JP007853$NOVARTIS$$38$YR$$F$Y$60$KG$20240809$$MD$JP$JP
240523611$24052361$1$I$20240501$20240704$20240704$20240704$EXP$GB-MHRA-MED-202405011500085190-YGDCP$GB-JNJFOC-20240713326$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240705$$HP$GB$GB
240523621$24052362$1$I$20240612$20240626$20240704$20240704$EXP$$UA-ROCHE-10000010343$ROCHE$$62$YR$A$M$Y$$$20240705$$MD$UA$UA
240523641$24052364$1$I$20210201$20240701$20240704$20240704$EXP$DK-DKMA-30730686$DK-BIOGEN-2024BI01271904$BIOGEN$$60$YR$$M$Y$$$20240704$$MD$DK$DK
240523651$24052365$1$I$20240516$20240624$20240704$20240704$EXP$$JP-BIOGEN-2024BI01266398$BIOGEN$$36$YR$$F$Y$$$20240704$$PH$JP$JP
240523661$24052366$1$I$20240506$20240627$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-009964$BEIGENE$$$$$$Y$$$20240704$$HP$CN$CN
240523673$24052367$3$F$20240614$20240711$20240704$20240729$PER$$US-AMGEN-USASP2024123572$AMGEN$$73$YR$E$F$Y$89$KG$20240729$$PH$US$US
240523681$24052368$1$I$20240701$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130147$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240523691$24052369$1$I$$20231002$20240704$20240704$PER$$US-AMGEN-USASP2023235565$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240523701$24052370$1$I$$20240626$20240704$20240704$PER$$US-ROCHE-10000012265$ROCHE$$$$$$Y$$$20240705$$PH$US$US
240523711$24052371$1$I$$20240702$20240704$20240704$EXP$$US-ABBVIE-5825830$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240523721$24052372$1$I$$20240702$20240704$20240704$EXP$$US-ABBVIE-5826207$ABBVIE$$$$$F$Y$65$KG$20240704$$CN$US$US
240523731$24052373$1$I$20240604$20240703$20240704$20240704$EXP$$TW-ABBVIE-5826288$ABBVIE$$38$YR$$M$Y$$$20240704$$HP$TW$TW
240523741$24052374$1$I$$20240701$20240704$20240704$PER$$US-BAUSCHBL-2023BNL011703$BAUSCH AND LOMB$$$$$F$Y$$$20240705$$CN$US$US
240523751$24052375$1$I$20240502$20240703$20240704$20240704$EXP$$US-ABBVIE-5825908$ABBVIE$$53$YR$$F$Y$$$20240704$$CN$US$US
240523761$24052376$1$I$20240626$20240702$20240704$20240704$EXP$$SE-ABBVIE-5825167$ABBVIE$$71$YR$$M$Y$$$20240704$$CN$SE$SE
240523772$24052377$2$F$20240630$20240710$20240704$20240712$PER$$US-AMGEN-USASP2024130782$AMGEN$$36$YR$A$F$Y$105.67$KG$20240711$$MD$US$US
240523781$24052378$1$I$20240626$20240627$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-009971$BEIGENE$$$$$$Y$$$20240704$$HP$CN$CN
240523791$24052379$1$I$20240619$20240627$20240704$20240704$EXP$$CN-BEIGENE-BGN-2024-009978$BEIGENE$$$$$$Y$$$20240704$$HP$CN$CN
240523803$24052380$3$F$20240618$20240918$20240704$20240920$PER$$NVSC2024US139268$NOVARTIS$$67$YR$$F$Y$90$KG$20240920$$CN$US$US
240523811$24052381$1$I$20240517$20240628$20240704$20240704$PER$$US-SA-2024SA196334$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240705$$MD$US$US
240523823$24052382$3$F$$20240703$20240704$20240718$30DAY$$GB-JNJFOC-20240621829$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240718$$CN$GB$GB
240523831$24052383$1$I$$20240701$20240704$20240704$EXP$$US-ABBVIE-5824624$ABBVIE$$$$$M$Y$$$20240704$$CN$US$US
240523842$24052384$2$F$$20240725$20240704$20240808$EXP$$JP-Unichem Pharmaceuticals (USA) Inc-UCM202407-000832$UNICHEM$$47$YR$A$F$Y$$$20240809$$HP$JP$
240523851$24052385$1$I$$20240626$20240704$20240704$EXP$$CN-JNJFOC-20240675290$JOHNSON AND JOHNSON$Ma L. Clinical Exploration of Immunosuppressants Combined with Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer. Journal of clinical and nursing research. 2024;124-128.$$$$M$Y$$$20240705$$HP$CN$CN
240523862$24052386$2$F$$20240829$20240704$20240901$EXP$$US-ABBVIE-5826336$ABBVIE$$$$$F$Y$$$20240901$$CN$US$US
240523871$24052387$1$I$20240701$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002437$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240704$$HP$US$US
240523882$24052388$2$F$$20240722$20240704$20240731$30DAY$$FR-JNJFOC-20240642065$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240731$$PH$FR$FR
240523891$24052389$1$I$20240620$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024132049$AMGEN$$82$YR$E$F$Y$$$20240704$$CN$US$US
240523901$24052390$1$I$20240612$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130971$AMGEN$$81$YR$E$F$Y$$$20240704$$CN$US$US
240523912$24052391$2$F$$20240722$20240704$20240724$PER$$NVSC2024US139256$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
240523922$24052392$2$F$20240101$20240821$20240704$20240825$EXP$$US-ABBVIE-5822213$ABBVIE$$$$$F$Y$$$20240825$$CN$US$US
240523931$24052393$1$I$20230805$20240626$20240704$20240704$EXP$$DE-ABBVIE-5642701$ABBVIE$$53$YR$$M$Y$$$20240704$$HP$DE$DE
240523941$24052394$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5825704$ABBVIE$$48$YR$$M$Y$$$20240704$$HP$US$US
240523961$24052396$1$I$$20240521$20240704$20240704$PER$$US-AMGEN-USASP2024130657$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240523971$24052397$1$I$$20240618$20240704$20240704$PER$$US-ABBVIE-5826314$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240523981$24052398$1$I$20240609$20240629$20240704$20240704$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2158860$JIANGSU HANSOH PHARMACEUTICAL$$70$YR$$F$Y$64$KG$20240704$$MD$CN$CN
240523992$24052399$2$F$20240627$20240719$20240704$20240730$PER$$US-SA-2024SA194100$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240730$$MD$US$US
240524004$24052400$4$F$$20240716$20240704$20240720$EXP$$JP-JNJFOC-20240678408$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240719$$MD$JP$JP
240524011$24052401$1$I$20240101$20240628$20240704$20240704$PER$$US-SA-2024SA196396$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240705$$MD$US$US
240524021$24052402$1$I$20240201$20240701$20240704$20240704$EXP$$DE-BIOGEN-2024BI01272026$BIOGEN$$38$YR$$F$Y$$$20240704$$CN$DE$DE
240524031$24052403$1$I$20240101$20240626$20240704$20240704$PER$$US-BAUSCHBL-2024BNL029257$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240705$$CN$US$US
240524041$24052404$1$I$$20240702$20240704$20240704$PER$$NVSC2024US139237$NOVARTIS$$$$$F$Y$$$20240705$$MD$US$US
240524052$24052405$2$F$$20240816$20240704$20240823$EXP$$US-BIOGEN-2024BI01272205$BIOGEN$$$$$M$Y$$$20240823$$CN$US$US
240524061$24052406$1$I$20240528$20240628$20240704$20240704$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2158861$JIANGSU HANSOH PHARMACEUTICAL$$78$YR$$F$Y$$$20240704$$MD$CN$CN
240524072$24052407$2$F$20240101$20240806$20240704$20240809$PER$$US-ABBVIE-5826785$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
240524081$24052408$1$I$$20240703$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407003555$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240704$$CN$US$US
240524091$24052409$1$I$$20240701$20240704$20240704$PER$$US-HALEON-2184845$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240524101$24052410$1$I$$20240629$20240704$20240704$EXP$$US-ASTELLAS-2024US018695$ASTELLAS$$$$$M$Y$$$20240705$$CN$US$US
240524111$24052411$1$I$$20240613$20240704$20240704$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105712$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240705$$CN$US$US
240524121$24052412$1$I$$20240628$20240704$20240704$EXP$$CA-BIOGEN-2024BI01271957$BIOGEN$$$$$F$Y$$$20240704$$CN$CA$CA
240524133$24052413$3$F$20240501$20240802$20240704$20240808$EXP$$US-ABBVIE-5823442$ABBVIE$$74$YR$$M$Y$72.6$KG$20240808$$CN$US$US
240524141$24052414$1$I$$20230301$20240704$20240704$PER$$US-AMGEN-USASP2023235500$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240524151$24052415$1$I$20240601$20240701$20240704$20240704$PER$$US-AMGEN-USASP2024130268$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240524161$24052416$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5826486$ABBVIE$$47$YR$$F$Y$$$20240704$$HP$US$US
240524171$24052417$1$I$$20240627$20240704$20240704$EXP$$US-AstraZeneca-2024A150625$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240524181$24052418$1$I$$20240703$20240704$20240704$PER$$US-HALEON-2185390$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240524201$24052420$1$I$$20240703$20240704$20240704$EXP$$SK-ABBVIE-5827390$ABBVIE$$81$YR$$M$Y$$$20240704$$CN$SK$SK
240524211$24052421$1$I$$20240701$20240704$20240704$PER$$US-SA-2024SA194683$SANOFI AVENTIS$$$$E$M$Y$$$20240705$$MD$US$US
240524221$24052422$1$I$$20240627$20240704$20240704$PER$$US-BAUSCHBL-2024BNL029373$BAUSCH AND LOMB$$$$$M$Y$$$20240705$$MD$US$US
240524231$24052423$1$I$20240101$20240701$20240704$20240704$EXP$$US-ABBVIE-5826069$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240524241$24052424$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5826475$ABBVIE$$23$YR$$F$Y$$$20240704$$HP$US$US
240524251$24052425$1$I$20230101$20240627$20240704$20240704$EXP$$UY-ABBVIE-5820427$ABBVIE$$$$$F$Y$$$20240704$$CN$UY$UY
240524261$24052426$1$I$$20240630$20240704$20240704$EXP$$AU-BAUSCHBL-2024BNL029406$BAUSCH AND LOMB$$34$YR$$M$Y$$$20240705$$CN$AU$AU
240524271$24052427$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5823569$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240524281$24052428$1$I$$20240630$20240704$20240704$EXP$$AU-BAUSCHBL-2024BNL029409$BAUSCH AND LOMB$$85$YR$$M$Y$$$20240705$$CN$AU$AU
240524291$24052429$1$I$$20240701$20240704$20240704$PER$$US-SA-2024SA196160$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240705$$MD$US$US
240524301$24052430$1$I$20240101$20240627$20240704$20240704$PER$$US-SA-2024SA196466$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240705$$MD$US$US
240524311$24052431$1$I$$20240630$20240704$20240704$EXP$$AU-BAUSCHBL-2024BNL029412$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240705$$CN$AU$AU
240524321$24052432$1$I$20240304$20240701$20240704$20240704$EXP$$US-AstraZeneca-2024A151444$ASTRAZENECA$$32722$DY$$F$Y$$$20240705$$MD$US$
240524331$24052433$1$I$$20240617$20240704$20240704$PER$$US-AstraZeneca-2024A140506$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240524341$24052434$1$I$$20240702$20240704$20240704$PER$$US-ELI_LILLY_AND_COMPANY-US202407002094$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240704$$CN$US$US
240524351$24052435$1$I$$20240625$20240704$20240704$EXP$$US-JNJFOC-20240675246$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240705$$HP$US$US
240524361$24052436$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5823642$ABBVIE$$$$$F$Y$$$20240704$$CN$US$US
240524371$24052437$1$I$20240601$20240701$20240704$20240704$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105162$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$95.07$KG$20240705$$PH$US$US
240524381$24052438$1$I$$20240627$20240704$20240704$PER$$US-ABBVIE-5826479$ABBVIE$$35$YR$$F$Y$$$20240704$$HP$US$US
240524391$24052439$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131548$AMGEN$Foulger L.; Simmons K.; Schiano M. et al.. Rare phalanges soft tissue and bony metastasis in vulvar squamous cell carcinoma- Case report. Gynecologic Oncology Reports. 2024;54:1-3$52$YR$A$F$Y$$$20240704$$HP$US$US
240524402$24052440$2$F$20240708$20240710$20240704$20240715$PER$$US-AMGEN-USASP2024131772$AMGEN$$79$YR$E$M$Y$$$20240714$$CN$US$US
240524411$24052441$1$I$$20240702$20240704$20240704$PER$$US-AMGEN-USASP2024131475$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240524422$24052442$2$F$20200617$20240722$20240704$20240724$EXP$$JP-TAKEDA-2024TJP010013$TAKEDA$$69$YR$$F$Y$$$20240724$$MD$JP$JP
240524432$24052443$2$F$20240601$20240724$20240704$20240729$EXP$$IT-ABBVIE-5826062$ABBVIE$$12$YR$$M$Y$54.7$KG$20240729$$MD$IT$IT
240524441$24052444$1$I$$20240627$20240704$20240704$EXP$$DE-ABBVIE-5820962$ABBVIE$$$$$M$Y$$$20240704$$CN$DE$DE
240524452$24052445$2$F$$20240711$20240704$20240713$EXP$$NVSC2024ZA134139$NOVARTIS$$37$YR$$F$Y$$$20240713$$HP$ZA$ZA
240524461$24052446$1$I$20240702$20240703$20240704$20240704$EXP$GB-MHRA-TPP36063804C16432420YC1719916233924$GB-GSK-GB2024082514$GLAXOSMITHKLINE$$$$$$Y$$$20240704$$PH$GB$GB
240524471$24052447$1$I$$20240703$20240704$20240704$PER$$US-AMGEN-USASP2024132501$AMGEN$$$$$F$Y$$$20240704$$HP$US$US
240524483$24052448$3$F$$20240709$20240704$20240806$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000226$EMCURE$$$$$$Y$$$20240806$$CN$US$US
240524495$24052449$5$F$20240101$20240904$20240704$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019959$UNITED THERAPEUTICS$$$$$F$Y$76.19$KG$20240914$$$US$US
240524501$24052450$1$I$20240621$20240626$20240704$20240704$PER$$US-ABBVIE-5825773$ABBVIE$$72$YR$$F$Y$$$20240704$$CN$US$US
240524512$24052451$2$F$20240501$20240703$20240704$20240711$EXP$$US-TAKEDA-2024TUS066852$TAKEDA$$63$YR$$F$Y$$$20240711$$MD$US$US
240524521$24052452$1$I$$20240627$20240705$20240705$PER$$US-SA-2024SA194419$SANOFI AVENTIS$$$$T$F$Y$49.8$KG$20240705$$MD$US$US
240524531$24052453$1$I$$20240618$20240705$20240705$PER$$US-AstraZeneca-2024A141371$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240524541$24052454$1$I$$20240624$20240705$20240705$PER$$US-AstraZeneca-2024A145974$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240524552$24052455$2$F$20240628$20240802$20240705$20240807$30DAY$$US-AMGEN-USASP2024128792$AMGEN$$36$YR$A$F$Y$100$KG$20240807$$PH$US$US
240524561$24052456$1$I$20240701$20240702$20240705$20240705$EXP$$CA-ABBVIE-5825319$ABBVIE$$$$E$M$Y$$$20240705$$CN$CA$CA
240524571$24052457$1$I$$20240628$20240705$20240705$EXP$$US-TAKEDA-2024TUS067268$TAKEDA$$$$$M$Y$$$20240705$$CN$US$US
240524581$24052458$1$I$$20240702$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106529$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240705$$CN$US$US
240524592$24052459$2$F$$20240823$20240705$20240901$EXP$$JP-SA-2024SA192270$SANOFI AVENTIS$$$$$$Y$$$20240902$$MD$JP$JP
240524601$24052460$1$I$20240616$20240702$20240705$20240705$EXP$FR-AFSSAPS-PA2024001280$FR-GSK-FR2024082386$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$FR$FR
240524614$24052461$4$F$20230101$20240705$20240705$20240716$EXP$$US-ABBVIE-5824562$ABBVIE$$$$$F$Y$79.378$KG$20240716$$CN$US$US
240524621$24052462$1$I$20240101$20240628$20240705$20240705$PER$$US-SA-2024SA034397$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240705$$MD$US$US
240524631$24052463$1$I$20210101$20240701$20240705$20240705$PER$$US-SA-2024SA196699$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240705$$CN$US$US
240524641$24052464$1$I$$20240627$20240705$20240705$EXP$$CN-BEIGENE-BGN-2024-009889$BEIGENE$$$$$$Y$$$20240705$$HP$CN$CN
240524651$24052465$1$I$$20240701$20240705$20240705$EXP$$US-TAKEDA-2024TUS067492$TAKEDA$$$$$M$Y$$$20240705$$MD$US$US
240524662$24052466$2$F$$20240702$20240705$20240709$PER$$NVSC2024US137978$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240524671$24052467$1$I$$20240627$20240705$20240705$PER$$US-ROCHE-10000015391$ROCHE$$$$A$F$Y$$$20240705$$MD$US$US
240524681$24052468$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5825833$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240524691$24052469$1$I$20240316$20240627$20240705$20240705$EXP$$US-ABBVIE-5681331$ABBVIE$$36$YR$$F$Y$$$20240705$$CN$US$US
240524701$24052470$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA194170$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240705$$MD$US$US
240524712$24052471$2$F$$20240902$20240705$20240904$EXP$$CH-AstraZeneca-2024A152281$ASTRAZENECA$$$$$$Y$$$20240905$$MD$CH$
240524721$24052472$1$I$20240403$20240628$20240705$20240705$EXP$$BR-JNJFOC-20240701862$JOHNSON AND JOHNSON$$32$YR$A$M$Y$65$KG$20240705$$CN$BR$BR
240524731$24052473$1$I$$20240703$20240705$20240705$PER$$US-HALEON-2185386$Haleon PLC$$75$YR$$F$Y$$$20240705$$CN$US$US
240524741$24052474$1$I$$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132062$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240524751$24052475$1$I$20240601$20240628$20240705$20240705$PER$$US-AMGEN-USASP2024130486$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240524761$24052476$1$I$$20230503$20240705$20240705$PER$$US-AMGEN-USASP2023235558$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240524782$24052478$2$F$20240501$20240705$20240705$20240709$EXP$$US-ABBVIE-5825326$ABBVIE$$66$YR$$F$Y$74$KG$20240709$$CN$US$US
240524793$24052479$3$F$20240628$20240808$20240705$20240810$PER$$US-AMGEN-USASP2024131240$AMGEN$$83$YR$E$M$Y$$$20240810$$CN$US$US
240524801$24052480$1$I$$20240703$20240705$20240705$PER$$US-HALEON-2185396$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240524812$24052481$2$F$$20240716$20240705$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037117$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240722$$CN$US$US
240524821$24052482$1$I$20230401$20240627$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062772$SANDOZ$$46$YR$$F$Y$$$20240705$$CN$US$US
240524834$24052483$4$F$$20240704$20240705$20240706$30DAY$$US-SANDOZ INC.-SDZ2024US062792$SANDOZ$$$$$F$Y$$$20240706$$CN$US$US
240524841$24052484$1$I$20210401$20240701$20240705$20240705$EXP$CZ-EMA-DD-20240626-7482701-083121$CZ-SANDOZ INC.-SDZ2024CZ061772$SANDOZ$$51$YR$$F$Y$$$20240705$$MD$CZ$CZ
240524851$24052485$1$I$$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407001732$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240705$$CN$US$US
240524863$24052486$3$F$20240101$20240819$20240705$20240822$EXP$$US-ABBVIE-5821069$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
240524871$24052487$1$I$$20230313$20240705$20240705$PER$$US-AMGEN-USASP2023235480$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240524881$24052488$1$I$20240628$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130845$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240524891$24052489$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130503$AMGEN$$$$A$F$Y$$$20240704$$CN$US$US
240524901$24052490$1$I$$20240702$20240705$20240705$PER$$US-HALEON-2185006$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240524913$24052491$3$F$20221201$20240705$20240705$20240712$EXP$$US-ABBVIE-5826339$ABBVIE$$86$YR$$F$Y$$$20240712$$CN$US$US
240524921$24052492$1$I$20240411$20240626$20240705$20240705$EXP$IT-MINISAL02-981031$IT-TEVA-VS-3214916$TEVA$$75$YR$$F$Y$$$20240705$$MD$IT$IT
240524931$24052493$1$I$$20240630$20240705$20240705$EXP$$US-GSK-US2024AMR081798$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$US$US
240524941$24052494$1$I$20240101$20240701$20240705$20240705$EXP$$US-ABBVIE-5825460$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240524951$24052495$1$I$20240201$20240702$20240705$20240705$EXP$$US-ABBVIE-5825821$ABBVIE$$73$YR$$M$Y$$$20240705$$CN$US$US
240524962$24052496$2$F$$20240802$20240705$20240812$PER$$US-AstraZeneca-2024A148876$ASTRAZENECA$$$$$$Y$$$20240812$$CN$US$
240524971$24052497$1$I$$20240628$20240705$20240705$EXP$$GB-AstraZeneca-2024A149650$ASTRAZENECA$$$$$$Y$75$KG$20240705$$MD$GB$
240524982$24052498$2$F$20240627$20240802$20240705$20240809$30DAY$$US-AMGEN-USASP2024128590$AMGEN$$52$YR$A$M$Y$121.09$KG$20240809$$HP$US$US
240524992$24052499$2$F$20240608$20240718$20240705$20240723$30DAY$$US-AMGEN-USASP2024128528$AMGEN$$$$$$Y$$$20240723$$PH$US$US
240525002$24052500$2$F$20240625$20240709$20240705$20240716$PER$$US-AMGEN-USASP2024127496$AMGEN$$80$YR$E$M$Y$66.576$KG$20240716$$PH$US$US
240525011$24052501$1$I$20240101$20240701$20240705$20240705$EXP$$CA-ABBVIE-5825016$ABBVIE$$96$YR$$M$Y$$$20240705$$HP$CA$CA
240525021$24052502$1$I$$20240627$20240705$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106952$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240705$$MD$JP$JP
240525031$24052503$1$I$20240601$20240703$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106484$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$79.38$KG$20240705$$CN$US$US
240525041$24052504$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5779827$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240525051$24052505$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824806$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240525067$24052506$7$F$20240501$20240919$20240705$20240930$EXP$$AU-JNJFOC-20240538981$JOHNSON AND JOHNSON$$35$YR$A$M$Y$116$KG$20240930$$CN$AU$AU
240525071$24052507$1$I$20240629$20240702$20240705$20240705$EXP$$GR-ABBVIE-5826068$ABBVIE$$70$YR$$M$Y$$$20240705$$CN$GR$GR
240525081$24052508$1$I$20240101$20240701$20240705$20240705$EXP$$US-ABBVIE-5825043$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240525092$24052509$2$F$$20240923$20240705$20240926$EXP$$GB-TAKEDA-2024TUS059986$TAKEDA$$$$$M$Y$$$20240926$$CN$GB$GB
240525101$24052510$1$I$$20240629$20240705$20240705$EXP$$US-GSK-US2024AMR082026$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$US$US
240525111$24052511$1$I$20240501$20240627$20240705$20240705$30DAY$$US-GSK-US2024080407$GLAXOSMITHKLINE$$67$YR$$M$Y$$$20240705$$CN$US$US
240525122$24052512$2$F$20240101$20240909$20240705$20240913$EXP$$US-ABBVIE-5824617$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
240525131$24052513$1$I$20240630$20240702$20240705$20240705$EXP$$IL-ABBVIE-5825079$ABBVIE$$34$YR$$M$Y$$$20240705$$CN$IL$IL
240525141$24052514$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5825409$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240525152$24052515$2$F$20240702$20240809$20240705$20240810$EXP$$RO-ABBVIE-5825488$ABBVIE$$76$YR$$M$Y$$$20240810$$CN$RO$RO
240525172$24052517$2$F$20240501$20240715$20240705$20240717$PER$$US-ROCHE-10000015429$ROCHE$$$$$F$Y$$$20240717$$CN$US$US
240525181$24052518$1$I$20240702$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132893$AMGEN$$61$YR$A$M$Y$$$20240704$$CN$US$US
240525191$24052519$1$I$$20230814$20240705$20240705$PER$$US-AMGEN-USASP2023235461$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240525201$24052520$1$I$20240702$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131258$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240525212$24052521$2$F$20240624$20240731$20240705$20240806$EXP$$US-ABBVIE-5824786$ABBVIE$$36$YR$$F$Y$$$20240806$$CN$US$US
240525221$24052522$1$I$$20240626$20240705$20240705$PER$$US-ROCHE-10000015347$ROCHE$$$$A$F$Y$$$20240705$$CN$US$US
240525234$24052523$4$F$20240617$20240805$20240705$20240808$PER$$US-ROCHE-10000013072$ROCHE$$79$YR$E$F$Y$$$20240808$$CN$US$US
240525242$24052524$2$F$$20240917$20240705$20240918$PER$$NVSC2024US133397$NOVARTIS$$$$$$Y$$$20240918$$CN$US$US
240525251$24052525$1$I$$20240701$20240705$20240705$30DAY$$US-GSK-US2024082124$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$CN$US$US
240525261$24052526$1$I$$20240626$20240705$20240705$PER$$US-ROCHE-10000011875$ROCHE$$$$E$F$Y$$$20240705$$CN$US$US
240525271$24052527$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131016$AMGEN$$$$E$M$Y$$$20240704$$HP$US$US
240525282$24052528$2$F$20240301$20240830$20240705$20240906$PER$$US-ROCHE-10000010142$ROCHE$$69$YR$E$M$Y$77.11$KG$20240906$$CN$US$US
240525291$24052529$1$I$20240606$20240625$20240705$20240705$EXP$FR-AFSSAPS-BX2024001256$FR-TEVA-VS-3214493$TEVA$$73$YR$$M$Y$74$KG$20240705$$PH$FR$FR
240525303$24052530$3$F$20240601$20240919$20240705$20240926$EXP$$CA-ABBVIE-5825153$ABBVIE$$82$YR$$F$Y$$$20240926$$CN$CA$CA
240525312$24052531$2$F$20220827$20240920$20240705$20240926$EXP$$GR-ABBVIE-5780013$ABBVIE$$72$YR$$M$Y$110$KG$20240926$$MD$GR$GR
240525321$24052532$1$I$20240101$20240701$20240705$20240705$EXP$$US-ABBVIE-5825129$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240525331$24052533$1$I$$20240625$20240705$20240705$EXP$$IN-KOANAAP-SML-IN-2024-00620$Unknown Manufacturer$Chatterjee A, Kazi M, Ostwal V, Ramaswamy A, Desouza A, Saklani A. Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases. Ind-J-Surg-Oncol. 2023;14192-14197.$49$YR$A$F$Y$$$20240705$$MD$IN$IN
240525341$24052534$1$I$$20240625$20240705$20240705$EXP$$IN-KOANAAP-SML-IN-2024-00621$Unknown Manufacturer$Chatterjee A, Kazi M, Ostwal V, Ramaswamy A, Desouza A, Desouza A. Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases. Ind-J-Surg-Oncol. 2023;$19$YR$A$M$Y$$$20240705$$MD$IN$IN
240525351$24052535$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130923$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240525361$24052536$1$I$$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A150971$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240525371$24052537$1$I$$20240112$20240705$20240705$PER$$US-AMGEN-USASP2024129825$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240525381$24052538$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824762$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240525391$24052539$1$I$20230101$20240703$20240705$20240705$EXP$$FR-PFIZER INC-202400185134$PFIZER$$$$E$F$Y$83$KG$20240705$$CN$FR$FR
240525402$24052540$2$F$20240101$20240626$20240705$20240709$EXP$$US-ABBVIE-5826143$ABBVIE$$$$$M$Y$91$KG$20240709$$CN$US$US
240525411$24052541$1$I$$20240625$20240705$20240705$EXP$$IN-KOANAAP-SML-IN-2024-00619$Unknown Manufacturer$Chatterjee A, Kazi M, Ostwal V, Ramaswamy A, Ramaswamy A, Desouza A. Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases. Ind-J-Surg-Oncol. 2023;14192-14197.$32$YR$A$M$Y$$$20240705$$MD$IN$IN
240525421$24052542$1$I$$20240704$20240705$20240705$EXP$$AR-PFIZER INC-202400206910$PFIZER$$83$YR$$M$Y$$$20240705$$CN$AR$AR
240525431$24052543$1$I$20240614$20240702$20240705$20240705$EXP$$CN-PFIZER INC-PV202400086951$PFIZER$$73$YR$$M$Y$$$20240705$$HP$CN$CN
240525442$24052544$2$F$20240620$20240829$20240705$20240829$EXP$$CA-PFIZER INC-202300357916$PFIZER$$75$YR$$M$Y$$$20240829$$MD$CA$CA
240525452$24052545$2$F$$20240626$20240705$20240708$EXP$$US-ABBVIE-5816174$ABBVIE$$$$$M$Y$$$20240708$$MD$US$US
240525471$24052547$1$I$$20240625$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406017680$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240705$$CN$US$US
240525481$24052548$1$I$20240606$20240619$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406005610$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240705$$CN$US$US
240525491$24052549$1$I$20240620$20240702$20240705$20240705$EXP$$US-ABBVIE-5825896$ABBVIE$$55$YR$$F$Y$$$20240705$$CN$US$US
240525503$24052550$3$F$$20240801$20240705$20240814$EXP$$ES-AMGEN-ESPSP2024122241$AMGEN$$69$YR$E$F$Y$42$KG$20240814$$CN$ES$ES
240525511$24052551$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824662$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240525521$24052552$1$I$20240101$20240702$20240705$20240705$EXP$$CA-ABBVIE-5825067$ABBVIE$$50$YR$$$Y$$$20240705$$HP$CA$CA
240525532$24052553$2$F$$20240713$20240705$20240716$EXP$$GB-ABBVIE-5825865$ABBVIE$$$$E$M$Y$$$20240716$$HP$GB$GB
240525542$24052554$2$F$20240125$20240910$20240705$20240911$EXP$$NVSJ2024JP007873$NOVARTIS$$55$YR$$F$Y$$$20240912$$MD$JP$JP
240525551$24052555$1$I$$20240626$20240705$20240705$EXP$$US-LAURUS LABS LIMITED-2024LAU000053$LAURUS LABS LIMITED$Al-Moussally F, Thompson BM, Masarweh OM, Shah N, Gaudi S, Restrepo J.. Atorvastatin-Associated Eosinophilic Spongiosis: A Case Report and a Relevant Literature Review of Dermatological Manifestations.. Cureus.. 2024;16(5)$73$YR$$M$Y$$$20240704$$HP$US$US
240525561$24052556$1$I$20240501$20240701$20240705$20240705$EXP$$US-ABBVIE-5825253$ABBVIE$$61$YR$$F$Y$$$20240705$$CN$US$US
240525571$24052557$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824719$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240525584$24052558$4$F$$20240702$20240705$20240710$PER$$US-ROCHE-10000013705$ROCHE$$$$C$F$Y$$$20240710$$CN$US$US
240525591$24052559$1$I$$20231012$20240705$20240705$PER$$US-AMGEN-USASP2023235250$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240525602$24052560$2$F$$20240621$20240705$20240708$EXP$$GR-ROCHE-10000013872$ROCHE$Unknown ,  Unknown.$61$YR$A$M$Y$$$20240708$$MD$GR$GR
240525611$24052561$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5826067$ABBVIE$$$$$F$Y$$$20240705$$MD$US$US
240525622$24052562$2$F$20240501$20240808$20240705$20240816$30DAY$$US-GSK-US2024082176$GLAXOSMITHKLINE$$64$YR$$M$Y$89$KG$20240816$$MD$US$US
240525641$24052564$1$I$$20240624$20240705$20240705$EXP$$US-NOVOPROD-1246443$NOVO NORDISK$$$$$M$Y$$$20240705$$MD$US$US
240525651$24052565$1$I$20231201$20240626$20240705$20240705$EXP$$US-NOVOPROD-1248131$NOVO NORDISK$$71$YR$$F$Y$$$20240705$$CN$US$US
240525672$24052567$2$F$20240521$20240907$20240705$20240918$EXP$$US-NOVOPROD-1246285$NOVO NORDISK$$65$YR$$M$Y$$$20240918$$CN$US$US
240525691$24052569$1$I$20240101$20240625$20240705$20240705$EXP$$US-NOVOPROD-1247268$NOVO NORDISK$$45$YR$$F$Y$$$20240705$$CN$US$US
240525701$24052570$1$I$$20240624$20240705$20240705$EXP$$TR-NOVOPROD-1246617$NOVO NORDISK$$751$MON$$M$Y$84$KG$20240705$$CN$TR$TR
240525711$24052571$1$I$20240518$20240625$20240705$20240705$EXP$HR-HALMED-300085750$HR-NOVOPROD-1246188$NOVO NORDISK$$$$A$F$Y$$$20240705$$MD$HR$HR
240525721$24052572$1$I$$20240624$20240705$20240705$EXP$$US-NOVOPROD-1246209$NOVO NORDISK$$$$A$F$Y$$$20240705$$HP$US$US
240525731$24052573$1$I$$20240626$20240705$20240705$EXP$GB-MHRA-MED-202406261522143630-SDCLZ$GB-NOVOPROD-1246564$NOVO NORDISK$$$$$M$Y$$$20240705$$MD$GB$GB
240525741$24052574$1$I$$20240627$20240705$20240705$EXP$$US-NOVOPROD-1246334$NOVO NORDISK$$$$$F$Y$$$20240705$$MD$US$US
240525751$24052575$1$I$$20240624$20240705$20240705$EXP$$US-NOVOPROD-1246467$NOVO NORDISK$$$$$$Y$$$20240705$$CN$US$US
240525761$24052576$1$I$20240618$20240625$20240705$20240705$EXP$$US-NOVOPROD-1246279$NOVO NORDISK$$58$YR$$F$Y$$$20240705$$CN$US$US
240525771$24052577$1$I$$20240624$20240705$20240705$EXP$$US-NOVOPROD-1246213$NOVO NORDISK$$88$YR$$F$Y$$$20240705$$CN$US$US
240525782$24052578$2$F$20240423$20240826$20240705$20240905$EXP$$DE-NOVOPROD-1246277$NOVO NORDISK$$30$YR$$F$Y$$$20240905$$MD$DE$DE
240525792$24052579$2$F$$20240716$20240705$20240729$EXP$$US-NOVOPROD-1246466$NOVO NORDISK$$88$YR$$M$Y$$$20240729$$CN$US$US
240525801$24052580$1$I$$20240624$20240705$20240705$EXP$$US-NOVOPROD-1246490$NOVO NORDISK$$$$$M$Y$$$20240705$$HP$US$US
240525812$24052581$2$F$20240701$20240715$20240705$20240717$PER$$US-AMGEN-USASP2024130624$AMGEN$$82$YR$E$M$Y$$$20240717$$CN$US$US
240525821$24052582$1$I$$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132943$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240525831$24052583$1$I$20240215$20240625$20240705$20240705$EXP$$DE-NOVOPROD-1246204$NOVO NORDISK$$64$YR$$M$Y$$$20240705$$MD$DE$DE
240525841$24052584$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130260$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240525852$24052585$2$F$$20240705$20240705$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002779$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
240525861$24052586$1$I$$20240629$20240705$20240705$EXP$$US-ABBVIE-5824966$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240525871$24052587$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5825991$ABBVIE$$33$YR$$F$Y$$$20240705$$HP$US$US
240525881$24052588$1$I$20240702$20240702$20240705$20240705$EXP$$CA-TAKEDA-2020TUS028530$TAKEDA$$68$YR$$F$Y$$$20240705$$CN$CA$CA
240525891$24052589$1$I$20240416$20240626$20240705$20240705$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-023402$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$$$20240705$$CN$US$US
240525901$24052590$1$I$20240419$20240624$20240705$20240705$EXP$FR-AFSSAPS-TO2024000758$FR-GSK-FR2024078505$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$PH$FR$FR
240525912$24052591$2$F$$20240627$20240705$20240706$EXP$$US-ABBVIE-5826266$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240525921$24052592$1$I$$20240628$20240705$20240705$EXP$$US-CHIESI-2024CHF03941$CHIESI$$$$$F$Y$77$KG$20240705$$PH$US$US
240525931$24052593$1$I$$20240627$20240705$20240705$30DAY$$US-GSK-US2024080410$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240705$$CN$US$US
240525941$24052594$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824563$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240525951$24052595$1$I$$20240626$20240705$20240705$EXP$$ES-ABBVIE-5827127$ABBVIE$$$$$$Y$$$20240705$$MD$ES$ES
240525961$24052596$1$I$20240101$20240701$20240705$20240705$EXP$$US-ABBVIE-5825820$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240525971$24052597$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824251$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240525981$24052598$1$I$$20240622$20240705$20240705$EXP$$EC-ROCHE-10000007752$ROCHE$$$$$$Y$$$20240705$$CN$EC$EC
240525991$24052599$1$I$20240628$20240702$20240705$20240705$EXP$$US-AstraZeneca-2024A152120$ASTRAZENECA$$30818$DY$$M$Y$$$20240705$$CN$US$
240526001$24052600$1$I$$20240702$20240705$20240705$EXP$$US-AstraZeneca-2024A152590$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240526011$24052601$1$I$20240101$20240701$20240705$20240705$EXP$$US-ABBVIE-5825330$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240526022$24052602$2$F$$20240724$20240705$20240802$EXP$$JP-AMGEN-JPNSP2024130249$AMGEN$$7$DEC$E$M$Y$$$20240802$$MD$JP$JP
240526031$24052603$1$I$$20240627$20240705$20240705$EXP$$US-ABBVIE-5822061$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240526043$24052604$3$F$20240622$20240722$20240705$20240724$EXP$$PL-ABBVIE-5825837$ABBVIE$$72$YR$$M$Y$$$20240724$$HP$PL$PL
240526051$24052605$1$I$$20240610$20240705$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002773$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
240526061$24052606$1$I$$20240624$20240705$20240705$EXP$$US-HALEON-2183693$Haleon PLC$$$$$$Y$$$20240704$$CN$US$US
240526071$24052607$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131623$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240526081$24052608$1$I$$20240630$20240705$20240705$PER$$US-AMGEN-USASP2024130493$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240526093$24052609$3$F$$20240812$20240705$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002785$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
240526102$24052610$2$F$20240401$20240707$20240705$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002775$ACADIA PHARMACEUTICALS$$61$YR$$M$Y$$$20240730$$CN$US$US
240526111$24052611$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202405000159$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240705$$CN$US$US
240526121$24052612$1$I$$20240703$20240705$20240705$PER$$US-HALEON-2185273$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240526131$24052613$1$I$20240101$20240701$20240705$20240705$EXP$$US-ABBVIE-5825001$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240526151$24052615$1$I$$20240625$20240705$20240705$EXP$$ES-AUROBINDO-AUR-APL-2018-019593$AUROBINDO$$59$YR$$F$Y$$$20240705$$MD$ES$ES
240526162$24052616$2$F$$20240806$20240705$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002780$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
240526171$24052617$1$I$$20240622$20240705$20240705$EXP$$EC-ROCHE-10000007740$ROCHE$$$$$$Y$$$20240705$$CN$EC$EC
240526181$24052618$1$I$20240628$20240701$20240705$20240705$EXP$$US-ABBVIE-5825996$ABBVIE$$61$YR$$F$Y$$$20240705$$CN$US$US
240526191$24052619$1$I$$20240701$20240705$20240705$EXP$$US-JNJFOC-20240700860$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240526211$24052621$1$I$$20240610$20240705$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002836$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$HP$US$US
240526222$24052622$2$F$$20240708$20240705$20240716$EXP$$JP-TAKEDA-2024TUS066644$TAKEDA$$59$YR$$F$Y$$$20240716$$MD$JP$JP
240526231$24052623$1$I$$20240625$20240705$20240705$EXP$$CA-002147023-NVSC2024CA059707$Haleon PLC$$44$YR$$F$Y$$$20240704$$HP$CA$CA
240526243$24052624$3$F$$20240731$20240705$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002798$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
240526251$24052625$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5826572$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240526261$24052626$1$I$$20240622$20240705$20240705$EXP$$EC-ROCHE-10000007733$ROCHE$$$$$$Y$$$20240705$$CN$EC$EC
240526271$24052627$1$I$20240621$20240627$20240705$20240705$PER$$US-AMGEN-USASP2024130193$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240526281$24052628$1$I$20240101$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132672$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240526292$24052629$2$F$20240401$20240708$20240705$20240710$PER$$US-AMGEN-USASP2024130413$AMGEN$$43$YR$A$F$Y$$$20240709$$CN$US$US
240526301$24052630$1$I$$20240620$20240705$20240705$PER$$US-ROCHE-10000014383$ROCHE$$$$A$F$Y$$$20240705$$CN$US$US
240526311$24052631$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5827167$ABBVIE$$40$YR$$F$Y$$$20240705$$HP$US$US
240526322$24052632$2$F$20240514$20240726$20240705$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002799$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240820$$CN$US$US
240526331$24052633$1$I$$20240628$20240705$20240705$PER$$US-AMGEN-USASP2024129686$AMGEN$$68$YR$E$F$Y$$$20240704$$CN$US$US
240526342$24052634$2$F$20240701$20240723$20240705$20240726$PER$$US-AMGEN-USASP2024131267$AMGEN$$45$YR$A$F$Y$$$20240726$$MD$US$US
240526353$24052635$3$F$20240607$20240913$20240705$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002800$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240930$$CN$US$US
240526362$24052636$2$F$20240611$20240903$20240705$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002801$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240926$$CN$US$US
240526372$24052637$2$F$20240606$20240807$20240705$20240814$EXP$$CA-CELLTRION INC.-2022CA007467$CELLTRION$$$$$$Y$$$20240814$$MD$CA$CA
240526381$24052638$1$I$$20240703$20240705$20240705$EXP$$NVSC2024US138938$NOVARTIS$$$$$$Y$$$20240705$$CN$US$US
240526391$24052639$1$I$$20240622$20240705$20240705$EXP$$EC-ROCHE-10000007735$ROCHE$$$$$$Y$$$20240705$$CN$EC$EC
240526401$24052640$1$I$$20240625$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR082394$VIIV$$$$$$Y$$$20240705$$HP$US$US
240526412$24052641$2$F$$20240726$20240705$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02414$AMNEAL$$$$$M$Y$$$20240806$$MD$US$US
240526421$24052642$1$I$20240318$20240611$20240705$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002124$ACADIA PHARMACEUTICALS$$53$YR$$M$Y$$$20240705$$CN$US$US
240526431$24052643$1$I$20240702$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132575$AMGEN$$82$YR$E$F$Y$$$20240704$$CN$US$US
240526441$24052644$1$I$$20240626$20240705$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-032365$AUROBINDO$Magro CM, Kalomeris T, Shreve CR, Geyer JT, Patel SS. Subcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administration. Leuk-Lymphoma. 2024;65(5):638-646$61$YR$$F$Y$$$20240705$$HP$US$US
240526452$24052645$2$F$20240702$20240705$20240705$20240708$PER$$US-AMGEN-USASP2024132160$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240526461$24052646$1$I$$20240626$20240705$20240705$EXP$$US-NOVITIUMPHARMA-2024USNVP01131$NOVITIUM PHARMA$Mohammad El-Atoum.Persistent neurological symptoms and elevated intracranial pressures in a previously healthy host with cryptococcal meningitis.BMC Infectious Diseases.14-JUN-2023;NA:1-4$55$YR$A$M$Y$$$20240705$$HP$US$US
240526472$24052647$2$F$$20240805$20240705$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407002588$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240807$$CN$US$US
240526481$24052648$1$I$$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407001001$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240705$$CN$US$US
240526491$24052649$1$I$$20240626$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406018632$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240705$$CN$US$US
240526503$24052650$3$F$20240820$20240905$20240705$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002771$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240926$$CN$US$US
240526511$24052651$1$I$20240614$20240627$20240705$20240705$EXP$$CN-BEIGENE-BGN-2024-009979$BEIGENE$$$$$$Y$$$20240705$$HP$CN$CN
240526523$24052652$3$F$20240701$20240806$20240705$20240808$PER$$US-AMGEN-USASP2024130375$AMGEN$$66$YR$E$F$Y$$$20240807$$CN$US$US
240526531$24052653$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA192819$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$CN$US$US
240526541$24052654$1$I$$20240704$20240705$20240705$EXP$$IL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037924$BOEHRINGER INGELHEIM$$7$YR$C$M$Y$$$20240705$$PH$IL$IL
240526551$24052655$1$I$20240601$20240627$20240705$20240705$PER$$US-SA-2024SA195046$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240705$$MD$US$US
240526561$24052656$1$I$$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A153194$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240526571$24052657$1$I$20240101$20240701$20240705$20240705$EXP$$US-UCBSA-2024033891$UCB$$$$$F$Y$$$20240705$$HP$US$US
240526581$24052658$1$I$20240701$20240702$20240705$20240705$EXP$$US-AstraZeneca-2024A152179$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240526591$24052659$1$I$$20240703$20240705$20240705$EXP$$NVSJ2024JP007996$NOVARTIS$$$$E$F$Y$$$20240705$$MD$JP$JP
240526601$24052660$1$I$20240620$20240627$20240705$20240705$EXP$$CN-BEIGENE-BGN-2024-009980$BEIGENE$$$$$$Y$$$20240705$$HP$CN$CN
240526611$24052661$1$I$$20240625$20240705$20240705$EXP$$JP-Umedica-000074$UMEDICA LABS$Sakurazawa C, Habuka M, Hoshino Y, Sakamaki Y, Ogawa A, Yamamoto S, Kinoshita H, Narita I. A case of multiorgan failure due to carbamazepine intoxication successfully treated with multimodal blood purification therapy. CEN Case Rep. 2024 Jun 18. doi: 10.1007/s13730-024-00900-3.$47$YR$$F$Y$$$20240628$$HP$JP$
240526621$24052662$1$I$$20240703$20240705$20240705$EXP$$CN-BEIGENE-BGN-2024-010277$BEIGENE$$$$$$Y$$$20240705$$CN$CN$CN
240526631$24052663$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5825992$ABBVIE$$25$YR$$F$Y$$$20240705$$HP$US$US
240526651$24052665$1$I$$20240626$20240705$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-032637$AUROBINDO$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al.. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease.. Rheumatology. 2024;63(5):1291-1296$68$YR$$M$Y$$$20240705$$HP$US$US
240526661$24052666$1$I$20240618$20240626$20240705$20240705$EXP$$NL-KOANAAP-SML-NL-2024-00624$Unknown Manufacturer$$49$YR$A$M$Y$130$KG$20240705$$MD$NL$NL
240526671$24052667$1$I$$20240624$20240705$20240705$EXP$$CA-HALEON-2183594$Haleon PLC$$40$YR$$F$Y$$$20240704$$HP$CA$CA
240526683$24052668$3$F$20230615$20240916$20240705$20240924$PER$$US-GSK-US2024079098$GLAXOSMITHKLINE$$31$YR$$F$Y$$$20240924$$CN$US$US
240526692$24052669$2$F$$20231202$20240705$20240925$EXP$$US-HALEON-2185100$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
240526702$24052670$2$F$20230516$20240628$20240705$20240706$EXP$$US-ABBVIE-5823436$ABBVIE$$66$YR$$M$Y$$$20240706$$CN$US$US
240526711$24052671$1$I$20240101$20240628$20240705$20240705$EXP$$US-ABBVIE-5823376$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240526731$24052673$1$I$20230901$20240703$20240705$20240705$EXP$$FR-JNJFOC-20240711007$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240705$$MD$FR$FR
240526741$24052674$1$I$20240629$20240702$20240705$20240705$PER$$US-JNJFOC-20240707423$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240705$$CN$US$US
240526765$24052676$5$F$$20240820$20240705$20240823$PER$$US-JNJFOC-20240702486$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240823$$HP$US$US
240526771$24052677$1$I$$20240626$20240705$20240705$EXP$$NZ-JNJFOC-20240712172$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$NZ$NZ
240526781$24052678$1$I$$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132690$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240526791$24052679$1$I$$20230814$20240705$20240705$PER$$US-AMGEN-USASP2023235433$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240526803$24052680$3$F$20230101$20240919$20240705$20240927$EXP$$US-ABBVIE-5824582$ABBVIE$$65$YR$$F$Y$72$KG$20240927$$CN$US$US
240526811$24052681$1$I$20240524$20240701$20240705$20240705$EXP$ES-AEMPS-1535352$ES-HALEON-2184972$Haleon PLC$$37$YR$$M$Y$$$20240704$$MD$ES$ES
240526831$24052683$1$I$$20240702$20240705$20240705$EXP$$NVSC2024US137823$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
240526841$24052684$1$I$20240505$20240624$20240705$20240705$EXP$ES-AEMPS-1538238$ES-GLENMARK PHARMACEUTICALS-2024GMK091932$GLENMARK$$$$$$Y$$$20240705$$PH$ES$ES
240526851$24052685$1$I$20240531$20240627$20240705$20240705$EXP$$CN-BEIGENE-BGN-2024-009985$BEIGENE$$$$$$Y$$$20240705$$HP$CN$CN
240526861$24052686$1$I$20240628$20240701$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105872$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$44.91$KG$20240705$$HP$US$US
240526872$24052687$2$F$20240629$20240718$20240705$20240722$PER$$US-AMGEN-USASP2024131082$AMGEN$$64$YR$A$F$Y$$$20240721$$CN$US$US
240526881$24052688$1$I$$20230509$20240705$20240705$PER$$US-AMGEN-USASP2023235474$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240526891$24052689$1$I$20240101$20240701$20240705$20240705$EXP$$PR-ABBVIE-5825410$ABBVIE$$$$$F$Y$$$20240705$$CN$PR$PR
240526901$24052690$1$I$20240702$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002604$ELI LILLY AND CO$$64$YR$A$$Y$$$20240705$$CN$US$US
240526911$24052691$1$I$20170801$20240620$20240705$20240705$EXP$$CA-JNJFOC-20240708638$JOHNSON AND JOHNSON$$40$YR$A$F$Y$73$KG$20240705$$MD$CA$CA
240526922$24052692$2$F$20240401$20240731$20240705$20240805$PER$$US-ROCHE-10000014769$ROCHE$$10$YR$C$M$Y$$$20240806$$CN$US$US
240526933$24052693$3$F$20240624$20240731$20240705$20240805$PER$$US-ROCHE-10000013555$ROCHE$$46$YR$A$F$Y$$$20240806$$CN$US$US
240526941$24052694$1$I$$20240626$20240705$20240705$PER$$US-ROCHE-10000014676$ROCHE$$64$YR$A$M$Y$$$20240705$$CN$US$US
240526952$24052695$2$F$20240610$20240709$20240705$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002754$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240731$$CN$US$US
240526962$24052696$2$F$$20240724$20240705$20240726$EXP$$GB-UCBSA-2024033811$UCB$$$$$F$Y$$$20240726$$CN$GB$GB
240526971$24052697$1$I$20240101$20240701$20240705$20240705$EXP$$US-UCBSA-2024033897$UCB$$$$$F$Y$$$20240705$$HP$US$US
240526983$24052698$3$F$20070618$20240711$20240705$20240718$EXP$$DE-HALEON-2184193$Haleon PLC$$58$YR$$F$Y$60$KG$20240717$$MD$DE$DE
240526992$24052699$2$F$$20240710$20240705$20240720$EXP$$US-TEVA-VS-3212263$TEVA$Andrews K, Meshinchi S, Marri P, Siddiqui AH, Polski J, Molina A, et al. Pediatric Acute Myeloid Leukemia with Co-Occurring BCR::ABL and CBFA2T3::GLIS2 Dual Fusion with Deep Response to FOLR1-Targeting Antibody Drug Conjugate Stro-002 and Tyrosine Kinase Inhibitor. Blood 2022; 140 (Suppl. 1) 11757-11758.; Vivekanandan DD, Singh H, Royall NA. Case report: a case report of neoadjuvant mFOLFIRINOX leading to a partial pathologic response in pancreatic adenosquamous carcinoma. J-Surg-Case-Rep 202...$$$$F$Y$$$20240720$$HP$US$US
240527001$24052700$1$I$20240123$20240627$20240705$20240705$EXP$$FR-CELLTRION INC.-2024FR015822$CELLTRION$$$$$$Y$$$20240705$$MD$FR$FR
240527012$24052701$2$F$$20240819$20240705$20240821$PER$$US-AMGEN-USASP2024132017$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
240527021$24052702$1$I$$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132809$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240527032$24052703$2$F$20240601$20240705$20240705$20240708$PER$$US-AMGEN-USASP2024129433$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240527042$24052704$2$F$$20240802$20240705$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002820$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
240527051$24052705$1$I$$20240304$20240705$20240705$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00301$TARO$$$$$$Y$$$20240705$$CN$US$US
240527061$24052706$1$I$20231126$20231128$20240705$20240705$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01273$TARO$$$$$$Y$$$20240705$$CN$US$US
240527071$24052707$1$I$$20240627$20240705$20240705$EXP$$CA-TOLMAR, INC.-24CA050600$TOLMAR$$$$$M$Y$$$20240705$$CN$CA$CA
240527081$24052708$1$I$$20240626$20240705$20240705$EXP$$CA-TOLMAR, INC.-24CA050546$TOLMAR$$40$YR$$F$Y$$$20240705$$MD$CA$CA
240527091$24052709$1$I$20230101$20240627$20240705$20240705$EXP$$US-TOLMAR, INC.-24US050672$TOLMAR$Chalker C., Yilmaz B., Trone K., Parecki G., Chen A., Lim J.Y., Mallak N., Sokolova A.O.. Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule. npj Precision Oncology. 2024;8:132$$$E$M$Y$$$20240705$$MD$US$US
240527101$24052710$1$I$$20240125$20240705$20240705$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00118$TARO$$$$$$Y$$$20240705$$CN$US$US
240527111$24052711$1$I$$20240703$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106807$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240705$$CN$US$US
240527122$24052712$2$F$$20240730$20240705$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-105350$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$MD$JP$JP
240527131$24052713$1$I$$20240617$20240705$20240705$EXP$$US-TEVA-VS-3212346$TEVA$Jumaili WA, Gburi NA, Chaudhary N, Brown K, Jain S. Two Cases of Montelukast-Associated Psychosis in Children. Prim-Care-Companion-CNS-Disord 2024; 26 (3):.$11$YR$$M$Y$$$20240705$$MD$US$US
240527141$24052714$1$I$20231001$20240623$20240705$20240705$PER$$US-ROCHE-10000015608$ROCHE$$83$YR$E$$Y$$$20240705$$CN$US$US
240527151$24052715$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5826821$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240527162$24052716$2$F$$20240711$20240705$20240721$EXP$$US-TEVA-VS-3212258$TEVA$Portillo DU, Lathrop K. A rare unilateral expression of hand-foot syndrome: a case report. Cancer-Res 2024; 84 (Suppl.) (9): abstr. PO1-20-09.; Portillo DU, Lathrop K. A rare unilateral expression of hand-foot syndrome: a case report. Cancer-Res 2024; 84 (Suppl.) (9): abstr. PO1-20-09.$38$YR$$F$Y$$$20240721$$HP$US$US
240527171$24052717$1$I$20240101$20240628$20240705$20240705$PER$$US-SA-2024SA197866$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240705$$MD$US$US
240527182$24052718$2$F$20240101$20240701$20240705$20240710$PER$$US-SA-2024SA196017$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240710$$MD$US$US
240527191$24052719$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA194627$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240705$$MD$US$US
240527201$24052720$1$I$20240501$20240628$20240705$20240705$PER$$US-SA-2024SA193561$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240705$$HP$US$US
240527211$24052721$1$I$$20231211$20240705$20240705$PER$$US-AMGEN-USASP2023235266$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240527222$24052722$2$F$$20240802$20240705$20240806$PER$$US-ALXN-202406USA001909US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240527232$24052723$2$F$$20240814$20240705$20240823$30DAY$$US-GSK-US2024081051$GLAXOSMITHKLINE$$$$$M$Y$$$20240823$$CN$US$US
240527241$24052724$1$I$$20240703$20240705$20240705$EXP$$US-UCBSA-2024033830$UCB$$$$$F$Y$$$20240705$$CN$US$US
240527252$24052725$2$F$20240617$20240725$20240705$20240729$EXP$$JP-TAKEDA-2024TJP009901$TAKEDA$$41$YR$$F$Y$$$20240729$$HP$JP$JP
240527261$24052726$1$I$$20240612$20240705$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002825$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240527281$24052728$1$I$$20230707$20240705$20240705$EXP$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00762$TARO$$$$$$Y$$$20240705$$CN$US$US
240527291$24052729$1$I$$20240627$20240705$20240705$EXP$$CA-HALEON-2184015$Haleon PLC$$40$YR$$F$Y$$$20240704$$HP$CA$CA
240527301$24052730$1$I$20240630$20240701$20240705$20240705$PER$$US-LEO Pharma-371705$LEO PHARM$$73$YR$$F$Y$$$20240705$$CN$US$US
240527311$24052731$1$I$20240501$20240703$20240705$20240705$EXP$DK-DKMA-30733865$DK-JNJFOC-20240711994$JOHNSON AND JOHNSON$$72$YR$E$F$Y$115$KG$20240705$$MD$DK$DK
240527322$24052732$2$F$20240701$20240704$20240705$20240708$PER$$US-AMGEN-USASP2024132474$AMGEN$$73$YR$E$M$Y$$$20240708$$CN$US$US
240527332$24052733$2$F$$20240701$20240705$20240709$EXP$$JP-AstraZeneca-2024A150682$ASTRAZENECA$$$$$F$Y$$$20240709$$PH$JP$
240527342$24052734$2$F$$20240803$20240705$20240813$PER$$US-ROCHE-10000013350$ROCHE$$$$$$Y$$$20240813$$CN$US$US
240527351$24052735$1$I$$20240627$20240705$20240705$EXP$$ZA-AstraZeneca-2024A150163$ASTRAZENECA$$81$YR$$F$Y$$$20240705$$CN$ZA$
240527361$24052736$1$I$20240529$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A152426$ASTRAZENECA$$31431$DY$$F$Y$$$20240705$$CN$US$
240527371$24052737$1$I$20240620$20240702$20240705$20240705$EXP$$US-AstraZeneca-2024A152595$ASTRAZENECA$$27017$DY$$M$Y$$$20240705$$CN$US$
240527381$24052738$1$I$$20240702$20240705$20240705$EXP$$US-GSK-US2024082224$GLAXOSMITHKLINE$$8$DEC$$F$Y$$$20240705$$HP$US$US
240527391$24052739$1$I$$20240701$20240705$20240705$EXP$$US-GSK-US2024AMR081958$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$US$US
240527401$24052740$1$I$$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A148872$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240527411$24052741$1$I$$20231017$20240705$20240705$PER$$US-AMGEN-USASP2023235587$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240527421$24052742$1$I$$20231129$20240705$20240705$PER$$US-AMGEN-USASP2023235552$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240527432$24052743$2$F$$20240210$20240705$20240916$EXP$$US-HALEON-2185125$Haleon PLC$$$$$$Y$$$20240916$$CN$US$US
240527441$24052744$1$I$$20240702$20240705$20240705$EXP$$GB-ABBVIE-5825841$ABBVIE$$$$E$F$Y$$$20240705$$CN$GB$GB
240527451$24052745$1$I$20240101$20240701$20240705$20240705$EXP$$US-ABBVIE-5824226$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240527461$24052746$1$I$20240101$20240626$20240705$20240705$EXP$$CA-APOTEX-2024AP007873$APOTEX$$$$E$M$Y$$$20240705$$PH$CA$CA
240527471$24052747$1$I$$20240621$20240705$20240705$PER$$US-ROCHE-10000009763$ROCHE$$$$$$Y$$$20240705$$CN$US$US
240527482$24052748$2$F$$20240710$20240705$20240720$EXP$$NL-TEVA-VS-3212079$TEVA$Diercks GFH, Meijer JM, Bolling MC, Scholtens-Jaegers SMHJ, Bremer J, Horvath B. Absence of epidermal antibodies in stevens-johnson syndrome/toxic epidermal necrolysis patients but beware of single positive results. Dermatology Research and Practice. 2024;2024:1-5.; Diercks GFH, Meijer JM, Bolling MC, Scholtens-Jaegers SMHJ, Bremer J, Horvath B. Absence of epidermal antibodies in stevens-johnson syndrome/toxic epidermal necrolysis patients but beware of single positive results. Dermatology Re...$60$YR$$M$Y$$$20240720$$HP$NL$NL
240527491$24052749$1$I$$20240624$20240705$20240705$PER$$US-ROCHE-10000014416$ROCHE$$$$A$F$Y$$$20240705$$CN$US$US
240527501$24052750$1$I$$20240625$20240705$20240705$PER$$US-ROCHE-10000014347$ROCHE$$$$$$Y$$$20240705$$MD$US$US
240527511$24052751$1$I$$20231220$20240705$20240705$PER$$US-AMGEN-USASP2023235314$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240527521$24052752$1$I$20240625$20240627$20240705$20240705$PER$$US-ROCHE-10000015450$ROCHE$$$$$F$Y$$$20240705$$CN$US$US
240527531$24052753$1$I$$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407000987$ELI LILLY AND CO$$66$YR$E$$Y$$$20240705$$CN$US$US
240527541$24052754$1$I$20230624$20240624$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406016466$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240705$$CN$US$US
240527551$24052755$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003383$ELI LILLY AND CO$$73$YR$E$$Y$$$20240705$$CN$US$US
240527561$24052756$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002683$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240705$$CN$US$US
240527571$24052757$1$I$20240516$20240628$20240705$20240705$EXP$$CN-BEIGENE-BGN-2024-010010$BEIGENE$$$$$$Y$$$20240705$$HP$CN$CN
240527582$24052758$2$F$20240629$20240709$20240705$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407001200$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240712$$CN$US$US
240527591$24052759$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002680$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240705$$CN$US$US
240527601$24052760$1$I$20230701$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407001243$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240705$$CN$US$US
240527611$24052761$1$I$20240703$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002701$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240705$$CN$US$US
240527621$24052762$1$I$$20240628$20240705$20240705$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001340$BLUEPRINT MEDICINES$$$$$F$Y$$$20240705$$CN$US$US
240527633$24052763$3$F$20240628$20240814$20240705$20240916$EXP$$CA-ABBVIE-5825125$ABBVIE$$55$YR$$M$Y$$$20240916$$CN$CA$CA
240527641$24052764$1$I$$20240624$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101550$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240705$$HP$US$US
240527651$24052765$1$I$$20240628$20240705$20240705$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001341$BLUEPRINT MEDICINES$$$$$M$Y$$$20240705$$CN$US$US
240527661$24052766$1$I$20240601$20240628$20240705$20240705$EXP$$US-ABBVIE-5824579$ABBVIE$$52$YR$$F$Y$$$20240705$$CN$US$US
240527671$24052767$1$I$$20240621$20240705$20240705$PER$$US-SA-2024SA190696$SANOFI AVENTIS$$$$A$F$Y$60.78$KG$20240705$$MD$US$US
240527682$24052768$2$F$$20240626$20240705$20240711$EXP$$CA-HALEON-2183186$Haleon PLC$$$$$F$Y$97$KG$20240711$$MD$CA$CA
240527691$24052769$1$I$$20240625$20240705$20240705$PER$$US-ROCHE-10000014558$ROCHE$$$$$F$Y$$$20240705$$CN$US$US
240527701$24052770$1$I$$20240627$20240705$20240705$PER$$US-SA-2024SA195247$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240527711$24052771$1$I$20231201$20240628$20240705$20240705$PER$$US-SA-2024SA196691$SANOFI AVENTIS$$31$YR$A$F$Y$61.23$KG$20240705$$MD$US$US
240527722$24052772$2$F$$20240708$20240705$20240717$PER$$US-SA-2024SA197562$SANOFI AVENTIS$$54$YR$A$F$Y$77$KG$20240717$$MD$US$US
240527731$24052773$1$I$$20240701$20240705$20240705$PER$$US-SA-2024SA196435$SANOFI AVENTIS$$$$$M$Y$$$20240705$$CN$US$US
240527743$24052774$3$F$20240601$20240628$20240705$20240712$PER$$US-SA-2024SA190188$SANOFI AVENTIS$$13$YR$T$M$Y$40.8$KG$20240712$$MD$US$US
240527751$24052775$1$I$$20240625$20240705$20240705$PER$$US-SA-2024SA191137$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240705$$MD$US$US
240527761$24052776$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024132283$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240527771$24052777$1$I$20240701$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131606$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240527781$24052778$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131203$AMGEN$$$$$F$Y$$$20240704$$CN$US$US
240527791$24052779$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024132268$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240527801$24052780$1$I$$20240624$20240705$20240705$EXP$$US-MSNLABS-2024MSNLIT01437$MSN LABORATORIES$Deshpande P, Vyata V, Diaz-Abad M, Konikkara J.Sleep-related Hallucinations.Sleep.2024;47 (1):A511$$$$$Y$$$20240705$$HP$US$US
240527811$24052781$1$I$$20240625$20240705$20240705$PER$$US-TEVA-VS-3213717$TEVA$$$$$$Y$$$20240705$$PH$US$US
240527821$24052782$1$I$$20240625$20240705$20240705$PER$$US-ROCHE-10000013188$ROCHE$$$$A$F$Y$$$20240705$$CN$US$US
240527831$24052783$1$I$20240701$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131058$AMGEN$$63$YR$A$F$Y$$$20240704$$CN$US$US
240527841$24052784$1$I$$20240627$20240705$20240705$EXP$$GB-AMGEN-GBRNI2024131958$AMGEN$$$$$F$Y$$$20240704$$PH$GB$GB
240527851$24052785$1$I$$20240703$20240705$20240705$EXP$$BE-AMGEN-BELSP2024132309$AMGEN$$$$$M$Y$$$20240704$$MD$BE$BE
240527861$24052786$1$I$$20240123$20240705$20240705$PER$$US-AMGEN-USASP2024131497$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240527871$24052787$1$I$$20240703$20240705$20240705$EXP$$JP-ASTELLAS-2024JP004640$ASTELLAS$$$$$M$Y$$$20240705$$PH$JP$JP
240527881$24052788$1$I$$20240628$20240705$20240705$PER$$US-BIOGEN-2024BI01271718$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
240527891$24052789$1$I$$20240628$20240705$20240705$PER$$US-BIOGEN-2024BI01272011$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
240527901$24052790$1$I$$20240628$20240705$20240705$PER$$US-BIOGEN-2024BI01271752$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
240527912$24052791$2$F$20240501$20240702$20240705$20240709$PER$$US-BIOGEN-2024BI01270412$BIOGEN$$51$YR$$F$Y$$$20240709$$CN$US$US
240527931$24052793$1$I$$20240626$20240705$20240705$30DAY$$US-GSK-US2024079874$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240527941$24052794$1$I$20240101$20240627$20240705$20240705$EXP$$CA-CELLTRION INC.-2024CA006221$CELLTRION$$$$$$Y$$$20240705$$MD$CA$CA
240527951$24052795$1$I$$20240625$20240705$20240705$EXP$$US-GSK-US2024AMR079961$GLAXOSMITHKLINE$$$$$F$Y$78$KG$20240705$$CN$US$US
240527961$24052796$1$I$$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151021$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240527971$24052797$1$I$20240402$20240702$20240705$20240705$EXP$$US-AstraZeneca-2024A152299$ASTRAZENECA$$$$$$Y$$$20240705$$CN$US$
240527982$24052798$2$F$20240623$20240821$20240705$20240831$PER$$US-AstraZeneca-2024A145663$ASTRAZENECA$$30751$DY$$F$Y$$$20240831$$CN$US$
240527992$24052799$2$F$$20240703$20240705$20240708$EXP$$US-AstraZeneca-2024A153064$ASTRAZENECA$$$$$M$Y$$$20240708$$HP$US$
240528002$24052800$2$F$$20231128$20240705$20240918$EXP$$US-HALEON-2185146$Haleon PLC$$$$$$Y$$$20240918$$CN$US$US
240528011$24052801$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131550$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240528021$24052802$1$I$$20240626$20240705$20240705$PER$$US-AMGEN-USASP2024131558$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240528031$24052803$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130492$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240528042$24052804$2$F$20240607$20240708$20240705$20240709$PER$$US-AMGEN-USASP2024130747$AMGEN$$21$YR$A$F$Y$$$20240709$$HP$US$US
240528051$24052805$1$I$$20240626$20240705$20240705$PER$$US-AMGEN-USASP2024132840$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240528061$24052806$1$I$$20240617$20240705$20240705$EXP$$CA-002147023-NVSC2021CA296035$Haleon PLC$$44$YR$$F$Y$$$20240704$$HP$CA$CA
240528072$24052807$2$F$$20240705$20240705$20240709$EXP$$TW-ASTELLAS-2024US018501$ASTELLAS$$40$YR$$F$Y$$$20240709$$CN$TW$TW
240528081$24052808$1$I$20240601$20240624$20240705$20240705$EXP$$FR-CIPLA LTD.-2024FR06831$CIPLA$$$$$$Y$$$20240705$$MD$FR$FR
240528091$24052809$1$I$$20240626$20240705$20240705$EXP$E2B_07063878$CA-USP-004883$USPHARMA$$66$YR$E$M$Y$$$20240705$$HP$CA$CA
240528101$24052810$1$I$$20240626$20240705$20240705$EXP$001084682$CA-USP-004882$USPHARMA$$71$YR$E$F$Y$$$20240705$$HP$CA$CA
240528112$24052811$2$F$$20240625$20240705$20240716$EXP$$CA-HALEON-2183855$Haleon PLC$$56$YR$$F$Y$$$20240715$$HP$CA$CA
240528121$24052812$1$I$$20240626$20240705$20240705$EXP$$IN-STL-000208$Stallion Laboratories$Khadela A, Dave B, Premal Y, Patel N, Sadhwani D. The Phenytoin Ataxia Enigma Unveiled ^^A Case Report^^. J Pharm Pract. 2024 Jun 13:8971900241262379. doi: 10.1177/08971900241262379.$16$YR$$M$Y$$$20240705$$PH$IN$IN
240528131$24052813$1$I$20200101$20240624$20240705$20240705$EXP$FR-EMA-DD-20200311-abdul_j-175516$FR-CIPLA LTD.-2024FR06811$CIPLA$$$$$$Y$$$20240705$$MD$FR$FR
240528141$24052814$1$I$20240614$20240628$20240705$20240705$EXP$$CN-BEIGENE-BGN-2024-010011$BEIGENE$$$$$$Y$$$20240705$$HP$CN$CN
240528151$24052815$1$I$20240411$20240703$20240705$20240705$EXP$$JP-ASTELLAS-2024JP002493$ASTELLAS$$67$YR$$M$Y$$$20240705$$HP$JP$JP
240528162$24052816$2$F$20240624$20240627$20240705$20240712$EXP$$ZA-GLENMARK PHARMACEUTICALS-2024GMK091942$GLENMARK$$$$$$Y$$$20240712$$MD$ZA$ZA
240528172$24052817$2$F$20231007$20240726$20240705$20240731$EXP$FR-AFSSAPS-TO2024001215$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-107071$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$57$KG$20240731$$PH$FR$FR
240528181$24052818$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05744$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240528191$24052819$1$I$20240701$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130639$AMGEN$$47$YR$A$M$Y$$$20240704$$CN$US$US
240528201$24052820$1$I$20240601$20240625$20240705$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019268$UNITED THERAPEUTICS$$64$YR$$F$Y$118.82$KG$20240705$$$US$US
240528214$24052821$4$F$$20240617$20240705$20240805$EXP$$CA-HALEON-2183482$Haleon PLC$$44$YR$$F$Y$97$KG$20240805$$HP$CA$CA
240528221$24052822$1$I$20240615$20240624$20240705$20240705$EXP$$CN-ASTELLAS-2024US018662$ASTELLAS$$74$YR$$M$Y$$$20240705$$CN$CN$CN
240528231$24052823$1$I$$20240629$20240705$20240705$EXP$$ZA-HALEON-2184636$Haleon PLC$$$$$$Y$$$20240705$$CN$ZA$ZA
240528241$24052824$1$I$$20240626$20240705$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-033091$AUROBINDO$Locke M, Kohn N, Seetharamu N. Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas. Clin-Otolaryngol. 2023;48(6):915-919$$$$$Y$$$20240705$$HP$US$US
240528251$24052825$1$I$$20240624$20240705$20240705$EXP$$BR-MSNLABS-2024MSNLIT01447$MSN LABORATORIES$Costa F, Silva A, Pedroso L, Biancardi A, Curi A.Bilateral acute depigmentation of the iris (BADI) and bilateral acute iris transillumination (BAIT): A case series from a center in Brazil.Arquivos Brasileiros de Oftalmologia.2024;87(4):1-4$$$$$Y$$$20240705$$MD$BR$BR
240528261$24052826$1$I$20240101$20240701$20240705$20240705$EXP$$US-AMGEN-USASP2024130098$AMGEN$$78$YR$E$F$Y$$$20240704$$CN$US$US
240528271$24052827$1$I$20240630$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130829$AMGEN$$58$YR$A$F$Y$$$20240704$$CN$US$US
240528281$24052828$1$I$20240601$20240628$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407000962$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240705$$CN$US$US
240528291$24052829$1$I$$20240625$20240705$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002993$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
240528301$24052830$1$I$$20240624$20240705$20240705$EXP$$CA-HALEON-2183414$Haleon PLC$$43$YR$$F$Y$96$KG$20240704$$HP$CA$CA
240528311$24052831$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05704$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240528321$24052832$1$I$20240628$20240628$20240705$20240705$PER$$US-AMGEN-USASP2024129651$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240528331$24052833$1$I$$20231023$20240705$20240705$PER$$US-AMGEN-USASP2023235569$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240528341$24052834$1$I$20240701$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131080$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240528351$24052835$1$I$$20240626$20240705$20240705$PER$$US-ROCHE-10000014491$ROCHE$$$$A$F$Y$$$20240705$$CN$US$US
240528361$24052836$1$I$$20231226$20240705$20240705$PER$$US-AMGEN-USASP2023235582$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240528371$24052837$1$I$$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151012$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240528381$24052838$1$I$20240429$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151153$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240528391$24052839$1$I$20240604$20240624$20240705$20240705$EXP$$FR-HALEON-2183920$Haleon PLC$$52$YR$$M$Y$73$KG$20240704$$PH$FR$FR
240528401$24052840$1$I$$20240627$20240705$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-024482$AUROBINDO$Van Gompel JJ, Hong S, Mahajan A, Shinya Y, Laack NN, Link MJ, et al. Longitudinal treatment outcomes of recurrent clival chordomas: a single-center retrospective study. J-Neurosurg. 2023;140(4):920-928$44$YR$$M$Y$$$20240705$$MD$US$US
240528421$24052842$1$I$20240101$20240628$20240705$20240705$PER$$US-SA-2024SA195424$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240705$$CN$US$US
240528431$24052843$1$I$$20240628$20240705$20240705$EXP$$US-JNJFOC-20240678098$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240705$$HP$US$US
240528443$24052844$3$F$20240101$20240627$20240705$20240710$PER$$US-SA-2024SA195634$SANOFI AVENTIS$$$$A$F$Y$146$KG$20240710$$CN$US$US
240528451$24052845$1$I$20130101$20240624$20240705$20240705$EXP$$AU-BEH-2024174739$CSL BEHRING$$$$$F$Y$$$20240705$$CN$AU$AU
240528461$24052846$1$I$20230525$20240703$20240705$20240705$PER$$US-BIOVITRUM-2024-US-009462$BIOVITRUM$$79$YR$$M$Y$$$20240705$$CN$US$US
240528471$24052847$1$I$$20240624$20240705$20240705$EXP$$BR-MSNLABS-2024MSNLIT01448$MSN LABORATORIES$Costa F, Silva A, Pedroso L, Biancardi A, Curi A.Bilateral acute depigmentation of the iris (BADI) and bilateral acute iris transillumination (BAIT): A case series from a center in Brazil.Arquivos Brasileiros de Oftalmologia.2024;87(4):1-4$$$$$Y$$$20240705$$MD$BR$BR
240528483$24052848$3$F$20240601$20240805$20240705$20240809$EXP$$JP-JNJFOC-20240713477$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240809$$MD$JP$JP
240528491$24052849$1$I$$20240703$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106673$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$58.17$KG$20240705$$HP$US$US
240528501$24052850$1$I$$20240628$20240705$20240705$EXP$$GB-JNJFOC-20240679040$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240705$$MD$GB$GB
240528511$24052851$1$I$$20240617$20240705$20240705$EXP$$CA-002147023-NVSC2024CA010739$Haleon PLC$$44$YR$$F$Y$97$KG$20240704$$HP$CA$CA
240528522$24052852$2$F$20240615$20240917$20240705$20240920$EXP$$US-JNJFOC-20240675001$JOHNSON AND JOHNSON$$51$YR$$F$Y$$$20240920$$CN$US$US
240528532$24052853$2$F$$20240709$20240705$20240717$EXP$$JP-JNJFOC-20240702747$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240718$$HP$JP$JP
240528541$24052854$1$I$20240501$20240628$20240705$20240705$PER$$US-SA-2024SA197755$SANOFI AVENTIS$$$$A$F$Y$83.91$KG$20240705$$MD$US$US
240528551$24052855$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA196222$SANOFI AVENTIS$$$$T$F$Y$$$20240705$$MD$US$US
240528561$24052856$1$I$20220622$20240703$20240705$20240705$PER$$US-BIOVITRUM-2024-US-009473$BIOVITRUM$$71$YR$$M$Y$$$20240705$$CN$US$US
240528571$24052857$1$I$$20231227$20240705$20240705$PER$$US-AMGEN-USASP2023235583$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240528581$24052858$1$I$$20240703$20240705$20240705$PER$$NVSC2024US139313$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
240528601$24052860$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131858$AMGEN$$$$$M$Y$$$20240704$$CN$US$US
240528611$24052861$1$I$$20231226$20240705$20240705$PER$$US-AMGEN-USASP2023235575$AMGEN$$$$$$Y$$$20240704$$HP$US$US
240528621$24052862$1$I$$20240422$20240705$20240705$PER$$US-AMGEN-USASP2024130043$AMGEN$$$$$$Y$$$20240704$$MD$US$US
240528632$24052863$2$F$20240331$20240828$20240705$20240830$EXP$IT-009507513-2406ITA008119$IT-VIIV HEALTHCARE LIMITED-IT2024082547$VIIV$$$$$$Y$$$20240830$$MD$IT$IT
240528641$24052864$1$I$20240624$20240627$20240705$20240705$30DAY$$US-GSK-US2024080353$GLAXOSMITHKLINE$$65$YR$$M$Y$$$20240705$$CN$US$US
240528655$24052865$5$F$$20240814$20240705$20240822$30DAY$$US-JNJFOC-20240706429$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$PH$US$US
240528662$24052866$2$F$20240301$20240822$20240705$20240830$EXP$$DE-ROCHE-10000013550$ROCHE$$52$YR$A$F$Y$67$KG$20240830$$MD$DE$DE
240528671$24052867$1$I$20220701$20240627$20240705$20240705$EXP$$FR-CELLTRION INC.-2024FR015934$CELLTRION$$$$$$Y$$$20240705$$MD$FR$FR
240528681$24052868$1$I$$20240702$20240705$20240705$EXP$$BR-Bion-013367$BIONPHARMA$$55$YR$A$M$Y$$$20240705$$HP$BR$BR
240528691$24052869$1$I$$20240702$20240705$20240705$EXP$$PT-Bion-013364$BIONPHARMA$$63$YR$A$F$Y$$$20240705$$HP$PT$PT
240528701$24052870$1$I$$20240626$20240705$20240705$EXP$$US-Bion-013360$BIONPHARMA$$76$YR$E$M$Y$$$20240705$$CN$US$US
240528712$24052871$2$F$$20240715$20240705$20240722$PER$$US-ALXN-202406USA001804US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
240528722$24052872$2$F$$20240708$20240705$20240717$PER$$US-AMGEN-USASP2024132027$AMGEN$$76$YR$E$F$Y$$$20240717$$CN$US$US
240528731$24052873$1$I$$20240516$20240705$20240705$PER$$US-AMGEN-USASP2024132472$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240528741$24052874$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131181$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240528751$24052875$1$I$20240701$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130996$AMGEN$$60$YR$A$F$Y$$$20240704$$CN$US$US
240528762$24052876$2$F$20240701$20240703$20240705$20240716$PER$$US-AMGEN-USASP2024131840$AMGEN$$63$YR$A$M$Y$$$20240715$$CN$US$US
240528771$24052877$1$I$$20240626$20240705$20240705$EXP$$US-APOTEX-2024AP007889$APOTEX$Rubannelsonkumar C, Hornak J.. Treatment of Mucormycosis Infection With Combination Therapy Using Echinocandin and Amphotericin B. American Journal of Respiratory and Critical Care Medicine. 2024;209$46$YR$$M$Y$$$20240705$$HP$US$US
240528782$24052878$2$F$20240318$20240628$20240705$20240710$EXP$$CN-JNJFOC-20240701693$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240710$$HP$CN$CN
240528791$24052879$1$I$20240101$20240701$20240705$20240705$PER$$US-SA-2024SA196684$SANOFI AVENTIS$$12$YR$T$M$Y$67.131$KG$20240705$$MD$US$US
240528801$24052880$1$I$$20240626$20240705$20240705$PER$$US-SA-2021SA401638$SANOFI AVENTIS$$$$E$F$Y$80.7$KG$20240705$$MD$US$US
240528822$24052882$2$F$$20240705$20240705$20240713$PER$$US-SA-2024SA198046$SANOFI AVENTIS$$$$E$M$Y$86.18$KG$20240713$$MD$US$US
240528841$24052884$1$I$$20240624$20240705$20240705$EXP$$BR-MSNLABS-2024MSNLIT01450$MSN LABORATORIES$Costa F, Silva A, Pedroso L, Biancardi A, Curi A.Bilateral acute depigmentation of the iris (BADI) and bilateral acute iris transillumination (BAIT): A case series from a center in Brazil.Arquivos Brasileiros de Oftalmologia.2024;87(4):1-4$$$$$Y$$$20240705$$MD$BR$BR
240528852$24052885$2$F$20240623$20240916$20240705$20240925$PER$$US-GSK-US2024079887$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240925$$HP$US$US
240528861$24052886$1$I$20240601$20240628$20240705$20240705$EXP$$US-ABBVIE-5824201$ABBVIE$$45$YR$$F$Y$$$20240705$$CN$US$US
240528871$24052887$1$I$$20240627$20240705$20240705$EXP$$US-INTERCEPT-PM2024001318$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240528882$24052888$2$F$20240101$20240718$20240705$20240726$EXP$$US-INTERCEPT-PM2024001316$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
240528891$24052889$1$I$$20240624$20240705$20240705$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05717$LUPIN$Faris M, Saad E, Abdulrahman A, Albanna M, Friedman H. A life-threatening bradyarrhythmia in the ICU: Beware of Phenytoin loading!. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3646$75$YR$$F$Y$$$20240705$$HP$US$US
240528902$24052890$2$F$20240617$20240725$20240705$20240802$EXP$$US-INTERCEPT-PM2024001323$INTERCEPT PHARMACEUTICALS$$65$YR$$F$Y$$$20240802$$CN$US$US
240528912$24052891$2$F$20240501$20240725$20240705$20240802$EXP$$US-INTERCEPT-PM2024001328$INTERCEPT PHARMACEUTICALS$$44$YR$$F$Y$59.864$KG$20240802$$HP$US$US
240528922$24052892$2$F$20240101$20240716$20240705$20240725$EXP$$US-INTERCEPT-PM2024001301$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
240528931$24052893$1$I$20240604$20240628$20240705$20240705$EXP$$US-JNJFOC-20240700075$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240705$$CN$US$US
240528941$24052894$1$I$$20240624$20240705$20240705$PER$$US-AstraZeneca-2024A145835$ASTRAZENECA$$$$$$Y$$$20240705$$CN$US$
240528951$24052895$1$I$$20240627$20240705$20240705$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01147$NOVITIUM PHARMA$Zhen Fan.From pill to pain: Alendronate-induced esophageal injury-A case report and review.Journal of Gastroenterology and Hepatology Foundation.02-JUN-2024;8(6):e13080$62$YR$A$$Y$$$20240705$$HP$CN$CN
240528961$24052896$1$I$20240618$20240620$20240705$20240705$EXP$$CN-Hisun Pharmaceuticals-2158864$HISUN PHARMACEUTICALS$$37$YR$$M$Y$$$20240705$$$CN$CN
240528971$24052897$1$I$$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407001892$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240705$$CN$US$US
240528981$24052898$1$I$$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003147$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240705$$CN$US$US
240528991$24052899$1$I$$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002173$ELI LILLY AND CO$$$$$$Y$$$20240705$$CN$US$US
240529001$24052900$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002970$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240705$$CN$US$US
240529011$24052901$1$I$20240703$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002719$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240705$$CN$US$US
240529021$24052902$1$I$20240702$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002989$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240705$$CN$US$US
240529031$24052903$1$I$20240701$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003376$ELI LILLY AND CO$$54$YR$A$$Y$$$20240705$$CN$US$US
240529051$24052905$1$I$$20240625$20240705$20240705$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004755$BIOCON$$$$$$Y$$$20240705$$HP$CA$CA
240529061$24052906$1$I$$20231002$20240705$20240705$PER$$US-AMGEN-USASP2023235528$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240529072$24052907$2$F$20240101$20240805$20240705$20240806$PER$$US-AMGEN-USASP2024130931$AMGEN$$57$YR$A$F$Y$$$20240806$$PH$US$US
240529081$24052908$1$I$20240301$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131896$AMGEN$$67$YR$E$F$Y$$$20240704$$HP$US$US
240529091$24052909$1$I$20240630$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130707$AMGEN$$50$YR$A$F$Y$$$20240704$$CN$US$US
240529101$24052910$1$I$$20240201$20240705$20240705$PER$$US-AMGEN-USASP2024131588$AMGEN$$$$$$Y$$$20240704$$PH$US$US
240529111$24052911$1$I$$20240624$20240705$20240705$EXP$$BR-MSNLABS-2024MSNLIT01451$MSN LABORATORIES$Costa F, Silva A, Pedroso L, Biancardi A, Curi A.Bilateral acute depigmentation of the iris (BADI) and bilateral acute iris transillumination (BAIT): A case series from a center in Brazil.Arquivos Brasileiros de Oftalmologia.2024;87(4):1-4$$$$$Y$$$20240705$$MD$BR$BR
240529121$24052912$1$I$$20240625$20240705$20240705$PER$$US-TEVA-VS-3213698$TEVA$$$$E$F$Y$$$20240705$$HP$US$US
240529135$24052913$5$F$$20240819$20240705$20240820$PER$$US-ROCHE-10000013215$ROCHE$$$$A$M$Y$72.57$KG$20240820$$CN$US$US
240529141$24052914$1$I$20220101$20240625$20240705$20240705$PER$$US-009507513-2407USA000613$MERCK$$$$$F$Y$$$20240705$$MD$US$US
240529151$24052915$1$I$20130101$20240625$20240705$20240705$EXP$$ES-EMD Serono-2024031402$EMD SERONO INC$$51$YR$A$M$Y$90$KG$20240705$$CN$ES$ES
240529161$24052916$1$I$$20240621$20240705$20240705$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001631$IPCA$M Elsayed. An interesting case of drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis with pulmonary and renal involvement. Am J Respir Crit Care Med. 2024;209:A5780$$$$$Y$$$20240705$$HP$US$US
240529171$24052917$1$I$$20240626$20240705$20240705$EXP$$CN-PBT-009471$PANACEA BIOTEC$Xu X, Zhang H, Liu L, Fu Q, Wu C, Lin X, et al. Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients. Eur J Clin Pharmacol. 2024 May 1. doi: 10.1007/s00228-024-03691-9.$28$YR$A$M$Y$$$20240705$$HP$CN$CN
240529181$24052918$1$I$20240509$20240626$20240705$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014504$UNITED THERAPEUTICS$$59$YR$$F$Y$68.481$KG$20240705$$$US$US
240529191$24052919$1$I$$20240626$20240705$20240705$EXP$$CN-PBT-009472$PANACEA BIOTEC$Xu X, Zhang H, Liu L, Fu Q, Wu C, Lin X, et al. Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients. Eur J Clin Pharmacol. 2024 May 1. doi: 10.1007/s00228-024-03691-9.$53$YR$A$M$Y$$$20240705$$HP$CN$CN
240529201$24052920$1$I$$20240626$20240705$20240705$EXP$$CN-PBT-009465$PANACEA BIOTEC$Xu X, Zhang H, Liu L, Fu Q, Wu C, Lin X, et al. Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients. Eur J Clin Pharmacol. 2024 May 1. doi: 10.1007/s00228-024-03691-9.$43$YR$A$F$Y$$$20240705$$HP$CN$CN
240529211$24052921$1$I$$20240626$20240705$20240705$EXP$$CN-PBT-009473$PANACEA BIOTEC$Xu X, Zhang H, Liu L, Fu Q, Wu C, Lin X, et al. Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients. Eur J Clin Pharmacol. 2024 May 1. doi: 10.1007/s00228-024-03691-9.$59$YR$A$F$Y$$$20240705$$HP$CN$CN
240529221$24052922$1$I$$20240626$20240705$20240705$EXP$$CN-PBT-009475$PANACEA BIOTEC$Xu X, Zhang H, Liu L, Fu Q, Wu C, Lin X, et al. Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients. Eur J Clin Pharmacol. 2024 May 1. doi: 10.1007/s00228-024-03691-9.$58$YR$A$M$Y$$$20240705$$HP$CN$CN
240529231$24052923$1$I$$20240626$20240705$20240705$EXP$$CN-PBT-009474$PANACEA BIOTEC$Xu X, Zhang H, Liu L, Fu Q, Wu C, Lin X, et al. Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients. Eur J Clin Pharmacol. 2024 May 1. doi: 10.1007/s00228-024-03691-9.$50$YR$A$M$Y$$$20240705$$HP$CN$CN
240529241$24052924$1$I$$20240627$20240705$20240705$PER$$US-ALXN-202406USA001827US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240529252$24052925$2$F$20240630$20240704$20240705$20240706$PER$$US-AMGEN-USASP2024132319$AMGEN$$64$YR$A$M$Y$$$20240706$$CN$US$US
240529261$24052926$1$I$$20240429$20240705$20240705$PER$$US-AMGEN-USASP2024131614$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240529271$24052927$1$I$20231029$20240624$20240705$20240705$EXP$ES-EMA-DD-20240618-7482827-175456$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109158$ZYDUS PHARM$$$$$$Y$$$20240705$$HP$ES$ES
240529281$24052928$1$I$20240510$20240624$20240705$20240705$EXP$ES-AEMPS-1538596$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109015$ZYDUS PHARM$$$$$$Y$$$20240705$$MD$ES$ES
240529291$24052929$1$I$20240501$20240624$20240705$20240705$EXP$FR-AFSSAPS-SE2024000060$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108934$ZYDUS PHARM$$$$$$Y$$$20240705$$PH$FR$FR
240529301$24052930$1$I$20240527$20240624$20240705$20240705$EXP$FR-AFSSAPS-MA2024001063$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108939$ZYDUS PHARM$$$$$$Y$$$20240705$$MD$FR$FR
240529311$24052931$1$I$20240521$20240624$20240705$20240705$EXP$FR-AFSSAPS-NC2024000728$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108969$ZYDUS PHARM$$$$$$Y$$$20240705$$PH$FR$FR
240529323$24052932$3$F$20240617$20240716$20240705$20240722$PER$$US-ROCHE-10000009852$ROCHE$$$$$$Y$$$20240719$$MD$US$US
240529331$24052933$1$I$$20240624$20240705$20240705$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108927$ZYDUS PHARM$Karczewski D, Backer H, Andronic O, Bedi A, Adelhoefer S, Mullner M, et al.. Serratia marcescens prosthetic joint infection: two case reports and a review of the literature.. J-Med-Case-Rep. 2023;17 No. 1$$$$$Y$$$20240705$$HP$US$US
240529341$24052934$1$I$20240510$20240624$20240705$20240705$EXP$FR-AFSSAPS-TO2024000922$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109032$ZYDUS PHARM$$$$$$Y$$$20240705$$MD$FR$FR
240529352$24052935$2$F$$20240711$20240705$20240722$EXP$$US-TEVA-VS-3214789$TEVA$Yosry N, Chajkowski A, Rodriguez C, Medik Y, Lali M, Qaiser S, et al. A Rare Cause of Rhabdomyolysis and Acute Renal Failure: Legionnaires Disease. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster); Yosry N, Chajkowski A, Rodriguez C, Medik Y, Lali M, Qaiser S, et al. A Rare Cause of Rhabdomyolysis and Acute Renal Failure: Legionnaires Disease. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$55$YR$$M$Y$$$20240722$$HP$US$US
240529361$24052936$1$I$20240419$20240624$20240705$20240705$EXP$FR-AFSSAPS-TO2024000758$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109038$ZYDUS PHARM$$$$$$Y$$$20240705$$PH$FR$FR
240529371$24052937$1$I$20240621$20240624$20240705$20240705$PER$$US-ROCHE-10000009656$ROCHE$$60$YR$A$F$Y$90.72$KG$20240705$$CN$US$US
240529381$24052938$1$I$$20240624$20240705$20240705$EXP$$CN-MSNLABS-2024MSNLIT01453$MSN LABORATORIES$Wu J, Zhou Y.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.04-JUN-2024;18 (267):1-10$$$$$Y$$$20240705$$HP$CN$CN
240529391$24052939$1$I$$20230726$20240705$20240705$PER$$US-AMGEN-USASP2023235444$AMGEN$$$$$$Y$$$20240704$$CN$US$US
240529401$24052940$1$I$20240630$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024132776$AMGEN$$75$YR$E$F$Y$$$20240704$$CN$US$US
240529411$24052941$1$I$$20240702$20240705$20240705$PER$$US-JNJFOC-20240707220$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240529421$24052942$1$I$20240515$20240701$20240705$20240705$EXP$$FR-GENMAB-2024-02358$GENMAB$$82$YR$$F$Y$86$KG$20240705$$MD$FR$FR
240529431$24052943$1$I$$20240627$20240705$20240705$PER$$US-ROCHE-10000014536$ROCHE$$$$A$F$Y$$$20240705$$CN$US$US
240529441$24052944$1$I$$20240624$20240705$20240705$EXP$$US-ROCHE-10000012610$ROCHE$$$$$$Y$$$20240705$$HP$US$US
240529451$24052945$1$I$$20240627$20240705$20240705$PER$$US-ROCHE-10000014929$ROCHE$$$$E$F$Y$$$20240705$$CN$US$US
240529461$24052946$1$I$20240101$20240701$20240705$20240705$EXP$$US-ABBVIE-5824670$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240529471$24052947$1$I$$20240701$20240705$20240705$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-024199$JAZZ$$$$$F$Y$$$20240704$$CN$US$US
240529484$24052948$4$F$20240420$20240913$20240705$20240920$EXP$$JP-ADVANZ PHARMA-202406005454$ADVANZ PHARMA$$$$$$Y$$$20240920$$HP$JP$JP
240529491$24052949$1$I$$20240629$20240705$20240705$EXP$$US-ABBVIE-5824655$ABBVIE$$$$$F$Y$134$KG$20240705$$CN$US$US
240529502$24052950$2$F$20240409$20240709$20240705$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024080336$VIIV$$35$YR$$M$Y$$$20240719$$CN$US$US
240529521$24052952$1$I$$20240625$20240705$20240705$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004767$BIOCON$$$$$$Y$$$20240705$$HP$CA$CA
240529531$24052953$1$I$$20240626$20240705$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-033092$AUROBINDO$Locke M, Kohn N, Seetharamu N.. Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas. Clin-Otolaryngol. 2023;48(6):915-919$$$$$Y$$$20240705$$HP$US$US
240529545$24052954$5$F$$20240925$20240705$20240930$PER$$NVSC2024US139254$NOVARTIS$$$$$$Y$$$20240929$$CN$US$US
240529551$24052955$1$I$$20240620$20240705$20240705$EXP$$PT-OCTA-LIT04524$OCTAPHARMA$Lavrador V, Correia F, Sampaio R, C?ndido C, Sameiro-Faria M, Marques L, Mota C. Membranoproliferative glomerulonephritis and x-linked agammaglobulinemia: an uncommon association. Case Rep Pediatr. 2014;2014:480947. doi: 10.1155/2014/480947. Epub 2014 Mar 4. PMID: 24716070; PMCID: PMC3971515.$10$YR$C$M$Y$$$20240704$$HP$EU$EU
240529561$24052956$1$I$$20240615$20240705$20240705$PER$$US-ROCHE-10000012049$ROCHE$$$$$$Y$$$20240705$$CN$US$US
240529571$24052957$1$I$20240625$20240627$20240705$20240705$EXP$$CA-CELLTRION INC.-2024CA016089$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
240529591$24052959$1$I$20240101$20240626$20240705$20240705$EXP$$CA-AMGEN-CANNI2024131863$AMGEN$$57$YR$A$F$Y$$$20240705$$CN$CA$CA
240529601$24052960$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05799$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240529611$24052961$1$I$20220627$20240624$20240705$20240705$EXP$$JP-ARGENX-2022-ARGX-JP001066AA$ARGENX BVBA$$$$$$Y$$$20240705$$MD$JP$JP
240529621$24052962$1$I$20240524$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130208$AMGEN$$61$YR$A$F$Y$$$20240705$$CN$US$US
240529631$24052963$1$I$$20240627$20240705$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-024483$AUROBINDO$Van Gompel JJ, Mahajan A, Shinya Y, Laack NN, Link MJ, O^Brien EK, et al.. Longitudinal treatment outcomes of recurrent clival chordomas: a single-center retrospective study. J-Neurosurg. 2023;140(4):920-928$57$YR$$M$Y$$$20240705$$MD$US$US
240529641$24052964$1$I$$20240628$20240705$20240705$30DAY$$US-GSK-US2024081152$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240529651$24052965$1$I$$20240628$20240705$20240705$30DAY$$US-GSK-US2024081153$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240529661$24052966$1$I$$20240624$20240705$20240705$EXP$GB-MHRA-MED-202406230715043650-LSZJH$GB-LUPIN EUROPE GMBH-2024-05609$LUPIN$$$$$$Y$$$20240705$$CN$GB$GB
240529671$24052967$1$I$$20240628$20240705$20240705$30DAY$$US-GSK-US2024AMR081984$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$PH$US$US
240529682$24052968$2$F$$20240711$20240705$20240722$EXP$$CA-APOTEX-2024AP007888$APOTEX$$$$E$M$Y$$$20240722$$PH$CA$CA
240529691$24052969$1$I$20240621$20240627$20240705$20240705$EXP$$TW-AstraZeneca-2024A150277$ASTRAZENECA$$31839$DY$$F$Y$$$20240705$$CN$TW$
240529701$24052970$1$I$$20240628$20240705$20240705$EXP$$US-SA-2024SA196142$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240705$$MD$US$US
240529711$24052971$1$I$20240629$20240702$20240705$20240705$EXP$$US-AstraZeneca-2024A152271$ASTRAZENECA$$29223$DY$$M$Y$$$20240705$$CN$US$
240529722$24052972$2$F$20240615$20240724$20240705$20240809$PER$$US-AstraZeneca-2024A140289$ASTRAZENECA$$27018$DY$$M$Y$$$20240809$$CN$US$
240529731$24052973$1$I$$20240701$20240705$20240705$EXP$$CA-AstraZeneca-2024A152406$ASTRAZENECA$$19$YR$$M$Y$98$KG$20240705$$MD$CA$
240529741$24052974$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824599$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240529751$24052975$1$I$$20240627$20240705$20240705$PER$$US-ROCHE-10000015093$ROCHE$$$$A$$Y$$$20240705$$CN$US$US
240529761$24052976$1$I$20240201$20240627$20240705$20240705$EXP$DE-EMBRYOTOX-202309591$DE-RDY-SPO/DEU/24/0009407$DR REDDYS$$$$$F$Y$3.58$KG$20240705$$MD$DE$DE
240529771$24052977$1$I$20240602$20240627$20240705$20240705$PER$$US-ROCHE-10000015170$ROCHE$$72$YR$E$M$Y$$$20240705$$CN$US$US
240529791$24052979$1$I$$20231103$20240705$20240705$PER$$US-AMGEN-USASP2023235564$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240529803$24052980$3$F$20240420$20240808$20240705$20240809$PER$$US-AMGEN-USASP2024131228$AMGEN$$37$YR$A$F$Y$$$20240809$$CN$US$US
240529811$24052981$1$I$$20240501$20240705$20240705$PER$$US-AMGEN-USASP2024130039$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240529821$24052982$1$I$20230101$20240627$20240705$20240705$PER$$US-ROCHE-10000015070$ROCHE$$54$YR$A$F$Y$98.88$KG$20240705$$CN$US$US
240529831$24052983$1$I$$20240625$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406017687$ELI LILLY AND CO$$51$YR$A$$Y$$$20240705$$CN$US$US
240529842$24052984$2$F$20240629$20240723$20240705$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037818$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240724$$CN$US$US
240529851$24052985$1$I$$20240624$20240705$20240705$EXP$$CN-ROCHE-10000007783$ROCHE$$80$YR$E$M$Y$$$20240705$$CN$CN$CN
240529861$24052986$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003004$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240705$$CN$US$US
240529871$24052987$1$I$20240703$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003011$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240705$$CN$US$US
240529882$24052988$2$F$$20240627$20240705$20240903$PER$$US-ROCHE-10000011911$ROCHE$$$$E$F$Y$$$20240903$$MD$US$US
240529891$24052989$1$I$20240101$20240620$20240705$20240705$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-19664$SAMSUNG BIOEPIS$$68$YR$E$F$Y$$$20240705$$CN$CA$CA
240529901$24052990$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05750$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240529911$24052991$1$I$20230101$20240701$20240705$20240705$PER$$US-SA-2024SA196656$SANOFI AVENTIS$$$$A$$Y$$$20240705$$CN$US$US
240529921$24052992$1$I$$20240626$20240705$20240705$EXP$$CA-TEVA-VS-3213305$TEVA$$15$YR$$F$Y$53$KG$20240705$$HP$CA$CA
240529931$24052993$1$I$20240101$20240701$20240705$20240705$PER$$US-SA-2024SA196673$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240705$$MD$US$US
240529941$24052994$1$I$$20240627$20240705$20240705$30DAY$$US-GSK-US2024080361$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240529951$24052995$1$I$$20240629$20240705$20240705$EXP$$US-GSK-US2024AMR082051$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$US$US
240529962$24052996$2$F$20240508$20240715$20240705$20240724$EXP$FR-AFSSAPS-MA2024000923$FR-BAXTER-2024BAX020531$BAXTER$$34$YR$$F$Y$$$20240724$$HP$FR$FR
240529971$24052997$1$I$$20240624$20240705$20240705$EXP$$CA-BAXTER-2024BAX020763$BAXTER$$21$YR$$F$Y$$$20240705$$CN$CA$CA
240529981$24052998$1$I$$20240628$20240705$20240705$EXP$$NVSC2024GT138012$NOVARTIS$$$$$M$Y$$$20240705$$CN$GT$GT
240529991$24052999$1$I$$20240625$20240705$20240705$EXP$$CA-TEVA-VS-3213301$TEVA$$64$YR$$F$Y$$$20240705$$CN$CA$CA
240530001$24053000$1$I$$20240620$20240705$20240705$PER$$US-ROCHE-10000010616$ROCHE$$$$$$Y$$$20240705$$MD$US$US
240530011$24053001$1$I$20240505$20240628$20240705$20240705$EXP$$CN-JNJFOC-20240703792$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240705$$HP$CN$CN
240530021$24053002$1$I$$20240621$20240705$20240705$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-13278$ALKEM$Abdelnabi M, Elmassry M, Sekhon J, Benjanuwattra J.. Acute onset of fever, eosinophilia, rash, acute kidney injury, and a positive Monospot test in a patient on lamotrigine: DRESS syndrome. Lancet. 2022;399:1902$20$YR$$F$Y$$$20240705$$MD$US$US
240530031$24053003$1$I$$20240621$20240705$20240705$EXP$$PT-ALKEM LABORATORIES LIMITED-PT-ALKEM-2024-13385$ALKEM$Valido R, Caldas F, Ferreira P. Severe Catatonia Following Sudden Withdrawal of Quetiapine. Prim Care Companion CNS Disord. 2022;24(6):2203268$66$YR$$F$Y$$$20240705$$MD$PT$PT
240530041$24053004$1$I$$20240621$20240705$20240705$EXP$US-MLMSERVICE-20240614-PI095618-00206-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-07291$ALKEM$Hennen MA, Zhang V, Opler DJ.. An unwelcome side-effect of trazodone use in a trans-male. Psychiatry and Clinical Neurosciences. 2024;78(6):376$24$YR$$$Y$$$20240705$$MD$US$US
240530051$24053005$1$I$$20240621$20240705$20240705$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-14399$ALKEM$Takinami Y. Case of serious lidocaine intoxication. Masui The Japanese journal of anesthesiology. 2008;57(4):460-3$$$$$Y$$$20240705$$HP$JP$JP
240530062$24053006$2$F$$20240702$20240705$20240716$EXP$US-MLMSERVICE-20240613-PI099784-00306-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-13965$ALKEM$Patel KH, Halicki J, Dachert S, Mamary A.. Large Pericardial Cyst in a Lung Transplant Patient.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1688$74$YR$$M$Y$$$20240716$$MD$US$US
240530072$24053007$2$F$$20240702$20240705$20240716$EXP$JP-MLMSERVICE-20240613-PI100122-00306-1$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-13947$ALKEM$Arakawa N, Shiota Y, Onizawa F, Miyata F, Miyoshi A, Akaba T, Tsuji M, Arimura K, Yagi O, Kondo M, Katsura H, Tagaya E.. Autoimmune pulmonary alveolar proteinosis during the treatment of nonspecific interstitial pneumonia complicated by clinically amyopathic dermatomyositis: A case report. Respirology case reports. 2024;12(6):e01403$46$YR$$M$Y$$$20240716$$HP$JP$JP
240530081$24053008$1$I$20240416$20240621$20240705$20240705$EXP$GB-MHRA-MED-202406201533404010-TSHDG$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13916$ALKEM$$25$YR$$M$Y$78$KG$20240705$$CN$GB$GB
240530092$24053009$2$F$$20240702$20240705$20240716$EXP$US-MLMSERVICE-20240613-PI098302-00232-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-13964$ALKEM$Pandhair O.. Confoundingly Persistent Pneumonia in a Heart Transplant Patient. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2442$67$YR$$M$Y$$$20240716$$MD$US$US
240530102$24053010$2$F$$20240702$20240705$20240716$EXP$US-MLMSERVICE-20240613-PI099841-00232-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-13966$ALKEM$Rozenbaum Lerner G, Villamizar JP, Pelaez A, Salgado JC. Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3531$68$YR$$M$Y$84$KG$20240716$$MD$US$US
240530111$24053011$1$I$$20240621$20240705$20240705$EXP$$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-14405$ALKEM$Chiang Y, Tseng K, Lih Y, Tsai T, Liu C, Leung H.. Lidocaine-induced CNS toxicity-a case report. Acta Anaesthesiol Sin. 1996;34(4):243-6$$$$$Y$$$20240705$$HP$TW$TW
240530121$24053012$1$I$$20240621$20240705$20240705$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-14109$ALKEM$Rahimi M, Elmi M, Hassanian-Moghaddam H, Zamani N, Soltaninejad K, Forouzanfar R, Shadnia S.. Acute Lidocaine Toxicity; a Case Series. Emergency. 2018;6(1):e38$27$YR$$M$Y$$$20240705$$HP$IR$IR
240530131$24053013$1$I$$20240621$20240705$20240705$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-14107$ALKEM$Rahimi M, Elmi M, Hassanian-Moghaddam H, Zamani N, Soltaninejad K, Forouzanfar R, Shadnia S.. Acute Lidocaine Toxicity; a Case Series. Emergency. 2018;6(1):e38$21$YR$$M$Y$$$20240705$$HP$IR$IR
240530141$24053014$1$I$$20240621$20240705$20240705$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-14401$ALKEM$Giordano D, Panini A, Pernice C, Raso MG, Barbieri V. Neurologic toxicity of lidocaine during awake intubation in a patient with tongue base abscess. Case report. American journal of otolaryngology. 2014;35(1):62-5$$$$$Y$$$20240705$$HP$IT$IT
240530151$24053015$1$I$$20240621$20240705$20240705$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-14104$ALKEM$Rahimi M, Elmi M, Hassanian-Moghaddam H, Zamani N, Soltaninejad K, Forouzanfar R, Shadnia S.. Acute Lidocaine Toxicity; a Case Series. Emergency. 2018;6(1):e38$20$YR$$M$Y$$$20240705$$HP$IR$IR
240530161$24053016$1$I$20240323$20240621$20240705$20240705$EXP$GB-MHRA-MED-202406201846177150-WKSDF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13919$ALKEM$$24$YR$$$Y$$$20240705$$CN$GB$GB
240530171$24053017$1$I$$20240621$20240705$20240705$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-14122$ALKEM$Ben M^rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, Guesmi M, Rollot F, Dehoux M, Guillevin L, Moachon L. Drug-induced hypersensitivity syndrome: Clinical and biologic disease patterns in 24 patients. Medicine (Baltimore). 2009;88:131-140$64$YR$$M$Y$$$20240705$$MD$FR$FR
240530182$24053018$2$F$$20240702$20240705$20240716$EXP$US-MLMSERVICE-20240613-PI098018-00232-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-13963$ALKEM$Landis AR, Minish J, Zouk AN.. A Case of Kaposi Sarcoma masquerading as bilateral pleural effusions in a patient with orthotopic heart transplant. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1941$57$YR$$M$Y$$$20240716$$MD$US$US
240530192$24053019$2$F$$20240702$20240705$20240716$EXP$US-MLMSERVICE-20240614-PI097175-00306-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-13942$ALKEM$Huang L, Ellis TJ, Bagavathy K.. The Unfortunate Trifecta: Tuberculosis, EBV, and CMV Induced Hemophagocytic Lymphohistiocytosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7416$52$YR$$M$Y$$$20240716$$MD$US$US
240530202$24053020$2$F$$20240702$20240705$20240716$EXP$US-MLMSERVICE-20240617-PI098991-00232-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-13943$ALKEM$Raymond-Forde S, Raymond-Forde S, Godfrey AM, Alexander KR.. The Gift of a Heart, With Strings Attached: A Case of Strongyloides Stercoralis Hyperinfection Syndrome With Fulminant Respiratory Failure. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1134$43$YR$$F$Y$$$20240716$$MD$US$US
240530212$24053021$2$F$20240530$20240722$20240705$20240729$PER$$US-ROCHE-10000007398$ROCHE$$87$YR$E$F$Y$$$20240729$$MD$US$US
240530222$24053022$2$F$$20240702$20240705$20240716$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13945$ALKEM$Li S, Lili C, Guangbiao H.. Deutetrabenazine in the treatment of tardive dyskinesia induced by antipsychotics: a case report. Chinese Journal of Psychiatry. 2022;55(2):142-144$19$YR$$F$Y$$$20240716$$HP$CN$CN
240530231$24053023$1$I$$20240703$20240705$20240705$PER$$NVSC2024US139236$NOVARTIS$$$$$$Y$$$20240705$$MD$US$US
240530242$24053024$2$F$20240101$20240805$20240705$20240809$EXP$$NVSC2024DE138875$NOVARTIS$$36$YR$$M$Y$82$KG$20240809$$MD$DE$DE
240530252$24053025$2$F$$20240702$20240705$20240716$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-13936$ALKEM$Hansel A, Oms E, Tronnier M. Drug reaction with eosinophilia and systemic symptoms (DRESS): a hypersensitivity reaction with various symptoms. Die Dermatologie. 2024;unk:1-4$47$YR$$F$Y$$$20240716$$HP$DE$DE
240530261$24053026$1$I$$20240622$20240705$20240705$EXP$$EC-ROCHE-10000007744$ROCHE$$$$$$Y$$$20240705$$CN$EC$EC
240530271$24053027$1$I$$20240703$20240705$20240705$EXP$$GB-SANDOZ INC.-SDZ2024GB062832$SANDOZ$$56$YR$$F$Y$85$KG$20240705$$MD$GB$GB
240530281$24053028$1$I$$20230501$20240705$20240705$PER$$US-AMGEN-USASP2023235375$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240530291$24053029$1$I$$20230929$20240705$20240705$PER$$US-AMGEN-USASP2023235576$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240530302$24053030$2$F$$20240628$20240705$20240709$PER$$US-ROCHE-10000016857$ROCHE$$42$YR$A$F$Y$$$20240709$$CN$US$US
240530311$24053031$1$I$$20240625$20240705$20240705$EXP$$US-ARGENX-2024-ARGX-US004898$ARGENX BVBA$$$$$$Y$$$20240705$$MD$US$US
240530331$24053033$1$I$20240515$20240610$20240705$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002755$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240705$$CN$US$US
240530342$24053034$2$F$20240101$20240726$20240705$20240801$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018969$UNITED THERAPEUTICS$$$$$F$Y$72.109$KG$20240801$$$US$US
240530351$24053035$1$I$20240101$20240702$20240705$20240705$EXP$$US-UCBSA-2024034019$UCB$$$$$F$Y$$$20240705$$HP$US$US
240530361$24053036$1$I$20240101$20240628$20240705$20240705$EXP$$US-009507513-2406USA010319$MERCK$$$$$F$Y$$$20240705$$CN$US$US
240530371$24053037$1$I$$20240628$20240705$20240705$PER$$US-APOTEX-2024AP007915$APOTEX$Iqbal P, Sharma P, Alladin F, Al-Khazraji Y, Ahmed F, Nawaz S, et al.. Managing Intermediate High-Risk Pulmonary Embolism in a Patient With Deep Venous Thrombosis: A Case Report. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-3$35$YR$$M$Y$$$20240705$$HP$US$US
240530382$24053038$2$F$20240101$20240705$20240705$20240709$PER$$US-JNJFOC-20240675214$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240709$$CN$US$US
240530391$24053039$1$I$$20240702$20240705$20240705$PER$$US-HALEON-2185306$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240530401$24053040$1$I$20231013$20240614$20240705$20240705$EXP$$DE-ROCHE-3443049$ROCHE$$38$YR$A$M$Y$$$20240705$$CN$DE$DE
240530411$24053041$1$I$$20240701$20240705$20240705$30DAY$$US-GSK-US2024AMR082038$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$PH$US$US
240530421$24053042$1$I$20240625$20240627$20240705$20240705$EXP$$ES-AUROBINDO-AUR-APL-2024-032136$AUROBINDO$$22$YR$$M$Y$$$20240705$$PH$ES$ES
240530432$24053043$2$F$20240601$20240713$20240705$20240717$EXP$$US-JNJFOC-20240700672$JOHNSON AND JOHNSON$$40$YR$A$F$Y$96.702$KG$20240717$$HP$US$US
240530442$24053044$2$F$$20240625$20240705$20240710$EXP$$MY-GC Biopharma Corp.-2158865$GC Biopharma$$24$MON$$M$Y$$$20240710$$MD$MY$MY
240530451$24053045$1$I$20240601$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406261625494370-HVWBP$GB-BIOCON BIOLOGICS LIMITED-BBL2024004859$BIOCON$$$$$$Y$$$20240705$$PH$GB$GB
240530461$24053046$1$I$20230701$20240702$20240705$20240705$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266347$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240705$$CN$US$US
240530471$24053047$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05839$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240530481$24053048$1$I$$20240624$20240705$20240705$PER$$US-ROCHE-10000013563$ROCHE$Ghabra S, Desale S, Sugarbaker H. Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years. Diseases Of The Colon and Rectum. 2023;66(10):1329-1338. DOI:10.1097/DCR.0000000000002448.$31$YR$A$M$Y$$$20240705$$HP$US$US
240530491$24053049$1$I$$20240110$20240705$20240705$PER$$US-AMGEN-USASP2024132800$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240530501$24053050$1$I$$20240220$20240705$20240705$PER$$US-AMGEN-USASP2024131721$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240530511$24053051$1$I$$20240621$20240705$20240705$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001628$IPCA$Shrea Goswami, Amy E. Hanson, Evan Rajadhyaksha et al.. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series. Pediatric Nephrology. 2024$$$$$Y$$$20240705$$HP$US$US
240530521$24053052$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131167$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240530531$24053053$1$I$$20240625$20240705$20240705$EXP$$US-AMGEN-USASP2024130888$AMGEN$Ghabra S.. Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years. Diseases of the Colon and Rectum. 2023;66(10):1329-1338$54$YR$A$M$Y$$$20240705$$MD$US$US
240530541$24053054$1$I$$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407000907$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240705$$CN$US$US
240530551$24053055$1$I$$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002642$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240705$$CN$US$US
240530562$24053056$2$F$20240101$20240904$20240705$20240911$EXP$$JP-009507513-2407JPN000231J$MERCK$$73$YR$$M$Y$$$20240911$$MD$JP$JP
240530571$24053057$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003013$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240705$$CN$US$US
240530581$24053058$1$I$$20240626$20240705$20240705$EXP$$CA-APOTEX-2024AP007808$APOTEX$$46$YR$$F$Y$75$KG$20240705$$HP$CA$CA
240530591$24053059$1$I$$20240625$20240705$20240705$EXP$$US-GSK-US2024079703$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$MD$US$US
240530601$24053060$1$I$$20240627$20240705$20240705$PER$$US-SA-2024SA192459$SANOFI AVENTIS$$6$YR$C$M$Y$19.5$KG$20240705$$CN$US$US
240530611$24053061$1$I$20221101$20240628$20240705$20240705$EXP$$US-SA-2024SA194617$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240705$$HP$US$US
240530621$24053062$1$I$$20240626$20240705$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-031801$AUROBINDO$Postoll-Downs MA, Ozguc F, Vasudevan J, Stawinski PM, Wright R.. Breaking Patterns: A Case of Dieulafoy Lesion in a Young Patient Without Comorbid Conditions. Cureus. 2024;16(5):e60513$18$YR$$M$Y$$$20240705$$MD$US$US
240530631$24053063$1$I$$20240626$20240705$20240705$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001323$BLUEPRINT MEDICINES$$$$$F$Y$$$20240705$$CN$US$US
240530651$24053065$1$I$20240624$20240630$20240705$20240705$PER$$US-BIOGEN-2024BI01271864$BIOGEN$$56$YR$$M$Y$$$20240705$$CN$US$US
240530662$24053066$2$F$$20240802$20240705$20240817$PER$$US-AstraZeneca-2024A148954$ASTRAZENECA$$$$$$Y$$$20240817$$CN$US$
240530671$24053067$1$I$20240507$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151133$ASTRAZENECA$$$$$M$Y$$$20240705$$HP$US$
240530683$24053068$3$F$20230803$20240721$20240705$20240724$EXP$$AT-BAUSCH-BL-2024-010084$BAUSCH AND LOMB$$60$YR$$M$Y$$$20240724$$CN$AT$AT
240530691$24053069$1$I$$20240703$20240705$20240705$EXP$$CA-BAUSCH-BL-2024-010240$BAUSCH AND LOMB$$$$$M$Y$$$20240705$$CN$CA$CA
240530701$24053070$1$I$$20240624$20240705$20240705$EXP$$US-ROCHE-10000010767$ROCHE$$76$YR$E$F$Y$$$20240705$$CN$US$US
240530711$24053071$1$I$20240101$20240701$20240705$20240705$EXP$$RO-BAUSCH-BL-2024-010172$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240705$$MD$RO$RO
240530722$24053072$2$F$$20240809$20240705$20240820$EXP$$JP-SA-2024SA194342$SANOFI AVENTIS$$$$E$M$Y$$$20240820$$PH$JP$JP
240530731$24053073$1$I$20240501$20240626$20240705$20240705$PER$$US-SA-2024SA194457$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240705$$MD$US$US
240530741$24053074$1$I$20240201$20240626$20240705$20240705$PER$$US-SA-2024SA047783$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240705$$MD$US$US
240530752$24053075$2$F$20240701$20240710$20240705$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105355$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240717$$CN$US$US
240530761$24053076$1$I$20240610$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032173$AUROBINDO$$72$YR$$M$Y$75.2$KG$20240705$$MD$FR$FR
240530772$24053077$2$F$$20240628$20240705$20240728$PER$$US-009507513-2407USA001092$MERCK$$$$$F$Y$$$20240728$$MD$US$US
240530782$24053078$2$F$$20240711$20240705$20240723$EXP$$PT-TEVA-VS-3215306$TEVA$Gouveia I, Xavier M, Silva J, Martins P. Malignant tumour in pregnancy: Ewing-like sarcoma of the gluteal region. BMJ-Case-Rep 2024; 17 (4):.; Gouveia I, Xavier M, Silva J, Martins P. Malignant tumour in pregnancy: Ewing-like sarcoma of the gluteal region. BMJ-Case-Rep 2024; 17 (4):.$4$DEC$$F$Y$$$20240723$$MD$PT$PT
240530791$24053079$1$I$$20240621$20240705$20240705$PER$$US-TEVA-VS-3213528$TEVA$$$$$F$Y$$$20240705$$CN$US$US
240530801$24053080$1$I$$20230601$20240705$20240705$PER$$US-ABBVIE-5826649$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240530814$24053081$4$F$$20240729$20240705$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000570$DECIPHERA PHARMACEUTICALS$$66$YR$A$F$Y$113$KG$20240806$$CN$US$US
240530821$24053082$1$I$20240610$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032189$AUROBINDO$$63$YR$$M$Y$103$KG$20240705$$MD$FR$FR
240530831$24053083$1$I$$20240628$20240705$20240705$PER$$US-AMGEN-USASP2024129161$AMGEN$$$$$M$Y$$$20240705$$MD$US$US
240530841$24053084$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131337$AMGEN$$$$$M$Y$$$20240705$$CN$US$US
240530851$24053085$1$I$$20240212$20240705$20240705$PER$$US-ABBVIE-5828148$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240530861$24053086$1$I$$20240627$20240705$20240705$EXP$$CA-APOTEX-2024AP007854$APOTEX$$53$YR$$M$Y$$$20240705$$CN$CA$CA
240530871$24053087$1$I$$20240703$20240705$20240705$PER$$US-JNJFOC-20240709937$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240530881$24053088$1$I$20240514$20240626$20240705$20240705$EXP$$US-JNJFOC-20240540354$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240705$$HP$US$US
240530902$24053090$2$F$20240624$20240710$20240705$20240718$EXP$$BR-CELLTRION INC.-2024BR016012$CELLTRION$$$$$$Y$$$20240719$$CN$BR$BR
240530911$24053091$1$I$20240623$20240627$20240705$20240705$EXP$$GB-AUROBINDO-AUR-APL-2024-031984$AUROBINDO$$78$YR$$M$Y$91$KG$20240705$$CN$GB$GB
240530921$24053092$1$I$20230301$20240612$20240705$20240705$EXP$$DE-ROCHE-10000014444$ROCHE$$51$YR$A$F$Y$$$20240705$$MD$DE$DE
240530932$24053093$2$F$20240624$20240805$20240705$20240814$EXP$$JP-AMGEN-JPNSP2024129738$AMGEN$$$$E$F$Y$$$20240813$$MD$JP$JP
240530941$24053094$1$I$$20240624$20240705$20240705$EXP$$US-NOVAST LABORATORIES INC.-2024NOV000264$NOVAST$Prasad M, El Sabbagh A, Rihal C, Lerman A.. Phentermine and Coronary Vasospasm-Induced Myocardial Infarction.. Mayo Clin Proc.. 2019;94(7):1374-1377$48$YR$$F$Y$$$20240705$$MD$US$US
240530952$24053095$2$F$20240628$20240814$20240705$20240820$EXP$$US-AMGEN-USASP2024130956$AMGEN$$70$YR$E$F$Y$$$20240820$$CN$US$US
240530961$24053096$1$I$$20240624$20240705$20240705$EXP$$US-NOVAST LABORATORIES INC.-2024NOV000265$NOVAST$Prasad M, El Sabbagh A, Rihal C, Lerman A.. Phentermine and Coronary Vasospasm-Induced Myocardial Infarction.. Mayo Clin Proc.. 2019;94(7):1374-1377$47$YR$$F$Y$$$20240705$$MD$US$US
240530971$24053097$1$I$$20240123$20240705$20240705$PER$$US-AMGEN-USASP2024132814$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240530983$24053098$3$F$20240501$20240906$20240705$20240911$EXP$$PK-AMGEN-PAKSP2023136658$AMGEN$$37$YR$A$F$Y$$$20240911$$CN$PK$PK
240530991$24053099$1$I$20240601$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130152$AMGEN$$64$YR$A$M$Y$$$20240705$$CN$US$US
240531001$24053100$1$I$$20240627$20240705$20240705$EXP$$DE-JNJFOC-20240679103$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$DE$DE
240531011$24053101$1$I$20231023$20240627$20240705$20240705$EXP$$CA-TAKEDA-2023TUS103300$TAKEDA$$78$YR$$M$Y$$$20240705$$CN$CA$CA
240531022$24053102$2$F$20240701$20240828$20240705$20240902$EXP$$US-SA-2024SA191688$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240902$$HP$US$US
240531032$24053103$2$F$$20240705$20240705$20240715$EXP$$US-SA-2024SA190156$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240715$$MD$US$US
240531041$24053104$1$I$$20240626$20240705$20240705$EXP$$US-GSK-US2024079644$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$PH$US$US
240531051$24053105$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281412466070-YKBNQ$GB-RDY-SPO/GBR/24/0009636$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240531061$24053106$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281419074630-BMTGL$GB-RDY-SPO/GBR/24/0009599$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240531071$24053107$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281432464540-VLDZP$GB-RDY-SPO/GBR/24/0009597$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240531081$24053108$1$I$20240323$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281136243400-GYCWK$GB-RDY-SPO/GBR/24/0009603$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240531091$24053109$1$I$$20240702$20240705$20240705$PER$$US-JNJFOC-20240711462$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$PH$US$US
240531101$24053110$1$I$$20240628$20240705$20240705$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001338$BLUEPRINT MEDICINES$$$$$M$Y$$$20240705$$CN$US$US
240531113$24053111$3$F$20240627$20240816$20240705$20240823$PER$$US-ALXN-202406USA001923US$ALEXION PHARMACEUTICALS$$88$YR$$M$Y$$$20240823$$HP$US$US
240531121$24053112$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003160$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240705$$CN$US$US
240531131$24053113$1$I$20240401$20240629$20240705$20240705$EXP$$GB-AstraZeneca-2024A149700$ASTRAZENECA$$63$YR$$F$Y$$$20240705$$MD$GB$
240531141$24053114$1$I$$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407001142$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240705$$CN$US$US
240531151$24053115$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002817$ELI LILLY AND CO$$$$$$Y$$$20240705$$CN$US$US
240531161$24053116$1$I$$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002243$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240705$$CN$US$US
240531172$24053117$2$F$20240501$20240705$20240705$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407002660$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240709$$CN$US$US
240531181$24053118$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002734$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$US$US
240531191$24053119$1$I$20230101$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002273$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240705$$CN$US$US
240531201$24053120$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003068$ELI LILLY AND CO$$49$YR$A$$Y$$$20240705$$CN$US$US
240531211$24053121$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002711$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240705$$CN$US$US
240531221$24053122$1$I$20240520$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002725$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240705$$CN$US$US
240531231$24053123$1$I$$20240625$20240705$20240705$EXP$$US-EMD Serono-2024035009$EMD SERONO INC$$52$YR$A$F$Y$$$20240705$$CN$US$US
240531241$24053124$1$I$$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106584$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240705$$CN$US$US
240531252$24053125$2$F$$20240711$20240705$20240713$PER$$US-AMGEN-USASP2024131159$AMGEN$$$$$$Y$$$20240713$$CN$US$US
240531261$24053126$1$I$20240701$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132169$AMGEN$$77$YR$E$F$Y$$$20240705$$CN$US$US
240531271$24053127$1$I$$20240701$20240705$20240705$PER$$US-UNITED THERAPEUTICS-UNT-2024-020377$UNITED THERAPEUTICS$$$$$F$Y$50.794$KG$20240705$$$US$US
240531281$24053128$1$I$$20240520$20240705$20240705$PER$$US-AMGEN-USASP2024131829$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240531291$24053129$1$I$$20221220$20240705$20240705$PER$$US-AMGEN-USASP2022230360$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240531301$24053130$1$I$$20240624$20240705$20240705$EXP$$ES-ROCHE-10000007071$ROCHE$Martin-Gutierrez A, Loricera J, Narvaez J, Aldasoro V, Maiz O, Vela P, et al. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis. European Journal Of Internal Medicine. 2024-Jun-21;1-9. doi:10.1016/j.ejim.2024.06.013.$$$$$Y$$$20240705$$HP$ES$ES
240531312$24053131$2$F$20240610$20240706$20240705$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-031896$AUROBINDO$$23$YR$$M$Y$$$20240716$$MD$FR$FR
240531321$24053132$1$I$$20240622$20240705$20240705$EXP$$EC-ROCHE-10000007749$ROCHE$$$$$$Y$$$20240705$$CN$EC$EC
240531331$24053133$1$I$20240101$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130278$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240531341$24053134$1$I$$20240613$20240705$20240705$PER$$US-JNJFOC-20240636728$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240705$$HP$US$US
240531351$24053135$1$I$$20230905$20240705$20240705$PER$$US-AMGEN-USASP2023235492$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240531362$24053136$2$F$20240626$20240725$20240705$20240805$30DAY$$US-GSK-US2024080411$GLAXOSMITHKLINE$$$$$F$Y$$$20240804$$CN$US$US
240531372$24053137$2$F$20240606$20240708$20240705$20240716$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017675$UNITED THERAPEUTICS$$43$YR$$F$Y$68.027$KG$20240716$$PH$US$US
240531381$24053138$1$I$$20240628$20240705$20240705$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036969$BOEHRINGER INGELHEIM$$52$YR$A$M$Y$$$20240705$$CN$AU$AU
240531392$24053139$2$F$20230207$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS066956$TAKEDA$$27$YR$$M$Y$$$20240709$$HP$CN$CN
240531401$24053140$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281422291500-CTQJK$GB-RDY-SPO/GBR/24/0009650$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240531411$24053141$1$I$$20240622$20240705$20240705$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14068$ALKEM$$$$$M$Y$$$20240705$$CN$GB$GB
240531421$24053142$1$I$$20240627$20240705$20240705$EXP$$US-APOTEX-2024AP007905$APOTEX$Mignone D, Shah K, Alawneh B, Papadakos SP, Michelakis N. A RUDE AWAKENING: A CASE OF SUGAMMADEX CAUSING TRANSIENT CARDIOMYOPATHY MIMICKING STEMI. Journal of the American College of Cardiology. 2024;83 (Suppl. 13):3618$43$YR$$M$Y$$$20240705$$HP$US$US
240531431$24053143$1$I$$20240624$20240705$20240705$EXP$$US-MSNLABS-2024MSNLIT01421$MSN LABORATORIES$Pham LL, Landeen C.New Onset Refractory Status Epilepticus in Prion Disease.American Journal of Respiratory and Critical Care Medicine.2024;209:A5614$$$$$Y$$$20240705$$HP$US$US
240531441$24053144$1$I$20240625$20240626$20240705$20240705$EXP$$AU-BEH-2024174707$CSL BEHRING$$61$YR$A$M$Y$$$20240705$$HP$AU$AU
240531461$24053146$1$I$20240613$20240613$20240705$20240705$PER$$US-JNJFOC-20240637047$JOHNSON AND JOHNSON$$6$YR$C$F$Y$18.16$KG$20240705$$CN$US$US
240531471$24053147$1$I$20240605$20240627$20240705$20240705$EXP$$CN-JNJFOC-20240676508$JOHNSON AND JOHNSON$$61$YR$A$M$Y$35$KG$20240705$$HP$CN$CN
240531481$24053148$1$I$$20240701$20240705$20240705$PER$$US-JNJFOC-20240705108$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$HP$US$US
240531493$24053149$3$F$$20240712$20240705$20240718$EXP$$CA-ROCHE-10000014785$ROCHE$$$$A$F$Y$$$20240718$$CN$CA$CA
240531501$24053150$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA196513$SANOFI AVENTIS$$$$A$M$Y$$$20240705$$MD$US$US
240531521$24053152$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA191461$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240705$$MD$US$US
240531532$24053153$2$F$20240626$20240812$20240705$20240820$EXP$$CA-CELLTRION INC.-2024CA016189$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
240531541$24053154$1$I$$20240627$20240705$20240705$PER$$US-ALXN-202406USA001938US$ALEXION PHARMACEUTICALS$$$$$F$Y$180$KG$20240705$$CN$US$US
240531551$24053155$1$I$$20240131$20240705$20240705$PER$$US-AMGEN-USASP2024130094$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240531561$24053156$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131790$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240531571$24053157$1$I$20240611$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151155$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240531582$24053158$2$F$$20240625$20240705$20240712$PER$$US-ROCHE-10000012991$ROCHE$$5$YR$C$M$Y$$$20240712$$HP$US$US
240531591$24053159$1$I$20240523$20240627$20240705$20240705$EXP$$CN-AstraZeneca-2024A151652$ASTRAZENECA$$68$YR$$M$Y$60$KG$20240705$$MD$CN$
240531611$24053161$1$I$$20240701$20240705$20240705$PER$$US-JNJFOC-20240701895$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240531621$24053162$1$I$$20240702$20240705$20240705$PER$$US-JNJFOC-20240706377$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240705$$CN$US$US
240531632$24053163$2$F$20240628$20240710$20240705$20240715$EXP$$US-JNJFOC-20240703120$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240715$$HP$US$US
240531641$24053164$1$I$$20240702$20240705$20240705$EXP$$US-JNJFOC-20240704149$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$CN$US$US
240531651$24053165$1$I$$20240703$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107090$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240705$$CN$US$US
240531661$24053166$1$I$$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107087$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240705$$CN$US$US
240531672$24053167$2$F$20240624$20240705$20240705$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106713$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$77.3$KG$20240710$$HP$US$US
240531681$24053168$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05486$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240531692$24053169$2$F$20221114$20240702$20240705$20240705$EXP$$DE-UCBSA-2024030519$UCB$$$$A$M$Y$107$KG$20240705$$MD$DE$DE
240531701$24053170$1$I$20240101$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003008$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240705$$CN$US$US
240531711$24053171$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002853$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240705$$CN$US$US
240531722$24053172$2$F$20230920$20240701$20240705$20240711$EXP$$KR-ABBVIE-5823330$ABBVIE$$65$YR$$F$Y$58$KG$20240711$$MD$KR$KR
240531731$24053173$1$I$20190901$20240624$20240705$20240705$EXP$$CN-ABBVIE-5826326$ABBVIE$Pu H, Cai L, Wang C, Liu C, Zhu H, Lu X, Yang B, Wang J. One Case of Elderly Advanced Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia Treated with the Ibrutinib-containing Regimen. Chinese Journal of Multiple Organ Diseases in the Elderly. 2024;384-385.$82$YR$$M$Y$$$20240705$$HP$CN$CN
240531741$24053174$1$I$20240101$20240627$20240705$20240705$EXP$$JP-GENMAB-2024-01473AA$GENMAB$$71$YR$$M$Y$72$KG$20240705$$HP$JP$JP
240531751$24053175$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002872$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240705$$CN$US$US
240531762$24053176$2$F$$20240726$20240705$20240801$30DAY$$AU-JNJFOC-20240650541$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$PH$AU$AU
240531771$24053177$1$I$$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002074$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240705$$CN$US$US
240531782$24053178$2$F$20240401$20240705$20240705$20240708$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024079926$VIIV$$5$DEC$$F$Y$$$20240708$$HP$US$US
240531791$24053179$1$I$20240401$20240627$20240705$20240705$EXP$$DE-AUROBINDO-AUR-APL-2024-031998$AUROBINDO$$29$YR$$F$Y$58$KG$20240705$$MD$DE$DE
240531802$24053180$2$F$20230601$20240708$20240705$20240712$EXP$$DE-EMD Serono-2024035581$EMD SERONO INC$$$$$F$Y$3$KG$20240712$$MD$DE$DE
240531811$24053181$1$I$$20240628$20240705$20240705$EXP$$US-ABBVIE-5825843$ABBVIE$Begun Z, Thompson E, Zhan T, Keiffer G, Kasner M, Wilde L. Tumor lysis syndrome in patients with aml initiated on venetoclax-based treatment without a dose ramp-up. Blood. 2023;142(Supplement 1):3720-3721.$$$A$$Y$$$20240705$$HP$US$US
240531821$24053182$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA191592$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240705$$MD$US$US
240531831$24053183$1$I$$20230803$20240705$20240705$PER$$US-AMGEN-USASP2023235454$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240531842$24053184$2$F$20240702$20240703$20240705$20240709$PER$$US-AMGEN-USASP2024132752$AMGEN$$46$YR$A$F$Y$$$20240709$$HP$US$US
240531851$24053185$1$I$$20240312$20240705$20240705$PER$$US-AMGEN-USASP2024130629$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240531861$24053186$1$I$$20240621$20240705$20240705$EXP$$US-CIPLA LTD.-2024US06936$CIPLA$O?halloran K, Phadnis S, Friedman GK, Metrock K, Davidson TB, Robison NJ, et al. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6(1), vdae070:1 to 9$$$$$Y$$$20240705$$HP$US$US
240531871$24053187$1$I$$20240624$20240705$20240705$EXP$$CH-MSNLABS-2024MSNLIT01422$MSN LABORATORIES$Ballmer A, Loretz L, Henzen C, Ulmer T, Van Veelen N.Small tablet, large effect: statin- induced rhabdomyolysis.Swiss Medical Weekly.2024;154 (276):40S$$$$$Y$$$20240705$$MD$CH$CH
240531881$24053188$1$I$$20240629$20240705$20240705$PER$$US-ROCHE-10000015412$ROCHE$$$$A$F$Y$$$20240705$$CN$US$US
240531891$24053189$1$I$20180101$20240627$20240705$20240705$EXP$$PL-AUROBINDO-AUR-APL-2024-032497$AUROBINDO$Pempkowiak M, Chamienia A, Debska-Slizien A, Rutkowski B.. Progressive multifocal leukoencephalopathy in a kidney transplant recipient - case report and review of the literature. Renal Disease and Transplantation Forum. 2024;17(1):25-32$52$YR$$F$Y$$$20240705$$HP$PL$PL
240531901$24053190$1$I$20240201$20240701$20240705$20240705$PER$$US-ABBVIE-5822939$ABBVIE$$39$YR$$M$Y$81.646$KG$20240705$$CN$US$US
240531911$24053191$1$I$20240606$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032228$AUROBINDO$$23$YR$$M$Y$$$20240705$$HP$FR$FR
240531921$24053192$1$I$$20240627$20240705$20240705$EXP$$BR-JNJFOC-20240679055$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$MD$BR$BR
240531936$24053193$6$F$$20240809$20240705$20240820$PER$$US-ROCHE-10000015926$ROCHE$$$$$M$Y$$$20240820$$CN$US$US
240531941$24053194$1$I$$20240627$20240705$20240705$EXP$$US-TAKEDA-2024TUS031465$TAKEDA$$$$$M$Y$$$20240705$$CN$US$US
240531951$24053195$1$I$$20240702$20240705$20240705$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037834$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240705$$CN$US$US
240531961$24053196$1$I$$20240627$20240705$20240705$EXP$$US-TAKEDA-2024TUS065508$TAKEDA$$$$$M$Y$80.4$KG$20240705$$HP$US$US
240531971$24053197$1$I$$20231204$20240705$20240705$PER$$US-AMGEN-USASP2023235421$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240531982$24053198$2$F$20240701$20240701$20240705$20240717$PER$$US-AMGEN-USASP2024130248$AMGEN$$64$YR$A$M$Y$$$20240717$$CN$US$US
240531991$24053199$1$I$20240201$20240701$20240705$20240705$EXP$$US-ABBVIE-5825986$ABBVIE$$61$YR$$F$Y$$$20240705$$CN$US$US
240532002$24053200$2$F$20240131$20240905$20240705$20240909$EXP$$US-TAKEDA-2024TUS019395$TAKEDA$$16$YR$$F$Y$99$KG$20240909$$HP$US$US
240532011$24053201$1$I$$20240625$20240705$20240705$EXP$GB-MHRA-MED-202406240939544720-VTGJN$GB-MSNLABS-2024MSNSPO01455$MSN LABORATORIES$$$$$$Y$$$20240705$$CN$GB$GB
240532021$24053202$1$I$$20240627$20240705$20240705$EXP$$VN-AstraZeneca-2024A150278$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$VN$
240532041$24053204$1$I$$20240627$20240705$20240705$PER$$US-AstraZeneca-2024A154380$ASTRAZENECA$$$$$$Y$$$20240705$$CN$US$
240532051$24053205$1$I$$20240703$20240705$20240705$PER$$US-HALEON-2185387$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240532061$24053206$1$I$20240628$20240701$20240705$20240705$EXP$$US-BIOGEN-2024BI01272224$BIOGEN$$28$YR$$F$Y$$$20240705$$CN$US$US
240532071$24053207$1$I$$20240627$20240705$20240705$EXP$$IN-BRISTOL-MYERS SQUIBB COMPANY-2024-103202$BRISTOL MYERS SQUIBB$Tambe S, Jangid K, Shinde G, Jadhav S, Mahobia S, Lala M, et al. Drug-induced systemic lupus erythematosus in a child living with HIV. Indian Journal of Sexually Transmitted Diseases and AIDS. 2024 Jun 06;45(1):59-61. doi:10.4103/ijstd.ijstd_69_23.$12$YR$T$M$Y$$$20240705$$HP$IN$IN
240532081$24053208$1$I$$20240704$20240705$20240705$EXP$PL-URPL-2-926-2019$PL-JNJFOC-20240712221$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$CN$PL$PL
240532091$24053209$1$I$20240101$20240703$20240705$20240705$PER$$US-JNJFOC-20240709666$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240705$$CN$US$US
240532101$24053210$1$I$20240629$20240703$20240705$20240705$PER$$US-JNJFOC-20240709449$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$US$US
240532111$24053211$1$I$$20240703$20240705$20240705$PER$$US-GILEAD-2024-0679513$GILEAD$$$$$M$Y$$$20240705$$CN$US$US
240532121$24053212$1$I$$20240702$20240705$20240705$PER$$US-SA-2024SA198127$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240705$$CN$US$US
240532131$24053213$1$I$20190101$20240701$20240705$20240705$PER$$US-SA-2024SA196105$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240705$$CN$US$US
240532141$24053214$1$I$20200801$20240701$20240705$20240705$PER$$US-SA-2024SA196581$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240705$$MD$US$US
240532151$24053215$1$I$20240124$20240626$20240705$20240705$EXP$FR-AFSSAPS-ST2024001089$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06116$HIKMA$$$$$$Y$$$20240705$$MD$FR$FR
240532161$24053216$1$I$20220901$20240628$20240705$20240705$EXP$$NVSC2024AR057724$NOVARTIS$$63$YR$$F$Y$$$20240705$$CN$AR$AR
240532171$24053217$1$I$19810101$20240626$20240705$20240705$EXP$FR-AFSSAPS-AVCN2024000464$FR-TEVA-VS-3215228$TEVA$$55$YR$$F$Y$$$20240705$$MD$FR$FR
240532183$24053218$3$F$20240814$20240822$20240705$20240830$EXP$$US-TAKEDA-2024TUS067491$TAKEDA$$25$YR$$F$Y$$$20240830$$CN$US$US
240532192$24053219$2$F$$20240808$20240705$20240812$EXP$$US-TAKEDA-2024TUS067538$TAKEDA$$$$$M$Y$$$20240812$$MD$US$US
240532201$24053220$1$I$$20240702$20240705$20240705$EXP$BE-FAMHP-DHH-N2024-122299$BE-ORGANON-O2407BEL000199$ORGANON$$75$YR$$M$Y$100$KG$20240705$$MD$BE$BE
240532211$24053221$1$I$$20240625$20240705$20240705$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004770$BIOCON$$$$$$Y$$$20240705$$HP$CA$CA
240532221$24053222$1$I$$20240629$20240705$20240705$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00360$VELOXIS PHARMACEUTICALS$Sharma P, Tahiru M, Li H, Bansari A, Baskaran N.. A case of ocular diffuse large B-cell lymphoma unveiled through Pars Plana Vitrectomy: surgical insight and multidisciplinary management. Journal of surgical case reports. 2024;2024(6):rjae399$74$YR$$M$Y$$$20240705$$MD$US$US
240532231$24053223$1$I$$20230614$20240705$20240705$PER$$US-AMGEN-USASP2023235469$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240532241$24053224$1$I$20230901$20240701$20240705$20240705$EXP$$FR-ABBVIE-5822350$ABBVIE$$25$YR$$F$Y$$$20240705$$MD$FR$FR
240532251$24053225$1$I$$20240629$20240705$20240705$EXP$$AU-SANDOZ INC.-NVSC2023AU124522$SANDOZ$Morton A. Low haptoglobin and a positive direct antiglobulin test without haemolysis in pregnancy. OBSTETRIC MEDICINE. 2022;15 (4):280-2$35$WK$$$Y$$$20240705$$MD$AU$AU
240532262$24053226$2$F$20240623$20240812$20240705$20240817$EXP$$CO-TAKEDA-2024TUS036250$TAKEDA$$21$YR$$F$Y$55$KG$20240817$$CN$CO$CO
240532271$24053227$1$I$$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002591$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240705$$CN$US$US
240532281$24053228$1$I$$20240701$20240705$20240705$EXP$$GB-BIOGEN-2024BI01272022$BIOGEN$$$$A$F$Y$$$20240705$$CN$GB$GB
240532291$24053229$1$I$20240603$20240627$20240705$20240705$EXP$$ES-AUROBINDO-AUR-APL-2024-032156$AUROBINDO$$77$YR$$M$Y$57$KG$20240705$$MD$ES$ES
240532301$24053230$1$I$20240626$20240626$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406018572$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240705$$PH$US$US
240532311$24053231$1$I$$20230329$20240705$20240705$EXP$$DE-OCTA-LIT03824$OCTAPHARMA$Wolfert C, Shiban E, Sommer B. Disseminated Intravascular Coagulopathy in Cranial Surgery: Case Report and Review of the Literature. Case Rep. Oncol. 2022; 15(2):624-9. DOI: 10.1159/000523897$61$YR$A$M$Y$$$20240704$$HP$EU$EU
240532322$24053232$2$F$20230101$20240706$20240705$20240710$EXP$$EG-BIOGEN-2024BI01272028$BIOGEN$$$$$F$Y$54$KG$20240710$$CN$EG$EG
240532331$24053233$1$I$20240101$20240701$20240705$20240705$EXP$$US-UCBSA-2024033726$UCB$$$$$M$Y$$$20240705$$HP$US$US
240532341$24053234$1$I$$20240617$20240705$20240705$PER$$US-009507513-2406USA006076$MERCK$$$$$F$Y$$$20240705$$CN$US$US
240532353$24053235$3$F$$20240821$20240705$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106776$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240829$$CN$US$US
240532363$24053236$3$F$20240614$20240718$20240705$20240731$30DAY$$GB-JNJFOC-20240638630$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$GB$GB
240532371$24053237$1$I$$20240701$20240705$20240705$EXP$$US-JNJFOC-20240703602$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$CN$US$US
240532381$24053238$1$I$$20240625$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR081421$VIIV$$$$$M$Y$$$20240705$$PH$US$US
240532391$24053239$1$I$$20240627$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR081431$VIIV$$$$$M$Y$$$20240705$$HP$US$US
240532401$24053240$1$I$$20231009$20240705$20240705$PER$$US-AMGEN-USASP2023235506$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240532412$24053241$2$F$$20240909$20240705$20240912$EXP$$US-INCYTE CORPORATION-2024IN006903$INCYTE$$$$$$Y$$$20240912$$MD$US$US
240532421$24053242$1$I$$20240701$20240705$20240705$EXP$$US-UCBSA-2024033904$UCB$$$$$F$Y$$$20240705$$HP$US$US
240532431$24053243$1$I$$20240620$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05713$HIKMA$$$$$$Y$$$20240705$$CN$US$US
240532441$24053244$1$I$20240201$20240627$20240705$20240705$EXP$$DE-AUROBINDO-AUR-APL-2024-032078$AUROBINDO$$$$$F$Y$3.58$KG$20240705$$MD$DE$DE
240532451$24053245$1$I$$20240625$20240705$20240705$EXP$$ZA-HALEON-2184122$Haleon PLC$$$$$$Y$$$20240705$$CN$ZA$ZA
240532463$24053246$3$F$20240101$20240910$20240705$20240919$PER$$US-SA-2024SA097501$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240919$$MD$US$US
240532471$24053247$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA196687$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240705$$MD$US$US
240532481$24053248$1$I$$20240625$20240705$20240705$EXP$$US-ROCHE-10000013882$ROCHE$$27$YR$A$$Y$$$20240705$$CN$US$US
240532492$24053249$2$F$$20240802$20240705$20240806$PER$$US-ALXN-202406USA001864US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240532501$24053250$1$I$$20240701$20240705$20240705$EXP$$US-GSK-US2024081565$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$MD$US$US
240532511$24053251$1$I$$20240614$20240705$20240705$PER$$US-JNJFOC-20240641731$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240532522$24053252$2$F$$20240703$20240705$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002772$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
240532531$24053253$1$I$$20240627$20240705$20240705$30DAY$$US-GSK-US2024080421$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240532541$24053254$1$I$$20240630$20240705$20240705$EXP$$US-GSK-US2024AMR081799$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$US$US
240532551$24053255$1$I$$20240626$20240705$20240705$EXP$$US-EMD Serono-2024035330$EMD SERONO INC$$$$A$M$Y$$$20240705$$CN$US$US
240532561$24053256$1$I$$20240627$20240705$20240705$PER$$US-CHATTEMPRD-2024OHG022523$CHATTEM$$93$YR$E$F$Y$$$20240705$$CN$US$US
240532571$24053257$1$I$$20231204$20240705$20240705$PER$$US-AMGEN-USASP2023235471$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240532581$24053258$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130899$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240532591$24053259$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130197$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240532601$24053260$1$I$$20240628$20240705$20240705$PER$$US-ABBVIE-5823586$ABBVIE$$$$E$$Y$$$20240705$$CN$US$US
240532612$24053261$2$F$$20240625$20240705$20240709$PER$$US-ROCHE-10000012951$ROCHE$$$$A$F$Y$$$20240703$$HP$US$US
240532621$24053262$1$I$20240401$20240626$20240705$20240705$EXP$DE-BFARM-24003983$DE-TEVA-VS-3209278$TEVA$$58$YR$$M$Y$93$KG$20240705$$MD$DE$DE
240532631$24053263$1$I$$20231124$20240705$20240705$PER$$US-AMGEN-USASP2023235580$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240532641$24053264$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5826057$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240532651$24053265$1$I$20240218$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032331$AUROBINDO$$26$YR$$M$Y$$$20240705$$PH$FR$FR
240532661$24053266$1$I$$20240621$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05931$HIKMA$$$$$$Y$$$20240705$$HP$US$US
240532671$24053267$1$I$$20240627$20240705$20240705$30DAY$$US-GSK-US2024AMR081024$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$CN$US$US
240532681$24053268$1$I$20240501$20240627$20240705$20240705$EXP$$CA-CELLTRION INC.-2024CA016078$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
240532691$24053269$1$I$20240703$20240703$20240705$20240705$PER$$US-JNJFOC-20240711691$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240705$$CN$US$US
240532701$24053270$1$I$$20240627$20240705$20240705$EXP$$DE-JNJFOC-20240701093$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$DE$DE
240532711$24053271$1$I$$20240610$20240705$20240705$PER$$US-ALK-ABELLO A/S-2024AA002452$ALK-ABELLO$$$$$$Y$$$20240705$$MD$US$US
240532721$24053272$1$I$$20240628$20240705$20240705$PER$$US-CHATTEMPRD-2024OHG022573$CHATTEM$$10$YR$C$F$Y$$$20240705$$CN$US$US
240532732$24053273$2$F$$20240702$20240705$20240709$EXP$$JP-AMGEN-JPNSP2024131037$AMGEN$$$$$$Y$$$20240709$$PH$JP$JP
240532741$24053274$1$I$$20230113$20240705$20240705$PER$$US-AMGEN-USASP2023235486$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240532751$24053275$1$I$20230216$20240627$20240705$20240705$EXP$$ES-CELLTRION INC.-2024ES015865$CELLTRION$$$$$$Y$$$20240705$$HP$ES$ES
240532761$24053276$1$I$$20240701$20240705$20240705$EXP$$JP-AMGEN-JPNSP2024131066$AMGEN$$$$$$Y$$$20240705$$MD$JP$JP
240532771$24053277$1$I$$20240626$20240705$20240705$PER$$US-ROCHE-10000013812$ROCHE$$10$YR$C$M$Y$$$20240705$$HP$US$US
240532783$24053278$3$F$$20240724$20240705$20240727$PER$$US-AMGEN-USASP2024130669$AMGEN$$$$$F$Y$$$20240727$$CN$US$US
240532791$24053279$1$I$20240601$20240625$20240705$20240705$PER$$US-AMGEN-USASP2024127244$AMGEN$$$$$F$Y$$$20240705$$HP$US$US
240532801$24053280$1$I$$20240627$20240705$20240705$EXP$$CH-GSK-CH2024GSK081905$GLAXOSMITHKLINE$Amandine D, Luiza De Bortolli N, Cecilia N, Jessica L, Mary K, Emmanuelle R, et al. Hypokalemic paralysis a side-effect of short action beta2-agonist. Swiss Medical Weekly. 2024;154(S277):35S$$$$$Y$$$20240705$$HP$CH$CH
240532812$24053281$2$F$$20240705$20240705$20240709$PER$$NVSC2024US139386$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240532831$24053283$1$I$$20240614$20240705$20240705$PER$$US-JNJFOC-20240642190$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240705$$CN$US$US
240532841$24053284$1$I$$20240619$20240705$20240705$EXP$$US-IBIGEN-2024-015491$ISTITUTO BICHIMICO ITALIANO GIOVANNI LORENZINI (IBIGEN)$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316(6):279. DOI: 10.1007/s00403-024-03083-0.$49$YR$$M$Y$$$20240625$$MD$US$
240532851$24053285$1$I$20231201$20240626$20240705$20240705$EXP$FR-AFSSAPS-TO2024001026$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06117$HIKMA$$$$$$Y$$$20240705$$MD$FR$FR
240532861$24053286$1$I$$20240701$20240705$20240705$EXP$$RU-GSK-RU2024GSK082463$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$HP$RU$RU
240532871$24053287$1$I$20240527$20240625$20240705$20240705$EXP$FR-AFSSAPS-LM2024000339$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-06085$HIKMA$$32$YR$$M$Y$72$KG$20240705$$MD$FR$FR
240532881$24053288$1$I$20200127$20240628$20240705$20240705$EXP$$FR-TAKEDA-FR202003960$TAKEDA$$45$YR$$F$Y$54$KG$20240705$$CN$FR$FR
240532891$24053289$1$I$$20230823$20240705$20240705$PER$$US-AMGEN-USASP2023235464$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240532902$24053290$2$F$$20240725$20240705$20240806$EXP$$DE-EIGER BIOPHARMACEUTICALS-EIG-2024-000015$EIGER BIOPHARMACEUTICALS$$22$YR$$M$Y$$$20240806$$HP$DE$DE
240532911$24053291$1$I$$20231127$20240705$20240705$PER$$US-AMGEN-USASP2023235535$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240532921$24053292$1$I$20240101$20240701$20240705$20240705$EXP$$US-ABBVIE-5826561$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240532931$24053293$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002925$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240705$$PH$US$US
240532941$24053294$1$I$20240702$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002761$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240705$$CN$US$US
240532951$24053295$1$I$$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002795$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240705$$CN$US$US
240532961$24053296$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002971$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$US$US
240532971$24053297$1$I$20240702$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003063$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240705$$CN$US$US
240532993$24053299$3$F$20240625$20240821$20240705$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002930$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240826$$CN$US$US
240533003$24053300$3$F$$20240926$20240705$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106985$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240930$$CN$US$US
240533012$24053301$2$F$20240624$20240705$20240705$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107172$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240717$$HP$US$US
240533021$24053302$1$I$20240122$20240627$20240705$20240705$EXP$$FR-CELLTRION INC.-2024FR015821$CELLTRION$$$$$$Y$$$20240705$$MD$FR$FR
240533031$24053303$1$I$$20240702$20240705$20240705$PER$$US-JNJFOC-20240707849$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$US$US
240533041$24053304$1$I$20230101$20240628$20240705$20240705$EXP$$CA-JNJFOC-20231179180$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240705$$PH$CA$CA
240533051$24053305$1$I$$20240701$20240705$20240705$EXP$$US-JNJFOC-20240703156$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$CN$US$US
240533061$24053306$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131424$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240533072$24053307$2$F$20240101$20240701$20240705$20240709$EXP$$US-AMGEN-USASP2024129201$AMGEN$$55$YR$A$F$Y$$$20240709$$HP$US$US
240533081$24053308$1$I$$20230511$20240705$20240705$PER$$US-AMGEN-USASP2023235487$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240533091$24053309$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05752$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240533102$24053310$2$F$20230101$20240628$20240705$20240712$EXP$$IT-009507513-2407ITA001142$MERCK$Longhitano C, Cordio S.. Pembrolizumab: maintenance of response after treatment discontinuation. METASTATIC RECURRENT HEAD AND NECK CANCER CLINICAL EXPERIENCE WITH PEMBROLIZUMAB. 2024;1$$$A$M$Y$83$KG$20240712$$MD$IT$IT
240533111$24053311$1$I$$20240702$20240705$20240705$PER$$US-TAKEDA-2024TUS067433$TAKEDA$$$$$F$Y$50$KG$20240705$$MD$US$US
240533121$24053312$1$I$20220101$20240624$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101804$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$81.65$KG$20240705$$CN$US$US
240533131$24053313$1$I$$20240628$20240705$20240705$EXP$$US-JNJFOC-20240677374$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240533141$24053314$1$I$$20240628$20240705$20240705$EXP$$CO-GSK-CO2024AMR081963$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$CO$CO
240533151$24053315$1$I$20240614$20240701$20240705$20240705$EXP$IT-MINISAL02-991799$IT-IBIGEN-2024-015490$ISTITUTO BICHIMICO ITALIANO GIOVANNI LORENZINI (IBIGEN)$$75$YR$$M$Y$95$KG$20240701$$MD$IT$
240533162$24053316$2$F$$20240723$20240705$20240725$PER$$NVSC2024US138007$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
240533171$24053317$1$I$$20240630$20240705$20240705$PER$$US-UNITED THERAPEUTICS-UNT-2024-020139$UNITED THERAPEUTICS$$$$$F$Y$86.621$KG$20240705$$$US$US
240533181$24053318$1$I$$20240217$20240705$20240705$PER$$US-ABBVIE-5828215$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240533192$24053319$2$F$$20240802$20240705$20240806$PER$$US-ALXN-202406USA001867US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$CN$US$US
240533201$24053320$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05751$LUPIN$$$$$$Y$$$20240705$$PH$US$US
240533211$24053321$1$I$$20240627$20240705$20240705$EXP$GB-MHRA-WEBCOVID-202406271802274960-JCKBV$GB-RDY-SPO/GBR/24/0009492$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240533226$24053322$6$F$20240101$20240916$20240705$20240924$EXP$$CA-CELLTRION INC.-2024CA009515$CELLTRION$$$$$$Y$$$20240924$$MD$CA$CA
240533231$24053323$1$I$20240327$20240624$20240705$20240705$EXP$$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-06007$HIKMA$$53$YR$$F$Y$60$KG$20240705$$MD$IT$IT
240533241$24053324$1$I$$20240626$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06024$HIKMA$$$$$$Y$$$20240705$$CN$US$US
240533252$24053325$2$F$20210101$20240711$20240705$20240721$EXP$$CA-TEVA-VS-3212288$TEVA$Phillips WJ, Lo B, Corredor ALG, Gomes MM, Wheatley-Price P. A rare case of false negative ROS1 fusion in metastatic pulmonary adenocarcinoma: Case report and lessons learned. Clin-Lung-Cancer 2023; 24 (5): e172-e175.; Phillips WJ, Lo B, Corredor ALG, Gomes MM, Wheatley-Price P. A rare case of false negative ROS1 fusion in metastatic pulmonary adenocarcinoma: Case report and lessons learned. Clin-Lung-Cancer 2023; 24 (5): e172-e175.; Phillips WJ, Lo B, Corredor ALG, Gomes MM, Wheatley-Price P...$46$YR$$M$Y$$$20240721$$HP$CA$CA
240533261$24053326$1$I$$20240625$20240705$20240705$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004792$BIOCON$$$$$$Y$$$20240705$$MD$CA$CA
240533271$24053327$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824648$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240533281$24053328$1$I$$20240119$20240705$20240705$PER$$US-AMGEN-USASP2024131739$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240533291$24053329$1$I$20240630$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132084$AMGEN$$63$YR$A$F$Y$$$20240705$$PH$US$US
240533301$24053330$1$I$$20230523$20240705$20240705$PER$$US-AMGEN-USASP2023235463$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240533311$24053331$1$I$20240430$20240701$20240705$20240705$EXP$$ES-AMGEN-ESPSP2024130271$AMGEN$$83$YR$E$F$Y$$$20240705$$HP$ES$ES
240533321$24053332$1$I$$20240703$20240705$20240705$PER$$US-JNJFOC-20240711423$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240533331$24053333$1$I$20240623$20240702$20240705$20240705$PER$$US-JNJFOC-20240707083$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$PH$US$US
240533341$24053334$1$I$$20240625$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107255$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$108.86$KG$20240705$$CN$US$US
240533351$24053335$1$I$$20240701$20240705$20240705$PER$$US-AstraZeneca-2024A151648$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$US$
240533361$24053336$1$I$$20240221$20240705$20240705$PER$$US-AMGEN-USASP2024132692$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240533371$24053337$1$I$$20240622$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-05950$HIKMA$Jamison K, Medepalli, LC, Ye S. Jamison K, Medepalli, LC, Ye S. Isolated Pericardial Effusion Without Associated Myocarditis in a Small-Cell Lung Cancer Patient Undergoing Atezolizumab Therapy. Cureus. 2024;16(5):e60184$67$YR$$M$Y$$$20240705$$MD$US$US
240533381$24053338$1$I$20240511$20240628$20240705$20240705$EXP$$GB-AstraZeneca-2024A149629$ASTRAZENECA$$85$YR$$F$Y$$$20240705$$MD$GB$
240533392$24053339$2$F$20240209$20240709$20240705$20240717$EXP$$PT-CELLTRION INC.-2024PT016404$CELLTRION$$$$$$Y$$$20240717$$PH$PT$PT
240533401$24053340$1$I$$20240625$20240705$20240705$PER$$US-ROCHE-10000016483$ROCHE$$52$YR$A$M$Y$$$20240705$$HP$US$US
240533411$24053341$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002801$ELI LILLY AND CO$$$$$$Y$$$20240705$$CN$US$US
240533421$24053342$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002737$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240705$$CN$US$US
240533431$24053343$1$I$$20240620$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05799$HIKMA$Pierce V, Bollavaram V, Ali A.. Pierce V, Bollavaram V, Ali A. A case of long QT syndrome masquerading as epilepsy.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1699$$$$$Y$$$20240705$$MD$US$US
240533441$24053344$1$I$$20240701$20240705$20240705$PER$$US-BIOGEN-2023BI01234965$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
240533451$24053345$1$I$20240601$20240703$20240705$20240705$EXP$$US-UCBSA-2024034086$UCB$$44$YR$$F$Y$$$20240705$$HP$US$US
240533461$24053346$1$I$$20240702$20240705$20240705$EXP$$NVSC2024US138433$NOVARTIS$$$$$M$Y$$$20240705$$CN$US$US
240533472$24053347$2$F$$20240716$20240705$20240718$EXP$$IL-JNJFOC-20240700520$JOHNSON AND JOHNSON$$19$YR$A$F$Y$$$20240719$$HP$IL$IL
240533481$24053348$1$I$20240620$20240629$20240705$20240705$EXP$$CA-JNJFOC-20240704969$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240705$$CN$CA$CA
240533491$24053349$1$I$$20240702$20240705$20240705$EXP$$US-GILEAD-2024-0666948$GILEAD$$$$A$F$Y$$$20240705$$CN$US$US
240533501$24053350$1$I$20240101$20240626$20240705$20240705$EXP$$PL-GILEAD-2024-0678692$GILEAD$$$$A$M$Y$$$20240705$$MD$PL$PL
240533512$24053351$2$F$$20240722$20240705$20240801$EXP$$BE-BEH-2024168977$CSL BEHRING$$$$T$M$Y$$$20240801$$HP$BE$BE
240533521$24053352$1$I$$20240220$20240705$20240705$PER$$US-AMGEN-USASP2024131879$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240533531$24053353$1$I$$20240628$20240705$20240705$EXP$$US-ABBVIE-5827107$ABBVIE$$$$E$$Y$$$20240705$$CN$US$US
240533542$24053354$2$F$20240617$20240729$20240705$20240801$EXP$$US-ABBVIE-5824993$ABBVIE$$64$YR$$F$Y$$$20240801$$CN$US$US
240533551$24053355$1$I$$20240626$20240705$20240705$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024004811$BIOCON$$$$$$Y$$$20240705$$CN$AU$AU
240533562$24053356$2$F$$20240712$20240705$20240722$EXP$$ES-CELLTRION INC.-2024ES015815$CELLTRION$$$$$$Y$$$20240722$$MD$ES$ES
240533575$24053357$5$F$20240605$20240912$20240705$20240924$EXP$$DE-ROCHE-10000012931$ROCHE$$52$YR$A$M$Y$93$KG$20240924$$MD$DE$DE
240533582$24053358$2$F$$20240703$20240705$20240712$EXP$$US-GSK-US2024AMR080678$GLAXOSMITHKLINE$$$$$F$Y$62.585$KG$20240712$$CN$US$US
240533591$24053359$1$I$$20240701$20240705$20240705$30DAY$$US-GSK-US2024081591$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240705$$CN$US$US
240533602$24053360$2$F$20240501$20240819$20240705$20240829$30DAY$$US-GSK-US2024081575$GLAXOSMITHKLINE$$63$YR$$M$Y$$$20240829$$MD$US$US
240533611$24053361$1$I$20240302$20240620$20240705$20240705$EXP$ES-AEMPS-1534471$ES-TEVA-VS-3213224$TEVA$$92$YR$$F$Y$$$20240705$$MD$ES$ES
240533621$24053362$1$I$20240418$20240625$20240705$20240705$EXP$FR-AFSSAPS-LL2024001144$FR-TEVA-VS-3214067$TEVA$$47$YR$$F$Y$90$KG$20240705$$CN$FR$FR
240533631$24053363$1$I$20230621$20230915$20240705$20240705$EXP$$DE-OCTA-GAM17424$OCTAPHARMA$$29$YR$A$M$Y$117$KG$20240613$$MD$EU$EU
240533641$24053364$1$I$$20240624$20240705$20240705$EXP$$GB-ROCHE-3435992$ROCHE$$$$E$M$Y$$$20240705$$CN$GB$GB
240533651$24053365$1$I$$20240703$20240705$20240705$PER$$US-ABBVIE-5827266$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240533661$24053366$1$I$20240614$20240702$20240705$20240705$EXP$$US-AstraZeneca-2024A152620$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240533672$24053367$2$F$$20240802$20240705$20240806$PER$$US-ALXN-202406USA001905US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240533681$24053368$1$I$$20240701$20240705$20240705$EXP$$US-JNJFOC-20240703777$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240705$$HP$US$US
240533691$24053369$1$I$$20240625$20240705$20240705$PER$$US-TEVA-VS-3215270$TEVA$$$$A$F$Y$$$20240705$$CN$US$US
240533711$24053371$1$I$20240617$20240701$20240705$20240705$PER$$US-ABBVIE-5825237$ABBVIE$$56$YR$$F$Y$$$20240705$$CN$US$US
240533721$24053372$1$I$$20240415$20240705$20240705$PER$$US-AMGEN-USASP2024130653$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240533731$24053373$1$I$20240701$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130806$AMGEN$$57$YR$A$F$Y$$$20240705$$CN$US$US
240533741$24053374$1$I$20240621$20240627$20240705$20240705$EXP$$ES-TEVA-VS-3215759$TEVA$$83$YR$$F$Y$$$20240705$$CN$ES$ES
240533751$24053375$1$I$20230317$20240701$20240705$20240705$EXP$FR-AFSSAPS-PC2024000502$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-104927$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$56$KG$20240705$$MD$FR$FR
240533761$24053376$1$I$$20240702$20240705$20240705$EXP$$AT-TAKEDA-2024TUS067827$TAKEDA$$$$$M$Y$$$20240705$$CN$GB$AT
240533771$24053377$1$I$$20240701$20240705$20240705$PER$$US-HALEON-2185169$Haleon PLC$$48$YR$$M$Y$$$20240705$$MD$US$US
240533783$24053378$3$F$$20240831$20240705$20240909$EXP$$US-ROCHE-10000012038$ROCHE$$56$YR$A$M$Y$$$20240910$$MD$US$US
240533791$24053379$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5826716$ABBVIE$$22$YR$$F$Y$$$20240705$$HP$US$US
240533801$24053380$1$I$$20240625$20240705$20240705$PER$$US-JNJFOC-20240669919$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240533811$24053381$1$I$$20240630$20240705$20240705$EXP$$ES-JNJFOC-20240703988$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$MD$ES$ES
240533821$24053382$1$I$$20240611$20240705$20240705$PER$$US-JNJFOC-20240641479$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240533831$24053383$1$I$$20240620$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05810$HIKMA$Sompalli S, Foray N, Sreedhar R.. Sompalli S, Foray N, Sreedhar R. A Rare Case of Non-traumatic Splenic Rupture Following Portal Vein Thrombosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1727$53$YR$$F$Y$$$20240705$$MD$US$US
240533841$24053384$1$I$$20240703$20240705$20240705$EXP$$GB-GILEAD-2024-0679455$GILEAD$$75$YR$E$F$Y$$$20240705$$CN$GB$GB
240533851$24053385$1$I$$20230828$20240705$20240705$PER$$US-AMGEN-USASP2023235585$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240533861$24053386$1$I$20240701$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132354$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240533871$24053387$1$I$20240626$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130849$AMGEN$$32$YR$A$F$Y$$$20240705$$CN$US$US
240533881$24053388$1$I$20240703$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002733$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240705$$CN$US$US
240533891$24053389$1$I$20240101$20240702$20240705$20240705$EXP$$US-ABBVIE-5826088$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240533901$24053390$1$I$20240614$20240614$20240705$20240705$PER$$TR-TOLMAR, INC.-24TR050219$TOLMAR$$88$YR$$M$Y$$$20240705$$PH$TR$TR
240533911$24053391$1$I$20240607$20240613$20240705$20240705$PER$$TR-TOLMAR, INC.-24TR050214$TOLMAR$$80$YR$$M$Y$$$20240705$$PH$TR$TR
240533921$24053392$1$I$20240613$20240613$20240705$20240705$PER$$TR-TOLMAR, INC.-24TR050212$TOLMAR$$92$YR$$M$Y$$$20240705$$PH$TR$TR
240533931$24053393$1$I$20240612$20240614$20240705$20240705$PER$$TR-TOLMAR, INC.-24TR050226$TOLMAR$$59$YR$$M$Y$$$20240705$$PH$TR$TR
240533942$24053394$2$F$$20240705$20240705$20240709$EXP$$US-GILEAD-2024-0679517$GILEAD$$33$YR$A$M$Y$$$20240709$$PH$US$US
240533952$24053395$2$F$$20240816$20240705$20240822$EXP$$US-GILEAD-2024-0679519$GILEAD$$61$YR$A$M$Y$$$20240822$$CN$US$US
240533961$24053396$1$I$20240627$20240628$20240705$20240705$PER$$US-ROCHE-10000014695$ROCHE$$$$$$Y$$$20240705$$HP$US$US
240533971$24053397$1$I$$20240621$20240705$20240705$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001636$IPCA$G. M. Calderon Barahona , R. Ali , C. Ortega Giron,et.al.. Beta-blocked: a severe propranolol overdose case report. Am J Respir Crit Care Med. 2024;209:A5699$$$$$Y$$$20240705$$HP$US$US
240533991$24053399$1$I$20240114$20240627$20240705$20240705$EXP$$NL-CELLTRION INC.-2024NL015856$CELLTRION$$$$$$Y$$$20240705$$MD$NL$NL
240534001$24053400$1$I$$20240620$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05705$HIKMA$Pickos J, Farmer MJS.. Pickos J, Farmer MJS. Management of DIC in the Setting of Lung Adenocarcinoma Complicated by Pulmonary Embolism and Hemorrhagic Pericardial Effusion With Tamponade.. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A3551$$$$$Y$$$20240705$$MD$US$US
240534013$24053401$3$F$20240620$20240827$20240705$20240905$30DAY$$US-GSK-US2024079869$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240905$$CN$US$US
240534021$24053402$1$I$$20240624$20240705$20240705$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP007791$STRIDES$Fernandes G, Patil M, Harinkhede N, Khumanthem G, Rojekar A.. Renal allograft failure resulting from diffuse cortical necrosis.. Indian-J-Pathol-Microbiol. 2024;1-4$28$YR$$F$Y$$$20240705$$MD$IN$IN
240534031$24053403$1$I$$20240628$20240705$20240705$EXP$$US-TAKEDA-2024TUS041068$TAKEDA$$$$$M$Y$$$20240705$$CN$US$US
240534042$24053404$2$F$20140101$20240625$20240705$20240809$EXP$$US-ROCHE-10000011779$ROCHE$$53$YR$A$F$Y$71.21$KG$20240809$$CN$US$US
240534051$24053405$1$I$$20240702$20240705$20240705$PER$$US-AstraZeneca-2024A153050$ASTRAZENECA$$$$$$Y$$$20240705$$CN$US$
240534061$24053406$1$I$$20240627$20240705$20240705$EXP$$VN-AstraZeneca-2024A150105$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$VN$
240534071$24053407$1$I$20240619$20240627$20240705$20240705$EXP$$CN-AstraZeneca-2024A151550$ASTRAZENECA$$26637$DY$$M$Y$74$KG$20240705$$MD$CN$
240534081$24053408$1$I$$20240702$20240705$20240705$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037950$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240705$$CN$US$US
240534092$24053409$2$F$20240301$20240731$20240705$20240802$PER$$US-AMGEN-USASP2024129729$AMGEN$$73$YR$E$M$Y$$$20240802$$CN$US$US
240534101$24053410$1$I$$20240624$20240705$20240705$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007932$STRIDES$Bhatia S, Jamil A, Sharif M, Skenderi S.. Cardiovascular Collapse Shortly After Beta Blockers in Atrial Fibrillationcomplicated Thyroid Storm.. Am-J-Respir-Crit-Care-Med. 2024;209 (0):no pagination$49$YR$$M$Y$$$20240705$$HP$US$US
240534111$24053411$1$I$$20231229$20240705$20240705$PER$$US-AMGEN-USASP2023235584$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240534121$24053412$1$I$20240113$20240701$20240705$20240705$EXP$GB-MHRA-MED-202406301130511070-FLYHN$GB-ORGANON-O2407GBR000140$ORGANON$$24$YR$$M$Y$$$20240705$$CN$GB$GB
240534132$24053413$2$F$$20240705$20240705$20240710$PER$$US-AMGEN-USASP2024132488$AMGEN$$$$$M$Y$$$20240710$$HP$US$US
240534142$24053414$2$F$$20240701$20240705$20240708$EXP$$US-GSK-US2024036256$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$HP$US$US
240534151$24053415$1$I$$20240219$20240705$20240705$PER$$US-ABBVIE-5828336$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240534161$24053416$1$I$20240401$20240703$20240705$20240705$EXP$FR-AFSSAPS-SE2024000540$FR-ABBVIE-5824260$ABBVIE$$32$YR$$F$Y$90$KG$20240705$$MD$FR$FR
240534171$24053417$1$I$$20240701$20240705$20240705$EXP$$JP-GILEAD-2024-0679317$GILEAD$Kanzaki N.. P-140 Examination of half a conventional dose of remdesivir administration for dialysis patients with moderate level 1 or more severe COVID-19. The 98th Annual Meeting of the Japanese Association for Infectious Diseases. 2024;UNK:UNK$$$A$$Y$$$20240705$$MD$JP$JP
240534181$24053418$1$I$$20240501$20240705$20240705$PER$$US-AMGEN-USASP2024133121$AMGEN$$$$$$Y$$$20240705$$MD$US$US
240534191$24053419$1$I$20230101$20240701$20240705$20240705$EXP$$US-JNJFOC-20240703161$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240534201$24053420$1$I$20240701$20240702$20240705$20240705$PER$$US-JNJFOC-20240708522$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$US$US
240534216$24053421$6$F$$20240826$20240705$20240902$30DAY$$IL-JNJFOC-20240668347$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240902$$HP$IL$IL
240534221$24053422$1$I$$20240626$20240705$20240705$EXP$$US-RECORDATI RARE DISEASE INC.-2024004939$RECORDATI$$$$$$Y$$$20240705$$CN$US$US
240534231$24053423$1$I$20240624$20240702$20240705$20240705$EXP$$US-TAKEDA-2023TUS077329$TAKEDA$$65$YR$$F$Y$$$20240705$$HP$US$US
240534241$24053424$1$I$$20240628$20240705$20240705$PER$$US-ALXN-202406USA001937US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240705$$CN$US$US
240534251$24053425$1$I$$20240625$20240705$20240705$PER$$US-TEVA-VS-3213728$TEVA$$$$$$Y$$$20240705$$HP$US$US
240534261$24053426$1$I$$20230619$20240705$20240705$PER$$US-AMGEN-USASP2023235597$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240534271$24053427$1$I$20231001$20240701$20240705$20240705$EXP$$TW-UCBSA-2024028800$UCB$$42$YR$$F$Y$68$KG$20240705$$CN$TW$TW
240534282$24053428$2$F$20240101$20240708$20240705$20240710$EXP$$US-UCBSA-2024033424$UCB$$$$$F$Y$68.04$KG$20240710$$HP$US$US
240534291$24053429$1$I$$20240628$20240705$20240705$EXP$$GB-ABBVIE-5826211$ABBVIE$$42$YR$$F$Y$$$20240705$$CN$GB$GB
240534301$24053430$1$I$20240601$20240703$20240705$20240705$EXP$$AR-ABBVIE-5826148$ABBVIE$$37$YR$$F$Y$$$20240705$$CN$AR$AR
240534311$24053431$1$I$$20240702$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062640$SANDOZ$$$$$M$Y$$$20240705$$CN$US$US
240534321$24053432$1$I$$20240617$20240705$20240705$EXP$$US-TEVA-VS-3212236$TEVA$Gupta A, Jatwani K, Gupta K, Qiu J, Dy GK. Loss of Rb1 Associated With the Onset of Acquired Resistance to Trastuzumab Deruxtecan in TP53-/HER2-Mutated Non-Small-Cell Lung Cancer: Case Series. JCO-Precis-Oncol 2023; 7.$57$YR$$F$Y$$$20240705$$MD$US$US
240534331$24053433$1$I$$20240627$20240705$20240705$EXP$$JP-ROCHE-3514823$ROCHE$$62$YR$A$F$Y$$$20240705$$MD$JP$JP
240534341$24053434$1$I$20240601$20240701$20240705$20240705$EXP$$US-ABBVIE-5824989$ABBVIE$$58$YR$$M$Y$$$20240705$$CN$US$US
240534351$24053435$1$I$$20240702$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062641$SANDOZ$$$$$F$Y$$$20240705$$HP$US$US
240534361$24053436$1$I$$20240703$20240705$20240705$EXP$$PR-ABBVIE-5827642$ABBVIE$$$$$M$Y$$$20240705$$CN$PR$PR
240534371$24053437$1$I$$20240702$20240705$20240705$EXP$$US-GILEAD-2024-0679457$GILEAD$$$$$$Y$$$20240705$$CN$US$US
240534381$24053438$1$I$$20240702$20240705$20240705$EXP$$US-GILEAD-2024-0679587$GILEAD$$42$YR$A$M$Y$$$20240705$$CN$US$US
240534391$24053439$1$I$20240517$20240611$20240705$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002781$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240705$$CN$US$US
240534401$24053440$1$I$20230731$20240621$20240705$20240705$EXP$IT-MINISAL02-990555$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-05924$HIKMA$$59$YR$$F$Y$58$KG$20240705$$MD$IT$IT
240534412$24053441$2$F$20240526$20240724$20240705$20240730$EXP$FR-AFSSAPS-RN2024000701$FR-TAKEDA-2024TUS065862$TAKEDA$$62$YR$$F$Y$$$20240730$$HP$FR$FR
240534421$24053442$1$I$$20240625$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024079096$VIIV$$$$$M$Y$$$20240705$$HP$US$US
240534431$24053443$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281444339100-ZPDRB$GB-RDY-SPO/GBR/24/0009540$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240534441$24053444$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281440345420-HKJBF$GB-RDY-SPO/GBR/24/0009668$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240534451$24053445$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281438310700-KPJBZ$GB-RDY-SPO/GBR/24/0009667$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240534461$24053446$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281446000970-SKTYP$GB-RDY-SPO/GBR/24/0009663$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240534472$24053447$2$F$$20240708$20240705$20240715$EXP$GB-MHRA-MED-202406281431213880-YGRFD$GB-RDY-SPO/GBR/24/0009550$DR REDDYS$$$$$$Y$$$20240715$$CN$GB$GB
240534481$24053448$1$I$20230101$20240629$20240705$20240705$EXP$$GB-UCBSA-2023054508$UCB$$$$$F$Y$$$20240705$$CN$GB$GB
240534491$24053449$1$I$20240602$20240701$20240705$20240705$EXP$$CN-ABBVIE-5824665$ABBVIE$$76$YR$$M$Y$71$KG$20240705$$HP$CN$CN
240534502$24053450$2$F$$20240705$20240705$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407003124$ELI LILLY AND CO$$$$$F$Y$$$20240709$$CN$US$US
240534511$24053451$1$I$20240625$20240626$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406018657$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240705$$CN$US$US
240534521$24053452$1$I$20240601$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002758$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240705$$CN$US$US
240534531$24053453$1$I$$20240625$20240705$20240705$PER$$US-TEVA-VS-3215360$TEVA$$$$E$F$Y$$$20240705$$CN$US$US
240534541$24053454$1$I$$20240701$20240705$20240705$PER$$US-BIOGEN-2024BI01271857$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
240534551$24053455$1$I$$20240627$20240705$20240705$EXP$$IL-STRIDES ARCOLAB LIMITED-2024SP007941$STRIDES$Shehadeh K, Levinsky Y, Kagan S, Zuabi T, Tal R, Aviran NH, et al.. An ^On Demand^ canakinumab regimen for treating children with Colchicine-Resistant familial Mediterranean fever - A multicentre study. Int-Immunopharmacol. 2024;132 (0)$$$C$$Y$$$20240705$$HP$IL$IL
240534561$24053456$1$I$$20240628$20240705$20240705$PER$$US-BIOGEN-2024BI01271072$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
240534572$24053457$2$F$$20240709$20240705$20240713$PER$$US-ABBVIE-5827463$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240534581$24053458$1$I$$20230911$20240705$20240705$PER$$US-AMGEN-USASP2023235578$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240534591$24053459$1$I$$20240109$20240705$20240705$PER$$US-AMGEN-USASP2024129549$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240534601$24053460$1$I$20240101$20240701$20240705$20240705$EXP$$US-JNJFOC-20240703706$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240705$$HP$US$US
240534611$24053461$1$I$$20240628$20240705$20240705$30DAY$$US-GSK-US2024081043$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$CN$US$US
240534621$24053462$1$I$20231201$20240703$20240705$20240705$EXP$$US-TAKEDA-2024TUS067602$TAKEDA$$53$YR$$M$Y$71$KG$20240705$$MD$US$US
240534631$24053463$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824227$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240534641$24053464$1$I$20240501$20240702$20240705$20240705$EXP$$CA-ABBVIE-5825329$ABBVIE$$82$YR$$$Y$$$20240705$$CN$CA$CA
240534652$24053465$2$F$$20240909$20240705$20240915$EXP$$JP-ALXN-202407JPN000001JP$ALEXION PHARMACEUTICALS$$57$YR$$M$Y$$$20240915$$MD$JP$JP
240534661$24053466$1$I$$20240628$20240705$20240705$PER$$US-ALXN-202406USA001907US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
240534671$24053467$1$I$20240101$20240702$20240705$20240705$EXP$$CA-ABBVIE-5825056$ABBVIE$$41$YR$$M$Y$$$20240705$$CN$CA$CA
240534681$24053468$1$I$$20240627$20240705$20240705$EXP$$GB-EMD Serono-2024035504$EMD SERONO INC$$$$$$Y$$$20240705$$HP$GB$GB
240534691$24053469$1$I$$20240703$20240705$20240705$EXP$$US-TAKEDA-2024TUS067585$TAKEDA$$$$$F$Y$$$20240705$$HP$US$US
240534701$24053470$1$I$$20240625$20240705$20240705$EXP$$DE-UCBSA-2024033001$UCB$$4$MON$$F$Y$$$20240705$$MD$DE$DE
240534711$24053471$1$I$20240501$20240621$20240705$20240705$EXP$GB-MHRA-MED-202406211806513460-WFPTY$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-05850$HIKMA$$$$$$Y$$$20240705$$MD$GB$GB
240534721$24053472$1$I$$20240628$20240705$20240705$PER$$NVSC2024US139114$NOVARTIS$$$$$$Y$$$20240705$$MD$US$US
240534731$24053473$1$I$20240525$20240624$20240705$20240705$EXP$SE-SEMPA-2024-005021$SE-STRIDES ARCOLAB LIMITED-2024SP007590$STRIDES$$28$YR$$M$Y$$$20240705$$MD$SE$SE
240534743$24053474$3$F$$20240904$20240705$20240906$EXP$$NVSC2024GB139154$NOVARTIS$$$$$$Y$$$20240906$$MD$GB$GB
240534751$24053475$1$I$$20240627$20240705$20240705$EXP$$CA-APOTEX-2024AP007274$APOTEX$$7$DEC$$F$Y$$$20240705$$MD$CA$CA
240534761$24053476$1$I$$20240701$20240705$20240705$EXP$$US-JAZZ-2019-US-003229$JAZZ$$$$$F$Y$$$20240705$$CN$US$US
240534772$24053477$2$F$20240629$20240828$20240705$20240902$EXP$$CA-TAKEDA-2024TUS067434$TAKEDA$$66$YR$$F$Y$$$20240902$$CN$CA$CA
240534783$24053478$3$F$20240419$20240828$20240705$20240906$EXP$$US-JNJFOC-20240563860$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240906$$HP$US$US
240534791$24053479$1$I$$20240627$20240705$20240705$EXP$$IL-STRIDES ARCOLAB LIMITED-2024SP007942$STRIDES$Shehadeh K, Levinsky Y, Kagan S, Zuabi T, Tal R, Aviran NH, et al.. An ^On Demand^ canakinumab regimen for treating children with Colchicine-Resistant familial Mediterranean fever - A multicentre study.. Int-Immunopharmacol. 2024;132 (0)$$$C$$Y$$$20240705$$HP$IL$IL
240534801$24053480$1$I$20240510$20240625$20240705$20240705$EXP$FR-AFSSAPS-PA2024001138$FR-TEVA-VS-3214438$TEVA$$68$YR$$F$Y$$$20240705$$MD$FR$FR
240534812$24053481$2$F$$20240823$20240705$20240828$EXP$$US-TAKEDA-2021TUS028796$TAKEDA$$$$$F$Y$49.887$KG$20240828$$MD$US$US
240534821$24053482$1$I$20240605$20240701$20240705$20240705$EXP$$JP-TAKEDA-2024TUS067846$TAKEDA$$62$YR$$M$Y$49$KG$20240705$$MD$JP$JP
240534831$24053483$1$I$20231129$20240626$20240705$20240705$EXP$$EG-EMD Serono-2024000002$EMD SERONO INC$$38$YR$A$F$Y$$$20240705$$CN$EG$EG
240534841$24053484$1$I$$20240627$20240705$20240705$EXP$$IL-STRIDES ARCOLAB LIMITED-2024SP007943$STRIDES$Shehadeh K, Levinsky Y, Kagan S, Zuabi T, Tal R, Aviran NH, et al.. An ^On Demand^ canakinumab regimen for treating children with Colchicine-Resistant familial Mediterranean fever - A multicentre study.. Int-Immunopharmacol. 2024;132 (0)$$$C$$Y$$$20240705$$HP$IL$IL
240534851$24053485$1$I$$20240627$20240705$20240705$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000825$AZURITY PHARMACEUTICALS$Khan M.S., Ahmed O., Nwaedozie S. Anaconda right coronary artery. Arterioscler. Thromb. Vasc. Biol.. 2023;43 Suppl (1)$61$YR$$M$Y$$$20240705$$HP$US$US
240534861$24053486$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824715$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240534871$24053487$1$I$$20240628$20240705$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107176$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240705$$PH$JP$JP
240534883$24053488$3$F$$20240820$20240705$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107290$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240828$$PH$JP$JP
240534891$24053489$1$I$$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107257$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240705$$PH$US$US
240534902$24053490$2$F$20240601$20240709$20240705$20240716$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107303$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240716$$MD$JP$JP
240534921$24053492$1$I$$20240627$20240705$20240705$EXP$$IL-STRIDES ARCOLAB LIMITED-2024SP007922$STRIDES$Shehadeh K, Levinsky Y, Kagan S, Zuabi T, Tal R, Aviran NH, et al.. An ^On Demand^ canakinumab regimen for treating children with Colchicine-Resistant familial Mediterranean fever - A multicentre study.. Int-Immunopharmacol. 2024;132 (0)$$$C$$Y$$$20240705$$HP$IL$IL
240534931$24053493$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5826474$ABBVIE$$25$YR$$F$Y$$$20240705$$HP$US$US
240534941$24053494$1$I$$20231130$20240705$20240705$PER$$US-AMGEN-USASP2023235490$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240534951$24053495$1$I$20240601$20240628$20240705$20240705$PER$$US-ABBVIE-5826723$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240534961$24053496$1$I$$20240628$20240705$20240705$PER$$US-ABBVIE-5826714$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240534974$24053497$4$F$20100101$20240801$20240705$20240805$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037356$BOEHRINGER INGELHEIM$$25$YR$A$F$Y$68$KG$20240805$$CN$BR$BR
240534981$24053498$1$I$$20230621$20240705$20240705$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397443$RANBAXY$$$$$$Y$$$20240705$$HP$US$US
240534991$24053499$1$I$$20240620$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05749$HIKMA$Deanda S, Razia D, Zaidi W, Lee R, Arjuna A.. Deanda S, Razia D, Zaidi W, Lee R, Arjuna A. Post-transplant lymphoproliferative disorder: A nodular area that kept growing.. American Journal of Respiratory and Critical Care Medicine.. 202;209:A5942.$82$YR$$F$Y$$$20240705$$MD$US$US
240535001$24053500$1$I$20240101$20240628$20240705$20240705$EXP$$US-SA-2024SA195890$SANOFI AVENTIS$$75$YR$E$F$Y$75.737$KG$20240705$$MD$US$US
240535011$24053501$1$I$$20240405$20240705$20240705$PER$$US-ABBVIE-5828411$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240535021$24053502$1$I$$20240620$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05841$HIKMA$Dhaliwal K, Patel N, Aulakh B.. Dhaliwal K, Patel N, Aulakh B. Toxic Megacolon: A Rare Adverse Effect of Etoposide Chemotherapy. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5663$59$YR$$M$Y$$$20240705$$MD$US$US
240535031$24053503$1$I$20240601$20240626$20240705$20240705$PER$$US-TEVA-VS-3214726$TEVA$$36$YR$$F$Y$$$20240705$$CN$US$US
240535042$24053504$2$F$$20240802$20240705$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002371$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
240535051$24053505$1$I$20240614$20240626$20240705$20240705$EXP$IT-MINISAL02-991207$IT-TEVA-VS-3215137$TEVA$$47$YR$$M$Y$$$20240705$$CN$IT$IT
240535061$24053506$1$I$$20240702$20240705$20240705$EXP$$CA-TAKEDA-2024TUS067385$TAKEDA$$$$$F$Y$$$20240705$$MD$CA$CA
240535071$24053507$1$I$20240510$20240627$20240705$20240705$EXP$ES-AEMPS-1538596$ES-SA-2024SA193388$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240705$$MD$ES$ES
240535091$24053509$1$I$20240701$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130847$AMGEN$$60$YR$A$M$Y$$$20240705$$CN$US$US
240535101$24053510$1$I$$20230613$20240705$20240705$PER$$US-AMGEN-USASP2023235596$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240535111$24053511$1$I$$20240627$20240705$20240705$EXP$$US-BIOGEN-2024BI01270615$BIOGEN$$$$$M$Y$$$20240705$$HP$US$US
240535121$24053512$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5826488$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240535142$24053514$2$F$$20240711$20240705$20240721$EXP$$US-TEVA-VS-3214782$TEVA$Razi S, Mcguire RJ, Krings JG. Use of the Anti-interleukin-5-Receptor Monoclonal Antibody, Benralizumab, for the Treatment of Allergic Bronchopulmonary Aspergillosis. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A5287; Razi S, Mcguire RJ, Krings JG. Use of the Anti-interleukin-5-Receptor Monoclonal Antibody, Benralizumab, for the Treatment of Allergic Bronchopulmonary Aspergillosis. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A5287.$64$YR$$M$Y$$$20240721$$HP$US$US
240535151$24053515$1$I$$20240701$20240705$20240705$EXP$$US-JNJFOC-20240701016$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$HP$US$US
240535161$24053516$1$I$$20240628$20240705$20240705$EXP$$BE-TAKEDA-2024TUS067483$TAKEDA$$70$YR$$F$Y$$$20240705$$MD$BE$BE
240535171$24053517$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002893$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240705$$CN$US$US
240535181$24053518$1$I$20240501$20240628$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407000378$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240705$$CN$US$US
240535191$24053519$1$I$20240522$20240611$20240705$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002788$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240705$$HP$US$US
240535201$24053520$1$I$$20240627$20240705$20240705$EXP$$CH-TAKEDA-2024TUS067945$TAKEDA$$$$E$M$Y$$$20240705$$MD$CH$CH
240535211$24053521$1$I$$20240627$20240705$20240705$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007923$STRIDES$Habib A, Butt K, Ibrahim R, Shaaban A, Lee HS.. BRASH syndrome: A rare but reversible cause of sinus node dysfunction.. HeartRhythm-Case-Rep. 2024;10 (6):398-401$57$YR$$F$Y$$$20240705$$MD$US$US
240535222$24053522$2$F$20190509$20240912$20240705$20240916$PER$$US-GILEAD-2024-0679557$GILEAD$$40$YR$A$F$Y$$$20240916$$LW$US$US
240535231$24053523$1$I$$20240705$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107324$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240705$$CN$US$US
240535252$24053525$2$F$$20240826$20240705$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106473$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240827$$CN$US$US
240535261$24053526$1$I$$20240702$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106307$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240705$$CN$US$US
240535271$24053527$1$I$$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106644$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240705$$HP$US$US
240535282$24053528$2$F$$20240716$20240705$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106880$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240722$$HP$US$US
240535292$24053529$2$F$$20240920$20240705$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106888$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240924$$CN$US$US
240535312$24053531$2$F$$20240719$20240705$20240726$EXP$$US-TAKEDA-2024TUS007006$TAKEDA$$$$$F$Y$$$20240726$$CN$US$US
240535322$24053532$2$F$20240101$20240703$20240705$20240709$PER$$US-AMGEN-USASP2024132828$AMGEN$$65$YR$E$F$Y$$$20240709$$CN$US$US
240535331$24053533$1$I$$20230731$20240705$20240705$PER$$US-AMGEN-USASP2023235539$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240535341$24053534$1$I$20230101$20240702$20240705$20240705$PER$$US-ABBVIE-5826838$ABBVIE$$$$$F$Y$136$KG$20240705$$CN$US$US
240535352$24053535$2$F$20240614$20240807$20240705$20240809$EXP$IT-MINISAL02-992596$IT-ABBVIE-5822444$ABBVIE$$78$YR$$M$Y$$$20240809$$MD$IT$IT
240535362$24053536$2$F$$20240809$20240705$20240812$PER$$US-AMGEN-USASP2024130671$AMGEN$$$$$$Y$$$20240811$$CN$US$US
240535371$24053537$1$I$20240101$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130269$AMGEN$$51$YR$A$F$Y$$$20240705$$CN$US$US
240535382$24053538$2$F$$20240801$20240705$20240806$EXP$$ES-AMGEN-ESPSP2024129461$AMGEN$$$$$$Y$$$20240806$$PH$ES$ES
240535391$24053539$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024132144$AMGEN$$$$$M$Y$$$20240705$$CN$US$US
240535401$24053540$1$I$20240101$20240702$20240705$20240705$EXP$$CA-UCBSA-2024033644$UCB$$$$$M$Y$$$20240705$$CN$CA$CA
240535411$24053541$1$I$20231230$20240628$20240705$20240705$30DAY$$US-GSK-US2024081188$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240535421$24053542$1$I$$20240621$20240705$20240705$EXP$$RO-ROCHE-10000016696$ROCHE$$70$YR$E$$Y$$$20240705$$HP$RO$RO
240535431$24053543$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5826797$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240535442$24053544$2$F$$20240710$20240705$20240720$EXP$$US-TEVA-VS-3212267$TEVA$Jain MD, Smith M, Shah NN. How I treat refractory CRS and ICANS after CAR T-cell therapy. Blood 2023; 141 (20): 2430-2442.; Jain MD, Smith M, Shah NN. How I treat refractory CRS and ICANS after CAR T-cell therapy. Blood 2023; 141 (20): 2430-2442.; Jain MD, Smith M, Shah NN. How I treat refractory CRS and ICANS after CAR T-cell therapy. Blood 2023; 141 (20): 2430-2442.$15$YR$$M$Y$$$20240720$$MD$US$US
240535451$24053545$1$I$$20240624$20240705$20240705$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP007459$STRIDES$$71$YR$$M$Y$$$20240705$$HP$FR$FR
240535471$24053547$1$I$20240703$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46619$$FDA-CTU$$41$YR$$M$N$$$20240703$N$$US$
240535481$24053548$1$I$20240703$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46620$$FDA-CTU$$41$YR$$M$N$$$20240703$N$$US$
240535491$24053549$1$I$20240701$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46568$$FDA-CTU$$48$YR$$M$N$81.6$KG$20240703$N$PH$US$
240535511$24053551$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46577$$FDA-CTU$$81$YR$$M$N$$$20240703$N$$US$
240535521$24053552$1$I$20240630$20240702$20240705$20240705$EXP$$GB-BIOGEN-2024BI01272216$BIOGEN$$56$YR$$F$Y$$$20240705$$CN$GB$GB
240535531$24053553$1$I$$20240611$20240705$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002786$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240535541$24053554$1$I$20220607$20240627$20240705$20240705$EXP$$DE-TEVA-VS-3215670$TEVA$$$$A$F$Y$$$20240705$$MD$DE$DE
240535551$24053555$1$I$20231128$20240628$20240705$20240705$EXP$$US-009507513-2407USA001189$MERCK$$78$YR$$F$Y$$$20240705$$MD$US$US
240535563$24053556$3$F$$20240716$20240705$20240801$EXP$$JP-JNJFOC-20240713569$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$PH$JP$JP
240535571$24053557$1$I$$20240701$20240705$20240705$EXP$$US-JNJFOC-20240702541$JOHNSON AND JOHNSON$$9$DEC$E$M$Y$$$20240705$$CN$US$US
240535581$24053558$1$I$20240624$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46626$$FDA-CTU$$59$YR$$F$N$$$20240703$Y$PH$US$
240535591$24053559$1$I$$20240702$20240705$20240705$EXP$$US-GSK-US2024082174$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240535601$24053560$1$I$20240628$20240628$20240703$20240703$DIR$FDA-CDER-CTU-2024-46582$$FDA-CTU$$62$YR$$F$N$$$20240628$N$HP$US$
240535611$24053561$1$I$20240128$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46566$$FDA-CTU$$63$YR$$M$N$$$20240703$N$HP$US$
240535621$24053562$1$I$20240618$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46659$$FDA-CTU$$76$YR$$M$N$$$20240703$Y$PH$US$
240535631$24053563$1$I$20240101$20240702$20240705$20240705$EXP$$US-UCBSA-2024033750$UCB$$$$$M$Y$$$20240705$$CN$US$US
240535641$24053564$1$I$20240101$20240701$20240705$20240705$EXP$$IQ-009507513-2407IRQ001855$MERCK$$$$$M$Y$$$20240705$$MD$IQ$IQ
240535651$24053565$1$I$20240527$20240627$20240705$20240705$EXP$FR-AFSSAPS-LM2024000348$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-06033$HIKMA$$$$$$Y$$$20240705$$PH$FR$FR
240535662$24053566$2$F$20240524$20240627$20240705$20240710$EXP$$JP-ADVANZ PHARMA-202406005150$ADVANZ PHARMA$$$$$$Y$$$20240710$$PH$JP$JP
240535683$24053568$3$F$20240612$20240920$20240705$20240930$EXP$$CA-CELLTRION INC.-2024CA015400$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
240535691$24053569$1$I$20240702$20240702$20240705$20240705$PER$$US-TAKEDA-2024TUS067269$TAKEDA$$1$YR$$M$Y$$$20240705$$HP$US$US
240535711$24053571$1$I$$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106862$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240705$$CN$US$US
240535721$24053572$1$I$$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106885$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$84.82$KG$20240705$$PH$US$US
240535732$24053573$2$F$$20240924$20240705$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106257$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240924$$CN$US$US
240535751$24053575$1$I$20240627$20240628$20240705$20240705$PER$$US-AMGEN-USASP2024129403$AMGEN$$70$YR$E$F$Y$$$20240705$$CN$US$US
240535761$24053576$1$I$$20231101$20240705$20240705$PER$$US-AMGEN-USASP2023235519$AMGEN$$$$$$Y$$$20240705$$MD$US$US
240535771$24053577$1$I$$20240620$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05703$HIKMA$Bhatt G, Meyer C, Shalit B, Butcher BW.. Bhatt G, Meyer C, Shalit B, Butcher BW. Collision of Clots: When Catastrophic Antiphospholipid Syndrome Meets Heparin-induced Thrombocytopenia. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A3544.$50$YR$$M$Y$$$20240705$$MD$US$US
240535782$24053578$2$F$$20240802$20240705$20240807$EXP$$ES-AMGEN-ESPSP2024129093$AMGEN$Gonzalez-lopez T.; Bermejo-vega N.; Cardesa-cabrera R. et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Blood. 2024;1-29$76$YR$E$F$Y$$$20240807$$HP$ES$ES
240535792$24053579$2$F$20240601$20240710$20240705$20240712$EXP$$US-AMGEN-USASP2024127687$AMGEN$$79$YR$E$F$Y$$$20240712$$CN$US$US
240535802$24053580$2$F$$20240724$20240705$20240731$EXP$$JP-AMGEN-JPNSP2024129067$AMGEN$$13$YR$T$M$Y$$$20240731$$MD$JP$JP
240535811$24053581$1$I$$20240216$20240705$20240705$PER$$US-ABBVIE-5828378$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240535821$24053582$1$I$$20240212$20240705$20240705$PER$$US-ABBVIE-5828491$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240535831$24053583$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5825802$ABBVIE$$51$YR$$F$Y$$$20240705$$HP$US$US
240535841$24053584$1$I$20240101$20240624$20240705$20240705$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01010$AIMMUNE$$$$$$Y$$$20240705$$CN$US$US
240535851$24053585$1$I$20240604$20240621$20240705$20240705$EXP$PT-INFARMED-J202406-119$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-05905$HIKMA$$39$YR$$F$Y$$$20240705$$MD$PT$PT
240535861$24053586$1$I$$20240625$20240705$20240705$EXP$$JP-BELUSA-2024BELLIT0074$BIOLOGICAL E.$Miyazaki T, Taguchi S, Obata N, Mizobuchi S..Severe hypotension and postoperative cardiac arrest caused by 5-aminolevulinic acid: a case report..Journal of Medical Case Reports..30-MAY-2024;18 (1):1-5$$$$$Y$$$20240705$$HP$JP$JP
240535871$24053587$1$I$$20240306$20240705$20240705$PER$$US-AMGEN-USASP2024133405$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240535881$24053588$1$I$$20230921$20240705$20240705$PER$$US-AMGEN-USASP2023235082$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240535891$24053589$1$I$$20240627$20240705$20240705$PER$$US-UNITED THERAPEUTICS-UNT-2024-020180$UNITED THERAPEUTICS$$$$$F$Y$81.633$KG$20240705$$$US$US
240535901$24053590$1$I$20240606$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46658$$FDA-CTU$$62$YR$$M$N$$$20240703$Y$PH$US$
240535911$24053591$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46632$$FDA-CTU$$65$YR$$M$N$$$20240703$N$PH$US$
240535921$24053592$1$I$20240107$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46625$$FDA-CTU$$33$YR$$F$N$72.57$KG$20240703$Y$CN$US$
240535931$24053593$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46628$$FDA-CTU$$$$$F$N$68.04$KG$20240703$Y$CN$US$
240535941$24053594$1$I$20240511$20240620$20240705$20240705$EXP$FR-AFSSAPS-AM2024000499$FR-TEVA-VS-3213338$TEVA$$64$YR$$F$Y$50$KG$20240705$$MD$FR$FR
240535953$24053595$3$F$20240101$20240708$20240705$20240709$PER$$US-AMGEN-USASP2024132003$AMGEN$$45$YR$A$F$Y$$$20240709$$CN$US$US
240535961$24053596$1$I$20240608$20240703$20240705$20240705$EXP$CZ-CZSUKL-24001873$CZ-AMGEN-CZESP2024132090$AMGEN$$63$YR$A$F$Y$60$KG$20240705$$PH$CZ$CZ
240535971$24053597$1$I$$20240628$20240705$20240705$EXP$$ES-AMGEN-ESPSP2024129109$AMGEN$Gonzalez-lopez T.; Bermejo-vega N.; Cardesa-cabrera R. et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Blood. 2024;1-29$87$YR$E$M$Y$$$20240705$$HP$ES$ES
240535984$24053598$4$F$20240101$20240728$20240705$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-020115$UNITED THERAPEUTICS$$$$$F$Y$77.098$KG$20240807$$$US$US
240535991$24053599$1$I$20240626$20240626$20240705$20240705$30DAY$$US-GSK-US2024079873$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240705$$CN$US$US
240536001$24053600$1$I$20240101$20240627$20240705$20240705$EXP$$CA-CELLTRION INC.-2024CA016227$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
240536011$24053601$1$I$20230408$20240627$20240705$20240705$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158867$JIANGSU HENGRUI MEDICINE$Coronary Artery Spasm induced by Tegafur, Gimeracil and Oteracil Potassium Combined with Oxaliplatin in Elderly Patients with Gastric Cancer: A Report of 2 Cases.$61$YR$$M$Y$$$20240705$$MD$CN$CN
240536021$24053602$1$I$$20231220$20240705$20240705$PER$$US-AMGEN-USASP2023235503$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240536031$24053603$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002673$ELI LILLY AND CO$$$$$$Y$$$20240705$$CN$US$US
240536041$24053604$1$I$$20240412$20240705$20240705$PER$$US-ABBVIE-5828322$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240536051$24053605$1$I$$20240625$20240705$20240705$EXP$$US-BELUSA-2024BELLIT0075$BIOLOGICAL E.$Haghparast P, Nadybal M, Yuan C..Treatment-Resistant Priapism in a 61-Year-Old Male After Combined Use of Trazodone, Quetiapine, and Fluoxetine..Journal of Clinical Psychopharmacology.2024;44 (3):316-7$$$$$Y$$$20240705$$PH$US$US
240536061$24053606$1$I$20240619$20240704$20240705$20240705$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-107152$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240705$$CN$PR$PR
240536071$24053607$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5826699$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240536081$24053608$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5826116$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240536092$24053609$2$F$$20240920$20240705$20240925$EXP$$GB-ROCHE-10000012535$ROCHE$$$$A$F$Y$$$20240925$$CN$GB$GB
240536101$24053610$1$I$$20240703$20240705$20240705$PER$$US-GILEAD-2024-0679558$GILEAD$$46$YR$A$M$Y$$$20240705$$PH$US$US
240536111$24053611$1$I$$20240627$20240705$20240705$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP007929$STRIDES$Chimenti G, Magli A, Njandjo L, Fois A, Santagati G, Piccoli G, et al.. New onset proteinuria in two pregnancies: glomerulopathy or preeclampsia?.. Nephrol-Dial-Transplant. 2024;39 (Suppl. 1):i2048-i2049$27$YR$$F$Y$$$20240705$$HP$FR$FR
240536122$24053612$2$F$$20240909$20240705$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019946$UNITED THERAPEUTICS$$$$$F$Y$119.27$KG$20240918$$$US$US
240536131$24053613$1$I$$20240622$20240705$20240705$EXP$$CN-ROCHE-10000007075$ROCHE$$60$YR$A$F$Y$$$20240705$$CN$CN$CN
240536141$24053614$1$I$$20240701$20240705$20240705$EXP$$US-JNJFOC-20240701227$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240705$$CN$US$US
240536151$24053615$1$I$20240701$20240703$20240705$20240705$EXP$$CO-JNJFOC-20240713767$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240705$$CN$CO$CO
240536161$24053616$1$I$$20240628$20240705$20240705$EXP$$CN-AstraZeneca-2024A150036$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$CN$
240536171$24053617$1$I$$20240621$20240705$20240705$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001629$IPCA$Shrea Goswami, Amy E. Hanson, Evan Rajadhyaksha et al.. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series. Pediatric Nephrology. 2024$$$$$Y$$$20240705$$HP$US$US
240536182$24053618$2$F$$20240625$20240705$20240705$PER$$US-ROCHE-10000014714$ROCHE$$68$YR$E$F$Y$$$20240705$$CN$US$US
240536191$24053619$1$I$$20240628$20240705$20240705$EXP$$CA-AstraZeneca-2024A150232$ASTRAZENECA$$78$YR$$M$Y$78$KG$20240705$$MD$CA$
240536212$24053621$2$F$$20240812$20240705$20240815$EXP$$US-AMGEN-USASP2024128858$AMGEN$Conner E.; Hasserjian R.; Martinez-lage M. et al.. A Rapidly Progressive Case of Primary CNS T-Cell Lymphoma. Journal of Neuropathology + Experimental Neurology. 2024;83 (6):528$64$YR$A$M$Y$$$20240815$$HP$US$US
240536221$24053622$1$I$$20240329$20240705$20240705$PER$$US-AMGEN-USASP2024132719$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240536232$24053623$2$F$$20240718$20240705$20240722$EXP$$JP-GILEAD-2024-0679336$GILEAD$Kita T, Araya T. P-085 An autopsy case of COVID-19 complicated by anti-ARS antibody-associated interstitial pneumonia with pulmonary aspergillosis and cytomegalovirus pneumonia. The 98th Annual Meeting of the Japanese Association for Infectious Diseases. 2024;unk:unk$80$YR$E$M$Y$$$20240722$$MD$JP$JP
240536241$24053624$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5826798$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240536251$24053625$1$I$$20240627$20240705$20240705$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP007930$STRIDES$Chimenti G, Magli A, Njandjo L, Fois A, Santagati G, Piccoli G, et al.. New onset proteinuria in two pregnancies: glomerulopathy or preeclampsia?.. Nephrol-Dial-Transplant. 2024;9 (Suppl. 1):i2048-i2049$$$$F$Y$$$20240705$$HP$FR$FR
240536262$24053626$2$F$20240507$20240813$20240705$20240822$EXP$$DE-BIOCON BIOLOGICS LIMITED-BBL2024004797$BIOCON$$$$$$Y$$$20240822$$CN$DE$DE
240536282$24053628$2$F$20240101$20240705$20240705$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-016986$UNITED THERAPEUTICS$$$$$M$Y$$$20240710$$$US$US
240536291$24053629$1$I$20240609$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46681$$FDA-CTU$$60$YR$$M$N$$$20240703$Y$PH$US$
240536301$24053630$1$I$$20240627$20240705$20240705$EXP$$IL-STRIDES ARCOLAB LIMITED-2024SP007924$STRIDES$Shehadeh K, Levinsky Y, Kagan S, Zuabi T, Tal R, Aviran NH, et al.. An ^On Demand^ canakinumab regimen for treating children with Colchicine-Resistant familial Mediterranean fever - A multicentre study.. Int-Immunopharmacol. 2024;132 (0)$$$C$$Y$$$20240705$$HP$IL$IL
240536311$24053631$1$I$20221014$20240624$20240705$20240705$PER$$US-ROCHE-10000012786$ROCHE$$$$$F$Y$$$20240705$$HP$US$US
240536321$24053632$1$I$$20240701$20240705$20240705$EXP$$JP-AMGEN-JPNSP2024131063$AMGEN$$$$$$Y$$$20240705$$MD$JP$JP
240536331$24053633$1$I$$20240702$20240705$20240705$EXP$$GB-AMGEN-GBRSP2024132446$AMGEN$$$$$M$Y$$$20240705$$CN$GB$GB
240536341$24053634$1$I$$20230830$20240705$20240705$PER$$US-AMGEN-USASP2023235174$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240536351$24053635$1$I$$20240627$20240705$20240705$EXP$$US-AMGEN-USASP2024128364$AMGEN$Chiou D.; Mooney B.H.; Shi B. et.al.. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240705$$MD$US$US
240536363$24053636$3$F$20240101$20240731$20240705$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-019693$UNITED THERAPEUTICS$$$$$M$Y$111.11$KG$20240807$$$US$US
240536371$24053637$1$I$20240521$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46603$$FDA-CTU$$43$YR$$F$N$$$20240702$N$HP$US$
240536381$24053638$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46578$$FDA-CTU$$81$YR$$M$N$$$20240703$N$$US$
240536391$24053639$1$I$20240401$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46621$$FDA-CTU$$68$YR$$F$N$$$20240703$N$PH$US$
240536401$24053640$1$I$20240627$20240701$20240703$20240703$DIR$FDA-CDER-CTU-2024-46565$$FDA-CTU$$32$YR$$M$N$$$20240701$N$HP$US$
240536411$24053641$1$I$20240601$20240626$20240705$20240705$EXP$$US-GSK-US2024AMR080711$GLAXOSMITHKLINE$$48$YR$$F$Y$$$20240705$$CN$US$US
240536422$24053642$2$F$$20240802$20240705$20240805$EXP$$BR-BEIGENE-BGN-2024-010399$BEIGENE$$$$$$Y$$$20240804$$HP$BR$BR
240536431$24053643$1$I$$20240627$20240705$20240705$EXP$$IL-STRIDES ARCOLAB LIMITED-2024SP007925$STRIDES$Shehadeh K, Levinsky Y, Kagan S, Zuabi T, Tal R, Aviran NH, et al.. An ^On Demand^ canakinumab regimen for treating children with Colchicine-Resistant familial Mediterranean fever - A multicentre study.. Int-Immunopharmacol. 2024;132 (0)$$$C$$Y$$$20240705$$HP$IL$IL
240536441$24053644$1$I$20240630$20240702$20240705$20240705$EXP$$FR-TAKEDA-2024TUS067922$TAKEDA$$$$E$M$Y$$$20240705$$MD$FR$FR
240536452$24053645$2$F$20240625$20240711$20240705$20240718$EXP$$US-Calliditas-2024CAL01217$CALLIDITAS THERAPEUTICS$$49$YR$A$F$Y$$$20240718$$CN$US$US
240536461$24053646$1$I$$20240623$20240705$20240705$PER$$US-ROCHE-10000013275$ROCHE$$$$$M$Y$$$20240705$$CN$US$US
240536471$24053647$1$I$$20240624$20240705$20240705$EXP$$JP-ROCHE-10000011942$ROCHE$$77$YR$E$F$Y$$$20240705$$MD$JP$JP
240536481$24053648$1$I$20240601$20240625$20240705$20240705$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00522$PARATEK PHARMACEUTICALS$$16$YR$$M$Y$69$KG$20240705$$HP$CN$CN
240536491$24053649$1$I$20240301$20240628$20240705$20240705$EXP$$US-AMGEN-USASP2024130194$AMGEN$$82$YR$E$F$Y$$$20240705$$CN$US$US
240536501$24053650$1$I$20240601$20240628$20240705$20240705$EXP$$US-SERVIER-S24008245$SERVIER$$$$$$Y$$$20240705$$CN$US$US
240536511$24053651$1$I$20240627$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46631$$FDA-CTU$$89$YR$$M$N$51$KG$20240703$Y$PH$US$
240536531$24053653$1$I$20240101$20240701$20240705$20240705$PER$$US-ABBVIE-5826878$ABBVIE$$$$$F$Y$$$20240705$$HP$US$US
240536541$24053654$1$I$20240101$20240417$20240705$20240705$PER$$US-ABBVIE-5828366$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240536571$24053657$1$I$20240520$20240604$20240703$20240703$DIR$FDA-CDER-CTU-2024-46653$$FDA-CTU$$79$YR$$F$N$$$20240604$N$HP$US$
240536591$24053659$1$I$$20240625$20240705$20240705$PER$$US-TEVA-VS-3213869$TEVA$$$$$F$Y$$$20240705$$CN$US$US
240536601$24053660$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46569$$FDA-CTU$$44$YR$$M$N$$$20240703$N$$US$
240536611$24053661$1$I$$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106586$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240705$$PH$US$US
240536622$24053662$2$F$20240601$20240729$20240705$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002790$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240821$$CN$US$US
240536631$24053663$1$I$20190101$20240627$20240705$20240705$PER$$US-SA-2024SA194150$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240705$$CN$US$US
240536642$24053664$2$F$$20240829$20240705$20240905$EXP$$JP-ROCHE-10000008894$ROCHE$Takada Y, Kurosawa S, Ueki T, Najima Y, Wakita S, Yamaguchi H. Overcoming post-transplant graft failure and adenovirus infection in a patient with FLT3-TKD-mutated mixed-phenotype acute leukemia: A case report. eJHaem. 2024;5 (4):802-9. doi:10.1002/jha2.956.$31$YR$A$M$Y$$$20240905$$HP$JP$JP
240536652$24053665$2$F$20240101$20240829$20240705$20240911$PER$$US-SA-2024SA193029$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240911$$MD$US$US
240536661$24053666$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193214$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240536671$24053667$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA194728$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240705$$MD$US$US
240536681$24053668$1$I$20240501$20240626$20240705$20240705$PER$$US-SA-2024SA194578$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240705$$MD$US$US
240536692$24053669$2$F$20240101$20240829$20240705$20240910$PER$$US-SA-2024SA192842$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240910$$MD$US$US
240536701$24053670$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA194283$SANOFI AVENTIS$$67$YR$E$M$Y$88$KG$20240705$$MD$US$US
240536711$24053671$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA192985$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240705$$MD$US$US
240536721$24053672$1$I$20240513$20240629$20240705$20240705$PER$$US-SA-2024SA196189$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240705$$MD$US$US
240536731$24053673$1$I$20240625$20240628$20240705$20240705$PER$$US-SA-2024SA192163$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240705$$MD$US$US
240536741$24053674$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193000$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240705$$MD$US$US
240536751$24053675$1$I$20230601$20240628$20240705$20240705$PER$$US-SA-2024SA195516$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240705$$MD$US$US
240536761$24053676$1$I$20240601$20240628$20240705$20240705$PER$$US-SA-2024SA195467$SANOFI AVENTIS$$$$$M$Y$$$20240705$$HP$US$US
240536771$24053677$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA196490$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240705$$MD$US$US
240536781$24053678$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193177$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240705$$MD$US$US
240536791$24053679$1$I$20240101$20240702$20240705$20240705$PER$$US-SA-2024SA197789$SANOFI AVENTIS$$$$$$Y$$$20240705$$CN$US$US
240536801$24053680$1$I$$20240701$20240705$20240705$PER$$US-SA-2024SA196722$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240705$$MD$US$US
240536811$24053681$1$I$$20240629$20240705$20240705$PER$$US-SA-2024SA163394$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240705$$MD$US$US
240536822$24053682$2$F$20240630$20240822$20240705$20240905$PER$$US-SA-2024SA195803$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240905$$MD$US$US
240536831$24053683$1$I$$20240628$20240705$20240705$EXP$TW-MLMSERVICE-20240624-PI107138-00030-1$TW-STRIDES ARCOLAB LIMITED-2024SP007946$STRIDES$Chang-Chieh L, Shen-Han C, Yu-Han F, Chi-Ta H.. Eczema herpeticum in an immunocompetent man.. Diagnostic Microbiology and Infectious Disease. 2024;110(1):116304$40$YR$$M$Y$$$20240705$$MD$TW$TW
240536843$24053684$3$F$20240101$20240903$20240705$20240911$PER$$US-SA-2024SA196404$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240911$$MD$US$US
240536851$24053685$1$I$20240301$20240630$20240705$20240705$PER$$US-SA-2024SA196395$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240705$$MD$US$US
240536861$24053686$1$I$20240701$20240703$20240705$20240705$EXP$$TR-ABBVIE-5827386$ABBVIE$$69$YR$$M$Y$76$KG$20240705$$CN$TR$TR
240536871$24053687$1$I$20240501$20240626$20240705$20240705$EXP$IT-MINISAL02-991182$IT-TEVA-VS-3215070$TEVA$$17$YR$$M$Y$$$20240705$$MD$IT$IT
240536881$24053688$1$I$$20240624$20240705$20240705$EXP$JP-ELI_LILLY_AND_COMPANY-JP202304014386$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP000868$JUBILANT$Komoriya H,et al. A fatal case of fulminant neuroleptic malignant syndrome: A case report. Psychiatry and Clinical Neurosciences  Reports (RCN Reports). 2023;1:1-5$$$A$M$Y$$$20240705$$MD$JP$JP
240536891$24053689$1$I$20240420$20240627$20240705$20240705$EXP$MT-ADM-03062024$MT-JUBILANT CADISTA PHARMACEUTICALS-2024MT000874$JUBILANT$$26$YR$$M$Y$90$KG$20240705$$CN$MT$MT
240536901$24053690$1$I$20170101$20240626$20240705$20240705$EXP$IT-MLMSERVICE-20190115-1573864-1$IT-JUBILANT CADISTA PHARMACEUTICALS-2019IT000077$JUBILANT$Maffeis L, Dilena R, Guez S, Menni F, Bana C, Osnaghi S et al.. Pseudotumour cerebri associated with mycoplasma pneumoniae infection and treatment with levofloxacin: a case report.. BMC pediatrics. 2019;19(1):4$14$YR$$M$Y$66$KG$20240705$$MD$IT$IT
240536911$24053691$1$I$$20240624$20240705$20240705$EXP$$DE-JUBILANT CADISTA PHARMACEUTICALS-2024DE000899$JUBILANT$Brueckner I, Luedeke JW, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of analytical toxicology. 2024;48:299-313$39$YR$$F$Y$$$20240705$$HP$DE$DE
240536921$24053692$1$I$20151015$20240703$20240705$20240705$EXP$$NVSC2024TR139144$NOVARTIS$$22$YR$$F$Y$90$KG$20240705$$CN$TR$TR
240536932$24053693$2$F$20220511$20240902$20240705$20240909$EXP$$JP-JNJFOC-20230803148$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240909$$MD$JP$JP
240536941$24053694$1$I$$20240611$20240705$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002791$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
240536961$24053696$1$I$$20240624$20240705$20240705$EXP$$US-PBT-009467$PANACEA BIOTEC$Abdelrahim M, Esmail A, Divatia MK, Xu J, Kodali S, Victor DW, et al. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. J Clin Med. 2024 May 24;13(11):3068. doi: 10.3390/jcm13113068.$64$YR$A$M$Y$$$20240705$$HP$US$US
240536971$24053697$1$I$$20240624$20240705$20240705$EXP$$US-PBT-009480$PANACEA BIOTEC$Abdelrahim M, Esmail A, Divatia MK, Xu J, Kodali S, Victor DW, et al. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. J Clin Med. 2024 May 24;13(11):3068. doi: 10.3390/jcm13113068.$68$YR$E$M$Y$$$20240705$$HP$US$US
240536981$24053698$1$I$20240610$20240701$20240705$20240705$EXP$GB-MHRA-MED-202406281346577850-VNFCP$GB-STRIDES ARCOLAB LIMITED-2024SP007934$STRIDES$$$$$$Y$$$20240705$$PH$GB$GB
240536991$24053699$1$I$$20240701$20240705$20240705$EXP$$JP-AMGEN-JPNSP2024131027$AMGEN$$$$$$Y$$$20240705$$MD$JP$JP
240537001$24053700$1$I$20240412$20240705$20240705$20240705$EXP$GB-MHRA-MED-202405091436493750-HCFSB$GB-JNJFOC-20240713485$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$MD$GB$GB
240537013$24053701$3$F$20240609$20240711$20240705$20240719$30DAY$$CA-JNJFOC-20240653242$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240719$$PH$CA$CA
240537021$24053702$1$I$20240625$20240627$20240705$20240705$PER$$US-JNJFOC-20240675030$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$CN$US$US
240537031$24053703$1$I$$20240625$20240705$20240705$30DAY$$US-GSK-US2024079553$GLAXOSMITHKLINE$$7$DEC$$F$Y$$$20240705$$CN$US$US
240537041$24053704$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131699$AMGEN$$$$$M$Y$$$20240705$$CN$US$US
240537051$24053705$1$I$20240626$20240629$20240705$20240705$PER$$US-AMGEN-USASP2024129493$AMGEN$$48$YR$A$M$Y$$$20240705$$HP$US$US
240537062$24053706$2$F$20240629$20240726$20240705$20240731$30DAY$$US-AMGEN-USASP2024130828$AMGEN$$34$YR$A$M$Y$78.8$KG$20240731$$PH$US$US
240537073$24053707$3$F$20240608$20240916$20240705$20240923$EXP$$JP-CHEPLA-2024008256$CHEPLAPHARM$$68$YR$$M$Y$$$20240923$$PH$COUNTRY NOT SPECIFIED$JP
240537081$24053708$1$I$$20240626$20240705$20240705$EXP$$US-GSK-US2024AMR079921$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$US$US
240537091$24053709$1$I$$20240627$20240705$20240705$EXP$$ZA-AstraZeneca-2024A149242$ASTRAZENECA$$79$YR$$F$Y$$$20240705$$CN$ZA$
240537101$24053710$1$I$$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151500$ASTRAZENECA$$$$$M$Y$$$20240705$$MD$US$
240537112$24053711$2$F$$20240702$20240705$20240708$EXP$$JP-AstraZeneca-2024A151789$ASTRAZENECA$Matsui R, et al.. P-210 Experience with the use of dapagliflozin for treatments other than diabetes mellitus treatment at our hospital.. The Japanese Journal of Nephrology 2024;66(4):664-.$$$$$Y$$$20240708$$MD$JP$
240537121$24053712$1$I$$20240627$20240705$20240705$EXP$$VN-AstraZeneca-2024A150001$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$VN$
240537131$24053713$1$I$$20240703$20240705$20240705$EXP$$TR-GILEAD-2024-0679461$GILEAD$$$$E$F$Y$$$20240705$$HP$TR$TR
240537141$24053714$1$I$$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407001190$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240705$$CN$US$US
240537161$24053716$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46623$$FDA-CTU$$60$YR$$F$N$$$20240703$N$$US$
240537171$24053717$1$I$$20240628$20240703$20240703$DIR$FDA-CDER-CTU-2024-46587$$FDA-CTU$$$$$M$N$$$20240628$N$HP$US$
240537181$24053718$1$I$$20240704$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107114$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$88.9$KG$20240705$$CN$US$US
240537192$24053719$2$F$$20240716$20240705$20240718$EXP$$US-TAKEDA-2024TUS067639$TAKEDA$$$$$F$Y$$$20240718$$CN$US$US
240537201$24053720$1$I$20240516$20240703$20240705$20240705$EXP$FR-AFSSAPS-TS2024000761$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-106469$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$63$KG$20240705$$MD$FR$FR
240537212$24053721$2$F$$20240827$20240705$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002792$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
240537222$24053722$2$F$$20240906$20240705$20240909$PER$$NVSC2024US138741$NOVARTIS$$$$$F$Y$$$20240909$$HP$US$US
240537234$24053723$4$F$20240702$20240808$20240705$20240809$EXP$JP-MMM-BPYOE82R$JP-GSK-JP2024082285$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$MD$JP$JP
240537241$24053724$1$I$$20240620$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-05762$HIKMA$Braat J, Shacker M, Arjuna A.. Braat J, Shacker M, Arjuna A. Atypical Presentation of Central Serous Chorioretinopathy (CSCR) After Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5938$59$YR$$F$Y$$$20240705$$HP$US$US
240537252$24053725$2$F$$20240722$20240705$20240724$EXP$$CA-TAKEDA-2024TUS057145$TAKEDA$$$$$M$Y$$$20240724$$CN$CA$CA
240537261$24053726$1$I$20240401$20240701$20240705$20240705$EXP$$US-ABBVIE-5824992$ABBVIE$$78$YR$$F$Y$$$20240705$$CN$US$US
240537271$24053727$1$I$$20240703$20240705$20240705$EXP$$JP-JNJFOC-20240713752$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$MD$JP$JP
240537281$24053728$1$I$$20240626$20240705$20240705$PER$$US-JNJFOC-20240672022$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$CN$US$US
240537291$24053729$1$I$20171222$20180821$20240705$20240705$EXP$$JP-009507513-1801JPN002192J$MERCK$Uchida K,Hiroshi Y, Tsujii E,Minami T, Ito S. A case of anaphylactic shock by Sugamadex using the basophil stimulation test for diagnosis. The Japanese Society of Anesthesiologists^ Association 2018 Branch Academic Meet. 2018;4001-05$70$YR$$F$Y$50$KG$20240705$$MD$JP$JP
240537302$24053730$2$F$$20240711$20240705$20240720$EXP$$GB-AUROBINDO-AUR-APL-2024-032082$AUROBINDO$$37$YR$$$Y$$$20240720$$CN$GB$GB
240537311$24053731$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5826641$ABBVIE$$56$YR$$F$Y$$$20240705$$HP$US$US
240537321$24053732$1$I$$20240703$20240705$20240705$PER$$NVSC2024US139388$NOVARTIS$$$$$$Y$$$20240705$$CN$US$US
240537332$24053733$2$F$$20240822$20240705$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002806$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
240537341$24053734$1$I$20230101$20240626$20240705$20240705$EXP$$CN-PBT-009482$PANACEA BIOTEC$Peng M, Lin T, Song Z, Huang T, Pan X. High dose tacrolimus-induced acute pancreatitis after kidney transplantation: a case report. Pancreas. 2024 Jun 24. doi: 10.1097/MPA.0000000000002382.$31$YR$A$M$Y$$$20240705$$MD$CN$CN
240537351$24053735$1$I$20240430$20240627$20240705$20240705$EXP$$ES-AUROBINDO-AUR-APL-2024-032150$AUROBINDO$$83$YR$$F$Y$$$20240705$$HP$ES$ES
240537361$24053736$1$I$$20240628$20240705$20240705$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-104881$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240705$$HP$PR$PR
240537371$24053737$1$I$$20240626$20240705$20240705$EXP$$AT-PDX-000356$PHARMADAX$Finsterer J. Glofitamab-Associated Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Presenting as Serial Seizures and Responding Positively to Antiseizure Drugs and Anakinra: A Case Report. Cureus. 2024 May 22;16(5):e60833. doi: 10.7759/cureus.60833.$63$YR$A$M$Y$$$20240705$$HP$AT$AT
240537382$24053738$2$F$20240421$20240804$20240705$20240814$EXP$$CN-ROCHE-3571602$ROCHE$$70$YR$E$M$Y$$$20240814$$MD$CN$CN
240537391$24053739$1$I$20240410$20240627$20240705$20240705$EXP$$ES-AUROBINDO-AUR-APL-2024-032163$AUROBINDO$$77$YR$$F$Y$52.4$KG$20240705$$MD$ES$ES
240537401$24053740$1$I$$20240612$20240705$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002803$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
240537411$24053741$1$I$$20240701$20240705$20240705$EXP$$BR-JNJFOC-20240705285$JOHNSON AND JOHNSON$$40$YR$A$F$Y$158$KG$20240705$$CN$BR$BR
240537421$24053742$1$I$20240701$20240703$20240705$20240705$PER$$US-JNJFOC-20240708864$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240537431$24053743$1$I$20240630$20240704$20240705$20240705$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024EME082891$VIIV$$$$$$Y$$$20240705$$CN$GB$GB
240537441$24053744$1$I$20240615$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032010$AUROBINDO$$63$YR$$M$Y$$$20240705$$PH$FR$FR
240537451$24053745$1$I$20240516$20240704$20240705$20240705$EXP$FR-AFSSAPS-NY2024000743$FR-JNJFOC-20240713751$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240705$$PH$FR$FR
240537461$24053746$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46608$$FDA-CTU$$48$YR$$M$N$$$20240703$N$$US$
240537471$24053747$1$I$20240127$20240702$20240705$20240705$EXP$$US-TAKEDA-2024TUS020012$TAKEDA$$65$YR$$M$Y$$$20240705$$CN$US$US
240537491$24053749$1$I$20240101$20240621$20240705$20240705$EXP$$US-SERVIER-S24007923$SERVIER$$$$$$Y$$$20240705$$HP$US$US
240537501$24053750$1$I$20240701$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131180$AMGEN$$77$YR$E$M$Y$$$20240705$$CN$US$US
240537511$24053751$1$I$20240627$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130149$AMGEN$$74$YR$E$F$Y$$$20240705$$CN$US$US
240537521$24053752$1$I$$20240628$20240705$20240705$PER$$US-AMGEN-USASP2024131353$AMGEN$$51$YR$A$F$Y$$$20240705$$HP$US$US
240537531$24053753$1$I$20240426$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032168$AUROBINDO$$71$YR$$F$Y$$$20240705$$MD$FR$FR
240537542$24053754$2$F$$20240806$20240705$20240807$PER$$US-ALXN-202406USA001822US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240537551$24053755$1$I$20240521$20240626$20240705$20240705$EXP$$DE-TEVA-VS-3214673$TEVA$$77$YR$$F$Y$98$KG$20240705$$MD$DE$DE
240537561$24053756$1$I$20240701$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107002$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$53.5$KG$20240705$$PH$US$US
240537572$24053757$2$F$$20240711$20240705$20240721$EXP$$US-TEVA-VS-3212410$TEVA$Singhal AB, Silverman SB, Romero JM, Lang-Orsini M. Case 6-2023: A 68-Year-Old Man with Recurrent Strokes. N-Engl-J-Med 2023; 388 (8): 747-757; Singhal AB, Silverman SB, Romero JM, Lang-Orsini M. Case 6-2023: A 68-Year-Old Man with Recurrent Strokes. N-Engl-J-Med 2023; 388 (8): 747-757.$68$YR$$M$Y$$$20240721$$MD$US$US
240537581$24053758$1$I$20240507$20240628$20240705$20240705$EXP$FR-AFSSAPS-TO2024000823$FR-EMD Serono-2024035532$EMD SERONO INC$$78$YR$E$F$Y$$$20240705$$MD$FR$FR
240537591$24053759$1$I$$20240625$20240705$20240705$EXP$$AT-GENMAB-2024-02355$GENMAB$$72$YR$$M$Y$$$20240705$$MD$AT$AT
240537612$24053761$2$F$20240228$20240702$20240705$20240711$EXP$IT-MINISAL02-993109$IT-TAKEDA-2024TUS067307$TAKEDA$$56$YR$$F$Y$$$20240711$$PH$IT$IT
240537623$24053762$3$F$$20240806$20240705$20240813$EXP$$US-TAKEDA-2024TUS060129$TAKEDA$$$$$M$Y$$$20240813$$CN$US$US
240537631$24053763$1$I$$20240621$20240705$20240705$EXP$$US-SERVIER-S24007924$SERVIER$$$$$$Y$$$20240705$$HP$US$US
240537641$24053764$1$I$20240616$20240703$20240705$20240705$EXP$IT-MINISAL02-993389$IT-ABBVIE-5824304$ABBVIE$$54$YR$$F$Y$$$20240705$$MD$IT$IT
240537651$24053765$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5825029$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240537661$24053766$1$I$$20240704$20240705$20240705$EXP$$BR-SANDOZ INC.-SDZ2024BR061601$SANDOZ$$$$$M$Y$$$20240705$$CN$BR$BR
240537671$24053767$1$I$$20240627$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062824$SANDOZ$$$$$$Y$$$20240705$$PH$US$US
240537681$24053768$1$I$$20240702$20240705$20240705$30DAY$$GR-SANDOZ INC.-SDZ2024GR062820$SANDOZ$$12$YR$$F$Y$$$20240705$$CN$GR$GR
240537692$24053769$2$F$$20240705$20240705$20240708$PER$$US-TAKEDA-2024TUS068024$TAKEDA$$$$$F$Y$54$KG$20240708$$HP$US$US
240537701$24053770$1$I$$20240702$20240705$20240705$PER$$US-JNJFOC-20240706984$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240537711$24053771$1$I$20240630$20240701$20240705$20240705$30DAY$$US-GSK-US2024081595$GLAXOSMITHKLINE$$33$YR$$M$Y$$$20240705$$CN$US$US
240537722$24053772$2$F$20210101$20240626$20240705$20240710$EXP$$CH-ROCHE-10000015341$ROCHE$$$$A$M$Y$$$20240709$$MD$CH$CH
240537731$24053773$1$I$$20240702$20240705$20240705$PER$$US-TAKEDA-2024TUS067405$TAKEDA$$$$$F$Y$$$20240705$$CN$US$US
240537741$24053774$1$I$$20240627$20240705$20240705$EXP$$PL-AUROBINDO-AUR-APL-2024-005691$AUROBINDO$Rozlucka L, Gawlik R, Gluck J.. Dwa typy reakcji nadwra?liwo?ci: anafilaksja oraz symetryczna, wyprzeniowa i zgi?ciowa osutka wywo?ana lekiem (SDRIFE), kt?re wyst?pi?y u pacjenta po za?yciu aminopenicyliny (Two types of hypersensitivity reaction including anaphylaxis and symmetrical drug-related intertriginous and flexuralexanthema (SDRIFE) after amino penicillin administration in the same patient). Alergologia Polska - Polish Journal of Allergology. 2023;10(4):315-318$56$YR$$F$Y$$$20240705$$HP$PL$PL
240537753$24053775$3$F$$20240906$20240705$20240911$EXP$$AT-ROCHE-10000014221$ROCHE$$26$YR$A$F$Y$$$20240911$$MD$AT$AT
240537761$24053776$1$I$$20240628$20240705$20240705$PER$$NVSC2024US139395$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
240537771$24053777$1$I$$20240621$20240705$20240705$EXP$$US-SERVIER-S24007926$SERVIER$$$$$$Y$$$20240705$$HP$US$US
240537782$24053778$2$F$$20240828$20240705$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106615$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$56.25$KG$20240902$$CN$US$US
240537791$24053779$1$I$$20240703$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106998$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240705$$CN$US$US
240537801$24053780$1$I$$20240628$20240705$20240705$EXP$$ES-AstraZeneca-2024A151422$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$ES$
240537811$24053781$1$I$$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A149022$ASTRAZENECA$$$$$F$Y$97$KG$20240705$$HP$US$
240537821$24053782$1$I$$20240701$20240705$20240705$PER$$US-JNJFOC-20240702847$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240537831$24053783$1$I$20240101$20240628$20240705$20240705$EXP$$JP-AstraZeneca-2024A151762$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$JP$
240537841$24053784$1$I$20240611$20240701$20240705$20240705$EXP$$ZA-AstraZeneca-2024A151267$ASTRAZENECA$$75$YR$$M$Y$$$20240705$$CN$ZA$
240537851$24053785$1$I$20240604$20240627$20240705$20240705$EXP$$ES-AUROBINDO-AUR-APL-2024-032004$AUROBINDO$$68$YR$$M$Y$68$KG$20240705$$HP$ES$ES
240537861$24053786$1$I$$20240625$20240705$20240705$30DAY$$US-GSK-US2024079204$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240537871$24053787$1$I$$20240628$20240705$20240705$PER$$US-ROCHE-10000016454$ROCHE$$$$$$Y$$$20240705$$CN$US$US
240537881$24053788$1$I$$20240624$20240705$20240705$EXP$$US-PBT-009479$PANACEA BIOTEC$Abdelrahim M, Esmail A, Divatia MK, Xu J, Kodali S, Victor DW, et al. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. J Clin Med. 2024 May 24;13(11):3068. doi: 10.3390/jcm13113068.$58$YR$A$M$Y$$$20240705$$HP$US$US
240537891$24053789$1$I$$20240523$20240705$20240705$PER$$US-AMGEN-USASP2024133365$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240537901$24053790$1$I$$20240702$20240705$20240705$EXP$$GB-AMGEN-GBRSP2024131386$AMGEN$$$$$M$Y$$$20240705$$HP$GB$GB
240537911$24053791$1$I$20240701$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130815$AMGEN$$60$YR$A$F$Y$$$20240705$$PH$US$US
240537922$24053792$2$F$20240701$20240716$20240705$20240722$EXP$$JP-AMGEN-JPNSP2024130030$AMGEN$$76$YR$E$F$Y$$$20240722$$PH$JP$JP
240537931$24053793$1$I$$20240624$20240705$20240705$EXP$$US-MSNLABS-2024MSNLIT01420$MSN LABORATORIES$$$$$$Y$$$20240705$$MD$US$US
240537942$24053794$2$F$20240101$20240711$20240705$20240716$PER$$US-AMGEN-USASP2024131151$AMGEN$$73$YR$E$F$Y$$$20240716$$CN$US$US
240537951$24053795$1$I$20240527$20240612$20240705$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002807$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240705$$CN$US$US
240537961$24053796$1$I$$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003417$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240705$$CN$US$US
240537971$24053797$1$I$20240701$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002928$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240705$$CN$US$US
240537981$24053798$1$I$$20240627$20240705$20240705$EXP$$BR-CELLTRION INC.-2024BR015926$CELLTRION$$$$$$Y$$$20240705$$CN$BR$BR
240537994$24053799$4$F$20231002$20240906$20240705$20240923$PER$$US-SAGE-2024SAGE000077$SAGE$$39$YR$$F$Y$$$20240923$$PH$US$US
240538001$24053800$1$I$20240701$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407001340$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240705$$CN$US$US
240538013$24053801$3$F$20230522$20240803$20240705$20240822$PER$$US-SAGE-2024SAGE000076$SAGE$$34$YR$$F$Y$$$20240822$$PH$US$US
240538021$24053802$1$I$$20240629$20240705$20240705$PER$$US-ROCHE-10000016095$ROCHE$$$$A$F$Y$$$20240705$$CN$US$US
240538031$24053803$1$I$20231211$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032174$AUROBINDO$$65$YR$$F$Y$$$20240705$$MD$FR$FR
240538042$24053804$2$F$$20240715$20240705$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202406016122$ELI LILLY AND CO$$65$YR$E$F$Y$61.224$KG$20240806$$CN$US$US
240538051$24053805$1$I$$20240626$20240705$20240705$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024004814$BIOCON$$$$$$Y$$$20240705$$CN$AU$AU
240538061$24053806$1$I$$20230714$20240705$20240705$PER$$US-AMGEN-USASP2023235538$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240538072$24053807$2$F$20240608$20240628$20240705$20240710$EXP$$ES-009507513-2407ESP000120$MERCK$$72$YR$$F$Y$$$20240710$$MD$ES$ES
240538081$24053808$1$I$20240615$20240703$20240705$20240705$EXP$GB-MHRA-MED-202407030846073730-WGDPS$GB-SANDOZ INC.-SDZ2024GB062847$SANDOZ$$63$YR$$F$Y$68$KG$20240705$$CN$GB$GB
240538091$24053809$1$I$$20240625$20240705$20240705$30DAY$$US-GSK-US2024AMR079554$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$CN$US$US
240538101$24053810$1$I$$20240624$20240705$20240705$EXP$$CO-MSNLABS-2024MSNLIT01438$MSN LABORATORIES$Nati-Castillo HA, Aristizabal-Colorado D, Lopez Ordonez C, Egas Proano D, Ortiz-Prado E, Izquierdo-Condoy JS.Takotsubo syndrome as an acute cardiac complication following combined chemotherapy.International Journal of Cardiology Cardiovascular Risk and Prevention.31-MAY-2024;22:1-5$$$$$Y$$$20240705$$HP$CO$CO
240538111$24053811$1$I$$20240627$20240705$20240705$EXP$$DE-AUROBINDO-AUR-APL-2024-032298$AUROBINDO$$$$$F$Y$$$20240705$$CN$DE$DE
240538121$24053812$1$I$20240501$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032324$AUROBINDO$$59$YR$$M$Y$$$20240705$$PH$FR$FR
240538131$24053813$1$I$$20240625$20240705$20240705$EXP$$CA-SANDOZ INC.-SDZ2024CA062674$SANDOZ$$44$YR$$F$Y$97$KG$20240705$$HP$CA$CA
240538141$24053814$1$I$$20240625$20240705$20240705$EXP$$CA-SANDOZ INC.-SDZ2024CA062675$SANDOZ$$44$YR$$F$Y$97$KG$20240705$$HP$CA$CA
240538153$24053815$3$F$20231206$20240808$20240705$20240821$EXP$$CA-SANDOZ INC.-NVSC2023CA144180$SANDOZ$$70$YR$$F$Y$$$20240821$$HP$CA$CA
240538161$24053816$1$I$$20240702$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062569$SANDOZ$Bulsara, K. G., Patel, H., Goldstein, A., Mathew, M.. A rare case of Argatroban-induced anaphylaxis in a patient with intermediate-high risk pulmonary embolism.. Cureus. 2024;01-05$32$YR$$F$Y$$$20240705$$HP$US$US
240538171$24053817$1$I$$20240630$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062064$SANDOZ$$$$$F$Y$$$20240705$$CN$US$US
240538181$24053818$1$I$$20240627$20240705$20240705$EXP$$DE-AUROBINDO-AUR-APL-2024-032339$AUROBINDO$$$$$F$Y$3.41$KG$20240705$$MD$DE$DE
240538191$24053819$1$I$$20240626$20240705$20240705$EXP$$CA-APOTEX-2024AP007824$APOTEX$$66$YR$$F$Y$54.875$KG$20240705$$MD$CA$CA
240538201$24053820$1$I$20230101$20240627$20240705$20240705$EXP$$US-ABBVIE-5533634$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240538211$24053821$1$I$$20240702$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062805$SANDOZ$$$$$$Y$$$20240705$$PH$US$US
240538221$24053822$1$I$20240601$20240702$20240705$20240705$EXP$GB-MHRA-MED-202407021249159180-LHKWS$GB-SANDOZ INC.-SDZ2024GB062570$SANDOZ$$$$$F$Y$$$20240705$$HP$GB$GB
240538231$24053823$1$I$$20240702$20240705$20240705$30DAY$$US-SANDOZ INC.-SDZ2024US062831$SANDOZ$$$$$F$Y$$$20240705$$CN$US$US
240538241$24053824$1$I$$20240611$20240705$20240705$30DAY$$US-SANDOZ INC.-SDZ2024US062769$SANDOZ$$$$$M$Y$71.202$KG$20240705$$CN$US$US
240538251$24053825$1$I$20240427$20240704$20240705$20240705$EXP$GB-MHRA-MED-202405021141582620-BCQHN$GB-SANDOZ INC.-SDZ2024GB062936$SANDOZ$$39$YR$$F$Y$105$KG$20240705$$CN$GB$GB
240538261$24053826$1$I$$20240704$20240705$20240705$EXP$$IT-SANDOZ INC.-SDZ2024IT062741$SANDOZ$$64$YR$$F$Y$$$20240705$$HP$IT$IT
240538271$24053827$1$I$20240530$20240701$20240705$20240705$EXP$$NL-SANDOZ INC.-SDZ2024NL061944$SANDOZ$$83$YR$$F$Y$$$20240705$$CN$NL$NL
240538282$24053828$2$F$20240101$20240708$20240705$20240717$EXP$$ZA-CELLTRION INC.-2024ZA015938$CELLTRION$$$$$$Y$$$20240717$$MD$ZA$ZA
240538291$24053829$1$I$20240621$20240703$20240705$20240705$EXP$$US-ABBVIE-5825899$ABBVIE$$94$YR$$M$Y$$$20240705$$CN$US$US
240538301$24053830$1$I$20240525$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032265$AUROBINDO$$49$YR$$F$Y$89$KG$20240705$$MD$FR$FR
240538311$24053831$1$I$$20240702$20240705$20240705$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-093894$REGENERON$$$$$F$Y$$$20240705$$CN$CA$CA
240538321$24053832$1$I$20240616$20240701$20240705$20240705$EXP$$AE-REGENERON PHARMACEUTICALS, INC.-2024-089196$REGENERON$$63$YR$$F$Y$$$20240705$$MD$AE$AE
240538332$24053833$2$F$20140604$20240808$20240705$20240821$EXP$$PL-AUROBINDO-AUR-APL-2024-032098$AUROBINDO$Maciej S, Hanna A, Letachowicz K, Dorota K, Miros?aw B, Oktawia M, et al.. Severe Bullous Erysipelas/Cellulitis, Atypically Caused by Escherichia coli, in Kidney Transplant Recipient ? Case Report and Review of Literature. Transplantation Proceedings. 2024;56(4):976-80$57$YR$$F$Y$$$20240821$$MD$PL$PL
240538342$24053834$2$F$20240601$20240625$20240705$20240825$EXP$$US-BAUSCHBL-2024BNL029203$BAUSCH AND LOMB$$74$YR$$F$Y$$$20240826$$CN$US$US
240538352$24053835$2$F$$20240916$20240705$20240926$30DAY$$VN-JNJFOC-20240711949$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$PH$VN$VN
240538361$24053836$1$I$20240201$20240610$20240705$20240705$PER$$US-JNJFOC-20240633146$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240538371$24053837$1$I$$20240703$20240705$20240705$PER$$US-JNJFOC-20240710005$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$CN$US$US
240538381$24053838$1$I$$20240217$20240705$20240705$PER$$US-ABBVIE-5828251$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240538391$24053839$1$I$20240501$20240627$20240705$20240705$EXP$$DE-AUROBINDO-AUR-APL-2024-032032$AUROBINDO$$64$YR$$F$Y$$$20240705$$PH$DE$DE
240538402$24053840$2$F$$20240716$20240705$20240729$EXP$$US-CPL-004338$CADILA$Dogrul BN, Park C. Hydralazine Induced Visual and Auditory Hallucinations in a Kidney Transplant Patient: Case Report. J Acad Consult Liaison Psychiatry. 2024 Jun 18: S2667-2960(24)00066-1$49$YR$A$F$Y$$$20240729$$MD$US$US
240538411$24053841$1$I$20240621$20240627$20240705$20240705$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109140$ZYDUS PHARM$$$$$$Y$$$20240705$$CN$US$US
240538421$24053842$1$I$20240519$20240621$20240705$20240705$EXP$GB-MHRA-MED-202406211630171300-RVHCP$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-108874$ZYDUS PHARM$$$$$$Y$$$20240705$$CN$GB$GB
240538431$24053843$1$I$$20240620$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05783$HIKMA$Puri C, Khan AA, Sher N. Puri C, Khan AA, Sher N. A Case of Emphysematous Gastritis With Septic Shock and Clostridioides Difficile.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1630$72$YR$$F$Y$$$20240705$$MD$US$US
240538441$24053844$1$I$$20240617$20240705$20240705$PER$$US-UniquePharma-US-2024UPLSPO00016$UNIQUE PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
240538451$24053845$1$I$$20240624$20240705$20240705$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109166$ZYDUS PHARM$$$$$$Y$$$20240705$$CN$US$US
240538461$24053846$1$I$$20240621$20240705$20240705$EXP$$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-108873$ZYDUS PHARM$$$$$$Y$$$20240705$$CN$GB$GB
240538473$24053847$3$F$20240610$20240911$20240705$20240927$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000396$BECTON DICKINSON$$52$YR$$$Y$$$20240927$$CN$GB$GB
240538481$24053848$1$I$$20240626$20240705$20240705$30DAY$$US-GSK-US2024079816$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$CN$US$US
240538491$24053849$1$I$$20240627$20240705$20240705$EXP$$US-GSK-US2024003239$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$HP$US$US
240538501$24053850$1$I$$20240626$20240705$20240705$30DAY$$US-GSK-US2024079832$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$MD$US$US
240538511$24053851$1$I$$20240702$20240705$20240705$EXP$$US-GSK-US2024082586$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$HP$US$US
240538521$24053852$1$I$20231211$20240628$20240705$20240705$EXP$$ES-ABBVIE-5826174$ABBVIE$$43$YR$$F$Y$$$20240705$$MD$ES$ES
240538532$24053853$2$F$$20240708$20240705$20240716$EXP$$US-AstraZeneca-2024A149533$ASTRAZENECA$$$$$M$Y$$$20240716$$HP$US$
240538541$24053854$1$I$20201201$20240627$20240705$20240705$EXP$$GB-AUROBINDO-AUR-APL-2024-032124$AUROBINDO$$$$$F$Y$75$KG$20240705$$CN$GB$GB
240538551$24053855$1$I$$20240627$20240705$20240705$EXP$$GB-AstraZeneca-2024A147779$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$GB$
240538561$24053856$1$I$$20240701$20240705$20240705$EXP$$GB-AstraZeneca-2024A154101$ASTRAZENECA$$26$YR$$F$Y$85$KG$20240705$$MD$GB$
240538571$24053857$1$I$$20240627$20240705$20240705$EXP$$FR-AstraZeneca-2024A151102$ASTRAZENECA$$84$YR$$F$Y$$$20240705$$MD$FR$
240538581$24053858$1$I$$20240510$20240705$20240705$PER$$US-AMGEN-USASP2024133329$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240538591$24053859$1$I$$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132714$AMGEN$$$$$$Y$$$20240705$$MD$US$US
240538601$24053860$1$I$$20240702$20240705$20240705$EXP$$BE-AMGEN-BELSP2024131147$AMGEN$$58$YR$A$F$Y$$$20240705$$MD$BE$BE
240538611$24053861$1$I$20240703$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106614$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240705$$CN$US$US
240538621$24053862$1$I$20240101$20240627$20240705$20240705$EXP$$JP-GENMAB-2024-01474AA$GENMAB$$60$YR$$F$Y$56$KG$20240705$$HP$JP$JP
240538631$24053863$1$I$20240619$20240628$20240705$20240705$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-090482$REGENERON$$$$$M$Y$$$20240705$$CN$CA$CA
240538642$24053864$2$F$20240601$20240802$20240705$20240806$PER$$US-ALXN-202406USA001868US$ALEXION PHARMACEUTICALS$$70$YR$$F$Y$$$20240806$$CN$US$US
240538651$24053865$1$I$20230202$20240627$20240705$20240705$EXP$IT-MINISAL02-991979$IT-TAKEDA-2024TUS064502$TAKEDA$$69$YR$$M$Y$$$20240705$$HP$IT$IT
240538661$24053866$1$I$$20240621$20240705$20240705$PER$$US-RISINGPHARMA-US-2024RISSPO00224$RISING PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
240538671$24053867$1$I$$20240628$20240705$20240705$PER$$US-AMGEN-USASP2024128973$AMGEN$$$$$$Y$$$20240705$$MD$US$US
240538681$24053868$1$I$20240616$20240627$20240705$20240705$EXP$$DE-AUROBINDO-AUR-APL-2024-032146$AUROBINDO$$20$YR$$F$Y$60$KG$20240705$$PH$DE$DE
240538691$24053869$1$I$$20231105$20240705$20240705$PER$$US-ABBVIE-5827502$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240538701$24053870$1$I$$20240626$20240705$20240705$30DAY$$US-GSK-US2024079834$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240538713$24053871$3$F$20240629$20240718$20240705$20240725$PER$$US-BAUSCHBL-2024BNL029546$BAUSCH AND LOMB$$80$YR$$M$Y$$$20240726$$CN$US$US
240538722$24053872$2$F$$20240704$20240705$20240710$PER$$US-JNJFOC-20240711752$JOHNSON AND JOHNSON$$77$YR$E$$Y$$$20240710$$CN$US$US
240538731$24053873$1$I$$20240702$20240705$20240705$PER$$US-JNJFOC-20240708589$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240538741$24053874$1$I$$20240628$20240705$20240705$PER$$US-JNJFOC-20240700746$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240538751$24053875$1$I$$20240616$20240705$20240705$PER$$US-JNJFOC-20240645888$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240538761$24053876$1$I$$20240702$20240705$20240705$EXP$$CN-JNJFOC-20240707787$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240705$$HP$CN$CN
240538771$24053877$1$I$$20240626$20240705$20240705$EXP$$IR-MPL-000042$MLV PHARMA$$9$YR$C$F$Y$$$20240629$$MD$IR$IR
240538781$24053878$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA197357$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240705$$HP$US$US
240538801$24053880$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193517$SANOFI AVENTIS$$67$YR$E$$Y$$$20240705$$CN$US$US
240538812$24053881$2$F$20240601$20240810$20240705$20240814$PER$$US-SA-2024SA183952$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240815$$MD$US$US
240538821$24053882$1$I$$20240625$20240705$20240705$EXP$$CA-SANDOZ INC.-SDZ2024CA062677$SANDOZ$$44$YR$$F$Y$97$KG$20240705$$HP$CA$CA
240538831$24053883$1$I$$20240627$20240705$20240705$PER$$US-SA-2024SA194589$SANOFI AVENTIS$$$$C$F$Y$$$20240705$$MD$US$US
240538841$24053884$1$I$$20240701$20240705$20240705$PER$$US-SA-2024SA195878$SANOFI AVENTIS$$$$A$$Y$$$20240705$$CN$US$US
240538851$24053885$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA196197$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240705$$MD$US$US
240538861$24053886$1$I$20230101$20240626$20240705$20240705$PER$$US-SA-2024SA192336$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240705$$MD$US$US
240538871$24053887$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA192098$SANOFI AVENTIS$$$$$F$Y$$$20240705$$CN$US$US
240538882$24053888$2$F$20240618$20240813$20240705$20240826$PER$$US-SA-2024SA188685$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240826$$MD$US$US
240538893$24053889$3$F$$20240628$20240705$20240726$PER$$US-SA-2024SA191122$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240726$$HP$US$US
240538901$24053890$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA195390$SANOFI AVENTIS$$$$A$M$Y$86.18$KG$20240705$$MD$US$US
240538911$24053891$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA192111$SANOFI AVENTIS$$$$A$$Y$$$20240705$$CN$US$US
240538921$24053892$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA192435$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240705$$MD$US$US
240538931$24053893$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA195492$SANOFI AVENTIS$$$$C$M$Y$34.2$KG$20240705$$MD$US$US
240538942$24053894$2$F$20240601$20240626$20240705$20240711$PER$$US-SA-2024SA194896$SANOFI AVENTIS$$7$YR$C$M$Y$21.7$KG$20240711$$MD$US$US
240538952$24053895$2$F$20240401$20240822$20240705$20240917$PER$$US-SA-2024SA191691$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240918$$MD$US$US
240538961$24053896$1$I$20240625$20240629$20240705$20240705$PER$$US-SA-2024SA196203$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240705$$MD$US$US
240538971$24053897$1$I$20240601$20240628$20240705$20240705$PER$$US-SA-2024SA195593$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240538981$24053898$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193076$SANOFI AVENTIS$$$$A$M$Y$$$20240705$$MD$US$US
240538991$24053899$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA196198$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240539001$24053900$1$I$$20240627$20240705$20240705$EXP$$JP-ROCHE-10000015013$ROCHE$$$$A$$Y$$$20240705$$MD$JP$JP
240539012$24053901$2$F$$20240705$20240705$20240718$PER$$US-MSNLABS-2024MSNSPO01440$MSN LABORATORIES$$$$$$Y$$$20240718$$PH$US$US
240539021$24053902$1$I$20240214$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032230$AUROBINDO$$26$YR$$M$Y$$$20240705$$PH$FR$FR
240539031$24053903$1$I$$20240625$20240705$20240705$PER$$US-TEVA-VS-3213713$TEVA$$$$$$Y$$$20240705$$HP$US$US
240539041$24053904$1$I$$20240220$20240705$20240705$EXP$GB-MHRA-ADR 28546503$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03414$ALKEM$$22$YR$$M$Y$$$20240705$$CN$GB$GB
240539051$24053905$1$I$$20230602$20240705$20240705$EXP$GB-MHRA-ADR 27942079$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-06368$ALKEM$$77$YR$$F$Y$$$20240705$$PH$GB$GB
240539061$24053906$1$I$20230707$20230801$20240705$20240705$EXP$GB-MHRA-ADR 28086041$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-08795$ALKEM$$$$$F$Y$$$20240705$$PH$GB$GB
240539071$24053907$1$I$$20230920$20240705$20240705$EXP$GB-MHRA-ADR 28190909$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-11094$ALKEM$$$$$F$Y$$$20240705$$CN$GB$GB
240539081$24053908$1$I$20230907$20230925$20240705$20240705$EXP$GB-MHRA-ADR 28200797$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-11567$ALKEM$$64$YR$$F$Y$$$20240705$$HP$GB$GB
240539091$24053909$1$I$$20240130$20240705$20240705$EXP$GB-MHRA-ADR 28495782$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-01837$ALKEM$$83$YR$$F$Y$$$20240705$$HP$GB$GB
240539101$24053910$1$I$$20231214$20240705$20240705$EXP$GB-MHRA-ADR 28389428$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-16072$ALKEM$$$$$F$Y$$$20240705$$CN$GB$GB
240539111$24053911$1$I$$20230613$20240705$20240705$EXP$GB-MHRA-ADR 27966415$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-06666$ALKEM$$42$YR$$F$Y$76$KG$20240705$$MD$GB$GB
240539121$24053912$1$I$20230530$20230627$20240705$20240705$EXP$DE-DCGMA-23201331$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-07323$ALKEM$$80$YR$$F$Y$$$20240705$$MD$DE$DE
240539131$24053913$1$I$$20230912$20240705$20240705$EXP$GB-MHRA-ADR 28164040$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10568$ALKEM$$84$YR$$F$Y$59$KG$20240705$$HP$GB$GB
240539141$24053914$1$I$$20230525$20240705$20240705$EXP$GB-MHRA-ADR 27924561$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-06058$ALKEM$$61$YR$$F$Y$$$20240705$$PH$GB$GB
240539151$24053915$1$I$20231104$20231115$20240705$20240705$EXP$GB-MHRA-ADR 28322918$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-14272$ALKEM$$42$YR$$F$Y$63$KG$20240705$$CN$GB$GB
240539161$24053916$1$I$20230627$20230711$20240705$20240705$EXP$GB-MHRA-ADR 28034331$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-07981$ALKEM$$57$YR$$F$Y$95$KG$20240705$$CN$GB$GB
240539171$24053917$1$I$20240322$20240410$20240705$20240705$EXP$GB-MHRA-ADR 28663719$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-07764$ALKEM$$51$YR$$F$Y$$$20240705$$CN$GB$GB
240539181$24053918$1$I$$20230525$20240705$20240705$EXP$GB-MHRA-ADR 27922567$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-06055$ALKEM$$$$$F$Y$$$20240705$$CN$GB$GB
240539191$24053919$1$I$$20230626$20240705$20240705$EXP$GB-MHRA-ADR 27995296$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-07273$ALKEM$$74$YR$$M$Y$$$20240705$$CN$GB$GB
240539201$24053920$1$I$20230825$20230918$20240705$20240705$EXP$GB-MHRA-ADR 28146949$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10176$ALKEM$$79$YR$$F$Y$60$KG$20240705$$MD$GB$GB
240539211$24053921$1$I$20230517$20230602$20240705$20240705$EXP$GB-MHRA-ADR 27945340$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-06380$ALKEM$$52$YR$$F$Y$91$KG$20240705$$PH$GB$GB
240539221$24053922$1$I$20230602$20230606$20240705$20240705$EXP$GB-MHRA-ADR 27950130$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-06474$ALKEM$$19$YR$$F$Y$44$KG$20240705$$MD$GB$GB
240539231$24053923$1$I$$20230810$20240705$20240705$EXP$GB-MHRA-ADR 28103543$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09089$ALKEM$$67$YR$$M$Y$122$KG$20240705$$MD$GB$GB
240539241$24053924$1$I$20230622$20230626$20240705$20240705$EXP$GB-MHRA-ADR 27998206$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-07281$ALKEM$$66$YR$$F$Y$61$KG$20240705$$MD$GB$GB
240539251$24053925$1$I$20230714$20230803$20240705$20240705$EXP$GB-MHRA-ADR 28090752$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-08882$ALKEM$$$$$M$Y$73$KG$20240705$$MD$GB$GB
240539261$24053926$1$I$20230101$20240305$20240705$20240705$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-04382$ALKEM$$54$YR$$M$Y$$$20240705$$CN$DE$DE
240539271$24053927$1$I$20240113$20240120$20240705$20240705$EXP$GB-MHRA-ADR 28471839$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-01202$ALKEM$$$$$F$Y$$$20240705$$PH$GB$GB
240539281$24053928$1$I$20231114$20240111$20240705$20240705$EXP$GB-MHRA-ADR 28452587$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-00472$ALKEM$$72$YR$$F$Y$$$20240705$$CN$GB$GB
240539291$24053929$1$I$$20231130$20240705$20240705$EXP$GB-MHRA-ADR 28346095$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15306$ALKEM$$72$YR$$M$Y$90$KG$20240705$$HP$GB$GB
240539301$24053930$1$I$$20231226$20240705$20240705$EXP$GB-MHRA-ADR 28414357$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-16766$ALKEM$$37$YR$$M$Y$60$KG$20240705$$HP$GB$GB
240539311$24053931$1$I$20230623$20230707$20240705$20240705$EXP$GB-MHRA-ADR 28024960$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-07813$ALKEM$$26$YR$$M$Y$$$20240705$$PH$GB$GB
240539321$24053932$1$I$20231026$20231127$20240705$20240705$EXP$GB-MHRA-ADR 28339617$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15011$ALKEM$$65$YR$$F$Y$$$20240705$$MD$GB$GB
240539331$24053933$1$I$20231121$20231220$20240705$20240705$EXP$GB-MHRA-ADR 28346789$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-14969$ALKEM$$58$YR$$F$Y$91$KG$20240705$$CN$GB$GB
240539341$24053934$1$I$$20240401$20240705$20240705$EXP$GB-MHRA-ADR 28645061$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06893$ALKEM$$62$YR$$F$Y$60$KG$20240705$$CN$GB$GB
240539351$24053935$1$I$20240218$20240305$20240705$20240705$EXP$GB-MHRA-ADR 28579132$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03702$ALKEM$$92$YR$$M$Y$$$20240705$$CN$GB$GB
240539361$24053936$1$I$$20240323$20240705$20240705$EXP$GB-MHRA-ADR 28622304$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06522$ALKEM$$$$$$Y$$$20240705$$PH$GB$GB
240539371$24053937$1$I$20240203$20240214$20240705$20240705$EXP$GB-MHRA-ADR 28533503$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-02958$ALKEM$$61$YR$$F$Y$$$20240705$$PH$GB$GB
240539381$24053938$1$I$20231112$20231120$20240705$20240705$EXP$GB-MHRA-ADR 28334912$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-14614$ALKEM$$23$YR$$F$Y$$$20240705$$CN$GB$GB
240539391$24053939$1$I$20231106$20231201$20240705$20240705$EXP$GB-MHRA-ADR 28358380$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15340$ALKEM$$$$$$Y$$$20240705$$PH$GB$GB
240539401$24053940$1$I$20231124$20231215$20240705$20240705$EXP$GB-MHRA-ADR 28393601$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-16233$ALKEM$$76$YR$$F$Y$71$KG$20240705$$CN$GB$GB
240539411$24053941$1$I$$20231204$20240705$20240705$EXP$GB-MHRA-ADR 28362031$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15476$ALKEM$$$$$F$Y$$$20240705$$HP$GB$GB
240539421$24053942$1$I$20231205$20231211$20240705$20240705$EXP$GB-MHRA-ADR 28383088$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15873$ALKEM$$86$YR$$F$Y$$$20240705$$MD$GB$GB
240539431$24053943$1$I$20140101$20240106$20240705$20240705$EXP$GB-MHRA-ADR 28444453$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-00112$ALKEM$$75$YR$$F$Y$129$KG$20240705$$CN$GB$GB
240539441$24053944$1$I$20231002$20231009$20240705$20240705$EXP$GB-MHRA-ADR 28223147$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-12313$ALKEM$$86$YR$$M$Y$65$KG$20240705$$MD$GB$GB
240539451$24053945$1$I$$20240308$20240705$20240705$EXP$GB-MHRA-ADR 28588189$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-04741$ALKEM$$85$YR$$F$Y$92.63$KG$20240705$$MD$GB$GB
240539461$24053946$1$I$$20240326$20240705$20240705$EXP$GB-MHRA-ADR 28630797$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06495$ALKEM$$68$YR$$F$Y$$$20240705$$CN$GB$GB
240539471$24053947$1$I$20240123$20240125$20240705$20240705$EXP$GB-MHRA-ADR 28484759$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-01459$ALKEM$$33$YR$$F$Y$73$KG$20240705$$MD$GB$GB
240539481$24053948$1$I$$20240301$20240705$20240705$EXP$GB-MHRA-ADR 28556063$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-04134$ALKEM$$78$YR$$M$Y$76$KG$20240705$$MD$GB$GB
240539491$24053949$1$I$20231107$20231208$20240705$20240705$EXP$GB-MHRA-ADR 28370133$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15770$ALKEM$$58$YR$$F$Y$69$KG$20240705$$PH$GB$GB
240539502$24053950$2$F$$20240729$20240705$20240802$EXP$$US-ABBVIE-5826640$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
240539512$24053951$2$F$20240522$20240701$20240705$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002776$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240725$$CN$US$US
240539523$24053952$3$F$20240609$20240906$20240705$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002777$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240927$$CN$US$US
240539531$24053953$1$I$$20240627$20240705$20240705$EXP$$US-BAUSCHBL-2024BNL029258$BAUSCH AND LOMB$Credo R, Kesey J, Bharadia D, Griswold J, Pang A. Acute Intermittent Porphyria in a Burn Patient: Case Study and Review of the Literature. Journal of Burn Care + Research. 2024;45 (3):790-795. doi:10.1093/jbcr/irad135$60$YR$$M$Y$$$20240705$$HP$US$US
240539542$24053954$2$F$$20240703$20240705$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002778$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
240539551$24053955$1$I$$20240610$20240705$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001166$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240539561$24053956$1$I$$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106712$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240705$$CN$US$US
240539571$24053957$1$I$$20240704$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107136$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$137.89$KG$20240705$$CN$US$US
240539581$24053958$1$I$20230701$20240627$20240705$20240705$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-105430$BRISTOL MYERS SQUIBB$$60$YR$A$$Y$$$20240705$$MD$ES$ES
240539591$24053959$1$I$$20240611$20240705$20240705$EXP$$SG-ROCHE-10000001513$ROCHE$$71$YR$E$F$Y$$$20240705$$CN$SG$SG
240539601$24053960$1$I$20231201$20240626$20240705$20240705$EXP$IT-MINISAL02-991191$IT-TEVA-VS-3214796$TEVA$$39$YR$$M$Y$89$KG$20240705$$MD$IT$IT
240539611$24053961$1$I$$20240625$20240705$20240705$EXP$$CA-ROCHE-10000012547$ROCHE$$$$$F$Y$$$20240705$$HP$CA$CA
240539621$24053962$1$I$$20240702$20240705$20240705$PER$$US-JNJFOC-20240705165$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240539631$24053963$1$I$$20240703$20240705$20240705$EXP$$CA-JNJFOC-20240711459$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240705$$HP$CA$CA
240539641$24053964$1$I$$20240616$20240705$20240705$PER$$US-JNJFOC-20240645121$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240539651$24053965$1$I$$20240627$20240705$20240705$EXP$$GB-AUROBINDO-AUR-APL-2024-032065$AUROBINDO$$83$YR$$F$Y$$$20240705$$PH$GB$GB
240539661$24053966$1$I$20230201$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032318$AUROBINDO$$16$YR$$M$Y$67.3$KG$20240705$$MD$FR$FR
240539671$24053967$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5825546$ABBVIE$$76$YR$$$Y$$$20240705$$CN$US$US
240539681$24053968$1$I$$20231106$20240705$20240705$PER$$US-ABBVIE-5827630$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240539691$24053969$1$I$$20240625$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR082396$VIIV$$$$$$Y$$$20240705$$HP$US$US
240539701$24053970$1$I$$20240627$20240705$20240705$EXP$$US-GSK-US2024080368$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$HP$US$US
240539711$24053971$1$I$$20240626$20240705$20240705$EXP$$DE-SA-2024SA192993$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$DE$DE
240539721$24053972$1$I$20221201$20240702$20240705$20240705$EXP$$US-ABBVIE-5825385$ABBVIE$$43$YR$$F$Y$$$20240705$$CN$US$US
240539751$24053975$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5825904$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240539761$24053976$1$I$$20240621$20240705$20240705$EXP$$US-CIPLA LTD.-2024US06765$CIPLA$Garcha G, Shah T, Rao R, Mary KR. Uncontrolled asthma unmasking allergic bronchopulmonary aspergillosis (ABPA). Chest. 2022;162 (Suppl)(4):A44x`$$$$$Y$$$20240705$$HP$US$US
240539771$24053977$1$I$20240618$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032191$AUROBINDO$$73$YR$$M$Y$70$KG$20240705$$MD$FR$FR
240539781$24053978$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5827707$ABBVIE$$$$$F$Y$$$20240705$$MD$US$US
240539791$24053979$1$I$20231224$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032336$AUROBINDO$$51$YR$$F$Y$$$20240705$$PH$FR$FR
240539811$24053981$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5825309$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240539822$24053982$2$F$20240619$20240712$20240705$20240717$EXP$$BR-SA-2024SA196825$SANOFI AVENTIS$$11$MON$I$M$Y$$$20240717$$MD$BR$BR
240539831$24053983$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5826346$ABBVIE$$$$$F$Y$55$KG$20240705$$CN$US$US
240539851$24053985$1$I$20240601$20240610$20240705$20240705$PER$$US-JNJFOC-20240628982$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240539861$24053986$1$I$20240702$20240702$20240705$20240705$PER$$US-ABBVIE-5827396$ABBVIE$$50$YR$$F$Y$$$20240705$$CN$US$US
240539871$24053987$1$I$20240310$20240701$20240705$20240705$EXP$SE-SEMPA-2024-005145$SE-REGENERON PHARMACEUTICALS, INC.-2024-092395$REGENERON$$91$YR$$F$Y$$$20240705$$MD$SE$SE
240539881$24053988$1$I$20240628$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131691$AMGEN$$71$YR$E$F$Y$$$20240705$$CN$US$US
240539891$24053989$1$I$20240623$20240626$20240705$20240705$EXP$$US-EMD Serono-2024035075$EMD SERONO INC$$68$YR$E$F$Y$$$20240705$$CN$US$US
240539902$24053990$2$F$20240616$20240916$20240705$20240930$PER$$US-SA-2024SA187309$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240930$$CN$US$US
240539911$24053991$1$I$$20240217$20240705$20240705$PER$$US-ABBVIE-5828413$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240539921$24053992$1$I$$20230626$20240705$20240705$PER$$US-AMGEN-USASP2023235598$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240539931$24053993$1$I$$20240220$20240705$20240705$PER$$US-AMGEN-USASP2024132972$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240539941$24053994$1$I$$20230718$20240705$20240705$PER$$US-AMGEN-USASP2023235525$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240539951$24053995$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA196273$SANOFI AVENTIS$$42$YR$A$F$Y$96.16$KG$20240705$$MD$US$US
240539961$24053996$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193178$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240705$$MD$US$US
240539971$24053997$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA176564$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240705$$MD$US$US
240539981$24053998$1$I$20240101$20240621$20240705$20240705$PER$$US-SA-2024SA187913$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240705$$MD$US$US
240539991$24053999$1$I$20240501$20240627$20240705$20240705$PER$$US-SA-2024SA193787$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240705$$MD$US$US
240540001$24054000$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA192437$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240705$$MD$US$US
240540011$24054001$1$I$$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A152482$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240540021$24054002$1$I$$20240627$20240705$20240705$EXP$$ZA-AstraZeneca-2024A150079$ASTRAZENECA$$9496$DY$$F$Y$$$20240705$$CN$ZA$
240540031$24054003$1$I$$20240628$20240705$20240705$EXP$$CA-AstraZeneca-2024A149785$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$CA$
240540042$24054004$2$F$20210101$20240712$20240705$20240719$EXP$$US-AstraZeneca-2024A150734$ASTRAZENECA$$74$YR$$F$Y$$$20240719$$CN$US$
240540051$24054005$1$I$20240627$20240627$20240705$20240705$EXP$$GB-AUROBINDO-AUR-APL-2024-031989$AUROBINDO$$68$YR$$F$Y$65$KG$20240705$$MD$GB$GB
240540061$24054006$1$I$$20240702$20240705$20240705$PER$$US-HALEON-2181382$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240540071$24054007$1$I$$20240701$20240705$20240705$PER$$US-AstraZeneca-2024A151647$ASTRAZENECA$$$$$M$Y$$$20240705$$PH$US$
240540081$24054008$1$I$20240301$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A150274$ASTRAZENECA$$747$MON$$F$Y$$$20240705$$CN$US$
240540091$24054009$1$I$20240630$20240702$20240705$20240705$PER$$US-ABBVIE-5827480$ABBVIE$$11$YR$$M$Y$$$20240705$$CN$US$US
240540102$24054010$2$F$20231201$20240701$20240705$20240710$PER$$US-SA-2024SA196678$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240710$$MD$US$US
240540111$24054011$1$I$20240101$20240628$20240705$20240705$PER$$US-SA-2024SA194223$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240705$$CN$US$US
240540121$24054012$1$I$20230901$20240702$20240705$20240705$PER$$US-SA-2024SA198017$SANOFI AVENTIS$$1$YR$I$M$Y$15.873$KG$20240705$$MD$US$US
240540132$24054013$2$F$20210201$20240705$20240705$20240715$PER$$US-SA-2024SA196735$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240715$$CN$US$US
240540141$24054014$1$I$$20240628$20240705$20240705$EXP$$IN-AstraZeneca-2024A152293$ASTRAZENECA$$55$YR$$M$Y$$$20240705$$PH$IN$
240540151$24054015$1$I$$20240702$20240705$20240705$EXP$$ZA-AstraZeneca-2024A152136$ASTRAZENECA$$28854$DY$$F$Y$$$20240705$$CN$ZA$
240540161$24054016$1$I$20240618$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151224$ASTRAZENECA$$$$$$Y$$$20240705$$CN$US$
240540172$24054017$2$F$20240601$20240923$20240705$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106727$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240924$$HP$US$US
240540191$24054019$1$I$20210801$20240603$20240705$20240705$EXP$$CA-CELLTRION INC.-2021CA019541$CELLTRION$$$$$$Y$$$20240705$$HP$CA$CA
240540201$24054020$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA193221$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240705$$MD$US$US
240540211$24054021$1$I$20240430$20240627$20240705$20240705$EXP$$IT-AUROBINDO-AUR-APL-2024-032075$AUROBINDO$$69$YR$$F$Y$63$KG$20240705$$MD$IT$IT
240540232$24054023$2$F$20231201$20240824$20240705$20240903$EXP$DE-BFARM-24003670$DE-TEVA-VS-3214459$TEVA$$66$YR$$F$Y$83$KG$20240903$$CN$DE$DE
240540241$24054024$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA197083$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240540251$24054025$1$I$20240610$20240624$20240705$20240705$EXP$GB-MHRA-MED-202406231945493330-VCGQN$GB-MACLEODS PHARMA-MAC2024047951$MACLEODS$$$$$$Y$$$20240705$$CN$GB$GB
240540261$24054026$1$I$$20240624$20240705$20240705$EXP$$JP-MACLEODS PHARMA-MAC2024047971$MACLEODS$Komoriya H, Nomura K, Shirata T, Kobayashi T, Nakane M, Noto K et al.A fatal caseof fulminant neuroleptic malignant syndrome: A case report.PCN reports : psychiatryandclinicalneurosciences.2023;2(1):e75$$$$$Y$$$20240705$$MD$JP$JP
240540271$24054027$1$I$$20231016$20240705$20240705$PER$$US-AMGEN-USASP2023235554$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240540281$24054028$1$I$$20240624$20240705$20240705$EXP$$GR-MACLEODS PHARMA-MAC2024047987$MACLEODS$$$$$$Y$$$20240705$$MD$GR$GR
240540291$24054029$1$I$$20240624$20240705$20240705$EXP$$CN-MACLEODS PHARMA-MAC2024047969$MACLEODS$Lei M, Cao Y, Yuan M, Xiong J, He H..Case report: A case of bradycardia triggered by diarrhea.Frontiers in medicine.2024;11:1405494$$$$$Y$$$20240705$$MD$CN$CN
240540301$24054030$1$I$20240628$20240703$20240705$20240705$30DAY$$US-GSK-US2024082650$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240705$$CN$US$US
240540311$24054031$1$I$$20240701$20240705$20240705$EXP$$KR-JAZZ PHARMACEUTICALS-2024-KR-010274$JAZZ$$$$A$M$Y$$$20240705$$MD$KR$KR
240540321$24054032$1$I$20240613$20240627$20240705$20240705$EXP$$ES-AUROBINDO-AUR-APL-2024-032129$AUROBINDO$$71$YR$$M$Y$$$20240705$$PH$ES$ES
240540331$24054033$1$I$20240516$20240703$20240705$20240705$EXP$$IL-ABBVIE-5827657$ABBVIE$$23$YR$$M$Y$$$20240705$$CN$IL$IL
240540341$24054034$1$I$$20240703$20240705$20240705$EXP$$NVSC2024GB139182$NOVARTIS$$$$$F$Y$$$20240705$$MD$GB$GB
240540351$24054035$1$I$$20240627$20240705$20240705$EXP$$IT-AUROBINDO-AUR-APL-2024-032375$AUROBINDO$Balestri R, Bortolotti R, Rech G, Girardelli CR, Zorzi MG, Magnano M.. Treatment of Oral Erosive Lichen Planus With Upadacitinib. JAMA Dermatology. 2022;158 (4):457-458$45$YR$$F$Y$$$20240705$$MD$IT$IT
240540361$24054036$1$I$$20231107$20240705$20240705$PER$$US-ABBVIE-5827591$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240540371$24054037$1$I$20240525$20240702$20240705$20240705$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-13353$IPSEN$$99$YR$E$M$Y$$$20240705$$CN$GB$GB
240540381$24054038$1$I$$20240704$20240705$20240705$PER$$US-ROCHE-10000016440$ROCHE$Chaisrimaneepan N, Saowapa S, Pangkanon W, Thongpiya J, Yingchoncharoen P, Polpichai N, et al. Neutrophilic eccrine hidradenitis from granulocyte-stimulating factor in a patient with ANCA vasculitis. Clinical Case Reports. 2024-Jul;12 (7):1-4. doi:10.1002/ccr3.9114.$$$A$M$Y$$$20240705$$HP$US$US
240540392$24054039$2$F$$20240708$20240705$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-032493$AUROBINDO$$$$$$Y$$$20240717$$CN$GB$GB
240540401$24054040$1$I$$20240627$20240705$20240705$EXP$$CA-APOTEX-2024AP007866$APOTEX$$$$$F$Y$$$20240705$$HP$CA$CA
240540411$24054041$1$I$20240529$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032287$AUROBINDO$$47$YR$$F$Y$68$KG$20240705$$PH$FR$FR
240540422$24054042$2$F$20240601$20240705$20240705$20240708$PER$$US-AMGEN-USASP2024131957$AMGEN$$31$YR$A$F$Y$$$20240707$$CN$US$US
240540431$24054043$1$I$$20240627$20240705$20240705$EXP$$BD-ROCHE-10000014018$ROCHE$$$$$$Y$$$20240705$$MD$BD$BD
240540441$24054044$1$I$20240531$20240612$20240705$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002783$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240705$$CN$US$US
240540451$24054045$1$I$$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106588$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$58.51$KG$20240705$$CN$US$US
240540461$24054046$1$I$$20240620$20240705$20240705$PER$$US-ABBVIE-5828039$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240540471$24054047$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA191573$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240705$$MD$US$US
240540483$24054048$3$F$$20240827$20240705$20240910$EXP$$PT-SA-2024SA192636$SANOFI AVENTIS$$$$E$$Y$$$20240910$$HP$PT$PT
240540491$24054049$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5826098$ABBVIE$$$$$M$Y$$$20240705$$HP$US$US
240540501$24054050$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193223$SANOFI AVENTIS$$$$A$M$Y$89.8$KG$20240705$$MD$US$US
240540511$24054051$1$I$$20240703$20240705$20240705$EXP$$AU-ABBVIE-5827824$ABBVIE$$$$$M$Y$$$20240705$$HP$AU$AU
240540521$24054052$1$I$$20240620$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-05937$HIKMA$Xiong J, Prasad S, Embry E, Singh K, Singh M.. Xiong J, Prasad S, Embry E, Singh K, Singh M. Resistant Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6323$68$YR$$M$Y$$$20240705$$MD$US$US
240540531$24054053$1$I$$20240625$20240705$20240705$EXP$$NVSC2024US133330$NOVARTIS$$$$$$Y$$$20240705$$CN$US$US
240540553$24054055$3$F$20240426$20240731$20240705$20240826$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002162$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240826$$CN$US$US
240540561$24054056$1$I$$20240220$20240705$20240705$PER$$US-ABBVIE-5828542$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240540571$24054057$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5825159$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240540582$24054058$2$F$$20231121$20240705$20240909$PER$$US-HALEON-2185249$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
240540591$24054059$1$I$20230918$20240627$20240705$20240705$EXP$$GB-CELLTRION INC.-2023GB016881$CELLTRION$$$$$$Y$$$20240705$$HP$GB$GB
240540601$24054060$1$I$20230101$20240624$20240705$20240705$EXP$$CA-APOTEX-2023AP012494$APOTEX$$$$E$M$Y$$$20240705$$PH$CA$CA
240540611$24054061$1$I$$20240624$20240705$20240705$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-12792$IPSEN$$$$$F$Y$$$20240705$$CN$US$US
240540621$24054062$1$I$20231221$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032183$AUROBINDO$$29$YR$$F$Y$$$20240705$$PH$FR$FR
240540631$24054063$1$I$20240427$20240626$20240705$20240705$EXP$FR-AFSSAPS-AM2024000424$FR-Accord-433123$ACCORD$$76$YR$E$M$Y$90$KG$20240705$$MD$FR$FR
240540641$24054064$1$I$20240514$20240625$20240705$20240705$EXP$FR-AFSSAPS-PC2024000523$FR-Accord-432779$ACCORD$$38$YR$A$F$Y$48$KG$20240705$$PH$FR$FR
240540651$24054065$1$I$$20240624$20240705$20240705$EXP$$RU-Accord-432565$ACCORD$Goloshchapov OV, Chukhlovin AB, Bug DS, Polev DE, Kosarev OV, Klementeva RV, et al. Safety, Feasibility, and Advantages of Oral Microbiota Transplantation: The First Clinical Case. Journal of pediatric hematology/oncology. 2024. DOI: 10.1097/MPH.0000000000002896.$6$MON$I$F$Y$$$20240705$$MD$RU$RU
240540661$24054066$1$I$$20240624$20240705$20240705$EXP$$JP-Accord-424533$ACCORD$Koyama G, Kawaguchi T, Sato T, Hamada C, Hara S. Acute myeloid leukemia with central nervous system involvement successfully treated with gilteritinib. The Japanese journal of clinical hematology. 2024;65(4):231-6. DOI: 10.11406/rinketsu.65.231.$69$YR$E$F$Y$$$20240705$$MD$JP$JP
240540671$24054067$1$I$$20240626$20240705$20240705$EXP$CA-MHPD-E2B_07058290$CA-Accord-432767$ACCORD$$71$YR$E$M$Y$$$20240705$$HP$CA$CA
240540681$24054068$1$I$20240627$20240628$20240705$20240705$PER$$US-JNJFOC-20240677859$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240540691$24054069$1$I$20240625$20240702$20240705$20240705$PER$$US-JNJFOC-20240708228$JOHNSON AND JOHNSON$$50$YR$$M$Y$$$20240705$$HP$US$US
240540701$24054070$1$I$$20240702$20240705$20240705$EXP$$ZA-AstraZeneca-2024A153235$ASTRAZENECA$$70$YR$$M$Y$$$20240705$$CN$ZA$
240540711$24054071$1$I$20240527$20240626$20240705$20240705$EXP$FR-AFSSAPS-LM2024000339$FR-TEVA-VS-3214911$TEVA$$32$YR$$M$Y$72$KG$20240705$$MD$FR$FR
240540732$24054073$2$F$$20240806$20240705$20240808$30DAY$$BR-JNJFOC-20240711913$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$MD$BR$BR
240540741$24054074$1$I$20240501$20240620$20240705$20240705$PER$$US-AstraZeneca-2024A138471$ASTRAZENECA$$83$MON$$M$Y$$$20240705$$CN$US$
240540751$24054075$1$I$20240404$20240626$20240705$20240705$EXP$FR-AFSSAPS-TO2024001090$FR-TEVA-VS-3214797$TEVA$$72$YR$$F$Y$$$20240705$$MD$FR$FR
240540761$24054076$1$I$$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A149576$ASTRAZENECA$$$$$F$Y$58.5$KG$20240705$$CN$US$
240540771$24054077$1$I$$20240628$20240705$20240705$EXP$$ZA-AstraZeneca-2024A150088$ASTRAZENECA$$70$YR$$F$Y$$$20240705$$CN$ZA$
240540781$24054078$1$I$$20240620$20240705$20240705$PER$$US-AstraZeneca-2024A144852$ASTRAZENECA$$$$$$Y$$$20240705$$MD$US$
240540801$24054080$1$I$$20240626$20240705$20240705$EXP$$US-GSK-US2024079700$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240540815$24054081$5$F$20240719$20240722$20240705$20240926$PER$$US-GSK-US2024AMR082467$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240926$$CN$US$US
240540821$24054082$1$I$20240608$20240703$20240705$20240705$EXP$$FR-AstraZeneca-2024A154064$ASTRAZENECA$$45$YR$$M$Y$67$KG$20240705$$MD$FR$
240540831$24054083$1$I$$20230926$20240705$20240705$PER$$US-AMGEN-USASP2023235523$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240540841$24054084$1$I$$20240423$20240705$20240705$PER$$US-AMGEN-USASP2024133323$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240540851$24054085$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002959$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240705$$CN$US$US
240540861$24054086$1$I$20240701$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002985$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240705$$HP$US$US
240540871$24054087$1$I$20240702$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002270$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240705$$CN$US$US
240540881$24054088$1$I$20240702$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002784$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240705$$CN$US$US
240540891$24054089$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002947$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240705$$CN$US$US
240540901$24054090$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5825697$ABBVIE$$46$YR$$M$Y$$$20240705$$HP$US$US
240540911$24054091$1$I$$20240703$20240705$20240705$EXP$$NVSC2024US139076$NOVARTIS$$$$$F$Y$$$20240705$$HP$US$US
240540922$24054092$2$F$$20240726$20240705$20240729$EXP$$US-ROCHE-10000016589$ROCHE$$$$A$F$Y$82.8$KG$20240729$$HP$US$US
240540931$24054093$1$I$$20240624$20240705$20240705$EXP$$CN-ROCHE-10000007866$ROCHE$Wang M, Fan Z, Q L, Zhnag Y, Li W, Yu H. Safety of tocilizumab combined with traditional antirheumatic drugs in the treatment of systemic juvenile idiopathic arthritis. Chinese Journal of Rheumatology. 2024-May;28 (5):P321-6. doi:10.3760/cma.j.cn141217-20230109-00009.$$$$$Y$$$20240705$$HP$CN$CN
240540941$24054094$1$I$20240501$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032270$AUROBINDO$$51$YR$$F$Y$$$20240705$$MD$FR$FR
240540951$24054095$1$I$20240620$20240627$20240705$20240705$EXP$$PT-AUROBINDO-AUR-APL-2024-031995$AUROBINDO$$52$YR$$F$Y$87$KG$20240705$$HP$PT$PT
240540961$24054096$1$I$$20240627$20240705$20240705$EXP$$US-BIOCON BIOLOGICS LIMITED-BBL2024004867$BIOCON$$$$$$Y$$$20240705$$CN$US$US
240540972$24054097$2$F$20240101$20240917$20240705$20240920$EXP$$US-SA-2024SA196311$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240920$$MD$US$US
240540982$24054098$2$F$$20240702$20240705$20240705$PER$$US-ABBVIE-5826749$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240541001$24054100$1$I$$20240702$20240705$20240705$EXP$$NVSJ2024JP007889$NOVARTIS$$$$T$$Y$$$20240705$$MD$JP$JP
240541012$24054101$2$F$20180901$20240726$20240705$20240729$EXP$$US-UCBSA-2024033099$UCB$$0$YR$$M$Y$3.12$KG$20240729$$HP$US$US
240541021$24054102$1$I$20230824$20240703$20240705$20240705$EXP$$NVSC2024US129864$NOVARTIS$$64$YR$$F$Y$$$20240705$$HP$US$US
240541031$24054103$1$I$20190101$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032084$AUROBINDO$$23$YR$$F$Y$64$KG$20240705$$MD$FR$FR
240541041$24054104$1$I$20240625$20240625$20240705$20240705$EXP$$JP-ROCHE-10000010818$ROCHE$$7$DEC$E$$Y$$$20240705$$MD$JP$JP
240541051$24054105$1$I$20231101$20240628$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032364$AUROBINDO$$30$YR$$F$Y$68$KG$20240705$$MD$FR$FR
240541063$24054106$3$F$20180910$20240912$20240705$20240916$EXP$$US-GILEAD-2024-0679559$GILEAD$$31$YR$A$M$Y$$$20240916$$LW$US$US
240541071$24054107$1$I$20240323$20240628$20240705$20240705$EXP$$GB-AUROBINDO-AUR-APL-2024-032346$AUROBINDO$$$$$M$Y$78$KG$20240705$$CN$GB$GB
240541081$24054108$1$I$$20240704$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107160$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$63.05$KG$20240705$$CN$US$US
240541091$24054109$1$I$$20230828$20240705$20240705$PER$$US-AMGEN-USASP2023235512$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240541101$24054110$1$I$$20240228$20240705$20240705$PER$$US-AMGEN-USASP2024132843$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240541111$24054111$1$I$$20240603$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090547$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$66.13$KG$20240705$$PH$US$US
240541121$24054112$1$I$$20240704$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107130$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$78.47$KG$20240705$$CN$US$US
240541131$24054113$1$I$$20240704$20240705$20240705$EXP$$NVSC2024IE139150$NOVARTIS$$30$YR$$M$Y$$$20240705$$MD$IE$IE
240541141$24054114$1$I$$20240625$20240705$20240705$EXP$$US-862174955-ML2024-03722$Unknown Manufacturer$Kim JH, Shelat N, Ji CS. Apixaban and Rivaroxaban Anti-Xa Concentration Utilization in Clinical Practice. J Cardiovasc Pharmacol. 2023 Feb;81(Number 2): 165-170. doi:10.1097/FJC.0000000000001383.$69$YR$E$F$Y$$$20240705$$PH$US$US
240541151$24054115$1$I$$20240625$20240705$20240705$EXP$$US-862174955-ML2024-03710$Unknown Manufacturer$Ryan A, Jones M, Broadwell M. Cold and Confused: A Case of Suspected Adrenal Insufficiency After COVID-19. Am J Respir Crit Care Med. 2024 May 20;(209):$92$YR$E$F$Y$$$20240705$$HP$US$US
240541161$24054116$1$I$$20240625$20240705$20240705$EXP$$US-862174955-ML2024-03707$Unknown Manufacturer$Hamad HM, Miett T, Kopec S. Statin and Fenofibrate-Induced Rhabdomyolysis in Liver Transplant; A Case of Multiple Organ Dysfunction. Am J Respir Crit Care Med. 2024;209:$49$YR$A$M$Y$$$20240705$$HP$US$US
240541171$24054117$1$I$$20240625$20240705$20240705$EXP$$IR-862174955-ML2024-03711$Unknown Manufacturer$Lotfollahi L, Golmohammadi M, Gharehbagh FJ, Darazam IA. Self-induced Anuria with Diclofenac: An Interesting Case of Quadruple Whammy Acute Kidney Injury. International Journal of Medical Toxicology and Forensic Medicine. 2024 May 29;14(2): 1-5. doi:doi.org/10.32598/ijmtfm.v14i2.E43065.$66$YR$E$F$Y$$$20240705$$HP$IR$IR
240541181$24054118$1$I$20231001$20240625$20240705$20240705$EXP$$SA-862174955-ML2024-03708$Unknown Manufacturer$Kashif S, Al-Mani SY, Almani NY. Case Report A Rare Psoriasis Drug Eruption Induced by Levetiracetam: A Case Study from Saudi Arabia. International Journal of Pharmacology. 2024;20(4): 704-708. doi:10.3923/ijp.2024.704.708.$40$YR$A$F$Y$$$20240705$$HP$SA$SA
240541191$24054119$1$I$$20240625$20240705$20240705$EXP$$US-862174955-ML2024-03714$Unknown Manufacturer$Sasidharan S, Jatoi T, Milla C, Mallappallil M, Agarwal S, Puri I. Triple Whammy of Amlodipine, Carvedilol and Diphenhydramine Overdose. Am J Respir Crit Care Med. 2024;209: A5669.$27$YR$A$F$Y$$$20240705$$HP$US$US
240541201$24054120$1$I$$20240625$20240705$20240705$EXP$$US-862174955-ML2024-03713$Unknown Manufacturer$Bolivar SA, Holman P, Eng KJ, Betancourt J. Black Esophagus: A Case of Sevelamer Induced Esophagitis Presenting as a Gastrointestinal Bleed. Am J Respir Crit Care Med. 2024 May 21;209: A5690.$92$YR$E$M$Y$$$20240705$$HP$US$US
240541211$24054121$1$I$20200101$20240628$20240705$20240705$EXP$$NVSJ2024JP007803$NOVARTIS$$51$YR$$F$Y$$$20240705$$MD$JP$JP
240541221$24054122$1$I$$20240625$20240705$20240705$EXP$$US-862174955-ML2024-03719$Unknown Manufacturer$Kim JH, Shelat N, Ji CS. Apixaban and Rivaroxaban Anti-Xa Concentration Utilization in Clinical Practice. J Cardiovasc Pharmacol. 2023 Feb;81(Number 2): 165-170. doi:10.1097/FJC.0000000000001383.$45$YR$A$M$Y$$$20240705$$PH$US$US
240541231$24054123$1$I$$20240625$20240705$20240705$EXP$$US-862174955-ML2024-03720$Unknown Manufacturer$Kim JH, Shelat N, Ji CS. Apixaban and Rivaroxaban Anti-Xa Concentration Utilization in Clinical Practice. J Cardiovasc Pharmacol. 2023 Feb;81(Number 2): 165-170. doi:10.1097/FJC.0000000000001383.$79$YR$E$F$Y$$$20240705$$PH$US$US
240541241$24054124$1$I$$20230627$20240705$20240705$PER$$US-AMGEN-USASP2023235505$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240541251$24054125$1$I$$20230429$20240705$20240705$PER$$US-AMGEN-USASP2023235592$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240541261$24054126$1$I$20240625$20240628$20240705$20240705$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-020499$UNITED THERAPEUTICS$$77$YR$$F$Y$$$20240705$$$JP$JP
240541271$24054127$1$I$$20240626$20240705$20240705$EXP$$IR-MPL-000043$MLV PHARMA$$46$YR$A$F$Y$$$20240629$$MD$IR$IR
240541281$24054128$1$I$$20240626$20240705$20240705$EXP$$IR-MPL-000044$MLV PHARMA$$$$A$F$Y$$$20240629$$MD$IR$IR
240541292$24054129$2$F$$20240730$20240705$20240802$PER$$US-ROCHE-10000015014$ROCHE$$$$$$Y$$$20240802$$CN$US$US
240541301$24054130$1$I$$20231017$20240705$20240705$PER$$US-AMGEN-USASP2023235513$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240541311$24054131$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5826055$ABBVIE$$$$$$Y$$$20240705$$HP$US$US
240541321$24054132$1$I$$20240704$20240705$20240705$EXP$$NVSJ2024JP008177$NOVARTIS$$$$$$Y$$$20240705$$HP$JP$JP
240541331$24054133$1$I$$20240627$20240705$20240705$EXP$$CA-TAKEDA-2024TUS046408$TAKEDA$$$$$F$Y$$$20240705$$CN$CA$CA
240541342$24054134$2$F$20240628$20240813$20240705$20240816$EXP$$NVSC2024FR139160$NOVARTIS$$40$YR$$F$Y$52$KG$20240816$$MD$FR$FR
240541351$24054135$1$I$$20240626$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR081220$VIIV$$$$$F$Y$$$20240705$$CN$US$US
240541362$24054136$2$F$20240702$20240801$20240705$20240807$EXP$$CA-ABBVIE-5825202$ABBVIE$$$$A$M$Y$$$20240807$$CN$CA$CA
240541372$24054137$2$F$$20240813$20240705$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002810$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$HP$US$US
240541381$24054138$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5825716$ABBVIE$$26$YR$$F$Y$$$20240705$$HP$US$US
240541391$24054139$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5825717$ABBVIE$$61$YR$$F$Y$$$20240705$$HP$US$US
240541404$24054140$4$F$$20240725$20240705$20240807$30DAY$$US-JNJFOC-20240669316$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$HP$US$US
240541411$24054141$1$I$20240501$20240628$20240705$20240705$PER$$US-SA-2024SA194881$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240705$$MD$US$US
240541421$24054142$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA194954$SANOFI AVENTIS$$$$A$F$Y$73.482$KG$20240705$$MD$US$US
240541431$24054143$1$I$20240101$20240627$20240705$20240705$PER$$US-SA-2024SA196416$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240705$$MD$US$US
240541441$24054144$1$I$$20231019$20240705$20240705$PER$$US-AMGEN-USASP2023235517$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240541451$24054145$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131277$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240541461$24054146$1$I$$20240119$20240705$20240705$PER$$US-AMGEN-USASP2024131927$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240541471$24054147$1$I$$20240514$20240705$20240705$PER$$US-AMGEN-USASP2024131750$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240541481$24054148$1$I$$20240221$20240705$20240705$PER$$US-AMGEN-USASP2024131726$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240541492$24054149$2$F$$20240725$20240705$20240801$EXP$$US-JNJFOC-20240678771$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240802$$HP$US$US
240541501$24054150$1$I$20240603$20240701$20240705$20240705$EXP$$US-ABBVIE-5799363$ABBVIE$$56$YR$$F$Y$$$20240705$$CN$US$US
240541513$24054151$3$F$$20240802$20240705$20240809$EXP$$US-ABBVIE-5826082$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
240541521$24054152$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5825719$ABBVIE$$39$YR$$$Y$$$20240705$$HP$US$US
240541532$24054153$2$F$20240520$20240715$20240705$20240722$PER$$AE-REGENERON PHARMACEUTICALS, INC.-2024-093974$REGENERON$$$$$M$Y$$$20240722$$MD$AE$AE
240541541$24054154$1$I$20240608$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032343$AUROBINDO$$31$YR$$M$Y$$$20240705$$MD$FR$FR
240541552$24054155$2$F$20240611$20240617$20240705$20240904$PER$$US-ROCHE-10000006502$ROCHE$$49$YR$A$F$Y$94.35$KG$20240904$$CN$US$US
240541571$24054157$1$I$$20240612$20240705$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002811$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
240541581$24054158$1$I$20240604$20240610$20240705$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002758$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240705$$CN$US$US
240541591$24054159$1$I$$20240702$20240705$20240705$EXP$$CA-ABBVIE-5813950$ABBVIE$$$$E$F$Y$$$20240705$$CN$CA$CA
240541601$24054160$1$I$20240625$20240628$20240705$20240705$EXP$$US-MALLINCKRODT-MNK202404307$MALLINCKRODT$$16$MON$I$$Y$$$20240705$$HP$US$US
240541611$24054161$1$I$$20240626$20240705$20240705$EXP$$US-GSK-US2024AMR081035$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240541621$24054162$1$I$20230901$20240701$20240705$20240705$EXP$$US-ABBVIE-5826603$ABBVIE$$31$YR$$F$Y$$$20240705$$CN$US$US
240541632$24054163$2$F$$20240711$20240705$20240715$EXP$$US-ABBVIE-5747589$ABBVIE$$$$$M$Y$77$KG$20240715$$CN$US$US
240541643$24054164$3$F$$20240809$20240705$20240822$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13293$IPSEN$$68$YR$E$F$Y$52.61$KG$20240822$$CN$US$US
240541651$24054165$1$I$$20240612$20240705$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002812$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240541661$24054166$1$I$20231010$20240626$20240705$20240705$EXP$$AT-CELLTRION INC.-2024AT015775$CELLTRION$$$$$$Y$$$20240705$$MD$AT$AT
240541671$24054167$1$I$20240425$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032154$AUROBINDO$$89$YR$$M$Y$$$20240705$$PH$FR$FR
240541681$24054168$1$I$$20240404$20240705$20240705$PER$$US-AMGEN-USASP2024133306$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240541692$24054169$2$F$$20240802$20240705$20240806$PER$$US-AMGEN-USASP2024131264$AMGEN$$47$YR$A$F$Y$$$20240806$$MD$US$US
240541701$24054170$1$I$20240414$20240626$20240705$20240705$EXP$FR-AFSSAPS-TO2024000752$FR-TEVA-VS-3215092$TEVA$$63$YR$$M$Y$100$KG$20240705$$MD$FR$FR
240541711$24054171$1$I$$20221214$20240705$20240705$PER$$US-AMGEN-USASP2022230362$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240541721$24054172$1$I$20240701$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024133386$AMGEN$$69$YR$E$F$Y$$$20240705$$CN$US$US
240541731$24054173$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281437578480-ZYWPV$GB-RDY-SPO/GBR/24/0009630$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240541741$24054174$1$I$$20240625$20240705$20240705$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004788$BIOCON$$$$$$Y$$$20240705$$PH$CA$CA
240541751$24054175$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281436108240-JYFTK$GB-RDY-SPO/GBR/24/0009633$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240541761$24054176$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281443140430-YKFLG$GB-RDY-SPO/GBR/24/0009628$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240541771$24054177$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281504408720-TKDCS$GB-RDY-SPO/GBR/24/0009626$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240541781$24054178$1$I$$20240624$20240705$20240705$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05715$LUPIN$Holbert K. Multiorgan failure from heat stroke in a person taking Glycopyrrolate. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7329$24$YR$$M$Y$$$20240705$$HP$US$US
240541791$24054179$1$I$20240608$20240624$20240705$20240705$EXP$$CN-CHEPLA-2024008110$CHEPLAPHARM$$52$YR$A$M$Y$65$KG$20240705$$CN$COUNTRY NOT SPECIFIED$CN
240541801$24054180$1$I$20240207$20240627$20240705$20240705$EXP$$HR-CELLTRION INC.-2024HR015835$CELLTRION$$$$$$Y$$$20240705$$MD$HR$HR
240541811$24054181$1$I$$20240702$20240705$20240705$PER$$US-TAKEDA-2024TUS067578$TAKEDA$$$$$M$Y$$$20240705$$MD$US$US
240541821$24054182$1$I$20200727$20240702$20240705$20240705$EXP$$CA-TAKEDA-2024TUS067407$TAKEDA$$37$YR$$M$Y$$$20240705$$MD$CA$CA
240541831$24054183$1$I$20240610$20240612$20240705$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002813$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240705$$CN$US$US
240541842$24054184$2$F$$20240724$20240705$20240802$30DAY$$US-GSK-US2024080424$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$PH$US$US
240541851$24054185$1$I$20240531$20240610$20240705$20240705$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002764$ACADIA PHARMACEUTICALS$$63$YR$$M$Y$$$20240705$$CN$US$US
240541871$24054187$1$I$$20240704$20240705$20240705$PER$$US-HALEON-2185550$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240541881$24054188$1$I$$20240628$20240705$20240705$EXP$$GB-AUROBINDO-AUR-APL-2024-032434$AUROBINDO$$$$$$Y$$$20240705$$CN$GB$GB
240541891$24054189$1$I$$20240621$20240705$20240705$EXP$$ZA-ELI_LILLY_AND_COMPANY-ZA202406017617$ELI LILLY AND CO$$$$$M$Y$$$20240705$$CN$ZA$ZA
240541903$24054190$3$F$20240109$20240726$20240705$20240731$EXP$FR-AFSSAPS-ST2024001087$FR-ELI_LILLY_AND_COMPANY-FR202406015918$ELI LILLY AND CO$$78$YR$E$F$Y$45.8$KG$20240731$$CN$FR$FR
240541911$24054191$1$I$20240618$20240621$20240705$20240705$EXP$GB-MHRA-MED-202406211843038350-FRVDB$GB-ELI_LILLY_AND_COMPANY-GB202406015859$ELI LILLY AND CO$$59$YR$A$F$Y$90$KG$20240705$$CN$GB$GB
240541921$24054192$1$I$20240619$20240621$20240705$20240705$EXP$GB-MHRA-MED-202406211144226160-MGVTW$GB-ELI_LILLY_AND_COMPANY-GB202406014984$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240705$$CN$GB$GB
240541931$24054193$1$I$$20240621$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015604$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240705$$CN$US$US
240541941$24054194$1$I$20240614$20240627$20240705$20240705$EXP$$SE-AUROBINDO-AUR-APL-2024-032408$AUROBINDO$$46$YR$$F$Y$$$20240705$$MD$SE$SE
240541952$24054195$2$F$$20240730$20240705$20240802$PER$$US-AMGEN-USASP2024132829$AMGEN$$78$YR$E$F$Y$$$20240802$$CN$US$US
240541961$24054196$1$I$$20240621$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406015538$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240705$$CN$US$US
240541971$24054197$1$I$$20240229$20240705$20240705$PER$$US-AMGEN-USASP2024131922$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240541981$24054198$1$I$20240626$20240702$20240705$20240705$EXP$$NVSC2024US139044$NOVARTIS$$$$$F$Y$$$20240705$$HP$US$US
240541992$24054199$2$F$$20240904$20240705$20240904$PER$$NVSC2024US139119$NOVARTIS$$$$$M$Y$$$20240904$$MD$US$US
240542001$24054200$1$I$$20240703$20240705$20240705$PER$$US-BAUSCH-BL-2024-010294$BAUSCH AND LOMB$$26$YR$$F$Y$$$20240705$$MD$US$US
240542012$24054201$2$F$$20240708$20240705$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-032534$AUROBINDO$$$$$$Y$$$20240718$$CN$GB$GB
240542021$24054202$1$I$$20240605$20240705$20240705$PER$$US-009507513-2406USA002207$MERCK$Alagha Z, Bills E, Al-Hiari M, Abdeen AM, Zeid F. Survival Against the Odds-Hemophagocytic Lymphohistiocytosis Amidst the Shadows of Disseminated Histoplasmosis: A Case Report and Literature Review. Journal of investigative medicine high impact case reports. 2024;12$57$YR$$F$Y$$$20240705$$MD$US$US
240542031$24054203$1$I$20240621$20240621$20240705$20240705$EXP$$VN-ROCHE-10000016689$ROCHE$$61$YR$A$M$Y$$$20240705$$MD$VN$VN
240542041$24054204$1$I$20240703$20240703$20240705$20240705$PER$$US-JNJFOC-20240710230$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240705$$CN$US$US
240542051$24054205$1$I$$20240701$20240705$20240705$EXP$$MX-JNJFOC-20240705581$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$MX$MX
240542061$24054206$1$I$20240102$20240624$20240705$20240705$EXP$$CN-ROCHE-3577655$ROCHE$$$$N$F$Y$$$20240705$$MD$CN$CN
240542072$24054207$2$F$$20240708$20240705$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05742$LUPIN$$$$$$Y$$$20240723$$CN$US$US
240542081$24054208$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA194276$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240542091$24054209$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA193416$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240705$$MD$US$US
240542101$24054210$1$I$20060101$20240628$20240705$20240705$EXP$$US-SA-2024SA195953$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240705$$MD$US$US
240542111$24054211$1$I$$20240328$20240705$20240705$PER$$US-AMGEN-USASP2024133377$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240542121$24054212$1$I$$20240528$20240705$20240705$PER$$US-AMGEN-USASP2024132194$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240542133$24054213$3$F$20240615$20240808$20240705$20240813$PER$$US-AMGEN-USASP2024130348$AMGEN$$76$YR$E$F$Y$$$20240812$$CN$US$US
240542142$24054214$2$F$$20240903$20240705$20240918$EXP$$GB-PERRIGO-24GB006292$PERRIGO$$53$YR$$M$Y$$$20240918$$CN$GB$GB
240542151$24054215$1$I$$20240703$20240705$20240705$PER$$US-BAYER-2024A096347$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240542161$24054216$1$I$20240101$20240702$20240705$20240705$PER$$US-SA-2024SA197292$SANOFI AVENTIS$$$$$$Y$$$20240705$$PH$US$US
240542171$24054217$1$I$20240101$20240702$20240705$20240705$EXP$$US-UCBSA-2024033982$UCB$$$$$M$Y$$$20240705$$HP$US$US
240542181$24054218$1$I$$20240628$20240705$20240705$EXP$$GB-AUROBINDO-AUR-APL-2024-032646$AUROBINDO$$$$$$Y$$$20240705$$CN$GB$GB
240542201$24054220$1$I$$20240703$20240705$20240705$30DAY$$US-GSK-US2024AMR083265$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$HP$US$US
240542211$24054221$1$I$$20240625$20240705$20240705$EXP$$JP-SMPA-2024SMP009773$SUNOVION$$$$$$Y$$$20240705$$CN$JP$JP
240542221$24054222$1$I$$20240703$20240705$20240705$PER$$US-BAYER-2024A096350$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240542231$24054223$1$I$20240611$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107060$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240705$$CN$US$US
240542241$24054224$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05762$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240542251$24054225$1$I$$20240701$20240705$20240705$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107309$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240705$$CN$JP$JP
240542261$24054226$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05837$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240542271$24054227$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281436490710-YBJTK$GB-RDY-SPO/GBR/24/0009582$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240542281$24054228$1$I$20221129$20240627$20240705$20240705$EXP$$ES-AUROBINDO-AUR-APL-2023-002983$AUROBINDO$$69$YR$$M$Y$59.65$KG$20240705$$MD$ES$ES
240542292$24054229$2$F$$20240807$20240705$20240813$EXP$$JP-SMPA-2024SMP009902$SUNOVION$$$$$$Y$$$20240813$$CN$JP$JP
240542301$24054230$1$I$$20240628$20240705$20240705$EXP$$GB-AUROBINDO-AUR-APL-2024-032471$AUROBINDO$$$$$$Y$$$20240705$$CN$GB$GB
240542311$24054231$1$I$$20240627$20240705$20240705$PER$$US-ALXN-202406USA001875US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240705$$CN$US$US
240542321$24054232$1$I$20240110$20240626$20240705$20240705$EXP$IT-MINISAL02-991135$IT-TEVA-VS-3215138$TEVA$$58$YR$$M$Y$88$KG$20240705$$MD$IT$IT
240542331$24054233$1$I$20221211$20240627$20240705$20240705$EXP$DE-EMA-DD-20240626-7482641-081629$DE-BIOCON BIOLOGICS LIMITED-BBL2024004843$BIOCON$$$$$$Y$$$20240705$$MD$DE$DE
240542341$24054234$1$I$$20240622$20240705$20240705$PER$$US-SA-2024SA188366$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240705$$MD$US$US
240542351$24054235$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193476$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240705$$MD$US$US
240542361$24054236$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA194742$SANOFI AVENTIS$$64$YR$A$F$Y$61.688$KG$20240705$$MD$US$US
240542373$24054237$3$F$20240101$20240821$20240705$20240905$PER$$US-SA-2024SA193224$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240905$$MD$US$US
240542381$24054238$1$I$$20240621$20240705$20240705$PER$$US-SA-2024SA189094$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240542391$24054239$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193349$SANOFI AVENTIS$$$$$M$Y$$$20240705$$CN$US$US
240542401$24054240$1$I$20240625$20240701$20240705$20240705$PER$$US-SA-2024SA196430$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240705$$CN$US$US
240542411$24054241$1$I$20240601$20240620$20240705$20240705$PER$$US-SA-2024SA188396$SANOFI AVENTIS$$$$A$M$Y$65.77$KG$20240705$$MD$US$US
240542421$24054242$1$I$20240101$20240702$20240705$20240705$PER$$US-SA-2024SA197691$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240705$$CN$US$US
240542431$24054243$1$I$$20240628$20240705$20240705$EXP$$US-SA-2024SA195837$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240705$$MD$US$US
240542441$24054244$1$I$20240501$20240621$20240705$20240705$PER$$US-SA-2024SA189340$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240705$$MD$US$US
240542451$24054245$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA194977$SANOFI AVENTIS$$$$A$F$Y$105$KG$20240705$$MD$US$US
240542461$24054246$1$I$20240415$20240627$20240705$20240705$EXP$$FR-AUROBINDO-AUR-APL-2024-032320$AUROBINDO$$63$YR$$M$Y$86$KG$20240705$$MD$FR$FR
240542471$24054247$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05981$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240542481$24054248$1$I$$20240624$20240705$20240705$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05722$LUPIN$Bhatia S, Jamil A, Sharif M, Skenderi S. Cardiovascular collapse shortly after beta blockers in atrial fibrillation complicated thyroid storm. American Journal of Respiratory and Critical Care Medicine. 2024;209$49$YR$$M$Y$$$20240705$$HP$US$US
240542491$24054249$1$I$$20240625$20240705$20240705$EXP$$US-GSK-US2024AMR080172$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$MD$US$US
240542501$24054250$1$I$$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A149198$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240542511$24054251$1$I$20240406$20240620$20240705$20240705$EXP$$PK-ROCHE-10000016782$ROCHE$$77$YR$E$M$Y$$$20240705$$CN$PK$PK
240542522$24054252$2$F$$20240628$20240705$20240801$EXP$$US-AstraZeneca-2024A151496$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
240542531$24054253$1$I$$20240701$20240705$20240705$EXP$$ZA-AstraZeneca-2024A151986$ASTRAZENECA$$78$YR$$F$Y$$$20240705$$CN$ZA$
240542542$24054254$2$F$$20240709$20240705$20240717$EXP$$JP-AstraZeneca-2024A150700$ASTRAZENECA$$$$$$Y$$$20240717$$PH$JP$
240542552$24054255$2$F$20240606$20240807$20240705$20240819$EXP$$GB-AUROBINDO-AUR-APL-2024-032301$AUROBINDO$$89$YR$$F$Y$55$KG$20240819$$PH$GB$GB
240542563$24054256$3$F$$20240813$20240705$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-032068$AUROBINDO$Singh AD, Kurin M. An Unusual Case of Refractory Esophagitis and Esophageal Diverticulum. Digestive Diseases and Sciences. 2024;69(6):1913-14$76$YR$$F$Y$$$20240827$$MD$US$US
240542571$24054257$1$I$$20230329$20240705$20240705$PER$$US-AMGEN-USASP2023235590$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240542581$24054258$1$I$$20240308$20240705$20240705$PER$$US-AMGEN-USASP2024132995$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240542592$24054259$2$F$20231201$20240905$20240705$20240911$EXP$$NVSC2024IL139093$NOVARTIS$$$$$F$Y$$$20240911$$CN$IL$IL
240542601$24054260$1$I$$20240626$20240705$20240705$EXP$$DK-AJANTA-2024AJA00120$AJANTA PHARMA$Nordal T, Burcharth J, Cordtz AC, Storm N, Jensen TK.Cholestyramine crystal deposits as a possible cause of small bowel perforation.PHYSICIANS` JOURNAL.17-JUN-2024;186 (25)$70$YR$E$F$Y$$$20240705$$HP$DK$DK
240542612$24054261$2$F$20240101$20240828$20240705$20240905$EXP$$CA-CELLTRION INC.-2024CA016178$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
240542621$24054262$1$I$$20231127$20240705$20240705$PER$$US-ABBVIE-5827771$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240542631$24054263$1$I$$20231104$20240705$20240705$PER$$US-ABBVIE-5827613$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240542641$24054264$1$I$20240627$20240627$20240705$20240705$EXP$$US-JNJFOC-20240674945$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240705$$MD$US$US
240542651$24054265$1$I$$20240628$20240705$20240705$EXP$$NVSC2024GB135889$NOVARTIS$$$$$F$Y$$$20240705$$CN$GB$GB
240542661$24054266$1$I$$20240626$20240705$20240705$EXP$$CA-TEVA-VS-3214050$TEVA$$75$YR$$F$Y$$$20240705$$CN$CA$CA
240542671$24054267$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05969$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240542681$24054268$1$I$$20240701$20240705$20240705$EXP$$US-CHATTEMPRD-2024OHG022838$CHATTEM$$$$E$M$Y$$$20240705$$CN$US$US
240542694$24054269$4$F$20240628$20240828$20240705$20240910$EXP$$US-CHATTEMPRD-2024OHG022581$CHATTEM$$47$YR$A$F$Y$$$20240910$$CN$US$US
240542702$24054270$2$F$20240101$20240709$20240705$20240717$EXP$$US-Valinor Pharma, LLC-VLR202406-000086$Valinor Pharma$$48$YR$A$F$Y$106.59$KG$20240717$$HP$US$
240542711$24054271$1$I$20240620$20240624$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101743$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240705$$HP$US$US
240542722$24054272$2$F$$20240704$20240705$20240712$PER$$US-ROCHE-10000013308$ROCHE$$$$A$M$Y$97.07$KG$20240712$$CN$US$US
240542731$24054273$1$I$$20240626$20240705$20240705$EXP$$CA-TEVA-VS-3214299$TEVA$$34$YR$$F$Y$$$20240705$$CN$CA$CA
240542741$24054274$1$I$$20240704$20240705$20240705$EXP$$IT-GILEAD-2024-0679603$GILEAD$$$$$M$Y$$$20240705$$MD$IT$IT
240542753$24054275$3$F$$20240708$20240705$20240716$EXP$$CA-CELLTRION INC.-2024CA016214$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
240542761$24054276$1$I$$20240626$20240705$20240705$EXP$$CA-TEVA-VS-3214326$TEVA$$69$YR$$F$Y$$$20240705$$HP$CA$CA
240542771$24054277$1$I$$20240625$20240705$20240705$EXP$$US-862174955-ML2024-03712$Unknown Manufacturer$Lam E, Santos C, Patrawalla AS. A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose. Am J Respir Crit Care Med. 2024;209:$32$YR$A$F$Y$$$20240705$$HP$US$US
240542793$24054279$3$F$$20240822$20240705$20240827$PER$$US-ROCHE-10000008090$ROCHE$Sharma P, Tahiru M, Li H, Bansari A, Baskaran N. A case of ocular diffuse large B-cell lymphoma unveiled through Pars Plana Vitrectomy: surgical insight and multidisciplinary management. Journal of Surgical Case Reports. 2024-Jun-01;2024 (6): doi:10.1093/jscr/rjae399.$74$YR$E$M$Y$$$20240827$$HP$US$US
240542801$24054280$1$I$20170408$20240701$20240705$20240705$EXP$FR-AFSSAPS-ST2024001111$FR-ASTELLAS-2024EU006515$ASTELLAS$$17$YR$$F$Y$50$KG$20240705$$CN$FR$FR
240542811$24054281$1$I$$20240628$20240705$20240705$EXP$$GB-AUROBINDO-AUR-APL-2024-032518$AUROBINDO$$$$$$Y$$$20240705$$CN$GB$GB
240542821$24054282$1$I$$20240701$20240705$20240705$EXP$$US-CHATTEMPRD-2024OHG022808$CHATTEM$$$$E$F$Y$$$20240705$$LW$US$US
240542831$24054283$1$I$$20240701$20240705$20240705$EXP$$US-CHATTEMPRD-2024OHG022824$CHATTEM$$$$$F$Y$$$20240705$$LW$US$US
240542841$24054284$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193480$SANOFI AVENTIS$$$$T$M$Y$59$KG$20240705$$MD$US$US
240542851$24054285$1$I$$20240626$20240705$20240705$EXP$$CA-TEVA-VS-3214419$TEVA$$11$YR$$M$Y$37$KG$20240705$$HP$CA$CA
240542861$24054286$1$I$$20240621$20240705$20240705$PER$$US-SA-2024SA188260$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240705$$MD$US$US
240542871$24054287$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06029$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240542881$24054288$1$I$$20240626$20240705$20240705$EXP$$CA-TEVA-VS-3214424$TEVA$$77$YR$$M$Y$66$KG$20240705$$HP$CA$CA
240542892$24054289$2$F$$20240624$20240705$20240705$PER$$US-ROCHE-10000013879$ROCHE$Song E. Case Report: Approaches for managing resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplantation recipients. Frontiers in Pediatrics.2024;1-8.DOI: 10.3389/fped.2024.1394006.$12$YR$T$M$Y$$$20240705$$HP$US$US
240542901$24054290$1$I$20240601$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002984$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240705$$CN$US$US
240542911$24054291$1$I$$20240625$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406018999$ELI LILLY AND CO$$$$$$Y$$$20240705$$CN$US$US
240542921$24054292$1$I$$20240622$20240705$20240705$EXP$GB-MHRA-MED-202406221548436280-DGCLF$GB-ELI_LILLY_AND_COMPANY-GB202406015853$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$GB$GB
240542932$24054293$2$F$$20240806$20240705$20240813$30DAY$$JP-JNJFOC-20240711869$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$PH$JP$JP
240542941$24054294$1$I$$20240701$20240705$20240705$EXP$$US-CHATTEMPRD-2024OHG022840$CHATTEM$$$$$M$Y$$$20240705$$LW$US$US
240542964$24054296$4$F$20240626$20240821$20240705$20240831$EXP$$US-GSK-US2024AMR080757$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240831$$CN$US$US
240542973$24054297$3$F$20240627$20240731$20240705$20240806$PER$$US-BIOGEN-2024BI01271989$BIOGEN$$61$YR$$M$Y$$$20240806$$CN$US$US
240542981$24054298$1$I$$20240628$20240705$20240705$EXP$$GB-AUROBINDO-AUR-APL-2024-032634$AUROBINDO$$$$$$Y$$$20240705$$CN$GB$GB
240543001$24054300$1$I$$20240704$20240705$20240705$EXP$$US-ROCHE-10000016595$ROCHE$Puthumana R, Koch A, Schettino C, Vehar S. Asymptomatic and slowly progressive anti-MDA5 ILD: A report of three cases deviating from a notoriously rapidly progressive ILD. Respiratory Medicine Case Reports. 2024-Jan;51:1-9. doi:10.1016/j.rmcr.2024.102072.$54$YR$A$F$Y$$$20240705$$HP$US$US
240543021$24054302$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131086$AMGEN$$75$YR$E$$Y$$$20240705$$CN$US$US
240543031$24054303$1$I$$20240626$20240705$20240705$EXP$$US-AMGEN-USASP2024127117$AMGEN$Takla A.; Eid F.; Eid M.M. et.al.. Anterior STEMI in a 25-year-old with Cogan syndrome. Journal of Cardiology Cases. 2024;30 (1):9-11$25$YR$A$M$Y$$$20240705$$MD$US$US
240543043$24054304$3$F$20240601$20240829$20240705$20240904$EXP$$CN-SA-2024SA195800$SANOFI AVENTIS$$18$YR$A$$Y$$$20240904$$CN$CN$CN
240543061$24054306$1$I$$20240627$20240705$20240705$EXP$$US-AMGEN-USASP2024128058$AMGEN$Chiou D.; Mooney B.H.; Shi B. et.al. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240705$$MD$US$US
240543071$24054307$1$I$$20240621$20240705$20240705$PER$$US-SA-2024SA187986$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240705$$CN$US$US
240543091$24054309$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA192662$SANOFI AVENTIS$$$$A$F$Y$104.3$KG$20240705$$MD$US$US
240543101$24054310$1$I$$20240621$20240705$20240705$PER$$US-SA-2024SA188985$SANOFI AVENTIS$$$$A$M$Y$$$20240705$$MD$US$US
240543121$24054312$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA196533$SANOFI AVENTIS$$$$E$M$Y$123.1$KG$20240705$$MD$US$US
240543131$24054313$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46684$$FDA-CTU$$66$YR$$M$N$$$20240703$N$$US$
240543141$24054314$1$I$$20240627$20240705$20240705$EXP$$US-SA-2024SA194973$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240705$$MD$US$US
240543151$24054315$1$I$20240101$20240621$20240705$20240705$PER$$US-SA-2024SA189004$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240705$$MD$US$US
240543161$24054316$1$I$$20240624$20240705$20240705$EXP$$NL-UCBSA-2024033880$UCB$Van der Veen S, Eggink H, Elting JW, Sival D, Verschuuren-Bemelmans CC, de Koning TJ et al. The natural history of progressive myoclonus ataxia. Neurobiology of Disease. 2024;199:1-12$$$$F$Y$$$20240705$$HP$NL$NL
240543171$24054317$1$I$$20240626$20240705$20240705$PER$$US-ROCHE-10000014502$ROCHE$$$$$F$Y$$$20240705$$CN$US$US
240543181$24054318$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A149957$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240543192$24054319$2$F$$20240705$20240705$20240708$EXP$$AU-AstraZeneca-2024A154332$ASTRAZENECA$$60$YR$$M$Y$$$20240708$$HP$AU$
240543201$24054320$1$I$$20240626$20240705$20240705$30DAY$$US-GSK-US2024AMR080178$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240543212$24054321$2$F$$20240905$20240705$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05786$LUPIN$$$$$$Y$$$20240920$$CN$US$US
240543222$24054322$2$F$$20240726$20240705$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05845$LUPIN$$$$$$Y$$$20240819$$CN$US$US
240543231$24054323$1$I$20240323$20240703$20240705$20240705$EXP$$US-AstraZeneca-2024A153238$ASTRAZENECA$$33079$DY$$F$Y$$$20240705$$MD$US$
240543241$24054324$1$I$20240202$20240628$20240705$20240705$EXP$$FR-AstraZeneca-2024A149391$ASTRAZENECA$$82$YR$$M$Y$38$KG$20240705$$MD$FR$
240543251$24054325$1$I$$20240628$20240705$20240705$EXP$$GB-AstraZeneca-2024A149671$ASTRAZENECA$$62$YR$$M$Y$$$20240705$$MD$GB$
240543261$24054326$1$I$$20240628$20240705$20240705$EXP$$CA-AstraZeneca-2024A150380$ASTRAZENECA$$46$YR$$M$Y$166$KG$20240705$$MD$CA$
240543271$24054327$1$I$20240507$20240610$20240705$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002769$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240705$$CN$US$US
240543281$24054328$1$I$20240509$20240627$20240705$20240705$EXP$$GR-KOANAAP-SML-GR-2024-00675$Unknown Manufacturer$$71$YR$E$M$Y$64$KG$20240705$$MD$GR$GR
240543291$24054329$1$I$20230609$20240629$20240705$20240705$EXP$$ES-KOANAAP-SML-ES-2024-00684$Unknown Manufacturer$$72$YR$E$F$Y$58$KG$20240705$$MD$ES$ES
240543301$24054330$1$I$20240625$20240703$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106794$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240705$$CN$US$US
240543321$24054332$1$I$20240623$20240625$20240705$20240705$EXP$GB-MHRA-MED-202406251525027570-VMBDF$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-06111$HIKMA$$$$$$Y$$$20240705$$CN$GB$GB
240543331$24054333$1$I$20210101$20240626$20240705$20240705$EXP$$US-AMGEN-USASP2024126321$AMGEN$Maakaron. J.. EFFICACY AND SAFETY OF THE G-CSF BIOSIMILAR FILGRASTIM-AAFI COMPARED TO FILGRASTIM: A REPORT FROM THE NATIONAL MARROW DONOR PROGRAM. Bone Marrow Transplantation. 2023;58 (1):603-604$$$$$Y$$$20240705$$HP$US$US
240543341$24054334$1$I$$20231018$20240705$20240705$PER$$US-AMGEN-USASP2023235534$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240543351$24054335$1$I$$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024133127$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240543361$24054336$1$I$$20230607$20240705$20240705$PER$$US-AMGEN-USASP2023235595$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240543371$24054337$1$I$$20240625$20240705$20240705$EXP$$MX-ABBVIE-5828134$ABBVIE$$$$$M$Y$$$20240705$$MD$MX$MX
240543382$24054338$2$F$$20240701$20240705$20240710$PER$$US-ROCHE-3576141$ROCHE$$52$YR$A$F$Y$$$20240710$$CN$US$US
240543391$24054339$1$I$$20240625$20240705$20240705$EXP$CA-MHPD-E2B_07059527$CA-Accord-432357$ACCORD$$39$YR$A$F$Y$$$20240705$$HP$CA$CA
240543402$24054340$2$F$20210101$20240719$20240705$20240730$EXP$$FR-Accord-432560$ACCORD$Solignac J, Boschi C, Pernin V, Fouilloux V, Motte A, Aherfi S, et al. The question of screening organ donors for hepatitis e virus: a case report of transmission by kidney transplantation in France and a review of the literature. Virology journal. 2024;21(1):136. DOI: 10.1186/s12985-024-02401-2.$6$DEC$A$F$Y$64$KG$20240730$$MD$FR$FR
240543411$24054341$1$I$$20240625$20240705$20240705$EXP$CA-MHPD-001081609$CA-Accord-432348$ACCORD$$16$YR$T$M$Y$75$KG$20240705$$HP$CA$CA
240543422$24054342$2$F$$20240628$20240705$20240710$EXP$$FR-Accord-432613$ACCORD$Diot T, Mouchabac S, Giraud P, Ferreri F, Adrien V. Electroconvulsive therapy for major depressive disorder induced by androgen deprivation therapy: Report of 2 cases. Journal of ECT. 2024;40(2):E7-8.$76$YR$E$M$Y$$$20240710$$MD$FR$FR
240543431$24054343$1$I$20240618$20240620$20240705$20240705$30DAY$$US-AMGEN-USASL2024123429$AMGEN$$24$YR$A$M$Y$$$20240705$$CN$US$US
240543441$24054344$1$I$20230601$20240701$20240705$20240705$EXP$$RO-AMGEN-ROUSP2024131145$AMGEN$Sanchez-monge S. L.; Navarro C. F.; Gonzalez M. V. et al.. SURGICAL APPROACH IN AN ULCERATIVE COLITIS PATIENT UNRESPONSIVE TO MAXIMAL THERAPY. Acta Medica Marisiensis. 2024;70(SUPPL_3):299$26$YR$A$M$Y$$$20240705$$HP$RO$RO
240543451$24054345$1$I$$20240627$20240705$20240705$EXP$$US-AMGEN-USASP2024128333$AMGEN$Chiou C.; Mooney B.H.; Shi B. et.al.. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240705$$MD$US$US
240543461$24054346$1$I$20230822$20240625$20240705$20240705$EXP$$BR-Accord-432847$ACCORD$$60$YR$A$F$Y$48.4$KG$20240705$$PH$BR$BR
240543471$24054347$1$I$20240529$20240626$20240705$20240705$PER$$US-TEVA-VS-3214577$TEVA$$33$YR$$F$Y$$$20240705$$CN$US$US
240543482$24054348$2$F$20240601$20240805$20240705$20240806$PER$$US-ALXN-202406USA001984US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240543492$24054349$2$F$$20240711$20240705$20240723$EXP$$DE-TEVA-VS-3212979$TEVA$Sobel J, Ruppel R, Tremel C, Schmitt-Grohe S, Schnell A, Wolfle J, et al. Life threatening infection with a highly resistant Achromobacter xylosoxidans strain. J-Cystic-Fibrosis 2024; 23 (Suppl. 1) S138 (plus Poster) abstr. P227; Sobel J, Ruppel R, Tremel C, Schmitt-Grohe S, Schnell A, Wolfle J, et al. Life threatening infection with a highly resistant Achromobacter xylosoxidans strain. J-Cystic-Fibrosis 2024; 23 (Suppl. 1) S138 (plus Poster) abstr. P227.$16$YR$$F$Y$$$20240723$$HP$DE$DE
240543501$24054350$1$I$20240609$20240702$20240705$20240705$EXP$FR-AFSSAPS-LL2024001225$FR-KOANAAP-SML-FR-2024-00688$Unknown Manufacturer$$12$YR$C$M$Y$$$20240705$$PH$FR$FR
240543511$24054351$1$I$20240701$20240703$20240705$20240705$EXP$GB-MHRA-MED-202407031549500560-PVHNW$GB-SANDOZ INC.-SDZ2024GB062808$SANDOZ$$77$YR$$M$Y$61$KG$20240705$$PH$GB$GB
240543521$24054352$1$I$$20240702$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US063008$SANDOZ$$$$$$Y$$$20240705$$CN$US$US
240543531$24054353$1$I$$20211230$20240705$20240705$EXP$$FR-Merck Healthcare KGaA-9049971$MERCK KGAA$$33$YR$A$F$Y$$$20240703$$CN$FR$FR
240543543$24054354$3$F$20240619$20240826$20240705$20240830$EXP$$DE-SANDOZ INC.-SDZ2024DE062833$SANDOZ$$81$YR$$F$Y$70$KG$20240830$$MD$DE$DE
240543561$24054356$1$I$$20240701$20240703$20240703$DIR$FDA-CDER-CTU-2024-46592$$FDA-CTU$$$$$F$N$$$20240701$N$HP$US$
240543581$24054358$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46581$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240543592$24054359$2$F$$20240826$20240705$20240830$EXP$$CA-GLAXOSMITHKLINE-CACH2024008903$Haleon PLC$$$$A$F$Y$$$20240830$$HP$CA$CA
240543601$24054360$1$I$$20240625$20240705$20240705$EXP$$CA-HALEON-2183635$Haleon PLC$$43$YR$$F$Y$96$KG$20240705$$HP$CA$CA
240543611$24054361$1$I$$20240625$20240705$20240705$EXP$$CA-SANDOZ INC.-SDZ2024CA062680$SANDOZ$$44$YR$$F$Y$97$KG$20240705$$HP$CA$CA
240543621$24054362$1$I$$20240625$20240705$20240705$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004763$BIOCON$$$$$$Y$$$20240705$$HP$CA$CA
240543631$24054363$1$I$$20240120$20240705$20240705$PER$$US-ABBVIE-5829213$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240543642$24054364$2$F$20240627$20240627$20240705$20240711$PER$$US-ROCHE-10000014528$ROCHE$$59$YR$A$$Y$$$20240711$$HP$US$US
240543651$24054365$1$I$$20240627$20240705$20240705$PER$$US-ROCHE-10000014659$ROCHE$$$$E$F$Y$$$20240705$$MD$US$US
240543661$24054366$1$I$$20240627$20240705$20240705$PER$$US-ROCHE-3571240$ROCHE$Chisato U, Tomohiko N, Yuji T, Yoshitaka W, Koji S, Hitohiko M, Shuichiro F. A case of a 9-year-old girl who developed IgA nephropathy after rituximab administration for steroid-dependent minimal change nephrotic syndrome. JSPRF 2019;39:111-4.$9$YR$C$F$Y$28$KG$20240705$$HP$US$US
240543671$24054367$1$I$20230807$20240628$20240705$20240705$EXP$$CN-JNJFOC-20240707373$JOHNSON AND JOHNSON$$5$MON$I$M$Y$$$20240705$$HP$CN$CN
240543681$24054368$1$I$$20240703$20240705$20240705$EXP$$JP-JNJFOC-20240713705$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$MD$JP$JP
240543701$24054370$1$I$20240620$20240626$20240705$20240705$30DAY$$US-GSK-US2024079885$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240705$$CN$US$US
240543711$24054371$1$I$$20240628$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR082397$VIIV$$$$$$Y$$$20240705$$HP$US$US
240543721$24054372$1$I$20240601$20240702$20240705$20240705$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-13285$IPSEN$$92$YR$E$F$Y$$$20240705$$CN$GB$GB
240543731$24054373$1$I$$20240624$20240705$20240705$EXP$$CA-HALEON-2183541$Haleon PLC$$$$$F$Y$$$20240705$$HP$CA$CA
240543744$24054374$4$F$$20240807$20240705$20240812$PER$$US-BIOGEN-2024BI01271974$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
240543751$24054375$1$I$$20240628$20240705$20240705$EXP$$US-SA-2024SA195775$SANOFI AVENTIS$$$$E$F$Y$86.18$KG$20240705$$MD$US$US
240543761$24054376$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214692$TEVA$$$$$F$Y$$$20240705$$CN$CA$CA
240543771$24054377$1$I$20220101$20240628$20240705$20240705$PER$$US-SA-2024SA196686$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240705$$MD$US$US
240543781$24054378$1$I$20231110$20240626$20240705$20240705$EXP$FR-AFSSAPS-TO2023002213$FR-TEVA-VS-3215230$TEVA$$73$YR$$M$Y$73$KG$20240705$$MD$FR$FR
240543791$24054379$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193728$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240705$$MD$US$US
240543801$24054380$1$I$$20240703$20240705$20240705$PER$$US-ROCHE-10000016808$ROCHE$$37$YR$A$M$Y$$$20240705$$CN$US$US
240543813$24054381$3$F$20230401$20240708$20240705$20240725$PER$$US-SA-2024SA196210$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240725$$MD$US$US
240543821$24054382$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05979$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240543831$24054383$1$I$$20230626$20240705$20240705$PER$$US-STRIDES ARCOLAB LIMITED-2023SP010578$STRIDES$Alkharisi B, Dostzada K, Kaur H, Kumar M, Wei JY, Azhar G.. The Importance of Dopamine Deficiency Evaluation in Non-Alzheimer Disease Dementias.. Am-J-Case-Rep. 2023$85$YR$$M$Y$$$20240705$$HP$US$US
240543841$24054384$1$I$$20240614$20240705$20240705$PER$$NVSC2024US139505$NOVARTIS$$$$$F$Y$$$20240705$$HP$US$US
240543852$24054385$2$F$20240701$20240709$20240705$20240710$PER$$US-AMGEN-USASP2024132137$AMGEN$$47$YR$A$F$Y$56.689$KG$20240710$$PH$US$US
240543861$24054386$1$I$20240626$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130853$AMGEN$$51$YR$A$M$Y$$$20240705$$CN$US$US
240543871$24054387$1$I$$20240422$20240705$20240705$PER$$US-AMGEN-USASP2024132989$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240543881$24054388$1$I$$20240627$20240705$20240705$PER$$US-AMGEN-USASP2024129494$AMGEN$$$$A$F$Y$$$20240705$$MD$US$US
240543891$24054389$1$I$$20230303$20240705$20240705$PER$$US-AMGEN-USASP2023235589$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240543901$24054390$1$I$$20240702$20240705$20240705$EXP$$RO-AMGEN-ROUSP2024131480$AMGEN$Matei A; Bilha S. C.; Branisteanu D. D. et al.. Coincidence or Causality: Parathyroid Carcinoma in Chronic Kidney Disease-Case Report and Literature Review. Diagnostics. 2024;14 (11):1-18$50$YR$A$M$Y$$$20240705$$HP$RO$RO
240543911$24054391$1$I$$20240516$20240705$20240705$PER$$US-AMGEN-USASP2024131982$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240543921$24054392$1$I$20220801$20240626$20240705$20240705$EXP$NO-NOMAADVRE-E2B_00097825$NO-Accord-432908$ACCORD$$38$YR$A$M$Y$$$20240705$$CN$NO$NO
240543931$24054393$1$I$$20240626$20240705$20240705$EXP$CA-MHPD-E2B_07080128$CA-Accord-432797$ACCORD$$84$YR$E$M$Y$$$20240705$$HP$CA$CA
240543941$24054394$1$I$$20240626$20240705$20240705$EXP$CA-MHPD-E2B_07079902$CA-Accord-432806$ACCORD$$$$A$M$Y$$$20240705$$CN$CA$CA
240543951$24054395$1$I$20240630$20240701$20240705$20240705$PER$$US-ABBVIE-5822853$ABBVIE$$28$YR$$M$Y$77.11$KG$20240705$$MD$US$US
240543961$24054396$1$I$20240101$20240625$20240705$20240705$EXP$SE-SEMPA-2024-005135$SE-Accord-432785$ACCORD$$56$YR$A$M$Y$$$20240705$$MD$SE$SE
240543971$24054397$1$I$$20240620$20240705$20240705$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454798$RANBAXY$$$$$F$Y$$$20240705$$MD$GB$GB
240543982$24054398$2$F$$20240704$20240705$20240720$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454908$RANBAXY$Liu L-H, Lee M-D, Huang T-H, Chu S-H, Hsieh M-Y. Endovascular treatment of acute limb ischemia in an adolescent with newly diagnosed lupus. Front Cardiovasc Med. 2023;10:1-5$14$YR$$M$Y$$$20240719$$HP$TW$TW
240543991$24054399$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454921$RANBAXY$Islam I, Makaryus M, Khanijo S. Breathing Blue: Sulfasalazine-Induced Methemoglobinemia and Hypoxemia. Am J Respir Crit Care Med. 2024;May 19;209 (0):A1998;A52$80$YR$$M$Y$$$20240705$$HP$US$US
240544001$24054400$1$I$$20240620$20240705$20240705$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454626$RANBAXY$$$$$F$Y$$$20240705$$HP$GB$GB
240544011$24054401$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455014$RANBAXY$Lackey E, Shen J, Veal K, Shah S, Eckstein C. Neurosarcoidosis causing hydrocephalus: A case series. J Neuroimmunol. 2023;381:578120;1-4$38$YR$$F$Y$$$20240705$$HP$US$US
240544021$24054402$1$I$$20240620$20240705$20240705$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455119$RANBAXY$Gazolyszyn N., Pragnacy K. Diagnostics of comorbidities in a non-binary person - a study case. Psychiatry after diploma. 2024;3:no information$23$YR$$M$Y$$$20240705$$HP$PL$PL
240544031$24054403$1$I$20190101$20240620$20240705$20240705$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454620$RANBAXY$$$$$F$Y$$$20240705$$MD$GB$GB
240544041$24054404$1$I$20240423$20240620$20240705$20240705$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454339$RANBAXY$$64$YR$$M$Y$$$20240705$$HP$DE$DE
240544051$24054405$1$I$$20240620$20240705$20240705$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454707$RANBAXY$Chao AS, Chang SD, Wang CJ, Chao A, Wang TH. Abscess formation in ovarian endometriomas after failure of mifepristone-induced abortion. Clin Exp Obstet Gynecol. 2016;43:766-768$36$YR$$F$Y$$$20240705$$HP$TW$TW
240544062$24054406$2$F$$20240705$20240705$20240720$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454684$RANBAXY$Koroglu E, Ayroba B. Manic episode associated with COVID-19 and corticosteroids in a Patient with prior mild cognitive impairment. Int J Gerontol. 2022;16 (4):400-402$69$YR$$M$Y$$$20240719$$HP$TR$TR
240544071$24054407$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454916$RANBAXY$Agudelo Higuita NI, Yuen C. Hemophagocytic Lymphohistiocytosis Secondary to Ehrlichia Chaffeensis in Adults: A Case Series From Oklahoma. Am J Med Sci. 2021;361(2):269-273$62$YR$$F$Y$$$20240705$$MD$US$US
240544083$24054408$3$F$$20240716$20240705$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455039$RANBAXY$$7$YR$$M$Y$16.1$KG$20240731$$HP$US$DE
240544091$24054409$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454932$RANBAXY$Braat J, Shacker M, Arjuna A. Atypical Presentation of Central Serous Chorioretinopathy (CSCR) After Lung Transplantation. Am J Respir Crit Care Med. 2024;209(0)$59$YR$$F$Y$$$20240705$$HP$US$US
240544101$24054410$1$I$$20240620$20240705$20240705$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455136$RANBAXY$Aydin SA, Metbulut AP, Misirlioglu ED, Metin A. Use of Valacyclovir Prophylaxis in Herpes Virus-Associated Recurrent Erythema Multiforme Cases. Turk J Pediatr Dis. 2023;17 (2):166-170$12$YR$$M$Y$$$20240705$$HP$TR$TR
240544111$24054411$1$I$$20240620$20240705$20240705$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455130$RANBAXY$Aydin SA, Metbulut AP, Misirlioglu ED, Metin A. Use of Valacyclovir Prophylaxis in Herpes Virus-Associated Recurrent Erythema Multiforme Cases. Turk J Pediatr Dis. 2023;17 (2):166-170$17$YR$$F$Y$$$20240705$$HP$TR$TR
240544121$24054412$1$I$$20240620$20240705$20240705$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454720$RANBAXY$Wiederkehr I, Kaufmann C, Hor H, Wiederkehr M, Bachli E. Varicella-zoster-virus infection associated Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM). Swiss Med Wkly. 2024;154 (Suppl.):122S (P158)$80$YR$$F$Y$$$20240705$$HP$CH$CH
240544131$24054413$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455053$RANBAXY$Lackey E, Shen J, Veal K, Shah S, Eckstein C. Neurosarcoidosis causing hydrocephalus: A case series. J Neuroimmunol. 2023;381:578120;1-4$34$YR$$M$Y$$$20240705$$HP$US$US
240544141$24054414$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454838$RANBAXY$Hong A, Durant CE, Watson RL, Betancourt J, Eng KJ. Recurrent Hypoxia With Feeding: Uncovering the Hidden Fistula. Am J Respir Crit Care Med. 2024;209:A5578$77$YR$$M$Y$$$20240705$$HP$US$US
240544151$24054415$1$I$$20240620$20240705$20240705$EXP$$ET-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454852$RANBAXY$Mohammed A, Shewaye AB, Abdela F, Gorfu ZT, Adem A. Diagnostic and therapeutic challenges of chronic portal vein thrombosis secondary to myeloproliferative neoplasm in sub-saharan region: a series of cases and literature review. Int Med Case Rep J. 2023;16:13-25$46$YR$$M$Y$$$20240705$$HP$ET$ET
240544161$24054416$1$I$$20240620$20240705$20240705$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454640$RANBAXY$Berloffa S, Dosi C, Tascini B, Fossati B, Lupetti I, Masi G. Neuroleptic malignant syndrome in children with autism spectrum disorder (Asd): A case report and brief review of recent literature. Children Basel. 2021;8(12):no pagination$18$YR$$M$Y$$$20240705$$HP$IT$IT
240544171$24054417$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455057$RANBAXY$Lackey E, Shen J, Veal K, Shah S, Eckstein C. Neurosarcoidosis causing hydrocephalus. J Neuroimmunol. 2023;381:578120;1-4$35$YR$$M$Y$$$20240705$$HP$US$US
240544181$24054418$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454717$RANBAXY$Schwartz BI, Bear B, Short LV, Kazak EA. Outcomes of Menstrual Management Use in Transgender and Gender-Diverse Adolescents. Obstet Gynecol. 2023;141(4);apr:748-55$$$T$$Y$$$20240705$$MD$US$US
240544191$24054419$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454693$RANBAXY$Khawam S, Goudie M, Hartfield R, Hassan S, Padder F. A Case of Trazadone and Omeprazole Associated Wenckebach Phenomenon Disguised as Second-degree Mobitz Type 2 AV Block. Am J respir Crit Care Med. 2024;209:A5664$26$YR$$F$Y$$$20240705$$HP$US$US
240544201$24054420$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454937$RANBAXY$Abdalla AA, Ali RF, Zamora-Martinez AC, Wesselius LJ. Vexas Syndrome Presenting as Recurrent Relapses of Organizing Pneumonia- A Case Series. Am J Respir Crit Care Med. 2024;209:A5321$69$YR$$M$Y$$$20240705$$HP$US$US
240544211$24054421$1$I$$20240620$20240705$20240705$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454970$RANBAXY$Nakai C, Yoneda T, Kakeshita K, Saeki K, Aoki G, Yano S. A Patient with Lung Cancer and Multiple Myeloma Treated with Lenalidomide, Dexamethasone, and Pembrolizumab. Haigan. 2023;63(3):200-205$73$YR$$F$Y$$$20240705$$HP$JP$JP
240544221$24054422$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454928$RANBAXY$Riha EN, Kim A, Tang J, Kesavan R, Girgawy E, Sarva S. Catching Flights and Malaria. Am J Respir Crit Care Med. 2024;209 (0):A5545$69$YR$$F$Y$$$20240705$$HP$US$US
240544231$24054423$1$I$20240618$20240620$20240705$20240705$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454566$RANBAXY$$$$$M$Y$$$20240705$$PH$GB$GB
240544241$24054424$1$I$20230801$20240620$20240705$20240705$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454979$RANBAXY$Fenclova, NS. Eculizumab in the treatment of DITMA in a patient with pancreatic adenocarcinoma. Postgraduate nephrology. 2024;22(2):31-3$62$YR$$F$Y$$$20240705$$HP$CZ$CZ
240544251$24054425$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454923$RANBAXY$Ernst EB, Khalil H, Marron RM. Radiologic Improvement in Native Lung After Single Lung Transplantation for Coronavirus 19 (COVID-19). Am J Respir Crit Care Med. 2024;May 22;209 (0):A7059;D24$70$YR$$M$Y$$$20240705$$HP$US$US
240544261$24054426$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454936$RANBAXY$Abdalla AA, Ali RF, Zamora- Martinez AC, Wesselius LJ. Vexas Syndrome Presenting as Recurrent Relapses of Organizing Pneumonia- A Case Series. Am J Respir Crit Care Med. 2024;209(0):A5321$69$YR$$M$Y$$$20240705$$HP$US$US
240544271$24054427$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454917$RANBAXY$Gupta UD, Chowdhury T, Niriyan J, Bellamkonda A, Aryal B, Al-Ghuraibawi M. Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care. Am J Respir Crit Care Med. 2024;209(0):A3415$43$YR$$F$Y$$$20240705$$HP$US$US
240544281$24054428$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454866$RANBAXY$Brown AF, Fowler CM. Diffuse Interstitial Lung Disease With Organizing Pneumonia in 12-year- Old Female With TNFRSF13B Monoallelic Common Variable Immunodeficiency. Am J Respir Crit Care Med. 2024;209 (0):A2315/A63$12$YR$$F$Y$$$20240705$$HP$US$US
240544291$24054429$1$I$$20240625$20240705$20240705$EXP$$CA-SANDOZ INC.-SDZ2024CA062681$SANDOZ$$44$YR$$F$Y$97$KG$20240705$$HP$CA$CA
240544301$24054430$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454926$RANBAXY$Tajfiroozeh D, Silva R, Otsuka KN, Wai A. A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis. Am J Respir Crit Care Med. 2024;May 19;209 (0):A2289;A62$15$YR$$M$Y$$$20240705$$HP$US$US
240544311$24054431$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454706$RANBAXY$Agudelo Higuita NI, Yuen C. Hemophagocytic Lymphohistiocytosis Secondary to Ehrlichia Chaffeensis in Adults: A Case Series From Oklahoma. Am J Med Sci. 2021;FEB; 361(2):269-273$49$YR$$M$Y$$$20240705$$MD$US$US
240544321$24054432$1$I$$20231121$20240705$20240705$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017758$STRIDES$Qiu S, Jan D, Kim KY.. Association Between Lower Extremity Edema and Risperidone in an Older Adult.. Prim-Care-Comp-CNS-Disorders. 2023;25(4):1-5$71$YR$$F$Y$$$20240705$$MD$US$US
240544331$24054433$1$I$$20231212$20240705$20240705$PER$US-MLMSERVICE-20231208-4107782-1$US-STRIDES ARCOLAB LIMITED-2023SP018898$STRIDES$Ong M, Patterson E, Stewart L, Pierce D, Smith JR.. Morbidity Due to Disparity in Pediatric Electroconvulsive Therapy.. Journal of the American Academy of Child and Adolescent Psychiatry.. 2023;62(3):279-281$15$YR$$M$Y$$$20240705$$MD$US$US
240544341$24054434$1$I$$20240214$20240705$20240705$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002132$STRIDES$Harvey-Nuckles K, Ganguly M, Schwartz N, Kasick D.. Case Report: Treatment of a Medically Complex Adult Patient with Down^s Syndrome in a Children^s Hospital.. J-Acad-Consult-Liaison-Psychiatry. 2023;64 (Suppl.):S131-S132$35$YR$$M$Y$$$20240705$$HP$US$US
240544351$24054435$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454635$RANBAXY$Costa Filho FF, Furlan A, Gusfa DW, Tang HM, Issack W, Avner BS. Acute Respiratory Distress Syndrome Secondary to Blastomycosis Dermatitis Infection: Successful Recover After Adjunctive Systemic Steroids. Am J Respir Crit Care Med. 2024;209 (0):A5542$22$YR$$M$Y$$$20240705$$HP$US$US
240544361$24054436$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453803$RANBAXY$$$$E$M$Y$$$20240705$$CN$US$US
240544371$24054437$1$I$$20240621$20240705$20240705$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454472$RANBAXY$Ota H, Igarashi T, Matsui R, Takeshita H, Hashimoto K, Miyao M, et al. Use of tocilizumab to treat arthritis associated with mixed connective tissue disease complicated by ovarian teratoma: a case report. J Nippon Med Sch. 2024;Jun 18:Online ahead of print$10$YR$$F$Y$$$20240705$$HP$JP$JP
240544381$24054438$1$I$$20230307$20240705$20240705$EXP$$NVSC2023CA280791$NOVARTIS$$44$YR$$F$Y$70$KG$20240705$$HP$CA$CA
240544392$24054439$2$F$$20240628$20240705$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454674$RANBAXY$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. Rheumatol. 2024;63 (5):1291-1296$35$YR$$M$Y$$$20240712$$HP$US$US
240544401$24054440$1$I$$20240620$20240705$20240705$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454540$RANBAXY$Jatana R, Kalra BP, Rawat A. Assessment of doxorubicin induced cardiac dysfunction on 2D ECHO in children with cancer. Eur J Cardiovasc Med. 2024;14 (2):18-22$$$C$$Y$$$20240705$$HP$IN$IN
240544411$24054441$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454602$RANBAXY$Zahedi S, Parsons A, Vahabzadeh A, Franco-Palacios DJ. Success of Mechanical Circulatory Support as a Bridge to Treatment in Acute Right Ventricular Failure. Am J Respir Crit Care Med. 2024;209 (0):A2212$40$YR$$M$Y$$$20240705$$HP$US$US
240544421$24054442$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454653$RANBAXY$Hassan S, Khawam S, Hartfield R, Patel P, Cole R, Goudie MP. Unmasking the Peril of Minoxidil: A Case of Pericardial Effusion Leading to Tamponade in Resistant Hypertension. Am J Respir Crit Care Med. 2024;209 (0):A5668$26$YR$$F$Y$$$20240705$$HP$US$US
240544431$24054443$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453504$RANBAXY$Wu YF, Skinner L, Lewis J, Khodadoust MS, Kim YH, Kwong BY, et al. Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell Transplantation. Cancer Invest. 2023;41 (3):263-270$37$YR$$M$Y$$$20240705$$HP$US$US
240544441$24054444$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453143$RANBAXY$$$$A$M$Y$$$20240705$$CN$US$US
240544451$24054445$1$I$20240614$20240621$20240705$20240705$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454856$RANBAXY$$$$$F$Y$$$20240705$$HP$GB$GB
240544462$24054446$2$F$$20240709$20240705$20240724$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454905$RANBAXY$Ozgun N, Akdeniz O. Effectiveness of Valproic Acid in the Treatment of Sydenham^s Chorea and a Literature Review. Clin Pediatir Phila. 2024;63 (6):798-804$$$C$$Y$$$20240724$$MD$TR$TR
240544471$24054447$1$I$$20240621$20240705$20240705$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454907$RANBAXY$Zhu J, Wang Y, Xu B, Pu W, He P, Zhang J, et al. Photodynamic therapy may salvage chemotherapy failure in gastric cancer: A case report and a literature review. Photodian Photodyn Ther. 2024;46(0):104038$56$YR$$M$Y$$$20240705$$HP$CN$CN
240544481$24054448$1$I$$20240621$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455162$RANBAXY$Yasmin M, Rojas LJ, Marshall SH, Hujer AM, Cmolik A, Marshall E, et al. Characterization of a Novel Pathogen in Immunocompromised Patients: Elizabethkingia anophelis-Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and beta-lactamase Inhibitors. Open Forum Infect Dis. 2023;10 (2):1-8$60$YR$$F$Y$$$20240705$$MD$US$US
240544493$24054449$3$F$$20240725$20240705$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454418$RANBAXY$Yuan YH, Zhang H, Xiao ZH, Zhang XP, Lu XL, Xu ZY, et al. Therapeutic effect of plasma exchange on antibody mediated rejection after living relative donor liver transplantation in children. J Clin Pediatr Surg. 2022;21 (5):425-430$7$MON$$M$Y$$$20240809$$HP$CN$CN
240544501$24054450$1$I$$20240621$20240705$20240705$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454470$RANBAXY$Guevara A, Siqueira NP, de Sousa RP, Dos Santos TB, Assis SB, de Camargo ZP et al. Clinical response to prednisone in a severe case of infant-juvenile paracoccidioidomycosis. Rev Iberoam Micol. 2024;Jun 18:S1130-1406(24)00005-6;13$$$C$$Y$$$20240705$$HP$BR$BR
240544511$24054451$1$I$$20240622$20240705$20240705$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455304$RANBAXY$$$$$$Y$$$20240705$$CN$GB$GB
240544521$24054452$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453556$RANBAXY$Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk Lymphoma. 2023;64(2):407-414$$$A$$Y$$$20240705$$HP$US$US
240544531$24054453$1$I$20220703$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-348403$RANBAXY$$49$YR$$M$Y$58$KG$20240705$$MD$FR$FR
240544541$24054454$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46618$$FDA-CTU$$83$YR$$F$N$$$20240703$N$$US$
240544551$24054455$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46612$$FDA-CTU$$66$YR$$M$N$$$20240703$N$$US$
240544561$24054456$1$I$$20230307$20240705$20240705$EXP$$NVSC2023CA280790$NOVARTIS$$44$YR$$F$Y$70$KG$20240705$$HP$CA$CA
240544571$24054457$1$I$$20240621$20240705$20240705$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454860$RANBAXY$$$$$$Y$$$20240705$$PH$GB$GB
240544581$24054458$1$I$$20240621$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455200$RANBAXY$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allerg Asth Clin Immunol. 2023;19 (1):78/1-6$58$YR$$F$Y$$$20240705$$HP$US$US
240544591$24054459$1$I$20240313$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454559$RANBAXY$$73$YR$$F$Y$79$KG$20240705$$MD$FR$FR
240544601$24054460$1$I$$20240621$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455198$RANBAXY$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allerg Asth Clin Immunol. 2023;19 (1):78/1-6$39$YR$$M$Y$$$20240705$$HP$US$US
240544611$24054461$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46573$$FDA-CTU$$77$YR$$M$N$$$20240703$N$$US$
240544641$24054464$1$I$$20240621$20240705$20240705$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454812$RANBAXY$$$$$M$Y$$$20240705$$CN$GB$GB
240544651$24054465$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453555$RANBAXY$Bici A, Pianko MJ, Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk Lymphoma. 2023;64 (2):407-414$$$A$$Y$$$20240705$$HP$US$US
240544661$24054466$1$I$$20240621$20240705$20240705$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455399$RANBAXY$$39$YR$$F$Y$$$20240705$$HP$ES$ES
240544671$24054467$1$I$$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455013$RANBAXY$Laurent C, Hentzien M, Pavel S, Didier K, Bermejo M, N^Guyen Y, et al. Mycobacterium genavense mesenteritis responsible for refractory chylous ascites despite multiple immunomodulatory therapies in a patient with AIDS. AIDS. 2023;37(5):856-858$32$YR$$F$Y$$$20240705$$HP$FR$FR
240544681$24054468$1$I$$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455279$RANBAXY$Mouillot P, Favrolt N, Khouri C, Grandvuillemin A, Chaumais M-C, Schenesse D. Characteristics and outcomes of gemcitabine-associated pulmonary hypertension. ERJ Open Res. 2024;10(3):1-11$$$$$Y$$$20240705$$HP$FR$FR
240544691$24054469$1$I$$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455256$RANBAXY$Mouillot P, Favrolt N, Khouri C, Grandvuillemin A, Chaumais M-C, Schenesse D. Characteristics and outcomes of gemcitabine-associated pulmonary hypertension. ERJ Open Res. 2024;10(3):1-11$$$$$Y$$$20240705$$HP$FR$FR
240544701$24054470$1$I$20240627$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46605$$FDA-CTU$$59$YR$$M$N$84.37$KG$20240702$N$PH$US$
240544711$24054471$1$I$$20240620$20240705$20240705$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452932$RANBAXY$Babu K, Padmapriya PG, Gowda SMN, Murthy PR. Recurrent Choroidal Neovascular Membrane as the Initial Presentation of Mycobacterium chimaera. Ocul Immunol Inflamm. 2024;Jun; 18:Online ahead of print(1-6)$30$YR$$F$Y$$$20240705$$HP$IN$IN
240544722$24054472$2$F$$20240703$20240705$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454997$RANBAXY$$61$YR$$M$Y$$$20240718$$MD$IT$IT
240544731$24054473$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454666$RANBAXY$Liu J, Rosenfeld PJ, Dubovy SR. Branch retinal artery occlusion in a 49-year-Old woman taking phentermine. Am J Ophthalmol Case Rep. 2024;35 (0):102013/1-4$49$YR$$F$Y$$$20240705$$HP$US$US
240544741$24054474$1$I$20240305$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454868$RANBAXY$$53$YR$$F$Y$75$KG$20240705$$MD$FR$FR
240544751$24054475$1$I$20240217$20240621$20240705$20240705$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455384$RANBAXY$$28$YR$$F$Y$$$20240705$$MD$DE$DE
240544761$24054476$1$I$20240329$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454777$RANBAXY$$59$YR$$F$Y$72$KG$20240705$$MD$FR$FR
240544771$24054477$1$I$20231124$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455149$RANBAXY$$32$YR$$M$Y$$$20240705$$PH$FR$FR
240544781$24054478$1$I$$20240621$20240705$20240705$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454879$RANBAXY$$15$YR$$F$Y$44$KG$20240705$$CN$RO$RO
240544791$24054479$1$I$$20240621$20240705$20240705$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454972$RANBAXY$Nishihama K, Inoue C, Nishikawa K, Okano Y, Takeshita A, Uemura M, et al. Bilateral Nephrectomy for Resistant Hypertension and Secondary Aldosteronism in a Hemodialysis Patient: A Case Report. Intern Med. 2024;63 (11):1597-1602$42$YR$$F$Y$$$20240705$$HP$JP$JP
240544801$24054480$1$I$$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455290$RANBAXY$Mouillot P, Favrolt N, Khouri C, Grandvuillemin A, Chaumais M-C, Schenesse D. Characteristics and outcomes of gemcitabine-associated pulmonary hypertension. ERJ Open Res. 2024;10(3):no pagination$$$$$Y$$$20240705$$HP$FR$FR
240544812$24054481$2$F$20240605$20240718$20240705$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455321$RANBAXY$$47$YR$$F$Y$95$KG$20240802$$CN$GB$GB
240544821$24054482$1$I$20230528$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455007$RANBAXY$$32$YR$$M$Y$$$20240705$$MD$FR$FR
240544831$24054483$1$I$20161101$20240621$20240705$20240705$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455372$RANBAXY$$77$YR$$M$Y$82$KG$20240705$$MD$GR$GR
240544841$24054484$1$I$20230715$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455167$RANBAXY$$75$YR$$F$Y$77$KG$20240705$$MD$FR$FR
240544852$24054485$2$F$20240314$20240819$20240705$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454787$RANBAXY$$36$YR$$F$Y$62$KG$20240903$$MD$FR$FR
240544861$24054486$1$I$$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454535$RANBAXY$$33$YR$$F$Y$$$20240705$$MD$FR$FR
240544871$24054487$1$I$20240325$20240621$20240705$20240705$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454200$RANBAXY$$81$YR$$M$Y$78$KG$20240705$$MD$IT$IT
240544881$24054488$1$I$20240126$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455106$RANBAXY$$11$YR$$M$Y$46$KG$20240705$$PH$FR$FR
240544891$24054489$1$I$$20240621$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454876$RANBAXY$Grabie Y, Acharya S, Sadiq W, Rotblat D, Chalhoub MN. Iatrogenic Bilothorax Following Dislodgment of Cholecystostomy Tube. Am J Respir Crit Care Med. 2024;209 (0):no pagination$83$YR$$M$Y$$$20240705$$HP$US$US
240544901$24054490$1$I$$20240621$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455195$RANBAXY$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allerg Asth Clin Immunol. 2023;19 (1):78/1-6$35$YR$$M$Y$$$20240705$$HP$US$US
240544911$24054491$1$I$$20240621$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455160$RANBAXY$Stone EG. Unintended adverse consequences of a clinical decision support system: two cases. J Am Med Inf Assoc. 2018;25 (5):564-567$63$YR$$M$Y$$$20240705$$HP$US$US
240544922$24054492$2$F$20240303$20240715$20240705$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455337$RANBAXY$$74$YR$$M$Y$100$KG$20240730$$MD$FR$FR
240544931$24054493$1$I$$20240621$20240705$20240705$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454785$RANBAXY$Li Y, Liu Y, Wen L, Chen H, Wang W, Tian M, et al. Clinical efficacy analysis of paxlovid in children with hematological diseases infected with the omicron SARS-CoV-2 new variant. Front Pediatr. 2023;11:1-9$4$YR$$M$Y$18$KG$20240705$$HP$CN$CN
240544941$24054494$1$I$20220617$20240621$20240705$20240705$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454802$RANBAXY$$76$YR$$M$Y$$$20240705$$MD$ES$ES
240544951$24054495$1$I$$20240621$20240705$20240705$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454863$RANBAXY$Ozkan A, Aydogan E. Report of a Case with Status Epilepticus Associated Rhabdomyolisis. Int J Curr Med Biol Sci. 2024;4 (1):5-7$41$YR$$F$Y$$$20240705$$MD$TR$TR
240544961$24054496$1$I$$20240621$20240705$20240705$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454901$RANBAXY$Gong M-Q, Zhang Y-Q, Wang X-D. Expectant management for umbilical artery thrombosis in the third trimester of pregnancy: a case report. Front Pharmacol. 2024;15(0):1-6$34$YR$$F$Y$$$20240705$$HP$CN$CN
240544971$24054497$1$I$20231217$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455021$RANBAXY$$22$YR$$M$Y$$$20240705$$MD$FR$FR
240544981$24054498$1$I$20240619$20240622$20240705$20240705$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455331$RANBAXY$$20$YR$$M$Y$$$20240705$$CN$GB$GB
240544991$24054499$1$I$$20240621$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455161$RANBAXY$Faryad S, Tran J, Prasad B. VAGAL NERVE STIMULATOR-INDUCED SLEEP DISORDERED BREATHING. Sleep. 2024;47 (Suppl. 1):A522-A523/1225$40$YR$$F$Y$$$20240705$$HP$US$US
240545001$24054500$1$I$20240318$20240621$20240705$20240705$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454829$RANBAXY$$79$YR$$F$Y$$$20240705$$MD$ES$ES
240545012$24054501$2$F$20230425$20240705$20240705$20240720$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454586$RANBAXY$$48$YR$$F$Y$$$20240719$$MD$IT$IT
240545021$24054502$1$I$20240316$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455077$RANBAXY$$58$YR$$M$Y$140$KG$20240705$$MD$FR$FR
240545031$24054503$1$I$$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454254$RANBAXY$$41$YR$$M$Y$$$20240705$$CN$FR$FR
240545041$24054504$1$I$20240317$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455108$RANBAXY$$44$YR$$M$Y$75$KG$20240705$$PH$FR$FR
240545051$24054505$1$I$20230928$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454983$RANBAXY$$56$YR$$M$Y$88$KG$20240705$$PH$FR$FR
240545061$24054506$1$I$20240104$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455385$RANBAXY$$21$YR$$M$Y$57$KG$20240705$$PH$FR$FR
240545071$24054507$1$I$$20240627$20240705$20240705$30DAY$$US-GSK-US2024AMR080714$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$CN$US$US
240545081$24054508$1$I$20230515$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455010$RANBAXY$$19$YR$$F$Y$$$20240705$$MD$FR$FR
240545093$24054509$3$F$20231201$20240821$20240705$20240904$EXP$$US-UCBSA-2024033538$UCB$$15$YR$$M$Y$39$KG$20240904$$HP$US$US
240545102$24054510$2$F$$20240702$20240705$20240709$EXP$$CA-JNJFOC-20240707657$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240710$$CN$CA$CA
240545112$24054511$2$F$20240626$20240703$20240705$20240712$30DAY$$US-GSK-US2024082110$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240712$$CN$US$US
240545121$24054512$1$I$20240514$20240705$20240705$20240705$EXP$GB-MHRA-MED-202405141734586440-BYKDG$GB-JNJFOC-20240713833$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$GB$GB
240545131$24054513$1$I$20240702$20240702$20240705$20240705$PER$$US-JNJFOC-20240706362$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240545141$24054514$1$I$$20240306$20240705$20240705$PER$$US-AMGEN-USASP2024130916$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240545151$24054515$1$I$$20240325$20240705$20240705$EXP$$SE-HALEON-2184197$Haleon PLC$$58$YR$$M$Y$$$20240705$$MD$SE$SE
240545161$24054516$1$I$$20240703$20240705$20240705$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-107338$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240705$$HP$DE$DE
240545172$24054517$2$F$$20240729$20240705$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106479$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240731$$CN$US$US
240545192$24054519$2$F$$20240712$20240705$20240720$EXP$$PL-AUROBINDO-AUR-APL-2024-032116$AUROBINDO$$25$YR$$M$Y$$$20240720$$MD$PL$PL
240545201$24054520$1$I$20240301$20240626$20240705$20240705$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-13058$IPSEN$$21$YR$A$F$Y$$$20240705$$HP$US$US
240545211$24054521$1$I$$20240624$20240705$20240705$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05728$LUPIN$Gans A, Taylor J, Goel NN. A case of drug-Induced Stevens-Johnson Syndrome with primarily visceral involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209$76$YR$$F$Y$$$20240705$$HP$US$US
240545222$24054522$2$F$20240514$20240723$20240705$20240730$EXP$$NVSC2024US139045$NOVARTIS$$37$YR$$M$Y$83.9$KG$20240730$$HP$US$US
240545232$24054523$2$F$$20240621$20240705$20240705$EXP$$US-FMCRTG-FMC-2406-000729$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240705$$HP$US$US
240545241$24054524$1$I$$20240625$20240705$20240705$EXP$$ES-862174955-ML2024-03709$Unknown Manufacturer$Rubio I, de la Puente EM, Boveda O, Jimenez I, Pena I. Green neutrophilic inclusions in patient with drug intoxication: a case report. Journal of Laboratory and Precision Medicine. 2023 Nov 20;9(9): 1-4. doi:10.21037/jlpm-23-30.$54$YR$A$F$Y$$$20240705$$HP$ES$ES
240545251$24054525$1$I$$20240620$20240705$20240705$EXP$$US-FMCRTG-FMC-2406-000742$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240705$$CN$US$US
240545262$24054526$2$F$20240101$20240822$20240705$20240828$EXP$$JP-AMGEN-JPNSP2024129280$AMGEN$$$$E$M$Y$$$20240828$$MD$JP$JP
240545281$24054528$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46571$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240545311$24054531$1$I$$20240629$20240705$20240705$EXP$$GR-EXELIXIS-CABO-24079058$EXELIXIS$Violetis O, Konstantakou P, Spyroglou A, et al.. The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review.. J Pers Med.. 2024;14(6):654$45$YR$$M$Y$$$20240705$$MD$GR$GR
240545321$24054532$1$I$20240627$20240627$20240705$20240705$EXP$$US-AUROBINDO-AUR-APL-2024-032703$AUROBINDO$$44$YR$$F$Y$$$20240705$$PH$US$US
240545341$24054534$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46669$$FDA-CTU$$63$YR$$M$N$$$20240703$N$$US$
240545362$24054536$2$F$$20240711$20240705$20240721$EXP$$GB-TEVA-VS-3212506$TEVA$Ball HA, Stevens J, Gillmore JD. Peripheral neuropathy secondary to a ^domino^ liver transplant: a case report. J-Med-Case-Rep 2023; 17 (1): 2-4.; Ball HA, Stevens J, Gillmore JD. Peripheral neuropathy secondary to a ^domino^ liver transplant: a case report. J-Med-Case-Rep 2023; 17 (1): 2-4.$76$YR$$M$Y$$$20240721$$HP$GB$GB
240545371$24054537$1$I$$20240623$20240705$20240705$EXP$$IL-Merck Healthcare KGaA-2024034309$MERCK KGAA$$71$YR$E$F$Y$$$20240702$$MD$IL$IL
240545381$24054538$1$I$20240201$20240628$20240705$20240705$EXP$$US-SA-2024SA195630$SANOFI AVENTIS$$19$YR$A$M$Y$88.9$KG$20240705$$MD$US$US
240545391$24054539$1$I$20230512$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151053$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240545401$24054540$1$I$$20240627$20240705$20240705$EXP$$JP-ROCHE-3549043$ROCHE$$10$DEC$E$M$Y$$$20240705$$MD$JP$JP
240545411$24054541$1$I$20240412$20240626$20240705$20240705$EXP$FR-AFSSAPS-TO2024000756$FR-TEVA-VS-3215151$TEVA$$34$YR$$F$Y$54$KG$20240705$$PH$FR$FR
240545422$24054542$2$F$$20240628$20240705$20240710$EXP$$CA-AstraZeneca-2024A060001$ASTRAZENECA$$$$$F$Y$$$20240710$$PH$CA$
240545431$24054543$1$I$$20240620$20240705$20240705$EXP$$US-IBIGEN-2024-015492$ISTITUTO BICHIMICO ITALIANO GIOVANNI LORENZINI (IBIGEN)$Abdelghany Y, Resnyk J, Nadi Khalil A, Zimrin A, Rose J. A case of anaphylaxis associated thrombocytopenia. American Journal of Respiratory and Critical Care Medicine. 2024:209.$80$YR$$M$Y$$$20240625$$MD$US$
240545441$24054544$1$I$$20240624$20240705$20240705$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP007937$STRIDES$Hayashi M, Shiraishi K, Yoshida S, Yatsuzuka K, Kohri N, Kuroo Y, et al.. Cutaneous arteritis combined with antiphospholipid syndrome associated with the use of immune checkpoint inhibitors in a patient with a metastatic lung adenocarcinoma.. J-Dermatol. 2024;51 (5):e166-e167$41$YR$$M$Y$$$20240705$$HP$JP$JP
240545452$24054545$2$F$$20240703$20240705$20240711$EXP$$NVSC2024GB139147$NOVARTIS$$$$$$Y$$$20240711$$HP$GB$GB
240545461$24054546$1$I$$20231204$20240705$20240705$PER$$US-AMGEN-USASP2023235260$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240545471$24054547$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131061$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240545481$24054548$1$I$$20240627$20240705$20240705$PER$$US-AMGEN-USASP2024130031$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240545494$24054549$4$F$20240515$20240725$20240705$20240806$30DAY$$US-JNJFOC-20240666824$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$US$US
240545501$24054550$1$I$$20240701$20240705$20240705$EXP$$JP-PFIZER INC-PV202400086548$PFIZER$Katagiri, H.. A case of metastatic renal cell carcinoma with suppressed disease progression after pleurodesis with OK-432. The 94th Saitama Regional Meeting of the Japanese Urological Association. 2024;94th:13$56$YR$$M$Y$$$20240705$$MD$JP$JP
240545511$24054551$1$I$$20240701$20240705$20240705$EXP$$US-PFIZER INC-202400204994$PFIZER$Lam, K.. Eruptive Melanocytic Nevi in the Setting of Encorafenib, Cetuximab, and Binimetinib Combination Therapy: A Case Report. Case Reports in Dermatology. 2024;16 (1):133-139$39$YR$$F$Y$$$20240705$$HP$US$US
240545521$24054552$1$I$$20240704$20240705$20240705$EXP$$CA-PFIZER INC-202400206884$PFIZER$$$$$$Y$$$20240705$$HP$CA$CA
240545531$24054553$1$I$$20240701$20240705$20240705$EXP$$JP-PFIZER INC-PV202400086445$PFIZER$Sugahara, S.. A case of KIT-positive gastric primary gastrointestinal stromal tumour treated with fourth-line therapy with pimitespib. The 121st Regular Meeting of The Japanese Society of Gastroenterology Shikoku. 2024;121st:73$56$YR$$F$Y$$$20240705$$HP$JP$JP
240545541$24054554$1$I$$20240701$20240705$20240705$EXP$$US-PFIZER INC-PV202400086659$PFIZER$Lam, K.. Eruptive Melanocytic Nevi in the Setting of Encorafenib, Cetuximab, and Binimetinib Combination Therapy: A Case Report. Case Reports in Dermatology. 2024;16 (1):133-139$39$YR$$F$Y$$$20240705$$HP$US$US
240545571$24054557$1$I$20240617$20240620$20240703$20240703$DIR$FDA-CDER-CTU-2024-46600$$FDA-CTU$$44$YR$$M$N$$$20240620$N$HP$US$
240545601$24054560$1$I$20240703$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46629$$FDA-CTU$$87$YR$$M$N$$$20240703$Y$PH$US$
240545611$24054561$1$I$$20240621$20240705$20240705$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455083$RANBAXY$Kim CJ, Ide H, Nakamura M, Hanada E.. Occurrence of Distant Metastasis During Bladder Presevation in T1 high-grade Bladder Cancer: Report of Three Cases. Hinyokika Kiyo. 2023;69:249-254$82$YR$$M$Y$$$20240705$$HP$JP$JP
240545621$24054562$1$I$20240301$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455089$RANBAXY$$32$YR$$M$Y$$$20240705$$MD$FR$FR
240545631$24054563$1$I$20240402$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455127$RANBAXY$$92$YR$$F$Y$$$20240705$$MD$FR$FR
240545641$24054564$1$I$$20240621$20240705$20240705$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454904$RANBAXY$Gong M-Q, Zhang Y-Q, Wang X-D. Expectant management for umbilical artery thrombosis in the third trimester of pregnancy: a case report. Front Pharmacol. 2024;15 (0):1-6$$$N$F$Y$$$20240705$$HP$CN$CN
240545651$24054565$1$I$$20240621$20240705$20240705$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455062$RANBAXY$Kim CJ, Ide H, Nakamura M, Hanada E.. Occurrence of Distant Metastasis During Bladder Presevation in T1 high-grade Bladder Cancer: Report of Three Cases. Hinyokika Kiyo. 2023;69:249-254$48$YR$$F$Y$$$20240705$$HP$JP$JP
240545661$24054566$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454670$RANBAXY$Sasidharan S, Jatoi T, Milla C, Mallappallil M, Agarwal S, Puri I. Triple Whammy of Amlodipine, Carvedilol and Diphenhydramine Overdose. Am J Respir Crit Care Med. 2024;209:A5669$27$YR$$F$Y$$$20240705$$HP$US$US
240545671$24054567$1$I$$20240621$20240705$20240705$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454585$RANBAXY$$62$YR$$F$Y$87$KG$20240705$$MD$NL$NL
240545681$24054568$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454668$RANBAXY$Simone C, Axelband J. Levetiracetam-associated Rhabdomyolysis. Am J Respir Crit Care Med. 2024;209:A5704$20$YR$$M$Y$$$20240705$$HP$US$US
240545691$24054569$1$I$$20240622$20240705$20240705$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455480$RANBAXY$Lumchee M, Yue M, Laurie J, Morton A.. Therapeutic plasma exchange for Graves^ disease in pregnancy. Obstet Med. 2023;16 (2):126-129$33$YR$$F$Y$$$20240705$$HP$AU$AU
240545701$24054570$1$I$20240229$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454492$RANBAXY$$73$YR$$F$Y$65$KG$20240705$$MD$FR$FR
240545711$24054571$1$I$20220330$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455351$RANBAXY$$23$YR$$M$Y$$$20240705$$MD$FR$FR
240545721$24054572$1$I$$20240621$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455157$RANBAXY$Manjunath J, Liao V, Kambala A, Bao A, Kollhoff AL, Ma EZ, et al. Immune stimulus exposure as a trigger for the development of chronic pruritus and circulating blood type 2 inflammation. JAAD INT. 2024;16 (0):97-102$54$YR$$M$Y$$$20240705$$HP$US$US
240545731$24054573$1$I$$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002251$ELI LILLY AND CO$$$$$$Y$$$20240705$$CN$US$US
240545741$24054574$1$I$$20240620$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454576$RANBAXY$Gooding K, Salunke R, Fiscus G, Quental A, Kaur A. Beating to Its Own Drum; Flecainide Toxicity and Cardiogenic Shock in a Patient With Dual-Chamber Pacemaker. Am J Respir Crit Care Med. 2024;209:A5667$76$YR$$F$Y$$$20240705$$HP$US$US
240545751$24054575$1$I$$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407001978$ELI LILLY AND CO$$63$YR$A$$Y$$$20240705$$CN$US$US
240545762$24054576$2$F$$20240730$20240705$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407001972$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240801$$CN$US$US
240545771$24054577$1$I$20231101$20240628$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407000544$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240705$$CN$US$US
240545791$24054579$1$I$$20240625$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406017576$ELI LILLY AND CO$$30$YR$A$$Y$$$20240705$$LW$US$US
240545801$24054580$1$I$20220101$20240625$20240705$20240705$EXP$$CZ-EMD Serono-2024025685$EMD SERONO INC$Dolezalova B. Glucose sensors: support in the treatment of all types of diabetes. CURRENT MEDICINE. 2024;8(1): 32-36.$57$YR$A$F$Y$$$20240705$$MD$CZ$CZ
240545811$24054581$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46692$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240545821$24054582$1$I$20221214$20240702$20240705$20240705$EXP$$CN-CHEPLA-2022012714$CHEPLAPHARM$$48$YR$$M$Y$46$KG$20240705$$MD$COUNTRY NOT SPECIFIED$CN
240545831$24054583$1$I$20240101$20240701$20240705$20240705$EXP$$AR-BIOGEN-2024BI01272035$BIOGEN$$$$$F$Y$$$20240705$$CN$AR$AR
240545841$24054584$1$I$$20240627$20240705$20240705$EXP$$GB-TAKEDA-2024TUS066153$TAKEDA$$$$$F$Y$$$20240705$$CN$GB$GB
240545872$24054587$2$F$20240428$20240708$20240705$20240716$EXP$$US-ZENPEP LLC-2024AIMT01014$AIMMUNE$$$$$$Y$$$20240716$$HP$US$US
240545881$24054588$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46591$$FDA-CTU$$69$YR$$F$N$47.17$KG$20240703$N$$US$
240545901$24054590$1$I$20240614$20240627$20240705$20240705$EXP$$IT-AUROBINDO-AUR-APL-2024-032274$AUROBINDO$$50$YR$$F$Y$$$20240705$$PH$IT$IT
240545911$24054591$1$I$$20240701$20240703$20240703$DIR$FDA-CDER-CTU-2024-46607$$FDA-CTU$$$$$M$N$$$20240701$N$HP$US$
240545921$24054592$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA193715$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240705$$MD$US$US
240545931$24054593$1$I$20240620$20240626$20240705$20240705$PER$$US-SA-2024SA191295$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240705$$MD$US$US
240545941$24054594$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA196044$SANOFI AVENTIS$$$$$M$Y$$$20240705$$CN$US$US
240545951$24054595$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193719$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240705$$MD$US$US
240545961$24054596$1$I$20240101$20240627$20240705$20240705$PER$$US-SA-2024SA194523$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240705$$MD$US$US
240545971$24054597$1$I$20240618$20240620$20240705$20240705$PER$$US-SA-2024SA186822$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240705$$MD$US$US
240545981$24054598$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA197138$SANOFI AVENTIS$$$$A$F$Y$77.1$KG$20240705$$MD$US$US
240545991$24054599$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA194453$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240705$$MD$US$US
240546001$24054600$1$I$$20240701$20240705$20240705$PER$$US-ROCHE-10000015591$ROCHE$Cole E, Dedania V, Demirci H. Occlusive Vasculitis Following Intravitreal Rituximab Injection for Primary Vitreoretinal Lymphoma. Ocular immunology and inflammation. 2024-Jun-24;1-5. doi:10.1080/09273948.2024.2367270.$50$YR$A$F$Y$$$20240705$$MD$US$US
240546011$24054601$1$I$$20240621$20240705$20240705$PER$$US-SA-2024SA189344$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240705$$MD$US$US
240546021$24054602$1$I$$20240212$20240705$20240705$PER$$US-AMGEN-USASP2024130132$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240546031$24054603$1$I$$20230201$20240705$20240705$PER$$US-AMGEN-USASP2023235588$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240546041$24054604$1$I$$20240621$20240705$20240705$EXP$$US-QUAGEN-2024QUALIT00196$QUAGEN PHARMACEUTICALS$Dhairya A. Lakhani.A young man with amnesia after drug overdose.European Journal of Internal Medicine.11-FEB-2024;122:117-118$29$YR$A$M$Y$$$20240705$$HP$US$US
240546051$24054605$1$I$$20240629$20240705$20240705$PER$$US-AMGEN-USASP2024128998$AMGEN$Vesely M.; Singh K.; Breidbart R. et al.. Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab. JAAD Case Reports. 2024;49:102-105$40$YR$A$F$Y$$$20240705$$MD$US$US
240546061$24054606$1$I$$20240627$20240705$20240705$EXP$$PL-AUROBINDO-AUR-APL-2024-032123$AUROBINDO$Welian-Polus I, Mazur B, Bielak M, Mazur M, Rypulak E, Wilanowska W et al.. Aggravation of Cardiovascular and Respiratory Decline in Advanced Duchenne Muscular Dystrophy Complicated by Dilated Cardiomyopathy - Case Study and Review of Literature.. Journal of Education, Health and Sport.. 2024;68(1):1-15$28$YR$$M$Y$$$20240705$$HP$PL$PL
240546071$24054607$1$I$20240617$20240621$20240705$20240705$EXP$$BR-BAXTER-2024BAX020718$BAXTER$$38$YR$$F$Y$63$KG$20240705$$CN$BR$BR
240546092$24054609$2$F$20210101$20240912$20240705$20240916$PER$$US-GILEAD-2024-0679561$GILEAD$$57$YR$A$F$Y$$$20240916$$LW$US$US
240546101$24054610$1$I$20230905$20240702$20240705$20240705$EXP$$CA-GSK-CA2023082293$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$CA$CA
240546131$24054613$1$I$$20240626$20240705$20240705$EXP$$US-BAXTER-2024BAX020807$BAXTER$$3$DEC$$F$Y$$$20240705$$HP$US$US
240546141$24054614$1$I$$20240703$20240705$20240705$EXP$$PH-TAKEDA-2024TUS068101$TAKEDA$$$$$M$Y$$$20240705$$MD$PH$PH
240546152$24054615$2$F$$20240709$20240705$20240710$PER$$US-JNJFOC-20240666559$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$HP$US$US
240546161$24054616$1$I$20240605$20240625$20240705$20240705$EXP$CN-NMPACDR-3310021059353202400258$CN-BAXTER-2024BAX020758$BAXTER$$75$YR$$M$Y$56.7$KG$20240705$$MD$CN$CN
240546171$24054617$1$I$$20240623$20240705$20240705$EXP$$IT-Long Grove-000057$Long Grove Pharmaceuticals$Cianci V, Pitrone C, Sapienza D, Meduri A, Ieni A, Gualniera P, et.al. Fatal Outcome Due to Kounis Syndrome Following Fluorescein Retinal Angiography: A Case Report. Diagnostics (Basel). 2024 May 24;14(11):1092$80$YR$E$M$Y$$$20240705$$HP$IT$IT
240546181$24054618$1$I$$20240623$20240705$20240705$EXP$$IT-Nexus Pharma-000289$NEXUS PHARMACEUTICALS$Cianci V, Pitrone C, Sapienza D, Meduri A, Ieni A, Gualniera P, et.al. Fatal Outcome Due to Kounis Syndrome Following Fluorescein Retinal Angiography: A Case Report. Diagnostics (Basel). 2024 May 24;14(11):1092$80$YR$E$M$Y$$$20240705$$HP$IT$IT
240546191$24054619$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3215040$TEVA$$71$YR$$M$Y$$$20240705$$HP$CA$CA
240546201$24054620$1$I$$20240623$20240705$20240705$EXP$$US-Indicus Pharma-001023$INDICUS$Al-Moussally F, Tien JJ, Rajagopalan K, Boterosuarez C, Crouse R. Euglycemic Ketoacidosis and Lactic Acidosis Associated with Metformin Toxicity. Cureus. 2024 May 20;16(5): e60661.$67$YR$E$F$Y$$$20240705$$HP$US$US
240546212$24054621$2$F$20240618$20240710$20240705$20240721$EXP$$AU-BAXTER-2024BAX020768$BAXTER$$73$YR$$M$Y$86.7$KG$20240719$$MD$AU$AU
240546221$24054622$1$I$$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024133311$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240546231$24054623$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131166$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240546241$24054624$1$I$$20240625$20240705$20240705$EXP$AU-TGA-802760$AU-Accord-432347$ACCORD$$$$$M$Y$$$20240705$$CN$AU$AU
240546251$24054625$1$I$$20240701$20240705$20240705$PER$$US-ROCHE-10000016387$ROCHE$Cole E, Dedania V, Demirci H. Occlusive Vasculitis Following Intravitreal Rituximab Injection for Primary Vitreoretinal Lymphoma. Ocular immunology and inflammation. 2024-Jun-24;1-5. doi:10.1080/09273948.2024.2367270.$70$YR$E$M$Y$$$20240705$$MD$US$US
240546261$24054626$1$I$$20240625$20240705$20240705$EXP$CA-MHPD-E2B_07102418$CA-Accord-432692$ACCORD$$701$MON$A$M$Y$$$20240705$$CN$CA$CA
240546272$24054627$2$F$20240623$20240717$20240705$20240725$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13204$IPSEN$$28$YR$A$F$Y$46.2$KG$20240725$$CN$US$US
240546281$24054628$1$I$20240306$20240626$20240705$20240705$EXP$$BG-TAKEDA-2024TUS024255$TAKEDA$$78$YR$$F$Y$40$KG$20240705$$CN$BG$BG
240546291$24054629$1$I$20240626$20240702$20240705$20240705$EXP$$CA-TAKEDA-2024TUS068055$TAKEDA$$63$YR$$F$Y$$$20240705$$CN$CA$CA
240546301$24054630$1$I$$20240701$20240705$20240705$PER$$US-ROCHE-10000016385$ROCHE$Cole E, Dedania V, Demirci H. Occlusive Vasculitis Following Intravitreal Rituximab Injection for Primary Vitreoretinal Lymphoma. Ocular immunology and inflammation. 2024-Jun-24;1-5. doi:10.1080/09273948.2024.2367270.$66$YR$E$F$Y$$$20240705$$MD$US$US
240546311$24054631$1$I$20211221$20240625$20240705$20240705$EXP$$HU-Accord-432950$ACCORD$Alexandra, B., Bela, B.. Broken Hearted Women^s Club: Myth or Reality? MINOCA - Takotsubo cardiomyopathy - case report. LAM 2024;34(4) :205-211.$40$YR$A$F$Y$$$20240705$$MD$HU$HU
240546321$24054632$1$I$$20240210$20240705$20240705$PER$$US-ABBVIE-5828559$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240546331$24054633$1$I$$20240621$20240705$20240705$PER$$US-ROCHE-10000010828$ROCHE$$$$$$Y$$$20240705$$MD$US$US
240546342$24054634$2$F$20240101$20240626$20240705$20240822$EXP$$FR-REGENERON PHARMACEUTICALS, INC.-2024-084261$REGENERON$$54$YR$$F$Y$$$20240822$$MD$FR$FR
240546351$24054635$1$I$$20240628$20240705$20240705$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007957$STRIDES$Wu LW, Qasim Hussaini SM, Lee JW, Shu DH, Hruban RH, Laheru DA.. Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma-two case reports.. Ann-Pancreat-Cancer. 2022;5$$$$$Y$$$20240705$$MD$US$US
240546372$24054637$2$F$$20240904$20240705$20240905$EXP$$NVSC2024BR139239$NOVARTIS$$$$$F$Y$$$20240905$$MD$BR$BR
240546392$24054639$2$F$$20230307$20240705$20240708$EXP$$NVSC2023CA280783$NOVARTIS$$44$YR$$F$Y$70$KG$20240708$$HP$CA$CA
240546402$24054640$2$F$$20240801$20240705$20240805$EXP$$JP-EXELIXIS-CABO-24079124$EXELIXIS$$8$DEC$$M$Y$$$20240805$$MD$JP$JP
240546412$24054641$2$F$$20240709$20240705$20240716$EXP$$US-EMD Serono-2024035591$EMD SERONO INC$$$$A$F$Y$$$20240716$$CN$US$US
240546421$24054642$1$I$$20240624$20240705$20240705$30DAY$$US-JNJFOC-20240711848$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240546431$24054643$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214748$TEVA$$69$YR$$F$Y$$$20240705$$HP$CA$CA
240546441$24054644$1$I$$20240701$20240705$20240705$EXP$$JP-PFIZER INC-PV202400086571$PFIZER$Shibagaki, K. A case of primary central nervous system lymphomatoid granulomatosis with visual field disorders. The 97th Chugoku Shikoku Branch Meeting of the Japan Neurosurgical Society. 2024;97th$7$DEC$$M$Y$$$20240705$$HP$JP$JP
240546452$24054645$2$F$$20240702$20240705$20240710$EXP$$NL-PFIZER INC-PV202400087938$PFIZER$Van Schaik, A.. Gezien Hevige vulvaire pijn. Medisch contact. 2024;79 (26):26-27$24$YR$$F$Y$$$20240710$$MD$NL$NL
240546461$24054646$1$I$$20240627$20240705$20240705$EXP$$US-GSK-US2024080213$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$MD$US$US
240546471$24054647$1$I$$20240626$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR081402$VIIV$$52$YR$$M$Y$$$20240705$$HP$US$US
240546482$24054648$2$F$$20240708$20240705$20240712$EXP$$TW-PFIZER INC-PV202400087053$PFIZER$Liu, C.. Combined Dacomitinib and Selpercatinib Treatment for a Patient with EGFR-Mutant Non-Small Cell Lung Cancer and Acquired CCDC6-RET Fusion. OncoTargets and Therapy. 2024;17:499-506$68$YR$$M$Y$$$20240712$$HP$TW$TW
240546491$24054649$1$I$$20240628$20240705$20240705$30DAY$$US-GSK-US2024AMR081401$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$PH$US$US
240546502$24054650$2$F$$20240704$20240705$20240709$EXP$$CN-PFIZER INC-202400206588$PFIZER$Hu, Y.. A late-onset hyperammonemia syndrome caused by Ureaplasma parvum infection after kidney transplantation. Heliyon. 2024;10(11):e32134$64$YR$$M$Y$$$20240709$$MD$CN$CN
240546511$24054651$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131977$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240546521$24054652$1$I$$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132579$AMGEN$$54$YR$A$F$Y$$$20240705$$PH$US$US
240546531$24054653$1$I$$20230526$20240705$20240705$PER$$US-AMGEN-USASP2023235594$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240546551$24054655$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05798$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240546561$24054656$1$I$$20240624$20240705$20240705$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05733$LUPIN$Chowdhury T, Mainali A, Uprety N, Bisural R, Adhikari S, Gousy N, et al. The deadly duel: Legionnaires disease and multiple myeloma: A case of fatal pulmonary renal syndrome. American Journal of Respiratory and Critical Care Medicine. 2024;209$57$YR$$M$Y$$$20240705$$HP$US$US
240546571$24054657$1$I$20240331$20240408$20240705$20240705$PER$$US-Stallergenes SAS-2158868$STALLERGENES$$6$YR$$F$Y$$$20240705$$PH$US$US
240546581$24054658$1$I$$20240701$20240705$20240705$EXP$$CA-002147023-NVSC2020CA282677$Haleon PLC$$63$YR$$F$Y$$$20240705$$HP$CA$CA
240546591$24054659$1$I$20240623$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46686$$FDA-CTU$$54$YR$$M$N$$$20240703$Y$PH$US$
240546601$24054660$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46594$$FDA-CTU$$83$YR$$F$N$$$20240703$N$$US$
240546621$24054662$1$I$20240101$20240701$20240705$20240705$PER$$US-UNITED THERAPEUTICS-UNT-2024-020357$UNITED THERAPEUTICS$$$$$F$Y$96.145$KG$20240705$$$US$US
240546631$24054663$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214716$TEVA$$19$YR$$F$Y$64$KG$20240705$$HP$CA$CA
240546641$24054664$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46633$$FDA-CTU$$43$YR$$F$N$$$20240703$N$$US$
240546651$24054665$1$I$$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46630$$FDA-CTU$$$$$M$N$$$20240702$N$HP$US$
240546661$24054666$1$I$$20240623$20240705$20240705$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453294$RANBAXY$$$$$M$Y$$$20240705$$CN$IN$IN
240546671$24054667$1$I$$20240622$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455156$RANBAXY$Williams LA, Adamski J, Kinard TN, ErtzArchambault NM, Lu Q, Gray K, et al. The first reported use of red blood cell exchange to treat hemoglobin Evans with secondary methemoglobinemia. J Clin Apher. 2023;38:755-759$60$YR$$M$Y$$$20240705$$MD$US$US
240546681$24054668$1$I$20240304$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455087$RANBAXY$$64$YR$$F$Y$53$KG$20240705$$PH$FR$FR
240546692$24054669$2$F$20220804$20240912$20240705$20240918$PER$$US-GILEAD-2024-0679562$GILEAD$$50$YR$A$F$Y$$$20240918$$LW$US$US
240546701$24054670$1$I$$20240622$20240705$20240705$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455326$RANBAXY$Yan T, Xie Y, Liu Y, Shan Y, Wu X, Wang J, et al. Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types. Front Immunol. 2023;14:1194088/1-10$87$YR$$F$Y$$$20240705$$HP$CN$CN
240546711$24054671$1$I$$20240701$20240705$20240705$EXP$$US-TAKEDA-2024TUS066957$TAKEDA$$67$YR$$F$Y$$$20240705$$MD$US$US
240546721$24054672$1$I$$20240621$20240705$20240705$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-12SUNOX23P$RANBAXY$Racca P, Spadi R, Fora G, Fanchini L, Ritorto G, Ferrari L, et al. Hemolytic uremic syndrome induced by infusion of oxaliplatin: a case report. Tumoti. 2011;97(5):31e-33e$49$YR$$F$Y$$$20240705$$MD$IT$IT
240546731$24054673$1$I$$20240622$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455140$RANBAXY$Gualano FM, Hassoun P, Carter CL, Hanson D. Embryonal tumor with multilayered rosettes: Post-treatment maturation and implications for future therapy. Cancer Rep. 2023;6 (5):e1812 (1-7)$5$MON$$F$Y$$$20240705$$HP$US$US
240546741$24054674$1$I$$20240622$20240705$20240705$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455324$RANBAXY$Yan T, Xie Y, Liu Y, Shan Y, Wu X, Wang J, et al. Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types. Front Immunol. 2023;14:1194088/1-10$79$YR$$F$Y$$$20240705$$HP$CN$CN
240546751$24054675$1$I$$20240621$20240705$20240705$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455091$RANBAXY$$$$$M$Y$$$20240705$$MD$GB$GB
240546761$24054676$1$I$$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455079$RANBAXY$$44$YR$$F$Y$$$20240705$$MD$FR$FR
240546771$24054677$1$I$$20240622$20240705$20240705$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455344$RANBAXY$Yan T, Xie Y, Liu Y, Shan Y, Wu X, Wang J, et al. Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types. Front Immunol. 2023;14:1194088/1-10$84$YR$$F$Y$$$20240705$$HP$CN$CN
240546781$24054678$1$I$$20240622$20240705$20240705$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455327$RANBAXY$Yan T, Xie Y, Liu Y, Shan Y, Wu X, Wang J, et al. Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types. Front Immunol. 2023;14:1194088/1-10$79$YR$$F$Y$$$20240705$$HP$CN$CN
240546791$24054679$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA164134$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240705$$MD$US$US
240546801$24054680$1$I$20240625$20240626$20240705$20240705$PER$$US-SA-2024SA193731$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240705$$MD$US$US
240546811$24054681$1$I$$20240701$20240705$20240705$PER$$US-SA-2024SA196688$SANOFI AVENTIS$$$$A$M$Y$$$20240705$$MD$US$US
240546821$24054682$1$I$$20240622$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455214$RANBAXY$Puri A, Iusim S. Dust to Dawn: A Case of Complicated Silicosis With Progressive Massive Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024;209:A5983$57$YR$$M$Y$$$20240705$$HP$US$US
240546831$24054683$1$I$$20240622$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455212$RANBAXY$Zemel MC, Hughes A, Wong WW. A Tale of Two Chest Tubes, Marijuana Versus Sarcoid. Am J Respir Crit Care Med. 2024;209 (0):A5918$27$YR$$M$Y$$$20240705$$HP$US$US
240546841$24054684$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193239$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240705$$HP$US$US
240546852$24054685$2$F$$20240729$20240705$20240730$PER$$US-JNJFOC-20240674199$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$HP$US$US
240546861$24054686$1$I$20230101$20240702$20240705$20240705$EXP$$GB-ABBVIE-5826076$ABBVIE$$$$$$Y$$$20240705$$MD$GB$GB
240546871$24054687$1$I$20240424$20240704$20240705$20240705$EXP$GB-MHRA-MED-202405031013598790-BDRCS$GB-TAKEDA-2024TUS068000$TAKEDA$$$$$F$Y$$$20240705$$HP$GB$GB
240546881$24054688$1$I$$20240626$20240705$20240705$EXP$$US-STERISCIENCE B.V.-2024-ST-000965$Steriscience PTE$Folkerth R, Jayakumar J, Manesh A, Pandurangan K, Perl D, Priemer D, et al.. Comparison of neuropathologies among rabies patients treated with standard, Milwaukee, and/or experimental AAV-RAB strategies.. J-Neuropathol-Exp-Neurol. 2024;83 (6):453$17$YR$$M$Y$$$20240705$$HP$US$US
240546891$24054689$1$I$$20240626$20240705$20240705$EXP$CN-MLMSERVICE-20240522-PI069095-00117-2$CN-STRIDES ARCOLAB LIMITED-2024SP007824$STRIDES$Bo Y, Zhong X, Xiang Y, Ren Q, Hao P.. Death Caused by Disseminated Herpes Zoster in a Patient with Multiple Myeloma: A Case Report and Literature Review.. Clin-Cosmet-Invest-Dermatol. 2024;17:941-951$58$YR$$M$Y$$$20240705$$HP$CN$CN
240546901$24054690$1$I$$20240624$20240705$20240705$EXP$$IN-STERISCIENCE B.V.-2024-ST-000968$Steriscience PTE$Selvan AT, Agarwal I, Behera B, Singh S. Scrub typhus in pregnancy: A report of two cases.. Obstet-Med. 2024;17 (1):58-60$$$N$F$Y$1.545$KG$20240705$$HP$IN$IN
240546911$24054691$1$I$$20240624$20240705$20240705$EXP$$IN-STERISCIENCE B.V.-2024-ST-000967$Steriscience PTE$Selvan AT, Agarwal I, Behera B, Singh S.. Scrub typhus in pregnancy: A report of two cases.. Obstet-Med. 2024;17 (1):58-60.$24$YR$$F$Y$$$20240705$$HP$IN$IN
240546921$24054692$1$I$$20240624$20240705$20240705$EXP$$JP-STERISCIENCE B.V.-2024-ST-000947$Steriscience PTE$Sako Y, Fujihara T, Ishida R, Sato M, Sato H, Yamamoto T, et al. Fatal Severe Fever with Thrombocytopenia Syndrome Virus and Pasteurella multocida Coinfection. Intern-Med. 2024;63 (5):749-752$65$YR$$M$Y$$$20240705$$HP$JP$JP
240546931$24054693$1$I$$20240624$20240705$20240705$EXP$$US-STERISCIENCE B.V.-2024-ST-000948$Steriscience PTE$Meland J, Bockerstett K, Desai N, Vaidyan N, Ferguson K. A Rare Case of Candida Auris Fungemia Leading to Cardiac Arrest. Am-J-Respir-Crit-Care-Med. 2024;209$83$YR$$M$Y$$$20240705$$HP$US$US
240546941$24054694$1$I$$20240624$20240705$20240705$EXP$$US-STERISCIENCE B.V.-2024-ST-000950$Steriscience PTE$Chowdhury T, Mainali A, Uprety N, Bisural R, Adhikari S, Gousy N, et al.. The Deadly Duel: Legionnaires Disease and Multiple Myeloma: A Case of Fatal Pulmonary Renal Syndrome.. Am-J-Respir-Crit-Care-Med. 2024;209:A3608 (plus Poster)$57$YR$$M$Y$$$20240705$$HP$US$US
240546951$24054695$1$I$$20240624$20240705$20240705$EXP$$TR-STERISCIENCE B.V.-2024-ST-000958$Steriscience PTE$Akpinar S, Ergun H.. Thoracal Epidural Anaesthesia for Emergency Laparotomies in the Elderly Patients.. Anest-Derg. 2023;31:307-310$69$YR$$$Y$$$20240705$$HP$TR$TR
240546961$24054696$1$I$$20240624$20240705$20240705$EXP$$IN-STERISCIENCE B.V.-2024-ST-000959$Steriscience PTE$Fernandes G, Patil M, Harinkhede N, Khumanthem G, Rojekar A.. Renal allograft failure resulting from diffuse cortical necrosis.. Indian-J-Pathol-Microbiol. 2024;1-4$28$YR$$F$Y$$$20240705$$MD$IN$IN
240546971$24054697$1$I$$20240624$20240705$20240705$EXP$$US-STERISCIENCE B.V.-2024-ST-000941$Steriscience PTE$Rabah AK, Ahmed R, Duarte A, Wang-kocik C. A Rare Cause of Toxic Shock Syndrome.. Am-J-Respir-Crit-Care-Med. 2024;209$38$YR$$M$Y$$$20240705$$HP$US$US
240546981$24054698$1$I$$20240624$20240705$20240705$EXP$$CN-STERISCIENCE B.V.-2024-ST-000945$Steriscience PTE$Ge T, Xie X, Liu J. A rare case of pheochromocytoma in a pregnant woman presenting with chest pain: extraordinary management.. BMC-Cardiovasc-Disord. 2024;24$32$YR$$F$Y$$$20240705$$HP$CN$CN
240546991$24054699$1$I$$20240624$20240705$20240705$EXP$$US-STERISCIENCE B.V.-2024-ST-000949$Steriscience PTE$Okura M, Sheikhan N, Thind GS.. First Case of Elizabethkingia Lung Infection Strikes Central Valley California.. Am-J-Respir-Crit-Care-Med. 2024;209:A6009 (plus Poster).$24$YR$$F$Y$$$20240705$$HP$US$US
240547001$24054700$1$I$$20240624$20240705$20240705$EXP$$JP-STERISCIENCE B.V.-2019-ST-000004$Steriscience PTE$Furumi Y, Shimizu S, Ogawa Y, Hirose D, Takada Y, Kanetaka H et al.. A suspicious case of coagulation disorder caused by vitamin K deficiency associated with fasting and antibiotics. Nihon Ronen Igakkai zasshi.. Japanese journal of geriatrics.. 2019;56(2):204-208.$91$YR$$M$Y$$$20240705$$PH$JP$JP
240547011$24054701$1$I$$20240624$20240705$20240705$EXP$$CN-STERISCIENCE B.V.-2024-ST-000946$Steriscience PTE$Ge T, Xie X, Liu J. A rare case of pheochromocytoma in a pregnant woman presenting with chest pain: extraordinary management.. BMC-Cardiovasc-Disord. 2024;24$$$N$$Y$0.905$KG$20240705$$HP$CN$CN
240547021$24054702$1$I$$20240701$20240705$20240705$PER$$NVSC2024US138276$NOVARTIS$$44$YR$$M$Y$$$20240705$$CN$US$US
240547031$24054703$1$I$20240701$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131913$AMGEN$$77$YR$E$M$Y$$$20240705$$CN$US$US
240547041$24054704$1$I$$20240624$20240705$20240705$EXP$$TR-STERISCIENCE B.V.-2024-ST-000957$Steriscience PTE$Akpinar S, Ergun H.. Thoracal Epidural Anaesthesia for Emergency Laparotomies in the Elderly Patients.. Anest-Derg. 2023;31:307-310$90$YR$$M$Y$$$20240705$$HP$TR$TR
240547051$24054705$1$I$$20240624$20240705$20240705$EXP$$RO-STERISCIENCE B.V.-2024-ST-000951$Steriscience PTE$Marza AM, Barsac C, Sutoi D, Cindrea AC, Herlo A, Trebuian CI, et al.. Cardiac Arrest and Complete Heart Block: Complications after Electrical Cardioversion for Unstable Supraventricular Tachycardia in the Emergency Department.. J-Pers-Med. 2024;14 (3)$53$YR$$M$Y$$$20240705$$HP$RO$RO
240547061$24054706$1$I$$20240701$20240705$20240705$EXP$$US-AMGEN-USASP2024131811$AMGEN$Hoyek C.; Zheng-lin B.; Abidoye O. et al.. Post-treatment ctDNA analysis reveals patterns of HER2therapy resistance in advanced HER2-amplified colorectal cancer. Annals of Oncology. 2024;35 (S1):S33$$$$$Y$$$20240705$$HP$US$US
240547071$24054707$1$I$$20230905$20240705$20240705$PER$$US-AMGEN-USASP2023235556$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240547082$24054708$2$F$20240628$20240823$20240705$20240827$PER$$US-AMGEN-USASP2024129964$AMGEN$$80$YR$E$M$Y$$$20240827$$CN$US$US
240547091$24054709$1$I$$20240701$20240705$20240705$EXP$$TW-AMGEN-TWNSP2024132897$AMGEN$Jaing T.; Wang Y.; Chang T. et al.. Blinatumomab in Children with MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 11 Cases. Hematology Reports. 2024;16:347-353$12$YR$T$F$Y$$$20240705$$HP$TW$TW
240547102$24054710$2$F$$20240724$20240705$20240726$PER$$US-AMGEN-USASP2024131523$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
240547111$24054711$1$I$$20240702$20240705$20240705$PER$$US-TAKEDA-2024TUS067628$TAKEDA$$$$$$Y$$$20240705$$CN$US$US
240547121$24054712$1$I$$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151383$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240547131$24054713$1$I$$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A150290$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240547141$24054714$1$I$$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A148948$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240547151$24054715$1$I$20240215$20240625$20240705$20240705$EXP$$PK-ROCHE-10000014094$ROCHE$$30$YR$A$M$Y$$$20240705$$CN$PK$PK
240547161$24054716$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5827592$ABBVIE$$$$$$Y$$$20240705$$HP$US$US
240547171$24054717$1$I$20240624$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024132221$AMGEN$$60$YR$A$$Y$$$20240705$$CN$US$US
240547181$24054718$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003000$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240705$$CN$US$US
240547192$24054719$2$F$20231101$20240917$20240705$20240926$EXP$$PT-EMD Serono-2024036169$EMD SERONO INC$$47$YR$A$F$Y$$$20240926$$CN$PT$PT
240547201$24054720$1$I$20240627$20240628$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407000377$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240705$$CN$US$US
240547211$24054721$1$I$20240101$20240704$20240705$20240705$EXP$GB-MHRA-MED-202405042231105190-PZMTW$GB-JNJFOC-20240713464$JOHNSON AND JOHNSON$$$$$F$Y$71$KG$20240705$$CN$GB$GB
240547221$24054722$1$I$20240614$20240621$20240705$20240705$EXP$$GB-MDD US Operations-E2B_00006353$MDD OPERATIONS$$68$YR$$M$Y$$$20240705$$HP$GB$GB
240547241$24054724$1$I$20140528$20240626$20240705$20240705$EXP$GR-GREOF-202400660$GR-TEVA-VS-3215177$TEVA$$61$YR$$F$Y$70$KG$20240705$$MD$GR$GR
240547253$24054725$3$F$20180205$20240913$20240705$20240917$PER$$US-GILEAD-2024-0679564$GILEAD$$47$YR$A$M$Y$$$20240917$$LW$US$US
240547261$24054726$1$I$$20240627$20240705$20240705$EXP$$US-ROCHE-10000014534$ROCHE$$61$YR$A$F$Y$$$20240705$$CN$US$US
240547271$24054727$1$I$$20240701$20240705$20240705$EXP$$VN-AMGEN-VNMSP2024131716$AMGEN$Hoang H. T.. Result of atezolizumab plus bevacizumab for advanced or metastatic hepatocellular carcinoma in Vietnamese patients. Annals of Oncology. 2024;35:S88$$$$$Y$$$20240705$$HP$VN$VN
240547283$24054728$3$F$20240702$20240822$20240705$20240827$PER$$US-AMGEN-USASP2024131577$AMGEN$$82$YR$E$F$Y$$$20240826$$CN$US$US
240547291$24054729$1$I$$20240627$20240705$20240705$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP007938$STRIDES$Nathi D, Vinarkar SS, Chowdhury SS, Parihar M, Kumar J, Nair R, et al.. Unraveling Ibrutinib Resistance in Chronic Lymphocytic Leukemia: A Case Study on the Role of Bruton Tyrosine Kinase Mutation. Indian-J-Hematol-Blood-Transf. 2023;39:S185-S186.$67$YR$$F$Y$$$20240705$$HP$IN$IN
240547302$24054730$2$F$20240224$20240705$20240705$20240710$EXP$$CA-UCBSA-2024011062$UCB$$53$YR$$F$Y$$$20240710$$CN$CA$CA
240547311$24054731$1$I$20240501$20240705$20240705$20240705$EXP$GB-MHRA-MED-202405081549204060-JKDRF$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037996$BOEHRINGER INGELHEIM$$$$$M$Y$106$KG$20240705$$PH$GB$GB
240547321$24054732$1$I$$20240624$20240705$20240705$EXP$$JP-ABBVIE-5826323$ABBVIE$Sasaki T, Shindo Y, Kikuchi K, Kawamata Y, Sugawara N, Yasui Furukori N. Vortioxetine induced syndrome of inappropriate secretion of antidiuretic hormone: A case report. Neuropsychopharm Rep. 2024;44(2):479-481.; Sasaki T, Shindo Y, Kikuchi K, Kawamata Y, Sugawara N, Yasui Furukori N. Vortioxetine induced syndrome of inappropriate secretion of antidiuretic hormone: A case report. Neuropsychopharm Rep. 2024;44(2):479-481.$74$YR$$M$Y$$$20240705$$HP$JP$JP
240547331$24054733$1$I$20240524$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46665$$FDA-CTU$$73$YR$$F$N$$$20240703$Y$PH$US$
240547341$24054734$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46694$$FDA-CTU$$77$YR$$M$N$$$20240703$N$$US$
240547352$24054735$2$F$$20240717$20240705$20240722$PER$$US-ROCHE-10000015459$ROCHE$$$$E$F$Y$$$20240722$$CN$US$US
240547361$24054736$1$I$20240703$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46689$$FDA-CTU$$69$YR$$F$N$$$20240703$Y$PH$US$
240547381$24054738$1$I$20240601$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46654$$FDA-CTU$$$$$M$N$$$20240702$N$HP$US$
240547391$24054739$1$I$$20240704$20240705$20240705$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107392$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240705$$CN$CA$CA
240547401$24054740$1$I$20240201$20240626$20240705$20240705$EXP$GB-MHRA-MED-202406251436015840-SWCZQ$GB-MSNLABS-2024MSNSPO01464$MSN LABORATORIES$$$$$$Y$$$20240705$$CN$GB$GB
240547412$24054741$2$F$20240401$20240911$20240705$20240919$EXP$$JP-009507513-2406JPN003990J$MERCK$$71$YR$$M$Y$$$20240919$$MD$JP$JP
240547423$24054742$3$F$20240604$20240920$20240705$20240925$EXP$$JP-009507513-2406JPN000187J$MERCK$$97$YR$$M$Y$$$20240925$$MD$JP$JP
240547431$24054743$1$I$$20240624$20240705$20240705$EXP$$US-ABBVIE-5828578$ABBVIE$Santosh N, Savani S, Iskapalli S. Beefing Up! Fulminant Liver Failure Secondary to Anabolic Steroid Use. Am J Respir Crit Care Med. 2024;209:A5688.$30$YR$$M$Y$$$20240705$$HP$US$US
240547443$24054744$3$F$20141116$20240913$20240705$20240918$PER$$US-GILEAD-2024-0679566$GILEAD$$37$YR$A$M$Y$$$20240918$$LW$US$US
240547461$24054746$1$I$20240627$20240627$20240705$20240705$EXP$$DE-EMD Serono-2024035273$EMD SERONO INC$$71$YR$E$F$Y$$$20240705$$CN$DE$DE
240547471$24054747$1$I$20200410$20240630$20240705$20240705$PER$$US-SA-2021SA356957$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240705$$MD$US$US
240547481$24054748$1$I$20240101$20240627$20240705$20240705$PER$$US-SA-2024SA194446$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240705$$MD$US$US
240547491$24054749$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA196066$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240705$$CN$US$US
240547501$24054750$1$I$20240624$20240625$20240705$20240705$EXP$$US-RECORDATI RARE DISEASE INC.-2024004867$RECORDATI$$$$$$Y$$$20240705$$CN$US$US
240547511$24054751$1$I$$20240701$20240705$20240705$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP007945$STRIDES$Kim MY, Jung SY, Hong S, Oh SW, Jin KN, Kim JE, et al.. Establishment and characterization of BMC-PDC-019: a novel patient-derived cell line of EGFR-mutant pulmonary adenocarcinoma transformed into small-cell lung cancer.. Hum-Cell. 2023;36 (6):2179-2186$58$YR$$F$Y$$$20240705$$HP$KR$KR
240547521$24054752$1$I$$20240429$20240705$20240705$PER$$US-AMGEN-USASP2024132378$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240547541$24054754$1$I$20240615$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130475$AMGEN$$67$YR$E$F$Y$$$20240705$$CN$US$US
240547551$24054755$1$I$$20221212$20240705$20240705$PER$$US-AMGEN-USASP2022230363$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240547561$24054756$1$I$20230801$20240626$20240705$20240705$EXP$DE-BFARM-24004349$DE-INSUD PHARMA-2406DE05058$INSUD PHARMA$$22$YR$$F$Y$83$KG$20240705$$MD$DE$DE
240547572$24054757$2$F$20230801$20240801$20240705$20240821$EXP$$FR-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2406FR05138$INSUD PHARMA$$21$YR$$F$Y$$$20240821$$MD$FR$FR
240547581$24054758$1$I$$20240701$20240705$20240705$EXP$GB-MHRA-MED-202406191521210010-ZJBRL$GB-LABORATORIOS LICONSA S.A.-2407GB05166$INSUD PHARMA$$$$$F$Y$$$20240705$$PH$GB$GB
240547592$24054759$2$F$$20240827$20240705$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05990$LUPIN$$$$$$Y$$$20240918$$CN$US$US
240547601$24054760$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05747$LUPIN$$$$$$Y$$$20240705$$PH$US$US
240547611$24054761$1$I$20240601$20240703$20240705$20240705$EXP$$US-UCBSA-2024034067$UCB$$35$YR$$F$Y$$$20240705$$HP$US$US
240547621$24054762$1$I$20240611$20240703$20240705$20240705$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033582$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240705$$MD$JP$JP
240547632$24054763$2$F$$20240725$20240705$20240727$PER$$US-JNJFOC-20240676540$JOHNSON AND JOHNSON$$$$$M$Y$$$20240727$$HP$US$US
240547641$24054764$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024132657$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240547651$24054765$1$I$$20231017$20240705$20240705$PER$$US-AMGEN-USASP2023235547$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240547661$24054766$1$I$$20240122$20240705$20240705$PER$$US-AMGEN-USASP2024131884$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240547671$24054767$1$I$$20230711$20240705$20240705$PER$$US-AMGEN-USASP2023235179$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240547681$24054768$1$I$$20240627$20240705$20240705$EXP$$US-AMGEN-USASP2024128350$AMGEN$Chiou D.; Mooney B.H.; Shi B. et.al.. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240705$$MD$US$US
240547691$24054769$1$I$20240101$20240625$20240705$20240705$EXP$$US-RECORDATI RARE DISEASE INC.-2024003238$RECORDATI$$$$$$Y$$$20240705$$CN$US$US
240547701$24054770$1$I$$20240703$20240705$20240705$EXP$$AU-ABBVIE-5826772$ABBVIE$$$$$F$Y$$$20240705$$CN$AU$AU
240547711$24054771$1$I$20240501$20240626$20240705$20240705$EXP$DE-AMK-276339$DE-TEVA-VS-3215182$TEVA$$61$YR$$F$Y$$$20240705$$PH$DE$DE
240547741$24054774$1$I$20240422$20240702$20240705$20240705$EXP$$US-AstraZeneca-2024A152115$ASTRAZENECA$$26736$DY$$F$Y$$$20240705$$MD$US$
240547752$24054775$2$F$$20240701$20240705$20240705$EXP$$NVSC2024US137680$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
240547761$24054776$1$I$$20240121$20240705$20240705$PER$$US-AMGEN-USASP2024131769$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240547771$24054777$1$I$$20240627$20240705$20240705$EXP$$US-AMGEN-USASP2024128109$AMGEN$Chiou D.; Mooney B.H.; Shi B.et.al. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240705$$MD$US$US
240547781$24054778$1$I$20240607$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46662$$FDA-CTU$$51$YR$$F$N$$$20240703$Y$PH$US$
240547791$24054779$1$I$$20240628$20240705$20240705$EXP$TR-TEVA-VS-3209008$TR-JUBILANT CADISTA PHARMACEUTICALS-2024TR000897$JUBILANT$Atabay E, Arman AR. Olanzapine induced diabetic ketoacidosis. Psychiatr-Clin-Psychopharmacolog. 2019;29(1):129$17$YR$$M$Y$$$20240705$$HP$TR$TR
240547801$24054780$1$I$20240418$20240626$20240705$20240705$EXP$FR-AFSSAPS-TS2024000703$FR-TEVA-VS-3215155$TEVA$$63$YR$$F$Y$$$20240705$$MD$FR$FR
240547811$24054781$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46585$$FDA-CTU$$$$$M$N$$$20240703$N$HP$US$
240547821$24054782$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824815$ABBVIE$$$$$M$Y$$$20240705$$HP$US$US
240547841$24054784$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46572$$FDA-CTU$$78$YR$$F$N$$$20240703$N$CN$US$
240547852$24054785$2$F$20191213$20240913$20240705$20240918$EXP$$US-GILEAD-2024-0679568$GILEAD$$61$YR$A$M$Y$$$20240918$$LW$US$US
240547861$24054786$1$I$$20240628$20240705$20240705$EXP$$CA-AstraZeneca-2024A149902$ASTRAZENECA$$53$YR$$M$Y$$$20240705$$MD$CA$
240547871$24054787$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46601$$FDA-CTU$$$$$M$N$$$20240703$Y$PH$US$
240547881$24054788$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46657$$FDA-CTU$$42$YR$$M$N$63.5$KG$20240703$N$HP$US$
240547901$24054790$1$I$20221023$20240623$20240705$20240705$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454849$RANBAXY$$60$YR$$M$Y$$$20240705$$HP$DE$DE
240547912$24054791$2$F$$20240702$20240705$20240717$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455100$RANBAXY$$$$$M$Y$$$20240717$$CN$GB$GB
240547921$24054792$1$I$$20240622$20240705$20240705$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455320$RANBAXY$Del Casale A, Ferracuti S, Rapinesi C, Serata D, Simonetti A, Caloro M, et al. Factitious disorder comorbid with bipolar I disorder. A case report. Forensic Sci Int. 2012;219:e37-e40$37$YR$$F$Y$$$20240705$$HP$IT$IT
240547931$24054793$1$I$20240212$20240621$20240705$20240705$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455082$RANBAXY$$36$YR$$F$Y$81$KG$20240705$$MD$FR$FR
240547941$24054794$1$I$$20240703$20240705$20240705$EXP$$NO-PFIZER INC-202400205911$PFIZER$Krohn J.. Endogenous fungal endophthalmitis caused by Cladophialophora devriesii: report of a case and literature review. Journal of Ophthalmic Inflammation and Infection. 2024;14:25$73$YR$$F$Y$$$20240705$$MD$NO$NO
240547951$24054795$1$I$$20240624$20240705$20240705$PER$$CA-PFM-2024-03717$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240705$$CN$CA$CA
240547961$24054796$1$I$$20240520$20240705$20240705$PER$$US-Stallergenes SAS-2158870$STALLERGENES$$19$YR$$F$Y$$$20240705$$$US$US
240547981$24054798$1$I$20240625$20240701$20240703$20240703$DIR$FDA-CDER-CTU-2024-46599$$FDA-CTU$$57$YR$$M$N$$$20240701$N$HP$US$
240547991$24054799$1$I$$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46567$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240548001$24054800$1$I$$20240701$20240703$20240703$DIR$FDA-CDER-CTU-2024-46606$$FDA-CTU$$$$$F$N$$$20240701$N$HP$US$
240548011$24054801$1$I$$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46622$$FDA-CTU$$63$YR$$F$N$$$20240703$N$$US$
240548021$24054802$1$I$20240510$20240702$20240703$20240703$DIR$FDA-CDER-CTU-2024-46586$$FDA-CTU$$70$YR$$M$N$$$20240702$N$HP$US$
240548031$24054803$1$I$20240627$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46564$$FDA-CTU$$46$YR$$F$N$$$20240703$N$CN$US$
240548051$24054805$1$I$$20240702$20240705$20240705$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-092991$REGENERON$$$$$M$Y$$$20240705$$CN$US$US
240548062$24054806$2$F$$20240801$20240705$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05995$LUPIN$$$$$$Y$$$20240828$$CN$US$US
240548071$24054807$1$I$$20240624$20240705$20240705$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05730$LUPIN$Okura M, Sheikhan N, Thind GS. First case of Elizabethkingia lung Infection strikes central valley California. American Journal of Respiratory and Critical Care Medicine. 2024;209$24$YR$$F$Y$$$20240705$$HP$US$US
240548081$24054808$1$I$$20240702$20240705$20240705$EXP$$GB-ABBVIE-5825075$ABBVIE$$$$E$F$Y$$$20240705$$CN$GB$GB
240548091$24054809$1$I$$20240202$20240705$20240705$PER$$US-ABBVIE-5829318$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240548101$24054810$1$I$20240620$20240625$20240705$20240705$EXP$$US-JNJFOC-20240675115$JOHNSON AND JOHNSON$$54$YR$A$F$Y$82.4$KG$20240705$$HP$US$US
240548111$24054811$1$I$$20240627$20240705$20240705$EXP$$US-AMGEN-USASP2024128083$AMGEN$Chiou D.; Mooney B. H.; Shi B. et al.. Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment. Journal of Orthopaedic Trauma. 2024;38 (7):e238-e244$$$$$Y$$$20240705$$MD$US$US
240548121$24054812$1$I$$20240627$20240705$20240705$EXP$$US-GSK-US2024080319$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240548131$24054813$1$I$20240514$20240626$20240705$20240705$PER$$US-SA-2024SA191288$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240705$$MD$US$US
240548141$24054814$1$I$20240620$20240628$20240705$20240705$PER$$US-SA-2024SA194847$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240705$$MD$US$US
240548151$24054815$1$I$$20240701$20240705$20240705$PER$$US-SA-2024SA196718$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240705$$CN$US$US
240548161$24054816$1$I$20240512$20240705$20240705$20240705$EXP$GB-MHRA-MED-202405150909206860-HFRDV$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038023$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$74$KG$20240705$$HP$GB$GB
240548173$24054817$3$F$20231218$20240808$20240705$20240816$EXP$$FR-Waylis Therapeutics LLC-ATNAHS20240601859$Waylis$$39$YR$A$F$Y$$$20240815$$CN$FR$FR
240548181$24054818$1$I$20160901$20240626$20240705$20240705$EXP$$US-AMGEN-USASP2024127234$AMGEN$$10$YR$C$M$Y$104.31$KG$20240705$$CN$US$US
240548191$24054819$1$I$$20240215$20240705$20240705$PER$$US-AMGEN-USASP2024133509$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240548201$24054820$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131836$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240548213$24054821$3$F$20240619$20240717$20240705$20240722$PER$$US-ROCHE-10000007418$ROCHE$$77$YR$E$F$Y$85.73$KG$20240722$$CN$US$US
240548222$24054822$2$F$20221011$20240913$20240705$20240918$PER$$US-GILEAD-2024-0679569$GILEAD$$57$YR$A$M$Y$$$20240918$$LW$US$US
240548231$24054823$1$I$20240601$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002914$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240705$$CN$US$US
240548242$24054824$2$F$20240501$20240701$20240705$20240709$EXP$$NVSC2024ZA137466$NOVARTIS$$72$YR$$F$Y$$$20240709$$CN$ZA$ZA
240548251$24054825$1$I$20240101$20240617$20240705$20240705$PER$$US-JNJFOC-20240645892$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240705$$CN$US$US
240548262$24054826$2$F$20240101$20240712$20240705$20240718$EXP$$CA-PFIZER INC-202400206346$PFIZER$$60$YR$$F$Y$$$20240718$$PH$CA$CA
240548273$24054827$3$F$20231201$20240925$20240705$20240927$EXP$$CA-PFIZER INC-202400206371$PFIZER$$81$YR$$F$Y$$$20240927$$HP$CA$CA
240548281$24054828$1$I$20240702$20240703$20240703$20240703$DIR$708964$$FDA-CTU$$$$$UNK$N$$$20240703$N$CN$US$
240548291$24054829$1$I$20240401$20240702$20240705$20240705$EXP$$US-PFIZER INC-PV202300101206$PFIZER$$84$YR$$M$Y$65.77$KG$20240705$$CN$US$US
240548301$24054830$1$I$$20240703$20240705$20240705$EXP$$CN-PFIZER INC-PV202400087698$PFIZER$$$$A$M$Y$$$20240705$$CN$CN$CN
240548311$24054831$1$I$20240614$20240703$20240705$20240705$EXP$$US-PFIZER INC-PV202400087729$PFIZER$$89$YR$$F$Y$$$20240705$$CN$US$US
240548322$24054832$2$F$20240101$20240814$20240705$20240816$EXP$$US-PFIZER INC-PV202400044922$PFIZER$$71$YR$$F$Y$$$20240816$$HP$US$US
240548331$24054833$1$I$$20240626$20240705$20240705$EXP$$AU-PFIZER INC-202400206097$PFIZER$$47$YR$$F$Y$$$20240705$$MD$AU$AU
240548361$24054836$1$I$$20240703$20240705$20240705$EXP$$US-ABBVIE-5827245$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240548371$24054837$1$I$$20240628$20240705$20240705$30DAY$$US-GSK-US2024081053$GLAXOSMITHKLINE$$85$YR$$F$Y$$$20240705$$CN$US$US
240548381$24054838$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06024$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240548391$24054839$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214967$TEVA$$53$YR$$M$Y$70$KG$20240705$$CN$CA$CA
240548401$24054840$1$I$$20240226$20240705$20240705$PER$$US-AMGEN-USASP2024131873$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240548411$24054841$1$I$20240101$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132495$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240548421$24054842$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131930$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240548433$24054843$3$F$20240506$20240710$20240705$20240716$EXP$$ES-MYLANLABS-2024M1061073$MYLAN$$67$YR$$F$Y$69.1$KG$20240716$$HP$ES$ES
240548441$24054844$1$I$$20240704$20240705$20240705$PER$$US-HALEON-2185505$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240548453$24054845$3$F$20240101$20240819$20240705$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000583$DECIPHERA PHARMACEUTICALS$$68$YR$A$M$Y$88.6$KG$20240905$$CN$US$US
240548462$24054846$2$F$20220101$20240722$20240705$20240801$EXP$$DE-INSMED, INC.-2022-01666-DE$INSMED$$$$$F$Y$$$20240801$$HP$DE$DE
240548471$24054847$1$I$$20240624$20240705$20240705$PER$$CA-Waylis Therapeutics LLC-ATNAHS20210802971$Waylis$$83$YR$E$F$Y$$$20240704$$HP$CA$CA
240548481$24054848$1$I$20240507$20240705$20240705$20240705$EXP$GB-MHRA-MED-202405161553542540-MZDKT$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037998$BOEHRINGER INGELHEIM$$52$YR$A$M$Y$111$KG$20240705$$PH$GB$GB
240548491$24054849$1$I$$20240205$20240705$20240705$EXP$$US-BAYER-2024A096952$BAYER$$$$$$Y$$$20240705$$HP$US$US
240548501$24054850$1$I$$20240624$20240705$20240705$EXP$$CA-Waylis Therapeutics LLC-ATNAHS20210300975$Waylis$$54$YR$A$F$Y$$$20240704$$HP$CA$CA
240548511$24054851$1$I$20240101$20240701$20240705$20240705$EXP$$JP-JNJFOC-20240713532$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240705$$PH$JP$JP
240548521$24054852$1$I$20240617$20240627$20240705$20240705$EXP$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00329$Unknown Manufacturer$$$$$$Y$$$20240705$$MD$US$US
240548531$24054853$1$I$20240312$20240628$20240705$20240705$EXP$FR-AFSSAPS-AVMA2024000276$FR-Waylis Therapeutics LLC-ATNAHS20240601881$Waylis$$26$YR$A$M$Y$$$20240704$$PH$FR$FR
240548541$24054854$1$I$$20240703$20240705$20240705$EXP$$US-VIIV HEALTHCARE LIMITED-US2024082607$VIIV$$$$$M$Y$$$20240705$$CN$US$US
240548551$24054855$1$I$$20231129$20240705$20240705$PER$$US-AMGEN-USASP2023235581$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240548561$24054856$1$I$$20240624$20240705$20240705$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-103606$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240705$$PH$AU$AU
240548571$24054857$1$I$20240520$20240626$20240705$20240705$EXP$FR-AFSSAPS-DJ2024000778$FR-TEVA-VS-3215203$TEVA$$61$YR$$M$Y$$$20240705$$MD$FR$FR
240548581$24054858$1$I$$20240627$20240705$20240705$EXP$$VN-AstraZeneca-2024A150257$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$VN$
240548591$24054859$1$I$20240101$20240628$20240705$20240705$EXP$$US-SA-2024SA196900$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240705$$MD$US$US
240548601$24054860$1$I$$20240621$20240705$20240705$EXP$$US-EPICPHARMA-US-2024EPCSPO00775$EPIC PHARM$$$$$F$Y$$$20240705$$MD$US$US
240548611$24054861$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281437236830-WVLTH$GB-RDY-SPO/GBR/24/0009558$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240548621$24054862$1$I$$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A149724$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240548634$24054863$4$F$$20240828$20240705$20240830$PER$$US-AstraZeneca-2024A151605$ASTRAZENECA$$73$YR$$F$Y$$$20240830$$CN$US$
240548641$24054864$1$I$$20240702$20240705$20240705$EXP$$CN-AstraZeneca-2024A153242$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$CN$
240548652$24054865$2$F$20240514$20240627$20240705$20240731$EXP$$CA-AstraZeneca-2022A188695$ASTRAZENECA$$16210$DY$$F$Y$$$20240731$$CN$CA$
240548661$24054866$1$I$20240622$20240703$20240703$20240703$DIR$709043$$FDA-CTU$$77$YR$$UNK$N$$$20240703$N$HP$US$
240548681$24054868$1$I$$20240627$20240705$20240705$PER$$US-SA-2024SA195389$SANOFI AVENTIS$$$$C$F$Y$32.6$KG$20240705$$MD$US$US
240548691$24054869$1$I$20240604$20240630$20240705$20240705$EXP$$CN-SA-2024SA196883$SANOFI AVENTIS$$52$YR$A$M$Y$85$KG$20240705$$HP$CN$CN
240548702$24054870$2$F$20240409$20240819$20240705$20240827$EXP$$IT-IMMUNOCORE, LTD-2024-IMC-002793$IMMUNOCORE$$$$$$Y$$$20240827$$MD$IT$IT
240548713$24054871$3$F$20170101$20240913$20240705$20240916$EXP$$US-GILEAD-2024-0679570$GILEAD$$52$YR$A$M$Y$$$20240916$$LW$US$US
240548721$24054872$1$I$20240208$20240626$20240705$20240705$EXP$FR-AFSSAPS-GR2024000682$FR-TEVA-VS-3215239$TEVA$$40$YR$$F$Y$$$20240705$$PH$FR$FR
240548732$24054873$2$F$20221201$20240711$20240705$20240719$EXP$$IT-BAYER-2024A092682$BAYER$$39$YR$A$F$Y$56$KG$20240719$$MD$IT$IT
240548742$24054874$2$F$20240124$20240723$20240705$20240802$EXP$$PK-ROCHE-10000016487$ROCHE$$52$YR$A$F$Y$$$20240802$$CN$PK$PK
240548751$24054875$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05991$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240548762$24054876$2$F$20221120$20240916$20240705$20240918$EXP$$US-GILEAD-2024-0679487$GILEAD$$51$YR$A$F$Y$$$20240918$$LW$US$US
240548771$24054877$1$I$$20240626$20240705$20240705$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01016$AIMMUNE$$$$$$Y$$$20240705$$CN$US$US
240548781$24054878$1$I$20240629$20240630$20240705$20240705$PER$$US-UNITED THERAPEUTICS-UNT-2024-020171$UNITED THERAPEUTICS$$87$YR$$F$Y$49.887$KG$20240705$$$US$US
240548791$24054879$1$I$20240601$20240625$20240705$20240705$PER$$US-TEVA-VS-3214276$TEVA$$44$YR$$F$Y$$$20240705$$PH$US$US
240548801$24054880$1$I$$20240703$20240705$20240705$EXP$$US-TAKEDA-2020TUS052796$TAKEDA$$$$$M$Y$$$20240705$$CN$US$US
240548812$24054881$2$F$$20240802$20240705$20240810$PER$$US-ALXN-202406USA001892US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240810$$CN$US$US
240548821$24054882$1$I$$20240506$20240705$20240705$PER$$US-ABBVIE-5818643$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240548831$24054883$1$I$20240624$20240627$20240705$20240705$EXP$GB-MHRA-MED-202406261953331850-BRFYG$GB-Atnahs Limited-ATNAHS20240701888$Atnahs Healthcare$$39$YR$A$M$Y$$$20240705$$HP$GB$GB
240548842$24054884$2$F$20240601$20240822$20240705$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-019055$UNITED THERAPEUTICS$$68$YR$$F$Y$74.83$KG$20240830$$$US$US
240548854$24054885$4$F$20240101$20240726$20240705$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-019290$UNITED THERAPEUTICS$$$$$F$Y$62.585$KG$20240803$$$US$US
240548861$24054886$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05911$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240548872$24054887$2$F$$20240802$20240705$20240806$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037462$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240806$$CN$US$US
240548884$24054888$4$F$20240726$20240820$20240705$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-020327$UNITED THERAPEUTICS$$44$YR$$F$Y$64.853$KG$20240827$$$US$US
240548891$24054889$1$I$$20240202$20240705$20240705$PER$$US-ABBVIE-5829116$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240548901$24054890$1$I$$20240621$20240705$20240705$EXP$$US-EPICPHARMA-US-2024EPCSPO00808$EPIC PHARM$$$$$F$Y$$$20240705$$MD$US$US
240548921$24054892$1$I$20240430$20240704$20240705$20240705$EXP$GB-MHRA-MED-202405031440330930-PMBTF$GB-GILEAD-2024-0679650$GILEAD$$38$YR$A$M$Y$48$KG$20240705$$PH$GB$GB
240548931$24054893$1$I$$20240627$20240705$20240705$30DAY$$US-GSK-US2024080235$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$CN$US$US
240548941$24054894$1$I$$20240701$20240705$20240705$EXP$$KR-GSK-KR2024APC081772$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$PH$KR$KR
240548951$24054895$1$I$20240625$20240625$20240705$20240705$EXP$$US-BAYER-2024A092858$BAYER$$49$YR$A$F$Y$$$20240705$$PH$US$US
240548961$24054896$1$I$$20240617$20240705$20240705$PER$$US-JNJFOC-20240645710$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240548971$24054897$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5828061$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240548982$24054898$2$F$$20240627$20240705$20240705$EXP$$BR-JNJFOC-20240679425$JOHNSON AND JOHNSON$$$$$M$Y$102$KG$20240705$$HP$BR$BR
240548991$24054899$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281456410520-PYKZQ$GB-RDY-SPO/GBR/24/0009567$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240549001$24054900$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA146316$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240705$$CN$US$US
240549011$24054901$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193751$SANOFI AVENTIS$$$$E$F$Y$$$20240705$$MD$US$US
240549021$24054902$1$I$20240101$20240628$20240705$20240705$PER$$US-SA-2024SA196384$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240705$$MD$US$US
240549033$24054903$3$F$20240101$20240911$20240705$20240923$PER$$US-SA-2024SA191714$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240923$$CN$US$US
240549042$24054904$2$F$20240702$20240815$20240705$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-020480$UNITED THERAPEUTICS$$31$YR$$F$Y$119.27$KG$20240824$$$US$US
240549051$24054905$1$I$$20240625$20240705$20240705$EXP$$CA-Atnahs Limited-ATNAHS20230802564$Atnahs Healthcare$$44$YR$A$F$Y$97$KG$20240704$$MD$CA$CA
240549061$24054906$1$I$$20240221$20240705$20240705$PER$$US-AMGEN-USASP2024131887$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240549071$24054907$1$I$$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024133420$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240549081$24054908$1$I$20240629$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131757$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240549091$24054909$1$I$20240629$20240629$20240705$20240705$PER$$US-AMGEN-USASP2024130379$AMGEN$$$$$M$Y$$$20240705$$CN$US$US
240549101$24054910$1$I$20240702$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131684$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240549111$24054911$1$I$$20230705$20240705$20240705$PER$$US-AMGEN-USASP2023235599$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240549121$24054912$1$I$$20231204$20240705$20240705$PER$$US-AMGEN-USASP2023235542$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240549132$24054913$2$F$20240101$20240628$20240705$20240708$EXP$$DE-009507513-2405DEU007676$MERCK$$56$YR$$F$Y$66$KG$20240708$$MD$DE$DE
240549141$24054914$1$I$20230601$20240626$20240705$20240705$EXP$$US-BAYER-2024A092748$BAYER$$40$YR$A$F$Y$$$20240705$$HP$US$US
240549151$24054915$1$I$$20240628$20240705$20240705$PER$$US-ORGANON-O2407USA000055$ORGANON$$$$$F$Y$$$20240705$$CN$US$US
240549161$24054916$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214783$TEVA$$21$YR$$M$Y$$$20240705$$HP$CA$CA
240549172$24054917$2$F$$20240723$20240705$20240731$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406016142AA$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$JP$JP
240549181$24054918$1$I$$20240624$20240705$20240705$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406017181$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240705$$CN$JP$JP
240549191$24054919$1$I$$20240702$20240705$20240705$EXP$AU-MYLANLABS-2024M1040219$AU-TAKEDA-2023TUS122589$TAKEDA$$50$YR$$$Y$$$20240705$$HP$AU$AU
240549202$24054920$2$F$20240531$20240906$20240705$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202406016460$ELI LILLY AND CO$$50$YR$A$F$Y$102.04$KG$20240918$$CN$US$US
240549211$24054921$1$I$$20240624$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406016420$ELI LILLY AND CO$$70$YR$E$$Y$$$20240705$$CN$US$US
240549221$24054922$1$I$$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002906$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240705$$CN$US$US
240549231$24054923$1$I$20240629$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407001138$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240705$$CN$US$US
240549242$24054924$2$F$$20240805$20240705$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202406016366$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240816$$HP$US$US
240549251$24054925$1$I$$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002922$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240705$$CN$US$US
240549262$24054926$2$F$20240301$20240822$20240705$20240826$30DAY$$US-ELI_LILLY_AND_COMPANY-US202406016032$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240826$$HP$US$US
240549281$24054928$1$I$20240101$20240624$20240705$20240705$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202406017640$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240705$$CN$KR$KR
240549291$24054929$1$I$$20240624$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406017933$ELI LILLY AND CO$$$$$$Y$$$20240705$$CN$CN$CN
240549301$24054930$1$I$20240614$20240624$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406017587$ELI LILLY AND CO$$53$YR$A$F$Y$74$KG$20240705$$CN$CN$CN
240549316$24054931$6$F$$20240924$20240705$20240930$30DAY$$US-PFIZER INC-PV202400085143$PFIZER$$10$YR$$M$Y$$$20240930$$CN$US$US
240549344$24054934$4$F$$20240923$20240705$20240925$30DAY$$US-PFIZER INC-202400201214$PFIZER$$16$YR$$M$Y$$$20240925$$CN$US$US
240549352$24054935$2$F$$20240916$20240705$20240917$30DAY$$US-PFIZER INC-202400205172$PFIZER$$$$$M$Y$$$20240917$$CN$US$US
240549363$24054936$3$F$$20240916$20240705$20240919$30DAY$$US-PFIZER INC-PV202400084117$PFIZER$$16$YR$$M$Y$$$20240919$$MD$US$US
240549371$24054937$1$I$$20240703$20240703$20240703$DIR$709031$$FDA-CTU$$$$$F$N$$$20240703$Y$HP$US$
240549381$24054938$1$I$20240501$20240621$20240705$20240705$EXP$$JP-ROCHE-10000017703$ROCHE$$8$DEC$E$M$Y$$$20240705$$MD$JP$JP
240549391$24054939$1$I$20240623$20240626$20240705$20240705$EXP$$CN-009507513-2406CHN010303$MERCK$$63$YR$$M$Y$59$KG$20240705$$HP$CN$CN
240549401$24054940$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214766$TEVA$$$$$$Y$$$20240705$$HP$CA$CA
240549411$24054941$1$I$20220201$20240702$20240705$20240705$EXP$$JP-JNJFOC-20240712519$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240705$$MD$JP$JP
240549422$24054942$2$F$$20240628$20240705$20240722$EXP$$NVSC2024FR137623$NOVARTIS$$77$YR$$M$Y$$$20240722$$MD$FR$FR
240549431$24054943$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214753$TEVA$$59$YR$$M$Y$$$20240705$$MD$CA$CA
240549442$24054944$2$F$20240701$20240822$20240705$20240826$EXP$$CN-GILEAD-2024-0679653$GILEAD$$36$YR$A$M$Y$$$20240826$$CN$CN$CN
240549452$24054945$2$F$20200128$20240918$20240705$20240919$PER$$US-GILEAD-2024-0679573$GILEAD$$41$YR$A$M$Y$$$20240919$$LW$US$US
240549461$24054946$1$I$$20240628$20240705$20240705$EXP$$US-SA-2024SA195741$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240549471$24054947$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214713$TEVA$$27$YR$$M$Y$$$20240705$$HP$CA$CA
240549481$24054948$1$I$$20240624$20240705$20240705$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05905$LUPIN$$$$$$Y$$$20240705$$CN$US$US
240549491$24054949$1$I$20220901$20240625$20240705$20240705$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06002$HIKMA$Antonelli JP, Quach M, Mahajan A, Pleva J, Ma VT. Antonelli JP, Quach M, Mahajan A, Pleva J, Ma VT. Rapid Life-Saving Response to Anti-PD-1 in a Solid Organ Transplant Recipient with Metastatic Cutaneous Squamous Cell Carcinoma: A Case Report and Review.. Journal of Immunotherapy. 2024;47(6):/$5$DEC$$M$Y$$$20240705$$MD$US$US
240549511$24054951$1$I$$20240621$20240705$20240705$EXP$GB-MHRA-MED-202406211602178080-BSMDG$GB-ROCHE-10000007139$ROCHE$$$$$F$Y$$$20240705$$HP$GB$GB
240549521$24054952$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214604$TEVA$$56$YR$$F$Y$$$20240705$$MD$CA$CA
240549531$24054953$1$I$$20240626$20240705$20240705$EXP$$US-RADIUS HEALTH, INC.-2024US004715$RADIUS PHARM$$$$$F$Y$$$20240705$$CN$US$US
240549541$24054954$1$I$$20240626$20240705$20240705$EXP$$US-BAYER-2024A096661$BAYER$Tran L.T.; Dada J.A.; Meadows J.M.; Willard M.D.. Over-the-Scope-Clip Iatrogenic Ligation of the Gastroduodenal Artery: A Case Report. American Journal of Case Reports () Article Number:. 2024;25:e943891$71$YR$E$M$Y$$$20240705$$HP$US$US
240549551$24054955$1$I$$20240626$20240705$20240705$EXP$$US-FreseniusKabi-FK202410381$FRESENIUS KABI$Qaiser S, Divanna M, Amir N, Luzuriaga A, Rodriguez C. Real-World Administration of Dantrolene: Harder Than a Board Exam. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: 3654. doi:https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A3654.$65$YR$E$F$Y$$$20240705$$HP$US$US
240549561$24054956$1$I$20240615$20240626$20240705$20240705$EXP$$US-BAYER-2024A094409$BAYER$$66$YR$E$F$Y$78.912$KG$20240705$$CN$US$US
240549572$24054957$2$F$20240409$20240806$20240705$20240809$PER$$US-JNJFOC-20240710874$JOHNSON AND JOHNSON$$34$YR$A$F$Y$57.204$KG$20240809$$MD$US$US
240549583$24054958$3$F$20221121$20240913$20240705$20240918$EXP$$US-GILEAD-2024-0679516$GILEAD$$65$YR$E$F$Y$$$20240918$$LW$US$US
240549591$24054959$1$I$$20240626$20240705$20240705$EXP$$CA-JNJFOC-20240676019$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240705$$CN$CA$CA
240549611$24054961$1$I$$20240620$20240705$20240705$PER$$US-COSETTE-CP2024US000141$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240549621$24054962$1$I$$20240624$20240705$20240705$PER$$CA-PFM-2024-03719$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240705$$CN$CA$CA
240549631$24054963$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193467$SANOFI AVENTIS$$$$$$Y$$$20240705$$CN$US$US
240549641$24054964$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193475$SANOFI AVENTIS$$$$A$F$Y$65.31$KG$20240705$$MD$US$US
240549651$24054965$1$I$$20230713$20240705$20240705$PER$$US-AMGEN-USASP2023235555$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240549661$24054966$1$I$20240601$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131364$AMGEN$$83$YR$E$M$Y$$$20240705$$CN$US$US
240549671$24054967$1$I$$20240627$20240705$20240705$EXP$$GB-PERRIGO-24GB006131$PERRIGO$$$$$F$Y$$$20240705$$CN$GB$GB
240549681$24054968$1$I$20240625$20240627$20240705$20240705$EXP$GB-MHRA-MED-202406271421199320-NPRHB$GB-PERRIGO-24GB006113$PERRIGO$$31$YR$$F$Y$$$20240705$$CN$GB$GB
240549691$24054969$1$I$20240601$20240703$20240705$20240705$EXP$$US-UCBSA-2024034072$UCB$$32$YR$$F$Y$$$20240705$$HP$US$US
240549701$24054970$1$I$$20240630$20240705$20240705$EXP$$AU-BAUSCHBL-2024BNL029411$BAUSCH AND LOMB$$40$YR$$M$Y$$$20240705$$CN$AU$AU
240549711$24054971$1$I$$20240628$20240705$20240705$PER$$US-ABBVIE-5827437$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240549722$24054972$2$F$$20240626$20240705$20240726$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006165$AURINIA PHARMACEUTICALS$Vineetha Phillip, Myriam Guevara, Angelina Edwards and Ziad M. El-Zataari. A case of Lupus Podocytopathy. Rheumatologist. 2024;23-25$70$YR$$F$Y$$$20240726$$MD$US$US
240549732$24054973$2$F$20220318$20240712$20240705$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020127$UNITED THERAPEUTICS$$59$YR$$F$Y$56.689$KG$20240719$$$US$US
240549741$24054974$1$I$20240420$20240703$20240703$20240703$DIR$708995$$FDA-CTU$$47$YR$$M$N$$$20240703$N$$US$
240549751$24054975$1$I$$20240703$20240703$20240703$DIR$708986$$FDA-CTU$$$$$UNK$N$$$20240703$N$CN$US$
240549761$24054976$1$I$$20240703$20240703$20240703$DIR$708971$$FDA-CTU$$$$$M$N$$$20240703$Y$HP$US$
240549771$24054977$1$I$$20240703$20240703$20240703$DIR$709049$$FDA-CTU$$$$$UNK$N$$$20240703$N$CN$US$
240549781$24054978$1$I$$20240703$20240703$20240703$DIR$708978$$FDA-CTU$$$$$UNK$N$$$20240703$N$CN$US$
240549791$24054979$1$I$20240411$20240703$20240703$20240703$DIR$709011$$FDA-CTU$$66$YR$$M$N$$$20240703$N$$US$
240549801$24054980$1$I$$20240627$20240705$20240705$PER$$US-ALXN-A202312580$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240705$$CN$US$US
240549811$24054981$1$I$20240208$20240210$20240705$20240705$PER$$US-ABBVIE-5828267$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240549822$24054982$2$F$20240430$20240723$20240705$20240725$EXP$GB-MHRA-MED-202405081653055240-HCSJK$GB-GSK-GB2024083429$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$GB$GB
240549831$24054983$1$I$20240615$20240626$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024074212$VIIV$$40$YR$$M$Y$$$20240705$$CN$US$US
240549841$24054984$1$I$$20240703$20240705$20240705$EXP$$GB-SANDOZ INC.-SDZ2024GB000451$SANDOZ$$$$$F$Y$$$20240705$$CN$GB$GB
240549851$24054985$1$I$$20240701$20240705$20240705$EXP$$JP-SANDOZ INC.-SDZ2024JP062887$SANDOZ$Munakata K et al... Factors affecting the quality of life of patients with medication-related osteonecrosis of the jaw during treatment: A quality-of-lifesurvey and causal analysis.. Journal of Cranio-Maxillofacial Surgery. 2024;52(6):715-721$$$$$Y$$$20240705$$MD$JP$JP
240549861$24054986$1$I$$20240703$20240705$20240705$EXP$$CA-SANDOZ INC.-PHHY2019CA219720$SANDOZ$$$$$F$Y$$$20240705$$CN$CA$CA
240549872$24054987$2$F$$20240813$20240705$20240819$EXP$$GB-SANDOZ INC.-SDZ2024GB062842$SANDOZ$$$$$M$Y$$$20240819$$CN$GB$GB
240549881$24054988$1$I$20240101$20240621$20240705$20240705$PER$$US-LEADINGPHARMA-US-2024LEASPO00261$LEADING PHARMA$$$$$F$Y$$$20240705$$CN$US$US
240549891$24054989$1$I$20150613$20240628$20240705$20240705$PER$FR-AFSSAPS-AN2024000810$FR-PFM-2024-03770$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240705$$PH$FR$FR
240549904$24054990$4$F$20190101$20240820$20240705$20240827$EXP$$CO-SANDOZ INC.-PHHY2019CO149343$SANDOZ$$$$$F$Y$46$KG$20240827$$CN$CO$CO
240549912$24054991$2$F$$20240715$20240705$20240717$EXP$$GB-SANDOZ INC.-SDZ2024GB062925$SANDOZ$$5$DEC$$F$Y$$$20240717$$HP$GB$GB
240549922$24054992$2$F$$20240906$20240705$20240909$EXP$$NVSC2024US138995$NOVARTIS$$$$$$Y$$$20240909$$MD$US$US
240549932$24054993$2$F$20240401$20240709$20240705$20240720$EXP$$CO-SANDOZ INC.-NVSC2021CO297729$SANDOZ$$69$YR$$F$Y$44$KG$20240720$$CN$CO$CO
240549941$24054994$1$I$20240401$20240703$20240705$20240705$EXP$$NVSC2024GR107155$NOVARTIS$$62$YR$$F$Y$$$20240705$$MD$GR$GR
240549951$24054995$1$I$20240628$20240701$20240705$20240705$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006167$AURINIA PHARMACEUTICALS$$55$YR$$F$Y$$$20240705$$CN$US$US
240549961$24054996$1$I$$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024133517$AMGEN$$$$$M$Y$$$20240705$$CN$US$US
240549971$24054997$1$I$$20240704$20240705$20240705$EXP$GB-MHRA-MED-202405011122222830-SDZKL$GB-GILEAD-2024-0679647$GILEAD$$$$$F$Y$$$20240705$$MD$GB$GB
240549981$24054998$1$I$$20240703$20240705$20240705$EXP$$US-UCBSA-2024034121$UCB$$$$$F$Y$$$20240705$$CN$US$US
240549993$24054999$3$F$$20240718$20240705$20240730$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001061$AKEBIA THERAPEUTICS$$74$YR$$F$Y$$$20240730$$PH$JP$JP
240550001$24055000$1$I$$20240624$20240705$20240705$EXP$$IT-PYROS PHARMACEUTICALS, INC-2024-PYROS-IT000033$Pyros Pharmaceuticals$Alessandro Iodice, Giuliana Marchio, Francesca Asta, Katia Rocchetti, Anna Rosati. Vigabatrin-associated hyperkinetic movements in two children with epileptic spasms: Case reports and video phenomenology description. Seizure:European Journal of Epilepsy. 2024;120:12-14$12$MON$$M$Y$$$20240705$$HP$IT$IT
240550012$24055001$2$F$20240612$20240731$20240705$20240802$EXP$FR-AFSSAPS-AN2024000835$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-106837$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$87$KG$20240802$$MD$FR$FR
240550021$24055002$1$I$20240623$20240630$20240705$20240705$EXP$$CN-FreseniusKabi-FK202410350$FRESENIUS KABI$$45$YR$A$M$Y$60$KG$20240705$$HP$CN$CN
240550031$24055003$1$I$$20240630$20240705$20240705$EXP$$AU-BAUSCHBL-2024BNL029422$BAUSCH AND LOMB$$$$$M$Y$$$20240705$$CN$AU$AU
240550041$24055004$1$I$20240610$20240701$20240705$20240705$EXP$FR-AFSSAPS-MP2024001013$FR-FreseniusKabi-FK202410393$FRESENIUS KABI$$8$YR$C$F$Y$37.9$KG$20240705$$MD$FR$FR
240550051$24055005$1$I$$20240626$20240705$20240705$PER$$US-FreseniusKabi-FK202410139$FRESENIUS KABI$$61$YR$A$F$Y$48$KG$20240705$$PH$US$US
240550062$24055006$2$F$20240611$20240705$20240705$20240715$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024080398$VIIV$$60$YR$$M$Y$$$20240715$$HP$US$US
240550072$24055007$2$F$20240630$20240701$20240705$20240711$30DAY$$US-GSK-US2024081606$GLAXOSMITHKLINE$$85$YR$$M$Y$$$20240711$$CN$US$US
240550083$24055008$3$F$20240501$20240812$20240705$20240822$EXP$$US-GSK-US2024082175$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240822$$CN$US$US
240550091$24055009$1$I$$20240701$20240705$20240705$EXP$$GB-JNJFOC-20240706768$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240705$$CN$GB$GB
240550101$24055010$1$I$20240501$20240703$20240705$20240705$PER$$US-JNJFOC-20240709720$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240705$$HP$US$US
240550111$24055011$1$I$$20240626$20240705$20240705$EXP$$IT-RDY-LIT/ITA/24/0009736$DR REDDYS$Del Fabro V, Pennisi C, Leotta S, Petronaci A, Longo L, Di Raimondo F, et al. PRACTICAL CONSIDERATIONS ON MANAGEMENT OF INFECTION IN PATIENTS RECEIVING BISPECIFIC ANTIBODIES: A SINGLE CENTER EXPERIENCE. Haematologica. 2024 Apr;109(33):$$$$$Y$$$20240705$$HP$IT$IT
240550121$24055012$1$I$20240613$20240703$20240703$20240703$DIR$709081$$FDA-CTU$$23$YR$$M$N$56.7$KG$20240703$N$CN$US$
240550131$24055013$1$I$20240703$20240703$20240703$20240703$DIR$708972$$FDA-CTU$$51$YR$$F$N$55.35$KG$20240703$N$CN$US$
240550141$24055014$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281457303540-MZPCV$GB-RDY-SPO/GBR/24/0009576$DR REDDYS$$$$$$Y$$$20240705$$CN$GB$GB
240550152$24055015$2$F$20200207$20240903$20240705$20240905$PER$$US-GILEAD-2024-0679574$GILEAD$$36$YR$A$M$Y$$$20240905$$LW$US$US
240550161$24055016$1$I$20240702$20240703$20240703$20240703$DIR$709064$$FDA-CTU$$30$YR$$F$N$107.55$KG$20240703$Y$CN$US$
240550172$24055017$2$F$20240621$20240801$20240705$20240809$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010129$JAZZ$$27$YR$$F$Y$$$20240809$$CN$US$US
240550181$24055018$1$I$$20240627$20240705$20240705$EXP$$ZA-AstraZeneca-2024A150146$ASTRAZENECA$$78$YR$$M$Y$$$20240705$$CN$ZA$
240550191$24055019$1$I$$20240624$20240705$20240705$PER$$CA-PFM-2024-03724$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240705$$HP$CA$CA
240550201$24055020$1$I$$20240623$20240705$20240705$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455642$RANBAXY$$$$$M$Y$$$20240705$$CN$GB$GB
240550211$24055021$1$I$$20240623$20240705$20240705$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455635$RANBAXY$$$$$F$Y$$$20240705$$CN$GB$GB
240550221$24055022$1$I$$20240622$20240705$20240705$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455128$RANBAXY$Baadh P, Kellermier H, Mudrakola HV. Cryptogenic organizing pneumonia and concomitant usual interstitial pneumonia: an unusual presentation with an accelerated time-course. Am J Respir Crit Care Med. 2024;19 May 209 (0):A2050$70$YR$$M$Y$$$20240705$$HP$US$US
240550231$24055023$1$I$$20240621$20240705$20240705$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455442$RANBAXY$Perillo T, D^Agostino V, Pagano A, Serino A, Manto A. Sphenoid bone localization in the setting of highly aggressive and refractory Multiple Myeloma: A case report.. J-Med-Imag-Radiat-Sci. 2023;54 (3):562-565.$58$YR$$F$Y$$$20240705$$HP$IT$IT
240550241$24055024$1$I$20231101$20240626$20240705$20240705$PER$$US-SA-2023SA248359$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240705$$MD$US$US
240550251$24055025$1$I$$20240523$20240705$20240705$PER$$US-AMGEN-USASP2024133455$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240550262$24055026$2$F$20240601$20240801$20240705$20240802$EXP$GB-ORGANON-O2407GBR000355$GB-ORGANON-O2407GBR000355$ORGANON$$$$$F$Y$$$20240802$$HP$GB$GB
240550272$24055027$2$F$$20240627$20240705$20240726$PER$$US-BAYER-2024A093286$BAYER$$38$YR$A$F$Y$$$20240726$$MD$US$US
240550281$24055028$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407003715$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240705$$CN$US$US
240550291$24055029$1$I$$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002257$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240705$$CN$US$US
240550303$24055030$3$F$$20240719$20240705$20240724$EXP$$IT-ORGANON-O2407ITA000351$ORGANON$Munari S, Ciotti G, Cestaro W, Corsi L, Tonin S, Ballarin A, et al.. Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review... Drugs-Cont. 2024;13:1-11$64$YR$$F$Y$$$20240724$$HP$IT$IT
240550311$24055031$1$I$$20240626$20240705$20240705$EXP$$CA-TEVA-VS-3215030$TEVA$$60$YR$$F$Y$$$20240705$$HP$CA$CA
240550321$24055032$1$I$$20240605$20240705$20240705$PER$$US-009507513-2406USA002269$MERCK$Cha J, Grinshpun A, Buckley L, Alexander B, Tolaney S, Lin N. Exceptional long-term disease control on pembrolizumab monotherapy in a patient with TMB-high PMS2-mutated MMR-deficient triple negative breast cancer brain metastasis. Cancer Research. 2024;84 (9)$62$YR$$F$Y$$$20240705$$HP$US$US
240550331$24055033$1$I$$20240624$20240705$20240705$EXP$$IT-PYROS PHARMACEUTICALS, INC-2024-PYROS-IT000032$Pyros Pharmaceuticals$Alessandro Iodice, Giuliana Marchio, Francesca Asta, Katia Rocchetti, Anna Rosati. Vigabatrin-associated hyperkinetic movements in two children with epileptic spasms: Case reports and video phenomenology description. Seizure:European Journal of Epilepsy. 2024;120:12-14$4$YR$$M$Y$$$20240705$$HP$IT$IT
240550341$24055034$1$I$20240702$20240703$20240705$20240705$PER$$US-JNJFOC-20240710096$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240705$$HP$US$US
240550351$24055035$1$I$$20240703$20240705$20240705$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-107073$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240705$$PH$DE$DE
240550361$24055036$1$I$20240604$20240612$20240705$20240705$PER$$US-BEH-2024174049$CSL BEHRING$$67$YR$E$F$Y$$$20240705$$CN$US$US
240550371$24055037$1$I$20240601$20240627$20240705$20240705$EXP$FR-AFSSAPS-PB2024000677$FR-TEVA-VS-3215175$TEVA$$62$YR$$F$Y$$$20240705$$MD$FR$FR
240550381$24055038$1$I$$20240626$20240705$20240705$EXP$$CA-TEVA-VS-3214348$TEVA$$63$YR$$F$Y$$$20240705$$PH$CA$CA
240550391$24055039$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824988$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240550402$24055040$2$F$20240528$20240718$20240705$20240723$EXP$$US-OTSUKA-2024_015591$OTSUKA$$32$YR$$F$Y$$$20240723$$MD$US$US
240550411$24055041$1$I$$20240625$20240705$20240705$EXP$$CA-SANDOZ INC.-SDZ2024CA062679$SANDOZ$$44$YR$$F$Y$97$KG$20240705$$HP$CA$CA
240550421$24055042$1$I$$20240625$20240705$20240705$EXP$$CA-SANDOZ INC.-SDZ2024CA062678$SANDOZ$$44$YR$$F$Y$97$KG$20240705$$HP$CA$CA
240550451$24055045$1$I$$20240704$20240705$20240705$PER$$NVSC2024US139561$NOVARTIS$$$$$$Y$$$20240705$$CN$US$US
240550461$24055046$1$I$$20240628$20240705$20240705$EXP$$US-ABBVIE-5826154$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240550471$24055047$1$I$20240619$20240628$20240705$20240705$EXP$FR-AFSSAPS-TO2024001145$FR-BAYER-2024A093895$BAYER$$27$YR$A$F$Y$$$20240705$$MD$FR$FR
240550481$24055048$1$I$$20240627$20240705$20240705$EXP$$CH-BAYER-2024A081783$BAYER$$$$$F$Y$$$20240705$$MD$CH$CH
240550492$24055049$2$F$20140507$20240923$20240705$20240925$PER$$US-GILEAD-2024-0679485$GILEAD$$45$YR$A$M$Y$$$20240925$$LW$US$US
240550501$24055050$1$I$$20240628$20240705$20240705$EXP$$CA-PUMA BIOTECHNOLOGY, INC.-2024-PUM-CA000898$PUMA$$$$$$Y$$$20240705$$MD$CA$CA
240550511$24055051$1$I$$20240523$20240705$20240705$PER$$US-Eisai-EC-2024-166452$EISAI$$$$$M$Y$$$20240705$$MD$US$US
240550521$24055052$1$I$$20240701$20240705$20240705$EXP$$US-GSK-US2024082182$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240550531$24055053$1$I$20240401$20240702$20240705$20240705$30DAY$$US-GSK-US2024082055$GLAXOSMITHKLINE$$58$YR$$M$Y$$$20240705$$CN$US$US
240550542$24055054$2$F$$20240806$20240705$20240821$PER$$US-GRANULES-US-2024GRASPO00247$GRANULES INDIA$$$$$$Y$$$20240821$$CN$US$US
240550561$24055056$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3215064$TEVA$$57$YR$$M$Y$$$20240705$$HP$CA$CA
240550572$24055057$2$F$20240625$20240906$20240705$20240909$PER$$NVSC2024US134513$NOVARTIS$$34$YR$$F$Y$$$20240909$$CN$US$US
240550581$24055058$1$I$$20240626$20240705$20240705$EXP$$US-OTSUKA-2024_018413$OTSUKA$$$$$M$Y$$$20240705$$HP$US$US
240550591$24055059$1$I$20231201$20240627$20240705$20240705$EXP$FR-AFSSAPS-NT2024000640$FR-TEVA-VS-3215489$TEVA$$72$YR$$M$Y$$$20240705$$MD$FR$FR
240550603$24055060$3$F$20180910$20240903$20240705$20240905$EXP$$US-GILEAD-2024-0679575$GILEAD$$51$YR$A$M$Y$$$20240905$$LW$US$US
240550612$24055061$2$F$$20240710$20240705$20240715$EXP$$BR-009507513-2407BRA000475$MERCK$$65$YR$$$Y$$$20240715$$MD$BR$BR
240550621$24055062$1$I$20230101$20240703$20240705$20240705$EXP$$GB-JNJFOC-20240713865$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$GB$GB
240550631$24055063$1$I$$20240627$20240705$20240705$EXP$$JP-ROCHE-10000016929$ROCHE$$82$YR$E$M$Y$$$20240705$$MD$JP$JP
240550651$24055065$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131974$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240550671$24055067$1$I$$20231212$20240705$20240705$PER$$US-AMGEN-USASP2023235495$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240550681$24055068$1$I$$20240701$20240705$20240705$EXP$$GB-TAKEDA-2024TUS068347$TAKEDA$$$$$F$Y$$$20240705$$CN$GB$GB
240550692$24055069$2$F$20240301$20240723$20240705$20240730$EXP$$US-TAKEDA-2024TUS017396$TAKEDA$$58$YR$$F$Y$77$KG$20240730$$CN$US$US
240550711$24055071$1$I$$20240522$20240705$20240705$PER$$US-Eisai-EC-2024-166369$EISAI$$$$$M$Y$$$20240705$$MD$US$US
240550721$24055072$1$I$$20240522$20240705$20240705$PER$$US-Eisai-EC-2024-166318$EISAI$$$$$F$Y$$$20240705$$HP$US$US
240550731$24055073$1$I$20240628$20240703$20240705$20240705$EXP$$US-GSK-US2024082519$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240705$$CN$US$US
240550741$24055074$1$I$20240628$20240628$20240705$20240705$EXP$$CA-GSK-CA2023177958$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$HP$CA$CA
240550751$24055075$1$I$$20240701$20240705$20240705$EXP$$JP-009507513-2407JPN000078J$MERCK$$39$YR$$$Y$$$20240705$$MD$JP$JP
240550761$24055076$1$I$20240407$20240626$20240705$20240705$EXP$$CN-TAKEDA-2024TUS064511$TAKEDA$$$$A$M$Y$81$KG$20240705$$MD$CN$CN
240550771$24055077$1$I$$20240704$20240705$20240705$EXP$GB-MHRA-MED-202407041240280040-RYPMW$GB-GSK-GB2024083003$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$PH$GB$GB
240550781$24055078$1$I$$20240701$20240705$20240705$EXP$$GB-JNJFOC-20230430480$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240705$$CN$GB$GB
240550791$24055079$1$I$20240101$20240627$20240705$20240705$EXP$$US-INDIVIOR US-INDV-145805-2024$RECKITT BENCKISER$$$$$$Y$$$20240705$$CN$US$US
240550801$24055080$1$I$$20240629$20240705$20240705$EXP$GB-MHRA-MED-202406290956091950-BTVGZ$GB-RDY-SPO/GBR/24/0009580$DR REDDYS$$$$$M$Y$$$20240705$$CN$GB$GB
240550821$24055082$1$I$20240701$20240701$20240705$20240705$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010151$JAZZ$$53$YR$$F$Y$$$20240705$$CN$US$US
240550831$24055083$1$I$$20240627$20240705$20240705$PER$$US-SA-2024SA195414$SANOFI AVENTIS$$$$A$M$Y$115$KG$20240705$$MD$US$US
240550841$24055084$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA195330$SANOFI AVENTIS$$3$YR$C$M$Y$16.9$KG$20240705$$MD$US$US
240550851$24055085$1$I$20240616$20240626$20240705$20240705$PER$$US-SA-2024SA193767$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240705$$MD$US$US
240550861$24055086$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA194128$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240550871$24055087$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA194625$SANOFI AVENTIS$$4$YR$C$F$Y$15.87$KG$20240705$$MD$US$US
240550882$24055088$2$F$20240101$20240724$20240705$20240801$PER$$US-SA-2024SA196074$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240801$$MD$US$US
240550891$24055089$1$I$20240101$20240628$20240705$20240705$PER$$US-SA-2024SA195990$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240705$$MD$US$US
240550902$24055090$2$F$20240101$20240826$20240705$20240905$PER$$US-SA-2024SA195974$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240905$$MD$US$US
240550912$24055091$2$F$20220602$20240813$20240705$20240819$EXP$$US-PAREXEL-2021-KAM-US003482$TAKEDA$$73$YR$$M$Y$77$KG$20240819$$MD$US$US
240550922$24055092$2$F$$20240627$20240705$20240705$EXP$$US-ROCHE-10000015556$ROCHE$$$$$$Y$$$20240705$$CN$US$US
240550931$24055093$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA195314$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240550941$24055094$1$I$20190101$20240627$20240705$20240705$EXP$SE-SEMPA-2024-005025$SE-TEVA-VS-3215562$TEVA$$$$$F$Y$$$20240705$$CN$SE$SE
240550952$24055095$2$F$$20240711$20240705$20240721$EXP$$US-TEVA-VS-3214613$TEVA$Lakhani M, Azulay H. From Rashes to Ruin: The Methotrexate Misadventure. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A5682.; Lakhani M, Azulay H. From Rashes to Ruin: The Methotrexate Misadventure. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A5682.$43$YR$$M$Y$$$20240721$$HP$US$US
240550971$24055097$1$I$20240512$20240704$20240705$20240705$EXP$$US-TAKEDA-2024TUS067988$TAKEDA$$61$YR$$F$Y$$$20240705$$HP$US$US
240550981$24055098$1$I$20230301$20240628$20240705$20240705$EXP$$US-AMGEN-USASP2024128562$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240550991$24055099$1$I$$20240603$20240705$20240705$PER$US-SEPTODONT-2024018598$US-SEPTODONT-2024018598$SEPTODONT$$$$$$Y$$$20240705$$HP$US$US
240551001$24055100$1$I$20230621$20240627$20240705$20240705$EXP$$ES-TEVA-2023-ES-2912610$TEVA$$78$YR$$F$Y$$$20240705$$CN$ES$ES
240551011$24055101$1$I$20230222$20240621$20240705$20240705$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000550$PAREXEL$Yaoxing Liu, Lixia Chen, Chunxia Duan, Xiaojuan Chen. A Case Report of Gemcitabine Combined with Oxaliplatin and Toripalimab in the Treatment of Thrombocytopenia Caused by Splenic Metastasis after Surgery for Intrahepatic Cholangiocarcinoma. China Journal of Rational Drug Use. 2024;21(05):25-28$$$$$Y$$$20240705$$MD$CN$CN
240551024$24055102$4$F$20240607$20240725$20240705$20240807$30DAY$$US-JNJFOC-20240666671$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
240551031$24055103$1$I$$20240628$20240705$20240705$EXP$$US-TAKEDA-2024TUS032744$TAKEDA$$$$$F$Y$$$20240705$$CN$US$US
240551041$24055104$1$I$$20240624$20240705$20240705$PER$$US-MSNLABS-2024MSNSPO01439$MSN LABORATORIES$$$$$$Y$$$20240705$$CN$US$US
240551071$24055107$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5825373$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240551083$24055108$3$F$20220703$20240925$20240705$20240930$EXP$$BR-UCBSA-2024033961$UCB$$52$YR$$M$Y$95$KG$20240930$$CN$BR$BR
240551091$24055109$1$I$20240623$20240703$20240705$20240705$EXP$$NVSC2024US139285$NOVARTIS$$55$YR$$M$Y$$$20240705$$CN$US$US
240551101$24055110$1$I$20230101$20240628$20240705$20240705$EXP$$IN-BIOGEN-2024BI01272010$BIOGEN$$$$$F$Y$46.762$KG$20240705$$HP$IN$IN
240551111$24055111$1$I$20240612$20240621$20240705$20240705$EXP$$US-SUPERNUS Pharmaceuticals, Inc.-SUP202406-002249$SUPERNUS$$67$YR$$M$Y$88.45$KG$20240705$$HP$US$
240551123$24055112$3$F$20200101$20240902$20240705$20240906$EXP$$BR-TAKEDA-BR202023968$TAKEDA$$$$$F$Y$63$KG$20240906$$MD$BR$BR
240551131$24055113$1$I$$20240702$20240705$20240705$PER$$US-SA-2024SA196315$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240705$$CN$US$US
240551141$24055114$1$I$$20240621$20240705$20240705$EXP$$IN-ROCHE-10000013331$ROCHE$$78$YR$E$F$Y$$$20240705$$CN$IN$IN
240551151$24055115$1$I$20211119$20240628$20240705$20240705$EXP$$CN-ABBVIE-5828425$ABBVIE$Wang, G,. Strategy analysis of a case of failure in the treatment of severe pneumonia with ceftazidime avibactam and aztreonam. Chinese Journal of Pharmacoepidemiology. 2024;33(3):342-348$63$YR$$M$Y$60$KG$20240705$$HP$CN$CN
240551161$24055116$1$I$$20240705$20240705$20240705$EXP$GB-MHRA-MED-202405131136262050-GDCYM$GB-Orion Corporation ORION PHARMA-24_00030653$ORION$$$$$$Y$$$20240705$$PH$GB$
240551171$24055117$1$I$20240614$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130588$AMGEN$$$$$F$Y$$$20240705$$PH$US$US
240551181$24055118$1$I$$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024132228$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240551191$24055119$1$I$$20240705$20240705$20240705$EXP$$PH-TAKEDA-2024TUS068217$TAKEDA$$$$$F$Y$$$20240705$$CN$PH$PH
240551201$24055120$1$I$20240508$20240515$20240705$20240705$PER$$US-Eisai-EC-2024-166257$EISAI$$74$YR$E$M$Y$$$20240705$$HP$US$US
240551211$24055121$1$I$20240510$20240521$20240705$20240705$PER$$US-Eisai-EC-2024-166261$EISAI$$75$YR$E$M$Y$$$20240705$$HP$US$US
240551221$24055122$1$I$20240512$20240521$20240705$20240705$PER$$US-Eisai-EC-2024-166262$EISAI$$83$YR$E$M$Y$$$20240705$$MD$US$US
240551231$24055123$1$I$20240628$20240702$20240705$20240705$EXP$$US-ABBVIE-5825988$ABBVIE$$71$YR$$F$Y$$$20240705$$CN$US$US
240551241$24055124$1$I$20240503$20240521$20240705$20240705$PER$$US-Eisai-EC-2024-166260$EISAI$$$$$F$Y$$$20240705$$HP$US$US
240551251$24055125$1$I$20240503$20240522$20240705$20240705$PER$$US-Eisai-EC-2024-166304$EISAI$$80$YR$E$F$Y$$$20240705$$HP$US$US
240551261$24055126$1$I$20240401$20240627$20240705$20240705$EXP$FR-AFSSAPS-PO2024000633$FR-TEVA-VS-3215604$TEVA$$55$YR$$F$Y$98$KG$20240705$$MD$FR$FR
240551271$24055127$1$I$20240623$20240625$20240705$20240705$EXP$$US-GSK-US2024079139$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240705$$CN$US$US
240551281$24055128$1$I$$20240624$20240705$20240705$EXP$$AU-OTSUKA-2024_018648$OTSUKA$$$$$$Y$$$20240705$$CN$AU$AU
240551291$24055129$1$I$$20240627$20240705$20240705$EXP$$CN-TAKEDA-2024TUS065598$TAKEDA$$55$YR$$M$Y$$$20240705$$HP$CN$CN
240551301$24055130$1$I$$20240703$20240705$20240705$PER$$US-TAKEDA-2024TUS067767$TAKEDA$$$$$M$Y$$$20240705$$CN$US$US
240551311$24055131$1$I$$20240629$20240705$20240705$EXP$GB-MHRA-MED-202406291156204580-GSRWB$GB-RDY-SPO/GBR/24/0009560$DR REDDYS$$25$YR$A$M$Y$88$KG$20240705$$CN$GB$GB
240551321$24055132$1$I$20200209$20240629$20240705$20240705$EXP$GB-MHRA-MED-202406291153551960-YVRTB$GB-RDY-SPO/GBR/24/0009564$DR REDDYS$$24$YR$A$M$Y$65$KG$20240705$$CN$GB$GB
240551331$24055133$1$I$$20240627$20240705$20240705$EXP$$US-RDY-LIT/USA/24/0009743$DR REDDYS$Woodard VV, Ragland MF. A Rare Case of Necrotizing Pneumonia in an Immunocompromised Patient. American Journal of Respiratory and Critical Care Medicine. 2024 May;209(0): doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2444.$67$YR$E$M$Y$$$20240705$$HP$US$US
240551341$24055134$1$I$20240603$20240704$20240705$20240705$EXP$HR-HALMED-300085849$HR-TAKEDA-2024TUS067978$TAKEDA$$25$YR$$F$Y$$$20240705$$HP$HR$HR
240551361$24055136$1$I$20240619$20240703$20240703$20240703$DIR$709080$$FDA-CTU$$46$YR$$F$N$60.75$KG$20240703$N$CN$US$
240551371$24055137$1$I$20240616$20240703$20240703$20240703$DIR$708996$$FDA-CTU$$30$YR$$F$N$66.6$KG$20240703$N$CN$US$
240551381$24055138$1$I$20240703$20240703$20240703$20240703$DIR$709074$$FDA-CTU$$58$YR$$M$N$$$20240703$N$HP$US$
240551391$24055139$1$I$20240702$20240703$20240703$20240703$DIR$709044$$FDA-CTU$$60$YR$$F$N$135$KG$20240703$N$CN$US$
240551401$24055140$1$I$$20240704$20240705$20240705$EXP$GB-MHRA-MED-202405030841217640-RCGSB$GB-ABBVIE-5828137$ABBVIE$$$$$F$Y$$$20240705$$HP$GB$GB
240551415$24055141$5$F$20230101$20240911$20240705$20240920$EXP$$GB-BAYER-2024A094719$BAYER$$33$YR$A$F$Y$$$20240920$$CN$GB$GB
240551431$24055143$1$I$20240101$20240621$20240705$20240705$PER$$US-SA-2024SA189424$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240705$$HP$US$US
240551441$24055144$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA192898$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240705$$MD$US$US
240551452$24055145$2$F$20240101$20240816$20240705$20240830$PER$$US-SA-2024SA195336$SANOFI AVENTIS$$$$A$M$Y$122$KG$20240830$$MD$US$US
240551461$24055146$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA192310$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240705$$MD$US$US
240551472$24055147$2$F$20240101$20240723$20240705$20240726$EXP$$JP-OTSUKA-2024_015559$OTSUKA$$9$DEC$$F$Y$$$20240726$$PH$JP$JP
240551481$24055148$1$I$$20240701$20240705$20240705$PER$$US-SA-2024SA195954$SANOFI AVENTIS$$$$A$F$Y$43$KG$20240705$$MD$US$US
240551491$24055149$1$I$20240630$20240703$20240703$20240703$DIR$709056$$FDA-CTU$$23$YR$$F$N$108$KG$20240703$N$CN$US$
240551501$24055150$1$I$$20240627$20240705$20240705$PER$$US-SA-2024SA195361$SANOFI AVENTIS$$$$A$M$Y$$$20240705$$MD$US$US
240551511$24055151$1$I$20240628$20240628$20240705$20240705$PER$$US-SA-2024SA194323$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240705$$MD$US$US
240551521$24055152$1$I$20240101$20240628$20240705$20240705$PER$$US-SA-2024SA194863$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240705$$MD$US$US
240551531$24055153$1$I$20240618$20240626$20240705$20240705$PER$$US-SA-2024SA195341$SANOFI AVENTIS$$4$YR$C$M$Y$19$KG$20240705$$MD$US$US
240551542$24055154$2$F$20240701$20240808$20240705$20240808$PER$$US-ALXN-202407USA000244US$ALEXION PHARMACEUTICALS$$$$I$M$Y$$$20240808$$MD$US$US
240551551$24055155$1$I$20210101$20240627$20240705$20240705$PER$$US-ALXN-202406USA001920US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240551561$24055156$1$I$20240702$20240703$20240703$20240703$DIR$708967$$FDA-CTU$$81$YR$$F$N$66.1$KG$20240703$Y$PH$US$
240551572$24055157$2$F$$20240805$20240705$20240806$PER$$US-ALXN-202406USA001958US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240551581$24055158$1$I$$20240622$20240705$20240705$EXP$$IN-ROCHE-10000013292$ROCHE$$75$YR$E$M$Y$$$20240705$$CN$IN$IN
240551592$24055159$2$F$20191201$20240704$20240705$20240828$EXP$$AR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036992$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240828$$MD$AR$AR
240551601$24055160$1$I$20240501$20240628$20240705$20240705$EXP$$NVSC2024CA091279$NOVARTIS$$48$YR$$F$Y$$$20240705$$CN$CA$CA
240551611$24055161$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214718$TEVA$$34$YR$$F$Y$84$KG$20240705$$HP$CA$CA
240551621$24055162$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214767$TEVA$$63$YR$$F$Y$$$20240705$$HP$CA$CA
240551631$24055163$1$I$20240112$20240621$20240705$20240705$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000542$PAREXEL$$$$$$Y$$$20240705$$HP$CN$CN
240551642$24055164$2$F$20240116$20240627$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103988$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$123.38$KG$20240705$$CN$US$US
240551651$24055165$1$I$$20240627$20240705$20240705$30DAY$$US-GSK-US2024080403$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240551661$24055166$1$I$20240523$20240625$20240705$20240705$EXP$$US-JNJFOC-20240675185$JOHNSON AND JOHNSON$$64$YR$A$M$Y$89$KG$20240705$$HP$US$US
240551682$24055168$2$F$20230104$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS066217$TAKEDA$$40$YR$$M$Y$$$20240709$$HP$CN$CN
240551691$24055169$1$I$$20240627$20240705$20240705$EXP$$JP-AstraZeneca-2024A150726$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$JP$
240551701$24055170$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA195321$SANOFI AVENTIS$$$$T$F$Y$90$KG$20240705$$MD$US$US
240551711$24055171$1$I$$20240615$20240705$20240705$EXP$$GB-AstraZeneca-2024A153764$ASTRAZENECA$$$$N$F$Y$$$20240705$$CN$GB$
240551721$24055172$1$I$20191210$20240627$20240705$20240705$EXP$FR-AFSSAPS-ST2024001090$FR-TEVA-VS-3215714$TEVA$$43$YR$$F$Y$$$20240705$$MD$FR$FR
240551731$24055173$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA195324$SANOFI AVENTIS$$$$A$F$Y$76.2$KG$20240705$$MD$US$US
240551741$24055174$1$I$$20240625$20240705$20240705$EXP$$IE-ROCHE-10000016625$ROCHE$$$$$$Y$$$20240705$$PH$IE$IE
240551752$24055175$2$F$20240625$20240703$20240705$20240708$EXP$$US-BAUSCH-BL-2024-010143$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240708$$CN$US$US
240551761$24055176$1$I$20240326$20240704$20240705$20240705$EXP$FR-AFSSAPS-CN2024000635$FR-BAUSCH-BL-2024-010340$BAUSCH AND LOMB$$15$DY$$M$Y$4.4$KG$20240705$$MD$FR$FR
240551773$24055177$3$F$$20240926$20240705$20240930$30DAY$$CL-PFIZER INC-PV202400080862$PFIZER$$11$YR$$M$Y$$$20240930$$CN$CL$CL
240551783$24055178$3$F$$20240920$20240705$20240924$30DAY$$US-PFIZER INC-202400199894$PFIZER$$12$YR$$M$Y$$$20240924$$CN$US$US
240551794$24055179$4$F$$20240922$20240705$20240925$30DAY$$KR-PFIZER INC-202400204704$PFIZER$$12$YR$$$Y$$$20240925$$CN$KR$KR
240551801$24055180$1$I$20240426$20240702$20240705$20240705$EXP$$CN-PFIZER INC-PV202400083421$PFIZER$$28$YR$$M$Y$$$20240705$$CN$CN$CN
240551815$24055181$5$F$$20240905$20240705$20240910$30DAY$$JP-PFIZER INC-PV202400083749$PFIZER$$$$$$Y$$$20240910$$PH$JP$JP
240551821$24055182$1$I$$20240703$20240705$20240705$EXP$GB-MHRA-MED-202407031204104760-DQJMH$GB-PFIZER INC-202400205853$PFIZER$$$$$F$Y$$$20240705$$PH$GB$GB
240551841$24055184$1$I$$20240408$20240705$20240705$PER$$US-ABBVIE-5828580$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240551851$24055185$1$I$$20240627$20240705$20240705$PER$$US-BAYER-2024A094064$BAYER$$$$$$Y$$$20240705$$HP$US$US
240551861$24055186$1$I$20240101$20240702$20240705$20240705$EXP$$US-UCBSA-2024034084$UCB$$$$$F$Y$87.49$KG$20240705$$HP$US$US
240551871$24055187$1$I$20240511$20240629$20240705$20240705$EXP$$CN-BAYER-2024A095790$BAYER$$67$YR$E$M$Y$55$KG$20240705$$HP$CN$CN
240551883$24055188$3$F$20240605$20240716$20240705$20240903$EXP$$SE-BAYER-2024A095225$BAYER$$34$YR$A$F$Y$$$20240903$$CN$SE$SE
240551891$24055189$1$I$20240531$20240626$20240705$20240705$EXP$$FR-ZAMBON SWITZERLAND LTD.-2024-ZAM-FR000037$PAREXEL$$$$$$Y$$$20240705$$PH$FR$FR
240551901$24055190$1$I$20240621$20240622$20240705$20240705$EXP$$JP-ROCHE-10000017698$ROCHE$$6$DEC$A$F$Y$$$20240705$$MD$JP$JP
240551911$24055191$1$I$20240101$20240607$20240705$20240705$PER$$US-Eisai-EC-2024-167772$EISAI$$60$YR$A$F$Y$$$20240705$$CN$US$US
240551921$24055192$1$I$20240527$20240624$20240705$20240705$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000546$PAREXEL$$$$$$Y$$$20240705$$HP$CN$CN
240551931$24055193$1$I$20240101$20240524$20240705$20240705$PER$$US-Eisai-EC-2024-166503$EISAI$$76$YR$E$M$Y$$$20240705$$CN$US$US
240551941$24055194$1$I$$20240701$20240705$20240705$EXP$$US-OTSUKA-2024_018816$OTSUKA$$$$$F$Y$$$20240705$$HP$US$US
240551951$24055195$1$I$20240406$20240702$20240705$20240705$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037178$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240705$$PH$AU$AU
240551971$24055197$1$I$$20240629$20240705$20240705$EXP$GB-MHRA-MED-202406291145190840-GJMRH$GB-RDY-SPO/GBR/24/0009572$DR REDDYS$$$$$M$Y$$$20240705$$CN$GB$GB
240551981$24055198$1$I$20240601$20240702$20240705$20240705$EXP$$CA-UCBSA-2022059647$UCB$$47$YR$$F$Y$$$20240705$$CN$CA$CA
240551991$24055199$1$I$$20240627$20240705$20240705$30DAY$$US-GSK-US2024080420$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240552001$24055200$1$I$$20230223$20240705$20240705$EXP$$NVSC2023US280827$NOVARTIS$$$$$M$Y$$$20240705$$CN$US$US
240552011$24055201$1$I$20240527$20240702$20240705$20240705$EXP$$CA-ABBVIE-5825907$ABBVIE$$36$YR$$M$Y$$$20240705$$CN$CA$CA
240552022$24055202$2$F$$20240717$20240705$20240726$EXP$$CA-TEVA-VS-3214811$TEVA$$67$YR$$M$Y$$$20240726$$HP$CA$CA
240552031$24055203$1$I$$20240628$20240705$20240705$EXP$$US-BAYER-2024A094252$BAYER$$83$YR$E$F$Y$$$20240705$$CN$US$US
240552041$24055204$1$I$20240618$20240702$20240705$20240705$EXP$$CN-BAYER-2024A096041$BAYER$$66$YR$E$F$Y$$$20240705$$HP$CN$CN
240552054$24055205$4$F$20240628$20240808$20240705$20240809$EXP$$GB-BAYER-2024A095241$BAYER$$56$YR$A$F$Y$$$20240809$$MD$GB$GB
240552061$24055206$1$I$$20240701$20240705$20240705$EXP$$NVSC2024CO134909$NOVARTIS$Carlier ID, Rengifo LJ, Mora LA, Figueroa IA, Rincon AB. Surgical management in Super-refractory epilepticus status (Manejo quir?rgico en el estado epil?ptico  superrefractario). ACTA NEUROL COLOMB. 2024;40(2):e1722$32$YR$$M$Y$$$20240705$$HP$CO$CO
240552071$24055207$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA195347$SANOFI AVENTIS$$$$C$M$Y$38.367$KG$20240705$$MD$US$US
240552081$24055208$1$I$20240101$20240621$20240705$20240705$PER$$US-SA-2024SA188721$SANOFI AVENTIS$$6$MON$I$M$Y$$$20240705$$CN$US$US
240552091$24055209$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193746$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240705$$MD$US$US
240552101$24055210$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193741$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240705$$MD$US$US
240552111$24055211$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3215035$TEVA$$$$$F$Y$$$20240705$$MD$CA$CA
240552121$24055212$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA192879$SANOFI AVENTIS$$$$A$M$Y$$$20240705$$MD$US$US
240552131$24055213$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193407$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240705$$MD$US$US
240552151$24055215$1$I$20240630$20240703$20240703$20240703$DIR$709066$$FDA-CTU$$23$YR$$M$N$63$KG$20240703$N$CN$US$
240552161$24055216$1$I$20240601$20240621$20240705$20240705$PER$$US-SA-2024SA188585$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240705$$MD$US$US
240552171$24055217$1$I$$20240703$20240705$20240705$PER$$US-JNJFOC-20240709112$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$US$US
240552181$24055218$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3215023$TEVA$$17$YR$$M$Y$$$20240705$$HP$CA$CA
240552191$24055219$1$I$20240101$20240701$20240705$20240705$EXP$$US-ABBVIE-5818960$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240552201$24055220$1$I$20240101$20240702$20240705$20240705$EXP$$CA-ABBVIE-5826093$ABBVIE$$67$YR$$F$Y$$$20240705$$CN$CA$CA
240552212$24055221$2$F$20240601$20240905$20240705$20240918$PER$$US-SA-2024SA188596$SANOFI AVENTIS$$54$YR$A$M$Y$99.7$KG$20240918$$MD$US$US
240552221$24055222$1$I$20240201$20240626$20240705$20240705$PER$$US-SA-2024SA194140$SANOFI AVENTIS$$63$YR$A$F$Y$103.4$KG$20240705$$MD$US$US
240552231$24055223$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA191874$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240705$$MD$US$US
240552241$24055224$1$I$$20240702$20240705$20240705$PER$$US-SA-2024SA197524$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240705$$CN$US$US
240552251$24055225$1$I$20220701$20240628$20240705$20240705$PER$$US-SA-2024SA196378$SANOFI AVENTIS$$5$YR$C$M$Y$26.3$KG$20240705$$MD$US$US
240552262$24055226$2$F$20240101$20240807$20240705$20240814$PER$$US-SA-2024SA191889$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240814$$MD$US$US
240552271$24055227$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA194407$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240705$$MD$US$US
240552281$24055228$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA192465$SANOFI AVENTIS$$$$E$F$Y$$$20240705$$MD$US$US
240552291$24055229$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA191846$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240705$$MD$US$US
240552301$24055230$1$I$$20240626$20240705$20240705$EXP$$CA-TEVA-VS-3214301$TEVA$$44$YR$$F$Y$60$KG$20240705$$HP$CA$CA
240552311$24055231$1$I$20231001$20240702$20240705$20240705$EXP$$CN-ABBVIE-5475735$ABBVIE$$6$YR$$F$Y$22$KG$20240705$$MD$CN$CN
240552321$24055232$1$I$$20240703$20240705$20240705$EXP$$NVSC2024US139238$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
240552333$24055233$3$F$20060101$20240711$20240705$20240719$EXP$$FR-OTSUKA-2024_018266$OTSUKA$$27$YR$$M$Y$$$20240719$$CN$FR$FR
240552342$24055234$2$F$$20240701$20240705$20240712$EXP$$MY-ELI_LILLY_AND_COMPANY-MY202406019463$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240712$$CN$MY$MY
240552351$24055235$1$I$20230101$20240701$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407001224$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240705$$CN$US$US
240552362$24055236$2$F$20240611$20240730$20240705$20240802$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202406017839$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$BR$BR
240552374$24055237$4$F$20240622$20240819$20240705$20240830$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406018022$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240830$$CN$JP$JP
240552381$24055238$1$I$$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017319$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240705$$CN$US$US
240552392$24055239$2$F$$20240711$20240705$20240722$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02357$AMNEAL$$$$$M$Y$$$20240722$$CN$US$US
240552401$24055240$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002924$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$US$US
240552411$24055241$1$I$20240620$20240625$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406018533$ELI LILLY AND CO$$48$YR$A$M$Y$76$KG$20240705$$CN$CN$CN
240552421$24055242$1$I$$20240628$20240705$20240705$PER$$US-ALXN-202406USA001969US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240552431$24055243$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5825367$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240552441$24055244$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214940$TEVA$$52$YR$$F$Y$$$20240705$$HP$CA$CA
240552451$24055245$1$I$20240428$20240628$20240705$20240705$EXP$$PK-ROCHE-10000014760$ROCHE$$68$YR$E$M$Y$$$20240705$$CN$PK$PK
240552461$24055246$1$I$20240611$20240624$20240705$20240705$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000547$PAREXEL$$$$$$Y$$$20240705$$HP$CN$CN
240552471$24055247$1$I$$20240516$20240705$20240705$PER$$US-AMGEN-USASP2024131970$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240552483$24055248$3$F$$20240724$20240705$20240729$EXP$$CA-AstraZeneca-2024A149869$ASTRAZENECA$$$$$F$Y$$$20240729$$MD$CA$
240552491$24055249$1$I$$20240629$20240705$20240705$EXP$$VN-AstraZeneca-2024A152061$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$VN$
240552501$24055250$1$I$20240623$20240629$20240705$20240705$EXP$$US-AstraZeneca-2024A153007$ASTRAZENECA$$94$MON$$F$Y$43.5$KG$20240705$$HP$US$
240552511$24055251$1$I$$20240627$20240705$20240705$EXP$$TR-AstraZeneca-2024A149511$ASTRAZENECA$Alp A, Yildiz MI, Eroglu EO, Isikay AI, Ayhan Y, Ertugrul A. RECURRENT PSYCHOTIC DEPRESSION ASSOCIATED WITH CHRONIC SUBDURAL HAEMATOMA: A CASE REPORT. Archives of Neuropsychiatry 2024;$77$YR$$F$Y$$$20240705$$HP$TR$
240552521$24055252$1$I$20240619$20240627$20240705$20240705$EXP$$CN-AstraZeneca-2024A150931$ASTRAZENECA$$66$YR$$F$Y$59$KG$20240705$$MD$CN$
240552531$24055253$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA192495$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240705$$MD$US$US
240552541$24055254$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA194545$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240705$$MD$US$US
240552552$24055255$2$F$$20231228$20240705$20240716$PER$$US-AstraZeneca-2024A154262$ASTRAZENECA$$$$$$Y$$$20240716$$HP$US$
240552561$24055256$1$I$$20240702$20240705$20240705$EXP$$IT-AstraZeneca-2024A152670$ASTRAZENECA$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicology Reports 2024;13:Art nr 101683 .$15$YR$$F$Y$48$KG$20240705$$HP$IT$
240552571$24055257$1$I$$20240625$20240705$20240705$EXP$$CA-INDIVIOR US-INDV-145759-2024$RECKITT BENCKISER$Pouya Azar, Hannah Schneiderman, Henry Barron, James S. H. Wong, Maximilian Meyer, Dayyon Newman-Azar, Matin Narimani, Martha J. Ignaszewski, Nickie Mathew, Rodney Mullen, Reinhard M. Krausz and Anil. Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder. Addiction Science + Clinical Practice. 2024;19 (50):1-6$34$YR$$F$Y$$$20240705$$MD$CA$CA
240552581$24055258$1$I$20240601$20240618$20240705$20240705$PER$$US-AstraZeneca-2024A142113$ASTRAZENECA$$719$MON$$F$Y$$$20240705$$CN$US$
240552591$24055259$1$I$$20240701$20240705$20240705$EXP$$ZA-AstraZeneca-2024A152026$ASTRAZENECA$$66$YR$$M$Y$$$20240705$$CN$ZA$
240552601$24055260$1$I$20240629$20240702$20240705$20240705$EXP$$US-AstraZeneca-2024A152183$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240552611$24055261$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA196240$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240705$$MD$US$US
240552622$24055262$2$F$20240101$20240708$20240705$20240716$PER$$US-SA-2024SA192314$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240716$$MD$US$US
240552641$24055264$1$I$20240101$20240628$20240705$20240705$PER$$US-SA-2024SA196006$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240705$$MD$US$US
240552651$24055265$1$I$$20240628$20240705$20240705$EXP$$CA-AstraZeneca-2024A150370$ASTRAZENECA$$46$YR$$M$Y$166$KG$20240705$$MD$CA$
240552662$24055266$2$F$$20240819$20240705$20240822$EXP$$NVSC2024US089813$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
240552672$24055267$2$F$$20240711$20240705$20240723$EXP$$RU-TEVA-VS-3212586$TEVA$Novikov PS, Novikov IA, Mironov NYu, Saidova MA, Dulaev LO, Maykov IEB. TAKOTSUBO CARDIOMYOPATHY AFTER CRYOBALLOON PULMONARY VEIN ABLATION IN A PATIENT WITH PERSISTENT ATRIAL FIBRILLATION: CLINICAL CASE. J-Arrhythmology 2022; 29 (1): 63-68.; Novikov PS, Novikov IA, Mironov NYu, Saidova MA, Dulaev LO, Maykov IEB. TAKOTSUBO CARDIOMYOPATHY AFTER CRYOBALLOON PULMONARY VEIN ABLATION IN A PATIENT WITH PERSISTENT ATRIAL FIBRILLATION: CLINICAL CASE. J-Arrhythmology 2022; 29 (1): 63-68.$66$YR$$F$Y$$$20240723$$HP$RU$RU
240552682$24055268$2$F$20220301$20240710$20240705$20240716$EXP$$CA-MYLANLABS-2023M1006933$BIOCON$$$$$$Y$$$20240716$$CN$CA$CA
240552701$24055270$1$I$$20240614$20240705$20240705$EXP$$PH-ROCHE-10000014937$ROCHE$$65$YR$E$F$Y$$$20240705$$MD$PH$PH
240552711$24055271$1$I$20240330$20240627$20240705$20240705$PER$$US-BAYER-2024A094563$BAYER$$72$YR$E$M$Y$$$20240705$$CN$US$US
240552723$24055272$3$F$20240623$20240913$20240705$20240916$30DAY$$JP-PFIZER INC-PV202400082383$PFIZER$$$$$$Y$$$20240916$$CN$JP$JP
240552732$24055273$2$F$$20240729$20240705$20240805$EXP$$US-ROCHE-3527511$ROCHE$$$$A$F$Y$$$20240805$$CN$US$US
240552741$24055274$1$I$20240526$20240703$20240705$20240705$EXP$$US-TAKEDA-2023TUS035195$TAKEDA$$58$YR$$M$Y$$$20240705$$MD$US$US
240552751$24055275$1$I$$20240620$20240705$20240705$EXP$$AT-NOVOPROD-1247824$NOVO NORDISK$?AZ Austrian Pharmacist Newspaper (??AZ ?sterreichische Apotheker-Zeitung?). 2024;23$$$$F$Y$$$20240705$$CN$AT$AT
240552761$24055276$1$I$20240601$20240624$20240705$20240705$EXP$$US-FARMAPROD-202406-2384$DOMPE FARMACEUTICI$$74$YR$E$M$Y$$$20240705$$CN$US$US
240552771$24055277$1$I$20240502$20240606$20240705$20240705$PER$$US-Eisai-EC-2024-167777$EISAI$$75$YR$E$F$Y$$$20240705$$HP$US$US
240552781$24055278$1$I$20240101$20240528$20240705$20240705$PER$$US-Eisai-EC-2024-166706$EISAI$$76$YR$E$M$Y$$$20240705$$CN$US$US
240552793$24055279$3$F$20220401$20240905$20240705$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-105595$BRISTOL MYERS SQUIBB$Hayashi Y, Tsukada M, Shinoda D, Matsui M, Iwama K, Kajiwara K, et al. Successful treatment of steroid-refractory immune thrombocytopenia in a patient developing multiple myeloma while on immune checkpoint inhibitor therapy for lung cancer: a case report. Journal of Blood Medicine. 2024 Jun 21;15:285-90. doi:10.2147/JBM.S468921.$79$YR$E$M$Y$$$20240916$$MD$JP$JP
240552801$24055280$1$I$20240601$20240605$20240705$20240705$PER$$US-Eisai-EC-2024-167768$EISAI$$78$YR$E$M$Y$$$20240705$$MD$US$US
240552811$24055281$1$I$20240531$20240607$20240705$20240705$PER$$US-Eisai-EC-2024-167775$EISAI$$76$YR$E$F$Y$$$20240705$$CN$US$US
240552821$24055282$1$I$20240612$20240701$20240705$20240705$EXP$AT-BASGAGES-2024-004750$AT-SHIONOGI, INC-2024001510$SHIONOGI$$$$$$Y$$$20240705$$PH$AT$AT
240552831$24055283$1$I$20240627$20240628$20240705$20240705$EXP$$CN-BAYER-2024A095109$BAYER$$9$YR$C$M$Y$31$KG$20240705$$HP$CN$CN
240552842$24055284$2$F$20190101$20240628$20240705$20240709$EXP$$BR-BIOGEN-2024BI01272013$BIOGEN$$$$$F$Y$65$KG$20240709$$CN$BR$BR
240552851$24055285$1$I$$20230922$20240705$20240705$PER$$US-AMGEN-USASP2023235586$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240552862$24055286$2$F$20240702$20240703$20240705$20240717$PER$$US-AMGEN-USASP2024132588$AMGEN$$$$$$Y$$$20240717$$PH$US$US
240552871$24055287$1$I$$20240530$20240705$20240705$PER$$US-AMGEN-USASP2024129872$AMGEN$$$$$$Y$$$20240705$$MD$US$US
240552881$24055288$1$I$$20230929$20240705$20240705$PER$$US-AMGEN-USASP2023235543$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240552891$24055289$1$I$$20240516$20240705$20240705$PER$$US-AMGEN-USASP2024131758$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240552902$24055290$2$F$20240530$20240702$20240705$20240711$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0601204$MYOVANT SCIENCES$$56$YR$$M$Y$$$20240711$$CN$US$US
240552911$24055291$1$I$20240101$20240701$20240705$20240705$EXP$GB-ABBVIE-5821035$GB-RDY-SPO/GBR/24/0009727$DR REDDYS$$88$YR$E$M$Y$$$20240705$$MD$GB$GB
240552921$24055292$1$I$20240613$20240702$20240705$20240705$EXP$$US-ABBVIE-5827098$ABBVIE$$73$YR$$F$Y$$$20240705$$CN$US$US
240552931$24055293$1$I$20240702$20240703$20240705$20240705$EXP$$US-ABBVIE-5827326$ABBVIE$$96$YR$$F$Y$$$20240705$$CN$US$US
240552943$24055294$3$F$20240315$20240625$20240705$20240906$EXP$$US-FARMAPROD-202402-0625$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$US
240552951$24055295$1$I$20240101$20240703$20240705$20240705$EXP$$AU-ABBVIE-5827878$ABBVIE$$$$$M$Y$$$20240705$$CN$AU$AU
240552961$24055296$1$I$20240702$20240702$20240705$20240705$PER$$US-BAYER-2024A095585$BAYER$$84$YR$E$F$Y$$$20240705$$CN$US$US
240552971$24055297$1$I$20240101$20240701$20240705$20240705$EXP$$CN-BAYER-2024A096387$BAYER$$34$YR$A$F$Y$52$KG$20240705$$HP$CN$CN
240552981$24055298$1$I$$20240604$20240705$20240705$PER$$US-AMGEN-USASP2024132777$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240552991$24055299$1$I$$20240628$20240705$20240705$PER$$US-AMGEN-USASP2024129919$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240553002$24055300$2$F$20240622$20240628$20240705$20240708$PER$$US-ABBVIE-5828304$ABBVIE$$58$YR$$M$Y$$$20240708$$PH$US$US
240553011$24055301$1$I$$20240703$20240705$20240705$EXP$$US-TAKEDA-2024TUS058260$TAKEDA$$$$$M$Y$103$KG$20240705$$HP$US$US
240553021$24055302$1$I$$20231107$20240705$20240705$PER$$US-AMGEN-USASP2023235602$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240553032$24055303$2$F$$20240708$20240705$20240709$PER$$US-JNJFOC-20240713001$JOHNSON AND JOHNSON$$70$YR$E$F$Y$90.2$KG$20240709$$CN$US$US
240553041$24055304$1$I$$20240628$20240705$20240705$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0601262$MYOVANT SCIENCES$$$$$M$Y$$$20240705$$CN$US$US
240553051$24055305$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5825051$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240553061$24055306$1$I$20240601$20240626$20240705$20240705$PER$$US-009507513-2407USA000651$MERCK$$81$YR$$F$Y$$$20240705$$CN$US$US
240553071$24055307$1$I$20240625$20240702$20240705$20240705$PER$$US-BAYER-2024A095591$BAYER$$34$YR$A$F$Y$$$20240705$$CN$US$US
240553081$24055308$1$I$20211101$20240626$20240705$20240705$EXP$$US-AMGEN-USASP2024127854$AMGEN$$$$$M$Y$$$20240705$$HP$US$US
240553091$24055309$1$I$$20240627$20240705$20240705$PER$$US-ROCHE-10000015827$ROCHE$$77$YR$E$F$Y$$$20240705$$HP$US$US
240553101$24055310$1$I$20240601$20240625$20240705$20240705$EXP$$JP-ROCHE-10000011946$ROCHE$$$$$F$Y$$$20240705$$MD$JP$JP
240553111$24055311$1$I$$20231106$20240705$20240705$PER$$US-ABBVIE-5827651$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240553121$24055312$1$I$20240313$20240703$20240703$20240703$DIR$708977$$FDA-CTU$$33$YR$$M$N$$$20240703$N$$US$
240553131$24055313$1$I$20240419$20240627$20240705$20240705$EXP$FR-AFSSAPS-TO2024000758$FR-TEVA-VS-3215717$TEVA$$65$YR$$M$Y$98$KG$20240705$$PH$FR$FR
240553141$24055314$1$I$$20240628$20240705$20240705$EXP$$CA-TAKEDA-2024TUS066890$TAKEDA$$$$$M$Y$$$20240705$$MD$CA$CA
240553151$24055315$1$I$20240628$20240703$20240703$20240703$DIR$709060$$FDA-CTU$$62$YR$$M$N$81.45$KG$20240703$N$MD$US$
240553161$24055316$1$I$20240703$20240703$20240703$20240703$DIR$709057$$FDA-CTU$$36$YR$$F$N$90$KG$20240703$N$CN$US$
240553181$24055318$1$I$20240326$20240703$20240703$20240703$DIR$708980$$FDA-CTU$$63$YR$$M$N$$$20240703$N$$US$
240553191$24055319$1$I$20210924$20240703$20240703$20240703$DIR$709038$$FDA-CTU$$73$YR$$M$N$78.75$KG$20240703$N$CN$US$
240553213$24055321$3$F$20240625$20240807$20240705$20240807$PER$$US-BAYER-2024A095523$BAYER$$41$YR$A$F$Y$$$20240807$$CN$US$US
240553221$24055322$1$I$$20240626$20240705$20240705$EXP$$ES-SA-2024SA192180$SANOFI AVENTIS$Rubio-Mora E, Rodr?guez JG, Carrascoso GR.. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?.. Transpl Infect Dis.. 2024;26(3):1-3$6$MON$I$M$Y$$$20240705$$HP$ES$ES
240553231$24055323$1$I$20240619$20240702$20240705$20240705$EXP$$DE-ABBVIE-5826126$ABBVIE$$70$YR$$F$Y$$$20240705$$CN$DE$DE
240553241$24055324$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA195384$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240705$$MD$US$US
240553262$24055326$2$F$20240101$20240808$20240705$20240814$EXP$$US-OTSUKA-2024_018803$OTSUKA$$$$$F$Y$$$20240814$$CN$US$US
240553271$24055327$1$I$20240521$20240605$20240705$20240705$PER$$US-Eisai-EC-2024-167774$EISAI$$76$YR$E$M$Y$$$20240705$$CN$US$US
240553281$24055328$1$I$20240403$20240520$20240705$20240705$PER$$US-Eisai-EC-2024-166485$EISAI$$$$$F$Y$$$20240705$$HP$US$US
240553291$24055329$1$I$$20240702$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106149$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240705$$CN$US$US
240553301$24055330$1$I$20240426$20240701$20240705$20240705$EXP$FR-AFSSAPS-TO2024001181$FR-FreseniusKabi-FK202410403$FRESENIUS KABI$$71$YR$A$F$Y$$$20240705$$MD$FR$FR
240553311$24055331$1$I$$20240328$20240705$20240705$PER$$US-AMGEN-USASP2024132678$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240553322$24055332$2$F$20220712$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS066898$TAKEDA$$37$YR$$M$Y$$$20240709$$HP$CN$CN
240553331$24055333$1$I$20240601$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130746$AMGEN$$61$YR$A$F$Y$$$20240705$$CN$US$US
240553341$24055334$1$I$$20240702$20240705$20240705$PER$$US-BAYER-2024A095700$BAYER$$66$YR$E$M$Y$$$20240705$$CN$US$US
240553351$24055335$1$I$$20240704$20240705$20240705$EXP$$CN-BAYER-2024A096595$BAYER$$$$$$Y$$$20240705$$MD$CN$CN
240553361$24055336$1$I$20240607$20240704$20240705$20240705$EXP$$CN-BAYER-2024A097266$BAYER$$42$YR$A$F$Y$62$KG$20240705$$HP$CN$CN
240553372$24055337$2$F$20240702$20240707$20240705$20240709$EXP$$JP-BAYER-2024A095599$BAYER$$$$$F$Y$$$20240709$$MD$JP$JP
240553381$24055338$1$I$$20240628$20240705$20240705$PER$$US-BAYER-2024A094527$BAYER$$81$YR$E$M$Y$$$20240705$$CN$US$US
240553391$24055339$1$I$20240703$20240703$20240703$20240703$DIR$709072$$FDA-CTU$$77$YR$$M$N$$$20240703$N$$US$
240553402$24055340$2$F$20240601$20240805$20240705$20240806$PER$$US-ALXN-202406USA001960US$ALEXION PHARMACEUTICALS$$63$YR$$F$Y$$$20240806$$CN$US$US
240553411$24055341$1$I$$20240704$20240705$20240705$EXP$$AU-AstraZeneca-2024A154190$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$AU$
240553421$24055342$1$I$20240509$20240704$20240705$20240705$EXP$$IN-AstraZeneca-2024A154060$ASTRAZENECA$$27782$DY$$M$Y$$$20240705$$CN$IN$
240553431$24055343$1$I$$20240701$20240705$20240705$EXP$$CH-AstraZeneca-2024A154086$ASTRAZENECA$$$$$$Y$$$20240705$$MD$CH$
240553441$24055344$1$I$20240507$20240702$20240705$20240705$EXP$$US-AstraZeneca-2024A152140$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$US$
240553451$24055345$1$I$20240521$20240703$20240703$20240703$DIR$709015$$FDA-CTU$$56$YR$$F$N$$$20240703$N$$US$
240553462$24055346$2$F$20200701$20240704$20240705$20240708$EXP$FR-AFSSAPS-BR2024000535$FR-BIOVITRUM-2024-FR-009485$BIOVITRUM$$61$YR$$F$Y$$$20240708$$PH$FR$FR
240553471$24055347$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A150286$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240553483$24055348$3$F$$20240708$20240705$20240716$PER$$US-AstraZeneca-2024A132257$ASTRAZENECA$$69$YR$$F$Y$$$20240716$$CN$US$
240553493$24055349$3$F$20230901$20240904$20240705$20240909$30DAY$$JP-PFIZER INC-202400203458$PFIZER$$9$YR$$M$Y$$$20240909$$MD$JP$JP
240553503$24055350$3$F$20240630$20240905$20240705$20240910$30DAY$$GR-PFIZER INC-PV202400086088$PFIZER$$11$YR$$F$Y$32$KG$20240910$$CN$GR$GR
240553511$24055351$1$I$20240627$20240703$20240703$20240703$DIR$709029$$FDA-CTU$$68$YR$$M$N$65.25$KG$20240703$Y$HP$US$
240553524$24055352$4$F$20210101$20240917$20240705$20240919$30DAY$$US-PFIZER INC-202400203204$PFIZER$$19$YR$$F$Y$57$KG$20240919$$CN$US$US
240553531$24055353$1$I$$20230623$20240705$20240705$PER$$US-AMGEN-USASP2023235571$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240553541$24055354$1$I$$20240102$20240705$20240705$PER$$US-AMGEN-USASP2024132966$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240553551$24055355$1$I$20240609$20240628$20240705$20240705$EXP$$CN-BAYER-2024A095750$BAYER$$62$YR$A$M$Y$60$KG$20240705$$HP$CN$CN
240553561$24055356$1$I$20240626$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130819$AMGEN$$60$YR$A$F$Y$$$20240705$$CN$US$US
240553572$24055357$2$F$20231001$20240708$20240705$20240710$EXP$$US-ABBVIE-5826270$ABBVIE$$33$YR$$F$Y$$$20240710$$CN$US$US
240553581$24055358$1$I$20240701$20240702$20240705$20240705$EXP$$JP-BAYER-2024A095136$BAYER$$$$$M$Y$$$20240705$$MD$JP$JP
240553591$24055359$1$I$20240531$20240703$20240703$20240703$DIR$708994$$FDA-CTU$$50$YR$$F$N$$$20240703$N$$US$
240553602$24055360$2$F$20240620$20240926$20240705$20240927$30DAY$$TW-PFIZER INC-PV202400081985$PFIZER$$5$YR$$M$Y$15$KG$20240927$$HP$TW$TW
240553615$24055361$5$F$20240628$20240814$20240705$20240815$30DAY$$US-PFIZER INC-202400204411$PFIZER$$65$YR$$F$Y$63.492$KG$20240815$$CN$US$US
240553621$24055362$1$I$20240625$20240702$20240705$20240705$EXP$$US-BAYER-2024A096397$BAYER$$87$YR$E$F$Y$63.946$KG$20240705$$MD$US$US
240553632$24055363$2$F$20240628$20240820$20240705$20240822$30DAY$$JP-PFIZER INC-PV202400085501$PFIZER$$$$$F$Y$$$20240822$$CN$JP$JP
240553641$24055364$1$I$$20240627$20240705$20240705$30DAY$$FR-PFIZER INC-202400203077$PFIZER$$60$YR$$F$Y$$$20240705$$PH$FR$FR
240553652$24055365$2$F$$20240712$20240705$20240723$EXP$$DK-BAYER-2024A095060$BAYER$$$$$$Y$$$20240723$$CN$DK$DK
240553661$24055366$1$I$20240621$20240628$20240705$20240705$EXP$$US-SA-2024SA197702$SANOFI AVENTIS$$75$YR$E$M$Y$95.2$KG$20240705$$MD$US$US
240553672$24055367$2$F$20240321$20240711$20240705$20240716$EXP$$JP-BAYER-2024A093009$BAYER$$81$YR$E$M$Y$$$20240716$$MD$JP$JP
240553682$24055368$2$F$20240601$20240725$20240705$20240729$EXP$$JP-EMD Serono-2024036317$EMD SERONO INC$$$$E$M$Y$$$20240729$$MD$JP$JP
240553691$24055369$1$I$$20240704$20240705$20240705$EXP$GB-MHRA-MED-202407041108352300-YCRQS$GB-SANDOZ INC.-SDZ2024GB062971$SANDOZ$$$$$F$Y$$$20240705$$CN$GB$GB
240553701$24055370$1$I$$20240703$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062810$SANDOZ$$$$$$Y$$$20240705$$CN$US$US
240553711$24055371$1$I$$20240702$20240705$20240705$PER$$US-SA-2024SA196872$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240705$$CN$US$US
240553721$24055372$1$I$20240607$20240701$20240705$20240705$PER$$US-SA-2024SA196497$SANOFI AVENTIS$$39$YR$A$F$Y$58.96$KG$20240705$$CN$US$US
240553731$24055373$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA195383$SANOFI AVENTIS$$20$YR$A$F$Y$55$KG$20240705$$MD$US$US
240553741$24055374$1$I$$20240621$20240705$20240705$PER$$US-ABBVIE-5827725$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240553751$24055375$1$I$$20240701$20240705$20240705$EXP$$NL-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003666$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240705$$HP$NL$NL
240553761$24055376$1$I$20240406$20240627$20240705$20240705$EXP$$JP-TAKEDA-2024TUS067688$TAKEDA$$77$YR$$M$Y$$$20240705$$MD$JP$JP
240553771$24055377$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5826597$ABBVIE$$19$YR$$F$Y$$$20240705$$HP$US$US
240553781$24055378$1$I$20240101$20240628$20240705$20240705$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016882$UNITED THERAPEUTICS$$$$$F$Y$63.039$KG$20240705$$$US$US
240553791$24055379$1$I$20240513$20240703$20240703$20240703$DIR$708987$$FDA-CTU$$19$YR$$F$N$$$20240703$N$$US$
240553801$24055380$1$I$$20240628$20240705$20240705$30DAY$$US-PFIZER INC-202400203340$PFIZER$$$$$F$Y$$$20240705$$HP$US$US
240553813$24055381$3$F$$20240905$20240705$20240911$30DAY$$CO-PFIZER INC-202400202573$PFIZER$$16$YR$$M$Y$$$20240911$$CN$CO$CO
240553823$24055382$3$F$20240624$20240912$20240705$20240913$30DAY$$AR-PFIZER INC-202400204412$PFIZER$$33$YR$$F$Y$$$20240913$$HP$AR$AR
240553833$24055383$3$F$$20240917$20240705$20240918$30DAY$$GB-PFIZER INC-202400204226$PFIZER$$$$$$Y$$$20240918$$HP$GB$GB
240553841$24055384$1$I$$20240625$20240705$20240705$30DAY$$KR-PFIZER INC-202400206383$PFIZER$$12$YR$$$Y$$$20240705$$CN$KR$KR
240553851$24055385$1$I$20200101$20240620$20240705$20240705$EXP$$US-FOUNDATIONCONSUMERHC-2024-US-034608$FOUNDATION CONSUMER HEALTHCARE$$31$YR$$F$Y$77.11$KG$20240705$$CN$US$US
240553861$24055386$1$I$20240604$20240610$20240705$20240705$PER$$US-Eisai-EC-2024-168044$EISAI$$73$YR$E$M$Y$$$20240705$$HP$US$US
240553881$24055388$1$I$20240601$20240606$20240705$20240705$PER$$US-Eisai-EC-2024-167979$EISAI$$$$E$M$Y$$$20240705$$HP$US$US
240553891$24055389$1$I$$20240701$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105176$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240705$$MD$US$US
240553901$24055390$1$I$20240704$20240705$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107504$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240705$$HP$US$US
240553911$24055391$1$I$$20240703$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107227$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240705$$HP$US$US
240553921$24055392$1$I$$20240629$20240705$20240705$PER$$US-ROCHE-10000016373$ROCHE$$74$YR$E$F$Y$$$20240705$$CN$US$US
240553931$24055393$1$I$$20240626$20240705$20240705$PER$$US-ROCHE-10000015551$ROCHE$$$$E$F$Y$$$20240705$$CN$US$US
240553941$24055394$1$I$20240415$20240701$20240705$20240705$EXP$FR-AFSSAPS-NC2024000756$FR-FreseniusKabi-FK202410406$FRESENIUS KABI$$74$YR$E$F$Y$$$20240705$$MD$FR$FR
240553951$24055395$1$I$$20240628$20240705$20240705$EXP$$CA-BAYER-2024A096193$BAYER$Garneau B.; Roy C.; Motard J.; Desharnais B.; Bouchard C.; Mireault P.. Atypical postmortem redistribution in chronic methadone consumers. Journal of Analytical Toxicology. 2024;48:5:343-349$43$YR$A$F$Y$$$20240705$$HP$CA$CA
240553961$24055396$1$I$20240201$20240701$20240705$20240705$EXP$FR-AFSSAPS-MA2024001109$FR-FreseniusKabi-FK202410404$FRESENIUS KABI$$48$YR$A$M$Y$$$20240705$$PH$FR$FR
240553972$24055397$2$F$20240629$20240702$20240705$20240711$EXP$$CN-TAKEDA-2024TUS067350$TAKEDA$$69$YR$$M$Y$60$KG$20240711$$HP$CN$CN
240553981$24055398$1$I$20220301$20240701$20240705$20240705$EXP$PL-URPL-DML-MLP.4401.1.722.2022$PL-FreseniusKabi-FK202410321$FRESENIUS KABI$$67$YR$E$F$Y$80$KG$20240705$$HP$PL$PL
240553991$24055399$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA195254$SANOFI AVENTIS$$$$A$M$Y$108.86$KG$20240705$$MD$US$US
240554001$24055400$1$I$$20240630$20240705$20240705$EXP$$CA-GSK-CA2024082168$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$CA$CA
240554021$24055402$1$I$20240701$20240703$20240703$20240703$DIR$709073$$FDA-CTU$$31$YR$$F$N$48.15$KG$20240703$Y$CN$US$
240554031$24055403$1$I$20240621$20240630$20240705$20240705$EXP$$CN-JNJFOC-20240703698$JOHNSON AND JOHNSON$$11$YR$C$F$Y$37$KG$20240705$$HP$CN$CN
240554041$24055404$1$I$20240702$20240702$20240705$20240705$EXP$$AU-ABBVIE-5826023$ABBVIE$$72$YR$$M$Y$$$20240705$$CN$AU$AU
240554051$24055405$1$I$20240426$20240607$20240705$20240705$PER$$US-009507513-2406USA003641$MERCK$$69$YR$$M$Y$$$20240705$$CN$US$US
240554072$24055407$2$F$20240101$20240711$20240705$20240716$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003693$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
240554081$24055408$1$I$$20240703$20240703$20240703$DIR$709017$$FDA-CTU$$$$$UNK$N$$$20240703$N$CN$US$
240554092$24055409$2$F$20220427$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS067000$TAKEDA$$61$YR$$M$Y$$$20240709$$HP$CN$CN
240554102$24055410$2$F$$20240830$20240705$20240905$EXP$$US-BAYER-2024A093021$BAYER$$68$YR$E$M$Y$$$20240905$$CN$US$US
240554112$24055411$2$F$$20240710$20240705$20240712$EXP$$JP-BAYER-2024A096038$BAYER$$5$DEC$A$F$Y$$$20240712$$PH$JP$JP
240554121$24055412$1$I$20240309$20240625$20240705$20240705$EXP$$AU-ROCHE-10000008500$ROCHE$$76$YR$E$M$Y$$$20240705$$HP$AU$AU
240554131$24055413$1$I$20240518$20240627$20240705$20240705$EXP$FR-AFSSAPS-PO2024000626$FR-TEVA-VS-3215724$TEVA$$78$YR$$M$Y$$$20240705$$MD$FR$FR
240554141$24055414$1$I$$20240702$20240705$20240705$PER$$US-ORGANON-O2407USA000408$ORGANON$$$$$F$Y$$$20240705$$CN$US$US
240554151$24055415$1$I$$20240226$20240705$20240705$PER$$US-AMGEN-USASP2024133137$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240554161$24055416$1$I$20240607$20240703$20240703$20240703$DIR$709014$$FDA-CTU$$30$YR$$M$N$69.75$KG$20240703$N$CN$US$
240554171$24055417$1$I$20240624$20240628$20240705$20240705$EXP$$JP-AMGEN-JPNSP2024130044$AMGEN$$$$E$F$Y$$$20240705$$MD$JP$JP
240554181$24055418$1$I$20240618$20240703$20240705$20240705$EXP$$US-ABBVIE-5828202$ABBVIE$$72$YR$$F$Y$$$20240705$$CN$US$US
240554191$24055419$1$I$$20240626$20240705$20240705$EXP$$CN-AstraZeneca-2024A150050$ASTRAZENECA$$49$YR$$M$Y$$$20240705$$MD$CN$
240554201$24055420$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA195222$SANOFI AVENTIS$$$$C$M$Y$11.791$KG$20240705$$MD$US$US
240554211$24055421$1$I$$20240621$20240705$20240705$PER$$US-SA-2024SA189477$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240554223$24055422$3$F$20240101$20240730$20240705$20240808$PER$$US-SA-2024SA194710$SANOFI AVENTIS$$42$YR$A$M$Y$117.93$KG$20240808$$MD$US$US
240554231$24055423$1$I$20240524$20240701$20240705$20240705$EXP$ES-AEMPS-1538966$ES-BAYER-2024A094677$BAYER$$67$YR$E$F$Y$$$20240705$$MD$ES$ES
240554251$24055425$1$I$$20240702$20240705$20240705$EXP$$CA-AstraZeneca-2024A058581$ASTRAZENECA$$$$$F$Y$$$20240705$$HP$CA$
240554261$24055426$1$I$$20240628$20240705$20240705$EXP$$JP-AstraZeneca-2024A152723$ASTRAZENECA$$$$$$Y$$$20240705$$MD$JP$
240554271$24055427$1$I$20220101$20240630$20240705$20240705$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003704$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240705$$MD$US$US
240554281$24055428$1$I$$20240703$20240705$20240705$EXP$$CN-VANTIVE-2024VAN018142$Vantive US Healthcare$$$$$F$Y$$$20240705$$CN$CN$CN
240554291$24055429$1$I$$20240702$20240705$20240705$PER$$US-JNJFOC-20240706123$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$CN$US$US
240554301$24055430$1$I$$20240705$20240705$20240705$EXP$GB-MHRA-MED-202405171248538180-YNKBR$GB-JNJFOC-20240713994$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240705$$HP$GB$GB
240554311$24055431$1$I$$20240626$20240705$20240705$PER$$US-ABBVIE-5828077$ABBVIE$$$$$F$Y$$$20240705$$HP$US$US
240554321$24055432$1$I$$20240620$20240705$20240705$EXP$$US-TEVA-VS-3215331$TEVA$$70$YR$$M$Y$$$20240705$$PH$US$US
240554333$24055433$3$F$20240526$20240812$20240705$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002796$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240905$$CN$US$US
240554341$24055434$1$I$20240601$20240625$20240705$20240705$EXP$$US-BAYER-2024A093337$BAYER$$62$YR$A$M$Y$$$20240705$$CN$US$US
240554361$24055436$1$I$20240612$20240626$20240705$20240705$EXP$SE-SEMPA-2024-004936$SE-TEVA-VS-3214621$TEVA$$61$YR$$F$Y$53$KG$20240705$$MD$SE$SE
240554372$24055437$2$F$$20240826$20240705$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002797$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
240554381$24055438$1$I$20240513$20240626$20240705$20240705$EXP$FR-AFSSAPS-CN2024000546$FR-TEVA-VS-3215117$TEVA$$59$YR$$M$Y$80$KG$20240705$$MD$FR$FR
240554392$24055439$2$F$$20240906$20240705$20240909$EXP$$NVSC2024US139142$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
240554402$24055440$2$F$$20240708$20240705$20240710$EXP$$CA-BAYER-2024A096364$BAYER$$$$$F$Y$$$20240710$$HP$CA$CA
240554412$24055441$2$F$$20240916$20240705$20240919$30DAY$$GB-PFIZER INC-PV202400086075$PFIZER$$18$YR$$M$Y$$$20240919$$CN$GB$GB
240554434$24055443$4$F$$20240924$20240705$20240927$30DAY$$GB-PFIZER INC-PV202400086061$PFIZER$$75$YR$$F$Y$$$20240927$$CN$GB$GB
240554451$24055445$1$I$$20240606$20240705$20240705$PER$$US-Eisai-EC-2024-167980$EISAI$$$$$$Y$$$20240705$$HP$US$US
240554461$24055446$1$I$$20240611$20240705$20240705$PER$$US-Eisai-EC-2024-167994$EISAI$$$$$F$Y$$$20240705$$CN$US$US
240554471$24055447$1$I$20240604$20240612$20240705$20240705$PER$$US-Eisai-EC-2024-168056$EISAI$$62$YR$A$M$Y$$$20240705$$CN$US$US
240554481$24055448$1$I$$20240702$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107519$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240705$$CN$US$US
240554491$24055449$1$I$20240703$20240703$20240703$20240703$DIR$709045$$FDA-CTU$$45$YR$$F$N$65.25$KG$20240703$N$HP$US$
240554511$24055451$1$I$20240618$20240703$20240703$20240703$DIR$709070$$FDA-CTU$$79$YR$$F$N$$$20240703$Y$PH$US$
240554521$24055452$1$I$$20240703$20240703$20240703$DIR$709012$$FDA-CTU$$$$$UNK$N$$$20240703$$CN$US$
240554531$24055453$1$I$20240525$20240703$20240703$20240703$DIR$709016$$FDA-CTU$$49$YR$$M$N$$$20240703$N$$US$
240554541$24055454$1$I$20240509$20240701$20240705$20240705$EXP$ES-AEMPS-1538970$ES-FreseniusKabi-FK202410362$FRESENIUS KABI$$$$E$F$Y$$$20240705$$MD$ES$ES
240554561$24055456$1$I$20240630$20240703$20240703$20240703$DIR$709079$$FDA-CTU$$56$YR$$F$N$59.85$KG$20240703$N$CN$US$
240554581$24055458$1$I$$20240701$20240705$20240705$EXP$$US-BAYER-2024A095435$BAYER$$$$$$Y$$$20240705$$CN$US$US
240554592$24055459$2$F$$20240802$20240705$20240806$PER$$US-ALXN-202406USA001802US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240554601$24055460$1$I$20240629$20240703$20240703$20240703$DIR$709032$$FDA-CTU$$57$YR$$F$N$56.25$KG$20240703$Y$CN$US$
240554621$24055462$1$I$20240418$20240621$20240705$20240705$PER$$US-ROCHE-3551309$ROCHE$$35$YR$A$F$Y$104.33$KG$20240705$$CN$US$US
240554632$24055463$2$F$20240703$20240815$20240705$20240820$PER$$US-JNJFOC-20240710967$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240820$$CN$US$US
240554651$24055465$1$I$$20240628$20240705$20240705$EXP$$JP-BAYER-2024A095247$BAYER$$90$YR$E$M$Y$$$20240705$$MD$JP$JP
240554661$24055466$1$I$20240101$20240628$20240705$20240705$EXP$$US-ORGANON-O2406USA002442$ORGANON$$$$$F$Y$$$20240705$$CN$US$US
240554671$24055467$1$I$$20240605$20240705$20240705$PER$$US-009507513-2406USA002534$MERCK$Scott J, Jenkins A. Navigating Diagnostic Dilemmas: Distinguishing Acute Fatty Liver of Pregnancy from HELLP syndrome - A Case Report. International Journal of Obstetric Anesthesia. 2024;58 (Supple. 1):36-7$36$YR$$F$Y$$$20240705$$HP$US$US
240554681$24055468$1$I$$20240612$20240705$20240705$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002805$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240554701$24055470$1$I$$20240228$20240705$20240705$PER$$US-AMGEN-USASP2024133149$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240554711$24055471$1$I$$20240701$20240705$20240705$EXP$$JP-AMGEN-JPNSP2024131106$AMGEN$$$$$$Y$$$20240705$$MD$JP$JP
240554721$24055472$1$I$$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132207$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240554732$24055473$2$F$20240101$20240731$20240705$20240807$EXP$$JP-AMGEN-JPNSP2024118844$AMGEN$$86$YR$E$F$Y$$$20240807$$HP$JP$JP
240554741$24055474$1$I$20240628$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024132934$AMGEN$$81$YR$E$F$Y$$$20240705$$CN$US$US
240554751$24055475$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193510$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240554761$24055476$1$I$20240101$20240621$20240705$20240705$PER$$US-SA-2024SA158937$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240705$$MD$US$US
240554771$24055477$1$I$$20240629$20240705$20240705$EXP$$GB-JNJFOC-20240705410$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240705$$HP$GB$GB
240554781$24055478$1$I$$20240703$20240705$20240705$EXP$$US-ABBVIE-5825853$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240554792$24055479$2$F$$20240628$20240705$20240705$EXP$$US-SERB S.A.S.-2158871$LABORATOIRES SERB$$$$$F$Y$$$20240705$$PH$US$US
240554801$24055480$1$I$20240422$20240619$20240705$20240705$PER$$US-BAYER-2024A094081$BAYER$$46$YR$A$F$Y$$$20240705$$CN$US$US
240554812$24055481$2$F$20240629$20240711$20240705$20240718$EXP$$IT-BAYER-2024A096055$BAYER$$53$YR$A$M$Y$$$20240718$$HP$IT$IT
240554821$24055482$1$I$$20240628$20240705$20240705$EXP$$JP-BAYER-2024A095248$BAYER$$85$YR$E$M$Y$$$20240705$$MD$JP$JP
240554831$24055483$1$I$$20240628$20240705$20240705$EXP$$JP-BAYER-2024A095249$BAYER$$76$YR$E$M$Y$$$20240705$$MD$JP$JP
240554841$24055484$1$I$20190401$20240702$20240705$20240705$EXP$$FR-PURDUE-USA-2024-0310596$PURDUE$$64$YR$$M$Y$$$20240705$$MD$FR$FR
240554852$24055485$2$F$$20240705$20240705$20240710$EXP$$CA-JNJFOC-20240703329$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$CA$CA
240554861$24055486$1$I$20240501$20240704$20240705$20240705$EXP$$FR-PURDUE-USA-2024-0310621$PURDUE$$59$YR$$M$Y$$$20240705$$PH$FR$FR
240554871$24055487$1$I$$20240703$20240705$20240705$EXP$$US-PURDUE PHARMA-USA-2024-0310600$PURDUE$$$$$M$Y$$$20240705$$CN$US$US
240554881$24055488$1$I$$20240621$20240705$20240705$EXP$$US-FENNEC PHARMACEUTICALS, INC.-2024FEN00020$FENNEC PHARMACEUTICALS$Giese D., Ernste K., Jnaneswaran G., Elkhedr A.. Non-chronic kidney disease-induced calciphylaxis: a rare case report. Journal of Surgical Case Reports. 2024;6:1-3$65$YR$$F$Y$$$20240705$$HP$US$US
240554891$24055489$1$I$$20240626$20240705$20240705$EXP$$CA-TEVA-VS-3214665$TEVA$$79$YR$$F$Y$$$20240705$$HP$CA$CA
240554901$24055490$1$I$$20240705$20240705$20240705$PER$$US-HALEON-2185574$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240554912$24055491$2$F$20240527$20240813$20240705$20240815$PER$$US-AstraZeneca-2024A149513$ASTRAZENECA$$73$YR$$M$Y$$$20240815$$HP$US$
240554921$24055492$1$I$20240612$20240613$20240705$20240705$PER$$US-Eisai-EC-2024-168193$EISAI$$81$YR$E$F$Y$$$20240705$$HP$US$US
240554931$24055493$1$I$20240612$20240613$20240705$20240705$PER$$US-Eisai-EC-2024-168192$EISAI$$79$YR$E$M$Y$$$20240705$$CN$US$US
240554941$24055494$1$I$$20240629$20240705$20240705$EXP$$NVSC2024US137101$NOVARTIS$$$$$M$Y$$$20240705$$CN$US$US
240554951$24055495$1$I$20240606$20240612$20240705$20240705$PER$$US-Eisai-EC-2024-168145$EISAI$$71$YR$E$F$Y$$$20240705$$CN$US$US
240554961$24055496$1$I$20240101$20240704$20240705$20240705$EXP$$GB-UCBSA-2024034029$UCB$$$$$F$Y$$$20240705$$CN$GB$GB
240554971$24055497$1$I$$20240603$20240705$20240705$EXP$$ZA-AstraZeneca-2024A154044$ASTRAZENECA$$62$YR$$M$Y$$$20240705$$CN$ZA$
240554981$24055498$1$I$20190502$20210428$20240705$20240705$EXP$$FR-KYOWAKIRIN-2021BKK007510$KYOWA$$$$$$Y$$$20240705$$HP$FR$FR
240555001$24055500$1$I$20240511$20240703$20240703$20240703$DIR$709068$$FDA-CTU$$38$YR$$F$N$112.5$KG$20240703$N$CN$US$
240555011$24055501$1$I$20240507$20240703$20240703$20240703$DIR$709085$$FDA-CTU$$67$YR$$F$N$63.9$KG$20240703$N$CN$US$
240555021$24055502$1$I$$20240627$20240705$20240705$EXP$$US-ZENPEP LLC-2024AIMT01029$AIMMUNE$$$$$$Y$$$20240705$$CN$US$US
240555032$24055503$2$F$$20240716$20240705$20240726$30DAY$$US-GSK-US2024AMR080636$GLAXOSMITHKLINE$$$$$F$Y$108.86$KG$20240726$$CN$US$US
240555041$24055504$1$I$$20240627$20240705$20240705$EXP$$US-GSK-US2024AMR080721$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240555051$24055505$1$I$20240703$20240703$20240703$20240703$DIR$709067$$FDA-CTU$$82$YR$$M$N$80.5$KG$20240703$Y$PH$US$
240555083$24055508$3$F$$20240809$20240705$20240816$EXP$$JP-AMGEN-JPNSP2024131010$AMGEN$$60$YR$A$F$Y$$$20240816$$MD$JP$JP
240555091$24055509$1$I$$20230828$20240705$20240705$PER$$US-AMGEN-USASP2023235386$AMGEN$$$$$$Y$$$20240705$$MD$US$US
240555101$24055510$1$I$$20240701$20240705$20240705$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-012374$JAZZ$$$$$M$Y$$$20240705$$CN$US$US
240555111$24055511$1$I$20240101$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024130254$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240555121$24055512$1$I$20240626$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131270$AMGEN$$24$YR$A$F$Y$$$20240705$$CN$US$US
240555131$24055513$1$I$20240630$20240703$20240703$20240703$DIR$709008$$FDA-CTU$$27$YR$$F$N$114.3$KG$20240703$N$CN$US$
240555141$24055514$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214956$TEVA$$68$YR$$M$Y$$$20240705$$HP$CA$CA
240555161$24055516$1$I$20240101$20240627$20240705$20240705$EXP$$US-TEVA-VS-3215792$TEVA$$65$YR$$F$Y$$$20240705$$CN$US$US
240555171$24055517$1$I$20240605$20240626$20240705$20240705$EXP$IT-MINISAL02-991166$IT-TEVA-VS-3214682$TEVA$$70$YR$$F$Y$$$20240705$$PH$IT$IT
240555181$24055518$1$I$20231203$20240626$20240705$20240705$EXP$FR-AFSSAPS-BS2024000373$FR-TEVA-VS-3214653$TEVA$$29$YR$$M$Y$77$KG$20240705$$MD$FR$FR
240555191$24055519$1$I$20240619$20240703$20240703$20240703$DIR$708968$$FDA-CTU$$77$YR$$F$N$$$20240703$N$PH$US$
240555202$24055520$2$F$$20240730$20240705$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106900$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240801$$CN$US$US
240555211$24055521$1$I$20240101$20240702$20240705$20240705$EXP$$US-UCBSA-2024034116$UCB$$$$$F$Y$$$20240705$$HP$US$US
240555224$24055522$4$F$20240702$20240819$20240705$20240820$EXP$$JP-BAYER-2024A095298$BAYER$$73$YR$E$F$Y$$$20240820$$PH$JP$JP
240555231$24055523$1$I$20240628$20240703$20240705$20240705$EXP$$NVSC2024CN139689$NOVARTIS$$44$YR$$F$Y$50$KG$20240705$$HP$CN$CN
240555241$24055524$1$I$$20240625$20240705$20240705$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004748$BIOCON$$$$$$Y$$$20240705$$MD$CA$CA
240555251$24055525$1$I$20240626$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131864$AMGEN$$$$$M$Y$$$20240705$$CN$US$US
240555262$24055526$2$F$$20240704$20240705$20240710$EXP$$US-GSK-US2024080286$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$MD$US$US
240555272$24055527$2$F$20240601$20240708$20240705$20240711$EXP$$CO-BAYER-2024A096318$BAYER$$73$YR$E$M$Y$$$20240711$$CN$CO$CO
240555281$24055528$1$I$$20240703$20240705$20240705$PER$$US-HALEON-2185389$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240555301$24055530$1$I$$20240629$20240705$20240705$EXP$$NVSC2024US136854$NOVARTIS$$57$YR$$$Y$$$20240705$$CN$US$US
240555311$24055531$1$I$20240628$20240701$20240705$20240705$EXP$$US-AMGEN-USASP2024130075$AMGEN$$24$YR$A$F$Y$$$20240705$$CN$US$US
240555321$24055532$1$I$20231216$20240705$20240705$20240705$EXP$FR-AFSSAPS-PP2024000446$FR-BAYER-2024A097351$BAYER$$32$YR$A$F$Y$55$KG$20240705$$CN$FR$FR
240555331$24055533$1$I$20240610$20240610$20240705$20240705$PER$$US-Eisai-EC-2024-168194$EISAI$$72$YR$E$F$Y$$$20240705$$HP$US$US
240555341$24055534$1$I$$20240703$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107015$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240705$$CN$US$US
240555351$24055535$1$I$$20240624$20240705$20240705$EXP$$IN-RDY-LIT/IND/24/0009461$DR REDDYS$Datta D, Engineer R, Saklani A, D^souza A, Baheti A, Kumar S, et al. Non-operative management in low-lying rectal cancers undergoing chemoradiation. Journal of Cancer Research and Therapeutics. 2024;20(1): 417-422. doi:10.4103/jcrt.jcrt_189_23.$$$$$Y$$$20240705$$HP$IN$IN
240555371$24055537$1$I$$20240703$20240705$20240705$EXP$$US-BAYER-2024A096234$BAYER$$70$YR$E$M$Y$$$20240705$$CN$US$US
240555381$24055538$1$I$$20240705$20240705$20240705$EXP$$JP-BAYER-2024A097081$BAYER$$50$YR$A$F$Y$$$20240705$$HP$JP$JP
240555393$24055539$3$F$20240624$20240805$20240705$20240808$30DAY$$AR-JNJFOC-20240673847$JOHNSON AND JOHNSON$$35$YR$A$F$Y$79$KG$20240809$$CN$AR$AR
240555401$24055540$1$I$$20240628$20240705$20240705$PER$$US-009507513-2407USA000160$MERCK$Wang M, Reynolds K, Montazeri K, Schaefer E, Sullivan R, Dougan M. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clinical Gastroenterology and Hepatology. 2024;22(7):1539-41.e2$63$YR$$M$Y$$$20240705$$HP$US$US
240555411$24055541$1$I$$20240626$20240705$20240705$EXP$$US-JNJFOC-20240672183$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240705$$HP$US$US
240555421$24055542$1$I$$20240702$20240705$20240705$30DAY$$US-GSK-US2024082231$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$CN$US$US
240555432$24055543$2$F$$20240801$20240705$20240809$EXP$$US-AstraZeneca-2024A150235$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
240555441$24055544$1$I$$20240627$20240705$20240705$EXP$$CA-AstraZeneca-2024A138758$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$CA$
240555451$24055545$1$I$20240617$20240628$20240705$20240705$EXP$$CN-AstraZeneca-2024A152972$ASTRAZENECA$$20356$DY$$F$Y$58.5$KG$20240705$$MD$CN$
240555461$24055546$1$I$$20240621$20240705$20240705$PER$$US-BAYER-2024A090263$BAYER$$$$$M$Y$$$20240705$$PH$US$US
240555471$24055547$1$I$$20240621$20240705$20240705$PER$$US-BAYER-2024A096232$BAYER$$$$$M$Y$$$20240705$$PH$US$US
240555481$24055548$1$I$20230101$20240621$20240705$20240705$PER$$US-SA-2024SA191138$SANOFI AVENTIS$$55$YR$A$F$Y$81.6$KG$20240705$$MD$US$US
240555491$24055549$1$I$20240619$20240702$20240705$20240705$EXP$$US-GILEAD-2024-0679344$GILEAD$$30$YR$A$M$Y$$$20240705$$CN$US$US
240555501$24055550$1$I$$20240624$20240705$20240705$EXP$$CA-TEVA-VS-3214652$TEVA$$44$YR$$F$Y$$$20240705$$HP$CA$CA
240555521$24055552$1$I$20240620$20240703$20240703$20240703$DIR$708982$$FDA-CTU$$84$YR$$F$N$56.25$KG$20240703$N$$US$
240555531$24055553$1$I$20240606$20240625$20240705$20240705$EXP$GB-MHRA-MED-202406241516134150-CFYMQ$GB-ELI_LILLY_AND_COMPANY-GB202406016920$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$GB$GB
240555541$24055554$1$I$$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017717$ELI LILLY AND CO$$$$$M$Y$$$20240705$$CN$US$US
240555551$24055555$1$I$$20240701$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000693$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240705$$CN$US$US
240555562$24055556$2$F$$20240627$20240705$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017732$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240709$$HP$US$US
240555571$24055557$1$I$$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281138183320-MCJNW$GB-ELI_LILLY_AND_COMPANY-GB202406019768$ELI LILLY AND CO$$$$$F$Y$68$KG$20240705$$CN$GB$GB
240555581$24055558$1$I$20240613$20240627$20240705$20240705$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202406019712$ELI LILLY AND CO$$$$E$M$Y$$$20240705$$CN$CO$CO
240555591$24055559$1$I$$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017673$ELI LILLY AND CO$$14$YR$T$F$Y$$$20240705$$CN$US$US
240555601$24055560$1$I$20230101$20240627$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019224$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$US$US
240555611$24055561$1$I$$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019604$ELI LILLY AND CO$$46$YR$A$$Y$$$20240705$$LW$US$US
240555621$24055562$1$I$20240618$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017739$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240705$$CN$US$US
240555631$24055563$1$I$$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017704$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240705$$CN$US$US
240555641$24055564$1$I$20240401$20240625$20240705$20240705$EXP$GB-MHRA-MED-202406250917113170-SLYKQ$GB-ELI_LILLY_AND_COMPANY-GB202406017798$ELI LILLY AND CO$$$$$M$Y$102$KG$20240705$$CN$GB$GB
240555651$24055565$1$I$20070101$20240628$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000416$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240705$$CN$US$US
240555661$24055566$1$I$20240628$20240628$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407001446$ELI LILLY AND CO$$$$$M$Y$$$20240705$$CN$CN$CN
240555671$24055567$1$I$$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017678$ELI LILLY AND CO$$$$$M$Y$$$20240705$$CN$US$US
240555681$24055568$1$I$20240427$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018639$ELI LILLY AND CO$$$$$$Y$$$20240705$$CN$US$US
240555691$24055569$1$I$$20240703$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002977$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240705$$CN$US$US
240555701$24055570$1$I$$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018676$ELI LILLY AND CO$$$$$$Y$$$20240705$$CN$US$US
240555712$24055571$2$F$20240622$20240710$20240705$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407002764$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240712$$CN$US$US
240555721$24055572$1$I$20240418$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017497$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240705$$CN$US$US
240555731$24055573$1$I$$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017309$ELI LILLY AND CO$$$$$$Y$$$20240705$$CN$US$US
240555741$24055574$1$I$20240623$20240625$20240705$20240705$EXP$GB-MHRA-MED-202406242306558990-HPBQK$GB-ELI_LILLY_AND_COMPANY-GB202406016923$ELI LILLY AND CO$$37$YR$A$F$Y$81$KG$20240705$$CN$GB$GB
240555751$24055575$1$I$20240101$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017792$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$US$US
240555761$24055576$1$I$20240606$20240625$20240705$20240705$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202406017967$ELI LILLY AND CO$$41$YR$A$F$Y$108$KG$20240705$$CN$DE$DE
240555771$24055577$1$I$$20240703$20240705$20240705$EXP$$DK-ABBVIE-5827856$ABBVIE$$$$$M$Y$$$20240705$$CN$DK$DK
240555783$24055578$3$F$$20240820$20240705$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017563$ELI LILLY AND CO$$55$YR$A$M$Y$91$KG$20240830$$CN$US$US
240555791$24055579$1$I$20231230$20240702$20240705$20240705$EXP$$US-ABBVIE-5826056$ABBVIE$$69$YR$$F$Y$$$20240705$$CN$US$US
240555801$24055580$1$I$$20240628$20240705$20240705$PER$$US-009507513-2407USA002653$MERCK$Wang M, Reynolds K, Montazeri K, Schaefer E, Sullivan R, Dougan M. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clinical Gastroenterology and Hepatology. 2024;22(7):1539-41.e2$46$YR$$F$Y$$$20240705$$HP$US$US
240555811$24055581$1$I$20240626$20240701$20240705$20240705$EXP$$US-ABBVIE-5824590$ABBVIE$$64$YR$$F$Y$$$20240705$$CN$US$US
240555821$24055582$1$I$$20240621$20240705$20240705$PER$$US-BAYER-2024A096233$BAYER$$$$$M$Y$$$20240705$$PH$US$US
240555831$24055583$1$I$$20240103$20240705$20240705$PER$$US-ABBVIE-5829128$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240555842$24055584$2$F$20240702$20240815$20240705$20240820$PER$$US-AMGEN-USASP2024133393$AMGEN$$66$YR$E$F$Y$$$20240820$$CN$US$US
240555871$24055587$1$I$20240501$20240626$20240705$20240705$PER$$US-BAYER-2024A092719$BAYER$$23$YR$A$F$Y$$$20240705$$HP$US$US
240555882$24055588$2$F$20221019$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS066897$TAKEDA$$66$YR$$M$Y$$$20240709$$HP$CN$CN
240555891$24055589$1$I$$20240628$20240705$20240705$EXP$$CA-GILEAD-2024-0679339$GILEAD$$$$A$M$Y$$$20240705$$MD$CA$CA
240555901$24055590$1$I$$20240627$20240705$20240705$EXP$$US-TEVA-VS-3215607$TEVA$$57$YR$$M$Y$$$20240705$$HP$US$US
240555911$24055591$1$I$$20240104$20240705$20240705$PER$$US-ABBVIE-5829274$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240555921$24055592$1$I$$20240626$20240705$20240705$PER$$US-BAYER-2024A092836$BAYER$$19$YR$A$F$Y$$$20240705$$PH$US$US
240555931$24055593$1$I$$20240701$20240705$20240705$PER$$US-BAYER-2024A095243$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240555941$24055594$1$I$$20240301$20240705$20240705$EXP$$BR-NOVOPROD-1242257$NOVO NORDISK$$70$YR$$F$Y$$$20240705$$CN$BR$BR
240555952$24055595$2$F$$20240708$20240705$20240711$EXP$$US-JNJFOC-20240709134$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240711$$HP$US$US
240555961$24055596$1$I$$20240614$20240705$20240705$PER$$US-Eisai-EC-2024-168302$EISAI$$$$$$Y$$$20240705$$MD$US$US
240555971$24055597$1$I$$20240613$20240705$20240705$PER$$US-Eisai-EC-2024-168204$EISAI$$$$$$Y$$$20240705$$MD$US$US
240555982$24055598$2$F$20240612$20240703$20240705$20240716$PER$$US-Eisai-EC-2024-168262$EISAI$$78$YR$E$F$Y$65.3$KG$20240716$$MD$US$US
240555991$24055599$1$I$$20240614$20240705$20240705$PER$$US-Eisai-EC-2024-168304$EISAI$$$$$$Y$$$20240705$$MD$US$US
240556001$24055600$1$I$$20240701$20240705$20240705$PER$$US-BAYER-2024A095431$BAYER$$$$$$Y$$$20240705$$CN$US$US
240556011$24055601$1$I$20240617$20240627$20240705$20240705$PER$$US-BAYER-2024A093190$BAYER$$50$YR$A$F$Y$$$20240705$$MD$US$US
240556022$24055602$2$F$20240101$20240711$20240705$20240718$PER$$US-SA-2024SA195391$SANOFI AVENTIS$$44$YR$A$M$Y$127.91$KG$20240718$$MD$US$US
240556031$24055603$1$I$20240628$20240703$20240703$20240703$DIR$709004$$FDA-CTU$$7$YR$$F$N$30.7$KG$20240703$Y$PH$US$
240556041$24055604$1$I$20240608$20240701$20240705$20240705$EXP$$ES-FreseniusKabi-FK202410366$FRESENIUS KABI$$72$YR$E$F$Y$$$20240705$$MD$ES$ES
240556051$24055605$1$I$20240101$20240621$20240705$20240705$PER$$US-SA-2024SA190935$SANOFI AVENTIS$$90$YR$E$F$Y$54$KG$20240705$$MD$US$US
240556071$24055607$1$I$$20240629$20240705$20240705$PER$$US-BAYER-2024A094603$BAYER$$$$$$Y$$$20240705$$CN$US$US
240556081$24055608$1$I$20240529$20240627$20240705$20240705$EXP$FR-AFSSAPS-DJ2024000794$FR-TEVA-VS-3215399$TEVA$$52$YR$$F$Y$62.2$KG$20240705$$PH$FR$FR
240556101$24055610$1$I$20240701$20240703$20240703$20240703$DIR$709023$$FDA-CTU$$66$YR$$F$N$$$20240703$N$PH$US$
240556111$24055611$1$I$20240703$20240703$20240703$20240703$DIR$709040$$FDA-CTU$$74$YR$$M$N$71.82$KG$20240703$N$$US$
240556124$24055612$4$F$20240616$20240731$20240705$20240807$EXP$$CN-BEIGENE-BGN-2024-010482$BEIGENE$$$$$$Y$$$20240807$$CN$CN$CN
240556131$24055613$1$I$20210201$20240626$20240705$20240705$PER$$US-SA-2024SA193365$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240705$$MD$US$US
240556141$24055614$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA194092$SANOFI AVENTIS$$40$YR$A$M$Y$95.25$KG$20240705$$MD$US$US
240556161$24055616$1$I$20240601$20240703$20240703$20240703$DIR$709036$$FDA-CTU$$62$YR$$M$N$96.2$KG$20240703$N$PH$US$
240556171$24055617$1$I$20240627$20240703$20240703$20240703$DIR$708970$$FDA-CTU$$93$YR$$M$N$73$KG$20240703$N$PH$US$
240556181$24055618$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA196530$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240705$$CN$US$US
240556191$24055619$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA192695$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240705$$MD$US$US
240556201$24055620$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA192944$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240705$$MD$US$US
240556211$24055621$1$I$$20240702$20240705$20240705$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-130795$DAIICHI$$$$$F$Y$$$20240705$$MD$US$US
240556222$24055622$2$F$20221223$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS066952$TAKEDA$$64$YR$$M$Y$$$20240709$$HP$CN$CN
240556241$24055624$1$I$$20240625$20240705$20240705$EXP$$CN-BAYER-2024A092028$BAYER$$69$YR$E$M$Y$$$20240705$$CN$CN$CN
240556251$24055625$1$I$20240101$20240627$20240705$20240705$PER$$US-BAYER-2024A093469$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240556261$24055626$1$I$$20240629$20240705$20240705$PER$$US-BAYER-2024A095303$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240556271$24055627$1$I$$20240703$20240705$20240705$EXP$$CA-TAKEDA-2024TUS068153$TAKEDA$$$$$F$Y$$$20240705$$CN$CA$CA
240556282$24055628$2$F$20240528$20240705$20240705$20240712$EXP$$US-TAKEDA-2024TUS056022$TAKEDA$$41$YR$$M$Y$$$20240712$$CN$US$US
240556293$24055629$3$F$20180718$20240806$20240705$20240809$EXP$$AU-ANIPHARMA-2024-AU-000300$ANI$$56$YR$$F$Y$$$20240809$$MD$AU$AU
240556301$24055630$1$I$20230101$20240626$20240705$20240705$EXP$$US-TEVA-VS-3215982$TEVA$$20$YR$$F$Y$$$20240705$$HP$US$US
240556311$24055631$1$I$20240218$20240703$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106749$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240705$$HP$US$US
240556322$24055632$2$F$$20240802$20240705$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106893$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240806$$CN$US$US
240556331$24055633$1$I$$20240627$20240705$20240705$PER$$US-BAYER-2024A093750$BAYER$$69$YR$E$F$Y$$$20240705$$CN$US$US
240556341$24055634$1$I$20240627$20240627$20240705$20240705$PER$$US-BAYER-2024A093884$BAYER$$48$YR$A$F$Y$$$20240705$$MD$US$US
240556352$24055635$2$F$20231213$20240712$20240705$20240722$EXP$$IT-TAKEDA-2024TUS065612$TAKEDA$$77$YR$$F$Y$$$20240722$$HP$IT$IT
240556361$24055636$1$I$20240629$20240703$20240703$20240703$DIR$709078$$FDA-CTU$$62$YR$$F$N$63$KG$20240703$N$CN$US$
240556371$24055637$1$I$20240701$20240703$20240703$20240703$DIR$709042$$FDA-CTU$$76$YR$$F$N$66.6$KG$20240703$N$CN$US$
240556381$24055638$1$I$20240628$20240703$20240703$20240703$DIR$709026$$FDA-CTU$$41$YR$$M$N$$$20240703$N$HP$US$
240556401$24055640$1$I$20240703$20240703$20240703$20240703$DIR$709027$$FDA-CTU$$37$YR$$M$N$85$KG$20240703$N$$US$
240556411$24055641$1$I$$20240703$20240703$20240703$DIR$708983$$FDA-CTU$$$$$UNK$N$$$20240703$N$CN$US$
240556422$24055642$2$F$20240610$20240625$20240705$20240711$EXP$$CN-009507513-2406CHN010058$MERCK$$81$YR$$F$Y$65$KG$20240711$$HP$CN$CN
240556431$24055643$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA192647$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240705$$MD$US$US
240556441$24055644$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA194639$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240705$$MD$US$US
240556451$24055645$1$I$$20240621$20240705$20240705$PER$$US-SA-2024SA189651$SANOFI AVENTIS$$$$A$F$Y$65.77$KG$20240705$$MD$US$US
240556461$24055646$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA196371$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240705$$CN$US$US
240556471$24055647$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA191458$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240705$$MD$US$US
240556481$24055648$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA192573$SANOFI AVENTIS$$70$YR$E$F$Y$58.513$KG$20240705$$MD$US$US
240556491$24055649$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA192650$SANOFI AVENTIS$$50$YR$A$M$Y$72.57$KG$20240705$$MD$US$US
240556501$24055650$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193103$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240705$$MD$US$US
240556512$24055651$2$F$$20240722$20240705$20240730$PER$$US-SA-2024SA197366$SANOFI AVENTIS$$80$YR$E$M$Y$58$KG$20240730$$MD$US$US
240556521$24055652$1$I$20240101$20240621$20240705$20240705$PER$$US-SA-2024SA189831$SANOFI AVENTIS$$44$YR$A$M$Y$99.79$KG$20240705$$MD$US$US
240556531$24055653$1$I$$20240628$20240705$20240705$PER$$US-BAYER-2024A094267$BAYER$$4$YR$C$$Y$$$20240705$$CN$US$US
240556541$24055654$1$I$$20240626$20240705$20240705$PER$$US-ROCHE-10000015809$ROCHE$$$$$F$Y$$$20240705$$CN$US$US
240556553$24055655$3$F$$20240919$20240705$20240923$PER$$US-ROCHE-10000016305$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
240556561$24055656$1$I$$20240626$20240705$20240705$PER$$US-ROCHE-10000015773$ROCHE$$$$$M$Y$$$20240705$$CN$US$US
240556572$24055657$2$F$$20240625$20240705$20240707$30DAY$$CA-JNJFOC-20240670510$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240707$$HP$CA$CA
240556581$24055658$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5825690$ABBVIE$$44$YR$$F$Y$$$20240705$$HP$US$US
240556591$24055659$1$I$$20240628$20240705$20240705$PER$$US-ALXN-202406USA001941US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240556602$24055660$2$F$20240621$20240708$20240705$20240709$PER$$US-BAYER-2024A093886$BAYER$$34$YR$A$F$Y$$$20240709$$HP$US$US
240556611$24055661$1$I$$20240628$20240705$20240705$PER$$US-BAYER-2024A094578$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240556621$24055662$1$I$$20240626$20240705$20240705$PER$$US-BAYER-2024A093988$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240556631$24055663$1$I$20240425$20240701$20240705$20240705$EXP$$CN-BAYER-2024A096432$BAYER$$44$YR$A$M$Y$53$KG$20240705$$HP$CN$CN
240556641$24055664$1$I$20240624$20240628$20240705$20240705$EXP$$CN-AstraZeneca-2024A153835$ASTRAZENECA$$82$YR$$F$Y$58$KG$20240705$$MD$CN$
240556651$24055665$1$I$$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151218$ASTRAZENECA$$$$$F$Y$$$20240705$$HP$US$
240556663$24055666$3$F$20240101$20240910$20240705$20240930$PER$$US-Eisai-EC-2024-168391$EISAI$$70$YR$E$M$Y$$$20240930$$CN$US$US
240556671$24055667$1$I$20240101$20240614$20240705$20240705$PER$$US-Eisai-EC-2024-168317$EISAI$$77$YR$E$M$Y$75$KG$20240705$$CN$US$US
240556681$24055668$1$I$20231110$20240627$20240705$20240705$PER$$US-AstraZeneca-2024A149479$ASTRAZENECA$$70$YR$$F$Y$92.1$KG$20240705$$CN$US$
240556691$24055669$1$I$$20240627$20240705$20240705$EXP$$JP-AstraZeneca-2024A150707$ASTRAZENECA$$$$E$M$Y$$$20240705$$MD$JP$
240556702$24055670$2$F$20240501$20240702$20240705$20240731$EXP$$MY-AstraZeneca-2024A152383$ASTRAZENECA$$789$MON$$M$Y$$$20240801$$CN$MY$
240556711$24055671$1$I$20240618$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151373$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240556721$24055672$1$I$20231203$20240701$20240705$20240705$EXP$ES-AEMPS-1530421$ES-FreseniusKabi-FK202410372$FRESENIUS KABI$$66$YR$E$M$Y$$$20240705$$MD$ES$ES
240556731$24055673$1$I$20240124$20240701$20240705$20240705$EXP$FR-AFSSAPS-TS2024000740$FR-FreseniusKabi-FK202410408$FRESENIUS KABI$$50$YR$A$F$Y$60$KG$20240705$$MD$FR$FR
240556741$24055674$1$I$20240504$20240629$20240705$20240705$EXP$$GB-AstraZeneca-2024A149701$ASTRAZENECA$$$$$M$Y$$$20240705$$MD$GB$
240556751$24055675$1$I$20240601$20240628$20240705$20240705$EXP$$FR-AstraZeneca-2024A152571$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$FR$
240556761$24055676$1$I$20240624$20240628$20240705$20240705$EXP$$CN-AstraZeneca-2024A152983$ASTRAZENECA$$61$YR$$M$Y$63$KG$20240705$$MD$CN$
240556772$24055677$2$F$$20240708$20240705$20240716$EXP$$US-AstraZeneca-2024A151370$ASTRAZENECA$$$$$$Y$$$20240716$$CN$US$
240556781$24055678$1$I$$20240629$20240705$20240705$PER$$US-AMGEN-USASP2024128507$AMGEN$Vesely M.; Singh K.; Breidbart R. et al.. Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab. JAAD Case Reports. 2024;49:102-105$78$YR$E$M$Y$$$20240705$$MD$US$US
240556791$24055679$1$I$$20240628$20240705$20240705$PER$$US-BAYER-2024A094722$BAYER$$58$YR$A$F$Y$$$20240705$$CN$US$US
240556801$24055680$1$I$20240601$20240702$20240705$20240705$PER$$US-ABBVIE-5827397$ABBVIE$$71$YR$$F$Y$$$20240705$$CN$US$US
240556811$24055681$1$I$$20240628$20240705$20240705$PER$$US-ABBVIE-5826738$ABBVIE$$45$YR$$F$Y$$$20240705$$HP$US$US
240556821$24055682$1$I$$20240703$20240705$20240705$PER$$US-JNJFOC-20240711255$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$HP$US$US
240556832$24055683$2$F$20240501$20240715$20240705$20240726$PER$$US-ABBVIE-5820308$ABBVIE$$66$YR$$F$Y$55$KG$20240726$$CN$US$US
240556841$24055684$1$I$$20240628$20240705$20240705$PER$$US-BAYER-2024A094794$BAYER$$68$YR$E$F$Y$$$20240705$$CN$US$US
240556851$24055685$1$I$$20240702$20240705$20240705$PER$$US-HALEON-2185466$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240556862$24055686$2$F$20240101$20240715$20240705$20240718$PER$$US-BAYER-2024A094066$BAYER$$62$YR$A$F$Y$$$20240718$$CN$US$US
240556871$24055687$1$I$$20231106$20240705$20240705$PER$$US-ABBVIE-5827807$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240556883$24055688$3$F$$20240926$20240705$20240928$EXP$$JP-ABBVIE-5828231$ABBVIE$$9$DEC$$M$Y$$$20240928$$MD$JP$JP
240556901$24055690$1$I$20240501$20240702$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202407002756$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240705$$CN$US$US
240556911$24055691$1$I$20240501$20240627$20240705$20240705$PER$$US-BAYER-2024A094346$BAYER$$37$YR$A$F$Y$$$20240705$$MD$US$US
240556921$24055692$1$I$$20240703$20240705$20240705$EXP$$US-BAYER-2024A096376$BAYER$$$$$$Y$$$20240705$$CN$US$US
240556931$24055693$1$I$$20240620$20240705$20240705$EXP$$AU-ROCHE-10000016592$ROCHE$$$$$$Y$$$20240705$$MD$AU$AU
240556942$24055694$2$F$20240426$20240703$20240705$20240715$EXP$$NVSC2024DE139685$NOVARTIS$$69$YR$$F$Y$65$KG$20240715$$MD$DE$DE
240556952$24055695$2$F$20221008$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS066226$TAKEDA$$32$YR$$M$Y$$$20240709$$HP$CN$CN
240556961$24055696$1$I$$20240628$20240705$20240705$PER$$US-BAYER-2024A094351$BAYER$$20$YR$A$F$Y$$$20240705$$MD$US$US
240556971$24055697$1$I$$20240627$20240705$20240705$PER$$US-BAYER-2024A094348$BAYER$$23$YR$A$F$Y$$$20240705$$HP$US$US
240556981$24055698$1$I$20240531$20240703$20240703$20240703$DIR$708974$$FDA-CTU$$67$YR$$F$N$69$KG$20240703$N$PH$US$
240557001$24055700$1$I$20240628$20240703$20240703$20240703$DIR$709005$$FDA-CTU$$37$YR$$F$N$76.5$KG$20240703$N$CN$US$
240557011$24055701$1$I$20240517$20240703$20240703$20240703$DIR$709013$$FDA-CTU$$34$YR$$F$N$$$20240703$N$$US$
240557021$24055702$1$I$$20240625$20240705$20240705$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004769$BIOCON$$$$$$Y$$$20240705$$HP$CA$CA
240557031$24055703$1$I$20240601$20240703$20240703$20240703$DIR$708992$$FDA-CTU$$47$YR$$F$N$75.15$KG$20240703$N$MD$US$
240557041$24055704$1$I$20240701$20240703$20240703$20240703$DIR$709006$$FDA-CTU$$71$YR$$F$N$66.15$KG$20240703$Y$HP$US$
240557051$24055705$1$I$20240330$20240703$20240703$20240703$DIR$708985$$FDA-CTU$$66$YR$$M$N$$$20240703$N$$US$
240557061$24055706$1$I$20240602$20240703$20240703$20240703$DIR$709019$$FDA-CTU$$61$YR$$F$N$74.25$KG$20240703$N$CN$US$
240557072$24055707$2$F$$20240906$20240705$20240909$EXP$$NVSC2024BE139345$NOVARTIS$$$$E$F$Y$$$20240909$$MD$BE$BE
240557081$24055708$1$I$20240614$20240701$20240705$20240705$EXP$$CN-BAYER-2024A096699$BAYER$$71$YR$E$M$Y$65$KG$20240705$$HP$CN$CN
240557091$24055709$1$I$20240627$20240628$20240705$20240705$PER$$US-BAYER-2024A094419$BAYER$$18$YR$A$F$Y$$$20240705$$MD$US$US
240557101$24055710$1$I$$20240628$20240705$20240705$PER$$US-AMGEN-USASP2024129606$AMGEN$Kowdley K. V.; Sohal A.. Complete Biochemical Remission With Oral Vancomycin in a Patient With Primary Sclerosing Cholangitis and High Serum Immunoglobulin G4 Levels. ACG Case Reports Journal. 2024;11 (1):e01256$20$YR$A$M$Y$$$20240705$$MD$US$US
240557111$24055711$1$I$$20240628$20240705$20240705$EXP$$US-AMGEN-USASP2024129661$AMGEN$Pearson B.G.; Walker D.H.; Lea A.S. et al. Early, rapidly progressive vasculopathy in a transplanted heart: A possible complication of COVID-19. Cardiovascular Pathology. 2024;72:1-6$45$YR$A$M$Y$$$20240705$$HP$US$US
240557121$24055712$1$I$$20240203$20240705$20240705$PER$$US-ABBVIE-5829563$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240557131$24055713$1$I$$20240628$20240705$20240705$PER$$US-BAYER-2024A094529$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240557141$24055714$1$I$20240601$20240703$20240705$20240705$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-107266$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240705$$MD$KR$KR
240557151$24055715$1$I$20240621$20240625$20240705$20240705$PER$$US-FreseniusKabi-FK202410133$FRESENIUS KABI$$24$YR$A$F$Y$50.8$KG$20240705$$CN$US$US
240557161$24055716$1$I$20240622$20240626$20240705$20240705$EXP$$CN-009507513-2407CHN000159$MERCK$$74$YR$$M$Y$72$KG$20240705$$HP$CN$CN
240557171$24055717$1$I$20240601$20240702$20240705$20240705$EXP$$EG-JNJFOC-20240712378$JOHNSON AND JOHNSON$$40$YR$A$F$Y$100$KG$20240705$$CN$EG$EG
240557181$24055718$1$I$$20240701$20240705$20240705$EXP$$US-AMGEN-USASP2024131888$AMGEN$Schwartz M.; McMahon C.M.; Amaya M.L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240705$$MD$US$US
240557191$24055719$1$I$$20240701$20240705$20240705$EXP$$US-AMGEN-USASP2024131955$AMGEN$Schwartz M.; McMahon C.M.; Amaya M.L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240705$$MD$US$US
240557201$24055720$1$I$$20240701$20240705$20240705$EXP$$US-AMGEN-USASP2024131866$AMGEN$Schwartz M.; McMahon C.M.; Amaya M.L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240705$$MD$US$US
240557221$24055722$1$I$$20240701$20240705$20240705$EXP$$US-AMGEN-USASP2024131849$AMGEN$Schwartz M.; McMahon C.M.; Amaya M.L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240705$$MD$US$US
240557231$24055723$1$I$$20240701$20240705$20240705$EXP$$US-AMGEN-USASP2024131877$AMGEN$Schwartz M.; McMahon C.M.; Amaya M.L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240705$$MD$US$US
240557241$24055724$1$I$$20240701$20240705$20240705$EXP$$KR-009507513-2407KOR000816$MERCK$$$$$M$Y$$$20240705$$CN$KR$KR
240557251$24055725$1$I$20240625$20240626$20240705$20240705$EXP$$CN-009507513-2407CHN000224$MERCK$$59$YR$$F$Y$65$KG$20240705$$HP$CN$CN
240557262$24055726$2$F$20240622$20240709$20240705$20240711$EXP$$US-BAYER-2024A096244$BAYER$$60$YR$A$F$Y$$$20240711$$CN$US$US
240557271$24055727$1$I$20240628$20240628$20240705$20240705$PER$$US-BAYER-2024A094695$BAYER$$21$YR$A$F$Y$$$20240705$$MD$US$US
240557281$24055728$1$I$$20240627$20240705$20240705$PER$$US-BAYER-2024A093293$BAYER$$47$YR$A$F$Y$$$20240705$$MD$US$US
240557292$24055729$2$F$20240529$20240625$20240705$20240710$PER$$US-ROCHE-3574403$ROCHE$$62$YR$A$M$Y$107.95$KG$20240710$$CN$US$US
240557301$24055730$1$I$20240701$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131178$AMGEN$$73$YR$E$F$Y$$$20240705$$CN$US$US
240557311$24055731$1$I$$20240701$20240705$20240705$EXP$$US-AMGEN-USASP2024131899$AMGEN$Schwartz, M.; Mcmahon M. C.; Witkowski M. et.al. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Ch rom osome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240705$$MD$US$US
240557322$24055732$2$F$20230804$20240808$20240705$20240816$EXP$$JP-ROCHE-10000013566$ROCHE$$71$YR$E$F$Y$53.6$KG$20240816$$MD$JP$JP
240557331$24055733$1$I$$20240705$20240705$20240705$PER$$NVSC2024US139842$NOVARTIS$$$$$$Y$$$20240705$$HP$US$US
240557341$24055734$1$I$$20230305$20240705$20240705$EXP$$US-JNJFOC-20240666028$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240705$$HP$US$US
240557351$24055735$1$I$$20240705$20240705$20240705$EXP$ES-AEMPS-1542730$ES-JNJFOC-20240714255$JOHNSON AND JOHNSON$$35$YR$A$M$Y$80$KG$20240705$$CN$ES$ES
240557361$24055736$1$I$$20230305$20240705$20240705$EXP$$US-JNJFOC-20240665712$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$HP$US$US
240557371$24055737$1$I$$20240703$20240705$20240705$EXP$$US-TAKEDA-2024TUS068211$TAKEDA$$$$$M$Y$$$20240705$$CN$US$US
240557381$24055738$1$I$20240415$20240628$20240705$20240705$PER$$US-BAYER-2024A094950$BAYER$$38$YR$A$F$Y$$$20240705$$HP$US$US
240557392$24055739$2$F$$20240802$20240705$20240806$PER$$US-ALXN-202406USA001908US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240557401$24055740$1$I$20231001$20240628$20240705$20240705$EXP$$CL-GSK-CL2024AMR074284$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$CL$CL
240557411$24055741$1$I$$20240628$20240705$20240705$PER$$US-ABBVIE-5826694$ABBVIE$$$$$$Y$$$20240705$$HP$US$US
240557421$24055742$1$I$$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106852$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240705$$HP$US$US
240557441$24055744$1$I$20240625$20240703$20240703$20240703$DIR$709071$$FDA-CTU$$41$YR$$F$N$101.25$KG$20240703$Y$$US$
240557451$24055745$1$I$$20240703$20240703$20240703$DIR$709076$$FDA-CTU$$21$YR$$UNK$N$$$20240703$N$CN$US$
240557461$24055746$1$I$20240703$20240703$20240703$20240703$DIR$709055$$FDA-CTU$$56$YR$$F$N$94.05$KG$20240703$N$CN$US$
240557471$24055747$1$I$20130330$20240703$20240703$20240703$DIR$709010$$FDA-CTU$$62$YR$$M$N$112.05$KG$20240703$Y$CN$US$
240557481$24055748$1$I$$20240703$20240703$20240703$DIR$709046$$FDA-CTU$$$$$UNK$N$$$20240703$N$CN$US$
240557492$24055749$2$F$20240601$20240702$20240705$20240718$PER$$US-Eisai-EC-2024-168468$EISAI$$68$YR$E$F$Y$$$20240718$$CN$US$US
240557501$24055750$1$I$20240501$20240618$20240705$20240705$PER$$US-Eisai-EC-2024-168472$EISAI$$71$YR$E$F$Y$$$20240705$$MD$US$US
240557511$24055751$1$I$$20240627$20240705$20240705$EXP$$US-Calliditas-2024CAL01203$CALLIDITAS THERAPEUTICS$$81$YR$E$M$Y$$$20240705$$CN$US$US
240557521$24055752$1$I$$20240703$20240703$20240703$DIR$709018$$FDA-CTU$$44$YR$$F$N$$$20240703$N$CN$US$
240557532$24055753$2$F$20240601$20240809$20240705$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA051895$SANDOZ$$77$YR$$M$Y$$$20240814$$MD$CA$CA
240557541$24055754$1$I$$20240628$20240705$20240705$PER$$US-BAYER-2024A094952$BAYER$$36$YR$A$F$Y$$$20240705$$MD$US$US
240557551$24055755$1$I$20240523$20240703$20240703$20240703$DIR$708988$$FDA-CTU$$60$YR$$M$N$$$20240703$N$$US$
240557561$24055756$1$I$20240101$20240628$20240705$20240705$PER$$US-BAYER-2024A094953$BAYER$$19$YR$A$F$Y$$$20240705$$MD$US$US
240557571$24055757$1$I$$20240626$20240705$20240705$EXP$$US-BAYER-2024A095748$BAYER$Blakeslee-Carter J.; Novak Z.; Jansen J.O.; Schanzer A.; Eagleton M.J.; Farber M.A.; Gasper W.; Lee W.A.; Oderich G.S.; Timaran C.H.; Schneider D.B.; Sweet M.P.; Beck A.W.. Prospective randomized pilot trial comparing prophylactic and therapeutic cerebrospinal fluid drainage during complex endovascular thoracoabdominal aortic aneurysm repair. Journal of Vascular Surgery ()  (). 2024;80:1:11-19$$$$$Y$$$20240705$$MD$US$US
240557581$24055758$1$I$20240701$20240703$20240703$20240703$DIR$709053$$FDA-CTU$$63$YR$$UNK$N$$$20240703$N$HP$US$
240557591$24055759$1$I$$20240703$20240703$20240703$DIR$709003$$FDA-CTU$$$$$UNK$N$$$20240703$$CN$US$
240557601$24055760$1$I$20240101$20240703$20240705$20240705$PER$$US-JNJFOC-20240710338$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240705$$CN$US$US
240557611$24055761$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA195246$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240705$$MD$US$US
240557622$24055762$2$F$20240510$20240625$20240705$20240705$EXP$ES-AEMPS-1538596$ES-STRIDES ARCOLAB LIMITED-2024SP007676$STRIDES$$75$YR$$M$Y$$$20240705$$MD$ES$ES
240557631$24055763$1$I$20240627$20240628$20240705$20240705$EXP$$US-AMGEN-USASP2024130023$AMGEN$$68$YR$E$F$Y$$$20240705$$CN$US$US
240557641$24055764$1$I$$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131599$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240557651$24055765$1$I$20230701$20240702$20240705$20240705$EXP$$US-ABBVIE-5826065$ABBVIE$$53$YR$$M$Y$104.32$KG$20240705$$CN$US$US
240557661$24055766$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5826425$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240557674$24055767$4$F$$20240704$20240705$20240731$PER$$US-BAYER-2024A095357$BAYER$$$$$F$Y$$$20240731$$CN$US$US
240557681$24055768$1$I$20240514$20240626$20240705$20240705$PER$$US-BAYER-2024A096006$BAYER$$26$YR$A$F$Y$$$20240705$$MD$US$US
240557701$24055770$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA192529$SANOFI AVENTIS$$$$A$F$Y$$$20240705$$MD$US$US
240557711$24055771$1$I$20221214$20240628$20240705$20240705$EXP$$DE-OTSUKA-2024_018476$OTSUKA$$$$A$F$Y$73$KG$20240705$$MD$DE$DE
240557721$24055772$1$I$20240606$20240627$20240705$20240705$EXP$FR-AFSSAPS-LY2024000923$FR-009507513-2406FRA009980$MERCK$$77$YR$$F$Y$68$KG$20240705$$PH$FR$FR
240557731$24055773$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193333$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240705$$MD$US$US
240557741$24055774$1$I$$20230305$20240705$20240705$EXP$$US-JNJFOC-20240665586$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240705$$HP$US$US
240557751$24055775$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214754$TEVA$$27$YR$$F$Y$$$20240705$$HP$CA$CA
240557761$24055776$1$I$$20240627$20240705$20240705$EXP$$GB-TEVA-VS-3215005$TEVA$$$$$$Y$$$20240705$$CN$GB$GB
240557771$24055777$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A151386$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240557781$24055778$1$I$$20240627$20240705$20240705$EXP$$CN-AstraZeneca-2024A149839$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$CN$
240557801$24055780$1$I$$20240627$20240705$20240705$EXP$$FR-AstraZeneca-2024A151085$ASTRAZENECA$$78$YR$$M$Y$$$20240705$$CN$FR$
240557812$24055781$2$F$$20240725$20240705$20240802$EXP$$US-AstraZeneca-2024A149021$ASTRAZENECA$$83$YR$$M$Y$$$20240802$$CN$US$
240557821$24055782$1$I$$20240629$20240705$20240705$PER$$US-BAYER-2024A095097$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240557851$24055785$1$I$$20240702$20240705$20240705$EXP$$US-AstraZeneca-2024A152204$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240557861$24055786$1$I$$20240628$20240705$20240705$EXP$$CA-AstraZeneca-2024A149814$ASTRAZENECA$$64$YR$$F$Y$76$KG$20240705$$MD$CA$
240557871$24055787$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A150525$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240557881$24055788$1$I$$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A150411$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240557891$24055789$1$I$20240213$20240628$20240705$20240705$EXP$$JP-AstraZeneca-2024A141252$ASTRAZENECA$$78$YR$$M$Y$55$KG$20240705$$MD$JP$
240557902$24055790$2$F$20220801$20240708$20240705$20240710$EXP$$NVSC2024PT138837$NOVARTIS$Teixeira CM, Barbosa M, Ribeiro MJ, Rodrigues E, Fernandes C. Paraganglioma ? Fatores preditores de maior agressividade [Paraganglioma ? Predictors factors of major aggressivity]. REVISTA PORTUGUESA DE ONCOLOGIA. 2024;7(N1-2):42-5$45$YR$$M$Y$$$20240710$$HP$PT$PT
240557921$24055792$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214679$TEVA$$71$YR$$M$Y$73$KG$20240705$$HP$CA$CA
240557931$24055793$1$I$20240524$20240607$20240705$20240705$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000491$PAREXEL$$$$$$Y$$$20240705$$HP$US$US
240557941$24055794$1$I$20240603$20240628$20240705$20240705$EXP$$FR-ABBVIE-5828470$ABBVIE$$36$YR$$M$Y$$$20240705$$HP$FR$FR
240557951$24055795$1$I$20240621$20240627$20240705$20240705$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00528$PARATEK PHARMACEUTICALS$$18$YR$$M$Y$65$KG$20240705$$HP$CN$CN
240557961$24055796$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214681$TEVA$$86$YR$$M$Y$$$20240705$$PH$CA$CA
240557981$24055798$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214774$TEVA$$69$YR$$F$Y$$$20240705$$HP$CA$CA
240557991$24055799$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193458$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240705$$MD$US$US
240558001$24055800$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193516$SANOFI AVENTIS$$$$A$$Y$$$20240705$$HP$US$US
240558011$24055801$1$I$20230101$20240626$20240705$20240705$PER$$US-SA-2024SA192452$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240705$$MD$US$US
240558021$24055802$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193271$SANOFI AVENTIS$$$$C$M$Y$22$KG$20240705$$MD$US$US
240558031$24055803$1$I$20240301$20240626$20240705$20240705$PER$$US-SA-2024SA193431$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240705$$MD$US$US
240558042$24055804$2$F$20240601$20240701$20240705$20240710$PER$$US-SA-2024SA193324$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240710$$MD$US$US
240558052$24055805$2$F$$20240815$20240705$20240828$PER$$US-SA-2024SA193331$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240828$$CN$US$US
240558062$24055806$2$F$20240101$20240719$20240705$20240724$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-092877$REGENERON$$$$$F$Y$$$20240724$$CN$US$US
240558071$24055807$1$I$20230214$20240703$20240703$20240703$DIR$709028$$FDA-CTU$$35$YR$$F$N$60.75$KG$20240703$Y$CN$US$
240558081$24055808$1$I$20240629$20240703$20240703$20240703$DIR$709009$$FDA-CTU$$81$YR$$M$N$$$20240703$N$PH$US$
240558091$24055809$1$I$20240625$20240703$20240703$20240703$DIR$708999$$FDA-CTU$$44$YR$$M$N$83.25$KG$20240703$N$CN$US$
240558101$24055810$1$I$20240605$20240703$20240703$20240703$DIR$708981$$FDA-CTU$$71$YR$$M$N$74.25$KG$20240703$N$CN$US$
240558131$24055813$1$I$20240628$20240703$20240703$20240703$DIR$709059$$FDA-CTU$$42$YR$$M$N$74.25$KG$20240703$N$CN$CA$
240558151$24055815$1$I$$20240702$20240705$20240705$EXP$$NVSC2024US138410$NOVARTIS$$$$$$Y$$$20240705$$CN$US$US
240558161$24055816$1$I$$20230305$20240705$20240705$EXP$$US-JNJFOC-20240666043$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240705$$HP$US$US
240558171$24055817$1$I$20240101$20240702$20240705$20240705$PER$$US-AMGEN-USASP2024131248$AMGEN$$$$$F$Y$$$20240705$$HP$US$US
240558181$24055818$1$I$$20240629$20240705$20240705$PER$$US-ABBVIE-5828317$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240558191$24055819$1$I$20240301$20240626$20240705$20240705$EXP$PT-INFARMED-T202406-443$PT-TEVA-VS-3215232$TEVA$$54$YR$$F$Y$$$20240705$$MD$PT$PT
240558201$24055820$1$I$20240630$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130226$AMGEN$$39$YR$A$$Y$$$20240705$$CN$US$US
240558211$24055821$1$I$$20231219$20240705$20240705$PER$$US-ABBVIE-5829588$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240558221$24055822$1$I$$20240702$20240705$20240705$PER$$US-BAYER-2024A096837$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240558231$24055823$1$I$$20240702$20240705$20240705$PER$$US-BAYER-2024A095835$BAYER$$44$YR$A$F$Y$$$20240705$$HP$US$US
240558241$24055824$1$I$$20240629$20240705$20240705$PER$$US-BAYER-2024A095239$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240558251$24055825$1$I$20240529$20240701$20240705$20240705$PER$$US-BAYER-2024A095505$BAYER$$16$YR$T$F$Y$$$20240705$$HP$US$US
240558261$24055826$1$I$$20240628$20240705$20240705$PER$$US-AMGEN-USASP2024129369$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240558273$24055827$3$F$20240228$20240826$20240705$20240903$EXP$$BE-BEIGENE-BGN-2024-009095$BEIGENE$$$$$$Y$$$20240903$$HP$BE$BE
240558281$24055828$1$I$20220701$20240628$20240705$20240705$EXP$$CA-GSK-CA2019AMR158198$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$HP$CA$CA
240558291$24055829$1$I$$20240629$20240705$20240705$EXP$$CO-GSK-CO2024AMR081829$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$CO$CO
240558301$24055830$1$I$20240423$20240627$20240705$20240705$EXP$GB-MHRA-MED-202406271249557900-BCMJH$GB-TEVA-VS-3214705$TEVA$$52$YR$$M$Y$70$KG$20240705$$MD$GB$GB
240558312$24055831$2$F$20221201$20240812$20240705$20240820$EXP$$NVSC2024AT139266$NOVARTIS$$$$E$F$Y$97$KG$20240820$$MD$AT$AT
240558322$24055832$2$F$20230101$20240811$20240705$20240814$EXP$$NVSC2024FI139140$NOVARTIS$$$$A$F$Y$86$KG$20240814$$CN$FI$FI
240558331$24055833$1$I$$20240703$20240705$20240705$PER$$US-JNJFOC-20240709151$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240558341$24055834$1$I$$20240704$20240705$20240705$EXP$$US-JNJFOC-20240713630$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240558351$24055835$1$I$$20240620$20240705$20240705$PER$$US-Eisai-EC-2024-168559$EISAI$$$$$$Y$$$20240705$$HP$US$US
240558361$24055836$1$I$20240307$20240701$20240705$20240705$EXP$DE-CADRBFARM-2024328896$DE-FreseniusKabi-FK202410302$FRESENIUS KABI$$31$YR$A$F$Y$67$KG$20240705$$CN$DE$DE
240558371$24055837$1$I$20240614$20240626$20240705$20240705$PER$$US-FreseniusKabi-FK202410140$FRESENIUS KABI$$58$YR$A$M$Y$111$KG$20240705$$HP$US$US
240558381$24055838$1$I$$20240626$20240705$20240705$EXP$$US-PADAGIS-2024PAD01090$PADAGIS$Nguyen E, Mendoza R, Dong T. Synchronicity in Syringomas: Bilateral Cases with Distinct Clinical Profiles. Journal of Clinical and Aesthetic Dermatology. 2024;17(6):11-12$$$$$Y$$$20240705$$MD$US$US
240558391$24055839$1$I$$20240627$20240705$20240705$EXP$$US-PADAGIS-2024PAD01098$PADAGIS$Singh K., Breidbart R., Jaiswal A., Damsky W., Choate K.A., Vesely M.. Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab. JAAD Case Reports. 2024;49:102-105$$$$$Y$$$20240705$$MD$US$US
240558401$24055840$1$I$20240615$20240625$20240705$20240705$EXP$$US-PADAGIS-2024PAD01083$PADAGIS$$$$$$Y$$$20240705$$CN$US$US
240558411$24055841$1$I$$20240627$20240705$20240705$EXP$$US-PADAGIS-2024PAD01097$PADAGIS$Singh K., Breidbart R., Jaiswal A., Damsky W., Choate K.A., Vesely M.. Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab. JAAD Case Reports. 2024;49:102-105$$$$$Y$$$20240705$$MD$US$US
240558421$24055842$1$I$$20240703$20240705$20240705$PER$$NVSC2024US139849$NOVARTIS$$$$$M$Y$$$20240705$$HP$US$US
240558432$24055843$2$F$20240624$20240705$20240705$20240715$EXP$$ES-DSJP-DSE-2024-129994$DAIICHI$$72$YR$$M$Y$$$20240715$$CN$ES$ES
240558442$24055844$2$F$20240515$20240703$20240705$20240712$EXP$$RS-DSJP-DSE-2024-130649$DAIICHI$$87$YR$$F$Y$$$20240712$$MD$RS$RS
240558452$24055845$2$F$20240629$20240905$20240705$20240913$PER$$US-JNJFOC-20240704827$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240913$$HP$US$US
240558471$24055847$1$I$20240603$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46541$$FDA-CTU$$36$YR$$M$N$61.69$KG$20240703$N$$US$
240558483$24055848$3$F$$20240718$20240705$20240729$EXP$$CA-AstraZeneca-2024A152970$ASTRAZENECA$Zhu K.; Drew Y.; Jayakumar S.. Challenges in PARP inhibitor therapy: A case of Olaparib-induced liver. Gynecologic Oncology Reports 2024;54(54):101439.$70$YR$$F$Y$$$20240729$$HP$CA$
240558491$24055849$1$I$$20240702$20240705$20240705$EXP$$AU-AstraZeneca-2024A154144$ASTRAZENECA$Ar B.. The precipitation of mania by citalopram in a patient with interferon-induced depression.. Psychosomatics 2008;49(4):362-363.$33$YR$$F$Y$$$20240705$$MD$AU$
240558501$24055850$1$I$20240402$20240703$20240703$20240703$DIR$FDA-CDER-CTU-2024-46549$$FDA-CTU$$60$YR$$F$N$108.8$KG$20240703$N$HP$US$
240558521$24055852$1$I$20240401$20240628$20240705$20240705$PER$$US-AstraZeneca-2024A152745$ASTRAZENECA$$$$$$Y$$$20240705$$CN$US$
240558531$24055853$1$I$20240101$20240626$20240705$20240705$PER$$US-ABBVIE-5820009$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240558541$24055854$1$I$$20240630$20240705$20240705$EXP$$JP-AstraZeneca-2024A151794$ASTRAZENECA$NOT REPORTED. NOT REPORTED$$$$$Y$$$20240705$$MD$JP$
240558551$24055855$1$I$$20240630$20240705$20240705$EXP$$US-GSK-US2024AMR082054$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$US$US
240558561$24055856$1$I$20230917$20240618$20240705$20240705$EXP$$DE-ROCHE-10000017926$ROCHE$$9$YR$C$F$Y$29$KG$20240705$$MD$DE$DE
240558571$24055857$1$I$$20240625$20240705$20240705$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK091969$GLENMARK$$$$$$Y$$$20240705$$PH$CA$CA
240558581$24055858$1$I$$20240624$20240705$20240705$EXP$$US-AMGEN-USASP2024128611$AMGEN$Abdelrahim M.; Esmail A.; Divatia M.K. et al.. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. Journal of Clinical Medicine. 2024;13 (11):1-14$59$YR$A$M$Y$$$20240705$$HP$US$US
240558591$24055859$1$I$20240517$20240701$20240705$20240705$PER$$US-BAYER-2024A095215$BAYER$$41$YR$A$M$Y$$$20240705$$CN$US$US
240558601$24055860$1$I$20240627$20240701$20240705$20240705$PER$$US-BAYER-2024A095261$BAYER$$68$YR$E$M$Y$$$20240705$$HP$US$US
240558611$24055861$1$I$$20240629$20240705$20240705$PER$$US-BAYER-2024A095164$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240558621$24055862$1$I$$20240705$20240705$20240705$PER$$NVSC2024US139840$NOVARTIS$$$$$$Y$$$20240705$$HP$US$US
240558631$24055863$1$I$$20231127$20240705$20240705$PER$$US-ABBVIE-5829478$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240558652$24055865$2$F$$20240712$20240705$20240717$EXP$$US-AMGEN-USASP2024128774$AMGEN$$$$$M$Y$$$20240717$$CN$US$US
240558663$24055866$3$F$20240101$20240729$20240705$20240808$PER$$US-AMGEN-USASP2024130484$AMGEN$$49$YR$A$F$Y$$$20240808$$HP$US$US
240558671$24055867$1$I$$20240705$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107545$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240705$$CN$US$US
240558681$24055868$1$I$20231029$20240626$20240705$20240705$EXP$ES-EMA-DD-20240618-7482827-175456$ES-TEVA-VS-3214729$TEVA$$44$YR$$M$Y$74$KG$20240705$$HP$ES$ES
240558691$24055869$1$I$20240501$20240628$20240705$20240705$EXP$$US-SA-2024SA196001$SANOFI AVENTIS$$65$YR$E$M$Y$77.11$KG$20240705$$MD$US$US
240558701$24055870$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193332$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240705$$MD$US$US
240558711$24055871$1$I$$20240628$20240705$20240705$PER$$US-ALXN-202406USA001885US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240558723$24055872$3$F$20240617$20240812$20240705$20240822$EXP$$ES-TAKEDA-2024TUS067561$TAKEDA$$83$YR$$F$Y$$$20240822$$MD$ES$ES
240558732$24055873$2$F$20240627$20240801$20240705$20240809$PER$$US-ROCHE-10000017510$ROCHE$$42$YR$A$F$Y$89$KG$20240809$$CN$US$US
240558742$24055874$2$F$$20240702$20240705$20240710$PER$$US-ROCHE-10000017498$ROCHE$$$$$$Y$$$20240710$$CN$US$US
240558751$24055875$1$I$$20240703$20240705$20240705$EXP$$CA-BAUSCH-BL-2024-010242$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240705$$CN$CA$CA
240558762$24055876$2$F$20240601$20240708$20240705$20240715$EXP$$US-BAUSCH-BL-2024-010100$BAUSCH AND LOMB$$37$YR$$F$Y$$$20240715$$PH$US$US
240558771$24055877$1$I$20230501$20240628$20240705$20240705$EXP$$US-AMGEN-USASP2024128772$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240558781$24055878$1$I$$20240701$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062358$SANDOZ$$$$$F$Y$$$20240705$$CN$US$US
240558791$24055879$1$I$$20240703$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062982$SANDOZ$$$$$$Y$$$20240705$$CN$US$US
240558802$24055880$2$F$20240628$20240708$20240705$20240711$EXP$$JP-BAYER-2024A097019$BAYER$$47$YR$A$F$Y$$$20240711$$HP$JP$JP
240558811$24055881$1$I$20240702$20240702$20240705$20240705$EXP$$CA-SANDOZ INC.-SDZ2023CA025523$SANDOZ$$67$YR$$M$Y$$$20240705$$HP$CA$CA
240558821$24055882$1$I$$20240629$20240705$20240705$EXP$$AU-SANDOZ INC.-NVSC2023AU124520$SANDOZ$Morton A. Low haptoglobin and a positive direct antiglobulin test without haemolysis in pregnancy. OBSTETRIC MEDICINE. 2022;15(4):280-2$29$YR$$F$Y$$$20240705$$MD$AU$AU
240558831$24055883$1$I$$20240628$20240705$20240705$PER$$US-BAYER-2024A094537$BAYER$$$$$F$Y$$$20240705$$CN$US$US
240558841$24055884$1$I$$20240627$20240705$20240705$PER$$US-BAYER-2024A094121$BAYER$$61$YR$A$F$Y$72.562$KG$20240705$$CN$US$US
240558851$24055885$1$I$$20240627$20240705$20240705$PER$$US-BAYER-2024A094452$BAYER$$66$YR$E$M$Y$$$20240705$$CN$US$US
240558861$24055886$1$I$$20240628$20240705$20240705$EXP$$PT-VANTIVE-2024VAN018103$Vantive US Healthcare$$60$YR$$F$Y$$$20240705$$HP$PT$PT
240558874$24055887$4$F$20240619$20240906$20240705$20240912$EXP$$NVSC2024FR135640$NOVARTIS$$$$A$F$Y$52.5$KG$20240912$$MD$FR$FR
240558886$24055888$6$F$20240624$20240829$20240705$20240903$EXP$$JP-OTSUKA-2024_018960$OTSUKA$$84$YR$$M$Y$40.3$KG$20240903$$MD$JP$JP
240558892$24055889$2$F$20210310$20240630$20240705$20240708$EXP$$NVSC2021IN102262$NOVARTIS$$64$YR$$M$Y$$$20240708$$CN$IN$IN
240558901$24055890$1$I$20240628$20240702$20240705$20240705$EXP$$CN-SA-2024SA198923$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240705$$HP$CN$CN
240558911$24055891$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA110798$SANOFI AVENTIS$$$$E$F$Y$$$20240705$$MD$US$US
240558921$24055892$1$I$20240601$20240704$20240705$20240705$EXP$$TW-TAKEDA-2024TUS068035$TAKEDA$$64$YR$$M$Y$$$20240705$$CN$TW$TW
240558932$24055893$2$F$20240623$20240705$20240705$20240712$EXP$IT-MINISAL02-992675$IT-GILEAD-2024-0679172$GILEAD$$73$YR$E$M$Y$64$KG$20240712$$MD$IT$IT
240558942$24055894$2$F$20240617$20240702$20240705$20240711$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019149$UNITED THERAPEUTICS$$35$YR$$F$Y$73.832$KG$20240711$$$US$US
240558953$24055895$3$F$$20240813$20240705$20240819$EXP$$DE-SANDOZ INC.-SDZ2024DE062902$SANDOZ$$$$$M$Y$$$20240819$$PH$DE$DE
240558962$24055896$2$F$20200807$20240702$20240705$20240709$EXP$$DE-SANDOZ INC.-NVSC2020DE275435$SANDOZ$$$$E$F$Y$59$KG$20240709$$HP$DE$DE
240558971$24055897$1$I$$20240703$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062965$SANDOZ$$$$$$Y$$$20240705$$CN$US$US
240558981$24055898$1$I$$20240705$20240705$20240705$EXP$$NL-SANDOZ INC.-SDZ2023NL076625$SANDOZ$Achten NB., Been JV.,  Schoenmakers S, Vermont CL., Verdijk RM., Reiss IKM., Taal HR. Fatal Early-onset Sepsis Caused by Intrauterine Transmission of Serogroup Y Meningococcus. Pediatr Infect Dis J. 2022;41:e517-e519$$$I$M$Y$1.587$KG$20240705$$HP$NL$NL
240558991$24055899$1$I$20240402$20240705$20240705$20240705$EXP$GB-MHRA-MED-202405081419436040-YLDTZ$GB-SANDOZ INC.-SDZ2024GB062974$SANDOZ$$72$YR$$F$Y$53$KG$20240705$$CN$GB$GB
240559001$24055900$1$I$20240614$20240628$20240705$20240705$PER$$US-BAYER-2024A094897$BAYER$$9$YR$C$M$Y$$$20240705$$CN$US$US
240559011$24055901$1$I$20200401$20240702$20240705$20240705$EXP$$US-TAKEDA-2024TUS067308$TAKEDA$$50$YR$$F$Y$$$20240705$$CN$US$US
240559021$24055902$1$I$20240704$20240704$20240705$20240705$EXP$$GB-SANDOZ INC.-SDZ2024GB062980$SANDOZ$$67$YR$$F$Y$76$KG$20240705$$MD$GB$GB
240559031$24055903$1$I$$20240703$20240705$20240705$EXP$GB-MHRA-DEFECT-202406221311545970-BHSNJ$GB-SANDOZ INC.-SDZ2024GB062637$SANDOZ$$$$$$Y$$$20240705$$CN$GB$GB
240559042$24055904$2$F$20240101$20240808$20240705$20240812$PER$$US-AMGEN-USASP2024131916$AMGEN$$88$YR$E$F$Y$$$20240812$$CN$US$US
240559051$24055905$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5826304$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240559061$24055906$1$I$20240501$20240702$20240705$20240705$EXP$$US-ABBVIE-5826524$ABBVIE$$30$YR$$F$Y$$$20240705$$CN$US$US
240559071$24055907$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5827915$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240559081$24055908$1$I$$20240702$20240705$20240705$EXP$$IT-SANDOZ INC.-SDZ2024IT062596$SANDOZ$M. Marano, BM Goffredo, S. Faraci, F. Torroni, Sharada H. Gowda, S. Perdichizzi, M. Di Nardo. Pharmacokinetic effects of endoscopic gastric decontamination formultidrug gastric pharmacobezoars. Toxicology Reports$15$YR$$F$Y$48$KG$20240705$$HP$IT$IT
240559091$24055909$1$I$$20240703$20240705$20240705$EXP$$CA-SANDOZ INC.-NVSC2023CA140988$SANDOZ$$$$$F$Y$$$20240705$$CN$CA$CA
240559101$24055910$1$I$$20240702$20240705$20240705$EXP$$DE-SANDOZ INC.-SDZ2024DE062592$SANDOZ$$$$$M$Y$$$20240705$$CN$DE$DE
240559111$24055911$1$I$20240624$20240624$20240705$20240705$PER$$US-BAYER-2024A094515$BAYER$$55$YR$A$F$Y$$$20240705$$HP$US$US
240559121$24055912$1$I$20221226$20240627$20240705$20240705$EXP$$CN-TAKEDA-2024TUS067421$TAKEDA$$69$YR$$M$Y$$$20240705$$HP$CN$CN
240559141$24055914$1$I$20240628$20240702$20240705$20240705$EXP$$US-BAYER-2024A096499$BAYER$$70$YR$E$F$Y$91.61$KG$20240705$$HP$US$US
240559151$24055915$1$I$$20240627$20240705$20240705$PER$$US-VERTEX PHARMACEUTICALS-2024-010840$VERTEX$$$$A$$Y$$$20240705$$CN$US$US
240559161$24055916$1$I$$20240626$20240705$20240705$PER$$US-VERTEX PHARMACEUTICALS-2024-010814$VERTEX$$$$A$F$Y$$$20240705$$MD$US$US
240559173$24055917$3$F$$20240924$20240705$20240926$EXP$$US-VERTEX PHARMACEUTICALS-2024-006702$VERTEX$$$$$F$Y$24$KG$20240926$$CN$US$US
240559191$24055919$1$I$20231201$20240701$20240705$20240705$EXP$FR-AFSSAPS-TS2024000727$FR-VERTEX PHARMACEUTICALS-2024-010982$VERTEX$$44$YR$$F$Y$77$KG$20240705$$MD$FR$FR
240559201$24055920$1$I$20240601$20240628$20240705$20240705$EXP$$US-VERTEX PHARMACEUTICALS-2024-010992$VERTEX$$25$YR$$F$Y$$$20240705$$CN$US$US
240559212$24055921$2$F$20240619$20240705$20240705$20240717$EXP$$US-BAYER-2024A096467$BAYER$$55$YR$A$F$Y$114.29$KG$20240717$$HP$US$US
240559231$24055923$1$I$$20240625$20240705$20240705$EXP$$CA-SANDOZ INC.-SDZ2024CA062682$SANDOZ$$44$YR$$F$Y$97$KG$20240705$$HP$CA$CA
240559241$24055924$1$I$20240501$20240701$20240705$20240705$EXP$$US-ABBVIE-5826316$ABBVIE$$82$YR$$M$Y$$$20240705$$CN$US$US
240559251$24055925$1$I$20230101$20240627$20240705$20240705$EXP$$CA-BIOGEN-2023BI01203024$BIOGEN$$$$$F$Y$$$20240705$$CN$CA$CA
240559271$24055927$1$I$$20240704$20240705$20240705$EXP$$CN-TAKEDA-2024TUS068399$TAKEDA$$$$$M$Y$$$20240705$$CN$CN$CN
240559281$24055928$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA192390$SANOFI AVENTIS$$$$E$M$Y$$$20240705$$MD$US$US
240559293$24055929$3$F$20240610$20240729$20240705$20240731$EXP$FR-AFSSAPS-TS2024000763$FR-SANDOZ INC.-SDZ2024FR063049$SANDOZ$$14$YR$$M$Y$75$KG$20240731$$MD$FR$FR
240559302$24055930$2$F$20240628$20240722$20240705$20240726$EXP$$DE-BAXTER-2024BAX020872$BAXTER$$61$YR$$M$Y$$$20240726$$HP$DE$DE
240559311$24055931$1$I$20240618$20240626$20240705$20240705$EXP$CN-NMPACDR-3708281020400202400516$CN-BAXTER-2024BAX020832$BAXTER$$55$YR$$F$Y$61$KG$20240705$$MD$CN$CN
240559321$24055932$1$I$$20240626$20240705$20240705$EXP$$MY-Alcon Laboratories-ALC2024MY003113$ALCON$$16$DY$$M$Y$$$20240705$$CN$MY$MY
240559331$24055933$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214788$TEVA$$77$YR$$M$Y$81$KG$20240705$$HP$CA$CA
240559341$24055934$1$I$20240601$20240701$20240705$20240705$EXP$$US-JNJFOC-20240703495$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240705$$CN$US$US
240559351$24055935$1$I$$20240703$20240705$20240705$PER$$US-JNJFOC-20240710252$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240559362$24055936$2$F$20240101$20240805$20240705$20240807$EXP$$US-ABBVIE-5825845$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
240559371$24055937$1$I$$20240628$20240705$20240705$EXP$$ES-AMGEN-ESPSP2024129158$AMGEN$Gonzalez-lopez T. J.; Bermejo-vega N.; Cardesa-cabrera R. et al.. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Blood. 2024;1-29$$$$$Y$$$20240705$$HP$ES$ES
240559381$24055938$1$I$20240628$20240704$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107150$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240705$$CN$US$US
240559401$24055940$1$I$20240101$20240621$20240705$20240705$PER$$US-Eisai-EC-2024-168675$EISAI$$73$YR$E$F$Y$$$20240705$$CN$US$US
240559411$24055941$1$I$$20240628$20240705$20240705$EXP$$US-GSK-US2024081200$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$US$US
240559421$24055942$1$I$$20231221$20240705$20240705$PER$$US-ABBVIE-5829412$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240559431$24055943$1$I$20240331$20240701$20240705$20240705$EXP$$NVSC2024US071825$NOVARTIS$$83$YR$$F$Y$$$20240705$$CN$US$US
240559441$24055944$1$I$$20240702$20240705$20240705$EXP$$AU-AMGEN-AUSSP2024131745$AMGEN$Viki M.; MorrowR.. Metastatic Hepatocellular Carcinoma Represents an Important but Rare Pitfall in the Diagnostic Evaluation of ER Negative Ovarian Malignancy- A Case Report. International Journal of Gynecological Pathology. 2024;43(4):378-381$50$YR$A$F$Y$$$20240705$$MD$AU$AU
240559452$24055945$2$F$$20240710$20240705$20240711$EXP$$ES-GILEAD-2024-0679312$GILEAD$$41$YR$A$M$Y$$$20240711$$PH$ES$ES
240559461$24055946$1$I$20240501$20240626$20240705$20240705$PER$$US-SA-2024SA193802$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240705$$MD$US$US
240559471$24055947$1$I$$20240701$20240705$20240705$EXP$$DE-ABBVIE-5826357$ABBVIE$$$$$F$Y$$$20240705$$CN$DE$DE
240559481$24055948$1$I$20240501$20240628$20240705$20240705$EXP$$US-AMGEN-USASP2024131701$AMGEN$$51$YR$A$F$Y$$$20240705$$CN$US$US
240559491$24055949$1$I$20240622$20240702$20240705$20240705$EXP$$EG-SA-2024SA197711$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240705$$PH$EG$EG
240559501$24055950$1$I$$20240621$20240705$20240705$PER$$US-SA-2024SA188178$SANOFI AVENTIS$$$$A$M$Y$$$20240705$$MD$US$US
240559511$24055951$1$I$$20240621$20240705$20240705$PER$$US-SA-2024SA188171$SANOFI AVENTIS$$$$A$M$Y$$$20240705$$MD$US$US
240559521$24055952$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA028894$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240705$$CN$US$US
240559531$24055953$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193264$SANOFI AVENTIS$$$$E$F$Y$45.35$KG$20240705$$MD$US$US
240559541$24055954$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193269$SANOFI AVENTIS$$$$A$F$Y$77.11$KG$20240705$$MD$US$US
240559551$24055955$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193252$SANOFI AVENTIS$$66$YR$E$$Y$$$20240705$$CN$US$US
240559561$24055956$1$I$$20240625$20240705$20240705$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK091970$GLENMARK$$$$$$Y$$$20240705$$HP$CA$CA
240559572$24055957$2$F$$20240813$20240705$20240822$PER$$US-APELLIS-2024-APL-0000312$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240822$$CN$US$US
240559581$24055958$1$I$$20240702$20240705$20240705$EXP$$JP-AstraZeneca-2024A153650$ASTRAZENECA$Nawa H, et al.. O5-5 A case of successfully treated central airway obstruction induced by haemorrhage and blood clots from oral ulcer by performing VV-ECMO removal.. The 38th Annual Meeting of the Tohoku Association for Acute Medicine [The 34th Tohoku Regional Meeting of the Association of the Japanese Association for Acute Medicine] 2024;63-.$75$YR$$M$Y$$$20240705$$MD$JP$
240559591$24055959$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A150381$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240559601$24055960$1$I$$20240702$20240705$20240705$EXP$$AU-AstraZeneca-2024A154375$ASTRAZENECA$Chan B, Chiew A.. Endoscopic decontamination reduces risk of life threatening poisoning. .. Emergency Medicine Australasia. 2018;30(s1):33-34..$13$YR$$F$Y$$$20240705$$MD$AU$
240559611$24055961$1$I$20240423$20240628$20240705$20240705$EXP$$KR-AstraZeneca-2024A149698$ASTRAZENECA$$796$MON$$F$Y$$$20240705$$MD$KR$
240559622$24055962$2$F$20220908$20240708$20240705$20240715$EXP$FR-AFSSAPS-RE2024000576$FR-OTSUKA-2024_018426$OTSUKA$$19$YR$$F$Y$98$KG$20240715$$CN$FR$FR
240559631$24055963$1$I$$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A145116$ASTRAZENECA$$83$YR$$F$Y$76.1$KG$20240705$$CN$US$
240559641$24055964$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5827304$ABBVIE$$$$$$Y$$$20240705$$HP$US$US
240559651$24055965$1$I$$20240703$20240705$20240705$EXP$$AU-GILEAD-2024-0679524$GILEAD$$$$E$F$Y$$$20240705$$HP$AU$AU
240559661$24055966$1$I$$20240703$20240705$20240705$PER$$US-TAKEDA-2024TUS067836$TAKEDA$$$$$F$Y$$$20240705$$MD$US$US
240559671$24055967$1$I$20240626$20240627$20240705$20240705$PER$$US-ALXN-202406USA001880US$ALEXION PHARMACEUTICALS$$68$YR$$F$Y$$$20240705$$CN$US$US
240559681$24055968$1$I$20240101$20240628$20240705$20240705$EXP$$BR-BIOGEN-2024BI01262138$BIOGEN$$45$YR$$F$Y$96$KG$20240705$$HP$BR$BR
240559691$24055969$1$I$20240106$20240627$20240705$20240705$EXP$$ES-GILEAD-2024-0679556$GILEAD$$$$$$Y$$$20240705$$HP$ES$ES
240559711$24055971$1$I$20230101$20240703$20240705$20240705$PER$$US-ABBVIE-5827248$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240559731$24055973$1$I$$20240705$20240705$20240705$EXP$GB-MHRA-MED-202405101353462320-FHVKZ$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037973$BOEHRINGER INGELHEIM$$$$$M$Y$78$KG$20240705$$MD$GB$GB
240559741$24055974$1$I$$20240703$20240705$20240705$EXP$$DK-ABBVIE-5828235$ABBVIE$$$$$F$Y$$$20240705$$HP$DK$DK
240559751$24055975$1$I$$20240629$20240705$20240705$EXP$$US-GSK-US2024AMR082020$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$US$US
240559762$24055976$2$F$20231214$20240708$20240705$20240717$EXP$FR-AFSSAPS-TO2024000808$FR-TEVA-VS-3214086$TEVA$$88$YR$$M$Y$75$KG$20240717$$PH$FR$FR
240559771$24055977$1$I$$20240625$20240705$20240705$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK091983$GLENMARK$$$$$$Y$$$20240705$$HP$CA$CA
240559802$24055980$2$F$$20240716$20240705$20240723$EXP$$NVSC2024ZA072267$NOVARTIS$$52$YR$$M$Y$$$20240723$$HP$ZA$ZA
240559811$24055981$1$I$20240604$20240628$20240705$20240705$EXP$$CN-009507513-2407CHN001281$MERCK$$53$YR$$M$Y$68$KG$20240705$$HP$CN$CN
240559821$24055982$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193578$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240705$$MD$US$US
240559831$24055983$1$I$20240101$20240625$20240705$20240705$EXP$FR-AFSSAPS-TS2024000716$FR-STRIDES ARCOLAB LIMITED-2024SP007677$STRIDES$$17$YR$$F$Y$51$KG$20240705$$MD$FR$FR
240559841$24055984$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193566$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240705$$CN$US$US
240559851$24055985$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193743$SANOFI AVENTIS$$$$A$M$Y$$$20240705$$HP$US$US
240559861$24055986$1$I$20240401$20240626$20240705$20240705$PER$$US-SA-2024SA193135$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240705$$MD$US$US
240559871$24055987$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193275$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240705$$MD$US$US
240559881$24055988$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193580$SANOFI AVENTIS$$21$YR$A$F$Y$61.23$KG$20240705$$MD$US$US
240559891$24055989$1$I$$20240625$20240705$20240705$PER$$US-JNJFOC-20240714005$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$PH$US$US
240559901$24055990$1$I$$20240627$20240705$20240705$PER$$US-JNJFOC-20240714004$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$HP$US$US
240559911$24055991$1$I$$20240703$20240705$20240705$PER$$US-JNJFOC-20240713224$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240559921$24055992$1$I$$20240625$20240705$20240705$PER$$US-JNJFOC-20240714118$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$HP$US$US
240559932$24055993$2$F$20240627$20240824$20240705$20240826$EXP$$US-PFIZER INC-202400204403$PFIZER$$73$YR$$M$Y$101.6$KG$20240826$$HP$US$US
240559942$24055994$2$F$20240628$20240722$20240705$20240725$EXP$$CN-PFIZER INC-PV202400087552$PFIZER$$68$YR$$M$Y$$$20240725$$HP$CN$CN
240559951$24055995$1$I$$20240703$20240705$20240705$EXP$$JP-PFIZER INC-PV202400087448$PFIZER$$81$YR$$$Y$$$20240705$$MD$JP$JP
240559962$24055996$2$F$$20240708$20240705$20240711$EXP$$MX-PFIZER INC-2023SGN05392$PFIZER$$$$$$Y$$$20240711$$MD$MX$MX
240559971$24055997$1$I$20240304$20240702$20240705$20240705$EXP$FR-AFSSAPS-BX2024001290$FR-PFIZER INC-202400204782$PFIZER$$45$YR$$F$Y$$$20240705$$CN$FR$FR
240559982$24055998$2$F$20240410$20240705$20240705$20240710$EXP$$BE-PFIZER INC-2024SGN05093$PFIZER$$17$YR$$F$Y$53$KG$20240710$$HP$BE$BE
240559991$24055999$1$I$20220711$20240703$20240705$20240705$EXP$$CA-PFIZER INC-202201279763$PFIZER$$75$YR$$F$Y$$$20240705$$MD$CA$CA
240560008$24056000$8$F$20240206$20240828$20240705$20240904$EXP$$ES-PFIZER INC-202400172786$PFIZER$$67$YR$$F$Y$69.1$KG$20240904$$MD$ES$ES
240560011$24056001$1$I$20240101$20240702$20240705$20240705$EXP$$CA-PFIZER INC-202400016042$PFIZER$$79$YR$$F$Y$$$20240705$$MD$CA$CA
240560021$24056002$1$I$$20240701$20240705$20240705$EXP$$US-GSK-US2024AMR082506$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$US$US
240560031$24056003$1$I$$20240630$20240705$20240705$EXP$$US-GSK-US2024AMR082035$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$US$US
240560041$24056004$1$I$20240627$20240627$20240705$20240705$PER$$US-ALXN-202406USA001855US$ALEXION PHARMACEUTICALS$$50$YR$$F$Y$$$20240705$$CN$US$US
240560051$24056005$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5827114$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240560062$24056006$2$F$$20240708$20240705$20240716$EXP$$JP-AstraZeneca-2024A151757$ASTRAZENECA$$$$$$Y$$$20240716$$CN$JP$
240560071$24056007$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A103599$ASTRAZENECA$$83$YR$$F$Y$$$20240705$$CN$US$
240560081$24056008$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A153218$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240560101$24056010$1$I$$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A149061$ASTRAZENECA$$$$$F$Y$75.8$KG$20240705$$CN$US$
240560111$24056011$1$I$$20240627$20240705$20240705$EXP$$JP-AstraZeneca-2024A150705$ASTRAZENECA$$80$YR$$F$Y$$$20240705$$MD$JP$
240560121$24056012$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A150567$ASTRAZENECA$$$$$$Y$$$20240705$$CN$US$
240560131$24056013$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A150095$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240560141$24056014$1$I$20240501$20240626$20240705$20240705$PER$$US-SA-2024SA193543$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240705$$MD$US$US
240560153$24056015$3$F$20180101$20240716$20240705$20240722$EXP$$US-BIOGEN-2024BI01272406$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
240560161$24056016$1$I$$20231108$20240705$20240705$PER$$US-ABBVIE-5827845$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240560171$24056017$1$I$$20240702$20240705$20240705$PER$$US-HALEON-2185003$Haleon PLC$$98$YR$$$Y$$$20240705$$CN$US$US
240560181$24056018$1$I$$20240701$20240705$20240705$EXP$$FR-TAKEDA-2024TUS065633$TAKEDA$$13$YR$$M$Y$$$20240705$$HP$FR$FR
240560191$24056019$1$I$20240626$20240628$20240705$20240705$EXP$$CN-JNJFOC-20240714783$JOHNSON AND JOHNSON$$11$YR$C$M$Y$50$KG$20240705$$HP$CN$CN
240560201$24056020$1$I$20240501$20240703$20240705$20240705$PER$$US-JNJFOC-20240710197$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240705$$CN$US$US
240560212$24056021$2$F$20240501$20240722$20240705$20240727$EXP$$ES-ABBVIE-5826562$ABBVIE$$69$YR$$M$Y$$$20240727$$CN$ES$ES
240560222$24056022$2$F$20240624$20240726$20240705$20240730$EXP$$US-BAYER-2024A095094$BAYER$$36$YR$A$M$Y$$$20240730$$CN$US$US
240560231$24056023$1$I$$20240627$20240705$20240705$EXP$$US-BAYER-2024A082691$BAYER$$84$YR$E$M$Y$$$20240705$$CN$US$US
240560241$24056024$1$I$$20240624$20240705$20240705$EXP$$US-BAYER-2024A090882$BAYER$$79$YR$E$M$Y$$$20240705$$CN$US$US
240560253$24056025$3$F$$20240909$20240705$20240913$30DAY$$FR-PFIZER INC-202400107261$PFIZER$$63$YR$$F$Y$$$20240913$$PH$FR$FR
240560263$24056026$3$F$$20240712$20240705$20240717$30DAY$$TR-PFIZER INC-PV202400054967$PFIZER$$$$$$Y$$$20240717$$PH$TR$TR
240560273$24056027$3$F$$20240626$20240705$20240725$EXP$$DE-BEH-2024174710$CSL BEHRING$$$$$M$Y$$$20240725$$MD$DE$DE
240560281$24056028$1$I$20230213$20240702$20240705$20240705$EXP$$CA-TAKEDA-2024TUS067606$TAKEDA$$66$YR$$F$Y$$$20240705$$CN$CA$CA
240560291$24056029$1$I$$20240702$20240705$20240705$EXP$$CA-ABBVIE-5827016$ABBVIE$$$$A$M$Y$$$20240705$$HP$CA$CA
240560301$24056030$1$I$$20240626$20240705$20240705$EXP$$US-BAYER-2024A093026$BAYER$$82$YR$E$M$Y$$$20240705$$CN$US$US
240560314$24056031$4$F$20240101$20240827$20240705$20240904$EXP$$US-ABBVIE-5821768$ABBVIE$$$$$F$Y$$$20240904$$HP$US$US
240560321$24056032$1$I$$20240702$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106211$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240705$$HP$US$US
240560331$24056033$1$I$20240611$20240628$20240705$20240705$EXP$GB-MHRA-MED-202406281654552320-MTFRQ$GB-TEVA-VS-3216106$TEVA$$71$YR$$F$Y$57$KG$20240705$$PH$GB$GB
240560341$24056034$1$I$20200126$20240704$20240705$20240705$EXP$PL-URPL-1-1188-2020$PL-GSK-PL2024083229$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$PL$PL
240560351$24056035$1$I$$20240703$20240705$20240705$EXP$$NVSC2024US139062$NOVARTIS$$$$$F$Y$$$20240705$$CN$US$US
240560361$24056036$1$I$$20240626$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107159$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$73.94$KG$20240705$$PH$US$US
240560371$24056037$1$I$20221001$20240701$20240705$20240705$EXP$$SI-OTSUKA-2024_012724$OTSUKA$Korosec HL, Blagus T, Redensek TS, Dolzan V, Bon J, Pjevac M. Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics.. Front Psychiatry. 2024;15:1-9$60$YR$$F$Y$$$20240705$$HP$SI$SI
240560381$24056038$1$I$$20231124$20240705$20240705$PER$$US-ABBVIE-5829506$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240560391$24056039$1$I$20240611$20240621$20240705$20240705$PER$$US-Eisai-EC-2024-168684$EISAI$$77$YR$E$M$Y$$$20240705$$CN$US$US
240560403$24056040$3$F$20240620$20240905$20240705$20240926$PER$$US-Eisai-EC-2024-168719$EISAI$$83$YR$E$M$Y$$$20240926$$CN$US$US
240560411$24056041$1$I$$20240703$20240705$20240705$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-130883$DAIICHI$$$$$F$Y$$$20240705$$MD$US$US
240560423$24056042$3$F$20231201$20240911$20240705$20240921$EXP$$GB-TEVA-VS-3215756$TEVA$$40$YR$$F$Y$$$20240921$$HP$GB$GB
240560431$24056043$1$I$20240520$20240626$20240705$20240705$EXP$FR-AFSSAPS-AN2024000786$FR-TEVA-VS-3215147$TEVA$$83$YR$$F$Y$50.3$KG$20240705$$PH$FR$FR
240560442$24056044$2$F$20220827$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS066202$TAKEDA$$36$YR$$M$Y$$$20240709$$HP$CN$CN
240560451$24056045$1$I$20240701$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130297$AMGEN$$68$YR$E$F$Y$$$20240705$$CN$US$US
240560461$24056046$1$I$$20231215$20240705$20240705$PER$$US-ABBVIE-5829529$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240560471$24056047$1$I$20240615$20240626$20240705$20240705$EXP$GB-MHRA-MED-202406260854336600-NTQGV$GB-TORRENT-00036923$TORRENT$$30$YR$A$F$Y$$$20240705$$CN$GB$GB
240560481$24056048$1$I$20230605$20240625$20240705$20240705$EXP$GB-ROCHE-3433029$GB-TORRENT-00033568$TORRENT$$63$YR$A$M$Y$80$KG$20240705$$MD$GB$GB
240560492$24056049$2$F$20240626$20240809$20240705$20240814$EXP$$US-TORRENT-00013657$TORRENT$$35$YR$A$F$Y$90$KG$20240814$$CN$US$US
240560502$24056050$2$F$20231003$20240629$20240705$20240710$EXP$GB-Accord-429989$GB-TORRENT-00036917$TORRENT$$93$YR$E$M$Y$$$20240710$$CN$GB$GB
240560511$24056051$1$I$$20240704$20240705$20240705$EXP$$JP-PFIZER INC-PV202400088028$PFIZER$$9$DEC$$$Y$$$20240705$$MD$JP$JP
240560521$24056052$1$I$20240126$20240704$20240705$20240705$EXP$$IN-PFIZER INC-PV202400087800$PFIZER$$54$YR$$F$Y$$$20240705$$CN$IN$IN
240560531$24056053$1$I$20240701$20240701$20240705$20240705$EXP$GB-MHRA-MED-202407011812526650-VWLTB$GB-PFIZER INC-202400204438$PFIZER$$$$$F$Y$70$KG$20240705$$HP$GB$GB
240560542$24056054$2$F$20240613$20240710$20240705$20240711$EXP$$CN-PFIZER INC-PV202400088135$PFIZER$$33$YR$$M$Y$75$KG$20240711$$HP$CN$CN
240560552$24056055$2$F$$20240731$20240705$20240808$EXP$$JP-PFIZER INC-202400205964$PFIZER$$8$DEC$$M$Y$$$20240808$$MD$JP$JP
240560561$24056056$1$I$$20240703$20240705$20240705$EXP$$FR-PFIZER INC-202400205689$PFIZER$$$$$F$Y$$$20240705$$MD$FR$FR
240560571$24056057$1$I$20240522$20240704$20240705$20240705$EXP$$GB-PFIZER INC-202400175502$PFIZER$$76$YR$$M$Y$$$20240705$$CN$GB$GB
240560581$24056058$1$I$20240617$20240704$20240705$20240705$EXP$$CN-PFIZER INC-PV202400088169$PFIZER$$81$YR$$M$Y$75$KG$20240705$$HP$CN$CN
240560592$24056059$2$F$20240613$20240828$20240705$20240902$EXP$$JP-PFIZER INC-PV202400087824$PFIZER$$76$YR$$M$Y$$$20240902$$MD$JP$JP
240560601$24056060$1$I$20240101$20240704$20240705$20240705$EXP$$IN-PFIZER INC-PV202400087917$PFIZER$$44$YR$$M$Y$$$20240705$$CN$IN$IN
240560611$24056061$1$I$20240615$20240627$20240705$20240705$EXP$$CN-PFIZER INC-PV202400086883$PFIZER$$41$DY$$F$Y$4$KG$20240705$$HP$CN$CN
240560631$24056063$1$I$20240614$20240704$20240705$20240705$EXP$$AR-PFIZER INC-202400207682$PFIZER$$79$YR$$F$Y$$$20240705$$CN$AR$AR
240560641$24056064$1$I$$20240704$20240705$20240705$EXP$$MA-PFIZER INC-PV202400088459$PFIZER$$$$$F$Y$$$20240705$$CN$MA$MA
240560651$24056065$1$I$20230927$20240701$20240705$20240705$EXP$FR-AFSSAPS-MP2024001063$FR-PFIZER INC-202400203988$PFIZER$$70$YR$$F$Y$$$20240705$$PH$FR$FR
240560662$24056066$2$F$20230318$20240731$20240705$20240805$EXP$$JP-PFIZER INC-202400206301$PFIZER$$86$YR$$F$Y$$$20240805$$CN$JP$JP
240560671$24056067$1$I$20240611$20240703$20240705$20240705$EXP$$CN-PFIZER INC-PV202400087536$PFIZER$$41$YR$$F$Y$90$KG$20240705$$HP$CN$CN
240560681$24056068$1$I$$20240627$20240705$20240705$EXP$$NVSC2024PT137649$NOVARTIS$$$$$$Y$$$20240705$$HP$PT$PT
240560691$24056069$1$I$$20240703$20240705$20240705$EXP$$NVSC2024US139001$NOVARTIS$$$$$M$Y$$$20240705$$CN$US$US
240560702$24056070$2$F$$20240529$20240705$20240711$EXP$$IN-ABBVIE-5829131$ABBVIE$Basera DS, Sutar RF, Kaur G, Modak T. Cariprazine-induced extrapyramidal symptoms and a rare downward eye deviation in oculogyric crisis: a case series. Indian Journal of Psychological Medicine. 2024:1-4$19$YR$$F$Y$$$20240711$$MD$IN$IN
240560713$24056071$3$F$$20240717$20240705$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407002535$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240722$$CN$US$US
240560721$24056072$1$I$$20240702$20240705$20240705$PER$$US-JNJFOC-20240706347$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$MD$US$US
240560731$24056073$1$I$$20240614$20240705$20240705$EXP$$RO-ALXN-202406EEA000885RO$ALEXION PHARMACEUTICALS$$$$C$$Y$$$20240705$$MD$RO$RO
240560741$24056074$1$I$$20240702$20240705$20240705$EXP$$US-ASTELLAS-2024EU006564$ASTELLAS$$66$YR$$M$Y$$$20240705$$MD$US$US
240560751$24056075$1$I$$20240703$20240705$20240705$EXP$$JP-ASTELLAS-2024JP004661$ASTELLAS$$8$DEC$$F$Y$$$20240705$$MD$JP$JP
240560761$24056076$1$I$20240618$20240701$20240705$20240705$EXP$$US-BAYER-2024A095840$BAYER$$40$YR$A$F$Y$58.957$KG$20240705$$CN$US$US
240560771$24056077$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA191246$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240705$$CN$US$US
240560781$24056078$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA185364$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240705$$MD$US$US
240560791$24056079$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193748$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240705$$MD$US$US
240560802$24056080$2$F$$20240905$20240705$20240914$PER$$US-SA-2024SA192122$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240914$$MD$US$US
240560811$24056081$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA137565$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240705$$CN$US$US
240560821$24056082$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193636$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240705$$MD$US$US
240560832$24056083$2$F$20240101$20240821$20240705$20240917$PER$$US-SA-2024SA193706$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240918$$MD$US$US
240560841$24056084$1$I$$20240620$20240705$20240705$EXP$$CN-GILEAD-2024-0677020$GILEAD$$$$$M$Y$$$20240705$$CN$CN$CN
240560851$24056085$1$I$$20240627$20240705$20240705$EXP$$CH-OTSUKA-2024_005845$OTSUKA$$$$A$F$Y$$$20240705$$HP$CH$CH
240560862$24056086$2$F$$20240913$20240705$20240919$EXP$$JP-009507513-2407JPN000192J$MERCK$Ogino Y, Nagumo H, Yoshimine N, Mukozu T, Matsui T, Wakui N, et al.. 14. Review of immune-related adverse event (immune-related adverse event: irAE) in which liver stiffness could be measured over time by abdominal ultrasound. The 37th Japanese Association of Contrast-Enhanced Ultrasound and Doppler Abdomi. 34$7$DEC$$M$Y$$$20240919$$MD$JP$JP
240560871$24056087$1$I$$20240627$20240705$20240705$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR080717$VIIV$$$$$$Y$$$20240705$$HP$US$US
240560881$24056088$1$I$20240705$20240705$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107578$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240705$$CN$US$US
240560891$24056089$1$I$20240312$20240624$20240705$20240705$PER$$US-Eisai-EC-2024-168898$EISAI$$80$YR$E$M$Y$$$20240705$$CN$US$US
240560901$24056090$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A150447$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240560911$24056091$1$I$$20240628$20240705$20240705$EXP$$ZA-AstraZeneca-2024A150184$ASTRAZENECA$$77$YR$$F$Y$$$20240705$$CN$ZA$
240560922$24056092$2$F$20240101$20240822$20240705$20240827$EXP$$JP-AstraZeneca-2024A151764$ASTRAZENECA$$62$YR$$F$Y$50$KG$20240827$$MD$JP$
240560931$24056093$1$I$20240201$20240625$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-058926$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$108.86$KG$20240705$$CN$US$US
240560941$24056094$1$I$$20240621$20240705$20240705$PER$$US-ALKERMES INC.-ALK-2024-001280$ALKERMES$$$$$M$Y$$$20240705$$HP$US$US
240560951$24056095$1$I$20240503$20240702$20240705$20240705$EXP$$DE-TAKEDA-2024TUS066292$TAKEDA$$64$YR$$F$Y$86$KG$20240705$$HP$DE$DE
240560961$24056096$1$I$$20240702$20240705$20240705$EXP$$BR-AstraZeneca-2024A154270$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$BR$
240560971$24056097$1$I$$20240620$20240705$20240705$EXP$$US-PHARMAAND GMBH-2024PHR00397$pharmaAND$$$$$F$Y$$$20240705$$CN$US$US
240560981$24056098$1$I$$20240627$20240705$20240705$PER$$US-AMGEN-USASP2024128198$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240560992$24056099$2$F$$20240710$20240705$20240715$PER$$US-AMGEN-USASP2024130079$AMGEN$$$$$M$Y$$$20240715$$CN$US$US
240561004$24056100$4$F$20240703$20240723$20240705$20240729$PER$$US-AMGEN-USASP2024132787$AMGEN$$58$YR$A$F$Y$$$20240729$$CN$US$US
240561011$24056101$1$I$$20240628$20240705$20240705$EXP$$US-BAUSCH-BL-2024-010082$BAUSCH AND LOMB$Kurashima M, Nahal C, Saliba C, Okeke R. Intestinal obstruction due to a congenital mesenteric hernia in a newborn with cystic fibrosis: A case report. Journal of Pediatric Surgery Case Reports. 2024 MAY 28;107:1-5. doi:10.1016/j.epsc.2024.10284$0$DY$$F$Y$$$20240705$$HP$US$US
240561022$24056102$2$F$20230913$20240730$20240705$20240809$EXP$$US-INSMED, INC.-2023-03500-US$INSMED$$86$YR$$M$Y$$$20240809$$CN$US$US
240561034$24056103$4$F$20150613$20240729$20240705$20240812$EXP$FR-AFSSAPS-AN2024000810$FR-OTSUKA-2024_018459$OTSUKA$$50$YR$$F$Y$74$KG$20240812$$PH$FR$FR
240561041$24056104$1$I$20240118$20240628$20240705$20240705$EXP$FR-AFSSAPS-AVMA2024000256$FR-OTSUKA-2024_018468$OTSUKA$$60$YR$$F$Y$$$20240705$$PH$FR$FR
240561052$24056105$2$F$20240601$20240906$20240705$20240909$EXP$$NVSC2024US138020$NOVARTIS$$0$YR$$M$Y$$$20240909$$CN$US$US
240561072$24056107$2$F$$20240723$20240705$20240726$PER$$US-AMGEN-USASP2024132747$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
240561081$24056108$1$I$$20240704$20240705$20240705$PER$$US-HALEON-2185472$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240561092$24056109$2$F$$20240703$20240705$20240712$EXP$$CN-SA-2024SA197967$SANOFI AVENTIS$$$$A$$Y$$$20240712$$CN$CN$CN
240561102$24056110$2$F$$20240715$20240705$20240717$PER$$US-AMGEN-USASP2024133426$AMGEN$$73$YR$E$M$Y$$$20240717$$CN$US$US
240561111$24056111$1$I$20230801$20240626$20240705$20240705$EXP$ES-AEMPS-1419576$ES-TEVA-VS-3214846$TEVA$$62$YR$$M$Y$$$20240705$$MD$ES$ES
240561121$24056112$1$I$$20240627$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR082395$VIIV$$$$$$Y$$$20240705$$HP$US$US
240561132$24056113$2$F$$20240706$20240705$20240716$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024079244$VIIV$$$$$M$Y$$$20240716$$HP$US$US
240561141$24056114$1$I$$20240625$20240705$20240705$PER$$US-Eisai-EC-2024-168811$EISAI$$68$YR$E$M$Y$$$20240705$$CN$US$US
240561151$24056115$1$I$20240429$20240627$20240705$20240705$EXP$ES-AEMPS-1533371$ES-BIOCON BIOLOGICS LIMITED-BBL2024004415$BIOCON$$$$$$Y$$$20240705$$PH$ES$ES
240561161$24056116$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA196013$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240705$$MD$US$US
240561171$24056117$1$I$20240101$20240704$20240705$20240705$EXP$$RS-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038002$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$70$KG$20240705$$CN$RS$RS
240561181$24056118$1$I$$20240705$20240705$20240705$PER$$NVSC2024US139872$NOVARTIS$$$$$$Y$$$20240705$$HP$US$US
240561191$24056119$1$I$20240618$20240630$20240705$20240705$EXP$$CN-JNJFOC-20240708187$JOHNSON AND JOHNSON$$10$MON$I$F$Y$7$KG$20240705$$HP$CN$CN
240561201$24056120$1$I$$20240701$20240705$20240705$EXP$$BR-JNJFOC-20240705391$JOHNSON AND JOHNSON$$12$YR$T$M$Y$29$KG$20240705$$CN$BR$BR
240561221$24056122$1$I$20240601$20240627$20240705$20240705$EXP$$US-JNJFOC-20240675939$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240705$$HP$US$US
240561241$24056124$1$I$$20240627$20240705$20240705$EXP$$JP-TEVA-VS-3177849$TEVA$$8$DEC$$$Y$$$20240705$$MD$JP$JP
240561251$24056125$1$I$$20240625$20240705$20240705$30DAY$$US-GSK-US2024079190$GLAXOSMITHKLINE$$$$$M$Y$$$20240705$$PH$US$US
240561262$24056126$2$F$20240531$20240819$20240705$20240823$EXP$$KR-PHARMAESSENTIA CORPORATION-KR-2024-PEC-004057$PHARMAESSENTIA$$49$YR$$F$Y$$$20240823$$HP$KR$KR
240561271$24056127$1$I$$20240701$20240705$20240705$EXP$$NVSC2024BR139273$NOVARTIS$$$$$F$Y$$$20240705$$MD$BR$BR
240561281$24056128$1$I$$20240627$20240705$20240705$EXP$$ZA-AstraZeneca-2024A150313$ASTRAZENECA$$86$YR$$M$Y$$$20240705$$CN$ZA$
240561292$24056129$2$F$$20240813$20240705$20240821$EXP$$FR-AstraZeneca-2024A145933$ASTRAZENECA$$43$YR$$F$Y$$$20240821$$MD$FR$
240561301$24056130$1$I$$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151084$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240561322$24056132$2$F$$20240819$20240705$20240903$PER$$US-AstraZeneca-2024A148096$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
240561332$24056133$2$F$$20240705$20240705$20240709$EXP$$US-AstraZeneca-2024A152322$ASTRAZENECA$$$$$$Y$$$20240709$$MD$US$
240561342$24056134$2$F$$20240813$20240705$20240821$EXP$$US-AstraZeneca-2024A150385$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
240561351$24056135$1$I$20240616$20240628$20240705$20240705$EXP$$CN-AstraZeneca-2024A152570$ASTRAZENECA$$31332$DY$$F$Y$$$20240705$$MD$CN$
240561362$24056136$2$F$20240101$20240904$20240705$20240906$PER$$US-AMGEN-USASP2024129267$AMGEN$$65$YR$E$F$Y$$$20240906$$CN$US$US
240561373$24056137$3$F$$20240712$20240705$20240719$EXP$$CA-AstraZeneca-2024A149931$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$CA$
240561381$24056138$1$I$20231111$20240702$20240705$20240705$EXP$$JP-AstraZeneca-2023A273978$ASTRAZENECA$$68$YR$$M$Y$$$20240705$$MD$JP$
240561391$24056139$1$I$$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A149898$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240561401$24056140$1$I$20240501$20240626$20240705$20240705$PER$$US-SA-2024SA193768$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240705$$MD$US$US
240561411$24056141$1$I$20231016$20240626$20240705$20240705$PER$$US-SA-2024SA193471$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240705$$MD$US$US
240561422$24056142$2$F$20240625$20240625$20240705$20240709$EXP$GB-MHRA-MED-202406250919257530-VZWCK$GB-GLENMARK PHARMACEUTICALS-2024GMK091940$GLENMARK$$$$$$Y$$$20240709$$MD$GB$GB
240561431$24056143$1$I$$20240517$20240705$20240705$PER$$US-AMGEN-USASP2024129844$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240561442$24056144$2$F$20240620$20240703$20240705$20240709$PER$$US-ABBVIE-5827359$ABBVIE$$40$YR$$F$Y$$$20240709$$CN$US$US
240561452$24056145$2$F$20240629$20240717$20240705$20240720$EXP$$CN-TAKEDA-2024TUS066988$TAKEDA$$58$YR$$M$Y$$$20240720$$CN$CN$CN
240561461$24056146$1$I$$20240628$20240705$20240705$EXP$$US-GSK-US2024081139$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$US$US
240561471$24056147$1$I$$20240704$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107477$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240705$$CN$US$US
240561484$24056148$4$F$20220526$20240828$20240705$20240905$EXP$$CA-OTSUKA-2022_024941$OTSUKA$$61$YR$$F$Y$$$20240905$$MD$CA$CA
240561492$24056149$2$F$20240101$20240709$20240705$20240712$PER$$US-ABBVIE-5827510$ABBVIE$$$$$F$Y$91$KG$20240712$$CN$US$US
240561502$24056150$2$F$20240624$20240808$20240705$20240814$30DAY$$US-GSK-US2024079198$GLAXOSMITHKLINE$$74$YR$$F$Y$69$KG$20240814$$MD$US$US
240561511$24056151$1$I$$20240702$20240705$20240705$EXP$GB-MHRA-MIDB- 5c5977f1-7f26-4321-b456-1036d1661ac9$GB-TEVA-VS-3216468$TEVA$$88$YR$$F$Y$$$20240705$$HP$GB$GB
240561521$24056152$1$I$$20240625$20240705$20240705$EXP$$PL-TEVA-VS-3214840$TEVA$Sajdak P. Unmasking the nature of granulomatosis with polyangiitis - a diagnostic odyssey revealed through a compelling case report. EUROPEAN JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. 2024;(2):462-468.$52$YR$$M$Y$$$20240705$$HP$PL$PL
240561531$24056153$1$I$20240520$20240628$20240705$20240705$EXP$$US-009507513-2407USA000911$MERCK$$84$YR$$M$Y$$$20240705$$HP$US$US
240561541$24056154$1$I$$20231218$20240705$20240705$PER$$US-ABBVIE-5829560$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240561551$24056155$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193618$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240705$$MD$US$US
240561561$24056156$1$I$20240101$20240626$20240705$20240705$PER$$US-SA-2024SA193498$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240705$$MD$US$US
240561571$24056157$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193464$SANOFI AVENTIS$$$$A$F$Y$123.3$KG$20240705$$MD$US$US
240561581$24056158$1$I$$20240624$20240705$20240705$EXP$$US-RDY-LIT/USA/24/0009433$DR REDDYS$Hodson EL, Kranyak A, Salem I, Buckey Jr. JC. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases. Journal of Tissue Viability. 2024 Jun 05;doi:10.1016/j.jtv.2024.06.001.$54$YR$A$F$Y$$$20240705$$HP$US$US
240561591$24056159$1$I$20240626$20240628$20240705$20240705$PER$$US-BIOGEN-2024BI01271908$BIOGEN$$41$YR$$F$Y$$$20240705$$CN$US$US
240561601$24056160$1$I$20080520$20240701$20240705$20240705$PER$$US-BIOGEN-2008BI033238$BIOGEN$$53$YR$$F$Y$$$20240705$$CN$US$US
240561611$24056161$1$I$20240601$20240628$20240705$20240705$PER$$US-BIOGEN-2024BI01271667$BIOGEN$$45$YR$$F$Y$$$20240705$$CN$US$US
240561621$24056162$1$I$$20231221$20240705$20240705$PER$$US-ABBVIE-5829899$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240561631$24056163$1$I$$20240123$20240705$20240705$PER$$US-AMGEN-USASP2024131855$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240561642$24056164$2$F$$20240911$20240705$20240917$EXP$$JP-009507513-2403JPN004020J$MERCK$$$$$M$Y$$$20240917$$MD$JP$JP
240561651$24056165$1$I$$20240701$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105574$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240705$$CN$US$US
240561661$24056166$1$I$20240607$20240705$20240705$20240705$EXP$FR-AFSSAPS-PO2024000675$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-107481$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$74$KG$20240705$$PH$FR$FR
240561671$24056167$1$I$20240701$20240705$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107568$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240705$$HP$US$US
240561681$24056168$1$I$$20240705$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107585$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240705$$HP$US$US
240561691$24056169$1$I$$20240701$20240705$20240705$EXP$$UA-BAYER-2024A095959$BAYER$$$$$$Y$$$20240705$$MD$UA$UA
240561701$24056170$1$I$$20240109$20240705$20240705$PER$$US-ABBVIE-5829393$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240561711$24056171$1$I$20230612$20240701$20240705$20240705$EXP$$RU-ABBVIE-5829407$ABBVIE$$5$YR$$F$Y$$$20240705$$CN$RU$RU
240561721$24056172$1$I$20240628$20240626$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107413$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$73.94$KG$20240705$$PH$US$US
240561731$24056173$1$I$$20240628$20240705$20240705$30DAY$$US-GSK-US2024AMR081410$GLAXOSMITHKLINE$$$$$F$Y$$$20240705$$PH$US$US
240561741$24056174$1$I$$20240628$20240705$20240705$EXP$$US-GSK-US2024081084$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$US$US
240561751$24056175$1$I$20240521$20240628$20240705$20240705$EXP$$US-GSK-US2024081189$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$US$US
240561761$24056176$1$I$20240624$20240626$20240704$20240704$DIR$FDA-CDER-CTU-2024-46639$$FDA-CTU$$$$$F$N$94.8$KG$20240626$N$$US$
240561771$24056177$1$I$20240624$20240703$20240704$20240704$DIR$FDA-CDER-CTU-2024-46640$$FDA-CTU$$46$YR$$F$N$94.8$KG$20240703$N$$US$
240561781$24056178$1$I$20240615$20240625$20240704$20240704$DIR$FDA-CDER-CTU-2024-46641$$FDA-CTU$$70$YR$$M$N$80.6$KG$20240625$N$$US$
240561791$24056179$1$I$20240626$20240703$20240704$20240704$DIR$FDA-CDER-CTU-2024-46638$$FDA-CTU$$44$YR$$M$N$73.5$KG$20240703$N$$US$
240561801$24056180$1$I$20240627$20240703$20240704$20240704$DIR$FDA-CDER-CTU-2024-46637$$FDA-CTU$$72$YR$$F$N$73.2$KG$20240703$N$$US$
240561811$24056181$1$I$$20240629$20240704$20240704$DIR$FDA-CDER-CTU-2024-46699$$FDA-CTU$$$$$F$N$$$20240629$N$HP$US$
240561821$24056182$1$I$20240501$20240703$20240704$20240704$DIR$FDA-CDER-CTU-2024-46706$$FDA-CTU$$47$YR$$F$N$$$20240703$N$HP$US$
240561843$24056184$3$F$20240626$20240725$20240705$20240805$EXP$$US-LANTHEUS-LMI-2024-00811$LANTHEUS MEDICAL IMAGING$$85$YR$$F$Y$59$KG$20240802$$CN$US$US
240561851$24056185$1$I$20230103$20240627$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR081226$VIIV$$50$YR$$M$Y$$$20240705$$PH$US$US
240561861$24056186$1$I$$20240625$20240705$20240705$EXP$$PL-TEVA-VS-3214771$TEVA$Krawczyk M. Pneumothorax as a complication of respiratory failure - two case reports and literature review. JOURNAL OF PRE-CLINICAL AND CLINICAL RESEARCH. 2024;(2):139-146.$28$YR$$M$Y$$$20240705$$HP$PL$PL
240561871$24056187$1$I$$20240506$20240705$20240705$PER$$US-AMGEN-USASP2024133399$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240561881$24056188$1$I$20240601$20240628$20240705$20240705$EXP$$US-ABBVIE-5822752$ABBVIE$$78$YR$$F$Y$$$20240705$$CN$US$US
240561891$24056189$1$I$$20240625$20240705$20240705$EXP$$GB-BAXTER-2024BAX019475$BAXTER$$$$$F$Y$$$20240705$$HP$GB$GB
240561906$24056190$6$F$20240624$20240910$20240705$20240918$EXP$$AE-TAKEDA-2024TUS066507$TAKEDA$$$$$$Y$$$20240918$$HP$AE$AE
240561911$24056191$1$I$$20240702$20240705$20240705$PER$$US-ABBVIE-5827053$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240561921$24056192$1$I$$20240627$20240705$20240705$EXP$$IL-TEVA-VS-3216701$TEVA$$33$YR$$M$Y$$$20240705$$MD$IL$IL
240561931$24056193$1$I$$20240626$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR081223$VIIV$$$$$M$Y$89$KG$20240705$$CN$US$US
240561943$24056194$3$F$20240401$20240913$20240705$20240920$EXP$$BR-GSK-BR2024AMR081375$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$MD$BR$BR
240561951$24056195$1$I$20220101$20240630$20240705$20240705$EXP$$PT-009507513-2407PRT001707$MERCK$$70$YR$$M$Y$$$20240705$$MD$PT$PT
240561961$24056196$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824634$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240561971$24056197$1$I$$20240629$20240705$20240705$EXP$$US-GSK-US2024AMR081797$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$MD$US$US
240561981$24056198$1$I$$20240628$20240705$20240705$PER$$US-TEVA-VS-3214160$TEVA$$$$$F$Y$$$20240705$$CN$US$US
240561992$24056199$2$F$$20240628$20240705$20240805$EXP$$US-AstraZeneca-2024A150026$ASTRAZENECA$$$$$F$Y$72$KG$20240805$$CN$US$
240562002$24056200$2$F$20230412$20240730$20240705$20240807$EXP$$JP-AstraZeneca-2024A112840$ASTRAZENECA$$81$YR$$F$Y$$$20240807$$PH$JP$
240562011$24056201$1$I$20240626$20240701$20240705$20240705$EXP$$US-AstraZeneca-2024A151073$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240562022$24056202$2$F$20240601$20240828$20240705$20240905$EXP$$JP-AstraZeneca-2024A151788$ASTRAZENECA$$$$E$F$Y$$$20240905$$MD$JP$
240562032$24056203$2$F$20240214$20240719$20240705$20240726$EXP$$US-TAKEDA-2024TUS064764$TAKEDA$$$$C$F$Y$$$20240726$$MD$US$US
240562041$24056204$1$I$20240501$20240702$20240705$20240705$PER$$US-ABBVIE-5827125$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240562051$24056205$1$I$$20240624$20240705$20240705$PER$$US-ELI_LILLY_AND_COMPANY-US202406016461$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240705$$CN$US$US
240562061$24056206$1$I$$20231208$20240705$20240705$PER$$US-ABBVIE-5829530$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240562071$24056207$1$I$20220101$20240624$20240705$20240705$EXP$$US-JNJFOC-20240668966$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$HP$US$US
240562081$24056208$1$I$20240701$20240701$20240705$20240705$EXP$$US-OTSUKA-2024_018822$OTSUKA$$$$$$Y$$$20240705$$CN$US$US
240562101$24056210$1$I$20231107$20240702$20240705$20240705$EXP$$NVSC2023DE246397$NOVARTIS$$$$A$F$Y$69$KG$20240705$$MD$DE$DE
240562113$24056211$3$F$20240317$20240725$20240705$20240729$EXP$$IT-ROCHE-10000017721$ROCHE$$36$YR$A$F$Y$$$20240729$$MD$IT$IT
240562121$24056212$1$I$$20240702$20240705$20240705$PER$$US-DSJP-DSU-2024-130694$DAIICHI$$$$$F$Y$$$20240705$$MD$US$US
240562131$24056213$1$I$$20231127$20240705$20240705$PER$$US-ABBVIE-5829390$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240562142$24056214$2$F$20240101$20240729$20240705$20240731$PER$$US-AMGEN-USASP2024131077$AMGEN$$36$YR$A$F$Y$$$20240731$$HP$US$US
240562151$24056215$1$I$$20240506$20240705$20240705$PER$$US-AMGEN-USASP2024133427$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240562161$24056216$1$I$$20240628$20240704$20240704$DIR$FDA-CDER-CTU-2024-46719$$FDA-CTU$$$$$M$N$$$20240628$N$HP$US$
240562171$24056217$1$I$$20240626$20240704$20240704$DIR$FDA-CDER-CTU-2024-46711$$FDA-CTU$$$$$F$N$$$20240626$N$HP$US$
240562181$24056218$1$I$$20240703$20240704$20240704$DIR$FDA-CDER-CTU-2024-46646$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240562201$24056220$1$I$$20240628$20240704$20240704$DIR$FDA-CDER-CTU-2024-46714$$FDA-CTU$$$$$M$N$$$20240628$N$HP$US$
240562211$24056221$1$I$$20240628$20240704$20240704$DIR$FDA-CDER-CTU-2024-46651$$FDA-CTU$$$$$F$N$$$20240628$N$HP$US$
240562221$24056222$1$I$$20240703$20240704$20240704$DIR$FDA-CDER-CTU-2024-46644$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240562231$24056223$1$I$$20240704$20240704$20240704$DIR$FDA-CDER-CTU-2024-46725$$FDA-CTU$$71$YR$$M$N$$$20240704$N$CN$US$
240562261$24056226$1$I$20240625$20240702$20240705$20240705$EXP$$CN-PURDUE-USA-2024-0310618$PURDUE$$60$YR$$M$Y$63$KG$20240705$$HP$CN$CN
240562281$24056228$1$I$20240101$20240627$20240705$20240705$EXP$$JP-009507513-2406JPN003976J$MERCK$$60$YR$$F$Y$$$20240705$$MD$JP$JP
240562291$24056229$1$I$$20240701$20240705$20240705$EXP$$FR-REGENERON PHARMACEUTICALS, INC.-2024-093895$REGENERON$$70$YR$$F$Y$$$20240705$$HP$FR$FR
240562301$24056230$1$I$$20240624$20240705$20240705$EXP$$US-RDY-LIT/USA/24/0009434$DR REDDYS$Lord ML, Rana D, Hossain S, Chang C, Palli V. A Fatal Case of Lyme Myocarditis With Babesia Co-infection. American Journal of Respiratory and Critical Care Medicine. 2024;209:$79$YR$E$F$Y$$$20240705$$HP$US$US
240562311$24056231$1$I$20231201$20240627$20240705$20240705$EXP$$US-ASTELLAS-2024US018611$ASTELLAS$$56$YR$$F$Y$$$20240705$$HP$US$US
240562321$24056232$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5826272$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240562331$24056233$1$I$20240415$20240627$20240705$20240705$EXP$FR-AFSSAPS-PO2024000691$FR-TEVA-VS-3215721$TEVA$$98$YR$$M$Y$55$KG$20240705$$MD$FR$FR
240562342$24056234$2$F$$20240702$20240705$20240902$PER$$US-ASTELLAS-2024US018815$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
240562353$24056235$3$F$20240101$20240726$20240705$20240902$PER$$US-ASTELLAS-2024US018816$ASTELLAS$$52$YR$A$F$Y$$$20240830$$MD$US$US
240562362$24056236$2$F$20240701$20240718$20240705$20240723$EXP$$SE-ABBVIE-5826075$ABBVIE$$72$YR$$M$Y$$$20240723$$HP$SE$SE
240562372$24056237$2$F$20240101$20240917$20240705$20240926$EXP$$NL-ABBVIE-5826205$ABBVIE$$71$YR$$M$Y$$$20240926$$MD$NL$NL
240562381$24056238$1$I$$20240627$20240705$20240705$EXP$$VN-AstraZeneca-2024A150057$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$VN$
240562391$24056239$1$I$$20240627$20240705$20240705$EXP$$US-AstraZeneca-2024A149557$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240562401$24056240$1$I$$20240627$20240705$20240705$EXP$$IT-AstraZeneca-2024A154210$ASTRAZENECA$Ahcene-Djaballah S, Iachini I, Napetti D, Roma A, Lonardi S. TRUST THE SYMPTOMS: CASE REPORT OF MEDICATION-RELATED OSTEONECROSIS OF THE JAW DURING TREATMENT WITH ZOLEDRONATE AND OSIMERTINIB. 2024 Congress on Osteonecrosis of the Jaw Bones Due to Biphosphonates and Other Drugs: Prevention, Diagnosis, Pharmacovigilance - Italian Society of Pathology and Oral Medicine (SIPMO) 2024;$73$YR$$F$Y$$$20240705$$HP$IT$
240562411$24056241$1$I$20240601$20240703$20240704$20240704$DIR$FDA-CDER-CTU-2024-46642$$FDA-CTU$$43$YR$$F$N$$$20240703$N$HP$US$
240562421$24056242$1$I$20231101$20240704$20240705$20240705$EXP$GB-MHRA-MED-202407041053066220-FWYTH$GB-ORGANON-O2407GBR000484$ORGANON$$41$YR$$M$Y$65$KG$20240705$$CN$GB$GB
240562441$24056244$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214922$TEVA$$$$$$Y$$$20240705$$MD$CA$CA
240562451$24056245$1$I$20240401$20240701$20240705$20240705$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2024-065906$REGENERON$$$$$M$Y$$$20240705$$MD$GB$GB
240562461$24056246$1$I$20240229$20240626$20240705$20240705$EXP$BE-FAMHP-DHH-N2024-122275$BE-TEVA-VS-3215010$TEVA$$$$E$M$Y$56$KG$20240705$$MD$BE$BE
240562471$24056247$1$I$$20240415$20240705$20240705$PER$$US-AMGEN-USASP2024129831$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240562481$24056248$1$I$$20240506$20240705$20240705$PER$$US-AMGEN-USASP2024133667$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240562511$24056251$1$I$$20240702$20240704$20240704$DIR$FDA-CDER-CTU-2024-46645$$FDA-CTU$$$$$M$N$$$20240702$N$HP$US$
240562521$24056252$1$I$$20240506$20240705$20240705$PER$$US-AMGEN-USASP2024133669$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240562532$24056253$2$F$$20240710$20240705$20240713$PER$$US-AMGEN-USASP2024132166$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240562541$24056254$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214712$TEVA$$27$YR$$M$Y$$$20240705$$HP$CA$CA
240562551$24056255$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214793$TEVA$$74$YR$$F$Y$$$20240705$$MD$CA$CA
240562561$24056256$1$I$20240610$20240701$20240705$20240705$EXP$$US-ASTELLAS-2024US018849$ASTELLAS$$68$YR$$M$Y$$$20240705$$CN$US$US
240562571$24056257$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214732$TEVA$$70$YR$$F$Y$$$20240705$$HP$CA$CA
240562591$24056259$1$I$$20240705$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107559$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240705$$CN$US$US
240562601$24056260$1$I$$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106609$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240705$$CN$US$US
240562611$24056261$1$I$20240529$20240627$20240705$20240705$EXP$$NVSC2024US137734$NOVARTIS$$80$YR$$F$Y$45$KG$20240705$$PH$US$US
240562621$24056262$1$I$$20240703$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US063018$SANDOZ$$$$$$Y$$$20240705$$CN$US$US
240562631$24056263$1$I$$20240702$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062665$SANDOZ$$65$YR$$M$Y$$$20240705$$MD$US$US
240562641$24056264$1$I$20240614$20240704$20240705$20240705$EXP$GB-MHRA-TPP8438156C9935529YC1720027423126$GB-SANDOZ INC.-SDZ2024GB062957$SANDOZ$$57$YR$$F$Y$65$KG$20240705$$MD$GB$GB
240562661$24056266$1$I$$20240703$20240704$20240704$DIR$FDA-CDER-CTU-2024-46643$$FDA-CTU$$$$$M$N$$$20240703$N$HP$US$
240562671$24056267$1$I$$20240625$20240705$20240705$EXP$$CA-SANDOZ INC.-SDZ2024CA062676$SANDOZ$$44$YR$$F$Y$97$KG$20240705$$HP$CA$CA
240562681$24056268$1$I$20240607$20240701$20240704$20240704$DIR$FDA-CDER-CTU-2024-46716$$FDA-CTU$$75$YR$$F$N$$$20240701$N$HP$US$
240562701$24056270$1$I$$20240625$20240704$20240704$DIR$FDA-CDER-CTU-2024-46649$$FDA-CTU$$$$$M$N$$$20240625$N$HP$US$
240562711$24056271$1$I$$20240701$20240704$20240704$DIR$FDA-CDER-CTU-2024-46634$$FDA-CTU$$$$$M$N$$$20240701$N$HP$US$
240562721$24056272$1$I$$20240617$20240704$20240704$DIR$FDA-CDER-CTU-2024-46704$$FDA-CTU$$$$$F$N$$$20240617$N$HP$US$
240562741$24056274$1$I$$20240109$20240705$20240705$PER$$US-ABBVIE-5829378$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240562751$24056275$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5825692$ABBVIE$$42$YR$$F$Y$$$20240705$$HP$US$US
240562761$24056276$1$I$$20240701$20240705$20240705$EXP$$DE-SANDOZ INC.-SDZ2024DE062913$SANDOZ$$82$YR$$M$Y$$$20240705$$CN$DE$DE
240562773$24056277$3$F$20240223$20240814$20240705$20240820$EXP$$CL-SANDOZ INC.-SDZ2024CL062909$SANDOZ$$$$$M$Y$$$20240820$$PH$CL$CL
240562781$24056278$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA193658$SANOFI AVENTIS$$$$$F$Y$$$20240705$$MD$US$US
240562791$24056279$1$I$$20240705$20240705$20240705$EXP$$DE-SANDOZ INC.-SDZ2024DE062994$SANDOZ$$$$$F$Y$$$20240705$$HP$DE$DE
240562801$24056280$1$I$$20240625$20240705$20240705$EXP$$BA-BAYER-2024A093729$BAYER$$62$YR$A$M$Y$$$20240705$$MD$BA$BA
240562811$24056281$1$I$$20240516$20240705$20240705$PER$$US-AMGEN-USASP2024132770$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240562833$24056283$3$F$20240101$20240722$20240705$20240724$EXP$FR-AFSSAPS-AN2024000833$FR-OTSUKA-2024_018634$OTSUKA$$54$YR$$M$Y$80$KG$20240724$$PH$FR$FR
240562841$24056284$1$I$$20231220$20240705$20240705$PER$$US-ABBVIE-5829595$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240562851$24056285$1$I$$20240701$20240705$20240705$EXP$$US-ASTELLAS-2024US018413$ASTELLAS$$$$$M$Y$$$20240705$$CN$US$US
240562861$24056286$1$I$$20240701$20240705$20240705$EXP$$US-ASTELLAS-2024US015264$ASTELLAS$$$$$F$Y$$$20240705$$MD$US$US
240562871$24056287$1$I$$20240704$20240705$20240705$EXP$GB-MHRA-MED-202405021803196890-NFPBC$GB-TEVA-VS-3217252$TEVA$$$$$$Y$44$KG$20240705$$CN$GB$GB
240562881$24056288$1$I$$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017861$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240705$$CN$US$US
240562891$24056289$1$I$20240611$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017547$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240705$$CN$US$US
240562901$24056290$1$I$20240605$20240627$20240705$20240705$EXP$ES-AEMPS-1537602$ES-TEVA-VS-3215415$TEVA$$63$YR$$F$Y$$$20240705$$MD$ES$ES
240562912$24056291$2$F$$20240716$20240705$20240719$EXP$$US-OTSUKA-2024_016466$OTSUKA$$$$$M$Y$92.08$KG$20240719$$MD$US$US
240562921$24056292$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193612$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240705$$MD$US$US
240562931$24056293$1$I$$20231104$20240705$20240705$PER$$US-ABBVIE-5829788$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240562941$24056294$1$I$$20240704$20240705$20240705$EXP$GB-MHRA-MED-202407041136045490-HKLQD$GB-ORGANON-O2407GBR000486$ORGANON$$$$$M$Y$70$KG$20240705$$CN$GB$GB
240562952$24056295$2$F$20240501$20240725$20240705$20240808$PER$$US-009507513-2406USA002908$MERCK$$32$YR$$M$Y$145$KG$20240808$$CN$US$US
240562961$24056296$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A150062$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$US$
240562971$24056297$1$I$$20240628$20240705$20240705$PER$$US-AstraZeneca-2024A150644$ASTRAZENECA$$$$$F$Y$$$20240705$$HP$US$
240562981$24056298$1$I$$20240628$20240705$20240705$EXP$$GR-AstraZeneca-2024A153938$ASTRAZENECA$NOT REPORTED. NOT REPORTED. NOT REPORTED$70$YR$$F$Y$$$20240705$$HP$GR$
240562991$24056299$1$I$$20240627$20240705$20240705$EXP$$ZA-AstraZeneca-2024A149846$ASTRAZENECA$$77$YR$$F$Y$$$20240705$$CN$ZA$
240563001$24056300$1$I$20240516$20240628$20240705$20240705$EXP$$CN-AstraZeneca-2024A152778$ASTRAZENECA$$18197$DY$$F$Y$55$KG$20240705$$MD$CN$
240563011$24056301$1$I$$20240629$20240705$20240705$EXP$$CA-AstraZeneca-2024A151902$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$CA$
240563021$24056302$1$I$$20240704$20240705$20240705$EXP$$AU-AstraZeneca-2024A154063$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$AU$
240563031$24056303$1$I$$20240628$20240705$20240705$EXP$$ZA-AstraZeneca-2024A151194$ASTRAZENECA$$66$YR$$F$Y$$$20240705$$CN$ZA$
240563051$24056305$1$I$$20240704$20240705$20240705$PER$$US-HALEON-2185530$Haleon PLC$$$$$$Y$$$20240705$$CN$US$US
240563061$24056306$1$I$$20240701$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107165$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$95.07$KG$20240705$$PH$US$US
240563071$24056307$1$I$$20240626$20240705$20240705$PER$$US-JNJFOC-20240670939$JOHNSON AND JOHNSON$$$$$M$Y$$$20240705$$CN$US$US
240563081$24056308$1$I$20240612$20240621$20240705$20240705$PER$$US-Eisai-EC-2024-168884$EISAI$$86$YR$E$M$Y$$$20240705$$CN$US$US
240563091$24056309$1$I$$20240618$20240705$20240705$EXP$$US-UROVANT SCIENCES GMBH-202406-URV-000919$UROVANT SCIENCES$$$$$F$Y$$$20240705$$HP$US$US
240563101$24056310$1$I$20240625$20240628$20240705$20240705$PER$$US-BAYER-2024A095150$BAYER$$45$YR$A$F$Y$$$20240705$$CN$US$US
240563121$24056312$1$I$$20240625$20240705$20240705$EXP$$PL-TEVA-VS-3215110$TEVA$$46$YR$$F$Y$$$20240705$$HP$PL$PL
240563131$24056313$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193745$SANOFI AVENTIS$$$$E$F$Y$$$20240705$$HP$US$US
240563141$24056314$1$I$$20240701$20240705$20240705$PER$$US-SA-2024SA197341$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240705$$HP$US$US
240563152$24056315$2$F$$20240704$20240705$20240729$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037860$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240729$$HP$DE$DE
240563161$24056316$1$I$$20240627$20240705$20240705$EXP$$JP-009507513-2406JPN004240J$MERCK$Kawabata M, Nagano H, Ohori J, Yamashita M. P-128 Investigation of recurrent and metastatic head and neck cancer cases which treated with pembrolizumab. Japanese Journal of  Head and Neck Cancer The 47th Annual Meeting of Japan Socie. 2023;49(2):229$71$YR$$M$Y$$$20240705$$MD$JP$JP
240563171$24056317$1$I$20230210$20240627$20240705$20240705$EXP$FR-AFSSAPS-MA2024001069$FR-TEVA-VS-3215699$TEVA$$51$YR$$F$Y$100$KG$20240705$$CN$FR$FR
240563181$24056318$1$I$$20240626$20240705$20240705$EXP$$BR-NALPROPION PHARMACEUTICALS INC.-BR-2024CUR003230$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$BR$BR
240563191$24056319$1$I$$20240705$20240705$20240705$EXP$GB-MHRA-MED-202405091129453300-NFQDJ$GB-ORGANON-O2407GBR000604$ORGANON$$$$$$Y$$$20240705$$HP$GB$GB
240563211$24056321$1$I$$20240702$20240705$20240705$EXP$$US-OTSUKA-2024_018833$OTSUKA$$$$$F$Y$$$20240705$$CN$US$US
240563222$24056322$2$F$20240621$20240705$20240705$20240715$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024079893$VIIV$$22$YR$$M$Y$$$20240715$$HP$US$US
240563231$24056323$1$I$$20240701$20240705$20240705$EXP$$US-GSK-US2024AMR082492$GLAXOSMITHKLINE$$$$$$Y$$$20240705$$CN$US$US
240563241$24056324$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214824$TEVA$$69$YR$$M$Y$$$20240705$$HP$CA$CA
240563251$24056325$1$I$20240510$20240626$20240705$20240705$EXP$FR-AFSSAPS-TO2024000922$FR-TEVA-VS-3214869$TEVA$$67$YR$$F$Y$$$20240705$$MD$FR$FR
240563271$24056327$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214617$TEVA$$78$YR$$M$Y$$$20240705$$MD$CA$CA
240563281$24056328$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5825710$ABBVIE$$26$YR$$F$Y$$$20240705$$HP$US$US
240563291$24056329$1$I$20240513$20240628$20240705$20240705$EXP$$GB-TEVA-VS-3215802$TEVA$$63$YR$$F$Y$83$KG$20240705$$CN$GB$GB
240563301$24056330$1$I$20100101$20240705$20240705$20240705$EXP$GB-MHRA-MED-202405011158072330-YRBMF$GB-ORGANON-O2407GBR000533$ORGANON$$$$$$Y$$$20240705$$CN$GB$GB
240563311$24056331$1$I$$20240620$20240705$20240705$PER$$US-EMERGENT BIOSOLUTIONS,-24000086$EMERGENT BIOSOLUTIONS$Arjun S, Kang J, Otero J, Tsai J, Iqbal J. Whippet Too Hard: Nitrous Inhalant Abuse Leading to Acute Lung Injury. Am J Respir Crit Care Med. 2024;209:A2035$22$YR$$F$Y$$$20240705$$HP$US$US
240563321$24056332$1$I$$20240705$20240705$20240705$PER$$US-JNJFOC-20240714882$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240563331$24056333$1$I$$20240702$20240705$20240705$PER$$US-JNJFOC-20240705874$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$CN$US$US
240563341$24056334$1$I$20240120$20240627$20240705$20240705$EXP$FR-AFSSAPS-TO2024000180$FR-TEVA-VS-3215401$TEVA$$50$YR$$F$Y$70$KG$20240705$$CN$FR$FR
240563361$24056336$1$I$$20240627$20240705$20240705$PER$$US-ALXN-202406USA001971US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240563371$24056337$1$I$$20231105$20240705$20240705$PER$$US-ABBVIE-5827499$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240563381$24056338$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5825764$ABBVIE$$30$YR$$F$Y$$$20240705$$HP$US$US
240563391$24056339$1$I$$20240701$20240705$20240705$PER$$US-BIOGEN-2024BI01272232$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
240563401$24056340$1$I$$20240701$20240705$20240705$PER$$US-BIOGEN-2024BI01269987$BIOGEN$$$$$F$Y$$$20240705$$CN$US$US
240563412$24056341$2$F$$20240913$20240705$20240920$EXP$$JP-009507513-2407JPN000194J$MERCK$Ogino Y, Nagumo H, Yoshimine N, Mukozu T, Matsui T, Wakui N, et al.. 14. Review of Immune-related Adverse Event (immune-related Adverse Event: irAE) in which Liver Stiffness could be Measured Over Time by Abdominal Ultrasound. The 37th Japanese Association of Contrast-Enhanced Ultrasound and Doppler Abdomi. 34$7$DEC$$F$Y$$$20240920$$MD$JP$JP
240563421$24056342$1$I$20240623$20240628$20240705$20240705$EXP$$GB-AstraZeneca-2024A149681$ASTRAZENECA$$80$YR$$M$Y$$$20240705$$MD$GB$
240563431$24056343$1$I$$20240628$20240705$20240705$PER$$US-JNJFOC-20240677347$JOHNSON AND JOHNSON$$80$YR$E$F$Y$55.8$KG$20240705$$CN$US$US
240563442$24056344$2$F$20240101$20240726$20240705$20240801$PER$$US-BIOGEN-2024BI01249430$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
240563451$24056345$1$I$$20240624$20240705$20240705$EXP$$US-RDY-LIT/USA/24/0009463$DR REDDYS$Poondru S, Joseph A, Harding JC, Sundaramoorthi H, Shah NM, Green P, et al. Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy. Case Reports in Oncology. 2022;15(3): 918-926. doi:10.1159/000525174.$51$YR$A$F$Y$$$20240705$$HP$US$US
240563461$24056346$1$I$20240527$20240626$20240705$20240705$EXP$FR-AFSSAPS-MA2024001063$FR-TEVA-VS-3215086$TEVA$$43$YR$$M$Y$$$20240705$$MD$FR$FR
240563471$24056347$1$I$$20240704$20240705$20240705$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107444$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240705$$PH$CA$CA
240563481$24056348$1$I$$20240620$20240705$20240705$PER$$US-EMERGENT BIOSOLUTIONS,-24000087$EMERGENT BIOSOLUTIONS$Bangash H, Marwat A, Mahmoud A, Le C. A Case of Non-cardiogenic Pulmonary Edema Secondary to Fentanyl Overdose. Am J Respir Crit Care Med. 2024;209:A2036$33$YR$$M$Y$$$20240705$$HP$US$US
240563491$24056349$1$I$$20240620$20240705$20240705$PER$$US-EMERGENT BIOSOLUTIONS,-24000088$EMERGENT BIOSOLUTIONS$Nasir S, Sedghian M, Khan Z, Roberge MR. IVDU, I Can^t Hear You: Sudden Hearing Loss After Fentanyl Use. Am J Respir Crit Care Med. 2024;209:A2132$36$YR$$M$Y$$$20240705$$HP$US$US
240563513$24056351$3$F$20240601$20240708$20240705$20240715$EXP$$US-GSK-US2024GSK082710$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$US$US
240563521$24056352$1$I$$20240122$20240705$20240705$EXP$$US-ABBVIE-5829571$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240563531$24056353$1$I$$20240704$20240705$20240705$EXP$GB-MHRA-MED-202407041350123850-LJDQC$GB-ORGANON-O2407GBR000563$ORGANON$$$$$F$Y$66$KG$20240705$$CN$GB$GB
240563541$24056354$1$I$$20231215$20240705$20240705$PER$$US-ABBVIE-5829439$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240563551$24056355$1$I$20240628$20240702$20240705$20240705$PER$$US-ABBVIE-5827018$ABBVIE$$20$YR$$F$Y$$$20240705$$CN$US$US
240563562$24056356$2$F$20220517$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS066221$TAKEDA$$36$YR$$M$Y$$$20240709$$HP$CN$CN
240563571$24056357$1$I$20221213$20240627$20240705$20240705$EXP$$CN-TAKEDA-2024TUS066891$TAKEDA$$33$YR$$M$Y$$$20240705$$HP$CN$CN
240563582$24056358$2$F$20240527$20240628$20240705$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-093021$BRISTOL MYERS SQUIBB$$8$DEC$E$$Y$$$20240711$$MD$JP$JP
240563601$24056360$1$I$$20240628$20240705$20240705$PER$$US-ALXN-202406USA001953US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240563611$24056361$1$I$$20240619$20240705$20240705$EXP$$US-CBFLEET-202406-US-002083$CB FLEET$Razia D, Khokar A, Saeed A. A Flurry of Pulmonary Nodules: Recurrent Metastatic Pancreatic Cancer, or Just Mineral Oil?. Am J Respir Crit Care Med.. 2024 May 20;$77$YR$E$M$Y$$$20240705$$MD$US$US
240563621$24056362$1$I$20240601$20240626$20240705$20240705$PER$$US-Eisai-EC-2024-168927$EISAI$$61$YR$A$F$Y$$$20240705$$CN$US$US
240563632$24056363$2$F$$20240815$20240705$20240821$EXP$$US-Taiho Oncology Inc-2024-006571$TAIHO ONCOLOGY INC$$84$YR$E$M$Y$$$20240821$$PH$US$US
240563641$24056364$1$I$20240618$20240624$20240705$20240705$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024078540$VIIV$$40$YR$$M$Y$$$20240705$$HP$US$US
240563651$24056365$1$I$$20240614$20240705$20240705$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06077$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240705$$HP$US$US
240563661$24056366$1$I$$20240626$20240705$20240705$PER$$US-SA-2024SA193596$SANOFI AVENTIS$$$$A$M$Y$$$20240705$$MD$US$US
240563671$24056367$1$I$20220701$20240626$20240705$20240705$PER$$US-SA-2024SA192244$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240705$$CN$US$US
240563681$24056368$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5824637$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240563691$24056369$1$I$$20240626$20240705$20240705$EXP$$CN-BEIGENE-BGN-2024-010003$BEIGENE$Xingmei Xie. Tislelizumab induced immune-related pancreatitis in the treatment of advanced non-small cell lung cancer: a case report. Central South Pharmacy. 2024$$$$$Y$$$20240705$$PH$CN$CN
240563702$24056370$2$F$$20240911$20240705$20240919$EXP$$NVSC2024CA120434$NOVARTIS$$47$YR$$F$Y$$$20240919$$CN$CA$CA
240563712$24056371$2$F$20230228$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS066222$TAKEDA$$32$YR$$M$Y$$$20240709$$HP$CN$CN
240563722$24056372$2$F$20240601$20240822$20240705$20240823$PER$$US-Millicent Holdings Ltd.-MILL20241008$MILLICENT HOLDINGS$$47$YR$A$F$Y$$$20240823$$CN$US$US
240563731$24056373$1$I$20220902$20240627$20240705$20240705$EXP$$CN-TAKEDA-2024TUS066909$TAKEDA$$40$YR$$M$Y$$$20240705$$HP$CN$CN
240563741$24056374$1$I$20230901$20240703$20240705$20240705$EXP$$AR-ABBVIE-5826133$ABBVIE$$73$YR$$F$Y$$$20240705$$CN$AR$AR
240563751$24056375$1$I$$20240111$20240705$20240705$PER$$US-ABBVIE-5828953$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240563761$24056376$1$I$$20240702$20240705$20240705$PER$$NVSC2024US139728$NOVARTIS$$$$$M$Y$$$20240705$$CN$US$US
240563772$24056377$2$F$20230101$20240715$20240705$20240723$EXP$$US-SMPA-2024SPA000095$SUNOVION$$$$$$Y$$$20240723$$CN$US$US
240563782$24056378$2$F$20240101$20240702$20240705$20240709$EXP$$CA-ABBVIE-5823196$ABBVIE$$32$YR$$F$Y$$$20240709$$CN$CA$CA
240563791$24056379$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5826435$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240563801$24056380$1$I$20240624$20240628$20240705$20240705$EXP$$CN-TEVA-VS-3216373$TEVA$$51$YR$$M$Y$62$KG$20240705$$CN$CN$CN
240563811$24056381$1$I$$20240625$20240705$20240705$EXP$$US-ASCENT-2024ASLIT00009$ASCENT$Barnett BS, Koons CJ, Van den Eynde V, Gillman PK, Bodkin JA.Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine.JOURNAL OF PSYCHOACTIVE DRUGS.21-jun-2024;1-7$42$YR$A$M$Y$$$20240705$$HP$US$US
240563821$24056382$1$I$20240101$20240701$20240705$20240705$EXP$$US-ABBVIE-5825014$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240563831$24056383$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA193172$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240705$$PH$US$US
240563841$24056384$1$I$$20240621$20240705$20240705$PER$$US-SA-2024SA191255$SANOFI AVENTIS$$$$A$M$Y$132$KG$20240705$$MD$US$US
240563851$24056385$1$I$20221229$20240627$20240705$20240705$EXP$$CN-TAKEDA-2024TUS067419$TAKEDA$$39$YR$$M$Y$$$20240705$$HP$CN$CN
240563862$24056386$2$F$20220822$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS067002$TAKEDA$$29$YR$$M$Y$$$20240709$$HP$CN$CN
240563871$24056387$1$I$20221216$20240627$20240705$20240705$EXP$$CN-TAKEDA-2024TUS067394$TAKEDA$$29$YR$$M$Y$$$20240705$$HP$CN$CN
240563881$24056388$1$I$20211103$20240703$20240705$20240705$EXP$$CA-TAKEDA-2020TUS029043$TAKEDA$$67$YR$$M$Y$$$20240705$$CN$CA$CA
240563891$24056389$1$I$$20240628$20240705$20240705$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006175$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240705$$HP$US$US
240563903$24056390$3$F$$20240827$20240705$20240828$EXP$$NVSC2024US101281$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
240563912$24056391$2$F$20240601$20240816$20240705$20240826$EXP$DE-CADRBFARM-2024328767$DE-TEVA-VS-3215418$TEVA$$61$YR$$M$Y$89$KG$20240826$$CN$DE$DE
240563921$24056392$1$I$20210415$20240626$20240705$20240705$EXP$FR-AFSSAPS-AVCN2024000458$FR-TEVA-VS-3215122$TEVA$$26$YR$$F$Y$$$20240705$$MD$FR$FR
240563931$24056393$1$I$20240613$20240625$20240705$20240705$PER$$US-Eisai-EC-2024-168953$EISAI$$$$$$Y$$$20240705$$MD$US$US
240563941$24056394$1$I$20240601$20240626$20240705$20240705$PER$$US-SA-2024SA193398$SANOFI AVENTIS$$60$YR$A$F$Y$95.7$KG$20240705$$MD$US$US
240563951$24056395$1$I$20240113$20240701$20240705$20240705$EXP$GB-MHRA-MED-202406301130511070-FLYHN$GB-RDY-SPO/GBR/24/0009703$DR REDDYS$$24$YR$A$M$Y$$$20240705$$CN$GB$GB
240563961$24056396$1$I$20190101$20240627$20240705$20240705$EXP$FR-AFSSAPS-NT2024000686$FR-TEVA-VS-3215722$TEVA$$58$YR$$F$Y$45$KG$20240705$$PH$FR$FR
240563971$24056397$1$I$$20240702$20240705$20240705$PER$$US-ABBVIE-5826960$ABBVIE$$18$YR$$M$Y$$$20240705$$MD$US$US
240563983$24056398$3$F$20211101$20240829$20240705$20240909$EXP$$JP-TAKEDA-2024TUS067829$TAKEDA$$36$YR$$M$Y$$$20240909$$MD$JP$JP
240563991$24056399$1$I$$20240627$20240705$20240705$EXP$$CA-AstraZeneca-2024A149253$ASTRAZENECA$$$$$M$Y$$$20240705$$CN$CA$
240564002$24056400$2$F$20230604$20240719$20240705$20240726$EXP$$JP-AstraZeneca-2024A127275$ASTRAZENECA$$76$YR$$F$Y$51$KG$20240726$$MD$JP$
240564012$24056401$2$F$$20240708$20240705$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002782$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
240564021$24056402$1$I$20240611$20240627$20240705$20240705$EXP$IT-MINISAL02-991376$IT-TEVA-VS-3215484$TEVA$$54$YR$$F$Y$$$20240705$$MD$IT$IT
240564031$24056403$1$I$$20240701$20240705$20240705$EXP$$RO-AMGEN-ROUSP2024130745$AMGEN$Gombar A.; Burz C.. MAKE A LONG STORY SHORT- IMPORTANCE OF GENETIC TESTING IN DIAGNOSIS OF LYNCH SYNDROME - A CASE REPORT. Acta Medica Marisiensis. 2024;70 (3):241$55$YR$A$M$Y$$$20240705$$HP$RO$RO
240564041$24056404$1$I$20221221$20240627$20240705$20240705$EXP$$CN-TAKEDA-2024TUS067392$TAKEDA$$54$YR$$M$Y$$$20240705$$HP$CN$CN
240564051$24056405$1$I$20221010$20240627$20240705$20240705$EXP$$CN-TAKEDA-2024TUS067400$TAKEDA$$35$YR$$M$Y$$$20240705$$HP$CN$CN
240564062$24056406$2$F$20220308$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS066992$TAKEDA$$31$YR$$M$Y$$$20240709$$HP$CN$CN
240564071$24056407$1$I$20240228$20240627$20240705$20240705$EXP$IT-MINISAL02-991348$IT-TEVA-VS-3215710$TEVA$$62$YR$$F$Y$$$20240705$$MD$IT$IT
240564081$24056408$1$I$$20240524$20240705$20240705$PER$$US-ASCENT-2024ASSPO00001$ASCENT$$78$YR$E$M$Y$170$KG$20240705$$CN$US$US
240564091$24056409$1$I$$20240111$20240705$20240705$PER$$US-ABBVIE-5829540$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240564101$24056410$1$I$20240402$20240703$20240705$20240705$EXP$$ES-009507513-2407ESP002717$MERCK$$77$YR$$M$Y$$$20240705$$MD$ES$ES
240564111$24056411$1$I$$20240627$20240705$20240705$EXP$$NVSC2024PT137527$NOVARTIS$$$$$$Y$$$20240705$$HP$PT$PT
240564121$24056412$1$I$$20240701$20240705$20240705$EXP$$US-ZENPEP LLC-2024AIMT01042$AIMMUNE$$$$$$Y$$$20240705$$CN$US$US
240564131$24056413$1$I$$20240705$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107620$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240705$$CN$US$US
240564141$24056414$1$I$$20240624$20240705$20240705$PER$$US-Eisai-EC-2024-168976$EISAI$$$$$$Y$$$20240705$$HP$US$US
240564151$24056415$1$I$20240617$20240627$20240705$20240705$PER$$US-Eisai-EC-2024-169040$EISAI$$81$YR$E$F$Y$$$20240705$$CN$US$US
240564161$24056416$1$I$$20240627$20240705$20240705$PER$$US-Eisai-EC-2024-169043$EISAI$$85$YR$E$M$Y$$$20240705$$CN$US$US
240564171$24056417$1$I$$20240624$20240705$20240705$PER$$US-Eisai-EC-2024-168977$EISAI$$$$$M$Y$$$20240705$$HP$US$US
240564182$24056418$2$F$20240614$20240730$20240705$20240826$PER$$US-Eisai-EC-2024-168995$EISAI$$$$$M$Y$$$20240826$$MD$US$US
240564191$24056419$1$I$20240101$20240702$20240705$20240705$EXP$$US-ABBVIE-5827393$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240564201$24056420$1$I$$20240625$20240705$20240705$EXP$$US-JNJFOC-20240671810$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$PH$US$US
240564211$24056421$1$I$$20240705$20240705$20240705$EXP$GB-MHRA-MED-202405131112288600-JVYZS$GB-ABBVIE-5828874$ABBVIE$$$$$M$Y$72$KG$20240705$$MD$GB$GB
240564221$24056422$1$I$$20240627$20240705$20240705$PER$$US-SA-2024SA192562$SANOFI AVENTIS$$98$YR$E$M$Y$$$20240705$$CN$US$US
240564231$24056423$1$I$$20240624$20240705$20240705$EXP$$US-RDY-LIT/USA/24/0009483$DR REDDYS$Kanack AJ, Schaefer JK, Sridharan M, Splinter NP, Kohlhagen MC, Singh B, et al. Monoclonal gammopathy of thrombotic/thrombocytopenic significance. Blood. 2023;141(14): 1772-1776.$64$YR$A$M$Y$$$20240705$$HP$US$US
240564242$24056424$2$F$$20240910$20240705$20240914$EXP$$US-ABBVIE-5825031$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
240564251$24056425$1$I$20240101$20240702$20240705$20240705$EXP$$FR-ABBVIE-5827631$ABBVIE$$67$YR$$F$Y$$$20240705$$CN$FR$FR
240564262$24056426$2$F$$20240702$20240705$20240802$PER$$US-BAUSCH-BL-2024-010289$BAUSCH AND LOMB$$$$$M$Y$$$20240802$$CN$US$US
240564271$24056427$1$I$$20240621$20240705$20240705$PER$$US-009507513-2406USA008609$MERCK$$12$YR$$F$Y$$$20240705$$PH$US$US
240564282$24056428$2$F$$20240711$20240705$20240723$EXP$$PL-TEVA-VS-3217365$TEVA$Krawczyk M. Pneumothorax as a complication of respiratory failure - two case reports and literature review. JOURNAL OF PRE-CLINICAL AND CLINICAL RESEARCH. 2024;(2):139-146$41$YR$$M$Y$$$20240723$$HP$PL$PL
240564292$24056429$2$F$20201114$20240822$20240705$20240828$EXP$$CO-TAKEDA-2020TUS052173$TAKEDA$$41$YR$$F$Y$83$KG$20240828$$CN$CO$CO
240564301$24056430$1$I$20240401$20240627$20240705$20240705$EXP$$CO-ABBVIE-5827218$ABBVIE$$78$YR$$M$Y$71$KG$20240705$$HP$CO$CO
240564311$24056431$1$I$$20240627$20240705$20240705$EXP$$ZA-AstraZeneca-2024A150052$ASTRAZENECA$$81$YR$$M$Y$$$20240705$$CN$ZA$
240564321$24056432$1$I$$20240701$20240705$20240705$EXP$$VN-AstraZeneca-2024A151964$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$VN$
240564331$24056433$1$I$$20240627$20240705$20240705$EXP$$ID-AstraZeneca-2024A150887$ASTRAZENECA$$$$$F$Y$$$20240705$$MD$ID$
240564341$24056434$1$I$20231117$20240627$20240705$20240705$EXP$$CN-AstraZeneca-2024A150919$ASTRAZENECA$$56$YR$$F$Y$62.5$KG$20240705$$MD$CN$
240564351$24056435$1$I$$20240701$20240705$20240705$PER$$US-JNJFOC-20240700852$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$HP$US$US
240564362$24056436$2$F$$20240715$20240705$20240716$PER$$US-JNJFOC-20240714125$JOHNSON AND JOHNSON$$68$YR$E$F$Y$66.5$KG$20240716$$CN$US$US
240564371$24056437$1$I$20230306$20240625$20240705$20240705$EXP$$CN-009507513-2407CHN000037$MERCK$$66$YR$$F$Y$$$20240705$$HP$CN$CN
240564381$24056438$1$I$$20240628$20240705$20240705$PER$$US-ALXN-202406USA001939US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240705$$PH$US$US
240564401$24056440$1$I$20240619$20240705$20240705$20240705$EXP$FR-AFSSAPS-RN2024000735$FR-SANDOZ INC.-SDZ2024FR063028$SANDOZ$$49$YR$$M$Y$$$20240705$$MD$FR$FR
240564412$24056441$2$F$$20240806$20240705$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107595$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240807$$CN$US$US
240564421$24056442$1$I$20240629$20240701$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107540$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240705$$CN$US$US
240564431$24056443$1$I$20240627$20240627$20240705$20240705$PER$$US-Eisai-EC-2024-169089$EISAI$$78$YR$E$F$Y$$$20240705$$CN$US$US
240564441$24056444$1$I$20240613$20240626$20240705$20240705$EXP$IT-MINISAL02-991199$IT-TEVA-VS-3215181$TEVA$$47$YR$$F$Y$$$20240705$$PH$IT$IT
240564462$24056446$2$F$20240619$20240827$20240705$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR078810$VIIV$$$$$$Y$$$20240906$$MD$US$US
240564471$24056447$1$I$20240704$20240704$20240705$20240705$EXP$$AU-ABBVIE-5828073$ABBVIE$$70$YR$$F$Y$$$20240705$$HP$AU$AU
240564481$24056448$1$I$20240627$20240627$20240705$20240705$PER$$US-RDY-SPO/USA/24/0009509$DR REDDYS$$23$YR$A$M$Y$$$20240705$$MD$US$US
240564492$24056449$2$F$$20240703$20240705$20240713$EXP$AU-TGA-0000810931$AU-TEVA-VS-3215333$TEVA$$$$$$Y$$$20240713$$CN$AU$AU
240564501$24056450$1$I$20221207$20240627$20240705$20240705$EXP$$CN-TAKEDA-2024TUS067389$TAKEDA$$48$YR$$M$Y$$$20240705$$HP$CN$CN
240564511$24056451$1$I$20230101$20240705$20240705$20240705$EXP$FR-AFSSAPS-BX2024001350$FR-SANDOZ INC.-SDZ2024FR063014$SANDOZ$$57$YR$$F$Y$$$20240705$$MD$FR$FR
240564521$24056452$1$I$20230401$20240703$20240705$20240705$EXP$$IN-SANDOZ INC.-SDZ2024IN062837$SANDOZ$$2$YR$$F$Y$$$20240705$$CN$IN$IN
240564531$24056453$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5825750$ABBVIE$$59$YR$$F$Y$$$20240705$$HP$US$US
240564541$24056454$1$I$$20240624$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107390$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$58.3$KG$20240705$$MD$US$US
240564551$24056455$1$I$$20240621$20240705$20240705$EXP$$US-Ascend Therapeutics US, LLC-2158878$ASCEND$$30$YR$$M$Y$$$20240705$$MD$US$US
240564561$24056456$1$I$20200101$20240626$20240705$20240705$EXP$FR-AFSSAPS-RN2024000680$FR-TEVA-VS-3215208$TEVA$$55$YR$$F$Y$$$20240705$$MD$FR$FR
240564571$24056457$1$I$$20240705$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107606$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$79.83$KG$20240705$$CN$US$US
240564581$24056458$1$I$20240101$20240702$20240705$20240705$EXP$$US-ABBVIE-5826611$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240564592$24056459$2$F$20240513$20240709$20240705$20240711$EXP$$CO-JNJFOC-20240667936$JOHNSON AND JOHNSON$$37$YR$A$M$Y$85$KG$20240711$$HP$CO$CO
240564601$24056460$1$I$$20240111$20240705$20240705$PER$$US-ABBVIE-5829980$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240564611$24056461$1$I$$20240623$20240705$20240705$EXP$$IL-JNJFOC-20240664241$JOHNSON AND JOHNSON$$$$$F$Y$$$20240705$$MD$IL$IL
240564621$24056462$1$I$20240102$20240620$20240705$20240705$EXP$IT-MINISAL02-979194$IT-SAMSUNG BIOEPIS-SB-2024-19404$SAMSUNG BIOEPIS$$45$YR$A$M$Y$70$KG$20240705$$MD$IT$IT
240564631$24056463$1$I$20231201$20240627$20240705$20240705$PER$$US-Eisai-EC-2024-169092$EISAI$$82$YR$E$F$Y$$$20240705$$MD$US$US
240564641$24056464$1$I$$20240627$20240705$20240705$PER$$US-Eisai-EC-2024-169100$EISAI$$$$$$Y$$$20240705$$MD$US$US
240564651$24056465$1$I$20240607$20240627$20240705$20240705$PER$$US-Eisai-EC-2024-169118$EISAI$$$$E$F$Y$$$20240705$$HP$US$US
240564661$24056466$1$I$20240101$20240627$20240705$20240705$PER$$US-Eisai-EC-2024-169091$EISAI$$78$YR$E$M$Y$$$20240705$$MD$US$US
240564671$24056467$1$I$$20240702$20240705$20240705$EXP$$US-GILEAD-2024-0679253$GILEAD$$$$$$Y$$$20240705$$HP$US$US
240564682$24056468$2$F$$20240703$20240705$20240711$EXP$$AU-AstraZeneca-2024A152457$ASTRAZENECA$$$$$M$Y$$$20240711$$MD$AU$
240564691$24056469$1$I$20240510$20240624$20240705$20240705$PER$$US-RDY-SPO/USA/24/0009284$DR REDDYS$$77$YR$E$F$Y$60.327$KG$20240705$$HP$US$US
240564701$24056470$1$I$$20240624$20240705$20240705$PER$$US-RDY-SPO/USA/24/0009267$DR REDDYS$$$$$F$Y$$$20240705$$PH$US$US
240564711$24056471$1$I$20240606$20240620$20240705$20240705$PER$$US-RDY-SPO/USA/24/0008982$DR REDDYS$$67$YR$E$F$Y$$$20240705$$CN$US$US
240564721$24056472$1$I$$20240620$20240705$20240705$PER$$US-RDY-LIT/USA/24/0009231$DR REDDYS$Kruttiventi S, Olcott J, Doubledee B. Ditch the Itch: Propofol in the Management of Cholestatic Pruritus. Clinical Pediatrics. 2023;0(0): doi:10.1177/00099228231182821.$17$YR$T$F$Y$$$20240705$$HP$US$US
240564741$24056474$1$I$$20240624$20240705$20240705$PER$$US-RDY-SPO/USA/24/0009285$DR REDDYS$$$$$F$Y$$$20240705$$CN$US$US
240564752$24056475$2$F$$20240708$20240705$20240717$PER$$US-RDY-SPO/USA/24/0009336$DR REDDYS$$70$YR$E$M$Y$$$20240717$$CN$US$US
240564761$24056476$1$I$$20240621$20240705$20240705$PER$$US-RDY-LIT/USA/24/0009388$DR REDDYS$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allergy, Asthma and Clinical Immunology. 2023;19: doi:10.1186/s13223-023-00820-4.$24$YR$A$F$Y$$$20240705$$HP$US$US
240564771$24056477$1$I$$20240620$20240705$20240705$PER$US-MLMSERVICE-20240614-PI096481-00128-1$US-RDY-SPO/USA/24/0009175$DR REDDYS$Ramirez AL, Townsend AN, Weber L, Piccinini PS, Wolfe EM, Taylor MW, et al. An Oncoplastic Approach to Primary Pediatric Pterygomaxillary Osteosarcoma. Cleft Palate Craniofacial Journal. 2024;61(6):1054-60. DOI: 10.1177/10556656231154814.$6$YR$C$M$Y$$$20240705$$MD$US$US
240564781$24056478$1$I$$20240621$20240705$20240705$PER$$US-RDY-LIT/USA/24/0009389$DR REDDYS$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allergy, Asthma and Clinical Immunology. 2023;19: doi:10.1186/s13223-023-00820-4.$35$YR$A$M$Y$$$20240705$$HP$US$US
240564791$24056479$1$I$20240504$20240704$20240705$20240705$EXP$IT-MINISAL02-993220$IT-TAKEDA-2024TUS067975$TAKEDA$$29$YR$$M$Y$$$20240705$$HP$IT$IT
240564801$24056480$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5828020$ABBVIE$$52$YR$$F$Y$$$20240705$$HP$US$US
240564811$24056481$1$I$20230626$20240703$20240705$20240705$EXP$$CN-BEIGENE-BGN-2024-010430$BEIGENE$Wang, L.. A case of autoimmune polyendocrine syndrome caused by tislelizumab. Chinese Journal of Hospital Pharmacy. 2024$$$$$Y$$$20240705$$MD$CN$CN
240564821$24056482$1$I$20240411$20240627$20240705$20240705$EXP$FR-AFSSAPS-AVLL2024000144$FR-TEVA-VS-3215727$TEVA$$14$YR$$F$Y$$$20240705$$MD$FR$FR
240564831$24056483$1$I$$20240628$20240705$20240705$EXP$$US-TEVA-VS-3216444$TEVA$$$$E$M$Y$$$20240705$$CN$US$US
240564841$24056484$1$I$20240515$20240627$20240705$20240705$EXP$FR-AFSSAPS-TS2024000707$FR-TEVA-VS-3215719$TEVA$$75$YR$$M$Y$$$20240705$$MD$FR$FR
240564851$24056485$1$I$20230124$20240705$20240705$20240705$EXP$ES-AEMPS-1425087$ES-GILEAD-2024-0679726$GILEAD$$78$YR$E$F$Y$68$KG$20240705$$PH$ES$ES
240564865$24056486$5$F$20240629$20240730$20240705$20240802$EXP$$US-SANDOZ INC.-SDZ2024US062879$SANDOZ$$44$YR$$M$Y$87.07$KG$20240802$$MD$US$US
240564871$24056487$1$I$20240101$20240627$20240705$20240705$PER$$US-Eisai-EC-2024-169221$EISAI$$$$$M$Y$$$20240705$$HP$US$US
240564882$24056488$2$F$20240601$20240730$20240705$20240809$PER$$US-Millicent Holdings Ltd.-MILL20241012$MILLICENT HOLDINGS$$$$$F$Y$$$20240809$$CN$US$US
240564891$24056489$1$I$20210615$20240627$20240705$20240705$EXP$PL-URPL-DML-MLP.4401.1.4885.2021$PL-TEVA-VS-3215535$TEVA$$52$YR$$F$Y$68.5$KG$20240705$$HP$PL$PL
240564902$24056490$2$F$20240606$20240807$20240705$20240814$EXP$GB-MHRA-TPP36064774C23315082YC1719488124401$GB-RDY-SPO/GBR/24/0009642$DR REDDYS$$89$YR$E$F$Y$55$KG$20240814$$PH$GB$GB
240564911$24056491$1$I$$20240701$20240705$20240705$EXP$$GB-MYLANLABS-2024M1062346$MYLAN$$$$$F$Y$$$20240705$$CN$GB$GB
240564921$24056492$1$I$20240402$20240624$20240705$20240705$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13006$IPSEN$$$$$F$Y$$$20240705$$CN$US$US
240564931$24056493$1$I$20240501$20240628$20240705$20240705$EXP$$CN-009507513-2407CHN001038$MERCK$$49$YR$$M$Y$76$KG$20240705$$HP$CN$CN
240564941$24056494$1$I$20240624$20240625$20240705$20240705$EXP$GB-MHRA-MED-202406251254152640-QYSGL$GB-ELI_LILLY_AND_COMPANY-GB202406017054$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$GB$GB
240564951$24056495$1$I$20240317$20240621$20240705$20240705$EXP$$US-APELLIS-APL-2024-004362$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240705$$MD$US$US
240564961$24056496$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A150219$ASTRAZENECA$$$$$F$Y$64.9$KG$20240705$$CN$US$
240564971$24056497$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5827862$ABBVIE$$30$YR$$F$Y$$$20240705$$HP$US$US
240564981$24056498$1$I$$20240705$20240705$20240705$PER$$NVSC2024US139870$NOVARTIS$$$$$$Y$$$20240705$$HP$US$US
240564991$24056499$1$I$$20240625$20240705$20240705$EXP$$US-TEVA-VS-3213909$TEVA$$$$$$Y$$$20240705$$PH$US$US
240565001$24056500$1$I$20240518$20240627$20240705$20240705$EXP$FR-AFSSAPS-PO2024000697$FR-TEVA-VS-3215584$TEVA$$78$YR$$M$Y$$$20240705$$MD$FR$FR
240565012$24056501$2$F$20240101$20240705$20240705$20240712$EXP$$FI-009507513-2407FIN002085$MERCK$$55$YR$$M$Y$$$20240712$$MD$FI$FI
240565021$24056502$1$I$$20240702$20240705$20240705$PER$$US-ABBVIE-5827405$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240565031$24056503$1$I$$20240703$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106650$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$64.86$KG$20240705$$CN$US$US
240565041$24056504$1$I$$20240523$20240705$20240705$PER$$US-Eisai-EC-2024-166371$EISAI$$81$YR$E$M$Y$$$20240705$$HP$US$US
240565051$24056505$1$I$$20240624$20240705$20240705$PER$$US-FreseniusKabi-FK202410056$FRESENIUS KABI$$26$YR$A$F$Y$92.99$KG$20240705$$HP$US$US
240565061$24056506$1$I$$20240625$20240705$20240705$EXP$$US-RDY-LIT/USA/24/0009484$DR REDDYS$Yasir M, Gelaye AE. Rare Case of Resistant Aspergillus Niger Invasive Pulmonary Aspergillosis. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: A3586. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A3586.$70$YR$E$F$Y$$$20240705$$HP$US$US
240565071$24056507$1$I$20240101$20240523$20240705$20240705$PER$$US-Eisai-EC-2024-166490$EISAI$$62$YR$A$F$Y$62$KG$20240705$$CN$US$US
240565081$24056508$1$I$$20240624$20240705$20240705$PER$$US-FreseniusKabi-FK202410055$FRESENIUS KABI$$$$$F$Y$102.06$KG$20240705$$HP$US$US
240565091$24056509$1$I$$20240630$20240705$20240705$EXP$$US-JNJFOC-20240710751$JOHNSON AND JOHNSON$$$$$$Y$$$20240705$$CN$US$US
240565102$24056510$2$F$20240620$20240719$20240705$20240813$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000416$BECTON DICKINSON$$$$$$Y$$$20240812$$CN$GB$GB
240565112$24056511$2$F$20240620$20240719$20240705$20240809$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000415$BECTON DICKINSON$$$$$$Y$$$20240809$$CN$GB$GB
240565121$24056512$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5826030$ABBVIE$$24$YR$$F$Y$$$20240705$$HP$US$US
240565131$24056513$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5827854$ABBVIE$$67$YR$$M$Y$$$20240705$$HP$US$US
240565142$24056514$2$F$20240620$20240719$20240705$20240813$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000411$BECTON DICKINSON$$$$$$Y$$$20240812$$CN$GB$GB
240565151$24056515$1$I$20231201$20240702$20240705$20240705$EXP$$US-PFIZER INC-PV202400087962$PFIZER$$64$YR$$F$Y$$$20240705$$HP$US$US
240565161$24056516$1$I$$20240702$20240705$20240705$EXP$$US-PFIZER INC-2024SGN02306$PFIZER$$75$YR$$M$Y$$$20240705$$MD$US$US
240565171$24056517$1$I$20240620$20240702$20240705$20240705$EXP$$CN-PFIZER INC-PV202400086937$PFIZER$$80$YR$$M$Y$43$KG$20240705$$HP$CN$CN
240565181$24056518$1$I$$20240702$20240705$20240705$EXP$$US-PFIZER INC-PV202300079756$PFIZER$$61$YR$$F$Y$$$20240705$$CN$US$US
240565193$24056519$3$F$20240627$20240806$20240705$20240809$EXP$$US-PFIZER INC-202400205235$PFIZER$$64$YR$$F$Y$78.5$KG$20240809$$PH$US$US
240565201$24056520$1$I$20240330$20240627$20240705$20240705$EXP$FR-AFSSAPS-NT2024000690$FR-TEVA-VS-3215596$TEVA$$74$YR$$F$Y$77$KG$20240705$$MD$FR$FR
240565211$24056521$1$I$20240607$20240627$20240705$20240705$EXP$SE-SEMPA-2024-005034$SE-TEVA-VS-3215635$TEVA$$75$YR$$M$Y$$$20240705$$MD$SE$SE
240565222$24056522$2$F$$20240729$20240705$20240806$30DAY$$CA-JNJFOC-20240672033$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$CA$CA
240565231$24056523$1$I$20240301$20240702$20240705$20240705$EXP$DK-DKMA-30729381$DK-TEVA-VS-3216604$TEVA$$38$YR$$M$Y$$$20240705$$MD$DK$DK
240565241$24056524$1$I$$20240628$20240705$20240705$PER$$US-ALXN-202406USA001954US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240705$$CN$US$US
240565251$24056525$1$I$20231201$20240627$20240705$20240705$EXP$FR-AFSSAPS-TO2024001026$FR-TEVA-VS-3215571$TEVA$$64$YR$$M$Y$$$20240705$$MD$FR$FR
240565261$24056526$1$I$$20240703$20240705$20240705$EXP$$CA-PFIZER INC-PV202400087408$PFIZER$$63$YR$$F$Y$$$20240705$$HP$CA$CA
240565271$24056527$1$I$20220201$20240702$20240705$20240705$EXP$$GB-PFIZER INC-2022SGN06596$PFIZER$$63$YR$$F$Y$$$20240705$$MD$GB$GB
240565281$24056528$1$I$$20240702$20240705$20240705$EXP$$GB-PFIZER INC-2023SGN06541$PFIZER$$$$$F$Y$$$20240705$$PH$GB$GB
240565293$24056529$3$F$$20240722$20240705$20240805$EXP$$CA-HLS-202401615$HLS THERAPEUTICS$$$$E$F$Y$$$20240805$$PH$CA$CA
240565301$24056530$1$I$$20240625$20240705$20240705$EXP$$FR-TEVA-VS-3214234$TEVA$$33$YR$$F$Y$$$20240705$$MD$FR$FR
240565321$24056532$1$I$$20240528$20240705$20240705$PER$$US-Eisai-EC-2024-166716$EISAI$$$$$$Y$$$20240705$$MD$US$US
240565331$24056533$1$I$$20240528$20240705$20240705$PER$$US-Eisai-EC-2024-166655$EISAI$$$$E$F$Y$$$20240705$$CN$US$US
240565341$24056534$1$I$20240125$20240628$20240705$20240705$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-048859$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240705$$MD$DE$DE
240565351$24056535$1$I$20240101$20240530$20240705$20240705$PER$$US-Eisai-EC-2024-166870$EISAI$$56$YR$A$M$Y$$$20240705$$CN$US$US
240565361$24056536$1$I$$20240628$20240705$20240705$EXP$$US-RDY-SPO/USA/24/0009506$DR REDDYS$$59$YR$A$M$Y$$$20240705$$PH$US$US
240565371$24056537$1$I$$20240629$20240705$20240705$EXP$$IN-AstraZeneca-2024A151324$ASTRAZENECA$$62$YR$$F$Y$54$KG$20240705$$CN$IN$
240565386$24056538$6$F$20231001$20240712$20240705$20240725$PER$$US-ROCHE-10000013467$ROCHE$$62$YR$A$F$Y$$$20240726$$CN$US$US
240565391$24056539$1$I$$20240626$20240705$20240705$EXP$$CA-TEVA-VS-3214315$TEVA$$35$YR$$M$Y$$$20240705$$HP$CA$CA
240565401$24056540$1$I$$20240626$20240705$20240705$EXP$$CA-TEVA-VS-3215044$TEVA$$40$YR$$F$Y$$$20240705$$CN$CA$CA
240565411$24056541$1$I$20240621$20240628$20240705$20240705$EXP$$CN-009507513-2407CHN001048$MERCK$$61$YR$$M$Y$$$20240705$$HP$CN$CN
240565421$24056542$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214787$TEVA$$49$YR$$M$Y$$$20240705$$HP$CA$CA
240565431$24056543$1$I$20240512$20240628$20240705$20240705$EXP$IT-MINISAL02-992283$IT-REGENERON PHARMACEUTICALS, INC.-2024-091919$REGENERON$$76$YR$$M$Y$$$20240705$$MD$IT$IT
240565441$24056544$1$I$$20240530$20240705$20240705$PER$$US-Eisai-EC-2024-167135$EISAI$$$$$F$Y$$$20240705$$HP$US$US
240565451$24056545$1$I$20240101$20240603$20240705$20240705$PER$$US-Eisai-EC-2024-167287$EISAI$$$$$$Y$$$20240705$$PH$US$US
240565462$24056546$2$F$20240507$20240703$20240705$20240718$PER$$US-Eisai-EC-2024-167320$EISAI$$63$YR$A$M$Y$114$KG$20240718$$CN$US$US
240565471$24056547$1$I$20240506$20240530$20240705$20240705$PER$$US-Eisai-EC-2024-166873$EISAI$$72$YR$E$F$Y$$$20240705$$CN$US$US
240565482$24056548$2$F$$20240722$20240705$20240730$EXP$$CA-TEVA-VS-3214625$TEVA$$50$YR$$M$Y$$$20240730$$HP$CA$CA
240565491$24056549$1$I$20240304$20240628$20240705$20240705$EXP$FR-AFSSAPS-GR2024000541$FR-SAMSUNG BIOEPIS-SB-2024-20226$SAMSUNG BIOEPIS$$59$YR$A$F$Y$73.5$KG$20240705$$PH$FR$FR
240565501$24056550$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214688$TEVA$$67$YR$$M$Y$$$20240705$$HP$CA$CA
240565511$24056551$1$I$20240301$20240626$20240705$20240705$EXP$IT-MINISAL02-991226$IT-TEVA-VS-3215174$TEVA$$52$YR$$F$Y$$$20240705$$MD$IT$IT
240565521$24056552$1$I$$20240611$20240705$20240705$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038108$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240705$$CN$US$US
240565531$24056553$1$I$$20240627$20240705$20240705$EXP$$CA-TEVA-VS-3214971$TEVA$$22$YR$$M$Y$$$20240705$$HP$CA$CA
240565541$24056554$1$I$$20240628$20240705$20240705$EXP$$NZ-NALPROPION PHARMACEUTICALS INC.-NZ-2024CUR003221$CURRAX PHARMACEUTICALS$$34$YR$$F$Y$$$20240705$$CN$NZ$NZ
240565551$24056555$1$I$$20240703$20240705$20240705$EXP$FR-AFSSAPS-PV2023000738$FR-PFIZER INC-2023SGN08926$PFIZER$$$$$M$Y$0.456$KG$20240705$$MD$FR$FR
240565561$24056556$1$I$$20240703$20240705$20240705$EXP$$GB-PFIZER INC-2023SGN06542$PFIZER$$$$$F$Y$$$20240705$$PH$GB$GB
240565571$24056557$1$I$20240201$20240703$20240705$20240705$EXP$$BG-PFIZER INC-2024SGN04664$PFIZER$$78$YR$$F$Y$$$20240705$$MD$BG$BG
240565581$24056558$1$I$20240627$20240627$20240705$20240705$PER$$US-ALKERMES INC.-ALK-2024-001782$ALKERMES$$56$YR$$M$Y$$$20240705$$PH$US$US
240565591$24056559$1$I$20221107$20240627$20240705$20240705$EXP$$CN-TAKEDA-2024TUS067388$TAKEDA$$49$YR$$M$Y$$$20240705$$HP$CN$CN
240565601$24056560$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA194561$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240705$$MD$US$US
240565611$24056561$1$I$$20240627$20240705$20240705$PER$$US-ALKERMES INC.-ALK-2024-001778$ALKERMES$$$$$$Y$$$20240705$$PH$US$US
240565621$24056562$1$I$$20240604$20240705$20240705$PER$$US-Eisai-EC-2024-167394$EISAI$$$$E$F$Y$$$20240705$$CN$US$US
240565631$24056563$1$I$$20240606$20240705$20240705$PER$$US-Eisai-EC-2024-167648$EISAI$$$$$F$Y$$$20240705$$CN$US$US
240565662$24056566$2$F$$20240820$20240705$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-014120$JAZZ$$$$$F$Y$$$20240823$$HP$US$US
240565671$24056567$1$I$$20240702$20240705$20240705$EXP$$JP-ALSI-2024000196$AIRGAS$$40$YR$$M$Y$$$20240705$$$JP$JP
240565691$24056569$1$I$$20240703$20240705$20240705$PER$$US-PFIZER INC-2024SGN04174$PFIZER$$$$$F$Y$$$20240705$$MD$US$US
240565711$24056571$1$I$$20240704$20240705$20240705$PER$$US-PFIZER INC-2024SGN04171$PFIZER$$$$$F$Y$$$20240705$$MD$US$US
240565721$24056572$1$I$20240628$20240702$20240705$20240705$EXP$$US-SANDOZ INC.-SDZ2024US062988$SANDOZ$$$$$$Y$$$20240705$$HP$US$US
240565731$24056573$1$I$$20240624$20240705$20240705$EXP$$US-MAYNE PHARMA-2024MYN000259$MAYNE$Sarantopoulos N, Wiltchik E, Thakkar V, Klein W. Fluconazole Associated DRESS Syndrome in Patient With Coccidioidomycosis Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240705$$MD$US$US
240565741$24056574$1$I$$20240702$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107134$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240705$$HP$US$US
240565752$24056575$2$F$$20240702$20240705$20240709$EXP$$CN-TAKEDA-2024TUS067074$TAKEDA$$49$YR$$M$Y$$$20240709$$HP$CN$CN
240565761$24056576$1$I$20240403$20240610$20240705$20240705$PER$$US-Eisai-EC-2024-167876$EISAI$$$$$F$Y$$$20240705$$HP$US$US
240565771$24056577$1$I$$20240702$20240705$20240705$EXP$$JP-OTSUKA-2024_018871$OTSUKA$Hoshino T, Hatsumi N, Kajita M, Tsukada A, Lino H, Takada S. Autopsy case of acute myeloid leukemia with human herpesvirus-6B (HHV-6B) encephalitis following cord blood transplantation and persistent HHV-6B DNA detection in the Blood. Japanese Journal of Transplantation and Cellular Therapy. 2024;13(1):42-6$29$YR$$M$Y$$$20240705$$HP$JP$JP
240565781$24056578$1$I$20240528$20240606$20240705$20240705$PER$$US-Eisai-EC-2024-167661$EISAI$$70$YR$E$M$Y$$$20240705$$HP$US$US
240565791$24056579$1$I$$20240620$20240705$20240705$PER$$US-ABBVIE-5828960$ABBVIE$$$$$M$Y$$$20240705$$MD$US$US
240565801$24056580$1$I$$20240625$20240705$20240705$EXP$$US-BIOGEN-2024BI01272043$BIOGEN$Humphrey W, BOON B, Constantopoulos E, Graff-Radford N, Johnson D, Knopman D, McCarter S, Murray M, Nguyen A, Reichard R. Amyloid Clearance, Alzheimer^s Disease Neuropathologic Change, and Comorbid Pathology in Four Patients Treated with Aducanumab. Journal of Neuropathology and Experimental Neurology. 2024 JUN;472-473.$$$$M$Y$$$20240705$$MD$US$US
240565821$24056582$1$I$$20240625$20240705$20240705$EXP$$US-BIOGEN-2024BI01272042$BIOGEN$Humphrey W, Boon B, Constantopoulos E, Graff-Radford N, Johnson D, Knopman D, McCarter S, Murray M, Nguyen A, Reichard R. Amyloid Clearance, Alzheimer^s Disease Neuropathologic Change, and Comorbid Pathology in Four Patients Treated with Aducanumab. Journal of Neuropathology and Experimental Neurology. 2024 JUN;472-473.$$$$M$Y$$$20240705$$MD$US$US
240565831$24056583$1$I$$20240627$20240705$20240705$PER$$US-ABBVIE-5826168$ABBVIE$$47$YR$$F$Y$$$20240705$$HP$US$US
240565841$24056584$1$I$20240615$20240701$20240705$20240705$EXP$$NVSC2024GB137359$NOVARTIS$$51$YR$$M$Y$$$20240705$$CN$GB$GB
240565851$24056585$1$I$20230101$20240628$20240705$20240705$EXP$$US-BAUSCH-BL-2024-010157$BAUSCH AND LOMB$$35$YR$$F$Y$126.67$KG$20240705$$CN$US$US
240565861$24056586$1$I$$20240705$20240705$20240705$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038105$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240705$$CN$US$US
240565871$24056587$1$I$20240523$20240610$20240705$20240705$PER$$US-Eisai-EC-2024-168195$EISAI$$82$YR$E$$Y$$$20240705$$HP$US$US
240565881$24056588$1$I$20221224$20240626$20240705$20240705$EXP$$US-Genus_Lifesciences-USA-POI0580202400140$GENUS LIFESCIENCES$$32$YR$A$F$Y$101.6$KG$20240703$$MD$DE$US
240565892$24056589$2$F$20240624$20240718$20240705$20240723$EXP$$JP-GILEAD-2024-0678739$GILEAD$$94$YR$E$F$Y$$$20240723$$PH$JP$JP
240565902$24056590$2$F$$20240722$20240705$20240727$EXP$$NVSC2024US137705$NOVARTIS$$$$$M$Y$$$20240727$$CN$US$US
240565912$24056591$2$F$20240101$20240814$20240705$20240820$EXP$$US-ABBVIE-5826096$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
240565931$24056593$1$I$20240101$20240702$20240705$20240705$EXP$$US-ABBVIE-5826107$ABBVIE$$66$YR$$M$Y$$$20240705$$CN$US$US
240565941$24056594$1$I$20240101$20240628$20240705$20240705$EXP$$CN-Genus_Lifesciences-USA-POI0580202400141$GENUS LIFESCIENCES$Hu Z. Mallory Weiss Syndrome. The New England Journal of Medicine. 2024 MAY 30;390(20):E49.$79$YR$E$F$Y$$$20240703$$HP$CN$CN
240565951$24056595$1$I$20240418$20240702$20240705$20240705$EXP$$CZ-ABBVIE-5825057$ABBVIE$$89$YR$$M$Y$$$20240705$$MD$CZ$CZ
240565961$24056596$1$I$$20240703$20240705$20240705$PER$$US-009507513-2407USA002116$MERCK$$$$$F$Y$$$20240705$$CN$US$US
240565971$24056597$1$I$$20240627$20240705$20240705$EXP$$PL-GALDERMA-PL2024010546$GALDERMA$$$$$$Y$$$20240705$$HP$PL$PL
240565981$24056598$1$I$20240101$20240626$20240705$20240705$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004802$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240705$$CN$US$US
240565991$24056599$1$I$20240612$20240703$20240705$20240705$EXP$$MY-PFIZER INC-202400205837$PFIZER$$87$YR$$M$Y$$$20240705$$HP$MY$MY
240566001$24056600$1$I$$20240625$20240705$20240705$EXP$$IN-Ipsen Biopharmaceuticals, Inc.-2024-12828$IPSEN$A.K. Jha, M. Kumar, R. Priyadarshi, A. Badani. ^PNEUMOMEDIASTINUM AS A SEQUELA OF PRE-OPERATIVE PROGRESSIVE PNEUMOPERITONEUM - A RARE PHENOMENON^, British Journal of Surgery, 27-May-2024, Vol. 111.0, Iss. 5, Pp. v92. doi:10.1093/bjs/znae122.343$42$YR$A$M$Y$$$20240705$$MD$IN$IN
240566015$24056601$5$F$20240701$20240909$20240705$20240916$EXP$$CA-JNJFOC-20240709149$JOHNSON AND JOHNSON$$14$YR$T$F$Y$46$KG$20240917$$HP$CA$CA
240566021$24056602$1$I$$20240625$20240705$20240705$EXP$$CH-CARA THERAPEUTICS, INC.-2024-00331-CH$CARA THERAPEUTICS$$$$E$F$Y$$$20240705$$MD$CH$CH
240566041$24056604$1$I$$20240703$20240705$20240705$PER$$NVSC2024US139653$NOVARTIS$$$$$$Y$$$20240705$$CN$US$US
240566061$24056606$1$I$$20240607$20240705$20240705$PER$$US-009507513-2406USA003874$MERCK$$$$$F$Y$53.5$KG$20240705$$CN$US$US
240566081$24056608$1$I$$20240605$20240705$20240705$PER$$US-009507513-2406USA002027$MERCK$Batra-Sharma H, Sivakumar S, Ashok KP, Sokol E, Shatsky R, Ross J.. Genomic Landscape and Clinical Outcomes of Triple-Negative Invasive Lobular Carcinoma. Cancer Research. 2024;84(9 Suppl.)$$$$F$Y$$$20240705$$HP$US$US
240566091$24056609$1$I$$20240628$20240705$20240705$EXP$$US-AstraZeneca-2024A149942$ASTRAZENECA$$$$$F$Y$$$20240705$$CN$US$
240566102$24056610$2$F$20230227$20240703$20240705$20240710$EXP$$IQ-009507513-2407IRQ002080$MERCK$$$$$M$Y$$$20240710$$MD$IQ$IQ
240566111$24056611$1$I$$20240426$20240705$20240705$PER$$US-AMGEN-USASP2024133315$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240566122$24056612$2$F$20240501$20240802$20240705$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202405012548$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240814$$CN$US$US
240566131$24056613$1$I$$20240627$20240705$20240705$EXP$$CA-CARA THERAPEUTICS, INC.-2024-00329-CA$CARA THERAPEUTICS$$$$$F$Y$$$20240705$$HP$CA$CA
240566141$24056614$1$I$20240611$20240627$20240705$20240705$EXP$$CN-009507513-2407CHN000749$MERCK$$67$YR$$M$Y$$$20240705$$HP$CN$CN
240566172$24056617$2$F$$20240718$20240705$20240726$PER$$US-ALXN-202406USA001854US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
240566181$24056618$1$I$$20240605$20240705$20240705$PER$$US-009507513-2406USA002595$MERCK$Onalaja-Underwood A, Pincelli T, Sokumbi O. Indurated Subcutaneous Thigh Nodules: Challenge. American Journal of Dermatopathology. 2024;46:e42?e43:393-4$64$YR$$M$Y$$$20240705$$MD$US$US
240566191$24056619$1$I$20240201$20240702$20240705$20240705$EXP$$FR-009507513-2407FRA000901$MERCK$$50$YR$$F$Y$$$20240705$$MD$FR$FR
240566201$24056620$1$I$$20240618$20240705$20240705$PER$$US-APELLIS-2024-APL-0000326$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240705$$HP$US$US
240566212$24056621$2$F$$20240730$20240705$20240805$30DAY$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097689$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240805$$CN$US$US
240566222$24056622$2$F$$20240705$20240705$20240708$PER$$NVSC2024US139951$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
240566243$24056624$3$F$20240619$20240918$20240705$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106920$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$94$KG$20240925$$PH$US$US
240566251$24056625$1$I$20240608$20240611$20240705$20240705$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038111$BOEHRINGER INGELHEIM$$52$YR$A$F$Y$$$20240705$$CN$US$US
240566262$24056626$2$F$20240601$20240717$20240705$20240729$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407001781$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$JP$JP
240566281$24056628$1$I$$20240619$20240705$20240705$PER$$US-009507513-2406USA007532$MERCK$Khan A, Murag S, Chinchilla D.. When Time Is of the Essence: Fatal Delay in Diagnosis and Surgical Management of Pulmonary Mucormycosis in a Renal Transplant Patient. American Journal of Respiratory and Critical Care Medicine. 2024;209$67$YR$$M$Y$$$20240705$$HP$US$US
240566301$24056630$1$I$$20240626$20240705$20240705$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406019295$ELI LILLY AND CO$$$$$$Y$$$20240705$$CN$JP$JP
240566311$24056631$1$I$20240218$20240624$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406016934$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240705$$CN$CN$CN
240566322$24056632$2$F$$20240715$20240705$20240725$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002773$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240725$$CN$US$US
240566331$24056633$1$I$20220101$20240703$20240705$20240705$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407001835$ELI LILLY AND CO$$$$E$F$Y$$$20240705$$CN$AU$AU
240566341$24056634$1$I$$20240624$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406016474$ELI LILLY AND CO$$60$YR$A$$Y$$$20240705$$CN$US$US
240566351$24056635$1$I$$20240701$20240705$20240705$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407001040$ELI LILLY AND CO$$$$$$Y$$$20240705$$PH$JP$JP
240566361$24056636$1$I$$20240627$20240705$20240705$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202405004075$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240705$$CN$JP$JP
240566371$24056637$1$I$$20240625$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018536$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240705$$CN$US$US
240566391$24056639$1$I$20240629$20240703$20240705$20240705$PER$$US-009507513-2407USA002261$MERCK$$$$$F$Y$$$20240705$$HP$US$US
240566401$24056640$1$I$$20240703$20240705$20240705$EXP$$US-009507513-2407USA002112$MERCK$$$$$M$Y$$$20240705$$CN$US$US
240566412$24056641$2$F$$20240827$20240705$20240904$EXP$$JP-009507513-2403JPN002402J$MERCK$Kosaka S, Mori S, Ueki H. SY-7 Investigation of perioperative triple negative breast cancer treated with Pembrolizumab. The 21st Tohoku Regional Meeting of Japanese Breast Cancer Society. 25$6$DEC$$F$Y$$$20240904$$MD$JP$JP
240566421$24056642$1$I$$20240605$20240705$20240705$PER$$US-009507513-2406USA001846$MERCK$$$$$M$Y$$$20240705$$CN$US$US
240566431$24056643$1$I$$20240626$20240705$20240705$EXP$$US-009507513-2407USA002285$MERCK$O^Halloran K, Phadnis S, Metrock L, Friedman G, Davidson T, Robison N, et al.. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2022;24 (1):i126-7$119$MON$$M$Y$$$20240705$$HP$US$US
240566441$24056644$1$I$$20240626$20240705$20240705$EXP$$US-009507513-2407USA002284$MERCK$O^Halloran K, Phadnis S, Friedman G. K, Metrock K, Davidson T, Robison Nathan J, et al.. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6 (1)$$$T$M$Y$$$20240705$$HP$US$US
240566451$24056645$1$I$$20240705$20240705$20240705$EXP$$US-ANIPHARMA-2024-US-037032$ANI$Calderon Barahona GM, Ali R, Ortega Giron C, et al.Beta-blocked: a severe propranolol overdose case report..American Journal of Respiratory and Critical Care Medicine.2024;209A5699.$25$YR$$F$Y$$$20240705$$HP$US$US
240566461$24056646$1$I$$20240626$20240705$20240705$EXP$$CA-GILEAD-2023-0619226$GILEAD$$83$YR$E$M$Y$$$20240705$$CN$CA$CA
240566471$24056647$1$I$$20240626$20240705$20240705$EXP$$US-009507513-2208USA001760$MERCK$O^Halloran K, Phadnis S, Friedman G. K, Metrock K, Davidson T, Robison N J, Tamrazi B et al. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6 (1):1-9$75$MON$$F$Y$$$20240705$$MD$US$US
240566482$24056648$2$F$20240101$20240719$20240705$20240730$EXP$$US-RECORDATI-2024003151$RECORDATI$$$$$$Y$$$20240730$$CN$US$US
240566491$24056649$1$I$$20240624$20240705$20240705$EXP$$US-TRAVERE-2024TVT00642$TRAVERE THERAPEUTICS$$$$$$Y$$$20240705$$MD$US$US
240566501$24056650$1$I$$20240605$20240705$20240705$PER$$US-009507513-2406USA001805$MERCK$Mccallum A, McAllister S, Kearns R. Incidental surgery during pregnancy and sugammadex usage ? a four year retrospective review. International Journal of Obstetric Anesthesia. 2024;58:12-13$$$A$F$Y$$$20240705$$HP$US$US
240566511$24056651$1$I$$20240605$20240705$20240705$PER$$US-009507513-2406USA003302$MERCK$Mccallum A, McAllister S, Kearns R.. Incidental surgery during pregnancy and sugammadex usage ? a four year retrospective review. International Journal of Obstetric Anesthesia. 2024;58:12-13$$$$F$Y$$$20240705$$HP$US$US
240566521$24056652$1$I$20210101$20240627$20240705$20240705$EXP$HR-009507513-2406HRV001152$HR-ELI_LILLY_AND_COMPANY-HR202407002203$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240705$$CN$HR$HR
240566531$24056653$1$I$20240201$20240624$20240705$20240705$EXP$GB-MHRA-MED-202406212011402830-KBZHS$GB-ELI_LILLY_AND_COMPANY-GB202406016904$ELI LILLY AND CO$$43$YR$A$M$Y$102$KG$20240705$$CN$GB$GB
240566543$24056654$3$F$$20240717$20240705$20240724$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406003552AA$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240723$$CN$JP$JP
240566551$24056655$1$I$$20240623$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406017694$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$CN$CN
240566561$24056656$1$I$20240614$20240625$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407003023$ELI LILLY AND CO$$25$YR$A$F$Y$33$KG$20240705$$CN$DE$CN
240566571$24056657$1$I$20240611$20240624$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406016889$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240705$$CN$CN$CN
240566582$24056658$2$F$20240406$20240717$20240705$20240724$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407001326$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240723$$CN$JP$JP
240566591$24056659$1$I$20240417$20240625$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406017828$ELI LILLY AND CO$$33$YR$A$M$Y$49$KG$20240705$$CN$CN$CN
240566602$24056660$2$F$$20240710$20240705$20240722$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407002775$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240722$$CN$JP$JP
240566611$24056661$1$I$$20240623$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406017683$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$CN$CN
240566621$24056662$1$I$20240515$20240625$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407003115$ELI LILLY AND CO$$49$YR$A$M$Y$41$KG$20240705$$CN$DE$CN
240566632$24056663$2$F$20231120$20240724$20240705$20240731$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202401015182$ELI LILLY AND CO$$74$YR$E$M$Y$57$KG$20240731$$CN$JP$JP
240566641$24056664$1$I$20240520$20240624$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202406016087$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240705$$CN$US$US
240566651$24056665$1$I$20240501$20240624$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406016736$ELI LILLY AND CO$$80$YR$E$F$Y$36$KG$20240705$$CN$CN$CN
240566661$24056666$1$I$20230901$20240625$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406017819$ELI LILLY AND CO$$$$$F$Y$50$KG$20240705$$CN$CN$CN
240566671$24056667$1$I$20240610$20240629$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407000504$ELI LILLY AND CO$$59$YR$A$M$Y$58$KG$20240705$$CN$CN$CN
240566681$24056668$1$I$$20240625$20240705$20240705$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406017881$ELI LILLY AND CO$$$$$F$Y$$$20240705$$CN$CN$CN
240566692$24056669$2$F$$20240711$20240705$20240716$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407000963$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240716$$CN$JP$JP
240566702$24056670$2$F$20240520$20240710$20240705$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000494$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240723$$CN$US$US
240566711$24056671$1$I$20240516$20240624$20240705$20240705$EXP$FR-AFSSAPS-PV2024000544$FR-ELI_LILLY_AND_COMPANY-FR202406016051$ELI LILLY AND CO$$34$YR$A$F$Y$110$KG$20240705$$CN$FR$FR
240566721$24056672$1$I$$20240627$20240705$20240705$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103763$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240705$$HP$US$US
240566732$24056673$2$F$$20240913$20240705$20240918$EXP$$JP-009507513-2407JPN000193J$MERCK$Ogino Y, Nagumo H, Yoshimine N, Mukozu T, Matsui T, Wakui N, et al.. 14 Review of Immune-related Adverse Event (immune-related Adverse Event: irAE) in which Liver Stiffness could be Measured Over Time by Abdominal Ultrasound. The 37th Annual Meeting of Japan Society for Abdominal Contrast-enhanced Echogra. 34$7$DEC$$M$Y$$$20240918$$MD$JP$JP
240566741$24056674$1$I$$20240626$20240705$20240705$EXP$$US-009507513-2407USA002289$MERCK$O^Halloran K, Phadnis S, Friedman G. K, Metrock K, Davidson T, Robison N J, Tamrazi B et al. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6 (1):1-9$53$MON$$F$Y$$$20240705$$MD$US$US
240566751$24056675$1$I$20240610$20240621$20240705$20240705$EXP$$US-AnazaoHealth Corporation-2158882$ANAZAOHEALTH CORPORATION$$54$YR$$F$Y$$$20240705$$$US$US
240566761$24056676$1$I$20240101$20240624$20240705$20240705$PER$$US-Eisai-EC-2024-164313$EISAI$$$$$F$Y$$$20240705$$CN$US$US
240566771$24056677$1$I$$20240620$20240705$20240705$PER$$US-009507513-2406USA007537$MERCK$Alagha Z, Bills E., Abdeen AZ, Zeid FM.. Survival Against the Odds: Hemophagocytic Lymphohistiocytosis Amidst the Shadows of Disseminated Histoplasmosis. American Journal of Respiratory and Critical Care Medicine. 2024$57$YR$$F$Y$$$20240705$$HP$US$US
240566781$24056678$1$I$$20240618$20240705$20240705$PER$$US-APELLIS-2024-APL-0000342$APELLIS PHARMACEUTICALS$Kalluru D, Adkins D, Mei L. When Blood was thinner than water: A case of Paroxysmal Nocturnal Hemoglobinuria Breakthrough Hemolysis in Pregnancy.American Journal of Respiratory and Critical Care Medicine . 2024;209:A6735.$$$$$Y$$$20240705$$HP$US$US
240566791$24056679$1$I$20240101$20240630$20240705$20240705$EXP$$NVSC2024KW137766$NOVARTIS$$50$YR$$F$Y$$$20240706$$CN$KW$KW
240566801$24056680$1$I$$20240626$20240705$20240705$PER$$US-009507513-2407USA002288$MERCK$O^Halloran K, Phadnis S, Friedman G. K, Metrock K, Davidson T, Robison N J, Tamrazi B et al. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6 (1):1-9$65$MON$$M$Y$$$20240705$$MD$US$US
240566811$24056681$1$I$20240101$20240531$20240705$20240705$PER$$US-Eisai-EC-2024-167143$EISAI$$72$YR$E$F$Y$$$20240705$$CN$US$US
240566831$24056683$1$I$20240326$20240701$20240705$20240705$EXP$$HR-009507513-2407HRV002070$MERCK$$$$$M$Y$$$20240705$$MD$HR$HR
240566841$24056684$1$I$$20240626$20240705$20240705$EXP$$US-009507513-2407USA002291$MERCK$O^Halloran K, Phadnis S, Friedman G. K, Metrock K, Davidson T, Robison N J, Tamrazi B et al. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6 (1):1-9$107$MON$$M$Y$$$20240705$$MD$US$US
240566851$24056685$1$I$20231101$20240625$20240705$20240705$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103665$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$93$KG$20240705$$MD$US$US
240566862$24056686$2$F$$20240626$20240705$20240710$EXP$$US-009507513-2407USA002286$MERCK$O^Halloran K, Phadnis S, Metrock L, Friedman G, Davidson T, Robison N, et al.. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2022;24 (1):i126-7$31$MON$$M$Y$$$20240710$$HP$US$US
240566871$24056687$1$I$$20240614$20240705$20240705$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06110$NEUROCRINE BIOSCIENCES$$$$E$$Y$$$20240705$$MD$US$US
240566881$24056688$1$I$20240609$20240625$20240705$20240705$EXP$$CN-009507513-2406CHN010174$MERCK$$73$YR$$M$Y$60$KG$20240705$$HP$CN$CN
240566891$24056689$1$I$$20240614$20240705$20240705$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06042$NEUROCRINE BIOSCIENCES$$6$DEC$$F$Y$$$20240705$$HP$US$US
240566902$24056690$2$F$$20240710$20240705$20240716$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000448$ELI LILLY AND CO$$$$$M$Y$$$20240716$$CN$US$US
240566911$24056691$1$I$$20240627$20240705$20240705$EXP$$US-ELI_LILLY_AND_COMPANY-US202407003808$ELI LILLY AND CO$Kosaraju S.,Zhang R.M..Retrospective Study on the Efficacy and Safety of Dulaglutide in Patients with Diabetes and Moderate-Advanced Chronic Kidney Disease..International Journal of Nephrology and Renovascular Disease. 2024;17:163-166.DOI:10.2147/IJNRD.S450772$$$A$$Y$$$20240705$$HP$US$US
240566921$24056692$1$I$$20240614$20240705$20240705$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06090$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240705$$HP$US$US
240566932$24056693$2$F$20240429$20240809$20240705$20240822$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06073$NEUROCRINE BIOSCIENCES$$54$YR$$M$Y$$$20240822$$HP$US$US
240566941$24056694$1$I$$20240620$20240705$20240705$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06265$NEUROCRINE BIOSCIENCES$$5$DEC$$F$Y$$$20240705$$HP$US$US
240566951$24056695$1$I$$20240626$20240705$20240705$PER$$US-009507513-2407USA002287$MERCK$O^Halloran K, Phadnis S, Friedman GK, Metrock K, Davidson TB, Robison NJ, et al.. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6(1):1-9$69$MON$$F$Y$$$20240705$$HP$US$US
240566961$24056696$1$I$20230901$20240605$20240705$20240705$PER$$US-009507513-2406USA002593$MERCK$$$$$M$Y$$$20240705$$MD$US$US
240566971$24056697$1$I$$20240704$20240705$20240705$PER$$US-ABBVIE-5829835$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240566981$24056698$1$I$$20240620$20240705$20240705$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06315$NEUROCRINE BIOSCIENCES$$73$YR$$F$Y$$$20240705$$MD$US$US
240566993$24056699$3$F$20240703$20240705$20240705$20240718$EXP$$CA-HLS-202401676$HLS THERAPEUTICS$$71$YR$E$M$Y$$$20240718$$CN$CA$CA
240567001$24056700$1$I$20240101$20240630$20240705$20240705$EXP$$PT-009507513-2407PRT001633$MERCK$$77$YR$$F$Y$$$20240705$$MD$PT$PT
240567012$24056701$2$F$$20240802$20240705$20240803$PER$$US-AstraZeneca-2024A148972$ASTRAZENECA$$$$$$Y$$$20240803$$CN$US$
240567021$24056702$1$I$20240616$20240627$20240705$20240705$EXP$$CN-AstraZeneca-2024A150890$ASTRAZENECA$$75$YR$$F$Y$56$KG$20240706$$MD$CN$
240567032$24056703$2$F$20181201$20240918$20240705$20240925$EXP$$US-009507513-2407USA000409$MERCK$Bedrose S, Turin GC, Lavis RV, Kim TS, Thosani NS. A case of acquired generalized lipodystrophy associated with pembrolizumab in a patient with metastatic malignant melanoma. AACE Clin Case Rep. 2020;6(1):e40?5$67$YR$$M$Y$87.9$KG$20240925$$HP$US$US
240567041$24056704$1$I$$20240625$20240705$20240705$PER$$US-TEVA-VS-3215809$TEVA$$$$$F$Y$$$20240705$$CN$US$US
240567052$24056705$2$F$20240101$20240721$20240705$20240805$PER$$US-ALKERMES INC.-ALK-2024-001777$ALKERMES$$$$$F$Y$$$20240805$$CN$US$US
240567061$24056706$1$I$$20240703$20240705$20240705$PER$$US-Prasco Laboratories-PRAS20241013$PRASCO$$$$$F$Y$$$20240706$$$US$US
240567072$24056707$2$F$$20240826$20240705$20240904$EXP$$JP-ROCHE-10000013328$ROCHE$Sato Y, Sato Y, Irie K, Nanjo S, Hara S, Fujiwara S, et al. Successful intracranial response of lorlatinib after resistance with alectinib and brigatinib in patients with ALK-positive lung adenocarcinoma: Implications of CNS penetration rate of brigatinib. Thoracic Cancer. 2024;15 (23):1772-5. doi:10.1111/1759-7714.15395.$34$YR$A$M$Y$$$20240904$$HP$JP$JP
240567092$24056709$2$F$20240701$20240731$20240705$20240801$EXP$$US-ABBVIE-5828735$ABBVIE$$22$YR$$M$Y$113$KG$20240801$$CN$US$US
240567103$24056710$3$F$20240701$20240806$20240705$20240808$PER$$US-AMGEN-USASP2024130615$AMGEN$$74$YR$E$M$Y$$$20240808$$CN$US$US
240567111$24056711$1$I$20240608$20240627$20240705$20240705$EXP$$US-ROCHE-10000015351$ROCHE$$62$YR$A$F$Y$$$20240706$$HP$US$US
240567121$24056712$1$I$$20240628$20240705$20240705$EXP$$JP-ROCHE-10000014919$ROCHE$$7$DEC$E$M$Y$$$20240706$$MD$JP$JP
240567133$24056713$3$F$20240518$20240628$20240705$20240711$EXP$$DE-009507513-2405DEU007671$MERCK$$69$YR$$F$Y$42$KG$20240711$$MD$DE$DE
240567141$24056714$1$I$$20240702$20240705$20240705$EXP$$NVSC2024CA138757$NOVARTIS$$24$YR$$F$Y$$$20240706$$CN$CA$CA
240567151$24056715$1$I$20240601$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024130817$AMGEN$$73$YR$E$F$Y$$$20240705$$CN$US$US
240567161$24056716$1$I$$20240628$20240705$20240705$EXP$$US-AMGEN-USASP2024129291$AMGEN$$$$$F$Y$$$20240705$$HP$US$US
240567171$24056717$1$I$$20240702$20240705$20240705$EXP$GB-MHRA-MED-202407021657439190-VBJZM$GB-ROCHE-10000014661$ROCHE$$$$$M$Y$$$20240706$$HP$GB$GB
240567181$24056718$1$I$$20240702$20240705$20240705$EXP$GB-MHRA-MED-202407021702084410-SYWHN$GB-ROCHE-10000014679$ROCHE$$$$$M$Y$$$20240706$$HP$GB$GB
240567191$24056719$1$I$$20240702$20240705$20240705$EXP$GB-MHRA-MED-202407021645515840-LWBGM$GB-ROCHE-10000014688$ROCHE$$$$$F$Y$$$20240706$$HP$GB$GB
240567202$24056720$2$F$$20240821$20240705$20240823$EXP$$US-ROCHE-10000012129$ROCHE$$71$YR$E$F$Y$$$20240823$$CN$US$US
240567211$24056721$1$I$$20240627$20240705$20240705$EXP$$US-ROCHE-10000014442$ROCHE$$74$YR$E$M$Y$$$20240706$$CN$US$US
240567222$24056722$2$F$$20240822$20240705$20240823$EXP$$US-ROCHE-10000015850$ROCHE$$88$YR$E$F$Y$$$20240823$$CN$US$US
240567241$24056724$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5826261$ABBVIE$$$$$F$Y$68.038$KG$20240705$$CN$US$US
240567252$24056725$2$F$20240801$20240905$20240705$20240917$EXP$$US-ROCHE-10000015021$ROCHE$$84$YR$E$M$Y$$$20240917$$CN$US$US
240567261$24056726$1$I$$20231214$20240705$20240705$PER$$US-AMGEN-USASP2023235611$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240567271$24056727$1$I$$20240426$20240705$20240705$PER$$US-AMGEN-USASP2024133644$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240567281$24056728$1$I$20240408$20240702$20240705$20240705$EXP$$ZA-ABBVIE-5826083$ABBVIE$$18$YR$$F$Y$$$20240705$$MD$ZA$ZA
240567292$24056729$2$F$20240101$20240815$20240705$20240820$EXP$$CO-ABBVIE-5828499$ABBVIE$$$$$F$Y$68$KG$20240820$$CN$CO$CO
240567302$24056730$2$F$20240601$20240708$20240705$20240708$PER$$US-AMGEN-USASP2024131127$AMGEN$$79$YR$E$F$Y$$$20240708$$CN$US$US
240567311$24056731$1$I$20240401$20240701$20240705$20240705$EXP$$US-ABBVIE-5791060$ABBVIE$$68$YR$$F$Y$$$20240705$$CN$US$US
240567326$24056732$6$F$20240101$20240919$20240705$20240930$EXP$$US-ABBVIE-5826170$ABBVIE$$$$$F$Y$52.163$KG$20240930$$CN$US$US
240567331$24056733$1$I$20240701$20240701$20240705$20240705$EXP$$CA-ABBVIE-5825906$ABBVIE$$75$YR$$M$Y$$$20240705$$CN$CA$CA
240567341$24056734$1$I$20240101$20240702$20240705$20240705$EXP$$US-ABBVIE-5825930$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240567351$24056735$1$I$$20240628$20240705$20240705$PER$$US-SA-2024SA196558$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240706$$MD$US$US
240567361$24056736$1$I$$20240701$20240705$20240705$EXP$$BE-ABBVIE-5826638$ABBVIE$$$$E$F$Y$56$KG$20240705$$CN$BE$BE
240567372$24056737$2$F$$20240715$20240705$20240716$PER$$US-AMGEN-USASP2024130605$AMGEN$$$$$M$Y$$$20240716$$CN$US$US
240567381$24056738$1$I$20240702$20240703$20240705$20240705$EXP$$US-ABBVIE-5828626$ABBVIE$$91$YR$$F$Y$$$20240705$$HP$US$US
240567391$24056739$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5827040$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240567401$24056740$1$I$20240627$20240702$20240705$20240705$EXP$$IT-ABBVIE-5828909$ABBVIE$$76$YR$$F$Y$$$20240705$$CN$IT$IT
240567411$24056741$1$I$$20240701$20240705$20240705$EXP$$RO-ROCHE-10000016285$ROCHE$Gombar A, Claudia-Cristina B. MAKE A LONG STORY SHORT: IMPORTANCE OF GENETIC TESTING IN DIAGNOSIS OF LYNCH SYNDROME - A CASE REPORT. Acta Medica Marisiensis. 2024;Vol. 70 (Suppl 3):241-241.$55$YR$A$M$Y$$$20240706$$MD$RO$RO
240567422$24056742$2$F$20240608$20240910$20240705$20240916$EXP$$JP-ROCHE-10000016147$ROCHE$$68$YR$E$M$Y$$$20240916$$PH$JP$JP
240567432$24056743$2$F$20240101$20240705$20240705$20240708$EXP$$US-ABBVIE-5827268$ABBVIE$$$$$F$Y$70$KG$20240708$$CN$US$US
240567441$24056744$1$I$20240101$20240702$20240705$20240705$EXP$$US-ABBVIE-5826417$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240567452$24056745$2$F$20240101$20240708$20240705$20240711$EXP$$US-ABBVIE-5826696$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240567461$24056746$1$I$20220601$20240701$20240705$20240705$EXP$$CN-ROCHE-10000015071$ROCHE$Zhang Q, Xie P, Hou X, Zhao C, Duan L, Qiao H. Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report. Journal of Chemotherapy. 2024;36 (4):334-42. doi:10.1080/1120009X.2023.2276574.$52$YR$A$M$Y$$$20240706$$HP$CN$CN
240567473$24056747$3$F$$20240805$20240705$20240807$EXP$$IN-ROCHE-10000005147$ROCHE$$$$E$$Y$$$20240807$$MD$IN$IN
240567482$24056748$2$F$$20240827$20240705$20240905$EXP$$US-ABBVIE-5826132$ABBVIE$$$$$F$Y$$$20240905$$HP$US$US
240567493$24056749$3$F$20231102$20240712$20240705$20240716$EXP$$US-ABBVIE-5826195$ABBVIE$$67$YR$$M$Y$86$KG$20240716$$CN$US$US
240567501$24056750$1$I$20240531$20240614$20240705$20240705$EXP$$PK-ROCHE-10000016404$ROCHE$$47$YR$A$M$Y$$$20240706$$CN$PK$PK
240567521$24056752$1$I$$20240701$20240705$20240705$EXP$$JP-ROCHE-10000015371$ROCHE$Tamura A, Inaba Higashiyama R, Yoshida T, Satozono Y, Ohe Y. Response to dabrafenib plus trametinib on a rare BRAF mutation (V600_W604 deletion-insertion R) in an advanced non-small cell lung cancer patient.. Thoracic Cancer. 2024-Jun;15 (18):1454-6. doi:10.1111/1759-7714.15330.$70$YR$E$F$Y$$$20240706$$HP$JP$JP
240567532$24056753$2$F$20240701$20240809$20240705$20240813$PER$$US-AMGEN-USASP2024131746$AMGEN$$38$YR$A$F$Y$$$20240812$$HP$US$US
240567541$24056754$1$I$$20240701$20240705$20240705$PER$$US-ABBVIE-5825730$ABBVIE$$$$$$Y$$$20240705$$CN$US$US
240567553$24056755$3$F$$20240709$20240705$20240710$EXP$$PT-ABBVIE-5829064$ABBVIE$Lafuente S, Faria N, Matos AR. Eosinophilic pneumonia - when the cause lies in the medication. Med Interna. 2024;30(1):121.; Lafuente S, Faria N, Matos AR. Eosinophilic pneumonia - when the cause lies in the medication. Med Interna. 2024;30(1):121.$48$YR$$M$Y$$$20240710$$MD$PT$PT
240567561$24056756$1$I$20240601$20240701$20240705$20240705$PER$$US-AMGEN-USASP2024131703$AMGEN$$41$YR$A$F$Y$$$20240705$$CN$US$US
240567571$24056757$1$I$20220101$20240702$20240705$20240705$EXP$$US-ABBVIE-5826110$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240567581$24056758$1$I$$20240627$20240705$20240705$EXP$$IN-ROCHE-10000014871$ROCHE$$74$YR$E$M$Y$$$20240706$$CN$IN$IN
240567591$24056759$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5826465$ABBVIE$$$$$F$Y$$$20240705$$HP$US$US
240567601$24056760$1$I$$20240703$20240705$20240705$EXP$$GB-ABBVIE-5828272$ABBVIE$$$$E$F$Y$$$20240705$$CN$GB$GB
240567611$24056761$1$I$20240501$20240701$20240705$20240705$EXP$$US-ABBVIE-5825878$ABBVIE$$80$YR$$M$Y$$$20240705$$CN$US$US
240567621$24056762$1$I$20240101$20240628$20240705$20240705$EXP$$US-ABBVIE-5821916$ABBVIE$$$$$F$Y$$$20240705$$MD$US$US
240567631$24056763$1$I$20240601$20240703$20240705$20240705$EXP$$US-ABBVIE-5826159$ABBVIE$$63$YR$$M$Y$$$20240705$$CN$US$US
240567641$24056764$1$I$20240101$20240702$20240705$20240705$EXP$$US-ABBVIE-5826911$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240567661$24056766$1$I$$20240704$20240705$20240705$EXP$GB-MHRA-MED-202407041115298280-VTPWN$GB-ABBVIE-5827163$ABBVIE$$$$$$Y$$$20240705$$PH$GB$GB
240567671$24056767$1$I$$20240701$20240705$20240705$PER$$US-ROCHE-10000013443$ROCHE$Fenton G, Fenton G, Dean E. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient  with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case Reports in Oncology. 2024-Jan-09;17 (1):75-81. doi:10.1159/000535426.$64$YR$A$F$Y$$$20240706$$HP$US$US
240567682$24056768$2$F$$20240715$20240705$20240722$EXP$$US-ABBVIE-5826395$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
240567691$24056769$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5826583$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240567702$24056770$2$F$20240101$20240821$20240705$20240827$EXP$$CA-ABBVIE-5825955$ABBVIE$$61$YR$$F$Y$$$20240827$$CN$CA$CA
240567712$24056771$2$F$$20240710$20240705$20240718$PER$$US-ABBVIE-5826955$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
240567721$24056772$1$I$20240703$20240703$20240705$20240705$EXP$$AT-ABBVIE-5827670$ABBVIE$$79$YR$$F$Y$$$20240705$$CN$AT$AT
240567732$24056773$2$F$20240403$20240626$20240705$20240709$EXP$$US-ABBVIE-5620165$ABBVIE$$80$YR$$M$Y$85$KG$20240709$$CN$US$US
240567742$24056774$2$F$$20240721$20240705$20240725$EXP$$US-ABBVIE-5826315$ABBVIE$$$$$F$Y$81$KG$20240725$$CN$US$US
240567751$24056775$1$I$20240601$20240701$20240705$20240705$EXP$$US-ABBVIE-5825985$ABBVIE$$16$YR$$F$Y$$$20240705$$CN$US$US
240567761$24056776$1$I$$20240702$20240705$20240705$EXP$$CA-ABBVIE-5826345$ABBVIE$$$$A$F$Y$$$20240705$$CN$CA$CA
240567771$24056777$1$I$$20240703$20240705$20240705$PER$$US-AMGEN-USASP2024132650$AMGEN$$$$E$F$Y$$$20240705$$CN$US$US
240567781$24056778$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5828055$ABBVIE$$$$$F$Y$81.646$KG$20240705$$CN$US$US
240567791$24056779$1$I$$20240627$20240705$20240705$EXP$$IN-ROCHE-10000014865$ROCHE$$68$YR$E$M$Y$$$20240706$$CN$IN$IN
240567801$24056780$1$I$20231101$20240701$20240705$20240705$EXP$$US-ABBVIE-5828044$ABBVIE$$67$YR$$M$Y$$$20240705$$CN$US$US
240567811$24056781$1$I$$20240701$20240705$20240705$EXP$$US-ABBVIE-5828065$ABBVIE$$$$$F$Y$$$20240705$$HP$US$US
240567821$24056782$1$I$$20240703$20240705$20240705$EXP$$PT-ABBVIE-5829844$ABBVIE$$$$$$Y$$$20240705$$MD$PT$PT
240567831$24056783$1$I$$20240628$20240705$20240705$PER$$US-ABBVIE-5829482$ABBVIE$$$$E$$Y$$$20240705$$CN$US$US
240567841$24056784$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5827664$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240567852$24056785$2$F$$20240708$20240705$20240710$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037982$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240710$$MD$FR$FR
240567861$24056786$1$I$20240628$20240702$20240705$20240705$PER$$US-ABBVIE-5827478$ABBVIE$$35$YR$$F$Y$76.2$KG$20240705$$CN$US$US
240567871$24056787$1$I$$20240628$20240705$20240705$EXP$$US-AMGEN-USASP2024129742$AMGEN$$$$A$F$Y$$$20240705$$HP$US$US
240567881$24056788$1$I$$20240529$20240705$20240705$PER$$US-AMGEN-USASP2024133411$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240567891$24056789$1$I$$20231127$20240705$20240705$PER$$US-AMGEN-USASP2023235604$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240567902$24056790$2$F$20240619$20240805$20240705$20240807$EXP$$US-ABBVIE-5825898$ABBVIE$$60$YR$$F$Y$$$20240807$$CN$US$US
240567912$24056791$2$F$20231201$20240711$20240705$20240716$EXP$$US-ABBVIE-5825963$ABBVIE$$69$YR$$F$Y$$$20240716$$CN$US$US
240567921$24056792$1$I$20240613$20240702$20240705$20240705$EXP$$US-ABBVIE-5826257$ABBVIE$$62$YR$$F$Y$$$20240705$$CN$US$US
240567931$24056793$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5828054$ABBVIE$$$$$F$Y$$$20240705$$HP$US$US
240567942$24056794$2$F$20240619$20240711$20240705$20240717$EXP$$IT-009507513-2407ITA000426$MERCK$$91$YR$$F$Y$$$20240717$$MD$IT$IT
240567961$24056796$1$I$20240629$20240702$20240705$20240705$EXP$$US-ABBVIE-5826090$ABBVIE$$81$YR$$F$Y$$$20240705$$CN$US$US
240567971$24056797$1$I$20240101$20240702$20240705$20240705$EXP$$US-ABBVIE-5826617$ABBVIE$$$$$M$Y$$$20240705$$CN$US$US
240567981$24056798$1$I$$20230720$20240705$20240705$PER$$US-AMGEN-USASP2023235600$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240567991$24056799$1$I$$20240702$20240705$20240705$PER$$US-ABBVIE-5826494$ABBVIE$$$$$F$Y$$$20240705$$PH$US$US
240568001$24056800$1$I$20240601$20240702$20240705$20240705$EXP$$US-ABBVIE-5826431$ABBVIE$$72$YR$$M$Y$$$20240705$$CN$US$US
240568011$24056801$1$I$$20240629$20240705$20240705$PER$$US-SA-2024SA195716$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240706$$MD$US$US
240568021$24056802$1$I$$20240702$20240705$20240705$EXP$$US-ABBVIE-5827087$ABBVIE$$$$$F$Y$$$20240705$$CN$US$US
240568031$24056803$1$I$20240625$20240703$20240705$20240705$EXP$$CA-ABBVIE-5828209$ABBVIE$$63$YR$$$Y$$$20240705$$HP$CA$CA
240568043$24056804$3$F$20120101$20240820$20240705$20240824$EXP$$US-ABBVIE-5826521$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
240568051$24056805$1$I$$20230918$20240705$20240705$PER$$US-AMGEN-USASP2023235601$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240568061$24056806$1$I$$20240701$20240706$20240706$EXP$$BG-ABBVIE-5827627$ABBVIE$$48$YR$$M$Y$$$20240706$$CN$BG$BG
240568071$24056807$1$I$20240601$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05754$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240568081$24056808$1$I$$20240121$20240706$20240706$PER$$US-AMGEN-USASP2024133281$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240568091$24056809$1$I$$20231016$20240706$20240706$PER$$US-AMGEN-USASP2023235605$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240568102$24056810$2$F$20240630$20240723$20240706$20240725$PER$$US-AMGEN-USASP2024131067$AMGEN$$72$YR$E$M$Y$$$20240725$$CN$US$US
240568111$24056811$1$I$20230101$20240628$20240706$20240706$PER$$US-ABBVIE-5824036$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240568121$24056812$1$I$$20240210$20240706$20240706$PER$$US-ABBVIE-5829712$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240568132$24056813$2$F$$20240628$20240706$20240709$PER$$US-ROCHE-10000017258$ROCHE$$$$A$F$Y$$$20240709$$HP$US$US
240568142$24056814$2$F$$20240708$20240706$20240723$PER$$US-COSETTE-CP2024US000150$COSETTE PHARMACEUTICALS$$66$YR$E$$Y$285$KG$20240723$$CN$US$US
240568151$24056815$1$I$$20231121$20240706$20240706$PER$$US-AMGEN-USASP2023235609$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240568161$24056816$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05795$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240568171$24056817$1$I$$20240109$20240706$20240706$PER$$US-AMGEN-USASP2024133461$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240568181$24056818$1$I$$20240627$20240706$20240706$EXP$$US-ABBVIE-5828986$ABBVIE$$$$$F$Y$$$20240706$$HP$US$US
240568191$24056819$1$I$20240323$20240618$20240706$20240706$EXP$$TH-ROCHE-3503156$ROCHE$$54$YR$A$F$Y$$$20240706$$HP$TH$TH
240568201$24056820$1$I$20240601$20240628$20240706$20240706$EXP$$US-ABBVIE-5821234$ABBVIE$$70$YR$$F$Y$89$KG$20240706$$CN$US$US
240568211$24056821$1$I$$20240115$20240706$20240706$PER$$US-ABBVIE-5828904$ABBVIE$$$$$$Y$$$20240706$$CN$US$US
240568221$24056822$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05813$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240568231$24056823$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05816$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240568242$24056824$2$F$20240104$20240710$20240706$20240829$EXP$$AR-ROCHE-10000015296$ROCHE$$66$YR$E$F$Y$$$20240829$$CN$AR$AR
240568251$24056825$1$I$$20240126$20240706$20240706$PER$$US-ABBVIE-5829730$ABBVIE$$$$$$Y$$$20240706$$CN$US$US
240568261$24056826$1$I$$20240524$20240706$20240706$PER$$US-AMGEN-USASP2024133463$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240568271$24056827$1$I$$20240507$20240706$20240706$PER$$US-AMGEN-USASP2024133820$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240568281$24056828$1$I$20240603$20240624$20240706$20240706$EXP$$PK-ROCHE-10000013608$ROCHE$$53$YR$A$F$Y$$$20240706$$CN$PK$PK
240568291$24056829$1$I$20240626$20240701$20240706$20240706$PER$$US-SA-2024SA196857$SANOFI AVENTIS$$3$YR$C$$Y$$$20240706$$CN$US$US
240568302$24056830$2$F$20240523$20240726$20240706$20240731$EXP$$DE-ABBVIE-5826102$ABBVIE$$40$YR$$F$Y$71$KG$20240731$$CN$DE$DE
240568314$24056831$4$F$20240101$20240919$20240706$20240925$EXP$$ES-ABBVIE-5789241$ABBVIE$$$$$M$Y$$$20240925$$CN$ES$ES
240568322$24056832$2$F$20231127$20240725$20240706$20240731$EXP$$US-ABBVIE-5826371$ABBVIE$$64$YR$$F$Y$$$20240731$$CN$US$US
240568331$24056833$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05855$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240568341$24056834$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826308$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240568351$24056835$1$I$$20240702$20240706$20240706$PER$$US-ELI_LILLY_AND_COMPANY-US202407003405$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240706$$CN$US$US
240568361$24056836$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05900$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240568371$24056837$1$I$20240601$20240702$20240706$20240706$EXP$$US-ABBVIE-5826376$ABBVIE$$65$YR$$M$Y$$$20240706$$CN$US$US
240568381$24056838$1$I$20240612$20240702$20240706$20240706$EXP$$US-ABBVIE-5826883$ABBVIE$$51$YR$$F$Y$$$20240706$$CN$US$US
240568391$24056839$1$I$$20240628$20240706$20240706$PER$$US-ABBVIE-5827435$ABBVIE$$$$$$Y$$$20240706$$CN$US$US
240568402$24056840$2$F$20240101$20240730$20240706$20240801$EXP$$US-ABBVIE-5828217$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
240568411$24056841$1$I$20240624$20240702$20240706$20240706$EXP$$US-ABBVIE-5826906$ABBVIE$$44$YR$$M$Y$$$20240706$$CN$US$US
240568423$24056842$3$F$20240101$20240905$20240706$20240912$EXP$$US-ABBVIE-5826265$ABBVIE$$$$$M$Y$88$KG$20240912$$CN$US$US
240568432$24056843$2$F$20240701$20240816$20240706$20240821$PER$$US-AMGEN-USASP2024130495$AMGEN$$74$YR$E$M$Y$$$20240820$$CN$US$US
240568441$24056844$1$I$20231201$20240628$20240706$20240706$EXP$$NO-ROCHE-10000013517$ROCHE$$15$YR$T$F$Y$$$20240706$$MD$NO$NO
240568451$24056845$1$I$$20240627$20240706$20240706$PER$$US-SA-2024SA194717$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240706$$CN$US$US
240568461$24056846$1$I$20240601$20240702$20240706$20240706$EXP$$US-ABBVIE-5827095$ABBVIE$$51$YR$$F$Y$$$20240706$$CN$US$US
240568471$24056847$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05913$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240568481$24056848$1$I$$20240702$20240706$20240706$EXP$$PR-ABBVIE-5826931$ABBVIE$$$$$F$Y$$$20240706$$CN$PR$PR
240568493$24056849$3$F$20240101$20240709$20240706$20240711$EXP$$US-ABBVIE-5749423$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240568502$24056850$2$F$20240502$20240701$20240706$20240710$EXP$ES-AEMPS-1541111$ES-ROCHE-10000014686$ROCHE$$78$YR$E$M$Y$$$20240710$$MD$ES$ES
240568512$24056851$2$F$$20240711$20240706$20240715$PER$$US-ROCHE-3571665$ROCHE$$69$YR$E$M$Y$$$20240715$$CN$US$US
240568522$24056852$2$F$$20240726$20240706$20240731$PER$$US-ROCHE-10000016781$ROCHE$$54$YR$A$M$Y$$$20240731$$CN$US$US
240568532$24056853$2$F$$20240814$20240706$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05918$LUPIN$$$$$$Y$$$20240901$$CN$US$US
240568542$24056854$2$F$$20240705$20240706$20240708$EXP$GB-MHRA-MED-202405101415057720-NPTCZ$GB-UCBSA-2024034158$UCB$$$$$F$Y$70$KG$20240708$$HP$GB$GB
240568551$24056855$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05921$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240568572$24056857$2$F$$20240709$20240706$20240715$EXP$$TR-ROCHE-10000013644$ROCHE$$20$YR$A$F$Y$$$20240715$$CN$TR$TR
240568581$24056858$1$I$$20240626$20240706$20240706$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404014176$ELI LILLY AND CO$$51$YR$A$M$Y$63$KG$20240706$$CN$JP$JP
240568591$24056859$1$I$$20240624$20240706$20240706$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407002525$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240706$$CN$DE$JP
240568603$24056860$3$F$$20240823$20240706$20240904$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407002877$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240904$$CN$JP$JP
240568611$24056861$1$I$$20240624$20240706$20240706$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407002521$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240706$$CN$DE$JP
240568621$24056862$1$I$20240605$20240624$20240706$20240706$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407003676$ELI LILLY AND CO$$67$YR$E$M$Y$71$KG$20240706$$CN$DE$CN
240568631$24056863$1$I$$20240626$20240706$20240706$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406018628$ELI LILLY AND CO$$66$YR$E$F$Y$45$KG$20240706$$CN$CN$CN
240568641$24056864$1$I$$20240623$20240706$20240706$EXP$$RS-ELI_LILLY_AND_COMPANY-RS202407003483$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240706$$CN$DE$RS
240568652$24056865$2$F$$20240705$20240706$20240711$EXP$$ZA-ELI_LILLY_AND_COMPANY-ZA202406019675$ELI LILLY AND CO$$$$$M$Y$$$20240711$$CN$ZA$ZA
240568661$24056866$1$I$20240601$20240625$20240706$20240706$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406017722$ELI LILLY AND CO$$57$YR$A$F$Y$68$KG$20240706$$CN$CN$CN
240568671$24056867$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05924$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240568681$24056868$1$I$20240617$20240627$20240706$20240706$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407003739$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240706$$CN$DE$CN
240568691$24056869$1$I$20240101$20240702$20240706$20240706$EXP$$US-ABBVIE-5824976$ABBVIE$$86$YR$$M$Y$$$20240706$$CN$US$US
240568701$24056870$1$I$$20240701$20240706$20240706$PER$$US-AMGEN-USASP2024130061$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240568711$24056871$1$I$$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024132244$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240568721$24056872$1$I$$20240510$20240706$20240706$PER$$US-AMGEN-USASP2024133751$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240568731$24056873$1$I$$20240115$20240706$20240706$PER$$US-ABBVIE-5829038$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240568741$24056874$1$I$20240702$20240702$20240706$20240706$EXP$GB-MHRA-MED-202407021251589430-MBTGK$GB-ABBVIE-5828379$ABBVIE$$$$$$Y$$$20240706$$CN$GB$GB
240568752$24056875$2$F$$20240710$20240706$20240712$EXP$$JP-ABBVIE-5826185$ABBVIE$Kajikawa S, Tanei Z, Shirai Y, Izumiyama K, Saito M, Kanaya M, et al. 19. A case of adult B-ALL without KMT2A rearrangement developed lineage switch after administration of Blinatumomab, resulting in AML. The 59th Spring Hokkaido Branch Meeting of the Japanese Society of Hematology. 2024;25-25; Kajikawa S, Tanei Z, Shirai Y, Izumiyama K, Saito M, Kanaya M, et al. 19. A case of adult B-ALL without KMT2A rearrangement developed lineage switch after administration of Blinatumomab, resulting in A...$81$YR$$M$Y$$$20240712$$MD$JP$JP
240568761$24056876$1$I$20240101$20240702$20240706$20240706$EXP$$US-ABBVIE-5826448$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240568771$24056877$1$I$20240101$20240629$20240706$20240706$PER$$US-SA-2024SA196130$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240706$$MD$US$US
240568781$24056878$1$I$$20240701$20240706$20240706$PER$$US-ABBVIE-5826633$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240568791$24056879$1$I$20220101$20240702$20240706$20240706$PER$$US-ABBVIE-5824825$ABBVIE$$$$$F$Y$70$KG$20240706$$CN$US$US
240568802$24056880$2$F$$20240704$20240706$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05982$LUPIN$$$$$$Y$$$20240807$$CN$US$US
240568811$24056881$1$I$20240624$20240628$20240706$20240706$EXP$$JP-ROCHE-10000016180$ROCHE$$53$YR$A$F$Y$$$20240706$$MD$JP$JP
240568825$24056882$5$F$20170401$20240902$20240706$20240911$EXP$$NL-CELLTRION INC.-2024NL015880$CELLTRION$$$$$$Y$$$20240911$$MD$NL$NL
240568832$24056883$2$F$20240101$20240701$20240706$20240710$EXP$$US-ABBVIE-5742864$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
240568841$24056884$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05985$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240568851$24056885$1$I$$20240623$20240706$20240706$EXP$$US-GLANDPHARMA-US-2024GLNSPO00412$GLAND PHARMA$$3$YR$C$F$Y$$$20240706$$CN$US$US
240568861$24056886$1$I$20240101$20240701$20240706$20240706$EXP$$US-ABBVIE-5826700$ABBVIE$$$$$$Y$$$20240706$$CN$US$US
240568871$24056887$1$I$$20240703$20240706$20240706$PER$$US-ABBVIE-5828463$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240568881$24056888$1$I$20240630$20240701$20240706$20240706$PER$$US-AMGEN-USASP2024130286$AMGEN$$$$$M$Y$$$20240705$$CN$US$US
240568891$24056889$1$I$$20240513$20240706$20240706$PER$$US-AMGEN-USASP2024133753$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240568901$24056890$1$I$20240101$20240702$20240706$20240706$EXP$$US-ABBVIE-5827244$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240568911$24056891$1$I$20231104$20240628$20240706$20240706$EXP$$IT-CELLTRION INC.-2024IT015920$CELLTRION$$$$$$Y$$$20240706$$MD$IT$IT
240568921$24056892$1$I$20230511$20240629$20240706$20240706$EXP$$US-ABBVIE-5825041$ABBVIE$$76$YR$$M$Y$$$20240706$$CN$US$US
240568932$24056893$2$F$$20240827$20240706$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05986$LUPIN$$$$$$Y$$$20240918$$CN$US$US
240568952$24056895$2$F$$20240829$20240706$20240831$EXP$$JP-ABBVIE-5829115$ABBVIE$$70$YR$$M$Y$$$20240831$$MD$JP$JP
240568961$24056896$1$I$20240101$20240701$20240706$20240706$EXP$$IT-GENMAB-2024-02385$GENMAB$$70$YR$$M$Y$60$KG$20240706$$MD$IT$IT
240568971$24056897$1$I$$20240515$20240706$20240706$PER$$US-AMGEN-USASP2024133755$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240568981$24056898$1$I$$20240701$20240706$20240706$EXP$$US-ABBVIE-5824324$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240568991$24056899$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05987$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240569002$24056900$2$F$20240627$20240716$20240706$20240722$EXP$BE-FAMHP-DHH-N2024-122337$BE-ABBVIE-5825799$ABBVIE$$63$YR$$M$Y$106$KG$20240722$$PH$BE$BE
240569011$24056901$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05989$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240569022$24056902$2$F$20240119$20240918$20240706$20240925$EXP$$JP-ROCHE-10000015681$ROCHE$$8$DEC$E$M$Y$$$20240925$$MD$JP$JP
240569031$24056903$1$I$$20240409$20240706$20240706$PER$$US-AMGEN-USASP2024133310$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569041$24056904$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06020$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240569051$24056905$1$I$20240701$20240701$20240706$20240706$PER$$US-AMGEN-USASP2024132058$AMGEN$$64$YR$A$F$Y$$$20240705$$CN$US$US
240569061$24056906$1$I$$20240701$20240706$20240706$PER$$US-ABBVIE-5827996$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240569071$24056907$1$I$20240101$20240701$20240706$20240706$EXP$$US-ABBVIE-5826704$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240569081$24056908$1$I$$20240528$20240706$20240706$PER$$US-AMGEN-USASP2024133674$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569091$24056909$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06175$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240569101$24056910$1$I$20240525$20240627$20240706$20240706$EXP$$JP-ROCHE-10000007948$ROCHE$$67$YR$E$M$Y$$$20240706$$MD$JP$JP
240569111$24056911$1$I$$20240628$20240706$20240706$PER$$US-ROCHE-10000016100$ROCHE$$$$A$F$Y$$$20240706$$CN$US$US
240569121$24056912$1$I$$20240627$20240706$20240706$PER$$US-AMGEN-USASP2024131687$AMGEN$$$$$$Y$$$20240705$$MD$US$US
240569131$24056913$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06060$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240569141$24056914$1$I$20240624$20240701$20240706$20240706$EXP$$US-VIIV HEALTHCARE LIMITED-US2024081568$VIIV$$50$YR$$M$Y$$$20240706$$CN$US$US
240569152$24056915$2$F$$20240802$20240706$20240811$PER$$US-AstraZeneca-2024A149107$ASTRAZENECA$$$$$M$Y$$$20240811$$CN$US$
240569162$24056916$2$F$$20240729$20240706$20240811$PER$$US-AstraZeneca-2024A147842$ASTRAZENECA$$$$$M$Y$$$20240811$$CN$US$
240569171$24056917$1$I$20161215$20240627$20240706$20240706$EXP$AT-BASGAGES-184867$AT-SA-2018SA183189$SANOFI AVENTIS$$28$YR$A$F$Y$65$KG$20240706$$HP$AT$AT
240569181$24056918$1$I$$20240611$20240706$20240706$EXP$$HR-ROCHE-10000011277$ROCHE$$25$YR$A$M$Y$$$20240706$$MD$HR$HR
240569191$24056919$1$I$$20230202$20240706$20240706$PER$$US-AMGEN-USASP2023235630$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240569201$24056920$1$I$$20240528$20240706$20240706$PER$$US-AMGEN-USASP2024133772$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569211$24056921$1$I$20240401$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131440$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240569223$24056922$3$F$20230701$20240705$20240706$20240713$PER$$US-ABBVIE-5827588$ABBVIE$$60$YR$$F$Y$69.4$KG$20240713$$CN$US$US
240569231$24056923$1$I$$20240205$20240706$20240706$PER$$US-AMGEN-USASP2024130414$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240569241$24056924$1$I$$20231130$20240706$20240706$PER$$US-AMGEN-USASP2023235531$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569261$24056926$1$I$20240101$20240702$20240706$20240706$PER$$US-ABBVIE-5826971$ABBVIE$$65$YR$$F$Y$$$20240706$$CN$US$US
240569271$24056927$1$I$$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024132848$AMGEN$$$$$M$Y$$$20240705$$PH$US$US
240569281$24056928$1$I$$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131461$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240569291$24056929$1$I$$20230306$20240706$20240706$PER$$US-AMGEN-USASP2023235613$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240569301$24056930$1$I$20240101$20240702$20240706$20240706$PER$$US-SA-2024SA196935$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240706$$CN$US$US
240569312$24056931$2$F$$20240919$20240706$20240930$EXP$$JP-ROCHE-10000013701$ROCHE$Omori-Shimano S, Ikeda K, Miyauchi J, Fukami M. Genitourinary and craniofacial/cervicothoracic anomalies in a neonate with in-utero mycophenolate mofetil exposure. Japanese Teratology Society. 2024;1-3. doi:10.1111/cga.12583.$$$$F$Y$1.33$KG$20240930$$MD$JP$JP
240569321$24056932$1$I$20240601$20240701$20240706$20240706$PER$$US-SA-2024SA196204$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240706$$MD$US$US
240569331$24056933$1$I$20240618$20240618$20240706$20240706$PER$$US-JNJFOC-20240649196$JOHNSON AND JOHNSON$$$$$M$Y$$$20240706$$CN$US$US
240569341$24056934$1$I$20240703$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132051$AMGEN$$64$YR$A$F$Y$$$20240705$$CN$US$US
240569351$24056935$1$I$20240101$20240701$20240706$20240706$PER$$US-SA-2024SA196233$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240706$$MD$US$US
240569361$24056936$1$I$$20240703$20240706$20240706$PER$$US-ABBVIE-5827709$ABBVIE$$$$$$Y$$$20240706$$CN$US$US
240569381$24056938$1$I$$20240606$20240706$20240706$PER$$US-AMGEN-USASP2024133687$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569391$24056939$1$I$20240703$20240703$20240706$20240706$PER$$US-JNJFOC-20240709278$JOHNSON AND JOHNSON$$$$$$Y$$$20240706$$HP$US$US
240569401$24056940$1$I$$20240703$20240706$20240706$PER$$US-JNJFOC-20240709877$JOHNSON AND JOHNSON$$$$$F$Y$$$20240706$$CN$US$US
240569411$24056941$1$I$20240328$20240702$20240706$20240706$EXP$$CN-ROCHE-10000015079$ROCHE$$43$YR$A$M$Y$$$20240706$$MD$CN$CN
240569421$24056942$1$I$$20240628$20240706$20240706$PER$$US-JNJFOC-20240678324$JOHNSON AND JOHNSON$$$$$F$Y$$$20240706$$CN$US$US
240569431$24056943$1$I$20240127$20240629$20240706$20240706$EXP$DE-CADRBFARM-2024329055$DE-AMAROX PHARMA-AMR2024DE02077$HETERO$$69$YR$$M$Y$70$KG$20240706$$CN$DE$DE
240569441$24056944$1$I$20240617$20240702$20240706$20240706$PER$$US-JNJFOC-20240705830$JOHNSON AND JOHNSON$$71$YR$E$$Y$$$20240706$$HP$US$US
240569451$24056945$1$I$$20240109$20240706$20240706$PER$$US-AMGEN-USASP2024131681$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569461$24056946$1$I$$20231221$20240706$20240706$PER$$US-AMGEN-USASP2023235450$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569471$24056947$1$I$$20230922$20240706$20240706$PER$$US-AMGEN-USASP2023235633$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569481$24056948$1$I$$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131636$AMGEN$$$$$F$Y$$$20240705$$CN$US$US
240569491$24056949$1$I$$20231025$20240706$20240706$PER$$US-AMGEN-USASP2023235624$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569501$24056950$1$I$$20240607$20240706$20240706$EXP$$AU-ABBVIE-5826373$ABBVIE$$$$$$Y$$$20240706$$CN$AU$AU
240569511$24056951$1$I$$20240506$20240706$20240706$PER$$US-AMGEN-USASP2024133732$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569521$24056952$1$I$20240701$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024132980$AMGEN$$57$YR$A$M$Y$$$20240705$$CN$US$US
240569531$24056953$1$I$$20240131$20240706$20240706$PER$$US-TEVA-VS-3212055$TEVA$$$$$$Y$$$20240706$$HP$US$US
240569543$24056954$3$F$20240620$20240711$20240706$20240718$EXP$$JP-ROCHE-10000014799$ROCHE$$75$YR$E$M$Y$$$20240718$$MD$JP$JP
240569551$24056955$1$I$20240702$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132583$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569571$24056957$1$I$$20240425$20240706$20240706$PER$$US-AMGEN-USASP2024133757$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240569581$24056958$1$I$$20240702$20240706$20240706$EXP$$GB-GSK-GB2024EME083586$GLAXOSMITHKLINE$$$$$$Y$$$20240706$$CN$GB$GB
240569591$24056959$1$I$20240601$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131725$AMGEN$$71$YR$E$F$Y$$$20240705$$CN$US$US
240569601$24056960$1$I$$20240628$20240706$20240706$EXP$$RO-CELLTRION INC.-2024RO015899$CELLTRION$$$$$$Y$$$20240706$$MD$RO$RO
240569611$24056961$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032412$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240569621$24056962$1$I$$20230610$20240706$20240706$EXP$$IN-ROCHE-10000015836$ROCHE$$63$YR$A$F$Y$$$20240706$$CN$IN$IN
240569631$24056963$1$I$$20240627$20240706$20240706$EXP$$JP-ROCHE-10000014741$ROCHE$$8$DEC$E$M$Y$$$20240706$$MD$JP$JP
240569641$24056964$1$I$$20231228$20240706$20240706$PER$$US-AMGEN-USASP2023235504$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240569651$24056965$1$I$$20240628$20240706$20240706$EXP$$DE-AUROBINDO-AUR-APL-2024-032344$AUROBINDO$$8$DEC$$M$Y$$$20240706$$MD$DE$DE
240569662$24056966$2$F$$20240709$20240706$20240711$PER$$US-AMGEN-USASP2024132127$AMGEN$$69$YR$E$F$Y$$$20240711$$CN$US$US
240569673$24056967$3$F$20220101$20240729$20240706$20240806$PER$$US-AMGEN-USASP2024128478$AMGEN$$56$YR$A$F$Y$$$20240806$$LW$US$US
240569681$24056968$1$I$$20231127$20240706$20240706$PER$$US-AMGEN-USASP2023235544$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240569691$24056969$1$I$$20240507$20240706$20240706$PER$$US-AMGEN-USASP2024133396$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569701$24056970$1$I$$20240624$20240706$20240706$PER$$US-The ACME Laboratories Ltd-2158884$THE ACME LABORATORIES$$$$$$Y$$$20240706$$$US$US
240569712$24056971$2$F$$20240606$20240706$20240710$PER$$US-AMGEN-USASP2024129666$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240569721$24056972$1$I$$20240109$20240706$20240706$PER$$US-AMGEN-USASP2024132639$AMGEN$$$$$$Y$$$20240705$$MD$US$US
240569731$24056973$1$I$$20240701$20240706$20240706$PER$$US-ABBVIE-5827907$ABBVIE$$$$$$Y$$$20240706$$CN$US$US
240569741$24056974$1$I$$20240627$20240706$20240706$EXP$$RO-TEVA-VS-3216067$TEVA$$31$YR$$F$Y$$$20240706$$MD$RO$RO
240569751$24056975$1$I$20240429$20240628$20240706$20240706$EXP$ES-AEMPS-1540865$ES-AMAROX PHARMA-AMR2024ES02069$HETERO$$87$YR$$F$Y$$$20240706$$HP$ES$ES
240569761$24056976$1$I$$20231025$20240706$20240706$PER$$US-AMGEN-USASP2023235635$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569771$24056977$1$I$$20240221$20240706$20240706$PER$$US-AMGEN-USASP2024132541$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569781$24056978$1$I$$20240701$20240706$20240706$EXP$$US-ABBVIE-5729674$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240569791$24056979$1$I$$20240625$20240706$20240706$EXP$$JP-ROCHE-10000011910$ROCHE$$8$DEC$E$$Y$$$20240706$$MD$JP$JP
240569801$24056980$1$I$$20240702$20240706$20240706$PER$$US-ABBVIE-5828026$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240569811$24056981$1$I$$20240626$20240706$20240706$EXP$$CZ-TEVA-VS-3215460$TEVA$$63$YR$$F$Y$$$20240706$$MD$CZ$CZ
240569821$24056982$1$I$20240627$20240701$20240706$20240706$PER$$US-ABBVIE-5828266$ABBVIE$$19$YR$$F$Y$$$20240706$$MD$US$US
240569831$24056983$1$I$20240501$20240703$20240706$20240706$EXP$$US-ABBVIE-5826052$ABBVIE$$29$YR$$M$Y$70$KG$20240706$$CN$US$US
240569843$24056984$3$F$20240101$20240820$20240706$20240830$PER$$US-SA-2022SA363487$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240830$$MD$US$US
240569851$24056985$1$I$20240101$20240628$20240706$20240706$PER$$US-SA-2024SA196375$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240706$$MD$US$US
240569861$24056986$1$I$20240101$20240627$20240706$20240706$EXP$$US-CELLTRION INC.-2024US016338$CELLTRION$$$$$$Y$$$20240706$$HP$US$US
240569871$24056987$1$I$$20240606$20240706$20240706$PER$$US-AMGEN-USASP2024133638$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240569881$24056988$1$I$$20240611$20240706$20240706$PER$$US-009507513-2406USA004045$MERCK$$$$$F$Y$$$20240706$$MD$US$US
240569891$24056989$1$I$$20240521$20240706$20240706$PER$$US-AMGEN-USASP2024133239$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240569901$24056990$1$I$20240529$20240628$20240706$20240706$EXP$$ES-AUROBINDO-AUR-APL-2024-032304$AUROBINDO$$26$YR$$F$Y$52$KG$20240706$$PH$ES$ES
240569911$24056991$1$I$$20240624$20240706$20240706$PER$$US-SA-2024SA193104$SANOFI AVENTIS$$52$YR$A$F$Y$97$KG$20240706$$MD$US$US
240569921$24056992$1$I$$20240701$20240706$20240706$PER$$US-AstraZeneca-2024A151272$ASTRAZENECA$$$$$F$Y$$$20240706$$CN$US$
240569931$24056993$1$I$20240101$20240702$20240706$20240706$EXP$$DE-ABBVIE-5825984$ABBVIE$$$$$F$Y$$$20240706$$CN$DE$DE
240569941$24056994$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032639$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240569951$24056995$1$I$$20230822$20240706$20240706$PER$$US-AMGEN-USASP2023235435$AMGEN$$$$$$Y$$$20240705$$CN$US$US
240569961$24056996$1$I$$20240627$20240706$20240706$PER$$US-SA-2024SA192371$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240706$$MD$US$US
240569971$24056997$1$I$$20240702$20240706$20240706$PER$$US-ABBVIE-5828860$ABBVIE$$$$$$Y$$$20240706$$CN$US$US
240569981$24056998$1$I$$20240626$20240706$20240706$PER$$US-009507513-2407USA002290$MERCK$O^Halloran K, Phadnis S, Friedman G. K, Metrock K, Davidson T, Robison N J, Tamrazi B, et al.. Effective re-induction regimen for children with recurrent medulloblastoma. Neuro-Oncology Advances. 2024;6 (1):1-9$36$MON$$M$Y$$$20240706$$MD$US$US
240569991$24056999$1$I$$20240703$20240706$20240706$PER$$US-SA-2024SA198370$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240706$$HP$US$US
240570001$24057000$1$I$20240101$20240628$20240706$20240706$PER$$US-SA-2024SA196402$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240706$$MD$US$US
240570011$24057001$1$I$$20240630$20240706$20240706$PER$$US-SA-2024SA197258$SANOFI AVENTIS$$$$A$F$Y$$$20240706$$MD$US$US
240570021$24057002$1$I$$20240419$20240706$20240706$PER$$US-AMGEN-USASP2024133833$AMGEN$$$$$$Y$$$20240705$$HP$US$US
240570031$24057003$1$I$20240703$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132691$AMGEN$$79$YR$E$M$Y$$$20240705$$CN$US$US
240570041$24057004$1$I$$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133089$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240570051$24057005$1$I$20240601$20240702$20240706$20240706$PER$$US-ABBVIE-5827595$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240570061$24057006$1$I$$20231107$20240706$20240706$PER$$US-AMGEN-USASP2023235491$AMGEN$$$$$$Y$$$20240705$$PH$US$US
240570071$24057007$1$I$20210610$20230206$20240706$20240706$EXP$FR-AFSSAPS-PV2023000070$FR-SA-2024SA195000$SANOFI AVENTIS$$15$YR$T$M$Y$55$KG$20240706$$MD$FR$FR
240570092$24057009$2$F$$20240729$20240706$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-032033$AUROBINDO$Martin G, Narvaez-Guerra O, Aurigemma G, Kovell L. Peripartum ventricular tachycardia and PVC-induced cardiomyopathy: Delivering optimal care when it^s time to deliver. BMJ Case Reports. 2024;17(6):e259075$3$DEC$$F$Y$$$20240808$$MD$US$US
240570101$24057010$1$I$20240501$20240627$20240706$20240706$EXP$$ES-AUROBINDO-AUR-APL-2024-032137$AUROBINDO$$97$YR$$$Y$$$20240706$$MD$ES$ES
240570122$24057012$2$F$$20240724$20240706$20240807$EXP$$US-AUROBINDO-AUR-APL-2024-032723$AUROBINDO$$16$YR$$M$Y$$$20240807$$MD$US$US
240570131$24057013$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032529$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240570141$24057014$1$I$$20240702$20240706$20240706$EXP$$US-SANDOZ INC.-SDZ2024US062762$SANDOZ$$82$YR$$M$Y$84.354$KG$20240706$$MD$US$US
240570152$24057015$2$F$20240701$20240812$20240706$20240814$PER$$US-AMGEN-USASP2024130675$AMGEN$$58$YR$A$F$Y$$$20240814$$CN$US$US
240570161$24057016$1$I$$20240321$20240706$20240706$PER$$US-AMGEN-USASP2024133806$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240570171$24057017$1$I$20150101$20240627$20240706$20240706$EXP$$PL-AUROBINDO-AUR-APL-2024-032114$AUROBINDO$Maciej S, Hanna A, Letachowicz K, Dorota K, Miros?aw B, Oktawia M, et al.. Severe Bullous Erysipelas/Cellulitis, Atypically Caused by Escherichia coli, in Kidney Transplant Recipient ? Case Report and Review of Literature. Transplantation Proceedings. 2024;56(4):976-80$57$YR$$F$Y$$$20240706$$MD$PL$PL
240570181$24057018$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032527$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240570192$24057019$2$F$20230705$20240627$20240706$20240709$EXP$$JP-ROCHE-3505846$ROCHE$$8$DEC$E$F$Y$$$20240709$$MD$JP$JP
240570201$24057020$1$I$$20240627$20240706$20240706$EXP$$CA-AUROBINDO-AUR-APL-2024-033162$AUROBINDO$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM.. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. Journal of Analytical Toxicology. 2023;47:385?392$55$YR$$M$Y$$$20240706$$HP$CA$CA
240570211$24057021$1$I$$20240704$20240706$20240706$EXP$GB-MHRA-MED-202405030852197980-SBFKV$GB-ABBVIE-5828142$ABBVIE$$$$$$Y$$$20240706$$HP$GB$GB
240570221$24057022$1$I$20231223$20240703$20240706$20240706$EXP$FR-AFSSAPS-NY2024000761$FR-ABBVIE-5825753$ABBVIE$$30$YR$$F$Y$50$KG$20240706$$MD$FR$FR
240570242$24057024$2$F$20240701$20240726$20240706$20240802$PER$$US-AMGEN-USASP2024131557$AMGEN$$65$YR$E$F$Y$$$20240802$$CN$US$US
240570252$24057025$2$F$$20240712$20240706$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-032022$AUROBINDO$Pelser S, Geluk A, Vissers WHPM, Knijn N, Van Hees CL, Hassing RL. A case of leprosy in an immunocompromised traveller. Journal of Travel Medicine. 2024;31(4):taae060$63$YR$$M$Y$66.2$KG$20240723$$MD$NL$NL
240570261$24057026$1$I$20230801$20240702$20240706$20240706$EXP$$US-ABBVIE-5826115$ABBVIE$$59$YR$$F$Y$$$20240706$$CN$US$US
240570271$24057027$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826194$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240570281$24057028$1$I$$20240701$20240706$20240706$PER$$US-AMGEN-USASP2024131083$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240570291$24057029$1$I$$20240416$20240706$20240706$PER$$US-AMGEN-USASP2024133630$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240570302$24057030$2$F$20240620$20240805$20240706$20240809$EXP$$US-ABBVIE-5826273$ABBVIE$$73$YR$$F$Y$63.5$KG$20240809$$CN$US$US
240570311$24057031$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032438$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240570321$24057032$1$I$20240101$20240703$20240706$20240706$EXP$$CA-ABBVIE-5827265$ABBVIE$$30$YR$$M$Y$$$20240706$$CN$CA$CA
240570335$24057033$5$F$20230906$20240803$20240706$20240814$EXP$$CZ-AUROBINDO-AUR-APL-2024-029140$AUROBINDO$Mocikova H. Lecba periferniho T-bunecneho lymfomu s hemofagocytujici lymfohistiocytozou. FARMAKOTERAPIE. (Treatment of peripheral T-cell lymphoma with hemophagocytic lymphohistiocytosis). FARMAKOTERAPIE/Pharmacotherapy. 2024;20(6 - Ext 1/2):13-14$41$YR$$F$Y$$$20240814$$MD$CZ$CZ
240570341$24057034$1$I$20240621$20240627$20240706$20240706$PER$$US-AMGEN-USASP2024130192$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240570352$24057035$2$F$20240101$20240712$20240706$20240716$EXP$$ES-AMGEN-ESPSP2024127879$AMGEN$$$$$F$Y$$$20240716$$CN$ES$ES
240570361$24057036$1$I$20240409$20240627$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032012$AUROBINDO$$63$YR$$M$Y$$$20240706$$MD$FR$FR
240570371$24057037$1$I$$20240627$20240706$20240706$EXP$$CA-AUROBINDO-AUR-APL-2024-033158$AUROBINDO$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM.. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. Journal of Analytical Toxicology. 2023;47:385?392$46$YR$$M$Y$$$20240706$$HP$CA$CA
240570381$24057038$1$I$$20240628$20240706$20240706$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-019380$UNITED THERAPEUTICS$$$$$F$Y$$$20240706$$$CA$CA
240570391$24057039$1$I$20240101$20240704$20240706$20240706$EXP$$CA-ABBVIE-5828964$ABBVIE$$$$$F$Y$$$20240706$$CN$CA$CA
240570401$24057040$1$I$$20240627$20240706$20240706$EXP$$NL-ROCHE-10000011240$ROCHE$Lin L, Houwink A, Van Dieren J, Wolthuis E, Van Thienen J. Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitors. Cancer Medicine. 2024-Jun;13 (12): doi:10.1002/cam4.7302.$$$$$Y$$$20240706$$HP$NL$NL
240570411$24057041$1$I$$20240404$20240706$20240706$PER$$US-AMGEN-USASP2024133771$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240570421$24057042$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032436$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240570431$24057043$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032611$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240570441$24057044$1$I$$20240425$20240706$20240706$PER$$US-AMGEN-USASP2024133815$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240570461$24057046$1$I$$20240617$20240706$20240706$EXP$$IN-ROCHE-10000009113$ROCHE$$$$$F$Y$$$20240706$$MD$IN$IN
240570471$24057047$1$I$20230101$20240701$20240706$20240706$EXP$$US-009507513-2407USA000575$MERCK$$$$$F$Y$$$20240706$$CN$US$US
240570482$24057048$2$F$$20240905$20240706$20240911$EXP$$HR-AMGEN-HRVSP2024130204$AMGEN$$56$YR$A$F$Y$$$20240911$$HP$HR$HR
240570491$24057049$1$I$20240408$20240705$20240706$20240706$EXP$GB-MHRA-MED-202405071341477550-VTSPR$GB-ABBVIE-5828419$ABBVIE$$$$$M$Y$$$20240706$$MD$GB$GB
240570501$24057050$1$I$20240511$20240627$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032205$AUROBINDO$$76$YR$$M$Y$57.5$KG$20240706$$MD$FR$FR
240570511$24057051$1$I$$20240509$20240706$20240706$PER$$US-AMGEN-USASP2024133634$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240570521$24057052$1$I$$20240104$20240706$20240706$PER$$US-AMGEN-USASP2024133372$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240570541$24057054$1$I$$20240701$20240706$20240706$PER$$US-SA-2024SA196149$SANOFI AVENTIS$$$$A$M$Y$$$20240706$$MD$US$US
240570551$24057055$1$I$20240101$20240702$20240706$20240706$EXP$$US-ABBVIE-5826051$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240570561$24057056$1$I$$20240619$20240706$20240706$EXP$$JP-JNJFOC-20240714217$JOHNSON AND JOHNSON$$$$$$Y$$$20240706$$HP$JP$JP
240570571$24057057$1$I$$20240219$20240706$20240706$PER$$US-AMGEN-USASP2024133861$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240570581$24057058$1$I$20240630$20240701$20240706$20240706$PER$$US-AMGEN-USASP2024130656$AMGEN$$73$YR$E$F$Y$$$20240706$$CN$US$US
240570591$24057059$1$I$$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133244$AMGEN$$$$$$Y$$$20240706$$MD$US$US
240570602$24057060$2$F$$20240729$20240706$20240802$EXP$$US-ABBVIE-5827015$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
240570611$24057061$1$I$20240629$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132634$AMGEN$$65$YR$E$F$Y$$$20240706$$CN$US$US
240570621$24057062$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032524$AUROBINDO$$$$$M$Y$$$20240706$$CN$GB$GB
240570632$24057063$2$F$20240301$20240822$20240706$20240827$EXP$$US-ABBVIE-5828901$ABBVIE$$82$YR$$F$Y$$$20240827$$CN$US$US
240570641$24057064$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032509$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240570651$24057065$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826282$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240570661$24057066$1$I$$20240616$20240706$20240706$PER$$US-JNJFOC-20240645640$JOHNSON AND JOHNSON$$$$$$Y$$$20240706$$CN$US$US
240570671$24057067$1$I$$20240314$20240706$20240706$PER$$US-AMGEN-USASP2024133839$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240570681$24057068$1$I$$20240702$20240706$20240706$EXP$$BR-ABBVIE-5826175$ABBVIE$$$$$F$Y$$$20240706$$MD$BR$BR
240570691$24057069$1$I$$20240703$20240706$20240706$EXP$$BG-ABBVIE-5827872$ABBVIE$$78$YR$$F$Y$$$20240706$$CN$BG$BG
240570701$24057070$1$I$20240519$20240628$20240706$20240706$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2023-20364$IPSEN$$78$YR$E$F$Y$$$20240706$$CN$GB$GB
240570711$24057071$1$I$$20240701$20240706$20240706$EXP$$US-ABBVIE-5826263$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240570721$24057072$1$I$20240703$20240703$20240706$20240706$PER$$US-ABBVIE-5827275$ABBVIE$$57$YR$$M$Y$$$20240706$$CN$US$US
240570731$24057073$1$I$20240528$20240701$20240706$20240706$EXP$$DE-ABBVIE-5828204$ABBVIE$$30$YR$$M$Y$110$KG$20240706$$MD$DE$DE
240570741$24057074$1$I$20240501$20240612$20240706$20240706$PER$$US-009507513-2406USA004122$MERCK$$$$$M$Y$$$20240706$$CN$US$US
240570751$24057075$1$I$$20240217$20240706$20240706$PER$$US-AMGEN-USASP2024133851$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240570761$24057076$1$I$$20231109$20240706$20240706$PER$$US-AMGEN-USASP2023235621$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240570771$24057077$1$I$$20231121$20240706$20240706$PER$$US-AMGEN-USASP2023235619$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240570782$24057078$2$F$20230101$20240701$20240706$20240709$EXP$$CA-CELLTRION INC.-2023CA022345$CELLTRION$$$$$$Y$$$20240709$$CN$CA$CA
240570791$24057079$1$I$$20240627$20240706$20240706$EXP$$CA-TEVA-VS-3214817$TEVA$$63$YR$$M$Y$$$20240706$$HP$CA$CA
240570801$24057080$1$I$20240701$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024132702$AMGEN$$48$YR$A$F$Y$$$20240706$$CN$US$US
240570811$24057081$1$I$$20240702$20240706$20240706$EXP$$CA-ABBVIE-5826092$ABBVIE$$$$A$F$Y$$$20240706$$CN$CA$CA
240570822$24057082$2$F$20240401$20240705$20240706$20240709$EXP$$US-ABBVIE-5826405$ABBVIE$$57$YR$$F$Y$94$KG$20240709$$CN$US$US
240570832$24057083$2$F$$20240708$20240706$20240716$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020082$UNITED THERAPEUTICS$$$$$M$Y$95.238$KG$20240716$$$US$US
240570844$24057084$4$F$20240628$20240812$20240706$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020058$UNITED THERAPEUTICS$$80$YR$$M$Y$79.365$KG$20240821$$$US$US
240570851$24057085$1$I$$20231106$20240706$20240706$PER$$US-AMGEN-USASP2023235634$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240570861$24057086$1$I$$20240628$20240706$20240706$PER$$US-AMGEN-USASL2024130691$AMGEN$$$$$M$Y$$$20240706$$CN$US$US
240570872$24057087$2$F$$20240815$20240706$20240829$PER$$US-SA-2024SA196921$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240829$$MD$US$US
240570882$24057088$2$F$$20240625$20240706$20240923$PER$$US-TEVA-VS-3214188$TEVA$$80$YR$$F$Y$$$20240923$$PH$US$US
240570894$24057089$4$F$20240630$20240724$20240706$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020267$UNITED THERAPEUTICS$$75$YR$$M$Y$102.49$KG$20240726$$$US$US
240570901$24057090$1$I$20231201$20240701$20240706$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-018887$UNITED THERAPEUTICS$$71$YR$$M$Y$72.562$KG$20240706$$$US$US
240570911$24057091$1$I$19960101$20240703$20240706$20240706$PER$$US-SA-2024SA198519$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240706$$CN$US$US
240570921$24057092$1$I$$20230831$20240706$20240706$PER$$US-AMGEN-USASP2023235620$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240570931$24057093$1$I$$20231229$20240706$20240706$PER$$US-AMGEN-USASP2023235560$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240570942$24057094$2$F$20240325$20240823$20240706$20240902$EXP$$CA-CELLTRION INC.-2024CA003164$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
240570952$24057095$2$F$20240624$20240718$20240706$20240725$PER$$US-AMGEN-USASP2024130585$AMGEN$$73$YR$E$F$Y$99.79$KG$20240725$$CN$US$US
240570962$24057096$2$F$$20240718$20240706$20240724$EXP$$JP-ABBVIE-5828075$ABBVIE$Saburi M, Nishikawa T, Miyazaki Y, Kohno K, Sakata M, Okuhiro K, et al. Real-world outcomes of venetoclax and rituximab for chronic lymphocytic leukemia/small lymphocytic lymphoma: A retrospective analysis of nine Japanese cases. JCEH. 2024;64(2):152-155.$80$YR$$M$Y$$$20240724$$MD$JP$JP
240570971$24057097$1$I$20240101$20240701$20240706$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-020309$UNITED THERAPEUTICS$$$$$M$Y$62.132$KG$20240706$$$US$US
240570981$24057098$1$I$20240101$20240702$20240706$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-013222$UNITED THERAPEUTICS$$$$$F$Y$64.853$KG$20240706$$$US$US
240570991$24057099$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032473$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240571001$24057100$1$I$$20240627$20240706$20240706$EXP$$IT-AUROBINDO-AUR-APL-2024-032811$AUROBINDO$Stano S, Barp A, Bacchin R, Zuccarino R. Parkinsonism may aggravate dysphagia in myotonic  dystrophy type 1:  two case reports. Acta Myol. 2023;41:31-34$75$YR$$F$Y$$$20240706$$HP$IT$IT
240571011$24057101$1$I$20240101$20240702$20240706$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-020466$UNITED THERAPEUTICS$$$$$F$Y$61.678$KG$20240706$$$US$US
240571021$24057102$1$I$20240101$20240702$20240706$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-013861$UNITED THERAPEUTICS$$$$$F$Y$69.841$KG$20240706$$$US$US
240571036$24057103$6$F$20240101$20240822$20240706$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020094$UNITED THERAPEUTICS$$$$$F$Y$61.224$KG$20240831$$$US$US
240571042$24057104$2$F$$20240708$20240706$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-032457$AUROBINDO$$$$$$Y$$$20240717$$CN$GB$GB
240571051$24057105$1$I$$20240628$20240706$20240706$EXP$$CA-ABBVIE-5829139$ABBVIE$$20$YR$$M$Y$$$20240706$$HP$CA$CA
240571061$24057106$1$I$$20240703$20240706$20240706$EXP$$US-ABBVIE-5828554$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240571071$24057107$1$I$20240629$20240702$20240706$20240706$EXP$$US-ABBVIE-5826662$ABBVIE$$80$YR$$F$Y$$$20240706$$CN$US$US
240571081$24057108$1$I$$20240702$20240706$20240706$EXP$$ZA-ABBVIE-5826146$ABBVIE$$75$YR$$F$Y$$$20240706$$PH$ZA$ZA
240571091$24057109$1$I$$20240627$20240706$20240706$PER$$US-AstraZeneca-2024A148725$ASTRAZENECA$$$$$F$Y$$$20240706$$CN$US$
240571101$24057110$1$I$20240101$20240703$20240706$20240706$PER$$PR-ABBVIE-5829701$ABBVIE$$46$YR$$M$Y$$$20240706$$MD$PR$PR
240571111$24057111$1$I$20240514$20240701$20240706$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-014832$UNITED THERAPEUTICS$$65$YR$$F$Y$97.052$KG$20240706$$$US$US
240571121$24057112$1$I$20240702$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132061$AMGEN$$55$YR$A$F$Y$$$20240706$$CN$US$US
240571131$24057113$1$I$20240601$20240702$20240706$20240706$EXP$$US-ABBVIE-5825967$ABBVIE$$50$YR$$M$Y$$$20240706$$CN$US$US
240571142$24057114$2$F$20180101$20240719$20240706$20240726$EXP$$AR-ROCHE-10000015577$ROCHE$$59$YR$A$F$Y$56$KG$20240726$$MD$AR$AR
240571151$24057115$1$I$$20240627$20240706$20240706$PER$$US-TEVA-VS-3215777$TEVA$$$$A$$Y$$$20240706$$CN$US$US
240571161$24057116$1$I$$20240627$20240706$20240706$EXP$$GB-ABBVIE-5828473$ABBVIE$Eissa M, Mathew C, Arora R. Ibrutinib-induced cystoid Macular oedema. J Clin Med Img Case Rep. 2023;3(6):1580.$85$YR$$M$Y$$$20240706$$HP$GB$GB
240571171$24057117$1$I$$20240627$20240706$20240706$EXP$$CA-AUROBINDO-AUR-APL-2024-033157$AUROBINDO$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM.. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. Journal of Analytical Toxicology. 2023;47:385?392$27$YR$$M$Y$$$20240706$$HP$CA$CA
240571181$24057118$1$I$20240618$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132618$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571191$24057119$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281040200250-ZJMNR$GB-TEVA-VS-3215859$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240571201$24057120$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281444339100-ZPDRB$GB-TEVA-VS-3215752$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240571211$24057121$1$I$$20240124$20240706$20240706$PER$$US-AMGEN-USASP2024132357$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571221$24057122$1$I$20240617$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132152$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571231$24057123$1$I$$20240222$20240706$20240706$PER$$US-AMGEN-USASP2024130903$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571241$24057124$1$I$$20230829$20240706$20240706$PER$$US-AMGEN-USASP2023235549$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240571251$24057125$1$I$20240509$20240628$20240706$20240706$EXP$GB-MHRA-MIDB-41044ecb-1347-4981-ac26-69141f820ea3$GB-TEVA-VS-3215808$TEVA$$59$YR$$F$Y$$$20240706$$HP$GB$GB
240571261$24057126$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281413365890-NGPDS$GB-TEVA-VS-3215922$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240571272$24057127$2$F$$20240708$20240706$20240718$EXP$GB-MHRA-MED-202406281441057610-CBYGW$GB-TEVA-VS-3215931$TEVA$$$$$$Y$$$20240718$$CN$GB$GB
240571282$24057128$2$F$20240606$20240807$20240706$20240817$EXP$$GB-TEVA-VS-3215880$TEVA$$89$YR$$F$Y$55$KG$20240817$$PH$GB$GB
240571291$24057129$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826495$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240571301$24057130$1$I$$20231228$20240706$20240706$PER$$US-AMGEN-USASP2023235550$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240571311$24057131$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281441485000-MGTNK$GB-TEVA-VS-3215952$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240571321$24057132$1$I$20240613$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281519521420-KFLNQ$GB-TEVA-VS-3215975$TEVA$$68$YR$$M$Y$75$KG$20240706$$CN$GB$GB
240571331$24057133$1$I$$20240516$20240706$20240706$PER$$US-AMGEN-USASP2024133719$AMGEN$$$$$$Y$$$20240706$$MD$US$US
240571341$24057134$1$I$$20231213$20240706$20240706$PER$$US-AMGEN-USASP2023235551$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571351$24057135$1$I$$20240121$20240706$20240706$PER$$US-AMGEN-USASP2024132453$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240571361$24057136$1$I$$20240220$20240706$20240706$PER$$US-AMGEN-USASP2024132694$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571371$24057137$1$I$$20240102$20240706$20240706$PER$$US-AMGEN-USASP2024132442$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240571381$24057138$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281434234840-MKDNF$GB-TEVA-VS-3216003$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240571391$24057139$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281432034530-LJZCK$GB-TEVA-VS-3216086$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240571401$24057140$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281437236830-WVLTH$GB-TEVA-VS-3215623$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240571412$24057141$2$F$20240627$20240725$20240706$20240814$PER$$US-AstraZeneca-2024A149949$ASTRAZENECA$$26543$DY$$M$Y$$$20240814$$CN$US$
240571421$24057142$1$I$$20240629$20240706$20240706$EXP$GB-MHRA-MED-202406290959216370-ZTQWJ$GB-TEVA-VS-3215917$TEVA$$$$$M$Y$$$20240706$$CN$GB$GB
240571431$24057143$1$I$20240314$20240625$20240706$20240706$EXP$GB-MHRA-MED-202406241152331600-RZSNW$GB-AMAROX PHARMA-AMR2024GB01981$HETERO$$22$YR$$F$Y$53$KG$20240706$$CN$GB$GB
240571441$24057144$1$I$20240501$20240701$20240706$20240706$PER$$US-ABBVIE-5827975$ABBVIE$$$$$$Y$$$20240706$$CN$US$US
240571453$24057145$3$F$20220505$20240828$20240706$20240906$EXP$$CA-CELLTRION INC.-2022CA009129$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
240571461$24057146$1$I$$20240115$20240706$20240706$PER$$US-AMGEN-USASP2024132322$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240571471$24057147$1$I$20240702$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131715$AMGEN$$78$YR$E$F$Y$$$20240706$$CN$US$US
240571481$24057148$1$I$20240630$20240701$20240706$20240706$PER$$US-AMGEN-USASP2024131230$AMGEN$$85$YR$E$F$Y$$$20240706$$CN$US$US
240571491$24057149$1$I$$20240627$20240706$20240706$EXP$$CA-TEVA-VS-3214676$TEVA$$38$YR$$M$Y$$$20240706$$HP$CA$CA
240571501$24057150$1$I$$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024132348$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240571511$24057151$1$I$$20240606$20240706$20240706$PER$$US-AMGEN-USASP2024133178$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571521$24057152$1$I$$20240627$20240706$20240706$EXP$$CA-TEVA-VS-3214689$TEVA$$67$YR$$M$Y$$$20240706$$MD$CA$CA
240571531$24057153$1$I$$20240625$20240706$20240706$EXP$$US-ABBVIE-5830399$ABBVIE$$$$$M$Y$$$20240706$$MD$US$US
240571541$24057154$1$I$$20240627$20240706$20240706$EXP$$CA-TEVA-VS-3214731$TEVA$$45$YR$$F$Y$$$20240706$$MD$CA$CA
240571553$24057155$3$F$$20240629$20240706$20240712$EXP$$CA-ABBVIE-5829148$ABBVIE$$76$YR$$M$Y$$$20240712$$PH$CA$CA
240571561$24057156$1$I$$20240624$20240706$20240706$PER$$US-AstraZeneca-2024A145781$ASTRAZENECA$$$$$M$Y$$$20240706$$CN$US$
240571571$24057157$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5827050$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240571581$24057158$1$I$$20240612$20240706$20240706$PER$$US-009507513-2406USA004112$MERCK$$61$YR$$F$Y$106.58$KG$20240706$$CN$US$US
240571591$24057159$1$I$$20230707$20240706$20240706$PER$$US-AMGEN-USASP2023235623$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240571601$24057160$1$I$$20240606$20240706$20240706$PER$$US-AMGEN-USASP2024132478$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571611$24057161$1$I$20240618$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133614$AMGEN$$85$YR$E$F$Y$$$20240706$$CN$US$US
240571622$24057162$2$F$20240101$20240808$20240706$20240812$PER$$US-AMGEN-USASP2024131118$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
240571631$24057163$1$I$20231103$20240627$20240706$20240706$EXP$FR-AFSSAPS-MP2024001063$FR-BIOCON BIOLOGICS LIMITED-BBL2024004837$BIOCON$$$$$$Y$$$20240706$$PH$FR$FR
240571642$24057164$2$F$$20240627$20240706$20240706$PER$$US-ABBVIE-5828956$ABBVIE$$35$YR$$F$Y$$$20240706$$HP$US$US
240571651$24057165$1$I$$20240627$20240706$20240706$EXP$$CA-TEVA-VS-3215001$TEVA$$27$YR$$M$Y$$$20240706$$HP$CA$CA
240571661$24057166$1$I$$20240701$20240706$20240706$PER$$US-ABBVIE-5827662$ABBVIE$$7$YR$$F$Y$$$20240706$$HP$US$US
240571671$24057167$1$I$$20230731$20240706$20240706$PER$$US-AMGEN-USASP2023235489$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571681$24057168$1$I$$20240226$20240706$20240706$PER$$US-AMGEN-USASP2024131897$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571691$24057169$1$I$$20240603$20240706$20240706$PER$$US-AMGEN-USASP2024132471$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240571701$24057170$1$I$$20240705$20240706$20240706$EXP$GB-MHRA-MED-202405132328117890-HTSGN$GB-ABBVIE-5828835$ABBVIE$$$$$M$Y$$$20240706$$CN$GB$GB
240571711$24057171$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826281$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240571721$24057172$1$I$$20240627$20240706$20240706$EXP$$CA-AUROBINDO-AUR-APL-2024-024442$AUROBINDO$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM.. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. J-Anal-Toxicol. 2023;47(4):385-392$55$YR$$F$Y$$$20240706$$HP$CA$CA
240571731$24057173$1$I$$20240627$20240706$20240706$EXP$$CA-TEVA-VS-3214720$TEVA$$54$YR$$F$Y$68$KG$20240706$$HP$CA$CA
240571741$24057174$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826392$ABBVIE$$$$$$Y$$$20240706$$CN$US$US
240571751$24057175$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826375$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240571761$24057176$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032335$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240571781$24057178$1$I$20210101$20240628$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032454$AUROBINDO$$55$YR$$F$Y$$$20240706$$PH$FR$FR
240571792$24057179$2$F$20240627$20240703$20240706$20240711$PER$$US-AMGEN-USASP2024132676$AMGEN$$77$YR$E$F$Y$$$20240711$$CN$US$US
240571801$24057180$1$I$$20240703$20240706$20240706$EXP$$GB-JNJFOC-20240710219$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240706$$HP$GB$GB
240571811$24057181$1$I$$20240627$20240706$20240706$EXP$$FR-JNJFOC-20240676287$JOHNSON AND JOHNSON$$$$$$Y$$$20240706$$PH$FR$FR
240571821$24057182$1$I$$20240628$20240706$20240706$PER$$US-ROCHE-10000016473$ROCHE$$42$YR$A$F$Y$$$20240706$$CN$US$US
240571831$24057183$1$I$$20240702$20240706$20240706$PER$$US-AstraZeneca-2024A152946$ASTRAZENECA$$$$$F$Y$$$20240706$$HP$US$
240571841$24057184$1$I$$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133144$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571851$24057185$1$I$$20240516$20240706$20240706$PER$$US-AMGEN-USASP2024133696$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571861$24057186$1$I$20231201$20240627$20240706$20240706$EXP$$ES-AUROBINDO-AUR-APL-2024-032219$AUROBINDO$$59$YR$$F$Y$$$20240706$$MD$ES$ES
240571871$24057187$1$I$$20240212$20240706$20240706$PER$$US-AMGEN-USASP2024132585$AMGEN$$$$$$Y$$$20240706$$MD$US$US
240571881$24057188$1$I$$20240318$20240706$20240706$PER$$US-AMGEN-USASP2024132344$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240571891$24057189$1$I$20240623$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131229$AMGEN$$77$YR$E$F$Y$$$20240706$$CN$US$US
240571901$24057190$1$I$20240601$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131276$AMGEN$$74$YR$E$F$Y$$$20240706$$CN$US$US
240571911$24057191$1$I$$20240627$20240706$20240706$EXP$$US-AMGEN-USASP2024129478$AMGEN$Lund T. C.; Gupta A. O.; Furcich J. W. et al.. Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy. Journal of neuroimmunology. 2024;393:1-12$12$YR$T$M$Y$$$20240706$$HP$US$US
240571921$24057192$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826269$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240571936$24057193$6$F$20240628$20240816$20240706$20240826$PER$$US-ROCHE-10000013441$ROCHE$$60$YR$A$F$Y$70.3$KG$20240826$$CN$US$US
240571941$24057194$1$I$$20240627$20240706$20240706$EXP$$CA-TEVA-VS-3214763$TEVA$$33$YR$$M$Y$$$20240706$$HP$CA$CA
240571951$24057195$1$I$$20240702$20240706$20240706$PER$$US-ROCHE-10000016882$ROCHE$$$$A$F$Y$$$20240706$$CN$US$US
240571961$24057196$1$I$$20240702$20240706$20240706$PER$$US-ABBVIE-5827143$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240571971$24057197$1$I$$20240628$20240706$20240706$PER$$US-ROCHE-10000016898$ROCHE$$$$E$F$Y$$$20240706$$CN$US$US
240571981$24057198$1$I$20240604$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132097$AMGEN$$44$YR$A$F$Y$$$20240706$$CN$US$US
240571991$24057199$1$I$20240101$20240626$20240706$20240706$EXP$$ZA-AMGEN-ZAFSL2024128055$AMGEN$$71$YR$E$F$Y$$$20240706$$CN$ZA$ZA
240572001$24057200$1$I$$20240628$20240706$20240706$EXP$$US-AMGEN-USASP2024130022$AMGEN$Khurana S.; Shipley M.; Chandler T. et al.. Clinical characteristics and outcomes of community-acquired pneumonia in solid organ transplant recipients. Respiratory Medicine. 2024;230:1-5$$$$$Y$$$20240706$$HP$US$US
240572011$24057201$1$I$$20240627$20240706$20240706$PER$$US-SA-2024SA192729$SANOFI AVENTIS$$$$$$Y$$$20240706$$CN$US$US
240572021$24057202$1$I$20240606$20240702$20240706$20240706$EXP$$US-ABBVIE-5800397$ABBVIE$$72$YR$$M$Y$$$20240706$$CN$US$US
240572031$24057203$1$I$20240602$20240702$20240706$20240706$EXP$$US-ABBVIE-5826370$ABBVIE$$65$YR$$F$Y$$$20240706$$CN$US$US
240572041$24057204$1$I$20240601$20240701$20240706$20240706$EXP$$US-ABBVIE-5826605$ABBVIE$$66$YR$$F$Y$$$20240706$$CN$US$US
240572051$24057205$1$I$20240626$20240702$20240706$20240706$EXP$$CA-ABBVIE-5826289$ABBVIE$$29$YR$$M$Y$$$20240706$$CN$CA$CA
240572061$24057206$1$I$20240101$20240702$20240706$20240706$EXP$$US-ABBVIE-5826179$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240572072$24057207$2$F$20240617$20240703$20240706$20240715$EXP$$US-ABBVIE-5821157$ABBVIE$$83$YR$$F$Y$86$KG$20240715$$CN$US$US
240572081$24057208$1$I$20240703$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132647$AMGEN$$38$YR$A$F$Y$$$20240706$$CN$US$US
240572091$24057209$1$I$20240604$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131449$AMGEN$$60$YR$A$M$Y$$$20240706$$CN$US$US
240572102$24057210$2$F$20240601$20240702$20240706$20240710$PER$$US-AMGEN-USASP2024132303$AMGEN$$$$$M$Y$$$20240710$$PH$US$US
240572111$24057211$1$I$20240516$20240702$20240706$20240706$EXP$$US-ABBVIE-5826212$ABBVIE$$72$YR$$F$Y$$$20240706$$CN$US$US
240572121$24057212$1$I$20240101$20240701$20240706$20240706$EXP$$US-ABBVIE-5827857$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240572131$24057213$1$I$20240302$20240627$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032014$AUROBINDO$$88$YR$$M$Y$70$KG$20240706$$MD$FR$FR
240572141$24057214$1$I$$20240702$20240706$20240706$EXP$$CA-ABBVIE-5826278$ABBVIE$$24$YR$$F$Y$$$20240706$$CN$CA$CA
240572151$24057215$1$I$20240605$20240702$20240706$20240706$EXP$$UY-ABBVIE-5826058$ABBVIE$$41$YR$$M$Y$$$20240706$$CN$UY$UY
240572161$24057216$1$I$$20240702$20240706$20240706$PER$$US-ABBVIE-5829330$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240572174$24057217$4$F$20231117$20240919$20240706$20240928$EXP$$CA-CELLTRION INC.-2023CA022646$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
240572181$24057218$1$I$20240605$20240701$20240706$20240706$EXP$$BR-ABBVIE-5830448$ABBVIE$$$$$F$Y$$$20240706$$CN$BR$BR
240572191$24057219$1$I$$20240703$20240706$20240706$PER$$US-ABBVIE-5827249$ABBVIE$$$$$$Y$$$20240706$$MD$US$US
240572201$24057220$1$I$$20240627$20240706$20240706$EXP$$CA-AUROBINDO-AUR-APL-2024-033134$AUROBINDO$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM.. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. Journal of Analytical Toxicology. 2023;47:385?392$28$YR$$F$Y$$$20240706$$HP$CA$CA
240572211$24057221$1$I$$20240221$20240706$20240706$PER$$US-AMGEN-USASP2024132464$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240572221$24057222$1$I$$20240627$20240706$20240706$30DAY$$US-GSK-US2024080415$GLAXOSMITHKLINE$$$$$F$Y$$$20240706$$CN$US$US
240572231$24057223$1$I$$20240702$20240706$20240706$PER$$US-ABBVIE-5826780$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240572241$24057224$1$I$$20240703$20240706$20240706$EXP$$BR-ABBVIE-5826073$ABBVIE$$$$$F$Y$$$20240706$$CN$BR$BR
240572251$24057225$1$I$20240601$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131710$AMGEN$$64$YR$A$M$Y$$$20240706$$CN$US$US
240572261$24057226$1$I$$20240530$20240706$20240706$PER$$US-AMGEN-USASP2024132381$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240572271$24057227$1$I$$20231106$20240706$20240706$PER$$US-AMGEN-USASP2023235627$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240572281$24057228$1$I$20240701$20240702$20240706$20240706$EXP$$US-ABBVIE-5827235$ABBVIE$$63$YR$$M$Y$$$20240706$$CN$US$US
240572291$24057229$1$I$$20240627$20240706$20240706$EXP$$CA-AUROBINDO-AUR-APL-2024-033155$AUROBINDO$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM.. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. Journal of Analytical Toxicology. 2023;47:385?392$54$YR$$M$Y$$$20240706$$HP$CA$CA
240572301$24057230$1$I$20240101$20240628$20240706$20240706$PER$$US-SA-2024SA195699$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240706$$MD$US$US
240572311$24057231$1$I$$20240621$20240706$20240706$EXP$$JP-AMGEN-JPNSP2024132511$AMGEN$Nishi K, Hasegawa T, Yamato Y, Yoshida G, Banno T, Arima H, et al... Reshrinkage of Giant-Cell Tumor of the Bone in the Thoracic Vertebrae after Resumption of Denosumab Treatment: A Case Report.. Spine Surg Relat Res. 2024;8:347-51$76$YR$E$F$Y$$$20240706$$MD$JP$JP
240572322$24057232$2$F$20240101$20240805$20240706$20240813$PER$$US-SA-2024SA191675$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240814$$MD$US$US
240572331$24057233$1$I$20240622$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132616$AMGEN$$71$YR$E$M$Y$$$20240706$$CN$US$US
240572341$24057234$1$I$20240702$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133263$AMGEN$$76$YR$E$F$Y$$$20240706$$CN$US$US
240572351$24057235$1$I$$20240703$20240706$20240706$EXP$$US-SANDOZ INC.-SDZ2024US063027$SANDOZ$$$$$M$Y$$$20240706$$MD$US$US
240572362$24057236$2$F$$20240628$20240706$20240723$EXP$$CA-CELLTRION INC.-2024CA015770$CELLTRION$$$$$$Y$$$20240723$$HP$CA$CA
240572373$24057237$3$F$20240601$20240822$20240706$20240829$EXP$$CA-CELLTRION INC.-2024CA015785$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
240572381$24057238$1$I$20240101$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132928$AMGEN$$43$YR$A$M$Y$$$20240706$$HP$US$US
240572391$24057239$1$I$20240101$20240627$20240706$20240706$PER$$US-SA-2024SA192849$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240706$$MD$US$US
240572401$24057240$1$I$$20240702$20240706$20240706$PER$$US-SA-2024SA198657$SANOFI AVENTIS$$$$E$F$Y$$$20240706$$CN$US$US
240572411$24057241$1$I$$20240626$20240706$20240706$EXP$$US-RDY-LIT/USA/24/0009684$DR REDDYS$Puri C, Khan AA, Sher N. A Case of Emphysematous Gastritis With Septic Shock and Clostridioides Difficile. American Journal of Respiratory and Critical Care Medicine. 2024 May;209(0): A1630. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1630.$72$YR$E$F$Y$$$20240706$$HP$US$US
240572421$24057242$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826361$ABBVIE$$$$$$Y$$$20240706$$CN$US$US
240572431$24057243$1$I$20240101$20240703$20240706$20240706$EXP$$US-ABBVIE-5828456$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240572441$24057244$1$I$20240630$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131870$AMGEN$$78$YR$E$M$Y$$$20240706$$PH$US$US
240572452$24057245$2$F$20240303$20240723$20240706$20240803$EXP$$FR-AUROBINDO-AUR-APL-2024-032175$AUROBINDO$$44$YR$$F$Y$$$20240803$$PH$FR$FR
240572461$24057246$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281425089800-RYTVB$GB-TEVA-VS-3216077$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240572471$24057247$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281429282700-HZCNF$GB-TEVA-VS-3215841$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240572481$24057248$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281432323530-HKSTC$GB-TEVA-VS-3215980$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240572491$24057249$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281504408720-TKDCS$GB-TEVA-VS-3215995$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240572501$24057250$1$I$$20240701$20240706$20240706$EXP$$US-HETERO-HET2024US02115$HETERO$Patel D, Zafar P, Nasrullah A, Patel D, Holden K, Balaan MR. Community Acquired Pneumonia or Hydralazine-Induced Vasculitis - A Clinical Dilemma. American Journal Respiratory Critical Care Medicine. 2024;209:A2014$82$YR$$F$Y$$$20240706$$HP$US$US
240572511$24057251$1$I$20240628$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281641059960-RTYKS$GB-TEVA-VS-3216008$TEVA$$73$YR$$F$Y$49$KG$20240706$$PH$GB$GB
240572521$24057252$1$I$20240122$20240627$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032276$AUROBINDO$$59$YR$$M$Y$$$20240706$$MD$FR$FR
240572531$24057253$1$I$$20240626$20240706$20240706$EXP$$AT-STL-000209$Stallion Laboratories$Finsterer J. Glofitamab-Associated Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Presenting as Serial Seizures and Responding Positively to Antiseizure Drugs and Anakinra: A Case Report. Cureus. 2024 May 22;16(5):e60833. doi: 10.7759/cureus.60833.$63$YR$$M$Y$$$20240706$$HP$AT$AT
240572541$24057254$1$I$$20240627$20240706$20240706$EXP$$CA-AUROBINDO-AUR-APL-2024-033156$AUROBINDO$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. Journal of Analytical Toxicology. 2023;47:385?392$21$YR$$M$Y$$$20240706$$HP$CA$CA
240572551$24057255$1$I$20240702$20240702$20240706$20240706$PER$$US-SA-2024SA197149$SANOFI AVENTIS$$$$A$M$Y$$$20240706$$MD$US$US
240572561$24057256$1$I$$20240627$20240706$20240706$EXP$$CA-AUROBINDO-AUR-APL-2024-033160$AUROBINDO$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM.. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. Journal of Analytical Toxicology. 2023;47:385?392$50$YR$$M$Y$$$20240706$$HP$CA$CA
240572571$24057257$1$I$20240401$20240703$20240706$20240706$EXP$$US-ABBVIE-5826184$ABBVIE$$71$YR$$M$Y$$$20240706$$CN$US$US
240572581$24057258$1$I$20240703$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132481$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240572591$24057259$1$I$20240414$20240626$20240706$20240706$EXP$FR-AFSSAPS-TO2024000811$FR-AMGEN-FRASP2024126659$AMGEN$$39$YR$A$F$Y$44$KG$20240706$$CN$FR$FR
240572601$24057260$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826300$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240572611$24057261$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826547$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240572621$24057262$1$I$20240101$20240702$20240706$20240706$EXP$$US-ABBVIE-5826698$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240572631$24057263$1$I$$20240627$20240706$20240706$EXP$$CA-TEVA-VS-3214857$TEVA$$77$YR$$M$Y$$$20240706$$PH$CA$CA
240572641$24057264$1$I$20240515$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032202$AUROBINDO$$59$YR$$M$Y$104$KG$20240706$$PH$GB$GB
240572652$24057265$2$F$$20240911$20240706$20240918$PER$$US-SA-2024SA195506$SANOFI AVENTIS$$12$YR$T$F$Y$34$KG$20240918$$MD$US$US
240572661$24057266$1$I$$20240606$20240706$20240706$PER$$US-AMGEN-USASP2024133735$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240572671$24057267$1$I$$20240627$20240706$20240706$EXP$$CA-TEVA-VS-3214998$TEVA$$40$YR$$F$Y$$$20240706$$HP$CA$CA
240572682$24057268$2$F$20240701$20240709$20240706$20240727$PER$$US-AMGEN-USASP2024132457$AMGEN$$68$YR$E$F$Y$$$20240727$$HP$US$US
240572691$24057269$1$I$$20230706$20240706$20240706$PER$$US-AMGEN-USASP2023235626$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240572701$24057270$1$I$$20231113$20240706$20240706$PER$$US-AMGEN-USASP2023235615$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240572712$24057271$2$F$20240105$20240710$20240706$20240725$EXP$LT-SMCA-9230N$LT-TEVA-VS-3164276$TEVA$$37$YR$$M$Y$84$KG$20240725$$CN$LT$LT
240572722$24057272$2$F$20240501$20240826$20240706$20240828$EXP$$CA-ABBVIE-5827699$ABBVIE$$58$YR$$F$Y$$$20240828$$CN$CA$CA
240572731$24057273$1$I$$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133096$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240572741$24057274$1$I$$20240627$20240706$20240706$PER$$US-ABBVIE-5826139$ABBVIE$$53$YR$$F$Y$$$20240706$$HP$US$US
240572751$24057275$1$I$20240401$20240702$20240706$20240706$EXP$$US-ABBVIE-5828982$ABBVIE$$39$YR$$M$Y$$$20240706$$CN$US$US
240572764$24057276$4$F$20240201$20240913$20240706$20240919$EXP$$US-ABBVIE-5828218$ABBVIE$$68$YR$$F$Y$64$KG$20240919$$CN$US$US
240572771$24057277$1$I$20190501$20240702$20240706$20240706$EXP$$US-ABBVIE-5828575$ABBVIE$$51$YR$$F$Y$$$20240706$$CN$US$US
240572781$24057278$1$I$20240702$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131700$AMGEN$$63$YR$A$M$Y$$$20240706$$MD$US$US
240572791$24057279$1$I$$20240701$20240706$20240706$PER$$US-AMGEN-USASP2024130824$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240572802$24057280$2$F$20240703$20240708$20240706$20240714$PER$$US-AMGEN-USASP2024132718$AMGEN$$68$YR$E$M$Y$$$20240714$$CN$US$US
240572812$24057281$2$F$20240109$20240816$20240706$20240822$30DAY$$US-AMGEN-USASP2024129024$AMGEN$$88$YR$E$F$Y$$$20240822$$PH$US$US
240572841$24057284$1$I$$20240705$20240706$20240706$EXP$GB-MHRA-MED-202405160826169790-NJRVM$GB-ABBVIE-5829526$ABBVIE$$$$$F$Y$63$KG$20240706$$PH$GB$GB
240572851$24057285$1$I$$20240628$20240706$20240706$PER$$US-SA-2024SA196682$SANOFI AVENTIS$$$$C$M$Y$$$20240706$$MD$US$US
240572861$24057286$1$I$$20231010$20240706$20240706$PER$$US-AMGEN-USASP2023235618$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240572871$24057287$1$I$20240501$20240701$20240706$20240706$EXP$$NVSC2024BR138828$NOVARTIS$$62$YR$$F$Y$$$20240706$$CN$BR$BR
240572881$24057288$1$I$20130101$20240627$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032091$AUROBINDO$$$$$F$Y$87$KG$20240706$$HP$GB$GB
240572891$24057289$1$I$$20231113$20240706$20240706$PER$$US-AMGEN-USASP2023235616$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240572901$24057290$1$I$$20231113$20240706$20240706$PER$$US-AMGEN-USASP2023235631$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240572911$24057291$1$I$$20240627$20240706$20240706$EXP$$CA-AUROBINDO-AUR-APL-2024-033163$AUROBINDO$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM.. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. Journal of Analytical Toxicology. 2023;47:385?392$$$$M$Y$$$20240706$$HP$CA$CA
240572921$24057292$1$I$$20240629$20240706$20240706$EXP$$PT-AUROBINDO-AUR-APL-2024-029435$AUROBINDO$Pina R, Santos M, Rodrigues D. PERIOPERATIVE MANAGEMENT OF A PATIENT WITH HEMOPHILIA A UNDERGOING TOTAL KNEE ARTHROPLASTY(TKA). Region-Anesth-Pain-Med. 2022;47(1):A191-A191$30$YR$$M$Y$$$20240706$$MD$PT$PT
240572931$24057293$1$I$$20240301$20240706$20240706$PER$$US-AMGEN-USASP2024133872$AMGEN$$$$$$Y$$$20240706$$MD$US$US
240572942$24057294$2$F$$20240708$20240706$20240709$PER$$US-AMGEN-USASP2024129719$AMGEN$$$$$F$Y$$$20240709$$MD$US$US
240572951$24057295$1$I$20220301$20240626$20240706$20240706$EXP$$JP-ABBVIE-2219937US$ABBVIE$$20$YR$$M$Y$$$20240706$$MD$JP$JP
240572961$24057296$1$I$$20240702$20240706$20240706$EXP$$PH-TAKEDA-2024TUS068674$TAKEDA$$$$$$Y$$$20240706$$MD$PH$PH
240572971$24057297$1$I$$20240701$20240706$20240706$PER$$US-ABBVIE-5826246$ABBVIE$$$$A$F$Y$$$20240706$$HP$US$US
240572981$24057298$1$I$$20240605$20240706$20240706$PER$$US-AMGEN-USASP2024133677$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240572991$24057299$1$I$20240702$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131788$AMGEN$$$$$F$Y$$$20240706$$CN$US$US
240573001$24057300$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032630$AUROBINDO$$$$$F$Y$$$20240706$$CN$GB$GB
240573011$24057301$1$I$20240610$20240625$20240706$20240706$EXP$$CA-TEVA-VS-3217295$TEVA$$30$YR$$F$Y$$$20240706$$CN$CA$CA
240573021$24057302$1$I$$20230706$20240706$20240706$PER$$US-AMGEN-USASP2023235625$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240573061$24057306$1$I$$20240613$20240706$20240706$PER$$US-009507513-2406USA004682$MERCK$$$$$$Y$$$20240706$$HP$US$US
240573071$24057307$1$I$20240206$20240701$20240706$20240706$EXP$$DE-CELLTRION INC.-2024DE016222$CELLTRION$$$$$$Y$$$20240706$$MD$DE$DE
240573084$24057308$4$F$20240703$20240813$20240706$20240815$EXP$$TW-ABBVIE-5829702$ABBVIE$$53$YR$$F$Y$$$20240815$$CN$TW$TW
240573093$24057309$3$F$20240601$20240813$20240706$20240827$PER$$US-SA-2024SA197020$SANOFI AVENTIS$$68$YR$E$F$Y$66.2$KG$20240827$$MD$US$US
240573101$24057310$1$I$$20240701$20240706$20240706$PER$$US-SA-2024SA196993$SANOFI AVENTIS$$$$A$M$Y$92$KG$20240706$$MD$US$US
240573111$24057311$1$I$$20240627$20240706$20240706$EXP$$CA-AUROBINDO-AUR-APL-2024-033154$AUROBINDO$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM.. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. Journal of Analytical Toxicology. 2023;47:385?392$48$YR$$M$Y$$$20240706$$HP$CA$CA
240573123$24057312$3$F$20240418$20240722$20240706$20240724$EXP$$JP-TAKEDA-2024TUS067944$TAKEDA$$78$YR$$F$Y$47.5$KG$20240724$$MD$JP$JP
240573132$24057313$2$F$$20240702$20240706$20240709$PER$$US-ROCHE-10000018297$ROCHE$$31$YR$A$F$Y$$$20240709$$HP$US$US
240573141$24057314$1$I$$20240701$20240706$20240706$PER$$US-AMGEN-USASP2024131622$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240573152$24057315$2$F$20240703$20240715$20240706$20240717$PER$$US-AMGEN-USASP2024132582$AMGEN$$74$YR$E$F$Y$$$20240717$$HP$US$US
240573161$24057316$1$I$$20240627$20240706$20240706$EXP$$US-GSK-US2024AMR081250$GLAXOSMITHKLINE$$$$$F$Y$$$20240706$$CN$US$US
240573171$24057317$1$I$20240701$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131874$AMGEN$$62$YR$A$M$Y$$$20240706$$CN$US$US
240573181$24057318$1$I$20240101$20240702$20240706$20240706$PER$$US-ABBVIE-5826884$ABBVIE$$$$$M$Y$$$20240706$$MD$US$US
240573192$24057319$2$F$$20240702$20240706$20240711$PER$$US-ABBVIE-5827310$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240573202$24057320$2$F$$20240708$20240706$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-032508$AUROBINDO$Contag CA, Studemeister L, Bogler Y, Cooper JD. Q fever presenting as splenic infarct without endocarditis. IDCases. 2024;37:e02012$44$YR$$M$Y$$$20240718$$MD$US$US
240573211$24057321$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032531$AUROBINDO$$30$YR$$M$Y$$$20240706$$HP$GB$GB
240573221$24057322$1$I$$20240627$20240706$20240706$PER$$US-ABBVIE-5826210$ABBVIE$$50$YR$$F$Y$$$20240706$$HP$US$US
240573231$24057323$1$I$20240521$20240628$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032359$AUROBINDO$$68$YR$$M$Y$$$20240706$$MD$FR$FR
240573241$24057324$1$I$20210208$20240702$20240706$20240706$EXP$$US-TAKEDA-US201804477$TAKEDA$$31$YR$$F$Y$82.54$KG$20240706$$CN$US$US
240573251$24057325$1$I$$20240627$20240706$20240706$PER$$US-ABBVIE-5826224$ABBVIE$$54$YR$$M$Y$$$20240706$$HP$US$US
240573261$24057326$1$I$$20240626$20240706$20240706$EXP$CA-MHPD-E2B_07080809$CA-Accord-432765$ACCORD$$40$YR$A$F$Y$$$20240706$$MD$CA$CA
240573271$24057327$1$I$20231208$20240626$20240706$20240706$EXP$FR-AFSSAPS-2024055466$FR-Accord-432931$ACCORD$$61$YR$A$M$Y$86.9$KG$20240706$$MD$FR$FR
240573282$24057328$2$F$$20240705$20240706$20240717$EXP$$KR-Accord-432984$ACCORD$Kim J, Lee J, Lee S, Kim K. Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report. Medicina. 2024;60(6):992.$79$YR$E$M$Y$$$20240717$$HP$KR$KR
240573291$24057329$1$I$20240516$20240626$20240706$20240706$EXP$$BR-Accord-432093$ACCORD$$58$YR$A$F$Y$72.8$KG$20240706$$PH$BR$BR
240573301$24057330$1$I$20230730$20240626$20240706$20240706$EXP$GB-MHRA-MED-202406251749470470-SQZKD$GB-Accord-432980$ACCORD$$70$YR$E$F$Y$$$20240706$$PH$GB$GB
240573311$24057331$1$I$20231201$20240626$20240706$20240706$EXP$FR-AFSSAPS-LY2024000922$FR-Accord-432935$ACCORD$$73$YR$E$F$Y$76$KG$20240706$$PH$FR$FR
240573321$24057332$1$I$$20240702$20240706$20240706$EXP$$GB-AMGEN-GBRSP2024131582$AMGEN$$$$$F$Y$$$20240706$$HP$GB$GB
240573331$24057333$1$I$$20231127$20240706$20240706$PER$$US-AMGEN-USASP2023235614$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240573341$24057334$1$I$$20240701$20240706$20240706$EXP$$US-ABBVIE-5830466$ABBVIE$$$$A$$Y$$$20240706$$CN$US$US
240573351$24057335$1$I$20240611$20240701$20240706$20240706$EXP$$JP-SA-2024SA193495$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240706$$PH$JP$JP
240573371$24057337$1$I$$20231206$20240706$20240706$PER$$US-AMGEN-USASP2023235622$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240573382$24057338$2$F$20240705$20240710$20240706$20240712$PER$$US-AMGEN-USASP2024133910$AMGEN$$71$YR$E$F$Y$$$20240712$$CN$US$US
240573391$24057339$1$I$$20240628$20240706$20240706$EXP$$US-AUROBINDO-AUR-APL-2024-033095$AUROBINDO$$33$YR$$F$Y$$$20240706$$HP$US$US
240573401$24057340$1$I$$20240628$20240706$20240706$EXP$$PL-AUROBINDO-AUR-APL-2024-032333$AUROBINDO$$71$YR$$$Y$$$20240706$$HP$PL$PL
240573411$24057341$1$I$$20240627$20240706$20240706$EXP$$US-AMGEN-USASP2024128061$AMGEN$Dispenzieri A.. Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures. Leukemia. 2024;38(6):1423-1426$$$$$Y$$$20240706$$HP$US$US
240573421$24057342$1$I$$20240701$20240706$20240706$PER$$US-ROCHE-10000017567$ROCHE$$3$YR$C$M$Y$$$20240706$$CN$US$US
240573431$24057343$1$I$$20240701$20240706$20240706$PER$$US-ROCHE-10000017127$ROCHE$$$$C$M$Y$$$20240706$$CN$US$US
240573441$24057344$1$I$$20240629$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032472$AUROBINDO$$$$$M$Y$$$20240706$$CN$GB$GB
240573451$24057345$1$I$$20230613$20240706$20240706$PER$$US-ABBVIE-5830662$ABBVIE$$$$$$Y$$$20240706$$CN$US$US
240573461$24057346$1$I$$20240412$20240706$20240706$EXP$$CA-TEVA-VS-3198651$TEVA$$65$YR$$F$Y$$$20240706$$HP$CA$CA
240573471$24057347$1$I$$20240626$20240706$20240706$PER$$US-ROCHE-10000015792$ROCHE$$$$$$Y$$$20240706$$CN$US$US
240573481$24057348$1$I$$20240626$20240706$20240706$PER$$US-ROCHE-10000015837$ROCHE$$8$YR$C$M$Y$$$20240706$$CN$US$US
240573491$24057349$1$I$$20240626$20240706$20240706$PER$$US-ROCHE-10000015843$ROCHE$$5$YR$C$M$Y$$$20240706$$CN$US$US
240573501$24057350$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826276$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240573511$24057351$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826301$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240573521$24057352$1$I$20210101$20240702$20240706$20240706$EXP$$US-ABBVIE-5826188$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240573531$24057353$1$I$20240402$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406252245009800-ZDLYG$GB-TEVA-VS-3215551$TEVA$$12$YR$$M$Y$36$KG$20240706$$CN$GB$GB
240573541$24057354$1$I$20240703$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133478$AMGEN$$72$YR$E$F$Y$$$20240706$$CN$US$US
240573551$24057355$1$I$$20230627$20240706$20240706$PER$$US-AMGEN-USASP2023235636$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240573561$24057356$1$I$20240613$20240629$20240706$20240706$EXP$$ES-AUROBINDO-AUR-APL-2024-032563$AUROBINDO$$61$YR$$F$Y$$$20240706$$MD$ES$ES
240573571$24057357$1$I$$20231228$20240706$20240706$PER$$US-AMGEN-USASP2023235632$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240573581$24057358$1$I$$20240623$20240706$20240706$EXP$$TR-MankindUS-000214$MANKIND PHARMA$Unal O, Turker AH, Akcam FZ. A Case Report of Black Hairy Tongue (Melanotrichia Linguae or Lingua Pilosa Nigra). Cureus. 2024 May 20;16(5):e60685.$64$YR$A$M$Y$$$20240706$$HP$TR$TR
240573591$24057359$1$I$20240625$20240704$20240706$20240706$PER$$US-ROCHE-10000017324$ROCHE$$11$YR$C$M$Y$37.65$KG$20240706$$CN$US$US
240573601$24057360$1$I$$20240617$20240706$20240706$PER$$US-TEVA-VS-3212232$TEVA$Nguyen D-D, Herzog P, Cone EB, Labban M, Zorn KC, Chughtai B, et al. Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase. J-Am-Acad-Dermatol 2023; 88 (1): 179-181.; Nguyen D-D, Herzog P, Cone EB, Labban M, Zorn KC, Chughtai B, et al. Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance an...$$$$M$Y$$$20240706$$MD$US$CA
240573611$24057361$1$I$20240613$20240627$20240706$20240706$PER$$US-SA-2024SA191687$SANOFI AVENTIS$$$$A$$Y$$$20240706$$HP$US$US
240573622$24057362$2$F$20240506$20240710$20240706$20240718$PER$$US-SA-2024SA197023$SANOFI AVENTIS$$68$YR$E$F$Y$108$KG$20240718$$PH$US$US
240573631$24057363$1$I$$20240628$20240706$20240706$EXP$$TN-NOVITIUMPHARMA-2024TNNVP01152$NOVITIUM PHARMA$Ben Hammamia.Neurotoxicity Related to Multidrug Association: A Case Report.Journal of Clinical Psychopharmacology.05-JUN-2024;44(3):317-319$57$YR$A$F$Y$$$20240706$$HP$TN$TN
240573641$24057364$1$I$20240601$20240628$20240706$20240706$EXP$$US-AMGEN-USASP2024120271$AMGEN$$65$YR$E$M$Y$$$20240706$$CN$US$US
240573651$24057365$1$I$20200228$20240626$20240706$20240706$PER$$US-INCYTE CORPORATION-2024IN006839$INCYTE$$$$$$Y$$$20240706$$CN$US$US
240573661$24057366$1$I$20240601$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024132756$AMGEN$$69$YR$$$Y$$$20240706$$HP$US$US
240573671$24057367$1$I$$20240704$20240706$20240706$PER$$US-AMGEN-USASP2024133432$AMGEN$$$$$F$Y$$$20240706$$CN$US$US
240573681$24057368$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032641$AUROBINDO$$$$$F$Y$$$20240706$$CN$GB$GB
240573691$24057369$1$I$$20240627$20240706$20240706$PER$$US-TEVA-VS-3214992$TEVA$$$$A$F$Y$$$20240706$$CN$US$US
240573701$24057370$1$I$20240101$20240628$20240706$20240706$EXP$$US-AMGEN-USASL2024129590$AMGEN$$67$YR$E$M$Y$$$20240706$$CN$US$US
240573711$24057371$1$I$$20240628$20240706$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020014$UNITED THERAPEUTICS$$$$$M$Y$$$20240706$$$US$US
240573721$24057372$1$I$$20240701$20240706$20240706$EXP$$US-ABBVIE-5826080$ABBVIE$$5$YR$$F$Y$$$20240706$$CN$US$US
240573731$24057373$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032192$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240573741$24057374$1$I$$20240628$20240706$20240706$EXP$$US-NOVITIUMPHARMA-2024USNVP01154$NOVITIUM PHARMA$R. Hoerle.A Last Resort: Lipid Emulsion Therapy in Lidocaine Anesthetic Systemic Toxicity (LAST).American Journal of Respiratory and Critical Care Medicine .21-MAY-2024;209:A5683 - A5683$81$YR$E$F$Y$$$20240706$$HP$US$US
240573751$24057375$1$I$$20240625$20240706$20240706$EXP$$ZA-MACLEODS PHARMA-MAC2024047926$MACLEODS$$$$$$Y$$$20240706$$CN$ZA$ZA
240573761$24057376$1$I$$20240625$20240706$20240706$EXP$$US-MACLEODS PHARMA-MAC2024047925$MACLEODS$$$$$$Y$$$20240706$$CN$US$US
240573771$24057377$1$I$$20240625$20240706$20240706$EXP$$ZA-MACLEODS PHARMA-MAC2024047954$MACLEODS$$$$$$Y$$$20240706$$CN$ZA$ZA
240573781$24057378$1$I$$20240625$20240706$20240706$EXP$$ES-MACLEODS PHARMA-MAC2024047989$MACLEODS$Asensio-Sanchez VM, Lopez-Minarro I..Woman with vigorexia experiencing severe bilateral vision loss.Archivos de la Sociedad Espanola de Oftalmologia(Engl Ed).18-JUN-2024;S2173-5794(24)00106-3$$$$$Y$$$20240706$$HP$ES$ES
240573791$24057379$1$I$$20240703$20240706$20240706$PER$$US-ABBVIE-5828452$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240573801$24057380$1$I$$20240617$20240706$20240706$PER$$US-TEVA-VS-3212241$TEVA$Nguyen D-D, Herzog P, Cone EB, Labban M, Zorn KC, Chughtai B, et al. Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase. J-Am-Acad-Dermatol 2023; 88 (1): 179-181.; Nguyen D-D, Herzog P, Cone EB, Labban M, Zorn KC, Chughtai B, et al. Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance an...$$$$M$Y$$$20240706$$MD$US$CA
240573811$24057381$1$I$$20240210$20240706$20240706$PER$$US-AMGEN-USASP2024133488$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240573821$24057382$1$I$$20240627$20240706$20240706$PER$$US-SA-2024SA195385$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240706$$HP$US$US
240573831$24057383$1$I$20230801$20240704$20240706$20240706$EXP$$BR-ABBVIE-5828717$ABBVIE$$25$YR$$F$Y$63$KG$20240706$$CN$BR$BR
240573841$24057384$1$I$$20240109$20240706$20240706$PER$$US-AMGEN-USASP2024133810$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240573852$24057385$2$F$20240702$20240821$20240706$20240826$PER$$US-AMGEN-USASP2024133489$AMGEN$$84$YR$E$F$Y$$$20240825$$CN$US$US
240573861$24057386$1$I$20240629$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131451$AMGEN$$64$YR$A$F$Y$$$20240706$$CN$US$US
240573871$24057387$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032632$AUROBINDO$$73$YR$$$Y$$$20240706$$PH$GB$GB
240573891$24057389$1$I$20240101$20240702$20240706$20240706$EXP$$US-ABBVIE-5825931$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240573901$24057390$1$I$$20240628$20240706$20240706$EXP$$IT-AUROBINDO-AUR-APL-2024-032421$AUROBINDO$Federica, F. Surgical treatment of invasive fungal infection in pediatric oncology. European Journal of Haematology. 2024;113 (1):90-98$6$YR$$F$Y$$$20240706$$HP$IT$IT
240573911$24057391$1$I$20240624$20240627$20240706$20240706$PER$$US-ABBVIE-5823743$ABBVIE$$38$YR$$F$Y$96$KG$20240706$$MD$US$US
240573921$24057392$1$I$$20240702$20240706$20240706$PER$$US-ABBVIE-5828245$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240573931$24057393$1$I$20240415$20240705$20240706$20240706$EXP$FR-AFSSAPS-LL2024001071$FR-ROCHE-10000017870$ROCHE$$74$YR$E$M$Y$70$KG$20240706$$PH$FR$FR
240573941$24057394$1$I$20240117$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032618$AUROBINDO$$52$YR$$F$Y$$$20240706$$MD$GB$GB
240573951$24057395$1$I$20230701$20240628$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032713$AUROBINDO$$66$YR$$F$Y$$$20240706$$MD$FR$FR
240573961$24057396$1$I$20240301$20240704$20240706$20240706$EXP$FR-AFSSAPS-SE2024000456$FR-ROCHE-10000016731$ROCHE$$91$YR$E$F$Y$43.5$KG$20240706$$MD$FR$FR
240573971$24057397$1$I$$20240112$20240706$20240706$PER$$US-AMGEN-USASP2024133754$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240573981$24057398$1$I$20240620$20240628$20240706$20240706$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-020554$UNITED THERAPEUTICS$$69$YR$$F$Y$$$20240706$$$JP$JP
240573991$24057399$1$I$$20240627$20240706$20240706$PER$$US-SA-2024SA192455$SANOFI AVENTIS$$$$A$F$Y$$$20240706$$CN$US$US
240574001$24057400$1$I$$20240623$20240706$20240706$EXP$$US-MankindUS-000213$MANKIND PHARMA$Sheth K, Odukoya D, Joseph K, Agarwal A. An Uncommon Side Effect of Baclofen Withdrawal in End Stage Renal Disease. Cureus. 2024 May 16;16(5):e60411.$77$YR$E$M$Y$$$20240706$$HP$US$
240574012$24057401$2$F$$20240719$20240706$20240730$EXP$$PT-AUROBINDO-AUR-APL-2024-032356$AUROBINDO$$82$YR$$F$Y$$$20240730$$PH$PT$PT
240574021$24057402$1$I$20240702$20240703$20240706$20240706$PER$$US-ABBVIE-5827801$ABBVIE$$27$YR$$F$Y$$$20240706$$MD$US$US
240574031$24057403$1$I$$20240701$20240706$20240706$EXP$$US-JNJFOC-20240707124$JOHNSON AND JOHNSON$$$$$$Y$$$20240706$$HP$US$US
240574043$24057404$3$F$20240630$20240903$20240706$20240904$PER$$US-AMGEN-USASP2024130918$AMGEN$$68$YR$E$F$Y$$$20240904$$CN$US$US
240574051$24057405$1$I$$20230502$20240706$20240706$PER$$US-AMGEN-USASP2023235637$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240574061$24057406$1$I$20240701$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131183$AMGEN$$$$$F$Y$$$20240706$$CN$US$US
240574071$24057407$1$I$$20230412$20240706$20240706$PER$$US-AMGEN-USASP2023235638$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240574081$24057408$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5828276$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240574091$24057409$1$I$20240703$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133712$AMGEN$$89$YR$E$F$Y$$$20240706$$CN$US$US
240574101$24057410$1$I$$20240629$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032551$AUROBINDO$$25$YR$$M$Y$88$KG$20240706$$CN$GB$GB
240574111$24057411$1$I$$20240702$20240706$20240706$EXP$$US-ABBVIE-5826325$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240574121$24057412$1$I$20240606$20240627$20240706$20240706$PER$$US-ABBVIE-5828368$ABBVIE$$22$YR$$F$Y$74.389$KG$20240706$$HP$US$US
240574131$24057413$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032481$AUROBINDO$$$$$M$Y$$$20240706$$CN$GB$GB
240574142$24057414$2$F$20240427$20240829$20240706$20240907$EXP$$IT-AUROBINDO-AUR-APL-2024-032814$AUROBINDO$$76$YR$$F$Y$71$KG$20240907$$MD$IT$IT
240574151$24057415$1$I$$20240404$20240706$20240706$PER$$US-AMGEN-USASP2024134236$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240574161$24057416$1$I$$20240703$20240706$20240706$EXP$$US-ABBVIE-5828533$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240574171$24057417$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032610$AUROBINDO$$74$YR$$M$Y$$$20240706$$PH$GB$GB
240574182$24057418$2$F$$20240823$20240706$20240828$EXP$$CA-ABBVIE-5829113$ABBVIE$$71$YR$$F$Y$82$KG$20240828$$CN$CA$CA
240574191$24057419$1$I$20240301$20240705$20240706$20240706$EXP$$AU-ABBVIE-5830038$ABBVIE$$89$YR$$F$Y$$$20240706$$CN$AU$AU
240574201$24057420$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032214$AUROBINDO$$$$$F$Y$$$20240706$$CN$GB$GB
240574212$24057421$2$F$20240108$20240704$20240706$20240709$EXP$IT-MINISAL02-989245$IT-ROCHE-10000016499$ROCHE$$45$YR$A$F$Y$$$20240709$$MD$IT$IT
240574221$24057422$1$I$20240501$20240702$20240706$20240706$EXP$$US-ABBVIE-5825970$ABBVIE$$65$YR$$M$Y$$$20240706$$CN$US$US
240574231$24057423$1$I$20230417$20240629$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032540$AUROBINDO$$39$YR$$F$Y$$$20240706$$MD$FR$FR
240574251$24057425$1$I$$20240701$20240706$20240706$PER$$US-AMGEN-USASP2024130499$AMGEN$$$$$M$Y$$$20240706$$MD$US$US
240574261$24057426$1$I$$20240118$20240706$20240706$PER$$US-AMGEN-USASP2024133747$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240574271$24057427$1$I$20230615$20240629$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032702$AUROBINDO$$96$YR$$M$Y$62$KG$20240706$$PH$FR$FR
240574281$24057428$1$I$$20240701$20240706$20240706$PER$$US-ABBVIE-5827920$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240574291$24057429$1$I$20240101$20240704$20240706$20240706$EXP$$CO-ABBVIE-5773328$ABBVIE$$$$$F$Y$69$KG$20240706$$CN$CO$CO
240574301$24057430$1$I$20240525$20240629$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032791$AUROBINDO$$30$YR$$M$Y$75$KG$20240706$$CN$FR$FR
240574311$24057431$1$I$20240101$20240705$20240706$20240706$EXP$GB-MHRA-MED-202405082047265920-VHRDF$GB-ABBVIE-5828438$ABBVIE$$38$YR$$F$Y$$$20240706$$MD$GB$GB
240574321$24057432$1$I$20240620$20240620$20240706$20240706$PER$$US-JNJFOC-20240656902$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240706$$CN$US$US
240574331$24057433$1$I$$20240704$20240706$20240706$EXP$$EC-ROCHE-10000018206$ROCHE$$$$$$Y$$$20240706$$HP$EC$EC
240574352$24057435$2$F$$20240822$20240706$20240902$EXP$$DE-AUROBINDO-AUR-APL-2024-031267$AUROBINDO$Riedhammer C, Dull J, Kestler C, Kadel S, Franz J, Weis P, et al.. Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma.. Annals of Hematology.. 2024;103(4):1327-1332$59$YR$$M$Y$$$20240902$$HP$DE$DE
240574361$24057436$1$I$20240601$20240628$20240706$20240706$EXP$$SI-AUROBINDO-AUR-APL-2024-032319$AUROBINDO$$72$YR$$M$Y$$$20240706$$MD$SI$SI
240574371$24057437$1$I$$20240628$20240706$20240706$EXP$$US-AUROBINDO-AUR-APL-2024-033094$AUROBINDO$$27$YR$$M$Y$$$20240706$$PH$US$US
240574382$24057438$2$F$20240101$20240809$20240706$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020245$UNITED THERAPEUTICS$$$$C$F$Y$$$20240817$$$US$US
240574392$24057439$2$F$20240616$20240906$20240706$20240918$EXP$$IT-AUROBINDO-AUR-APL-2024-032251$AUROBINDO$$76$YR$$F$Y$56$KG$20240918$$MD$IT$IT
240574401$24057440$1$I$$20240627$20240706$20240706$EXP$$CA-AUROBINDO-AUR-APL-2024-033159$AUROBINDO$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM.. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. Journal of Analytical Toxicology. 2023;47:385?392$37$YR$$M$Y$$$20240706$$HP$CA$CA
240574412$24057441$2$F$20231218$20240809$20240706$20240822$EXP$$FR-AUROBINDO-AUR-APL-2024-032234$AUROBINDO$$39$YR$$F$Y$$$20240822$$PH$FR$FR
240574421$24057442$1$I$$20230312$20240706$20240706$PER$$US-ABBVIE-5830841$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240574431$24057443$1$I$$20240702$20240706$20240706$EXP$$US-HETERO-HET2024US01759$HETERO$$$$$F$Y$$$20240706$$CN$US$US
240574441$24057444$1$I$$20240702$20240706$20240706$PER$$US-ABBVIE-5827394$ABBVIE$$$$$$Y$$$20240706$$CN$US$US
240574451$24057445$1$I$$20240412$20240706$20240706$PER$$US-AMGEN-USASP2024133691$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240574461$24057446$1$I$$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131680$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240574471$24057447$1$I$$20230501$20240706$20240706$PER$$US-AMGEN-USASP2023235644$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240574481$24057448$1$I$20240701$20240701$20240706$20240706$EXP$$AU-AMGEN-AUSSP2024130053$AMGEN$$64$YR$A$F$Y$$$20240706$$HP$AU$AU
240574491$24057449$1$I$$20240506$20240706$20240706$PER$$US-AMGEN-USASP2024134238$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240574501$24057450$1$I$$20240208$20240706$20240706$PER$$US-AMGEN-USASP2024133474$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240574511$24057451$1$I$$20240606$20240706$20240706$PER$$US-AMGEN-USASP2024133736$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240574521$24057452$1$I$$20240627$20240706$20240706$EXP$$FR-TAKEDA-2024TUS067947$TAKEDA$$$$$$Y$$$20240706$$CN$FR$FR
240574531$24057453$1$I$$20240530$20240706$20240706$PER$$US-AMGEN-USASP2024133683$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240574541$24057454$1$I$$20230123$20240706$20240706$PER$$US-AMGEN-USASP2023235643$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240574551$24057455$1$I$20240617$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024132540$AMGEN$$53$YR$A$F$Y$$$20240706$$CN$US$US
240574561$24057456$1$I$20240323$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032651$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240574571$24057457$1$I$$20240703$20240706$20240706$EXP$$NVSC2024ZA139422$NOVARTIS$$43$YR$$F$Y$$$20240706$$HP$ZA$ZA
240574591$24057459$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032190$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240574601$24057460$1$I$20240702$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131832$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240574611$24057461$1$I$$20231119$20240706$20240706$PER$$US-AMGEN-USASP2023235603$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240574621$24057462$1$I$$20240623$20240706$20240706$EXP$$US-Inventia-000729$INVENTIA HEALTHCARE$Al-Moussally F, Tien JJ, Rajagopalan K, Boterosuarez C, Crouse R. Euglycemic Ketoacidosis and Lactic Acidosis Associated With Metformin Toxicity. Cureus. 2024 May 20;16(5):e60661.$67$YR$E$F$Y$$$20240706$$HP$US$US
240574631$24057463$1$I$20240620$20240628$20240706$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019337$UNITED THERAPEUTICS$$61$YR$$F$Y$58.05$KG$20240706$$$US$US
240574641$24057464$1$I$20231001$20240702$20240706$20240706$PER$$US-ABBVIE-5827058$ABBVIE$$72$YR$$F$Y$$$20240706$$CN$US$US
240574651$24057465$1$I$$20240628$20240706$20240706$EXP$$CA-ABBVIE-5829110$ABBVIE$$65$YR$$M$Y$$$20240706$$HP$CA$CA
240574663$24057466$3$F$20240101$20240808$20240706$20240816$EXP$$US-ABBVIE-5708780$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
240574672$24057467$2$F$20231010$20240725$20240706$20240801$EXP$$NVSC2024CA136645$NOVARTIS$$32$YR$$F$Y$$$20240801$$MD$CA$CA
240574681$24057468$1$I$20240702$20240703$20240706$20240706$PER$$US-SA-2024SA197192$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240706$$CN$US$US
240574691$24057469$1$I$$20240628$20240706$20240706$PER$$US-ABBVIE-5826117$ABBVIE$$50$YR$$F$Y$$$20240706$$MD$US$US
240574701$24057470$1$I$20230101$20240628$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032432$AUROBINDO$$15$YR$$M$Y$$$20240706$$MD$FR$FR
240574711$24057471$1$I$$20240627$20240706$20240706$PER$$US-ABBVIE-5826456$ABBVIE$$44$YR$$F$Y$$$20240706$$HP$US$US
240574721$24057472$1$I$$20240628$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032463$AUROBINDO$$$$$$Y$$$20240706$$CN$GB$GB
240574731$24057473$1$I$$20240628$20240706$20240706$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009045$JAZZ$$$$$M$Y$$$20240706$$CN$US$US
240574741$24057474$1$I$20190401$20240628$20240706$20240706$EXP$$DE-AUROBINDO-AUR-APL-2024-032284$AUROBINDO$$67$YR$$M$Y$$$20240706$$MD$DE$DE
240574751$24057475$1$I$$20230425$20240706$20240706$PER$$US-AMGEN-USASP2023235642$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240574761$24057476$1$I$$20240627$20240706$20240706$PER$$US-ABBVIE-5825782$ABBVIE$$46$YR$$M$Y$$$20240706$$HP$US$US
240574773$24057477$3$F$$20240802$20240706$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-032293$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology. European Journal of Haematology. 2024;113 (1):90-98$9$YR$$F$Y$$$20240814$$HP$IT$IT
240574781$24057478$1$I$20240627$20240627$20240706$20240706$PER$$US-SA-2024SA194422$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240706$$CN$US$US
240574791$24057479$1$I$$20240630$20240706$20240706$PER$$US-ABBVIE-5824472$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240574801$24057480$1$I$20240603$20240628$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032443$AUROBINDO$$84$YR$$M$Y$65.3$KG$20240706$$PH$FR$FR
240574814$24057481$4$F$20240101$20240903$20240706$20240910$EXP$$GB-ABBVIE-5827674$ABBVIE$$42$YR$$M$Y$82$KG$20240910$$HP$GB$GB
240574821$24057482$1$I$20240605$20240702$20240706$20240706$PER$$US-ABBVIE-5826100$ABBVIE$$60$YR$$M$Y$91$KG$20240706$$CN$US$US
240574831$24057483$1$I$20160101$20240628$20240706$20240706$EXP$$FR-AUROBINDO-AUR-APL-2024-032312$AUROBINDO$$$$$F$Y$$$20240706$$CN$FR$FR
240574841$24057484$1$I$20240703$20240704$20240706$20240706$EXP$$CN-ROCHE-10000017435$ROCHE$$59$YR$A$F$Y$60$KG$20240706$$HP$CN$CN
240574851$24057485$1$I$20230726$20240628$20240706$20240706$EXP$$PL-AUROBINDO-AUR-APL-2024-032334$AUROBINDO$$70$YR$$F$Y$108$KG$20240706$$HP$PL$PL
240574863$24057486$3$F$$20240729$20240706$20240808$EXP$$IT-AUROBINDO-AUR-APL-2024-032345$AUROBINDO$Munari S, Ciotti G, Cestaro W, Corsi L, Tonin S, Ballarin A, et al. Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review. Drugs-Cont. 2024;13:1-11$64$YR$$F$Y$$$20240809$$HP$IT$IT
240574871$24057487$1$I$20240701$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133138$AMGEN$$80$YR$E$F$Y$$$20240706$$CN$US$US
240574881$24057488$1$I$$20240104$20240706$20240706$PER$$US-AMGEN-USASP2024133789$AMGEN$$$$$$Y$$$20240706$$MD$US$US
240574891$24057489$1$I$20240620$20240627$20240706$20240706$PER$$US-TEVA-VS-3214567$TEVA$$46$YR$$F$Y$58.97$KG$20240706$$CN$US$US
240574901$24057490$1$I$20240322$20240629$20240706$20240706$EXP$$ES-AUROBINDO-AUR-APL-2024-032649$AUROBINDO$$73$YR$$M$Y$$$20240706$$PH$ES$ES
240574911$24057491$1$I$$20240628$20240706$20240706$EXP$$US-AMGEN-USASP2024130797$AMGEN$Willard M.D.; Tran L.T.; Dada J.A. et al.. Over-the-Scope-Clip latrogenic Ligation of the Gastroduodenal Artery: A Case Report. The American journal of case reports. 2024;25:e943891-1 to e943891-5$71$YR$E$M$Y$$$20240706$$HP$US$US
240574921$24057492$1$I$$20240627$20240706$20240706$EXP$$US-AMGEN-USASP2024131432$AMGEN$Bansari A.; Wallace J.A.; Yang L. et al.. Paraneoplastic pemphigus presenting as a prodrome to aggressive T cell lymphoma. BMJ Case Reports. 2024;17 (6):1-5$$$A$M$Y$$$20240706$$MD$US$US
240574932$24057493$2$F$$20240822$20240706$20240827$PER$$US-AMGEN-USASP2024131015$AMGEN$$71$YR$E$F$Y$$$20240827$$CN$US$US
240574941$24057494$1$I$20240321$20240629$20240706$20240706$EXP$$PT-AUROBINDO-AUR-APL-2024-032554$AUROBINDO$$27$YR$$M$Y$78$KG$20240706$$MD$PT$PT
240574952$24057495$2$F$$20240711$20240706$20240714$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007453$JAZZ$$$$$F$Y$$$20240714$$HP$US$US
240574961$24057496$1$I$$20240627$20240706$20240706$PER$$US-ABBVIE-5826186$ABBVIE$$57$YR$$F$Y$$$20240706$$HP$US$US
240574971$24057497$1$I$$20240626$20240706$20240706$PER$$US-AstraZeneca-2024A148103$ASTRAZENECA$$$$$F$Y$$$20240706$$CN$US$
240574982$24057498$2$F$$20240814$20240706$20240831$PER$$US-AstraZeneca-2024A152257$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
240574991$24057499$1$I$20240703$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133786$AMGEN$$74$YR$E$F$Y$$$20240706$$CN$US$US
240575001$24057500$1$I$20200209$20240629$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032528$AUROBINDO$$24$YR$$M$Y$65$KG$20240706$$CN$GB$GB
240575011$24057501$1$I$$20240201$20240706$20240706$PER$$US-AMGEN-USASP2024133737$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240575021$24057502$1$I$$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133452$AMGEN$$$$$F$Y$$$20240706$$PH$US$US
240575031$24057503$1$I$$20240302$20240706$20240706$PER$$US-AMGEN-USASP2024133595$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240575041$24057504$1$I$$20240701$20240706$20240706$EXP$$US-ABBVIE-5825235$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240575051$24057505$1$I$$20240204$20240706$20240706$PER$$US-AMGEN-USASP2024133776$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240575061$24057506$1$I$$20240701$20240706$20240706$EXP$$US-AMGEN-USASP2024130317$AMGEN$$$$$F$Y$$$20240706$$CN$US$US
240575071$24057507$1$I$20240504$20240701$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032741$AUROBINDO$$71$YR$$M$Y$91$KG$20240706$$MD$GB$GB
240575081$24057508$1$I$20240101$20240701$20240706$20240706$EXP$$US-ABBVIE-5826364$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240575101$24057510$1$I$20240624$20240627$20240706$20240706$EXP$GB-MHRA-MED-202406261953331850-BRFYG$GB-BAXTER-2024BAX020700$BAXTER$$39$YR$$M$Y$$$20240706$$HP$GB$GB
240575111$24057511$1$I$$20240701$20240706$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-020293$UNITED THERAPEUTICS$$$$$F$Y$79.365$KG$20240706$$$US$US
240575121$24057512$1$I$20240603$20240627$20240706$20240706$EXP$CN-NMPACDR-3704011509867202400589$CN-BAXTER-2024BAX020894$BAXTER$$58$YR$$F$Y$59$KG$20240706$$MD$CN$CN
240575131$24057513$1$I$20240625$20240627$20240706$20240706$EXP$CN-NMPACDR-3701031012442202400194$CN-BAXTER-2024BAX020908$BAXTER$$62$YR$$F$Y$75$KG$20240706$$MD$CN$CN
240575141$24057514$1$I$20240616$20240626$20240706$20240706$EXP$CN-NMPACDR-3303811064810202400024$CN-BAXTER-2024BAX020809$BAXTER$$28$YR$$M$Y$$$20240706$$MD$CN$CN
240575151$24057515$1$I$20240101$20240702$20240706$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-020452$UNITED THERAPEUTICS$$$$$F$Y$81.633$KG$20240706$$$US$US
240575161$24057516$1$I$$20240627$20240706$20240706$EXP$$CA-BAXTER-2024BAX020841$BAXTER$$66$YR$$F$Y$$$20240706$$HP$CA$CA
240575171$24057517$1$I$$20240628$20240706$20240706$EXP$$CA-CELLTRION INC.-2024CA016380$CELLTRION$$$$$$Y$$$20240706$$HP$CA$CA
240575181$24057518$1$I$$20240625$20240706$20240706$EXP$$SK-Accord-433333$ACCORD$Horna S, Lecky P, Krivus J, Michalova R, Galajda P, Mokan M. Anorexia nervosa - a review of complications and nutritional support (case report). LEKARSKY OBZOR. 2024;73(6):218-225.$20$YR$A$F$Y$$$20240706$$HP$SK$SK
240575191$24057519$1$I$$20240626$20240706$20240706$EXP$CA-MHPD-E2B_07068185$CA-Accord-432802$ACCORD$$$$$M$Y$$$20240706$$HP$CA$CA
240575201$24057520$1$I$20231101$20240626$20240706$20240706$EXP$DE-BFARM-24004493$DE-Accord-433038$ACCORD$$$$$M$Y$2.59$KG$20240706$$MD$DE$DE
240575211$24057521$1$I$$20240626$20240706$20240706$EXP$DE-BFARM-24004495$DE-Accord-432906$ACCORD$$$$A$F$Y$73$KG$20240706$$MD$DE$DE
240575221$24057522$1$I$$20240626$20240706$20240706$EXP$CA-MHPD-E2B_001083465$CA-Accord-432766$ACCORD$$53$YR$A$M$Y$$$20240706$$HP$CA$CA
240575231$24057523$1$I$$20240626$20240706$20240706$EXP$CA-MHPD-E2B_07075772$CA-Accord-432804$ACCORD$$$$A$M$Y$$$20240706$$HP$CA$CA
240575242$24057524$2$F$20240630$20240722$20240706$20240725$PER$$US-AMGEN-USASP2024130789$AMGEN$$62$YR$A$F$Y$$$20240725$$MD$US$US
240575251$24057525$1$I$20240601$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131773$AMGEN$$59$YR$A$F$Y$$$20240706$$CN$US$US
240575261$24057526$1$I$20240529$20240627$20240706$20240706$EXP$ES-AEMPS-1538967$ES-BAXTER-2024BAX020703$BAXTER$$$$A$M$Y$$$20240706$$MD$ES$ES
240575271$24057527$1$I$$20240701$20240706$20240706$PER$$US-ABBVIE-5826764$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240575281$24057528$1$I$$20240628$20240706$20240706$EXP$$GR-BAXTER-2024BAX020959$BAXTER$$30$YR$$F$Y$$$20240706$$HP$GR$GR
240575291$24057529$1$I$$20240408$20240706$20240706$PER$$US-AMGEN-USASP2024133481$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240575301$24057530$1$I$$20240226$20240706$20240706$PER$$US-AMGEN-USASP2024133784$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240575311$24057531$1$I$20240101$20240702$20240706$20240706$EXP$$US-ABBVIE-5826498$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240575322$24057532$2$F$$20240829$20240706$20240925$PER$$US-SA-2024SA099452$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
240575331$24057533$1$I$20240401$20240702$20240706$20240706$EXP$$US-ABBVIE-5825989$ABBVIE$$47$YR$$M$Y$$$20240706$$CN$US$US
240575342$24057534$2$F$20240624$20240729$20240706$20240806$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020076$UNITED THERAPEUTICS$$82$YR$$F$Y$76.19$KG$20240806$$$US$US
240575351$24057535$1$I$$20240410$20240706$20240706$PER$$US-AMGEN-USASP2024133578$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240575371$24057537$1$I$$20231106$20240706$20240706$PER$$US-AMGEN-USASP2023235628$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240575381$24057538$1$I$20230523$20240630$20240706$20240706$EXP$$CN-009507513-2407CHN001835$MERCK$$61$YR$$M$Y$74$KG$20240706$$HP$CN$CN
240575391$24057539$1$I$$20240627$20240706$20240706$PER$$US-ABBVIE-5826032$ABBVIE$$30$YR$$F$Y$$$20240706$$HP$US$US
240575401$24057540$1$I$$20240627$20240706$20240706$PER$$US-SA-2024SA192834$SANOFI AVENTIS$$$$E$M$Y$$$20240706$$HP$US$US
240575411$24057541$1$I$20240601$20240701$20240706$20240706$PER$$US-SA-2024SA197045$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240706$$MD$US$US
240575421$24057542$1$I$20230101$20240702$20240706$20240706$PER$$US-SA-2024SA196305$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240706$$CN$US$US
240575431$24057543$1$I$$20240703$20240706$20240706$PER$$US-JNJFOC-20240708767$JOHNSON AND JOHNSON$$$$$F$Y$$$20240706$$HP$US$US
240575443$24057544$3$F$20240101$20240822$20240706$20240828$EXP$$US-ABBVIE-5828458$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
240575451$24057545$1$I$20240101$20240703$20240706$20240706$EXP$$CA-ABBVIE-5827686$ABBVIE$$$$A$M$Y$$$20240706$$CN$CA$CA
240575461$24057546$1$I$20240101$20240503$20240706$20240706$PER$$US-Eisai-EC-2024-165166$EISAI$$$$$M$Y$$$20240706$$CN$US$US
240575471$24057547$1$I$$20240501$20240706$20240706$PER$$US-Eisai-EC-2024-165009$EISAI$$$$$M$Y$$$20240706$$HP$US$US
240575482$24057548$2$F$$20240801$20240706$20240806$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-131011$DAIICHI$$$$$M$Y$$$20240806$$CN$US$US
240575491$24057549$1$I$20240626$20240703$20240706$20240706$PER$$US-JNJFOC-20240709628$JOHNSON AND JOHNSON$$$$$F$Y$$$20240706$$CN$US$US
240575501$24057550$1$I$$20240627$20240706$20240706$PER$$US-SA-2024SA192816$SANOFI AVENTIS$$$$A$F$Y$$$20240706$$MD$US$US
240575511$24057551$1$I$$20230504$20240706$20240706$PER$$US-AMGEN-USASP2023235639$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240575521$24057552$1$I$$20240627$20240706$20240706$EXP$$CA-AMGEN-CANSP2024128578$AMGEN$Marois, L.. Refractory wound healing and cytopenias treated with a sodium-glucose cotransporter-2 inhibitor in a patient with glucose-6-phosphatase catalytic subunit 3 deficiency. JAAD CASE REPORTS. 2024;49:22-24$30$YR$A$F$Y$$$20240706$$MD$CA$CA
240575531$24057553$1$I$$20240522$20240706$20240706$PER$$US-Eisai-EC-2024-166388$EISAI$$63$YR$A$F$Y$$$20240706$$MD$US$US
240575541$24057554$1$I$$20240507$20240706$20240706$PER$$US-Eisai-EC-2024-165365$EISAI$$$$$F$Y$$$20240706$$CN$US$US
240575551$24057555$1$I$$20240515$20240706$20240706$PER$$US-Eisai-EC-2024-165892$EISAI$$$$$M$Y$$$20240706$$MD$US$US
240575561$24057556$1$I$20240101$20240627$20240706$20240706$PER$$US-SA-2024SA192889$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240706$$MD$US$US
240575571$24057557$1$I$$20240612$20240706$20240706$PER$$US-TEVA-VS-3216120$TEVA$$22$YR$$$Y$$$20240706$$MD$US$US
240575581$24057558$1$I$20240501$20240702$20240706$20240706$EXP$$UY-ABBVIE-5826009$ABBVIE$$$$$M$Y$$$20240706$$CN$UY$UY
240575591$24057559$1$I$$20240628$20240706$20240706$EXP$$US-ABBVIE-5828961$ABBVIE$$$$$F$Y$$$20240706$$HP$US$US
240575601$24057560$1$I$20240101$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131631$AMGEN$$$$$F$Y$$$20240706$$CN$US$US
240575612$24057561$2$F$$20240711$20240706$20240723$EXP$$GB-TEVA-VS-3215303$TEVA$McMillan A, Basu S, Karunanithi K, Parkins E, Lau EYM, Cook G, et al. Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis. Br-J-Haematol 2023; 201 (4): 682-689.; McMillan A, Basu S, Karunanithi K, Parkins E, Lau EYM, Cook G, et al. Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis. Br-J-Haematol 2023; 201 ...$$$$$Y$$$20240723$$HP$GB$GB
240575621$24057562$1$I$20240703$20240703$20240706$20240706$EXP$$US-ABBVIE-5828980$ABBVIE$$61$YR$$F$Y$$$20240706$$CN$US$US
240575631$24057563$1$I$$20240703$20240706$20240706$EXP$$CL-ROCHE-10000016902$ROCHE$$$$$M$Y$$$20240706$$HP$CL$CL
240575641$24057564$1$I$$20240702$20240706$20240706$PER$$US-SA-2024SA196805$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240706$$MD$US$US
240575654$24057565$4$F$20240809$20240904$20240706$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-020462$UNITED THERAPEUTICS$$58$YR$$F$Y$37.642$KG$20240912$$$US$US
240575661$24057566$1$I$$20240528$20240706$20240706$PER$$US-Eisai-EC-2024-166855$EISAI$$59$YR$A$F$Y$$$20240706$$MD$US$US
240575671$24057567$1$I$$20240702$20240706$20240706$PER$$US-ABBVIE-5827395$ABBVIE$$$$$$Y$$$20240706$$HP$US$US
240575681$24057568$1$I$20240630$20240704$20240706$20240706$EXP$$BG-ABBVIE-5830410$ABBVIE$$68$YR$$$Y$$$20240706$$HP$BG$BG
240575692$24057569$2$F$$20240711$20240706$20240723$EXP$$SE-TEVA-VS-3215307$TEVA$Alpman MS, Jarting A, Magnusson K, Manouras A, Henter J-I, Broberg AM, et al. Longitudinal strain analysis for assessment of early cardiotoxicity during anthracycline treatment in childhood sarcoma: A single center experience. Cancer-Rep 2023; 6 (9):; Alpman MS, Jarting A, Magnusson K, Manouras A, Henter J-I, Broberg AM, et al. Longitudinal strain analysis for assessment of early cardiotoxicity during anthracycline treatment in childhood sarcoma: A single center experience. Cancer-Rep 2023; 6...$$$$$Y$$$20240723$$HP$SE$SE
2405757014$24057570$14$F$$20240918$20240706$20240925$EXP$GB-MHRA-ADR 28304985$GB-ABBVIE-5825761$ABBVIE$$$$$M$Y$$$20240925$$CN$GB$GB
240575711$24057571$1$I$20141029$20240703$20240706$20240706$EXP$$DE-ABBVIE-5824633$ABBVIE$$9$YR$$F$Y$28$KG$20240706$$MD$DE$DE
240575721$24057572$1$I$$20240627$20240706$20240706$PER$$US-SA-2024SA193701$SANOFI AVENTIS$$$$A$M$Y$$$20240706$$MD$US$US
240575735$24057573$5$F$$20240814$20240706$20240818$EXP$$US-ABBVIE-5825312$ABBVIE$$$$$F$Y$$$20240818$$CN$US$US
240575741$24057574$1$I$20240622$20240703$20240706$20240706$EXP$$US-ABBVIE-5830798$ABBVIE$$50$YR$$F$Y$$$20240706$$CN$US$US
240575751$24057575$1$I$$20240531$20240706$20240706$PER$$US-AMGEN-USASP2024132612$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240575761$24057576$1$I$$20240701$20240706$20240706$EXP$$US-ABBVIE-5830590$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240575771$24057577$1$I$$20240625$20240706$20240706$EXP$CA-MHPD-E2B_07062445$CA-Accord-432538$ACCORD$$64$YR$A$F$Y$$$20240706$$CN$CA$CA
240575782$24057578$2$F$$20240703$20240706$20240715$EXP$$US-Accord-433315$ACCORD$Al-Moussally F, Thompson B M, Masarweh O M, et al. (May 25, 2024) Atorvastatin-Associated Eosinophilic Spongiosis: A Case Report and a Relevant Literature Review of Dermatological Manifestations. Cureus 16(5): e61071$73$YR$E$M$Y$$$20240715$$HP$US$US
240575791$24057579$1$I$$20240625$20240706$20240706$EXP$AU-TGA-800169$AU-Accord-432342$ACCORD$$$$$F$Y$$$20240706$$HP$AU$AU
240575802$24057580$2$F$20240101$20240706$20240706$20240710$EXP$$US-ABBVIE-5828613$ABBVIE$$$$$F$Y$118$KG$20240710$$CN$US$US
240575811$24057581$1$I$20220901$20240625$20240706$20240706$EXP$$US-Accord-432614$ACCORD$Antonelli JP, Quach M, Mahajan A, Pleva J, Ma VT. Rapid Life-Saving Response to Anti-PD-1 in a Solid Organ Transplant Recipient with Metastatic Cutaneous Squamous Cell Carcinoma: A Case Report and Review. Journal of Immunotherapy. 2024;47(6):216-9. DOI: 10.1097/CJI.0000000000000514.$$$$M$Y$$$20240706$$MD$US$US
240575821$24057582$1$I$20240609$20240625$20240706$20240706$EXP$FR-AFSSAPS-BR2024000524$FR-Accord-432778$ACCORD$$77$YR$E$F$Y$69$KG$20240706$$MD$FR$FR
240575831$24057583$1$I$20240610$20240625$20240706$20240706$EXP$FR-AFSSAPS-BS2024000381$FR-Accord-432669$ACCORD$$45$YR$A$F$Y$79$KG$20240706$$MD$FR$FR
240575841$24057584$1$I$20230101$20240704$20240706$20240706$EXP$$CO-Accord-434164$ACCORD$Alza-Arcila J, Ramirez-Sanchez IC, Diaz-Sanabria RA. Histoplasma capsulatum tenosynovitis: An unusual presentation in a kidney transplant recipient. Transplant Infectious Disease. 2024;26(3):e14269. DOI: 10.1111/tid.14269.$66$YR$E$F$Y$$$20240706$$MD$CO$CO
240575852$24057585$2$F$$20240630$20240706$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-020036$UNITED THERAPEUTICS$$$$$$Y$$$20240719$$$US$US
240575861$24057586$1$I$20240520$20240625$20240706$20240706$EXP$FR-AFSSAPS-AN2024000826$FR-Accord-432825$ACCORD$$58$YR$A$F$Y$90$KG$20240706$$PH$FR$FR
240575871$24057587$1$I$$20240627$20240706$20240706$PER$$US-AstraZeneca-2024A150656$ASTRAZENECA$$$$$F$Y$$$20240706$$MD$US$
240575881$24057588$1$I$$20240626$20240706$20240706$PER$$US-AstraZeneca-2024A147780$ASTRAZENECA$$$$$F$Y$$$20240706$$CN$US$
240575891$24057589$1$I$$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024134154$AMGEN$$$$$F$Y$$$20240706$$HP$US$US
240575901$24057590$1$I$$20240704$20240706$20240706$PER$$US-AMGEN-USASP2024133929$AMGEN$$$$$F$Y$$$20240706$$CN$US$US
240575911$24057591$1$I$$20231003$20240706$20240706$PER$$US-AMGEN-USASP2023235453$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240575921$24057592$1$I$$20231128$20240706$20240706$PER$$US-AMGEN-USASP2023235645$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240575931$24057593$1$I$$20240702$20240706$20240706$PER$$US-UNITED THERAPEUTICS-UNT-2024-020453$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240706$$$US$US
240575942$24057594$2$F$$20240711$20240706$20240721$EXP$$US-TEVA-VS-3214108$TEVA$Lackey E, Shen J, Veal K, Shah S, Eckstein C. Neurosarcoidosis causing hydrocephalus: A case series. J-Neuroimmunol 2023; 381.; Lackey E, Shen J, Veal K, Shah S, Eckstein C. Neurosarcoidosis causing hydrocephalus: A case series. J-Neuroimmunol 2023; 381.$38$YR$$F$Y$$$20240721$$HP$US$US
240575951$24057595$1$I$$20240701$20240706$20240706$EXP$$GB-AUROBINDO-AUR-APL-2024-032799$AUROBINDO$Hutton D, Kameda-Smith M, Afshari FT, Elawadly A, Hogg F, Mehta S, et al.. Intracranial invasive group A streptococcus: a neurosurgical emergency in children. J-Neurosurg-Pediatr. 2023;32(4):478- 487$5$YR$$F$Y$$$20240706$$HP$GB$GB
240575961$24057596$1$I$20240601$20240628$20240706$20240706$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019580$UNITED THERAPEUTICS$$84$YR$$M$Y$98.866$KG$20240706$$$US$US
240575971$24057597$1$I$$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133091$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240575981$24057598$1$I$$20240311$20240706$20240706$PER$$US-AMGEN-USASP2024133670$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240575991$24057599$1$I$$20240520$20240706$20240706$PER$$US-AMGEN-USASP2024133716$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240576001$24057600$1$I$20240209$20240213$20240706$20240706$PER$$US-AMGEN-USASP2024134395$AMGEN$$53$YR$A$F$Y$$$20240706$$CN$US$US
240576011$24057601$1$I$20240625$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132668$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240576021$24057602$1$I$20240701$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132002$AMGEN$$60$YR$A$F$Y$$$20240706$$CN$US$US
240576033$24057603$3$F$20240101$20240918$20240706$20240927$PER$$US-SA-2024SA193017$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240927$$MD$US$US
240576041$24057604$1$I$20240601$20240702$20240706$20240706$PER$$US-SA-2024SA196800$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240706$$MD$US$US
240576051$24057605$1$I$20240101$20240702$20240706$20240706$PER$$US-ABBVIE-5827844$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240576061$24057606$1$I$20240614$20240620$20240706$20240706$PER$$US-JNJFOC-20240656720$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240706$$CN$US$US
240576072$24057607$2$F$$20240703$20240706$20240716$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05817$LUPIN$$$$$$Y$$$20240716$$CN$US$US
240576081$24057608$1$I$$20240624$20240706$20240706$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06171$LUPIN$$$$$$Y$$$20240706$$CN$US$US
240576091$24057609$1$I$$20240515$20240706$20240706$PER$$US-AMGEN-USASP2024133713$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240576103$24057610$3$F$20240101$20240809$20240706$20240820$PER$$US-SA-2024SA196593$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240820$$MD$US$US
240576111$24057611$1$I$$20240702$20240706$20240706$PER$$US-AMGEN-USASL2024131893$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240576121$24057612$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281435011580-DLRNY$GB-TEVA-VS-3215886$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240576131$24057613$1$I$20240627$20240627$20240706$20240706$EXP$$AU-BAXTER-2024BAX021052$BAXTER$$$$$$Y$$$20240706$$CN$AU$AU
240576141$24057614$1$I$$20240702$20240706$20240706$PER$$NVSC2024US138438$NOVARTIS$$65$YR$$M$Y$$$20240706$$CN$US$US
240576151$24057615$1$I$$20240702$20240706$20240706$PER$$US-BAYER-2024A095827$BAYER$$36$YR$A$F$Y$$$20240706$$MD$US$US
240576161$24057616$1$I$20240702$20240702$20240706$20240706$PER$$US-BAYER-2024A096127$BAYER$$45$YR$A$F$Y$$$20240706$$CN$US$US
240576173$24057617$3$F$20240628$20240710$20240706$20240712$PER$$US-AMGEN-USASP2024132111$AMGEN$$77$YR$E$M$Y$$$20240712$$CN$US$US
240576181$24057618$1$I$20240101$20240701$20240706$20240706$PER$$US-BAYER-2024A094968$BAYER$$42$YR$A$F$Y$$$20240706$$PH$US$US
240576191$24057619$1$I$20240101$20240701$20240706$20240706$PER$$US-BAYER-2024A094975$BAYER$$40$YR$A$F$Y$$$20240706$$PH$US$US
240576201$24057620$1$I$20240617$20240701$20240706$20240706$PER$$US-BAYER-2024A094978$BAYER$$31$YR$A$F$Y$$$20240706$$HP$US$US
240576211$24057621$1$I$$20240628$20240706$20240706$PER$$US-SA-2024SA195813$SANOFI AVENTIS$$$$A$$Y$$$20240706$$PH$US$US
240576221$24057622$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281433366540-CNLMB$GB-TEVA-VS-3215901$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240576232$24057623$2$F$20240310$20240710$20240706$20240717$PER$$US-BAYER-2024A095115$BAYER$$23$YR$A$F$Y$$$20240717$$CN$US$US
240576241$24057624$1$I$20240701$20240701$20240706$20240706$PER$$US-BAYER-2024A095173$BAYER$$16$YR$T$F$Y$$$20240706$$HP$US$US
240576253$24057625$3$F$20240101$20240724$20240706$20240801$PER$$US-SA-2024SA192596$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240801$$CN$US$US
240576261$24057626$1$I$$20240701$20240706$20240706$PER$$US-BAYER-2024A095183$BAYER$$$$$F$Y$$$20240706$$CN$US$US
240576271$24057627$1$I$20240629$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133797$AMGEN$$63$YR$A$M$Y$$$20240706$$CN$US$US
240576281$24057628$1$I$$20240624$20240706$20240706$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05768$LUPIN$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. American Journal of Transplantation. 2023;23:1048-1057$7$DEC$$M$Y$$$20240706$$HP$US$US
240576293$24057629$3$F$20230302$20240722$20240706$20240729$PER$$US-BAYER-2024A095307$BAYER$$20$YR$A$F$Y$102.86$KG$20240729$$MD$US$US
240576301$24057630$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281414140760-PYGTQ$GB-TEVA-VS-3215927$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240576311$24057631$1$I$$20240703$20240706$20240706$PER$$US-BAYER-2024A096400$BAYER$$40$YR$A$F$Y$$$20240706$$MD$US$US
240576321$24057632$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281423510310-QYSNJ$GB-TEVA-VS-3215959$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240576331$24057633$1$I$$20240627$20240706$20240706$PER$$US-SA-2024SA192477$SANOFI AVENTIS$$$$E$F$Y$$$20240706$$CN$US$US
240576341$24057634$1$I$$20240628$20240706$20240706$PER$$US-SA-2024SA194999$SANOFI AVENTIS$$$$$F$Y$$$20240706$$CN$US$US
240576351$24057635$1$I$$20240624$20240706$20240706$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05769$LUPIN$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. American Journal of Transplantation. 2023;23:1048-1057$5$DEC$$M$Y$$$20240706$$HP$US$US
240576362$24057636$2$F$20240524$20240824$20240706$20240830$PER$$US-BAYER-2024A095203$BAYER$$55$YR$A$F$Y$$$20240830$$CN$US$US
240576371$24057637$1$I$$20240701$20240706$20240706$PER$$US-AMGEN-USASP2024130563$AMGEN$$$$$$Y$$$20240706$$HP$US$US
240576381$24057638$1$I$$20240416$20240706$20240706$PER$$US-AMGEN-USASP2024133252$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240576391$24057639$1$I$$20240628$20240706$20240706$EXP$$US-AMGEN-USASP2024129640$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240706$$HP$US$US
240576401$24057640$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281446000970-SKTYP$GB-TEVA-VS-3216093$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240576411$24057641$1$I$$20240624$20240706$20240706$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05770$LUPIN$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. American Journal of Transplantation. 2023;23:1048-1057$7$DEC$$M$Y$$$20240706$$HP$US$US
240576421$24057642$1$I$$20240624$20240706$20240706$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05771$LUPIN$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. American Journal of Transplantation. 2023;23:1048-1057$7$DEC$$M$Y$$$20240706$$HP$US$US
240576431$24057643$1$I$$20240701$20240706$20240706$PER$$US-AstraZeneca-2024A151441$ASTRAZENECA$$$$$$Y$$$20240706$$CN$US$
240576441$24057644$1$I$$20240628$20240706$20240706$EXP$GB-MHRA-MED-202406281436490710-YBJTK$GB-TEVA-VS-3216098$TEVA$$$$$$Y$$$20240706$$CN$GB$GB
240576452$24057645$2$F$$20240802$20240706$20240810$PER$$US-AstraZeneca-2024A150526$ASTRAZENECA$$$$$F$Y$$$20240810$$HP$US$
240576461$24057646$1$I$$20240624$20240706$20240706$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05772$LUPIN$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. American Journal of Transplantation. 2023;23:1048-1057$6$DEC$$M$Y$$$20240706$$HP$US$US
240576471$24057647$1$I$$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133369$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240576483$24057648$3$F$$20240827$20240706$20240902$PER$$US-AMGEN-USASP2024131298$AMGEN$$$$$$Y$$$20240902$$PH$US$US
240576491$24057649$1$I$$20240703$20240706$20240706$PER$$US-ELI_LILLY_AND_COMPANY-US202407002730$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240706$$CN$US$US
240576501$24057650$1$I$$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024132508$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240576511$24057651$1$I$20240601$20240701$20240706$20240706$PER$$US-AMGEN-USASP2024131358$AMGEN$$67$YR$$F$Y$$$20240706$$CN$US$US
240576522$24057652$2$F$20240615$20240726$20240706$20240728$PER$$US-AstraZeneca-2024A146405$ASTRAZENECA$$64$YR$$M$Y$$$20240728$$CN$US$
240576533$24057653$3$F$$20240710$20240706$20240713$PER$$US-AMGEN-USASP2024134299$AMGEN$$79$YR$E$F$Y$$$20240712$$CN$US$US
240576541$24057654$1$I$$20240411$20240706$20240706$PER$$US-AMGEN-USASP2024133486$AMGEN$$$$$$Y$$$20240706$$MD$US$US
240576551$24057655$1$I$$20240222$20240706$20240706$PER$$US-AMGEN-USASP2024133254$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240576562$24057656$2$F$$20240711$20240706$20240723$EXP$$RS-TEVA-VS-3214667$TEVA$Stojiljkovic D, Cvetkovic A, Jokic A, Mircic D, Mihajlovic S, Krivokuca A, et al. Li-Fraumeni Syndrome with Six Primary Tumors - Case Report. Case-Rep-Oncol-Med 2024; 2024.; Stojiljkovic D, Cvetkovic A, Jokic A, Mircic D, Mihajlovic S, Krivokuca A, et al. Li-Fraumeni Syndrome with Six Primary Tumors - Case Report. Case-Rep-Oncol-Med 2024; 2024.; Stojiljkovic D, Cvetkovic A, Jokic A, Mircic D, Mihajlovic S, Krivokuca A, et al. Li-Fraumeni Syndrome with Six Primary Tumors - Case Report. Case-Re...$$$$F$Y$$$20240723$$HP$RS$RS
240576571$24057657$1$I$$20240702$20240706$20240706$PER$$US-BAYER-2024A095918$BAYER$$$$$F$Y$$$20240706$$CN$US$US
240576583$24057658$3$F$20240629$20240729$20240706$20240805$PER$$US-SA-2024SA196672$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240805$$MD$US$US
240576591$24057659$1$I$$20240702$20240706$20240706$PER$$US-ABBVIE-5828307$ABBVIE$$$$$F$Y$$$20240706$$HP$US$US
240576601$24057660$1$I$$20240628$20240706$20240706$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008633$JAZZ$$$$$M$Y$$$20240706$$CN$US$US
240576611$24057661$1$I$$20240702$20240706$20240706$PER$$US-ROCHE-10000017809$ROCHE$$59$YR$A$F$Y$$$20240706$$CN$US$US
240576631$24057663$1$I$20240601$20240627$20240706$20240706$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13194$IPSEN$$62$YR$A$F$Y$98$KG$20240706$$CN$US$US
240576643$24057664$3$F$20240702$20240730$20240706$20240801$EXP$$FR-TAKEDA-2024TUS065769$TAKEDA$$$$E$M$Y$$$20240801$$CN$GB$FR
240576651$24057665$1$I$$20240705$20240706$20240706$EXP$$CZ-TAKEDA-2024TUS068464$TAKEDA$$20$YR$$F$Y$$$20240706$$HP$CZ$CZ
240576662$24057666$2$F$$20240711$20240706$20240723$EXP$$IL-TEVA-VS-3215301$TEVA$Cahn A, Mor-Shaked H, Rosenberg-Fogler H, Pollack R, Tolhuis B, Sharma G, et al. Complex rearrangement in TBC1D4 in an individual with diabetes due to severe insulin resistance syndrome. Eur-J-Hum-Genet 2024; 32 232-237; Cahn A, Mor-Shaked H, Rosenberg-Fogler H, Pollack R, Tolhuis B, Sharma G, et al. Complex rearrangement in TBC1D4 in an individual with diabetes due to severe insulin resistance syndrome. Eur-J-Hum-Genet 2024; 32 232-237.; Cahn A, Mor-Shaked H, Rosenberg-Fogler H, Pollack R, T...$27$YR$$M$Y$$$20240723$$HP$IL$IL
240576671$24057667$1$I$$20240627$20240706$20240706$EXP$$CA-BAXTER-2024BAX020837$BAXTER$$62$YR$$F$Y$53$KG$20240706$$HP$CA$CA
240576681$24057668$1$I$$20240627$20240706$20240706$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-016175$UNITED THERAPEUTICS$$38$YR$$F$Y$$$20240706$$$JP$JP
240576692$24057669$2$F$20180101$20240705$20240706$20240708$EXP$$US-ABBVIE-5825932$ABBVIE$$$$$M$Y$85$KG$20240708$$CN$US$US
240576702$24057670$2$F$$20240716$20240706$20240723$EXP$$US-TAKEDA-2024TUS063072$TAKEDA$$$$$M$Y$$$20240723$$CN$US$US
240576711$24057671$1$I$$20240627$20240706$20240706$EXP$$CA-BAXTER-2024BAX020838$BAXTER$$$$$F$Y$97$KG$20240706$$HP$CA$CA
240576732$24057673$2$F$$20240711$20240706$20240723$EXP$$CH-TEVA-VS-3215390$TEVA$Galland-Decker C, Kraege V, Sartori C. Central nervous system manifestations due to iatrogenic adrenal insufficiency in a Ewing sarcoma patient. World-J-Emerg-Med 2019; 10 (2): 119-121.; Galland-Decker C, Kraege V, Sartori C. Central nervous system manifestations due to iatrogenic adrenal insufficiency in a Ewing sarcoma patient. World-J-Emerg-Med 2019; 10 (2): 119-121.$20$YR$$M$Y$$$20240723$$HP$CH$CH
240576743$24057674$3$F$20240601$20240808$20240706$20240812$EXP$$US-AMGEN-USASP2024131989$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
240576751$24057675$1$I$$20240703$20240706$20240706$EXP$$NVSC2024CA139261$NOVARTIS$$$$$F$Y$$$20240706$$MD$CA$CA
240576761$24057676$1$I$20240602$20240626$20240706$20240706$EXP$$US-ARDELYX-2024ARDX004715$ARDELYX$$46$YR$$F$Y$91$KG$20240706$$CN$US$US
240576772$24057677$2$F$$20240701$20240706$20240709$EXP$$US-JNJFOC-20240675580$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240709$$HP$US$US
240576782$24057678$2$F$$20240708$20240706$20240716$EXP$$ID-BAXTER-2024BAX020764$BAXTER$$42$YR$$$Y$$$20240716$$MD$ID$ID
240576792$24057679$2$F$$20240802$20240706$20240806$PER$$US-AMGEN-USASP2024132311$AMGEN$$57$YR$A$M$Y$$$20240806$$HP$US$US
240576801$24057680$1$I$$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024132794$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240576811$24057681$1$I$$20240628$20240706$20240706$EXP$CZ-TEVA-VS-3206549$CZ-Ipsen Biopharmaceuticals, Inc.-2024-13477$IPSEN$$72$YR$E$F$Y$$$20240706$$MD$CZ$CZ
240576821$24057682$1$I$20240616$20240702$20240706$20240706$PER$$US-AMGEN-USASP2024131486$AMGEN$$72$YR$E$F$Y$$$20240706$$CN$US$US
240576831$24057683$1$I$20240701$20240701$20240706$20240706$PER$$US-AMGEN-USASP2024130822$AMGEN$$71$YR$E$F$Y$$$20240706$$CN$US$US
240576841$24057684$1$I$20240601$20240628$20240706$20240706$PER$$US-SA-2024SA194756$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240706$$CN$US$US
240576851$24057685$1$I$20240704$20240704$20240706$20240706$PER$$US-AMGEN-USASP2024133804$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240576861$24057686$1$I$$20240701$20240706$20240706$PER$$US-SA-2024SA197230$SANOFI AVENTIS$$67$YR$E$F$Y$58.9$KG$20240706$$MD$US$US
240576872$24057687$2$F$$20240802$20240706$20240809$PER$$US-AstraZeneca-2024A150209$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
240576881$24057688$1$I$$20230504$20240706$20240706$PER$$US-AMGEN-USASP2023235479$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240576893$24057689$3$F$20240412$20240917$20240706$20240919$EXP$$NVSC2024GB080826$NOVARTIS$$$$$M$Y$$$20240920$$CN$GB$GB
240576902$24057690$2$F$20240624$20240717$20240706$20240726$PER$$US-AstraZeneca-2024A146932$ASTRAZENECA$$30722$DY$$F$Y$$$20240726$$CN$US$
240576911$24057691$1$I$$20240628$20240706$20240706$PER$$US-AstraZeneca-2024A150458$ASTRAZENECA$$$$$F$Y$$$20240706$$CN$US$
240576921$24057692$1$I$$20240516$20240706$20240706$PER$$US-AMGEN-USASP2024130962$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240576931$24057693$1$I$20220101$20240702$20240706$20240706$EXP$$US-ABBVIE-5826215$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240576941$24057694$1$I$20240617$20240701$20240706$20240706$EXP$$US-ABBVIE-5826103$ABBVIE$$60$YR$$M$Y$$$20240706$$CN$US$US
240576952$24057695$2$F$$20240711$20240706$20240722$EXP$$US-TEVA-VS-3214640$TEVA$Ghose M, Anwar M, Rajamohan A, Vangala A, Roy P, Weiner SM. Vancomycin Induced Anaphylaxis Presenting With Cardiac Arrest: Judicious Use of Antibiotic in Low Risk Procedures. Am-J-Respir-Crit-Care-Med 2024; 209 no pagination.; Ghose M, Anwar M, Rajamohan A, Vangala A, Roy P, Weiner SM. Vancomycin Induced Anaphylaxis Presenting With Cardiac Arrest: Judicious Use of Antibiotic in Low Risk Procedures. Am-J-Respir-Crit-Care-Med 2024; 209 no pagination.$74$YR$$F$Y$$$20240722$$HP$US$US
240576961$24057696$1$I$$20240703$20240706$20240706$EXP$$US-ABBVIE-5828593$ABBVIE$$$$$M$Y$$$20240706$$CN$US$US
240576971$24057697$1$I$20240626$20240703$20240706$20240706$EXP$$US-ABBVIE-5828919$ABBVIE$$69$YR$$M$Y$$$20240706$$CN$US$US
240576982$24057698$2$F$20240702$20240710$20240706$20240716$PER$$US-AMGEN-USASP2024131246$AMGEN$$86$YR$E$F$Y$$$20240716$$PH$US$US
240576991$24057699$1$I$20240601$20240628$20240706$20240706$PER$$US-SA-2024SA195857$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240706$$MD$US$US
240577001$24057700$1$I$$20240703$20240706$20240706$EXP$$US-ABBVIE-5829021$ABBVIE$$$$$F$Y$$$20240706$$CN$US$US
240577012$24057701$2$F$$20240711$20240706$20240721$EXP$$US-TEVA-VS-3214744$TEVA$Gutierrez L, Ramanujam D, Patel D, Modugula S, Disilvio BE. The Downside of Your Uppers: Venlafaxine-induced Hypertriglyceridemia Causing Acute Pancreatitis. Am-J-Respir-Crit-Care-Med 2024; 209; Gutierrez L, Ramanujam D, Patel D, Modugula S, Disilvio BE. The Downside of Your Uppers: Venlafaxine-induced Hypertriglyceridemia Causing Acute Pancreatitis. Am-J-Respir-Crit-Care-Med 2024; 209.$45$YR$$F$Y$$$20240721$$HP$US$US
240577021$24057702$1$I$20240610$20240704$20240706$20240706$EXP$$NL-ABBVIE-5830302$ABBVIE$$80$YR$$M$Y$$$20240706$$CN$NL$NL
240577032$24057703$2$F$$20240708$20240706$20240709$PER$$US-AMGEN-USASP2024134082$AMGEN$$$$$M$Y$$$20240709$$CN$US$US
240577041$24057704$1$I$$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133511$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240577052$24057705$2$F$20240627$20240701$20240706$20240710$EXP$$US-ABBVIE-5830651$ABBVIE$$88$YR$$M$Y$$$20240709$$CN$US$US
240577062$24057706$2$F$$20240711$20240706$20240721$EXP$$US-TEVA-VS-3214776$TEVA$Wang Q, Tang Z, See X, Yang A. Atypical Presentation of Pulmonary-Renal Syndrome (PRS) Caused by Hydralazine-induced Antineutrophil Cytoplasmic Antibody Vasculitis/Lupus Overlap: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209; Wang Q, Tang Z, See X, Yang A. Atypical Presentation of Pulmonary-Renal Syndrome (PRS) Caused by Hydralazine-induced Antineutrophil Cytoplasmic Antibody Vasculitis/Lupus Overlap: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209.$74$YR$$F$Y$$$20240721$$HP$US$US
240577071$24057707$1$I$20240101$20240623$20240706$20240706$EXP$$SK-TEVA-VS-3216350$TEVA$$41$YR$$M$Y$$$20240706$$CN$SK$SK
240577082$24057708$2$F$$20240711$20240706$20240721$EXP$$US-TEVA-VS-3214820$TEVA$Sasidharan S, Jatoi T, Milla C, Mallappallil M, Agarwal S, Puri I. Triple Whammy of Amlodipine, Carvedilol and Diphenhydramine Overdose. Am-J-Respir-Crit-Care-Med 2024; 209.; Sasidharan S, Jatoi T, Milla C, Mallappallil M, Agarwal S, Puri I. Triple Whammy of Amlodipine, Carvedilol and Diphenhydramine Overdose. Am-J-Respir-Crit-Care-Med 2024; 209.$27$YR$$F$Y$$$20240721$$HP$US$US
240577092$24057709$2$F$20240101$20240812$20240706$20240821$PER$$US-SA-2024SA196399$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240821$$MD$US$US
240577101$24057710$1$I$20240601$20240702$20240706$20240706$EXP$$US-ABBVIE-5827724$ABBVIE$$64$YR$$F$Y$$$20240706$$CN$US$US
240577111$24057711$1$I$$20240703$20240706$20240706$PER$$US-AMGEN-USASP2024133500$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240577121$24057712$1$I$$20240612$20240706$20240706$PER$$US-AstraZeneca-2024A137114$ASTRAZENECA$$$$$F$Y$$$20240706$$CN$US$
240577132$24057713$2$F$20230101$20240709$20240706$20240713$EXP$$US-ABBVIE-5312657$ABBVIE$$$$$M$Y$64$KG$20240713$$CN$US$US
240577146$24057714$6$F$20240101$20240909$20240706$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019342$UNITED THERAPEUTICS$$$$$F$Y$58.957$KG$20240919$$$US$US
240577161$24057716$1$I$$20240627$20240706$20240706$PER$$US-ABBVIE-5825800$ABBVIE$$67$YR$$F$Y$$$20240706$$HP$US$US
240577172$24057717$2$F$$20240807$20240706$20240820$PER$$US-AstraZeneca-2024A150365$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
240577181$24057718$1$I$$20240625$20240706$20240706$EXP$$CA-TEVA-VS-3215505$TEVA$$67$YR$$M$Y$76.5$KG$20240706$$CN$CA$CA
240577191$24057719$1$I$$20240619$20240706$20240706$PER$$US-JNJFOC-20240655851$JOHNSON AND JOHNSON$$18$MON$I$F$Y$$$20240706$$CN$US$US
240577201$24057720$1$I$$20240628$20240706$20240706$EXP$$US-AMGEN-USASP2024130738$AMGEN$Saliba F.; Mina J.; Aoun L.et. al.. Automatic implantable cardioverter defibrillator (AICD) implantation as secondary prevention of cardiac sarcoidosis-associated ventricular tachycardia. European journal of case reports in internal medicine. 2024$60$YR$A$F$Y$$$20240706$$HP$US$US
240577211$24057721$1$I$$20231127$20240706$20240706$PER$$US-AMGEN-USASP2023235606$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240577221$24057722$1$I$$20240702$20240706$20240706$PER$$US-SA-2024SA198039$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240706$$CN$US$US
240577231$24057723$1$I$$20230522$20240706$20240706$PER$$US-AMGEN-USASP2023235460$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240577241$24057724$1$I$$20231220$20240706$20240706$PER$$US-AMGEN-USASP2023235496$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240577251$24057725$1$I$$20240628$20240706$20240706$PER$$US-AstraZeneca-2024A150696$ASTRAZENECA$$$$$$Y$$$20240706$$MD$US$
240577262$24057726$2$F$$20240627$20240706$20240708$EXP$$NVSC2024IN138029$NOVARTIS$$$$$M$Y$$$20240709$$CN$IN$IN
240577271$24057727$1$I$20230304$20240705$20240706$20240706$EXP$FR-AFSSAPS-AM2024000472$FR-ROCHE-10000017881$ROCHE$$41$YR$A$M$Y$95$KG$20240706$$MD$FR$FR
240577282$24057728$2$F$20240603$20240708$20240706$20240717$EXP$IT-MINISAL02-989301$IT-ROCHE-10000017526$ROCHE$$24$YR$A$F$Y$$$20240717$$MD$IT$IT
240577292$24057729$2$F$$20240702$20240706$20240712$EXP$$US-ROCHE-10000018305$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240577301$24057730$1$I$$20240701$20240706$20240706$PER$$US-ROCHE-10000017197$ROCHE$$$$A$F$Y$$$20240706$$CN$US$US
240577311$24057731$1$I$$20240701$20240706$20240706$EXP$$US-ROCHE-10000017279$ROCHE$$$$$F$Y$$$20240706$$HP$US$US
240577321$24057732$1$I$20231116$20240625$20240706$20240706$EXP$$AU-ROCHE-10000018302$ROCHE$$30$YR$A$M$Y$$$20240706$$PH$AU$AU
240577332$24057733$2$F$$20240702$20240706$20240714$EXP$$CA-ROCHE-10000017471$ROCHE$$$$A$F$Y$$$20240714$$CN$CA$CA
240577342$24057734$2$F$20191202$20240701$20240706$20240708$EXP$$US-ROCHE-10000017465$ROCHE$$29$YR$A$F$Y$74.84$KG$20240708$$CN$US$US
240577351$24057735$1$I$$20240701$20240706$20240706$PER$$US-ROCHE-10000017275$ROCHE$$$$$$Y$$$20240706$$CN$US$US
240577362$24057736$2$F$$20240705$20240706$20240708$PER$$US-ROCHE-10000016523$ROCHE$$58$YR$A$F$Y$$$20240708$$CN$US$US
240577373$24057737$3$F$$20240913$20240706$20240924$EXP$$CA-ROCHE-10000016597$ROCHE$$$$A$F$Y$$$20240924$$HP$CA$CA
240577393$24057739$3$F$20240704$20240705$20240706$20240715$EXP$$CA-ROCHE-3501605$ROCHE$$37$YR$A$M$Y$$$20240715$$CN$CA$CA
240577401$24057740$1$I$20240507$20240627$20240706$20240706$PER$$US-ROCHE-3579843$ROCHE$$67$YR$E$F$Y$$$20240706$$CN$US$US
240577412$24057741$2$F$$20240624$20240706$20240712$EXP$$IN-ROCHE-10000012192$ROCHE$$$$$$Y$$$20240712$$CN$IN$IN
240577421$24057742$1$I$20231201$20240618$20240706$20240706$EXP$$DE-ROCHE-10000016853$ROCHE$$49$YR$A$F$Y$62$KG$20240706$$MD$DE$DE
240577431$24057743$1$I$$20240703$20240706$20240706$PER$$US-ELI_LILLY_AND_COMPANY-US202407002818$ELI LILLY AND CO$$54$YR$A$$Y$$$20240706$$CN$US$US
240577442$24057744$2$F$20240101$20240705$20240706$20240709$PER$$US-JNJFOC-20240711417$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240709$$CN$US$US
240577451$24057745$1$I$$20240703$20240706$20240706$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106958$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240707$$CN$US$US
240577473$24057747$3$F$20231129$20240827$20240706$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106816$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240904$$MD$JP$JP
240577482$24057748$2$F$$20240802$20240706$20240827$PER$$US-AstraZeneca-2024A153474$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
240577492$24057749$2$F$20240702$20240702$20240706$20240709$PER$$US-AMGEN-USASP2024132126$AMGEN$$65$YR$E$F$Y$$$20240709$$HP$US$US
240577501$24057750$1$I$20240601$20240629$20240706$20240706$PER$$US-SA-2024SA196517$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240707$$CN$US$US
240577511$24057751$1$I$$20240627$20240706$20240706$EXP$$CA-APOTEX-2024AP007860$APOTEX$$68$YR$$F$Y$$$20240706$$HP$CA$CA
240577523$24057752$3$F$20240717$20240722$20240707$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407002559$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240726$$CN$US$US
240577531$24057753$1$I$$20230522$20240707$20240707$PER$$US-AMGEN-USASP2023235608$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240577543$24057754$3$F$20230301$20240916$20240707$20240924$EXP$$CO-AMGEN-COLSL2023059837$AMGEN$$70$YR$E$M$Y$$$20240924$$CN$CO$CO
240577552$24057755$2$F$$20240828$20240707$20240906$PER$$US-AstraZeneca-2024A152116$ASTRAZENECA$$$$$$Y$$$20240906$$CN$US$
240577561$24057756$1$I$$20230523$20240707$20240707$PER$$US-AMGEN-USASP2023235610$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240577571$24057757$1$I$$20240613$20240707$20240707$PER$$US-JNJFOC-20240636986$JOHNSON AND JOHNSON$$$$$M$Y$$$20240707$$CN$US$US
240577581$24057758$1$I$$20230429$20240707$20240707$PER$$US-AMGEN-USASP2023235607$AMGEN$$$$$$Y$$$20240706$$CN$US$US
240577592$24057759$2$F$$20240703$20240707$20240711$PER$$US-AstraZeneca-2024A151051$ASTRAZENECA$$$$$$Y$$$20240711$$HP$US$
240577601$24057760$1$I$$20240704$20240707$20240707$EXP$$PT-ROCHE-10000016723$ROCHE$Freitas J, Rodrigues A, Lisboa S, Mariz J. Composite mantle cell and Burkitt lymphoma: a rare case report (Letter to the Editor). Porto Biomedical Journal. 2024;9 (3):1-2. doi:10.1097/j.pbj.0000000000000257.$68$YR$E$M$Y$$$20240707$$HP$PT$PT
240577611$24057761$1$I$$20240703$20240707$20240707$PER$$US-AstraZeneca-2024A153641$ASTRAZENECA$$$$$$Y$$$20240707$$CN$US$
240577621$24057762$1$I$$20240703$20240707$20240707$PER$$NVSC2024US139265$NOVARTIS$$74$YR$$F$Y$58.503$KG$20240707$$CN$US$US
240577631$24057763$1$I$$20240416$20240707$20240707$EXP$$ID-DEXPHARM-2024-2083$DEXCEL$Novianti, Y.; Hidayat, W.; Rosa, D. E.  Severe Xerostomia Induced by Multiple Systemic Diseases in a Patient with Psoriasis Vulgaris: A Case Report and Literature Review. International Medical Case Reports Journal 2024, V17, P77-88$51$YR$A$M$Y$63$KG$20240707$$HP$ID$ID
240577641$24057764$1$I$20240624$20240626$20240707$20240707$EXP$$JP-ROCHE-10000015495$ROCHE$$60$YR$A$F$Y$$$20240707$$MD$JP$JP
240577651$24057765$1$I$20221101$20240627$20240707$20240707$EXP$$ZA-SA-2024SA193428$SANOFI AVENTIS$$$$$F$Y$$$20240707$$MD$ZA$ZA
240577661$24057766$1$I$$20240627$20240707$20240707$PER$$US-SA-2024SA193003$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240707$$CN$US$US
240577672$24057767$2$F$$20240617$20240707$20240801$EXP$$VN-ROCHE-10000007080$ROCHE$$40$YR$A$F$Y$$$20240801$$MD$VN$VN
240577681$24057768$1$I$$20240626$20240707$20240707$EXP$US-MLMSERVICE-20240619-PI104961-00030-1$US-RDY-SPO/USA/24/0009403$DR REDDYS$Postoll-Downs MA, Ozguc F, Vasudevan J, Stawinski PM, Wright R. Breaking Patterns: A Case of Dieulafoy Lesion in a Young Patient Without Comorbid Conditions. Cureus. 2024;16(5):e60513. DOI: 10.7759/cureus.60513.$18$YR$A$M$Y$$$20240707$$MD$US$US
240577691$24057769$1$I$$20240705$20240707$20240707$EXP$GB-MHRA-MED-202405090951105230-RWJSH$GB-ROCHE-10000017960$ROCHE$$$$$F$Y$$$20240707$$HP$GB$GB
240577701$24057770$1$I$$20240628$20240707$20240707$PER$$US-SA-2024SA196380$SANOFI AVENTIS$$$$E$F$Y$$$20240707$$MD$US$US
240577711$24057771$1$I$$20240701$20240707$20240707$PER$$US-JNJFOC-20240703092$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240707$$MD$US$US
240577722$24057772$2$F$20240314$20240627$20240707$20240712$EXP$FR-AFSSAPS-AM2024000527$FR-SA-2024SA192084$SANOFI AVENTIS$$73$YR$E$F$Y$50$KG$20240712$$PH$FR$FR
240577732$24057773$2$F$$20240815$20240707$20240828$PER$$US-SA-2024SA195740$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240828$$MD$US$US
240577751$24057775$1$I$20240610$20240628$20240707$20240707$EXP$FR-AFSSAPS-PC2024000522$FR-RDY-SPO/FRA/24/0009446$DR REDDYS$$53$YR$A$M$Y$87$KG$20240707$$PH$FR$FR
240577761$24057776$1$I$20240513$20240628$20240707$20240707$EXP$FR-AFSSAPS-PC2024000498$FR-RDY-SPO/FRA/24/0009447$DR REDDYS$$49$YR$A$F$Y$$$20240707$$PH$FR$FR
240577771$24057777$1$I$$20240628$20240707$20240707$EXP$$US-AMGEN-USASP2024129693$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240706$$HP$US$US
240577781$24057778$1$I$20240601$20240628$20240707$20240707$PER$$US-SA-2024SA197533$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240707$$MD$US$US
240577791$24057779$1$I$20240101$20240625$20240707$20240707$EXP$$DK-GLENMARK PHARMACEUTICALS-2024GMK091936$GLENMARK$$$$$$Y$$$20240707$$MD$DK$DK
240577801$24057780$1$I$$20240624$20240707$20240707$EXP$$US-RDY-LIT/USA/24/0009436$DR REDDYS$Gans A, Taylor J, Goel NN. A Case of Drug-Induced Stevens-Johnson Syndrome With Primarily Visceral Involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209: doi:10.1164/ajrccmconference.2024.209.1_MeetingAbstracts.A5678?download=true#:~:text=We.$76$YR$E$F$Y$$$20240707$$HP$US$US
240577811$24057781$1$I$20240516$20240627$20240707$20240707$EXP$$US-RDY-SPO/USA/24/0009520$DR REDDYS$$70$YR$E$M$Y$63$KG$20240707$$MD$US$US
240577821$24057782$1$I$$20240626$20240707$20240707$EXP$$US-RDY-LIT/USA/24/0009699$DR REDDYS$Koga S, Pai E, Banihashemi A. Diffuse lymphocytic encephalomyelitis with stiff-person-like syndrome in multiple myeloma after Teclistamab treatment. Journal of Neuropathology and Experimental Neurology. 2024 Jun;83(6): 457-458. doi:10.1093/jnen/nlae036.$45$YR$A$M$Y$$$20240707$$HP$US$US
240577831$24057783$1$I$$20240628$20240707$20240707$EXP$GB-MHRA-30949595$GB-RDY-SPO/GBR/24/0009608$DR REDDYS$$75$YR$E$$Y$$$20240707$$PH$GB$GB
240577841$24057784$1$I$$20240625$20240707$20240707$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK091988$GLENMARK$$$$$$Y$$$20240707$$HP$CA$CA
240577851$24057785$1$I$$20231113$20240707$20240707$PER$$US-AMGEN-USASP2023235612$AMGEN$$$$$$Y$$$20240706$$PH$US$US
240577872$24057787$2$F$$20240802$20240707$20240809$PER$$US-AstraZeneca-2024A147538$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
240577881$24057788$1$I$20240501$20240629$20240707$20240707$PER$$US-SA-2024SA196447$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240707$$MD$US$US
240577901$24057790$1$I$$20240425$20240707$20240707$PER$$US-AMGEN-USASP2024133314$AMGEN$$$$$$Y$$$20240707$$PH$US$US
240577911$24057791$1$I$$20240628$20240707$20240707$EXP$GB-MHRA-30919045$GB-RDY-SPO/GBR/24/0009596$DR REDDYS$$$$$F$Y$$$20240707$$CN$GB$GB
240577921$24057792$1$I$20210901$20240705$20240707$20240707$EXP$$CZ-SANDOZ INC.-SDZ2024CZ061177$SANDOZ$$40$YR$$M$Y$$$20240707$$MD$CZ$CZ
240577931$24057793$1$I$20181219$20240705$20240707$20240707$EXP$FR-AFSSAPS-ST2024001115$FR-SANDOZ INC.-SDZ2024FR063046$SANDOZ$$39$YR$$F$Y$$$20240707$$MD$FR$FR
240577951$24057795$1$I$20240509$20240703$20240707$20240707$EXP$$US-AstraZeneca-2024A153256$ASTRAZENECA$$$$$M$Y$$$20240707$$CN$US$
240577961$24057796$1$I$20240401$20240611$20240707$20240707$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001482$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240707$$CN$US$US
240577971$24057797$1$I$20240629$20240701$20240707$20240707$PER$$US-SA-2024SA198118$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240707$$CN$US$US
240577981$24057798$1$I$$20240628$20240707$20240707$EXP$GB-MHRA-MED-202406280855400820-VQTNC$GB-RDY-SPO/GBR/24/0009551$DR REDDYS$$$$$M$Y$$$20240707$$CN$GB$GB
240577991$24057799$1$I$20240504$20240611$20240707$20240707$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002793$ACADIA PHARMACEUTICALS$$87$YR$$F$Y$$$20240707$$CN$US$US
240578002$24057800$2$F$$20240901$20240707$20240906$PER$$US-AstraZeneca-2024A151849$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
240578011$24057801$1$I$$20240701$20240707$20240707$PER$$US-SA-2024SA196904$SANOFI AVENTIS$$$$$M$Y$$$20240707$$CN$US$US
240578022$24057802$2$F$20240902$20240905$20240707$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002794$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240916$$CN$US$US
240578031$24057803$1$I$$20240703$20240707$20240707$PER$$US-ELI_LILLY_AND_COMPANY-US202407002619$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240707$$CN$US$US
240578041$24057804$1$I$20240515$20240611$20240707$20240707$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002795$ACADIA PHARMACEUTICALS$$89$YR$$M$Y$$$20240707$$CN$US$US
240578051$24057805$1$I$$20240626$20240707$20240707$PER$$US-AstraZeneca-2024A148123$ASTRAZENECA$$$$$M$Y$$$20240707$$CN$US$
240578062$24057806$2$F$20240101$20240702$20240707$20240711$PER$$US-SA-2024SA194166$SANOFI AVENTIS$$40$YR$A$F$Y$73.48$KG$20240711$$MD$US$US
240578071$24057807$1$I$$20240624$20240707$20240707$PER$$US-AstraZeneca-2024A145685$ASTRAZENECA$$$$$M$Y$$$20240707$$CN$US$
240578081$24057808$1$I$$20240702$20240707$20240707$PER$$US-SA-2024SA196930$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240707$$CN$US$US
240578091$24057809$1$I$20240601$20240703$20240707$20240707$30DAY$$US-GSK-US2024082602$GLAXOSMITHKLINE$$44$YR$$F$Y$61.23$KG$20240707$$CN$US$US
240578101$24057810$1$I$20240509$20240628$20240707$20240707$EXP$GB-MHRA-MIDB-41044ecb-1347-4981-ac26-69141f820ea3$GB-RDY-SPO/GBR/24/0009643$DR REDDYS$$59$YR$A$F$Y$$$20240707$$HP$GB$GB
240578111$24057811$1$I$$20240703$20240707$20240707$PER$$US-ELI_LILLY_AND_COMPANY-US202407002741$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240707$$CN$US$US
240578121$24057812$1$I$$20240702$20240707$20240707$PER$$US-ELI_LILLY_AND_COMPANY-US202407002934$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240707$$CN$US$US
240578131$24057813$1$I$20170101$20240705$20240707$20240707$EXP$$RO-SANDOZ INC.-SDZ2024RO063088$SANDOZ$$66$YR$$F$Y$78$KG$20240707$$MD$RO$RO
240578141$24057814$1$I$20230501$20240628$20240707$20240707$EXP$$AU-SANDOZ INC.-SDZ2024AU061554$SANDOZ$$$$$F$Y$$$20240707$$CN$AU$AU
240578151$24057815$1$I$20200223$20240628$20240707$20240707$EXP$$IN-SANDOZ INC.-NVSC2020IN104265$SANDOZ$$36$YR$$M$Y$$$20240707$$CN$IN$IN
240578161$24057816$1$I$$20240703$20240707$20240707$PER$$US-SA-2024SA198292$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240707$$CN$US$US
240578171$24057817$1$I$20240501$20240628$20240707$20240707$PER$$US-ROCHE-10000016530$ROCHE$$75$YR$E$M$Y$81.64$KG$20240707$$CN$US$US
240578181$24057818$1$I$$20240627$20240707$20240707$PER$$US-SA-2024SA192368$SANOFI AVENTIS$$$$A$M$Y$$$20240707$$CN$US$US
240578191$24057819$1$I$20240101$20240627$20240707$20240707$PER$$US-SA-2024SA195170$SANOFI AVENTIS$$9$YR$C$F$Y$24$KG$20240707$$MD$US$US
240578202$24057820$2$F$$20240808$20240707$20240819$30DAY$$US-GSK-US2024082656$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$MD$US$US
240578212$24057821$2$F$$20240723$20240707$20240801$PER$$US-SA-2024SA192739$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240801$$CN$US$US
240578221$24057822$1$I$$20240612$20240707$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002815$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240707$$CN$US$US
240578231$24057823$1$I$$20240628$20240707$20240707$EXP$GB-MHRA-30919072$GB-RDY-SPO/GBR/24/0009644$DR REDDYS$$$$$$Y$$$20240707$$CN$GB$GB
240578241$24057824$1$I$$20240626$20240707$20240707$EXP$$US-RDY-LIT/USA/24/0009683$DR REDDYS$Qaiser S, Divanna M, Amir N, Luzuriaga A, Rodriguez C. Real-World Administration of Dantrolene: Harder Than a Board Exam. American Journal of Respiratory and Critical Care Medicine. 209: A3654. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A3654.$65$YR$E$F$Y$$$20240707$$HP$US$US
240578251$24057825$1$I$20240323$20240628$20240707$20240707$EXP$GB-MHRA-MED-202406271040542900-VDNJS$GB-RDY-SPO/GBR/24/0009541$DR REDDYS$$$$$M$Y$78$KG$20240707$$CN$GB$GB
240578262$24057826$2$F$$20240708$20240707$20240715$EXP$GB-MHRA-MED-202406281442341590-SCYTR$GB-RDY-SPO/GBR/24/0009556$DR REDDYS$$$$$$Y$$$20240715$$CN$GB$GB
240578271$24057827$1$I$$20240628$20240707$20240707$EXP$GB-MHRA-MED-202406281140265240-PFTZY$GB-RDY-SPO/GBR/24/0009661$DR REDDYS$$$$$$Y$$$20240707$$CN$GB$GB
240578282$24057828$2$F$20240323$20240708$20240707$20240715$EXP$GB-MHRA-MED-202406281038502460-PFVRS$GB-RDY-SPO/GBR/24/0009614$DR REDDYS$$$$$$Y$$$20240715$$CN$GB$GB
240578291$24057829$1$I$$20240628$20240707$20240707$EXP$GB-MHRA-MED-202406281459532020-PFYZC$GB-RDY-SPO/GBR/24/0009574$DR REDDYS$$$$$M$Y$$$20240707$$CN$GB$GB
240578301$24057830$1$I$$20240612$20240707$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002817$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240707$$CN$US$US
240578311$24057831$1$I$$20240627$20240707$20240707$PER$$US-SA-2024SA192844$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240707$$CN$US$US
240578321$24057832$1$I$$20240628$20240707$20240707$EXP$GB-MHRA-MED-202406281502574640-CFGVW$GB-RDY-SPO/GBR/24/0009536$DR REDDYS$$$$$$Y$$$20240707$$CN$GB$GB
240578331$24057833$1$I$$20240628$20240707$20240707$EXP$GB-MHRA-MED-202406281432323530-HKSTC$GB-RDY-SPO/GBR/24/0009665$DR REDDYS$$$$$$Y$$$20240707$$CN$GB$GB
240578341$24057834$1$I$20240531$20240612$20240707$20240707$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002819$ACADIA PHARMACEUTICALS$$90$YR$$F$Y$$$20240707$$CN$US$US
240578352$24057835$2$F$$20240717$20240707$20240726$EXP$$CA-RDY-CLI/CAN/24/0009692$DR REDDYS$$78$YR$E$F$Y$$$20240726$$HP$CA$CA
240578361$24057836$1$I$20240101$20240703$20240707$20240707$PER$$US-AMGEN-USASP2024132149$AMGEN$$61$YR$A$F$Y$$$20240707$$CN$US$US
240578371$24057837$1$I$$20240612$20240707$20240707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002808$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240707$$CN$US$US
240578381$24057838$1$I$$20240702$20240707$20240707$PER$$US-SA-2024SA196968$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240707$$CN$US$US
240578391$24057839$1$I$$20240701$20240707$20240707$PER$$US-JNJFOC-20240707125$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$CN$US$US
240578401$24057840$1$I$$20240701$20240707$20240707$PER$$US-AMGEN-USASP2024130698$AMGEN$$$$$M$Y$$$20240707$$CN$US$US
240578411$24057841$1$I$$20240620$20240707$20240707$PER$$US-JNJFOC-20240662247$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$CN$US$US
240578421$24057842$1$I$$20240628$20240707$20240707$EXP$$FR-JNJFOC-20240676828$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$PH$FR$FR
240578431$24057843$1$I$20240101$20240705$20240707$20240707$PER$$US-JNJFOC-20240716151$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240707$$CN$US$US
240578441$24057844$1$I$20240101$20240705$20240707$20240707$PER$$US-JNJFOC-20240715454$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240707$$CN$US$US
240578451$24057845$1$I$$20240702$20240707$20240707$PER$$US-SA-2024SA196933$SANOFI AVENTIS$$$$$F$Y$$$20240707$$CN$US$US
240578462$24057846$2$F$$20240718$20240707$20240816$PER$$US-AstraZeneca-2024A153786$ASTRAZENECA$$75$YR$$F$Y$64.3$KG$20240816$$HP$US$
240578471$24057847$1$I$20240623$20240624$20240707$20240707$PER$$US-ROCHE-10000016958$ROCHE$$87$YR$E$F$Y$$$20240707$$CN$US$US
240578481$24057848$1$I$$20240627$20240707$20240707$PER$$US-SA-2024SA194520$SANOFI AVENTIS$$$$E$F$Y$72.1$KG$20240707$$MD$US$US
240578491$24057849$1$I$$20240625$20240707$20240707$EXP$$US-RDY-LIT/USA/24/0009487$DR REDDYS$Basnet A, Sharma NR, Gautam S, Lamichhane S, Kansakar S, Tiwari K, et al. Immune checkpoint inhibitor-induced myasthenia gravis, myocarditis, and myositis: A case report. Clinical Case Reports. 2024;12: doi:10.1002/ccr3.8968.$76$YR$E$F$Y$$$20240707$$HP$US$US
240578501$24057850$1$I$$20240624$20240707$20240707$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05934$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578511$24057851$1$I$$20240627$20240707$20240707$PER$$US-SA-2024SA194452$SANOFI AVENTIS$$$$E$F$Y$67.58$KG$20240707$$MD$US$US
240578522$24057852$2$F$20081128$20240624$20240707$20240717$EXP$AU-TGA-0000803564$AU-SANDOZ INC.-SDZ2024AU060180$SANDOZ$$39$YR$$F$Y$$$20240717$$CN$AU$AU
240578531$24057853$1$I$$20240627$20240707$20240707$EXP$$US-RDY-LIT/USA/24/0009815$DR REDDYS$Chan W, Park S, Shirkhoda L, O^Connell R, Houshyar R. Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells: a case report. Journal of Medical Case Reports. 2023;17: doi:10.1186/s13256-023-04213-4.$54$YR$A$M$Y$$$20240707$$HP$US$US
240578541$24057854$1$I$$20240625$20240707$20240707$EXP$$US-RDY-LIT/USA/24/0009486$DR REDDYS$Thompson TZ, Rearick WA, Pizzuto MF, Quinsey C, Enyart CE, Trau SP. Increasing Seizures, Encephalopathy, and Hypothermia in an 18-Year-Old Woman. Pediatrics. 2023;151(3): doi:10.1542/peds.2022-057229.$18$YR$A$F$Y$$$20240707$$HP$US$US
240578552$24057855$2$F$20240524$20240722$20240707$20240724$EXP$FR-AFSSAPS-AN2024000785$FR-SA-2024SA182390$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240724$$MD$FR$FR
240578561$24057856$1$I$$20240624$20240707$20240707$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05767$LUPIN$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. American Journal of Transplantation. 2023;23:1048-1057$6$DEC$$F$Y$$$20240707$$HP$US$US
240578571$24057857$1$I$$20240703$20240707$20240707$PER$$US-SA-2024SA198777$SANOFI AVENTIS$$$$$F$Y$$$20240707$$CN$US$US
240578581$24057858$1$I$$20240624$20240707$20240707$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05997$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578591$24057859$1$I$$20240624$20240707$20240707$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06013$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578601$24057860$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05983$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578611$24057861$1$I$$20240702$20240707$20240707$PER$$US-AstraZeneca-2024A152859$ASTRAZENECA$$$$$$Y$$$20240707$$HP$US$
240578621$24057862$1$I$20240701$20240701$20240707$20240707$PER$$US-SA-2024SA196970$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240707$$HP$US$US
240578631$24057863$1$I$$20240627$20240707$20240707$EXP$$US-RDY-LIT/USA/24/0009686$DR REDDYS$Johnson DJ, Baadh P, Mudrakola HV. Eosinophilic Pleural Effusion and Eosinophilic Pneumonia Following Prolonged Daptomycin Administration. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: A1947. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1947.$76$YR$E$M$Y$$$20240707$$HP$US$US
240578641$24057864$1$I$$20240626$20240707$20240707$EXP$$IT-RDY-LIT/ITA/24/0009737$DR REDDYS$Liberatore C, Rossi E, Malerba L, Fioritoni F, Di Landro F, Fazio F, et al. EARLY RESULTS OF TANDEM AUTOLOGOUS STEM-CELL TRANSPLANTATION AFTER DARATUMUMAB VTD INDUCTION IN NEWLY DIAGNOSED MULTIPLE MYELOMA. Haematologica. 2024;109(2): 22-23.$$$$$Y$$$20240707$$HP$IT$IT
240578651$24057865$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06071$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578663$24057866$3$F$$20240814$20240707$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05852$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240578671$24057867$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05930$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578681$24057868$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05809$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578691$24057869$1$I$$20240627$20240707$20240707$EXP$$US-RDY-LIT/USA/24/0009742$DR REDDYS$Mignone D, Shah K, Alawneh B, Papadakos SP, Michelakis N. A RUDE AWAKENING: A CASE OF SUGAMMADEX CAUSING TRANSIENT CARDIOMYOPATHY MIMICKING STEMI. Journal of the American College of Cardiology. 2024;83(13): 3618. doi:10.1016/S0735-1097%2824%2905608-0.$43$YR$A$M$Y$$$20240707$$HP$US$US
240578701$24057870$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06019$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578712$24057871$2$F$20240615$20240708$20240707$20240709$PER$$US-JNJFOC-20240716077$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240709$$CN$US$US
240578721$24057872$1$I$20240705$20240705$20240707$20240707$PER$$US-JNJFOC-20240715508$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240707$$PH$US$US
240578731$24057873$1$I$20240620$20240705$20240707$20240707$PER$$US-JNJFOC-20240716056$JOHNSON AND JOHNSON$$$$$F$Y$$$20240707$$CN$US$US
240578741$24057874$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05919$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578751$24057875$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05815$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578761$24057876$1$I$$20240627$20240707$20240707$EXP$$US-RDY-LIT/USA/24/0009746$DR REDDYS$Habib A, Butt K, Ibrahim R, Shaaban A, Lee HS. BRASH syndrome: A rare but reversible cause of sinus node dysfunction. Heart Rhythm Case Reports. 2024;10(6): 398-401. doi:10.1016/j.hrcr.2024.03.005.$57$YR$A$F$Y$$$20240707$$MD$US$US
240578771$24057877$1$I$$20240628$20240707$20240707$EXP$$US-RDY-LIT/USA/24/0009739$DR REDDYS$Malik T, Gordon B, Ramanathan R, Mcguire EL. A Tale of Broken Hearts: Cardiac Aspergillosis in an Immunocompromised Patient. American Journal of Respiratory and Critical Care Medicine. 207: doi:10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A1801.$27$YR$A$M$Y$$$20240707$$HP$US$US
240578781$24057878$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05931$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578791$24057879$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05980$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578801$24057880$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05999$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578812$24057881$2$F$20240101$20240813$20240707$20240826$PER$$US-SA-2024SA196531$SANOFI AVENTIS$$60$YR$A$F$Y$71.985$KG$20240826$$MD$US$US
240578821$24057882$1$I$$20240626$20240707$20240707$PER$$US-JNJFOC-20240715388$JOHNSON AND JOHNSON$$$$$M$Y$$$20240707$$CN$US$US
240578831$24057883$1$I$20240615$20240626$20240707$20240707$PER$$US-JNJFOC-20240714762$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240707$$CN$US$US
240578841$24057884$1$I$$20240626$20240707$20240707$PER$$US-JNJFOC-20240714764$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240707$$HP$US$US
240578851$24057885$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06014$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578861$24057886$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06034$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578871$24057887$1$I$$20240628$20240707$20240707$EXP$US-MLMSERVICE-20240621-PI109499-00129-2$US-RDY-SPO/USA/24/0009532$DR REDDYS$Contag CA, Studemeister L, Bogler Y, Cooper JD. Q fever presenting as splenic infarct without endocarditis. IDCases. 2024;37:e02012. DOI: 10.1016/j.idcr.2024.e02012.$44$YR$A$M$Y$$$20240707$$MD$US$US
240578882$24057888$2$F$20221231$20240716$20240707$20240728$EXP$$IN-RDY-LIT/IND/24/0009491$DR REDDYS$Edison DC, Philip J, Mallhi RS, Basnotra R, Pynadath V, Sane K. Severe amlodipine toxicity: A medical dilemma managed with therapeutic plasma exchange. Transfusion and Apheresis Science. 2024;63(4): doi:10.1016/j.transci.2024.103958.$$$$M$Y$68$KG$20240728$$HP$IN$IN
240578891$24057889$1$I$$20240626$20240707$20240707$EXP$$IT-RDY-LIT/ITA/24/0009738$DR REDDYS$Garbo V, Condemi A, Albano C, Polara VF, Parrino R, Macaluso A, et al. Dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients: a case series. Infezioni in Medicina. 2024;32(2): 231-240. doi:10.53854/liim-3202-11.$3$MON$I$$Y$$$20240707$$HP$IT$IT
240578901$24057890$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06035$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578911$24057891$1$I$20240107$20240115$20240707$20240707$PER$$US-DEXPHARM-20240131$DEXCEL$$87$YR$E$F$Y$$$20240707$$CN$US$US
240578922$24057892$2$F$$20240906$20240707$20240910$EXP$$NVSC2024MX139908$NOVARTIS$Catherine P, Rodrigo C, Marco J. Q, Mario V. Mucormycosis in liver allograft following transplant for secondary biliary cirrhosis. EXPERIMENTAL AND CLINICAL TRANSPLANTATION. 2024;4:314-7$57$YR$$M$Y$$$20240910$$HP$CA$MX
240578932$24057893$2$F$$20240807$20240707$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06072$LUPIN$$$$$$Y$$$20240817$$CN$US$US
240578941$24057894$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06038$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240578951$24057895$1$I$$20240628$20240707$20240707$EXP$$US-RDY-LIT/USA/24/0009700$DR REDDYS$Suthar PP, Hughes K, Mafraji M, Akyuz M, Jhaveri M, Dua SG. Case 324: CHANTER Syndrome. Radiology. 2024 Apr;311(1): 1-4. doi:10.1148/radiol.222748.$69$YR$E$M$Y$$$20240707$$MD$US$US
240578961$24057896$1$I$$20240629$20240707$20240707$PER$$US-SA-2024SA196152$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240707$$MD$US$US
240578971$24057897$1$I$$20240627$20240707$20240707$EXP$$US-RDY-LIT/USA/24/0009685$DR REDDYS$Mcgee JD, Vyas H, Heyer M, Rahim M, Tang B, Kim B, et al. A Case of Tumoral Pulmonary Hypertension Resulting in Right Ventricular Failure. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2232.$44$YR$A$F$Y$$$20240707$$HP$US$US
240578981$24057898$1$I$$20240611$20240707$20240707$PER$$US-JNJFOC-20240633894$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$CN$US$US
240578991$24057899$1$I$20240704$20240705$20240707$20240707$PER$$US-JNJFOC-20240715722$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240707$$PH$US$US
240579011$24057901$1$I$20240101$20240627$20240707$20240707$PER$$US-SA-2024SA194657$SANOFI AVENTIS$$42$YR$A$F$Y$68$KG$20240707$$MD$US$US
240579021$24057902$1$I$$20240628$20240707$20240707$PER$$US-AstraZeneca-2024A150751$ASTRAZENECA$$$$$$Y$$$20240707$$HP$US$
240579031$24057903$1$I$$20240703$20240707$20240707$PER$$US-AstraZeneca-2024A153887$ASTRAZENECA$$$$$F$Y$$$20240707$$HP$US$
240579041$24057904$1$I$20231001$20240704$20240707$20240707$EXP$FR-AFSSAPS-BR2024000467$FR-ROCHE-10000016703$ROCHE$$25$YR$A$M$Y$42$KG$20240707$$MD$FR$FR
240579051$24057905$1$I$$20240530$20240707$20240707$PER$$US-AMGEN-USASP2024133636$AMGEN$$$$$$Y$$$20240707$$CN$US$US
240579061$24057906$1$I$$20240703$20240707$20240707$PER$$US-BAYER-2024A096537$BAYER$$$$E$F$Y$$$20240707$$CN$US$US
240579071$24057907$1$I$20230101$20240628$20240707$20240707$PER$$US-SA-2024SA194771$SANOFI AVENTIS$$$$A$$Y$$$20240707$$CN$US$US
240579084$24057908$4$F$20240701$20240808$20240707$20240814$PER$$US-SA-2024SA197625$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240814$$CN$US$US
240579091$24057909$1$I$$20240703$20240707$20240707$PER$$US-BAYER-2024A097171$BAYER$$$$$F$Y$$$20240707$$CN$US$US
240579101$24057910$1$I$20240101$20240705$20240707$20240707$PER$$US-BAYER-2024A097483$BAYER$$27$YR$A$F$Y$$$20240707$$PH$US$US
240579111$24057911$1$I$$20240702$20240707$20240707$PER$$US-AstraZeneca-2024A153683$ASTRAZENECA$$$$$$Y$$$20240707$$MD$US$
240579122$24057912$2$F$20240621$20240724$20240707$20240802$PER$$US-BAYER-2024A095588$BAYER$$37$YR$A$F$Y$$$20240802$$MD$US$US
240579131$24057913$1$I$20240701$20240702$20240707$20240707$PER$$US-AstraZeneca-2024A152878$ASTRAZENECA$$$$$F$Y$$$20240707$$MD$US$
240579141$24057914$1$I$$20240516$20240707$20240707$PER$$US-AMGEN-USASP2024133729$AMGEN$$$$$$Y$$$20240707$$PH$US$US
240579152$24057915$2$F$20240627$20240708$20240707$20240718$EXP$$US-AMGEN-USASP2024129807$AMGEN$$$$$F$Y$$$20240718$$MD$US$US
240579161$24057916$1$I$20240513$20240702$20240707$20240707$PER$$US-BAYER-2024A095590$BAYER$$43$YR$A$F$Y$$$20240707$$MD$US$US
240579171$24057917$1$I$$20240702$20240707$20240707$PER$$US-BAYER-2024A095823$BAYER$$19$YR$A$F$Y$$$20240707$$MD$US$US
240579182$24057918$2$F$20210101$20240716$20240707$20240719$EXP$$US-AMGEN-USASP2024130324$AMGEN$$$$$M$Y$$$20240719$$CN$US$US
240579193$24057919$3$F$20240620$20240710$20240707$20240716$EXP$$US-BAYER-2024A095520$BAYER$$56$YR$A$F$Y$$$20240716$$CN$US$US
240579201$24057920$1$I$$20230123$20240707$20240707$PER$$US-AMGEN-USASP2023235641$AMGEN$$$$$$Y$$$20240707$$CN$US$US
240579211$24057921$1$I$$20240701$20240707$20240707$PER$$US-SA-2024SA196362$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240707$$HP$US$US
240579221$24057922$1$I$$20240613$20240707$20240707$PER$$US-JNJFOC-20240636939$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$CN$US$US
240579231$24057923$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06194$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240579241$24057924$1$I$$20240702$20240707$20240707$PER$$US-SA-2024SA197696$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240707$$CN$US$US
240579251$24057925$1$I$$20240625$20240707$20240707$EXP$$GR-JNJFOC-20240674644$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240707$$MD$GR$GR
240579261$24057926$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06298$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240579271$24057927$1$I$20240601$20240628$20240707$20240707$PER$$US-SA-2024SA196515$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240707$$MD$US$US
240579281$24057928$1$I$20240625$20240628$20240707$20240707$PER$$US-SA-2024SA196164$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240707$$MD$US$US
240579291$24057929$1$I$$20240624$20240707$20240707$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06031$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240579301$24057930$1$I$20240627$20240701$20240707$20240707$PER$$US-AMGEN-USASL2024131321$AMGEN$$$$$$Y$$$20240707$$CN$US$US
240579311$24057931$1$I$$20240703$20240707$20240707$PER$$US-JNJFOC-20240711472$JOHNSON AND JOHNSON$$$$$M$Y$$$20240707$$HP$US$US
240579322$24057932$2$F$$20240708$20240707$20240709$PER$$US-AMGEN-USASP2024134293$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240579332$24057933$2$F$$20240827$20240707$20240905$PER$$US-AstraZeneca-2024A151092$ASTRAZENECA$$$$$F$Y$$$20240905$$PH$US$
240579341$24057934$1$I$$20240703$20240707$20240707$PER$$US-ELI_LILLY_AND_COMPANY-US202407002879$ELI LILLY AND CO$$$$$$Y$$$20240707$$PH$US$US
240579351$24057935$1$I$$20240624$20240707$20240707$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05773$LUPIN$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al.. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. American Journal of Transplantation. 2023;23 (7):1048-1057$6$DEC$$M$Y$$$20240707$$HP$US$US
240579361$24057936$1$I$$20240703$20240707$20240707$PER$$US-ELI_LILLY_AND_COMPANY-US202407002700$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240707$$CN$US$US
240579371$24057937$1$I$20240530$20240629$20240707$20240707$EXP$$ZA-AMGEN-ZAFSP2024131285$AMGEN$$57$YR$A$M$Y$$$20240707$$CN$ZA$ZA
240579381$24057938$1$I$20240701$20240705$20240707$20240707$PER$$US-AMGEN-USASP2024134311$AMGEN$$49$YR$A$M$Y$$$20240707$$CN$US$US
240579391$24057939$1$I$$20240702$20240707$20240707$EXP$$US-AVEVA-000695$AVEVA$Golparvar A, Nafeh O, Alzamani M, Singh V, Jennings M. The Development of Disinhibited Social Engagement Disorder: A Case Report on the Psychiatric Implications of Prenatal Fentanyl Use. Cureus. 2024,16(5):e61078. doi: 10.7759/cureus.61078. PMID: 38915968.$5$YR$C$F$Y$$$20240707$$HP$US$US
240579401$24057940$1$I$20240701$20240703$20240707$20240707$PER$$US-AMGEN-USASP2024133384$AMGEN$$49$YR$A$M$Y$$$20240707$$CN$US$US
240579411$24057941$1$I$$20240627$20240707$20240707$PER$$US-JNJFOC-20240703826$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$CN$US$US
240579421$24057942$1$I$20240101$20240705$20240707$20240707$EXP$$BE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038043$BOEHRINGER INGELHEIM$$55$YR$A$F$Y$$$20240707$$MD$BE$BE
240579431$24057943$1$I$20240702$20240703$20240707$20240707$PER$$US-ELI_LILLY_AND_COMPANY-US202407002740$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240707$$CN$US$US
240579441$24057944$1$I$20240627$20240627$20240707$20240707$PER$$US-SA-2024SA192995$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240707$$CN$US$US
240579451$24057945$1$I$$20240627$20240707$20240707$PER$$US-SA-2024SA193016$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240707$$CN$US$US
240579461$24057946$1$I$$20240628$20240707$20240707$PER$$US-SA-2024SA196669$SANOFI AVENTIS$$$$$F$Y$63.04$KG$20240707$$CN$US$US
240579471$24057947$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06179$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240579481$24057948$1$I$20240101$20240701$20240707$20240707$PER$$US-SA-2024SA195951$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240707$$MD$US$US
240579491$24057949$1$I$$20240701$20240707$20240707$EXP$$IL-ROCHE-10000016737$ROCHE$$34$YR$A$M$Y$$$20240707$$MD$IL$IL
240579501$24057950$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06043$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240579511$24057951$1$I$20240622$20240628$20240707$20240707$EXP$$CO-JNJFOC-20240702247$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240707$$MD$CO$CO
240579521$24057952$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06078$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240579531$24057953$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06093$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240579541$24057954$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06133$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240579551$24057955$1$I$$20240628$20240707$20240707$PER$$US-AstraZeneca-2024A150473$ASTRAZENECA$$$$$F$Y$$$20240707$$CN$US$
240579562$24057956$2$F$20240601$20240628$20240707$20240710$PER$$US-SA-2024SA194536$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240710$$MD$US$US
240579573$24057957$3$F$$20240812$20240707$20240822$30DAY$$US-GSK-US2024AMR081036$GLAXOSMITHKLINE$$$$$M$Y$$$20240822$$PH$US$US
240579581$24057958$1$I$$20240624$20240707$20240707$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06186$LUPIN$$$$$$Y$$$20240707$$CN$US$US
240579591$24057959$1$I$$20240702$20240707$20240707$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037608$BOEHRINGER INGELHEIM$Toshiki Igai, Takeshi Kashio, Sayuri Yasuda, Eri Amano, Sei Hirano, Ikugo Funakoshi, Taro Horino, Norio Terada, Shinpei Fujimoto; One case of euglycemic ketoacidosis during oral administration of SGLT2 inhibitor;$81$YR$E$M$Y$$$20240707$$MD$JP$JP
240579601$24057960$1$I$$20240628$20240707$20240707$EXP$US-MLMSERVICE-20240627-PI109357-00232-4$US-RDY-SPO/USA/24/0009674$DR REDDYS$Sharma P, Tahiru M, Li H, Bansari A, Baskaran N. A case of ocular diffuse large B-cell lymphoma unveiled through Pars Plana Vitrectomy: surgical insight and multidisciplinary management. Journal of Surgical Case Reports. 2024;2024(6):rjae399. DOI:10.1093/jscr/rjae399.$74$YR$E$M$Y$$$20240707$$MD$US$US
240579611$24057961$1$I$$20240628$20240707$20240707$PER$US-MLMSERVICE-20240625-PI109043-00338-4$US-RDY-SPO/USA/24/0009657$DR REDDYS$Mahajan A, Vatti T, Coulter A, Khawam E, Howland M. Palliative ECT for Catatonia in a Terminal Cancer Patient: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65(3):315-6. DOI: 10.1016/j.jaclp.2024.01.005.$78$YR$E$M$Y$$$20240707$$MD$US$US
240579621$24057962$1$I$$20240627$20240707$20240707$EXP$$US-GSK-US2024AMR081225$GLAXOSMITHKLINE$$$$$$Y$$$20240707$$HP$US$US
240579631$24057963$1$I$20240703$20240703$20240707$20240707$PER$$US-ELI_LILLY_AND_COMPANY-US202407002623$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240707$$CN$US$US
240579641$24057964$1$I$$20240702$20240707$20240707$PER$$US-EMD Serono-2024036248$EMD SERONO INC$$54$YR$A$F$Y$$$20240707$$CN$US$US
240579651$24057965$1$I$20240603$20240628$20240707$20240707$EXP$IT-MINISAL02-992202$IT-AMGEN-ITASP2024132046$AMGEN$$65$YR$E$F$Y$$$20240707$$MD$IT$IT
240579661$24057966$1$I$$20240626$20240707$20240707$EXP$$FR-AMGEN-FRASP2024131823$AMGEN$$$$$F$Y$$$20240707$$PH$FR$FR
240579672$24057967$2$F$20240629$20240716$20240707$20240724$30DAY$$US-AMGEN-USASP2024130972$AMGEN$$$$$$Y$$$20240724$$PH$US$US
240579682$24057968$2$F$20221101$20240613$20240707$20240708$EXP$$ES-ROCHE-10000010477$ROCHE$$65$YR$E$M$Y$$$20240708$$MD$ES$ES
240579692$24057969$2$F$$20240916$20240707$20240926$PER$$US-GSK-US2024080251$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$MD$US$US
240579701$24057970$1$I$$20240703$20240707$20240707$PER$$US-ELI_LILLY_AND_COMPANY-US202407004029$ELI LILLY AND CO$$$$$F$Y$$$20240707$$CN$US$US
240579711$24057971$1$I$20240630$20240701$20240707$20240707$PER$$US-SA-2024SA196554$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240707$$MD$US$US
240579723$24057972$3$F$$20240826$20240707$20240904$PER$$US-AstraZeneca-2024A149160$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
240579732$24057973$2$F$20240101$20240708$20240707$20240709$PER$$US-AMGEN-USASP2024134446$AMGEN$$55$YR$A$M$Y$$$20240709$$CN$US$US
240579741$24057974$1$I$$20240625$20240707$20240707$EXP$$US-ENDO USA, INC.-2024-002782$ENDO$$3$DEC$$$Y$$$20240707$$CN$US$US
240579752$24057975$2$F$20240619$20240827$20240707$20240909$PER$$US-JNJFOC-20240715605$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$MD$US$US
240579761$24057976$1$I$20240618$20240624$20240707$20240707$PER$$US-JNJFOC-20240715604$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240707$$HP$US$US
240579771$24057977$1$I$$20240628$20240707$20240707$PER$$US-SA-2024SA196571$SANOFI AVENTIS$$43$YR$A$F$Y$56.24$KG$20240707$$MD$US$US
240579781$24057978$1$I$20240701$20240701$20240707$20240707$PER$$US-SA-2024SA196644$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240707$$HP$US$US
240579792$24057979$2$F$$20240703$20240707$20240709$EXP$$NVSC2024JP139895$NOVARTIS$Nakamura S, Masuda S, Oda S, Yamakawa D, Yamaguchi S, Ishima T, et al.. Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine.. INTERNAL MEDICINE. 2024;63(12):1829-35$72$YR$$F$Y$$$20240709$$HP$JP$JP
240579801$24057980$1$I$20240703$20240705$20240707$20240707$PER$$US-AMGEN-USASP2024134417$AMGEN$$$$$$Y$$$20240707$$PH$US$US
240579811$24057981$1$I$$20240626$20240707$20240707$EXP$$US-AUROBINDO-AUR-APL-2024-030293$AUROBINDO$$45$YR$$M$Y$$$20240708$$PH$US$US
240579821$24057982$1$I$20240601$20240629$20240707$20240707$PER$$US-SA-2024SA196959$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240707$$MD$US$US
240579832$24057983$2$F$$20240802$20240707$20240810$PER$$US-AstraZeneca-2024A150697$ASTRAZENECA$$$$$F$Y$$$20240810$$MD$US$
240579841$24057984$1$I$20231001$20240701$20240707$20240707$EXP$$NVSC2024GB136502$NOVARTIS$$44$YR$$F$Y$$$20240707$$CN$GB$GB
240579852$24057985$2$F$$20240625$20240707$20240709$EXP$$NVSC2024IT135701$NOVARTIS$Zaccheddu E, Zappu A, Barella S, Clemente MG, Orecchia V, Pilia MP et. al.. Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept.. BRITISH JOURNAL OF HAEMATOLOGY. 2024;204 (6):2505-7$28$YR$$F$Y$$$20240709$$HP$IT$IT
240579861$24057986$1$I$$20240629$20240707$20240707$EXP$$US-AUROBINDO-AUR-APL-2024-033211$AUROBINDO$$70$YR$$F$Y$$$20240708$$MD$US$US
240579872$24057987$2$F$$20240722$20240707$20240730$PER$$US-ALXN-202407USA000012US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
240579881$24057988$1$I$20240322$20240701$20240707$20240707$EXP$$US-JNJFOC-20240702362$JOHNSON AND JOHNSON$$$$$F$Y$$$20240707$$HP$US$US
240579902$24057990$2$F$20240501$20240717$20240707$20240723$PER$$US-SA-2024SA198184$SANOFI AVENTIS$$65$YR$E$F$Y$99.79$KG$20240723$$MD$US$US
240579911$24057991$1$I$$20240627$20240707$20240707$30DAY$$US-GSK-US2024AMR081249$GLAXOSMITHKLINE$$$$$F$Y$$$20240707$$CN$US$US
240579921$24057992$1$I$$20240628$20240707$20240707$PER$$US-SA-2024SA197227$SANOFI AVENTIS$$14$YR$T$M$Y$58.957$KG$20240707$$MD$US$US
240579932$24057993$2$F$$20240702$20240707$20240726$PER$$US-AstraZeneca-2024A152308$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
240579941$24057994$1$I$$20240701$20240707$20240707$PER$$US-ALXN-202407USA000010US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240707$$CN$US$US
240579951$24057995$1$I$$20240701$20240707$20240707$EXP$$US-SA-2024SA196873$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240707$$CN$US$US
240579962$24057996$2$F$$20240805$20240707$20240806$PER$$US-ALXN-202407USA000008US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240579971$24057997$1$I$$20240628$20240707$20240707$30DAY$$US-GSK-US2024081056$GLAXOSMITHKLINE$$$$$F$Y$$$20240707$$CN$US$US
240579981$24057998$1$I$$20240701$20240707$20240707$EXP$$ES-SA-2024SA198399$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240707$$HP$ES$ES
240579992$24057999$2$F$20240630$20240805$20240707$20240806$PER$$US-ALXN-202406USA001962US$ALEXION PHARMACEUTICALS$$71$YR$$F$Y$$$20240806$$CN$US$US
240580001$24058000$1$I$$20240627$20240707$20240707$PER$$US-JNJFOC-20240700528$JOHNSON AND JOHNSON$$$$$F$Y$$$20240707$$CN$US$US
240580011$24058001$1$I$$20240628$20240707$20240707$PER$$US-JNJFOC-20240700620$JOHNSON AND JOHNSON$$$$$F$Y$$$20240707$$CN$US$US
240580022$24058002$2$F$20240703$20240827$20240707$20240829$PER$$US-AMGEN-USASP2024132684$AMGEN$$74$YR$E$M$Y$$$20240828$$CN$US$US
240580031$24058003$1$I$$20240630$20240707$20240707$PER$$US-JNJFOC-20240700675$JOHNSON AND JOHNSON$$$$$$Y$$$20240707$$CN$US$US
240580044$24058004$4$F$20240703$20240829$20240707$20240905$PER$$US-AMGEN-USASP2024132768$AMGEN$$84$YR$E$F$Y$$$20240904$$CN$US$US
240580054$24058005$4$F$$20240702$20240707$20240712$EXP$$ES-009507513-2407ESP002043$MERCK$$$$$F$Y$$$20240712$$MD$ES$ES
240580062$24058006$2$F$20240701$20240715$20240707$20240722$PER$$US-JNJFOC-20240707109$JOHNSON AND JOHNSON$$$$$M$Y$$$20240721$$CN$US$US
240580071$24058007$1$I$20170101$20240701$20240707$20240707$EXP$$IT-009507513-2407ITA002200$MERCK$$67$YR$$M$Y$$$20240707$$MD$IT$IT
240580081$24058008$1$I$$20240625$20240707$20240707$EXP$$XG-B.Braun Medical Inc.-2158888$B BRAUN$Literature Article$49$YR$$M$Y$$$20240707$$$XG$XG
240580093$24058009$3$F$$20240812$20240707$20240814$PER$$US-AMGEN-USASP2024134255$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
240580101$24058010$1$I$$20240625$20240707$20240707$EXP$$US-B.Braun Medical Inc.-2158889$B BRAUN$Literature Article$63$YR$$F$Y$$$20240707$$$US$US
240580111$24058011$1$I$$20240703$20240707$20240707$PER$$US-SA-2024SA198069$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240708$$HP$US$US
240580121$24058012$1$I$$20240625$20240707$20240707$EXP$$US-B.Braun Medical Inc.-2158891$B BRAUN$Literature Article$53$YR$$F$Y$$$20240707$$$US$US
240580132$24058013$2$F$20240703$20240823$20240707$20240827$PER$$US-AMGEN-USASP2024132586$AMGEN$$73$YR$E$F$Y$$$20240827$$CN$US$US
240580142$24058014$2$F$20240705$20240822$20240707$20240827$PER$$US-AMGEN-USASP2024134306$AMGEN$$69$YR$E$F$Y$$$20240826$$CN$US$US
240580151$24058015$1$I$$20240625$20240707$20240707$EXP$$MY-B.Braun Medical Inc.-2158892$B BRAUN$Literature Article$75$YR$$F$Y$$$20240707$$$MY$MY
240580161$24058016$1$I$$20240701$20240707$20240707$EXP$$JP-JNJFOC-20240714327$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240708$$PH$JP$JP
240580172$24058017$2$F$$20240828$20240707$20240902$EXP$$US-ABBVIE-5826250$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
240580181$24058018$1$I$20240101$20240702$20240707$20240707$EXP$$US-JNJFOC-20240707249$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240708$$HP$US$US
240580191$24058019$1$I$20240630$20240702$20240707$20240707$EXP$$US-ABBVIE-5826360$ABBVIE$$70$YR$$F$Y$$$20240707$$CN$US$US
240580202$24058020$2$F$20240701$20240801$20240707$20240806$EXP$$CA-ABBVIE-5828646$ABBVIE$$87$YR$$M$Y$$$20240806$$CN$CA$CA
240580211$24058021$1$I$20240702$20240703$20240707$20240707$EXP$$US-ABBVIE-5828675$ABBVIE$$73$YR$$F$Y$$$20240707$$CN$US$US
240580221$24058022$1$I$$20240703$20240707$20240707$EXP$$US-ABBVIE-5828683$ABBVIE$$$$$F$Y$$$20240707$$CN$US$US
240580231$24058023$1$I$$20240702$20240707$20240707$EXP$$US-JNJFOC-20240707197$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240708$$HP$US$US
240580241$24058024$1$I$20240401$20240502$20240707$20240707$PER$$US-Eisai-EC-2024-165083$EISAI$$$$$M$Y$$$20240708$$CN$US$US
240580251$24058025$1$I$$20240626$20240707$20240707$EXP$$US-JNJFOC-20240670549$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$PH$US$US
240580262$24058026$2$F$$20240826$20240707$20240827$EXP$$DE-JNJFOC-20240714523$JOHNSON AND JOHNSON$$17$YR$T$F$Y$62$KG$20240827$$MD$DE$DE
240580271$24058027$1$I$$20240702$20240707$20240707$EXP$$GB-AMGEN-GBRNI2024133575$AMGEN$$$$$F$Y$$$20240707$$CN$GB$GB
240580281$24058028$1$I$20240701$20240702$20240707$20240707$EXP$$US-ABBVIE-5827372$ABBVIE$$73$YR$$M$Y$$$20240707$$CN$US$US
240580291$24058029$1$I$$20240702$20240707$20240707$EXP$$NVSJ2024JP008006$NOVARTIS$$83$YR$$M$Y$$$20240708$$MD$JP$JP
240580301$24058030$1$I$$20240701$20240707$20240707$EXP$$US-JNJFOC-20240703638$JOHNSON AND JOHNSON$$$$$M$Y$$$20240708$$HP$US$US
240580311$24058031$1$I$$20240702$20240707$20240707$PER$$US-BIOGEN-2023BI01241153$BIOGEN$$$$$F$Y$$$20240707$$CN$US$US
240580321$24058032$1$I$$20240705$20240707$20240707$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038153$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240708$$CN$US$US
240580332$24058033$2$F$20240403$20240719$20240707$20240725$PER$$US-BIOGEN-2024BI01272038$BIOGEN$$27$YR$$M$Y$$$20240725$$CN$US$US
240580341$24058034$1$I$20240401$20240702$20240707$20240707$PER$$US-BIOGEN-2024BI01259679$BIOGEN$$76$YR$$F$Y$$$20240707$$CN$US$US
240580351$24058035$1$I$$20240625$20240707$20240707$EXP$$MY-B.Braun Medical Inc.-2158893$B BRAUN$Literature Article$80$YR$$M$Y$$$20240707$$$MY$MY
240580361$24058036$1$I$$20240705$20240707$20240707$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038155$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240708$$HP$US$US
240580371$24058037$1$I$20220825$20240701$20240707$20240707$EXP$$NVSC2023JP023625$NOVARTIS$$74$YR$$M$Y$57.5$KG$20240708$$MD$JP$JP
240580382$24058038$2$F$$20240715$20240707$20240716$EXP$$IT-SANDOZ INC.-NVSC2022IT200189$SANDOZ$$16$YR$$M$Y$$$20240716$$MD$IT$IT
240580391$24058039$1$I$$20240705$20240707$20240707$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038174$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240708$$CN$US$US
240580401$24058040$1$I$$20240702$20240707$20240707$EXP$$US-ABBVIE-5826220$ABBVIE$$$$$F$Y$$$20240707$$CN$US$US
240580411$24058041$1$I$$20240702$20240707$20240707$EXP$$CA-ABBVIE-5826239$ABBVIE$$$$E$M$Y$$$20240707$$CN$CA$CA
240580421$24058042$1$I$20240617$20240703$20240707$20240707$EXP$$US-ABBVIE-5828656$ABBVIE$$86$YR$$F$Y$$$20240707$$CN$US$US
240580432$24058043$2$F$20240101$20240826$20240707$20240830$EXP$$US-ABBVIE-5825257$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
240580442$24058044$2$F$$20240708$20240707$20240718$EXP$$AR-AMGEN-ARGSP2024132882$AMGEN$$77$YR$E$F$Y$$$20240718$$CN$AR$AR
240580451$24058045$1$I$$20240701$20240707$20240707$PER$$US-JNJFOC-20240701222$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$US$US
240580461$24058046$1$I$$20240702$20240707$20240707$EXP$$JP-009507513-2405JPN001656J$MERCK$$74$YR$$M$Y$$$20240707$$MD$JP$JP
240580473$24058047$3$F$20231123$20240906$20240707$20240913$EXP$$JP-009507513-2406JPN004417J$MERCK$$62$YR$$F$Y$$$20240913$$MD$JP$JP
240580481$24058048$1$I$$20240625$20240707$20240707$EXP$$US-B.Braun Medical Inc.-2158894$B BRAUN$Literatue Article$43$YR$$F$Y$$$20240707$$$US$US
240580491$24058049$1$I$$20240701$20240707$20240707$EXP$$JP-AMGEN-JPNSP2024132240$AMGEN$$$$$$Y$$$20240707$$MD$JP$JP
240580504$24058050$4$F$20240715$20240910$20240707$20240916$EXP$$CO-TAKEDA-2024TUS068360$TAKEDA$$64$YR$$M$Y$54$KG$20240916$$CN$CO$CO
240580514$24058051$4$F$20230101$20240910$20240707$20240914$EXP$$US-ABBVIE-5788557$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
240580521$24058052$1$I$$20240702$20240707$20240707$EXP$$US-JNJFOC-20240708085$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$HP$US$US
240580531$24058053$1$I$20240514$20240705$20240707$20240707$EXP$GB-MHRA-MED-202405162327535440-LQSTK$GB-ABBVIE-5829599$ABBVIE$$54$YR$$F$Y$93$KG$20240707$$CN$GB$GB
240580541$24058054$1$I$$20240702$20240707$20240707$PER$$US-SA-2024SA197068$SANOFI AVENTIS$$$$$$Y$$$20240708$$PH$US$US
240580552$24058055$2$F$20240101$20240722$20240707$20240731$PER$$US-SA-2024SA197082$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240731$$CN$US$US
240580561$24058056$1$I$$20240703$20240707$20240707$EXP$$NVSC2024GT139847$NOVARTIS$$$$$F$Y$$$20240708$$CN$GT$GT
240580571$24058057$1$I$$20240704$20240707$20240707$EXP$$GB-ABBVIE-5828557$ABBVIE$$$$A$M$Y$$$20240707$$CN$GB$GB
240580591$24058059$1$I$$20240703$20240707$20240707$EXP$$US-JNJFOC-20240708977$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$HP$US$US
240580601$24058060$1$I$$20240703$20240707$20240707$EXP$$US-JNJFOC-20240709964$JOHNSON AND JOHNSON$$$$$M$Y$$$20240708$$CN$US$US
240580611$24058061$1$I$20240601$20240703$20240707$20240707$EXP$$US-ABBVIE-5828696$ABBVIE$$45$YR$$F$Y$$$20240707$$CN$US$US
240580621$24058062$1$I$20240101$20240703$20240707$20240707$EXP$$US-ABBVIE-5828936$ABBVIE$$$$$F$Y$$$20240707$$CN$US$US
240580631$24058063$1$I$$20240625$20240707$20240707$EXP$$GB-B.Braun Medical Inc.-2158895$B BRAUN$$69$YR$$F$Y$$$20240707$$$GB$GB
240580643$24058064$3$F$20240901$20240911$20240707$20240913$EXP$$US-SANDOZ INC.-SDZ2024US063006$SANDOZ$$60$YR$$M$Y$$$20240913$$HP$US$US
240580651$24058065$1$I$$20240703$20240707$20240707$EXP$$US-ABBVIE-5828614$ABBVIE$$$$$F$Y$$$20240707$$CN$US$US
240580661$24058066$1$I$20240618$20240703$20240707$20240707$EXP$$CN-ABBVIE-5827003$ABBVIE$$72$YR$$F$Y$62$KG$20240707$$MD$CN$CN
240580674$24058067$4$F$20211001$20240718$20240707$20240725$EXP$$AT-ABBVIE-22K-009-4328414-00$ABBVIE$$25$YR$$M$Y$65$KG$20240725$$MD$AT$AT
240580681$24058068$1$I$$20240626$20240707$20240707$EXP$$IN-JNJFOC-20240701667$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240708$$HP$IN$IN
240580691$24058069$1$I$$20240703$20240707$20240707$EXP$$US-JNJFOC-20240708667$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$US$US
240580704$24058070$4$F$$20240902$20240707$20240906$EXP$$JP-GSK-JP2024JPN081677$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$JP$JP
240580711$24058071$1$I$$20240701$20240707$20240707$EXP$$NVSC2024VE139894$NOVARTIS$$$$A$M$Y$$$20240708$$CN$VE$VE
240580722$24058072$2$F$$20240808$20240707$20240813$30DAY$$IL-JNJFOC-20240663351$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$PH$IL$IL
240580731$24058073$1$I$$20240701$20240707$20240707$EXP$$US-ABBVIE-5830447$ABBVIE$$$$E$$Y$$$20240707$$CN$US$US
240580741$24058074$1$I$20240701$20240702$20240707$20240707$EXP$$CO-ABBVIE-5829449$ABBVIE$$86$YR$$M$Y$62$KG$20240707$$HP$CO$CO
240580751$24058075$1$I$$20240701$20240707$20240707$EXP$$JP-GSK-JP2024081502$GLAXOSMITHKLINE$$$$$$Y$$$20240707$$CN$JP$JP
240580761$24058076$1$I$20240201$20240703$20240707$20240707$EXP$$IE-ABBVIE-5830015$ABBVIE$$$$$M$Y$$$20240707$$CN$IE$IE
240580771$24058077$1$I$$20240701$20240707$20240707$EXP$$US-ABBVIE-5826607$ABBVIE$$$$$F$Y$$$20240707$$CN$US$US
240580781$24058078$1$I$20220101$20240701$20240707$20240707$PER$$US-DSJP-DSJ-2024-130233$DAIICHI$Rangel M, Julia A, Alison C, Lily H, Elizabeth M, Julie W. A Case of Metastatic Breast Cancer to Soft Tissue of the Thigh. Cancer Research. 2024;84(9 Suppl)$70$YR$$F$Y$$$20240708$$HP$US$US
240580791$24058079$1$I$$20240701$20240707$20240707$EXP$$US-ABBVIE-5714086$ABBVIE$$$$$F$Y$$$20240707$$CN$US$US
240580802$24058080$2$F$20240628$20240708$20240707$20240719$EXP$$JP-AMGEN-JPNSP2024133270$AMGEN$$86$YR$E$F$Y$$$20240719$$PH$JP$JP
240580811$24058081$1$I$20240601$20240702$20240707$20240707$EXP$$GB-ABBVIE-5828440$ABBVIE$$62$YR$$F$Y$$$20240707$$CN$GB$GB
240580822$24058082$2$F$20240208$20240913$20240707$20240923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106520$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$48.6$KG$20240923$$PH$JP$JP
240580832$24058083$2$F$20240101$20240806$20240707$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-096080$BRISTOL MYERS SQUIBB$$17$YR$T$F$Y$55$KG$20240813$$CN$CA$CA
240580844$24058084$4$F$$20240808$20240707$20240812$EXP$$US-ABBVIE-5828484$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
240580851$24058085$1$I$$20240703$20240707$20240707$EXP$$US-ABBVIE-5828509$ABBVIE$$$$$M$Y$$$20240707$$CN$US$US
240580871$24058087$1$I$$20240704$20240707$20240707$EXP$$US-ABBVIE-5829902$ABBVIE$$$$$M$Y$$$20240707$$CN$US$US
240580881$24058088$1$I$$20231220$20240707$20240707$PER$$US-AMGEN-USASP2023235546$AMGEN$$$$$$Y$$$20240707$$PH$US$US
240580891$24058089$1$I$$20240701$20240707$20240707$PER$$US-ABBVIE-5825117$ABBVIE$$$$$$Y$$$20240707$$CN$US$US
240580901$24058090$1$I$20240601$20240701$20240707$20240707$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105298$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$88.45$KG$20240708$$PH$US$US
240580911$24058091$1$I$$20240625$20240707$20240707$EXP$$CH-B.Braun Medical Inc.-2158896$B BRAUN$Literature Article$41$YR$$M$Y$$$20240707$$$CH$CH
240580921$24058092$1$I$$20240701$20240707$20240707$EXP$$US-BIOGEN-2024BI01268156$BIOGEN$$$$$M$Y$$$20240707$$CN$US$US
240580933$24058093$3$F$20240101$20240712$20240707$20240723$PER$$US-SA-2024SA196482$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240724$$MD$US$US
240580943$24058094$3$F$$20240820$20240707$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-096991$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240828$$PH$JP$JP
240580951$24058095$1$I$20240519$20240703$20240707$20240707$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107634$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240708$$CN$US$US
240580961$24058096$1$I$$20240627$20240707$20240707$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103983$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240708$$CN$US$US
240580971$24058097$1$I$$20240620$20240707$20240707$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101765$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240708$$CN$US$US
240580982$24058098$2$F$$20240902$20240707$20240912$EXP$$JP-AMGEN-JPNSP2024132751$AMGEN$$81$YR$E$M$Y$$$20240912$$MD$JP$JP
240580991$24058099$1$I$$20240701$20240707$20240707$EXP$$US-SA-2024SA196344$SANOFI AVENTIS$$$$E$F$Y$76.2$KG$20240708$$MD$US$US
240581003$24058100$3$F$20240511$20240802$20240707$20240805$EXP$FR-AFSSAPS-LY2024000876$FR-JNJFOC-20240714811$JOHNSON AND JOHNSON$$13$DY$N$M$Y$4$KG$20240805$$MD$FR$FR
240581011$24058101$1$I$20240601$20240702$20240707$20240707$EXP$$JP-PFIZER INC-PV202400081778$PFIZER$$6$DEC$$F$Y$$$20240707$$MD$JP$JP
240581021$24058102$1$I$$20240702$20240707$20240707$EXP$$JP-PFIZER INC-202400196366$PFIZER$$71$YR$$F$Y$$$20240707$$HP$JP$JP
240581031$24058103$1$I$20240625$20240701$20240707$20240707$EXP$GB-MHRA-MED-202407011600556830-BYQSC$GB-PFIZER INC-202400204437$PFIZER$$41$YR$$F$Y$70$KG$20240707$$CN$GB$GB
240581041$24058104$1$I$20240611$20240701$20240707$20240707$EXP$$JP-PFIZER INC-PV202400077231$PFIZER$$80$YR$$M$Y$68.6$KG$20240707$$PH$JP$JP
240581051$24058105$1$I$$20240701$20240707$20240707$PER$$US-SA-2024SA197128$SANOFI AVENTIS$$$$A$M$Y$72$KG$20240708$$MD$US$US
240581061$24058106$1$I$20240606$20240703$20240707$20240707$EXP$HR-HALMED-300085852$HR-TAKEDA-2024TUS067325$TAKEDA$$27$YR$$F$Y$$$20240707$$HP$HR$HR
240581071$24058107$1$I$20240703$20240703$20240707$20240707$PER$$US-AMGEN-USASP2024132173$AMGEN$$$$$F$Y$$$20240707$$PH$US$US
240581081$24058108$1$I$20240701$20240701$20240707$20240707$PER$$US-ABBVIE-5825283$ABBVIE$$31$YR$$F$Y$$$20240707$$CN$US$US
240581092$24058109$2$F$$20240806$20240707$20240807$EXP$$DE-JNJFOC-20240708668$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$MD$DE$DE
240581103$24058110$3$F$$20240807$20240707$20240812$PER$$US-AMGEN-USASP2024132148$AMGEN$$69$YR$E$F$Y$$$20240812$$CN$US$US
240581111$24058111$1$I$20240612$20240705$20240707$20240707$EXP$FR-AFSSAPS-LY2024000999$FR-JNJFOC-20240714638$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240708$$MD$FR$FR
240581121$24058112$1$I$$20240628$20240707$20240707$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107277$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240708$$MD$JP$JP
240581131$24058113$1$I$$20240705$20240707$20240707$30DAY$$US-SANDOZ INC.-SDZ2023US008726$SANDOZ$$$$$F$Y$$$20240707$$CN$US$US
240581141$24058114$1$I$$20240703$20240707$20240707$EXP$$US-JNJFOC-20240709255$JOHNSON AND JOHNSON$$$$$M$Y$$$20240708$$CN$US$US
240581151$24058115$1$I$20231201$20240705$20240707$20240707$EXP$FR-AFSSAPS-ST2024001128$NVSC2024FR139732$NOVARTIS$$47$YR$$F$Y$102$KG$20240708$$PH$FR$FR
240581161$24058116$1$I$$20240628$20240707$20240707$PER$$US-AMGEN-USASP2024129506$AMGEN$$$$$M$Y$$$20240707$$CN$US$US
240581172$24058117$2$F$$20240710$20240707$20240715$EXP$$CN-ABBVIE-5828166$ABBVIE$Zhangsong Y, Yang Li, Bin Z, Jinsong He, Jiesi Li, Shuning W, et al. Venetoclax combined with dose reduced HAD as induction treatment for patients with de novo acute myeloid leukemia. Chin J Hematol. 2024;45(4):387-390; Yan ZS, Li Y, Zhang B, He JS, Li JS, Wei SN, Wang Q et.al. Venetoclax combined with dose reduced HAD as induction treatment for patients with de novo acute myeloid leukemia. Zhonghua xue ye xue za zhi  Zhonghua xueyexue zazhi. 2024;45(4):387-390$$$$$Y$$$20240715$$HP$CN$CN
240581182$24058118$2$F$20240701$20240718$20240707$20240724$EXP$$NL-BIOGEN-2024BI01272207$BIOGEN$$58$YR$$M$Y$$$20240724$$CN$NL$NL
240581192$24058119$2$F$20240501$20240715$20240707$20240722$EXP$$EG-BIOGEN-2024BI01272203$BIOGEN$$42$YR$$F$Y$139$KG$20240722$$CN$EG$EG
240581201$24058120$1$I$$20240130$20240707$20240707$PER$$US-AMGEN-USASP2024132507$AMGEN$$$$$$Y$$$20240707$$CN$US$US
240581213$24058121$3$F$20240702$20240827$20240707$20240829$PER$$US-AMGEN-USASP2024134479$AMGEN$$58$YR$A$M$Y$$$20240829$$CN$US$US
240581222$24058122$2$F$$20240909$20240707$20240916$EXP$$CA-BIOGEN-2024BI01272208$BIOGEN$$$$$F$Y$$$20240916$$MD$CA$CA
240581232$24058123$2$F$$20240711$20240707$20240717$EXP$$JP-BIOGEN-2024BI01272175$BIOGEN$$44$YR$$F$Y$$$20240717$$PH$JP$JP
240581241$24058124$1$I$$20240702$20240707$20240707$EXP$$US-BIOGEN-2024BI01272403$BIOGEN$$$$$F$Y$$$20240707$$CN$US$US
240581251$24058125$1$I$20190201$20240703$20240707$20240707$EXP$PL-URPL-1-3450-2019$PL-BIOGEN-2024BI01272410$BIOGEN$$43$YR$$F$Y$65$KG$20240707$$MD$PL$PL
240581262$24058126$2$F$20240701$20240725$20240707$20240730$EXP$$JP-JNJFOC-20240713961$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20240730$$PH$JP$JP
240581271$24058127$1$I$$20240628$20240707$20240707$PER$$US-SA-2024SA198067$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240708$$MD$US$US
240581282$24058128$2$F$$20240705$20240707$20240709$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-107571$BRISTOL MYERS SQUIBB$$68$YR$E$$Y$$$20240710$$MD$PL$PL
240581292$24058129$2$F$20240101$20240703$20240707$20240709$PER$$US-ABBVIE-5825994$ABBVIE$$$$$M$Y$$$20240709$$MD$US$US
240581301$24058130$1$I$$20240630$20240707$20240707$EXP$$IL-BEIGENE-BGN-2024-010234$BEIGENE$$$$$$Y$$$20240707$$MD$IL$IL
240581312$24058131$2$F$$20240611$20240707$20240719$PER$$US-009507513-2406USA003840$MERCK$Max A, Glasgow H.L, Santiago T.C.B., Holland A, Inaba H, Canete-Gibas C.R, et al.. Choanephora infundibulifera Rhinosinusitis in Man with Acute Lymphoblastic Leukemia, Tennessee, USA. Emerging Infectious Diseases. 2024;30 (6):1245-8$18$YR$$M$Y$$$20240719$$HP$US$US
240581321$24058132$1$I$$20240628$20240707$20240707$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106008$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240708$$CN$US$US
240581331$24058133$1$I$$20240707$20240707$20240707$EXP$$PT-BAUSCHBL-2024BNL029707$BAUSCH AND LOMB$$69$YR$$F$Y$$$20240707$$MD$PT$PT
240581341$24058134$1$I$20220801$20240706$20240707$20240707$EXP$$AT-BAUSCHBL-2024BNL029706$BAUSCH AND LOMB$$53$YR$$M$Y$$$20240707$$MD$AT$AT
240581351$24058135$1$I$$20240701$20240707$20240707$EXP$$NVSC2024US137900$NOVARTIS$$$$$$Y$$$20240708$$MD$US$US
240581361$24058136$1$I$20240528$20240705$20240707$20240707$EXP$$US-ABBVIE-5830604$ABBVIE$$75$YR$$M$Y$$$20240707$$CN$US$US
240581371$24058137$1$I$$20240705$20240707$20240707$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038185$BOEHRINGER INGELHEIM$$$$$$Y$$$20240708$$CN$US$US
240581381$24058138$1$I$$20240701$20240707$20240707$PER$$US-ALXN-202407USA000026US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
240581391$24058139$1$I$20240125$20240705$20240707$20240707$EXP$FR-AFSSAPS-DJ2024000812$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-107503$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$74$KG$20240708$$MD$FR$FR
240581401$24058140$1$I$20240705$20240705$20240707$20240707$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038182$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240708$$CN$US$US
240581412$24058141$2$F$20240624$20240708$20240707$20240715$PER$$US-AMGEN-USASP2024129578$AMGEN$$69$YR$E$M$Y$96.4$KG$20240715$$HP$US$US
240581421$24058142$1$I$20240703$20240703$20240707$20240707$PER$$US-AMGEN-USASP2024133508$AMGEN$$79$YR$E$M$Y$$$20240707$$CN$US$US
240581433$24058143$3$F$20240626$20240815$20240707$20240823$30DAY$$US-AMGEN-USASP2024128604$AMGEN$$70$YR$E$M$Y$54.1$KG$20240823$$PH$US$US
240581442$24058144$2$F$$20240703$20240707$20240710$PER$$US-AMGEN-USASP2024132158$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240581451$24058145$1$I$$20240703$20240707$20240707$EXP$ES-AEMPS-1541780$ES-GSK-ES2024082340$GLAXOSMITHKLINE$$$$$$Y$$$20240707$$CN$ES$ES
240581461$24058146$1$I$20240501$20240704$20240707$20240707$EXP$FR-SA-SAC20240603000418$FR-GSK-FR2024082908$GLAXOSMITHKLINE$$$$$$Y$$$20240707$$MD$FR$FR
240581472$24058147$2$F$$20240809$20240707$20240816$30DAY$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000797$PAREXEL$$$$$M$Y$$$20240816$$CN$US$US
240581481$24058148$1$I$20240617$20240704$20240708$20240708$EXP$FR-AFSSAPS-RN2024000728$FR-GSK-FR2024082910$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$FR$FR
240581492$24058149$2$F$$20240807$20240708$20240821$EXP$$CL-SA-2024SA197199$SANOFI AVENTIS$$$$$$Y$$$20240821$$PH$CL$CL
240581501$24058150$1$I$20240702$20240702$20240708$20240708$EXP$$KR-GSK-KR2024APC082317$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$KR$KR
240581512$24058151$2$F$$20240812$20240708$20240812$PER$$US-ALXN-202407USA000020US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
240581521$24058152$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000024US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
240581531$24058153$1$I$$20240703$20240708$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107650$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240708$$CN$US$US
240581541$24058154$1$I$$20240704$20240708$20240708$PER$$US-HALEON-2185603$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240581551$24058155$1$I$20240705$20240705$20240708$20240708$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038150$BOEHRINGER INGELHEIM$$64$YR$A$$Y$$$20240708$$CN$US$US
240581561$24058156$1$I$20240702$20240703$20240708$20240708$EXP$GB-MHRA-TPP29674899C11033857YC1719919505660$GB-GSK-GB2024082505$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$GB$GB
240581571$24058157$1$I$$20240627$20240708$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103524$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240708$$HP$US$US
240581581$24058158$1$I$20240517$20240612$20240708$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002787$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240708$$HP$US$US
240581592$24058159$2$F$20240401$20240708$20240708$20240708$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038034$BOEHRINGER INGELHEIM$$53$YR$A$M$Y$$$20240709$$MD$RU$RU
240581602$24058160$2$F$20240101$20240819$20240708$20240827$EXP$$ES-ABBVIE-5830016$ABBVIE$$$$$M$Y$82$KG$20240827$$MD$ES$ES
240581612$24058161$2$F$$20240904$20240708$20240905$PER$$NVSC2024US136746$NOVARTIS$$$$$$Y$$$20240905$$CN$US$US
240581621$24058162$1$I$20230101$20240702$20240708$20240708$EXP$$US-ABBVIE-5828206$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240581631$24058163$1$I$20240621$20240628$20240708$20240708$PER$$US-JNJFOC-20240677544$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240708$$CN$US$US
240581641$24058164$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000019US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
240581651$24058165$1$I$20220225$20240629$20240708$20240708$EXP$$JP-JNJFOC-20220638533$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240708$$PH$JP$JP
240581662$24058166$2$F$$20240802$20240708$20240806$PER$$US-AMGEN-USASP2024131097$AMGEN$$68$YR$E$F$Y$$$20240806$$CN$US$US
240581673$24058167$3$F$20240626$20240807$20240708$20240813$30DAY$$US-AMGEN-USASP2024129682$AMGEN$$59$YR$A$F$Y$104$KG$20240813$$PH$US$US
240581682$24058168$2$F$20240701$20240708$20240708$20240718$PER$$US-AMGEN-USASP2024132208$AMGEN$$38$YR$A$F$Y$$$20240717$$HP$US$US
240581692$24058169$2$F$20240328$20240627$20240708$20240712$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451477$RANBAXY$$65$YR$$M$Y$65$KG$20240712$$MD$IN$IN
240581702$24058170$2$F$$20240627$20240708$20240712$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451478$RANBAXY$$65$YR$$M$Y$65$KG$20240712$$MD$IN$IN
240581713$24058171$3$F$20230101$20240709$20240708$20240723$PER$$US-AMGEN-USASP2024132093$AMGEN$$48$YR$A$M$Y$$$20240723$$CN$US$US
240581722$24058172$2$F$20240601$20240812$20240708$20240815$EXP$$US-ABBVIE-5821556$ABBVIE$$15$YR$$F$Y$80$KG$20240815$$CN$US$US
240581732$24058173$2$F$20231101$20240710$20240708$20240716$EXP$$US-ABBVIE-5825467$ABBVIE$$60$YR$$F$Y$64.41$KG$20240716$$CN$US$US
240581741$24058174$1$I$$20240628$20240708$20240708$EXP$$CA-CELLTRION INC.-2024CA001919$CELLTRION$$$$$$Y$$$20240708$$CN$CA$CA
240581751$24058175$1$I$20240513$20240702$20240708$20240708$EXP$GB-MHRA-MED-202407011346291020-HKQML$GB-DEXPHARM-2024-2147$DEXCEL$$67$YR$E$F$Y$$$20240708$$HP$GB$GB
240581761$24058176$1$I$20140101$20240701$20240708$20240708$EXP$$US-ABBVIE-5822657$ABBVIE$$$$$F$Y$86.18$KG$20240708$$CN$US$US
240581771$24058177$1$I$$20240701$20240708$20240708$EXP$$TW-AMGEN-TWNSP2024130732$AMGEN$Lin H.; Mai Y.; Hwang Z. et al.. The Dilemma of Balancing Anti-Tumor Necrosis Factor-Alpha (Anti-TNF-a) Biologics for Psoriatic Arthritis Control With the Risk of Severe Systemic Infection. Cureus. 2024;16 (5):1-6$66$YR$E$F$Y$$$20240707$$HP$TW$TW
240581781$24058178$1$I$20240101$20240628$20240708$20240708$EXP$FR-AFSSAPS-AN2024000813$FR-EMD Serono-2024034500$EMD SERONO INC$$62$YR$A$F$Y$$$20240708$$PH$FR$FR
240581791$24058179$1$I$20240601$20240702$20240708$20240708$EXP$$US-ABBVIE-5822365$ABBVIE$$16$YR$$M$Y$81.646$KG$20240708$$CN$US$US
240581811$24058181$1$I$$20240703$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107613$BRISTOL MYERS SQUIBB$$18$YR$A$F$Y$$$20240708$$CN$US$US
240581821$24058182$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000265$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$59$YR$A$M$Y$$$20240708$$HP$CN$CN
240581831$24058183$1$I$$20231222$20240708$20240708$PER$$US-AMGEN-USASP2023235629$AMGEN$$$$$$Y$$$20240707$$PH$US$US
240581842$24058184$2$F$$20240702$20240708$20240715$EXP$$US-ABBVIE-5826331$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240581852$24058185$2$F$$20240729$20240708$20240802$EXP$$PT-BAUSCH-BL-2024-010400$BAUSCH AND LOMB$Lafuente S, Faria N, Matos A. Pneumonia eosinof?lica - quando a causa esta no medicamento. Medicina Interna. 2024;30(SUP 1):121.$48$YR$$M$Y$$$20240802$$HP$PT$PT
240581861$24058186$1$I$20240627$20240628$20240708$20240708$PER$$US-AMGEN-USASP2024130025$AMGEN$$76$YR$E$M$Y$$$20240707$$CN$US$US
240581882$24058188$2$F$20231129$20240918$20240708$20240923$EXP$$JP-TAKEDA-2024TJP010124$TAKEDA$$57$YR$$F$Y$60$KG$20240923$$MD$JP$JP
240581891$24058189$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5829047$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240581902$24058190$2$F$$20240805$20240708$20240806$PER$$US-ALXN-202407USA000015US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240581911$24058191$1$I$$20240703$20240708$20240708$PER$$US-ABBVIE-5829936$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240581922$24058192$2$F$$20240702$20240708$20240710$EXP$$JP-JNJFOC-20240713475$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240711$$MD$JP$JP
240581931$24058193$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000268$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$65$YR$E$M$Y$$$20240708$$HP$CN$CN
240581941$24058194$1$I$20240703$20240702$20240708$20240708$EXP$GB-MHRA-MED-202407021247153770-FZSYW$GB-CHATTEMPRD-2024OHG022955$CHATTEM$$$$A$M$Y$$$20240708$$HP$GB$GB
240581951$24058195$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202407051958175750-YVZGF$GB-JNJFOC-20240715729$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$PH$GB$GB
240581962$24058196$2$F$20240529$20240729$20240708$20240731$PER$$US-JNJFOC-20240676455$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$HP$US$US
240581971$24058197$1$I$20230413$20240705$20240708$20240708$EXP$ES-AEMPS-1433408$ES-JNJFOC-20240714792$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240708$$MD$ES$ES
240581992$24058199$2$F$20240315$20240805$20240708$20240808$PER$$US-AMGEN-USASP2024128063$AMGEN$$22$YR$A$F$Y$$$20240808$$PH$US$US
240582003$24058200$3$F$20240628$20240814$20240708$20240816$PER$$US-JNJFOC-20240706399$JOHNSON AND JOHNSON$$19$YR$A$F$Y$$$20240816$$CN$US$US
240582011$24058201$1$I$$20240702$20240708$20240708$EXP$$TR-GSK-TR2024TRK082067$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$TR$TR
240582023$24058202$3$F$$20240916$20240708$20240926$PER$$US-GSK-US2024081561$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
240582031$24058203$1$I$20210101$20240703$20240708$20240708$EXP$$US-ABBVIE-5829080$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240582041$24058204$1$I$$20240627$20240708$20240708$EXP$$US-AUROBINDO-AUR-APL-2024-032059$AUROBINDO$Aljbour Almajali D, Cherabuddi MR, Ayyad A, Fram F, Abu Sayf A. Brivaracetam-Related Neurological Decline in a Patient With Complex Medical History. Am-J-Respir-Crit-Care-Med. 2024;209:A5642$68$YR$$F$Y$$$20240708$$HP$US$US
240582051$24058205$1$I$$20240703$20240708$20240708$EXP$$CA-ABBVIE-5827404$ABBVIE$$$$A$F$Y$$$20240708$$CN$CA$CA
240582061$24058206$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5828528$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240582071$24058207$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000259$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$60$YR$A$M$Y$$$20240708$$HP$CN$CN
240582081$24058208$1$I$20240630$20240702$20240708$20240708$PER$$US-AMGEN-USASP2024131689$AMGEN$$64$YR$A$F$Y$$$20240707$$PH$US$US
240582093$24058209$3$F$$20240802$20240708$20240807$EXP$$JP-AMGEN-JPNSP2024131235$AMGEN$$$$$$Y$$$20240806$$MD$JP$JP
240582111$24058211$1$I$20240701$20240701$20240708$20240708$PER$$US-ABBVIE-5825486$ABBVIE$$48$YR$$F$Y$$$20240708$$CN$US$US
240582121$24058212$1$I$20240222$20240625$20240708$20240708$EXP$FR-AFSSAPS-NC2024000431$FR-SAMSUNG BIOEPIS-SB-2024-19761$SAMSUNG BIOEPIS$$54$YR$A$F$Y$$$20240708$$PH$FR$FR
240582134$24058213$4$F$20240626$20240814$20240708$20240820$30DAY$$US-AMGEN-USASP2024127647$AMGEN$$51$YR$A$F$Y$56.689$KG$20240820$$HP$US$US
240582141$24058214$1$I$20240101$20240703$20240708$20240708$EXP$$US-ABBVIE-5828344$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240582151$24058215$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000264$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$36$YR$A$M$Y$$$20240708$$HP$CN$CN
240582161$24058216$1$I$20240601$20240705$20240708$20240708$EXP$$US-BAUSCH-BL-2024-000700$BAUSCH AND LOMB$$79$YR$$F$Y$$$20240708$$CN$US$US
240582171$24058217$1$I$$20240705$20240708$20240708$EXP$$US-ABBVIE-5830561$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240582181$24058218$1$I$20240601$20240702$20240708$20240708$PER$$US-AMGEN-USASP2024131685$AMGEN$$$$$F$Y$$$20240707$$CN$US$US
240582194$24058219$4$F$20240501$20240729$20240708$20240801$30DAY$$US-AMGEN-USASP2024130840$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
240582201$24058220$1$I$20240501$20240703$20240708$20240708$EXP$$US-ABBVIE-5828912$ABBVIE$$74$YR$$M$Y$$$20240708$$CN$US$US
240582212$24058221$2$F$20240701$20240823$20240708$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103613$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240902$$CN$US$US
240582221$24058222$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000262$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$39$YR$A$M$Y$$$20240708$$HP$CN$CN
240582231$24058223$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107684$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$82.1$KG$20240708$$CN$US$US
240582251$24058225$1$I$20231225$20240627$20240708$20240708$EXP$$US-JNJFOC-20240436533$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240708$$HP$US$US
240582261$24058226$1$I$$20240702$20240708$20240708$EXP$GB-MHRA-MED-202406302141532850-LTFKC$GB-DEXPHARM-2024-2146$DEXCEL$$$$$F$Y$$$20240708$$HP$GB$GB
240582271$24058227$1$I$20231220$20240627$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032239$AUROBINDO$$55$YR$$M$Y$$$20240708$$PH$FR$FR
240582283$24058228$3$F$20240601$20240716$20240708$20240722$EXP$$US-ABBVIE-5825061$ABBVIE$$69$YR$$F$Y$$$20240722$$CN$US$US
240582291$24058229$1$I$20210826$20240704$20240708$20240708$EXP$$UY-ABBVIE-5830414$ABBVIE$$46$YR$$F$Y$80$KG$20240708$$MD$UY$UY
240582302$24058230$2$F$20240101$20240703$20240708$20240711$EXP$$US-ABBVIE-5828500$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240582312$24058231$2$F$$20240710$20240708$20240713$EXP$$US-ABBVIE-5828448$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240582322$24058232$2$F$$20240712$20240708$20240723$EXP$$DE-AUROBINDO-AUR-APL-2024-032122$AUROBINDO$Zugaj MR, Gutzeit O, Mayer VL, Ishak B, Gumbinger C, Weigand MA, et al. Incomplete sensorimotor paresis after upper abdominal surgery with TEA and spinal epidural lipomatosis: a case report. Regional Anesthesia and Pain Medicine. 2024;49(6):465?468$60$YR$$F$Y$$$20240723$$MD$DE$DE
240582331$24058233$1$I$20240601$20240703$20240708$20240708$EXP$$US-ABBVIE-5827772$ABBVIE$$60$YR$$F$Y$$$20240708$$CN$US$US
240582341$24058234$1$I$20240615$20240703$20240708$20240708$EXP$$FR-ABBVIE-5830046$ABBVIE$$77$YR$$M$Y$$$20240708$$CN$FR$FR
240582353$24058235$3$F$20240725$20240801$20240708$20240809$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000585$DECIPHERA PHARMACEUTICALS$$77$YR$E$M$Y$$$20240809$$CN$US$US
240582361$24058236$1$I$$20240701$20240708$20240708$EXP$$US-ABBVIE-5828412$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240582371$24058237$1$I$$20240704$20240708$20240708$EXP$$DE-ABBVIE-5829869$ABBVIE$$$$$F$Y$$$20240708$$CN$DE$DE
240582381$24058238$1$I$20240702$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407003310$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240708$$CN$US$US
240582391$24058239$1$I$$20240701$20240708$20240708$EXP$$RO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037011$BOEHRINGER INGELHEIM$Zokaris A, Osan VP, Sbiera F, Veres A, Marinescu A, Grebenisan L. ANTIPARKINSONIAN MEDICATION-INDUCED DELIRIUM - A CASE REPORT. Acta Medica Marisiensis. 2024;(Vol. 70): 253-254.$80$YR$E$F$Y$$$20240708$$MD$RO$RO
240582401$24058240$1$I$20240618$20240705$20240708$20240708$EXP$$US-ABBVIE-5830608$ABBVIE$$59$YR$$F$Y$$$20240708$$CN$US$US
240582411$24058241$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5830687$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240582421$24058242$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5830883$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240582431$24058243$1$I$$20240628$20240708$20240708$EXP$$DE-CELLTRION INC.-2024DE015878$CELLTRION$Holzhauer, P. New Therapeutic and Supportive Options in Ovarian Cancer New Tricks for old Ponies. Deutsche Zeitschrift fur Onkologie. 2023;55:166 -168$$$$$Y$$$20240708$$HP$DE$DE
240582441$24058244$1$I$$20240627$20240708$20240708$EXP$$US-AUROBINDO-AUR-APL-2024-032802$AUROBINDO$Rodriguez E,  Antar-Shultz M, Lazcano G, Zervogiannis P, Taha M, Lamarche J. ANTICOAGULANT RELATED NEPHROPATHY AFTER COVID INFECTION. AJKD. 2024;83 (4)(Suppl 2):S121$76$YR$$M$Y$$$20240708$$HP$US$US
240582451$24058245$1$I$$20240703$20240708$20240708$PER$$US-HALEON-2185314$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240582461$24058246$1$I$20240609$20240705$20240708$20240708$EXP$FR-AFSSAPS-TS2024000767$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-107493$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$58$KG$20240708$$MD$FR$FR
240582471$24058247$1$I$$20240702$20240708$20240708$PER$$US-JNJFOC-20240705115$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$CN$US$US
240582482$24058248$2$F$20240520$20240807$20240708$20240813$EXP$$BR-ABBVIE-5825968$ABBVIE$$56$YR$$M$Y$92$KG$20240813$$CN$BR$BR
240582491$24058249$1$I$$20240627$20240708$20240708$EXP$$US-AUROBINDO-AUR-APL-2024-032052$AUROBINDO$McFarland BJ, Luo A, Wang X.. Male breast cancer: Report of two cases with bloody nipple discharge. Radiol-Case-Rep. 2023;18(9):3323-3330$70$YR$$M$Y$$$20240708$$MD$US$US
240582504$24058250$4$F$$20240923$20240708$20240927$EXP$$NL-ABBVIE-5826109$ABBVIE$$$$E$M$Y$$$20240927$$HP$NL$NL
240582511$24058251$1$I$20240610$20240629$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010085$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240582521$24058252$1$I$$20240221$20240708$20240708$PER$$US-ABBVIE-5830982$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240582533$24058253$3$F$20240101$20240905$20240708$20240912$EXP$$US-ABBVIE-5825311$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
240582542$24058254$2$F$20240501$20240722$20240708$20240730$PER$$US-AMGEN-USASP2024128784$AMGEN$$61$YR$A$M$Y$95.8$KG$20240729$$HP$US$US
240582551$24058255$1$I$20240101$20240702$20240708$20240708$EXP$$US-ABBVIE-5826334$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240582561$24058256$1$I$$20240702$20240708$20240708$EXP$$US-ABBVIE-5826255$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240582591$24058259$1$I$20240702$20240703$20240708$20240708$EXP$$CA-ABBVIE-5827161$ABBVIE$$77$YR$$M$Y$$$20240708$$CN$CA$CA
240582601$24058260$1$I$$20240627$20240708$20240708$EXP$$CA-AUROBINDO-AUR-APL-2024-033161$AUROBINDO$Merette SAM, Theriault S, Piramide LEC, Davis MD, Shapiro AM.. Bromazolam Blood Concentrations in Postmortem Cases-A British Columbia Perspective. Journal of Analytical Toxicology. 2023;47:385?392$$$$M$Y$$$20240708$$HP$CA$CA
240582611$24058261$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5829159$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240582621$24058262$1$I$20220101$20240703$20240708$20240708$EXP$$US-ABBVIE-5829035$ABBVIE$$58$YR$$F$Y$$$20240708$$CN$US$US
240582633$24058263$3$F$20240101$20240711$20240708$20240723$EXP$$US-ABBVIE-5826369$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
240582641$24058264$1$I$20240101$20240621$20240708$20240708$EXP$$US-ABBVIE-5830679$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240582652$24058265$2$F$$20240715$20240708$20240722$PER$$US-AstraZeneca-2024A145982$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
240582661$24058266$1$I$$20240702$20240708$20240708$EXP$$GB-ESPERIONTHERAPEUTICS-2024GBR01032$ESPERION THERAPEUTICS$$71$YR$$F$Y$118$KG$20240708$$MD$GB$GB
240582671$24058267$1$I$20240401$20240703$20240708$20240708$EXP$$US-ABBVIE-5828644$ABBVIE$$69$YR$$M$Y$$$20240708$$CN$US$US
240582681$24058268$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5828673$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240582692$24058269$2$F$$20240722$20240708$20240726$EXP$$AU-AMGEN-AUSSP2024133106$AMGEN$$$$$$Y$$$20240725$$MD$AU$AU
240582701$24058270$1$I$$20230615$20240708$20240708$PER$$US-AMGEN-USASP2023235640$AMGEN$$$$$$Y$$$20240707$$CN$US$US
240582711$24058271$1$I$$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002743$ELI LILLY AND CO$$$$$$Y$$$20240708$$CN$US$US
240582721$24058272$1$I$20231210$20240704$20240708$20240708$EXP$$NVSC2024IN139758$NOVARTIS$$43$YR$$M$Y$$$20240708$$CN$IN$IN
240582732$24058273$2$F$$20240701$20240708$20240802$PER$$US-ROCHE-10000016493$ROCHE$$$$A$F$Y$$$20240802$$CN$US$US
240582741$24058274$1$I$20240601$20240703$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107654$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240708$$HP$US$US
240582751$24058275$1$I$20240601$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107627$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240708$$HP$US$US
240582771$24058277$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA195806$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240708$$MD$US$US
240582781$24058278$1$I$$20240702$20240708$20240708$PER$$US-SA-2024SA197061$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$HP$US$US
240582791$24058279$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA195769$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240708$$CN$US$US
240582801$24058280$1$I$20240701$20240702$20240708$20240708$EXP$$US-JNJFOC-20240707142$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
240582811$24058281$1$I$$20240702$20240708$20240708$EXP$$US-JNJFOC-20240708900$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
240582821$24058282$1$I$$20240705$20240708$20240708$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038192$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240708$$CN$US$US
240582831$24058283$1$I$20240701$20240703$20240708$20240708$EXP$$US-AstraZeneca-2024A153296$ASTRAZENECA$$28633$DY$$F$Y$$$20240708$$MD$US$
240582841$24058284$1$I$20240621$20240629$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010086$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240582851$24058285$1$I$20240620$20240629$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010090$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240582861$24058286$1$I$$20230825$20240708$20240708$PER$$US-AMGEN-USASP2023235522$AMGEN$$$$$$Y$$$20240707$$CN$US$US
240582881$24058288$1$I$$20240529$20240708$20240708$PER$$ES-TOLMAR, INC.-24ES050627$TOLMAR$$$$$$Y$$$20240708$$HP$ES$ES
240582891$24058289$1$I$$20240529$20240708$20240708$PER$$ES-TOLMAR, INC.-24ES050630$TOLMAR$$$$$$Y$$$20240708$$HP$ES$ES
240582901$24058290$1$I$$20240529$20240708$20240708$PER$$ES-TOLMAR, INC.-24ES050629$TOLMAR$$$$$$Y$$$20240708$$HP$ES$ES
240582911$24058291$1$I$$20240529$20240708$20240708$PER$$ES-TOLMAR, INC.-24ES050634$TOLMAR$$$$$M$Y$$$20240708$$HP$ES$ES
240582921$24058292$1$I$$20240529$20240708$20240708$PER$$ES-TOLMAR, INC.-24ES050641$TOLMAR$$$$$$Y$$$20240708$$HP$ES$ES
240582931$24058293$1$I$$20240529$20240708$20240708$PER$$ES-TOLMAR, INC.-24ES050647$TOLMAR$$$$$$Y$$$20240708$$PH$ES$ES
240582942$24058294$2$F$20230101$20240822$20240708$20240902$EXP$$JP-JNJFOC-20240363994$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240902$$MD$JP$JP
240582951$24058295$1$I$20240619$20240629$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010092$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240582961$24058296$1$I$20240625$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024132626$AMGEN$$$$$$Y$$$20240707$$HP$US$US
240582971$24058297$1$I$$20240422$20240708$20240708$PER$$US-AMGEN-USASP2024131765$AMGEN$$$$$$Y$$$20240707$$CN$US$US
240582981$24058298$1$I$20240531$20240701$20240708$20240708$EXP$GB-MHRA-TPP26051177C1247946YC1719780042953$GB-ESPERIONTHERAPEUTICS-2024GBR01030$ESPERION THERAPEUTICS$$70$YR$$F$Y$60$KG$20240708$$MD$GB$GB
240583001$24058300$1$I$20240608$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010013$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240583011$24058301$1$I$$20240703$20240708$20240708$PER$$US-TAKEDA-2024TUS067834$TAKEDA$$$$$F$Y$$$20240708$$HP$US$US
240583021$24058302$1$I$20240603$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010015$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240583033$24058303$3$F$20240401$20240705$20240708$20240716$PER$$US-ABBVIE-5827128$ABBVIE$$44$YR$$F$Y$68$KG$20240716$$CN$US$US
240583041$24058304$1$I$20230113$20240628$20240708$20240708$EXP$$ES-CELLTRION INC.-2024ES015979$CELLTRION$$$$$$Y$$$20240708$$MD$ES$ES
240583061$24058306$1$I$$20240605$20240708$20240708$PER$$PT-TOLMAR, INC.-24PT050622$TOLMAR$$$$$$Y$$$20240708$$HP$PT$PT
240583071$24058307$1$I$20240614$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010022$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240583081$24058308$1$I$20240624$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134482$AMGEN$$$$$$Y$$$20240707$$PH$US$US
240583091$24058309$1$I$20240422$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010023$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240583101$24058310$1$I$$20240629$20240708$20240708$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000231$EMCURE$Dogrul BN, Park C.. Hydralazine Induced Visual and Auditory Hallucinations in a Kidney Transplant Patient: Case Report. Journal of the Academy of Consultation?Liaison Psychiatry. 2024;(24)00066-1:S2667-2960$49$YR$$F$Y$$$20240708$$MD$US$US
240583111$24058311$1$I$$20240624$20240708$20240708$EXP$$EG-NOVOPROD-1246645$NOVO NORDISK$$$$$F$Y$$$20240708$$CN$EG$EG
240583122$24058312$2$F$20240614$20240814$20240708$20240826$EXP$$DZ-NOVOPROD-1245700$NOVO NORDISK$$$$$M$Y$15$KG$20240826$$MD$DZ$DZ
240583131$24058313$1$I$$20240624$20240708$20240708$EXP$$US-NOVOPROD-1246108$NOVO NORDISK$$$$$F$Y$$$20240708$$CN$US$US
240583142$24058314$2$F$20240517$20240714$20240708$20240725$EXP$$EG-NOVOPROD-1245584$NOVO NORDISK$$37$YR$$F$Y$63$KG$20240725$$CN$EG$EG
240583152$24058315$2$F$20160101$20240709$20240708$20240722$EXP$$EG-NOVOPROD-1246630$NOVO NORDISK$$$$$F$Y$64$KG$20240722$$CN$EG$EG
240583171$24058317$1$I$$20240702$20240708$20240708$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024082625$VIIV$$3$DEC$$M$Y$$$20240708$$CN$US$US
240583181$24058318$1$I$$20240624$20240708$20240708$EXP$$US-NOVOPROD-1244841$NOVO NORDISK$$$$$F$Y$$$20240708$$CN$US$US
240583191$24058319$1$I$20240601$20240625$20240708$20240708$EXP$$MX-NOVOPROD-1245302$NOVO NORDISK$$86$YR$$M$Y$70$KG$20240708$$CN$MX$MX
240583202$24058320$2$F$20110101$20240704$20240708$20240715$EXP$$EG-NOVOPROD-1244668$NOVO NORDISK$$$$N$$Y$$$20240715$$CN$EG$EG
240583211$24058321$1$I$$20240624$20240708$20240708$EXP$$US-NOVOPROD-1245437$NOVO NORDISK$$$$$M$Y$$$20240708$$CN$US$US
240583222$24058322$2$F$$20240714$20240708$20240725$EXP$$EG-NOVOPROD-1246669$NOVO NORDISK$$$$$F$Y$$$20240725$$CN$EG$EG
240583231$24058323$1$I$20240703$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133226$AMGEN$$$$$$Y$$$20240707$$CN$US$US
240583241$24058324$1$I$20240522$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010024$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240583251$24058325$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA195576$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240708$$CN$US$US
240583262$24058326$2$F$20240710$20240717$20240708$20240726$PER$$US-SA-2024SA194570$SANOFI AVENTIS$$74$YR$E$M$Y$79.37$KG$20240726$$MD$US$US
240583272$24058327$2$F$20240702$20240702$20240708$20240711$PER$$US-SA-2024SA197910$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240711$$MD$US$US
240583281$24058328$1$I$20240620$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010020$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240583292$24058329$2$F$$20240702$20240708$20240710$EXP$$JP-009507513-2403JPN000711J$MERCK$$42$YR$$F$Y$$$20240710$$MD$JP$JP
240583301$24058330$1$I$$20240625$20240708$20240708$EXP$GB-MHRA-MED-202406241807136560-MGJNT$GB-NOVOPROD-1245790$NOVO NORDISK$$$$$F$Y$$$20240708$$CN$GB$GB
240583312$24058331$2$F$20240409$20240705$20240708$20240716$EXP$$TW-NOVOPROD-1245372$NOVO NORDISK$$53$YR$$F$Y$$$20240716$$MD$TW$TW
240583321$24058332$1$I$20240520$20240625$20240708$20240708$EXP$GB-MHRA-MED-202406240815294550-KZQFM$GB-NOVOPROD-1245791$NOVO NORDISK$$$$$F$Y$$$20240708$$PH$GB$GB
240583333$24058333$3$F$$20240726$20240708$20240730$PER$$US-ABBVIE-5827224$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
240583341$24058334$1$I$20230610$20240703$20240708$20240708$EXP$FR-AFSSAPS-PA2024001320$FR-VIIV HEALTHCARE LIMITED-FR2024082713$VIIV$$$$$$Y$$$20240708$$PH$FR$FR
240583351$24058335$1$I$$20240702$20240708$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106835$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240708$$CN$US$US
240583361$24058336$1$I$20240615$20240701$20240708$20240708$PER$$US-SA-2024SA195520$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240708$$CN$US$US
240583371$24058337$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA123131$SANOFI AVENTIS$$42$YR$A$F$Y$86.18$KG$20240708$$MD$US$US
240583381$24058338$1$I$20240421$20240424$20240708$20240708$EXP$$CN-TEVA-VS-3216599$TEVA$$57$YR$$M$Y$56.7$KG$20240708$$CN$CN$CN
240583391$24058339$1$I$$20240704$20240708$20240708$EXP$$GB-ABBVIE-5827938$ABBVIE$$$$A$F$Y$$$20240708$$CN$GB$GB
240583401$24058340$1$I$$20240628$20240708$20240708$PER$$US-ROCHE-10000019020$ROCHE$$79$YR$E$F$Y$$$20240708$$CN$US$US
240583411$24058341$1$I$20230717$20240701$20240708$20240708$PER$$US-BIOGEN-2023BI01218163$BIOGEN$$67$YR$$F$Y$$$20240708$$CN$US$US
240583421$24058342$1$I$$20240628$20240708$20240708$PER$$US-ALXN-202406USA001903US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
240583431$24058343$1$I$20240628$20240705$20240708$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010321$JAZZ$$68$YR$$M$Y$$$20240707$$HP$US$US
240583442$24058344$2$F$$20240826$20240708$20240904$PER$$US-AstraZeneca-2024A150891$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
240583451$24058345$1$I$20240630$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024132781$AMGEN$$23$YR$A$F$Y$$$20240707$$CN$US$US
240583461$24058346$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133443$AMGEN$$$$$$Y$$$20240707$$CN$US$US
240583471$24058347$1$I$$20240702$20240708$20240708$PER$$US-BIOGEN-2024BI01272064$BIOGEN$$$$$F$Y$$$20240708$$CN$US$US
240583483$24058348$3$F$20240401$20240730$20240708$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106751$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240806$$PH$JP$JP
240583491$24058349$1$I$20240620$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010096$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240583501$24058350$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133467$AMGEN$$$$$$Y$$$20240707$$MD$US$US
240583512$24058351$2$F$$20240716$20240708$20240723$PER$$US-ROCHE-10000013871$ROCHE$Haq K, Yadav A, Mejia C. Safe Use of SGLT2-Inhibitor in a Pancreas Transplant Recipient with a Functioning Graft and Chronic Kidney Disease: A Case Report (Abstract: B293). American Transplant Congress 2024 - American Journal of Transplantation. 2024-Jun;24 (6 (SUPP 1)):S833-4.$50$YR$A$F$Y$$$20240723$$HP$US$US
240583521$24058352$1$I$20221011$20240701$20240708$20240708$PER$$US-BIOGEN-2024BI01271078$BIOGEN$$31$YR$$F$Y$$$20240708$$CN$US$US
240583532$24058353$2$F$20240601$20240710$20240708$20240717$PER$$US-BIOGEN-2024BI01272021$BIOGEN$$71$YR$$M$Y$$$20240717$$CN$US$US
240583541$24058354$1$I$$20240626$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407000649$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240708$$CN$US$US
240583551$24058355$1$I$$20240702$20240708$20240708$EXP$$GB-ABBVIE-5709005$ABBVIE$$$$A$M$Y$$$20240708$$CN$GB$GB
240583561$24058356$1$I$$20240626$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407000638$ELI LILLY AND CO$$$$E$F$Y$$$20240708$$CN$US$US
240583571$24058357$1$I$20240529$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010012$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240583581$24058358$1$I$$20240701$20240708$20240708$EXP$$JP-GSK-JP2024083618$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$JP$JP
240583591$24058359$1$I$$20240627$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103850$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240708$$PH$US$US
240583601$24058360$1$I$$20240704$20240708$20240708$PER$$US-ROCHE-10000016820$ROCHE$Saigal K, Maleki A. Intravitreal Fluocinolone Acetonide 0.19 mg Implant in a Patient with Resistant Blau Syndrome: A Case Report. Case Reports in Ophthalmology. 2024-Jan-19;15 (1):63-70. doi:10.1159/000535984.$6$YR$C$F$Y$$$20240708$$HP$US$US
240583611$24058361$1$I$$20240703$20240708$20240708$PER$US-MLMSERVICE-20240607-PI092253-00232-1$US-ROCHE-10000018121$ROCHE$Evbuomwan M, Ingram T, Saleem N. A Case of Overlapping Autoimmune Syndrome. Cureus. 2024;16 (5):e59714. doi:10.7759/cureus.59714.$44$YR$A$F$Y$$$20240708$$HP$US$US
240583621$24058362$1$I$20240615$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010017$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240583631$24058363$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405071249126050-CYFKR$GB-ROCHE-10000017434$ROCHE$$$$$F$Y$$$20240708$$HP$GB$GB
240583641$24058364$1$I$$20240701$20240708$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107288$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240708$$MD$JP$JP
240583651$24058365$1$I$20240610$20240702$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106342$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240708$$PH$US$US
240583661$24058366$1$I$$20240221$20240708$20240708$PER$$US-HALEON-2184481$Haleon PLC$$$$A$$Y$$$20240708$$HP$US$US
240583671$24058367$1$I$$20240702$20240708$20240708$PER$$US-ROCHE-10000019016$ROCHE$$$$$M$Y$$$20240708$$HP$US$US
240583681$24058368$1$I$$20240624$20240708$20240708$EXP$$TN-AGEPHA PHARMA FZ LLC-AGP202402-000011$Agepha Pharmaceuticals$Mansour K, Romdhane HB, Boussada M, Fredj NB, Chadli Z, Fadhel NB, et al.. Relevance of Drug Hypersensitivity Evaluations in the Setting of a Polymedicated Patient with Stevens-Johnson Syndrome: Colchicine Unmasked. Dermatitis. 2024;00:NA$20$YR$$M$Y$$$20240708$$MD$TN$TN
240583691$24058369$1$I$$20240628$20240708$20240708$EXP$$CA-CELLTRION INC.-2024CA015737$CELLTRION$$$$$$Y$$$20240708$$MD$CA$CA
240583701$24058370$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06068$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240583711$24058371$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05805$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240583721$24058372$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05933$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240583731$24058373$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06033$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240583742$24058374$2$F$20240101$20240726$20240708$20240805$EXP$$CA-CELLTRION INC.-2024CA010261$CELLTRION$$$$$$Y$$$20240805$$MD$CA$CA
240583751$24058375$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129614$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240583761$24058376$1$I$20240601$20240701$20240708$20240708$EXP$$US-SA-2024SA195870$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240708$$MD$US$US
240583771$24058377$1$I$20240101$20240701$20240708$20240708$EXP$$US-SA-2024SA198474$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240708$$MD$US$US
240583783$24058378$3$F$$20240827$20240708$20240901$EXP$$US-ABBVIE-5828677$ABBVIE$$$$$F$Y$58$KG$20240901$$CN$US$US
240583791$24058379$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281414490710-DZNCP$GB-TEVA-VS-3215589$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240583801$24058380$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133251$AMGEN$$$$$$Y$$$20240707$$PH$US$US
240583811$24058381$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133483$AMGEN$$$$$$Y$$$20240707$$PH$US$US
240583821$24058382$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133470$AMGEN$$$$$$Y$$$20240707$$CN$US$US
240583832$24058383$2$F$$20240712$20240708$20240718$EXP$GB-MHRA-30925142$GB-SA-2024SA198463$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240718$$PH$GB$GB
240583841$24058384$1$I$$20240703$20240708$20240708$EXP$$JP-SA-2024SA198307$SANOFI AVENTIS$$8$DEC$E$M$Y$$$20240708$$PH$JP$JP
240583853$24058385$3$F$$20240731$20240708$20240816$EXP$$US-GSK-US2024AMR081700$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
240583861$24058386$1$I$20240616$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010098$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240583873$24058387$3$F$20240306$20240806$20240708$20240810$EXP$$JP-009507513-2407JPN000392J$MERCK$$75$YR$$M$Y$$$20240810$$MD$JP$JP
240583882$24058388$2$F$$20240711$20240708$20240722$EXP$$US-TEVA-VS-3213973$TEVA$Daoud A, Hobby G, Gokden N, Arthur JM, Singh M. Case Report: A Case of Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis, Drug Induced Lupus and Sweet Syndrome. J-Am-Soc-Nephrol 2016; 27 1023A abstr. PUB521.; Daoud A, Hobby G, Gokden N, Arthur JM, Singh M. Case Report: A Case of Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis, Drug Induced Lupus and Sweet Syndrome. J-Am-Soc-Nephrol 2016; 27 1023A abstr. PUB521.$73$YR$$M$Y$$$20240722$$HP$US$US
240583891$24058389$1$I$$20240701$20240708$20240708$PER$$US-AstraZeneca-2024A151157$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$US$
240583901$24058390$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06074$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240583911$24058391$1$I$20240601$20240701$20240708$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105608$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240708$$CN$US$US
240583921$24058392$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281503492060-NTSCD$GB-TEVA-VS-3215590$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240583931$24058393$1$I$$20240624$20240708$20240708$EXP$$IN-RDY-LIT/IND/24/0009441$DR REDDYS$Datta D, Saklani A, Engineer R, D^souza A, Baheti A, Kumar S, et al. Non-operative management in low-lying rectal cancers undergoing chemoradiation. Journal of Cancer Research and Therapeutics. 2024;20(1): 417-422. doi:10.4103/jcrt.jcrt_189_23.$$$$$Y$$$20240708$$HP$IN$IN
240583941$24058394$1$I$$20240705$20240708$20240708$EXP$$US-SANDOZ INC.-SDZ2024US063121$SANDOZ$$$$$F$Y$$$20240708$$HP$US$US
240583952$24058395$2$F$20240401$20240905$20240708$20240912$EXP$$US-ABBVIE-5827889$ABBVIE$$77$YR$$M$Y$$$20240912$$CN$US$US
240583961$24058396$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129659$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240583971$24058397$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5691920$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240583981$24058398$1$I$20240101$20240703$20240708$20240708$EXP$$US-JNJFOC-20240711418$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
240583991$24058399$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281411346130-TDLKP$GB-TEVA-VS-3215658$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240584001$24058400$1$I$20240609$20240627$20240708$20240708$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158897$JIANGSU HENGRUI MEDICINE$$63$YR$$F$Y$60$KG$20240708$$MD$CN$CN
240584011$24058401$1$I$20240501$20240701$20240708$20240708$EXP$$DE-AMGEN-DEUSP2024116025$AMGEN$$56$YR$A$F$Y$$$20240707$$MD$DE$DE
240584021$24058402$1$I$$20240703$20240708$20240708$EXP$$CN-ROCHE-10000015740$ROCHE$$50$YR$A$F$Y$$$20240708$$CN$CN$CN
240584031$24058403$1$I$20240629$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407003106$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240708$$CN$US$US
240584041$24058404$1$I$$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407003706$ELI LILLY AND CO$$$$$F$Y$$$20240708$$PH$US$US
240584051$24058405$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06193$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240584061$24058406$1$I$$20240703$20240708$20240708$EXP$$GB-GSK-GB2024EME083328$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$GB$GB
240584071$24058407$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129667$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240584081$24058408$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129702$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240584091$24058409$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129685$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240584101$24058410$1$I$20240629$20240701$20240708$20240708$PER$$US-SA-2024SA196829$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240708$$MD$US$US
240584111$24058411$1$I$20240101$20240627$20240708$20240708$PER$$US-SA-2024SA192987$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240708$$MD$US$US
240584121$24058412$1$I$20240101$20240701$20240708$20240708$EXP$$US-SA-2024SA195581$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240708$$CN$US$US
240584131$24058413$1$I$$20240626$20240708$20240708$EXP$$US-LAURUS LABS LIMITED-2024LAU000054$LAURUS LABS LIMITED$Al-Moussally F, Tien JJ, Rajagopalan K, Boterosuarez C, Crouse R. Euglycemic Ketoacidosis and Lactic Acidosis Associated With Metformin Toxicity. Cureus. 2024;16(5)$67$YR$$F$Y$$$20240708$$HP$US$US
240584141$24058414$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA195433$SANOFI AVENTIS$$$$$$Y$$$20240708$$PH$US$US
240584161$24058416$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA192964$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240708$$MD$US$US
240584172$24058417$2$F$20240101$20240719$20240708$20240729$EXP$$US-JNJFOC-20240708617$JOHNSON AND JOHNSON$$32$YR$A$F$Y$113.5$KG$20240729$$HP$US$US
240584181$24058418$1$I$20240620$20240701$20240708$20240708$EXP$$US-SA-2024SA198365$SANOFI AVENTIS$$52$YR$A$F$Y$83$KG$20240708$$MD$US$US
240584191$24058419$1$I$20240101$20240625$20240708$20240708$EXP$$US-NOVOPROD-1247096$NOVO NORDISK$$$$$M$Y$$$20240708$$MD$US$US
240584201$24058420$1$I$$20240625$20240708$20240708$EXP$$CA-NOVOPROD-1246680$NOVO NORDISK$$$$$M$Y$$$20240708$$MD$CA$CA
240584211$24058421$1$I$$20240625$20240708$20240708$EXP$$US-NOVOPROD-1246951$NOVO NORDISK$$$$$$Y$$$20240708$$CN$US$US
240584221$24058422$1$I$$20240625$20240708$20240708$EXP$$TR-NOVOPROD-1246655$NOVO NORDISK$$73$YR$$F$Y$60$KG$20240708$$CN$TR$TR
240584234$24058423$4$F$$20240715$20240708$20240911$EXP$$US-NOVOPROD-1246837$NOVO NORDISK$$$$A$M$Y$$$20240911$$CN$US$US
240584241$24058424$1$I$20240521$20240625$20240708$20240708$EXP$CN-NMPA-32020511005804202400040$CN-NOVOPROD-1245997$NOVO NORDISK$$64$YR$$M$Y$75$KG$20240708$$HP$CN$CN
240584251$24058425$1$I$20240101$20240625$20240708$20240708$EXP$$BR-NOVOPROD-1246348$NOVO NORDISK$$819$MON$$M$Y$$$20240708$$CN$BR$BR
240584262$24058426$2$F$$20240730$20240708$20240812$EXP$$CN-NOVOPROD-1247124$NOVO NORDISK$$$$$F$Y$$$20240812$$CN$CN$CN
240584271$24058427$1$I$20240613$20240626$20240708$20240708$EXP$$US-NOVOPROD-1246843$NOVO NORDISK$$$$A$F$Y$$$20240708$$CN$US$US
240584282$24058428$2$F$$20240714$20240708$20240725$EXP$$EG-NOVOPROD-1246621$NOVO NORDISK$$$$$F$Y$$$20240725$$CN$EG$EG
240584291$24058429$1$I$$20240625$20240708$20240708$EXP$$CA-NOVOPROD-1246652$NOVO NORDISK$$$$$F$Y$$$20240708$$MD$CA$CA
240584301$24058430$1$I$20240501$20240625$20240708$20240708$EXP$GB-MHRA-MED-202406251118266340-WKJVH$GB-NOVOPROD-1249375$NOVO NORDISK$$38$YR$$F$Y$89$KG$20240708$$CN$GB$GB
240584311$24058431$1$I$$20240625$20240708$20240708$EXP$$CO-NOVOPROD-1246099$NOVO NORDISK$$$$$F$Y$62$KG$20240708$$CN$CO$CO
240584321$24058432$1$I$20230101$20240625$20240708$20240708$EXP$$US-NOVOPROD-1246913$NOVO NORDISK$$$$$F$Y$$$20240708$$CN$US$US
240584332$24058433$2$F$$20240914$20240708$20240924$EXP$$US-NOVOPROD-1247053$NOVO NORDISK$$$$$$Y$$$20240924$$CN$US$US
240584343$24058434$3$F$20240101$20240709$20240708$20240717$EXP$$CA-CELLTRION INC.-2024CA016317$CELLTRION$$$$$$Y$$$20240717$$CN$CA$CA
240584351$24058435$1$I$$20240701$20240708$20240708$EXP$$JP-ROCHE-10000017428$ROCHE$$$$$M$Y$$$20240708$$PH$JP$JP
240584361$24058436$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06190$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240584371$24058437$1$I$$20240628$20240708$20240708$EXP$$GB-CELLTRION INC.-2024GB015901$CELLTRION$$$$$$Y$$$20240708$$MD$GB$GB
240584381$24058438$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129718$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240584391$24058439$1$I$20231214$20240624$20240708$20240708$EXP$FR-AFSSAPS-TO2024000808$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108940$ZYDUS PHARM$$$$$$Y$$$20240708$$PH$FR$FR
240584401$24058440$1$I$20231201$20240624$20240708$20240708$EXP$FR-AFSSAPS-TO2024001026$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108956$ZYDUS PHARM$$$$$$Y$$$20240708$$MD$FR$FR
240584411$24058441$1$I$20230817$20240624$20240708$20240708$EXP$FR-AFSSAPS-LL2024001173$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108966$ZYDUS PHARM$$$$$$Y$$$20240708$$MD$FR$FR
240584421$24058442$1$I$20240527$20240624$20240708$20240708$EXP$FR-AFSSAPS-LM2024000339$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108954$ZYDUS PHARM$$$$$$Y$$$20240708$$MD$FR$FR
240584431$24058443$1$I$$20240628$20240708$20240708$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109221$ZYDUS PHARM$$$$$$Y$$$20240708$$MD$US$US
240584441$24058444$1$I$$20240628$20240708$20240708$EXP$$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-109150$ZYDUS PHARM$$$$$$Y$$$20240708$$PH$GB$GB
240584451$24058445$1$I$20240501$20240624$20240708$20240708$EXP$FR-AFSSAPS-PV2024000566$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108989$ZYDUS PHARM$$$$$$Y$$$20240708$$MD$FR$FR
240584461$24058446$1$I$$20240628$20240708$20240708$PER$$US-AstraZeneca-2024A103343$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$US$
240584471$24058447$1$I$20240611$20240703$20240708$20240708$EXP$$US-AstraZeneca-2024A153271$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$US$
240584481$24058448$1$I$$20240701$20240708$20240708$PER$$US-EMD Serono-2024035866$EMD SERONO INC$$49$YR$A$M$Y$$$20240708$$HP$US$US
240584491$24058449$1$I$$20240625$20240708$20240708$EXP$$GB-ROCHE-10000010548$ROCHE$$$$A$F$Y$$$20240708$$CN$GB$GB
240584501$24058450$1$I$$20231103$20240708$20240708$EXP$$US-ABBVIE-5830600$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240584511$24058451$1$I$$20240701$20240708$20240708$EXP$$JP-ROCHE-10000017911$ROCHE$Danzuka Y, Nakamura K, Yamasaki S, Takayama K, Ikezaki H, Murata M et al.. P-138 A case where the influence of remdesivir-resistant gene was considered because the patient persistently tested positive for nasopharyngeal swab testing for SARS-CoV-2 and serum PCR. The 98th Annual Meeting of the Japanese Association for Infectious Diseases / Th. 2024$71$YR$E$F$Y$$$20240708$$MD$JP$JP
240584521$24058452$1$I$$20240701$20240708$20240708$EXP$$US-SA-2024SA195650$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240708$$CN$US$US
240584531$24058453$1$I$20220101$20240701$20240708$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107320$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240708$$MD$JP$JP
240584541$24058454$1$I$20240628$20240701$20240708$20240708$PER$$US-ABBVIE-5825301$ABBVIE$$51$YR$$F$Y$$$20240708$$CN$US$US
240584551$24058455$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129751$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240584561$24058456$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129762$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240584581$24058458$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129799$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240584591$24058459$1$I$20230921$20231107$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2023-061263$AUROBINDO$$68$YR$$F$Y$$$20240708$$CN$US$US
240584601$24058460$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129776$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240584611$24058461$1$I$20240625$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024132708$AMGEN$$42$YR$A$F$Y$$$20240707$$PH$US$US
240584621$24058462$1$I$20240703$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133562$AMGEN$$79$YR$E$F$Y$$$20240707$$HP$US$US
240584631$24058463$1$I$20240511$20240627$20240708$20240708$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158898$JIANGSU HENGRUI MEDICINE$$65$YR$$F$Y$45$KG$20240708$$MD$CN$CN
240584642$24058464$2$F$$20240821$20240708$20240823$EXP$$US-CHEPLA-2024008240$CHEPLAPHARM$$62$YR$$F$Y$$$20240823$$MD$COUNTRY NOT SPECIFIED$US
240584651$24058465$1$I$$20240702$20240708$20240708$EXP$$JP-009507513-2407JPN000386J$MERCK$$$$$M$Y$$$20240708$$CN$JP$JP
240584661$24058466$1$I$$20230607$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2023-042429$AUROBINDO$$71$YR$$F$Y$57.6$KG$20240708$$CN$US$US
240584671$24058467$1$I$20240327$20240702$20240708$20240708$EXP$FR-AFSSAPS-BR2024000532$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-105026$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240708$$MD$FR$FR
240584681$24058468$1$I$$20231103$20240708$20240708$EXP$$US-ABBVIE-5830742$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240584694$24058469$4$F$20240608$20240715$20240708$20240724$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037922$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$55$KG$20240725$$CN$BR$BR
240584702$24058470$2$F$20210901$20240911$20240708$20240917$EXP$$US-ABBVIE-5813623$ABBVIE$$76$YR$$F$Y$118$KG$20240917$$CN$US$US
240584711$24058471$1$I$20240617$20240628$20240708$20240708$EXP$IT-MINISAL02-991669$IT-TEVA-VS-3215678$TEVA$$56$YR$$M$Y$$$20240708$$PH$IT$IT
240584721$24058472$1$I$$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407003407$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240708$$CN$US$US
240584732$24058473$2$F$$20240711$20240708$20240721$EXP$$US-TEVA-VS-3214508$TEVA$Ryan A, Jones M, Broadwell M. Cold and Confused: A Case of Suspected Adrenal Insufficiency After COVID-19. Am-J-Respir-Crit-Care-Med 2024; 209.; Ryan A, Jones M, Broadwell M. Cold and Confused: A Case of Suspected Adrenal Insufficiency After COVID-19. Am-J-Respir-Crit-Care-Med 2024; 209.$92$YR$$F$Y$$$20240721$$HP$US$US
240584741$24058474$1$I$$20230607$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2023-042430$AUROBINDO$$71$YR$$F$Y$57.6$KG$20240708$$HP$US$US
240584752$24058475$2$F$$20240702$20240708$20240709$PER$$US-ROCHE-10000017044$ROCHE$$54$YR$A$F$Y$$$20240709$$HP$US$US
240584761$24058476$1$I$$20240707$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107731$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$66.22$KG$20240708$$CN$US$US
240584771$24058477$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129823$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240584781$24058478$1$I$$20240701$20240708$20240708$PER$$US-AMGEN-USASP2024130936$AMGEN$$$$$F$Y$$$20240707$$HP$US$US
240584792$24058479$2$F$$20240709$20240708$20240717$PER$$US-CHATTEMPRD-2024OHG022799$CHATTEM$$$$$F$Y$$$20240717$$CN$US$US
240584801$24058480$1$I$$20240628$20240708$20240708$PER$$US-AstraZeneca-2024A150339$ASTRAZENECA$$$$C$$Y$$$20240708$$MD$US$
240584811$24058481$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024130277$AMGEN$$$$$F$Y$$$20240707$$CN$US$US
240584821$24058482$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129843$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240584831$24058483$1$I$$20240704$20240708$20240708$EXP$$EC-ROCHE-10000018192$ROCHE$$$$$$Y$$$20240708$$MD$EC$EC
240584843$24058484$3$F$$20240709$20240708$20240726$PER$$US-CHATTEMPRD-2024OHG022826$CHATTEM$$$$$F$Y$$$20240719$$CN$US$US
240584851$24058485$1$I$$20240628$20240708$20240708$EXP$$US-GSK-US2024AMR081991$GLAXOSMITHKLINE$$$$$F$Y$68.027$KG$20240708$$CN$US$US
240584862$24058486$2$F$20230301$20240802$20240708$20240806$PER$$US-AMGEN-USASP2024132574$AMGEN$$17$YR$T$F$Y$$$20240806$$CN$US$US
240584871$24058487$1$I$20231029$20240625$20240708$20240708$EXP$$AU-ROCHE-10000008987$ROCHE$$61$YR$A$F$Y$$$20240708$$CN$AU$AU
240584881$24058488$1$I$$20240629$20240708$20240708$PER$$US-CHATTEMPRD-2024OHG022805$CHATTEM$$$$$$Y$$$20240708$$CN$US$US
240584891$24058489$1$I$20240319$20240624$20240708$20240708$EXP$FR-AFSSAPS-RS2024000590$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108949$ZYDUS PHARM$$$$$$Y$$$20240708$$CN$FR$FR
240584901$24058490$1$I$20240616$20240628$20240708$20240708$EXP$$CA-APOTEX-2024AP007939$APOTEX$$59$YR$A$M$Y$$$20240708$$PH$CA$CA
240584911$24058491$1$I$$20240629$20240708$20240708$PER$$US-CHATTEMPRD-2024OHG022739$CHATTEM$$$$$$Y$$$20240708$$CN$US$US
240584922$24058492$2$F$$20240630$20240708$20240722$PER$$US-CHATTEMPRD-2024OHG022659$CHATTEM$$$$$M$Y$$$20240722$$CN$US$US
240584931$24058493$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281437578480-ZYWPV$GB-TEVA-VS-3215753$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240584941$24058494$1$I$20240626$20240701$20240708$20240708$EXP$$US-ALXN-202407USA000076US$ALEXION PHARMACEUTICALS$$35$YR$$F$Y$$$20240708$$HP$US$US
240584952$24058495$2$F$$20240708$20240708$20240717$PER$$US-CHATTEMPRD-2024OHG022811$CHATTEM$$$$$F$Y$$$20240717$$CN$US$US
240584961$24058496$1$I$20240617$20240702$20240708$20240708$EXP$$US-ABBVIE-5824677$ABBVIE$$76$YR$$F$Y$$$20240708$$CN$US$US
240584973$24058497$3$F$20120312$20240903$20240708$20240905$PER$$US-GILEAD-2024-0679563$GILEAD$$54$YR$A$M$Y$$$20240905$$LW$US$US
240584981$24058498$1$I$20240323$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281136243400-GYCWK$GB-TEVA-VS-3215789$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240584991$24058499$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281418165880-YWTHP$GB-TEVA-VS-3215824$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240585001$24058500$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129856$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240585011$24058501$1$I$$20240202$20240708$20240708$PER$$US-APOTEX-2024AP001866$APOTEX$$31$YR$$M$Y$$$20240708$$MD$US$US
240585021$24058502$1$I$20240604$20240703$20240708$20240708$EXP$$AU-ABBVIE-5830020$ABBVIE$$70$YR$$M$Y$$$20240708$$MD$AU$AU
240585031$24058503$1$I$$20231109$20240708$20240708$PER$$US-APOTEX-2023AP016488$APOTEX$$$$$$Y$$$20240708$$MD$US$US
240585041$24058504$1$I$$20240206$20240708$20240708$PER$$US-APOTEX-2024AP002051$APOTEX$$$$C$$Y$$$20240708$$PH$US$US
240585052$24058505$2$F$$20240704$20240708$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06090$LUPIN$$$$$$Y$$$20240728$$CN$US$US
240585061$24058506$1$I$$20230620$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2023-044736$AUROBINDO$$$$$F$Y$$$20240708$$CN$US$US
240585071$24058507$1$I$20220101$20230731$20240708$20240708$PER$$US-APOTEX-2023AP009616$APOTEX$$$$$F$Y$$$20240708$$CN$US$US
240585081$24058508$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024130251$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240585091$24058509$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129874$AMGEN$Inoue Y. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240585103$24058510$3$F$20240304$20240828$20240708$20240905$EXP$$CA-CELLTRION INC.-2024CA006456$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
240585111$24058511$1$I$20240627$20240703$20240708$20240708$EXP$$BE-AUROBINDO-AUR-APL-2024-033001$AUROBINDO$$63$YR$$M$Y$106$KG$20240708$$PH$BE$BE
240585121$24058512$1$I$$20231220$20240708$20240708$PER$$US-AMGEN-USASP2023235545$AMGEN$$$$$$Y$$$20240707$$PH$US$US
240585134$24058513$4$F$$20240819$20240708$20240828$EXP$$US-GSK-US2024AMR081791$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$CN$US$US
240585141$24058514$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06092$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240585151$24058515$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129904$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240585161$24058516$1$I$$20240620$20240708$20240708$EXP$$LB-ROCHE-10000012821$ROCHE$$$$$$Y$$$20240708$$MD$LB$LB
240585172$24058517$2$F$20240618$20240627$20240708$20240721$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158899$JIANGSU HENGRUI MEDICINE$$76$YR$$$Y$110.2$KG$20240721$$$US$US
240585181$24058518$1$I$20240501$20240704$20240708$20240708$EXP$$EC-ROCHE-10000018185$ROCHE$$$$$$Y$$$20240708$$MD$EC$EC
240585193$24058519$3$F$20240626$20240724$20240708$20240911$PER$$US-AstraZeneca-2024A147824$ASTRAZENECA$$23720$DY$$F$Y$$$20240911$$CN$US$
240585201$24058520$1$I$$20240626$20240708$20240708$EXP$GB-MHRA-MED-202406261556280970-KDVYB$GB-NOVOPROD-1247325$NOVO NORDISK$$$$$F$Y$$$20240708$$HP$GB$GB
240585211$24058521$1$I$20170101$20240626$20240708$20240708$EXP$$US-NOVOPROD-1246252$NOVO NORDISK$$42$YR$$F$Y$$$20240708$$CN$US$US
240585221$24058522$1$I$$20240626$20240708$20240708$EXP$$US-NOVOPROD-1247271$NOVO NORDISK$$46$YR$$$Y$$$20240708$$CN$US$US
240585232$24058523$2$F$$20240813$20240708$20240820$PER$$US-AstraZeneca-2024A150537$ASTRAZENECA$$40$YR$$F$Y$$$20240820$$CN$US$
240585241$24058524$1$I$20240625$20240626$20240708$20240708$EXP$$US-NOVOPROD-1247236$NOVO NORDISK$$$$A$M$Y$$$20240708$$CN$US$US
240585251$24058525$1$I$$20240626$20240708$20240708$EXP$$AU-NOVOPROD-1246658$NOVO NORDISK$$$$$F$Y$$$20240708$$PH$AU$AU
240585262$24058526$2$F$20240405$20240807$20240708$20240819$EXP$$DK-NOVOPROD-1246693$NOVO NORDISK$$$$$M$Y$128$KG$20240819$$HP$DK$DK
240585281$24058528$1$I$$20240626$20240708$20240708$EXP$$DE-NOVOPROD-1247342$NOVO NORDISK$$$$$M$Y$$$20240708$$PH$DE$DE
240585301$24058530$1$I$$20240626$20240708$20240708$EXP$$US-NOVOPROD-1246256$NOVO NORDISK$$$$$F$Y$$$20240708$$CN$US$US
240585311$24058531$1$I$$20240626$20240708$20240708$EXP$$CA-NOVOPROD-1246181$NOVO NORDISK$$$$$$Y$$$20240708$$CN$CA$CA
240585321$24058532$1$I$20240424$20240626$20240708$20240708$EXP$GB-MHRA-MED-202406251358214930-QMBSL$GB-NOVOPROD-1247330$NOVO NORDISK$$68$YR$$F$Y$89$KG$20240708$$MD$GB$GB
240585331$24058533$1$I$$20240626$20240708$20240708$EXP$$US-NOVOPROD-1247326$NOVO NORDISK$$36$YR$$$Y$$$20240708$$CN$US$US
240585341$24058534$1$I$$20240701$20240708$20240708$PER$$US-CHATTEMPRD-2024OHG023135$CHATTEM$$$$$F$Y$$$20240708$$CN$US$US
240585351$24058535$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107705$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$56$KG$20240708$$PH$US$US
240585361$24058536$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107675$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$90.72$KG$20240708$$CN$US$US
240585371$24058537$1$I$$20240701$20240708$20240708$PER$$US-CHATTEMPRD-2024OHG022977$CHATTEM$$$$$F$Y$$$20240708$$CN$US$US
240585382$24058538$2$F$$20240716$20240708$20240729$PER$$US-CHATTEMPRD-2024OHG022951$CHATTEM$$59$YR$A$F$Y$$$20240729$$CN$US$US
240585401$24058540$1$I$$20240702$20240708$20240708$EXP$$US-JNJFOC-20240706602$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
240585411$24058541$1$I$$20240703$20240708$20240708$EXP$$CA-ABBVIE-5830968$ABBVIE$$$$$F$Y$$$20240708$$HP$CA$CA
240585421$24058542$1$I$$20230720$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2023-050358$AUROBINDO$$$$$F$Y$$$20240708$$CN$US$US
240585431$24058543$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06105$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240585441$24058544$1$I$20231219$20240628$20240708$20240708$EXP$FI-FIMEA-202402051$FI-TEVA-VS-3215873$TEVA$$61$YR$$F$Y$$$20240708$$MD$FI$FI
240585451$24058545$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129923$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240585461$24058546$1$I$$20231128$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2023-076957$AUROBINDO$$$$$F$Y$$$20240708$$CN$US$US
240585474$24058547$4$F$20220301$20240706$20240708$20240715$EXP$$US-ROCHE-10000017039$ROCHE$$42$YR$A$F$Y$74.84$KG$20240715$$CN$US$US
240585481$24058548$1$I$$20240704$20240708$20240708$EXP$$EC-ROCHE-10000018188$ROCHE$$$$$$Y$$$20240708$$MD$EC$EC
240585492$24058549$2$F$20240101$20240704$20240708$20240711$EXP$$JP-TEVA-VS-3216315$TEVA$$75$YR$$M$Y$$$20240711$$PH$JP$JP
240585501$24058550$1$I$$20231205$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2023-078499$AUROBINDO$$$$$F$Y$$$20240708$$CN$US$US
240585511$24058551$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024130240$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240585521$24058552$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024130203$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240585531$24058553$1$I$$20240702$20240708$20240708$EXP$$US-AMGEN-USASP2024134580$AMGEN$$$$$$Y$$$20240707$$CN$US$US
240585541$24058554$1$I$$20240701$20240708$20240708$EXP$$JP-AMGEN-JPNSP2024131805$AMGEN$$$$$$Y$$$20240707$$MD$JP$JP
240585552$24058555$2$F$20240627$20240807$20240708$20240809$PER$$US-AMGEN-USASP2024132196$AMGEN$$62$YR$A$M$Y$$$20240809$$CN$US$US
240585562$24058556$2$F$20240702$20240705$20240708$20240710$EXP$$US-VIIV HEALTHCARE LIMITED-US2024082138$VIIV$$32$YR$$M$Y$$$20240710$$MD$US$US
240585571$24058557$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129936$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240585581$24058558$1$I$$20240626$20240708$20240708$EXP$$KR-Innogenix, LLC-2158900$INNOGENIX$Source document (Full text)$77$YR$$F$Y$$$20240708$$MD$KR$KR
240585591$24058559$1$I$$20240626$20240708$20240708$PER$$US-ROCHE-10000019002$ROCHE$$35$YR$A$F$Y$$$20240708$$HP$US$US
240585602$24058560$2$F$20240627$20240722$20240708$20240730$30DAY$$US-AMGEN-USASP2024130915$AMGEN$$$$$$Y$$$20240730$$HP$US$US
240585611$24058561$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129970$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240585621$24058562$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129947$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240585631$24058563$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129966$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240707$$HP$US$US
240585641$24058564$1$I$20230901$20240625$20240708$20240708$EXP$FR-AFSSAPS-TS2024000432$FR-SAMSUNG BIOEPIS-SB-2024-19803$SAMSUNG BIOEPIS$$17$YR$T$F$Y$$$20240708$$MD$FR$FR
240585651$24058565$1$I$20240112$20240628$20240708$20240708$EXP$$CN-EMD Serono-2024035737$EMD SERONO INC$$30$YR$A$F$Y$61$KG$20240708$$HP$CN$CN
240585661$24058566$1$I$20240427$20240704$20240708$20240708$EXP$$DE-TAKEDA-2024TUS060918$TAKEDA$$82$YR$$M$Y$$$20240708$$CN$DE$DE
240585672$24058567$2$F$$20240711$20240708$20240716$EXP$$JP-TAKEDA-2024TJP010054$TAKEDA$$$$$$Y$$$20240716$$MD$JP$JP
240585681$24058568$1$I$20240101$20240625$20240708$20240708$EXP$IT-MINISAL02-981157$IT-SAMSUNG BIOEPIS-SB-2024-19766$SAMSUNG BIOEPIS$$53$YR$A$F$Y$$$20240708$$MD$IT$IT
240585691$24058569$1$I$$20240704$20240708$20240708$EXP$$EC-ROCHE-10000018163$ROCHE$$$$$$Y$$$20240708$$MD$EC$EC
240585701$24058570$1$I$20231001$20240625$20240708$20240708$EXP$FR-AFSSAPS-TS2024000408$FR-SAMSUNG BIOEPIS-SB-2024-19793$SAMSUNG BIOEPIS$$30$YR$A$M$Y$$$20240708$$MD$FR$FR
240585711$24058571$1$I$$20240701$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105043$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240708$$HP$US$US
240585721$24058572$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5829854$ABBVIE$$$$A$F$Y$$$20240708$$CN$US$US
240585731$24058573$1$I$$20240702$20240708$20240708$EXP$$US-GSK-US2024083118$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$PH$US$US
240585741$24058574$1$I$20040101$20240701$20240708$20240708$EXP$$JP-GSK-JP2024081496$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$JP$JP
240585751$24058575$1$I$$20240702$20240708$20240708$EXP$$NVSC2024AT139270$NOVARTIS$$$$$$Y$$$20240708$$MD$AT$AT
240585761$24058576$1$I$20240314$20240625$20240708$20240708$EXP$FR-AFSSAPS-RN2024000440$FR-SAMSUNG BIOEPIS-SB-2024-19764$SAMSUNG BIOEPIS$$9$YR$C$M$Y$$$20240708$$MD$FR$FR
240585773$24058577$3$F$$20240821$20240708$20240830$EXP$$US-TEVA-VS-3216950$TEVA$$63$YR$$$Y$$$20240830$$CN$US$US
240585782$24058578$2$F$$20240703$20240708$20240709$PER$$US-AMGEN-USASP2024133635$AMGEN$$75$YR$E$F$Y$$$20240709$$CN$US$US
240585791$24058579$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024130216$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240585801$24058580$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129980$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240585811$24058581$1$I$$20240627$20240708$20240708$EXP$$JP-NOVOPROD-1247011$NOVO NORDISK$$60$YR$$F$Y$$$20240708$$PH$JP$JP
240585821$24058582$1$I$$20240627$20240708$20240708$EXP$GB-MHRA-MED-202406271529488710-HSWVZ$GB-NOVOPROD-1247612$NOVO NORDISK$$$$$F$Y$$$20240708$$PH$GB$GB
240585831$24058583$1$I$20230915$20240627$20240708$20240708$EXP$SE-SEMPA-2024-003197$SE-NOVOPROD-1246496$NOVO NORDISK$$41$YR$$M$Y$109$KG$20240708$$CN$SE$SE
240585841$24058584$1$I$20240101$20240627$20240708$20240708$EXP$SE-SEMPA-2024-005070$SE-NOVOPROD-1246493$NOVO NORDISK$$43$YR$$F$Y$80$KG$20240708$$MD$SE$SE
240585851$24058585$1$I$$20240627$20240708$20240708$EXP$$CA-NOVOPROD-1246532$NOVO NORDISK$$$$$F$Y$$$20240708$$HP$CA$CA
240585861$24058586$1$I$20240626$20240627$20240708$20240708$EXP$$US-NOVOPROD-1216537$NOVO NORDISK$$$$$M$Y$$$20240708$$CN$US$US
240585872$24058587$2$F$20240529$20240712$20240708$20240723$EXP$$CN-NOVOPROD-1247009$NOVO NORDISK$$70$YR$$F$Y$60$KG$20240723$$CN$CN$CN
240585881$24058588$1$I$$20240627$20240708$20240708$EXP$$MX-NOVOPROD-1247007$NOVO NORDISK$$$$$M$Y$$$20240708$$CN$MX$MX
240585891$24058589$1$I$20240624$20240627$20240708$20240708$EXP$$US-NOVOPROD-1238120$NOVO NORDISK$$55$YR$$F$Y$$$20240708$$CN$US$US
240585901$24058590$1$I$$20240627$20240708$20240708$EXP$$GB-NOVOPROD-1246694$NOVO NORDISK$$62$YR$$M$Y$$$20240708$$CN$GB$GB
240585911$24058591$1$I$$20240627$20240708$20240708$EXP$DE-BFARM-24004568$DE-NOVOPROD-1246498$NOVO NORDISK$$$$E$M$Y$91$KG$20240708$$MD$DE$DE
240585921$24058592$1$I$20231206$20231220$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2023-078787$AUROBINDO$$69$YR$$M$Y$106.59$KG$20240708$$CN$US$US
240585931$24058593$1$I$$20240627$20240708$20240708$EXP$GB-MHRA-30749191$GB-NOVOPROD-1247558$NOVO NORDISK$$$$$F$Y$$$20240708$$CN$GB$GB
240585951$24058595$1$I$$20240702$20240708$20240708$EXP$$NVSC2024RU139882$NOVARTIS$$$$$F$Y$$$20240708$$MD$RU$RU
240585961$24058596$1$I$20240101$20240628$20240708$20240708$EXP$FI-FIMEA-202402052$FI-TEVA-VS-3215851$TEVA$$47$YR$$F$Y$$$20240708$$MD$FI$FI
240585971$24058597$1$I$20240605$20240702$20240708$20240708$EXP$$US-AstraZeneca-2024A152147$ASTRAZENECA$$27499$DY$$M$Y$$$20240708$$CN$US$
240585981$24058598$1$I$20240622$20240627$20240708$20240708$PER$$US-AstraZeneca-2024A148965$ASTRAZENECA$$23809$DY$$F$Y$$$20240708$$CN$US$
240585991$24058599$1$I$$20240206$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2024-001008$AUROBINDO$$$$$F$Y$$$20240708$$CN$US$US
240586003$24058600$3$F$20240629$20240729$20240708$20240802$PER$$US-AMGEN-USASP2024131813$AMGEN$$49$YR$A$F$Y$$$20240802$$PH$US$US
240586011$24058601$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129811$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240586021$24058602$1$I$20240701$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024132693$AMGEN$$68$YR$E$F$Y$$$20240708$$CN$US$US
240586031$24058603$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024130231$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240586041$24058604$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024130239$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240586051$24058605$1$I$20240520$20240625$20240708$20240708$EXP$$PK-ROCHE-10000017373$ROCHE$$61$YR$A$F$Y$$$20240708$$CN$PK$PK
240586062$24058606$2$F$$20240704$20240708$20240711$EXP$$JP-TEVA-VS-3216351$TEVA$$$$E$M$Y$$$20240711$$CN$JP$JP
240586071$24058607$1$I$$20240517$20240708$20240708$EXP$$US-ENDO USA, INC.-2024-002251$ENDO$$$$$F$Y$$$20240708$$CN$US$US
240586081$24058608$1$I$$20240701$20240708$20240708$EXP$$US-ABBVIE-5830774$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240586091$24058609$1$I$$20240702$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002191$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240708$$CN$US$US
240586101$24058610$1$I$$20240223$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2024-001469$AUROBINDO$$$$$F$Y$$$20240708$$PH$US$US
240586111$24058611$1$I$20240623$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407003002$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240708$$CN$US$US
240586121$24058612$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024130245$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240586131$24058613$1$I$$20240208$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2024-007318$AUROBINDO$$74$YR$$F$Y$78.47$KG$20240708$$CN$US$US
240586141$24058614$1$I$20240325$20240628$20240708$20240708$EXP$$DE-AUROBINDO-AUR-APL-2024-032233$AUROBINDO$$76$YR$$F$Y$72$KG$20240708$$MD$DE$DE
240586152$24058615$2$F$20221101$20240823$20240708$20240829$EXP$$US-TAKEDA-2022TUS084054$TAKEDA$$35$YR$$F$Y$$$20240829$$CN$US$US
240586161$24058616$1$I$20240429$20240628$20240708$20240708$EXP$$ES-AUROBINDO-AUR-APL-2024-032242$AUROBINDO$$87$YR$$F$Y$$$20240708$$HP$ES$ES
240586172$24058617$2$F$$20240711$20240708$20240723$EXP$$IT-TEVA-VS-3215321$TEVA$Pietrantonio F, Lordi M, Vinci F, Alessi E, Pascucci M, Castelli MD, et al. Leptomeningeal carcinomatosis, an emerging disease in internal medicine departments with a generally poor prognosis: two case reports. Italian-J-Med 2024; 18 (2):.; Pietrantonio F, Lordi M, Vinci F, Alessi E, Pascucci M, Castelli MD, et al. Leptomeningeal carcinomatosis, an emerging disease in internal medicine departments with a generally poor prognosis: two case reports. Italian-J-Med 2024; 18 (2):.$61$YR$$F$Y$$$20240723$$HP$IT$IT
240586181$24058618$1$I$$20240626$20240708$20240708$PER$$US-TEVA-VS-3215358$TEVA$$$$A$$Y$$$20240708$$HP$US$US
240586191$24058619$1$I$20240608$20240628$20240708$20240708$EXP$$IT-AUROBINDO-AUR-APL-2024-032237$AUROBINDO$$75$YR$$M$Y$$$20240708$$MD$IT$IT
240586201$24058620$1$I$20231228$20240220$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2024-009421$AUROBINDO$$70$YR$$F$Y$60.7$KG$20240708$$CN$US$US
240586211$24058621$1$I$20240416$20240628$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032363$AUROBINDO$$68$YR$$M$Y$90.5$KG$20240708$$MD$FR$FR
240586222$24058622$2$F$20210101$20240809$20240708$20240812$EXP$$US-BIOVITRUM-2024-US-009533$BIOVITRUM$$63$YR$$M$Y$107.04$KG$20240812$$HP$US$US
240586231$24058623$1$I$$20240318$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2024-014148$AUROBINDO$$45$YR$$F$Y$77.111$KG$20240708$$CN$US$US
240586241$24058624$1$I$$20240601$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2024-018444$AUROBINDO$$74$WK$$F$Y$95.254$KG$20240708$$CN$US$US
240586251$24058625$1$I$20240323$20240628$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032656$AUROBINDO$$$$$$Y$$$20240708$$CN$GB$GB
240586261$24058626$1$I$20240123$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010101$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240586271$24058627$1$I$$20240703$20240708$20240708$EXP$$US-JNJFOC-20240710949$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
240586281$24058628$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129663$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240586291$24058629$1$I$20240501$20240703$20240708$20240708$EXP$ES-AEMPS-1541873$ES-AMGEN-ESPSP2024132054$AMGEN$$74$YR$E$M$Y$$$20240708$$MD$ES$ES
240586302$24058630$2$F$$20240802$20240708$20240811$PER$$US-AstraZeneca-2024A147187$ASTRAZENECA$$$$$$Y$$$20240811$$CN$US$
240586311$24058631$1$I$20240302$20240426$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2024-011729$AUROBINDO$$71$YR$$F$Y$49.89$KG$20240708$$CN$US$US
240586322$24058632$2$F$$20240923$20240708$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06198$LUPIN$$$$$$Y$$$20240927$$CN$US$US
240586331$24058633$1$I$$20240628$20240708$20240708$EXP$$ES-TEVA-VS-3216565$TEVA$$$$$F$Y$$$20240708$$CN$ES$ES
240586341$24058634$1$I$$20240411$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2024-016542$AUROBINDO$$$$$F$Y$$$20240708$$HP$US$US
240586351$24058635$1$I$$20240629$20240708$20240708$EXP$$DE-TAKEDA-2024TUS066335$TAKEDA$$$$$$Y$$$20240708$$CN$DE$DE
240586363$24058636$3$F$20240714$20240904$20240708$20240923$PER$$US-SA-2024SA193106$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240923$$MD$US$US
240586371$24058637$1$I$20240601$20240627$20240708$20240708$PER$$US-SA-2024SA193173$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240708$$MD$US$US
240586381$24058638$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193242$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240586391$24058639$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193096$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240708$$CN$US$US
240586401$24058640$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193251$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240586411$24058641$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193012$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240708$$MD$US$US
240586421$24058642$1$I$20240601$20240627$20240708$20240708$PER$$US-SA-2024SA193237$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240708$$CN$US$US
240586431$24058643$1$I$20240606$20240627$20240708$20240708$PER$$US-SA-2024SA193203$SANOFI AVENTIS$$$$A$M$Y$$$20240708$$HP$US$US
240586441$24058644$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA195503$SANOFI AVENTIS$$$$A$M$Y$$$20240708$$MD$US$US
240586451$24058645$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA195942$SANOFI AVENTIS$$$$$F$Y$$$20240708$$CN$US$US
240586462$24058646$2$F$20240601$20240708$20240708$20240716$PER$$US-SA-2024SA197385$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240716$$MD$US$US
240586481$24058648$1$I$20240101$20240627$20240708$20240708$EXP$IT-MINISAL02-982668$IT-SAMSUNG BIOEPIS-SB-2024-20111$SAMSUNG BIOEPIS$$17$YR$T$M$Y$$$20240708$$MD$IT$IT
240586492$24058649$2$F$20240414$20240806$20240708$20240816$EXP$FR-AFSSAPS-ST2024000775$FR-SAMSUNG BIOEPIS-SB-2024-20100$SAMSUNG BIOEPIS$$48$YR$A$M$Y$83$KG$20240816$$MD$FR$FR
240586501$24058650$1$I$$20240411$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2024-016685$AUROBINDO$$$$$F$Y$$$20240708$$HP$US$US
240586511$24058651$1$I$20240101$20240612$20240708$20240708$EXP$GB-MHRA-MED-202406121555351530-DCBFY$GB-SA-2024SA191883$SANOFI AVENTIS$$$$$F$Y$$$20240708$$CN$GB$GB
240586522$24058652$2$F$$20240723$20240708$20240731$EXP$$TH-TAKEDA-2024TUS067954$TAKEDA$$$$$M$Y$$$20240731$$MD$TH$TH
240586531$24058653$1$I$20240412$20240627$20240708$20240708$EXP$ES-AEMPS-1515381$ES-SAMSUNG BIOEPIS-SB-2024-20097$SAMSUNG BIOEPIS$$68$YR$E$F$Y$$$20240708$$MD$ES$ES
240586541$24058654$1$I$20240523$20240623$20240708$20240708$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000545$PAREXEL$$$$$$Y$$$20240708$$HP$CN$CN
240586552$24058655$2$F$20240620$20240703$20240708$20240711$EXP$$IT-AUROBINDO-AUR-APL-2024-032263$AUROBINDO$$84$YR$$F$Y$$$20240711$$PH$IT$IT
240586561$24058656$1$I$$20240627$20240708$20240708$EXP$$JP-TAKEDA-2024TUS068252$TAKEDA$$6$DEC$$F$Y$$$20240708$$MD$JP$JP
240586571$24058657$1$I$$20240624$20240708$20240708$EXP$$US-BIOCODEX2-2024000962$BIOCODEX$$$$$M$Y$26.9$KG$20240704$$CN$US$US
240586582$24058658$2$F$20240201$20240814$20240708$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06063$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240586591$24058659$1$I$20240524$20240628$20240708$20240708$EXP$$CN-AUROBINDO-AUR-APL-2024-033404$AUROBINDO$$59$YR$$M$Y$74.6$KG$20240708$$HP$CN$CN
240586601$24058660$1$I$20240101$20240701$20240708$20240708$PER$$US-SA-2024SA196137$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240708$$CN$US$US
240586612$24058661$2$F$20240702$20240703$20240708$20240712$PER$$US-SA-2024SA197800$SANOFI AVENTIS$$15$YR$T$F$Y$43.09$KG$20240712$$MD$US$US
240586621$24058662$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA196434$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240708$$CN$US$US
240586631$24058663$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA195156$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240708$$CN$US$US
240586641$24058664$1$I$20240101$20240629$20240708$20240708$PER$$US-SA-2024SA196546$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240708$$MD$US$US
240586651$24058665$1$I$20240312$20240628$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032458$AUROBINDO$$26$YR$$M$Y$$$20240708$$PH$FR$FR
240586661$24058666$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA195337$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240708$$CN$US$US
240586671$24058667$1$I$20220401$20240629$20240708$20240708$PER$$US-SA-2024SA196461$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240586681$24058668$1$I$20230101$20240626$20240708$20240708$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06052$HIKMA$$46$YR$$M$Y$$$20240708$$HP$US$US
240586691$24058669$1$I$20231201$20240702$20240708$20240708$EXP$$US-BIOGEN-2024BI01272123$BIOGEN$$67$YR$$F$Y$$$20240708$$CN$US$US
240586701$24058670$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129678$AMGEN$Inoue Y. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240586711$24058671$1$I$20240616$20240701$20240708$20240708$EXP$$US-BIOGEN-2024BI01272020$BIOGEN$$50$YR$$F$Y$$$20240708$$CN$US$US
240586721$24058672$1$I$$20240628$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032198$AUROBINDO$$76$YR$$$Y$$$20240708$$PH$GB$GB
240586731$24058673$1$I$$20240701$20240708$20240708$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001345$BLUEPRINT MEDICINES$$$$$F$Y$$$20240708$$HP$US$US
240586742$24058674$2$F$$20240829$20240708$20240905$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001348$BLUEPRINT MEDICINES$$$$$F$Y$$$20240905$$CN$US$US
240586751$24058675$1$I$$20240626$20240708$20240708$EXP$$JP-ROCHE-10000013734$ROCHE$$6$DEC$A$M$Y$$$20240708$$MD$JP$JP
240586762$24058676$2$F$$20240724$20240708$20240731$EXP$$US-BIOGEN-2024BI01251640$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
240586771$24058677$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5766015$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240586783$24058678$3$F$20240327$20240909$20240708$20240919$EXP$$JP-UCBSA-2024017511$UCB$$9$DEC$$F$Y$$$20240919$$MD$JP$JP
240586791$24058679$1$I$20240101$20240628$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032217$AUROBINDO$$54$YR$$M$Y$80$KG$20240708$$PH$FR$FR
240586801$24058680$1$I$$20240624$20240708$20240708$PER$$US-ROCHE-10000016046$ROCHE$$$$A$M$Y$$$20240708$$CN$US$US
240586812$24058681$2$F$$20240828$20240708$20240904$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001349$BLUEPRINT MEDICINES$$$$$M$Y$$$20240904$$CN$US$US
240586821$24058682$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06197$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240586831$24058683$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06088$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240586841$24058684$1$I$$20240704$20240708$20240708$EXP$$CA-ABBVIE-5828921$ABBVIE$$$$A$F$Y$$$20240708$$CN$CA$CA
240586851$24058685$1$I$$20240206$20240708$20240708$PER$$US-AMGEN-USASP2024133253$AMGEN$$$$$$Y$$$20240708$$MD$US$US
240586861$24058686$1$I$$20240702$20240708$20240708$EXP$$IL-AMGEN-ISRSP2024132936$AMGEN$$20$YR$A$F$Y$$$20240708$$CN$IL$IL
240586871$24058687$1$I$20240628$20240628$20240708$20240708$PER$$US-SA-2024SA195014$SANOFI AVENTIS$$33$YR$A$F$Y$94.785$KG$20240708$$MD$US$US
240586881$24058688$1$I$$20240701$20240708$20240708$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001350$BLUEPRINT MEDICINES$$$$$F$Y$$$20240708$$CN$US$US
240586891$24058689$1$I$$20240701$20240708$20240708$EXP$$ES-SA-2024SA198400$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240708$$HP$ES$ES
240586901$24058690$1$I$$20240627$20240708$20240708$EXP$GB-002147023-NVSC2024GB133606$GB-UCBSA-2024032840$UCB$$64$YR$$F$Y$$$20240708$$CN$GB$GB
240586912$24058691$2$F$20211204$20240716$20240708$20240721$EXP$$JP-TAKEDA-2022TJP062532$TAKEDA$$55$YR$$F$Y$40$KG$20240721$$MD$JP$JP
240586922$24058692$2$F$$20240701$20240708$20240722$EXP$$US-BIOGEN-2024BI01272170$BIOGEN$$$$$F$Y$50.848$KG$20240722$$HP$US$US
240586931$24058693$1$I$$20240502$20240708$20240708$PER$$US-AMGEN-USASP2024133507$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240586941$24058694$1$I$20240601$20240705$20240708$20240708$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038252$BOEHRINGER INGELHEIM$$84$YR$E$M$Y$$$20240708$$CN$US$US
240586951$24058695$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129708$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240586961$24058696$1$I$$20240702$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009589$DR REDDYS$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocritical Care. 2024;40: 976-983. doi:https://dx.doi.org/10.1007/s12028-023-01853-8.$26$YR$A$M$Y$76.5$KG$20240708$$HP$US$US
240586971$24058697$1$I$$20240628$20240708$20240708$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024081063$VIIV$$$$$$Y$$$20240708$$PH$US$US
240586981$24058698$1$I$20240221$20240627$20240708$20240708$EXP$GB-MHRA-MED-202406271241115440-QVRBZ$GB-SA-2024SA192530$SANOFI AVENTIS$$62$YR$A$F$Y$106$KG$20240708$$CN$GB$GB
240586991$24058699$1$I$20240101$20240614$20240708$20240708$PER$$CA-TOLMAR, INC.-24CA050240$TOLMAR$$$$$M$Y$$$20240708$$CN$CA$CA
240587001$24058700$1$I$$20240617$20240708$20240708$PER$$CA-TOLMAR, INC.-24CA050241$TOLMAR$$$$$M$Y$$$20240708$$CN$CA$CA
240587011$24058701$1$I$20240227$20240617$20240708$20240708$PER$$CA-TOLMAR, INC.-24CA050237$TOLMAR$$70$YR$$M$Y$$$20240708$$CN$CA$CA
240587021$24058702$1$I$20240614$20240614$20240708$20240708$PER$$CA-TOLMAR, INC.-24CA050258$TOLMAR$$70$YR$$M$Y$$$20240708$$CN$CA$CA
240587032$24058703$2$F$20240101$20240906$20240708$20240924$PER$$CA-TOLMAR, INC.-24CA050246$TOLMAR$$77$YR$$M$Y$$$20240924$$CN$CA$CA
240587042$24058704$2$F$20240614$20240906$20240708$20240924$PER$$CA-TOLMAR, INC.-24CA050255$TOLMAR$$78$YR$$M$Y$$$20240924$$CN$CA$CA
240587051$24058705$1$I$20240606$20240614$20240708$20240708$PER$$CA-TOLMAR, INC.-24CA050261$TOLMAR$$87$YR$$M$Y$$$20240708$$CN$CA$CA
240587061$24058706$1$I$20240617$20240617$20240708$20240708$PER$$CA-TOLMAR, INC.-24CA050311$TOLMAR$$76$YR$$M$Y$$$20240708$$CN$CA$CA
240587071$24058707$1$I$$20240617$20240708$20240708$PER$$CA-TOLMAR, INC.-24CA050292$TOLMAR$$$$$M$Y$$$20240708$$CN$CA$CA
240587081$24058708$1$I$20240617$20240617$20240708$20240708$PER$$CA-TOLMAR, INC.-24CA050312$TOLMAR$$82$YR$$M$Y$$$20240708$$CN$CA$CA
240587092$24058709$2$F$$20240711$20240708$20240801$PER$$US-TOLMAR, INC.-24US049868$TOLMAR$$$$$$Y$$$20240801$$MD$US$US
240587101$24058710$1$I$$20240626$20240708$20240708$EXP$$US-ENDO USA, INC.-2024-002804$ENDO$$$$$M$Y$$$20240708$$CN$US$US
240587111$24058711$1$I$$20240702$20240708$20240708$PER$$US-SA-2024SA197506$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240708$$HP$US$US
240587121$24058712$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA198071$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240708$$MD$US$US
240587131$24058713$1$I$20240501$20240629$20240708$20240708$PER$$US-SA-2024SA195335$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240708$$MD$US$US
240587141$24058714$1$I$20240620$20240628$20240708$20240708$EXP$$IT-AUROBINDO-AUR-APL-2024-032275$AUROBINDO$$59$YR$$M$Y$$$20240708$$PH$IT$IT
240587152$24058715$2$F$20240101$20240708$20240708$20240710$PER$$US-AMGEN-USASP2024133886$AMGEN$$79$YR$E$F$Y$$$20240709$$CN$US$US
240587161$24058716$1$I$20220823$20240628$20240708$20240708$EXP$$FR-CELLTRION INC.-2024FR016001$CELLTRION$$$$$$Y$$$20240708$$PH$FR$FR
240587172$24058717$2$F$20240909$20240910$20240708$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106781$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240912$$CN$US$US
240587181$24058718$1$I$$20240702$20240708$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107659$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240708$$MD$JP$JP
240587191$24058719$1$I$$20240629$20240708$20240708$EXP$$AU-TEVA-VS-3216612$TEVA$$$$$$Y$$$20240708$$HP$AU$AU
240587201$24058720$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214802$TEVA$$$$$M$Y$$$20240708$$CN$CA$CA
240587211$24058721$1$I$20240101$20240702$20240708$20240708$PER$$US-ABBVIE-5826926$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240587221$24058722$1$I$20240309$20240628$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032389$AUROBINDO$$39$YR$$F$Y$$$20240708$$PH$FR$FR
240587231$24058723$1$I$$20240528$20240708$20240708$EXP$$US-ENDO USA, INC.-2024-002467$ENDO$$$$$M$Y$$$20240708$$CN$US$US
240587242$24058724$2$F$20240101$20240708$20240708$20240715$EXP$$UA-SA-2024SA195872$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240715$$MD$UA$UA
240587251$24058725$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214815$TEVA$$14$MON$$M$Y$10$KG$20240708$$HP$CA$CA
240587261$24058726$1$I$$20240705$20240708$20240708$PER$$US-HALEON-2185679$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240587271$24058727$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214847$TEVA$$73$YR$$M$Y$$$20240708$$MD$CA$CA
240587281$24058728$1$I$20240317$20240629$20240708$20240708$EXP$$PT-AUROBINDO-AUR-APL-2024-032601$AUROBINDO$$$$$F$Y$$$20240708$$MD$PT$PT
240587291$24058729$1$I$20240616$20240628$20240708$20240708$EXP$$IT-AUROBINDO-AUR-APL-2024-032264$AUROBINDO$$30$YR$$F$Y$59$KG$20240708$$MD$IT$IT
240587301$24058730$1$I$20240625$20240701$20240708$20240708$PER$$US-EMD Serono-2024035867$EMD SERONO INC$$69$YR$E$M$Y$$$20240708$$HP$US$US
240587312$24058731$2$F$20240601$20240731$20240708$20240802$EXP$$JP-TAKEDA-2024TJP010107$TAKEDA$$55$YR$$F$Y$$$20240802$$MD$JP$JP
240587321$24058732$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06235$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240587331$24058733$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214832$TEVA$$71$YR$$F$Y$$$20240708$$HP$CA$CA
240587341$24058734$1$I$20240703$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134189$AMGEN$$69$YR$E$M$Y$$$20240708$$CN$US$US
240587352$24058735$2$F$20240601$20240627$20240708$20240708$EXP$$US-AMGEN-USASP2024129781$AMGEN$$$$$M$Y$$$20240708$$HP$US$US
240587361$24058736$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129734$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240587371$24058737$1$I$20240426$20240628$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032243$AUROBINDO$$25$YR$$M$Y$$$20240708$$MD$FR$FR
240587384$24058738$4$F$20240601$20240723$20240708$20240803$EXP$$FR-AUROBINDO-AUR-APL-2024-032492$AUROBINDO$$58$YR$$M$Y$61$KG$20240803$$HP$FR$FR
240587391$24058739$1$I$$20240628$20240708$20240708$EXP$$DE-AUROBINDO-AUR-APL-2024-032306$AUROBINDO$$6$DEC$$M$Y$$$20240708$$HP$DE$DE
240587411$24058741$1$I$$20240702$20240708$20240708$EXP$$US-JNJFOC-20240705996$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
240587421$24058742$1$I$$20240628$20240708$20240708$EXP$$US-AUROBINDO-AUR-APL-2024-032520$AUROBINDO$Sharma P, Tahiru M, Li H, Bansari A, Baskaran N.. A case of ocular diffuse large B-cell lymphoma unveiled through Pars Plana Vitrectomy: surgical insight and multidisciplinary management. Journal of Surgical Case Reports. 2024;2024(6):rjae399$74$YR$$M$Y$$$20240708$$MD$US$US
240587431$24058743$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024132687$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240587442$24058744$2$F$20240101$20240731$20240708$20240802$PER$$US-AMGEN-USASP2024133890$AMGEN$$$$$M$Y$$$20240802$$CN$US$US
240587452$24058745$2$F$20240306$20240724$20240708$20240803$EXP$$FR-AUROBINDO-AUR-APL-2024-032248$AUROBINDO$$74$YR$$F$Y$$$20240803$$PH$FR$FR
240587461$24058746$1$I$$20240701$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407001994$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240708$$CN$US$US
240587471$24058747$1$I$20240622$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004099$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240708$$CN$US$US
240587481$24058748$1$I$$20240702$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407001911$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240708$$CN$US$US
240587492$24058749$2$F$$20240709$20240708$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407000826$ELI LILLY AND CO$$68$YR$E$F$Y$66.485$KG$20240801$$CN$US$US
240587501$24058750$1$I$20240307$20240628$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032462$AUROBINDO$$22$YR$$F$Y$$$20240708$$PH$FR$FR
240587511$24058751$1$I$20231128$20240702$20240708$20240708$EXP$$RU-GILEAD-2024-0678974$GILEAD$$49$YR$A$M$Y$$$20240708$$HP$RU$RU
240587521$24058752$1$I$20240622$20240628$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032441$AUROBINDO$$22$YR$$F$Y$76.5$KG$20240708$$MD$FR$FR
240587531$24058753$1$I$20240321$20240626$20240708$20240708$EXP$PT-INFARMED-F202404-309$PT-SAMSUNG BIOEPIS-SB-2024-19969$SAMSUNG BIOEPIS$$73$YR$E$F$Y$$$20240708$$PH$PT$PT
240587541$24058754$1$I$20231212$20240626$20240708$20240708$EXP$IT-MINISAL02-981125$IT-SAMSUNG BIOEPIS-SB-2024-19935$SAMSUNG BIOEPIS$$55$YR$A$F$Y$$$20240708$$MD$IT$IT
240587551$24058755$1$I$20230214$20240626$20240708$20240708$EXP$IT-MINISAL02-981025$IT-SAMSUNG BIOEPIS-SB-2024-19908$SAMSUNG BIOEPIS$$71$YR$E$M$Y$91$KG$20240708$$MD$IT$IT
240587561$24058756$1$I$$20240630$20240708$20240708$EXP$$US-HETERO-HET2024US02088$HETERO$Reinsch N, Haq E, Ramakrishna K, Craft L.. Cardiovascular Collapse Requiring Veno-Arterial Extracorporeal Membrane Oxygenation and Lidocaine: A Case of Massive Bupropion Overdose. Cureus. 2024;16(6):e62873$18$YR$$F$Y$$$20240708$$HP$US$US
240587571$24058757$1$I$$20240704$20240708$20240708$PER$$US-AMGEN-USASP2024133367$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240587582$24058758$2$F$20231101$20240801$20240708$20240807$PER$$US-AMGEN-USASP2024132081$AMGEN$$10$YR$C$F$Y$$$20240807$$MD$US$US
240587591$24058759$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129857$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240587601$24058760$1$I$$20240628$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032262$AUROBINDO$$$$$F$Y$$$20240708$$CN$GB$GB
240587611$24058761$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06094$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240587621$24058762$1$I$$20240702$20240708$20240708$EXP$$CA-ABBVIE-5826733$ABBVIE$$74$YR$$M$Y$$$20240708$$HP$CA$CA
240587631$24058763$1$I$$20240501$20240708$20240708$PER$$US-AVEVA-000677$AVEVA$$$$$M$Y$$$20240708$$CN$US$US
240587642$24058764$2$F$$20240702$20240708$20240805$PER$$US-AVEVA-000676$AVEVA$$$$$M$Y$$$20240804$$CN$US$US
240587651$24058765$1$I$$20240611$20240708$20240708$PER$$US-AVEVA-000679$AVEVA$Zaidi KA, Chapagain P, Mahmud A. Opioid Intoxication to Withdrawal: A Case of Takotsubo Cardiomyopathy. Cureus. 2024,16(5):e59484. doi: 10.7759/cureus.59484. PMID: 38826989.$73$YR$E$F$Y$$$20240708$$HP$US$US
240587661$24058766$1$I$20240601$20240613$20240708$20240708$PER$$CA-AVEVACA-000021$AVEVA$$70$YR$$F$Y$$$20240708$$CN$CA$CA
240587671$24058767$1$I$20240611$20240611$20240708$20240708$PER$$US-AVEVA-000678$AVEVA$$$$$F$Y$$$20240708$$CN$US$US
240587681$24058768$1$I$$20240611$20240708$20240708$PER$$US-AVEVA-000680$AVEVA$Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J Med Toxicol. 2024, doi: 10.1007/s13181-024-01016-x. PMID: 38839731.$$$I$M$Y$$$20240708$$HP$US$US
240587691$24058769$1$I$$20240611$20240708$20240708$PER$$US-AVEVA-000681$AVEVA$Alghalith A, Nguyen H, Tennant R. The Complexities of Kratom: Insights on an Increasingly Frequent Clinical Encounter. Cureus. 2024,16(5):e59650. doi: 10.7759/cureus.59650. PMID: 38832209.$72$YR$E$M$Y$$$20240708$$HP$US$US
240587701$24058770$1$I$$20240629$20240708$20240708$EXP$GB-MHRA-MED-202406291352445690-FRSGZ$GB-RDY-SPO/GBR/24/0009555$DR REDDYS$$$$$M$Y$$$20240708$$CN$GB$GB
240587711$24058771$1$I$$20240604$20240708$20240708$PER$$US-AVEVA-000674$AVEVA$Jackson LK, Poon IO, Garcia MA, Imam S, Braun UK. Buprenorphine Use for Analgesia in Palliative Care. Pharmacy (Basel). 2024,12(3):78. doi: 10.3390/pharmacy12030078. PMID: 38804470.$70$YR$E$M$Y$$$20240708$$HP$US$US
240587721$24058772$1$I$$20240702$20240708$20240708$EXP$$US-ABBVIE-5829023$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240587731$24058773$1$I$20240602$20240604$20240708$20240708$PER$$US-AVEVA-000675$AVEVA$$77$YR$E$F$Y$$$20240708$$CN$US$US
240587741$24058774$1$I$20240507$20240628$20240708$20240708$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS003426$TERSERA THERAPEUTICS$$$$$$Y$$$20240708$$MD$CN$CN
240587752$24058775$2$F$20240724$20240905$20240708$20240911$EXP$$US-GSK-US2024AMR082086$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240911$$CN$US$US
240587763$24058776$3$F$20240601$20240716$20240708$20240809$EXP$$UY-ROCHE-10000008909$ROCHE$$51$YR$A$F$Y$$$20240809$$MD$UY$UY
240587772$24058777$2$F$$20240912$20240708$20240923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-033452$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$62.8$KG$20240923$$MD$JP$JP
240587781$24058778$1$I$$20240625$20240708$20240708$EXP$$CA-ROCHE-10000011427$ROCHE$$65$YR$E$F$Y$34$KG$20240708$$HP$CA$CA
240587791$24058779$1$I$20230305$20240624$20240708$20240708$EXP$$DE-NORDICGR-056605$NORDIC PHARMA$$$$$F$Y$$$20240705$$HP$DE$DE
240587801$24058780$1$I$20230501$20240624$20240708$20240708$EXP$$DE-NORDICGR-056579$NORDIC PHARMA$$$$$F$Y$$$20240705$$HP$DE$DE
240587811$24058781$1$I$20200601$20240624$20240708$20240708$EXP$$DE-NORDICGR-056603$NORDIC PHARMA$$77$YR$$F$Y$$$20240705$$MD$DE$DE
240587821$24058782$1$I$20230501$20240624$20240708$20240708$EXP$$DE-NORDICGR-056578$NORDIC PHARMA$$$$E$M$Y$$$20240704$$MD$DE$DE
240587832$24058783$2$F$20221201$20240904$20240708$20240917$EXP$$DE-NORDICGR-056566$NORDIC PHARMA$$$$A$F$Y$$$20240917$$MD$DE$DE
240587841$24058784$1$I$20230715$20240624$20240708$20240708$EXP$$DE-NORDICGR-056612$NORDIC PHARMA$$$$E$F$Y$$$20240705$$HP$DE$DE
240587851$24058785$1$I$20230902$20240624$20240708$20240708$EXP$$DE-NORDICGR-056565$NORDIC PHARMA$$60$YR$$F$Y$$$20240703$$MD$DE$DE
240587861$24058786$1$I$20230801$20240624$20240708$20240708$EXP$$DE-NORDICGR-056616$NORDIC PHARMA$$58$YR$$F$Y$$$20240705$$MD$DE$DE
240587871$24058787$1$I$20230501$20240624$20240708$20240708$EXP$$DE-NORDICGR-056577$NORDIC PHARMA$$$$$M$Y$$$20240704$$HP$DE$DE
240587881$24058788$1$I$20230508$20240624$20240708$20240708$EXP$$DE-NORDICGR-056620$NORDIC PHARMA$$$$$M$Y$$$20240705$$HP$DE$DE
240587891$24058789$1$I$20210519$20240624$20240708$20240708$EXP$$DE-NORDICGR-056613$NORDIC PHARMA$$$$A$M$Y$$$20240705$$MD$DE$DE
240587901$24058790$1$I$20230701$20240624$20240708$20240708$EXP$$DE-NORDICGR-053917$NORDIC PHARMA$$78$YR$$F$Y$$$20240704$$MD$DE$DE
240587911$24058791$1$I$20191201$20240624$20240708$20240708$EXP$$DE-NORDICGR-056590$NORDIC PHARMA$$$$A$F$Y$$$20240704$$MD$DE$DE
240587921$24058792$1$I$20221107$20240624$20240708$20240708$EXP$$DE-NORDICGR-056610$NORDIC PHARMA$$61$YR$$M$Y$$$20240705$$MD$DE$DE
240587931$24058793$1$I$20230522$20240624$20240708$20240708$EXP$$DE-NORDICGR-056597$NORDIC PHARMA$$$$$F$Y$$$20240705$$MD$DE$DE
240587941$24058794$1$I$20201001$20240624$20240708$20240708$EXP$$DE-NORDICGR-056607$NORDIC PHARMA$$8$YR$$F$Y$$$20240705$$MD$DE$DE
240587951$24058795$1$I$20220101$20240624$20240708$20240708$EXP$$DE-NORDICGR-056611$NORDIC PHARMA$$$$E$F$Y$$$20240705$$MD$DE$DE
240587961$24058796$1$I$20211229$20240624$20240708$20240708$EXP$$DE-NORDICGR-056602$NORDIC PHARMA$$$$A$M$Y$$$20240705$$MD$DE$DE
240587971$24058797$1$I$20220923$20240624$20240708$20240708$EXP$$DE-NORDICGR-056638$NORDIC PHARMA$$$$A$F$Y$$$20240705$$MD$DE$DE
240587981$24058798$1$I$20240402$20240628$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032352$AUROBINDO$$72$YR$$M$Y$112$KG$20240708$$PH$FR$FR
240587991$24058799$1$I$20200512$20240624$20240708$20240708$EXP$$DE-NORDICGR-2021002189$NORDIC PHARMA$$$$E$F$Y$$$20240705$$MD$DE$DE
240588001$24058800$1$I$20230628$20240624$20240708$20240708$EXP$$DE-NORDICGR-2022001919$NORDIC PHARMA$$$$E$F$Y$$$20240705$$CN$DE$DE
240588011$24058801$1$I$20230201$20240624$20240708$20240708$EXP$$DE-NORDICGR-2023003302$NORDIC PHARMA$$27$YR$$F$Y$$$20240703$$CN$DE$DE
240588021$24058802$1$I$20240401$20240624$20240708$20240708$EXP$$DE-NORDICGR-056634$NORDIC PHARMA$$37$YR$$F$Y$$$20240705$$CN$DE$DE
240588032$24058803$2$F$20240623$20240808$20240708$20240816$EXP$$IN-VANTIVE-2024VAN018062$Vantive US Healthcare$$34$YR$$M$Y$$$20240816$$CN$IN$IN
240588041$24058804$1$I$20190816$20240624$20240708$20240708$EXP$$DE-NORDICGR-2021002185$NORDIC PHARMA$$$$A$F$Y$$$20240705$$MD$DE$DE
240588052$24058805$2$F$$20240802$20240708$20240812$EXP$$IT-AUROBINDO-AUR-APL-2024-032393$AUROBINDO$Federica, F. Surgical treatment of invasive fungal infection in pediatric oncology. European Journal of Haematology. 202;113(1):90-98$16$YR$$M$Y$$$20240812$$HP$IT$IT
240588061$24058806$1$I$$20240702$20240708$20240708$PER$$US-ROCHE-10000018775$ROCHE$$61$YR$A$F$Y$$$20240708$$MD$US$US
240588071$24058807$1$I$20200401$20240624$20240708$20240708$EXP$$DE-NORDICGR-202002889$NORDIC PHARMA$$$$E$F$Y$$$20240705$$HP$DE$DE
240588081$24058808$1$I$20230104$20240624$20240708$20240708$EXP$$DE-NORDICGR-056622$NORDIC PHARMA$$$$A$F$Y$$$20240705$$MD$DE$DE
240588091$24058809$1$I$20240524$20240702$20240708$20240708$EXP$$SG-VANTIVE-2024VAN018108$Vantive US Healthcare$$80$YR$$M$Y$$$20240708$$CN$SG$SG
240588101$24058810$1$I$$20240628$20240708$20240708$EXP$$US-VANTIVE-2024VAN018043$Vantive US Healthcare$$$$$M$Y$$$20240708$$HP$US$US
240588111$24058811$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5828944$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240588121$24058812$1$I$$20240630$20240708$20240708$EXP$$JP-ACS-20240228$ACS DOBFAR$Sakai Y, Karakawa S, Koutaki T, Higuchi K, Hashimoto A, Watanabe H. Concomitant Administration of Vancomycin with a High Dose of Meropenem May Cause Acute Kidney Injury. Case Rep Infect Dis. 2024 Jun 20;2024:7956014. doi: 10.1155/2024/7956014. PMID: 38939108; PMCID: PMC11211007.$65$YR$A$F$Y$58.3$KG$20240702$$HP$JP$
240588131$24058813$1$I$20210811$20240628$20240708$20240708$EXP$$DE-AUROBINDO-AUR-APL-2024-032249$AUROBINDO$$$$A$F$Y$90$KG$20240708$$MD$DE$DE
240588142$24058814$2$F$$20240724$20240708$20240731$PER$$US-HETERO-HET2024US02086$HETERO$$$$$M$Y$122.47$KG$20240731$$CN$US$US
240588151$24058815$1$I$$20240627$20240708$20240708$EXP$$US-Axsome Therapeutics, Inc.-AXS202406-000926$AXSOME THERAPEUTICS$$$$$$Y$$$20240708$$CN$US$
240588161$24058816$1$I$20240628$20240702$20240708$20240708$EXP$$NL-BIOGEN-2024BI01272210$BIOGEN$$58$YR$$M$Y$$$20240708$$HP$NL$NL
240588171$24058817$1$I$$20240625$20240708$20240708$PER$$US-RDY-SPO/USA/24/0009261$DR REDDYS$$$$$M$Y$$$20240708$$CN$US$US
240588181$24058818$1$I$$20240628$20240708$20240708$EXP$PL-URPL-DML-MLP.4401.2.1578.2022$PL-TEVA-VS-3215939$TEVA$$73$YR$$M$Y$68$KG$20240708$$CN$PL$PL
240588191$24058819$1$I$20240310$20240628$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032247$AUROBINDO$$31$YR$$F$Y$$$20240708$$PH$FR$FR
240588204$24058820$4$F$20240101$20240726$20240708$20240805$EXP$$BR-AMGEN-BRASP2024131105$AMGEN$$61$YR$A$F$Y$68$KG$20240805$$PH$BR$BR
240588212$24058821$2$F$20230101$20240814$20240708$20240822$EXP$$US-BIOGEN-2024BI01272347$BIOGEN$$$$$M$Y$$$20240822$$CN$US$US
240588222$24058822$2$F$$20240718$20240708$20240724$EXP$$US-BIOGEN-2022BI01174231$BIOGEN$$$$$F$Y$$$20240724$$CN$US$US
240588231$24058823$1$I$20240701$20240702$20240708$20240708$EXP$$TR-BIOGEN-2024BI01272386$BIOGEN$$$$$F$Y$$$20240708$$MD$TR$TR
240588251$24058825$1$I$$20240705$20240708$20240708$PER$$NVSC2024US140371$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
240588262$24058826$2$F$$20240710$20240708$20240723$EXP$$IE-AUROBINDO-AUR-APL-2023-003163$AUROBINDO$Creaney M, Moriarty R, Milner M, Murphy C. Dexmedetomidine, high-flow nasal oxygen and sugammadex-reversal of rocuronium: overcoming anaesthetic challenges in a parturient with congenital muscular dystrophy presenting for caesarean section. International Journal Of Obstetric Anesthesia.. 2018;34:108-12$$$$F$Y$1.5$KG$20240719$$HP$IE$IE
240588271$24058827$1$I$20240601$20240701$20240708$20240708$PER$$US-BAUSCHBL-2024BNL029462$BAUSCH AND LOMB$$84$YR$$F$Y$$$20240708$$CN$US$US
240588281$24058828$1$I$20240101$20240703$20240708$20240708$EXP$$US-JNJFOC-20240711076$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
240588291$24058829$1$I$$20240702$20240708$20240708$EXP$$ES-BAUSCHBL-2024BNL029495$BAUSCH AND LOMB$Rubio-Mora E, Rodriguez J, Carrascoso G. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection. Transplant Infectious Diseases. 2024;1-3. doi:10.1111/tid.14276$4$YR$$F$Y$$$20240708$$HP$ES$ES
240588301$24058830$1$I$$20240614$20240708$20240708$EXP$$CN-ROCHE-10000014452$ROCHE$Jin Y, Mingxi L, Jian Z. A case report of HER2-positive breast cancer with failed treatment of DS-8201 with post treatment with Initumumab. China Medicine and Pharmacy. 2024;14 (8):195-8.$47$YR$A$F$Y$$$20240708$$HP$CN$CN
240588311$24058831$1$I$$20240701$20240708$20240708$EXP$$US-HETERO-HET2024US02116$HETERO$Devault KF, Mudrakola HV. Hydralazine Induced Pleuropericarditis With Bilateral Eosinophilic Pleural Effusions. American Journal of Respiratory Critical Care Medicine. 2024;209:A2029$81$YR$$M$Y$$$20240708$$HP$US$US
240588322$24058832$2$F$20221101$20240806$20240708$20240812$EXP$$GB-TAKEDA-2023TUS008392$TAKEDA$$78$YR$$F$Y$$$20240812$$CN$GB$GB
240588331$24058833$1$I$$20240627$20240708$20240708$EXP$$US-NOVOPROD-1248110$NOVO NORDISK$$$$$M$Y$$$20240708$$CN$US$US
240588341$24058834$1$I$$20240627$20240708$20240708$EXP$$US-NOVOPROD-1247881$NOVO NORDISK$$$$$F$Y$$$20240708$$CN$US$US
240588351$24058835$1$I$$20240627$20240708$20240708$EXP$$US-NOVOPROD-1248111$NOVO NORDISK$$$$$F$Y$$$20240708$$CN$US$US
240588361$24058836$1$I$20240401$20240627$20240708$20240708$EXP$$US-NOVOPROD-1247908$NOVO NORDISK$$57$YR$$F$Y$$$20240708$$CN$US$US
240588371$24058837$1$I$$20240627$20240708$20240708$EXP$$US-NOVOPROD-1247852$NOVO NORDISK$$$$$M$Y$$$20240708$$CN$US$US
240588381$24058838$1$I$$20240627$20240708$20240708$EXP$GB-MHRA-MED-202406270436097120-KDVTM$GB-NOVOPROD-1247775$NOVO NORDISK$$$$$F$Y$$$20240708$$CN$GB$GB
240588391$24058839$1$I$$20240627$20240708$20240708$EXP$$US-NOVOPROD-1248288$NOVO NORDISK$$$$A$M$Y$$$20240708$$CN$US$US
240588402$24058840$2$F$$20240729$20240708$20240807$EXP$$US-NOVOPROD-1247914$NOVO NORDISK$$$$A$$Y$$$20240807$$MD$US$US
240588411$24058841$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133603$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240588422$24058842$2$F$20240703$20240826$20240708$20240828$PER$$US-AMGEN-USASP2024131962$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
240588431$24058843$1$I$$20240627$20240708$20240708$EXP$$US-NOVOPROD-1248048$NOVO NORDISK$$$$$F$Y$$$20240708$$MD$US$US
240588442$24058844$2$F$20240626$20240801$20240708$20240812$EXP$$JP-ROCHE-10000016650$ROCHE$$38$YR$A$F$Y$$$20240812$$MD$JP$JP
240588451$24058845$1$I$20240601$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107693$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240708$$HP$US$US
240588463$24058846$3$F$$20240712$20240708$20240725$EXP$$AU-INTERCEPT-PM2024001355$INTERCEPT PHARMACEUTICALS$$$$A$F$Y$$$20240725$$MD$AU$AU
240588471$24058847$1$I$$20240626$20240708$20240708$EXP$$GB-INTERCEPT-PM2024000291$INTERCEPT PHARMACEUTICALS$$$$A$F$Y$$$20240708$$CN$GB$GB
240588482$24058848$2$F$$20240711$20240708$20240721$EXP$$US-TEVA-VS-3214386$TEVA$Simmer P, Ghandi P, Gulati S. HOT AND BOTHERED: A RARE CASE OF DYSKINESIA HYPERPYREXIA SYNDROME. Crit-Care-Med 2024; 52 (1): S289 abstr. 632.; Simmer P, Ghandi P, Gulati S. HOT AND BOTHERED: A RARE CASE OF DYSKINESIA HYPERPYREXIA SYNDROME. Crit-Care-Med 2024; 52 (1): S289 abstr. 632.$53$YR$$F$Y$$$20240721$$HP$US$US
240588491$24058849$1$I$$20240628$20240708$20240708$EXP$PL-URPL-DML-MLP.4401.1.4896.2021$PL-TEVA-VS-3215877$TEVA$$72$YR$$F$Y$66$KG$20240708$$MD$PL$PL
240588501$24058850$1$I$20240422$20240701$20240708$20240708$EXP$ES-AEMPS-1537608$ES-LEO Pharma-371628$LEO PHARM$$43$YR$$F$Y$90$KG$20240708$$PH$ES$ES
240588511$24058851$1$I$$20240704$20240708$20240708$EXP$$DE-ABBVIE-5830396$ABBVIE$$$$$M$Y$$$20240708$$CN$DE$DE
240588521$24058852$1$I$$20240703$20240708$20240708$EXP$$CA-ABBVIE-5830964$ABBVIE$$$$$M$Y$$$20240708$$HP$CA$CA
240588531$24058853$1$I$$20240629$20240708$20240708$EXP$$CZ-AUROBINDO-AUR-APL-2024-032602$AUROBINDO$Repkov? Z. Terapeutick? menu v labyrinte depresie (Therapeutic menu in the labyrinth of depression). PSYCHIATRIA PRE PRAX (PSYCHIATRY FOR PRACTICE). 2024;25(2):68-71$85$YR$$F$Y$$$20240708$$HP$CZ$CZ
240588541$24058854$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004090$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240708$$CN$US$US
240588551$24058855$1$I$$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407003005$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240708$$CN$US$US
240588561$24058856$1$I$20240703$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004223$ELI LILLY AND CO$$87$YR$E$F$Y$$$20240708$$CN$US$US
240588572$24058857$2$F$$20240724$20240708$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202406018208$ELI LILLY AND CO$$$$E$F$Y$57.61$KG$20240726$$CN$US$US
240588581$24058858$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004214$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240708$$CN$US$US
240588592$24058859$2$F$20240425$20240731$20240708$20240805$30DAY$$US-AMGEN-USASP2024131996$AMGEN$$58$YR$A$F$Y$52$KG$20240805$$PH$US$US
240588601$24058860$1$I$20240701$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024132696$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240588611$24058861$1$I$$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134179$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240588621$24058862$1$I$20240101$20240702$20240708$20240708$EXP$$US-ABBVIE-5828917$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240588631$24058863$1$I$20230522$20240629$20240708$20240708$EXP$$IT-AUROBINDO-AUR-APL-2024-032546$AUROBINDO$$58$YR$$M$Y$$$20240708$$MD$IT$IT
240588642$24058864$2$F$$20240703$20240708$20240709$PER$$US-ABBVIE-5827513$ABBVIE$$$$$F$Y$65.77$KG$20240709$$CN$US$US
240588651$24058865$1$I$20140101$20240702$20240708$20240708$EXP$$RU-ORGANON-O2407RUS000581$ORGANON$$42$YR$$F$Y$66$KG$20240708$$MD$RU$RU
240588666$24058866$6$F$20240101$20240722$20240708$20240802$EXP$$ES-ABBVIE-5824490$ABBVIE$$$$$M$Y$$$20240802$$CN$ES$ES
240588671$24058867$1$I$$20240627$20240708$20240708$EXP$$JP-TAKEDA-2024TUS068287$TAKEDA$$41$YR$$F$Y$$$20240708$$MD$JP$JP
240588681$24058868$1$I$$20240701$20240708$20240708$EXP$$BR-TAKEDA-2024TUS036312$TAKEDA$$$$$F$Y$$$20240708$$CN$BR$BR
240588691$24058869$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06159$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240588701$24058870$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281412466070-YKBNQ$GB-TEVA-VS-3215920$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240588715$24058871$5$F$20240701$20240821$20240708$20240824$EXP$$US-AMGEN-USASP2024131763$AMGEN$$61$YR$A$F$Y$$$20240824$$CN$US$US
240588721$24058872$1$I$20240315$20240624$20240708$20240708$EXP$$FR-CIPLA LTD.-2024FR06815$CIPLA$$$$$$Y$$$20240708$$PH$FR$FR
240588734$24058873$4$F$20240627$20240730$20240708$20240802$PER$$US-AMGEN-USASP2024132000$AMGEN$$84$YR$E$F$Y$$$20240802$$CN$US$US
240588741$24058874$1$I$20240412$20240629$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032537$AUROBINDO$$85$YR$$F$Y$$$20240708$$PH$FR$FR
240588751$24058875$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281423022780-LSYQG$GB-TEVA-VS-3215936$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240588761$24058876$1$I$$20240702$20240708$20240708$EXP$$JP-SANDOZ INC.-SDZ2024JP062393$SANDOZ$$9$DEC$$M$Y$$$20240708$$MD$JP$JP
240588771$24058877$1$I$$20240705$20240708$20240708$EXP$$NL-SANDOZ INC.-SDZ2023NL016895$SANDOZ$Achten NB., Been JV.,  Schoenmakers S, Vermont CL., Verdijk RM., Reiss IKM., Taal HR. Fatal Early-onset Sepsis Caused by Intrauterine Transmission of Serogroup Y Meningococcus. Pediatr Infect Dis J. 2022;41:e517-e519$$$I$M$Y$1.587$KG$20240708$$HP$NL$NL
240588782$24058878$2$F$20240701$20240802$20240708$20240806$PER$$US-AMGEN-USASP2024131581$AMGEN$$57$YR$A$M$Y$$$20240805$$CN$US$US
240588791$24058879$1$I$20240323$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281053549520-RCDFK$GB-TEVA-VS-3215852$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240588801$24058880$1$I$$20240628$20240708$20240708$EXP$$GB-TEVA-VS-3215897$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240588811$24058881$1$I$20240322$20240624$20240708$20240708$EXP$$FR-CIPLA LTD.-2024FR06821$CIPLA$$$$$$Y$$$20240708$$PH$FR$FR
240588822$24058882$2$F$20240620$20240731$20240708$20240814$EXP$$IT-CIPLA LTD.-2024IT06797$CIPLA$$$$$$Y$$$20240814$$MD$IT$IT
240588831$24058883$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281443140430-YKFLG$GB-TEVA-VS-3215900$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240588843$24058884$3$F$20240624$20240715$20240708$20240722$EXP$$ES-EXELIXIS-CABO-24079130$EXELIXIS$$58$YR$$M$Y$88$KG$20240722$$MD$ES$ES
240588851$24058885$1$I$20240101$20240619$20240708$20240708$EXP$$US-UCBSA-2024031452$UCB$$$$$F$Y$$$20240708$$HP$US$US
240588861$24058886$1$I$$20240629$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032478$AUROBINDO$$$$$M$Y$$$20240708$$CN$GB$GB
240588881$24058888$1$I$20240201$20240628$20240708$20240708$EXP$SE-SEMPA-2024-001236$SE-TEVA-VS-3215686$TEVA$$49$YR$$F$Y$62$KG$20240708$$HP$SE$SE
240588891$24058889$1$I$20240101$20240703$20240708$20240708$EXP$$BR-UCBSA-2024034312$UCB$$$$$M$Y$$$20240708$$CN$BR$BR
240588901$24058890$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024134575$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240588911$24058891$1$I$$20240701$20240708$20240708$EXP$$US-AMAROX PHARMA-ASP2024US02131$ASPIRO PHARMA$Hossain S, Patten E, Anigbogu J. Daptomycin-induced Lung Injury. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2004$55$YR$$M$Y$$$20240708$$HP$US$US
240588921$24058892$1$I$20200101$20240702$20240708$20240708$PER$$US-ABBVIE-5829041$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240588931$24058893$1$I$$20240627$20240708$20240708$EXP$$JP-TAKEDA-2024TUS068210$TAKEDA$$73$YR$$M$Y$$$20240708$$MD$JP$JP
240588942$24058894$2$F$20240621$20240726$20240708$20240731$30DAY$$US-AMGEN-USASP2024130960$AMGEN$$32$YR$A$F$Y$1$KG$20240731$$PH$US$US
240588951$24058895$1$I$$20240326$20240708$20240708$PER$$US-AMGEN-USASP2024133763$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240588961$24058896$1$I$20240625$20240630$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010072$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240588972$24058897$2$F$$20240925$20240708$20240926$PER$$NVSC2024US139234$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
240588981$24058898$1$I$20240621$20240628$20240708$20240708$EXP$$CN-EMD Serono-2024035622$EMD SERONO INC$$66$YR$E$F$Y$67$KG$20240708$$HP$CN$CN
240588992$24058899$2$F$$20240712$20240708$20240722$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001062$AKEBIA THERAPEUTICS$$80$YR$$M$Y$$$20240722$$PH$JP$JP
240589001$24058900$1$I$20100415$20240702$20240708$20240708$EXP$$DE-HALEON-2185360$Haleon PLC$Arzneimittelkommission der deutschen Aerzteschaft. ^Aus der UAW-Datenbank^. Agranulozytose nach Metamizol - sehr selten, aber haeufiger als gedacht.. Dtsch Aerztebl 2011 Aug 19;108:33:A1758-A1759.$41$YR$$F$Y$72$KG$20240705$$MD$DE$DE
240589021$24058902$1$I$20240327$20240701$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010170$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240589033$24058903$3$F$20240701$20240729$20240708$20240803$PER$$US-AMGEN-USASP2024130900$AMGEN$$$$$$Y$$$20240803$$HP$US$US
240589041$24058904$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024130234$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240589051$24058905$1$I$20240601$20240701$20240708$20240708$PER$$US-AMGEN-USASP2024130649$AMGEN$$65$YR$E$F$Y$$$20240708$$CN$US$US
240589062$24058906$2$F$20240516$20240711$20240708$20240719$EXP$IT-MINISAL02-991763$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-06175$HIKMA$$$$$$Y$$$20240719$$MD$IT$IT
240589073$24058907$3$F$20240531$20240726$20240708$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-032578$AUROBINDO$$61$YR$$M$Y$74$KG$20240807$$PH$FR$FR
240589081$24058908$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06075$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240589091$24058909$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06149$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240589101$24058910$1$I$20170101$20240702$20240708$20240708$EXP$$PL-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00366$VELOXIS PHARMACEUTICALS$Storoniak H, Debska-Slizien A.. Miliary tuberculosis as postmortem diagnosis in solid organ transplant recipient: Case report and review of the literature. Transplantation proceedings. 2024;56(4):968-71$70$YR$$M$Y$$$20240708$$MD$PL$PL
240589111$24058911$1$I$$20240704$20240708$20240708$EXP$$GB-SANDOZ INC.-SDZ2024GB063142$SANDOZ$$$$$M$Y$$$20240708$$CN$GB$GB
240589121$24058912$1$I$$20240626$20240708$20240708$EXP$$CA-HALEON-2183913$Haleon PLC$$42$YR$$M$Y$$$20240705$$MD$CA$CA
240589131$24058913$1$I$$20240629$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032499$AUROBINDO$$1$MON$$F$Y$2.36$KG$20240708$$MD$FR$FR
240589141$24058914$1$I$$20240701$20240708$20240708$EXP$$US-HETERO-HET2024US02138$HETERO$Peters JD, Shastri D, Hajjar S, York J, Erpenwar S, Vanlandingham A.. A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2021$85$YR$$F$Y$$$20240708$$HP$US$US
240589152$24058915$2$F$$20240802$20240708$20240802$PER$$US-AstraZeneca-2024A148888$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
240589161$24058916$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06188$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240589171$24058917$1$I$$20240702$20240708$20240708$EXP$$JP-GSK-JP2024081994$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$PH$JP$JP
240589181$24058918$1$I$20240622$20240701$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010172$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240589191$24058919$1$I$$20240628$20240708$20240708$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP007953$STRIDES$Kumar S, Memon SS, Lila AR, Sarathi V, Sehemby M, Karlekar M, et al.. Giant prolactinoma in Asian-Indians: A single-center experience from Western India.. Ann-Endocrinol-(Paris). 2023;84 (6):711-718$$$$F$Y$$$20240708$$HP$IN$IN
240589201$24058920$1$I$$20240626$20240708$20240708$EXP$$CA-HALEON-2183915$Haleon PLC$$64$YR$$M$Y$$$20240705$$MD$CA$CA
240589211$24058921$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214828$TEVA$$$$A$$Y$$$20240708$$MD$CA$CA
240589221$24058922$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214933$TEVA$$$$$M$Y$$$20240708$$MD$CA$CA
240589231$24058923$1$I$$20240628$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407000594$ELI LILLY AND CO$$$$$F$Y$$$20240708$$CN$US$US
240589241$24058924$1$I$20240330$20240515$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2024-016989$AUROBINDO$$60$YR$$F$Y$70.306$KG$20240708$$CN$US$US
240589251$24058925$1$I$$20240630$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032570$AUROBINDO$$$$$F$Y$$$20240708$$PH$GB$GB
240589261$24058926$1$I$20240704$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004126$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240708$$CN$US$US
240589281$24058928$1$I$20240501$20240630$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032606$AUROBINDO$$41$YR$$F$Y$65$KG$20240708$$CN$GB$GB
240589291$24058929$1$I$$20240703$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106460$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240708$$HP$US$US
240589301$24058930$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214877$TEVA$$43$YR$$M$Y$$$20240708$$CN$CA$CA
240589311$24058931$1$I$$20240628$20240708$20240708$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP007956$STRIDES$Gao Q, Luo H.. Successful diagnosis of asymptomatic choriocarcinoma by ultrasonography during a viable pregnancy: A rare case report.. Medicine. 2024;103 (9)$$$$F$Y$$$20240708$$MD$CN$CN
240589321$24058932$1$I$$20240628$20240708$20240708$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP007965$STRIDES$Gao Q, Luo H.. Successful diagnosis of asymptomatic choriocarcinoma by ultrasonography during a viable pregnancy: A rare case report.. Medicine. 2024;103 (9)$$$$M$Y$$$20240708$$MD$CN$CN
240589331$24058933$1$I$$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134419$AMGEN$$67$YR$E$F$Y$$$20240708$$CN$US$US
240589342$24058934$2$F$20240630$20240723$20240708$20240726$PER$$US-AMGEN-USASP2024133586$AMGEN$$82$YR$E$F$Y$$$20240726$$MD$US$US
240589351$24058935$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129780$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240589361$24058936$1$I$$20240627$20240708$20240708$PER$$US-Kindeva Drug Delivery L.P.-2158901$KINDEVA DRUG DELIVERY$$81$YR$$M$Y$$$20240708$$MD$US$US
240589371$24058937$1$I$$20240419$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2024-017881$AUROBINDO$$58$YR$$F$Y$$$20240708$$CN$US$US
240589382$24058938$2$F$20240601$20240827$20240708$20240830$EXP$$JP-ABBVIE-5828214$ABBVIE$$20$YR$$M$Y$$$20240830$$MD$JP$JP
240589393$24058939$3$F$20240607$20240830$20240708$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002847$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240924$$CN$US$US
240589401$24058940$1$I$$20240702$20240708$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010248$JAZZ$$$$$M$Y$$$20240708$$MD$US$US
240589411$24058941$1$I$20240627$20240630$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032600$AUROBINDO$$20$YR$$M$Y$96$KG$20240708$$CN$GB$GB
240589421$24058942$1$I$$20240626$20240708$20240708$EXP$$US-ENDO USA, INC.-2024-002805$ENDO$$$$$F$Y$$$20240708$$CN$US$US
240589431$24058943$1$I$$20240510$20240708$20240708$PER$$US-AUROBINDO-AUR-APL-2024-024329$AUROBINDO$$44$YR$$F$Y$55.338$KG$20240708$$HP$US$US
240589441$24058944$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129884$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240589451$24058945$1$I$$20240701$20240708$20240708$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP007974$STRIDES$Fu J, Chen L, Su T, Xu S, Liu Y.. Mild phenotypes of phosphoglycerate dehydrogenase deficiency by a novel mutation of PHGDH gene: Case report and literature review.. Int-J-Dev-Neurosci. 2023;83 (1):44-52$14$YR$$M$Y$$$20240708$$HP$CN$CN
240589461$24058946$1$I$20240611$20240629$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032617$AUROBINDO$$73$YR$$M$Y$$$20240708$$MD$FR$FR
240589471$24058947$1$I$$20240624$20240708$20240708$EXP$$TR-ROCHE-10000015802$ROCHE$Durmaz Engin C, Saatci AO. Macular oedema exacerbation and bacillary layer detachment following the scatter laser photocoagulation in a patient with proliferative diabetic retinopathy.. CLINICAL AND EXPERIMENTAL OPTOMETRY. 2024;107 (4):465-8. doi:10.1080/08164622.2023.2188175$49$YR$A$M$Y$$$20240708$$HP$TR$TR
240589481$24058948$1$I$20230818$20240629$20240708$20240708$EXP$$DE-AUROBINDO-AUR-APL-2024-032754$AUROBINDO$$34$YR$$F$Y$68$KG$20240708$$CN$DE$DE
240589496$24058949$6$F$20240610$20240905$20240708$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002760$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240916$$CN$US$US
240589501$24058950$1$I$$20240702$20240708$20240708$PER$$US-AMGEN-USASP2024131547$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240589511$24058951$1$I$20240630$20240704$20240708$20240708$EXP$$CN-ROCHE-10000017156$ROCHE$$41$YR$A$F$Y$70$KG$20240708$$HP$CN$CN
240589521$24058952$1$I$$20240702$20240708$20240708$PER$$US-LEO Pharma-371737$LEO PHARM$$57$YR$$M$Y$$$20240708$$PH$US$US
240589531$24058953$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06306$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240589541$24058954$1$I$$20240628$20240708$20240708$EXP$$IT-GILEAD-2024-0679010$GILEAD$Bajardi E. Use of Sacituzumab Govitecan in a Frail Patient with Skin Disease. Medical Oncology Unit Clinica La Maddalena. 2024;unk:unk. doi:UNK$53$YR$A$F$Y$$$20240708$$MD$IT$IT
240589551$24058955$1$I$$20240704$20240708$20240708$PER$$US-ABBVIE-5830262$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240589561$24058956$1$I$20240617$20240630$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010073$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240589571$24058957$1$I$20240624$20240703$20240708$20240708$EXP$GB-MHRA-TPP20250639C9122355YC1719302864556$GB-STRIDES ARCOLAB LIMITED-2024SP007950$STRIDES$$63$YR$$F$Y$57$KG$20240708$$PH$GB$GB
240589581$24058958$1$I$$20240702$20240708$20240708$PER$$US-PCCINC-2024-PPL-000505$PIRAMAL$$$$$$Y$$$20240708$$HP$US$US
240589591$24058959$1$I$20240628$20240628$20240708$20240708$PER$$US-ABBVIE-5821948$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240589611$24058961$1$I$$20240625$20240708$20240708$EXP$$US-ROCHE-10000012667$ROCHE$$71$YR$E$M$Y$$$20240708$$HP$US$US
240589621$24058962$1$I$$20240702$20240708$20240708$EXP$$US-HALEON-2185279$Haleon PLC$$56$YR$$F$Y$$$20240705$$CN$US$US
240589632$24058963$2$F$$20240711$20240708$20240721$EXP$$US-TEVA-VS-3213877$TEVA$Riaz T, Collins M, Enzler M, Rizzo M, Schuetz AN, Lehman JS, et al. Left hand extensor tenosynovitis due to Histoplasma capsulatum complicated by immune reconstitution inflammatory syndrome. J-Bone-Joint-Infect 2021; 6 (8): 355-361.; Riaz T, Collins M, Enzler M, Rizzo M, Schuetz AN, Lehman JS, et al. Left hand extensor tenosynovitis due to Histoplasma capsulatum complicated by immune reconstitution inflammatory syndrome. J-Bone-Joint-Infect 2021; 6 (8): 355-361.$46$YR$$F$Y$$$20240721$$HP$US$US
240589641$24058964$1$I$$20240703$20240708$20240708$EXP$$US-GILEAD-2024-0679727$GILEAD$$$$A$M$Y$$$20240708$$HP$US$US
240589651$24058965$1$I$$20240624$20240708$20240708$PER$$US-QUAGEN-2024QUASPO00200$QUAGEN PHARMACEUTICALS$$19$YR$A$F$Y$$$20240708$$CN$US$US
240589661$24058966$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MIDB-486312bc-5e46-422f-a350-7fa5252217c3$GB-TEVA-VS-3215869$TEVA$$30$YR$$M$Y$$$20240708$$HP$GB$GB
240589672$24058967$2$F$$20240719$20240708$20240723$EXP$$JP-GILEAD-2024-0679645$GILEAD$$$$E$M$Y$$$20240723$$PH$JP$JP
240589681$24058968$1$I$20230101$20240629$20240708$20240708$EXP$$IT-AUROBINDO-AUR-APL-2024-032486$AUROBINDO$$48$YR$$M$Y$94$KG$20240708$$MD$IT$IT
240589691$24058969$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107752$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240708$$CN$US$US
240589701$24058970$1$I$$20240702$20240708$20240708$PER$$US-PCCINC-2024-PPL-000506$PIRAMAL$$$$$$Y$$$20240708$$HP$US$US
240589712$24058971$2$F$$20240802$20240708$20240805$EXP$GB-MHRA-MED-202405162318157690-FNGQT$GB-ORGANON-O2407GBR000666$ORGANON$$$$$M$Y$$$20240805$$CN$GB$GB
240589723$24058972$3$F$$20240725$20240708$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06249$LUPIN$$$$$$Y$$$20240813$$CN$US$US
240589731$24058973$1$I$20240601$20240701$20240708$20240708$EXP$$US-SA-2024SA197831$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240708$$MD$US$US
240589741$24058974$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129927$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240589751$24058975$1$I$$20240701$20240708$20240708$EXP$$US-HETERO-HET2024US02133$HETERO$Goldberg E, Syed A, Desai S, Franco R, Ali Z.. Diffuse Alveolar Hemorrhage Secondary to Hydralazine-induced Vasculitis Causing Pulmonary-renal Syndrome. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2007$80$YR$$F$Y$$$20240708$$HP$US$US
240589761$24058976$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129915$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240589771$24058977$1$I$20240619$20240625$20240708$20240708$EXP$$CN-HALEON-2183857$Haleon PLC$$41$YR$$M$Y$$$20240708$$HP$CN$CN
240589781$24058978$1$I$20240620$20240703$20240708$20240708$EXP$$US-ABBVIE-5829077$ABBVIE$$64$YR$$F$Y$$$20240708$$CN$US$US
240589791$24058979$1$I$20240701$20240701$20240708$20240708$EXP$$JP-SA-2024SA192290$SANOFI AVENTIS$$$$$M$Y$$$20240708$$CN$JP$JP
240589801$24058980$1$I$20240612$20240701$20240708$20240708$EXP$FR-AFSSAPS-NY2024000697$FR-SA-2024SA197030$SANOFI AVENTIS$$9$YR$C$M$Y$35$KG$20240708$$CN$FR$FR
240589811$24058981$1$I$$20240701$20240708$20240708$EXP$$US-SA-2024SA195880$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240708$$MD$US$US
240589821$24058982$1$I$20240520$20240702$20240708$20240708$EXP$$AU-TAKEDA-2024TUS056514$TAKEDA$$52$YR$$F$Y$$$20240708$$CN$AU$AU
240589831$24058983$1$I$$20240702$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009497$DR REDDYS$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocritical Care. 2024;40: 976-983. doi:https://dx.doi.org/10.1007/s12028-023-01853-8.$58$YR$A$M$Y$71$KG$20240708$$HP$US$US
240589841$24058984$1$I$$20240701$20240708$20240708$EXP$$SK-SA-2024SA196830$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$SK$SK
240589853$24058985$3$F$$20240725$20240708$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002784$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
240589861$24058986$1$I$$20240705$20240708$20240708$PER$$NVSC2024US140453$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
240589871$24058987$1$I$$20240703$20240708$20240708$EXP$$US-AstraZeneca-2024A153228$ASTRAZENECA$$$$$M$Y$$$20240708$$HP$US$
240589882$24058988$2$F$$20240826$20240708$20240904$PER$$US-AstraZeneca-2024A150731$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
240589891$24058989$1$I$$20240703$20240708$20240708$EXP$$US-AstraZeneca-2024A153234$ASTRAZENECA$$$$$M$Y$$$20240708$$MD$US$
240589901$24058990$1$I$20230609$20240629$20240708$20240708$EXP$$ES-AUROBINDO-AUR-APL-2024-032541$AUROBINDO$$72$YR$$F$Y$58$KG$20240708$$MD$ES$ES
240589911$24058991$1$I$$20240611$20240708$20240708$PER$$US-ALK-ABELLO A/S-2024AA002095$ALK-ABELLO$$$$$$Y$$$20240708$$CN$US$US
240589921$24058992$1$I$$20240611$20240708$20240708$PER$$US-ALK-ABELLO A/S-2024AA002511$ALK-ABELLO$$$$$$Y$$$20240708$$CN$US$US
240589931$24058993$1$I$20240603$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010018$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240589941$24058994$1$I$20240202$20240629$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010094$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240589951$24058995$1$I$$20240614$20240708$20240708$PER$$US-ALK-ABELLO A/S-2024AA002074$ALK-ABELLO$$$$$$Y$$$20240708$$HP$US$US
240589961$24058996$1$I$$20240614$20240708$20240708$PER$$US-ALK-ABELLO A/S-2024AA002073$ALK-ABELLO$$$$$$Y$$$20240708$$HP$US$US
240589971$24058997$1$I$20240402$20240614$20240708$20240708$PER$$US-ALK-ABELLO A/S-2024AA002076$ALK-ABELLO$$$$$$Y$$$20240708$$HP$US$US
240589982$24058998$2$F$20171101$20240708$20240708$20240715$EXP$$US-TAKEDA-2018TUS005175$TAKEDA$$59$YR$$M$Y$$$20240715$$CN$US$US
240589993$24058999$3$F$20240619$20240904$20240708$20240916$EXP$$DE-AUROBINDO-AUR-APL-2024-032771$AUROBINDO$$81$YR$$F$Y$70$KG$20240916$$MD$DE$DE
240590001$24059000$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129833$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240590011$24059001$1$I$20240621$20240703$20240708$20240708$PER$$US-ABBVIE-5829473$ABBVIE$$21$YR$$F$Y$$$20240708$$MD$US$US
240590022$24059002$2$F$$20240702$20240708$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107658$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240708$$MD$JP$JP
240590032$24059003$2$F$$20240718$20240708$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107932$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$77.56$KG$20240722$$CN$US$US
240590041$24059004$1$I$20240514$20240701$20240708$20240708$EXP$$AR-JNJFOC-20240542975$JOHNSON AND JOHNSON$$70$YR$E$M$Y$99$KG$20240708$$$COUNTRY NOT SPECIFIED$AR
240590051$24059005$1$I$$20240701$20240708$20240708$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001347$BLUEPRINT MEDICINES$$$$$F$Y$$$20240708$$CN$US$US
240590062$24059006$2$F$$20240703$20240708$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106684$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240712$$PH$US$US
240590073$24059007$3$F$$20240820$20240708$20240827$EXP$$CA-SANDOZ INC.-SDZ2024CA041363$SANDOZ$$$$$M$Y$$$20240827$$MD$CA$CA
240590082$24059008$2$F$$20240711$20240708$20240717$30DAY$$GB-SANDOZ INC.-NVSC2021GB106843$SANDOZ$$$$$F$Y$$$20240717$$CN$GB$GB
240590091$24059009$1$I$20240622$20240628$20240708$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003064$ACADIA PHARMACEUTICALS$$56$YR$$F$Y$$$20240708$$CN$US$US
240590101$24059010$1$I$20240601$20240630$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032572$AUROBINDO$$39$YR$$F$Y$82$KG$20240708$$CN$GB$GB
240590111$24059011$1$I$$20240628$20240708$20240708$PER$$US-BAUSCHBL-2024BNL029376$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240708$$CN$US$US
240590121$24059012$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129940$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240590131$24059013$1$I$$20240623$20240708$20240708$EXP$$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JUB00055$JUBILANT$Sakurazawa C, Habuka M, Hoshino Y, Sakamaki Y, Ogawa A, Yamamoto S, et.al. A case of multiorgan failure due to carbamazepine intoxication successfully treated with multimodal blood purification therapy.. Clinical and Experimental Nephrology Case Rep.. 2024$47$YR$$F$Y$$$20240708$$HP$JP$JP
240590141$24059014$1$I$20240120$20240630$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032573$AUROBINDO$$30$YR$$F$Y$97$KG$20240708$$HP$GB$GB
240590151$24059015$1$I$$20240702$20240708$20240708$EXP$$US-TAKEDA-2023TUS101623$TAKEDA$$$$$M$Y$29$KG$20240708$$HP$US$US
240590161$24059016$1$I$$20240626$20240708$20240708$PER$$US-BAUSCHBL-2024BNL029588$BAUSCH AND LOMB$$$$$F$Y$$$20240708$$CN$US$US
240590171$24059017$1$I$$20240702$20240708$20240708$PER$$US-BAUSCHBL-2024BNL029681$BAUSCH AND LOMB$$$$$F$Y$$$20240708$$CN$US$US
240590181$24059018$1$I$$20240626$20240708$20240708$PER$$US-BAUSCHBL-2024BNL029577$BAUSCH AND LOMB$$$$$F$Y$$$20240708$$CN$US$US
240590191$24059019$1$I$20240704$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107869$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240708$$CN$US$US
240590202$24059020$2$F$$20240805$20240708$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106903$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240808$$CN$US$US
240590211$24059021$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5740400$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240590222$24059022$2$F$$20240716$20240708$20240717$EXP$GB-MHRA-MED-202405101401069270-STKMW$GB-SANDOZ INC.-SDZ2024GB063061$SANDOZ$$$$$$Y$$$20240717$$MD$GB$GB
240590231$24059023$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281440345420-HKJBF$GB-TEVA-VS-3215615$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240590242$24059024$2$F$20240611$20240905$20240708$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002809$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240916$$CN$US$US
240590251$24059025$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129759$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240590261$24059026$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129848$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240590272$24059027$2$F$$20240729$20240708$20240805$PER$$US-ABBVIE-5825702$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
240590282$24059028$2$F$$20240705$20240708$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002843$ACADIA PHARMACEUTICALS$$$$$F$Y$77$KG$20240729$$CN$US$US
240590291$24059029$1$I$20240620$20240703$20240708$20240708$EXP$$CN-GILEAD-2024-0679597$GILEAD$$27$YR$A$M$Y$80$KG$20240708$$HP$CN$CN
240590301$24059030$1$I$$20240705$20240708$20240708$PER$$NVSC2024US140461$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
240590311$24059031$1$I$$20240705$20240708$20240708$EXP$$US-SANDOZ INC.-SDZ2024US063297$SANDOZ$$$$$F$Y$$$20240708$$CN$US$US
240590322$24059032$2$F$20220708$20240826$20240708$20240902$EXP$$NVSC2022KR192592$NOVARTIS$$47$YR$$F$Y$$$20240902$$MD$KR$KR
240590331$24059033$1$I$20190620$20240704$20240708$20240708$EXP$$GB-SANDOZ INC.-PHHY2019GB157729$SANDOZ$$19$YR$$F$Y$$$20240708$$HP$GB$GB
240590341$24059034$1$I$20240401$20240705$20240708$20240708$30DAY$$US-SANDOZ INC.-SDZ2024US063301$SANDOZ$$61$YR$$M$Y$$$20240708$$HP$US$US
240590351$24059035$1$I$$20240701$20240708$20240708$EXP$$IN-VANTIVE-2024VAN018100$Vantive US Healthcare$$59$YR$$M$Y$$$20240708$$CN$IN$IN
240590361$24059036$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024129770$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240590371$24059037$1$I$20240515$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281019467880-WQTRJ$GB-TEVA-VS-3215643$TEVA$$59$YR$$M$Y$104$KG$20240708$$PH$GB$GB
240590382$24059038$2$F$$20240705$20240708$20240709$EXP$$CA-SANDOZ INC.-SDZ2023CA000171$SANDOZ$$$$$F$Y$$$20240709$$CN$CA$CA
240590391$24059039$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281457303540-MZPCV$GB-TEVA-VS-3215627$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240590401$24059040$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405011700175730-BMCHD$GB-ORGANON-O2407GBR000552$ORGANON$$6$YR$$F$Y$$$20240708$$CN$GB$GB
240590415$24059041$5$F$20240702$20240801$20240708$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-019586$UNITED THERAPEUTICS$$44$YR$$M$Y$131.52$KG$20240806$$$US$US
240590421$24059042$1$I$$20240705$20240708$20240708$EXP$$NVSC2024NI139962$NOVARTIS$$$$$F$Y$$$20240708$$CN$NI$NI
240590434$24059043$4$F$$20240919$20240708$20240923$EXP$$JP-EXELIXIS-CABO-24079168$EXELIXIS$$7$DEC$$M$Y$$$20240923$$MD$JP$JP
240590441$24059044$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5828617$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240590451$24059045$1$I$$20240703$20240708$20240708$EXP$$CA-ABBVIE-5829908$ABBVIE$$$$A$F$Y$$$20240708$$CN$CA$CA
240590461$24059046$1$I$20100201$20240702$20240708$20240708$EXP$$CH-ABBVIE-5827900$ABBVIE$$61$YR$$F$Y$$$20240708$$MD$CH$CH
240590473$24059047$3$F$20240514$20240912$20240708$20240919$EXP$$JP-ROCHE-10000013557$ROCHE$$84$YR$E$F$Y$44$KG$20240919$$MD$JP$JP
240590481$24059048$1$I$20240501$20240628$20240708$20240708$30DAY$$US-GSK-US2024081055$GLAXOSMITHKLINE$$68$YR$$M$Y$$$20240708$$CN$US$US
240590491$24059049$1$I$$20240702$20240708$20240708$PER$$US-ABBVIE-5830536$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240590501$24059050$1$I$$20240613$20240708$20240708$EXP$$CA-HALEON-2183611$Haleon PLC$$$$$F$Y$$$20240708$$MD$CA$CA
240590511$24059051$1$I$$20240704$20240708$20240708$EXP$$DE-GILEAD-2024-0679637$GILEAD$$$$$M$Y$$$20240708$$MD$DE$DE
240590522$24059052$2$F$20240520$20240805$20240708$20240813$EXP$$US-EMD Serono-2024029806$EMD SERONO INC$$53$YR$A$F$Y$$$20240813$$CN$US$US
240590531$24059053$1$I$20240614$20240628$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010102$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240590541$24059054$1$I$20240601$20240703$20240708$20240708$EXP$$US-UCBSA-2024034265$UCB$$41$YR$$F$Y$$$20240708$$HP$US$US
240590551$24059055$1$I$$20240628$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032468$AUROBINDO$Leleu X, Hulin C, Lambert J, Bobin A, Perrot A, Karlin L, et al.. Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.. Nature Medicine. 2024$$$E$$Y$$$20240708$$MD$FR$FR
240590561$24059056$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024130223$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240590571$24059057$1$I$20240622$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024132842$AMGEN$$82$YR$E$M$Y$$$20240708$$CN$US$US
240590582$24059058$2$F$$20240703$20240708$20240712$PER$$US-AMGEN-USASP2024132688$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240590591$24059059$1$I$20240620$20240629$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032693$AUROBINDO$$87$YR$$F$Y$72$KG$20240708$$MD$FR$FR
240590601$24059060$1$I$$20240625$20240708$20240708$EXP$$CA-ROCHE-10000012492$ROCHE$$57$YR$A$F$Y$$$20240708$$HP$CA$CA
240590611$24059061$1$I$$20240628$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032415$AUROBINDO$$$$$$Y$$$20240708$$CN$GB$GB
240590623$24059062$3$F$$20240711$20240708$20240905$EXP$$US-TEVA-VS-3214522$TEVA$Chan E, Ngo TT, Liang L, Ling J, Horng GS. The Imitation Game: Concurrent Tuberculous Myositis in a Dermatomyositis Patient. Am-J-Respir-Crit-Care-Med 2024; 209 A7415 (plus Poster).; Chan E, Ngo TT, Liang L, Ling J, Horng GS. The Imitation Game: Concurrent Tuberculous Myositis in a Dermatomyositis Patient. Am-J-Respir-Crit-Care-Med 2024; 209 A7415 (plus Poster).$82$YR$$F$Y$$$20240905$$HP$US$US
240590631$24059063$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004195$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240708$$CN$US$US
240590641$24059064$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004129$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240708$$CN$US$US
240590651$24059065$1$I$20240528$20240703$20240708$20240708$EXP$$CA-JNJFOC-20240570203$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240708$$$COUNTRY NOT SPECIFIED$CA
240590662$24059066$2$F$20240101$20240827$20240708$20240902$EXP$$NVSC2024DE139896$NOVARTIS$$$$A$F$Y$$$20240902$$MD$DE$DE
240590672$24059067$2$F$20240501$20240722$20240708$20240729$30DAY$$US-AMGEN-USASP2024129737$AMGEN$$58$YR$A$F$Y$87.1$KG$20240729$$HP$US$US
240590683$24059068$3$F$20240627$20240802$20240708$20240806$PER$$US-AMGEN-USASP2024132675$AMGEN$$52$YR$A$F$Y$$$20240806$$MD$US$US
240590692$24059069$2$F$20240520$20240723$20240708$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001879$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240816$$CN$US$US
240590701$24059070$1$I$$20240629$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032539$AUROBINDO$$28$YR$$M$Y$$$20240708$$HP$FR$FR
240590712$24059071$2$F$20240301$20240708$20240708$20240717$EXP$$KR-CELLTRION INC.-2024KR016300$CELLTRION$$$$$$Y$$$20240717$$HP$KR$KR
240590721$24059072$1$I$20240219$20240629$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032512$AUROBINDO$$21$YR$$F$Y$$$20240708$$PH$FR$FR
240590731$24059073$1$I$$20240703$20240708$20240708$EXP$$US-AstraZeneca-2024A153529$ASTRAZENECA$$$$$M$Y$$$20240708$$MD$US$
240590742$24059074$2$F$$20240808$20240708$20240816$EXP$$US-GSK-US2024AMR082460$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
240590751$24059075$1$I$20240517$20240629$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032514$AUROBINDO$$89$YR$$F$Y$77.8$KG$20240708$$MD$FR$FR
240590761$24059076$1$I$$20240704$20240708$20240708$EXP$$JP-GSK-JP2024084116$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$JP$JP
240590771$24059077$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107771$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240708$$CN$US$US
240590782$24059078$2$F$$20240625$20240708$20240712$EXP$$CA-HALEON-2183376$Haleon PLC$$59$YR$$F$Y$68$KG$20240711$$HP$CA$CA
240590791$24059079$1$I$$20240629$20240708$20240708$EXP$$NL-AUROBINDO-AUR-APL-2024-032494$AUROBINDO$Boer M, de Voogd M, Niemeijer ND, van Hoeven L.. Tetanus? a case report highlighting the challenges in diagnosis and treatment. Tropical Diseases. Travel Medicine and Vaccines.. 2024;10 (1)$8$YR$$F$Y$$$20240708$$HP$NL$NL
240590801$24059080$1$I$20240624$20240624$20240708$20240708$EXP$$IE-ROCHE-10000013430$ROCHE$$$$$M$Y$$$20240708$$CN$IE$IE
240590811$24059081$1$I$20240515$20240629$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032515$AUROBINDO$$58$YR$$M$Y$60$KG$20240708$$PH$FR$FR
240590821$24059082$1$I$20230101$20240701$20240708$20240708$EXP$$RO-RDY-LIT/ROU/24/0009688$DR REDDYS$Spatar M, R?du?iu D, Matei P, Muntean L. DIFFUSE ALVEOLAR HEMORRHAGE AS A RECURRENT MANIFESTATION OFPANCAPOSITIVE MICROSCOPIC POLYANGIITIS: LONG-TERM PROGNOSIS ANDEFFECTS ON DISEASE MANAGEMENT. Acta Medica Marisiensis. 70(3): 283.$63$YR$A$F$Y$$$20240708$$HP$RO$RO
240590831$24059083$1$I$20240701$20240703$20240708$20240708$EXP$$US-ABBVIE-5828552$ABBVIE$$41$YR$$M$Y$$$20240708$$CN$US$US
240590841$24059084$1$I$$20240624$20240708$20240708$EXP$$CA-HALEON-2184185$Haleon PLC$$$$$F$Y$$$20240708$$HP$CA$CA
240590851$24059085$1$I$$20240702$20240708$20240708$EXP$$US-ABBVIE-5828581$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240590861$24059086$1$I$$20240701$20240708$20240708$EXP$$US-TAKEDA-2024TUS066886$TAKEDA$$$$$M$Y$$$20240708$$CN$US$US
240590871$24059087$1$I$$20230818$20240708$20240708$EXP$$US-ABBVIE-5829686$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240590881$24059088$1$I$$20240701$20240708$20240708$EXP$$CA-HALEON-2185001$Haleon PLC$$44$YR$$F$Y$70$KG$20240708$$HP$CA$CA
240590892$24059089$2$F$20240617$20240619$20240708$20240709$EXP$$ES-ROCHE-10000007438$ROCHE$$61$YR$A$F$Y$$$20240703$$MD$ES$ES
240590902$24059090$2$F$$20240627$20240708$20240709$EXP$$US-ROCHE-10000015472$ROCHE$$$$$F$Y$$$20240708$$MD$US$US
240590911$24059091$1$I$$20240626$20240708$20240708$EXP$$IR-MSNLABS-2024MSNLIT01459$MSN LABORATORIES$$$$$$Y$$$20240708$$HP$IR$IR
240590921$24059092$1$I$20240501$20240629$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032536$AUROBINDO$$79$YR$$M$Y$$$20240708$$PH$FR$FR
240590931$24059093$1$I$20240625$20240708$20240708$20240708$EXP$ES-AEMPS-1544611$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038304$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$89$KG$20240708$$MD$ES$ES
240590942$24059094$2$F$$20240814$20240708$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06191$LUPIN$$$$$$Y$$$20240901$$CN$US$US
240590951$24059095$1$I$20240418$20240629$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-033004$AUROBINDO$$86$YR$$F$Y$$$20240708$$PH$FR$FR
240590961$24059096$1$I$20240626$20240702$20240708$20240708$EXP$$US-TAKEDA-2024TUS067543$TAKEDA$$36$YR$$M$Y$$$20240708$$MD$US$US
240590972$24059097$2$F$20130224$20240705$20240708$20240807$EXP$$DE-JNJFOC-20130509508$Haleon PLC$$30$YR$$M$Y$70$KG$20240807$$MD$DE$DE
240590981$24059098$1$I$20240602$20240628$20240708$20240708$EXP$$PT-AUROBINDO-AUR-APL-2024-032397$AUROBINDO$$74$YR$$M$Y$$$20240708$$MD$PT$PT
240590991$24059099$1$I$20230101$20240702$20240708$20240708$EXP$$US-ABBVIE-5822387$ABBVIE$$$$$M$Y$99.8$KG$20240708$$CN$US$US
240591001$24059100$1$I$20240625$20240703$20240708$20240708$EXP$$DE-ABBVIE-5830022$ABBVIE$$80$YR$$M$Y$$$20240708$$CN$DE$DE
240591011$24059101$1$I$$20240702$20240708$20240708$PER$$US-LEO Pharma-371733$LEO PHARM$$64$YR$$M$Y$$$20240708$$CN$US$US
240591021$24059102$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194291$SANOFI AVENTIS$$$$E$M$Y$$$20240708$$MD$US$US
240591031$24059103$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA197343$SANOFI AVENTIS$$$$T$M$Y$$$20240708$$MD$US$US
240591042$24059104$2$F$20240627$20240725$20240708$20240801$PER$$US-SA-2024SA194107$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240801$$CN$US$US
240591051$24059105$1$I$20240101$20240628$20240708$20240708$PER$$US-SA-2024SA196052$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240708$$MD$US$US
240591061$24059106$1$I$20240501$20240627$20240708$20240708$PER$$US-SA-2024SA194349$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240708$$MD$US$US
240591071$24059107$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA192884$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240591081$24059108$1$I$$20240629$20240708$20240708$PER$$US-SA-2024SA194511$SANOFI AVENTIS$$$$E$M$Y$$$20240708$$MD$US$US
240591091$24059109$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA194230$SANOFI AVENTIS$$11$YR$C$M$Y$40.36$KG$20240708$$CN$US$US
240591101$24059110$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA198213$SANOFI AVENTIS$$$$C$$Y$$$20240708$$CN$US$US
240591111$24059111$1$I$20240601$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107822$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240708$$HP$US$US
240591121$24059112$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107797$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$57.61$KG$20240708$$CN$US$US
240591131$24059113$1$I$$20240630$20240708$20240708$EXP$GB-MHRA-MED-202406302141532850-LTFKC$GB-BAXTER-2024BAX020867$BAXTER$$$$$F$Y$$$20240708$$PH$GB$GB
240591141$24059114$1$I$20240620$20240627$20240708$20240708$EXP$CN-NMPACDR-4301011002666202400359$CN-BAXTER-2024BAX020903$BAXTER$$38$YR$$F$Y$63$KG$20240708$$MD$CN$CN
240591152$24059115$2$F$$20240628$20240708$20240821$EXP$$US-BAXTER-2024BAX020777$BAXTER$$$$$$Y$$$20240821$$PH$US$US
240591161$24059116$1$I$20240101$20240517$20240708$20240708$EXP$$DE-AUROBINDO-AUR-APL-2024-024879$AUROBINDO$$65$YR$$F$Y$51$KG$20240708$$CN$DE$DE
240591171$24059117$1$I$$20240702$20240708$20240708$PER$$US-SA-2024SA198003$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240591181$24059118$1$I$$20240703$20240708$20240708$PER$$US-SA-2024SA199424$SANOFI AVENTIS$$$$$M$Y$$$20240708$$CN$US$US
240591192$24059119$2$F$20240621$20240911$20240708$20240923$PER$$US-SA-2024SA198074$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240923$$MD$US$US
240591201$24059120$1$I$20240619$20240703$20240708$20240708$PER$$US-SA-2024SA197940$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240708$$CN$US$US
240591211$24059121$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA196356$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240708$$CN$US$US
240591221$24059122$1$I$$20240623$20240708$20240708$PER$$US-GLANDPHARMA-US-2024GLNSPO00418$GLAND PHARMA$$$$$F$Y$$$20240708$$CN$US$US
240591232$24059123$2$F$20240708$20240708$20240708$20240711$EXP$$CA-TAKEDA-2024TUS067597$TAKEDA$$52$YR$$M$Y$$$20240711$$CN$CA$CA
240591241$24059124$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06187$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240591251$24059125$1$I$$20240627$20240708$20240708$EXP$$CA-BAXTER-2024BAX020839$BAXTER$$43$YR$$F$Y$$$20240708$$HP$CA$CA
240591261$24059126$1$I$$20240705$20240708$20240708$PER$$NVSC2024US140366$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
240591271$24059127$1$I$20240621$20240701$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032847$AUROBINDO$$67$YR$$M$Y$110$KG$20240708$$CN$GB$GB
240591281$24059128$1$I$20240531$20240630$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032582$AUROBINDO$$59$YR$$M$Y$76$KG$20240708$$CN$GB$GB
240591291$24059129$1$I$$20240703$20240708$20240708$EXP$$US-AstraZeneca-2024A153616$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$US$
240591301$24059130$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA196840$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240591312$24059131$2$F$$20240702$20240708$20240711$PER$$US-AMGEN-USASP2024132867$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240591321$24059132$1$I$20240101$20240703$20240708$20240708$EXP$$US-ABBVIE-5828659$ABBVIE$$$$$F$Y$57$KG$20240708$$CN$US$US
240591331$24059133$1$I$$20240617$20240708$20240708$PER$$US-AMGEN-USASP2024123217$AMGEN$Patel D.; Zafar P.; Nasrullah A. et. al.. Community Acquired Pneumonia or Hydralazine-Induced Vasculitis - A Clinical Dilemma. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A2014$82$YR$E$F$Y$$$20240708$$HP$US$US
240591341$24059134$1$I$20200101$20240624$20240708$20240708$EXP$$US-ROCHE-10000010324$ROCHE$$65$YR$E$M$Y$86.18$KG$20240708$$CN$US$US
240591351$24059135$1$I$$20240627$20240708$20240708$EXP$$CA-BAXTER-2024BAX020840$BAXTER$$59$YR$$F$Y$$$20240708$$HP$CA$CA
240591361$24059136$1$I$20240510$20240629$20240708$20240708$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158903$JIANGSU HENGRUI MEDICINE$$57$YR$$F$Y$67$KG$20240708$$MD$CN$CN
240591371$24059137$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004093$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240708$$CN$US$US
240591381$24059138$1$I$20231016$20240628$20240708$20240708$EXP$$CA-TAKEDA-2023TUS100749$TAKEDA$$56$YR$$F$Y$$$20240708$$CN$CA$CA
240591391$24059139$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05883$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240591401$24059140$1$I$20240525$20240624$20240708$20240708$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00333$Unknown Manufacturer$$$$$$Y$$$20240708$$MD$CN$CN
240591422$24059142$2$F$20240101$20240711$20240708$20240722$EXP$$DE-UCBSA-2024034235$UCB$$26$YR$$F$Y$78$KG$20240722$$MD$DE$DE
240591431$24059143$1$I$20240501$20240701$20240708$20240708$EXP$$IT-AUROBINDO-AUR-APL-2024-032657$AUROBINDO$$70$YR$$F$Y$$$20240708$$MD$IT$IT
240591441$24059144$1$I$$20240514$20240708$20240708$PER$$US-AMGEN-USASP2024133303$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240591452$24059145$2$F$$20240709$20240708$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST004021$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240715$$CN$US$US
240591462$24059146$2$F$$20240807$20240708$20240823$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06199$LUPIN$$$$$$Y$$$20240823$$CN$US$US
240591472$24059147$2$F$$20240723$20240708$20240731$EXP$$US-Stemline Therapeutics, Inc.-2024ST004013$STEMLINE THERAPEUTICS$$86$YR$E$F$Y$$$20240729$$CN$US$US
240591481$24059148$1$I$$20240628$20240708$20240708$EXP$$NL-CELLTRION INC.-2024NL016002$CELLTRION$$$$$$Y$$$20240708$$MD$NL$NL
240591491$24059149$1$I$20240521$20240624$20240708$20240708$EXP$$FR-CIPLA LTD.-2024FR06830$CIPLA$$$$$$Y$$$20240708$$PH$FR$FR
240591501$24059150$1$I$$20240628$20240708$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST004014$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240703$$CN$US$US
240591511$24059151$1$I$$20240701$20240708$20240708$EXP$$SY-ROCHE-10000015506$ROCHE$Wannous H,  Idiopathic nephrotic syndrome in Syrian children: clinicopathological spectrum, treatment, and outcomes. Pediatric Nephrology. 2024;39 (8):2413-2422. doi:10.1007/s00467-024-06333-5.$$$$$Y$$$20240708$$HP$SY$SY
240591521$24059152$1$I$20240606$20240701$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032718$AUROBINDO$$83$YR$$$Y$$$20240708$$PH$GB$GB
240591531$24059153$1$I$$20240702$20240708$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST004078$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240705$$CN$US$US
240591551$24059155$1$I$20240101$20240703$20240708$20240708$EXP$$US-UCBSA-2024028819$UCB$$$$$M$Y$$$20240708$$CN$US$US
240591561$24059156$1$I$20240630$20240702$20240708$20240708$EXP$$US-AMGEN-USASP2024131482$AMGEN$$80$YR$E$F$Y$$$20240708$$CN$US$US
240591571$24059157$1$I$20240703$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133238$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240591581$24059158$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133366$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240591591$24059159$1$I$20240624$20240702$20240708$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST004080$STEMLINE THERAPEUTICS$$85$YR$E$F$Y$$$20240705$$CN$US$US
240591601$24059160$1$I$$20240628$20240708$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST004011$STEMLINE THERAPEUTICS$$87$YR$E$F$Y$$$20240703$$HP$US$US
240591621$24059162$1$I$20240516$20240701$20240708$20240708$EXP$$IT-AUROBINDO-AUR-APL-2024-032845$AUROBINDO$$30$YR$$F$Y$61$KG$20240708$$MD$IT$IT
240591631$24059163$1$I$$20240623$20240708$20240708$PER$$US-GLANDPHARMA-US-2024GLNSPO00417$GLAND PHARMA$$35$YR$A$F$Y$$$20240708$$CN$US$US
240591641$24059164$1$I$20240628$20240701$20240708$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST004061$STEMLINE THERAPEUTICS$$84$YR$E$F$Y$$$20240703$$CN$US$US
240591651$24059165$1$I$$20240624$20240708$20240708$EXP$$CH-NORDICGR-056677$NORDIC PHARMA$$$$$$Y$$$20240708$$MD$CH$CH
240591661$24059166$1$I$20240601$20240704$20240708$20240708$EXP$GB-MHRA-MED-202407040829504800-CHNDY$GB-TAKEDA-2024TUS067811$TAKEDA$$62$YR$$F$Y$58$KG$20240708$$HP$GB$GB
240591671$24059167$1$I$$20240626$20240708$20240708$EXP$$DE-MELINTA THERAPEUTICS, LLC-DE-MLNT-24-00327$Unknown Manufacturer$$$$$$Y$$$20240708$$MD$DE$DE
240591681$24059168$1$I$$20240702$20240708$20240708$PER$$US-ROCHE-10000019138$ROCHE$$43$YR$A$F$Y$$$20240708$$CN$US$US
240591691$24059169$1$I$20240619$20240624$20240708$20240708$PER$$US-Kiniksa Pharmaceuticals Ltd.-2024KPU001021$KINIKSA PHARMACEUTICALS$$44$YR$A$F$Y$$$20240703$$HP$US$US
240591701$24059170$1$I$$20240701$20240708$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST004034$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240705$$CN$US$US
240591712$24059171$2$F$20230101$20240722$20240708$20240729$EXP$$CL-ROCHE-10000010077$ROCHE$$39$YR$A$M$Y$76$KG$20240729$$CN$CL$CL
240591721$24059172$1$I$20210701$20240627$20240708$20240708$EXP$$CO-ROCHE-2911548$ROCHE$$56$YR$A$F$Y$69$KG$20240708$$CN$CO$CO
240591731$24059173$1$I$20240619$20240701$20240708$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST004039$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240705$$CN$US$US
240591741$24059174$1$I$$20240628$20240708$20240708$PER$$US-APOTEX-2024AP007900$APOTEX$$$$E$F$Y$$$20240708$$HP$US$US
240591751$24059175$1$I$20240630$20240702$20240708$20240708$EXP$$US-JNJFOC-20240711448$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
240591761$24059176$1$I$20240701$20240701$20240708$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST004045$STEMLINE THERAPEUTICS$$62$YR$A$F$Y$$$20240705$$CN$US$US
240591771$24059177$1$I$20240704$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134133$AMGEN$$78$YR$E$M$Y$$$20240708$$CN$US$US
240591782$24059178$2$F$$20240720$20240708$20240731$EXP$$NL-AUROBINDO-AUR-APL-2019-087975$AUROBINDO$Van Zuilekom S, Gijsman HJ.. A patient on clozapine in the general hospital: The need for discussion between specialists from different disciplines and for close monitoring of the patient^s plasma level.. TIJDSCHRIFT VOOR PSYCHIATRIE. 2013;55(12):955-959$49$YR$$M$Y$$$20240731$$HP$NL$NL
240591791$24059179$1$I$$20240624$20240708$20240708$PER$$US-GLANDPHARMA-US-2024GLNSPO00442$GLAND PHARMA$$$$$M$Y$$$20240708$$HP$US$US
240591803$24059180$3$F$20231011$20240806$20240708$20240808$EXP$$CA-TAKEDA-2023TUS075615$TAKEDA$$33$YR$$F$Y$66$KG$20240808$$CN$CA$CA
240591814$24059181$4$F$20240510$20240904$20240708$20240911$EXP$$US-TAKEDA-2024TUS067548$TAKEDA$$68$YR$$F$Y$$$20240911$$HP$US$US
240591821$24059182$1$I$20240405$20240703$20240708$20240708$EXP$$CA-TAKEDA-2024TUS068324$TAKEDA$$62$YR$$F$Y$$$20240708$$CN$CA$CA
240591831$24059183$1$I$20240626$20240703$20240708$20240708$EXP$$US-AstraZeneca-2024A153096$ASTRAZENECA$$33204$DY$$F$Y$$$20240708$$CN$US$
240591841$24059184$1$I$20240305$20240705$20240708$20240708$EXP$$US-TAKEDA-2024TUS021820$TAKEDA$$71$YR$$F$Y$$$20240708$$CN$US$US
240591851$24059185$1$I$20240424$20240703$20240708$20240708$EXP$$US-AstraZeneca-2024A153055$ASTRAZENECA$$19895$DY$$F$Y$$$20240708$$MD$US$
240591861$24059186$1$I$$20240624$20240708$20240708$EXP$$IN-CIPLA LTD.-2024IN06905$CIPLA$Tambe S, Jangid K, Shinde G, Jadhav S, Mahobia S, Lala M, et.al. Drug-induced systemic lupus erythematosus in a child living with HIV. Indian Journal of Sexually Transmitted Diseases and AIDS. 2024;45 (1):59 to 61$$$$$Y$$$20240708$$HP$IN$IN
240591871$24059187$1$I$$20240702$20240708$20240708$EXP$$US-UCBSA-2024033738$UCB$$$$$$Y$$$20240708$$CN$US$US
240591884$24059188$4$F$$20240807$20240708$20240813$PER$$US-LEO Pharma-371730$LEO PHARM$$76$YR$$F$Y$$$20240813$$CN$US$US
240591894$24059189$4$F$20221109$20240723$20240708$20240725$EXP$$CA-UCBSA-2022023566$UCB$$37$YR$$F$Y$$$20240725$$PH$CA$CA
240591901$24059190$1$I$20240521$20240702$20240708$20240708$EXP$$JP-AMGEN-JPNSP2024102160$AMGEN$$84$YR$E$F$Y$$$20240708$$PH$JP$JP
240591912$24059191$2$F$20240705$20240708$20240708$20240710$PER$$US-AMGEN-USASP2024134483$AMGEN$$73$YR$E$F$Y$$$20240709$$CN$US$US
240591921$24059192$1$I$20240528$20240628$20240708$20240708$EXP$FR-AFSSAPS-PB2024000700$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06165$HIKMA$$60$YR$$M$Y$$$20240708$$MD$FR$FR
240591931$24059193$1$I$20240517$20240704$20240708$20240708$EXP$FR-AFSSAPS-LM2024000370$FR-TAKEDA-2024TUS067604$TAKEDA$$89$YR$$F$Y$77.8$KG$20240708$$HP$FR$FR
240591941$24059194$1$I$$20240701$20240708$20240708$EXP$$GB-TAKEDA-2024TUS067497$TAKEDA$Byrne N, Forde K, Mcdonald S, Malladi R, Chan S. Ponatinib-induced lamellar ichthyosis-like drug eruption. 2024;34$46$YR$$M$Y$$$20240708$$MD$GB$GB
240591951$24059195$1$I$$20240701$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032778$AUROBINDO$$$$$F$Y$$$20240708$$CN$GB$GB
240591962$24059196$2$F$$20240814$20240708$20240829$PER$$US-GLANDPHARMA-US-2024GLNSPO00445$GLAND PHARMA$$$$$F$Y$$$20240829$$HP$US$US
240591971$24059197$1$I$20240229$20240701$20240708$20240708$EXP$FR-AFSSAPS-CN2024000563$FR-SA-2024SA195300$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240708$$MD$FR$FR
240591981$24059198$1$I$$20240701$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407001089$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240708$$CN$US$US
240591991$24059199$1$I$20240703$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004075$ELI LILLY AND CO$$$$$F$Y$$$20240708$$CN$US$US
240592001$24059200$1$I$20240703$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002726$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240708$$CN$US$US
240592011$24059201$1$I$$20240702$20240708$20240708$EXP$$US-KOANAAP-SML-US-2024-00687$Unknown Manufacturer$Kaur L, Kaur R, Shakir M, Basit S, Ray B, Chaudhary T. Navigating the Uncharted: Primary Pulmonary Carcinosarcoma With Metastasis Treated With Induction Chemotherapy. Am-J-Respir-Crit-Care-Med. 2024;(209): A6526.$56$YR$A$M$Y$$$20240708$$MD$US$US
240592022$24059202$2$F$$20240903$20240708$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202407004076$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240905$$CN$US$US
240592031$24059203$1$I$$20240701$20240708$20240708$EXP$$BR-EMD Serono-2024035894$EMD SERONO INC$$$$$M$Y$$$20240708$$CN$BR$BR
240592052$24059205$2$F$$20240702$20240708$20240709$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR082567$VIIV$$$$$M$Y$$$20240709$$CN$US$US
240592061$24059206$1$I$20191025$20240628$20240708$20240708$EXP$$AU-TAKEDA-2024TUS068510$TAKEDA$$69$YR$$M$Y$$$20240708$$MD$AU$AU
240592071$24059207$1$I$20240414$20240627$20240708$20240708$EXP$$BR-TAKEDA-2023TUS090303$TAKEDA$$7$YR$$F$Y$23$KG$20240708$$CN$BR$BR
240592081$24059208$1$I$$20240626$20240708$20240708$PER$$US-HALEON-2184326$Haleon PLC$$$$$$Y$$$20240708$$LW$US$US
240592091$24059209$1$I$$20240701$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-029099$AUROBINDO$$82$YR$$M$Y$85$KG$20240708$$MD$GB$GB
240592101$24059210$1$I$$20240702$20240708$20240708$EXP$$AR-TAKEDA-2024TUS068084$TAKEDA$$70$YR$$$Y$$$20240708$$CN$AR$AR
240592114$24059211$4$F$20211215$20240921$20240708$20240930$EXP$$US-TAKEDA-2021TUS081238$TAKEDA$$62$YR$$F$Y$$$20240930$$HP$US$US
240592121$24059212$1$I$20240613$20240703$20240708$20240708$PER$$US-TAKEDA-2024TUS068038$TAKEDA$$72$YR$$F$Y$$$20240708$$MD$US$US
240592132$24059213$2$F$$20240702$20240708$20240711$PER$$US-ROCHE-10000018860$ROCHE$$56$YR$A$M$Y$$$20240711$$MD$US$US
240592141$24059214$1$I$$20240626$20240708$20240708$EXP$$TW-AMGEN-TWNSP2024129631$AMGEN$Teng H. The salvage lenvatinib-based regimen provides survival benefit in patients with refractory metastatic colorectal cancer. American journal of cancer research. 2024;14 (5):2187-2201$$$$$Y$$$20240708$$MD$TW$TW
240592152$24059215$2$F$20240601$20240703$20240708$20240708$PER$$US-AMGEN-USA-20200407046$AMGEN$$65$YR$E$F$Y$$$20240708$$HP$US$US
240592162$24059216$2$F$20240701$20240829$20240708$20240904$EXP$$CA-ABBVIE-5830413$ABBVIE$$76$YR$$M$Y$$$20240904$$CN$CA$CA
240592171$24059217$1$I$$20240701$20240708$20240708$EXP$$JP-GSK-JP2024JPN081792$GLAXOSMITHKLINE$Sekiguchi Y, Sugama Y, Shirato S, Ibuki S, Fujita C, Goto A, et al. 12- Metabolic encephalopathy observed during treatment of relapsed/refractory myeloma. The 59th Hokkaido Regional Spring Meeting of the Japanese Society of Hematology. 18$$$$$Y$$$20240708$$MD$JP$JP
240592181$24059218$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107908$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240708$$HP$US$US
240592191$24059219$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107933$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$69.4$KG$20240708$$CN$US$US
240592201$24059220$1$I$20240624$20240625$20240708$20240708$PER$$US-RDY-SPO/USA/24/0009414$DR REDDYS$$51$YR$A$F$Y$$$20240708$$CN$US$US
240592211$24059221$1$I$20240625$20240701$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032849$AUROBINDO$$73$YR$$F$Y$$$20240708$$PH$GB$GB
240592221$24059222$1$I$20240703$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134478$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240592231$24059223$1$I$$20240703$20240708$20240708$EXP$$CA-TAKEDA-2024TUS068454$TAKEDA$$$$$M$Y$$$20240708$$MD$CA$CA
240592241$24059224$1$I$$20240703$20240708$20240708$EXP$$US-AstraZeneca-2024A153284$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$US$
240592251$24059225$1$I$$20240703$20240708$20240708$EXP$$BR-ROCHE-10000016720$ROCHE$$$$$$Y$$$20240708$$MD$BR$BR
240592261$24059226$1$I$20240601$20240625$20240708$20240708$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024079203$VIIV$$50$YR$$M$Y$$$20240708$$PH$US$US
240592271$24059227$1$I$20210317$20240702$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032926$AUROBINDO$$70$YR$$F$Y$$$20240708$$PH$FR$FR
240592281$24059228$1$I$20240501$20240626$20240708$20240708$EXP$$JP-ROCHE-10000014013$ROCHE$$29$YR$A$F$Y$$$20240708$$MD$JP$JP
240592291$24059229$1$I$$20240702$20240708$20240708$PER$$US-TAKEDA-2024TUS067310$TAKEDA$$$$$F$Y$$$20240708$$CN$US$US
240592302$24059230$2$F$20240523$20240705$20240708$20240710$EXP$GB-MHRA-MED-202407051422592780-LWDBZ$GB-ABBVIE-5830474$ABBVIE$$56$YR$$F$Y$$$20240710$$PH$GB$GB
240592311$24059231$1$I$$20240701$20240708$20240708$PER$$US-ABBVIE-5827728$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240592321$24059232$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281417420110-KQVHC$GB-TEVA-VS-3215586$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240592331$24059233$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06192$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240592341$24059234$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281436108240-JYFTK$GB-TEVA-VS-3215622$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240592351$24059235$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000045US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
240592361$24059236$1$I$$20240628$20240708$20240708$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR081786$VIIV$$$$$M$Y$$$20240708$$CN$US$US
240592371$24059237$1$I$$20240701$20240708$20240708$EXP$$TW-AMGEN-TWNSP2024132885$AMGEN$$$$A$F$Y$$$20240708$$HP$TW$TW
240592382$24059238$2$F$20240701$20240712$20240708$20240716$PER$$US-UNITED THERAPEUTICS-UNT-2024-020492$UNITED THERAPEUTICS$$48$YR$$F$Y$79.819$KG$20240716$$$US$US
240592392$24059239$2$F$20240404$20240805$20240708$20240809$EXP$SE-SEMPA-2024-005082$SE-009507513-2407SWE001834$MERCK$$20$YR$$F$Y$$$20240809$$MD$SE$SE
240592402$24059240$2$F$$20240708$20240708$20240717$EXP$GB-MHRA-MED-202406281431213880-YGRFD$GB-TEVA-VS-3215662$TEVA$$$$$$Y$$$20240717$$CN$GB$GB
240592411$24059241$1$I$20240501$20240628$20240708$20240708$EXP$DE-AMK-276339$DE-862174955-ML2024-03690$MICRO LABS$$61$YR$A$F$Y$$$20240708$$PH$DE$DE
240592421$24059242$1$I$20220101$20240628$20240708$20240708$EXP$FR-AFSSAPS-AVMP2024000181$FR-TEVA-VS-3216061$TEVA$$23$YR$$F$Y$$$20240708$$MD$FR$FR
240592431$24059243$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281502574640-CFGVW$GB-TEVA-VS-3216103$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240592441$24059244$1$I$$20240606$20240708$20240708$PER$$US-JNJFOC-20240617517$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$US$US
240592453$24059245$3$F$20240623$20240909$20240708$20240910$EXP$$NVSC2024BR140175$NOVARTIS$$1$YR$$$Y$$$20240910$$MD$BR$BR
240592461$24059246$1$I$$20240703$20240708$20240708$PER$$US-ABBVIE-5829950$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240592471$24059247$1$I$$20240628$20240708$20240708$PER$$US-ROCHE-10000017029$ROCHE$$16$YR$T$F$Y$$$20240708$$CN$US$US
240592483$24059248$3$F$20240611$20240812$20240708$20240816$EXP$$BR-ROCHE-10000016849$ROCHE$$48$YR$A$F$Y$70$KG$20240817$$MD$BR$BR
240592491$24059249$1$I$20240314$20240625$20240708$20240708$EXP$GB-MHRA-MED-202406241152331600-RZSNW$GB-GLENMARK PHARMACEUTICALS-2024GMK091957$GLENMARK$$$$$$Y$$$20240708$$CN$GB$GB
240592502$24059250$2$F$20240530$20240709$20240708$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002135$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240731$$HP$US$US
240592511$24059251$1$I$20240101$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134072$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240592531$24059253$1$I$20240703$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002791$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240708$$CN$US$US
240592541$24059254$1$I$$20240702$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002008$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240708$$CN$US$US
240592551$24059255$1$I$20240625$20240625$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202406018016$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240708$$CN$US$US
240592561$24059256$1$I$$20240624$20240708$20240708$EXP$$CH-EPICPHARMA-CH-2024EPCLIT00801$EPIC PHARM$Emmanuelle Massie.Combined lactic acidosis and ketoacidosis in a female diabetic patient with severe heart failure.Cardiovascular Endocrinology and Metabolism.JUN-2023;12:1-3$58$YR$A$F$Y$$$20240708$$MD$CH$CH
240592571$24059257$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004208$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240708$$CN$US$US
240592581$24059258$1$I$$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407003704$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240708$$CN$US$US
240592591$24059259$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06189$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240592602$24059260$2$F$20220101$20240724$20240708$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407003142$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240726$$CN$US$US
240592611$24059261$1$I$$20240701$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032631$AUROBINDO$$$$$F$Y$$$20240708$$MD$FR$FR
240592621$24059262$1$I$$20240705$20240708$20240708$PER$$US-HALEON-2185528$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240592631$24059263$1$I$20240501$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107640$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240708$$CN$US$US
240592641$24059264$1$I$$20240626$20240708$20240708$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000956$ALEMBIC$Martinez K.A, Bains S, Neves R, Giudicessi J.R, Bos J.M, Ackerman M.J. Sudden cardiac arrest occurring in temporal proximity to consumption of energy drinks. Heart Rhythm. 2024;21 (7):1083-1088$$$$$Y$$$20240708$$HP$US$US
240592651$24059265$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107629$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$66.22$KG$20240708$$CN$US$US
240592661$24059266$1$I$$20240626$20240708$20240708$EXP$$AU-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000957$ALEMBIC$Kamsani S.H, Middeldorp M.E, Chiang G, Stefil M, Evans S, Nguyen M.T. et. al. Safety of outpatient commencement of sotalol. Heart Rhythm O2. 2024;5 (6):341-350$$$$$Y$$$20240708$$MD$AU$AU
240592671$24059267$1$I$20240113$20240624$20240708$20240708$EXP$IT-MINISAL02-990949$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-06010$HIKMA$$$$$$Y$$$20240708$$MD$IT$IT
240592683$24059268$3$F$20240606$20240827$20240708$20240830$EXP$$US-EXELIXIS-CABO-24078004$EXELIXIS$$70$YR$$F$Y$$$20240830$$CN$US$US
240592692$24059269$2$F$20230101$20240819$20240708$20240822$PER$$US-AMGEN-USASP2024132792$AMGEN$$72$YR$E$F$Y$$$20240821$$CN$US$US
240592701$24059270$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202404302314239710-HQGPK$GB-ORGANON-O2407GBR000546$ORGANON$$$$$F$Y$$$20240708$$CN$GB$GB
240592711$24059271$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05929$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240592721$24059272$1$I$20240619$20240702$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032836$AUROBINDO$$49$YR$$M$Y$$$20240708$$MD$FR$FR
240592733$24059273$3$F$$20240731$20240708$20240802$PER$$US-LEO Pharma-371764$LEO PHARM$$41$YR$$M$Y$$$20240802$$CN$US$US
240592742$24059274$2$F$$20240821$20240708$20240831$EXP$$ES-AUROBINDO-AUR-APL-2022-042369$AUROBINDO$Soto JEV, Parra JC, Lopez CEM, Marcos MC, Romero IS, Forteza A.. First report of Brevundimonas aurantiaca human infection: infective endocarditis on aortic bioprostheses and supracoronary aortic graft acquired by water dispenser of domestic refrigerator.. Int-J-Infect-Dis. 2022;122:8-9$52$YR$$M$Y$$$20240831$$HP$ES$ES
240592752$24059275$2$F$$20240705$20240708$20240724$PER$$US-AstraZeneca-2024A107235$ASTRAZENECA$$68$YR$$F$Y$134.3$KG$20240724$$MD$US$
240592761$24059276$1$I$$20240626$20240708$20240708$PER$$US-AstraZeneca-2024A148961$ASTRAZENECA$$$$$$Y$$$20240708$$HP$US$
240592771$24059277$1$I$$20240702$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032923$AUROBINDO$$30$YR$$M$Y$$$20240708$$CN$GB$GB
240592782$24059278$2$F$20240505$20240712$20240708$20240722$EXP$ES-AEMPS-1538238$ES-TEVA-VS-3215708$TEVA$$90$YR$$M$Y$$$20240722$$PH$ES$ES
240592792$24059279$2$F$20220101$20240710$20240708$20240716$PER$$US-ABBVIE-5829606$ABBVIE$$$$$F$Y$43$KG$20240716$$CN$US$US
240592801$24059280$1$I$20230814$20240628$20240708$20240708$EXP$$CO-RECORDATI-2023006555$RECORDATI$$$$$$Y$$$20240708$$CN$CO$CO
240592811$24059281$1$I$$20240624$20240708$20240708$EXP$$US-EPICPHARMA-US-2024EPCLIT00781$EPIC PHARM$Reda H.Neurologic Complications of Endocrine Disorders.CONTINUUM Lifelong Learning in Neurology.JUN-2023;29 (3):887-902$70$YR$E$M$Y$$$20240708$$HP$US$US
240592821$24059282$1$I$$20240701$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032857$AUROBINDO$$$$$F$Y$$$20240708$$CN$GB$GB
240592831$24059283$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000047US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$HP$US$US
240592841$24059284$1$I$$20240629$20240708$20240708$PER$$US-TAKEDA-2024TUS066465$TAKEDA$$$$$$Y$$$20240708$$CN$US$US
240592851$24059285$1$I$20240628$20240701$20240708$20240708$PER$$US-ALXN-202407USA000115US$ALEXION PHARMACEUTICALS$$61$YR$$M$Y$$$20240708$$CN$US$US
240592861$24059286$1$I$20240626$20240701$20240708$20240708$PER$$US-ALXN-202407USA000036US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240708$$HP$US$US
240592871$24059287$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06025$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240592881$24059288$1$I$$20240702$20240708$20240708$EXP$$BR-UCBSA-2024034262$UCB$$65$YR$$M$Y$$$20240708$$MD$BR$BR
240592891$24059289$1$I$$20240703$20240708$20240708$EXP$$GB-SANDOZ INC.-SDZ2024GB063084$SANDOZ$$$$$F$Y$$$20240708$$CN$GB$GB
240592901$24059290$1$I$$20240625$20240708$20240708$EXP$$VN-RDY-LIT/null/24/0009464$DR REDDYS$Do TA, Nguyen AQ, Nguyen TV, Vu PT, Tran HT. A giant metaplastic breast carcinoma with osseous differentiation: A rare case report and review of the literature. International Journal of Surgery Case Reports. 2024;120(0): doi:/10.1016/j.ijscr.2024.109840.$59$YR$A$F$Y$$$20240708$$HP$VN$VN
240592911$24059291$1$I$$20240625$20240708$20240708$PER$$US-ROCHE-10000018914$ROCHE$$36$YR$A$F$Y$$$20240708$$CN$US$US
240592922$24059292$2$F$$20240702$20240708$20240708$PER$$US-ROCHE-10000018342$ROCHE$$$$A$F$Y$$$20240708$$CN$US$US
240592933$24059293$3$F$20240501$20240702$20240708$20240711$EXP$$GR-GILEAD-2024-0679431$GILEAD$$60$YR$A$M$Y$$$20240711$$MD$GR$GR
240592941$24059294$1$I$20240428$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405011435245730-HPSGD$GB-SANDOZ INC.-SDZ2024GB063259$SANDOZ$$78$YR$$$Y$$$20240708$$PH$GB$GB
240592956$24059295$6$F$$20240801$20240708$20240806$PER$$US-ROCHE-10000017016$ROCHE$$$$A$F$Y$92.98$KG$20240806$$CN$US$US
240592962$24059296$2$F$$20240705$20240708$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA028694$SANDOZ$$$$$F$Y$$$20240709$$PH$CA$CA
240592971$24059297$1$I$$20240404$20240708$20240708$PER$$US-AMGEN-USASP2024130879$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240592981$24059298$1$I$$20240703$20240708$20240708$EXP$$CA-SANDOZ INC.-SDZ2024CA062963$SANDOZ$$$$$M$Y$$$20240708$$MD$CA$CA
240592991$24059299$1$I$$20240702$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-033066$AUROBINDO$$$$$M$Y$$$20240708$$HP$GB$GB
240593001$24059300$1$I$$20240704$20240708$20240708$30DAY$$US-GSK-US2024AMR083785$GLAXOSMITHKLINE$$$$$F$Y$101$KG$20240708$$CN$US$US
240593011$24059301$1$I$$20240628$20240708$20240708$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024081186$VIIV$$$$$$Y$$$20240708$$HP$US$US
240593031$24059303$1$I$$20240705$20240708$20240708$EXP$$US-GILEAD-2024-0679698$GILEAD$$$$A$M$Y$$$20240708$$CN$US$US
240593041$24059304$1$I$$20240624$20240708$20240708$EXP$$US-EPICPHARMA-US-2024EPCLIT00807$EPIC PHARM$Deepak Dev Vivekanandan.Case report: a case report of neoadjuvant mFOLFIRINOX leading to a partial pathologic response in pancreatic adenosquamous carcinoma.Journal of Surgical Case Reports.05-MAY-2024;1-3$7$DEC$$F$Y$$$20240708$$HP$US$US
240593051$24059305$1$I$$20240613$20240708$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002846$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
240593061$24059306$1$I$20231118$20240703$20240708$20240708$EXP$$CA-UCBSA-2024034099$UCB$$45$YR$$F$Y$$$20240708$$CN$CA$CA
240593071$24059307$1$I$$20240702$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032928$AUROBINDO$$49$YR$$F$Y$53$KG$20240708$$MD$GB$GB
240593081$24059308$1$I$$20240704$20240708$20240708$EXP$$NVSC2024US140224$NOVARTIS$$$$$M$Y$$$20240708$$CN$US$US
240593091$24059309$1$I$$20230919$20240708$20240708$PER$$US-AMGEN-USASP2023235388$AMGEN$$$$$$Y$$$20240708$$MD$US$US
240593101$24059310$1$I$$20240624$20240708$20240708$PER$$US-AMGEN-USASP2024130035$AMGEN$A:O.. Evaluation of Real-World Treatment Patterns in Patients With Uncontrolled Gout in the USA. Value in Health. 2024;27 (6):S234-S235$$$$$Y$$$20240708$$HP$US$US
240593111$24059311$1$I$20240705$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134124$AMGEN$$67$YR$E$F$Y$$$20240708$$CN$US$US
240593121$24059312$1$I$20240508$20240701$20240708$20240708$EXP$$IT-AUROBINDO-AUR-APL-2024-032786$AUROBINDO$$62$YR$$F$Y$$$20240708$$MD$IT$IT
240593132$24059313$2$F$20240702$20240809$20240708$20240814$EXP$$US-AMGEN-USASP2024132669$AMGEN$$46$YR$A$F$Y$$$20240814$$MD$US$US
240593142$24059314$2$F$20230424$20240807$20240708$20240812$EXP$$PL-AMGEN-POLSP2024130224$AMGEN$$72$YR$E$M$Y$$$20240812$$MD$PL$PL
240593152$24059315$2$F$20240611$20240723$20240708$20240729$EXP$$US-AMGEN-USASP2024132078$AMGEN$$56$YR$A$M$Y$$$20240728$$CN$US$US
240593161$24059316$1$I$20240101$20240703$20240708$20240708$EXP$$CA-TAKEDA-2024TUS040225$TAKEDA$$$$$F$Y$$$20240708$$CN$CA$CA
240593171$24059317$1$I$$20240626$20240708$20240708$EXP$$DE-ROCHE-10000015838$ROCHE$$75$YR$E$M$Y$$$20240708$$MD$DE$DE
240593181$24059318$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05907$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240593191$24059319$1$I$$20240627$20240708$20240708$PER$$US-ABBVIE-5826286$ABBVIE$$30$YR$$F$Y$$$20240708$$HP$US$US
240593202$24059320$2$F$$20240717$20240708$20240722$EXP$$US-862174955-ML2024-03601$Unknown Manufacturer$$81$YR$E$F$Y$$$20240722$$CN$US$US
240593211$24059321$1$I$$20240704$20240708$20240708$PER$$US-ROCHE-10000000638$ROCHE$Le X, Baik C, Bauman J, Gilbert J, Brose M, Grilley-Olson J, et al. Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers. Oncologist. 2024-Jun;29 (6):e779-88. doi:10.1093/oncolo/oyac080.$$$$$Y$$$20240708$$HP$US$US
240593222$24059322$2$F$20220101$20240906$20240708$20240909$EXP$$NVSC2024BE140123$NOVARTIS$$58$YR$$F$Y$$$20240909$$MD$BE$BE
240593231$24059323$1$I$20240516$20240612$20240708$20240708$PER$$US-JNJFOC-20240638109$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$US$US
240593242$24059324$2$F$20240612$20240709$20240708$20240716$EXP$$BR-CELLTRION INC.-2024BR016124$CELLTRION$$$$$$Y$$$20240716$$CN$BR$BR
240593251$24059325$1$I$$20240702$20240708$20240708$EXP$$KR-GILEAD-2024-0679219$GILEAD$$69$YR$E$F$Y$$$20240708$$CN$KR$KR
240593261$24059326$1$I$$20240624$20240708$20240708$EXP$$US-EPICPHARMA-US-2024EPCLIT00778$EPIC PHARM$Jane Hand.Iatrogenic Cushing^s Syndrome With a Remote History of Synthetic Glucocorticoid Use in the Setting of a CYP3A4 Inhibitor - Location Matters.Endocrine Society.DEC-2022;6 (Suppl.):A110-A111$34$YR$A$M$Y$$$20240708$$MD$US$US
240593271$24059327$1$I$$20240624$20240708$20240708$PER$$US-ROCHE-10000019250$ROCHE$El-Atoum M, Hargarten JC, Park YD, Ssebambulidde K, Ding L, Chittiboina P, et al. Persistent neurological symptoms and elevated intracranial pressures in a previously healthy host with cryptococcal meningitis. BMC Infectious Diseases. 2023;23:407. https://doi.org/10.1186/s12879-023-08349-y.$55$YR$A$M$Y$60$KG$20240708$$HP$US$US
240593281$24059328$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024131824$AMGEN$Schwartz M.; McMahon C.M.; Amaya M.L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Ch rom osome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240708$$MD$US$US
240593291$24059329$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024131933$AMGEN$Schwartz M.; Mcmahon C.M.; Amaya M.L. et.al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Ch rom osome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240708$$MD$US$US
240593301$24059330$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107697$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240708$$CN$US$US
240593311$24059331$1$I$$20240707$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107736$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$86.64$KG$20240708$$CN$US$US
240593332$24059333$2$F$$20240806$20240708$20240812$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-107828$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240812$$MD$DE$DE
240593341$24059334$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06183$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240593351$24059335$1$I$$20230830$20240708$20240708$PER$$US-AMGEN-USASP2023235346$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240593361$24059336$1$I$20240102$20240628$20240708$20240708$EXP$FR-AFSSAPS-GR2024000755$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06162$HIKMA$$69$YR$$F$Y$78$KG$20240708$$PH$FR$FR
240593371$24059337$1$I$$20240701$20240708$20240708$EXP$$US-ROCHE-3477634$ROCHE$Nguyen V, Wong H, Mok T, Cushing M, Lam M, Ho S, Law L, Aziz A, Niu F and Hui R Evaluation of outcomes between rituximab-abbs and reference product rituximab in adult patients with newly diagnosed diffuse large B-cell lymphoma in a non-inferiority study. DOI: 10.1200/jco.2023.41.16_suppl.7556. Journal of Clinical Oncology 2023 Jun;41 (16):7556-.$$$$$Y$$$20240708$$HP$US$US
240593381$24059338$1$I$20230401$20240627$20240708$20240708$EXP$$US-APOTEX-2024AP007903$APOTEX$Razia D, Moin A, Arjuna A, Evans S.. VASCULOPATHY AND DEMYELINATING COMPLICATIONS OF VARICELLA IN AN IMMUNOCOMPROMISED PATIENT. Critical Care Medicine. 2024;52 (Suppl. 1):S228$42$YR$$F$Y$$$20240708$$HP$US$US
240593401$24059340$1$I$20220617$20240629$20240708$20240708$EXP$$AT-CELLTRION INC.-2024AT016043$CELLTRION$$$$$$Y$$$20240708$$HP$AT$AT
240593412$24059341$2$F$$20240722$20240708$20240729$PER$$US-ABBVIE-5830971$ABBVIE$$$$$$Y$$$20240729$$HP$US$US
240593421$24059342$1$I$$20240624$20240708$20240708$EXP$$AU-EPICPHARMA-AU-2024EPCLIT00798$EPIC PHARM$Isha Gupta.Diagnosis of an unusual orbital abscess following sub-Tenon^s steroid injection: a case report .Journal of Surgical Case Reports.2024;1-4$83$YR$E$M$Y$$$20240708$$HP$AU$AU
240593431$24059343$1$I$20231108$20240702$20240708$20240708$EXP$$IE-TAKEDA-2024TUS001367$TAKEDA$$66$YR$$M$Y$$$20240708$$MD$IE$IE
240593441$24059344$1$I$$20240625$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009465$DR REDDYS$Guzman A. Should Severe Hypertriglyceridemia Also Be Considered as a Contraindication for Use of Glucagon like Peptide 1 (GLP-1) Agonists?. Journal of the Endocrine Society. 2020;4: doi:10.1210/jendso/bvaa046.242.$46$YR$A$M$Y$$$20240708$$MD$US$US
240593451$24059345$1$I$$20240702$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009590$DR REDDYS$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocritical Care. 2024;40: 976-983. doi:10.1007/s12028-023-01853-8.$45$YR$A$M$Y$65$KG$20240708$$HP$US$US
240593461$24059346$1$I$$20240705$20240708$20240708$PER$$US-ABBVIE-5830731$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240593471$24059347$1$I$$20240627$20240708$20240708$PER$$US-BEH-2024174787$CSL BEHRING$$$$A$F$Y$$$20240708$$CN$US$US
240593482$24059348$2$F$20240724$20240724$20240708$20240729$EXP$$CA-TAKEDA-2023TUS110302$TAKEDA$$79$YR$$M$Y$$$20240729$$MD$CA$CA
240593491$24059349$1$I$$20240628$20240708$20240708$30DAY$$US-GSK-US2024AMR081276$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$CN$US$US
240593501$24059350$1$I$20240518$20240624$20240708$20240708$EXP$FR-AFSSAPS-PO2024000626$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108961$ZYDUS PHARM$$$$$$Y$$$20240708$$MD$FR$FR
240593521$24059352$1$I$20220101$20240624$20240708$20240708$EXP$FR-AFSSAPS-AVMP2024000181$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108974$ZYDUS PHARM$$$$$$Y$$$20240708$$MD$FR$FR
240593531$24059353$1$I$$20240624$20240708$20240708$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108894$ZYDUS PHARM$Sasidharan S, Jatoi T, Milla C, Mallappallil M, Agarwal S, Puri I.. Triple whammy of amlodipine, carvedilol and diphenhydramine overdose.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240708$$HP$US$US
240593541$24059354$1$I$$20240701$20240708$20240708$EXP$$CH-UCBSA-2024033873$UCB$$$$C$$Y$$$20240708$$MD$CH$CH
240593561$24059356$1$I$20240101$20240624$20240708$20240708$EXP$$CN-SA-2024SA195289$SANOFI AVENTIS$$$$T$$Y$$$20240708$$CN$CN$CN
240593572$24059357$2$F$$20240807$20240708$20240813$EXP$$IN-ROCHE-10000017397$ROCHE$$66$YR$E$M$Y$$$20240813$$CN$IN$IN
240593581$24059358$1$I$20240618$20240627$20240708$20240708$EXP$$CN-ROCHE-10000013755$ROCHE$$68$YR$E$F$Y$50$KG$20240708$$HP$CN$CN
240593591$24059359$1$I$20240404$20240627$20240708$20240708$EXP$IT-MINISAL02-991748$IT-SA-2024SA192717$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240708$$MD$IT$IT
240593601$24059360$1$I$$20240625$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06252$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240593611$24059361$1$I$20240101$20240703$20240708$20240708$EXP$$US-ABBVIE-5829029$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240593621$24059362$1$I$$20240530$20240708$20240708$PER$$US-AMGEN-USASP2024133561$AMGEN$$$$$$Y$$$20240708$$MD$US$US
240593631$24059363$1$I$20240601$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133450$AMGEN$$49$YR$A$M$Y$$$20240708$$HP$US$US
240593641$24059364$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5830142$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240593651$24059365$1$I$20240601$20240627$20240708$20240708$EXP$IT-MINISAL02-991756$IT-SA-2024SA192669$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240708$$MD$IT$IT
240593661$24059366$1$I$20240101$20240629$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106251$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240708$$CN$US$US
240593671$24059367$1$I$20240630$20240701$20240708$20240708$PER$$US-AMGEN-USASP2024130237$AMGEN$$69$YR$E$F$Y$$$20240708$$CN$US$US
240593681$24059368$1$I$$20230828$20240708$20240708$PER$$US-AMGEN-USASP2023235344$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240593691$24059369$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5830748$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240593701$24059370$1$I$$20240624$20240708$20240708$EXP$$IL-ROCHE-10000012511$ROCHE$$36$YR$A$M$Y$$$20240708$$MD$IL$IL
240593711$24059371$1$I$$20240624$20240708$20240708$PER$$US-ROCHE-10000013311$ROCHE$$$$$$Y$$$20240708$$CN$US$US
240593721$24059372$1$I$$20240629$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032532$AUROBINDO$$$$$M$Y$$$20240708$$CN$GB$GB
240593731$24059373$1$I$20231005$20240702$20240708$20240708$EXP$$CA-TAKEDA-2024TUS000142$TAKEDA$$72$YR$$F$Y$$$20240708$$MD$CA$CA
240593741$24059374$1$I$20240624$20240704$20240708$20240708$EXP$$CN-ORGANON-O2407CHN000599$ORGANON$$79$YR$$F$Y$47$KG$20240708$$HP$CN$CN
240593752$24059375$2$F$$20240706$20240708$20240711$PER$$US-ROCHE-10000016039$ROCHE$$$$$$Y$$$20240711$$CN$US$US
240593761$24059376$1$I$$20240625$20240708$20240708$PER$$US-ROCHE-10000015129$ROCHE$$59$YR$A$M$Y$$$20240708$$HP$US$US
240593771$24059377$1$I$$20240624$20240708$20240708$PER$$US-ROCHE-10000015976$ROCHE$$$$$$Y$$$20240708$$CN$US$US
240593781$24059378$1$I$$20240701$20240708$20240708$EXP$$US-SA-2024SA196979$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240708$$MD$US$US
240593791$24059379$1$I$$20240629$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032521$AUROBINDO$$$$$M$Y$$$20240708$$CN$GB$GB
240593801$24059380$1$I$20240515$20240701$20240708$20240708$EXP$$CN-SA-2024SA196817$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240708$$HP$CN$CN
240593811$24059381$1$I$$20230828$20240708$20240708$PER$$US-AMGEN-USASP2023235343$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240593821$24059382$1$I$$20240703$20240708$20240708$PER$$US-ABBVIE-5830190$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240593831$24059383$1$I$20240510$20240624$20240708$20240708$EXP$ES-AEMPS-1536027$ES-HIKMA PHARMACEUTICALS USA INC.-ES-H14001-24-06015$HIKMA$$47$YR$$F$Y$$$20240708$$HP$ES$ES
240593841$24059384$1$I$$20240630$20240708$20240708$EXP$GB-MHRA-MED-202406301110344120-JLQHY$GB-RDY-SPO/GBR/24/0009610$DR REDDYS$$$$$M$Y$$$20240708$$CN$GB$GB
240593851$24059385$1$I$20240531$20240630$20240708$20240708$EXP$GB-MHRA-MED-202406301749069030-FDMTJ$GB-RDY-SPO/GBR/24/0009530$DR REDDYS$$59$YR$A$M$Y$76$KG$20240708$$CN$GB$GB
240593861$24059386$1$I$20231127$20240703$20240708$20240708$EXP$IT-MINISAL02-992618$IT-TAKEDA-2024TUS067327$TAKEDA$$46$YR$$F$Y$$$20240708$$HP$IT$IT
240593871$24059387$1$I$$20240626$20240708$20240708$PER$$US-TEVA-VS-3215003$TEVA$$$$$$Y$$$20240708$$CN$US$US
240593881$24059388$1$I$$20240702$20240708$20240708$EXP$$CA-TAKEDA-2024TUS064801$TAKEDA$$$$$M$Y$$$20240708$$CN$CA$CA
240593891$24059389$1$I$20240601$20240701$20240708$20240708$EXP$$US-ABBVIE-5826013$ABBVIE$$57$YR$$F$Y$$$20240706$$CN$US$US
240593901$24059390$1$I$20240417$20240702$20240708$20240708$EXP$$DE-TAKEDA-2024TUS066294$TAKEDA$$57$YR$$M$Y$$$20240708$$HP$DE$DE
240593911$24059391$1$I$$20240701$20240708$20240708$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007976$STRIDES$Laughter MR, Tegla CA, Pawar S, Moshiri AS, Orlow SJ.. Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C.. JAAD-Case-Rep. 2024;49:28-31$$$$$Y$$$20240708$$MD$US$US
240593921$24059392$1$I$$20240628$20240708$20240708$EXP$$SI-MYLANLABS-2024M1061280$MYLAN$$68$YR$$F$Y$$$20240708$$CN$SI$SI
240593931$24059393$1$I$$20240625$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202406018262$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240708$$CN$US$US
240593941$24059394$1$I$20240301$20240702$20240708$20240708$EXP$$US-ABBVIE-5623687$ABBVIE$$62$YR$$F$Y$$$20240708$$CN$US$US
240593951$24059395$1$I$20220601$20240625$20240708$20240708$EXP$$AT-ROCHE-10000014275$ROCHE$Finsterer J, -. Glofitamab-Associated Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Presenting as Serial Seizures and Responding Positively to Antiseizure Drugs and Anakinra: A Case Report. Cureus. 2024-May-22;16 (5):1-7. doi:10.7759/cureus.60833.$63$YR$A$M$Y$$$20240708$$HP$AT$AT
240593961$24059396$1$I$20240705$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004286$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240708$$CN$US$US
240593972$24059397$2$F$$20240730$20240708$20240803$EXP$$US-ABBVIE-5799850$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
240593981$24059398$1$I$$20240626$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202406019765$ELI LILLY AND CO$$$$A$F$Y$$$20240708$$CN$US$US
240593991$24059399$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004302$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240708$$CN$US$US
240594001$24059400$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004190$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240708$$CN$US$US
240594021$24059402$1$I$$20240701$20240708$20240708$PER$$US-ROCHE-10000017171$ROCHE$$86$YR$E$F$Y$$$20240708$$HP$US$US
240594032$24059403$2$F$20200714$20240731$20240708$20240806$EXP$$CA-TAKEDA-2024TUS068100$TAKEDA$$39$YR$$F$Y$$$20240806$$CN$CA$CA
240594041$24059404$1$I$20240405$20240629$20240708$20240708$EXP$$ES-AUROBINDO-AUR-APL-2024-032565$AUROBINDO$$50$YR$$M$Y$$$20240708$$PH$ES$ES
240594051$24059405$1$I$$20240625$20240708$20240708$PER$$US-TEVA-VS-3214947$TEVA$$$$A$M$Y$113.38$KG$20240708$$CN$US$US
240594061$24059406$1$I$20240610$20240702$20240708$20240708$EXP$FR-AFSSAPS-AN2024000823$FR-MYLANLABS-2024M1061960$MYLAN$$72$YR$$M$Y$75.2$KG$20240708$$MD$FR$FR
240594072$24059407$2$F$20230101$20240715$20240708$20240722$EXP$$MX-ORGANON-O2407MEX000425$ORGANON$$26$YR$$F$Y$$$20240722$$HP$MX$MX
240594081$24059408$1$I$$20240703$20240708$20240708$EXP$$US-JNJFOC-20240711689$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
240594091$24059409$1$I$$20240615$20240708$20240708$PER$$US-JNJFOC-20240661729$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$60.5$KG$20240708$$CN$US$US
240594101$24059410$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05814$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240594114$24059411$4$F$20240608$20240830$20240708$20240906$EXP$$CA-ABBVIE-5829776$ABBVIE$$64$YR$$M$Y$$$20240906$$CN$CA$CA
240594121$24059412$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5828219$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240594131$24059413$1$I$20240405$20240630$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032562$AUROBINDO$$$$$$Y$$$20240708$$CN$GB$GB
240594141$24059414$1$I$$20240705$20240708$20240708$EXP$$DE-TAKEDA-2024TUS068536$TAKEDA$$55$YR$$F$Y$$$20240708$$HP$DE$DE
240594153$24059415$3$F$$20240717$20240708$20240724$EXP$$CZ-MYLANLABS-2024M1062016$MYLAN$Oulehle K, Vachek J. Malnutrition in patients with chronic kidney disease. Postgradual Nephrology. 2024;22(2):13-6.$74$YR$$M$Y$$$20240724$$MD$CZ$CZ
240594161$24059416$1$I$$20240703$20240708$20240708$EXP$$AU-ABBVIE-5828662$ABBVIE$$$$$M$Y$$$20240708$$HP$AU$AU
240594171$24059417$1$I$$20240703$20240708$20240708$PER$$NVSC2024US139688$NOVARTIS$$$$$F$Y$$$20240708$$MD$US$US
240594181$24059418$1$I$20240512$20240702$20240708$20240708$PER$$NVSC2024US138275$NOVARTIS$$65$YR$$F$Y$81.09$KG$20240708$$CN$US$US
240594191$24059419$1$I$$20240702$20240708$20240708$PER$$US-AMGEN-USASP2024132811$AMGEN$$74$YR$E$M$Y$$$20240708$$HP$US$US
240594202$24059420$2$F$20210101$20240722$20240708$20240726$PER$$US-AMGEN-USASP2024131665$AMGEN$$67$YR$E$F$Y$$$20240725$$MD$US$US
240594211$24059421$1$I$20240601$20240702$20240708$20240708$PER$$US-AMGEN-USASP2024131182$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240594222$24059422$2$F$$20240701$20240708$20240716$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14251$ALKEM$Dogrul BN, Park C.. Hydralazine Induced Visual and Auditory Hallucinations in a Kidney Transplant Patient: Case Report. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;S2667-2960(24):00066-1$49$YR$$F$Y$$$20240716$$MD$US$US
240594232$24059423$2$F$$20240701$20240708$20240716$EXP$$DK-ALKEM LABORATORIES LIMITED-DK-ALKEM-2024-14154$ALKEM$Nordal T, Burcharth J, Cordtz AC, Storm N, Jensen TK.. Cholestyramine crystal deposits as a possible cause of small bowel perforation. Ugeskr Laeger. 2024;186(25):V02240109$70$YR$$F$Y$$$20240716$$HP$DK$DK
240594241$24059424$1$I$$20240624$20240708$20240708$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14268$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$40$YR$$M$Y$$$20240708$$HP$BR$BR
240594252$24059425$2$F$$20240701$20240708$20240716$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-14158$ALKEM$Zhang F, Wang W, Zhu Y, Mao Y, Wang T, Gao P. Coronary stent implantation links to the occurrence of eosinophilia and interstitial pneumonia: a case report and systematic review. BMC Pulmonary Medicine. 2024;24(1):1-8$75$YR$$M$Y$$$20240716$$HP$CN$CN
240594262$24059426$2$F$20240501$20240904$20240708$20240906$PER$$US-TAKEDA-2024TUS065824$TAKEDA$$78$YR$$M$Y$94$KG$20240906$$MD$US$US
240594272$24059427$2$F$$20240709$20240708$20240712$EXP$$CA-ABBVIE-5829909$ABBVIE$$$$A$M$Y$$$20240712$$CN$CA$CA
240594282$24059428$2$F$20230101$20240701$20240708$20240716$EXP$TW-MLMSERVICE-20240620-PI108324-00306-1$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-14155$ALKEM$You MW, Chuang SC, Liang HR, Chuang SH, Chen YL, Wang SN. Tacrolimus Induced Hepatic Vein Occlusive Disease After Deceased Donor Liver Transplantation: A Case Report.. Transplantation proceedings. 2024;S0041-1345(24):00276-8$66$YR$$M$Y$$$20240716$$MD$TW$TW
240594292$24059429$2$F$$20240806$20240708$20240809$30DAY$$CA-JNJFOC-20240714351$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$PH$CA$CA
240594301$24059430$1$I$$20240704$20240708$20240708$EXP$$GB-GSK-GB2024EME083735$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$GB$GB
240594311$24059431$1$I$$20240701$20240708$20240708$30DAY$$US-GSK-US2024082283$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$HP$US$US
240594321$24059432$1$I$$20240701$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032850$AUROBINDO$$$$$$Y$$$20240708$$HP$GB$GB
240594331$24059433$1$I$$20240628$20240708$20240708$PER$$US-RDY-SPO/USA/24/0009504$DR REDDYS$$60$YR$A$$Y$$$20240708$$HP$US$US
240594341$24059434$1$I$$20240626$20240708$20240708$PER$$US-RDY-SPO/USA/24/0009518$DR REDDYS$$85$YR$E$$Y$$$20240708$$MD$US$US
240594351$24059435$1$I$$20240628$20240708$20240708$PER$$US-RDY-SPO/USA/24/0009722$DR REDDYS$$$$$F$Y$$$20240708$$MD$US$US
240594361$24059436$1$I$$20240628$20240708$20240708$PER$$US-RDY-SPO/USA/24/0009584$DR REDDYS$$24$YR$A$F$Y$$$20240708$$MD$US$US
240594371$24059437$1$I$$20240701$20240708$20240708$PER$$US-RDY-SPO/USA/24/0009713$DR REDDYS$$18$YR$T$$Y$$$20240708$$MD$US$US
240594381$24059438$1$I$$20240628$20240708$20240708$PER$$US-RDY-SPO/USA/24/0009600$DR REDDYS$$49$YR$A$$Y$$$20240708$$MD$US$US
240594391$24059439$1$I$$20240703$20240708$20240708$PER$$US-TAKEDA-2024TUS067816$TAKEDA$$$$$F$Y$$$20240708$$MD$US$US
240594404$24059440$4$F$20230411$20240801$20240708$20240806$EXP$$GB-MYLANLABS-2023M1039184$MYLAN$$62$YR$$M$Y$$$20240806$$MD$GB$GB
240594411$24059441$1$I$20240614$20240628$20240708$20240708$EXP$IT-MINISAL02-991624$IT-TEVA-VS-3216117$TEVA$$44$YR$$F$Y$$$20240708$$HP$IT$IT
240594421$24059442$1$I$$20240627$20240708$20240708$PER$$US-TAKEDA-2024TUS065312$TAKEDA$$$$$$Y$$$20240708$$CN$US$US
240594431$24059443$1$I$$20240705$20240708$20240708$EXP$$GB-ABBVIE-5830427$ABBVIE$$$$A$F$Y$$$20240708$$CN$GB$GB
240594441$24059444$1$I$$20240701$20240708$20240708$EXP$$JP-AMGEN-JPNSP2024130943$AMGEN$$$$$$Y$$$20240708$$CN$JP$JP
240594451$24059445$1$I$$20240624$20240708$20240708$EXP$$US-GRANULES-US-2024GRASPO00253$GRANULES INDIA$$$$$F$Y$$$20240708$$CN$US$US
240594461$24059446$1$I$$20240702$20240708$20240708$EXP$$NVSC2024GR139898$NOVARTIS$$$$$$Y$$$20240708$$MD$GR$GR
240594473$24059447$3$F$20240101$20240705$20240708$20240808$EXP$$CA-BAUSCH-BL-2024-010273$BAUSCH AND LOMB$$59$YR$$M$Y$$$20240808$$CN$CA$CA
240594481$24059448$1$I$$20240628$20240708$20240708$PER$$US-BAUSCH-BL-2024-010074$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240708$$CN$US$US
240594491$24059449$1$I$$20240704$20240708$20240708$EXP$$KR-ASTELLAS-2024US019048$ASTELLAS$$73$YR$$M$Y$$$20240708$$CN$KR$KR
240594501$24059450$1$I$$20240624$20240708$20240708$EXP$$PT-EPICPHARMA-PT-2024EPCLIT00786$EPIC PHARM$Ana Hipolito Reis.Cardiac Arrest in the Oncologic Patient: New Causes, New Challenges .European Journal of Case Reports in Internal Medicine.JAN-2019;213$57$YR$A$M$Y$$$20240708$$HP$PT$PT
240594511$24059451$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR081952$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240594525$24059452$5$F$20240710$20240924$20240708$20240930$EXP$$CA-TAKEDA-2024TUS068144$TAKEDA$$57$YR$$F$Y$$$20240930$$HP$CA$CA
240594531$24059453$1$I$$20240705$20240708$20240708$PER$$US-HALEON-2185696$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240594542$24059454$2$F$20240527$20240910$20240708$20240917$EXP$$JP-ASTELLAS-2024JP004707$ASTELLAS$$84$YR$E$M$Y$$$20240917$$MD$JP$JP
240594552$24059455$2$F$20240703$20240708$20240708$20240709$PER$$US-AMGEN-USASP2024134418$AMGEN$$74$YR$E$F$Y$$$20240709$$PH$US$US
240594561$24059456$1$I$$20240701$20240708$20240708$PER$$US-AMGEN-USASP2024132635$AMGEN$Baker M.; Thakker S.; Cardis M. et al.. A Vexing Case of a Treatment-Refractory, Idiopathic Rash Resembling Histiocytoid Sweet Syndrome: Insights into the Diagnostic Challenge of Vexas Syndrome. American Journal of Dermatopathology, The. 2024;46 (7):S1-S2$71$YR$E$M$Y$$$20240708$$MD$US$US
240594571$24059457$1$I$$20240703$20240708$20240708$EXP$$CN-ROCHE-10000016913$ROCHE$$33$YR$A$M$Y$$$20240708$$CN$CN$CN
240594581$24059458$1$I$20240629$20240701$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032855$AUROBINDO$$$$$F$Y$75$KG$20240708$$CN$GB$GB
240594591$24059459$1$I$20240530$20240701$20240708$20240708$EXP$$NL-ASTELLAS-2024EU006520$ASTELLAS$$83$YR$$F$Y$$$20240708$$CN$NL$NL
240594601$24059460$1$I$$20240627$20240708$20240708$EXP$$CA-ROCHE-10000014643$ROCHE$$63$YR$A$F$Y$$$20240708$$HP$CA$CA
240594611$24059461$1$I$$20240514$20240708$20240708$PER$$US-AMGEN-USASP2024131409$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240594621$24059462$1$I$$20240624$20240708$20240708$EXP$$US-GRANULES-US-2024GRASPO00254$GRANULES INDIA$$$$$M$Y$$$20240708$$CN$US$US
240594631$24059463$1$I$$20240705$20240708$20240708$PER$$US-HALEON-2185770$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240594651$24059465$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281456410520-PYKZQ$GB-TEVA-VS-3215755$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240594661$24059466$1$I$$20240703$20240708$20240708$EXP$$US-TAKEDA-2022TUS093228$TAKEDA$$$$$M$Y$$$20240708$$CN$US$US
240594671$24059467$1$I$$20240623$20240708$20240708$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05948$HIKMA$Hesham A, Kim D.D, Alshamrani Y, AlOtaibi F, Hyppolito Y.. The efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy in recurrent head and neck squamous cell carcinoma. Report of a case and review of the literature. Oral. Oncol. 2024;154:106863$66$YR$$M$Y$$$20240705$$MD$US$US
240594682$24059468$2$F$$20240708$20240708$20240717$EXP$GB-MHRA-MED-202406281144360370-LSKWG$GB-TEVA-VS-3215775$TEVA$$$$$$Y$$$20240717$$CN$GB$GB
240594691$24059469$1$I$$20240701$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032784$AUROBINDO$$78$YR$$M$Y$$$20240708$$PH$GB$GB
240594702$24059470$2$F$20240622$20240709$20240708$20240712$PER$$US-ABBVIE-5829333$ABBVIE$$28$YR$$M$Y$86.182$KG$20240712$$CN$US$US
240594711$24059471$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281140265240-PFTZY$GB-TEVA-VS-3215782$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240594721$24059472$1$I$20240621$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134364$AMGEN$$71$YR$E$F$Y$$$20240708$$CN$US$US
240594731$24059473$1$I$20220101$20240703$20240708$20240708$EXP$$CO-AMGEN-COLSL2022127115$AMGEN$$61$YR$A$F$Y$$$20240708$$CN$CO$CO
240594741$24059474$1$I$20240701$20240705$20240708$20240708$EXP$$US-VIIV HEALTHCARE LIMITED-US2024084009$VIIV$$43$YR$$M$Y$$$20240708$$CN$US$US
240594751$24059475$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107649$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240708$$CN$US$US
240594762$24059476$2$F$$20240808$20240708$20240808$PER$$US-ALXN-202407USA000214US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
240594771$24059477$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405151231073030-RFQYK$GB-GILEAD-2024-0679667$GILEAD$$$$$M$Y$$$20240708$$HP$GB$GB
240594783$24059478$3$F$20240129$20240712$20240708$20240719$EXP$$NVSC2024ES120907$NOVARTIS$$43$YR$$F$Y$$$20240719$$MD$ES$ES
240594791$24059479$1$I$$20240701$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032735$AUROBINDO$$$$$F$Y$96$KG$20240708$$CN$GB$GB
240594801$24059480$1$I$$20240704$20240708$20240708$PER$$US-AMGEN-USASP2024134287$AMGEN$$$$$F$Y$$$20240708$$HP$US$US
240594812$24059481$2$F$20240703$20240711$20240708$20240712$PER$$US-AMGEN-USASP2024134303$AMGEN$$39$YR$A$F$Y$$$20240712$$CN$US$US
240594821$24059482$1$I$$20240515$20240708$20240708$PER$$US-AMGEN-USASP2024131429$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240594832$24059483$2$F$20240701$20240813$20240708$20240828$EXP$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-01291$ULTRAGENYX PHARMACEUTICAL$$6$YR$$M$Y$13.8$KG$20240828$$CN$US$US
240594841$24059484$1$I$$20240613$20240708$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002830$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
240594851$24059485$1$I$$20240628$20240708$20240708$EXP$$JP-009507513-2406JPN004193J$MERCK$$$$$F$Y$$$20240708$$MD$JP$JP
240594862$24059486$2$F$$20240906$20240708$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002829$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
240594871$24059487$1$I$$20240701$20240708$20240708$PER$$US-AstraZeneca-2024A151076$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$US$
240594881$24059488$1$I$20240630$20240630$20240708$20240708$EXP$$US-AstraZeneca-2024A151333$ASTRAZENECA$$28789$DY$$M$Y$$$20240708$$CN$US$
240594891$24059489$1$I$$20240626$20240708$20240708$PER$$US-TEVA-VS-3215404$TEVA$$$$A$F$Y$$$20240708$$MD$US$US
240594902$24059490$2$F$$20240722$20240708$20240801$EXP$$JP-ROCHE-10000017625$ROCHE$Adachi Y, Mita H, Sasaki Y, Yoshida Y, Endo T, Ishii Y. Liver metastasis recurrence of gastric adenocarcinoma mixed with neuroendocrine cancer [Abstract number: WS4-3]. The 33rd Annual Meeting of the Japanese Association for Metastatic Research. 2024;80.$80$YR$E$M$Y$$$20240801$$MD$JP$JP
240594911$24059491$1$I$20240620$20240626$20240708$20240708$PER$$US-RDY-SPO/USA/24/0009477$DR REDDYS$$22$YR$A$$Y$85$KG$20240708$$HP$US$US
240594923$24059492$3$F$$20240822$20240708$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002828$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
240594932$24059493$2$F$$20240622$20240708$20240709$EXP$$BE-ROCHE-10000015401$ROCHE$$56$YR$A$$Y$$$20240705$$MD$BE$BE
240594942$24059494$2$F$20240426$20240709$20240708$20240717$EXP$$CA-CELLTRION INC.-2024CA013811$CELLTRION$$$$$$Y$$$20240717$$CN$CA$CA
240594951$24059495$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214977$TEVA$$69$YR$$F$Y$$$20240708$$PH$CA$CA
240594961$24059496$1$I$$20240627$20240708$20240708$EXP$$US-GSK-US2024AMR081031$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240594974$24059497$4$F$20240101$20240718$20240708$20240725$PER$$US-BIOGEN-2024BI01271951$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
240594981$24059498$1$I$$20240521$20240708$20240708$PER$$US-AMGEN-USASP2024132767$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240594991$24059499$1$I$$20240626$20240708$20240708$PER$$US-TEVA-VS-3215026$TEVA$$$$A$F$Y$$$20240708$$CN$US$US
240595001$24059500$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215014$TEVA$$79$YR$$F$Y$$$20240708$$PH$CA$CA
240595021$24059502$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215020$TEVA$$$$$M$Y$$$20240708$$HP$CA$CA
240595032$24059503$2$F$$20240702$20240708$20240712$PER$$US-ROCHE-10000018417$ROCHE$$$$A$F$Y$$$20240712$$CN$US$US
240595042$24059504$2$F$$20240821$20240708$20240821$PER$$NVSC2024US140124$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
240595051$24059505$1$I$20230612$20231128$20240708$20240708$EXP$NL-LRB-00923817$NL-TEVA-VS-3145128$TEVA$$14$YR$$F$Y$$$20240708$$MD$NL$NL
240595061$24059506$1$I$$20240627$20240708$20240708$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-06054$HIKMA$AlHamer B, Singh A, Patrascu C, Al Mukaddam M.. AlHamer B, Singh A, Patrascu C, Al Mukaddam M. Tumor-Induced Osteomalacia due to Sarcomatoid Non-Small Cell Lung Carcinoma Confounded by Drug-Induced Fanconi Syndrome.. JCEM Case Reports. 2024;2(6):luae101:1-5$39$YR$$M$Y$$$20240708$$MD$US$US
240595071$24059507$1$I$$20240311$20240708$20240708$PER$$US-AMGEN-USASP2024133248$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240595081$24059508$1$I$$20231122$20240708$20240708$PER$$US-AMGEN-USASP2023235579$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240595091$24059509$1$I$$20231130$20240708$20240708$PER$$US-AMGEN-USASP2023235221$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240595101$24059510$1$I$20240703$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134392$AMGEN$$72$YR$E$M$Y$$$20240708$$CN$US$US
240595111$24059511$1$I$20240601$20240701$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105139$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240708$$HP$US$US
240595121$24059512$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107973$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240708$$HP$US$US
240595131$24059513$1$I$$20240701$20240708$20240708$EXP$$US-VIIV HEALTHCARE LIMITED-US2024083013$VIIV$$$$$$Y$$$20240708$$PH$US$US
240595141$24059514$1$I$$20240704$20240708$20240708$EXP$$US-GSK-US2024AMR083483$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240708$$MD$US$US
240595153$24059515$3$F$$20240807$20240708$20240817$EXP$$US-GSK-US2024AMR081945$GLAXOSMITHKLINE$$$$$F$Y$$$20240817$$CN$US$US
240595161$24059516$1$I$$20240701$20240708$20240708$EXP$$GB-AUROBINDO-AUR-APL-2024-032697$AUROBINDO$$88$YR$$M$Y$$$20240708$$MD$GB$GB
240595171$24059517$1$I$$20240613$20240708$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002831$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
240595181$24059518$1$I$20170101$20240701$20240708$20240708$EXP$$PL-AUROBINDO-AUR-APL-2024-032730$AUROBINDO$Storoniak H, Debska-Slizien A.. Miliary Tuberculosis as Postmortem Diagnosis in Solid Organ Transplant Recipient: Case Report and Review of the Literature.. Transplantation Proceedings.. 2024;56(4):968-71$70$YR$$M$Y$$$20240708$$MD$PL$PL
240595191$24059519$1$I$20240101$20240703$20240708$20240708$EXP$$US-UCBSA-2024034227$UCB$$$$$F$Y$$$20240708$$HP$US$US
240595201$24059520$1$I$$20240702$20240708$20240708$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13424$IPSEN$$89$YR$E$F$Y$82.55$KG$20240708$$CN$US$US
240595211$24059521$1$I$$20240703$20240708$20240708$PER$$US-ABBVIE-5829260$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240595221$24059522$1$I$20240617$20240627$20240708$20240708$EXP$$CN-JNJFOC-20240703281$JOHNSON AND JOHNSON$$31$YR$A$F$Y$48$KG$20240708$$HP$CN$CN
240595231$24059523$1$I$$20240701$20240708$20240708$EXP$$US-AUROBINDO-AUR-APL-2024-032924$AUROBINDO$Lord ML, Rana D, Hossain S, Chang C, Palli V. A Fatal Case of Lyme Myocarditis With Babesia Co-infection.. Am-J-Respir-Crit-Care-Med. 2024;209:A3591$79$YR$$F$Y$$$20240708$$HP$US$US
240595241$24059524$1$I$20220101$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405071957286520-FKGWQ$GB-ORGANON-O2407GBR000531$ORGANON$$72$YR$$M$Y$64$KG$20240708$$CN$GB$GB
240595251$24059525$1$I$$20240630$20240708$20240708$EXP$$AU-TOLMAR, INC.-24AU050611$TOLMAR$$$$$M$Y$$$20240708$$CN$AU$AU
240595261$24059526$1$I$$20240629$20240708$20240708$EXP$$CA-TOLMAR, INC.-24CA050714$TOLMAR$$$$$M$Y$$$20240708$$CN$CA$CA
240595272$24059527$2$F$20240101$20240919$20240708$20240930$EXP$$US-ROCHE-10000012606$ROCHE$$68$YR$E$M$Y$$$20240930$$CN$US$US
240595281$24059528$1$I$$20240704$20240708$20240708$EXP$$NVSC2024IT140096$NOVARTIS$$$$$F$Y$$$20240708$$MD$IT$IT
240595291$24059529$1$I$$20240628$20240708$20240708$EXP$$CA-TOLMAR, INC.-24CA050605$TOLMAR$$$$$M$Y$$$20240708$$CN$CA$CA
240595302$24059530$2$F$$20240805$20240708$20240807$EXP$$NVSJ2024JP008056$NOVARTIS$$$$$$Y$$$20240807$$PH$JP$JP
240595311$24059531$1$I$$20240703$20240708$20240708$EXP$$NVSC2024AR127395$NOVARTIS$$66$YR$$M$Y$$$20240708$$CN$AR$AR
240595331$24059533$1$I$$20240704$20240708$20240708$EXP$$NVSC2024PA139965$NOVARTIS$$27$YR$$F$Y$$$20240708$$MD$PA$PA
240595341$24059534$1$I$20240610$20240701$20240708$20240708$EXP$$NVSC2024RU139247$NOVARTIS$$38$YR$$$Y$$$20240708$$MD$RU$RU
240595351$24059535$1$I$20240210$20240701$20240708$20240708$EXP$$NVSJ2024JP003096$NOVARTIS$$$$E$F$Y$$$20240708$$MD$JP$JP
240595361$24059536$1$I$$20240701$20240708$20240708$EXP$$NVSC2024US138018$NOVARTIS$$61$YR$$F$Y$51.61$KG$20240708$$CN$US$US
240595371$24059537$1$I$20180501$20240704$20240708$20240708$EXP$$NVSJ2024JP008107$NOVARTIS$$$$A$M$Y$$$20240708$$MD$JP$JP
240595381$24059538$1$I$20240603$20240626$20240708$20240708$PER$$US-RDY-SPO/USA/24/0009485$DR REDDYS$$17$YR$A$F$Y$$$20240708$$MD$US$US
240595392$24059539$2$F$20200528$20240805$20240708$20240808$EXP$$NVSJ2020JP006313$NOVARTIS$$61$YR$$F$Y$47.4$KG$20240808$$MD$JP$JP
240595402$24059540$2$F$20240501$20240709$20240708$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002832$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240731$$CN$US$US
240595411$24059541$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024081608$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240595421$24059542$1$I$20240628$20240628$20240708$20240708$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024081157$VIIV$$33$YR$$M$Y$$$20240708$$HP$US$US
240595432$24059543$2$F$$20240824$20240708$20240829$EXP$$US-ASTELLAS-2024US019204$ASTELLAS$$70$YR$E$M$Y$$$20240828$$HP$US$US
240595441$24059544$1$I$20240601$20240701$20240708$20240708$EXP$$EC-VANTIVE-2024VAN018040$Vantive US Healthcare$$63$YR$$F$Y$69$KG$20240708$$HP$EC$EC
240595451$24059545$1$I$20240629$20240703$20240708$20240708$EXP$$PH-VANTIVE-2024VAN018152$Vantive US Healthcare$$20$YR$$F$Y$$$20240708$$CN$PH$PH
240595463$24059546$3$F$$20240817$20240708$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05794$LUPIN$$$$$$Y$$$20240904$$CN$US$US
240595472$24059547$2$F$$20240829$20240708$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002833$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
240595481$24059548$1$I$20240329$20240704$20240708$20240708$30DAY$$IT-SANDOZ INC.-SDZ2024IT036271$SANDOZ$$10$YR$$M$Y$34$KG$20240708$$HP$IT$IT
240595491$24059549$1$I$$20240702$20240708$20240708$EXP$$CO-VANTIVE-2024VAN018032$Vantive US Healthcare$$$$$F$Y$65$KG$20240708$$HP$CO$CO
240595503$24059550$3$F$$20240626$20240708$20240709$PER$$US-ROCHE-10000015600$ROCHE$$$$A$F$Y$$$20240704$$CN$US$US
240595511$24059551$1$I$20240204$20240629$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032609$AUROBINDO$$78$YR$$F$Y$74$KG$20240708$$MD$FR$FR
240595521$24059552$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004146$ELI LILLY AND CO$$$$$F$Y$$$20240708$$CN$US$US
240595532$24059553$2$F$$20240711$20240708$20240723$EXP$$US-TEVA-VS-3214861$TEVA$Haghparast P, Nadybal M, Yuan C. Treatment-Resistant Priapism in a 61-Year-Old Male After Combined Use of Trazodone, Quetiapine, and Fluoxetine. J-Clin-Psychopharmacol 2024; 44 (3): 316-317.; Haghparast P, Nadybal M, Yuan C. Treatment-Resistant Priapism in a 61-Year-Old Male After Combined Use of Trazodone, Quetiapine, and Fluoxetine. J-Clin-Psychopharmacol 2024; 44 (3): 316-317.$61$YR$$M$Y$$$20240723$$PH$US$US
240595541$24059554$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004222$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240708$$CN$US$US
240595551$24059555$1$I$$20240702$20240708$20240708$PER$$US-ABBVIE-5829044$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240595561$24059556$1$I$$20240702$20240708$20240708$PER$$US-ABBVIE-5829419$ABBVIE$$$$$$Y$$$20240708$$HP$US$US
240595571$24059557$1$I$20240625$20240703$20240708$20240708$EXP$GB-MEN-2024-102940$GB-MEN-2024-102940$MENARINI$$75$YR$$M$Y$99$KG$20240708$$MD$GB$GB
240595581$24059558$1$I$20240701$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024132367$AMGEN$$76$YR$E$M$Y$$$20240708$$CN$US$US
240595592$24059559$2$F$20240501$20240710$20240708$20240711$PER$$US-AMGEN-USASP2024134355$AMGEN$$57$YR$A$F$Y$$$20240711$$HP$US$US
240595602$24059560$2$F$20240629$20240705$20240708$20240714$PER$$US-AMGEN-USASP2024134493$AMGEN$$$$$F$Y$$$20240713$$CN$US$US
240595612$24059561$2$F$$20240711$20240708$20240717$30DAY$$US-GSK-US2024083244$GLAXOSMITHKLINE$$$$$M$Y$$$20240717$$CN$US$US
240595621$24059562$1$I$$20240620$20240708$20240708$PER$$US-JNJFOC-20240662141$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$CN$US$US
240595631$24059563$1$I$20240620$20240703$20240708$20240708$EXP$$GB-MYLANLABS-2024M1063116$MYLAN$$49$YR$$M$Y$$$20240708$$PH$GB$GB
240595642$24059564$2$F$$20240704$20240708$20240711$EXP$$GB-MYLANLABS-2024M1063001$MYLAN$$$$$M$Y$$$20240711$$CN$GB$GB
240595653$24059565$3$F$$20240801$20240708$20240805$PER$$US-ALXN-202407USA000069US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240595661$24059566$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000037US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$US$US
240595671$24059567$1$I$$20240701$20240708$20240708$EXP$$DE-ABBVIE-5830973$ABBVIE$$23$YR$$F$Y$$$20240708$$MD$DE$DE
240595681$24059568$1$I$$20240704$20240708$20240708$PER$$US-HALEON-2185493$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240595701$24059570$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107793$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240708$$HP$US$US
240595711$24059571$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107673$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240708$$HP$US$US
240595721$24059572$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024081571$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$US$US
240595732$24059573$2$F$20240101$20240717$20240708$20240726$EXP$$CZ-MSNLABS-2024MSNLIT01435$MSN LABORATORIES$Skopal D.First-line treatment of nodal TFH lymphoma, angioimmunoblastic subtype.FARMAKOTERAPIE.2024;6 (1/2):15-16$$$$$Y$$$20240726$$MD$CZ$CZ
240595743$24059574$3$F$20240624$20240719$20240708$20240723$EXP$FR-AFSSAPS-MP2024001111$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038283$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$65.2$KG$20240719$$PH$FR$FR
240595751$24059575$1$I$$20240702$20240708$20240708$PER$$US-BAUSCH-BL-2024-010251$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240708$$CN$US$US
240595761$24059576$1$I$$20240701$20240708$20240708$EXP$$CA-BAUSCH-BL-2024-010179$BAUSCH AND LOMB$$60$YR$$M$Y$$$20240708$$HP$CA$CA
240595771$24059577$1$I$20210201$20210323$20240708$20240708$EXP$FR-AFSSAPS-AM20210534$FR-SA-2024SA196940$SANOFI AVENTIS$$65$YR$E$M$Y$54$KG$20240708$$PH$FR$FR
240595781$24059578$1$I$20170609$20240626$20240708$20240708$EXP$$CN-ROCHE-2331618$ROCHE$$47$YR$A$F$Y$49$KG$20240708$$CN$CN$CN
240595791$24059579$1$I$20240424$20240703$20240708$20240708$PER$$MA-REGENERON PHARMACEUTICALS, INC.-2024-094312$REGENERON$$56$YR$$M$Y$$$20240708$$CN$MA$MA
240595801$24059580$1$I$20180707$20240703$20240708$20240708$EXP$$CA-JNJFOC-20240711821$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240708$$$COUNTRY NOT SPECIFIED$CA
240595821$24059582$1$I$$20240520$20240708$20240708$PER$$US-AMGEN-USASP2024132931$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240595831$24059583$1$I$20240703$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134130$AMGEN$$21$YR$A$F$Y$$$20240708$$CN$US$US
240595851$24059585$1$I$20240703$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024132945$AMGEN$$35$YR$A$F$Y$$$20240708$$CN$US$US
240595861$24059586$1$I$20240210$20240628$20240708$20240708$EXP$FR-AFSSAPS-PA2024001296$FR-TEVA-VS-3215689$TEVA$$71$YR$$M$Y$72$KG$20240708$$PH$FR$FR
240595871$24059587$1$I$$20240624$20240708$20240708$PER$$US-ROCHE-10000009986$ROCHE$Unal S, Kuskonmaz B B. Autoimmune hemolytic anemia and giant cell hepatitis: Report of three infants.. Turk J Haematol. 2010;27:308-13. doi:10.1016/j.clinre.2024.102392.$11$MON$I$$Y$$$20240708$$HP$US$US
240595881$24059588$1$I$20240618$20240625$20240708$20240708$EXP$$US-BEH-2024174649$CSL BEHRING$$11$YR$C$M$Y$$$20240708$$HP$US$US
240595891$24059589$1$I$20240428$20240701$20240708$20240708$EXP$$FR-BIOGEN-2024BI01272221$BIOGEN$$40$YR$$M$Y$73$KG$20240708$$MD$FR$FR
240595903$24059590$3$F$20240708$20240911$20240708$20240918$EXP$$CA-TAKEDA-2024TUS068152$TAKEDA$$30$YR$$M$Y$$$20240918$$CN$CA$CA
240595911$24059591$1$I$$20240701$20240708$20240708$30DAY$$US-GSK-US2024083021$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$CN$US$US
240595921$24059592$1$I$$20240701$20240708$20240708$EXP$$US-ARIAD-2016US007093$TAKEDA$$$$$M$Y$$$20240708$$CN$US$US
240595931$24059593$1$I$$20240112$20240708$20240708$PER$$US-AMGEN-USASP2024131586$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240595942$24059594$2$F$$20240826$20240708$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05935$LUPIN$$$$$$Y$$$20240913$$CN$US$US
240595951$24059595$1$I$$20240703$20240708$20240708$EXP$$CA-TAKEDA-2024TUS068189$TAKEDA$$$$$F$Y$$$20240708$$MD$CA$CA
240595961$24059596$1$I$$20240613$20240708$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002837$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
240595972$24059597$2$F$$20240705$20240708$20240712$EXP$$GB-AstraZeneca-2024A154756$ASTRAZENECA$$32$YR$$F$Y$$$20240712$$MD$GB$
240595981$24059598$1$I$20240613$20240627$20240708$20240708$EXP$$CN-SA-2024SA194981$SANOFI AVENTIS$$60$YR$A$F$Y$46$KG$20240708$$HP$CN$CN
240595992$24059599$2$F$20230816$20240823$20240708$20240830$EXP$$JP-FERRINGPH-2024FE02468$FERRING$$$$$$Y$$$20240830$$MD$JP$JP
240596001$24059600$1$I$20240601$20240625$20240708$20240708$EXP$$PE-FERRINGPH-2024FE03535$FERRING$$$$$$Y$$$20240708$$CN$PE$PE
240596011$24059601$1$I$20240125$20240627$20240708$20240708$EXP$GB-MHRA-MED-202406271652103500-TSZGR$GB-FERRINGPH-2024FE03552$FERRING$$$$$$Y$$$20240708$$CN$GB$GB
240596021$24059602$1$I$$20240624$20240708$20240708$EXP$$US-MYLANLABS-2024M1060815$MYLAN$Hodson EL, Kranyak A, Salem I, Buckey JC. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases. J-Tissue-Viability 2024;.$54$YR$$F$Y$$$20240708$$HP$US$US
240596031$24059603$1$I$$20240624$20240708$20240708$EXP$$IR-MYLANLABS-2024M1062266$MYLAN$Emami AH, Alizadehasl A, Sayad M, Shavandi F, Firoozbakhsh P, Meshgi S, et al. Diagnosis and management of cancer therapy-related myocarditis in a young female: A case report and review of literature. BMC-Cardiovasc-Disord 2024; 24 (1): 1-5.$18$YR$$F$Y$$$20240708$$HP$IR$IR
240596042$24059604$2$F$$20240705$20240708$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107953$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240709$$CN$US$US
240596051$24059605$1$I$$20240624$20240708$20240708$EXP$$US-MYLANLABS-2024M1061449$MYLAN$Meier M, Linn BS. Record Setting Temperatures in the Setting of SARS-CoV-2 Suggests Dexmedetomidine Drug-Induced Fever: A Case Report. J-Investig-Med-High-Impact-Case-Rep 2024; 12 (0): 23247096241260959.$51$YR$$M$Y$$$20240708$$HP$US$US
240596061$24059606$1$I$$20240624$20240708$20240708$EXP$$US-MYLANLABS-2024M1059283$MYLAN$Shakir M, Nawaz M, Abdul Basit S, Jethani KR, Zaidi SMH, Patel NA. Spontaneous Pulmonary Hematoma on Heparin Infusion With Rapid Progression. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$66$YR$$M$Y$$$20240708$$HP$US$US
240596071$24059607$1$I$20180523$20240624$20240708$20240708$EXP$$JP-MYLANLABS-2023M1070838$MYLAN$$67$YR$$M$Y$$$20240708$$MD$JP$JP
240596081$24059608$1$I$$20240624$20240708$20240708$EXP$$PT-MYLANLABS-2024M1061498$MYLAN$Sousa BSGC, de Sa ZC, Ramos J. Decoding the enigma: Valproate encephalopathy in a bipolar affective disorder without hyperammonemia. Bipolar-Disord 2024;.$63$YR$$F$Y$$$20240708$$HP$PT$PT
240596091$24059609$1$I$$20240606$20240708$20240708$EXP$$NVSC2024BE140088$NOVARTIS$$$$$M$Y$$$20240708$$MD$BE$BE
240596102$24059610$2$F$$20240706$20240708$20240716$EXP$$CH-ROCHE-10000009411$ROCHE$Plomer E, Fruh M, Lauber A, Demmer I, Jochum W, Koster K. Prolonged Response to Afatinib and Crizotinib in a Rare Case of EGFR-, HER2-, METand ROS1-Alterated Lung Adenocarcinoma. International Journal of Molecular Sciences. 2024-Jun;25 (11): doi:10.3390/ijms25115698.$70$YR$E$F$Y$$$20240716$$HP$CH$CH
240596111$24059611$1$I$20240514$20240514$20240708$20240708$PER$$US-ROCHE-3564359$ROCHE$$75$YR$E$F$Y$$$20240708$$CN$US$US
240596122$24059612$2$F$20240629$20240723$20240708$20240726$PER$$US-AMGEN-USASP2024130816$AMGEN$$14$YR$T$F$Y$$$20240726$$CN$US$US
240596131$24059613$1$I$20240603$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024132306$AMGEN$$74$YR$E$M$Y$$$20240708$$CN$US$US
240596141$24059614$1$I$20240628$20240701$20240708$20240708$EXP$$US-SA-2024SA197179$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240708$$MD$US$US
240596151$24059615$1$I$$20240702$20240708$20240708$EXP$$US-KOANAAP-SML-US-2024-00689$Unknown Manufacturer$Padte S, Sharma N, Plzak C, Kashyap R. Uncommon Breast Metastasis in PDL1 and EGFR-Positive Non-Small Cell Lung Cancer. Am-J-Respir-Crit-Care-Med. 2024;209: A6513.$75$YR$E$F$Y$$$20240708$$MD$US$US
240596161$24059616$1$I$$20240624$20240708$20240708$EXP$$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109021$ZYDUS PHARM$Seoane Blanco L, Fernandez Suarez B, Gomez Rivas M, Garcia Gomez A.. Association of microscopic colitis and enteropathy due to olmesartan.. Rev Esp Enferm Dig.. 2024$$$$$Y$$$20240708$$MD$ES$ES
240596171$24059617$1$I$20240625$20240626$20240708$20240708$EXP$GB-MHRA-MED-202406250919257530-VZWCK$GB-MSNLABS-2024MSNSPO01463$MSN LABORATORIES$$$$$$Y$$$20240708$$MD$GB$GB
240596182$24059618$2$F$20240404$20240701$20240708$20240715$EXP$FR-AFSSAPS-TO2024001135$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108979$ZYDUS PHARM$$$$$$Y$$$20240715$$MD$FR$FR
240596191$24059619$1$I$$20240624$20240708$20240708$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108905$ZYDUS PHARM$Venkat Ramanan S, Ghazal F, Addanki PR, Perez MF.. Thyroid Tempest: Unravelling a Rare Case of Amiodarone-Induced Thyroid Storm.. Am-J-Respir-Crit-Care-Med. 2024;209:A3400$$$$$Y$$$20240708$$HP$US$US
240596201$24059620$1$I$$20240624$20240708$20240708$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001672$IPCA$R. M. Puthumana, J. Mintz, M. Perez et al.. Too much of a good thing: A case of beta blocker and warfarin toxicity. Am J Respir Crit Care Med. 2024;209:A5692$$$$$Y$$$20240708$$HP$US$US
240596212$24059621$2$F$$20240730$20240708$20240805$30DAY$$CA-JNJFOC-20240714011$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$PH$CA$CA
240596221$24059622$1$I$$20240701$20240708$20240708$30DAY$$US-GSK-US2024083016$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$CN$US$US
240596231$24059623$1$I$$20240703$20240708$20240708$EXP$DE-DEXPHARM-20110349$DE-HALEON-2185286$Haleon PLC$Pfersdorff M; Spes J; Kraus M R. 17-year-old patient with neutropenia and fever during therapy with analgesics. German medical weekly (1946), (2011 Feb) Vol. 136, No. 8, pp. 365-8.; Anonymous. Agranulocytosis: young ones are also at risk. Med Trib 2011;19:.$17$YR$$M$Y$$$20240708$$HP$DE$DE
240596241$24059624$1$I$20240613$20240613$20240708$20240708$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002839$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240708$$CN$US$US
240596251$24059625$1$I$$20240702$20240708$20240708$EXP$$US-KOANAAP-SML-US-2024-00690$Unknown Manufacturer$Puri C, Khan AA, Sher N. A Case of Emphysematous Gastritis With Septic Shock and Clostridioides Difficile. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1630. DOI:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1630$72$YR$E$F$Y$$$20240708$$MD$US$US
240596261$24059626$1$I$$20240701$20240708$20240708$EXP$$ES-SA-2024SA198402$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240708$$HP$ES$ES
240596271$24059627$1$I$20240705$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004089$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240708$$MD$US$US
240596281$24059628$1$I$20240628$20240628$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407001097$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240708$$CN$US$US
240596291$24059629$1$I$20240409$20240626$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202406019017$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240708$$CN$US$US
240596301$24059630$1$I$20240701$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004147$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240708$$CN$US$US
240596311$24059631$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004080$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240708$$CN$US$US
240596321$24059632$1$I$20240705$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004259$ELI LILLY AND CO$$63$YR$A$$Y$$$20240708$$CN$US$US
240596331$24059633$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004241$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240708$$CN$US$US
240596341$24059634$1$I$20240610$20240626$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202406019366$ELI LILLY AND CO$$$$$$Y$$$20240708$$CN$US$US
240596351$24059635$1$I$20240704$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004265$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240708$$CN$US$US
240596361$24059636$1$I$20240601$20240701$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407001381$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240708$$HP$US$US
240596371$24059637$1$I$20240705$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004197$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240708$$CN$US$US
240596381$24059638$1$I$20240613$20240628$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407000092$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240708$$CN$US$US
240596391$24059639$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004176$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240708$$CN$US$US
240596401$24059640$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107882$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$81.19$KG$20240708$$CN$US$US
240596412$24059641$2$F$20240607$20240710$20240708$20240716$EXP$$CO-VANTIVE-2024VAN017839$Vantive US Healthcare$$74$YR$$F$Y$53$KG$20240716$$HP$CO$CO
240596421$24059642$1$I$20240601$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107845$BRISTOL MYERS SQUIBB$$24$YR$A$M$Y$$$20240708$$PH$US$US
240596431$24059643$1$I$20221028$20240627$20240708$20240708$EXP$$GB-CELLTRION INC.-2022GB018446$CELLTRION$$$$$$Y$$$20240708$$HP$GB$GB
240596441$24059644$1$I$$20240624$20240708$20240708$EXP$$HU-TEVA-VS-3215413$TEVA$Cegledi A, Batai A, Dolgos J, Fekete M, Gopcsa L, Kiraly V, et al. Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol. Pathol-Oncol-Res 2024; 30.$$$$$Y$$$20240708$$HP$HU$HU
240596453$24059645$3$F$20240629$20240712$20240708$20240801$EXP$$US-SA-2024SA198361$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240719$$MD$US$US
240596461$24059646$1$I$$20201013$20240708$20240708$EXP$$CA-HALEON-2185568$Haleon PLC$$63$YR$$F$Y$$$20240708$$HP$CA$CA
240596472$24059647$2$F$$20240702$20240708$20240712$PER$$US-ROCHE-10000019704$ROCHE$$51$YR$A$F$Y$$$20240712$$MD$US$US
240596482$24059648$2$F$20240323$20240708$20240708$20240717$EXP$GB-MHRA-MED-202406281038502460-PFVRS$GB-TEVA-VS-3215785$TEVA$$$$$$Y$$$20240717$$CN$GB$GB
240596491$24059649$1$I$$20231120$20240708$20240708$PER$$US-AMGEN-USASP2023235518$AMGEN$$$$$$Y$$$20240708$$MD$US$US
240596501$24059650$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46880$$FDA-CTU$$73$YR$$F$N$108.86$KG$20240705$N$$US$
240596511$24059651$1$I$20240630$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46982$$FDA-CTU$$75$YR$$M$N$$$20240705$N$HP$US$
240596521$24059652$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46912$$FDA-CTU$$64$YR$$F$N$119.29$KG$20240705$N$$US$
240596541$24059654$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46909$$FDA-CTU$$72$YR$$F$N$$$20240705$N$$US$
240596551$24059655$1$I$20240703$20240704$20240704$20240704$DIR$709091$$FDA-CTU$$35$YR$$M$N$90$KG$20240704$N$CN$US$
240596561$24059656$1$I$$20240704$20240704$20240704$DIR$709104$$FDA-CTU$$$$$F$N$$$20240704$N$CN$US$
240596571$24059657$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46903$$FDA-CTU$$$$$F$N$$$20240705$N$HP$US$
240596581$24059658$1$I$20240624$20240704$20240704$20240704$DIR$709101$$FDA-CTU$$50$YR$$F$N$73.8$KG$20240704$N$CN$US$
240596591$24059659$1$I$20240615$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47032$$FDA-CTU$$37$YR$$F$N$$$20240705$N$HP$US$
240596601$24059660$1$I$20240704$20240704$20240704$20240704$DIR$709099$$FDA-CTU$$63$YR$$M$N$75.15$KG$20240704$Y$MD$US$
240596622$24059662$2$F$$20240712$20240708$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002821$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240596632$24059663$2$F$20220101$20240717$20240708$20240722$EXP$$US-SA-2024SA198840$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240722$$MD$US$US
240596641$24059664$1$I$20240605$20240703$20240708$20240708$EXP$$JP-EXELIXIS-CABO-24079164$EXELIXIS$$7$DEC$$M$Y$140$KG$20240708$$MD$JP$JP
240596651$24059665$1$I$$20240627$20240708$20240708$EXP$$HU-Accord-433229$ACCORD$Adam O.. A race against time: POEMS syndrome. Clinical Neuroscience. 2024,77(5-6):212-216.$46$YR$A$M$Y$$$20240708$$MD$HU$HU
240596661$24059666$1$I$20240328$20240627$20240708$20240708$EXP$FR-AFSSAPS-CF2024000238$FR-Accord-433326$ACCORD$$53$YR$A$M$Y$176$KG$20240708$$MD$FR$FR
240596671$24059667$1$I$20170101$20240627$20240708$20240708$EXP$GB-MHRA-MED-202406272142396880-JPSTH$GB-Accord-433222$ACCORD$$$$$$Y$$$20240708$$CN$GB$GB
240596681$24059668$1$I$20240607$20240626$20240708$20240708$EXP$BE-FAMHP-DHH-N2024-122286$BE-Accord-432910$ACCORD$$23$YR$A$F$Y$97$KG$20240708$$CN$BE$BE
240596691$24059669$1$I$$20240627$20240708$20240708$EXP$GB-MHRA-30708036$GB-Accord-433106$ACCORD$$8$MON$I$$Y$$$20240708$$PH$GB$GB
240596701$24059670$1$I$20140604$20240627$20240708$20240708$EXP$$PL-Accord-432994$ACCORD$Maciej S, Hanna A, Letachowicz K, Dorota K, Miroslaw B, Oktawia M, et al. Severe Bullous Erysipelas/Cellulitis, Atypically Caused by Escherichia coli, in Kidney Transplant Recipient -Case Report and Review of Literature. Transplantation Proceedings. 2024;56(4):976-80. DOI: 10.1016/j.transproceed.2024.02.005.$57$YR$A$F$Y$$$20240708$$MD$PL$PL
240596711$24059671$1$I$$20240626$20240708$20240708$EXP$AU-TGA-801560$AU-Accord-432835$ACCORD$$40$YR$A$M$Y$$$20240708$$HP$AU$AU
240596721$24059672$1$I$$20240627$20240708$20240708$EXP$$CH-Accord-432983$ACCORD$Hosek N, Montani M, Mani L. Acute post-renal kidney graft dysfunction due to cytomegalovirus-positive nephrogenic adenoma-case report and review of the literature. Frontiers in Medicine. 2024;11:1394028. DOI: 10.3389/fmed.2024.1394028.$33$YR$A$M$Y$$$20240708$$MD$CH$CH
240596731$24059673$1$I$20211122$20240626$20240708$20240708$EXP$IE-HPRA-2024-113115$IE-Accord-432918$ACCORD$$$$N$F$Y$1.535$KG$20240708$$MD$IE$IE
240596741$24059674$1$I$20240423$20240627$20240708$20240708$EXP$GB-MHRA-MED-202406271249557900-BCMJH$GB-MSNLABS-2024MSNSPO01471$MSN LABORATORIES$$$$$$Y$$$20240708$$MD$GB$GB
240596752$24059675$2$F$20150613$20240730$20240708$20240808$EXP$FR-AFSSAPS-AN2024000810$FR-Accord-433117$ACCORD$$50$YR$A$F$Y$74$KG$20240808$$PH$FR$FR
240596761$24059676$1$I$20240323$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281137402150-JMBTC$GB-TEVA-VS-3215783$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240596774$24059677$4$F$$20240907$20240708$20240911$EXP$$NVSC2024CH139791$NOVARTIS$Morin S, Boroli F, Vandenberghe?Durr S, Allali D, Masouridi?Levrat S, Chalandon Y et al.. Severe anaphylaxis after chimeric antigen receptor T-cell injection: a case report. EJHAEM. 2024;5:603-6$77$YR$$M$Y$$$20240911$$HP$CH$CH
240596784$24059678$4$F$$20240814$20240708$20240821$EXP$$NVSC2024FR140153$NOVARTIS$$18$YR$$M$Y$$$20240821$$PH$FR$FR
240596791$24059679$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281145082300-JSMBZ$GB-TEVA-VS-3215834$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240596801$24059680$1$I$20240606$20240704$20240704$20240704$DIR$709094$$FDA-CTU$$65$YR$$F$N$108$KG$20240704$Y$CN$US$
240596811$24059681$1$I$20240522$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46968$$FDA-CTU$$68$YR$$M$N$$$20240705$Y$PH$US$
240596821$24059682$1$I$20231102$20240704$20240704$20240704$DIR$709109$$FDA-CTU$$54$YR$$M$N$99$KG$20240704$Y$CN$US$
240596841$24059684$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133284$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240596851$24059685$1$I$$20240703$20240705$20240705$DIR$FDA-CDER-CTU-2024-46898$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240596861$24059686$1$I$20240622$20240703$20240708$20240708$EXP$$CN-SA-2024SA199507$SANOFI AVENTIS$$75$YR$E$F$Y$51$KG$20240708$$HP$CN$CN
240596872$24059687$2$F$$20240705$20240708$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002816$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
240596881$24059688$1$I$$20240701$20240708$20240708$EXP$$US-BIOGEN-2024BI01272156$BIOGEN$$$$$F$Y$$$20240708$$CN$US$US
240596891$24059689$1$I$20240628$20240704$20240704$20240704$DIR$709093$$FDA-CTU$$39$YR$$M$N$85$KG$20240704$N$MD$US$
240596901$24059690$1$I$$20230307$20240708$20240708$EXP$$CA-HALEON-2185018$Haleon PLC$$44$YR$$F$Y$70$KG$20240708$$HP$CA$CA
240596911$24059691$1$I$20240503$20240628$20240708$20240708$EXP$$FR-AUROBINDO-AUR-APL-2024-032218$AUROBINDO$$66$YR$$F$Y$65$KG$20240708$$PH$FR$FR
240596921$24059692$1$I$$20240706$20240708$20240708$PER$$US-HALEON-2185780$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240596932$24059693$2$F$$20240808$20240708$20240821$EXP$$JP-AMGEN-JPNSP2024133235$AMGEN$$$$$$Y$$$20240821$$PH$JP$JP
240596941$24059694$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281432464540-VLDZP$GB-TEVA-VS-3215836$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240596951$24059695$1$I$$20240703$20240708$20240708$EXP$$US-TAKEDA-2024TUS067529$TAKEDA$$59$YR$$M$Y$$$20240708$$CN$US$US
240596961$24059696$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281419074630-BMTGL$GB-TEVA-VS-3215837$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240596972$24059697$2$F$20230919$20240819$20240708$20240829$EXP$DE-CADRBFARM-2024328857$DE-TEVA-VS-3215914$TEVA$$32$YR$$F$Y$64$KG$20240829$$CN$DE$DE
240596981$24059698$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06076$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240596991$24059699$1$I$20240601$20240701$20240708$20240708$EXP$$PR-JNJFOC-20240704608$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240708$$$COUNTRY NOT SPECIFIED$PR
240597001$24059700$1$I$20240323$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281122461890-DVTGF$GB-TEVA-VS-3215858$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240597012$24059701$2$F$20240617$20240816$20240708$20240819$EXP$$US-AstraZeneca-2024A153248$ASTRAZENECA$$27878$DY$$M$Y$$$20240819$$CN$US$
240597022$24059702$2$F$$20240702$20240708$20240711$PER$$US-ROCHE-10000019342$ROCHE$$34$YR$A$F$Y$$$20240711$$HP$US$US
240597032$24059703$2$F$20240612$20240823$20240708$20240827$EXP$$FR-AMERICAN REGENT INC-2024002550$AMERICAN REGENT$$70$YR$$M$Y$$$20240827$$PH$FR$FR
240597041$24059704$1$I$20240210$20240701$20240708$20240708$EXP$IT-MINISAL02-992193$IT-MYLANLABS-2024M1061878$MYLAN$$18$YR$$F$Y$57$KG$20240708$$CN$IT$IT
240597051$24059705$1$I$20240401$20240624$20240708$20240708$EXP$$US-MYLANLABS-2024M1058367$MYLAN$$29$YR$$F$Y$72.57$KG$20240708$$CN$US$US
240597062$24059706$2$F$$20240812$20240708$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107829$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240814$$HP$US$US
240597071$24059707$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107766$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240708$$CN$US$US
240597081$24059708$1$I$$20240701$20240708$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-105268$BRISTOL MYERS SQUIBB$Ochiai S, Kikuchi M, Kaikita K. An unusual contrast computed tomography scan finding in a patient with immune checkpoint inhibitor-associated AKI. Kidney360. 2024 Jun 01;5(6):927-8. doi:10.34067/KID.0000000000000463.$56$YR$A$M$Y$$$20240708$$HP$JP$JP
240597091$24059709$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06091$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240597101$24059710$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281141493050-NJBWG$GB-TEVA-VS-3215865$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240597111$24059711$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000257$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$35$YR$A$M$Y$$$20240708$$HP$CN$CN
240597121$24059712$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281042408830-QRLPK$GB-TEVA-VS-3215871$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240597132$24059713$2$F$20240422$20240712$20240708$20240717$EXP$$CO-UCBSA-2024034290$UCB$$57$YR$$M$Y$$$20240717$$CN$CO$CO
240597141$24059714$1$I$$20240628$20240708$20240708$EXP$$US-JNJFOC-20240679020$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240708$$$COUNTRY NOT SPECIFIED$US
240597153$24059715$3$F$$20240806$20240708$20240828$EXP$$US-GSK-US2024081567$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
240597171$24059717$1$I$20240609$20240628$20240708$20240708$EXP$$CN-SPECGX-T202401477$SPECGX$$$$C$M$Y$$$20240708$$CN$CN$CN
240597181$24059718$1$I$$20240702$20240708$20240708$EXP$$JP-009507513-2407JPN000639J$MERCK$$69$YR$$M$Y$$$20240708$$MD$JP$JP
240597191$24059719$1$I$$20240604$20240708$20240708$PER$$US-AMGEN-USASP2024131433$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240597201$24059720$1$I$20240701$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024132807$AMGEN$$74$YR$E$F$Y$$$20240708$$CN$US$US
240597211$24059721$1$I$20240703$20240704$20240704$20240704$DIR$709097$$FDA-CTU$$37$YR$$M$N$81$KG$20240704$N$CN$US$
240597231$24059723$1$I$20240301$20240704$20240704$20240704$DIR$709116$$FDA-CTU$$68$YR$$F$N$82.8$KG$20240704$N$CN$US$
240597251$24059725$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000261$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$66$YR$E$M$Y$$$20240708$$HP$CN$CN
240597261$24059726$1$I$$20240627$20240708$20240708$PER$$US-RDY-SPO/USA/24/0009514$DR REDDYS$$17$YR$T$M$Y$$$20240708$$MD$US$US
240597281$24059728$1$I$$20240624$20240708$20240708$PER$$US-GRANULES-US-2024GRASPO00252$GRANULES INDIA$$$$$$Y$$$20240708$$CN$US$US
240597291$24059729$1$I$$20240701$20240708$20240708$EXP$$US-VIIV HEALTHCARE LIMITED-US2024081625$VIIV$$$$$F$Y$$$20240708$$CN$US$US
240597303$24059730$3$F$20240710$20240820$20240708$20240829$30DAY$$US-GSK-US2024081658$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240829$$MD$US$US
240597311$24059731$1$I$$20240705$20240708$20240708$PER$$NVSC2024US140575$NOVARTIS$$$$$M$Y$$$20240708$$CN$US$US
240597321$24059732$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06055$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240597341$24059734$1$I$$20240704$20240704$20240704$DIR$709103$$FDA-CTU$$41$YR$$M$N$$$20240704$N$$IE$
240597352$24059735$2$F$20240601$20240806$20240708$20240807$PER$$US-ALXN-202407USA000117US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240597362$24059736$2$F$$20240806$20240708$20240807$PER$$US-ALXN-202407USA000018US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240597371$24059737$1$I$$20240626$20240708$20240708$EXP$$US-MSNLABS-2024MSNLIT01436$MSN LABORATORIES$Crawford M, Trinh J, Chaudhary S.A Case Report of Statin-induced Necrotizing Autoimmune Myopathy With Extramuscular Involvement.American Journal of Respiratory and Critical Care Medicine.2024;209:A1363$$$$$Y$$$20240708$$MD$US$US
240597381$24059738$1$I$20240625$20240704$20240704$20240704$DIR$709134$$FDA-CTU$$38$YR$$F$N$48.15$KG$20240704$N$CN$US$
240597401$24059740$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202400087782$PFIZER$$55$YR$$F$Y$$$20240708$$CN$US$US
240597411$24059741$1$I$20240611$20240613$20240708$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002827$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240708$$CN$US$US
240597421$24059742$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000263$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$50$YR$A$M$Y$$$20240708$$HP$CN$CN
240597431$24059743$1$I$20240704$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004139$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240708$$CN$US$US
240597441$24059744$1$I$$20240704$20240708$20240708$EXP$$CA-ABBVIE-5830820$ABBVIE$$$$A$M$Y$$$20240708$$CN$CA$CA
240597451$24059745$1$I$$20240624$20240708$20240708$EXP$$AU-ROCHE-3559592$ROCHE$$$$A$M$Y$50$KG$20240708$$MD$AU$AU
240597462$24059746$2$F$$20240702$20240708$20240711$PER$$US-ROCHE-10000019716$ROCHE$$34$YR$A$F$Y$$$20240711$$HP$US$US
240597486$24059748$6$F$20240420$20240821$20240708$20240828$EXP$$US-BIOGEN-2024BI01267932$BIOGEN$$64$YR$$F$Y$$$20240828$$CN$US$US
240597491$24059749$1$I$20220301$20240626$20240708$20240708$EXP$PL-URPL-DML-MLP.4401.1.722.2022$PL-Accord-433045$ACCORD$$67$YR$$F$Y$80$KG$20240708$$HP$PL$PL
240597501$24059750$1$I$20231103$20240627$20240708$20240708$EXP$FR-AFSSAPS-MP2024001063$FR-Accord-433626$ACCORD$$70$YR$E$F$Y$$$20240708$$PH$FR$FR
240597511$24059751$1$I$$20240626$20240708$20240708$EXP$CA-MHPD-E2B_07076350$CA-Accord-432800$ACCORD$$96$YR$E$M$Y$$$20240708$$HP$CA$CA
240597521$24059752$1$I$$20240626$20240708$20240708$EXP$$SI-Accord-432734$ACCORD$Trampuz BV. Electrolyte disorders in the emergency department-clinical cases and emergency treatment. Urgentna Medicina - Izbrana Poglavja. 2024:142-6.$75$YR$E$M$Y$$$20240708$$MD$SI$SI
240597531$24059753$1$I$$20240626$20240708$20240708$EXP$CA-MHPD-E2B_07063107$CA-Accord-432801$ACCORD$$$$$M$Y$$$20240708$$CN$CA$CA
240597541$24059754$1$I$$20240627$20240708$20240708$EXP$AU-TGA-800243$AU-Accord-432742$ACCORD$$68$YR$E$M$Y$$$20240708$$HP$AU$AU
240597551$24059755$1$I$$20240627$20240708$20240708$EXP$$MY-Accord-432993$ACCORD$Ng KL, Huan N, Tan WL, Aminudin NH, Hassan F, Nordin KM. Unravelling lung adenocarcinoma in an immunocompetent patient with endobronchial aspergilloma: A case report. Respirology case reports. 2024;12(6):e01409$73$YR$E$M$Y$$$20240708$$MD$MY$MY
240597561$24059756$1$I$$20240626$20240708$20240708$EXP$CA-MHPD-E2B_07089342$CA-Accord-432808$ACCORD$$$$E$M$Y$$$20240708$$HP$CA$CA
240597571$24059757$1$I$$20240628$20240708$20240708$30DAY$$US-GSK-US2024081069$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$CN$US$US
240597581$24059758$1$I$20240606$20240627$20240708$20240708$EXP$FR-AFSSAPS-RE2024000594$FR-Accord-433190$ACCORD$$61$YR$A$F$Y$61.5$KG$20240708$$PH$FR$FR
240597591$24059759$1$I$$20240626$20240708$20240708$EXP$$DE-Accord-432729$ACCORD$Solimani F, Nast A, Dilling A, Pahl S, Graf B, Gabner J, et al. Fatal course of cutaneous mucormycosis in an immunosuppressed patient. JDDG - Journal of the German Society of Dermatology. 2024;22(6):850-2.$41$YR$A$F$Y$$$20240708$$MD$DE$DE
240597601$24059760$1$I$20240429$20240626$20240708$20240708$EXP$DE-BFARM-24003707$DE-Accord-432921$ACCORD$$61$YR$A$F$Y$57$KG$20240708$$MD$DE$DE
240597611$24059761$1$I$20240611$20240626$20240708$20240708$EXP$CN-HENLIUS-24CN015623$CN-Accord-434119$ACCORD$$54$YR$A$F$Y$80$KG$20240708$$MD$CN$CN
240597621$24059762$1$I$20240423$20240627$20240708$20240708$EXP$GB-MHRA-MED-202406271249557900-BCMJH$GB-Accord-433083$ACCORD$$52$YR$A$M$Y$70$KG$20240708$$MD$GB$GB
240597631$24059763$1$I$$20240627$20240708$20240708$EXP$FR-AFSSAPS-AVMA2024000271$FR-Accord-433092$ACCORD$$26$YR$A$M$Y$$$20240708$$PH$FR$FR
240597641$24059764$1$I$$20240627$20240708$20240708$EXP$DE-BFARM-24004557$DE-Accord-433171$ACCORD$$$$$F$Y$3.41$KG$20240708$$MD$DE$DE
240597651$24059765$1$I$$20240625$20240708$20240708$EXP$$US-MYLANLABS-2024M1061556$MYLAN$Le CT, Mahmoud A, Kurt O, Bangash H, Saad Eldin M, Ayaz S. Advanced Care in Rheumatoid Arthritis With Biologic Agents: The Role of Pneumocystis Jirovecii Pneumonia Prophylaxis. Am-J-Respir-Crit-Care-Med 2024; 209 A2388.$66$YR$$F$Y$$$20240708$$HP$US$US
240597662$24059766$2$F$20240112$20240827$20240708$20240904$EXP$$CA-CELLTRION INC.-2024CA004950$CELLTRION$$$$$$Y$$$20240904$$CN$CA$CA
240597671$24059767$1$I$$20240623$20240708$20240708$EXP$GB-MHRA-MED-202406230715043650-LSZJH$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-05853$HIKMA$$$$$F$Y$60$KG$20240708$$CN$GB$GB
240597681$24059768$1$I$$20240625$20240708$20240708$EXP$$US-MYLANLABS-2024M1061418$MYLAN$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series. Pediatr-Nephrol 2024; 0 (0).$6$YR$$F$Y$$$20240708$$HP$US$US
240597691$24059769$1$I$$20240625$20240708$20240708$EXP$$US-MYLANLABS-2024M1061545$MYLAN$Yasir M, Gelaye AE. Rare Case of Resistant Aspergillus Niger Invasive Pulmonary Aspergillosis. Am-J-Respir-Crit-Care-Med 2024; 209 A3586.$70$YR$$F$Y$$$20240708$$HP$US$US
240597702$24059770$2$F$$20240806$20240708$20240809$30DAY$$DK-MYLANLABS-2024M1062107$MYLAN$$$$$$Y$$$20240809$$CN$DK$DK
240597711$24059771$1$I$20230808$20240704$20240708$20240708$EXP$$CA-JNJFOC-20230844651$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240708$$CN$CA$CA
240597722$24059772$2$F$$20240807$20240708$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05925$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240597731$24059773$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05842$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240597741$24059774$1$I$$20240625$20240708$20240708$EXP$$US-MYLANLABS-2024M1061455$MYLAN$Thompson TZ, Rearick WA, Pizzuto MF, Quinsey C, Enyart CE, Trau SP. Increasing Seizures, Encephalopathy, and Hypothermia in an 18-Year-Old Woman. Pediatrics 2023; 151 (3).$18$YR$$F$Y$$$20240708$$HP$US$US
240597752$24059775$2$F$20240601$20240719$20240708$20240801$PER$$US-APOTEX-2024AP007610$APOTEX$$$$$M$Y$$$20240801$$CN$US$US
240597761$24059776$1$I$$20240701$20240708$20240708$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP007959$STRIDES$Muller F, Boeltz S, Knitza J, Aigner M, Volkl S, Kharboutli S, et al.. CD19-targeted CAR T cells in refractory antisynthetase syndrome.. Lancet. 2023;401 (10379):815-818.$41$YR$$M$Y$$$20240708$$HP$DE$DE
240597773$24059777$3$F$$20240828$20240708$20240904$EXP$$US-AstraZeneca-2024A154226$ASTRAZENECA$$49$YR$$F$Y$79.8$KG$20240904$$MD$US$
240597782$24059778$2$F$$20240812$20240708$20240816$30DAY$$DE-PFIZER INC-202400130386$PFIZER$$6$DEC$$F$Y$$$20240816$$PH$DE$DE
240597791$24059779$1$I$$20240701$20240708$20240708$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP007960$STRIDES$Adak I, Yasoz C, Yuce B, Ozturk Tunali BD, Ekinci O.. Symptomatic esophagitis with methylphenidate in a boy with epilepsy and attention-deficit/hyperactivity disorder. Psychiatr-Clin-Psychopharmacolog. 2019;29 (Suppl. 1):222-223 abstr. 0455$10$YR$$M$Y$$$20240708$$HP$TR$TR
240597801$24059780$1$I$20220101$20240628$20240708$20240708$EXP$$FI-AMGEN-FINSP2024129330$AMGEN$$66$YR$E$F$Y$$$20240708$$CN$FI$FI
240597811$24059781$1$I$20240509$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405161729032150-RBSZK$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-107975$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240708$$MD$GB$GB
240597821$24059782$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000272$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$59$YR$A$M$Y$$$20240708$$HP$CN$CN
240597831$24059783$1$I$$20240625$20240708$20240708$EXP$$US-PHARMING-PHAUS2024000531$PHARMING GROUP$$$$$$Y$$$20240708$$CN$US$US
240597841$24059784$1$I$$20240701$20240708$20240708$EXP$SY-MLMSERVICE-20230619-4356187-1$SY-STRIDES ARCOLAB LIMITED-2023SP010685$STRIDES$Alsultan M, Kliea M, Hassan Q, Basha K.. Delayed acyclovir therapy for disseminated varicella zoster in an adult kidney transplant recipient: a case report and literature review.. Annals of Medicine and Surgery. 2023;85(3):519-523$31$YR$$M$Y$$$20240708$$MD$SY$SY
240597851$24059785$1$I$$20240625$20240708$20240708$EXP$$US-PHARMING-PHAUS2024000533$PHARMING GROUP$$$$$$Y$$$20240708$$CN$US$US
240597861$24059786$1$I$$20240220$20240708$20240708$PER$$US-BAYER-2024A095528$BAYER$$66$YR$E$F$Y$$$20240708$$CN$US$US
240597871$24059787$1$I$20240313$20240624$20240708$20240708$EXP$$RU-SERVIER-S24007918$SERVIER$$$$$$Y$$$20240708$$MD$RU$RU
240597881$24059788$1$I$20240625$20240625$20240708$20240708$EXP$$US-PHARMING-PHAUS2024000525$PHARMING GROUP$$$$$$Y$$$20240708$$CN$US$US
240597891$24059789$1$I$20240412$20240703$20240708$20240708$EXP$GB-MHRA-MED-202407010018118840-CQPRJ$GB-STRIDES ARCOLAB LIMITED-2024SP007951$STRIDES$$32$YR$$F$Y$76$KG$20240708$$CN$GB$GB
240597901$24059790$1$I$20240703$20240704$20240704$20240704$DIR$709120$$FDA-CTU$$27$YR$$M$N$51.75$KG$20240704$N$CN$US$
240597911$24059791$1$I$20240615$20240704$20240704$20240704$DIR$709122$$FDA-CTU$$74$YR$$M$N$108$KG$20240704$N$CN$US$
240597931$24059793$1$I$$20240704$20240704$20240704$DIR$709113$$FDA-CTU$$42$YR$$F$N$$$20240704$N$MD$US$
240597941$24059794$1$I$$20240704$20240704$20240704$DIR$709107$$FDA-CTU$$71$YR$$F$N$$$20240704$N$$US$
240597951$24059795$1$I$$20240624$20240708$20240708$PER$$US-Kindeva Drug Delivery L.P.-2158904$KINDEVA DRUG DELIVERY$$$$$F$Y$$$20240708$$$US$US
240597961$24059796$1$I$$20240701$20240708$20240708$EXP$$TW-AMGEN-TWNSP2024132902$AMGEN$Jaing T.; Wang Y.; Chang T. et al.. Blinatumomab in Children with MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 11 Cases. Hematology Reports. 2024;16 (2):347-353$18$YR$A$F$Y$$$20240708$$HP$TW$TW
240597971$24059797$1$I$$20240701$20240708$20240708$EXP$$NVSC2024PK138054$NOVARTIS$Muhammad Shah SY, Ajmal, Nawaz D, Lodhi AU, Rehman JU, Bahadar R, et al.. The responsiveness of childhood/adolescent chronic myeloid leukaemia patients of pakistani origin to tyrosine kinase inhibitor. JOURNAL OF AYUB MEDICAL COLLEGE ABBOTTABAD. 2023;32 (2):313-5$14$YR$$M$Y$$$20240708$$HP$PK$PK
240597981$24059798$1$I$$20240630$20240708$20240708$EXP$$AU-BAUSCHBL-2024BNL029414$BAUSCH AND LOMB$$18$YR$$F$Y$$$20240708$$CN$AU$AU
240597991$24059799$1$I$$20240630$20240708$20240708$EXP$$AU-BAUSCHBL-2024BNL029426$BAUSCH AND LOMB$$$$$F$Y$$$20240708$$CN$AU$AU
240598011$24059801$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000258$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$69$YR$E$M$Y$$$20240708$$HP$CN$CN
240598021$24059802$1$I$20240413$20240624$20240708$20240708$EXP$FR-AFSSAPS-AVNY2024000148$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108975$ZYDUS PHARM$$$$$$Y$$$20240708$$MD$FR$FR
240598031$24059803$1$I$$20240630$20240708$20240708$EXP$$AU-BAUSCHBL-2024BNL029430$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240708$$CN$AU$AU
240598041$24059804$1$I$20230918$20240627$20240708$20240708$EXP$IT-MINISAL02-992332$IT-Accord-433081$ACCORD$$44$YR$A$$Y$74$KG$20240708$$PH$IT$IT
240598051$24059805$1$I$20240401$20240626$20240708$20240708$EXP$DE-BFARM-24004506$DE-Accord-433147$ACCORD$$1$DY$N$F$Y$3.18$KG$20240708$$MD$DE$DE
240598061$24059806$1$I$$20240627$20240708$20240708$EXP$CA-MHPD-E2B_07101100$CA-Accord-432960$ACCORD$$77$YR$E$M$Y$$$20240708$$HP$CA$CA
240598071$24059807$1$I$20240518$20240626$20240708$20240708$EXP$FR-AFSSAPS-RN2024000697$FR-Accord-432915$ACCORD$$69$YR$E$M$Y$$$20240708$$MD$FR$FR
240598081$24059808$1$I$$20240626$20240708$20240708$EXP$CA-MHPD-E2B_07091591$CA-Accord-432799$ACCORD$$90$YR$E$M$Y$$$20240708$$HP$CA$CA
240598091$24059809$1$I$$20240624$20240708$20240708$PER$$US-ROCHE-10000015463$ROCHE$$$$T$F$Y$$$20240708$$CN$US$US
240598101$24059810$1$I$$20240625$20240708$20240708$EXP$$DE-MYLANLABS-2024M1061476$MYLAN$Knorr F, Schellekens KPJ, Schoot RA, Landman-Parker J, Teltschik H-M, Forster J, et al. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica 2023; 108 (5): 1442-1446.$17$YR$$M$Y$$$20240708$$HP$DE$DE
240598111$24059811$1$I$$20240625$20240708$20240708$EXP$$IT-MYLANLABS-2024M1061438$MYLAN$Celardo G, Scaffei E, Buchignani B, Donatelli G, Costagli M, Cristofani P, et al. Case report: Exploring chemoradiotherapy-induced leukoencephalopathy with 7T imaging and quantitative susceptibility mapping. Front-Neurol 2024; 15 1-6.$9$YR$$M$Y$$$20240708$$HP$IT$IT
240598121$24059812$1$I$$20240625$20240708$20240708$EXP$$PT-MYLANLABS-2024M1061443$MYLAN$Pombal R, Silva L, Ferreira D. Genetic predisposition to vaccine-induced immune thrombotic thrombocytopenia: is there a family link?. Eur-J-Case-Rep-Intern-Med 2024; 11 (6):.$28$YR$$M$Y$$$20240708$$HP$PT$PT
240598131$24059813$1$I$$20240625$20240708$20240708$EXP$$DE-MYLANLABS-2024M1061795$MYLAN$Knorr F, Schellekens KPJ, Schoot RA, Landman-Parker J, Teltschik H-M, Forster J, et al. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica 2023; 108 (5): 1442-1446.$6$YR$$M$Y$$$20240708$$HP$DE$DE
240598141$24059814$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05970$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240598151$24059815$1$I$20240101$20240624$20240708$20240708$PER$$US-COSETTE-CP2024US000145$COSETTE PHARMACEUTICALS$$$$A$F$Y$$$20240708$$PH$US$US
240598161$24059816$1$I$20240610$20240624$20240708$20240708$EXP$GB-MHRA-MED-202406231945493330-VCGQN$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-06082$HIKMA$$43$YR$$F$Y$100$KG$20240708$$CN$GB$GB
240598171$24059817$1$I$20240624$20240705$20240708$20240708$EXP$$CN-ROCHE-10000019178$ROCHE$$78$YR$E$F$Y$40$KG$20240708$$HP$CN$CN
240598181$24059818$1$I$$20240703$20240708$20240708$EXP$$BR-JNJFOC-20240714564$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$BR$BR
240598191$24059819$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000271$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$49$YR$A$M$Y$$$20240708$$HP$CN$CN
240598201$24059820$1$I$$20240630$20240708$20240708$EXP$$AU-BAUSCHBL-2024BNL029433$BAUSCH AND LOMB$$33$YR$$F$Y$$$20240708$$CN$AU$AU
240598211$24059821$1$I$$20240630$20240708$20240708$EXP$$AU-BAUSCHBL-2024BNL029432$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240708$$CN$AU$AU
240598221$24059822$1$I$20231219$20240703$20240708$20240708$EXP$$JP-EXELIXIS-CABO-24079177$EXELIXIS$$66$YR$$M$Y$$$20240708$$MD$JP$JP
240598231$24059823$1$I$$20240703$20240708$20240708$EXP$$NVSC2024DO140129$NOVARTIS$$$$$F$Y$$$20240708$$CN$DO$DO
240598241$24059824$1$I$20240703$20240704$20240704$20240704$DIR$709124$$FDA-CTU$$16$YR$$F$N$47.25$KG$20240704$Y$CN$US$
240598251$24059825$1$I$$20240626$20240708$20240708$EXP$$DE-MYLANLABS-2022M1031060$MYLAN$Bonnet U, Kanti AK, Scherbaum N, Specka M.. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study.. J Psychoactive Drugs. 2023;55 (1):102-111$37$YR$$M$Y$$$20240708$$HP$DE$DE
240598261$24059826$1$I$20240616$20240708$20240708$20240708$EXP$SK-SUKLSK-20240414$NVSC2024SK140356$NOVARTIS$$35$YR$$M$Y$96$KG$20240708$$MD$SK$SK
240598271$24059827$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05932$LUPIN$$$$$M$Y$$$20240708$$CN$US$US
240598281$24059828$1$I$20230701$20240704$20240704$20240704$DIR$709126$$FDA-CTU$$66$YR$$F$N$82.35$KG$20240704$N$CN$US$
240598291$24059829$1$I$20240301$20240703$20240708$20240708$EXP$$US-UCBSA-2024013939$UCB$$35$YR$$M$Y$117.91$KG$20240708$$HP$US$US
240598301$24059830$1$I$20240618$20240703$20240705$20240705$DIR$FDA-CDER-CTU-2024-46727$$FDA-CTU$$57$YR$$F$N$$$20240703$N$HP$US$
240598311$24059831$1$I$$20240630$20240708$20240708$EXP$$AU-BAUSCHBL-2024BNL029435$BAUSCH AND LOMB$$60$YR$$$Y$$$20240708$$CN$AU$AU
240598321$24059832$1$I$20240321$20240705$20240708$20240708$EXP$PT-INFARMED-J202406-503$PT-GILEAD-2024-0679731$GILEAD$$27$YR$A$M$Y$78$KG$20240708$$MD$PT$PT
240598331$24059833$1$I$$20240606$20240708$20240708$EXP$$IN-ROCHE-10000016325$ROCHE$$$$$$Y$$$20240708$$MD$IN$IN
240598342$24059834$2$F$$20240802$20240708$20240814$EXP$$IN-CIPLA LTD.-2024IN06909$CIPLA$Ramadoss I, ArulRajamurugan P, Varadhan MS, Ramamoorthy R, Priya SV.. An unusual duo: immunodeficiency disorder and scleroderma. Indian Journal of Sexually Transmitted Diseases and AIDS. 2024;45 (1):P 52 to P 54$$$$$Y$$$20240814$$MD$IN$IN
240598352$24059835$2$F$$20240716$20240708$20240726$EXP$$FR-TEVA-VS-3215473$TEVA$Porte J, Hennequin C, Krizch D, Vercellino L, Guillerm S, Thieblemont C, et al. Extranodal nasal-type NK/T lymphoma treated with chemotherapy and radiotherapy: case series from a European tertiary referral center and review of the literature. Strahlenther-Onkol 2024; 200 (5): 434-443.; Porte J, Hennequin C, Krizch D, Vercellino L, Guillerm S, Thieblemont C, et al. Extranodal nasal-type NK/T lymphoma treated with chemotherapy and radiotherapy: case series from a European tertiary referral cent...$$$$$Y$$$20240726$$HP$FR$FR
240598361$24059836$1$I$$20240704$20240704$20240704$DIR$709115$$FDA-CTU$$16$YR$$F$N$$$20240704$N$HP$US$
240598371$24059837$1$I$20240622$20240628$20240708$20240708$EXP$CN-NMPACDR-3708281020400202400519$CN-BAXTER-2024BAX021006$BAXTER$$52$YR$$M$Y$65$KG$20240708$$MD$CN$CN
240598381$24059838$1$I$20230101$20240702$20240708$20240708$EXP$$RU-BIOGEN-2024BI01272498$BIOGEN$$45$YR$$F$Y$$$20240708$$MD$RU$RU
240598391$24059839$1$I$$20240704$20240708$20240708$PER$$US-ABBVIE-5830955$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240598401$24059840$1$I$$20240624$20240708$20240708$EXP$$JP-TEYRO-2024-TY-000253$Teyro Labs$Kawaguchi T, Yamasaki K, Shigemi S, Dosaka H, Hirosawa R, Nagasawa T, et al..A combined small cell lung carcinoma patient with only small cell carcinoma components in mediastinal lymph node metastasis and chondrosarcoma-like components in liver metastasis.Respirol Case Rep.2024;12:e01416$69$YR$A$M$Y$$$20240708$$HP$JP$JP
240598421$24059842$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194766$SANOFI AVENTIS$$$$A$F$Y$59.87$KG$20240708$$MD$US$US
240598433$24059843$3$F$20240101$20240711$20240708$20240722$PER$$US-SA-2024SA194887$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240722$$MD$US$US
240598441$24059844$1$I$$20240625$20240708$20240708$PER$$US-SA-2024SA193098$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$HP$US$US
240598451$24059845$1$I$$20240625$20240708$20240708$PER$$US-SA-2024SA019765$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240598462$24059846$2$F$20240619$20240820$20240708$20240905$PER$$US-APOTEX-2024AP007675$APOTEX$$77$YR$E$F$Y$$$20240905$$CN$US$US
240598473$24059847$3$F$20240501$20240919$20240708$20240927$EXP$$CA-MYLANLABS-2022M1087082$BIOCON$$$$$$Y$$$20240927$$HP$CA$CA
240598481$24059848$1$I$20240601$20240629$20240708$20240708$PER$$US-SA-2024SA197373$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240708$$MD$US$US
240598491$24059849$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194748$SANOFI AVENTIS$$$$T$M$Y$44.68$KG$20240708$$MD$US$US
240598501$24059850$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194785$SANOFI AVENTIS$$$$A$M$Y$164$KG$20240708$$MD$US$US
240598511$24059851$1$I$20240101$20240627$20240708$20240708$PER$$US-SA-2024SA194352$SANOFI AVENTIS$$2$YR$C$M$Y$16.782$KG$20240708$$MD$US$US
240598522$24059852$2$F$20140901$20240715$20240708$20240723$PER$$US-SA-2024SA194857$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240723$$MD$US$US
240598532$24059853$2$F$20240623$20240820$20240708$20240913$PER$$US-SA-2024SA194841$SANOFI AVENTIS$$4$YR$C$M$Y$15.8$KG$20240913$$MD$US$US
240598543$24059854$3$F$$20240802$20240708$20240812$PER$$US-SA-2024SA195084$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240812$$MD$US$US
240598553$24059855$3$F$20230101$20240909$20240708$20240917$PER$$US-SA-2024SA194994$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240918$$MD$US$US
240598562$24059856$2$F$20240601$20240815$20240708$20240828$PER$$US-SA-2024SA194911$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240828$$MD$US$US
240598571$24059857$1$I$20240501$20240629$20240708$20240708$PER$$US-SA-2024SA196478$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240708$$MD$US$US
240598581$24059858$1$I$20240401$20240627$20240708$20240708$PER$$US-SA-2024SA195101$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240708$$MD$US$US
240598591$24059859$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194085$SANOFI AVENTIS$$$$$F$Y$$$20240708$$MD$US$US
240598602$24059860$2$F$$20240801$20240708$20240809$PER$$US-SA-2023SA205301$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240809$$CN$US$US
240598611$24059861$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194866$SANOFI AVENTIS$$$$A$M$Y$109.29$KG$20240708$$MD$US$US
240598621$24059862$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193823$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240708$$MD$US$US
240598641$24059864$1$I$20240601$20240627$20240708$20240708$PER$$US-SA-2024SA194384$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240708$$MD$US$US
240598651$24059865$1$I$20240601$20240627$20240708$20240708$PER$$US-SA-2024SA194393$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240708$$MD$US$US
240598662$24059866$2$F$20240601$20240628$20240708$20240712$PER$$US-SA-2024SA193942$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240712$$MD$US$US
240598671$24059867$1$I$20240101$20240627$20240708$20240708$PER$$US-SA-2024SA194823$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240708$$MD$US$US
240598681$24059868$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA195107$SANOFI AVENTIS$$$$A$M$Y$67$KG$20240708$$CN$US$US
240598691$24059869$1$I$20240101$20240629$20240708$20240708$PER$$US-SA-2024SA196448$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240708$$MD$US$US
240598701$24059870$1$I$20240611$20240701$20240708$20240708$PER$$US-SA-2024SA197580$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240708$$MD$US$US
240598711$24059871$1$I$20240630$20240701$20240708$20240708$PER$$US-SA-2024SA196696$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240708$$MD$US$US
240598731$24059873$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA197729$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240708$$MD$US$US
240598741$24059874$1$I$$20240629$20240708$20240708$PER$$US-SA-2024SA196483$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240598751$24059875$1$I$$20240702$20240708$20240708$PER$$US-SA-2024SA197783$SANOFI AVENTIS$$17$YR$T$F$Y$59.864$KG$20240708$$MD$US$US
240598761$24059876$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA137343$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240598771$24059877$1$I$20240101$20240628$20240708$20240708$PER$$US-SA-2024SA152425$SANOFI AVENTIS$$52$YR$A$F$Y$158.75$KG$20240708$$MD$US$US
240598791$24059879$1$I$$20240629$20240708$20240708$PER$$US-SA-2024SA194564$SANOFI AVENTIS$$$$A$$Y$$$20240708$$MD$US$US
240598801$24059880$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA197250$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240708$$MD$US$US
240598811$24059881$1$I$20240101$20240701$20240708$20240708$PER$$US-SA-2024SA198083$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240708$$MD$US$US
240598831$24059883$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA196008$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240708$$PH$US$US
240598841$24059884$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA197631$SANOFI AVENTIS$$$$A$M$Y$113$KG$20240708$$MD$US$US
240598851$24059885$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA198082$SANOFI AVENTIS$$$$T$M$Y$$$20240708$$MD$US$US
240598861$24059886$1$I$20240601$20240701$20240708$20240708$PER$$US-SA-2024SA197945$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240708$$MD$US$US
240598881$24059888$1$I$20240101$20240703$20240708$20240708$PER$$US-SA-2024SA199834$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240708$$MD$US$US
240598891$24059889$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA197407$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240708$$MD$US$US
240598901$24059890$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA195788$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240708$$MD$US$US
240598911$24059891$1$I$20240101$20240702$20240708$20240708$PER$$US-SA-2024SA198249$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240708$$CN$US$US
240598922$24059892$2$F$20240101$20240819$20240708$20240828$PER$$US-SA-2024SA197632$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240828$$MD$US$US
240598932$24059893$2$F$20240101$20240724$20240708$20240802$PER$$US-SA-2024SA197731$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240802$$MD$US$US
240598941$24059894$1$I$20240101$20240701$20240708$20240708$PER$$US-SA-2024SA197445$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240708$$MD$US$US
240598952$24059895$2$F$$20240716$20240708$20240724$PER$$US-SA-2024SA197950$SANOFI AVENTIS$$$$A$F$Y$57.5$KG$20240724$$MD$US$US
240598962$24059896$2$F$20240702$20240710$20240708$20240718$PER$$US-SA-2024SA197762$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240719$$MD$US$US
240598971$24059897$1$I$20240601$20240702$20240708$20240708$PER$$US-SA-2024SA197296$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240708$$MD$US$US
240598982$24059898$2$F$$20240802$20240708$20240812$PER$$US-SA-2024SA198066$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240812$$MD$US$US
240598991$24059899$1$I$20240101$20240701$20240708$20240708$PER$$US-SA-2024SA197207$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240708$$MD$US$US
240599002$24059900$2$F$$20240808$20240708$20240819$PER$$US-SA-2023SA306883$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240819$$MD$US$US
240599021$24059902$1$I$$20240703$20240708$20240708$PER$$US-SA-2024SA199374$SANOFI AVENTIS$$$$$F$Y$$$20240708$$PH$US$US
240599031$24059903$1$I$20240702$20240703$20240708$20240708$PER$$US-SA-2024SA198856$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$CN$US$US
240599041$24059904$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA197744$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240599051$24059905$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA197699$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240708$$MD$US$US
240599061$24059906$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA148875$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240708$$MD$US$US
240599071$24059907$1$I$20240630$20240701$20240708$20240708$EXP$$US-VIIV HEALTHCARE LIMITED-US2024081674$VIIV$$35$YR$$M$Y$$$20240708$$CN$US$US
240599081$24059908$1$I$$20240628$20240708$20240708$30DAY$$US-GSK-US2024AMR081274$GLAXOSMITHKLINE$$$$$M$Y$$$20240708$$CN$US$US
240599091$24059909$1$I$$20240625$20240708$20240708$EXP$$US-VIVUS LLC-2024V1000809$VIVUS$$$$E$F$Y$$$20240703$$CN$US$US
240599103$24059910$3$F$20240501$20240820$20240708$20240828$EXP$$RO-AstraZeneca-2024A154993$ASTRAZENECA$$27602$DY$$M$Y$$$20240828$$MD$RO$
240599111$24059911$1$I$$20240705$20240708$20240708$EXP$$ID-AstraZeneca-2024A154961$ASTRAZENECA$$$$$$Y$$$20240708$$MD$ID$
240599123$24059912$3$F$20240101$20240801$20240708$20240810$PER$$US-SA-2024SA197760$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240810$$CN$US$US
240599131$24059913$1$I$$20240624$20240708$20240708$PER$$US-JNJFOC-20240675677$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$CN$US$US
240599142$24059914$2$F$20240101$20240802$20240708$20240806$EXP$$JP-JNJFOC-20240661603$JOHNSON AND JOHNSON$$81$YR$E$M$Y$53$KG$20240806$$PH$JP$JP
240599151$24059915$1$I$$20240705$20240708$20240708$PER$$NVSC2024US140639$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
240599161$24059916$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47035$$FDA-CTU$$72$YR$$F$N$$$20240705$N$$US$
240599171$24059917$1$I$20240625$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46970$$FDA-CTU$$65$YR$$F$N$$$20240705$Y$PH$US$
240599181$24059918$1$I$20240616$20240704$20240704$20240704$DIR$709132$$FDA-CTU$$67$YR$$F$N$73.8$KG$20240704$N$CN$US$
240599191$24059919$1$I$20220901$20240704$20240704$20240704$DIR$709121$$FDA-CTU$$64$YR$$F$N$60.75$KG$20240704$N$CN$US$
240599211$24059921$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47027$$FDA-CTU$$$$$F$N$$$20240705$N$HP$US$
240599245$24059924$5$F$20240629$20240904$20240708$20240905$30DAY$$US-PFIZER INC-PV202400080204$PFIZER$$12$YR$$F$Y$38.2$KG$20240905$$MD$US$US
240599254$24059925$4$F$$20240916$20240708$20240920$30DAY$$US-PFIZER INC-202400206193$PFIZER$$11$YR$$F$Y$$$20240920$$CN$US$US
240599265$24059926$5$F$20240601$20240919$20240708$20240924$30DAY$$US-PFIZER INC-PV202400008674$PFIZER$$10$YR$$M$Y$$$20240924$$CN$US$US
240599272$24059927$2$F$20240601$20240902$20240708$20240904$30DAY$$US-PFIZER INC-202400204578$PFIZER$$15$YR$$M$Y$$$20240904$$CN$US$US
240599284$24059928$4$F$$20240812$20240708$20240812$PER$$US-ALXN-202407USA000113US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
240599291$24059929$1$I$$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002783$ELI LILLY AND CO$$$$$$Y$$$20240708$$CN$US$US
240599301$24059930$1$I$20240101$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002624$ELI LILLY AND CO$$$$$F$Y$$$20240708$$CN$US$US
240599311$24059931$1$I$20240704$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004132$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240708$$CN$US$US
240599321$24059932$1$I$20240704$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004135$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240708$$CN$US$US
240599332$24059933$2$F$$20240821$20240708$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107685$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240829$$CN$US$US
240599345$24059934$5$F$20240625$20240919$20240708$20240923$30DAY$$US-PFIZER INC-202400203105$PFIZER$$11$YR$$M$Y$29.478$KG$20240923$$CN$US$US
240599395$24059939$5$F$20240701$20240911$20240708$20240911$30DAY$$US-PFIZER INC-202400206255$PFIZER$$13$YR$$M$Y$$$20240911$$CN$US$US
240599401$24059940$1$I$$20240626$20240708$20240708$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001423$SK LIFE SCIENCE$$$$$$Y$$$20240708$$CN$US$US
240599414$24059941$4$F$20240627$20240726$20240708$20240801$EXP$$KR-CELLTRION INC.-2024KR015857$CELLTRION$$$$$$Y$$$20240801$$MD$KR$KR
240599421$24059942$1$I$20240603$20240624$20240708$20240708$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-001077$SK LIFE SCIENCE$$$$$$Y$$$20240708$$HP$CA$CA
240599431$24059943$1$I$20240523$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46857$$FDA-CTU$$56$YR$$M$N$$$20240705$N$$US$
240599447$24059944$7$F$20240605$20240910$20240708$20240923$EXP$$ES-ACRAF SpA-2024-034720$SK LIFE SCIENCE$$$$$$Y$$$20240923$$CN$ES$ES
240599451$24059945$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06021$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240599461$24059946$1$I$$20240624$20240708$20240708$EXP$$US-EPICPHARMA-US-2024EPCLIT00785$EPIC PHARM$A. Patel.Pulmonary Tuberculosis Leading to Severe Acute Respiratory Distress Syndrome.American Journal of Respiratory and Critical Care Medicine.JAN-2023;207:A4334$65$YR$A$M$Y$$$20240708$$HP$US$US
240599471$24059947$1$I$20240703$20240704$20240704$20240704$DIR$709123$$FDA-CTU$$79$YR$$M$N$90$KG$20240704$N$CN$US$
240599481$24059948$1$I$$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134506$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240599491$24059949$1$I$20240201$20240701$20240708$20240708$EXP$$US-SA-2024SA196963$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240708$$MD$US$US
240599501$24059950$1$I$20240524$20240626$20240705$20240705$DIR$FDA-CDER-CTU-2024-46855$$FDA-CTU$$36$YR$$M$N$$$20240626$N$HP$US$
240599511$24059951$1$I$20240703$20240704$20240704$20240704$DIR$709135$$FDA-CTU$$62$YR$$F$N$74.25$KG$20240704$N$CN$US$
240599521$24059952$1$I$20240411$20240625$20240708$20240708$EXP$IT-MINISAL02-981031$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-03582$HIKMA$$75$YR$$F$Y$$$20240708$$MD$IT$IT
240599531$24059953$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000256$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..nature communication.2024;15:5251$57$YR$A$M$Y$$$20240708$$HP$CN$CN
240599541$24059954$1$I$$20240703$20240705$20240705$DIR$FDA-CDER-CTU-2024-46810$$FDA-CTU$$$$$M$N$$$20240703$N$HP$US$
240599551$24059955$1$I$$20240613$20240708$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002848$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
240599574$24059957$4$F$20240604$20240824$20240708$20240830$EXP$$KR-JNJFOC-20240707759$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240830$$MD$KR$KR
240599581$24059958$1$I$$20240701$20240708$20240708$30DAY$$US-GSK-US2024083019$GLAXOSMITHKLINE$$$$A$F$Y$$$20240708$$CN$US$US
240599591$24059959$1$I$20240627$20240704$20240704$20240704$DIR$709114$$FDA-CTU$$69$YR$$F$N$57.15$KG$20240704$N$CN$US$
240599601$24059960$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46839$$FDA-CTU$$37$YR$$F$N$$$20240705$N$$US$
240599612$24059961$2$F$20230928$20240704$20240708$20240709$EXP$$BY-MYLANLABS-2024M1062839$MYLAN$$72$YR$$M$Y$44.7$KG$20240709$$MD$BY$BY
240599625$24059962$5$F$$20240909$20240708$20240911$30DAY$$US-PFIZER INC-202400205736$PFIZER$$16$YR$$M$Y$$$20240911$$CN$US$US
240599631$24059963$1$I$20240530$20240624$20240708$20240708$PER$$US-COSETTE-CP2024US000146$COSETTE PHARMACEUTICALS$$41$YR$A$F$Y$148$KG$20240708$$HP$US$US
240599651$24059965$1$I$20240101$20240627$20240708$20240708$PER$$US-SA-2024SA193756$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240708$$MD$US$US
240599661$24059966$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405060340208450-NZPQH$GB-ORGANON-O2407GBR000624$ORGANON$$$$$F$Y$$$20240708$$CN$GB$GB
240599671$24059967$1$I$20240621$20240628$20240708$20240708$PER$$US-SA-2024SA197236$SANOFI AVENTIS$$54$YR$A$F$Y$62.142$KG$20240708$$MD$US$US
240599681$24059968$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA198202$SANOFI AVENTIS$$$$A$M$Y$32$KG$20240708$$MD$US$US
240599691$24059969$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA194600$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240708$$MD$US$US
240599701$24059970$1$I$20240101$20240627$20240708$20240708$PER$$US-SA-2024SA193279$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240708$$MD$US$US
240599711$24059971$1$I$20240618$20240702$20240708$20240708$PER$$US-SA-2024SA197988$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240708$$MD$US$US
240599721$24059972$1$I$20230101$20240701$20240708$20240708$PER$$US-SA-2024SA197286$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240708$$MD$US$US
240599731$24059973$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193759$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240708$$HP$US$US
240599742$24059974$2$F$20240101$20240809$20240708$20240820$PER$$US-SA-2024SA197759$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240820$$MD$US$US
240599751$24059975$1$I$20240601$20240627$20240708$20240708$PER$$US-SA-2024SA195834$SANOFI AVENTIS$$51$YR$A$M$Y$108.86$KG$20240708$$MD$US$US
240599761$24059976$1$I$$20240624$20240708$20240708$EXP$$US-EPICPHARMA-US-2024EPCLIT00790$EPIC PHARM$Erin Y. Chew.Giant cell arteritis associated with intravenous zoledronic acid administration.JBMR Plus.15-FEB-2024;8:1-6$79$YR$E$F$Y$$$20240708$$HP$US$US
240599771$24059977$1$I$20240101$20240702$20240708$20240708$PER$$US-SA-2024SA198497$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240708$$HP$US$US
240599781$24059978$1$I$$20240701$20240708$20240708$EXP$$JP-SA-2024SA198888$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240708$$HP$JP$JP
240599791$24059979$1$I$20240501$20240701$20240708$20240708$PER$$US-SA-2024SA197439$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240708$$MD$US$US
240599801$24059980$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR081959$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240599811$24059981$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000274$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$52$YR$A$M$Y$$$20240708$$HP$CN$CN
240599821$24059982$1$I$$20240701$20240708$20240708$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003720$ALNYLAM PHARMACEUTICALS$Urbinati G., Cani I., Curro Dossi M., Longhi S., Carigi S., Gagliardi C., Biagini E., Galie N., Cortelli P., Guaraldi P.. Patisiran for the treatment of patients with p.Ile88Leu hereditary transthyretin amyloidosis: an Italian real-life experience. Frontiers in Neurology. 2024$$$$$Y$$$20240708$$HP$IT$IT
240599831$24059983$1$I$20240315$20240510$20240708$20240708$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000212$PAREXEL$$$$$$Y$$$20240708$$CN$US$US
240599841$24059984$1$I$20240406$20240409$20240708$20240708$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000232$PAREXEL$$$$$$Y$$$20240708$$PH$US$US
240599851$24059985$1$I$$20240701$20240708$20240708$PER$$US-ABBVIE-5826774$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240599861$24059986$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR082270$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240599871$24059987$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR081901$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240599881$24059988$1$I$$20240624$20240708$20240708$PER$$US-JNJFOC-20240672744$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$US$US
240599891$24059989$1$I$$20240626$20240708$20240708$EXP$CA-MHPD-E2B_07092960$CA-Accord-432809$ACCORD$$$$E$M$Y$$$20240708$$HP$CA$CA
240599901$24059990$1$I$$20240626$20240708$20240708$EXP$AU-TGA-799628$AU-Accord-432575$ACCORD$$36$YR$A$M$Y$$$20240708$$HP$AU$AU
240599911$24059991$1$I$$20240626$20240708$20240708$EXP$GB-MHRA-MED-202406251436015840-SWCZQ$GB-Accord-432978$ACCORD$$67$YR$E$M$Y$98$KG$20240708$$CN$GB$GB
240599922$24059992$2$F$20240601$20240722$20240708$20240725$EXP$$CA-JNJFOC-20240582257$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240725$$HP$CA$CA
240599931$24059993$1$I$20240613$20240626$20240708$20240708$EXP$ES-AEMPS-1536377$ES-Accord-433046$ACCORD$$61$YR$A$F$Y$$$20240708$$HP$ES$ES
240599941$24059994$1$I$$20240626$20240708$20240708$EXP$$GB-Accord-432731$ACCORD$Gan YL, Bashir A, Sunni N. THE DIVERSITY OF CARDIAC MANIFESTATIONS IN RHEUMATOLOGICAL DISORDERS: HIGHLIGHTS ON IMMUNOSUPPRESSION AND CARDIAC COMPLICATIONS. Heart. 2024;110(Supplement 3):A33-4. DOI: 10.1136/heartjnl-2024-BCS.29$30$YR$A$F$Y$$$20240708$$HP$GB$GB
240599951$24059995$1$I$$20240626$20240708$20240708$EXP$CA-MHPD-E2B_07090540$CA-Accord-432768$ACCORD$$75$YR$E$M$Y$$$20240708$$MD$CA$CA
240599961$24059996$1$I$20240610$20240626$20240708$20240708$EXP$$US-Accord-432772$ACCORD$$77$YR$E$F$Y$82$KG$20240708$$HP$US$US
240599971$24059997$1$I$20240118$20240626$20240708$20240708$EXP$FR-AFSSAPS-AVMA2024000256$FR-Accord-432913$ACCORD$$60$YR$A$F$Y$$$20240708$$PH$FR$FR
240599982$24059998$2$F$20210401$20240702$20240708$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06032$LUPIN$$$$$$Y$$$20240725$$CN$US$US
240599991$24059999$1$I$$20240626$20240708$20240708$EXP$AU-TGA-802964$AU-Accord-432578$ACCORD$$$$$M$Y$$$20240708$$HP$AU$AU
240600002$24060000$2$F$$20240709$20240708$20240715$EXP$$CA-TAKEDA-2024TUS068145$TAKEDA$$$$$F$Y$$$20240715$$MD$CA$CA
240600012$24060001$2$F$20240101$20240710$20240708$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038291$BOEHRINGER INGELHEIM$$61$YR$A$F$Y$$$20240711$$CN$US$US
240600021$24060002$1$I$20240619$20240624$20240708$20240708$PER$$US-ALKERMES INC.-ALK-2024-001746$ALKERMES$$17$YR$$F$Y$44.444$KG$20240708$$HP$US$US
240600031$24060003$1$I$$20240624$20240708$20240708$EXP$$US-EPICPHARMA-US-2024EPCLIT00776$EPIC PHARM$Dhairya A. Lakhani.A young man with amnesia after drug overdose.European Journal of Internal Medicine.FEB-2024;122:117-118$29$YR$A$M$Y$$$20240708$$HP$US$US
240600041$24060004$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000260$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$57$YR$A$M$Y$$$20240708$$HP$CN$CN
240600051$24060005$1$I$$20240704$20240708$20240708$EXP$$EC-ROCHE-10000018195$ROCHE$$$$$$Y$$$20240708$$MD$EC$EC
240600061$24060006$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000144US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
240600071$24060007$1$I$$20240702$20240708$20240708$PER$$US-ROCHE-10000017103$ROCHE$$62$YR$A$M$Y$$$20240708$$CN$US$US
240600081$24060008$1$I$$20240702$20240708$20240708$PER$$US-ROCHE-10000017986$ROCHE$$$$A$F$Y$$$20240708$$CN$US$US
240600091$24060009$1$I$$20240624$20240708$20240708$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-05963$HIKMA$Nwodim O, Karsalia R, Heslin ME, Lieberman AE, Wang SZ, Kalanuria AA, Elser HC, Driessen B, Caruso C, Anesi GL.. Nwodim O, Karsalia R, Heslin ME, Lieberman AE, Wang SZ, Kalanuria AA, Elser HC, Driessen B, Caruso C, Anesi GL. Opioid-related xylazine toxicity manifesting as myonecrosis, rhabdomyolysis, multifocal ischemic cerebral infarcts, and cerebral edema. American college of emergency physicians open. 2024;5(3):e13187$27$YR$$F$Y$$$20240708$$MD$US$US
240600101$24060010$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46962$$FDA-CTU$$$$$M$N$$$20240705$N$HP$US$
240600111$24060011$1$I$$20240704$20240704$20240704$DIR$709112$$FDA-CTU$$40$YR$$F$N$$$20240704$N$HP$KR$
240600121$24060012$1$I$20240229$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47025$$FDA-CTU$$75$YR$$F$N$$$20240705$N$$US$
240600131$24060013$1$I$$20240704$20240704$20240704$DIR$709110$$FDA-CTU$$77$YR$$F$N$$$20240704$N$HP$KR$
240600141$24060014$1$I$$20240704$20240704$20240704$DIR$709117$$FDA-CTU$$73$YR$$F$N$$$20240704$N$HP$SE$
240600151$24060015$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46918$$FDA-CTU$$84$YR$$F$N$$$20240705$N$$US$
240600161$24060016$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46950$$FDA-CTU$$63$YR$$F$N$$$20240705$N$$US$
240600171$24060017$1$I$$20240704$20240704$20240704$DIR$709118$$FDA-CTU$$$$$UNK$N$$$20240704$N$HP$AU$
240600212$24060021$2$F$$20240705$20240708$20240713$EXP$$US-TAKEDA-2024TUS066132$TAKEDA$Fitzsimons J, Phelan K, Dhanarajan A. Hearing loss in a patient with waldenstrom macroglobulinemia receiving bortezomib. Case Reports In Oncology. 2024;17 (1):653-657$67$YR$$M$Y$$$20240713$$MD$US$US
240600221$24060022$1$I$20240521$20240628$20240708$20240708$EXP$FR-AFSSAPS-NC2024000728$FR-TEVA-VS-3215911$TEVA$$68$YR$$M$Y$$$20240708$$PH$FR$FR
240600231$24060023$1$I$$20240613$20240708$20240708$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002849$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
240600241$24060024$1$I$$20240630$20240708$20240708$EXP$$AU-BAUSCHBL-2024BNL029436$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240708$$CN$AU$AU
240600251$24060025$1$I$$20240628$20240708$20240708$EXP$$US-BAYER-2024A094634$BAYER$$65$YR$E$M$Y$$$20240708$$CN$US$US
240600261$24060026$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR082275$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240600271$24060027$1$I$20230101$20240624$20240708$20240708$PER$$US-ALKERMES INC.-ALK-2024-001761$ALKERMES$$$$$F$Y$$$20240708$$CN$US$US
240600281$24060028$1$I$$20240423$20240708$20240708$PER$$US-AMGEN-USASP2024133276$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240600291$24060029$1$I$$20230627$20240708$20240708$PER$$US-AMGEN-USASP2023235470$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240600303$24060030$3$F$$20240729$20240708$20240807$PER$$US-SA-2023SA264836$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240807$$CN$US$US
240600311$24060031$1$I$$20240702$20240708$20240708$PER$$US-SA-2024SA198119$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$CN$US$US
240600321$24060032$1$I$$20240702$20240708$20240708$PER$$US-SA-2024SA200010$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240708$$MD$US$US
240600331$24060033$1$I$20240101$20240701$20240708$20240708$PER$$US-SA-2024SA197483$SANOFI AVENTIS$$$$$M$Y$$$20240708$$CN$US$US
240600341$24060034$1$I$$20240627$20240708$20240708$PER$$US-ROCHE-10000015783$ROCHE$$$$$$Y$$$20240708$$MD$US$US
240600351$24060035$1$I$20240401$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405061455541680-ZSDVW$GB-ORGANON-O2407GBR000557$ORGANON$$25$YR$$M$Y$$$20240708$$MD$GB$GB
240600361$24060036$1$I$$20240702$20240708$20240708$PER$$US-ROCHE-10000018878$ROCHE$$$$A$F$Y$$$20240708$$CN$US$US
240600371$24060037$1$I$$20240628$20240708$20240708$EXP$$US-BAYER-2024A095836$BAYER$$$$$F$Y$$$20240708$$HP$US$US
240600381$24060038$1$I$$20240626$20240708$20240708$PER$$US-TEVA-VS-3213939$TEVA$$20$YR$$M$Y$$$20240708$$CN$US$US
240600391$24060039$1$I$$20240624$20240708$20240708$EXP$$IN-EPICPHARMA-IN-2024EPCLIT00809$EPIC PHARM$Bandaru Yeswanth Raja.Anabolic androgenic steroids induced iatrogenic cushing syndrome in a patient with relapse of antitubercular drugs induced hepatitis.Journal of Young Pharmacists.06-APR-2023;15(3):581-584$32$YR$A$M$Y$$$20240708$$HP$IN$IN
240600401$24060040$1$I$20240424$20240625$20240708$20240708$PER$$US-ALKERMES INC.-ALK-2024-001405$ALKERMES$$53$YR$$F$Y$$$20240708$$PH$US$US
240600411$24060041$1$I$$20240624$20240708$20240708$EXP$$US-EPICPHARMA-US-2024EPCLIT00803$EPIC PHARM$MP Whyte.Drug-induced osteopetrosis.Bone.AUG-2023;173$7$YR$C$F$Y$$$20240708$$HP$US$US
240600421$24060042$1$I$$20240701$20240708$20240708$EXP$$NVSC2024GB138166$NOVARTIS$$$$$F$Y$$$20240708$$CN$GB$GB
240600431$24060043$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000275$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$48$YR$A$M$Y$$$20240708$$HP$CN$CN
240600441$24060044$1$I$$20240624$20240708$20240708$PER$$US-JNJFOC-20240669871$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$HP$US$US
240600451$24060045$1$I$$20240528$20240708$20240708$EXP$$GB-SANDOZ INC.-SDZ2024GB063189$SANDOZ$$$$$M$Y$$$20240708$$CN$GB$GB
240600461$24060046$1$I$$20240703$20240708$20240708$EXP$$VN-SANDOZ INC.-SDZ2024VN063132$SANDOZ$$74$YR$$F$Y$$$20240708$$MD$VN$VN
240600471$24060047$1$I$20240703$20240705$20240708$20240708$EXP$$RU-SANDOZ INC.-SDZ2024RU063063$SANDOZ$$$$$F$Y$90$KG$20240708$$MD$RU$RU
240600481$24060048$1$I$$20240702$20240708$20240708$EXP$$CH-SANDOZ INC.-SDZ2024CH062615$SANDOZ$SoaP, FortesaM.. Plasmapheresis in a Pediatric Case of Multiorgan failure with Suspected DRESS or TSS. Swiss Medical Weekly$7$YR$$F$Y$$$20240708$$HP$CH$CH
240600491$24060049$1$I$20240524$20240705$20240708$20240708$EXP$FR-AFSSAPS-ST2024001119$FR-SANDOZ INC.-SDZ2024FR063067$SANDOZ$$37$YR$$M$Y$79.9$KG$20240708$$MD$FR$FR
240600502$24060050$2$F$$20240625$20240708$20240723$EXP$$MX-BEH-2024175070$CSL BEHRING$$$$$$Y$$$20240723$$CN$MX$MX
240600512$24060051$2$F$$20240723$20240708$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104715$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240802$$CN$US$US
240600521$24060052$1$I$20240617$20240628$20240708$20240708$EXP$ES-AEMPS-1538287$ES-TEVA-VS-3215741$TEVA$$44$YR$$M$Y$$$20240708$$PH$ES$ES
240600532$24060053$2$F$$20240803$20240708$20240808$PER$$US-RDY-SPO/USA/24/0009511$DR REDDYS$$80$YR$E$M$Y$$$20240808$$CN$US$US
240600543$24060054$3$F$20240429$20240730$20240708$20240801$EXP$$FR-TAKEDA-2024TUS067809$TAKEDA$$$$A$M$Y$$$20240801$$CN$FR$FR
240600551$24060055$1$I$20240229$20240628$20240708$20240708$EXP$$CN-TAKEDA-2024TUS068373$TAKEDA$$47$YR$$F$Y$$$20240708$$HP$CN$CN
240600561$24060056$1$I$20240616$20240628$20240708$20240708$EXP$IT-MINISAL02-991614$IT-TEVA-VS-3215653$TEVA$$62$YR$$M$Y$95$KG$20240708$$HP$IT$IT
240600573$24060057$3$F$$20240711$20240708$20240716$EXP$$JP-SANDOZ INC.-SDZ2024JP063268$SANDOZ$Nakamura S, Masuda S, Oda S, Yamakawa D, Yamaguchi S, Ishima T, et al. . Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine.. INTERNAL MEDICINE. 2024;63(12):1829-35.:10.2169/internalmedicine.2012-$72$YR$$F$Y$$$20240716$$HP$JP$JP
240600581$24060058$1$I$$20240702$20240708$20240708$PER$$US-BIOGEN-2024BI01272168$BIOGEN$$$$$F$Y$$$20240708$$CN$US$US
240600592$24060059$2$F$20240622$20240705$20240708$20240713$PER$$US-SA-2024SA198143$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240713$$MD$US$US
240600601$24060060$1$I$$20240702$20240708$20240708$PER$$US-SA-2024SA198080$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240708$$HP$US$US
240600611$24060061$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193424$SANOFI AVENTIS$$$$$$Y$$$20240708$$PH$US$US
240600621$24060062$1$I$$20240701$20240708$20240708$EXP$$US-SA-2024SA197725$SANOFI AVENTIS$$$$A$M$Y$96$KG$20240708$$MD$US$US
240600631$24060063$1$I$20231024$20231207$20240708$20240708$EXP$GB-MHRA-MED-202312061052026150-YJKFG$GB-TEVA-VS-3144542$TEVA$$18$YR$$M$Y$68$KG$20240708$$MD$GB$GB
240600641$24060064$1$I$20240203$20240703$20240708$20240708$EXP$$NVSC2024AR031043$NOVARTIS$$80$YR$$F$Y$$$20240708$$CN$AR$AR
240600651$24060065$1$I$20240704$20240705$20240708$20240708$PER$$US-TAKEDA-2024TUS068937$TAKEDA$$71$YR$$F$Y$45$KG$20240708$$HP$US$US
240600661$24060066$1$I$$20240624$20240708$20240708$PER$$US-EPICPHARMA-US-2024EPCSPO00794$EPIC PHARM$$$$$$Y$$$20240708$$CN$US$US
240600671$24060067$1$I$$20240703$20240708$20240708$EXP$$VN-AstraZeneca-2024A155209$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$VN$
240600681$24060068$1$I$$20240627$20240708$20240708$PER$$US-AstraZeneca-2024A151533$ASTRAZENECA$$$$$F$Y$$$20240708$$HP$US$
240600691$24060069$1$I$$20240620$20240708$20240708$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06259$NEUROCRINE BIOSCIENCES$$72$YR$$F$Y$$$20240708$$HP$US$US
240600701$24060070$1$I$$20240625$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06255$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240600711$24060071$1$I$$20240624$20240708$20240708$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108918$ZYDUS PHARM$Simmer P, Ghandi P, Gulati S.. Hot and bothered: A rare case of dyskinesia hyperpyrexia syndrome.. Crit-Care-Med. 2024;52(1):S289$$$$$Y$$$20240708$$HP$US$US
240600721$24060072$1$I$20240520$20240624$20240708$20240708$EXP$FR-AFSSAPS-NT2024000749$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108983$ZYDUS PHARM$$$$$$Y$$$20240708$$PH$FR$FR
240600731$24060073$1$I$$20240624$20240708$20240708$EXP$$JP-PURACAP-JP-2024EPCLIT00779$PURACAP$Hiramatsu Y.Hypothermia, bradycardia and hypotension during glucocorticoid or cyclosporine A therapy in a boy with Kikuchi-Fujimoto disease.Modern Rheumatology Case Reports : no pagination.MAY-2024$$$$M$Y$$$20240708$$HP$JP$JP
240600741$24060074$1$I$20240423$20240627$20240708$20240708$EXP$GB-MHRA-MED-202406271249557900-BCMJH$GB-TORRENT-00036949$TORRENT$$52$YR$A$M$Y$70$KG$20240708$$MD$GB$GB
240600751$24060075$1$I$$20240627$20240708$20240708$EXP$GB-MHRA-30950590$GB-TORRENT-00036952$TORRENT$$83$YR$E$F$Y$$$20240708$$PH$GB$GB
240600761$24060076$1$I$20240601$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004240$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240708$$CN$US$US
240600771$24060077$1$I$20240626$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004263$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240708$$CN$US$US
240600783$24060078$3$F$20240705$20240724$20240708$20240727$PER$$US-AMGEN-USASP2024134464$AMGEN$$73$YR$E$M$Y$$$20240727$$PH$US$US
240600791$24060079$1$I$$20240626$20240708$20240708$EXP$$FR-TAKEDA-2024TUS066440$TAKEDA$$$$$F$Y$$$20240708$$CN$FR$FR
240600801$24060080$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004150$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240708$$CN$US$US
240600811$24060081$1$I$$20240611$20240708$20240708$EXP$$TN-ROCHE-10000014388$ROCHE$Dhrif O, Bourguiba R M. systemic lupus erythematosus revealed through Purtscher retinopathy and autoimmune pancreatitis lupus. Journal of Internal Medicine.193-94.$54$YR$A$F$Y$$$20240708$$HP$TN$TN
240600824$24060082$4$F$$20240628$20240708$20240725$EXP$$MX-BEH-2024174954$CSL BEHRING$$$$$$Y$$$20240725$$CN$MX$MX
240600831$24060083$1$I$$20240624$20240708$20240708$EXP$$CN-TEYRO-2024-TY-000267$Teyro Labs$Gong H, Tian S, Ding H, Tao L, Wang L, Zhou L, et al..Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial..Nature Communications.2024;15:5251$62$YR$A$M$Y$$$20240708$$HP$CN$CN
240600845$24060084$5$F$$20240706$20240708$20240718$PER$$NVSC2024US140137$NOVARTIS$$$$$F$Y$$$20240718$$CN$US$US
240600851$24060085$1$I$$20240625$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06258$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240600861$24060086$1$I$$20240703$20240708$20240708$EXP$$US-UCBSA-2024033962$UCB$$$$$M$Y$$$20240708$$CN$US$US
240600871$24060087$1$I$$20240627$20240708$20240708$EXP$AU-TGA-800243$AU-Accord-432741$ACCORD$$68$YR$E$M$Y$$$20240708$$HP$AU$AU
240600881$24060088$1$I$$20240627$20240708$20240708$EXP$$US-Accord-433232$ACCORD$Bulsara KG, Patel H, Goldstein A, Mathew M. A Rare Case of Argatroban-Induced Anaphylaxis in a Patient With Intermediate-High Risk Pulmonary Embolism. Cureus. 2024 May 26;16(5):e61129. doi: 10.7759/cureus.61129.$32$YR$A$F$Y$$$20240708$$HP$US$US
240600901$24060090$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46854$$FDA-CTU$$45$YR$$F$N$98.88$KG$20240705$N$$US$
240600911$24060091$1$I$20130101$20240627$20240708$20240708$EXP$GB-MHRA-MED-202406261423533000-KSBRD$GB-Accord-433166$ACCORD$$$$$F$Y$87$KG$20240708$$HP$GB$GB
240600921$24060092$1$I$20240410$20240627$20240708$20240708$EXP$ES-AEMPS-1540138$ES-Accord-433396$ACCORD$$77$YR$E$F$Y$52.4$KG$20240708$$MD$ES$ES
240600931$24060093$1$I$20240201$20240627$20240708$20240708$EXP$DE-BFARM-24004558$DE-Accord-433109$ACCORD$$$$$F$Y$3.58$KG$20240708$$MD$DE$DE
240600941$24060094$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR081802$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$US$US
240600951$24060095$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46956$$FDA-CTU$$58$YR$$F$N$70.31$KG$20240705$N$$US$
240600961$24060096$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46826$$FDA-CTU$$51$YR$$F$N$55.79$KG$20240705$N$$US$
240600971$24060097$1$I$$20240627$20240708$20240708$EXP$$GR-Accord-432989$ACCORD$Giachos I, Velegraki A, Palioura S. First case of fungal keratitis secondary to Yamadazyma mexicana. International Journal of Ophthalmology. 2024;17(6):1164-7.$71$YR$E$M$Y$$$20240708$$MD$GR$GR
240600991$24060099$1$I$20240620$20240624$20240708$20240708$PER$$US-ROCHE-10000008018$ROCHE$$$$$F$Y$$$20240708$$CN$US$GR
240601001$24060100$1$I$20240619$20240625$20240708$20240708$PER$$US-ALKERMES INC.-ALK-2024-001757$ALKERMES$$$$$F$Y$$$20240708$$PH$US$US
240601011$24060101$1$I$$20240625$20240708$20240708$PER$$US-ALKERMES INC.-ALK-2024-001760$ALKERMES$$$$$M$Y$$$20240708$$CN$US$US
240601021$24060102$1$I$$20240624$20240708$20240708$EXP$$CA-EPICPHARMA-CA-2024EPCLIT00797$EPIC PHARM$Gabriela S. Gilmour.Functional Seizures in the Elderly: Accurate Diagnosis Can Reduce Iatrogenic Harm..Canadian Journal of Neurological Sciences.2024;51: 330-332$87$YR$E$M$Y$$$20240708$$HP$CA$CA
240601031$24060103$1$I$$20240624$20240708$20240708$PER$$US-EPICPHARMA-US-2024EPCSPO00806$EPIC PHARM$$$$$$Y$$$20240708$$CN$US$US
240601041$24060104$1$I$20240322$20240701$20240708$20240708$PER$$US-ABBVIE-5822986$ABBVIE$$64$YR$$F$Y$$$20240708$$CN$US$US
240601051$24060105$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05994$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240601071$24060107$1$I$20231001$20240625$20240708$20240708$EXP$$US-SPECGX-T202401414$SPECGX$$57$YR$$M$Y$95$KG$20240708$$CN$US$US
240601081$24060108$1$I$$20240628$20240708$20240708$EXP$$IN-RDY-LIT/IND/24/0009873$DR REDDYS$Samal DD, Samal P, Chandra Patra P, Sahu S. An unusual case of Blastic Plasmacytoid Dendritic Cell Neoplasm Masquerading as Primary Refractory Cutaneous T-Cell Lymphoma. Indian Journal of Hematology and Blood Transfusion. 2023;39: S133. doi:10.1007/s12288-023-01705-7.$40$YR$A$F$Y$$$20240708$$HP$IN$IN
240601091$24060109$1$I$20240708$20240708$20240708$20240708$EXP$$VN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038298$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$63$KG$20240708$$MD$VN$VN
240601101$24060110$1$I$20240101$20240629$20240708$20240708$PER$$US-SA-2024SA196481$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240708$$MD$US$US
240601113$24060111$3$F$20240101$20240905$20240708$20240912$EXP$$US-ABBVIE-5828691$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
240601131$24060113$1$I$$20240705$20240708$20240708$PER$$US-HALEON-2185598$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240601141$24060114$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46825$$FDA-CTU$$35$YR$$F$N$146.51$KG$20240705$N$$US$
240601161$24060116$1$I$$20240625$20240708$20240708$EXP$$CA-ROCHE-10000012560$ROCHE$$60$YR$A$F$Y$$$20240708$$HP$CA$CA
240601171$24060117$1$I$20240622$20240628$20240708$20240708$EXP$$CN-JNJFOC-20240704395$JOHNSON AND JOHNSON$$42$YR$A$F$Y$55.8$KG$20240708$$HP$CN$CN
240601181$24060118$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46847$$FDA-CTU$$47$YR$$F$N$$$20240705$N$$US$
240601202$24060120$2$F$$20240709$20240708$20240715$EXP$$LK-PERRIGO-24LK006281$PERRIGO$$67$YR$$M$Y$$$20240715$$MD$LK$LK
240601211$24060121$1$I$20240702$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133681$AMGEN$$81$YR$E$F$Y$$$20240708$$CN$US$US
240601222$24060122$2$F$$20240802$20240708$20240807$EXP$$JP-AMGEN-JPNSP2024131262$AMGEN$$$$$$Y$$$20240806$$MD$JP$JP
240601231$24060123$1$I$20240601$20240626$20240708$20240708$EXP$$US-PERRIGO-24US006244$PERRIGO$$$$$M$Y$$$20240708$$CN$US$US
240601242$24060124$2$F$20240101$20240805$20240708$20240813$EXP$$GB-UCBSA-2024034256$UCB$$$$$F$Y$$$20240813$$CN$GB$GB
240601251$24060125$1$I$20240626$20240626$20240708$20240708$PER$$US-ALKERMES INC.-ALK-2024-001765$ALKERMES$$42$YR$$F$Y$$$20240708$$MD$US$US
240601261$24060126$1$I$20240626$20240626$20240708$20240708$PER$$US-ALKERMES INC.-ALK-2024-001768$ALKERMES$$36$YR$$M$Y$$$20240708$$HP$US$US
240601271$24060127$1$I$$20240625$20240708$20240708$PER$$US-EPICPHARMA-US-2024EPCSPO00795$EPIC PHARM$$$$$$Y$$$20240708$$CN$US$US
240601282$24060128$2$F$$20240813$20240708$20240821$EXP$$US-AstraZeneca-2024A151845$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
240601291$24060129$1$I$20240624$20240703$20240708$20240708$EXP$$VN-AstraZeneca-2024A155256$ASTRAZENECA$$23916$DY$$M$Y$$$20240708$$CN$VN$
240601301$24060130$1$I$$20240625$20240708$20240708$EXP$$CA-ROCHE-10000010320$ROCHE$$34$YR$A$F$Y$$$20240708$$CN$CA$CA
240601312$24060131$2$F$$20240701$20240708$20240802$PER$$US-ROCHE-10000017893$ROCHE$$$$$$Y$$$20240802$$CN$US$US
240601321$24060132$1$I$20230801$20240626$20240708$20240708$PER$$US-ALKERMES INC.-ALK-2024-001770$ALKERMES$$13$YR$$M$Y$$$20240708$$CN$US$US
240601332$24060133$2$F$$20240729$20240708$20240806$EXP$$US-ALXN-202407USA000061US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240601341$24060134$1$I$$20240701$20240708$20240708$PER$$US-ROCHE-10000017759$ROCHE$$38$YR$A$F$Y$$$20240708$$CN$US$US
240601352$24060135$2$F$$20240711$20240708$20240721$EXP$$US-TEVA-VS-3214670$TEVA$Hussain M, Tiwana HZJ, Sivanandham R, Barsoum A, Bagheri S, Hussain S, et al. Aripiprazole-Induced Diabetic Ketoacidosis and Hypertriglyceridemia Triggering Concurrent Pancreatitis: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209; Hussain M, Tiwana HZJ, Sivanandham R, Barsoum A, Bagheri S, Hussain S, et al. Aripiprazole-Induced Diabetic Ketoacidosis and Hypertriglyceridemia Triggering Concurrent Pancreatitis: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209.$35$YR$$M$Y$$$20240721$$HP$US$US
240601361$24060136$1$I$20240522$20240522$20240708$20240708$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000401$PAREXEL$$$$$$Y$$$20240708$$CN$US$US
240601371$24060137$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000048US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$US$US
240601382$24060138$2$F$20240423$20240701$20240708$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000283$PAREXEL$$$$$$Y$$$20240930$$CN$US$US
240601392$24060139$2$F$20240501$20240626$20240708$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000319$PAREXEL$$$$$$Y$$$20240930$$PH$US$US
240601402$24060140$2$F$$20240822$20240708$20240829$EXP$$US-GSK-US2024GSK084290$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
240601412$24060141$2$F$$20240709$20240708$20240720$EXP$$JP-JNJFOC-A-CH2019-190930$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240719$$MD$JP$JP
240601421$24060142$1$I$20240624$20240701$20240708$20240708$EXP$$US-BAYER-2024A095110$BAYER$$28$YR$A$M$Y$$$20240708$$CN$US$US
240601433$24060143$3$F$$20240916$20240708$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024081067$VIIV$$$$$F$Y$$$20240926$$HP$US$US
240601441$24060144$1$I$20191215$20240624$20240708$20240708$EXP$$DE-NORDICGR-202002900$NORDIC PHARMA$$$$E$M$Y$$$20240708$$MD$DE$DE
240601451$24060145$1$I$20231201$20240628$20240708$20240708$EXP$FR-AFSSAPS-LY2024000922$FR-AMGEN-FRASP2024132105$AMGEN$$73$YR$E$F$Y$76$KG$20240708$$PH$FR$FR
240601471$24060147$1$I$$20240624$20240708$20240708$EXP$$NVSC2024CA139492$NOVARTIS$$97$YR$$F$Y$$$20240708$$HP$CA$CA
240601481$24060148$1$I$20240703$20240705$20240705$20240705$DIR$709159$$FDA-CTU$$$$$UNK$N$$$20240705$N$CN$US$
240601541$24060154$1$I$20240703$20240705$20240705$20240705$DIR$709161$$FDA-CTU$$$$$UNK$N$$$20240705$N$CN$US$
240601561$24060156$1$I$$20240705$20240705$20240705$DIR$709163$$FDA-CTU$$$$$UNK$N$$$20240705$$CN$US$
240601581$24060158$1$I$$20240705$20240705$20240705$DIR$709162$$FDA-CTU$$$$$UNK$N$$$20240705$$CN$US$
240601611$24060161$1$I$$20240705$20240705$20240705$DIR$709174$$FDA-CTU$$$$$F$N$$$20240705$Y$HP$US$
240601623$24060162$3$F$$20240808$20240708$20240816$EXP$$JP-AMGEN-JPNSP2024132921$AMGEN$$8$DEC$E$F$Y$$$20240816$$PH$JP$JP
240601631$24060163$1$I$$20240410$20240708$20240708$EXP$$US-GUERBET / LLC-US-20240066$GUERBET$$$$$F$Y$$$20240708$$HP$US$US
240601641$24060164$1$I$20240705$20240705$20240705$20240705$DIR$709177$$FDA-CTU$$68$YR$$F$N$$$20240705$Y$PH$US$
240601661$24060166$1$I$$20240702$20240705$20240705$DIR$FDA-CDER-CTU-2024-46934$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240601671$24060167$1$I$$20240705$20240705$20240705$DIR$709180$$FDA-CTU$$$$$UNK$N$$$20240705$$CN$US$
240601683$24060168$3$F$20240624$20240809$20240708$20240813$EXP$$CA-ABBVIE-5829876$ABBVIE$$84$YR$$F$Y$$$20240813$$CN$CA$CA
240601691$24060169$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06173$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240601701$24060170$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06160$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240601711$24060171$1$I$20240624$20240702$20240708$20240708$PER$$US-ROCHE-10000018672$ROCHE$$46$YR$A$M$Y$$$20240708$$CN$US$US
240601721$24060172$1$I$$20240620$20240708$20240708$EXP$$AU-ROCHE-10000009232$ROCHE$$$$$M$Y$$$20240708$$HP$AU$AU
240601732$24060173$2$F$$20240701$20240708$20240709$PER$$US-ROCHE-10000017300$ROCHE$$$$$F$Y$$$20240709$$HP$US$US
240601741$24060174$1$I$$20240701$20240708$20240708$PER$$US-ABBVIE-5830974$ABBVIE$$$$$$Y$$$20240708$$MD$US$CH
240601752$24060175$2$F$20240101$20240711$20240708$20240716$EXP$$CA-ABBVIE-5829951$ABBVIE$$69$YR$$F$Y$65.7$KG$20240716$$CN$CA$CA
240601762$24060176$2$F$20240701$20240716$20240708$20240723$EXP$$US-ORG100016242-2024000441$PACIRA$$71$YR$E$M$Y$65$KG$20240723$$MD$US$US
240601772$24060177$2$F$$20240814$20240708$20240821$30DAY$$US-GSK-US2024083011$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
240601781$24060178$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR082060$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$US$US
240601792$24060179$2$F$$20240703$20240708$20240715$EXP$$US-MYLANLABS-2024M1061818$MYLAN$Taylor C, Loukas V, Muwonge J, Taylor J, Boyle J. Early Surgical Excision of Necrotic Tissue Following Unintentional Dermal Injection of Extended-Release Buprenorphine. J-Addict-Med 2024; 0 (0).$33$YR$$M$Y$$$20240715$$HP$US$US
240601801$24060180$1$I$$20240626$20240708$20240708$EXP$$US-MYLANLABS-2024M1061808$MYLAN$Deanda S, Razia D, Zaidi W, Lee R, Arjuna A. Post-transplant Lymphoproliferative Disorder: A Nodular Area That Kept Growing!. Am-J-Respir-Crit-Care-Med 2024; 209 A5942.$79$YR$$F$Y$$$20240708$$HP$US$US
240601811$24060181$1$I$$20240626$20240708$20240708$EXP$$US-MYLANLABS-2024M1061793$MYLAN$Mehta V, Satuluru S, Azam MU, Acosta Sanchez I, Healy W. How Many Times Must We Rule Out Pulmonary Embolism? A Representative Case. Am-J-Respir-Crit-Care-Med 2024; 209.$39$YR$$M$Y$$$20240708$$HP$US$US
240601821$24060182$1$I$$20240626$20240708$20240708$EXP$$US-MYLANLABS-2024M1061591$MYLAN$Androsov A, Leo T. Ablation of persistent atrial fibrillation in a patient with cardiogenic shock on VA ECMO. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3968.$72$YR$$M$Y$$$20240708$$HP$US$US
240601831$24060183$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004375$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240708$$CN$US$US
240601841$24060184$1$I$$20240704$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004098$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240708$$HP$US$US
240601851$24060185$1$I$20240601$20240703$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107970$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240708$$MD$US$US
240601861$24060186$1$I$$20231225$20240708$20240708$EXP$GB-MHRA-MED-202312211403447760-CVTBG$GB-TEVA-VS-3145436$TEVA$$60$YR$$M$Y$$$20240708$$HP$GB$GB
240601872$24060187$2$F$$20240619$20240708$20240723$PER$$US-009507513-2406USA006797$MERCK$Kao C, Andika R. Disseminated Histoplasmosis - A Rare Cause of Shock in Non-HIV Patient. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1616$75$YR$$F$Y$$$20240723$$HP$US$US
240601881$24060188$1$I$$20240628$20240708$20240708$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-104481$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$81$KG$20240708$$PH$CA$CA
240601891$24060189$1$I$20240702$20240703$20240708$20240708$PER$$US-ROCHE-10000018189$ROCHE$$$$$$Y$$$20240708$$HP$US$US
240601921$24060192$1$I$20240630$20240705$20240708$20240708$PER$$US-ABBVIE-5830552$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240601931$24060193$1$I$20240101$20240703$20240708$20240708$EXP$$US-SA-2024SA199446$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240708$$MD$US$US
240601941$24060194$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06195$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240601951$24060195$1$I$20240101$20240628$20240708$20240708$PER$$US-SA-2024SA194782$SANOFI AVENTIS$$$$$$Y$$$20240708$$CN$US$US
240601961$24060196$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA195123$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240601971$24060197$1$I$20240617$20240701$20240708$20240708$PER$$US-SA-2024SA197833$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240708$$MD$US$US
240601981$24060198$1$I$20240626$20240701$20240708$20240708$PER$$US-SA-2024SA197723$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240708$$MD$US$US
240601991$24060199$1$I$20240101$20240628$20240708$20240708$PER$$US-SA-2024SA194387$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240708$$MD$US$US
240602001$24060200$1$I$$20240701$20240708$20240708$EXP$$CA-SA-2024SA196278$SANOFI AVENTIS$Wilken BF, Moran-Mendoza O, Pourafkari M, Asai Y.. Drug-induced interstitial lung disease associated with dupilumab for the treatment of atopic dermatitis.. JAAD Case Reports. 2024;50:12-5$73$YR$E$F$Y$$$20240708$$HP$CA$CA
240602011$24060201$1$I$$20240516$20240708$20240708$EXP$$KZ-BAYER-2024A085068$BAYER$$51$YR$A$M$Y$$$20240708$$CN$KZ$KZ
240602021$24060202$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA194432$SANOFI AVENTIS$$$$C$M$Y$$$20240708$$MD$US$US
240602031$24060203$1$I$20240622$20240628$20240708$20240708$PER$$US-SA-2024SA194478$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240708$$MD$US$US
240602041$24060204$1$I$$20240624$20240708$20240708$EXP$$FR-TEVA-VS-3216656$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240708$$HP$FR$FR
240602061$24060206$1$I$$20240628$20240708$20240708$EXP$$CA-BAXTER-2024BAX021034$BAXTER$$41$YR$$F$Y$$$20240708$$CN$CA$CA
240602071$24060207$1$I$20240704$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134374$AMGEN$$75$YR$E$M$Y$$$20240708$$CN$US$US
240602082$24060208$2$F$20240701$20240823$20240708$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107601$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240903$$HP$US$US
240602093$24060209$3$F$20240620$20240807$20240708$20240816$EXP$$CN-BAXTER-2024BAX021043$BAXTER$$72$YR$$F$Y$54.5$KG$20240816$$MD$CN$CN
240602104$24060210$4$F$20240702$20240909$20240708$20240924$EXP$$NVSC2024CL139957$NOVARTIS$$1$YR$$M$Y$$$20240924$$MD$CL$CL
240602111$24060211$1$I$20240702$20240702$20240708$20240708$EXP$$US-VANTIVE-2024VAN018135$Vantive US Healthcare$$$$$F$Y$$$20240708$$HP$US$US
240602122$24060212$2$F$$20240709$20240708$20240714$EXP$$JP-Eisai-EC-2024-169525$EISAI$Fuke Tomohiko. Usefulness of tracheal stents in patients with tracheal stenosis due to head and neck cancer. Abstracts of The 48th Annual Meeting of Japan Society for Head and Neck Cancer. 2024; 50(2): O-289-.$58$YR$A$M$Y$$$20240714$$MD$JP$JP
240602132$24060213$2$F$20240701$20240812$20240708$20240816$EXP$$US-AMGEN-USASP2024131173$AMGEN$$69$YR$E$F$Y$$$20240816$$CN$US$US
240602141$24060214$1$I$20240616$20240702$20240708$20240708$EXP$$CO-VANTIVE-2024VAN017885$Vantive US Healthcare$$72$YR$$M$Y$70$KG$20240708$$HP$CO$CO
240602151$24060215$1$I$20230101$20240702$20240708$20240708$EXP$$IT-ASTELLAS-2024EU006598$ASTELLAS$Livrieri A, Massari F, Scicchitano P, De Feo D, Pinto M, Abruzzese S et al. Cardiovascular toxicity in metastatic prostate cancer treatment: balancing risks treating consequences. European Heart Journal, Supplement. 2024;26(suppl 2):ii180$$$E$M$Y$$$20240708$$HP$IT$IT
240602161$24060216$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA194778$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240708$$CN$US$US
240602171$24060217$1$I$20240101$20240628$20240708$20240708$PER$$US-SA-2024SA195133$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240708$$MD$US$US
240602181$24060218$1$I$$20240624$20240708$20240708$EXP$$SG-ROCHE-10000007842$ROCHE$$57$YR$A$F$Y$$$20240708$$CN$SG$SG
240602191$24060219$1$I$20240330$20240410$20240708$20240708$EXP$$US-GUERBET / LLC-US-20240056$GUERBET$$39$YR$A$M$Y$74.8$KG$20240708$$HP$US$US
240602201$24060220$1$I$$20240626$20240708$20240708$PER$$US-TEVA-VS-3215320$TEVA$$$$$F$Y$$$20240708$$CN$US$US
240602211$24060221$1$I$20240704$20240705$20240705$20240705$DIR$709139$$FDA-CTU$$49$YR$$F$N$$$20240705$N$CN$US$
240602221$24060222$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46859$$FDA-CTU$$56$YR$$F$N$$$20240705$N$$US$
240602231$24060223$1$I$$20240705$20240705$20240705$DIR$709188$$FDA-CTU$$$$$UNK$N$$$20240705$$CN$US$
240602241$24060224$1$I$20240703$20240705$20240705$20240705$DIR$709192$$FDA-CTU$$$$$UNK$N$$$20240705$N$CN$US$
240602251$24060225$1$I$20240705$20240705$20240705$20240705$DIR$709189$$FDA-CTU$$53$YR$$F$N$$$20240705$N$HP$US$
240602261$24060226$1$I$20240215$20240705$20240705$20240705$DIR$709190$$FDA-CTU$$54$YR$$UNK$N$103.5$KG$20240705$Y$CN$US$
240602271$24060227$1$I$$20240705$20240705$20240705$DIR$709185$$FDA-CTU$$$$$UNK$N$$$20240705$$CN$US$
240602281$24060228$1$I$20240620$20240705$20240705$20240705$DIR$709154$$FDA-CTU$$30$YR$$F$N$103.95$KG$20240705$N$CN$US$
240602322$24060232$2$F$20240625$20240710$20240708$20240712$EXP$$US-BAYER-2024A093947$BAYER$$63$YR$A$F$Y$$$20240712$$HP$US$US
240602331$24060233$1$I$20240705$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134162$AMGEN$$56$YR$A$M$Y$$$20240708$$CN$US$US
240602341$24060234$1$I$$20240205$20240708$20240708$PER$$US-AMGEN-USASP2024131593$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240602351$24060235$1$I$$20240702$20240708$20240708$EXP$$GB-AMGEN-GBRSP2024132074$AMGEN$$$$$M$Y$$$20240708$$HP$GB$GB
240602361$24060236$1$I$20240101$20240701$20240708$20240708$EXP$$CH-ASTELLAS-2024US018858$ASTELLAS$$82$YR$$M$Y$$$20240708$$CN$CH$CH
240602372$24060237$2$F$20210621$20240903$20240708$20240910$EXP$$JP-ABBVIE-5828699$ABBVIE$$60$YR$$F$Y$70$KG$20240910$$MD$JP$JP
240602381$24060238$1$I$$20240701$20240708$20240708$EXP$$TW-AMGEN-TWNSP2024132994$AMGEN$Jaing T.; Wang Y.; Chang T. et al. Blinatumomab in Children with MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 11 Cases. Hematology Reports. 2024;16:347-353$$$$$Y$$$20240708$$HP$TW$TW
240602391$24060239$1$I$20240601$20240702$20240708$20240708$EXP$$US-ABBVIE-5826791$ABBVIE$$72$YR$$F$Y$$$20240708$$CN$US$US
240602401$24060240$1$I$20240101$20240703$20240708$20240708$EXP$$CA-ABBVIE-5829839$ABBVIE$$$$A$F$Y$$$20240708$$HP$CA$CA
240602411$24060241$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215121$TEVA$$25$YR$$M$Y$$$20240708$$HP$CA$CA
240602421$24060242$1$I$$20240624$20240708$20240708$EXP$$FR-TEVA-VS-3216657$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240708$$HP$FR$FR
240602431$24060243$1$I$$20210701$20240708$20240708$EXP$FR-AFSSAPS-PO20213118$FR-SA-2024SA195677$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240708$$MD$FR$FR
240602441$24060244$1$I$20190101$20240625$20240708$20240708$EXP$$AU-ROCHE-10000008612$ROCHE$$56$YR$A$M$Y$$$20240708$$MD$AU$AU
240602451$24060245$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215047$TEVA$$70$YR$$F$Y$160$KG$20240708$$CN$CA$CA
240602464$24060246$4$F$20240826$20240920$20240708$20240924$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038251$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240924$$CN$JP$JP
240602481$24060248$1$I$20230518$20240701$20240708$20240708$EXP$$US-RECORDATI-2023003196$RECORDATI$$$$$$Y$$$20240708$$CN$US$US
240602491$24060249$1$I$$20240626$20240708$20240708$PER$$US-TEVA-VS-3213946$TEVA$$$$$$Y$$$20240708$$CN$US$US
240602501$24060250$1$I$20240101$20240703$20240708$20240708$EXP$$US-SA-2024SA198936$SANOFI AVENTIS$$63$YR$A$M$Y$122.47$KG$20240708$$MD$US$US
240602511$24060251$1$I$20231219$20240704$20240708$20240708$EXP$$BR-ABBVIE-5830407$ABBVIE$$54$YR$$M$Y$95$KG$20240708$$CN$BR$BR
240602521$24060252$1$I$$20240705$20240708$20240708$EXP$$AR-ABBVIE-5830436$ABBVIE$$$$$F$Y$$$20240708$$CN$AR$AR
240602531$24060253$1$I$20240401$20240703$20240708$20240708$EXP$$US-ABBVIE-5828701$ABBVIE$$78$YR$$M$Y$$$20240708$$CN$US$US
240602542$24060254$2$F$20240621$20240813$20240708$20240826$PER$$US-ALKERMES INC.-ALK-2024-001780$ALKERMES$$54$YR$$F$Y$100.68$KG$20240826$$HP$US$US
240602551$24060255$1$I$$20240624$20240708$20240708$EXP$$PK-EPICPHARMA-PK-2024EPCLIT00788$EPIC PHARM$Aisha Jamal.A rare incidence of severe dermatological toxicities triggered by concomitant administration of all-trans retinoic acid and triazole antifungal in patients with acute promyelocytic leukemia: a case series and review of the literature.Journal of Medical Case Reports.MAY-2024;18(1):1-7$33$YR$A$F$Y$$$20240708$$HP$PK$PK
240602563$24060256$3$F$20231001$20240816$20240708$20240827$EXP$$US-BAYER-2024A092110$BAYER$$76$YR$E$F$Y$$$20240827$$CN$US$US
240602572$24060257$2$F$$20240913$20240708$20240923$PER$$US-GSK-US2024AMR082983$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
240602581$24060258$1$I$$20240628$20240708$20240708$30DAY$$US-GSK-US2024AMR081306$GLAXOSMITHKLINE$$8$YR$$F$Y$$$20240708$$CN$US$US
240602592$24060259$2$F$$20240826$20240708$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05906$LUPIN$$$$$$Y$$$20240913$$CN$US$US
240602601$24060260$1$I$20240410$20240417$20240708$20240708$EXP$$US-FERRINGPH-2024FE01941$FERRING$$$$$$Y$$$20240708$$CN$US$US
240602611$24060261$1$I$$20240411$20240708$20240708$EXP$$US-FERRINGPH-2024FE01843$FERRING$$$$$$Y$$$20240708$$HP$US$US
240602621$24060262$1$I$20240426$20240427$20240708$20240708$EXP$$US-FERRINGPH-2024FE02147$FERRING$$$$$M$Y$$$20240708$$CN$US$US
240602631$24060263$1$I$$20240424$20240708$20240708$EXP$$US-FERRINGPH-2024FE02066$FERRING$$$$$F$Y$$$20240708$$MD$US$US
240602641$24060264$1$I$$20240322$20240708$20240708$EXP$$US-FERRINGPH-2024FE01481$FERRING$$58$YR$$M$Y$$$20240708$$CN$US$US
240602651$24060265$1$I$20240501$20240507$20240708$20240708$EXP$$US-FERRINGPH-2024FE02319$FERRING$$74$YR$$M$Y$$$20240708$$CN$US$US
240602661$24060266$1$I$20240502$20240507$20240708$20240708$EXP$$US-FERRINGPH-2024FE02324$FERRING$$$$$M$Y$$$20240708$$MD$US$US
240602671$24060267$1$I$$20240502$20240708$20240708$EXP$$US-FERRINGPH-2024FE02234$FERRING$$71$YR$$M$Y$115$KG$20240708$$PH$US$US
240602681$24060268$1$I$$20240503$20240708$20240708$EXP$$US-FERRINGPH-2024FE02336$FERRING$$$$$$Y$$$20240708$$MD$US$US
240602691$24060269$1$I$20240501$20240517$20240708$20240708$EXP$$US-FERRINGPH-2024FE02529$FERRING$$$$$M$Y$$$20240708$$CN$US$US
240602701$24060270$1$I$$20240520$20240708$20240708$EXP$$US-FERRINGPH-2024FE02583$FERRING$$$$$$Y$$$20240708$$CN$US$US
240602711$24060271$1$I$20240502$20240503$20240708$20240708$EXP$$US-FERRINGPH-2024FE02269$FERRING$$$$$F$Y$$$20240708$$CN$US$US
240602721$24060272$1$I$20240611$20240612$20240708$20240708$EXP$$US-FERRINGPH-2024FE03084$FERRING$$92$YR$$M$Y$$$20240708$$CN$US$US
240602731$24060273$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA194121$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240708$$CN$US$US
240602741$24060274$1$I$20240703$20240705$20240705$20240705$DIR$709194$$FDA-CTU$$85$YR$$UNK$N$$$20240705$N$HP$US$
240602761$24060276$1$I$20240201$20240701$20240708$20240708$EXP$$US-SA-2024SA195812$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240708$$MD$US$US
240602771$24060277$1$I$20240203$20240412$20240708$20240708$EXP$$US-GUERBET / LLC-US-20240065$GUERBET$$13$YR$T$M$Y$$$20240708$$HP$US$US
240602781$24060278$1$I$20190408$20240702$20240708$20240708$EXP$$IT-AMGEN-ITANI2024123677$AMGEN$$$$$$Y$$$20240708$$MD$IT$IT
240602792$24060279$2$F$$20240711$20240708$20240719$EXP$$JP-RIGEL-20240700021$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240719$$PH$JP$JP
240602801$24060280$1$I$20240627$20240627$20240708$20240708$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700006$RIGEL PHARMACEUTICALS$$77$YR$$F$Y$$$20240708$$CN$US$US
240602822$24060282$2$F$20240101$20240912$20240708$20240920$PER$$US-SA-2024SA197878$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240920$$MD$US$US
240602831$24060283$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA197360$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240708$$MD$US$US
240602841$24060284$1$I$20240613$20240702$20240708$20240708$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700016$RIGEL PHARMACEUTICALS$$65$YR$$F$Y$$$20240708$$CN$US$US
240602851$24060285$1$I$$20240705$20240708$20240708$EXP$$US-ROCHE-10000016741$ROCHE$Liddle C, Capone A, Trese M. PATIENT-PHYSICIAN FACE MASKING^S INFLUENCE ON THE POST-INTRAVITREAL INJECTION ENDOPHTHALMITIS. Retina. 2024-Jul-01;44 (7):1203-8. doi:10.1097/IAE.0000000000004072.$$$$$Y$$$20240708$$HP$US$US
240602861$24060286$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA194747$SANOFI AVENTIS$$$$A$M$Y$82.5$KG$20240708$$MD$US$US
240602871$24060287$1$I$20240625$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134426$AMGEN$$26$YR$A$F$Y$$$20240708$$CN$US$US
240602881$24060288$1$I$20240101$20240701$20240708$20240708$EXP$$US-ABBVIE-5826104$ABBVIE$$$$$F$Y$$$20240708$$HP$US$US
240602891$24060289$1$I$$20240624$20240708$20240708$EXP$$PK-EPICPHARMA-PK-2024EPCLIT00789$EPIC PHARM$Aisha Jamal.A rare incidence of severe dermatological toxicities triggered by concomitant administration of all-trans retinoic acid and triazole antifungal in patients with acute promyelocytic leukemia: a case series and review of the literature.Journal of Medical Case Reports.MAY-2024;18(1):1-7$28$YR$A$M$Y$$$20240708$$HP$PK$PK
240602901$24060290$1$I$$20240706$20240708$20240708$PER$$US-HALEON-2185818$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240602911$24060291$1$I$20240617$20240628$20240708$20240708$EXP$IT-MINISAL02-991667$IT-TEVA-VS-3215733$TEVA$$50$YR$$F$Y$$$20240708$$PH$IT$IT
240602921$24060292$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46867$$FDA-CTU$$65$YR$$M$N$184$LBS$20240705$N$$US$
240602931$24060293$1$I$20220104$20240702$20240708$20240708$EXP$$US-PFIZER INC-202400205233$PFIZER$$19$YR$$F$Y$$$20240708$$CN$US$US
240602951$24060295$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46860$$FDA-CTU$$59$YR$$F$N$$$20240705$N$$US$
240602961$24060296$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46938$$FDA-CTU$$54$YR$$F$N$$$20240705$N$$US$
240602972$24060297$2$F$20240601$20240731$20240708$20240805$30DAY$$US-AMGEN-USASP2024131827$AMGEN$$49$YR$A$F$Y$104$KG$20240805$$PH$US$US
240602981$24060298$1$I$$20240626$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018471$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240708$$CN$US$US
240602991$24060299$1$I$$20240624$20240708$20240708$EXP$$FR-TEVA-VS-3216658$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240708$$HP$FR$FR
240603001$24060300$1$I$20240614$20240625$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018439$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240708$$CN$US$US
240603011$24060301$1$I$20200101$20240625$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017643$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240708$$CN$US$US
240603023$24060302$3$F$20240624$20240710$20240708$20240722$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202406013240$ELI LILLY AND CO$$56$YR$A$M$Y$120$KG$20240722$$CN$BR$BR
240603031$24060303$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004329$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240708$$CN$US$US
240603041$24060304$1$I$20240626$20240626$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019159$ELI LILLY AND CO$$$$$$Y$$$20240708$$CN$US$US
240603051$24060305$1$I$$20240626$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019010$ELI LILLY AND CO$$$$E$$Y$$$20240708$$PH$US$US
240603061$24060306$1$I$$20240628$20240708$20240708$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407000198$ELI LILLY AND CO$$$$$$Y$$$20240708$$CN$JP$JP
240603071$24060307$1$I$20240620$20240623$20240708$20240708$EXP$GB-MHRA-MED-202406221821347150-HYNRS$GB-ELI_LILLY_AND_COMPANY-GB202406015847$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240708$$CN$GB$GB
240603081$24060308$1$I$$20240627$20240708$20240708$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406018972$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240708$$CN$JP$JP
240603091$24060309$1$I$20240703$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004377$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240708$$CN$US$US
240603101$24060310$1$I$$20240627$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108018$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240708$$HP$US$US
240603111$24060311$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107856$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240708$$PH$US$US
240603121$24060312$1$I$$20240627$20240708$20240708$PER$$US-TEVA-VS-3216015$TEVA$$$$$$Y$$$20240708$$CN$US$US
240603141$24060314$1$I$20240601$20240625$20240708$20240708$EXP$$JP-ROCHE-10000013951$ROCHE$$$$$M$Y$$$20240708$$CN$JP$JP
240603152$24060315$2$F$$20240808$20240708$20240813$30DAY$$FR-JNJFOC-20240711830$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$PH$FR$FR
240603163$24060316$3$F$20240615$20240809$20240708$20240814$30DAY$$US-AMGEN-USASP2024132045$AMGEN$$68$YR$E$F$Y$68.4$KG$20240814$$PH$US$US
240603172$24060317$2$F$20240621$20240713$20240708$20240717$PER$$US-AMGEN-USASP2024132786$AMGEN$$82$YR$E$M$Y$$$20240716$$MD$US$US
240603182$24060318$2$F$20240628$20240724$20240708$20240727$PER$$US-AMGEN-USASP2024131055$AMGEN$$46$YR$A$F$Y$88$KG$20240727$$PH$US$US
240603192$24060319$2$F$20240705$20240708$20240708$20240710$PER$$US-AMGEN-USASP2024134343$AMGEN$$22$YR$A$F$Y$$$20240709$$CN$US$US
240603201$24060320$1$I$$20240626$20240708$20240708$EXP$$US-MYLANLABS-2024M1061600$MYLAN$Bergus KC, Srinivas S, Minneci PC. Site wedge resection technique for gastrostomy tube site revision: A case series. J-Pediatr-Surg-Case-Reports 2024; 107.$8$YR$$M$Y$$$20240708$$HP$US$US
240603211$24060321$1$I$20240101$20240628$20240708$20240708$PER$$US-SA-2024SA194925$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240708$$MD$US$US
240603221$24060322$1$I$20240101$20240702$20240708$20240708$PER$$US-SA-2024SA198308$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240708$$MD$US$US
240603231$24060323$1$I$$20240629$20240708$20240708$PER$$US-SA-2024SA195213$SANOFI AVENTIS$$$$$$Y$$$20240708$$LW$US$US
240603241$24060324$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA194692$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240708$$MD$US$US
240603251$24060325$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA194904$SANOFI AVENTIS$$$$A$F$Y$31$KG$20240708$$MD$US$US
240603261$24060326$1$I$$20240704$20240708$20240708$EXP$$EC-ROCHE-10000018155$ROCHE$$$$$$Y$$$20240708$$MD$EC$EC
240603271$24060327$1$I$20240301$20240628$20240708$20240708$PER$$US-SA-2024SA195048$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240708$$MD$US$US
240603281$24060328$1$I$$20240703$20240708$20240708$EXP$$VN-AstraZeneca-2024A155021$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$VN$
240603291$24060329$1$I$$20240624$20240708$20240708$EXP$$CN-EPICPHARMA-CN-2024EPCLIT00800$EPIC PHARM$Yu N.Disseminated Cunninghamella elegans Infection Diagnosed by mNGS During Induction Therapy in a Child With Intermediate-risk Acute Lymphoblastic Leukemia: A Case Report and Review of Literature.Journal of Pediatric Hematology/Oncology.MAR-2023;45(2):e266-e271$14$YR$T$F$Y$$$20240708$$HP$CN$CN
240603301$24060330$1$I$$20240701$20240708$20240708$PER$$US-ROCHE-10000018175$ROCHE$$$$C$M$Y$$$20240708$$HP$US$US
240603311$24060331$1$I$$20240704$20240708$20240708$PER$$US-JNJFOC-20240714199$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$US$US
240603323$24060332$3$F$$20240916$20240708$20240919$30DAY$$US-PFIZER INC-202400204926$PFIZER$$5$YR$$M$Y$$$20240919$$CN$US$US
240603333$24060333$3$F$$20240828$20240708$20240828$30DAY$$US-PFIZER INC-202400206810$PFIZER$$69$YR$$F$Y$$$20240828$$MD$US$US
240603341$24060334$1$I$20240312$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405052157387750-NYWHP$GB-PFIZER INC-202400207027$PFIZER$$27$YR$$F$Y$63$KG$20240708$$CN$GB$GB
240603353$24060335$3$F$$20240903$20240708$20240905$30DAY$$US-PFIZER INC-202400206257$PFIZER$$10$YR$$M$Y$$$20240905$$CN$US$US
240603364$24060336$4$F$20240628$20240925$20240708$20240930$30DAY$$US-PFIZER INC-202400205656$PFIZER$$7$YR$$M$Y$25.4$KG$20240930$$CN$US$US
240603372$24060337$2$F$$20240904$20240708$20240906$30DAY$$US-PFIZER INC-202400205168$PFIZER$$3$YR$$M$Y$$$20240906$$CN$US$US
240603385$24060338$5$F$$20240916$20240708$20240919$30DAY$$US-PFIZER INC-202400204603$PFIZER$$8$YR$$F$Y$$$20240919$$CN$US$US
240603401$24060340$1$I$$20240701$20240708$20240708$EXP$$ZA-BAYER-2024A095271$BAYER$$37$YR$A$F$Y$$$20240708$$CN$ZA$ZA
240603412$24060341$2$F$20240101$20240703$20240708$20240715$PER$$CA-PFIZER INC-202400205080$PFIZER$$55$YR$$F$Y$$$20240715$$MD$CA$CA
240603421$24060342$1$I$$20240626$20240708$20240708$EXP$$AU-PERRIGO-24AU006046$PERRIGO$$71$YR$$F$Y$$$20240708$$MD$AU$AU
240603431$24060343$1$I$20231031$20240626$20240708$20240708$EXP$AU-TGA-0000809100$AU-PERRIGO-24AU006081$PERRIGO$$18$YR$$M$Y$$$20240708$$CN$AU$AU
240603441$24060344$1$I$$20240626$20240708$20240708$EXP$AU-TGA-0000808247$AU-PERRIGO-24AU006109$PERRIGO$$$$A$$Y$$$20240708$$HP$AU$AU
240603451$24060345$1$I$20240507$20240626$20240708$20240708$EXP$AU-PFIZER INC-PV202400059477$AU-PERRIGO-24AU006058$PERRIGO$$75$YR$$F$Y$$$20240708$$MD$AU$AU
240603461$24060346$1$I$20231224$20240626$20240708$20240708$EXP$AU-PFIZER INC-PV202400058009$AU-PERRIGO-24AU006080$PERRIGO$$26$YR$$F$Y$$$20240708$$HP$AU$AU
240603471$24060347$1$I$20100506$20240626$20240708$20240708$EXP$AU-PFIZER INC-2010SE44774$AU-PERRIGO-24AU006042$PERRIGO$$48$YR$$M$Y$$$20240708$$MD$AU$AU
240603481$24060348$1$I$$20240626$20240708$20240708$EXP$AU-ASPEN-AUS2024AU001571$AU-PERRIGO-24AU006079$PERRIGO$$31$YR$$F$Y$$$20240708$$CN$AU$AU
240603491$24060349$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46865$$FDA-CTU$$46$YR$$F$N$179$LBS$20240705$N$$US$
240603501$24060350$1$I$$20240625$20240708$20240708$EXP$$GB-NOVOPROD-1246679$NOVO NORDISK$$86$YR$$M$Y$$$20240708$$CN$GB$GB
240603511$24060351$1$I$$20240701$20240708$20240708$EXP$$IL-BAYER-2024A095640$BAYER$$$$$F$Y$$$20240708$$MD$IL$IL
240603521$24060352$1$I$$20240627$20240708$20240708$EXP$$US-MYLANLABS-2024M1062190$MYLAN$Edminster S, Ji J, Zhou S, Schmidt R, Rebhun C, Chang J, et al. Aggressive Periorbital Epithelioid Hemangioma with GATA6::FOXO1 Fusion and Low-level KRAS Mutation. J-Neuropathol-Exp-Neurol 2024; 83 (6): 491-492 abstr. 87.$15$YR$$M$Y$$$20240708$$HP$US$US
240603531$24060353$1$I$20240424$20240626$20240708$20240708$EXP$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-069412$AU-PERRIGO-24AU006110$PERRIGO$$52$YR$$M$Y$$$20240708$$HP$AU$AU
240603541$24060354$1$I$$20240627$20240708$20240708$EXP$$US-MYLANLABS-2024M1061468$MYLAN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.$45$YR$$M$Y$$$20240708$$HP$US$US
240603551$24060355$1$I$$20240627$20240708$20240708$EXP$$IN-MYLANLABS-2024M1061956$MYLAN$Das P, Meena R, Jain S, Jha A, Kataria B, Mallick SR. Classic Hodkin Lymphoma with Cutaneous Involvement: A Rare Phenomenon. Indian-J-Hematol-Blood-Transf 2023; 39 S145.$22$YR$$M$Y$$$20240708$$HP$IN$IN
240603561$24060356$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46944$$FDA-CTU$$53$YR$$F$N$$$20240705$N$$US$
240603571$24060357$1$I$$20240627$20240708$20240708$EXP$$US-MYLANLABS-2024M1062178$MYLAN$Woodard VV, Ragland MF. A Rare Case of Necrotizing Pneumonia in an Immunocompromised Patient. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A2444.$67$YR$$M$Y$$$20240708$$HP$US$US
240603581$24060358$1$I$$20240627$20240708$20240708$EXP$$US-MYLANLABS-2024M1062170$MYLAN$Chan W, Park S, Shirkhoda L, O^Connell R, Houshyar R. Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells: a case report. J-Med-Case-Rep 2023; 17.$54$YR$$M$Y$$$20240708$$HP$US$US
240603591$24060359$1$I$$20240627$20240708$20240708$EXP$$US-MYLANLABS-2024M1061465$MYLAN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.$58$YR$$M$Y$$$20240708$$HP$US$US
240603602$24060360$2$F$$20240719$20240708$20240729$EXP$$RU-MYLANLABS-2024M1062760$MYLAN$Guska, MS., Kuznetsova, AD., Kazymov, BI., Alekberov, KF., Kaziakhmedova, ZG., Yaremin, BI.. Portal vein thrombosis after double installation of transjugular intrahepatic portosystemic stent (clinical observation). Vestnik meditsinskogo instituta ?REAVIZ?. Reabilitatsiya, Vrach i Zdorov^ye. 2024;14(1):91-97$53$YR$$M$Y$$$20240729$$HP$RU$RU
240603611$24060361$1$I$$20240627$20240708$20240708$EXP$$US-MYLANLABS-2024M1061599$MYLAN$Johnson DJ, Baadh P, Mudrakola HV. Eosinophilic Pleural Effusion and Eosinophilic Pneumonia Following Prolonged Daptomycin Administration. Am-J-Respir-Crit-Care-Med 2024; 209.$76$YR$$M$Y$$$20240708$$HP$US$US
240603623$24060362$3$F$$20240801$20240708$20240805$EXP$$TR-MYLANLABS-2024M1061325$MYLAN$$$$$F$Y$$$20240805$$CN$TR$TR
240603631$24060363$1$I$$20240627$20240708$20240708$EXP$$US-MYLANLABS-2024M1061973$MYLAN$Van Arnam J, Blessing M, Mohila C. Diffuse Spinal Cord Necrosis and Peripheral Neuropathy Due To Neuroleukemiosis in the Setting of Menin Inhibitor Treatment. J-Neuropathol-Exp-Neurol 2024; 83 (6): 527 abstr. 174.$15$YR$$M$Y$$$20240708$$HP$US$US
240603641$24060364$1$I$$20240627$20240708$20240708$EXP$$IT-MYLANLABS-2024M1061964$MYLAN$Maniezzi C, Bastaroli F, Dusi V, Florindi C, Eskandr M, Anzaldi I, et al. Electrophysiological effects of estrogen on hiPSC-derived cardiomyocytes of a patient affected by estrogen-sensitive Long-QT Syndrome Type 2. Vasc-Pharmacol 2024; 155 (0):.$$$$F$Y$$$20240708$$HP$IT$IT
240603651$24060365$1$I$$20240627$20240708$20240708$EXP$$US-MYLANLABS-2024M1061420$MYLAN$Singh M, Kuo JK, Raza A. Lamotrigine Induced Drug Reaction With Eosinophilia With Systemic Symptoms (DRESS)With HHV-6 Reactivation Causing Severe Encephalitis and Status Epilepticus. Am-J-Respir-Crit-Care-Med 2024; 209 A1358.$18$YR$$F$Y$$$20240708$$HP$US$US
240603661$24060366$1$I$$20240627$20240708$20240708$EXP$$US-MYLANLABS-2024M1061975$MYLAN$Sharp JA, Jones D, Rotow JK, Fidias PM, Bertino E, Owen DH. Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non-Small Cell Lung Cancer. J-Natl-Compr-Canc-Netw 2024; 22 (3).$79$YR$$F$Y$$$20240708$$HP$US$US
240603671$24060367$1$I$20220201$20240703$20240708$20240708$EXP$$US-ABBVIE-5830039$ABBVIE$$69$YR$$F$Y$$$20240708$$CN$US$US
240603681$24060368$1$I$$20240627$20240708$20240708$EXP$$IN-MYLANLABS-2024M1061952$MYLAN$Das P, Meena R, Jain S, Jha A, Kataria B, Mallick SR. Classic Hodkin Lymphoma with Cutaneous Involvement: A Rare Phenomenon. Indian-J-Hematol-Blood-Transf 2023; 39 S145.$70$YR$$M$Y$$$20240708$$HP$IN$IN
240603693$24060369$3$F$20240101$20240818$20240708$20240828$EXP$$CA-UCBSA-2024023547$UCB$$$$$F$Y$$$20240829$$CN$CA$CA
240603701$24060370$1$I$$20240624$20240708$20240708$EXP$$US-EPICPHARMA-US-2024EPCLIT00804$EPIC PHARM$MP Whyte.Drug-induced osteopetrosis.Bone.AUG-2023;173$4$YR$C$F$Y$$$20240708$$HP$US$US
240603711$24060371$1$I$20240601$20240704$20240708$20240708$EXP$$IT-GILEAD-2024-0679183$GILEAD$$45$YR$A$M$Y$$$20240708$$HP$IT$IT
240603721$24060372$1$I$$20240703$20240708$20240708$EXP$$US-SA-2024SA199190$SANOFI AVENTIS$$$$E$F$Y$$$20240708$$MD$US$US
240603731$24060373$1$I$$20240613$20240708$20240708$EXP$$ID-ROCHE-10000000190$ROCHE$$49$YR$A$F$Y$$$20240708$$CN$ID$ID
240603741$24060374$1$I$20220618$20240705$20240705$20240705$DIR$709156$$FDA-CTU$$68$YR$$F$N$$$20240705$N$CN$US$
240603751$24060375$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46953$$FDA-CTU$$70$YR$$F$N$174$LBS$20240705$N$$US$
240603761$24060376$1$I$20240209$20240705$20240705$20240705$DIR$709200$$FDA-CTU$$71$YR$$F$N$68.4$KG$20240705$N$CN$US$
240603771$24060377$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46907$$FDA-CTU$$57$YR$$F$N$107$LBS$20240705$N$$US$
240603781$24060378$1$I$20240704$20240705$20240705$20240705$DIR$709198$$FDA-CTU$$67$YR$$F$N$85.5$KG$20240705$N$CN$US$
240603791$24060379$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46988$$FDA-CTU$$$$$F$N$$$20240705$N$HP$US$
240603821$24060382$1$I$$20240705$20240708$20240708$PER$$US-HALEON-2185829$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240603831$24060383$1$I$20240704$20240705$20240705$20240705$DIR$709197$$FDA-CTU$$64$YR$$M$N$110.25$KG$20240705$Y$CN$US$
240603841$24060384$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5828920$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240603851$24060385$1$I$$20240701$20240708$20240708$EXP$$JP-ROCHE-10000019457$ROCHE$Tada A, Yokoyama S, Suzuki T, Yamakawa T, Wakasa K.. 3 Two cases of PEL-like lymphoma that flared up with nodal lesions. The 59th Hokkaido Regional Spring Meeting of the Japanese Society of Hematology. 2024;9$6$DEC$A$M$Y$$$20240708$$MD$JP$JP
240603861$24060386$1$I$$20240629$20240708$20240708$EXP$$US-MYLANLABS-2024M1062434$MYLAN$$$$$$Y$$$20240708$$HP$US$US
240603871$24060387$1$I$$20240703$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108153$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240708$$CN$US$US
240603881$24060388$1$I$20240703$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107759$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240708$$MD$US$US
240603891$24060389$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107680$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240708$$CN$US$US
240603942$24060394$2$F$20240705$20240904$20240708$20240906$PER$$US-JNJFOC-20240715430$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240906$$PH$US$US
240603952$24060395$2$F$20240501$20240715$20240708$20240721$EXP$$US-BAYER-2024A095254$BAYER$$92$YR$E$M$Y$$$20240719$$PH$US$US
240603963$24060396$3$F$20240620$20240802$20240708$20240813$30DAY$$US-AMGEN-USASP2024130953$AMGEN$$$$$$Y$$$20240813$$HP$US$US
240603982$24060398$2$F$20240116$20240705$20240708$20240808$EXP$$US-ROCHE-10000016438$ROCHE$$$$$F$Y$$$20240808$$CN$US$US
240603991$24060399$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47034$$FDA-CTU$$88$YR$$M$N$$$20240705$N$$US$
240604002$24060400$2$F$$20240701$20240708$20240711$PER$$US-ROCHE-10000018871$ROCHE$$$$A$F$Y$$$20240711$$HP$US$US
240604013$24060401$3$F$20240501$20240819$20240708$20240823$EXP$$US-EXELIXIS-CABO-24078050$EXELIXIS$$65$YR$$M$Y$$$20240823$$CN$US$US
240604021$24060402$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46946$$FDA-CTU$$76$YR$$M$N$$$20240705$N$$US$
240604031$24060403$1$I$20240101$20240702$20240708$20240708$PER$$US-ABBVIE-5827566$ABBVIE$$$$$M$Y$$$20240708$$HP$US$US
240604041$24060404$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5828688$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240604051$24060405$1$I$20240609$20240628$20240708$20240708$EXP$IT-MINISAL02-991717$IT-TEVA-VS-3215746$TEVA$$40$YR$$F$Y$$$20240708$$MD$IT$IT
240604061$24060406$1$I$$20240629$20240708$20240708$EXP$$US-MYLANLABS-2024M1062723$MYLAN$Abbas Z, Mahmood T, Bellman V, Koirala P, Myers T. Relationship Between Pericallosal Lipoma and Neuropsychiatric Symptoms: A Case Report. J-Nerv-Ment-Dis 2023; 211 (8): 639-640.$15$YR$$M$Y$$$20240708$$MD$US$US
240604071$24060407$1$I$$20240703$20240708$20240708$PER$$US-SA-2024SA198439$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240708$$CN$US$US
240604081$24060408$1$I$$20240629$20240708$20240708$PER$$US-SA-2024SA195832$SANOFI AVENTIS$$$$$$Y$$$20240708$$LW$US$US
240604092$24060409$2$F$$20240916$20240708$20240924$PER$$US-SA-2024SA192682$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240924$$MD$US$US
240604101$24060410$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194138$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$CN$US$US
240604112$24060411$2$F$$20240701$20240708$20240715$EXP$$JP-ROCHE-10000017738$ROCHE$Koga K, Higuchi Y, Yasunaga J. P-130 A case of malignant lymphoma which was complicated by persistent SARS-CoV-2 infection during chemotherapy and responded to continuous administration of nirmatrelvir/ritonavir. The 98th Annual Meeting of the Japanese Association for Infectious Diseases / Th. 2024$6$DEC$A$M$Y$$$20240715$$MD$JP$JP
240604122$24060412$2$F$$20240905$20240708$20240909$EXP$$US-BAYER-2024A095627$BAYER$$86$YR$E$M$Y$$$20240909$$CN$US$US
240604134$24060413$4$F$$20240913$20240708$20240915$PER$$US-ALXN-202407USA000065US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
240604141$24060414$1$I$20220907$20240701$20240708$20240708$EXP$$BG-TAKEDA-2022TUS065876$TAKEDA$$50$YR$$M$Y$$$20240708$$CN$BG$BG
240604151$24060415$1$I$20191015$20240703$20240708$20240708$EXP$$CA-TAKEDA-2022TUS027123$TAKEDA$$46$YR$$M$Y$$$20240708$$CN$CA$CA
240604161$24060416$1$I$20240201$20240627$20240708$20240708$EXP$$CA-JNJFOC-20240513780$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240708$$HP$CA$CA
240604171$24060417$1$I$$20240624$20240708$20240708$EXP$$US-EPICPHARMA-US-2024EPCLIT00792$EPIC PHARM$MP Whyte.Drug-induced osteopetrosis.Bone.AUG-2023;173$13$YR$T$M$Y$$$20240708$$HP$US$US
240604192$24060419$2$F$$20240806$20240708$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108122$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240808$$CN$US$US
240604201$24060420$1$I$$20240703$20240708$20240708$EXP$$DE-TAKEDA-2024TUS067772$TAKEDA$$$$$F$Y$$$20240708$$CN$DE$DE
240604211$24060421$1$I$$20240508$20240708$20240708$PER$$US-Eisai-EC-2024-165429$EISAI$$$$$M$Y$$$20240708$$CN$US$US
240604221$24060422$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193504$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240604231$24060423$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193483$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240708$$MD$US$US
240604251$24060425$1$I$20240520$20240628$20240708$20240708$EXP$FR-AFSSAPS-AVLL2024000148$FR-TEVA-VS-3216096$TEVA$$16$YR$$F$Y$$$20240708$$MD$FR$FR
240604261$24060426$1$I$$20240624$20240708$20240708$EXP$$FR-TEVA-VS-3216659$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240708$$HP$FR$FR
240604281$24060428$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193374$SANOFI AVENTIS$$$$A$M$Y$$$20240708$$MD$US$US
240604291$24060429$1$I$$20240706$20240708$20240708$PER$$US-HALEON-2185816$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240604311$24060431$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46866$$FDA-CTU$$55$YR$$F$N$148$LBS$20240705$N$$US$
240604321$24060432$1$I$$20240628$20240708$20240708$EXP$$US-AMGEN-USASP2024130150$AMGEN$Inoue Y.. Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143:1-8$$$$$Y$$$20240708$$HP$US$US
240604333$24060433$3$F$20240702$20240731$20240708$20240806$30DAY$$US-AMGEN-USASP2024132822$AMGEN$$64$YR$E$M$Y$92.063$KG$20240806$$MD$US$US
240604341$24060434$1$I$$20240630$20240708$20240708$EXP$$US-MYLANLABS-2024M1062602$MYLAN$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. J-Matern-Fetal-Neonat-Med 2024; 37 (1):.$$$$F$Y$$$20240708$$HP$US$US
240604352$24060435$2$F$20211101$20240821$20240708$20240826$EXP$$JP-BEH-2024174987$CSL BEHRING$$$$E$M$Y$$$20240826$$MD$JP$JP
240604361$24060436$1$I$$20240628$20240708$20240708$EXP$$DE-ROCHE-10000016886$ROCHE$$$$A$F$Y$$$20240708$$MD$DE$DE
240604371$24060437$1$I$$20240630$20240708$20240708$EXP$$US-MYLANLABS-2024M1062732$MYLAN$Yeung SJ, Qdaisat A, Bischof JJ, Caterino JM, Kyriacou DN, Coyne Md C. A case series of adrenal insufficiency (likely due to hypophysitis) in cancer patients treated with immune checkpoint inhibitors. Am-J-Emerg-Med 2024; 80 (0): 227.e1-227.e5.$37$YR$$F$Y$$$20240708$$MD$US$US
240604389$24060438$9$F$20231113$20240902$20240708$20240913$EXP$$CA-AstraZeneca-2024A154222$ASTRAZENECA$$23174$DY$$F$Y$86.2$KG$20240913$$CN$CA$
240604391$24060439$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004156$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240708$$CN$US$US
240604401$24060440$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004358$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240708$$CN$US$US
240604411$24060441$1$I$20240301$20240703$20240708$20240708$PER$$US-009507513-2407USA002139$MERCK$$$$$F$Y$$$20240708$$CN$US$US
240604421$24060442$1$I$$20240703$20240708$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106626$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240708$$HP$US$US
240604431$24060443$1$I$20240110$20240111$20240708$20240708$EXP$GB-MHRA-TPP49046329C10588870YC1704887365175$GB-TEVA-VS-3145565$TEVA$$52$YR$$M$Y$110$KG$20240708$$MD$GB$GB
240604441$24060444$1$I$$20240624$20240708$20240708$EXP$$US-EPICPHARMA-US-2024EPCLIT00799$EPIC PHARM$MP Whyte.Drug-induced osteopetrosis.Bone.AUG-2023;173$6$YR$C$M$Y$$$20240708$$HP$US$US
240604451$24060445$1$I$$20240703$20240708$20240708$EXP$$NVSC2024DO140131$NOVARTIS$$$$$F$Y$$$20240708$$CN$DO$DO
240604464$24060446$4$F$$20240905$20240708$20240912$EXP$$NVSC2024BR140216$NOVARTIS$$$$$$Y$$$20240912$$MD$BR$BR
240604472$24060447$2$F$20220101$20240725$20240708$20240729$EXP$$NVSC2024AT140365$NOVARTIS$HCP A. RCC: rapid response to multiple therapies. JATROS HAEMATOLOGY AND ONCOLOGY. 2023$46$YR$$F$Y$$$20240729$$HP$AT$AT
240604481$24060448$1$I$20240301$20240708$20240708$20240708$EXP$DK-DKMA-30734303$NVSC2024DK140513$NOVARTIS$$54$YR$$F$Y$$$20240708$$HP$DK$DK
240604491$24060449$1$I$20230709$20230810$20240708$20240708$EXP$FR-AFSSAPS-PC2023000688$FR-SA-2024SA195912$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240708$$MD$FR$FR
240604502$24060450$2$F$$20240630$20240708$20240710$EXP$$TR-MYLANLABS-2024M1062708$MYLAN$Mustafa Dan?sman, Gonca Asut. Silencing the Phantom - Pregabalin Misuse in Amputation Patients: A Case Report. Bagimlilik Dergisi. 2024;25(4):498-504$25$YR$$M$Y$$$20240710$$MD$TR$TR
240604511$24060451$1$I$$20240630$20240708$20240708$EXP$$DE-MYLANLABS-2024M1062550$MYLAN$Makhmudova U, Schulze PC, Lorkowski S, Marz W, Geiling JA, Weingartner O. Monogenic hypertriglyceridemia and recurrent pancreatitis in a homozygous carrier of a rare APOA5 mutation: a case report. J-Med-Case-Rep 2024; 18 (1): 278.$25$YR$$M$Y$$$20240708$$HP$DE$DE
240604521$24060452$1$I$$20240702$20240708$20240708$EXP$$US-BAYER-2024A061310$BAYER$$71$YR$E$M$Y$$$20240708$$CN$US$US
240604531$24060453$1$I$$20240630$20240708$20240708$EXP$$BE-MYLANLABS-2024M1062315$MYLAN$Tijtgat J, Calliauw E, Dirven I, Vounckx M, Kamel R, Vanbinst AM, et al. Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series. Cancers 2023; 15 (9).$33$YR$$M$Y$$$20240708$$HP$BE$BE
240604542$24060454$2$F$20200101$20240711$20240708$20240723$EXP$$GB-TEVA-VS-3215071$TEVA$Mohamed M, Athar MW, Mamoojee Y, Brown A, Dowen F, MacFarlane J. Rifabutin-Induced SIADH and Leucopenia in a Renal Transplant Recipient with Genitourinary Tract Tuberculosis: A Case Report and Review of the Literature. Case-Rep-Nephrol-Dial 2022; 12 (2): 117-123.; Mohamed M, Athar MW, Mamoojee Y, Brown A, Dowen F, MacFarlane J. Rifabutin-Induced SIADH and Leucopenia in a Renal Transplant Recipient with Genitourinary Tract Tuberculosis: A Case Report and Review of the Literature. Case-Rep-Neph...$66$YR$$F$Y$$$20240723$$HP$GB$GB
240604552$24060455$2$F$$20240815$20240708$20240821$EXP$$AU-AMGEN-AUSSP2024130112$AMGEN$$$$$F$Y$$$20240821$$PH$AU$AU
240604561$24060456$1$I$$20240701$20240708$20240708$PER$$US-AMGEN-USASP2024130609$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240604572$24060457$2$F$20240704$20240718$20240708$20240723$PER$$US-AMGEN-USASP2024134466$AMGEN$$60$YR$A$M$Y$$$20240722$$CN$US$US
240604581$24060458$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133259$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240604591$24060459$1$I$20240101$20240704$20240708$20240708$EXP$$GB-ABBVIE-5829857$ABBVIE$$87$YR$$F$Y$$$20240708$$CN$GB$GB
240604631$24060463$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46936$$FDA-CTU$$62$YR$$M$N$$$20240705$N$CN$US$
240604641$24060464$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46892$$FDA-CTU$$72$YR$$M$N$$$20240705$N$$US$
240604651$24060465$1$I$20240101$20240703$20240708$20240708$EXP$$GB-UCBSA-2024033905$UCB$$$$$F$Y$$$20240708$$CN$GB$GB
240604663$24060466$3$F$$20240805$20240708$20240807$PER$$US-ALXN-202407USA000062US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
240604673$24060467$3$F$20240630$20240812$20240708$20240812$PER$$US-ALXN-202407USA000087US$ALEXION PHARMACEUTICALS$$88$YR$$M$Y$102.04$KG$20240812$$CN$US$US
240604691$24060469$1$I$$20240701$20240708$20240708$EXP$$US-TAKEDA-2024TUS067305$TAKEDA$$14$YR$$M$Y$$$20240708$$CN$US$US
240604701$24060470$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46951$$FDA-CTU$$67$YR$$F$N$$$20240705$N$CN$US$
240604711$24060471$1$I$$20240624$20240708$20240708$EXP$$SE-EPICPHARMA-SE-2024EPCLIT00802$EPIC PHARM$Michael Ott.Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques.Therapeutic Advances in Psychopharmacology.2019;9:1-32$73$YR$E$F$Y$$$20240708$$HP$SE$SE
240604721$24060472$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405171305488340-NRGVL$GB-SANDOZ INC.-SDZ2024GB063231$SANDOZ$$$$$F$Y$75$KG$20240708$$CN$GB$GB
240604731$24060473$1$I$20240615$20240627$20240708$20240708$EXP$$US-SANDOZ INC.-SDZ2024US063371$SANDOZ$$$$$$Y$$$20240708$$PH$US$US
240604751$24060475$1$I$$20231016$20240708$20240708$EXP$$CA-SANDOZ INC.-SDZ2023CA043506$SANDOZ$$$$$$Y$$$20240708$$HP$CA$CA
240604761$24060476$1$I$$20240702$20240708$20240708$EXP$$US-SANDOZ INC.-SDZ2024US062814$SANDOZ$Feras Al-Moussally. Atorvastatin-Associated Eosinophilic Spongiosis:A Case Report and a Relevant Literature Reviewof Dermatological Manifestations. Cureus. 2024;Ref ID 412629$73$YR$$M$Y$$$20240708$$MD$US$US
240604771$24060477$1$I$20100101$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405011158072330-YRBMF$GB-SANDOZ INC.-SDZ2024GB063240$SANDOZ$$$$$$Y$$$20240708$$CN$GB$GB
240604781$24060478$1$I$20240422$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405022331099720-SBJLR$GB-SANDOZ INC.-SDZ2024GB063279$SANDOZ$$66$YR$$M$Y$$$20240708$$CN$GB$GB
240604791$24060479$1$I$20210504$20231201$20240708$20240708$EXP$FR-EMA-DD-20230725-7180175-185215$FR-SANDOZ INC.-SDZ2023FR062825$SANDOZ$$14$YR$$F$Y$64.5$KG$20240708$$MD$FR$FR
240604811$24060481$1$I$$20240628$20240708$20240708$EXP$$DE-ROCHE-10000018190$ROCHE$$60$YR$A$M$Y$$$20240708$$MD$DE$DE
240604822$24060482$2$F$20240629$20240719$20240708$20240724$EXP$$US-BAYER-2024A095825$BAYER$$25$YR$A$M$Y$$$20240724$$CN$US$US
240604832$24060483$2$F$$20240731$20240708$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-037416$JAZZ$$$$$F$Y$$$20240808$$CN$US$US
240604851$24060485$1$I$20240618$20240703$20240708$20240708$EXP$$US-ABBVIE-5830893$ABBVIE$$38$YR$$M$Y$$$20240708$$CN$US$US
240604861$24060486$1$I$20240101$20240703$20240708$20240708$EXP$$US-ABBVIE-5830627$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240604871$24060487$1$I$$20240629$20240708$20240708$PER$$US-SA-2024SA194909$SANOFI AVENTIS$$$$A$M$Y$$$20240708$$MD$US$US
240604881$24060488$1$I$20240101$20240628$20240708$20240708$PER$$US-SA-2024SA195164$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240708$$MD$US$US
240604901$24060490$1$I$20240624$20240630$20240708$20240708$EXP$GB-MHRA-MED-202406301317387680-TLPHZ$GB-MYLANLABS-2024M1061723$MYLAN$$42$YR$$F$Y$78$KG$20240708$$CN$GB$GB
240604911$24060491$1$I$$20240630$20240708$20240708$EXP$GB-MHRA-MED-202406301455300240-QMJZC$GB-MYLANLABS-2024M1061536$MYLAN$$$$$F$Y$$$20240708$$CN$GB$GB
240604921$24060492$1$I$20240501$20240630$20240708$20240708$EXP$GB-MHRA-MED-202406302222374210-PLJMT$GB-MYLANLABS-2024M1061488$MYLAN$$41$YR$$F$Y$65$KG$20240708$$CN$GB$GB
240604931$24060493$1$I$20240329$20240628$20240708$20240708$EXP$FR-AFSSAPS-NC2024000679$FR-TEVA-VS-3216095$TEVA$$69$YR$$M$Y$$$20240708$$MD$FR$FR
240604941$24060494$1$I$20240628$20240702$20240708$20240708$EXP$$US-BEH-2024174924$CSL BEHRING$$96$YR$E$F$Y$$$20240708$$HP$US$US
240604951$24060495$1$I$$20240707$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107987$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$61.23$KG$20240708$$CN$US$US
240604971$24060497$1$I$$20240701$20240708$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010116$JAZZ$$$$$F$Y$$$20240708$$CN$US$US
240604982$24060498$2$F$20240501$20240829$20240708$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106013$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$79.38$KG$20240830$$CN$US$US
240604991$24060499$1$I$20240527$20240702$20240708$20240708$EXP$$VN-BAYER-2024A096710$BAYER$$53$YR$A$M$Y$70$KG$20240708$$HP$VN$VN
240605001$24060500$1$I$20231002$20240627$20240708$20240708$EXP$IT-MINISAL02-991619$IT-MYLANLABS-2024M1058391$MYLAN$$38$YR$$F$Y$55$KG$20240708$$MD$IT$IT
240605011$24060501$1$I$20240601$20240703$20240708$20240708$EXP$$US-GILEAD-2024-0679555$GILEAD$$49$YR$A$M$Y$$$20240708$$CN$US$US
240605021$24060502$1$I$20240601$20240627$20240708$20240708$PER$$US-SA-2024SA194760$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240708$$MD$US$US
240605031$24060503$1$I$20240501$20240702$20240708$20240708$PER$$US-SA-2024SA048577$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240708$$CN$US$US
240605041$24060504$1$I$20240101$20240629$20240708$20240708$PER$$US-SA-2024SA196390$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240708$$MD$US$US
240605051$24060505$1$I$20240601$20240702$20240708$20240708$EXP$$US-BAYER-2024A095833$BAYER$$18$YR$A$F$Y$$$20240708$$CN$US$US
240605061$24060506$1$I$20240101$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405011943502680-MHYWC$GB-ORGANON-O2407GBR000551$ORGANON$$66$YR$$F$Y$$$20240708$$HP$GB$GB
240605151$24060515$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46872$$FDA-CTU$$76$YR$$F$N$$$20240705$N$$US$
240605161$24060516$1$I$$20240701$20240708$20240708$EXP$$JP-CHEPLA-2024008360$CHEPLAPHARM$Orihara Y, Kurahashi S, Kamei K, Hiramatsu K. Surgical treatment of appendiceal mucormycosis in an immunocompromised patient: a case report. Surg Case Rep. 2024 Jun 25;10(1):159. doi: 10.1186/s40792-024-01958-y. PMID: 38916715; PMCID: PMC11199453.$29$YR$$F$Y$$$20240708$$HP$COUNTRY NOT SPECIFIED$JP
240605172$24060517$2$F$20220301$20240716$20240708$20240723$EXP$$BR-009507513-2407BRA002920$MERCK$$$$$F$Y$$$20240723$$MD$BR$BR
240605181$24060518$1$I$20240607$20240628$20240708$20240708$EXP$IT-MINISAL02-991656$IT-TEVA-VS-3215736$TEVA$$58$YR$$F$Y$90$KG$20240708$$MD$IT$IT
240605221$24060522$1$I$20231201$20240626$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018504$ELI LILLY AND CO$$$$$F$Y$$$20240708$$MD$US$US
240605231$24060523$1$I$$20240701$20240708$20240708$EXP$$RO-CHEPLA-2024008296$CHEPLAPHARM$Hategan A, Grosu E, Terciu BG, Soric R, Preda C, Dorcioman B. Resilience: The Journey Of Leukemia And DIC In A Breast Carcinoma Survivor- Case Report. Acta Medica Marisiensis. 2024;70(3):210-211.$68$YR$$F$Y$$$20240708$$HP$COUNTRY NOT SPECIFIED$RO
240605241$24060524$1$I$$20240626$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018569$ELI LILLY AND CO$$$$$$Y$$$20240708$$CN$US$US
240605251$24060525$1$I$20240625$20240625$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406017805$ELI LILLY AND CO$$$$$$Y$$$20240708$$CN$US$US
240605261$24060526$1$I$$20240626$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019009$ELI LILLY AND CO$$81$YR$E$F$Y$53.515$KG$20240708$$CN$US$US
240605271$24060527$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004077$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240708$$CN$US$US
240605281$24060528$1$I$20221101$20240626$20240708$20240708$EXP$GB-MHRA-MED-202406260038570290-BDSYP$GB-ELI_LILLY_AND_COMPANY-GB202406017879$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240708$$CN$GB$GB
240605291$24060529$1$I$$20240626$20240708$20240708$EXP$$ZA-ELI_LILLY_AND_COMPANY-ZA202407000380$ELI LILLY AND CO$$$$$F$Y$$$20240708$$MD$ZA$ZA
240605302$24060530$2$F$$20240906$20240708$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202407004084$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240910$$CN$US$US
240605311$24060531$1$I$20240418$20240625$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018540$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240708$$CN$US$US
240605321$24060532$1$I$$20240626$20240708$20240708$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406019341$ELI LILLY AND CO$$39$YR$A$F$Y$57$KG$20240708$$CN$CN$CN
240605332$24060533$2$F$20150613$20240725$20240708$20240805$EXP$FR-AFSSAPS-AN2024000810$FR-ELI_LILLY_AND_COMPANY-FR202406018887$ELI LILLY AND CO$$50$YR$A$F$Y$74$KG$20240805$$CN$FR$FR
240605341$24060534$1$I$$20240704$20240708$20240708$EXP$$CA-PFIZER INC-202400207705$PFIZER$$$$$$Y$$$20240708$$HP$CA$CA
240605353$24060535$3$F$$20240911$20240708$20240911$30DAY$$CO-PFIZER INC-202400201592$PFIZER$$6$YR$$F$Y$$$20240911$$CN$CO$CO
240605372$24060537$2$F$$20240705$20240708$20240710$EXP$$KE-PFIZER INC-202400205749$PFIZER$Mongare, N.. Plasma Exchange for Refractory Pruritus Due to Drug-Induced Chronic Cholestasis Following Azithromycin Misuse in COVID-19 Infection. Cureus. 2024;16(5):e60884$48$YR$$F$Y$$$20240710$$MD$KE$KE
240605387$24060538$7$F$20230707$20240826$20240708$20240830$EXP$$JP-PFIZER INC-PV202400087844$PFIZER$Fujita, T.. A case of intractable chylothorax associated with lymphatic malformation successfully controlled by Denver shunt placement. The 143rd Tokai Branch Meeting of the Japanese Society for Tuberculosis and Nont. 2024;26$38$YR$$F$Y$$$20240830$$HP$JP$JP
240605392$24060539$2$F$$20240705$20240708$20240710$EXP$$JP-PFIZER INC-202400205746$PFIZER$Manabe, M.. Methotrexate-associated B-cell lymphoproliferative disease that exhibits hematuria due to urinary bladder lesions: A case report. Medicine international. 2024;4(4):44$75$YR$$F$Y$$$20240710$$MD$JP$JP
240605402$24060540$2$F$20240301$20240916$20240708$20240923$EXP$$AR-PFIZER INC-202400205281$PFIZER$$15$YR$$M$Y$$$20240923$$CN$AR$AR
240605412$24060541$2$F$$20240705$20240708$20240710$EXP$$KE-PFIZER INC-202400205745$PFIZER$Mongare, N.. Plasma Exchange for Refractory Pruritus Due to Drug-Induced Chronic Cholestasis Following Azithromycin Misuse in COVID-19 Infection. Cureus. 2024;16(5):e60884$60$YR$$M$Y$$$20240710$$MD$KE$KE
240605422$24060542$2$F$$20240717$20240708$20240805$PER$$US-ROCHE-10000019092$ROCHE$$60$YR$A$F$Y$$$20240805$$CN$US$US
240605432$24060543$2$F$$20240729$20240708$20240801$30DAY$$CN-JNJFOC-20240711038$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$CN$CN
240605442$24060544$2$F$$20240712$20240708$20240718$EXP$$CN-JNJFOC-20240700264$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$HP$CN$CN
240605451$24060545$1$I$$20240701$20240708$20240708$EXP$$US-SA-2024SA197303$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240708$$MD$US$US
240605461$24060546$1$I$20240705$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134439$AMGEN$$80$YR$E$F$Y$$$20240708$$CN$US$US
240605471$24060547$1$I$$20240628$20240708$20240708$EXP$$GR-ROCHE-10000013613$ROCHE$$41$YR$A$F$Y$$$20240708$$MD$GR$GR
240605481$24060548$1$I$20240703$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134566$AMGEN$$69$YR$E$F$Y$$$20240708$$CN$US$US
240605491$24060549$1$I$$20240603$20240708$20240708$PER$$US-AMGEN-USASP2024132551$AMGEN$$$$$$Y$$$20240708$$HP$US$US
240605503$24060550$3$F$$20240807$20240708$20240807$30DAY$$DO-PFIZER INC-PV202400081509$PFIZER$$13$YR$$M$Y$$$20240807$$CN$DO$DO
240605511$24060551$1$I$$20240703$20240708$20240708$EXP$$US-AMGEN-USASP2024132526$AMGEN$$$$$M$Y$$$20240708$$CN$US$US
240605521$24060552$1$I$20230322$20240628$20240708$20240708$EXP$IT-MINISAL02-985546$IT-TEVA-VS-3202105$TEVA$$66$YR$$M$Y$73$KG$20240708$$PH$IT$IT
240605533$24060553$3$F$$20240820$20240708$20240821$30DAY$$DO-PFIZER INC-PV202400081501$PFIZER$$14$YR$$M$Y$$$20240821$$CN$DO$DO
240605541$24060554$1$I$$20240703$20240708$20240708$30DAY$$US-GSK-US2024082604$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$CN$US$US
240605553$24060555$3$F$$20240730$20240708$20240806$EXP$$DE-GSK-DE2024EME082501$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$MD$DE$DE
240605561$24060556$1$I$20240601$20240701$20240708$20240708$EXP$$FR-GSK-FR2024EME081833$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$FR$FR
240605573$24060557$3$F$20240601$20240717$20240708$20240724$EXP$$GB-GSK-GB2024083057$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$GB$GB
240605582$24060558$2$F$20240519$20240628$20240708$20240923$EXP$HR-HALMED-300085784$HR-TEVA-VS-3216051$TEVA$$26$YR$$M$Y$$$20240923$$MD$HR$HR
240605592$24060559$2$F$$20240917$20240708$20240930$PER$$US-SA-2024SA194652$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240930$$MD$US$US
240605601$24060560$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193479$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240708$$CN$US$US
240605611$24060561$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA197448$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240708$$MD$US$US
240605621$24060562$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193487$SANOFI AVENTIS$$$$I$M$Y$$$20240708$$HP$US$US
240605631$24060563$1$I$20240101$20240605$20240708$20240708$PER$$US-TEVA-VS-3212603$TEVA$$81$YR$$M$Y$$$20240708$$CN$US$US
240605641$24060564$1$I$20240601$20240708$20240708$20240708$EXP$ES-AEMPS-1541109$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038311$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240708$$HP$ES$ES
240605651$24060565$1$I$$20240624$20240708$20240708$EXP$$FR-TEVA-VS-3216661$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240708$$HP$FR$FR
240605661$24060566$1$I$20240607$20240708$20240708$20240708$EXP$ES-AEMPS-1538309$NVSC2024ES140616$NOVARTIS$$59$YR$$F$Y$80$KG$20240708$$MD$ES$ES
240605672$24060567$2$F$20240530$20240906$20240708$20240910$PER$$US-BIOVITRUM-2024-US-009541$BIOVITRUM$$69$YR$$M$Y$$$20240910$$CN$US$US
240605681$24060568$1$I$20240518$20240625$20240708$20240708$EXP$$PK-ROCHE-10000017531$ROCHE$$40$YR$A$M$Y$$$20240708$$CN$PK$PK
240605691$24060569$1$I$$20240627$20240708$20240708$EXP$$US-SA-2024SA192527$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240708$$CN$US$US
240605702$24060570$2$F$$20240719$20240708$20240724$EXP$$JP-OTSUKA-2024_018972$OTSUKA$$3$DEC$$M$Y$$$20240724$$MD$JP$JP
240605711$24060571$1$I$20240601$20240628$20240708$20240708$EXP$$US-IBSA PHARMA INC.-2024IBS000303$IBSA INSTITUT BIOCHIMIQUE$$72$YR$$F$Y$$$20240704$$CN$US$US
240605721$24060572$1$I$20240601$20240704$20240708$20240708$EXP$$JP-AstraZeneca-2024A154385$ASTRAZENECA$$$$E$M$Y$$$20240708$$MD$JP$
240605731$24060573$1$I$$20240705$20240705$20240705$DIR$709155$$FDA-CTU$$$$$UNK$N$$$20240705$N$HP$AU$
240605741$24060574$1$I$20240621$20240705$20240705$20240705$DIR$709208$$FDA-CTU$$63$YR$$F$N$$$20240705$N$$US$
240605751$24060575$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46861$$FDA-CTU$$77$YR$$F$N$158$LBS$20240705$N$$US$
240605761$24060576$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47033$$FDA-CTU$$61$YR$$M$N$$$20240705$N$$US$
240605771$24060577$1$I$$20240624$20240708$20240708$EXP$$FR-TEVA-VS-3216660$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240708$$HP$FR$FR
240605781$24060578$1$I$20240601$20240701$20240708$20240708$EXP$$US-SA-2024SA199647$SANOFI AVENTIS$$3$YR$C$M$Y$13.2$KG$20240708$$MD$US$US
240605802$24060580$2$F$$20240704$20240708$20240711$PER$$US-AMGEN-USASP2024131443$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240605811$24060581$1$I$$20240626$20240708$20240708$PER$$US-009507513-2406USA009319$MERCK$Arjomand A Myers A Akella P. A case of Scedosporium prolificans pulmonary infection in a patient with acute myeloid leukemia. Respiratory Medicine Case Reports. 2024;51$63$YR$$F$Y$$$20240708$$HP$US$US
240605821$24060582$1$I$$20240703$20240708$20240708$EXP$$US-BAYER-2024A096443$BAYER$$$$$F$Y$$$20240708$$HP$US$US
240605831$24060583$1$I$$20240708$20240708$20240708$EXP$PL-URPL-1-1308-2020$NVSC2024PL140439$NOVARTIS$$40$YR$$M$Y$80$KG$20240708$$MD$PL$PL
240605842$24060584$2$F$20240101$20240718$20240708$20240730$EXP$$US-TEVA-VS-3213914$TEVA$$69$YR$$F$Y$62.6$KG$20240730$$CN$US$US
240605851$24060585$1$I$$20240707$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107989$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$85.28$KG$20240708$$CN$US$US
240605871$24060587$1$I$$20240623$20240708$20240708$EXP$$US-SERVIER-S24007856$SERVIER$Suffian H., Le T., Pandya A.. Complications post-chemotherapy in a child with T-cell leukemia and ataxiatelangiectasia. Annals of Allergy, Asthma Immunology. 2023;S156$$$$$Y$$$20240708$$MD$US$US
240605891$24060589$1$I$$20240627$20240708$20240708$PER$$US-ABBVIE-5826464$ABBVIE$$31$YR$$F$Y$$$20240708$$HP$US$US
240605901$24060590$1$I$$20240702$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106613$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240708$$CN$US$US
240605911$24060591$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107850$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240708$$CN$US$US
240605921$24060592$1$I$$20240624$20240708$20240708$EXP$$US-CIPLA LTD.-2024US06039$CIPLA$$$$$$Y$$$20240708$$CN$US$US
240605932$24060593$2$F$20240328$20240904$20240708$20240916$EXP$$CA-UCBSA-2024032134$UCB$$52$YR$$F$Y$$$20240916$$CN$CA$CA
240605941$24060594$1$I$20180101$20240703$20240708$20240708$EXP$$US-GSK-US2024082563$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$CN$US$US
240605951$24060595$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46863$$FDA-CTU$$65$YR$$M$N$$$20240705$N$$US$
240605961$24060596$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46955$$FDA-CTU$$22$YR$$F$N$$$20240705$N$$US$
240605971$24060597$1$I$20230103$20240627$20240708$20240708$PER$$US-JNJFOC-20240715312$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240708$$PH$US$US
240605981$24060598$1$I$20240704$20240705$20240705$20240705$DIR$709207$$FDA-CTU$$56$YR$$F$N$$$20240705$N$$US$
240605991$24060599$1$I$$20240703$20240708$20240708$EXP$$DE-JNJFOC-20240717639$JOHNSON AND JOHNSON$$$$$M$Y$$$20240708$$CN$DE$DE
240606001$24060600$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46952$$FDA-CTU$$60$YR$$F$N$168$LBS$20240705$N$$US$
240606016$24060601$6$F$$20240805$20240708$20240813$PER$$US-ROCHE-10000016094$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
240606021$24060602$1$I$20230301$20240701$20240708$20240708$EXP$$US-SA-2024SA197304$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240708$$MD$US$US
240606031$24060603$1$I$20240109$20240701$20240708$20240708$EXP$$GB-SA-2024SA198293$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240708$$HP$GB$GB
240606041$24060604$1$I$20240514$20240628$20240708$20240708$PER$$CN-BRACCO-2024CN03945$BRACCO$$31$YR$$F$Y$$$20240708$$HP$CN$CN
240606051$24060605$1$I$$20240704$20240708$20240708$PER$$US-ABBVIE-5830729$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240606062$24060606$2$F$$20240715$20240708$20240718$EXP$$AU-MYLANLABS-2024M1061938$MYLAN$$$$$M$Y$$$20240718$$HP$AU$AU
240606071$24060607$1$I$$20240701$20240708$20240708$EXP$FR-AFSSAPS-AVNT2024000424$FR-MYLANLABS-2024M1061920$MYLAN$$49$YR$$F$Y$$$20240708$$PH$FR$FR
240606081$24060608$1$I$20240626$20240705$20240705$20240705$DIR$709153$$FDA-CTU$$35$YR$$M$N$103.5$KG$20240705$N$CN$US$
240606091$24060609$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47018$$FDA-CTU$$48$YR$$F$N$325$LBS$20240705$N$$US$
240606101$24060610$1$I$20240328$20240705$20240705$20240705$DIR$709209$$FDA-CTU$$83$YR$$M$N$90.9$KG$20240705$N$CN$US$
240606111$24060611$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46935$$FDA-CTU$$62$YR$$F$N$$$20240705$N$$US$
240606122$24060612$2$F$$20240701$20240708$20240710$EXP$$FR-MYLANLABS-2024M1061713$MYLAN$$28$YR$$M$Y$$$20240710$$CN$FR$FR
240606132$24060613$2$F$$20240801$20240708$20240802$EXP$$GB-MYLANLABS-2024M1061925$MYLAN$$$$$F$Y$$$20240802$$HP$GB$GB
240606141$24060614$1$I$$20240701$20240708$20240708$EXP$FR-AFSSAPS-AVNT2024000458$FR-MYLANLABS-2024M1061641$MYLAN$$62$YR$$M$Y$$$20240708$$PH$FR$FR
240606151$24060615$1$I$20240409$20240701$20240708$20240708$EXP$$DE-MYLANLABS-2024M1061633$MYLAN$$26$YR$$F$Y$113$KG$20240708$$MD$DE$DE
240606161$24060616$1$I$20231208$20240701$20240708$20240708$EXP$FR-AFSSAPS-GR2024000787$FR-MYLANLABS-2024M1061672$MYLAN$$61$YR$$M$Y$86.9$KG$20240708$$MD$FR$FR
240606171$24060617$1$I$$20240701$20240708$20240708$EXP$$AU-MYLANLABS-2024M1061950$MYLAN$$$$$M$Y$$$20240708$$HP$AU$AU
240606181$24060618$1$I$$20240701$20240708$20240708$EXP$$GB-MYLANLABS-2024M1062700$MYLAN$$$$$F$Y$$$20240708$$CN$GB$GB
240606191$24060619$1$I$$20240701$20240708$20240708$EXP$GB-MHRA-MED-202407012148170490-RGMNT$GB-MYLANLABS-2024M1061887$MYLAN$$$$$F$Y$$$20240708$$CN$GB$GB
240606201$24060620$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000046US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
240606211$24060621$1$I$20240601$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024132929$AMGEN$$55$YR$A$F$Y$$$20240708$$CN$US$US
240606221$24060622$1$I$$20240630$20240708$20240708$EXP$$US-AMGEN-USASP2024129675$AMGEN$$$$A$F$Y$$$20240708$$CN$US$US
240606231$24060623$1$I$$20240624$20240708$20240708$EXP$$SA-EPICPHARMA-SA-2024EPCLIT00805$EPIC PHARM$Sultan Al-Khenaizan.Hyperkalemia due to topical timolol for hemangioma.JAAD Case Reports.2023;39:53-54$4$MON$N$F$Y$2.6$KG$20240708$$MD$SA$SA
240606247$24060624$7$F$20240530$20240919$20240708$20240919$EXP$$US-PFIZER INC-PV202400088573$PFIZER$$75$YR$$F$Y$82.993$KG$20240919$$CN$US$US
240606251$24060625$1$I$20240619$20240703$20240708$20240708$EXP$$CA-JNJFOC-20240712087$JOHNSON AND JOHNSON$$37$YR$A$M$Y$72$KG$20240708$$HP$CA$CA
240606261$24060626$1$I$20240528$20240624$20240708$20240708$EXP$$CO-AKCEA THERAPEUTICS, INC.-2024IS005419$AKCEA THERAPEUTICS$$$$$$Y$$$20240705$$CN$CO$CO
240606274$24060627$4$F$$20240828$20240708$20240901$EXP$$DE-JNJFOC-20240714295$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240902$$HP$DE$DE
240606282$24060628$2$F$20240426$20240717$20240708$20240801$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000125$PPD DEVELOPMENT LP$$$$$$Y$$$20240731$$CN$CN$CN
240606291$24060629$1$I$20240702$20240705$20240708$20240708$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038279$BOEHRINGER INGELHEIM$$51$YR$A$F$Y$$$20240708$$MD$JP$JP
240606301$24060630$1$I$$20240628$20240708$20240708$EXP$$US-ARGENX-2024-ARGX-US005029$ARGENX BVBA$$$$$$Y$$$20240708$$HP$US$US
240606311$24060631$1$I$20240628$20240702$20240708$20240708$EXP$$AE-Stemline Therapeutics, Inc.-2024ST004090$STEMLINE THERAPEUTICS$$34$YR$A$F$Y$$$20240705$$CN$AE$AE
240606322$24060632$2$F$$20240725$20240708$20240730$EXP$$CA-ABBVIE-5830237$ABBVIE$$$$A$F$Y$$$20240730$$CN$CA$CA
240606331$24060633$1$I$20230817$20240628$20240708$20240708$EXP$FR-AFSSAPS-LL2024001173$FR-TEVA-VS-3215962$TEVA$$40$DY$$M$Y$$$20240708$$MD$FR$FR
240606342$24060634$2$F$20240628$20240815$20240708$20240827$EXP$$US-SA-2024SA195936$SANOFI AVENTIS$$35$YR$A$F$Y$58.059$KG$20240827$$MD$US$US
240606351$24060635$1$I$$20240703$20240708$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST004109$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240705$$CN$US$US
240606361$24060636$1$I$$20240610$20240708$20240708$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00638$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$US$US
240606371$24060637$1$I$$20240703$20240708$20240708$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-093397$REGENERON$$$$$M$Y$$$20240708$$CN$US$US
240606381$24060638$1$I$$20240702$20240708$20240708$EXP$$PR-AMGEN-PRISP2024132447$AMGEN$$$$$M$Y$$$20240708$$CN$PR$PR
240606391$24060639$1$I$20240619$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134339$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240606401$24060640$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215078$TEVA$$$$$F$Y$$$20240708$$CN$CA$CA
240606411$24060641$1$I$20230101$20240704$20240708$20240708$EXP$$CA-ABBVIE-5830272$ABBVIE$$57$YR$$F$Y$$$20240708$$MD$CA$CA
240606422$24060642$2$F$20230101$20240724$20240708$20240805$EXP$$CO-AUROBINDO-AUR-APL-2024-033288$AUROBINDO$Alza-Arcila J, Ram?rez-S?nchez IC, Diaz-Sanabria RA. Histoplasma capsulatum tenosynovitis: An unusual presentation in a kidney transplant recipient.. Transplant Infectious Disease.. 2024;26(3):e14269$66$YR$$F$Y$$$20240805$$MD$CO$CO
240606433$24060643$3$F$20240619$20240711$20240708$20240723$EXP$$CN-BBU-2024000160$BIOGEN$$62$YR$$F$Y$57.5$KG$20240719$$CN$CN$CN
240606441$24060644$1$I$$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134074$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240606451$24060645$1$I$20240704$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024133971$AMGEN$$66$YR$E$M$Y$$$20240708$$CN$US$US
240606461$24060646$1$I$20230101$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024130444$AMGEN$$66$YR$E$F$Y$$$20240708$$CN$US$US
240606472$24060647$2$F$$20240710$20240708$20240724$EXP$$BR-AKCEA THERAPEUTICS, INC.-2024IS005884$AKCEA THERAPEUTICS$$$$$$Y$$$20240723$$CN$BR$BR
240606481$24060648$1$I$20240612$20240703$20240708$20240708$EXP$$US-AstraZeneca-2024A155118$ASTRAZENECA$$29811$DY$$F$Y$$$20240708$$CN$US$
240606491$24060649$1$I$$20240703$20240708$20240708$EXP$$US-AstraZeneca-2024A153408$ASTRAZENECA$$$$$$Y$$$20240708$$CN$US$
240606501$24060650$1$I$$20240624$20240708$20240708$EXP$$US-EPICPHARMA-US-2024EPCLIT00796$EPIC PHARM$Brown DJ.The Difficulty With Treating Alcohol Withdrawal in Severe Chronic Obstructive Pulmonary Disease.American Journal of Respiratory and Critical Care Medicine.MAY-2022;207:B41$67$YR$E$M$Y$$$20240708$$HP$US$US
240606511$24060651$1$I$$20240703$20240708$20240708$EXP$$VN-AstraZeneca-2024A154924$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$VN$
240606521$24060652$1$I$$20240630$20240708$20240708$EXP$$VN-AstraZeneca-2024A152078$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$VN$
240606531$24060653$1$I$$20240504$20240708$20240708$EXP$$ZA-AstraZeneca-2024A154928$ASTRAZENECA$$27393$DY$$M$Y$$$20240708$$CN$ZA$
240606541$24060654$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215069$TEVA$$39$YR$$F$Y$83$KG$20240708$$PH$CA$CA
240606551$24060655$1$I$$20240612$20240708$20240708$PER$$US-ROCHE-10000007352$ROCHE$$$$$$Y$$$20240708$$CN$US$US
240606571$24060657$1$I$20240501$20240701$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407001510$ELI LILLY AND CO$$$$$F$Y$$$20240708$$CN$US$US
240606581$24060658$1$I$$20240624$20240708$20240708$EXP$$FR-TEVA-VS-3216662$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240708$$HP$FR$FR
240606591$24060659$1$I$20240618$20240618$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407003708$ELI LILLY AND CO$$$$$$Y$$$20240708$$CN$US$US
240606601$24060660$1$I$20240206$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002681$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240708$$CN$US$US
240606611$24060661$1$I$$20240703$20240708$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST004103$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240708$$CN$US$US
240606621$24060662$1$I$20240704$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004216$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240708$$CN$US$US
240606631$24060663$1$I$$20240703$20240708$20240708$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-131017$DAIICHI$$$$$M$Y$$$20240708$$CN$US$US
240606643$24060664$3$F$20240701$20240705$20240708$20240717$EXP$$US-009507513-2407USA001325$MERCK$$$$$F$Y$$$20240717$$HP$US$US
240606652$24060665$2$F$20240702$20240809$20240708$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108060$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$73.94$KG$20240814$$PH$US$US
240606661$24060666$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108100$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$40.37$KG$20240708$$CN$US$US
240606675$24060667$5$F$20240621$20240723$20240708$20240731$EXP$$US-JNJFOC-20240711082$JOHNSON AND JOHNSON$$27$YR$A$F$Y$72.1$KG$20240731$$CN$US$US
240606681$24060668$1$I$20240623$20240702$20240708$20240708$EXP$$US-Stemline Therapeutics, Inc.-2024ST004079$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240708$$CN$US$US
240606691$24060669$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194647$SANOFI AVENTIS$$$$A$M$Y$84.82$KG$20240708$$MD$US$US
240606702$24060670$2$F$20180701$20240716$20240708$20240723$EXP$$IL-SA-2024SA196813$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240723$$CN$IL$IL
240606711$24060671$1$I$20240625$20240628$20240708$20240708$PER$$US-SA-2024SA195412$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240708$$MD$US$US
240606721$24060672$1$I$20240705$20240705$20240705$20240705$DIR$709213$$FDA-CTU$$$$$UNK$N$$$20240705$N$CN$US$
240606733$24060673$3$F$$20240730$20240708$20240801$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-001882$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
240606741$24060674$1$I$$20240625$20240708$20240708$EXP$$DE-ROCHE-10000018875$ROCHE$$37$YR$A$F$Y$$$20240708$$HP$DE$DE
240606751$24060675$1$I$20240301$20240628$20240708$20240708$EXP$FR-AFSSAPS-AVMP2024000183$FR-TEVA-VS-3215932$TEVA$$16$YR$$M$Y$$$20240708$$MD$FR$FR
240606761$24060676$1$I$20240622$20240704$20240708$20240708$EXP$$CN-BAYER-2024A097136$BAYER$$37$YR$A$F$Y$50$KG$20240708$$HP$CN$CN
240606771$24060677$1$I$20240628$20240702$20240708$20240708$EXP$$US-AMGEN-USASP2024131116$AMGEN$$73$YR$E$M$Y$$$20240708$$PH$US$US
240606783$24060678$3$F$20240417$20240717$20240708$20240817$EXP$$CA-CELLTRION INC.-2024CA011683$CELLTRION$$$$$$Y$$$20240817$$CN$CA$CA
240606792$24060679$2$F$20240601$20240723$20240708$20240726$EXP$$JP-BAYER-2024A086137$BAYER$$41$YR$A$F$Y$$$20240726$$CN$JP$JP
240606821$24060682$1$I$$20240624$20240708$20240708$EXP$$CN-EPICPHARMA-CN-2024EPCLIT00791$EPIC PHARM$Wu Cunbo.Psychiatric side effects of methylphenidate in treating attention deficit hyperactivity disorder: a case report.Chinese Journal of Psychiatry.JAN-2022;55:1-11$15$YR$T$M$Y$$$20240708$$HP$CN$CN
240606831$24060683$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06015$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240606841$24060684$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281438310700-KPJBZ$GB-TEVA-VS-3215894$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240606861$24060686$1$I$20240705$20240705$20240705$20240705$DIR$709215$$FDA-CTU$$$$$UNK$N$$$20240705$N$CN$US$
240606881$24060688$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214970$TEVA$$76$YR$$M$Y$$$20240708$$PH$CA$CA
240606892$24060689$2$F$20240705$20240708$20240708$20240709$PER$$US-AMGEN-USASP2024134018$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240606902$24060690$2$F$$20240708$20240708$20240717$EXP$GB-MHRA-MED-202406281421496220-GBHVJ$GB-TEVA-VS-3215940$TEVA$$$$$$Y$$$20240717$$CN$GB$GB
240606921$24060692$1$I$20240101$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108170$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240708$$CN$US$US
240606931$24060693$1$I$$20240628$20240708$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104648$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240708$$HP$US$US
240606961$24060696$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-30919045$GB-TEVA-VS-3215291$TEVA$$$$$F$Y$$$20240708$$CN$GB$GB
240606971$24060697$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281459532020-PFYZC$GB-TEVA-VS-3215842$TEVA$$$$$M$Y$$$20240708$$CN$GB$GB
240606981$24060698$1$I$$20240621$20240708$20240708$EXP$$ES-GRUNENTHAL-2018-20671$AVERITAS$$50$YR$$M$Y$$$20240705$$MD$ES$ES
240606991$24060699$1$I$$20240619$20240708$20240708$PER$$US-BAYER-2024A097176$BAYER$Radhakrishnan S.; Safdar H.; Gubeladze T.; Reed M.. An Unusual Presentation of Mycobacterium Fortuitum With Classical Findings of Pleuroparenchymal Fibroelastosis on Imaging. American Journal of Respiratory and Critical Care Medicine (2024) 209, American. 2024;209$86$YR$E$M$Y$$$20240708$$HP$US$US
240607011$24060701$1$I$20240531$20240630$20240708$20240708$EXP$GB-MHRA-MED-202406301749069030-FDMTJ$GB-MYLANLABS-2024M1061550$MYLAN$$59$YR$$M$Y$76$KG$20240708$$CN$GB$GB
240607021$24060702$1$I$20240421$20240702$20240708$20240708$EXP$PT-INFARMED-R202406-532$PT-Waylis Therapeutics LLC-ATNAHS20240701896$Waylis$$39$YR$A$F$Y$$$20240705$$PH$PT$PT
240607032$24060703$2$F$20240101$20240723$20240708$20240731$PER$$US-BIOGEN-2024BI01267295$BIOGEN$$$$$M$Y$$$20240731$$CN$US$US
240607071$24060707$1$I$$20240627$20240708$20240708$PER$$US-INCYTE CORPORATION-2024IN006909$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240607081$24060708$1$I$$20240705$20240708$20240708$EXP$$US-BAYER-2024A097760$BAYER$$27$YR$A$F$Y$$$20240708$$HP$US$US
240607091$24060709$1$I$20240701$20240705$20240705$20240705$DIR$709211$$FDA-CTU$$68$YR$$M$N$$$20240705$N$$US$
240607111$24060711$1$I$20240601$20240705$20240705$20240705$DIR$709195$$FDA-CTU$$77$YR$$F$N$$$20240705$N$PH$US$
240607121$24060712$1$I$20240705$20240705$20240705$20240705$DIR$709175$$FDA-CTU$$70$YR$$UNK$N$$$20240705$N$$US$
240607131$24060713$1$I$$20240703$20240705$20240705$DIR$FDA-CDER-CTU-2024-46819$$FDA-CTU$$$$$M$N$$$20240703$N$HP$US$
240607151$24060715$1$I$20240626$20240705$20240705$20240705$DIR$709229$$FDA-CTU$$28$YR$$F$N$$$20240705$N$HP$US$
240607182$24060718$2$F$$20240708$20240708$20240717$EXP$GB-MHRA-MED-202406281442341590-SCYTR$GB-TEVA-VS-3215654$TEVA$$$$$$Y$$$20240717$$CN$GB$GB
240607192$24060719$2$F$$20240708$20240708$20240716$EXP$GB-MHRA-MED-202406281415559760-KVNGH$GB-TEVA-VS-3215957$TEVA$$$$$$Y$$$20240716$$CN$GB$GB
240607202$24060720$2$F$20230423$20240802$20240708$20240812$EXP$$JP-ROCHE-10000014716$ROCHE$Chiba K, Sato R, Sakuishi K, Shimura S, Hinata S, Ujino M, Okabayashi K et al.. PP777 Hematologic malignancy cases with COVID-19 pneumonia refractory to standard antiviral therapy in our hospital. The 64th Annual Meeting of the Japanese Respiratory Society. 2024$75$YR$E$M$Y$$$20240812$$MD$JP$JP
240607211$24060721$1$I$20240605$20240705$20240708$20240708$EXP$$US-INCYTE CORPORATION-2024IN006951$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240607221$24060722$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281417043890-YNTHC$GB-TEVA-VS-3215963$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240607232$24060723$2$F$$20240709$20240708$20240710$EXP$$FR-BAYER-2024A097319$BAYER$$50$YR$A$F$Y$$$20240710$$MD$FR$FR
240607244$24060724$4$F$$20240731$20240708$20240806$EXP$$IN-PFIZER INC-PV202400088066$PFIZER$$45$YR$$M$Y$$$20240806$$CN$IN$IN
240607251$24060725$1$I$20240101$20240704$20240708$20240708$EXP$$PT-PFIZER INC-202400207556$PFIZER$$60$YR$$F$Y$$$20240708$$MD$PT$PT
240607261$24060726$1$I$20240629$20240704$20240708$20240708$EXP$$CN-PFIZER INC-PV202400088087$PFIZER$$44$YR$$F$Y$50.4$KG$20240708$$HP$CN$CN
240607271$24060727$1$I$$20240624$20240708$20240708$EXP$$TR-EPICPHARMA-TR-2024EPCLIT00780$EPIC PHARM$Begum Ogur.Valproate-induced hyperammonemic encephalopathy aggravated by benzodiazepine: Evaluation of the 3 cases and managment.Psychiatry and Clinical Psychopharmacology.JAN-2019;29:159 abstr. 0202$27$YR$A$F$Y$$$20240708$$HP$TR$TR
240607285$24060728$5$F$$20240724$20240708$20240805$EXP$$BE-PFIZER INC-2023SGN02121$PFIZER$$$$$M$Y$$$20240805$$MD$BE$BE
240607291$24060729$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-202400206161$PFIZER$$$$$M$Y$$$20240708$$MD$US$US
240607301$24060730$1$I$20211222$20240704$20240708$20240708$EXP$FR-AFSSAPS-MA2024001138$FR-PFIZER INC-202400206522$PFIZER$$72$YR$$F$Y$$$20240708$$PH$FR$FR
240607311$24060731$1$I$20240419$20240703$20240708$20240708$EXP$$CA-PFIZER INC-202400206840$PFIZER$$65$YR$$M$Y$$$20240708$$MD$CA$CA
240607321$24060732$1$I$20240601$20240704$20240708$20240708$EXP$FR-AFSSAPS-BR2024000537$FR-PFIZER INC-202400206524$PFIZER$$54$YR$$F$Y$98$KG$20240708$$PH$FR$FR
240607333$24060733$3$F$20240801$20240821$20240708$20240827$EXP$$IN-PFIZER INC-PV202400087790$PFIZER$$51$YR$$M$Y$$$20240827$$CN$IN$IN
240607341$24060734$1$I$20240628$20240704$20240708$20240708$EXP$$CN-PFIZER INC-PV202400088128$PFIZER$$35$YR$$F$Y$45$KG$20240708$$HP$CN$CN
240607351$24060735$1$I$20240625$20240703$20240708$20240708$EXP$$US-PFIZER INC-PV202400087952$PFIZER$$75$YR$$M$Y$$$20240708$$CN$US$US
240607361$24060736$1$I$20231201$20240703$20240708$20240708$EXP$$US-PFIZER INC-PV202400088456$PFIZER$$51$YR$$F$Y$$$20240708$$HP$US$US
240607372$24060737$2$F$$20240710$20240708$20240716$30DAY$$GB-PFIZER INC-PV202400086726$PFIZER$$9$YR$$M$Y$$$20240716$$CN$GB$GB
240607381$24060738$1$I$20240628$20240703$20240708$20240708$EXP$$CN-PFIZER INC-PV202400087501$PFIZER$$70$YR$$F$Y$58$KG$20240708$$HP$CN$CN
240607391$24060739$1$I$$20240704$20240708$20240708$EXP$$CA-PFIZER INC-202400206983$PFIZER$$88$YR$$F$Y$77$KG$20240708$$PH$CA$CA
240607401$24060740$1$I$$20240703$20240708$20240708$EXP$$FR-PFIZER INC-202400205702$PFIZER$$25$YR$$F$Y$$$20240708$$MD$FR$FR
240607411$24060741$1$I$$20240703$20240708$20240708$EXP$$CA-PFIZER INC-202400207747$PFIZER$$59$YR$$F$Y$$$20240708$$MD$CA$CA
240607421$24060742$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-202400206131$PFIZER$$$$$F$Y$$$20240708$$CN$US$US
240607431$24060743$1$I$20240625$20240704$20240708$20240708$EXP$$CN-PFIZER INC-PV202400088190$PFIZER$$72$YR$$M$Y$60$KG$20240708$$HP$CN$CN
240607441$24060744$1$I$20240616$20240704$20240708$20240708$EXP$$CN-PFIZER INC-PV202400088178$PFIZER$$73$YR$$M$Y$65$KG$20240708$$HP$CN$CN
240607451$24060745$1$I$20240201$20240704$20240708$20240708$EXP$FR-AFSSAPS-MA2024000810$FR-PFIZER INC-202400206541$PFIZER$$10$YR$$F$Y$$$20240708$$MD$FR$FR
240607461$24060746$1$I$20240618$20240703$20240708$20240708$EXP$$CN-PFIZER INC-PV202400087486$PFIZER$$80$YR$$M$Y$$$20240708$$HP$CN$CN
240607471$24060747$1$I$$20240704$20240708$20240708$EXP$$CA-PFIZER INC-202400207011$PFIZER$$7$YR$$M$Y$25$KG$20240708$$HP$CA$CA
240607481$24060748$1$I$20221103$20240704$20240708$20240708$EXP$$SG-PFIZER INC-202400206623$PFIZER$$36$YR$$M$Y$$$20240708$$MD$SG$SG
240607491$24060749$1$I$20240327$20240704$20240708$20240708$EXP$FR-AFSSAPS-TO2024001134$FR-PFIZER INC-202400206531$PFIZER$$77$YR$$M$Y$88$KG$20240708$$PH$FR$FR
240607501$24060750$1$I$20240601$20240704$20240708$20240708$EXP$$CN-PFIZER INC-PV202400088112$PFIZER$$57$YR$$M$Y$89.8$KG$20240708$$HP$CN$CN
240607511$24060751$1$I$$20240704$20240708$20240708$EXP$$CA-PFIZER INC-202400206999$PFIZER$$53$YR$$F$Y$$$20240708$$MD$CA$CA
240607521$24060752$1$I$$20240703$20240708$20240708$EXP$$DE-PFIZER INC-202400206010$PFIZER$$2$MON$$F$Y$$$20240708$$PH$DE$DE
240607531$24060753$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-202200212488$PFIZER$$75$YR$$F$Y$$$20240708$$CN$US$US
240607541$24060754$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-202400207141$PFIZER$$66$YR$$M$Y$60.3$KG$20240708$$HP$US$US
240607551$24060755$1$I$$20240701$20240708$20240708$EXP$$AR-PFIZER INC-202400085292$PFIZER$$79$YR$$F$Y$$$20240708$$CN$AR$AR
240607561$24060756$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281143566360-GQMFV$GB-TEVA-VS-3215807$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240607571$24060757$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR081900$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240607581$24060758$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR081953$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240607592$24060759$2$F$20240618$20240723$20240708$20240801$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-103015$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$62$KG$20240801$$HP$ES$ES
240607601$24060760$1$I$$20240624$20240708$20240708$EXP$$FR-TEVA-VS-3216664$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240708$$HP$FR$FR
240607621$24060762$1$I$20240629$20240705$20240708$20240708$EXP$$US-INCYTE CORPORATION-2024IN007122$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240607631$24060763$1$I$$20240628$20240708$20240708$EXP$$JP-OTSUKA-2024_018614$OTSUKA$$$$I$$Y$$$20240708$$MD$JP$JP
240607651$24060765$1$I$$20240701$20240708$20240708$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003721$ALNYLAM PHARMACEUTICALS$Urbinati G., Cani I., Curro Dossi M., Longhi S., Carigi S., Gagliardi C., Biagini E., Galie N., Cortelli P., Guaraldi P.. Patisiran for the treatment of patients with p.Ile88Leu hereditary transthyretin amyloidosis: an Italian real-life experience. Frontiers in Neurology. 2024$$$$$Y$$$20240708$$HP$IT$IT
240607661$24060766$1$I$$20240628$20240708$20240708$EXP$GB-MHRA-MED-202406281412107900-RNBWT$GB-TEVA-VS-3215908$TEVA$$$$$$Y$$$20240708$$CN$GB$GB
240607671$24060767$1$I$$20240628$20240708$20240708$EXP$$US-GALDERMA-US2024010805$GALDERMA$Qadir N, Rulka K, Shirazi I, Durgun A, Trehan M. A Day on the beach, a Risk for vulnificus. Am J Respir Crit Care Med. 2024;209:A1667$$$$$Y$$$20240708$$HP$US$US
240607681$24060768$1$I$$20240626$20240708$20240708$EXP$$US-SPRINGWORKS THERAPEUTICS-SW-001775$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240708$$CN$US$US
240607691$24060769$1$I$20240628$20240704$20240708$20240708$EXP$$CN-BAYER-2024A097199$BAYER$$83$YR$E$F$Y$60$KG$20240708$$HP$CN$CN
240607701$24060770$1$I$$20240624$20240708$20240708$EXP$$FR-TEVA-VS-3216663$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240708$$HP$FR$FR
240607711$24060771$1$I$20220421$20240628$20240708$20240708$EXP$IT-MINISAL02-991249$IT-TEVA-VS-3215726$TEVA$$71$YR$$M$Y$95$KG$20240708$$MD$IT$IT
240607722$24060772$2$F$$20240725$20240708$20240730$PER$$US-AMGEN-USASP2024133997$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
240607732$24060773$2$F$$20240710$20240708$20240710$EXP$$CA-BAYER-2024A097598$BAYER$$$$$F$Y$$$20240710$$HP$CA$CA
240607751$24060775$1$I$$20240702$20240708$20240708$30DAY$$AU-SA-2024SA197684$SANOFI AVENTIS$$$$A$$Y$$$20240708$$HP$AU$AU
240607761$24060776$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194629$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240708$$HP$US$US
240607771$24060777$1$I$20240514$20240625$20240708$20240708$EXP$$AU-ROCHE-10000018388$ROCHE$$73$YR$E$F$Y$$$20240708$$HP$AU$AU
240607781$24060778$1$I$20240524$20240702$20240708$20240708$EXP$IT-MINISAL02-992471$IT-SA-2024SA196035$SANOFI AVENTIS$$68$YR$E$M$Y$70$KG$20240708$$MD$IT$IT
240607791$24060779$1$I$20231207$20240702$20240708$20240708$EXP$FR-AFSSAPS-AVMA2024000285$FR-Waylis Therapeutics LLC-ATNAHS20240701898$Waylis$$50$YR$A$F$Y$$$20240705$$PH$FR$FR
240607801$24060780$1$I$20240605$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46833$$FDA-CTU$$64$YR$$F$N$$$20240705$Y$PH$US$
240607812$24060781$2$F$20220101$20240716$20240708$20240721$EXP$$CA-PFIZER INC-202400207596$PFIZER$$44$YR$$F$Y$$$20240721$$HP$CA$CA
240607841$24060784$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405071452323360-WHMRS$GB-PFIZER INC-202400207198$PFIZER$$$$$F$Y$40$KG$20240708$$HP$GB$GB
240607852$24060785$2$F$20240616$20240711$20240708$20240715$PER$$US-ORGANON-O2406USA002720$ORGANON$$75$YR$$M$Y$96.7$KG$20240715$$MD$US$US
240607871$24060787$1$I$20240320$20240704$20240708$20240708$EXP$FR-AFSSAPS-NY2024000727$FR-PFIZER INC-202400206521$PFIZER$$59$YR$$F$Y$70$KG$20240708$$PH$FR$FR
240607881$24060788$1$I$20240627$20240704$20240708$20240708$EXP$$CN-PFIZER INC-PV202400088110$PFIZER$$53$YR$$F$Y$60$KG$20240708$$HP$CN$CN
240607892$24060789$2$F$20240619$20240709$20240708$20240711$EXP$$US-PFIZER INC-PV202400088647$PFIZER$$65$YR$$M$Y$$$20240711$$HP$US$US
240607903$24060790$3$F$20240104$20240717$20240708$20240722$EXP$GB-MHRA-MED-202405052133325440-RMPYF$GB-PFIZER INC-202400207032$PFIZER$$$$$F$Y$70$KG$20240722$$CN$GB$GB
240607911$24060791$1$I$20210317$20240704$20240708$20240708$EXP$FR-AFSSAPS-MA2024001144$FR-PFIZER INC-202400206525$PFIZER$$70$YR$$F$Y$$$20240708$$PH$FR$FR
240607921$24060792$1$I$20240502$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405021524539240-GSLWN$GB-PFIZER INC-202400206984$PFIZER$$64$YR$$M$Y$78$KG$20240708$$HP$GB$GB
240607931$24060793$1$I$$20240705$20240708$20240708$EXP$$MA-PFIZER INC-PV202400088549$PFIZER$$$$$F$Y$$$20240708$$CN$MA$MA
240607941$24060794$1$I$$20240704$20240708$20240708$EXP$$JP-PFIZER INC-202400206640$PFIZER$$77$YR$$F$Y$$$20240708$$PH$JP$JP
240607952$24060795$2$F$20240622$20240711$20240708$20240715$EXP$$BR-PFIZER INC-202400206949$PFIZER$$53$YR$$F$Y$92.35$KG$20240715$$PH$BR$BR
240607961$24060796$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405091232574480-CBJKQ$GB-PFIZER INC-202400207241$PFIZER$$$$$M$Y$$$20240708$$HP$GB$GB
240607971$24060797$1$I$20240615$20240704$20240708$20240708$EXP$FR-AFSSAPS-PO2024000732$FR-PFIZER INC-202400206527$PFIZER$$66$YR$$F$Y$54.5$KG$20240708$$MD$FR$FR
240607981$24060798$1$I$20240705$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46971$$FDA-CTU$$75$YR$$M$N$$$20240705$Y$PH$US$
240607991$24060799$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107604$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240708$$CN$US$US
240608001$24060800$1$I$20240101$20240701$20240708$20240708$EXP$$US-SA-2024SA196941$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240708$$HP$US$US
240608011$24060801$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46824$$FDA-CTU$$67$YR$$F$N$88.45$KG$20240705$N$$US$
240608021$24060802$1$I$20240605$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46967$$FDA-CTU$$17$YR$$M$N$$$20240705$N$PH$US$
240608031$24060803$1$I$$20240704$20240708$20240708$EXP$$US-PFIZER INC-PV202400088269$PFIZER$$$$$$Y$$$20240708$$CN$US$US
240608041$24060804$1$I$$20240624$20240708$20240708$EXP$$TR-EPICPHARMA-TR-2024EPCLIT00783$EPIC PHARM$Begum Ogur.Valproate-induced hyperammonemic encephalopathy aggravated by benzodiazepine: Evaluation of the 3 cases and managment.Psychiatry and Clinical Psychopharmacology.JAN-2019;29:159 abstr. 0202$39$YR$A$F$Y$$$20240708$$HP$TR$TR
240608051$24060805$1$I$20230901$20240701$20240708$20240708$EXP$$US-SA-2024SA197682$SANOFI AVENTIS$$76$YR$E$F$Y$78.005$KG$20240708$$MD$US$US
240608061$24060806$1$I$$20240702$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009591$DR REDDYS$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocritical Care. 2024;40: 976-983. doi:10.1007/s12028-023-01853-8.$68$YR$E$M$Y$60$KG$20240708$$HP$US$US
240608081$24060808$1$I$$20240702$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009593$DR REDDYS$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocritical Care. 2024;40: 976-983. doi:10.1007/s12028-023-01853-8.$61$YR$A$M$Y$83$KG$20240708$$HP$US$US
240608091$24060809$1$I$$20240702$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009592$DR REDDYS$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocritical Care. 2024;40: 976-983. doi:10.1007/s12028-023-01853-8.$70$YR$E$M$Y$61.8$KG$20240708$$HP$US$US
240608101$24060810$1$I$20240101$20240627$20240708$20240708$PER$$US-SA-2024SA194722$SANOFI AVENTIS$$$$$$Y$$$20240708$$MD$US$US
240608111$24060811$1$I$20240501$20240627$20240708$20240708$PER$$US-SA-2024SA194598$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240708$$MD$US$US
240608121$24060812$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA195241$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240708$$MD$US$US
240608131$24060813$1$I$$20240625$20240708$20240708$EXP$$CA-ROCHE-10000014631$ROCHE$$27$YR$A$F$Y$$$20240708$$CN$CA$CA
240608141$24060814$1$I$20240101$20240624$20240708$20240708$PER$$US-SA-2024SA191930$SANOFI AVENTIS$$61$YR$A$F$Y$84.36$KG$20240708$$MD$US$US
240608151$24060815$1$I$20220101$20240701$20240708$20240708$PER$$US-SA-2024SA197820$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240708$$MD$US$US
240608161$24060816$1$I$20240401$20240629$20240708$20240708$PER$$US-SA-2024SA196541$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240708$$MD$US$US
240608171$24060817$1$I$$20240626$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018213$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240708$$CN$US$US
240608181$24060818$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214921$TEVA$$$$$M$Y$$$20240708$$CN$CA$CA
240608191$24060819$1$I$20240601$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004236$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240708$$CN$US$US
240608201$24060820$1$I$$20240704$20240708$20240708$EXP$$GB-UCBSA-2024034203$UCB$$$$$F$Y$$$20240708$$CN$GB$GB
240608211$24060821$1$I$20240101$20240625$20240708$20240708$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406018585$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240708$$CN$CN$CN
240608221$24060822$1$I$20240529$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46883$$FDA-CTU$$87$YR$$M$N$$$20240705$Y$PH$US$
240608231$24060823$1$I$20240701$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134368$AMGEN$$62$YR$A$F$Y$$$20240708$$CN$US$US
240608241$24060824$1$I$20240615$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46973$$FDA-CTU$$79$YR$$M$N$$$20240705$Y$PH$US$
240608251$24060825$1$I$20240614$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46966$$FDA-CTU$$75$YR$$M$N$$$20240705$Y$PH$US$
240608271$24060827$1$I$20240621$20240705$20240705$20240705$DIR$709204$$FDA-CTU$$63$YR$$F$N$74$KG$20240705$N$PH$US$
240608282$24060828$2$F$$20240806$20240708$20240807$PER$$US-ALXN-202407USA000096US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240608291$24060829$1$I$$20240628$20240708$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104793$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240708$$MD$US$US
240608301$24060830$1$I$$20240703$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106796$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240708$$HP$US$US
240608314$24060831$4$F$20230528$20240805$20240708$20240816$PER$$US-ROCHE-10000017609$ROCHE$$59$YR$A$F$Y$81.65$KG$20240816$$CN$US$US
240608321$24060832$1$I$20240626$20240702$20240708$20240708$EXP$$BR-TAKEDA-2024TUS068954$TAKEDA$$49$YR$$M$Y$$$20240708$$CN$BR$BR
240608331$24060833$1$I$20231201$20240701$20240708$20240708$EXP$SE-SEMPA-2024-005109$SE-TAKEDA-2024TUS065574$TAKEDA$$38$YR$$F$Y$75$KG$20240708$$HP$SE$SE
240608341$24060834$1$I$20240601$20240705$20240708$20240708$EXP$$US-PFIZER INC-PV202400088987$PFIZER$$$$$M$Y$$$20240708$$CN$US$US
240608352$24060835$2$F$20240423$20240709$20240708$20240712$EXP$FR-AFSSAPS-PV2024000548$FR-PFIZER INC-202400207360$PFIZER$$11$MON$$M$Y$10$KG$20240712$$MD$FR$FR
240608361$24060836$1$I$$20240705$20240708$20240708$EXP$$JP-PFIZER INC-202400207173$PFIZER$$$$$$Y$$$20240708$$PH$JP$JP
240608371$24060837$1$I$20240301$20240705$20240708$20240708$EXP$$US-PFIZER INC-202400208016$PFIZER$$20$YR$$M$Y$$$20240708$$MD$US$US
240608381$24060838$1$I$20240101$20240705$20240708$20240708$EXP$$US-PFIZER INC-202400208039$PFIZER$$63$YR$$F$Y$$$20240708$$HP$US$US
240608391$24060839$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405091156004180-HMBTC$GB-PFIZER INC-202400207029$PFIZER$$$$$M$Y$$$20240708$$PH$GB$GB
240608401$24060840$1$I$20240531$20240705$20240708$20240708$EXP$AT-BASGAGES-2024-004520$AT-PFIZER INC-202400207279$PFIZER$$56$YR$$F$Y$$$20240708$$CN$AT$AT
240608411$24060841$1$I$$20240705$20240708$20240708$EXP$$US-PFIZER INC-PV202400088398$PFIZER$$$$$F$Y$$$20240708$$CN$US$US
240608421$24060842$1$I$$20240705$20240708$20240708$EXP$$MA-PFIZER INC-PV202400088548$PFIZER$$$$$F$Y$$$20240708$$CN$MA$MA
240608433$24060843$3$F$20240703$20240918$20240708$20240919$EXP$$JP-PFIZER INC-PV202400088833$PFIZER$$59$YR$$M$Y$48.8$KG$20240919$$MD$JP$JP
240608441$24060844$1$I$$20240705$20240708$20240708$EXP$$MA-PFIZER INC-PV202400088550$PFIZER$$$$$M$Y$$$20240708$$CN$MA$MA
240608451$24060845$1$I$20240303$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405091750579480-GMBDS$GB-PFIZER INC-202400207049$PFIZER$$$$$M$Y$$$20240708$$CN$GB$GB
240608461$24060846$1$I$$20240701$20240708$20240708$EXP$$US-ARGENX-2024-ARGX-US005080$ARGENX BVBA$$$$$$Y$$$20240708$$CN$US$US
240608471$24060847$1$I$20240622$20240701$20240708$20240708$EXP$$CL-JNJFOC-20240709923$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240708$$CN$CL$CL
240608482$24060848$2$F$20240616$20240830$20240708$20240906$EXP$$JP-009507513-2407JPN000064J$MERCK$$70$YR$$F$Y$$$20240906$$MD$JP$JP
240608491$24060849$1$I$20240620$20240703$20240708$20240708$EXP$FR-AFSSAPS-PB2024000744$FR-Waylis Therapeutics LLC-ATNAHS20240701906$Waylis$$21$YR$A$M$Y$$$20240708$$MD$FR$FR
240608501$24060850$1$I$$20240701$20240708$20240708$PER$$US-ROCHE-10000019355$ROCHE$$$$A$M$Y$$$20240708$$CN$US$US
240608511$24060851$1$I$$20240701$20240708$20240708$PER$$US-ROCHE-10000018944$ROCHE$$$$A$F$Y$$$20240708$$CN$US$US
240608521$24060852$1$I$$20240705$20240708$20240708$EXP$$NVSC2024IN140570$NOVARTIS$$$$$F$Y$$$20240708$$MD$IN$IN
240608531$24060853$1$I$$20240624$20240708$20240708$EXP$$US-MDD US Operations-MDD202406-002275$MDD OPERATIONS$$78$YR$$M$Y$120.65$KG$20240708$$CN$US$
240608552$24060855$2$F$20240401$20240705$20240708$20240718$PER$$US-SA-2024SA194665$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240718$$MD$US$US
240608571$24060857$1$I$20240601$20240627$20240708$20240708$PER$$US-SA-2024SA194239$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240708$$MD$US$US
240608582$24060858$2$F$$20240807$20240708$20240809$PER$$US-ROCHE-10000018768$ROCHE$$$$C$M$Y$110.4$KG$20240809$$CN$US$US
240608591$24060859$1$I$$20240703$20240708$20240708$EXP$GB-MHRA-MED-202406291228213970-KGHYM$GB-ORGANON-O2407GBR000412$ORGANON$$30$YR$$M$Y$$$20240708$$CN$GB$GB
240608601$24060860$1$I$20240401$20240628$20240708$20240708$EXP$$FR-BEH-2024174898$CSL BEHRING$$$$$F$Y$$$20240708$$MD$FR$FR
240608611$24060861$1$I$20240312$20240705$20240708$20240708$EXP$$IN-PFIZER INC-PV202400089161$PFIZER$$38$YR$$M$Y$$$20240708$$CN$IN$IN
240608621$24060862$1$I$$20240705$20240708$20240708$EXP$$MA-PFIZER INC-PV202400088546$PFIZER$$$$$M$Y$$$20240708$$CN$MA$MA
240608631$24060863$1$I$20240621$20240705$20240708$20240708$EXP$FR-AFSSAPS-NT2024000803$FR-PFIZER INC-202400207392$PFIZER$$93$YR$$F$Y$44.7$KG$20240708$$MD$FR$FR
240608641$24060864$1$I$$20240703$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106744$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240708$$HP$US$US
240608651$24060865$1$I$20240516$20240701$20240708$20240708$PER$$US-ROCHE-10000017108$ROCHE$$21$YR$A$F$Y$$$20240708$$CN$US$US
240608661$24060866$1$I$$20240701$20240708$20240708$EXP$$US-JNJFOC-20240701174$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$HP$US$US
240608681$24060868$1$I$$20240624$20240708$20240708$PER$$US-FreseniusKabi-FK202410054$FRESENIUS KABI$$41$YR$A$F$Y$54.43$KG$20240708$$HP$US$US
240608701$24060870$1$I$20240402$20240628$20240708$20240708$EXP$IT-MINISAL02-983260$IT-TEVA-VS-3215735$TEVA$$6$YR$$M$Y$24$KG$20240708$$PH$IT$IT
240608711$24060871$1$I$20240605$20240607$20240708$20240708$PER$$US-009507513-2406USA003095$MERCK$$$$$M$Y$$$20240708$$CN$US$US
240608721$24060872$1$I$20240418$20240624$20240708$20240708$PER$$US-ROCHE-10000012936$ROCHE$$79$YR$E$F$Y$70.3$KG$20240708$$CN$US$US
240608732$24060873$2$F$$20240625$20240708$20240906$PER$$US-FARMAPROD-202406-2321$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$US
240608741$24060874$1$I$$20240627$20240708$20240708$PER$$US-ALKERMES INC.-ALK-2024-001786$ALKERMES$$$$$F$Y$$$20240708$$CN$US$US
240608751$24060875$1$I$20240104$20240624$20240708$20240708$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000552$PAREXEL$$$$$$Y$$$20240708$$HP$CN$CN
240608762$24060876$2$F$$20240830$20240708$20240831$EXP$$JP-ABBVIE-5831240$ABBVIE$$71$YR$$F$Y$$$20240831$$CN$JP$JP
240608781$24060878$1$I$20231126$20240626$20240708$20240708$EXP$$FR-AstraZeneca-2024A154834$ASTRAZENECA$$1$WK$$M$Y$3.4$KG$20240708$$MD$FR$
240608792$24060879$2$F$$20240808$20240708$20240816$PER$$US-JNJFOC-20240661720$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
240608802$24060880$2$F$$20240709$20240708$20240722$30DAY$$US-JNJFOC-20240710461$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$PH$US$US
240608812$24060881$2$F$20240627$20240808$20240708$20240820$PER$$US-SA-2024SA194417$SANOFI AVENTIS$$53$YR$A$F$Y$87.4$KG$20240820$$MD$US$US
240608821$24060882$1$I$20240428$20240708$20240708$20240708$EXP$FR-AFSSAPS-BX2024001374$NVSC2024FR140585$NOVARTIS$$79$YR$$M$Y$89$KG$20240708$$PH$FR$FR
240608831$24060883$1$I$$20240627$20240708$20240708$PER$$US-SA-2023SA119188$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240708$$MD$US$US
240608841$24060884$1$I$20240201$20240628$20240708$20240708$PER$$US-SA-2024SA195887$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240708$$MD$US$US
240608851$24060885$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA196147$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$CN$US$US
240608861$24060886$1$I$20240703$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47031$$FDA-CTU$$63$YR$$M$N$$$20240705$N$CN$US$
240608871$24060887$1$I$20190901$20240627$20240708$20240708$PER$$US-SA-2024SA194654$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240708$$MD$US$US
240608881$24060888$1$I$20240702$20240707$20240707$20240707$DIR$709351$$FDA-CTU$$43$YR$$F$N$99$KG$20240707$N$CN$US$
240608891$24060889$1$I$$20240621$20240708$20240708$EXP$$SG-ROCHE-10000006957$ROCHE$$62$YR$A$F$Y$$$20240708$$CN$SG$SG
240608901$24060890$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194425$SANOFI AVENTIS$$$$E$F$Y$99$KG$20240708$$MD$US$US
240608912$24060891$2$F$$20240807$20240708$20240809$EXP$$JP-BAYER-2024A097815$BAYER$$$$$F$Y$$$20240809$$CN$JP$JP
240608921$24060892$1$I$$20240705$20240705$20240705$DIR$709221$$FDA-CTU$$$$$UNK$N$$$20240705$$CN$US$
240608931$24060893$1$I$$20240705$20240705$20240705$DIR$709222$$FDA-CTU$$$$$UNK$N$$$20240705$$CN$US$
240608951$24060895$1$I$20240704$20240705$20240705$20240705$DIR$709223$$FDA-CTU$$70$YR$$F$N$85.4$KG$20240705$N$PH$US$
240608961$24060896$1$I$20240703$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46937$$FDA-CTU$$78$YR$$F$N$$$20240705$N$$US$
240608981$24060898$1$I$$20240628$20240705$20240705$DIR$FDA-CDER-CTU-2024-46823$$FDA-CTU$$$$$M$N$$$20240628$N$HP$US$
240608991$24060899$1$I$$20240703$20240705$20240705$DIR$FDA-CDER-CTU-2024-46856$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240609001$24060900$1$I$20231101$20240701$20240708$20240708$EXP$$DE-MYLANLABS-2024M1061563$MYLAN$$88$YR$$M$Y$$$20240708$$MD$DE$DE
240609012$24060901$2$F$20240601$20240826$20240708$20240903$EXP$$JP-009507513-2407JPN000205J$MERCK$$8$DEC$$F$Y$$$20240903$$MD$JP$JP
240609021$24060902$1$I$$20240630$20240708$20240708$PER$$US-ROCHE-10000017570$ROCHE$$$$$$Y$$$20240708$$CN$US$US
240609032$24060903$2$F$$20240701$20240708$20240710$PER$$US-ROCHE-10000014976$ROCHE$$35$YR$A$$Y$$$20240710$$CN$US$US
240609042$24060904$2$F$20210601$20240816$20240708$20240819$PER$$US-009507513-2407USA003160$MERCK$$56$YR$$F$Y$$$20240819$$CN$US$US
240609051$24060905$1$I$20240617$20240705$20240705$20240705$DIR$709226$$FDA-CTU$$61$YR$$M$N$114.3$KG$20240705$N$PH$US$
240609061$24060906$1$I$20240629$20240705$20240705$20240705$DIR$709233$$FDA-CTU$$10$YR$$M$N$$$20240705$N$PH$US$
240609091$24060909$1$I$20240609$20240705$20240705$20240705$DIR$709210$$FDA-CTU$$66$YR$$M$N$77.4$KG$20240705$N$PH$US$
240609101$24060910$1$I$20240201$20240626$20240708$20240708$PER$$US-FreseniusKabi-FK202410136$FRESENIUS KABI$$34$YR$A$F$Y$67$KG$20240708$$PH$US$US
240609111$24060911$1$I$20230701$20240701$20240708$20240708$EXP$FR-AFSSAPS-ST2024001112$FR-FreseniusKabi-FK202410496$FRESENIUS KABI$$66$YR$E$F$Y$$$20240708$$MD$FR$FR
240609121$24060912$1$I$20230918$20240701$20240708$20240708$EXP$IT-MINISAL02-992332$IT-FreseniusKabi-FK202410360$FRESENIUS KABI$$44$YR$A$$Y$74$KG$20240708$$PH$IT$IT
240609131$24060913$1$I$$20240703$20240708$20240708$EXP$$GB-SANDOZ INC.-SDZ2024GB063096$SANDOZ$$$$$F$Y$$$20240708$$CN$GB$GB
240609141$24060914$1$I$20240506$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405092002414090-BNKQS$GB-SANDOZ INC.-SDZ2024GB063258$SANDOZ$$68$YR$$M$Y$85$KG$20240708$$CN$GB$GB
240609151$24060915$1$I$20130801$20240705$20240708$20240708$EXP$$FI-SANDOZ INC.-NVSC2020FI165624$SANDOZ$$40$YR$$F$Y$$$20240708$$MD$FI$FI
240609161$24060916$1$I$20240601$20240705$20240708$20240708$30DAY$$US-SANDOZ INC.-SDZ2024US063152$SANDOZ$$52$YR$$F$Y$$$20240708$$CN$US$US
240609171$24060917$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405081535377470-TPYSN$GB-SANDOZ INC.-SDZ2024GB063348$SANDOZ$$$$$F$Y$87$KG$20240708$$PH$GB$GB
240609181$24060918$1$I$$20240707$20240708$20240708$30DAY$$EG-SANDOZ INC.-SDZ2024EG033563$SANDOZ$$$$$F$Y$$$20240708$$CN$EG$EG
240609191$24060919$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194430$SANOFI AVENTIS$$$$A$F$Y$69$KG$20240708$$MD$US$US
240609201$24060920$1$I$$20240701$20240708$20240708$EXP$$GB-EMD Serono-2024036251$EMD SERONO INC$$$$A$F$Y$$$20240708$$CN$GB$GB
240609221$24060922$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000104US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$US$US
240609231$24060923$1$I$20240701$20240704$20240708$20240708$EXP$GB-MHRA-MED-202407041208117070-KDRST$GB-PFIZER INC-202400206764$PFIZER$$10$YR$$F$Y$37$KG$20240708$$HP$GB$GB
240609241$24060924$1$I$20240621$20240705$20240705$20240705$DIR$709231$$FDA-CTU$$71$YR$$F$N$53.1$KG$20240705$N$CN$US$
240609251$24060925$1$I$20240703$20240705$20240705$20240705$DIR$709259$$FDA-CTU$$55$YR$$F$N$66.6$KG$20240705$N$CN$US$
240609271$24060927$1$I$20240606$20240701$20240708$20240708$EXP$$JP-GENMAB-2024-02316$GENMAB$$8$DEC$$F$Y$$$20240708$$MD$JP$JP
240609291$24060929$1$I$$20240705$20240708$20240708$EXP$$GB-PFIZER INC-PV202400088423$PFIZER$$$$E$M$Y$$$20240708$$CN$GB$GB
240609303$24060930$3$F$20240101$20240816$20240708$20240816$30DAY$$CA-PFIZER INC-202400042805$PFIZER$$65$YR$$F$Y$$$20240816$$HP$CA$CA
240609321$24060932$1$I$$20240625$20240708$20240708$PER$$US-ROCHE-10000012926$ROCHE$$$$$$Y$$$20240708$$HP$US$US
240609331$24060933$1$I$$20240704$20240708$20240708$PER$$US-AMGEN-USASP2024133844$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240609341$24060934$1$I$20240601$20240703$20240708$20240708$EXP$$US-KYOWAKIRIN-2024KK016296$KYOWA$$$$$$Y$$$20240708$$HP$US$US
240609351$24060935$1$I$$20240609$20240708$20240708$30DAY$$US-VEROBIOTECH-2024USVEROSPO00138$VERO BIOTECH$$$$$$Y$$$20240708$$HP$US$US
240609361$24060936$1$I$$20240627$20240708$20240708$PER$$US-ABBVIE-5826225$ABBVIE$$35$YR$$F$Y$$$20240708$$HP$US$US
240609372$24060937$2$F$20240601$20240709$20240708$20240709$PER$$US-BAYER-2024A094651$BAYER$$49$YR$A$F$Y$$$20240709$$CN$US$US
240609381$24060938$1$I$$20240624$20240708$20240708$PER$$US-MYLANLABS-2024M1060705$MYLAN$$$$$$Y$$$20240708$$CN$US$US
240609391$24060939$1$I$$20240625$20240708$20240708$EXP$$PL-ROCHE-10000016709$ROCHE$$10$YR$C$M$Y$$$20240708$$CN$PL$PL
240609401$24060940$1$I$20240601$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215919$TEVA$$58$YR$$M$Y$$$20240708$$CN$CA$CA
240609411$24060941$1$I$$20240613$20240708$20240708$30DAY$$US-VEROBIOTECH-2024USVEROSPO00135$VERO BIOTECH$$$$$$Y$$$20240708$$HP$US$US
240609421$24060942$1$I$$20240626$20240708$20240708$EXP$$AT-RICHTER-2024-GR-006584$MYOVANT SCIENCES$$74$YR$$F$Y$$$20240708$$MD$AT$AT
240609432$24060943$2$F$$20240221$20240708$20240726$PER$$US-AstraZeneca-2024A155251$ASTRAZENECA$$$$$M$Y$104.3$KG$20240726$$CN$US$
240609441$24060944$1$I$$20240703$20240708$20240708$EXP$$CA-ABBVIE-5828078$ABBVIE$$$$A$F$Y$$$20240708$$CN$CA$CA
240609462$24060946$2$F$$20240704$20240708$20240715$EXP$$CA-BEH-2024174960$CSL BEHRING$$$$$F$Y$36$KG$20240715$$HP$CA$CA
240609471$24060947$1$I$$20240628$20240708$20240708$EXP$$US-MYLANLABS-2024M1062337$MYLAN$Iqbal P, Sharma P, Alladin F, Al-Khazraji Y, Ahmed F, Nawaz S, et al. Managing Intermediate High-Risk Pulmonary Embolism in a Patient With Deep Venous Thrombosis: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$35$YR$$M$Y$$$20240708$$HP$US$US
240609481$24060948$1$I$$20240628$20240708$20240708$EXP$$SG-MYLANLABS-2024M1062209$MYLAN$Wong R, Neo A, Chua J. Unravelling the Unexplained: Cancer of Unknown Origin Presenting as Interstitial Lung Disease. Am-J-Respir-Crit-Care-Med 2024; 209.$66$YR$$F$Y$$$20240708$$HP$SG$SG
240609491$24060949$1$I$$20240628$20240708$20240708$EXP$$IN-MYLANLABS-2024M1062554$MYLAN$Samal DD, Samal P, Chandra Patra P, Sahu S. An unusual case of Blastic Plasmacytoid Dendritic Cell Neoplasm Masquerading as Primary Refractory Cutaneous T-Cell Lymphoma. Indian-J-Hematol-Blood-Transf 2023; 39 (Suppl. 1) S133.$40$YR$$F$Y$$$20240708$$HP$IN$IN
240609501$24060950$1$I$20231201$20240628$20240708$20240708$EXP$FR-AFSSAPS-BX2024001287$FR-MYLANLABS-2024M1061903$MYLAN$$66$YR$$M$Y$94$KG$20240708$$MD$FR$FR
240609512$24060951$2$F$20240612$20240919$20240708$20240927$EXP$FR-AFSSAPS-LL2024001174$FR-TEVA-VS-3215691$TEVA$$50$YR$$M$Y$79.4$KG$20240927$$MD$FR$FR
240609521$24060952$1$I$20240314$20240628$20240708$20240708$EXP$$CN-MYLANLABS-2024M1061847$MYLAN$$16$YR$$F$Y$50$KG$20240708$$HP$CN$CN
240609531$24060953$1$I$20240627$20240628$20240708$20240708$EXP$$US-MYLANLABS-2024M1061715$MYLAN$$30$YR$$F$Y$$$20240708$$HP$US$US
240609541$24060954$1$I$20240214$20240628$20240708$20240708$EXP$HR-HALMED-300085585$HR-MYLANLABS-2024M1062225$MYLAN$$65$YR$$M$Y$94$KG$20240708$$MD$HR$HR
240609551$24060955$1$I$$20240628$20240708$20240708$EXP$$US-MYLANLABS-2024M1062167$MYLAN$Xiong J, Singh K, Zahid U, Embry E, Singh M. Extramedullary Plasmacytoma of the Pleura With Myelomatous Pleural Effusions. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A2676.$65$YR$$F$Y$$$20240708$$HP$US$US
240609561$24060956$1$I$$20240628$20240708$20240708$EXP$$GB-MYLANLABS-2024M1061942$MYLAN$$$$$F$Y$$$20240708$$PH$GB$GB
240609571$24060957$1$I$20240627$20240628$20240708$20240708$EXP$$US-MYLANLABS-2024M1061901$MYLAN$$54$YR$$M$Y$$$20240708$$HP$US$US
240609581$24060958$1$I$20230914$20240628$20240708$20240708$EXP$IE-HPRA-2024-113765$IE-MYLANLABS-2024M1061921$MYLAN$$45$YR$$F$Y$65$KG$20240708$$CN$IE$IE
240609591$24060959$1$I$$20240628$20240708$20240708$EXP$$US-MYLANLABS-2024M1061807$MYLAN$Mccaughey C, Elezaby A, Varr B, Mendoza MD, Rajan SS, Nasiri HU. Pulmonary Artery Catheter Directed Alteplase Infusion to Treat Prosthetic Mitral Valve Thrombosis in a Patient on ECMO. Am-J-Respir-Crit-Care-Med 2024; 209.$50$YR$$M$Y$$$20240708$$HP$US$US
240609601$24060960$1$I$$20240628$20240708$20240708$EXP$$US-MYLANLABS-2024M1062322$MYLAN$Wu LW, Qasim Hussaini SM, Lee JW, Shu DH, Hruban RH, Laheru DA. Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma-two case reports. Ann-Pancreat-Cancer 2022; 5.$78$YR$$M$Y$$$20240708$$MD$US$US
240609611$24060961$1$I$$20240628$20240708$20240708$EXP$$US-MYLANLABS-2024M1061828$MYLAN$Suthar PP, Hughes K, Mafraji M, Akyuz M, Jhaveri M, Dua SG. Case 324: CHANTER Syndrome. Radiology 2024; 311 (1): 1-4.$69$YR$$M$Y$$$20240708$$MD$US$US
240609621$24060962$1$I$$20240628$20240708$20240708$EXP$$US-MYLANLABS-2024M1062417$MYLAN$$$$$M$Y$$$20240708$$CN$US$US
240609631$24060963$1$I$$20240628$20240708$20240708$EXP$$US-MYLANLABS-2024M1061814$MYLAN$Malik T, Gordon B, Ramanathan R, Mcguire EL. A Tale of Broken Hearts: Cardiac Aspergillosis in an Immunocompromised Patient. Am-J-Respir-Crit-Care-Med 2023; 207.$27$YR$$M$Y$$$20240708$$HP$US$US
240609641$24060964$1$I$$20240628$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009862$DR REDDYS$Wu LW, Qasim Hussaini SM, Lee JW, Shu DH, Hruban RH, Laheru DA. Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma-two case reports. Annals of Pancreatic Cancer. 2022 Jun 21;5: doi:10.21037/APC-22-1.$67$YR$E$M$Y$$$20240708$$HP$US$US
240609651$24060965$1$I$$20240628$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009864$DR REDDYS$Wu LW, Qasim Hussaini SM, Lee JW, Shu DH, Hruban RH, Laheru DA. Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma-two case reports. Annals of Pancreatic Cancer. 2022 Jun 21;5: doi:10.21037/APC-22-1.$69$YR$E$M$Y$$$20240708$$HP$US$US
240609661$24060966$1$I$$20240626$20240708$20240708$PER$$US-JNJFOC-20240676123$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$US$US
240609671$24060967$1$I$20240523$20240701$20240708$20240708$EXP$FR-AFSSAPS-NC2024000755$FR-FreseniusKabi-FK202410407$FRESENIUS KABI$$56$YR$A$M$Y$$$20240708$$MD$FR$FR
240609691$24060969$1$I$20240624$20240701$20240708$20240708$EXP$PT-INFARMED-V202406-652$PT-FreseniusKabi-FK202410388$FRESENIUS KABI$$64$YR$A$M$Y$$$20240708$$PH$PT$PT
240609701$24060970$1$I$$20240627$20240708$20240708$EXP$$US-FreseniusKabi-FK202410635$FRESENIUS KABI$Woodard VV, Ragland MF. A Rare Case of Necrotizing Pneumonia in an Immunocompromised Patient. A Rare Case of Necrotizing Pneumonia in an Immunocompromised Patient. 2024 May;209(0): 2444. doi:https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2444.$67$YR$E$M$Y$$$20240708$$HP$US$US
240609711$24060971$1$I$20240610$20240701$20240708$20240708$PER$$US-BAYER-2024A095184$BAYER$$35$YR$A$F$Y$$$20240708$$CN$US$US
240609721$24060972$1$I$20231103$20240701$20240708$20240708$EXP$FR-AFSSAPS-MP2024001063$FR-FreseniusKabi-FK202410405$FRESENIUS KABI$$70$YR$E$F$Y$$$20240708$$PH$FR$FR
240609731$24060973$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA195286$SANOFI AVENTIS$$$$A$F$Y$72.5$KG$20240708$$MD$US$US
240609741$24060974$1$I$20240705$20240705$20240705$20240705$DIR$709261$$FDA-CTU$$59$YR$$M$N$95.25$KG$20240705$N$PH$US$
240609751$24060975$1$I$20240430$20240705$20240705$20240705$DIR$709219$$FDA-CTU$$24$YR$$M$N$69.75$KG$20240705$N$CN$US$
240609772$24060977$2$F$20240501$20240826$20240708$20240827$PER$$US-BAYER-2024A095608$BAYER$$27$YR$A$F$Y$$$20240827$$MD$US$US
240609791$24060979$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05992$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240609801$24060980$1$I$$20240702$20240708$20240708$PER$$US-BAYER-2024A095614$BAYER$$39$YR$A$F$Y$$$20240708$$MD$US$US
240609811$24060981$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46841$$FDA-CTU$$41$YR$$F$N$$$20240705$N$$US$
240609821$24060982$1$I$$20240610$20240708$20240708$30DAY$$US-VEROBIOTECH-2024USVEROSPO00134$VERO BIOTECH$$$$$$Y$$$20240708$$HP$US$US
240609831$24060983$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46862$$FDA-CTU$$26$YR$$F$N$81.65$KG$20240705$N$$US$
240609841$24060984$1$I$$20240703$20240705$20240705$DIR$FDA-CDER-CTU-2024-46990$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240609851$24060985$1$I$20240615$20240705$20240705$20240705$DIR$709214$$FDA-CTU$$43$YR$$F$N$74$KG$20240705$N$CN$IL$
240609861$24060986$1$I$$20240702$20240708$20240708$PER$$US-BAYER-2024A095618$BAYER$$25$YR$A$F$Y$$$20240708$$HP$US$US
240609871$24060987$1$I$20240623$20240708$20240708$20240708$EXP$IT-MINISAL02-993906$NVSC2024IT140398$NOVARTIS$$79$YR$$F$Y$$$20240708$$MD$IT$IT
240609882$24060988$2$F$20240702$20240827$20240708$20240903$EXP$$US-JNJFOC-20240710794$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240904$$HP$US$US
240609891$24060989$1$I$$20240701$20240708$20240708$PER$$US-JNJFOC-20240714018$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$US$US
240609901$24060990$1$I$$20240703$20240708$20240708$EXP$$CA-JNJFOC-20240711731$JOHNSON AND JOHNSON$$$$$M$Y$$$20240708$$HP$CA$CA
240609911$24060991$1$I$$20240701$20240708$20240708$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700006$MYOVANT SCIENCES$$$$$M$Y$$$20240708$$CN$US$US
240609921$24060992$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215075$TEVA$$74$YR$$F$Y$$$20240708$$HP$CA$CA
240609933$24060993$3$F$$20240611$20240708$20240709$30DAY$$US-VEROBIOTECH-2024USVEROSPO00139$VERO BIOTECH$$$$$$Y$$$20240709$$HP$US$US
240609941$24060994$1$I$20240101$20240701$20240708$20240708$EXP$$US-CHIESI-2024CHF03975$CHIESI$$$$$M$Y$$$20240708$$MD$US$US
240609951$24060995$1$I$$20240702$20240708$20240708$PER$$US-BAYER-2024A095942$BAYER$$$$$F$Y$$$20240708$$HP$US$US
240609962$24060996$2$F$$20240717$20240708$20240720$PER$$US-AMGEN-USASP2024124184$AMGEN$$$$$F$Y$$$20240720$$CN$US$US
240609971$24060997$1$I$$20240701$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105490$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240708$$CN$US$US
240609982$24060998$2$F$20240101$20240904$20240708$20240907$PER$$US-AMGEN-USASP2024131975$AMGEN$$31$YR$A$F$Y$$$20240907$$HP$US$US
240609991$24060999$1$I$20231229$20240103$20240708$20240708$EXP$GB-MHRA-MED-202401021539289780-HLYZJ$GB-TEVA-VS-3145662$TEVA$$61$YR$$F$Y$$$20240708$$HP$GB$GB
240610001$24061000$1$I$20240527$20240628$20240708$20240708$EXP$FR-AFSSAPS-LM2024000348$FR-TEVA-VS-3215926$TEVA$$65$YR$$M$Y$71.5$KG$20240708$$PH$FR$FR
240610011$24061001$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06022$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240610021$24061002$1$I$$20240702$20240708$20240708$PER$$US-BAYER-2024A096000$BAYER$$$$$F$Y$$$20240708$$CN$US$US
240610031$24061003$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA195320$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240708$$MD$US$US
240610042$24061004$2$F$20240101$20240827$20240708$20240916$PER$$US-SA-2024SA196906$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240916$$MD$US$US
240610051$24061005$1$I$20240601$20240627$20240708$20240708$PER$$US-SA-2024SA194473$SANOFI AVENTIS$$28$YR$A$F$Y$72.5$KG$20240708$$MD$US$US
240610061$24061006$1$I$20240101$20240628$20240708$20240708$PER$$US-SA-2024SA195527$SANOFI AVENTIS$$2$YR$C$F$Y$39$KG$20240708$$MD$US$US
240610073$24061007$3$F$20220101$20240711$20240708$20240722$PER$$US-SA-2024SA198163$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240720$$MD$US$US
240610091$24061009$1$I$$20240702$20240708$20240708$PER$$US-BIOGEN-2024BI01272385$BIOGEN$$$$$$Y$$$20240708$$HP$US$US
240610101$24061010$1$I$20240606$20240702$20240708$20240708$PER$$US-BAYER-2024A096228$BAYER$$41$YR$A$F$Y$$$20240708$$HP$US$US
240610111$24061011$1$I$20240214$20240701$20240708$20240708$EXP$FR-AFSSAPS-AVMA2024000271$FR-OTSUKA-2024_018663$OTSUKA$$26$YR$$M$Y$$$20240708$$PH$FR$FR
240610122$24061012$2$F$$20240812$20240708$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06172$LUPIN$$$$$$Y$$$20240901$$CN$US$US
240610131$24061013$1$I$$20240702$20240708$20240708$PER$$US-BAYER-2024A096652$BAYER$$$$$F$Y$$$20240708$$CN$US$US
240610141$24061014$1$I$$20240415$20240708$20240708$PER$$US-AMGEN-USASP2024131404$AMGEN$$$$$$Y$$$20240708$$HP$US$US
240610152$24061015$2$F$20240711$20240711$20240708$20240715$EXP$$CA-TAKEDA-2024TUS068193$TAKEDA$$68$YR$$M$Y$$$20240715$$CN$CA$CA
240610161$24061016$1$I$$20240702$20240708$20240708$EXP$$NVSC2024CA138284$NOVARTIS$$6$YR$$M$Y$$$20240708$$HP$CA$CA
240610171$24061017$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47007$$FDA-CTU$$$$$F$N$$$20240705$N$HP$US$
240610181$24061018$1$I$20240624$20240705$20240705$20240705$DIR$709228$$FDA-CTU$$62$YR$$M$N$$$20240705$N$CN$US$
240610191$24061019$1$I$$20240704$20240705$20240705$DIR$FDA-CDER-CTU-2024-46786$$FDA-CTU$$$$$F$N$$$20240704$N$HP$US$
240610211$24061021$1$I$$20240703$20240705$20240705$DIR$FDA-CDER-CTU-2024-46896$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240610234$24061023$4$F$20240501$20240820$20240708$20240822$PER$$US-ROCHE-10000014884$ROCHE$$61$YR$A$F$Y$$$20240822$$CN$US$US
240610241$24061024$1$I$$20240627$20240708$20240708$EXP$GB-MHRA-30708036$GB-ROCHE-10000012404$ROCHE$$8$MON$I$$Y$$$20240708$$PH$GB$GB
240610251$24061025$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004405$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240708$$CN$US$US
240610261$24061026$1$I$20240519$20240628$20240708$20240708$EXP$$MX-BIOVITRUM-2024-MX-009544$BIOVITRUM$$12$WK$$M$Y$4$KG$20240708$$CN$MX$MX
240610271$24061027$1$I$$20240701$20240708$20240708$EXP$$DE-OTSUKA-2024_018632$OTSUKA$$$$$F$Y$3.41$KG$20240708$$MD$DE$DE
240610281$24061028$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107315$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240708$$CN$US$US
240610292$24061029$2$F$20240626$20240708$20240708$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108057$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$58.42$KG$20240710$$PH$US$US
240610301$24061030$1$I$$20240628$20240708$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104853$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240708$$HP$US$US
240610322$24061032$2$F$$20240711$20240708$20240715$PER$$US-ROCHE-10000015621$ROCHE$$$$E$M$Y$$$20240715$$CN$US$US
240610331$24061033$1$I$$20240703$20240708$20240708$EXP$$DE-AstraZeneca-2024A152683$ASTRAZENECA$$61$YR$$M$Y$105$KG$20240708$$MD$DE$
240610341$24061034$1$I$20240101$20240627$20240708$20240708$PER$$US-SA-2024SA194576$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240708$$MD$US$US
240610351$24061035$1$I$20240629$20240629$20240708$20240708$PER$$US-SA-2024SA196901$SANOFI AVENTIS$$57$YR$A$M$Y$102$KG$20240708$$MD$US$US
240610361$24061036$1$I$$20240701$20240708$20240708$EXP$$GB-MYLANLABS-2024M1062578$MYLAN$Umakanthan T. The Impact of Stigma on Forensic Psychiatric Patients - a Case Report. BJPsych-Open 2022; 8 (Suppl.) S125-S126.$60$YR$$M$Y$$$20240708$$MD$GB$GB
240610371$24061037$1$I$$20240701$20240708$20240708$EXP$$FR-MYLANLABS-2024M1062054$MYLAN$Ndoudi-Likoho B, Simon D, Maroni A, Dauger S, Levy M. Excessive pickle consumption: beware of adrenal crisis. Archives de Pediatrie. 2024;31(4):279-282$13$YR$$M$Y$$$20240708$$HP$FR$FR
240610381$24061038$1$I$$20240701$20240708$20240708$EXP$$ES-MYLANLABS-2024M1050484$MYLAN$Latorre S., Moreno I., Gordillo M.J.. Case Report: Three Years of Refractory Atypical Depression Successfully Treated With?Old School? Moclobemide (maoi-r). European Psychiatry. 2017;41:s239$54$YR$$F$Y$$$20240708$$MD$ES$ES
240610394$24061039$4$F$$20240913$20240708$20240921$PER$$US-ROCHE-10000015620$ROCHE$$$$E$M$Y$$$20240921$$CN$US$US
240610401$24061040$1$I$$20240627$20240708$20240708$PER$$US-ROCHE-10000016290$ROCHE$$$$E$M$Y$$$20240708$$CN$US$US
240610411$24061041$1$I$$20240701$20240708$20240708$EXP$$TN-MYLANLABS-2024M1063204$MYLAN$Brahmi N, Ben Ghezala H, Mrad A, Ben Jazia A. High-dose norepinephrine infusion (100 microg/kg/min) in a near-fatal amlodipine and perindopril poisoning: are there any limits?. Clin-Toxicol-(Phila) 2024; 62 (4): 273-274.$23$YR$$F$Y$$$20240708$$HP$TN$TN
240610421$24061042$1$I$$20240625$20240708$20240708$EXP$$US-ELITEPHARMA-2024ELLIT00147$ELITE$B. S. BARNETT ET AL..Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine.JOURNAL OF PSYCHOACTIVE DRUGS.21-JUN-2024;1-7$42$YR$A$M$Y$$$20240708$$HP$US$US
240610431$24061043$1$I$20240618$20240705$20240708$20240708$PER$$US-JNJFOC-20240716066$JOHNSON AND JOHNSON$$31$YR$A$$Y$$$20240708$$CN$US$US
240610441$24061044$1$I$$20240701$20240708$20240708$EXP$$US-JNJFOC-20240706734$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$LW$US$US
240610451$24061045$1$I$$20240701$20240708$20240708$PER$$US-ROCHE-10000019061$ROCHE$$80$YR$E$M$Y$$$20240708$$CN$US$US
240610461$24061046$1$I$$20240701$20240708$20240708$PER$$US-ROCHE-10000017919$ROCHE$$$$E$M$Y$$$20240708$$CN$US$US
240610471$24061047$1$I$20240703$20240703$20240708$20240708$PER$$US-BAYER-2024A096349$BAYER$$$$$F$Y$$$20240708$$CN$US$US
240610481$24061048$1$I$$20240703$20240708$20240708$PER$$US-BAYER-2024A096389$BAYER$$23$YR$A$F$Y$$$20240708$$MD$US$US
240610491$24061049$1$I$$20240624$20240708$20240708$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06178$LUPIN$$$$$$Y$$$20240708$$CN$US$US
240610501$24061050$1$I$$20240530$20240708$20240708$PER$$AU-Karo Pharma-2158910$Karo Pharma$$57$YR$$M$Y$$$20240708$$$AU$AU
240610511$24061051$1$I$20240501$20240628$20240708$20240708$EXP$FR-AFSSAPS-NT2024000710$FR-TEVA-VS-3215916$TEVA$$80$YR$$F$Y$50$KG$20240708$$PH$FR$FR
240610521$24061052$1$I$$20240702$20240708$20240708$PER$$US-PFIZER INC-PV202400087249$PFIZER$$66$YR$$M$Y$94.4$KG$20240708$$MD$US$US
240610534$24061053$4$F$20240703$20240730$20240708$20240806$EXP$$US-PFIZER INC-202400207216$PFIZER$$91$YR$$F$Y$54.422$KG$20240806$$CN$US$US
240610541$24061054$1$I$20240705$20240705$20240708$20240708$PER$$JP-PFIZER INC-202400207118$PFIZER$$$$$$Y$$$20240708$$PH$JP$JP
240610551$24061055$1$I$20240101$20240705$20240708$20240708$PER$$US-PFIZER INC-202400207888$PFIZER$$65$YR$$M$Y$$$20240708$$CN$US$US
240610561$24061056$1$I$$20240702$20240708$20240708$PER$$US-PFIZER INC-PV202400087983$PFIZER$$$$E$M$Y$$$20240708$$HP$US$US
240610571$24061057$1$I$20240704$20240705$20240708$20240708$PER$$US-PFIZER INC-202400208087$PFIZER$$51$YR$$M$Y$$$20240708$$CN$US$US
240610581$24061058$1$I$$20240702$20240708$20240708$PER$$US-PFIZER INC-PV202400087163$PFIZER$$67$YR$$M$Y$65.76$KG$20240708$$CN$US$US
240610591$24061059$1$I$20240704$20240705$20240708$20240708$PER$$US-PFIZER INC-202400207730$PFIZER$$38$YR$$F$Y$$$20240708$$HP$US$US
240610601$24061060$1$I$20240630$20240704$20240708$20240708$PER$$US-PFIZER INC-202400207465$PFIZER$$56$YR$$F$Y$$$20240708$$CN$US$US
240610611$24061061$1$I$20240705$20240706$20240708$20240708$PER$$US-PFIZER INC-202400208121$PFIZER$$54$YR$$M$Y$$$20240708$$CN$US$US
240610621$24061062$1$I$$20240702$20240708$20240708$PER$$US-PFIZER INC-PV202400087010$PFIZER$$61$YR$$F$Y$$$20240708$$CN$US$US
240610633$24061063$3$F$20240201$20240719$20240708$20240723$PER$$US-PFIZER INC-202400205727$PFIZER$$44$YR$$F$Y$$$20240723$$CN$US$US
240610641$24061064$1$I$20240705$20240706$20240708$20240708$PER$$US-PFIZER INC-202400208071$PFIZER$$69$YR$$M$Y$$$20240708$$CN$US$US
240610651$24061065$1$I$$20240704$20240708$20240708$PER$$US-PFIZER INC-202400207123$PFIZER$$52$YR$$F$Y$$$20240708$$CN$US$US
240610661$24061066$1$I$20240704$20240704$20240708$20240708$PER$$US-PFIZER INC-202400207342$PFIZER$$70$YR$$F$Y$$$20240708$$HP$US$US
240610671$24061067$1$I$20240704$20240705$20240708$20240708$PER$$US-PFIZER INC-202400207830$PFIZER$$61$YR$$F$Y$$$20240708$$CN$US$US
240610681$24061068$1$I$20240704$20240704$20240708$20240708$PER$$US-PFIZER INC-202400207220$PFIZER$$63$YR$$M$Y$$$20240708$$MD$US$US
240610691$24061069$1$I$20240620$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206632$PFIZER$$82$YR$$F$Y$$$20240708$$CN$US$US
240610704$24061070$4$F$20230101$20240830$20240708$20240904$PER$$US-PFIZER INC-PV202400088856$PFIZER$$72$YR$$F$Y$$$20240904$$HP$US$US
240610711$24061071$1$I$20240707$20240707$20240708$20240708$PER$$US-PFIZER INC-202400208211$PFIZER$$54$YR$$F$Y$$$20240708$$CN$US$US
240610721$24061072$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202400088621$PFIZER$$68$YR$$F$Y$$$20240708$$CN$US$US
240610733$24061073$3$F$$20240723$20240708$20240726$PER$$US-PFIZER INC-202400206912$PFIZER$$70$YR$$F$Y$$$20240726$$CN$US$US
240610742$24061074$2$F$$20240707$20240708$20240709$PER$$US-PFIZER INC-PV202400087628$PFIZER$$$$$F$Y$$$20240709$$CN$US$US
240610751$24061075$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47003$$FDA-CTU$$87$YR$$F$N$70.31$KG$20240705$N$$US$
240610762$24061076$2$F$20240705$20240729$20240708$20240802$PER$$US-PFIZER INC-202400208206$PFIZER$$61$YR$$F$Y$87.075$KG$20240802$$HP$US$US
240610771$24061077$1$I$20240627$20240704$20240708$20240708$PER$$US-PFIZER INC-202400207403$PFIZER$$27$YR$$M$Y$$$20240708$$CN$US$US
240610781$24061078$1$I$20240318$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46969$$FDA-CTU$$56$YR$$M$N$$$20240705$Y$PH$US$
240610801$24061080$1$I$20240701$20240705$20240708$20240708$PER$$US-PFIZER INC-202400208050$PFIZER$$43$YR$$M$Y$$$20240708$$CN$US$US
240610812$24061081$2$F$20240101$20240801$20240708$20240805$PER$$US-PFIZER INC-PV202400087979$PFIZER$$53$YR$$F$Y$$$20240805$$HP$US$US
240610821$24061082$1$I$20240703$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206631$PFIZER$$69$YR$$M$Y$$$20240708$$CN$US$US
240610831$24061083$1$I$20240706$20240706$20240708$20240708$PER$$US-PFIZER INC-202400208065$PFIZER$$42$YR$$F$Y$$$20240708$$HP$US$US
240610841$24061084$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46837$$FDA-CTU$$64$YR$$F$N$115.67$KG$20240705$N$$US$
240610851$24061085$1$I$20240701$20240704$20240708$20240708$PER$$US-PFIZER INC-202400207105$PFIZER$$$$$$Y$$$20240708$$CN$US$US
240610861$24061086$1$I$20240704$20240706$20240708$20240708$PER$$US-PFIZER INC-202400208010$PFIZER$$50$YR$$F$Y$$$20240708$$HP$US$US
240610881$24061088$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206665$PFIZER$$58$YR$$F$Y$$$20240708$$CN$US$US
240610891$24061089$1$I$20240703$20240704$20240708$20240708$PER$$US-PFIZER INC-202400207343$PFIZER$$69$YR$$M$Y$$$20240708$$CN$US$US
240610901$24061090$1$I$20240706$20240706$20240708$20240708$PER$$US-PFIZER INC-202400208031$PFIZER$$45$YR$$F$Y$$$20240708$$CN$US$US
240610911$24061091$1$I$20240705$20240705$20240708$20240708$PER$$US-PFIZER INC-202400208254$PFIZER$$73$YR$$F$Y$$$20240708$$CN$US$US
240610921$24061092$1$I$$20240618$20240708$20240708$PER$$US-PFIZER INC-202400206933$PFIZER$$$$$F$Y$$$20240708$$CN$US$US
240610931$24061093$1$I$$20240701$20240708$20240708$PER$$US-PFIZER INC-2020294465$PFIZER$$78$YR$$F$Y$$$20240708$$CN$US$US
240610941$24061094$1$I$20240601$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400088826$PFIZER$$44$YR$$F$Y$$$20240708$$CN$US$US
240610951$24061095$1$I$20240702$20240705$20240708$20240708$PER$$US-PFIZER INC-202400207800$PFIZER$$53$YR$$F$Y$$$20240708$$CN$US$US
240610961$24061096$1$I$$20240628$20240708$20240708$PER$$US-PFIZER INC-PV202400085938$PFIZER$$83$YR$$M$Y$72.109$KG$20240708$$MD$US$US
240610971$24061097$1$I$20240601$20240702$20240708$20240708$PER$$US-PFIZER INC-202400206195$PFIZER$$65$YR$$F$Y$$$20240708$$HP$US$US
240610982$24061098$2$F$20240706$20240723$20240708$20240725$PER$$US-PFIZER INC-202400208173$PFIZER$$68$YR$$F$Y$48.073$KG$20240725$$CN$US$US
240610991$24061099$1$I$20240705$20240706$20240708$20240708$PER$$US-PFIZER INC-202400208175$PFIZER$$63$YR$$M$Y$$$20240708$$CN$US$US
240611001$24061100$1$I$20240702$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206624$PFIZER$$$$E$F$Y$$$20240708$$CN$US$US
240611011$24061101$1$I$20240701$20240704$20240708$20240708$PER$$US-PFIZER INC-202400207302$PFIZER$$46$YR$$M$Y$$$20240708$$CN$US$US
240611021$24061102$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202400087751$PFIZER$$80$YR$$F$Y$$$20240708$$HP$US$US
240611031$24061103$1$I$20240623$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400084843$PFIZER$$67$YR$$F$Y$57.15$KG$20240708$$CN$US$US
240611041$24061104$1$I$20240707$20240707$20240708$20240708$PER$$US-PFIZER INC-202400208589$PFIZER$$29$YR$$F$Y$$$20240708$$HP$US$US
240611051$24061105$1$I$$20240624$20240708$20240708$EXP$$FR-TEVA-VS-3216673$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240708$$HP$FR$FR
240611061$24061106$1$I$20240627$20240702$20240708$20240708$PER$$US-PFIZER INC-202400205388$PFIZER$$74$YR$$M$Y$$$20240708$$CN$US$US
240611072$24061107$2$F$$20240730$20240708$20240801$PER$$US-PFIZER INC-2022SGN12009$PFIZER$$69$YR$$F$Y$$$20240801$$CN$US$US
240611081$24061108$1$I$20240601$20240706$20240708$20240708$PER$$US-PFIZER INC-202400208138$PFIZER$$58$YR$$M$Y$$$20240708$$PH$US$US
240611091$24061109$1$I$20240501$20240628$20240708$20240708$PER$$US-PFIZER INC-202400204508$PFIZER$$81$YR$$F$Y$$$20240708$$HP$US$US
240611101$24061110$1$I$20240625$20240704$20240708$20240708$PER$$US-PFIZER INC-202400207201$PFIZER$$62$YR$$F$Y$$$20240708$$CN$US$US
240611111$24061111$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206739$PFIZER$$65$YR$$F$Y$$$20240708$$CN$US$US
240611121$24061112$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206276$PFIZER$$$$$M$Y$$$20240708$$CN$US$US
240611131$24061113$1$I$20240201$20240701$20240708$20240708$PER$$US-PFIZER INC-PV202300209210$PFIZER$$63$YR$$M$Y$$$20240708$$HP$US$US
240611152$24061115$2$F$20240704$20240723$20240708$20240726$PER$$US-PFIZER INC-202400208283$PFIZER$$67$YR$$F$Y$58.957$KG$20240726$$MD$US$US
240611161$24061116$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206652$PFIZER$$53$YR$$F$Y$$$20240708$$PH$US$US
240611171$24061117$1$I$20240704$20240706$20240708$20240708$PER$$US-PFIZER INC-202400208160$PFIZER$$67$YR$$F$Y$$$20240708$$CN$US$US
240611181$24061118$1$I$20240703$20240704$20240708$20240708$PER$$US-PFIZER INC-202400207351$PFIZER$$54$YR$$F$Y$$$20240708$$CN$US$US
240611191$24061119$1$I$$20240706$20240708$20240708$PER$$US-PFIZER INC-202400208151$PFIZER$$75$YR$$F$Y$$$20240708$$CN$US$US
240611201$24061120$1$I$20240703$20240707$20240708$20240708$PER$$US-PFIZER INC-202400208167$PFIZER$$$$A$F$Y$$$20240708$$CN$US$US
240611213$24061121$3$F$20091113$20240819$20240708$20240822$PER$$US-PFIZER INC-202400203535$PFIZER$$66$YR$$F$Y$80.47$KG$20240822$$HP$US$US
240611221$24061122$1$I$20240705$20240707$20240708$20240708$PER$$US-PFIZER INC-202400208212$PFIZER$$65$YR$$F$Y$$$20240708$$CN$US$US
240611231$24061123$1$I$20240704$20240704$20240708$20240708$PER$$US-PFIZER INC-202400207377$PFIZER$$50$YR$$F$Y$$$20240708$$CN$US$US
240611251$24061125$1$I$20240101$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400088632$PFIZER$$58$YR$$M$Y$$$20240708$$HP$US$US
240611261$24061126$1$I$20240706$20240707$20240708$20240708$PER$$US-PFIZER INC-202400208213$PFIZER$$66$YR$$$Y$$$20240708$$CN$US$US
240611271$24061127$1$I$$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400088829$PFIZER$$65$YR$$F$Y$$$20240708$$CN$US$US
240611281$24061128$1$I$$20240706$20240708$20240708$PER$$US-PFIZER INC-202400208037$PFIZER$$71$YR$$F$Y$$$20240708$$HP$US$US
240611291$24061129$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202400087839$PFIZER$$76$YR$$F$Y$$$20240708$$CN$US$US
240611301$24061130$1$I$20240704$20240705$20240708$20240708$PER$$US-PFIZER INC-202400208070$PFIZER$$57$YR$$M$Y$$$20240708$$CN$US$US
240611311$24061131$1$I$20240601$20240628$20240708$20240708$EXP$FR-AFSSAPS-TS2024000708$FR-TEVA-VS-3215921$TEVA$$40$YR$$M$Y$62$KG$20240708$$MD$FR$FR
240611321$24061132$1$I$20240508$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405171519544830-SQPTG$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-108079$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$79$KG$20240708$$MD$GB$GB
240611331$24061133$1$I$$20240624$20240708$20240708$EXP$$FR-TEVA-VS-3216674$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240708$$HP$FR$FR
240611343$24061134$3$F$20240523$20240730$20240708$20240806$PER$$US-BAYER-2024A096405$BAYER$$47$YR$A$F$Y$$$20240806$$MD$US$US
240611351$24061135$1$I$$20240630$20240708$20240708$EXP$$US-JNJFOC-20240704752$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$CN$US$US
240611361$24061136$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215067$TEVA$$75$YR$$F$Y$$$20240708$$MD$CA$CA
240611371$24061137$1$I$$20240701$20240708$20240708$EXP$$US-OTSUKA-2024_018706$OTSUKA$Wu K, Shugoll J, Zisk C.. Risk Factors For Thromboembolism In patients on chronic antipsychotics. American Psychiatric Association Annual Meeting 2024. 2024$$$$M$Y$$$20240708$$HP$US$US
240611382$24061138$2$F$20230101$20240710$20240708$20240717$EXP$$US-ABBVIE-5830205$ABBVIE$$$$$M$Y$127$KG$20240717$$CN$US$US
240611391$24061139$1$I$$20240624$20240708$20240708$EXP$$FR-TEVA-VS-3216668$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240708$$HP$FR$FR
240611402$24061140$2$F$$20240902$20240708$20240910$EXP$$JP-OTSUKA-2024_018643$OTSUKA$$5$DEC$$F$Y$$$20240910$$MD$JP$JP
240611413$24061141$3$F$20240702$20240805$20240708$20240808$EXP$$US-INCYTE CORPORATION-2024IN007047$INCYTE$$$$$$Y$$$20240808$$MD$US$US
240611421$24061142$1$I$20240703$20240705$20240705$20240705$DIR$709254$$FDA-CTU$$62$YR$$F$N$66.15$KG$20240705$N$CN$US$
240611431$24061143$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46884$$FDA-CTU$$77$YR$$F$N$$$20240705$N$$US$
240611451$24061145$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46999$$FDA-CTU$$53$YR$$F$N$147.42$KG$20240705$N$$US$
240611461$24061146$1$I$20240612$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46878$$FDA-CTU$$65$YR$$F$N$$$20240705$N$$US$
240611471$24061147$1$I$20240705$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46986$$FDA-CTU$$69$YR$$M$N$$$20240705$Y$PH$US$
240611481$24061148$1$I$20240703$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46910$$FDA-CTU$$84$YR$$M$N$$$20240705$Y$PH$US$
240611491$24061149$1$I$20240613$20240702$20240705$20240705$DIR$FDA-CDER-CTU-2024-46830$$FDA-CTU$$35$YR$$F$N$$$20240702$N$HP$US$
240611501$24061150$1$I$20240607$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46893$$FDA-CTU$$72$YR$$F$N$$$20240705$Y$PH$US$
240611511$24061151$1$I$20240301$20240705$20240705$20240705$DIR$709225$$FDA-CTU$$$$$UNK$N$$$20240705$Y$CN$US$
240611521$24061152$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46835$$FDA-CTU$$27$YR$$M$N$$$20240705$N$$US$
240611531$24061153$1$I$$20240703$20240705$20240705$DIR$FDA-CDER-CTU-2024-46800$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240611551$24061155$1$I$$20240703$20240705$20240705$DIR$FDA-CDER-CTU-2024-46895$$FDA-CTU$$$$$M$N$$$20240703$N$HP$US$
240611561$24061156$1$I$$20240705$20240708$20240708$PER$$NVSC2024US140821$NOVARTIS$$$$$F$Y$$$20240708$$MD$US$US
240611571$24061157$1$I$$20240702$20240708$20240708$PER$$US-ABBVIE-5827584$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240611581$24061158$1$I$20240506$20240703$20240708$20240708$PER$$US-BAYER-2024A096482$BAYER$$33$YR$A$F$Y$$$20240708$$HP$US$US
240611591$24061159$1$I$20240628$20240702$20240708$20240708$PER$$US-ABBVIE-5830918$ABBVIE$$24$YR$$F$Y$$$20240708$$MD$US$US
240611602$24061160$2$F$20240101$20240715$20240708$20240729$PER$$US-BAYER-2024A096846$BAYER$$36$YR$A$F$Y$$$20240729$$CN$US$US
240611611$24061161$1$I$$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134491$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240611621$24061162$1$I$20240531$20240702$20240708$20240708$EXP$$US-INCYTE CORPORATION-2024IN007034$INCYTE$$$$$$Y$$$20240708$$MD$US$US
240611632$24061163$2$F$$20240807$20240708$20240807$PER$$US-PFIZER INC-2024SGN05527$PFIZER$$$$$$Y$$$20240807$$PH$US$US
240611641$24061164$1$I$$20240701$20240708$20240708$EXP$$DE-AMGEN-DEUSP2024132506$AMGEN$Khaled N. B.; Jochheim L.; Boettcher K. et al.. Early mortality in atezolizumab/bevacizumab for unresectable hepatocellular carcinoma: European, real-world study. Annals of Oncology. 2024;35:S84-S85$$$$$Y$$$20240708$$HP$DE$DE
240611651$24061165$1$I$20240601$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206966$PFIZER$$61$YR$$F$Y$65.77$KG$20240708$$CN$US$US
240611664$24061166$4$F$$20240705$20240708$20240711$EXP$$US-PFIZER INC-PV202400087640$PFIZER$$66$YR$$F$Y$$$20240711$$CN$US$US
240611671$24061167$1$I$$20240628$20240708$20240708$EXP$$IN-PFIZER INC-PV202400085943$PFIZER$CS, C.. Hypercalcemic Ovarian Carcinoma (Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)): A Case Series and Review of Literature of a Rare Malignancy. Indian Journal of Surgical Oncology. 2024;10.1007/s13193-024-01979-x$30$YR$$F$Y$$$20240708$$HP$IN$IN
240611681$24061168$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206289$PFIZER$$57$YR$$F$Y$$$20240708$$CN$US$US
240611692$24061169$2$F$20240623$20240716$20240708$20240718$PER$$US-PFIZER INC-202400207810$PFIZER$$29$YR$$F$Y$$$20240718$$HP$US$US
240611701$24061170$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206085$PFIZER$$$$$M$Y$$$20240708$$PH$US$US
240611711$24061171$1$I$$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400088601$PFIZER$$71$YR$$F$Y$$$20240708$$HP$US$US
240611721$24061172$1$I$$20240701$20240708$20240708$EXP$$JP-PFIZER INC-PV202400086471$PFIZER$Ogino, Y.. Investigation of immune-related adverse events (irAEs) in which the liver stiffness was able to be measured by abdominal ultrasound over time. The 37th Japan Association for Contrast-enhanced Ultrasonography in Abdomen [JAC. 2024;37th:34$7$DEC$$M$Y$$$20240708$$HP$JP$JP
240611731$24061173$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206666$PFIZER$$70$YR$$F$Y$$$20240708$$MD$US$US
240611741$24061174$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400208013$PFIZER$$62$YR$$F$Y$$$20240708$$HP$US$US
240611761$24061176$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202400088262$PFIZER$$43$YR$$$Y$$$20240708$$HP$US$US
240611782$24061178$2$F$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206718$PFIZER$$16$YR$$F$Y$$$20240708$$HP$US$US
240611791$24061179$1$I$$20240701$20240708$20240708$EXP$$JP-PFIZER INC-PV202400086541$PFIZER$Ebata, K.. Other iatrogenic immunodeficiency-associated lymphoproliferative diseases in which EBV-DNA quantitative monitoring was associated with pathology. The 59th Spring Hokkaido Regional Meeting of the Japanese Society of Hematology. 2024;59th:8$9$DEC$$F$Y$$$20240708$$HP$JP$JP
240611801$24061180$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206194$PFIZER$$$$$$Y$$$20240708$$CN$US$US
240611813$24061181$3$F$20231219$20240917$20240708$20240919$EXP$$AT-PFIZER INC-PV202400084380$PFIZER$$60$YR$$F$Y$80$KG$20240919$$MD$AT$AT
240611831$24061183$1$I$20240101$20240703$20240708$20240708$PER$$US-PFIZER INC-202400207999$PFIZER$$42$YR$$F$Y$$$20240708$$HP$US$US
240611841$24061184$1$I$$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400088615$PFIZER$$$$$$Y$$$20240708$$CN$US$US
240611852$24061185$2$F$$20240702$20240708$20240710$EXP$$IN-PFIZER INC-202400204529$PFIZER$Wakankar, R.. A Rare Case of Renal Malakoplakia Incidentally Detected on 18F-FDG PET/CT in a Patient With Concomitant Breast Cancer and Lymphoma. Clinical Nuclear Medicine. 2024;00 (00):10.1097/RLU.0000000000005310$68$YR$$F$Y$$$20240710$$MD$IN$IN
240611881$24061188$1$I$$20240630$20240708$20240708$EXP$$US-OTSUKA-2024_018608$OTSUKA$$$$$M$Y$$$20240708$$CN$US$US
240611891$24061189$1$I$20230101$20240702$20240708$20240708$EXP$$US-INCYTE CORPORATION-2024IN006985$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240611902$24061190$2$F$$20240716$20240708$20240726$EXP$$FR-TEVA-VS-3216655$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4); Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240726$$HP$FR$FR
240611911$24061191$1$I$$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400088371$PFIZER$$46$YR$$F$Y$$$20240708$$HP$US$US
240611921$24061192$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR082273$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240611931$24061193$1$I$$20240703$20240708$20240708$PER$$US-BAYER-2024A096850$BAYER$$$$$F$Y$$$20240708$$CN$US$US
240611941$24061194$1$I$20240704$20240705$20240708$20240708$EXP$$CN-BAYER-2024A097790$BAYER$$55$YR$A$F$Y$$$20240708$$MD$CN$CN
240611951$24061195$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194580$SANOFI AVENTIS$$$$E$M$Y$94.8$KG$20240708$$MD$US$US
240611961$24061196$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA195322$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240708$$MD$US$US
240611971$24061197$1$I$$20240705$20240708$20240708$PER$$US-BAYER-2024A097553$BAYER$$41$YR$A$F$Y$$$20240708$$MD$US$US
240611981$24061198$1$I$$20240704$20240708$20240708$EXP$$CN-TAKEDA-2024TUS068394$TAKEDA$$$$$M$Y$$$20240708$$CN$CN$CN
240611992$24061199$2$F$20230421$20240903$20240708$20240909$EXP$$AU-TAKEDA-2023TUS041331$TAKEDA$$88$YR$$F$Y$$$20240909$$CN$AU$AU
240612001$24061200$1$I$20240101$20240628$20240708$20240708$PER$$US-SA-2024SA195350$SANOFI AVENTIS$$75$YR$E$F$Y$66.22$KG$20240708$$MD$US$US
240612011$24061201$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46963$$FDA-CTU$$53$YR$$F$N$$$20240705$N$$US$
240612021$24061202$1$I$$20240701$20240708$20240708$PER$$US-VERTEX PHARMACEUTICALS-2024-011019$VERTEX$$$$$$Y$$$20240708$$CN$US$US
240612031$24061203$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46851$$FDA-CTU$$63$YR$$F$N$$$20240705$N$$US$
240612041$24061204$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46846$$FDA-CTU$$60$YR$$M$N$$$20240705$N$$US$
240612051$24061205$1$I$20230101$20240708$20240708$20240708$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038376$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240708$$CN$US$US
240612062$24061206$2$F$20230101$20240709$20240708$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-010984$VERTEX$$3$YR$$F$Y$$$20240715$$PH$US$US
240612071$24061207$1$I$20240601$20240702$20240708$20240708$EXP$$US-UCBSA-2024034384$UCB$$55$YR$$F$Y$$$20240708$$HP$US$US
240612081$24061208$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46858$$FDA-CTU$$66$YR$$F$N$81.65$KG$20240705$N$$US$
240612091$24061209$1$I$20240522$20240705$20240705$20240705$DIR$709201$$FDA-CTU$$48$YR$$M$N$111.15$KG$20240705$N$CN$US$
240612101$24061210$1$I$$20240626$20240708$20240708$EXP$$BG-COHERUS BIOSCIENCES, INC-2024-COH-BG000528$PAREXEL$Siyana Valova, Eduard Tilkiyan, Stefka Kostyaneva, Irina Zdravkova, Iskui Erkanyan, Bozhidar Hristov, Ivanka Yotovska and Teodor Kuskunov. Glomerulonephritis associated with anti -TNF-? therapy. Nephrol. Dial. Transplant.. 2024;39:i2073$$$$$Y$$$20240708$$MD$BG$BG
240612112$24061211$2$F$$20240705$20240708$20240711$EXP$DE-BFARM-24004574$DE-OTSUKA-2024_018621$OTSUKA$$$$$F$Y$$$20240711$$CN$DE$DE
240612121$24061212$1$I$$20240703$20240708$20240708$EXP$$US-TAKEDA-US202034204$TAKEDA$$$$$F$Y$$$20240708$$HP$US$US
240612131$24061213$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46864$$FDA-CTU$$$$$F$N$$$20240705$N$HP$US$
240612151$24061215$1$I$20240521$20240628$20240708$20240708$EXP$FR-AFSSAPS-CN2024000514$FR-TEVA-VS-3215923$TEVA$$76$YR$$F$Y$53$KG$20240708$$PH$FR$FR
240612161$24061216$1$I$$20240705$20240708$20240708$PER$$US-BAYER-2024A097737$BAYER$$52$YR$A$F$Y$$$20240708$$HP$US$US
240612171$24061217$1$I$20240101$20240702$20240708$20240708$PER$$US-SA-2024SA198098$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240708$$MD$US$US
240612181$24061218$1$I$20240628$20240708$20240708$20240708$EXP$ES-AEMPS-1542821$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038342$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$56$KG$20240708$$MD$ES$ES
240612191$24061219$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR081902$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240612201$24061220$1$I$$20240701$20240708$20240708$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700022$MYOVANT SCIENCES$$$$$M$Y$$$20240708$$CN$US$US
240612211$24061221$1$I$$20240624$20240708$20240708$EXP$GB-MHRA-MED-202406211555079020-BHCJY$GB-MYOVANT SCIENCES GMBH-2024MYSCI0601233$MYOVANT SCIENCES$$$$$F$Y$73$KG$20240708$$CN$GB$GB
240612222$24061222$2$F$20240513$20240709$20240708$20240712$EXP$FR-AFSSAPS-LL2024001124$FR-GILEAD-2024-0678590$GILEAD$$74$YR$E$F$Y$67$KG$20240712$$PH$FR$FR
240612231$24061223$1$I$20240216$20240626$20240708$20240708$EXP$$GB-RICHTER-2024-GR-006613$MYOVANT SCIENCES$$$$$F$Y$$$20240708$$HP$GB$GB
240612252$24061225$2$F$$20240712$20240708$20240719$PER$$US-ALXN-202407USA000009US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
240612261$24061226$1$I$$20240627$20240708$20240708$PER$$US-Covis Pharma GmbH-2024COV00826$COVIS PHARMA$$$$$F$Y$$$20240708$$CN$US$US
240612272$24061227$2$F$20090101$20240626$20240708$20240819$EXP$$US-Covis Pharma GmbH-2024COV00840$COVIS PHARMA$$69$YR$E$F$Y$27.694$KG$20240819$$$COUNTRY NOT SPECIFIED$US
240612281$24061228$1$I$$20240707$20240708$20240708$PER$$US-BAYER-2024A098035$BAYER$$$$$$Y$$$20240708$$CN$US$US
240612291$24061229$1$I$20240704$20240705$20240708$20240708$EXP$$CN-BAYER-2024A097792$BAYER$$18$YR$A$M$Y$$$20240708$$HP$CN$CN
240612301$24061230$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR082266$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240612311$24061231$1$I$$20240701$20240708$20240708$EXP$$NVSC2024CN139638$NOVARTIS$Chai F, Jiang M, Zhou X. Effect of sacubitril valsartan on cardiac function and ventricular remodeling in patients with heart failure with reduced ejection fraction. CHIN J OF CLINICAL RATIONAL DRUG USE. 2024;17(18):9-13$$$A$$Y$$$20240708$$HP$CN$CN
240612321$24061232$1$I$20240608$20240702$20240708$20240708$EXP$FR-AFSSAPS-AVGR2024000119$FR-MYLANLABS-2024M1062405$MYLAN$$31$YR$$M$Y$$$20240708$$MD$FR$FR
240612331$24061233$1$I$20240601$20240702$20240708$20240708$EXP$GB-MHRA-MED-202407021249159180-LHKWS$GB-MYLANLABS-2024M1062310$MYLAN$$$$$F$Y$$$20240708$$HP$GB$GB
240612341$24061234$1$I$$20240702$20240708$20240708$EXP$$GB-MYLANLABS-2024M1062229$MYLAN$$65$YR$$F$Y$88$KG$20240708$$PH$GB$GB
240612351$24061235$1$I$$20240701$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202407001959$ELI LILLY AND CO$$$$$F$Y$$$20240708$$CN$US$US
240612361$24061236$1$I$20240622$20240702$20240708$20240708$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407002215$ELI LILLY AND CO$$$$$$Y$$$20240708$$HP$CN$CN
240612372$24061237$2$F$20240701$20240917$20240708$20240923$EXP$$AU-MYLANLABS-2024M1062541$MYLAN$$40$YR$$M$Y$$$20240923$$HP$AU$AU
240612381$24061238$1$I$20190106$20240702$20240708$20240708$EXP$GB-MHRA-MED-202407022222049650-KTBQJ$GB-MYLANLABS-2024M1062235$MYLAN$$21$YR$$F$Y$$$20240708$$CN$GB$GB
240612391$24061239$1$I$20240511$20240702$20240708$20240708$EXP$FR-AFSSAPS-RE2024000625$FR-MYLANLABS-2024M1062255$MYLAN$$76$YR$$M$Y$57.5$KG$20240708$$MD$FR$FR
240612401$24061240$1$I$20240624$20240702$20240708$20240708$EXP$GB-MHRA-MED-202407021416012270-JCRSH$GB-MYLANLABS-2024M1062330$MYLAN$$72$YR$$F$Y$$$20240708$$MD$GB$GB
240612411$24061241$1$I$20240401$20240702$20240708$20240708$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407001770$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240708$$CN$JP$JP
240612422$24061242$2$F$20240601$20240917$20240708$20240924$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406019863$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240924$$CN$JP$JP
240612431$24061243$1$I$20240401$20240628$20240708$20240708$EXP$CN-NMPACDR-3501021028942202400271$CN-BAXTER-2024BAX020964$BAXTER$$12$YR$$M$Y$35$KG$20240708$$MD$CN$CN
240612441$24061244$1$I$20200126$20240702$20240708$20240708$EXP$PL-URPL-1-1188-2020$PL-ELI_LILLY_AND_COMPANY-PL202407002478$ELI LILLY AND CO$$30$YR$A$M$Y$$$20240708$$CN$PL$PL
240612451$24061245$1$I$20240627$20240628$20240708$20240708$PER$$US-BAYER-2024A094380$BAYER$$61$YR$A$M$Y$$$20240708$$CN$US$US
240612461$24061246$1$I$20240417$20240628$20240708$20240708$EXP$FR-AFSSAPS-DJ2024000806$FR-BAXTER-2024BAX020790$BAXTER$$37$YR$$M$Y$92$KG$20240708$$MD$FR$FR
240612471$24061247$1$I$$20240701$20240708$20240708$EXP$$BR-DSJP-DSE-2024-130235$DAIICHI$$47$YR$$F$Y$$$20240708$$MD$BR$BR
240612491$24061249$1$I$20181009$20240703$20240708$20240708$EXP$$CA-TAKEDA-2018TUS035249$TAKEDA$$10$YR$$M$Y$$$20240708$$CN$CA$CA
240612501$24061250$1$I$20240627$20240705$20240708$20240708$EXP$$US-UCBSA-2024034306$UCB$$71$YR$$F$Y$$$20240708$$CN$US$US
240612512$24061251$2$F$$20240802$20240708$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108017$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$94.8$KG$20240806$$CN$US$US
240612521$24061252$1$I$$20240705$20240708$20240708$EXP$$IE-BRISTOL-MYERS SQUIBB COMPANY-2024-107764$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240708$$PH$IE$IE
240612552$24061255$2$F$$20240709$20240708$20240711$PER$$US-ROCHE-10000016966$ROCHE$$$$E$M$Y$$$20240711$$CN$US$US
240612561$24061256$1$I$$20240703$20240708$20240708$PER$$US-ABBVIE-5827916$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240612571$24061257$1$I$$20240628$20240708$20240708$PER$$US-INCYTE CORPORATION-2024IN006933$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240612581$24061258$1$I$20220301$20240702$20240708$20240708$EXP$$NVSC2024MX140142$NOVARTIS$$36$YR$$F$Y$83$KG$20240708$$CN$MX$MX
240612591$24061259$1$I$20240101$20240628$20240708$20240708$EXP$$US-TG THERAPEUTICS INC.-TGT003756$TG THERAPEUTICS$$$$$M$Y$$$20240708$$CN$US$US
240612601$24061260$1$I$$20240702$20240708$20240708$PER$$US-ROCHE-10000018778$ROCHE$$$$A$M$Y$$$20240708$$CN$US$US
240612611$24061261$1$I$20240101$20240703$20240708$20240708$EXP$$CA-JNJFOC-20240711758$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240708$$HP$CA$CA
240612621$24061262$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405071208398980-GHSVM$GB-GSK-GB2024083419$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$HP$GB$GB
240612632$24061263$2$F$20231001$20240710$20240708$20240721$EXP$$US-BAXTER-2023BAX034508AA$BAXTER$$74$YR$$M$Y$86$KG$20240719$$HP$US$US
240612641$24061264$1$I$20170101$20240701$20240708$20240708$EXP$$AR-ROCHE-10000014537$ROCHE$$64$YR$A$M$Y$$$20240708$$MD$AR$AR
240612651$24061265$1$I$20240101$20240626$20240708$20240708$EXP$PT-INFARMED-E202406-400$PT-BAYER-2024A092577$BAYER$$38$YR$A$F$Y$58$KG$20240708$$PH$PT$PT
240612661$24061266$1$I$20240401$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405031257526320-JTVBG$GB-ORGANON-O2407GBR000556$ORGANON$$$$C$$Y$$$20240708$$CN$GB$GB
240612671$24061267$1$I$20240626$20240628$20240708$20240708$PER$$US-SA-2024SA195386$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240708$$CN$US$US
240612681$24061268$1$I$20240601$20240627$20240708$20240708$PER$$US-SA-2024SA194214$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240708$$MD$US$US
240612691$24061269$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000042US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$US$US
240612701$24061270$1$I$20240621$20240704$20240708$20240708$EXP$$CN-BAYER-2024A097894$BAYER$$55$YR$A$F$Y$$$20240708$$HP$CN$CN
240612721$24061272$1$I$20240523$20240628$20240708$20240708$EXP$FR-AFSSAPS-LL2024001177$FR-TEVA-VS-3215739$TEVA$$46$YR$$M$Y$$$20240708$$MD$FR$FR
240612731$24061273$1$I$20220101$20240701$20240708$20240708$EXP$$US-OTSUKA-2024_018821$OTSUKA$$$$$M$Y$$$20240708$$CN$US$US
240612741$24061274$1$I$$20240703$20240705$20240705$DIR$FDA-CDER-CTU-2024-46964$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240612751$24061275$1$I$$20240705$20240705$20240705$DIR$709232$$FDA-CTU$$$$$UNK$N$$$20240705$N$PH$US$
240612761$24061276$1$I$$20240627$20240708$20240708$EXP$$AE-DSJP-DSJ-2024-130901$DAIICHI$$$$$F$Y$$$20240708$$CN$AE$AE
240612771$24061277$1$I$20240628$20240705$20240708$20240708$EXP$GB-MHRA-MED-202407051516043990-HDYFZ$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038225$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$90$KG$20240708$$PH$GB$GB
240612781$24061278$1$I$$20240701$20240708$20240708$PER$$US-LEO Pharma-371736$LEO PHARM$$23$YR$$F$Y$$$20240708$$PH$US$US
240612821$24061282$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46961$$FDA-CTU$$$$$M$N$$$20240705$N$HP$US$
240612832$24061283$2$F$$20240808$20240708$20240813$EXP$$JP-DSJP-DSJ-2024-130944$DAIICHI$$7$DEC$$F$Y$$$20240813$$MD$JP$JP
240612842$24061284$2$F$$20240628$20240708$20240710$EXP$$US-ARGENX-2024-ARGX-US005024$ARGENX BVBA$$$$$$Y$$$20240710$$CN$US$US
240612851$24061285$1$I$$20240703$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107596$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240708$$CN$US$US
240612861$24061286$1$I$$20240703$20240708$20240708$EXP$$IL-AstraZeneca-2024A155084$ASTRAZENECA$$$$$M$Y$$$20240708$$MD$IL$
240612871$24061287$1$I$$20240703$20240708$20240708$PER$$US-ROCHE-10000018384$ROCHE$$$$$F$Y$$$20240708$$MD$US$US
240612881$24061288$1$I$$20240702$20240708$20240708$PER$$US-AMGEN-USASP2024131779$AMGEN$$$$E$$Y$$$20240708$$CN$US$US
240612891$24061289$1$I$$20240628$20240708$20240708$PER$$US-INCYTE CORPORATION-2024IN006932$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240612901$24061290$1$I$$20240628$20240708$20240708$EXP$FR-AFSSAPS-RS2024000609$FR-MYLANLABS-2024M1061183$MYLAN$$24$YR$$F$Y$67$KG$20240708$$MD$FR$FR
240612911$24061291$1$I$$20240628$20240708$20240708$EXP$$US-MYLANLABS-2024M1061611$MYLAN$Kollasch-McGarvey A, Moore S, Eschbacher K. Gross and microscopic manifestations of Wernicke encephalopathy in a 67-year-old female. J-Neuropathol-Exp-Neurol 2024; 83 (6): 487 abstr. 76.$67$YR$$F$Y$$$20240708$$HP$US$US
240612921$24061292$1$I$$20240628$20240708$20240708$EXP$$US-MYLANLABS-2024M1061603$MYLAN$Torelli VA, Ernest Jean R, Tran E. Rapidly Progressive Interstitial Lung Disease Due to Silicosis in an Otherwise Healthy Jeweler. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$83$YR$$F$Y$$$20240708$$HP$US$US
240612931$24061293$1$I$20240507$20240628$20240708$20240708$EXP$FR-AFSSAPS-TO2024000823$FR-MYLANLABS-2024M1061186$MYLAN$$78$YR$$F$Y$$$20240708$$MD$FR$FR
240612942$24061294$2$F$$20240709$20240708$20240715$EXP$$SE-MYLANLABS-2024M1061487$MYLAN$Fink K, Gorczyca A.Alping P, Englund S, Farmand S, Langer-Gould AM, et al. Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study.. Mult Scler.. 2023;29(6):731-40.$$$$$Y$$$20240715$$MD$SE$SE
240612951$24061295$1$I$20190418$20240628$20240708$20240708$EXP$SE-SEMPA-2024-005111$SE-MYLANLABS-2024M1061148$MYLAN$$27$YR$$F$Y$54$KG$20240708$$CN$SE$SE
240612962$24061296$2$F$20230501$20240710$20240708$20240716$EXP$$SI-MYLANLABS-2024M1061163$MYLAN$$72$YR$$F$Y$$$20240716$$MD$SI$SI
240612971$24061297$1$I$$20240701$20240708$20240708$EXP$$US-SA-2024SA195597$SANOFI AVENTIS$$$$$F$Y$$$20240708$$HP$US$US
240612981$24061298$1$I$$20240703$20240708$20240708$EXP$$PH-DAIICHI SANKYO, INC.-DSJ-2024-131031$DAIICHI$$$$$F$Y$$$20240708$$CN$PH$PH
240612993$24061299$3$F$$20240725$20240708$20240806$EXP$$RU-DSJP-DSJ-2024-131034$DAIICHI$$$$$F$Y$$$20240806$$MD$RU$RU
240613001$24061300$1$I$$20240705$20240708$20240708$EXP$$AU-MYLANLABS-2024M1062931$MYLAN$$$$$F$Y$$$20240708$$PH$AU$AU
240613012$24061301$2$F$$20240809$20240708$20240811$PER$$US-JNJFOC-20240670752$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240811$$PH$US$US
240613021$24061302$1$I$20240514$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405140824070430-GTNLS$GB-MYLANLABS-2024M1063138$MYLAN$$61$YR$$M$Y$82$KG$20240708$$MD$GB$GB
240613031$24061303$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405012341446720-KTSFY$GB-MYLANLABS-2024M1063260$MYLAN$$$$$$Y$$$20240708$$CN$GB$GB
240613041$24061304$1$I$$20240628$20240708$20240708$EXP$$CZ-MYLANLABS-2024M1061509$MYLAN$Jurica J, Gonec R, Bartova A, Gregorova J. Immune mediated adverse effects of checkpoint inhibitors: A clinical experience. European Pharmaceutical Journal. 2022;69(S1):84-6.$52$YR$$F$Y$88$KG$20240708$$MD$CZ$CZ
240613052$24061305$2$F$20240701$20240829$20240708$20240903$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-107245$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240903$$PH$DE$DE
240613061$24061306$1$I$$20240516$20240708$20240708$PER$$ES-APELLIS-2024-APL-0000180$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240708$$HP$ES$ES
240613071$24061307$1$I$$20240628$20240708$20240708$PER$$US-INCYTE CORPORATION-2024IN006893$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240613081$24061308$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47005$$FDA-CTU$$78$YR$$F$N$$$20240705$N$$US$
240613091$24061309$1$I$20240703$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46939$$FDA-CTU$$78$YR$$F$N$$$20240705$N$$US$
240613101$24061310$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47011$$FDA-CTU$$48$YR$$F$N$83.01$KG$20240705$N$$US$
240613111$24061311$1$I$20240307$20240702$20240708$20240708$EXP$$US-OTSUKA-2024_005073$OTSUKA$$75$YR$$F$Y$$$20240708$$HP$US$US
240613121$24061312$1$I$$20240703$20240705$20240705$DIR$FDA-CDER-CTU-2024-46992$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240613131$24061313$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46972$$FDA-CTU$$$$$F$N$$$20240705$N$HP$US$
240613141$24061314$1$I$20240624$20240627$20240708$20240708$EXP$$CN-SA-2024SA194594$SANOFI AVENTIS$$91$YR$E$M$Y$$$20240708$$HP$CN$CN
240613151$24061315$1$I$$20240628$20240708$20240708$PER$$US-INCYTE CORPORATION-2024IN006921$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240613161$24061316$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405081535377470-TPYSN$GB-MYLANLABS-2024M1062962$MYLAN$$$$$F$Y$87$KG$20240708$$PH$GB$GB
240613171$24061317$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46871$$FDA-CTU$$33$YR$$F$N$$$20240705$N$$US$
240613181$24061318$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46947$$FDA-CTU$$29$YR$$F$N$$$20240705$N$$US$
240613191$24061319$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000114US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
240613202$24061320$2$F$$20240701$20240708$20240711$EXP$$CA-DSJP-DSJ-2024-127787$DAIICHI$$$$$F$Y$$$20240711$$CN$CA$CA
240613211$24061321$1$I$20240601$20240628$20240708$20240708$EXP$$CN-009507513-2407CHN001135$MERCK$$67$YR$$M$Y$68$KG$20240708$$HP$CN$CN
240613221$24061322$1$I$20240617$20240701$20240708$20240708$EXP$FR-AFSSAPS-LY2024000927$FR-FreseniusKabi-FK202410504$FRESENIUS KABI$$52$YR$A$F$Y$$$20240708$$PH$FR$FR
240613231$24061323$1$I$20240609$20240628$20240708$20240708$EXP$$CN-FreseniusKabi-FK202410268$FRESENIUS KABI$$60$YR$A$F$Y$60$KG$20240708$$HP$CN$CN
240613241$24061324$1$I$20240101$20240703$20240708$20240708$EXP$$US-ABBVIE-5831092$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240613251$24061325$1$I$20231107$20240701$20240708$20240708$EXP$FR-AFSSAPS-AN2024000832$FR-FreseniusKabi-FK202410500$FRESENIUS KABI$$66$YR$E$F$Y$$$20240708$$PH$FR$FR
240613261$24061326$1$I$$20240624$20240708$20240708$PER$$US-MYLANLABS-2024M1058294$MYLAN$$$$$$Y$$$20240708$$CN$US$US
240613271$24061327$1$I$$20240703$20240708$20240708$EXP$$FR-GSK-FR2024EME082985$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$FR$FR
240613283$24061328$3$F$$20240826$20240708$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06028$LUPIN$$$$$$Y$$$20240913$$CN$US$US
240613291$24061329$1$I$$20240707$20240708$20240708$PER$$US-HALEON-2185827$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240613301$24061330$1$I$20201104$20240701$20240708$20240708$EXP$$US-CHIESI-2024CHF03994$CHIESI$$41$YR$$F$Y$74.8$KG$20240708$$CN$US$US
240613311$24061331$1$I$$20240626$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202406018238$ELI LILLY AND CO$$55$YR$A$$Y$$$20240708$$CN$US$US
240613321$24061332$1$I$$20240624$20240708$20240708$PER$$US-MYLANLABS-2024M1058393$MYLAN$$$$$$Y$$$20240708$$CN$US$US
240613331$24061333$1$I$20240101$20240628$20240708$20240708$EXP$$AT-TEVA-VS-3215650$TEVA$$65$YR$$F$Y$$$20240708$$CN$AT$AT
240613342$24061334$2$F$20220101$20240809$20240708$20240813$EXP$$US-BIOVITRUM-2024-US-009527$BIOVITRUM$$75$YR$$F$Y$100.6$KG$20240813$$MD$US$US
240613351$24061335$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108189$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240708$$CN$US$US
240613362$24061336$2$F$$20240708$20240708$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107716$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240711$$PH$US$US
240613371$24061337$1$I$$20240529$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086892$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240708$$CN$US$US
240613381$24061338$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107812$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240708$$HP$US$US
240613391$24061339$1$I$$20240702$20240708$20240708$PER$$US-SA-2024SA198207$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240708$$MD$US$US
240613401$24061340$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR081954$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240613411$24061341$1$I$20240708$20240708$20240708$20240708$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038385$BOEHRINGER INGELHEIM$$82$YR$E$M$Y$$$20240708$$CN$US$US
240613422$24061342$2$F$20240513$20240806$20240708$20240808$EXP$GB-MHRA-MED-202405140626359200-LVCRM$GB-MYLANLABS-2024M1063266$MYLAN$$45$YR$$F$Y$91$KG$20240808$$CN$GB$GB
240613441$24061344$1$I$20240703$20240704$20240708$20240708$EXP$GB-MHRA-MED-202407041459345310-HBWCZ$GB-MYLANLABS-2024M1063201$MYLAN$$58$YR$$F$Y$$$20240708$$HP$GB$GB
240613451$24061345$1$I$20240301$20240704$20240708$20240708$EXP$$AU-MYLANLABS-2024M1063147$MYLAN$$22$YR$$F$Y$$$20240708$$HP$AU$AU
240613461$24061346$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215100$TEVA$$44$YR$$M$Y$$$20240708$$HP$CA$CA
240613472$24061347$2$F$$20240728$20240708$20240806$PER$$US-SA-2024SA196206$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
240613481$24061348$1$I$20191101$20240704$20240708$20240708$EXP$GB-MHRA-MED-202404301931392500-MGPHN$GB-MYLANLABS-2024M1063106$MYLAN$$$$$M$Y$$$20240708$$CN$GB$GB
240613491$24061349$1$I$20240501$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405132350412670-PJFYG$GB-MYLANLABS-2024M1063236$MYLAN$$42$YR$$M$Y$$$20240708$$CN$GB$GB
240613501$24061350$1$I$20240101$20240701$20240708$20240708$EXP$$US-OTSUKA-2024_018819$OTSUKA$$$$$M$Y$$$20240708$$CN$US$US
240613512$24061351$2$F$$20240812$20240708$20240815$EXP$GB-MHRA-MED-202405051644346530-QGMWK$GB-MYLANLABS-2024M1063209$MYLAN$$$$$M$Y$89$KG$20240815$$CN$GB$GB
240613521$24061352$1$I$$20240624$20240708$20240708$PER$$US-MYLANLABS-2024M1060500$MYLAN$$57$YR$$M$Y$$$20240708$$CN$US$US
240613531$24061353$1$I$$20240704$20240708$20240708$EXP$$IE-MYLANLABS-2024M1063273$MYLAN$$$$$M$Y$$$20240708$$PH$IE$IE
240613541$24061354$1$I$20240101$20240705$20240708$20240708$EXP$$ZA-ABBVIE-5830412$ABBVIE$$49$YR$$M$Y$$$20240708$$MD$ZA$ZA
240613551$24061355$1$I$20240601$20240708$20240708$20240708$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038377$BOEHRINGER INGELHEIM$$58$YR$A$$Y$$$20240708$$CN$US$US
240613561$24061356$1$I$$20240626$20240708$20240708$PER$$US-AstraZeneca-2024A150780$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$US$
240613571$24061357$1$I$20240706$20240706$20240706$20240706$DIR$FDA-CDER-CTU-2024-47153$$FDA-CTU$$67$YR$$M$N$$$20240706$N$PH$US$
240613582$24061358$2$F$$20240719$20240708$20240729$EXP$$JP-TAKEDA-2024TUS068400$TAKEDA$$71$YR$$M$Y$$$20240729$$MD$JP$JP
240613592$24061359$2$F$$20240730$20240708$20240801$PER$$US-PFIZER INC-PV202400079444$PFIZER$$74$YR$$F$Y$61.688$KG$20240801$$CN$US$US
240613605$24061360$5$F$$20240829$20240708$20240903$30DAY$$US-PFIZER INC-202400206898$PFIZER$$67$YR$$F$Y$$$20240903$$CN$US$US
240613611$24061361$1$I$$20240705$20240708$20240708$PER$$NVSC2024US140864$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
240613621$24061362$1$I$$20240707$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107702$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$73.48$KG$20240708$$CN$US$US
240613631$24061363$1$I$20240702$20240706$20240706$20240706$DIR$709262$$FDA-CTU$$38$YR$$F$N$74.7$KG$20240706$N$CN$US$
240613641$24061364$1$I$20240704$20240706$20240706$20240706$DIR$709268$$FDA-CTU$$44$YR$$F$N$117$KG$20240706$N$CN$US$
240613651$24061365$1$I$20191021$20240706$20240706$20240706$DIR$709265$$FDA-CTU$$32$YR$$F$N$$$20240706$N$CN$US$
240613661$24061366$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107860$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240708$$CN$US$US
240613671$24061367$1$I$20240617$20240703$20240708$20240708$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-106780$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$68.95$KG$20240708$$CN$PR$PR
240613681$24061368$1$I$$20240705$20240708$20240708$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038243$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240708$$CN$US$US
240613691$24061369$1$I$20240621$20240704$20240708$20240708$EXP$$GB-MYLANLABS-2024M1062905$MYLAN$$$$$M$Y$$$20240708$$CN$GB$GB
240613701$24061370$1$I$20240703$20240704$20240708$20240708$EXP$$GB-MYLANLABS-2024M1062900$MYLAN$$$$$M$Y$$$20240708$$CN$GB$GB
240613711$24061371$1$I$20240422$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405031303370180-SCPBV$GB-MYLANLABS-2024M1062996$MYLAN$$72$YR$$F$Y$78$KG$20240708$$PH$GB$GB
240613721$24061372$1$I$20240624$20240704$20240708$20240708$EXP$$AU-MYLANLABS-2024M1062988$MYLAN$$44$YR$$M$Y$$$20240708$$HP$AU$AU
240613731$24061373$1$I$$20240704$20240708$20240708$EXP$$AU-MYLANLABS-2024M1063019$MYLAN$$$$$F$Y$$$20240708$$PH$AU$AU
240613741$24061374$1$I$20240401$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405021346199740-TWCQK$GB-MYLANLABS-2024M1062957$MYLAN$$$$$M$Y$100$KG$20240708$$CN$GB$GB
240613751$24061375$1$I$$20240703$20240708$20240708$EXP$$GB-AMGEN-GBRSP2024133114$AMGEN$$$$$F$Y$$$20240708$$HP$GB$GB
240613761$24061376$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202407041156036650-BMCRP$GB-MYLANLABS-2024M1063017$MYLAN$$$$$F$Y$85$KG$20240708$$PH$GB$GB
240613771$24061377$1$I$20240626$20240701$20240708$20240708$EXP$$CN-FreseniusKabi-FK202410380$FRESENIUS KABI$$67$YR$E$F$Y$43$KG$20240708$$HP$CN$CN
240613781$24061378$1$I$20240629$20240702$20240708$20240708$EXP$$CN-FreseniusKabi-FK202410576$FRESENIUS KABI$$80$YR$E$M$Y$50$KG$20240708$$HP$CN$CN
240613792$24061379$2$F$20240101$20240710$20240708$20240711$PER$$US-ORGANON-O2407USA000736$ORGANON$$30$YR$$F$Y$$$20240711$$HP$US$US
240613801$24061380$1$I$20180715$20240701$20240708$20240708$EXP$PT-EMA-DD-20240122-7482715-064121$PT-FreseniusKabi-FK202410382$FRESENIUS KABI$$32$YR$A$F$Y$$$20240708$$MD$PT$PT
240613811$24061381$1$I$20240701$20240701$20240708$20240708$PER$$US-SA-2024SA197639$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240708$$MD$US$US
240613822$24061382$2$F$$20240701$20240708$20240713$PER$$US-SA-2024SA192833$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240713$$HP$US$US
240613832$24061383$2$F$20240101$20240717$20240708$20240726$PER$$US-SA-2024SA195395$SANOFI AVENTIS$$55$YR$A$F$Y$87.075$KG$20240726$$MD$US$US
240613841$24061384$1$I$20240412$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405161342509090-YDSMH$GB-ORGANON-O2407GBR000633$ORGANON$$55$YR$$F$Y$$$20240708$$HP$GB$GB
240613851$24061385$1$I$$20240627$20240708$20240708$EXP$$FR-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2406FR05137$INSUD PHARMA$$$$$F$Y$$$20240708$$MD$FR$FR
240613861$24061386$1$I$20240415$20240702$20240708$20240708$EXP$GB-MHRA-MED-202407021248095350-GNCRY$GB-LABORATORIOS LICONSA S.A.-2407GB05214$INSUD PHARMA$$77$YR$$M$Y$$$20240708$$CN$GB$GB
240613872$24061387$2$F$20240705$20240708$20240708$20240718$EXP$$US-APELLIS-2024-APL-0000313$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240718$$CN$US$US
240613882$24061388$2$F$$20240708$20240708$20240708$PER$$US-JNJFOC-20240710957$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$US$US
240613892$24061389$2$F$20240623$20240705$20240708$20240708$PER$$US-JNJFOC-20240715357$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240708$$CN$US$US
240613902$24061390$2$F$$20240712$20240708$20240718$EXP$$JP-OTSUKA-2024_018596$OTSUKA$$61$YR$$M$Y$$$20240718$$PH$JP$JP
240613911$24061391$1$I$20240706$20240706$20240706$20240706$DIR$709274$$FDA-CTU$$30$YR$$M$N$71.5$KG$20240706$N$$US$
240613921$24061392$1$I$20240622$20240703$20240708$20240708$EXP$$NVSC2024CN139620$NOVARTIS$$59$YR$$F$Y$$$20240708$$HP$CN$CN
240613931$24061393$1$I$$20240627$20240708$20240708$PER$$US-ROCHE-10000015207$ROCHE$$20$YR$A$M$Y$$$20240708$$HP$US$US
240613941$24061394$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202406241048130840-PVLDJ$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038256$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240708$$MD$GB$GB
240613951$24061395$1$I$$20240610$20240708$20240708$PER$$US-SCIEGENP-2024SCSPO00313$SCIEGEN$$$$$$Y$$$20240708$$CN$US$US
240613961$24061396$1$I$$20240702$20240708$20240708$EXP$$CA-OTSUKA-2024_018930$OTSUKA$$66$YR$$F$Y$$$20240708$$CN$CA$CA
240613972$24061397$2$F$$20240830$20240708$20240902$EXP$$JP-ABBVIE-5831243$ABBVIE$$39$YR$$F$Y$$$20240902$$CN$JP$JP
240613981$24061398$1$I$$20240627$20240708$20240708$PER$$US-ROCHE-10000014501$ROCHE$$57$YR$A$F$Y$$$20240708$$HP$US$US
240613992$24061399$2$F$20240705$20240812$20240708$20240813$PER$$US-JNJFOC-20240715796$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240813$$PH$US$US
240614001$24061400$1$I$$20240704$20240708$20240708$EXP$$GB-MYLANLABS-2024M1062892$MYLAN$$$$$M$Y$$$20240708$$HP$GB$GB
240614011$24061401$1$I$20230910$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405031033527580-SZPTF$GB-MYLANLABS-2024M1062893$MYLAN$$$$$F$Y$$$20240708$$PH$GB$GB
240614021$24061402$1$I$20240701$20240701$20240708$20240708$EXP$$IN-GSK-IN2024APC082029$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$IN$IN
240614031$24061403$1$I$20240601$20240703$20240708$20240708$30DAY$$US-GSK-US2024082588$GLAXOSMITHKLINE$$70$YR$$M$Y$70.31$KG$20240708$$CN$US$US
240614041$24061404$1$I$20240705$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134424$AMGEN$$73$YR$E$F$Y$$$20240708$$CN$US$US
240614051$24061405$1$I$20240619$20240625$20240708$20240708$EXP$$PK-ROCHE-10000013999$ROCHE$$66$YR$E$M$Y$$$20240708$$CN$PK$PK
240614061$24061406$1$I$$20240702$20240708$20240708$EXP$$US-AMERICAN REGENT INC-2024002582$AMERICAN REGENT$Jain T, Choudhary M, Grover P. Severe Lactic Acidosis Following Epinephrine Use in Anaphylaxis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3413 [abstract]$57$YR$$M$Y$$$20240708$$HP$US$US
240614071$24061407$1$I$20240628$20240702$20240708$20240708$EXP$$US-OTSUKA-2024_019021$OTSUKA$$41$YR$$F$Y$$$20240708$$CN$US$US
240614082$24061408$2$F$20240701$20240710$20240708$20240715$EXP$$US-KARYOPHARM-2024KPT001279$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240614093$24061409$3$F$20240401$20240710$20240708$20240727$PER$$US-AMGEN-USASP2024134363$AMGEN$$74$YR$E$F$Y$$$20240727$$CN$US$US
240614112$24061411$2$F$20230101$20240711$20240708$20240722$PER$$CH-Merck Healthcare KGaA-2024034599$MERCK KGAA$$62$YR$A$F$Y$$$20240719$$CN$CH$CH
240614121$24061412$1$I$20240601$20240611$20240708$20240708$PER$$US-KARYOPHARM-2024KPT001179$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240708$$CN$US$US
240614132$24061413$2$F$$20240724$20240708$20240819$PER$$US-KARYOPHARM-2024KPT001273$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240819$$CN$US$US
240614141$24061414$1$I$20240610$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107909$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240708$$CN$US$US
240614151$24061415$1$I$20240601$20240702$20240708$20240708$PER$$US-ROCHE-10000018939$ROCHE$$$$A$M$Y$$$20240708$$HP$US$US
240614161$24061416$1$I$20240601$20240702$20240708$20240708$EXP$$US-Eisai-EC-2024-168398$EISAI$$64$YR$A$M$Y$$$20240708$$CN$US$US
240614173$24061417$3$F$$20240725$20240708$20240730$PER$$US-AMGEN-USASP2024133912$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
240614181$24061418$1$I$$20240701$20240708$20240708$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003688$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$US$US
240614191$24061419$1$I$$20240702$20240708$20240708$PER$$US-ABBVIE-5830605$ABBVIE$$$$$$Y$$$20240708$$HP$US$US
240614202$24061420$2$F$$20240515$20240708$20240724$PER$$US-HALEON-2183309$Haleon PLC$$5$YR$$M$Y$$$20240724$$CN$US$US
240614211$24061421$1$I$$20240706$20240708$20240708$PER$$US-HALEON-2185800$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240614222$24061422$2$F$$20240711$20240708$20240722$EXP$$US-TEVA-VS-3214523$TEVA$Huang L, Ellis TJ, Bagavathy K. The Unfortunate Trifecta: Tuberculosis, EBV, and CMV Induced Hemophagocytic Lymphohistiocytosis. Am-J-Respir-Crit-Care-Med 2024; 209 1.; Huang L, Ellis TJ, Bagavathy K. The Unfortunate Trifecta: Tuberculosis, EBV, and CMV Induced Hemophagocytic Lymphohistiocytosis. Am-J-Respir-Crit-Care-Med 2024; 209 1.$52$YR$$M$Y$$$20240722$$HP$US$US
240614231$24061423$1$I$$20240626$20240708$20240708$PER$$US-JNJFOC-20240673629$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240708$$CN$US$US
240614245$24061424$5$F$20240307$20240912$20240708$20240918$EXP$$AR-MYLANLABS-2024M1023770$MYLAN$$21$YR$$M$Y$$$20240918$$CN$AR$AR
240614252$24061425$2$F$20240629$20240715$20240708$20240724$EXP$$IL-AstraZeneca-2024A154286$ASTRAZENECA$$27246$DY$$F$Y$$$20240724$$CN$IL$
240614271$24061427$1$I$20240601$20240702$20240708$20240708$EXP$$CN-BAYER-2024A095730$BAYER$$47$YR$A$F$Y$45$KG$20240708$$HP$CN$CN
240614281$24061428$1$I$20231101$20240625$20240708$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106420$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$93.1$KG$20240708$$MD$US$US
240614301$24061430$1$I$$20240702$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105803$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240708$$CN$US$US
240614311$24061431$1$I$20240501$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405132350412670-PJFYG$GB-TEVA-VS-3217741$TEVA$$42$YR$$M$Y$$$20240708$$CN$GB$GB
240614321$24061432$1$I$20240628$20240701$20240708$20240708$EXP$$US-VANTIVE-2024VAN018089$Vantive US Healthcare$$$$$F$Y$$$20240708$$HP$US$US
240614332$24061433$2$F$$20240730$20240708$20240805$EXP$$IN-VANTIVE-2024VAN018122$Vantive US Healthcare$$70$YR$$M$Y$$$20240805$$CN$IN$IN
240614341$24061434$1$I$20221026$20240703$20240708$20240708$EXP$$AR-MYLANLABS-2024M1062977$MYLAN$$16$YR$$M$Y$$$20240708$$HP$AR$AR
240614352$24061435$2$F$20240531$20240711$20240708$20240712$EXP$$NZ-MYLANLABS-2024M1062544$MYLAN$$52$YR$$M$Y$$$20240712$$PH$NZ$NZ
240614361$24061436$1$I$$20240703$20240708$20240708$EXP$$GB-MYLANLABS-2024M1062897$MYLAN$$$$$F$Y$$$20240708$$CN$GB$GB
240614372$24061437$2$F$$20240920$20240708$20240920$EXP$$AU-MYLANLABS-2024M1062669$MYLAN$$$$$M$Y$$$20240920$$HP$AU$AU
240614381$24061438$1$I$20240529$20240703$20240708$20240708$EXP$ES-AEMPS-1541374$ES-MYLANLABS-2024M1062395$MYLAN$$26$YR$$F$Y$52$KG$20240708$$PH$ES$ES
240614391$24061439$1$I$$20240703$20240708$20240708$EXP$$IE-MYLANLABS-2024M1062553$MYLAN$$$$$M$Y$$$20240708$$HP$IE$IE
240614401$24061440$1$I$$20240624$20240708$20240708$PER$$US-MYLANLABS-2024M1058419$MYLAN$$$$$$Y$$$20240708$$CN$US$US
240614411$24061441$1$I$20231110$20240703$20240708$20240708$EXP$GB-MHRA-MED-202407022337350880-HWTLS$GB-MYLANLABS-2024M1062410$MYLAN$$39$YR$$F$Y$$$20240708$$CN$GB$GB
240614421$24061442$1$I$$20240703$20240708$20240708$EXP$$GB-MYLANLABS-2024M1062562$MYLAN$$$$$M$Y$$$20240708$$PH$GB$GB
240614432$24061443$2$F$20240622$20240916$20240708$20240923$EXP$$GB-MYLANLABS-2024M1062774$MYLAN$$$$$M$Y$$$20240923$$PH$GB$GB
240614443$24061444$3$F$$20240827$20240708$20240903$EXP$$GB-MYLANLABS-2024M1063007$MYLAN$$$$$M$Y$$$20240903$$MD$GB$GB
240614451$24061445$1$I$20240401$20240703$20240708$20240708$EXP$$FI-MYLANLABS-2024M1062894$MYLAN$$54$YR$$F$Y$$$20240708$$MD$FI$FI
240614461$24061446$1$I$$20240703$20240708$20240708$EXP$GB-MHRA-TPP15329347C8328081YC1719917328130$GB-MYLANLABS-2024M1062402$MYLAN$$56$YR$$F$Y$85$KG$20240708$$MD$GB$GB
240614471$24061447$1$I$20240620$20240703$20240708$20240708$EXP$$MX-ROCHE-10000018252$ROCHE$$49$YR$A$F$Y$60$KG$20240708$$CN$MX$MX
240614484$24061448$4$F$20240702$20240805$20240708$20240808$EXP$$US-AMERICAN REGENT INC-2024002297$AMERICAN REGENT$$27$YR$$F$Y$$$20240808$$HP$US$US
240614492$24061449$2$F$20240401$20240808$20240708$20240815$30DAY$$US-GSK-US2024081662$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240815$$MD$US$US
240614503$24061450$3$F$20240419$20240910$20240708$20240916$EXP$$US-OTSUKA-2024_012837$OTSUKA$$$$$M$Y$$$20240916$$CN$US$US
240614511$24061451$1$I$$20240705$20240708$20240708$PER$$US-ROCHE-10000019808$ROCHE$$$$$$Y$$$20240708$$CN$US$US
240614521$24061452$1$I$$20240628$20240708$20240708$EXP$$US-ARGENX-2024-ARGX-US005216$ARGENX BVBA$$$$$$Y$$$20240708$$HP$US$US
240614534$24061453$4$F$20240627$20240807$20240708$20240814$EXP$$US-BAYER-2024A096511$BAYER$$71$YR$E$M$Y$$$20240814$$CN$US$US
240614541$24061454$1$I$20240421$20240703$20240708$20240708$EXP$$US-OTSUKA-2024_013526$OTSUKA$$$$$F$Y$$$20240708$$CN$US$US
240614551$24061455$1$I$20240703$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134433$AMGEN$$76$YR$E$F$Y$$$20240708$$PH$US$US
240614561$24061456$1$I$20240620$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134209$AMGEN$$81$YR$E$F$Y$$$20240708$$CN$US$US
240614571$24061457$1$I$20221201$20240704$20240708$20240708$EXP$$NVSC2023AR023656$NOVARTIS$$65$YR$$F$Y$$$20240708$$CN$AR$AR
240614581$24061458$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47012$$FDA-CTU$$48$YR$$F$N$$$20240705$N$$US$
240614591$24061459$1$I$$20240703$20240708$20240708$EXP$$US-INCYTE CORPORATION-2024IN007088$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240614611$24061461$1$I$20240618$20240703$20240708$20240708$EXP$$GB-MYLANLABS-2024M1056603$MYLAN$$$$$F$Y$$$20240708$$HP$GB$GB
240614622$24061462$2$F$20240101$20240712$20240708$20240723$PER$$US-JNJFOC-20240701032$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240722$$CN$US$US
240614631$24061463$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46996$$FDA-CTU$$59$YR$$M$N$86.18$KG$20240705$N$$US$
240614641$24061464$1$I$20240615$20240703$20240708$20240708$EXP$GB-MHRA-MED-202407030846073730-WGDPS$GB-MYLANLABS-2024M1062317$MYLAN$$63$YR$$F$Y$68$KG$20240708$$CN$GB$GB
240614651$24061465$1$I$$20240610$20240708$20240708$PER$$US-SCIEGENP-2024SCSPO00314$SCIEGEN$$$$$$Y$$$20240708$$CN$US$US
240614661$24061466$1$I$20240610$20240703$20240708$20240708$EXP$NO-NOMAADVRE-RELISSO-2024-Vdkdge$NO-MYLANLABS-2024M1062287$MYLAN$$73$YR$$M$Y$$$20240708$$HP$NO$NO
240614671$24061467$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47001$$FDA-CTU$$47$YR$$F$N$$$20240705$N$$US$
240614681$24061468$1$I$20240622$20240703$20240708$20240708$EXP$FR-AFSSAPS-PB2024000740$FR-MYLANLABS-2024M1062275$MYLAN$$22$YR$$F$Y$76.5$KG$20240708$$MD$FR$FR
240614691$24061469$1$I$$20240610$20240708$20240708$PER$$US-SCIEGENP-2024SCSPO00316$SCIEGEN$$$$$$Y$$$20240708$$CN$US$US
240614701$24061470$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46874$$FDA-CTU$$62$YR$$F$N$$$20240705$N$$US$
240614711$24061471$1$I$20231001$20231225$20240708$20240708$EXP$GB-MHRA-MED-202312221003318000-FSDVR$GB-TEVA-VS-3145699$TEVA$$57$YR$$M$Y$180$KG$20240708$$CN$GB$GB
240614721$24061472$1$I$20240615$20240701$20240708$20240708$EXP$$IN-PFIZER INC-PV202400087202$PFIZER$$$$$F$Y$$$20240708$$MD$IN$IN
240614731$24061473$1$I$$20240704$20240708$20240708$EXP$$KE-PFIZER INC-PV202400087898$PFIZER$$34$YR$$M$Y$$$20240708$$CN$KE$KE
240614741$24061474$1$I$20240509$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405152059002080-NSMBZ$GB-ORGANON-O2407GBR000605$ORGANON$$56$YR$$F$Y$$$20240708$$CN$GB$GB
240614751$24061475$1$I$20231028$20240703$20240708$20240708$EXP$$US-PFIZER INC-2023SGN10787$PFIZER$$40$YR$$F$Y$$$20240708$$CN$US$US
240614762$24061476$2$F$$20240710$20240708$20240710$EXP$$BE-PFIZER INC-2019SGN04443$PFIZER$$$$E$M$Y$$$20240710$$MD$BE$BE
240614771$24061477$1$I$$20240702$20240708$20240708$EXP$$TW-PFIZER INC-202400205604$PFIZER$Liu, C.. Combined Dacomitinib and Selpercatinib Treatment for a Patient with EGFR-Mutant Non-Small Cell Lung Cancer and Acquired CCDC6-RET Fusion. OncoTargets and Therapy. 2024;17:499-506$68$YR$$M$Y$$$20240708$$HP$TW$TW
240614782$24061478$2$F$$20240703$20240708$20240708$EXP$$PT-PFIZER INC-PV202400086499$PFIZER$Lobato, C.. Rhabdomyolysis secondary to a weight-loss prescription. BMJ Case Reports. 2024;17(6):10.1136/bcr-2023-258208$8$DEC$$M$Y$$$20240708$$HP$PT$PT
240614791$24061479$1$I$20230806$20240704$20240708$20240708$EXP$$BE-PFIZER INC-2023SGN10072$PFIZER$$69$YR$$F$Y$70.8$KG$20240708$$MD$BE$BE
240614801$24061480$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-2023SGN12958$PFIZER$$36$YR$$F$Y$$$20240708$$HP$US$US
240614811$24061481$1$I$$20240701$20240708$20240708$EXP$$SA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003715$ALNYLAM PHARMACEUTICALS$Zakariyah A., Alzahrani R., Alhazmi I., Abotaleb A., Alasmari M., Basendwah A., Alsubaie R., Khan M.S., Alnajjar L., Altouri S.. Hydroxymethylbilane Synthase Gene Mutation: The Hidden Driver of Abdominal Pain and Neurological Symptoms in Acute Intermittent Porphyria. Journal of Applied Hematology. 2024;15:147-151$$$$$Y$$$20240708$$MD$SA$SA
240614821$24061482$1$I$$20240628$20240708$20240708$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-006979$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$FR$FR
240614832$24061483$2$F$$20240812$20240708$20240815$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003740$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240815$$CN$US$US
240614852$24061485$2$F$20240501$20240904$20240708$20240919$EXP$$US-SA-2024SA196045$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240919$$MD$US$US
240614871$24061487$1$I$$20240628$20240708$20240708$PER$$US-SA-2024SA195425$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240614881$24061488$1$I$$20230801$20240708$20240708$PER$$US-AMGEN-USASP2023235593$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240614891$24061489$1$I$$20240703$20240708$20240708$EXP$$US-BIOVITRUM-2024-US-009565$BIOVITRUM$$64$YR$$F$Y$$$20240708$$CN$US$US
240614901$24061490$1$I$$20240518$20240708$20240708$30DAY$$DE-UCBSA-2024026441$UCB$$$$A$F$Y$$$20240708$$PH$DE$DE
240614912$24061491$2$F$20230920$20240813$20240708$20240816$EXP$IT-MINISAL02-992676$IT-BAYER-2024A096866$BAYER$$47$YR$A$M$Y$95$KG$20240816$$CN$IT$IT
240614921$24061492$1$I$$20240702$20240708$20240708$EXP$$AU-BAYER-2024A095077$BAYER$$$$$F$Y$$$20240708$$MD$AU$AU
240614931$24061493$1$I$$20240705$20240708$20240708$PER$$US-JNJFOC-20240717028$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240708$$CN$US$US
240614941$24061494$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46873$$FDA-CTU$$64$YR$$F$N$$$20240705$N$$US$
240614951$24061495$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47008$$FDA-CTU$$54$YR$$F$N$$$20240705$N$$US$
240615001$24061500$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46906$$FDA-CTU$$75$YR$$M$N$$$20240705$N$$US$
240615011$24061501$1$I$20240701$20240706$20240706$20240706$DIR$709281$$FDA-CTU$$74$YR$$F$N$81$KG$20240706$N$CN$US$
240615031$24061503$1$I$20240704$20240706$20240706$20240706$DIR$709313$$FDA-CTU$$29$YR$$F$N$67.5$KG$20240706$N$CN$US$
240615041$24061504$1$I$20230701$20240706$20240706$20240706$DIR$709273$$FDA-CTU$$68$YR$$F$N$91.35$KG$20240706$N$CN$US$
240615051$24061505$1$I$$20240627$20240708$20240708$PER$$US-Covis Pharma GmbH-2024COV00748$COVIS PHARMA$$5$YR$C$M$Y$$$20240708$$CN$US$US
240615061$24061506$1$I$$20240702$20240708$20240708$EXP$GB-MHRA-MED-202407020643199960-VMKHF$GB-OTSUKA-2024_018723$OTSUKA$$$$$F$Y$95$KG$20240708$$CN$GB$GB
240615071$24061507$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000136US$ALEXION PHARMACEUTICALS$$$$$F$Y$58.957$KG$20240708$$CN$US$US
240615082$24061508$2$F$$20240705$20240708$20240709$EXP$$US-BAYER-2024A096611$BAYER$$59$YR$A$M$Y$$$20240709$$CN$US$US
240615092$24061509$2$F$20201201$20240827$20240708$20240905$EXP$$CH-INCYTE CORPORATION-2024IN004918$INCYTE$$$$$$Y$$$20240905$$MD$CH$CH
240615101$24061510$1$I$20240115$20240703$20240708$20240708$EXP$$NZ-MYLANLABS-2024M1005657$MYLAN$$23$YR$$M$Y$$$20240708$$CN$NZ$NZ
240615111$24061511$1$I$$20240706$20240708$20240708$PER$$US-HALEON-2185776$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240615131$24061513$1$I$$20240628$20240708$20240708$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00520$PARATEK PHARMACEUTICALS$$$$$$Y$$$20240708$$HP$US$US
240615141$24061514$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202402191603379640-YRNGP$GB-TEVA-VS-3217747$TEVA$$40$YR$$F$Y$$$20240708$$HP$GB$GB
240615161$24061516$1$I$20240316$20240628$20240708$20240708$PER$$US-INCYTE CORPORATION-2024IN006928$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240615171$24061517$1$I$$20240629$20240708$20240708$PER$$US-INCYTE CORPORATION-2024IN006919$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240615181$24061518$1$I$$20240701$20240708$20240708$EXP$$FR-VIIV HEALTHCARE LIMITED-FR2024083062$VIIV$$$$$$Y$$$20240708$$PH$FR$FR
240615191$24061519$1$I$20090601$20240706$20240706$20240706$DIR$709275$$FDA-CTU$$53$YR$$F$N$90$KG$20240706$N$CN$US$
240615201$24061520$1$I$20240621$20240705$20240708$20240708$EXP$GB-MHRA-MED-202406221520006820-PSGCJ$GB-TEVA-VS-3217744$TEVA$$24$YR$$M$Y$126$KG$20240708$$CN$GB$GB
240615222$24061522$2$F$20240101$20240917$20240708$20240927$PER$$US-ABBVIE-5829846$ABBVIE$$$$$F$Y$$$20240927$$HP$US$US
240615232$24061523$2$F$20240620$20240809$20240708$20240816$PER$$IT-KARYOPHARM-2024KPT001252$KARYOPHARM THERAPEUTICS$$59$YR$$F$Y$$$20240816$$MD$IT$IT
240615241$24061524$1$I$20240601$20240705$20240708$20240708$EXP$$US-ORGANON-O2407USA000700$ORGANON$$$$$F$Y$$$20240708$$PH$US$US
240615271$24061527$1$I$20240627$20240706$20240706$20240706$DIR$709314$$FDA-CTU$$35$YR$$M$N$96.75$KG$20240706$N$CN$US$
240615281$24061528$1$I$20220101$20240701$20240708$20240708$EXP$$US-SA-2024SA198372$SANOFI AVENTIS$$58$YR$A$M$Y$90$KG$20240708$$MD$US$US
240615292$24061529$2$F$$20240719$20240708$20240725$EXP$$GB-MYLANLABS-2024M1062176$MYLAN$$$$$F$Y$$$20240725$$PH$GB$GB
240615301$24061530$1$I$20240618$20240702$20240708$20240708$EXP$FR-AFSSAPS-SE2024000523$FR-MYLANLABS-2024M1062053$MYLAN$$96$YR$$F$Y$58.4$KG$20240708$$PH$FR$FR
240615312$24061531$2$F$20240627$20240730$20240708$20240802$EXP$$IE-MYLANLABS-2024M1062201$MYLAN$$$$$F$Y$$$20240802$$HP$IE$IE
240615321$24061532$1$I$$20240702$20240708$20240708$EXP$GB-MHRA-TPP48479908C4939370YC1719825653837$GB-MYLANLABS-2024M1062195$MYLAN$$49$YR$$F$Y$53$KG$20240708$$MD$GB$GB
240615331$24061533$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46834$$FDA-CTU$$82$YR$$F$N$88$KG$20240705$N$$US$
240615341$24061534$1$I$20240101$20240702$20240708$20240708$EXP$$GB-MYLANLABS-2024M1061980$MYLAN$$33$YR$$F$Y$80$KG$20240708$$PH$GB$GB
240615351$24061535$1$I$20240501$20240702$20240708$20240708$EXP$FR-AFSSAPS-RS2024000636$FR-MYLANLABS-2024M1062032$MYLAN$$51$YR$$F$Y$$$20240708$$MD$FR$FR
240615361$24061536$1$I$20240627$20240706$20240706$20240706$DIR$709264$$FDA-CTU$$58$YR$$F$N$107.1$KG$20240706$N$CN$US$
240615371$24061537$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47026$$FDA-CTU$$14$YR$$F$N$$$20240705$N$$US$
240615381$24061538$1$I$$20240702$20240708$20240708$EXP$$JP-009507513-2407JPN000637J$MERCK$$73$YR$$M$Y$$$20240708$$MD$JP$JP
240615392$24061539$2$F$$20240725$20240708$20240731$EXP$$CA-OTSUKA-2024_019038$OTSUKA$$$$$M$Y$$$20240731$$CN$CA$CA
240615401$24061540$1$I$$20240701$20240708$20240708$EXP$$US-VIIV HEALTHCARE LIMITED-US2024083031$VIIV$$$$$$Y$$$20240708$$PH$US$US
240615412$24061541$2$F$20240622$20240902$20240708$20240903$PER$$US-ROCHE-10000017707$ROCHE$$54$YR$A$M$Y$$$20240903$$CN$US$US
240615421$24061542$1$I$20240101$20240626$20240708$20240708$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13054$IPSEN$$29$YR$A$F$Y$$$20240708$$HP$US$US
240615431$24061543$1$I$$20240702$20240708$20240708$PER$$US-ROCHE-10000018323$ROCHE$$$$C$M$Y$$$20240708$$CN$US$US
240615441$24061544$1$I$20240618$20240704$20240708$20240708$EXP$$LT-BAYER-2024A097086$BAYER$$$$$M$Y$$$20240708$$HP$LT$LT
240615451$24061545$1$I$20220607$20240702$20240708$20240708$EXP$FR-AFSSAPS-BR2024000519$FR-MYLANLABS-2024M1062268$MYLAN$$78$YR$$F$Y$53$KG$20240708$$PH$FR$FR
240615462$24061546$2$F$20240614$20240702$20240708$20240709$EXP$SE-SEMPA-2024-005166$SE-MYLANLABS-2024M1061995$MYLAN$$46$YR$$F$Y$$$20240709$$MD$SE$SE
240615472$24061547$2$F$$20240709$20240708$20240712$EXP$$US-INCYTE CORPORATION-2024IN005720$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240615481$24061548$1$I$$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002997$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240708$$CN$US$US
240615491$24061549$1$I$20240501$20240702$20240708$20240708$EXP$FR-AFSSAPS-AVNT2024000484$FR-MYLANLABS-2024M1061969$MYLAN$$59$YR$$M$Y$$$20240708$$PH$FR$FR
240615501$24061550$1$I$20231127$20240626$20240708$20240708$EXP$$FR-AstraZeneca-2024A154870$ASTRAZENECA$$3$WK$$M$Y$4.3$KG$20240708$$MD$FR$
240615513$24061551$3$F$20240625$20240731$20240708$20240808$EXP$$FR-AstraZeneca-2024A150962$ASTRAZENECA$$45$YR$$F$Y$73$KG$20240808$$MD$FR$
240615522$24061552$2$F$20240612$20240709$20240708$20240809$PER$$FR-TOLMAR, INC.-24FR050193$TOLMAR$$66$YR$$M$Y$$$20240809$$PH$FR$FR
240615532$24061553$2$F$$20240703$20240708$20240730$PER$$FR-TOLMAR, INC.-24FR050740$TOLMAR$$$$$M$Y$$$20240730$$PH$FR$FR
240615542$24061554$2$F$20240424$20240711$20240708$20240801$PER$$US-TOLMAR, INC.-24US049851$TOLMAR$$$$$$Y$$$20240801$$HP$US$US
240615552$24061555$2$F$20240314$20240712$20240708$20240801$PER$$US-TOLMAR, INC.-24US049911$TOLMAR$$$$$$Y$$$20240801$$HP$US$US
240615562$24061556$2$F$20240220$20240709$20240708$20240729$PER$$US-TOLMAR, INC.-24US049894$TOLMAR$$$$$$Y$$$20240729$$HP$US$US
240615572$24061557$2$F$$20240712$20240708$20240801$PER$$US-TOLMAR, INC.-24US050009$TOLMAR$$$$$$Y$$$20240731$$HP$US$US
240615582$24061558$2$F$20240606$20240722$20240708$20240816$PER$$US-TOLMAR, INC.-24US050012$TOLMAR$$63$YR$$M$Y$$$20240816$$HP$US$US
240615595$24061559$5$F$20240630$20240826$20240708$20240918$PER$$US-AstraZeneca-2024A151066$ASTRAZENECA$$26337$DY$$F$Y$$$20240918$$HP$US$
240615611$24061561$1$I$$20240702$20240708$20240708$PER$$US-ROCHE-10000017637$ROCHE$$$$A$M$Y$$$20240708$$CN$US$US
240615622$24061562$2$F$20240604$20240711$20240708$20240801$PER$$US-TOLMAR, INC.-24US050023$TOLMAR$$68$YR$$M$Y$$$20240731$$HP$US$US
240615632$24061563$2$F$20240616$20240725$20240708$20240729$PER$$US-ROCHE-10000017715$ROCHE$$52$YR$A$M$Y$83.46$KG$20240729$$CN$US$US
240615641$24061564$1$I$$20240701$20240708$20240708$PER$$US-ROCHE-10000017814$ROCHE$$$$A$M$Y$$$20240708$$CN$US$US
240615652$24061565$2$F$$20240612$20240708$20240717$PER$$US-TOLMAR, INC.-24US050039$TOLMAR$$$$$M$Y$$$20240717$$CN$US$US
240615661$24061566$1$I$20240620$20240702$20240708$20240708$PER$$US-ROCHE-10000017125$ROCHE$$$$$M$Y$$$20240708$$CN$US$US
240615672$24061567$2$F$20240101$20240828$20240708$20240902$EXP$$JP-AstraZeneca-2024A154439$ASTRAZENECA$$83$YR$$F$Y$$$20240902$$MD$JP$
240615681$24061568$1$I$$20240703$20240708$20240708$PER$$US-ABBVIE-5830418$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240615691$24061569$1$I$$20240703$20240708$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107424$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$$$20240708$$CN$US$US
240615701$24061570$1$I$20240602$20240703$20240708$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107616$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240708$$CN$US$US
240615711$24061571$1$I$$20240701$20240708$20240708$EXP$$CA-BAUSCH-BL-2024-010163$BAUSCH AND LOMB$$71$YR$$F$Y$69$KG$20240708$$HP$CA$CA
240615741$24061574$1$I$$20240621$20240708$20240708$EXP$$DE-ROCHE-10000018863$ROCHE$$47$YR$A$M$Y$$$20240708$$MD$DE$DE
240615761$24061576$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000021US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240708$$HP$US$US
240615774$24061577$4$F$$20240903$20240708$20240913$PER$$US-INCYTE CORPORATION-2024IN006948$INCYTE$$$$$$Y$$$20240913$$CN$US$US
240615781$24061578$1$I$$20230814$20240708$20240708$PER$$US-AMGEN-USASP2023235591$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240615791$24061579$1$I$20240702$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134199$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240615803$24061580$3$F$$20240722$20240708$20240727$30DAY$$US-AMGEN-USASP2024131921$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
240615812$24061581$2$F$$20240813$20240708$20240820$PER$$US-BEH-2024173928$CSL BEHRING$$$$E$M$Y$$$20240820$$HP$US$US
240615821$24061582$1$I$$20240704$20240708$20240708$PER$$US-ROCHE-10000018798$ROCHE$$$$C$M$Y$$$20240708$$CN$US$US
240615832$24061583$2$F$$20240723$20240708$20240726$EXP$$GB-MYLANLABS-2024M1055894$MYLAN$$$$$F$Y$$$20240726$$MD$GB$GB
240615844$24061584$4$F$20240708$20240731$20240708$20240805$EXP$$US-APELLIS-2024-APL-0000408$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
240615853$24061585$3$F$20240418$20240914$20240708$20240920$EXP$$IL-Blueprint Medicines Corporation-SP-IL-2024-001358$BLUEPRINT MEDICINES$$61$YR$A$F$Y$$$20240920$$MD$IL$IL
240615861$24061586$1$I$20240401$20240704$20240708$20240708$EXP$$DE-ABBVIE-5831194$ABBVIE$$83$YR$$M$Y$$$20240708$$CN$DE$DE
240615872$24061587$2$F$20240705$20240708$20240708$20240711$PER$$US-JNJFOC-20240715494$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240711$$CN$US$US
240615881$24061588$1$I$20220101$20231206$20240708$20240708$EXP$FR-AFSSAPS-TO2023002051$FR-TEVA-VS-3147346$TEVA$$27$YR$$F$Y$$$20240708$$MD$FR$FR
240615891$24061589$1$I$20240101$20240703$20240708$20240708$EXP$$US-ABBVIE-5830884$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240615902$24061590$2$F$20240617$20240719$20240708$20240729$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001343$BLUEPRINT MEDICINES$$8$YR$C$M$Y$$$20240729$$HP$US$US
240615911$24061591$1$I$20240424$20240705$20240708$20240708$EXP$$IT-BAUSCH-BL-2024-010378$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240708$$HP$IT$IT
240615921$24061592$1$I$20240101$20240705$20240708$20240708$EXP$$US-BAUSCH-BL-2024-010372$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240708$$CN$US$US
240615931$24061593$1$I$20240401$20240701$20240708$20240708$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001346$BLUEPRINT MEDICINES$$77$YR$E$M$Y$$$20240708$$CN$US$US
240615941$24061594$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-47010$$FDA-CTU$$46$YR$$F$N$$$20240705$N$$US$
240615961$24061596$1$I$20231207$20240704$20240708$20240708$EXP$FR-AFSSAPS-AVMA2024000285$FR-BAUSCH-BL-2024-010335$BAUSCH AND LOMB$$50$YR$$F$Y$$$20240708$$PH$FR$FR
240615971$24061597$1$I$$20240704$20240708$20240708$EXP$$NVSC2024IL140228$NOVARTIS$$$$$F$Y$$$20240708$$MD$IL$IL
240615983$24061598$3$F$20240614$20240727$20240708$20240730$EXP$$ES-BAUSCH-BL-2024-010393$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240730$$HP$ES$ES
240615991$24061599$1$I$20240705$20240706$20240706$20240706$DIR$709263$$FDA-CTU$$47$YR$$F$N$110.25$KG$20240706$N$CN$US$
240616001$24061600$1$I$20240628$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46984$$FDA-CTU$$52$YR$$F$N$$$20240705$N$$US$
240616011$24061601$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46987$$FDA-CTU$$27$YR$$M$N$$$20240705$N$$US$
240616041$24061604$1$I$20240611$20240706$20240706$20240706$DIR$709287$$FDA-CTU$$$$$M$N$$$20240706$$CN$US$
240616061$24061606$1$I$20240703$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46981$$FDA-CTU$$69$YR$$F$N$$$20240705$N$$US$
240616072$24061607$2$F$20231024$20240805$20240708$20240812$EXP$$BR-TAKEDA-2023TUS110359$TAKEDA$$51$YR$$M$Y$$$20240812$$CN$BR$BR
240616081$24061608$1$I$$20240618$20240708$20240708$EXP$$US-CIDARA THERAPEUTICS, INC-2024-RZ-0022-US$CIDARA THERAPEUTICS$$$$$$Y$$$20240708$$MD$US$US
240616101$24061610$1$I$$20240702$20240708$20240708$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001353$BLUEPRINT MEDICINES$$$$$F$Y$$$20240708$$CN$US$US
240616111$24061611$1$I$$20240705$20240708$20240708$EXP$$US-BAUSCH-BL-2024-010369$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240708$$MD$US$US
240616123$24061612$3$F$20240603$20240821$20240708$20240826$EXP$$US-ABBVIE-5825910$ABBVIE$$0$YR$$M$Y$8$KG$20240826$$CN$US$US
240616131$24061613$1$I$20240501$20240629$20240708$20240708$EXP$$US-RDY-SPO/USA/24/0009609$DR REDDYS$$19$YR$A$F$Y$$$20240708$$CN$US$US
240616141$24061614$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202407041638114080-CWTRH$GB-ORGANON-O2407GBR000631$ORGANON$$$$$M$Y$$$20240708$$MD$GB$GB
240616151$24061615$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405091618218170-JRLNH$GB-ORGANON-O2407GBR000627$ORGANON$$$$$M$Y$$$20240708$$CN$GB$GB
240616161$24061616$1$I$20240601$20240627$20240708$20240708$PER$$US-SA-2024SA193786$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240708$$MD$US$US
240616171$24061617$1$I$$20240629$20240708$20240708$PER$$US-SA-2024SA197658$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240708$$MD$US$US
240616181$24061618$1$I$20240621$20240701$20240708$20240708$EXP$$CN-SA-2024SA199724$SANOFI AVENTIS$$80$YR$E$F$Y$60$KG$20240708$$HP$CN$CN
240616194$24061619$4$F$$20240731$20240708$20240808$EXP$$US-GSK-US2024AMR082489$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
240616201$24061620$1$I$20210224$20240704$20240708$20240708$EXP$$DE-BAUSCH-BL-2024-010344$BAUSCH AND LOMB$$$$A$F$Y$$$20240708$$MD$DE$US
240616211$24061621$1$I$$20240703$20240708$20240708$EXP$$US-BAUSCH-BL-2024-010309$BAUSCH AND LOMB$Roma N, Padala V, Pattoli M, Desai S, Krinock M, Durkin M, Field P, Sheikh T. BRASH Syndrome: A Rare Clinical Phenomenon. CJC Open. 2024;6:840-842. doi:10.1016/j.cjco.2024.03.013.$66$YR$$F$Y$$$20240708$$MD$US$US
240616221$24061622$1$I$$20240701$20240708$20240708$EXP$$IT-BAUSCH-BL-2024-009356$BAUSCH AND LOMB$$23$YR$$M$Y$$$20240708$$MD$IT$IT
240616231$24061623$1$I$$20240702$20240708$20240708$EXP$$US-ABBVIE-5826294$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240616241$24061624$1$I$20240705$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134386$AMGEN$$52$YR$A$F$Y$$$20240708$$CN$US$US
240616255$24061625$5$F$$20240730$20240708$20240806$30DAY$$CA-JNJFOC-20240669820$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240806$$HP$CA$CA
240616261$24061626$1$I$20240618$20240627$20240708$20240708$EXP$$CA-TAKEDA-2023TUS124004$TAKEDA$$76$YR$$M$Y$$$20240708$$CN$CA$CA
240616271$24061627$1$I$$20240705$20240708$20240708$PER$$US-JNJFOC-20240716023$JOHNSON AND JOHNSON$$$$$M$Y$$$20240708$$CN$US$US
240616281$24061628$1$I$20240615$20240701$20240708$20240708$EXP$GB-MHRA-MED-202406290731408350-JDBNM$GB-TEVA-VS-3215983$TEVA$$77$YR$$M$Y$90$KG$20240708$$CN$GB$GB
240616291$24061629$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214957$TEVA$$23$YR$$F$Y$$$20240708$$HP$CA$CA
240616302$24061630$2$F$$20240703$20240708$20240819$PER$$US-LUNDBECK-DKLU4000209$LUNDBECK$$$$$$Y$$$20240819$$CN$US$US
240616311$24061631$1$I$$20240618$20240708$20240708$PER$$US-APELLIS-2024-APL-0000324$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240708$$CN$US$US
240616321$24061632$1$I$$20240702$20240708$20240708$EXP$$GR-009507513-2407GRC001828$MERCK$$52$YR$$M$Y$$$20240708$$MD$GR$GR
240616331$24061633$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214958$TEVA$$62$YR$$F$Y$$$20240708$$HP$CA$CA
240616351$24061635$1$I$$20240705$20240708$20240708$EXP$$US-AstraZeneca-2024A155489$ASTRAZENECA$$$$$F$Y$$$20240708$$MD$US$
240616361$24061636$1$I$20230818$20240705$20240708$20240708$EXP$DE-CADRBFARM-2024329058$DE-BAYER-2024A097277$BAYER$$34$YR$A$F$Y$68$KG$20240708$$CN$DE$DE
240616371$24061637$1$I$20240415$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46974$$FDA-CTU$$43$YR$$F$N$$$20240705$Y$PH$US$
240616381$24061638$1$I$20240610$20240701$20240705$20240705$DIR$FDA-CDER-CTU-2024-46821$$FDA-CTU$$20$YR$$F$N$$$20240701$N$HP$US$
240616391$24061639$1$I$20240620$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46831$$FDA-CTU$$57$YR$$F$N$$$20240705$N$$US$
240616401$24061640$1$I$20240618$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46965$$FDA-CTU$$64$YR$$F$N$65$KG$20240705$N$HP$US$
240616411$24061641$1$I$$20240703$20240708$20240708$EXP$$US-AstraZeneca-2024A153297$ASTRAZENECA$$$$$F$Y$$$20240708$$MD$US$
240616421$24061642$1$I$$20240626$20240708$20240708$PER$$US-TEVA-VS-3214923$TEVA$$$$$$Y$$$20240708$$MD$US$US
240616431$24061643$1$I$$20240705$20240708$20240708$EXP$$BR-AstraZeneca-2024A155446$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$BR$
240616441$24061644$1$I$$20240629$20240708$20240708$PER$$US-SA-2024SA196443$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240708$$CN$US$US
240616451$24061645$1$I$$20240703$20240708$20240708$EXP$$CA-SA-2024SA199998$SANOFI AVENTIS$$$$$M$Y$$$20240708$$MD$CA$CA
240616461$24061646$1$I$$20240705$20240705$20240705$DIR$FDA-CDER-CTU-2024-46828$$FDA-CTU$$55$YR$$F$N$$$20240705$N$$US$
240616471$24061647$1$I$$20240703$20240705$20240705$DIR$FDA-CDER-CTU-2024-46809$$FDA-CTU$$$$$F$N$$$20240703$N$HP$US$
240616491$24061649$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214961$TEVA$$51$YR$$M$Y$$$20240708$$HP$CA$CA
240616502$24061650$2$F$20240702$20240718$20240708$20240722$EXP$$JP-GILEAD-2024-0679224$GILEAD$$69$YR$E$M$Y$$$20240722$$HP$JP$JP
240616511$24061651$1$I$20240609$20240703$20240708$20240708$EXP$$PH-OTSUKA-2024_018976$OTSUKA$$74$YR$$F$Y$$$20240708$$CN$PH$PH
240616521$24061652$1$I$$20240703$20240708$20240708$30DAY$$US-GSK-US2024082627$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$HP$US$US
240616532$24061653$2$F$$20240801$20240708$20240806$PER$$US-BAYER-2024A096382$BAYER$$30$YR$A$F$Y$$$20240806$$MD$US$US
240616541$24061654$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024083216$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240616553$24061655$3$F$$20240630$20240708$20240723$EXP$$MX-BEH-2024174956$CSL BEHRING$$$$$$Y$$$20240723$$CN$MX$MX
240616561$24061656$1$I$$20240628$20240708$20240708$EXP$$US-Bion-013370$BIONPHARMA$$$$$F$Y$$$20240708$$CN$US$US
240616571$24061657$1$I$$20240703$20240708$20240708$EXP$$CN-Bion-013380$BIONPHARMA$$58$YR$A$M$Y$$$20240708$$HP$CN$CN
240616581$24061658$1$I$$20240703$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107977$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240708$$CN$US$US
240616591$24061659$1$I$$20240701$20240708$20240708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105538$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$79$KG$20240708$$CN$US$US
240616601$24061660$1$I$20240610$20240706$20240706$20240706$DIR$709269$$FDA-CTU$$43$YR$$F$N$$$20240706$N$HP$US$
240616611$24061661$1$I$20240628$20240705$20240706$20240706$DIR$FDA-CDER-CTU-2024-46979$$FDA-CTU$$64$YR$$M$N$60$KG$20240705$N$$US$
240616621$24061662$1$I$20240324$20240706$20240706$20240706$DIR$709291$$FDA-CTU$$22$YR$$F$N$53.8$KG$20240706$N$PH$US$
240616631$24061663$1$I$20240701$20240705$20240706$20240706$DIR$FDA-CDER-CTU-2024-46978$$FDA-CTU$$69$YR$$F$N$77.8$KG$20240705$N$$US$
240616641$24061664$1$I$$20240706$20240706$20240706$DIR$FDA-CDER-CTU-2024-46975$$FDA-CTU$$67$YR$$M$N$$$20240706$N$$US$
240616661$24061666$1$I$20240614$20240705$20240706$20240706$DIR$FDA-CDER-CTU-2024-47037$$FDA-CTU$$70$YR$$F$N$57.2$KG$20240705$N$$US$
240616671$24061667$1$I$19600317$20240706$20240706$20240706$DIR$709312$$FDA-CTU$$64$YR$$M$N$$$20240706$N$CN$US$
240616681$24061668$1$I$$20240703$20240708$20240708$EXP$$IT-Bion-013381$BIONPHARMA$$9$YR$C$M$Y$$$20240708$$HP$IT$IT
240616691$24061669$1$I$$20240702$20240708$20240708$EXP$$US-Bion-013371$BIONPHARMA$$45$YR$A$M$Y$65$KG$20240708$$HP$US$US
240616701$24061670$1$I$$20240703$20240708$20240708$EXP$$US-Bion-013378$BIONPHARMA$$6$YR$C$F$Y$$$20240708$$HP$US$US
240616711$24061671$1$I$$20240705$20240708$20240708$EXP$$DE-BAYER-2024A097647$BAYER$$52$YR$A$F$Y$$$20240708$$CN$DE$DE
240616721$24061672$1$I$20240101$20240702$20240708$20240708$PER$$US-ABBVIE-5828784$ABBVIE$$$$$$Y$$$20240708$$HP$US$US
240616732$24061673$2$F$$20240709$20240708$20240712$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003708$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240712$$MD$US$US
240616741$24061674$1$I$20240405$20240701$20240708$20240708$EXP$ES-AEMPS-1541918$ES-RDY-SPO/ESP/24/0009533$DR REDDYS$$50$YR$A$M$Y$$$20240708$$PH$ES$ES
240616751$24061675$1$I$$20240703$20240708$20240708$EXP$$NVSC2024IN139981$NOVARTIS$$$$$M$Y$$$20240708$$CN$IN$IN
240616761$24061676$1$I$$20240703$20240708$20240708$EXP$$US-Bion-013386$BIONPHARMA$$47$YR$A$F$Y$$$20240708$$HP$US$US
240616771$24061677$1$I$$20240703$20240708$20240708$EXP$$US-Bion-013388$BIONPHARMA$$61$YR$A$M$Y$$$20240708$$HP$US$US
240616781$24061678$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024AMR081957$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240616791$24061679$1$I$$20240703$20240708$20240708$EXP$$US-Bion-013389$BIONPHARMA$$15$YR$T$M$Y$$$20240708$$HP$US$US
240616811$24061681$1$I$$20240707$20240708$20240708$PER$$US-HALEON-2185828$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240616821$24061682$1$I$$20240703$20240708$20240708$PER$$US-JNJFOC-20240715154$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$CN$US$US
240616831$24061683$1$I$$20240705$20240708$20240708$EXP$$AU-JNJFOC-20240717005$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240708$$CN$AU$AU
240616841$24061684$1$I$$20240705$20240708$20240708$EXP$$US-OTSUKA-2024_019166$OTSUKA$$$$$F$Y$$$20240708$$CN$US$US
240616851$24061685$1$I$20240628$20240707$20240708$20240708$EXP$$CN-BAYER-2024A097672$BAYER$$62$YR$A$F$Y$49$KG$20240708$$HP$CN$CN
240616863$24061686$3$F$20240624$20240704$20240708$20240712$30DAY$$US-JNJFOC-20240668567$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240616871$24061687$1$I$20240518$20240701$20240708$20240708$EXP$HR-HALMED-300085751$HR-MYLANLABS-2024M1061602$MYLAN$$17$YR$$F$Y$$$20240708$$MD$HR$HR
240616881$24061688$1$I$$20240701$20240708$20240708$EXP$FR-AFSSAPS-AVPO2024000121$FR-MYLANLABS-2024M1061637$MYLAN$$$$$M$Y$$$20240708$$PH$FR$FR
240616891$24061689$1$I$20230101$20240701$20240708$20240708$EXP$$PL-MYLANLABS-2024M1061577$MYLAN$$74$YR$$M$Y$$$20240708$$MD$PL$PL
240616901$24061690$1$I$20240703$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108151$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240708$$PH$US$US
240616911$24061691$1$I$20240601$20240624$20240708$20240708$EXP$$US-SPECGX-T202401415$SPECGX$$$$$F$Y$$$20240708$$CN$US$US
240616921$24061692$1$I$20180810$20240701$20240708$20240708$EXP$$AT-MYLANLABS-2024M1061626$MYLAN$$$$$F$Y$$$20240708$$HP$AT$AT
240616941$24061694$1$I$20240422$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405041732454370-NBZDJ$GB-TAKEDA-2024TUS068382$TAKEDA$$27$YR$$F$Y$60$KG$20240708$$HP$GB$GB
240616951$24061695$1$I$20230201$20240702$20240708$20240708$EXP$$US-OTSUKA-2024_018946$OTSUKA$$86$YR$$F$Y$$$20240708$$MD$US$US
240616961$24061696$1$I$20240428$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405071732242780-PSWMT$GB-TAKEDA-2024TUS068545$TAKEDA$$51$YR$$F$Y$63$KG$20240708$$HP$GB$GB
240616972$24061697$2$F$20231031$20240806$20240708$20240812$PER$$US-BAYER-2024A096627$BAYER$$53$YR$A$F$Y$$$20240812$$CN$US$US
240616982$24061698$2$F$20240101$20240703$20240708$20240711$PER$$US-ABBVIE-5828830$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240616991$24061699$1$I$$20240701$20240708$20240708$EXP$$IT-ALXN-202407EEA000030IT$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$MD$IT$IT
240617004$24061700$4$F$$20240828$20240708$20240902$EXP$$FR-TAKEDA-2024TUS067162$TAKEDA$Luque-Paz D, Lalanne S, Besombes J, Dorel M, Maamar A, Revest M. Absence of maribavir penetration into the central nervous system: confirmation by multiple cerebrospinal fluid dosages in a solid organ transplant recipient. Journal Of Antimicrobial Chemotherapy. 2024;1-2$59$YR$$F$Y$$$20240902$$HP$FR$FR
240617011$24061701$1$I$$20240705$20240708$20240708$PER$$US-BAYER-2024A097731$BAYER$$$$$$Y$$$20240708$$CN$US$US
240617021$24061702$1$I$20240101$20240703$20240708$20240708$PER$$US-ABBVIE-5830230$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240617031$24061703$1$I$20210827$20240628$20240708$20240708$EXP$$US-APOTEX-2024AP007916$APOTEX$Lager S, Balakrishnan G, Eiberger R. Intra-abdominal hematomas and identifiable risk factors in patients receiving subcutaneous enoxaparin. PLoS ONE. 2024;19 (4):e0301906 (1-6)$69$YR$$F$Y$$$20240708$$HP$US$US
240617042$24061704$2$F$$20240716$20240708$20240726$EXP$$GB-TEVA-VS-3215449$TEVA$Jarman GL, Webb GJ. Delayed drug-induced liver injury (DILI) and flare of chronic plaque psoriasis secondary to lisinopril use. BMJ Case Reports. 2024;17(1): e256317, DOI: 10.1136/bcr-2023-256317$4$DEC$$M$Y$$$20240726$$MD$GB$GB
240617051$24061705$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN04096$PFIZER$$68$YR$$F$Y$$$20240708$$CN$US$US
240617061$24061706$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405012101234690-ZYKVF$GB-PFIZER INC-202400206971$PFIZER$$$$$M$Y$78$KG$20240708$$CN$GB$GB
240617071$24061707$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN03987$PFIZER$$75$YR$$F$Y$$$20240708$$HP$US$US
240617081$24061708$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN04279$PFIZER$$52$YR$$F$Y$$$20240708$$CN$US$US
240617091$24061709$1$I$20240501$20240628$20240708$20240708$EXP$$US-RADIUS HEALTH, INC.-2024US004813$RADIUS PHARM$$85$YR$$F$Y$$$20240708$$HP$US$US
240617101$24061710$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN04309$PFIZER$$71$YR$$F$Y$$$20240708$$MD$US$US
240617111$24061711$1$I$$20240703$20240708$20240708$EXP$$CA-PFIZER INC-202400206028$PFIZER$$27$YR$$F$Y$$$20240708$$HP$CA$CA
240617121$24061712$1$I$20240406$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN04168$PFIZER$$36$YR$$F$Y$$$20240708$$CN$US$US
240617132$24061713$2$F$20240418$20240827$20240708$20240829$EXP$$US-PFIZER INC-2024SGN03719$PFIZER$$71$YR$$F$Y$$$20240829$$CN$US$US
240617142$24061714$2$F$20230101$20240709$20240708$20240710$EXP$CH-SM-2023-17210$CH-PFIZER INC-202400206845$PFIZER$$47$YR$$F$Y$$$20240710$$MD$CH$CH
240617151$24061715$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN05001$PFIZER$$68$YR$$F$Y$$$20240708$$CN$US$US
240617161$24061716$1$I$20180401$20240626$20240708$20240708$EXP$$CO-PFIZER INC-2018SGN00859$PFIZER$$28$YR$$M$Y$43$KG$20240708$$HP$CO$CO
240617172$24061717$2$F$$20240710$20240708$20240711$EXP$$US-PFIZER INC-2024SGN02893$PFIZER$$36$YR$$F$Y$$$20240711$$HP$US$US
240617182$24061718$2$F$20240522$20240822$20240708$20240902$EXP$$CN-PFIZER INC-202400206944$PFIZER$$67$YR$$F$Y$51$KG$20240902$$MD$CN$CN
240617192$24061719$2$F$20240101$20240709$20240708$20240716$EXP$$US-PFIZER INC-202400205920$PFIZER$$68$YR$$F$Y$$$20240716$$CN$US$US
240617201$24061720$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN04390$PFIZER$$52$YR$$F$Y$$$20240708$$CN$US$US
240617213$24061721$3$F$20240620$20240730$20240708$20240807$EXP$$FR-PFIZER INC-202400207518$PFIZER$$53$YR$$F$Y$71$KG$20240807$$MD$FR$FR
240617226$24061722$6$F$20240301$20240916$20240708$20240917$EXP$IT-MINISAL02-993391$IT-PFIZER INC-202400207278$PFIZER$$65$YR$$M$Y$65$KG$20240917$$CN$IT$IT
240617231$24061723$1$I$20240515$20240702$20240708$20240708$EXP$$FR-PFIZER INC-202400204863$PFIZER$$62$YR$$F$Y$53$KG$20240708$$MD$FR$FR
240617242$24061724$2$F$$20240708$20240708$20240711$EXP$$US-PFIZER INC-202400207980$PFIZER$$92$YR$$M$Y$$$20240711$$HP$US$US
240617251$24061725$1$I$20231223$20240705$20240708$20240708$EXP$FR-AFSSAPS-NY2024000761$FR-PFIZER INC-202400207361$PFIZER$$30$YR$$F$Y$50$KG$20240708$$MD$FR$FR
240617261$24061726$1$I$20240419$20240627$20240708$20240708$EXP$$CN-PFIZER INC-2024SGN05215$PFIZER$$69$YR$$M$Y$67$KG$20240708$$MD$CN$CN
240617271$24061727$1$I$$20240704$20240708$20240708$EXP$$KE-PFIZER INC-PV202400087900$PFIZER$$46$YR$$M$Y$$$20240708$$CN$KE$KE
240617281$24061728$1$I$20230409$20240703$20240708$20240708$EXP$$US-PFIZER INC-202400207777$PFIZER$$23$YR$$F$Y$$$20240708$$HP$US$US
240617291$24061729$1$I$20230101$20240704$20240708$20240708$EXP$$IN-PFIZER INC-202400207274$PFIZER$$$$$M$Y$$$20240708$$CN$IN$IN
240617301$24061730$1$I$20240326$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN03538$PFIZER$$26$YR$$M$Y$$$20240708$$CN$US$US
240617311$24061731$1$I$$20240703$20240708$20240708$EXP$$CA-PFIZER INC-202400206116$PFIZER$$41$YR$$F$Y$67$KG$20240708$$HP$CA$CA
240617321$24061732$1$I$20240304$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN04163$PFIZER$$56$YR$$F$Y$$$20240708$$HP$US$US
240617331$24061733$1$I$$20240702$20240708$20240708$EXP$$CA-PFIZER INC-202400205912$PFIZER$$60$YR$$F$Y$$$20240708$$HP$CA$CA
240617341$24061734$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN04362$PFIZER$$71$YR$$F$Y$$$20240708$$MD$US$US
240617351$24061735$1$I$$20240705$20240708$20240708$EXP$$IN-PFIZER INC-PV202400089105$PFIZER$$54$YR$$F$Y$$$20240708$$CN$IN$IN
240617361$24061736$1$I$20240116$20240705$20240708$20240708$EXP$$IN-PFIZER INC-PV202400089108$PFIZER$$48$YR$$F$Y$$$20240708$$CN$IN$IN
240617371$24061737$1$I$$20240703$20240708$20240708$EXP$$CA-PFIZER INC-202400206127$PFIZER$$73$YR$$F$Y$$$20240708$$HP$CA$CA
240617381$24061738$1$I$$20240702$20240708$20240708$EXP$$US-PFIZER INC-PV202400087126$PFIZER$$55$YR$$F$Y$$$20240708$$PH$US$US
240617392$24061739$2$F$$20240704$20240708$20240715$EXP$$US-PFIZER INC-202400206323$PFIZER$Anwar, M.. Community-Acquired Meningitis Complicated With Pyogenic Ventriculitis and Hydrocephalus in a Patient With Haematological Malignancy: A Case Report and Literature Review. Cureus. 2024;16(5):10.7759/cureus.60800$85$YR$$F$Y$$$20240715$$MD$US$US
240617401$24061740$1$I$$20240704$20240708$20240708$EXP$$US-PFIZER INC-2024SGN04541$PFIZER$$38$YR$$F$Y$$$20240708$$HP$US$US
240617411$24061741$1$I$20240517$20240628$20240708$20240708$EXP$IT-MINISAL02-992160$IT-PFIZER INC-202400202849$PFIZER$$8$YR$$F$Y$27$KG$20240708$$PH$IT$IT
240617421$24061742$1$I$$20240704$20240708$20240708$EXP$$MA-PFIZER INC-PV202400088463$PFIZER$$$$$M$Y$$$20240708$$CN$MA$MA
240617431$24061743$1$I$$20240701$20240708$20240708$EXP$$US-PFIZER INC-202400205293$PFIZER$$69$YR$$F$Y$$$20240708$$HP$US$US
240617441$24061744$1$I$20240603$20240704$20240708$20240708$EXP$$IN-PFIZER INC-PV202400088478$PFIZER$$76$YR$$F$Y$$$20240708$$CN$IN$IN
240617451$24061745$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN05123$PFIZER$$75$YR$$F$Y$$$20240708$$CN$US$US
240617461$24061746$1$I$20240505$20240704$20240708$20240708$EXP$$US-PFIZER INC-2024SGN05007$PFIZER$$42$YR$$F$Y$$$20240708$$CN$US$US
240617471$24061747$1$I$20240424$20240704$20240708$20240708$EXP$$US-PFIZER INC-2024SGN05068$PFIZER$$95$YR$$M$Y$$$20240708$$CN$US$US
240617481$24061748$1$I$20240404$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN04267$PFIZER$$5$YR$$F$Y$$$20240708$$HP$US$US
240617491$24061749$1$I$$20240702$20240708$20240708$EXP$$CA-PFIZER INC-202400205890$PFIZER$$42$YR$$F$Y$$$20240708$$HP$CA$CA
240617512$24061751$2$F$$20240713$20240708$20240717$EXP$$US-PFIZER INC-PV202400087682$PFIZER$$76$YR$$F$Y$54.4$KG$20240717$$CN$US$US
240617521$24061752$1$I$$20230724$20240708$20240708$PER$$US-ABBVIE-5830551$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240617531$24061753$1$I$20240620$20240706$20240706$20240706$DIR$709267$$FDA-CTU$$49$YR$$F$N$79.65$KG$20240706$N$CN$US$
240617541$24061754$1$I$20240622$20240705$20240706$20240706$DIR$FDA-CDER-CTU-2024-47036$$FDA-CTU$$59$YR$$F$N$64.3$KG$20240705$N$$US$
240617551$24061755$1$I$20240705$20240706$20240706$20240706$DIR$709290$$FDA-CTU$$60$YR$$F$N$69.75$KG$20240706$N$CN$US$
240617561$24061756$1$I$$20240701$20240708$20240708$EXP$GB-MHRA-MED-202406281336531360-CFMRD$GB-RDY-SPO/GBR/24/0009694$DR REDDYS$$$$$F$Y$$$20240708$$CN$GB$GB
240617571$24061757$1$I$20160801$20240702$20240708$20240708$PER$$US-BIOGEN-2016BI00286886$BIOGEN$$56$YR$$F$Y$$$20240708$$CN$US$US
240617581$24061758$1$I$20240703$20240706$20240706$20240706$DIR$709284$$FDA-CTU$$49$YR$$F$N$73.8$KG$20240706$N$CN$US$
240617591$24061759$1$I$20240624$20240706$20240706$20240706$DIR$FDA-CDER-CTU-2024-47039$$FDA-CTU$$45$YR$$F$N$$$20240706$N$PH$US$
240617601$24061760$1$I$20220610$20240706$20240706$20240706$DIR$709289$$FDA-CTU$$56$YR$$M$N$108$KG$20240706$N$CN$US$
240617611$24061761$1$I$$20240706$20240706$20240706$DIR$FDA-CDER-CTU-2024-46976$$FDA-CTU$$75$YR$$F$N$$$20240706$N$$US$
240617631$24061763$1$I$$20240706$20240706$20240706$DIR$709270$$FDA-CTU$$$$$UNK$N$$$20240706$N$$US$
240617641$24061764$1$I$20200320$20240705$20240706$20240706$DIR$FDA-CDER-CTU-2024-47038$$FDA-CTU$$76$YR$$F$N$85$KG$20240705$N$$US$
240617651$24061765$1$I$$20240702$20240708$20240708$PER$$US-BIOGEN-2024BI01272112$BIOGEN$$$$$F$Y$$$20240708$$CN$US$US
240617661$24061766$1$I$$20240701$20240708$20240708$PER$$US-BIOGEN-2024BI01272518$BIOGEN$$$$$M$Y$$$20240708$$MD$US$US
240617672$24061767$2$F$20240501$20240815$20240708$20240821$EXP$$CO-JNJFOC-20240715689$JOHNSON AND JOHNSON$$35$YR$A$F$Y$57$KG$20240821$$HP$CO$CO
240617683$24061768$3$F$$20240805$20240708$20240808$30DAY$$AT-JNJFOC-20240666657$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$PH$AT$AT
240617701$24061770$1$I$$20240702$20240708$20240708$EXP$$JP-009507513-2407JPN000628J$MERCK$$78$YR$$M$Y$$$20240708$$MD$JP$JP
240617711$24061771$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107740$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240708$$HP$US$US
240617722$24061772$2$F$$20240702$20240708$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107986$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240712$$MD$JP$JP
240617732$24061773$2$F$20240101$20240716$20240708$20240724$PER$$US-SA-2024SA194507$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240724$$MD$US$US
240617741$24061774$1$I$$20240703$20240708$20240708$PER$$US-BAYER-2024A097083$BAYER$$$$$F$Y$$$20240708$$HP$US$US
240617752$24061775$2$F$20231213$20240712$20240708$20240718$EXP$$IT-MYLANLABS-2024M1061662$MYLAN$$77$YR$$F$Y$$$20240718$$HP$IT$IT
240617761$24061776$1$I$20230302$20240701$20240708$20240708$EXP$FR-AFSSAPS-AVCN2024000475$FR-MYLANLABS-2024M1061664$MYLAN$$15$YR$$F$Y$$$20240708$$MD$FR$FR
240617771$24061777$1$I$20240601$20240701$20240708$20240708$EXP$FR-AFSSAPS-AVCN2024000488$FR-MYLANLABS-2024M1061665$MYLAN$$20$YR$$F$Y$$$20240708$$MD$FR$FR
240617781$24061778$1$I$20231201$20240701$20240708$20240708$EXP$FR-AFSSAPS-LY2024000922$FR-MYLANLABS-2024M1061649$MYLAN$$73$YR$$F$Y$76$KG$20240708$$PH$FR$FR
240617792$24061779$2$F$20231227$20240710$20240708$20240716$EXP$$IT-MYLANLABS-2024M1061654$MYLAN$$63$YR$$M$Y$$$20240716$$HP$IT$IT
240617801$24061780$1$I$20240118$20240701$20240708$20240708$EXP$FR-AFSSAPS-AVMA2024000256$FR-MYLANLABS-2024M1061667$MYLAN$$60$YR$$F$Y$$$20240708$$PH$FR$FR
240617812$24061781$2$F$20240528$20240709$20240708$20240715$EXP$CZ-CZSUKL-24001762$CZ-MYLANLABS-2024M1061640$MYLAN$$62$YR$$F$Y$85$KG$20240715$$CN$CZ$CZ
240617821$24061782$1$I$$20240625$20240708$20240708$PER$$US-009507513-2406USA009397$MERCK$$$$$F$Y$$$20240708$$CN$US$US
240617832$24061783$2$F$20230519$20240709$20240708$20240722$EXP$$US-APELLIS-APL-2023-002795$APELLIS PHARMACEUTICALS$Andre J. Witkin, MD, FASRS1 , Glenn J. Jaffe, MD2, Sunil K. Srivastava, MD3, Janet L. Davis, MD4, Judy E. Kim, MD, FARVO, FASRS5, and the ReST Committee. Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee.Journal of VitreoRetinal Diseases . 2023;. doi:10.1177/24741264231220224$$$$$Y$$$20240719$$MD$US$US
240617842$24061784$2$F$$20240920$20240708$20240920$PER$$NVSC2024US140861$NOVARTIS$$$$$F$Y$$$20240920$$MD$US$US
240617851$24061785$1$I$20240618$20240702$20240708$20240708$PER$$US-JNJFOC-20240705575$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240708$$HP$US$US
240617861$24061786$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024083035$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240617873$24061787$3$F$$20240809$20240708$20240813$30DAY$$FR-JNJFOC-20240666631$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240813$$PH$FR$FR
240617882$24061788$2$F$$20240905$20240708$20240912$PER$$US-BIOGEN-2024BI01271612$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
240617891$24061789$1$I$$20240702$20240708$20240708$PER$$US-BIOGEN-2024BI01272087$BIOGEN$$$$$F$Y$$$20240708$$CN$US$US
240617901$24061790$1$I$$20240701$20240708$20240708$EXP$$SG-BEIGENE-BGN-2024-010235$BEIGENE$$$$$$Y$$$20240708$$CN$SG$SG
240617911$24061791$1$I$20240601$20240628$20240708$20240708$PER$$US-ALKERMES INC.-ALK-2024-001803$ALKERMES$$57$YR$$F$Y$$$20240708$$HP$US$US
240617921$24061792$1$I$20240611$20240705$20240708$20240708$EXP$FR-AFSSAPS-AN2024000845$FR-BAYER-2024A097226$BAYER$$73$YR$E$M$Y$$$20240708$$MD$FR$FR
240617936$24061793$6$F$$20240906$20240708$20240913$EXP$$NVSC2024HR136335$NOVARTIS$$56$YR$$F$Y$$$20240913$$HP$HR$HR
240617942$24061794$2$F$$20240627$20240708$20240717$EXP$$BE-DSJP-DSJ-2024-130877$DAIICHI$$$$E$F$Y$68$KG$20240717$$MD$BE$BE
240617951$24061795$1$I$20240601$20240703$20240708$20240708$EXP$$JP-AMGEN-JPNSP2024133126$AMGEN$$$$E$M$Y$$$20240708$$MD$JP$JP
240617961$24061796$1$I$$20240701$20240708$20240708$EXP$$DE-MYLANLABS-2024M1061678$MYLAN$$$$A$F$Y$73$KG$20240708$$MD$DE$DE
240617971$24061797$1$I$20240322$20240701$20240708$20240708$EXP$FR-AFSSAPS-GR2024000776$FR-MYLANLABS-2024M1061690$MYLAN$$56$YR$$M$Y$$$20240708$$PH$FR$FR
240617981$24061798$1$I$$20240701$20240708$20240708$EXP$$CZ-MYLANLABS-2024M1061704$MYLAN$$72$YR$$F$Y$$$20240708$$MD$CZ$CZ
240617991$24061799$1$I$20230725$20240701$20240708$20240708$EXP$FR-AFSSAPS-GR2024000789$FR-MYLANLABS-2024M1061692$MYLAN$$55$YR$$F$Y$$$20240708$$MD$FR$FR
240618001$24061800$1$I$20240427$20240701$20240708$20240708$EXP$FR-AFSSAPS-AM2024000424$FR-MYLANLABS-2024M1061727$MYLAN$$76$YR$$M$Y$90$KG$20240708$$MD$FR$FR
240618011$24061801$1$I$20231224$20240701$20240708$20240708$EXP$FR-AFSSAPS-AVNY2024000190$FR-MYLANLABS-2024M1061728$MYLAN$$34$YR$$M$Y$69$KG$20240708$$MD$FR$FR
240618021$24061802$1$I$20240521$20240628$20240708$20240708$EXP$$US-009507513-2407USA001098$MERCK$$64$YR$$F$Y$$$20240708$$CN$US$US
240618031$24061803$1$I$20220901$20240701$20240708$20240708$EXP$$PL-MYLANLABS-2024M1061688$MYLAN$$65$YR$$F$Y$$$20240708$$MD$PL$PL
240618041$24061804$1$I$20220502$20240701$20240708$20240708$EXP$$BE-MYLANLABS-2024M1061682$MYLAN$$81$YR$$F$Y$57.6$KG$20240708$$HP$BE$BE
240618051$24061805$1$I$20211229$20240701$20240708$20240708$EXP$ES-AEMPS-1539764$ES-MYLANLABS-2024M1061717$MYLAN$$81$YR$$F$Y$$$20240708$$PH$ES$ES
240618061$24061806$1$I$20240610$20240701$20240708$20240708$EXP$FR-AFSSAPS-RN2024000699$FR-MYLANLABS-2024M1061687$MYLAN$$23$YR$$M$Y$$$20240708$$MD$FR$FR
240618071$24061807$1$I$$20240625$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202406018610$ELI LILLY AND CO$$$$$M$Y$$$20240708$$CN$US$US
240618082$24061808$2$F$20240422$20240718$20240708$20240725$EXP$$NVSC2024US100301$NOVARTIS$$70$YR$$M$Y$$$20240725$$CN$US$US
240618091$24061809$1$I$$20240702$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407003330$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240708$$CN$US$US
240618111$24061811$1$I$$20240704$20240708$20240708$EXP$$US-PFIZER INC-2024SGN06262$PFIZER$$45$YR$$F$Y$$$20240708$$CN$US$US
240618121$24061812$1$I$$20240704$20240708$20240708$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107841$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240708$$MD$JP$JP
240618131$24061813$1$I$$20240703$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108205$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240708$$CN$US$US
240618141$24061814$1$I$$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107754$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240708$$HP$US$US
240618151$24061815$1$I$20240703$20240705$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108248$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240708$$CN$US$US
240618161$24061816$1$I$$20240705$20240708$20240708$EXP$$US-BAYER-2024A098147$BAYER$$67$YR$E$F$Y$$$20240708$$CN$US$US
240618171$24061817$1$I$$20240703$20240708$20240708$EXP$$JP-AstraZeneca-2024A154394$ASTRAZENECA$$$$$$Y$$$20240708$$PH$JP$
240618191$24061819$1$I$20240101$20240703$20240708$20240708$EXP$$US-SA-2024SA199530$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240708$$MD$US$US
240618201$24061820$1$I$$20240703$20240708$20240708$PER$$US-SA-2024SA199581$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240708$$MD$US$US
240618211$24061821$1$I$20240624$20240704$20240708$20240708$EXP$$JP-AstraZeneca-2024A154386$ASTRAZENECA$$$$$M$Y$$$20240708$$MD$JP$
240618221$24061822$1$I$$20240705$20240708$20240708$EXP$$IN-AstraZeneca-2024A154946$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$IN$
240618232$24061823$2$F$20240201$20240708$20240708$20240712$EXP$FR-AFSSAPS-NT2024000760$NVSC2024FR140391$NOVARTIS$$40$YR$$F$Y$86$KG$20240712$$MD$FR$FR
240618241$24061824$1$I$$20240702$20240708$20240708$EXP$$NVSC2024CN140046$NOVARTIS$Lin F, Dong X, Zhang Y, Cheng Y, Han T, Mo X, et al.. Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia.. ANNALS OF HEMATOLOGY. 2023;102 (9):2589-98$$$$$Y$$$20240708$$HP$CN$CN
240618251$24061825$1$I$20240521$20240701$20240708$20240708$EXP$$NVSC2024US137626$NOVARTIS$$66$YR$$F$Y$67.57$KG$20240708$$CN$US$US
240618261$24061826$1$I$$20240630$20240708$20240708$EXP$$JP-AstraZeneca-2024A153652$ASTRAZENECA$Matsui R, et al.. P-210 Experience with the use of dapagliflozin for treatments other than diabetes mellitus treatment at our hospital.. The Japanese Journal of Nephrology 2024;66((4)):664-.$$$$$Y$$$20240708$$MD$JP$
240618274$24061827$4$F$20240628$20240820$20240708$20240822$EXP$$NVSC2024DE139890$NOVARTIS$$$$T$M$Y$74.5$KG$20240822$$MD$DE$DE
240618282$24061828$2$F$$20240711$20240708$20240717$EXP$$JP-AstraZeneca-2024A154965$ASTRAZENECA$Fujinuma C, Suzuki T, Iwasawa U, Ishii G.. [Case Report: A Case of Axillary Lymph Node Metastasis Considered from Recurrence at Abdominal Ports after Surgery for Lung Cancer].. Japanese Journal of Clinical Dermatology 2024;78((2)):143-8.$73$YR$$M$Y$$$20240717$$MD$JP$
240618291$24061829$1$I$$20240702$20240708$20240708$EXP$$NVSC2024FI139697$NOVARTIS$$55$YR$$M$Y$$$20240708$$MD$FI$FI
240618301$24061830$1$I$$20240702$20240708$20240708$EXP$$NVSC2024JP140332$NOVARTIS$Saburi M, Takumi N, Miyazaki Y, Kohno K, Sakata M, Okuhiro K et al.. Real world outcomes of venetoclax and rituximab for chronic lymphocytic leukemia/small lymphocytic lymphoma: A retrospective analysis of nine Japanese cases. JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY. 2024;64(2):152-5$54$YR$$M$Y$$$20240708$$HP$JP$JP
240618312$24061831$2$F$$20240715$20240708$20240722$EXP$$NVSC2024IL138216$NOVARTIS$$69$YR$$M$Y$$$20240722$$CN$IL$IL
240618321$24061832$1$I$$20240705$20240708$20240708$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038315$BOEHRINGER INGELHEIM$$27$YR$A$M$Y$$$20240708$$MD$PL$PL
240618332$24061833$2$F$20231101$20240822$20240708$20240826$PER$$US-BAYER-2024A094804$BAYER$$58$YR$A$F$Y$$$20240826$$CN$US$US
240618341$24061834$1$I$20220101$20240701$20240708$20240708$EXP$FR-AFSSAPS-AVPA2024000601$FR-MYLANLABS-2024M1062021$MYLAN$$33$YR$$F$Y$$$20240708$$MD$FR$FR
240618351$24061835$1$I$$20240701$20240708$20240708$EXP$GB-MHRA-MED-202407011411135000-YPNHD$GB-MYLANLABS-2024M1061880$MYLAN$$$$$$Y$$$20240708$$HP$GB$GB
240618361$24061836$1$I$$20240701$20240708$20240708$EXP$$DE-MYLANLABS-2024M1061944$MYLAN$$$$$F$Y$$$20240708$$CN$DE$DE
240618371$24061837$1$I$20240113$20240701$20240708$20240708$EXP$GB-MHRA-MED-202406301130511070-FLYHN$GB-MYLANLABS-2024M1061842$MYLAN$$24$YR$$M$Y$$$20240708$$CN$GB$GB
240618381$24061838$1$I$20240528$20240701$20240708$20240708$EXP$GB-MHRA-MED-202406290042282300-ZNCFH$GB-MYLANLABS-2024M1061865$MYLAN$$66$YR$$M$Y$73$KG$20240708$$CN$GB$GB
240618391$24061839$1$I$20240606$20240708$20240708$20240708$EXP$ES-AEMPS-1543827$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038326$BOEHRINGER INGELHEIM$$40$YR$A$F$Y$$$20240708$$MD$ES$ES
240618401$24061840$1$I$$20240701$20240708$20240708$EXP$$JP-AMGEN-JPNSP2024130100$AMGEN$$$$$$Y$$$20240708$$CN$JP$JP
240618411$24061841$1$I$20240521$20240705$20240708$20240708$EXP$FR-AFSSAPS-SE2024000539$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-108118$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$85$KG$20240708$$MD$FR$FR
240618421$24061842$1$I$20240603$20240628$20240708$20240708$EXP$FR-AFSSAPS-LL2024001182$FR-TEVA-VS-3215882$TEVA$$82$YR$$M$Y$$$20240708$$MD$FR$FR
240618431$24061843$1$I$$20240701$20240708$20240708$EXP$$JP-JNJFOC-20240713925$JOHNSON AND JOHNSON$$7$MON$I$$Y$$$20240708$$MD$JP$JP
240618441$24061844$1$I$20231201$20240702$20240708$20240708$EXP$$US-ABBVIE-5826134$ABBVIE$$68$YR$$F$Y$$$20240708$$CN$US$US
240618451$24061845$1$I$$20240627$20240708$20240708$EXP$$GR-SA-2024SA194585$SANOFI AVENTIS$$$$E$F$Y$$$20240708$$PH$GR$GR
240618461$24061846$1$I$20240101$20240701$20240708$20240708$EXP$$DE-ABBVIE-5826081$ABBVIE$$$$$F$Y$$$20240708$$CN$DE$DE
240618481$24061848$1$I$20240101$20240701$20240708$20240708$EXP$$US-ABBVIE-5826111$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240618491$24061849$1$I$$20240701$20240708$20240708$EXP$$GB-MYLANLABS-2024M1062377$MYLAN$$$$$F$Y$$$20240708$$MD$GB$GB
240618501$24061850$1$I$$20240701$20240708$20240708$EXP$$DE-MYLANLABS-2024M1062052$MYLAN$$$$$F$Y$$$20240708$$MD$DE$DE
240618511$24061851$1$I$$20240701$20240708$20240708$EXP$$CR-MYLANLABS-2024M1062412$MYLAN$$$$$M$Y$$$20240708$$CN$CR$CR
240618522$24061852$2$F$20240601$20240722$20240708$20240725$PER$$NVSC2024US139057$NOVARTIS$$68$YR$$F$Y$$$20240725$$CN$US$US
240618531$24061853$1$I$20240101$20240703$20240708$20240708$EXP$$CA-ABBVIE-5828205$ABBVIE$$$$A$F$Y$$$20240708$$MD$CA$CA
240618551$24061855$1$I$$20240707$20240707$20240707$DIR$FDA-CDER-CTU-2024-47040$$FDA-CTU$$43$YR$$F$N$$$20240707$N$$US$
240618561$24061856$1$I$$20240707$20240707$20240707$DIR$FDA-CDER-CTU-2024-47041$$FDA-CTU$$60$YR$$F$N$$$20240707$N$$US$
240618571$24061857$1$I$$20240705$20240708$20240708$DIR$FDA-CDER-CTU-2024-47042$$FDA-CTU$$$$$M$N$$$20240705$N$HP$US$
240618581$24061858$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47053$$FDA-CTU$$88$YR$$M$N$$$20240708$N$$US$
240618591$24061859$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47160$$FDA-CTU$$64$YR$$M$N$86.64$KG$20240708$N$$US$
240618611$24061861$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47219$$FDA-CTU$$42$YR$$F$N$$$20240708$N$$US$
240618621$24061862$1$I$20240629$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47131$$FDA-CTU$$65$YR$$F$N$$$20240708$N$$US$
240618631$24061863$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47055$$FDA-CTU$$72$YR$$F$N$$$20240708$N$$US$
240618641$24061864$1$I$$20240521$20240708$20240708$PER$$US-AMGEN-USASP2024129969$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240618651$24061865$1$I$$20240702$20240708$20240708$EXP$$US-BAYER-2024A096070$BAYER$$79$YR$E$F$Y$$$20240708$$MD$US$US
240618661$24061866$1$I$$20240702$20240708$20240708$PER$$US-ABBVIE-5827508$ABBVIE$$$$$$Y$$$20240708$$HP$US$US
240618671$24061867$1$I$20240501$20240627$20240708$20240708$PER$$US-SA-2024SA193720$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240708$$MD$US$US
240618681$24061868$1$I$20240101$20240628$20240708$20240708$PER$$US-SA-2023SA220650$SANOFI AVENTIS$$$$E$M$Y$$$20240708$$MD$US$US
240618692$24061869$2$F$20240424$20240715$20240708$20240722$PER$$US-SA-2024SA196452$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240722$$MD$US$US
240618701$24061870$1$I$$20240702$20240708$20240708$PER$$US-SA-2024SA198147$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240618721$24061872$1$I$$20240628$20240708$20240708$EXP$$CA-BAXTER-2024BAX021084$BAXTER$$81$YR$$F$Y$$$20240708$$CN$CA$CA
240618731$24061873$1$I$$20240704$20240708$20240708$PER$$US-HALEON-2185515$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240618741$24061874$1$I$20240401$20240702$20240708$20240708$PER$$US-SA-2024SA198567$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240708$$MD$US$US
240618751$24061875$1$I$20240629$20240707$20240708$20240708$EXP$$US-INCYTE CORPORATION-2024IN007127$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240618762$24061876$2$F$$20240806$20240708$20240814$EXP$HU-EMA-DD-20240626-7482831-112214$HU-BAXTER-2024BAX021050$BAXTER$$52$YR$$M$Y$$$20240814$$HP$HU$HU
240618771$24061877$1$I$20240701$20240702$20240708$20240708$EXP$$US-ABBVIE-5827827$ABBVIE$$83$YR$$M$Y$$$20240708$$CN$US$US
240618781$24061878$1$I$20240118$20240628$20240708$20240708$EXP$FR-AFSSAPS-TO2024001132$FR-BAXTER-2024BAX020788$BAXTER$$63$YR$$F$Y$$$20240708$$PH$FR$FR
240618794$24061879$4$F$20240701$20240813$20240708$20240826$EXP$$US-BAYER-2024A097017$BAYER$$27$YR$A$F$Y$$$20240826$$MD$US$US
240618801$24061880$1$I$20240210$20240210$20240708$20240708$PER$$US-BAYER-2024A095535$BAYER$$$$$F$Y$$$20240708$$CN$US$US
240618811$24061881$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215139$TEVA$$69$YR$$M$Y$$$20240708$$CN$CA$CA
240618821$24061882$1$I$$20240614$20240708$20240708$EXP$$CN-NOVOPROD-1244456$NOVO NORDISK$Huang Yiling et al.. Clinical characteristics, treatment strategies, and perinatal outcomes of human insulin and analogue allergies during pregnancy. Chin J Diabetes Mellitus. 2024;16(5):543-547$39$YR$$F$Y$$$20240708$$HP$CN$CN
240618841$24061884$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202400087683$PFIZER$$$$$$Y$$$20240708$$CN$US$US
240618851$24061885$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400207317$PFIZER$$65$YR$$M$Y$$$20240708$$PH$US$US
240618881$24061888$1$I$20240327$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202400087860$PFIZER$$60$YR$$F$Y$$$20240708$$HP$US$US
240618892$24061889$2$F$$20240708$20240708$20240711$PER$$US-PFIZER INC-202400206601$PFIZER$$$$$$Y$$$20240711$$HP$US$US
240618902$24061890$2$F$$20240712$20240708$20240712$PER$$US-PFIZER INC-PV202400088582$PFIZER$$49$YR$$M$Y$$$20240712$$CN$US$US
240618921$24061892$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400204827$PFIZER$$60$YR$$F$Y$$$20240708$$CN$US$US
240618941$24061894$1$I$$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400088634$PFIZER$$48$YR$$F$Y$$$20240708$$CN$US$US
240618951$24061895$1$I$$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400088626$PFIZER$$$$$M$Y$$$20240708$$CN$US$US
240618961$24061896$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206429$PFIZER$$45$YR$$M$Y$$$20240708$$MD$US$US
240618971$24061897$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202400087717$PFIZER$$47$YR$$F$Y$$$20240708$$HP$US$US
240618982$24061898$2$F$$20240805$20240708$20240807$PER$$US-PFIZER INC-202400206888$PFIZER$$65$YR$$M$Y$$$20240807$$CN$US$US
240618991$24061899$1$I$$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400088425$PFIZER$$$$$$Y$$$20240708$$CN$US$US
240619001$24061900$1$I$$20240705$20240708$20240708$PER$$US-PFIZER INC-202400207983$PFIZER$$77$YR$$F$Y$$$20240708$$HP$US$US
240619011$24061901$1$I$20240101$20240703$20240708$20240708$PER$$US-PFIZER INC-202400207733$PFIZER$$78$YR$$F$Y$$$20240708$$HP$US$US
240619021$24061902$1$I$20240601$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400088650$PFIZER$$61$YR$$F$Y$$$20240708$$HP$US$US
240619032$24061903$2$F$$20240707$20240708$20240712$PER$$US-PFIZER INC-PV202400071569$PFIZER$$81$YR$$F$Y$$$20240712$$HP$US$US
240619041$24061904$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206162$PFIZER$$$$$M$Y$$$20240708$$MD$US$US
240619051$24061905$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202400088224$PFIZER$$54$YR$$F$Y$$$20240708$$HP$US$US
240619062$24061906$2$F$$20240711$20240708$20240715$PER$$US-PFIZER INC-202400197324$PFIZER$$65$YR$$F$Y$$$20240715$$MD$US$US
240619073$24061907$3$F$20240701$20240705$20240708$20240710$PER$$US-PFIZER INC-202400206905$PFIZER$$64$YR$$M$Y$$$20240710$$CN$US$US
240619081$24061908$1$I$20230101$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206280$PFIZER$$80$YR$$F$Y$63.5$KG$20240708$$CN$US$US
240619091$24061909$1$I$20240629$20240707$20240708$20240708$PER$$US-PFIZER INC-202400208161$PFIZER$$56$YR$$F$Y$$$20240708$$HP$US$US
240619101$24061910$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202400088260$PFIZER$$55$YR$$F$Y$$$20240708$$HP$US$US
240619111$24061911$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400206797$PFIZER$$71$YR$$M$Y$$$20240708$$CN$US$US
240619121$24061912$1$I$$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400088692$PFIZER$$91$YR$$F$Y$$$20240708$$CN$US$US
240619131$24061913$1$I$$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400088605$PFIZER$$50$YR$$F$Y$$$20240708$$PH$US$US
240619141$24061914$1$I$20240601$20240703$20240708$20240708$PER$$US-PFIZER INC-202400207792$PFIZER$$52$YR$$F$Y$$$20240708$$HP$US$US
240619151$24061915$1$I$$20240705$20240708$20240708$PER$$US-PFIZER INC-PV202400050236$PFIZER$$50$YR$$F$Y$$$20240708$$HP$US$US
240619161$24061916$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202400088627$PFIZER$$$$$F$Y$$$20240708$$CN$US$US
240619172$24061917$2$F$$20240731$20240708$20240802$PER$$US-PFIZER INC-PV202400088613$PFIZER$$57$YR$$F$Y$$$20240802$$CN$US$US
240619181$24061918$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202300076258$PFIZER$$84$YR$$F$Y$44.45$KG$20240708$$CN$US$US
240619191$24061919$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400207137$PFIZER$$8$YR$$M$Y$$$20240708$$CN$US$US
240619201$24061920$1$I$20240703$20240703$20240708$20240708$PER$$US-PFIZER INC-PV202400088268$PFIZER$$$$$F$Y$$$20240708$$CN$US$US
240619211$24061921$1$I$20240507$20240704$20240708$20240708$EXP$$NVSC2024CN140690$NOVARTIS$$86$YR$$M$Y$50$KG$20240708$$HP$CN$CN
240619221$24061922$1$I$$20240705$20240708$20240708$PER$$US-PFIZER INC-202400048912$PFIZER$$81$YR$$F$Y$$$20240708$$CN$US$US
240619231$24061923$1$I$$20240702$20240708$20240708$PER$$NVSC2024US140524$NOVARTIS$$45$YR$$M$Y$$$20240708$$CN$US$US
240619242$24061924$2$F$20240501$20240711$20240708$20240718$PER$$US-SA-2024SA193795$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240719$$MD$US$US
240619251$24061925$1$I$20240604$20240705$20240708$20240708$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038397$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240708$$HP$CO$CO
240619261$24061926$1$I$20240601$20240628$20240708$20240708$EXP$$US-ORGANON-O2406USA002763$ORGANON$$$$$M$Y$$$20240708$$PH$US$US
240619271$24061927$1$I$20240627$20240704$20240708$20240708$EXP$SE-SEMPA-2024-005218$SE-BAYER-2024A096702$BAYER$$28$YR$A$F$Y$85$KG$20240708$$MD$SE$SE
240619281$24061928$1$I$20240101$20240619$20240708$20240708$EXP$$JP-AstraZeneca-2024A155232$ASTRAZENECA$$$$$M$Y$$$20240708$$MD$JP$
240619291$24061929$1$I$$20240705$20240708$20240708$PER$$NVSC2024US140369$NOVARTIS$$$$$F$Y$$$20240708$$CN$US$US
240619301$24061930$1$I$20240501$20240705$20240708$20240708$PER$$US-BIOGEN-2024BI01269096$BIOGEN$$55$YR$$F$Y$$$20240708$$CN$US$US
240619311$24061931$1$I$$20240702$20240708$20240708$PER$$US-BIOGEN-2024BI01272166$BIOGEN$$$$$F$Y$$$20240708$$CN$US$US
240619321$24061932$1$I$20240601$20240625$20240708$20240708$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0601075$MYOVANT SCIENCES$$66$YR$$M$Y$$$20240708$$CN$US$US
240619331$24061933$1$I$20240401$20240628$20240708$20240708$EXP$FR-AFSSAPS-AVMP2024000186$FR-MYLANLABS-2024M1061079$MYLAN$$41$YR$$M$Y$$$20240708$$PH$FR$FR
240619341$24061934$1$I$20240101$20240628$20240708$20240708$EXP$FR-AFSSAPS-RS2024000607$FR-MYLANLABS-2024M1061027$MYLAN$$55$YR$$F$Y$51$KG$20240708$$PH$FR$FR
240619351$24061935$1$I$20240613$20240628$20240708$20240708$EXP$FR-AFSSAPS-BX2024001270$FR-MYLANLABS-2024M1061043$MYLAN$$36$YR$$M$Y$123$KG$20240708$$PH$FR$FR
240619361$24061936$1$I$20230301$20240628$20240708$20240708$EXP$FR-AFSSAPS-AVCN2024000470$FR-MYLANLABS-2024M1060945$MYLAN$$42$YR$$M$Y$$$20240708$$MD$FR$FR
240619372$24061937$2$F$20230929$20240725$20240708$20240731$EXP$$IT-MYLANLABS-2024M1061040$MYLAN$$76$YR$$F$Y$$$20240731$$CN$IT$IT
240619381$24061938$1$I$20240501$20240628$20240708$20240708$EXP$CZ-CZSUKL-24001722$CZ-MYLANLABS-2024M1060980$MYLAN$$74$YR$$F$Y$$$20240708$$CN$CZ$CZ
240619392$24061939$2$F$20240513$20240814$20240708$20240820$EXP$FR-AFSSAPS-BX2024001296$FR-MYLANLABS-2024M1061091$MYLAN$$30$YR$$F$Y$$$20240820$$PH$FR$FR
240619402$24061940$2$F$$20240628$20240708$20240712$EXP$$DE-MYLANLABS-2024M1061029$MYLAN$$$$E$$Y$$$20240712$$MD$DE$DE
240619411$24061941$1$I$20240610$20240628$20240708$20240708$EXP$FR-AFSSAPS-MP2024001013$FR-MYLANLABS-2024M1061055$MYLAN$$8$YR$$F$Y$37.9$KG$20240708$$MD$FR$FR
240619421$24061942$1$I$20240417$20240628$20240708$20240708$EXP$FR-AFSSAPS-DJ2024000806$FR-MYLANLABS-2024M1061042$MYLAN$$37$YR$$M$Y$92$KG$20240708$$MD$FR$FR
240619431$24061943$1$I$20240423$20240628$20240708$20240708$EXP$FR-AFSSAPS-AM2024000532$FR-MYLANLABS-2024M1060986$MYLAN$$57$YR$$M$Y$$$20240708$$MD$FR$FR
240619441$24061944$1$I$20240609$20240628$20240708$20240708$EXP$FR-AFSSAPS-BR2024000524$FR-MYLANLABS-2024M1061081$MYLAN$$77$YR$$F$Y$69$KG$20240708$$MD$FR$FR
240619451$24061945$1$I$20240208$20240628$20240708$20240708$EXP$FR-AFSSAPS-AVMA2024000249$FR-MYLANLABS-2024M1061099$MYLAN$$38$YR$$M$Y$$$20240708$$PH$FR$FR
240619462$24061946$2$F$20240625$20240812$20240708$20240814$30DAY$$US-AMGEN-USASP2024129842$AMGEN$$77$YR$E$M$Y$57.15$KG$20240814$$HP$US$US
240619471$24061947$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004433$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240708$$CN$US$US
240619481$24061948$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-2024SGN05352$PFIZER$$57$YR$$F$Y$$$20240708$$HP$US$US
240619491$24061949$1$I$20240613$20240701$20240708$20240708$EXP$$US-PFIZER INC-2024SGN05367$PFIZER$$60$YR$$F$Y$$$20240708$$CN$US$US
240619501$24061950$1$I$$20240703$20240708$20240708$EXP$$US-PFIZER INC-PV202400087759$PFIZER$Beydoun, H.. An Unusual Case of Jaundice Secondary to Hilar Lymphoma. The American Journal of GASTROENTEROLOGY. 2022;117 (supp):S1346$70$YR$$F$Y$$$20240708$$HP$US$US
240619511$24061951$1$I$20240306$20240628$20240708$20240708$EXP$$FR-MYLANLABS-2024M1060958$MYLAN$$73$YR$$F$Y$87$KG$20240708$$MD$FR$FR
240619542$24061954$2$F$20220101$20240705$20240708$20240712$EXP$$AT-PFIZER INC-202400205751$PFIZER$Finsterer, J.. Glofitamab-Associated Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Presenting as Serial Seizures and Responding Positively to Antiseizure Drugs and Anakinra: A Case Report. Cureus. 2024;16(5):10.7759/cureus.60833$61$YR$$M$Y$$$20240712$$MD$AT$AT
240619551$24061955$1$I$$20240628$20240708$20240708$PER$$US-JNJFOC-20240717985$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$PH$US$US
240619561$24061956$1$I$$20240702$20240708$20240708$PER$$US-JNJFOC-20240717785$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240708$$CN$US$US
240619572$24061957$2$F$$20240702$20240708$20240709$PER$$US-JNJFOC-20240718123$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240619591$24061959$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-202400207143$PFIZER$$$$$$Y$$$20240708$$CN$US$US
240619601$24061960$1$I$$20240701$20240708$20240708$EXP$$US-GSK-US2024083020$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$CN$US$US
240619612$24061961$2$F$20220830$20240712$20240708$20240712$EXP$IT-MINISAL02-993766$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038286$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$$$20240712$$MD$IT$IT
240619621$24061962$1$I$$20240628$20240708$20240708$EXP$GR-MLMSERVICE-20240624-PI109761-00136-1$GR-ABBVIE-5831276$ABBVIE$Betsikos A, Mousia M, Simopoulou E, Gazouni E, Magaliou S, Paschou E, et al.. Cutaneous Small-Vessel Vasculitis Induced by Escitalopram: A Case-Based Brief Review of the Literature. Cureus. 2024;16 (6):1-7.$$$$$Y$$$20240708$$MD$GR$GR
240619631$24061963$1$I$20240101$20240621$20240708$20240708$PER$$US-JNJFOC-20240664613$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240708$$CN$US$US
240619642$24061964$2$F$20240701$20240722$20240708$20240723$PER$$NVSC2024US140875$NOVARTIS$$37$YR$$F$Y$$$20240723$$CN$US$US
240619651$24061965$1$I$20240303$20240705$20240708$20240708$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038379$BOEHRINGER INGELHEIM$$46$YR$A$F$Y$57$KG$20240708$$HP$CO$CO
240619661$24061966$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47050$$FDA-CTU$$67$YR$$F$N$$$20240708$N$$US$
240619681$24061968$1$I$20240708$20240708$20240708$20240708$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038412$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240708$$CN$US$US
240619691$24061969$1$I$20240701$20240707$20240707$20240707$DIR$709328$$FDA-CTU$$45$YR$$M$N$78.75$KG$20240707$Y$CN$US$
240619712$24061971$2$F$20240601$20240703$20240708$20240820$PER$$US-LUNDBECK-DKLU4001174$LUNDBECK$$$$$$Y$$$20240820$$CN$US$US
240619721$24061972$1$I$$20240705$20240708$20240708$PER$$NVSC2024US140905$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
240619731$24061973$1$I$20240101$20240629$20240708$20240708$PER$$US-SA-2024SA195986$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240708$$MD$US$US
240619742$24061974$2$F$$20240805$20240708$20240806$PER$$US-ALXN-202407USA000007US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240619751$24061975$1$I$$20240702$20240708$20240708$30DAY$$US-GSK-US2024082152$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$CN$US$US
240619761$24061976$1$I$$20240705$20240708$20240708$PER$$US-JNJFOC-20240717600$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$HP$US$US
240619771$24061977$1$I$20240619$20240629$20240708$20240708$EXP$$CN-JNJFOC-20240701765$JOHNSON AND JOHNSON$$68$YR$E$M$Y$52$KG$20240708$$HP$CN$CN
240619781$24061978$1$I$$20240701$20240708$20240708$EXP$$GR-TAKEDA-2024TUS069134$TAKEDA$$86$YR$$F$Y$$$20240708$$CN$GR$GR
240619791$24061979$1$I$20240101$20240610$20240708$20240708$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00645$BIOCRYST PHARMACEUTICALS$$86$YR$$F$Y$$$20240708$$CN$US$US
240619801$24061980$1$I$$20240701$20240708$20240708$EXP$$FR-AstraZeneca-2024A155008$ASTRAZENECA$$$$$M$Y$76$KG$20240708$$CN$FR$
240619813$24061981$3$F$$20240822$20240708$20240830$EXP$$CA-ABBVIE-5830257$ABBVIE$$$$A$F$Y$$$20240828$$CN$CA$CA
240619821$24061982$1$I$20240601$20240702$20240708$20240708$PER$$US-ABBVIE-5827560$ABBVIE$$$$$F$Y$$$20240708$$HP$US$US
240619831$24061983$1$I$$20240516$20240708$20240708$PER$$US-LUNDBECK-DKLU3078229$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240619841$24061984$1$I$$20240708$20240708$20240708$PER$$NVSC2024US140907$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
240619851$24061985$1$I$$20240701$20240708$20240708$EXP$$BR-PFIZER INC-PV202400088009$PFIZER$$32$YR$$F$Y$$$20240708$$CN$BR$BR
240619865$24061986$5$F$20240702$20240725$20240708$20240731$EXP$$JP-PFIZER INC-PV202400087456$PFIZER$$77$YR$$M$Y$51$KG$20240731$$PH$JP$JP
240619872$24061987$2$F$20240415$20240731$20240708$20240807$PER$$US-JNJFOC-20240715907$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240807$$CN$US$US
240619881$24061988$1$I$20240429$20240704$20240708$20240708$EXP$HR-HALMED-300085452$HR-TAKEDA-2024TUS068251$TAKEDA$$68$YR$$F$Y$$$20240708$$HP$HR$HR
240619892$24061989$2$F$20230101$20240725$20240708$20240731$EXP$$US-ABBVIE-5822966$ABBVIE$$$$$F$Y$107$KG$20240731$$CN$US$US
240619901$24061990$1$I$20240706$20240707$20240707$20240707$DIR$709326$$FDA-CTU$$36$YR$$F$N$83.25$KG$20240707$N$CN$US$
240619911$24061991$1$I$20240707$20240707$20240707$20240707$DIR$709331$$FDA-CTU$$56$YR$$F$N$78.75$KG$20240707$N$CN$US$
240619931$24061993$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47240$$FDA-CTU$$73$YR$$M$N$73.89$KG$20240708$Y$PH$US$
240619941$24061994$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47215$$FDA-CTU$$71$YR$$M$N$$$20240708$N$$US$
240619951$24061995$1$I$20240623$20240707$20240707$20240707$DIR$709319$$FDA-CTU$$24$YR$$F$N$58$KG$20240707$N$CN$CH$
240619961$24061996$1$I$$20240705$20240708$20240708$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038191$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240708$$CN$US$US
240619971$24061997$1$I$20230701$20240705$20240708$20240708$EXP$$MX-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038400$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$$$20240708$$CN$MX$MX
240619981$24061998$1$I$20240101$20240517$20240708$20240708$PER$$US-LUNDBECK-DKLU3078275$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240619991$24061999$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024132783$AMGEN$Masias C.; Sridharan M.; Burwick R. et al.. Pregnancy and Immune Mediated Thrombotic Thrombocytopenic Purpura (iTTP); A Descriptive Analysis from the US Thrombotic Microangiopathy (USTMA) Registry. Blood. 2023;142:4009-4010$$$$$Y$$$20240708$$MD$US$US
240620001$24062000$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024131783$AMGEN$Schwartz M.; McMahon C.M.; Amaya M.L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240708$$MD$US$US
240620011$24062001$1$I$$20240703$20240708$20240708$EXP$$GB-AMGEN-GBRSP2024133148$AMGEN$$$$$$Y$$$20240708$$PH$GB$GB
240620021$24062002$1$I$$20240701$20240708$20240708$EXP$$ES-AMGEN-ESPSP2024132881$AMGEN$Martelli V.; Vidal Barrull J.; Fernandez Rodriguez C. et al.. Circulating tumor DNA (ctDNA) to detect acquired resistance to first-line (IL) treatment of RASWT metastatic colorectal cancer (mCRC): Insights from the PLATFORM-B study. Annals of Oncology. 2024;35 (S1):S51-S52$$$$$Y$$$20240708$$HP$ES$ES
240620031$24062003$1$I$$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024133675$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240620041$24062004$1$I$$20240705$20240708$20240708$PER$$NVSC2024US140756$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
240620055$24062005$5$F$20200303$20240912$20240708$20240919$EXP$BE-TAKEDA-2020TUS059098$BE-GSK-BE2024081553$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$BE$BE
240620072$24062007$2$F$$20240703$20240708$20240709$EXP$$US-PFIZER INC-PV202400087401$PFIZER$Javadi, T.. Extracavitary primary effusion lymphoma presenting as a solitary brain mass. CNS Oncology. 2024;13(1):10.1080/20450907.2024.2357535$62$YR$$M$Y$$$20240709$$HP$US$US
240620081$24062008$1$I$20240628$20240702$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002452$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240708$$CN$US$US
240620091$24062009$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000049US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
240620101$24062010$1$I$20230501$20240702$20240708$20240708$EXP$$CR-BAYER-2024A096312$BAYER$$$$$F$Y$$$20240708$$CN$CR$CR
240620111$24062011$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024132742$AMGEN$Masias C.; Sridharan M.; Burwick R. et al.. Pregnancy and Immune Mediated Thrombotic Thrombocytopenic Purpura (iTTP); A Descriptive Analysis from the US Thrombotic Microangiopathy (USTMA) Registry. Blood. 2023;142:4009-4010$$$$F$Y$$$20240708$$MD$US$US
240620121$24062012$1$I$20240101$20240704$20240708$20240708$PER$$US-AMGEN-USASP2024133654$AMGEN$$57$YR$A$M$Y$$$20240708$$HP$US$US
240620131$24062013$1$I$$20240701$20240708$20240708$EXP$$FR-AMGEN-FRASP2024133353$AMGEN$Moinard-butot F.; Barbe-richaud J.; Husson Wetzel S. et al.. Retrospective multicenter real-life study evaluating the efficacy of atezolizumab in combination with bevacizumab in metastatic hepatocellular carcinoma: HIREAL study. Annals of Oncology. 2024;35 (SUPPL_1):S88-S89$$$$$Y$$$20240708$$HP$FR$FR
240620141$24062014$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024131842$AMGEN$Schwartz M.; Mcmahon C. M.; Amaya M. L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240708$$MD$US$US
240620154$24062015$4$F$$20240909$20240708$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106928$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240911$$CN$US$US
240620161$24062016$1$I$$20240703$20240708$20240708$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108178$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240708$$CN$US$US
240620171$24062017$1$I$$20240627$20240708$20240708$PER$$US-SA-2023SA405149$SANOFI AVENTIS$$$$C$M$Y$21.769$KG$20240708$$MD$US$US
240620182$24062018$2$F$20240101$20240719$20240708$20240801$PER$$US-SA-2024SA198167$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240801$$MD$US$US
240620202$24062020$2$F$20240615$20240709$20240708$20240718$EXP$GB-MHRA-MED-202406260854336600-NTQGV$GB-PERRIGO-24GB006078$PERRIGO$$30$YR$$F$Y$$$20240718$$CN$GB$GB
240620221$24062022$1$I$20240625$20240702$20240708$20240708$EXP$$CN-009507513-2407CHN002478$MERCK$$62$YR$$M$Y$$$20240708$$HP$CN$CN
240620231$24062023$1$I$20240626$20240628$20240708$20240708$EXP$$GB-PERRIGO-24GB006155$PERRIGO$$24$YR$$F$Y$89$KG$20240708$$HP$GB$GB
240620242$24062024$2$F$$20240709$20240708$20240718$EXP$GB-MHRA-MIDB-b13c9216-0236-4bf2-b228-6b20ef976515$GB-PERRIGO-24GB006156$PERRIGO$$74$YR$$M$Y$$$20240718$$MD$GB$GB
240620251$24062025$1$I$20220906$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405111227472190-RWVFM$GB-SANDOZ INC.-SDZ2024GB063227$SANDOZ$$71$YR$$M$Y$70$KG$20240708$$CN$GB$GB
240620271$24062027$1$I$20240702$20240707$20240707$20240707$DIR$709341$$FDA-CTU$$29$YR$$F$N$81$KG$20240707$N$CN$US$
240620281$24062028$1$I$20230803$20240627$20240708$20240708$EXP$$FR-TAKEDA-2024TUS068135$TAKEDA$$51$YR$$M$Y$$$20240708$$MD$FR$FR
240620291$24062029$1$I$20240430$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405012015382740-NWRQP$GB-SANDOZ INC.-SDZ2024GB063275$SANDOZ$$63$YR$$F$Y$78$KG$20240708$$CN$GB$GB
240620301$24062030$1$I$20240622$20240708$20240708$20240708$EXP$IT-MINISAL02-993719$NVSC2024IT140475$NOVARTIS$$40$YR$$F$Y$$$20240708$$MD$IT$IT
240620311$24062031$1$I$$20240701$20240708$20240708$EXP$$DE-SANDOZ INC.-PHHY2018DE091420$SANDOZ$$$$I$$Y$$$20240708$$MD$DE$DE
240620321$24062032$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024132024$AMGEN$Schwartz M.; Mcmahon C. M.; Amaya M. L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240708$$MD$US$US
240620331$24062033$1$I$20240621$20240707$20240707$20240707$DIR$709342$$FDA-CTU$$48$YR$$M$N$103.5$KG$20240707$N$CN$US$
240620341$24062034$1$I$20240610$20240707$20240707$20240707$DIR$709334$$FDA-CTU$$43$YR$$M$N$94.5$KG$20240707$N$CN$US$
240620351$24062035$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47218$$FDA-CTU$$72$YR$$F$N$$$20240708$N$$US$
240620362$24062036$2$F$$20240717$20240708$20240718$EXP$$CA-SANDOZ INC.-NVSC2023CA122617$SANDOZ$$$$N$F$Y$$$20240718$$MD$CA$CA
240620371$24062037$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024132016$AMGEN$Schwartz M.; Mcmahon C. M.; Amaya M. L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240708$$MD$US$US
240620381$24062038$1$I$20240625$20240703$20240708$20240708$EXP$$NVSC2024CN139753$NOVARTIS$$59$YR$$F$Y$52.5$KG$20240708$$HP$CN$CN
240620391$24062039$1$I$$20240703$20240708$20240708$EXP$$VN-AstraZeneca-2024A154905$ASTRAZENECA$$$$$M$Y$$$20240708$$CN$VN$
240620401$24062040$1$I$20240310$20240705$20240708$20240708$EXP$$GB-AstraZeneca-2024A154462$ASTRAZENECA$$68$YR$$M$Y$94$KG$20240708$$MD$GB$
240620411$24062041$1$I$20240420$20240703$20240708$20240708$EXP$$IN-AstraZeneca-2024A155418$ASTRAZENECA$$29662$DY$$F$Y$$$20240708$$CN$IN$
240620421$24062042$1$I$20240424$20240707$20240707$20240707$DIR$709318$$FDA-CTU$$77$YR$$M$N$81$KG$20240707$N$CN$US$
240620431$24062043$1$I$20240702$20240707$20240707$20240707$DIR$709335$$FDA-CTU$$55$YR$$F$N$58.5$KG$20240707$N$CN$US$
240620441$24062044$1$I$20220501$20240701$20240708$20240708$EXP$$PT-AstraZeneca-2024A155152$ASTRAZENECA$$68$YR$$F$Y$$$20240708$$MD$PT$
240620452$24062045$2$F$20240614$20240704$20240708$20240709$EXP$$JP-AstraZeneca-2024A154019$ASTRAZENECA$$59$YR$$M$Y$54$KG$20240709$$MD$JP$
240620461$24062046$1$I$20240501$20240703$20240708$20240708$PER$$US-ABBVIE-5830179$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240620471$24062047$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024131995$AMGEN$Schwartz M.; McMahon C.M.; Amaya M.L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240708$$MD$US$US
240620481$24062048$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024132030$AMGEN$Schwartz M.; Mcmahon C. M.; Amaya M. L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240708$$MD$US$US
240620491$24062049$1$I$20240101$20240624$20240708$20240708$EXP$$US-SA-2024SA196284$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240708$$MD$US$US
240620501$24062050$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024131945$AMGEN$Schwartz M.; Mcmahon C.M.; Amaya M.L.et.al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Ch rom osome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240708$$MD$US$US
240620511$24062051$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024131920$AMGEN$Schwartz M.; Mcmahon C.M.; Amaya M.L. et.al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Ch rom osome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240708$$MD$US$US
240620521$24062052$1$I$$20240701$20240708$20240708$EXP$$US-AMGEN-USASP2024132009$AMGEN$Schwartz M.; Mcmahon C. M.; Amaya M. L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240708$$MD$US$US
240620551$24062055$1$I$20240630$20240707$20240707$20240707$DIR$709340$$FDA-CTU$$59$YR$$F$N$56.25$KG$20240707$N$CN$US$
240620561$24062056$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47241$$FDA-CTU$$62$YR$$F$N$88.45$KG$20240708$N$$US$
240620571$24062057$1$I$20240622$20240707$20240707$20240707$DIR$709346$$FDA-CTU$$25$YR$$F$N$78.75$KG$20240707$N$CN$US$
240620581$24062058$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47239$$FDA-CTU$$55$YR$$M$N$170.1$KG$20240708$N$$US$
240620591$24062059$1$I$20240705$20240707$20240707$20240707$DIR$709321$$FDA-CTU$$62$YR$$M$N$96.75$KG$20240707$N$CN$US$
240620601$24062060$1$I$20150101$20240707$20240707$20240707$DIR$709354$$FDA-CTU$$25$YR$$F$N$$$20240707$N$CN$US$
240620611$24062061$1$I$20240531$20240603$20240708$20240708$DIR$FDA-CDER-CTU-2024-46980$$FDA-CTU$$70$YR$$F$N$106.6$KG$20240603$N$$US$
240620621$24062062$1$I$20240708$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47253$$FDA-CTU$$73$YR$$M$N$$$20240708$N$$US$
240620641$24062064$1$I$20240701$20240705$20240708$20240708$EXP$$US-BAYER-2024A098163$BAYER$$79$YR$E$F$Y$$$20240708$$HP$US$US
240620652$24062065$2$F$$20240902$20240708$20240907$EXP$$US-AMGEN-USASP2024132417$AMGEN$Hoffmann M.S.; Munoz J.L.; Westin. J et. al. Golcadomide (GOLCA; CC-99282), a Novel CELMoD Agent, Plus R-CHOP in Patients (pts) with Previously Untreated Aggressive B-Cell Lymphoma (a-BCL): Safety and Efficacy Results from Phase lb Dose Expansion. Blood. 2023;142:4459-4463$$$$$Y$$$20240907$$MD$US$US
240620671$24062067$1$I$$20240701$20240708$20240708$EXP$$US-MYLANLABS-2024M1062933$MYLAN$Kobayashi T, Ford B, Diekema DJ, Sekar P. Disseminated Mycobacterium chimaera infection successfully treated with a clofazimine-containing regimen and long-term follow-up after discontinuing treatment. IDCases 2024; 36 1-4.$67$YR$$M$Y$$$20240708$$HP$US$US
240620681$24062068$1$I$$20240701$20240708$20240708$EXP$$US-MYLANLABS-2024M1062731$MYLAN$Merrill K, Davis A, Jackson E, Riker M, Kirk C, Yung D. Direct prostacyclin transition in pediatric patients with pulmonary hypertension. Pulm-Circ 2024; 14 (2): 1-5.$12$YR$$F$Y$$$20240708$$HP$US$US
240620691$24062069$1$I$$20240701$20240708$20240708$EXP$$US-MYLANLABS-2024M1062941$MYLAN$Hogan KO. Preventative plasmapheresis in a diabetic pregnant patient with hypertriglyceridemia and distal pancreatectomy. Transfus-Med 2023; 33 (5): 413-415.$22$YR$$F$Y$$$20240708$$HP$US$US
240620701$24062070$1$I$$20240701$20240708$20240708$EXP$$US-MYLANLABS-2024M1062914$MYLAN$Goudie MP, Khawam S, Levy JM, Hartfield R, Hassan S, Dawson M. A Storm is Brewing: A Case of Thyrotoxic Crisis. Am-J-Respir-Crit-Care-Med 2024; 209 (0).$27$YR$$$Y$$$20240708$$HP$US$US
240620711$24062071$1$I$$20240701$20240708$20240708$EXP$$US-MYLANLABS-2024M1062725$MYLAN$Arnouk S, Huynh Q, Saric M, Papadopoulos J. A Case Report of Cardiac Arrest After Intravenous Administration of Sulfur Hexafluoride (Lumason R) Ultrasound Enhancing Agent. J-Pharm-Pract 2024; 37 (2): 509-512.$35$YR$$M$Y$$$20240708$$PH$US$US
240620721$24062072$1$I$$20240701$20240708$20240708$EXP$$US-MYLANLABS-2024M1062586$MYLAN$Saleh A, D^Amico A, Hasnie A, Clarkson S, Heindl B. Atrial arrhythmias and acute pericarditis triggered by bleach ingestion-associated oesophageal perforation: a case report. Eur-Heart-J-Case-Rep 2024; 8 (2):$36$YR$$M$Y$$$20240708$$HP$US$US
240620732$24062073$2$F$$20240918$20240708$20240918$PER$$NVSC2024US140900$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
240620741$24062074$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47242$$FDA-CTU$$72$YR$$M$N$$$20240708$N$$US$
240620751$24062075$1$I$20240620$20240707$20240707$20240707$DIR$709374$$FDA-CTU$$70$YR$$F$N$53.1$KG$20240707$N$CN$US$
240620761$24062076$1$I$$20240627$20240708$20240708$EXP$$NVSC2024IN139243$NOVARTIS$$53$YR$$M$Y$$$20240708$$CN$IN$IN
240620771$24062077$1$I$20231225$20240707$20240707$20240707$DIR$709349$$FDA-CTU$$60$YR$$F$N$53.55$KG$20240707$N$CN$US$
240620781$24062078$1$I$20240616$20240704$20240708$20240708$EXP$$NVSC2024CN140605$NOVARTIS$$54$YR$$F$Y$$$20240708$$HP$CN$CN
240620813$24062081$3$F$$20240708$20240708$20240709$EXP$$NVSC2024US140909$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240620821$24062082$1$I$20240301$20240321$20240708$20240708$EXP$$US-BRACCO-2024US01364$BRACCO$$$$$M$Y$$$20240708$$CN$US$US
240620831$24062083$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47234$$FDA-CTU$$64$YR$$F$N$200$LBS$20240708$N$$US$
240620841$24062084$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47206$$FDA-CTU$$73$YR$$F$N$$$20240708$N$$US$
240620851$24062085$1$I$20240301$20240321$20240708$20240708$EXP$$US-BRACCO-2024US01511$BRACCO$$$$$M$Y$$$20240708$$HP$US$US
240620861$24062086$1$I$$20240627$20240708$20240708$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13253$IPSEN$$$$$F$Y$$$20240708$$HP$US$US
240620871$24062087$1$I$20240604$20240620$20240708$20240708$EXP$$US-BRACCO-2024US03312$BRACCO$$32$YR$$M$Y$$$20240708$$CN$US$US
240620881$24062088$1$I$$20240624$20240708$20240708$EXP$$US-MEITHEAL-2024MPLIT00190$MEITHEAL PHARMACEUTICALS$Fu K, et al.Manifestations and Management of Trimethoprim/ Sulfamethoxazole-Resistant Nocardia otitidiscaviarum Infection. Emerging Infectious Diseases.JUN-2023;29 (6):1266-7$73$YR$E$M$Y$$$20240704$$HP$US$US
240620891$24062089$1$I$20240301$20240321$20240708$20240708$EXP$$US-BRACCO-2024US01513$BRACCO$$$$$M$Y$$$20240708$$CN$US$US
240620901$24062090$1$I$$20240409$20240708$20240708$EXP$$US-BRACCO-2024US01942$BRACCO$$4$YR$$$Y$$$20240708$$CN$US$US
240620911$24062091$1$I$20240610$20240618$20240708$20240708$EXP$$US-BRACCO-2024US03601$BRACCO$$75$YR$$M$Y$$$20240708$$CN$US$US
240620921$24062092$1$I$20240516$20240606$20240708$20240708$EXP$$US-BRACCO-2024US02855$BRACCO$$$$$F$Y$$$20240708$$CN$US$US
240620931$24062093$1$I$20240422$20240424$20240708$20240708$EXP$$US-BRACCO-2024US02393$BRACCO$$82$YR$$F$Y$$$20240708$$HP$US$US
240620941$24062094$1$I$20240605$20240620$20240708$20240708$EXP$$US-BRACCO-2024US03703$BRACCO$$83$YR$$M$Y$$$20240708$$HP$US$US
240620951$24062095$1$I$20240611$20240612$20240708$20240708$EXP$$US-BRACCO-2024US03500$BRACCO$$34$YR$$F$Y$$$20240708$$CN$US$US
240620961$24062096$1$I$20240705$20240705$20240708$20240708$EXP$$CA-BAYER-2024A098159$BAYER$$81$YR$E$M$Y$$$20240708$$PH$CA$CA
240620981$24062098$1$I$$20240704$20240708$20240708$PER$$US-PFIZER INC-2024SGN05608$PFIZER$$$$$F$Y$$$20240708$$MD$US$US
240620991$24062099$1$I$$20240708$20240708$20240708$EXP$$TN-ANIPHARMA-2024-TN-000008$ANI$Ben Hammamia S, Jabri FE, Belhadj A, et al.Neurotoxicity related to multidrug association: a case report..Journal of Clinical Psychopharmacology.2024;44(3):317-319.$57$YR$$F$Y$$$20240708$$MD$TN$TN
240621001$24062100$1$I$20240101$20240702$20240708$20240708$EXP$$US-AMGEN-USASP2024131242$AMGEN$$72$YR$E$F$Y$$$20240708$$CN$US$US
240621012$24062101$2$F$$20240903$20240708$20240912$EXP$$CA-TEVA-VS-3215068$TEVA$$55$YR$$F$Y$$$20240912$$HP$CA$CA
240621021$24062102$1$I$20240623$20240704$20240708$20240708$EXP$$NVSC2024CN140713$NOVARTIS$$61$YR$$M$Y$40.5$KG$20240708$$HP$CN$CN
240621031$24062103$1$I$20240327$20240702$20240708$20240708$EXP$FR-AFSSAPS-TO2024001134$FR-RDY-SPO/FRA/24/0009740$DR REDDYS$$77$YR$E$M$Y$88$KG$20240708$$PH$FR$FR
240621041$24062104$1$I$20240513$20240708$20240708$20240708$EXP$IT-MINISAL02-993676$NVSC2024IT140479$NOVARTIS$$96$YR$$F$Y$65$KG$20240708$$MD$IT$IT
240621051$24062105$1$I$$20240627$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009744$DR REDDYS$Sharp JA, Jones D, Rotow JK, Fidias PM, Bertino E, Owen DH. Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non-Small Cell Lung Cancer. JNCCN Journal of the National Comprehensive Cancer Network. 2024;22(3): doi:10.6004/jnccn.2024.7009.$79$YR$E$F$Y$$$20240708$$MD$US$US
240621061$24062106$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214903$TEVA$$50$YR$$M$Y$$$20240708$$CN$CA$CA
240621071$24062107$1$I$$20231219$20240708$20240708$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00010$UPSHER-SMITH$$$$$F$Y$$$20240708$$CN$US$US
240621081$24062108$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214885$TEVA$$58$YR$$M$Y$$$20240708$$CN$CA$CA
240621091$24062109$1$I$$20231004$20240708$20240708$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00858$UPSHER-SMITH$$$$$F$Y$$$20240708$$CN$US$US
240621101$24062110$1$I$$20231004$20240708$20240708$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00857$UPSHER-SMITH$$$$$F$Y$$$20240708$$CN$US$US
240621121$24062112$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214868$TEVA$$71$YR$$F$Y$69$KG$20240708$$HP$CA$CA
240621131$24062113$1$I$$20240701$20240708$20240708$EXP$$US-MYLANLABS-2024M1062727$MYLAN$Razia D, Moin A, Walia T, Arjuna A. Metastatic Large Cell Neuroendocrine Carcinoma of Unknown Primary in a Lung Transplant Recipient. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A5947.$73$YR$$M$Y$$$20240708$$HP$US$US
240621141$24062114$1$I$$20240701$20240708$20240708$EXP$$US-MYLANLABS-2024M1062335$MYLAN$Khattar G, Sanayeh EB, Makram M, Rabah H, Baker SA, Khan S, et al. THE CONCOMITANT OCCURRENCE OF HIDRADENITIS SUPPURATIVA AND FOURNIER^S GANGRENE. Eur-J-Case-Rep-Intern-Med 2024; 11 (6):.$42$YR$$F$Y$$$20240708$$HP$US$US
240621151$24062115$1$I$20240704$20240705$20240708$20240708$EXP$$RO-AstraZeneca-2024A155330$ASTRAZENECA$$$$E$M$Y$$$20240708$$MD$RO$
240621161$24062116$1$I$$20240701$20240708$20240708$EXP$$US-MYLANLABS-2024M1062332$MYLAN$Laughter MR, Tegla CA, Pawar S, Moshiri AS, Orlow SJ. Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C. JAAD-Case-Rep 2024; 49 28-31.$37$YR$$M$Y$$$20240708$$MD$US$US
240621171$24062117$1$I$20240701$20240702$20240708$20240708$PER$$US-JNJFOC-20240704956$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240708$$PH$US$US
240621181$24062118$1$I$$20240701$20240708$20240708$EXP$$US-MYLANLABS-2024M1062579$MYLAN$Portuguese AJ, Gauthier J, Tykodi SS, Hall ET, Hirayama AV, Yeung CCS, et al. CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic review. Bone-Marrow-Transplant 2023; 58 353-359.$47$YR$$M$Y$$$20240708$$HP$US$US
240621191$24062119$1$I$20221001$20240701$20240708$20240708$EXP$$US-MYLANLABS-2024M1062329$MYLAN$Ouyang J, Sasidharan S, Jatoi T, Salifu M. How High Can Anion Gaps Be in Patients With Metabolic Acidosis? A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$61$YR$$F$Y$$$20240708$$HP$US$US
240621202$24062120$2$F$20240518$20240705$20240708$20240814$EXP$$TR-ABBVIE-5829945$ABBVIE$$$$$F$Y$$$20240814$$MD$TR$TR
240621211$24062121$1$I$$20240624$20240708$20240708$EXP$$JP-MEITHEAL-2024MPLIT00191$MEITHEAL PHARMACEUTICALS$Sasaki W, et al.Coronary vasospasms induced by a dexmedetomidine infusion for deep sedation during catheter ablation in a patient with negative findings of an acetylcholine provocation test. Journal of Arrhythmia.OCT-2023;39 (5):819-21$68$YR$A$M$Y$80$KG$20240704$$MD$JP$JP
240621234$24062123$4$F$20240425$20240924$20240708$20240926$EXP$$AR-MYLANLABS-2024M1042669$MYLAN$$61$YR$$F$Y$$$20240926$$CN$AR$AR
240621241$24062124$1$I$$20240708$20240708$20240708$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038363$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240708$$MD$FR$FR
240621251$24062125$1$I$$20240624$20240708$20240708$EXP$$US-SINTETICA US LLC-US-SIN-2024-00008$Sintetica$Hoerle R, Qiao X.. Hoerle R, Qiao X. A Last Resort: Lipid Emulsion Therapy in Lidocaine Anesthetic Systemic Toxicity (LAST).. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5683$81$YR$$F$Y$65$KG$20240705$$MD$US$US
240621261$24062126$1$I$$20240705$20240708$20240708$EXP$$CN-TAKEDA-2024TUS069271$TAKEDA$$$$$M$Y$$$20240708$$CN$CN$CN
240621271$24062127$1$I$20220617$20240628$20240708$20240708$EXP$$AT-PFIZER INC-PV202400086187$PFIZER$$29$YR$$M$Y$88.2$KG$20240708$$MD$AT$AT
240621291$24062129$1$I$$20240703$20240708$20240708$EXP$$IR-PFIZER INC-PV202400087754$PFIZER$Amanati, A.. Severe acute respiratory syndrome coronavirus-2 Alpha variant (B.1.1.7), original wild-type severe acute respiratory syndrome coronavirus 2, and cytomegalovirus co-infection in a young adult with acute lymphoblastic leukemia, case report, and review of the possible cytomegalovirus reactivation mechanisms.. Journal of Medical Case Reports. 2023;17:66:10.1186/s13256-022-03750-8$18$YR$$M$Y$$$20240708$$HP$IR$IR
240621301$24062130$1$I$20240619$20240704$20240708$20240708$EXP$$NVSC2024CN140549$NOVARTIS$$58$YR$$M$Y$68$KG$20240708$$HP$CN$CN
240621315$24062131$5$F$20210913$20240813$20240708$20240819$EXP$$TW-PFIZER INC-PV202400085932$PFIZER$$71$YR$$F$Y$60$KG$20240819$$MD$TW$TW
240621321$24062132$1$I$$20240701$20240708$20240708$EXP$GB-MHRA-MED-202407011617558320-GHRBD$GB-TEVA-VS-3215810$TEVA$$$$$M$Y$$$20240708$$PH$GB$GB
240621331$24062133$1$I$20240701$20240702$20240708$20240708$EXP$$US-AMGEN-USASP2024131212$AMGEN$$51$YR$A$M$Y$$$20240708$$CN$US$US
240621341$24062134$1$I$$20240521$20240708$20240708$PER$$US-CMP PHARMA-2024CMP00028$CMP PHARMA$$$$$F$Y$$$20240708$$CN$US$US
240621351$24062135$1$I$$20240702$20240708$20240708$EXP$$US-AMERICAN REGENT INC-2024002574$AMERICAN REGENT$Simone C, Axelband J. Levetiracetamassociated Rhabdomyolysis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5704[abstract]$20$YR$$M$Y$$$20240708$$HP$US$US
240621361$24062136$1$I$$20240624$20240708$20240708$EXP$$DE-MEITHEAL-2024MPLIT00192$MEITHEAL PHARMACEUTICALS$Stojiljkovic D, et al.Li-Fraumeni Syndrome with Six Primary Tumors - Case Report.Case Reports in Oncological Medicine.JAN-2024;1 (1):1-7$3$DEC$A$F$Y$$$20240704$$HP$DE$DE
240621372$24062137$2$F$$20240712$20240708$20240721$EXP$$RO-MYLANLABS-2024M1061904$MYLAN$Zokarias AM, Osan VP, Sbiera F, Marinescu A, Veres A, Grebenisan L, Mihai A.. Antiparkinsonian medication-induced delirium - a case report.. Acta Marisiensis - Seria Medica. 2024;70:3:253-254$80$YR$$F$Y$$$20240719$$MD$RO$RO
240621382$24062138$2$F$20210101$20240710$20240708$20240716$EXP$$HU-MYLANLABS-2024M1061906$MYLAN$Gulyas A, Berzy K, Agnes Domotor M, Santa H, Laszlo Batai A.. High-grade transformation in our patient treated for lymphoplasmacytic lymphoma-Case report. Haematology-Transfusiology. 2024;68-9$58$YR$$F$Y$$$20240716$$HP$HU$HU
240621391$24062139$1$I$$20240701$20240708$20240708$EXP$$FR-MYLANLABS-2024M1061638$MYLAN$Leleu X, Hulin C, Lambert J, Bobin A, Perrot A, Karlin L, et al. Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial. Nature Medicine. 2024$$$E$$Y$$$20240708$$MD$FR$FR
240621402$24062140$2$F$$20240723$20240708$20240729$EXP$$CZ-MYLANLABS-2024M1062632$MYLAN$Lukac A. Individualised therapy for patient with prostatic cancer. ONKOLOGIE. 2024;18(3):216-218$58$YR$$M$Y$$$20240729$$MD$CZ$CZ
240621411$24062141$1$I$20240415$20240702$20240708$20240708$EXP$$CA-LUNDBECK-DKLU4001213$LUNDBECK$$$$$$Y$$$20240708$$HP$CA$CA
240621421$24062142$1$I$$20240701$20240708$20240708$EXP$$CZ-MYLANLABS-2024M1062061$MYLAN$Skopal D, Belada D.. First-line treatment of nodal TFH lymphoma, angioimmunoblastic subtype.. kazuistiky/klinicka praxe. 2024;20 (S6):1-36$$$$F$Y$$$20240708$$MD$CZ$CZ
240621431$24062143$1$I$$20240701$20240708$20240708$EXP$$CZ-MYLANLABS-2024M1061915$MYLAN$Mocikova H. Treatment of angioimmunoblastic lymphoma with the combination of brentuximab vedotin with cyclophosphamide, doxorubicin and prednisone. kaczynski/klinicka praxis. 2024;20 (S6):1-36$71$YR$$M$Y$$$20240708$$HP$CZ$CZ
240621441$24062144$1$I$20240601$20240702$20240708$20240708$PER$$US-BAYER-2024A096172$BAYER$$47$YR$A$F$Y$$$20240708$$HP$US$US
240621451$24062145$1$I$$20240703$20240708$20240708$EXP$$US-TAKEDA-2024TUS067821$TAKEDA$$$$$F$Y$$$20240708$$CN$US$US
240621461$24062146$1$I$20240607$20240707$20240707$20240707$DIR$709330$$FDA-CTU$$30$YR$$M$N$69.75$KG$20240707$N$CN$US$
240621501$24062150$1$I$20240707$20240707$20240707$20240707$DIR$709375$$FDA-CTU$$54$YR$$M$N$117$KG$20240707$N$CN$US$
240621511$24062151$1$I$$20240624$20240708$20240708$EXP$$HU-MEITHEAL-2024MPLIT00193$MEITHEAL PHARMACEUTICALS$Juhasz M, et al..Hemorrhagic Pneumonia in a Kidney Transplant Recipient Caused by Stenotrophomonas Maltophilia Infection: A Case Report.Transplantation Proceedings.JAN-2024;1 (1):1-4$73$YR$E$M$Y$$$20240704$$HP$HU$HU
240621523$24062152$3$F$20230929$20240924$20240708$20240926$EXP$$FR-TAKEDA-2024TUS069256$TAKEDA$$59$YR$$F$Y$$$20240926$$HP$FR$FR
240621551$24062155$1$I$$20240624$20240708$20240708$EXP$$GB-MEITHEAL-2024MPLIT00196$MEITHEAL PHARMACEUTICALS$Rehman U, et al.Guidance on the treatment of rare deep subcutaneous mycobacterium abscess following cosmetic procedures: a case series and systematic review of the literature.European Journal of Plastic Surgery.AUG-2023;46 (4):625-35$36$YR$A$F$Y$$$20240704$$HP$GB$GB
240621571$24062157$1$I$20240705$20240707$20240707$20240707$DIR$709377$$FDA-CTU$$66$YR$$M$N$69.75$KG$20240707$N$CN$US$
240621581$24062158$1$I$$20240707$20240707$20240707$DIR$709324$$FDA-CTU$$55$YR$$F$N$$$20240707$N$CN$US$
240621591$24062159$1$I$20240703$20240707$20240707$20240707$DIR$709345$$FDA-CTU$$68$YR$$F$N$$$20240707$N$CN$US$
240621611$24062161$1$I$20240506$20240707$20240707$20240707$DIR$709353$$FDA-CTU$$45$YR$$F$N$84.6$KG$20240707$Y$CN$US$
240621621$24062162$1$I$20240707$20240707$20240707$20240707$DIR$709376$$FDA-CTU$$45$YR$$M$N$83.25$KG$20240707$N$CN$US$
240621641$24062164$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47243$$FDA-CTU$$51$YR$$M$N$220$LBS$20240708$N$$US$
240621651$24062165$1$I$20231215$20240707$20240707$20240707$DIR$709380$$FDA-CTU$$35$YR$$M$N$78.75$KG$20240707$Y$CN$US$
240621671$24062167$1$I$20240406$20240707$20240707$20240707$DIR$709383$$FDA-CTU$$72$YR$$F$N$75.6$KG$20240707$N$CN$US$
240621711$24062171$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47141$$FDA-CTU$$57$YR$$M$N$$$20240708$N$$US$
240621721$24062172$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47236$$FDA-CTU$$34$YR$$F$N$315$LBS$20240708$N$$US$
240621741$24062174$1$I$$20240706$20240706$20240706$DIR$FDA-CDER-CTU-2024-47264$$FDA-CTU$$$$$F$N$90.72$KG$20240706$Y$$US$
240621751$24062175$1$I$20240601$20240707$20240707$20240707$DIR$FDA-CDER-CTU-2024-47273$$FDA-CTU$$45$YR$$F$N$74.84$KG$20240707$N$CN$PR$
240621761$24062176$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-2019-CA-1003895$TEVA$$$$$F$Y$$$20240708$$CN$CA$CA
240621771$24062177$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405081141565520-NYFKC$GB-DSJP-DSE-2024-130916$DAIICHI$$$$$M$Y$$$20240708$$HP$GB$GB
240621781$24062178$1$I$$20240629$20240708$20240708$EXP$GB-MHRA-MED-202406291352445690-FRSGZ$GB-TEVA-VS-3216047$TEVA$$$$$M$Y$$$20240708$$CN$GB$GB
240621791$24062179$1$I$$20240708$20240708$20240708$PER$$NVSC2024US140930$NOVARTIS$$$$$$Y$$$20240708$$HP$US$US
240621801$24062180$1$I$$20240612$20240708$20240708$PER$$US-LUNDBECK-DKLU4000443$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240621813$24062181$3$F$20231001$20240910$20240708$20240918$EXP$$IT-PFIZER INC-202400207654$PFIZER$$40$YR$$F$Y$$$20240918$$MD$IT$IT
240621824$24062182$4$F$20240627$20240828$20240708$20240830$EXP$$US-PFIZER INC-202400205503$PFIZER$$64$YR$$F$Y$71.9$KG$20240830$$PH$US$US
240621832$24062183$2$F$$20240703$20240708$20240801$EXP$$CH-BAUSCH-BL-2024-010303$BAUSCH AND LOMB$Amandine D, Luiza De Bortolli N, Cecilia N, Jessica L, Mary K, Emmanuelle R, Cosette R, Olmo R. Hypokalemic paralysis a side-effect of short action beta2-agonist. Swiss Medical Weekly. 2024 MAY 01;154:35S.$6$YR$$F$Y$$$20240801$$HP$CH$CH
240621842$24062184$2$F$20210101$20240708$20240708$20240716$EXP$$IQ-009507513-2303IRQ005747$MERCK$$62$YR$$F$Y$$$20240716$$MD$IQ$IQ
240621851$24062185$1$I$20240703$20240703$20240708$20240708$PER$$US-JNJFOC-20240709782$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240708$$CN$US$US
240621862$24062186$2$F$$20240710$20240708$20240715$EXP$$CZ-BAUSCH-BL-2024-010260$BAUSCH AND LOMB$Gregova M. Bimekizumab napric spektrem axialnich spondyloartritid. Farmakoterapeuticka revue. 2024;9(3):245-250.$27$YR$$M$Y$$$20240715$$MD$CZ$CZ
240621871$24062187$1$I$20240502$20240705$20240708$20240708$EXP$FR-AFSSAPS-NT2024000808$FR-BAUSCH-BL-2024-010354$BAUSCH AND LOMB$$72$YR$$F$Y$92$KG$20240708$$MD$FR$FR
240621881$24062188$1$I$$20240708$20240708$20240708$EXP$$CA-BAUSCH-BL-2024-010436$BAUSCH AND LOMB$$17$YR$$F$Y$$$20240708$$PH$CA$CA
240621891$24062189$1$I$$20240708$20240708$20240708$EXP$$CA-BAUSCH-BL-2024-010435$BAUSCH AND LOMB$$14$YR$$M$Y$41$KG$20240708$$PH$CA$CA
240621901$24062190$1$I$20240515$20240624$20240708$20240708$EXP$FR-AFSSAPS-TO2024000864$FR-GUERBET / LLC-FR-20240242$GUERBET$$30$YR$A$F$Y$$$20240708$$PH$FR$FR
240621911$24062191$1$I$$20240514$20240708$20240708$EXP$$SE-BRAEBURN-SE-BRA-24-000492$BRAEBURN PHARMACEUTICALS$$45$YR$$M$Y$$$20240708$$HP$SE$SE
240621921$24062192$1$I$$20240708$20240708$20240708$EXP$$CA-BAUSCH-BL-2024-010433$BAUSCH AND LOMB$$50$YR$$M$Y$$$20240708$$HP$CA$CA
240621932$24062193$2$F$$20240704$20240708$20240710$EXP$$CA-PFIZER INC-202400206147$PFIZER$Lam, G.. Primary Effusion Lymphoma (PEL)-Like Lymphoma in a Child With Congenital Immunodeficiency. Pediatr Blood Cancer. 2016;63:1674-1676$9$YR$$F$Y$$$20240710$$MD$CA$CA
240621941$24062194$1$I$$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004247$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240708$$CN$US$US
240621952$24062195$2$F$20240705$20240801$20240708$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202407004158$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240811$$CN$US$US
240621961$24062196$1$I$20240601$20240705$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407004422$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240708$$CN$US$US
240621971$24062197$1$I$20240101$20240702$20240708$20240708$PER$$US-ABBVIE-5827410$ABBVIE$$3$YR$$$Y$$$20240708$$HP$US$US
240621994$24062199$4$F$20240101$20240722$20240708$20240726$EXP$$DE-BIOMARINAP-DE-2024-158983$BIOMARIN$$$$$$Y$$$20240726$$HP$DE$DE
240622002$24062200$2$F$20240101$20240724$20240708$20240805$EXP$$IE-BIOMARINAP-IE-2024-158964$BIOMARIN$$$$$$Y$$$20240805$$CN$US$IE
240622012$24062201$2$F$$20240812$20240708$20240814$EXP$$FI-ABBVIE-5831321$ABBVIE$$$$$M$Y$$$20240814$$HP$FI$FI
240622022$24062202$2$F$20240101$20240719$20240708$20240724$PER$$US-BAYER-2024A096385$BAYER$$33$YR$A$F$Y$$$20240724$$CN$US$US
240622031$24062203$1$I$$20240701$20240708$20240708$EXP$$ES-TAKEDA-2024TUS067935$TAKEDA$$$$$F$Y$$$20240708$$MD$ES$ES
240622051$24062205$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47255$$FDA-CTU$$62$YR$$F$N$$$20240708$N$$US$
240622061$24062206$1$I$$20240705$20240708$20240708$DIR$FDA-CDER-CTU-2024-47135$$FDA-CTU$$$$$F$N$$$20240705$N$HP$US$
240622071$24062207$1$I$$20240705$20240708$20240708$DIR$FDA-CDER-CTU-2024-47087$$FDA-CTU$$$$$F$N$$$20240705$N$HP$US$
240622081$24062208$1$I$$20240705$20240708$20240708$DIR$FDA-CDER-CTU-2024-47235$$FDA-CTU$$$$$M$N$$$20240705$N$HP$US$
240622091$24062209$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47220$$FDA-CTU$$59$YR$$M$N$$$20240708$N$$US$
240622101$24062210$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47233$$FDA-CTU$$59$YR$$M$N$200$LBS$20240708$N$$US$
240622111$24062211$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47092$$FDA-CTU$$63$YR$$F$N$$$20240708$N$$US$
240622121$24062212$1$I$$20240702$20240708$20240708$DIR$FDA-CDER-CTU-2024-47224$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240622131$24062213$1$I$20240625$20240705$20240708$20240708$DIR$FDA-CDER-CTU-2024-47075$$FDA-CTU$$41$YR$$F$N$$$20240705$N$HP$US$
240622151$24062215$1$I$20240415$20240703$20240708$20240708$EXP$FR-AFSSAPS-BS2024000382$FR-MYLANLABS-2024M1062279$MYLAN$$65$YR$$M$Y$71$KG$20240708$$MD$FR$FR
240622161$24062216$1$I$$20240703$20240708$20240708$EXP$$ZA-MYLANLABS-2024M1062956$MYLAN$$3$YR$$F$Y$$$20240708$$PH$ZA$ZA
240622171$24062217$1$I$20240429$20240703$20240708$20240708$EXP$ES-AEMPS-1540865$ES-MYLANLABS-2024M1062772$MYLAN$$87$YR$$F$Y$$$20240708$$HP$ES$ES
240622181$24062218$1$I$20240625$20240630$20240708$20240708$EXP$$CN-ALCON LABORATORIES-ALC2024CN003220$ALCON$$49$YR$$M$Y$75$KG$20240708$$HP$CN$CN
240622191$24062219$1$I$20230101$20240705$20240708$20240708$EXP$$US-DSJP-DSU-2024-104309$DAIICHI$$$$$M$Y$$$20240708$$HP$US$US
240622204$24062220$4$F$20200701$20240712$20240708$20240722$EXP$$CA-SHIRE-CA202024785$TAKEDA$$50$YR$$F$Y$58$KG$20240722$$CN$CA$CA
240622213$24062221$3$F$20191104$20240906$20240708$20240920$EXP$$FR-GUERBET / LLC-FR-20240249$GUERBET$Iodine-induced thyrotoxicosis in a patient treated with glue and lipiodised oil for pelvic congestion syndrome. Lancet. 2024;403: 2732-2733.$38$YR$A$F$Y$62$KG$20240920$$MD$FR$FR
240622223$24062222$3$F$20240627$20240806$20240708$20240812$EXP$$JP-CARA THERAPEUTICS, INC.-2024-00328-JP$CARA THERAPEUTICS$$92$YR$$M$Y$$$20240812$$PH$JP$JP
240622231$24062223$1$I$20240414$20240701$20240708$20240708$PER$$US-BIOMARINAP-US-2024-158943$BIOMARIN$$$$$$Y$$$20240708$$CN$US$US
240622241$24062224$1$I$$20240629$20240708$20240708$EXP$GB-MHRA-MED-202406291145190840-GJMRH$GB-TEVA-VS-3216159$TEVA$$$$$M$Y$$$20240708$$CN$GB$GB
240622252$24062225$2$F$20240625$20240707$20240708$20240805$EXP$PT-INFARMED-R202406-732$PT-BAUSCH-BL-2024-010422$BAUSCH AND LOMB$$37$YR$$M$Y$$$20240805$$PH$PT$PT
240622263$24062226$3$F$20240605$20240729$20240708$20240801$PER$$NVSC2024US140948$NOVARTIS$$68$YR$$M$Y$$$20240801$$HP$US$US
240622272$24062227$2$F$20240606$20240819$20240708$20240829$EXP$$CN-G1 THERAPEUTICS-2024G1CN0000083$G1 THERAPEUTICS$$$$$$Y$$$20240829$$CN$CN$CN
240622282$24062228$2$F$20240702$20240716$20240708$20240717$EXP$$US-INCYTE CORPORATION-2024IN007078$INCYTE$$$$$$Y$$$20240717$$CN$US$US
240622291$24062229$1$I$20240101$20240701$20240708$20240708$PER$$US-SA-2024SA198153$SANOFI AVENTIS$$60$YR$A$F$Y$68.9$KG$20240708$$MD$US$US
240622301$24062230$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215114$TEVA$$58$YR$$M$Y$$$20240708$$MD$CA$CA
240622311$24062231$1$I$$20240708$20240708$20240708$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038431$BOEHRINGER INGELHEIM$$$$$$Y$$$20240708$$CN$US$US
240622322$24062232$2$F$$20240716$20240708$20240726$EXP$$US-TEVA-VS-3217779$TEVA$Manjunath J, Liao V, Kambala A, Bao A, Kollhoff AL, Ma EZ, et al. Immune stimulus exposure as a trigger for the development of chronic pruritus and circulating blood type 2 inflammation. JAAD-Int 2024; 16 97-102; Manjunath J, Liao V, Kambala A, Bao A, Kollhoff AL, Ma EZ, et al. Immune stimulus exposure as a trigger for the development of chronic pruritus and circulating blood type 2 inflammation. JAAD-Int 2024; 16 97-102.; Manjunath J, Liao V, Kambala A, Bao A, Kollhoff AL, Ma EZ, et al. Immu...$54$YR$$M$Y$$$20240726$$HP$US$US
240622331$24062233$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214972$TEVA$$47$YR$$M$Y$$$20240708$$HP$CA$CA
240622341$24062234$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214962$TEVA$$73$YR$$F$Y$$$20240708$$HP$CA$CA
240622351$24062235$1$I$20240330$20240703$20240708$20240708$EXP$$FR-AMERICAN REGENT INC-2024002546$AMERICAN REGENT$$57$YR$$F$Y$62$KG$20240708$$MD$FR$FR
240622361$24062236$1$I$$20240629$20240708$20240708$EXP$GB-MHRA-MED-202406291146576770-GMFCW$GB-TEVA-VS-3215913$TEVA$$$$$$Y$78$KG$20240708$$CN$GB$GB
240622371$24062237$1$I$$20240629$20240708$20240708$EXP$GB-MHRA-MED-202406291156204580-GSRWB$GB-TEVA-VS-3216160$TEVA$$25$YR$$M$Y$88$KG$20240708$$CN$GB$GB
240622381$24062238$1$I$$20240703$20240708$20240708$EXP$$US-INCYTE CORPORATION-2024IN007051$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240622391$24062239$1$I$20240614$20240614$20240708$20240708$PER$$CO-TOLMAR, INC.-24CO050276$TOLMAR$$70$YR$$M$Y$$$20240708$$CN$CO$CO
240622402$24062240$2$F$20240614$20240906$20240708$20240924$PER$$CA-TOLMAR, INC.-24CA050277$TOLMAR$$83$YR$$M$Y$$$20240924$$CN$CA$CA
240622411$24062241$1$I$20240501$20240614$20240708$20240708$PER$$CO-TOLMAR, INC.-24CO050207$TOLMAR$$75$YR$$M$Y$$$20240708$$CN$CO$CO
240622431$24062243$1$I$20190101$20240703$20240708$20240708$EXP$$US-INCYTE CORPORATION-2024IN007053$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240622442$24062244$2$F$20240601$20240709$20240708$20240809$PER$$FR-TOLMAR, INC.-24FR050179$TOLMAR$$70$YR$$M$Y$$$20240809$$PH$FR$FR
240622452$24062245$2$F$20240612$20240709$20240708$20240808$PER$$FR-TOLMAR, INC.-24FR050176$TOLMAR$$$$$F$Y$$$20240808$$PH$FR$FR
240622462$24062246$2$F$20240601$20240702$20240708$20240808$PER$$FR-TOLMAR, INC.-24FR049938$TOLMAR$$88$YR$$M$Y$$$20240808$$PH$FR$FR
240622471$24062247$1$I$20200209$20240629$20240708$20240708$EXP$GB-MHRA-MED-202406291153551960-YVRTB$GB-TEVA-VS-3216026$TEVA$$24$YR$$M$Y$65$KG$20240708$$CN$GB$GB
240622481$24062248$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000034US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
240622491$24062249$1$I$$20240701$20240708$20240708$PER$$US-ALXN-202407USA000066US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
240622501$24062250$1$I$$20240701$20240708$20240708$DIR$FDA-CDER-CTU-2024-47090$$FDA-CTU$$$$$M$N$$$20240701$N$HP$US$
240622511$24062251$1$I$20240708$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47254$$FDA-CTU$$73$YR$$M$N$$$20240708$N$$US$
240622521$24062252$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47093$$FDA-CTU$$81$YR$$M$N$$$20240708$N$$US$
240622531$24062253$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47144$$FDA-CTU$$55$YR$$F$N$$$20240708$N$$US$
240622541$24062254$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47149$$FDA-CTU$$50$YR$$F$N$240$LBS$20240708$N$$US$
240622551$24062255$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47250$$FDA-CTU$$$$$M$N$$$20240708$N$HP$US$
240622561$24062256$1$I$$20240706$20240708$20240708$DIR$FDA-CDER-CTU-2024-47168$$FDA-CTU$$58$YR$$F$N$$$20240706$N$$US$
240622571$24062257$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47120$$FDA-CTU$$70$YR$$F$N$$$20240708$N$$US$
240622581$24062258$1$I$20240630$20240701$20240708$20240708$EXP$GB-MHRA-MED-202407011525489870-HMPDZ$GB-RDY-SPO/GBR/24/0009698$DR REDDYS$$21$YR$A$M$Y$$$20240708$$CN$GB$GB
240622591$24062259$1$I$20150312$20201022$20240708$20240708$EXP$$FR-Ipsen Biopharmaceuticals, Inc.-2019-18877$IPSEN$$4$YR$C$M$Y$10$KG$20240708$$MD$FR$FR
240622601$24062260$1$I$$20240627$20240708$20240708$EXP$$JP-TAKEDA-2024TUS068914$TAKEDA$$57$YR$$F$Y$$$20240708$$MD$JP$JP
240622611$24062261$1$I$20240201$20240703$20240708$20240708$EXP$$US-INCYTE CORPORATION-2024IN007050$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240622621$24062262$1$I$20240703$20240703$20240708$20240708$EXP$$HN-MYLANLABS-2024M1063206$MYLAN$$69$YR$$F$Y$79.33$KG$20240708$$CN$HN$HN
240622631$24062263$1$I$$20240703$20240708$20240708$EXP$$HN-MYLANLABS-2024M1063125$MYLAN$$$$$M$Y$$$20240708$$CN$HN$HN
240622641$24062264$1$I$$20240704$20240708$20240708$EXP$$NVSC2024PL140138$NOVARTIS$$$$$F$Y$$$20240708$$MD$PL$PL
240622651$24062265$1$I$$20240703$20240708$20240708$EXP$$US-INCYTE CORPORATION-2024IN007048$INCYTE$$$$$$Y$$$20240708$$CN$US$US
240622661$24062266$1$I$$20240629$20240708$20240708$EXP$GB-MHRA-MED-202406291148076400-HYSNB$GB-TEVA-VS-3215918$TEVA$$$$$M$Y$78$KG$20240708$$CN$GB$GB
240622673$24062267$3$F$$20240723$20240708$20240726$EXP$$US-INCYTE CORPORATION-2024IN007046$INCYTE$$$$$$Y$$$20240726$$HP$US$US
240622681$24062268$1$I$$20240629$20240708$20240708$EXP$GB-MHRA-MED-202406291149288680-KLQWZ$GB-TEVA-VS-3216041$TEVA$$$$$M$Y$78$KG$20240708$$CN$GB$GB
240622692$24062269$2$F$20240531$20240731$20240708$20240810$EXP$$DE-TEVA-VS-3216309$TEVA$$52$YR$$F$Y$$$20240810$$CN$DE$DE
240622701$24062270$1$I$$20240629$20240708$20240708$EXP$GB-MHRA-MED-202406290956091950-BTVGZ$GB-TEVA-VS-3216158$TEVA$$$$$M$Y$$$20240708$$CN$GB$GB
240622711$24062271$1$I$$20240701$20240708$20240708$PER$$US-KREUSSLER-2024-US-000026$CHEMISCHE FABRIK KREUSSLER$$$$$UNK$Y$$$20240708$$MD$US$US
240622721$24062272$1$I$20190301$20240624$20240708$20240708$EXP$$US-FOUNDATIONCONSUMERHC-2024-US-035005$FOUNDATION CONSUMER HEALTHCARE$$18$YR$$F$Y$72.58$KG$20240708$$CN$US$US
240622732$24062273$2$F$$20240815$20240708$20240820$EXP$$US-INCYTE CORPORATION-2024IN007009$INCYTE$$$$$$Y$$$20240820$$CN$US$US
240622741$24062274$1$I$20240601$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3216706$TEVA$$24$YR$$F$Y$$$20240708$$CN$CA$CA
240622751$24062275$1$I$20240604$20240704$20240708$20240708$EXP$$TR-DSJP-DSE-2024-130849$DAIICHI$$$$A$F$Y$$$20240708$$MD$TR$TR
240622762$24062276$2$F$$20240827$20240708$20240828$PER$$NVSC2024US140950$NOVARTIS$$$$$M$Y$$$20240828$$MD$US$US
240622771$24062277$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47201$$FDA-CTU$$83$YR$$F$N$$$20240708$N$PH$US$
240622781$24062278$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47244$$FDA-CTU$$62$YR$$M$N$$$20240708$N$$US$
240622791$24062279$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215090$TEVA$$$$$M$Y$$$20240708$$CN$CA$CA
240622801$24062280$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214917$TEVA$$60$YR$$F$Y$$$20240708$$HP$CA$CA
240622811$24062281$1$I$$20240703$20240708$20240708$PER$$US-ABBVIE-5830758$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240622832$24062283$2$F$$20240702$20240708$20240718$30DAY$$US-JNJFOC-20240711320$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$US$US
240622841$24062284$1$I$20240705$20240705$20240708$20240708$PER$$US-JNJFOC-20240716795$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240708$$HP$US$US
240622851$24062285$1$I$$20240705$20240708$20240708$EXP$$US-WOODWARD-2024-US-036143$WOODWARD PHARMA SERVICES$Elkhapery A, Vallabhajosyula S, Niu C, Taifour H, O^Connor K..An Unintentional Second Chance: Co-poisoning With Insulin Glargine and Carvidolol..American Journal of Respiratory and Critical Care Medicine.2024;(209):A5660.$54$YR$$M$Y$$$20240708$$HP$US$US
240622861$24062286$1$I$20160101$20240628$20240708$20240708$EXP$$RO-AstraZeneca-2024A148409$ASTRAZENECA$Aursulesei V, Moloce A, Petris AO, Costache I, Papa GT... SUPINE HYPERTENSION AND ORTHOSTATIC HYPOTENSION ? A MANAGEMENT CHALLENGE... The Medical Surgical Journal / Magazine medical and surgical. 2018;122(3):489-94.$80$YR$$M$Y$$$20240708$$MD$RO$
240622871$24062287$1$I$20240520$20240529$20240708$20240708$DIR$FDA-CDER-CTU-2024-47212$$FDA-CTU$$58$YR$$F$N$123.83$KG$20240529$N$HP$US$
240622881$24062288$1$I$20240501$20240705$20240708$20240708$DIR$FDA-CDER-CTU-2024-47118$$FDA-CTU$$77$YR$$M$N$$$20240705$N$HP$US$
240622891$24062289$1$I$20240619$20240624$20240708$20240708$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00330$XERIS PHARMACEUTICALS$$72$YR$$M$Y$$$20240703$$CN$US$US
240622901$24062290$1$I$$20240628$20240708$20240708$PER$$US-ALKERMES INC.-ALK-2024-001798$ALKERMES$$$$$M$Y$$$20240708$$HP$US$US
240622921$24062292$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215124$TEVA$$69$YR$$M$Y$$$20240708$$CN$CA$CA
240622931$24062293$1$I$20240501$20240625$20240708$20240708$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI06532$NEUROCRINE BIOSCIENCES$$5$DEC$$M$Y$$$20240708$$MD$JP$JP
240622941$24062294$1$I$$20240628$20240708$20240708$EXP$$IN-ROCHE-10000014730$ROCHE$$$$$M$Y$$$20240708$$CN$IN$IN
240622962$24062296$2$F$$20240716$20240708$20240726$EXP$$US-TEVA-VS-3217780$TEVA$Schaeffer AM, Fanous C, Yasir M, Shankar S, Hildebrandt G. Refractory Covid-19-induced ITP Complicated by Secondary Hemophagocytic Lymphohistiocytosis. Am-J-Respir-Crit-Care-Med 2024; 209 A3527.; Schaeffer AM, Fanous C, Yasir M, Shankar S, Hildebrandt G. Refractory Covid-19-induced ITP Complicated by Secondary Hemophagocytic Lymphohistiocytosis. Am-J-Respir-Crit-Care-Med 2024; 209 A3527.$71$YR$$F$Y$$$20240726$$HP$US$US
240622971$24062297$1$I$$20240703$20240708$20240708$EXP$$US-VISTAPHARM-2024-US-036911$VISTAPHARM$Yousaf Z, Jyothi Ramachandran Nair D, Kamel A.Nystatin induced laryngeal edema - first reported case..American Journal of Respiratory and Critical Care Medicine.2024;209A1360.$64$YR$$F$Y$$$20240708$$HP$US$US
240623011$24062301$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214835$TEVA$$7$YR$$M$Y$25$KG$20240708$$HP$CA$CA
240623021$24062302$1$I$20240625$20240703$20240708$20240708$EXP$$GB-MYLANLABS-2024M1061215$MYLAN$$$$$M$Y$$$20240708$$CN$GB$GB
240623031$24062303$1$I$20240617$20240703$20240708$20240708$EXP$FR-AFSSAPS-LL2024001179$FR-MYLANLABS-2024M1062269$MYLAN$$42$YR$$F$Y$105$KG$20240708$$PH$FR$FR
240623051$24062305$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3218174$TEVA$$15$YR$$F$Y$54$KG$20240708$$HP$CA$CA
240623061$24062306$1$I$20240628$20240703$20240708$20240708$EXP$GB-MHRA-MED-202407030306076070-MLWDZ$GB-MYLANLABS-2024M1062239$MYLAN$$31$YR$$F$Y$$$20240708$$CN$GB$GB
240623071$24062307$1$I$20240630$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47227$$FDA-CTU$$31$YR$$M$N$$$20240708$N$HP$US$
240623081$24062308$1$I$20240524$20240703$20240708$20240708$EXP$FR-AFSSAPS-BS2024000396$FR-MYLANLABS-2024M1062352$MYLAN$$88$YR$$F$Y$58$KG$20240708$$MD$FR$FR
240623092$24062309$2$F$20240101$20240725$20240708$20240730$EXP$FR-AFSSAPS-AN2024000833$FR-MYLANLABS-2024M1062319$MYLAN$$54$YR$$M$Y$80$KG$20240730$$PH$FR$FR
240623101$24062310$1$I$20240629$20240701$20240708$20240708$EXP$$US-LUNDBECK-DKLU4001246$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240623112$24062311$2$F$20240101$20240717$20240708$20240726$PER$$US-SA-2024SA196242$SANOFI AVENTIS$$28$YR$A$M$Y$72.5$KG$20240726$$MD$US$US
240623121$24062312$1$I$$20240704$20240708$20240708$EXP$$NVSC2024TR139906$NOVARTIS$$36$YR$$F$Y$$$20240708$$CN$TR$TR
240623131$24062313$1$I$20211225$20240603$20240708$20240708$EXP$$AU-Eisai-EC-2024-169609$EISAI$$$$$M$Y$$$20240708$$HP$AU$AU
240623141$24062314$1$I$$20240703$20240708$20240708$EXP$$US-GILEAD-2024-0679748$GILEAD$$$$A$F$Y$$$20240708$$MD$US$US
240623151$24062315$1$I$$20240628$20240708$20240708$PER$$US-ALKERMES INC.-ALK-2024-001800$ALKERMES$$$$$F$Y$$$20240708$$CN$US$US
240623161$24062316$1$I$$20231204$20240708$20240708$EXP$$US-SANDOZ INC.-SDZ2023US065249$SANDOZ$Jagtiani Amit, Veigne Sandra, Gandhi Raghu, Rizvi Abid. Haloperidol Decanoate-Induced Pancytopenia: ACase Report. Cureus. 2023;15:1-4$85$YR$$F$Y$$$20240708$$MD$US$US
240623171$24062317$1$I$$20240704$20240708$20240708$EXP$$GB-SANDOZ INC.-SDZ2024GB063163$SANDOZ$$$$$F$Y$$$20240708$$HP$GB$GB
240623181$24062318$1$I$20240526$20240704$20240708$20240708$EXP$$CA-SANDOZ INC.-SDZ2024CA063362$SANDOZ$$86$YR$$F$Y$$$20240708$$MD$CA$CA
240623201$24062320$1$I$20210809$20230925$20240708$20240708$EXP$FR-AFSSAPS-PO2023000936$FR-SANDOZ INC.-SDZ2023FR034112$SANDOZ$$80$YR$$M$Y$60$KG$20240708$$MD$FR$FR
240623211$24062321$1$I$20240611$20240705$20240708$20240708$30DAY$$US-SANDOZ INC.-SDZ2024US063379$SANDOZ$$26$YR$$F$Y$$$20240708$$HP$US$US
240623221$24062322$1$I$20200930$20240104$20240708$20240708$EXP$$DE-SANDOZ INC.-SDZ2023DE067258$SANDOZ$$63$YR$$M$Y$$$20240708$$MD$DE$DE
240623232$24062323$2$F$$20240710$20240708$20240714$EXP$$CA-SANDOZ INC.-NVSC2022CA167975$SANDOZ$$$$$M$Y$159$KG$20240714$$CN$CA$CA
240623241$24062324$1$I$$20231019$20240708$20240708$EXP$NL-LRB-00913854$NL-SANDOZ INC.-SDZ2023NL045259$SANDOZ$$32$YR$$F$Y$86$KG$20240708$$CN$NL$NL
240623251$24062325$1$I$$20240124$20240708$20240708$EXP$$CA-SANDOZ INC.-SDZ2024CA007798$SANDOZ$$$$$$Y$$$20240708$$CN$CA$CA
240623261$24062326$1$I$20230123$20230809$20240708$20240708$EXP$FR-AFSSAPS-CN2023000657$FR-SANDOZ INC.-SDZ2023FR013505$SANDOZ$$68$YR$$M$Y$$$20240708$$MD$FR$FR
240623281$24062328$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47238$$FDA-CTU$$60$YR$$M$N$$$20240708$N$$US$
240623291$24062329$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47232$$FDA-CTU$$54$YR$$F$N$$$20240708$N$$US$
240623301$24062330$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47179$$FDA-CTU$$45$YR$$F$N$$$20240708$N$$US$
240623311$24062331$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47085$$FDA-CTU$$77$YR$$F$N$96.16$KG$20240708$N$$US$
240623333$24062333$3$F$$20240923$20240708$20240926$30DAY$$GB-PFIZER INC-202400206720$PFIZER$$15$YR$$F$Y$$$20240926$$CN$GB$GB
240623341$24062334$1$I$$20240610$20240708$20240708$PER$$US-LUNDBECK-DKLU4000336$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240623351$24062335$1$I$$20240626$20240708$20240708$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202407000292$ELI LILLY AND CO$$$$$F$Y$$$20240708$$MD$IN$IN
240623361$24062336$1$I$20240601$20240626$20240708$20240708$EXP$FR-AFSSAPS-PP2024000670$FR-ELI_LILLY_AND_COMPANY-FR202406018843$ELI LILLY AND CO$$43$YR$A$M$Y$76$KG$20240708$$CN$FR$FR
240623371$24062337$1$I$20240613$20240626$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018499$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240708$$CN$US$US
240623381$24062338$1$I$$20240626$20240708$20240708$EXP$$PL-ELI_LILLY_AND_COMPANY-PL202406019648$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240708$$CN$PL$PL
240623392$24062339$2$F$20240703$20240705$20240708$20240711$PER$$US-AMGEN-USASP2024133981$AMGEN$$60$YR$A$F$Y$$$20240711$$PH$US$US
240623411$24062341$1$I$20240601$20240702$20240708$20240708$EXP$$IL-AMERICAN REGENT INC-2024002541$AMERICAN REGENT$$72$YR$$F$Y$$$20240708$$HP$IL$IL
240623421$24062342$1$I$$20240614$20240708$20240708$PER$$US-LUNDBECK-DKLU4000563$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240623431$24062343$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3214924$TEVA$$69$YR$$F$Y$85$KG$20240708$$MD$CA$CA
240623441$24062344$1$I$20240513$20240703$20240708$20240708$EXP$FR-AFSSAPS-PC2024000498$FR-MYLANLABS-2024M1062656$MYLAN$$49$YR$$F$Y$$$20240708$$PH$FR$FR
240623451$24062345$1$I$20240503$20240703$20240708$20240708$EXP$FR-AFSSAPS-AN2024000803$FR-MYLANLABS-2024M1062369$MYLAN$$66$YR$$F$Y$65$KG$20240708$$PH$FR$FR
240623461$24062346$1$I$$20240703$20240708$20240708$EXP$GB-MHRA-TPP17680614C969841YC1719835277354$GB-MYLANLABS-2024M1062538$MYLAN$$60$YR$$M$Y$92$KG$20240708$$MD$GB$GB
240623472$24062347$2$F$20230703$20240701$20240708$20240712$EXP$$AU-009507513-2407AUS001334$MERCK$$79$YR$$M$Y$$$20240712$$HP$AU$AU
240623481$24062348$1$I$$20240702$20240708$20240708$EXP$$US-BAUSCHBL-2024BNL029690$BAUSCH AND LOMB$$62$YR$$F$Y$62.6$KG$20240708$$CN$US$US
240623491$24062349$1$I$20240329$20240703$20240708$20240708$EXP$$FR-AMERICAN REGENT INC-2024002547$AMERICAN REGENT$$79$YR$$M$Y$65$KG$20240708$$PH$FR$FR
240623501$24062350$1$I$$20240703$20240708$20240708$EXP$GB-MHRA-MED-202407031106237230-CRTDW$GB-MYLANLABS-2024M1062482$MYLAN$$$$$F$Y$$$20240708$$HP$GB$GB
240623511$24062351$1$I$$20240703$20240708$20240708$EXP$GB-MHRA-DEFECT-202406221311545970-BHSNJ$GB-MYLANLABS-2024M1062686$MYLAN$$$$$$Y$$$20240708$$CN$GB$GB
240623522$24062352$2$F$20240607$20240712$20240708$20240719$PER$$GB-Eisai-EC-2024-169606$EISAI$$$$$M$Y$$$20240719$$CN$GB$GB
240623531$24062353$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47237$$FDA-CTU$$84$YR$$M$N$$$20240708$N$$US$
240623541$24062354$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133187$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240623551$24062355$1$I$$20240703$20240708$20240708$EXP$$GB-MYLANLABS-2024M1062463$MYLAN$$79$YR$$$Y$$$20240708$$PH$GB$GB
240623561$24062356$1$I$$20240703$20240708$20240708$EXP$$BE-MYLANLABS-2024M1062689$MYLAN$$32$YR$$M$Y$$$20240708$$MD$BE$BE
240623571$24062357$1$I$$20240707$20240708$20240708$DIR$FDA-CDER-CTU-2024-47247$$FDA-CTU$$$$$F$N$$$20240707$N$HP$US$
240623581$24062358$1$I$$20240706$20240708$20240708$DIR$FDA-CDER-CTU-2024-47115$$FDA-CTU$$$$$M$N$$$20240706$N$HP$US$
240623591$24062359$1$I$$20240612$20240708$20240708$PER$$US-LUNDBECK-DKLU4000466$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240623601$24062360$1$I$$20240702$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009586$DR REDDYS$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocritical Care. 2024;40: 976-983. doi:https://dx.doi.org/10.1007/s12028-023-01853-8.$72$YR$E$F$Y$86$KG$20240708$$HP$US$US
240623611$24062361$1$I$$20240702$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009587$DR REDDYS$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocritical Care. 2024;40: 976-983. doi:https://dx.doi.org/10.1007/s12028-023-01853-8.$67$YR$E$M$Y$70$KG$20240708$$HP$US$US
240623621$24062362$1$I$$20240702$20240708$20240708$EXP$$US-RDY-LIT/USA/24/0009588$DR REDDYS$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocritical Care. 2024;40: 976-983. doi:https://dx.doi.org/10.1007/s12028-023-01853-8.$59$YR$A$F$Y$85$KG$20240708$$HP$US$US
240623631$24062363$1$I$20230101$20240703$20240708$20240708$EXP$$NL-MYLANLABS-2024M1063032$MYLAN$van der HeideDH, Bogers JPAM, Schulte PRFJ. Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma. Schizophr-Res 2024; 267 72-74.$54$YR$$M$Y$$$20240708$$HP$NL$NL
240623641$24062364$1$I$$20240703$20240708$20240708$EXP$$IN-MYLANLABS-2024M1062899$MYLAN$Chandrakar Y. Unforeseen Complication Of Tramadol Administration: A Case Report. Asian-J-Pharmaceut-Clin-Res 2024; 17 (6): 1-2.$22$YR$$M$Y$$$20240708$$HP$IN$IN
240623651$24062365$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5829923$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240623661$24062366$1$I$$20240702$20240708$20240708$EXP$$JP-DSJP-DSJ-2024-126459$DAIICHI$$9$DEC$$M$Y$$$20240708$$PH$JP$JP
240623672$24062367$2$F$$20240711$20240708$20240716$EXP$$JP-DSJP-DSJ-2024-130606$DAIICHI$Ishige H. Case: A case of intussusception caused by small intestinal muco-submucosal elongated polyp. Journal of Japan Surgical Association. 2024;85:744-748$89$YR$$F$Y$$$20240716$$MD$JP$JP
240623683$24062368$3$F$$20240723$20240708$20240729$EXP$$US-APELLIS-2024-APL-0000397$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
240623691$24062369$1$I$$20240628$20240708$20240708$EXP$$GB-ANIPHARMA-2024-UK-000129$ANI$$$$$UNK$Y$$$20240708$$CN$GB$GB
240623703$24062370$3$F$20240101$20240829$20240708$20240904$EXP$$HN-MYLANLABS-2024M1062832$MYLAN$$$$$F$Y$76.2$KG$20240904$$CN$HN$HN
240623711$24062371$1$I$$20240702$20240708$20240708$EXP$$MY-MYLANLABS-2024M1063100$MYLAN$Liew KC, O^Keeffe J, Rajandas H, Lee YP, Harris O, Parimannan S, et al. Insights into the Evolution of P. aeruginosa Antimicrobial Resistance in a Patient Undergoing Intensive Therapy. Antibiotics-(Basel) 2023; 12 (3): 1-6.$51$YR$$M$Y$$$20240708$$HP$MY$MY
240623723$24062372$3$F$20240606$20240814$20240708$20240820$EXP$$US-MYLANLABS-2024M1063284$MYLAN$$0$YR$$F$Y$3.34$KG$20240820$$CN$US$US
240623731$24062373$1$I$$20240702$20240708$20240708$EXP$$US-MYLANLABS-2024M1062768$MYLAN$$$$$M$Y$$$20240708$$HP$US$US
240623741$24062374$1$I$20170101$20240702$20240708$20240708$EXP$$ES-MYLANLABS-2024M1062619$MYLAN$Tornero C, Bonilla G, G?mez L, Aguado P, L?pez-Mu?oz S.. Biological therapy with  sarilumab in a patient with rheumatoid arthritis  and associated pulmonary impairment. Experiencias kevzara$63$YR$$F$Y$$$20240708$$MD$ES$ES
240623751$24062375$1$I$$20240702$20240708$20240708$EXP$$US-MYLANLABS-2024M1062927$MYLAN$Langford B, D^Souza RS, Pingree M, Mauck WD. Treatment of Ulnar Neuropathic Pain with Peripheral Nerve Stimulation: Two Case Reports. Pain-Med 2023; 24 (5): 566-569.$58$YR$$M$Y$$$20240708$$MD$US$US
240623761$24062376$1$I$$20240702$20240708$20240708$EXP$$US-MYLANLABS-2024M1063103$MYLAN$Gullapalli D, Raza A, Khan A, Ganti SS, Pervaiz A. Battling the breath-stealers: Blastomyces and Pseudomonas triggering acute respiratory distress syndrome (ARDS). Med-Mycol-Case-Reports 2024; 45.$46$YR$$M$Y$$$20240708$$HP$US$US
240623782$24062378$2$F$20230712$20240729$20240708$20240801$EXP$$JP-DSJP-DSJ-2024-130751$DAIICHI$$72$YR$$M$Y$59.8$KG$20240801$$MD$JP$JP
240623791$24062379$1$I$$20240702$20240708$20240708$EXP$$GR-MYLANLABS-2024M1062785$MYLAN$D. Kouvidakias, E. Koutoulaki, G. Frantzeskos, A. Papaioannou, V. Nyktari. THE USE OF DULOXETINE IN A PAEDIATRIC PATIENT WITH PHANTOM LIMB PAIN: CASE PRESENTATION AND LITERATURE REVIEW. 2024$8$YR$$M$Y$$$20240708$$MD$GR$GR
240623801$24062380$1$I$$20240702$20240708$20240708$EXP$$DE-MYLANLABS-2024M1062510$MYLAN$$$$$F$Y$3.41$KG$20240708$$MD$DE$DE
240623811$24062381$1$I$$20240702$20240708$20240708$EXP$$AT-MYLANLABS-2024M1062715$MYLAN$Muller A, Franzoi M, Enokl-Tomantschger U, Pollheimer M, Steidl K, Hatzenbichler P, et al. Case report: a man with a pancreatic adenocarcinoma and negative CA 19-9, but positive CA 125. Z-Gastroenterol 2024; 62 (5): e493.$46$YR$$M$Y$$$20240708$$HP$AT$AT
240623821$24062382$1$I$20230401$20240522$20240708$20240708$PER$$US-LUNDBECK-DKLU3078485$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240623831$24062383$1$I$20100401$20240621$20240708$20240708$EXP$$BR-ASTELLAS-2010001429$ASTELLAS$$62$YR$$M$Y$64$KG$20240708$$CN$GB$BR
240623841$24062384$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215112$TEVA$$50$YR$$F$Y$$$20240708$$HP$CA$CA
240623861$24062386$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3218201$TEVA$$55$YR$$M$Y$$$20240708$$HP$CA$CA
240623881$24062388$1$I$20240702$20240705$20240708$20240708$EXP$$US-GILEAD-2024-0679761$GILEAD$$46$YR$A$F$Y$$$20240708$$HP$US$US
240623891$24062389$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215094$TEVA$$41$YR$$F$Y$133$KG$20240708$$HP$CA$CA
240623901$24062390$1$I$$20240704$20240708$20240708$EXP$FI-FIMEA-202402315$FI-MYLANLABS-2024M1062828$MYLAN$$19$YR$$F$Y$$$20240708$$CN$FI$FI
240623911$24062391$1$I$20240501$20240704$20240708$20240708$EXP$FR-AFSSAPS-GR2024000801$FR-MYLANLABS-2024M1062816$MYLAN$$79$YR$$M$Y$$$20240708$$PH$FR$FR
240623921$24062392$1$I$20240201$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405040555034480-WJKLS$GB-MYLANLABS-2024M1063185$MYLAN$$59$YR$$M$Y$90$KG$20240708$$CN$GB$GB
240623931$24062393$1$I$20240630$20240705$20240708$20240708$EXP$$US-DSJP-DSU-2024-131019$DAIICHI$$57$YR$$M$Y$$$20240708$$PH$US$US
240623941$24062394$1$I$20240101$20240703$20240708$20240708$EXP$$US-ABBVIE-5831091$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240623951$24062395$1$I$20240625$20240630$20240708$20240708$EXP$$CN-GE HEALTHCARE-2024CSU007464$GE HEALTHCARE$$36$YR$$M$Y$60$KG$20240708$$HP$CN$CN
240623961$24062396$1$I$20240625$20240627$20240708$20240708$EXP$$CN-GE HEALTHCARE-2024CSU007357$GE HEALTHCARE$$76$YR$$M$Y$60$KG$20240708$$HP$CN$CN
240623971$24062397$1$I$20240617$20240627$20240708$20240708$EXP$$CN-GE HEALTHCARE-2024CSU007365$GE HEALTHCARE$$65$YR$$M$Y$65$KG$20240708$$HP$CN$CN
240623981$24062398$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215105$TEVA$$73$YR$$M$Y$$$20240708$$MD$CA$CA
240623991$24062399$1$I$20240607$20240628$20240708$20240708$EXP$$BR-GE HEALTHCARE-2024CSU007490$GE HEALTHCARE$$62$YR$$F$Y$70$KG$20240708$$HP$BR$BR
240624001$24062400$1$I$20240601$20240628$20240708$20240708$EXP$$CN-GE HEALTHCARE-2024CSU007426$GE HEALTHCARE$$61$YR$$F$Y$65$KG$20240708$$HP$CN$CN
240624011$24062401$1$I$20240627$20240628$20240708$20240708$EXP$$CN-GE HEALTHCARE-2024CSU007415$GE HEALTHCARE$$60$YR$$M$Y$75$KG$20240708$$HP$CN$CN
240624021$24062402$1$I$20240401$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405061455541680-ZSDVW$GB-MYLANLABS-2024M1063365$MYLAN$$25$YR$$M$Y$$$20240708$$MD$GB$GB
240624031$24062403$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405081127236150-GTRHJ$GB-MYLANLABS-2024M1063445$MYLAN$$$$$F$Y$$$20240708$$HP$GB$GB
240624041$24062404$1$I$20240101$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405042231105190-PZMTW$GB-MYLANLABS-2024M1063160$MYLAN$$$$$F$Y$71$KG$20240708$$CN$GB$GB
240624051$24062405$1$I$20240219$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405041418106620-QDMKV$GB-MYLANLABS-2024M1063288$MYLAN$$31$YR$$F$Y$$$20240708$$CN$GB$GB
240624061$24062406$1$I$20240413$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405051200506980-WGNQK$GB-MYLANLABS-2024M1063468$MYLAN$$58$YR$$F$Y$$$20240708$$CN$GB$GB
240624071$24062407$1$I$20240421$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405062010158120-YBLMV$GB-MYLANLABS-2024M1063189$MYLAN$$49$YR$$F$Y$75$KG$20240708$$CN$GB$GB
240624081$24062408$1$I$20240423$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405011152303220-GPJSV$GB-MYLANLABS-2024M1063274$MYLAN$$64$YR$$M$Y$$$20240708$$MD$GB$GB
240624091$24062409$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405060721540350-JFMKW$GB-MYLANLABS-2024M1063280$MYLAN$$$$$M$Y$82$KG$20240708$$CN$GB$GB
240624114$24062411$4$F$$20240916$20240708$20240919$30DAY$$US-PFIZER INC-202400201770$PFIZER$$13$YR$$M$Y$36.281$KG$20240919$$HP$US$US
240624121$24062412$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215062$TEVA$$77$YR$$F$Y$$$20240708$$HP$CA$CA
240624132$24062413$2$F$20240702$20240814$20240708$20240814$30DAY$$CL-PFIZER INC-PV202400087346$PFIZER$$13$YR$$F$Y$$$20240814$$MD$CL$CL
240624143$24062414$3$F$$20240916$20240708$20240918$30DAY$$CL-PFIZER INC-PV202400087342$PFIZER$$4$YR$$F$Y$$$20240918$$CN$CL$CL
240624152$24062415$2$F$20240630$20240814$20240708$20240814$30DAY$$CL-PFIZER INC-PV202400086696$PFIZER$$18$YR$$M$Y$$$20240814$$CN$CL$CL
240624162$24062416$2$F$$20240830$20240708$20240830$30DAY$$CO-PFIZER INC-202400206861$PFIZER$$12$YR$$F$Y$$$20240830$$CN$CO$CO
240624171$24062417$1$I$$20240703$20240708$20240708$PER$$US-VERTEX PHARMACEUTICALS-2024-011123$VERTEX$$$$$$Y$$$20240708$$HP$US$US
240624181$24062418$1$I$20240611$20240628$20240708$20240708$PER$$CN-Eisai-EC-2024-169264$EISAI$$57$YR$A$M$Y$$$20240708$$HP$CN$CN
240624191$24062419$1$I$20240614$20240628$20240708$20240708$PER$$CN-Eisai-EC-2024-169265$EISAI$$46$YR$A$M$Y$51$KG$20240708$$HP$CN$CN
240624201$24062420$1$I$20240627$20240628$20240708$20240708$PER$$JP-Eisai-EC-2024-160895$EISAI$Honda Makie. A case of poorly differentiated thyroid cancer that had not undergone high-dose RAI treatment but was successfully treated with lenvatinib. 66th Japanese Thyroid Society Academic Meeting Program/Abstract Collection. 2023; -(-): O6-4-.$60$YR$A$F$Y$$$20240708$$MD$JP$JP
240624211$24062421$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA196253$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240708$$CN$US$US
240624222$24062422$2$F$$20240906$20240708$20240916$PER$$US-BAUSCHBL-2024BNL029504$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240916$$CN$US$US
240624243$24062424$3$F$20240601$20240927$20240708$20240930$30DAY$$AR-PFIZER INC-202400205042$PFIZER$$9$YR$$F$Y$$$20240930$$CN$AR$AR
240624251$24062425$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202407041350123850-LJDQC$GB-MYLANLABS-2024M1063010$MYLAN$$$$$F$Y$66$KG$20240708$$CN$GB$GB
240624261$24062426$1$I$$20240628$20240708$20240708$EXP$$CA-TEVA-VS-3215072$TEVA$$34$YR$$F$Y$$$20240708$$HP$CA$CA
240624271$24062427$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202407041332334290-KQCNF$GB-MYLANLABS-2024M1062985$MYLAN$$$$$M$Y$$$20240708$$CN$GB$GB
240624281$24062428$1$I$$20240628$20240708$20240708$EXP$$US-ASTELLAS-2024US018738$ASTELLAS$$$$$$Y$$$20240708$$CN$US$US
240624291$24062429$1$I$20240428$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405011435245730-HPSGD$GB-MYLANLABS-2024M1063015$MYLAN$$78$YR$$$Y$$$20240708$$PH$GB$GB
240624301$24062430$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405011630278270-FQSZT$GB-MYLANLABS-2024M1062983$MYLAN$$$$$F$Y$$$20240708$$HP$GB$GB
240624312$24062431$2$F$$20240716$20240708$20240718$EXP$GB-MHRA-MED-202405101401069270-STKMW$GB-MYLANLABS-2024M1063146$MYLAN$$$$$F$Y$$$20240718$$MD$GB$GB
240624321$24062432$1$I$20240101$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405042231105190-PZMTW$GB-SANDOZ INC.-SDZ2024GB063291$SANDOZ$$$$$F$Y$71$KG$20240708$$CN$GB$GB
240624331$24062433$1$I$20231101$20240702$20240708$20240708$EXP$$EG-SANDOZ INC.-SDZ2023EG067337$SANDOZ$$10$YR$$F$Y$35$KG$20240708$$CN$EG$EG
240624341$24062434$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405072127436610-YVGCZ$GB-SANDOZ INC.-SDZ2024GB063339$SANDOZ$$$$$F$Y$$$20240708$$CN$GB$GB
240624351$24062435$1$I$20230710$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405031246208040-FRJDH$GB-SANDOZ INC.-SDZ2024GB063218$SANDOZ$$67$YR$$M$Y$83$KG$20240708$$CN$GB$GB
240624361$24062436$1$I$20220605$20240706$20240708$20240708$30DAY$$EG-SANDOZ INC.-SDZ2023EG072677$SANDOZ$$10$YR$$F$Y$$$20240708$$CN$EG$EG
240624371$24062437$1$I$$20240704$20240708$20240708$30DAY$$US-SANDOZ INC.-SDZ2023US016547$SANDOZ$$$$$F$Y$$$20240708$$CN$US$US
240624381$24062438$1$I$$20240704$20240708$20240708$30DAY$$US-SANDOZ INC.-SDZ2024US032185$SANDOZ$$$$$M$Y$$$20240708$$CN$US$US
240624391$24062439$1$I$$20231128$20240708$20240708$EXP$$US-SANDOZ INC.-SDZ2023US061895$SANDOZ$$$$$M$Y$$$20240708$$MD$US$US
240624401$24062440$1$I$20240601$20240705$20240708$20240708$EXP$RU-RZN- 2444572$RU-SANDOZ INC.-SDZ2024RU063062$SANDOZ$$$$$F$Y$45.3$KG$20240708$$MD$RU$RU
240624411$24062441$1$I$$20240229$20240708$20240708$EXP$$GB-SANDOZ INC.-SDZ2024GB024081$SANDOZ$$$$$F$Y$$$20240708$$CN$GB$GB
240624421$24062442$1$I$20230601$20230927$20240708$20240708$EXP$ES-AEMPS-1422164$ES-SANDOZ INC.-SDZ2023ES031682$SANDOZ$$$$A$M$Y$$$20240708$$HP$ES$ES
240624431$24062443$1$I$$20240702$20240708$20240708$EXP$$US-SANDOZ INC.-SDZ2024US062996$SANDOZ$$$$$F$Y$$$20240708$$CN$US$US
240624441$24062444$1$I$$20230821$20240708$20240708$EXP$$CA-SANDOZ INC.-SDZ2023CA018768$SANDOZ$$74$YR$$F$Y$65$KG$20240708$$MD$CA$CA
240624451$24062445$1$I$$20230801$20240708$20240708$EXP$$BR-SANDOZ INC.-SDZ2023BR012268$SANDOZ$$$$$F$Y$$$20240708$$HP$BR$BR
240624462$24062446$2$F$$20240711$20240708$20240715$EXP$$US-SANDOZ INC.-SDZ2024US063357$SANDOZ$$$$$$Y$$$20240715$$HP$US$US
240624472$24062447$2$F$20240226$20240705$20240708$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA021927$SANDOZ$$36$YR$$F$Y$$$20240710$$MD$CA$CA
240624481$24062448$1$I$$20230821$20240708$20240708$EXP$$US-SANDOZ INC.-NVSC2023US139929$SANDOZ$$$$$F$Y$63.5$KG$20240708$$MD$US$US
240624492$24062449$2$F$$20240812$20240708$20240813$EXP$GB-MHRA-MED-202405051644346530-QGMWK$GB-SANDOZ INC.-SDZ2024GB063242$SANDOZ$$$$$M$Y$89$KG$20240813$$CN$GB$GB
240624501$24062450$1$I$20230712$20230821$20240708$20240708$EXP$FR-AFSSAPS-DJ2023000992$FR-SANDOZ INC.-SDZ2023FR017244$SANDOZ$$37$YR$$F$Y$59$KG$20240708$$MD$FR$FR
240624511$24062451$1$I$20180501$20240701$20240708$20240708$EXP$$FR-SANDOZ INC.-PHHY2018FR068269$SANDOZ$$49$YR$$F$Y$$$20240708$$MD$FR$FR
240624521$24062452$1$I$$20240213$20240708$20240708$EXP$$IT-SANDOZ INC.-SDZ2024IT014445$SANDOZ$$$$T$F$Y$$$20240708$$MD$IT$IT
240624531$24062453$1$I$$20240704$20240708$20240708$EXP$$GB-SANDOZ INC.-NVSC2020GB083338$SANDOZ$$$$$F$Y$$$20240708$$CN$GB$GB
240624541$24062454$1$I$20240401$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405021346199740-TWCQK$GB-SANDOZ INC.-SDZ2024GB063216$SANDOZ$$$$$M$Y$100$KG$20240708$$CN$GB$GB
240624551$24062455$1$I$20230815$20230831$20240708$20240708$EXP$FR-AFSSAPS-NT2023000947$FR-SANDOZ INC.-SDZ2023FR023483$SANDOZ$$33$YR$$F$Y$$$20240708$$PH$FR$FR
240624563$24062456$3$F$20231219$20240916$20240708$20240917$EXP$AT-STADA-01262402$AT-SANDOZ INC.-SDZ2024AT063016$SANDOZ$$60$YR$$F$Y$80$KG$20240917$$HP$AT$AT
240624571$24062457$1$I$$20240222$20240708$20240708$EXP$$US-SANDOZ INC.-SDZ2024US019464$SANDOZ$Dragonetti JD, Posada JG, Key RG, Kugler JL. Catatonia-related adverse outcomes afterlong-acting injectable antipsychotics: Caseseries. SAGE Open Medical Case Reports. 2024;12:1- 7$66$YR$$F$Y$$$20240708$$HP$US$US
240624581$24062458$1$I$$20240704$20240708$20240708$EXP$$IE-MYLANLABS-2024M1062947$MYLAN$$$$$M$Y$$$20240708$$PH$IE$IE
240624591$24062459$1$I$20240401$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405021349419550-JDVKB$GB-MYLANLABS-2024M1062980$MYLAN$$7$YR$$F$Y$$$20240708$$MD$GB$GB
240624601$24062460$1$I$20100101$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405011158072330-YRBMF$GB-MYLANLABS-2024M1062926$MYLAN$$$$$$Y$$$20240708$$CN$GB$GB
240624611$24062461$1$I$20240703$20240704$20240708$20240708$EXP$GB-MHRA-MED-202407041235375950-QYHNL$GB-MYLANLABS-2024M1062932$MYLAN$$$$$M$Y$$$20240708$$PH$GB$GB
240624621$24062462$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405020930463390-BMKSH$GB-MYLANLABS-2024M1062982$MYLAN$$$$$$Y$$$20240708$$PH$GB$GB
240624631$24062463$1$I$20240602$20240705$20240708$20240708$EXP$ES-AEMPS-1543148$NVSC2024ES139859$NOVARTIS$$14$YR$$F$Y$$$20240708$$HP$ES$ES
240624641$24062464$1$I$20230609$20240701$20240708$20240708$EXP$$NVSC2024KR138223$NOVARTIS$$53$YR$$F$Y$49.71$KG$20240708$$CN$KR$KR
240624653$24062465$3$F$$20240710$20240708$20240725$EXP$$CA-HLS-202401678$HLS THERAPEUTICS$$$$A$M$Y$$$20240725$$MD$CA$CA
240624661$24062466$1$I$$20240704$20240708$20240708$PER$$US-ABBVIE-5829897$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240624671$24062467$1$I$20231220$20240702$20240708$20240708$EXP$FR-AFSSAPS-AVMA2024000261$FR-MYLANLABS-2024M1062364$MYLAN$$55$YR$$M$Y$$$20240708$$PH$FR$FR
240624681$24062468$1$I$$20240702$20240708$20240708$EXP$$US-MYLANLABS-2024M1062946$MYLAN$Radaelli M, Husain M, Makepeace J, Hadadi C, Kenigsberg BB. Chylothorax: A Rare Complication After Single Chamber Implantable Cardioverter Defibrillator Extraction. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$63$YR$$M$Y$$$20240708$$HP$US$US
240624691$24062469$1$I$$20240702$20240708$20240708$EXP$$PT-MYLANLABS-2024M1062390$MYLAN$$$$A$$Y$$$20240708$$MD$PT$PT
240624701$24062470$1$I$20240520$20240702$20240708$20240708$EXP$FR-AFSSAPS-AVGR2024000123$FR-MYLANLABS-2024M1062259$MYLAN$$15$YR$$F$Y$$$20240708$$CN$FR$FR
240624711$24062471$1$I$20231224$20240702$20240708$20240708$EXP$FR-AFSSAPS-AVMA2024000263$FR-MYLANLABS-2024M1062252$MYLAN$$51$YR$$F$Y$$$20240708$$PH$FR$FR
240624723$24062472$3$F$20240101$20240909$20240708$20240918$PER$$US-BAUSCHBL-2024BNL029441$BAUSCH AND LOMB$$$$$M$Y$$$20240918$$CN$US$US
240624732$24062473$2$F$$20240725$20240708$20240729$EXP$$US-MYLANLABS-2024M1062445$MYLAN$$$$$F$Y$$$20240729$$PH$US$US
240624741$24062474$1$I$20240501$20240702$20240708$20240708$EXP$$DE-MYLANLABS-2024M1062415$MYLAN$$64$YR$$F$Y$$$20240708$$PH$DE$DE
240624751$24062475$1$I$20240616$20240702$20240708$20240708$EXP$$DE-MYLANLABS-2024M1062371$MYLAN$$20$YR$$F$Y$60$KG$20240708$$PH$DE$DE
240624761$24062476$1$I$$20240702$20240708$20240708$PER$$US-RDY-LIT/USA/24/0009585$DR REDDYS$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocritical Care. 2024;40(1): 262-271. doi:10.1007/s12028-023-01749-7.$$$$$Y$$$20240708$$HP$US$US
240624771$24062477$1$I$20240401$20240702$20240708$20240708$EXP$$DE-MYLANLABS-2024M1062378$MYLAN$$29$YR$$F$Y$58$KG$20240708$$MD$DE$DE
240624781$24062478$1$I$20230309$20230809$20240708$20240708$EXP$FR-AFSSAPS-CN2023000663$FR-SANDOZ INC.-SDZ2023FR013129$SANDOZ$$67$YR$$M$Y$71$KG$20240708$$MD$FR$FR
240624793$24062479$3$F$$20240725$20240708$20240731$EXP$$US-MYLANLABS-2024M1062460$MYLAN$$$$$F$Y$$$20240731$$CN$US$US
240624801$24062480$1$I$$20221003$20240708$20240708$EXP$$CA-SANDOZ INC.-NVSC2022CA223699$SANDOZ$$65$YR$$M$Y$63$KG$20240708$$HP$CA$CA
240624821$24062482$1$I$$20240628$20240708$20240708$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-039111$JAZZ$$$$$F$Y$$$20240708$$CN$US$US
240624832$24062483$2$F$20240723$20240724$20240708$20240805$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407003917$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240805$$CN$DE$BR
240624841$24062484$1$I$20240628$20240629$20240708$20240708$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202405005582$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240708$$CN$DE$CO
240624852$24062485$2$F$20240624$20240801$20240708$20240813$EXP$$AR-ELI_LILLY_AND_COMPANY-AR202406004051$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240813$$CN$DE$AR
240624861$24062486$1$I$20240702$20240702$20240708$20240708$PER$$US-ALXN-202407USA000139US$ALEXION PHARMACEUTICALS$$14$YR$$F$Y$$$20240708$$CN$US$US
240624872$24062487$2$F$$20240806$20240708$20240807$PER$$US-ALXN-202407USA000080US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240624881$24062488$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202407041215189050-SRPKJ$GB-MYLANLABS-2024M1062924$MYLAN$$$$$M$Y$$$20240708$$CN$GB$GB
240624891$24062489$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202407041136045490-HKLQD$GB-MYLANLABS-2024M1062788$MYLAN$$$$$M$Y$70$KG$20240708$$CN$GB$GB
240624901$24062490$1$I$20240704$20240704$20240708$20240708$EXP$GB-MHRA-MED-202407040842268510-NPTFG$GB-MYLANLABS-2024M1062747$MYLAN$$54$YR$$M$Y$73$KG$20240708$$CN$GB$GB
240624911$24062491$1$I$$20240701$20240708$20240708$PER$$US-MYLANLABS-2024M1062108$MYLAN$$$$$F$Y$$$20240708$$CN$US$US
240624921$24062492$1$I$$20240628$20240708$20240708$PER$$US-MYLANLABS-2024M1061997$MYLAN$$$$$M$Y$$$20240708$$CN$US$US
240624931$24062493$1$I$$20240627$20240708$20240708$PER$$US-MYLANLABS-2024M1058325$MYLAN$$81$YR$$$Y$$$20240708$$CN$US$US
240624941$24062494$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405011700175730-BMCHD$GB-MYLANLABS-2024M1062918$MYLAN$$6$YR$$F$Y$$$20240708$$CN$GB$GB
240624951$24062495$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405021803196890-NFPBC$GB-MYLANLABS-2024M1062904$MYLAN$$$$$$Y$44$KG$20240708$$CN$GB$GB
240624962$24062496$2$F$$20240708$20240708$20240716$PER$$US-MYLANLABS-2024M1058488$MYLAN$$$$$M$Y$78.02$KG$20240716$$CN$US$US
240624971$24062497$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202404301829409070-KFDHQ$GB-MYLANLABS-2024M1062917$MYLAN$$$$$F$Y$$$20240708$$CN$GB$GB
240624981$24062498$1$I$$20240628$20240708$20240708$PER$$US-MYLANLABS-2024M1062058$MYLAN$$$$$M$Y$$$20240708$$CN$US$US
240624991$24062499$1$I$$20240704$20240708$20240708$EXP$GB-MHRA-MED-202405021617124220-NDSPQ$GB-MYLANLABS-2024M1062901$MYLAN$$$$$$Y$$$20240708$$PH$GB$GB
240625002$24062500$2$F$20240219$20240704$20240708$20240716$EXP$FR-AFSSAPS-CN2024000584$FR-MYLANLABS-2024M1062819$MYLAN$$21$YR$$F$Y$$$20240716$$PH$FR$FR
240625011$24062501$1$I$20240621$20240628$20240708$20240708$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700008$RIGEL PHARMACEUTICALS$$83$YR$$M$Y$96.162$KG$20240708$$CN$US$US
240625022$24062502$2$F$$20240704$20240708$20240710$EXP$$DE-AstraZeneca-2024A154247$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$DE$
240625031$24062503$1$I$$20240628$20240708$20240708$EXP$$JP-Eisai-EC-2024-169166$EISAI$$$$$F$Y$$$20240708$$MD$JP$JP
240625042$24062504$2$F$20240627$20240715$20240708$20240719$EXP$$IT-Eisai-EC-2024-169187$EISAI$$20$YR$A$F$Y$43$KG$20240719$$MD$IT$IT
240625051$24062505$1$I$$20240702$20240708$20240708$EXP$GB-MHRA-MED-202406291157398850-KGTCR$GB-RDY-SPO/GBR/24/0009750$DR REDDYS$$30$YR$A$M$Y$$$20240708$$CN$GB$GB
240625062$24062506$2$F$$20240806$20240708$20240809$EXP$$US-KYOWAKIRIN-2024KK016348$KYOWA$$$$$$Y$$$20240809$$HP$US$US
240625071$24062507$1$I$20210901$20240703$20240708$20240708$EXP$FR-AFSSAPS-AVBX20220046$FR-INDIVIOR UK LIMITED-INDV-132943-2022$RECKITT BENCKISER$$$$$$Y$$$20240708$$HP$FR$FR
240625082$24062508$2$F$$20240725$20240708$20240726$EXP$$JP-CARA THERAPEUTICS, INC.-2024-00322-JP$CARA THERAPEUTICS$$91$YR$$M$Y$$$20240726$$MD$JP$JP
240625091$24062509$1$I$$20240705$20240708$20240708$PER$$US-JNJFOC-20240715402$JOHNSON AND JOHNSON$$$$$F$Y$$$20240708$$CN$US$US
240625101$24062510$1$I$$20240628$20240708$20240708$PER$$US-JNJFOC-20240718196$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$HP$US$US
240625111$24062511$1$I$$20240703$20240708$20240708$EXP$$KR-009507513-2407KOR002198$MERCK$$$$$M$Y$$$20240708$$HP$KR$KR
240625131$24062513$1$I$20230908$20240206$20240708$20240708$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00032$Unknown Manufacturer$$57$YR$$F$Y$$$20240708$$CN$US$US
240625141$24062514$1$I$20190101$20240408$20240708$20240708$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00134$Unknown Manufacturer$$$$$F$Y$$$20240708$$CN$US$US
240625153$24062515$3$F$$20240716$20240708$20240724$EXP$$JP-009507513-2407JPN000195J$MERCK$Otsuka S, Fujino K, Ijichi K, Kawata M, Hiranuma K, Ishii S, et al.. O-20 A Case of neuroendocrine carcinoma of the uterine body with rapid progression of visual field defect after the use of anti-PD-1 antibody agents. Kanto Journal of Obstetrics and Gynecology, the 147th Meeting of the Kanto Socie. 2024;61(2):183$40$YR$$F$Y$$$20240724$$MD$JP$JP
240625161$24062516$1$I$20240628$20240628$20240708$20240708$PER$$US-JNJFOC-20240718282$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240708$$HP$US$US
240625171$24062517$1$I$$20240708$20240708$20240708$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038456$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240708$$CN$US$US
240625181$24062518$1$I$$20240702$20240708$20240708$EXP$$US-ALXN-202407USA000143US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
240625193$24062519$3$F$20230725$20240812$20240708$20240812$PER$$US-ALXN-202407USA000082US$ALEXION PHARMACEUTICALS$$31$YR$$F$Y$54.422$KG$20240812$$CN$US$US
240625212$24062521$2$F$$20240708$20240708$20240709$EXP$$US-SANDOZ INC.-SDZ2024US063394$SANDOZ$$$$$F$Y$$$20240709$$CN$US$US
240625221$24062522$1$I$$20240704$20240708$20240708$30DAY$$US-SANDOZ INC.-SDZ2023US006667$SANDOZ$$$$$M$Y$$$20240708$$CN$US$US
240625231$24062523$1$I$$20240705$20240708$20240708$EXP$$AU-SANDOZ INC.-SDZ2024AU063303$SANDOZ$$$$$F$Y$$$20240708$$MD$AU$AU
240625245$24062524$5$F$20240701$20240821$20240708$20240826$EXP$$US-SANDOZ INC.-SDZ2024US063167$SANDOZ$$63$YR$$M$Y$89$KG$20240826$$HP$US$US
240625251$24062525$1$I$20240628$20240701$20240708$20240708$PER$$SG-Eisai-EC-2024-169617$EISAI$$67$YR$E$F$Y$$$20240708$$MD$SG$SG
240625261$24062526$1$I$$20240701$20240708$20240708$30DAY$$US-GSK-US2024083024$GLAXOSMITHKLINE$$$$$F$Y$$$20240708$$CN$US$US
240625271$24062527$1$I$$20240701$20240708$20240708$EXP$$JP-009507513-2407JPN000068J$MERCK$$7$DEC$$F$Y$$$20240708$$MD$JP$JP
240625283$24062528$3$F$20240715$20240716$20240708$20240729$EXP$$US-APELLIS-2024-APL-0000396$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
240625292$24062529$2$F$20240703$20240806$20240708$20240809$PER$$US-PFIZER INC-202400206572$PFIZER$$29$YR$$F$Y$82$KG$20240809$$HP$US$US
240625301$24062530$1$I$20240502$20240705$20240708$20240708$EXP$GB-MHRA-MED-202405040802234880-HJLVR$GB-009507513-2407GBR002634$MERCK$$25$YR$$M$Y$105$KG$20240708$$MD$GB$GB
240625313$24062531$3$F$$20240806$20240708$20240809$PER$$US-PFIZER INC-PV202400088960$PFIZER$$75$YR$$F$Y$$$20240809$$HP$US$US
240625332$24062533$2$F$$20240725$20240708$20240726$EXP$$JP-CARA THERAPEUTICS, INC.-2024-00323-JP$CARA THERAPEUTICS$$73$YR$$M$Y$$$20240726$$MD$JP$JP
240625341$24062534$1$I$$20240516$20240708$20240708$PER$$US-LUNDBECK-DKLU3078240$LUNDBECK$$$$$$Y$$$20240708$$HP$US$US
240625351$24062535$1$I$20240619$20240628$20240708$20240708$PER$$CN-Eisai-EC-2024-169261$EISAI$$65$YR$E$F$Y$50$KG$20240708$$HP$CN$CN
240625361$24062536$1$I$20240502$20240629$20240708$20240708$PER$$CN-Eisai-EC-2024-169269$EISAI$$70$YR$E$M$Y$48$KG$20240708$$HP$CN$CN
240625372$24062537$2$F$$20240704$20240708$20240712$PER$$JP-Eisai-EC-2024-169581$EISAI$$$$$F$Y$$$20240712$$MD$JP$JP
240625381$24062538$1$I$$20240702$20240708$20240708$EXP$$JP-009507513-2407JPN000630J$MERCK$$72$YR$$M$Y$$$20240708$$MD$JP$JP
240625391$24062539$1$I$20240601$20240705$20240708$20240708$EXP$$US-KYOWAKIRIN-2024KK016379$KYOWA$$$$$$Y$$$20240708$$HP$US$US
240625401$24062540$1$I$$20240629$20240708$20240708$EXP$$SE-ANIPHARMA-2024-SE-000013$ANI$Ott M, Mannchen JK, Jamshidi F, Werneke U.Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques..Therapeutic Advances in Psychopharmacology.2019;91-32.$73$YR$$F$Y$$$20240708$$HP$SE$SE
240625413$24062541$3$F$$20240708$20240708$20240715$EXP$$IN-ROCHE-10000014910$ROCHE$$52$YR$A$M$Y$$$20240715$$MD$IN$IN
240625421$24062542$1$I$20240601$20240627$20240708$20240708$PER$$US-SA-2024SA193810$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240708$$MD$US$US
240625431$24062543$1$I$20210116$20231003$20240708$20240708$EXP$$SK-ROCHE-10000018562$ROCHE$Majernik S, Lencesova B, Valachova M. Recurrent Course of COVID-19 in patients treated with anti-CD20 monoclonal antibodies - case reports. Pneumology. 2023;14:18-19.$38$YR$A$F$Y$$$20240708$$MD$SK$SK
240625441$24062544$1$I$$20240703$20240708$20240708$EXP$$ES-INCYTE CORPORATION-2024IN006422$INCYTE$$$$$$Y$$$20240708$$MD$ES$ES
240625452$24062545$2$F$$20240808$20240708$20240808$PER$$US-ALXN-202407USA000147US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
240625462$24062546$2$F$$20240802$20240708$20240814$PER$$US-ALXN-202407USA000108US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
240625471$24062547$1$I$20240101$20240703$20240708$20240708$PER$$US-JNJFOC-20240711608$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240708$$CN$US$US
240625481$24062548$1$I$$20240627$20240708$20240708$EXP$$JP-AstraZeneca-2024A151761$ASTRAZENECA$$$$$F$Y$$$20240708$$CN$JP$
240625491$24062549$1$I$20240625$20240701$20240708$20240708$EXP$GB-MHRA-MED-202407011500448070-RNYHF$GB-RDY-SPO/GBR/24/0009705$DR REDDYS$$73$YR$E$F$Y$$$20240708$$PH$GB$GB
240625501$24062550$1$I$$20240626$20240708$20240708$PER$$US-EMERGENT BIOSOLUTIONS,-24000091$EMERGENT BIOSOLUTIONS$$$$A$F$Y$$$20240708$$CN$US$US
240625511$24062551$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA193820$SANOFI AVENTIS$$$$A$F$Y$$$20240708$$MD$US$US
240625531$24062553$1$I$$20240628$20240708$20240708$EXP$$JP-Eisai-EC-2024-169178$EISAI$$$$$F$Y$$$20240708$$PH$JP$JP
240625541$24062554$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194097$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240708$$MD$US$US
240625551$24062555$1$I$20240528$20240606$20240708$20240708$PER$$US-FMCRTG-FMC-2406-000693$FRESENIUS MEDICAL CARE$$59$YR$A$M$Y$$$20240708$$HP$US$US
240625561$24062556$1$I$20240528$20240612$20240708$20240708$PER$$US-FMCRTG-FMC-2406-000726$FRESENIUS MEDICAL CARE$$71$YR$E$F$Y$$$20240708$$HP$US$US
240625573$24062557$3$F$20240626$20240716$20240708$20240729$EXP$$US-FMCRTG-FMC-2407-000776$FRESENIUS MEDICAL CARE$$79$YR$E$M$Y$$$20240729$$HP$US$US
240625581$24062558$1$I$20240607$20240612$20240708$20240708$PER$$US-FMCRTG-FMC-2406-000717$FRESENIUS MEDICAL CARE$$39$YR$A$M$Y$$$20240708$$HP$US$US
240625592$24062559$2$F$$20240719$20240708$20240821$PER$$US-FMCRTG-FMC-2406-000734$FRESENIUS MEDICAL CARE$$41$YR$A$F$Y$76$KG$20240821$$HP$US$US
240625601$24062560$1$I$20220901$20240610$20240708$20240708$PER$$US-FMCRTG-FMC-2406-000709$FRESENIUS MEDICAL CARE$$36$YR$A$F$Y$71$KG$20240708$$HP$US$US
240625611$24062561$1$I$$20240606$20240708$20240708$PER$$US-FMCRTG-FMC-2406-000696$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240708$$HP$US$US
240625621$24062562$1$I$$20240612$20240708$20240708$PER$$US-FMCRTG-FMC-2406-000730$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240708$$CN$US$US
240625631$24062563$1$I$20240608$20240613$20240708$20240708$PER$$US-FMCRTG-FMC-2406-000722$FRESENIUS MEDICAL CARE$$67$YR$E$M$Y$$$20240708$$HP$US$US
240625641$24062564$1$I$$20240702$20240708$20240708$PER$$US-ALXN-202407USA000110US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240708$$HP$US$US
240625651$24062565$1$I$$20240703$20240708$20240708$PER$$US-ABBVIE-5829288$ABBVIE$$$$$M$Y$$$20240708$$HP$US$US
240625661$24062566$1$I$$20240705$20240708$20240708$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038319$BOEHRINGER INGELHEIM$$53$YR$A$M$Y$$$20240708$$CN$US$US
240625671$24062567$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA196191$SANOFI AVENTIS$$$$E$M$Y$$$20240708$$CN$US$US
240625681$24062568$1$I$$20240702$20240708$20240708$PER$$US-JNJFOC-20240710804$JOHNSON AND JOHNSON$$$$$M$Y$$$20240708$$MD$US$US
240625691$24062569$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA196047$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240708$$CN$US$US
240625701$24062570$1$I$$20240627$20240708$20240708$PER$$US-SA-2024SA194132$SANOFI AVENTIS$$$$E$M$Y$73.9$KG$20240708$$MD$US$US
240625711$24062571$1$I$$20240701$20240708$20240708$EXP$$PT-009507513-2407PRT002145$MERCK$$48$YR$$F$Y$$$20240708$$MD$PT$PT
240625721$24062572$1$I$20220901$20240701$20240708$20240708$PER$$US-SA-2024SA196441$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240708$$HP$US$US
240625731$24062573$1$I$$20240701$20240708$20240708$PER$$US-SA-2024SA195956$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240708$$CN$US$US
240625742$24062574$2$F$20240603$20240722$20240708$20240725$EXP$$JP-Eisai-EC-2024-169588$EISAI$$$$$F$Y$$$20240725$$PH$JP$JP
240625751$24062575$1$I$$20240704$20240708$20240708$EXP$$CL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038387$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$$$20240708$$PH$CL$CL
240625761$24062576$1$I$$20240701$20240708$20240708$EXP$GB-MHRA-MED-202406191521210010-ZJBRL$GB-RDY-SPO/GBR/24/0009701$DR REDDYS$$$$$F$Y$$$20240708$$PH$GB$GB
240625772$24062577$2$F$$20240828$20240708$20240904$EXP$$CA-ANIPHARMA-2024-CA-003141$ANI$$59$YR$$F$Y$$$20240904$$HP$CA$CA
240625781$24062578$1$I$$20240624$20240708$20240708$EXP$$NL-VER-202400047$VERITY PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$NL$NL
240625791$24062579$1$I$$20240705$20240708$20240708$EXP$$DE-AstraZeneca-2024A155846$ASTRAZENECA$$$$$M$Y$$$20240708$$MD$DE$
240625803$24062580$3$F$$20240709$20240708$20240712$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038274$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240712$$PH$JP$JP
240625811$24062581$1$I$$20240707$20240708$20240708$EXP$GB-MHRA-MED-202407071142221400-TRQSZ$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038231$BOEHRINGER INGELHEIM$$50$YR$A$M$Y$$$20240708$$PH$GB$GB
240625821$24062582$1$I$$20240702$20240708$20240708$PER$$US-ALXN-202407USA000133US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
240625841$24062584$1$I$20230901$20240702$20240708$20240708$EXP$$IT-AstraZeneca-2024A155436$ASTRAZENECA$$30292$DY$$M$Y$$$20240708$$MD$IT$
240625851$24062585$1$I$$20240702$20240708$20240708$EXP$$US-PFIZER INC-2019SGN02025$PFIZER$$38$YR$$F$Y$$$20240708$$MD$US$US
240625862$24062586$2$F$$20240903$20240708$20240909$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202407002494$ELI LILLY AND CO$$18$YR$A$F$Y$$$20240909$$CN$MX$MX
240625871$24062587$1$I$$20240630$20240708$20240708$EXP$$CH-ANIPHARMA-2024-CH-000023$ANI$Jeltsch S, Van Der Wegen M, Gerrits E.How to differentiate erythema multiforme major from Stevens-Johnson syndrome?.Swiss Medical Weekly.2024;154112S-113S.$41$YR$$M$Y$$$20240708$$HP$CH$CH
240625881$24062588$1$I$$20240626$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018273$ELI LILLY AND CO$$$$A$F$Y$$$20240708$$CN$US$US
240625891$24062589$1$I$$20240701$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202407001452$ELI LILLY AND CO$$78$YR$E$M$Y$76.19$KG$20240708$$CN$US$US
240625901$24062590$1$I$20190101$20240626$20240708$20240708$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202406018571$ELI LILLY AND CO$$$$$$Y$$$20240708$$CN$CN$CN
240625911$24062591$1$I$20240201$20240626$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018620$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240708$$CN$US$US
240625921$24062592$1$I$$20240627$20240708$20240708$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202407000374$ELI LILLY AND CO$$$$$M$Y$$$20240708$$MD$AE$AE
240625931$24062593$1$I$$20240626$20240708$20240708$EXP$$US-ELI_LILLY_AND_COMPANY-US202406018105$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240708$$CN$US$US
240625941$24062594$1$I$20230313$20240628$20240708$20240708$EXP$FR-AFSSAPS-AM2024000524$FR-LUNDBECK-DKLU4001314$LUNDBECK$$$$$$Y$$$20240708$$MD$FR$FR
240625951$24062595$1$I$$20240705$20240708$20240708$30DAY$$CA-SANDOZ INC.-SDZ2024US063304$SANDOZ$$$$$$Y$$$20240708$$CN$CA$US
240625961$24062596$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-2021SGN06012$PFIZER$$5$DEC$$M$Y$$$20240708$$PH$US$US
240625971$24062597$1$I$$20240703$20240708$20240708$PER$$US-PFIZER INC-2021SGN01886$PFIZER$$$$$$Y$$$20240708$$MD$US$US
240625981$24062598$1$I$$20240517$20240708$20240708$PER$$US-LUNDBECK-DKLU3078272$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240625992$24062599$2$F$20240705$20240710$20240708$20240715$EXP$$JP-009507513-2407JPN000767J$MERCK$$95$YR$$F$Y$$$20240715$$PH$JP$JP
240626001$24062600$1$I$$20240517$20240708$20240708$PER$$US-LUNDBECK-DKLU3078277$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240626011$24062601$1$I$$20240705$20240708$20240708$EXP$$CA-ACERUSPHRM-2024-CA-000450$ACERUS PHARMACEUTICALS$$45$YR$A$M$Y$$$20240708$$$CA$CA
240626021$24062602$1$I$$20240516$20240708$20240708$PER$$US-LUNDBECK-DKLU3078203$LUNDBECK$$$$$$Y$$$20240708$$HP$US$US
240626031$24062603$1$I$$20240702$20240708$20240708$PER$$NVSC2024US139833$NOVARTIS$$66$YR$$F$Y$$$20240708$$CN$US$US
240626041$24062604$1$I$$20240704$20240708$20240708$EXP$$NVSC2024NZ138924$NOVARTIS$$$$$M$Y$$$20240709$$MD$NZ$NZ
240626051$24062605$1$I$20240101$20240517$20240708$20240708$PER$$US-LUNDBECK-DKLU3078282$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240626061$24062606$1$I$20240101$20240517$20240708$20240708$PER$$US-LUNDBECK-DKLU3078279$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240626071$24062607$1$I$$20240703$20240708$20240708$PER$$US-GILEAD-2024-0679596$GILEAD$$$$$M$Y$$$20240708$$MD$US$US
240626081$24062608$1$I$$20240516$20240708$20240708$PER$$US-LUNDBECK-DKLU3078290$LUNDBECK$$$$$$Y$$$20240708$$CN$US$US
240626091$24062609$1$I$20240331$20240619$20240708$20240708$EXP$$US-GSK-US2024GSK076285$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$MD$US$US
240626102$24062610$2$F$20240328$20240730$20240708$20240802$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038031$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$42$KG$20240802$$PH$JP$JP
240626111$24062611$1$I$$20240619$20240708$20240708$PER$$US-JNJFOC-20240652756$JOHNSON AND JOHNSON$$$$$$Y$$$20240708$$CN$US$US
240626121$24062612$1$I$20240608$20240628$20240708$20240708$EXP$$CN-009507513-2407CHN001002$MERCK$$64$YR$$M$Y$70$KG$20240708$$HP$CN$CN
240626131$24062613$1$I$20240101$20240520$20240708$20240708$PER$$US-LUNDBECK-DKLU3078311$LUNDBECK$$$$$$Y$$$20240708$$HP$US$US
240626144$24062614$4$F$20240626$20240711$20240708$20240723$30DAY$$US-ALKERMES INC.-ALK-2024-001766$ALKERMES$$$$$$Y$$$20240723$$MD$US$US
240626151$24062615$1$I$$20240625$20240708$20240708$EXP$$CA-GSK-CA2021059582$GLAXOSMITHKLINE$$53$YR$$M$Y$$$20240708$$MD$CA$CA
240626162$24062616$2$F$20240702$20240807$20240708$20240807$PER$$US-ALXN-202407USA000134US$ALEXION PHARMACEUTICALS$$39$YR$$F$Y$$$20240807$$CN$US$US
240626171$24062617$1$I$$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002462$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240708$$CN$US$US
240626181$24062618$1$I$$20240702$20240708$20240708$EXP$$US-ALXN-202407USA000137US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$HP$US$US
240626191$24062619$1$I$$20240516$20240708$20240708$PER$$US-LUNDBECK-DKLU3078245$LUNDBECK$$$$$$Y$$$20240708$$HP$US$US
240626201$24062620$1$I$$20240624$20240708$20240708$EXP$$US-HLS-202400182$HLS THERAPEUTICS$$49$YR$A$F$Y$$$20240708$$MD$PL$US
240626212$24062621$2$F$$20240812$20240708$20240812$PER$$US-ALXN-202407USA000228US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
240626221$24062622$1$I$20240623$20240703$20240708$20240708$PER$$US-ELI_LILLY_AND_COMPANY-US202407002463$ELI LILLY AND CO$$$$$F$Y$$$20240708$$CN$US$US
240626231$24062623$1$I$$20240621$20240708$20240708$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06330$NEUROCRINE BIOSCIENCES$$72$YR$$F$Y$$$20240708$$CN$US$US
240626242$24062624$2$F$$20240808$20240708$20240808$PER$$US-ALXN-202407USA000157US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
240626256$24062625$6$F$$20240905$20240708$20240908$PER$$US-ALXN-202407USA000011US$ALEXION PHARMACEUTICALS$$$$$F$Y$59.864$KG$20240908$$CN$US$US
240626261$24062626$1$I$$20240702$20240708$20240708$PER$$US-ALXN-202407USA000200US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240708$$CN$US$US
240626272$24062627$2$F$$20240808$20240708$20240808$PER$$US-ALXN-202407USA000155US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
240626281$24062628$1$I$$20240610$20240708$20240708$PER$$US-AstraZeneca-2024A135714$ASTRAZENECA$$$$$F$Y$$$20240709$$HP$US$
240626291$24062629$1$I$$20240702$20240708$20240708$PER$$US-ALXN-202407USA000127US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240708$$CN$US$US
240626301$24062630$1$I$$20240624$20240708$20240708$EXP$$US-HLS-202400183$HLS THERAPEUTICS$$31$YR$A$M$Y$$$20240708$$MD$IN$US
240626323$24062632$3$F$$20240821$20240708$20240821$PER$$US-ALXN-202407USA000189US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
240626352$24062635$2$F$$20240807$20240708$20240807$PER$$US-ALXN-202407USA000142US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240807$$CN$US$US
240626361$24062636$1$I$$20240624$20240708$20240708$EXP$$US-HLS-202400184$HLS THERAPEUTICS$$48$YR$A$M$Y$$$20240708$$MD$IN$US
240626372$24062637$2$F$$20240808$20240708$20240808$PER$$US-ALXN-202407USA000175US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
240626381$24062638$1$I$20240424$20240628$20240708$20240708$EXP$$US-APELLIS-2024-APL-0000385$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240708$$MD$US$US
240626391$24062639$1$I$20240527$20240620$20240708$20240708$PER$$US-JNJFOC-20240655990$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240708$$CN$US$US
240626401$24062640$1$I$20240608$20240620$20240708$20240708$PER$$US-JNJFOC-20240656853$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240708$$CN$US$US
240626411$24062641$1$I$20240601$20240702$20240708$20240708$EXP$$JP-009507513-2407JPN000395J$MERCK$$6$DEC$$F$Y$$$20240708$$MD$JP$JP
240626423$24062642$3$F$$20240904$20240708$20240911$EXP$$NVSC2024CA139798$NOVARTIS$$43$YR$$F$Y$96$KG$20240911$$HP$CA$CA
240626441$24062644$1$I$20231001$20240702$20240708$20240708$PER$$US-AMGEN-USASP2024131724$AMGEN$$58$YR$A$F$Y$$$20240708$$CN$US$US
240626451$24062645$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133865$AMGEN$$$$A$F$Y$$$20240708$$HP$US$US
240626461$24062646$1$I$$20240626$20240708$20240708$PER$$US-009507513-2407USA002568$MERCK$$73$YR$$M$Y$$$20240708$$CN$US$US
240626472$24062647$2$F$20240606$20240708$20240708$20240711$EXP$$AR-BIOMARINAP-AR-2024-158987$BIOMARIN$$$$$$Y$$$20240711$$CN$AR$AR
240626482$24062648$2$F$$20240822$20240708$20240828$EXP$$BR-BIOMARINAP-BR-2024-158995$BIOMARIN$$$$$$Y$$$20240828$$CN$BR$BR
240626492$24062649$2$F$20240601$20240717$20240708$20240722$EXP$$JP-SA-2024SA195863$SANOFI AVENTIS$$$$$F$Y$$$20240722$$MD$JP$JP
240626501$24062650$1$I$20240217$20240705$20240708$20240708$EXP$FR-AFSSAPS-BX2024001354$FR-GILEAD-2024-0679707$GILEAD$$68$YR$E$F$Y$$$20240708$$HP$FR$FR
240626511$24062651$1$I$20230601$20240701$20240708$20240708$EXP$$AR-JNJFOC-20240705556$JOHNSON AND JOHNSON$$60$YR$A$F$Y$62$KG$20240709$$CN$AR$AR
240626521$24062652$1$I$$20240703$20240708$20240708$EXP$$US-SANDOZ INC.-SDZ2024US063331$SANDOZ$$$$$$Y$$$20240708$$HP$US$US
240626531$24062653$1$I$$20240705$20240708$20240708$EXP$$GB-SANDOZ INC.-SDZ2024GB063313$SANDOZ$$$$$M$Y$$$20240708$$MD$GB$GB
240626542$24062654$2$F$20240501$20240709$20240708$20240715$EXP$$JP-009507513-2407JPN000421J$MERCK$$71$YR$$F$Y$$$20240715$$MD$JP$JP
240626551$24062655$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133335$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240626561$24062656$1$I$$20240703$20240708$20240708$PER$$US-AMGEN-USASP2024133273$AMGEN$$$$$$Y$$$20240708$$HP$US$US
240626571$24062657$1$I$$20240705$20240708$20240708$30DAY$$US-SANDOZ INC.-SDZ2024US063319$SANDOZ$$$$$M$Y$$$20240708$$HP$US$US
240626581$24062658$1$I$$20240703$20240708$20240708$EXP$$US-SANDOZ INC.-SDZ2024US063389$SANDOZ$$$$$F$Y$$$20240708$$CN$US$US
240626591$24062659$1$I$20240521$20240702$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010266$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240626601$24062660$1$I$$20240708$20240708$20240708$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038460$BOEHRINGER INGELHEIM$$$$$$Y$$$20240709$$CN$US$US
240626611$24062661$1$I$20240301$20240703$20240708$20240708$EXP$$NVSJ2024JP008054$NOVARTIS$$$$$M$Y$$$20240709$$MD$JP$JP
240626622$24062662$2$F$20230602$20240708$20240708$20240709$EXP$$NVSJ2024JP008227$NOVARTIS$$85$YR$$F$Y$$$20240710$$MD$JP$JP
240626631$24062663$1$I$$20240701$20240708$20240708$EXP$$JP-AMGEN-JPNSP2024134480$AMGEN$Saito, T.. A case of vertebral osteomyelitis due to penicillin G-susceptible Staphylococcus aureus followed by endocarditis infective and cerebral embolus, which were treated with penicillin G. Joint Meeting of the 96th Annual Meeting of the Japanese Association for Infecti. 2024;98th$6$DEC$A$F$Y$$$20240708$$HP$JP$JP
240626641$24062664$1$I$$20240708$20240708$20240708$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038495$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240709$$CN$US$US
240626651$24062665$1$I$20240620$20240628$20240708$20240708$EXP$$US-JNJFOC-20240703479$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240709$$MD$US$US
240626663$24062666$3$F$20240703$20240827$20240708$20240829$PER$$US-AMGEN-USASP2024134450$AMGEN$$68$YR$E$M$Y$$$20240828$$CN$US$US
240626671$24062667$1$I$20240229$20240703$20240708$20240708$EXP$$RU-JNJFOC-20240717897$JOHNSON AND JOHNSON$$68$YR$E$$Y$75$KG$20240709$$HP$RU$RU
240626682$24062668$2$F$20240619$20240708$20240708$20240710$PER$$US-AMGEN-USASP2024134267$AMGEN$$78$YR$E$F$Y$$$20240709$$CN$US$US
240626691$24062669$1$I$$20240703$20240708$20240708$EXP$$JP-AMGEN-JPNSP2024134555$AMGEN$$7$DEC$E$M$Y$$$20240708$$MD$JP$JP
240626701$24062670$1$I$20240620$20240701$20240708$20240708$EXP$$CN-JNJFOC-20240701203$JOHNSON AND JOHNSON$$70$YR$E$M$Y$79.3$KG$20240709$$HP$CN$CN
240626711$24062671$1$I$20240101$20240702$20240708$20240708$EXP$$US-ABBVIE-5826303$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240626722$24062672$2$F$20240101$20240717$20240708$20240722$EXP$$US-ABBVIE-5829088$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
240626731$24062673$1$I$$20240704$20240708$20240708$EXP$$US-JNJFOC-20240713617$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240626741$24062674$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5831107$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240626751$24062675$1$I$$20240627$20240708$20240708$PER$$US-JNJFOC-20240675163$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$PH$US$US
240626761$24062676$1$I$20240427$20240701$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010174$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240626771$24062677$1$I$$20240705$20240708$20240708$PER$$US-AMGEN-USASP2024134119$AMGEN$$$$T$F$Y$$$20240708$$CN$US$US
240626781$24062678$1$I$20240626$20240701$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010177$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240626791$24062679$1$I$$20240702$20240708$20240708$EXP$$US-BIOGEN-2024BI01272400$BIOGEN$$$$$F$Y$$$20240708$$CN$US$US
240626801$24062680$1$I$$20240705$20240708$20240708$PER$$NVSC2024US140957$NOVARTIS$$$$$M$Y$$$20240709$$MD$US$US
240626811$24062681$1$I$$20240625$20240708$20240708$PER$$US-JNJFOC-20240678926$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240626821$24062682$1$I$20230704$20240701$20240708$20240708$EXP$$US-AMGEN-USASL2024130721$AMGEN$$68$YR$E$F$Y$$$20240708$$CN$US$US
240626832$24062683$2$F$20240601$20240730$20240708$20240801$PER$$US-JNJFOC-20240674237$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240801$$PH$US$US
240626841$24062684$1$I$20240601$20240703$20240708$20240708$EXP$$CA-ABBVIE-5826820$ABBVIE$$25$YR$$M$Y$$$20240708$$CN$CA$CA
240626854$24062685$4$F$20111018$20240716$20240708$20240718$EXP$$NVSJ2024JP007089$NOVARTIS$Sugahara Y, Hashiguchi T and Hashimoto T. Three Cases of Oesophageal Gastrointestinal Stromal Tumour (GIST) in Our Department. The Journal of Japanese Gastroenterological Association/The 51st Meeting of the. 2024;8:P1-4$58$YR$$F$Y$$$20240719$$HP$JP$JP
240626861$24062686$1$I$$20240701$20240708$20240708$EXP$$US-JNJFOC-20240702340$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$MD$US$US
240626901$24062690$1$I$20240101$20240701$20240708$20240708$PER$$US-AMGEN-USASP2024130326$AMGEN$$$$$F$Y$$$20240708$$CN$US$US
240626911$24062691$1$I$20240621$20240701$20240708$20240708$EXP$$CN-ROCHE-10000017756$ROCHE$$80$YR$E$F$Y$52$KG$20240709$$HP$CN$CN
240626922$24062692$2$F$$20240702$20240708$20240711$PER$$US-ROCHE-10000018721$ROCHE$$21$YR$A$F$Y$$$20240711$$CN$US$US
240626931$24062693$1$I$20240620$20240702$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010267$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240626942$24062694$2$F$$20240807$20240708$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038505$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240808$$CN$US$US
240626952$24062695$2$F$$20240830$20240708$20240903$EXP$$CA-ABBVIE-5831035$ABBVIE$$$$A$M$Y$$$20240903$$MD$CA$CA
240626961$24062696$1$I$20240626$20240702$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010282$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240626971$24062697$1$I$$20240704$20240708$20240708$PER$$US-ABBVIE-5830284$ABBVIE$$78$YR$$F$Y$$$20240708$$CN$US$US
240626981$24062698$1$I$20240101$20240705$20240708$20240708$EXP$$CA-ABBVIE-5831191$ABBVIE$$42$YR$$M$Y$$$20240708$$CN$CA$CA
240626991$24062699$1$I$20240702$20240703$20240708$20240708$EXP$$FR-ABBVIE-5831193$ABBVIE$$78$YR$$F$Y$$$20240708$$CN$FR$FR
240627002$24062700$2$F$$20240903$20240708$20240906$EXP$$CA-ABBVIE-5831076$ABBVIE$$$$A$F$Y$$$20240906$$CN$CA$CA
240627011$24062701$1$I$20221001$20240703$20240708$20240708$EXP$$US-ABBVIE-5831104$ABBVIE$$56$YR$$F$Y$$$20240708$$CN$US$US
240627021$24062702$1$I$20240101$20240705$20240708$20240708$EXP$$CA-ABBVIE-5831114$ABBVIE$$51$YR$$M$Y$$$20240708$$CN$CA$CA
240627031$24062703$1$I$20240101$20240626$20240708$20240708$EXP$$JP-AMGEN-JPNSP2024134245$AMGEN$$9$DEC$E$M$Y$$$20240708$$MD$JP$JP
240627044$24062704$4$F$20240627$20240812$20240708$20240826$30DAY$$US-AMGEN-USASL2024131107$AMGEN$$47$YR$A$$Y$$$20240826$$PH$US$US
240627052$24062705$2$F$20240704$20240712$20240708$20240717$EXP$$NVSJ2024JP008126$NOVARTIS$$86$YR$$F$Y$$$20240718$$PH$JP$JP
240627061$24062706$1$I$$20240704$20240708$20240708$EXP$$US-ABBVIE-5830591$ABBVIE$$$$$F$Y$$$20240708$$HP$US$US
240627072$24062707$2$F$20240415$20240815$20240708$20240819$EXP$$DE-JNJFOC-20240718966$JOHNSON AND JOHNSON$$84$YR$E$M$Y$65$KG$20240819$$MD$DE$DE
240627081$24062708$1$I$20231124$20240125$20240708$20240708$EXP$$GB-AMGEN-GBRSP2024132403$AMGEN$$77$YR$E$M$Y$74.2$KG$20240708$$HP$GB$GB
240627091$24062709$1$I$20240708$20240708$20240708$20240708$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038508$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240709$$CN$US$US
240627101$24062710$1$I$20240617$20240701$20240708$20240708$EXP$$JP-AMGEN-JPNSP2024130462$AMGEN$$$$E$$Y$$$20240708$$HP$JP$JP
240627112$24062711$2$F$20240621$20240716$20240708$20240719$PER$$US-AMGEN-USASP2024132192$AMGEN$$$$$$Y$$$20240719$$HP$US$US
240627131$24062713$1$I$$20240705$20240708$20240708$EXP$$UY-ABBVIE-5830380$ABBVIE$$82$YR$$M$Y$$$20240708$$MD$UY$UY
240627142$24062714$2$F$$20240830$20240708$20240902$EXP$$JP-ABBVIE-5831492$ABBVIE$$82$YR$$F$Y$$$20240902$$CN$JP$JP
240627151$24062715$1$I$$20240703$20240708$20240708$PER$$US-ABBVIE-5829664$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240627161$24062716$1$I$20160101$20240701$20240708$20240708$PER$$US-AMGEN-USASP2024130243$AMGEN$$68$YR$E$F$Y$$$20240708$$CN$US$US
240627172$24062717$2$F$20231201$20240710$20240708$20240712$EXP$$TW-009507513-2407TWN001405$MERCK$$63$YR$$F$Y$$$20240712$$MD$TW$TW
240627181$24062718$1$I$20240516$20240706$20240708$20240708$EXP$GB-MHRA-MED-202407062043044440-DTNCY$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038259$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240709$$HP$GB$GB
240627191$24062719$1$I$$20240703$20240708$20240708$EXP$$US-ABBVIE-5828932$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240627201$24062720$1$I$$20240707$20240708$20240708$EXP$$IL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038241$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240709$$MD$IL$IL
240627212$24062721$2$F$20240531$20240806$20240708$20240809$PER$$US-AMGEN-USASP2024128176$AMGEN$$$$$F$Y$$$20240809$$PH$US$US
240627221$24062722$1$I$$20240704$20240708$20240708$PER$$US-ABBVIE-5829507$ABBVIE$$$$$$Y$$$20240708$$CN$US$US
240627231$24062723$1$I$20240628$20240703$20240708$20240708$PER$$US-ABBVIE-5829848$ABBVIE$$25$YR$$F$Y$$$20240708$$MD$US$US
240627241$24062724$1$I$20240605$20240705$20240708$20240708$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032092$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240709$$CN$US$US
240627251$24062725$1$I$20120727$20240708$20240708$20240708$EXP$FR-AFSSAPS-TO2024001218$FR-JNJFOC-20240718917$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240709$$HP$FR$FR
240627261$24062726$1$I$$20240708$20240708$20240708$EXP$$NVSC2024US140965$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240627271$24062727$1$I$20240621$20240705$20240708$20240708$PER$$US-JNJFOC-20240715198$JOHNSON AND JOHNSON$$62$YR$A$F$Y$64$KG$20240709$$CN$US$US
240627282$24062728$2$F$$20240926$20240708$20240927$PER$$NVSC2024US141041$NOVARTIS$$$$$F$Y$$$20240927$$HP$US$US
240627291$24062729$1$I$20240626$20240703$20240708$20240708$PER$$US-ABBVIE-5830311$ABBVIE$$41$YR$$F$Y$$$20240708$$MD$US$US
240627301$24062730$1$I$$20240705$20240708$20240708$PER$$US-JNJFOC-20240716732$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$HP$US$US
240627311$24062731$1$I$$20240705$20240708$20240708$EXP$GB-MHRA-MED-202406251221265000-PMZRF$GB-GSK-GB2024083976$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$PH$GB$GB
240627321$24062732$1$I$$20240704$20240708$20240708$EXP$$US-JNJFOC-20240714286$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240627333$24062733$3$F$20240221$20240719$20240708$20240724$EXP$$US-JNJFOC-20240708567$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240724$$HP$US$US
240627341$24062734$1$I$$20240513$20240708$20240708$PER$$US-AMGEN-USASP2024133723$AMGEN$$$$$$Y$$$20240708$$HP$US$US
240627352$24062735$2$F$$20240808$20240708$20240808$PER$$US-ALXN-202407USA000239US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
240627361$24062736$1$I$20240601$20240630$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010070$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240627371$24062737$1$I$$20240706$20240708$20240708$PER$$US-HALEON-2185864$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240627381$24062738$1$I$$20240704$20240708$20240708$EXP$$CA-ABBVIE-5829916$ABBVIE$$$$E$F$Y$$$20240708$$CN$CA$CA
240627392$24062739$2$F$20240101$20240730$20240708$20240805$EXP$$US-JNJFOC-20240703411$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240806$$CN$US$US
240627401$24062740$1$I$20240101$20240705$20240708$20240708$EXP$$US-ABBVIE-5830696$ABBVIE$$$$$M$Y$$$20240708$$CN$US$US
240627411$24062741$1$I$$20240704$20240708$20240708$EXP$$CA-ABBVIE-5830411$ABBVIE$$$$E$M$Y$$$20240708$$HP$CA$CA
240627421$24062742$1$I$20240702$20240703$20240708$20240708$EXP$$US-ABBVIE-5829197$ABBVIE$$24$YR$$F$Y$$$20240708$$CN$US$US
240627431$24062743$1$I$$20240701$20240708$20240708$PER$$US-BAUSCHBL-2024BNL029448$BAUSCH AND LOMB$$86$YR$$M$Y$$$20240709$$CN$US$US
240627441$24062744$1$I$20240621$20240628$20240708$20240708$PER$$US-BAUSCHBL-2024BNL029494$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240709$$CN$US$US
240627451$24062745$1$I$20240507$20240627$20240708$20240708$EXP$$JP-ROCHE-10000014692$ROCHE$$9$DEC$E$M$Y$$$20240709$$MD$JP$JP
240627461$24062746$1$I$$20240626$20240708$20240708$PER$$US-TEVA-VS-3213968$TEVA$$58$YR$$F$Y$$$20240708$$CN$US$US
240627471$24062747$1$I$20240618$20240701$20240708$20240708$EXP$$CN-BEIGENE-BGN-2024-010171$BEIGENE$$$$$$Y$$$20240708$$HP$CN$CN
240627481$24062748$1$I$20240101$20240630$20240708$20240708$PER$$US-JNJFOC-20240700506$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240709$$CN$US$US
240627491$24062749$1$I$20240615$20240703$20240708$20240708$EXP$FR-AFSSAPS-RE2024000630$FR-JNJFOC-20240718334$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240709$$PH$FR$FR
240627503$24062750$3$F$20240617$20240823$20240708$20240925$EXP$$CA-ABBVIE-5813219$ABBVIE$$84$YR$$F$Y$$$20240925$$MD$CA$CA
240627511$24062751$1$I$20240702$20240703$20240708$20240708$PER$$US-ALXN-202407USA000220US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240709$$CN$US$US
240627532$24062753$2$F$$20240423$20240708$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240790$IRONSHORE PHARMA$$6$YR$C$M$Y$16.662$KG$20240810$$MD$US$US
240627542$24062754$2$F$20240324$20240528$20240708$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240882$IRONSHORE PHARMA$$6$YR$C$M$Y$23.4$KG$20240801$$MD$US$US
240627552$24062755$2$F$20240101$20240516$20240708$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240842$IRONSHORE PHARMA$$23$YR$A$F$Y$$$20240801$$HP$US$US
240627561$24062756$1$I$$20240708$20240708$20240708$PER$$US-HALEON-2185862$Haleon PLC$$$$$$Y$$$20240708$$CN$US$US
240627571$24062757$1$I$$20240702$20240708$20240708$PER$$US-SA-2024SA198181$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240709$$MD$US$US
240627581$24062758$1$I$20240702$20240704$20240708$20240708$EXP$$CN-GSK-CN2024APC083611$GLAXOSMITHKLINE$$$$$$Y$$$20240708$$HP$CN$CN
240627591$24062759$1$I$20220101$20240703$20240708$20240708$EXP$$JP-BAUSCHBL-2024BNL029575$BAUSCH AND LOMB$Sawada K, Kawaji T, Yamana K, Matsuhashi K, Hara Y, Kuriyama N, Nakamura T, Maekawa A, Takagi Y, Nishid O. Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory distress syndrome: a case report.. Journal of cardiothoracic surgery. 2024 JUN 24;19:358:1-7. doi:10.1186/s13019-024-02890-w$40$YR$$F$Y$43$KG$20240709$$HP$JP$JP
240627602$24062760$2$F$$20240801$20240708$20240806$PER$$US-ROCHE-10000019647$ROCHE$$57$YR$A$F$Y$$$20240806$$CN$US$US
240627613$24062761$3$F$$20240802$20240708$20240806$PER$$US-ROCHE-10000013279$ROCHE$$$$C$M$Y$28.6$KG$20240806$$CN$US$US
240627621$24062762$1$I$$20240703$20240708$20240708$EXP$$US-BAUSCHBL-2024BNL029581$BAUSCH AND LOMB$Javadi T, Morales B, Olson J, Kothari S, Zhang L, Abedalthagafi M. Extracavitary primary effusion lymphoma presenting as a solitary brain mass. CNS Oncology. 2024 JUN 12;13 (1):1-6. doi:10.1080/20450907.2024.2357535$62$YR$$M$Y$$$20240709$$HP$US$US
240627631$24062763$1$I$20240601$20240630$20240708$20240708$EXP$$CA-JNJFOC-20240676917$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240709$$CN$CA$CA
240627651$24062765$1$I$$20230825$20240708$20240708$EXP$$US-SANDOZ INC.-SDZ2023US022604$SANDOZ$$$$$M$Y$$$20240708$$CN$US$US
240627661$24062766$1$I$20240101$20240702$20240708$20240708$EXP$$US-ABBVIE-5826318$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240627671$24062767$1$I$$20240626$20240708$20240708$PER$$US-TEVA-VS-3214915$TEVA$$$$$F$Y$$$20240708$$CN$US$US
240627682$24062768$2$F$20240427$20240903$20240708$20240912$EXP$$US-JNJFOC-20240711430$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240912$$HP$US$US
240627691$24062769$1$I$$20240703$20240708$20240708$EXP$$CA-ABBVIE-5828695$ABBVIE$$$$A$F$Y$$$20240708$$CN$CA$CA
240627701$24062770$1$I$20240525$20240703$20240708$20240708$EXP$ES-AEMPS-1540602$ES-009507513-2407ESP002133$MERCK$$78$YR$$M$Y$$$20240708$$MD$ES$ES
240627711$24062771$1$I$20230101$20240703$20240708$20240708$EXP$$US-ABBVIE-5349536$ABBVIE$$$$$F$Y$$$20240708$$CN$US$US
240627721$24062772$1$I$20240523$20240708$20240708$20240708$EXP$FR-AFSSAPS-NT2024000766$FR-JNJFOC-20240718521$JOHNSON AND JOHNSON$$63$YR$A$F$Y$32$KG$20240709$$HP$FR$FR
240627731$24062773$1$I$20240517$20240704$20240709$20240709$EXP$$DE-ABBVIE-5829853$ABBVIE$$43$YR$$F$Y$64$KG$20240708$$MD$DE$DE
240627741$24062774$1$I$20240301$20240703$20240709$20240709$EXP$$US-ABBVIE-5696837$ABBVIE$$77$YR$$F$Y$$$20240709$$CN$US$US
240627751$24062775$1$I$20240530$20240703$20240709$20240709$EXP$$US-ABBVIE-5828466$ABBVIE$$42$YR$$F$Y$$$20240709$$CN$US$US
240627761$24062776$1$I$$20240703$20240709$20240709$EXP$$US-ABBVIE-5831100$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240627781$24062778$1$I$$20240701$20240709$20240709$EXP$$BH-STRIDES ARCOLAB LIMITED-2024SP008010$STRIDES$Ghanem H, Wilson PT, Gill DS. Intravenous magnesium sulphate for treatment of pediatric migraine: case series.. Signa-Vitae. 2023;19:194-200$17$YR$$F$Y$$$20240709$$HP$BH$BH
240627791$24062779$1$I$20240101$20240703$20240709$20240709$EXP$$US-ABBVIE-5831112$ABBVIE$$$$$M$Y$$$20240709$$CN$US$US
240627801$24062780$1$I$$20240705$20240709$20240709$EXP$$JP-ABBVIE-4280847$ABBVIE$$57$YR$$F$Y$$$20240709$$HP$JP$JP
240627813$24062781$3$F$20240608$20240812$20240709$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002804$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240830$$CN$US$US
240627821$24062782$1$I$$20240701$20240709$20240709$EXP$$MA-STRIDES ARCOLAB LIMITED-2024SP008013$STRIDES$Nedday S, Naji Y, Laadami S, Adali N. Une toxicite cerebelleuse au metronidazole : a propos d^un cas.. Rev-Neurol-Paris. 2024;180 (Suppl.):S77$17$YR$$M$Y$$$20240709$$HP$MA$MA
240627831$24062783$1$I$$20240627$20240709$20240709$EXP$$BD-ROCHE-10000012355$ROCHE$Ferdause J, Momtahena S, Karim R, Chowdhury A, Hossain N, Islam M, et al. Trastuzumab-induced toxic epidermal necrolysis in a Her-2-positive metastatic breast cancer patient-A rare case report. Clinical case reports. 2024-Jun-23;12 (7):1-7. doi:10.1002/ccr3.9103.$36$YR$A$F$Y$$$20240709$$HP$BD$BD
240627841$24062784$1$I$$20240701$20240709$20240709$EXP$$BH-STRIDES ARCOLAB LIMITED-2024SP008012$STRIDES$Ghanem H, Wilson PT, Gill DS. Intravenous magnesium sulphate for treatment of pediatric migraine: case series. Signa-Vitae. 2023;19:194-200$16$YR$$M$Y$$$20240709$$HP$BH$BH
240627851$24062785$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA198183$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240709$$MD$US$US
240627861$24062786$1$I$20231101$20240702$20240709$20240709$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-024386$JAZZ$$50$YR$$F$Y$$$20240708$$CN$US$US
240627871$24062787$1$I$20240704$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134088$AMGEN$$78$YR$E$F$Y$$$20240708$$CN$US$US
240627881$24062788$1$I$20230306$20240704$20240709$20240709$EXP$$TW-ASTELLAS-2024US019147$ASTELLAS$$79$YR$$M$Y$$$20240709$$CN$TW$TW
240627891$24062789$1$I$20240627$20240703$20240709$20240709$EXP$$CA-ABBVIE-5826653$ABBVIE$$55$YR$$F$Y$$$20240709$$CN$CA$CA
240627904$24062790$4$F$$20240822$20240709$20240823$PER$$US-ALXN-202407USA000067US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
240627911$24062791$1$I$$20240703$20240709$20240709$PER$$US-ABBVIE-5830097$ABBVIE$$$$T$F$Y$$$20240709$$HP$US$US
240627921$24062792$1$I$$20240703$20240709$20240709$EXP$$CA-ABBVIE-5829912$ABBVIE$Buckstein R. Therapy for myelodysplastic syndromes beyond the front line in 2024 in Canada. Canadian Hematology Today. 2024;3(2):22-29.$$$$$Y$$$20240709$$MD$CA$CA
240627931$24062793$1$I$$20240701$20240709$20240709$EXP$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000817$PAREXEL$Barnett B.S., Koons C.J., Van den Eynde V., Gillman P.K., Bodkin J.A.. Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine. Journal of Psychoactive Drugs. 2024$42$YR$$M$Y$$$20240709$$MD$US$US
240627941$24062794$1$I$$20240701$20240709$20240709$EXP$$TN-STRIDES ARCOLAB LIMITED-2024SP008001$STRIDES$Brahmi N, Ben Ghezala H, Mrad A, Ben Jazia A.. High-dose norepinephrine infusion (100 microg/kg/min) in a near-fatal amlodipine and perindopril poisoning: are there any limits?.. Clin-Toxicol-(Phila). 2024;62 (4):273-274$23$YR$$F$Y$$$20240709$$HP$TN$TN
240627951$24062795$1$I$20240401$20240702$20240709$20240709$EXP$FR-AFSSAPS-PB2024000738$FR-ASTELLAS-2024EU006548$ASTELLAS$$73$YR$$M$Y$$$20240709$$CN$FR$FR
240627962$24062796$2$F$$20240708$20240709$20240715$EXP$$CA-GSK-CA2024056783$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$HP$CA$CA
240627973$24062797$3$F$20240101$20240730$20240709$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-019581$UNITED THERAPEUTICS$$$$$F$Y$71.655$KG$20240807$$$US$US
240627982$24062798$2$F$20240101$20240729$20240709$20240802$EXP$$US-UROGEN PHARMA LTD.-2024-UGN-000091$UROGEN PHARMA$$$$$$Y$$$20240803$$CN$US$US
240627991$24062799$1$I$$20240704$20240709$20240709$EXP$$EU-BAUSCHBL-2024BNL029689$BAUSCH AND LOMB$$$$A$M$Y$$$20240709$$MD$EU$EU
240628001$24062800$1$I$$20240701$20240709$20240709$EXP$$UY-STRIDES ARCOLAB LIMITED-2024SP003046$STRIDES$Cunetti L, Oricchio F, Vazquez M, Peyraube R, Manzo L, Nalerio C, et al.. Drug-Drug Interaction Between Cannabidiol, Cyclosporine, and Mycophenolate Mofetil: A Case Report.. Transplant-Proc. 2024;56 (1):252-256$50$YR$$M$Y$$$20240709$$HP$UY$UY
240628011$24062801$1$I$$20240702$20240709$20240709$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008002$STRIDES$Langford B, D^Souza RS, Pingree M, Mauck WD.. Treatment of Ulnar Neuropathic Pain with Peripheral Nerve Stimulation: Two Case Reports.. Pain-Med. 2023;24 (5):566-569$58$YR$$M$Y$$$20240709$$MD$US$US
240628021$24062802$1$I$$20240703$20240709$20240709$EXP$$US-ABBVIE-5829679$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240628033$24062803$3$F$20240606$20240719$20240709$20240724$EXP$$JP-GSK-JP2024082481$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$PH$JP$JP
240628041$24062804$1$I$$20240703$20240709$20240709$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008000$STRIDES$Chandrakar Y.. UNFORESEEN COMPLICATION OF TRAMADOL ADMINISTRATION: A CASE REPORT.. Asian-J-Pharmaceut-Clin-Res. 2024;17 (6):1-2.$22$YR$$M$Y$$$20240709$$HP$IN$IN
240628051$24062805$1$I$$20240705$20240709$20240709$EXP$$US-ABBVIE-5808635$ABBVIE$$$$A$F$Y$$$20240709$$MD$US$US
240628061$24062806$1$I$20240619$20240629$20240709$20240709$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019060$UNITED THERAPEUTICS$$27$YR$$M$Y$59.41$KG$20240709$$PH$US$US
240628071$24062807$1$I$$20240619$20240709$20240709$PER$$US-RDY-LIT/USA/24/0009037$DR REDDYS$Sutton P, Read C, Soller D, Vojtek A, Schwed DE. Refractory Goodpasture^s: A Clinical Conundrum. American Journal of Respiratory and Critical Care Medicine. 2024;209: A5326. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5326.$22$YR$A$M$Y$$$20240709$$HP$US$US
240628081$24062808$1$I$20240424$20240705$20240709$20240709$EXP$$EU-BAUSCHBL-2024BNL029697$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240709$$HP$EU$EU
240628091$24062809$1$I$20240622$20240703$20240709$20240709$EXP$$US-ABBVIE-5831013$ABBVIE$$80$YR$$F$Y$$$20240709$$CN$US$US
240628101$24062810$1$I$20240613$20240703$20240709$20240709$EXP$$CA-ABBVIE-5826355$ABBVIE$$26$YR$$M$Y$$$20240709$$HP$CA$CA
240628111$24062811$1$I$$20240702$20240709$20240709$EXP$$US-ABBVIE-5827818$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240628121$24062812$1$I$$20240705$20240709$20240709$PER$$US-ABBVIE-5831371$ABBVIE$$$$$F$Y$$$20240709$$HP$US$US
240628131$24062813$1$I$20240101$20240701$20240709$20240709$EXP$$PE-JNJFOC-20240348227$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240709$$HP$PE$PE
240628142$24062814$2$F$20240705$20240708$20240709$20240711$PER$$US-AMGEN-USASP2024134444$AMGEN$$65$YR$E$M$Y$$$20240711$$PH$US$US
240628151$24062815$1$I$20230120$20240704$20240709$20240709$EXP$$NVSC2023IN071513$NOVARTIS$$52$YR$$F$Y$$$20240709$$CN$IN$IN
240628162$24062816$2$F$20240214$20240724$20240709$20240730$EXP$$CN-ROCHE-3567419$ROCHE$$52$YR$A$F$Y$$$20240730$$MD$CN$CN
240628172$24062817$2$F$20240624$20240715$20240709$20240725$EXP$$CO-CIPLA LTD.-2024CO06907$CIPLA$$$$$$Y$$$20240725$$MD$CO$CO
240628181$24062818$1$I$20230301$20240703$20240709$20240709$EXP$HR-HALMED-300085691$HR-BIOGEN-2024BI01272483$BIOGEN$$26$YR$$F$Y$68$KG$20240709$$MD$HR$HR
240628191$24062819$1$I$20230101$20240625$20240709$20240709$EXP$$US-CIPLA LTD.-2024US06945$CIPLA$$$$$$Y$$$20240709$$CN$US$US
240628202$24062820$2$F$$20240708$20240709$20240711$PER$$US-ROCHE-10000018714$ROCHE$$44$YR$A$F$Y$$$20240711$$MD$US$US
240628211$24062821$1$I$20240703$20240708$20240709$20240709$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038494$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$$$20240709$$CN$US$US
240628221$24062822$1$I$$20240625$20240709$20240709$PER$$US-TEVA-VS-3214873$TEVA$$$$$M$Y$$$20240709$$CN$US$US
240628231$24062823$1$I$$20240707$20240709$20240709$PER$$US-HALEON-2185871$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240628242$24062824$2$F$20230101$20240920$20240709$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018470$UNITED THERAPEUTICS$$$$$F$Y$68.934$KG$20240928$$$US$US
240628254$24062825$4$F$20060101$20240905$20240709$20240916$EXP$$JP-CHATTEMPRD-2021SA299449$CHATTEM$$40$YR$A$M$Y$100$KG$20240916$$CN$JP$JP
240628264$24062826$4$F$20240101$20240718$20240709$20240723$EXP$$CA-BIOGEN-2024BI01272475$BIOGEN$$$$$F$Y$$$20240723$$CN$CA$CA
240628272$24062827$2$F$$20240716$20240709$20240718$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037976$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$PH$JP$JP
240628281$24062828$1$I$$20240703$20240709$20240709$EXP$$IE-CHATTEMPRD-2019SA038853$CHATTEM$Creaney M., Moriarty RM., Milner M., Murphy C. Dexmedetomidine, high-flow nasal oxygen and sugammadex-reversal of rocuronium: overcoming anaesthetic challenges in a parturient with congenital muscular dystrophy presenting for caesarean section. International Journal of Obstetric Anesthesia. 2018;34:108-12$$$N$F$Y$1.5$KG$20240709$$MD$IE$IE
240628301$24062830$1$I$20240601$20240703$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407002772$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240709$$CN$US$US
240628311$24062831$1$I$$20240702$20240709$20240709$EXP$$NL-PFIZER INC-2018SGN00718$PFIZER$$26$YR$$M$Y$$$20240709$$HP$NL$NL
240628321$24062832$1$I$20210824$20240702$20240709$20240709$EXP$FR-AFSSAPS-MP2024001059$FR-PFIZER INC-202400204865$PFIZER$$1$MON$$F$Y$2.36$KG$20240709$$MD$FR$FR
240628332$24062833$2$F$20240401$20240828$20240709$20240905$EXP$$CN-PFIZER INC-2024SGN04287$PFIZER$$18$YR$$F$Y$67$KG$20240905$$MD$CN$CN
240628342$24062834$2$F$20240403$20240710$20240709$20240715$EXP$$CN-PFIZER INC-2024SGN05159$PFIZER$$47$YR$$M$Y$70$KG$20240715$$MD$CN$CN
240628351$24062835$1$I$20220112$20240702$20240709$20240709$EXP$$ES-PFIZER INC-202400204801$PFIZER$$72$YR$$F$Y$58$KG$20240709$$MD$ES$ES
240628361$24062836$1$I$20221119$20240702$20240709$20240709$EXP$$NL-PFIZER INC-2023SGN02877$PFIZER$$$$$F$Y$$$20240709$$MD$NL$NL
240628373$24062837$3$F$$20240820$20240709$20240829$EXP$$JP-AMGEN-JPNSP2024132057$AMGEN$$$$$M$Y$$$20240828$$CN$JP$JP
240628383$24062838$3$F$$20240815$20240709$20240820$EXP$$US-BIOGEN-2024BI01272450$BIOGEN$$$$$F$Y$$$20240820$$CN$US$US
240628401$24062840$1$I$20240101$20240704$20240709$20240709$EXP$$CA-ABBVIE-5830766$ABBVIE$$58$YR$$F$Y$$$20240709$$CN$CA$CA
240628411$24062841$1$I$$20240701$20240709$20240709$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01163$NOVITIUM PHARMA$Liu Zhongan.Pneumocystis jirovecii infection during immune checkpoint inhibitor therapy: a report of two cases and review of literature.Anti-Tumor Pharmacy.2023;13(1):127-132$52$YR$A$F$Y$$$20240709$$HP$CN$CN
240628421$24062842$1$I$$20240624$20240709$20240709$EXP$$US-SUPERNUS Pharmaceuticals, Inc.-SUP202407-002339$SUPERNUS$$$$$F$Y$$$20240708$$$COUNTRY NOT SPECIFIED$
240628431$24062843$1$I$$20240703$20240709$20240709$EXP$$CA-ABBVIE-5827816$ABBVIE$$51$YR$$F$Y$$$20240709$$HP$CA$CA
240628441$24062844$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA197749$SANOFI AVENTIS$$$$E$F$Y$$$20240709$$MD$US$US
240628451$24062845$1$I$20240619$20240703$20240709$20240709$EXP$$US-ABBVIE-5829716$ABBVIE$$44$YR$$F$Y$$$20240709$$CN$US$US
240628461$24062846$1$I$20240201$20240702$20240709$20240709$EXP$$TN-EMD Serono-2024036653$EMD SERONO INC$$30$YR$A$F$Y$$$20240709$$CN$TN$TN
240628471$24062847$1$I$20240601$20240703$20240709$20240709$EXP$$US-ABBVIE-5829057$ABBVIE$$80$YR$$M$Y$$$20240709$$CN$US$US
240628481$24062848$1$I$20240101$20240704$20240709$20240709$EXP$$CA-ABBVIE-5662909$ABBVIE$$90$YR$$F$Y$$$20240709$$CN$CA$CA
240628491$24062849$1$I$$20240704$20240709$20240709$EXP$$CA-ABBVIE-5829929$ABBVIE$$$$A$F$Y$$$20240709$$CN$CA$CA
240628501$24062850$1$I$$20240627$20240709$20240709$EXP$$IN-ROCHE-10000013414$ROCHE$$70$YR$E$F$Y$$$20240709$$CN$IN$IN
240628511$24062851$1$I$20240701$20240703$20240709$20240709$EXP$$US-ABBVIE-5831085$ABBVIE$$73$YR$$F$Y$$$20240709$$CN$US$US
240628521$24062852$1$I$$20240703$20240709$20240709$EXP$$US-ABBVIE-5831102$ABBVIE$$$$$$Y$$$20240709$$HP$US$US
240628531$24062853$1$I$20240101$20240705$20240709$20240709$EXP$$CA-ABBVIE-5830773$ABBVIE$$63$YR$$M$Y$$$20240709$$CN$CA$CA
240628541$24062854$1$I$19740101$20240701$20240709$20240709$EXP$$US-CHATTEMPRD-2024OHG022842$CHATTEM$$$$E$F$Y$$$20240709$$LW$US$US
240628561$24062856$1$I$$20240701$20240709$20240709$EXP$$US-CHATTEMPRD-2024OHG022777$CHATTEM$$$$$M$Y$$$20240709$$LW$US$US
240628571$24062857$1$I$20240501$20240702$20240709$20240709$PER$$US-JNJFOC-20240706358$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240709$$CN$US$US
240628582$24062858$2$F$20240629$20240730$20240709$20240801$PER$$US-JNJFOC-20240679667$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240801$$CN$US$US
240628591$24062859$1$I$20240624$20240701$20240709$20240709$PER$$US-JNJFOC-20240701380$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240709$$CN$US$US
240628601$24062860$1$I$$20240701$20240709$20240709$EXP$$US-CHATTEMPRD-2024OHG022833$CHATTEM$$$$$F$Y$$$20240709$$LW$US$US
240628612$24062861$2$F$20240621$20240729$20240709$20240813$EXP$$CN-Techdow-J2024HPR000397$SHENZHEN TECHDOW PHARMACEUTICAL$$71$YR$E$M$Y$62$KG$20240813$$MD$CN$CN
240628621$24062862$1$I$$20240702$20240709$20240709$PER$$US-AstraZeneca-2024A152424$ASTRAZENECA$$$$$M$Y$$$20240709$$CN$US$
240628631$24062863$1$I$$20240701$20240709$20240709$EXP$$US-CHATTEMPRD-2024OHG022803$CHATTEM$$$$$F$Y$$$20240709$$LW$US$US
240628641$24062864$1$I$$20240703$20240709$20240709$PER$$US-ABBVIE-5829491$ABBVIE$$25$YR$$F$Y$$$20240709$$CN$US$US
240628651$24062865$1$I$20180101$20240628$20240709$20240709$PER$$US-SA-2024SA196697$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240709$$MD$US$US
240628662$24062866$2$F$20240627$20240726$20240709$20240730$EXP$$JP-JNJFOC-20240720397$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240730$$MD$JP$JP
240628671$24062867$1$I$$20240703$20240709$20240709$EXP$$CA-ABBVIE-5829055$ABBVIE$$$$A$F$Y$$$20240709$$CN$CA$CA
240628681$24062868$1$I$19870101$20240701$20240709$20240709$EXP$$US-CHATTEMPRD-2024OHG022903$CHATTEM$$$$$M$Y$$$20240709$$LW$US$US
240628691$24062869$1$I$$20240703$20240709$20240709$EXP$$US-BIOGEN-2024BI01272515$BIOGEN$$$$$F$Y$$$20240709$$MD$US$US
240628702$24062870$2$F$$20240917$20240709$20240922$EXP$$US-BIOGEN-2024BI01272505$BIOGEN$$$$$F$Y$$$20240922$$CN$US$US
240628711$24062871$1$I$20240301$20240705$20240709$20240709$EXP$$CA-ABBVIE-5831021$ABBVIE$$61$YR$$F$Y$$$20240709$$PH$CA$CA
240628721$24062872$1$I$$20240701$20240709$20240709$EXP$$US-NOVITIUMPHARMA-2024USNVP01164$NOVITIUM PHARMA$Kiley KD.A Controversial Topic: PJP Prophylaxis in Patients With Long-Term Immunologic Agents +/- Steroids.American Journal of Respiratory and Critical Care Medicine .2024;209:A3572$30$YR$A$F$Y$$$20240709$$HP$US$US
240628732$24062873$2$F$20240425$20240813$20240709$20240816$30DAY$$US-AMGEN-USASP2024130434$AMGEN$$$$$$Y$$$20240816$$HP$US$US
240628742$24062874$2$F$20240101$20240805$20240709$20240810$EXP$$CA-ABBVIE-5831052$ABBVIE$$25$YR$$F$Y$$$20240810$$MD$CA$CA
240628751$24062875$1$I$20240501$20240705$20240709$20240709$EXP$$US-ABBVIE-5830595$ABBVIE$$60$YR$$M$Y$$$20240709$$CN$US$US
240628771$24062877$1$I$20240101$20240705$20240709$20240709$EXP$$US-ABBVIE-5830656$ABBVIE$$$$$M$Y$$$20240709$$CN$US$US
240628791$24062879$1$I$$20240109$20240709$20240709$PER$$US-AMGEN-USASP2024133418$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240628801$24062880$1$I$20240101$20240703$20240709$20240709$EXP$$US-ABBVIE-5831097$ABBVIE$$$$$M$Y$$$20240709$$CN$US$US
240628811$24062881$1$I$20240626$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134312$AMGEN$$26$YR$A$F$Y$$$20240708$$CN$US$US
240628821$24062882$1$I$$20240702$20240709$20240709$PER$$US-AMGEN-USASP2024131266$AMGEN$$$$$M$Y$$$20240708$$CN$US$US
240628832$24062883$2$F$20240627$20240703$20240709$20240711$PER$$US-JNJFOC-20240675064$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240712$$CN$US$US
240628842$24062884$2$F$20240701$20240701$20240709$20240709$EXP$$US-CHATTEMPRD-2024OHG022988$CHATTEM$$$$$$Y$$$20240709$$CN$US$US
240628851$24062885$1$I$20190101$20240705$20240709$20240709$EXP$$BR-ABBVIE-5830398$ABBVIE$$$$$F$Y$$$20240709$$CN$BR$BR
240628861$24062886$1$I$20240624$20240627$20240709$20240709$PER$$US-SA-2024SA193501$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240709$$MD$US$US
240628881$24062888$1$I$20240601$20240627$20240709$20240709$PER$$US-SA-2024SA193522$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240709$$MD$US$US
240628891$24062889$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA197794$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240709$$MD$US$US
240628901$24062890$1$I$20240101$20240702$20240709$20240709$PER$$US-ABBVIE-5828832$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240628911$24062891$1$I$$20240625$20240709$20240709$PER$$US-TEVA-VS-3215251$TEVA$$$$$F$Y$$$20240709$$HP$US$US
240628922$24062892$2$F$20240701$20240709$20240709$20240711$PER$$US-AMGEN-USASP2024134883$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240628931$24062893$1$I$$20240703$20240709$20240709$EXP$$US-ABBVIE-5831082$ABBVIE$$$$$M$Y$$$20240709$$CN$US$US
240628941$24062894$1$I$20231201$20240702$20240709$20240709$EXP$$NVSC2024IN060524$NOVARTIS$$57$YR$$F$Y$$$20240709$$CN$IN$IN
240628951$24062895$1$I$20240606$20240627$20240709$20240709$EXP$$US-NOVOPROD-1246444$NOVO NORDISK$$$$$F$Y$$$20240709$$CN$US$US
240628961$24062896$1$I$$20240626$20240709$20240709$EXP$$US-NOVOPROD-1246249$NOVO NORDISK$$$$$F$Y$$$20240709$$CN$US$US
240628971$24062897$1$I$$20240627$20240709$20240709$EXP$$US-NOVOPROD-1246302$NOVO NORDISK$$$$$M$Y$$$20240709$$CN$US$US
240628981$24062898$1$I$$20240626$20240709$20240709$EXP$$US-NOVOPROD-1247864$NOVO NORDISK$$$$$M$Y$$$20240709$$HP$US$US
240628991$24062899$1$I$$20240627$20240709$20240709$EXP$$US-NOVOPROD-1248061$NOVO NORDISK$$$$$M$Y$$$20240709$$HP$US$US
240629001$24062900$1$I$20230707$20240627$20240709$20240709$EXP$$US-NOVOPROD-1247333$NOVO NORDISK$$57$YR$$M$Y$$$20240709$$CN$US$US
240629011$24062901$1$I$20240601$20240626$20240709$20240709$EXP$$US-NOVOPROD-1247560$NOVO NORDISK$$$$$$Y$$$20240709$$CN$US$US
240629021$24062902$1$I$20240531$20240628$20240709$20240709$EXP$SE-SEMPA-2024-005198$SE-NOVOPROD-1247164$NOVO NORDISK$$23$YR$$F$Y$$$20240709$$MD$SE$SE
240629031$24062903$1$I$20240101$20240627$20240709$20240709$EXP$$US-NOVOPROD-1248115$NOVO NORDISK$$66$YR$$F$Y$$$20240709$$CN$US$US
240629041$24062904$1$I$20240624$20240628$20240709$20240709$EXP$FR-AFSSAPS-MA2024001119$FR-NOVOPROD-1247135$NOVO NORDISK$$33$YR$$M$Y$85$KG$20240709$$MD$FR$FR
240629051$24062905$1$I$20220601$20240627$20240709$20240709$EXP$$US-NOVOPROD-1246486$NOVO NORDISK$$76$YR$$F$Y$$$20240709$$CN$US$US
240629061$24062906$1$I$$20240703$20240709$20240709$EXP$$JP-GSK-JP2024JPN082716$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$PH$JP$JP
240629071$24062907$1$I$$20240702$20240709$20240709$EXP$CA-Accord-298708$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037557$BOEHRINGER INGELHEIM$$56$YR$A$F$Y$$$20240709$$HP$CA$CA
240629081$24062908$1$I$$20240626$20240709$20240709$EXP$$US-DEXPHARM-2024-2088$DEXCEL$Khawam S, Goudie M, Hartfield R, Hassan S, Padder F. A Case of Trazadone and Omeprazole Associated Wenckebach Phenomenon Disguised as Second-degree Mobitz Type 2 AV Block. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5664. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5664.$26$YR$A$F$Y$$$20240709$$HP$US$US
240629092$24062909$2$F$$20240707$20240709$20240710$PER$$US-AMGEN-USASP2024134710$AMGEN$$$$$F$Y$$$20240710$$HP$US$US
240629101$24062910$1$I$20240601$20240628$20240709$20240709$EXP$$US-MALLINCKRODT-MNK202404274$MALLINCKRODT$$52$YR$A$F$Y$200$KG$20240709$$HP$US$US
240629112$24062911$2$F$$20240807$20240709$20240813$EXP$$JP-JNJFOC-20240720618$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240813$$MD$JP$JP
240629121$24062912$1$I$$20240628$20240709$20240709$EXP$$AU-NOVOPROD-1247412$NOVO NORDISK$$31$YR$$F$Y$$$20240709$$MD$AU$AU
240629131$24062913$1$I$$20240705$20240709$20240709$EXP$$CA-AstraZeneca-2024A129347$ASTRAZENECA$$$$$M$Y$$$20240709$$CN$CA$
240629142$24062914$2$F$20240412$20240718$20240709$20240726$EXP$GB-MHRA-MED-202406281509187300-RMWGY$GB-NOVOPROD-1247391$NOVO NORDISK$$22$YR$$M$Y$88$KG$20240726$$PH$GB$GB
240629151$24062915$1$I$$20240629$20240709$20240709$EXP$$BR-NOVOPROD-1247410$NOVO NORDISK$$61$YR$$M$Y$98$KG$20240709$$MD$BR$BR
240629161$24062916$1$I$$20240628$20240709$20240709$EXP$$US-NOVOPROD-1248610$NOVO NORDISK$$$$A$F$Y$$$20240709$$CN$US$US
240629171$24062917$1$I$20240625$20240628$20240709$20240709$EXP$$US-NOVOPROD-1248843$NOVO NORDISK$$$$$F$Y$$$20240709$$CN$US$US
240629182$24062918$2$F$20240621$20240712$20240709$20240723$EXP$$JP-NOVOPROD-1247408$NOVO NORDISK$$8$DEC$$M$Y$94.1$KG$20240723$$MD$JP$JP
240629191$24062919$1$I$20230417$20240628$20240709$20240709$EXP$$US-NOVOPROD-1248700$NOVO NORDISK$$64$YR$$F$Y$$$20240709$$CN$US$US
240629201$24062920$1$I$$20240628$20240709$20240709$EXP$$US-NOVOPROD-1248124$NOVO NORDISK$$$$$F$Y$$$20240709$$CN$US$US
240629211$24062921$1$I$$20240629$20240709$20240709$EXP$$BR-NOVOPROD-1248531$NOVO NORDISK$$51$YR$$M$Y$85$KG$20240709$$CN$BR$BR
240629221$24062922$1$I$$20240628$20240709$20240709$EXP$$JP-NOVOPROD-1249536$NOVO NORDISK$$$$$M$Y$$$20240709$$CN$JP$JP
240629231$24062923$1$I$$20240701$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407003423$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240709$$CN$US$US
240629242$24062924$2$F$20240625$20240717$20240709$20240723$EXP$$CA-JNJFOC-20240708214$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240723$$CN$CA$CA
240629251$24062925$1$I$20220101$20240703$20240709$20240709$30DAY$$US-SANDOZ INC.-SDZ2024US062764$SANDOZ$$72$YR$$F$Y$$$20240709$$CN$US$US
240629261$24062926$1$I$$20240706$20240709$20240709$PER$$US-HALEON-2185866$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240629272$24062927$2$F$$20240830$20240709$20240831$EXP$$JP-ABBVIE-5831432$ABBVIE$$81$YR$$F$Y$$$20240831$$CN$JP$JP
240629283$24062928$3$F$$20240916$20240709$20240926$EXP$$PR-MALLINCKRODT-MNK202404227$MALLINCKRODT$$$$$F$Y$64$KG$20240926$$HP$PR$PR
240629292$24062929$2$F$20230101$20240822$20240709$20240915$PER$$US-SA-2024SA197338$SANOFI AVENTIS$$54$YR$A$F$Y$170$KG$20240915$$MD$US$US
240629301$24062930$1$I$$20240702$20240709$20240709$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01179$NOVITIUM PHARMA$Yang Bo.Death Caused by Disseminated Herpes Zoster in a Patient with Multiple Myeloma: A Case Report and Literature Review.Clinical, Cosmetic and Investigational Dermatology.27-APR-2024;17:941-951$58$YR$A$M$Y$$$20240709$$HP$CN$CN
240629311$24062931$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134782$AMGEN$$$$$$Y$$$20240708$$HP$US$US
240629321$24062932$1$I$$20240704$20240709$20240709$EXP$PL-URPL-2-973-2020$PL-JNJFOC-20240716810$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240709$$CN$PL$PL
240629332$24062933$2$F$$20240617$20240709$20240808$PER$$AU-TOLMAR, INC.-24AU050271$TOLMAR$$$$$M$Y$$$20240808$$CN$AU$AU
240629341$24062934$1$I$20240616$20240616$20240709$20240709$PER$$CA-TOLMAR, INC.-24CA050284$TOLMAR$$7$YR$$M$Y$$$20240709$$CN$CA$CA
240629352$24062935$2$F$20240616$20240705$20240709$20240731$PER$$CA-TOLMAR, INC.-24CA050263$TOLMAR$$66$YR$$M$Y$$$20240731$$CN$CA$CA
240629372$24062937$2$F$20240101$20240730$20240709$20240826$PER$$IL-TOLMAR, INC.-24IL050267$TOLMAR$$$$$M$Y$$$20240826$$PH$IL$IL
240629381$24062938$1$I$$20240616$20240709$20240709$PER$$US-TOLMAR, INC.-24US050265$TOLMAR$$$$$M$Y$$$20240709$$CN$US$US
240629391$24062939$1$I$$20240616$20240709$20240709$PER$$US-TOLMAR, INC.-24US050280$TOLMAR$$$$$M$Y$$$20240709$$CN$US$US
240629401$24062940$1$I$20240101$20240701$20240709$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-020185$UNITED THERAPEUTICS$$$$$F$Y$$$20240709$$$US$US
240629411$24062941$1$I$20210901$20240702$20240709$20240709$EXP$$US-BEIGENE-BGN-2024-010358$BEIGENE$$$$$$Y$$$20240709$$PH$US$US
240629423$24062942$3$F$$20240626$20240709$20240712$PER$$US-ROCHE-10000018876$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240629433$24062943$3$F$20240616$20240711$20240709$20240715$PER$$US-ROCHE-10000007197$ROCHE$$74$YR$E$F$Y$94.34$KG$20240715$$CN$US$US
240629441$24062944$1$I$$20240625$20240709$20240709$EXP$$PT-STERISCIENCE B.V.-2024-ST-000962$Steriscience PTE$Bourbon Ruao M, Pestana I, Passos R, Monte JR, Martinho A.. Acute Iron Poisoning: A Case of Fulminant Hepatic Failure.. Acta-Med-Port. 2024;37 (6):470-472$38$YR$$F$Y$$$20240709$$HP$PT$PT
240629451$24062945$1$I$20240101$20240701$20240709$20240709$PER$$US-SA-2024SA198028$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240709$$MD$US$US
240629461$24062946$1$I$20240322$20240704$20240709$20240709$EXP$ES-AEMPS-1541914$ES-SA-2024SA197959$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240709$$PH$ES$ES
240629471$24062947$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA198047$SANOFI AVENTIS$$$$C$M$Y$$$20240709$$MD$US$US
240629482$24062948$2$F$20240601$20240717$20240709$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002670$ACADIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240809$$CN$US$US
240629491$24062949$1$I$$20240708$20240709$20240709$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038535$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240709$$CN$US$US
240629501$24062950$1$I$$20240703$20240709$20240709$PER$$US-ALXN-202407USA000217US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240629511$24062951$1$I$$20240703$20240709$20240709$PER$$US-ABBVIE-5829335$ABBVIE$$$$A$F$Y$$$20240709$$HP$US$US
240629521$24062952$1$I$$20240701$20240709$20240709$EXP$$FR-EMD Serono-2024033284$EMD SERONO INC$$33$YR$A$F$Y$$$20240709$$CN$FR$FR
240629531$24062953$1$I$20240201$20240704$20240709$20240709$EXP$FR-AFSSAPS-TS2024000749$FR-SA-2024SA197609$SANOFI AVENTIS$$79$YR$E$M$Y$107$KG$20240709$$MD$FR$FR
240629541$24062954$1$I$$20240705$20240709$20240709$EXP$$CN-BEIGENE-BGN-2024-010506$BEIGENE$Zhao Z.-R.; Liu S.-L.; Zhou T.; Li Z.-C.; Wu J.-D.; Xi M.; Lin Y.-B.; Yang H.. Stereotactic body radiation therapy with sequential immunochemotherapy as neoadjuvant therapy in resectable non-small cell lung cancer (SACTION-01 study). Journal of Clinical Oncology. 2023;41:16$$$$$Y$$$20240709$$MD$CN$CN
240629551$24062955$1$I$$20240626$20240709$20240709$PER$$US-SA-2024SA195368$SANOFI AVENTIS$$$$$$Y$$$20240709$$HP$US$US
240629561$24062956$1$I$20240501$20240703$20240709$20240709$PER$$US-SA-2024SA200204$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240709$$MD$US$US
240629571$24062957$1$I$$20240626$20240709$20240709$PER$$US-SA-2024SA193558$SANOFI AVENTIS$$$$A$F$Y$81.64$KG$20240709$$MD$US$US
240629581$24062958$1$I$20240704$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134198$AMGEN$$56$YR$A$F$Y$$$20240708$$CN$US$US
240629591$24062959$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134816$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240629602$24062960$2$F$20240622$20240807$20240709$20240809$PER$$US-ROCHE-10000018547$ROCHE$$$$$F$Y$$$20240809$$CN$US$US
240629611$24062961$1$I$$20240626$20240709$20240709$PER$$US-ROCHE-10000014287$ROCHE$$$$T$F$Y$$$20240709$$CN$US$US
240629621$24062962$1$I$$20240707$20240709$20240709$PER$$US-HALEON-2185873$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240629642$24062964$2$F$20240416$20240705$20240709$20240718$EXP$$US-UCBSA-2024019755$UCB$$41$YR$$M$Y$$$20240718$$CN$US$US
240629651$24062965$1$I$$20240704$20240709$20240709$PER$$US-ABBVIE-5830098$ABBVIE$$$$$$Y$$$20240709$$CN$US$US
240629662$24062966$2$F$20240614$20240704$20240709$20240711$EXP$$PL-JNJFOC-20240715122$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240711$$MD$PL$PL
240629681$24062968$1$I$20230601$20240701$20240709$20240709$EXP$FR-AFSSAPS-GR2024000774$FR-Orion Corporation ORION PHARMA-24_00030607$ORION$$84$YR$E$F$Y$$$20240709$$PH$FR$
240629691$24062969$1$I$20081103$20081107$20240709$20240709$PER$$US-CHATTEMPRD-BI2008BP16941BP$CHATTEM$$49$YR$A$F$Y$$$20240709$$CN$US$US
240629703$24062970$3$F$$20240708$20240709$20240712$EXP$$FR-GSK-FR2024GSK084140$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$MD$FR$FR
240629711$24062971$1$I$$20240704$20240709$20240709$PER$$US-ABBVIE-5830279$ABBVIE$$$$$$Y$$$20240709$$CN$US$US
240629721$24062972$1$I$$20240702$20240709$20240709$EXP$$IN-NOVITIUMPHARMA-2024INNVP01186$NOVITIUM PHARMA$S. M. Chiu.Interstitial Pneumonia With Autoimmune Features Mimicking Paradoxical Responses in a Patient Under Treatment for Tuberculosis: A Case Report.American Journal of Respiratory and Critical Care Medicine.19-MAY-2024;209:A2080 - A2080$25$YR$A$M$Y$$$20240709$$HP$IN$IN
240629732$24062973$2$F$20240626$20240809$20240709$20240811$PER$$US-JNJFOC-20240671377$JOHNSON AND JOHNSON$$$$$F$Y$$$20240811$$CN$US$US
240629743$24062974$3$F$$20240812$20240709$20240815$EXP$$RU-JNJFOC-20240711935$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240815$$HP$RU$RU
240629751$24062975$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004595$ELI LILLY AND CO$$$$$F$Y$$$20240709$$HP$US$US
240629762$24062976$2$F$$20240830$20240709$20240905$EXP$$GR-AMGEN-GRCSP2024133932$AMGEN$$40$YR$A$F$Y$$$20240904$$MD$GR$GR
240629773$24062977$3$F$20240617$20240709$20240709$20240729$PER$$US-AMGEN-USASP2024134284$AMGEN$$82$YR$E$F$Y$$$20240729$$CN$US$US
240629784$24062978$4$F$20240601$20240802$20240709$20240808$EXP$$US-AMGEN-USASP2024134748$AMGEN$$$$$M$Y$$$20240808$$CN$US$US
240629792$24062979$2$F$20240705$20240709$20240709$20240712$PER$$US-AMGEN-USASP2024134301$AMGEN$$69$YR$E$F$Y$$$20240712$$HP$US$US
240629801$24062980$1$I$$20240707$20240709$20240709$PER$$US-HALEON-2185877$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240629811$24062981$1$I$$20240702$20240709$20240709$EXP$$US-GSK-US2024AMR082867$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$US$US
240629821$24062982$1$I$20240605$20240703$20240709$20240709$EXP$DE-PEI-CADR2024329042$DE-GSK-DE2024082531$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$DE$DE
240629842$24062984$2$F$$20240731$20240709$20240805$EXP$$US-BIOGEN-2024BI01272652$BIOGEN$$$$$F$Y$$$20240805$$HP$US$US
240629851$24062985$1$I$$20240704$20240709$20240709$EXP$$IT-BIOGEN-2024BI01272683$BIOGEN$$$$$M$Y$$$20240709$$MD$IT$IT
240629863$24062986$3$F$20240509$20240829$20240709$20240903$EXP$$US-BIOGEN-2024BI01272677$BIOGEN$$57$YR$$F$Y$$$20240903$$CN$US$US
240629871$24062987$1$I$$20240704$20240709$20240709$EXP$$CA-BIOGEN-2024BI01272673$BIOGEN$$$$$F$Y$$$20240709$$CN$CA$CA
240629882$24062988$2$F$20240509$20240716$20240709$20240719$PER$$US-AMGEN-USASP2024131967$AMGEN$$61$YR$A$F$Y$65$KG$20240719$$PH$US$US
240629891$24062989$1$I$$20240701$20240709$20240709$EXP$$CN-WT-2024-38916435-P1$Waylis$Zhang Z, Lian Q. et. al. Lentivirus-modified hematopoietic stem cell gene therapy for advanced symptomatic juvenile metachromatic leukodystrophy: A long-term follow-up pilot study. Protein Cell. 2024 Jun 25:pwae037.$18$YR$$F$Y$$$20240709$$MD$CN$CN
240629901$24062990$1$I$$20240701$20240709$20240709$EXP$$US-VIIV HEALTHCARE LIMITED-US2024081655$VIIV$$$$$M$Y$$$20240709$$HP$US$US
240629911$24062991$1$I$$20240702$20240709$20240709$EXP$$NVSC2024RU139607$NOVARTIS$$$$$F$Y$$$20240709$$MD$RU$RU
240629921$24062992$1$I$$20240627$20240709$20240709$PER$$US-CHATTEMPRD-2024OHG022973$CHATTEM$$$$$$Y$$$20240709$$CN$US$US
240629931$24062993$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2010-02469$AUROBINDO$CHAUDHRY M, TARNEJA N, GUNDALE A, ROA D, LEVEY R. Bone marrow suppression: a side effect of ciprofloxacin therapy. American journal of therapeutics. 2010;17(5):167 - 168$50$YR$$F$Y$$$20240709$$HP$US$US
240629941$24062994$1$I$$20240701$20240709$20240709$EXP$$US-BIOGEN-2024BI01272031$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
240629952$24062995$2$F$$20240729$20240709$20240806$30DAY$$US-GSK-US2024082981$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$CN$US$US
240629961$24062996$1$I$20240701$20240701$20240709$20240709$30DAY$$US-GSK-US2024082200$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240709$$CN$US$US
240629971$24062997$1$I$$20240701$20240709$20240709$PER$$US-CHATTEMPRD-2024OHG022827$CHATTEM$$$$$M$Y$$$20240709$$CN$US$US
240629981$24062998$1$I$$20240702$20240709$20240709$PER$$NVSC2024US138206$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240629992$24062999$2$F$20240518$20240705$20240709$20240712$EXP$$NVSC2024IN109016$NOVARTIS$$1$YR$$M$Y$$$20240712$$MD$IN$IN
240630011$24063001$1$I$$20240514$20240709$20240709$PER$$US-AMGEN-USASP2024133659$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240630022$24063002$2$F$20240702$20240711$20240709$20240715$PER$$US-AMGEN-USASP2024133778$AMGEN$$52$YR$A$F$Y$$$20240715$$CN$US$US
240630033$24063003$3$F$$20240906$20240709$20240911$EXP$$AU-AMGEN-AUSSP2024130708$AMGEN$$77$YR$E$M$Y$53.6$KG$20240911$$MD$AU$AU
240630042$24063004$2$F$20240705$20240912$20240709$20240916$PER$$US-AMGEN-USASP2024134321$AMGEN$$60$YR$A$F$Y$$$20240916$$HP$US$US
240630051$24063005$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134719$AMGEN$$$$$$Y$$$20240708$$CN$US$US
240630061$24063006$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134867$AMGEN$$$$$$Y$$$20240708$$PH$US$US
240630071$24063007$1$I$$20240702$20240709$20240709$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR082904$VIIV$$$$$M$Y$$$20240709$$HP$US$US
240630082$24063008$2$F$20240501$20240722$20240709$20240725$EXP$$JP-SA-2024SA195451$SANOFI AVENTIS$$$$$$Y$$$20240726$$MD$JP$JP
240630091$24063009$1$I$20240520$20240701$20240709$20240709$EXP$$CN-ROCHE-10000019196$ROCHE$$66$YR$E$F$Y$69$KG$20240709$$HP$CN$CN
240630101$24063010$1$I$20240703$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004394$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240709$$CN$US$US
240630112$24063011$2$F$$20240722$20240709$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002477$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
240630121$24063012$1$I$$20240613$20240709$20240709$EXP$$CN-ROCHE-10000005533$ROCHE$$72$YR$E$F$Y$$$20240709$$MD$CN$CN
240630132$24063013$2$F$$20240716$20240709$20240726$EXP$$DE-TEVA-VS-3215302$TEVA$Literature Reference: Doldi F, Gessler N, Anwar O, Kahle A-K, Scherschel K, Rath B, et al. In-hospital mortality and major complications related to radiofrequency catheter ablations of over 10 000 supraventricular arrhythmias from 2005 to 2020: individualized case analysis of multicentric administrative data. Europace 2023; 25 (1): 130-136.; Doldi F, Gessler N, Anwar O, Kahle A-K, Scherschel K, Rath B, et al. In-hospital mortality and major complications related to radiofrequency catheter abl...$64$YR$$M$Y$$$20240726$$HP$DE$DE
240630145$24063014$5$F$20240101$20240806$20240709$20240814$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020229$UNITED THERAPEUTICS$$$$$F$Y$68.481$KG$20240814$$$US$US
240630153$24063015$3$F$20240622$20240627$20240709$20240717$30DAY$$US-JNJFOC-20240675063$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240717$$HP$US$US
240630163$24063016$3$F$20240601$20240813$20240709$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002855$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240830$$CN$US$US
240630172$24063017$2$F$20240628$20240715$20240709$20240722$PER$$US-BIOGEN-2024BI01272209$BIOGEN$$79$YR$$F$Y$$$20240722$$CN$US$US
240630181$24063018$1$I$$20240701$20240709$20240709$PER$$US-BIOGEN-2024BI01272284$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
240630192$24063019$2$F$20240501$20240807$20240709$20240810$EXP$$TR-ABBVIE-5831277$ABBVIE$$$$A$F$Y$$$20240810$$MD$TR$TR
240630201$24063020$1$I$$20240220$20240709$20240709$PER$$US-AUROBINDO-AUR-APL-2024-006676$AUROBINDO$$$$$F$Y$$$20240709$$CN$US$US
240630211$24063021$1$I$$20240621$20240709$20240709$EXP$$PT-ROCHE-10000018659$ROCHE$$62$YR$A$M$Y$$$20240709$$HP$PT$PT
240630221$24063022$1$I$$20240701$20240709$20240709$PER$$US-CHATTEMPRD-2024OHG022901$CHATTEM$$31$YR$A$$Y$$$20240709$$CN$US$US
240630231$24063023$1$I$$20240702$20240709$20240709$EXP$$US-NOVITIUMPHARMA-2024USNVP01188$NOVITIUM PHARMA$Rachel M. Kirven.Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.Archives of Dermatological Research.25-MAY-2024;316:1-4$49$YR$A$F$Y$$$20240709$$HP$US$US
240630241$24063024$1$I$$20240328$20240709$20240709$PER$$US-AUROBINDO-AUR-APL-2024-016588$AUROBINDO$$19$YR$$M$Y$$$20240709$$HP$US$US
240630251$24063025$1$I$$20240405$20240709$20240709$PER$$US-AUROBINDO-AUR-APL-2024-017637$AUROBINDO$$$$$$Y$$$20240709$$CN$US$US
240630261$24063026$1$I$$20240703$20240709$20240709$PER$$US-CHATTEMPRD-2024OHG021426$CHATTEM$$84$YR$E$F$Y$$$20240709$$CN$US$US
240630272$24063027$2$F$$20240701$20240709$20240712$PER$$US-ROCHE-10000018947$ROCHE$$53$YR$A$F$Y$$$20240712$$HP$US$US
240630281$24063028$1$I$$20240705$20240709$20240709$PER$$US-ABBVIE-5830772$ABBVIE$$$$$$Y$$$20240709$$CN$US$US
240630292$24063029$2$F$$20240705$20240709$20240715$PER$$US-CHATTEMPRD-2024OHG023351$CHATTEM$$$$$F$Y$$$20240715$$CN$US$US
240630305$24063030$5$F$20240610$20240801$20240709$20240806$EXP$$NVSJ2024JP008203$NOVARTIS$$90$YR$$F$Y$$$20240806$$MD$JP$JP
240630311$24063031$1$I$20180828$20190314$20240709$20240709$EXP$$JP-GSK-JP2018JPN160824$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$JP$JP
240630322$24063032$2$F$$20240703$20240709$20240711$PER$$US-ROCHE-10000020190$ROCHE$$58$YR$A$F$Y$$$20240711$$CN$US$US
240630342$24063034$2$F$20240601$20240709$20240709$20240710$PER$$US-AMGEN-USASP2024134774$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240630351$24063035$1$I$$20240627$20240709$20240709$EXP$$PT-TEVA-VS-3215693$TEVA$$$$E$$Y$$$20240709$$HP$PT$PT
240630361$24063036$1$I$$20240702$20240709$20240709$EXP$$US-JNJFOC-20240708367$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240630371$24063037$1$I$$20240617$20240709$20240709$PER$$AU-TOLMAR, INC.-24AU050299$TOLMAR$$$$$M$Y$$$20240709$$CN$AU$AU
240630391$24063039$1$I$20240608$20240617$20240709$20240709$PER$$BR-TOLMAR, INC.-24BR050304$TOLMAR$$8$YR$$F$Y$$$20240709$$CN$BR$BR
240630402$24063040$2$F$20240521$20240722$20240709$20240807$PER$$BR-TOLMAR, INC.-24BR049919$TOLMAR$$9$YR$$F$Y$$$20240806$$MD$BR$BR
240630411$24063041$1$I$20240501$20240617$20240709$20240709$PER$$BR-TOLMAR, INC.-24BR050306$TOLMAR$$9$YR$$F$Y$$$20240709$$CN$BR$BR
240630421$24063042$1$I$20240501$20240617$20240709$20240709$PER$$BR-TOLMAR, INC.-24BR050307$TOLMAR$$10$YR$$F$Y$$$20240709$$CN$BR$BR
240630431$24063043$1$I$20240617$20240617$20240709$20240709$PER$$BR-TOLMAR, INC.-24BR050308$TOLMAR$$9$YR$$F$Y$$$20240709$$CN$BR$BR
240630441$24063044$1$I$20240620$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024133984$AMGEN$$62$YR$A$M$Y$$$20240708$$CN$US$US
240630451$24063045$1$I$$20240624$20240709$20240709$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01058$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240709$$HP$US$US
240630461$24063046$1$I$$20240624$20240709$20240709$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01055$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240709$$MD$US$US
240630481$24063048$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004078$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240709$$CN$US$US
240630491$24063049$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407002830$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240709$$CN$US$US
240630501$24063050$1$I$$20240613$20240709$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002840$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240630511$24063051$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004469$ELI LILLY AND CO$$58$YR$A$$Y$$$20240709$$CN$US$US
240630521$24063052$1$I$20240101$20240704$20240709$20240709$EXP$IT-MINISAL02-989234$IT-ROCHE-10000016721$ROCHE$$51$YR$A$F$Y$$$20240709$$MD$IT$IT
240630531$24063053$1$I$20170210$20191121$20240709$20240709$EXP$$IT-GSK-IT2024EME083601$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$IT$IT
240630542$24063054$2$F$$20240917$20240709$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024083048$VIIV$$$$$$Y$$$20240927$$HP$US$US
240630551$24063055$1$I$20140101$20240701$20240709$20240709$EXP$$US-JNJFOC-20240706630$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240709$$HP$US$US
240630561$24063056$1$I$$20240701$20240709$20240709$EXP$$CN-WT-2024-38916435-P2$Waylis$Zhang Z, Lian Q. et. al. Lentivirus-modified hematopoietic stem cell gene therapy for advanced symptomatic juvenile metachromatic leukodystrophy: A long-term follow-up pilot study. Protein Cell. 2024 Jun 25:pwae037$6$YR$$F$Y$$$20240709$$MD$CN$CN
240630573$24063057$3$F$20230101$20240821$20240709$20240829$EXP$$JP-009507513-2404JPN000970J$MERCK$Saito F, Kawamata S, Arita H, Sumazaki M, Goto M, Shibayama T et al.. EP-0527 Preoperative chemotherapy for TNBC: Efforts to introduce ICI and examination of treatment efficacy. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 309$51$YR$$F$Y$$$20240829$$MD$JP$JP
240630581$24063058$1$I$$20240701$20240709$20240709$EXP$$CN-WT-2024-38916435-P3$Waylis$Zhang Z, Lian Q. et. al. Lentivirus-modified hematopoietic stem cell gene therapy for advanced symptomatic juvenile metachromatic leukodystrophy: A long-term follow-up pilot study. Protein Cell. 2024 Jun 25:pwae037$4$YR$$F$Y$$$20240709$$MD$CN$CN
240630592$24063059$2$F$$20240719$20240709$20240724$EXP$$US-EXELIXIS-CABO-24078771$EXELIXIS$$$$$F$Y$$$20240724$$CN$US$US
240630604$24063060$4$F$20240617$20240625$20240709$20240709$PER$$US-ROCHE-10000013583$ROCHE$$41$YR$A$F$Y$$$20240704$$CN$US$US
240630611$24063061$1$I$$20240703$20240709$20240709$EXP$$PT-ABBVIE-5830139$ABBVIE$$$$$$Y$$$20240709$$MD$PT$PT
240630621$24063062$1$I$$20240701$20240709$20240709$EXP$$DK-ROCHE-10000012858$ROCHE$Ammitzboll C, Thomsen M, Bartels L, Hansen C, Hermansen M, Hanel M, et al. COVID-19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post-Pandemic Concerns About the Impact of Rituximab. ACR Open Rheumatology John Wiley and Sons Inc. 2024;0 (0):1-10. doi:10.1002/acr2.11681.$$$$$Y$$$20240709$$MD$DK$DK
240630632$24063063$2$F$20240601$20240802$20240709$20240805$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038244$BOEHRINGER INGELHEIM$$88$YR$E$M$Y$$$20240805$$MD$JP$JP
240630641$24063064$1$I$$20240613$20240709$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002842$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240709$$CN$US$US
240630651$24063065$1$I$$20240708$20240709$20240709$EXP$PL-URPL-1-2794-2020$PL-JNJFOC-20240718961$JOHNSON AND JOHNSON$$20$YR$A$F$Y$60$KG$20240709$$HP$PL$PL
240630661$24063066$1$I$$20240704$20240709$20240709$PER$$NVSC2024US140130$NOVARTIS$$$$$$Y$$$20240709$$CN$US$US
240630672$24063067$2$F$20240619$20240809$20240709$20240820$EXP$$JP-ROCHE-10000016429$ROCHE$$54$YR$A$F$Y$$$20240820$$MD$JP$JP
240630692$24063069$2$F$$20240708$20240709$20240711$PER$$US-AMGEN-USASP2024134940$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240630702$24063070$2$F$20240528$20240619$20240709$20240709$EXP$$TW-ROCHE-10000009437$ROCHE$$79$YR$E$F$Y$69.7$KG$20240702$$MD$TW$TW
240630712$24063071$2$F$20240601$20240719$20240709$20240729$PER$$US-SA-2024SA195218$SANOFI AVENTIS$$53$YR$A$F$Y$63.5$KG$20240729$$MD$US$US
240630721$24063072$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA198174$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240709$$MD$US$US
240630731$24063073$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA195136$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240709$$MD$US$US
240630741$24063074$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA195215$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240709$$MD$US$US
240630751$24063075$1$I$20240708$20240708$20240709$20240709$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038497$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240709$$CN$US$US
240630761$24063076$1$I$20240316$20240614$20240709$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002858$ACADIA PHARMACEUTICALS$$86$YR$$F$Y$$$20240709$$PH$US$US
240630771$24063077$1$I$20240327$20240614$20240709$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002857$ACADIA PHARMACEUTICALS$$70$YR$$F$Y$$$20240709$$CN$US$US
240630781$24063078$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA198576$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240709$$MD$US$US
240630791$24063079$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134128$AMGEN$$$$A$M$Y$$$20240708$$CN$US$US
240630802$24063080$2$F$$20240702$20240709$20240709$PER$$US-ROCHE-10000018971$ROCHE$$$$A$F$Y$102.05$KG$20240709$$CN$US$US
240630811$24063081$1$I$$20240701$20240709$20240709$EXP$$RU-ROCHE-10000017209$ROCHE$$52$YR$A$$Y$$$20240709$$HP$RU$RU
240630822$24063082$2$F$20220217$20240722$20240709$20240730$EXP$ES-AEMPS-1539079$ES-SA-2024SA192756$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240730$$MD$ES$ES
240630831$24063083$1$I$$20240614$20240709$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002860$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240630841$24063084$1$I$$20240701$20240709$20240709$EXP$GB-MHRA-MED-202407010509548730-KZYWJ$GB-JUBILANT CADISTA PHARMACEUTICALS-2024GB000905$JUBILANT$$$$A$F$Y$$$20240709$$CN$GB$GB
240630851$24063085$1$I$20200101$20240628$20240709$20240709$EXP$DK-002147023-NVSC2021DK184095$DK-JUBILANT CADISTA PHARMACEUTICALS-2021DK001095$JUBILANT$$$$A$F$Y$$$20240709$$CN$DK$DK
240630861$24063086$1$I$20140215$20240624$20240709$20240709$EXP$$US-COOPERSURGICAL, INC.-2024CPS001989$COOPERSURGICAL$$$$$F$Y$$$20240709$$LW$US$US
240630871$24063087$1$I$$20240624$20240709$20240709$EXP$$GB-NORDICGR-056507$NORDIC PHARMA$$$$$F$Y$$$20240708$$PH$GB$GB
240630881$24063088$1$I$$20240624$20240709$20240709$EXP$GB-MHRA-MED-202404101048337590-NHLFW$GB-NORDICGR-056483$NORDIC PHARMA$$77$YR$$F$Y$$$20240708$$HP$GB$GB
240630891$24063089$1$I$20240129$20240624$20240709$20240709$EXP$$GB-NORDICGR-056496$NORDIC PHARMA$$81$YR$$F$Y$70.2$KG$20240709$$MD$GB$GB
240630902$24063090$2$F$$20240625$20240709$20240709$PER$$US-ROCHE-10000012690$ROCHE$$90$YR$E$F$Y$$$20240709$$CN$US$US
240630911$24063091$1$I$20240522$20240701$20240709$20240709$PER$$US-RDY-SPO/USA/24/0009709$DR REDDYS$$17$YR$T$$Y$$$20240709$$CN$US$US
240630921$24063092$1$I$$20240626$20240709$20240709$PER$$US-JNJFOC-20240673321$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$US$US
240630932$24063093$2$F$20240705$20240724$20240709$20240730$EXP$$JP-JNJFOC-20240720407$JOHNSON AND JOHNSON$$95$YR$E$F$Y$$$20240730$$PH$JP$JP
240630941$24063094$1$I$20230522$20240704$20240709$20240709$EXP$IT-MINISAL02-992833$IT-SA-2024SA199262$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240709$$MD$IT$IT
240630951$24063095$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-032889$AUROBINDO$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL.. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome. Pediatr-Nephrol. 2024$6$YR$$F$Y$$$20240709$$HP$US$US
240630962$24063096$2$F$20240601$20240710$20240709$20240716$PER$$US-UNITED THERAPEUTICS-UNT-2024-017542$UNITED THERAPEUTICS$$13$YR$$F$Y$41.27$KG$20240716$$$US$US
240630971$24063097$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004231$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240709$$CN$US$US
240630981$24063098$1$I$$20240625$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202406017362$ELI LILLY AND CO$$$$$F$Y$$$20240709$$CN$US$US
240630993$24063099$3$F$$20240821$20240709$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202407004986$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240822$$CN$US$US
240631001$24063100$1$I$20240703$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004178$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240709$$CN$US$US
240631011$24063101$1$I$$20240628$20240709$20240709$EXP$$US-RECORDATI RARE DISEASES-2024004980$RECORDATI$$$$$$Y$$$20240709$$CN$US$US
240631021$24063102$1$I$$20240625$20240709$20240709$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05788$LUPIN$Singh KB, Kumar S, Almalouf P. From the sea to the ICU: the unexpected journey of vibrio vulnificus compartment syndrome. American journal of respiratory and critical care medicine.. 2024;209:A1683$59$YR$$M$Y$$$20240709$$HP$US$US
240631032$24063103$2$F$20240101$20240807$20240709$20240812$PER$$US-AMGEN-USASP2024134531$AMGEN$$50$YR$A$M$Y$$$20240811$$HP$US$US
240631044$24063104$4$F$$20240904$20240709$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002834$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
240631053$24063105$3$F$20240704$20240718$20240709$20240722$PER$$US-AMGEN-USASP2024134425$AMGEN$$74$YR$E$M$Y$$$20240722$$PH$US$US
240631061$24063106$1$I$20240601$20240628$20240709$20240709$EXP$$AT-JNJFOC-20240714652$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240709$$MD$AT$AT
240631071$24063107$1$I$$20240701$20240709$20240709$PER$$US-JNJFOC-20240707352$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$MD$US$US
240631081$24063108$1$I$20240501$20240702$20240709$20240709$PER$$US-AMGEN-USASP2024131254$AMGEN$$55$YR$A$F$Y$$$20240708$$CN$US$US
240631091$24063109$1$I$20240416$20240702$20240709$20240709$EXP$LV-SAM-2024068252$LV-EMD Serono-2024033048$EMD SERONO INC$$43$YR$A$F$Y$63$KG$20240709$$CN$LV$LV
240631101$24063110$1$I$20240407$20240625$20240709$20240709$EXP$$PK-ROCHE-10000017495$ROCHE$$80$YR$E$M$Y$$$20240709$$CN$PK$PK
240631113$24063111$3$F$$20240808$20240709$20240813$30DAY$$FI-JNJFOC-20240666609$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$PH$FI$FI
240631121$24063112$1$I$20240708$20240708$20240709$20240709$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038345$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$52$KG$20240709$$MD$GB$GB
240631131$24063113$1$I$20201027$20210112$20240709$20240709$EXP$FR-AFSSAPS-TO20202003$FR-SA-2024SA197551$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240709$$MD$FR$FR
240631141$24063114$1$I$$20240703$20240709$20240709$EXP$$US-TAKEDA-2024TUS069100$TAKEDA$$$$$M$Y$64$KG$20240709$$MD$US$US
240631151$24063115$1$I$$20240612$20240709$20240709$EXP$$HU-SA-2018SA232593$SANOFI AVENTIS$$$$N$F$Y$$$20240709$$HP$HU$HU
240631174$24063117$4$F$20240301$20240730$20240709$20240806$EXP$$US-TORRENT-00013658$TORRENT$$84$YR$E$F$Y$$$20240806$$CN$US$US
240631181$24063118$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-032908$AUROBINDO$Khan A, Murag S, Chinchilla D.. Fatal Delay in Diagnosis and Surgical Management of Pulmonary Mucormycosis in a Renal Transplant Patient. Am-J-Respir-Crit-Care-Med. 2024$67$YR$$M$Y$$$20240709$$HP$US$US
240631191$24063119$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-033138$AUROBINDO$Lodh A, Blankenship S, Minish-Pron J, Lalani I.. Treatment of Acute Respiratory Failure Secondary to Chronic Graft-Versus-Host Disease With Fluticasone, Azithromycin, Montelukast, and High-Dose Glucocorticoids. Am-J-Respir-Crit-Care-Med. 2024;209:A5898$38$YR$$M$Y$$$20240709$$HP$US$US
240631202$24063120$2$F$$20240708$20240709$20240710$PER$$US-AMGEN-USASP2024134834$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240631212$24063121$2$F$20040705$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134409$AMGEN$$53$YR$A$M$Y$$$20240709$$CN$US$US
240631222$24063122$2$F$$20240716$20240709$20240726$EXP$$GB-TEVA-VS-3215353$TEVA$Cooray S, Price-Kuehne F, Hong Y, Omoyinmi E, Burleigh A, Gilmour KC, et al. Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4. Front-Immunol 2023; 14; Cooray S, Price-Kuehne F, Hong Y, Omoyinmi E, Burleigh A, Gilmour KC, et al. Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4. Front-Immunol 2023; 14.$$$C$M$Y$$$20240726$$HP$GB$GB
240631231$24063123$1$I$$20240624$20240709$20240709$EXP$$NL-MEDEXUS PHARMA, INC.-2024MED00297$MEDEXUS PHARMA$Baksteen-Van Den Berg M.C, Veen M, Roach R.E.J, van Andel M. Fatal epidermal necrosis due to methotrexate use. Ned. Tijdschr. Geneeskd. 2024;(1)$53$YR$$F$Y$$$20240709$$HP$NL$NL
240631241$24063124$1$I$20240705$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134262$AMGEN$$76$YR$E$M$Y$$$20240708$$CN$US$US
240631252$24063125$2$F$$20240708$20240709$20240711$PER$$US-ROCHE-10000019122$ROCHE$$68$YR$E$M$Y$$$20240711$$CN$US$US
240631261$24063126$1$I$$20240624$20240709$20240709$EXP$$GB-TEVA-VS-3215354$TEVA$Cooray S, Price-Kuehne F, Hong Y, Omoyinmi E, Burleigh A, Gilmour KC, et al. Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4. Front-Immunol 2023; 14.$$$C$F$Y$$$20240709$$HP$GB$GB
240631271$24063127$1$I$$20240606$20240709$20240709$EXP$$US-PTA-005697$BANNER$$$$$F$Y$$$20240709$$CN$US$US
240631281$24063128$1$I$$20240701$20240709$20240709$EXP$$GB-AstraZeneca-2024A151617$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$GB$
240631292$24063129$2$F$$20240709$20240709$20240711$PER$$US-ROCHE-10000018977$ROCHE$$$$$F$Y$$$20240711$$CN$US$US
240631301$24063130$1$I$$20240630$20240709$20240709$PER$$US-GILEAD-2024-0679828$GILEAD$$55$YR$A$M$Y$$$20240709$$CN$US$US
240631312$24063131$2$F$$20240628$20240709$20240709$PER$$US-ROCHE-10000018315$ROCHE$$68$YR$E$F$Y$$$20240709$$CN$US$US
240631321$24063132$1$I$20240101$20240702$20240709$20240709$EXP$$CA-APOTEX-2024AP007931$APOTEX$$$$E$M$Y$$$20240709$$CN$CA$CA
240631331$24063133$1$I$$20240624$20240709$20240709$EXP$$BR-PHATHOM PHARMACEUTICALS INC.-2024PHT00521$Phathom Pharmaceuticals$$$$$F$Y$88$KG$20240709$$CN$BR$BR
240631341$24063134$1$I$20240620$20240701$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-032854$AUROBINDO$$69$YR$$M$Y$96$KG$20240709$$CN$GB$GB
240631351$24063135$1$I$$20240627$20240709$20240709$PER$$US-ROCHE-10000015610$ROCHE$$$$$$Y$$$20240709$$CN$US$US
240631361$24063136$1$I$$20240625$20240709$20240709$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05781$LUPIN$Shapoo N, Poor A, Trenard N. Lost in the mix: A challenging diagnosis of myxedema coma in an elderly patient. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3392:1$86$YR$$M$Y$$$20240709$$HP$US$US
240631371$24063137$1$I$20240619$20240708$20240709$20240709$EXP$GB-MHRA-MED-202407080948169110-QCBRP$GB-JNJFOC-20240718828$JOHNSON AND JOHNSON$$55$YR$A$F$Y$93$KG$20240709$$HP$GB$GB
240631381$24063138$1$I$20240603$20240705$20240709$20240709$30DAY$$US-SANDOZ INC.-SDZ2024US063322$SANDOZ$$55$YR$$F$Y$$$20240709$$HP$US$US
240631392$24063139$2$F$$20240704$20240709$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063044$SANDOZ$$$$$M$Y$$$20240710$$CN$CA$CA
240631401$24063140$1$I$$20240708$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063450$SANDOZ$$63$YR$$M$Y$54$KG$20240709$$HP$CA$CA
240631411$24063141$1$I$$20240701$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-032712$AUROBINDO$$$$$F$Y$$$20240709$$CN$GB$GB
240631423$24063142$3$F$$20240911$20240709$20240913$EXP$$CA-SANDOZ INC.-NVSC2022CA172291$SANDOZ$$$$$M$Y$$$20240913$$CN$CA$CA
240631431$24063143$1$I$20240626$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004321$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240709$$HP$US$US
240631442$24063144$2$F$20240703$20240708$20240709$20240713$PER$$US-ELI_LILLY_AND_COMPANY-US202407004353$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240713$$CN$US$US
240631451$24063145$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004250$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240709$$CN$US$US
240631462$24063146$2$F$20240702$20240705$20240709$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407004110$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240712$$CN$US$US
240631483$24063148$3$F$20240621$20240802$20240709$20240813$PER$$US-ROCHE-10000011332$ROCHE$$68$YR$E$M$Y$94.8$KG$20240813$$CN$US$US
240631493$24063149$3$F$20240628$20240712$20240709$20240723$EXP$$JP-ROCHE-10000016993$ROCHE$$59$YR$A$F$Y$$$20240723$$MD$JP$JP
240631502$24063150$2$F$$20240703$20240709$20240711$PER$$US-ROCHE-10000020215$ROCHE$$28$YR$A$F$Y$$$20240711$$CN$US$US
240631521$24063152$1$I$$20240702$20240709$20240709$PER$$US-ROCHE-10000017929$ROCHE$$$$A$F$Y$$$20240709$$CN$US$US
240631531$24063153$1$I$20240201$20240703$20240709$20240709$PER$$US-ABBVIE-5829548$ABBVIE$$$$A$F$Y$$$20240709$$HP$US$US
240631541$24063154$1$I$20240101$20240627$20240709$20240709$PER$$US-SA-2024SA179041$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240709$$MD$US$US
240631551$24063155$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA102529$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240709$$MD$US$US
240631561$24063156$1$I$20240624$20240701$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-032674$AUROBINDO$$63$YR$$F$Y$57$KG$20240709$$PH$GB$GB
240631571$24063157$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA194960$SANOFI AVENTIS$$$$$$Y$110$KG$20240709$$PH$US$US
240631584$24063158$4$F$20240601$20240911$20240709$20240920$PER$$US-SA-2024SA194143$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240920$$MD$US$US
240631591$24063159$1$I$20240425$20240701$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-032717$AUROBINDO$$74$YR$$F$Y$$$20240709$$PH$GB$GB
240631601$24063160$1$I$$20240630$20240709$20240709$PER$$US-SA-2024SA195625$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240709$$MD$US$US
240631612$24063161$2$F$$20240711$20240709$20240722$PER$$US-SA-2024SA195828$SANOFI AVENTIS$$71$YR$E$M$Y$121.09$KG$20240722$$CN$US$US
240631622$24063162$2$F$20240101$20240924$20240709$20240927$PER$$US-SA-2024SA198577$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240927$$MD$US$US
240631631$24063163$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA197266$SANOFI AVENTIS$$$$A$M$Y$$$20240709$$MD$US$US
240631641$24063164$1$I$20240601$20240703$20240709$20240709$PER$$US-SA-2024SA199308$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240709$$MD$US$US
240631651$24063165$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA199305$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240709$$MD$US$US
240631662$24063166$2$F$20240628$20240701$20240709$20240713$PER$$US-SA-2024SA196727$SANOFI AVENTIS$$$$A$F$Y$$$20240713$$HP$US$US
240631672$24063167$2$F$$20240702$20240709$20240711$PER$$US-SA-2024SA196031$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240711$$CN$US$US
240631681$24063168$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA195260$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240709$$MD$US$US
240631691$24063169$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA198320$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240709$$CN$US$US
240631701$24063170$1$I$20210101$20240701$20240709$20240709$EXP$$DE-AUROBINDO-AUR-APL-2024-032765$AUROBINDO$$72$YR$$F$Y$$$20240709$$MD$DE$DE
240631711$24063171$1$I$$20240501$20240709$20240709$PER$$US-ROCHE-10000017627$ROCHE$$$$$F$Y$$$20240709$$CN$US$US
240631722$24063172$2$F$20240601$20240703$20240709$20240729$PER$$US-ROCHE-10000018262$ROCHE$$54$YR$A$M$Y$$$20240729$$CN$US$US
240631731$24063173$1$I$20240621$20240701$20240709$20240709$EXP$$IT-AUROBINDO-AUR-APL-2024-032843$AUROBINDO$$$$$M$Y$$$20240709$$MD$IT$IT
240631741$24063174$1$I$$20240701$20240709$20240709$PER$$US-ROCHE-10000017075$ROCHE$$$$$$Y$$$20240709$$HP$US$US
240631752$24063175$2$F$$20240829$20240709$20240906$PER$$US-ROCHE-10000019764$ROCHE$$$$E$F$Y$$$20240906$$CN$US$US
240631772$24063177$2$F$$20240731$20240709$20240815$EXP$$JP-VISIOX-2024VSX00058$Visiox$Matsuo M, et al. Minimally Invasive Direct Internal Cyclopexy in the Management of Goniotomy-Related Cyclodialysis Cleft with Hypotony Maculopathy. International Medical Case Reports Journal. 2024;17:545-553$67$YR$$M$Y$$$20240815$$MD$JP$JP
240631781$24063178$1$I$20240601$20240703$20240709$20240709$EXP$FR-AFSSAPS-PB2024000734$FR-RDY-SPO/FRA/24/0009768$DR REDDYS$$41$YR$A$F$Y$$$20240709$$MD$FR$FR
240631791$24063179$1$I$$20240703$20240709$20240709$PER$$US-AMGEN-USASP2024132816$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240631801$24063180$1$I$$20240703$20240709$20240709$EXP$$US-AMGEN-USASP2024132554$AMGEN$Fitzsimons J.; Phelan K.; Dhanarajan A. et al.. Hearing Loss in a Patient with Waldenstrom Macroglobulinemia Receiving  Bortezomib. Case Reports in Oncology. 2024;17 (1):653-657$67$YR$E$M$Y$$$20240709$$HP$US$US
240631811$24063181$1$I$$20240624$20240709$20240709$EXP$GB-MHRA-MED-202406220013389710-QTKVS$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001596$IPCA$$$$$$Y$$$20240709$$CN$GB$GB
240631822$24063182$2$F$$20240716$20240709$20240726$EXP$$FR-TEVA-VS-3215300$TEVA$Laurent C, Hentzien M, Pavel S, Didier K, Bermejo M, N^Guyen Y, et al. Mycobacterium genavense mesenteritis responsible for refractory chylous ascites despite multiple immunomodulatory therapies in a patient with AIDS. AIDS 2023; 37 (5): 856-858; Laurent C, Hentzien M, Pavel S, Didier K, Bermejo M, N^Guyen Y, et al. Mycobacterium genavense mesenteritis responsible for refractory chylous ascites despite multiple immunomodulatory therapies in a patient with AIDS. AIDS 2023; 37 (5): 856-858.; La...$35$YR$$F$Y$$$20240726$$HP$FR$FR
240631831$24063183$1$I$20230901$20240701$20240709$20240709$EXP$$FR-AUROBINDO-AUR-APL-2024-032795$AUROBINDO$$25$YR$$F$Y$$$20240709$$MD$FR$FR
240631841$24063184$1$I$20211022$20230306$20240709$20240709$PER$$US-CHIESI-2023CHF07219$CHIESI$$44$YR$$M$Y$66$KG$20240709$$CN$US$US
240631851$24063185$1$I$20240701$20240701$20240709$20240709$EXP$$IN-GSK-IN2024APC084303$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$IN$IN
240631862$24063186$2$F$20240601$20240708$20240709$20240712$EXP$$JP-JNJFOC-20240720499$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240712$$MD$JP$JP
240631871$24063187$1$I$20180101$20240708$20240709$20240709$EXP$$CA-ABBVIE-5456321$ABBVIE$$40$YR$$M$Y$136$KG$20240709$$HP$CA$CA
240631883$24063188$3$F$$20240708$20240709$20240716$EXP$$TW-JNJFOC-20240705106$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240716$$HP$TW$TW
240631901$24063190$1$I$$20240701$20240709$20240709$EXP$$IT-AUROBINDO-AUR-APL-2024-032813$AUROBINDO$Gardin A, Cavallaro M, Labate A. The importance of MRI in the acute phase of herpes encephalitis mimicking an acute ischemic stroke. Neurol-Sci. 2023;44:4563-4567$80$YR$$M$Y$$$20240709$$HP$IT$IT
240631911$24063191$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA197488$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240709$$MD$US$US
240631921$24063192$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA198052$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240709$$MD$US$US
240631933$24063193$3$F$20240601$20240819$20240709$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002841$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240912$$CN$US$US
240631944$24063194$4$F$20240610$20240823$20240709$20240829$EXP$$PK-ROCHE-10000014737$ROCHE$$52$YR$A$M$Y$$$20240829$$CN$PK$PK
240631951$24063195$1$I$$20240703$20240709$20240709$EXP$GB-MHRA-MED-202406281414140760-PYGTQ$GB-AMAROX PHARMA-AMR2024GB02104$HETERO$$$$$$Y$$$20240709$$CN$GB$GB
240631961$24063196$1$I$$20240628$20240709$20240709$PER$$US-ROCHE-10000016353$ROCHE$$$$$$Y$$$20240709$$CN$US$US
240631971$24063197$1$I$20240624$20240702$20240709$20240709$EXP$GB-MHRA-MED-202407021431371020-NYHLZ$GB-BAXTER-2024BAX021102$BAXTER$$42$YR$$M$Y$103$KG$20240709$$PH$GB$GB
240631981$24063198$1$I$$20240704$20240709$20240709$PER$$NVSC2024US139928$NOVARTIS$$$$$$Y$$$20240709$$CN$US$US
240631991$24063199$1$I$$20240701$20240709$20240709$PER$$US-ROCHE-10000018567$ROCHE$$69$YR$E$F$Y$$$20240709$$CN$US$US
240632001$24063200$1$I$$20240701$20240709$20240709$PER$$US-ROCHE-10000019152$ROCHE$$$$A$M$Y$$$20240709$$CN$US$US
240632011$24063201$1$I$$20240702$20240709$20240709$PER$$US-ROCHE-10000019225$ROCHE$$$$A$F$Y$$$20240709$$CN$US$US
240632022$24063202$2$F$20240514$20240830$20240709$20240830$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-020928$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240830$$CN$JP$JP
240632042$24063204$2$F$20240520$20240624$20240709$20240722$PER$$US-ROCHE-10000007387$ROCHE$$40$YR$A$F$Y$$$20240722$$CN$US$US
240632051$24063205$1$I$$20240704$20240709$20240709$PER$$US-AMGEN-USASP2024133387$AMGEN$$$$$$Y$$$20240709$$MD$US$US
240632061$24063206$1$I$$20240705$20240709$20240709$PER$$US-BIOVITRUM-2024-US-009553$BIOVITRUM$$$$E$M$Y$$$20240709$$CN$US$US
240632071$24063207$1$I$20240201$20240627$20240709$20240709$PER$$US-ROCHE-10000015465$ROCHE$$17$YR$T$F$Y$$$20240709$$HP$US$US
240632081$24063208$1$I$$20240702$20240709$20240709$PER$$US-AMGEN-USASP2024131799$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240632092$24063209$2$F$20240301$20240729$20240709$20240730$EXP$$NVSC2024PG140986$NOVARTIS$$41$YR$$M$Y$$$20240730$$MD$PG$PG
240632102$24063210$2$F$20240101$20240726$20240709$20240813$PER$$US-AstraZeneca-2024A146037$ASTRAZENECA$$25941$DY$$F$Y$$$20240813$$CN$US$
240632111$24063211$1$I$$20240704$20240709$20240709$EXP$$IN-Bion-013398$BIONPHARMA$$$$A$F$Y$1.54$KG$20240709$$HP$IN$IN
240632124$24063212$4$F$$20240627$20240709$20240808$PER$$US-ROCHE-10000016457$ROCHE$$54$YR$A$F$Y$$$20240808$$CN$US$US
240632132$24063213$2$F$20210812$20240702$20240709$20240710$EXP$$DE-EXELIXIS-XL18421046373$EXELIXIS$$61$YR$$M$Y$83$KG$20240710$$MD$DE$DE
240632141$24063214$1$I$$20240704$20240709$20240709$EXP$$IN-Bion-013396$BIONPHARMA$$$$A$F$Y$1.58$KG$20240709$$HP$IN$IN
240632151$24063215$1$I$$20240701$20240709$20240709$EXP$$US-Bion-013395$BIONPHARMA$$$$$$Y$$$20240709$$CN$US$US
240632161$24063216$1$I$$20240704$20240709$20240709$EXP$$US-Bion-013390$BIONPHARMA$$71$YR$E$F$Y$$$20240709$$HP$US$US
240632171$24063217$1$I$$20240705$20240709$20240709$PER$$NVSC2024US141234$NOVARTIS$$$$$F$Y$$$20240709$$MD$US$US
240632182$24063218$2$F$$20240808$20240709$20240812$EXP$$NVSC2024CL140967$NOVARTIS$$$$$M$Y$$$20240812$$CN$CL$CL
240632191$24063219$1$I$20240703$20240703$20240709$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-020419$UNITED THERAPEUTICS$$47$YR$$F$Y$$$20240709$$$US$US
240632201$24063220$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-032866$AUROBINDO$Tatapudi S, Sarva ST, Jayaraman G, Krupa MS, Bhimaraj A, Kesavan RB.. Silicone Heart: Unraveling Cardiac Sarcoidosis in a 42-Year-Old Female.. Am-J-Respir-Crit-Care-Med. 2024;209:A5912$42$YR$$F$Y$$$20240709$$HP$US$US
240632211$24063221$1$I$$20240704$20240709$20240709$PER$$US-ABBVIE-5829631$ABBVIE$$$$A$$Y$$$20240709$$CN$US$US
240632221$24063222$1$I$20240528$20240705$20240709$20240709$EXP$$JP-TAKEDA-2024TJP008248$TAKEDA$$6$DEC$$M$Y$$$20240709$$MD$JP$JP
240632245$24063224$5$F$$20240828$20240709$20240902$EXP$$US-ABBVIE-5828249$ABBVIE$$$$$F$Y$91$KG$20240902$$CN$US$US
240632251$24063225$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-032930$AUROBINDO$Guzman A. Should Severe Hypertriglyceridemia Also Be Considered as a Contraindication for Use of Glucagon like Peptide 1 (GLP-1) Agonists. J-Endocr-Soc (Journal of the Endocrine Society). 2020;4 (Suppl.):A122$46$YR$$M$Y$$$20240709$$MD$US$US
240632261$24063226$1$I$20240101$20240630$20240709$20240709$PER$$US-SA-2024SA196118$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240709$$MD$US$US
240632272$24063227$2$F$$20240710$20240709$20240718$PER$$US-SA-2024SA197170$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240718$$MD$US$US
240632281$24063228$1$I$20240101$20240627$20240709$20240709$PER$$US-SA-2024SA195374$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240709$$MD$US$US
240632291$24063229$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA195331$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240709$$MD$US$US
240632301$24063230$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA195349$SANOFI AVENTIS$$$$E$F$Y$58.5$KG$20240709$$MD$US$US
240632311$24063231$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA195422$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240709$$CN$US$US
240632321$24063232$1$I$20240701$20240703$20240709$20240709$PER$$US-SA-2024SA198946$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240709$$CN$US$US
240632332$24063233$2$F$20240507$20240701$20240709$20240711$PER$$US-SA-2024SA198838$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240711$$MD$US$US
240632341$24063234$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA198631$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240709$$MD$US$US
240632351$24063235$1$I$$20240630$20240709$20240709$EXP$$US-Bion-013401$BIONPHARMA$$$$$$Y$$$20240709$$CN$US$US
240632361$24063236$1$I$20230801$20240701$20240709$20240709$PER$$US-SA-2024SA199311$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240709$$MD$US$US
240632372$24063237$2$F$20240601$20240715$20240709$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002646$ACADIA PHARMACEUTICALS$$17$YR$$M$Y$$$20240809$$CN$US$US
240632381$24063238$1$I$20240601$20240703$20240709$20240709$EXP$$JP-009507513-2407JPN000420J$MERCK$$8$DEC$$F$Y$$$20240709$$MD$JP$JP
240632392$24063239$2$F$$20240718$20240709$20240723$EXP$$DE-UNITED THERAPEUTICS-UNT-2024-020559$UNITED THERAPEUTICS$$$$E$$Y$$$20240723$$$DE$DE
240632401$24063240$1$I$20150101$20211021$20240709$20240709$EXP$FR-AFSSAPS-AVGR20211135$FR-SA-2024SA197443$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240709$$PH$FR$FR
240632411$24063241$1$I$20231017$20240123$20240709$20240709$PER$$US-AUROBINDO-AUR-APL-2023-063853$AUROBINDO$$85$YR$$$Y$67$KG$20240709$$PH$US$US
240632421$24063242$1$I$$20240614$20240709$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-005638$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240709$$HP$US$US
240632431$24063243$1$I$20231017$20240123$20240709$20240709$PER$$US-AUROBINDO-AUR-APL-2023-063841$AUROBINDO$$34$YR$$F$Y$58$KG$20240709$$PH$US$US
240632441$24063244$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-032789$AUROBINDO$Singh KB, Kumar S, Almalouf P.. From the Sea to the ICU: The Unexpected Journey of Vibrio Vulnificus Compartment Syndrome. Am-J-Respir-Crit-Care-Med. 2024$59$YR$$M$Y$$$20240709$$HP$US$US
240632451$24063245$1$I$$20240703$20240709$20240709$PER$$US-BIOGEN-2024BI01272333$BIOGEN$$$$$M$Y$$$20240709$$CN$US$US
240632462$24063246$2$F$$20240723$20240709$20240730$PER$$US-BIOGEN-2024BI01272256$BIOGEN$$$$$M$Y$$$20240730$$CN$US$US
240632473$24063247$3$F$20240708$20240809$20240709$20240812$PER$$US-AMGEN-USASP2024135025$AMGEN$$74$YR$E$M$Y$$$20240812$$CN$US$US
240632482$24063248$2$F$20240620$20240708$20240709$20240712$PER$$US-AMGEN-USASP2024129118$AMGEN$$72$YR$E$F$Y$9$KG$20240712$$HP$US$US
240632491$24063249$1$I$$20240701$20240709$20240709$EXP$$ES-AstraZeneca-2024A152143$ASTRAZENECA$$62$YR$$F$Y$$$20240709$$CN$ES$
240632501$24063250$1$I$20230615$20240628$20240709$20240709$EXP$$JP-JNJFOC-20230709041$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240709$$MD$JP$JP
240632511$24063251$1$I$$20240703$20240709$20240709$PER$$US-JNJFOC-20240710658$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$HP$US$US
240632521$24063252$1$I$20231207$20240629$20240709$20240709$EXP$$US-UCBSA-2024000943$UCB$$5$YR$$M$Y$21.2$KG$20240709$$CN$US$US
240632531$24063253$1$I$20240622$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004204$ELI LILLY AND CO$$31$YR$A$M$Y$$$20240709$$CN$US$US
240632541$24063254$1$I$20240601$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004364$ELI LILLY AND CO$$$$$$Y$$$20240709$$CN$US$US
240632551$24063255$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004210$ELI LILLY AND CO$$$$$F$Y$$$20240709$$CN$US$US
240632561$24063256$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004170$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240709$$CN$US$US
240632571$24063257$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004750$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240709$$CN$US$US
240632582$24063258$2$F$20220101$20240226$20240709$20240710$PER$$DE-ROCHE-3274264$ROCHE$$39$YR$A$M$Y$95$KG$20240701$$MD$DE$DE
240632591$24063259$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004243$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240709$$CN$US$US
240632601$24063260$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004607$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240709$$CN$US$US
240632611$24063261$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA198857$SANOFI AVENTIS$$$$C$M$Y$26.3$KG$20240709$$MD$US$US
240632622$24063262$2$F$$20240708$20240709$20240710$PER$$NVSC2024US140373$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
240632632$24063263$2$F$20240601$20240820$20240709$20240828$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001352$BLUEPRINT MEDICINES$$34$YR$A$F$Y$$$20240828$$CN$US$US
240632641$24063264$1$I$$20240703$20240709$20240709$PER$$US-AMGEN-USASP2024133583$AMGEN$$$$$$Y$$$20240709$$PH$US$US
240632651$24063265$1$I$$20240701$20240709$20240709$EXP$$US-JNJFOC-20240707398$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$US$US
240632662$24063266$2$F$$20240815$20240709$20240815$PER$$US-JNJFOC-20240710662$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$CN$US$US
240632672$24063267$2$F$20240603$20240703$20240709$20240723$EXP$$MX-JNJFOC-20240647056$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240722$$CN$MX$MX
240632681$24063268$1$I$$20240703$20240709$20240709$PER$$US-JNJFOC-20240711383$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240632693$24063269$3$F$$20240910$20240709$20240910$EXP$$BE-JNJFOC-20240700302$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240910$$MD$BE$BE
240632702$24063270$2$F$$20240701$20240709$20240717$EXP$$BR-JNJFOC-20240461446$JOHNSON AND JOHNSON$$70$YR$E$F$Y$68$KG$20240717$$CN$BR$BR
240632711$24063271$1$I$20230607$20230614$20240709$20240709$PER$$US-DEXPHARM-20231499$DEXCEL$$75$YR$E$F$Y$$$20240709$$CN$US$US
240632731$24063273$1$I$$20240513$20240709$20240709$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-10419$ALKEM$Chambers A, Patton J, Wills BK.. Precipitated opioid withdrawal in a patient started on olanzapine/samidorphan. American Journal of Emergency Medicine. 2024;79:230.e1-230.e2$36$YR$$$Y$$$20240709$$MD$US$US
240632744$24063274$4$F$20240605$20240906$20240709$20240920$EXP$$CA-UCBSA-2024021760$UCB$$53$YR$$F$Y$99.5$KG$20240920$$MD$CA$CA
240632751$24063275$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141351$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240632761$24063276$1$I$$20240708$20240709$20240709$EXP$PT-INFARMED-F202406-607$NVSC2024PT140775$NOVARTIS$$63$YR$$F$Y$56$KG$20240709$$PH$PT$PT
240632771$24063277$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405012341446720-KTSFY$GB-ORGANON-O2407GBR000635$ORGANON$$$$$$Y$$$20240709$$CN$GB$GB
240632782$24063278$2$F$$20240704$20240709$20240718$EXP$CN-MLMSERVICE-20240617-PI102486-00097-1$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13703$ALKEM$Yang M, Cai YU, Wan L, Ji L, Song XM. Case report: Autoimmune encephalomyelitis following cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.. Frontiers in medicine. 2024;11:1373062$53$YR$$F$Y$$$20240718$$MD$CN$CN
240632791$24063279$1$I$$20240625$20240709$20240709$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14295$ALKEM$Bickel J, Jungen H, Muller A, Szewczyk A, Ondruschka B, Iwersen-Bergmann S.. Toxicologic analysis of 35 drugs in post mortem human blood samples with focus on antihypertensive and antiarrhythmic drugs. Journal of Chromatography B. 2024;1242:124196$70$YR$$M$Y$$$20240709$$HP$DE$DE
240632802$24063280$2$F$$20240815$20240709$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002844$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
240632811$24063281$1$I$$20240625$20240709$20240709$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-14501$ALKEM$Garneau B, Roy C, Motard J, Desharnais B, Bouchard C, Mireault P.. Atypical postmortem redistribution in chronic methadone consumers. Journal of Analytical Toxicology. 2024;48(5):343-349$64$YR$$M$Y$$$20240709$$HP$CA$CA
240632821$24063282$1$I$$20240625$20240709$20240709$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-14492$ALKEM$Garneau B, Roy C, Motard J, Desharnais B, Bouchard C, Mireault P.. Atypical postmortem redistribution in chronic methadone consumers. Journal of Analytical Toxicology. 2024;48(5):343-349$54$YR$$M$Y$$$20240709$$HP$CA$CA
240632831$24063283$1$I$$20240625$20240709$20240709$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-14481$ALKEM$Garneau B, Roy C, Motard J, Desharnais B, Bouchard C, Mireault P.. Atypical postmortem redistribution in chronic methadone consumers. Journal of Analytical Toxicology. 2024;48:343-349$44$YR$$M$Y$$$20240709$$HP$CA$CA
240632841$24063284$1$I$$20240625$20240709$20240709$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-14483$ALKEM$Garneau B, Roy C, Motard J, Desharnais B, Bouchard C, Mireault P.. Atypical postmortem redistribution in chronic methadone consumers. Journal of Analytical Toxicology. 2024;48:343-349$57$YR$$M$Y$$$20240709$$HP$CA$CA
240632851$24063285$1$I$$20240625$20240709$20240709$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-14482$ALKEM$Garneau B, Roy C, Motard J, Desharnais B, Bouchard C, Mireault P.. Atypical postmortem redistribution in chronic methadone consumers. Journal of Analytical Toxicology. 2024;48:343-349$30$YR$$M$Y$$$20240709$$HP$CA$CA
240632861$24063286$1$I$$20240625$20240709$20240709$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-14480$ALKEM$Garneau B, Roy C, Motard J, Desharnais B, Bouchard C, Mireault P. Atypical postmortem redistribution in chronic methadone consumers. Journal of Analytical Toxicology. 2024;48(5):343-349$38$YR$$M$Y$$$20240709$$HP$CA$CA
240632871$24063287$1$I$$20240630$20240709$20240709$PER$$US-APOTEX-2024AP008027$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240709$$HP$US$US
240632881$24063288$1$I$20230816$20230816$20240709$20240709$EXP$$US-RECORDATI RARE DISEASE INC.-2023005832$RECORDATI$$$$$$Y$$$20240709$$CN$US$US
240632891$24063289$1$I$$20240625$20240709$20240709$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-14497$ALKEM$Garneau B, Roy C, Motard J, Desharnais B, Bouchard C, Mireault P.. Atypical postmortem redistribution in chronic methadone consumers. Journal of Analytical Toxicology. 2024;48(5):343-349$43$YR$$M$Y$$$20240709$$HP$CA$CA
240632901$24063290$1$I$$20240625$20240709$20240709$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-14486$ALKEM$Garneau B, Roy C, Motard J, Desharnais B, Bouchard C, Mireault P.. Atypical postmortem redistribution in chronic methadone consumers. Journal of Analytical Toxicology. 2024;48(5):343-349$36$YR$$M$Y$$$20240709$$HP$CA$CA
240632911$24063291$1$I$$20240625$20240709$20240709$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-14494$ALKEM$Garneau B, Roy C, Motard J, Desharnais B, Bouchard C, Mireault P.. Atypical postmortem redistribution in chronic methadone consumers. Journal of Analytical Toxicology. 2024;48(5):343-349$54$YR$$F$Y$$$20240709$$HP$CA$CA
240632921$24063292$1$I$20230816$20231031$20240709$20240709$EXP$$US-RECORDATI RARE DISEASE INC.-2023005841$RECORDATI$$$$$$Y$$$20240709$$CN$US$US
240632931$24063293$1$I$$20230926$20240709$20240709$EXP$$US-RECORDATI RARE DISEASE INC.-2023008618$RECORDATI$$$$$$Y$$$20240709$$CN$US$US
240632941$24063294$1$I$20230101$20231004$20240709$20240709$EXP$$US-RECORDATI RARE DISEASE INC.-2023007764$RECORDATI$$$$$$Y$$$20240709$$CN$US$US
240632951$24063295$1$I$20230101$20230829$20240709$20240709$EXP$$US-RECORDATI RARE DISEASE INC.-2023006082$RECORDATI$$$$$$Y$$$20240709$$CN$US$US
240632961$24063296$1$I$$20240625$20240709$20240709$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-14496$ALKEM$Garneau B, Roy C, Motard J, Desharnais B, Bouchard C, Mireault P. Atypical postmortem redistribution in chronic methadone consumers. Journal of Analytical Toxicology. 2024;48:343-349$43$YR$$F$Y$$$20240709$$HP$CA$CA
240632971$24063297$1$I$20230615$20230831$20240709$20240709$EXP$$US-RECORDATI RARE DISEASE INC.-2023005979$RECORDATI$$$$$$Y$$$20240709$$PH$US$US
240632991$24063299$1$I$$20240705$20240709$20240709$PER$$NVSC2024US141124$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240633001$24063300$1$I$$20240703$20240709$20240709$EXP$$US-ABBVIE-5830401$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240633011$24063301$1$I$20240627$20240628$20240709$20240709$EXP$$CN-JNJFOC-20240701285$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240709$$HP$CN$CN
240633021$24063302$1$I$20240705$20240705$20240709$20240709$PER$$US-JNJFOC-20240716431$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$PH$US$US
240633031$24063303$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000018804$ROCHE$$$$A$M$Y$$$20240709$$CN$US$US
240633041$24063304$1$I$$20240702$20240709$20240709$PER$$US-JNJFOC-20240706127$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$HP$US$US
240633051$24063305$1$I$$20240702$20240709$20240709$PER$$US-JNJFOC-20240707472$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240633061$24063306$1$I$20240101$20240702$20240709$20240709$PER$$US-JNJFOC-20240707492$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20240709$$CN$US$US
240633071$24063307$1$I$20240101$20240704$20240709$20240709$EXP$FR-AFSSAPS-LL2024001222$FR-JNJFOC-20240714003$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240709$$MD$FR$FR
240633092$24063309$2$F$$20240705$20240709$20240709$PER$$US-JNJFOC-20240711898$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240709$$CN$US$US
240633101$24063310$1$I$20230530$20240702$20240709$20240709$EXP$ES-AEMPS-1539896$ES-SA-2024SA195975$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240709$$MD$ES$ES
240633111$24063311$1$I$$20240625$20240709$20240709$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-20107$SAMSUNG BIOEPIS$$10$YR$C$M$Y$30.9$KG$20240709$$CN$CA$CA
240633122$24063312$2$F$20240616$20240722$20240709$20240728$EXP$$US-ABBVIE-5831606$ABBVIE$$60$YR$$F$Y$$$20240728$$CN$US$US
240633132$24063313$2$F$20240701$20240715$20240709$20240719$EXP$$IT-ABBVIE-5831382$ABBVIE$$70$YR$$M$Y$$$20240719$$CN$IT$IT
240633141$24063314$1$I$$20240626$20240709$20240709$EXP$$US-NEBO-662792$PHARMACOSMOS$$$$A$F$Y$$$20240709$$HP$US$US
240633152$24063315$2$F$20240610$20240805$20240709$20240806$EXP$FR-AFSSAPS-LY2024000894$FR-GILEAD-2024-0679028$GILEAD$$48$YR$A$F$Y$68$KG$20240806$$PH$FR$FR
240633161$24063316$1$I$$20240705$20240709$20240709$PER$$NVSC2024US140944$NOVARTIS$$$$$M$Y$$$20240709$$CN$US$US
240633171$24063317$1$I$20231111$20231114$20240709$20240709$EXP$$US-RECORDATI RARE DISEASE INC.-2023008278$RECORDATI$$$$$$Y$$$20240709$$CN$US$US
240633182$24063318$2$F$$20240726$20240709$20240730$EXP$$JP-SA-2024SA193933$SANOFI AVENTIS$Aya H, Sasaki K, Ishimoto A, Kobayashi Y, Fukuda K, Takahashi K, et al.. GE-05-04: Effects of antibody therapy on scleritis associated with eosinophilic granulomatosis with polyangiitis.. Ocular Infection, Inflammation and Allergy.. 2024;UNK:UNK$50$YR$A$M$Y$$$20240731$$MD$JP$JP
240633191$24063319$1$I$$20240703$20240709$20240709$PER$$US-ALXN-202407USA000251US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
240633201$24063320$1$I$20240621$20240702$20240709$20240709$EXP$$CN-JNJFOC-20240707767$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240709$$HP$CN$CN
240633211$24063321$1$I$20240626$20240627$20240709$20240709$PER$$US-JNJFOC-20240673963$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240709$$CN$US$US
240633222$24063322$2$F$20240626$20240729$20240709$20240730$PER$$US-JNJFOC-20240674422$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240730$$PH$US$US
240633231$24063323$1$I$20240101$20240705$20240709$20240709$PER$$US-JNJFOC-20240715548$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240709$$CN$US$US
240633251$24063325$1$I$20240628$20240705$20240709$20240709$PER$$US-JNJFOC-20240715385$JOHNSON AND JOHNSON$$31$YR$A$$Y$$$20240709$$HP$US$US
240633261$24063326$1$I$20240702$20240702$20240709$20240709$EXP$$US-JNJFOC-20240708060$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$HP$US$US
240633271$24063327$1$I$$20240702$20240709$20240709$EXP$$AU-UCBSA-2024034105$UCB$$$$$$Y$$$20240709$$MD$AU$AU
240633281$24063328$1$I$20240702$20240703$20240709$20240709$EXP$$US-VANTIVE-2024VAN018139$Vantive US Healthcare$$$$$M$Y$$$20240709$$HP$US$US
240633291$24063329$1$I$$20240701$20240709$20240709$EXP$$BG-VIWITPHARMA-2024VWTLIT00005$VIWIT PHARMACEUTICAL$Vassileva Z, Pavlova E, Marinov R, Ibryam I, Radulova P.Fetal ductal constriction caused by SSRI: A case report.J Clin Ultrasound.07-JUN-2024;1-4$$$N$F$Y$1.7$KG$20240709$$MD$BG$BG
240633301$24063330$1$I$$20240703$20240709$20240709$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-009671$JAZZ$$$$$M$Y$$$20240709$$HP$US$US
240633312$24063331$2$F$$20240821$20240709$20240822$EXP$$CA-WT-2024-AMR-079592$Waylis$$$$$$Y$$$20240822$$CN$CA$CA
240633321$24063332$1$I$20240627$20240627$20240709$20240709$PER$$US-JNJFOC-20240675203$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240709$$PH$US$US
240633341$24063334$1$I$20240627$20240627$20240709$20240709$PER$$US-JNJFOC-20240675208$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240709$$PH$US$US
240633351$24063335$1$I$$20240620$20240709$20240709$PER$$US-JNJFOC-20240704040$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240633362$24063336$2$F$$20240806$20240709$20240808$30DAY$$NL-JNJFOC-20240714418$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$CN$NL$NL
240633371$24063337$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06319$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240633381$24063338$1$I$$20240701$20240709$20240709$PER$$US-JNJFOC-20240702087$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$HP$US$US
240633391$24063339$1$I$$20240702$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407002105$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240709$$CN$US$US
240633401$24063340$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004308$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240709$$CN$US$US
240633411$24063341$1$I$20240705$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004249$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240709$$CN$US$US
240633421$24063342$1$I$$20240703$20240709$20240709$PER$$US-ABBVIE-5829807$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240633431$24063343$1$I$20240705$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004396$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240709$$CN$US$US
240633441$24063344$1$I$20240701$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004232$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240709$$CN$US$US
240633452$24063345$2$F$$20240709$20240709$20240710$PER$$US-AMGEN-USASP2024134835$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240633461$24063346$1$I$20240704$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134135$AMGEN$$49$YR$A$F$Y$$$20240709$$CN$US$US
240633471$24063347$1$I$20240101$20240627$20240709$20240709$PER$$US-SA-2024SA195830$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240709$$MD$US$US
240633481$24063348$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA198164$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240709$$MD$US$US
240633492$24063349$2$F$20240101$20240708$20240709$20240711$PER$$US-AMGEN-USASP2024134157$AMGEN$$78$YR$E$M$Y$$$20240711$$CN$US$US
240633511$24063351$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06067$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240633522$24063352$2$F$20240626$20240703$20240709$20240718$PER$$US-JNJFOC-20240709604$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$MD$US$US
240633541$24063354$1$I$$20240627$20240709$20240709$30DAY$$FR-JNJFOC-20240714559$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$FR$FR
240633551$24063355$1$I$$20240703$20240709$20240709$EXP$$US-JNJFOC-20240709398$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$HP$US$US
240633561$24063356$1$I$$20240703$20240709$20240709$EXP$$NVSJ2024JP008110$NOVARTIS$$76$YR$$F$Y$$$20240709$$MD$JP$JP
240633571$24063357$1$I$20240621$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134366$AMGEN$$68$YR$E$M$Y$$$20240709$$CN$US$US
240633582$24063358$2$F$20240703$20240712$20240709$20240716$30DAY$$US-AMGEN-USASP2024132560$AMGEN$$75$YR$E$M$Y$$$20240716$$PH$US$US
240633592$24063359$2$F$$20240716$20240709$20240726$EXP$$US-TEVA-VS-3214185$TEVA$Agudelo Higuita NI, Yuen C. Hemophagocytic Lymphohistiocytosis Secondary to Ehrlichia Chaffeensis in Adults: A Case Series From Oklahoma. [Review]. Am-J-Med-Sci 2021; 361 (2): 269-273.; Agudelo Higuita NI, Yuen C. Hemophagocytic Lymphohistiocytosis Secondary to Ehrlichia Chaffeensis in Adults: A Case Series From Oklahoma. [Review]. Am-J-Med-Sci 2021; 361 (2): 269-273.$49$YR$$M$Y$$$20240726$$MD$US$US
240633601$24063360$1$I$$20240702$20240709$20240709$EXP$$IL-JNJFOC-20240714654$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$MD$IL$IL
240633611$24063361$1$I$20240401$20240704$20240709$20240709$EXP$FR-AFSSAPS-NT2024000513$FR-JNJFOC-20240714632$JOHNSON AND JOHNSON$$62$YR$A$F$Y$52$KG$20240709$$MD$FR$FR
240633624$24063362$4$F$20240703$20240812$20240709$20240822$30DAY$$US-JNJFOC-20240709540$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240822$$PH$US$US
240633631$24063363$1$I$$20240628$20240709$20240709$EXP$$US-JNJFOC-20240677705$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240709$$CN$US$US
240633641$24063364$1$I$$20240707$20240709$20240709$PER$$NVSC2024US141080$NOVARTIS$$$$$$Y$$$20240709$$CN$US$US
240633651$24063365$1$I$$20240705$20240709$20240709$PER$$NVSC2024US141119$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240633661$24063366$1$I$$20240705$20240709$20240709$EXP$$US-HALEON-2185701$Haleon PLC$$$$$M$Y$$$20240708$$CN$US$US
240633671$24063367$1$I$20240616$20240701$20240709$20240709$30DAY$$US-GSK-US2024081601$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240709$$CN$US$US
240633681$24063368$1$I$$20240705$20240709$20240709$EXP$$US-ABBVIE-5830724$ABBVIE$$$$$M$Y$$$20240709$$CN$US$US
240633697$24063369$7$F$20240101$20240821$20240709$20240829$EXP$$CN-MIRUM PHARMACEUTICALS, INC.-CN-MIR-24-00378$MIRUM PHARMACEUTICALS$$$$$$Y$$$20240829$$CN$CN$CN
240633701$24063370$1$I$20201231$20240626$20240709$20240709$EXP$$FR-SIEMENS HEALTHCARE LIMITED-PET-000056-2024$SIEMENS$$55$YR$A$F$Y$64.6$KG$20240709$$MD$FR$FR
240633711$24063371$1$I$$20240703$20240709$20240709$PER$$US-JNJFOC-20240709912$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240709$$CN$US$US
240633722$24063372$2$F$$20240729$20240709$20240808$30DAY$$KR-JNJFOC-20240713165$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$HP$KR$KR
240633731$24063373$1$I$20240101$20240702$20240709$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-012664$UNITED THERAPEUTICS$$$$$M$Y$63.946$KG$20240709$$$US$US
240633743$24063374$3$F$20240612$20240805$20240709$20240806$EXP$FR-AFSSAPS-AN2024000835$FR-JNJFOC-20240714680$JOHNSON AND JOHNSON$$74$YR$E$M$Y$87$KG$20240806$$MD$FR$FR
240633753$24063375$3$F$20240702$20240906$20240709$20240912$PER$$US-JNJFOC-20240710275$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240912$$CN$US$US
240633761$24063376$1$I$20240122$20240701$20240709$20240709$EXP$FR-AFSSAPS-CN2024000625$FR-JNJFOC-20240704537$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240709$$MD$FR$FR
240633774$24063377$4$F$$20240830$20240709$20240909$EXP$$JP-ABBVIE-5831592$ABBVIE$$56$YR$$M$Y$$$20240909$$CN$JP$JP
240633782$24063378$2$F$20240101$20240708$20240709$20240710$PER$$US-AMGEN-USASP2024134260$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240633791$24063379$1$I$$20240628$20240709$20240709$EXP$$US-TAKEDA-2024TUS065715$TAKEDA$$$$$M$Y$$$20240709$$CN$US$US
240633801$24063380$1$I$20240615$20240626$20240709$20240709$EXP$$US-Axsome Therapeutics, Inc.-AXS202406-000929$AXSOME THERAPEUTICS$$47$YR$A$F$Y$$$20240709$$HP$US$
240633812$24063381$2$F$20240703$20240709$20240709$20240710$PER$$US-AMGEN-USASP2024134367$AMGEN$$72$YR$E$F$Y$$$20240710$$CN$US$US
240633821$24063382$1$I$$20240702$20240709$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-020432$UNITED THERAPEUTICS$$$$$F$Y$56.236$KG$20240709$$$US$US
240633831$24063383$1$I$20240619$20240702$20240709$20240709$EXP$$CN-JNJFOC-20240715033$JOHNSON AND JOHNSON$$76$YR$E$F$Y$70$KG$20240709$$HP$CN$CN
240633841$24063384$1$I$$20240702$20240709$20240709$PER$$US-JNJFOC-20240706171$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240633852$24063385$2$F$$20240806$20240709$20240809$30DAY$$FR-JNJFOC-20240716679$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$PH$FR$FR
240633862$24063386$2$F$20240702$20240807$20240709$20240808$PER$$US-JNJFOC-20240710473$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240808$$CN$US$US
240633871$24063387$1$I$$20240703$20240709$20240709$PER$$PR-JNJFOC-20240710444$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$MD$PR$PR
240633881$24063388$1$I$$20240705$20240709$20240709$PER$$US-HALEON-2185707$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240633901$24063390$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004381$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240709$$CN$US$US
240633911$24063391$1$I$20240528$20240705$20240709$20240709$EXP$$US-TAKEDA-2024TUS069166$TAKEDA$$0$YR$$F$Y$$$20240709$$CN$US$US
240633933$24063393$3$F$$20240821$20240709$20240822$PER$$NVSC2024US141059$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
240633941$24063394$1$I$$20240629$20240709$20240709$30DAY$$PR-VIIV HEALTHCARE LIMITED-PR2024081564$VIIV$$$$$M$Y$$$20240709$$MD$PR$US
240633953$24063395$3$F$20200101$20240718$20240709$20240723$EXP$$RU-ORGANON-O2407RUS000373$ORGANON$$42$YR$$F$Y$57$KG$20240723$$CN$RU$RU
240633961$24063396$1$I$20230201$20240704$20240709$20240709$EXP$BE-FAMHP-DHH-N2024-122315$BE-JNJFOC-20240713507$JOHNSON AND JOHNSON$$46$YR$A$M$Y$91$KG$20240709$$CN$BE$BE
240633977$24063397$7$F$20240605$20240807$20240709$20240808$EXP$FR-AFSSAPS-BX2024001331$FR-JNJFOC-20240715076$JOHNSON AND JOHNSON$$36$YR$A$F$Y$80$KG$20240808$$PH$FR$FR
240633981$24063398$1$I$$20240706$20240709$20240709$PER$$US-JNJFOC-20240717031$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240633992$24063399$2$F$20240710$20240710$20240709$20240711$PER$$US-JNJFOC-20240716042$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240711$$CN$US$US
240634001$24063400$1$I$$20240705$20240709$20240709$EXP$$US-TAKEDA-2024TUS069296$TAKEDA$$$$$M$Y$$$20240709$$CN$US$US
240634011$24063401$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405031619313950-THBDL$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038010$BOEHRINGER INGELHEIM$$$$$M$Y$175$KG$20240709$$CN$GB$GB
240634021$24063402$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06322$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240634031$24063403$1$I$$20240701$20240709$20240709$EXP$$US-BIOCON-BCN-2024-000122$BIOCON$Al-Moussally F, Thompson BM, Masarweh OM, Shah M, Gaudi S, Restrepo J. Atorvastatin-Associated Eosinophilic Spongiosis: A Case Report and a Relevant Literature Review of Dermatological Manifestations. Cureus. 25-May-2024; 16(5): e61071; 1-5. doi: 10.7759/cureus.61071.$73$YR$E$M$Y$$$20240709$$HP$US$US
240634041$24063404$1$I$$20211223$20240709$20240709$EXP$$CA-HALEON-2184133$Haleon PLC$$59$YR$$F$Y$68$KG$20240709$$HP$CA$CA
240634051$24063405$1$I$20240703$20240704$20240709$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-020608$UNITED THERAPEUTICS$$68$YR$$F$Y$74.83$KG$20240709$$$US$US
240634061$24063406$1$I$20240101$20240704$20240709$20240709$EXP$$CA-UCBSA-2024010962$UCB$$$$$F$Y$$$20240709$$CN$CA$CA
240634071$24063407$1$I$20240610$20240610$20240709$20240709$PER$$US-JNJFOC-20240713774$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240634081$24063408$1$I$$20240708$20240709$20240709$EXP$$US-JNJFOC-20240719843$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240709$$HP$US$US
240634091$24063409$1$I$20240101$20240703$20240709$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-020620$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240709$$$US$US
240634101$24063410$1$I$$20240614$20240709$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002845$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240634111$24063411$1$I$20240113$20240701$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-032747$AUROBINDO$$24$YR$$M$Y$$$20240709$$CN$GB$GB
240634121$24063412$1$I$20231223$20240112$20240709$20240709$EXP$GB-MHRA-TPP6919314C10256243YC1704967107035$GB-TEVA-VS-3146826$TEVA$$79$YR$$F$Y$74$KG$20240709$$MD$GB$GB
240634131$24063413$1$I$$20240708$20240709$20240709$EXP$$CA-ORGANON-O2407CAN000722$ORGANON$$$$$$Y$$$20240709$$CN$CA$CA
240634141$24063414$1$I$$20240703$20240709$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-020640$UNITED THERAPEUTICS$$$$$F$Y$57.868$KG$20240709$$$US$US
240634152$24063415$2$F$$20240827$20240709$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06314$LUPIN$$$$$$Y$$$20240918$$CN$US$US
240634161$24063416$1$I$$20240706$20240709$20240709$PER$$NVSC2024US141079$NOVARTIS$$$$$$Y$$$20240709$$CN$US$US
240634171$24063417$1$I$$20240425$20240709$20240709$PER$$US-AMGEN-USASP2024133300$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240634181$24063418$1$I$20240101$20240704$20240709$20240709$PER$$US-009507513-2407USA002329$MERCK$$$$$F$Y$$$20240709$$CN$US$US
240634192$24063419$2$F$20240528$20240828$20240709$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-032732$AUROBINDO$$66$YR$$M$Y$73$KG$20240906$$CN$GB$GB
240634202$24063420$2$F$$20240731$20240709$20240807$EXP$$US-INTERCEPT-PM2024001354$INTERCEPT PHARMACEUTICALS$$$$$M$Y$66.213$KG$20240807$$CN$US$US
240634211$24063421$1$I$$20240705$20240709$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-020700$UNITED THERAPEUTICS$$$$$F$Y$$$20240709$$$US$US
240634221$24063422$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06212$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240634231$24063423$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134933$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240634251$24063425$1$I$$20240630$20240709$20240709$EXP$$US-APOTEX-2024AP007912$APOTEX$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. The Journal of Maternal-Fetal + Neonatal Medicine. 2024;37 (1): 2355293:1-9$$$A$F$Y$$$20240709$$HP$US$US
240634261$24063426$1$I$20210801$20240701$20240709$20240709$EXP$$DE-AUROBINDO-AUR-APL-2024-032834$AUROBINDO$$72$YR$$F$Y$$$20240709$$MD$DE$DE
240634272$24063427$2$F$20240701$20240905$20240709$20240919$30DAY$$US-GSK-US2024083032$GLAXOSMITHKLINE$$77$YR$$M$Y$$$20240919$$CN$US$US
240634282$24063428$2$F$$20240823$20240709$20240829$EXP$$CA-ROCHE-3580210$ROCHE$$40$YR$A$F$Y$$$20240829$$HP$CA$CA
240634291$24063429$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005194$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240709$$CN$US$US
240634301$24063430$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004206$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240709$$CN$US$US
240634311$24063431$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004550$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240709$$CN$US$US
240634321$24063432$1$I$20240702$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004224$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240709$$CN$US$US
240634331$24063433$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004334$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240709$$CN$US$US
240634342$24063434$2$F$$20240705$20240709$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407004235$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240715$$MD$US$US
240634351$24063435$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004172$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240709$$CN$US$US
240634361$24063436$1$I$20240629$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004386$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240709$$CN$US$US
240634371$24063437$1$I$$20240702$20240709$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-000452$UNITED THERAPEUTICS$$$$$F$Y$51.701$KG$20240709$$$US$US
240634381$24063438$1$I$20240705$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004111$ELI LILLY AND CO$$65$YR$E$$Y$$$20240709$$HP$US$US
240634391$24063439$1$I$20240601$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004367$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240709$$CN$US$US
240634401$24063440$1$I$$20240702$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407001995$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240709$$CN$US$US
240634411$24063441$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004169$ELI LILLY AND CO$$$$$M$Y$$$20240709$$CN$US$US
240634422$24063442$2$F$20240604$20240719$20240709$20240722$PER$$US-AMGEN-USASP2024134824$AMGEN$$$$$M$Y$$$20240722$$CN$US$US
240634431$24063443$1$I$$20240611$20240709$20240709$PER$$US-ROCHE-10000000095$ROCHE$$56$YR$A$M$Y$$$20240618$$HP$US$US
240634441$24063444$1$I$20240304$20240705$20240709$20240709$EXP$$CA-UCBSA-2024034485$UCB$$75$YR$$M$Y$$$20240709$$CN$CA$CA
240634451$24063445$1$I$20240615$20240626$20240709$20240709$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000102-2024$QILU PHARMACEUTICAL$$80$YR$E$M$Y$60$KG$20240702$$HP$CN$CN
240634462$24063446$2$F$20240201$20240714$20240709$20240717$EXP$$GB-UCBSA-2024034383$UCB$$$$E$M$Y$$$20240717$$CN$GB$GB
240634471$24063447$1$I$$20240611$20240709$20240709$EXP$$CA-ROCHE-3580302$ROCHE$$43$YR$A$M$Y$$$20240618$$HP$CA$CA
240634481$24063448$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06061$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240634492$24063449$2$F$20240712$20240712$20240709$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002862$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240805$$CN$US$US
240634501$24063450$1$I$20230915$20240705$20240709$20240709$EXP$GB-MHRA-WEBCOVID-202405031001175710-NGDRS$GB-ORGANON-O2407GBR000690$ORGANON$$70$YR$$$Y$83$KG$20240709$$CN$GB$GB
240634511$24063451$1$I$$20240610$20240709$20240709$PER$$US-ROCHE-10000000311$ROCHE$$72$YR$E$M$Y$$$20240618$$CN$US$US
240634521$24063452$1$I$$20240705$20240709$20240709$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038187$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240709$$CN$US$US
240634531$24063453$1$I$20240501$20240627$20240709$20240709$EXP$PT-INFARMED-J202406-287$PT-SA-2024SA193385$SANOFI AVENTIS$$65$YR$E$F$Y$60$KG$20240709$$MD$PT$PT
240634543$24063454$3$F$20230601$20240913$20240709$20240919$EXP$$JP-009507513-2407JPN000612J$MERCK$$78$YR$$F$Y$$$20240919$$MD$JP$JP
240634554$24063455$4$F$20240601$20240916$20240709$20240925$EXP$$CA-CELLTRION INC.-2024CA016490$CELLTRION$$$$$$Y$$$20240925$$MD$CA$CA
240634561$24063456$1$I$20240620$20240624$20240709$20240709$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00332$Unknown Manufacturer$$$$$$Y$$$20240709$$MD$CN$CN
240634571$24063457$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141475$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240634581$24063458$1$I$$20240707$20240709$20240709$PER$$NVSC2024US141078$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240634591$24063459$1$I$20240620$20240701$20240709$20240709$EXP$$IT-AUROBINDO-AUR-APL-2024-032790$AUROBINDO$$56$YR$$M$Y$$$20240709$$MD$IT$IT
240634601$24063460$1$I$$20240703$20240709$20240709$EXP$FR-AFSSAPS-AVMA2024000286$FR-INDIVIOR UK LIMITED-INDV-145858-2024$RECKITT BENCKISER$$$$$$Y$$$20240709$$PH$FR$FR
240634611$24063461$1$I$20230101$20240701$20240709$20240709$EXP$$US-Indivior Limited-INDV-145863-2024$RECKITT BENCKISER$$$$$$Y$$$20240709$$HP$US$US
240634621$24063462$1$I$$20240702$20240709$20240709$EXP$$CL-JNJFOC-20240713382$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240709$$CN$CL$CL
240634632$24063463$2$F$$20240725$20240709$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-032859$AUROBINDO$$15$YR$$F$Y$$$20240806$$HP$GB$GB
240634641$24063464$1$I$$20240325$20240709$20240709$PER$$US-AUROBINDO-AUR-APL-2024-014964$AUROBINDO$$$$$F$Y$$$20240709$$CN$US$US
240634651$24063465$1$I$20230101$20240701$20240709$20240709$EXP$$US-Indivior Limited-INDV-145866-2024$RECKITT BENCKISER$$$$$$Y$$$20240709$$HP$US$US
240634661$24063466$1$I$$20240618$20240709$20240709$PER$$US-JNJFOC-20240648853$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$US$US
240634681$24063468$1$I$20230701$20240614$20240709$20240709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001372$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240709$$CN$US$US
240634691$24063469$1$I$$20240614$20240709$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002850$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240634701$24063470$1$I$20240319$20240702$20240709$20240709$EXP$$FR-AUROBINDO-AUR-APL-2024-032986$AUROBINDO$$84$YR$$M$Y$92$KG$20240709$$MD$FR$FR
240634711$24063471$1$I$20231101$20240625$20240709$20240709$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-19314$SAMSUNG BIOEPIS$$72$YR$E$F$Y$$$20240709$$MD$DE$DE
240634721$24063472$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024135082$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240634733$24063473$3$F$20240601$20240718$20240709$20240724$PER$$US-AMGEN-USASP2024130795$AMGEN$$58$YR$A$F$Y$93.5$KG$20240724$$PH$US$US
240634741$24063474$1$I$20240701$20240702$20240709$20240709$EXP$$US-AMGEN-USASL2024131313$AMGEN$$73$YR$E$M$Y$$$20240709$$CN$US$US
240634751$24063475$1$I$20230818$20240703$20240709$20240709$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-23-00534$CATALYST PHARMA$$36$YR$$M$Y$86.18$KG$20240709$$CN$US$US
240634762$24063476$2$F$$20240701$20240709$20240709$PER$$US-SA-2024SA197395$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240709$$MD$US$US
240634772$24063477$2$F$20240703$20240719$20240709$20240724$PER$$IQ-REGENERON PHARMACEUTICALS, INC.-2024-095008$REGENERON$$46$YR$$M$Y$$$20240724$$CN$IQ$IQ
240634781$24063478$1$I$$20240705$20240709$20240709$EXP$$GB-BIOVITRUM-2024-GB-009588$BIOVITRUM$$$$$F$Y$$$20240709$$CN$GB$GB
240634791$24063479$1$I$$20240614$20240709$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002864$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240709$$CN$US$US
240634801$24063480$1$I$20240618$20240702$20240709$20240709$EXP$$US-SA-2024SA197661$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240709$$MD$US$US
240634811$24063481$1$I$20240326$20240702$20240709$20240709$EXP$$FR-AUROBINDO-AUR-APL-2024-032976$AUROBINDO$$15$DY$$M$Y$4.4$KG$20240709$$MD$FR$FR
240634822$24063482$2$F$20240101$20240725$20240709$20240806$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00462$CATALYST PHARMA$$$$$M$Y$118.82$KG$20240806$$CN$US$US
240634831$24063483$1$I$20240416$20240702$20240709$20240709$EXP$FR-AFSSAPS-CN2024000636$FR-ORGANON-O2407FRA000245$ORGANON$$68$YR$$M$Y$90.5$KG$20240709$$MD$FR$FR
240634841$24063484$1$I$$20240704$20240709$20240709$EXP$$SG-SA-2024SA199698$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240709$$HP$SG$SG
240634851$24063485$1$I$20240101$20240705$20240709$20240709$EXP$$US-UCBSA-2024034484$UCB$$$$$F$Y$$$20240709$$CN$US$US
240634861$24063486$1$I$20240617$20240702$20240709$20240709$EXP$$FR-AUROBINDO-AUR-APL-2024-032838$AUROBINDO$$68$YR$$F$Y$$$20240709$$MD$FR$FR
240634881$24063488$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A151116$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240634891$24063489$1$I$$20240630$20240709$20240709$EXP$$US-APOTEX-2024AP008023$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240709$$HP$US$US
240634902$24063490$2$F$$20240723$20240709$20240726$PER$$US-LEO Pharma-371785$LEO PHARM$$48$YR$$F$Y$$$20240726$$CN$US$US
240634911$24063491$1$I$$20240708$20240709$20240709$EXP$$JP-TAKEDA-2024TJP010269$TAKEDA$$8$DEC$$F$Y$$$20240709$$MD$JP$JP
240634931$24063493$1$I$20240704$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004294$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240709$$CN$US$US
240634941$24063494$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004157$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240709$$CN$US$US
240634951$24063495$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004577$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240709$$CN$US$US
240634961$24063496$1$I$20240703$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004239$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240709$$CN$US$US
240634971$24063497$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004121$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240709$$CN$US$US
240634981$24063498$1$I$20240707$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005298$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240709$$CN$US$US
240634994$24063499$4$F$20240601$20240826$20240709$20240829$PER$$US-AMGEN-USASP2024134404$AMGEN$$58$YR$A$M$Y$$$20240829$$CN$US$US
240635001$24063500$1$I$20230707$20240701$20240709$20240709$EXP$$CN-CHEPLA-2024008380$CHEPLAPHARM$Bo Y, Zhong X, Xiang Y, Ren Q, Hao P. Death Caused by Disseminated Herpes Zoster in a Patient with Multiple Myeloma: A Case Report and Literature Review. Clinical, Cosmetic and Investigational Dermatology. 2024;17:941?951.$58$YR$$M$Y$$$20240708$$HP$COUNTRY NOT SPECIFIED$CN
240635011$24063501$1$I$20221201$20240701$20240709$20240709$EXP$$ES-CHEPLA-2024008381$CHEPLAPHARM$D?az-Alberola I, Espuch-Oliver A, Fern?ndez-Segovia F, L?pez-Nevot M?. Possible Role of Cytomegalovirus in Gastric Cancer Development and Recurrent Macrolide-Resistant Campylobacter jejuni Infection in Common Variable Immunodeficiency: A Case Report and Literature Discussion. Microorganisms. 2024 May 27;12(6):1078. doi: 10.3390/microorganisms12061078. PMID: 38930460; PMCID: PMC11205354.$46$YR$$M$Y$$$20240708$$HP$COUNTRY NOT SPECIFIED$ES
240635022$24063502$2$F$$20240724$20240709$20240731$EXP$$JP-CHEPLA-2024008490$CHEPLAPHARM$Hara S, Ureshino H. M4-4 A Case of Gastric Cancer Associated with Sister Mary Joseph^s Nodule that was Resected after Chemotherap. The 46th Annual Meeting of the Japanese Society for Research of Loco-Regional Ca.2024;78.$6$DEC$$F$Y$$$20240731$$MD$COUNTRY NOT SPECIFIED$JP
240635031$24063503$1$I$$20240522$20240709$20240709$PER$$US-AUROBINDO-AUR-APL-2024-017136$AUROBINDO$$$$$$Y$$$20240709$$HP$US$US
240635041$24063504$1$I$20240628$20240708$20240709$20240709$PER$$US-JNJFOC-20240719920$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240709$$CN$US$US
240635051$24063505$1$I$$20240511$20240709$20240709$PER$$US-AUROBINDO-AUR-APL-2024-021915$AUROBINDO$$$$$$Y$$$20240709$$HP$US$US
240635062$24063506$2$F$$20240821$20240709$20240821$PER$$NVSC2024US140822$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
240635073$24063507$3$F$$20240920$20240709$20240926$PER$$NVSC2024US140127$NOVARTIS$$$$$$Y$$$20240926$$CN$US$US
240635081$24063508$1$I$20240223$20240701$20240709$20240709$EXP$FR-AFSSAPS-NC2024000785$FR-RDY-SPO/FRA/24/0009622$DR REDDYS$$48$YR$A$F$Y$77.6$KG$20240709$$HP$FR$FR
240635091$24063509$1$I$$20240702$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-032902$AUROBINDO$$$$$M$Y$$$20240709$$HP$GB$GB
240635101$24063510$1$I$$20240708$20240709$20240709$EXP$$US-BAUSCH-BL-2024-010453$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240709$$CN$US$US
240635111$24063511$1$I$20240101$20240627$20240709$20240709$EXP$$DE-GENMAB-2024-02404$GENMAB$$80$YR$$M$Y$$$20240709$$MD$DE$DE
240635121$24063512$1$I$$20240708$20240709$20240709$EXP$$CA-BAUSCH-BL-2024-010448$BAUSCH AND LOMB$$18$YR$$F$Y$49$KG$20240709$$HP$CA$CA
240635131$24063513$1$I$$20240614$20240709$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002865$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240635141$24063514$1$I$20190106$20240702$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-032936$AUROBINDO$$21$YR$$F$Y$$$20240709$$CN$GB$GB
240635151$24063515$1$I$$20240628$20240709$20240709$EXP$$JP-COLLEGIUM PHARMACEUTICAL, INC.-20240700499$COLLEGIUM PHARMACEUTICAL$$85$YR$$M$Y$$$20240709$$MD$JP$JP
240635161$24063516$1$I$$20240614$20240709$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001353$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240709$$CN$US$US
240635171$24063517$1$I$20230101$20231106$20240709$20240709$EXP$$US-KHC-000040$Kilitch Healthcare$$$$$F$Y$$$20240709$$CN$US$US
240635181$24063518$1$I$20230321$20240610$20240709$20240709$EXP$$CN-Ipsen Biopharmaceuticals, Inc.-2024-07857$IPSEN$GUO DF, LIU GR, XU L, CHEN G, YUAN XY, CHEN YJ, et al. Injection botulism: a case report. Chinese Journal of Industrial Medicine. 2024 Apr;37(2): P214. doi:10.13631 / j.cnki.zggyyx.2024.02.035.$34$YR$A$F$Y$$$20240709$$MD$CN$CN
240635192$24063519$2$F$$20240716$20240709$20240724$EXP$$US-TEVA-VS-3213983$TEVA$Hu G, Hauk PJ, Zhang N, Elsegeiny W, Guardia CM, Kullas A, et al. Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in ATG9A. Autophagy 202319 (2): 678-691; Hu G, Hauk PJ, Zhang N, Elsegeiny W, Guardia CM, Kullas A, et al. Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in ATG9A. Autophagy 2023; 19 (2): 678-691.; Hu G, Hauk PJ, Zhang N, Elsegeiny W, Guardia CM, Kullas A, et al...$11$YR$$M$Y$$$20240724$$HP$US$US
240635201$24063520$1$I$20240601$20240703$20240709$20240709$EXP$$US-GILEAD-2024-0679773$GILEAD$$36$YR$A$M$Y$$$20240709$$CN$US$US
240635211$24063521$1$I$20240515$20240703$20240709$20240709$EXP$GB-MHRA-MED-202406281019467880-WQTRJ$GB-HETERO-AMR2024GB02094$HETERO$$59$YR$$M$Y$104$KG$20240709$$PH$GB$GB
240635221$24063522$1$I$20240701$20240702$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-033024$AUROBINDO$$55$YR$$F$Y$$$20240709$$HP$GB$GB
240635232$24063523$2$F$$20240801$20240709$20240801$PER$$US-ALXN-202407USA000253US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
240635241$24063524$1$I$$20240703$20240709$20240709$EXP$$GB-ALXN-202407GBR000169GB$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$PH$GB$GB
240635251$24063525$1$I$20240101$20240701$20240709$20240709$EXP$$JP-AMGEN-JPNSP2024129931$AMGEN$$80$YR$E$F$Y$$$20240709$$CN$JP$JP
240635261$24063526$1$I$$20240628$20240709$20240709$EXP$$KR-KOWA-24JP001815AA$KOWA PHARM$$$$$F$Y$$$20240709$$CN$KR$KR
240635271$24063527$1$I$20240522$20240702$20240709$20240709$EXP$$FR-AUROBINDO-AUR-APL-2024-032998$AUROBINDO$$87$YR$$F$Y$$$20240709$$MD$FR$FR
240635281$24063528$1$I$$20240705$20240709$20240709$EXP$$NVSC2024VE140999$NOVARTIS$$$$A$M$Y$$$20240709$$CN$VE$VE
240635291$24063529$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405011630278270-FQSZT$GB-ORGANON-O2407GBR000570$ORGANON$$$$$F$Y$$$20240709$$HP$GB$GB
240635311$24063531$1$I$20240421$20240702$20240709$20240709$EXP$$PT-AUROBINDO-AUR-APL-2024-033037$AUROBINDO$$39$YR$$F$Y$$$20240709$$PH$PT$PT
240635321$24063532$1$I$20240601$20240702$20240709$20240709$EXP$DE-CADRBFARM-2024329068$DE-RDY-SPO/DEU/24/0009747$DR REDDYS$$61$YR$A$F$Y$80$KG$20240709$$CN$DE$DE
240635331$24063533$1$I$20240627$20240705$20240709$20240709$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038248$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240709$$CN$US$US
240635341$24063534$1$I$$20240614$20240709$20240709$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002869$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240709$$CN$US$US
240635351$24063535$1$I$20240623$20240627$20240709$20240709$EXP$GB-MHRA-MED-202406270852281540-HWGRJ$GB-MSNLABS-2024MSNSPO01472$MSN LABORATORIES$$$$$$Y$$$20240709$$CN$GB$GB
240635361$24063536$1$I$$20240707$20240709$20240709$PER$$US-HALEON-2185961$Haleon PLC$$67$YR$$F$Y$$$20240709$$CN$US$US
240635371$24063537$1$I$20240524$20240702$20240709$20240709$EXP$$FR-AUROBINDO-AUR-APL-2024-032956$AUROBINDO$$37$YR$$M$Y$79.9$KG$20240709$$MD$FR$FR
240635381$24063538$1$I$20231001$20240702$20240709$20240709$EXP$$US-BIOGEN-2024BI01272040$BIOGEN$$64$YR$$F$Y$$$20240709$$CN$US$US
240635391$24063539$1$I$20240101$20240703$20240709$20240709$EXP$$US-UCBSA-2024034181$UCB$$$$$F$Y$74.39$KG$20240709$$HP$US$US
240635401$24063540$1$I$20240101$20240111$20240709$20240709$EXP$$US-TEVA-VS-3217337$TEVA$$70$YR$$F$Y$$$20240709$$CN$US$US
240635411$24063541$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004368$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240709$$CN$US$US
240635421$24063542$1$I$20240101$20240701$20240709$20240709$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02454$AMNEAL$$$$$F$Y$$$20240709$$CN$US$US
240635431$24063543$1$I$20240601$20240702$20240709$20240709$EXP$$FR-AUROBINDO-AUR-APL-2024-032989$AUROBINDO$$54$YR$$F$Y$98$KG$20240709$$PH$FR$FR
240635441$24063544$1$I$20240307$20240702$20240709$20240709$EXP$$FR-AUROBINDO-AUR-APL-2024-033000$AUROBINDO$$28$YR$$M$Y$$$20240709$$PH$FR$FR
240635451$24063545$1$I$$20240708$20240709$20240709$PER$$US-JNJFOC-20240719609$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240635461$24063546$1$I$20231109$20240702$20240709$20240709$EXP$$FR-AUROBINDO-AUR-APL-2024-032977$AUROBINDO$$73$YR$$F$Y$$$20240709$$MD$FR$FR
240635471$24063547$1$I$20240703$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134416$AMGEN$$67$YR$E$M$Y$$$20240709$$CN$US$US
240635491$24063549$1$I$20240120$20240121$20240709$20240709$EXP$$US-RECORDATI RARE DISEASE INC.-2024000445$RECORDATI$$$$$$Y$$$20240709$$CN$US$US
240635501$24063550$1$I$20211222$20240702$20240709$20240709$EXP$$FR-AUROBINDO-AUR-APL-2024-032966$AUROBINDO$$72$YR$$F$Y$$$20240709$$PH$FR$FR
240635512$24063551$2$F$20240619$20240708$20240709$20240716$PER$$US-AstraZeneca-2024A143299$ASTRAZENECA$$27078$DY$$M$Y$$$20240716$$CN$US$
240635522$24063552$2$F$$20240708$20240709$20240718$PER$$US-AstraZeneca-2024A148253$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
240635531$24063553$1$I$$20240704$20240709$20240709$EXP$$IE-AstraZeneca-2024A154195$ASTRAZENECA$$$$$F$Y$$$20240709$$MD$IE$
240635541$24063554$1$I$20240627$20240701$20240709$20240709$PER$$US-ALXN-202407USA000393US$ALEXION PHARMACEUTICALS$$72$YR$$M$Y$$$20240709$$CN$US$US
240635551$24063555$1$I$20240101$20240124$20240709$20240709$EXP$$US-RECORDATI RARE DISEASE INC.-2024000153$RECORDATI$$$$$$Y$$$20240709$$CN$US$US
240635561$24063556$1$I$$20240610$20240709$20240709$PER$$US-AMGEN-USASP2024134975$AMGEN$$$$$M$Y$$$20240709$$CN$US$US
240635571$24063557$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141008$NOVARTIS$$$$$F$Y$$$20240709$$HP$US$US
240635581$24063558$1$I$$20240629$20240709$20240709$30DAY$$PR-VIIV HEALTHCARE LIMITED-US2024AMR081845$VIIV$$$$$$Y$$$20240709$$MD$PR$US
240635591$24063559$1$I$$20240629$20240709$20240709$EXP$GB-MHRA-MED-202406281035540500-DRMKH$GB-MSNLABS-2024MSNSPO01483$MSN LABORATORIES$$$$$$Y$$$20240709$$CN$GB$GB
240635601$24063560$1$I$$20240624$20240709$20240709$EXP$$FR-TEVA-VS-3216671$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240709$$HP$FR$FR
240635611$24063561$1$I$$20240703$20240709$20240709$EXP$$CA-TAKEDA-2024TUS068331$TAKEDA$$$$$M$Y$$$20240709$$CN$CA$CA
240635621$24063562$1$I$$20240311$20240709$20240709$EXP$$US-RECORDATI RARE DISEASE INC.-2024001816$RECORDATI$$$$$$Y$$$20240709$$CN$US$US
240635631$24063563$1$I$$20240702$20240709$20240709$EXP$$CA-TAKEDA-2024TUS067779$TAKEDA$$$$$F$Y$$$20240709$$MD$CA$CA
240635641$24063564$1$I$$20240624$20240709$20240709$EXP$$FR-TEVA-VS-3216672$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240709$$HP$FR$FR
240635651$24063565$1$I$$20240624$20240709$20240709$EXP$$FR-TEVA-VS-3216670$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240709$$HP$FR$FR
240635661$24063566$1$I$$20240624$20240709$20240709$EXP$$FR-TEVA-VS-3216669$TEVA$Lalanne S, Bouzille G, Tron C, Revest M, Polard E, Bellissant E, et al. Amoxicillin-Induced Neurotoxicity: Contribution of a Healthcare Data Warehouse to the Determination of a Toxic Concentration Threshold. Antibiotics-(Basel) 2023; 12 (4):.$$$$$Y$$$20240709$$HP$FR$FR
240635671$24063567$1$I$20240626$20240703$20240709$20240709$EXP$$CN-ABBVIE-5831569$ABBVIE$$30$YR$$M$Y$130$KG$20240709$$HP$CN$CN
240635681$24063568$1$I$$20240703$20240709$20240709$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02493$AMNEAL$$$$$F$Y$$$20240709$$CN$US$US
240635691$24063569$1$I$$20240701$20240709$20240709$EXP$GB-MHRA-MED-202407010929464220-CMFKW$GB-TEVA-VS-3215924$TEVA$$$$$M$Y$78$KG$20240709$$CN$GB$GB
240635702$24063570$2$F$20240626$20240730$20240709$20240808$PER$$US-SA-2024SA195357$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240808$$MD$US$US
240635711$24063571$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA195250$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240709$$CN$US$US
240635721$24063572$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA195162$SANOFI AVENTIS$$$$A$F$Y$53.5$KG$20240709$$MD$US$US
240635731$24063573$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA070678$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240709$$CN$US$US
240635741$24063574$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA124004$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240709$$CN$US$US
240635752$24063575$2$F$$20240802$20240709$20240813$PER$$US-SA-2024SA197246$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240814$$MD$US$US
240635761$24063576$1$I$20240601$20240701$20240709$20240709$PER$$US-SA-2024SA197458$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240709$$MD$US$US
240635771$24063577$1$I$20240101$20240627$20240709$20240709$PER$$US-SA-2024SA195701$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240709$$CN$US$US
240635781$24063578$1$I$20240625$20240701$20240709$20240709$PER$$US-SA-2024SA198058$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240709$$MD$US$US
240635791$24063579$1$I$20240630$20240702$20240709$20240709$EXP$$US-VIIV HEALTHCARE LIMITED-US2024082142$VIIV$$58$YR$$M$Y$$$20240709$$CN$US$US
240635801$24063580$1$I$20240601$20240703$20240709$20240709$PER$$US-SA-2024SA199332$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240709$$MD$US$US
240635811$24063581$1$I$$20240705$20240709$20240709$PER$$US-SA-2024SA200058$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240709$$CN$US$US
240635821$24063582$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA198053$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240709$$MD$US$US
240635831$24063583$1$I$20240622$20240701$20240709$20240709$PER$$US-SA-2024SA197512$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240709$$MD$US$US
240635841$24063584$1$I$$20240703$20240709$20240709$PER$$US-JNJFOC-20240710021$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$HP$US$US
240635851$24063585$1$I$20240527$20240629$20240709$20240709$EXP$$CN-ARGENX-2024-ARGX-CN005090$ARGENX BVBA$$$$$$Y$$$20240709$$MD$CN$CN
240635861$24063586$1$I$$20240703$20240709$20240709$EXP$$NL-ABBVIE-5656928$ABBVIE$$$$A$M$Y$$$20240709$$HP$NL$NL
240635871$24063587$1$I$20240207$20240702$20240709$20240709$EXP$$FR-AUROBINDO-AUR-APL-2024-032840$AUROBINDO$$61$YR$$F$Y$70$KG$20240709$$MD$FR$FR
240635881$24063588$1$I$$20240702$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-033020$AUROBINDO$$$$$F$Y$95$KG$20240709$$CN$GB$GB
240635892$24063589$2$F$$20240708$20240709$20240712$EXP$$GB-TAKEDA-2024TUS066899$TAKEDA$$$$$M$Y$$$20240712$$HP$GB$GB
240635901$24063590$1$I$$20240705$20240709$20240709$EXP$$US-ABBVIE-5830629$ABBVIE$$$$$F$Y$$$20240709$$HP$US$US
240635912$24063591$2$F$$20240902$20240709$20240915$EXP$$GB-UCBSA-2024034447$UCB$$$$$M$Y$$$20240915$$CN$GB$GB
240635921$24063592$1$I$20240615$20240704$20240709$20240709$EXP$$DE-ABBVIE-5831487$ABBVIE$$61$YR$$M$Y$$$20240709$$CN$DE$DE
240635931$24063593$1$I$$20240625$20240709$20240709$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05997$HIKMA$Kerai A, Doshi S, Laleker A, Majumdar A. Kerai A, Doshi S, Laleker A, Majumdar A. Fungal Foe and Mechanical Hearts: A Retrospective Case Series on Candida auris Bloodstream Infection With Left Ventricular Assist Devices.. Open Forum Infectious Diseases. 2024;11(6):ofae286:6 pgs$62$YR$$M$Y$$$20240709$$MD$US$US
240635941$24063594$1$I$20240625$20240708$20240709$20240709$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038352$BOEHRINGER INGELHEIM$$88$YR$E$F$Y$42$KG$20240709$$HP$CN$CN
240635951$24063595$1$I$20230131$20240703$20240709$20240709$EXP$$US-ABBVIE-5290535$ABBVIE$$65$YR$$M$Y$$$20240709$$CN$US$US
240635961$24063596$1$I$20220201$20240701$20240709$20240709$EXP$FR-AFSSAPS-AVCN2024000484$FR-SA-2024SA195095$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240709$$MD$FR$FR
240635971$24063597$1$I$20240531$20240624$20240709$20240709$EXP$FR-AFSSAPS-SE2024000507$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108992$ZYDUS PHARM$$$$$$Y$$$20240709$$MD$FR$FR
240635981$24063598$1$I$$20240704$20240709$20240709$EXP$$NVSC2024FR121472$NOVARTIS$$$$$F$Y$$$20240709$$MD$FR$FR
240635992$24063599$2$F$20240630$20240722$20240709$20240724$PER$$US-AMGEN-USASP2024134322$AMGEN$$70$YR$E$F$Y$$$20240724$$CN$US$US
240636001$24063600$1$I$$20240625$20240709$20240709$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109016$ZYDUS PHARM$Vu VA, Bhayana S, Sweiss H, Castro N, Hall R, Nelson J.. Impact of Cumulative 6 mg/kg Antithymocyte Globulin on Early Posttransplant Outcomes in Kidney Transplant Recipients with Delayed Graft Function.. Prog-Transplant. 2024;34(1-2):47-52$$$$$Y$$$20240709$$HP$US$US
240636011$24063601$1$I$20160727$20240703$20240709$20240709$EXP$$CA-TAKEDA-2016TUS014178$TAKEDA$$46$YR$$F$Y$$$20240709$$CN$CA$CA
240636022$24063602$2$F$20240527$20240812$20240709$20240815$PER$$US-009507513-2406USA007505$MERCK$$35$YR$$M$Y$$$20240815$$HP$US$US
240636031$24063603$1$I$20240418$20240705$20240709$20240709$EXP$$GB-AstraZeneca-2024A154015$ASTRAZENECA$$79$YR$$M$Y$95$KG$20240709$$MD$GB$
240636041$24063604$1$I$20240601$20240623$20240709$20240709$PER$$US-009507513-2406USA008667$MERCK$$48$YR$$M$Y$$$20240709$$CN$US$US
240636051$24063605$1$I$$20240701$20240709$20240709$EXP$$CA-AstraZeneca-2024A152766$ASTRAZENECA$$$$$F$Y$$$20240709$$MD$CA$
240636061$24063606$1$I$20240528$20240625$20240709$20240709$EXP$$CN-Techdow-J2024HPR000408$SHENZHEN TECHDOW PHARMACEUTICAL$$57$YR$A$F$Y$$$20240709$$MD$CN$CN
240636071$24063607$1$I$20230101$20240703$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407002767$ELI LILLY AND CO$$$$$F$Y$$$20240709$$CN$US$US
240636081$24063608$1$I$$20240701$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407002015$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240709$$CN$US$US
240636091$24063609$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005009$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240709$$CN$US$US
240636102$24063610$2$F$20240706$20240709$20240709$20240710$PER$$US-AMGEN-USASP2024135258$AMGEN$$62$YR$A$F$Y$$$20240710$$CN$US$US
240636121$24063612$1$I$20240202$20240523$20240709$20240709$EXP$$GB-AMGEN-GBRNI2024131455$AMGEN$$78$YR$E$M$Y$74.2$KG$20240709$$HP$GB$GB
240636131$24063613$1$I$20240601$20240705$20240709$20240709$EXP$$US-UCBSA-2024034489$UCB$$52$YR$$F$Y$$$20240709$$HP$US$US
240636154$24063615$4$F$$20240906$20240709$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-020465$UNITED THERAPEUTICS$$$$$F$Y$44.898$KG$20240912$$$US$US
240636161$24063616$1$I$$20240625$20240709$20240709$EXP$$CH-STERISCIENCE B.V.-2024-ST-000969$Steriscience PTE$Herken J, Uerlings V, Zundel S, Aichner J, Hodel M.. Fetal bladder rupture after high-dose maternal opioid treatment: a case report.. Case-Rep-Perinat-Med. 2024;13 (1)$$$$M$Y$$$20240709$$MD$CH$CH
240636171$24063617$1$I$20240612$20240702$20240709$20240709$EXP$$CN-ROCHE-10000015096$ROCHE$$51$YR$A$F$Y$62$KG$20240709$$HP$CN$CN
240636182$24063618$2$F$20240101$20240723$20240709$20240726$PER$$US-UNITED THERAPEUTICS-UNT-2024-020567$UNITED THERAPEUTICS$$$$$M$Y$77.098$KG$20240726$$$US$US
240636191$24063619$1$I$$20240704$20240709$20240709$EXP$$CA-TAKEDA-2024TUS068835$TAKEDA$$$$$F$Y$$$20240709$$MD$CA$CA
240636201$24063620$1$I$$20240703$20240709$20240709$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010354$JAZZ$$$$$F$Y$$$20240709$$HP$US$US
240636211$24063621$1$I$20240117$20240708$20240709$20240709$EXP$GB-MHRA-MED-202405081305445350-DFQWG$GB-JNJFOC-20240720068$JOHNSON AND JOHNSON$$78$YR$E$M$Y$67$KG$20240709$$MD$GB$GB
240636221$24063622$1$I$$20240625$20240709$20240709$EXP$$IT-STERISCIENCE B.V.-2024-ST-000963$Steriscience PTE$Cavazza G, Motto C, Regna-Gladin C, Travi G, Di Gennaro E, Peracchi F, et al. Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management. Antibiotics-(Basel). 2024;13 (5)$48$YR$$M$Y$$$20240709$$HP$IT$IT
240636231$24063623$1$I$20240517$20240708$20240709$20240709$EXP$FR-AFSSAPS-MA2024001129$FR-UCBSA-2024034428$UCB$$53$YR$$M$Y$$$20240709$$HP$FR$FR
240636242$24063624$2$F$20240101$20240827$20240709$20240906$EXP$$US-INSMED, INC.-2024-01973-US$INSMED$$$$$F$Y$$$20240906$$CN$US$US
240636252$24063625$2$F$20240101$20240703$20240709$20240717$EXP$$US-INSMED, INC.-2024-02220-US$INSMED$$$$$F$Y$$$20240717$$CN$US$US
240636261$24063626$1$I$$20240701$20240709$20240709$EXP$$DE-PBT-009489$PANACEA BIOTEC$Bieneck V, Decker A, Schmitt-Graeff A, Kreisel W, Schauer F. Remission of refractory esophageal lichen planus induced by tofacitinib. Z Gastroenterol. 2024 Jun 25. English. doi: 10.1055/a-2300-0375.$56$YR$A$F$Y$$$20240709$$HP$DE$DE
240636271$24063627$1$I$$20240625$20240709$20240709$EXP$$US-STERISCIENCE B.V.-2024-ST-000961$Steriscience PTE$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM.. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.. Arch-Dermatol-Res. 2024;316 (6)$49$YR$$M$Y$$$20240709$$HP$US$US
240636281$24063628$1$I$$20240707$20240709$20240709$PER$$US-HALEON-2185973$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240636291$24063629$1$I$20240502$20240708$20240709$20240709$EXP$FR-AFSSAPS-BX2024001345$FR-UCBSA-2024034438$UCB$$62$YR$$F$Y$67$KG$20240709$$MD$FR$FR
240636301$24063630$1$I$$20240701$20240709$20240709$EXP$$US-ABBVIE-5826284$ABBVIE$$$$$$Y$$$20240709$$CN$US$US
240636313$24063631$3$F$$20240729$20240709$20240806$EXP$$CA-TAKEDA-2024TUS068260$TAKEDA$$75$YR$$$Y$$$20240806$$CN$CA$CA
240636321$24063632$1$I$$20240625$20240709$20240709$EXP$$US-STERISCIENCE B.V.-2024-ST-000960$Steriscience PTE$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch-Dermatol-Res. 2024;316 (6)$63$YR$$F$Y$$$20240709$$HP$US$US
240636341$24063634$1$I$$20240708$20240709$20240709$EXP$$US-TAKEDA-2024TUS069543$TAKEDA$$$$$M$Y$$$20240709$$CN$US$US
240636351$24063635$1$I$20240703$20240704$20240709$20240709$EXP$GB-MHRA-MED-202407041459345310-HBWCZ$NVSC2024GB140934$NOVARTIS$$58$YR$$F$Y$$$20240709$$HP$GB$GB
240636362$24063636$2$F$$20240924$20240709$20240926$PER$$NVSC2024US140872$NOVARTIS$$$$$$Y$$$20240926$$CN$US$US
240636372$24063637$2$F$$20240910$20240709$20240913$EXP$$US-JNJFOC-20240707300$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$MD$US$US
240636381$24063638$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134706$AMGEN$$$$$M$Y$$$20240709$$PH$US$US
240636391$24063639$1$I$20240705$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024133908$AMGEN$$62$YR$A$F$Y$$$20240709$$CN$US$US
240636401$24063640$1$I$$20240626$20240709$20240709$EXP$$US-STERISCIENCE B.V.-2024-ST-000964$Steriscience PTE$Folkerth R, Jayakumar J, Manesh A, Pandurangan K, Perl D, Priemer D, et al.. Comparison of neuropathologies among rabies patients treated with standard, Milwaukee, and/or experimental AAV-RAB strategies.. J-Neuropathol-Exp-Neurol. 2024;83 (6):453$57$YR$$M$Y$$$20240709$$HP$US$US
240636411$24063641$1$I$20231104$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405042054079270-GQPTS$GB-TAKEDA-2024TUS068334$TAKEDA$$71$YR$$M$Y$83$KG$20240709$$HP$GB$GB
240636431$24063643$1$I$$20240705$20240709$20240709$EXP$$SE-SANDOZ INC.-SDZ2024SE063461$SANDOZ$$$$$F$Y$$$20240709$$HP$SE$SE
240636441$24063644$1$I$20200101$20240702$20240709$20240709$EXP$$US-SANDOZ INC.-SDZ2024US062631$SANDOZ$$$$$F$Y$$$20240709$$CN$US$US
240636453$24063645$3$F$20230101$20240806$20240709$20240809$EXP$$US-TAKEDA-2024TUS067694$TAKEDA$$$$$F$Y$$$20240809$$CN$US$US
240636462$24063646$2$F$$20240905$20240709$20240913$EXP$$CA-TAKEDA-2023TUS068622$TAKEDA$$$$$M$Y$$$20240913$$CN$CA$CA
240636471$24063647$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A151495$ASTRAZENECA$$$$$F$Y$54$KG$20240709$$CN$US$
240636481$24063648$1$I$$20240705$20240709$20240709$EXP$$CA-TAKEDA-2024TUS069571$TAKEDA$$$$$M$Y$$$20240709$$CN$CA$CA
240636496$24063649$6$F$20240101$20240821$20240709$20240828$EXP$$CN-MIRUM PHARMACEUTICALS, INC.-CN-MIR-24-00380$MIRUM PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$CN$CN
240636501$24063650$1$I$20240410$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405011750000060-NVGMH$GB-ORGANON-O2407GBR000544$ORGANON$$7$YR$$F$Y$29$KG$20240709$$CN$GB$GB
240636511$24063651$1$I$$20240625$20240709$20240709$EXP$$CH-STERISCIENCE B.V.-2024-ST-000970$Steriscience PTE$Herken J, Uerlings V, Zundel S, Aichner J, Hodel M.. Fetal bladder rupture after high-dose maternal opioid treatment: a case report.. Case-Rep-Perinat-Med. 2024;13 (1)$18$YR$$F$Y$$$20240709$$MD$CH$CH
240636521$24063652$1$I$$20240702$20240709$20240709$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02462$AMNEAL$$$$$F$Y$70.8$KG$20240709$$MD$US$US
240636531$24063653$1$I$$20240628$20240709$20240709$EXP$$US-JNJFOC-20240700608$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240636541$24063654$1$I$20240528$20240702$20240709$20240709$PER$$US-ABBVIE-5831301$ABBVIE$$42$YR$$F$Y$$$20240709$$MD$US$US
240636552$24063655$2$F$20240101$20240716$20240709$20240725$EXP$$CA-CELLTRION INC.-2024CA012977$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
240636565$24063656$5$F$20240329$20240813$20240709$20240821$EXP$$CN-MIRUM PHARMACEUTICALS, INC.-CN-MIR-24-00379$MIRUM PHARMACEUTICALS$$$$$$Y$$$20240821$$CN$CN$CN
240636571$24063657$1$I$$20240701$20240709$20240709$EXP$FR-AFSSAPS-RE2024000605$FR-TEVA-VS-3215853$TEVA$$28$YR$$F$Y$66$KG$20240709$$MD$FR$FR
240636581$24063658$1$I$20240101$20240705$20240709$20240709$EXP$$US-ABBVIE-5830638$ABBVIE$$$$$M$Y$$$20240709$$CN$US$US
240636593$24063659$3$F$$20240730$20240709$20240808$PER$$US-UNITED THERAPEUTICS-UNT-2024-016397$UNITED THERAPEUTICS$$$$$F$Y$53.061$KG$20240808$$$US$US
240636611$24063661$1$I$$20240705$20240709$20240709$EXP$$US-TAKEDA-2024TUS069044$TAKEDA$$$$$F$Y$$$20240709$$MD$US$US
240636621$24063662$1$I$$20240702$20240709$20240709$EXP$$HU-TAKEDA-2024TUS067250$TAKEDA$$65$YR$$M$Y$$$20240709$$HP$HU$HU
240636632$24063663$2$F$$20240819$20240709$20240823$EXP$$GB-ABBVIE-5830303$ABBVIE$$$$A$F$Y$$$20240823$$CN$GB$GB
240636641$24063664$1$I$$20240701$20240709$20240709$PER$$US-RDY-SPO/USA/24/0009581$DR REDDYS$$$$$F$Y$$$20240709$$CN$US$US
240636651$24063665$1$I$20220318$20240701$20240709$20240709$EXP$$KR-TAKEDA-2024TUS067418$TAKEDA$$76$YR$$F$Y$46.9$KG$20240709$$MD$KR$KR
240636661$24063666$1$I$$20240625$20240709$20240709$PER$US-MLMSERVICE-20240619-PI101873-00108-2$US-RDY-SPO/USA/24/0009386$DR REDDYS$Leung JG, Allen ND, Markota M. A case series of clozapine titrations affected by inflammatory processes. Schizophrenia Research. 2024;268:94-7. DOI:10.1016/j.schres.2023.08.007.$41$YR$A$F$Y$$$20240709$$PH$US$US
240636673$24063667$3$F$20240609$20240805$20240709$20240816$PER$$US-ROCHE-3578826$ROCHE$$30$YR$A$F$Y$86.36$KG$20240816$$CN$US$US
240636682$24063668$2$F$20240603$20240801$20240709$20240808$EXP$$CO-TAKEDA-2024TUS069566$TAKEDA$$18$YR$$M$Y$54$KG$20240808$$CN$CO$CO
240636691$24063669$1$I$$20240625$20240709$20240709$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-19459$SAMSUNG BIOEPIS$$64$YR$A$F$Y$$$20240709$$PH$CA$CA
240636701$24063670$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA199254$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240709$$MD$US$US
240636711$24063671$1$I$20240101$20240703$20240709$20240709$PER$$US-SA-2024SA199121$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240709$$MD$US$US
240636721$24063672$1$I$20240626$20240627$20240709$20240709$PER$$US-SA-2024SA194965$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240709$$CN$US$US
240636731$24063673$1$I$20240608$20240702$20240709$20240709$PER$$US-SA-2024SA199092$SANOFI AVENTIS$$91$YR$E$M$Y$81.6$KG$20240709$$MD$US$US
240636751$24063675$1$I$20240101$20240701$20240709$20240709$PER$$US-SA-2024SA198677$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240709$$MD$US$US
240636772$24063677$2$F$$20240801$20240709$20240810$PER$$US-SA-2024SA194856$SANOFI AVENTIS$$62$YR$A$M$Y$62.585$KG$20240810$$MD$US$US
240636781$24063678$1$I$20240301$20240630$20240709$20240709$PER$$US-SA-2024SA197150$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240709$$MD$US$US
240636791$24063679$1$I$$20240627$20240709$20240709$PER$$CA-SA-2024SA188484$SANOFI AVENTIS$$$$$F$Y$$$20240709$$CN$US$US
240636801$24063680$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA198171$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240709$$MD$US$US
240636812$24063681$2$F$$20240830$20240709$20240913$PER$$US-SA-2024SA198347$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240913$$MD$US$US
240636831$24063683$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA198952$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240709$$MD$US$US
240636841$24063684$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA194774$SANOFI AVENTIS$$$$A$$Y$$$20240709$$HP$US$US
240636851$24063685$1$I$$20240630$20240709$20240709$PER$$US-SA-2024SA198135$SANOFI AVENTIS$$$$C$M$Y$10.43$KG$20240709$$MD$US$US
240636861$24063686$1$I$$20240705$20240709$20240709$EXP$$CA-TAKEDA-2024TUS069521$TAKEDA$$$$$F$Y$$$20240709$$MD$CA$CA
240636871$24063687$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA199730$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240709$$MD$US$US
240636881$24063688$1$I$20240401$20240702$20240709$20240709$PER$$US-SA-2024SA198935$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240709$$MD$US$US
240636893$24063689$3$F$20240601$20240729$20240709$20240803$PER$$US-SA-2024SA197416$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240803$$HP$US$US
240636901$24063690$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005184$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240709$$CN$US$US
240636911$24063691$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134384$AMGEN$$$$$M$Y$74.966$KG$20240709$$CN$US$US
240636921$24063692$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004753$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240709$$CN$US$US
240636932$24063693$2$F$$20240703$20240709$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407002777$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240710$$HP$US$US
240636941$24063694$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004471$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240709$$CN$US$US
240636951$24063695$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004479$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240709$$CN$US$US
240636961$24063696$1$I$20240708$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005017$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240709$$CN$US$US
240636971$24063697$1$I$20240101$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005113$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240709$$CN$US$US
240636981$24063698$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA195183$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240636991$24063699$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA194591$SANOFI AVENTIS$$18$YR$A$F$Y$52.1$KG$20240709$$MD$US$US
240637001$24063700$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA198590$SANOFI AVENTIS$$$$A$F$Y$86$KG$20240709$$MD$US$US
240637011$24063701$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA198941$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240709$$MD$US$US
240637021$24063702$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA198185$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$HP$US$US
240637031$24063703$1$I$20240101$20240705$20240709$20240709$EXP$$CA-ABBVIE-5795103$ABBVIE$$$$A$M$Y$$$20240709$$CN$CA$CA
240637041$24063704$1$I$20240101$20240705$20240709$20240709$EXP$$US-ABBVIE-5830611$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240637056$24063705$6$F$20240719$20240809$20240709$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020403$UNITED THERAPEUTICS$$23$YR$$F$Y$77.098$KG$20240817$$$US$US
240637064$24063706$4$F$20240525$20240730$20240709$20240807$30DAY$$US-JNJFOC-20240674221$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
240637071$24063707$1$I$$20240704$20240709$20240709$EXP$$CO-JNJFOC-20240715661$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$MD$CO$CO
240637081$24063708$1$I$$20240612$20240709$20240709$PER$$US-JNJFOC-20240637355$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$US$US
240637091$24063709$1$I$20240703$20240705$20240709$20240709$PER$$US-JNJFOC-20240715539$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240709$$CN$US$US
240637101$24063710$1$I$20240501$20240706$20240709$20240709$EXP$$US-ABBVIE-5831376$ABBVIE$$91$YR$$F$Y$$$20240709$$CN$US$US
240637111$24063711$1$I$$20240628$20240709$20240709$EXP$$JP-ROCHE-3546511$ROCHE$Okahashi A, Hijikata M, Seimiya A, Nagano N, Yokota H, Kimura Y, et al Successful valganciclovir treatment initiated beyond 60 days of age in a preterm infant with congenital cytomegalovirus disease. Doi:10.1111/ped.15755.. Pediatr Int. 2024;66:1-3.$89$DY$I$F$Y$1.04$KG$20240709$$HP$JP$JP
240637121$24063712$1$I$20240501$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134361$AMGEN$$64$YR$A$M$Y$$$20240709$$CN$US$US
240637131$24063713$1$I$$20240702$20240709$20240709$EXP$$RU-AMGEN-RUSSP2024133604$AMGEN$Popov A. M.; Rumyantseva Y. V.; Mikhailova E. V. et al.. The use of blinatumomab in children with de novo Ph-negative B-lineage acute lymphoblastic leukemia and slowclearance of minimal residual disease. Pediatric Hematology/Oncology and Immunopathology. 2024;23 (1):63-72$$$$$Y$$$20240709$$HP$RU$RU
240637141$24063714$1$I$20240601$20240628$20240709$20240709$EXP$$CA-CELLTRION INC.-2024CA007544$CELLTRION$$$$$$Y$$$20240709$$MD$CA$CA
240637151$24063715$1$I$20240627$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134093$AMGEN$$56$YR$A$M$Y$$$20240709$$CN$US$US
240637161$24063716$1$I$20240201$20240708$20240709$20240709$EXP$IT-MINISAL02-993520$NVSC2024IT140512$NOVARTIS$$46$YR$$M$Y$$$20240709$$MD$IT$IT
240637171$24063717$1$I$$20240627$20240709$20240709$PER$$US-TAKEDA-2024TUS065179$TAKEDA$$$$$$Y$$$20240709$$MD$US$US
240637181$24063718$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135305$AMGEN$$$$$$Y$$$20240709$$PH$US$US
240637191$24063719$1$I$$20240704$20240709$20240709$PER$$US-TAKEDA-2024TUS068898$TAKEDA$$$$$M$Y$$$20240709$$MD$US$US
240637201$24063720$1$I$20231201$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405060341067210-TCMHK$GB-ORGANON-O2407GBR000642$ORGANON$$$$$F$Y$$$20240709$$CN$GB$GB
240637211$24063721$1$I$$20240104$20240709$20240709$EXP$GB-MHRA-MED-202401031216039080-JTPRG$GB-TEVA-VS-3146603$TEVA$$83$YR$$$Y$$$20240709$$HP$GB$GB
240637221$24063722$1$I$20240420$20240701$20240709$20240709$EXP$FR-AFSSAPS-MP2024001042$FR-TEVA-VS-3215847$TEVA$$72$YR$$M$Y$$$20240709$$PH$FR$FR
240637231$24063723$1$I$$20240705$20240709$20240709$EXP$$US-ABBVIE-4724176$ABBVIE$$$$$M$Y$$$20240709$$CN$US$US
240637241$24063724$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A152485$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240637251$24063725$1$I$$20240701$20240709$20240709$PER$$US-AstraZeneca-2024A151319$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240637263$24063726$3$F$20240601$20240731$20240709$20240830$PER$$US-AstraZeneca-2024A150555$ASTRAZENECA$$74$YR$$F$Y$$$20240830$$CN$US$
240637282$24063728$2$F$20240601$20240709$20240709$20240711$PER$$US-AMGEN-USASP2024135169$AMGEN$$78$YR$E$F$Y$$$20240710$$CN$US$US
240637291$24063729$1$I$$20231122$20240709$20240709$PER$$US-AMGEN-USASP2023235233$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240637301$24063730$1$I$$20240702$20240709$20240709$EXP$$RU-AMGEN-RUSSP2024133542$AMGEN$Popov A. M.; Rumyantseva Y. V.; Mikhailova E. V. et al.. The use of blinatumomab in children with de novo Ph-negative B-lineage acute lymphoblastic leukemia and slowclearance of minimal residual disease. Pediatric Hematology/Oncology and Immunopathology. 2024;23 (1):63-72$$$$$Y$$$20240709$$HP$RU$RU
240637311$24063731$1$I$$20240701$20240709$20240709$EXP$$GB-AMGEN-GBRSP2024132448$AMGEN$Bridgewater J. A.; Chantrill L.; Gillmore R. et al.. Phase 11 results of the porcupine (PORCN) inhibitor zamaporvint (RXCO04) in patients with pancreatic and biliary tract cancer. Annals of Oncology. 2024;35(S1):S157$$$$$Y$$$20240709$$HP$GB$GB
240637321$24063732$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA199282$SANOFI AVENTIS$$$$E$M$Y$$$20240709$$MD$US$US
240637331$24063733$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA199139$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240709$$MD$US$US
240637341$24063734$1$I$20231201$20240627$20240709$20240709$PER$$US-SA-2024SA195201$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240709$$MD$US$US
240637351$24063735$1$I$20240401$20240702$20240709$20240709$PER$$US-SA-2024SA198992$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240709$$MD$US$US
240637361$24063736$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA196374$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240709$$MD$US$US
240637371$24063737$1$I$$20240701$20240709$20240709$EXP$$US-JNJFOC-20240704136$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$MD$US$US
240637381$24063738$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05862$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240637391$24063739$1$I$$20240702$20240709$20240709$EXP$$US-GSK-US2024AMR082703$GLAXOSMITHKLINE$$$$$F$Y$74$KG$20240709$$CN$US$US
240637401$24063740$1$I$20240702$20240703$20240709$20240709$30DAY$$US-GSK-US2024082652$GLAXOSMITHKLINE$$54$YR$$M$Y$$$20240709$$CN$US$US
240637412$24063741$2$F$$20240709$20240709$20240716$PER$$US-PCCINC-2024-PPL-000507$PIRAMAL$$$$$$Y$$$20240716$$CN$US$US
240637421$24063742$1$I$20240101$20240703$20240709$20240709$EXP$$US-ABBVIE-5831099$ABBVIE$$$$$M$Y$$$20240709$$CN$US$US
240637431$24063743$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05996$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240637443$24063744$3$F$$20240830$20240709$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05936$LUPIN$$$$$$Y$$$20240919$$CN$US$US
240637451$24063745$1$I$$20240505$20240709$20240709$EXP$$US-PTA-005629$BANNER$$41$YR$A$F$Y$$$20240709$$CN$US$US
240637461$24063746$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05871$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240637472$24063747$2$F$$20240503$20240709$20240723$EXP$$US-PTA-005618$BANNER$$$$$$Y$$$20240723$$CN$US$
240637481$24063748$1$I$$20240502$20240709$20240709$EXP$$US-PTA-005617$BANNER$$$$$$Y$$$20240709$$CN$US$
240637491$24063749$1$I$20240401$20240621$20240709$20240709$EXP$$US-PTA-005688$BANNER$$52$YR$A$M$Y$$$20240709$$CN$US$US
240637501$24063750$1$I$$20240708$20240709$20240709$PER$$US-TAKEDA-2024TUS069380$TAKEDA$$$$$F$Y$$$20240709$$CN$US$US
240637511$24063751$1$I$20240318$20240628$20240709$20240709$PER$$US-SA-2024SA089979$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240709$$CN$US$US
240637521$24063752$1$I$$20240527$20240709$20240709$EXP$$US-PTA-005646$BANNER$$$$$F$Y$$$20240709$$CN$US$US
240637531$24063753$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA199840$SANOFI AVENTIS$$$$$M$Y$$$20240709$$HP$US$US
240637542$24063754$2$F$20230701$20240820$20240709$20240903$PER$$US-SA-2024SA198068$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240903$$MD$US$US
240637551$24063755$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA196710$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240637561$24063756$1$I$$20240706$20240709$20240709$PER$$US-TAKEDA-2024TUS069493$TAKEDA$$$$$F$Y$$$20240709$$HP$US$US
240637571$24063757$1$I$$20240630$20240709$20240709$EXP$$US-APOTEX-2024AP008024$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240709$$HP$US$US
240637581$24063758$1$I$20240101$20240619$20240709$20240709$PER$$US-APOTEX-2024AP007542$APOTEX$$$$$F$Y$$$20240709$$CN$US$US
240637591$24063759$1$I$$20240702$20240709$20240709$EXP$$US-GSK-US2024082199$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$US$US
240637601$24063760$1$I$$20240706$20240709$20240709$EXP$GB-MHRA-MED-202406241158499430-PQWVD$GB-ORGANON-O2407GBR000728$ORGANON$$$$$$Y$$$20240709$$HP$GB$GB
240637612$24063761$2$F$20240110$20240802$20240709$20240805$EXP$GB-MHRA-MED-202405161316449030-BKDSY$GB-ORGANON-O2407GBR000652$ORGANON$$13$YR$$M$Y$$$20240805$$CN$GB$GB
240637621$24063762$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134967$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240637631$24063763$1$I$$20240701$20240709$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-020529$UNITED THERAPEUTICS$$$$$M$Y$83.9$KG$20240709$$$US$US
240637641$24063764$1$I$20240101$20240703$20240709$20240709$EXP$$US-ABBVIE-5827092$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240637651$24063765$1$I$$20240625$20240709$20240709$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05998$HIKMA$Kerai A, Doshi S, Laleker A, Majumdar A. Kerai A, Doshi S, Laleker A, Majumdar A. Fungal Foe and Mechanical Hearts: A Retrospective Case Series on Candida auris Bloodstream Infection With Left Ventricular Assist Devices.. Open Forum Infectious Diseases. 2024;11(6):ofae286:6 pgs$52$YR$$M$Y$$$20240709$$MD$US$US
240637661$24063766$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05706$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240637671$24063767$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05708$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240637681$24063768$1$I$$20240419$20240709$20240709$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03511$HIKMA$$$$$M$Y$$$20240708$$CN$US$US
240637691$24063769$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06065$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240637701$24063770$1$I$$20240701$20240709$20240709$EXP$$MX-PBT-009487$PANACEA BIOTEC$Gutierrez-Govea A, Jalomo-Martinez B, Evangelista-Carrillo LA, Cerrillos-Gutierrez JI, Medina-Perez M. Thrombotic microangiopathy associated with calcineurin inhibitor induction doses in patients with a kidney transplant. Clin Case Rep. 2024 Jun 28;12(7):e9125. doi: 10.1002/ccr3.9125.$23$YR$A$M$Y$$$20240709$$HP$MX$MX
240637711$24063771$1$I$$20240703$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407002865$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240709$$CN$US$US
240637721$24063772$1$I$$20240703$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407002967$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240709$$CN$US$US
240637731$24063773$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004573$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240709$$CN$US$US
240637741$24063774$1$I$20220101$20240701$20240709$20240709$EXP$$US-AMGEN-USASP2024132321$AMGEN$Onukogu I. D.; Medawar G.; Mangala Y. O. et al.. Sotorasib as Fourth-Line Treatment in Pancreatic Cancer: A Case Report and Literature Review. Rhode Island medical journal. 2024;107 (7):10-13$65$YR$E$F$Y$$$20240709$$MD$US$US
240637751$24063775$1$I$20240601$20240702$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-033061$AUROBINDO$$$$$F$Y$$$20240709$$HP$GB$GB
240637761$24063776$1$I$$20240702$20240709$20240709$EXP$$JP-009507513-2407JPN000218J$MERCK$$8$DEC$$F$Y$$$20240709$$PH$JP$JP
240637772$24063777$2$F$$20240724$20240709$20240730$EXP$GB-MHRA-30959484$GB-REGENERON PHARMACEUTICALS, INC.-2024-094805$REGENERON$$65$YR$$$Y$$$20240730$$PH$GB$GB
240637781$24063778$1$I$$20240703$20240709$20240709$EXP$$US-VIIV HEALTHCARE LIMITED-US2024083141$VIIV$$$$A$F$Y$$$20240709$$HP$US$US
240637791$24063779$1$I$$20240703$20240709$20240709$EXP$$CN-TAKEDA-2024TUS067982$TAKEDA$$$$$F$Y$$$20240709$$CN$CN$CN
240637801$24063780$1$I$$20240702$20240709$20240709$PER$$US-JNJFOC-20240721193$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$HP$US$US
240637811$24063781$1$I$20190507$20240703$20240709$20240709$EXP$$CA-TAKEDA-2019TUS029734$TAKEDA$$47$YR$$F$Y$$$20240709$$CN$CA$CA
240637821$24063782$1$I$$20240702$20240709$20240709$PER$$US-JNJFOC-20240705090$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$MD$US$US
240637831$24063783$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05861$LUPIN$$$$$$Y$$$20240709$$PH$US$US
240637841$24063784$1$I$$20240701$20240709$20240709$EXP$$DE-AMGEN-DEUSP2024130638$AMGEN$Kaufmann J.. Excellent long-term pain response and local control following postoperative radiotherapy in patients with multiple myeloma. Strahlentherapie und Onkologie. 2024;200:633-641$$$$$Y$$$20240709$$HP$DE$DE
240637852$24063785$2$F$$20240713$20240709$20240722$EXP$$US-TAKEDA-2024TUS056763$TAKEDA$$$$$M$Y$68$KG$20240722$$MD$US$US
240637861$24063786$1$I$$20240701$20240709$20240709$EXP$$IE-002147023-PHHY2018IE008708$Haleon PLC$Journal: INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA?Author: Creaney M, Moriarty RM, Milner M, Murphy C?Title: Dexmedetomidine, high-flow nasal oxygen and sugammadex-reversal of rocuronium: overcoming anaesthetic challenges in a?parturient with congenital muscular dystrophy presenting for caesarean section?Volume: 34 Year: 2018 Pages: 108-12$$$$F$Y$1.5$KG$20240709$$HP$IE$IE
240637871$24063787$1$I$20240423$20240627$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-032025$AUROBINDO$$52$YR$$M$Y$70$KG$20240709$$MD$GB$GB
240637881$24063788$1$I$$20240701$20240709$20240709$EXP$$ZA-AstraZeneca-2024A152815$ASTRAZENECA$$89$YR$$F$Y$$$20240709$$CN$ZA$
240637891$24063789$1$I$$20240627$20240709$20240709$EXP$$US-ASTELLAS-2024US019250$ASTELLAS$$75$YR$$F$Y$$$20240709$$MD$US$US
240637901$24063790$1$I$$20240625$20240709$20240709$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14196$ALKEM$$$$$F$Y$$$20240709$$MD$US$US
240637912$24063791$2$F$20240621$20240705$20240709$20240715$EXP$$IT-AUROBINDO-AUR-APL-2024-032862$AUROBINDO$$57$YR$$M$Y$$$20240715$$MD$IT$IT
240637922$24063792$2$F$20240526$20240711$20240709$20240716$EXP$FR-AFSSAPS-LL2024001211$FR-GILEAD-2024-0679735$GILEAD$$64$YR$A$F$Y$70$KG$20240716$$PH$FR$FR
240637931$24063793$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA200200$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240709$$PH$US$US
240637941$24063794$1$I$20240101$20240701$20240709$20240709$PER$$US-SA-2024SA198583$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240709$$MD$US$US
240637953$24063795$3$F$20240601$20240802$20240709$20240816$PER$$US-SA-2024SA198018$SANOFI AVENTIS$$64$YR$A$F$Y$68.03$KG$20240816$$MD$US$US
240637961$24063796$1$I$$20240625$20240709$20240709$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14604$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$33$YR$$M$Y$$$20240709$$HP$DE$DE
240637971$24063797$1$I$20240101$20240701$20240709$20240709$PER$$US-SA-2024SA198084$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240709$$MD$US$US
240637981$24063798$1$I$20230501$20240701$20240709$20240709$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-094813$REGENERON$$69$YR$$M$Y$$$20240709$$MD$DE$DE
240637991$24063799$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06201$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240638004$24063800$4$F$20240612$20240821$20240709$20240829$EXP$$JP-ASTELLAS-2024JP004227$ASTELLAS$$9$DEC$E$M$Y$$$20240829$$MD$JP$JP
240638011$24063801$1$I$$20240629$20240709$20240709$EXP$$MY-EMD Serono-2024036024$EMD SERONO INC$$53$YR$A$M$Y$78$KG$20240709$$MD$MY$MY
240638021$24063802$1$I$$20240701$20240709$20240709$EXP$PL-URPL-1-3344-2020$PL-TEVA-VS-3215845$TEVA$$56$YR$$F$Y$47$KG$20240709$$MD$PL$PL
240638031$24063803$1$I$20220729$20240702$20240709$20240709$EXP$$PL-CELLTRION INC.-2024PL016233$CELLTRION$$$$$$Y$$$20240709$$MD$PL$PL
240638044$24063804$4$F$$20240826$20240709$20240910$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14652$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$39$YR$$F$Y$$$20240910$$HP$DE$DE
240638052$24063805$2$F$20230322$20240831$20240709$20240926$PER$$US-SA-2024SA199288$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240926$$MD$US$US
240638061$24063806$1$I$$20240704$20240709$20240709$EXP$$CO-JNJFOC-20240715731$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$MD$CO$CO
240638071$24063807$1$I$$20240701$20240709$20240709$EXP$$JP-009507513-2407JPN000070J$MERCK$$5$DEC$$F$Y$$$20240709$$MD$JP$JP
240638081$24063808$1$I$20240701$20240701$20240709$20240709$PER$$US-HETERO-HET2024US02087$HETERO$$68$YR$$F$Y$88.9$KG$20240709$$CN$US$US
240638091$24063809$1$I$20240624$20240702$20240709$20240709$PER$$US-SA-2024SA198326$SANOFI AVENTIS$$75$YR$E$M$Y$79.37$KG$20240709$$MD$US$US
240638102$24063810$2$F$$20240716$20240709$20240726$EXP$$US-TEVA-VS-3214524$TEVA$Hamad HM, Miett T, Kopec S. Statin and Fenofibrate-Induced Rhabdomyolysis in Liver Transplant; A Case of Multiple Organ Dysfunction. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).; Hamad HM, Miett T, Kopec S. Statin and Fenofibrate-Induced Rhabdomyolysis in Liver Transplant; A Case of Multiple Organ Dysfunction. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$49$YR$$M$Y$$$20240726$$HP$US$US
240638111$24063811$1$I$$20240625$20240709$20240709$PER$$US-EMD Serono-2024034788$EMD SERONO INC$$30$YR$A$F$Y$$$20240709$$CN$US$US
240638121$24063812$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141247$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240638131$24063813$1$I$$20240708$20240709$20240709$EXP$$CN-VANTIVE-2024VAN018216$Vantive US Healthcare$$$$$M$Y$$$20240709$$CN$CN$CN
240638141$24063814$1$I$$20240703$20240709$20240709$PER$$US-ABBVIE-5830946$ABBVIE$$$$$$Y$$$20240709$$HP$US$US
240638151$24063815$1$I$20200126$20240702$20240709$20240709$EXP$$PL-AUROBINDO-AUR-APL-2024-033015$AUROBINDO$$30$YR$$M$Y$$$20240709$$MD$PL$PL
240638161$24063816$1$I$$20240704$20240709$20240709$EXP$$CO-JNJFOC-20240715757$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$MD$CO$CO
240638171$24063817$1$I$$20240704$20240709$20240709$EXP$$CA-TAKEDA-2022TUS061650$TAKEDA$$$$$M$Y$$$20240709$$CN$CA$CA
240638181$24063818$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405141158074040-VFDPQ$GB-GILEAD-2024-0679807$GILEAD$$$$$F$Y$$$20240709$$CN$GB$GB
240638192$24063819$2$F$$20240703$20240709$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06214$LUPIN$$$$$$Y$$$20240728$$CN$US$US
240638201$24063820$1$I$$20240703$20240709$20240709$EXP$$JP-009507513-2407JPN000429J$MERCK$$$$$F$Y$$$20240709$$MD$JP$JP
240638211$24063821$1$I$$20240701$20240709$20240709$EXP$$US-ASTELLAS-2024US019200$ASTELLAS$$$$$M$Y$$$20240709$$MD$US$US
240638222$24063822$2$F$$20240716$20240709$20240726$EXP$$DE-TEVA-VS-3215298$TEVA$Koschitzki K, Karrer S, Berneburg M, Niebel D, Drexler K. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema). J-Dtsch-Dermatol-Ges 2024; 22 (6): 833-836.; Koschitzki K, Karrer S, Berneburg M, Niebel D, Drexler K. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema). J-Dtsch-Dermatol-Ges 2024; 22 (6): 833-836.; Koschitzki K, Karrer S, Berneburg M, Niebel D, Drexler K. Rare case of itraco...$53$YR$$M$Y$$$20240726$$HP$DE$DE
240638231$24063823$1$I$$20240708$20240709$20240709$EXP$$CA-ADIENNEP-2024AD000555$ADIENNE PHARMA + BIOTECH$$7$YR$$M$Y$18$KG$20240708$$HP$CA$
240638241$24063824$1$I$20240628$20240628$20240709$20240709$PER$$US-SA-2024SA194528$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$HP$US$US
240638252$24063825$2$F$20240701$20240708$20240709$20240715$PER$$US-SA-2024SA198160$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240715$$CN$US$US
240638261$24063826$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA199010$SANOFI AVENTIS$$$$E$F$Y$$$20240709$$MD$US$US
240638272$24063827$2$F$$20240718$20240709$20240728$PER$$US-SA-2024SA196188$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
240638281$24063828$1$I$20240101$20240701$20240709$20240709$PER$$US-SA-2024SA197214$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240709$$MD$US$US
240638291$24063829$1$I$20240101$20240703$20240709$20240709$PER$$US-SA-2024SA199223$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240709$$MD$US$US
240638301$24063830$1$I$$20240702$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-032896$AUROBINDO$$65$YR$$F$Y$88$KG$20240709$$PH$GB$GB
240638311$24063831$1$I$20240705$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135123$AMGEN$$$$$$Y$$$20240709$$PH$US$US
240638321$24063832$1$I$$20240704$20240709$20240709$EXP$$JP-AMGEN-JPNSP2024133864$AMGEN$$$$$F$Y$$$20240709$$CN$JP$JP
240638341$24063834$1$I$$20240611$20240709$20240709$EXP$$US-MACLEODS PHARMA-MAC2024048193$MACLEODS$$$$$$Y$$$20240709$$CN$US$US
240638351$24063835$1$I$20200101$20240708$20240709$20240709$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038601$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240709$$CN$US$US
240638362$24063836$2$F$20240708$20240719$20240709$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038595$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240722$$CN$US$US
240638371$24063837$1$I$20231207$20240702$20240709$20240709$EXP$$FR-AUROBINDO-AUR-APL-2024-032987$AUROBINDO$$50$YR$$F$Y$$$20240709$$PH$FR$FR
240638381$24063838$1$I$20240620$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135163$AMGEN$$44$YR$A$M$Y$$$20240709$$CN$US$US
240638392$24063839$2$F$20240628$20240722$20240709$20240724$EXP$$JP-ASTELLAS-2024JP004725$ASTELLAS$$8$DEC$$F$Y$$$20240724$$PH$JP$JP
240638402$24063840$2$F$20240604$20240722$20240709$20240730$EXP$FR-AFSSAPS-BR2024000498$FR-TEVA-VS-3215856$TEVA$$55$YR$$F$Y$81.3$KG$20240730$$MD$FR$FR
240638411$24063841$1$I$$20240701$20240709$20240709$EXP$$CA-AstraZeneca-2024A152510$ASTRAZENECA$$57$YR$$F$Y$$$20240709$$MD$CA$
240638421$24063842$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A151316$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240638431$24063843$1$I$20240501$20240627$20240709$20240709$PER$$US-SA-2024SA194680$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240709$$MD$US$US
240638443$24063844$3$F$20240218$20240917$20240709$20240924$EXP$$NVSC2024DE139889$NOVARTIS$$$$A$F$Y$78$KG$20240924$$HP$DE$DE
240638451$24063845$1$I$20220210$20240703$20240709$20240709$EXP$$US-CHATTEMPRD-2024OHG023122$CHATTEM$$79$YR$E$M$Y$$$20240709$$LW$US$US
240638461$24063846$1$I$20240530$20240702$20240709$20240709$EXP$$PL-AUROBINDO-AUR-APL-2024-033013$AUROBINDO$$36$YR$$M$Y$64$KG$20240709$$PH$PL$PL
240638472$24063847$2$F$$20240628$20240709$20240710$PER$$US-SA-2024SA194483$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240710$$MD$US$US
240638483$24063848$3$F$$20240823$20240709$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202407004936$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240827$$CN$US$US
240638491$24063849$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005177$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240709$$CN$US$US
240638501$24063850$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005030$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240709$$CN$US$US
240638511$24063851$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004502$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240709$$CN$US$US
240638521$24063852$1$I$$20240704$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004449$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240709$$CN$US$US
240638531$24063853$1$I$$20240701$20240709$20240709$EXP$$JP-ROCHE-10000017692$ROCHE$Inada S, Omori K, Nomura T, Kitagawa H, Shigemoto N, Oge H et al.. P-228 A case of omarthritis caused by Mycobacterium intracellulare aggravated immediately after administration of immune checkpoint inhibitor. The Joint Meeting of the 98th Annual Meeting of the Japanese Association for Inf. 2024$75$YR$E$M$Y$$$20240709$$MD$JP$JP
240638541$24063854$1$I$20240601$20240705$20240709$20240709$EXP$$JP-ASTELLAS-2024JP004763$ASTELLAS$$8$DEC$$F$Y$$$20240709$$MD$JP$JP
240638551$24063855$1$I$$20240702$20240709$20240709$EXP$$BE-AUROBINDO-AUR-APL-2024-032912$AUROBINDO$$74$YR$$M$Y$100$KG$20240709$$PH$BE$BE
240638562$24063856$2$F$$20240913$20240709$20240919$EXP$$US-ABBVIE-5831087$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
240638571$24063857$1$I$$20240630$20240709$20240709$EXP$$US-APOTEX-2024AP008025$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240709$$HP$US$US
240638581$24063858$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06299$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240638591$24063859$1$I$20240223$20240701$20240709$20240709$EXP$$BR-CELLTRION INC.-2024BR005008$CELLTRION$$$$$$Y$$$20240709$$CN$BR$BR
240638602$24063860$2$F$$20240906$20240709$20240916$30DAY$$US-GSK-US2024AMR082046$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
240638611$24063861$1$I$20240521$20240705$20240709$20240709$EXP$HR-HALMED-300085851$HR-TAKEDA-2024TUS068952$TAKEDA$$65$YR$$F$Y$$$20240709$$HP$HR$HR
240638621$24063862$1$I$$20240702$20240709$20240709$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13263$IPSEN$$$$$F$Y$$$20240709$$CN$US$US
240638633$24063863$3$F$20240516$20240910$20240709$20240916$EXP$$JP-009507513-2407JPN000387J$MERCK$$8$DEC$$M$Y$$$20240916$$MD$JP$JP
240638641$24063864$1$I$$20230911$20240709$20240709$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03228$AMNEAL$$$$$$Y$$$20240709$$CN$US$US
240638651$24063865$1$I$20240601$20240701$20240709$20240709$30DAY$$US-GSK-US2024081558$GLAXOSMITHKLINE$$71$YR$$M$Y$$$20240709$$CN$US$US
240638661$24063866$1$I$20240615$20240703$20240709$20240709$EXP$GB-MHRA-MED-202407030846073730-WGDPS$GB-862174955-ML2024-03754$Unknown Manufacturer$$63$YR$A$F$Y$68$KG$20240709$$CN$GB$GB
240638671$24063867$1$I$20240301$20240703$20240709$20240709$EXP$GB-MHRA-EMIS-3984-acddb543-c910-4a4c-b39f-cd64ce95bafc$GB-862174955-ML2024-01751$Unknown Manufacturer$$66$YR$E$M$Y$75$KG$20240709$$MD$GB$GB
240638681$24063868$1$I$$20240702$20240709$20240709$EXP$$GB-862174955-ML2024-03746$Unknown Manufacturer$$65$YR$E$F$Y$88$KG$20240709$$PH$GB$GB
240638692$24063869$2$F$20240401$20240801$20240709$20240802$EXP$GB-MHRA-MED-202405060000030850-KHQNL$GB-ORGANON-O2407GBR000529$ORGANON$$36$YR$$F$Y$52$KG$20240802$$CN$GB$GB
240638702$24063870$2$F$20240101$20240920$20240709$20240930$EXP$$CA-CELLTRION INC.-2024CA003200$CELLTRION$$$$$$Y$$$20240930$$CN$CA$CA
240638711$24063871$1$I$$20240703$20240709$20240709$EXP$$CA-TAKEDA-2022TUS078898$TAKEDA$$$$$F$Y$$$20240709$$MD$CA$CA
240638721$24063872$1$I$20170501$20240702$20240709$20240709$EXP$$AU-TAKEDA-2024TUS068993$TAKEDA$$68$YR$$F$Y$$$20240709$$MD$AU$AU
240638731$24063873$1$I$20240101$20240613$20240709$20240709$PER$$US-JNJFOC-20240675956$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240638741$24063874$1$I$$20240626$20240709$20240709$EXP$$US-SCIEGENP-2024SCLIT00325$SCIEGEN$Reinsch N, Haq E, Ramakrishna K, Craft L.Cardiovascular Collapse Requiring Veno-Arterial Extracorporeal Membrane Oxygenation and Lidocaine: A Case of Massive Bupropion Overdose.Cureus.21-Jun-2024;16 (6):1-5$18$YR$T$F$Y$$$20240709$$HP$US$US
240638751$24063875$1$I$20230101$20231109$20240709$20240709$PER$$US-ABBVIE-5831582$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240638762$24063876$2$F$$20240716$20240709$20240723$EXP$$US-GILEAD-2024-0679837$GILEAD$$58$YR$A$F$Y$$$20240723$$PH$US$US
240638771$24063877$1$I$$20240628$20240709$20240709$EXP$$DE-ROCHE-10000017939$ROCHE$$78$YR$E$F$Y$$$20240709$$MD$DE$DE
240638781$24063878$1$I$20230609$20240705$20240709$20240709$EXP$FR-AFSSAPS-PV2024000538$FR-ROCHE-10000019616$ROCHE$$11$YR$C$M$Y$40$KG$20240709$$MD$FR$FR
240638795$24063879$5$F$20230612$20240902$20240709$20240907$EXP$$GB-JNJFOC-20240546811$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240908$$HP$GB$GB
240638803$24063880$3$F$20240411$20240722$20240709$20240725$EXP$$FR-BAUSCH-BL-2024-010427$BAUSCH AND LOMB$$62$YR$$F$Y$50$KG$20240725$$HP$FR$FR
240638811$24063881$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06318$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240638821$24063882$1$I$$20240625$20240709$20240709$EXP$$US-GRAVITIPHARMA-GRA-2406-US-LIT-0188$GRAVITI PHARMACEUTICALS$Hamad HM, Miett T, Kopec S.Statin and Fenofibrate-Induced Rhabdomyolysis in Liver Transplant; A Case of Multiple Organ Dysfunction.Am-J-Respir-Crit-Care-Med.MAY-2024;NA:A5694$49$YR$A$M$Y$$$20240709$$HP$US$US
240638831$24063883$1$I$$20240628$20240709$20240709$30DAY$$CN-SA-2024SA194381$SANOFI AVENTIS$$$$A$$Y$$$20240709$$HP$CN$CN
240638841$24063884$1$I$20240301$20240701$20240709$20240709$PER$$US-SA-2024SA199339$SANOFI AVENTIS$$34$YR$A$F$Y$47.627$KG$20240709$$MD$US$US
240638851$24063885$1$I$$20240708$20240709$20240709$EXP$$CA-BAUSCH-BL-2024-010442$BAUSCH AND LOMB$$23$YR$$F$Y$$$20240709$$HP$CA$CA
240638864$24063886$4$F$20240101$20240731$20240709$20240809$EXP$$US-SA-2024SA195696$SANOFI AVENTIS$$89$YR$E$F$Y$56$KG$20240809$$CN$US$US
240638871$24063887$1$I$$20240627$20240709$20240709$EXP$$US-SA-2024SA195343$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240638892$24063889$2$F$20240707$20240709$20240709$20240710$PER$$US-AMGEN-USASP2024135116$AMGEN$$70$YR$E$F$Y$$$20240710$$CN$US$US
240638901$24063890$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024135214$AMGEN$$$$$$Y$$$20240709$$HP$US$US
240638911$24063891$1$I$$20240705$20240709$20240709$EXP$$FR-AMGEN-FRASP2024133954$AMGEN$$$$A$F$Y$$$20240709$$MD$FR$FR
240638921$24063892$1$I$$20240703$20240709$20240709$PER$$US-BAUSCH-BL-2024-010334$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240709$$CN$US$US
240638931$24063893$1$I$20240101$20240701$20240709$20240709$PER$$US-BAUSCH-BL-2024-010164$BAUSCH AND LOMB$$68$YR$$F$Y$61.744$KG$20240709$$CN$US$US
240638941$24063894$1$I$$20240705$20240709$20240709$EXP$$AU-GILEAD-2024-0679829$GILEAD$$80$YR$E$M$Y$$$20240709$$MD$AU$AU
240638951$24063895$1$I$$20240704$20240709$20240709$EXP$$CA-TAKEDA-2024TUS068912$TAKEDA$$$$$F$Y$$$20240709$$CN$CA$CA
240638961$24063896$1$I$20240701$20240703$20240709$20240709$PER$$US-SA-2024SA198950$SANOFI AVENTIS$$17$YR$T$F$Y$104$KG$20240709$$CN$US$US
240638971$24063897$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA199179$SANOFI AVENTIS$$28$YR$A$F$Y$104$KG$20240709$$MD$US$US
240638981$24063898$1$I$$20240708$20240709$20240709$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038504$BOEHRINGER INGELHEIM$$$$$$Y$$$20240709$$CN$US$US
240638991$24063899$1$I$20240501$20240630$20240709$20240709$EXP$GB-MHRA-MED-202406302222374210-PLJMT$GB-TEVA-VS-3216066$TEVA$$41$YR$$F$Y$65$KG$20240709$$CN$GB$GB
240639001$24063900$1$I$$20240702$20240709$20240709$30DAY$$US-GSK-US2024082517$GLAXOSMITHKLINE$$$$$M$Y$$$20240709$$MD$US$US
240639011$24063901$1$I$$20240628$20240709$20240709$EXP$$CA-TAKEDA-2024TUS067076$TAKEDA$$$$$M$Y$$$20240709$$CN$CA$CA
240639021$24063902$1$I$20240614$20240708$20240709$20240709$EXP$FR-AFSSAPS-AN2024000876$FR-UCBSA-2024034430$UCB$$53$YR$$M$Y$$$20240709$$PH$FR$FR
240639036$24063903$6$F$20240301$20240712$20240709$20240911$PER$$US-Ipsen Biopharmaceuticals, Inc.-2023-19685$IPSEN$$84$YR$E$F$Y$53$KG$20240911$$CN$US$US
240639041$24063904$1$I$20240603$20240708$20240709$20240709$EXP$IT-MINISAL02-993874$IT-ABBVIE-5831273$ABBVIE$$60$YR$$F$Y$$$20240709$$PH$IT$IT
240639054$24063905$4$F$20240624$20240708$20240709$20240718$EXP$$US-ROCHE-10000019174$ROCHE$$81$YR$E$F$Y$$$20240718$$CN$US$US
240639061$24063906$1$I$20240101$20240628$20240709$20240709$EXP$$US-HBP-2024US030931$HELSINN HEALTHCARE$$$$$M$Y$$$20240709$$CN$US$US
240639071$24063907$1$I$20240501$20240705$20240709$20240709$EXP$FR-AFSSAPS-LL2024001232$FR-TAKEDA-2024TUS068938$TAKEDA$$30$YR$$M$Y$$$20240709$$HP$FR$FR
240639092$24063909$2$F$$20240918$20240709$20240923$EXP$$CA-TAKEDA-2024TUS069118$TAKEDA$$$$$M$Y$$$20240923$$CN$CA$CA
240639112$24063911$2$F$$20240903$20240709$20240909$EXP$$JP-TAKEDA-2024TUS069415$TAKEDA$$51$YR$$M$Y$$$20240909$$MD$JP$JP
240639121$24063912$1$I$20240601$20240627$20240709$20240709$PER$$US-SA-2024SA195058$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240709$$MD$US$US
240639131$24063913$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA199062$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240709$$CN$US$US
240639141$24063914$1$I$20220101$20240702$20240709$20240709$PER$$US-SA-2024SA199309$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240709$$MD$US$US
240639151$24063915$1$I$20240301$20240701$20240709$20240709$PER$$US-SA-2024SA197421$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240709$$MD$US$US
240639162$24063916$2$F$$20240703$20240709$20240711$PER$$US-ROCHE-10000019988$ROCHE$$29$YR$A$F$Y$$$20240711$$HP$US$US
240639171$24063917$1$I$$20240702$20240709$20240709$EXP$$JP-RDY-LIT/JPN/24/0009920$DR REDDYS$Baba Y, Hida N, Sambe T, Abe M, Kabasawa N, sakai H, et al. Efficacy of Venetoclax and Azacitidine in Acute Myeloid Leukemia Compared to Azacitidine Monotherapy: Real-World Experience. Anticancer Research. 2024 May;44(5): 2003-2007. doi:10.21873/anticanres.17003.$$$$$Y$$$20240709$$HP$JP$JP
240639181$24063918$1$I$$20240702$20240709$20240709$EXP$$JP-RDY-LIT/JPN/24/0009925$DR REDDYS$Baba Y, Hida N, Sambe T, Abe M, Kabasawa N, Sakai H, et al. Efficacy of Venetoclax and Azacitidine in Acute Myeloid Leukemia Compared to Azacitidine Monotherapy: Real-World Experience. Anticancer Research. 2024 May;44(5): 2003-2007. doi:10.21873/anticanres.17003.$$$$$Y$$$20240709$$HP$JP$JP
240639191$24063919$1$I$$20240702$20240709$20240709$EXP$GB-MHRA-TPP4089143C2183622YC1719841820576$GB-RDY-SPO/GBR/24/0009735$DR REDDYS$$75$YR$E$F$Y$55$KG$20240709$$MD$GB$GB
240639201$24063920$1$I$$20240703$20240709$20240709$PER$$AU-REGENERON PHARMACEUTICALS, INC.-2024-095020$REGENERON$$$$$M$Y$$$20240709$$CN$AU$AU
240639212$24063921$2$F$$20240708$20240709$20240714$PER$$US-AMGEN-USASP2024135122$AMGEN$$$$$$Y$$$20240714$$HP$US$US
240639222$24063922$2$F$20240706$20240709$20240709$20240710$PER$$US-AMGEN-USASP2024134804$AMGEN$$72$YR$E$M$Y$$$20240710$$CN$US$US
240639231$24063923$1$I$$20240702$20240709$20240709$EXP$$JP-RDY-LIT/JPN/24/0009929$DR REDDYS$Baba Y, Hida N, Sambe T, Abe M, Kabasawa N, Sakai H, et al. Efficacy of Venetoclax and Azacitidine in Acute Myeloid Leukemia Compared to Azacitidine Monotherapy: Real-World Experience. Anticancer Research. 2024 May;44(5): 2003-2007. doi:10.21873/anticanres.17003.$$$$$Y$$$20240709$$HP$JP$JP
240639241$24063924$1$I$$20240625$20240709$20240709$EXP$$JP-AMGEN-JPNSP2024121072$AMGEN$$8$DEC$E$F$Y$$$20240709$$MD$JP$JP
240639251$24063925$1$I$$20240625$20240709$20240709$PER$US-MLMSERVICE-20240619-PI101873-00108-1$US-RDY-SPO/USA/24/0009385$DR REDDYS$Leung JG, Allen ND, Markota M. A case series of clozapine titrations affected by inflammatory processes. Schizophrenia Research. 2024;268:94-7. DOI:10.1016/j.schres.2023.08.007.$69$YR$E$M$Y$$$20240709$$PH$US$US
240639261$24063926$1$I$$20240706$20240709$20240709$EXP$GB-MHRA-MED-202406261659083070-WNLCP$GB-ORGANON-O2407GBR000691$ORGANON$$$$$M$Y$$$20240709$$PH$GB$GB
240639271$24063927$1$I$$20240708$20240709$20240709$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038549$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240709$$CN$US$US
240639291$24063929$1$I$$20240625$20240709$20240709$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05999$HIKMA$Kerai A, Doshi S, Laleker A, Majumdar A. Kerai A, Doshi S, Laleker A, Majumdar A. Fungal Foe and Mechanical Hearts: A Retrospective Case Series on Candida auris Bloodstream Infection With Left Ventricular Assist Devices. Open Forum Infectious Diseases. 2024;11(6):ofae286:6 pgs$39$YR$$F$Y$$$20240709$$MD$US$US
240639301$24063930$1$I$20240401$20240705$20240709$20240709$EXP$$FR-GILEAD-2024-0679712$GILEAD$$62$YR$A$F$Y$52$KG$20240709$$MD$FR$FR
240639311$24063931$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004215$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240709$$HP$US$US
240639321$24063932$1$I$20240621$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004617$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240709$$CN$US$US
240639331$24063933$1$I$20240618$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004159$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240709$$CN$US$US
240639341$24063934$1$I$$20240626$20240709$20240709$PER$$US-AstraZeneca-2024A151936$ASTRAZENECA$$74$YR$$F$Y$$$20240709$$CN$US$
240639351$24063935$1$I$$20240701$20240709$20240709$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004892$BIOCON$$$$$$Y$$$20240709$$CN$CA$CA
240639363$24063936$3$F$20240707$20240717$20240709$20240720$PER$$US-AMGEN-USASP2024135257$AMGEN$$64$YR$A$F$Y$$$20240720$$CN$US$US
240639371$24063937$1$I$20240101$20240704$20240709$20240709$EXP$$JP-AMGEN-JPNSP2024133348$AMGEN$$$$$$Y$$$20240709$$MD$JP$JP
240639381$24063938$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA198438$SANOFI AVENTIS$$$$A$F$Y$107.9$KG$20240709$$MD$US$US
240639391$24063939$1$I$20240628$20240703$20240709$20240709$PER$$US-SA-2024SA199199$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240709$$MD$US$US
240639401$24063940$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA198880$SANOFI AVENTIS$$$$E$F$Y$$$20240709$$MD$US$US
240639412$24063941$2$F$20240101$20240708$20240709$20240717$PER$$US-SA-2024SA196139$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240717$$MD$US$US
240639421$24063942$1$I$20240301$20240701$20240709$20240709$EXP$$BR-BIOVITRUM-2024-BR-009598$BIOVITRUM$$$$$M$Y$$$20240709$$CN$BR$BR
240639444$24063944$4$F$$20240725$20240709$20240730$EXP$$US-MYLANLABS-2024M1062825$MYLAN$$$$$F$Y$108.8$KG$20240730$$CN$US$US
240639451$24063945$1$I$$20240624$20240709$20240709$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108903$ZYDUS PHARM$Lu J.. Rescue of immediate post-transcarotid artery revascularization carotid stent thrombosis due to clopidogrel resistance using flow-reversal and aspiration thrombectomy.. J-Vasc-Surg-Cases-Innov-Tech. 2023;9(2):1-5$$$$$Y$$$20240709$$MD$US$US
240639462$24063946$2$F$$20240811$20240709$20240814$EXP$$US-ROCHE-10000015318$ROCHE$$$$$$Y$$$20240814$$CN$US$US
240639471$24063947$1$I$$20240703$20240709$20240709$30DAY$$US-GSK-US2024082609$GLAXOSMITHKLINE$$$$$F$Y$$$20240709$$CN$US$US
240639482$24063948$2$F$$20240702$20240709$20240709$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP008029$STRIDES$Bulley SJ, Santarsieri A, Lentell IC, O^Sullivan B, Hodson A, Firth O, et al.. Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study. EJHaem. 2022;3 (4):1316-1320$$$$$Y$$$20240709$$HP$GB$GB
240639492$24063949$2$F$$20240708$20240709$20240715$EXP$$ES-ALCON LABORATORIES-ALC2024ES003265$ALCON$$$$$$Y$$$20240715$$CN$COUNTRY NOT SPECIFIED$ES
240639502$24063950$2$F$$20240709$20240709$20240709$PER$$US-AMGEN-USASP2024135167$AMGEN$$$$$M$Y$$$20240709$$CN$US$US
240639512$24063951$2$F$$20240903$20240709$20240909$EXP$$JP-TAKEDA-2024TUS069416$TAKEDA$$65$YR$$M$Y$$$20240909$$MD$JP$JP
240639531$24063953$1$I$$20240625$20240709$20240709$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05992$HIKMA$Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. Journal of medical toxicology. 2024$$$N$M$Y$$$20240709$$MD$US$US
240639543$24063954$3$F$$20240717$20240709$20240723$PER$$US-AMGEN-USASP2024135226$AMGEN$$$$$F$Y$$$20240723$$HP$US$US
240639551$24063955$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134796$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240639562$24063956$2$F$$20240716$20240709$20240730$PER$$US-APOTEX-2024AP007691$APOTEX$$$$$F$Y$$$20240730$$CN$US$US
240639573$24063957$3$F$$20240903$20240709$20240909$EXP$$JP-BEH-2024175043$CSL BEHRING$$37$YR$A$M$Y$$$20240909$$MD$JP$JP
240639581$24063958$1$I$$20240701$20240709$20240709$PER$$US-ROCHE-10000019948$ROCHE$$49$YR$A$F$Y$$$20240709$$CN$US$US
240639592$24063959$2$F$20240627$20240702$20240709$20240709$PER$$US-ROCHE-10000019937$ROCHE$$50$YR$A$F$Y$$$20240709$$CN$US$US
240639601$24063960$1$I$$20240627$20240709$20240709$EXP$$DE-MACLEODS PHARMA-MAC2024048012$MACLEODS$$$$$$Y$$$20240709$$MD$DE$DE
240639611$24063961$1$I$20240624$20240627$20240709$20240709$EXP$GB-MHRA-MED-202406270853023080-WKPFJ$GB-MACLEODS PHARMA-MAC2024048019$MACLEODS$$$$$$Y$$$20240709$$HP$GB$GB
240639622$24063962$2$F$$20240703$20240709$20240715$EXP$$US-MACLEODS PHARMA-MAC2024048052$MACLEODS$Al-Moussally F, Thompson BM, Masarweh OM, Shah N, Gaudi S, Restrepo J..Atorvastatin-Associated Eosinophilic Spongiosis: A Case Report and a Relevant Literature Review of Dermatological Manifestations.Cureus.2024;16(5):e61071$$$$$Y$$$20240715$$MD$US$US
240639635$24063963$5$F$20240101$20240918$20240709$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009276$UNITED THERAPEUTICS$$$$$F$Y$47.166$KG$20240927$$$US$US
240639641$24063964$1$I$$20240703$20240709$20240709$EXP$$BE-CHEPLA-2024007780$CHEPLAPHARM$$12$YR$$M$Y$$$20240709$$CN$COUNTRY NOT SPECIFIED$BE
240639651$24063965$1$I$$20240708$20240709$20240709$EXP$DE-JNJFOC-20240656294$DE-UCBSA-2024034436$UCB$$6$DEC$$M$Y$$$20240709$$HP$DE$DE
240639662$24063966$2$F$$20240723$20240709$20240726$EXP$$JP-BEH-2024175045$CSL BEHRING$$60$YR$A$M$Y$$$20240726$$MD$JP$JP
240639671$24063967$1$I$$20240627$20240709$20240709$EXP$$DE-MACLEODS PHARMA-MAC2024048028$MACLEODS$Zugaj MR, Gutzeit O, Mayer VL, Ishak B, Gumbinger C, Weigand MA, et al..Incomplete sensorimotor paresis after upper abdominal surgery with TEA and spinal epidural lipomatosis: a case report.Regional Anesthesia and Pain Medicine.2024;49(6):465-8$$$$$Y$$$20240709$$MD$DE$DE
240639681$24063968$1$I$$20240701$20240709$20240709$PER$US-MLMSERVICE-20240625-PI109043-00219-3$US-RDY-SPO/USA/24/0009755$DR REDDYS$Mahajan A, Vatti T, Coulter A, Khawam E, Howland M. Palliative ECT for Catatonia in a Terminal Cancer Patient: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65(3):315-6. DOI: 10.1016/j.jaclp.2024.01.005.$78$YR$E$M$Y$$$20240709$$MD$US$US
240639692$24063969$2$F$$20240727$20240709$20240806$PER$$US-RDY-SPO/USA/24/0009416$DR REDDYS$$$$$M$Y$$$20240806$$CN$US$US
240639701$24063970$1$I$$20240628$20240709$20240709$EXP$$US-SANDOZ INC.-SDZ2024US063454$SANDOZ$$$$$F$Y$67.57$KG$20240709$$CN$US$US
240639711$24063971$1$I$$20240704$20240709$20240709$30DAY$$US-SANDOZ INC.-SDZ2024US031501$SANDOZ$$$$$F$Y$$$20240709$$CN$US$US
240639721$24063972$1$I$$20240704$20240709$20240709$EXP$$US-SANDOZ INC.-SDZ2023US022252$SANDOZ$$$$$M$Y$$$20240709$$CN$US$US
240639731$24063973$1$I$$20240708$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063491$SANDOZ$$66$YR$$F$Y$$$20240709$$HP$CA$CA
240639741$24063974$1$I$$20240704$20240709$20240709$30DAY$$US-SANDOZ INC.-SDZ2023US009999$SANDOZ$$$$$F$Y$$$20240709$$CN$US$US
240639751$24063975$1$I$$20240701$20240709$20240709$EXP$$US-ASPIRO-ASP2024US02143$ASPIRO PHARMA$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316(6):279$63$YR$$F$Y$$$20240709$$HP$US$US
240639761$24063976$1$I$$20240706$20240709$20240709$EXP$$US-SANDOZ INC.-SDZ2024US063520$SANDOZ$$$$$$Y$$$20240709$$CN$US$US
240639771$24063977$1$I$20231204$20240702$20240709$20240709$EXP$$US-GSK-US2024AMR082711$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$US$US
240639781$24063978$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-033077$AUROBINDO$Folkerth R, Jayakumar J, Manesh A, Pandurangan K, Perl D, Priemer D, et al.. Comparison of neuropathologies among rabies patients treated with standard, Milwaukee, and/or experimental AAVRAB strategies.. J-Neuropathol-Exp-Neurol. 2024;83(6):453$17$YR$$M$Y$$$20240709$$MD$US$US
240639793$24063979$3$F$20240705$20240731$20240709$20240802$EXP$$US-TAKEDA-2024TUS068924$TAKEDA$$26$YR$$M$Y$$$20240802$$MD$US$US
240639802$24063980$2$F$20240625$20240906$20240709$20240916$PER$$US-SA-2024SA196138$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240916$$MD$US$US
240639811$24063981$1$I$$20240629$20240709$20240709$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP007986$STRIDES$Balighi K, Ghiasi M, Aryanian Z, Nikyar Z, Hatami P.. Kaposi^s sarcoma in a patient with pemphigus vulgaris mimicking exacerbation of pemphigus. Cancer-Rep. 2023;6 (5):no pagination$39$YR$$M$Y$$$20240709$$HP$IR$IR
240639831$24063983$1$I$20240101$20240627$20240709$20240709$PER$$US-SA-2024SA194197$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240709$$MD$US$US
240639842$24063984$2$F$20240315$20240725$20240709$20240730$EXP$$CA-HALEON-2184012$Haleon PLC$$6$YR$$F$Y$$$20240730$$CN$CA$CA
240639851$24063985$1$I$20240101$20240701$20240709$20240709$EXP$$IT-AstraZeneca-2024A150314$ASTRAZENECA$$48$YR$$F$Y$45$KG$20240709$$MD$IT$
240639861$24063986$1$I$$20240701$20240709$20240709$PER$$US-AstraZeneca-2024A152129$ASTRAZENECA$$$$$$Y$$$20240709$$CN$US$
240639871$24063987$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA196322$SANOFI AVENTIS$$$$A$M$Y$83$KG$20240709$$MD$US$US
240639881$24063988$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA198908$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240709$$MD$US$US
240639891$24063989$1$I$$20240703$20240709$20240709$PER$$US-SA-2023SA403399$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240709$$MD$US$US
240639901$24063990$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA198614$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240639911$24063991$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA198542$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240709$$MD$US$US
240639921$24063992$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA198599$SANOFI AVENTIS$$$$T$M$Y$$$20240709$$CN$US$US
240639931$24063993$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A152798$ASTRAZENECA$$$$$F$Y$$$20240709$$HP$US$
240639941$24063994$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-032915$AUROBINDO$Rabah AK, Ahmed R, Duarte A, Wang-kocik C. Rare Cause of Toxic Shock Syndrome. Am-JRespir-Crit-Care-Med. 2024;209:A1629$38$YR$$M$Y$$$20240709$$HP$US$US
240639952$24063995$2$F$20240611$20240628$20240709$20240710$EXP$$ALC2024US002987$ALCON$$59$YR$$M$Y$$$20240710$$HP$US$US
240639962$24063996$2$F$20240703$20240718$20240709$20240728$30DAY$$US-AMGEN-USASP2024132780$AMGEN$$64$YR$A$F$Y$104.9$KG$20240727$$HP$US$US
240639973$24063997$3$F$20240702$20240726$20240709$20240802$30DAY$$US-AMGEN-USASP2024132463$AMGEN$$$$$$Y$$$20240802$$PH$US$US
240639982$24063998$2$F$20240601$20240718$20240709$20240725$30DAY$$US-AMGEN-USASP2024132330$AMGEN$$$$$$Y$$$20240724$$HP$US$US
240639991$24063999$1$I$$20240701$20240709$20240709$EXP$$US-ABBVIE-5826306$ABBVIE$$$$$M$Y$$$20240709$$MD$US$US
240640001$24064000$1$I$20240523$20240708$20240709$20240709$EXP$IT-MINISAL02-993703$NVSC2024IT140509$NOVARTIS$$81$YR$$F$Y$68$KG$20240709$$MD$IT$IT
240640011$24064001$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-032932$AUROBINDO$Shakir M, Nawaz M, Abdul Basit S, Jethani KR, Zaidi SMH, Patel NA.. Spontaneous Pulmonary Hematoma on Heparin Infusion With Rapid Progression.. Am-J-Respir-Crit-Care-Med. 2024;209:A5767$66$YR$$M$Y$$$20240709$$HP$US$US
240640022$24064002$2$F$$20240716$20240709$20240726$EXP$$US-TEVA-VS-3214408$TEVA$Federman M, Dragomer D, Grant S, Reemtsen B, Biniwale R. Use of bivalirudin for anticoagulation during implantation of total artificial heart. J-Extra-Corpor-Technol 2014; 46 (2): 170-172.; Federman M, Dragomer D, Grant S, Reemtsen B, Biniwale R. Use of bivalirudin for anticoagulation during implantation of total artificial heart. J-Extra-Corpor-Technol 2014; 46 (2): 170-172.$19$YR$$M$Y$$$20240726$$MD$US$US
240640031$24064003$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000019606$ROCHE$$43$YR$A$M$Y$$$20240709$$CN$US$US
240640042$24064004$2$F$$20240906$20240709$20240916$30DAY$$US-GSK-US2024083056$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
240640051$24064005$1$I$20240506$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05462$VIFOR$$63$YR$$M$Y$66.6$KG$20240709$$HP$US$US
240640061$24064006$1$I$20240525$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05465$VIFOR$$65$YR$$F$Y$96.7$KG$20240709$$HP$US$US
240640071$24064007$1$I$20240501$20240614$20240709$20240709$EXP$$US-Vifor (International) Inc.-VIT-2024-05466$VIFOR$$64$YR$$F$Y$81$KG$20240709$$HP$US$US
240640081$24064008$1$I$$20240701$20240709$20240709$PER$$US-BIOGEN-2021BI01012981$BIOGEN$$$$$F$Y$75.046$KG$20240709$$CN$US$US
240640094$24064009$4$F$20240707$20240807$20240709$20240808$PER$$US-JNJFOC-20240719436$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240808$$HP$US$US
240640101$24064010$1$I$$20240708$20240709$20240709$PER$$US-JNJFOC-20240719563$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240640111$24064011$1$I$20240503$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05471$VIFOR$$50$YR$$M$Y$$$20240709$$HP$US$US
240640121$24064012$1$I$20240423$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05470$VIFOR$$75$YR$$F$Y$45$KG$20240709$$HP$US$US
240640131$24064013$1$I$20240528$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05481$VIFOR$$40$YR$$F$Y$70$KG$20240709$$HP$US$US
240640141$24064014$1$I$$20240703$20240709$20240709$EXP$$US-AMGEN-USASP2024132452$AMGEN$Liu M.C.; Lizaola-mayo B.; Jayasekera C.R. et al.. Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant. Journal of Gastrointestinal Cancer. 2024;55 (2):969-974$40$YR$A$M$Y$$$20240709$$HP$US$US
240640151$24064015$1$I$20240517$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05475$VIFOR$$39$YR$$M$Y$64$KG$20240709$$HP$US$US
240640161$24064016$1$I$20240508$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05467$VIFOR$$75$YR$$F$Y$52.8$KG$20240709$$HP$US$US
240640171$24064017$1$I$20240507$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05485$VIFOR$$49$YR$$M$Y$66$KG$20240709$$HP$US$US
240640191$24064019$1$I$20240501$20240627$20240709$20240709$PER$$US-SA-2024SA194758$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240709$$MD$US$US
240640201$24064020$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA198718$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240709$$CN$US$US
240640221$24064022$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA198805$SANOFI AVENTIS$$60$YR$A$F$Y$89.8$KG$20240709$$MD$US$US
240640231$24064023$1$I$$20240624$20240709$20240709$EXP$$ID-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455883$RANBAXY$Dewi ST, Qomariah LN, Sarkowi WK, Puspitasari M, Khalidah M, Anggatama M, et al. Combination of cyclosporine A and methylprednisolone to treat pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome. Dermatol Rep. 2023;15(2):no page$8$YR$$M$Y$$$20240709$$HP$ID$ID
240640242$24064024$2$F$$20240701$20240709$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455527$RANBAXY$Kibby D, Trinkman H. Methotrexate level discrepancy post-glucarpidase: A pediatric case series and review of literature. Pediatr Blood Cancer. 2024;71:-$$$C$$Y$$$20240716$$HP$US$US
240640251$24064025$1$I$$20240624$20240709$20240709$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455438$RANBAXY$Gent DG, Ali N, Olsson-Brown A, Lip GYH, Wright DJ, Dobson R.. Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights.. Case Rep Oncol. 2022;15 (3):950-959$78$YR$$F$Y$$$20240709$$HP$GB$GB
240640261$24064026$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455318$RANBAXY$Shakir M, Nawaz M, Abdul Basit S, Jethani KR, Zaidi SMH, Patel NA. Spontaneous Pulmonary Hematoma on Heparin Infusion With Rapid Progression. Am J Respir Crit Care Med. 2024;209(0):A5767$66$YR$$M$Y$$$20240709$$HP$US$US
240640271$24064027$1$I$$20240701$20240709$20240709$EXP$$BH-STRIDES ARCOLAB LIMITED-2024SP008014$STRIDES$Ghanem H, Wilson PT, Gill DS. Intravenous magnesium sulphate for treatment of pediatric migraine: case series.. Signa-Vitae. 2023;19:194-200$7$YR$$F$Y$$$20240709$$HP$BH$BH
240640281$24064028$1$I$$20240624$20240709$20240709$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455848$RANBAXY$Nadeem NJ, Moawad A, Howatson S, Ahmed A, Cassell D. Case report: Diagnostic challenges in an adolescent case of autistic catatonia. Front Psychiatry. 2024;15 (0)::01-07$15$YR$$M$Y$$$20240709$$HP$GB$GB
240640291$24064029$1$I$$20240624$20240709$20240709$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455221$RANBAXY$Sugai Y, Toyoguchi Y, Kanoto M, Kirri K, Hiraka T, Konno Y, et al. Clinical and image features: large-vessel vasculitis after granulocyte colony stimulating factor administration. Acta Radiologica. 2024;65(4):383-391$69$YR$$F$Y$$$20240709$$HP$JP$JP
240640301$24064030$1$I$$20240624$20240709$20240709$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455437$RANBAXY$Hendrickx T, Peetermans M, D^hoore A, Claes K, Van Hootegem A, Sabino J. STEC colitis mimicking acute severe colitis with life-threatening consequences: a case report. Acta Gastroenterol Belg. 2024;Jan-Mar;87 (1):37-39$18$YR$$M$Y$$$20240709$$HP$BE$BE
240640311$24064031$1$I$$20240624$20240709$20240709$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455512$RANBAXY$Asensio-Sanchez VM, Lopez-Minarro I. Woman with vigorexia experiencing severe bilateral vision loss. Arch Soc Esp Oftalmol. 2024;Jun 18:Online ahead of print$28$YR$$F$Y$$$20240709$$HP$ES$ES
240640321$24064032$1$I$$20240624$20240709$20240709$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455295$RANBAXY$Chatterjee A, Kazi M, Ostwal V, Ramaswamy A, Desouza A, Saklani A. Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases. Ind J Surg Oncol. 2023;Mar; 14 (Suppl):S192-S197$49$YR$$F$Y$$$20240709$$HP$IN$IN
240640331$24064033$1$I$$20240624$20240709$20240709$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455539$RANBAXY$Varol F, Can YY, Kilic A, Kotcioglu AC, Durak C, Altas U, et al. Evaluation of Intoxication Cases Followed up in Pediatric Intensive Care Unit During COVID-19 Pandemic with Social Restrictions. J Curr Pediatr. 2022;20:258-65$13$YR$$F$Y$$$20240709$$MD$TR$TR
240640341$24064034$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455422$RANBAXY$Lord ML, Rana D, Hossain S, Chang C, Palli V. A Fatal Case of Lyme Myocarditis With Babesia Co-infection. Am J Respir Crit Care Med. 2024;209 (0):A3591$79$YR$$F$Y$$$20240709$$HP$US$US
240640351$24064035$1$I$$20240624$20240709$20240709$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455616$RANBAXY$Grifoni G, Haissaguerre M, Bongiorni MG, Benali K, Soldati E, Zucchelli G. Short-coupled Purkinje ectopy inducible by pharmacological and hyperventilation tests. HeartRhythm Case Rep. 2023;10(1):68-71$50$YR$$M$Y$$$20240709$$MD$IT$IT
240640361$24064036$1$I$$20240624$20240709$20240709$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452285$RANBAXY$Yang W, Tang C, Shen S, Shi Q, Hu F. Spread and evolution of blaKPC-plasmid between Serratia marcescens and Klebsiella pneumoniae. Int J Antimicrob Agents. 2024;63 (5):no pagination$68$YR$$M$Y$$$20240709$$HP$CN$CN
240640371$24064037$1$I$$20240624$20240709$20240709$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454075$RANBAXY$Kamsani SH, Middeldorp ME, Chiang G, Stefil M,  Evans S, Nguyen MT,et al. Safety of outpatient commencement of sotalol. Heart Rhythm. 2024;jun, 5(6):1-10/ 341?350$69$YR$$F$Y$$$20240709$$MD$AU$AU
240640381$24064038$1$I$20180101$20240624$20240709$20240709$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455402$RANBAXY$Gent DG, Ali N, Olsson-Brown A, Lip GYH, Wright DJ, Dobson R.. Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights.. Case Rep Oncol. 2022;15 (3):950-959$50$YR$$M$Y$$$20240709$$HP$GB$GB
240640391$24064039$1$I$$20240624$20240709$20240709$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455540$RANBAXY$Varol F, Can YY, Kilic A, Kotcioglu AC, Durak C, Altas U, et al. Evaluation of Intoxication Cases Followed up in Pediatric Intensive Care Unit During COVID-19 Pandemic with Social Restrictions. J Curr Pediatr. 2022;20:258-65$155$MON$$M$Y$$$20240709$$MD$TR$TR
240640401$24064040$1$I$$20240624$20240709$20240709$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455532$RANBAXY$Varol F, Can YY, Kilic A, Kotcioglu AC, Durak C, Altas U, et al. Evaluation of Intoxication Cases Followed up in Pediatric Intensive Care Unit During COVID-19 Pandemic with Social Restrictions. J Curr Pediatr. 2022;20 (3):258-65$162$MON$$F$Y$$$20240709$$MD$TR$TR
240640411$24064041$1$I$$20240624$20240709$20240709$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455478$RANBAXY$Ge T, Xie X, Liu J. A rare case of pheochromocytoma in a pregnant woman presenting with chest pain: extraordinary management. BMC Cardiovasc Disord. 2024;24(1):261, 1-5$$$I$$Y$68.5$KG$20240709$$HP$CN$CN
240640421$24064042$1$I$$20240624$20240709$20240709$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455206$RANBAXY$Guo K, Wang G, Zhang L, Feng Z, Xia X, Sun X, et al. Hemorrhage induced by antithrombotic agents:new insights from a real-world pharmacovigilance study. Expert Opin Drug Saf. 2024;23(4):487-495$63$YR$$M$Y$$$20240709$$HP$CN$CN
240640431$24064043$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455266$RANBAXY$Yegudkin I, Feng L, Manzouri S,Funnamark R, Ciurczak N, McKenzie ME, et al. Neurogenic Pulmonary Edema in the Setting of Intracerebral Hemorrhage: A Case Report. Am J Respir Crit Care Med. 2024;209 (0):A1157/A24$40$YR$$M$Y$$$20240709$$HP$US$US
240640441$24064044$1$I$$20240624$20240709$20240709$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454074$RANBAXY$Kamsani SH, Middeldorp ME, Chiang G, Stefil M,  Evans S, Nguyen MT,et al. Safety of outpatient commencement of sotalol. Heart Rhythm. 2024;jun, 5(6):1-10/ 341?350$74$YR$$M$Y$$$20240709$$MD$AU$AU
240640451$24064045$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455475$RANBAXY$Chowdhury T, Mainali A Uprety N, Bisural R, Adhikari S, Gousy N, et al. The Deadly Duel: Legionnaires Disease and Multiple Myeloma: A Case of Fatal Pulmonary Renal Syndrome. Am J Respir Crit Care Med. 2024;209:A3608/B43$57$YR$$M$Y$$$20240709$$HP$US$US
240640461$24064046$1$I$$20240624$20240709$20240709$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455409$RANBAXY$Ren J, Yang F, Su Y, Wang H, Luo S. Skin mucormycosis secondary to herpes zoster in a patient with diabetic ketoacidosis. Eur J Dermatol. 2023;33(1):49-51$77$YR$$F$Y$$$20240709$$HP$CN$CN
240640471$24064047$1$I$$20240624$20240709$20240709$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455297$RANBAXY$Chatterjee A, Kazi M, Ostwal V, Ramaswamy A, Desouza A, Saklani A. Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases. Ind J Surg Oncol. 2023;Mar; 14 (Suppl):S192-S197$19$YR$$M$Y$$$20240709$$HP$IN$IN
240640481$24064048$1$I$$20240624$20240709$20240709$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455284$RANBAXY$Ge T, Xie X, Liu J. A rare case of pheochromocytoma in a pregnant woman presenting with chest pain: extraordinary management. BMC Cardiovasc Disord. 2024;24 (1):261, 1-5$32$YR$$F$Y$68.5$KG$20240709$$HP$CN$CN
240640491$24064049$1$I$$20240624$20240709$20240709$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455233$RANBAXY$Chatterjee A, Kazi M, Ostwal V, Ramaswamy A, Desouza A, Saklani A. Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases. Ind J Surg Oncol. 2023;Mar; 14 (Suppl):S192-S197$41$YR$$F$Y$$$20240709$$HP$IN$IN
240640501$24064050$1$I$$20240624$20240709$20240709$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454054$RANBAXY$Kamsani SH, Middeldorp ME, Chiang G, Stefil M,  Evans S, Nguyen MT,et al. Safety of outpatient commencement of sotalol. Heart Rhythm. 2024;jun, 5(6):1-10/ 341?350$53$YR$$M$Y$$$20240709$$MD$AU$AU
240640511$24064051$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455433$RANBAXY$Pandey M, Vallapu Reddy T, Khattri B, Hemmige A, Pujar S, Aashish A. Pneumocystis Pneumonia in a Patient With Prolonged Steroid Therapy. Am J Respir Crit Care Med. 2024;209:A2392 (A65)$65$YR$$M$Y$$$20240709$$HP$US$US
240640521$24064052$1$I$$20240624$20240709$20240709$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454064$RANBAXY$Kamsani SH, Middeldorp ME, Chiang G, Stefil M,  Evans S, Nguyen MT,et al. Safety of outpatient commencement of sotalol. Heart Rhythm. 2024;jun, 5(6):1-10/ 341-350$78$YR$$F$Y$$$20240709$$MD$AU$AU
240640534$24064053$4$F$20240622$20240827$20240709$20240903$EXP$$JP-GENMAB-2024-02268$GENMAB$$77$YR$$M$Y$$$20240903$$MD$JP$JP
240640541$24064054$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455362$RANBAXY$Hammond TC, Channick CL, Favano T, Purbhoo M, Exley MA, Vandiver MS, et al. Persistent SARS-CoV-2 Viremia, COVID-19 Associated Acute Respiratory Distress Syndrome, Severe Coagulopathy and Massive Hemoptysis in a Renal Transplant Patient on Veno-Venous Extracorporeal Membrane Oxygenation. Am J Respir Crit Care Med. 2024;209(0):A5563$26$YR$$M$Y$$$20240709$$HP$US$US
240640552$24064055$2$F$20140101$20240919$20240709$20240926$EXP$$GB-CHEPLA-2024008356$CHEPLAPHARM$$$$A$M$Y$73$KG$20240926$$CN$COUNTRY NOT SPECIFIED$GB
240640581$24064058$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454724$RANBAXY$$$$T$F$Y$$$20240709$$HP$US$US
240640591$24064059$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455448$RANBAXY$Kazi I, Vallejo S, Estrada RA. Suffocated by Autoimmunity: A Bloodbath. Am J Respir Crit Care Med. 2024;209:A5332$57$YR$$F$Y$$$20240709$$HP$US$US
240640611$24064061$1$I$20200101$20240624$20240709$20240709$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455429$RANBAXY$Gent DG, Ali N, Olsson-Brown A, Lip GYH, Wright DJ, Dobson R.. Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights.. Case Rep Oncol. 2022;15 (3):950-959$73$YR$$F$Y$$$20240709$$HP$GB$GB
240640621$24064062$1$I$20240611$20240628$20240709$20240709$EXP$CN-NMPACDR-5301001034228202400224$CN-BAXTER-2024BAX020983$BAXTER$$2$YR$$F$Y$9$KG$20240709$$MD$CN$CN
240640631$24064063$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA198638$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240709$$MD$US$US
240640641$24064064$1$I$20240623$20240701$20240709$20240709$EXP$FR-AFSSAPS-PO2024000718$FR-BAXTER-2024BAX020859$BAXTER$$22$YR$$F$Y$58$KG$20240709$$MD$FR$FR
240640651$24064065$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455447$RANBAXY$Faris M, Saad E, Abdulrahman A, Albanna M, Friedman H. A Life-threatening Bradyarrhythmia in the ICU: Beware of Phenytoin Loading!. Am J Respir Crit Care Med. 2024;209:A34646$75$YR$$F$Y$$$20240709$$HP$US$US
240640661$24064066$1$I$$20240624$20240709$20240709$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455303$RANBAXY$Chatterjee A, Kazi M, Ostwal V, Ramaswamy A, Desouza A, Saklani A. Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases. Ind J Surg Oncol. 2023;Mar; 14 (Suppl):S192-S197$61$YR$$M$Y$$$20240709$$HP$IN$IN
240640671$24064067$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455341$RANBAXY$Poondru S, Joseph A, Harding JC, Sundaramoorthi H, Mehta-Shah N, Green P, et al. Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy. Case Rep Oncol. 2022;15(3):918-926$51$YR$$F$Y$$$20240709$$HP$US$US
240640681$24064068$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455288$RANBAXY$Carter M, Kumar S, Almalouf P. When Abdominal Pain and Pseudo-stemi Unleash Paroxysmal Granulomatosis. Am J Respir Crit Care Med. 2024;209(0):A2072$30$YR$$M$Y$$$20240709$$HP$US$US
240640691$24064069$1$I$$20240624$20240709$20240709$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455282$RANBAXY$Biala M, Pencakowski B, Maczynska B, Starzynski K, Szetela B. Two New Strains of Drug-resistant Neisseria gonorrhoeae in a Bisexual Man having Sex with Men in Wroclaw, Poland. Acta Derm Venereol. 2024;104:adv35658, 1-2$31$YR$$M$Y$$$20240709$$HP$PL$PL
240640701$24064070$1$I$$20240624$20240709$20240709$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455238$RANBAXY$Oguni K, Fukushima S, Otsuka Y, Soejima Y, Kawaguchi M, Sazumi Y, et al. Disseminated septic arthritis caused by Ureaplasma urealyticum in an immunocompromised patient with hypogammaglobulinemia after rituximab therapy. Infection. 2024;May:1-5$23$YR$$F$Y$$$20240709$$HP$CN$CN
240640711$24064071$1$I$20200101$20240624$20240709$20240709$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455418$RANBAXY$Gent DG, Ali N, Olsson-Brown A, Lip GYH, Wright DJ, Dobson R.. Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights.. Case Rep Oncol. 2022;15 (3):950-959$46$YR$$F$Y$$$20240709$$HP$GB$GB
240640721$24064072$1$I$$20240624$20240709$20240709$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454076$RANBAXY$Kamsani SH, Middeldorp ME, Chiang G, Stefil M,  Evans S, Nguyen MT,et al. Safety of outpatient commencement of sotalol. Heart Rhythm. 2024;jun, 5(6):1-10/ 341?350$62$YR$$F$Y$$$20240709$$MD$AU$AU
240640731$24064073$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455430$RANBAXY$Holbert K. Multiorgan Failure From Heat Stroke in a Person Taking Glycopyrrolate. Am J Respir Crit Care Med. 2024;209(0):A7329$24$YR$$M$Y$$$20240709$$HP$US$US
240640741$24064074$1$I$$20240624$20240709$20240709$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455255$RANBAXY$Modi T, Sood T, Moudgil S, Arora N. Neurological manifestations of scrub typhus: encephalitis and guillain- barre syndrome (GBS). BMJ Case Rep. 2023;16(3):e253350 (1-5)$3$DEC$$M$Y$$$20240709$$HP$IN$IN
240640751$24064075$1$I$$20240624$20240709$20240709$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454073$RANBAXY$Kamsani SH, Middeldorp ME, Chiang G, Stefil M,  Evans S, Nguyen MT,et al. Safety of outpatient commencement of sotalol. Heart Rhythm. 2024;jun, 5(6):1-10/ 341-350$69$YR$$M$Y$$$20240709$$MD$AU$AU
240640761$24064076$1$I$$20240624$20240709$20240709$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455123$RANBAXY$Novikov PS, Novikov IA, Mironov NYu, Saidova MA,  Dulaev LO, Maykov EB. TAKOTSUBO CARDIOMYOPATHY AFTER CRYOBALLOON PULMONARY VEIN ABLATION IN A PATIENT WITH PERSISTENT ATRIAL FIBRILLATION: CLINICAL CASE. Journal of Arrhythmology. 2022;29(1):63-68$66$YR$$$Y$$$20240709$$HP$RU$RU
240640771$24064077$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455453$RANBAXY$Prabhu S, Malempati S, Markowitz D.. Amlodipine: Not an Ace in the Hole. Am J Respir Crit Care Med. 2024;209 (0):A1361$56$YR$$M$Y$$$20240709$$HP$US$US
240640782$24064078$2$F$$20240701$20240709$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455371$RANBAXY$Patel P, Turbin RE, Husain S, Wang S. Neurosyphilis Mimicking Connective Tissue Disease. BMJ Case Rep. 2023;16:e256301(1-5)$7$DEC$$M$Y$$$20240716$$HP$US$US
240640791$24064079$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455264$RANBAXY$Geller A, Martinez Manzano J, Benzaquen S. An Exudative Enigma: Recurrent Pleural Effusions Following Drug-Eluting Bead Transarterial Chemoembolization With Percutaneous Ethanol Injection for Palliative Treatment of Hepatocellular Carcinoma. Am J Respir Crit Care Med. 2024;209(0):A5812/C49$64$YR$$M$Y$$$20240709$$HP$US$US
240640801$24064080$1$I$$20240624$20240709$20240709$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455502$RANBAXY$Panwar A, Vaidyanathan S, Udupa ST, Munoli RN, Praharaj SK. Anticraving Effect of N-Acetyl Cysteine in a Patient With Pregabalin and Alcohol Dependence. Am-J-Ther. 2023;30(6):e597-e598$36$YR$$M$Y$$$20240709$$MD$IN$IN
240640811$24064081$1$I$$20240624$20240709$20240709$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455205$RANBAXY$Guo K, Wang G, Zhang L, Feng Z, Xia X, Sun X, et al. Hemorrhage induced by antithrombotic agents:new insights from a real-world pharmacovigilance study. Expert Opin Drug Saf. 2024;23(4):487-495$54$YR$$M$Y$$$20240709$$HP$CN$CN
240640821$24064082$1$I$$20240624$20240709$20240709$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455085$RANBAXY$Emami AH, Alizadehasl A, Sayad M, Shavandi F, Firoozbakhsh P, Meshgi S, et al.. Diagnosis and management of cancer therapy-related myocarditis in a young female: A case report and review of literature. BMC Cardiovasc Disord. 2024;24 (1):1-5(299)$19$YR$$F$Y$$$20240709$$HP$IR$IR
240640832$24064083$2$F$$20240829$20240709$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454055$RANBAXY$Kamsani SH, Middeldorp ME, Chiang G, Stefil M,  Evans S, Nguyen MT,et al. Safety of outpatient commencement of sotalol. Heart Rhythm. 2024;jun, 5(6):1-10/ 341?350$65$YR$$M$Y$$$20240913$$MD$AU$AU
240640841$24064084$1$I$$20240624$20240709$20240709$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454061$RANBAXY$Kamsani SH, Middeldorp ME, Chiang G, Stefil M,  Evans S, Nguyen MT,et al. Safety of outpatient commencement of sotalol. Heart Rhythm. 2024;jun, 5(6):1-10/ 341?350$78$YR$$M$Y$$$20240709$$MD$AU$AU
240640851$24064085$1$I$$20240701$20240709$20240709$EXP$$NL-AUROBINDO-AUR-APL-2017-04681$AUROBINDO$Brouwers EE, Sohne M, Kuipers S, van Gorp EC, Schellens JH, Koks CH et al. Ciprofloxacin strongly inhibits clozapine metabolism: two case reports.. Clin Drug Investig.. 2009;29(1):59-63$46$YR$$M$Y$$$20240709$$MD$NL$NL
240640861$24064086$1$I$20190101$20240701$20240709$20240709$EXP$$US-TRIS PHARMA, INC.-24US011561$TRIS PHARM$Panjiyar BK, Changlani N, Medina C, Trevino LR.. Cocaine, amphetamine, or titin: Unraveling the genetic underpinnings of dilated cardiomyopathy.. Clin Case Rep. 2024;12(6):e9069$$$$$Y$$$20240709$$HP$US$US
240640871$24064087$1$I$$20240702$20240709$20240709$EXP$$US-GSK-US2024AMR082811$GLAXOSMITHKLINE$$$$$F$Y$58.05$KG$20240709$$CN$US$US
240640881$24064088$1$I$$20240702$20240709$20240709$EXP$$JP-CHEPLA-2024008467$CHEPLAPHARM$Komoriya H, Nomura K, Shirata T, Kobayashi T, Nakane M, Noto K et al. A fatal case of fulminant neuroleptic malignant syndrome: A case report. PCN reports : psychiatry and clinical neurosciences,2023;2(1):e75  DOI: 10.1002/pcn5.75.$67$YR$$M$Y$$$20240709$$MD$COUNTRY NOT SPECIFIED$JP
240640891$24064089$1$I$20240602$20240703$20240709$20240709$EXP$$KW-JNJFOC-20240712702$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240709$$CN$KW$KW
240640904$24064090$4$F$20240101$20240731$20240709$20240806$EXP$$JP-JNJFOC-20240721232$JOHNSON AND JOHNSON$$30$YR$A$M$Y$82.4$KG$20240806$$MD$JP$JP
240640911$24064091$1$I$20230612$20240702$20240709$20240709$EXP$$NVSC2015IN015946$NOVARTIS$$59$YR$$F$Y$$$20240709$$CN$IN$IN
240640921$24064092$1$I$$20240701$20240709$20240709$PER$$US-MYLANLABS-2024M1062480$MYLAN$$$$$F$Y$$$20240709$$MD$US$US
240640931$24064093$1$I$$20240701$20240709$20240709$EXP$$BH-STRIDES ARCOLAB LIMITED-2024SP008016$STRIDES$Ghanem H, Wilson PT, Gill DS. Intravenous magnesium sulphate for treatment of pediatric migraine: case series.. Signa-Vitae. 2023;19:194-200$11$YR$$F$Y$$$20240709$$HP$BH$BH
240640941$24064094$1$I$$20240704$20240709$20240709$EXP$$AU-BIOGEN-2024BI01272601$BIOGEN$$$$$M$Y$$$20240709$$CN$AU$AU
240640951$24064095$1$I$$20240702$20240709$20240709$EXP$$GB-AUROBINDO-AUR-APL-2024-032913$AUROBINDO$$88$YR$$F$Y$$$20240709$$HP$GB$GB
240640961$24064096$1$I$$20240626$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407000633$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240709$$CN$US$US
240640971$24064097$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004155$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240709$$CN$US$US
240640981$24064098$1$I$20240621$20240702$20240709$20240709$EXP$$US-SA-2024SA197849$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240709$$CN$US$US
240640991$24064099$1$I$$20240701$20240709$20240709$EXP$$BH-STRIDES ARCOLAB LIMITED-2024SP008017$STRIDES$Ghanem H, Wilson PT, Gill DS. Intravenous magnesium sulphate for treatment of pediatric migraine: case series. Signa-Vitae. 2023;19:194-200$17$YR$$M$Y$$$20240709$$HP$BH$BH
240641001$24064100$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455479$RANBAXY$Huang H, Greven MA. TRAUMATIC LENS SUBLUXATION FROM PICKLEBALL INJURY: A CASE SERIES. Retin Cases Brief Rep. 2024;18(1):15-17$76$YR$$F$Y$$$20240709$$HP$US$US
240641021$24064102$1$I$$20240624$20240709$20240709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454669$RANBAXY$Adegoke T, Subramanian S, Daunis D, Bick S, Ward HB. A Case of Treatment-Resistant Depression Complicated by Traumatic Brain Injury and Seizure: Implications for Interventional Treatment and Psychiatric Training. Harv Rev Psychiatry. 2024;May/Jun;32(3):117-125$45$YR$$M$Y$$$20240709$$MD$US$US
240641031$24064103$1$I$$20240624$20240709$20240709$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454058$RANBAXY$Kamsani SH, Middeldorp ME, Chiang G, Stefil M,  Evans S, Nguyen MT,et al. Safety of outpatient commencement of sotalol. Heart Rhythm. 2024;jun, 5(6):1-10/ 341?350$71$YR$$M$Y$$$20240709$$MD$AU$AU
240641042$24064104$2$F$$20240828$20240709$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455498$RANBAXY$Costantini I, Mantelli G, Carollo M, Losso L, Morando E, Bacchion M, et al. Not only Van Gogh: a case of BRASH syndrome with concomitant digoxin toxicity. J Med Case Rep. 2024;18 (1):273$66$YR$$F$Y$$$20240912$$HP$IT$IT
240641061$24064106$1$I$20240625$20240705$20240709$20240709$EXP$$US-TAKEDA-2024TUS069253$TAKEDA$$68$YR$$M$Y$$$20240709$$HP$US$US
240641071$24064107$1$I$$20240624$20240709$20240709$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455222$RANBAXY$Sugai Y, Toyoguchi Y, Kanoto M, Kirri K, Hiraka T, Konno Y, et al. Clinical and image features: large-vessel vasculitis after granulocyte colony stimulating factor administration. Acta Radiologica. 2024;65(4):383?391$59$YR$$F$Y$$$20240709$$HP$JP$JP
240641081$24064108$1$I$20240501$20240618$20240709$20240709$PER$$US-AMGEN-USASP2024120896$AMGEN$$41$YR$A$F$Y$$$20240709$$CN$US$US
240641091$24064109$1$I$$20240705$20240709$20240709$30DAY$$US-GSK-US2024084040$GLAXOSMITHKLINE$$$$$F$Y$$$20240709$$CN$US$US
240641101$24064110$1$I$20240401$20240705$20240709$20240709$PER$$US-JNJFOC-20240715964$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240709$$CN$US$US
240641111$24064111$1$I$$20240701$20240709$20240709$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004926$BIOCON$$$$$$Y$$$20240709$$MD$CA$CA
240641122$24064112$2$F$20220101$20240903$20240709$20240917$EXP$$US-UCBSA-2024033384$UCB$$$$$F$Y$65.76$KG$20240917$$MD$US$US
240641131$24064113$1$I$20240120$20240630$20240709$20240709$EXP$GB-MHRA-MED-202406302239302250-SFMJQ$GB-TEVA-VS-3216181$TEVA$$30$YR$$F$Y$97$KG$20240709$$HP$GB$GB
240641142$24064114$2$F$20240611$20240813$20240709$20240819$EXP$$US-AstraZeneca-2024A151537$ASTRAZENECA$$14794$DY$$F$Y$$$20240819$$CN$US$
240641151$24064115$1$I$20240627$20240701$20240709$20240709$EXP$$ES-AUROBINDO-AUR-APL-2024-032756$AUROBINDO$$52$YR$$F$Y$$$20240709$$MD$ES$ES
240641171$24064117$1$I$$20240704$20240709$20240709$EXP$$ZA-AstraZeneca-2024A155742$ASTRAZENECA$$74$YR$$F$Y$$$20240709$$CN$ZA$
240641181$24064118$1$I$$20240701$20240709$20240709$EXP$$CA-AstraZeneca-2024A152407$ASTRAZENECA$$15$WK$$M$Y$$$20240709$$MD$CA$
240641191$24064119$1$I$$20240704$20240709$20240709$EXP$$KR-ASTELLAS-2024EU006688$ASTELLAS$$39$YR$$$Y$$$20240709$$HP$GB$KR
240641201$24064120$1$I$$20240702$20240709$20240709$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020543$UNITED THERAPEUTICS$$$$$F$Y$80.726$KG$20240709$$$US$US
240641211$24064121$1$I$20240704$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135188$AMGEN$$72$YR$E$M$Y$$$20240709$$CN$US$US
240641222$24064122$2$F$20240624$20240624$20240709$20240709$EXP$$US-GSK-US2024078561$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240709$$CN$US$US
240641232$24064123$2$F$$20240802$20240709$20240814$PER$$US-APOTEX-2024AP007757$APOTEX$$$$$$Y$$$20240814$$HP$US$US
240641241$24064124$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-032921$AUROBINDO$Aribindi K, Arif MZ, Quon SM, Inaty H. From the Pipes to the Pleural Space: A Rare Case of a Cryptococcal Effusion. Am-J-Respir-Crit-Care-Med. 2024;209:A6007$54$YR$$F$Y$$$20240709$$HP$US$US
240641261$24064126$1$I$$20240701$20240709$20240709$EXP$$JP-JNJFOC-20240717936$JOHNSON AND JOHNSON$$$$C$$Y$$$20240709$$CN$JP$JP
240641271$24064127$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA198755$SANOFI AVENTIS$$$$A$M$Y$$$20240709$$CN$US$US
240641281$24064128$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA196214$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240641301$24064130$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA194261$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240641311$24064131$1$I$20230301$20240701$20240709$20240709$PER$$US-SA-2024SA154823$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240709$$CN$US$US
240641321$24064132$1$I$$20240626$20240709$20240709$EXP$$CN-TAKEDA-2024TUS067952$TAKEDA$$$$E$$Y$$$20240709$$HP$CN$CN
240641331$24064133$1$I$20240629$20240701$20240709$20240709$PER$$US-SA-2024SA196248$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240709$$MD$US$US
240641341$24064134$1$I$20240601$20240702$20240709$20240709$PER$$US-SA-2024SA199047$SANOFI AVENTIS$$24$YR$A$F$Y$72.57$KG$20240709$$MD$US$US
240641351$24064135$1$I$$20240702$20240709$20240709$30DAY$$US-GSK-US2024083125$GLAXOSMITHKLINE$$$$$F$Y$$$20240709$$CN$US$US
240641361$24064136$1$I$$20240708$20240709$20240709$PER$$US-HALEON-2185942$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240641372$24064137$2$F$$20240624$20240709$20240709$EXP$$US-VIIV HEALTHCARE LIMITED-US2024078612$VIIV$$$$$M$Y$$$20240709$$MD$US$US
240641381$24064138$1$I$$20240411$20240709$20240709$PER$$US-AUROBINDO-AUR-APL-2024-016392$AUROBINDO$$$$$$Y$$$20240709$$HP$US$US
240641391$24064139$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-032867$AUROBINDO$Deiss T, Harper A, Sanne S, Imsais W. Delayed clostridium difficile diagnosis in a patient with chronic constipation and diarrhea. Am-J-Med-Sci. 2024;367:S47-S48$77$YR$$F$Y$$$20240709$$HP$US$US
240641401$24064140$1$I$$20240701$20240709$20240709$PER$$US-ROCHE-10000020091$ROCHE$$69$YR$E$M$Y$$$20240709$$MD$US$US
240641411$24064141$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA198643$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240709$$HP$US$US
240641421$24064142$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA196287$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240641432$24064143$2$F$$20240827$20240709$20240911$PER$$US-SA-2024SA196279$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240911$$MD$US$US
240641441$24064144$1$I$20240101$20240627$20240709$20240709$PER$$US-SA-2024SA194427$SANOFI AVENTIS$$41$YR$A$F$Y$122$KG$20240709$$MD$US$US
240641451$24064145$1$I$20190601$20240704$20240709$20240709$EXP$$HU-Orion Corporation ORION PHARMA-TREX2024-0171$ORION$Kurokawa T, Varga E. Successful treatment of a challenging periprosthetic femoral fracture on a premenopausal patient with a long history of immunosuppression. Case report.. Magyar Traumatol?gia Ortop?dia, K?zseb?szet, Plasztikai Seb?szet. 2024;67(1):47-57.$39$YR$A$F$Y$$$20240709$$MD$HU$
240641461$24064146$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405140857136860-LVHKT$GB-MYLANLABS-2024M1063563$MYLAN$$$$$F$Y$$$20240709$$HP$GB$GB
240641471$24064147$1$I$$20240708$20240709$20240709$EXP$$GB-MYLANLABS-2024M1064032$MYLAN$$$$$M$Y$$$20240709$$HP$GB$GB
240641482$24064148$2$F$$20240722$20240709$20240723$EXP$GB-MHRA-MED-202405151353006080-KDBHY$GB-MYLANLABS-2024M1064020$MYLAN$$93$YR$$M$Y$$$20240723$$MD$GB$GB
240641491$24064149$1$I$20231008$20231227$20240709$20240709$PER$$US-AUROBINDO-AUR-APL-2023-066379$AUROBINDO$$76$YR$$F$Y$92$KG$20240709$$CN$US$US
240641503$24064150$3$F$$20240814$20240709$20240821$EXP$$BR-TAKEDA-2024TUS068679$TAKEDA$$$$$M$Y$$$20240821$$CN$BR$BR
240641521$24064152$1$I$20230904$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405031001342450-RVGZF$GB-MYLANLABS-2024M1063824$MYLAN$$17$YR$$M$Y$$$20240709$$MD$GB$GB
240641531$24064153$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134852$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240641541$24064154$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134454$AMGEN$$$$$$Y$$$20240709$$HP$US$US
240641562$24064156$2$F$20240501$20240712$20240709$20240722$EXP$$US-VIIV HEALTHCARE LIMITED-US2024083893$VIIV$$37$YR$$F$Y$$$20240722$$CN$US$US
240641571$24064157$1$I$20240601$20240628$20240709$20240709$EXP$FR-AFSSAPS-TS2024000708$FR-ROCHE-10000016976$ROCHE$$40$YR$A$M$Y$62$KG$20240709$$MD$FR$FR
240641591$24064159$1$I$$20240628$20240709$20240709$EXP$CA-MHPD-E2B_001082900$CA-Accord-433148$ACCORD$$66$YR$E$F$Y$$$20240709$$MD$CA$CA
240641601$24064160$1$I$20240323$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281136243400-GYCWK$GB-Accord-433179$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240641612$24064161$2$F$$20240708$20240709$20240718$EXP$GB-MHRA-MED-202406281141054980-NZHDV$GB-Accord-433368$ACCORD$$$$$$Y$$$20240718$$CN$GB$GB
240641621$24064162$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281412466070-YKBNQ$GB-Accord-433188$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240641631$24064163$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281432323530-HKSTC$GB-Accord-433458$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240641643$24064164$3$F$$20240718$20240709$20240729$EXP$GB-MHRA-MED-202406271102593100-MTLRW$GB-Accord-433217$ACCORD$$37$YR$A$M$Y$$$20240729$$CN$GB$GB
240641651$24064165$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281429282700-HZCNF$GB-Accord-433433$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240641661$24064166$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281433366540-CNLMB$GB-Accord-433477$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240641671$24064167$1$I$$20240627$20240709$20240709$EXP$AU-TGA-803181$AU-Accord-432651$ACCORD$$$$$F$Y$$$20240709$$HP$AU$AU
240641681$24064168$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281412107900-RNBWT$GB-Accord-433181$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240641691$24064169$1$I$20240618$20240627$20240709$20240709$EXP$CN-HENLIUS-24CN015653$CN-Accord-434496$ACCORD$$60$YR$A$F$Y$$$20240709$$MD$CN$CN
240641701$24064170$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281503492060-NTSCD$GB-Accord-433238$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240641711$24064171$1$I$20240606$20240627$20240709$20240709$EXP$CN-HENLIUS-24CN015657$CN-Accord-434127$ACCORD$$41$YR$A$F$Y$$$20240709$$MD$CN$CN
240641721$24064172$1$I$20240501$20240627$20240709$20240709$EXP$FR-AFSSAPS-RS2024000636$FR-Accord-433316$ACCORD$$51$YR$A$F$Y$$$20240709$$MD$FR$FR
240641731$24064173$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281414140760-PYGTQ$GB-Accord-433423$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240641741$24064174$1$I$$20240628$20240709$20240709$EXP$$US-Accord-431000$ACCORD$Sharma P, Tahiru M, Li H, Bansari A, Baskaran N. A case of ocular diffuse large B-cell lymphoma unveiled through Pars Plana Vitrectomy: surgical insight and multidisciplinary management. J Surg Case Rep. 2024 Jun 11;2024(6):rjae399.$74$YR$E$M$Y$$$20240709$$HP$US$US
240641751$24064175$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281140265240-PFTZY$GB-Accord-433385$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240641761$24064176$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281419074630-BMTGL$GB-Accord-433425$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240641771$24064177$1$I$20240525$20240627$20240709$20240709$EXP$ES-AEMPS-1540602$ES-Accord-433459$ACCORD$$78$YR$E$M$Y$$$20240709$$MD$ES$ES
240641781$24064178$1$I$$20240704$20240709$20240709$EXP$$US-JNJFOC-20240713625$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240709$$HP$US$US
240641791$24064179$1$I$20220604$20220606$20240709$20240709$EXP$$PL-ASTELLAS-2022US021173$ASTELLAS$$84$YR$$F$Y$$$20240709$$CN$PL$PL
240641801$24064180$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-033245$AUROBINDO$Huff RR, Jose A, Karpinska-Leydier K, Theriault K, Kapadia S. Kartagener^s Syndrome With Situs Inversus Total Is: Breaking the Vicious Cycle. Am-J-Respir-Crit-Care-Med. 2024;209:2024$71$YR$$F$Y$$$20240709$$HP$US$US
240641811$24064181$1$I$$20240701$20240709$20240709$EXP$$US-HETERO-HET2024US02141$HETERO$Holbert K. Multiorgan failure from heat stroke in a person taking glycopyrrolate. American Thoracic Society.. 2024;209:A7329$24$YR$$M$Y$$$20240709$$HP$US$US
240641821$24064182$1$I$20240601$20240705$20240709$20240709$EXP$$US-UCBSA-2024034520$UCB$$37$YR$$F$Y$$$20240709$$HP$US$US
240641831$24064183$1$I$$20240701$20240709$20240709$EXP$$US-AUROBINDO-AUR-APL-2024-032904$AUROBINDO$Chowdhury T, Mainali A, Uprety N, Bisural R, Adhikari S, Gousy N, et al.. The Deadly Duel: Legionnaires Disease and Multiple Myeloma: A Case of Fatal Pulmonary Renal Syndrome. Am-JRespir-Crit-Care-Med. 2024;209:A3608$57$YR$$M$Y$$$20240709$$HP$US$US
240641841$24064184$1$I$$20240704$20240709$20240709$EXP$$JP-AMGEN-JPNSP2024134943$AMGEN$$78$YR$E$F$Y$$$20240709$$MD$JP$JP
240641851$24064185$1$I$$20220831$20240709$20240709$EXP$$BR-ASTELLAS-2022US006716$ASTELLAS$$30$YR$$M$Y$$$20240709$$HP$BR$BR
240641861$24064186$1$I$20080315$20240621$20240709$20240709$EXP$$NL-ROCHE-10000018928$ROCHE$$61$YR$A$F$Y$$$20240709$$CN$NL$NL
240641875$24064187$5$F$20240701$20240715$20240709$20240718$30DAY$$US-AMGEN-USASP2024134141$AMGEN$$72$YR$E$F$Y$56.236$KG$20240718$$PH$US$US
240641881$24064188$1$I$20240302$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05461$VIFOR$$44$YR$$F$Y$53.5$KG$20240709$$HP$US$US
240641891$24064189$1$I$20240520$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05460$VIFOR$$55$YR$$F$Y$79$KG$20240709$$HP$US$US
240641901$24064190$1$I$20240425$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05469$VIFOR$$65$YR$$F$Y$113$KG$20240709$$HP$US$US
240641911$24064191$1$I$$20240624$20240709$20240709$EXP$$CA-GSK-CA2024059646$GLAXOSMITHKLINE$$$$$M$Y$$$20240709$$HP$CA$CA
240641921$24064192$1$I$$20240708$20240709$20240709$EXP$$CA-ORGANON-O2407CAN000751$ORGANON$$57$YR$$F$Y$44$KG$20240709$$CN$CA$CA
240641931$24064193$1$I$$20240704$20240709$20240709$PER$$US-HETERO-HET2024US01723$HETERO$$$$$$Y$$$20240709$$CN$US$US
240641941$24064194$1$I$20240507$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05474$VIFOR$$74$YR$$F$Y$71$KG$20240709$$HP$US$US
240641951$24064195$1$I$$20240703$20240709$20240709$EXP$GB-MHRA-MED-202406291157398850-KGTCR$GB-AMAROX PHARMA-AMR2024GB02105$HETERO$$30$YR$$M$Y$$$20240709$$CN$GB$GB
240641961$24064196$1$I$$20240703$20240709$20240709$EXP$$US-JNJFOC-20240711641$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$US$US
240641971$24064197$1$I$20240708$20240708$20240709$20240709$PER$$US-JNJFOC-20240719400$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240709$$CN$US$US
240641982$24064198$2$F$20240502$20240731$20240709$20240807$EXP$$JP-ASTELLAS-2024JP003400$ASTELLAS$$8$DEC$$M$Y$$$20240807$$MD$JP$JP
240641992$24064199$2$F$$20240708$20240709$20240710$PER$$US-HALEON-2186010$Haleon PLC$$47$YR$$M$Y$$$20240710$$CN$US$US
240642001$24064200$1$I$$20240702$20240709$20240709$EXP$$ES-ASTELLAS-2024EU006562$ASTELLAS$$$$$$Y$$$20240709$$HP$GB$ES
240642011$24064201$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA199126$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240642021$24064202$1$I$20240630$20240701$20240709$20240709$PER$$US-SA-2024SA196291$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240709$$CN$US$US
240642031$24064203$1$I$20240630$20240630$20240709$20240709$PER$$US-SA-2024SA197217$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240709$$MD$US$US
240642041$24064204$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA199326$SANOFI AVENTIS$$46$YR$A$M$Y$125$KG$20240709$$CN$US$US
240642051$24064205$1$I$20230214$20240628$20240709$20240709$PER$$US-SA-2024SA196366$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240709$$MD$US$US
240642071$24064207$1$I$$20240703$20240709$20240709$PER$$US-AstraZeneca-2024A153306$ASTRAZENECA$$$$$M$Y$$$20240709$$CN$US$
240642081$24064208$1$I$$20240701$20240709$20240709$EXP$$CA-AstraZeneca-2024A152505$ASTRAZENECA$$71$YR$$F$Y$69$KG$20240709$$MD$CA$
240642101$24064210$1$I$$20240701$20240709$20240709$EXP$$PA-AstraZeneca-2024A152581$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$PA$
240642111$24064211$1$I$$20240701$20240709$20240709$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008026$STRIDES$Hanif IH, Abdelrahim S, Al Shaarani M, Lu H, Ahmad R, Goswami S, et al.. Immune Checkpoint Therapy-Induced Lupus Nephritis.. Kidney-Int-Rep. 2024;9 (5):1534-1537$9$DEC$$M$Y$$$20240709$$HP$US$US
240642131$24064213$1$I$$20240708$20240709$20240709$PER$$US-HALEON-2185978$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240642141$24064214$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005201$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240709$$CN$US$US
240642161$24064216$1$I$$20240702$20240709$20240709$EXP$$US-GENMAB-2024-02331$GENMAB$$63$YR$$M$Y$$$20240709$$MD$US$US
240642181$24064218$1$I$$20240707$20240709$20240709$PER$$US-HALEON-2186056$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240642191$24064219$1$I$20240105$20240702$20240709$20240709$EXP$$NVSC2024GB002993$NOVARTIS$$52$YR$$F$Y$$$20240709$$CN$GB$GB
240642202$24064220$2$F$$20240906$20240709$20240912$EXP$$PHHY2017IN014240$NOVARTIS$$$$$M$Y$$$20240912$$CN$IN$IN
240642211$24064221$1$I$$20240701$20240709$20240709$EXP$$CA-TOLMAR, INC.-24CA050729$TOLMAR$$$$$M$Y$$$20240709$$CN$CA$CA
240642221$24064222$1$I$$20240701$20240709$20240709$EXP$$CA-TOLMAR, INC.-24CA050730$TOLMAR$$$$$M$Y$$$20240709$$CN$CA$CA
240642231$24064223$1$I$$20240701$20240709$20240709$EXP$$GB-EMD Serono-2024036070$EMD SERONO INC$$$$A$F$Y$$$20240709$$CN$GB$GB
240642241$24064224$1$I$$20240702$20240709$20240709$30DAY$$US-GSK-US2024083055$GLAXOSMITHKLINE$$$$$F$Y$$$20240709$$CN$US$US
240642251$24064225$1$I$$20240702$20240709$20240709$PER$$US-BIOGEN-2024BI01272286$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
240642261$24064226$1$I$20240107$20240705$20240709$20240709$EXP$GB-MHRA-MED-202406251219224260-VPSWC$GB-JNJFOC-20240715579$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240709$$MD$GB$GB
240642271$24064227$1$I$$20240628$20240709$20240709$PER$$US-ROCHE-10000017661$ROCHE$$$$$F$Y$$$20240709$$CN$US$US
240642281$24064228$1$I$$20240708$20240709$20240709$PER$$US-HALEON-2185810$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240642291$24064229$1$I$$20240706$20240709$20240709$PER$$US-HALEON-2186035$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240642302$24064230$2$F$$20240716$20240709$20240726$EXP$$US-TEVA-VS-3218564$TEVA$Calderon Barahona GM, Ali R, Ortega Giron C, Ng W, Bobrysheva H, Calderon Martinez E, et al. Beta-Blocked: A Severe Propranolol Overdose Case Report. Am-J-Respir-Crit-Care-Med 2024; 209.; Calderon Barahona GM, Ali R, Ortega Giron C, Ng W, Bobrysheva H, Calderon Martinez E, et al. Beta-Blocked: A Severe Propranolol Overdose Case Report. Am-J-Respir-Crit-Care-Med 2024; 209.$25$YR$$F$Y$$$20240726$$HP$US$US
240642311$24064231$1$I$$20240705$20240709$20240709$PER$$NVSC2024US140901$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240642321$24064232$1$I$20220317$20240625$20240709$20240709$EXP$IT-MINISAL02-991175$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-06098$HIKMA$$81$YR$$M$Y$$$20240709$$MD$IT$IT
240642331$24064233$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024133985$AMGEN$$$$$M$Y$$$20240709$$CN$US$US
240642341$24064234$1$I$$20240704$20240709$20240709$PER$$US-HETERO-HET2024US01769$HETERO$$$$$M$Y$$$20240709$$CN$US$US
240642351$24064235$1$I$$20240701$20240709$20240709$EXP$$US-AMAROX PHARMA-HET2024US02123$HETERO$Gans A, Taylor J, Goel NN. A Case of drug-induced Stevens-Johnson syndrome with primarily visceral involvement. American Thoracic Society. 2024;209:A5678$76$YR$$F$Y$$$20240709$$HP$US$US
240642361$24064236$1$I$$20240701$20240709$20240709$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP008030$STRIDES$Fabozzi F, Palumbo G, Di Pastena M, Zangari P, Bernardi S.. Prolonged neutropenia in patients with lymphoma treated with antiretroviral therapy: Raltegravir too? A single-case report.. Pediatr-Blood-Cancer. 2023;70 (4)$6$YR$$F$Y$$$20240709$$HP$IT$IT
240642372$24064237$2$F$20240101$20240708$20240709$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038611$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240709$$CN$US$US
240642382$24064238$2$F$$20240723$20240709$20240731$PER$$US-RDY-SPO/USA/24/0009325$DR REDDYS$$81$YR$E$F$Y$$$20240731$$CN$US$US
240642392$24064239$2$F$$20240716$20240709$20240726$EXP$$US-TEVA-VS-3218397$TEVA$Pattupara A, Nguyen D, Gaikwad M, Gnirke M, Yarra S, Su M, et al. Breaking the Spell: A Rare Case of Prolonged Benzodiazepine Elimination. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A5703; Pattupara A, Nguyen D, Gaikwad M, Gnirke M, Yarra S, Su M, et al. Breaking the Spell: A Rare Case of Prolonged Benzodiazepine Elimination. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A5703.$67$YR$$M$Y$$$20240726$$HP$US$US
240642401$24064240$1$I$$20240703$20240709$20240709$EXP$$GB-AMGEN-GBRSL2024133163$AMGEN$$59$YR$A$M$Y$$$20240709$$CN$GB$GB
240642411$24064241$1$I$$20240701$20240709$20240709$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007987$STRIDES$Bengio M, Goodwin G, Roka A, Marin M. Pediatric headache patient with cerebral abscesses: a brief review of the literature and case report. J-Int-Med-Res. 2023;51$12$YR$$M$Y$$$20240709$$HP$US$US
240642431$24064243$1$I$$20240705$20240709$20240709$EXP$$US-VIIV HEALTHCARE LIMITED-US2024083992$VIIV$$$$$F$Y$$$20240709$$CN$US$US
240642441$24064244$1$I$20240101$20240708$20240709$20240709$PER$$US-JNJFOC-20240720258$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240709$$CN$US$US
240642451$24064245$1$I$$20240628$20240709$20240709$PER$$US-JNJFOC-20240677997$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240709$$HP$US$US
240642461$24064246$1$I$$20240701$20240709$20240709$EXP$$BH-STRIDES ARCOLAB LIMITED-2024SP007989$STRIDES$Ghanem H, Wilson PT, Gill DS. Intravenous magnesium sulphate for treatment of pediatric migraine: case series. Signa-Vitae. 2023;19:194-200$13$YR$$F$Y$$$20240709$$HP$BH$BH
240642471$24064247$1$I$20240606$20240628$20240709$20240709$EXP$$CN-SA-2024SA197079$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240709$$HP$CN$CN
240642491$24064249$1$I$20220101$20240702$20240709$20240709$EXP$$NVSC2024IE140030$NOVARTIS$Mulkerrin G, Hennessy MJ. Nonsense mutation in DEPDC5 gene in a patient with carbamazepine-responsive focal epilepsy. EPILEPSY AND BEHAVIOR REPORTS. 2024;27:1-3$41$YR$$M$Y$$$20240709$$HP$IE$IE
240642501$24064250$1$I$$20240702$20240709$20240709$EXP$$NVSC2024TW139658$NOVARTIS$$48$YR$$F$Y$$$20240709$$MD$TW$TW
240642511$24064251$1$I$$20240703$20240709$20240709$PER$$US-BIOGEN-2024BI01271547$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
240642521$24064252$1$I$$20240708$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063494$SANDOZ$$84$YR$$F$Y$$$20240709$$CN$CA$CA
240642531$24064253$1$I$20240515$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405160857576820-FNDVS$GB-SANDOZ INC.-SDZ2024GB063552$SANDOZ$$37$YR$$F$Y$$$20240709$$CN$GB$GB
240642541$24064254$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405101132538610-LZDKT$GB-SANDOZ INC.-SDZ2024GB063644$SANDOZ$$$$$F$Y$62$KG$20240709$$CN$GB$GB
240642561$24064256$1$I$$20240708$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063513$SANDOZ$$78$YR$$F$Y$$$20240709$$HP$CA$CA
240642571$24064257$1$I$$20240704$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063361$SANDOZ$$$$$M$Y$$$20240709$$MD$CA$CA
240642583$24064258$3$F$20240621$20240823$20240709$20240829$EXP$$US-SANDOZ INC.-SDZ2024US063153$SANDOZ$$62$YR$$F$Y$64$KG$20240829$$CN$US$US
240642591$24064259$1$I$$20240701$20240709$20240709$EXP$$BH-STRIDES ARCOLAB LIMITED-2024SP007990$STRIDES$Ghanem H, Wilson PT, Gill DS. Intravenous magnesium sulphate for treatment of pediatric migraine: case series. Signa-Vitae. 2023;19:194-200$17$YR$$M$Y$$$20240709$$HP$BH$BH
240642601$24064260$1$I$20100111$20240702$20240709$20240709$EXP$$CN-ASTELLAS-2024US018740$ASTELLAS$$61$YR$$M$Y$51$KG$20240709$$HP$GB$CN
240642613$24064261$3$F$$20240806$20240709$20240902$PER$$US-ASTELLAS-2024US019085$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
240642621$24064262$1$I$20100331$20240702$20240709$20240709$EXP$$GB-ASTELLAS-2024US018759$ASTELLAS$$40$YR$$M$Y$65$KG$20240709$$HP$GB$GB
240642631$24064263$1$I$$20240708$20240709$20240709$EXP$$CN-TAKEDA-2024TUS069472$TAKEDA$Liu YC, Zhou ZK, Yi MM, Wang LJ, Shou ST, Chai FY. Colchicine poisoning: case report of three homicides in a family. Heliyon. 2024;10(11):e32407$68$YR$$F$Y$$$20240709$$MD$CN$CN
240642643$24064264$3$F$20240705$20240808$20240709$20240813$PER$$US-AMGEN-USASP2024134806$AMGEN$$80$YR$E$F$Y$$$20240813$$CN$US$US
240642651$24064265$1$I$20240510$20240701$20240709$20240709$EXP$$JP-009507513-2405JPN000882J$MERCK$$6$DEC$$M$Y$$$20240709$$PH$JP$JP
240642663$24064266$3$F$20240501$20240909$20240709$20240920$EXP$$US-ASTELLAS-2024US018904$ASTELLAS$$63$YR$A$F$Y$$$20240920$$HP$US$US
240642671$24064267$1$I$20210101$20240701$20240709$20240709$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP007996$STRIDES$Schumaier NP, Heidemann DG, Gupta C.. Durvalumab-associated limbal stem cell deficiency and secondary corneal perforation.. Am-J-Ophthalmol-Case-Rep. 2024;35$7$DEC$$M$Y$$$20240709$$HP$US$US
240642681$24064268$1$I$$20240630$20240709$20240709$EXP$$CN-MYLANLABS-2024M1062719$MYLAN$Wang F, Lv Z. A patient suffered a second myocardial infarction after a bee sting: a case report. J-Int-Med-Res 2024; 52 (6).$7$DEC$$M$Y$$$20240709$$HP$CN$CN
240642691$24064269$1$I$$20240708$20240709$20240709$EXP$$CN-VANTIVE-2024VAN018217$Vantive US Healthcare$$$$$F$Y$$$20240709$$CN$CN$CN
240642701$24064270$1$I$20240318$20240708$20240709$20240709$EXP$FR-AFSSAPS-BX2024001332$NVSC2024FR140793$NOVARTIS$$61$YR$$M$Y$66$KG$20240709$$MD$FR$FR
240642711$24064271$1$I$20230604$20230607$20240709$20240709$PER$$US-CIPLA LTD.-2023US03208$CIPLA$$$$$$Y$$$20240709$$HP$US$US
240642721$24064272$1$I$$20240702$20240709$20240709$PER$$US-ROCHE-10000019586$ROCHE$$45$YR$A$F$Y$$$20240709$$CN$US$US
240642731$24064273$1$I$$20231012$20240709$20240709$PER$$US-CIPLA LTD.-2023US06541$CIPLA$$$$$$Y$$$20240709$$CN$US$US
240642741$24064274$1$I$$20240630$20240709$20240709$EXP$$US-HETERO-HET2024US02212$HETERO$Morcate L, Sanders I, Chen KC, Galavis YS, Villarroya-Marquina I, Makkoukdji N et.al.. Nonsexual Genital Ulcers Secondary to Epstein-Barr Virus in a Pediatric Patient. Journal of Pediatric Health Care. 2024;00:1-7$14$YR$$F$Y$$$20240709$$MD$US$US
240642752$24064275$2$F$$20240729$20240709$20240809$PER$$US-AstraZeneca-2024A148034$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
240642761$24064276$1$I$20240501$20240702$20240709$20240709$PER$$US-SA-2024SA198602$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240709$$MD$US$US
240642773$24064277$3$F$20240522$20240730$20240709$20240802$30DAY$$US-JNJFOC-20240674268$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$HP$US$US
240642781$24064278$1$I$$20240701$20240709$20240709$EXP$$US-HETERO-HET2024US02126$HETERO$Simpson M, Awuah KF, Patel D, Ogline O, Pratapneni S, Disilvio BE. Early Extra Corporeal Membrane Oxygenation (ECMO) and Esophagogastroduodenoscopy (EGD) Implementation: A Timely Intervention in a Patient With Extended-Release Bupropion Overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5672$41$YR$$M$Y$$$20240709$$HP$US$US
240642792$24064279$2$F$20240628$20240823$20240709$20240903$PER$$US-AstraZeneca-2024A151462$ASTRAZENECA$$67$YR$$F$Y$$$20240903$$CN$US$
240642811$24064281$1$I$$20240702$20240709$20240709$EXP$$GB-MSNLABS-2024MSNSPO01490$MSN LABORATORIES$$$$$$Y$$$20240709$$MD$GB$GB
240642821$24064282$1$I$20240618$20240702$20240709$20240709$EXP$$CA-TAKEDA-2024TUS067374$TAKEDA$$34$YR$$F$Y$$$20240709$$CN$CA$CA
240642831$24064283$1$I$$20240626$20240709$20240709$EXP$$US-NEBO-661392$PHARMACOSMOS$$$$$F$Y$$$20240709$$HP$US$US
240642841$24064284$1$I$$20240707$20240709$20240709$PER$$NVSC2024US141161$NOVARTIS$$$$$$Y$$$20240709$$CN$US$US
240642851$24064285$1$I$$20240705$20240709$20240709$PER$$US-HALEON-2185705$Haleon PLC$$$$$M$Y$$$20240709$$CN$US$US
240642861$24064286$1$I$20240629$20240707$20240709$20240709$EXP$$CN-ORGANON-O2407CHN000754$ORGANON$$6$YR$$F$Y$25$KG$20240709$$HP$CN$CN
240642871$24064287$1$I$20230601$20240704$20240709$20240709$EXP$$PE-AMGEN-PERSL2024119678$AMGEN$$79$YR$E$F$Y$$$20240709$$CN$PE$PE
240642881$24064288$1$I$20240701$20240702$20240709$20240709$30DAY$$US-GSK-US2024083102$GLAXOSMITHKLINE$$$$$F$Y$$$20240709$$CN$US$US
240642892$24064289$2$F$$20240709$20240709$20240711$PER$$US-JNJFOC-20240721205$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240642901$24064290$1$I$20240620$20240703$20240709$20240709$EXP$$BR-JNJFOC-20240713391$JOHNSON AND JOHNSON$$16$YR$T$$Y$48$KG$20240709$$CN$BR$BR
240642911$24064291$1$I$20240624$20240702$20240709$20240709$EXP$GB-MHRA-MED-202407021416012270-JCRSH$GB-RDY-SPO/GBR/24/0009733$DR REDDYS$$72$YR$E$F$Y$$$20240709$$MD$GB$GB
240642921$24064292$1$I$20240703$20240703$20240709$20240709$PER$$US-AMGEN-USASP2024133652$AMGEN$$75$YR$E$M$Y$$$20240709$$PH$US$US
240642931$24064293$1$I$20240501$20240625$20240709$20240709$EXP$$US-BAYER-2024A077986$BAYER$$73$YR$E$M$Y$$$20240709$$CN$US$US
240642941$24064294$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004138$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240709$$MD$US$US
240642951$24064295$1$I$$20240704$20240709$20240709$EXP$SG-SA-SAC20240705000951$SG-SA-2024SA199499$SANOFI AVENTIS$$$$$M$Y$$$20240709$$HP$SG$SG
240642961$24064296$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005209$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240709$$CN$US$US
240642971$24064297$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA196319$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240709$$CN$US$US
240642981$24064298$1$I$$20240701$20240709$20240709$EXP$$US-MYLANLABS-2024M1062584$MYLAN$Stratman S, Zhou L, Kim RH, Phelps RG, Glickman J, Mikhaylov D, et al. Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic symptoms. JAAD-Case-Rep 2024; 49 36-39.$77$YR$$F$Y$$$20240709$$MD$US$US
240642991$24064299$1$I$20240601$20240630$20240709$20240709$PER$$US-SA-2024SA196459$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240643001$24064300$1$I$$20240703$20240709$20240709$EXP$$NVSJ2024JP008164$NOVARTIS$$49$YR$$M$Y$$$20240709$$MD$JP$JP
240643011$24064301$1$I$20240101$20240701$20240709$20240709$PER$$US-SA-2024SA198608$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240709$$MD$US$US
240643021$24064302$1$I$20240626$20240627$20240709$20240709$PER$$US-SA-2024SA194804$SANOFI AVENTIS$$52$YR$A$F$Y$68.934$KG$20240709$$MD$US$US
240643031$24064303$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA199156$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240709$$MD$US$US
240643042$24064304$2$F$20240705$20240709$20240709$20240710$PER$$US-AMGEN-USASP2024135191$AMGEN$$52$YR$A$M$Y$$$20240710$$CN$US$US
240643051$24064305$1$I$20220428$20240626$20240709$20240709$EXP$$US-COOPERSURGICAL, INC.-2024CPS002012$COOPERSURGICAL$$$$$F$Y$$$20240709$$LW$US$US
240643061$24064306$1$I$20230512$20240626$20240709$20240709$EXP$$US-COOPERSURGICAL, INC.-2024CPS002013$COOPERSURGICAL$$$$$F$Y$$$20240709$$LW$US$US
240643071$24064307$1$I$20170520$20240626$20240709$20240709$EXP$$US-COOPERSURGICAL, INC.-2024CPS002026$COOPERSURGICAL$$$$$F$Y$$$20240709$$LW$US$US
240643081$24064308$1$I$20180301$20240626$20240709$20240709$EXP$$US-COOPERSURGICAL, INC.-2024CPS002027$COOPERSURGICAL$$$$$F$Y$$$20240709$$LW$US$US
240643091$24064309$1$I$20150601$20240626$20240709$20240709$EXP$$US-COOPERSURGICAL, INC.-2024CPS002030$COOPERSURGICAL$$$$$F$Y$$$20240709$$LW$US$US
240643101$24064310$1$I$20130701$20240626$20240709$20240709$EXP$$US-COOPERSURGICAL, INC.-2024CPS002036$COOPERSURGICAL$$$$$F$Y$$$20240709$$LW$US$US
240643111$24064311$1$I$20160601$20240626$20240709$20240709$EXP$$US-COOPERSURGICAL, INC.-2024CPS002034$COOPERSURGICAL$$$$$F$Y$$$20240709$$LW$US$US
240643122$24064312$2$F$20240201$20240711$20240709$20240720$EXP$$GB-TEVA-VS-3215984$TEVA$$31$YR$$F$Y$76$KG$20240720$$CN$GB$GB
240643132$24064313$2$F$$20240812$20240709$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06324$LUPIN$$$$$$Y$$$20240901$$CN$US$US
240643141$24064314$1$I$20240601$20240703$20240709$20240709$EXP$GB-MHRA-MED-202407021249159180-LHKWS$GB-MSNLABS-2024MSNSPO01509$MSN LABORATORIES$$$$$$Y$$$20240709$$HP$GB$GB
240643151$24064315$1$I$$20240701$20240709$20240709$EXP$$IN-MYLANLABS-2024M1063132$MYLAN$Bishnoi K, Agrawal K, Mishra SK, Purkait S. Uncommon Site of Metastasis: A Case Report of Breast Carcinoma Spreading to the Pancreas. Indian-J-Nucl-Med 2024; 39 (2): 120-122.$5$DEC$$F$Y$$$20240709$$MD$IN$IN
240643161$24064316$1$I$20210101$20240701$20240709$20240709$EXP$$US-MYLANLABS-2024M1062923$MYLAN$Schumaier NP, Heidemann DG, Gupta C. Durvalumab-associated limbal stem cell deficiency and secondary corneal perforation. Am-J-Ophthalmol-Case-Rep 2024; 35.$65$YR$$M$Y$$$20240709$$HP$US$US
240643181$24064318$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47301$$FDA-CTU$$88$YR$$M$N$$$20240708$N$$US$
240643191$24064319$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47401$$FDA-CTU$$72$YR$$M$N$$$20240708$N$$US$
240643201$24064320$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47383$$FDA-CTU$$77$YR$$M$N$$$20240708$N$$US$
240643211$24064321$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47343$$FDA-CTU$$68$YR$$F$N$128.82$KG$20240708$N$$US$
240643226$24064322$6$F$20240702$20240814$20240709$20240822$30DAY$$US-JNJFOC-20240706109$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240822$$HP$US$US
240643235$24064323$5$F$20240705$20240808$20240709$20240812$30DAY$$US-JNJFOC-20240719661$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240812$$CN$US$US
240643242$24064324$2$F$$20240819$20240709$20240821$EXP$$NVSC2024DE140837$NOVARTIS$$$$A$F$Y$$$20240821$$MD$DE$DE
240643261$24064326$1$I$$20240705$20240709$20240709$EXP$$AU-JNJFOC-20240715085$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$AU$AU
240643272$24064327$2$F$20240101$20240708$20240709$20240712$PER$$US-AMGEN-USASP2024135194$AMGEN$$67$YR$E$M$Y$$$20240711$$CN$US$US
240643281$24064328$1$I$$20240626$20240709$20240709$EXP$$IT-MACLEODS PHARMA-MAC2024047996$MACLEODS$$$$$$Y$$$20240709$$MD$IT$IT
240643291$24064329$1$I$$20240626$20240709$20240709$EXP$$DE-MACLEODS PHARMA-MAC2024047997$MACLEODS$$$$$$Y$$$20240709$$MD$DE$DE
240643301$24064330$1$I$$20240626$20240709$20240709$EXP$$SI-MACLEODS PHARMA-MAC2024048008$MACLEODS$Trampuz BV.ELECTROLYTE DISORDERS IN THE EMERGENCY DEPARTMENT ? CLINICAL CASES AND EMERGENCY TREATMENT.Urgentna Medicina - Izbrana Poglavja.2024;142-6$$$$$Y$$$20240709$$MD$SI$SI
240643312$24064331$2$F$$20240710$20240709$20240722$EXP$$ZA-MACLEODS PHARMA-MAC2024048029$MACLEODS$$$$$$Y$$$20240722$$CN$ZA$ZA
240643322$24064332$2$F$20240416$20240711$20240709$20240724$EXP$$US-MACLEODS PHARMA-MAC2024048031$MACLEODS$$$$$$Y$$$20240724$$CN$US$US
240643331$24064333$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000020073$ROCHE$$$$A$F$Y$$$20240709$$CN$US$US
240643341$24064334$1$I$$20240703$20240709$20240709$EXP$US-MLMSERVICE-20240626-PI113039-00200-1$US-RDY-SPO/USA/24/0009846$DR REDDYS$Khan MS, Ahmed O, Nwaedozie S. Anaconda Right Coronary Artery. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(Suppl 1). DOI:10.1161/atvb.43.suppl_1.442.$61$YR$A$M$Y$$$20240709$$MD$US$US
240643352$24064335$2$F$20240621$20240828$20240709$20240905$EXP$$CA-CELLTRION INC.-2024CA016533$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
240643361$24064336$1$I$$20240626$20240709$20240709$EXP$$IN-MACLEODS PHARMA-MAC2024048011$MACLEODS$Chandrakar Y..Unforeseen complication of tramadol administration: A case report.Asian Journal of Pharmaceutical and Clinical Research.2024;17(6):1-2$$$$$Y$$$20240709$$MD$IN$IN
240643372$24064337$2$F$$20240703$20240709$20240711$EXP$$HU-MYLANLABS-2024M1062912$MYLAN$$65$YR$$M$Y$$$20240711$$MD$HU$HU
240643381$24064338$1$I$20240521$20240703$20240709$20240709$EXP$FR-AFSSAPS-TS2024000748$FR-MYLANLABS-2024M1062993$MYLAN$$68$YR$$M$Y$$$20240709$$MD$FR$FR
240643391$24064339$1$I$$20240703$20240709$20240709$EXP$IT-MINISAL02-992676$IT-MYLANLABS-2024M1062435$MYLAN$$47$YR$$M$Y$95$KG$20240709$$CN$IT$IT
240643401$24064340$1$I$$20240702$20240709$20240709$PER$$US-ROCHE-10000020726$ROCHE$$$$A$M$Y$$$20240709$$CN$US$US
240643412$24064341$2$F$$20240708$20240709$20240711$PER$$US-JNJFOC-20240718339$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240643423$24064342$3$F$20240705$20240710$20240709$20240714$PER$$US-AMGEN-USASP2024135229$AMGEN$$72$YR$E$F$Y$$$20240714$$MD$US$US
240643431$24064343$1$I$$20240625$20240709$20240709$PER$$FR-APOTEX-2024AP007849$APOTEX$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al.. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. Journal of Clinical Immunology. 2023;43 (3):647-652$$$A$M$Y$$$20240709$$HP$FR$US
240643442$24064344$2$F$20240705$20240806$20240709$20240926$EXP$$CA-ABBVIE-5831007$ABBVIE$$66$YR$$M$Y$$$20240926$$MD$CA$CA
240643453$24064345$3$F$20240626$20240923$20240709$20240927$EXP$$NVSC2024AT140786$NOVARTIS$$56$YR$$M$Y$$$20240927$$CN$AT$AT
240643461$24064346$1$I$20180101$20240624$20240709$20240709$EXP$$NL-TEVA-VS-3214894$TEVA$van Weringh G, van Koolwijk L, Haan LD, Touw DJ, de Koning MB. Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/norclozapine ratio after switching valproic acid to carbamazepine: a case report. Therap-Adv-Psychopharmacol 2024; 14 (0):.$39$YR$$M$Y$65.9$KG$20240709$$HP$NL$NL
240643471$24064347$1$I$20240603$20240708$20240709$20240709$EXP$FR-AFSSAPS-AN2024000837$NVSC2024FR140796$NOVARTIS$$66$YR$$M$Y$81$KG$20240709$$MD$FR$FR
240643481$24064348$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A151042$ASTRAZENECA$$$$$F$Y$142$KG$20240709$$CN$US$
240643491$24064349$1$I$$20240701$20240709$20240709$EXP$$ZA-AstraZeneca-2024A152480$ASTRAZENECA$$48$YR$$F$Y$$$20240709$$CN$ZA$
240643501$24064350$1$I$$20240701$20240709$20240709$EXP$$CA-AstraZeneca-2024A152513$ASTRAZENECA$$50$YR$$F$Y$$$20240709$$MD$CA$
240643514$24064351$4$F$20240101$20240822$20240709$20240830$EXP$$FR-ABBVIE-5828357$ABBVIE$$78$YR$$M$Y$$$20240830$$HP$FR$FR
240643522$24064352$2$F$$20240708$20240709$20240718$EXP$GB-MHRA-MED-202406281421496220-GBHVJ$GB-Accord-433427$ACCORD$$$$$$Y$$$20240718$$CN$GB$GB
240643531$24064353$1$I$$20240627$20240709$20240709$EXP$DE-BFARM-24004574$DE-Accord-433275$ACCORD$$$$$F$Y$$$20240709$$CN$DE$DE
240643541$24064354$1$I$20240430$20240627$20240709$20240709$EXP$ES-AEMPS-1540249$ES-Accord-433292$ACCORD$$83$YR$E$F$Y$$$20240709$$HP$ES$ES
240643551$24064355$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281457303540-MZPCV$GB-Accord-433483$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240643561$24064356$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281042408830-QRLPK$GB-Accord-433412$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240643571$24064357$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281432034530-LJZCK$GB-Accord-433234$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240643581$24064358$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281053549520-RCDFK$GB-Accord-433364$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240643591$24064359$1$I$$20240627$20240709$20240709$EXP$IT-EMA-2022911-AUTODUP-1662925104411$IT-Accord-286363$ACCORD$$45$YR$A$F$Y$$$20240709$$HP$IT$IT
240643601$24064360$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406280003484410-MPGTC$GB-Accord-433383$ACCORD$$$$$F$Y$$$20240709$$CN$GB$GB
240643612$24064361$2$F$$20240729$20240709$20240806$EXP$$CN-AstraZeneca-2024A153382$ASTRAZENECA$$$$$$Y$$$20240806$$MD$CN$
240643621$24064362$1$I$20240626$20240703$20240709$20240709$EXP$$US-ABBVIE-5829163$ABBVIE$$60$YR$$F$Y$$$20240709$$CN$US$US
240643631$24064363$1$I$20240424$20240701$20240709$20240709$EXP$$GB-AstraZeneca-2024A154499$ASTRAZENECA$$28375$DY$$M$Y$76$KG$20240709$$HP$GB$
240643642$24064364$2$F$20230801$20240705$20240709$20240711$EXP$$CZ-MYLANLABS-2024M1062542$MYLAN$Fenclova NS, Kacer M. Eculizumab in the treatment of DITMA in a patient with pancreatic adenocarcinoma. POSTGRADUALNI NEFROLOGIE. 2024;22(2):31-33$62$YR$$F$Y$$$20240711$$MD$CZ$CZ
240643652$24064365$2$F$$20240712$20240709$20240722$EXP$$IT-MYLANLABS-2024M1062886$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. European Journal of Haematology. 2024;113 (1):90-98$16$YR$$M$Y$$$20240722$$HP$IT$IT
240643661$24064366$1$I$$20240627$20240709$20240709$EXP$$US-PROCTER+GAMBLE-PH24005397$PROCTER AND GAMBLE$Aversa V, Hawa R, Lee E.K, Mak M.S.B. C-L Case Conference: Insomnia Disorder. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65:293-301$67$YR$$M$Y$$$20240709$$HP$US$US
240643671$24064367$1$I$$20240703$20240709$20240709$EXP$$US-MYLANLABS-2024M1063755$MYLAN$Hammond TC, Emeruwa I, Swain SR, Larson SM, Castells MC. Life-threatening Mast Cell Activation and Anaphylaxis in Mast Cell Leukemia and the Role of Omalizumab. Am-J-Respir-Crit-Care-Med 2024; 209.$31$YR$$M$Y$$$20240709$$HP$US$US
240643688$24064368$8$F$20240101$20240820$20240709$20240830$EXP$$IE-ABBVIE-5752440$ABBVIE$$73$YR$$F$Y$$$20240829$$CN$IE$IE
240643691$24064369$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA199284$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240709$$MD$US$US
240643702$24064370$2$F$20240627$20240717$20240709$20240724$PER$$US-SA-2024SA193666$SANOFI AVENTIS$$6$YR$C$M$Y$17.8$KG$20240724$$MD$US$US
240643711$24064371$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA198687$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240709$$MD$US$US
240643722$24064372$2$F$$20240730$20240709$20240807$PER$$US-SA-2024SA193670$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240807$$CN$US$US
240643731$24064373$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA195007$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240709$$MD$US$US
240643741$24064374$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA198799$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240709$$MD$US$US
240643751$24064375$1$I$20240416$20240705$20240708$20240708$DIR$FDA-CDER-CTU-2024-47299$$FDA-CTU$$26$YR$$F$N$$$20240705$N$HP$US$
240643771$24064377$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA196543$SANOFI AVENTIS$$$$E$M$Y$81.646$KG$20240709$$MD$US$US
240643781$24064378$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47356$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240643791$24064379$1$I$20240101$20240627$20240709$20240709$PER$$US-SA-2024SA193796$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240709$$MD$US$US
240643801$24064380$1$I$20240601$20240701$20240709$20240709$PER$$US-SA-2024SA196537$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240709$$MD$US$US
240643811$24064381$1$I$$20240705$20240709$20240709$PER$$US-ROCHE-10000019140$ROCHE$$$$$$Y$$$20240709$$PH$US$US
240643821$24064382$1$I$$20240705$20240709$20240709$PER$$US-ROCHE-10000019569$ROCHE$$$$$$Y$$$20240709$$HP$US$US
240643831$24064383$1$I$$20240705$20240709$20240709$EXP$$CA-TAKEDA-2024TUS069119$TAKEDA$$9$YR$$M$Y$$$20240709$$HP$CA$CA
240643842$24064384$2$F$$20240708$20240709$20240710$EXP$$CA-BAUSCH-BL-2024-010446$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240710$$CN$CA$CA
240643851$24064385$1$I$20240211$20240624$20240709$20240709$EXP$FR-AFSSAPS-NT2024000750$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-108982$ZYDUS PHARM$$$$$$Y$$$20240709$$MD$FR$FR
240643861$24064386$1$I$20240505$20240612$20240709$20240709$EXP$$CL-GSK-CL2024AMR082757$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$CL$CL
240643871$24064387$1$I$$20240625$20240709$20240709$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109029$ZYDUS PHARM$Jamison T, Kantarjian HM, Paul S, Cuglievan B, McCall D, Jain N, et al.. ^Dose-Dense^ Mini-Hyper- CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves High Rates of Rapid MRD-Negativity in Patients with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia: A Retrospective Analysis.. Blood. 2023;142 (Suppl. 1):1508$$$$$Y$$$20240709$$MD$US$US
240643881$24064388$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134913$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240643891$24064389$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141611$NOVARTIS$$$$$M$Y$$$20240709$$PH$US$US
240643901$24064390$1$I$$20240704$20240709$20240709$EXP$$GB-AMGEN-GBRSP2024134149$AMGEN$$$$$M$Y$$$20240709$$CN$GB$GB
240643911$24064391$1$I$$20240704$20240709$20240709$EXP$$JP-EXELIXIS-CABO-24079204$EXELIXIS$$67$YR$$M$Y$$$20240709$$MD$JP$JP
240643921$24064392$1$I$$20240626$20240709$20240709$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06114$HIKMA$$$$$M$Y$$$20240709$$CN$US$US
240643931$24064393$1$I$20240401$20240701$20240709$20240709$EXP$IT-MINISAL02-991734$IT-TEVA-VS-3216174$TEVA$$63$YR$$M$Y$$$20240709$$MD$IT$IT
240643942$24064394$2$F$20230908$20240924$20240709$20240930$EXP$$IT-EXELIXIS-XL18423068641$EXELIXIS$$$$$$Y$$$20240930$$MD$IT$IT
240643953$24064395$3$F$$20240812$20240709$20240813$PER$$US-AMGEN-USASP2024134391$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
240643961$24064396$1$I$20240417$20240704$20240709$20240709$EXP$$JP-ASTELLAS-2024JP004677$ASTELLAS$$78$YR$$F$Y$64$KG$20240709$$HP$JP$JP
240643981$24064398$1$I$$20240702$20240709$20240709$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005010$BIOCON$$$$$$Y$$$20240709$$HP$CA$CA
240643993$24064399$3$F$20240101$20240904$20240709$20240924$EXP$$US-SA-2024SA196810$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240924$$CN$US$US
240644003$24064400$3$F$$20240825$20240709$20240902$EXP$$JP-GENMAB-2024-02368$GENMAB$$62$YR$$M$Y$$$20240902$$MD$JP$JP
240644012$24064401$2$F$$20240703$20240709$20240711$PER$$US-ROCHE-10000020292$ROCHE$$50$YR$A$F$Y$$$20240711$$MD$US$US
240644021$24064402$1$I$$20240708$20240709$20240709$PER$$US-HALEON-2186045$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240644031$24064403$1$I$$20240708$20240709$20240709$PER$$US-TAKEDA-2024TUS069552$TAKEDA$$$$$F$Y$$$20240709$$PH$US$US
240644041$24064404$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47442$$FDA-CTU$$17$YR$$M$N$40.37$KG$20240708$N$$US$
240644051$24064405$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47309$$FDA-CTU$$17$YR$$F$N$63.5$KG$20240708$N$HP$US$
240644061$24064406$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47334$$FDA-CTU$$46$YR$$M$N$97.98$KG$20240708$N$$US$
240644081$24064408$1$I$20230913$20240704$20240709$20240709$EXP$$FR-MYLANLABS-2024M1062693$MYLAN$$52$YR$$M$Y$$$20240709$$MD$FR$FR
240644091$24064409$1$I$$20240702$20240709$20240709$EXP$$US-AMERICAN REGENT INC-2024002569$AMERICAN REGENT$Hashmi N, Basaleli C, Gupta S, John G, Birnbaum B, Kim U, et al.. Acute eosinophilic pneumonia in the setting of intramuscular progesterone usage. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6397[abstract]$33$YR$$F$Y$$$20240709$$HP$US$US
240644101$24064410$1$I$20230528$20240704$20240709$20240709$EXP$$CO-UCBSA-2024034463$UCB$$91$YR$$F$Y$$$20240709$$CN$CO$CO
240644112$24064411$2$F$20240706$20240717$20240709$20240718$EXP$$US-BAUSCH-BL-2024-010468$BAUSCH AND LOMB$$86$YR$$M$Y$$$20240718$$CN$US$US
240644121$24064412$1$I$20240101$20240704$20240709$20240709$EXP$$CA-ABBVIE-5831473$ABBVIE$$$$E$F$Y$$$20240709$$CN$CA$CA
240644131$24064413$1$I$20240430$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405111547264380-ZDQLF$GB-ORGANON-O2407GBR000536$ORGANON$$69$YR$$$Y$$$20240709$$CN$GB$GB
240644141$24064414$1$I$$20240708$20240709$20240709$EXP$$NVSC2024US141285$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240644152$24064415$2$F$$20240716$20240709$20240726$EXP$$IT-TEVA-VS-3215305$TEVA$Munari S, Ciotti G, Cestaro W, Corsi L, Tonin S, Ballarin A, et al. Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review. Drugs-Cont 2024; 13 1-11; Munari S, Ciotti G, Cestaro W, Corsi L, Tonin S, Ballarin A, et al. Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature...$64$YR$$F$Y$$$20240726$$HP$IT$IT
240644161$24064416$1$I$$20240708$20240709$20240709$EXP$$US-BAUSCH-BL-2024-010470$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240709$$CN$US$US
240644171$24064417$1$I$20240620$20240701$20240709$20240709$EXP$GB-MHRA-MED-202407010811065940-JBQDH$GB-TEVA-VS-3216004$TEVA$$69$YR$$M$Y$96$KG$20240709$$CN$GB$GB
240644181$24064418$1$I$$20240628$20240709$20240709$PER$$US-JNJFOC-20240704231$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240644191$24064419$1$I$$20240702$20240709$20240709$EXP$$US-GSK-US2024083069$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$US$US
240644201$24064420$1$I$$20240628$20240709$20240709$EXP$$CN-ASTELLAS-2024US019199$ASTELLAS$$55$YR$$F$Y$$$20240709$$CN$CH$CN
240644211$24064421$1$I$$20240627$20240709$20240709$EXP$$IT-ASTELLAS-2024US019306$ASTELLAS$$$$$F$Y$$$20240709$$CN$CH$IT
240644221$24064422$1$I$$20240627$20240709$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202407001073$ELI LILLY AND CO$$$$$$Y$$$20240709$$CN$US$US
240644231$24064423$1$I$$20240627$20240709$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019747$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240709$$CN$US$US
240644241$24064424$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005291$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240709$$CN$US$US
240644252$24064425$2$F$20240101$20240709$20240709$20240712$PER$$US-AMGEN-USASP2024134830$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240644261$24064426$1$I$$20240703$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004501$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240709$$CN$US$US
240644271$24064427$1$I$20240301$20240627$20240709$20240709$EXP$GB-MHRA-MED-202406261706552920-KCSRB$GB-ELI_LILLY_AND_COMPANY-GB202406018755$ELI LILLY AND CO$$$$$F$Y$97$KG$20240709$$CN$GB$GB
240644281$24064428$1$I$$20240627$20240709$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000552$ELI LILLY AND CO$$$$$M$Y$$$20240709$$CN$US$US
240644291$24064429$1$I$$20240627$20240709$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000195$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240709$$CN$US$US
240644301$24064430$1$I$$20240627$20240709$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019113$ELI LILLY AND CO$$$$$F$Y$$$20240709$$CN$US$US
240644311$24064431$1$I$$20240627$20240709$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000300$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240709$$CN$US$US
240644321$24064432$1$I$$20240702$20240709$20240709$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202407003424$ELI LILLY AND CO$$$$$M$Y$$$20240709$$CN$AE$AE
240644331$24064433$1$I$20240705$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004102$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240709$$CN$US$US
240644341$24064434$1$I$20230501$20240628$20240709$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000270$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240709$$CN$US$US
240644351$24064435$1$I$$20240701$20240709$20240709$EXP$$SY-STRIDES ARCOLAB LIMITED-2024SP007999$STRIDES$Khalayli N, Ibrahim R, Kudsi M.. Antineutrophil cytoplasmic antibody-associated vasculitis with systemic sclerosis: A fatal case report.. Ann-Med-Surgery. 2023;85 (11):5770-5775$8$DEC$$F$Y$$$20240709$$MD$SY$SY
240644401$24064440$1$I$20240416$20240701$20240709$20240709$EXP$ES-AEMPS-1539461$ES-BAXTER-2024BAX020945$BAXTER$$71$YR$$F$Y$$$20240709$$MD$ES$ES
240644412$24064441$2$F$$20240717$20240709$20240726$EXP$HU-EMA-DD-20240626-7482689-073756$HU-BAXTER-2024BAX021053$BAXTER$$46$YR$$M$Y$$$20240726$$MD$HU$HU
240644421$24064442$1$I$$20240628$20240709$20240709$PER$$US-JNJFOC-20240704228$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240644431$24064443$1$I$$20240624$20240709$20240709$EXP$$US-BAXTER-2024BAX020586$BAXTER$$$$$F$Y$$$20240709$$MD$US$US
240644441$24064444$1$I$20220203$20240701$20240709$20240709$EXP$$JP-ROCHE-10000017436$ROCHE$Ogata A, Igusa R, Inoue N, Komuro H, Itakura K, Sato K et al.. PP377 A retrospective study of carboplatin+paclitaxe-+bevacizumab+atezolizumab therapy for stage IV non-small cell carcinoma. The 64th Annual Meeting of the Japanese Respiratory Society. 2024$69$YR$E$M$Y$46.9$KG$20240709$$MD$JP$JP
240644451$24064445$1$I$$20240708$20240709$20240709$PER$$US-ROCHE-10000020944$ROCHE$$$$$$Y$$$20240709$$CN$US$US
240644461$24064446$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135124$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240644472$24064447$2$F$20240703$20240725$20240709$20240729$PER$$US-AMGEN-USASP2024135261$AMGEN$$72$YR$E$M$Y$$$20240728$$CN$US$US
240644482$24064448$2$F$$20240724$20240709$20240816$PER$$US-TOLMAR, INC.-24US050125$TOLMAR$$$$$M$Y$$$20240816$$HP$US$US
240644492$24064449$2$F$20240607$20240722$20240709$20240816$PER$$US-TOLMAR, INC.-24US050094$TOLMAR$$76$YR$$M$Y$$$20240816$$PH$US$US
240644501$24064450$1$I$20240611$20240612$20240709$20240709$PER$$US-TOLMAR, INC.-24US050150$TOLMAR$$64$YR$$F$Y$$$20240709$$HP$US$US
240644512$24064451$2$F$20240612$20240723$20240709$20240820$PER$$US-TOLMAR, INC.-24US050180$TOLMAR$$$$$F$Y$$$20240813$$HP$US$US
240644522$24064452$2$F$20240612$20240724$20240709$20240816$PER$$US-TOLMAR, INC.-24US050181$TOLMAR$$69$YR$$M$Y$$$20240816$$HP$US$US
240644533$24064453$3$F$20240628$20240718$20240709$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020001$UNITED THERAPEUTICS$$46$YR$$F$Y$67.12$KG$20240726$$MD$US$US
240644542$24064454$2$F$20240610$20240724$20240709$20240816$PER$$US-TOLMAR, INC.-24US050182$TOLMAR$$75$YR$$M$Y$$$20240816$$PH$US$US
240644552$24064455$2$F$20240101$20240621$20240709$20240716$PER$$US-TOLMAR, INC.-24US050195$TOLMAR$$$$$F$Y$$$20240716$$HP$US$US
240644561$24064456$1$I$20240610$20240613$20240709$20240709$PER$$US-TOLMAR, INC.-24US050209$TOLMAR$$$$$M$Y$$$20240709$$PH$US$US
240644571$24064457$1$I$$20240614$20240709$20240709$PER$$US-TOLMAR, INC.-24US050200$TOLMAR$$$$$M$Y$$$20240709$$HP$US$US
240644581$24064458$1$I$20240617$20240701$20240709$20240709$EXP$$US-BAYER-2024A091511$BAYER$$60$YR$A$F$Y$$$20240709$$CN$US$US
240644591$24064459$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A151086$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240644601$24064460$1$I$$20240703$20240709$20240709$30DAY$$US-GSK-US2024083142$GLAXOSMITHKLINE$$$$$F$Y$$$20240709$$CN$US$US
240644611$24064461$1$I$$20240703$20240709$20240709$EXP$$US-GSK-US2024082631$GLAXOSMITHKLINE$$$$$F$Y$$$20240709$$CN$US$US
240644621$24064462$1$I$20240630$20240702$20240709$20240709$EXP$$US-SA-2024SA200078$SANOFI AVENTIS$$61$YR$A$F$Y$69.3$KG$20240709$$MD$US$US
240644631$24064463$1$I$$20240704$20240709$20240709$EXP$$CO-UCBSA-2024034556$UCB$$$$$F$Y$$$20240709$$CN$CO$CO
240644641$24064464$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA199124$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240709$$CN$US$US
240644651$24064465$1$I$20211101$20240701$20240709$20240709$PER$$US-SA-2024SA197900$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240709$$MD$US$US
240644662$24064466$2$F$20230101$20240715$20240709$20240722$EXP$$US-MYLANLABS-2024M1062084$MYLAN$$$$$F$Y$126.55$KG$20240722$$CN$US$US
240644671$24064467$1$I$20240703$20240703$20240709$20240709$PER$$US-SA-2024SA199183$SANOFI AVENTIS$$33$YR$A$F$Y$70.9$KG$20240709$$CN$US$US
240644681$24064468$1$I$$20240627$20240709$20240709$EXP$$JP-AJANTA-2024AJA00121$AJANTA PHARMA$Sakurazawa C, Habuka M, Hoshino Y, Sakamaki Y, Ogawa A, Yamamoto S et.al.A case of multiorgan failure due to carbamazepine intoxication successfully treated with multimodal blood purification therapy..CEN Case Reports.18-JUN-2024$47$YR$A$F$Y$$$20240709$$HP$JP$JP
240644691$24064469$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA198811$SANOFI AVENTIS$$18$YR$A$F$Y$76.2$KG$20240709$$MD$US$US
240644701$24064470$1$I$20240618$20240701$20240709$20240709$PER$$US-SA-2024SA198973$SANOFI AVENTIS$$61$YR$A$F$Y$151$KG$20240709$$MD$US$US
240644711$24064471$1$I$$20240702$20240709$20240709$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004986$BIOCON$$$$$$Y$$$20240709$$MD$CA$CA
240644724$24064472$4$F$20240627$20240916$20240709$20240923$EXP$$US-BAYER-2024A095200$BAYER$$3$YR$C$M$Y$15.42$KG$20240923$$HP$US$US
240644731$24064473$1$I$$20240630$20240709$20240709$EXP$$US-Prasco Laboratories-PRAS20241009$PRASCO$Kim H, Brill D, Giuliari G. OCCLUSIVE CYTOMEGALOVIRUS PANUVEITIS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT. Retin Cases Brief Rep.. 2024;18(4):442-445. doi:10.1097/ICB.0000000000001407$60$YR$A$M$Y$$$20240709$$MD$US$US
240644742$24064474$2$F$$20240716$20240709$20240726$EXP$$VN-TEVA-VS-3217037$TEVA$Do TA, Nguyen AQ, Van Nguyen T, Vu PT, Tran HT. A giant metaplastic breast carcinoma with osseous differentiation: A rare case report and review of the literature. Int-J-Surg-Case-Rep 2024; 120 (0):.; Do TA, Nguyen AQ, Van Nguyen T, Vu PT, Tran HT. A giant metaplastic breast carcinoma with osseous differentiation: A rare case report and review of the literature. Int-J-Surg-Case-Rep 2024; 120 (0):.; Do TA, Nguyen AQ, Van Nguyen T, Vu PT, Tran HT. A giant metaplastic breast carcinoma with osseo...$59$YR$$F$Y$$$20240726$$HP$VN$VN
240644751$24064475$1$I$$20240701$20240709$20240709$EXP$$CO-ROCHE-10000013299$ROCHE$Diaz-Sanabria R, Ramirez-Sanchez I. Intussusception as the first manifestation of disseminated aspergillosis in a patient with autologous hematopoietic stem cell transplantation. Transplant Infectious Disease. 2024-Jun;26 (3):1-4. doi:10.1111/tid.14265.$65$YR$E$M$Y$$$20240709$$HP$CO$CO
240644762$24064476$2$F$$20240812$20240709$20240814$EXP$$CA-UCBSA-2024034533$UCB$$$$$F$Y$$$20240814$$CN$CA$CA
240644791$24064479$1$I$$20240626$20240709$20240709$EXP$CN-MLMSERVICE-20240522-PI069095-00117-2$CN-STERISCIENCE B.V.-2024-ST-000966$Steriscience PTE$Bo Y, Zhong X, Xiang Y, Ren Q, Hao P.. Death Caused by Disseminated Herpes Zoster in a Patient with Multiple Myeloma: A Case Report and Literature Review.. Clin-Cosmet-Invest-Dermatol. 2024;17:941-951$58$YR$$M$Y$$$20240709$$HP$CN$CN
240644801$24064480$1$I$20240329$20240617$20240709$20240709$PER$$US-ROCHE-3559775$ROCHE$$55$YR$A$M$Y$103.5$KG$20240709$$HP$US$US
240644811$24064481$1$I$20240301$20240625$20240709$20240709$EXP$$DE-GLENMARK PHARMACEUTICALS-2024GMK091935$GLENMARK$$$$$$Y$$$20240709$$MD$DE$DE
240644821$24064482$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47415$$FDA-CTU$$25$YR$$F$N$$$20240708$N$$US$
240644831$24064483$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA195159$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240709$$MD$US$US
240644841$24064484$1$I$20240601$20240627$20240709$20240709$PER$$US-SA-2024SA195245$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240709$$MD$US$US
240644851$24064485$1$I$20180726$20240704$20240709$20240709$EXP$$CA-TAKEDA-2024TUS064580$TAKEDA$$27$YR$$F$Y$$$20240709$$CN$CA$CA
240644861$24064486$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA194341$SANOFI AVENTIS$$$$$M$Y$$$20240709$$PH$US$US
240644871$24064487$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA194931$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240709$$MD$US$US
240644881$24064488$1$I$$20240624$20240709$20240709$EXP$$CA-ROCHE-10000016368$ROCHE$$$$A$M$Y$$$20240709$$CN$CA$CA
240644891$24064489$1$I$$20240705$20240709$20240709$PER$$US-BAUSCH-BL-2024-010384$BAUSCH AND LOMB$$$$$F$Y$$$20240709$$CN$US$US
240644902$24064490$2$F$20240601$20240702$20240709$20240711$EXP$$NVSC2024CA138552$NOVARTIS$$63$YR$$M$Y$$$20240711$$PH$CA$CA
240644911$24064491$1$I$$20240707$20240709$20240709$PER$$NVSC2024US141172$NOVARTIS$$$$$M$Y$$$20240709$$CN$US$US
240644922$24064492$2$F$$20240724$20240709$20240730$EXP$$NVSC2024GT140963$NOVARTIS$$$$$F$Y$$$20240731$$CN$GT$GT
240644931$24064493$1$I$$20240708$20240709$20240709$PER$$US-JNJFOC-20240719004$JOHNSON AND JOHNSON$$24$YR$A$F$Y$$$20240709$$HP$US$US
240644941$24064494$1$I$$20240613$20240709$20240709$PER$$US-JNJFOC-20240641908$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240644951$24064495$1$I$20240113$20240701$20240709$20240709$EXP$GB-MHRA-MED-202406301130511070-FLYHN$GB-TEVA-VS-3215988$TEVA$$24$YR$$M$Y$$$20240709$$CN$GB$GB
240644962$24064496$2$F$20240501$20240918$20240709$20240926$EXP$$US-ROCHE-10000017001$ROCHE$$70$YR$E$F$Y$$$20240926$$CN$US$US
240644971$24064497$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135117$AMGEN$$$$$M$Y$$$20240709$$CN$US$US
240644981$24064498$1$I$$20240702$20240709$20240709$EXP$$US-MYLANLABS-2024M1063708$MYLAN$Zarak MS, Rathore S, Bose RK, Janardhanan R, DeLeon D. Successful Percutaneous Closure of Gerbode Defect and Right Atrial-Aortic Fistula Following Infective Endocarditis. JACC-Case-Rep 2024; 29 (14):.$63$YR$$M$Y$$$20240709$$MD$US$US
240644991$24064499$1$I$20230918$20240702$20240709$20240709$EXP$IT-MINISAL02-992332$IT-MYLANLABS-2024M1062318$MYLAN$$44$YR$$$Y$74$KG$20240709$$PH$IT$IT
240645001$24064500$1$I$20240430$20240702$20240709$20240709$EXP$$IT-MYLANLABS-2024M1062328$MYLAN$$69$YR$$F$Y$63$KG$20240709$$MD$IT$IT
240645011$24064501$1$I$$20240702$20240709$20240709$EXP$$ZA-MYLANLABS-2024M1063699$MYLAN$Khan A, Pillay M, Chimukangara B, Gounder L, Manyana S, Francois K-L, et al. Identification of HIV-1 subtype CRF18_cpx in a patient with multidrug resistance in KwaZulu-Natal, South Africa: An epidemiological worry?. J-Clin-Virol-Plus 2023; 3 (2):.$31$YR$$F$Y$$$20240709$$HP$ZA$ZA
240645038$24064503$8$F$$20240923$20240709$20240927$EXP$$CZ-MYLANLABS-2024M1063148$MYLAN$Sitina M. Euglycemic ketoacidosis associated with SGLT2 inhibitors and DPP4 inhibitors - discussion of case reports.. Anesteziol. Intenzivni Med.. 2024;35(2):98-103$70$YR$$F$Y$$$20240927$$MD$CZ$CZ
240645041$24064504$1$I$$20240702$20240709$20240709$EXP$$US-MYLANLABS-2024M1063166$MYLAN$Suresh S, Chaitanya G, Kachhvah AD, Vashin V, Saranathan M, Pati S. Case report: Nocturnal low-frequency stimulation of the centromedian thalamic nucleus improves sleep quality and seizure control. Front-Hum-Neurosci 2024; 18.$39$YR$$M$Y$$$20240709$$HP$US$US
240645051$24064505$1$I$20240425$20240702$20240709$20240709$EXP$FR-AFSSAPS-CN2024000524$FR-MYLANLABS-2024M1062373$MYLAN$$89$YR$$M$Y$$$20240709$$PH$FR$FR
240645061$24064506$1$I$20240201$20240702$20240709$20240709$EXP$$DE-MYLANLABS-2024M1062416$MYLAN$$$$$F$Y$3.58$KG$20240709$$MD$DE$DE
240645071$24064507$1$I$$20240702$20240709$20240709$EXP$$US-MYLANLABS-2024M1063114$MYLAN$Sablaban IM, Gautam M. Kratom + Stimulant Co-Addiction: A Case Series and Brief Review. [Review]. J-Addict-Dis 2023; 41 (2): 181-184.$44$YR$$M$Y$$$20240709$$HP$US$US
240645082$24064508$2$F$20240101$20240701$20240709$20240713$PER$$US-SA-2024SA196631$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240713$$MD$US$US
240645091$24064509$1$I$20240601$20240702$20240709$20240709$PER$$US-SA-2024SA199295$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240709$$MD$US$US
240645101$24064510$1$I$20240620$20240624$20240709$20240709$EXP$$IN-ROCHE-3545780$ROCHE$$78$YR$E$M$Y$$$20240709$$MD$IN$IN
240645111$24064511$1$I$20240530$20240702$20240709$20240709$EXP$$NL-MYLANLABS-2024M1062356$MYLAN$$83$YR$$F$Y$$$20240709$$CN$NL$NL
240645121$24064512$1$I$$20240626$20240709$20240709$EXP$$JP-ROCHE-10000013975$ROCHE$$7$DEC$E$M$Y$$$20240709$$MD$JP$JP
240645132$24064513$2$F$$20240726$20240709$20240801$EXP$$JP-AMGEN-JPNSP2024134620$AMGEN$$71$YR$E$F$Y$$$20240801$$HP$JP$JP
240645142$24064514$2$F$20240624$20240718$20240709$20240726$EXP$$CO-CIPLA LTD.-2024CO07172$CIPLA$$$$$$Y$$$20240726$$MD$CO$CO
240645151$24064515$1$I$$20240114$20240709$20240709$EXP$GB-MHRA-MED-202401121049129770-PKDLH$GB-TEVA-VS-3146112$TEVA$$78$YR$$M$Y$$$20240709$$HP$GB$GB
240645161$24064516$1$I$20200506$20240709$20240709$20240709$EXP$PL-URPL-1-3691-2020$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038570$BOEHRINGER INGELHEIM$$40$YR$A$M$Y$80$KG$20240709$$MD$PL$PL
240645172$24064517$2$F$20240624$20240905$20240709$20240909$EXP$$GB-MYLANLABS-2024M1062965$MYLAN$$$$$M$Y$$$20240909$$CN$GB$GB
240645181$24064518$1$I$$20240620$20240709$20240709$EXP$$US-PERRIGO-24US006370$PERRIGO$Khawam S, Goudie M, Hartfield R, Hassan S, Padder F. A Case of Trazadone and Omeprazole Associated Wenckebach Phenomenon Disguised as Second-degree Mobitz Type 2 AV Block. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5664. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5664.$26$YR$$F$Y$$$20240709$$MD$US$US
240645191$24064519$1$I$20240430$20240704$20240709$20240709$EXP$GB-MHRA-MED-202405031440330930-PMBTF$GB-MYLANLABS-2024M1062909$MYLAN$$38$YR$$M$Y$48$KG$20240709$$PH$GB$GB
240645201$24064520$1$I$20230710$20240704$20240709$20240709$EXP$GB-MHRA-MED-202405031246208040-FRJDH$GB-MYLANLABS-2024M1063303$MYLAN$$67$YR$$M$Y$83$KG$20240709$$CN$GB$GB
240645211$24064521$1$I$$20240704$20240709$20240709$EXP$$JP-EXELIXIS-CABO-24079217$EXELIXIS$$62$YR$$M$Y$$$20240709$$MD$JP$JP
240645221$24064522$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134961$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240645231$24064523$1$I$$20240707$20240709$20240709$PER$$US-HALEON-2185963$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240645242$24064524$2$F$$20240702$20240709$20240711$PER$$US-ROCHE-10000020165$ROCHE$$36$YR$A$F$Y$$$20240711$$CN$US$US
240645251$24064525$1$I$20240101$20240703$20240709$20240709$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010285$JAZZ$$$$$F$Y$$$20240709$$CN$US$US
240645261$24064526$1$I$20240601$20240708$20240709$20240709$EXP$IT-MINISAL02-993880$IT-ABBVIE-5831226$ABBVIE$$68$YR$$F$Y$$$20240709$$PH$IT$IT
240645271$24064527$1$I$$20240701$20240709$20240709$EXP$$JP-AstraZeneca-2024A154090$ASTRAZENECA$$61$YR$$F$Y$$$20240709$$PH$JP$
240645282$24064528$2$F$20240627$20240823$20240709$20240830$EXP$$JP-AstraZeneca-2024A153758$ASTRAZENECA$$71$YR$$M$Y$60$KG$20240830$$MD$JP$
240645291$24064529$1$I$20231101$20240703$20240709$20240709$EXP$$US-ROCHE-10000019641$ROCHE$$67$YR$E$F$Y$$$20240709$$MD$US$US
240645303$24064530$3$F$$20240710$20240709$20240801$EXP$BE-EMA-DD-20240617-7482711-170159$BE-SA-2024SA194296$SANOFI AVENTIS$$47$YR$A$F$Y$83$KG$20240719$$HP$BE$BE
240645311$24064531$1$I$$20240701$20240709$20240709$EXP$$GB-AstraZeneca-2024A154680$ASTRAZENECA$$$$$F$Y$$$20240709$$MD$GB$
240645322$24064532$2$F$$20240813$20240709$20240821$EXP$$US-AstraZeneca-2024A151510$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
240645331$24064533$1$I$$20240614$20240709$20240709$PER$$US-AstraZeneca-2024A092645$ASTRAZENECA$$$$$M$Y$$$20240709$$CN$US$
240645341$24064534$1$I$20240601$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004182$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240709$$CN$US$US
240645351$24064535$1$I$20240606$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47395$$FDA-CTU$$22$YR$$M$N$$$20240708$Y$PH$US$
240645362$24064536$2$F$20240601$20240730$20240709$20240805$EXP$$US-SA-2024SA199528$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240805$$CN$US$US
240645372$24064537$2$F$$20240708$20240709$20240714$EXP$$US-SA-2024SA195613$SANOFI AVENTIS$Kuraitis D, Bogner P, Gopalakrishnan D, Pei S.. Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis.. JAAD Case Reports.. 2024;50:33-6$68$YR$E$M$Y$$$20240714$$MD$US$US
240645381$24064538$1$I$$20240628$20240709$20240709$PER$$US-TEVA-VS-3216575$TEVA$$72$YR$$M$Y$$$20240709$$MD$US$US
240645391$24064539$1$I$20230610$20240702$20240709$20240709$EXP$$US-SA-2024SA199761$SANOFI AVENTIS$$60$YR$A$M$Y$124$KG$20240709$$MD$US$US
240645401$24064540$1$I$20240101$20240627$20240709$20240709$PER$$US-SA-2024SA195437$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240709$$MD$US$US
240645421$24064542$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA199056$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240709$$MD$US$US
240645431$24064543$1$I$20240201$20240702$20240709$20240709$PER$$US-SA-2024SA196154$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$CN$US$US
240645441$24064544$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA198851$SANOFI AVENTIS$$$$E$M$Y$$$20240709$$MD$US$US
240645451$24064545$1$I$20240601$20240628$20240709$20240709$PER$$US-SA-2024SA196456$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240709$$MD$US$US
240645461$24064546$1$I$20240101$20240703$20240709$20240709$PER$$US-SA-2024SA199150$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240709$$MD$US$US
240645471$24064547$1$I$20240405$20240627$20240709$20240709$EXP$$JP-ROCHE-3559308$ROCHE$$44$YR$A$F$Y$38.5$KG$20240709$$MD$JP$JP
240645481$24064548$1$I$20240203$20240704$20240709$20240709$EXP$GB-MHRA-MED-202405072005473960-BTSHV$GB-MYLANLABS-2024M1063212$MYLAN$$$$$F$Y$$$20240709$$CN$GB$GB
240645491$24064549$1$I$$20240704$20240709$20240709$EXP$GB-MHRA-MED-202405091156004180-HMBTC$GB-MYLANLABS-2024M1063203$MYLAN$$$$$M$Y$$$20240709$$PH$GB$GB
240645501$24064550$1$I$$20240704$20240709$20240709$EXP$GB-MHRA-MED-202405060908552160-VRYJP$GB-MYLANLABS-2024M1063258$MYLAN$$$$$F$Y$56$KG$20240709$$MD$GB$GB
240645511$24064551$1$I$20240601$20240628$20240709$20240709$PER$$US-TEVA-VS-3216539$TEVA$$$$$F$Y$$$20240709$$CN$US$US
240645521$24064552$1$I$20130101$20240703$20240709$20240709$EXP$$CA-BEH-2024168284$CSL BEHRING$$41$YR$A$M$Y$83$KG$20240709$$HP$CA$CA
240645531$24064553$1$I$$20240627$20240709$20240709$PER$$US-TEVA-VS-3216547$TEVA$$47$YR$$M$Y$68$KG$20240709$$PH$US$US
240645541$24064554$1$I$20240624$20240701$20240709$20240709$30DAY$$US-GSK-US2024083217$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240709$$CN$US$US
240645551$24064555$1$I$$20240627$20240709$20240709$PER$$US-ROCHE-10000011531$ROCHE$$$$$F$Y$$$20240709$$CN$US$US
240645561$24064556$1$I$20220601$20240702$20240709$20240709$EXP$$NVSC2024TW138954$NOVARTIS$$41$YR$$F$Y$$$20240709$$MD$TW$TW
240645571$24064557$1$I$$20240628$20240709$20240709$EXP$$DE-ROCHE-10000012498$ROCHE$$$$$M$Y$$$20240709$$CN$DE$DE
240645582$24064558$2$F$$20240709$20240709$20240710$PER$$US-AMGEN-USASP2024135464$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240645591$24064559$1$I$$20240702$20240709$20240709$PER$$US-EMD Serono-2024036365$EMD SERONO INC$$$$$M$Y$$$20240709$$MD$US$US
240645602$24064560$2$F$$20240808$20240709$20240808$PER$$US-ALXN-202407USA000185US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
240645611$24064561$1$I$$20240702$20240709$20240709$PER$$US-ALXN-202407USA000179US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240645632$24064563$2$F$20240627$20240703$20240709$20240712$PER$$US-Eisai-EC-2024-169098$EISAI$$83$YR$E$M$Y$110.1$KG$20240712$$CN$US$US
240645641$24064564$1$I$$20240701$20240709$20240709$EXP$$US-SA-2024SA197195$SANOFI AVENTIS$$$$A$M$Y$68$KG$20240709$$MD$US$US
240645651$24064565$1$I$$20240708$20240709$20240709$EXP$$HU-SANDOZ INC.-SDZ2024HU063605$SANDOZ$$68$YR$$M$Y$$$20240709$$HP$HU$HU
240645662$24064566$2$F$$20240722$20240709$20240724$PER$$US-HALEON-2185937$Haleon PLC$$92$YR$$F$Y$$$20240724$$CN$US$US
240645671$24064567$1$I$20240101$20240627$20240709$20240709$EXP$$BR-BAYER-2024A094576$BAYER$$$$$F$Y$$$20240709$$CN$BR$BR
240645681$24064568$1$I$$20240702$20240709$20240709$EXP$$US-SA-2024SA195782$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240709$$CN$US$US
240645691$24064569$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024135269$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240645701$24064570$1$I$20230101$20240627$20240709$20240709$EXP$$US-SCILEX PHARMACEUTICALS INC.-US-SOR-24-00328$SCILEX PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240645711$24064571$1$I$20240101$20240624$20240709$20240709$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00147$OPKO HEALTH$$$$$M$Y$$$20240704$$PH$US$US
240645723$24064572$3$F$$20240913$20240709$20240923$PER$$US-GSK-US2024083221$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$PH$US$US
240645741$24064574$1$I$$20240708$20240709$20240709$EXP$$CA-ADIENNEP-2024AD000556$ADIENNE PHARMA + BIOTECH$$58$YR$$M$Y$110$KG$20240708$$HP$CA$
240645751$24064575$1$I$20240706$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134786$AMGEN$$62$YR$A$$Y$$$20240709$$CN$US$US
240645761$24064576$1$I$$20240702$20240709$20240709$PER$$US-JNJFOC-20240706293$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240645773$24064577$3$F$$20240919$20240709$20240930$30DAY$$NL-MYLANLABS-2024M1062486$MYLAN$$$$$$Y$$$20240930$$PH$NL$NL
240645781$24064578$1$I$20240507$20240627$20240709$20240709$EXP$FR-AFSSAPS-PB2024000708$FR-Accord-433087$ACCORD$$57$YR$A$F$Y$$$20240709$$PH$FR$FR
240645791$24064579$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281418165880-YWTHP$GB-Accord-433184$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240645801$24064580$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281141493050-NJBWG$GB-Accord-433398$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240645811$24064581$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281413365890-NGPDS$GB-Accord-433189$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240645822$24064582$2$F$$20240708$20240709$20240718$EXP$GB-MHRA-MED-202406281431213880-YGRFD$GB-Accord-433241$ACCORD$$$$$$Y$$$20240718$$CN$GB$GB
240645831$24064583$1$I$20240610$20240627$20240709$20240709$EXP$CN-HENLIUS-24CN015656$CN-Accord-434126$ACCORD$$40$YR$A$F$Y$$$20240709$$MD$CN$CN
240645842$24064584$2$F$20220101$20240705$20240709$20240716$EXP$$AE-Accord-433753$ACCORD$Mujahid B, Lutfi L, Alhassan A. Electric Shock Sensation and Recurrent Falls as a Side Effect of Clozapine Therapy: A Case Report. Cureus. 2024 May 26;16(5):e61143.$42$YR$A$F$Y$$$20240716$$HP$AE$AE
240645853$24064585$3$F$$20240708$20240709$20240723$EXP$GB-MHRA-MED-202406281442341590-SCYTR$GB-Accord-433237$ACCORD$$$$$$Y$$$20240722$$CN$GB$GB
240645861$24064586$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05859$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240645871$24064587$1$I$$20240628$20240709$20240709$PER$$US-BAYER-2024A097154$BAYER$$28$YR$A$F$Y$$$20240709$$MD$US$US
240645901$24064590$1$I$$20240704$20240709$20240709$EXP$$CA-PFIZER INC-202400206991$PFIZER$$10$YR$$F$Y$33$KG$20240709$$HP$CA$CA
240645911$24064591$1$I$$20240703$20240709$20240709$EXP$$GB-PFIZER INC-917197$PFIZER$Gupta, N.. An unusual cause of acute obstructive jaundice in an HIV-infected patient. International Journal of STD + AIDS. 2011;22:110-111$33$YR$$F$Y$$$20240709$$MD$GB$GB
240645922$24064592$2$F$$20240625$20240709$20240709$EXP$$US-PFIZER INC-K201100486$PFIZER$Singleton, R.. Iatrogenic cerebral venous sinus occlusion with flowable topical hemostatic matrix: Clinical article. Journal of Neurosurgery. 2011;115(3):576-583$29$YR$$F$Y$$$20240709$$MD$US$US
240645931$24064593$1$I$20240701$20240703$20240709$20240709$EXP$$BR-PFIZER INC-202400206856$PFIZER$$$$A$M$Y$$$20240709$$CN$BR$BR
240645941$24064594$1$I$20240701$20240703$20240709$20240709$EXP$$AR-PFIZER INC-202400208992$PFIZER$$86$YR$$F$Y$$$20240709$$CN$AR$AR
240645951$24064595$1$I$20240618$20240704$20240709$20240709$EXP$$CN-PFIZER INC-PV202400088095$PFIZER$$46$YR$$M$Y$56$KG$20240709$$HP$CN$CN
240645961$24064596$1$I$20240101$20240704$20240709$20240709$EXP$$CA-PFIZER INC-202400207789$PFIZER$$87$YR$$M$Y$$$20240709$$PH$CA$CA
240645972$24064597$2$F$$20240625$20240709$20240709$EXP$$US-PFIZER INC-K201100485$PFIZER$Singleton, R.. Iatrogenic cerebral venous sinus occlusion with flowable topical hemostatic matrix: Clinical article. Journal of Neurosurgery. 2011;115 (3):576-583$75$YR$$F$Y$$$20240709$$MD$US$US
240645981$24064598$1$I$20231117$20240702$20240709$20240709$EXP$$CA-PFIZER INC-202400206208$PFIZER$$48$YR$$F$Y$$$20240709$$HP$CA$CA
240645991$24064599$1$I$20240101$20240703$20240709$20240709$EXP$$CN-PFIZER INC-PV202400087489$PFIZER$$59$YR$$F$Y$49$KG$20240709$$HP$CN$CN
240646001$24064600$1$I$$20240629$20240709$20240709$EXP$$BR-PFIZER INC-202400207905$PFIZER$$30$YR$$F$Y$$$20240709$$MD$BR$BR
240646011$24064601$1$I$$20240704$20240709$20240709$EXP$$CA-PFIZER INC-2021SGN00312$PFIZER$$71$YR$$F$Y$54$KG$20240709$$HP$CA$CA
240646021$24064602$1$I$$20240625$20240709$20240709$EXP$CA-MHPD-001081844$CA-Accord-432544$ACCORD$$97$YR$E$F$Y$$$20240709$$HP$CA$CA
240646031$24064603$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-30919045$GB-Accord-433612$ACCORD$$$$$F$Y$$$20240709$$CN$GB$GB
240646041$24064604$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281423510310-QYSNJ$GB-Accord-433439$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240646051$24064605$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-30919072$GB-Accord-433620$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240646062$24064606$2$F$$20240709$20240709$20240722$EXP$$GB-Accord-433511$ACCORD$Berman G, Amel-Kashipaz R, Mahendra P, Ramalingam S, Rhodes B, Mollan S, et al. Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Polymyalgia Rheumatica Presenting with Double Vision. Neuro-Ophthalmology. 2024.$78$YR$E$F$Y$$$20240719$$MD$GB$GB
240646071$24064607$1$I$$20240627$20240709$20240709$EXP$$US-Accord-433006$ACCORD$Singh AD, Kurin M. An Unusual Case of Refractory Esophagitis and Esophageal Diverticulum. Digestive Diseases and Sciences. 2024;69(6):1913-14. DOI:10.1007/s10620-024-08301-3$76$YR$E$F$Y$$$20240709$$MD$US$US
240646081$24064608$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA195472$SANOFI AVENTIS$$$$$F$Y$$$20240709$$HP$US$US
240646091$24064609$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA197778$SANOFI AVENTIS$$$$C$M$Y$$$20240709$$CN$US$US
240646101$24064610$1$I$20240401$20240701$20240709$20240709$PER$$US-SA-2024SA198049$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240709$$MD$US$US
240646111$24064611$1$I$$20240704$20240709$20240709$EXP$$CA-PFIZER INC-202400206868$PFIZER$$$$$F$Y$$$20240709$$HP$CA$CA
240646121$24064612$1$I$20240703$20240703$20240709$20240709$PER$$US-SA-2024SA197867$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240709$$CN$US$US
240646132$24064613$2$F$$20240823$20240709$20240828$PER$$US-ROCHE-10000019995$ROCHE$$59$YR$A$F$Y$88$KG$20240828$$CN$US$US
240646141$24064614$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000020200$ROCHE$$$$A$F$Y$$$20240709$$CN$US$US
240646151$24064615$1$I$20240101$20240701$20240709$20240709$EXP$CN-UCBSA-2024033966$CN-UCBSA-2024033966$UCB$$65$YR$$M$Y$70$KG$20240709$$HP$CN$CN
240646165$24064616$5$F$20230619$20240917$20240709$20240920$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-245615$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$70$KG$20240920$$CN$US$US
240646171$24064617$1$I$20240613$20240625$20240709$20240709$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000554$PAREXEL$$$$$$Y$$$20240709$$HP$CN$CN
240646182$24064618$2$F$$20240828$20240709$20240902$EXP$$CA-TAKEDA-2024TUS068534$TAKEDA$$$$$F$Y$$$20240902$$MD$CA$CA
240646191$24064619$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47422$$FDA-CTU$$69$YR$$F$N$$$20240708$N$$US$
240646221$24064622$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47388$$FDA-CTU$$92$YR$$M$N$$$20240708$N$$US$
240646231$24064623$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47326$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240646254$24064625$4$F$20240620$20240904$20240709$20240916$EXP$$US-ROCHE-10000017076$ROCHE$$7$YR$C$F$Y$$$20240916$$CN$US$US
240646261$24064626$1$I$20240101$20240702$20240709$20240709$PER$$US-UNITED THERAPEUTICS-UNT-2024-020418$UNITED THERAPEUTICS$$$$$F$Y$58.957$KG$20240709$$$US$US
240646271$24064627$1$I$20240612$20240702$20240709$20240709$EXP$$FR-BAYER-2024A096273$BAYER$$35$YR$A$F$Y$$$20240709$$HP$FR$FR
240646281$24064628$1$I$$20240704$20240709$20240709$EXP$$CA-TAKEDA-2024TUS069151$TAKEDA$$$$$F$Y$$$20240709$$CN$CA$CA
240646291$24064629$1$I$$20240701$20240709$20240709$30DAY$$US-GSK-US2024AMR081686$GLAXOSMITHKLINE$$$$$M$Y$$$20240709$$CN$US$US
240646302$24064630$2$F$20240624$20240726$20240709$20240802$PER$$US-SA-2024SA198101$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240802$$MD$US$US
240646311$24064631$1$I$20240101$20240701$20240709$20240709$PER$$US-SA-2024SA198972$SANOFI AVENTIS$$$$C$F$Y$$$20240709$$MD$US$US
240646321$24064632$1$I$20220101$20240702$20240709$20240709$PER$$US-SA-2024SA198934$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240709$$MD$US$US
240646331$24064633$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA198683$SANOFI AVENTIS$$$$$M$Y$$$20240709$$CN$US$US
240646341$24064634$1$I$20240601$20240702$20240709$20240709$PER$$US-SA-2024SA198843$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240709$$CN$US$US
240646351$24064635$1$I$$20240627$20240709$20240709$EXP$$US-ASTELLAS-2024US019252$ASTELLAS$$60$YR$$F$Y$$$20240709$$MD$US$US
240646362$24064636$2$F$$20240709$20240709$20240711$PER$$US-AMGEN-USASP2024135289$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240646371$24064637$1$I$20240615$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134184$AMGEN$$67$YR$E$F$Y$$$20240709$$CN$US$US
240646381$24064638$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47374$$FDA-CTU$$68$YR$$M$N$$$20240708$N$$US$
240646391$24064639$1$I$$20240626$20240709$20240709$EXP$$US-MAIA Pharmaceuticals, Inc.-MAI202407-000021$MAIA PHARMACEUTICALS$$61$YR$A$M$Y$$$20240709$$HP$US$
240646403$24064640$3$F$$20240826$20240709$20240830$EXP$$US-TAKEDA-2024TUS068071$TAKEDA$$$$$M$Y$$$20240830$$CN$US$US
240646411$24064641$1$I$$20240701$20240709$20240709$EXP$$US-AMGEN-USASP2024132480$AMGEN$Jameson G.S. Phase 2 clinical trial of nab-paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer. Cancer Medicine. 2024;13 (12):1-10$$$$$Y$$$20240709$$HP$US$US
240646421$24064642$1$I$$20240704$20240709$20240709$EXP$$GB-MYLANLABS-2024M1062817$MYLAN$Koksa K, Acres R, Studley M, Briggs J. Disseminated Mucormycosis in a patient on long term immunosuppression: Severe fungal infections as multi-system disorders. J-Intens-Care-Soc. 2023;24 (Suppl) (1):43-44 abstr. 4736$$$A$F$Y$$$20240709$$HP$GB$GB
240646434$24064643$4$F$20240101$20240907$20240709$20240911$30DAY$$US-PFIZER INC-202400204915$PFIZER$$70$YR$$F$Y$67.59$KG$20240911$$CN$US$US
240646451$24064645$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05844$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240646461$24064646$1$I$$20240702$20240709$20240709$PER$$US-BAYER-2024A096714$BAYER$$$$$F$Y$$$20240709$$CN$US$US
240646472$24064647$2$F$20240601$20240805$20240709$20240806$EXP$$NVSC2024GB141036$NOVARTIS$$42$YR$$F$Y$$$20240806$$HP$GB$GB
240646481$24064648$1$I$$20240116$20240709$20240709$EXP$GB-MHRA-MED-202401031337326260-NGJVP$GB-TEVA-VS-3145883$TEVA$$86$YR$$M$Y$$$20240709$$HP$GB$GB
240646491$24064649$1$I$$20240701$20240709$20240709$PER$$US-RDY-SPO/USA/24/0009719$DR REDDYS$$16$YR$T$$Y$$$20240709$$MD$US$US
240646501$24064650$1$I$$20240628$20240709$20240709$EXP$$US-RDY-CLI/USA/24/0009937$DR REDDYS$$22$YR$A$F$Y$$$20240709$$HP$US$US
240646511$24064651$1$I$$20240703$20240709$20240709$EXP$$US-TAKEDA-2024TUS051764$TAKEDA$$$$$F$Y$$$20240709$$CN$US$US
240646521$24064652$1$I$$20240704$20240709$20240709$PER$$US-ROCHE-10000020798$ROCHE$$51$YR$A$F$Y$$$20240709$$CN$US$US
240646531$24064653$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06117$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240646541$24064654$1$I$$20240703$20240709$20240709$EXP$$CN-AMGEN-CHNSP2024131807$AMGEN$$$$$$Y$$$20240709$$CN$CN$CN
240646553$24064655$3$F$20240604$20240724$20240709$20240729$PER$$US-AMGEN-USASP2024134810$AMGEN$$49$YR$A$M$Y$$$20240729$$CN$US$US
240646571$24064657$1$I$20240627$20240703$20240709$20240709$EXP$$JP-BAYER-2024A095935$BAYER$$$$$F$Y$$$20240709$$CN$JP$JP
240646582$24064658$2$F$$20240811$20240709$20240819$EXP$$IT-AMGEN-ITASP2024132400$AMGEN$Ciraci P.; Conca V.; Moretto R. et al.. Trifluridine/tipiracil plus capecitabine and bevacizumab as upfront treatment for metastatic colorectal cancer: Results of the phase I TriComB study. Annals of Oncology. 2024;35 (1):25-26$$$$$Y$$$20240819$$HP$IT$IT
240646593$24064659$3$F$$20240828$20240709$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202407004934$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240902$$CN$US$US
240646601$24064660$1$I$$20240701$20240709$20240709$EXP$$DE-AstraZeneca-2024A137179$ASTRAZENECA$$$$$F$Y$77$KG$20240709$$PH$DE$
240646612$24064661$2$F$$20240726$20240709$20240802$EXP$$CH-AstraZeneca-2024A155910$ASTRAZENECA$$20$YR$$F$Y$$$20240802$$MD$CH$
240646621$24064662$1$I$$20240701$20240709$20240709$EXP$$CA-AstraZeneca-2024A152351$ASTRAZENECA$$69$YR$$M$Y$$$20240709$$MD$CA$
240646632$24064663$2$F$$20240813$20240709$20240820$EXP$$MY-AstraZeneca-2024A152538$ASTRAZENECA$$$$$F$Y$$$20240820$$MD$MY$
240646641$24064664$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A151144$ASTRAZENECA$$$$$M$Y$$$20240709$$CN$US$
240646651$24064665$1$I$20240626$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A152301$ASTRAZENECA$$23527$DY$$M$Y$83$KG$20240709$$CN$US$
240646662$24064666$2$F$$20240711$20240709$20240711$30DAY$$US-PFIZER INC-202400204425$PFIZER$$$$$F$Y$$$20240711$$CN$US$US
240646691$24064669$1$I$20240616$20240701$20240709$20240709$EXP$$CN-AstraZeneca-2024A153358$ASTRAZENECA$$15042$DY$$M$Y$$$20240709$$MD$CN$
240646722$24064672$2$F$$20240809$20240709$20240809$30DAY$$US-PFIZER INC-202400207761$PFIZER$$7$MON$$F$Y$$$20240809$$CN$US$US
240646734$24064673$4$F$$20240917$20240709$20240920$30DAY$$US-PFIZER INC-202400189552$PFIZER$$12$YR$$M$Y$$$20240920$$CN$US$US
240646741$24064674$1$I$20240516$20240708$20240709$20240709$EXP$$NVSC2024GB104121$NOVARTIS$$76$YR$$F$Y$41.1$KG$20240709$$CN$GB$GB
240646751$24064675$1$I$20240101$20240702$20240709$20240709$EXP$$US-SA-2024SA199134$SANOFI AVENTIS$$65$YR$E$F$Y$105$KG$20240709$$MD$US$US
240646761$24064676$1$I$$20240701$20240709$20240709$PER$$US-ROCHE-10000017491$ROCHE$$$$A$F$Y$$$20240709$$HP$US$US
240646771$24064677$1$I$$20240704$20240709$20240709$EXP$IT-MINISAL02-992914$IT-SA-2024SA197968$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240709$$MD$IT$IT
240646782$24064678$2$F$20240501$20240719$20240709$20240729$PER$$US-SA-2024SA194815$SANOFI AVENTIS$$58$YR$A$F$Y$74.8$KG$20240729$$MD$US$US
240646791$24064679$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA198942$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240709$$CN$US$US
240646801$24064680$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA199338$SANOFI AVENTIS$$45$YR$A$F$Y$113$KG$20240709$$MD$US$US
240646812$24064681$2$F$$20240801$20240709$20240810$PER$$US-SA-2024SA197487$SANOFI AVENTIS$$$$C$M$Y$39.4$KG$20240810$$CN$US$US
240646821$24064682$1$I$20240101$20240628$20240709$20240709$PER$$US-SA-2024SA195499$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240709$$MD$US$US
240646831$24064683$1$I$20240625$20240708$20240709$20240709$PER$$US-HALEON-2186024$Haleon PLC$$40$YR$$F$Y$$$20240709$$CN$US$US
240646841$24064684$1$I$20240101$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134965$AMGEN$$66$YR$E$F$Y$$$20240709$$CN$US$US
240646851$24064685$1$I$$20240708$20240709$20240709$PER$$US-JNJFOC-20240718815$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240646861$24064686$1$I$20240601$20240625$20240709$20240709$EXP$$JP-ROCHE-10000013558$ROCHE$$$$$M$Y$$$20240709$$PH$JP$JP
240646871$24064687$1$I$$20240614$20240709$20240709$PER$$US-JNJFOC-20240641977$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$US$US
240646881$24064688$1$I$20220901$20240625$20240709$20240709$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091953$GLENMARK$Antonelli JP, Quach M, Mahajan A, Pleva J, Ma VT. Rapid Life-Saving Response to Anti-PD-1 in a Solid Organ Transplant Recipient with Metastatic Cutaneous Squamous Cell Carcinoma: A Case Report and Review.. Journal of Immunotherapy. 2024;47(6):216-9$$$$$Y$$$20240709$$MD$US$US
240646893$24064689$3$F$$20240828$20240709$20240830$PER$$US-HALEON-2186049$Haleon PLC$$$$$$Y$$$20240830$$CN$US$US
240646901$24064690$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06320$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240646931$24064693$1$I$$20240617$20240709$20240709$EXP$$CA-002147023-NVSC2023CA200150$Haleon PLC$$63$YR$$F$Y$$$20240709$$HP$CA$CA
240646961$24064696$1$I$20240702$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47290$$FDA-CTU$$28$YR$$F$N$95.25$KG$20240708$N$MD$US$
240646971$24064697$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281444339100-ZPDRB$GB-Accord-433246$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240646982$24064698$2$F$$20240708$20240709$20240718$EXP$GB-MHRA-MED-202406281038502460-PFVRS$GB-Accord-433413$ACCORD$$$$$$Y$$$20240718$$CN$GB$GB
240646991$24064699$1$I$20240402$20240627$20240709$20240709$EXP$ES-AEMPS-1540689$ES-Accord-433289$ACCORD$$77$YR$E$M$Y$$$20240709$$MD$ES$ES
240647001$24064700$1$I$$20240628$20240709$20240709$EXP$CA-MHPD-001085506$CA-Accord-433174$ACCORD$$69$YR$$F$Y$111$KG$20240709$$MD$CA$CA
240647012$24064701$2$F$$20240703$20240709$20240715$EXP$GB-MHRA-MED-202406291157398850-KGTCR$GB-Accord-433747$ACCORD$$30$YR$A$M$Y$$$20240715$$CN$GB$GB
240647021$24064702$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281432464540-VLDZP$GB-Accord-433426$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240647041$24064704$1$I$$20240628$20240709$20240709$EXP$CA-MHPD-E2B_07090153$CA-Accord-433160$ACCORD$$66$YR$E$F$Y$79$KG$20240709$$HP$CA$CA
240647051$24064705$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281423022780-LSYQG$GB-Accord-433431$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240647061$24064706$1$I$$20240706$20240709$20240709$PER$$US-HALEON-2186070$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240647071$24064707$1$I$20240101$20240704$20240709$20240709$EXP$$CN-PFIZER INC-202400207100$PFIZER$$63$YR$$F$Y$$$20240709$$MD$CN$CN
240647081$24064708$1$I$$20240704$20240709$20240709$EXP$$IN-PFIZER INC-2021211717$PFIZER$$70$YR$$F$Y$$$20240709$$CN$IN$IN
240647091$24064709$1$I$20230101$20240704$20240709$20240709$EXP$$CA-PFIZER INC-202400207004$PFIZER$$67$YR$$M$Y$75$KG$20240709$$HP$CA$CA
240647101$24064710$1$I$20230101$20240704$20240709$20240709$EXP$$CA-PFIZER INC-202300444366$PFIZER$$80$YR$$M$Y$$$20240709$$PH$CA$CA
240647112$24064711$2$F$$20240923$20240709$20240930$EXP$$CA-PFIZER INC-2023SGN01647$PFIZER$$56$YR$$$Y$$$20240930$$MD$CA$CA
240647121$24064712$1$I$$20240704$20240709$20240709$EXP$$AU-PFIZER INC-202400208923$PFIZER$$38$YR$$F$Y$63$KG$20240709$$HP$AU$AU
240647131$24064713$1$I$$20240704$20240709$20240709$EXP$$ZA-BAYER-2024A097024$BAYER$$50$YR$A$F$Y$$$20240709$$CN$ZA$ZA
240647141$24064714$1$I$$20240521$20240709$20240709$30DAY$$US-UCBSA-2024026365$UCB$$$$$F$Y$$$20240709$$CN$US$US
240647151$24064715$1$I$20240624$20240628$20240709$20240709$EXP$$CA-ROCHE-10000019516$ROCHE$$69$YR$E$F$Y$$$20240709$$CN$CA$CA
240647161$24064716$1$I$20080821$20240621$20240709$20240709$EXP$$NL-ROCHE-10000018665$ROCHE$$57$YR$A$F$Y$$$20240709$$HP$NL$NL
240647171$24064717$1$I$20210101$20240701$20240709$20240709$EXP$DE-CADRBFARM-2024328923$DE-THEA-2024001485$Thea Pharma$$65$YR$$M$Y$65$KG$20240709$$CN$DE$DE
240647181$24064718$1$I$20240504$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405161742069620-FTHCJ$GB-TAKEDA-2024TUS068546$TAKEDA$$39$YR$$F$Y$$$20240709$$HP$GB$GB
240647191$24064719$1$I$$20240705$20240709$20240709$PER$$US-ROCHE-10000004519$ROCHE$Jabbehdari S, Veluvolu M, Kornhauser T, Jennings T, Pemberton J. Vismodegib as an adjuvant treatment for periorbital basal cell carcinoma: a case report and review of literature. Doi: 10.21037/atm-23-1589. Annals of Translational Medicine. 2024-Jun-10;12 (3):1-11. doi:10.21037/atm-23-1589.$50$YR$A$M$Y$$$20240709$$HP$US$US
240647201$24064720$1$I$20240505$20240702$20240709$20240709$EXP$$US-CHEPLA-2024008352$CHEPLAPHARM$$79$YR$$M$Y$$$20240709$$CN$COUNTRY NOT SPECIFIED$US
240647216$24064721$6$F$20240119$20240910$20240709$20240920$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-06118$HIKMA$$82$YR$$F$Y$79.46$KG$20240920$$MD$US$US
240647221$24064722$1$I$$20240701$20240709$20240709$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004921$BIOCON$$$$$$Y$$$20240709$$HP$CA$CA
240647232$24064723$2$F$20240601$20240808$20240709$20240808$PER$$US-ALXN-202407USA000159US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
240647241$24064724$1$I$20240117$20240702$20240709$20240709$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700096$MYOVANT SCIENCES$$85$YR$$M$Y$$$20240709$$CN$US$US
240647251$24064725$1$I$$20240705$20240709$20240709$PER$$US-JNJFOC-20240715650$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240647261$24064726$1$I$$20240629$20240709$20240709$PER$$PR-JNJFOC-20240721538$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$MD$PR$US
240647271$24064727$1$I$$20240629$20240709$20240709$PER$$PR-JNJFOC-20240721431$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$MD$PR$US
240647281$24064728$1$I$20240601$20240606$20240709$20240709$PER$$US-JNJFOC-20240713741$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$US$US
240647291$24064729$1$I$$20240703$20240709$20240709$30DAY$$US-GSK-US2024082635$GLAXOSMITHKLINE$$$$$F$Y$94.8$KG$20240709$$MD$US$US
240647301$24064730$1$I$20240101$20240708$20240709$20240709$PER$$US-ABBVIE-5831801$ABBVIE$$$$$$Y$$$20240709$$CN$US$US
240647311$24064731$1$I$$20240703$20240709$20240709$PER$$US-AMGEN-USASP2024133090$AMGEN$$$$$$Y$$$20240709$$PH$US$US
240647321$24064732$1$I$20230401$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405061512172570-ZNVKL$GB-MYLANLABS-2024M1063334$MYLAN$$64$YR$$F$Y$67$KG$20240709$$CN$GB$GB
240647331$24064733$1$I$$20240708$20240709$20240709$EXP$$CL-PFIZER INC-PV202400089316$PFIZER$$38$YR$$F$Y$$$20240709$$CN$CL$CL
240647341$24064734$1$I$20240508$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405092126187340-KVGCN$GB-MYLANLABS-2024M1063440$MYLAN$$35$YR$$F$Y$$$20240709$$CN$GB$GB
240647351$24064735$1$I$20240702$20240705$20240709$20240709$EXP$GB-MHRA-MED-202407051348598510-SBJGQ$GB-MYLANLABS-2024M1063814$MYLAN$$85$YR$$F$Y$$$20240709$$PH$GB$GB
240647361$24064736$1$I$20240610$20240703$20240709$20240709$EXP$FR-AFSSAPS-RN2024000699$FR-CHEPLA-2024008523$CHEPLAPHARM$$23$YR$$M$Y$$$20240709$$MD$COUNTRY NOT SPECIFIED$FR
240647372$24064737$2$F$20240607$20240716$20240709$20240717$EXP$$CN-PFIZER INC-PV202400088787$PFIZER$$39$YR$$M$Y$637$KG$20240717$$HP$CN$CN
240647381$24064738$1$I$20240501$20240705$20240709$20240709$EXP$$DE-PFIZER INC-202400207608$PFIZER$$73$YR$$M$Y$$$20240709$$MD$DE$DE
240647391$24064739$1$I$$20240706$20240709$20240709$EXP$$DO-PFIZER INC-PV202400089312$PFIZER$$70$YR$$F$Y$$$20240709$$CN$DO$DO
240647401$24064740$1$I$$20240705$20240709$20240709$EXP$$DE-PFIZER INC-202400207581$PFIZER$$$$$F$Y$$$20240709$$CN$DE$DE
240647411$24064741$1$I$20240327$20240705$20240709$20240709$EXP$$IN-PFIZER INC-PV202400019887$PFIZER$$78$YR$$F$Y$$$20240709$$CN$IN$IN
240647421$24064742$1$I$20240319$20240708$20240708$20240708$DIR$709392$$FDA-CTU$$44$YR$$F$N$88.65$KG$20240708$Y$CN$US$
240647431$24064743$1$I$20240419$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405071334285430-VTKJN$GB-PFIZER INC-202400207158$PFIZER$$37$YR$$F$Y$58$KG$20240709$$PH$GB$GB
240647451$24064745$1$I$20240509$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405091758184500-DSYLG$GB-PFIZER INC-202400207243$PFIZER$$65$YR$$$Y$$$20240709$$HP$GB$GB
240647461$24064746$1$I$20240219$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405120857115600-RYPJW$GB-PFIZER INC-202400207052$PFIZER$$63$YR$$F$Y$65$KG$20240709$$CN$GB$GB
240647471$24064747$1$I$20240305$20240705$20240709$20240709$EXP$GB-MHRA-MED-202406260926267920-QLDBR$GB-PFIZER INC-202400207857$PFIZER$$$$$F$Y$$$20240709$$CN$GB$GB
240647481$24064748$1$I$$20240705$20240709$20240709$EXP$$US-PFIZER INC-202400207988$PFIZER$$87$YR$$F$Y$$$20240709$$HP$US$US
240647491$24064749$1$I$$20240706$20240709$20240709$EXP$$IN-PFIZER INC-PV202300151251$PFIZER$$$$A$M$Y$$$20240709$$CN$IN$IN
240647501$24064750$1$I$20240610$20240704$20240709$20240709$EXP$FR-AFSSAPS-LL2024001228$FR-PFIZER INC-202400206528$PFIZER$$58$YR$$M$Y$$$20240709$$PH$FR$FR
240647511$24064751$1$I$20240617$20240705$20240709$20240709$EXP$$CN-PFIZER INC-PV202400088780$PFIZER$$39$YR$$F$Y$79$KG$20240709$$HP$CN$CN
240647521$24064752$1$I$20240601$20240704$20240709$20240709$EXP$$US-PFIZER INC-202400207718$PFIZER$$84$YR$$M$Y$$$20240709$$CN$US$US
240647531$24064753$1$I$20240101$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405131452203780-CTBQR$GB-PFIZER INC-202400207182$PFIZER$$16$YR$$M$Y$$$20240709$$HP$GB$GB
240647541$24064754$1$I$20240507$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405081228069050-KWJFN$GB-PFIZER INC-202400207237$PFIZER$$76$YR$$F$Y$$$20240709$$MD$GB$GB
240647551$24064755$1$I$20130101$20240705$20240709$20240709$EXP$$BR-PFIZER INC-202400208757$PFIZER$$48$YR$$F$Y$$$20240709$$CN$BR$BR
240647561$24064756$1$I$$20240705$20240709$20240709$EXP$$CA-PFIZER INC-202201178829$PFIZER$$66$YR$$F$Y$$$20240709$$MD$CA$CA
240647571$24064757$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06347$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240647592$24064759$2$F$$20240826$20240709$20240907$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK091974$GLENMARK$$$$$$Y$$$20240907$$HP$CA$CA
240647601$24064760$1$I$20240621$20240701$20240709$20240709$EXP$$CN-AstraZeneca-2024A153291$ASTRAZENECA$$67$YR$$M$Y$50$KG$20240709$$MD$CN$
240647611$24064761$1$I$$20240628$20240709$20240709$PER$$US-AstraZeneca-2024A150077$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240647621$24064762$1$I$20240705$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134275$AMGEN$$79$YR$E$M$Y$$$20240709$$CN$US$US
240647632$24064763$2$F$20240430$20240710$20240709$20240712$PER$$US-AMGEN-USASP2024134315$AMGEN$$70$YR$E$F$Y$$$20240712$$MD$US$US
240647642$24064764$2$F$20240101$20240725$20240709$20240729$EXP$SE-SEMPA-2024-003662$SE-AMGEN-SWESP2024132022$AMGEN$$75$YR$E$M$Y$82$KG$20240729$$CN$SE$SE
240647652$24064765$2$F$20240702$20240719$20240709$20240729$PER$$US-JNJFOC-20240709008$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240729$$HP$US$US
240647661$24064766$1$I$20240607$20240702$20240709$20240709$EXP$FR-AFSSAPS-AN2024000844$FR-REGENERON PHARMACEUTICALS, INC.-2024-093006$REGENERON$$54$YR$$F$Y$$$20240709$$PH$FR$FR
240647671$24064767$1$I$$20240708$20240709$20240709$EXP$$US-BAYER-2024A098431$BAYER$$75$YR$E$F$Y$$$20240709$$HP$US$US
240647682$24064768$2$F$20240101$20240710$20240709$20240718$PER$$US-SA-2024SA199114$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240718$$MD$US$US
240647691$24064769$1$I$20240611$20240702$20240709$20240709$PER$$US-SA-2024SA198672$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240709$$MD$US$US
240647701$24064770$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA197422$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240709$$CN$US$US
240647712$24064771$2$F$$20240710$20240709$20240718$PER$$US-SA-2024SA195556$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240718$$MD$US$US
240647722$24064772$2$F$20240701$20240710$20240709$20240711$PER$$US-ROCHE-10000019796$ROCHE$$28$YR$A$F$Y$$$20240711$$CN$US$US
240647731$24064773$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA199011$SANOFI AVENTIS$$15$YR$T$F$Y$118.6$KG$20240709$$MD$US$US
240647742$24064774$2$F$$20240625$20240709$20240814$EXP$$CA-ABBVIE-5828384$ABBVIE$$$$$$Y$$$20240814$$HP$CA$CA
240647751$24064775$1$I$$20240704$20240709$20240709$EXP$$IN-ROCHE-10000016469$ROCHE$Guha S, Suri D, Balan S, Janarthanan M, Agarwal M, Viswanathan V, et al. Exploring clinical features and therapeutic outcomes in Indian children with mixed connective tissue disease: A multicenter study. International Journal of Rheumatic Diseases. 2024-Jun;27 (6): doi:10.1111/1756-185X.15243.$$$$$Y$$$20240709$$HP$IN$IN
240647762$24064776$2$F$$20240725$20240709$20240802$EXP$$GB-TEVA-VS-3216262$TEVA$$15$YR$$F$Y$$$20240802$$HP$GB$GB
240647773$24064777$3$F$$20240828$20240709$20240906$PER$$US-SA-2024SA197986$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240906$$MD$US$US
240647781$24064778$1$I$20161215$20240701$20240709$20240709$EXP$AT-EMA-DD-20240621-7482655-074943$AT-TEVA-VS-3216276$TEVA$$28$YR$$F$Y$65$KG$20240709$$MD$AT$AT
240647811$24064781$1$I$20240705$20240708$20240708$20240708$DIR$709403$$FDA-CTU$$71$YR$$F$N$49.5$KG$20240708$N$CN$US$
240647821$24064782$1$I$20240705$20240708$20240708$20240708$DIR$709409$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240647831$24064783$1$I$20240705$20240708$20240708$20240708$DIR$709411$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240647841$24064784$1$I$$20240708$20240708$20240708$DIR$709413$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240647861$24064786$1$I$20240122$20240705$20240709$20240709$EXP$$DE-SANDOZ INC.-SDZ2024DE063196$SANDOZ$$$$$F$Y$$$20240709$$HP$DE$DE
240647871$24064787$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405071452323360-WHMRS$GB-SANDOZ INC.-SDZ2024GB063650$SANDOZ$$$$$F$Y$40$KG$20240709$$HP$GB$GB
240647881$24064788$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA196098$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240709$$MD$US$US
240647891$24064789$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA126971$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240709$$CN$US$US
240647902$24064790$2$F$20240101$20240815$20240709$20240828$PER$$US-SA-2024SA199360$SANOFI AVENTIS$$60$YR$A$M$Y$68.03$KG$20240828$$MD$US$US
240647911$24064791$1$I$20240617$20240708$20240709$20240709$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038606$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240709$$CN$US$US
240647921$24064792$1$I$20240101$20240626$20240709$20240709$EXP$$US-BEH-2024167945$CSL BEHRING$$16$YR$T$M$Y$$$20240709$$MD$US$US
240647931$24064793$1$I$$20240705$20240709$20240709$EXP$$AU-MYLANLABS-2024M1063568$MYLAN$$$$$F$Y$$$20240709$$PH$AU$AU
240647941$24064794$1$I$20170106$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405142045567050-ZYRQP$GB-MYLANLABS-2024M1063609$MYLAN$$18$YR$$F$Y$55$KG$20240709$$CN$GB$GB
240647951$24064795$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405132346085840-QZKWM$GB-MYLANLABS-2024M1063590$MYLAN$$$$$M$Y$69$KG$20240709$$CN$GB$GB
240647961$24064796$1$I$20240509$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405161321288170-VSLJQ$GB-MYLANLABS-2024M1063598$MYLAN$$$$$F$Y$$$20240709$$CN$GB$GB
240647971$24064797$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405071205522550-YWQRT$GB-MYLANLABS-2024M1063781$MYLAN$$$$$$Y$$$20240709$$PH$GB$GB
240647982$24064798$2$F$$20240808$20240709$20240818$EXP$$US-GSK-US2024083935$GLAXOSMITHKLINE$$66$YR$$M$Y$$$20240818$$CN$US$US
240647991$24064799$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA197003$SANOFI AVENTIS$$21$YR$A$F$Y$68$KG$20240709$$MD$US$US
240648001$24064800$1$I$$20240625$20240709$20240709$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK091978$GLENMARK$$$$$$Y$$$20240709$$HP$CA$CA
240648011$24064801$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004555$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240709$$CN$US$US
240648021$24064802$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024135157$AMGEN$$$$$M$Y$$$20240709$$CN$US$US
240648031$24064803$1$I$20240703$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135483$AMGEN$$$$$$Y$$$20240709$$HP$US$US
240648041$24064804$1$I$$20240702$20240709$20240709$PER$$US-AMGEN-USASP2024133389$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$56$YR$A$M$Y$$$20240709$$HP$US$US
240648051$24064805$1$I$$20240701$20240709$20240709$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004922$BIOCON$$$$$$Y$$$20240709$$CN$CA$CA
240648062$24064806$2$F$20240626$20240709$20240709$20240715$PER$$US-AMGEN-USASP2024135190$AMGEN$$57$YR$A$F$Y$$$20240715$$CN$US$US
240648071$24064807$1$I$20240708$20240708$20240708$20240708$DIR$709421$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240648081$24064808$1$I$$20240708$20240708$20240708$DIR$709422$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240648091$24064809$1$I$20170101$20240702$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108304$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240709$$HP$US$US
240648101$24064810$1$I$$20240708$20240708$20240708$DIR$709425$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240648111$24064811$1$I$$20240708$20240708$20240708$DIR$709415$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240648121$24064812$1$I$20240703$20240708$20240708$20240708$DIR$709424$$FDA-CTU$$54$YR$$F$N$$$20240708$N$HP$US$
240648131$24064813$1$I$20240331$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108012$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240709$$CN$US$US
240648141$24064814$1$I$$20240708$20240708$20240708$DIR$709419$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240648151$24064815$1$I$20240401$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108212$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$54.88$KG$20240709$$CN$US$US
240648161$24064816$1$I$$20240708$20240708$20240708$DIR$709420$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240648171$24064817$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47324$$FDA-CTU$$88$YR$$F$N$80.74$KG$20240708$N$$US$
240648181$24064818$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108213$BRISTOL MYERS SQUIBB$$4$YR$C$F$Y$$$20240709$$HP$US$US
240648191$24064819$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47345$$FDA-CTU$$68$YR$$F$N$$$20240708$N$$US$
240648201$24064820$1$I$20240708$20240708$20240708$20240708$DIR$709426$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240648211$24064821$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47429$$FDA-CTU$$64$YR$$M$N$$$20240708$N$$US$
240648221$24064822$1$I$$20240628$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105699$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240709$$MD$US$US
240648241$24064824$1$I$20240630$20240703$20240709$20240709$EXP$$JP-009507513-2407JPN000063J$MERCK$$77$YR$$F$Y$$$20240709$$PH$JP$JP
240648261$24064826$1$I$$20240708$20240708$20240708$DIR$709427$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240648271$24064827$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405060340208450-NZPQH$GB-MYLANLABS-2024M1063543$MYLAN$$$$$F$Y$$$20240709$$CN$GB$GB
240648281$24064828$1$I$20230505$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405101240033280-FJZBW$GB-MYLANLABS-2024M1063452$MYLAN$$44$YR$$M$Y$$$20240709$$CN$GB$GB
240648291$24064829$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405140926193210-RWLZF$GB-MYLANLABS-2024M1063453$MYLAN$$$$$F$Y$$$20240709$$HP$GB$GB
240648301$24064830$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405041847147620-RJSCK$GB-MYLANLABS-2024M1063418$MYLAN$$$$$F$Y$$$20240709$$PH$GB$GB
240648312$24064831$2$F$$20240802$20240709$20240807$EXP$GB-MHRA-MED-202405162318157690-FNGQT$GB-MYLANLABS-2024M1063696$MYLAN$$$$$M$Y$$$20240807$$CN$GB$GB
240648321$24064832$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405170858595570-QCHVJ$GB-MYLANLABS-2024M1063478$MYLAN$$$$$F$Y$$$20240709$$PH$GB$GB
240648331$24064833$1$I$20240322$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405161416520420-JKQYG$GB-MYLANLABS-2024M1063431$MYLAN$$44$YR$$M$Y$$$20240709$$CN$GB$GB
240648341$24064834$1$I$$20240703$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108188$BRISTOL MYERS SQUIBB$$32$YR$A$M$Y$$$20240709$$CN$US$US
240648352$24064835$2$F$20240626$20240903$20240709$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107884$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240906$$CN$US$US
240648371$24064837$1$I$20240705$20240705$20240709$20240709$PER$$US-JNJFOC-20240716100$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240709$$CN$US$US
240648382$24064838$2$F$20240626$20240819$20240709$20240827$EXP$$JP-AMGEN-JPNSP2024133818$AMGEN$$80$YR$E$F$Y$$$20240827$$MD$JP$JP
240648391$24064839$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134872$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240648401$24064840$1$I$20240628$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135260$AMGEN$$72$YR$E$M$Y$$$20240709$$CN$US$US
240648411$24064841$1$I$$20240110$20240709$20240709$EXP$GB-MHRA-MED-202401091847051200-BSTYV$GB-TEVA-VS-3145852$TEVA$$$$$$Y$$$20240709$$CN$GB$GB
240648421$24064842$1$I$20240628$20240702$20240709$20240709$EXP$$CO-SA-2024SA198716$SANOFI AVENTIS$$86$YR$E$F$Y$82$KG$20240709$$HP$CO$CO
240648431$24064843$1$I$$20240702$20240709$20240709$PER$$US-BIOGEN-2024BI01272387$BIOGEN$$$$$$Y$$$20240709$$HP$US$US
240648442$24064844$2$F$20230901$20240704$20240709$20240711$EXP$GB-MHRA-MED-202407021235502260-VRZQL$GB-SA-2024SA198762$SANOFI AVENTIS$$$$$M$Y$$$20240711$$MD$GB$GB
240648452$24064845$2$F$20240701$20240701$20240709$20240710$EXP$$US-CSL-2024-006280$CSL Plasma$$30$YR$$F$Y$$$20240710$$HP$US$US
240648461$24064846$1$I$$20240702$20240709$20240709$PER$$US-BIOGEN-2024BI01272500$BIOGEN$$$$$M$Y$$$20240709$$HP$US$US
240648471$24064847$1$I$20240614$20240702$20240709$20240709$EXP$IT-MINISAL02-992507$IT-MYLANLABS-2024M1062244$MYLAN$$50$YR$$F$Y$$$20240709$$PH$IT$IT
240648484$24064848$4$F$20230303$20240807$20240709$20240809$EXP$$HU-MYLANLABS-2024M1062256$MYLAN$Lakatos V, Gopcsa L, Balogh A, Fabian J, Remenyi P.. T-cell prolymphocytic leukaemia treatment and transplantation presented through two case reports.. Haematology - Transfusiology. 2024;65-69$62$YR$$F$Y$$$20240809$$MD$HU$HU
240648491$24064849$1$I$20240618$20240702$20240709$20240709$EXP$FR-AFSSAPS-RS2024000626$FR-MYLANLABS-2024M1062226$MYLAN$$73$YR$$M$Y$70$KG$20240709$$MD$FR$FR
240648511$24064851$1$I$20240214$20240702$20240709$20240709$EXP$FR-AFSSAPS-AVMA2024000271$FR-MYLANLABS-2024M1062078$MYLAN$$26$YR$$M$Y$$$20240709$$PH$FR$FR
240648524$24064852$4$F$$20240730$20240709$20240806$EXP$$ZA-MYLANLABS-2024M1062220$MYLAN$$$$$F$Y$1.76$KG$20240806$$HP$ZA$ZA
240648531$24064853$1$I$20231029$20240702$20240709$20240709$EXP$BE-FAMHP-DHH-N2024-122301$BE-MYLANLABS-2024M1062218$MYLAN$$49$YR$$F$Y$72$KG$20240709$$CN$BE$BE
240648541$24064854$1$I$20240525$20240702$20240709$20240709$EXP$FR-AFSSAPS-TS2024000745$FR-MYLANLABS-2024M1062261$MYLAN$$49$YR$$F$Y$89$KG$20240709$$MD$FR$FR
240648551$24064855$1$I$20240410$20240702$20240709$20240709$EXP$ES-AEMPS-1540138$ES-MYLANLABS-2024M1062236$MYLAN$$77$YR$$F$Y$52.4$KG$20240709$$MD$ES$ES
240648581$24064858$1$I$20240415$20240702$20240709$20240709$EXP$FR-AFSSAPS-PC2024000499$FR-MYLANLABS-2024M1062207$MYLAN$$63$YR$$M$Y$86$KG$20240709$$MD$FR$FR
240648591$24064859$1$I$20240406$20240702$20240709$20240709$EXP$SE-SEMPA-2024-005191$SE-MYLANLABS-2024M1062282$MYLAN$$70$YR$$F$Y$72$KG$20240709$$MD$SE$SE
240648601$24064860$1$I$$20240702$20240709$20240709$EXP$$DE-MYLANLABS-2024M1062263$MYLAN$$$$$F$Y$$$20240709$$CN$DE$DE
240648613$24064861$3$F$20240303$20240808$20240709$20240814$EXP$FR-AFSSAPS-AVMA2024000266$FR-MYLANLABS-2024M1062096$MYLAN$$44$YR$$F$Y$$$20240814$$PH$FR$FR
240648641$24064864$1$I$20240707$20240708$20240709$20240709$EXP$$CN-PFIZER INC-PV202400089492$PFIZER$$36$YR$$F$Y$74$KG$20240709$$HP$CN$CN
240648655$24064865$5$F$$20240919$20240709$20240924$30DAY$$US-PFIZER INC-202400205184$PFIZER$$13$YR$$M$Y$$$20240924$$CN$US$US
240648661$24064866$1$I$20240613$20240708$20240709$20240709$EXP$$US-PFIZER INC-PV202400089289$PFIZER$$83$YR$$M$Y$$$20240709$$CN$US$US
240648674$24064867$4$F$$20240904$20240709$20240906$30DAY$$US-PFIZER INC-202400203297$PFIZER$$4$YR$$M$Y$$$20240906$$CN$US$US
240648683$24064868$3$F$$20240904$20240709$20240904$EXP$$GB-PFIZER INC-PV202400086675$PFIZER$$81$YR$$F$Y$$$20240904$$CN$GB$GB
240648692$24064869$2$F$20240625$20240801$20240709$20240805$EXP$PT-INFARMED-R202406-732$PT-PFIZER INC-202400208467$PFIZER$$37$YR$$M$Y$$$20240805$$PH$PT$PT
240648701$24064870$1$I$$20240708$20240709$20240709$EXP$$JP-PFIZER INC-202400208838$PFIZER$$85$YR$$F$Y$$$20240709$$MD$JP$JP
240648711$24064871$1$I$$20240625$20240709$20240709$EXP$$US-PFIZER INC-PV202400085050$PFIZER$Singleton, R.. Iatrogenic cerebral venous sinus occlusion with flowable topical hemostatic matrix. Journal of neurosurgery. 2011;115:576-583$33$YR$$M$Y$$$20240709$$MD$US$US
240648721$24064872$1$I$$20240708$20240709$20240709$EXP$$IN-PFIZER INC-PV202400089736$PFIZER$$61$YR$$F$Y$$$20240709$$CN$IN$IN
240648735$24064873$5$F$$20240925$20240709$20240927$30DAY$$US-PFIZER INC-202400205427$PFIZER$$7$YR$$M$Y$29.03$KG$20240927$$CN$US$US
240648742$24064874$2$F$20240623$20240708$20240709$20240710$EXP$$US-PFIZER INC-202400208944$PFIZER$$63$YR$$M$Y$$$20240710$$HP$US$US
240648751$24064875$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06066$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240648771$24064877$1$I$$20240619$20240709$20240709$PER$$US-TEVA-VS-3212972$TEVA$$49$YR$$F$Y$$$20240709$$CN$US$US
240648782$24064878$2$F$20221123$20240820$20240709$20240822$EXP$$CA-ROCHE-3224750$ROCHE$$38$YR$A$F$Y$$$20240822$$HP$CA$CA
240648791$24064879$1$I$20240627$20240627$20240709$20240709$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-105215$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240709$$MD$GB$GB
240648801$24064880$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107715$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240709$$CN$US$US
240648811$24064881$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107852$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240709$$PH$US$US
240648822$24064882$2$F$$20240821$20240709$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106705$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240829$$CN$US$US
240648831$24064883$1$I$20221201$20240626$20240709$20240709$EXP$$BR-TAKEDA-2024TUS066784$TAKEDA$$53$YR$$M$Y$$$20240709$$MD$BR$BR
240648841$24064884$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107646$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240709$$HP$US$US
240648851$24064885$1$I$$20240628$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104839$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240709$$CN$US$US
240648861$24064886$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107900$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240709$$MD$US$US
240648873$24064887$3$F$$20240918$20240709$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107974$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240923$$CN$US$US
240648881$24064888$1$I$$20240702$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106861$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240709$$MD$US$US
240648891$24064889$1$I$$20240701$20240709$20240709$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-106087$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240709$$HP$IL$IL
240648921$24064892$1$I$$20240701$20240709$20240709$EXP$$CA-AstraZeneca-2024A152669$ASTRAZENECA$$60$YR$$M$Y$$$20240709$$MD$CA$
240648931$24064893$1$I$$20240701$20240709$20240709$PER$$US-BAYER-2024A094964$BAYER$$24$YR$A$F$Y$$$20240709$$HP$US$US
240648941$24064894$1$I$20240704$20240705$20240709$20240709$EXP$GB-MHRA-MED-202407051142466950-LNFTY$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-108168$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240709$$HP$GB$GB
240648951$24064895$1$I$$20240701$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105332$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240709$$HP$US$US
240648961$24064896$1$I$$20240701$20240709$20240709$EXP$$VN-AstraZeneca-2024A155240$ASTRAZENECA$$$$$M$Y$$$20240709$$CN$VN$
240648971$24064897$1$I$20240513$20240701$20240709$20240709$EXP$FR-AFSSAPS-MA2024001032$FR-TEVA-VS-3216195$TEVA$$12$YR$$M$Y$$$20240709$$MD$FR$FR
240648981$24064898$1$I$20240618$20240628$20240709$20240709$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-104386$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240709$$PH$PR$PR
240648991$24064899$1$I$20231001$20240701$20240709$20240709$EXP$$DE-ROCHE-10000018370$ROCHE$$60$YR$A$F$Y$83$KG$20240709$$MD$DE$DE
240649001$24064900$1$I$$20240630$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104972$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$104.33$KG$20240709$$CN$US$US
240649011$24064901$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06325$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240649031$24064903$1$I$$20240701$20240709$20240709$EXP$$GB-TEVA-VS-3209105$TEVA$$82$YR$$M$Y$85$KG$20240709$$MD$GB$GB
240649041$24064904$1$I$20240703$20240708$20240708$20240708$DIR$709410$$FDA-CTU$$44$YR$$F$N$$$20240708$N$HP$US$
240649051$24064905$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47353$$FDA-CTU$$77$YR$$M$N$$$20240708$N$$US$
240649061$24064906$1$I$20240708$20240708$20240708$20240708$DIR$709433$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240649071$24064907$1$I$20240708$20240708$20240708$20240708$DIR$709431$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240649081$24064908$1$I$$20240705$20240708$20240708$DIR$FDA-CDER-CTU-2024-47310$$FDA-CTU$$$$$F$N$$$20240705$N$HP$US$
240649091$24064909$1$I$20240706$20240708$20240708$20240708$DIR$709436$$FDA-CTU$$41$YR$$M$N$$$20240708$N$CN$US$
240649101$24064910$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47319$$FDA-CTU$$79$YR$$M$N$$$20240708$N$$US$
240649111$24064911$1$I$20240706$20240708$20240708$20240708$DIR$709405$$FDA-CTU$$57$YR$$F$N$77.4$KG$20240708$N$CN$US$
240649141$24064914$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA196547$SANOFI AVENTIS$$$$A$F$Y$124.73$KG$20240709$$MD$US$US
240649193$24064919$3$F$$20240904$20240709$20240906$30DAY$$US-PFIZER INC-202400204653$PFIZER$$12$YR$$M$Y$$$20240906$$CN$US$US
240649222$24064922$2$F$20240101$20240716$20240709$20240723$EXP$$NVSC2024AU140962$NOVARTIS$$$$$F$Y$$$20240723$$CN$AU$AU
240649231$24064923$1$I$20240501$20240708$20240709$20240709$EXP$$NVSC2024GB107094$NOVARTIS$$61$YR$$F$Y$53$KG$20240709$$CN$GB$GB
240649241$24064924$1$I$20240601$20240701$20240709$20240709$PER$$US-BAYER-2024A095208$BAYER$$$$$F$Y$$$20240709$$MD$US$US
240649251$24064925$1$I$$20240703$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106968$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240709$$CN$US$US
240649261$24064926$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-011778$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240709$$CN$US$US
240649271$24064927$1$I$$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106836$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240709$$HP$US$US
240649291$24064929$1$I$$20240703$20240709$20240709$PER$$US-AMGEN-USASP2024133193$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240649302$24064930$2$F$$20240916$20240709$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107122$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$64.41$KG$20240923$$CN$US$US
240649312$24064931$2$F$$20240807$20240709$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107549$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240809$$CN$US$US
240649324$24064932$4$F$20240707$20240819$20240709$20240827$PER$$US-AMGEN-USASP2024135357$AMGEN$$83$YR$E$M$Y$$$20240827$$CN$US$US
240649331$24064933$1$I$$20240702$20240709$20240709$PER$$US-BAYER-2024A095606$BAYER$$30$YR$A$F$Y$$$20240709$$HP$US$US
240649341$24064934$1$I$20240624$20240708$20240708$20240708$DIR$709401$$FDA-CTU$$37$YR$$M$N$138$KG$20240708$N$HP$US$
240649351$24064935$1$I$20240501$20240708$20240709$20240709$PER$$US-JNJFOC-20240719694$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$US$US
240649361$24064936$1$I$$20240618$20240709$20240709$EXP$$CO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453956$RANBAXY$Nati-Castillo HA, Aristizabal-Colorado D, Lopez Ordonez C, Egas Proano D, Ortiz-Prado E, Izquierdo-Condoy JS. Takotsubo syndrome as an acute cardiac complication following combined chemotherapy. Int J Cardiol Cardiovasc Risk Prev. 2024;22:200292$61$YR$$F$Y$$$20240703$$HP$CO$CO
240649381$24064938$1$I$$20240703$20240709$20240709$EXP$$US-INCYTE CORPORATION-2024IN006085$INCYTE$$$$$$Y$$$20240709$$CN$US$US
240649391$24064939$1$I$20240401$20240703$20240709$20240709$PER$$US-SA-2024SA199137$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240709$$MD$US$US
240649402$24064940$2$F$$20240802$20240709$20240806$PER$$US-AMGEN-USASP2024134837$AMGEN$$$$$M$Y$$$20240805$$CN$US$US
240649421$24064942$1$I$20240501$20240628$20240709$20240709$PER$$US-SA-2024SA194382$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240709$$MD$US$US
240649431$24064943$1$I$$20240703$20240709$20240709$PER$$US-AMGEN-USASP2024132475$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240649441$24064944$1$I$$20240708$20240708$20240708$DIR$709407$$FDA-CTU$$$$$UNK$N$$$20240708$$CN$US$
240649451$24064945$1$I$20180801$20240703$20240709$20240709$EXP$$US-PFIZER INC-2018SGN02065$PFIZER$$67$YR$$M$Y$$$20240709$$HP$US$US
240649461$24064946$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06335$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240649481$24064948$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA195549$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$CN$US$US
240649491$24064949$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA198886$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240709$$MD$US$US
240649502$24064950$2$F$20240707$20240709$20240709$20240710$PER$$US-AMGEN-USASP2024134826$AMGEN$$66$YR$E$$Y$$$20240710$$PH$US$US
240649512$24064951$2$F$$20240919$20240709$20240928$EXP$$PT-ROCHE-10000007145$ROCHE$Serino M, Cardoso C, Veiga F, Santos V, Araujo D, Novais-Bastos H, et al. Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors. Pulmonology. 2024;30 (4):352-61. doi:10.1016/j.pulmoe.2022.03.003.$$$$$Y$$$20240928$$MD$PT$PT
240649521$24064952$1$I$$20240708$20240709$20240709$PER$$US-BAYER-2024A098208$BAYER$$$$$$Y$$$20240709$$CN$US$US
240649533$24064953$3$F$20240601$20240729$20240709$20240805$EXP$$CA-OTSUKA-2024_018969$OTSUKA$$23$YR$$M$Y$$$20240805$$HP$CA$CA
240649552$24064955$2$F$$20240729$20240709$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107701$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240807$$PH$JP$JP
240649571$24064957$1$I$20230815$20240628$20240709$20240709$EXP$$CA-ROCHE-3408275$ROCHE$$51$YR$A$M$Y$$$20240709$$CN$CA$CA
240649581$24064958$1$I$$20240630$20240709$20240709$EXP$$US-APOTEX-2024AP008026$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240709$$HP$US$US
240649591$24064959$1$I$20240628$20240701$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105235$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240709$$PH$US$US
240649601$24064960$1$I$$20240708$20240709$20240709$PER$$US-BAYER-2024A098272$BAYER$$$$$$Y$$$20240709$$CN$US$US
240649612$24064961$2$F$$20240920$20240709$20240920$PER$$NVSC2024US141695$NOVARTIS$$$$$F$Y$$$20240920$$MD$US$US
240649621$24064962$1$I$20231123$20240704$20240709$20240709$EXP$$IL-ABBVIE-5831029$ABBVIE$$73$YR$$M$Y$$$20240709$$CN$IL$IL
240649632$24064963$2$F$$20240716$20240709$20240726$EXP$$HU-TEVA-VS-3215412$TEVA$Cegledi A, Batai A, Dolgos J, Fekete M, Gopcsa L, Kiraly V, et al. Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol. Pathol-Oncol-Res 2024; 30.; Cegledi A, Batai A, Dolgos J, Fekete M, Gopcsa L, Kiraly V, et al. Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol. Pathol-Oncol-Res 2024; 30.$68$YR$$M$Y$$$20240726$$HP$HU$HU
240649641$24064964$1$I$20240629$20240701$20240709$20240709$PER$$US-SA-2024SA196166$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240709$$MD$US$US
240649651$24064965$1$I$20240522$20240625$20240709$20240709$EXP$FR-AFSSAPS-AN2024000797$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-06087$HIKMA$$$$$$Y$$$20240709$$MD$FR$FR
240649671$24064967$1$I$20240707$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005488$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240709$$CN$US$US
240649681$24064968$1$I$20240507$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405090234004530-TSGYV$GB-MYLANLABS-2024M1063092$MYLAN$$26$YR$$M$Y$108$KG$20240709$$CN$GB$GB
240649691$24064969$1$I$20240509$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405090820398950-MQBSY$GB-MYLANLABS-2024M1063156$MYLAN$$62$YR$$M$Y$78$KG$20240709$$MD$GB$GB
240649701$24064970$1$I$$20240703$20240709$20240709$EXP$FR-AFSSAPS-AVPO2024000121$FR-CHEPLA-2024008384$CHEPLAPHARM$$$$$M$Y$$$20240709$$PH$COUNTRY NOT SPECIFIED$FR
240649711$24064971$1$I$20240414$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405131552461280-YCJTB$GB-MYLANLABS-2024M1063277$MYLAN$$47$YR$$M$Y$137$KG$20240709$$HP$GB$GB
240649721$24064972$1$I$20240507$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405131348578650-VJQWD$GB-MYLANLABS-2024M1063021$MYLAN$$32$YR$$F$Y$65$KG$20240709$$CN$GB$GB
240649732$24064973$2$F$$20240819$20240709$20240823$EXP$$NVSC2024AU140150$NOVARTIS$$$$$F$Y$$$20240823$$CN$AU$AU
240649761$24064976$1$I$$20240708$20240709$20240709$EXP$$AT-ABBVIE-5831252$ABBVIE$$$$$F$Y$$$20240709$$CN$AT$AT
240649771$24064977$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05840$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240649781$24064978$1$I$$20240705$20240709$20240709$EXP$$NVSC2024US140910$NOVARTIS$$$$$$Y$$$20240709$$CN$US$US
240649791$24064979$1$I$$20240704$20240709$20240709$EXP$$NVSC2024AU139748$NOVARTIS$$$$$M$Y$$$20240709$$HP$AU$AU
240649801$24064980$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141648$NOVARTIS$$$$$F$Y$$$20240709$$HP$US$US
240649813$24064981$3$F$20240501$20240823$20240709$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106280$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240830$$CN$US$US
240649821$24064982$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108133$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$52.62$KG$20240709$$HP$US$US
240649831$24064983$1$I$$20240703$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108155$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240709$$CN$US$US
240649843$24064984$3$F$$20240827$20240709$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107830$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240829$$HP$US$US
240649851$24064985$1$I$$20240703$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108172$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240709$$CN$US$US
240649863$24064986$3$F$20240628$20240724$20240709$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106294$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240730$$CN$US$US
240649871$24064987$1$I$20230801$20240703$20240709$20240709$EXP$GB-MHRA-MED-202407021100306640-MFJBG$GB-BIOCON BIOLOGICS LIMITED-BBL2024004979$BIOCON$$$$$$Y$$$20240709$$CN$GB$GB
240649882$24064988$2$F$$20240729$20240709$20240805$EXP$$HK-BRISTOL-MYERS SQUIBB COMPANY-2024-107678$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$MD$HK$HK
240649891$24064989$1$I$20240626$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108110$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$51.71$KG$20240709$$HP$US$US
240649901$24064990$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156102$ASTRAZENECA$$$$$M$Y$61$KG$20240709$$HP$FR$
240649912$24064991$2$F$20240626$20240729$20240709$20240730$EXP$$NL-ABBVIE-5831197$ABBVIE$$57$YR$$M$Y$$$20240730$$CN$NL$NL
240649921$24064992$1$I$20240701$20240702$20240709$20240709$PER$$US-SA-2024SA198673$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240709$$CN$US$US
240649931$24064993$1$I$20240603$20240627$20240709$20240709$PER$$US-SA-2024SA194726$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240709$$MD$US$US
240649941$24064994$1$I$20240601$20240626$20240709$20240709$PER$$US-SA-2024SA193050$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240709$$MD$US$US
240649951$24064995$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA196183$SANOFI AVENTIS$$$$$$Y$$$20240709$$CN$US$US
240649963$24064996$3$F$20240521$20240816$20240709$20240821$EXP$$CN-SA-2024SA168393$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240821$$MD$CN$CN
240649971$24064997$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA199148$SANOFI AVENTIS$$70$YR$E$F$Y$62$KG$20240709$$MD$US$US
240649981$24064998$1$I$20240401$20240702$20240709$20240709$PER$$US-SA-2024SA198960$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240709$$MD$US$US
240649991$24064999$1$I$$20240701$20240709$20240709$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004923$BIOCON$$$$$$Y$$$20240709$$CN$CA$CA
240650001$24065000$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47312$$FDA-CTU$$80$YR$$F$N$$$20240708$N$$US$
240650011$24065001$1$I$20220906$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405111227472190-RWVFM$GB-MYLANLABS-2024M1063477$MYLAN$$71$YR$$M$Y$70$KG$20240709$$CN$GB$GB
240650021$24065002$1$I$20240517$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405171053306570-DYQVC$GB-MYLANLABS-2024M1064003$MYLAN$$78$YR$$M$Y$$$20240709$$PH$GB$GB
240650041$24065004$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024135485$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240650052$24065005$2$F$20240702$20240716$20240709$20240721$30DAY$$US-AMGEN-USASP2024132487$AMGEN$$67$YR$E$M$Y$91.3$KG$20240721$$PH$US$US
240650061$24065006$1$I$$20240618$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108224$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240709$$CN$US$US
240650071$24065007$1$I$20240330$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107644$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240709$$CN$US$US
240650081$24065008$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108119$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240709$$CN$US$US
240650101$24065010$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107952$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$63.05$KG$20240709$$CN$US$US
240650111$24065011$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107996$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240709$$HP$US$US
240650121$24065012$1$I$20240601$20240702$20240709$20240709$EXP$$US-009507513-2407USA001525$MERCK$$54$YR$$F$Y$$$20240709$$CN$US$US
240650131$24065013$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47425$$FDA-CTU$$62$YR$$F$N$$$20240708$N$$US$
240650141$24065014$1$I$$20240708$20240708$20240708$DIR$709408$$FDA-CTU$$$$$UNK$N$$$20240708$$CN$US$
240650161$24065016$1$I$$20240702$20240709$20240709$EXP$$AU-TAKEDA-2024TUS068117$TAKEDA$$23$YR$$F$Y$$$20240709$$HP$AU$AU
240650171$24065017$1$I$20240618$20240705$20240709$20240709$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038242$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$68$KG$20240709$$MD$JP$JP
240650182$24065018$2$F$$20240903$20240709$20240904$EXP$$NVSC2024FR141143$NOVARTIS$$$$$F$Y$$$20240904$$HP$FR$FR
240650191$24065019$1$I$$20240701$20240709$20240709$EXP$GB-MHRA-MED-202406290022557800-FPLVB$GB-TEVA-VS-3215990$TEVA$$$$$F$Y$96$KG$20240709$$CN$GB$GB
240650201$24065020$1$I$20240630$20240702$20240709$20240709$PER$$US-BAYER-2024A095831$BAYER$$16$YR$T$M$Y$$$20240709$$CN$US$US
240650211$24065021$1$I$$20240708$20240708$20240708$DIR$709438$$FDA-CTU$$$$$UNK$N$$$20240708$$CN$US$
240650221$24065022$1$I$$20240708$20240708$20240708$DIR$709440$$FDA-CTU$$$$$M$N$$$20240708$N$HP$US$
240650231$24065023$1$I$20240315$20240708$20240708$20240708$DIR$709444$$FDA-CTU$$44$YR$$F$N$$$20240708$N$HP$US$
240650251$24065025$1$I$$20240701$20240709$20240709$EXP$$US-TAKEDA-2024TUS066150$TAKEDA$$$$$M$Y$$$20240709$$CN$US$US
240650261$24065026$1$I$20240707$20240708$20240708$20240708$DIR$709446$$FDA-CTU$$59$YR$$F$N$64.8$KG$20240708$N$CN$US$
240650271$24065027$1$I$20240708$20240708$20240708$20240708$DIR$709450$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240650291$24065029$1$I$$20240708$20240708$20240708$DIR$709454$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240650301$24065030$1$I$$20240708$20240708$20240708$DIR$709455$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240650311$24065031$1$I$20240621$20240708$20240708$20240708$DIR$709448$$FDA-CTU$$55$YR$$M$N$84.15$KG$20240708$N$CN$US$
240650341$24065034$1$I$20110404$20240708$20240708$20240708$DIR$709396$$FDA-CTU$$37$YR$$M$N$81$KG$20240708$N$CN$US$
240650361$24065036$1$I$20240620$20240708$20240708$20240708$DIR$709412$$FDA-CTU$$71$YR$$F$N$58.5$KG$20240708$N$CN$US$
240650381$24065038$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47348$$FDA-CTU$$65$YR$$F$N$30.84$KG$20240708$N$$US$
240650391$24065039$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47406$$FDA-CTU$$59$YR$$M$N$$$20240708$N$$US$
240650401$24065040$1$I$20240626$20240708$20240708$20240708$DIR$709469$$FDA-CTU$$52$YR$$F$N$76.2$KG$20240708$N$PH$US$
240650411$24065041$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47414$$FDA-CTU$$67$YR$$M$N$$$20240708$N$$US$
240650421$24065042$1$I$20240708$20240708$20240708$20240708$DIR$709499$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240650433$24065043$3$F$$20240812$20240709$20240812$PER$$US-ALXN-202407USA000320US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240812$$MD$US$US
240650442$24065044$2$F$$20240703$20240709$20240715$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700108$MYOVANT SCIENCES$$$$$M$Y$$$20240715$$CN$US$US
240650451$24065045$1$I$20240618$20240702$20240709$20240709$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700080$MYOVANT SCIENCES$$73$YR$$M$Y$$$20240709$$CN$US$US
240650461$24065046$1$I$$20240701$20240709$20240709$EXP$$US-SA-2024SA198333$SANOFI AVENTIS$$$$A$M$Y$$$20240709$$MD$US$US
240650472$24065047$2$F$20210101$20240830$20240709$20240906$EXP$$BR-GSK-BR2021AMR105741$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$BR$BR
240650481$24065048$1$I$20240701$20240702$20240709$20240709$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024083044$VIIV$$47$YR$$F$Y$$$20240709$$HP$US$US
240650491$24065049$1$I$20240413$20240625$20240709$20240709$EXP$$AU-ROCHE-10000018394$ROCHE$$65$YR$E$F$Y$$$20240709$$MD$AU$AU
240650501$24065050$1$I$$20240702$20240709$20240709$EXP$$BE-PFIZER INC-202400206823$PFIZER$Boland, L.. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19. Transplant International. 2024;37:10.3389/ti.2024.12360$$$A$$Y$$$20240709$$HP$BE$BE
240650511$24065051$1$I$$20240702$20240709$20240709$EXP$$BE-PFIZER INC-202400206824$PFIZER$Boland, L.. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19. Transplant International. 2024;37:10.3389/ti.2024.12360$$$A$$Y$$$20240709$$HP$BE$BE
240650521$24065052$1$I$$20240702$20240709$20240709$EXP$$BE-PFIZER INC-202400206826$PFIZER$Boland, L.. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19. Transplant International. 2024;37:10.3389/ti.2024.12360$$$A$$Y$$$20240709$$HP$BE$BE
240650532$24065053$2$F$$20240809$20240709$20240814$EXP$$BE-PFIZER INC-202400206827$PFIZER$Boland, L.. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19. Transplant International. 2024;37:10.3389/ti.2024.12360$$$A$$Y$$$20240814$$HP$BE$BE
240650541$24065054$1$I$$20240702$20240709$20240709$EXP$$BE-PFIZER INC-202400206825$PFIZER$Boland, L.. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19. Transplant International. 2024;37:10.3389/ti.2024.12360$$$A$$Y$$$20240709$$HP$BE$BE
240650561$24065056$1$I$$20240705$20240709$20240709$PER$$US-BAYER-2024A097521$BAYER$$$$$$Y$$$20240709$$CN$US$US
240650571$24065057$1$I$$20240702$20240709$20240709$EXP$$BE-PFIZER INC-PV202400087942$PFIZER$Boland, L.. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19. Transplant International. 2024;37:10.3389/ti.2024.12360$$$A$$Y$$$20240709$$HP$BE$BE
240650581$24065058$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA194799$SANOFI AVENTIS$$$$A$F$Y$142$KG$20240709$$MD$US$US
240650591$24065059$1$I$20240703$20240703$20240709$20240709$PER$$US-SA-2024SA198778$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240709$$MD$US$US
240650601$24065060$1$I$20240501$20240702$20240709$20240709$PER$$US-SA-2024SA198461$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240709$$MD$US$US
240650611$24065061$1$I$20240701$20240701$20240709$20240709$PER$$US-SA-2024SA196202$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240709$$MD$US$US
240650621$24065062$1$I$$20240701$20240709$20240709$EXP$$JP-CHEPLA-2024008466$CHEPLAPHARM$Kunimoto M, Watanabe O, Takahashi H, Koizumi A, Shigehara F, Soeda N, et al.. DP-58: Two cases of delayed suture insufficiency due to bevacizumab. The 46th Annual Meeting of Japanese Society for Research of Loco-Regional Cancer. 2024;131$77$YR$$M$Y$$$20240709$$MD$COUNTRY NOT SPECIFIED$JP
240650632$24065063$2$F$$20240703$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106778$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240709$$HP$US$US
240650641$24065064$1$I$20240301$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108303$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240709$$CN$US$US
240650673$24065067$3$F$$20240828$20240709$20240909$EXP$$US-ZENPEP LLC-2024AIMT01041$AIMMUNE$$$$$$Y$$$20240909$$CN$US$US
240650691$24065069$1$I$$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107816$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240709$$CN$US$US
240650711$24065071$1$I$$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106582$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240709$$CN$US$US
240650721$24065072$1$I$20240708$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108394$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240709$$CN$US$US
240650731$24065073$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108370$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240709$$HP$US$US
240650741$24065074$1$I$20240702$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108326$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240709$$CN$US$US
240650751$24065075$1$I$20240119$20240708$20240709$20240709$EXP$FR-AFSSAPS-RN2024000751$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-108203$BRISTOL MYERS SQUIBB$$103$YR$E$F$Y$$$20240709$$HP$FR$FR
240650771$24065077$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108423$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240709$$HP$US$US
240650781$24065078$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108050$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240709$$CN$US$US
240650791$24065079$1$I$$20240707$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107964$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$109.77$KG$20240709$$CN$US$US
240650801$24065080$1$I$20240701$20240702$20240709$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107710$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$47.8$KG$20240709$$PH$JP$JP
240650811$24065081$1$I$20240101$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108338$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240709$$HP$US$US
240650821$24065082$1$I$20240617$20240704$20240709$20240709$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-108199$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240709$$HP$BR$BR
240650831$24065083$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108329$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240709$$HP$US$US
240650841$24065084$1$I$$20240702$20240709$20240709$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-106212$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240709$$MD$BR$BR
240650851$24065085$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108373$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240709$$HP$US$US
240650861$24065086$1$I$20240708$20240708$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108332$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$$$20240709$$CN$US$US
240650871$24065087$1$I$20231016$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108364$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$67.13$KG$20240709$$CN$US$US
240650884$24065088$4$F$20240702$20240826$20240709$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108391$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240903$$CN$US$US
240650901$24065090$1$I$$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108058$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240709$$CN$US$US
240650911$24065091$1$I$20240601$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106924$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$89.81$KG$20240709$$CN$US$US
240650931$24065093$1$I$20240621$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107773$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240709$$HP$US$US
240650941$24065094$1$I$$20240703$20240709$20240709$EXP$$JP-TAKEDA-2024TUS069231$TAKEDA$$$$$M$Y$$$20240709$$PH$JP$JP
240650951$24065095$1$I$$20231002$20240709$20240709$PER$$US-AMGEN-USASP2023235527$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240650961$24065096$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134842$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240650975$24065097$5$F$20240707$20240813$20240709$20240820$PER$$US-AMGEN-USASP2024134853$AMGEN$$72$YR$E$F$Y$$$20240820$$CN$US$US
240650982$24065098$2$F$20190123$20240816$20240709$20240830$EXP$$CZ-UCBSA-2024034422$UCB$$37$YR$$F$Y$$$20240830$$MD$CZ$CZ
240650991$24065099$1$I$20240603$20240610$20240709$20240709$EXP$$US-NEBO-661358$PHARMACOSMOS$$$$$F$Y$$$20240709$$CN$US$US
240651003$24065100$3$F$$20240805$20240709$20240807$PER$$US-LEO Pharma-371784$LEO PHARM$$39$YR$$M$Y$$$20240807$$CN$US$US
240651023$24065102$3$F$20240101$20240814$20240709$20240814$30DAY$$US-PFIZER INC-202400204631$PFIZER$$8$YR$$M$Y$$$20240814$$CN$US$US
240651031$24065103$1$I$20231201$20240703$20240709$20240709$EXP$FR-AFSSAPS-LY2024000224$FR-PFIZER INC-2024SGN01387$PFIZER$$47$YR$$F$Y$51.1$KG$20240709$$MD$FR$FR
240651051$24065105$1$I$$20240708$20240709$20240709$PER$$US-BAYER-2024A098289$BAYER$$$$$M$Y$$$20240709$$CN$US$US
240651061$24065106$1$I$$20240703$20240709$20240709$PER$$US-BAYER-2024A096394$BAYER$$26$YR$A$F$Y$$$20240709$$HP$US$US
240651072$24065107$2$F$20240705$20240809$20240709$20240812$PER$$US-AMGEN-USASP2024134400$AMGEN$$63$YR$A$F$Y$$$20240812$$CN$US$US
240651091$24065109$1$I$20240627$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108333$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240709$$CN$US$US
240651101$24065110$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108285$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240709$$CN$US$US
240651131$24065113$1$I$20240628$20240702$20240709$20240709$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-108560$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$76.2$KG$20240709$$CN$PR$PR
240651141$24065114$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108380$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240709$$CN$US$US
240651151$24065115$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107888$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240709$$CN$US$US
240651161$24065116$1$I$$20240701$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105732$BRISTOL MYERS SQUIBB$Philip AM, Fernandez-Santos CC, Dolinko AH, Massoudi Y, Valerio T, Maleki A, et al. Cogan-like syndrome following nivolumab immunotherapy for metastatic cutaneous melanoma. Ocular Immunology and Inflammation. 2024 Jun 24;1-5. doi:10.1080/09273948.2024.2367661.$54$YR$A$F$Y$$$20240709$$MD$US$US
240651171$24065117$1$I$$20240701$20240709$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-108096$BRISTOL MYERS SQUIBB$Saito Y, et al. A case of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in a patient after hematopoietic stem cell transplantation. The 232nd Tohoku Regional Meeting of the Japanese Society of Internal Medicine.$7$DEC$E$F$Y$$$20240709$$HP$JP$JP
240651181$24065118$1$I$$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107997$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240709$$CN$US$US
240651191$24065119$1$I$20240401$20240625$20240709$20240709$EXP$$NL-VER-202400048$VERITY PHARMACEUTICALS$$69$YR$E$M$Y$$$20240709$$HP$NL$NL
240651201$24065120$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024135231$AMGEN$$$$$$Y$$$20240709$$PH$US$US
240651212$24065121$2$F$20240612$20240801$20240709$20240807$EXP$FR-AFSSAPS-AN2024000835$FR-RDY-SPO/FRA/24/0009788$DR REDDYS$$74$YR$E$M$Y$87$KG$20240807$$MD$FR$FR
240651221$24065122$1$I$$20240624$20240709$20240709$PER$$US-ROCHE-10000010241$ROCHE$$$$$$Y$$$20240709$$CN$US$US
240651231$24065123$1$I$$20240618$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099003$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240709$$PH$US$US
240651251$24065125$1$I$$20240705$20240709$20240709$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107931$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240709$$HP$CA$CA
240651261$24065126$1$I$20240619$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108324$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240709$$CN$US$US
240651271$24065127$1$I$$20240705$20240709$20240709$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107537$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$60$KG$20240709$$HP$CA$CA
240651281$24065128$1$I$20240701$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106528$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240709$$HP$US$US
240651292$24065129$2$F$$20240816$20240709$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107248$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240819$$MD$JP$JP
240651301$24065130$1$I$$20240704$20240709$20240709$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107355$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240709$$PH$CA$CA
240651313$24065131$3$F$20230921$20240830$20240709$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-041548$BRISTOL MYERS SQUIBB$Maeda R, et al. A case of malignant melanoma with irAE-related pleurisy during nivolumab. The 437th Hokkaido Regional Meeting of the Japanese Dermatological Association. 2024;6.$9$DEC$E$M$Y$$$20240903$$MD$JP$JP
240651321$24065132$1$I$20240701$20240708$20240709$20240709$EXP$$US-GILEAD-2024-0679941$GILEAD$$37$YR$A$M$Y$$$20240709$$HP$US$US
240651331$24065133$1$I$20240708$20240708$20240708$20240708$DIR$709500$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240651341$24065134$1$I$20240101$20240703$20240709$20240709$EXP$$US-ORGANON-O2407USA000310$ORGANON$$$$$M$Y$189$KG$20240709$$CN$US$US
240651351$24065135$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156084$ASTRAZENECA$$$$$M$Y$105$KG$20240709$$HP$FR$
240651361$24065136$1$I$20240102$20240701$20240709$20240709$EXP$FR-AFSSAPS-GR2024000755$FR-TEVA-VS-3216201$TEVA$$69$YR$$F$Y$78$KG$20240709$$PH$FR$FR
240651371$24065137$1$I$$20240626$20240709$20240709$PER$$US-AstraZeneca-2024A151367$ASTRAZENECA$$70$YR$$M$Y$$$20240709$$CN$US$
240651381$24065138$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004999$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240709$$CN$US$US
240651391$24065139$1$I$20240704$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005248$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240709$$CN$US$US
240651403$24065140$3$F$20240424$20240919$20240709$20240924$30DAY$$US-AMGEN-USASP2024129660$AMGEN$$$$$$Y$$$20240924$$HP$US$US
240651411$24065141$1$I$20221201$20240612$20240709$20240709$PER$$US-JNJFOC-20240634327$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240709$$CN$US$US
240651421$24065142$1$I$20240515$20240701$20240709$20240709$PER$$US-SA-2024SA197623$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240709$$MD$US$US
240651431$24065143$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA196251$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240709$$MD$US$US
240651441$24065144$1$I$20240401$20240701$20240709$20240709$PER$$US-SA-2024SA198522$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240709$$MD$US$US
240651451$24065145$1$I$20231225$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405081504444240-PCBKT$GB-MYLANLABS-2024M1063547$MYLAN$$27$YR$$F$Y$76$KG$20240709$$CN$GB$GB
240651461$24065146$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108274$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240709$$CN$US$US
240651471$24065147$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108191$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240709$$HP$US$US
240651481$24065148$1$I$20240708$20240708$20240708$20240708$DIR$709465$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240651491$24065149$1$I$$20240629$20240709$20240709$EXP$$CA-ABBVIE-5831559$ABBVIE$$67$YR$$F$Y$$$20240709$$HP$CA$CA
240651501$24065150$1$I$20240705$20240706$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107966$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240709$$CN$US$US
240651511$24065151$1$I$20240630$20240708$20240708$20240708$DIR$709471$$FDA-CTU$$57$YR$$F$N$58$KG$20240708$N$HP$US$
240651521$24065152$1$I$$20240701$20240709$20240709$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-105870$BRISTOL MYERS SQUIBB$Logiacco A, Basile P, Mandunzio D, Gentile M, Carella M, Memeo R, et al. A rare case of ipilimumab/nivolumab-induced myocarditis complicated by high grade atrioventricular block in a patient with metastatic renal cell cancer. European Heart Journal. 2024 Apr 01;26(Supplement 2):ii175.$70$YR$E$F$Y$$$20240709$$HP$IT$IT
240651531$24065153$1$I$20200101$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108562$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240709$$HP$US$US
240651541$24065154$1$I$20240706$20240708$20240708$20240708$DIR$709428$$FDA-CTU$$40$YR$$F$N$69.3$KG$20240708$N$CN$US$
240651561$24065156$1$I$20220101$20240705$20240709$20240709$EXP$$CN-MYLANLABS-2024M1064185$MYLAN$Tang M, Zhang Z, Wang L, Qian H, Wu W, Liu Z, et al. Coronary artery ectasia associated with IgG4-related disease: a case report and literature review. BMC-Cardiovasc-Disord 2023; 23 (1):.$77$YR$$M$Y$$$20240709$$HP$CN$CN
240651571$24065157$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108378$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240709$$HP$US$US
240651581$24065158$1$I$$20240626$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108215$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240709$$HP$US$US
240651592$24065159$2$F$$20240711$20240709$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108456$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$78.02$KG$20240715$$HP$US$US
240651601$24065160$1$I$$20240701$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105700$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240709$$CN$US$US
240651611$24065161$1$I$20240603$20240702$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106103$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240709$$HP$US$US
240651621$24065162$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108301$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240709$$CN$US$US
240651631$24065163$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47399$$FDA-CTU$$52$YR$$M$N$$$20240708$N$$US$
240651641$24065164$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108048$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240709$$CN$US$US
240651652$24065165$2$F$$20240906$20240709$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108621$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240912$$CN$US$US
240651661$24065166$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108532$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240709$$CN$US$US
240651671$24065167$1$I$$20240707$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108311$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$69.4$KG$20240709$$CN$US$US
240651681$24065168$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108393$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240709$$CN$US$US
240651691$24065169$1$I$$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107099$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240709$$HP$US$US
240651711$24065171$1$I$20170101$20240703$20240709$20240709$EXP$$AR-BRISTOL-MYERS SQUIBB COMPANY-2024-108447$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240709$$CN$AR$AR
240651723$24065172$3$F$$20240729$20240709$20240802$EXP$$CA-ROCHE-10000016332$ROCHE$$75$YR$E$F$Y$$$20240802$$MD$CA$CA
240651731$24065173$1$I$$20240706$20240709$20240709$PER$$US-HALEON-2186079$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240651741$24065174$1$I$$20240705$20240709$20240709$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038021$BOEHRINGER INGELHEIM$$8$DEC$E$M$Y$$$20240709$$MD$JP$JP
240651761$24065176$1$I$20221215$20240708$20240708$20240708$DIR$709437$$FDA-CTU$$56$YR$$F$N$$$20240708$Y$CN$US$
240651831$24065183$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405151902076100-FZBVM$GB-MYLANLABS-2024M1063406$MYLAN$$$$$F$Y$54$KG$20240709$$CN$GB$GB
240651841$24065184$1$I$$20240705$20240709$20240709$EXP$$GB-MYLANLABS-2024M1063733$MYLAN$$$$$M$Y$$$20240709$$CN$GB$GB
240651851$24065185$1$I$20240515$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405151322554580-JFDSQ$GB-MYLANLABS-2024M1063511$MYLAN$$30$YR$$F$Y$110$KG$20240709$$CN$GB$GB
240651862$24065186$2$F$$20240709$20240709$20240728$30DAY$$CA-JNJFOC-20240718266$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$HP$CA$CA
240651871$24065187$1$I$$20240605$20240709$20240709$EXP$$US-BAYER-2024A085961$BAYER$Zimmer Z; Hill R; Fratto V; Lutgendorf MA. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:e250664$$$$$Y$$$20240709$$MD$US$US
240651883$24065188$3$F$20231221$20240720$20240709$20240726$EXP$$JP-CHIESI-2024CHF03989$CHIESI$$60$YR$$F$Y$46.8$KG$20240726$$MD$JP$JP
240651896$24065189$6$F$20240623$20240726$20240709$20240803$PER$$US-ROCHE-10000013840$ROCHE$$$$$M$Y$$$20240803$$CN$US$US
240651901$24065190$1$I$$20240625$20240709$20240709$EXP$$FR-CIPHER-2024-FR-000004$CIPHER$Drevin, Guillaume; Picard, Nicolas; Baudriller, Antoine; Pena-Martin, Maria; Ferec, S?verine; Leuger, Laurent; Briet, Marie; Abbara, Chadi.Tramadol intoxication in children: An emerging issue.Th?rapie.2024;.$5$YR$C$M$Y$$$20240709$$HP$FR$FR
240651911$24065191$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA199157$SANOFI AVENTIS$$$$E$F$Y$$$20240709$$MD$GB$US
240651921$24065192$1$I$20220618$20240701$20240709$20240709$PER$$US-SA-2024SA196382$SANOFI AVENTIS$$3$YR$C$F$Y$16.3$KG$20240709$$MD$US$US
240651931$24065193$1$I$20240101$20240628$20240709$20240709$PER$$US-SA-2024SA197891$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240709$$MD$US$US
240651951$24065195$1$I$20240627$20240627$20240709$20240709$EXP$$US-BAYER-2024A093585$BAYER$$65$YR$E$M$Y$$$20240709$$MD$US$US
240651962$24065196$2$F$$20240805$20240709$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108388$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240807$$CN$US$US
240651971$24065197$1$I$20220501$20240703$20240709$20240709$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-107464$BRISTOL MYERS SQUIBB$Zhang Q, Xie P, Hou X, Zhao C, Duan L, Qiao H. Benefit from almonertinib after osimertinib treat EGFR 19 exon deletion NSCLC induced severe rash: a case report. Journal of Chemotherapy. 2024;36(4):334-42. doi:10.1080/1120009X.2023.2276574.$52$YR$A$M$Y$$$20240709$$HP$CN$CN
240651981$24065198$1$I$$20240704$20240709$20240709$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107347$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240709$$HP$CA$CA
240651991$24065199$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108506$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$72.57$KG$20240709$$CN$US$US
240652001$24065200$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108635$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240709$$PH$US$US
240652011$24065201$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108573$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240709$$HP$US$US
240652021$24065202$1$I$$20240619$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100152$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240709$$MD$US$US
240652031$24065203$1$I$$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107379$BRISTOL MYERS SQUIBB$Park KS, Lieu AC, Ang MJ, Afshari NA. Reticular bullous epithelial corneal edema after netarsudil use for elevated intraocular pressure with concurrent fuchs endothelial corneal dystrophy: a case report. Case Reports in Ophthalmology. 2024 Apr 17;15(1):369-73. doi:10.1159/000538119.$74$YR$E$M$Y$$$20240709$$HP$US$US
240652042$24065204$2$F$20240604$20240708$20240709$20240716$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-095003$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240716$$PH$DE$DE
240652051$24065205$1$I$$20240703$20240709$20240709$30DAY$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097167$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240709$$CN$US$US
240652061$24065206$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107943$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240709$$HP$US$US
240652071$24065207$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108398$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240709$$HP$US$US
240652081$24065208$1$I$$20240701$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105433$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240709$$CN$US$US
240652091$24065209$1$I$$20240701$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105142$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$75.3$KG$20240709$$CN$US$US
240652111$24065211$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108637$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$74.84$KG$20240709$$CN$US$US
240652122$24065212$2$F$$20240812$20240709$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108004$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$67.13$KG$20240821$$CN$US$US
240652131$24065213$1$I$20240403$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107831$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$74.84$KG$20240709$$CN$US$US
240652151$24065215$1$I$20240101$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108639$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$94.35$KG$20240709$$CN$US$US
240652172$24065217$2$F$20240101$20240703$20240709$20240710$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-106011$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240710$$PH$FR$FR
240652181$24065218$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135579$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240652202$24065220$2$F$$20240805$20240709$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108323$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240806$$CN$US$US
240652222$24065222$2$F$20240625$20240711$20240709$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108098$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$66.22$KG$20240716$$HP$US$US
240652231$24065223$1$I$20240601$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108360$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240709$$HP$US$US
240652272$24065227$2$F$$20240827$20240709$20240828$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038572$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240828$$CN$JP$JP
240652281$24065228$1$I$20240606$20240702$20240709$20240709$EXP$FR-AFSSAPS-AVCF2024000441$FR-MYLANLABS-2024M1062051$MYLAN$$23$YR$$M$Y$$$20240709$$HP$FR$FR
240652291$24065229$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47325$$FDA-CTU$$71$YR$$F$N$$$20240708$N$$US$
240652301$24065230$1$I$20240124$20240702$20240709$20240709$EXP$FR-AFSSAPS-TS2024000740$FR-MYLANLABS-2024M1061962$MYLAN$$50$YR$$F$Y$60$KG$20240709$$MD$FR$FR
240652311$24065231$1$I$$20240704$20240709$20240709$EXP$$GB-MYLANLABS-2024M1063102$MYLAN$$$$$M$Y$$$20240709$$CN$GB$GB
240652321$24065232$1$I$20240707$20240708$20240708$20240708$DIR$709516$$FDA-CTU$$42$YR$$F$N$58.5$KG$20240708$N$CN$US$
240652331$24065233$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47339$$FDA-CTU$$82$YR$$F$N$$$20240708$N$$US$
240652351$24065235$1$I$$20240702$20240709$20240709$EXP$GB-MHRA-MED-202407020643199960-VMKHF$GB-MYLANLABS-2024M1061943$MYLAN$$$$$F$Y$95$KG$20240709$$CN$GB$GB
240652371$24065237$1$I$$20240708$20240708$20240708$DIR$709485$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240652381$24065238$1$I$20240610$20240702$20240709$20240709$EXP$FR-AFSSAPS-RE2024000631$FR-MYLANLABS-2024M1062009$MYLAN$$63$YR$$M$Y$103$KG$20240709$$MD$FR$FR
240652391$24065239$1$I$20240608$20240702$20240709$20240709$EXP$FR-AFSSAPS-AVCN2024000496$FR-MYLANLABS-2024M1062027$MYLAN$$26$YR$$M$Y$$$20240709$$MD$FR$FR
240652401$24065240$1$I$20231221$20240702$20240709$20240709$EXP$FR-AFSSAPS-AVMA2024000262$FR-MYLANLABS-2024M1062055$MYLAN$$29$YR$$F$Y$$$20240709$$PH$FR$FR
240652411$24065241$1$I$$20240702$20240709$20240709$EXP$$PL-MYLANLABS-2024M1061993$MYLAN$Welian-Polus I, Mazur B, Bielak M, Mazur M, Rypulak E, Wilanowska W et al.. Aggravation of Cardiovascular and Respiratory Decline in Advanced Duchenne Muscular Dystrophy Complicated by Dilated Cardiomyopathy - Case Study and Review of Literature.. Journal of Education, Health and Sport.. 2024;68(1):1-15$28$YR$$M$Y$$$20240709$$HP$PL$PL
240652421$24065242$1$I$20231010$20240708$20240708$20240708$DIR$709490$$FDA-CTU$$17$YR$$F$N$40.5$KG$20240708$N$CN$US$
240652431$24065243$1$I$20240520$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47362$$FDA-CTU$$51$YR$$F$N$$$20240708$N$$US$
240652451$24065245$1$I$20240605$20240702$20240709$20240709$EXP$FR-AFSSAPS-RS2024000622$FR-MYLANLABS-2024M1062060$MYLAN$$48$YR$$F$Y$$$20240709$$MD$FR$FR
240652461$24065246$1$I$20240611$20240702$20240709$20240709$EXP$IT-MINISAL02-992508$IT-MYLANLABS-2024M1062001$MYLAN$$63$YR$$M$Y$$$20240709$$MD$IT$IT
240652471$24065247$1$I$20240215$20240702$20240709$20240709$EXP$FR-AFSSAPS-LY2024000867$FR-MYLANLABS-2024M1062014$MYLAN$$67$YR$$F$Y$50$KG$20240709$$PH$FR$FR
240652481$24065248$1$I$$20240702$20240709$20240709$EXP$$HR-MYLANLABS-2024M1062025$MYLAN$$56$YR$$F$Y$$$20240709$$HP$HR$HR
240652501$24065250$1$I$20240501$20240702$20240709$20240709$EXP$$BR-MYLANLABS-2024M1062841$MYLAN$$16$YR$$F$Y$58$KG$20240709$$CN$BR$BR
240652512$24065251$2$F$20240201$20240822$20240709$20240827$EXP$$NVSC2024BR082796$NOVARTIS$$71$YR$$F$Y$73$KG$20240828$$CN$BR$BR
240652521$24065252$1$I$20240122$20240702$20240709$20240709$EXP$FR-AFSSAPS-CN2024000625$FR-MYLANLABS-2024M1062067$MYLAN$$59$YR$$M$Y$$$20240709$$MD$FR$FR
240652531$24065253$1$I$$20240708$20240709$20240709$EXP$$NVSC2024US141534$NOVARTIS$$$$$F$Y$$$20240709$$HP$US$US
240652543$24065254$3$F$20240320$20240826$20240709$20240829$30DAY$$US-AMGEN-USASP2024129690$AMGEN$$$$$$Y$$$20240829$$HP$US$US
240652551$24065255$1$I$$20240703$20240709$20240709$EXP$$CA-AMGEN-CANSP2024132922$AMGEN$$$$$M$Y$$$20240709$$CN$CA$CA
240652562$24065256$2$F$$20240709$20240709$20240710$PER$$US-AMGEN-USASP2024135131$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240652572$24065257$2$F$$20240722$20240709$20240726$EXP$$AU-AMGEN-AUSSP2024131148$AMGEN$$$$$M$Y$$$20240726$$PH$AU$AU
240652581$24065258$1$I$$20240708$20240709$20240709$PER$$US-BAYER-2024A098304$BAYER$$24$YR$A$F$Y$$$20240709$$MD$US$US
240652591$24065259$1$I$$20240621$20240709$20240709$EXP$$PT-ROCHE-10000020031$ROCHE$$62$YR$A$M$Y$$$20240709$$HP$PT$PT
240652601$24065260$1$I$$20240704$20240709$20240709$EXP$$TR-SA-2024SA197478$SANOFI AVENTIS$Koc G, Ersayoglu I, Cebeci K, C?narl? S, Ozkaya YP, Tuncer NO et al.. Life-threatening amlodipine and irbesartan poisoning in two adolescents: Extracorporeal life support is life-saving. Trends in Pediatrics. 2024;5:48-51$16$YR$T$F$Y$$$20240709$$HP$TR$TR
240652612$24065261$2$F$20240623$20240910$20240709$20240919$PER$$US-ROCHE-10000014726$ROCHE$$33$YR$A$F$Y$66.67$KG$20240919$$CN$US$US
240652631$24065263$1$I$$20240703$20240709$20240709$EXP$$FR-PFIZER INC-2022SGN08183$PFIZER$$$$$M$Y$$$20240709$$PH$FR$FR
240652641$24065264$1$I$20221116$20240703$20240709$20240709$EXP$$FR-PFIZER INC-2023SGN02340$PFIZER$$72$YR$$F$Y$59$KG$20240709$$PH$FR$FR
240652651$24065265$1$I$$20240703$20240709$20240709$EXP$$FR-PFIZER INC-2023SGN02428$PFIZER$$$$$M$Y$$$20240709$$PH$FR$FR
240652661$24065266$1$I$20211206$20240704$20240709$20240709$EXP$$BE-PFIZER INC-2021SGN06637$PFIZER$$71$YR$$M$Y$$$20240709$$MD$BE$BE
240652672$24065267$2$F$20220328$20240717$20240709$20240723$EXP$$FR-PFIZER INC-2023SGN04789$PFIZER$$50$YR$$F$Y$$$20240723$$HP$FR$FR
240652681$24065268$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47418$$FDA-CTU$$43$YR$$M$N$$$20240708$N$$US$
240652691$24065269$1$I$20240706$20240708$20240708$20240708$DIR$709443$$FDA-CTU$$36$YR$$M$N$83.25$KG$20240708$N$CN$US$
240652701$24065270$1$I$20240708$20240708$20240708$20240708$DIR$709513$$FDA-CTU$$38$YR$$F$N$$$20240708$N$$US$
240652711$24065271$1$I$20221001$20240703$20240709$20240709$EXP$$FR-PFIZER INC-2023SGN03973$PFIZER$$$$$F$Y$$$20240709$$MD$FR$FR
240652721$24065272$1$I$20240602$20240703$20240709$20240709$PER$$US-JNJFOC-20240710851$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240709$$CN$US$US
240652731$24065273$1$I$$20240708$20240709$20240709$PER$$US-BAYER-2024A098311$BAYER$$20$YR$A$F$Y$$$20240709$$MD$US$US
240652741$24065274$1$I$20240705$20240708$20240708$20240708$DIR$709502$$FDA-CTU$$68$YR$$M$N$106$KG$20240708$N$PH$US$
240652752$24065275$2$F$$20240712$20240709$20240725$EXP$$TH-ROCHE-10000008001$ROCHE$$$$$F$Y$$$20240725$$CN$TH$TH
240652762$24065276$2$F$20240615$20240709$20240709$20240712$PER$$US-AMGEN-USASP2024135224$AMGEN$$78$YR$E$F$Y$$$20240712$$CN$US$US
240652771$24065277$1$I$$20240703$20240709$20240709$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-106831$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240709$$MD$BR$BR
240652781$24065278$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108595$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240709$$CN$US$US
240652791$24065279$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108684$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240709$$CN$US$US
240652802$24065280$2$F$$20240712$20240709$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-108091$BRISTOL MYERS SQUIBB$Taniguchi T, Fujinuma C, Handa A, Suzuki T, Iwasawa U, Kametaka M, et al. A case of disseminated fusarium infection during treatment for myelodysplastic syndrome. Japanese Journal of Clinical Dermatology. 2024;78(7):527-32.$91$YR$E$F$Y$$$20240717$$MD$JP$JP
240652811$24065281$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108682$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240709$$CN$US$US
240652822$24065282$2$F$$20240805$20240709$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108655$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240813$$CN$US$US
240652831$24065283$1$I$20230501$20240701$20240709$20240709$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-106756$BRISTOL MYERS SQUIBB$Lee YJ, Lee JS, Lee HK. A case report of primary cutaneous diffuse large B-cell lymphoma in chronic myeloid leukemia after treatment with dasatinib. JAAD Case Reports. 2024;50:51-5. doi:10.1016/j.jdcr.2024.05.024.$63$YR$A$F$Y$$$20240709$$MD$KR$KR
240652841$24065284$1$I$$20240702$20240709$20240709$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003742$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$FR$FR
240652851$24065285$1$I$$20240510$20240709$20240709$30DAY$$DE-UCBSA-2024024738$UCB$$$$$F$Y$$$20240709$$HP$DE$DE
240652861$24065286$1$I$$20240708$20240709$20240709$PER$$US-BAYER-2024A098314$BAYER$$37$YR$A$F$Y$$$20240709$$HP$US$US
240652871$24065287$1$I$20231218$20240703$20240709$20240709$EXP$FR-AFSSAPS-LL2024001207$FR-MYLANLABS-2024M1062432$MYLAN$$34$YR$$F$Y$$$20240709$$MD$FR$FR
240652882$24065288$2$F$20240529$20240711$20240709$20240717$EXP$FR-AFSSAPS-AM2024000534$FR-MYLANLABS-2024M1062738$MYLAN$$47$YR$$F$Y$68$KG$20240717$$PH$FR$FR
240652891$24065289$1$I$20240527$20240628$20240709$20240709$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0601236$MYOVANT SCIENCES$$80$YR$$M$Y$$$20240709$$CN$US$US
240652901$24065290$1$I$20240422$20240702$20240709$20240709$EXP$IT-MINISAL02-992397$IT-SA-2024SA198801$SANOFI AVENTIS$$69$YR$E$M$Y$69$KG$20240709$$MD$IT$IT
240652912$24065291$2$F$20240624$20240731$20240709$20240810$EXP$$PY-TEVA-VS-3216335$TEVA$$53$YR$$F$Y$68$KG$20240810$$CN$PY$PY
240652921$24065292$1$I$$20240628$20240709$20240709$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0601239$MYOVANT SCIENCES$$$$$M$Y$$$20240709$$CN$US$US
240652931$24065293$1$I$$20240624$20240709$20240709$EXP$$TR-EPICPHARMA-TR-2024EPCLIT00784$EPIC PHARM$Begum Ogur.Valproate-induced hyperammonemic encephalopathy aggravated by benzodiazepine: Evaluation of the 3 cases and managment.Psychiatry and Clinical Psychopharmacology.JAN-2019;29:159 abstr. 0202$21$YR$A$F$Y$$$20240709$$HP$TR$TR
240652941$24065294$1$I$$20240704$20240709$20240709$EXP$$US-PFIZER INC-2024SGN04659$PFIZER$$$$$F$Y$$$20240709$$MD$US$US
240652952$24065295$2$F$$20240705$20240709$20240715$EXP$$US-PFIZER INC-202400206583$PFIZER$Nafeh, O.. The Development of Disinhibited Social Engagement Disorder: A Case Report on the Psychiatric Implications of Prenatal Fentanyl Use. Cureus. 2024;16(5):10.7759/cureus.61078$$$N$F$Y$$$20240715$$MD$US$US
240652961$24065296$1$I$20231101$20240704$20240709$20240709$EXP$GB-MHRA-MED-202405041936045700-LJSPV$GB-SA-2024SA199248$SANOFI AVENTIS$$44$YR$A$F$Y$70$KG$20240709$$CN$GB$GB
240652971$24065297$1$I$20240101$20240703$20240709$20240709$EXP$SI-JAZMP-NCPHV-2024SI0607_0607$SI-MYLANLABS-2024M1063139$MYLAN$$76$YR$$F$Y$$$20240709$$PH$SI$SI
240652981$24065298$1$I$$20240705$20240709$20240709$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003777$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
240652992$24065299$2$F$$20240717$20240709$20240726$PER$$US-TEVA-VS-3216253$TEVA$$71$YR$$M$Y$$$20240726$$CN$US$US
240653002$24065300$2$F$$20240710$20240709$20240722$EXP$$US-ZENPEP LLC-2024AIMT01038$AIMMUNE$$$$$$Y$$$20240722$$HP$US$US
240653015$24065301$5$F$20240702$20240730$20240709$20240731$PER$$US-SA-2024SA198055$SANOFI AVENTIS$$23$YR$A$F$Y$61.688$KG$20240731$$MD$US$US
240653021$24065302$1$I$20240620$20240628$20240709$20240709$PER$$US-SA-2024SA195822$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240709$$MD$US$US
240653031$24065303$1$I$20240502$20240708$20240708$20240708$DIR$709522$$FDA-CTU$$56$YR$$F$N$48.15$KG$20240708$N$CN$US$
240653041$24065304$1$I$20240306$20240702$20240709$20240709$PER$$US-SA-2024SA199196$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240709$$MD$US$US
240653071$24065307$1$I$20200609$20240708$20240709$20240709$EXP$DE-EMA-DD-20201127-kumarvn_p-113312$DE-SANDOZ INC.-SDZ2024DE063592$SANDOZ$$62$YR$$F$Y$66$KG$20240709$$MD$DE$DE
240653081$24065308$1$I$$20240625$20240709$20240709$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05782$LUPIN$Chaudhary AJ, Khan MZ, Sohail A, Zaidi SMH, Denha E, Venkat D. Acute onset nitrofurantoin-induced autoimmune hepatitis after urinary tract infection treatment. Clinical Case Reports. 2024;12:e9050:1-4$84$YR$$F$Y$$$20240709$$HP$US$US
240653101$24065310$1$I$$20240708$20240709$20240709$30DAY$$US-SANDOZ INC.-SDZ2024US063663$SANDOZ$$$$$F$Y$$$20240709$$CN$US$US
240653111$24065311$1$I$$20240708$20240708$20240708$DIR$709484$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240653121$24065312$1$I$20240625$20240701$20240709$20240709$EXP$GB-MHRA-MED-202407011500448070-RNYHF$GB-TEVA-VS-3216208$TEVA$$73$YR$$F$Y$$$20240709$$PH$GB$GB
240653131$24065313$1$I$$20240708$20240708$20240708$DIR$709488$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240653145$24065314$5$F$20240601$20240827$20240709$20240904$PER$$US-ALXN-202407USA000212US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
240653151$24065315$1$I$20240412$20240625$20240709$20240709$EXP$GB-MHRA-MED-202406251510244500-ZDPTF$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-06112$HIKMA$$58$YR$$F$Y$93$KG$20240709$$PH$GB$GB
240653162$24065316$2$F$20240101$20240806$20240709$20240816$PER$$US-SA-2024SA196387$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240816$$CN$US$US
240653171$24065317$1$I$$20240701$20240709$20240709$EXP$GB-MHRA-MED-202407010509548730-KZYWJ$GB-TEVA-VS-3216081$TEVA$$$$$F$Y$$$20240709$$CN$GB$GB
240653181$24065318$1$I$20240704$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134447$AMGEN$$61$YR$A$M$Y$$$20240709$$CN$US$US
240653191$24065319$1$I$$20240701$20240709$20240709$EXP$GB-MHRA-MED-202406191521210010-ZJBRL$GB-TEVA-VS-3215958$TEVA$$$$$F$Y$$$20240709$$PH$GB$GB
240653201$24065320$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202407051239129710-SHRWC$GB-MYLANLABS-2024M1063830$MYLAN$$$$$F$Y$$$20240709$$CN$GB$GB
240653211$24065321$1$I$20240621$20240705$20240709$20240709$EXP$GB-MHRA-MED-202406221520006820-PSGCJ$GB-MYLANLABS-2024M1064017$MYLAN$$24$YR$$M$Y$126$KG$20240709$$CN$GB$GB
240653221$24065322$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005297$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240709$$CN$US$US
240653231$24065323$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004365$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240709$$CN$US$US
240653241$24065324$1$I$20240601$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005256$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240709$$CN$US$US
240653261$24065326$1$I$20240626$20240705$20240709$20240709$PER$$US-JNJFOC-20240716133$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240709$$HP$US$US
240653271$24065327$1$I$$20240702$20240709$20240709$PER$$US-JNJFOC-20240706037$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240653281$24065328$1$I$20240702$20240702$20240709$20240709$PER$$US-JNJFOC-20240707359$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240653291$24065329$1$I$20190101$20240701$20240709$20240709$EXP$FR-AFSSAPS-RE2024000629$FR-BAUSCH-BL-2024-010349$BAUSCH AND LOMB$$23$YR$$F$Y$64$KG$20240709$$MD$FR$FR
240653302$24065330$2$F$$20240701$20240709$20240710$EXP$$DE-TORRENT-00026956$TORRENT$$32$YR$A$M$Y$78$KG$20240710$$CN$DE$DE
240653311$24065331$1$I$$20240624$20240709$20240709$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452322$RANBAXY$Sugai Y, Toyoguchi Y, Kanoto M, Kirii K, Hiraka T, Konno Y, et al. Clinical and image features: large-vessel vasculitis after granulocyte colony stimulating factor administration. Acta Radiol. 2024;65 (4):383-391$55$YR$$F$Y$$$20240709$$HP$JP$JP
240653321$24065332$1$I$20240515$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406281019467880-WQTRJ$GB-TORRENT-00036924$TORRENT$$59$YR$A$M$Y$104$KG$20240709$$PH$GB$GB
240653331$24065333$1$I$20240606$20240628$20240709$20240709$EXP$GB-MHRA-TPP36064774C23315082YC1719488124401$GB-TORRENT-00036943$TORRENT$$89$YR$E$F$Y$55$KG$20240709$$PH$GB$GB
240653351$24065335$1$I$$20240628$20240709$20240709$EXP$GB-MHRA-MED-202406251045593230-ZSKLH$GB-TORRENT-00036970$TORRENT$$$$$F$Y$$$20240709$$CN$GB$GB
240653361$24065336$1$I$20240704$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134204$AMGEN$$69$YR$E$F$Y$$$20240709$$CN$US$US
240653371$24065337$1$I$20240429$20240708$20240709$20240709$EXP$$CA-MYLANLABS-2024M1041783$MYLAN$$54$YR$$M$Y$$$20240709$$CN$CA$CA
240653381$24065338$1$I$$20240624$20240709$20240709$EXP$$CN-EPICPHARMA-CN-2024EPCLIT00787$EPIC PHARM$Cai J.Clinical and literature case analysis on duloxetine-related syndrome of inappropriate antidiuretic hormone secretion.Adverse drug reactions journal.DEC-2022;24 (No 12):633-640$60$YR$A$M$Y$$$20240709$$HP$CN$CN
240653391$24065339$1$I$$20240708$20240709$20240709$EXP$$CA-BAUSCH-BL-2024-010434$BAUSCH AND LOMB$$51$YR$$F$Y$$$20240709$$CN$CA$CA
240653401$24065340$1$I$$20240703$20240709$20240709$PER$$US-BAYER-2024A096458$BAYER$$$$E$F$Y$$$20240709$$CN$US$US
240653411$24065341$1$I$20240516$20240703$20240709$20240709$EXP$HR-HALMED-300085666$HR-CHEPLA-2024008433$CHEPLAPHARM$$$$A$M$Y$$$20240709$$MD$COUNTRY NOT SPECIFIED$HR
240653421$24065342$1$I$$20240703$20240709$20240709$EXP$GB-MHRA-DEFECT-202406221311545970-BHSNJ$GB-OTSUKA-2024_018999$OTSUKA$$$$$F$Y$$$20240709$$CN$GB$GB
240653431$24065343$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141746$NOVARTIS$$$$$F$Y$$$20240709$$MD$US$US
240653441$24065344$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A151809$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240653451$24065345$1$I$$20240703$20240709$20240709$PER$$US-AstraZeneca-2024A154630$ASTRAZENECA$$$$$$Y$$$20240709$$MD$US$
240653461$24065346$1$I$$20240701$20240709$20240709$EXP$$VN-AstraZeneca-2024A155279$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$VN$
240653471$24065347$1$I$$20240702$20240709$20240709$EXP$$GB-JNJFOC-20240707356$JOHNSON AND JOHNSON$$$$A$$Y$$$20240709$$CN$GB$GB
240653481$24065348$1$I$$20240701$20240709$20240709$EXP$$CA-AstraZeneca-2024A152555$ASTRAZENECA$$41$YR$$F$Y$133$KG$20240709$$MD$CA$
240653492$24065349$2$F$$20240815$20240709$20240815$30DAY$$CA-PFIZER INC-PV202400087976$PFIZER$$14$YR$$M$Y$$$20240815$$CN$CA$CA
240653501$24065350$1$I$20240701$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108612$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240709$$CN$US$US
240653511$24065351$1$I$20240510$20240701$20240709$20240709$EXP$ES-AEMPS-1538596$ES-TEVA-VS-3216968$TEVA$$75$YR$$M$Y$$$20240709$$MD$ES$ES
240653521$24065352$1$I$$20240625$20240709$20240709$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05819$LUPIN$Lu Y, Neyra JA. How I treat rhabdomyolysis-induced AKI?. American Society of Nephrology. 2024;19:385-387$40$YR$$M$Y$$$20240709$$HP$US$US
240653532$24065353$2$F$20230803$20240722$20240709$20240730$EXP$$AT-FreseniusKabi-FK202410312$FRESENIUS KABI$$60$YR$A$M$Y$$$20240730$$HP$AT$AT
240653541$24065354$1$I$20240607$20240703$20240709$20240709$EXP$$US-OTSUKA-2024_019217$OTSUKA$$85$YR$$F$Y$$$20240709$$CN$US$US
240653551$24065355$1$I$20230114$20240704$20240709$20240709$EXP$$AU-TAKEDA-2023TUS009424$TAKEDA$$32$YR$$F$Y$$$20240709$$HP$AU$AU
240653561$24065356$1$I$$20240531$20240709$20240709$30DAY$$US-UCBSA-2024028203$UCB$$$$$F$Y$$$20240709$$CN$US$US
240653571$24065357$1$I$20240708$20240708$20240708$20240708$DIR$709535$$FDA-CTU$$28$YR$$F$N$65.25$KG$20240708$N$CN$US$
240653581$24065358$1$I$20240628$20240701$20240709$20240709$EXP$$GB-EMD Serono-2024036364$EMD SERONO INC$$35$YR$A$F$Y$$$20240709$$CN$GB$GB
240653591$24065359$1$I$$20240702$20240709$20240709$PER$$US-ALXN-202407USA000236US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240653641$24065364$1$I$$20240705$20240708$20240708$DIR$FDA-CDER-CTU-2024-47332$$FDA-CTU$$$$$M$N$$$20240705$N$HP$US$
240653651$24065365$1$I$$20240705$20240708$20240708$DIR$FDA-CDER-CTU-2024-47328$$FDA-CTU$$$$$F$N$$$20240705$N$HP$US$
240653661$24065366$1$I$$20240624$20240709$20240709$EXP$$AR-Marksans Pharma Limited-2158946$MARKSANS$Cervantes JG, Gasque RA, Lenz ME, Barbero M, Navarro L, Roca I, Cairo F, Mattera FJ, Qui?onez EG. Trasplante hep?tico como tratamiento de intoxicaci?n por paracetamol [Liver transplantation as treatment for acetaminophen poisoning]. Medicina (B Aires). 2024;84(3):588-591. Spanish. PMID: 38907980. (Abstract)$28$YR$$F$Y$$$20240709$$$AR$AR
240653671$24065367$1$I$$20240626$20240709$20240709$EXP$$FR-B.Braun Medical Inc.-2158933$B BRAUN$$30$YR$$F$Y$51$KG$20240709$$$FR$FR
240653681$24065368$1$I$$20240625$20240709$20240709$EXP$$JP-MYOVANT SCIENCES GMBH-2024MYSCI0601313$MYOVANT SCIENCES$$$$$F$Y$$$20240709$$HP$JP$JP
240653691$24065369$1$I$$20240522$20240709$20240709$PER$$US-OrBion Pharmaceuticals Private Limited-2158944$ORBION PHARMACEUTICALS$$50$YR$$M$Y$$$20240709$$$US$US
240653701$24065370$1$I$20230601$20240624$20240709$20240709$EXP$$CN-Bio-Thera Solutions, Ltd.-2158949$BIO-THERA SOLUTIONS$Yunting Zhang, Fanchun Yang, Jining Wang, Hui Fu, Fuming Shen, Jie Liu and Dongjie Li Bevacizumab-induced immune thrombocytopenia in an ovarian?cancer patient with mixed connective tissue disease: case report and literature review Front. Immunol. 15:1382964. doi: 10.3389/fimmu.2024.1382964 2024$68$YR$$F$Y$$$20240709$$$CN$CN
240653711$24065371$1$I$$20240702$20240709$20240709$EXP$$CN-GSK-CN2024GSK083669$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$CN$CN
240653721$24065372$1$I$20230520$20240703$20240709$20240709$EXP$$US-Central Solutions, Inc.-2158927$CENTRAL SOLUTONS$$$$$F$Y$$$20240709$$$US$US
240653741$24065374$1$I$$20240704$20240709$20240709$EXP$$CA-PFIZER INC-2022SGN03394$PFIZER$$69$YR$$F$Y$$$20240709$$PH$CA$CA
240653751$24065375$1$I$$20240704$20240709$20240709$EXP$$FR-PFIZER INC-2022SGN03500$PFIZER$$$$$F$Y$$$20240709$$MD$FR$FR
240653771$24065377$1$I$$20240702$20240709$20240709$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003705$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
240653781$24065378$1$I$$20240627$20240709$20240709$EXP$$GB-OTSUKA-2024_018477$OTSUKA$Solanki G, Mohamedali Z, Tse C, Teles J, Sawyer J, Sharma B, et al.. Real-life efficacy of tolvaptan for polycystic kidney disease (PKD) and association with patient adherence in London North-West specialist clinic. Nephrology Dialysis Transplantation. 2024;39:i1189$$$$$Y$$$20240709$$HP$GB$GB
240653792$24065379$2$F$$20240805$20240709$20240808$EXP$$JP-OTSUKA-2024_018970$OTSUKA$$92$YR$$F$Y$$$20240808$$MD$JP$JP
240653801$24065380$1$I$20240101$20240627$20240709$20240709$PER$$US-SA-2024SA196498$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240709$$MD$US$US
240653821$24065382$1$I$20240101$20240630$20240709$20240709$PER$$US-SA-2024SA197333$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240709$$MD$US$US
240653831$24065383$1$I$20240512$20240628$20240709$20240709$PER$$US-SA-2024SA196689$SANOFI AVENTIS$$59$YR$A$F$Y$79.19$KG$20240709$$MD$US$US
240653843$24065384$3$F$20240601$20240716$20240709$20240724$PER$$US-SA-2024SA196332$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240724$$MD$US$US
240653851$24065385$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA198984$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240709$$MD$US$US
240653861$24065386$1$I$$20240626$20240709$20240709$EXP$$FR-B.Braun Medical Inc.-2158937$B BRAUN$$24$MON$$F$Y$12.6$KG$20240709$$$FR$FR
240653871$24065387$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA107401$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240653881$24065388$1$I$20240626$20240627$20240709$20240709$PER$$US-SA-2024SA197237$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240709$$MD$US$US
240653891$24065389$1$I$20240101$20240628$20240709$20240709$PER$$US-SA-2024SA196561$SANOFI AVENTIS$$24$YR$A$F$Y$58.9$KG$20240709$$MD$US$US
240653901$24065390$1$I$$20240626$20240709$20240709$EXP$$FR-B.Braun Medical Inc.-2158935$B BRAUN$$66$YR$$M$Y$61$KG$20240709$$$FR$FR
240653911$24065391$1$I$20240616$20240624$20240709$20240709$EXP$$US-Alva-Amco Pharmacal Companies, Inc.-2158923$ALVA-AMCO$$$$$$Y$$$20240709$$$US$US
240653921$24065392$1$I$$20240529$20240709$20240709$PER$$US-OrBion Pharmaceuticals Private Limited-2158945$ORBION PHARMACEUTICALS$$$$$F$Y$$$20240709$$$US$US
240653931$24065393$1$I$20160401$20240626$20240709$20240709$EXP$$GB-Nova Laboratories Limited-2158952$NOVA LABORATORIES$Oxford Medical Case Reports?Author: Robins AEM, Bowden DJ and Gelson WTH?Title: Chronic genotype 1 hepatitis E infection from immunosuppression for ileo-colonic Crohns disease?Volume: 9 Year: 2018 Pages: 278-281$33$YR$$M$Y$$$20240709$$$GB$GB
240653942$24065394$2$F$20240301$20240903$20240709$20240903$EXP$$US-D.O.R.C. International, b.v.-2158954$DUTCH OPTHALMIC RESEARCH CENTER$$65$YR$$F$Y$$$20240903$$$US$US
240653951$24065395$1$I$20240318$20240705$20240709$20240709$PER$$US-Mission Pharmacal Company-2158931$MISSION$$73$YR$$F$Y$$$20240709$$$US$US
240653962$24065396$2$F$$20240806$20240709$20240814$EXP$$JP-AMGEN-JPNSP2024133016$AMGEN$$$$$$Y$$$20240813$$PH$JP$JP
240653971$24065397$1$I$$20240624$20240709$20240709$EXP$$US-EPICPHARMA-US-2024EPCLIT00793$EPIC PHARM$Arlen Gaba.When Lorazepam Worsens Delirium in Your Catatonic Patient.Primary Care Companion for CNS Disorders.JAN-2024;26(1):1-5$77$YR$E$F$Y$$$20240709$$MD$US$US
240653981$24065398$1$I$$20240626$20240709$20240709$EXP$$CN-Oxford Pharmaceuticals, LLC-2158951$OXFORD PHARMACEUTICALS$Source document$17$YR$$F$Y$$$20240709$$$CN$CN
240653991$24065399$1$I$$20240618$20240709$20240709$PER$$US-Sofgen Pharmaceuticals, LLC-2158928$SOFGEN PHARMACEUTICALS$$$$$F$Y$61.818$KG$20240709$$$US$US
240654002$24065400$2$F$$20240822$20240709$20240904$EXP$$CN-Bio-Thera Solutions, Ltd.-2158950$BIO-THERA SOLUTIONS$$53$YR$$M$Y$$$20240904$$$CN$CN
240654011$24065401$1$I$$20240629$20240709$20240709$EXP$$US-BAYER-2024A095044$BAYER$$62$YR$A$M$Y$$$20240709$$CN$US$US
240654021$24065402$1$I$$20240701$20240709$20240709$EXP$GB-MHRA-MED-202407011428531960-JNZPM$GB-TEVA-VS-3216212$TEVA$$$$$F$Y$$$20240709$$HP$GB$GB
240654032$24065403$2$F$20240626$20240627$20240709$20240709$PER$$US-ROCHE-10000013410$ROCHE$$$$$M$Y$$$20240709$$PH$US$US
240654041$24065404$1$I$$20240625$20240709$20240709$PER$$US-ROCHE-10000020533$ROCHE$$$$$$Y$$$20240709$$CN$US$US
240654051$24065405$1$I$20240708$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47446$$FDA-CTU$$56$YR$$M$N$$$20240708$Y$PH$US$
240654061$24065406$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47410$$FDA-CTU$$61$YR$$F$N$$$20240708$N$$US$
240654071$24065407$1$I$$20240708$20240709$20240709$EXP$GB-MHRA-MED-202406281141054980-NZHDV$GB-MYLANLABS-2024M1061136$MYLAN$$$$$$Y$$$20240709$$CN$GB$GB
240654082$24065408$2$F$20230801$20240708$20240709$20240710$EXP$$US-ROCHE-10000020802$ROCHE$$37$YR$A$F$Y$$$20240710$$CN$US$US
240654091$24065409$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47302$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240654101$24065410$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47300$$FDA-CTU$$79$YR$$M$N$$$20240708$N$$US$
240654111$24065411$1$I$$20240614$20240709$20240709$PER$$US-BEH-2024174284$CSL BEHRING$$$$A$F$Y$$$20240709$$HP$US$US
240654122$24065412$2$F$$20240717$20240709$20240730$PER$$US-ROCHE-10000020350$ROCHE$$$$$$Y$$$20240730$$HP$US$US
240654131$24065413$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA196520$SANOFI AVENTIS$$$$E$M$Y$$$20240709$$MD$US$US
240654141$24065414$1$I$20240501$20240628$20240709$20240709$PER$$US-SA-2024SA196373$SANOFI AVENTIS$$65$YR$E$M$Y$102.1$KG$20240709$$MD$US$US
240654151$24065415$1$I$$20240625$20240709$20240709$PER$$US-ROCHE-10000020670$ROCHE$$$$$M$Y$$$20240709$$CN$US$US
240654171$24065417$1$I$20240101$20240705$20240709$20240709$EXP$$CA-BIOGEN-2024BI01272850$BIOGEN$$$$$F$Y$$$20240709$$HP$CA$CA
240654181$24065418$1$I$20230802$20231106$20240709$20240709$EXP$$US-BIOGEN-2023BI01226950$BIOGEN$$66$YR$$M$Y$79.1$KG$20240709$$CN$US$US
240654191$24065419$1$I$$20240618$20240709$20240709$PER$$AU-TOLMAR, INC.-24AU050253$TOLMAR$$$$$M$Y$$$20240709$$CN$AU$AU
240654201$24065420$1$I$$20240618$20240709$20240709$PER$$AU-TOLMAR, INC.-24AU050322$TOLMAR$$$$$M$Y$$$20240709$$CN$AU$AU
240654211$24065421$1$I$20240514$20240618$20240709$20240709$PER$$AU-TOLMAR, INC.-24AU050248$TOLMAR$$83$YR$$M$Y$$$20240709$$CN$AU$AU
240654222$24065422$2$F$20240601$20240712$20240709$20240731$PER$$BR-TOLMAR, INC.-24BR050022$TOLMAR$$$$$$Y$$$20240731$$PH$BR$BR
240654231$24065423$1$I$20240618$20240618$20240709$20240709$PER$$BR-TOLMAR, INC.-24BR050331$TOLMAR$$11$YR$$F$Y$$$20240709$$CN$BR$BR
240654241$24065424$1$I$20240618$20240618$20240709$20240709$PER$$BR-TOLMAR, INC.-24BR050329$TOLMAR$$9$YR$$F$Y$$$20240709$$CN$BR$BR
240654251$24065425$1$I$20240527$20240618$20240709$20240709$PER$$BR-TOLMAR, INC.-24BR050332$TOLMAR$$10$YR$$F$Y$$$20240709$$CN$BR$BR
240654261$24065426$1$I$20240521$20240618$20240709$20240709$PER$$CA-TOLMAR, INC.-24CA049864$TOLMAR$$90$YR$$M$Y$$$20240709$$CN$CA$CA
240654271$24065427$1$I$20231201$20240618$20240709$20240709$PER$$CA-TOLMAR, INC.-24CA049968$TOLMAR$$95$YR$$M$Y$$$20240709$$CN$CA$CA
240654281$24065428$1$I$$20240618$20240709$20240709$PER$$CA-TOLMAR, INC.-24CA050314$TOLMAR$$$$$M$Y$$$20240709$$CN$CA$CA
240654291$24065429$1$I$$20240702$20240709$20240709$EXP$$AU-GSK-AU2024083078$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$AU$AU
240654301$24065430$1$I$$20240618$20240709$20240709$PER$$CA-TOLMAR, INC.-24CA050315$TOLMAR$$$$$M$Y$$$20240709$$CN$CA$CA
240654311$24065431$1$I$$20240618$20240709$20240709$PER$$CA-TOLMAR, INC.-24CA050316$TOLMAR$$$$$M$Y$$$20240709$$CN$CA$CA
240654322$24065432$2$F$$20240705$20240709$20240731$PER$$CA-TOLMAR, INC.-24CA050318$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
240654331$24065433$1$I$$20240708$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108735$BRISTOL MYERS SQUIBB$$97$YR$E$F$Y$$$20240709$$CN$US$US
240654341$24065434$1$I$20240708$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135292$AMGEN$$65$YR$E$F$Y$$$20240709$$CN$US$US
240654351$24065435$1$I$20240617$20240701$20240709$20240709$EXP$FR-AFSSAPS-LL2024001179$FR-FreseniusKabi-FK202410410$FRESENIUS KABI$$42$YR$A$F$Y$105$KG$20240709$$PH$FR$FR
240654361$24065436$1$I$20240101$20240614$20240709$20240709$PER$$US-BEH-2024174294$CSL BEHRING$$50$YR$A$F$Y$$$20240709$$CN$US$US
240654371$24065437$1$I$20240101$20240701$20240709$20240709$EXP$$RO-FreseniusKabi-FK202410315$FRESENIUS KABI$$64$YR$A$M$Y$$$20240709$$MD$RO$RO
240654381$24065438$1$I$20240602$20240701$20240709$20240709$EXP$PT-INFARMED-B202406-406$PT-FreseniusKabi-FK202410376$FRESENIUS KABI$$74$YR$E$M$Y$$$20240709$$MD$PT$PT
240654391$24065439$1$I$20240603$20240701$20240709$20240709$EXP$ES-AEMPS-1540003$ES-FreseniusKabi-FK202410365$FRESENIUS KABI$$77$YR$E$M$Y$57$KG$20240709$$MD$ES$ES
240654401$24065440$1$I$$20240701$20240709$20240709$EXP$$CZ-FreseniusKabi-FK202410353$FRESENIUS KABI$$72$YR$E$F$Y$$$20240709$$MD$CZ$CZ
240654411$24065441$1$I$$20240624$20240709$20240709$EXP$$PT-EPICPHARMA-PT-2024EPCLIT00777$EPIC PHARM$Vasco Gaspar.Sulfadiazine-induced crystalluria and non-oliguric renal  failure in HIV-1 inaugural infection with presumed cerebral  toxoplasmosis.Jornal Brasileiro de Nefrologia.13-MAY-2024;46:1-2$30$YR$A$F$Y$$$20240709$$HP$PT$PT
240654421$24065442$1$I$20240501$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405091841178130-FVBTL$GB-MYLANLABS-2024M1063541$MYLAN$$47$YR$$F$Y$$$20240709$$CN$GB$GB
240654431$24065443$1$I$20230609$20240701$20240709$20240709$EXP$$ES-FreseniusKabi-FK202410375$FRESENIUS KABI$$72$YR$E$F$Y$58$KG$20240709$$MD$ES$ES
240654441$24065444$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06106$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240654451$24065445$1$I$$20240701$20240709$20240709$EXP$$US-BAYER-2024A095260$BAYER$$62$YR$A$M$Y$$$20240709$$CN$US$US
240654471$24065447$1$I$$20240704$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004472$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240709$$CN$US$US
240654481$24065448$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005093$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240709$$CN$US$US
240654491$24065449$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA196965$SANOFI AVENTIS$$$$$M$Y$$$20240709$$CN$US$US
240654501$24065450$1$I$20231001$20240628$20240709$20240709$PER$$US-SA-2024SA196029$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240709$$MD$US$US
240654511$24065451$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA196095$SANOFI AVENTIS$$$$A$F$Y$54.4$KG$20240709$$MD$US$US
240654521$24065452$1$I$20240101$20240703$20240709$20240709$PER$$US-SA-2024SA199165$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240709$$MD$US$US
240654531$24065453$1$I$$20240624$20240709$20240709$PER$$US-MYLANLABS-2024M1058336$MYLAN$$$$$M$Y$$$20240709$$CN$US$US
240654541$24065454$1$I$$20240624$20240709$20240709$PER$$US-MYLANLABS-2024M1058409$MYLAN$$66$YR$$M$Y$$$20240709$$CN$US$US
240654551$24065455$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108825$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240709$$CN$US$US
240654571$24065457$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108761$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240709$$CN$US$US
240654581$24065458$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06057$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240654591$24065459$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47344$$FDA-CTU$$64$YR$$F$N$$$20240708$N$$US$
240654602$24065460$2$F$$20240806$20240709$20240809$EXP$$AU-MYLANLABS-2024M1063066$MYLAN$$51$YR$$M$Y$$$20240809$$CN$AU$AU
240654611$24065461$1$I$$20240629$20240709$20240709$30DAY$$US-GSK-US2024AMR082719$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$US$US
240654621$24065462$1$I$$20240702$20240709$20240709$EXP$$GB-TEVA-VS-3217720$TEVA$$$$$$Y$$$20240709$$CN$GB$GB
240654632$24065463$2$F$$20240717$20240709$20240801$PER$$US-LEADINGPHARMA-US-2024LEASPO00272$LEADING PHARMA$$$$$F$Y$76.3$KG$20240801$$CN$US$US
240654641$24065464$1$I$$20240624$20240709$20240709$PER$$US-MYLANLABS-2024M1058428$MYLAN$$$$$$Y$$$20240709$$CN$US$US
240654651$24065465$1$I$$20240624$20240709$20240709$EXP$$US-EPICPHARMA-US-2024EPCLIT00782$EPIC PHARM$Arlen Gaba.When Lorazepam Worsens Delirium in Your Catatonic Patient.Primary Care Companion for CNS Disorders.JAN-2024;26(1):1-5$74$YR$E$M$Y$$$20240709$$MD$US$US
240654661$24065466$1$I$$20240624$20240709$20240709$PER$$US-MYLANLABS-2024M1058506$MYLAN$$$$$$Y$$$20240709$$CN$US$US
240654681$24065468$1$I$$20240624$20240709$20240709$EXP$$CA-TEVA-VS-3214664$TEVA$$$$$F$Y$$$20240709$$HP$CA$CA
240654701$24065470$1$I$$20231017$20240709$20240709$EXP$$FR-JNJFOC-20240721609$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240709$$MD$FR$FR
240654711$24065471$1$I$$20240624$20240709$20240709$PER$$US-MYLANLABS-2024M1060694$MYLAN$$$$$$Y$$$20240709$$CN$US$US
240654721$24065472$1$I$$20240703$20240709$20240709$PER$$US-FreseniusKabi-FK202410537$FRESENIUS KABI$$$$A$F$Y$$$20240709$$HP$US$US
240654742$24065474$2$F$20240628$20240729$20240709$20240807$PER$$US-FreseniusKabi-FK202410518$FRESENIUS KABI$$51$YR$A$M$Y$98$KG$20240807$$PH$US$US
240654751$24065475$1$I$$20240702$20240709$20240709$EXP$GB-MHRA-MED-202407021247153770-FZSYW$GB-RDY-SPO/GBR/24/0009731$DR REDDYS$$$$$M$Y$$$20240709$$HP$GB$GB
240654761$24065476$1$I$$20240626$20240709$20240709$PER$$CA-RDY-USA/CAN/20/0124229$DR REDDYS$$$$$M$Y$$$20240709$$CN$CA$CA
240654771$24065477$1$I$20230801$20240702$20240709$20240709$EXP$GB-MHRA-MED-202407021100306640-MFJBG$GB-FreseniusKabi-FK202410522$FRESENIUS KABI$$32$YR$A$M$Y$$$20240709$$CN$GB$GB
240654781$24065478$1$I$$20240702$20240709$20240709$EXP$$HU-FreseniusKabi-FK202410513$FRESENIUS KABI$$65$YR$E$M$Y$$$20240709$$MD$HU$HU
240654791$24065479$1$I$20240628$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47385$$FDA-CTU$$61$YR$$F$N$45.5$KG$20240708$N$$US$
240654811$24065481$1$I$$20240705$20240708$20240708$DIR$FDA-CDER-CTU-2024-47333$$FDA-CTU$$$$$F$N$$$20240705$N$HP$US$
240654821$24065482$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47392$$FDA-CTU$$16$YR$$M$N$$$20240708$N$$US$
240654831$24065483$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47367$$FDA-CTU$$46$YR$$M$N$$$20240708$N$$US$
240654851$24065485$1$I$20240708$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47511$$FDA-CTU$$76$YR$$F$N$$$20240708$N$$US$
240654871$24065487$1$I$$20231109$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00065$SIGMAPHARM$$$$$F$Y$$$20240709$$CN$US$US
240654881$24065488$1$I$$20230906$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00061$SIGMAPHARM$$$$$M$Y$$$20240709$$HP$US$US
240654891$24065489$1$I$$20240221$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2024SIG00012$SIGMAPHARM$$$$$M$Y$$$20240709$$MD$US$US
240654901$24065490$1$I$$20230816$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00055$SIGMAPHARM$$$$$M$Y$$$20240709$$MD$US$US
240654911$24065491$1$I$$20240426$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2024SIG00026$SIGMAPHARM$$$$$$Y$$$20240709$$CN$US$US
240654921$24065492$1$I$$20240520$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2024SIG00028$SIGMAPHARM$$$$$M$Y$$$20240709$$PH$US$US
240654941$24065494$1$I$$20230717$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00042$SIGMAPHARM$$67$YR$$M$Y$$$20240709$$HP$US$US
240654951$24065495$1$I$$20230717$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00043$SIGMAPHARM$$$$$F$Y$$$20240709$$MD$US$US
240654961$24065496$1$I$$20230727$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00050$SIGMAPHARM$$$$$M$Y$$$20240709$$MD$US$US
240654971$24065497$1$I$$20230725$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00048$SIGMAPHARM$$$$$M$Y$$$20240709$$MD$US$US
240654981$24065498$1$I$$20230731$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00051$SIGMAPHARM$$$$$M$Y$$$20240709$$MD$US$US
240654991$24065499$1$I$$20230807$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00052$SIGMAPHARM$$$$$M$Y$$$20240709$$MD$US$US
240655001$24065500$1$I$$20230809$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00053$SIGMAPHARM$$$$$M$Y$$$20240709$$HP$US$US
240655011$24065501$1$I$$20230816$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00056$SIGMAPHARM$$$$$M$Y$$$20240709$$MD$US$US
240655021$24065502$1$I$$20230901$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00060$SIGMAPHARM$$$$$M$Y$$$20240709$$MD$US$US
240655031$24065503$1$I$$20230725$20240709$20240709$PER$$US-SIGMAPHARM LABORATORIES, LLC-2023SIG00047$SIGMAPHARM$$$$$M$Y$$$20240709$$MD$US$US
240655041$24065504$1$I$$20240703$20240709$20240709$EXP$$DE-MYLANLABS-2024M1062546$MYLAN$$6$DEC$$M$Y$$$20240709$$HP$DE$DE
240655052$24065505$2$F$20240425$20240730$20240709$20240805$EXP$FR-AFSSAPS-TO2024001182$FR-MYLANLABS-2024M1062641$MYLAN$$72$YR$$M$Y$$$20240805$$PH$FR$FR
240655061$24065506$1$I$20240702$20240705$20240709$20240709$EXP$$CA-UCBSA-2024034579$UCB$$59$YR$$F$Y$$$20240709$$MD$CA$CA
240655071$24065507$1$I$$20240621$20240709$20240709$PER$$US-009507513-2406USA007831$MERCK$Griffin SP, Lee BJ, Doh J, Paradyse AR, Jeyakumar D, Arter Z, et al. Strategies to Mitigate the Drug-Drug Interaction between Nirmatrelvir/Ritonavir and Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Azole Antifungals: Results of a Case Series. Acta Haematologica. 2023;147(3):371-7$70$YR$$M$Y$$$20240709$$HP$US$US
240655081$24065508$1$I$20240424$20240617$20240709$20240709$PER$$NL-TOLMAR, INC.-24NL050245$TOLMAR$$70$YR$$M$Y$$$20240709$$CN$NL$NL
240655091$24065509$1$I$20240605$20240617$20240709$20240709$PER$$US-TOLMAR, INC.-24US050149$TOLMAR$$$$$F$Y$$$20240709$$HP$US$US
240655102$24065510$2$F$20240501$20240808$20240709$20240902$PER$$US-TOLMAR, INC.-24US049888$TOLMAR$$87$YR$$M$Y$$$20240902$$PH$US$US
240655112$24065511$2$F$20240603$20240726$20240709$20240822$PER$$US-TOLMAR, INC.-24US050112$TOLMAR$$$$$F$Y$$$20240822$$HP$US$US
240655121$24065512$1$I$20240613$20240617$20240709$20240709$PER$$US-TOLMAR, INC.-24US050257$TOLMAR$$90$YR$$M$Y$$$20240709$$HP$US$US
240655132$24065513$2$F$20240529$20240726$20240709$20240816$PER$$US-TOLMAR, INC.-24US050282$TOLMAR$$$$$F$Y$$$20240816$$HP$US$US
240655142$24065514$2$F$20240617$20240710$20240709$20240801$PER$$US-TOLMAR, INC.-24US050283$TOLMAR$$$$$F$Y$$$20240731$$HP$US$US
240655151$24065515$1$I$$20240705$20240709$20240709$PER$$US-ROCHE-10000020461$ROCHE$$$$A$F$Y$$$20240709$$CN$US$US
240655161$24065516$1$I$$20240610$20240709$20240709$PER$$US-ROCHE-10000020906$ROCHE$$$$A$F$Y$$$20240709$$MD$US$US
240655171$24065517$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405151449108640-RMGKQ$GB-BIOGEN-2024BI01272488$BIOGEN$$33$YR$$F$Y$$$20240709$$PH$GB$GB
240655181$24065518$1$I$$20240705$20240709$20240709$PER$$US-PFIZER INC-202400069263$PFIZER$$48$YR$$M$Y$$$20240709$$HP$US$US
240655191$24065519$1$I$$20240704$20240709$20240709$PER$$US-PFIZER INC-202400208028$PFIZER$$67$YR$$M$Y$$$20240709$$HP$US$US
240655201$24065520$1$I$$20240708$20240709$20240709$PER$$US-PFIZER INC-PV202400089546$PFIZER$$78$YR$$F$Y$$$20240709$$CN$US$US
240655211$24065521$1$I$20240706$20240707$20240709$20240709$PER$$US-PFIZER INC-202400208273$PFIZER$$35$YR$$F$Y$$$20240709$$CN$US$US
240655232$24065523$2$F$$20240819$20240709$20240821$EXP$$US-PFIZER INC-202400209101$PFIZER$$73$YR$$M$Y$$$20240821$$CN$US$US
240655241$24065524$1$I$$20240708$20240709$20240709$PER$$US-PFIZER INC-PV202400089637$PFIZER$$$$$$Y$$$20240709$$HP$US$US
240655251$24065525$1$I$$20240705$20240709$20240709$PER$$US-PFIZER INC-202400209061$PFIZER$$79$YR$$F$Y$$$20240709$$HP$US$US
240655261$24065526$1$I$20240708$20240708$20240709$20240709$PER$$PR-PFIZER INC-202400208979$PFIZER$$$$E$M$Y$$$20240709$$MD$PR$PR
240655271$24065527$1$I$20240701$20240705$20240709$20240709$PER$$US-PFIZER INC-202400207735$PFIZER$$62$YR$$F$Y$$$20240709$$CN$US$US
240655281$24065528$1$I$20240707$20240707$20240709$20240709$PER$$US-PFIZER INC-202400208126$PFIZER$$70$YR$$F$Y$$$20240709$$CN$US$US
240655291$24065529$1$I$$20240705$20240709$20240709$PER$$US-PFIZER INC-202400208285$PFIZER$$45$YR$$F$Y$$$20240709$$CN$US$US
240655311$24065531$1$I$$20240708$20240709$20240709$PER$$US-PFIZER INC-202400209489$PFIZER$$$$$$Y$$$20240709$$MD$US$US
240655322$24065532$2$F$20240705$20240711$20240709$20240712$PER$$US-PFIZER INC-202400209573$PFIZER$$80$YR$$F$Y$$$20240712$$CN$US$US
240655332$24065533$2$F$$20240722$20240709$20240724$EXP$$US-PFIZER INC-202400209110$PFIZER$$75$YR$$F$Y$$$20240724$$HP$US$US
240655341$24065534$1$I$$20240705$20240709$20240709$PER$$US-PFIZER INC-202400193247$PFIZER$$55$YR$$F$Y$$$20240709$$HP$US$US
240655351$24065535$1$I$20240706$20240707$20240709$20240709$PER$$US-PFIZER INC-202400208171$PFIZER$$70$YR$$M$Y$$$20240709$$CN$US$US
240655363$24065536$3$F$20240707$20240808$20240709$20240812$PER$$US-PFIZER INC-202400209150$PFIZER$$63$YR$$F$Y$71.202$KG$20240812$$CN$US$US
240655371$24065537$1$I$20240703$20240708$20240709$20240709$PER$$US-PFIZER INC-202400209138$PFIZER$$54$YR$$F$Y$$$20240709$$MD$US$US
240655381$24065538$1$I$$20240708$20240709$20240709$PER$$US-PFIZER INC-PV202400089624$PFIZER$$73$YR$$F$Y$$$20240709$$CN$US$US
240655391$24065539$1$I$20240707$20240707$20240709$20240709$PER$$US-PFIZER INC-202400208172$PFIZER$$72$YR$$F$Y$$$20240709$$CN$US$US
240655401$24065540$1$I$$20240703$20240709$20240709$PER$$US-PFIZER INC-202400207966$PFIZER$$64$YR$$M$Y$$$20240709$$HP$US$US
240655411$24065541$1$I$20240601$20240707$20240709$20240709$PER$$US-PFIZER INC-202400208141$PFIZER$$41$YR$$M$Y$$$20240709$$CN$US$US
240655421$24065542$1$I$20240601$20240705$20240709$20240709$PER$$US-PFIZER INC-202400209091$PFIZER$$74$YR$$F$Y$$$20240709$$HP$US$US
240655431$24065543$1$I$20240706$20240707$20240709$20240709$PER$$US-PFIZER INC-202400208202$PFIZER$$75$YR$$M$Y$$$20240709$$CN$US$US
240655441$24065544$1$I$$20240708$20240709$20240709$PER$$US-PFIZER INC-PV202400089384$PFIZER$$79$YR$$M$Y$$$20240709$$CN$US$US
240655451$24065545$1$I$20240706$20240706$20240709$20240709$PER$$US-PFIZER INC-202400208026$PFIZER$$39$YR$$M$Y$$$20240709$$CN$US$US
240655461$24065546$1$I$20230901$20240705$20240709$20240709$PER$$US-PFIZER INC-202400207995$PFIZER$$59$YR$$F$Y$$$20240709$$HP$US$US
240655471$24065547$1$I$$20240705$20240709$20240709$PER$$US-PFIZER INC-202400209043$PFIZER$$53$YR$$F$Y$$$20240709$$HP$US$US
240655481$24065548$1$I$20240703$20240707$20240709$20240709$PER$$US-PFIZER INC-202400208134$PFIZER$$45$YR$$M$Y$$$20240709$$CN$US$US
240655501$24065550$1$I$20240701$20240705$20240709$20240709$PER$$US-PFIZER INC-202400208275$PFIZER$$57$YR$$F$Y$$$20240709$$CN$US$US
240655511$24065551$1$I$20240601$20240707$20240709$20240709$PER$$US-PFIZER INC-202400208150$PFIZER$$66$YR$$M$Y$$$20240709$$CN$US$US
240655521$24065552$1$I$20240707$20240707$20240709$20240709$PER$$US-PFIZER INC-202400208217$PFIZER$$56$YR$$$Y$$$20240709$$CN$US$US
240655531$24065553$1$I$20240701$20240708$20240709$20240709$PER$$US-PFIZER INC-202400208916$PFIZER$$$$$F$Y$$$20240709$$MD$US$US
240655541$24065554$1$I$20240601$20240705$20240709$20240709$PER$$US-PFIZER INC-202400209128$PFIZER$$75$YR$$M$Y$$$20240709$$HP$US$US
240655551$24065555$1$I$20240705$20240705$20240709$20240709$PER$$JP-PFIZER INC-202400207429$PFIZER$$$$$$Y$$$20240709$$PH$JP$JP
240655561$24065556$1$I$20240101$20240705$20240709$20240709$PER$$US-PFIZER INC-202400209050$PFIZER$$64$YR$$F$Y$$$20240709$$HP$US$US
240655571$24065557$1$I$$20240707$20240709$20240709$PER$$US-PFIZER INC-202400208132$PFIZER$$56$YR$$M$Y$$$20240709$$CN$US$US
240655584$24065558$4$F$20240421$20240903$20240709$20240905$PER$$US-PFIZER INC-202400209086$PFIZER$$46$YR$$F$Y$62$KG$20240905$$HP$US$US
240655591$24065559$1$I$$20240705$20240709$20240709$PER$$US-PFIZER INC-202300288371$PFIZER$$18$YR$$M$Y$$$20240709$$CN$US$US
240655604$24065560$4$F$$20240821$20240709$20240826$EXP$$US-PFIZER INC-PV202400088870$PFIZER$$86$YR$$F$Y$$$20240826$$CN$US$US
240655611$24065561$1$I$20240101$20240708$20240709$20240709$PER$$US-PFIZER INC-202400208867$PFIZER$$$$$F$Y$$$20240709$$CN$US$US
240655621$24065562$1$I$20240706$20240706$20240709$20240709$PER$$US-PFIZER INC-202400208022$PFIZER$$66$YR$$M$Y$$$20240709$$CN$US$US
240655631$24065563$1$I$$20240705$20240709$20240709$PER$$US-PFIZER INC-202400207827$PFIZER$$60$YR$$M$Y$$$20240709$$HP$US$US
240655641$24065564$1$I$$20240705$20240709$20240709$PER$$JP-PFIZER INC-202400208021$PFIZER$$$$$$Y$$$20240709$$MD$JP$JP
240655661$24065566$1$I$$20240703$20240709$20240709$PER$$US-PFIZER INC-202400207804$PFIZER$$64$YR$$F$Y$$$20240709$$CN$US$US
240655671$24065567$1$I$20240601$20240705$20240709$20240709$PER$$US-PFIZER INC-202400175315$PFIZER$$21$YR$$M$Y$$$20240709$$MD$US$US
240655681$24065568$1$I$20240629$20240707$20240709$20240709$PER$$US-PFIZER INC-202400208147$PFIZER$$44$YR$$F$Y$$$20240709$$CN$US$US
240655691$24065569$1$I$20240705$20240705$20240709$20240709$PER$$US-PFIZER INC-202400208226$PFIZER$$41$YR$$M$Y$$$20240709$$CN$US$US
240655702$24065570$2$F$20240529$20240712$20240709$20240725$EXP$$JP-MYOVANT SCIENCES GMBH-2024MYSCI0601317$MYOVANT SCIENCES$$36$YR$$F$Y$$$20240725$$HP$JP$JP
240655712$24065571$2$F$$20240819$20240709$20240820$EXP$$US-KYOWAKIRIN-2024KK016355$KYOWA$$$$$$Y$$$20240820$$HP$US$US
240655721$24065572$1$I$20240131$20240701$20240709$20240709$EXP$PL-URPL-DML-MLP.4401.1.143.2024$PL-BAXTER-2024BAX020942$BAXTER$$76$YR$$F$Y$86$KG$20240709$$MD$PL$PL
240655731$24065573$1$I$20240226$20240702$20240709$20240709$EXP$$FR-VIIV HEALTHCARE LIMITED-FR2024EME053700$VIIV$$$$$$Y$$$20240709$$HP$FR$FR
240655741$24065574$1$I$20240618$20240629$20240709$20240709$EXP$CN-NMPACDR-3306871057009202400180$CN-BAXTER-2024BAX020999$BAXTER$$68$YR$$F$Y$52$KG$20240709$$MD$CN$CN
240655751$24065575$1$I$20240513$20240701$20240709$20240709$EXP$FR-AFSSAPS-PC2024000498$FR-BAXTER-2024BAX020870$BAXTER$$49$YR$$F$Y$$$20240709$$PH$FR$FR
240655761$24065576$1$I$20240625$20240702$20240709$20240709$EXP$$DE-BAXTER-2024BAX020682$BAXTER$$79$YR$$M$Y$$$20240709$$HP$DE$DE
240655771$24065577$1$I$20240626$20240702$20240709$20240709$EXP$$DE-BAXTER-2024BAX021083$BAXTER$$75$YR$$M$Y$$$20240709$$HP$DE$DE
240655781$24065578$1$I$20240614$20240629$20240709$20240709$EXP$CN-NMPACDR-4105011045395202400145$CN-BAXTER-2024BAX021003$BAXTER$$71$YR$$M$Y$70$KG$20240709$$MD$CN$CN
240655794$24065579$4$F$20240628$20240815$20240709$20240823$30DAY$$US-JNJFOC-20240701780$JOHNSON AND JOHNSON$$66$YR$E$$Y$$$20240823$$CN$US$US
240655801$24065580$1$I$20240620$20240703$20240709$20240709$EXP$IT-MINISAL02-992706$IT-MYLANLABS-2024M1062430$MYLAN$$59$YR$$M$Y$$$20240709$$PH$IT$IT
240655815$24065581$5$F$$20240814$20240709$20240824$PER$$US-JNJFOC-20240677986$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240824$$PH$US$US
240655824$24065582$4$F$20240518$20240812$20240709$20240821$PER$$US-AMGEN-USASP2024119399$AMGEN$$68$YR$E$F$Y$$$20240821$$CN$US$US
240655832$24065583$2$F$20240705$20240709$20240709$20240710$PER$$US-AMGEN-USASP2024135429$AMGEN$$66$YR$E$F$Y$$$20240710$$CN$US$US
240655841$24065584$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47439$$FDA-CTU$$77$YR$$F$N$$$20240708$N$$US$
240655852$24065585$2$F$$20240716$20240709$20240722$EXP$$AU-TAKEDA-2024TUS068871$TAKEDA$$$$$$Y$$$20240722$$HP$AU$AU
240655861$24065586$1$I$20240703$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134300$AMGEN$$32$YR$A$F$Y$$$20240709$$CN$US$US
240655881$24065588$1$I$$20240702$20240709$20240709$EXP$$US-SA-2024SA198688$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240655902$24065590$2$F$$20240718$20240709$20240726$EXP$$CA-BAXTER-2024BAX021162$BAXTER$$53$YR$$F$Y$60$KG$20240726$$HP$CA$CA
240655912$24065591$2$F$$20240710$20240709$20240715$PER$$US-ABBVIE-5831787$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240655921$24065592$1$I$$20240624$20240709$20240709$PER$$US-MYLANLABS-2024M1058481$MYLAN$$$$$$Y$$$20240709$$CN$US$US
240655931$24065593$1$I$20240624$20240702$20240709$20240709$EXP$$US-SA-2024SA198411$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240709$$MD$US$US
240655942$24065594$2$F$$20240707$20240709$20240712$EXP$$US-JNJFOC-20240701060$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$MD$US$US
240655951$24065595$1$I$$20240703$20240709$20240709$EXP$$PL-MYLANLABS-2024M1062920$MYLAN$$71$YR$$$Y$$$20240709$$HP$PL$PL
240655961$24065596$1$I$$20240621$20240709$20240709$PER$$US-009507513-2407USA003674$MERCK$Griffin SP, Lee BJ, Doh J, Paradyse AR, Jeyakumar D, Arter Z, et al. Strategies to Mitigate the Drug-Drug Interaction between Nirmatrelvir/Ritonavir and Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Azole Antifungals: Results of a Case Series. Acta Haematologica. 2023;147(3):371-7$36$YR$$M$Y$$$20240709$$HP$US$US
240655971$24065597$1$I$$20240625$20240709$20240709$EXP$$US-LEADINGPHARMA-US-2024LEALIT00268$LEADING PHARMA$Arlen Gaba.When Lorazepam Worsens Delirium in Your Catatonic Patient.Primary Care Companion for CNS Disorders.2024;26:e1-e3$77$YR$E$F$Y$$$20240709$$HP$US$US
240655981$24065598$1$I$20240630$20240705$20240709$20240709$EXP$$US-BAYER-2024A098352$BAYER$$73$YR$E$M$Y$63.492$KG$20240709$$CN$US$US
240655992$24065599$2$F$$20240801$20240709$20240805$EXP$$US-ALXN-202407USA000091US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240656001$24065600$1$I$20240101$20240628$20240709$20240709$PER$$US-SA-2024SA196566$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240709$$MD$US$US
240656011$24065601$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA196597$SANOFI AVENTIS$$$$A$F$Y$49$KG$20240709$$MD$US$US
240656021$24065602$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47359$$FDA-CTU$$78$YR$$F$N$$$20240708$N$$US$
240656031$24065603$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47298$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240656041$24065604$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47320$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240656051$24065605$1$I$$20240705$20240709$20240709$PER$$US-ROCHE-10000020580$ROCHE$$$$A$F$Y$$$20240709$$CN$US$US
240656062$24065606$2$F$20231201$20240708$20240709$20240711$EXP$$US-ROCHE-10000018424$ROCHE$$58$YR$A$F$Y$$$20240711$$CN$US$US
240656071$24065607$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06356$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240656081$24065608$1$I$20240705$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47528$$FDA-CTU$$62$YR$$F$N$$$20240708$N$$US$
240656091$24065609$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA197027$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240709$$MD$US$US
240656101$24065610$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA196985$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240709$$MD$US$US
240656111$24065611$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA195595$SANOFI AVENTIS$$$$E$M$Y$$$20240709$$MD$US$US
240656121$24065612$1$I$20240701$20240701$20240709$20240709$PER$$US-SA-2024SA197531$SANOFI AVENTIS$$$$$F$Y$$$20240709$$MD$US$US
240656131$24065613$1$I$20230101$20240701$20240709$20240709$PER$$US-SA-2024SA198016$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240709$$MD$US$US
240656141$24065614$1$I$$20240705$20240709$20240709$EXP$$US-TAKEDA-2024TUS069273$TAKEDA$$$$$M$Y$$$20240709$$CN$US$US
240656161$24065616$1$I$20240614$20240703$20240709$20240709$EXP$IT-MINISAL02-992930$IT-FreseniusKabi-FK202410587$FRESENIUS KABI$$53$YR$A$M$Y$60$KG$20240709$$MD$IT$IT
240656181$24065618$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134979$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240656191$24065619$1$I$$20240706$20240709$20240709$EXP$$US-TAKEDA-2023TUS119033$TAKEDA$$$$$F$Y$$$20240709$$HP$US$US
240656202$24065620$2$F$20240708$20240708$20240709$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202312008802$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240711$$CN$US$US
240656211$24065621$1$I$20240626$20240704$20240709$20240709$EXP$IT-MINISAL02-992915$IT-SA-2024SA199948$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240709$$MD$IT$IT
240656221$24065622$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005101$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240709$$CN$US$US
240656232$24065623$2$F$20240601$20240902$20240709$20240904$30DAY$$JP-PFIZER INC-202400205322$PFIZER$$$$C$M$Y$$$20240904$$MD$JP$JP
240656251$24065625$1$I$$20240701$20240709$20240709$EXP$$CA-AstraZeneca-2024A152373$ASTRAZENECA$$60$YR$$F$Y$$$20240709$$MD$CA$
240656261$24065626$1$I$$20240625$20240709$20240709$EXP$$ES-ACRAF SpA-2024-034971$SK LIFE SCIENCE$$$$$$Y$$$20240709$$MD$ES$ES
240656271$24065627$1$I$20240520$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156275$ASTRAZENECA$$58$YR$$F$Y$90$KG$20240709$$MD$FR$
240656283$24065628$3$F$20231127$20240814$20240709$20240823$EXP$$US-BIOGEN-2024BI01272388$BIOGEN$$52$YR$$F$Y$113.95$KG$20240823$$HP$US$US
240656291$24065629$1$I$20240101$20240625$20240709$20240709$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-000920$SK LIFE SCIENCE$$$$$$Y$$$20240709$$HP$CA$CA
240656301$24065630$1$I$20191101$20240701$20240709$20240709$EXP$$HR-FreseniusKabi-FK202105682$FRESENIUS KABI$$56$YR$A$F$Y$$$20240709$$HP$HR$HR
240656311$24065631$1$I$$20240708$20240709$20240709$EXP$$CN-TAKEDA-2024TUS069664$TAKEDA$Liu YC, Zhou ZK, Yi MM, Wang LJ, Shou ST, Chai FY. Colchicine poisoning: case report of three homicides in a family. Heliyon. 2024;10(11):e32407$40$YR$$M$Y$$$20240709$$MD$CN$CN
240656333$24065633$3$F$$20240913$20240709$20240919$EXP$$NVSC2024BE139972$NOVARTIS$$$$$$Y$$$20240919$$MD$BE$BE
240656341$24065634$1$I$$20240625$20240709$20240709$EXP$$US-LEADINGPHARMA-US-2024LEALIT00270$LEADING PHARMA$Arlen Gaba.When Lorazepam Worsens Delirium in Your Catatonic Patient.Primary Care Companion for CNS Disorders.2024;26:e1-e3$74$YR$E$M$Y$$$20240709$$HP$US$US
240656351$24065635$1$I$20240101$20240704$20240709$20240709$EXP$$NVSC2024CN140699$NOVARTIS$$34$YR$$F$Y$62$KG$20240709$$CN$CN$CN
240656362$24065636$2$F$20231201$20240625$20240709$20240709$EXP$$US-ROCHE-10000015807$ROCHE$$60$YR$A$F$Y$$$20240705$$CN$US$US
240656371$24065637$1$I$$20240103$20240709$20240709$EXP$GB-MHRA-MED-202401021750047870-CTZBN$GB-TEVA-VS-3145713$TEVA$$78$YR$$F$Y$$$20240709$$HP$GB$GB
240656381$24065638$1$I$20240101$20240702$20240709$20240709$EXP$$US-ABBVIE-5828063$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240656401$24065640$1$I$20240705$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47519$$FDA-CTU$$59$YR$$F$N$$$20240708$N$$US$
240656411$24065641$1$I$20240602$20240627$20240708$20240708$DIR$FDA-CDER-CTU-2024-47329$$FDA-CTU$$46$YR$$F$N$$$20240627$N$HP$US$
240656431$24065643$1$I$20240705$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47524$$FDA-CTU$$22$YR$$F$N$61.23$KG$20240708$N$CN$US$
240656451$24065645$1$I$20240626$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47421$$FDA-CTU$$67$YR$$$N$$$20240708$Y$PH$US$
240656471$24065647$1$I$$20240701$20240709$20240709$EXP$$US-SA-2024SA197926$SANOFI AVENTIS$$$$A$M$Y$$$20240709$$MD$US$US
240656481$24065648$1$I$$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134831$AMGEN$$$$$M$Y$$$20240709$$CN$US$US
240656491$24065649$1$I$$20240702$20240709$20240709$PER$$US-ALXN-202407USA000187US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
240656501$24065650$1$I$20240601$20240704$20240709$20240709$EXP$$IL-AMERICAN REGENT INC-2024002606$AMERICAN REGENT$$72$YR$$F$Y$$$20240709$$HP$IL$IL
240656511$24065651$1$I$$20240621$20240709$20240709$PER$$US-009507513-2407USA003675$MERCK$Griffin SP, Lee BJ, Doh J, Paradyse AR, Jeyakumar D, Arter Z, et al. Strategies to Mitigate the Drug-Drug Interaction between Nirmatrelvir/Ritonavir and Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Azole Antifungals: Results of a Case Series. Acta Haematologica. 2023;147(3):371-7$73$YR$$M$Y$$$20240709$$HP$US$US
240656522$24065652$2$F$$20240823$20240709$20240823$EXP$$CO-PFIZER INC-PV202400089323$PFIZER$$$$C$F$Y$$$20240823$$CN$CO$CO
240656533$24065653$3$F$$20240926$20240709$20240930$30DAY$$JP-PFIZER INC-PV202400087722$PFIZER$$$$C$$Y$$$20240930$$PH$JP$JP
240656541$24065654$1$I$$20240702$20240709$20240709$EXP$$MX-ABBVIE-5831621$ABBVIE$$$$$F$Y$56$KG$20240709$$CN$MX$MX
240656551$24065655$1$I$$20240702$20240709$20240709$EXP$$US-GSK-US2024AMR082268$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$US$US
240656561$24065656$1$I$20240701$20240705$20240709$20240709$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003764$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$IT$IT
240656571$24065657$1$I$20240628$20240702$20240709$20240709$EXP$$BG-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003769$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$BG$BG
240656582$24065658$2$F$20240502$20240808$20240709$20240819$EXP$$PT-ACRAF SpA-2024-034995$SK LIFE SCIENCE$$$$$$Y$$$20240819$$MD$PT$PT
240656591$24065659$1$I$$20240627$20240709$20240709$PER$$US-MYLANLABS-2024M1058011$MYLAN$$$$$$Y$$$20240709$$CN$US$US
240656601$24065660$1$I$$20240705$20240709$20240709$EXP$$US-ABBVIE-5830899$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240656611$24065661$1$I$20240101$20240701$20240709$20240709$EXP$FR-AFSSAPS-TS2024000716$FR-TEVA-VS-3216209$TEVA$$17$YR$$F$Y$51$KG$20240709$$MD$FR$FR
240656621$24065662$1$I$20240702$20240705$20240709$20240709$EXP$$JP-ABBVIE-5831246$ABBVIE$$86$YR$$F$Y$$$20240709$$MD$JP$JP
240656631$24065663$1$I$$20240708$20240709$20240709$EXP$$CA-ORGANON-O2407CAN000763$ORGANON$$88$YR$$F$Y$49.887$KG$20240709$$CN$CA$CA
240656641$24065664$1$I$$20240708$20240709$20240709$EXP$$CA-ORGANON-O2407CAN000741$ORGANON$$47$YR$$F$Y$$$20240709$$CN$CA$CA
240656661$24065666$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156218$ASTRAZENECA$$63$YR$$M$Y$85$KG$20240709$$HP$FR$
240656671$24065667$1$I$$20240701$20240709$20240709$EXP$$VN-AstraZeneca-2024A155268$ASTRAZENECA$$$$$M$Y$$$20240709$$CN$VN$
240656681$24065668$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A152182$ASTRAZENECA$$$$$M$Y$$$20240709$$CN$US$
240656701$24065670$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A151686$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240656711$24065671$1$I$$20240627$20240709$20240709$PER$$US-TAKEDA-2024TUS064638$TAKEDA$$$$$$Y$$$20240709$$CN$US$US
240656721$24065672$1$I$$20240625$20240709$20240709$EXP$$US-GLANDPHARMA-US-2024GLNLIT00437$GLAND PHARMA$Whyte MP.Drug-induced osteopetrosis.Bone.AUG-2023;173$7$YR$C$F$Y$$$20240709$$HP$US$US
240656733$24065673$3$F$20240101$20240816$20240709$20240821$PER$$US-SA-2024SA197131$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240821$$CN$US$US
240656741$24065674$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA197382$SANOFI AVENTIS$$$$T$F$Y$62.6$KG$20240709$$MD$US$US
240656751$24065675$1$I$20240101$20240701$20240709$20240709$PER$$US-SA-2024SA196791$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240709$$MD$US$US
240656761$24065676$1$I$20240623$20240701$20240709$20240709$PER$$US-SA-2024SA196731$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240709$$MD$US$US
240656772$24065677$2$F$20240101$20240726$20240709$20240807$PER$$US-SA-2024SA196797$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240807$$MD$US$US
240656782$24065678$2$F$20240501$20240726$20240709$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108040$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240802$$CN$US$US
240656791$24065679$1$I$$20240705$20240709$20240709$EXP$$US-BIOGEN-2024BI01272618$BIOGEN$$$$$M$Y$$$20240709$$CN$US$US
240656801$24065680$1$I$$20240704$20240709$20240709$EXP$$NL-BIOGEN-2024BI01272597$BIOGEN$$$$$F$Y$$$20240709$$HP$NL$NL
240656811$24065681$1$I$$20240708$20240709$20240709$PER$$US-TAKEDA-2024TUS069634$TAKEDA$$$$$$Y$$$20240709$$CN$US$US
240656821$24065682$1$I$20240615$20240703$20240709$20240709$EXP$$CA-GSK-CA2023132389$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$HP$CA$CA
240656832$24065683$2$F$$20240712$20240709$20240716$EXP$$JP-SA-2024SA024565$SANOFI AVENTIS$$20$YR$A$F$Y$62.1$KG$20240716$$HP$JP$JP
240656841$24065684$1$I$$20240701$20240709$20240709$EXP$$US-JNJFOC-20240719128$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240709$$PH$US$US
240656851$24065685$1$I$$20240702$20240709$20240709$PER$$US-VERTEX PHARMACEUTICALS-2024-011052$VERTEX$$$$A$F$Y$$$20240709$$CN$US$US
240656862$24065686$2$F$20240101$20240710$20240709$20240717$EXP$$US-VERTEX PHARMACEUTICALS-2024-009606$VERTEX$$$$$F$Y$$$20240717$$CN$US$US
240656871$24065687$1$I$$20240624$20240709$20240709$PER$$US-MYLANLABS-2024M1058430$MYLAN$$$$$$Y$$$20240709$$CN$US$US
240656881$24065688$1$I$$20240702$20240709$20240709$EXP$$US-AMERICAN REGENT INC-2024002601$AMERICAN REGENT$Salman A, Jabra E, Paul V. From Epi Rush to Multi-Organ Crush: A Case of Epinephrine Overdose and Organ Dysfunction. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3659[abstract]$62$YR$$M$Y$$$20240709$$HP$US$US
240656891$24065689$1$I$$20240702$20240709$20240709$PER$$US-ALXN-202407USA000184US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240656901$24065690$1$I$20240630$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134399$AMGEN$$66$YR$E$M$Y$$$20240709$$CN$US$US
240656911$24065691$1$I$20240610$20240705$20240709$20240709$EXP$$US-BAYER-2024A098762$BAYER$$66$YR$E$F$Y$$$20240709$$CN$US$US
240656921$24065692$1$I$20230226$20240705$20240709$20240709$EXP$$IT-PFIZER INC-2023SGN10476$PFIZER$$55$YR$$$Y$$$20240709$$MD$IT$IT
240656951$24065695$1$I$20240705$20240708$20240709$20240709$EXP$$US-PFIZER INC-PV202400089746$PFIZER$$91$YR$$$Y$$$20240709$$CN$US$US
240656962$24065696$2$F$$20240716$20240709$20240718$EXP$$IT-PFIZER INC-2023SGN05032$PFIZER$$$$$F$Y$$$20240718$$MD$IT$IT
240656971$24065697$1$I$$20240705$20240709$20240709$EXP$$DE-PFIZER INC-202101766431$PFIZER$$53$YR$$F$Y$$$20240709$$PH$DE$DE
240656981$24065698$1$I$$20240705$20240709$20240709$EXP$$IT-PFIZER INC-2023SGN00915$PFIZER$$59$YR$$M$Y$$$20240709$$MD$IT$IT
240656991$24065699$1$I$20240629$20240708$20240709$20240709$EXP$$US-PFIZER INC-PV202400089593$PFIZER$$73$YR$$M$Y$$$20240709$$HP$US$US
240657011$24065701$1$I$20240503$20240708$20240709$20240709$EXP$$CN-PFIZER INC-PV202400089404$PFIZER$$40$YR$$F$Y$52$KG$20240709$$HP$CN$CN
240657022$24065702$2$F$$20240905$20240709$20240909$EXP$$US-PFIZER INC-PV202400089390$PFIZER$$81$YR$$F$Y$$$20240909$$CN$US$US
240657031$24065703$1$I$20240624$20240708$20240709$20240709$EXP$$CN-PFIZER INC-PV202400089456$PFIZER$$55$YR$$F$Y$72.5$KG$20240709$$HP$CN$CN
240657041$24065704$1$I$$20240625$20240709$20240709$EXP$$US-GLANDPHARMA-US-2024GLNLIT00434$GLAND PHARMA$Whyte MP.Drug-induced osteopetrosis.Bone.AUG-2023;173$4$YR$C$F$Y$$$20240709$$HP$US$US
240657051$24065705$1$I$$20240701$20240709$20240709$EXP$$US-AMGEN-USASP2024131830$AMGEN$Schwartz M.; McMahon C.M.; Amaya M.L. et al.. Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Ch rom osome- Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution. Blood. 2023;142:4247-4249$$$A$$Y$$$20240709$$MD$US$US
240657061$24065706$1$I$$20240701$20240709$20240709$EXP$$US-AMGEN-USASP2024131170$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240657071$24065707$1$I$$20240612$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096240$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240709$$CN$US$US
240657091$24065709$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47350$$FDA-CTU$$68$YR$$F$N$$$20240708$N$$US$
240657101$24065710$1$I$20240622$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47453$$FDA-CTU$$72$YR$$M$N$$$20240708$N$PH$US$
240657111$24065711$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47304$$FDA-CTU$$81$YR$$M$N$$$20240708$N$$US$
240657121$24065712$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47307$$FDA-CTU$$78$YR$$F$N$70.31$KG$20240708$N$$US$
240657131$24065713$1$I$20240622$20240706$20240708$20240708$DIR$FDA-CDER-CTU-2024-47317$$FDA-CTU$$80$YR$$M$N$$$20240706$N$HP$US$
240657141$24065714$1$I$$20240705$20240708$20240708$DIR$FDA-CDER-CTU-2024-47308$$FDA-CTU$$$$$F$N$$$20240705$N$HP$US$
240657151$24065715$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47438$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240657172$24065717$2$F$20230101$20240715$20240709$20240722$EXP$$EG-BIOGEN-2024BI01272513$BIOGEN$$$$$F$Y$90$KG$20240722$$CN$EG$EG
240657194$24065719$4$F$$20240807$20240709$20240813$30DAY$$US-JNJFOC-20240701859$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$HP$US$US
240657201$24065720$1$I$$20240701$20240709$20240709$EXP$$DE-JNJFOC-20240705008$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$HP$DE$DE
240657212$24065721$2$F$$20240718$20240709$20240723$PER$$US-JNJFOC-20240720031$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
240657221$24065722$1$I$$20240624$20240709$20240709$EXP$$US-MYLANLABS-2024M1058379$MYLAN$$$$$M$Y$$$20240709$$MD$US$US
240657231$24065723$1$I$$20240708$20240709$20240709$PER$$US-BAYER-2024A098515$BAYER$$$$$$Y$$$20240709$$CN$US$US
240657251$24065725$1$I$20240101$20240614$20240709$20240709$PER$$US-BEH-2024174288$CSL BEHRING$$$$E$$Y$$$20240709$$MD$US$US
240657271$24065727$1$I$20240708$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005068$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240709$$CN$US$US
240657281$24065728$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004951$ELI LILLY AND CO$$$$$$Y$$$20240709$$CN$US$US
240657291$24065729$1$I$20240601$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005116$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240709$$CN$US$US
240657301$24065730$1$I$20240522$20240523$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00305$BRAINTREE$$51$YR$$F$Y$86.182$KG$20240709$$CN$US$US
240657311$24065731$1$I$$20240604$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00329$BRAINTREE$$$$$F$Y$$$20240709$$CN$US$US
240657321$24065732$1$I$20240601$20240610$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00336$BRAINTREE$$77$YR$$F$Y$$$20240709$$CN$US$US
240657331$24065733$1$I$20240414$20240414$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00210$BRAINTREE$$$$$M$Y$$$20240709$$CN$US$US
240657341$24065734$1$I$20240513$20240518$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00288$BRAINTREE$$$$$F$Y$$$20240709$$CN$US$US
240657351$24065735$1$I$$20240522$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00300$BRAINTREE$$$$$F$Y$$$20240709$$CN$US$US
240657361$24065736$1$I$20240321$20240325$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00152$BRAINTREE$$66$YR$$F$Y$$$20240709$$CN$US$US
240657371$24065737$1$I$20240401$20240417$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00225$BRAINTREE$$68$YR$$M$Y$61.678$KG$20240709$$CN$US$US
240657381$24065738$1$I$20240318$20240318$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00141$BRAINTREE$$$$$F$Y$$$20240709$$CN$US$US
240657391$24065739$1$I$20240101$20240401$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00180$BRAINTREE$$$$$M$Y$$$20240709$$CN$US$US
240657401$24065740$1$I$20240404$20240404$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00192$BRAINTREE$$$$$M$Y$$$20240709$$CN$US$US
240657411$24065741$1$I$20240401$20240408$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00196$BRAINTREE$$$$$M$Y$$$20240709$$CN$US$US
240657421$24065742$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47338$$FDA-CTU$$64$YR$$F$N$$$20240708$N$$US$
240657431$24065743$1$I$20240318$20240319$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00143$BRAINTREE$$76$YR$$F$Y$48.526$KG$20240709$$CN$US$US
240657441$24065744$1$I$20240401$20240401$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00184$BRAINTREE$$50$YR$$M$Y$$$20240709$$CN$US$US
240657451$24065745$1$I$20240404$20240404$20240709$20240709$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00193$BRAINTREE$$26$YR$$F$Y$$$20240709$$CN$US$US
240657461$24065746$1$I$$20240706$20240708$20240708$DIR$FDA-CDER-CTU-2024-47331$$FDA-CTU$$$$$M$N$$$20240706$N$HP$US$
240657471$24065747$1$I$$20240614$20240709$20240709$30DAY$$US-VEROBIOTECH-2024USVEROSPO00137$VERO BIOTECH$$$$$$Y$$$20240709$$HP$US$US
240657481$24065748$1$I$20231001$20231225$20240709$20240709$EXP$GB-MHRA-MED-202312221003318000-FSDVR$GB-TEVA-VS-3145701$TEVA$$57$YR$$M$Y$180$KG$20240709$$CN$GB$GB
240657511$24065751$1$I$20240601$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107742$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240709$$HP$US$US
240657521$24065752$1$I$20240630$20240708$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108705$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240709$$CN$US$US
240657532$24065753$2$F$20240703$20240708$20240709$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108691$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$$$20240711$$CN$US$US
240657541$24065754$1$I$$20240702$20240709$20240709$EXP$$US-AMERICAN REGENT INC-2024002602$AMERICAN REGENT$Puri C, Khan AA, Sher N. A case of emphysematous gastritis with septic shock and Clostridioides difficile. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1630 [abstract]$72$YR$$F$Y$$$20240709$$HP$US$US
240657551$24065755$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06381$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240657561$24065756$1$I$20240525$20240705$20240709$20240709$EXP$FR-AFSSAPS-AM2024000538$FR-009507513-2407FRA003075$MERCK$$78$YR$$M$Y$88$KG$20240709$$MD$FR$FR
240657572$24065757$2$F$$20240705$20240709$20240723$30DAY$$US-JNJFOC-20240717832$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
240657582$24065758$2$F$$20240710$20240709$20240715$EXP$$JP-JNJFOC-20240720429$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240715$$PH$JP$JP
240657592$24065759$2$F$$20240906$20240709$20240910$EXP$$FR-AMGEN-FRASP2024132629$AMGEN$Tougeron D.; Emile J.F.; Bodere A. et al.. Pembrolizumab in combination with xelox and bevacizumab in patients with microsatellite stable (pMMR/MSS) metastatic colorectal cancer (mCRC) and a high immune infiltrate: A proof of concept study - Preliminary results of FFCD 1703 POCHI trial. Annals of Oncology. 2024;35:S212$$$$$Y$$$20240910$$HP$FR$FR
240657601$24065760$1$I$20240510$20240701$20240709$20240709$EXP$FR-AFSSAPS-PA2024001286$FR-TEVA-VS-3216236$TEVA$$39$YR$$F$Y$110$KG$20240709$$PH$FR$FR
240657611$24065761$1$I$$20240701$20240709$20240709$EXP$$US-AMGEN-USASP2024132519$AMGEN$El Ters M.; Daum J.; Barbir E. et al.. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: effects of pretreatment on posttransplant outcomes. Nephrology Dialysis Transplantation. 2024;39 (SUPPL_1):i1623-i1624$$$$$Y$$$20240709$$HP$US$US
240657621$24065762$1$I$$20240625$20240709$20240709$EXP$$US-GLANDPHARMA-US-2024GLNLIT00432$GLAND PHARMA$MP Whyte.Drug-induced osteopetrosis.Bone.AUG-2023;173$13$YR$C$M$Y$$$20240709$$HP$US$US
240657631$24065763$1$I$20240610$20240708$20240709$20240709$PER$$US-ABBVIE-5832062$ABBVIE$$36$YR$$F$Y$$$20240709$$CN$US$US
240657641$24065764$1$I$$20240702$20240709$20240709$PER$$US-SA-2023SA331295$SANOFI AVENTIS$$$$C$F$Y$$$20240709$$MD$US$US
240657651$24065765$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA198204$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240709$$MD$US$US
240657661$24065766$1$I$20240428$20240705$20240709$20240709$EXP$$DE-UCBSA-2024034699$UCB$$$$A$F$Y$$$20240709$$MD$DE$DE
240657671$24065767$1$I$$20240701$20240709$20240709$EXP$$US-AMGEN-USASP2024133759$AMGEN$Morcate L.;Sanders I.; Chen. K. C. et.al. Nonsexual Genital Ulcers Secondary to Epstein-Barr Virus in a Pediatric Patient. Journal of Pediatric Health Care. 2024;1-7$14$YR$T$F$Y$$$20240709$$MD$US$US
240657681$24065768$1$I$$20240705$20240709$20240709$PER$$US-ROCHE-10000021109$ROCHE$$57$YR$A$F$Y$$$20240709$$CN$US$US
240657691$24065769$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108092$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240709$$CN$US$US
240657702$24065770$2$F$$20240820$20240709$20240830$EXP$$BE-BRISTOL-MYERS SQUIBB COMPANY-2024-102594$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240830$$PH$BE$BE
240657711$24065771$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A155989$ASTRAZENECA$$73$YR$$M$Y$$$20240709$$HP$FR$
240657721$24065772$1$I$$20240701$20240709$20240709$EXP$$CA-AstraZeneca-2024A152566$ASTRAZENECA$$$$$$Y$$$20240709$$MD$CA$
240657731$24065773$1$I$$20240613$20240709$20240709$30DAY$$US-VEROBIOTECH-2024USVEROSPO00136$VERO BIOTECH$$$$$$Y$$$20240709$$HP$US$US
240657741$24065774$1$I$20240617$20240703$20240709$20240709$EXP$DE-DCGMA-24203552$DE-RDY-SPO/DEU/24/0009780$DR REDDYS$$79$YR$E$F$Y$87$KG$20240709$$MD$DE$DE
240657761$24065776$1$I$$20240625$20240709$20240709$EXP$$US-GLANDPHARMA-US-2024GLNLIT00436$GLAND PHARMA$MP Whyte.Drug-induced osteopetrosis.Bone.AUG-2023;173$6$YR$C$M$Y$$$20240709$$HP$US$US
240657771$24065777$1$I$$20240702$20240709$20240709$EXP$$GB-GSK-GB2024EME082421$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$GB$GB
240657781$24065778$1$I$$20240702$20240709$20240709$PER$$US-MYLANLABS-2024M1062806$MYLAN$$$$$M$Y$$$20240709$$CN$US$US
240657791$24065779$1$I$20210620$20240704$20240709$20240709$EXP$IT-EMA-DD-20240703-7482665-055852$IT-RDY-SPO/ITA/24/0009857$DR REDDYS$$71$YR$E$F$Y$$$20240709$$HP$IT$IT
240657811$24065781$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47397$$FDA-CTU$$59$YR$$M$N$$$20240708$N$$US$
240657821$24065782$1$I$$20240706$20240708$20240708$DIR$FDA-CDER-CTU-2024-47378$$FDA-CTU$$$$$F$N$$$20240706$N$HP$US$
240657831$24065783$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47370$$FDA-CTU$$76$YR$$F$N$$$20240708$N$$US$
240657851$24065785$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47330$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240657861$24065786$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47342$$FDA-CTU$$84$YR$$M$N$$$20240708$N$$US$
240657871$24065787$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47322$$FDA-CTU$$71$YR$$M$N$$$20240708$N$$US$
240657881$24065788$1$I$20240623$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47412$$FDA-CTU$$1$YR$$M$N$$$20240708$Y$PH$US$
240657891$24065789$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47426$$FDA-CTU$$81$YR$$M$N$$$20240708$N$$US$
240657901$24065790$1$I$$20240705$20240709$20240709$PER$$US-BAYER-2024A097835$BAYER$$$$$F$Y$$$20240709$$CN$US$US
240657911$24065791$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47435$$FDA-CTU$$46$YR$$F$N$$$20240708$N$$US$
240657921$24065792$1$I$$20240708$20240708$20240708$DIR$FDA-CDER-CTU-2024-47297$$FDA-CTU$$$$$M$N$$$20240708$N$$US$
240657932$24065793$2$F$$20240701$20240709$20240709$EXP$$US-AMGEN-USASP2024131589$AMGEN$Amini S.; Allencherril R.; Lin M. et al.. A Case of Hepatic Tuberculosis in a Patient on Adalimumab for Ankylosing Spondylitis. Cureus. 2024;16 (5):1-5$52$YR$A$M$Y$$$20240709$$HP$US$US
240657942$24065794$2$F$$20240904$20240709$20240904$EXP$$GB-PFIZER INC-202400207921$PFIZER$$$$$M$Y$$$20240904$$PH$GB$GB
240657951$24065795$1$I$$20240703$20240709$20240709$EXP$$US-AMGEN-USASP2024132674$AMGEN$Zandieh A.; Seeger S. K.; Tunnell E. C. et. al.. A rare case of lupus cerebritis presenting as ictal epileptic headache: A case report. Headache: The Journal of Head and Face Pain. 2024;64(6):685-691$52$YR$A$F$Y$$$20240709$$MD$US$US
240657961$24065796$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141765$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240657971$24065797$1$I$20240705$20240705$20240709$20240709$EXP$$US-BAYER-2024A098797$BAYER$$85$YR$E$F$Y$54.422$KG$20240709$$CN$US$US
240657981$24065798$1$I$$20240704$20240709$20240709$EXP$$MX-AMGEN-MEXSP2024133672$AMGEN$Mora A.; Rios Olais F.D.; Rodriguez-rodriguez S. et.al. Should We Screen All the Immune Thrombocytopenia Patients for Helicobacter Pylori Infection in High-Prevalence Countries?. Blood. 2023;142 (SUPPL_1):3956-3957$$$$$Y$$$20240709$$HP$MX$MX
240657991$24065799$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107875$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240709$$CN$US$US
240658001$24065800$1$I$20240615$20240701$20240709$20240709$EXP$FR-AFSSAPS-PB2024000704$FR-TEVA-VS-3216211$TEVA$$29$YR$$M$Y$$$20240709$$MD$FR$FR
240658011$24065801$1$I$$20240704$20240709$20240709$EXP$$CO-JNJFOC-20240715681$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$MD$CO$CO
240658021$24065802$1$I$$20240707$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108000$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$68.04$KG$20240709$$CN$US$US
240658031$24065803$1$I$$20240704$20240709$20240709$EXP$GB-MHRA-MED-202405091211578540-ZJCYF$GB-BAXTER-2024BAX021262$BAXTER$$$$$M$Y$$$20240709$$PH$GB$GB
240658041$24065804$1$I$20240601$20240704$20240709$20240709$EXP$$CA-JNJFOC-20240714347$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240709$$CN$CA$CA
240658051$24065805$1$I$20240630$20240701$20240709$20240709$PER$$US-ALXN-202407USA000013US$ALEXION PHARMACEUTICALS$$85$YR$$F$Y$$$20240709$$CN$US$US
240658061$24065806$1$I$$20240704$20240709$20240709$EXP$$NVSC2024GB140248$NOVARTIS$$$$$F$Y$$$20240709$$CN$GB$GB
240658071$24065807$1$I$20240701$20240702$20240709$20240709$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010234$JAZZ$$29$YR$$M$Y$$$20240709$$CN$US$US
240658081$24065808$1$I$$20240709$20240709$20240709$PER$$US-HALEON-2186091$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240658091$24065809$1$I$20240413$20240702$20240709$20240709$EXP$$AU-PFIZER INC-202400208795$PFIZER$$75$YR$$M$Y$$$20240709$$HP$AU$AU
240658101$24065810$1$I$$20240702$20240709$20240709$EXP$$IT-TAKEDA-2024TUS067131$TAKEDA$Giuffrida AC, Siboni SM, Baronciani L, Poli G, Gandini G, Peyvandi F. Emicizumab in type 3 von willebrand disease: report of a case with an alloantibody and literature review. Emicizumab In Type 3 Von Willebrand Disease. 2024$$$$F$Y$$$20240709$$MD$IT$IT
240658115$24065811$5$F$20240101$20240911$20240709$20240916$EXP$$CA-PFIZER INC-202400207282$PFIZER$$65$YR$$M$Y$$$20240916$$HP$CA$CA
240658121$24065812$1$I$20240505$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405152321585420-PLBGQ$GB-PFIZER INC-202400207553$PFIZER$$46$YR$$F$Y$70$KG$20240709$$CN$GB$GB
240658131$24065813$1$I$$20240704$20240709$20240709$EXP$$FR-PFIZER INC-2021SGN03120$PFIZER$$$$$$Y$$$20240709$$HP$FR$FR
240658141$24065814$1$I$$20240705$20240709$20240709$EXP$$IN-PFIZER INC-PV202200020547$PFIZER$$51$YR$$F$Y$$$20240709$$CN$IN$IN
240658151$24065815$1$I$$20240703$20240709$20240709$EXP$$BE-PFIZER INC-2019SGN03028$PFIZER$$$$$F$Y$$$20240709$$MD$BE$BE
240658161$24065816$1$I$20240703$20240705$20240709$20240709$EXP$$CA-PFIZER INC-2019011267$PFIZER$$77$YR$$M$Y$$$20240709$$HP$CA$CA
240658171$24065817$1$I$20230601$20240704$20240709$20240709$EXP$$CA-PFIZER INC-202400207997$PFIZER$$60$YR$$F$Y$$$20240709$$HP$CA$CA
240658181$24065818$1$I$20240401$20240705$20240709$20240709$EXP$$ES-PFIZER INC-202400207509$PFIZER$$29$YR$$F$Y$$$20240709$$MD$ES$ES
240658193$24065819$3$F$20240101$20240909$20240709$20240911$EXP$$DE-PFIZER INC-202400204996$PFIZER$$89$YR$$M$Y$$$20240911$$CN$DE$DE
240658203$24065820$3$F$20240101$20240709$20240709$20240712$EXP$$CA-PFIZER INC-202400208608$PFIZER$$86$YR$$F$Y$$$20240712$$HP$CA$CA
240658211$24065821$1$I$20240101$20240705$20240709$20240709$EXP$$US-PFIZER INC-202400209057$PFIZER$$70$YR$$F$Y$$$20240709$$HP$US$US
240658223$24065822$3$F$$20240730$20240709$20240806$30DAY$$CA-JNJFOC-20240717687$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$CA$CA
240658232$24065823$2$F$20240125$20240802$20240709$20240808$EXP$$PL-PFIZER INC-202400200309$PFIZER$$68$YR$$M$Y$84$KG$20240808$$MD$PL$PL
240658241$24065824$1$I$$20240629$20240709$20240709$EXP$GB-MHRA-MED-202406291148076400-HYSNB$GB-RDY-SPO/GBR/24/0009570$DR REDDYS$$$$$M$Y$78$KG$20240709$$CN$GB$GB
240658251$24065825$1$I$20240703$20240705$20240709$20240709$EXP$$CN-FreseniusKabi-FK202410700$FRESENIUS KABI$$72$YR$E$M$Y$49$KG$20240709$$HP$CN$CN
240658263$24065826$3$F$20231218$20240808$20240709$20240814$EXP$$CA-GSK-CA2023161719$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$HP$CA$CA
240658272$24065827$2$F$20240626$20240703$20240709$20240712$PER$$US-MYLANLABS-2024M1062485$MYLAN$$55$YR$$F$Y$81.19$KG$20240712$$CN$US$US
240658281$24065828$1$I$$20240625$20240709$20240709$EXP$$PK-GLANDPHARMA-PK-2024GLNLIT00444$GLAND PHARMA$Aisha Jamal.A rare incidence of severe dermatological  toxicities triggered by concomitant  administration of all-trans retinoic acid  and triazole antifungal in patients with acute  promyelocytic leukemia: a case series  and review of the literature.Journal of Medical Case Reports.2024;18:1-7$33$YR$A$F$Y$$$20240709$$HP$PK$PK
240658301$24065830$1$I$$20240625$20240709$20240709$EXP$$CA-ABBVIE-5829500$ABBVIE$$65$YR$$M$Y$$$20240709$$MD$CA$CA
240658311$24065831$1$I$$20240705$20240709$20240709$EXP$$US-KYOWAKIRIN-2024KK016506$KYOWA$$$$$$Y$$$20240709$$HP$US$US
240658321$24065832$1$I$$20230522$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00014$VIRTUS PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240658331$24065833$1$I$20230101$20230607$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00015$VIRTUS PHARMACEUTICALS$$$$$F$Y$$$20240709$$PH$US$US
240658341$24065834$1$I$$20230627$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00016$VIRTUS PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240658351$24065835$1$I$$20230725$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00023$VIRTUS PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240658361$24065836$1$I$$20230828$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00029$VIRTUS PHARMACEUTICALS$$$$$F$Y$51.429$KG$20240709$$CN$US$US
240658371$24065837$1$I$20230801$20230807$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00026$VIRTUS PHARMACEUTICALS$$52$YR$$F$Y$90.703$KG$20240709$$CN$US$US
240658381$24065838$1$I$20240706$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004950$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240709$$CN$US$US
240658401$24065840$1$I$20240705$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004587$ELI LILLY AND CO$$$$$M$Y$$$20240709$$CN$US$US
240658411$24065841$1$I$$20240624$20240709$20240709$PER$$US-MYLANLABS-2024M1058390$MYLAN$$$$$$Y$$$20240709$$CN$US$US
240658431$24065843$1$I$$20240625$20240709$20240709$EXP$$PK-GLANDPHARMA-PK-2024GLNLIT00429$GLAND PHARMA$Aisha Jamal.A rare incidence of severe dermatological  toxicities triggered by concomitant  administration of all-trans retinoic acid  and triazole antifungal in patients with acute  promyelocytic leukemia: a case series  and review of the literature.Journal of Medical Case Reports.2024;18:1-7$28$YR$A$M$Y$$$20240709$$HP$PK$PK
240658441$24065844$1$I$$20240701$20240709$20240709$EXP$$CA-AstraZeneca-2024A152422$ASTRAZENECA$$45$YR$$F$Y$$$20240709$$MD$CA$
240658451$24065845$1$I$$20240702$20240709$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107679$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240709$$MD$JP$JP
240658461$24065846$1$I$$20240705$20240709$20240709$EXP$$JP-AstraZeneca-2024A155163$ASTRAZENECA$$$$A$F$Y$$$20240709$$MD$JP$
240658471$24065847$1$I$$20240701$20240709$20240709$PER$$US-AstraZeneca-2024A152942$ASTRAZENECA$$$$$$Y$$$20240709$$HP$US$
240658481$24065848$1$I$$20240701$20240709$20240709$EXP$$US-JNJFOC-20240703592$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$HP$US$US
240658492$24065849$2$F$$20240729$20240709$20240805$30DAY$$CN-JNJFOC-20240717625$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$CN$CN
240658501$24065850$1$I$$20240624$20240709$20240709$PER$$US-MYLANLABS-2024M1060690$MYLAN$$$$$M$Y$$$20240709$$CN$US$US
240658511$24065851$1$I$20240630$20240702$20240709$20240709$DIR$FDA-CDER-CTU-2024-47467$$FDA-CTU$$68$YR$$M$N$81.8$KG$20240702$N$$US$
240658522$24065852$2$F$20240131$20240802$20240709$20240805$EXP$$AU-MYLANLABS-2024M1022450$MYLAN$$45$YR$$F$Y$$$20240805$$HP$AU$AU
240658532$24065853$2$F$$20240827$20240709$20240917$PER$$US-SA-2024SA198816$SANOFI AVENTIS$$$$E$F$Y$70$KG$20240918$$MD$US$US
240658541$24065854$1$I$20240626$20240626$20240709$20240709$EXP$$US-SAMSUNG BIOEPIS-SB-2024-20201$SAMSUNG BIOEPIS$$92$YR$E$F$Y$$$20240709$$CN$US$US
240658552$24065855$2$F$20240501$20240721$20240709$20240724$PER$$US-ROCHE-10000014626$ROCHE$$16$YR$T$M$Y$60.33$KG$20240724$$CN$US$US
240658561$24065856$1$I$$20240702$20240709$20240709$EXP$$US-TEVA-VS-3217312$TEVA$$83$YR$$F$Y$$$20240709$$PH$US$US
240658571$24065857$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47522$$FDA-CTU$$84$YR$$M$N$$$20240709$N$$US$
240658582$24065858$2$F$$20240821$20240709$20240822$PER$$NVSC2024US140781$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
240658591$24065859$1$I$20240626$20240626$20240709$20240709$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-20136$SAMSUNG BIOEPIS$$23$YR$$M$Y$120$KG$20240709$$HP$CA$CA
240658611$24065861$1$I$$20240701$20240709$20240709$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004893$BIOCON$$$$$$Y$$$20240709$$CN$CA$CA
240658621$24065862$1$I$20240705$20240705$20240709$20240709$DIR$FDA-CDER-CTU-2024-47463$$FDA-CTU$$54$YR$$F$N$43.8$KG$20240705$N$$US$
240658641$24065864$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107870$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240709$$HP$US$US
240658651$24065865$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108823$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240709$$CN$US$US
240658661$24065866$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107924$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240709$$HP$US$US
240658671$24065867$1$I$$20240701$20240709$20240709$EXP$$US-MYLANLABS-2024M1062429$MYLAN$$$$$$Y$$$20240709$$CN$US$US
240658681$24065868$1$I$$20240624$20240709$20240709$PER$$US-MYLANLABS-2024M1060697$MYLAN$$$$$$Y$$$20240709$$CN$US$US
240658691$24065869$1$I$20220901$20240624$20240709$20240709$EXP$$DE-AIMMUNE THERAPEUTICS, INC.-2024AIMT01003$AIMMUNE$$$$$$Y$$$20240709$$CN$DE$DE
240658701$24065870$1$I$20240629$20240701$20240709$20240709$EXP$$CN-FreseniusKabi-FK202410443$FRESENIUS KABI$$73$YR$E$M$Y$49$KG$20240709$$HP$CN$CN
240658711$24065871$1$I$20240602$20240702$20240709$20240709$EXP$$TW-GSK-TW2024APC082725$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$PH$TW$TW
240658721$24065872$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06132$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240658731$24065873$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47520$$FDA-CTU$$69$YR$$M$N$$$20240709$N$$US$
240658741$24065874$1$I$$20240703$20240709$20240709$EXP$$CA-GSK-CA2023177911$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$CA$CA
240658752$24065875$2$F$20240616$20240723$20240709$20240731$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-20099$SAMSUNG BIOEPIS$$29$YR$A$F$Y$$$20240731$$CN$GB$GB
240658761$24065876$1$I$$20240707$20240709$20240709$PER$$US-HALEON-2186072$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240658771$24065877$1$I$20240101$20240705$20240709$20240709$PER$$US-BIOGEN-2024BI01271988$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
240658781$24065878$1$I$$20240703$20240709$20240709$PER$$US-BIOGEN-2024BI01272290$BIOGEN$$$$$M$Y$$$20240709$$HP$US$US
240658792$24065879$2$F$20240601$20240704$20240709$20240712$EXP$$FR-DSJP-DSE-2024-131007$DAIICHI$$65$YR$$F$Y$89$KG$20240712$$MD$FR$FR
240658801$24065880$1$I$20240601$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134320$AMGEN$$79$YR$E$F$Y$$$20240709$$CN$US$US
240658812$24065881$2$F$20231103$20240711$20240709$20240717$EXP$FR-AFSSAPS-MP2024001063$FR-AMGEN-FRASP2024130289$AMGEN$$70$YR$E$F$Y$$$20240717$$PH$FR$FR
240658822$24065882$2$F$$20240807$20240709$20240812$30DAY$$BE-JNJFOC-20240716698$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$PH$BE$BE
240658831$24065883$1$I$$20240701$20240709$20240709$EXP$$IT-ALXN-202407EEA000044IT$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$MD$IT$IT
240658841$24065884$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47594$$FDA-CTU$$67$YR$$M$N$$$20240708$N$$US$
240658851$24065885$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47585$$FDA-CTU$$45$YR$$M$N$$$20240709$N$HP$US$
240658861$24065886$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47598$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240658871$24065887$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47582$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240658881$24065888$1$I$20240605$20240703$20240709$20240709$DIR$FDA-CDER-CTU-2024-47495$$FDA-CTU$$62$YR$$F$N$$$20240703$N$HP$US$
240658891$24065889$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47574$$FDA-CTU$$$$$M$N$$$20240709$N$HP$US$
240658901$24065890$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47589$$FDA-CTU$$74$YR$$F$N$71.67$KG$20240709$N$$US$
240658911$24065891$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47507$$FDA-CTU$$28$YR$$F$N$$$20240709$N$$US$
240658961$24065896$1$I$$20240704$20240709$20240709$EXP$GB-MHRA-MED-202405011537581670-RBGLP$GB-TAKEDA-2024TUS067999$TAKEDA$$$$$F$Y$$$20240709$$HP$GB$GB
240658971$24065897$1$I$20240101$20240703$20240709$20240709$PER$$US-SA-2024SA199167$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240709$$MD$US$US
240658981$24065898$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA196694$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240709$$MD$US$US
240658991$24065899$1$I$20240626$20240705$20240709$20240709$EXP$$CA-INTERCEPT-PM2024001374$INTERCEPT PHARMACEUTICALS$$71$YR$$F$Y$$$20240709$$HP$CA$CA
240659001$24065900$1$I$20240507$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A150648$ASTRAZENECA$$57$YR$$F$Y$$$20240709$$MD$FR$
240659012$24065901$2$F$$20240701$20240709$20240711$PER$$US-MYLANLABS-2024M1062421$MYLAN$$$$$$Y$$$20240711$$CN$US$US
240659021$24065902$1$I$20190101$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A150340$ASTRAZENECA$$23$YR$$F$Y$64$KG$20240709$$MD$FR$
240659031$24065903$1$I$$20240701$20240709$20240709$EXP$$JP-TEVA-VS-3216250$TEVA$Tanabe M, Koba Y, Yaguchi T, Watanabe M. Detection of Schizophyllum commune in SARS-CoV-2 Pneumonia. Intern-Med 2024; 63 (7): 1037-1038.$72$YR$$M$Y$$$20240709$$MD$JP$JP
240659041$24065904$1$I$$20240703$20240709$20240709$PER$$US-BIOGEN-2024BI01272342$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
240659051$24065905$1$I$$20240703$20240709$20240709$EXP$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000249$SIGMA TAU$Rose K, Rubin R, Zacharias W.. Disseminated Blastomycosis Complicated by Multiorgan Failure Driven by Cytokine Release Syndrome in a Patient With Poorly Controlled Diabetes Mellitus.. American Journal of Respiratory And Critical Care Medicine.. 2024;209:A3588$37$YR$$F$Y$$$20240709$$HP$US$US
240659061$24065906$1$I$$20240708$20240709$20240709$PER$$US-JNJFOC-20240720875$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240659071$24065907$1$I$$20240701$20240709$20240709$EXP$$JP-TEVA-VS-3216273$TEVA$Takanosu T, Izawa Y, Yonekawa C, Mato T. Clostridium perfringens-induced liver abscess with severe haemolysis. BMJ-Case-Rep 2024; 17 (5):.$$$$M$Y$$$20240709$$HP$JP$JP
240659081$24065908$1$I$$20240703$20240709$20240709$EXP$$US-GILEAD-2024-0679764$GILEAD$$$$A$F$Y$$$20240709$$CN$US$US
240659094$24065909$4$F$$20240913$20240709$20240919$EXP$$NVSC2024US141378$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
240659102$24065910$2$F$$20240717$20240709$20240725$EXP$$NVSC2024GB140026$NOVARTIS$Cooper N, Scully M, Percy C, Nicolson PLR, Lowe G, Bagot CN et al.. Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.. BRITISH JOURNAL OF HAEMATOLOGY. 2024;204:2442-52$$$$$Y$$$20240725$$HP$GB$GB
240659111$24065911$1$I$$20240626$20240709$20240709$EXP$$NVSC2024US132619$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240659123$24065912$3$F$$20240708$20240709$20240715$EXP$$US-MYLANLABS-2024M1063983$MYLAN$$$$$M$Y$$$20240715$$MD$US$US
240659131$24065913$1$I$$20240624$20240709$20240709$EXP$$ES-TEVA-VS-3215431$TEVA$Rubio I, de la Puente EM, Boveda O, Jimenez I, Pena I. Green neutrophilic inclusions in patient with drug intoxication: a case report. J-Lab-Precis-Med 2024; 9.$54$YR$$F$Y$$$20240709$$HP$ES$ES
240659141$24065914$1$I$$20240703$20240709$20240709$EXP$$US-PFIZER INC-2024SGN04905$PFIZER$$58$YR$$F$Y$$$20240709$$CN$US$US
240659151$24065915$1$I$$20240703$20240709$20240709$EXP$$US-PFIZER INC-2024SGN04649$PFIZER$$46$YR$$F$Y$$$20240709$$CN$US$US
240659162$24065916$2$F$$20240731$20240709$20240805$EXP$$US-PFIZER INC-202400206201$PFIZER$$43$YR$$M$Y$$$20240805$$HP$US$US
240659171$24065917$1$I$20240601$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004652$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240709$$CN$US$US
240659181$24065918$1$I$20240209$20240627$20240709$20240709$EXP$$CN-PFIZER INC-2024SGN04468$PFIZER$$45$YR$$F$Y$47$KG$20240709$$MD$CN$CN
240659191$24065919$1$I$20240101$20240703$20240709$20240709$PER$$US-009507513-2407USA001815$MERCK$$$$$M$Y$$$20240709$$CN$US$US
240659201$24065920$1$I$$20231031$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00035$VIRTUS PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240659211$24065921$1$I$$20231108$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00038$VIRTUS PHARMACEUTICALS$$$$$F$Y$$$20240709$$MD$US$US
240659221$24065922$1$I$$20231113$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00040$VIRTUS PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240659231$24065923$1$I$$20231205$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00043$VIRTUS PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240659241$24065924$1$I$$20231221$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00045$VIRTUS PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240659251$24065925$1$I$$20240705$20240709$20240709$PER$$US-JNJFOC-20240717576$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$US$US
240659261$24065926$1$I$20230714$20230717$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00018$VIRTUS PHARMACEUTICALS$$59$YR$$F$Y$$$20240709$$CN$US$US
240659271$24065927$1$I$$20231122$20240709$20240709$PER$$US-VIRTUS PHARMACEUTICALS, LLC-2023VTS00041$VIRTUS PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240659282$24065928$2$F$$20240719$20240709$20240722$PER$$US-HALEON-2185947$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
240659292$24065929$2$F$$20240702$20240709$20240805$PER$$US-ROCHE-10000017380$ROCHE$$$$A$M$Y$$$20240805$$CN$US$US
240659301$24065930$1$I$20240625$20240702$20240709$20240709$PER$$US-ROCHE-10000018690$ROCHE$$32$YR$A$M$Y$$$20240709$$CN$US$US
240659315$24065931$5$F$20240722$20240924$20240709$20240926$PER$$US-ROCHE-10000020336$ROCHE$$8$YR$C$M$Y$35.38$KG$20240926$$MD$US$US
240659321$24065932$1$I$20240608$20240703$20240709$20240709$PER$$US-ROCHE-10000019862$ROCHE$$32$YR$A$M$Y$$$20240709$$CN$US$US
240659331$24065933$1$I$20240612$20240703$20240709$20240709$PER$$US-ROCHE-10000019907$ROCHE$$17$YR$T$M$Y$$$20240709$$CN$US$US
240659361$24065936$1$I$20220601$20240707$20240709$20240709$PER$$NVSC2024US141085$NOVARTIS$$$$$$Y$$$20240709$$CN$US$US
240659372$24065937$2$F$$20240718$20240709$20240723$PER$$US-ROCHE-10000020282$ROCHE$$$$C$M$Y$$$20240723$$CN$US$US
240659381$24065938$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000020010$ROCHE$$$$$M$Y$$$20240709$$CN$US$US
240659392$24065939$2$F$20240312$20240703$20240709$20240711$EXP$FR-AFSSAPS-AVMA2024000276$FR-MYLANLABS-2024M1062577$MYLAN$$26$YR$$M$Y$$$20240711$$PH$FR$FR
240659402$24065940$2$F$20240628$20240808$20240709$20240808$30DAY$$US-PFIZER INC-202400204663$PFIZER$$7$YR$$F$Y$$$20240808$$MD$US$US
240659412$24065941$2$F$$20240704$20240709$20240711$EXP$GB-MHRA-MED-202405071551083640-FNBDP$GB-MYLANLABS-2024M1063227$MYLAN$$$$$M$Y$85$KG$20240711$$CN$GB$GB
240659442$24065944$2$F$$20240906$20240709$20240910$30DAY$$US-PFIZER INC-202400204716$PFIZER$$66$YR$$F$Y$$$20240910$$CN$US$US
240659451$24065945$1$I$$20240701$20240709$20240709$30DAY$$US-PFIZER INC-202400204450$PFIZER$$26$YR$$F$Y$$$20240709$$PH$US$US
240659463$24065946$3$F$20240701$20240822$20240709$20240917$PER$$US-SA-2024SA197148$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$MD$US$US
240659471$24065947$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47609$$FDA-CTU$$66$YR$$F$N$$$20240709$N$HP$US$
240659481$24065948$1$I$20240207$20240708$20240708$20240708$DIR$709512$$FDA-CTU$$68$YR$$M$N$84.6$KG$20240708$N$CN$US$
240659491$24065949$1$I$20240624$20240708$20240708$20240708$DIR$709511$$FDA-CTU$$34$YR$$F$N$55.35$KG$20240708$N$CN$US$
240659511$24065951$1$I$20240621$20240708$20240708$20240708$DIR$709507$$FDA-CTU$$68$YR$$M$N$$$20240708$N$HP$US$
240659524$24065952$4$F$20231018$20240903$20240709$20240903$EXP$$JP-BAYER-2024A095998$BAYER$Sugawara M, Matsuura M, Manabe T, Noda A, Kubo A, Matsunaka T, et al. A case of KIT-positive gastrointestinal stromal tumor originating from the stomach treated with pimitespib as the fourth-line treatment. The 121st Regular Meeting of the Shikoku Branch of the Japanese Society of Gastr. 2024;73$56$YR$A$F$Y$$$20240903$$HP$JP$JP
240659531$24065953$1$I$20240329$20240703$20240709$20240709$DIR$FDA-CDER-CTU-2024-47458$$FDA-CTU$$15$YR$$F$N$102.7$KG$20240703$N$$US$
240659541$24065954$1$I$20240707$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47460$$FDA-CTU$$62$YR$$M$N$89.9$KG$20240708$N$$US$
240659551$24065955$1$I$$20240708$20240708$20240708$DIR$709487$$FDA-CTU$$$$$UNK$N$$$20240708$N$CN$US$
240659561$24065956$1$I$20240612$20240708$20240708$20240708$DIR$709495$$FDA-CTU$$56$YR$$F$N$103.95$KG$20240708$N$$US$
240659571$24065957$1$I$20240612$20240703$20240709$20240709$DIR$FDA-CDER-CTU-2024-47454$$FDA-CTU$$79$YR$$M$N$103.7$KG$20240703$N$$US$
240659581$24065958$1$I$20240627$20240708$20240708$20240708$DIR$709514$$FDA-CTU$$43$YR$$M$N$71.1$KG$20240708$N$CN$US$
240659601$24065960$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47588$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240659611$24065961$1$I$$20240708$20240708$20240708$DIR$709526$$FDA-CTU$$40$YR$$F$N$$$20240708$N$$US$
240659621$24065962$1$I$20240616$20240703$20240709$20240709$PER$$US-ROCHE-10000019827$ROCHE$$38$YR$A$M$Y$$$20240709$$CN$US$US
240659631$24065963$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000019949$ROCHE$$$$T$M$Y$$$20240709$$CN$US$US
240659641$24065964$1$I$20240620$20240701$20240709$20240709$EXP$PT-INFARMED-R202406-548$PT-FreseniusKabi-FK202410391$FRESENIUS KABI$$59$YR$A$F$Y$$$20240709$$PH$PT$PT
240659651$24065965$1$I$20231003$20240703$20240709$20240709$EXP$FR-AFSSAPS-CN2024000495$FR-MYLANLABS-2024M1062646$MYLAN$$63$YR$$M$Y$72$KG$20240709$$MD$FR$FR
240659662$24065966$2$F$$20240814$20240709$20240819$30DAY$$US-GSK-US2024084028$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
240659674$24065967$4$F$20240702$20240822$20240709$20240826$PER$$US-ROCHE-10000019805$ROCHE$$13$YR$T$M$Y$85.7$KG$20240826$$CN$US$US
240659683$24065968$3$F$$20240805$20240709$20240813$30DAY$$US-JNJFOC-20240716576$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
240659691$24065969$1$I$$20240625$20240709$20240709$PER$$US-ROCHE-10000020740$ROCHE$$$$$M$Y$$$20240709$$CN$US$US
240659701$24065970$1$I$$20240701$20240709$20240709$PER$$US-AstraZeneca-2024A151461$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240659711$24065971$1$I$$20240624$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06116$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240659722$24065972$2$F$20240524$20240808$20240709$20240813$PER$$US-ROCHE-10000020171$ROCHE$$32$YR$A$M$Y$$$20240813$$CN$US$US
240659731$24065973$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000020656$ROCHE$$$$A$M$Y$$$20240709$$CN$US$US
240659741$24065974$1$I$20240625$20240703$20240709$20240709$PER$$US-ROCHE-10000020431$ROCHE$$31$YR$A$M$Y$$$20240709$$CN$US$US
240659751$24065975$1$I$$20240704$20240709$20240709$EXP$$US-ABBVIE-5831105$ABBVIE$$$$$F$Y$$$20240709$$HP$US$US
240659761$24065976$1$I$$20240702$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106270$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240709$$HP$US$US
240659771$24065977$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108629$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240709$$CN$US$US
240659781$24065978$1$I$$20240703$20240709$20240709$PER$$US-TAKEDA-2024TUS068065$TAKEDA$$$$$M$Y$82$KG$20240709$$MD$US$US
240659791$24065979$1$I$$20240702$20240709$20240709$EXP$$NVSC2024US140724$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240659801$24065980$1$I$$20240627$20240709$20240709$PER$$US-BIOGEN-2024BI01271799$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
240659811$24065981$1$I$$20240628$20240709$20240709$EXP$$DE-RDY-SPO/DEU/24/0005000$DR REDDYS$$57$YR$A$F$Y$$$20240709$$PH$DE$DE
240659821$24065982$1$I$20240419$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405160833067880-ZLMSD$GB-MYLANLABS-2024M1063604$MYLAN$$$$$F$Y$100$KG$20240709$$CN$GB$GB
240659831$24065983$1$I$20230718$20240703$20240709$20240709$EXP$$RU-ABBVIE-5830445$ABBVIE$$4$YR$$M$Y$10$KG$20240709$$MD$RU$RU
240659841$24065984$1$I$$20240708$20240709$20240709$EXP$$CN-TAKEDA-2024TUS069665$TAKEDA$Liu YC, Zhou ZK, Yi MM, Wang LJ, Shou ST, Chai FY. Colchicine poisoning: case report of three homicides in a family. Heliyon. 2024;10(11):e32407$69$YR$$M$Y$$$20240709$$MD$CN$CN
240659851$24065985$1$I$20240523$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05457$VIFOR$$64$YR$$F$Y$53.5$KG$20240709$$HP$US$US
240659871$24065987$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405101852475700-BKTGS$GB-MYLANLABS-2024M1063131$MYLAN$$$$$$Y$$$20240709$$CN$GB$GB
240659881$24065988$1$I$20240626$20240705$20240709$20240709$EXP$GB-MHRA-MED-202406260823074440-ZTJLM$GB-MYLANLABS-2024M1063727$MYLAN$$58$YR$$M$Y$72$KG$20240709$$CN$GB$GB
240659891$24065989$1$I$20240207$20240705$20240709$20240709$EXP$FR-AFSSAPS-RE2024000648$FR-MYLANLABS-2024M1063079$MYLAN$$61$YR$$F$Y$70$KG$20240709$$MD$FR$FR
240659901$24065990$1$I$20210226$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05463$VIFOR$$74$YR$$F$Y$46.5$KG$20240709$$HP$US$US
240659911$24065991$1$I$$20240628$20240709$20240709$PER$$US-TEVA-VS-3216435$TEVA$$$$$F$Y$$$20240709$$CN$US$US
240659921$24065992$1$I$20240417$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05472$VIFOR$$76$YR$$M$Y$$$20240709$$HP$US$US
240659931$24065993$1$I$20240516$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05473$VIFOR$$32$YR$$M$Y$139$KG$20240709$$HP$US$US
240659941$24065994$1$I$20240101$20240708$20240709$20240709$PER$$US-JNJFOC-20240719973$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$MD$US$US
240659951$24065995$1$I$$20240703$20240709$20240709$PER$$US-BIOVITRUM-2024-US-009554$BIOVITRUM$$67$YR$$F$Y$$$20240709$$CN$US$US
240659961$24065996$1$I$20240702$20240702$20240709$20240709$EXP$$US-JNJFOC-20240706079$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20240709$$CN$US$US
240659971$24065997$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141606$NOVARTIS$$$$$M$Y$$$20240709$$CN$US$US
240659991$24065999$1$I$$20240702$20240709$20240709$EXP$$NVSC2024BR139826$NOVARTIS$$$$$M$Y$76$KG$20240709$$CN$BR$BR
240660001$24066000$1$I$$20240702$20240709$20240709$EXP$$US-GSK-US2024AMR082812$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$US$US
240660021$24066002$1$I$20240708$20240708$20240708$20240708$DIR$709501$$FDA-CTU$$33$YR$$F$N$$$20240708$N$HP$US$
240660031$24066003$1$I$20220725$20240708$20240708$20240708$DIR$709483$$FDA-CTU$$72$YR$$F$N$58.5$KG$20240708$N$CN$US$
240660071$24066007$1$I$20240627$20240708$20240708$20240708$DIR$709537$$FDA-CTU$$82$YR$$F$N$$$20240708$N$CN$US$
240660081$24066008$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47512$$FDA-CTU$$70$YR$$F$N$$$20240709$N$HP$US$
240660101$24066010$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47577$$FDA-CTU$$29$YR$$F$N$69.85$KG$20240709$N$HP$US$
240660111$24066011$1$I$20240706$20240708$20240708$20240708$DIR$709491$$FDA-CTU$$62$YR$$F$N$63.9$KG$20240708$N$$US$
240660121$24066012$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47584$$FDA-CTU$$29$YR$$F$N$69.85$KG$20240709$N$$US$
240660141$24066014$1$I$$20240626$20240709$20240709$DIR$FDA-CDER-CTU-2024-47496$$FDA-CTU$$$$$F$N$$$20240626$N$HP$US$
240660151$24066015$1$I$20240705$20240708$20240708$20240708$DIR$709461$$FDA-CTU$$21$YR$$M$N$$$20240708$N$$US$
240660161$24066016$1$I$20240708$20240708$20240708$20240708$DIR$709489$$FDA-CTU$$81$YR$$M$N$84.15$KG$20240708$N$PH$US$
240660171$24066017$1$I$20240630$20240708$20240708$20240708$DIR$709492$$FDA-CTU$$72$YR$$M$N$56.82$KG$20240708$N$PH$US$
240660181$24066018$1$I$20240512$20240708$20240708$20240708$DIR$709525$$FDA-CTU$$66$YR$$F$N$81$KG$20240708$N$CN$US$
240660191$24066019$1$I$20240505$20240708$20240708$20240708$DIR$709503$$FDA-CTU$$72$YR$$M$N$100$KG$20240708$N$HP$US$
240660221$24066022$1$I$$20240701$20240709$20240709$EXP$$US-TEVA-VS-3216576$TEVA$$$$I$M$Y$$$20240709$$HP$US$US
240660232$24066023$2$F$20240101$20240709$20240709$20240711$EXP$$US-ORGANON-O2407USA000717$ORGANON$$$$$F$Y$68$KG$20240711$$MD$US$US
240660241$24066024$1$I$$20240708$20240709$20240709$PER$$US-GILEAD-2024-0679849$GILEAD$$$$$M$Y$$$20240709$$CN$US$US
240660251$24066025$1$I$$20240702$20240709$20240709$EXP$$JP-TEVA-VS-3200593$TEVA$$$$E$$Y$$$20240709$$PH$JP$JP
240660261$24066026$1$I$20240201$20240704$20240709$20240709$EXP$FR-AFSSAPS-MA2024000810$FR-AMGEN-FRASP2024132967$AMGEN$$10$YR$C$F$Y$$$20240709$$MD$FR$FR
240660271$24066027$1$I$$20240707$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107946$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$69.4$KG$20240709$$CN$US$US
240660281$24066028$1$I$$20240705$20240709$20240709$EXP$$US-INCYTE CORPORATION-2024IN007147$INCYTE$$$$$$Y$$$20240709$$CN$US$US
240660292$24066029$2$F$20190424$20240812$20240709$20240814$EXP$$CO-UCBSA-2024034498$UCB$$33$YR$$F$Y$$$20240814$$CN$CO$CO
240660301$24066030$1$I$$20240625$20240709$20240709$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000561$PAREXEL$Xuehong Yu, Muyuan Wang, Lin Yao.. A case of toripalimab?induced immune?related adverse reactions with skin lesions as the initial manifestation. Chinese Journal of Dermatology. 2024;57:268-269$$$$$Y$$$20240709$$HP$CN$CN
240660311$24066031$1$I$$20240706$20240709$20240709$PER$$NVSC2024US141794$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240660321$24066032$1$I$20240619$20240703$20240709$20240709$EXP$$CN-AMGEN-CHNSP2024132302$AMGEN$$42$YR$A$M$Y$65$KG$20240709$$HP$CN$CN
240660332$24066033$2$F$20240622$20240701$20240709$20240720$PER$$US-TEVA-VS-3216111$TEVA$$44$YR$$M$Y$$$20240720$$CN$US$US
240660351$24066035$1$I$20240705$20240708$20240708$20240708$DIR$709498$$FDA-CTU$$86$YR$$F$N$64.89$KG$20240708$Y$PH$US$
240660361$24066036$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47539$$FDA-CTU$$55$YR$$$N$$$20240709$Y$HP$US$
240660371$24066037$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47563$$FDA-CTU$$56$YR$$F$N$$$20240709$N$$US$
240660381$24066038$1$I$$20240703$20240709$20240709$EXP$$US-GSK-US2024AMR084288$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$US$US
240660391$24066039$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47562$$FDA-CTU$$45$YR$$F$N$$$20240709$N$$US$
240660411$24066041$1$I$20240312$20240701$20240709$20240709$EXP$$US-TEVA-VS-3216807$TEVA$$62$YR$$F$Y$62.6$KG$20240709$$CN$US$US
240660422$24066042$2$F$$20240916$20240709$20240926$PER$$US-GSK-US2024083243$GLAXOSMITHKLINE$$$$$M$Y$$$20240926$$CN$US$US
240660442$24066044$2$F$$20240718$20240709$20240723$EXP$$US-INCYTE CORPORATION-2024IN007130$INCYTE$$$$$$Y$$$20240723$$HP$US$US
240660461$24066046$1$I$$20240702$20240709$20240709$EXP$$BR-TAKEDA-2024TUS069114$TAKEDA$$$$$F$Y$$$20240709$$CN$BR$BR
240660471$24066047$1$I$20240501$20240701$20240709$20240709$PER$$US-SA-2024SA197165$SANOFI AVENTIS$$11$YR$C$F$Y$43$KG$20240709$$MD$US$US
240660482$24066048$2$F$$20240624$20240709$20240814$EXP$$US-BRAEBURN-US-BRA-24-000608$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240814$$HP$US$US
240660491$24066049$1$I$$20240701$20240709$20240709$EXP$$NVSC2024CN140538$NOVARTIS$Zhang P, Yue Y, Gui D. Effectiveness of laparoscopic surgery combined with gonadotrophin - releasing hormone agonist therapy in the treatment of endometriosis and its  impact on recurrence and pregnancy status. JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. 2024;23(10):1064-67$$$A$F$Y$$$20240709$$HP$CN$CN
240660501$24066050$1$I$20240525$20240708$20240708$20240708$DIR$709505$$FDA-CTU$$35$YR$$F$N$$$20240708$Y$PH$US$
240660511$24066051$1$I$$20240705$20240709$20240709$EXP$$NVSC2024US141034$NOVARTIS$$$$$M$Y$$$20240709$$CN$US$US
240660521$24066052$1$I$20240513$20240705$20240709$20240709$EXP$$NVSC2024CN141478$NOVARTIS$$37$YR$$F$Y$60$KG$20240709$$HP$CN$CN
240660531$24066053$1$I$$20240705$20240709$20240709$EXP$$US-GSK-US2024083942$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$HP$US$US
240660541$24066054$1$I$$20240705$20240709$20240709$EXP$$US-GSK-US2024083849$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$US$US
240660551$24066055$1$I$$20240704$20240709$20240709$EXP$$US-GSK-US2024AMR084349$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$US$US
240660561$24066056$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47481$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240660601$24066060$1$I$20230226$20240705$20240709$20240709$EXP$$IT-PFIZER INC-202300304137$PFIZER$$55$YR$$$Y$$$20240709$$MD$IT$IT
240660612$24066061$2$F$$20240704$20240709$20240715$EXP$$CA-PFIZER INC-PV202400087432$PFIZER$Lam, G.. Primary Effusion Lymphoma (PEL)-Like Lymphoma in a Child With Congenital Immunodeficiency. Pediatr Blood Cancer. 2016;63:1674-1676$9$YR$$F$Y$$$20240715$$MD$CA$CA
240660621$24066062$1$I$20000117$20240703$20240709$20240709$EXP$$GR-PFIZER INC-PV202400087667$PFIZER$Michopoulos, S.. Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome. Digestive Diseases and Sciences. 2002;47 (4):730-734$36$YR$$M$Y$$$20240709$$MD$GR$GR
240660632$24066063$2$F$$20240704$20240709$20240712$EXP$$JP-OTSUKA-2024_019131$OTSUKA$Isobe K, Saida S, Honda Y, Nihira H, Hiejima E, Izawa K, et al.. Successful cord blood transplantation using reduced intensity conditioning in a 5-month-old patient with IL-10RA deficiency. Pediatric Blood and Cancer. 2024;71:e31056$2$DY$$F$Y$$$20240712$$HP$JP$JP
240660652$24066065$2$F$$20240828$20240709$20240828$EXP$$FR-PFIZER INC-2021SGN02728$PFIZER$$$$$F$Y$$$20240828$$HP$FR$FR
240660661$24066066$1$I$20200608$20240704$20240709$20240709$EXP$$BE-PFIZER INC-2020SGN02396$PFIZER$$$$E$F$Y$60$KG$20240709$$MD$BE$BE
240660672$24066067$2$F$20210407$20240810$20240709$20240813$EXP$$FR-PFIZER INC-2021SGN02202$PFIZER$$71$YR$$F$Y$$$20240813$$MD$FR$FR
240660681$24066068$1$I$20210202$20240703$20240709$20240709$EXP$$FR-PFIZER INC-2021SGN01668$PFIZER$$$$$F$Y$$$20240709$$HP$FR$FR
240660701$24066070$1$I$20200515$20240704$20240709$20240709$EXP$$BE-PFIZER INC-2020SGN02124$PFIZER$$47$YR$$F$Y$76$KG$20240709$$MD$BE$BE
240660711$24066071$1$I$20240201$20240702$20240709$20240709$30DAY$$CN-PFIZER INC-202400204510$PFIZER$$1$YR$$M$Y$8$KG$20240709$$CN$CN$CN
240660722$24066072$2$F$$20240830$20240709$20240830$30DAY$$CO-PFIZER INC-202400205117$PFIZER$$13$YR$$M$Y$$$20240830$$CN$CO$CO
240660731$24066073$1$I$$20240704$20240709$20240709$EXP$$BE-PFIZER INC-2020SGN02057$PFIZER$$$$E$F$Y$71.6$KG$20240709$$MD$BE$BE
240660743$24066074$3$F$20240615$20240907$20240709$20240909$30DAY$$CO-PFIZER INC-PV202400087935$PFIZER$$12$YR$$M$Y$$$20240909$$CN$CO$CO
240660751$24066075$1$I$20210422$20240705$20240709$20240709$EXP$$IT-PFIZER INC-2021SGN02463$PFIZER$$68$YR$$F$Y$62$KG$20240709$$MD$IT$IT
240660761$24066076$1$I$20230209$20240704$20240709$20240709$EXP$$BE-PFIZER INC-2023SGN02387$PFIZER$$48$YR$$F$Y$62$KG$20240709$$MD$BE$BE
240660771$24066077$1$I$20240623$20240705$20240709$20240709$EXP$$NVSC2024CN141495$NOVARTIS$$41$YR$$M$Y$85$KG$20240709$$HP$CN$CN
240660781$24066078$1$I$20240507$20240627$20240709$20240709$EXP$FR-AFSSAPS-PB2024000708$FR-ELI_LILLY_AND_COMPANY-FR202406019809$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240709$$CN$FR$FR
240660791$24066079$1$I$20240404$20240627$20240709$20240709$EXP$IT-MINISAL02-992445$IT-ELI_LILLY_AND_COMPANY-IT202406019786$ELI LILLY AND CO$$28$YR$A$F$Y$62$KG$20240709$$CN$IT$IT
240660801$24066080$1$I$20200927$20240703$20240709$20240709$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407004019$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240709$$CN$AU$AU
240660811$24066081$1$I$$20240703$20240709$20240709$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407004018$ELI LILLY AND CO$$$$$F$Y$$$20240709$$CN$AU$AU
240660821$24066082$1$I$20240524$20240626$20240709$20240709$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407000268$ELI LILLY AND CO$$38$YR$A$F$Y$56$KG$20240709$$CN$CN$CN
240660831$24066083$1$I$20220110$20240627$20240709$20240709$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202406018034$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240709$$CN$AU$AU
240660841$24066084$1$I$20240308$20240703$20240709$20240709$EXP$FR-AFSSAPS-LL2024001220$FR-ELI_LILLY_AND_COMPANY-FR202407003313$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240709$$CN$FR$FR
240660851$24066085$1$I$20240614$20240627$20240709$20240709$EXP$SE-SEMPA-2024-005166$SE-ELI_LILLY_AND_COMPANY-SE202406019778$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240709$$CN$SE$SE
240660861$24066086$1$I$$20240618$20240709$20240709$EXP$$IN-ROCHE-10000010748$ROCHE$$65$YR$E$M$Y$$$20240701$$CN$IN$IN
240660871$24066087$1$I$$20240627$20240709$20240709$PER$$US-SA-2024SA194659$SANOFI AVENTIS$$$$A$F$Y$63.502$KG$20240709$$MD$US$US
240660881$24066088$1$I$20240101$20240628$20240709$20240709$PER$$US-SA-2024SA197368$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240709$$MD$US$US
240660892$24066089$2$F$$20240618$20240709$20240802$EXP$$US-ROCHE-10000005826$ROCHE$$$$E$F$Y$73.48$KG$20240802$$CN$US$US
240660901$24066090$1$I$20240325$20240621$20240709$20240709$EXP$$CN-ROCHE-10000006737$ROCHE$$41$YR$A$F$Y$$$20240628$$HP$CN$CN
240660911$24066091$1$I$20200420$20240617$20240709$20240709$EXP$$IT-ROCHE-2908413$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IT$IT
240660921$24066092$1$I$20240610$20240620$20240709$20240709$EXP$$AU-ROCHE-10000008196$ROCHE$$66$YR$E$F$Y$$$20240628$$PH$AU$AU
240660932$24066093$2$F$$20240614$20240709$20240709$PER$$US-ROCHE-10000007524$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240660941$24066094$1$I$$20240624$20240709$20240709$EXP$$CN-ROCHE-10000009250$ROCHE$Fan H, Yan L, Tan Y, Feng J, Zhang W. Bevacizumab-associated toxic epidermal necrolysis in a patient with liver cancer. The Journal of dermatology. 2024-Jun-19;00:1-2. doi:10.1111/1346-8138.17285.$53$YR$A$M$Y$$$20240628$$HP$CN$CN
240660952$24066095$2$F$$20240624$20240709$20240709$PER$$US-ROCHE-10000011264$ROCHE$$40$YR$A$F$Y$$$20240701$$CN$US$US
240660964$24066096$4$F$20240620$20240904$20240709$20240906$EXP$$US-ROCHE-10000007953$ROCHE$$7$YR$C$F$Y$$$20240906$$CN$US$US
240660981$24066098$1$I$20240524$20240606$20240709$20240709$EXP$$CN-ROCHE-3580317$ROCHE$$75$YR$E$F$Y$$$20240617$$HP$CN$CN
240660994$24066099$4$F$20240615$20240620$20240709$20240819$PER$$US-ROCHE-10000008829$ROCHE$$77$YR$E$F$Y$$$20240819$$CN$US$US
240661012$24066101$2$F$20160229$20240613$20240709$20240709$EXP$$CA-ROCHE-1728150$ROCHE$$69$YR$E$M$Y$90$KG$20240705$$HP$CA$CA
240661022$24066102$2$F$$20240731$20240709$20240812$EXP$$GB-ROCHE-10000005947$ROCHE$$$$A$F$Y$$$20240812$$CN$GB$GB
240661031$24066103$1$I$$20240608$20240709$20240709$EXP$$IN-ROCHE-3518520$ROCHE$$76$YR$E$M$Y$$$20240701$$CN$IN$IN
240661041$24066104$1$I$20240401$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47622$$FDA-CTU$$59$YR$$F$N$$$20240708$N$HP$US$
240661071$24066107$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47623$$FDA-CTU$$$$$M$N$$$20240709$N$HP$US$
240661081$24066108$1$I$$20240619$20240709$20240709$EXP$$IN-ROCHE-10000010641$ROCHE$$64$YR$A$F$Y$$$20240701$$CN$IN$IN
240661091$24066109$1$I$$20240702$20240709$20240709$EXP$$US-MYLANLABS-2024M1063707$MYLAN$Fan J, Thanedar S, Ovechko V, Jana B. Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers. Case-Rep-Oncol 2024; 17 (1): 517-523.$56$YR$$M$Y$$$20240709$$HP$US$US
240661101$24066110$1$I$$20240618$20240709$20240709$EXP$$IN-ROCHE-10000005176$ROCHE$$$$E$M$Y$$$20240701$$CN$IN$IN
240661111$24066111$1$I$$20240624$20240709$20240709$EXP$$US-ROCHE-10000010385$ROCHE$Marian L, Harris K, Conway D. The patient-reported wearing-off phenomenon with monoclonal antibody treatments for multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical. 2024-May-06;1-8. doi:10.1177/20552173241251707.$$$$$Y$$$20240628$$HP$US$US
240661121$24066112$1$I$20181101$20240613$20240709$20240709$EXP$$RU-ROCHE-10000000837$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$RU$RU
240661131$24066113$1$I$20240531$20240617$20240709$20240709$EXP$$CN-ROCHE-10000001190$ROCHE$$65$YR$E$F$Y$70$KG$20240628$$HP$CN$CN
240661141$24066114$1$I$$20240702$20240709$20240709$EXP$$US-MYLANLABS-2024M1063704$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$51$YR$$M$Y$$$20240709$$HP$US$US
240661171$24066117$1$I$$20240702$20240709$20240709$EXP$$CA-ALCON LABORATORIES-ALC2024CA003207$ALCON$$$$$F$Y$$$20240709$$HP$CA$CA
240661182$24066118$2$F$20240627$20240715$20240709$20240729$30DAY$$US-ALKERMES INC.-ALK-2024-001787$ALKERMES$$$$$$Y$$$20240729$$HP$US$US
240661191$24066119$1$I$$20240704$20240709$20240709$EXP$$NVSC2024CA085853$NOVARTIS$$65$YR$$F$Y$$$20240709$$CN$CA$CA
240661201$24066120$1$I$20240401$20240705$20240709$20240709$EXP$$NVSC2024CN141484$NOVARTIS$$72$YR$$M$Y$71$KG$20240709$$HP$CN$CN
240661212$24066121$2$F$20240701$20240722$20240709$20240725$PER$$US-AMGEN-USASP2024135387$AMGEN$$58$YR$A$M$Y$$$20240724$$CN$US$US
240661221$24066122$1$I$20240601$20240701$20240709$20240709$PER$$US-FreseniusKabi-FK202410520$FRESENIUS KABI$$$$A$M$Y$80$KG$20240709$$PH$US$US
240661231$24066123$1$I$$20240704$20240709$20240709$EXP$$IN-ROCHE-10000016837$ROCHE$Gupta A, Meena J, Naranje P, Coshic P, Kanga U, Seth R. Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Including Matched Sibling and Alternate Donor Transplants  Adaptations and Outcomes From a Tertiary Care Government Institute in India. Indian Pediatrics. 2024-Jun;61 (6):564-70. doi:10.1007/s13312-024-3207-z.$$$$$Y$$$20240709$$HP$IN$IN
240661241$24066124$1$I$$20240702$20240709$20240709$PER$$US-INCYTE CORPORATION-2024IN007012$INCYTE$$$$$$Y$$$20240709$$CN$US$US
240661251$24066125$1$I$$20240708$20240709$20240709$PER$$US-HALEON-2185935$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240661261$24066126$1$I$20240528$20240705$20240709$20240709$EXP$$NVSC2024CN141671$NOVARTIS$$45$YR$$F$Y$$$20240709$$HP$CN$CN
240661271$24066127$1$I$$20240703$20240709$20240709$EXP$$NVSC2024BR139984$NOVARTIS$$$$$F$Y$$$20240709$$CN$BR$BR
240661281$24066128$1$I$$20240703$20240709$20240709$EXP$$NVSC2024US140444$NOVARTIS$$$$$M$Y$$$20240709$$CN$US$US
240661291$24066129$1$I$$20240702$20240709$20240709$EXP$$US-GSK-US2024083065$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$US$US
240661301$24066130$1$I$$20240702$20240709$20240709$EXP$$BR-JNJFOC-20240712737$JOHNSON AND JOHNSON$$11$YR$C$M$Y$37$KG$20240709$$CN$BR$BR
240661312$24066131$2$F$20240716$20240716$20240709$20240718$PER$$US-JNJFOC-20240715626$JOHNSON AND JOHNSON$$70$YR$$M$Y$$$20240719$$CN$US$US
240661322$24066132$2$F$20240325$20240710$20240709$20240716$PER$$US-BIOVITRUM-2024-US-000753$BIOVITRUM$$72$YR$$F$Y$$$20240716$$CN$US$US
240661331$24066133$1$I$20240630$20240703$20240709$20240709$EXP$$US-GSK-US2024083143$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240709$$CN$US$US
240661342$24066134$2$F$$20240729$20240709$20240806$30DAY$$IN-JNJFOC-20240711776$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$PH$IN$IN
240661351$24066135$1$I$$20240628$20240709$20240709$EXP$$US-JNJFOC-20240703849$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240709$$CN$US$US
240661361$24066136$1$I$$20240703$20240709$20240709$EXP$$US-JNJFOC-20240714920$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$HP$US$US
240661371$24066137$1$I$20240101$20240708$20240709$20240709$PER$$US-JNJFOC-20240720164$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240709$$PH$US$US
240661381$24066138$1$I$20230501$20240701$20240709$20240709$EXP$$CH-JNJFOC-20240706508$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$CH$CH
240661391$24066139$1$I$20220706$20240701$20240709$20240709$EXP$$ES-FreseniusKabi-FK202410377$FRESENIUS KABI$$55$YR$A$F$Y$$$20240709$$MD$ES$ES
240661402$24066140$2$F$20240101$20240826$20240709$20240902$EXP$$CA-JNJFOC-20240373558$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240902$$CN$CA$CA
240661414$24066141$4$F$20240506$20240709$20240709$20240718$30DAY$$US-ALKERMES INC.-ALK-2024-001820$ALKERMES$$49$YR$$M$Y$$$20240718$$PH$US$US
240661421$24066142$1$I$20240501$20240619$20240709$20240709$PER$$US-JNJFOC-20240655828$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240709$$CN$US$US
240661431$24066143$1$I$20240705$20240705$20240709$20240709$PER$$US-JNJFOC-20240717591$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240709$$PH$US$US
240661447$24066144$7$F$$20240816$20240709$20240827$30DAY$$AR-JNJFOC-20240674755$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$MD$AR$AR
240661451$24066145$1$I$$20240702$20240709$20240709$EXP$$US-SA-2024SA196843$SANOFI AVENTIS$$$$E$F$Y$$$20240709$$MD$US$US
240661461$24066146$1$I$20240101$20240627$20240709$20240709$PER$$US-SA-2024SA195205$SANOFI AVENTIS$$34$YR$A$F$Y$72$KG$20240709$$MD$US$US
240661471$24066147$1$I$20190301$20240628$20240709$20240709$PER$$US-SA-2024SA196479$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240709$$MD$US$US
240661482$24066148$2$F$$20240701$20240709$20240806$EXP$$FR-AstraZeneca-2024A156076$ASTRAZENECA$$75$YR$$M$Y$90$KG$20240806$$HP$FR$
240661494$24066149$4$F$$20240918$20240709$20240926$EXP$$US-PFIZER INC-202400201055$PFIZER$$71$YR$$M$Y$$$20240926$$CN$US$US
240661501$24066150$1$I$20240706$20240708$20240709$20240709$EXP$$NVSC2024US141559$NOVARTIS$$$$$F$Y$$$20240709$$MD$US$US
240661511$24066151$1$I$$20240701$20240709$20240709$EXP$$AU-AstraZeneca-2024A151327$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$AU$
240661521$24066152$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156069$ASTRAZENECA$$68$YR$$M$Y$87.3$KG$20240709$$HP$FR$
240661531$24066153$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005122$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240709$$CN$US$US
240661541$24066154$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005642$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240709$$CN$US$US
240661551$24066155$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156094$ASTRAZENECA$$67$YR$$F$Y$45$KG$20240709$$HP$FR$
240661561$24066156$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156276$ASTRAZENECA$$58$YR$$M$Y$62$KG$20240709$$HP$FR$
240661571$24066157$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156110$ASTRAZENECA$$69$YR$$M$Y$62$KG$20240709$$HP$FR$
240661581$24066158$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156301$ASTRAZENECA$$72$YR$$F$Y$$$20240709$$HP$FR$
240661591$24066159$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A151413$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240661601$24066160$1$I$20240628$20240705$20240709$20240709$EXP$$US-AstraZeneca-2024A155390$ASTRAZENECA$$25531$DY$$M$Y$$$20240709$$CN$US$
240661611$24066161$1$I$$20240702$20240709$20240709$PER$$US-INCYTE CORPORATION-2024IN007011$INCYTE$$$$$$Y$$$20240709$$CN$US$US
240661621$24066162$1$I$20240701$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135180$AMGEN$$41$YR$A$M$Y$$$20240709$$CN$US$US
240661631$24066163$1$I$$20240703$20240709$20240709$EXP$$US-PFIZER INC-2024SGN04190$PFIZER$$65$YR$$F$Y$$$20240709$$HP$US$US
240661641$24066164$1$I$$20240704$20240709$20240709$EXP$$US-PFIZER INC-2024SGN05326$PFIZER$$55$YR$$F$Y$$$20240709$$CN$US$US
240661651$24066165$1$I$$20240704$20240709$20240709$EXP$$US-PFIZER INC-2024SGN01895$PFIZER$$68$YR$$F$Y$$$20240709$$MD$US$US
240661661$24066166$1$I$20240307$20240704$20240709$20240709$EXP$$US-PFIZER INC-2024SGN02364$PFIZER$$62$YR$$F$Y$$$20240709$$CN$US$US
240661671$24066167$1$I$20240401$20240703$20240709$20240709$EXP$$US-PFIZER INC-2024SGN04739$PFIZER$$33$YR$$F$Y$$$20240709$$CN$US$US
240661681$24066168$1$I$$20240703$20240709$20240709$EXP$$US-PFIZER INC-2024SGN06291$PFIZER$$53$YR$$F$Y$$$20240709$$CN$US$US
240661691$24066169$1$I$$20240703$20240709$20240709$EXP$$US-PFIZER INC-2024SGN04112$PFIZER$$45$YR$$F$Y$$$20240709$$CN$US$US
240661701$24066170$1$I$20240408$20240703$20240709$20240709$EXP$$US-PFIZER INC-2024SGN04389$PFIZER$$83$YR$$F$Y$$$20240709$$CN$US$US
240661711$24066171$1$I$20240218$20240704$20240709$20240709$EXP$$US-PFIZER INC-2024SGN02084$PFIZER$$54$YR$$M$Y$$$20240709$$MD$US$US
240661721$24066172$1$I$20211013$20240703$20240709$20240709$EXP$$CN-PFIZER INC-PV202400087378$PFIZER$Li, Q.. Lethal Immune-Related Pneumonitis after Durvalumab Therapy for Small Cell Lung Cancer: A First Case in China. Case Reports in Oncology. 2024;17(1):673-680$68$YR$$M$Y$$$20240709$$HP$CN$CN
240661731$24066173$1$I$20240704$20240708$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108692$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240709$$CN$US$US
240661741$24066174$1$I$20240101$20240624$20240709$20240709$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01051$INTRA-CELLULAR THERAPIES$$5$DEC$$F$Y$$$20240709$$HP$US$US
240661752$24066175$2$F$$20240816$20240709$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108794$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240822$$CN$US$US
240661761$24066176$1$I$$20240703$20240709$20240709$PER$$US-BIOGEN-2024BI01272374$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
240661771$24066177$1$I$20220101$20240708$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108530$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240709$$CN$US$US
240661781$24066178$1$I$20240101$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108043$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240709$$HP$US$US
240661791$24066179$1$I$$20240626$20240709$20240709$PER$$US-AVEVA-000694$AVEVA$$$$$F$Y$$$20240709$$PH$US$US
240661801$24066180$1$I$$20240622$20240709$20240709$PER$$US-AVEVA-000690$AVEVA$$$$$F$Y$$$20240709$$CN$US$US
240661811$24066181$1$I$$20240621$20240709$20240709$PER$$US-AVEVA-000689$AVEVA$$$$$F$Y$$$20240709$$CN$US$US
240661821$24066182$1$I$$20240618$20240709$20240709$PER$$US-AVEVA-000686$AVEVA$$$$$F$Y$$$20240709$$CN$US$US
240661831$24066183$1$I$$20240614$20240709$20240709$PER$$US-AVEVA-000684$AVEVA$$$$$M$Y$$$20240709$$CN$US$US
240661842$24066184$2$F$$20240712$20240709$20240805$PER$$US-AVEVA-000683$AVEVA$$$$$M$Y$$$20240804$$CN$US$US
240661851$24066185$1$I$$20240621$20240709$20240709$PER$$US-AVEVA-000688$AVEVA$$$$$M$Y$$$20240709$$CN$US$US
240661861$24066186$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47572$$FDA-CTU$$54$YR$$F$N$78.93$KG$20240709$N$$US$
240661871$24066187$1$I$20240501$20240613$20240709$20240709$PER$$CA-AVEVA-000685$AVEVA$$62$YR$A$F$Y$$$20240709$$CN$CA$CA
240661882$24066188$2$F$20230101$20240726$20240709$20240802$EXP$$US-009507513-2407USA002162$MERCK$$$$$F$Y$$$20240802$$CN$US$US
240661891$24066189$1$I$20220301$20240708$20240709$20240709$EXP$$DE-UCBSA-2024034427$UCB$$72$YR$$F$Y$$$20240709$$MD$DE$DE
240661901$24066190$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47527$$FDA-CTU$$75$YR$$F$N$102.51$KG$20240709$N$$US$
240661911$24066191$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47561$$FDA-CTU$$47$YR$$F$N$96.16$KG$20240709$N$$US$
240661921$24066192$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47573$$FDA-CTU$$67$YR$$F$N$$$20240709$N$$US$
240661931$24066193$1$I$20240706$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47626$$FDA-CTU$$64$YR$$M$N$$$20240708$N$HP$US$
240661941$24066194$1$I$$20240708$20240709$20240709$EXP$$US-JNJFOC-20240718931$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20240709$$CN$US$US
240661951$24066195$1$I$20240617$20240702$20240709$20240709$PER$$US-INCYTE CORPORATION-2024IN007008$INCYTE$$$$$$Y$$$20240709$$CN$US$US
240661961$24066196$1$I$20240601$20240702$20240709$20240709$PER$$US-SA-2024SA199369$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240709$$MD$US$US
240661982$24066198$2$F$20240101$20240918$20240709$20240926$PER$$US-SA-2024SA199372$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240926$$MD$US$US
240661991$24066199$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA196500$SANOFI AVENTIS$$$$E$F$Y$$$20240709$$MD$US$US
240662001$24066200$1$I$20240501$20240702$20240709$20240709$PER$$US-SA-2024SA199274$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240709$$MD$US$US
240662011$24066201$1$I$20240101$20240701$20240709$20240709$PER$$US-SA-2024SA198034$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240709$$CN$US$US
240662021$24066202$1$I$20240501$20240702$20240709$20240709$PER$$US-INCYTE CORPORATION-2024IN007007$INCYTE$$$$$$Y$$$20240709$$CN$US$US
240662031$24066203$1$I$20230511$20240703$20240709$20240709$EXP$$CA-GSK-CA2023071150$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$HP$CA$CA
240662042$24066204$2$F$20240101$20240712$20240709$20240716$EXP$$US-UCBSA-2024008616$UCB$$$$$M$Y$$$20240716$$CN$US$US
240662051$24066205$1$I$20240625$20240702$20240709$20240709$EXP$$BG-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003768$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$BG$BG
240662072$24066207$2$F$20240705$20240708$20240709$20240712$PER$$US-AMGEN-USASP2024135168$AMGEN$$48$YR$A$M$Y$$$20240712$$CN$US$US
240662081$24066208$1$I$$20240704$20240709$20240709$EXP$$HU-JNJFOC-20240716839$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$MD$HU$HU
240662092$24066209$2$F$$20240809$20240709$20240816$30DAY$$FR-JNJFOC-20240710406$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$PH$FR$FR
240662101$24066210$1$I$20220413$20240702$20240709$20240709$EXP$$CA-GSK-CA2024AMR082516$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$CA$CA
240662111$24066211$1$I$$20240702$20240709$20240709$EXP$$GB-TEVA-VS-3216437$TEVA$$49$YR$$F$Y$53$KG$20240709$$MD$GB$GB
240662121$24066212$1$I$20171101$20240701$20240709$20240709$PER$$US-SA-2024SA196709$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240709$$MD$US$US
240662132$24066213$2$F$20230401$20240717$20240709$20240723$EXP$$BG-JNJFOC-20240665200$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240724$$HP$BG$BG
240662141$24066214$1$I$$20240701$20240709$20240709$EXP$$CA-AstraZeneca-2024A152540$ASTRAZENECA$$18$YR$$F$Y$$$20240709$$MD$CA$
240662151$24066215$1$I$$20240701$20240709$20240709$EXP$$EG-AstraZeneca-2024A145451$ASTRAZENECA$$25119$DY$$M$Y$$$20240709$$CN$EG$
240662161$24066216$1$I$20210916$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156030$ASTRAZENECA$$69$YR$$M$Y$85$KG$20240709$$MD$FR$
240662171$24066217$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156393$ASTRAZENECA$$65$YR$$M$Y$$$20240709$$HP$FR$
240662181$24066218$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156066$ASTRAZENECA$$$$$F$Y$60$KG$20240709$$HP$FR$
240662191$24066219$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156127$ASTRAZENECA$$79$YR$$F$Y$$$20240709$$HP$FR$
240662202$24066220$2$F$$20240920$20240709$20240925$EXP$$CA-TAKEDA-2024TUS067955$TAKEDA$$$$$M$Y$$$20240925$$CN$CA$CA
240662211$24066221$1$I$$20240701$20240709$20240709$EXP$$RU-DSJP-DSJ-2024-131042$DAIICHI$$$$$F$Y$$$20240709$$MD$RU$RU
240662221$24066222$1$I$$20240629$20240709$20240709$EXP$$BR-PFIZER INC-202400208445$PFIZER$$50$YR$$M$Y$$$20240709$$MD$BR$BR
240662231$24066223$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47556$$FDA-CTU$$57$YR$$$N$$$20240709$N$$US$
240662253$24066225$3$F$$20240715$20240709$20240722$EXP$$JP-PFIZER INC-PV202400087388$PFIZER$Nakamoto, K.. Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases. Internal Medicine. 2024;63(12):1783-1787$63$YR$$M$Y$70$KG$20240722$$HP$JP$JP
240662271$24066227$1$I$20240401$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47627$$FDA-CTU$$59$YR$$F$N$$$20240708$N$HP$US$
240662291$24066229$1$I$$20240702$20240709$20240709$DIR$FDA-CDER-CTU-2024-47484$$FDA-CTU$$$$$F$N$$$20240702$N$HP$US$
240662301$24066230$1$I$20220707$20240628$20240709$20240709$EXP$$MY-PFIZER INC-PV202400085951$PFIZER$$75$YR$$M$Y$52.8$KG$20240709$$MD$MY$MY
240662311$24066231$1$I$20240320$20240627$20240709$20240709$EXP$$CN-PFIZER INC-2024SGN04308$PFIZER$$26$YR$$F$Y$46$KG$20240709$$MD$CN$CN
240662321$24066232$1$I$$20240703$20240709$20240709$DIR$FDA-CDER-CTU-2024-47492$$FDA-CTU$$$$$M$N$$$20240703$N$HP$US$
240662331$24066233$1$I$20220328$20240709$20240709$20240709$EXP$$FR-PFIZER INC-2022SGN03461$PFIZER$$$$$F$Y$$$20240709$$MD$FR$FR
240662351$24066235$1$I$$20240629$20240709$20240709$EXP$$BR-PFIZER INC-202400208819$PFIZER$$77$YR$$M$Y$$$20240709$$MD$BR$BR
240662371$24066237$1$I$$20240701$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105145$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240709$$HP$US$US
240662381$24066238$1$I$$20240707$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107903$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240709$$HP$US$US
240662391$24066239$1$I$$20240706$20240709$20240709$EXP$$DE-DAIICHI SANKYO, INC.-DSE-2024-134772$DAIICHI$$33$YR$$F$Y$$$20240709$$MD$DE$DE
240662412$24066241$2$F$20240826$20240826$20240709$20240829$EXP$$CA-TAKEDA-2024TUS068092$TAKEDA$$28$YR$$F$Y$$$20240829$$MD$CA$CA
240662421$24066242$1$I$20231110$20240705$20240709$20240709$EXP$$DE-ABBVIE-5831196$ABBVIE$$50$YR$$F$Y$$$20240709$$MD$DE$DE
240662431$24066243$1$I$$20240704$20240709$20240709$EXP$$NVSC2024US141601$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240662451$24066245$1$I$20240625$20240627$20240709$20240709$DIR$FDA-CDER-CTU-2024-47444$$FDA-CTU$$66$YR$$M$N$78.3$KG$20240627$N$$US$
240662461$24066246$1$I$20240623$20240701$20240709$20240709$DIR$FDA-CDER-CTU-2024-47629$$FDA-CTU$$$$$F$N$$$20240701$N$HP$US$
240662482$24066248$2$F$20240701$20240719$20240709$20240726$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-022640$JAZZ$$11$YR$$F$Y$$$20240726$$HP$US$US
240662493$24066249$3$F$20240707$20240822$20240709$20240826$PER$$US-AMGEN-USASP2024135161$AMGEN$$81$YR$E$F$Y$$$20240826$$CN$US$US
240662501$24066250$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108101$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240709$$CN$US$US
240662511$24066251$1$I$20240630$20240702$20240709$20240709$PER$$PH-Eisai-EC-2024-169283$EISAI$$25$YR$A$M$Y$$$20240709$$CN$PH$PH
240662521$24066252$1$I$20240604$20240701$20240709$20240709$PER$$US-MYLANLABS-2024M1062083$MYLAN$$85$YR$$F$Y$85.45$KG$20240709$$HP$US$US
240662531$24066253$1$I$20240629$20240701$20240709$20240709$EXP$$JP-Eisai-EC-2024-169422$EISAI$$9$DEC$E$$Y$$$20240709$$MD$JP$JP
240662541$24066254$1$I$$20240619$20240709$20240709$EXP$$US-CBFLEET-202406-US-002068$CB FLEET$Shapoo N. Salicylate Induced Heart Block: A Silent Alarm. TOXIDROMES AND ADVERSE MEDICATION REACTIONS IN THE ICU. 2024 May 21;$67$YR$E$M$Y$$$20240709$$MD$US$US
240662551$24066255$1$I$20240706$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135193$AMGEN$$$$$$Y$$$20240709$$PH$US$US
240662561$24066256$1$I$$20240708$20240709$20240709$PER$$US-JNJFOC-20240720577$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$US$US
240662581$24066258$1$I$$20240630$20240709$20240709$EXP$$CA-LUNDBECK-DKLU4001315$LUNDBECK$$$$$$Y$$$20240709$$HP$CA$CA
240662591$24066259$1$I$$20240705$20240709$20240709$EXP$$FR-DSJP-DSE-2024-131021$DAIICHI$$70$YR$$F$Y$$$20240709$$MD$FR$FR
240662601$24066260$1$I$$20240702$20240709$20240709$30DAY$$US-GSK-US2024083087$GLAXOSMITHKLINE$$$$$M$Y$99.3$KG$20240709$$CN$US$US
240662611$24066261$1$I$20240623$20240705$20240709$20240709$EXP$DE-CADRBFARM-2024329117$DE-GSK-DE2024083815$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$DE$DE
240662622$24066262$2$F$$20240710$20240709$20240715$EXP$$GB-MYLANLABS-2024M1047702$MYLAN$$$$$M$Y$$$20240715$$MD$GB$GB
240662632$24066263$2$F$$20240912$20240709$20240916$30DAY$$US-PFIZER INC-202400201856$PFIZER$$$$$F$Y$$$20240916$$PH$US$US
240662641$24066264$1$I$$20240701$20240709$20240709$PER$$US-JNJFOC-20240702827$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240662652$24066265$2$F$$20240625$20240709$20240807$EXP$$CA-ABBVIE-5828353$ABBVIE$$$$$F$Y$$$20240807$$HP$CA$CA
240662661$24066266$1$I$$20240630$20240709$20240709$EXP$$US-JNJFOC-20240704021$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$MD$US$US
240662671$24066267$1$I$20240601$20240702$20240709$20240709$EXP$GB-MHRA-MED-202407021249159180-LHKWS$GB-TEVA-VS-3216488$TEVA$$$$$F$Y$$$20240709$$HP$GB$GB
240662681$24066268$1$I$$20240708$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063672$SANDOZ$$62$YR$$M$Y$$$20240709$$MD$CA$CA
240662691$24066269$1$I$20240610$20240708$20240709$20240709$EXP$$US-SANDOZ INC.-SDZ2024US063653$SANDOZ$$67$YR$$F$Y$$$20240709$$HP$US$US
240662702$24066270$2$F$$20240802$20240709$20240805$EXP$GB-MHRA-MED-202405162318157690-FNGQT$GB-SANDOZ INC.-SDZ2024GB063443$SANDOZ$$$$$M$Y$$$20240805$$CN$GB$GB
240662713$24066271$3$F$$20240916$20240709$20240919$PER$$PR-PFIZER INC-202400205162$PFIZER$$7$YR$$F$Y$$$20240919$$CN$PR$PR
240662721$24066272$1$I$20240501$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108124$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240709$$HP$US$US
240662731$24066273$1$I$$20240625$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104978$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240709$$MD$US$US
240662741$24066274$1$I$$20240628$20240709$20240709$EXP$$BR-SANDOZ INC.-SDZ2024BR063525$SANDOZ$$$$$F$Y$$$20240709$$CN$BR$BR
240662751$24066275$1$I$20240628$20240628$20240709$20240709$EXP$$CN-INCYTE CORPORATION-2024IN007003$INCYTE$$$$$$Y$$$20240709$$HP$CN$CN
240662761$24066276$1$I$20240530$20240702$20240709$20240709$EXP$$US-JNJFOC-20240603042$JOHNSON AND JOHNSON$$84$YR$E$F$Y$58.3$KG$20240709$$HP$US$US
240662771$24066277$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA199051$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240662782$24066278$2$F$20240101$20240805$20240709$20240813$PER$$US-SA-2021SA201841$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240814$$MD$US$US
240662791$24066279$1$I$$20240621$20240709$20240709$PER$$US-ALKERMES INC.-ALK-2024-001727$ALKERMES$$$$$$Y$$$20240709$$PH$US$US
240662801$24066280$1$I$20240620$20240628$20240709$20240709$EXP$$CN-INCYTE CORPORATION-2024IN007000$INCYTE$$$$$$Y$$$20240709$$HP$CN$CN
240662813$24066281$3$F$20240708$20240816$20240709$20240821$PER$$US-AMGEN-USASP2024135633$AMGEN$$68$YR$E$F$Y$$$20240821$$CN$US$US
240662821$24066282$1$I$20220101$20240702$20240709$20240709$EXP$$US-PFIZER INC-2023SGN02251$PFIZER$$40$YR$$F$Y$$$20240709$$CN$US$US
240662831$24066283$1$I$$20240708$20240709$20240709$EXP$$US-PFIZER INC-202400209606$PFIZER$$$$$M$Y$$$20240709$$HP$US$US
240662851$24066285$1$I$20230701$20240701$20240709$20240709$EXP$FR-AFSSAPS-TS2024000728$FR-VERTEX PHARMACEUTICALS-2024-010983$VERTEX$$26$YR$$F$Y$$$20240709$$MD$FR$FR
240662871$24066287$1$I$$20240701$20240709$20240709$PER$$US-INCYTE CORPORATION-2024IN006974$INCYTE$$$$$$Y$$$20240709$$CN$US$US
240662884$24066288$4$F$20240624$20240906$20240709$20240909$EXP$GB-MHRA-MED-202407081623476080-TCFKN$GB-MYLANLABS-2024M1064198$MYLAN$$77$YR$$M$Y$116$KG$20240909$$MD$GB$GB
240662891$24066289$1$I$20240301$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A150279$ASTRAZENECA$$51$YR$$F$Y$73$KG$20240709$$MD$FR$
240662901$24066290$1$I$$20240701$20240709$20240709$PER$$US-INCYTE CORPORATION-2024IN006961$INCYTE$$$$$$Y$$$20240709$$CN$US$US
240662912$24066291$2$F$$20240701$20240709$20240723$EXP$$FR-AstraZeneca-2024A156125$ASTRAZENECA$$66$YR$$M$Y$$$20240723$$HP$FR$
240662921$24066292$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A154991$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240662931$24066293$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156266$ASTRAZENECA$$58$YR$$M$Y$75$KG$20240709$$HP$FR$
240662941$24066294$1$I$$20240701$20240709$20240709$EXP$$ZA-AstraZeneca-2024A151455$ASTRAZENECA$$79$YR$$F$Y$$$20240709$$CN$ZA$
240662951$24066295$1$I$$20240701$20240709$20240709$DIR$FDA-CDER-CTU-2024-47632$$FDA-CTU$$$$$F$N$$$20240701$N$HP$US$
240662961$24066296$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47636$$FDA-CTU$$84$YR$$M$N$$$20240709$N$$US$
240662973$24066297$3$F$20240229$20240809$20240709$20240822$EXP$$US-AstraZeneca-2024A152263$ASTRAZENECA$$74$YR$$M$Y$81.7$KG$20240822$$HP$US$
240662981$24066298$1$I$$20240703$20240709$20240709$EXP$$US-VANTIVE-2024VAN018137$Vantive US Healthcare$$$$$M$Y$$$20240709$$CN$US$US
240662991$24066299$1$I$20240705$20240705$20240709$20240709$EXP$$US-VANTIVE-2024VAN018187$Vantive US Healthcare$$67$YR$$M$Y$$$20240709$$CN$US$US
240663002$24066300$2$F$$20240624$20240709$20240709$EXP$$US-TORRENT-00013620$TORRENT$$15$YR$T$F$Y$$$20240709$$MD$US$US
240663021$24066302$1$I$20240601$20240701$20240709$20240709$EXP$$EC-VANTIVE-2024VAN018041$Vantive US Healthcare$$60$YR$$F$Y$53$KG$20240709$$HP$EC$EC
240663031$24066303$1$I$20220701$20240702$20240709$20240709$EXP$$US-AMERICAN REGENT INC-2024002576$AMERICAN REGENT$Singla A, Vashi M.. Worsening Cavitary Lung Lesions in a Patient With Metastatic Colorectal Cancer on Stirvaga (Regorafenib). American Journal of Respiratory and Critical Care Medicine. 2024;209:A7478 [abstract]$67$YR$$M$Y$$$20240709$$HP$US$US
240663041$24066304$1$I$20240629$20240702$20240709$20240709$EXP$$CA-JNJFOC-20240713648$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240709$$HP$CA$CA
240663071$24066307$1$I$$20240702$20240709$20240709$EXP$$US-AMGEN-USASP2024133830$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31 (6):3529-3545$67$YR$E$M$Y$$$20240709$$HP$US$US
240663082$24066308$2$F$$20240702$20240709$20240709$EXP$$US-AMGEN-USASP2024133838$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31(6):3529-3545$58$YR$A$F$Y$$$20240709$$HP$US$US
240663101$24066310$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141261$NOVARTIS$$$$$$Y$$$20240709$$CN$US$US
240663111$24066311$1$I$20240626$20240703$20240709$20240709$PER$$US-SA-2024SA199166$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240709$$MD$US$US
240663121$24066312$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA198060$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240709$$MD$US$US
240663131$24066313$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA195461$SANOFI AVENTIS$$$$$F$Y$$$20240709$$CN$US$US
240663151$24066315$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA199048$SANOFI AVENTIS$$60$YR$A$F$Y$84$KG$20240709$$MD$US$US
240663161$24066316$1$I$20240517$20240705$20240709$20240709$EXP$CH-SM-2024-13635$CH-ORGANON-O2407CHE000764$ORGANON$$76$YR$$F$Y$$$20240709$$MD$CH$CH
240663171$24066317$1$I$$20240626$20240709$20240709$PER$$US-009507513-2406USA009336$MERCK$Rehman A, Olayiwola A, Vu CA, Bhatt P, Joseph J-A, Ayoade F. Nocardia brasiliensis Pyomyositis in an Immunocompetent Patient Following Gardening Activity. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-4$48$YR$$M$Y$$$20240709$$MD$US$US
240663181$24066318$1$I$$20240701$20240709$20240709$EXP$$GR-AMGEN-GRCSP2024131446$AMGEN$Tournis S.; Krikelis M.; Gazi S. et al.. Progression of multiple vertebral fractures after Denosumab discontinuation under treatment with Romosozumab. A case-report. Joint Bone Spine. 2024$68$YR$E$F$Y$$$20240709$$HP$GR$GR
240663192$24066319$2$F$$20240823$20240709$20240827$PER$$NVSC2024US140849$NOVARTIS$$$$$F$Y$$$20240827$$HP$US$US
240663201$24066320$1$I$$20240702$20240709$20240709$EXP$$US-AMGEN-USASP2024133849$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31(6):3529-3545$60$YR$A$M$Y$$$20240709$$HP$US$US
240663211$24066321$1$I$$20240701$20240709$20240709$EXP$$NL-ABBVIE-5827713$ABBVIE$$$$E$M$Y$$$20240709$$CN$NL$NL
240663221$24066322$1$I$20231205$20240702$20240709$20240709$EXP$$GB-TEVA-VS-3216491$TEVA$$76$YR$$M$Y$89$KG$20240709$$HP$GB$GB
240663231$24066323$1$I$20240101$20240702$20240709$20240709$PER$$US-SA-2024SA198891$SANOFI AVENTIS$$71$YR$E$M$Y$94.8$KG$20240709$$MD$US$US
240663241$24066324$1$I$$20231009$20240709$20240709$EXP$$CA-ABBVIE-5832204$ABBVIE$$$$$F$Y$$$20240709$$HP$CA$CA
240663251$24066325$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107818$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240709$$HP$US$US
240663261$24066326$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108827$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240709$$CN$US$US
240663271$24066327$1$I$20230822$20240701$20240709$20240709$EXP$FR-AFSSAPS-AM2023000781$FR-BAXTER-2023BAX030863$BAXTER$$82$YR$$F$Y$56$KG$20240709$$MD$FR$FR
240663281$24066328$1$I$20240503$20240701$20240709$20240709$EXP$FR-AFSSAPS-RS2024000627$FR-BAXTER-2024BAX020923$BAXTER$$70$YR$$F$Y$$$20240709$$MD$FR$FR
240663292$24066329$2$F$$20240701$20240709$20240711$EXP$$IT-BAXTER-2024BAX020963$BAXTER$$64$YR$$M$Y$$$20240711$$HP$IT$IT
240663301$24066330$1$I$$20240704$20240709$20240709$EXP$$GB-JNJFOC-20240721329$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240709$$CN$GB$GB
240663311$24066331$1$I$20230301$20240628$20240709$20240709$EXP$$US-JNJFOC-20240701905$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240709$$HP$US$US
240663331$24066333$1$I$$20240702$20240709$20240709$EXP$$BR-JNJFOC-20240709873$JOHNSON AND JOHNSON$$$$$F$Y$$$20240709$$CN$BR$BR
240663341$24066334$1$I$$20240704$20240709$20240709$EXP$$ES-AMGEN-ESPSP2024133933$AMGEN$Ferrer A. M.; Calderon J. L.; Hortelano S. L.. Dress syndrome induced by secukinumab in a patient allergic to adalimumab. Allergy. 2023;78 (112):602$30$YR$A$M$Y$$$20240709$$HP$ES$ES
240663351$24066335$1$I$$20240627$20240709$20240709$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202406019677$ELI LILLY AND CO$$$$$F$Y$$$20240709$$MD$GB$GB
240663361$24066336$1$I$$20240626$20240709$20240709$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202406009989$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240709$$CN$GB$GB
240663371$24066337$1$I$$20240628$20240709$20240709$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407000301$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240709$$CN$KR$KR
240663381$24066338$1$I$20240614$20240627$20240709$20240709$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407003580$ELI LILLY AND CO$$59$YR$A$F$Y$65$KG$20240709$$CN$DE$CN
240663391$24066339$1$I$$20240627$20240709$20240709$EXP$$IL-ELI_LILLY_AND_COMPANY-IL202406019381$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240709$$CN$IL$IL
240663406$24066340$6$F$20240801$20240830$20240709$20240911$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000832$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240911$$MD$US$US
240663412$24066341$2$F$$20240704$20240709$20240712$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407003566$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$JP$JP
240663421$24066342$1$I$20240101$20240701$20240709$20240709$PER$$US-SA-2024SA196417$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240709$$MD$US$US
240663431$24066343$1$I$$20240627$20240709$20240709$PER$$US-MYLANLABS-2024M1061326$MYLAN$$$$$F$Y$64.41$KG$20240709$$CN$US$US
240663442$24066344$2$F$$20240708$20240709$20240709$PER$$NVSC2024US141782$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
240663451$24066345$1$I$$20240703$20240709$20240709$PER$$US-BIOGEN-2024BI01272325$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
240663461$24066346$1$I$$20240708$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108747$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240709$$CN$US$US
240663471$24066347$1$I$$20240703$20240709$20240709$PER$$US-BIOGEN-2024BI01272328$BIOGEN$$$$$M$Y$$$20240709$$CN$US$US
240663481$24066348$1$I$$20240701$20240709$20240709$EXP$$JP-AstraZeneca-2024A154023$ASTRAZENECA$$$$$$Y$$$20240709$$PH$JP$
240663491$24066349$1$I$$20240702$20240709$20240709$EXP$$US-AstraZeneca-2024A113396$ASTRAZENECA$$$$$M$Y$$$20240709$$MD$US$
240663501$24066350$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156023$ASTRAZENECA$$73$YR$$M$Y$$$20240709$$HP$FR$
240663511$24066351$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156286$ASTRAZENECA$$65$YR$$M$Y$77$KG$20240709$$HP$FR$
240663521$24066352$1$I$$20240627$20240709$20240709$PER$$US-AstraZeneca-2024A149495$ASTRAZENECA$$$$$F$Y$$$20240709$$CN$US$
240663531$24066353$1$I$$20240701$20240709$20240709$PER$$US-APELLIS-APL-2023-003096$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
240663542$24066354$2$F$$20240711$20240709$20240719$EXP$$US-BAUSCH-BL-2024-010187$BAUSCH AND LOMB$$$$$$Y$$$20240719$$PH$US$US
240663552$24066355$2$F$$20240702$20240709$20240709$PER$$US-AMGEN-USASP2024133891$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31(6):3529-3545$44$YR$A$M$Y$$$20240709$$HP$US$US
240663561$24066356$1$I$20240622$20240702$20240709$20240709$PER$$US-BAYER-2024A096696$BAYER$$$$$F$Y$$$20240709$$CN$US$US
240663571$24066357$1$I$$20240702$20240709$20240709$EXP$$NL-GILEAD-2024-0679260$GILEAD$$$$$M$Y$$$20240709$$CN$NL$NL
240663591$24066359$1$I$20211217$20240624$20240709$20240709$EXP$$ES-JNJFOC-20240710299$JOHNSON AND JOHNSON$$67$YR$E$F$Y$71$KG$20240709$$MD$ES$ES
240663601$24066360$1$I$$20240321$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00042$Krystal Biotech$$$$$$Y$$$20240709$$HP$US$US
240663611$24066361$1$I$20240325$20240415$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00051$Krystal Biotech$$$$$$Y$$$20240709$$HP$US$US
240663621$24066362$1$I$$20240415$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00052$Krystal Biotech$$$$$$Y$$$20240709$$HP$US$US
240663631$24066363$1$I$$20240426$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00056$Krystal Biotech$$$$$$Y$$$20240709$$MD$US$US
240663641$24066364$1$I$$20240501$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00057$Krystal Biotech$$$$$F$Y$$$20240709$$HP$US$US
240663651$24066365$1$I$20231205$20231205$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2023KRYUS00055$Krystal Biotech$$8$YR$$F$Y$$$20240709$$CN$US$US
240663661$24066366$1$I$$20231208$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2023KRYUS00058$Krystal Biotech$$$$$F$Y$$$20240709$$HP$US$US
240663671$24066367$1$I$20230808$20230825$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2023KRYUS00008$Krystal Biotech$$$$$F$Y$$$20240709$$CN$US$US
240663681$24066368$1$I$$20240304$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00029$Krystal Biotech$$$$$F$Y$$$20240709$$HP$US$US
240663691$24066369$1$I$$20240308$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00030$Krystal Biotech$$$$$F$Y$$$20240709$$PH$US$US
240663701$24066370$1$I$$20231031$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2023KRYUS00037$Krystal Biotech$$$$$M$Y$$$20240709$$HP$US$US
240663711$24066371$1$I$$20231213$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2023KRYUS00062$Krystal Biotech$$$$$F$Y$$$20240709$$HP$US$US
240663721$24066372$1$I$$20240215$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00024$Krystal Biotech$$30$YR$$M$Y$$$20240709$$HP$US$US
240663731$24066373$1$I$$20240220$20240709$20240709$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00025$Krystal Biotech$$$$$$Y$$$20240709$$MD$US$US
240663741$24066374$1$I$$20240703$20240709$20240709$EXP$$JP-PFIZER INC-PV202400087589$PFIZER$Oguchi, K.. Reversible cerebral vasoconstriction syndrome with cardiac involvement during treatment for iron deficiency anemia: caser report. BMC Neurology. 2021;21:479$40$YR$$F$Y$$$20240709$$HP$JP$JP
240663751$24066375$1$I$20231109$20240705$20240709$20240709$EXP$FR-AFSSAPS-AN2024000830$FR-GILEAD-2024-0679728$GILEAD$$73$YR$E$F$Y$$$20240709$$MD$FR$FR
240663762$24066376$2$F$$20240807$20240709$20240809$EXP$$TR-PFIZER INC-PV202400087922$PFIZER$Guler, B.. Rare diagnosis of an Epstein-Barr virus-positive extracavitary/solid variant of primary effusion lymphoma by duodenal endoscopic biopsy in a human immunodeficiency virusseronegative and immunocompetent patient: A case report. Indian Journal of Pathology and Microbiology. 2024;67(1):226-229$50$YR$$M$Y$$$20240809$$HP$TR$TR
240663771$24066377$1$I$$20240708$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108756$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240709$$CN$US$US
240663782$24066378$2$F$$20240715$20240709$20240717$EXP$$NVSC2024CA141694$NOVARTIS$$3$YR$$M$Y$17$KG$20240717$$HP$CA$CA
240663802$24066380$2$F$$20240820$20240709$20240822$PER$$NVSC2024US141822$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
240663812$24066381$2$F$$20240708$20240709$20240711$EXP$$NVSC2024IT140763$NOVARTIS$Zaccheddu E, Zappu A, Barella S, Clemente MG, Orecchia V, Pilia MP et al.. Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept. BRITISH JOURNAL OF HAEMATOLOGY. 2024;204(6):2505-7$$$N$F$Y$2.5$KG$20240711$$HP$IT$IT
240663822$24066382$2$F$20240601$20240802$20240709$20240808$EXP$$NVSC2024BR125928$NOVARTIS$$57$YR$$F$Y$$$20240808$$CN$BR$BR
240663831$24066383$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141818$NOVARTIS$$$$$F$Y$$$20240709$$HP$US$US
240663841$24066384$1$I$$20240628$20240709$20240709$EXP$AU-GUERBET / ASPEN AUSTRALIA-AU-20240040$AU-GUERBET / LLC-AU-20240040$GUERBET$$37$YR$A$F$Y$$$20240709$$HP$AU$AU
240663852$24066385$2$F$20240613$20240628$20240709$20240711$EXP$$CN-Merck Healthcare KGaA-2024035748$MERCK KGAA$$77$YR$E$F$Y$51$KG$20240711$$HP$CN$CN
240663862$24066386$2$F$$20240709$20240709$20240715$EXP$$CA-BAUSCH-BL-2024-010463$BAUSCH AND LOMB$Gupta H, Bhavsar S, Lu J. Unusual features of myositis with amyloid myopathy. Neurological Sciences. 2022 DEC 08;44:1457-59. doi:10.1007/s10072-022-06538-2$58$YR$$F$Y$$$20240715$$HP$CA$CA
240663871$24066387$1$I$$20240707$20240709$20240709$EXP$$AT-BAUSCH-BL-2024-010429$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240709$$MD$AT$AT
240663881$24066388$1$I$20141029$20240708$20240709$20240709$EXP$$DE-TAKEDA-2024TUS069129$TAKEDA$$9$YR$$F$Y$28$KG$20240709$$HP$DE$DE
240663891$24066389$1$I$20240704$20240708$20240709$20240709$EXP$$US-INCYTE CORPORATION-2024IN007188$INCYTE$$$$$$Y$$$20240709$$CN$US$US
240663902$24066390$2$F$20221110$20240709$20240709$20240712$EXP$$US-KYOWAKIRIN-2024KK016512$KYOWA$$$$$$Y$$$20240712$$HP$US$US
240663911$24066391$1$I$$20240702$20240709$20240709$EXP$$IT-MYLANLABS-2024M1063107$MYLAN$Schiavello E, Spreafico F, Barretta F, Meraviglia G, Biassoni V, Terenziani M, et al. Ultra Short Course Chemotherapy for Early-Stage Non-Hodgkin^s Lymphoma in Children. Children-(Basel) 2022; 9 (9): 1-10.$$$C$$Y$$$20240709$$HP$IT$IT
240663921$24066392$1$I$$20240707$20240709$20240709$EXP$$PL-BAUSCH-BL-2024-010421$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240709$$MD$PL$PL
240663933$24066393$3$F$20240101$20240710$20240709$20240715$EXP$$US-BAUSCH-BL-2024-010457$BAUSCH AND LOMB$$53$YR$$F$Y$$$20240715$$CN$US$US
240663942$24066394$2$F$$20240709$20240709$20240715$EXP$$CA-BAUSCH-BL-2024-010465$BAUSCH AND LOMB$Levin D, Lewis E, McCulloch S, Lee H, Tay J, Duggan P, Neri P, Bahlis N, Jimenez-Zepeda V. Daratumumab for the treatment of relapsed/refractory AL amyloidosis: Experience from the amyloidosis Program of Calgary (APC). Leukemia and Lymphoma. 2024;65(3):403-406. doi:10.1080/10428194.2023.2290468$$$$$Y$$$20240715$$HP$CA$CA
240663952$24066395$2$F$$20240724$20240709$20240728$PER$$NVSC2024US141820$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
240663961$24066396$1$I$$20240708$20240709$20240709$EXP$$CA-BAUSCH-BL-2024-010432$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240709$$PH$CA$CA
240663971$24066397$1$I$$20240709$20240709$20240709$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038672$BOEHRINGER INGELHEIM$$$$$$Y$$$20240709$$CN$US$US
240663981$24066398$1$I$$20240708$20240709$20240709$EXP$$CA-ORGANON-O2407CAN000760$ORGANON$$$$$M$Y$$$20240709$$CN$CA$CA
240664051$24066405$1$I$20240501$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47638$$FDA-CTU$$75$YR$$F$N$$$20240709$N$HP$US$
240664071$24066407$1$I$20240701$20240705$20240709$20240709$DIR$FDA-CDER-CTU-2024-47641$$FDA-CTU$$87$YR$$F$N$$$20240705$N$HP$US$
240664081$24066408$1$I$$20240703$20240709$20240709$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006201$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240709$$MD$US$US
240664091$24066409$1$I$$20240703$20240709$20240709$EXP$$GB-AMGEN-GBRSP2024133167$AMGEN$$$$$F$Y$$$20240709$$CN$GB$GB
240664102$24066410$2$F$$20240703$20240709$20240725$EXP$$CA-009507513-2407CAN002867$MERCK$$76$YR$$F$Y$$$20240725$$HP$CA$CA
240664111$24066411$1$I$20240501$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405091841178130-FVBTL$GB-PFIZER INC-202400207239$PFIZER$$47$YR$$F$Y$$$20240709$$CN$GB$GB
240664121$24066412$1$I$$20240705$20240709$20240709$EXP$$US-PFIZER INC-PV202400089269$PFIZER$$88$YR$$M$Y$$$20240709$$CN$US$US
240664133$24066413$3$F$20200401$20240820$20240709$20240822$EXP$$AU-PFIZER INC-202400208142$PFIZER$Thorburn, S.. Chronic hepatitis E masquerading as allograft rejection in a liver transplant recipient. Transplant Infectious Disease. 2024;26(3):10.1111/tid.14303$41$YR$$M$Y$$$20240822$$MD$AU$AU
240664141$24066414$1$I$20240628$20240705$20240709$20240709$EXP$SE-SEMPA-2024-005275$SE-PFIZER INC-202400207443$PFIZER$$60$YR$$F$Y$79$KG$20240709$$CN$SE$SE
240664151$24066415$1$I$$20240703$20240709$20240709$EXP$$GB-PFIZER INC-PV202400087986$PFIZER$Veal, G.. Biliary excretion of etoposide in children with cancer. Cancer Chemother Pharmacol. 2006;58:415-417$3$YR$$M$Y$$$20240709$$HP$GB$GB
240664161$24066416$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405081329426520-VLQDT$GB-PFIZER INC-202400207766$PFIZER$$$$$F$Y$$$20240709$$CN$GB$GB
240664171$24066417$1$I$20240101$20240705$20240709$20240709$EXP$$CA-PFIZER INC-202400190704$PFIZER$$44$YR$$F$Y$$$20240709$$MD$CA$CA
240664191$24066419$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405101852475700-BKTGS$GB-PFIZER INC-202400207186$PFIZER$$$$$$Y$$$20240709$$CN$GB$GB
240664202$24066420$2$F$20240621$20240725$20240709$20240726$EXP$CZ-CZSUKL-24001912$CZ-PFIZER INC-202400208340$PFIZER$$40$YR$$M$Y$85$KG$20240726$$CN$CZ$CZ
240664211$24066421$1$I$20240607$20240708$20240709$20240709$EXP$ES-AEMPS-1538309$ES-PFIZER INC-202400208531$PFIZER$$59$YR$$F$Y$80$KG$20240709$$MD$ES$ES
240664224$24066422$4$F$20240705$20240909$20240709$20240911$EXP$$CO-PFIZER INC-PV202400089194$PFIZER$$89$YR$$M$Y$$$20240911$$CN$CO$CO
240664241$24066424$1$I$20240601$20240705$20240709$20240709$EXP$FR-AFSSAPS-PB2024000734$FR-PFIZER INC-202400207389$PFIZER$$41$YR$$F$Y$$$20240709$$MD$FR$FR
240664251$24066425$1$I$$20240708$20240709$20240709$PER$$US-JNJFOC-20240720181$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240664261$24066426$1$I$20240706$20240708$20240709$20240709$PER$$US-JNJFOC-20240719811$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240709$$CN$US$US
240664271$24066427$1$I$$20240701$20240709$20240709$EXP$$US-TEVA-VS-3215892$TEVA$$71$YR$$F$Y$$$20240709$$PH$US$US
240664292$24066429$2$F$20240401$20240702$20240709$20240709$30DAY$$US-GSK-US2024082154$GLAXOSMITHKLINE$$91$YR$$F$Y$50.35$KG$20240709$$CN$US$US
240664311$24066431$1$I$$20240705$20240709$20240709$PER$$US-ABBVIE-5832004$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240664321$24066432$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141408$NOVARTIS$$$$$F$Y$$$20240709$$CN$US$US
240664331$24066433$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141823$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240664341$24066434$1$I$$20240701$20240709$20240709$PER$$US-LEO Pharma-371741$LEO PHARM$$23$YR$$F$Y$$$20240709$$PH$US$US
240664351$24066435$1$I$$20240705$20240709$20240709$PER$$US-MYLANLABS-2024M1063309$MYLAN$$$$$M$Y$$$20240709$$HP$US$US
240664361$24066436$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USA-20190707911$AMGEN$$65$YR$E$M$Y$$$20240709$$CN$US$US
240664371$24066437$1$I$$20240701$20240709$20240709$EXP$GB-MHRA-MED-202407012148170490-RGMNT$GB-TEVA-VS-3216332$TEVA$$$$$F$Y$$$20240709$$CN$GB$GB
240664381$24066438$1$I$$20240701$20240709$20240709$EXP$$CN-AstraZeneca-2024A153789$ASTRAZENECA$$54$YR$$F$Y$$$20240709$$MD$CN$
240664391$24066439$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141819$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240664402$24066440$2$F$20240630$20240731$20240709$20240802$PER$$US-JNJFOC-20240701147$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240802$$CN$US$US
240664411$24066441$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156087$ASTRAZENECA$$68$YR$$M$Y$98$KG$20240709$$HP$FR$
240664421$24066442$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156005$ASTRAZENECA$$70$YR$$M$Y$$$20240709$$HP$FR$
240664441$24066444$1$I$$20240701$20240709$20240709$EXP$$RU-AstraZeneca-2024A154409$ASTRAZENECA$Pospelova T.I., Berezina O.V., Nechunaeva I.N., Vorontsova E.V., Obgolts Yu.N., Kolesnikova M.A., Borkovskaya A.A., Daragan E.V., Sibirtseva V.N.. EXPERIENCE WITH A BRUTON TYROSINE KINASE INHIBITOR ACALABRUTINIB IN NOVOSIBIRSK REGION. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY (GEMATOLOGIYA / TRANSFUSIOLOGIYA) 2024;69(2):302.$85$YR$$$Y$$$20240709$$HP$RU$
240664451$24066445$1$I$$20240701$20240709$20240709$EXP$$RU-AstraZeneca-2024A154421$ASTRAZENECA$Pospelova T.I., Berezina O.V., Nechunaeva I.N., Vorontsova E.V., Obgolts Yu.N., Kolesnikova M.A., Borkovskaya A.A., Daragan E.V., Sibirtseva V.N.. EXPERIENCE WITH A BRUTON TYROSINE KINASE INHIBITOR ACALABRUTINIB IN NOVOSIBIRSK REGION. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY (GEMATOLOGIYA / TRANSFUSIOLOGIYA) 2024;69(2):302.$83$YR$$$Y$$$20240709$$HP$RU$
240664461$24066446$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA197197$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240709$$HP$US$US
240664471$24066447$1$I$$20240701$20240709$20240709$PER$$US-LEO Pharma-371729$LEO PHARM$$76$YR$$F$Y$$$20240709$$PH$US$US
240664481$24066448$1$I$$20240701$20240709$20240709$EXP$$RU-AstraZeneca-2024A154458$ASTRAZENECA$Popova O.P., Bunin S.V., Shvetsova Yu.V., Trushakov S.V., Prokhorenko A.A., Krasnoslobodtsev K.G.. Combined course of severe whooping cough with rhinovirus Combined course of severe whooping cough with rhinovirusCombined course of severe whooping cough with rhinovirus infection and COVID-19 in an early child. Children^s Infections 2024;23(2):52-54.$1$MON$$F$Y$3.7$KG$20240709$$HP$RU$
240664491$24066449$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156081$ASTRAZENECA$$75$YR$$M$Y$$$20240709$$HP$FR$
240664501$24066450$1$I$20200107$20240627$20240709$20240709$EXP$ES-AEMPS-1539111$ES-ELI_LILLY_AND_COMPANY-ES202406019814$ELI LILLY AND CO$$65$YR$E$F$Y$73$KG$20240709$$CN$ES$ES
240664511$24066451$1$I$20240705$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407003934$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240709$$CN$US$US
240664521$24066452$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004656$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240709$$CN$US$US
240664532$24066453$2$F$$20240709$20240709$20240711$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407004058$ELI LILLY AND CO$$92$YR$E$M$Y$$$20240711$$CN$JP$JP
240664542$24066454$2$F$$20240710$20240709$20240717$EXP$$IL-ELI_LILLY_AND_COMPANY-IL202407003657$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240717$$CN$IL$IL
240664551$24066455$1$I$$20240701$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105104$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240709$$HP$US$US
240664561$24066456$1$I$$20240704$20240709$20240709$EXP$$CN-FERRINGPH-2024FE03702$FERRING$$$$$$Y$$$20240709$$CN$CN$CN
240664572$24066457$2$F$20240401$20240704$20240709$20240711$EXP$$FR-FERRINGPH-2024FE03577$FERRING$$$$$$Y$$$20240711$$CN$FR$FR
240664581$24066458$1$I$20240617$20240705$20240709$20240709$EXP$$NVSC2024RU140093$NOVARTIS$$17$YR$$F$Y$60$KG$20240709$$MD$RU$RU
240664594$24066459$4$F$$20240820$20240709$20240826$EXP$$IT-MYLANLABS-2024M1062615$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. European Journal of Haematology.. 2024;113 (1):90-98$9$YR$$F$Y$$$20240826$$HP$IT$IT
240664602$24066460$2$F$20240622$20240705$20240709$20240715$PER$$US-SA-2024SA190077$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240715$$CN$US$US
240664611$24066461$1$I$$20240701$20240709$20240709$EXP$$AU-MYLANLABS-2024M1063128$MYLAN$Kaazan P, Palmer AJ, Oliver K, Burger D, Segal J, Chao C-Y, et al. Primary intestinal Cytomegalovirus infection in a patient with severe ulcerative colitis. Intern-Med-J 2023; 53 (5): 875-876.$30$YR$$M$Y$$$20240709$$HP$AU$AU
240664621$24066462$1$I$20211001$20240703$20240709$20240709$EXP$$SE-MYLANLABS-2024M1062604$MYLAN$Frodlund M, Nived P, Chatzidionysiou A, Sodergren A, Klingberg E, Bengtsson A, et al.. The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA). Vaccine. 2023;41 (20):3247-57$79$YR$$M$Y$$$20240709$$HP$SE$SE
240664631$24066463$1$I$20240601$20240703$20240709$20240709$EXP$$FI-MYLANLABS-2024M1062557$MYLAN$$41$YR$$M$Y$$$20240709$$MD$FI$FI
240664661$24066466$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47593$$FDA-CTU$$62$YR$$F$N$$$20240709$N$$US$
240664671$24066467$1$I$20240708$20240708$20240708$20240708$DIR$709510$$FDA-CTU$$19$YR$$M$N$$$20240708$N$HP$US$
240664681$24066468$1$I$$20240708$20240708$20240708$DIR$709452$$FDA-CTU$$$$$F$N$85$KG$20240708$N$MD$US$
240664691$24066469$1$I$20240621$20240708$20240708$20240708$DIR$709541$$FDA-CTU$$63$YR$$M$N$126.9$KG$20240708$N$CN$US$
240664701$24066470$1$I$20240601$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47657$$FDA-CTU$$21$YR$$F$N$67.8$KG$20240709$N$PH$US$
240664711$24066471$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47649$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240664721$24066472$1$I$$20240626$20240709$20240709$DIR$FDA-CDER-CTU-2024-47497$$FDA-CTU$$$$$F$N$$$20240626$N$HP$US$
240664731$24066473$1$I$20240612$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47500$$FDA-CTU$$25$YR$$F$N$$$20240708$N$HP$US$
240664741$24066474$1$I$$20240626$20240709$20240709$DIR$FDA-CDER-CTU-2024-47490$$FDA-CTU$$$$$F$N$$$20240626$N$HP$US$
240664751$24066475$1$I$20240629$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47634$$FDA-CTU$$66$YR$$M$N$$$20240709$N$HP$US$
240664763$24066476$3$F$20240401$20240731$20240709$20240805$30DAY$$US-AMGEN-USASP2024132040$AMGEN$$73$YR$E$M$Y$76$KG$20240805$$PH$US$US
240664771$24066477$1$I$20240622$20240708$20240709$20240709$PER$$US-JNJFOC-20240720118$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240709$$CN$US$US
240664782$24066478$2$F$20240624$20240715$20240709$20240723$PER$$US-AMGEN-USASP2024130274$AMGEN$$67$YR$E$F$Y$92$KG$20240723$$PH$US$US
240664792$24066479$2$F$20240419$20240805$20240709$20240808$30DAY$$US-AMGEN-USASP2024129896$AMGEN$$$$$F$Y$$$20240808$$HP$US$US
240664801$24066480$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108850$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240709$$CN$US$US
240664811$24066481$1$I$$20240705$20240709$20240709$EXP$$NVSC2024PT140966$NOVARTIS$$$$$$Y$$$20240709$$MD$PT$PT
240664821$24066482$1$I$$20240701$20240709$20240709$EXP$$JP-ASTELLAS-2024JP004686$ASTELLAS$Kuma Y, Nakahara M, Fuyuno Y,  Inokuchi J, Oda Y, Eto M, et.al.. Skin disorder caused by enfortumab vedotin. The Japanese Journal of Dermatology (The 123rd Annual Meeting of the Japanese De. 2024;134(5):O8-6$52$YR$$F$Y$$$20240709$$MD$JP$JP
240664831$24066483$1$I$20240612$20240702$20240709$20240709$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000570$PAREXEL$$$$$$Y$$$20240709$$HP$CN$CN
240664841$24066484$1$I$$20240701$20240709$20240709$PER$$US-INCYTE CORPORATION-2024IN006980$INCYTE$$$$$$Y$$$20240709$$HP$US$US
240664851$24066485$1$I$$20240702$20240709$20240709$PER$$US-LEO Pharma-371739$LEO PHARM$$57$YR$$F$Y$$$20240709$$PH$US$US
240664861$24066486$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156103$ASTRAZENECA$$76$YR$$M$Y$$$20240709$$HP$FR$
240664871$24066487$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156183$ASTRAZENECA$$$$$M$Y$62$KG$20240709$$HP$FR$
240664881$24066488$1$I$20240301$20240701$20240709$20240709$EXP$$MX-AstraZeneca-2024A156827$ASTRAZENECA$$24588$DY$$F$Y$51$KG$20240709$$CN$MX$
240664891$24066489$1$I$$20240701$20240709$20240709$EXP$$JP-AstraZeneca-2024A154091$ASTRAZENECA$$$$E$F$Y$$$20240709$$MD$JP$
240664901$24066490$1$I$20240702$20240702$20240709$20240709$PER$$US-BRACCO-2024US04048$BRACCO$$$$$F$Y$$$20240709$$HP$US$US
240664911$24066491$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47569$$FDA-CTU$$48$YR$$F$N$$$20240709$N$$US$
240664921$24066492$1$I$$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106536$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240709$$HP$US$US
240664931$24066493$1$I$20240708$20240708$20240708$20240708$DIR$709477$$FDA-CTU$$76$YR$$M$N$119.25$KG$20240708$N$CN$US$
240664941$24066494$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47601$$FDA-CTU$$79$YR$$F$N$58.97$KG$20240709$N$$US$
240664951$24066495$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47606$$FDA-CTU$$79$YR$$F$N$62.14$KG$20240709$N$$US$
240664961$24066496$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108537$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240709$$CN$US$US
240664971$24066497$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108567$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240709$$CN$US$US
240664991$24066499$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47605$$FDA-CTU$$44$YR$$F$N$131.54$KG$20240709$N$$US$
240665011$24066501$1$I$$20240709$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108877$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240709$$HP$US$US
240665021$24066502$1$I$$20240706$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108610$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240709$$CN$US$US
240665031$24066503$1$I$20240625$20240702$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106242$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240709$$CN$US$US
240665051$24066505$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108419$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240709$$CN$US$US
240665061$24066506$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47570$$FDA-CTU$$69$YR$$F$N$$$20240709$N$$US$
240665071$24066507$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47531$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240665081$24066508$1$I$20240703$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47614$$FDA-CTU$$15$YR$$F$N$$$20240709$N$HP$US$
240665091$24066509$1$I$$20240708$20240708$20240708$DIR$709442$$FDA-CTU$$$$$M$N$$$20240708$N$HP$US$
240665102$24066510$2$F$20240520$20240702$20240709$20240712$EXP$$NVSC2024CN128049$NOVARTIS$$33$YR$$F$Y$55$KG$20240712$$CN$CN$CN
240665112$24066511$2$F$$20240716$20240709$20240722$EXP$$US-BIOMARINAP-US-2024-159016$BIOMARIN$$$$$$Y$$$20240722$$HP$US$US
240665123$24066512$3$F$20240702$20240715$20240709$20240718$EXP$$AR-BIOMARINAP-AR-2024-158999$BIOMARIN$$$$$$Y$$$20240718$$CN$AR$AR
240665131$24066513$1$I$$20240702$20240709$20240709$PER$$US-ALXN-202407USA000148US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$MD$US$US
240665141$24066514$1$I$$20240703$20240709$20240709$EXP$$JP-BAYER-2024A097245$BAYER$$71$YR$E$M$Y$$$20240709$$MD$JP$JP
240665151$24066515$1$I$20240611$20240702$20240709$20240709$PER$$US-SA-2024SA199163$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240709$$MD$US$US
240665161$24066516$1$I$20240621$20240705$20240709$20240709$DIR$FDA-CDER-CTU-2024-47486$$FDA-CTU$$21$YR$$F$N$$$20240705$N$HP$US$
240665171$24066517$1$I$20240703$20240708$20240708$20240708$DIR$709476$$FDA-CTU$$39$YR$$F$N$58.5$KG$20240708$N$CN$US$
240665184$24066518$4$F$20240612$20240822$20240709$20240826$PER$$US-AMGEN-USASP2024134407$AMGEN$$76$YR$E$F$Y$$$20240826$$CN$US$US
240665193$24066519$3$F$20240708$20240826$20240709$20240830$PER$$US-AMGEN-USASP2024135568$AMGEN$$61$YR$A$F$Y$$$20240830$$CN$US$US
240665201$24066520$1$I$20231120$20240705$20240709$20240709$EXP$IT-MINISAL02-993320$IT-PFIZER INC-202400207320$PFIZER$$36$YR$$F$Y$$$20240709$$MD$IT$IT
240665212$24066521$2$F$20240601$20240821$20240709$20240823$30DAY$$AR-PFIZER INC-202400202449$PFIZER$$8$YR$$F$Y$$$20240823$$CN$AR$AR
240665221$24066522$1$I$$20240703$20240709$20240709$EXP$$NVSC2024KE139886$NOVARTIS$Kimathi D, Butt F, Guthua S, Waweru W. Medication-related osteonecrosis of the jaw: Case series and literature review. CLINICAL CASE REPORTS. 2024;12(e8788):1-9$64$YR$$F$Y$$$20240709$$HP$KE$KE
240665242$24066524$2$F$$20240919$20240709$20240919$PER$$NVSC2024US141798$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
240665251$24066525$1$I$$20240612$20240709$20240709$PER$$US-JNJFOC-20240645164$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240665263$24066526$3$F$20240301$20240718$20240709$20240722$EXP$$PT-BAUSCH-BL-2024-010423$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240722$$PH$PT$PT
240665271$24066527$1$I$20240301$20240702$20240709$20240709$EXP$$NVSC2024US139112$NOVARTIS$$$$$M$Y$$$20240709$$CN$US$US
240665281$24066528$1$I$20240627$20240701$20240709$20240709$PER$$US-JNJFOC-20240702645$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240709$$CN$US$US
240665302$24066530$2$F$20240611$20240726$20240709$20240731$30DAY$$FR-JNJFOC-20240634264$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240731$$PH$FR$FR
240665311$24066531$1$I$$20240630$20240709$20240709$EXP$$BG-JNJFOC-20240712752$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240709$$HP$BG$BG
240665323$24066532$3$F$20240101$20240807$20240709$20240815$EXP$$JP-DSJP-DSJ-2024-129364$DAIICHI$$8$DEC$$F$Y$$$20240815$$MD$JP$JP
240665332$24066533$2$F$20240101$20240705$20240709$20240719$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0484$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240719$$CN$US$US
240665341$24066534$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47611$$FDA-CTU$$$$$M$N$$$20240709$N$HP$US$
240665361$24066536$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47529$$FDA-CTU$$84$YR$$M$N$$$20240709$N$$US$
240665371$24066537$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47607$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240665381$24066538$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47516$$FDA-CTU$$72$YR$$F$N$$$20240709$N$$US$
240665391$24066539$1$I$20240705$20240708$20240708$20240708$DIR$709451$$FDA-CTU$$56$YR$$F$N$80.1$KG$20240708$Y$CN$US$
240665401$24066540$1$I$$20240704$20240709$20240709$DIR$FDA-CDER-CTU-2024-47628$$FDA-CTU$$$$$F$N$$$20240704$N$HP$US$
240665411$24066541$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47483$$FDA-CTU$$42$YR$$F$N$95.25$KG$20240709$N$$US$
240665421$24066542$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47506$$FDA-CTU$$63$YR$$F$N$72.12$KG$20240709$N$$US$
240665431$24066543$1$I$$20240708$20240709$20240709$EXP$$CA-BAUSCH-BL-2024-010461$BAUSCH AND LOMB$$23$YR$$F$Y$$$20240709$$HP$CA$CA
240665442$24066544$2$F$$20240812$20240709$20240815$EXP$$CA-BAUSCH-BL-2024-010438$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240815$$CN$CA$CA
240665453$24066545$3$F$$20240909$20240709$20240910$EXP$$CA-BAUSCH-BL-2024-010439$BAUSCH AND LOMB$$54$YR$$F$Y$48$KG$20240910$$HP$CA$CA
240665461$24066546$1$I$$20240703$20240709$20240709$PER$$US-RDY-SPO/USA/24/0009785$DR REDDYS$$68$YR$E$M$Y$$$20240709$$CN$US$US
240665471$24066547$1$I$20240709$20240709$20240709$20240709$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038690$BOEHRINGER INGELHEIM$$50$YR$A$F$Y$$$20240709$$CN$US$US
240665481$24066548$1$I$20240606$20240701$20240709$20240709$EXP$AT-BASGAGES-2024-004544$AT-GUERBET / LLC-AT-20240006$GUERBET$$41$YR$A$F$Y$77$KG$20240709$$HP$AT$AT
240665491$24066549$1$I$20240619$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47535$$FDA-CTU$$10$YR$$F$N$22.5$KG$20240709$Y$MD$US$
240665523$24066552$3$F$$20240909$20240709$20240911$EXP$$CA-BAUSCH-BL-2024-010462$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240911$$HP$CA$CA
240665531$24066553$1$I$$20240708$20240709$20240709$EXP$$CA-BAUSCH-BL-2024-010464$BAUSCH AND LOMB$HC. Unspecified medical literature Article. Unspecified Journal.$63$YR$$F$Y$$$20240709$$HP$CA$CA
240665563$24066556$3$F$$20240815$20240709$20240816$EXP$$SA-BIOMARINAP-SA-2024-159013$BIOMARIN$$$$$$Y$$$20240816$$CN$SA$SA
240665572$24066557$2$F$20240620$20240709$20240709$20240717$PER$$US-MYLANLABS-2024M1062399$MYLAN$$47$YR$$F$Y$84.82$KG$20240717$$CN$US$US
240665581$24066558$1$I$$20240703$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407002472$ELI LILLY AND CO$$$$$$Y$$$20240709$$CN$US$US
240665591$24066559$1$I$20231101$20240708$20240709$20240709$PER$$US-JNJFOC-20240720390$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240709$$CN$US$US
240665621$24066562$1$I$20230731$20240702$20240709$20240709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-040616$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$61.9$KG$20240709$$MD$JP$JP
240665631$24066563$1$I$$20240706$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107972$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$95.25$KG$20240709$$CN$US$US
240665642$24066564$2$F$$20240812$20240709$20240819$EXP$$RU-TAKEDA-2024TUS069277$TAKEDA$$52$YR$$F$Y$80$KG$20240819$$HP$RU$RU
240665651$24066565$1$I$$20240704$20240709$20240709$EXP$$BR-MYLANLABS-2024M1063373$MYLAN$$$$$F$Y$$$20240709$$CN$BR$BR
240665671$24066567$1$I$20240608$20240703$20240709$20240709$EXP$$IT-MYLANLABS-2024M1062420$MYLAN$$75$YR$$M$Y$$$20240709$$PH$IT$IT
240665681$24066568$1$I$20240416$20240703$20240709$20240709$EXP$FR-AFSSAPS-CN2024000636$FR-MYLANLABS-2024M1062640$MYLAN$$68$YR$$M$Y$90.5$KG$20240709$$MD$FR$FR
240665691$24066569$1$I$$20240703$20240709$20240709$EXP$$DE-MYLANLABS-2024M1062683$MYLAN$$8$DEC$$M$Y$$$20240709$$MD$DE$DE
240665702$24066570$2$F$20240702$20240717$20240709$20240723$PER$$US-BAYER-2024A095993$BAYER$$77$YR$E$M$Y$$$20240723$$HP$US$US
240665713$24066571$3$F$20240306$20240730$20240709$20240807$EXP$FR-AFSSAPS-AVMA2024000272$FR-MYLANLABS-2024M1062607$MYLAN$$74$YR$$F$Y$$$20240807$$PH$FR$FR
240665721$24066572$1$I$$20240702$20240709$20240709$PER$$US-MYLANLABS-2024M1062829$MYLAN$$14$YR$$F$Y$$$20240709$$CN$US$US
240665731$24066573$1$I$$20240701$20240709$20240709$EXP$$US-AstraZeneca-2024A154914$ASTRAZENECA$$$$$M$Y$$$20240709$$CN$US$
240665741$24066574$1$I$20240201$20240703$20240709$20240709$EXP$$JP-009507513-2407JPN000424J$MERCK$$6$DEC$$F$Y$$$20240709$$MD$JP$JP
240665751$24066575$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156099$ASTRAZENECA$$57$YR$$F$Y$$$20240709$$HP$FR$
240665761$24066576$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156147$ASTRAZENECA$$59$YR$$M$Y$83.8$KG$20240709$$HP$FR$
240665773$24066577$3$F$20231227$20240801$20240709$20240809$EXP$$DE-AstraZeneca-2024A154901$ASTRAZENECA$$73$YR$$M$Y$$$20240809$$MD$DE$
240665781$24066578$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156143$ASTRAZENECA$$$$$M$Y$68$KG$20240709$$HP$FR$
240665791$24066579$1$I$20210826$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156078$ASTRAZENECA$$67$YR$$M$Y$$$20240709$$HP$FR$
240665801$24066580$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156062$ASTRAZENECA$$$$$M$Y$59$KG$20240709$$HP$FR$
240665811$24066581$1$I$20221103$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156158$ASTRAZENECA$$65$YR$$F$Y$$$20240709$$HP$FR$
240665821$24066582$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156332$ASTRAZENECA$$$$$M$Y$85$KG$20240709$$HP$FR$
240665831$24066583$1$I$$20240701$20240709$20240709$EXP$$ZA-AstraZeneca-2024A152025$ASTRAZENECA$$67$YR$$F$Y$$$20240709$$CN$ZA$
240665842$24066584$2$F$$20240725$20240709$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107993$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240726$$CN$US$US
240665851$24066585$1$I$$20240709$20240709$20240709$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038688$BOEHRINGER INGELHEIM$$70$YR$E$$Y$$$20240709$$MD$US$US
240665861$24066586$1$I$20240627$20240702$20240709$20240709$EXP$$BR-GUERBET / LLC-BR-20240214$GUERBET$$41$YR$A$F$Y$44$KG$20240709$$PH$BR$BR
240665871$24066587$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47652$$FDA-CTU$$$$$M$N$$$20240709$N$HP$US$
240665891$24066589$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47624$$FDA-CTU$$68$YR$$M$N$$$20240709$N$$US$
240665901$24066590$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47505$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240665911$24066591$1$I$20231206$20240624$20240709$20240709$PER$$US-MYLANLABS-2024M1058417$MYLAN$$70$YR$$M$Y$$$20240709$$CN$US$US
240665931$24066593$1$I$$20240624$20240709$20240709$EXP$$JP-JOURNEY MEDICAL CORPORATION-2024JNY00133$JOURNEY MEDICAL CORPORATION$Kurata R, Hiruta N, Kaneko K. Minocycline-induced vasculitis. Clin Rheumatol. 2024;43(2):815-816$35$YR$$F$Y$$$20240709$$HP$JP$JP
240665941$24066594$1$I$$20240624$20240709$20240709$EXP$$JP-JOURNEY MEDICAL CORPORATION-2024JNY00134$JOURNEY MEDICAL CORPORATION$Sumi T, Terai K, Suzuki K, et al. Minocycline-induced Acute Fibrinous and Organizing Pneumonia. Am J Respir Crit Care Med. 2023;208(12):e47-e48$71$YR$$F$Y$$$20240709$$HP$JP$JP
240665951$24066595$1$I$$20240618$20240709$20240709$EXP$$US-ROCHE-10000006108$ROCHE$$75$YR$E$M$Y$$$20240701$$MD$US$US
240665961$24066596$1$I$$20240703$20240709$20240709$EXP$$GR-PFIZER INC-PV202400087861$PFIZER$Papakonstantinou, C.. Chemotherapy-related acute rhabdomyolysis. Journal of the National Cancer Institute. 1992;84(7):536-537$55$YR$$F$Y$$$20240709$$HP$GR$GR
240665971$24066597$1$I$$20240618$20240709$20240709$EXP$$JP-ROCHE-10000007951$ROCHE$Mabe K, Sogabe N, Minamino S, Ko T, Kondo T, Mazaki T. P15-5 Stomatitis due to cytomegalovirus complicated with refractory diffuse large B-cell lymphoma. The 21st Annual Meeting of the Japanese Society of Medical Oncology. 2024;23-24?.$71$YR$E$M$Y$$$20240701$$HP$JP$JP
240665981$24066598$1$I$$20240611$20240709$20240709$EXP$$IN-ROCHE-10000003622$ROCHE$$$$E$F$Y$$$20240702$$CN$IN$IN
240665994$24066599$4$F$$20240708$20240709$20240711$PER$$US-ROCHE-10000010996$ROCHE$$$$$M$Y$$$20240711$$HP$US$US
240666001$24066600$1$I$$20240618$20240709$20240709$EXP$$IN-ROCHE-10000011900$ROCHE$$58$YR$A$M$Y$$$20240701$$CN$IN$IN
240666011$24066601$1$I$$20240619$20240709$20240709$EXP$$JP-ROCHE-10000008239$ROCHE$$85$YR$E$M$Y$$$20240701$$PH$JP$JP
240666022$24066602$2$F$$20240627$20240709$20240709$EXP$$RU-ROCHE-10000010134$ROCHE$$$$E$F$Y$83$KG$20240704$$MD$RU$RU
240666031$24066603$1$I$20240515$20240618$20240709$20240709$EXP$$JP-ROCHE-3570739$ROCHE$$83$YR$E$F$Y$61$KG$20240701$$MD$JP$JP
240666041$24066604$1$I$$20240624$20240709$20240709$EXP$$BR-ROCHE-10000008812$ROCHE$$78$YR$E$M$Y$$$20240701$$MD$BR$BR
240666051$24066605$1$I$$20240617$20240709$20240709$EXP$$IN-ROCHE-10000007896$ROCHE$$$$A$M$Y$$$20240702$$CN$IN$IN
240666061$24066606$1$I$20240410$20240619$20240709$20240709$EXP$$JP-ROCHE-10000008270$ROCHE$$6$DEC$A$M$Y$$$20240703$$MD$JP$JP
240666071$24066607$1$I$20100331$20240621$20240709$20240709$EXP$$BR-ROCHE-10000011245$ROCHE$$36$YR$A$M$Y$$$20240702$$HP$BR$BR
240666081$24066608$1$I$$20240617$20240709$20240709$EXP$$IN-ROCHE-10000004571$ROCHE$$$$E$F$Y$$$20240701$$CN$IN$IN
240666091$24066609$1$I$$20240618$20240709$20240709$EXP$$RU-ROCHE-10000002244$ROCHE$$$$A$F$Y$$$20240703$$MD$RU$RU
240666103$24066610$3$F$20240520$20240805$20240709$20240809$EXP$$JP-ROCHE-10000009218$ROCHE$$77$YR$E$F$Y$43.6$KG$20240810$$MD$JP$JP
240666112$24066611$2$F$20240601$20240626$20240709$20240709$EXP$$JP-ROCHE-10000008054$ROCHE$$64$YR$A$M$Y$$$20240705$$PH$JP$JP
240666121$24066612$1$I$$20240620$20240709$20240709$EXP$$TW-ROCHE-3474658$ROCHE$$59$YR$A$F$Y$$$20240701$$MD$TW$TW
240666132$24066613$2$F$20240612$20240613$20240709$20240909$EXP$$IL-ROCHE-10000012603$ROCHE$$39$YR$A$M$Y$$$20240909$$CN$IL$IL
240666161$24066616$1$I$20240703$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47525$$FDA-CTU$$67$YR$$F$N$$$20240708$N$HP$US$
240666171$24066617$1$I$$20240621$20240709$20240709$EXP$$ES-ROCHE-10000008404$ROCHE$$$$$$Y$$$20240702$$CN$ES$ES
240666181$24066618$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47557$$FDA-CTU$$51$YR$$M$N$$$20240709$N$$US$
240666191$24066619$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47631$$FDA-CTU$$62$YR$$F$N$$$20240709$N$$US$
240666201$24066620$1$I$$20240617$20240709$20240709$EXP$$CA-ROCHE-10000011787$ROCHE$$76$YR$E$F$Y$$$20240702$$CN$CA$CA
240666211$24066621$1$I$$20240617$20240709$20240709$EXP$$CN-ROCHE-10000007839$ROCHE$$78$YR$E$M$Y$86$KG$20240701$$CN$CN$CN
240666221$24066622$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47587$$FDA-CTU$$48$YR$$F$N$$$20240709$N$$US$
240666231$24066623$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47551$$FDA-CTU$$44$YR$$F$N$$$20240709$N$$US$
240666241$24066624$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47553$$FDA-CTU$$16$YR$$F$N$90$LBS$20240709$N$$US$
240666252$24066625$2$F$20230512$20240819$20240709$20240826$EXP$$JP-ROCHE-10000009501$ROCHE$$73$YR$E$F$Y$58.8$KG$20240826$$MD$JP$JP
240666272$24066627$2$F$20240101$20240611$20240709$20240710$EXP$$FR-ROCHE-10000013133$ROCHE$$$$$F$Y$$$20240709$$HP$FR$FR
240666281$24066628$1$I$$20240620$20240709$20240709$EXP$$IN-ROCHE-10000012345$ROCHE$$84$YR$E$M$Y$$$20240703$$CN$IN$IN
240666294$24066629$4$F$20240605$20240827$20240709$20240903$EXP$$JP-ROCHE-10000009434$ROCHE$$71$YR$E$M$Y$57.3$KG$20240903$$MD$JP$JP
240666311$24066631$1$I$$20240617$20240709$20240709$EXP$$CA-ROCHE-10000004504$ROCHE$$65$YR$E$F$Y$$$20240701$$HP$CA$CA
240666323$24066632$3$F$20240315$20240822$20240709$20240827$EXP$$US-ROCHE-10000010232$ROCHE$$16$YR$T$M$Y$48.9$KG$20240827$$CN$US$US
240666332$24066633$2$F$20200616$20240910$20240709$20240912$EXP$$DE-ROCHE-2838056$ROCHE$$52$YR$A$F$Y$$$20240912$$CN$DE$DE
240666341$24066634$1$I$$20240618$20240709$20240709$EXP$$US-ROCHE-10000007088$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
240666361$24066636$1$I$$20240618$20240709$20240709$EXP$$US-ROCHE-10000006204$ROCHE$$86$YR$E$F$Y$$$20240701$$MD$US$US
240666371$24066637$1$I$$20240620$20240709$20240709$EXP$$US-ROCHE-10000009737$ROCHE$$64$YR$A$F$Y$$$20240702$$CN$US$US
240666381$24066638$1$I$$20240608$20240709$20240709$EXP$$HU-ROCHE-10000010948$ROCHE$$62$YR$A$M$Y$$$20240702$$MD$HU$HU
240666391$24066639$1$I$20240528$20240618$20240709$20240709$EXP$$CN-ROCHE-10000005057$ROCHE$$84$YR$E$F$Y$48$KG$20240701$$HP$CN$CN
240666401$24066640$1$I$$20240624$20240709$20240709$EXP$$IN-CMP PHARMA-2024CMP00039$CMP PHARMA$Edison D.C, Philip J, Mallhi R.S, Basnotra R, Pynadath V, Sane K.. Severe amlodipine toxicity: A medical dilemma managed with therapeutic plasma exchange. Transfus. Apheresis Sci.. 2024;(63)4$25$YR$$M$Y$$$20240709$$HP$IN$IN
240666413$24066641$3$F$$20240729$20240709$20240812$EXP$$CA-HLS-202108268$HLS THERAPEUTICS$$$$A$F$Y$$$20240812$$PH$CA$CA
240666421$24066642$1$I$20240518$20240620$20240709$20240709$EXP$$PK-ROCHE-3579225$ROCHE$$60$YR$A$M$Y$$$20240701$$CN$PK$PK
240666433$24066643$3$F$$20240715$20240709$20240717$EXP$$US-ROCHE-10000006211$ROCHE$$50$YR$A$M$Y$$$20240717$$HP$US$US
240666453$24066645$3$F$$20240904$20240709$20240913$EXP$$JP-ROCHE-10000012187$ROCHE$Matsukawa R, Miyanishi Y, Ueda T, Tsukao H, Yamaguchi W.. A case of prolonged COVID-19 pneumonia which was diagnosed by bronchoscopy after anti-CD20 antibody therapy. The 253rd Hokuriku Regional Meeting of the Japanese Society of Internal Medicine. 2024;$79$YR$E$M$Y$$$20240913$$MD$JP$JP
240666462$24066646$2$F$20091101$20240622$20240709$20240709$EXP$$CN-ROCHE-10000007278$ROCHE$$48$YR$A$M$Y$52$KG$20240704$$HP$CN$CN
240666472$24066647$2$F$$20240704$20240709$20240718$EXP$$US-ROCHE-10000012661$ROCHE$$51$YR$A$F$Y$$$20240718$$MD$US$US
240666491$24066649$1$I$$20240624$20240709$20240709$EXP$$CN-ROCHE-10000011527$ROCHE$Zhang X, Gong J, Wang J, Feng J, Chen L, Xie X, et al. Efficacy of rituximab-containing regimens used as first-line and rescue therapy for giant cell hepatitis with autoimmune hemolytic anemia a retrospective study. Clinics and Research in Hepatology and Gastroenterology. 2024-Jun-17;48 (7):1-8. doi:10.1016/j.clinre.2024.102392.$6$MON$I$$Y$$$20240705$$HP$CN$CN
240666501$24066650$1$I$20240528$20240624$20240709$20240709$EXP$$PK-ROCHE-10000013200$ROCHE$$51$YR$A$F$Y$$$20240705$$CN$PK$PK
240666515$24066651$5$F$$20240808$20240709$20240812$PER$$US-ROCHE-10000008695$ROCHE$$$$E$M$Y$$$20240812$$MD$US$US
240666523$24066652$3$F$20240101$20240909$20240709$20240916$EXP$$DE-ROCHE-10000008291$ROCHE$$$$A$F$Y$74$KG$20240916$$CN$DE$DE
240666531$24066653$1$I$$20240622$20240709$20240709$EXP$$EC-ROCHE-10000007741$ROCHE$$$$$$Y$$$20240703$$CN$EC$EC
240666541$24066654$1$I$20240529$20240624$20240709$20240709$EXP$$PK-ROCHE-10000012166$ROCHE$$56$YR$A$F$Y$$$20240705$$CN$PK$PK
240666562$24066656$2$F$20240501$20240829$20240709$20240903$EXP$$SG-ROCHE-10000001452$ROCHE$$67$YR$E$F$Y$$$20240903$$CN$SG$SG
240666571$24066657$1$I$$20240622$20240709$20240709$EXP$$IN-ROCHE-10000012622$ROCHE$$65$YR$E$F$Y$$$20240703$$CN$IN$IN
240666591$24066659$1$I$20240611$20240624$20240709$20240709$EXP$$CN-ROCHE-10000008012$ROCHE$$60$YR$A$F$Y$50$KG$20240705$$HP$CN$CN
240666601$24066660$1$I$$20240621$20240709$20240709$EXP$$NO-ROCHE-10000013109$ROCHE$$40$YR$A$M$Y$$$20240703$$MD$NO$NO
240666612$24066661$2$F$$20240618$20240709$20240712$EXP$$SK-ROCHE-RCA5172492$ROCHE$Bellova B, Michalko D, Antony L, Figurova J, Deptova J, Felsoci M, et al. Diffuse Large B-Cell Lymphoma (DLBCL) In An Old Bachelor. Interna medicina. 2024;24 (4):169-71.$67$YR$E$M$Y$$$20240712$$MD$SK$SK
240666621$24066662$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47555$$FDA-CTU$$67$YR$$F$N$$$20240709$N$$US$
240666631$24066663$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47536$$FDA-CTU$$54$YR$$F$N$$$20240709$N$$US$
240666641$24066664$1$I$$20240622$20240709$20240709$EXP$$EC-ROCHE-10000007746$ROCHE$$$$$$Y$$$20240704$$CN$EC$EC
240666662$24066666$2$F$20240628$20240820$20240709$20240827$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006205$AURINIA PHARMACEUTICALS$$45$YR$$F$Y$76.7$KG$20240827$$CN$US$US
240666673$24066667$3$F$20240609$20240731$20240709$20240802$EXP$$IT-ROCHE-10000014975$ROCHE$$38$YR$A$$Y$$$20240802$$MD$IT$IT
240666682$24066668$2$F$20240505$20240628$20240709$20240711$EXP$$CA-ROCHE-3560735$ROCHE$$80$YR$E$F$Y$$$20240711$$CN$CA$CA
240666691$24066669$1$I$$20240620$20240709$20240709$EXP$$AU-ROCHE-10000016566$ROCHE$$$$$$Y$$$20240705$$MD$AU$AU
240666702$24066670$2$F$20240619$20240625$20240709$20240709$EXP$$CA-ROCHE-10000015136$ROCHE$$40$YR$A$F$Y$$$20240709$$MD$CA$CA
240666711$24066671$1$I$20240617$20240624$20240709$20240709$EXP$$PK-ROCHE-10000013160$ROCHE$$53$YR$A$M$Y$$$20240705$$CN$PK$PK
240666721$24066672$1$I$20240614$20240624$20240709$20240709$EXP$$CN-ROCHE-10000008181$ROCHE$$57$YR$A$M$Y$68$KG$20240705$$HP$CN$CN
240666731$24066673$1$I$20220501$20240620$20240709$20240709$EXP$$GB-ROCHE-10000013285$ROCHE$$54$YR$A$M$Y$$$20240705$$MD$GB$GB
240666741$24066674$1$I$20240617$20240621$20240709$20240709$EXP$$CN-ROCHE-10000008269$ROCHE$$62$YR$A$M$Y$$$20240703$$HP$CN$CN
240666761$24066676$1$I$$20240708$20240709$20240709$EXP$$US-ABBVIE-5832056$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240666771$24066677$1$I$$20240624$20240709$20240709$EXP$$IR-ROCHE-3326277$ROCHE$Farrokhnia M, Baniasad A and Mehdiabadi F. Co-infection of coronavirus disease 19 and cytomegalovirus in a kidney transplant recipient. DOI: 10.1002/ccr3.7046. Clinical Case Reports 2023 Mar;11 (3):1-4.$43$YR$A$F$Y$$$20240705$$HP$IR$IR
240666781$24066678$1$I$$20240621$20240709$20240709$EXP$$ES-ROCHE-10000008257$ROCHE$$32$YR$A$M$Y$$$20240705$$HP$ES$ES
240666791$24066679$1$I$$20240622$20240709$20240709$EXP$$EC-ROCHE-10000007755$ROCHE$$$$$$Y$$$20240705$$CN$EC$EC
240666805$24066680$5$F$$20240830$20240709$20240910$EXP$$CA-ROCHE-3533484$ROCHE$$$$A$F$Y$$$20240910$$CN$CA$CA
240666811$24066681$1$I$$20240708$20240709$20240709$EXP$$US-JNJFOC-20240719290$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240709$$CN$US$US
240666821$24066682$1$I$$20240617$20240709$20240709$EXP$$AU-ROCHE-3474280$ROCHE$$43$YR$A$F$Y$$$20240708$$HP$AU$AU
240666831$24066683$1$I$20220812$20240618$20240709$20240709$EXP$$DE-ROCHE-3178233$ROCHE$$30$YR$A$F$Y$$$20240709$$CN$DE$DE
240666851$24066685$1$I$20240124$20240620$20240709$20240709$EXP$$CN-ROCHE-3572059$ROCHE$$49$YR$A$F$Y$$$20240705$$MD$CN$CN
240666863$24066686$3$F$20240605$20240711$20240709$20240723$EXP$$IN-ROCHE-10000012789$ROCHE$$33$YR$A$F$Y$$$20240723$$CN$IN$IN
240666871$24066687$1$I$20160201$20240625$20240709$20240709$EXP$$PL-PFIZER INC-202400204982$PFIZER$Tomasik, J.. A 9-year-old patient with severe haemophilia A complicated by factor VIII inhibitor treated with emicizumab - case report and literature review. J Pre-Clin Clin Res.. 2024;18(2):128-134$1$YR$$M$Y$$$20240709$$HP$PL$PL
240666882$24066688$2$F$$20240708$20240709$20240722$EXP$$IN-ROCHE-10000005830$ROCHE$$$$E$$Y$$$20240719$$MD$IN$IN
240666891$24066689$1$I$20240501$20240605$20240709$20240709$EXP$$US-ROCHE-10000019103$ROCHE$$61$YR$A$F$Y$65.77$KG$20240709$$CN$US$US
240666901$24066690$1$I$20190101$20240624$20240709$20240709$EXP$$GB-ROCHE-10000008784$ROCHE$$47$YR$A$F$Y$$$20240709$$CN$GB$GB
240666931$24066693$1$I$20220218$20240709$20240709$20240709$DIR$709542$$FDA-CTU$$50$YR$$F$N$85.5$KG$20240709$N$CN$US$
240666941$24066694$1$I$20240708$20240709$20240709$20240709$DIR$709562$$FDA-CTU$$80$YR$$F$N$56.25$KG$20240709$N$CN$US$
240666951$24066695$1$I$$20240628$20240709$20240709$EXP$$US-BAYER-2024A091895$BAYER$$68$YR$E$M$Y$$$20240709$$CN$US$US
240666961$24066696$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156049$ASTRAZENECA$$$$$M$Y$101$KG$20240709$$HP$FR$
240666971$24066697$1$I$20230913$20240706$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063402$SANDOZ$$61$YR$$F$Y$$$20240709$$HP$CA$CA
240666993$24066699$3$F$20240311$20240806$20240709$20240902$EXP$$JP-AstraZeneca-2024A082479$ASTRAZENECA$$24085$DY$$F$Y$57$KG$20240902$$MD$JP$
240667001$24066700$1$I$$20240701$20240709$20240709$EXP$$GB-TEVA-VS-3216215$TEVA$$6$YR$$F$Y$$$20240709$$HP$GB$GB
240667011$24066701$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156067$ASTRAZENECA$$$$$M$Y$77$KG$20240709$$HP$FR$
240667021$24066702$1$I$20240615$20240705$20240709$20240709$DIR$FDA-CDER-CTU-2024-47448$$FDA-CTU$$64$YR$$F$N$69.7$KG$20240705$N$$US$
240667031$24066703$1$I$$20240709$20240709$20240709$DIR$709576$$FDA-CTU$$$$$UNK$N$$$20240709$N$CN$US$
240667041$24066704$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47550$$FDA-CTU$$66$YR$$M$N$245$LBS$20240709$N$$US$
240667051$24066705$1$I$20240708$20240709$20240709$20240709$DIR$709567$$FDA-CTU$$$$$UNK$N$$$20240709$N$CN$US$
240667061$24066706$1$I$20240617$20240701$20240709$20240709$EXP$$CN-AstraZeneca-2024A154724$ASTRAZENECA$$15639$DY$$M$Y$82$KG$20240709$$MD$CN$
240667071$24066707$1$I$$20240704$20240709$20240709$EXP$$CA-PFIZER INC-202400207709$PFIZER$$$$$F$Y$87$KG$20240709$$PH$CA$CA
240667081$24066708$1$I$$20240704$20240709$20240709$EXP$$US-PFIZER INC-2024SGN02750$PFIZER$$39$YR$$F$Y$$$20240709$$CN$US$US
240667101$24066710$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47552$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240667111$24066711$1$I$$20240704$20240709$20240709$EXP$$US-PFIZER INC-2024SGN02524$PFIZER$$78$YR$$F$Y$$$20240709$$MD$US$US
240667132$24066713$2$F$$20240711$20240709$20240712$EXP$$US-PFIZER INC-2024SGN06052$PFIZER$$71$YR$$F$Y$$$20240712$$CN$US$US
240667141$24066714$1$I$$20240704$20240709$20240709$EXP$$US-PFIZER INC-2024SGN04573$PFIZER$$73$YR$$F$Y$$$20240709$$CN$US$US
240667151$24066715$1$I$20240623$20240705$20240709$20240709$EXP$$US-BAYER-2024A098081$BAYER$$36$YR$A$F$Y$$$20240709$$CN$US$US
240667161$24066716$1$I$$20240709$20240709$20240709$PER$$NVSC2024US141831$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240667171$24066717$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004234$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240709$$CN$US$US
240667181$24066718$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005197$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240709$$CN$US$US
240667191$24066719$1$I$$20240703$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407002486$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240709$$CN$US$US
240667201$24066720$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA197202$SANOFI AVENTIS$$$$C$M$Y$23.084$KG$20240709$$MD$US$US
240667211$24066721$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407003938$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240709$$CN$US$US
240667221$24066722$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405071249126050-CYFKR$GB-SANDOZ INC.-SDZ2024GB063636$SANDOZ$$$$$F$Y$$$20240709$$HP$GB$GB
240667231$24066723$1$I$$20240703$20240709$20240709$EXP$$CH-SANDOZ INC.-SDZ2024CH063194$SANDOZ$$$$$$Y$$$20240709$$MD$CH$CH
240667241$24066724$1$I$20190401$20240703$20240709$20240709$EXP$$DE-MYLANLABS-2024M1062611$MYLAN$$67$YR$$M$Y$$$20240709$$CN$DE$DE
240667252$24066725$2$F$$20240712$20240709$20240722$EXP$$IT-MYLANLABS-2024M1062660$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology.. European Journal of Haematology. 2024;113 (1):90-98$6$YR$$F$Y$$$20240722$$HP$IT$IT
240667261$24066726$1$I$$20240704$20240709$20240709$EXP$$US-MYLANLABS-2024M1063786$MYLAN$Shukla P, Lubrin Si, Subramanian R, Joshi H. Severe ARDS and immune reconstitution syndrome in a rare case of multidrug-resistant tuberculosis: a case report and review. Chest 2023; 164 (Suppl.) (4): A1514.$42$YR$$F$Y$$$20240709$$HP$US$US
240667271$24066727$1$I$20240204$20240703$20240709$20240709$EXP$FR-AFSSAPS-RE2024000656$FR-MYLANLABS-2024M1062678$MYLAN$$78$YR$$F$Y$74$KG$20240709$$MD$FR$FR
240667281$24066728$1$I$$20240705$20240709$20240709$DIR$FDA-CDER-CTU-2024-47575$$FDA-CTU$$$$$M$N$$$20240705$N$HP$US$
240667301$24066730$1$I$20240626$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47470$$FDA-CTU$$69$YR$$M$N$71.5$KG$20240708$N$$US$
240667311$24066731$1$I$20240522$20240626$20240709$20240709$PER$$US-Calliditas-2024CAL01039$CALLIDITAS THERAPEUTICS$$60$YR$A$M$Y$146$KG$20240709$$CN$US$US
240667321$24066732$1$I$20220425$20240701$20240709$20240709$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-039112$JAZZ$$$$$$Y$$$20240709$$MD$US$US
240667331$24066733$1$I$20240531$20240614$20240709$20240709$PER$$US-Vifor (International) Inc.-VIT-2024-05410$VIFOR$$68$YR$$F$Y$105$KG$20240709$$HP$US$US
240667341$24066734$1$I$$20240703$20240709$20240709$EXP$$US-BAUSCH-BL-2023-007753$BAUSCH AND LOMB$$25$YR$$F$Y$66.3$KG$20240709$$CN$US$US
240667352$24066735$2$F$20240101$20240923$20240709$20240925$EXP$$CA-SANDOZ INC.-SDZ2023CA017106$SANDOZ$$$$$F$Y$77.27$KG$20240925$$CN$CA$CA
240667361$24066736$1$I$$20240708$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063627$SANDOZ$$$$$$Y$$$20240709$$HP$CA$CA
240667374$24066737$4$F$$20240910$20240709$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA063370$SANDOZ$$$$$F$Y$$$20240913$$CN$CA$CA
240667382$24066738$2$F$$20240827$20240709$20240828$EXP$$BG-SANDOZ INC.-SDZ2024BG063648$SANDOZ$$66$YR$$F$Y$$$20240828$$HP$BG$BG
240667391$24066739$1$I$$20240706$20240709$20240709$DIR$FDA-CDER-CTU-2024-47625$$FDA-CTU$$$$$F$N$$$20240706$N$$US$
240667401$24066740$1$I$$20240701$20240709$20240709$EXP$$VN-SANDOZ INC.-SDZ2024VN063668$SANDOZ$$47$YR$$F$Y$$$20240709$$MD$VN$VN
240667411$24066741$1$I$$20240705$20240709$20240709$DIR$FDA-CDER-CTU-2024-47487$$FDA-CTU$$$$$F$N$$$20240705$N$$US$
240667421$24066742$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47547$$FDA-CTU$$67$YR$$F$N$202$LBS$20240709$N$$US$
240667431$24066743$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47633$$FDA-CTU$$68$YR$$F$N$153$LBS$20240709$N$$US$
240667441$24066744$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47493$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240667451$24066745$1$I$$20240708$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063462$SANDOZ$$$$$F$Y$$$20240709$$HP$CA$CA
240667461$24066746$1$I$$20240708$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063629$SANDOZ$$92$YR$$F$Y$$$20240709$$PH$CA$CA
240667471$24066747$1$I$$20240708$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063642$SANDOZ$$44$YR$$F$Y$$$20240709$$HP$CA$CA
240667481$24066748$1$I$$20240708$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063661$SANDOZ$$80$YR$$F$Y$$$20240709$$PH$CA$CA
240667491$24066749$1$I$$20240705$20240709$20240709$EXP$$US-SANDOZ INC.-SDZ2024US063735$SANDOZ$$$$$F$Y$$$20240709$$CN$US$US
240667501$24066750$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47610$$FDA-CTU$$54$YR$$M$N$$$20240709$N$$US$
240667511$24066751$1$I$20240501$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405061024440000-QGVMZ$GB-SANDOZ INC.-SDZ2024GB063702$SANDOZ$$66$YR$$$Y$$$20240709$$CN$GB$GB
240667521$24066752$1$I$20210801$20240708$20240709$20240709$EXP$$DE-SANDOZ INC.-SDZ2024DE063437$SANDOZ$$14$YR$$M$Y$$$20240709$$MD$DE$DE
240667531$24066753$1$I$$20240708$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063505$SANDOZ$$54$YR$$M$Y$$$20240709$$MD$CA$CA
240667542$24066754$2$F$$20240711$20240709$20240712$30DAY$$GB-SANDOZ INC.-SDZ2023GB067556$SANDOZ$$$$$M$Y$$$20240712$$CN$GB$GB
240667552$24066755$2$F$20200401$20240923$20240709$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE063655$SANDOZ$$$$E$F$Y$59$KG$20240926$$MD$DE$DE
240667563$24066756$3$F$20221223$20240924$20240709$20240925$EXP$HU-EMA-DD-20240704-7482827-094920$HU-SANDOZ INC.-SDZ2024HU063609$SANDOZ$$68$YR$$M$Y$$$20240925$$HP$HU$HU
240667571$24066757$1$I$$20240706$20240709$20240709$EXP$$US-SANDOZ INC.-SDZ2024US063744$SANDOZ$$$$$$Y$$$20240709$$CN$US$US
240667581$24066758$1$I$$20240705$20240709$20240709$EXP$$US-SANDOZ INC.-SDZ2024US063691$SANDOZ$$$$$$Y$$$20240709$$CN$US$US
240667591$24066759$1$I$20240101$20240705$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA022617$SANDOZ$$$$$F$Y$$$20240709$$CN$CA$CA
240667601$24066760$1$I$20211119$20240705$20240709$20240709$EXP$$US-SANDOZ INC.-PHEH2019US025339$SANDOZ$$82$YR$$M$Y$54.871$KG$20240709$$MD$US$US
240667611$24066761$1$I$$20240708$20240709$20240709$EXP$$GB-SANDOZ INC.-SDZ2024GB063575$SANDOZ$$$$$M$Y$$$20240709$$CN$GB$GB
240667621$24066762$1$I$20240705$20240705$20240709$20240709$EXP$$US-SANDOZ INC.-NVSC2023US132877$SANDOZ$$85$YR$$F$Y$54.43$KG$20240709$$CN$US$US
240667632$24066763$2$F$20240621$20240729$20240709$20240801$PER$$US-BIOMARINAP-US-2024-158941$BIOMARIN$$$$$$Y$$$20240801$$CN$US$US
240667641$24066764$1$I$$20240701$20240709$20240709$PER$$US-BIOMARINAP-US-2024-158923$BIOMARIN$$$$$$Y$$$20240709$$CN$US$US
240667661$24066766$1$I$$20240703$20240709$20240709$EXP$$JP-DSJP-DSJ-2024-130745$DAIICHI$$77$YR$$$Y$$$20240709$$MD$JP$JP
240667671$24066767$1$I$$20240628$20240709$20240709$PER$$US-SA-2024SA195712$SANOFI AVENTIS$$$$E$F$Y$62.5$KG$20240709$$MD$US$US
240667681$24066768$1$I$20240628$20240703$20240709$20240709$EXP$$CN-JNJFOC-20240707452$JOHNSON AND JOHNSON$$71$YR$E$M$Y$54$KG$20240709$$HP$CN$CN
240667691$24066769$1$I$$20240701$20240709$20240709$EXP$$BR-ANIPHARMA-2024-BR-000067$ANI$Cavalcante Neto PM, Luz LC, Pereira LLS, et al.Non-eosinophilic exudative pleural effusion induced by valproic acid..American Journal of Respiratory and Critical Care Medicine.2024;209A1924.$55$YR$$M$Y$$$20240709$$HP$BR$BR
240667701$24066770$1$I$$20240701$20240709$20240709$PER$$US-AMGEN-USASP2024132909$AMGEN$Liu E. N.; Real M.; Yang J. H. et al.. Analysis of Evusheld safety and efficacy in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 2024;88:1-6$$$$$Y$$$20240709$$HP$US$US
240667711$24066771$1$I$$20240701$20240709$20240709$EXP$$NVSC2024CN140533$NOVARTIS$Zhang P, Yue Y, Gui D et al.. Effectiveness of laparoscopic surgery combined with gonadotrophin - releasing hormone agonist therapy in the treatment of endometriosis and its impact on recurrence and pregnancy status.. JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. 2024;23 (10):1064-67$$$A$F$Y$$$20240709$$HP$CN$CN
240667721$24066772$1$I$20240226$20240703$20240709$20240709$EXP$FR-AFSSAPS-GR2024000796$FR-MYLANLABS-2024M1063086$MYLAN$$61$YR$$F$Y$$$20240709$$PH$FR$FR
240667731$24066773$1$I$20240521$20240703$20240709$20240709$EXP$IT-MINISAL02-992625$IT-MYLANLABS-2024M1062818$MYLAN$$74$YR$$F$Y$55$KG$20240709$$MD$IT$IT
240667741$24066774$1$I$20240309$20240703$20240709$20240709$EXP$FR-AFSSAPS-AVMA2024000274$FR-MYLANLABS-2024M1062592$MYLAN$$39$YR$$F$Y$$$20240709$$PH$FR$FR
240667751$24066775$1$I$$20240701$20240709$20240709$EXP$$SE-ABBVIE-5831622$ABBVIE$$30$YR$$F$Y$$$20240709$$CN$SE$SE
240667761$24066776$1$I$$20240709$20240709$20240709$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038613$BOEHRINGER INGELHEIM$Hiroshi Fukumoto, Ayumu Inoue, Wataru Fukumoto, Kazuki Kuroshima, Kazutaka Miyamoto, Ryoichiro Matsuda, Takenori Gotanda, Issei Kawakami; A case of bladder tamponade improved by neutralizing drugs while taking anticoagulants;1$79$YR$E$M$Y$$$20240709$$MD$JP$JP
240667781$24066778$1$I$20240101$20240628$20240709$20240709$PER$$US-SA-2024SA195713$SANOFI AVENTIS$$38$YR$A$M$Y$113$KG$20240709$$MD$US$US
240667792$24066779$2$F$20240621$20240808$20240709$20240814$EXP$$US-TAKEDA-2024TUS045631$TAKEDA$$50$YR$$M$Y$$$20240814$$CN$US$US
240667802$24066780$2$F$20240413$20240814$20240709$20240829$PER$$US-SA-2024SA195781$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240829$$CN$US$US
240667812$24066781$2$F$$20240723$20240709$20240724$PER$$US-PFIZER INC-PV202400089271$PFIZER$$$$$$Y$$$20240724$$LW$US$US
240667833$24066783$3$F$20240101$20240822$20240709$20240828$PER$$US-PFIZER INC-PV202400089284$PFIZER$$43$YR$$M$Y$$$20240828$$HP$US$US
240667851$24066785$1$I$20200901$20240629$20240709$20240709$EXP$$BR-PFIZER INC-202400207802$PFIZER$$51$YR$$$Y$$$20240709$$MD$BR$BR
240667861$24066786$1$I$$20240704$20240709$20240709$EXP$$CN-PFIZER INC-PV202400088345$PFIZER$Zhang, Y.. Acute liver failure caused by high-dose tigecycline: A case report. International Journal of Clinical Pharmacology + Therapeutics. 2024;62(7):339-344$76$YR$$F$Y$$$20240709$$HP$CN$CN
240667872$24066787$2$F$$20240716$20240709$20240718$EXP$$BE-PFIZER INC-2023SGN11223$PFIZER$$54$YR$$F$Y$$$20240718$$MD$BE$BE
240667881$24066788$1$I$$20240703$20240709$20240709$EXP$$BE-PFIZER INC-2023SGN11225$PFIZER$$58$YR$$F$Y$$$20240709$$MD$BE$BE
240667891$24066789$1$I$20220201$20240703$20240709$20240709$EXP$$GB-PFIZER INC-2022SGN03790$PFIZER$$63$YR$$F$Y$$$20240709$$MD$GB$GB
240667901$24066790$1$I$$20240704$20240709$20240709$EXP$$BE-PFIZER INC-2019SGN04022$PFIZER$$$$$F$Y$$$20240709$$MD$BE$BE
240667911$24066791$1$I$$20240704$20240709$20240709$EXP$$PL-PFIZER INC-PV202400088460$PFIZER$Dybko, Z.. Fatal case of invasive fungal disease due to Aspergillus infection in a liver transplant recipient. Polish Archives of Internal Medicine. 2024;134(5):10.20452/pamw.16702$33$YR$$F$Y$$$20240709$$HP$PL$PL
240667921$24066792$1$I$20231208$20240704$20240709$20240709$EXP$BE-FAMHP-DHH-N2024-121595$BE-PFIZER INC-2024SGN01626$PFIZER$$47$YR$$F$Y$$$20240709$$PH$BE$BE
240667931$24066793$1$I$20240707$20240708$20240709$20240709$PER$$US-PFIZER INC-202400209323$PFIZER$$69$YR$$F$Y$$$20240709$$CN$US$US
240667941$24066794$1$I$20240701$20240708$20240709$20240709$EXP$$CN-PFIZER INC-PV202400089464$PFIZER$$41$YR$$F$Y$56$KG$20240709$$HP$CN$CN
240667951$24066795$1$I$$20240704$20240709$20240709$EXP$$FR-PFIZER INC-2022SGN04153$PFIZER$$46$YR$$F$Y$$$20240709$$MD$FR$FR
240667961$24066796$1$I$$20240708$20240709$20240709$PER$$US-PFIZER INC-PV202400089371$PFIZER$$62$YR$$$Y$$$20240709$$CN$US$US
240667971$24066797$1$I$$20240708$20240709$20240709$PER$$US-PFIZER INC-202400209217$PFIZER$$68$YR$$M$Y$$$20240709$$CN$US$US
240667981$24066798$1$I$20240112$20240703$20240709$20240709$EXP$FR-AFSSAPS-LL2024000581$FR-PFIZER INC-2024SGN04262$PFIZER$$57$YR$$F$Y$65$KG$20240709$$MD$FR$FR
240667991$24066799$1$I$20240607$20240610$20240709$20240709$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000482$PAREXEL$$$$$$Y$$$20240709$$PH$US$US
240668004$24066800$4$F$20240610$20240805$20240709$20240814$PER$$CH-TRAVERE-2024TVT00677$TRAVERE THERAPEUTICS$$34$YR$A$M$Y$79$KG$20240814$$MD$CH$CH
240668011$24066801$1$I$$20240702$20240709$20240709$EXP$$CZ-009507513-2407CZE001446$MERCK$$38$YR$$F$Y$$$20240709$$MD$CZ$CZ
240668021$24066802$1$I$20240101$20240701$20240709$20240709$PER$$US-SA-2024SA195591$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240709$$MD$US$US
240668031$24066803$1$I$20240526$20240705$20240709$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202407003904$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240709$$CN$US$US
240668041$24066804$1$I$20220101$20240627$20240709$20240709$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202406018845$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240709$$CN$DE$DE
240668051$24066805$1$I$$20240627$20240709$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019217$ELI LILLY AND CO$$$$$$Y$$$20240709$$MD$US$US
240668061$24066806$1$I$20240101$20240627$20240709$20240709$EXP$SE-SEMPA-2024-005070$SE-ELI_LILLY_AND_COMPANY-SE202406019779$ELI LILLY AND CO$$43$YR$A$F$Y$80$KG$20240709$$CN$SE$SE
240668071$24066807$1$I$20240301$20240627$20240709$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019050$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240709$$CN$US$US
240668081$24066808$1$I$$20240705$20240709$20240709$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004288$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240709$$CN$US$US
240668091$24066809$1$I$$20240704$20240709$20240709$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-108587$BRISTOL MYERS SQUIBB$$25$YR$A$F$Y$$$20240709$$HP$CA$CA
240668101$24066810$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108728$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240709$$CN$US$US
240668111$24066811$1$I$20240611$20240612$20240709$20240709$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000492$PAREXEL$$$$$$Y$$$20240709$$PH$US$US
240668121$24066812$1$I$$20240709$20240709$20240709$PER$$NVSC2024US141821$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240668131$24066813$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141854$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240668141$24066814$1$I$20240624$20240708$20240709$20240709$PER$$US-JNJFOC-20240720541$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240709$$CN$US$US
240668151$24066815$1$I$20231222$20240702$20240709$20240709$EXP$$NVSC2024BA138366$NOVARTIS$$$$$$Y$$$20240709$$MD$BA$BA
240668161$24066816$1$I$$20240702$20240709$20240709$EXP$$ES-MYLANLABS-2024M1063162$MYLAN$Neacsu ED, Montalban EM, de Miguel BM. Resolution of a rare case of hypercalcemia in a PTHrp-producing pancreatic neuroendocrine tumor using selective internal radiation therapy with 90Y microspheres. Ann-Pancreat-Cancer 2024; 7.$7$DEC$$F$Y$$$20240709$$HP$ES$ES
240668191$24066819$1$I$20240401$20240626$20240709$20240709$DIR$FDA-CDER-CTU-2024-47655$$FDA-CTU$$85$YR$$$N$170$LBS$20240626$N$CN$US$
240668201$24066820$1$I$20240415$20240705$20240709$20240709$DIR$FDA-CDER-CTU-2024-47645$$FDA-CTU$$64$YR$$M$N$225$LBS$20240705$N$CN$US$
240668211$24066821$1$I$$20240624$20240709$20240709$EXP$$US-HLS-202400185$HLS THERAPEUTICS$$36$YR$A$M$Y$$$20240709$$MD$IN$US
240668221$24066822$1$I$$20240604$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108672$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240709$$CN$US$US
240668231$24066823$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108892$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$81.65$KG$20240709$$PH$US$US
240668241$24066824$1$I$20240601$20240702$20240709$20240709$EXP$$US-Eisai-EC-2024-168446$EISAI$$60$YR$A$F$Y$53$KG$20240709$$CN$US$US
240668252$24066825$2$F$20231101$20240701$20240709$20240715$EXP$$PT-TRAVERE-2024TVT00680$TRAVERE THERAPEUTICS$$38$YR$A$M$Y$$$20240715$$MD$PT$PT
240668261$24066826$1$I$20231106$20240701$20240709$20240709$EXP$$ES-BAYER-2024A095888$BAYER$$84$YR$E$M$Y$$$20240709$$CN$ES$ES
240668272$24066827$2$F$20221201$20240705$20240709$20240711$EXP$$AU-ABBVIE-5829032$ABBVIE$$65$YR$$M$Y$$$20240711$$HP$AU$AU
240668282$24066828$2$F$$20240710$20240709$20240716$EXP$$TW-ABBVIE-5471828$ABBVIE$$$$$F$Y$57$KG$20240716$$CN$TW$TW
240668291$24066829$1$I$20230101$20240424$20240709$20240709$PER$$US-TEVA-VS-3218815$TEVA$$16$YR$$M$Y$$$20240709$$CN$US$US
240668301$24066830$1$I$20240101$20240708$20240709$20240709$EXP$$AU-ABBVIE-5831510$ABBVIE$$$$$F$Y$$$20240709$$CN$AU$AU
240668311$24066831$1$I$20240201$20240701$20240709$20240709$EXP$$PT-AstraZeneca-2024A155006$ASTRAZENECA$$43$YR$$F$Y$$$20240709$$MD$PT$
240668321$24066832$1$I$20240703$20240705$20240709$20240709$EXP$$US-ALXN-202407USA000410US$ALEXION PHARMACEUTICALS$$80$YR$$F$Y$83.9$KG$20240709$$HP$US$US
240668331$24066833$1$I$$20230814$20240709$20240709$EXP$$US-NOVOPROD-1246357$NOVO NORDISK$$$$$$Y$$$20240709$$CN$US$US
240668341$24066834$1$I$$20230614$20240709$20240709$EXP$$US-NOVOPROD-1219988$NOVO NORDISK$$$$$$Y$$$20240709$$CN$US$US
240668351$24066835$1$I$20240529$20240625$20240709$20240709$EXP$$US-NOVOPROD-1247837$NOVO NORDISK$$81$YR$$M$Y$$$20240709$$CN$US$US
240668361$24066836$1$I$$20240614$20240709$20240709$EXP$$CN-NOVOPROD-1241650$NOVO NORDISK$Huang Yiling et al.. Clinical characteristics, treatment strategies, and perinatal outcomes of human insulin and analogue allergies during pregnancy. Chin J Diabetes Mellitus. 2024;16(5):543-547$31$YR$$F$Y$$$20240709$$HP$CN$CN
240668371$24066837$1$I$$20240628$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105448$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240709$$CN$US$US
240668381$24066838$1$I$$20240701$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108002$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$79$KG$20240709$$CN$US$US
240668391$24066839$1$I$$20240701$20240709$20240709$EXP$GB-MHRA-MED-202406281336531360-CFMRD$GB-TEVA-VS-3216220$TEVA$$$$$F$Y$$$20240709$$CN$GB$GB
240668401$24066840$1$I$$20240628$20240709$20240709$PER$$US-TEVA-VS-3216088$TEVA$$30$YR$$M$Y$$$20240709$$CN$US$US
240668411$24066841$1$I$$20240705$20240709$20240709$EXP$$DE-MYLANLABS-2024M1063126$MYLAN$$$$N$$Y$$$20240709$$MD$DE$DE
240668492$24066849$2$F$$20240703$20240709$20240715$EXP$$CA-BEH-2024175138$CSL BEHRING$$41$YR$A$M$Y$83$KG$20240715$$HP$CA$CA
240668501$24066850$1$I$20240307$20240703$20240709$20240709$EXP$FR-AFSSAPS-AVMA2024000273$FR-MYLANLABS-2024M1062600$MYLAN$$22$YR$$F$Y$$$20240709$$PH$FR$FR
240668511$24066851$1$I$20221109$20240704$20240709$20240709$EXP$$BE-PFIZER INC-2023SGN00183$PFIZER$$58$YR$$F$Y$75.2$KG$20240709$$MD$BE$BE
240668522$24066852$2$F$20240409$20240902$20240709$20240911$EXP$$DE-ABBVIE-5831713$ABBVIE$$26$YR$$F$Y$113$KG$20240911$$MD$DE$DE
240668531$24066853$1$I$20240702$20240708$20240709$20240709$PER$$US-JNJFOC-20240720052$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240709$$CN$US$US
240668541$24066854$1$I$$20240514$20240709$20240709$PER$$US-MYLANLABS-2024M1044487$MYLAN$$$$$F$Y$$$20240709$$CN$US$US
240668561$24066856$1$I$$20240509$20240709$20240709$PER$$US-MYLANLABS-2024M1043020$MYLAN$$$$$F$Y$$$20240709$$CN$US$US
240668571$24066857$1$I$$20240509$20240709$20240709$PER$$US-MYLANLABS-2024M1042913$MYLAN$$50$YR$$M$Y$$$20240709$$MD$US$US
240668581$24066858$1$I$$20240621$20240709$20240709$PER$$US-MYLANLABS-2024M1057512$MYLAN$$$$$F$Y$$$20240709$$CN$US$US
240668591$24066859$1$I$$20240709$20240709$20240709$PER$$NVSC2024US141875$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240668601$24066860$1$I$20240705$20240705$20240709$20240709$PER$$US-JNJFOC-20240715963$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240709$$CN$US$US
240668611$24066861$1$I$20240601$20240709$20240709$20240709$EXP$FR-AFSSAPS-PB2024000774$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038567$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$78$KG$20240709$$PH$FR$FR
240668621$24066862$1$I$20240701$20240708$20240709$20240709$PER$$US-JNJFOC-20240719121$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240709$$CN$US$US
240668631$24066863$1$I$20240702$20240708$20240709$20240709$PER$$US-JNJFOC-20240719390$JOHNSON AND JOHNSON$$56$YR$A$$Y$$$20240709$$CN$US$US
240668641$24066864$1$I$$20240709$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108970$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$61.69$KG$20240709$$MD$US$US
240668671$24066867$1$I$$20240703$20240709$20240709$PER$$US-SA-2024SA199151$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240709$$CN$US$US
240668681$24066868$1$I$$20240624$20240709$20240709$EXP$$US-HLS-202400186$HLS THERAPEUTICS$$36$YR$A$M$Y$$$20240709$$MD$IN$US
240668691$24066869$1$I$20240101$20240703$20240709$20240709$EXP$$US-BAUSCHBL-2024BNL029674$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240709$$CN$US$US
240668701$24066870$1$I$$20240709$20240709$20240709$PER$$NVSC2024US141886$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240668711$24066871$1$I$$20240705$20240709$20240709$EXP$$NVSC2024TR141476$NOVARTIS$Babaoglu K, Basar EZ, Usta E, Yllmaz EH, Gunlemez A. Effect of different dose regimens of everolimus in a series of neonates with giant cardiac rhabdomyomas. CARDIOLOGY IN THE YOUNG. 2023;33(11):2291-6$$$N$F$Y$$$20240709$$HP$TR$TR
240668721$24066872$1$I$$20240709$20240709$20240709$PER$$NVSC2024US141867$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240668731$24066873$1$I$$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108711$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240709$$CN$US$US
240668741$24066874$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107690$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$65.32$KG$20240709$$CN$US$US
240668751$24066875$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108799$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240709$$CN$US$US
240668761$24066876$1$I$20240531$20240703$20240709$20240709$PER$$US-BIOGEN-2024BI01272397$BIOGEN$$$$$$Y$$$20240709$$CN$US$US
240668772$24066877$2$F$20240101$20240708$20240709$20240716$PER$$US-BAUSCH-BL-2024-010367$BAUSCH AND LOMB$$43$YR$$F$Y$41.768$KG$20240716$$CN$US$US
240668781$24066878$1$I$20240105$20240708$20240709$20240709$EXP$$IT-BAUSCH-BL-2024-010455$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240709$$HP$IT$IT
240668791$24066879$1$I$20240703$20240705$20240709$20240709$PER$$NVSC2024US141636$NOVARTIS$$9$YR$$M$Y$$$20240709$$CN$US$US
240668801$24066880$1$I$20220201$20240703$20240709$20240709$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-108845$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240709$$HP$CA$CA
240668812$24066881$2$F$20240423$20240702$20240709$20240712$PER$$US-009507513-2407USA001553$MERCK$$72$YR$$M$Y$$$20240712$$HP$US$US
240668821$24066882$1$I$$20240702$20240709$20240709$PER$$US-BAUSCHBL-2024BNL029549$BAUSCH AND LOMB$$$$$F$Y$$$20240709$$CN$US$US
240668831$24066883$1$I$$20240703$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407002483$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240709$$CN$US$US
240668841$24066884$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405101415057720-NPTCZ$GB-MYLANLABS-2024M1063494$MYLAN$$$$$F$Y$70$KG$20240709$$HP$GB$GB
240668851$24066885$1$I$$20240705$20240709$20240709$EXP$$US-MYLANLABS-2024M1063295$MYLAN$$$$$F$Y$$$20240709$$CN$US$US
240668861$24066886$1$I$20231207$20240705$20240709$20240709$EXP$FR-AFSSAPS-AVMA2024000285$FR-MYLANLABS-2024M1063741$MYLAN$$50$YR$$F$Y$$$20240709$$PH$FR$FR
240668871$24066887$1$I$20240201$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405091711040630-QMNWC$GB-MYLANLABS-2024M1063562$MYLAN$$36$YR$$M$Y$$$20240709$$CN$GB$GB
240668881$24066888$1$I$20240615$20240705$20240709$20240709$EXP$FR-AFSSAPS-PO2024000732$FR-MYLANLABS-2024M1063127$MYLAN$$66$YR$$F$Y$54.5$KG$20240709$$MD$FR$FR
240668891$24066889$1$I$20230701$20240705$20240709$20240709$EXP$GB-MHRA-MED-202407051918202680-JGMVB$GB-MYLANLABS-2024M1063779$MYLAN$$35$YR$$$Y$$$20240709$$CN$GB$GB
240668901$24066890$1$I$$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405071347078800-MHQSN$GB-MYLANLABS-2024M1063414$MYLAN$$$$$F$Y$56$KG$20240709$$HP$GB$GB
240668912$24066891$2$F$20240301$20240715$20240709$20240721$EXP$IT-MINISAL02-993260$IT-MYLANLABS-2024M1063272$MYLAN$$59$YR$$F$Y$$$20240719$$MD$IT$IT
240668923$24066892$3$F$20240705$20240709$20240709$20240711$PER$$US-AMGEN-USASP2024134850$AMGEN$$68$YR$E$F$Y$$$20240711$$CN$US$US
240668931$24066893$1$I$$20240703$20240709$20240709$PER$$US-BIOGEN-2024BI01272559$BIOGEN$$$$$M$Y$$$20240709$$CN$US$US
240668941$24066894$1$I$$20240702$20240709$20240709$EXP$$US-ALXN-202407USA000190US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240709$$MD$US$US
240668951$24066895$1$I$$20240625$20240709$20240709$PER$$US-TEVA-VS-3214313$TEVA$$$$A$F$Y$$$20240709$$CN$US$US
240668961$24066896$1$I$$20240628$20240709$20240709$PER$$US-TEVA-VS-3216016$TEVA$$78$YR$$M$Y$$$20240709$$CN$US$US
240668992$24066899$2$F$$20240906$20240709$20240926$30DAY$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02311$AMNEAL$$$$$$Y$$$20240926$$PH$US$US
240669001$24066900$1$I$20200701$20240702$20240709$20240709$EXP$$US-INDIVIOR UK LIMITED-INDV-145880-2024$RECKITT BENCKISER$Melissa J. Greenfield, Aaron D. Fobian, Rachel E. Fargason and Badari Birur. Optimizing outcomes when treating functional neurological disorder in acute care settings: case reports depicting the value of diagnostic precision and timely and appropriate psychological interventions using an interdisciplinary framework. Frontiers in Psychiatry. 2024;15$20$YR$$M$Y$$$20240709$$HP$US$US
240669011$24066901$1$I$$20240624$20240709$20240709$EXP$$JP-Owlpharma Consulting, Lda.-2158965$OWLPHARMA CONSULTING$Sasaki W, Tsutsui K, Arai T, Mori H, Kato R. Coronary vasospasms induced by a dexmedetomidine infusion for deep sedation during catheter ablation in a patient with negative findings of an acetylcholine provocation test. J Arrhythm. 2023 Aug 24;39(5):819-821.$68$YR$$M$Y$80$KG$20240709$$MD$JP$JP
240669021$24066902$1$I$$20240709$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108957$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240709$$CN$US$US
240669033$24066903$3$F$20240101$20240822$20240709$20240917$PER$$US-KARYOPHARM-2024KPT001050$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240917$$CN$US$US
240669051$24066905$1$I$20240101$20240624$20240709$20240709$PER$$US-009507513-2406USA008994$MERCK$$$$$M$Y$$$20240709$$MD$US$US
240669061$24066906$1$I$20240601$20240702$20240709$20240709$PER$$US-SA-2024SA199201$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240709$$MD$US$US
240669071$24066907$1$I$20240613$20240627$20240709$20240709$EXP$$US-PHARMING-PHAUS2024000542$PHARMING GROUP$$$$$$Y$$$20240709$$CN$US$US
240669081$24066908$1$I$$20240704$20240709$20240709$PER$$US-PFIZER INC-2024SGN06237$PFIZER$$$$$F$Y$$$20240709$$CN$US$US
240669091$24066909$1$I$20240101$20240514$20240709$20240709$PER$$GR-KARYOPHARM-2024KPT001093$KARYOPHARM THERAPEUTICS$$57$YR$$F$Y$$$20240709$$MD$GR$GR
240669102$24066910$2$F$20240101$20240712$20240709$20240715$PER$$US-JNJFOC-20240720835$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240715$$HP$US$US
240669111$24066911$1$I$$20240628$20240709$20240709$EXP$$US-PHARMING-PHAUS2024000547$PHARMING GROUP$$$$$$Y$$$20240709$$CN$US$US
240669121$24066912$1$I$20240501$20240529$20240709$20240709$PER$$GR-KARYOPHARM-2024KPT001154$KARYOPHARM THERAPEUTICS$$57$YR$$M$Y$$$20240709$$MD$GR$GR
240669131$24066913$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156019$ASTRAZENECA$$83$YR$$F$Y$$$20240709$$HP$FR$
240669141$24066914$1$I$20240422$20240531$20240709$20240709$PER$$GR-KARYOPHARM-2024KPT001167$KARYOPHARM THERAPEUTICS$$$$E$M$Y$$$20240709$$MD$GR$GR
240669151$24066915$1$I$$20240703$20240709$20240709$PER$$US-MYLANLABS-2024M1064219$MYLAN$$$$$F$Y$$$20240709$$MD$US$US
240669161$24066916$1$I$20221201$20240704$20240709$20240709$EXP$$AR-SANDOZ INC.-SDZ2024AR014732$SANDOZ$$65$YR$$F$Y$$$20240709$$CN$AR$AR
240669172$24066917$2$F$20230101$20240710$20240709$20240715$PER$$US-ABBVIE-5832025$ABBVIE$$$$$M$Y$91$KG$20240715$$CN$US$US
240669181$24066918$1$I$20231201$20240703$20240709$20240709$PER$$US-BIOGEN-2024BI01272502$BIOGEN$$67$YR$$F$Y$$$20240709$$CN$US$US
240669191$24066919$1$I$20240628$20240703$20240709$20240709$PER$$US-BIOGEN-2024BI01272503$BIOGEN$$$$$$Y$$$20240709$$CN$US$US
240669201$24066920$1$I$20240627$20240701$20240709$20240709$PER$$US-KARYOPHARM-2024KPT001254$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240709$$CN$US$US
240669213$24066921$3$F$20240701$20240731$20240709$20240805$PER$$US-KARYOPHARM-2024KPT001255$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240805$$CN$US$US
240669221$24066922$1$I$20240402$20240621$20240709$20240709$PER$$US-APELLIS-APL-2024-004378$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
240669231$24066923$1$I$20240508$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405131452203780-CTBQR$GB-MYLANLABS-2024M1063157$MYLAN$$16$YR$$M$Y$$$20240709$$HP$GB$GB
240669242$24066924$2$F$20240601$20240729$20240709$20240731$EXP$$US-SANDOZ INC.-SDZ2024US063588$SANDOZ$$75$YR$$M$Y$81.82$KG$20240731$$CN$US$US
240669251$24066925$1$I$20240501$20240521$20240709$20240709$PER$$US-KARYOPHARM-2024KPT001097$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240709$$CN$US$US
240669261$24066926$1$I$20161101$20240704$20240709$20240709$EXP$RU-RZN-2444255$RU-SANDOZ INC.-SDZ2024RU063464$SANDOZ$$$$$F$Y$60$KG$20240709$$MD$RU$RU
240669271$24066927$1$I$$20240708$20240709$20240709$EXP$$CA-SANDOZ INC.-SDZ2024CA063678$SANDOZ$$20$YR$$F$Y$$$20240709$$HP$CA$CA
240669302$24066930$2$F$$20240701$20240709$20240722$EXP$$US-ALXN-202407USA000058US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$MD$US$US
240669311$24066931$1$I$$20240706$20240709$20240709$EXP$$GR-BAUSCH-BL-2024-010389$BAUSCH AND LOMB$$55$YR$$F$Y$$$20240709$$MD$GR$GR
240669321$24066932$1$I$20240614$20240628$20240709$20240709$PER$$US-MYLANLABS-2024M1062011$MYLAN$$9$YR$$F$Y$22.68$KG$20240709$$CN$US$US
240669331$24066933$1$I$$20240709$20240709$20240709$PER$$NVSC2024US141893$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240669341$24066934$1$I$20240101$20240703$20240709$20240709$PER$$US-SA-2024SA199366$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240709$$MD$US$US
240669351$24066935$1$I$$20240703$20240709$20240709$EXP$$CN-009507513-2407CHN003152$MERCK$$75$YR$$F$Y$$$20240709$$MD$CN$CN
240669361$24066936$1$I$$20240702$20240709$20240709$EXP$PL-GEN-2024-2088$PL-RDY-SPO/POL/24/0009734$DR REDDYS$$24$YR$A$M$Y$$$20240709$$MD$PL$PL
240669371$24066937$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156038$ASTRAZENECA$$63$YR$$F$Y$64$KG$20240709$$HP$FR$
240669381$24066938$1$I$20090101$20240625$20240709$20240709$PER$$US-TEVA-VS-3214357$TEVA$$40$YR$$F$Y$$$20240709$$HP$US$US
240669391$24066939$1$I$20240624$20240701$20240709$20240709$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010358$JAZZ$$74$YR$$M$Y$$$20240709$$MD$JP$JP
240669401$24066940$1$I$20240125$20240708$20240709$20240709$EXP$ES-AEMPS-1542776$ES-GILEAD-2024-0679883$GILEAD$$36$YR$A$M$Y$$$20240709$$PH$ES$ES
240669412$24066941$2$F$$20240703$20240709$20240711$EXP$$CH-MYLANLABS-2024M1063714$MYLAN$Morin S, Boroli F, Vandenberghe-Durr S, Allali D, Masouridi-Levrat S, Chalandon Y, et al. Severe anaphylaxis after chimeric antigen receptor T-cell injection: a case report. EJHaem 2024; 5 (3): 603-606.$77$YR$$M$Y$$$20240711$$HP$CH$CH
240669423$24066942$3$F$20240101$20240705$20240709$20240826$PER$$US-IMP-2024000439$Harrow Health$$$$E$M$Y$$$20240826$$CN$US$US
240669431$24066943$1$I$$20240708$20240709$20240709$EXP$$GB-ABBVIE-5831889$ABBVIE$$$$A$M$Y$$$20240709$$HP$GB$GB
240669461$24066946$1$I$20240520$20240701$20240709$20240709$EXP$FR-AFSSAPS-NT2024000749$FR-TEVA-VS-3216203$TEVA$$12$YR$$M$Y$$$20240709$$PH$FR$FR
240669471$24066947$1$I$20240201$20240708$20240709$20240709$EXP$ES-AEMPS-1542777$ES-GILEAD-2024-0679884$GILEAD$$55$YR$A$F$Y$$$20240709$$PH$ES$ES
240669481$24066948$1$I$$20240702$20240709$20240709$PER$$US-SA-2024SA198532$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240709$$CN$US$US
240669491$24066949$1$I$$20240702$20240709$20240709$EXP$$EG-MYLANLABS-2024M1063077$MYLAN$Nofal A, Alakad R, Wahid R, Hoseiny HAM. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma. Arch-Dermatol-Res 2024; 316 1-6.$$$A$$Y$$$20240709$$HP$EG$EG
240669501$24066950$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005013$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240709$$CN$US$US
240669511$24066951$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407005301$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240709$$CN$US$US
240669521$24066952$1$I$20240702$20240703$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407003335$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240709$$CN$US$US
240669531$24066953$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141832$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240669542$24066954$2$F$$20240808$20240709$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108876$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240810$$CN$US$US
240669571$24066957$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108112$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240709$$PH$US$US
240669581$24066958$1$I$$20240709$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108932$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$76.66$KG$20240709$$CN$US$US
240669592$24066959$2$F$$20240830$20240709$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106915$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240905$$CN$US$US
240669601$24066960$1$I$20240624$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108853$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240709$$CN$US$US
240669611$24066961$1$I$20240609$20240705$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108707$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240709$$CN$US$US
240669621$24066962$1$I$$20240709$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108899$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$111.13$KG$20240709$$CN$US$US
240669631$24066963$1$I$$20240709$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108893$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240709$$HP$US$US
240669641$24066964$1$I$$20240701$20240709$20240709$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-105753$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240709$$MD$NL$NL
240669661$24066966$1$I$$20240709$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108965$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240709$$CN$US$US
240669671$24066967$1$I$$20240705$20240709$20240709$30DAY$$US-SANDOZ INC.-SDZ2024US039901$SANDOZ$$$$$M$Y$$$20240709$$HP$US$US
240669682$24066968$2$F$$20240913$20240709$20240916$30DAY$$CA-PFIZER INC-202400202384$PFIZER$$$$$$Y$$$20240916$$PH$CA$CA
240669711$24066971$1$I$$20240606$20240709$20240709$PER$$US-CARLSBAD-2024USCTISPO00007$CARLSBAD$$72$YR$E$M$Y$166$KG$20240709$$CN$US$US
240669721$24066972$1$I$20240326$20240708$20240709$20240709$EXP$ES-AEMPS-1542779$ES-GILEAD-2024-0679887$GILEAD$$62$YR$A$M$Y$$$20240709$$PH$ES$ES
240669731$24066973$1$I$$20240701$20240709$20240709$EXP$$US-SMPA-2024SPA000101$SUNOVION$$$$$$Y$$$20240709$$CN$US$US
240669741$24066974$1$I$$20240703$20240709$20240709$PER$$US-SMPA-2024SPA000113$SUNOVION$$$$$$Y$$$20240709$$CN$US$US
240669752$24066975$2$F$20240404$20240701$20240709$20240711$EXP$$US-SMPA-2024SPA000118$SUNOVION$$$$$$Y$$$20240711$$CN$US$US
240669764$24066976$4$F$20240430$20240822$20240709$20240911$PER$$US-SMPA-2024SPA000102$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
240669782$24066978$2$F$20240101$20240910$20240709$20240924$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0254$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240924$$CN$US$US
240669791$24066979$1$I$20240621$20240703$20240709$20240709$EXP$$CN-GE HEALTHCARE-2024CSU007598$GE HEALTHCARE$$32$YR$$F$Y$55$KG$20240709$$HP$CN$CN
240669801$24066980$1$I$20240702$20240702$20240709$20240709$EXP$$AU-GE HEALTHCARE-2024CSU007482$GE HEALTHCARE$$52$YR$$F$Y$90$KG$20240709$$HP$AU$AU
240669811$24066981$1$I$20240418$20240418$20240709$20240709$PER$$US-GE HEALTHCARE-2024CSU004049$GE HEALTHCARE$$$$$$Y$$$20240709$$HP$US$US
240669821$24066982$1$I$$20240708$20240709$20240709$30DAY$$CA-SANDOZ INC.-NVSC2022CA007872$SANDOZ$$$$$F$Y$$$20240709$$CN$CA$CA
240669831$24066983$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141830$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240669841$24066984$1$I$20240109$20240701$20240709$20240709$EXP$FR-AFSSAPS-AVMA2024000244$FR-TEVA-VS-3216254$TEVA$$25$YR$$M$Y$$$20240709$$PH$FR$FR
240669851$24066985$1$I$$20240703$20240709$20240709$EXP$$JP-PFIZER INC-PV202400087654$PFIZER$Fukuhara, S.. Obliteration of a Portosystemic Shunt by Hybrid Interventional Radiology Using a Transmesenteric Approach Under Minilaparotomy After Liver Transplantation: A Case Report. Transplantation Proceedings. 2020;52(9):2762-2766$53$YR$$M$Y$$$20240709$$HP$JP$JP
240669861$24066986$1$I$$20240703$20240709$20240709$EXP$$HU-PFIZER INC-2022SGN13009$PFIZER$Kiraly, P.. Clinical history of a patient diagnosed with monomorphic epiteliotrophic intestinal T-cell lymphoma. Hematologia-Transzfuziologia. 2022;55(3):117-121$41$YR$$M$Y$$$20240709$$MD$HU$HU
240669871$24066987$1$I$20140206$20240704$20240709$20240709$EXP$$DE-PFIZER INC-202400207618$PFIZER$Alig, S.. Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature. European Journal of Haematology. 2014;94:554-557$64$YR$$M$Y$70$KG$20240709$$MD$DE$DE
240669881$24066988$1$I$$20240704$20240709$20240709$EXP$$DE-PFIZER INC-202400206769$PFIZER$Kloehn, J.. SALVAGE TREATMENT OF PROGRESSIVE SEVERE CHRONIC GRAFT-VERSUS-HOST DISEASE BY IMMUNE ABLATION AND STEM CELL RESCUE IN 2 PEDIATRIC PATIENTS.. Bone Marrow Transplantation. 2023;58 (SUUPL_1):P579$8$YR$$F$Y$$$20240709$$HP$DE$DE
240669891$24066989$1$I$$20240704$20240709$20240709$EXP$$JP-PFIZER INC-202400206123$PFIZER$Mita, A.. Fatal disseminate mucormycosis due to Cunninghamella bertholletiae infection after ABO-incompatible living donor liver transplantation: a case report. Surgical Case Reports. 2022;8(1):10.1186/s40792-022-01516-4$47$YR$$M$Y$$$20240709$$HP$JP$JP
240669901$24066990$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05707$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240669911$24066991$1$I$20240702$20240707$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107985$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240709$$CN$US$US
240669924$24066992$4$F$$20240926$20240709$20240930$EXP$$ES-PFIZER INC-202400208057$PFIZER$Rubio-Mora, E.. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transplant Infectious Disease. 2024;26(3):10.1111/tid.14276$5$MON$$M$Y$$$20240930$$MD$ES$ES
240669932$24066993$2$F$20240601$20240822$20240709$20240830$EXP$$US-ALKERMES INC.-ALK-2024-001822$ALKERMES$$50$YR$$M$Y$91.156$KG$20240830$$HP$US$US
240669952$24066995$2$F$$20240719$20240709$20240723$PER$$US-JAZZ PHARMACEUTICALS-2023-US-019915$JAZZ$$$$$M$Y$29.478$KG$20240722$$HP$US$US
240669961$24066996$1$I$$20240703$20240709$20240709$PER$$US-ALXN-202407USA000231US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240709$$CN$US$US
240669971$24066997$1$I$$20240701$20240709$20240709$EXP$$ZA-AstraZeneca-2024A151963$ASTRAZENECA$$73$YR$$F$Y$$$20240709$$CN$ZA$
240669981$24066998$1$I$$20240709$20240709$20240709$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038722$BOEHRINGER INGELHEIM$$$$$$Y$$$20240709$$CN$US$US
240670001$24067000$1$I$$20240701$20240709$20240709$EXP$FR-AFSSAPS-AVNT2024000409$FR-TEVA-VS-3216243$TEVA$$26$YR$$M$Y$$$20240709$$PH$FR$FR
240670011$24067001$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141892$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240670021$24067002$1$I$$20240622$20240709$20240709$PER$$US-APELLIS-2024-APL-0000353$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240709$$MD$US$US
240670031$24067003$1$I$$20240627$20240709$20240709$EXP$$US-B.Braun Medical Inc.-2158966$B BRAUN$Literature Article$74$YR$$F$Y$$$20240709$$$US$US
240670041$24067004$1$I$$20240625$20240709$20240709$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05790$LUPIN$$$$$$Y$$$20240709$$CN$US$US
240670051$24067005$1$I$20240501$20240709$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108945$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240709$$PH$US$US
240670061$24067006$1$I$$20240629$20240709$20240709$PER$$AU-Eisai-EC-2024-169231$EISAI$$58$YR$A$F$Y$$$20240709$$MD$AU$AU
240670072$24067007$2$F$$20240717$20240709$20240724$EXP$$HU-GSK-HU2024EME082892$GLAXOSMITHKLINE$Koszoru K, Hidvegi B, Sardy M, Robert L, Kemeny Vl, Harsing J. kortikoszteroid ?s etanercept ter?pia toxikus epiderm?lis nekrol?zisben. Borgyogyaszati Es Venerologiai Szemle. 2024;100.3:148-151$$$$$Y$$$20240724$$MD$HU$HU
240670091$24067009$1$I$$20240704$20240709$20240709$EXP$$PK-WOODWARD-2024-PK-000005$WOODWARD PHARMA SERVICES$$$$$M$Y$$$20240708$$CN$PK$PK
240670101$24067010$1$I$20230911$20230915$20240709$20240709$PER$$US-VISTAPHARM-2023-US-029746$VISTAPHARM$$84$YR$$F$Y$68.95$KG$20240709$$CN$US$US
240670111$24067011$1$I$$20240424$20240709$20240709$PER$$US-VISTAPHARM-2024-US-024172$VISTAPHARM$$$$$M$Y$$$20240709$$CN$US$US
240670121$24067012$1$I$20230828$20230915$20240709$20240709$PER$$US-VISTAPHARM-2023-US-029680$VISTAPHARM$$65$YR$$F$Y$63.96$KG$20240709$$CN$US$US
240670131$24067013$1$I$$20240703$20240709$20240709$PER$$US-ALXN-202407USA000226US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240709$$CN$US$US
240670141$24067014$1$I$$20240703$20240709$20240709$PER$$US-ALXN-202407USA000230US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
240670151$24067015$1$I$20240701$20240702$20240709$20240709$PER$$US-JNJFOC-20240722182$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240709$$HP$US$US
240670171$24067017$1$I$20240101$20240611$20240709$20240709$PER$$US-009507513-2406USA003812$MERCK$$89$YR$$F$Y$$$20240709$$CN$US$US
240670181$24067018$1$I$$20240703$20240709$20240709$PER$$US-009507513-2407USA002025$MERCK$$$$$F$Y$$$20240709$$CN$US$US
240670191$24067019$1$I$$20240624$20240709$20240709$EXP$$US-HLS-202400187$HLS THERAPEUTICS$$35$YR$A$M$Y$$$20240709$$MD$IN$US
240670201$24067020$1$I$$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107274$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240709$$PH$US$US
240670211$24067021$1$I$20220101$20240701$20240709$20240709$EXP$FR-AFSSAPS-NT2024000728$FR-TEVA-VS-3216249$TEVA$$79$YR$$M$Y$71$KG$20240709$$PH$FR$FR
240670222$24067022$2$F$$20240708$20240709$20240715$PER$$US-BIOGEN-2024BI01272629$BIOGEN$$$$$M$Y$$$20240715$$CN$US$US
240670231$24067023$1$I$20240607$20240702$20240709$20240709$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06644$NEUROCRINE BIOSCIENCES$$64$YR$$M$Y$$$20240709$$HP$US$US
240670241$24067024$1$I$$20240701$20240709$20240709$EXP$$ZA-AstraZeneca-2024A152018$ASTRAZENECA$$76$YR$$F$Y$$$20240709$$CN$ZA$
240670261$24067026$1$I$20240702$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134379$AMGEN$$41$YR$A$F$Y$$$20240709$$CN$US$US
240670274$24067027$4$F$$20240819$20240709$20240827$PER$$US-ALXN-202407USA000141US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240827$$HP$US$US
240670282$24067028$2$F$20240610$20240627$20240709$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019448$ELI LILLY AND CO$$$$$$Y$$$20240711$$CN$US$US
240670302$24067030$2$F$20230927$20240823$20240709$20240830$EXP$$IN-INCYTE CORPORATION-2023IN012884$INCYTE$$$$$$Y$$$20240830$$CN$IN$IN
240670321$24067032$1$I$20240623$20240702$20240709$20240709$PER$$US-BIOMARINAP-US-2024-158976$BIOMARIN$$$$$$Y$$$20240709$$CN$US$US
240670331$24067033$1$I$$20240702$20240709$20240709$PER$$US-BIOMARINAP-US-2024-158946$BIOMARIN$$$$$$Y$$$20240709$$CN$US$US
240670342$24067034$2$F$$20240701$20240709$20240710$PER$$US-JNJFOC-20240704198$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
240670351$24067035$1$I$20240401$20240708$20240709$20240709$PER$$PR-JNJFOC-20240721621$JOHNSON AND JOHNSON$$94$YR$E$M$Y$83.01$KG$20240709$$CN$PR$PR
240670361$24067036$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108634$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240709$$PH$US$US
240670373$24067037$3$F$20240530$20240718$20240709$20240723$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038583$BOEHRINGER INGELHEIM$$59$YR$A$M$Y$$$20240719$$PH$JP$JP
240670381$24067038$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108230$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$85.28$KG$20240709$$HP$US$US
240670391$24067039$1$I$20240423$20240708$20240709$20240709$EXP$ES-AEMPS-1542762$ES-GILEAD-2024-0679901$GILEAD$$83$YR$E$F$Y$$$20240709$$PH$ES$ES
240670401$24067040$1$I$$20240703$20240709$20240709$EXP$$KR-009507513-2407KOR002035$MERCK$$$$$M$Y$$$20240709$$CN$KR$KR
240670411$24067041$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156164$ASTRAZENECA$$65$YR$$F$Y$$$20240709$$HP$FR$
240670421$24067042$1$I$20240501$20240701$20240709$20240709$EXP$FR-AFSSAPS-PV2024000566$FR-TEVA-VS-3216272$TEVA$$63$YR$$F$Y$87$KG$20240709$$MD$FR$FR
240670431$24067043$1$I$20240601$20240703$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106940$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240709$$HP$US$US
240670441$24067044$1$I$$20240704$20240709$20240709$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107341$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240709$$HP$CA$CA
240670462$24067046$2$F$$20240924$20240709$20240927$EXP$$NVSC2024US140961$NOVARTIS$$$$$F$Y$67$KG$20240927$$CN$US$US
240670472$24067047$2$F$$20240812$20240709$20240812$PER$$US-ALXN-202407USA000240US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
240670481$24067048$1$I$$20240620$20240709$20240709$PER$$US-ROCHE-10000007983$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240670491$24067049$1$I$$20240617$20240709$20240709$PER$$US-ROCHE-10000007335$ROCHE$$$$$$Y$$$20240701$$PH$US$US
240670501$24067050$1$I$$20240617$20240709$20240709$PER$$US-ROCHE-10000010963$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240670512$24067051$2$F$$20240520$20240709$20240710$PER$$US-ROCHE-3568099$ROCHE$$$$E$M$Y$$$20240628$$MD$US$US
240670521$24067052$1$I$$20240624$20240709$20240709$PER$$US-ROCHE-10000010930$ROCHE$$80$YR$E$F$Y$$$20240701$$CN$US$US
240670541$24067054$1$I$$20240625$20240709$20240709$EXP$$EC-ROCHE-10000007734$ROCHE$$$$$$Y$$$20240702$$CN$EC$EC
240670551$24067055$1$I$$20240618$20240709$20240709$PER$$US-ROCHE-3559808$ROCHE$$40$YR$A$M$Y$$$20240701$$MD$US$US
240670562$24067056$2$F$$20240619$20240709$20240711$PER$$US-ROCHE-3575145$ROCHE$$38$YR$A$F$Y$$$20240711$$MD$US$US
240670572$24067057$2$F$$20240812$20240709$20240813$PER$$US-ROCHE-10000006511$ROCHE$$54$YR$A$F$Y$$$20240813$$MD$US$US
240670581$24067058$1$I$20240521$20240626$20240709$20240709$EXP$$CN-ROCHE-10000010216$ROCHE$$65$YR$E$M$Y$74$KG$20240627$$HP$CN$CN
240670591$24067059$1$I$$20240612$20240709$20240709$PER$$US-ROCHE-10000000210$ROCHE$$$$E$F$Y$$$20240618$$MD$US$US
240670601$24067060$1$I$$20240622$20240709$20240709$PER$$US-ROCHE-10000009912$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240670611$24067061$1$I$$20240620$20240709$20240709$PER$$US-ROCHE-10000009208$ROCHE$$$$A$M$Y$$$20240628$$MD$US$US
240670622$24067062$2$F$20220901$20240705$20240709$20240709$PER$US-ROCHE-10000004766$US-ROCHE-10000004766$ROCHE$Ma V, Quach M, Mahajan A, Pleva J. Rapid Life-Saving Response to Anti-PD-1 in a Solid Organ Transplant Recipient with Metastatic Cutaneous Squamous Cell Carcinoma: A Case Report and Review. Journal of Immunotherapy. 2024;47 (6):216-219. doi:10.1097/CJI.0000000000000514.$5$DEC$A$M$Y$$$20240709$$MD$US$US
240670631$24067063$1$I$$20240620$20240709$20240709$PER$$US-ROCHE-10000011866$ROCHE$$10$YR$C$M$Y$$$20240701$$HP$US$US
240670641$24067064$1$I$20231207$20240624$20240709$20240709$PER$$US-ROCHE-10000011711$ROCHE$$35$YR$A$M$Y$$$20240701$$PH$US$US
240670651$24067065$1$I$$20240623$20240709$20240709$PER$$US-ROCHE-10000012121$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240670662$24067066$2$F$$20240711$20240709$20240717$EXP$$BE-ROCHE-10000013177$ROCHE$Ruythooren F, Ghijselings S, Depypere M, Metsemakers W, Henckaerts L, Noppe N, et al. Ureaplasma urealyticum osteomyelitis of the greater trochanter in a patient with multiple sclerosis using ocrelizumab - A case report. Journal of Bone and Joint Infection. 2024-Jun-13;9 (3):167-71. doi:10.5194/jbji-9-167-2024.$26$YR$A$M$Y$$$20240717$$HP$BE$BE
240670671$24067067$1$I$$20240624$20240709$20240709$PER$$US-ROCHE-10000010551$ROCHE$$11$YR$C$M$Y$$$20240628$$CN$US$US
240670681$24067068$1$I$$20240627$20240709$20240709$EXP$$BR-ROCHE-10000012407$ROCHE$$$$$$Y$$$20240702$$MD$BR$BR
240670694$24067069$4$F$$20240812$20240709$20240816$PER$$US-ROCHE-10000007405$ROCHE$$$$A$F$Y$$$20240816$$CN$US$US
240670701$24067070$1$I$$20240620$20240709$20240709$PER$$US-ROCHE-10000006005$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
240670721$24067072$1$I$$20240620$20240709$20240709$PER$$US-ROCHE-10000009461$ROCHE$$$$$$Y$$$20240701$$MD$US$US
240670731$24067073$1$I$20240606$20240621$20240709$20240709$PER$$US-ROCHE-10000010056$ROCHE$$58$YR$A$M$Y$$$20240702$$CN$US$US
240670741$24067074$1$I$$20240626$20240709$20240709$EXP$$US-ROCHE-10000012369$ROCHE$$$$$$Y$$$20240701$$MD$US$US
240670751$24067075$1$I$20240523$20240626$20240709$20240709$PER$$US-ROCHE-10000010536$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
240670761$24067076$1$I$$20240627$20240709$20240709$PER$$US-ROCHE-10000010951$ROCHE$Saaidi S, Bertolini R, Piroli F, Manca F, Cioni E, Tarantini L. Entrectinib-Induced Acute Right Heart Failure In A Patient With Metastatic Lung Adenocarcinoma.. European Heart Journal, Supplement. 2024-Apr;26:ii178. doi:10.1093/eurheartjsupp/suae036.430.$45$YR$A$F$Y$$$20240628$$HP$US$US
240670771$24067077$1$I$$20240617$20240709$20240709$PER$$US-ROCHE-10000005971$ROCHE$$63$YR$A$M$Y$$$20240701$$CN$US$US
240670781$24067078$1$I$$20240624$20240709$20240709$PER$$US-ROCHE-10000010353$ROCHE$$55$YR$A$F$Y$$$20240701$$MD$US$US
240670791$24067079$1$I$20240321$20240625$20240709$20240709$EXP$$CN-ROCHE-10000008964$ROCHE$$63$YR$A$M$Y$$$20240702$$HP$CN$CN
240670801$24067080$1$I$20240619$20240621$20240709$20240709$PER$$US-ROCHE-10000010012$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240670811$24067081$1$I$$20240624$20240709$20240709$PER$$US-ROCHE-10000012288$ROCHE$$39$YR$A$F$Y$$$20240701$$CN$US$US
240670823$24067082$3$F$20240101$20240908$20240709$20240910$EXP$$AU-ROCHE-10000010943$ROCHE$$33$YR$A$M$Y$$$20240910$$CN$AU$AU
240670842$24067084$2$F$$20240628$20240709$20240710$PER$$US-ROCHE-10000011226$ROCHE$$53$YR$A$F$Y$$$20240710$$CN$US$US
240670851$24067085$1$I$$20240622$20240709$20240709$PER$$US-ROCHE-10000010960$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240670861$24067086$1$I$20240531$20240624$20240709$20240709$PER$$US-ROCHE-10000010261$ROCHE$$41$YR$A$F$Y$65.77$KG$20240701$$CN$US$US
240670871$24067087$1$I$$20240625$20240709$20240709$PER$$US-ROCHE-10000011283$ROCHE$$$$$$Y$$$20240701$$PH$US$US
240670891$24067089$1$I$$20240626$20240709$20240709$PER$$US-ROCHE-10000013218$ROCHE$$$$$$Y$$$20240702$$MD$US$US
240670901$24067090$1$I$$20240624$20240709$20240709$PER$$US-ROCHE-10000010278$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240670911$24067091$1$I$$20240618$20240709$20240709$PER$$US-ROCHE-10000006194$ROCHE$$75$YR$E$M$Y$$$20240701$$MD$US$US
240670921$24067092$1$I$20240615$20240618$20240709$20240709$PER$$US-ROCHE-10000011389$ROCHE$$$$$$Y$$$20240702$$HP$US$US
240670934$24067093$4$F$$20240711$20240709$20240722$PER$$US-ROCHE-10000009134$ROCHE$$$$$F$Y$$$20240719$$CN$US$US
240670941$24067094$1$I$$20240613$20240709$20240709$PER$$US-ROCHE-10000010856$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240670951$24067095$1$I$20240624$20240625$20240709$20240709$EXP$$US-ROCHE-10000013256$ROCHE$$44$YR$A$F$Y$$$20240702$$CN$US$US
240670961$24067096$1$I$$20240614$20240709$20240709$PER$$US-ROCHE-10000012966$ROCHE$$$$A$F$Y$$$20240702$$HP$US$US
240670971$24067097$1$I$$20240619$20240709$20240709$PER$$US-ROCHE-10000012197$ROCHE$$$$A$M$Y$$$20240701$$HP$US$US
240670981$24067098$1$I$$20240620$20240709$20240709$PER$$US-ROCHE-10000012010$ROCHE$$56$YR$A$F$Y$$$20240701$$CN$US$US
240670993$24067099$3$F$$20240827$20240709$20240828$PER$$US-ROCHE-10000016003$ROCHE$$26$YR$A$F$Y$$$20240828$$HP$US$US
240671001$24067100$1$I$$20240627$20240709$20240709$PER$$US-ROCHE-10000015257$ROCHE$$$$A$M$Y$$$20240705$$CN$US$US
240671024$24067102$4$F$20240620$20240821$20240709$20240823$PER$$US-ROCHE-10000014142$ROCHE$$11$YR$C$F$Y$$$20240823$$CN$US$US
240671031$24067103$1$I$$20240624$20240709$20240709$PER$$US-ROCHE-10000014637$ROCHE$Huang L, Ellis TJ, Bagavathy K. The Unfortunate Trifecta: Tuberculosis, EBV, and CMV Induced Hemophagocytic Lymphohistiocytosis. Am J Respir Crit Care Med 2024;209.$52$YR$A$M$Y$$$20240705$$HP$US$US
240671041$24067104$1$I$$20240624$20240709$20240709$PER$$US-ROCHE-10000010283$ROCHE$$$$$$Y$$$20240704$$PH$US$US
240671051$24067105$1$I$20230620$20240626$20240709$20240709$EXP$$RU-ROCHE-10000011925$ROCHE$$55$YR$A$F$Y$$$20240705$$MD$RU$RU
240671061$24067106$1$I$20240622$20240702$20240709$20240709$EXP$$CN-ROCHE-10000014767$ROCHE$$43$YR$A$F$Y$$$20240704$$HP$CN$CN
240671072$24067107$2$F$20240601$20240708$20240709$20240717$EXP$$JP-ROCHE-10000013821$ROCHE$$42$YR$A$M$Y$$$20240717$$MD$JP$JP
240671081$24067108$1$I$$20240625$20240709$20240709$PER$$US-ROCHE-10000015613$ROCHE$$$$E$F$Y$$$20240705$$HP$US$US
240671101$24067110$1$I$$20240702$20240709$20240709$PER$$US-ROCHE-10000016788$ROCHE$$12$YR$T$M$Y$$$20240705$$MD$US$US
240671111$24067111$1$I$20240603$20240627$20240709$20240709$PER$$US-ROCHE-3576209$ROCHE$$28$YR$A$M$Y$80.74$KG$20240704$$HP$US$US
240671124$24067112$4$F$$20240731$20240709$20240805$PER$$US-ROCHE-10000008431$ROCHE$$$$E$F$Y$$$20240805$$CN$US$US
240671132$24067113$2$F$$20240701$20240709$20240711$EXP$$CN-ROCHE-10000012502$ROCHE$$76$YR$E$M$Y$$$20240711$$CN$CN$CN
240671151$24067115$1$I$20240516$20240619$20240709$20240709$PER$$US-ROCHE-3567351$ROCHE$$79$YR$E$F$Y$$$20240702$$CN$US$US
240671164$24067116$4$F$20240626$20240808$20240709$20240916$PER$$US-ROCHE-10000011703$ROCHE$$$$$F$Y$$$20240916$$CN$US$US
240671171$24067117$1$I$$20240625$20240709$20240709$EXP$$NL-ROCHE-10000011560$ROCHE$$$$$$Y$$$20240704$$HP$NL$NL
240671183$24067118$3$F$20240611$20240903$20240709$20240911$EXP$$JP-ROCHE-10000013706$ROCHE$$9$DEC$E$F$Y$48$KG$20240911$$MD$JP$JP
240671191$24067119$1$I$$20240626$20240709$20240709$EXP$$US-ROCHE-10000014665$ROCHE$$69$YR$E$F$Y$$$20240704$$CN$US$US
240671201$24067120$1$I$$20240625$20240709$20240709$EXP$$MY-ROCHE-10000013307$ROCHE$$38$YR$A$M$Y$$$20240705$$HP$MY$MY
240671211$24067121$1$I$$20240625$20240709$20240709$PER$$US-ROCHE-10000014114$ROCHE$$$$$$Y$$$20240705$$MD$US$US
240671222$24067122$2$F$$20240624$20240709$20240711$PER$$US-ROCHE-10000013498$ROCHE$$$$A$F$Y$125.6$KG$20240711$$CN$US$US
240671231$24067123$1$I$20240615$20240627$20240709$20240709$PER$$US-ROCHE-10000014957$ROCHE$$25$YR$A$M$Y$$$20240704$$CN$US$US
240671241$24067124$1$I$$20240625$20240709$20240709$EXP$$MY-ROCHE-10000013373$ROCHE$$46$YR$A$M$Y$$$20240703$$PH$MY$MY
240671251$24067125$1$I$$20240625$20240709$20240709$PER$$US-ROCHE-10000013398$ROCHE$$$$A$M$Y$$$20240702$$CN$US$US
240671261$24067126$1$I$$20240701$20240709$20240709$PER$$US-SA-2024SA063111$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240709$$MD$US$US
240671271$24067127$1$I$$20240627$20240709$20240709$PER$$US-ROCHE-10000015467$ROCHE$$$$A$M$Y$$$20240704$$CN$US$US
240671284$24067128$4$F$$20240626$20240709$20240712$PER$$US-ROCHE-RCA5213034$ROCHE$$$$$$Y$$$20240712$$MD$US$US
240671291$24067129$1$I$$20240626$20240709$20240709$EXP$$JP-ROCHE-10000013669$ROCHE$$66$YR$E$M$Y$$$20240705$$MD$JP$JP
240671302$24067130$2$F$20240603$20240729$20240709$20240730$PER$$US-ROCHE-10000015579$ROCHE$$35$YR$A$F$Y$$$20240730$$CN$US$US
240671312$24067131$2$F$$20240820$20240709$20240822$PER$$US-ROCHE-10000014905$ROCHE$$$$$F$Y$72.57$KG$20240822$$MD$US$US
240671322$24067132$2$F$20240616$20240819$20240709$20240820$PER$$US-ROCHE-10000015247$ROCHE$$49$YR$A$M$Y$107.5$KG$20240820$$CN$US$US
240671332$24067133$2$F$$20240812$20240709$20240815$PER$$US-ROCHE-10000014838$ROCHE$$33$YR$A$F$Y$$$20240815$$CN$US$US
240671341$24067134$1$I$$20240627$20240709$20240709$PER$$US-ROCHE-10000014765$ROCHE$$$$E$F$Y$$$20240705$$CN$US$US
240671351$24067135$1$I$$20240628$20240709$20240709$PER$$US-ROCHE-10000016114$ROCHE$$56$YR$A$F$Y$$$20240705$$CN$US$US
240671362$24067136$2$F$$20240807$20240709$20240808$PER$$US-ROCHE-10000015440$ROCHE$$$$A$M$Y$$$20240808$$CN$US$US
240671371$24067137$1$I$$20240626$20240709$20240709$PER$$US-ROCHE-10000014560$ROCHE$$33$YR$A$F$Y$$$20240705$$CN$US$US
240671382$24067138$2$F$$20240625$20240709$20240709$PER$$US-ROCHE-10000013866$ROCHE$$$$$$Y$$$20240704$$MD$US$US
240671392$24067139$2$F$$20240626$20240709$20240711$PER$$US-ROCHE-10000015124$ROCHE$$60$YR$A$F$Y$$$20240711$$MD$US$US
240671403$24067140$3$F$20240611$20240724$20240709$20240729$PER$$US-ROCHE-10000012084$ROCHE$$51$YR$A$F$Y$74.84$KG$20240729$$CN$US$US
240671411$24067141$1$I$$20240620$20240709$20240709$PER$$US-ROCHE-10000011134$ROCHE$$$$$$Y$$$20240704$$HP$US$US
240671422$24067142$2$F$$20240726$20240709$20240731$PER$$US-ROCHE-10000015471$ROCHE$$$$$F$Y$$$20240731$$CN$US$US
240671432$24067143$2$F$$20240626$20240709$20240904$EXP$$AT-ROCHE-10000014300$ROCHE$$$$$$Y$$$20240904$$MD$AT$AT
240671441$24067144$1$I$$20240701$20240709$20240709$PER$$US-ROCHE-10000013878$ROCHE$Ali F, Arshad K, Latif R, Farooq A, Nanjundappa A. Spontaneous spinal epidural hematoma following IV heparin and catheter-directed thrombolysis for deep vein thrombosis. Journal of Vascular Surgery Cases, Innovations and Techniques. 2024-Aug;10 (4):1-3. doi:10.1016/j.jvscit.2024.101541.$65$YR$E$M$Y$$$20240704$$MD$US$US
240671451$24067145$1$I$$20240624$20240709$20240709$PER$$US-ROCHE-10000010439$ROCHE$$$$$$Y$$$20240704$$CN$US$US
240671461$24067146$1$I$$20240621$20240709$20240709$PER$$US-ROCHE-10000012041$ROCHE$$$$$$Y$$$20240703$$CN$US$US
240671472$24067147$2$F$20210101$20240709$20240709$20240718$EXP$$RU-ROCHE-10000015047$ROCHE$$73$YR$E$$Y$$$20240718$$MD$RU$RU
240671482$24067148$2$F$$20240618$20240709$20240711$PER$$US-ROCHE-RCA4865254$ROCHE$$24$YR$A$F$Y$$$20240711$$CN$US$US
240671501$24067150$1$I$20240509$20240702$20240709$20240709$EXP$$CN-ROCHE-10000014796$ROCHE$$47$YR$A$M$Y$65$KG$20240704$$HP$CN$CN
240671512$24067151$2$F$$20240630$20240709$20240709$PER$$US-ROCHE-10000016476$ROCHE$$$$$$Y$$$20240705$$CN$US$US
240671521$24067152$1$I$$20240624$20240709$20240709$EXP$$US-HLS-202400188$HLS THERAPEUTICS$$25$YR$A$F$Y$$$20240709$$MD$IN$US
240671531$24067153$1$I$20240528$20240624$20240709$20240709$PER$$US-ROCHE-3572841$ROCHE$$$$$F$Y$$$20240705$$CN$US$US
240671541$24067154$1$I$20240401$20240628$20240709$20240709$EXP$$US-ROCHE-10000015825$ROCHE$$54$YR$A$F$Y$$$20240705$$CN$US$US
240671551$24067155$1$I$20240101$20240628$20240709$20240709$EXP$$US-ROCHE-10000016028$ROCHE$$42$YR$A$F$Y$$$20240705$$CN$US$US
240671562$24067156$2$F$$20240823$20240709$20240827$PER$$US-ROCHE-10000008311$ROCHE$Fourman L, Tsai L, Brown R, O^Rahilly S. Case 10-2024: A 46-Year-Old Woman with Hyperglycemia Refractory to Insulin Therapy. The New England Journal of Medicine. 2024;390 (13):1219-29. doi:10.1056/NEJMcpc2312729.$46$YR$A$F$Y$$$20240827$$MD$US$US
240671573$24067157$3$F$20240320$20240831$20240709$20240908$PER$$US-ROCHE-10000014979$ROCHE$$53$YR$A$F$Y$109.77$KG$20240908$$HP$US$US
240671582$24067158$2$F$$20240729$20240709$20240731$EXP$$DE-ROCHE-10000018493$ROCHE$$$$$F$Y$$$20240731$$MD$DE$DE
240671591$24067159$1$I$$20240629$20240709$20240709$PER$$US-ROCHE-10000016245$ROCHE$$$$$$Y$$$20240705$$CN$US$US
240671602$24067160$2$F$$20240701$20240709$20240711$PER$$US-ROCHE-10000018364$ROCHE$$7$YR$C$M$Y$$$20240711$$MD$US$US
240671611$24067161$1$I$20240529$20240701$20240709$20240709$PER$$US-ROCHE-10000018887$ROCHE$$49$YR$A$F$Y$$$20240708$$MD$US$US
240671622$24067162$2$F$$20240625$20240709$20240710$EXP$$RU-ROCHE-10000010842$ROCHE$$$$E$$Y$$$20240710$$MD$RU$RU
240671631$24067163$1$I$20240514$20240626$20240709$20240709$PER$$US-ROCHE-10000016488$ROCHE$$13$YR$T$M$Y$$$20240705$$CN$US$US
240671641$24067164$1$I$$20240626$20240709$20240709$PER$$US-ROCHE-10000013163$ROCHE$$$$$$Y$$$20240705$$CN$US$US
240671652$24067165$2$F$20240618$20240703$20240709$20240710$PER$$US-ROCHE-10000016586$ROCHE$$26$YR$A$M$Y$$$20240710$$CN$US$US
240671661$24067166$1$I$$20240701$20240709$20240709$PER$$US-ROCHE-10000017135$ROCHE$$50$YR$A$M$Y$$$20240705$$HP$US$US
240671671$24067167$1$I$20240226$20240702$20240709$20240709$PER$$US-ROCHE-10000017442$ROCHE$$38$YR$A$M$Y$88.45$KG$20240705$$CN$US$US
240671681$24067168$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000018728$ROCHE$$$$E$F$Y$$$20240708$$CN$US$US
240671701$24067170$1$I$20240622$20240702$20240709$20240709$PER$$US-ROCHE-10000017666$ROCHE$$37$YR$A$M$Y$$$20240708$$CN$US$US
240671712$24067171$2$F$20220122$20240711$20240709$20240717$EXP$$US-ROCHE-10000014521$ROCHE$$51$YR$A$F$Y$112.03$KG$20240717$$CN$US$US
240671721$24067172$1$I$$20240704$20240709$20240709$EXP$$EC-ROCHE-10000018178$ROCHE$$$$$$Y$$$20240708$$MD$EC$EC
240671731$24067173$1$I$$20240701$20240709$20240709$PER$$US-ROCHE-10000017080$ROCHE$$39$YR$A$F$Y$$$20240705$$HP$US$US
240671741$24067174$1$I$$20240625$20240709$20240709$EXP$$IN-ROCHE-10000018626$ROCHE$$82$YR$E$M$Y$$$20240708$$CN$IN$IN
240671761$24067176$1$I$$20240627$20240709$20240709$PER$$US-ROCHE-3571054$ROCHE$$$$$$Y$$$20240708$$CN$US$US
240671771$24067177$1$I$$20240626$20240709$20240709$PER$$US-ROCHE-10000016390$ROCHE$$$$$$Y$$$20240705$$CN$US$US
240671781$24067178$1$I$$20240627$20240709$20240709$EXP$$IN-ROCHE-10000014989$ROCHE$$72$YR$E$M$Y$$$20240705$$CN$IN$IN
240671791$24067179$1$I$20240530$20240626$20240709$20240709$EXP$$TW-ROCHE-10000000083$ROCHE$$53$YR$A$F$Y$51.5$KG$20240705$$CN$TW$TW
240671812$24067181$2$F$20240506$20240718$20240709$20240725$EXP$$IN-ROCHE-3551961$ROCHE$$64$YR$A$M$Y$62.1$KG$20240725$$CN$IN$IN
240671821$24067182$1$I$$20240701$20240709$20240709$PER$$US-ROCHE-10000018656$ROCHE$$$$A$M$Y$$$20240708$$CN$US$US
240671831$24067183$1$I$20191201$20240628$20240709$20240709$EXP$$US-ROCHE-10000015667$ROCHE$$69$YR$E$F$Y$86.18$KG$20240708$$CN$US$US
240671841$24067184$1$I$$20240701$20240709$20240709$PER$$US-ROCHE-10000017163$ROCHE$$$$T$M$Y$$$20240705$$CN$US$US
240671852$24067185$2$F$20240611$20240701$20240709$20240709$EXP$$US-ROCHE-10000018996$ROCHE$$58$YR$A$M$Y$$$20240708$$CN$US$US
240671862$24067186$2$F$20240611$20240627$20240709$20240712$PER$$US-ROCHE-10000015312$ROCHE$$$$C$$Y$$$20240712$$CN$US$US
240671871$24067187$1$I$$20240628$20240709$20240709$PER$$US-ROCHE-10000015884$ROCHE$$$$$$Y$$$20240705$$HP$US$US
240671881$24067188$1$I$$20240625$20240709$20240709$EXP$$GB-ROCHE-10000014514$ROCHE$$$$A$F$Y$$$20240705$$MD$GB$GB
240671892$24067189$2$F$$20240830$20240709$20240904$EXP$$US-ROCHE-10000013386$ROCHE$$$$$$Y$$$20240904$$CN$US$US
240671901$24067190$1$I$$20240704$20240709$20240709$EXP$$EC-ROCHE-10000018198$ROCHE$$$$$$Y$$$20240706$$HP$EC$EC
240671911$24067191$1$I$20240613$20240628$20240709$20240709$PER$$US-ROCHE-10000016203$ROCHE$$65$YR$E$F$Y$$$20240705$$CN$US$US
240671921$24067192$1$I$$20240624$20240709$20240709$PER$$US-ROCHE-10000010634$ROCHE$$$$$$Y$$$20240708$$CN$US$US
240671931$24067193$1$I$$20240628$20240709$20240709$EXP$$US-ROCHE-3559915$ROCHE$$54$YR$A$M$Y$$$20240705$$CN$US$US
240671941$24067194$1$I$20240612$20240626$20240709$20240709$PER$$US-ROCHE-10000014505$ROCHE$$$$$M$Y$$$20240708$$CN$US$US
240671961$24067196$1$I$$20240627$20240709$20240709$PER$$US-ROCHE-10000015400$ROCHE$$$$C$M$Y$$$20240705$$CN$US$US
240671971$24067197$1$I$$20240704$20240709$20240709$EXP$$EC-ROCHE-10000018136$ROCHE$$$$$$Y$$$20240708$$MD$EC$EC
240671981$24067198$1$I$$20240704$20240709$20240709$EXP$$EC-ROCHE-10000018196$ROCHE$$$$$$Y$$$20240708$$MD$EC$EC
240671991$24067199$1$I$20240419$20240625$20240709$20240709$EXP$$DE-ROCHE-10000018817$ROCHE$$32$YR$A$F$Y$$$20240708$$MD$DE$DE
240672001$24067200$1$I$$20240629$20240709$20240709$PER$$US-ROCHE-10000017144$ROCHE$$27$YR$A$F$Y$$$20240708$$CN$US$US
240672011$24067201$1$I$$20240626$20240709$20240709$PER$$US-ROCHE-10000013758$ROCHE$Papsun D.M, Chan-Hosokawal A, Lamb M.E, Logan B. Increasing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017 to 2021. Journal of Analytical Toxicology. 2023;47(8):668-679. DOI: https://doi.org/10.1093/jat/bkad036.$27$YR$A$M$Y$$$20240708$$HP$US$US
240672021$24067202$1$I$$20240628$20240709$20240709$PER$$US-ROCHE-10000015675$ROCHE$$$$$M$Y$$$20240708$$CN$US$US
240672031$24067203$1$I$$20240625$20240709$20240709$PER$$US-ROCHE-10000012497$ROCHE$$$$A$F$Y$$$20240708$$CN$US$US
240672041$24067204$1$I$20240101$20240701$20240709$20240709$PER$$IL-Eisai-EC-2024-169268$EISAI$$$$$F$Y$$$20240709$$HP$IL$IL
240672052$24067205$2$F$20230902$20240702$20240709$20240713$EXP$$US-ROCHE-10000015390$ROCHE$$$$$F$Y$$$20240713$$CN$US$US
240672082$24067208$2$F$20240101$20240911$20240709$20240919$EXP$$CN-ROCHE-10000013899$ROCHE$$20$MON$I$M$Y$12.2$KG$20240919$$MD$CN$CN
240672092$24067209$2$F$$20240814$20240709$20240823$PER$$US-ROCHE-10000018340$ROCHE$$$$A$F$Y$69.85$KG$20240823$$HP$US$US
240672101$24067210$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000019010$ROCHE$$27$YR$A$F$Y$$$20240709$$CN$US$US
240672121$24067212$1$I$20240627$20240705$20240709$20240709$EXP$$CN-ROCHE-10000019436$ROCHE$$56$YR$A$F$Y$55$KG$20240709$$HP$CN$CN
240672131$24067213$1$I$$20240701$20240709$20240709$EXP$$US-ROCHE-10000016869$ROCHE$$49$YR$A$F$Y$$$20240709$$CN$US$US
240672141$24067214$1$I$20240101$20240702$20240709$20240709$EXP$$JP-ROCHE-10000019558$ROCHE$$54$YR$A$F$Y$$$20240709$$PH$JP$JP
240672151$24067215$1$I$$20240628$20240709$20240709$EXP$$DE-ROCHE-10000018201$ROCHE$$46$YR$A$F$Y$$$20240709$$MD$DE$DE
240672165$24067216$5$F$$20240717$20240709$20240723$EXP$$CA-ROCHE-10000016601$ROCHE$$$$A$F$Y$$$20240723$$CN$CA$CA
240672181$24067218$1$I$$20240702$20240709$20240709$PER$$US-ROCHE-10000018685$ROCHE$$$$$F$Y$$$20240709$$MD$US$US
240672191$24067219$1$I$20240618$20240701$20240709$20240709$EXP$$CN-ROCHE-10000013869$ROCHE$$63$YR$A$F$Y$49$KG$20240709$$HP$CN$CN
240672201$24067220$1$I$20200101$20240625$20240709$20240709$EXP$$US-ROCHE-10000013096$ROCHE$$67$YR$E$F$Y$74.84$KG$20240709$$CN$US$US
240672211$24067221$1$I$$20240702$20240709$20240709$PER$$US-ROCHE-10000018671$ROCHE$$$$$F$Y$$$20240709$$MD$US$US
240672222$24067222$2$F$$20240914$20240709$20240923$EXP$$CN-ROCHE-10000008945$ROCHE$$73$YR$E$F$Y$$$20240923$$MD$CN$CN
240672231$24067223$1$I$$20240626$20240709$20240709$EXP$$CA-ROCHE-10000018404$ROCHE$$$$$$Y$$$20240709$$MD$CA$CA
240672242$24067224$2$F$20240617$20240726$20240709$20240802$PER$$US-ROCHE-10000011411$ROCHE$$20$YR$A$F$Y$92.98$KG$20240802$$CN$US$US
240672251$24067225$1$I$$20240701$20240709$20240709$EXP$$US-ROCHE-10000019048$ROCHE$$52$YR$A$M$Y$$$20240709$$CN$US$US
240672262$24067226$2$F$20240613$20240708$20240709$20240714$EXP$$BR-ROCHE-10000017011$ROCHE$$75$YR$E$M$Y$$$20240715$$CN$BR$BR
240672272$24067227$2$F$$20240703$20240709$20240711$PER$$US-ROCHE-10000020481$ROCHE$$$$A$M$Y$$$20240711$$MD$US$US
240672281$24067228$1$I$20170101$20240703$20240709$20240709$PER$$US-ROCHE-10000019998$ROCHE$$71$YR$E$M$Y$101.15$KG$20240709$$CN$US$US
240672292$24067229$2$F$20240504$20240719$20240709$20240727$EXP$$JP-ROCHE-3567584$ROCHE$$83$YR$E$M$Y$61.9$KG$20240727$$MD$JP$JP
240672302$24067230$2$F$20240624$20240807$20240709$20240809$PER$$US-ROCHE-10000015466$ROCHE$$$$$F$Y$$$20240809$$CN$US$US
240672311$24067231$1$I$20240210$20240628$20240709$20240709$EXP$$PK-ROCHE-10000014783$ROCHE$$33$YR$A$F$Y$$$20240709$$CN$PK$PK
240672321$24067232$1$I$20240616$20240705$20240709$20240709$EXP$$US-ROCHE-10000019954$ROCHE$$37$YR$A$F$Y$89.81$KG$20240709$$CN$US$US
240672331$24067233$1$I$20240624$20240626$20240709$20240709$EXP$$JP-ROCHE-10000013534$ROCHE$$7$DEC$E$F$Y$$$20240709$$MD$JP$JP
240672361$24067236$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000019962$ROCHE$$$$A$M$Y$$$20240709$$CN$US$US
240672371$24067237$1$I$20240702$20240702$20240709$20240709$PER$$US-ROCHE-10000018356$ROCHE$$6$YR$C$M$Y$$$20240709$$MD$US$US
240672382$24067238$2$F$20240301$20240808$20240709$20240816$EXP$$JP-ROCHE-10000013653$ROCHE$$75$YR$E$M$Y$65$KG$20240816$$MD$JP$JP
240672391$24067239$1$I$20240702$20240705$20240709$20240709$EXP$$CN-ROCHE-10000019094$ROCHE$$70$YR$E$M$Y$$$20240709$$CN$CN$CN
240672401$24067240$1$I$20240219$20240702$20240709$20240709$PER$$US-ROCHE-10000019272$ROCHE$$43$YR$A$F$Y$$$20240708$$CN$US$US
240672411$24067241$1$I$$20240627$20240709$20240709$EXP$$CA-ROCHE-10000019549$ROCHE$$56$YR$A$M$Y$$$20240709$$CN$CA$CA
240672421$24067242$1$I$$20240701$20240709$20240709$EXP$$US-ROCHE-10000013990$ROCHE$Yin X, Liu X R. The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFRmutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study.. Cancer Immunol Immunother. 2024;73 (7):$$$$$Y$$$20240708$$HP$US$US
240672431$24067243$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000019019$ROCHE$$$$$F$Y$$$20240709$$HP$US$US
240672441$24067244$1$I$$20240627$20240709$20240709$PER$$US-ROCHE-10000012080$ROCHE$$$$$$Y$$$20240709$$CN$US$US
240672451$24067245$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000020029$ROCHE$$$$$$Y$$$20240709$$CN$US$US
240672461$24067246$1$I$$20240626$20240709$20240709$PER$$US-ROCHE-10000017746$ROCHE$$45$YR$A$F$Y$$$20240709$$MD$US$US
240672491$24067249$1$I$$20240702$20240709$20240709$EXP$$US-ROCHE-10000017895$ROCHE$$$$$$Y$$$20240709$$CN$US$US
240672503$24067250$3$F$20240611$20240830$20240709$20240903$EXP$$CZ-ROCHE-10000018812$ROCHE$$45$YR$A$F$Y$55$KG$20240903$$MD$CZ$CZ
240672511$24067251$1$I$20240426$20240702$20240709$20240709$EXP$$JP-ROCHE-10000019526$ROCHE$$75$YR$E$M$Y$60$KG$20240709$$PH$JP$JP
240672531$24067253$1$I$20240625$20240702$20240709$20240709$EXP$$CN-ROCHE-10000014878$ROCHE$$61$YR$A$F$Y$70$KG$20240709$$HP$CN$CN
240672551$24067255$1$I$20240629$20240704$20240709$20240709$EXP$GB-MHRA-MED-202407040817297030-NCTYP$GB-ROCHE-10000017834$ROCHE$$52$YR$A$M$Y$70$KG$20240709$$PH$GB$GB
240672561$24067256$1$I$$20240701$20240709$20240709$EXP$$CN-ROCHE-10000013757$ROCHE$$$$$F$Y$$$20240709$$MD$CN$CN
240672572$24067257$2$F$$20240711$20240709$20240717$EXP$$CA-ROCHE-10000020547$ROCHE$$$$A$F$Y$$$20240717$$CN$CA$CA
240672601$24067260$1$I$20210101$20240626$20240709$20240709$EXP$$US-ROCHE-3112299$ROCHE$$86$YR$E$F$Y$63.05$KG$20240709$$CN$US$US
240672613$24067261$3$F$$20240731$20240709$20240807$EXP$$US-ROCHE-RCA5166915$ROCHE$$67$YR$E$F$Y$$$20240807$$CN$US$US
240672621$24067262$1$I$$20240626$20240709$20240709$EXP$$DE-ROCHE-10000015951$ROCHE$$70$YR$E$F$Y$$$20240709$$MD$DE$DE
240672631$24067263$1$I$$20240625$20240709$20240709$PER$$US-ROCHE-10000013062$ROCHE$$20$YR$A$F$Y$$$20240709$$CN$US$US
240672641$24067264$1$I$20231001$20240703$20240709$20240709$EXP$$US-ROCHE-10000018462$ROCHE$$47$YR$A$F$Y$81.64$KG$20240709$$CN$US$US
240672651$24067265$1$I$$20240626$20240709$20240709$EXP$$CA-ROCHE-10000018796$ROCHE$$$$A$F$Y$$$20240709$$CN$CA$CA
240672662$24067266$2$F$20240624$20240814$20240709$20240823$EXP$$DE-ROCHE-10000018335$ROCHE$$$$A$F$Y$$$20240823$$HP$DE$DE
240672671$24067267$1$I$$20240702$20240709$20240709$PER$$US-ROCHE-10000015434$ROCHE$$$$$F$Y$$$20240709$$HP$US$US
240672681$24067268$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000018480$ROCHE$$$$$$Y$$$20240709$$CN$US$US
240672691$24067269$1$I$20240624$20240701$20240709$20240709$PER$$PR-ROCHE-10000018746$ROCHE$$38$YR$A$M$Y$$$20240709$$CN$PR$PR
240672701$24067270$1$I$$20240703$20240709$20240709$PER$$US-ROCHE-10000018345$ROCHE$$44$YR$A$F$Y$$$20240709$$CN$US$US
240672713$24067271$3$F$20231201$20240806$20240709$20240808$EXP$$US-ROCHE-10000018337$ROCHE$$76$YR$E$F$Y$$$20240808$$CN$US$US
240672721$24067272$1$I$20200101$20240702$20240709$20240709$EXP$$US-ROCHE-10000019276$ROCHE$$45$YR$A$M$Y$97.52$KG$20240709$$CN$US$US
240672731$24067273$1$I$$20240708$20240709$20240709$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038709$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240709$$CN$CA$CA
240672741$24067274$1$I$20240601$20240703$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407002464$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240709$$CN$US$US
240672751$24067275$1$I$20240101$20240605$20240709$20240709$PER$$US-ROCHE-10000019755$ROCHE$$86$YR$E$F$Y$72.21$KG$20240708$$CN$US$US
240672761$24067276$1$I$20240528$20240701$20240709$20240709$EXP$FR-AFSSAPS-PB2024000700$FR-TEVA-VS-3216263$TEVA$$60$YR$$M$Y$$$20240709$$MD$FR$FR
240672771$24067277$1$I$$20240627$20240709$20240709$EXP$$US-B.Braun Medical Inc.-2158968$B BRAUN$Literature Article$45$YR$$F$Y$$$20240709$$$US$US
240672782$24067278$2$F$$20240809$20240709$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108063$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240816$$CN$US$US
240672792$24067279$2$F$20240628$20240724$20240709$20240729$EXP$$US-APELLIS-2024-APL-0000409$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
240672801$24067280$1$I$20240701$20240702$20240709$20240709$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-105942$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240709$$CN$PR$PR
240672811$24067281$1$I$$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107271$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240709$$PH$US$US
240672821$24067282$1$I$$20240709$20240709$20240709$PER$$NVSC2024US141891$NOVARTIS$$$$$$Y$$$20240709$$HP$US$US
240672831$24067283$1$I$$20240703$20240709$20240709$EXP$$US-INCYTE CORPORATION-2024IN007049$INCYTE$$$$$$Y$$$20240709$$CN$US$US
240672841$24067284$1$I$20220101$20240628$20240709$20240709$EXP$$SV-BIOGEN-2024BI01272924$BIOGEN$$$$$F$Y$59$KG$20240709$$CN$SV$SV
240672852$24067285$2$F$20240624$20240717$20240709$20240724$EXP$$US-APELLIS-2024-APL-0000400$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
240672861$24067286$1$I$20240301$20240401$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000148$AMARIN$$$$$M$Y$$$20240709$$CN$US$US
240672871$24067287$1$I$$20240418$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000150$AMARIN$$69$YR$E$F$Y$$$20240709$$CN$US$US
240672881$24067288$1$I$$20240402$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000151$AMARIN$$$$$M$Y$$$20240709$$CN$US$US
240672891$24067289$1$I$$20240401$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000149$AMARIN$$70$YR$E$M$Y$$$20240709$$CN$US$US
240672901$24067290$1$I$$20240403$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000155$AMARIN$$$$$M$Y$$$20240709$$CN$US$US
240672911$24067291$1$I$$20240402$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000152$AMARIN$$51$YR$A$F$Y$$$20240709$$CN$US$US
240672921$24067292$1$I$20240301$20240502$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000163$AMARIN$$82$YR$E$M$Y$$$20240709$$CN$US$US
240672931$24067293$1$I$20240301$20240418$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000158$AMARIN$$58$YR$A$M$Y$$$20240709$$CN$US$US
240672941$24067294$1$I$20240101$20240403$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000156$AMARIN$$$$$$Y$$$20240709$$CN$US$US
240672951$24067295$1$I$$20240405$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000159$AMARIN$$$$$$Y$$$20240709$$CN$US$US
240672961$24067296$1$I$20240301$20240408$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000161$AMARIN$$62$YR$A$M$Y$$$20240709$$CN$US$US
240672971$24067297$1$I$$20240409$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000173$AMARIN$$$$$$Y$$$20240709$$PH$US$US
240672981$24067298$1$I$20240401$20240415$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000176$AMARIN$$61$YR$A$M$Y$$$20240709$$PH$US$US
240672991$24067299$1$I$$20240412$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000174$AMARIN$$$$$M$Y$$$20240709$$CN$US$US
240673001$24067300$1$I$$20240502$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000162$AMARIN$$51$YR$A$M$Y$$$20240529$$CN$US$US
240673011$24067301$1$I$20240101$20240513$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000182$AMARIN$$50$YR$A$F$Y$$$20240709$$CN$US$US
240673021$24067302$1$I$20240401$20240411$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000171$AMARIN$$73$YR$E$M$Y$$$20240709$$CN$US$US
240673031$24067303$1$I$20240401$20240502$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000167$AMARIN$$65$YR$E$F$Y$$$20240709$$PH$US$US
240673041$24067304$1$I$20240401$20240502$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000184$AMARIN$$71$YR$E$M$Y$$$20240709$$CN$US$US
240673051$24067305$1$I$$20240421$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000191$AMARIN$$$$$M$Y$$$20240709$$CN$US$US
240673061$24067306$1$I$20240401$20240513$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000194$AMARIN$$68$YR$E$M$Y$$$20240709$$CN$US$US
240673071$24067307$1$I$$20240422$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000193$AMARIN$$$$$M$Y$$$20240709$$CN$US$US
240673081$24067308$1$I$$20240416$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000183$AMARIN$$$$$M$Y$$$20240709$$CN$US$US
240673091$24067309$1$I$$20240429$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000199$AMARIN$$$$$M$Y$$$20240709$$CN$US$US
240673101$24067310$1$I$$20240425$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000196$AMARIN$$75$YR$E$M$Y$$$20240709$$CN$US$US
240673111$24067311$1$I$20240501$20240613$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000204$AMARIN$$76$YR$E$M$Y$$$20240709$$CN$US$US
240673121$24067312$1$I$$20240510$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000220$AMARIN$$46$YR$A$M$Y$$$20240709$$CN$US$US
240673131$24067313$1$I$$20240509$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000217$AMARIN$$61$YR$A$F$Y$$$20240709$$CN$US$US
240673141$24067314$1$I$$20240614$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000206$AMARIN$$63$YR$A$F$Y$$$20240709$$CN$US$US
240673151$24067315$1$I$20240501$20240511$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000224$AMARIN$$82$YR$E$F$Y$$$20240709$$CN$US$US
240673161$24067316$1$I$$20240508$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000214$AMARIN$$59$YR$A$M$Y$$$20240709$$CN$US$US
240673171$24067317$1$I$20240101$20240509$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000219$AMARIN$$66$YR$E$M$Y$$$20240709$$CN$US$US
240673181$24067318$1$I$20240201$20240521$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000237$AMARIN$$68$YR$E$F$Y$$$20240709$$CN$US$US
240673191$24067319$1$I$20240101$20240515$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000231$AMARIN$$84$YR$E$M$Y$$$20240709$$CN$US$US
240673201$24067320$1$I$20240101$20240516$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000232$AMARIN$$57$YR$A$M$Y$$$20240709$$CN$US$US
240673211$24067321$1$I$$20240520$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000236$AMARIN$$$$$M$Y$$$20240709$$CN$US$US
240673221$24067322$1$I$$20240517$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000235$AMARIN$$64$YR$A$F$Y$$$20240709$$CN$US$US
240673231$24067323$1$I$20240101$20240514$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000226$AMARIN$$62$YR$A$F$Y$$$20240709$$MD$US$US
240673241$24067324$1$I$20240501$20240522$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000239$AMARIN$$38$YR$A$M$Y$$$20240709$$CN$US$US
240673251$24067325$1$I$$20240520$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000243$AMARIN$$71$YR$E$M$Y$$$20240709$$CN$US$US
240673261$24067326$1$I$$20240520$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000244$AMARIN$$69$YR$E$F$Y$$$20240709$$CN$US$US
240673271$24067327$1$I$$20240524$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000248$AMARIN$$48$YR$A$F$Y$$$20240709$$CN$US$US
240673281$24067328$1$I$20240501$20240521$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000238$AMARIN$$63$YR$A$F$Y$$$20240709$$CN$US$US
240673292$24067329$2$F$$20240725$20240709$20240730$PER$$US-TAKEDA-2024TUS069463$TAKEDA$$$$A$F$Y$$$20240730$$CN$US$US
240673301$24067330$1$I$$20240528$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000260$AMARIN$$$$$$Y$$$20240709$$HP$US$US
240673311$24067331$1$I$$20240528$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000253$AMARIN$$56$YR$A$M$Y$$$20240709$$CN$US$US
240673321$24067332$1$I$20240501$20240603$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000287$AMARIN$$57$YR$A$M$Y$$$20240709$$CN$US$US
240673331$24067333$1$I$$20240531$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000279$AMARIN$$$$$$Y$$$20240709$$PH$US$US
240673341$24067334$1$I$$20240606$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000298$AMARIN$$50$YR$A$M$Y$$$20240709$$CN$US$US
240673351$24067335$1$I$$20240604$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000297$AMARIN$$74$YR$E$M$Y$$$20240709$$CN$US$US
240673361$24067336$1$I$$20240611$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000305$AMARIN$$67$YR$E$M$Y$$$20240709$$CN$US$US
240673371$24067337$1$I$20240101$20240613$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000307$AMARIN$$79$YR$E$M$Y$$$20240709$$CN$US$US
240673381$24067338$1$I$$20240611$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000304$AMARIN$$82$YR$E$M$Y$$$20240709$$CN$US$US
240673391$24067339$1$I$20240501$20240614$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000309$AMARIN$$82$YR$E$M$Y$$$20240709$$PH$US$US
240673401$24067340$1$I$$20240625$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000321$AMARIN$$69$YR$E$M$Y$$$20240709$$CN$US$US
240673411$24067341$1$I$$20240614$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000308$AMARIN$$71$YR$E$F$Y$$$20240709$$CN$US$US
240673421$24067342$1$I$20240601$20240628$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000327$AMARIN$$$$$F$Y$$$20240709$$CN$US$US
240673431$24067343$1$I$$20240630$20240709$20240709$PER$$US-JNJFOC-20240704368$JOHNSON AND JOHNSON$$$$$M$Y$$$20240709$$CN$US$US
240673441$24067344$1$I$$20240619$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000316$AMARIN$$60$YR$A$M$Y$$$20240709$$CN$US$US
240673451$24067345$1$I$20240627$20240627$20240709$20240709$PER$$US-APELLIS-2024-APL-0000401$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240709$$CN$US$US
240673461$24067346$1$I$20120101$20240630$20240709$20240709$EXP$$US-Amarin Pharma, Inc-2024AMR000328$AMARIN$$$$$F$Y$$$20240709$$CN$US$US
240673471$24067347$1$I$$20240622$20240709$20240709$EXP$$CA-GILEAD-2023-0616943$GILEAD$$48$YR$A$F$Y$$$20240709$$MD$CA$CA
240673482$24067348$2$F$20230106$20240708$20240709$20240712$EXP$ES-AEMPS-1542780$ES-GILEAD-2024-0679892$GILEAD$$64$YR$A$M$Y$$$20240712$$PH$ES$ES
240673491$24067349$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141864$NOVARTIS$$$$$M$Y$$$20240709$$HP$US$US
240673501$24067350$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108807$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240709$$CN$US$US
240673511$24067351$1$I$20240705$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024134823$AMGEN$$$$$$Y$$$20240709$$PH$US$US
240673521$24067352$1$I$$20240627$20240709$20240709$EXP$$US-B.Braun Medical Inc.-2158969$B BRAUN$Literature Article$64$YR$$F$Y$$$20240709$$$US$US
240673531$24067353$1$I$20211001$20240626$20240709$20240709$PER$$US-009507513-2406USA009358$MERCK$Lim Oa, Maher E, Miller DD. PD?1 Inhibitor Induced Hypertrophic Lichen Planus: A Case Report. Drugs in R and D. 2024$64$YR$$M$Y$$$20240709$$HP$US$US
240673542$24067354$2$F$20240620$20240705$20240709$20240820$PER$$US-LUNDBECK-DKLU4001320$LUNDBECK$$$$$$Y$$$20240820$$CN$US$US
240673551$24067355$1$I$$20240701$20240709$20240709$EXP$$FR-AstraZeneca-2024A156007$ASTRAZENECA$$$$$F$Y$62$KG$20240709$$HP$FR$
240673562$24067356$2$F$$20240724$20240709$20240730$EXP$$FR-LUNDBECK-DKLU4001212$LUNDBECK$$$$$$Y$$$20240730$$PH$FR$FR
240673572$24067357$2$F$20240306$20240723$20240709$20240725$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-108618$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$MD$DE$DE
240673583$24067358$3$F$20240401$20240729$20240709$20240806$EXP$$CA-LUNDBECK-DKLU3077453$LUNDBECK$$$$$$Y$$$20240806$$CN$CA$CA
240673591$24067359$1$I$20240527$20240626$20240709$20240709$EXP$$CA-BEH-2024173139$CSL BEHRING$$87$YR$E$F$Y$72$KG$20240709$$CN$CA$CA
240673601$24067360$1$I$$20240704$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004020$ELI LILLY AND CO$$$$$$Y$$$20240709$$CN$US$US
240673611$24067361$1$I$$20240708$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004864$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240709$$CN$US$US
240673631$24067363$1$I$$20240703$20240709$20240709$PER$$US-JNJFOC-20240709480$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20240709$$CN$US$US
240673641$24067364$1$I$$20240703$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108115$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240709$$CN$US$US
240673653$24067365$3$F$20240805$20240820$20240709$20240822$PER$$NVSC2024US141909$NOVARTIS$$72$YR$$F$Y$$$20240822$$HP$US$US
240673682$24067368$2$F$20240708$20240708$20240709$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407004743$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240711$$CN$US$US
240673691$24067369$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134512$AMGEN$$$$$M$Y$$$20240709$$HP$US$US
240673711$24067371$1$I$20230323$20240708$20240709$20240709$EXP$ES-AEMPS-1542767$ES-GILEAD-2024-0679895$GILEAD$$62$YR$A$M$Y$$$20240709$$PH$ES$ES
240673721$24067372$1$I$20240109$20240708$20240709$20240709$EXP$ES-AEMPS-1542775$ES-GILEAD-2024-0679898$GILEAD$$53$YR$A$M$Y$$$20240709$$PH$ES$ES
240673731$24067373$1$I$20240619$20240709$20240709$20240709$EXP$FR-AFSSAPS-GR2024000866$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-108859$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$72$KG$20240709$$PH$FR$FR
240673741$24067374$1$I$20221227$20240625$20240709$20240709$EXP$$ES-VER-202400005$VERITY PHARMACEUTICALS$$75$YR$E$M$Y$$$20240709$$HP$ES$ES
240673751$24067375$1$I$$20240624$20240709$20240709$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06381$NEUROCRINE BIOSCIENCES$$64$YR$$M$Y$$$20240709$$HP$US$US
240673761$24067376$1$I$$20240624$20240709$20240709$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06382$NEUROCRINE BIOSCIENCES$$60$YR$$M$Y$$$20240709$$MD$US$US
240673771$24067377$1$I$$20240627$20240709$20240709$EXP$$US-B.Braun Medical Inc.-2158970$B BRAUN$Literature Article$40$YR$$M$Y$$$20240709$$$US$US
240673781$24067378$1$I$$20240624$20240709$20240709$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06447$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240709$$MD$US$US
240673791$24067379$1$I$$20240625$20240709$20240709$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06431$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240709$$HP$US$US
240673801$24067380$1$I$$20240703$20240709$20240709$PER$$US-BIOMARINAP-US-2024-158977$BIOMARIN$$$$$$Y$$$20240709$$CN$US$US
240673811$24067381$1$I$20240625$20240703$20240709$20240709$PER$$US-BIOMARINAP-US-2024-158979$BIOMARIN$$$$$$Y$$$20240709$$CN$US$US
240673821$24067382$1$I$$20240702$20240709$20240709$PER$$US-JNJFOC-20240711250$JOHNSON AND JOHNSON$$$$$$Y$$$20240709$$CN$US$US
240673831$24067383$1$I$20200301$20240702$20240709$20240709$EXP$$DE-EMD Serono-2024036507$EMD SERONO INC$$23$YR$A$F$Y$$$20240709$$CN$DE$DE
240673841$24067384$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407003939$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240709$$CN$US$US
240673851$24067385$1$I$20240604$20240702$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004745$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240709$$CN$US$US
240673861$24067386$1$I$20230201$20240701$20240709$20240709$EXP$$JP-009507513-2302JPN001342J$MERCK$$73$YR$$M$Y$46$KG$20240709$$MD$JP$JP
240673871$24067387$1$I$20240629$20240709$20240709$20240709$EXP$IT-MINISAL02-993295$IT-JNJFOC-20240721934$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240709$$MD$IT$IT
240673881$24067388$1$I$20240101$20240703$20240709$20240709$PER$$US-AMGEN-USASP2024132432$AMGEN$$$$A$F$Y$$$20240709$$MD$US$US
240673892$24067389$2$F$$20240808$20240709$20240808$PER$$US-ALXN-202407USA000178US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
240673901$24067390$1$I$$20240701$20240709$20240709$EXP$$VN-AstraZeneca-2024A155290$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$VN$
240673911$24067391$1$I$20240531$20240709$20240709$20240709$EXP$FR-AFSSAPS-PB2024000747$FR-JNJFOC-20240721564$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20240709$$PH$FR$FR
240673931$24067393$1$I$$20240627$20240709$20240709$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06563$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240710$$HP$US$US
240673941$24067394$1$I$20240211$20240708$20240709$20240709$EXP$SE-SEMPA-2024-003731$SE-JNJFOC-20240722220$JOHNSON AND JOHNSON$$48$YR$A$F$Y$65$KG$20240710$$CN$SE$SE
240673951$24067395$1$I$20240101$20240627$20240709$20240709$EXP$$US-BAYER-2024A094500$BAYER$$61$YR$A$M$Y$$$20240709$$PH$US$US
240673961$24067396$1$I$20240601$20240614$20240709$20240709$PER$$US-009507513-2406USA005487$MERCK$$64$YR$$F$Y$51.247$KG$20240709$$CN$US$US
240673973$24067397$3$F$$20240730$20240709$20240808$30DAY$$CH-JNJFOC-20240660457$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$HP$CH$CH
240673981$24067398$1$I$$20240702$20240709$20240709$EXP$$AU-JNJFOC-20240721163$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240710$$PH$AU$AU
240673991$24067399$1$I$$20240704$20240709$20240709$EXP$$DE-SANDOZ INC.-SDZ2024DE063472$SANDOZ$$$$$$Y$$$20240709$$HP$DE$DE
240674002$24067400$2$F$$20240722$20240709$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107316$BRISTOL MYERS SQUIBB$$72$YR$E$$Y$$$20240730$$PH$JP$JP
240674011$24067401$1$I$20240703$20240705$20240709$20240709$30DAY$$US-SANDOZ INC.-SDZ2024US063656$SANDOZ$$70$YR$$F$Y$$$20240709$$CN$US$US
240674021$24067402$1$I$$20240705$20240709$20240709$EXP$$NVSJ2024JP008215$NOVARTIS$$$$$$Y$$$20240710$$MD$JP$JP
240674032$24067403$2$F$$20240715$20240709$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108508$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240719$$CN$US$US
240674042$24067404$2$F$$20240606$20240709$20240724$EXP$$US-BAYER-2024A098103$BAYER$$71$YR$E$M$Y$$$20240724$$CN$US$US
240674051$24067405$1$I$$20240701$20240709$20240709$EXP$$CA-BAYER-2024A096046$BAYER$$10$YR$C$M$Y$32$KG$20240709$$HP$CA$CA
240674061$24067406$1$I$$20240708$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108589$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240710$$HP$US$US
240674074$24067407$4$F$$20240813$20240709$20240819$EXP$$US-SANDOZ INC.-SDZ2024US061244$SANDOZ$$$$$F$Y$$$20240819$$CN$US$US
240674081$24067408$1$I$$20240702$20240709$20240709$EXP$$CA-JNJFOC-20240714809$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240710$$MD$CA$CA
240674091$24067409$1$I$$20240626$20240709$20240709$PER$$US-JNJFOC-20240671357$JOHNSON AND JOHNSON$$9$YR$C$$Y$$$20240710$$HP$US$US
240674101$24067410$1$I$20230821$20230914$20240709$20240709$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202309008159$ELI LILLY AND CO$$70$YR$E$M$Y$65$KG$20240709$$PH$FR$FR
240674111$24067411$1$I$$20240705$20240709$20240709$PER$$US-ELI_LILLY_AND_COMPANY-US202407004356$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240709$$CN$US$US
240674121$24067412$1$I$20231109$20240705$20240709$20240709$EXP$$US-JNJFOC-20240716507$JOHNSON AND JOHNSON$$86$YR$E$M$Y$86.91$KG$20240710$$HP$US$US
240674131$24067413$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141883$NOVARTIS$$$$$$Y$$$20240710$$HP$US$US
240674142$24067414$2$F$$20240904$20240709$20240911$EXP$$GB-AMGEN-GBRSP2024133748$AMGEN$$84$YR$E$M$Y$$$20240911$$CN$GB$GB
240674152$24067415$2$F$20240322$20240709$20240709$20240717$EXP$IS-IMA-8687$IS-JNJFOC-20240721986$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240717$$PH$IS$IS
240674161$24067416$1$I$20240611$20240701$20240709$20240709$EXP$$AR-JNJFOC-20240708243$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240710$$CN$AR$AR
240674173$24067417$3$F$20240701$20240718$20240709$20240721$30DAY$$US-SANDOZ INC.-SDZ2024US063762$SANDOZ$$62$YR$$F$Y$$$20240721$$HP$US$US
240674181$24067418$1$I$$20240709$20240709$20240709$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038755$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240710$$CN$US$US
240674191$24067419$1$I$20240614$20240703$20240709$20240709$EXP$$US-JNJFOC-20240710910$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240710$$$US$US
240674201$24067420$1$I$$20240701$20240709$20240709$EXP$$NVSC2024IN138615$NOVARTIS$Khan MF, Siddini V, Ballal S, Mathur A.. Posttransplant thrombotic microangiopathy: unraveling a mystery. INDIAN JOURNAL OF TRANSPLANTATION. 2023;18(1):78-80$24$YR$$F$Y$$$20240709$$HP$IN$IN
240674211$24067421$1$I$20240601$20240706$20240709$20240709$EXP$$JP-ABBVIE-5831218$ABBVIE$$30$YR$$F$Y$64$KG$20240709$$MD$JP$JP
240674222$24067422$2$F$$20240802$20240709$20240806$EXP$$US-BIOGEN-2024BI01271435$BIOGEN$$$$$F$Y$$$20240806$$HP$US$US
240674232$24067423$2$F$$20240710$20240709$20240716$EXP$$US-ROCHE-3537177$ROCHE$$$$E$F$Y$$$20240716$$MD$US$US
240674241$24067424$1$I$20240531$20240708$20240709$20240709$EXP$$US-ABBVIE-5831822$ABBVIE$$95$YR$$M$Y$$$20240709$$HP$US$US
240674251$24067425$1$I$20200701$20230301$20240709$20240709$EXP$$JP-TAKEDA-SH202108550$TAKEDA$Two cases of guanfacine overdose. The 126th Meeting of Japanese Society of Pediatric Psychiatry and Neurology. 2021;52$10$YR$$M$Y$28$KG$20240709$$$COUNTRY NOT SPECIFIED$JP
240674261$24067426$1$I$$20240705$20240709$20240709$EXP$$GB-ABBVIE-5832030$ABBVIE$$$$E$M$Y$$$20240709$$CN$GB$GB
240674271$24067427$1$I$$20240709$20240709$20240709$EXP$$US-SANDOZ INC.-SDZ2024US063875$SANDOZ$$$$$F$Y$$$20240709$$CN$US$US
240674301$24067430$1$I$20240501$20240702$20240709$20240709$EXP$$DE-PFIZER INC-202400209231$PFIZER$$64$YR$$F$Y$$$20240709$$PH$DE$DE
240674313$24067431$3$F$$20240829$20240709$20240829$EXP$$US-PFIZER INC-2021SGN00167$PFIZER$$35$YR$$M$Y$$$20240829$$MD$US$US
240674321$24067432$1$I$20230101$20240703$20240709$20240709$EXP$$BR-PFIZER INC-PV202400089224$PFIZER$$41$YR$$F$Y$$$20240709$$CN$BR$BR
240674331$24067433$1$I$$20240703$20240709$20240709$EXP$$US-PFIZER INC-2024SGN04478$PFIZER$$54$YR$$F$Y$$$20240709$$CN$US$US
240674341$24067434$1$I$$20240705$20240709$20240709$EXP$$ZA-ABBVIE-5831338$ABBVIE$$$$A$M$Y$$$20240709$$MD$ZA$ZA
240674351$24067435$1$I$$20240702$20240709$20240709$EXP$$US-ABBVIE-5826209$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240674371$24067437$1$I$$20240702$20240709$20240709$PER$$US-BAUSCHBL-2024BNL029534$BAUSCH AND LOMB$$$$$M$Y$$$20240710$$CN$US$US
240674381$24067438$1$I$$20240708$20240709$20240709$EXP$$CA-ABBVIE-5831940$ABBVIE$$$$E$M$Y$$$20240709$$CN$CA$CA
240674391$24067439$1$I$$20240708$20240709$20240709$EXP$$US-ABBVIE-5832006$ABBVIE$$$$$F$Y$$$20240709$$CN$US$US
240674403$24067440$3$F$20240629$20240730$20240709$20240731$EXP$$NVSJ2024JP008205$NOVARTIS$$$$A$M$Y$$$20240801$$HP$JP$JP
240674413$24067441$3$F$$20240809$20240709$20240816$30DAY$$CH-JNJFOC-20240666624$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$HP$CH$CH
240674421$24067442$1$I$20220101$20240701$20240709$20240709$EXP$$US-JNJFOC-20240703758$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240710$$CN$US$US
240674431$24067443$1$I$$20240705$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108888$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240710$$CN$US$US
240674441$24067444$1$I$$20240520$20240709$20240709$PER$$US-JNJFOC-20240559026$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240674452$24067445$2$F$20240101$20240708$20240709$20240713$EXP$$CA-ABBVIE-5831490$ABBVIE$$$$A$F$Y$$$20240713$$CN$CA$CA
240674461$24067446$1$I$20240101$20240703$20240709$20240709$EXP$$US-BAUSCHBL-2024BNL029691$BAUSCH AND LOMB$$78$YR$$F$Y$$$20240710$$CN$US$US
240674481$24067448$1$I$20230101$20240627$20240709$20240709$EXP$$NL-ABBVIE-5434514$ABBVIE$$$$$F$Y$$$20240709$$CN$NL$NL
240674491$24067449$1$I$$20240626$20240709$20240709$EXP$$CH-ABBVIE-5831229$ABBVIE$Gutzwiller A, Kammerlander L, Schmid K, Becker B. Unusual cause of gastric retention. 2024.$74$YR$$M$Y$$$20240709$$MD$CH$CH
240674504$24067450$4$F$20240101$20240813$20240709$20240819$EXP$$CN-ABBVIE-5831716$ABBVIE$$29$YR$$F$Y$$$20240819$$HP$CN$CN
240674511$24067451$1$I$20240101$20240704$20240709$20240709$EXP$$CA-ABBVIE-5830191$ABBVIE$$20$YR$$F$Y$$$20240709$$CN$CA$CA
240674521$24067452$1$I$20240101$20240705$20240709$20240709$EXP$$CA-ABBVIE-5831118$ABBVIE$$$$A$M$Y$$$20240709$$MD$CA$CA
240674531$24067453$1$I$$20240703$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107088$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$CN$US$US
240674551$24067455$1$I$$20240701$20240709$20240709$PER$$US-JNJFOC-20240702840$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$PH$US$US
240674563$24067456$3$F$20240601$20240717$20240709$20240722$PER$$US-AMGEN-USASP2024134250$AMGEN$$62$YR$A$F$Y$$$20240722$$CN$US$US
240674571$24067457$1$I$$20240702$20240709$20240709$PER$$US-BAUSCHBL-2024BNL029518$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240710$$CN$US$US
240674581$24067458$1$I$20220101$20240702$20240709$20240709$EXP$$BR-ABBVIE-5826002$ABBVIE$$$$$F$Y$84$KG$20240709$$CN$BR$BR
240674591$24067459$1$I$20240601$20240628$20240709$20240709$PER$$US-BAUSCHBL-2024BNL029472$BAUSCH AND LOMB$$79$YR$$F$Y$$$20240710$$CN$US$US
240674602$24067460$2$F$$20240709$20240709$20240711$EXP$$NVSC2024US141834$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240674611$24067461$1$I$20240401$20240705$20240709$20240709$PER$$US-BAUSCHBL-2024BNL029741$BAUSCH AND LOMB$$47$YR$$F$Y$58.05$KG$20240710$$CN$US$US
240674621$24067462$1$I$$20240702$20240709$20240709$PER$$US-BAUSCHBL-2024BNL029544$BAUSCH AND LOMB$$84$YR$$M$Y$$$20240710$$CN$US$US
240674631$24067463$1$I$$20240708$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108949$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240710$$CN$US$US
240674643$24067464$3$F$$20240715$20240709$20240719$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407005762$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240719$$CN$FR$FR
240674654$24067465$4$F$$20240719$20240709$20240723$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407005776$ELI LILLY AND CO$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N, Pelletier R, Knappa A and al...A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA)..Toxicologie Analytique + Clinique 2023;35:376-394.DOI:10.1016/j.toxac.2023.09.008$44$YR$A$M$Y$$$20240723$$HP$FR$FR
240674664$24067466$4$F$$20240719$20240709$20240723$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407005771$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240723$$CN$FR$FR
240674673$24067467$3$F$$20240715$20240709$20240719$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407005781$ELI LILLY AND CO$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N, Pelletier R, Knappa A and al..A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA)..Toxicologie Analytique + Clinique. 2023;35:376-394.DOI:10.1016/j.toxac.2023.09.008$35$YR$A$M$Y$$$20240719$$CN$FR$FR
240674681$24067468$1$I$20240101$20240708$20240709$20240709$PER$$US-JNJFOC-20240720301$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$MD$US$US
240674691$24067469$1$I$20240621$20240702$20240709$20240709$EXP$$CN-BEIGENE-BGN-2024-010264$BEIGENE$$$$$$Y$$$20240709$$HP$CN$CN
240674701$24067470$1$I$$20240625$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102264$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240710$$CN$US$US
240674712$24067471$2$F$20240801$20240905$20240709$20240911$EXP$$GB-ABBVIE-5832045$ABBVIE$$47$YR$$F$Y$$$20240911$$CN$GB$GB
240674722$24067472$2$F$20240620$20240712$20240709$20240722$EXP$$US-IOVANCE BIOTHERAPEUTICS, INC-2024IOV000037$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240722$$MD$US$US
240674731$24067473$1$I$20240101$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134473$AMGEN$$81$YR$E$F$Y$$$20240709$$CN$US$US
240674741$24067474$1$I$$20240708$20240709$20240709$EXP$$US-ABBVIE-5832005$ABBVIE$$$$$F$Y$$$20240709$$HP$US$US
240674751$24067475$1$I$$20240709$20240709$20240709$EXP$$NVSC2024US141838$NOVARTIS$$$$$$Y$$$20240710$$HP$US$US
240674763$24067476$3$F$20240627$20240814$20240709$20240816$PER$$US-JNJFOC-20240701319$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240816$$HP$US$US
240674774$24067477$4$F$20240101$20240923$20240709$20240930$EXP$$AR-JNJFOC-20240705559$JOHNSON AND JOHNSON$$75$YR$E$F$Y$74$KG$20240930$$CN$AR$AR
240674781$24067478$1$I$$20240708$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108940$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240710$$CN$US$US
240674791$24067479$1$I$$20240701$20240709$20240709$PER$$US-AMGEN-USASP2024131165$AMGEN$$$$$$Y$$$20240709$$CN$US$US
240674803$24067480$3$F$20240619$20240718$20240709$20240725$30DAY$$US-AMGEN-USASP2024122904$AMGEN$$58$YR$A$M$Y$85.261$KG$20240724$$HP$US$US
240674811$24067481$1$I$20230101$20240705$20240709$20240709$EXP$$US-BIOGEN-2024BI01272854$BIOGEN$$$$$F$Y$$$20240709$$CN$US$US
240674821$24067482$1$I$20230801$20240708$20240709$20240709$EXP$$US-BIOGEN-2024BI01272880$BIOGEN$$57$YR$$F$Y$$$20240709$$MD$US$US
240674831$24067483$1$I$20240702$20240705$20240709$20240709$EXP$$US-BIOGEN-2024BI01272700$BIOGEN$$54$YR$$$Y$$$20240709$$CN$US$US
240674841$24067484$1$I$$20240705$20240709$20240709$PER$$US-AMGEN-USASP2024134771$AMGEN$$$$$$Y$$$20240709$$HP$US$US
240674851$24067485$1$I$$20240709$20240709$20240709$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108941$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240710$$CN$US$US
240674861$24067486$1$I$20240601$20240709$20240709$20240709$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108966$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240710$$CN$US$US
240674872$24067487$2$F$20240101$20240730$20240709$20240806$EXP$$US-ABBVIE-5827364$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
240674882$24067488$2$F$$20240914$20240709$20240915$PER$$US-ALXN-202407USA000298US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
240674892$24067489$2$F$$20240702$20240709$20240711$EXP$$JP-ABBVIE-5785716$ABBVIE$Manabe M, Hagiwara Y, Nanno S, Koh K, Inano N. Anisolymphocytosis: A clue for Richter transformation. Clin Case Rep. 2024;12(5):e8639.$70$YR$$F$Y$$$20240711$$HP$JP$JP
240674902$24067490$2$F$$20240731$20240709$20240806$EXP$$CA-ABBVIE-5830986$ABBVIE$$$$A$F$Y$$$20240806$$CN$CA$CA
240674911$24067491$1$I$$20240703$20240709$20240709$EXP$$US-ABBVIE-5831095$ABBVIE$$$$$M$Y$$$20240709$$CN$US$US
240674922$24067492$2$F$$20240807$20240709$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108987$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240813$$CN$US$US
240674931$24067493$1$I$20240601$20240704$20240709$20240709$EXP$$JP-AMGEN-JPNSP2024134461$AMGEN$$8$DEC$E$$Y$$$20240709$$MD$JP$JP
240674941$24067494$1$I$20240601$20240702$20240709$20240709$EXP$$US-JNJFOC-20240707299$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240710$$CN$US$US
240674952$24067495$2$F$20240627$20240726$20240709$20240727$PER$$US-JNJFOC-20240704806$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240727$$HP$US$US
240674962$24067496$2$F$$20240806$20240709$20240807$PER$$US-ALXN-A202206878$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240807$$CN$US$US
240674981$24067498$1$I$20240629$20240701$20240709$20240709$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010420$JAZZ$$84$YR$$F$Y$$$20240709$$MD$JP$JP
240674992$24067499$2$F$$20240703$20240709$20240716$EXP$$NVSC2024IN140191$NOVARTIS$$$$$M$Y$$$20240716$$CN$IN$IN
240675001$24067500$1$I$$20240708$20240709$20240709$PER$$NVSC2024US141910$NOVARTIS$$$$$F$Y$$$20240710$$HP$US$US
240675011$24067501$1$I$$20240620$20240709$20240709$PER$$US-JNJFOC-20240657548$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240675021$24067502$1$I$$20240709$20240709$20240709$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038759$BOEHRINGER INGELHEIM$$$$$$Y$$$20240710$$CN$US$US
240675032$24067503$2$F$$20240805$20240709$20240806$PER$$US-AstraZeneca-2024A140213$ASTRAZENECA$$$$E$F$Y$$$20240806$$CN$US$
240675043$24067504$3$F$20240601$20240924$20240709$20240928$EXP$$US-ABBVIE-5831078$ABBVIE$$63$YR$$M$Y$$$20240928$$CN$US$US
240675051$24067505$1$I$$20240704$20240709$20240709$EXP$$US-OrBion Pharmaceuticals Private Limited-2158971$ORBION PHARMACEUTICALS$Habib A, Butt K, Ibrahim R, Shaaban A, Lee HS. BRASH syndrome: A rare but reversible cause of sinus node dysfunction. Heart Rhythm Case Rep 2024 Jun;10(6):398-401. doi: 10.1016/j.hrcr.2024.03.005.$57$YR$$F$Y$$$20240709$$MD$US$US
240675062$24067506$2$F$20240622$20240716$20240709$20240724$EXP$$US-ABBVIE-5826560$ABBVIE$$$$A$F$Y$$$20240724$$HP$US$US
240675071$24067507$1$I$20240620$20240708$20240709$20240709$PER$$US-AMGEN-USASP2024135359$AMGEN$$65$YR$E$F$Y$$$20240709$$CN$US$US
240675082$24067508$2$F$$20240816$20240709$20240819$PER$$US-ALXN-202407USA000257US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
240675091$24067509$1$I$$20240629$20240709$20240709$EXP$$US-BIOGEN-2024BI01271896$BIOGEN$$$$$F$Y$$$20240709$$HP$US$US
240675101$24067510$1$I$20240601$20240629$20240709$20240709$EXP$$US-BIOGEN-2024BI01272222$BIOGEN$$37$YR$$F$Y$$$20240709$$CN$US$US
240675111$24067511$1$I$$20240704$20240709$20240709$EXP$$US-OrBion Pharmaceuticals Private Limited-2158972$ORBION PHARMACEUTICALS$Almazan EP, Ellaicy O, Carter DJ, Kaleka K, Faruqi M. Another Case of the Blues, Methylene Blue as Adjunctive Therapy in Calcium-channel Blocker Induced Vasoplegia. Am J Respir Crit Care Med 2024; 209:A5655. - [abstract]$65$YR$$F$Y$$$20240709$$MD$US$US
240675121$24067512$1$I$20240507$20240705$20240709$20240709$EXP$GB-MHRA-MED-202405101128256510-DTVFB$GB-GSK-GB2024083519$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$HP$GB$GB
240675131$24067513$1$I$$20240705$20240709$20240709$EXP$$DE-GSK-DE2024EME084494$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$MD$DE$DE
240675141$24067514$1$I$20240707$20240707$20240709$20240709$EXP$GB-MHRA-MED-202407072337013620-JQTSR$GB-GSK-GB2024084103$GLAXOSMITHKLINE$$$$$$Y$$$20240709$$CN$GB$GB
240675151$24067515$1$I$$20240701$20240709$20240709$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038738$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240710$$CN$US$US
240675161$24067516$1$I$$20240706$20240709$20240709$EXP$$US-ABBVIE-5831304$ABBVIE$$$$$M$Y$$$20240709$$CN$US$US
240675171$24067517$1$I$20240701$20240704$20240709$20240709$EXP$GB-MHRA-MED-202407041208117070-KDRST$GB-EMD Serono-2024036729$EMD SERONO INC$$10$YR$C$F$Y$37$KG$20240710$$HP$GB$GB
240675192$24067519$2$F$$20240911$20240709$20240912$EXP$$NVSC2024US140802$NOVARTIS$$6$MON$$$Y$$$20240912$$MD$US$US
240675201$24067520$1$I$$20240708$20240709$20240709$PER$$US-HALEON-2186068$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
240675211$24067521$1$I$$20240704$20240709$20240709$EXP$$BR-OrBion Pharmaceuticals Private Limited-2158973$ORBION PHARMACEUTICALS$Cavalcante Neto PM, Luz LC, Pereira LLS, De Souza YA, Pereira ADL, Simongini RL, et al. Non-Eosinophilic Exudative Pleural Effusion Induced by Valproic Acid. Am J Respir Crit Care Med 2024; 209:A1924 abstr. A50.$55$YR$$M$Y$$$20240709$$MD$BR$BR
240675231$24067523$1$I$$20240708$20240709$20240709$PER$$US-JNJFOC-20240721864$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$HP$US$US
240675241$24067524$1$I$$20240703$20240709$20240709$EXP$$BE-ABBVIE-5831271$ABBVIE$$$$E$F$Y$56$KG$20240709$$HP$BE$BE
240675251$24067525$1$I$20240613$20240703$20240709$20240709$EXP$ES-AEMPS-1541844$ES-JNJFOC-20240713666$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240710$$MD$ES$ES
240675261$24067526$1$I$20240101$20240701$20240710$20240710$EXP$$US-ABBVIE-5831987$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
240675271$24067527$1$I$$20240702$20240710$20240710$EXP$$NZ-ABBVIE-5756013$ABBVIE$$$$$F$Y$$$20240710$$HP$NZ$NZ
240675281$24067528$1$I$20240505$20240701$20240710$20240710$EXP$$CN-ROCHE-10000016676$ROCHE$$83$YR$E$M$Y$$$20240710$$HP$CN$CN
240675291$24067529$1$I$$20240703$20240710$20240710$PER$$US-HALEON-2186107$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240675301$24067530$1$I$$20240708$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108911$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240710$$HP$US$US
240675311$24067531$1$I$20240702$20240705$20240710$20240710$EXP$$FR-ABBVIE-5832663$ABBVIE$$63$YR$$F$Y$$$20240710$$CN$FR$FR
240675322$24067532$2$F$20240628$20240812$20240710$20240820$30DAY$$US-AMGEN-USASL2024132273$AMGEN$$74$YR$E$M$Y$$$20240820$$CN$US$US
240675331$24067533$1$I$$20240704$20240710$20240710$EXP$$US-OrBion Pharmaceuticals Private Limited-2158974$ORBION PHARMACEUTICALS$Simone C, Axelband J. Levetiracetam-associated Rhabdomyolysis. Am J Respir Crit Care Med 2024; 209: A5704. - [abstract]$20$YR$$M$Y$$$20240710$$MD$US$US
240675341$24067534$1$I$20240703$20240707$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108351$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$62.96$KG$20240710$$PH$US$US
240675352$24067535$2$F$$20240919$20240710$20240924$EXP$$BR-GENMAB-2024-02427$GENMAB$$$$$F$Y$$$20240924$$MD$BR$BR
240675361$24067536$1$I$20240601$20240701$20240710$20240710$EXP$$CN-ROCHE-10000013859$ROCHE$$80$YR$E$F$Y$45$KG$20240710$$HP$CN$CN
240675371$24067537$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405081509363750-MGTZS$GB-VIIV HEALTHCARE LIMITED-GB2024083532$VIIV$$$$$$Y$$$20240710$$HP$GB$GB
240675381$24067538$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405100921597700-NFQSP$GB-VIIV HEALTHCARE LIMITED-GB2024083478$VIIV$$$$$$Y$$$20240710$$HP$GB$GB
240675393$24067539$3$F$20240605$20240726$20240710$20240731$EXP$FR-AFSSAPS-BX2024001331$FR-VIIV HEALTHCARE LIMITED-FR2024083827$VIIV$$$$$$Y$$$20240731$$PH$FR$FR
240675401$24067540$1$I$$20240702$20240710$20240710$EXP$$NL-ABBVIE-5690136$ABBVIE$$$$E$M$Y$$$20240710$$CN$NL$NL
240675411$24067541$1$I$$20240306$20240710$20240710$EXP$$US-JNJFOC-20240700174$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$HP$US$US
240675421$24067542$1$I$$20240704$20240710$20240710$EXP$$US-OrBion Pharmaceuticals Private Limited-2158975$ORBION PHARMACEUTICALS$Woodard VV, Ragland MF. A Rare Case of Necrotizing Pneumonia in an Immunocompromised Patient. Am J Respir Crit Care Med 2024;209: A2444 [abstract].$67$YR$$M$Y$$$20240710$$MD$US$US
240675432$24067543$2$F$20240702$20240809$20240710$20240814$EXP$$US-ABBVIE-5831934$ABBVIE$$45$YR$$F$Y$76$KG$20240814$$CN$US$US
240675441$24067544$1$I$$20240704$20240710$20240710$EXP$$US-OrBion Pharmaceuticals Private Limited-2158976$ORBION PHARMACEUTICALS$Singh KB, Kumar S, Almalouf P. From the Sea to the ICU: The Unexpected Journey of Vibrio Vulnificus Compartment Syndrome. Am J Respir Crit Care Med 2024;209: A1683. - [abstract].$59$YR$$M$Y$$$20240710$$MD$US$US
240675451$24067545$1$I$$20240702$20240710$20240710$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000232$EMCURE$Im S, Paz Y Mino A, Garces E, Altamimi S.. Latent melioidosis activation presenting with urinary tract infection and bacteremia. IDCases. 2024;36:e02007$68$YR$$F$Y$$$20240710$$HP$US$US
240675461$24067546$1$I$$20230919$20240710$20240710$EXP$$PH-ROCHE-10000012552$ROCHE$$$$$$Y$$$20240710$$CN$PH$PH
240675471$24067547$1$I$$20240705$20240710$20240710$PER$$NVSC2024US141941$NOVARTIS$$32$YR$$F$Y$$$20240710$$CN$US$US
240675481$24067548$1$I$20240531$20240705$20240710$20240710$EXP$$GB-ASTELLAS-2024US019170$ASTELLAS$$81$YR$$F$Y$$$20240710$$CN$GB$GB
240675492$24067549$2$F$$20240708$20240710$20240710$PER$$US-ROCHE-10000020881$ROCHE$$$$$$Y$$$20240710$$PH$US$US
240675511$24067551$1$I$$20240704$20240710$20240710$EXP$$JP-OrBion Pharmaceuticals Private Limited-2158977$ORBION PHARMACEUTICALS$Tanabe M, Koba Y, Yaguchi T, Watanabe M. Detection of Schizophyllum commune in SARS-CoV-2 Pneumonia. Intern Med. 2024 Apr 1;63(7):1037-1038. doi: 10.2169/internalmedicine.3018-23.$72$YR$$M$Y$$$20240710$$MD$JP$JP
240675521$24067552$1$I$$20240702$20240710$20240710$EXP$$GB-AMGEN-GBRSP2024133794$AMGEN$$85$YR$E$M$Y$$$20240709$$CN$GB$GB
240675531$24067553$1$I$$20240705$20240710$20240710$EXP$PL-GILEAD-2023-0644063$PL-VIIV HEALTHCARE LIMITED-PL2024083880$VIIV$$$$$$Y$$$20240710$$MD$PL$PL
240675541$24067554$1$I$$20240702$20240710$20240710$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000234$EMCURE$Kwon D, Seu M, Barnes S.. Mind the Anion Gap: 5-Oxoproline-Induced High Anion Gap Metabolic Acidosis in End-Stage Renal Disease. Cureus. 2024;16(5):e61328$74$YR$$F$Y$$$20240710$$HP$US$US
240675551$24067555$1$I$$20240708$20240710$20240710$PER$$US-JNJFOC-20240720586$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240710$$CN$US$US
240675561$24067556$1$I$$20240627$20240710$20240710$EXP$GB-MHRA-WEBCOVID-202406271802274960-JCKBV$GB-Accord-433210$ACCORD$$$$$$Y$$$20240709$$CN$GB$GB
240675572$24067557$2$F$$20240702$20240710$20240710$PER$$US-ROCHE-10000018507$ROCHE$$79$YR$E$M$Y$$$20240710$$HP$US$US
240675582$24067558$2$F$20240629$20240729$20240710$20240802$EXP$$US-ABBVIE-5828450$ABBVIE$$86$YR$$M$Y$86$KG$20240802$$CN$US$US
240675591$24067559$1$I$$20240607$20240710$20240710$EXP$$JP-AMGEN-JPNSP2024133477$AMGEN$$$$$$Y$$$20240709$$MD$JP$JP
240675603$24067560$3$F$20240101$20240731$20240710$20240803$PER$$US-AMGEN-USASP2024134966$AMGEN$$80$YR$E$M$Y$$$20240803$$CN$US$US
240675621$24067562$1$I$20240101$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024133989$AMGEN$$75$YR$E$M$Y$$$20240709$$CN$US$US
240675631$24067563$1$I$$20240703$20240710$20240710$EXP$$US-ABBVIE-5830578$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
240675641$24067564$1$I$20240101$20240703$20240710$20240710$EXP$$US-ABBVIE-5830519$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240675651$24067565$1$I$$20240703$20240710$20240710$EXP$$CA-ABBVIE-5826458$ABBVIE$$$$A$F$Y$$$20240710$$CN$CA$CA
240675661$24067566$1$I$20240601$20240705$20240710$20240710$EXP$$IT-ABBVIE-5831311$ABBVIE$$77$YR$$M$Y$$$20240710$$CN$IT$IT
240675671$24067567$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405161522236280-PTZSM$GB-GSK-GB2024083568$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$GB$GB
240675681$24067568$1$I$20240401$20240703$20240710$20240710$PER$$US-ALXN-202407USA000255US$ALEXION PHARMACEUTICALS$$67$YR$$M$Y$$$20240710$$CN$US$US
240675691$24067569$1$I$$20240703$20240710$20240710$PER$$US-ALXN-202407USA000256US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
240675701$24067570$1$I$20240622$20240625$20240710$20240710$EXP$$GB-CIPLA LTD.-2024GB06853$CIPLA$$$$$$Y$$$20240710$$CN$GB$GB
240675711$24067571$1$I$20240612$20240626$20240710$20240710$EXP$$US-ABBVIE-5829310$ABBVIE$$$$$$Y$$$20240710$$CN$US$US
240675721$24067572$1$I$20240704$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005182$ELI LILLY AND CO$$$$$M$Y$$$20240710$$CN$US$US
240675731$24067573$1$I$20170101$20240701$20240710$20240710$EXP$$NL-CELLTRION INC.-2020NL034621$CELLTRION$Brinkman TK, Hubers AAM, van der Veek PPJ, Scholten EM, Gelinck LBS. Ileocolitis in a immunecompromised patient. Crohn^s disease or an infection after all?. Ned Tijdschr Geneeskd. 2020;164:D4813$$$$$Y$$$20240710$$MD$NL$NL
240675742$24067574$2$F$$20240716$20240710$20240722$EXP$$CA-JNJFOC-20240171203$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240722$$HP$CA$CA
240675751$24067575$1$I$20240708$20240708$20240710$20240710$PER$$US-JNJFOC-20240720054$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240710$$CN$US$US
240675763$24067576$3$F$$20240819$20240710$20240831$PER$$US-AstraZeneca-2024A149144$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
240675771$24067577$1$I$$20240626$20240710$20240710$PER$$US-ROCHE-10000017098$ROCHE$$$$A$F$Y$$$20240710$$CN$US$US
240675784$24067578$4$F$20230701$20240827$20240710$20240904$EXP$$EC-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038720$BOEHRINGER INGELHEIM$$44$YR$A$F$Y$76.3$KG$20240904$$MD$EC$EC
240675791$24067579$1$I$$20240708$20240710$20240710$PER$$US-JNJFOC-20240722029$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$HP$US$US
240675801$24067580$1$I$20240624$20240702$20240710$20240710$EXP$$US-JNJFOC-20240707946$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240710$$CN$US$US
240675813$24067581$3$F$20240704$20240722$20240710$20240725$EXP$$JP-SA-2024SA198235$SANOFI AVENTIS$$$$$$Y$$$20240726$$MD$JP$JP
240675821$24067582$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA201094$SANOFI AVENTIS$$$$T$M$Y$68.03$KG$20240710$$MD$US$US
240675832$24067583$2$F$20240707$20240709$20240710$20240711$PER$$US-AMGEN-USASP2024135154$AMGEN$$68$YR$E$F$Y$$$20240711$$CN$US$US
240675841$24067584$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135652$AMGEN$$$$$$Y$$$20240709$$HP$US$US
240675851$24067585$1$I$20240101$20240703$20240710$20240710$EXP$$US-ABBVIE-5831081$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
240675861$24067586$1$I$20240621$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010380$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240675872$24067587$2$F$20240325$20240827$20240710$20240903$EXP$$JP-ABBVIE-5747831$ABBVIE$$64$YR$$M$Y$82$KG$20240903$$MD$JP$JP
240675881$24067588$1$I$$20240708$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108420$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240710$$CN$US$US
240675891$24067589$1$I$20240416$20240709$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108986$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240710$$CN$US$US
240675902$24067590$2$F$$20240708$20240710$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108967$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240711$$CN$US$US
240675911$24067591$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108785$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240710$$CN$US$US
240675921$24067592$1$I$$20240703$20240710$20240710$EXP$$US-JNJFOC-20240709397$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$HP$US$US
240675931$24067593$1$I$20230904$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405031001342450-RVGZF$GB-GSK-GB2024083792$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$GB$GB
240675941$24067594$1$I$$20240703$20240710$20240710$PER$$US-ABBVIE-5827241$ABBVIE$$$$$F$Y$$$20240710$$MD$US$US
240675952$24067595$2$F$20240617$20240709$20240710$20240723$EXP$$CA-MDD US Operations-E2B_00006357$MDD OPERATIONS$$58$YR$$M$Y$$$20240723$$CN$CA$CA
240675961$24067596$1$I$$20240702$20240710$20240710$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008114$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240710$$HP$CN$CN
240675971$24067597$1$I$$20240701$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008007$STRIDES$Natarajan S, Amjad M, Zaidi S, Shah A, Ochieng PO.. Persistent Bilateral Spontaneous Pneumothorax in Combined Pulmonary Fibrosis and Emphysema.. Am-J-Respir-Crit-Care-Med. 2023;207(plusPoster)$72$YR$$M$Y$$$20240710$$HP$US$US
240675981$24067598$1$I$20240501$20240703$20240710$20240710$EXP$$DE-ABBVIE-5831459$ABBVIE$$33$YR$$M$Y$$$20240710$$CN$DE$DE
240675991$24067599$1$I$$20240702$20240710$20240710$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008115$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240710$$HP$CN$CN
240676001$24067600$1$I$20240704$20240705$20240710$20240710$EXP$$US-ABBVIE-5831903$ABBVIE$$85$YR$$F$Y$$$20240710$$CN$US$US
240676011$24067601$1$I$$20240702$20240710$20240710$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008116$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240710$$HP$CN$CN
240676021$24067602$1$I$$20240703$20240710$20240710$PER$$US-ALXN-202407USA000247US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
240676031$24067603$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186099$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240676041$24067604$1$I$$20240702$20240710$20240710$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008117$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240710$$HP$CN$CN
240676051$24067605$1$I$$20240703$20240710$20240710$EXP$$US-GSK-US2024082642$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$US$US
240676061$24067606$1$I$$20240708$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108778$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240710$$CN$US$US
240676071$24067607$1$I$$20240702$20240710$20240710$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008118$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240710$$HP$CN$CN
240676081$24067608$1$I$$20240702$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008077$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$58$YR$$M$Y$$$20240710$$HP$US$US
240676091$24067609$1$I$$20240702$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008078$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$56$YR$$M$Y$$$20240710$$HP$US$US
240676101$24067610$1$I$$20230724$20240710$20240710$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02616$AMNEAL$$$$$F$Y$$$20240710$$PH$US$US
240676112$24067611$2$F$$20240708$20240710$20240710$PER$$US-ROCHE-10000016995$ROCHE$$$$A$F$Y$$$20240710$$CN$US$US
240676121$24067612$1$I$$20240702$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008079$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$61$YR$$M$Y$$$20240710$$HP$US$US
240676131$24067613$1$I$20240101$20240628$20240710$20240710$PER$$US-SA-2024SA194375$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240710$$MD$US$US
240676142$24067614$2$F$20240101$20240725$20240710$20240731$EXP$$CA-JNJFOC-20240711096$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240731$$HP$CA$CA
240676152$24067615$2$F$20240627$20240715$20240710$20240723$EXP$$US-ABBVIE-5832602$ABBVIE$$60$YR$$M$Y$$$20240723$$CN$US$US
240676162$24067616$2$F$$20240724$20240710$20240726$30DAY$$US-SANDOZ INC.-SDZ2024US063308$SANDOZ$$$$$F$Y$$$20240726$$CN$US$US
240676171$24067617$1$I$20221101$20240701$20240710$20240710$EXP$$DE-CELLTRION INC.-2024DE016105$CELLTRION$$$$$$Y$$$20240710$$MD$DE$DE
240676181$24067618$1$I$$20240704$20240710$20240710$EXP$$TR-ABBVIE-5831272$ABBVIE$$$$$$Y$$$20240710$$MD$TR$TR
240676191$24067619$1$I$$20240702$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008080$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$29$YR$$M$Y$$$20240710$$HP$US$US
240676201$24067620$1$I$20240621$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010366$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240676211$24067621$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA200138$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$MD$US$US
240676221$24067622$1$I$20240601$20240709$20240710$20240710$EXP$FR-AFSSAPS-PA2024001266$FR-JNJFOC-20240722097$JOHNSON AND JOHNSON$$69$YR$E$M$Y$100$KG$20240710$$PH$FR$FR
240676231$24067623$1$I$20240306$20240625$20240710$20240710$EXP$$DK-CIPLA LTD.-2024DK06858$CIPLA$$$$$$Y$$$20240710$$MD$DK$DK
240676241$24067624$1$I$$20240625$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456025$RANBAXY$$$$$M$Y$$$20240710$$CN$US$US
240676251$24067625$1$I$$20240625$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455592$RANBAXY$Singh KB, Kumar S, Almalouf P. From the Sea to the ICU: The Unexpected Journey of Vibrio Vulnificus Compartment Syndrome. Am J Respir Crit Care Med. 2024;May 19;209 (0):A1683;A44$59$YR$$M$Y$$$20240710$$HP$US$US
240676261$24067626$1$I$$20240625$20240710$20240710$EXP$$AZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455742$RANBAXY$Patel MH, Brumfiel CM, Breen I, Glembocki D, Luber A. Granulomatous Panniculitis as a Complication of Subcutaneous Testosterone Pellet Therapy. Skinmed. 2023;21(3):203-204$51$YR$$M$Y$$$20240710$$HP$AZ$AZ
240676271$24067627$1$I$$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455760$RANBAXY$Celardo G, Scaffei E, Buchignani B, Donatelli G, Costagli M, Cristofani P,et al. Case report: Exploring chemoradiotherapy-induced leukoencephalopathy with 7T imaging and quantitative susceptibility mapping. Front Neurol. 2024;Feb,15 (0):1-6$6$YR$$M$Y$$$20240710$$HP$IT$IT
240676281$24067628$1$I$20240601$20240625$20240710$20240710$EXP$$JP-SUNPHARMA-2024R1-453837AA$RANBAXY$$80$YR$$M$Y$$$20240710$$MD$JP$JP
240676291$24067629$1$I$$20240625$20240710$20240710$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455808$RANBAXY$Knorr F, Schellekens KPJ, Schoot RA, Landman-Parker J, Teltschik H-M, Forster J, et al. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica. 2023;108 (5):1442-1446$$$$M$Y$$$20240710$$HP$DE$DE
240676301$24067630$1$I$$20240625$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455553$RANBAXY$Pattupara A, Nguyen D, Gaikwad M, Gnirke M, Yarra S, Su M, et al. Breaking the Spell: A Rare Case of Prolonged Benzodiazepine Elimination. Am J Respir Crit Care Med. 2024;209 (0):A5703$67$YR$$M$Y$$$20240710$$HP$US$US
240676311$24067631$1$I$$20240625$20240710$20240710$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455824$RANBAXY$Knorr F, Schellekens KPJ, Schoot RA, Landman-Parker J, Teltschik H-M, Forster J, et al. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica. 2023;108 (5):1442-1446$$$$F$Y$$$20240710$$HP$DE$DE
240676321$24067632$1$I$$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455736$RANBAXY$Negro G, Boccellino A, Napolano A, Micaglio E, Calovic Z, Anastasia L, et al. Arrhythmogenic substrate elimination for safe testosterone therapy in symptomatic Brugada syndrome patients. Europace. 2023;25 (9):1-4$26$YR$$M$Y$$$20240710$$HP$IT$IT
240676331$24067633$1$I$$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455737$RANBAXY$Negro G, Boccellino A, Napolano A, Micaglio E, Calovic Z, Anastasia L, et al. Arrhythmogenic substrate elimination for safe testosterone therapy in symptomatic Brugada syndrome patients. Europace. 2023;25 (9):1-4$21$YR$$M$Y$$$20240710$$HP$IT$IT
240676341$24067634$1$I$20240401$20240625$20240710$20240710$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455958$RANBAXY$$56$YR$$F$Y$75$KG$20240710$$MD$DE$DE
240676351$24067635$1$I$$20240625$20240710$20240710$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455741$RANBAXY$Knorr F, Schellekens KPJ, Schoot RA, Landman-Parker J, Teltschik H-M, Forster J, et al. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica. 2023;108 (5):1442-1446$$$$M$Y$$$20240710$$HP$DE$DE
240676361$24067636$1$I$$20240625$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455639$RANBAXY$Duchow M, White G, Benchakroun A, Chait R. Non-compaction Cardiomyopathy: A Rare Cause of Embolic Stroke in a Middle-aged Woman. Am J Respir Crit Care Med. 2024;209 (0):A5604$59$YR$$F$Y$$$20240710$$HP$US$US
240676371$24067637$1$I$$20240625$20240710$20240710$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455949$RANBAXY$Nan N, Pan L, Dong R, Song X.. Mismatch of systematic and local inflammatory activity in takayasu arteritis with coronary involvement: a case report. Eur Heart J Case Rep. 2023;25 JUL 7 (8):1-7$31$YR$$F$Y$$$20240710$$HP$CN$CN
240676381$24067638$1$I$20240408$20240625$20240710$20240710$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455878$RANBAXY$$11$YR$$F$Y$48$KG$20240710$$MD$ES$ES
240676391$24067639$1$I$$20240625$20240710$20240710$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455833$RANBAXY$Knorr F, Schellekens KPJ, Schoot RA, Landman-Parker J, Teltschik H-M, Forster J, et al. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica. 2023;108 (5):1442-1446$$$$M$Y$$$20240710$$HP$DE$DE
240676401$24067640$1$I$$20240625$20240710$20240710$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455730$RANBAXY$Xu H, Koszycki D. Application of interpersonal psychotherapy for late-life depression in China: A case report. Front Psychiatry. 2023;14:1167982$79$YR$$M$Y$$$20240710$$HP$CN$CN
240676411$24067641$1$I$$20240625$20240710$20240710$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455756$RANBAXY$Bourbon Ruao M, Pestana I, Passos R, Monte JR, Martinho A. Acute Iron Poisoning: A Case of Fulminant Hepatic Failure. Acta Med Port. 2024;JUN; 37 (6):470-472$38$YR$$F$Y$$$20240710$$HP$PT$PT
240676423$24067642$3$F$20240624$20240718$20240710$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455181$RANBAXY$$36$YR$A$F$Y$$$20240802$$MD$US$US
240676431$24067643$1$I$$20240625$20240710$20240710$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455972$RANBAXY$Jabiry-Zieniewicz Z, Stelmach DA, Jasak K, Knap-Wielgus W, Szumska A, Raszeja Wyszomirska J, et al. Pregnancies in Women After Liver Transplant due to Wilson?s Disease - CaseSeries. Transplantation Proceedings. 2024;56 (4):919-922$$$$F$Y$$$20240710$$HP$PL$PL
240676441$24067644$1$I$$20240625$20240710$20240710$EXP$$MX-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454744$RANBAXY$Torres BB, Torres Cardenas C, Peralta De Avila A, Oropeza Martinez V, Villegas Lopez C, Reyna Gonzalez G, et al. Plasmapheresis Exchange as Rescue Therapy in Rapidly Progressive Anti-synthetase Syndrome: A Case Report. Am J Respir Crit Care Med. 2024;May;209 (0):A1990 (A51)$50$YR$$F$Y$$$20240710$$HP$MX$MX
240676451$24067645$1$I$$20240625$20240710$20240710$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455975$RANBAXY$Jabiry-Zieniewicz Z, Stelmach DA, Jasak K, Knap-Wielgus W, Szumska A, Raszeja Wyszomirska J, et al. Pregnancies in Women After Liver Transplant due to Wilson?s Disease - CaseSeries. Transplantation Proceedings. 2024;56 (4):919-922$$$$F$Y$$$20240710$$HP$PL$PL
240676461$24067646$1$I$$20240625$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455568$RANBAXY$Le CT, Mahmoud A, Kurt O, Bangash H, Saad Eldin M, Ayaz S. Advanced Care in Rheumatoid Arthritis With Biologic Agents: The Role of Pneumocystis Jirovecii Pneumonia Prophylaxis. Am J Respir Crit Care Med. 2024;209(0):A2388$66$YR$$F$Y$$$20240710$$HP$US$US
240676471$24067647$1$I$20240624$20240625$20240710$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455864$RANBAXY$$79$YR$$F$Y$73$KG$20240710$$MD$GB$GB
240676481$24067648$1$I$$20240625$20240710$20240710$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455829$RANBAXY$Knorr F, Schellekens KPJ, Schoot RA, Landman-Parker J, Teltschik H-M, Forster J, et al. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica. 2023;108 (5):1442-1446$4$YR$$F$Y$$$20240710$$HP$DE$DE
240676491$24067649$1$I$$20240625$20240710$20240710$EXP$$VN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455752$RANBAXY$Do TA, Nguyen AQ, Van Nguyen T, Vu PT, Tran HT. A giant metaplastic breast carcinoma with osseous differentiation: a rare case report and review of the literature. Int J Surg Case Rep. 2024;120 (0):1-5$59$YR$$F$Y$$$20240710$$HP$VN$VN
240676501$24067650$1$I$20230724$20240625$20240710$20240710$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455015$RANBAXY$$44$YR$$M$Y$$$20240710$$HP$ES$ES
240676512$24067651$2$F$$20240801$20240710$20240816$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455487$RANBAXY$Nakano M, Funayama M, Takata T, Wakisaka R, Koyama G, Koreki A, et al. Caution for psychiatrists: malignant hyperthermia risks with the anesthetic agent succinylcholine (Suxamethonium) during electroconvulsive therapy. BMC Psychiatry. 2024;24 (1):411$79$YR$$F$Y$$$20240816$$HP$JP$JP
240676521$24067652$1$I$$20240625$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455614$RANBAXY$Bloom J, Cisse N, Howland MA, Doukas D, Wiener SW, Su MK. Late ventricular fibrillation cardiac arrest in a case of bupropion overdose with status epilepticus. Clin Toxicol (Phila). 2023;61:106-107/222$27$YR$$M$Y$$$20240710$$HP$US$US
240676531$24067653$1$I$$20240625$20240710$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455844$RANBAXY$$$$$F$Y$67$KG$20240710$$CN$GB$GB
240676541$24067654$1$I$$20240625$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455103$RANBAXY$$$$$M$Y$$$20240710$$MD$US$US
240676551$24067655$1$I$20240624$20240625$20240710$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455886$RANBAXY$$63$YR$$M$Y$77$KG$20240710$$HP$GB$GB
240676561$24067656$1$I$$20240625$20240710$20240710$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455790$RANBAXY$Jin Y, Xu J, Hua Y, Zhang H and Li Y. Challenging of ECMO application in pediatric restrictive cardiomyopathy: case report of a novel TNNI3 variant. Front Cardiovasc Med. 2024;11(0):1365209$8$YR$$F$Y$$$20240710$$HP$CN$CN
240676571$24067657$1$I$$20240625$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455644$RANBAXY$Chaudhary AJ, Khan MZ, Sohail A, Zaidi SMH, Denha E, Venkat D. Acute onset nitrofurantoin-induced autoimmune hepatitis after urinary tract infection treatment. Clin Case Rep. 2024;12(6):e9050$84$YR$$F$Y$$$20240710$$HP$US$US
240676581$24067658$1$I$$20240625$20240710$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455869$RANBAXY$$$$$F$Y$$$20240710$$PH$GB$GB
240676591$24067659$1$I$$20240625$20240710$20240710$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455807$RANBAXY$Naghibi SM, Hosseini SH. Improved anorgasmia following add-on lamotrigine treatment. Trends Pharm Sci. 2023;9(4):239-242$31$YR$$M$Y$$$20240710$$HP$IR$IR
240676601$24067660$1$I$$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455735$RANBAXY$Cavazza G, Motto C, Regna-Gladin C, Travi G, Di Gennaro E, Peracchi F, et al. Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management. Antibiotics (Basel). 2024;13 (5):387 (1-11)$48$YR$$M$Y$$$20240710$$HP$IT$IT
240676611$24067661$1$I$20240405$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455490$RANBAXY$$30$YR$$M$Y$$$20240710$$MD$IT$IT
240676621$24067662$1$I$$20240625$20240710$20240710$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455755$RANBAXY$Pombal R, Silva L, Ferreira D. GENETIC PREDISPOSITION TO VACCINE-INDUCED IMMUNE THROMBOTIC THROMBOCYTOPENIA: IS THERE A FAMILY LINK?. Eur J Case Rep Intern Med. 2024;11 (6):-$30$YR$$M$Y$$$20240710$$HP$PT$PT
240676631$24067663$1$I$$20240625$20240710$20240710$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455835$RANBAXY$Knorr F, Schellekens KPJ, Schoot RA, Landman-Parker J, Teltschik H-M, Forster J, et al. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica. 2023;108 (5):1442-1446$$$$M$Y$$$20240710$$HP$DE$DE
240676641$24067664$1$I$$20240625$20240710$20240710$EXP$$BD-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455761$RANBAXY$Ferdause J, Islam MA Ahmed N, Kadir AKMS, Haque MA. Radiation recall dermatitis in HER 2 positive breast cancer patients triggered by trastuzumab: A rare case report and review of literature. Int J Surg Case Rep. 2024;120 (0):109864$38$YR$$F$Y$$$20240710$$HP$BD$BD
240676651$24067665$1$I$$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455900$RANBAXY$Zaccheddu E, Zappu A, Barella S, Clemente MG, Orecchia V, Pilia MP, et al. Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept. Br J Haematol. 2024;204 (6):2505-2507$27$YR$$F$Y$$$20240710$$HP$IT$IT
240676661$24067666$1$I$$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455560$RANBAXY$$21$YR$$M$Y$70$KG$20240710$$CN$IT$IT
240676671$24067667$1$I$20240404$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455236$RANBAXY$$44$YR$$F$Y$$$20240710$$HP$IT$IT
240676681$24067668$1$I$$20240625$20240710$20240710$EXP$$US-CIPLA LTD.-2024US05079$CIPLA$$$$$$Y$$$20240710$$HP$US$US
240676693$24067669$3$F$$20240805$20240710$20240806$PER$$US-JNJFOC-20240722384$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$HP$US$US
240676703$24067670$3$F$20240626$20240813$20240710$20240819$30DAY$$US-AMGEN-USASP2024130889$AMGEN$$78$YR$E$M$Y$87.3$KG$20240819$$HP$US$US
240676711$24067671$1$I$$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024133873$AMGEN$$$$A$F$Y$$$20240709$$CN$US$US
240676721$24067672$1$I$20240101$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135691$AMGEN$$$$$F$Y$$$20240709$$HP$US$US
240676731$24067673$1$I$$20240702$20240710$20240710$EXP$$AU-TOLMAR, INC.-24AU050677$TOLMAR$$$$$M$Y$$$20240710$$HP$AU$AU
240676741$24067674$1$I$20240620$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010368$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240676752$24067675$2$F$$20240701$20240710$20240827$EXP$$AE-TAKEDA-2024TUS066556$TAKEDA$$$$$M$Y$$$20240827$$CN$LB$AE
240676761$24067676$1$I$20231001$20240701$20240710$20240710$EXP$$FR-CELLTRION INC.-2024FR016096$CELLTRION$$$$$$Y$$$20240710$$MD$FR$FR
240676771$24067677$1$I$20240406$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454971$RANBAXY$$72$YR$$M$Y$80$KG$20240710$$MD$IT$IT
240676781$24067678$1$I$20230201$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455042$RANBAXY$$41$YR$$M$Y$88$KG$20240710$$MD$IT$IT
240676791$24067679$1$I$$20240625$20240710$20240710$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455758$RANBAXY$Maia TF, Freire BL, De Santi Rodrigues A, Jorgetti V, Rocha AC, Moises CS, et al. Cutaneous Skeletal Hypophosphatemic Syndrome (Cshs) Caused by Somatic HRAS p.G13R Mutation: Long Follow-Up of Two Brazilian Women. J Endocr Soc. 2020;4(Suppl.):A700;MON-333$25$YR$$F$Y$$$20240710$$MD$BR$BR
240676801$24067680$1$I$$20240625$20240710$20240710$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455734$RANBAXY$Zhao J, Xu W, Zhuo X, Liu L, Zhang J, Jiang F, et al. Response to Pralsetinib in Multi-Drug-Resistant Breast Cancer With CCDC6-RET Mutation. Oncologist. 2023;28 (6):E416-E424$36$YR$$F$Y$$$20240710$$HP$CN$CN
240676811$24067681$1$I$$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455822$RANBAXY$Sculli CM, Ragni F, Porpiglia F, Tampellini M, Gorzegno G, Priola AM, et al. Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma. Ann Oncol. 2009;20 (2):389-390$69$YR$$F$Y$$$20240710$$HP$IT$IT
240676821$24067682$1$I$20230808$20240625$20240710$20240710$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455544$RANBAXY$$66$YR$$F$Y$$$20240710$$HP$ES$ES
240676841$24067684$1$I$$20240625$20240710$20240710$EXP$$HU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455751$RANBAXY$Vojcek E, Krikovszky D, Lodi C, Kovacs L, Schnur J, Szabo AJ. Whole lung lavage and GM-CSF use for pulmonary alveolar proteinosis in an infant with lysinuric protein intolerance: a case report. Ital J Pediatr. 2024;50 (1):111 (1-6)$8$MON$$F$Y$$$20240710$$HP$HU$HU
240676851$24067685$1$I$$20240625$20240710$20240710$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455968$RANBAXY$Jabiry-Zieniewicz Z, Stelmach DA, Jasak K, Knap-Wielgus W, Szumska A, Raszeja Wyszomirska J, et al. Pregnancies in Women After Liver Transplant due to Wilson?s Disease - CaseSeries. Transplantation Proceedings. 2024;56 (4):919-922$$$$F$Y$$$20240710$$HP$PL$PL
240676861$24067686$1$I$$20240625$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455110$RANBAXY$$$$E$M$Y$$$20240710$$CN$US$US
240676871$24067687$1$I$$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455904$RANBAXY$Zaccheddu E, Zappu A, Barella S, Clemente MG, Orecchia V, Pilia MP, et al. Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept. Br J Haematol. 2024;204 (6):2505-2507$28$YR$$F$Y$$$20240710$$HP$IT$IT
240676881$24067688$1$I$$20240625$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455589$RANBAXY$Ravi S, Ravi SN, Ballam Nagaraj N, Upadhyay H. Acute Respiratory Compromise in the Context of COVID-19 and Gemcitabine. Am J Respir Crit Care Med. 2024;May 21;209 (0):A5539;C42$48$YR$$F$Y$$$20240710$$HP$US$US
240676891$24067689$1$I$$20240625$20240710$20240710$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455868$RANBAXY$Zaborowska M, Pawelas A, Zagorowicz E. Colitis after immunotherapy. Clinical Gastroenterology. 2023;15(26):44-49$40$YR$$M$Y$$$20240710$$HP$PL$PL
240676911$24067691$1$I$20230820$20240625$20240710$20240710$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455397$RANBAXY$$42$YR$$F$Y$60$KG$20240710$$MD$ES$ES
240676921$24067692$1$I$$20240625$20240710$20240710$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455759$RANBAXY$Maia TF, Freire BL, De Santi Rodrigues A, Jorgetti V, Rocha AC, Moises CS, et al. Cutaneous Skeletal Hypophosphatemic Syndrome (Cshs) Caused by Somatic HRAS p.G13R Mutation: Long Follow-Up of Two Brazilian Women. J Endocr Soc. 2020;4(Suppl.):A700;MON-333$36$YR$$F$Y$$$20240710$$MD$BR$BR
240676931$24067693$1$I$$20240625$20240710$20240710$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455950$RANBAXY$Kaga M, Amano H, Kon T, Harada S, Ogura K. Other iatrogenic immunodeficiency associated lymphoproliferative disorder presenting with multiple facial tumors. JAAD CASE REP. 2024;49:8-10$71$YR$$F$Y$$$20240710$$MD$JP$JP
240676941$24067694$1$I$20240111$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455249$RANBAXY$$70$YR$$F$Y$$$20240710$$PH$IT$IT
240676961$24067696$1$I$20230529$20240625$20240710$20240710$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455831$RANBAXY$$63$YR$$M$Y$$$20240710$$MD$IT$IT
240676971$24067697$1$I$20240525$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024134854$AMGEN$$75$YR$E$F$Y$$$20240709$$CN$US$US
240676982$24067698$2$F$$20240709$20240710$20240710$PER$$US-AMGEN-USASL2024134688$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240676991$24067699$1$I$$20240704$20240710$20240710$PER$$US-AMGEN-USASP2024133197$AMGEN$$$$A$F$Y$$$20240709$$CN$US$US
240677001$24067700$1$I$20240611$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010382$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240677011$24067701$1$I$20240628$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010381$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240677021$24067702$1$I$$20240625$20240710$20240710$PER$$NVSC2024US141889$NOVARTIS$$67$YR$$F$Y$$$20240710$$MD$US$US
240677031$24067703$1$I$20240619$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010384$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240677041$24067704$1$I$20230516$20240703$20240710$20240710$EXP$$RU-ABBVIE-5832724$ABBVIE$$4$YR$$F$Y$15$KG$20240710$$MD$RU$RU
240677051$24067705$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135471$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240677073$24067707$3$F$20230101$20240801$20240710$20240805$PER$$US-AMGEN-USASP2024135530$AMGEN$$17$YR$T$F$Y$$$20240805$$HP$US$US
240677081$24067708$1$I$$20240703$20240710$20240710$EXP$$US-GSK-US2024AMR084132$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$US$US
240677092$24067709$2$F$20240101$20240925$20240710$20240930$EXP$$US-ABBVIE-5794337$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
240677102$24067710$2$F$$20240703$20240710$20240716$EXP$$US-ABBVIE-5831422$ABBVIE$$$$$F$Y$78.9$KG$20240716$$MD$US$US
240677111$24067711$1$I$20240607$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010374$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240677121$24067712$1$I$$20240708$20240710$20240710$PER$$US-HALEON-2186008$Haleon PLC$$37$YR$$M$Y$$$20240710$$CN$US$US
240677131$24067713$1$I$$20240701$20240710$20240710$PER$$US-AstraZeneca-2024A151311$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240677141$24067714$1$I$$20240708$20240710$20240710$EXP$$GB-AstraZeneca-2024A156009$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$GB$
240677151$24067715$1$I$20240618$20240618$20240710$20240710$PER$$CA-TOLMAR, INC.-24CA050335$TOLMAR$$82$YR$$M$Y$$$20240710$$CN$CA$CA
240677162$24067716$2$F$20240618$20240911$20240710$20240927$PER$$CA-TOLMAR, INC.-24CA050334$TOLMAR$$71$YR$$$Y$$$20240927$$CN$CA$CA
240677171$24067717$1$I$$20240618$20240710$20240710$PER$$CA-TOLMAR, INC.-24CA050333$TOLMAR$$$$$M$Y$$$20240710$$CN$CA$CA
240677182$24067718$2$F$20240610$20240705$20240710$20240813$PER$$FR-TOLMAR, INC.-24FR050097$TOLMAR$$79$YR$$M$Y$$$20240813$$PH$FR$FR
240677193$24067719$3$F$20240617$20240809$20240710$20240830$PER$$FR-TOLMAR, INC.-24FR050300$TOLMAR$$88$YR$$M$Y$$$20240830$$PH$FR$FR
240677201$24067720$1$I$20220301$20240618$20240710$20240710$PER$$ES-TOLMAR, INC.-24ES050298$TOLMAR$$72$YR$$M$Y$$$20240710$$MD$ES$ES
240677212$24067721$2$F$20240618$20240719$20240710$20240812$PER$$FR-TOLMAR, INC.-24FR050383$TOLMAR$$95$YR$$M$Y$$$20240812$$PH$FR$FR
240677222$24067722$2$F$20240617$20240717$20240710$20240809$PER$$FR-TOLMAR, INC.-24FR050323$TOLMAR$$72$YR$$M$Y$$$20240809$$PH$FR$FR
240677231$24067723$1$I$20240410$20240618$20240710$20240710$PER$$NL-TOLMAR, INC.-24NL050305$TOLMAR$$79$YR$$M$Y$$$20240710$$CN$NL$NL
240677242$24067724$2$F$20240416$20240711$20240710$20240801$PER$$US-TOLMAR, INC.-24US049913$TOLMAR$$$$$$Y$$$20240801$$HP$US$US
240677252$24067725$2$F$20240524$20240711$20240710$20240801$PER$$US-TOLMAR, INC.-24US049940$TOLMAR$$72$YR$$M$Y$$$20240801$$HP$US$US
240677261$24067726$1$I$$20240618$20240710$20240710$PER$$US-TOLMAR, INC.-24US050026$TOLMAR$$$$$F$Y$$$20240710$$HP$US$US
240677272$24067727$2$F$20240501$20240711$20240710$20240801$PER$$US-TOLMAR, INC.-24US050116$TOLMAR$$76$YR$$M$Y$$$20240731$$HP$US$US
240677282$24067728$2$F$20240611$20240723$20240710$20240820$PER$$US-TOLMAR, INC.-24US050172$TOLMAR$$88$YR$$M$Y$$$20240813$$HP$US$US
240677292$24067729$2$F$20240614$20240730$20240710$20240826$PER$$US-TOLMAR, INC.-24US050273$TOLMAR$$75$YR$$M$Y$$$20240826$$PH$US$US
240677302$24067730$2$F$$20240708$20240710$20240814$PER$$US-AMGEN-USASP2024135147$AMGEN$$68$YR$E$F$Y$$$20240814$$HP$US$US
240677313$24067731$3$F$20240601$20240807$20240710$20240814$EXP$$FR-GSK-FR2024083181$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$FR$FR
240677321$24067732$1$I$20240601$20240628$20240710$20240710$EXP$$BR-AUROBINDO-AUR-APL-2024-034207$AUROBINDO$$68$YR$$F$Y$$$20240710$$MD$BR$BR
240677331$24067733$1$I$$20240702$20240710$20240710$EXP$$US-ABBVIE-5831866$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240677341$24067734$1$I$20210701$20240702$20240710$20240710$EXP$$ES-CELLTRION INC.-2024ES016395$CELLTRION$$$$$$Y$$$20240710$$MD$ES$ES
240677352$24067735$2$F$20240707$20240709$20240710$20240711$PER$$US-AMGEN-USASP2024135201$AMGEN$$81$YR$E$F$Y$$$20240710$$CN$US$US
240677361$24067736$1$I$20231023$20240708$20240710$20240710$EXP$$AU-TAKEDA-2023TUS103795$TAKEDA$$30$YR$$F$Y$$$20240710$$CN$AU$AU
240677371$24067737$1$I$20240401$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405060910388660-LGKDY$GB-HALEON-2185637$Haleon PLC$$61$YR$$F$Y$116$KG$20240709$$CN$GB$GB
240677381$24067738$1$I$20240702$20240705$20240710$20240710$EXP$$GB-GSK-GB2024EME084282$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$GB$GB
240677391$24067739$1$I$$20240702$20240710$20240710$30DAY$$US-GSK-US2024083082$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
240677401$24067740$1$I$$20240708$20240710$20240710$EXP$$CA-ABBVIE-5831509$ABBVIE$$53$YR$$F$Y$$$20240710$$CN$CA$CA
240677411$24067741$1$I$$20240625$20240710$20240710$PER$$US-AstraZeneca-2024A147223$ASTRAZENECA$$$$$M$Y$$$20240710$$MD$US$
240677421$24067742$1$I$20240618$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010363$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240677431$24067743$1$I$20190320$20240705$20240710$20240710$EXP$$IT-AMGEN-ITANI2024124034$AMGEN$$$$$$Y$$$20240709$$MD$IT$IT
240677441$24067744$1$I$$20240705$20240710$20240710$EXP$$JP-ABBVIE-5832019$ABBVIE$$$$A$$Y$$$20240710$$PH$JP$JP
240677451$24067745$1$I$$20240701$20240710$20240710$EXP$$VN-ROCHE-10000014190$ROCHE$Hoang H,  Result of atezolizumab plus bevacizumab for advanced or metastatic hepatocellular carcinoma in Vietnamese patients (Abstract number: 199P).. Annals of Oncology. 2024-Jun;35 (SUP: 1):S88. doi:10.1016/j.annonc.2024.05.207.$$$$$Y$$$20240710$$HP$VN$VN
240677461$24067746$1$I$$20240702$20240710$20240710$EXP$$GB-NOVITIUMPHARMA-2024GBNVP01174$NOVITIUM PHARMA$Giulia Buckens.58 Antifungal resistance, a hot topic. A case report in co-infection of Mycobacterium avium-intracellulare and chronic cavitary pulmonary aspergillosis.Clinical Infection in Practice.20-DEC-2023;20:23$53$YR$A$M$Y$$$20240710$$HP$GB$GB
240677472$24067747$2$F$$20240715$20240710$20240720$EXP$$BR-JNJFOC-20240709730$JOHNSON AND JOHNSON$$57$YR$A$F$Y$103$KG$20240719$$CN$BR$BR
240677481$24067748$1$I$$20240702$20240710$20240710$EXP$$FR-JNJFOC-20240708480$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$MD$FR$FR
240677491$24067749$1$I$20240201$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405091711040630-QMNWC$GB-ORGANON-O2407GBR000685$ORGANON$$36$YR$$M$Y$$$20240709$$CN$GB$GB
240677501$24067750$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142064$NOVARTIS$$$$$$Y$$$20240710$$HP$US$US
240677511$24067751$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109056$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240710$$HP$US$US
240677531$24067753$1$I$20240703$20240703$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109134$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$53.07$KG$20240710$$CN$US$US
240677541$24067754$1$I$$20240701$20240710$20240710$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02495$AMNEAL$$$$$F$Y$47.619$KG$20240710$$CN$US$US
240677561$24067756$1$I$$20240617$20240710$20240710$EXP$$CA-HALEON-2183601$Haleon PLC$$$$$F$Y$$$20240709$$HP$CA$CA
240677571$24067757$1$I$$20240627$20240710$20240710$EXP$$US-B.Braun Medical Inc.-2158981$B BRAUN$Literature Article$42$YR$$F$Y$$$20240710$$$US$US
240677581$24067758$1$I$$20240628$20240710$20240710$PER$$US-TEVA-VS-3216550$TEVA$$$$$$Y$$$20240710$$CN$US$US
240677591$24067759$1$I$$20240625$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109063$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240710$$HP$US$US
240677601$24067760$1$I$$20240709$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038831$BOEHRINGER INGELHEIM$$$$$$Y$$$20240710$$CN$US$US
240677612$24067761$2$F$$20240709$20240710$20240717$EXP$$IT-ORGANON-O2407ITA000645$ORGANON$Sanna S, Lampus M.. A PARTICULAR CASE OF CARDIAC ARREST.. European Heart Journal, Supplement.. 2024;26 (2):270-1$88$YR$$M$Y$$$20240717$$MD$IT$IT
240677621$24067762$1$I$$20240707$20240710$20240710$PER$$US-HALEON-2186097$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240677631$24067763$1$I$$20240702$20240710$20240710$EXP$$US-CHATTEMPRD-2024OHG022958$CHATTEM$$$$$M$Y$$$20240710$$CN$US$US
240677642$24067764$2$F$$20240730$20240710$20240731$EXP$$NVSJ2024JP008233$NOVARTIS$$81$YR$$M$Y$$$20240801$$MD$JP$JP
240677651$24067765$1$I$$20240702$20240710$20240710$EXP$$GB-TEVA-VS-3216644$TEVA$$22$YR$$F$Y$147$KG$20240710$$MD$GB$GB
240677661$24067766$1$I$$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010365$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240677672$24067767$2$F$20240426$20240719$20240710$20240723$EXP$$FR-TAKEDA-2024TUS069817$TAKEDA$$65$YR$$F$Y$$$20240723$$HP$FR$FR
240677681$24067768$1$I$20240701$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024134242$AMGEN$$68$YR$E$M$Y$$$20240709$$CN$US$US
240677691$24067769$1$I$$20240706$20240710$20240710$PER$$US-ABBVIE-5831320$ABBVIE$$$$$F$Y$$$20240710$$MD$US$US
240677701$24067770$1$I$$20240703$20240710$20240710$EXP$$US-JNJFOC-20240711474$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$HP$US$US
240677711$24067771$1$I$$20240627$20240710$20240710$EXP$$PT-B.Braun Medical Inc.-2158982$B BRAUN$Literature Article$43$YR$$F$Y$$$20240710$$$PT$PT
240677721$24067772$1$I$$20240704$20240710$20240710$PER$$US-AstraZeneca-2024A155037$ASTRAZENECA$$$$$$Y$$$20240710$$CN$US$
240677731$24067773$1$I$$20240701$20240710$20240710$PER$$US-AstraZeneca-2024A151514$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240677741$24067774$1$I$$20240709$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038640$BOEHRINGER INGELHEIM$$$$$$Y$$$20240710$$CN$US$US
240677751$24067775$1$I$20240101$20240702$20240710$20240710$EXP$$CA-APOTEX-2024AP007940$APOTEX$$$$A$F$Y$$$20240710$$CN$CA$CA
240677762$24067776$2$F$$20240710$20240710$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407004179$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240712$$CN$US$US
240677771$24067777$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005044$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240710$$CN$US$US
240677781$24067778$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004333$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240710$$CN$US$US
240677791$24067779$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA199560$SANOFI AVENTIS$$$$$$Y$$$20240710$$MD$US$US
240677802$24067780$2$F$$20240627$20240710$20240726$EXP$$CA-HALEON-2185620$Haleon PLC$$44$YR$$F$Y$70$KG$20240725$$HP$CA$CA
240677811$24067781$1$I$$20240625$20240710$20240710$EXP$$CA-HALEON-2183896$Haleon PLC$$44$YR$$F$Y$$$20240709$$HP$CA$CA
240677821$24067782$1$I$20230101$20240702$20240710$20240710$EXP$$ES-SA-2024SA190398$SANOFI AVENTIS$$$$A$M$Y$$$20240710$$CN$ES$ES
240677832$24067783$2$F$$20240724$20240710$20240725$PER$$US-JNJFOC-20240721631$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$MD$US$US
240677842$24067784$2$F$20240419$20240813$20240710$20240818$EXP$$NVSC2023CL276227$NOVARTIS$$39$YR$$F$Y$$$20240818$$CN$CL$CL
240677851$24067785$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108552$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240710$$CN$US$US
240677861$24067786$1$I$$20240702$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01166$NOVITIUM PHARMA$J. Fomeche.Ketamine Chronicles: A Breath of Fresh Air in Status Asthmaticus.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;NA:A5301$64$YR$A$M$Y$$$20240710$$HP$US$US
240677872$24067787$2$F$20240605$20240916$20240710$20240926$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06029$HIKMA$$13$YR$$F$Y$40.6$KG$20240926$$HP$US$US
240677882$24067788$2$F$$20240723$20240710$20240724$PER$$US-JNJFOC-20240710364$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$HP$US$US
240677892$24067789$2$F$$20240917$20240710$20240925$EXP$$US-JNJFOC-20240711312$JOHNSON AND JOHNSON$$74$YR$E$M$Y$69.7$KG$20240925$$MD$US$US
240677901$24067790$1$I$20230712$20240701$20240710$20240710$EXP$$FR-CELLTRION INC.-2024FR016162$CELLTRION$$$$$$Y$$$20240710$$HP$FR$FR
240677911$24067791$1$I$$20240628$20240710$20240710$EXP$$US-NOVOPROD-1249356$NOVO NORDISK$$80$YR$$$Y$$$20240710$$CN$US$US
240677921$24067792$1$I$20240624$20240629$20240710$20240710$EXP$GB-MHRA-MED-202406291237418600-FDZKM$GB-NOVOPROD-1251603$NOVO NORDISK$$42$YR$$F$Y$180$KG$20240710$$HP$GB$GB
240677931$24067793$1$I$$20240627$20240710$20240710$EXP$$US-NOVOPROD-1247280$NOVO NORDISK$$$$$F$Y$$$20240710$$CN$US$US
240677941$24067794$1$I$$20240628$20240710$20240710$EXP$$EG-NOVOPROD-1249726$NOVO NORDISK$$$$$F$Y$$$20240710$$CN$EG$EG
240677953$24067795$3$F$20240708$20240716$20240710$20240718$PER$$US-AMGEN-USASP2024135730$AMGEN$$39$YR$A$F$Y$$$20240718$$CN$US$US
240677961$24067796$1$I$$20240704$20240710$20240710$EXP$$IT-Bion-013400$BIONPHARMA$$$$N$F$Y$$$20240710$$HP$IT$IT
240677971$24067797$1$I$$20240708$20240710$20240710$PER$$NVSC2024US142004$NOVARTIS$$$$$$Y$$$20240710$$HP$US$US
240677981$24067798$1$I$$20240705$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108781$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240710$$CN$US$US
240677991$24067799$1$I$20240101$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109158$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$59.87$KG$20240710$$CN$US$US
240678001$24067800$1$I$20240623$20240628$20240710$20240710$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000104-2024$QILU PHARMACEUTICAL$$69$YR$E$F$Y$50$KG$20240705$$CN$CN$CN
240678011$24067801$1$I$$20240513$20240710$20240710$EXP$$CA-002147023-NVSC2024CA054300$Haleon PLC$$44$YR$$F$Y$$$20240709$$HP$CA$CA
240678021$24067802$1$I$$20240701$20240710$20240710$EXP$$JP-NOVOPROD-1247375$NOVO NORDISK$$90$YR$$F$Y$$$20240710$$PH$JP$JP
240678031$24067803$1$I$$20240702$20240710$20240710$EXP$$US-Bion-013402$BIONPHARMA$$$$E$F$Y$$$20240710$$CN$US$US
240678041$24067804$1$I$$20240628$20240710$20240710$EXP$$US-NOVOPROD-1248500$NOVO NORDISK$$$$$F$Y$$$20240710$$CN$US$US
240678051$24067805$1$I$$20240701$20240710$20240710$EXP$GB-MHRA-MIDB-533f6a66-7568-4f54-bd68-088e26613121$GB-NOVOPROD-1249574$NOVO NORDISK$$63$YR$$M$Y$$$20240710$$PH$GB$GB
240678062$24067806$2$F$20240615$20240819$20240710$20240830$30DAY$$SE-NOVOPROD-1241158$NOVO NORDISK$$67$YR$$M$Y$$$20240830$$PH$SE$SE
240678072$24067807$2$F$$20240710$20240710$20240722$EXP$$US-NOVOPROD-1249244$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$US$US
240678081$24067808$1$I$$20240627$20240710$20240710$EXP$$US-NOVOPROD-1247976$NOVO NORDISK$$64$YR$$M$Y$$$20240710$$CN$US$US
240678091$24067809$1$I$20240103$20240628$20240710$20240710$EXP$$EG-NOVOPROD-1247428$NOVO NORDISK$$689$MON$$M$Y$$$20240710$$CN$EG$EG
240678102$24067810$2$F$$20240725$20240710$20240812$30DAY$$US-NOVOPROD-1251360$NOVO NORDISK$$$$$F$Y$$$20240812$$CN$US$US
240678111$24067811$1$I$20230109$20240628$20240710$20240710$EXP$$US-NOVOPROD-1248705$NOVO NORDISK$$63$YR$$F$Y$$$20240710$$CN$US$US
240678121$24067812$1$I$20230629$20240701$20240710$20240710$EXP$AU-TGA-0000781418$AU-NOVOPROD-1249614$NOVO NORDISK$$53$YR$$F$Y$$$20240710$$HP$AU$AU
240678131$24067813$1$I$20240606$20240628$20240710$20240710$EXP$$US-NOVOPROD-1248527$NOVO NORDISK$$24$YR$$M$Y$$$20240710$$CN$US$US
240678141$24067814$1$I$$20240701$20240710$20240710$EXP$AU-TGA-0000781022$AU-NOVOPROD-1249528$NOVO NORDISK$$46$YR$$F$Y$$$20240710$$CN$AU$AU
240678151$24067815$1$I$20240422$20240701$20240710$20240710$EXP$$JP-NOVOPROD-1233571$NOVO NORDISK$$74$YR$$M$Y$64$KG$20240710$$MD$JP$JP
240678161$24067816$1$I$20231213$20240701$20240710$20240710$EXP$NO-NOMAADVRE-RELISV-2024-Vzb8g8$NO-NOVOPROD-1247737$NOVO NORDISK$$43$YR$$F$Y$$$20240710$$MD$NO$NO
240678171$24067817$1$I$$20240701$20240710$20240710$EXP$$US-NOVOPROD-1250289$NOVO NORDISK$$$$$M$Y$$$20240710$$CN$US$US
240678181$24067818$1$I$$20240630$20240710$20240710$EXP$$US-NOVOPROD-1248832$NOVO NORDISK$$54$YR$$F$Y$$$20240710$$CN$US$US
240678192$24067819$2$F$$20240821$20240710$20240902$30DAY$$US-NOVOPROD-1249010$NOVO NORDISK$$$$$F$Y$$$20240902$$CN$US$US
240678201$24067820$1$I$20240311$20240628$20240710$20240710$EXP$$US-NOVOPROD-1248524$NOVO NORDISK$$75$YR$$M$Y$$$20240710$$CN$US$US
240678212$24067821$2$F$$20240628$20240710$20240712$EXP$$BE-NOVOPROD-1248629$NOVO NORDISK$$$$$F$Y$$$20240712$$MD$BE$BE
240678222$24067822$2$F$$20240903$20240710$20240906$PER$$US-AMGEN-USASP2024135594$AMGEN$$$$A$F$Y$$$20240906$$HP$US$US
240678241$24067824$1$I$$20240703$20240710$20240710$30DAY$$US-GSK-US2024083144$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
240678251$24067825$1$I$20240526$20240703$20240710$20240710$EXP$$BR-GSK-BR2024AMR073803$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$BR$BR
240678261$24067826$1$I$20220101$20240530$20240710$20240710$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS003421$TERSERA THERAPEUTICS$Cao J et al.. Comprehensive Treatment of Metastatic Prostate Cancer: a Case Report and Literature Review.. World Latest Medicine Information. 2024;24(24):340-342$$$$$Y$$$20240710$$MD$CN$CN
240678272$24067827$2$F$20240618$20240702$20240710$20240711$EXP$$CN-JNJFOC-20240708037$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240711$$HP$CN$CN
240678281$24067828$1$I$$20240704$20240710$20240710$EXP$$US-JNJFOC-20240713277$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240678291$24067829$1$I$20240705$20240708$20240710$20240710$PER$$US-BIOVITRUM-2024-US-009656$BIOVITRUM$$3$MON$$M$Y$$$20240710$$CN$US$US
240678301$24067830$1$I$20240527$20240701$20240710$20240710$PER$$US-AstraZeneca-2024A151589$ASTRAZENECA$$19916$DY$$F$Y$77.1$KG$20240710$$HP$US$
240678311$24067831$1$I$$20240701$20240710$20240710$EXP$$CH-DECIPHERA PHARMACEUTICALS LLC-2024CH000586$DECIPHERA PHARMACEUTICALS$$$$$$Y$$$20240710$$MD$CH$CH
240678322$24067832$2$F$$20240822$20240710$20240902$30DAY$$ES-NOVOPROD-1249327$NOVO NORDISK$$$$$F$Y$$$20240902$$CN$ES$ES
240678331$24067833$1$I$20240627$20240703$20240710$20240710$30DAY$$AR-NOVOPROD-1249639$NOVO NORDISK$$$$$M$Y$$$20240710$$CN$AR$AR
240678341$24067834$1$I$$20240704$20240710$20240710$PER$$US-ABBVIE-5829976$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240678351$24067835$1$I$20231101$20240702$20240710$20240710$EXP$$MX-BIOVITRUM-2024-MX-005816$BIOVITRUM$$3$MON$$F$Y$6.9$KG$20240710$$CN$MX$MX
240678363$24067836$3$F$20240702$20240730$20240710$20240828$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-095219$REGENERON$$49$YR$$M$Y$$$20240828$$HP$DE$DE
240678372$24067837$2$F$$20240705$20240710$20240712$EXP$$CA-GSK-CA2023062305$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$MD$CA$CA
240678381$24067838$1$I$$20240611$20240710$20240710$PER$$US-ROCHE-10000018407$ROCHE$Breneman A, Eber A, Haque H, Askanase A, Riley C, Et al.. Vulvovaginal Pyoderma Gangrenosum in a Patient Treated With Ocrelizumab for Multiple Sclerosis. Journal of Lower Genital Tract Disease. 2022-Apr-01;26 (2):189-91. doi:10.1097/LGT.0000000000000661.$55$YR$A$F$Y$$$20240710$$HP$US$US
240678391$24067839$1$I$$20240627$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-031166$AUROBINDO$$$$$F$Y$118.8$KG$20240710$$CN$US$US
240678401$24067840$1$I$$20240624$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06196$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240678411$24067841$1$I$20230704$20240705$20240710$20240710$EXP$$NVSJ2024JP008231$NOVARTIS$$59$YR$$M$Y$$$20240710$$MD$JP$JP
240678421$24067842$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005058$ELI LILLY AND CO$$44$YR$A$$Y$$$20240710$$CN$US$US
240678431$24067843$1$I$20240707$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005312$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240710$$CN$US$US
240678442$24067844$2$F$20240706$20240709$20240710$20240711$PER$$US-AMGEN-USASP2024134819$AMGEN$$83$YR$E$M$Y$$$20240710$$CN$US$US
240678451$24067845$1$I$20240508$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010379$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240678461$24067846$1$I$$20240701$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01161$NOVITIUM PHARMA$M. Pandey.Pneumocystis Pneumonia in a Patient With Prolonged Steroid Therapy.American Journal of Respiratory and Critical Care Medicine.19-MAY-2024;209:A2392$65$YR$A$M$Y$$$20240710$$HP$US$US
240678471$24067847$1$I$$20240703$20240710$20240710$EXP$$US-TAKEDA-2024TUS067553$TAKEDA$$$$$F$Y$$$20240710$$CN$US$US
240678494$24067849$4$F$20221221$20240816$20240710$20240912$EXP$$CA-BEH-2024175094$CSL BEHRING$$64$YR$A$M$Y$84$KG$20240912$$HP$CA$CA
240678501$24067850$1$I$20240101$20240703$20240710$20240710$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000595$DECIPHERA PHARMACEUTICALS$$53$YR$A$M$Y$$$20240710$$CN$US$US
240678521$24067852$1$I$$20240703$20240710$20240710$EXP$$US-GSK-US2024082655$GLAXOSMITHKLINE$$$$$M$Y$$$20240710$$MD$US$US
240678531$24067853$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135729$AMGEN$$$$$$Y$$$20240709$$MD$US$US
240678541$24067854$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135649$AMGEN$$$$$$Y$$$20240709$$HP$US$US
240678551$24067855$1$I$20240629$20240701$20240710$20240710$EXP$GB-MHRA-MED-202407011648125660-STYZG$GB-TEVA-VS-3216328$TEVA$$72$YR$$F$Y$$$20240710$$CN$GB$GB
240678561$24067856$1$I$$20240703$20240710$20240710$PER$$US-JNJFOC-20240710318$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
240678572$24067857$2$F$20240101$20240719$20240710$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-020796$UNITED THERAPEUTICS$$$$$M$Y$87.982$KG$20240724$$$US$US
240678581$24067858$1$I$$20240702$20240710$20240710$PER$$US-JNJFOC-20240709446$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$MD$US$US
240678592$24067859$2$F$20240622$20240703$20240710$20240710$EXP$$US-GILEAD-2024-0679526$GILEAD$$65$YR$E$F$Y$$$20240709$$HP$US$US
240678602$24067860$2$F$20240501$20240708$20240710$20240710$PER$$US-JNJFOC-20240709958$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$CN$US$US
240678611$24067861$1$I$$20240703$20240710$20240710$30DAY$$US-GSK-US2024083249$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
240678621$24067862$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2014-02260$AUROBINDO$Li Z, Rajan D, Wang X, Frieri M. Ciprofloxacin induced acute generalized exanthematous pustulosis.. Annals of Allergy, Asthma and Immunology. 2013;111:No.5:335 -$79$YR$$M$Y$$$20240710$$HP$US$US
240678631$24067863$1$I$$20240701$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01159$NOVITIUM PHARMA$C. T. Le.Advanced Care in Rheumatoid Arthritis With Biologic Agents: The Role of Pneumocystis Jirovecii Pneumonia Prophylaxis.American Journal of Respiratory and Critical Care Medicine .19-MAY-2024;209:A2388 - A2388$66$YR$A$F$Y$$$20240710$$HP$US$US
240678641$24067864$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA199736$SANOFI AVENTIS$$48$YR$A$M$Y$83.91$KG$20240710$$MD$US$US
240678651$24067865$1$I$20240620$20240702$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010269$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240678661$24067866$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA196420$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240710$$MD$US$US
240678671$24067867$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA196519$SANOFI AVENTIS$$57$YR$A$M$Y$124.7$KG$20240710$$MD$US$US
240678681$24067868$1$I$$20240703$20240710$20240710$PER$$US-ALXN-202407USA000249US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240710$$PH$US$US
240678691$24067869$1$I$20231201$20240622$20240710$20240710$EXP$$AE-ROCHE-10000017490$ROCHE$$$$$F$Y$$$20240710$$CN$AE$AE
240678703$24067870$3$F$20240701$20240726$20240710$20240729$PER$$US-AMGEN-USASP2024135776$AMGEN$$79$YR$E$F$Y$$$20240729$$CN$US$US
240678712$24067871$2$F$20240705$20240816$20240710$20240821$PER$$US-AMGEN-USASP2024134273$AMGEN$$77$YR$E$F$Y$$$20240820$$CN$US$US
240678722$24067872$2$F$20190101$20240722$20240710$20240730$EXP$$RO-AMGEN-ROUSP2024131791$AMGEN$$64$YR$A$F$Y$$$20240730$$MD$RO$RO
240678731$24067873$1$I$20240101$20240701$20240710$20240710$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000588$DECIPHERA PHARMACEUTICALS$$37$YR$A$M$Y$$$20240710$$CN$US$US
240678741$24067874$1$I$20240526$20240617$20240710$20240710$EXP$$CN-HALEON-2182362$Haleon PLC$$85$YR$$M$Y$50$KG$20240709$$HP$CN$CN
240678751$24067875$1$I$20240701$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135558$AMGEN$$68$YR$E$F$Y$$$20240709$$HP$US$US
240678761$24067876$1$I$20240601$20240703$20240710$20240710$PER$$US-ALMUS-US-2024-1597$ALMUS$$68$YR$E$F$Y$$$20240710$$CN$US$US
240678771$24067877$1$I$20240219$20240702$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010270$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240678781$24067878$1$I$$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024134172$AMGEN$$$$$M$Y$$$20240709$$CN$US$US
240678791$24067879$1$I$20240611$20240627$20240710$20240710$EXP$FR-AFSSAPS-PV2024000567$FR-AMGEN-FRASP2024133351$AMGEN$$2$YR$C$F$Y$12.8$KG$20240709$$MD$FR$FR
240678801$24067880$1$I$20240704$20240705$20240710$20240710$PER$$US-SA-2024SA201046$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240710$$CN$US$US
240678811$24067881$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA196494$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240710$$CN$US$US
240678821$24067882$1$I$$20240705$20240710$20240710$PER$$US-SA-2024SA200765$SANOFI AVENTIS$$$$A$M$Y$$$20240710$$MD$US$US
240678834$24067883$4$F$$20240820$20240710$20240822$PER$$US-ROCHE-10000019921$ROCHE$$$$T$M$Y$$$20240822$$CN$US$US
240678841$24067884$1$I$$20240628$20240710$20240710$PER$$US-ROCHE-10000019191$ROCHE$$$$C$M$Y$$$20240710$$MD$US$US
240678851$24067885$1$I$$20240701$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01165$NOVITIUM PHARMA$Singh N.A Growing Concern: Solitary Pulmonary Nodule Caused by Pneumocystis Jirovecci in an Immunocompromised Patient.American Journal of Respiratory and Critical Care Medicine.2024;209:A2381$71$YR$E$M$Y$$$20240710$$HP$US$US
240678862$24067886$2$F$$20240719$20240710$20240729$EXP$$HU-TEVA-VS-3217036$TEVA$Robert L, Kovacs A, Sardy M, Fabian M. SARS-CoV-2 Infection in Pemphigus Vulgaris Two Weeks after Rituximab Therapy with Total Recovery: A Case Report. Acta-Dermatovenerol-Croat 2023; 31 (3): 156-157.; Robert L, Kovacs A, Sardy M, Fabian M. SARS-CoV-2 Infection in Pemphigus Vulgaris Two Weeks after Rituximab Therapy with Total Recovery: A Case Report. Acta-Dermatovenerol-Croat 2023; 31 (3): 156-157.$63$YR$$F$Y$$$20240729$$MD$HU$HU
240678871$24067887$1$I$$20240705$20240710$20240710$PER$$NVSC2024US140844$NOVARTIS$$$$$$Y$$$20240710$$CN$US$US
240678881$24067888$1$I$$20240709$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038838$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240710$$CN$US$US
240678892$24067889$2$F$$20240717$20240710$20240720$PER$$US-JNJFOC-20240720370$JOHNSON AND JOHNSON$$46$YR$A$M$Y$86.26$KG$20240720$$CN$US$US
240678901$24067890$1$I$$20240705$20240710$20240710$EXP$$US-GSK-US2024AMR084352$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$US$US
240678912$24067891$2$F$$20240712$20240710$20240726$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14921$ALKEM$$$$$M$Y$$$20240726$$CN$US$US
240678921$24067892$1$I$$20240626$20240710$20240710$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14204$ALKEM$$87$YR$$M$Y$$$20240710$$HP$AU$AU
240678951$24067895$1$I$$20240626$20240710$20240710$EXP$DE-EMBRYOTOX-202301664$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14210$ALKEM$$$$A$F$Y$73$KG$20240710$$MD$DE$DE
240678961$24067896$1$I$$20240626$20240710$20240710$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14207$ALKEM$$$$$F$Y$$$20240710$$MD$DE$DE
240678971$24067897$1$I$$20240626$20240710$20240710$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14217$ALKEM$$61$YR$$F$Y$$$20240710$$HP$AU$AU
240678981$24067898$1$I$$20240701$20240710$20240710$EXP$$BE-AUROBINDO-AUR-APL-2024-033244$AUROBINDO$Hendrickx T, Peetermans M, D^hoore A, Claes K, Van Hootegem A, Sabino J. STEC colitis mimicking acute severe colitis with life-threatening consequences: a case report. Acta Gastro-Enterologica Belgica. 2024;87(1):37-39$18$YR$$M$Y$$$20240710$$MD$BE$BE
240678992$24067899$2$F$20220901$20240704$20240710$20240718$EXP$US-MLMSERVICE-20240619-PI103555-00232-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14214$ALKEM$Antonelli JP, Quach M, Mahajan A, Pleva J, Ma VT.. Rapid Life-Saving Response to Anti-PD-1 in a Solid Organ Transplant Recipient with Metastatic Cutaneous Squamous Cell Carcinoma: A Case Report and Review. Journal of Immunotherapy. 2024;47(6):216-219$5$DEC$$M$Y$$$20240718$$MD$US$US
240679001$24067900$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004205$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240710$$CN$US$US
240679011$24067901$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005060$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240710$$CN$US$US
240679021$24067902$1$I$$20240701$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01162$NOVITIUM PHARMA$J. Xiong.Resistant Pneumocystis Jiroveci Pneumonia in Patients With ANCAAssociated Vasculitis.American Journal of Respiratory and Critical Care Medicine.MAY-2024;NA:A6323$68$YR$A$M$Y$$$20240710$$HP$US$US
240679031$24067903$1$I$$20240610$20240710$20240710$PER$$US-GLK-002351$GLAUKOS$$$$$F$Y$$$20240710$$MD$US$US
240679041$24067904$1$I$$20240702$20240710$20240710$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01185$NOVITIUM PHARMA$Gaetano Maria Celardo.Case report: Exploring chemoradiotherapy-induced leukoencephalopathy with 7T imaging and quantitative susceptibility mapping.Frontiers in Neurology.14-FEB-2024;15:1-6$9$YR$C$M$Y$$$20240710$$HP$IT$IT
240679051$24067905$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186177$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240679063$24067906$3$F$20240627$20240720$20240710$20240801$EXP$$CA-ROCHE-10000019118$ROCHE$$47$YR$A$F$Y$$$20240801$$CN$CA$CA
240679073$24067907$3$F$20240501$20240823$20240710$20240826$EXP$$AU-ROCHE-10000018338$ROCHE$$35$YR$A$M$Y$$$20240826$$MD$AU$AU
240679081$24067908$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032945$AUROBINDO$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al.. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant. 2023;23(7):1048-1057$$$A$F$Y$$$20240710$$HP$US$US
240679091$24067909$1$I$20240630$20240701$20240710$20240710$EXP$$US-009507513-2407USA001083$MERCK$$$$$F$Y$$$20240710$$CN$US$US
240679102$24067910$2$F$20240612$20240802$20240710$20240806$EXP$FR-AFSSAPS-AN2024000835$FR-GSK-FR2024083831$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$MD$FR$FR
240679111$24067911$1$I$$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024134618$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240679121$24067912$1$I$$20240626$20240710$20240710$EXP$$IT-STERISCIENCE B.V.-2024-ST-000977$Steriscience PTE$Garbo V, Condemi A, Albano C, Polara VF, Parrino R, Macaluso A, et al.. Dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients: a case series.. Infezioni-in-Medicina. 2024;32(2):231-240$3$MON$$$Y$$$20240710$$HP$IT$IT
240679131$24067913$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032948$AUROBINDO$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant. 2023;23(7):1048-1057$$$E$M$Y$$$20240710$$HP$US$US
240679142$24067914$2$F$20240704$20240709$20240710$20240711$PER$$US-AMGEN-USASP2024135165$AMGEN$$81$YR$E$F$Y$$$20240711$$CN$US$US
240679152$24067915$2$F$20221212$20240708$20240710$20240716$EXP$$FR-CELLTRION INC.-2024FR016100$CELLTRION$$$$$$Y$$$20240716$$PH$FR$FR
240679161$24067916$1$I$$20240628$20240710$20240710$EXP$$ZA-MACLEODS PHARMA-MAC2024048030$MACLEODS$$$$$$Y$$$20240710$$CN$ZA$ZA
240679172$24067917$2$F$20240606$20240807$20240710$20240817$EXP$$GB-MACLEODS PHARMA-MAC2024048075$MACLEODS$$$$$$Y$$$20240817$$PH$GB$GB
240679181$24067918$1$I$$20240624$20240710$20240710$PER$$US-CHATTEMPRD-2024OHG023175$CHATTEM$$26$YR$A$F$Y$$$20240710$$CN$US$US
240679193$24067919$3$F$20240101$20240904$20240710$20240911$EXP$$CA-CELLTRION INC.-2024CA014177$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
240679201$24067920$1$I$$20240708$20240710$20240710$PER$$US-HALEON-2186113$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240679211$24067921$1$I$$20240703$20240710$20240710$EXP$CA-HPFB-001052520$CA-SERVIER-S24001480$SERVIER$$$$$$Y$$$20240710$$PH$CA$CA
240679221$24067922$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032925$AUROBINDO$Sherman M, Holden K, Sweeney R, Dumont TL, Appiah-Kubi E. A Case of Babesiosis Induced Sepsis Hemophagocytic Lymphohistiocytosis Overlap Syndrome in Pennsylvania. Am-J-Respir-CritCare-Med. 2024;209:A7336$74$YR$$F$Y$$$20240710$$HP$US$US
240679231$24067923$1$I$$20240702$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01171$NOVITIUM PHARMA$A. C. Yeates.Fungal Duo: A Case of Disseminated Histoplasmosis and Pneumocystis Pneumonia Competing for the Spotlight.American Journal of Respiratory and Critical Care Medicine.20-MAY-2024;209:A3575 - A3575$66$YR$A$M$Y$$$20240710$$HP$US$US
240679241$24067924$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-033227$AUROBINDO$Kaur L, Kaur R, Shakir M, Basit S, Ray B, Chaudhary T. Navigating the Uncharted: Primary Pulmonary Carcinosarcoma With Metastasis Treated With Induction Chemotherapy. Am J Respir Crit Care Med. 2024;209:A6526$56$YR$$M$Y$$$20240710$$HP$US$US
240679252$24067925$2$F$$20240822$20240710$20240904$EXP$$US-AUROBINDO-AUR-APL-2024-032897$AUROBINDO$Riha EN, Kim A, Tang J, Kesavan R, Girgawy E, Sarva S.. Catching Flights and Malaria.. Am-JRespir-Crit-Care-Med. 2024;209:A5545$69$YR$$F$Y$$$20240904$$HP$US$US
240679261$24067926$1$I$$20240702$20240710$20240710$PER$$US-CHATTEMPRD-2024OHG023032$CHATTEM$$$$$M$Y$$$20240710$$CN$US$US
240679272$24067927$2$F$$20240812$20240710$20240816$PER$$US-ROCHE-10000019063$ROCHE$$$$A$M$Y$$$20240816$$CN$US$US
240679282$24067928$2$F$20240312$20240821$20240710$20240827$EXP$$US-JNJFOC-20240429588$JOHNSON AND JOHNSON$$68$YR$E$M$Y$86.4$KG$20240827$$HP$US$US
240679291$24067929$1$I$$20240621$20240710$20240710$PER$$US-009507513-2406USA007872$MERCK$Schott C, Massad K.M, Held N. Disseminated Nocardiosis in a Sarcoidosis Patient Off Pneumocystis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2418$81$YR$$M$Y$$$20240709$$HP$US$US
240679301$24067930$1$I$$20240704$20240710$20240710$EXP$$DE-009507513-2407DEU002768$MERCK$$$$$F$Y$$$20240709$$MD$DE$DE
240679311$24067931$1$I$20230101$20240702$20240710$20240710$PER$$US-009507513-2407USA001126$MERCK$$72$YR$$M$Y$98.44$KG$20240709$$HP$US$US
240679322$24067932$2$F$$20240709$20240710$20240711$PER$$US-AMGEN-USASP2024135212$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240679332$24067933$2$F$20240702$20240709$20240710$20240711$PER$$US-AMGEN-USASP2024135220$AMGEN$$74$YR$E$M$Y$$$20240711$$PH$US$US
240679344$24067934$4$F$$20240905$20240710$20240909$PER$$US-HALEON-2186004$Haleon PLC$$57$YR$$M$Y$$$20240909$$CN$US$US
240679361$24067936$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032914$AUROBINDO$H. Khalil, E. B. Ernst, N. Fitzpatrick. The Worst Cough in HISTOry. Am-J-Respir-Crit-Care-Med. 2024;209:A2377$76$YR$$M$Y$$$20240710$$HP$US$US
240679371$24067937$1$I$$20240708$20240710$20240710$PER$$US-TAKEDA-2024TUS069555$TAKEDA$$$$$F$Y$56$KG$20240710$$CN$US$US
240679381$24067938$1$I$$20240627$20240710$20240710$PER$$US-ROCHE-10000020972$ROCHE$$39$YR$A$F$Y$$$20240710$$CN$US$US
240679391$24067939$1$I$$20240627$20240710$20240710$PER$$US-ROCHE-10000020500$ROCHE$$$$A$F$Y$$$20240710$$CN$US$US
240679401$24067940$1$I$$20240705$20240710$20240710$PER$$US-CHATTEMPRD-2024OHG023503$CHATTEM$$$$$$Y$$$20240710$$CN$US$US
240679411$24067941$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109169$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240710$$CN$US$US
240679422$24067942$2$F$20240228$20240709$20240710$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108956$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240711$$CN$US$US
240679431$24067943$1$I$$20240701$20240710$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-108620$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240710$$MD$JP$JP
240679441$24067944$1$I$20240607$20240705$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108195$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240710$$PH$US$US
240679453$24067945$3$F$20230407$20240918$20240710$20240923$EXP$$US-AMGEN-USASP2024133292$AMGEN$$50$YR$A$F$Y$$$20240923$$LW$US$US
240679461$24067946$1$I$$20240702$20240710$20240710$PER$$US-ROCHE-10000019786$ROCHE$$68$YR$E$F$Y$$$20240710$$CN$US$US
240679471$24067947$1$I$$20240703$20240710$20240710$PER$$US-ROCHE-10000018767$ROCHE$$$$$$Y$$$20240710$$HP$US$US
240679481$24067948$1$I$$20240701$20240710$20240710$30DAY$$US-GSK-US2024AMR082886$GLAXOSMITHKLINE$$72$YR$$M$Y$$$20240710$$CN$US$US
240679492$24067949$2$F$20240701$20240709$20240710$20240716$EXP$$CA-JNJFOC-20240610531$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240716$$HP$CA$CA
240679501$24067950$1$I$$20240704$20240710$20240710$PER$$US-ROCHE-10000019741$ROCHE$$$$$$Y$$$20240710$$CN$US$US
240679511$24067951$1$I$$20240704$20240710$20240710$PER$$US-ROCHE-10000018688$ROCHE$$59$YR$A$M$Y$$$20240710$$PH$US$US
240679521$24067952$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-033081$AUROBINDO$Bhatia S, Jamil A, Sharif M, Skenderi S. Cardiovascular Collapse Shortly After Beta Blockers in Atrial Fibrillationcomplicated Thyroid Storm. Am-J-Respir-Crit-Care-Med. 2024;209no:A3637$49$YR$$M$Y$$$20240710$$HP$US$US
240679531$24067953$1$I$$20240702$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01184$NOVITIUM PHARMA$C. Lam.A Critical Confluence: Acute Pulmonary Embolism Complicating Systemic Sclerosis- Associated Pulmonary Arterial Hypertension.American Journal of Respiratory and Critical Care Medicine.19-MAY-2024;209:1-3$58$YR$A$F$Y$$$20240710$$HP$US$US
240679542$24067954$2$F$$20240711$20240710$20240716$PER$$US-ROCHE-10000019699$ROCHE$$$$$F$Y$$$20240716$$CN$US$US
240679551$24067955$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032916$AUROBINDO$Simon LE, Rhoads S, Hippensteel JA.. Mucormycosis Tracheitis: A Rare Clinical Presentation.. AmJ-Respir-Crit-Care-Med. 2024;209:A6322$50$YR$$M$Y$$$20240710$$HP$US$US
240679561$24067956$1$I$20240415$20240708$20240710$20240710$EXP$$US-ROCHE-3565797$ROCHE$$65$YR$E$F$Y$$$20240710$$MD$US$US
240679571$24067957$1$I$$20240701$20240710$20240710$PER$$US-ROCHE-10000019458$ROCHE$$$$$$Y$$$20240710$$CN$US$US
240679583$24067958$3$F$20240707$20240827$20240710$20240828$PER$$US-AMGEN-USASP2024135430$AMGEN$$79$YR$E$M$Y$$$20240828$$CN$US$US
240679591$24067959$1$I$$20240701$20240710$20240710$PER$$US-TEVA-VS-3217388$TEVA$$49$YR$$F$Y$$$20240710$$CN$US$US
240679602$24067960$2$F$20220925$20240715$20240710$20240716$EXP$$NVSC2023GB094725$NOVARTIS$$83$YR$$M$Y$$$20240716$$HP$GB$GB
240679611$24067961$1$I$$20240702$20240710$20240710$EXP$$CO-AstraZeneca-2024A154040$ASTRAZENECA$$24388$DY$$F$Y$$$20240710$$CN$CO$
240679621$24067962$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005149$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240710$$CN$US$US
240679631$24067963$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005205$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240710$$CN$US$US
240679651$24067965$1$I$$20240702$20240710$20240710$PER$$US-JNJFOC-20240707054$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$HP$US$US
240679661$24067966$1$I$$20240702$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01173$NOVITIUM PHARMA$J. Huang.Recognizing Veno-occlusive Disease After Inotuzumab Treatment: An Urgent Call to Physicians in Non-Transplant Centers.American Journal of Respiratory and Critical Care Medicine.21-MAY-24;209:A5656 - A5656$47$YR$A$F$Y$$$20240710$$HP$US$US
240679671$24067967$1$I$$20240615$20240710$20240710$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002863$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
240679681$24067968$1$I$20240324$20240627$20240710$20240710$EXP$FR-AFSSAPS-GR2024000753$FR-Merck Healthcare KGaA-2024035143$MERCK KGAA$$53$YR$A$F$Y$$$20240703$$PH$FR$FR
240679692$24067969$2$F$20240627$20240917$20240710$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-032886$AUROBINDO$$$$A$F$Y$51.6$KG$20240926$$MD$FR$FR
240679702$24067970$2$F$$20240606$20240710$20240712$EXP$$SK-ROCHE-RCA5208427$ROCHE$$$$$$Y$$$20240712$$PH$SK$SK
240679711$24067971$1$I$20240619$20240703$20240710$20240710$EXP$$CN-ROCHE-10000020399$ROCHE$$71$YR$E$F$Y$61$KG$20240710$$HP$CN$CN
240679721$24067972$1$I$$20240624$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06213$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240679731$24067973$1$I$$20240705$20240710$20240710$EXP$$US-JNJFOC-20240715734$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$PH$US$US
240679741$24067974$1$I$$20240703$20240710$20240710$EXP$$US-GSK-US2024AMR084346$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$US$US
240679752$24067975$2$F$$20240808$20240710$20240816$30DAY$$US-GSK-US2024081569$GLAXOSMITHKLINE$$$$$M$Y$$$20240816$$MD$US$US
240679771$24067977$1$I$20240601$20240616$20240710$20240710$PER$$US-JNJFOC-20240666317$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240710$$CN$US$US
240679783$24067978$3$F$20240701$20240919$20240710$20240926$EXP$$NVSJ2024JP008171$NOVARTIS$$31$YR$$M$Y$$$20240927$$MD$JP$JP
240679791$24067979$1$I$20240108$20240625$20240710$20240710$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455583$RANBAXY$$56$YR$$F$Y$$$20240710$$PH$ES$ES
240679802$24067980$2$F$20090101$20240703$20240710$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455554$RANBAXY$$38$YR$$M$Y$$$20240718$$CN$FR$FR
240679811$24067981$1$I$$20240625$20240710$20240710$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455998$RANBAXY$Jabiry-Zieniewicz Z, Stelmach DA, Jasak K, Knap-Wielgus W, Szumska A, Raszeja Wyszomirska J, et al. Pregnancies in Women After Liver Transplant due to Wilson?s Disease - CaseSeries. Transplantation Proceedings. 2024;56 (4):919-922$$$I$$Y$$$20240710$$HP$PL$PL
240679821$24067982$1$I$20240126$20240625$20240710$20240710$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455565$RANBAXY$$91$YR$$F$Y$$$20240710$$MD$ES$ES
240679831$24067983$1$I$$20240625$20240710$20240710$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455982$RANBAXY$Jabiry-Zieniewicz Z, Stelmach DA, Jasak K, Knap-Wielgus W, Szumska A, Raszeja Wyszomirska J, et al. Pregnancies in Women After Liver Transplant due to Wilson?s Disease - CaseSeries. Transplantation Proceedings. 2024;56 (4):919-922$$$$F$Y$$$20240710$$HP$PL$PL
240679841$24067984$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135671$AMGEN$$$$$$Y$$$20240709$$HP$US$US
240679851$24067985$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135951$AMGEN$$$$$M$Y$$$20240709$$CN$US$US
240679861$24067986$1$I$$20240702$20240710$20240710$PER$$US-AMGEN-USASP2024133563$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$66$YR$E$M$Y$$$20240709$$HP$US$US
240679871$24067987$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135670$AMGEN$$$$$$Y$$$20240709$$MD$US$US
240679881$24067988$1$I$20230101$20240702$20240710$20240710$EXP$$DE-AMGEN-DEUSP2024131035$AMGEN$$65$YR$E$F$Y$$$20240709$$CN$DE$DE
240679891$24067989$1$I$$20240702$20240710$20240710$PER$$US-AMGEN-USASP2024133495$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$60$YR$A$F$Y$$$20240709$$HP$US$US
240679901$24067990$1$I$$20240702$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01177$NOVITIUM PHARMA$C. Barrows.A Case of Acute Hypoxic Respiratory Failure After Administration of Rituximab.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;209:A6326$61$YR$A$M$Y$$$20240710$$HP$US$US
240679911$24067991$1$I$20240502$20240701$20240710$20240710$30DAY$$US-GSK-US2024081599$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240710$$CN$US$US
240679921$24067992$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135977$AMGEN$$$$$F$Y$$$20240709$$CN$US$US
240679931$24067993$1$I$20240201$20240702$20240710$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-032979$AUROBINDO$$88$YR$$M$Y$62$KG$20240710$$MD$FR$FR
240679941$24067994$1$I$$20240702$20240710$20240710$PER$$US-AMGEN-USASP2024133569$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$63$YR$A$M$Y$$$20240709$$HP$US$US
240679951$24067995$1$I$$20240702$20240710$20240710$PER$$US-AMGEN-USASP2024133617$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$71$YR$E$M$Y$$$20240709$$HP$US$US
240679961$24067996$1$I$$20240217$20240710$20240710$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202402-000177$UNICHEM$$$$$F$Y$$$20240710$$CN$US$
240679981$24067998$1$I$20240629$20240705$20240710$20240710$EXP$$CN-ROCHE-10000019452$ROCHE$$54$YR$A$F$Y$68$KG$20240710$$HP$CN$CN
240679991$24067999$1$I$20221001$20240701$20240710$20240710$EXP$$US-APOTEX-2024AP007938$APOTEX$Ouyang J, Sasidharan S, Jatoi T, Salifu M.. How High Can Anion Gaps Be in Patients With Metabolic Acidosis? A Case Report. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3409$61$YR$$F$Y$$$20240710$$HP$US$US
240680001$24068000$1$I$$20240624$20240710$20240710$EXP$$CA-TEVA-VS-3214274$TEVA$$44$YR$$F$Y$97$KG$20240709$$HP$CA$CA
240680011$24068001$1$I$$20240627$20240710$20240710$EXP$$IT-STERISCIENCE B.V.-2024-ST-000980$Steriscience PTE$Marasco E, Bracaglia C, Merli P, Alvarez PM, Nicolai R, Algeri M, et al. ANTI-CD19 CAR-T CELL THERAPY FOR REFRACTORY CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS.. Lupus-Sci-Med. 2024;11 (Suppl. 1):A113 (plus Poster) abstr. P101$15$YR$$F$Y$$$20240710$$HP$IT$IT
240680021$24068002$1$I$$20240705$20240710$20240710$PER$$US-ROCHE-10000021205$ROCHE$$$$C$F$Y$$$20240710$$CN$US$US
240680032$24068003$2$F$$20240709$20240710$20240711$PER$$US-JNJFOC-20240721352$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240680041$24068004$1$I$20240621$20240705$20240710$20240710$EXP$$CN-ROCHE-10000019555$ROCHE$$51$YR$A$F$Y$61$KG$20240710$$HP$CN$CN
240680051$24068005$1$I$$20240627$20240710$20240710$EXP$$CA-STERISCIENCE B.V.-2024-ST-000974$Steriscience PTE$Mccoy J, Lobos A, De Nanassy J, Perrem L.. A Novel Mutation in Pulmonary Alveolar Microlithiasis With Disseminated Pseudomonas Infection.. Am-J-Respir-Crit-Care-Med. 2024;209$6$MON$$F$Y$$$20240710$$HP$CA$CA
240680062$24068006$2$F$20240101$20240902$20240710$20240910$EXP$$DE-CELLTRION INC.-2024DE016245$CELLTRION$$$$$$Y$$$20240910$$MD$DE$DE
240680071$24068007$1$I$$20240702$20240710$20240710$PER$$US-AMGEN-USASP2024133684$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$51$YR$A$F$Y$$$20240710$$HP$US$US
240680082$24068008$2$F$20240705$20240712$20240710$20240723$PER$$US-AMGEN-USASP2024134812$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
240680101$24068010$1$I$$20240701$20240710$20240710$30DAY$$US-GSK-US2024082068$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$HP$US$US
240680111$24068011$1$I$20231001$20240703$20240710$20240710$EXP$$IT-AUROBINDO-AUR-APL-2024-033108$AUROBINDO$$37$YR$$F$Y$57$KG$20240710$$MD$IT$IT
240680121$24068012$1$I$$20240702$20240710$20240710$PER$$US-AMGEN-USASP2024133731$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$65$YR$E$M$Y$$$20240710$$HP$US$US
240680131$24068013$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005556$ELI LILLY AND CO$$$$$F$Y$$$20240710$$CN$US$US
240680141$24068014$1$I$20240705$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005063$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240710$$CN$US$US
240680151$24068015$1$I$$20240702$20240710$20240710$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01181$NOVITIUM PHARMA$Ilaria Costantini.Not only Van Gogh: a case of BRASH syndrome with concomitant digoxin toxicity.Journal of Medical Case Reports.09-JUN-2024;18(1):273$66$YR$E$F$Y$$$20240710$$HP$IT$IT
240680161$24068016$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005178$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240710$$CN$US$US
240680171$24068017$1$I$$20240703$20240710$20240710$PER$$US-ROCHE-10000019955$ROCHE$$$$A$F$Y$$$20240710$$CN$US$US
240680182$24068018$2$F$20240707$20240709$20240710$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005538$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240711$$CN$US$US
240680192$24068019$2$F$$20240814$20240710$20240817$EXP$$CN-ROCHE-10000010192$ROCHE$$$$$F$Y$$$20240817$$MD$CN$CN
240680212$24068021$2$F$20240609$20240717$20240710$20240730$PER$$US-ROCHE-10000001860$ROCHE$$59$YR$A$F$Y$$$20240730$$CN$US$US
240680223$24068022$3$F$20240626$20240830$20240710$20240905$EXP$$CA-ROCHE-10000019853$ROCHE$$37$YR$A$M$Y$$$20240905$$CN$CA$CA
240680231$24068023$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135867$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240680241$24068024$1$I$20231128$20240625$20240710$20240710$EXP$$DE-ROCHE-10000018505$ROCHE$$46$YR$A$F$Y$$$20240709$$MD$DE$DE
240680251$24068025$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135611$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240680262$24068026$2$F$20240708$20240710$20240710$20240712$PER$$US-AMGEN-USASP2024135420$AMGEN$$79$YR$E$F$Y$$$20240712$$CN$US$US
240680272$24068027$2$F$20120101$20240812$20240710$20240826$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00337$MELINTA THERAPEUTICS$$$$$$Y$$$20240826$$CN$BR$BR
240680281$24068028$1$I$20240411$20240708$20240710$20240710$EXP$FR-AFSSAPS-CN2024000660$FR-ABBVIE-5832706$ABBVIE$$48$YR$$M$Y$70$KG$20240710$$MD$FR$FR
240680291$24068029$1$I$$20240703$20240710$20240710$EXP$$JP-ROCHE-10000019892$ROCHE$$9$DEC$E$$Y$$$20240710$$MD$JP$JP
240680301$24068030$1$I$$20240701$20240710$20240710$30DAY$$US-GSK-US2024AMR082899$GLAXOSMITHKLINE$$$$$M$Y$$$20240710$$CN$US$US
240680311$24068031$1$I$20240626$20240704$20240710$20240710$EXP$$ES-AUROBINDO-AUR-APL-2024-033318$AUROBINDO$$43$YR$$M$Y$$$20240710$$PH$ES$ES
240680321$24068032$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032890$AUROBINDO$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series. Pediatr-Nephrol. 2024$15$YR$$M$Y$$$20240710$$HP$US$US
240680331$24068033$1$I$20240101$20240702$20240710$20240710$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00572$CATALYST PHARMA$$$$$M$Y$64.5$KG$20240710$$CN$US$US
240680341$24068034$1$I$$20240701$20240710$20240710$EXP$$PT-AUROBINDO-AUR-APL-2024-032935$AUROBINDO$Pombal R, Silva L, Ferreira D. GENETIC PREDISPOSITION TO VACCINE-INDUCED IMMUNE THROMBOTIC THROMBOCYTOPENIA: IS THERE A FAMILYLINK?. European Journal of Case Reports in Internal Medicine. 2024;11No 6$28$YR$$M$Y$$$20240710$$HP$PT$PT
240680351$24068035$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405141202048080-JDHTV$GB-ABBVIE-5831453$ABBVIE$$51$YR$$F$Y$$$20240710$$MD$GB$GB
240680361$24068036$1$I$$20240703$20240710$20240710$EXP$$US-ROCHE-10000018319$ROCHE$$$$A$M$Y$$$20240710$$CN$US$US
240680371$24068037$1$I$$20240703$20240710$20240710$EXP$$CA-CELLTRION INC.-2024CA016672$CELLTRION$$$$$$Y$$$20240710$$CN$CA$CA
240680382$24068038$2$F$20221026$20240712$20240710$20240714$EXP$IT-MINISAL02-993802$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038295$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$$$20240714$$MD$IT$IT
240680392$24068039$2$F$$20240719$20240710$20240729$EXP$$US-TEVA-VS-3217759$TEVA$Patel S, Seibert AM, Murray NM, Arizmendez N, Lanspa MJ, Beesley SJ. West Nile Virus Meningoencephalitis in Liver Transplantation. Am-J-Respir-Crit-Care-Med 2024; 209 A7041.; Patel S, Seibert AM, Murray NM, Arizmendez N, Lanspa MJ, Beesley SJ. West Nile Virus Meningoencephalitis in Liver Transplantation. Am-J-Respir-Crit-Care-Med 2024; 209 A7041.$69$YR$$M$Y$$$20240729$$HP$US$US
240680411$24068041$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032947$AUROBINDO$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. American Journal of Transplantation. 2023;23(7):1048-1057$3$DEC$$M$Y$$$20240710$$HP$US$US
240680424$24068042$4$F$20240613$20240913$20240710$20240923$EXP$$ZA-CELLTRION INC.-2024ZA014626$CELLTRION$$$$$$Y$$$20240923$$CN$ZA$ZA
240680431$24068043$1$I$$20240701$20240710$20240710$30DAY$$US-GSK-US2024083012$GLAXOSMITHKLINE$$$$$M$Y$$$20240710$$CN$US$US
240680451$24068045$1$I$$20240704$20240710$20240710$PER$$US-JNJFOC-20240715515$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240710$$CN$US$US
240680464$24068046$4$F$20240703$20240807$20240710$20240809$PER$$US-JNJFOC-20240715485$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240809$$HP$US$US
240680471$24068047$1$I$20240621$20240702$20240710$20240710$EXP$$CN-ROCHE-10000014873$ROCHE$$60$YR$A$F$Y$52$KG$20240710$$HP$CN$CN
240680481$24068048$1$I$$20240630$20240710$20240710$EXP$$GB-JNJFOC-20240718080$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$HP$GB$GB
240680491$24068049$1$I$$20240701$20240710$20240710$EXP$$US-APOTEX-2024AP007933$APOTEX$Ozueh P, Agogbuo O, Walnofer A, Umezurike I, John L, Hammond TC, et al.. Breathtaking Intrathoracic Rhabdoid Tumor. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-3$63$YR$$M$Y$$$20240710$$HP$US$US
240680501$24068050$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06286$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240680511$24068051$1$I$20240708$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024134882$AMGEN$$$$$M$Y$$$20240710$$CN$US$US
240680522$24068052$2$F$$20240708$20240710$20240714$PER$$US-AMGEN-USASP2024135354$AMGEN$$84$YR$E$F$Y$$$20240714$$CN$US$US
240680531$24068053$1$I$$20240702$20240710$20240710$EXP$$CN-RDY-LIT/CHN/24/0009978$DR REDDYS$Zhai W, Liu H, Li J, Xin H. Pregabalin-induced rhabdomyolysis: a case series and literature analysis. Journal of International Medical Research. 2024 Jun;52(6): 1-7. doi:10.1177/03000605241257776.$10$DEC$E$F$Y$$$20240710$$HP$CN$CN
240680541$24068054$1$I$20231005$20240706$20240710$20240710$PER$$US-BIOVITRUM-2024-US-009614$BIOVITRUM$$71$YR$$M$Y$$$20240710$$CN$US$US
240680551$24068055$1$I$$20240701$20240710$20240710$30DAY$$US-GSK-US2024083228$GLAXOSMITHKLINE$$$$$M$Y$$$20240710$$CN$US$US
240680561$24068056$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-033223$AUROBINDO$Hossain S, Patten E, Anigbogu J. Daptomycin-induced Lung Injury. Am-J-Respir-Crit-Care-Med. 2024;209:A2004$55$YR$$M$Y$$$20240710$$HP$US$US
240680571$24068057$1$I$$20240627$20240710$20240710$PER$$US-ROCHE-10000014532$ROCHE$$$$$F$Y$$$20240710$$MD$US$US
240680581$24068058$1$I$$20240628$20240710$20240710$PER$$US-ROCHE-10000015481$ROCHE$$$$$F$Y$$$20240710$$HP$US$US
240680592$24068059$2$F$20210101$20240717$20240710$20240730$EXP$$US-ENDO USA, INC.-2024-002834$ENDO$$$$$M$Y$$$20240730$$CN$US$US
240680601$24068060$1$I$20240614$20240705$20240710$20240710$PER$$US-JNJFOC-20240716195$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$CN$US$US
240680611$24068061$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06291$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240680621$24068062$1$I$$20240709$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038813$BOEHRINGER INGELHEIM$$$$$$Y$$$20240710$$CN$US$US
240680631$24068063$1$I$$20240612$20240710$20240710$PER$$US-JNJFOC-20240648597$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$HP$US$US
240680641$24068064$1$I$$20240702$20240710$20240710$EXP$$GB-AUROBINDO-AUR-APL-2024-032898$AUROBINDO$$84$YR$$F$Y$$$20240710$$CN$GB$GB
240680651$24068065$1$I$$20240702$20240710$20240710$EXP$$FR-AUROBINDO-AUR-APL-2017-11839$AUROBINDO$Vayssade M, Makarawiez C, Mathieu S, Soubrier M, Tournadre A.. Immune reconstitution inflammatory syndrome (Iris) in Whipple disease (Wd). 12th Annual Congress of the European League Against Rheumatism. 2011$73$YR$$M$Y$$$20240710$$HP$FR$FR
240680663$24068066$3$F$20240601$20240903$20240710$20240910$EXP$$CO-JNJFOC-20240713354$JOHNSON AND JOHNSON$$79$YR$E$F$Y$87$KG$20240910$$HP$CO$CO
240680672$24068067$2$F$20210817$20240826$20240710$20240903$EXP$$US-AMGEN-USASP2024133233$AMGEN$$77$YR$E$F$Y$$$20240902$$LW$US$US
240680681$24068068$1$I$20240615$20240703$20240710$20240710$EXP$$GB-AUROBINDO-AUR-APL-2024-033179$AUROBINDO$$63$YR$$F$Y$68$KG$20240710$$CN$GB$GB
240680692$24068069$2$F$20240610$20240723$20240710$20240801$EXP$$FR-AUROBINDO-AUR-APL-2024-032973$AUROBINDO$$14$YR$$M$Y$75$KG$20240801$$MD$FR$FR
240680702$24068070$2$F$$20240814$20240710$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05851$LUPIN$$$$$$Y$$$20240901$$CN$US$US
240680711$24068071$1$I$$20240702$20240710$20240710$EXP$$CA-CELLTRION INC.-2024CA016022$CELLTRION$$$$$$Y$$$20240710$$HP$CA$CA
240680721$24068072$1$I$20240621$20240630$20240710$20240710$EXP$$CN-Eisai-EC-2024-169274$EISAI$$17$YR$T$M$Y$38$KG$20240709$$HP$CN$CN
240680733$24068073$3$F$$20240709$20240710$20240715$EXP$$IN-ROCHE-10000012986$ROCHE$$$$$$Y$$$20240715$$CN$IN$IN
240680741$24068074$1$I$20221230$20240703$20240710$20240710$EXP$$CA-CELLTRION INC.-2024CA012440$CELLTRION$$$$$$Y$$$20240710$$HP$CA$CA
240680753$24068075$3$F$$20240827$20240710$20240830$EXP$$NVSC2024IT141890$NOVARTIS$$66$YR$$M$Y$$$20240830$$MD$IT$IT
240680764$24068076$4$F$20230627$20240919$20240710$20240926$EXP$$CA-GSK-CA2023097027$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$CA$CA
240680773$24068077$3$F$$20240703$20240710$20240711$EXP$$CA-ROCHE-10000019801$ROCHE$$$$A$F$Y$$$20240711$$CN$CA$CA
240680781$24068078$1$I$20240621$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135709$AMGEN$$84$YR$E$F$Y$$$20240710$$MD$US$US
240680791$24068079$1$I$20240619$20240702$20240710$20240710$EXP$$PT-AUROBINDO-AUR-APL-2024-032909$AUROBINDO$$30$YR$$F$Y$$$20240710$$PH$PT$PT
240680802$24068080$2$F$$20240814$20240710$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06313$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240680811$24068081$1$I$$20240610$20240710$20240710$PER$$US-009507513-2406USA003598$MERCK$$$$$F$Y$$$20240710$$CN$US$US
240680822$24068082$2$F$$20240829$20240710$20240830$PER$$NVSC2024US142236$NOVARTIS$$96$YR$$M$Y$$$20240830$$HP$US$US
240680832$24068083$2$F$$20240704$20240710$20240712$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037893$BOEHRINGER INGELHEIM$Tanaka S, Yagi R, Yoshimura N, Asakawa R, Tobita S, Yaga M. Two cases of Takotsubo cardiomyopathy during epidermal growth factor receptor tyrosine kinase inhibitor treatment for rare non-small cell lung cancer with epidermal growth factor receptor mutation. Japanese Journal of Lung Cancer. 2024 Jun 20;64 (3): 200-205. doi:10.2482/haigan.64.200.$77$YR$E$F$Y$$$20240712$$HP$JP$JP
240680841$24068084$1$I$20240101$20240701$20240710$20240710$EXP$$US-JNJFOC-20240703135$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240710$$CN$US$US
240680851$24068085$1$I$20230201$20240708$20240710$20240710$EXP$$US-ROCHE-10000021548$ROCHE$$52$YR$A$F$Y$79.83$KG$20240710$$CN$US$US
240680861$24068086$1$I$20240319$20240702$20240710$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-032988$AUROBINDO$$84$YR$$M$Y$92$KG$20240710$$MD$FR$FR
240680873$24068087$3$F$20240707$20240812$20240710$20240812$PER$$US-AMGEN-USASP2024135807$AMGEN$$58$YR$A$M$Y$$$20240812$$CN$US$US
240680881$24068088$1$I$20240708$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024134871$AMGEN$$$$$M$Y$$$20240710$$PH$US$US
240680893$24068089$3$F$20240701$20240708$20240710$20240817$PER$$US-AMGEN-USASP2024135218$AMGEN$$50$YR$A$F$Y$$$20240817$$CN$US$US
240680901$24068090$1$I$20240528$20240701$20240710$20240710$EXP$FR-AFSSAPS-BR2024000461$FR-TEVA-VS-3216107$TEVA$$59$YR$$M$Y$57$KG$20240710$$PH$FR$FR
240680911$24068091$1$I$$20240704$20240710$20240710$PER$$US-LEO Pharma-371822$LEO PHARM$$62$YR$$F$Y$$$20240710$$PH$US$US
240680921$24068092$1$I$20240601$20240701$20240710$20240710$PER$$US-SA-2024SA197235$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240710$$MD$US$US
240680931$24068093$1$I$20240601$20240701$20240710$20240710$PER$$US-SA-2024SA197244$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240710$$MD$US$US
240680941$24068094$1$I$20220601$20240701$20240710$20240710$PER$$US-SA-2024SA197251$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240710$$MD$US$US
240680951$24068095$1$I$20240601$20240701$20240710$20240710$PER$$US-SA-2024SA197248$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240710$$MD$US$US
240680961$24068096$1$I$20240501$20240705$20240710$20240710$PER$$US-SA-2024SA201096$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240710$$HP$US$US
240680972$24068097$2$F$20240501$20240701$20240710$20240713$PER$$US-SA-2024SA197261$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240713$$MD$US$US
240680983$24068098$3$F$$20240730$20240710$20240806$PER$$US-SA-2024SA201089$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240806$$CN$US$US
240680991$24068099$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06282$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240681001$24068100$1$I$20230101$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005631$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240710$$CN$US$US
240681011$24068101$1$I$20240704$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004475$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240710$$CN$US$US
240681021$24068102$1$I$20200101$20240702$20240710$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-032907$AUROBINDO$$31$YR$$F$Y$$$20240710$$MD$FR$FR
240681031$24068103$1$I$$20240703$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407003006$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240710$$CN$US$US
240681043$24068104$3$F$20240703$20240807$20240710$20240808$PER$$US-JNJFOC-20240709872$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240808$$PH$US$US
240681051$24068105$1$I$20240326$20240708$20240710$20240710$PER$$US-JNJFOC-20240720909$JOHNSON AND JOHNSON$$37$YR$A$F$Y$118.95$KG$20240710$$CN$US$US
240681061$24068106$1$I$20231001$20240625$20240710$20240710$EXP$$CA-GSK-CA2023145849$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$CA$CA
240681071$24068107$1$I$$20240621$20240710$20240710$EXP$$IN-ROCHE-10000013703$ROCHE$$37$YR$A$F$Y$$$20240710$$MD$IN$IN
240681081$24068108$1$I$$20230912$20240710$20240710$PER$$US-AMGEN-USASP2023235335$AMGEN$$$$$$Y$$$20240710$$HP$US$US
240681093$24068109$3$F$20240704$20240717$20240710$20240720$EXP$$JP-JNJFOC-20240723819$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20240719$$MD$JP$JP
240681102$24068110$2$F$$20240805$20240710$20240808$30DAY$$AU-JNJFOC-20240665221$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$PH$AU$AU
240681111$24068111$1$I$20240430$20240703$20240710$20240710$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024083233$VIIV$$$$$M$Y$$$20240710$$HP$US$US
240681121$24068112$1$I$20240209$20240702$20240710$20240710$EXP$$FR-CELLTRION INC.-2024FR016250$CELLTRION$$$$$$Y$$$20240710$$MD$FR$FR
240681131$24068113$1$I$20240601$20240625$20240710$20240710$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000574$DECIPHERA PHARMACEUTICALS$$54$YR$A$F$Y$$$20240710$$CN$US$US
240681141$24068114$1$I$$20240626$20240710$20240710$EXP$$CA-GSK-CA2023AMR142465$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$CA$CA
240681151$24068115$1$I$$20240709$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038842$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240710$$PH$US$US
240681161$24068116$1$I$20200429$20240704$20240710$20240710$EXP$PL-URPL-1-1560-2020$PL-BIOCON BIOLOGICS LIMITED-BBL2020000015$BIOCON$$$$$$Y$$$20240710$$MD$PL$PL
240681171$24068117$1$I$20240401$20240701$20240710$20240710$EXP$DE-PEI-CADR2024328981$DE-ROCHE-10000015083$ROCHE$$8$MON$I$M$Y$8$KG$20240710$$MD$DE$DE
240681181$24068118$1$I$$20240614$20240710$20240710$30DAY$$US-GSK-US2024083848$GLAXOSMITHKLINE$$$$$M$Y$$$20240710$$CN$US$US
240681191$24068119$1$I$20240619$20240702$20240710$20240710$EXP$$CA-JNJFOC-20240514475$JOHNSON AND JOHNSON$$17$YR$T$M$Y$56$KG$20240710$$HP$CA$CA
240681203$24068120$3$F$20240705$20240909$20240710$20240913$EXP$$JP-TAKEDA-2024TJP010199$TAKEDA$$14$YR$$M$Y$51.7$KG$20240913$$MD$JP$JP
240681212$24068121$2$F$$20240715$20240710$20240725$EXP$$CA-ROCHE-10000013943$ROCHE$$63$YR$A$F$Y$58$KG$20240725$$CN$CA$CA
240681222$24068122$2$F$$20240801$20240710$20240814$EXP$$JP-AMGEN-JPNSP2024133925$AMGEN$$8$DEC$E$M$Y$$$20240814$$PH$JP$JP
240681231$24068123$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06095$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240681241$24068124$1$I$20230923$20240701$20240710$20240710$EXP$FR-AFSSAPS-PC2023000877$FR-TEVA-VS-3215861$TEVA$$66$YR$$M$Y$67$KG$20240710$$MD$FR$FR
240681252$24068125$2$F$$20240716$20240710$20240729$PER$$US-IGSA-BIG0029647$GRIFOLS$$57$YR$$F$Y$$$20240729$$HP$US$US
240681262$24068126$2$F$20240614$20240711$20240710$20240809$PER$$FR-TOLMAR, INC.-24FR050268$TOLMAR$$82$YR$$M$Y$$$20240809$$PH$FR$FR
240681272$24068127$2$F$20240615$20240711$20240710$20240809$PER$$FR-TOLMAR, INC.-24FR050272$TOLMAR$$73$YR$$M$Y$$$20240809$$PH$FR$FR
240681291$24068129$1$I$$20240617$20240710$20240710$PER$$LT-TOLMAR, INC.-24LT050598$TOLMAR$$$$$$Y$$$20240710$$HP$LT$LT
240681301$24068130$1$I$$20240703$20240710$20240710$PER$$US-ROCHE-10000020384$ROCHE$$5$YR$C$M$Y$$$20240710$$HP$US$US
240681311$24068131$1$I$20240708$20240708$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038484$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$$$20240710$$CN$US$US
240681321$24068132$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135311$AMGEN$$$$$$Y$$$20240710$$HP$US$US
240681331$24068133$1$I$$20240617$20240710$20240710$PER$$US-AMGEN-USASP2024122795$AMGEN$Elsayed M.. An Interesting Case of Drug-Induced Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Pulmonary and Renal Involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209 (1):A5780$75$YR$E$M$Y$$$20240710$$HP$US$US
240681343$24068134$3$F$20230901$20240918$20240710$20240926$EXP$$CA-GSK-CA2023095273$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$CA$CA
240681352$24068135$2$F$$20240814$20240710$20240829$PER$$US-AstraZeneca-2024A151246$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
240681362$24068136$2$F$$20240821$20240710$20240901$PER$$US-AstraZeneca-2024A151342$ASTRAZENECA$$$$$M$Y$$$20240901$$CN$US$
240681371$24068137$1$I$$20240702$20240710$20240710$PER$$US-AstraZeneca-2024A152352$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240681382$24068138$2$F$20240622$20240806$20240710$20240808$PER$$US-AMGEN-USASP2024135842$AMGEN$$27$YR$A$F$Y$$$20240808$$CN$US$US
240681391$24068139$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135862$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240681401$24068140$1$I$$20240627$20240710$20240710$PER$$US-ROCHE-10000014924$ROCHE$$$$$$Y$$$20240710$$MD$US$US
240681411$24068141$1$I$20240327$20240703$20240710$20240710$EXP$BE-FAMHP-DHH-N2024-122307$BE-CHEPLA-2024008539$CHEPLAPHARM$$53$YR$$F$Y$60$KG$20240710$$CN$COUNTRY NOT SPECIFIED$BE
240681431$24068143$1$I$$20240705$20240710$20240710$PER$$NVSC2024US140870$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
240681442$24068144$2$F$20240703$20240912$20240710$20240916$PER$$NVSC2024US142104$NOVARTIS$$26$YR$$F$Y$$$20240916$$HP$US$US
240681451$24068145$1$I$20240530$20240705$20240710$20240710$EXP$HR-HALMED-300085785$HR-CHEPLA-2024008475$CHEPLAPHARM$$60$YR$$F$Y$$$20240710$$MD$COUNTRY NOT SPECIFIED$HR
240681461$24068146$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197189$SANOFI AVENTIS$$$$A$F$Y$$$20240709$$MD$US$US
240681471$24068147$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197177$SANOFI AVENTIS$$$$A$M$Y$63.911$KG$20240709$$MD$US$US
240681491$24068149$1$I$$20240702$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01191$NOVITIUM PHARMA$T. C. Hammond.Persistent SARS-CoV-2 Viremia, COVID-19 Associated Acute Respiratory Distress Syndrome, Severe Coagulopathy and Massive Hemoptysis in a Renal Transplant Patient on Veno-Venous Extracorporeal Membrane Oxygenation.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;NA:A5563$26$YR$A$M$Y$$$20240710$$HP$US$US
240681501$24068150$1$I$$20240701$20240710$20240710$EXP$$US-VANTIVE-2024VAN018095$Vantive US Healthcare$$$$$F$Y$$$20240710$$CN$US$US
240681511$24068151$1$I$20220801$20240701$20240710$20240710$EXP$$LV-AMGEN-LVASP2024132502$AMGEN$Kreslina L.; Gasenko E.. Challenges in the treatment of metastatic colon and rectall cancer and the role of genetic testing. Journal Latvijas Arsts. 2024;46-49$48$YR$A$F$Y$$$20240710$$HP$LV$LV
240681521$24068152$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005321$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240710$$CN$US$US
240681532$24068153$2$F$$20240705$20240710$20240710$PER$$US-ROCHE-10000020915$ROCHE$$$$T$M$Y$$$20240710$$CN$US$US
240681541$24068154$1$I$$20240706$20240710$20240710$EXP$$US-JNJFOC-20240717725$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240710$$CN$US$US
240681553$24068155$3$F$20240101$20240821$20240710$20240830$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000582$DECIPHERA PHARMACEUTICALS$$58$YR$A$F$Y$$$20240830$$CN$US$US
240681563$24068156$3$F$20240619$20240725$20240710$20240808$30DAY$$US-JNJFOC-20240662832$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240808$$CN$US$US
240681573$24068157$3$F$20240101$20240919$20240710$20240925$PER$$US-AMGEN-USASP2024134928$AMGEN$$65$YR$E$M$Y$92.079$KG$20240925$$CN$US$US
240681582$24068158$2$F$20230808$20240709$20240710$20240716$EXP$$CA-TAKEDA-2023TUS032974$TAKEDA$$43$YR$$F$Y$$$20240716$$CN$CA$CA
240681592$24068159$2$F$20240101$20240708$20240710$20240714$PER$$US-AMGEN-USASP2024135805$AMGEN$$35$YR$A$F$Y$$$20240714$$PH$US$US
240681601$24068160$1$I$20240707$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135176$AMGEN$$78$YR$E$M$Y$$$20240710$$CN$US$US
240681611$24068161$1$I$19850101$20240701$20240710$20240710$EXP$$US-AMGEN-USASP2024132397$AMGEN$Slaczka F.;Slaczka M.; Janjua E.. Refractory Crohn^s Disease Responsive to Dietary Therapy: A Case Report. Cureus. 2024;16 (5):1-9$58$YR$A$M$Y$$$20240710$$HP$US$US
240681622$24068162$2$F$20190828$20240708$20240710$20240711$EXP$FR-AFSSAPS-DJ2024000822$FR-ROCHE-10000020457$ROCHE$$46$YR$A$F$Y$51$KG$20240711$$MD$FR$FR
240681631$24068163$1$I$20240605$20240701$20240710$20240710$PER$FR-AFSSAPS-AN2024000831$FR-PFM-2024-03812$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$PH$FR$FR
240681641$24068164$1$I$20240628$20240701$20240710$20240710$PER$$US-ABBVIE-5825185$ABBVIE$$59$YR$$M$Y$$$20240710$$CN$US$US
240681651$24068165$1$I$20240704$20240705$20240710$20240710$EXP$$BG-ABBVIE-5808415$ABBVIE$$73$YR$$F$Y$$$20240710$$CN$BG$BG
240681661$24068166$1$I$$20240704$20240710$20240710$EXP$$JP-ROCHE-10000020366$ROCHE$$16$YR$T$$Y$$$20240710$$MD$JP$JP
240681671$24068167$1$I$20240601$20240708$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038808$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240710$$CN$US$US
240681681$24068168$1$I$$20240708$20240710$20240710$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038580$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240710$$CN$US$US
240681692$24068169$2$F$20240621$20240730$20240710$20240805$30DAY$$CA-JNJFOC-20240659768$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240806$$HP$CA$CA
240681712$24068171$2$F$20230701$20240702$20240710$20240726$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-221484$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$98.88$KG$20240726$$CN$CA$CA
240681721$24068172$1$I$$20240625$20240710$20240710$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05826$LUPIN$Le CT, Mahmoud A, Kurt O, Bangash H, Saad Eldin M, Ayaz S. Advanced care in rheumatoid arthritis with biological agents: The role of Pneumocystis jirovecii pneumonia prophylaxis. American Journal Respiratory Critical Care Medicine. 2024;209:A2388$66$YR$$F$Y$$$20240710$$HP$US$US
240681731$24068173$1$I$20240701$20240701$20240710$20240710$EXP$$GB-TEVA-VS-3216305$TEVA$$89$YR$$M$Y$95$KG$20240710$$MD$GB$GB
240681741$24068174$1$I$$20240704$20240710$20240710$PER$$US-AstraZeneca-2024A154303$ASTRAZENECA$$$$$$Y$$$20240710$$CN$US$
240681751$24068175$1$I$20240428$20240708$20240710$20240710$EXP$$JP-009507513-2405JPN000784J$MERCK$$$$$F$Y$$$20240710$$PH$JP$JP
240681771$24068177$1$I$$20240703$20240710$20240710$EXP$$JP-SANDOZ INC.-SDZ2024JP062955$SANDOZ$Beppu R, Eto Y, Yagi K, Jo F. A case of bullous pemphigoid following COVID-19 vaccination in a patient on DPP-4 inhibitors. Journal of Saitama Medical Association. 2024;58(1):255-259$88$YR$$M$Y$$$20240710$$MD$JP$JP
240681782$24068178$2$F$20240707$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024135293$AMGEN$$74$YR$E$F$Y$$$20240710$$CN$US$US
240681791$24068179$1$I$20210101$20240611$20240710$20240710$PER$$US-009507513-2406USA003945$MERCK$$$$$F$Y$$$20240710$$CN$US$US
240681801$24068180$1$I$$20240708$20240710$20240710$PER$$NVSC2024US142038$NOVARTIS$$$$$$Y$$$20240710$$HP$US$US
240681811$24068181$1$I$$20240708$20240710$20240710$PER$$NVSC2024US142098$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
240681821$24068182$1$I$$20240709$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038870$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240710$$CN$US$US
240681834$24068183$4$F$20240703$20240808$20240710$20240810$PER$$US-AMGEN-USASP2024132565$AMGEN$$45$YR$A$M$Y$$$20240810$$MD$US$US
240681843$24068184$3$F$20240705$20240725$20240710$20240726$PER$$US-AMGEN-USASP2024134825$AMGEN$$70$YR$E$F$Y$$$20240725$$CN$US$US
240681851$24068185$1$I$$20240703$20240710$20240710$EXP$$JP-EMD Serono-2024037055$EMD SERONO INC$$$$$$Y$$$20240710$$MD$JP$JP
240681861$24068186$1$I$20240502$20240703$20240710$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-033274$AUROBINDO$$23$YR$$F$Y$$$20240710$$MD$FR$FR
240681872$24068187$2$F$$20240705$20240710$20240924$EXP$$US-ABBVIE-5830802$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
240681881$24068188$1$I$$20230307$20240710$20240710$EXP$$CA-HALEON-2185557$Haleon PLC$$44$YR$$F$Y$70$KG$20240710$$HP$CA$CA
240681892$24068189$2$F$$20240718$20240710$20240725$EXP$$JP-SANDOZ INC.-SDZ2024JP063837$SANDOZ$$86$YR$$F$Y$$$20240725$$PH$JP$JP
240681901$24068190$1$I$$20240703$20240710$20240710$EXP$$JP-SANDOZ INC.-SDZ2024JP062648$SANDOZ$Kudo Y, Shimada E, Nishimura T, Takeuchi D, Toyohara K, Yoshida H et al. Congenital Long QT Syndrome Treated with Thoracoscopic Sympathectomy for Refractory VT and VF. Program and Abstracts of the 27th Annual Meeting of the Japanese Society of Pedi. 2023;OS33$$$$F$Y$$$20240710$$MD$JP$JP
240681921$24068192$1$I$$20240705$20240710$20240710$PER$$US-HALEON-2186082$Haleon PLC$$$$$M$Y$$$20240710$$CN$US$US
240681931$24068193$1$I$$20240706$20240710$20240710$EXP$$US-JNJFOC-20240717864$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$CN$US$US
240681941$24068194$1$I$$20240701$20240710$20240710$PER$$US-SA-2022SA425509$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240710$$CN$US$US
240681953$24068195$3$F$$20240701$20240710$20240715$PER$$US-SA-2024SA192770$SANOFI AVENTIS$$$$$M$Y$$$20240715$$CN$US$US
240681961$24068196$1$I$$20240628$20240710$20240710$PER$$US-SA-2024SA196681$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240710$$MD$US$US
240681971$24068197$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197279$SANOFI AVENTIS$$$$C$M$Y$$$20240710$$MD$US$US
240681981$24068198$1$I$20240703$20240703$20240710$20240710$PER$$US-SA-2024SA199382$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240710$$CN$US$US
240681991$24068199$1$I$20240601$20240701$20240710$20240710$PER$$US-SA-2024SA197203$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240710$$MD$US$US
240682001$24068200$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA201309$SANOFI AVENTIS$$$$$M$Y$$$20240710$$PH$US$US
240682011$24068201$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197274$SANOFI AVENTIS$$$$C$F$Y$28$KG$20240710$$MD$US$US
240682022$24068202$2$F$20240101$20240828$20240710$20240909$PER$$US-SA-2024SA197331$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240909$$MD$US$US
240682031$24068203$1$I$20240201$20240701$20240710$20240710$PER$$US-SA-2024SA198205$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240710$$MD$US$US
240682041$24068204$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA196470$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$HP$US$US
240682052$24068205$2$F$$20240716$20240710$20240725$PER$$US-SA-2024SA198203$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240725$$MD$US$US
240682061$24068206$1$I$20240101$20240703$20240710$20240710$PER$$US-SA-2024SA201067$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240710$$MD$US$US
240682071$24068207$1$I$20240619$20240701$20240710$20240710$PER$$US-SA-2024SA197327$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240710$$MD$US$US
240682082$24068208$2$F$$20240702$20240710$20240715$PER$$US-SA-2024SA195610$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240715$$CN$US$US
240682091$24068209$1$I$20240101$20240702$20240710$20240710$PER$$US-SA-2024SA199318$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240710$$MD$US$US
240682101$24068210$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA197332$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240710$$CN$US$US
240682111$24068211$1$I$$20240705$20240710$20240710$PER$$US-SA-2024SA201351$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240710$$CN$US$US
240682121$24068212$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA167761$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240710$$MD$US$US
240682131$24068213$1$I$20230124$20240703$20240710$20240710$PER$$US-SA-2024SA201316$SANOFI AVENTIS$$10$YR$C$M$Y$28.07$KG$20240710$$MD$US$US
240682141$24068214$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405011900067820-RFLJN$GB-SANDOZ INC.-SDZ2024GB063446$SANDOZ$$$$$F$Y$$$20240710$$CN$GB$GB
240682152$24068215$2$F$20240201$20240709$20240710$20240716$EXP$$US-ORGANON-O2407USA000853$ORGANON$$$$$F$Y$122.01$KG$20240716$$MD$US$US
240682161$24068216$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005751$ELI LILLY AND CO$$71$YR$E$$Y$$$20240710$$CN$US$US
240682171$24068217$1$I$$20240703$20240710$20240710$EXP$$US-GSK-US2024082657$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$HP$US$US
240682181$24068218$1$I$$20240703$20240710$20240710$EXP$$GB-AUROBINDO-AUR-APL-2024-033113$AUROBINDO$$30$YR$$M$Y$$$20240710$$CN$GB$GB
240682191$24068219$1$I$20240101$20240704$20240710$20240710$EXP$$CA-JNJFOC-20240714254$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240710$$HP$CA$CA
240682201$24068220$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107129$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240710$$HP$US$US
240682212$24068221$2$F$20240101$20240719$20240710$20240723$EXP$$FR-SA-2024SA197647$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240723$$CN$FR$FR
240682221$24068222$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142002$NOVARTIS$$36$YR$$F$Y$$$20240710$$CN$US$US
240682241$24068224$1$I$$20240703$20240710$20240710$PER$$US-AMGEN-USASP2024133202$AMGEN$Goodlet K.J.; Martinez S.; Sindu D. et.al.. Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. Transplant Infectious disease. 2024;26 (3):1-8$57$YR$A$M$Y$$$20240710$$HP$US$US
240682251$24068225$1$I$$20240703$20240710$20240710$PER$$US-AMGEN-USASP2024133209$AMGEN$Goodlet K.J.; Martinez S.; Sindu D. et.al.. Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. Transplant Infectious disease. 2024;26 (3):1-8$69$YR$E$M$Y$$$20240710$$HP$US$US
240682261$24068226$1$I$$20240703$20240710$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017448$JAZZ$$$$$M$Y$$$20240710$$HP$US$US
240682271$24068227$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133841$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31 (6):3529-3545$49$YR$A$F$Y$$$20240710$$HP$US$US
240682281$24068228$1$I$$20240702$20240710$20240710$PER$$US-AstraZeneca-2024A152799$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240682291$24068229$1$I$$20240705$20240710$20240710$EXP$$US-AstraZeneca-2024A154967$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240682301$24068230$1$I$20240703$20240703$20240710$20240710$EXP$$GB-AUROBINDO-AUR-APL-2024-033176$AUROBINDO$$55$YR$$M$Y$80$KG$20240710$$MD$GB$GB
240682312$24068231$2$F$$20240705$20240710$20240711$EXP$$US-GSK-US2024083993$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240682321$24068232$1$I$$20240702$20240710$20240710$EXP$$TW-NOVITIUMPHARMA-2024TWNVP01183$NOVITIUM PHARMA$Lu Hang Liu.Case report: Endovascular treatment of acute limb ischemia in an adolescent with newly diagnosed lupus.Frontiers in Cardiovascular Medicine.30-MAY-2023;10:1-5$14$YR$T$M$Y$$$20240710$$HP$TW$TW
240682333$24068233$3$F$20240524$20240724$20240710$20240802$EXP$$US-TAKEDA-2024TUS069525$TAKEDA$$78$YR$$F$Y$$$20240802$$CN$US$US
240682342$24068234$2$F$20220101$20240829$20240710$20240906$EXP$$IT-CELLTRION INC.-2024IT003941$CELLTRION$$$$$$Y$$$20240906$$MD$IT$IT
240682351$24068235$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135731$AMGEN$$$$$$Y$$$20240710$$MD$US$US
240682361$24068236$1$I$20240701$20240708$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063774$SANDOZ$$48$YR$$F$Y$$$20240710$$CN$US$US
240682371$24068237$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109114$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240710$$HP$US$US
240682381$24068238$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109206$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$92.08$KG$20240710$$CN$US$US
240682391$24068239$1$I$20240526$20240704$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010447$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240682401$24068240$1$I$20230601$20240703$20240710$20240710$EXP$$NVSC2024ES140165$NOVARTIS$$$$$$Y$$$20240710$$MD$ES$ES
240682411$24068241$1$I$$20240703$20240710$20240710$EXP$$GB-AUROBINDO-AUR-APL-2024-033235$AUROBINDO$$$$$F$Y$$$20240710$$HP$GB$GB
240682421$24068242$1$I$20240708$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024136246$AMGEN$$59$YR$A$M$Y$$$20240710$$CN$US$US
240682431$24068243$1$I$$20240704$20240710$20240710$PER$$US-AMGEN-USASP2024133190$AMGEN$Verma K.; Hardy D.. Two Cases of Pediatric Leucine-Rich Glioma-inactivated Protein-1 Encephalitis: Clinical Course, Challenges, and Implications. Pediatric Neurology. 2024;157:96-99$17$YR$T$F$Y$$$20240710$$MD$US$US
240682442$24068244$2$F$20240601$20240808$20240710$20240808$PER$$US-ALXN-202407USA000246US$ALEXION PHARMACEUTICALS$$14$YR$$F$Y$$$20240808$$CN$US$US
240682452$24068245$2$F$$20240708$20240710$20240715$PER$$US-AMGEN-USASP2024135501$AMGEN$$36$YR$A$M$Y$$$20240714$$CN$US$US
240682461$24068246$1$I$$20240703$20240710$20240710$PER$$US-AMGEN-USASP2024133224$AMGEN$Goodlet K.J.; Martinez S.; Sindu D. et.al.. Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. Transplant Infectious disease. 2024;26 (3):1-8$68$YR$E$F$Y$$$20240710$$HP$US$US
240682471$24068247$1$I$$20240703$20240710$20240710$PER$$US-AMGEN-USASP2024133217$AMGEN$Goodlet K.J.; Martinez S.; Sindu D. et.al.. Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. Transplant Infectious disease. 2024;26 (3):1-8$27$YR$A$F$Y$$$20240710$$HP$US$US
240682481$24068248$1$I$20240603$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010386$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240682491$24068249$1$I$20210211$20240702$20240710$20240710$EXP$$ES-CELLTRION INC.-2024ES016230$CELLTRION$$$$$$Y$$$20240710$$PH$ES$ES
240682502$24068250$2$F$$20240722$20240710$20240730$EXP$$BR-TAKEDA-2024TUS068851$TAKEDA$$$$$M$Y$26$KG$20240730$$CN$BR$BR
240682511$24068251$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109010$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240710$$CN$US$US
240682522$24068252$2$F$$20240719$20240710$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108656$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240730$$CN$US$US
240682541$24068254$1$I$20240401$20240702$20240710$20240710$EXP$FR-AFSSAPS-AVMP2024000186$FR-TEVA-VS-3216497$TEVA$$41$YR$$M$Y$$$20240710$$PH$FR$FR
240682551$24068255$1$I$$20240708$20240710$20240710$PER$$US-JNJFOC-20240719668$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$HP$US$US
240682561$24068256$1$I$20240619$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010387$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240682572$24068257$2$F$$20240703$20240710$20240710$PER$$US-AMGEN-USASP2024133230$AMGEN$Goodlet K.J.; Martinez S.; Sindu D. et.al.. Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. Transplant Infectious disease. 2024;26 (3):1-8$69$YR$E$F$Y$$$20240710$$HP$US$US
240682581$24068258$1$I$$20240628$20240710$20240710$EXP$$US-WOCKHARDT LIMITED-2024WLD000025$WOCKHARDT$$$$$$Y$$$20240710$$CN$US$US
240682591$24068259$1$I$$20240403$20240710$20240710$PER$$US-ROCHE-3280021$ROCHE$$56$YR$A$M$Y$$$20240628$$CN$US$US
240682601$24068260$1$I$20240303$20240307$20240710$20240710$PER$$FR-ROCHE-3523593$ROCHE$$$$$$Y$$$20240628$$PH$FR$FR
240682613$24068261$3$F$20240205$20240223$20240710$20240710$PER$$SE-ROCHE-3510346$ROCHE$$$$$F$Y$$$20240628$$MD$SE$SE
240682621$24068262$1$I$$20240205$20240710$20240710$PER$$JP-ROCHE-3511922$ROCHE$$79$YR$E$F$Y$$$20240628$$MD$JP$JP
240682633$24068263$3$F$$20240507$20240710$20240710$PER$$CA-ROCHE-3556299$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$CA$CA
240682641$24068264$1$I$$20240430$20240710$20240710$PER$$US-ROCHE-3556001$ROCHE$$47$YR$A$M$Y$$$20240628$$MD$US$US
240682651$24068265$1$I$$20240220$20240710$20240710$PER$$US-ROCHE-3513824$ROCHE$$71$YR$E$M$Y$$$20240628$$MD$US$US
240682661$24068266$1$I$$20240304$20240710$20240710$PER$$US-ROCHE-3522177$ROCHE$$77$YR$E$F$Y$$$20240628$$MD$US$US
240682671$24068267$1$I$20221017$20240202$20240710$20240710$PER$$CA-ROCHE-3265436$ROCHE$$50$YR$A$F$Y$$$20240628$$CN$CA$CA
240682681$24068268$1$I$$20240313$20240710$20240710$PER$$US-ROCHE-3527416$ROCHE$$62$YR$A$F$Y$$$20240628$$CN$US$US
240682691$24068269$1$I$$20240130$20240710$20240710$PER$$JP-ROCHE-3379213$ROCHE$$$$E$$Y$$$20240628$$MD$JP$JP
240682701$24068270$1$I$$20240202$20240710$20240710$PER$$US-ROCHE-3504587$ROCHE$$$$A$M$Y$$$20240628$$MD$US$US
240682711$24068271$1$I$$20240229$20240710$20240710$PER$$CA-ROCHE-3519634$ROCHE$$74$YR$E$M$Y$$$20240628$$CN$CA$CA
240682721$24068272$1$I$$20230807$20240710$20240710$PER$$BR-ROCHE-3402558$ROCHE$$$$$$Y$$$20240628$$MD$BR$BR
240682731$24068273$1$I$$20240213$20240710$20240710$PER$$KE-ROCHE-3510073$ROCHE$$$$A$F$Y$$$20240628$$MD$KE$KE
240682741$24068274$1$I$$20240215$20240710$20240710$PER$$US-ROCHE-3511485$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$US$US
240682751$24068275$1$I$$20240411$20240710$20240710$PER$$JP-ROCHE-3559292$ROCHE$$9$DEC$E$$Y$$$20240628$$MD$JP$JP
240682761$24068276$1$I$$20240418$20240710$20240710$PER$$US-ROCHE-3549437$ROCHE$$53$YR$A$M$Y$$$20240628$$MD$US$US
240682771$24068277$1$I$$20240320$20240710$20240710$PER$$HK-ROCHE-3530754$ROCHE$$$$$$Y$$$20240628$$MD$HK$HK
240682781$24068278$1$I$$20240125$20240710$20240710$PER$$CN-ROCHE-3499460$ROCHE$$$$$F$Y$$$20240628$$CN$CN$CN
240682794$24068279$4$F$20221226$20231103$20240710$20240710$PER$$TR-ROCHE-3337952$ROCHE$$39$YR$A$M$Y$$$20240628$$MD$TR$TR
240682801$24068280$1$I$$20240229$20240710$20240710$PER$$US-ROCHE-3519257$ROCHE$$85$YR$E$F$Y$$$20240628$$MD$US$US
240682811$24068281$1$I$$20240129$20240710$20240710$PER$$ID-ROCHE-3446106$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$ID$ID
240682822$24068282$2$F$20240131$20240510$20240710$20240710$PER$$JP-ROCHE-3544162$ROCHE$$$$A$M$Y$$$20240628$$MD$JP$JP
240682831$24068283$1$I$$20240307$20240710$20240710$PER$$US-ROCHE-3523106$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240682841$24068284$1$I$$20240214$20240710$20240710$PER$$JP-ROCHE-3517929$ROCHE$$$$$M$Y$$$20240628$$MD$JP$JP
240682851$24068285$1$I$$20240212$20240710$20240710$PER$$US-ROCHE-3410860$ROCHE$$61$YR$A$M$Y$$$20240628$$MD$US$US
240682861$24068286$1$I$20240412$20240412$20240710$20240710$PER$$JP-ROCHE-3559876$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240682871$24068287$1$I$$20240314$20240710$20240710$PER$$US-ROCHE-3527231$ROCHE$$80$YR$E$F$Y$$$20240628$$MD$US$US
240682891$24068289$1$I$20240304$20240306$20240710$20240710$PER$$IN-ROCHE-3524056$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$IN$IN
240682901$24068290$1$I$$20230722$20240710$20240710$PER$$US-ROCHE-3397061$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240682911$24068291$1$I$$20240130$20240710$20240710$PER$$US-ROCHE-3504003$ROCHE$$74$YR$E$M$Y$$$20240628$$MD$US$US
240682921$24068292$1$I$$20240307$20240710$20240710$PER$$US-ROCHE-3524373$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$US$US
240682931$24068293$1$I$20240426$20240502$20240710$20240710$PER$$KR-ROCHE-3557203$ROCHE$$50$YR$A$M$Y$$$20240628$$CN$KR$KR
240682941$24068294$1$I$$20240305$20240710$20240710$PER$$US-ROCHE-3522278$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$US$US
240682951$24068295$1$I$20240118$20240305$20240710$20240710$PER$$JP-ROCHE-3535259$ROCHE$$7$DEC$E$M$Y$$$20240628$$MD$JP$JP
240682961$24068296$1$I$$20240327$20240710$20240710$PER$$US-ROCHE-3534998$ROCHE$$74$YR$E$M$Y$$$20240628$$MD$US$US
240682971$24068297$1$I$$20240401$20240710$20240710$PER$$IN-ROCHE-3537176$ROCHE$$86$YR$E$M$Y$$$20240628$$CN$IN$IN
240682981$24068298$1$I$20240226$20240402$20240710$20240710$PER$$IN-ROCHE-3537534$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$IN$IN
240682992$24068299$2$F$20240112$20240214$20240710$20240710$PER$$IN-ROCHE-3493538$ROCHE$$70$YR$E$M$Y$$$20240628$$CN$IN$IN
240683001$24068300$1$I$$20240417$20240710$20240710$PER$$SG-ROCHE-3548902$ROCHE$$$$$$Y$$$20240628$$MD$SG$SG
240683011$24068301$1$I$$20240315$20240710$20240710$PER$$US-ROCHE-3528490$ROCHE$$54$YR$A$M$Y$$$20240628$$MD$US$US
240683021$24068302$1$I$20240307$20240308$20240710$20240710$PER$$FR-ROCHE-3524439$ROCHE$$$$$$Y$$$20240628$$PH$FR$FR
240683032$24068303$2$F$$20240226$20240710$20240710$PER$$US-ROCHE-3437055$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$US$US
240683042$24068304$2$F$$20240210$20240710$20240710$PER$$FR-ROCHE-3498051$ROCHE$$85$YR$E$M$Y$$$20240628$$CN$FR$FR
240683051$24068305$1$I$$20240313$20240710$20240710$PER$$US-ROCHE-3526721$ROCHE$$68$YR$E$F$Y$$$20240628$$MD$US$US
240683061$24068306$1$I$$20240326$20240710$20240710$PER$$US-ROCHE-3534047$ROCHE$$79$YR$E$F$Y$$$20240628$$MD$US$US
240683071$24068307$1$I$$20240306$20240710$20240710$PER$$US-ROCHE-3521728$ROCHE$$54$YR$A$M$Y$$$20240628$$MD$US$US
240683081$24068308$1$I$20240220$20240223$20240710$20240710$PER$$CA-ROCHE-3516131$ROCHE$$63$YR$A$M$Y$$$20240628$$CN$CA$CA
240683091$24068309$1$I$$20240422$20240710$20240710$PER$$US-ROCHE-3552128$ROCHE$$84$YR$E$F$Y$$$20240628$$MD$US$US
240683101$24068310$1$I$$20240306$20240710$20240710$PER$$US-ROCHE-3522215$ROCHE$$$$E$F$Y$$$20240628$$CN$US$US
240683111$24068311$1$I$$20240313$20240710$20240710$PER$$JP-ROCHE-3534392$ROCHE$$78$YR$E$M$Y$$$20240628$$MD$JP$JP
240683121$24068312$1$I$$20240301$20240710$20240710$PER$$US-ROCHE-3521017$ROCHE$$71$YR$E$F$Y$$$20240628$$MD$US$US
240683131$24068313$1$I$$20230907$20240710$20240710$PER$$US-ROCHE-3419219$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$US$US
240683141$24068314$1$I$$20240326$20240710$20240710$PER$$US-ROCHE-3534882$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240683151$24068315$1$I$20240214$20240223$20240710$20240710$PER$$JP-ROCHE-3522808$ROCHE$$9$DEC$E$M$Y$$$20240628$$MD$JP$JP
240683161$24068316$1$I$20231002$20231222$20240710$20240710$PER$$JP-ROCHE-3440365$ROCHE$$69$YR$E$F$Y$$$20240628$$MD$JP$JP
240683172$24068317$2$F$$20240417$20240710$20240710$PER$$IT-ROCHE-3549401$ROCHE$$$$$F$Y$$$20240628$$MD$IT$IT
240683181$24068318$1$I$$20240213$20240710$20240710$PER$$US-ROCHE-3510987$ROCHE$$74$YR$E$M$Y$$$20240628$$MD$US$US
240683191$24068319$1$I$$20240507$20240710$20240710$PER$$SE-ROCHE-3562282$ROCHE$$$$A$F$Y$$$20240628$$HP$SE$SE
240683201$24068320$1$I$$20240213$20240710$20240710$PER$$CH-ROCHE-3516957$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240683211$24068321$1$I$$20240308$20240710$20240710$PER$$CA-ROCHE-3524786$ROCHE$$62$YR$A$M$Y$$$20240628$$CN$CA$CA
240683221$24068322$1$I$$20240328$20240710$20240710$PER$$JP-ROCHE-3552843$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240683231$24068323$1$I$20240216$20240219$20240710$20240710$PER$$FR-ROCHE-3513189$ROCHE$$$$$$Y$$$20240628$$PH$FR$FR
240683241$24068324$1$I$$20240326$20240710$20240710$PER$$IN-ROCHE-3534579$ROCHE$$70$YR$E$M$Y$$$20240628$$CN$IN$IN
240683251$24068325$1$I$$20240215$20240710$20240710$PER$$US-ROCHE-3511595$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$US$US
240683261$24068326$1$I$$20240307$20240710$20240710$PER$$KR-ROCHE-3523536$ROCHE$$$$$$Y$$$20240628$$CN$KR$KR
240683271$24068327$1$I$20231127$20240216$20240710$20240710$PER$$JP-ROCHE-3469308$ROCHE$$6$DEC$A$M$Y$$$20240628$$MD$JP$JP
240683281$24068328$1$I$$20240401$20240710$20240710$PER$$US-ROCHE-3536813$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$US$US
240683291$24068329$1$I$20240301$20240319$20240710$20240710$PER$$CN-ROCHE-3529999$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$CN$CN
240683301$24068330$1$I$$20240201$20240710$20240710$PER$$US-ROCHE-3503812$ROCHE$$85$YR$E$M$Y$$$20240628$$MD$US$US
240683311$24068331$1$I$$20240315$20240710$20240710$PER$$US-ROCHE-3529246$ROCHE$$75$YR$E$M$Y$$$20240628$$MD$US$US
240683321$24068332$1$I$$20240206$20240710$20240710$PER$$US-ROCHE-3507290$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240683331$24068333$1$I$$20240422$20240710$20240710$PER$$US-ROCHE-3385236$ROCHE$$93$YR$E$F$Y$$$20240628$$CN$US$US
240683341$24068334$1$I$20240221$20240322$20240710$20240710$PER$$CN-ROCHE-3531783$ROCHE$$26$YR$A$F$Y$$$20240628$$HP$CN$CN
240683361$24068336$1$I$20231231$20240221$20240710$20240710$PER$$RU-ROCHE-3515278$ROCHE$$86$YR$E$F$Y$$$20240628$$MD$RU$RU
240683371$24068337$1$I$20231019$20240220$20240710$20240710$PER$$CL-ROCHE-3513992$ROCHE$$$$$M$Y$83$KG$20240628$$CN$CL$CL
240683381$24068338$1$I$$20240422$20240710$20240710$PER$$US-ROCHE-3551488$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$US$US
240683391$24068339$1$I$$20231011$20240710$20240710$PER$$US-ROCHE-3438852$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240683401$24068340$1$I$$20240313$20240710$20240710$PER$$US-ROCHE-3526981$ROCHE$$57$YR$A$M$Y$$$20240628$$MD$US$US
240683411$24068341$1$I$$20240111$20240710$20240710$PER$$CN-ROCHE-3492306$ROCHE$$$$A$F$Y$$$20240628$$MD$CN$CN
240683421$24068342$1$I$$20240416$20240710$20240710$PER$$US-ROCHE-3547832$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$US$US
240683431$24068343$1$I$$20240221$20240710$20240710$PER$$JP-ROCHE-3522806$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240683441$24068344$1$I$$20240226$20240710$20240710$PER$$US-ROCHE-3445375$ROCHE$$62$YR$A$M$Y$$$20240628$$MD$US$US
240683451$24068345$1$I$$20240305$20240710$20240710$PER$$US-ROCHE-3522186$ROCHE$$77$YR$E$F$Y$$$20240628$$MD$US$US
240683461$24068346$1$I$$20240429$20240710$20240710$PER$$US-ROCHE-3557282$ROCHE$$78$YR$E$F$Y$$$20240628$$MD$US$US
240683472$24068347$2$F$20240223$20240306$20240710$20240710$PER$$FI-ROCHE-3522569$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$FI$FI
240683481$24068348$1$I$$20240326$20240710$20240710$PER$$BR-ROCHE-3536633$ROCHE$$$$$$Y$$$20240628$$MD$BR$BR
240683491$24068349$1$I$$20240314$20240710$20240710$PER$$CA-ROCHE-3528037$ROCHE$$$$A$M$Y$$$20240628$$HP$CA$CA
240683501$24068350$1$I$20240229$20240304$20240710$20240710$PER$$IN-ROCHE-3521740$ROCHE$$60$YR$A$F$Y$$$20240628$$CN$IN$IN
240683511$24068351$1$I$$20231018$20240710$20240710$PER$$MX-ROCHE-3443764$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$MX$MX
240683521$24068352$1$I$$20240422$20240710$20240710$PER$$KR-ROCHE-3551409$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$KR$KR
240683531$24068353$1$I$$20240207$20240710$20240710$PER$$MY-ROCHE-3506778$ROCHE$$53$YR$A$M$Y$$$20240628$$CN$MY$MY
240683541$24068354$1$I$$20240401$20240710$20240710$PER$$IN-ROCHE-3538012$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$IN$IN
240683553$24068355$3$F$20240210$20240425$20240710$20240710$PER$$IN-ROCHE-3513801$ROCHE$$70$YR$E$F$Y$$$20240628$$CN$IN$IN
240683561$24068356$1$I$$20240401$20240710$20240710$PER$$IN-ROCHE-3538108$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$IN$IN
240683572$24068357$2$F$20240404$20240409$20240710$20240710$PER$$IN-ROCHE-3545104$ROCHE$$64$YR$A$M$Y$$$20240628$$CN$IN$IN
240683581$24068358$1$I$$20230808$20240710$20240710$PER$$US-ROCHE-3402703$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240683592$24068359$2$F$$20240206$20240710$20240710$PER$$US-ROCHE-3505025$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240683601$24068360$1$I$$20240219$20240710$20240710$PER$$US-ROCHE-3513277$ROCHE$$70$YR$E$M$Y$$$20240628$$MD$US$US
240683611$24068361$1$I$$20240124$20240710$20240710$PER$$JP-ROCHE-3469421$ROCHE$$5$DEC$A$M$Y$$$20240628$$MD$JP$JP
240683622$24068362$2$F$$20231219$20240710$20240710$PER$$GB-ROCHE-3481597$ROCHE$$$$$$Y$$$20240628$$CN$GB$GB
240683631$24068363$1$I$$20240201$20240710$20240710$PER$$US-ROCHE-3504000$ROCHE$$59$YR$A$M$Y$$$20240628$$MD$US$US
240683641$24068364$1$I$$20240316$20240710$20240710$PER$$US-ROCHE-3529116$ROCHE$$63$YR$A$M$Y$$$20240628$$MD$US$US
240683651$24068365$1$I$$20240410$20240710$20240710$PER$$US-ROCHE-3544915$ROCHE$$67$YR$E$M$Y$$$20240628$$MD$US$US
240683671$24068367$1$I$$20240220$20240710$20240710$PER$$US-ROCHE-3513840$ROCHE$$68$YR$E$F$Y$$$20240628$$MD$US$US
240683681$24068368$1$I$$20240202$20240710$20240710$PER$$US-ROCHE-3507257$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$US$US
240683691$24068369$1$I$$20240131$20240710$20240710$PER$$FR-ROCHE-3503226$ROCHE$$$$$$Y$$$20240628$$MD$FR$FR
240683701$24068370$1$I$$20240304$20240710$20240710$PER$$US-ROCHE-3520577$ROCHE$$63$YR$A$M$Y$$$20240628$$CN$US$US
240683711$24068371$1$I$$20240129$20240710$20240710$PER$$US-ROCHE-3393996$ROCHE$$54$YR$A$M$Y$$$20240628$$MD$US$US
240683722$24068372$2$F$20230720$20230828$20240710$20240710$PER$$TR-ROCHE-3413708$ROCHE$$60$YR$A$M$Y$70$KG$20240628$$MD$TR$TR
240683731$24068373$1$I$$20240226$20240710$20240710$PER$$US-ROCHE-3516903$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$US$US
240683741$24068374$1$I$20240216$20240219$20240710$20240710$PER$$IN-ROCHE-3514269$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$IN$IN
240683752$24068375$2$F$$20240326$20240710$20240710$PER$$US-ROCHE-3533542$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$US$US
240683761$24068376$1$I$$20240315$20240710$20240710$PER$$US-ROCHE-3527902$ROCHE$$54$YR$A$M$Y$$$20240628$$HP$US$US
240683772$24068377$2$F$20230623$20240208$20240710$20240710$PER$$JP-ROCHE-3481046$ROCHE$$70$YR$E$M$Y$59$KG$20240628$$MD$JP$JP
240683783$24068378$3$F$20240208$20240322$20240710$20240710$PER$$IN-ROCHE-3510162$ROCHE$$61$YR$A$M$Y$$$20240628$$CN$IN$IN
240683791$24068379$1$I$20240311$20240313$20240710$20240710$PER$$AR-ROCHE-3526801$ROCHE$$43$YR$A$F$Y$52$KG$20240628$$MD$AR$AR
240683801$24068380$1$I$$20240313$20240710$20240710$PER$$CA-ROCHE-3526691$ROCHE$$$$$$Y$$$20240628$$MD$CA$CA
240683811$24068381$1$I$20230804$20230807$20240710$20240710$PER$$US-ROCHE-3401560$ROCHE$$11$YR$C$F$Y$31.4$KG$20240628$$PH$US$US
240683822$24068382$2$F$20231201$20240129$20240710$20240710$PER$$US-ROCHE-3501366$ROCHE$$87$YR$E$M$Y$$$20240628$$CN$US$US
240683832$24068383$2$F$$20240503$20240710$20240710$PER$$US-ROCHE-3558779$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$US$US
240683841$24068384$1$I$$20240305$20240710$20240710$PER$$JP-ROCHE-3538407$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240683851$24068385$1$I$20231201$20240129$20240710$20240710$PER$$US-ROCHE-3500942$ROCHE$$83$YR$E$F$Y$$$20240628$$CN$US$US
240683861$24068386$1$I$$20240214$20240710$20240710$PER$$JP-ROCHE-3517103$ROCHE$$41$YR$A$F$Y$$$20240628$$MD$JP$JP
240683871$24068387$1$I$$20240222$20240710$20240710$PER$$US-ROCHE-3383740$ROCHE$$69$YR$E$F$Y$$$20240628$$MD$US$US
240683881$24068388$1$I$20240223$20240304$20240710$20240710$PER$$IN-ROCHE-3523364$ROCHE$$69$YR$E$M$Y$85$KG$20240628$$CN$IN$IN
240683892$24068389$2$F$20231114$20240411$20240710$20240710$PER$$JP-ROCHE-3535672$ROCHE$$76$YR$E$M$Y$$$20240628$$MD$JP$JP
240683901$24068390$1$I$20240201$20240207$20240710$20240710$PER$$JP-ROCHE-3513359$ROCHE$$$$$M$Y$$$20240628$$MD$JP$JP
240683912$24068391$2$F$$20240426$20240710$20240710$PER$$CN-ROCHE-3553620$ROCHE$$48$YR$A$F$Y$$$20240628$$CN$CN$CN
240683921$24068392$1$I$20231007$20231012$20240710$20240710$PER$$IL-ROCHE-3438851$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$IL$IL
240683931$24068393$1$I$$20231019$20240710$20240710$PER$$US-ROCHE-3443477$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$US$US
240683941$24068394$1$I$$20240226$20240710$20240710$PER$$US-ROCHE-3516759$ROCHE$$91$YR$E$F$Y$$$20240628$$CN$US$US
240683951$24068395$1$I$20240118$20240304$20240710$20240710$PER$$IN-ROCHE-3523428$ROCHE$$84$YR$E$M$Y$$$20240628$$CN$IN$IN
240683961$24068396$1$I$20240209$20240216$20240710$20240710$PER$$IN-ROCHE-3513024$ROCHE$$79$YR$E$F$Y$$$20240628$$CN$IN$IN
240683971$24068397$1$I$$20240124$20240710$20240710$PER$$US-ROCHE-3499269$ROCHE$$59$YR$A$M$Y$$$20240628$$CN$US$US
240683981$24068398$1$I$$20240129$20240710$20240710$PER$$CA-ROCHE-3497611$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$CA$CA
240683992$24068399$2$F$20240112$20240226$20240710$20240710$PER$$IN-ROCHE-3517453$ROCHE$$83$YR$E$F$Y$$$20240628$$CN$IN$IN
240684001$24068400$1$I$$20240214$20240710$20240710$PER$$DE-ROCHE-3500651$ROCHE$$$$$$Y$$$20240628$$MD$DE$DE
240684011$24068401$1$I$$20240223$20240710$20240710$PER$$US-ROCHE-3515933$ROCHE$$93$YR$E$F$Y$$$20240628$$CN$US$US
240684023$24068402$3$F$$20240219$20240710$20240710$PER$$JP-ROCHE-3067704$ROCHE$$6$YR$C$M$Y$42$KG$20240628$$MD$JP$JP
240684032$24068403$2$F$20240212$20240318$20240710$20240710$PER$$IN-ROCHE-3526492$ROCHE$$67$YR$E$M$Y$$$20240628$$CN$IN$IN
240684041$24068404$1$I$$20240306$20240710$20240710$PER$$US-ROCHE-3523533$ROCHE$$59$YR$A$F$Y$$$20240628$$PH$US$US
240684051$24068405$1$I$$20240325$20240710$20240710$PER$$US-ROCHE-3533134$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$US$US
240684061$24068406$1$I$$20240306$20240710$20240710$PER$$DE-ROCHE-3522650$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$DE$DE
240684081$24068408$1$I$20230421$20240424$20240710$20240710$PER$$BE-ROCHE-3553111$ROCHE$$54$YR$A$M$Y$90$KG$20240628$$MD$BE$BE
240684091$24068409$1$I$$20240408$20240710$20240710$PER$$US-ROCHE-3543543$ROCHE$$75$YR$E$F$Y$$$20240628$$CN$US$US
240684101$24068410$1$I$$20240209$20240710$20240710$PER$$US-ROCHE-3508871$ROCHE$$64$YR$A$M$Y$$$20240628$$MD$US$US
240684111$24068411$1$I$20240228$20240323$20240710$20240710$PER$$DK-ROCHE-3534983$ROCHE$$39$YR$A$F$Y$$$20240628$$MD$DK$DK
240684121$24068412$1$I$$20240205$20240710$20240710$PER$$US-ROCHE-3287033$ROCHE$$95$YR$E$F$Y$$$20240628$$MD$US$US
240684131$24068413$1$I$$20240312$20240710$20240710$PER$$IN-ROCHE-3527229$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$IN$IN
240684142$24068414$2$F$$20240417$20240710$20240710$PER$$IN-ROCHE-3515229$ROCHE$$$$$$Y$$$20240628$$MD$IN$IN
240684151$24068415$1$I$20231001$20231013$20240710$20240710$PER$$CN-ROCHE-3440315$ROCHE$$71$YR$E$F$Y$$$20240628$$CN$CN$CN
240684161$24068416$1$I$$20240322$20240710$20240710$PER$$SE-ROCHE-3533279$ROCHE$$$$$$Y$$$20240628$$MD$SE$SE
240684172$24068417$2$F$$20240415$20240710$20240710$PER$$ZA-ROCHE-3544346$ROCHE$$$$$F$Y$$$20240628$$CN$ZA$ZA
240684181$24068418$1$I$$20240201$20240710$20240710$PER$$JP-ROCHE-3510443$ROCHE$$7$DEC$E$M$Y$$$20240628$$MD$JP$JP
240684191$24068419$1$I$20220401$20240702$20240710$20240710$EXP$$DE-CELLTRION INC.-2024DE016249$CELLTRION$$$$$$Y$$$20240710$$MD$DE$DE
240684201$24068420$1$I$$20240301$20240710$20240710$PER$$AU-ROCHE-3519176$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240684211$24068421$1$I$20240314$20240314$20240710$20240710$PER$$CA-ROCHE-3527614$ROCHE$$86$YR$E$F$Y$$$20240628$$CN$CA$CA
240684221$24068422$1$I$$20240409$20240710$20240710$PER$$JP-ROCHE-3557484$ROCHE$$7$DEC$E$M$Y$$$20240628$$MD$JP$JP
240684231$24068423$1$I$20240303$20240502$20240710$20240710$PER$$DE-ROCHE-3558007$ROCHE$$68$YR$E$M$Y$$$20240628$$MD$DE$DE
240684241$24068424$1$I$20240307$20240308$20240710$20240710$PER$$IN-ROCHE-3525460$ROCHE$$85$YR$E$M$Y$$$20240628$$CN$IN$IN
240684251$24068425$1$I$$20240327$20240710$20240710$PER$$KR-ROCHE-3534773$ROCHE$$64$YR$A$M$Y$$$20240628$$CN$KR$KR
240684261$24068426$1$I$$20240206$20240710$20240710$PER$$US-ROCHE-3196092$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$US$US
240684271$24068427$1$I$$20240305$20240710$20240710$PER$$US-ROCHE-3522230$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240684281$24068428$1$I$$20240415$20240710$20240710$PER$$IL-ROCHE-3547156$ROCHE$$$$$F$Y$$$20240628$$CN$IL$IL
240684301$24068430$1$I$$20240312$20240710$20240710$PER$$CA-ROCHE-3525284$ROCHE$$$$$M$Y$$$20240628$$MD$CA$CA
240684311$24068431$1$I$$20240411$20240710$20240710$PER$$US-ROCHE-3544782$ROCHE$$80$YR$E$M$Y$$$20240628$$CN$US$US
240684321$24068432$1$I$$20240404$20240710$20240710$PER$$US-ROCHE-3540484$ROCHE$$26$YR$A$F$Y$$$20240628$$MD$US$US
240684331$24068433$1$I$20231130$20240202$20240710$20240710$PER$$JP-ROCHE-3511100$ROCHE$$83$YR$E$F$Y$$$20240628$$MD$JP$JP
240684341$24068434$1$I$20240207$20240209$20240710$20240710$PER$$IN-ROCHE-3508526$ROCHE$$70$YR$E$F$Y$$$20240628$$CN$IN$IN
240684352$24068435$2$F$$20240522$20240710$20240710$PER$$JP-ROCHE-3536100$ROCHE$$9$DEC$E$F$Y$$$20240628$$MD$JP$JP
240684361$24068436$1$I$$20240219$20240710$20240710$PER$$US-ROCHE-3513473$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240684373$24068437$3$F$20220621$20230707$20240710$20240710$PER$$CN-ROCHE-3147276$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$CN$CN
240684381$24068438$1$I$$20240214$20240710$20240710$PER$$JP-ROCHE-3517894$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240684391$24068439$1$I$20240304$20240329$20240710$20240710$PER$$JP-ROCHE-3551721$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240684401$24068440$1$I$$20240214$20240710$20240710$PER$$US-ROCHE-3510730$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$US$US
240684411$24068441$1$I$$20240321$20240710$20240710$PER$$FR-ROCHE-3533444$ROCHE$$70$YR$E$M$Y$$$20240628$$PH$FR$FR
240684421$24068442$1$I$$20240219$20240710$20240710$PER$$JP-ROCHE-3513283$ROCHE$$$$$$Y$$$20240628$$HP$JP$JP
240684431$24068443$1$I$$20231013$20240710$20240710$PER$$IN-ROCHE-3441200$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IN$IN
240684441$24068444$1$I$$20240209$20240710$20240710$PER$$SK-ROCHE-3510356$ROCHE$$$$E$F$Y$$$20240628$$MD$SK$SK
240684451$24068445$1$I$$20240416$20240710$20240710$PER$$FR-ROCHE-3548825$ROCHE$$$$E$M$Y$$$20240628$$MD$FR$FR
240684461$24068446$1$I$$20240412$20240710$20240710$PER$$US-ROCHE-3546096$ROCHE$$86$YR$E$F$Y$$$20240628$$MD$US$US
240684471$24068447$1$I$$20240301$20240710$20240710$PER$$US-ROCHE-3520095$ROCHE$$84$YR$E$F$Y$$$20240628$$MD$US$US
240684481$24068448$1$I$$20240301$20240710$20240710$PER$$NL-ROCHE-3520281$ROCHE$$58$YR$A$M$Y$$$20240628$$CN$NL$NL
240684491$24068449$1$I$20240621$20240704$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010446$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240684502$24068450$2$F$20240226$20240227$20240710$20240710$PER$$IN-ROCHE-3518803$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$IN$IN
240684511$24068451$1$I$$20240123$20240710$20240710$PER$$TH-ROCHE-3498533$ROCHE$$$$$$Y$$$20240628$$MD$TH$TH
240684521$24068452$1$I$20230812$20231006$20240710$20240710$PER$$CN-ROCHE-3435389$ROCHE$$49$YR$A$M$Y$$$20240628$$HP$CN$CN
240684531$24068453$1$I$$20231025$20240710$20240710$PER$$US-ROCHE-3447176$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$US$US
240684541$24068454$1$I$20231101$20240319$20240710$20240710$PER$NO-NOMAADVRE-PASRAPP-2024-Vpk459$NO-ROCHE-3530172$ROCHE$$53$YR$A$F$Y$75$KG$20240628$$CN$NO$NO
240684551$24068455$1$I$$20240409$20240710$20240710$PER$$US-ROCHE-3423869$ROCHE$$63$YR$A$M$Y$$$20240628$$HP$US$US
240684561$24068456$1$I$$20240409$20240710$20240710$PER$$US-ROCHE-3546165$ROCHE$$58$YR$A$M$Y$$$20240628$$MD$US$US
240684572$24068457$2$F$20240101$20240301$20240710$20240710$PER$$US-ROCHE-3520071$ROCHE$$80$YR$E$F$Y$$$20240628$$CN$US$US
240684581$24068458$1$I$$20240412$20240710$20240710$PER$$US-ROCHE-3545927$ROCHE$$41$YR$A$M$Y$$$20240628$$MD$US$US
240684592$24068459$2$F$20240101$20240124$20240710$20240710$PER$$JP-ROCHE-3505164$ROCHE$$8$DEC$E$$Y$$$20240628$$PH$JP$JP
240684601$24068460$1$I$$20240423$20240710$20240710$PER$$KR-ROCHE-3551814$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$KR$KR
240684621$24068462$1$I$$20240228$20240710$20240710$PER$$US-ROCHE-3518512$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$US$US
240684631$24068463$1$I$$20240326$20240710$20240710$PER$$IN-ROCHE-3535435$ROCHE$$62$YR$A$F$Y$$$20240628$$CN$IN$IN
240684642$24068464$2$F$$20240404$20240710$20240710$PER$$AR-ROCHE-3540527$ROCHE$$$$$$Y$$$20240628$$MD$AR$AR
240684652$24068465$2$F$20240601$20240802$20240710$20240815$PER$$US-AstraZeneca-2024A156520$ASTRAZENECA$$883$MON$$M$Y$$$20240815$$CN$US$
240684661$24068466$1$I$$20240207$20240710$20240710$PER$$US-ROCHE-3432911$ROCHE$$72$YR$E$M$Y$$$20240628$$MD$US$US
240684671$24068467$1$I$$20240125$20240710$20240710$PER$$US-ROCHE-3499652$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240684681$24068468$1$I$$20240209$20240710$20240710$PER$$US-ROCHE-3508730$ROCHE$$53$YR$A$M$Y$$$20240628$$MD$US$US
240684691$24068469$1$I$$20240410$20240710$20240710$PER$$US-ROCHE-3544494$ROCHE$$46$YR$A$M$Y$$$20240628$$MD$US$US
240684701$24068470$1$I$$20240220$20240710$20240710$PER$$US-ROCHE-3513511$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$US$US
240684711$24068471$1$I$$20240320$20240710$20240710$PER$$US-ROCHE-3530603$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$US$US
240684721$24068472$1$I$20231107$20240202$20240710$20240710$PER$$JP-ROCHE-3483478$ROCHE$$48$YR$A$F$Y$48$KG$20240628$$MD$JP$JP
240684731$24068473$1$I$$20240205$20240710$20240710$PER$$US-ROCHE-3505494$ROCHE$$62$YR$A$M$Y$$$20240628$$MD$US$US
240684741$24068474$1$I$$20240311$20240710$20240710$PER$$US-ROCHE-3526116$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240684751$24068475$1$I$$20240418$20240710$20240710$PER$$US-ROCHE-3550667$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240684761$24068476$1$I$20211206$20240702$20240710$20240710$EXP$$GB-AstraZeneca-2024A151938$ASTRAZENECA$$66$YR$$M$Y$84$KG$20240710$$MD$GB$
240684771$24068477$1$I$$20240402$20240710$20240710$PER$$US-ROCHE-3538091$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$US$US
240684782$24068478$2$F$$20240307$20240710$20240710$PER$$IT-ROCHE-3523525$ROCHE$$$$$M$Y$$$20240628$$CN$IT$IT
240684791$24068479$1$I$$20240403$20240710$20240710$PER$$CN-ROCHE-3540951$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$CN$CN
240684801$24068480$1$I$$20240313$20240710$20240710$PER$$US-ROCHE-3527499$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240684811$24068481$1$I$$20240326$20240710$20240710$PER$$IN-ROCHE-3534749$ROCHE$$63$YR$A$M$Y$$$20240628$$CN$IN$IN
240684821$24068482$1$I$$20240411$20240710$20240710$PER$$US-ROCHE-3545846$ROCHE$$77$YR$E$M$Y$$$20240628$$MD$US$US
240684831$24068483$1$I$$20240314$20240710$20240710$PER$$US-ROCHE-3527754$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$US$US
240684841$24068484$1$I$20230921$20240429$20240710$20240710$PER$SE-SEMPA-2023-014855$SE-ROCHE-3555363$ROCHE$$58$YR$A$F$Y$67$KG$20240628$$CN$SE$SE
240684861$24068486$1$I$$20240221$20240710$20240710$PER$$US-ROCHE-3514433$ROCHE$$60$YR$A$M$Y$$$20240628$$CN$US$US
240684871$24068487$1$I$$20240708$20240710$20240710$PER$$US-ABBVIE-5832329$ABBVIE$$$$$$Y$$$20240710$$CN$US$US
240684882$24068488$2$F$$20240107$20240710$20240710$PER$$IL-ROCHE-3487758$ROCHE$$$$$$Y$$$20240628$$MD$IL$IL
240684891$24068489$1$I$$20240209$20240710$20240710$PER$$NZ-ROCHE-3478415$ROCHE$$$$$$Y$$$20240628$$HP$NZ$NZ
240684901$24068490$1$I$20240327$20240405$20240710$20240710$PER$$JP-ROCHE-3555658$ROCHE$$$$$M$Y$$$20240628$$MD$JP$JP
240684912$24068491$2$F$$20240419$20240710$20240710$PER$$CA-ROCHE-3550880$ROCHE$$$$$F$Y$$$20240628$$MD$CA$CA
240684921$24068492$1$I$$20240322$20240710$20240710$PER$$CA-ROCHE-3532667$ROCHE$$$$$F$Y$$$20240628$$CN$CA$CA
240684931$24068493$1$I$20240301$20240417$20240710$20240710$PER$$AU-ROCHE-3548811$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$AU$AU
240684941$24068494$1$I$20240201$20240306$20240710$20240710$PER$$IN-ROCHE-3522563$ROCHE$$76$YR$E$F$Y$$$20240628$$CN$IN$IN
240684951$24068495$1$I$$20240216$20240710$20240710$PER$$US-ROCHE-3512080$ROCHE$$$$E$M$Y$$$20240628$$CN$US$US
240684961$24068496$1$I$$20240313$20240710$20240710$PER$$US-ROCHE-3527426$ROCHE$$81$YR$E$F$Y$$$20240628$$MD$US$US
240684971$24068497$1$I$$20240206$20240710$20240710$PER$$US-ROCHE-3295432$ROCHE$$61$YR$A$M$Y$$$20240628$$MD$US$US
240684981$24068498$1$I$20240415$20240419$20240710$20240710$PER$$FR-ROCHE-3552438$ROCHE$$$$$$Y$$$20240628$$PH$FR$FR
240684991$24068499$1$I$$20240412$20240710$20240710$PER$$IN-ROCHE-3546900$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$IN$IN
240685001$24068500$1$I$20211223$20231031$20240710$20240710$PER$$AT-ROCHE-3078086$ROCHE$$58$YR$A$F$Y$56$KG$20240628$$MD$AT$AT
240685012$24068501$2$F$$20240202$20240710$20240710$PER$$PT-ROCHE-3528672$ROCHE$$$$$M$Y$$$20240628$$MD$PT$PT
240685021$24068502$1$I$$20240405$20240710$20240710$PER$$US-ROCHE-3541712$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$US$US
240685031$24068503$1$I$$20240411$20240710$20240710$PER$$JP-ROCHE-3559784$ROCHE$$$$E$$Y$$$20240628$$MD$JP$JP
240685041$24068504$1$I$$20240410$20240710$20240710$PER$$AR-ROCHE-3543872$ROCHE$$$$$M$Y$$$20240628$$MD$AR$AR
240685051$24068505$1$I$$20240226$20240710$20240710$PER$$JP-ROCHE-3524956$ROCHE$$9$DEC$E$F$Y$$$20240628$$MD$JP$JP
240685061$24068506$1$I$$20240307$20240710$20240710$PER$$ZA-ROCHE-3524908$ROCHE$$$$$$Y$$$20240628$$MD$ZA$ZA
240685071$24068507$1$I$$20240129$20240710$20240710$PER$$US-ROCHE-3500868$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$US$US
240685081$24068508$1$I$$20240321$20240710$20240710$PER$$US-ROCHE-3531966$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$US$US
240685091$24068509$1$I$$20240301$20240710$20240710$PER$$AU-ROCHE-3519867$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240685103$24068510$3$F$20231122$20240122$20240710$20240710$PER$$IT-ROCHE-3497100$ROCHE$$63$YR$A$M$Y$62$KG$20240628$$MD$IT$IT
240685111$24068511$1$I$20231225$20240110$20240710$20240710$PER$$JP-ROCHE-3493108$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240685121$24068512$1$I$$20240305$20240710$20240710$PER$$US-ROCHE-3521498$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$US$US
240685131$24068513$1$I$$20240324$20240710$20240710$PER$$ES-ROCHE-3533499$ROCHE$$$$$F$Y$$$20240628$$CN$ES$ES
240685141$24068514$1$I$$20240131$20240710$20240710$PER$$US-ROCHE-3503000$ROCHE$$73$YR$E$M$Y$$$20240628$$MD$US$US
240685151$24068515$1$I$$20240416$20240710$20240710$PER$$AT-ROCHE-3548912$ROCHE$$$$$F$Y$$$20240628$$MD$AT$AT
240685171$24068517$1$I$$20240319$20240710$20240710$PER$$AU-ROCHE-3528828$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240685181$24068518$1$I$20240223$20240226$20240710$20240710$PER$$FR-ROCHE-3516956$ROCHE$$$$$$Y$$$20240628$$PH$FR$FR
240685191$24068519$1$I$$20240410$20240710$20240710$PER$$JP-ROCHE-3559421$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240685202$24068520$2$F$$20240413$20240710$20240710$PER$$IT-ROCHE-3549410$ROCHE$$$$$M$Y$$$20240628$$MD$IT$IT
240685211$24068521$1$I$$20240304$20240710$20240710$PER$$US-ROCHE-3520909$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$US$US
240685221$24068522$1$I$$20240416$20240710$20240710$PER$$JP-ROCHE-3559981$ROCHE$$7$DEC$E$M$Y$$$20240628$$MD$JP$JP
240685231$24068523$1$I$$20240701$20240710$20240710$EXP$$US-TAKEDA-2024TUS068691$TAKEDA$$$$$F$Y$$$20240710$$CN$US$US
240685241$24068524$1$I$$20240425$20240710$20240710$PER$$US-ROCHE-3553941$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$US$US
240685261$24068526$1$I$$20240219$20240710$20240710$PER$$US-ROCHE-3513442$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240685271$24068527$1$I$$20240205$20240710$20240710$PER$$US-ROCHE-3506384$ROCHE$$53$YR$A$M$Y$$$20240628$$MD$US$US
240685281$24068528$1$I$$20230704$20240710$20240710$PER$$AR-ROCHE-3382979$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$AR$AR
240685291$24068529$1$I$$20240502$20240710$20240710$PER$$US-ROCHE-3557875$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$US$US
240685302$24068530$2$F$$20240409$20240710$20240710$PER$$DE-ROCHE-3538955$ROCHE$$$$$$Y$$$20240628$$MD$DE$DE
240685311$24068531$1$I$$20240308$20240710$20240710$PER$$US-ROCHE-3523901$ROCHE$$51$YR$A$M$Y$$$20240628$$MD$US$US
240685321$24068532$1$I$20210914$20230705$20240710$20240710$PER$$AU-ROCHE-3383205$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$AU$AU
240685331$24068533$1$I$20240430$20240506$20240710$20240710$PER$$CN-ROCHE-3558943$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$CN$CN
240685341$24068534$1$I$$20240202$20240710$20240710$PER$$US-ROCHE-3505124$ROCHE$$80$YR$E$F$Y$$$20240628$$MD$US$US
240685351$24068535$1$I$$20240128$20240710$20240710$PER$$US-ROCHE-3501373$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240685361$24068536$1$I$$20240415$20240710$20240710$PER$$US-ROCHE-3546541$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$US$US
240685371$24068537$1$I$$20240219$20240710$20240710$PER$$AU-ROCHE-3520981$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240685381$24068538$1$I$$20240313$20240710$20240710$PER$$US-ROCHE-3527108$ROCHE$$50$YR$A$M$Y$$$20240628$$MD$US$US
240685391$24068539$1$I$$20240205$20240710$20240710$PER$$CA-ROCHE-3505728$ROCHE$$84$YR$E$M$Y$$$20240628$$CN$CA$CA
240685401$24068540$1$I$$20240131$20240710$20240710$PER$$JP-ROCHE-3506646$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240685411$24068541$1$I$$20240216$20240710$20240710$PER$$FR-ROCHE-3513190$ROCHE$$$$$F$Y$$$20240628$$MD$FR$FR
240685421$24068542$1$I$$20240222$20240710$20240710$PER$$US-ROCHE-3515745$ROCHE$$41$YR$A$F$Y$$$20240628$$MD$US$US
240685431$24068543$1$I$$20240228$20240710$20240710$PER$$US-ROCHE-3404975$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$US$US
240685451$24068545$1$I$$20240207$20240710$20240710$PER$$JP-ROCHE-3513286$ROCHE$$$$$M$Y$$$20240628$$CN$JP$JP
240685461$24068546$1$I$$20240402$20240710$20240710$PER$$US-ROCHE-3538756$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240685473$24068547$3$F$20240306$20240415$20240710$20240710$PER$$BR-ROCHE-3522733$ROCHE$$74$YR$E$M$Y$$$20240628$$MD$BR$BR
240685481$24068548$1$I$$20240510$20240710$20240710$PER$$US-ROCHE-3562848$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$US$US
240685491$24068549$1$I$$20240201$20240710$20240710$PER$$DE-ROCHE-3503900$ROCHE$$$$$$Y$$$20240628$$PH$DE$DE
240685501$24068550$1$I$$20240321$20240710$20240710$PER$GB-MHRA-MED-202403181523383340-LNVHZ$GB-ROCHE-3531701$ROCHE$$$$$F$Y$$$20240628$$MD$GB$GB
240685511$24068551$1$I$$20240404$20240710$20240710$PER$$US-ROCHE-3540698$ROCHE$Subbiah V, Gouda M, Iorgulescu J, Dadu R, Patel K, Sherman S, Cabanillas M, Hu M, Castellanos L, Amini B, Meric-Bernstam F, Shen T and Wu J Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer. DOI:10.1038/S41698-024-00563-4. npj Precision Oncology 2024;8 (1):1-9.$$$A$F$Y$$$20240628$$HP$US$US
240685521$24068552$1$I$$20240311$20240710$20240710$PER$$US-ROCHE-3525456$ROCHE$$67$YR$E$$Y$$$20240628$$MD$US$US
240685531$24068553$1$I$$20231023$20240710$20240710$PER$$FR-ROCHE-3447185$ROCHE$$$$A$F$Y$$$20240628$$MD$FR$FR
240685541$24068554$1$I$$20240402$20240710$20240710$PER$$US-ROCHE-3538036$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$US$US
240685551$24068555$1$I$$20240208$20240710$20240710$PER$$GB-ROCHE-3507884$ROCHE$$$$$F$Y$$$20240628$$MD$GB$GB
240685562$24068556$2$F$20240311$20240312$20240710$20240710$PER$$CN-ROCHE-3526337$ROCHE$$58$YR$A$M$Y$$$20240628$$CN$CN$CN
240685571$24068557$1$I$$20240409$20240710$20240710$PER$$US-ROCHE-3543433$ROCHE$$88$YR$E$M$Y$$$20240628$$MD$US$US
240685581$24068558$1$I$$20240319$20240710$20240710$PER$$US-ROCHE-3529710$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$US$US
240685591$24068559$1$I$20220801$20240108$20240710$20240710$PER$$US-ROCHE-3488472$ROCHE$$$$E$F$Y$$$20240628$$CN$US$US
240685602$24068560$2$F$$20240205$20240710$20240710$PER$$TW-ROCHE-3503556$ROCHE$$80$YR$E$$Y$$$20240628$$MD$TW$TW
240685611$24068561$1$I$20240201$20240405$20240710$20240710$PER$$US-ROCHE-3540729$ROCHE$$75$YR$E$M$Y$$$20240628$$CN$US$US
240685621$24068562$1$I$$20240311$20240710$20240710$PER$$US-ROCHE-3527790$ROCHE$$45$YR$A$M$Y$$$20240628$$MD$US$US
240685632$24068563$2$F$$20240528$20240710$20240710$PER$$JP-ROCHE-3388229$ROCHE$$8$DEC$E$F$Y$$$20240628$$PH$JP$JP
240685641$24068564$1$I$$20240430$20240710$20240710$PER$$AT-ROCHE-3557409$ROCHE$$$$$$Y$$$20240628$$MD$AT$AT
240685651$24068565$1$I$20230615$20230725$20240710$20240710$PER$PT-INFARMED-B202307-275$PT-ROCHE-3393644$ROCHE$$56$YR$A$F$Y$$$20240628$$MD$PT$PT
240685661$24068566$1$I$$20240502$20240710$20240710$PER$$US-ROCHE-3559577$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240685671$24068567$1$I$20240327$20240401$20240710$20240710$PER$$CN-ROCHE-3536853$ROCHE$$54$YR$A$M$Y$95$KG$20240628$$HP$CN$CN
240685692$24068569$2$F$$20240507$20240710$20240710$PER$$JP-ROCHE-3403194$ROCHE$Matsumoto H, Hoshino J, Nakamura K, Nagashima T and Akiyama H. Induction Phase Results of Intravitreal Faricimab Injection for Untreated Exudative Age-related Macular Degeneration.. The 39th Annual Meeting of Japanese Society for Ocular Circulation. 2023;75:-.$$$E$$Y$$$20240628$$MD$JP$JP
240685701$24068570$1$I$$20240508$20240710$20240710$PER$$US-ROCHE-3348242$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$US$US
240685711$24068571$1$I$20240101$20240301$20240710$20240710$PER$$JP-ROCHE-3533594$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240685721$24068572$1$I$$20240305$20240710$20240710$PER$$JP-ROCHE-3538409$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240685732$24068573$2$F$20231025$20240318$20240710$20240710$PER$$AU-ROCHE-3517343$ROCHE$$82$YR$E$F$Y$$$20240628$$MD$AU$AU
240685741$24068574$1$I$$20240318$20240710$20240710$PER$$US-ROCHE-3529375$ROCHE$$25$YR$A$F$Y$$$20240628$$MD$US$US
240685751$24068575$1$I$$20240308$20240710$20240710$PER$$US-ROCHE-3524612$ROCHE$$50$YR$A$F$Y$$$20240628$$HP$US$US
240685761$24068576$1$I$20230101$20240221$20240710$20240710$PER$$JP-ROCHE-3526075$ROCHE$$7$DEC$E$$Y$$$20240628$$MD$JP$JP
240685771$24068577$1$I$$20240321$20240710$20240710$PER$$AU-ROCHE-3531765$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240685781$24068578$1$I$$20240305$20240710$20240710$PER$$US-ROCHE-3522173$ROCHE$$64$YR$A$F$Y$$$20240628$$MD$US$US
240685791$24068579$1$I$$20240402$20240710$20240710$PER$$JP-ROCHE-3555885$ROCHE$$5$DEC$A$F$Y$$$20240628$$PH$JP$JP
240685801$24068580$1$I$$20231009$20240710$20240710$PER$$JP-ROCHE-3437475$ROCHE$Sonehara K, Nozawa S, Suzuki Y, Araki T, Komatsu M, Tateishi K, Hanaoka M. Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement.. Case Reports in Oncology 2023;:939-45.$60$YR$A$F$Y$$$20240628$$HP$JP$JP
240685811$24068581$1$I$$20240229$20240710$20240710$PER$$US-ROCHE-3089281$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$US$US
240685821$24068582$1$I$$20240417$20240710$20240710$PER$$US-ROCHE-3548488$ROCHE$$74$YR$E$F$Y$$$20240628$$MD$US$US
240685831$24068583$1$I$$20240321$20240710$20240710$PER$$US-ROCHE-3531563$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240685841$24068584$1$I$$20240322$20240710$20240710$PER$$US-ROCHE-3533345$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$US$US
240685851$24068585$1$I$$20231226$20240710$20240710$PER$$US-ROCHE-3482557$ROCHE$$70$YR$E$F$Y$$$20240628$$CN$US$US
240685861$24068586$1$I$$20240207$20240710$20240710$PER$$CA-ROCHE-3507276$ROCHE$$48$YR$A$M$Y$$$20240628$$CN$CA$CA
240685871$24068587$1$I$$20240217$20240710$20240710$PER$$CH-ROCHE-3466785$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$CH$CH
240685881$24068588$1$I$$20240214$20240710$20240710$PER$$US-ROCHE-3388629$ROCHE$$53$YR$A$M$Y$$$20240628$$MD$US$US
240685891$24068589$1$I$20240115$20240131$20240710$20240710$PER$IT-MINISAL02-967373$IT-ROCHE-3502037$ROCHE$$69$YR$E$F$Y$$$20240628$$PH$IT$IT
240685901$24068590$1$I$$20240418$20240710$20240710$PER$$US-ROCHE-3549184$ROCHE$$92$YR$E$F$Y$$$20240628$$MD$US$US
240685911$24068591$1$I$$20240220$20240710$20240710$PER$$US-ROCHE-3514523$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$US$US
240685921$24068592$1$I$$20240314$20240710$20240710$PER$$US-ROCHE-3527824$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$US$US
240685931$24068593$1$I$$20240419$20240710$20240710$PER$$JP-ROCHE-3561456$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240685941$24068594$1$I$$20240131$20240710$20240710$PER$$CA-ROCHE-3502761$ROCHE$$$$E$$Y$$$20240628$$MD$CA$CA
240685951$24068595$1$I$$20240419$20240710$20240710$PER$$CN-ROCHE-3550446$ROCHE$$49$YR$A$M$Y$$$20240628$$CN$CN$CN
240685962$24068596$2$F$$20240223$20240710$20240710$PER$$US-ROCHE-3509439$ROCHE$$45$YR$A$M$Y$$$20240628$$MD$US$US
240685971$24068597$1$I$$20240112$20240710$20240710$PER$$JP-ROCHE-3494715$ROCHE$$8$DEC$E$$Y$$$20240628$$MD$JP$JP
240685981$24068598$1$I$$20240326$20240710$20240710$PER$$US-ROCHE-3535764$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240685991$24068599$1$I$$20240315$20240710$20240710$PER$$US-ROCHE-3528498$ROCHE$$81$YR$E$F$Y$$$20240628$$MD$US$US
240686001$24068600$1$I$$20240215$20240710$20240710$PER$$US-ROCHE-3511319$ROCHE$$85$YR$E$$Y$$$20240628$$MD$US$US
240686011$24068601$1$I$$20240405$20240710$20240710$PER$$IT-ROCHE-3542302$ROCHE$$7$DEC$E$M$Y$$$20240628$$MD$IT$IT
240686021$24068602$1$I$$20240319$20240710$20240710$PER$$JP-ROCHE-3546814$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240686031$24068603$1$I$$20240206$20240710$20240710$PER$$US-ROCHE-3506439$ROCHE$$77$YR$E$F$Y$$$20240628$$MD$US$US
240686041$24068604$1$I$$20240228$20240710$20240710$PER$$US-ROCHE-3519838$ROCHE$$83$YR$E$M$Y$$$20240628$$CN$US$US
240686051$24068605$1$I$20240222$20240229$20240710$20240710$PER$$JP-ROCHE-3532151$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240686061$24068606$1$I$20240207$20240221$20240710$20240710$PER$$JP-ROCHE-3528098$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240686071$24068607$1$I$$20240312$20240710$20240710$PER$$US-ROCHE-3526688$ROCHE$$52$YR$A$M$Y$$$20240628$$MD$US$US
240686081$24068608$1$I$$20240220$20240710$20240710$PER$$GB-ROCHE-3513755$ROCHE$$98$YR$E$F$Y$$$20240628$$HP$GB$GB
240686091$24068609$1$I$$20240214$20240710$20240710$PER$$JP-ROCHE-3518012$ROCHE$$9$DEC$E$M$Y$$$20240628$$MD$JP$JP
240686101$24068610$1$I$$20240501$20240710$20240710$PER$$US-ROCHE-3557161$ROCHE$$81$YR$E$M$Y$$$20240628$$MD$US$US
240686111$24068611$1$I$20240212$20240213$20240710$20240710$PER$$FR-ROCHE-3511001$ROCHE$$$$$$Y$$$20240628$$PH$FR$FR
240686122$24068612$2$F$$20240108$20240710$20240710$PER$$US-ROCHE-3488770$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$US$US
240686131$24068613$1$I$20240221$20240222$20240710$20240710$PER$$CA-ROCHE-3515363$ROCHE$$49$YR$A$F$Y$$$20240628$$CN$CA$CA
240686141$24068614$1$I$$20240315$20240710$20240710$PER$$US-ROCHE-3528437$ROCHE$$68$YR$E$M$Y$107.6$KG$20240628$$MD$US$US
240686151$24068615$1$I$$20240408$20240710$20240710$PER$$US-ROCHE-3542467$ROCHE$$90$YR$E$F$Y$$$20240628$$MD$US$US
240686161$24068616$1$I$$20240307$20240710$20240710$PER$$US-ROCHE-3523363$ROCHE$$77$YR$E$M$Y$$$20240628$$MD$US$US
240686171$24068617$1$I$$20240221$20240710$20240710$PER$$AU-ROCHE-3513835$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240686181$24068618$1$I$$20240329$20240710$20240710$PER$$US-ROCHE-3292379$ROCHE$$19$YR$A$F$Y$$$20240628$$MD$US$US
240686191$24068619$1$I$$20240228$20240710$20240710$PER$$US-ROCHE-3518270$ROCHE$$63$YR$A$M$Y$$$20240628$$CN$US$US
240686201$24068620$1$I$$20240423$20240710$20240710$PER$$KR-ROCHE-3551851$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$KR$KR
240686211$24068621$1$I$$20240201$20240710$20240710$PER$$JP-ROCHE-3503407$ROCHE$$$$$$Y$$$20240628$$MD$JP$JP
240686222$24068622$2$F$$20240406$20240710$20240710$PER$$IT-ROCHE-3542292$ROCHE$$$$$F$Y$$$20240628$$MD$IT$IT
240686241$24068624$1$I$$20240226$20240710$20240710$PER$$CA-ROCHE-3516950$ROCHE$$$$E$F$Y$$$20240628$$CN$CA$CA
240686251$24068625$1$I$$20240215$20240710$20240710$PER$$US-ROCHE-3511352$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$US$US
240686261$24068626$1$I$$20240220$20240710$20240710$PER$$US-ROCHE-3513730$ROCHE$$63$YR$A$M$Y$$$20240628$$MD$US$US
240686271$24068627$1$I$$20240213$20240710$20240710$PER$$AT-ROCHE-3511615$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$AT$AT
240686281$24068628$1$I$$20240408$20240710$20240710$PER$$US-ROCHE-3542130$ROCHE$$63$YR$A$M$Y$$$20240628$$MD$US$US
240686291$24068629$1$I$$20240220$20240710$20240710$PER$$CL-ROCHE-3513996$ROCHE$$$$$$Y$$$20240628$$CN$CL$CL
240686301$24068630$1$I$$20240326$20240710$20240710$PER$$US-ROCHE-3535196$ROCHE$$1$WK$N$M$Y$$$20240628$$MD$US$US
240686311$24068631$1$I$$20240117$20240710$20240710$PER$$JP-ROCHE-3498183$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240686321$24068632$1$I$$20240131$20240710$20240710$PER$$CH-ROCHE-3498061$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240686341$24068634$1$I$$20240411$20240710$20240710$PER$$KR-ROCHE-3546315$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$KR$KR
240686351$24068635$1$I$$20240411$20240710$20240710$PER$$US-ROCHE-3545363$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$US$US
240686361$24068636$1$I$$20240227$20240710$20240710$PER$$FR-ROCHE-3518587$ROCHE$$$$$$Y$$$20240628$$MD$FR$FR
240686371$24068637$1$I$20240213$20240213$20240710$20240710$PER$$CA-ROCHE-3510546$ROCHE$$62$YR$A$M$Y$$$20240628$$CN$CA$CA
240686381$24068638$1$I$$20240322$20240710$20240710$PER$$SE-ROCHE-3533352$ROCHE$$$$$$Y$$$20240628$$MD$SE$SE
240686392$24068639$2$F$$20240416$20240710$20240710$PER$$US-ROCHE-3548813$ROCHE$$65$YR$E$F$Y$132.2$KG$20240628$$MD$US$US
240686401$24068640$1$I$$20240422$20240710$20240710$PER$$AU-ROCHE-3552282$ROCHE$$$$$M$Y$$$20240628$$MD$AU$AU
240686411$24068641$1$I$$20240419$20240710$20240710$PER$$US-ROCHE-3551241$ROCHE$$67$YR$E$M$Y$$$20240628$$MD$US$US
240686421$24068642$1$I$$20230705$20240710$20240710$PER$$CA-ROCHE-3383017$ROCHE$$$$$$Y$$$20240628$$PH$CA$CA
240686431$24068643$1$I$20240125$20240129$20240710$20240710$PER$$CN-ROCHE-3501061$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$CN$CN
240686443$24068644$3$F$20240129$20240508$20240710$20240710$PER$$HR-ROCHE-3530506$ROCHE$$62$YR$A$M$Y$130$KG$20240628$$MD$HR$HR
240686461$24068646$1$I$$20240408$20240710$20240710$PER$$GB-ROCHE-3543508$ROCHE$$$$$F$Y$$$20240628$$CN$GB$GB
240686471$24068647$1$I$$20240416$20240710$20240710$PER$$FR-ROCHE-3548046$ROCHE$$$$$M$Y$$$20240628$$CN$FR$FR
240686481$24068648$1$I$$20240227$20240710$20240710$PER$$RO-ROCHE-3517820$ROCHE$$$$$M$Y$$$20240628$$MD$RO$RO
240686491$24068649$1$I$$20240227$20240710$20240710$PER$$US-ROCHE-3517340$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240686511$24068651$1$I$20240215$20240306$20240710$20240710$PER$$IN-ROCHE-3523898$ROCHE$$92$YR$E$F$Y$$$20240628$$CN$IN$IN
240686521$24068652$1$I$$20240129$20240710$20240710$PER$$SE-ROCHE-3503880$ROCHE$$$$$$Y$$$20240628$$MD$SE$SE
240686531$24068653$1$I$$20240321$20240710$20240710$PER$$US-ROCHE-3263265$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$US$US
240686541$24068654$1$I$$20240514$20240710$20240710$PER$$TW-ROCHE-3563915$ROCHE$$$$$$Y$$$20240628$$MD$TW$TW
240686551$24068655$1$I$20240123$20240131$20240710$20240710$PER$$CL-ROCHE-3503169$ROCHE$$$$$F$Y$68$KG$20240628$$CN$CL$CL
240686561$24068656$1$I$$20240131$20240710$20240710$PER$$US-ROCHE-3502951$ROCHE$$83$YR$E$F$Y$$$20240628$$MD$US$US
240686571$24068657$1$I$20240409$20240409$20240710$20240710$PER$$FR-ROCHE-3543786$ROCHE$$$$$M$Y$$$20240628$$MD$FR$FR
240686582$24068658$2$F$20230818$20231201$20240710$20240710$PER$$IT-ROCHE-3469195$ROCHE$$80$YR$E$M$Y$73$KG$20240628$$MD$IT$IT
240686591$24068659$1$I$$20240201$20240710$20240710$PER$$US-ROCHE-3503686$ROCHE$$59$YR$A$M$Y$$$20240628$$MD$US$US
240686601$24068660$1$I$20231020$20231021$20240710$20240710$PER$$US-ROCHE-3444466$ROCHE$$44$YR$A$F$Y$$$20240628$$CN$US$US
240686611$24068661$1$I$$20240403$20240710$20240710$PER$$DE-ROCHE-3538990$ROCHE$$$$$$Y$$$20240628$$MD$DE$DE
240686621$24068662$1$I$$20240319$20240710$20240710$PER$$JP-ROCHE-3546621$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240686631$24068663$1$I$$20240425$20240710$20240710$PER$$CH-ROCHE-3552755$ROCHE$Chen Y, Steiner S, Hagedorn C, Kollar S, Pliego- Mendieta A, Haberecker M, Plock J, Britschgi C, Planas-Paz L and Pauli C Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivo LMNA::NTRK1- rearranged soft-tissue sarcoma cell model. DOI:10.1002/path.6282. The Journal of pathology 2024 Apr 12;:1-13.$16$YR$T$F$Y$$$20240628$$HP$CH$CH
240686641$24068664$1$I$$20240207$20240710$20240710$PER$$DE-ROCHE-3507311$ROCHE$$$$$F$Y$$$20240628$$MD$DE$DE
240686651$24068665$1$I$$20240227$20240710$20240710$PER$$US-ROCHE-3517487$ROCHE$$79$YR$E$F$Y$$$20240628$$MD$US$US
240686661$24068666$1$I$$20240206$20240710$20240710$PER$$US-ROCHE-3505471$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$US$US
240686671$24068667$1$I$$20240124$20240710$20240710$PER$$US-ROCHE-3499561$ROCHE$$38$YR$A$F$Y$$$20240628$$MD$US$US
240686681$24068668$1$I$$20230911$20240710$20240710$PER$$TW-ROCHE-3423120$ROCHE$$65$YR$E$M$Y$$$20240628$$HP$TW$TW
240686691$24068669$1$I$$20240429$20240710$20240710$PER$$GB-ROCHE-3556069$ROCHE$$$$$$Y$$$20240628$$MD$GB$GB
240686701$24068670$1$I$$20240412$20240710$20240710$PER$$US-ROCHE-3545649$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240686711$24068671$1$I$$20240306$20240710$20240710$PER$$AU-ROCHE-3522512$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240686721$24068672$1$I$20230324$20231229$20240710$20240710$PER$IT-MINISAL02-962538$IT-ROCHE-3483458$ROCHE$$71$YR$E$F$Y$59$KG$20240628$$PH$IT$IT
240686731$24068673$1$I$$20240311$20240710$20240710$PER$$US-ROCHE-3524905$ROCHE$$1$YR$I$F$Y$$$20240628$$MD$US$US
240686741$24068674$1$I$$20240417$20240710$20240710$PER$$AU-ROCHE-3164998$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$AU$AU
240686751$24068675$1$I$$20240409$20240710$20240710$PER$$US-ROCHE-3545355$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$US$US
240686761$24068676$1$I$$20240507$20240710$20240710$PER$$CA-ROCHE-3560675$ROCHE$$$$$$Y$$$20240628$$HP$CA$CA
240686771$24068677$1$I$$20240314$20240710$20240710$PER$$US-ROCHE-3527027$ROCHE$$62$YR$A$M$Y$$$20240628$$MD$US$US
240686791$24068679$1$I$20220517$20240429$20240710$20240710$PER$$TR-ROCHE-3556264$ROCHE$$58$YR$A$M$Y$$$20240628$$MD$TR$TR
240686801$24068680$1$I$$20240319$20240710$20240710$PER$$JP-ROCHE-3547700$ROCHE$$7$DEC$E$$Y$$$20240628$$MD$JP$JP
240686811$24068681$1$I$$20240124$20240710$20240710$PER$$JP-ROCHE-3504980$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240686821$24068682$1$I$$20240209$20240710$20240710$PER$$US-ROCHE-3509625$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$US$US
240686831$24068683$1$I$$20240315$20240710$20240710$PER$$RU-ROCHE-3528484$ROCHE$$44$YR$A$F$Y$$$20240628$$MD$RU$RU
240686841$24068684$1$I$$20240229$20240710$20240710$PER$$US-ROCHE-3519991$ROCHE$$64$YR$A$M$Y$$$20240628$$MD$US$US
240686851$24068685$1$I$$20240501$20240710$20240710$PER$$US-ROCHE-3556621$ROCHE$$71$YR$E$M$Y$$$20240628$$MD$US$US
240686861$24068686$1$I$20240116$20240320$20240710$20240710$PER$$DE-ROCHE-3498013$ROCHE$$76$YR$E$F$Y$52$KG$20240628$$MD$DE$DE
240686871$24068687$1$I$20230501$20230714$20240710$20240710$PER$$US-ROCHE-3389748$ROCHE$$93$YR$E$F$Y$$$20240628$$CN$US$US
240686881$24068688$1$I$20231130$20240124$20240710$20240710$PER$$IN-ROCHE-3498732$ROCHE$$$$$M$Y$$$20240628$$MD$IN$IN
240686891$24068689$1$I$$20240301$20240710$20240710$PER$$IT-ROCHE-3520255$ROCHE$$$$$$Y$$$20240628$$MD$IT$IT
240686901$24068690$1$I$20240228$20240229$20240710$20240710$PER$$CA-ROCHE-3519468$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$CA$CA
240686911$24068691$1$I$$20240206$20240710$20240710$PER$$US-ROCHE-3301114$ROCHE$$51$YR$A$M$Y$$$20240628$$MD$US$US
240686921$24068692$1$I$$20240325$20240710$20240710$PER$$JP-ROCHE-3550075$ROCHE$$6$DEC$A$M$Y$$$20240628$$MD$JP$JP
240686931$24068693$1$I$$20240215$20240710$20240710$PER$$CA-ROCHE-3511721$ROCHE$$$$E$F$Y$$$20240628$$CN$CA$CA
240686941$24068694$1$I$$20240311$20240710$20240710$PER$$US-ROCHE-3525017$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240686951$24068695$1$I$$20240501$20240710$20240710$PER$$US-ROCHE-3558374$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$US$US
240686961$24068696$1$I$$20240319$20240710$20240710$PER$$JP-ROCHE-3544907$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240686971$24068697$1$I$$20240216$20240710$20240710$PER$$US-ROCHE-3512981$ROCHE$$70$YR$E$$Y$$$20240628$$MD$US$US
240686981$24068698$1$I$$20240131$20240710$20240710$PER$$FR-ROCHE-3503229$ROCHE$$$$$$Y$$$20240628$$PH$FR$FR
240686991$24068699$1$I$$20240222$20240710$20240710$PER$$AT-ROCHE-3515863$ROCHE$$$$$$Y$$$20240628$$MD$AT$AT
240687001$24068700$1$I$$20240215$20240710$20240710$PER$$US-ROCHE-3511337$ROCHE$$85$YR$E$F$Y$$$20240628$$MD$US$US
240687011$24068701$1$I$$20240229$20240710$20240710$PER$$US-ROCHE-3520570$ROCHE$$73$YR$E$M$Y$$$20240628$$MD$US$US
240687031$24068703$1$I$$20240425$20240710$20240710$PER$$GB-ROCHE-3552717$ROCHE$Deborah S, Tom G If at first you don^t succeed switching treatments in NTRK fusion NSCLC. (Abstract number:210).Doi:10.1016/j.lungcan.2024.107771. Lung Cancer 2024 Apr;190 (SUPP 1):112-.$25$YR$A$F$Y$$$20240628$$HP$GB$GB
240687041$24068704$1$I$$20240119$20240710$20240710$PER$$JP-ROCHE-3499328$ROCHE$$47$YR$A$M$Y$$$20240628$$MD$JP$JP
240687051$24068705$1$I$$20240329$20240710$20240710$PER$$JP-ROCHE-3551813$ROCHE$$7$DEC$E$$Y$$$20240628$$MD$JP$JP
240687061$24068706$1$I$$20240511$20240710$20240710$PER$$US-ROCHE-3562870$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$US$US
240687071$24068707$1$I$$20240328$20240710$20240710$PER$$US-ROCHE-2829279$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$US$US
240687081$24068708$1$I$$20240313$20240710$20240710$PER$$CA-ROCHE-3526695$ROCHE$$$$$$Y$$$20240628$$MD$CA$CA
240687091$24068709$1$I$20231218$20240429$20240710$20240710$PER$$US-ROCHE-3556361$ROCHE$$85$YR$E$M$Y$$$20240628$$MD$US$US
240687102$24068710$2$F$20230620$20240215$20240710$20240710$PER$PT-INFARMED-B202307-497$PT-ROCHE-3395471$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$PT$PT
240687111$24068711$1$I$$20240403$20240710$20240710$PER$$DE-ROCHE-3538987$ROCHE$$$$$$Y$$$20240628$$MD$DE$DE
240687121$24068712$1$I$$20240318$20240710$20240710$PER$$IN-ROCHE-3531251$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$IN$IN
240687131$24068713$1$I$$20240328$20240710$20240710$PER$$DE-ROCHE-3536559$ROCHE$$$$$$Y$$$20240628$$MD$DE$DE
240687141$24068714$1$I$$20240322$20240710$20240710$PER$$US-ROCHE-3532571$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240687151$24068715$1$I$$20240102$20240710$20240710$PER$$DE-ROCHE-3485169$ROCHE$$$$A$F$Y$$$20240628$$CN$DE$DE
240687161$24068716$1$I$$20240228$20240710$20240710$PER$$US-ROCHE-3518014$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$US$US
240687171$24068717$1$I$$20240221$20240710$20240710$PER$$AU-ROCHE-3513604$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240687181$24068718$1$I$$20240409$20240710$20240710$PER$$ZA-ROCHE-3557806$ROCHE$$$$$$Y$$$20240628$$CN$ZA$ZA
240687191$24068719$1$I$$20240116$20240710$20240710$PER$$JP-ROCHE-3496443$ROCHE$$9$DEC$E$F$Y$$$20240628$$MD$JP$JP
240687201$24068720$1$I$20240222$20240307$20240710$20240710$PER$$JP-ROCHE-3540175$ROCHE$$$$E$M$Y$$$20240628$$MD$JP$JP
240687211$24068721$1$I$$20240503$20240710$20240710$PER$$US-ROCHE-3558548$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$US$US
240687221$24068722$1$I$20231230$20240215$20240710$20240710$PER$$CA-ROCHE-3511757$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$CA$CA
240687231$24068723$1$I$$20240215$20240710$20240710$PER$$US-ROCHE-3511394$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240687241$24068724$1$I$20240409$20240412$20240710$20240710$PER$$CN-ROCHE-3545995$ROCHE$$69$YR$E$F$Y$53$KG$20240628$$HP$CN$CN
240687251$24068725$1$I$$20240313$20240710$20240710$PER$$US-ROCHE-3527352$ROCHE$$40$YR$A$F$Y$$$20240628$$MD$US$US
240687261$24068726$1$I$$20240229$20240710$20240710$PER$$US-ROCHE-3519885$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$US$US
240687271$24068727$1$I$$20240415$20240710$20240710$PER$$CA-ROCHE-3546593$ROCHE$$83$YR$E$F$Y$$$20240628$$CN$CA$CA
240687282$24068728$2$F$20240123$20240213$20240710$20240710$PER$$IN-ROCHE-3497613$ROCHE$$89$YR$E$F$Y$$$20240628$$CN$IN$IN
240687291$24068729$1$I$$20240318$20240710$20240710$PER$$JP-ROCHE-3536958$ROCHE$$77$YR$E$M$Y$$$20240628$$MD$JP$JP
240687311$24068731$1$I$20240115$20240115$20240710$20240710$PER$$JP-ROCHE-3495874$ROCHE$$74$YR$E$M$Y$$$20240628$$MD$JP$JP
240687321$24068732$1$I$$20240423$20240710$20240710$PER$$US-ROCHE-3551461$ROCHE$$56$YR$A$M$Y$$$20240628$$MD$US$US
240687331$24068733$1$I$$20230908$20240710$20240710$PER$$US-ROCHE-3422971$ROCHE$$31$YR$A$M$Y$$$20240628$$CN$US$US
240687341$24068734$1$I$$20240322$20240710$20240710$PER$$SE-ROCHE-3533263$ROCHE$$$$$$Y$$$20240628$$MD$SE$SE
240687351$24068735$1$I$20240407$20240409$20240710$20240710$PER$$US-ROCHE-3542955$ROCHE$$62$YR$A$F$Y$100.24$KG$20240628$$CN$US$US
240687363$24068736$3$F$20240221$20240429$20240710$20240710$PER$$IN-ROCHE-3516594$ROCHE$$56$YR$A$M$Y$$$20240628$$CN$IN$IN
240687371$24068737$1$I$20240513$20240704$20240710$20240710$EXP$$CO-UCBSA-2024034768$UCB$$79$YR$$F$Y$$$20240710$$CN$CO$CO
240687381$24068738$1$I$20240101$20240311$20240710$20240710$PER$$US-ROCHE-3524756$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$US$US
240687391$24068739$1$I$20240130$20240131$20240710$20240710$PER$$CA-ROCHE-3503612$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$CA$CA
240687401$24068740$1$I$$20240216$20240710$20240710$PER$$US-ROCHE-3512768$ROCHE$$66$YR$E$M$Y$$$20240628$$MD$US$US
240687411$24068741$1$I$$20240318$20240710$20240710$PER$$US-ROCHE-3529278$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$US$US
240687421$24068742$1$I$$20240228$20240710$20240710$PER$$CA-ROCHE-3517881$ROCHE$$$$E$M$Y$$$20240628$$CN$CA$CA
240687431$24068743$1$I$20240110$20240125$20240710$20240710$PER$$JP-ROCHE-3505249$ROCHE$$8$DEC$E$$Y$$$20240628$$MD$JP$JP
240687442$24068744$2$F$20230908$20240221$20240710$20240710$PER$$TR-ROCHE-3423116$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$TR$TR
240687451$24068745$1$I$$20240226$20240710$20240710$PER$$US-ROCHE-3516922$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$US$US
240687461$24068746$1$I$$20240216$20240710$20240710$PER$$US-ROCHE-3512942$ROCHE$$53$YR$A$M$Y$$$20240628$$MD$US$US
240687471$24068747$1$I$$20240206$20240710$20240710$PER$$US-ROCHE-3506279$ROCHE$$59$YR$A$M$Y$$$20240628$$MD$US$US
240687481$24068748$1$I$$20240416$20240710$20240710$PER$$US-ROCHE-3496978$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$US$US
240687491$24068749$1$I$20240207$20240207$20240710$20240710$PER$$MY-ROCHE-3506252$ROCHE$$$$$$Y$$$20240628$$MD$MY$MY
240687501$24068750$1$I$$20240131$20240710$20240710$PER$$US-ROCHE-3503012$ROCHE$$36$YR$A$M$Y$$$20240628$$MD$US$US
240687511$24068751$1$I$$20240419$20240710$20240710$PER$$US-ROCHE-3550340$ROCHE$$67$YR$E$M$Y$$$20240628$$MD$US$US
240687521$24068752$1$I$$20240308$20240710$20240710$PER$$US-ROCHE-3524636$ROCHE$$84$YR$E$F$Y$$$20240628$$CN$US$US
240687531$24068753$1$I$20220808$20240206$20240710$20240710$PER$$US-ROCHE-3506356$ROCHE$$79$YR$E$F$Y$$$20240628$$CN$US$US
240687541$24068754$1$I$$20240312$20240710$20240710$PER$$US-ROCHE-3525933$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$US$US
240687551$24068755$1$I$$20240209$20240710$20240710$PER$$DE-ROCHE-3509658$ROCHE$$$$$F$Y$$$20240628$$MD$DE$DE
240687561$24068756$1$I$$20240410$20240710$20240710$PER$$JP-ROCHE-3557496$ROCHE$$7$DEC$E$M$Y$$$20240628$$MD$JP$JP
240687571$24068757$1$I$20230706$20230710$20240710$20240710$PER$$CN-ROCHE-3385199$ROCHE$$57$YR$A$M$Y$$$20240628$$CN$CN$CN
240687581$24068758$1$I$$20240409$20240710$20240710$PER$$US-ROCHE-3543717$ROCHE$$$$A$M$Y$$$20240628$$CN$US$US
240687591$24068759$1$I$$20240227$20240710$20240710$PER$$US-ROCHE-3517468$ROCHE$$71$YR$E$F$Y$$$20240628$$MD$US$US
240687601$24068760$1$I$$20240206$20240710$20240710$PER$$GB-ROCHE-3506246$ROCHE$$$$$M$Y$$$20240628$$HP$GB$GB
240687611$24068761$1$I$$20240418$20240710$20240710$PER$$US-ROCHE-3549610$ROCHE$$69$YR$E$F$Y$$$20240628$$MD$US$US
240687621$24068762$1$I$$20240412$20240710$20240710$PER$$IN-ROCHE-3546709$ROCHE$$62$YR$A$M$Y$$$20240628$$CN$IN$IN
240687631$24068763$1$I$20240108$20240401$20240710$20240710$PER$$US-ROCHE-3537135$ROCHE$$74$YR$E$F$Y$65.77$KG$20240628$$CN$US$US
240687641$24068764$1$I$$20240408$20240710$20240710$PER$$US-ROCHE-3544776$ROCHE$$77$YR$E$F$Y$$$20240628$$MD$US$US
240687652$24068765$2$F$$20240319$20240710$20240710$PER$$IN-ROCHE-3527398$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$IN$IN
240687661$24068766$1$I$$20240403$20240710$20240710$PER$$RO-ROCHE-3541788$ROCHE$$$$$M$Y$$$20240628$$MD$RO$RO
240687671$24068767$1$I$$20240228$20240710$20240710$PER$$US-ROCHE-3404941$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$US$US
240687681$24068768$1$I$20240109$20240212$20240710$20240710$PER$$IN-ROCHE-3508738$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$IN$IN
240687691$24068769$1$I$$20240507$20240710$20240710$PER$$CA-ROCHE-3560668$ROCHE$$$$$$Y$$$20240628$$HP$CA$CA
240687701$24068770$1$I$$20240225$20240710$20240710$PER$$US-ROCHE-3516762$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$US$US
240687712$24068771$2$F$$20231112$20240710$20240710$PER$$CN-ROCHE-3446456$ROCHE$$61$YR$A$F$Y$70$KG$20240628$$CN$CN$CN
240687721$24068772$1$I$$20240508$20240710$20240710$PER$$US-ROCHE-3560815$ROCHE$$75$YR$E$M$Y$$$20240628$$MD$US$US
240687731$24068773$1$I$$20240318$20240710$20240710$PER$$US-ROCHE-3528822$ROCHE$$$$E$F$Y$$$20240628$$CN$US$US
240687741$24068774$1$I$$20240326$20240710$20240710$PER$$IN-ROCHE-3534018$ROCHE$$78$YR$E$M$Y$$$20240628$$CN$IN$IN
240687752$24068775$2$F$$20231101$20240710$20240710$PER$$CA-ROCHE-3451094$ROCHE$$66$YR$E$F$Y$85.9$KG$20240628$$CN$CA$CA
240687761$24068776$1$I$$20240313$20240710$20240710$PER$$US-ROCHE-3527634$ROCHE$$34$YR$A$F$Y$74.84$KG$20240628$$CN$US$US
240687771$24068777$1$I$$20231011$20240710$20240710$PER$$CN-ROCHE-3438417$ROCHE$$$$$F$Y$$$20240628$$MD$CN$CN
240687781$24068778$1$I$$20240416$20240710$20240710$PER$$US-ROCHE-3547838$ROCHE$$48$YR$A$M$Y$$$20240628$$MD$US$US
240687791$24068779$1$I$20240418$20240422$20240710$20240710$PER$$JP-ROCHE-3561424$ROCHE$$86$YR$E$F$Y$$$20240628$$CN$JP$JP
240687801$24068780$1$I$$20240403$20240710$20240710$PER$$JP-ROCHE-3557879$ROCHE$$6$DEC$A$M$Y$$$20240628$$PH$JP$JP
240687812$24068781$2$F$$20240215$20240710$20240710$PER$$US-ROCHE-3242566$ROCHE$$87$YR$E$F$Y$$$20240628$$MD$US$US
240687821$24068782$1$I$$20240312$20240710$20240710$PER$$US-ROCHE-3526514$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$US$US
240687831$24068783$1$I$20240411$20240412$20240710$20240710$PER$$CA-ROCHE-3546455$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$CA$CA
240687841$24068784$1$I$$20240305$20240710$20240710$PER$$US-ROCHE-3522247$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240687851$24068785$1$I$20230920$20230920$20240710$20240710$PER$$JP-ROCHE-3428007$ROCHE$$94$YR$E$M$Y$$$20240628$$PH$JP$JP
240687861$24068786$1$I$$20240401$20240710$20240710$PER$$IN-ROCHE-3538810$ROCHE$$72$YR$E$M$Y$$$20240628$$CN$IN$IN
240687872$24068787$2$F$$20240709$20240710$20240711$PER$$US-JNJFOC-20240722054$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240687881$24068788$1$I$$20240205$20240710$20240710$PER$$JP-ROCHE-3511859$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240687891$24068789$1$I$$20240412$20240710$20240710$PER$$US-ROCHE-3545934$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$US$US
240687901$24068790$1$I$$20240205$20240710$20240710$PER$$US-ROCHE-3505432$ROCHE$$75$YR$E$M$Y$$$20240628$$MD$US$US
240687911$24068791$1$I$$20240311$20240710$20240710$PER$$HK-ROCHE-3527259$ROCHE$$61$YR$A$M$Y$$$20240628$$MD$HK$HK
240687921$24068792$1$I$$20240221$20240710$20240710$PER$$US-ROCHE-3514368$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240687931$24068793$1$I$$20240131$20240710$20240710$PER$$US-ROCHE-3503207$ROCHE$$70$YR$E$M$Y$$$20240628$$MD$US$US
240687941$24068794$1$I$$20240328$20240710$20240710$PER$$TW-ROCHE-3535492$ROCHE$$$$$$Y$$$20240628$$MD$TW$TW
240687951$24068795$1$I$$20240305$20240710$20240710$PER$$US-ROCHE-3522242$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240687961$24068796$1$I$$20240701$20240710$20240710$EXP$$CA-CELLTRION INC.-2024CA016007$CELLTRION$$$$$$Y$$$20240710$$HP$CA$CA
240687971$24068797$1$I$$20240402$20240710$20240710$PER$$JP-ROCHE-3554546$ROCHE$$6$DEC$A$M$Y$$$20240628$$MD$JP$JP
240687981$24068798$1$I$$20240301$20240710$20240710$PER$$US-ROCHE-3520564$ROCHE$$76$YR$E$M$Y$$$20240628$$MD$US$US
240687991$24068799$1$I$20240304$20240409$20240710$20240710$PER$$JP-ROCHE-3559239$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240688001$24068800$1$I$20240411$20240417$20240710$20240710$PER$$CA-ROCHE-3548750$ROCHE$$70$YR$E$F$Y$$$20240628$$CN$CA$CA
240688011$24068801$1$I$$20240422$20240710$20240710$PER$$US-ROCHE-3397095$ROCHE$$37$YR$A$$Y$$$20240628$$MD$US$US
240688021$24068802$1$I$$20240420$20240710$20240710$PER$$US-ROCHE-3550698$ROCHE$$50$YR$A$M$Y$$$20240628$$MD$US$US
240688031$24068803$1$I$20230614$20240410$20240710$20240710$PER$$JP-ROCHE-3388017$ROCHE$$7$DEC$E$M$Y$$$20240628$$MD$JP$JP
240688041$24068804$1$I$$20240416$20240710$20240710$PER$$US-ROCHE-3548170$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240688051$24068805$1$I$$20240412$20240710$20240710$PER$$US-ROCHE-3545702$ROCHE$$76$YR$E$F$Y$$$20240628$$CN$US$US
240688061$24068806$1$I$20240123$20240315$20240710$20240710$PER$$IN-ROCHE-3529883$ROCHE$$62$YR$A$F$Y$$$20240628$$CN$IN$IN
240688071$24068807$1$I$20230920$20230926$20240710$20240710$PER$$JP-ROCHE-3431147$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240688081$24068808$1$I$$20240320$20240710$20240710$PER$$BR-ROCHE-3531928$ROCHE$$$$E$F$Y$$$20240628$$CN$BR$BR
240688091$24068809$1$I$$20230717$20240710$20240710$PER$$PE-ROCHE-3391326$ROCHE$$36$YR$A$M$Y$$$20240628$$CN$PE$PE
240688101$24068810$1$I$20240223$20240423$20240710$20240710$PER$FR-AFSSAPS-TO2024000701$FR-ROCHE-3551988$ROCHE$$79$YR$E$F$Y$$$20240628$$PH$FR$FR
240688111$24068811$1$I$$20240326$20240710$20240710$PER$$US-ROCHE-3390083$ROCHE$$77$YR$E$M$Y$$$20240628$$MD$US$US
240688121$24068812$1$I$20231127$20240213$20240710$20240710$PER$DK-DKMA-WBS-1006978$DK-ROCHE-3509396$ROCHE$$77$YR$E$M$Y$68$KG$20240628$$MD$DK$DK
240688131$24068813$1$I$$20240423$20240710$20240710$PER$$KR-ROCHE-3551838$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$KR$KR
240688141$24068814$1$I$20240124$20240129$20240710$20240710$PER$$CA-ROCHE-3501963$ROCHE$$91$YR$E$M$Y$$$20240628$$CN$CA$CA
240688151$24068815$1$I$$20240322$20240710$20240710$PER$$IN-ROCHE-3533782$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$IN$IN
240688161$24068816$1$I$20240303$20240404$20240710$20240710$PER$$FR-ROCHE-3542514$ROCHE$$$$$$Y$$$20240628$$PH$FR$FR
240688171$24068817$1$I$$20240424$20240710$20240710$PER$$US-ROCHE-3553043$ROCHE$$64$YR$A$M$Y$$$20240628$$MD$US$US
240688181$24068818$1$I$$20240312$20240710$20240710$PER$$US-ROCHE-3525927$ROCHE$$$$$M$Y$$$20240628$$MD$US$US
240688191$24068819$1$I$$20240405$20240710$20240710$PER$$JP-ROCHE-3555767$ROCHE$$74$YR$E$M$Y$$$20240628$$MD$JP$JP
240688201$24068820$1$I$$20240408$20240710$20240710$PER$$CA-ROCHE-3542305$ROCHE$$$$A$M$Y$$$20240628$$CN$CA$CA
240688211$24068821$1$I$$20240213$20240710$20240710$PER$$US-ROCHE-3344229$ROCHE$$58$YR$A$$Y$$$20240628$$MD$US$US
240688221$24068822$1$I$20240228$20240401$20240710$20240710$PER$$IN-ROCHE-3537720$ROCHE$$52$YR$A$M$Y$$$20240628$$CN$IN$IN
240688231$24068823$1$I$$20230906$20240710$20240710$PER$$MX-ROCHE-3420492$ROCHE$$$$A$M$Y$$$20240628$$CN$MX$MX
240688241$24068824$1$I$$20231013$20240710$20240710$PER$$US-ROCHE-3440108$ROCHE$$67$YR$E$F$Y$$$20240628$$HP$US$US
240688251$24068825$1$I$$20240227$20240710$20240710$PER$$US-ROCHE-3517670$ROCHE$$41$YR$A$F$Y$$$20240628$$MD$US$US
240688261$24068826$1$I$$20240226$20240710$20240710$PER$$US-ROCHE-3266841$ROCHE$$63$YR$A$M$Y$$$20240628$$MD$US$US
240688271$24068827$1$I$20240411$20240412$20240710$20240710$PER$$FR-ROCHE-3545550$ROCHE$$$$$$Y$$$20240628$$PH$FR$FR
240688281$24068828$1$I$$20240406$20240710$20240710$PER$$IT-ROCHE-3542337$ROCHE$$$$$F$Y$$$20240628$$MD$IT$IT
240688291$24068829$1$I$$20240404$20240710$20240710$PER$$IN-ROCHE-3542316$ROCHE$$82$YR$E$M$Y$$$20240628$$CN$IN$IN
240688301$24068830$1$I$$20240326$20240710$20240710$PER$$US-ROCHE-3534306$ROCHE$$73$YR$E$M$Y$$$20240628$$MD$US$US
240688311$24068831$1$I$20231101$20240324$20240710$20240710$PER$$IL-ROCHE-3532576$ROCHE$$44$YR$A$F$Y$69.5$KG$20240628$$MD$IL$IL
240688321$24068832$1$I$$20240410$20240710$20240710$PER$$GB-ROCHE-3544353$ROCHE$$$$$$Y$$$20240628$$MD$GB$GB
240688331$24068833$1$I$20240122$20240205$20240710$20240710$PER$$JP-ROCHE-3512659$ROCHE$$$$$M$Y$$$20240628$$MD$JP$JP
240688341$24068834$1$I$$20240425$20240710$20240710$PER$$TH-ROCHE-3555585$ROCHE$$36$YR$A$F$Y$$$20240628$$CN$TH$TH
240688352$24068835$2$F$$20240417$20240710$20240710$PER$$ES-ROCHE-3544372$ROCHE$$$$E$F$Y$$$20240628$$MD$ES$ES
240688361$24068836$1$I$$20240423$20240710$20240710$PER$$CA-ROCHE-3553321$ROCHE$$$$E$F$Y$$$20240628$$CN$CA$CA
240688371$24068837$1$I$$20240321$20240710$20240710$PER$$US-ROCHE-3532102$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240688382$24068838$2$F$20210909$20231102$20240710$20240710$PER$$IL-ROCHE-2991758$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$IL$IL
240688391$24068839$1$I$$20240207$20240710$20240710$PER$$US-ROCHE-3508485$ROCHE$$67$YR$E$M$Y$$$20240628$$HP$US$US
240688403$24068840$3$F$20230701$20240816$20240710$20240822$PER$$US-ROCHE-3556430$ROCHE$$73$YR$E$M$Y$82.9$KG$20240822$$CN$US$US
240688412$24068841$2$F$$20231127$20240710$20240710$PER$$ID-ROCHE-3465746$ROCHE$$52$YR$A$F$Y$$$20240628$$CN$ID$ID
240688421$24068842$1$I$$20240411$20240710$20240710$PER$$US-ROCHE-3545591$ROCHE$$74$YR$E$F$Y$$$20240628$$MD$US$US
240688431$24068843$1$I$$20231119$20240710$20240710$PER$$CN-ROCHE-3460682$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$CN$CN
240688441$24068844$1$I$$20240401$20240710$20240710$PER$$US-ROCHE-3537035$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$US$US
240688451$24068845$1$I$$20240420$20240710$20240710$PER$$IT-ROCHE-3553289$ROCHE$$$$$F$Y$$$20240628$$CN$IT$IT
240688461$24068846$1$I$$20240412$20240710$20240710$PER$$US-ROCHE-3546051$ROCHE$$16$YR$T$M$Y$$$20240628$$MD$US$US
240688471$24068847$1$I$$20240312$20240710$20240710$PER$$US-ROCHE-3525764$ROCHE$$71$YR$E$M$Y$$$20240628$$MD$US$US
240688481$24068848$1$I$$20240320$20240710$20240710$PER$$SE-ROCHE-3530932$ROCHE$$64$YR$A$F$Y$$$20240628$$CN$SE$SE
240688491$24068849$1$I$20231201$20240216$20240710$20240710$PER$$JP-ROCHE-3519662$ROCHE$$7$DEC$E$$Y$$$20240628$$MD$JP$JP
240688501$24068850$1$I$$20240202$20240710$20240710$PER$$US-ROCHE-3506003$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$US$US
240688512$24068851$2$F$20230831$20240306$20240710$20240710$PER$$BE-ROCHE-3522151$ROCHE$$77$YR$E$M$Y$72$KG$20240628$$MD$BE$BE
240688521$24068852$1$I$$20240306$20240710$20240710$PER$$JP-ROCHE-3536068$ROCHE$$67$YR$E$M$Y$$$20240628$$MD$JP$JP
240688531$24068853$1$I$$20240509$20240710$20240710$PER$$IN-ROCHE-3561585$ROCHE$$61$YR$A$M$Y$$$20240628$$CN$IN$IN
240688541$24068854$1$I$$20240206$20240710$20240710$PER$$JP-ROCHE-3512666$ROCHE$$79$YR$E$M$Y$$$20240628$$MD$JP$JP
240688552$24068855$2$F$20221001$20240103$20240710$20240710$PER$$CN-ROCHE-3301252$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$CN$CN
240688561$24068856$1$I$$20240319$20240710$20240710$PER$$US-ROCHE-3530462$ROCHE$$65$YR$E$M$Y$$$20240628$$MD$US$US
240688571$24068857$1$I$$20240419$20240710$20240710$PER$$KR-ROCHE-3550502$ROCHE$$46$YR$A$M$Y$$$20240628$$CN$KR$KR
240688581$24068858$1$I$$20231117$20240710$20240710$PER$$IE-ROCHE-3462165$ROCHE$$40$YR$A$F$Y$$$20240628$$CN$IE$IE
240688591$24068859$1$I$$20240410$20240710$20240710$PER$$US-ROCHE-3545109$ROCHE$$80$YR$E$F$Y$$$20240628$$MD$US$US
240688601$24068860$1$I$$20240410$20240710$20240710$PER$$IN-ROCHE-3544825$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$IN$IN
240688611$24068861$1$I$$20231113$20240710$20240710$PER$$US-ROCHE-3457388$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$US$US
240688621$24068862$1$I$$20240426$20240710$20240710$PER$$US-ROCHE-3555401$ROCHE$$81$YR$E$F$Y$$$20240628$$MD$US$US
240688631$24068863$1$I$$20240214$20240710$20240710$PER$$US-ROCHE-3511077$ROCHE$$83$YR$E$M$Y$$$20240628$$MD$US$US
240688641$24068864$1$I$20240512$20240516$20240710$20240710$PER$$CN-ROCHE-3566426$ROCHE$$49$YR$A$F$Y$56$KG$20240628$$HP$CN$CN
240688651$24068865$1$I$$20240131$20240710$20240710$PER$$US-ROCHE-3504009$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$US$US
240688671$24068867$1$I$$20240229$20240710$20240710$PER$$US-ROCHE-3519695$ROCHE$$88$YR$E$M$Y$$$20240628$$MD$US$US
240688681$24068868$1$I$$20240502$20240710$20240710$PER$$US-ROCHE-3557878$ROCHE$$25$YR$A$M$Y$$$20240628$$MD$US$US
240688692$24068869$2$F$$20240523$20240710$20240710$PER$$US-ROCHE-3569588$ROCHE$$60$YR$A$M$Y$$$20240628$$CN$US$US
240688701$24068870$1$I$20240308$20240311$20240710$20240710$PER$$US-ROCHE-3524774$ROCHE$$63$YR$A$M$Y$104.33$KG$20240628$$CN$US$US
240688711$24068871$1$I$$20240318$20240710$20240710$PER$$MX-ROCHE-3530203$ROCHE$$80$YR$E$$Y$$$20240628$$MD$MX$MX
240688721$24068872$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3527999$ROCHE$$9$DEC$E$$Y$$$20240628$$MD$JP$JP
240688731$24068873$1$I$20230314$20230707$20240710$20240710$PER$$BE-ROCHE-3385630$ROCHE$$56$YR$A$M$Y$74.5$KG$20240628$$MD$BE$BE
240688741$24068874$1$I$20230424$20230926$20240710$20240710$PER$$IL-ROCHE-3429449$ROCHE$$92$YR$E$M$Y$73$KG$20240628$$MD$IL$IL
240688751$24068875$1$I$$20240411$20240710$20240710$PER$$US-ROCHE-3546919$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$US$US
240688761$24068876$1$I$$20231228$20240710$20240710$PER$$CN-ROCHE-3483756$ROCHE$Zhao X, Hao M, Zhang X, Wei J, Feng S, He Y, Jiang E and Han M. Post-HSCT Maintenance Treatment Using Entrectinib for an AML Patient Accompanied with ETV6::NTRK3: A Case Report. Doi: 10.2147/OTT.S434590.. OncoTargets and Therapy 2023;16:1055-9.$46$YR$A$M$Y$$$20240628$$HP$CN$CN
240688781$24068878$1$I$$20231107$20240710$20240710$PER$$JP-ROCHE-3457279$ROCHE$$53$YR$A$M$Y$$$20240628$$MD$JP$JP
240688791$24068879$1$I$20240418$20240418$20240710$20240710$PER$$CA-ROCHE-3549345$ROCHE$$76$YR$E$M$Y$$$20240628$$CN$CA$CA
240688801$24068880$1$I$$20240308$20240710$20240710$PER$$JP-ROCHE-3538379$ROCHE$$3$DEC$A$F$Y$$$20240628$$MD$JP$JP
240688811$24068881$1$I$$20240402$20240710$20240710$PER$$US-ROCHE-3538042$ROCHE$$28$YR$A$F$Y$$$20240628$$MD$US$US
240688821$24068882$1$I$$20240229$20240710$20240710$PER$$AU-ROCHE-3518391$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240688831$24068883$1$I$20220924$20240228$20240710$20240710$PER$$TR-ROCHE-3518077$ROCHE$$49$YR$A$M$Y$$$20240628$$MD$TR$TR
240688841$24068884$1$I$20240520$20240521$20240710$20240710$PER$$JP-ROCHE-3573942$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240688851$24068885$1$I$20240117$20240118$20240710$20240710$PER$$JP-ROCHE-3498241$ROCHE$$8$DEC$E$$Y$$$20240628$$MD$JP$JP
240688861$24068886$1$I$$20240415$20240710$20240710$PER$$US-ROCHE-3547089$ROCHE$$23$YR$A$F$Y$$$20240628$$MD$US$US
240688871$24068887$1$I$20240222$20240226$20240710$20240710$PER$$JP-ROCHE-3524615$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240688881$24068888$1$I$$20240216$20240710$20240710$PER$$CA-ROCHE-3511754$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$CA$CA
240688891$24068889$1$I$20210908$20230908$20240710$20240710$PER$$TR-ROCHE-2941780$ROCHE$$$$A$M$Y$70$KG$20240628$$MD$TR$TR
240688901$24068890$1$I$$20240308$20240710$20240710$PER$$JP-ROCHE-3537406$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240688911$24068891$1$I$$20240325$20240710$20240710$PER$$US-ROCHE-3533789$ROCHE$$56$YR$A$M$Y$136.08$KG$20240628$$CN$US$US
240688921$24068892$1$I$$20240530$20240710$20240710$PER$$US-ROCHE-3574338$ROCHE$$73$YR$E$M$Y$$$20240628$$MD$US$US
240688931$24068893$1$I$$20240501$20240710$20240710$PER$$AU-ROCHE-3557838$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240688941$24068894$1$I$$20240514$20240710$20240710$PER$$IN-ROCHE-3563703$ROCHE$$70$YR$E$F$Y$$$20240628$$CN$IN$IN
240688951$24068895$1$I$$20240219$20240710$20240710$PER$$US-ROCHE-3516894$ROCHE$$83$YR$E$F$Y$$$20240628$$CN$US$US
240688961$24068896$1$I$$20240228$20240710$20240710$PER$$US-ROCHE-3475310$ROCHE$$92$YR$E$M$Y$$$20240628$$MD$US$US
240688971$24068897$1$I$$20240416$20240710$20240710$PER$$CN-ROCHE-3550116$ROCHE$$$$$$Y$$$20240628$$MD$CN$CN
240688981$24068898$1$I$$20240213$20240710$20240710$PER$$JP-ROCHE-3515630$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240688991$24068899$1$I$$20230801$20240710$20240710$PER$$IN-ROCHE-3400286$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IN$IN
240689002$24068900$2$F$$20240529$20240710$20240710$PER$$IN-ROCHE-3510612$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240689011$24068901$1$I$$20240410$20240710$20240710$PER$$RO-ROCHE-3545676$ROCHE$$60$YR$A$F$Y$52$KG$20240628$$CN$RO$RO
240689021$24068902$1$I$$20240405$20240710$20240710$PER$$IT-ROCHE-3542334$ROCHE$$$$E$M$Y$$$20240628$$MD$IT$IT
240689041$24068904$1$I$20240222$20240229$20240710$20240710$PER$$JP-ROCHE-3532201$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240689051$24068905$1$I$$20240417$20240710$20240710$PER$$SE-ROCHE-3550759$ROCHE$$$$$$Y$$$20240628$$MD$SE$SE
240689061$24068906$1$I$20231206$20231226$20240710$20240710$PER$$JP-ROCHE-3484180$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240689101$24068910$1$I$20240101$20240308$20240710$20240710$PER$$JP-ROCHE-3540171$ROCHE$$7$DEC$E$M$Y$$$20240628$$MD$JP$JP
240689113$24068911$3$F$$20231024$20240710$20240710$PER$$CN-ROCHE-3375283$ROCHE$$41$YR$A$F$Y$$$20240628$$CN$CN$CN
240689122$24068912$2$F$20220920$20240103$20240710$20240710$PER$$CN-ROCHE-3486632$ROCHE$$60$YR$A$F$Y$75$KG$20240628$$MD$CN$CN
240689144$24068914$4$F$20231108$20240128$20240710$20240710$PER$$HR-ROCHE-3484966$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$HR$HR
240689152$24068915$2$F$$20231219$20240710$20240710$PER$$IN-ROCHE-3360566$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$IN$IN
240689161$24068916$1$I$$20240425$20240710$20240710$PER$$JP-ROCHE-3564243$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240689171$24068917$1$I$$20231211$20240710$20240710$PER$$US-ROCHE-3476380$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240689181$24068918$1$I$$20240216$20240710$20240710$PER$$US-ROCHE-3512481$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$US$US
240689192$24068919$2$F$$20231221$20240710$20240710$PER$$US-ROCHE-3478837$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$US$US
240689202$24068920$2$F$$20230929$20240710$20240710$PER$$SG-ROCHE-3431744$ROCHE$$79$YR$E$F$Y$63$KG$20240628$$CN$SG$SG
240689211$24068921$1$I$20240124$20240125$20240710$20240710$PER$$JP-ROCHE-3505182$ROCHE$$25$YR$A$F$Y$$$20240628$$MD$JP$JP
240689221$24068922$1$I$20230125$20240426$20240710$20240710$PER$$TR-ROCHE-3554956$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$TR$TR
240689231$24068923$1$I$20240208$20240405$20240710$20240710$PER$FR-AFSSAPS-LL2024000601$FR-ROCHE-3540354$ROCHE$$70$YR$E$F$Y$$$20240628$$PH$FR$FR
240689241$24068924$1$I$$20240216$20240710$20240710$PER$$US-ROCHE-3512402$ROCHE$$59$YR$A$F$Y$$$20240628$$HP$US$US
240689251$24068925$1$I$$20240222$20240710$20240710$PER$$JP-ROCHE-3521970$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240689272$24068927$2$F$$20231002$20240710$20240710$PER$$US-ROCHE-3433162$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$US$US
240689281$24068928$1$I$20240214$20240215$20240710$20240710$PER$$JP-ROCHE-3517087$ROCHE$$6$DEC$A$F$Y$$$20240628$$PH$JP$JP
240689291$24068929$1$I$$20240419$20240710$20240710$PER$$CH-ROCHE-3549957$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240689301$24068930$1$I$$20240407$20240710$20240710$PER$$IN-ROCHE-3541805$ROCHE$$56$YR$A$F$Y$$$20240628$$MD$IN$IN
240689311$24068931$1$I$$20240501$20240710$20240710$PER$$IN-ROCHE-3557334$ROCHE$$57$YR$A$F$Y$$$20240628$$CN$IN$IN
240689321$24068932$1$I$20231215$20240118$20240710$20240710$PER$$TR-ROCHE-3494806$ROCHE$$50$YR$A$M$Y$$$20240628$$MD$TR$TR
240689331$24068933$1$I$$20231003$20240710$20240710$PER$$US-ROCHE-3433702$ROCHE$$66$YR$E$F$Y$$$20240628$$HP$US$US
240689341$24068934$1$I$$20231229$20240710$20240710$PER$$GB-ROCHE-3484294$ROCHE$$$$$F$Y$$$20240628$$CN$GB$GB
240689351$24068935$1$I$20220711$20230905$20240710$20240710$PER$$IT-ROCHE-3159178$ROCHE$$83$YR$E$F$Y$72$KG$20240628$$MD$IT$IT
240689361$24068936$1$I$$20231128$20240710$20240710$PER$$US-ROCHE-3466699$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$US$US
240689381$24068938$1$I$$20240515$20240710$20240710$PER$$GB-ROCHE-3566489$ROCHE$$$$$$Y$$$20240628$$MD$GB$GB
240689391$24068939$1$I$20240305$20240304$20240710$20240710$PER$$ID-ROCHE-3523400$ROCHE$$51$YR$A$F$Y$$$20240628$$CN$ID$ID
240689401$24068940$1$I$20230701$20230809$20240710$20240710$PER$$PR-ROCHE-3402974$ROCHE$$69$YR$E$F$Y$67.59$KG$20240628$$CN$PR$PR
240689411$24068941$1$I$$20230717$20240710$20240710$PER$$US-ROCHE-3391055$ROCHE$$$$E$F$Y$$$20240628$$CN$US$US
240689421$24068942$1$I$$20230821$20240710$20240710$PER$$US-ROCHE-3409574$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240689431$24068943$1$I$$20230731$20240710$20240710$PER$$CN-ROCHE-3397595$ROCHE$Qin J, Li  R, Ma H, Ding P, Yang Q, Hu L, Wu D and Xiong S TCM monotherapy achieves significant efficacy in crizotinib-refractory advanced NSCLC with brain metastasis.Doi:10.1097/MD.0000000000034138. Medicine 2023 Jul 21;102 (29):1-5.$53$YR$A$M$Y$$$20240628$$HP$CN$CN
240689441$24068944$1$I$$20240321$20240710$20240710$PER$$JP-ROCHE-3548302$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240689451$24068945$1$I$$20240425$20240710$20240710$PER$$DE-ROCHE-3555795$ROCHE$$$$$F$Y$$$20240628$$MD$DE$DE
240689461$24068946$1$I$20240116$20240226$20240710$20240710$PER$$JP-ROCHE-3524631$ROCHE$$73$YR$E$F$Y$$$20240628$$PH$JP$JP
240689471$24068947$1$I$$20240605$20240710$20240710$PER$$IN-ROCHE-3578250$ROCHE$$35$YR$A$F$Y$$$20240628$$CN$IN$IN
240689491$24068949$1$I$$20240305$20240710$20240710$PER$$PH-ROCHE-3521050$ROCHE$$45$YR$A$F$Y$$$20240628$$CN$PH$PH
240689502$24068950$2$F$20240424$20240429$20240710$20240710$PER$$US-ROCHE-3555847$ROCHE$$$$E$F$Y$52.16$KG$20240628$$CN$US$US
240689511$24068951$1$I$$20240514$20240710$20240710$PER$$US-ROCHE-3564263$ROCHE$$62$YR$A$M$Y$$$20240628$$CN$US$US
240689521$24068952$1$I$20220411$20240222$20240710$20240710$PER$$AU-ROCHE-3083666$ROCHE$$59$YR$A$M$Y$86.7$KG$20240628$$MD$AU$AU
240689531$24068953$1$I$$20240212$20240710$20240710$PER$$US-ROCHE-3510058$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240689541$24068954$1$I$$20230804$20240710$20240710$PER$$US-ROCHE-3400544$ROCHE$$84$YR$E$F$Y$$$20240628$$CN$US$US
240689551$24068955$1$I$$20240521$20240710$20240710$PER$$US-ROCHE-3569333$ROCHE$$$$$F$Y$$$20240628$$PH$US$US
240689561$24068956$1$I$$20240416$20240710$20240710$PER$$KR-ROCHE-3547589$ROCHE$$59$YR$A$M$Y$$$20240628$$CN$KR$KR
240689571$24068957$1$I$$20240314$20240710$20240710$PER$$JP-ROCHE-3543913$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$JP$JP
240689581$24068958$1$I$$20240604$20240710$20240710$PER$$US-ROCHE-3577349$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$US$US
240689591$24068959$1$I$$20231127$20240710$20240710$PER$$ES-ROCHE-3465986$ROCHE$$$$A$F$Y$50$KG$20240628$$MD$ES$ES
240689601$24068960$1$I$$20231130$20240710$20240710$PER$$US-ROCHE-3468532$ROCHE$$44$YR$A$F$Y$$$20240628$$CN$US$US
240689612$24068961$2$F$$20240413$20240710$20240710$PER$$IN-ROCHE-3346798$ROCHE$$50$YR$A$F$Y$$$20240628$$MD$IN$IN
240689621$24068962$1$I$$20231204$20240710$20240710$PER$$JP-ROCHE-3475560$ROCHE$$52$YR$A$M$Y$$$20240628$$MD$JP$JP
240689633$24068963$3$F$$20240419$20240710$20240710$PER$$IN-ROCHE-3524145$ROCHE$$59$YR$A$M$Y$$$20240628$$CN$IN$IN
240689641$24068964$1$I$$20240426$20240710$20240710$PER$$FR-ROCHE-3556036$ROCHE$$80$YR$E$F$Y$$$20240628$$MD$FR$FR
240689651$24068965$1$I$20230613$20230705$20240710$20240710$PER$$AU-ROCHE-3383556$ROCHE$$38$YR$A$F$Y$$$20240628$$MD$AU$AU
240689661$24068966$1$I$$20230713$20240710$20240710$PER$$CN-ROCHE-3347396$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$CN$CN
240689671$24068967$1$I$20231213$20231214$20240710$20240710$PER$$JP-ROCHE-3479415$ROCHE$$4$DEC$A$F$Y$$$20240628$$MD$JP$JP
240689681$24068968$1$I$$20231124$20240710$20240710$PER$$ES-ROCHE-3465146$ROCHE$$$$A$F$Y$60$KG$20240628$$MD$ES$ES
240689691$24068969$1$I$$20231024$20240710$20240710$PER$$IN-ROCHE-3446804$ROCHE$$35$YR$A$F$Y$$$20240628$$MD$IN$IN
240689701$24068970$1$I$$20231026$20240710$20240710$PER$$US-ROCHE-3448170$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$US$US
240689711$24068971$1$I$$20240228$20240710$20240710$PER$$TH-ROCHE-3519329$ROCHE$$$$$$Y$$$20240628$$CN$TH$TH
240689721$24068972$1$I$$20230801$20240710$20240710$PER$$TH-ROCHE-3399839$ROCHE$$$$$$Y$$$20240628$$PH$TH$TH
240689732$24068973$2$F$20220118$20240301$20240710$20240710$PER$$ES-ROCHE-3110710$ROCHE$$62$YR$A$$Y$$$20240628$$MD$ES$ES
240689741$24068974$1$I$20240117$20240418$20240710$20240710$PER$$DK-ROCHE-3551291$ROCHE$$58$YR$A$M$Y$$$20240628$$MD$DK$DK
240689761$24068976$1$I$20240402$20240404$20240710$20240710$PER$$JP-ROCHE-3557755$ROCHE$$68$YR$E$M$Y$$$20240628$$MD$JP$JP
240689771$24068977$1$I$$20240529$20240710$20240710$PER$$FI-ROCHE-3574798$ROCHE$$68$YR$E$F$Y$$$20240628$$MD$FI$FI
240689782$24068978$2$F$20240227$20240325$20240710$20240710$PER$$US-ROCHE-3522872$ROCHE$$59$YR$A$F$Y$77.11$KG$20240628$$HP$US$US
240689791$24068979$1$I$$20240425$20240710$20240710$PER$$CA-ROCHE-3554185$ROCHE$$$$A$M$Y$$$20240628$$PH$CA$CA
240689802$24068980$2$F$$20240307$20240710$20240710$PER$$JP-ROCHE-3517097$ROCHE$$6$DEC$A$F$Y$$$20240628$$PH$JP$JP
240689811$24068981$1$I$$20240131$20240710$20240710$PER$$US-ROCHE-3503491$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240689821$24068982$1$I$$20231124$20240710$20240710$PER$$BR-ROCHE-3466945$ROCHE$$$$E$F$Y$$$20240628$$CN$BR$BR
240689831$24068983$1$I$$20240123$20240710$20240710$PER$$US-ROCHE-3498118$ROCHE$$$$A$F$Y$$$20240628$$MD$US$US
240689841$24068984$1$I$$20230803$20240710$20240710$PER$$US-ROCHE-3399945$ROCHE$$$$A$M$Y$$$20240628$$CN$US$US
240689851$24068985$1$I$$20240503$20240710$20240710$PER$$FR-ROCHE-3559671$ROCHE$$$$$M$Y$$$20240628$$PH$FR$FR
240689861$24068986$1$I$20230623$20240102$20240710$20240710$PER$$US-ROCHE-3485301$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$US$US
240689871$24068987$1$I$$20240114$20240710$20240710$PER$$TH-ROCHE-3491974$ROCHE$$$$$$Y$$$20240628$$PH$TH$TH
240689882$24068988$2$F$$20240521$20240710$20240710$PER$$ES-ROCHE-3568682$ROCHE$$$$$$Y$$$20240628$$MD$ES$ES
240689891$24068989$1$I$$20230719$20240710$20240710$PER$$CN-ROCHE-3390909$ROCHE$$74$YR$E$M$Y$$$20240628$$CN$CN$CN
240689901$24068990$1$I$$20230821$20240710$20240710$PER$$SG-ROCHE-3411675$ROCHE$$79$YR$E$F$Y$$$20240628$$CN$SG$SG
240689911$24068991$1$I$$20240301$20240710$20240710$PER$$JP-ROCHE-3532926$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240689931$24068993$1$I$$20240524$20240710$20240710$PER$$JP-ROCHE-3575863$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240689941$24068994$1$I$$20230918$20240710$20240710$PER$$BR-ROCHE-3425284$ROCHE$$$$$F$Y$$$20240628$$MD$BR$BR
240689951$24068995$1$I$$20231117$20240710$20240710$PER$$NO-ROCHE-3464294$ROCHE$$$$$$Y$$$20240628$$HP$NO$NO
240689961$24068996$1$I$$20240531$20240710$20240710$PER$$ZA-ROCHE-3577374$ROCHE$$$$$F$Y$$$20240628$$MD$ZA$ZA
240689971$24068997$1$I$$20230721$20240710$20240710$PER$$IN-ROCHE-3253276$ROCHE$$68$YR$E$F$Y$$$20240628$$MD$IN$IN
240689981$24068998$1$I$20240301$20240419$20240710$20240710$PER$$US-ROCHE-3551517$ROCHE$$64$YR$A$M$Y$79.38$KG$20240628$$CN$US$US
240689991$24068999$1$I$20220826$20231205$20240710$20240710$PER$$ES-ROCHE-3470431$ROCHE$$53$YR$A$$Y$$$20240628$$MD$ES$ES
240690001$24069000$1$I$$20231107$20240710$20240710$PER$$IL-ROCHE-3454893$ROCHE$$$$E$F$Y$$$20240628$$CN$IL$IL
240690013$24069001$3$F$20211126$20240110$20240710$20240710$PER$$IT-ROCHE-3022547$ROCHE$$37$YR$A$M$Y$76$KG$20240628$$MD$IT$IT
240690022$24069002$2$F$20240111$20240117$20240710$20240710$PER$$JP-ROCHE-3499203$ROCHE$$$$$F$Y$$$20240628$$HP$JP$JP
240690032$24069003$2$F$$20240425$20240710$20240710$PER$$JO-ROCHE-3552278$ROCHE$$$$$$Y$$$20240628$$MD$JO$JO
240690041$24069004$1$I$$20231122$20240710$20240710$PER$$US-ROCHE-2225057$ROCHE$$77$YR$E$M$Y$$$20240628$$MD$US$US
240690051$24069005$1$I$20220601$20240414$20240710$20240710$PER$$RU-ROCHE-3547687$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$RU$RU
240690061$24069006$1$I$$20231102$20240710$20240710$PER$$IN-ROCHE-3453571$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$IN$IN
240690071$24069007$1$I$$20230912$20240710$20240710$PER$$US-ROCHE-3421852$ROCHE$$60$YR$A$F$Y$$$20240628$$CN$US$US
240690083$24069008$3$F$20231201$20240515$20240710$20240710$PER$$DE-ROCHE-3514793$ROCHE$$81$YR$E$F$Y$$$20240628$$CN$DE$DE
240690091$24069009$1$I$$20230714$20240710$20240710$PER$$IN-ROCHE-3388955$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$IN$IN
240690102$24069010$2$F$20211221$20240205$20240710$20240710$PER$$CN-ROCHE-3505347$ROCHE$$39$YR$A$F$Y$80$KG$20240628$$MD$CN$CN
240690111$24069011$1$I$20240110$20240110$20240710$20240710$PER$$JP-ROCHE-3493028$ROCHE$$4$DEC$A$F$Y$$$20240628$$HP$JP$JP
240690121$24069012$1$I$$20240524$20240710$20240710$PER$$US-ROCHE-3571132$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$US$US
240690131$24069013$1$I$20240305$20240305$20240710$20240710$PER$$ID-ROCHE-3521749$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$ID$ID
240690141$24069014$1$I$$20230920$20240710$20240710$PER$$US-ROCHE-3426833$ROCHE$$71$YR$E$F$Y$$$20240628$$MD$US$US
240690162$24069016$2$F$$20240305$20240710$20240710$PER$$IN-ROCHE-3522483$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$IN$IN
240690171$24069017$1$I$20240122$20240122$20240710$20240710$PER$$CN-ROCHE-3496714$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$CN$CN
240690181$24069018$1$I$20230228$20231026$20240710$20240710$PER$IT-MINISAL02-950670$IT-ROCHE-3446567$ROCHE$$41$YR$A$F$Y$$$20240628$$MD$IT$IT
240690191$24069019$1$I$$20240409$20240710$20240710$PER$$IN-ROCHE-3544510$ROCHE$$47$YR$A$F$Y$$$20240628$$MD$IN$IN
240690202$24069020$2$F$$20230920$20240710$20240710$PER$$IN-ROCHE-3425201$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$IN$IN
240690211$24069021$1$I$$20240202$20240710$20240710$PER$DE-PEI-CADR2024325663$DE-ROCHE-3503557$ROCHE$$64$YR$A$F$Y$79$KG$20240628$$CN$DE$DE
240690221$24069022$1$I$$20240427$20240710$20240710$PER$$IN-ROCHE-3556925$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$IN$IN
240690232$24069023$2$F$$20231107$20240710$20240710$PER$$IN-ROCHE-3432827$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$IN$IN
240690241$24069024$1$I$$20240516$20240710$20240710$PER$$US-ROCHE-3566423$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240690251$24069025$1$I$20230303$20230712$20240710$20240710$PER$$AU-ROCHE-3387452$ROCHE$$38$YR$A$F$Y$$$20240628$$MD$AU$AU
240690262$24069026$2$F$$20240213$20240710$20240710$PER$$JP-ROCHE-3515488$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240690271$24069027$1$I$20211013$20240318$20240710$20240710$PER$$KR-ROCHE-3529716$ROCHE$$39$YR$A$F$Y$$$20240628$$PH$KR$KR
240690282$24069028$2$F$20231030$20231204$20240710$20240710$PER$$DK-ROCHE-3472638$ROCHE$$37$YR$A$F$Y$$$20240628$$MD$DK$DK
240690291$24069029$1$I$$20240529$20240710$20240710$PER$$KR-ROCHE-3573692$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$KR$KR
240690301$24069030$1$I$$20231104$20240710$20240710$PER$$IN-ROCHE-3454051$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240690311$24069031$1$I$20240409$20240410$20240710$20240710$PER$$JP-ROCHE-3559382$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240690321$24069032$1$I$$20240607$20240710$20240710$PER$$US-ROCHE-10000001182$ROCHE$$68$YR$E$F$Y$$$20240628$$MD$US$US
240690332$24069033$2$F$$20240601$20240710$20240710$PER$$BD-ROCHE-3572162$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$BD$BD
240690343$24069034$3$F$20220315$20240412$20240710$20240710$PER$$CN-ROCHE-3274591$ROCHE$$59$YR$A$F$Y$75$KG$20240628$$MD$CN$CN
240690351$24069035$1$I$$20240108$20240710$20240710$PER$$IN-ROCHE-3488710$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$IN$IN
240690361$24069036$1$I$20231017$20231024$20240710$20240710$PER$$TR-ROCHE-3446169$ROCHE$$43$YR$A$F$Y$80$KG$20240628$$MD$TR$TR
240690371$24069037$1$I$20220101$20240606$20240710$20240710$PER$$US-ROCHE-3578604$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$US$US
240690381$24069038$1$I$$20240524$20240710$20240710$PER$$JP-ROCHE-3575999$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240690391$24069039$1$I$20240315$20240323$20240710$20240710$PER$$DK-ROCHE-3535055$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$DK$DK
240690401$24069040$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3527009$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240690411$24069041$1$I$$20231127$20240710$20240710$PER$$CH-ROCHE-3468427$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240690421$24069042$1$I$$20240604$20240710$20240710$PER$$FR-ROCHE-3578094$ROCHE$$71$YR$E$F$Y$$$20240628$$MD$FR$FR
240690431$24069043$1$I$20231024$20231204$20240710$20240710$PER$$DK-ROCHE-3472731$ROCHE$$43$YR$A$F$Y$$$20240628$$MD$DK$DK
240690441$24069044$1$I$$20240423$20240710$20240710$PER$$IN-ROCHE-3553892$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
240690451$24069045$1$I$$20240604$20240710$20240710$PER$$US-ROCHE-3577357$ROCHE$$91$YR$E$M$Y$$$20240628$$MD$US$US
240690461$24069046$1$I$$20240313$20240710$20240710$PER$$GB-ROCHE-3528635$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240690471$24069047$1$I$$20240115$20240710$20240710$PER$$SG-ROCHE-3491998$ROCHE$$$$$$Y$$$20240628$$CN$SG$SG
240690481$24069048$1$I$$20240529$20240710$20240710$PER$$PH-ROCHE-3575471$ROCHE$$49$YR$A$F$Y$67$KG$20240628$$CN$PH$PH
240690491$24069049$1$I$20240328$20240522$20240710$20240710$PER$$IN-ROCHE-3570840$ROCHE$$64$YR$A$F$Y$$$20240628$$CN$IN$IN
240690501$24069050$1$I$$20230927$20240710$20240710$PER$$IN-ROCHE-3319071$ROCHE$$35$YR$A$F$Y$$$20240628$$CN$IN$IN
240690511$24069051$1$I$$20240509$20240710$20240710$PER$$JP-ROCHE-3567228$ROCHE$$45$YR$A$F$Y$$$20240628$$PH$JP$JP
240690523$24069052$3$F$20240319$20240426$20240710$20240710$PER$$IN-ROCHE-3532979$ROCHE$$57$YR$A$M$Y$$$20240628$$CN$IN$IN
240690533$24069053$3$F$$20240523$20240710$20240710$PER$$FR-ROCHE-3562228$ROCHE$$$$$$Y$$$20240628$$MD$FR$FR
240690541$24069054$1$I$$20240509$20240710$20240710$PER$$ZA-ROCHE-3563441$ROCHE$$$$A$F$Y$$$20240628$$MD$ZA$ZA
240690551$24069055$1$I$$20240514$20240710$20240710$PER$$US-ROCHE-3564527$ROCHE$$44$YR$A$F$Y$$$20240628$$MD$US$US
240690561$24069056$1$I$$20240507$20240710$20240710$PER$$US-ROCHE-3096863$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$US$US
240690571$24069057$1$I$$20240403$20240710$20240710$PER$$CO-ROCHE-3541862$ROCHE$$$$$F$Y$$$20240628$$CN$CO$CO
240690581$24069058$1$I$$20230807$20240710$20240710$PER$$CN-ROCHE-3403959$ROCHE$Ma X, Zhang K, Xu J, Gao H, Yang S, Qin H, Wang H, Gao F and Liu X Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC. DOI: 10.1111/1759-7714.14980. Thoracic Cancer 2023 Jul;14 (20):1980-90.$60$YR$A$F$Y$$$20240628$$HP$CN$CN
240690591$24069059$1$I$$20230711$20240710$20240710$PER$$US-ROCHE-3387400$ROCHE$$61$YR$A$M$Y$$$20240628$$MD$US$US
240690601$24069060$1$I$20240509$20240522$20240710$20240710$PER$$JP-ROCHE-3575836$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240690611$24069061$1$I$$20231013$20240710$20240710$PER$$PH-ROCHE-3439263$ROCHE$$46$YR$A$F$Y$$$20240628$$CN$PH$PH
240690621$24069062$1$I$$20240529$20240710$20240710$PER$$JP-ROCHE-3579279$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240690631$24069063$1$I$$20240326$20240710$20240710$PER$$US-ROCHE-3534073$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$US$US
240690651$24069065$1$I$20240429$20240522$20240710$20240710$PER$$CN-ROCHE-3569147$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$CN$CN
240690671$24069067$1$I$$20240522$20240710$20240710$PER$$IN-ROCHE-3568576$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$IN$IN
240690681$24069068$1$I$20230404$20240112$20240710$20240710$PER$$TR-ROCHE-3327745$ROCHE$$70$YR$E$M$Y$$$20240628$$MD$TR$TR
240690691$24069069$1$I$$20231122$20240710$20240710$PER$$RO-ROCHE-3464376$ROCHE$$50$YR$A$F$Y$65$KG$20240628$$CN$RO$RO
240690701$24069070$1$I$$20240229$20240710$20240710$PER$$JP-ROCHE-3531347$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240690711$24069071$1$I$20240116$20240116$20240710$20240710$PER$$JP-ROCHE-3496514$ROCHE$$$$$F$Y$$$20240628$$HP$JP$JP
240690721$24069072$1$I$$20240521$20240710$20240710$PER$$US-ROCHE-3569286$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$US$US
240690741$24069074$1$I$$20240229$20240710$20240710$PER$$CN-ROCHE-3518208$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$CN$CN
240690751$24069075$1$I$$20230816$20240710$20240710$PER$$IN-ROCHE-3407217$ROCHE$$42$YR$A$F$Y$$$20240628$$MD$IN$IN
240690761$24069076$1$I$$20240524$20240710$20240710$PER$$US-ROCHE-3571253$ROCHE$$38$YR$A$F$Y$$$20240628$$MD$US$US
240690771$24069077$1$I$$20240423$20240710$20240710$PER$$IT-ROCHE-3554401$ROCHE$$45$YR$A$M$Y$$$20240628$$MD$IT$IT
240690781$24069078$1$I$$20230717$20240710$20240710$PER$$US-ROCHE-3389773$ROCHE$$$$$M$Y$$$20240628$$CN$US$US
240690791$24069079$1$I$$20240130$20240710$20240710$PER$$JP-ROCHE-3509156$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240690801$24069080$1$I$$20240513$20240710$20240710$PER$$IN-ROCHE-3564014$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$IN$IN
240690811$24069081$1$I$20240422$20240508$20240710$20240710$PER$$JP-ROCHE-3565857$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240690821$24069082$1$I$$20230718$20240710$20240710$PER$$GB-ROCHE-3373757$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240690831$24069083$1$I$$20231207$20240710$20240710$PER$$JP-ROCHE-3475573$ROCHE$$7$DEC$E$F$Y$$$20240628$$PH$JP$JP
240690842$24069084$2$F$$20240605$20240710$20240710$PER$$IN-ROCHE-3569084$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$IN$IN
240690851$24069085$1$I$$20240429$20240710$20240710$PER$$IN-ROCHE-3557103$ROCHE$$57$YR$A$M$Y$$$20240628$$CN$IN$IN
240690862$24069086$2$F$$20240405$20240710$20240710$PER$$IN-ROCHE-3538779$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
240690872$24069087$2$F$$20240524$20240710$20240710$PER$$IN-ROCHE-3466379$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$IN$IN
240690881$24069088$1$I$20240223$20240321$20240710$20240710$PER$IT-MINISAL02-976108$IT-ROCHE-3530903$ROCHE$$50$YR$A$F$Y$64$KG$20240628$$PH$IT$IT
240690891$24069089$1$I$$20240430$20240710$20240710$PER$$DE-ROCHE-3556728$ROCHE$$$$$F$Y$$$20240628$$PH$DE$DE
240690901$24069090$1$I$$20231128$20240710$20240710$PER$$SG-ROCHE-3466685$ROCHE$$40$YR$A$F$Y$$$20240628$$CN$SG$SG
240690911$24069091$1$I$$20230822$20240710$20240710$PER$$RO-ROCHE-3409656$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240690921$24069092$1$I$$20240430$20240710$20240710$PER$$IN-ROCHE-3557823$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$IN$IN
240690931$24069093$1$I$20230808$20230808$20240710$20240710$PER$$US-ROCHE-3402540$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240690941$24069094$1$I$$20230630$20240710$20240710$PER$$PH-ROCHE-3377993$ROCHE$$$$$F$Y$$$20240628$$MD$PH$PH
240690951$24069095$1$I$$20230831$20240710$20240710$PER$FR-AFSSAPS-CN2023000786$FR-ROCHE-3414460$ROCHE$$61$YR$A$F$Y$81$KG$20240628$$MD$FR$FR
240690961$24069096$1$I$$20231117$20240710$20240710$PER$$ES-ROCHE-3462193$ROCHE$$$$A$F$Y$80$KG$20240628$$MD$ES$ES
240690971$24069097$1$I$$20240110$20240710$20240710$PER$$RO-ROCHE-3491095$ROCHE$$70$YR$E$F$Y$60$KG$20240628$$CN$RO$RO
240690981$24069098$1$I$$20240126$20240710$20240710$PER$$US-ROCHE-3500378$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$US$US
240690991$24069099$1$I$20240329$20240412$20240710$20240710$PER$$IT-ROCHE-3546058$ROCHE$$81$YR$E$F$Y$68$KG$20240628$$MD$IT$IT
240691001$24069100$1$I$20240501$20240503$20240710$20240710$PER$$FR-ROCHE-3558873$ROCHE$$$$$$Y$$$20240628$$PH$FR$FR
240691011$24069101$1$I$20231125$20231215$20240710$20240710$PER$$JP-ROCHE-3480307$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240691021$24069102$1$I$$20240206$20240710$20240710$PER$$IN-ROCHE-3506292$ROCHE$$44$YR$A$F$Y$$$20240628$$CN$IN$IN
240691031$24069103$1$I$$20240301$20240710$20240710$PER$$US-ROCHE-3519565$ROCHE$$50$YR$A$M$Y$$$20240628$$CN$US$US
240691041$24069104$1$I$$20240410$20240710$20240710$PER$$EC-ROCHE-3544713$ROCHE$$$$$F$Y$$$20240628$$MD$EC$EC
240691052$24069105$2$F$$20240112$20240710$20240710$PER$$JP-ROCHE-3494795$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240691061$24069106$1$I$$20231011$20240710$20240710$PER$$US-ROCHE-3438177$ROCHE$$$$E$M$Y$87.54$KG$20240628$$CN$US$US
240691072$24069107$2$F$$20240408$20240710$20240710$PER$$IN-ROCHE-3446589$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240691083$24069108$3$F$20240315$20240318$20240710$20240710$PER$$US-ROCHE-3527817$ROCHE$$66$YR$E$F$Y$$$20240628$$HP$US$US
240691092$24069109$2$F$$20240408$20240710$20240710$PER$$IN-ROCHE-3530695$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$IN$IN
240691102$24069110$2$F$20230912$20240308$20240710$20240710$PER$$CO-ROCHE-3494884$ROCHE$$39$YR$A$M$Y$73.5$KG$20240628$$MD$CO$CO
240691113$24069111$3$F$20221101$20231205$20240710$20240710$PER$$CN-ROCHE-3312056$ROCHE$$33$YR$A$F$Y$60$KG$20240628$$MD$CN$CN
240691122$24069112$2$F$$20240430$20240710$20240710$PER$$US-ROCHE-3431908$ROCHE$$70$YR$E$F$Y$$$20240628$$CN$US$US
240691131$24069113$1$I$20240502$20240509$20240710$20240710$PER$$JP-ROCHE-3567247$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240691141$24069114$1$I$$20240425$20240710$20240710$PER$$PL-ROCHE-3555826$ROCHE$$40$YR$A$F$Y$$$20240628$$CN$PL$PL
240691151$24069115$1$I$$20231221$20240710$20240710$PER$$TH-ROCHE-3480975$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$TH$TH
240691161$24069116$1$I$$20240214$20240710$20240710$PER$$JP-ROCHE-3517090$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240691171$24069117$1$I$20230330$20240123$20240710$20240710$PER$IT-MINISAL02-965840$IT-ROCHE-3496896$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IT$IT
240691182$24069118$2$F$$20240418$20240710$20240710$PER$$KR-ROCHE-3550385$ROCHE$$36$YR$A$M$Y$$$20240628$$CN$KR$KR
240691191$24069119$1$I$20240119$20240119$20240710$20240710$PER$$JP-ROCHE-3501039$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240691202$24069120$2$F$$20230630$20240710$20240710$PER$$TH-ROCHE-3382675$ROCHE$$$$$F$Y$$$20240628$$CN$TH$TH
240691221$24069122$1$I$$20240327$20240710$20240710$PER$$JP-ROCHE-3551753$ROCHE$$9$DEC$E$F$Y$$$20240628$$MD$JP$JP
240691232$24069123$2$F$$20240328$20240710$20240710$PER$$IN-ROCHE-3536845$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$IN$IN
240691241$24069124$1$I$20220606$20231108$20240710$20240710$PER$$CN-ROCHE-3305835$ROCHE$$57$YR$A$F$Y$59$KG$20240628$$MD$CN$CN
240691251$24069125$1$I$$20240513$20240710$20240710$PER$$IN-ROCHE-3562875$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$IN$IN
240691261$24069126$1$I$20240213$20240409$20240710$20240710$PER$$JP-ROCHE-3559440$ROCHE$$8$DEC$E$F$Y$$$20240628$$HP$JP$JP
240691271$24069127$1$I$$20240522$20240710$20240710$PER$$US-ROCHE-3569375$ROCHE$$74$YR$E$F$Y$$$20240628$$MD$US$US
240691281$24069128$1$I$$20230814$20240710$20240710$PER$$IN-ROCHE-3406392$ROCHE$$68$YR$E$F$Y$$$20240628$$MD$IN$IN
240691291$24069129$1$I$$20240513$20240710$20240710$PER$$US-ROCHE-3563510$ROCHE$$57$YR$A$M$Y$$$20240628$$MD$US$US
240691301$24069130$1$I$20220309$20230811$20240710$20240710$PER$$AT-ROCHE-3050532$ROCHE$$79$YR$E$F$Y$89$KG$20240628$$MD$AT$AT
240691311$24069131$1$I$$20240409$20240710$20240710$PER$$US-ROCHE-3544520$ROCHE$$$$A$F$Y$$$20240628$$HP$US$US
240691322$24069132$2$F$$20240520$20240710$20240710$PER$$JP-ROCHE-3549080$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240691331$24069133$1$I$$20230912$20240710$20240710$PER$$TH-ROCHE-3423626$ROCHE$$64$YR$A$F$Y$$$20240628$$CN$TH$TH
240691341$24069134$1$I$$20240531$20240710$20240710$PER$$US-ROCHE-3575698$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$US$US
240691351$24069135$1$I$20211129$20230823$20240710$20240710$PER$$TR-ROCHE-3168580$ROCHE$$55$YR$A$M$Y$$$20240628$$MD$TR$TR
240691362$24069136$2$F$20240320$20240529$20240710$20240710$PER$$PE-ROCHE-3544077$ROCHE$$64$YR$A$F$Y$55.5$KG$20240628$$MD$PE$PE
240691371$24069137$1$I$20240101$20240313$20240710$20240710$PER$$JP-ROCHE-3544560$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240691381$24069138$1$I$$20240509$20240710$20240710$PER$$IN-ROCHE-3561562$ROCHE$$85$YR$E$F$Y$$$20240628$$CN$IN$IN
240691391$24069139$1$I$$20240510$20240710$20240710$PER$$IN-ROCHE-3564066$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IN$IN
240691401$24069140$1$I$20211119$20231128$20240710$20240710$PER$$IT-ROCHE-3386750$ROCHE$$68$YR$E$M$Y$74$KG$20240628$$MD$IT$IT
240691412$24069141$2$F$$20231201$20240710$20240710$PER$$JP-ROCHE-3436347$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240691421$24069142$1$I$20240301$20240323$20240710$20240710$PER$$DK-ROCHE-3535042$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$DK$DK
240691431$24069143$1$I$20240517$20240517$20240710$20240710$PER$$US-ROCHE-3566435$ROCHE$$80$YR$E$M$Y$$$20240628$$CN$US$US
240691441$24069144$1$I$$20230711$20240710$20240710$PER$$TH-ROCHE-3355453$ROCHE$$40$YR$A$F$Y$$$20240628$$CN$TH$TH
240691451$24069145$1$I$$20240311$20240710$20240710$PER$$JP-ROCHE-3542078$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240691461$24069146$1$I$20240603$20240603$20240710$20240710$PER$$AR-ROCHE-3579157$ROCHE$$$$$$Y$$$20240628$$CN$AR$AR
240691472$24069147$2$F$20240403$20240506$20240710$20240710$PER$$CN-ROCHE-3559371$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$CN$CN
240691482$24069148$2$F$$20240212$20240710$20240710$PER$$US-ROCHE-3504060$ROCHE$$17$YR$T$F$Y$$$20240628$$MD$US$US
240691491$24069149$1$I$$20240124$20240710$20240710$PER$$US-ROCHE-3498779$ROCHE$$56$YR$A$F$Y$$$20240628$$MD$US$US
240691501$24069150$1$I$$20231126$20240710$20240710$PER$$SG-ROCHE-3468668$ROCHE$$79$YR$E$$Y$$$20240628$$CN$SG$SG
240691511$24069151$1$I$20240319$20240319$20240710$20240710$PER$$JP-ROCHE-3548219$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240691521$24069152$1$I$20220606$20240424$20240710$20240710$PER$$CN-ROCHE-3552883$ROCHE$$66$YR$E$F$Y$58$KG$20240628$$MD$CN$CN
240691534$24069153$4$F$20240411$20240603$20240710$20240710$PER$$ES-ROCHE-3562962$ROCHE$$78$YR$E$F$Y$$$20240628$$MD$ES$ES
240691541$24069154$1$I$20231104$20231225$20240710$20240710$PER$$JP-ROCHE-3484047$ROCHE$$32$YR$A$M$Y$$$20240628$$CN$JP$JP
240691551$24069155$1$I$$20231011$20240710$20240710$PER$$IN-ROCHE-3440297$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$IN$IN
240691562$24069156$2$F$$20240610$20240710$20240710$PER$$US-ROCHE-3578923$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240691571$24069157$1$I$20220301$20230716$20240710$20240710$PER$$DK-ROCHE-3139629$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$DK$DK
240691591$24069159$1$I$$20240112$20240710$20240710$PER$$CO-ROCHE-3492850$ROCHE$$56$YR$A$M$Y$$$20240628$$CN$CO$CO
240691601$24069160$1$I$$20240313$20240710$20240710$PER$$JP-ROCHE-3543981$ROCHE$$7$DEC$E$F$Y$$$20240628$$PH$JP$JP
240691612$24069161$2$F$$20240917$20240710$20240923$EXP$$IN-ROCHE-3555594$ROCHE$$52$YR$A$F$Y$$$20240923$$CN$IN$IN
240691621$24069162$1$I$20240528$20240528$20240710$20240710$PER$$US-ROCHE-3572662$ROCHE$$58$YR$A$M$Y$$$20240628$$CN$US$US
240691631$24069163$1$I$$20240423$20240710$20240710$PER$$IT-ROCHE-3554403$ROCHE$$47$YR$A$F$Y$$$20240628$$MD$IT$IT
240691641$24069164$1$I$$20230814$20240710$20240710$PER$$IN-ROCHE-3405693$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240691651$24069165$1$I$$20240704$20240710$20240710$EXP$$CA-TAKEDA-2024TUS069111$TAKEDA$$$$$F$Y$$$20240710$$CN$CA$CA
240691661$24069166$1$I$$20230716$20240710$20240710$PER$$DK-ROCHE-3168964$ROCHE$$$$A$M$Y$$$20240628$$MD$DK$DK
240691671$24069167$1$I$20231002$20240313$20240710$20240710$PER$$IT-ROCHE-3525618$ROCHE$$56$YR$A$F$Y$78$KG$20240628$$MD$IT$IT
240691681$24069168$1$I$$20231213$20240710$20240710$PER$$MX-ROCHE-3477903$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$MX$MX
240691691$24069169$1$I$$20231017$20240710$20240710$PER$$CA-ROCHE-3441620$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$CA$CA
240691701$24069170$1$I$$20231127$20240710$20240710$PER$$US-ROCHE-3465937$ROCHE$$87$YR$E$F$Y$$$20240628$$CN$US$US
240691711$24069171$1$I$20240403$20240424$20240710$20240710$PER$$JP-ROCHE-3564233$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240691721$24069172$1$I$$20240419$20240710$20240710$PER$$US-ROCHE-3549930$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$US$US
240691731$24069173$1$I$$20231018$20240710$20240710$PER$$CA-ROCHE-3443346$ROCHE$$$$A$M$Y$$$20240628$$PH$CA$CA
240691741$24069174$1$I$$20231206$20240710$20240710$PER$$PE-ROCHE-3473629$ROCHE$$$$A$$Y$$$20240628$$MD$PE$PE
240691752$24069175$2$F$20231108$20231208$20240710$20240710$PER$$BE-ROCHE-3471361$ROCHE$$57$YR$A$M$Y$78$KG$20240628$$MD$BE$BE
240691761$24069176$1$I$20220513$20240108$20240710$20240710$PER$$ES-ROCHE-3133099$ROCHE$$78$YR$E$$Y$$$20240628$$MD$ES$ES
240691771$24069177$1$I$$20240307$20240710$20240710$PER$$TH-ROCHE-3523514$ROCHE$$45$YR$A$F$Y$$$20240628$$CN$TH$TH
240691781$24069178$1$I$20211112$20240105$20240710$20240710$PER$$TR-ROCHE-2978310$ROCHE$$$$A$F$Y$77$KG$20240628$$MD$TR$TR
240691791$24069179$1$I$20230901$20240509$20240710$20240710$PER$$JP-ROCHE-3432772$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240691802$24069180$2$F$$20240207$20240710$20240710$PER$$IT-ROCHE-3507335$ROCHE$$$$A$M$Y$71$KG$20240628$$MD$IT$IT
240691811$24069181$1$I$$20231219$20240710$20240710$PER$$TH-ROCHE-3479274$ROCHE$$49$YR$A$F$Y$$$20240628$$CN$TH$TH
240691821$24069182$1$I$20240529$20240708$20240710$20240710$EXP$$US-UCBSA-2024034757$UCB$$42$YR$$F$Y$$$20240710$$HP$US$US
240691831$24069183$1$I$20230818$20230907$20240710$20240710$PER$IT-MINISAL02-942961$IT-ROCHE-3418012$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$IT$IT
240691841$24069184$1$I$$20240524$20240710$20240710$PER$$US-ROCHE-3571100$ROCHE$$54$YR$A$M$Y$$$20240628$$MD$US$US
240691851$24069185$1$I$$20230825$20240710$20240710$PER$$US-ROCHE-3412334$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240691861$24069186$1$I$20221003$20240124$20240710$20240710$PER$$TR-ROCHE-3499046$ROCHE$$41$YR$A$F$Y$77$KG$20240628$$MD$TR$TR
240691871$24069187$1$I$$20240507$20240710$20240710$PER$$CA-ROCHE-3560543$ROCHE$$$$$M$Y$$$20240628$$HP$CA$CA
240691881$24069188$1$I$$20240404$20240710$20240710$PER$$IN-ROCHE-3541967$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$IN$IN
240691891$24069189$1$I$$20230710$20240710$20240710$PER$$CN-ROCHE-3388931$ROCHE$Shi L, Gao S, Tong L, Meng Q, Zhou S, Yu D, Dong Y and Liu Z. Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports. DOI: 10.3389/fonc.2023.1120511. Frontiers in oncology. 2023 Jun 20;13:1-12.$48$YR$A$M$Y$$$20240628$$HP$CN$CN
240691902$24069190$2$F$$20231012$20240710$20240710$PER$$US-ROCHE-3439244$ROCHE$$83$YR$E$F$Y$$$20240628$$CN$US$US
240691912$24069191$2$F$$20230814$20240710$20240710$PER$$US-ROCHE-2874013$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$US$US
240691921$24069192$1$I$$20240529$20240710$20240710$PER$$ES-ROCHE-3574596$ROCHE$$$$$$Y$$$20240628$$HP$ES$ES
240691931$24069193$1$I$$20230913$20240710$20240710$PER$$SE-ROCHE-3424507$ROCHE$$$$$$Y$$$20240628$$MD$SE$SE
240691941$24069194$1$I$$20231026$20240710$20240710$PER$$US-ROCHE-3448434$ROCHE$$$$$M$Y$$$20240628$$CN$US$US
240691951$24069195$1$I$$20231214$20240710$20240710$PER$$US-ROCHE-3476764$ROCHE$$63$YR$A$M$Y$$$20240628$$CN$US$US
240691961$24069196$1$I$$20240306$20240710$20240710$PER$$IN-ROCHE-3524356$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$IN$IN
240691971$24069197$1$I$$20240422$20240710$20240710$PER$$JP-ROCHE-3561476$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240691981$24069198$1$I$$20240415$20240710$20240710$PER$$LB-ROCHE-3549175$ROCHE$$$$$$Y$$$20240628$$MD$LB$LB
240691991$24069199$1$I$20240301$20240321$20240710$20240710$PER$$JP-ROCHE-3548197$ROCHE$$6$DEC$A$$Y$$$20240628$$MD$JP$JP
240692002$24069200$2$F$20240224$20240426$20240710$20240710$PER$$IN-ROCHE-3554337$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$IN$IN
240692011$24069201$1$I$$20231006$20240710$20240710$PER$$JP-ROCHE-3439022$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240692021$24069202$1$I$$20240424$20240710$20240710$PER$$US-ROCHE-3554952$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240692031$24069203$1$I$$20240509$20240710$20240710$PER$$ES-ROCHE-3563733$ROCHE$$$$A$F$Y$90$KG$20240628$$MD$ES$ES
240692042$24069204$2$F$$20240125$20240710$20240710$PER$$CA-ROCHE-3494772$ROCHE$$68$YR$E$F$Y$$$20240628$$HP$CA$CA
240692051$24069205$1$I$$20230728$20240710$20240710$PER$$US-ROCHE-3400339$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240692061$24069206$1$I$$20240419$20240710$20240710$PER$$ZA-ROCHE-3552391$ROCHE$$$$A$F$Y$$$20240628$$MD$ZA$ZA
240692071$24069207$1$I$$20240429$20240710$20240710$PER$$EC-ROCHE-3556129$ROCHE$$$$$F$Y$$$20240628$$MD$EC$EC
240692081$24069208$1$I$$20240517$20240710$20240710$PER$$KR-ROCHE-3567671$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$KR$KR
240692091$24069209$1$I$$20240409$20240710$20240710$PER$$IN-ROCHE-3544779$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$IN$IN
240692101$24069210$1$I$$20230901$20240710$20240710$PER$$US-ROCHE-3416212$ROCHE$$74$YR$E$M$Y$$$20240628$$CN$US$US
240692112$24069211$2$F$$20230914$20240710$20240710$PER$$ES-ROCHE-3451559$ROCHE$$$$$$Y$$$20240628$$MD$ES$ES
240692121$24069212$1$I$$20231025$20240710$20240710$PER$$US-ROCHE-3448023$ROCHE$$$$A$F$Y$$$20240628$$MD$US$US
240692131$24069213$1$I$$20230811$20240710$20240710$PER$$IN-ROCHE-3404787$ROCHE$$31$YR$A$F$Y$$$20240628$$MD$IN$IN
240692141$24069214$1$I$$20231218$20240710$20240710$PER$$CA-ROCHE-3478533$ROCHE$$47$YR$A$F$Y$$$20240628$$CN$CA$CA
240692151$24069215$1$I$$20240508$20240710$20240710$PER$$US-ROCHE-3560927$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240692161$24069216$1$I$$20240530$20240710$20240710$PER$$MX-ROCHE-3576696$ROCHE$$$$$$Y$$$20240628$$MD$MX$MX
240692171$24069217$1$I$$20240131$20240710$20240710$PER$$CL-ROCHE-3503192$ROCHE$$49$YR$A$F$Y$$$20240628$$CN$CL$CL
240692182$24069218$2$F$20221128$20230817$20240710$20240710$PER$$AT-ROCHE-3253569$ROCHE$$42$YR$A$M$Y$78$KG$20240628$$MD$AT$AT
240692191$24069219$1$I$$20231103$20240710$20240710$PER$$US-ROCHE-3452491$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$US$US
240692201$24069220$1$I$$20230804$20240710$20240710$PER$$IN-ROCHE-3400795$ROCHE$$42$YR$A$F$Y$$$20240628$$MD$IN$IN
240692211$24069221$1$I$$20240330$20240710$20240710$PER$$IN-ROCHE-3537780$ROCHE$$37$YR$A$F$Y$$$20240628$$MD$IN$IN
240692221$24069222$1$I$$20240224$20240710$20240710$PER$$IN-ROCHE-3516905$ROCHE$$88$YR$E$F$Y$$$20240628$$MD$IN$IN
240692232$24069223$2$F$20240316$20240506$20240710$20240710$PER$$IN-ROCHE-3554350$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$IN$IN
240692242$24069224$2$F$$20240515$20240710$20240710$PER$$FI-ROCHE-3565541$ROCHE$$57$YR$A$M$Y$$$20240628$$MD$FI$FI
240692252$24069225$2$F$20231213$20240219$20240710$20240710$PER$$CO-ROCHE-3513039$ROCHE$$84$YR$E$M$Y$59$KG$20240628$$MD$CO$CO
240692261$24069226$1$I$$20240223$20240710$20240710$PER$$IN-ROCHE-3515819$ROCHE$$$$$F$Y$$$20240628$$CN$IN$IN
240692271$24069227$1$I$$20240426$20240710$20240710$PER$$US-ROCHE-3556690$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$US$US
240692283$24069228$3$F$$20230828$20240710$20240710$PER$$IN-ROCHE-3291648$ROCHE$$35$YR$A$F$Y$$$20240628$$MD$IN$IN
240692292$24069229$2$F$$20230928$20240710$20240710$PER$$GB-ROCHE-3433249$ROCHE$$$$$$Y$$$20240628$$PH$GB$GB
240692301$24069230$1$I$$20240222$20240710$20240710$PER$$SG-ROCHE-3514569$ROCHE$$60$YR$A$F$Y$82$KG$20240628$$CN$SG$SG
240692311$24069231$1$I$$20240217$20240710$20240710$PER$$NZ-ROCHE-3533378$ROCHE$$28$YR$A$F$Y$$$20240628$$MD$NZ$NZ
240692322$24069232$2$F$$20240326$20240710$20240710$PER$$CO-ROCHE-3535053$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$CO$CO
240692331$24069233$1$I$20240308$20240308$20240710$20240710$PER$$JP-ROCHE-3538520$ROCHE$$72$YR$E$F$Y$$$20240628$$HP$JP$JP
240692341$24069234$1$I$$20240228$20240710$20240710$PER$$IN-ROCHE-3519392$ROCHE$$55$YR$A$M$Y$$$20240628$$MD$IN$IN
240692351$24069235$1$I$$20240426$20240710$20240710$PER$$RO-ROCHE-3555834$ROCHE$$40$YR$A$F$Y$67$KG$20240628$$CN$RO$RO
240692361$24069236$1$I$$20240207$20240710$20240710$PER$$JP-ROCHE-3512629$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240692371$24069237$1$I$$20230727$20240710$20240710$PER$$IN-ROCHE-3371983$ROCHE$$47$YR$A$F$Y$$$20240628$$MD$IN$IN
240692382$24069238$2$F$$20240328$20240710$20240710$PER$$JP-ROCHE-3532964$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240692391$24069239$1$I$$20240516$20240710$20240710$PER$$US-ROCHE-3565350$ROCHE$$62$YR$A$M$Y$$$20240628$$MD$US$US
240692411$24069241$1$I$$20240425$20240710$20240710$PER$$US-ROCHE-3555964$ROCHE$$57$YR$A$F$Y$$$20240628$$HP$US$US
240692421$24069242$1$I$$20231208$20240710$20240710$PER$$IN-ROCHE-3473509$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$IN$IN
240692431$24069243$1$I$$20231030$20240710$20240710$PER$$IT-ROCHE-3449647$ROCHE$$$$$$Y$$$20240628$$HP$IT$IT
240692441$24069244$1$I$$20230711$20240710$20240710$PER$$CU-ROCHE-3388744$ROCHE$$$$$$Y$$$20240628$$CN$CU$CU
240692451$24069245$1$I$20240424$20240425$20240710$20240710$PER$$JP-ROCHE-3564157$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240692461$24069246$1$I$20240321$20240402$20240710$20240710$PER$$JP-ROCHE-3543070$ROCHE$$42$YR$A$F$Y$$$20240628$$MD$JP$JP
240692471$24069247$1$I$$20240405$20240710$20240710$PER$$IN-ROCHE-3542485$ROCHE$$38$YR$A$F$Y$$$20240628$$MD$IN$IN
240692481$24069248$1$I$20240201$20240315$20240710$20240710$PER$$JP-ROCHE-3544873$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240692491$24069249$1$I$$20240315$20240710$20240710$PER$$JP-ROCHE-3544074$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240692501$24069250$1$I$$20240506$20240710$20240710$PER$$AE-ROCHE-3559031$ROCHE$$32$YR$A$F$Y$$$20240628$$CN$AE$AE
240692511$24069251$1$I$$20240606$20240710$20240710$PER$$US-ROCHE-3578857$ROCHE$$75$YR$E$M$Y$$$20240628$$MD$US$US
240692521$24069252$1$I$$20230901$20240710$20240710$PER$$IN-ROCHE-3415474$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IN$IN
240692531$24069253$1$I$$20231101$20240710$20240710$PER$$US-ROCHE-3451052$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240692542$24069254$2$F$$20240118$20240710$20240710$PER$$US-ROCHE-3495166$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240692551$24069255$1$I$$20230703$20240710$20240710$PER$$IN-ROCHE-3234043$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$IN$IN
240692562$24069256$2$F$20210630$20231115$20240710$20240710$PER$$JP-ROCHE-3441485$ROCHE$$72$YR$E$F$Y$$$20240628$$PH$JP$JP
240692581$24069258$1$I$$20240126$20240710$20240710$PER$$JP-ROCHE-3505245$ROCHE$$$$$F$Y$$$20240628$$PH$JP$JP
240692601$24069260$1$I$$20240506$20240710$20240710$PER$$IN-ROCHE-3559026$ROCHE$$60$YR$A$F$Y$$$20240628$$CN$IN$IN
240692611$24069261$1$I$$20240117$20240710$20240710$PER$$CN-ROCHE-3494170$ROCHE$Zhang X, Zhao Z, Wei H, Jing W, Yang S, Yu X and Wang S. Treatment of a case of advanced lung adenocarcinoma with mutation of epidermal growth factor receptor gene and anaplastic lymphoma kinase gene. DOI :10.3969/J.ISSN.1002-266X.2023.33. Shandong Medicine 2023;63 (33):80-2.$$$$$Y$$$20240628$$HP$CN$CN
240692621$24069262$1$I$$20230831$20240710$20240710$PER$$IN-ROCHE-3416185$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$IN$IN
240692631$24069263$1$I$20240201$20240509$20240710$20240710$PER$$US-ROCHE-3562688$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240692651$24069265$1$I$$20240301$20240710$20240710$PER$$US-ROCHE-3520919$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$US$US
240692661$24069266$1$I$$20231117$20240710$20240710$PER$$IN-ROCHE-3462038$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$IN$IN
240692671$24069267$1$I$$20240509$20240710$20240710$PER$$ES-ROCHE-3563724$ROCHE$$$$A$F$Y$74$KG$20240628$$MD$ES$ES
240692681$24069268$1$I$20221122$20240318$20240710$20240710$PER$$KR-ROCHE-3529690$ROCHE$$77$YR$E$M$Y$$$20240628$$HP$KR$KR
240692692$24069269$2$F$20221206$20240305$20240710$20240710$PER$$IT-ROCHE-3327842$ROCHE$$74$YR$E$F$Y$65$KG$20240628$$MD$IT$IT
240692701$24069270$1$I$$20240202$20240710$20240710$PER$$JP-ROCHE-3510473$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240692711$24069271$1$I$$20240527$20240710$20240710$PER$$ZA-ROCHE-3574768$ROCHE$$$$E$M$Y$$$20240628$$MD$ZA$ZA
240692721$24069272$1$I$20230515$20230704$20240710$20240710$PER$$CL-ROCHE-3357010$ROCHE$$62$YR$A$F$Y$$$20240628$$CN$CL$CL
240692732$24069273$2$F$$20240531$20240710$20240710$PER$$US-ROCHE-3566128$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240692741$24069274$1$I$20231122$20231130$20240710$20240710$PER$$CN-ROCHE-3468273$ROCHE$$70$YR$E$F$Y$51$KG$20240628$$HP$CN$CN
240692751$24069275$1$I$$20231118$20240710$20240710$PER$$US-ROCHE-3461072$ROCHE$$56$YR$A$F$Y$$$20240628$$CN$US$US
240692761$24069276$1$I$$20231113$20240710$20240710$PER$$RU-ROCHE-3457605$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$RU$RU
240692771$24069277$1$I$$20240418$20240710$20240710$PER$$FI-ROCHE-3549984$ROCHE$$$$E$F$Y$$$20240628$$MD$FI$FI
240692781$24069278$1$I$20230401$20230905$20240710$20240710$PER$$CN-ROCHE-3369851$ROCHE$$54$YR$A$M$Y$60$KG$20240628$$CN$CN$CN
240692791$24069279$1$I$$20240418$20240710$20240710$PER$$JP-ROCHE-3561499$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240692801$24069280$1$I$$20240314$20240710$20240710$PER$$US-ROCHE-3527310$ROCHE$$64$YR$A$F$Y$$$20240628$$HP$US$US
240692811$24069281$1$I$$20231117$20240710$20240710$PER$$US-ROCHE-3461280$ROCHE$$84$YR$E$F$Y$$$20240628$$MD$US$US
240692821$24069282$1$I$$20230824$20240710$20240710$PER$$US-ROCHE-3411822$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$US$US
240692831$24069283$1$I$$20231205$20240710$20240710$PER$$US-ROCHE-3470741$ROCHE$$64$YR$A$M$Y$$$20240628$$CN$US$US
240692841$24069284$1$I$20240418$20240418$20240710$20240710$PER$$JP-ROCHE-3560961$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240692851$24069285$1$I$20230201$20240111$20240710$20240710$PER$$CN-ROCHE-3490605$ROCHE$$78$YR$E$F$Y$66$KG$20240628$$MD$CN$CN
240692861$24069286$1$I$$20240418$20240710$20240710$PER$$US-ROCHE-3550719$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240692871$24069287$1$I$$20231103$20240710$20240710$PER$$RO-ROCHE-3453002$ROCHE$$74$YR$E$F$Y$80$KG$20240628$$CN$RO$RO
240692881$24069288$1$I$20230704$20230712$20240710$20240710$PER$$US-ROCHE-3387766$ROCHE$$$$A$F$Y$63.5$KG$20240628$$CN$US$US
240692891$24069289$1$I$$20230810$20240710$20240710$PER$$RO-ROCHE-3404376$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240692901$24069290$1$I$20221001$20230727$20240710$20240710$PER$$CN-ROCHE-3213346$ROCHE$$60$YR$A$M$Y$70$KG$20240628$$CN$CN$CN
240692911$24069291$1$I$$20230921$20240710$20240710$PER$$SG-ROCHE-3429220$ROCHE$$$$$F$Y$$$20240628$$MD$SG$SG
240692921$24069292$1$I$$20240508$20240710$20240710$PER$$IN-ROCHE-3560686$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$IN$IN
240692932$24069293$2$F$20240416$20240604$20240710$20240710$PER$$IN-ROCHE-3558324$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$IN$IN
240692941$24069294$1$I$$20231016$20240710$20240710$PER$$SG-ROCHE-3442641$ROCHE$$78$YR$E$F$Y$60$KG$20240628$$CN$SG$SG
240692951$24069295$1$I$20240318$20240523$20240710$20240710$PER$$US-ROCHE-3571590$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$US$US
240692961$24069296$1$I$$20240304$20240710$20240710$PER$$AU-ROCHE-3520968$ROCHE$Murali A, Simleit E Alectinib therapy: an important differential for spheroacanthocytosis.DOI:10.1016/j.pathol.2023.12.343. Pathology 2024 Feb;56 (SUPPLEMENT 1):S102-.$$$$$Y$$$20240628$$HP$AU$AU
240692971$24069297$1$I$20240509$20240530$20240710$20240710$PER$$JP-ROCHE-3577660$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240692981$24069298$1$I$$20240217$20240710$20240710$PER$$JP-ROCHE-3518770$ROCHE$$$$C$$Y$$$20240628$$MD$JP$JP
240692991$24069299$1$I$$20240424$20240710$20240710$PER$$GB-ROCHE-3556307$ROCHE$$$$$$Y$$$20240628$$MD$GB$GB
240693001$24069300$1$I$20240104$20240429$20240710$20240710$PER$$US-ROCHE-3556382$ROCHE$$67$YR$E$M$Y$$$20240628$$MD$US$US
240693011$24069301$1$I$$20231212$20240710$20240710$PER$$US-ROCHE-3475416$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$US$US
240693021$24069302$1$I$$20240108$20240710$20240710$PER$$US-ROCHE-3488402$ROCHE$$$$E$M$Y$$$20240628$$CN$US$US
240693031$24069303$1$I$$20230909$20240710$20240710$PER$$IN-ROCHE-3421217$ROCHE$$52$YR$A$F$Y$$$20240628$$CN$IN$IN
240693042$24069304$2$F$$20240523$20240710$20240710$PER$$GB-ROCHE-3557560$ROCHE$$$$A$F$Y$$$20240628$$MD$GB$GB
240693051$24069305$1$I$$20240522$20240710$20240710$PER$$US-ROCHE-3569191$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$US$US
240693065$24069306$5$F$20230808$20240129$20240710$20240710$PER$$DK-ROCHE-3472709$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$DK$DK
240693071$24069307$1$I$20230404$20240309$20240710$20240710$PER$$CN-ROCHE-3525042$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$CN$CN
240693081$24069308$1$I$$20240301$20240710$20240710$PER$$IN-ROCHE-3520246$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$IN$IN
240693091$24069309$1$I$$20240420$20240710$20240710$PER$$IN-ROCHE-3552853$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$IN$IN
240693101$24069310$1$I$$20240308$20240710$20240710$PER$$JP-ROCHE-3539256$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240693111$24069311$1$I$$20240522$20240710$20240710$PER$$US-ROCHE-3568807$ROCHE$$66$YR$E$F$Y$$$20240628$$HP$US$US
240693121$24069312$1$I$20221115$20231205$20240710$20240710$PER$$ES-ROCHE-3471192$ROCHE$$71$YR$E$$Y$$$20240628$$MD$ES$ES
240693131$24069313$1$I$$20230922$20240710$20240710$PER$$RO-ROCHE-3429919$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240693141$24069314$1$I$$20240214$20240710$20240710$PER$$RO-ROCHE-3512410$ROCHE$$76$YR$E$F$Y$100$KG$20240628$$CN$RO$RO
240693151$24069315$1$I$$20240509$20240710$20240710$PER$$US-ROCHE-3562109$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$US$US
240693163$24069316$3$F$$20240425$20240710$20240710$PER$$IN-ROCHE-3554374$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$IN$IN
240693172$24069317$2$F$20221116$20240402$20240710$20240710$PER$$ES-ROCHE-3435259$ROCHE$$76$YR$E$$Y$$$20240628$$MD$ES$ES
240693181$24069318$1$I$20231004$20240104$20240710$20240710$PER$IT-MINISAL02-963541$IT-ROCHE-3485512$ROCHE$$72$YR$E$F$Y$45$KG$20240628$$MD$IT$IT
240693191$24069319$1$I$$20240318$20240710$20240710$PER$$US-ROCHE-3528896$ROCHE$$53$YR$A$M$Y$$$20240628$$CN$US$US
240693201$24069320$1$I$$20240511$20240710$20240710$PER$$IN-ROCHE-3565259$ROCHE$$75$YR$E$F$Y$$$20240628$$CN$IN$IN
240693211$24069321$1$I$$20240504$20240710$20240710$PER$$IN-ROCHE-3559134$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$IN$IN
240693221$24069322$1$I$20240322$20240322$20240710$20240710$PER$$JP-ROCHE-3548642$ROCHE$$59$YR$A$F$Y$$$20240628$$PH$JP$JP
240693232$24069323$2$F$$20240514$20240710$20240710$PER$$US-ROCHE-3564553$ROCHE$$23$YR$A$F$Y$$$20240628$$CN$US$US
240693241$24069324$1$I$20240509$20240603$20240710$20240710$PER$IT-MINISAL02-987811$IT-ROCHE-3575005$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IT$IT
240693251$24069325$1$I$$20240605$20240710$20240710$PER$$IN-ROCHE-3578213$ROCHE$$52$YR$A$F$Y$$$20240628$$CN$IN$IN
240693261$24069326$1$I$$20240529$20240710$20240710$PER$$US-ROCHE-3573580$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240693272$24069327$2$F$$20231215$20240710$20240710$PER$$ID-ROCHE-3335200$ROCHE$$50$YR$A$F$Y$$$20240628$$CN$ID$ID
240693281$24069328$1$I$20230612$20240308$20240710$20240710$PER$$CN-ROCHE-3523854$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$CN$CN
240693292$24069329$2$F$20230615$20240426$20240710$20240710$PER$$CL-ROCHE-3371553$ROCHE$$54$YR$A$F$Y$84$KG$20240628$$MD$CL$CL
240693301$24069330$1$I$$20240528$20240710$20240710$PER$$CA-ROCHE-3572947$ROCHE$$57$YR$A$M$Y$$$20240628$$CN$CA$CA
240693311$24069331$1$I$$20240425$20240710$20240710$PER$$IN-ROCHE-3555184$ROCHE$$44$YR$A$F$Y$$$20240628$$CN$IN$IN
240693321$24069332$1$I$$20240130$20240710$20240710$PER$$JP-ROCHE-3509144$ROCHE$$6$DEC$A$M$Y$$$20240628$$MD$JP$JP
240693331$24069333$1$I$20230101$20230920$20240710$20240710$PER$$CN-ROCHE-3377244$ROCHE$$39$YR$A$F$Y$$$20240628$$MD$CN$CN
240693342$24069334$2$F$$20240530$20240710$20240710$PER$$FR-ROCHE-3575700$ROCHE$$$$$F$Y$$$20240628$$MD$FR$FR
240693351$24069335$1$I$$20240516$20240710$20240710$PER$$RU-ROCHE-3567640$ROCHE$$$$$$Y$$$20240628$$MD$RU$RU
240693361$24069336$1$I$20240110$20240119$20240710$20240710$PER$$JP-ROCHE-3500107$ROCHE$$47$YR$A$F$Y$$$20240628$$MD$JP$JP
240693372$24069337$2$F$20240706$20240710$20240710$20240712$PER$$US-AMGEN-USASP2024136008$AMGEN$$77$YR$E$F$Y$$$20240712$$CN$US$US
240693381$24069338$1$I$$20240517$20240710$20240710$PER$$JP-ROCHE-3572198$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240693391$24069339$1$I$$20240118$20240710$20240710$PER$$US-ROCHE-3495628$ROCHE$$$$$F$Y$$$20240628$$PH$US$US
240693401$24069340$1$I$$20240113$20240710$20240710$PER$$TW-ROCHE-3494887$ROCHE$$4$DEC$A$F$Y$$$20240628$$MD$TW$TW
240693411$24069341$1$I$20231001$20231007$20240710$20240710$PER$$CN-ROCHE-3435614$ROCHE$$58$YR$A$M$Y$72.5$KG$20240628$$CN$CN$CN
240693421$24069342$1$I$$20230811$20240710$20240710$PER$$RU-ROCHE-3406505$ROCHE$$71$YR$E$F$Y$$$20240628$$MD$RU$RU
240693431$24069343$1$I$$20231222$20240710$20240710$PER$$JP-ROCHE-3482791$ROCHE$$73$YR$E$M$Y$$$20240628$$MD$JP$JP
240693441$24069344$1$I$$20240322$20240710$20240710$PER$$JP-ROCHE-3549105$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240693451$24069345$1$I$$20240604$20240710$20240710$PER$$US-ROCHE-3577355$ROCHE$$1$MON$I$$Y$$$20240628$$MD$US$US
240693461$24069346$1$I$$20231204$20240710$20240710$PER$$CH-ROCHE-3470415$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240693472$24069347$2$F$20240220$20240403$20240710$20240710$PER$$JP-ROCHE-3533652$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240693481$24069348$1$I$20231215$20231220$20240710$20240710$PER$$JP-ROCHE-3482171$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240693491$24069349$1$I$$20231019$20240710$20240710$PER$$IN-ROCHE-3330508$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$IN$IN
240693501$24069350$1$I$20240308$20240408$20240710$20240710$PER$$JP-ROCHE-3559242$ROCHE$$$$$F$Y$$$20240628$$PH$JP$JP
240693511$24069351$1$I$$20240308$20240710$20240710$PER$$US-ROCHE-3524330$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240693521$24069352$1$I$$20230823$20240710$20240710$PER$$GB-ROCHE-3410511$ROCHE$$$$$$Y$$$20240628$$CN$GB$GB
240693531$24069353$1$I$$20240513$20240710$20240710$PER$$IN-ROCHE-3285018$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$IN$IN
240693541$24069354$1$I$$20240112$20240710$20240710$PER$$US-ROCHE-3492725$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$US$US
240693551$24069355$1$I$$20240212$20240710$20240710$PER$$FR-ROCHE-3511684$ROCHE$$30$YR$A$M$Y$$$20240628$$MD$FR$FR
240693561$24069356$1$I$20240228$20240301$20240710$20240710$PER$$JP-ROCHE-3533593$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240693571$24069357$1$I$$20231220$20240710$20240710$PER$$TH-ROCHE-3481190$ROCHE$$$$$$Y$$$20240628$$PH$TH$TH
240693581$24069358$1$I$$20240415$20240710$20240710$PER$$IN-ROCHE-3549343$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$IN$IN
240693591$24069359$1$I$20231013$20231014$20240710$20240710$PER$$US-ROCHE-3440023$ROCHE$$$$A$M$Y$$$20240628$$CN$US$US
240693601$24069360$1$I$20231201$20231226$20240710$20240710$PER$$JP-ROCHE-3486150$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240693611$24069361$1$I$$20240319$20240710$20240710$PER$$IN-ROCHE-3530720$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$IN$IN
240693621$24069362$1$I$20220808$20231207$20240710$20240710$PER$$RS-ROCHE-3187175$ROCHE$$77$YR$E$M$Y$$$20240628$$MD$RS$RS
240693631$24069363$1$I$$20240209$20240710$20240710$PER$$PE-ROCHE-3509622$ROCHE$$37$YR$A$M$Y$$$20240628$$CN$PE$PE
240693642$24069364$2$F$20230404$20231123$20240710$20240710$PER$$TR-ROCHE-3464191$ROCHE$$47$YR$A$M$Y$65$KG$20240628$$MD$TR$TR
240693652$24069365$2$F$$20240428$20240710$20240710$PER$$IN-ROCHE-3555333$ROCHE$$47$YR$A$F$Y$$$20240628$$CN$IN$IN
240693662$24069366$2$F$20220727$20231206$20240710$20240710$PER$$TR-ROCHE-3187451$ROCHE$$40$YR$A$F$Y$$$20240628$$MD$TR$TR
240693671$24069367$1$I$$20230703$20240710$20240710$PER$$IN-ROCHE-3382498$ROCHE$$40$YR$A$F$Y$$$20240628$$MD$IN$IN
240693681$24069368$1$I$$20231215$20240710$20240710$PER$$IN-ROCHE-3477196$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240693692$24069369$2$F$$20240118$20240710$20240710$PER$$US-ROCHE-3495545$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$US$US
240693701$24069370$1$I$$20240418$20240710$20240710$PER$$RO-ROCHE-3325506$ROCHE$$51$YR$A$F$Y$93$KG$20240628$$CN$RO$RO
240693711$24069371$1$I$$20240122$20240710$20240710$PER$$EG-ROCHE-3496637$ROCHE$$63$YR$A$$Y$87$KG$20240628$$CN$EG$EG
240693721$24069372$1$I$20220630$20231205$20240710$20240710$PER$$ES-ROCHE-3471193$ROCHE$$53$YR$A$$Y$$$20240628$$MD$ES$ES
240693731$24069373$1$I$$20240529$20240710$20240710$PER$$ES-ROCHE-3574595$ROCHE$$$$$$Y$$$20240628$$HP$ES$ES
240693741$24069374$1$I$$20240521$20240710$20240710$PER$$FR-ROCHE-3568743$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$FR$FR
240693751$24069375$1$I$$20230809$20240710$20240710$PER$$IN-ROCHE-3403394$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$IN$IN
240693761$24069376$1$I$$20231030$20240710$20240710$PER$$CN-ROCHE-3449416$ROCHE$$$$$M$Y$$$20240628$$MD$CN$CN
240693771$24069377$1$I$$20231116$20240710$20240710$PER$$JP-ROCHE-3463859$ROCHE$$7$DEC$E$$Y$$$20240628$$MD$JP$JP
240693781$24069378$1$I$$20240522$20240710$20240710$PER$$KR-ROCHE-3570143$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$KR$KR
240693791$24069379$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06185$LUPIN$$21$YR$$M$Y$$$20240710$$CN$US$US
240693801$24069380$1$I$$20240326$20240710$20240710$PER$$DE-ROCHE-3534348$ROCHE$$$$$M$Y$$$20240628$$MD$DE$DE
240693811$24069381$1$I$$20240207$20240710$20240710$PER$$JP-ROCHE-3513384$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240693821$24069382$1$I$$20240422$20240710$20240710$PER$$IN-ROCHE-3553140$ROCHE$$64$YR$A$F$Y$$$20240628$$MD$IN$IN
240693831$24069383$1$I$$20231115$20240710$20240710$PER$$IL-ROCHE-3458353$ROCHE$$$$A$M$Y$$$20240628$$MD$IL$IL
240693841$24069384$1$I$$20240426$20240710$20240710$PER$$JP-ROCHE-3564942$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240693852$24069385$2$F$20230315$20231106$20240710$20240710$PER$$TR-ROCHE-3328107$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$TR$TR
240693861$24069386$1$I$$20240411$20240710$20240710$PER$$JP-ROCHE-3559206$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240693871$24069387$1$I$20240401$20240426$20240710$20240710$PER$$JP-ROCHE-3564853$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240693881$24069388$1$I$$20240418$20240710$20240710$PER$$FI-ROCHE-3549985$ROCHE$$$$$$Y$$$20240628$$MD$FI$FI
240693891$24069389$1$I$$20240514$20240710$20240710$PER$$TH-ROCHE-3564176$ROCHE$$61$YR$A$F$Y$$$20240628$$HP$TH$TH
240693901$24069390$1$I$$20240531$20240710$20240710$PER$$IN-ROCHE-3575602$ROCHE$$52$YR$A$F$Y$$$20240628$$CN$IN$IN
240693911$24069391$1$I$$20240104$20240710$20240710$PER$$US-ROCHE-3486485$ROCHE$$33$YR$A$F$Y$$$20240628$$MD$US$US
240693921$24069392$1$I$20240325$20240329$20240710$20240710$PER$$JP-ROCHE-3551815$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240693932$24069393$2$F$20220926$20231013$20240710$20240710$PER$$BG-ROCHE-3189826$ROCHE$$78$YR$E$F$Y$60$KG$20240628$$MD$BG$BG
240693941$24069394$1$I$20240201$20240412$20240710$20240710$PER$$US-ROCHE-3545679$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$US$US
240693951$24069395$1$I$$20240118$20240710$20240710$PER$$US-ROCHE-3495658$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240693961$24069396$1$I$20240405$20240410$20240710$20240710$PER$$JP-ROCHE-3559483$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240693971$24069397$1$I$$20240524$20240710$20240710$PER$$IN-ROCHE-3571781$ROCHE$$69$YR$E$F$Y$$$20240628$$MD$IN$IN
240693981$24069398$1$I$20240418$20240425$20240710$20240710$PER$$JP-ROCHE-3564156$ROCHE$$7$DEC$E$$Y$$$20240628$$MD$JP$JP
240693991$24069399$1$I$$20240408$20240710$20240710$PER$$US-ROCHE-2878880$ROCHE$$62$YR$A$F$Y$$$20240628$$HP$US$US
240694001$24069400$1$I$20240403$20240410$20240710$20240710$PER$$IN-ROCHE-3545827$ROCHE$$81$YR$E$F$Y$$$20240628$$CN$IN$IN
240694011$24069401$1$I$20230221$20240111$20240710$20240710$PER$$CN-ROCHE-3490979$ROCHE$$67$YR$E$F$Y$75$KG$20240628$$MD$CN$CN
240694021$24069402$1$I$$20240513$20240710$20240710$PER$$JP-ROCHE-3572591$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240694031$24069403$1$I$$20231120$20240710$20240710$PER$$US-ROCHE-3461845$ROCHE$$76$YR$E$F$Y$$$20240628$$CN$US$US
240694041$24069404$1$I$$20240405$20240710$20240710$PER$$IN-ROCHE-3542067$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$IN$IN
240694051$24069405$1$I$$20240221$20240710$20240710$PER$$US-ROCHE-3514537$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$US$US
240694061$24069406$1$I$20230403$20240214$20240710$20240710$PER$$KR-ROCHE-3511346$ROCHE$$44$YR$A$$Y$$$20240628$$MD$KR$KR
240694071$24069407$1$I$20221212$20230718$20240710$20240710$PER$$CN-ROCHE-3263513$ROCHE$$39$YR$A$M$Y$78$KG$20240628$$CN$CN$CN
240694091$24069409$1$I$$20240531$20240710$20240710$PER$$KR-ROCHE-3575864$ROCHE$$76$YR$E$F$Y$$$20240628$$CN$KR$KR
240694101$24069410$1$I$$20240515$20240710$20240710$PER$$JP-ROCHE-3572093$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240694112$24069411$2$F$$20230814$20240710$20240710$PER$$GB-ROCHE-3404438$ROCHE$$$$A$F$Y$$$20240628$$CN$GB$GB
240694121$24069412$1$I$$20240423$20240710$20240710$PER$$JP-ROCHE-3569634$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240694131$24069413$1$I$20240110$20240312$20240710$20240710$PER$$JP-ROCHE-3543500$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240694142$24069414$2$F$$20240403$20240710$20240710$PER$$RO-ROCHE-3541757$ROCHE$$84$YR$E$M$Y$$$20240628$$MD$RO$RO
240694151$24069415$1$I$20240516$20240516$20240710$20240710$PER$$JP-ROCHE-3572089$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$JP$JP
240694161$24069416$1$I$20230124$20230721$20240710$20240710$PER$$DK-ROCHE-3368381$ROCHE$$69$YR$E$M$Y$$$20240628$$MD$DK$DK
240694171$24069417$1$I$$20230711$20240710$20240710$PER$$CU-ROCHE-3388747$ROCHE$$$$$$Y$$$20240628$$CN$CU$CU
240694181$24069418$1$I$$20230811$20240710$20240710$PER$$US-ROCHE-3404833$ROCHE$$$$$F$Y$58.97$KG$20240628$$CN$US$US
240694191$24069419$1$I$$20231030$20240710$20240710$PER$$CN-ROCHE-3450624$ROCHE$Xu J, Yao X, Wen Y, Lian H,  Han X and Xu Z. Alectinib In the Treatment of Systemic Juvenile Xanthogranuloma of Infancy With ALK Translocation. DOI : 10.1001/jamadermatol.2023.4027. JAMA dermatology 2023 Oct 25;:E1-3.$2$MON$I$F$Y$$$20240628$$MD$CN$CN
240694201$24069420$1$I$$20230828$20240710$20240710$PER$$IN-ROCHE-3413683$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$IN$IN
240694211$24069421$1$I$$20240521$20240710$20240710$PER$$KR-ROCHE-3570078$ROCHE$$80$YR$E$M$Y$$$20240628$$CN$KR$KR
240694222$24069422$2$F$20240118$20240502$20240710$20240710$PER$$IN-ROCHE-3558621$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$IN$IN
240694232$24069423$2$F$$20231103$20240710$20240710$PER$$IN-ROCHE-3453705$ROCHE$$29$YR$A$F$Y$$$20240628$$MD$IN$IN
240694251$24069425$1$I$$20231227$20240710$20240710$PER$$JP-ROCHE-3486163$ROCHE$$84$YR$E$F$Y$$$20240628$$MD$JP$JP
240694262$24069426$2$F$20240228$20240501$20240710$20240710$PER$$JP-ROCHE-3547526$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240694272$24069427$2$F$$20240405$20240710$20240710$PER$$IN-ROCHE-3543262$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$IN$IN
240694291$24069429$1$I$$20231107$20240710$20240710$PER$$PT-ROCHE-3455360$ROCHE$$44$YR$A$M$Y$$$20240628$$MD$PT$PT
240694303$24069430$3$F$20220509$20240528$20240710$20240710$PER$$CN-ROCHE-3139939$ROCHE$$66$YR$E$F$Y$75$KG$20240628$$MD$CN$CN
240694311$24069431$1$I$$20240509$20240710$20240710$PER$$JP-ROCHE-3567314$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240694321$24069432$1$I$20240605$20240607$20240710$20240710$PER$$IN-ROCHE-3579223$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$IN$IN
240694331$24069433$1$I$20230725$20240520$20240710$20240710$PER$$US-ROCHE-3566997$ROCHE$$68$YR$E$F$Y$$$20240628$$MD$US$US
240694341$24069434$1$I$20240222$20240306$20240710$20240710$PER$$JP-ROCHE-3536103$ROCHE$$9$DEC$E$F$Y$$$20240628$$MD$JP$JP
240694351$24069435$1$I$$20240419$20240710$20240710$PER$$PH-ROCHE-3552291$ROCHE$$62$YR$A$F$Y$68$KG$20240628$$MD$PH$PH
240694362$24069436$2$F$$20240523$20240710$20240710$PER$$CA-ROCHE-3554509$ROCHE$$56$YR$A$M$Y$$$20240628$$CN$CA$CA
240694371$24069437$1$I$$20240529$20240710$20240710$PER$$KR-ROCHE-3573666$ROCHE$$47$YR$A$M$Y$$$20240628$$CN$KR$KR
240694391$24069439$1$I$$20240125$20240710$20240710$PER$$JP-ROCHE-3504217$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240694401$24069440$1$I$$20240506$20240710$20240710$PER$$IN-ROCHE-3558694$ROCHE$$71$YR$E$M$Y$$$20240628$$CN$IN$IN
240694411$24069441$1$I$$20240525$20240710$20240710$PER$$IN-ROCHE-3571311$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
240694424$24069442$4$F$20220617$20240820$20240710$20240822$EXP$$CN-ROCHE-3525004$ROCHE$$53$YR$A$F$Y$$$20240822$$MD$CN$CN
240694431$24069443$1$I$20220215$20231205$20240710$20240710$PER$$TR-ROCHE-3028093$ROCHE$$58$YR$A$M$Y$89$KG$20240628$$MD$TR$TR
240694441$24069444$1$I$20240412$20240412$20240710$20240710$PER$$JP-ROCHE-3559504$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240694452$24069445$2$F$20240320$20240426$20240710$20240710$PER$$GB-ROCHE-3551599$ROCHE$$94$YR$E$F$Y$$$20240628$$MD$GB$GB
240694461$24069446$1$I$$20240605$20240710$20240710$PER$$US-ROCHE-3578086$ROCHE$$72$YR$E$M$Y$$$20240628$$MD$US$US
240694471$24069447$1$I$20230912$20240318$20240710$20240710$PER$$IT-ROCHE-3529235$ROCHE$$72$YR$E$M$Y$84$KG$20240628$$MD$IT$IT
240694481$24069448$1$I$$20240418$20240710$20240710$PER$$JP-ROCHE-3560799$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240694491$24069449$1$I$$20240313$20240710$20240710$PER$$ID-ROCHE-3526762$ROCHE$$$$A$F$Y$$$20240628$$MD$ID$ID
240694501$24069450$1$I$$20240521$20240710$20240710$PER$$US-ROCHE-3568109$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240694522$24069452$2$F$20230702$20231101$20240710$20240710$PER$$TR-ROCHE-3407424$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$TR$TR
240694532$24069453$2$F$$20240524$20240710$20240710$PER$$US-ROCHE-3570585$ROCHE$$24$YR$A$M$Y$61.23$KG$20240628$$CN$US$US
240694541$24069454$1$I$$20230817$20240710$20240710$PER$$JP-ROCHE-3408965$ROCHE$$46$YR$A$F$Y$$$20240628$$PH$JP$JP
240694551$24069455$1$I$$20230920$20240710$20240710$PER$$IN-ROCHE-3428121$ROCHE$$37$YR$A$F$Y$$$20240628$$MD$IN$IN
240694561$24069456$1$I$$20230713$20240710$20240710$PER$$IL-ROCHE-3388779$ROCHE$$$$A$M$Y$$$20240628$$CN$IL$IL
240694571$24069457$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3526945$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240694581$24069458$1$I$$20240417$20240710$20240710$PER$$US-ROCHE-3548509$ROCHE$$70$YR$E$F$Y$$$20240628$$CN$US$US
240694591$24069459$1$I$20221212$20240514$20240710$20240710$PER$$US-ROCHE-3564378$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$US$US
240694611$24069461$1$I$20240429$20240606$20240710$20240710$PER$$NL-ROCHE-3579090$ROCHE$$21$YR$A$M$Y$$$20240628$$MD$NL$NL
240694621$24069462$1$I$20210927$20231019$20240710$20240710$PER$$TR-ROCHE-3331239$ROCHE$$29$YR$A$F$Y$58$KG$20240628$$MD$TR$TR
240694632$24069463$2$F$$20231219$20240710$20240710$PER$$IN-ROCHE-3479605$ROCHE$$28$YR$A$F$Y$$$20240628$$MD$IN$IN
240694644$24069464$4$F$20211204$20240308$20240710$20240710$PER$$CN-ROCHE-3067569$ROCHE$$29$YR$A$F$Y$65$KG$20240628$$MD$CN$CN
240694651$24069465$1$I$$20231102$20240710$20240710$PER$$GB-ROCHE-3452437$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240694663$24069466$3$F$$20231002$20240710$20240710$PER$$US-ROCHE-3428203$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240694671$24069467$1$I$$20240514$20240710$20240710$PER$$FI-ROCHE-3565537$ROCHE$$74$YR$E$M$Y$$$20240628$$MD$FI$FI
240694691$24069469$1$I$$20240121$20240710$20240710$PER$$PH-ROCHE-3496181$ROCHE$$86$YR$E$F$Y$$$20240628$$MD$PH$PH
240694701$24069470$1$I$$20240409$20240710$20240710$PER$$US-ROCHE-3543652$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$US$US
240694712$24069471$2$F$$20240401$20240710$20240710$PER$$PH-ROCHE-3537305$ROCHE$$51$YR$A$F$Y$60$KG$20240628$$CN$PH$PH
240694731$24069473$1$I$20211009$20230810$20240710$20240710$PER$$CN-ROCHE-3204824$ROCHE$$31$YR$A$M$Y$70$KG$20240628$$CN$CN$CN
240694751$24069475$1$I$20231201$20240213$20240710$20240710$PER$$PE-ROCHE-3510164$ROCHE$$69$YR$E$M$Y$69.5$KG$20240628$$MD$PE$PE
240694761$24069476$1$I$20240129$20240212$20240710$20240710$PER$$US-ROCHE-3509397$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$US$US
240694772$24069477$2$F$20230726$20240321$20240710$20240710$PER$$CN-ROCHE-3531248$ROCHE$$55$YR$A$M$Y$50$KG$20240628$$MD$CN$CN
240694782$24069478$2$F$20231207$20240411$20240710$20240710$PER$$BE-ROCHE-3529769$ROCHE$$74$YR$E$M$Y$83$KG$20240628$$MD$BE$BE
240694791$24069479$1$I$$20231204$20240710$20240710$PER$$US-ROCHE-3470138$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240694801$24069480$1$I$$20240419$20240710$20240710$PER$$AU-ROCHE-3552255$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240694811$24069481$1$I$$20231214$20240710$20240710$PER$$CN-ROCHE-3475750$ROCHE$$$$$F$Y$$$20240628$$MD$CN$CN
240694821$24069482$1$I$$20240528$20240710$20240710$PER$$JP-ROCHE-3577674$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240694832$24069483$2$F$$20230808$20240710$20240710$PER$$MX-ROCHE-3404331$ROCHE$$$$$$Y$$$20240628$$MD$MX$MX
240694841$24069484$1$I$$20240119$20240710$20240710$PER$$CO-ROCHE-3495408$ROCHE$$41$YR$A$M$Y$$$20240628$$CN$CO$CO
240694851$24069485$1$I$$20240524$20240710$20240710$PER$$AU-ROCHE-3570823$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240694862$24069486$2$F$20230921$20231002$20240710$20240710$PER$$MX-ROCHE-3434637$ROCHE$$49$YR$A$F$Y$67.5$KG$20240628$$CN$MX$MX
240694871$24069487$1$I$$20240329$20240710$20240710$PER$$JP-ROCHE-3551850$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240694881$24069488$1$I$20240516$20240522$20240710$20240710$PER$$JP-ROCHE-3575164$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240694891$24069489$1$I$$20240604$20240710$20240710$PER$$US-ROCHE-3577095$ROCHE$$69$YR$E$F$Y$$$20240628$$HP$US$US
240694902$24069490$2$F$20240614$20240731$20240710$20240827$PER$$US-TOLMAR, INC.-24US050289$TOLMAR$$76$YR$$M$Y$$$20240827$$HP$US$US
240694911$24069491$1$I$20240417$20240417$20240710$20240710$PER$$JP-ROCHE-3559852$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240694921$24069492$1$I$20240101$20240618$20240710$20240710$PER$$US-TOLMAR, INC.-24US050295$TOLMAR$$$$$M$Y$$$20240710$$CN$US$US
240694932$24069493$2$F$20240618$20240731$20240710$20240827$PER$$US-TOLMAR, INC.-24US050303$TOLMAR$$81$YR$$M$Y$$$20240827$$HP$US$US
240694941$24069494$1$I$$20240531$20240710$20240710$PER$$RO-ROCHE-3575730$ROCHE$$75$YR$E$F$Y$$$20240628$$CN$RO$RO
240694951$24069495$1$I$$20240208$20240710$20240710$PER$$SG-ROCHE-3507888$ROCHE$$46$YR$A$F$Y$$$20240628$$CN$SG$SG
240694961$24069496$1$I$$20240223$20240710$20240710$PER$$IN-ROCHE-3515725$ROCHE$$$$$$Y$$$20240628$$CN$IN$IN
240694971$24069497$1$I$$20240508$20240710$20240710$PER$$CZ-ROCHE-3562288$ROCHE$$$$$M$Y$$$20240628$$MD$CZ$CZ
240694981$24069498$1$I$20240131$20240201$20240710$20240710$PER$$JP-ROCHE-3509879$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240694991$24069499$1$I$$20240530$20240710$20240710$PER$$US-ROCHE-3573991$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240695001$24069500$1$I$$20240412$20240710$20240710$PER$$IN-ROCHE-3545836$ROCHE$$79$YR$E$F$Y$$$20240628$$CN$IN$IN
240695011$24069501$1$I$20240402$20240412$20240710$20240710$PER$$JP-ROCHE-3559460$ROCHE$$$$$F$Y$$$20240628$$PH$JP$JP
240695021$24069502$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3526152$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240695031$24069503$1$I$$20240418$20240710$20240710$PER$$IN-ROCHE-3550911$ROCHE$$43$YR$A$F$Y$$$20240628$$CN$IN$IN
240695041$24069504$1$I$20220412$20231204$20240710$20240710$PER$$DK-ROCHE-3471980$ROCHE$$55$YR$A$M$Y$$$20240628$$MD$DK$DK
240695052$24069505$2$F$20230201$20240418$20240710$20240710$PER$$DK-ROCHE-3389894$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$DK$DK
240695061$24069506$1$I$$20240130$20240710$20240710$PER$$IN-ROCHE-3502278$ROCHE$$33$YR$A$M$Y$$$20240628$$CN$IN$IN
240695071$24069507$1$I$20220108$20240107$20240710$20240710$PER$$CN-ROCHE-3039091$ROCHE$$66$YR$E$F$Y$72$KG$20240628$$MD$CN$CN
240695081$24069508$1$I$$20240603$20240710$20240710$PER$$CA-ROCHE-3575950$ROCHE$$58$YR$A$M$Y$$$20240628$$CN$CA$CA
240695092$24069509$2$F$$20240514$20240710$20240710$PER$$FI-ROCHE-3565544$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$FI$FI
240695101$24069510$1$I$$20240306$20240710$20240710$PER$$KW-ROCHE-3524021$ROCHE$$$$E$$Y$$$20240628$$MD$KW$KW
240695111$24069511$1$I$$20230801$20240710$20240710$PER$$US-ROCHE-3398220$ROCHE$$80$YR$E$M$Y$$$20240628$$CN$US$US
240695131$24069513$1$I$20231228$20240119$20240710$20240710$PER$$JP-ROCHE-3499175$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240695141$24069514$1$I$20231205$20231206$20240710$20240710$PER$$JP-ROCHE-3476298$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240695151$24069515$1$I$$20231221$20240710$20240710$PER$$US-ROCHE-3480835$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$US$US
240695161$24069516$1$I$$20240517$20240710$20240710$PER$$ZA-ROCHE-3568524$ROCHE$$$$$M$Y$$$20240628$$MD$ZA$ZA
240695171$24069517$1$I$20231006$20231205$20240710$20240710$PER$$ES-ROCHE-3471191$ROCHE$$21$YR$A$$Y$$$20240628$$MD$ES$ES
240695181$24069518$1$I$$20240516$20240710$20240710$PER$$JP-ROCHE-3572091$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240695193$24069519$3$F$20230101$20240527$20240710$20240710$PER$$IT-ROCHE-3302966$ROCHE$$47$YR$A$F$Y$62$KG$20240628$$MD$IT$IT
240695201$24069520$1$I$20240303$20240418$20240710$20240710$PER$IT-MINISAL02-980661$IT-ROCHE-3548901$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$IT$IT
240695211$24069521$1$I$20240118$20240314$20240710$20240710$PER$$JP-ROCHE-3544753$ROCHE$$77$YR$E$F$Y$$$20240628$$MD$JP$JP
240695222$24069522$2$F$$20240513$20240710$20240710$PER$$FR-ROCHE-3559691$ROCHE$$56$YR$A$F$Y$$$20240628$$PH$FR$FR
240695231$24069523$1$I$$20240304$20240710$20240710$PER$$CN-ROCHE-3520581$ROCHE$$54$YR$A$F$Y$$$20240628$$CN$CN$CN
240695241$24069524$1$I$20231020$20231212$20240710$20240710$PER$$VN-ROCHE-3475336$ROCHE$$78$YR$E$F$Y$$$20240628$$MD$VN$VN
240695251$24069525$1$I$$20231005$20240710$20240710$PER$$US-ROCHE-3436123$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240695261$24069526$1$I$$20240520$20240710$20240710$PER$$IN-ROCHE-3568190$ROCHE$$71$YR$E$F$Y$$$20240628$$CN$IN$IN
240695271$24069527$1$I$20240201$20240315$20240710$20240710$PER$$JP-ROCHE-3544877$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240695281$24069528$1$I$$20231011$20240710$20240710$PER$$IN-ROCHE-3439335$ROCHE$$64$YR$A$F$Y$$$20240628$$MD$IN$IN
240695291$24069529$1$I$$20230919$20240710$20240710$PER$$IN-ROCHE-3342639$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$IN$IN
240695301$24069530$1$I$$20231128$20240710$20240710$PER$$CN-ROCHE-3466110$ROCHE$$$$A$F$Y$$$20240628$$CN$CN$CN
240695312$24069531$2$F$20240206$20240327$20240710$20240710$PER$$IL-ROCHE-3534497$ROCHE$$68$YR$E$M$Y$87$KG$20240628$$MD$IL$IL
240695321$24069532$1$I$$20230801$20240710$20240710$PER$$IN-ROCHE-3398328$ROCHE$$69$YR$E$M$Y$$$20240628$$MD$IN$IN
240695331$24069533$1$I$20240424$20240425$20240710$20240710$PER$$IN-ROCHE-3554348$ROCHE$$70$YR$E$F$Y$$$20240628$$CN$IN$IN
240695341$24069534$1$I$$20240420$20240710$20240710$PER$$DE-ROCHE-3550738$ROCHE$$75$YR$E$F$Y$$$20240628$$HP$DE$DE
240695351$24069535$1$I$$20240514$20240710$20240710$PER$$IN-ROCHE-3564038$ROCHE$$74$YR$E$M$Y$$$20240628$$CN$IN$IN
240695361$24069536$1$I$$20240503$20240710$20240710$PER$$IN-ROCHE-3558118$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$IN$IN
240695371$24069537$1$I$20240501$20240513$20240710$20240710$PER$$FR-ROCHE-3563846$ROCHE$$85$YR$E$F$Y$$$20240628$$PH$FR$FR
240695381$24069538$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3526154$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240695391$24069539$1$I$$20230912$20240710$20240710$PER$$PH-ROCHE-3423552$ROCHE$$36$YR$A$F$Y$53$KG$20240628$$CN$PH$PH
240695402$24069540$2$F$$20240501$20240710$20240710$PER$$SG-ROCHE-3546968$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$SG$SG
240695411$24069541$1$I$$20230824$20240710$20240710$PER$$US-ROCHE-3411240$ROCHE$$83$YR$E$F$Y$$$20240628$$CN$US$US
240695421$24069542$1$I$20221101$20231213$20240710$20240710$PER$$VN-ROCHE-3477773$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$VN$VN
240695431$24069543$1$I$20220728$20240207$20240710$20240710$PER$$CN-ROCHE-3156490$ROCHE$$56$YR$A$M$Y$$$20240628$$MD$CN$CN
240695441$24069544$1$I$20220512$20231122$20240710$20240710$PER$$IT-ROCHE-3273304$ROCHE$$70$YR$E$F$Y$80$KG$20240628$$MD$IT$IT
240695451$24069545$1$I$$20240610$20240710$20240710$PER$$IN-ROCHE-3378007$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$IN$IN
240695461$24069546$1$I$$20240205$20240710$20240710$PER$$US-ROCHE-3505290$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240695471$24069547$1$I$20240216$20240220$20240710$20240710$PER$$JP-ROCHE-3517236$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240695481$24069548$1$I$$20231031$20240710$20240710$PER$$TH-ROCHE-3451923$ROCHE$$$$$$Y$$$20240628$$PH$TH$TH
240695492$24069549$2$F$$20231129$20240710$20240710$PER$$IL-ROCHE-3460346$ROCHE$$$$E$F$Y$$$20240628$$CN$IL$IL
240695501$24069550$1$I$$20240515$20240710$20240710$PER$$US-ROCHE-3564471$ROCHE$$55$YR$A$M$Y$$$20240628$$MD$US$US
240695512$24069551$2$F$$20240425$20240710$20240710$PER$$JO-ROCHE-3552276$ROCHE$$$$$$Y$$$20240628$$MD$JO$JO
240695521$24069552$1$I$$20240125$20240710$20240710$PER$$PL-ROCHE-3501582$ROCHE$$$$$M$Y$$$20240628$$CN$PL$PL
240695531$24069553$1$I$$20240520$20240710$20240710$PER$$US-ROCHE-3567173$ROCHE$$78$YR$E$F$Y$$$20240628$$CN$US$US
240695541$24069554$1$I$$20240530$20240710$20240710$PER$$US-ROCHE-3575359$ROCHE$$64$YR$A$M$Y$$$20240628$$MD$US$US
240695551$24069555$1$I$$20230919$20240710$20240710$PER$$CH-ROCHE-3426131$ROCHE$$$$A$$Y$$$20240628$$MD$CH$CH
240695561$24069556$1$I$$20240521$20240710$20240710$PER$$US-ROCHE-3568250$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240695571$24069557$1$I$$20240325$20240710$20240710$PER$$US-ROCHE-3533133$ROCHE$$45$YR$A$F$Y$$$20240628$$HP$US$US
240695581$24069558$1$I$20240422$20240517$20240710$20240710$PER$$CN-ROCHE-3566801$ROCHE$$84$YR$E$M$Y$$$20240628$$MD$CN$CN
240695591$24069559$1$I$$20231103$20240710$20240710$PER$$IN-ROCHE-3452639$ROCHE$$78$YR$E$F$Y$$$20240628$$MD$IN$IN
240695601$24069560$1$I$20220601$20240216$20240710$20240710$PER$$NL-ROCHE-3513697$ROCHE$$49$YR$A$$Y$$$20240628$$MD$NL$NL
240695611$24069561$1$I$$20240203$20240710$20240710$PER$$IN-ROCHE-3505895$ROCHE$$34$YR$A$F$Y$$$20240628$$CN$IN$IN
240695621$24069562$1$I$$20240408$20240710$20240710$PER$$US-ROCHE-3545320$ROCHE$$63$YR$A$M$Y$$$20240628$$HP$US$US
240695631$24069563$1$I$$20230928$20240710$20240710$PER$$JP-ROCHE-3432729$ROCHE$$8$DEC$E$$Y$$$20240628$$MD$JP$JP
240695642$24069564$2$F$20240201$20240422$20240710$20240710$PER$$JP-ROCHE-3544183$ROCHE$$$$$F$Y$$$20240628$$PH$JP$JP
240695651$24069565$1$I$20240219$20240222$20240710$20240710$PER$$JP-ROCHE-3522935$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240695661$24069566$1$I$$20240131$20240710$20240710$PER$$JP-ROCHE-3509336$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240695671$24069567$1$I$20240221$20240405$20240710$20240710$PER$$JP-ROCHE-3555672$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240695681$24069568$1$I$$20240513$20240710$20240710$PER$$CA-ROCHE-3564259$ROCHE$$$$$M$Y$$$20240628$$MD$CA$CA
240695691$24069569$1$I$$20240528$20240710$20240710$PER$$JP-ROCHE-3577870$ROCHE$$$$$M$Y$$$20240628$$MD$JP$JP
240695701$24069570$1$I$20240307$20240308$20240710$20240710$PER$$JP-ROCHE-3533643$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240695711$24069571$1$I$$20240520$20240710$20240710$PER$$IN-ROCHE-3567771$ROCHE$$50$YR$A$F$Y$$$20240628$$MD$IN$IN
240695721$24069572$1$I$$20231116$20240710$20240710$PER$$RU-ROCHE-3460154$ROCHE$$39$YR$A$M$Y$$$20240628$$HP$RU$RU
240695731$24069573$1$I$20231215$20240415$20240710$20240710$PER$IT-MINISAL02-980004$IT-ROCHE-3545919$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$IT$IT
240695741$24069574$1$I$$20240521$20240710$20240710$PER$$US-ROCHE-3568005$ROCHE$$70$YR$E$M$Y$$$20240628$$CN$US$US
240695751$24069575$1$I$$20240409$20240710$20240710$PER$$JP-ROCHE-3559473$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240695763$24069576$3$F$$20230918$20240710$20240710$PER$$PT-ROCHE-3427584$ROCHE$$$$$$Y$$$20240628$$PH$PT$PT
240695771$24069577$1$I$$20240503$20240710$20240710$PER$$AU-ROCHE-3557776$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$AU$AU
240695782$24069578$2$F$$20240306$20240710$20240710$PER$$US-ROCHE-3520129$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240695791$24069579$1$I$20240322$20240412$20240710$20240710$PER$$JP-ROCHE-3559363$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240695801$24069580$1$I$$20230829$20240710$20240710$PER$$RO-ROCHE-3414151$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240695811$24069581$1$I$20240229$20240322$20240710$20240710$PER$$US-ROCHE-3532302$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240695821$24069582$1$I$$20240604$20240710$20240710$PER$$KR-ROCHE-3577224$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$KR$KR
240695831$24069583$1$I$20231025$20231204$20240710$20240710$PER$$CN-ROCHE-3470847$ROCHE$$53$YR$A$F$Y$85$KG$20240628$$HP$CN$CN
240695841$24069584$1$I$20230711$20231225$20240710$20240710$PER$$JP-ROCHE-3484132$ROCHE$$33$YR$A$M$Y$$$20240628$$CN$JP$JP
240695851$24069585$1$I$20220107$20240107$20240710$20240710$PER$$CN-ROCHE-3050416$ROCHE$$42$YR$A$F$Y$71.5$KG$20240628$$MD$CN$CN
240695862$24069586$2$F$$20240315$20240710$20240710$PER$$JP-ROCHE-3511108$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240695871$24069587$1$I$$20231129$20240710$20240710$PER$$US-ROCHE-3468806$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240695881$24069588$1$I$$20231209$20240710$20240710$PER$$IN-ROCHE-3473949$ROCHE$$35$YR$A$F$Y$$$20240628$$MD$IN$IN
240695891$24069589$1$I$$20240503$20240710$20240710$PER$$US-ROCHE-3558674$ROCHE$$50$YR$A$M$Y$$$20240628$$CN$US$US
240695901$24069590$1$I$$20231003$20240710$20240710$PER$$US-ROCHE-3433814$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240695911$24069591$1$I$20231012$20231019$20240710$20240710$PER$$JP-ROCHE-3445676$ROCHE$$7$DEC$E$M$Y$$$20240628$$PH$JP$JP
240695921$24069592$1$I$$20240425$20240710$20240710$PER$$IN-ROCHE-3554378$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240695941$24069594$1$I$$20230920$20240710$20240710$PER$$US-ROCHE-3426909$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240695951$24069595$1$I$$20231116$20240710$20240710$PER$$RO-ROCHE-3461183$ROCHE$$53$YR$A$F$Y$57$KG$20240628$$CN$RO$RO
240695961$24069596$1$I$$20231009$20240710$20240710$PER$$US-ROCHE-3437731$ROCHE$Zaman M, Malik S, Krishna Boppana H and Sheppard T. Rapid improvement in lymphangitic carcinomatosis after Brigatinib therapy: A case report. DOI: 10.1016/j.chest.2023.07.2800. Chest 2023 Oct;164 (SUP:4):4302A-4303A.$43$YR$A$F$Y$$$20240628$$HP$US$US
240695971$24069597$1$I$$20240501$20240710$20240710$PER$$US-ROCHE-3557292$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240695981$24069598$1$I$$20231122$20240710$20240710$PER$$BR-ROCHE-3463778$ROCHE$$64$YR$A$F$Y$$$20240628$$MD$BR$BR
240695992$24069599$2$F$$20240523$20240710$20240710$PER$$AU-ROCHE-3568268$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240696001$24069600$1$I$$20230911$20240710$20240710$PER$$IN-ROCHE-3338010$ROCHE$$51$YR$A$F$Y$$$20240628$$CN$IN$IN
240696011$24069601$1$I$20240322$20240325$20240710$20240710$PER$$JP-ROCHE-3550320$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240696021$24069602$1$I$20240311$20240319$20240710$20240710$PER$$JP-ROCHE-3547516$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240696031$24069603$1$I$20240406$20240418$20240710$20240710$PER$$IN-ROCHE-3550971$ROCHE$$49$YR$A$M$Y$$$20240628$$CN$IN$IN
240696041$24069604$1$I$$20240122$20240710$20240710$PER$$IN-ROCHE-3497771$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$IN$IN
240696051$24069605$1$I$$20240528$20240710$20240710$PER$$CL-ROCHE-3573744$ROCHE$$$$E$F$Y$90$KG$20240628$$CN$CL$CL
240696061$24069606$1$I$20240101$20240701$20240710$20240710$EXP$$US-INTERCEPT-PM2024001334$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
240696071$24069607$1$I$20240429$20240503$20240710$20240710$PER$$IN-ROCHE-3558068$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$IN$IN
240696081$24069608$1$I$$20240523$20240710$20240710$PER$$KR-ROCHE-3570174$ROCHE$$59$YR$A$M$Y$$$20240628$$CN$KR$KR
240696091$24069609$1$I$$20230725$20240710$20240710$PER$$RO-ROCHE-3396378$ROCHE$$48$YR$A$F$Y$66$KG$20240628$$CN$RO$RO
240696101$24069610$1$I$$20240408$20240710$20240710$PER$$IN-ROCHE-3544969$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$IN$IN
240696111$24069611$1$I$$20240305$20240710$20240710$PER$$US-ROCHE-3522554$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240696121$24069612$1$I$20240226$20240409$20240710$20240710$PER$$JP-ROCHE-3559475$ROCHE$$5$DEC$A$F$Y$$$20240628$$PH$JP$JP
240696131$24069613$1$I$$20240215$20240710$20240710$PER$$JP-ROCHE-3515507$ROCHE$$9$DEC$E$F$Y$$$20240628$$MD$JP$JP
240696141$24069614$1$I$$20230705$20240710$20240710$PER$$IN-ROCHE-3385224$ROCHE$$32$YR$A$F$Y$$$20240628$$MD$IN$IN
240696151$24069615$1$I$$20230825$20240710$20240710$PER$$PH-ROCHE-3362408$ROCHE$$57$YR$A$F$Y$$$20240628$$CN$PH$PH
240696161$24069616$1$I$$20240207$20240710$20240710$PER$$JP-ROCHE-3512579$ROCHE$$9$DEC$E$F$Y$$$20240628$$MD$JP$JP
240696171$24069617$1$I$$20240429$20240710$20240710$PER$$RO-ROCHE-3556650$ROCHE$$62$YR$A$F$Y$56$KG$20240628$$CN$RO$RO
240696191$24069619$1$I$$20240503$20240710$20240710$PER$$US-ROCHE-3558377$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240696202$24069620$2$F$20220705$20240506$20240710$20240710$PER$$AT-ROCHE-3266462$ROCHE$$69$YR$E$M$Y$51$KG$20240628$$MD$AT$AT
240696211$24069621$1$I$$20240416$20240710$20240710$PER$$MY-ROCHE-3546940$ROCHE$$38$YR$A$M$Y$$$20240628$$CN$MY$MY
240696221$24069622$1$I$$20240523$20240710$20240710$PER$$IN-ROCHE-3570250$ROCHE$$55$YR$A$M$Y$$$20240628$$CN$IN$IN
240696231$24069623$1$I$$20231212$20240710$20240710$PER$$US-ROCHE-3475258$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$US$US
240696241$24069624$1$I$$20240330$20240710$20240710$PER$$IN-ROCHE-3538278$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IN$IN
240696251$24069625$1$I$$20231222$20240710$20240710$PER$$IN-ROCHE-3481492$ROCHE$$70$YR$E$F$Y$$$20240628$$MD$IN$IN
240696261$24069626$1$I$20211121$20240207$20240710$20240710$PER$$CN-ROCHE-3290502$ROCHE$$79$YR$E$M$Y$60$KG$20240628$$MD$CN$CN
240696271$24069627$1$I$$20240527$20240710$20240710$PER$$AU-ROCHE-3571285$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$AU$AU
240696281$24069628$1$I$$20240404$20240710$20240710$PER$$IN-ROCHE-3541472$ROCHE$$64$YR$A$F$Y$$$20240628$$MD$IN$IN
240696301$24069630$1$I$$20240303$20240710$20240710$PER$$IN-ROCHE-3521856$ROCHE$$78$YR$E$F$Y$$$20240628$$CN$IN$IN
240696311$24069631$1$I$20240412$20240417$20240710$20240710$PER$$JP-ROCHE-3559818$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240696321$24069632$1$I$20230922$20231207$20240710$20240710$PER$IT-MINISAL02-958004$IT-ROCHE-3471529$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IT$IT
240696332$24069633$2$F$$20240510$20240710$20240710$PER$$ES-ROCHE-3563020$ROCHE$$$$$$Y$$$20240628$$MD$ES$ES
240696341$24069634$1$I$$20230705$20240710$20240710$PER$$IN-ROCHE-3358256$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$IN$IN
240696351$24069635$1$I$20231207$20231214$20240710$20240710$PER$$JP-ROCHE-3479469$ROCHE$$77$YR$E$F$Y$$$20240628$$PH$JP$JP
240696361$24069636$1$I$20240101$20240514$20240710$20240710$PER$$US-ROCHE-3564558$ROCHE$$$$E$F$Y$54.43$KG$20240628$$CN$US$US
240696371$24069637$1$I$$20240328$20240710$20240710$PER$$RO-ROCHE-3537311$ROCHE$$46$YR$A$F$Y$52$KG$20240628$$CN$RO$RO
240696381$24069638$1$I$$20240527$20240710$20240710$PER$$JP-ROCHE-3576001$ROCHE$$7$DEC$E$M$Y$$$20240628$$MD$JP$JP
240696391$24069639$1$I$$20231027$20240710$20240710$PER$$AE-ROCHE-3449726$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$AE$AE
240696401$24069640$1$I$$20240515$20240710$20240710$PER$$JP-ROCHE-3570699$ROCHE$$7$DEC$E$F$Y$$$20240628$$PH$JP$JP
240696411$24069641$1$I$$20240222$20240710$20240710$PER$$JP-ROCHE-3521998$ROCHE$$$$$F$Y$$$20240628$$PH$JP$JP
240696421$24069642$1$I$$20240229$20240710$20240710$PER$$DE-ROCHE-3519439$ROCHE$$50$YR$A$F$Y$$$20240628$$CN$DE$DE
240696431$24069643$1$I$$20240509$20240710$20240710$PER$$KR-ROCHE-3562218$ROCHE$$58$YR$A$M$Y$$$20240628$$CN$KR$KR
240696441$24069644$1$I$$20231005$20240710$20240710$PER$$IN-ROCHE-3436164$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IN$IN
240696451$24069645$1$I$$20240502$20240710$20240710$PER$$US-ROCHE-3289128$ROCHE$$82$YR$E$F$Y$$$20240628$$MD$US$US
240696461$24069646$1$I$$20240507$20240710$20240710$PER$$US-ROCHE-3561102$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240696471$24069647$1$I$$20231215$20240710$20240710$PER$$IN-ROCHE-3479194$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$IN$IN
240696481$24069648$1$I$$20240407$20240710$20240710$PER$$CN-ROCHE-3540901$ROCHE$$73$YR$E$M$Y$$$20240628$$CN$CN$CN
240696491$24069649$1$I$$20231122$20240710$20240710$PER$$US-ROCHE-3463465$ROCHE$$73$YR$E$M$Y$$$20240628$$HP$US$US
240696501$24069650$1$I$$20240223$20240710$20240710$PER$$US-ROCHE-2649223$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$US$US
240696511$24069651$1$I$$20240528$20240710$20240710$PER$$PH-ROCHE-3574488$ROCHE$$80$YR$E$F$Y$$$20240628$$CN$PH$PH
240696531$24069653$1$I$$20240403$20240710$20240710$PER$$IN-ROCHE-3541718$ROCHE$$62$YR$A$M$Y$$$20240628$$CN$IN$IN
240696541$24069654$1$I$$20240708$20240710$20240710$PER$$US-JNJFOC-20240718041$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240696551$24069655$1$I$20240328$20240403$20240710$20240710$PER$$JP-ROCHE-3557693$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240696561$24069656$1$I$$20240520$20240710$20240710$PER$$US-ROCHE-3567442$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$US$US
240696571$24069657$1$I$$20240229$20240710$20240710$PER$$US-ROCHE-2589266$ROCHE$$80$YR$E$F$Y$$$20240628$$CN$US$US
240696581$24069658$1$I$$20240605$20240710$20240710$PER$$CA-ROCHE-3578370$ROCHE$$84$YR$E$F$Y$$$20240628$$CN$CA$CA
240696591$24069659$1$I$$20240508$20240710$20240710$PER$$IN-ROCHE-3560565$ROCHE$$80$YR$E$M$Y$$$20240628$$CN$IN$IN
240696601$24069660$1$I$$20240510$20240710$20240710$PER$$CH-ROCHE-3563175$ROCHE$$$$A$F$Y$$$20240628$$MD$CH$CH
240696611$24069661$1$I$20231201$20240709$20240710$20240710$PER$$US-JNJFOC-20240722982$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240710$$CN$US$US
240696621$24069662$1$I$20240101$20240529$20240710$20240710$PER$$JP-ROCHE-3576041$ROCHE$$$$E$M$Y$$$20240628$$MD$JP$JP
240696632$24069663$2$F$$20240215$20240710$20240710$PER$$US-ROCHE-3510002$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240696641$24069664$1$I$$20240520$20240710$20240710$PER$$HK-ROCHE-3569380$ROCHE$$$$A$F$Y$$$20240628$$CN$HK$HK
240696653$24069665$3$F$20220812$20240604$20240710$20240710$PER$$ES-ROCHE-3174768$ROCHE$$69$YR$E$$Y$$$20240628$$MD$ES$ES
240696661$24069666$1$I$$20240313$20240710$20240710$PER$$IN-ROCHE-3528472$ROCHE$$45$YR$A$F$Y$$$20240628$$CN$IN$IN
240696673$24069667$3$F$$20240905$20240710$20240911$EXP$$US-ROCHE-3544931$ROCHE$$73$YR$E$F$Y$$$20240911$$CN$US$US
240696682$24069668$2$F$20240318$20240604$20240710$20240710$PER$$IN-ROCHE-3532067$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$IN$IN
240696691$24069669$1$I$$20240111$20240710$20240710$PER$$RO-ROCHE-3492585$ROCHE$$71$YR$E$F$Y$60$KG$20240628$$CN$RO$RO
240696701$24069670$1$I$20230925$20231018$20240710$20240710$PER$$LB-ROCHE-3444467$ROCHE$$$$$F$Y$$$20240628$$MD$LB$LB
240696711$24069671$1$I$20240201$20240220$20240710$20240710$PER$$JP-ROCHE-3516187$ROCHE$$50$YR$A$F$Y$$$20240628$$MD$JP$JP
240696721$24069672$1$I$$20240503$20240710$20240710$PER$$FR-ROCHE-3559674$ROCHE$$73$YR$E$F$Y$$$20240628$$PH$FR$FR
240696732$24069673$2$F$$20240507$20240710$20240710$PER$$FR-ROCHE-3562246$ROCHE$$$$$F$Y$$$20240628$$MD$FR$FR
240696741$24069674$1$I$20231016$20231229$20240710$20240710$PER$NO-NOMAADVRE-RELISSO-2023-V46gmr$NO-ROCHE-3483422$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$NO$NO
240696751$24069675$1$I$$20231222$20240710$20240710$PER$$CN-ROCHE-3482512$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$CN$CN
240696762$24069676$2$F$20230918$20240411$20240710$20240710$PER$$CN-ROCHE-3519748$ROCHE$$41$YR$A$F$Y$72$KG$20240628$$MD$CN$CN
240696773$24069677$3$F$$20240318$20240710$20240710$PER$$IN-ROCHE-3501514$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$IN$IN
240696782$24069678$2$F$$20230721$20240710$20240710$PER$$IN-ROCHE-3374407$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$IN$IN
240696792$24069679$2$F$20230909$20240502$20240710$20240710$PER$$CZ-ROCHE-3467192$ROCHE$$45$YR$A$M$Y$$$20240628$$MD$CZ$CZ
240696801$24069680$1$I$$20240220$20240710$20240710$PER$$PH-ROCHE-3515168$ROCHE$$65$YR$E$F$Y$55$KG$20240628$$CN$PH$PH
240696811$24069681$1$I$$20230922$20240710$20240710$PER$$PH-ROCHE-3429316$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$PH$PH
240696821$24069682$1$I$$20240424$20240710$20240710$PER$$RO-ROCHE-3554278$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$RO$RO
240696831$24069683$1$I$20230215$20240325$20240710$20240710$PER$$KR-ROCHE-3533188$ROCHE$$44$YR$A$F$Y$$$20240628$$HP$KR$KR
240696841$24069684$1$I$$20240530$20240710$20240710$PER$$US-ROCHE-3574522$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$US$US
240696851$24069685$1$I$20221020$20240325$20240710$20240710$PER$$KR-ROCHE-3533248$ROCHE$$64$YR$A$F$Y$$$20240628$$PH$KR$KR
240696861$24069686$1$I$20240130$20240312$20240710$20240710$PER$$CN-ROCHE-3525684$ROCHE$$40$YR$A$M$Y$74$KG$20240628$$MD$CN$CN
240696871$24069687$1$I$20240405$20240517$20240710$20240710$PER$$US-ROCHE-3566625$ROCHE$$88$YR$E$F$Y$$$20240628$$CN$US$US
240696881$24069688$1$I$$20240506$20240710$20240710$PER$$IN-ROCHE-3559343$ROCHE$$57$YR$A$F$Y$$$20240628$$CN$IN$IN
240696891$24069689$1$I$$20231114$20240710$20240710$PER$$ES-ROCHE-3458706$ROCHE$$$$A$F$Y$77$KG$20240628$$MD$ES$ES
240696901$24069690$1$I$20230703$20240424$20240710$20240710$PER$$TR-ROCHE-3553376$ROCHE$$69$YR$E$M$Y$87$KG$20240628$$MD$TR$TR
240696911$24069691$1$I$20240206$20240219$20240710$20240710$PER$$JP-ROCHE-3517101$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240696921$24069692$1$I$$20240524$20240710$20240710$PER$$ZA-ROCHE-3571146$ROCHE$$84$YR$E$F$Y$$$20240628$$MD$ZA$ZA
240696932$24069693$2$F$20240623$20240705$20240710$20240716$EXP$$IN-ROCHE-3529280$ROCHE$$57$YR$A$M$Y$$$20240716$$CN$IN$IN
240696941$24069694$1$I$$20231202$20240710$20240710$PER$$IN-ROCHE-3471780$ROCHE$$40$YR$A$F$Y$$$20240628$$MD$IN$IN
240696951$24069695$1$I$$20240610$20240710$20240710$PER$$US-ROCHE-3579775$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240696961$24069696$1$I$$20240207$20240710$20240710$PER$$US-ROCHE-3508596$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$US$US
240696971$24069697$1$I$$20231003$20240710$20240710$PER$$IN-ROCHE-3433593$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240696981$24069698$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3526158$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240696991$24069699$1$I$$20240403$20240710$20240710$PER$$JP-ROCHE-3556169$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240697001$24069700$1$I$20240213$20240402$20240710$20240710$PER$$ES-ROCHE-3538166$ROCHE$$59$YR$A$$Y$$$20240628$$MD$ES$ES
240697011$24069701$1$I$$20240524$20240710$20240710$PER$$ZA-ROCHE-3572183$ROCHE$$$$E$F$Y$$$20240628$$MD$ZA$ZA
240697021$24069702$1$I$$20230814$20240710$20240710$PER$$IN-ROCHE-3406867$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$IN$IN
240697032$24069703$2$F$$20240418$20240710$20240710$PER$$JP-ROCHE-3513299$ROCHE$Okura C, Morimoto C, Shimamura Y, Ueki Y, Tsukamoto S, Funauchi A et al A case of ALK fusion gene mutation-positive lung adenocarcinoma with acute pericarditis during the use of ALK tyrosine-kinase inhibitor (ALK-TKI). [Abstract number: O-3-4].. Joint Meeting of the 102nd Kinki Regional Meeting of the Japanese Respiratory So. 2024;79:-.$53$YR$A$F$Y$$$20240628$$MD$JP$JP
240697041$24069704$1$I$$20240425$20240710$20240710$PER$$GB-ROCHE-3554290$ROCHE$$85$YR$E$F$Y$$$20240628$$HP$GB$GB
240697051$24069705$1$I$$20240524$20240710$20240710$PER$$JP-ROCHE-3575186$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240697061$24069706$1$I$20230901$20240116$20240710$20240710$PER$$US-ROCHE-3493605$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240697071$24069707$1$I$$20230824$20240710$20240710$PER$$RO-ROCHE-3411712$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240697081$24069708$1$I$20240423$20240521$20240710$20240710$PER$$JP-ROCHE-3573916$ROCHE$$$$A$F$Y$$$20240628$$PH$JP$JP
240697091$24069709$1$I$$20240510$20240710$20240710$PER$$JP-ROCHE-3569615$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240697102$24069710$2$F$$20230727$20240710$20240710$PER$$IN-ROCHE-3386946$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IN$IN
240697111$24069711$1$I$$20230714$20240710$20240710$PER$$US-ROCHE-3083740$ROCHE$$84$YR$E$M$Y$$$20240628$$CN$US$US
240697121$24069712$1$I$$20231122$20240710$20240710$PER$$IL-ROCHE-3463700$ROCHE$$$$A$F$Y$$$20240628$$CN$IL$IL
240697131$24069713$1$I$20240419$20240420$20240710$20240710$PER$$IN-ROCHE-3553087$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$IN$IN
240697141$24069714$1$I$20240501$20240521$20240710$20240710$PER$$JP-ROCHE-3573528$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240697151$24069715$1$I$20231221$20240320$20240710$20240710$PER$$RS-ROCHE-3530664$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$RS$RS
240697163$24069716$3$F$20240405$20240506$20240710$20240710$PER$$IN-ROCHE-3543518$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$IN$IN
240697171$24069717$1$I$$20240412$20240710$20240710$PER$$JP-ROCHE-3559191$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240697181$24069718$1$I$20230516$20240124$20240710$20240710$PER$$IT-ROCHE-3498523$ROCHE$$47$YR$A$F$Y$54$KG$20240628$$MD$IT$IT
240697191$24069719$1$I$$20240228$20240710$20240710$PER$$GB-ROCHE-3564181$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240697201$24069720$1$I$20240227$20240323$20240710$20240710$PER$$DK-ROCHE-3534933$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$DK$DK
240697211$24069721$1$I$20240423$20240429$20240710$20240710$PER$$US-ROCHE-3555450$ROCHE$$63$YR$A$M$Y$$$20240628$$CN$US$US
240697221$24069722$1$I$$20240506$20240710$20240710$PER$$IN-ROCHE-3558677$ROCHE$$71$YR$E$M$Y$$$20240628$$CN$IN$IN
240697231$24069723$1$I$$20230724$20240710$20240710$PER$$US-ROCHE-3393645$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$US$US
240697241$24069724$1$I$$20240503$20240710$20240710$PER$$US-ROCHE-3558774$ROCHE$$35$YR$A$M$Y$$$20240628$$MD$US$US
240697251$24069725$1$I$20230727$20230914$20240710$20240710$PER$$RS-ROCHE-3423359$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$RS$RS
240697261$24069726$1$I$$20240509$20240710$20240710$PER$$ES-ROCHE-3563714$ROCHE$$$$A$F$Y$84$KG$20240628$$MD$ES$ES
240697271$24069727$1$I$20220119$20231128$20240710$20240710$PER$$TR-ROCHE-3011398$ROCHE$$54$YR$A$F$Y$75$KG$20240628$$MD$TR$TR
240697291$24069729$1$I$20240418$20240424$20240710$20240710$PER$$JP-ROCHE-3563431$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240697301$24069730$1$I$$20240412$20240710$20240710$PER$$IN-ROCHE-3547417$ROCHE$$88$YR$E$F$Y$$$20240628$$CN$IN$IN
240697311$24069731$1$I$$20230731$20240710$20240710$PER$$IN-ROCHE-3398002$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240697322$24069732$2$F$$20231026$20240710$20240710$PER$$GB-ROCHE-3434348$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240697333$24069733$3$F$20240108$20240520$20240710$20240710$PER$$IN-ROCHE-3566615$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$IN$IN
240697351$24069735$1$I$20240411$20240419$20240710$20240710$PER$$IN-ROCHE-3551666$ROCHE$$58$YR$A$M$Y$$$20240628$$CN$IN$IN
240697361$24069736$1$I$$20240606$20240710$20240710$PER$$IN-ROCHE-3265058$ROCHE$$64$YR$A$F$Y$$$20240628$$MD$IN$IN
240697371$24069737$1$I$20230914$20231013$20240710$20240710$PER$$CN-ROCHE-3441761$ROCHE$$45$YR$A$M$Y$$$20240628$$HP$CN$CN
240697381$24069738$1$I$20240318$20240318$20240710$20240710$PER$$JP-ROCHE-3546460$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240697391$24069739$1$I$20240428$20240508$20240710$20240710$PER$$US-ROCHE-3560969$ROCHE$$$$E$F$Y$$$20240628$$MD$US$US
240697401$24069740$1$I$20230907$20230928$20240710$20240710$PER$$CN-ROCHE-3431594$ROCHE$$65$YR$E$M$Y$60$KG$20240628$$HP$CN$CN
240697411$24069741$1$I$$20230629$20240710$20240710$PER$$US-ROCHE-3381254$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240697422$24069742$2$F$20240227$20240408$20240710$20240710$PER$$JP-ROCHE-3532868$ROCHE$$$$E$F$Y$$$20240628$$PH$JP$JP
240697431$24069743$1$I$$20240404$20240710$20240710$PER$$IN-ROCHE-3542012$ROCHE$$56$YR$A$F$Y$$$20240628$$CN$IN$IN
240697441$24069744$1$I$$20240523$20240710$20240710$PER$$CA-ROCHE-3570161$ROCHE$$$$E$M$Y$$$20240628$$CN$CA$CA
240697451$24069745$1$I$20240301$20240429$20240710$20240710$PER$$FR-ROCHE-3557384$ROCHE$$82$YR$E$F$Y$$$20240628$$MD$FR$FR
240697462$24069746$2$F$20240401$20240515$20240710$20240710$PER$$JP-ROCHE-3559282$ROCHE$$5$DEC$A$F$Y$$$20240628$$PH$JP$JP
240697471$24069747$1$I$$20230706$20240710$20240710$PER$$US-ROCHE-3384095$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$US$US
240697481$24069748$1$I$$20230711$20240710$20240710$PER$$CU-ROCHE-3388782$ROCHE$$$$$$Y$$$20240628$$CN$CU$CU
240697491$24069749$1$I$$20240110$20240710$20240710$PER$$US-ROCHE-3490054$ROCHE$$31$YR$A$F$Y$$$20240628$$CN$US$US
240697501$24069750$1$I$$20240510$20240710$20240710$PER$$IN-ROCHE-3561907$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$IN$IN
240697511$24069751$1$I$$20240405$20240710$20240710$PER$$JP-ROCHE-3556232$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240697521$24069752$1$I$20220324$20231205$20240710$20240710$PER$$ES-ROCHE-3470429$ROCHE$$73$YR$E$$Y$$$20240628$$MD$ES$ES
240697531$24069753$1$I$20240418$20240511$20240710$20240710$PER$$CN-ROCHE-3562639$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$CN$CN
240697541$24069754$1$I$$20230808$20240710$20240710$PER$$PT-ROCHE-3403714$ROCHE$$$$$$Y$$$20240628$$PH$PT$PT
240697551$24069755$1$I$$20231018$20240710$20240710$PER$$MX-ROCHE-3211412$ROCHE$$46$YR$A$F$Y$$$20240628$$CN$MX$MX
240697562$24069756$2$F$$20240415$20240710$20240710$PER$$CN-ROCHE-3546613$ROCHE$$60$YR$A$M$Y$$$20240628$$CN$CN$CN
240697571$24069757$1$I$$20240516$20240710$20240710$PER$$US-ROCHE-3565715$ROCHE$$$$$M$Y$$$20240628$$CN$US$US
240697581$24069758$1$I$20231215$20231215$20240710$20240710$PER$$JP-ROCHE-3480274$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240697591$24069759$1$I$20210901$20230901$20240710$20240710$PER$$TR-ROCHE-3319035$ROCHE$$$$A$M$Y$88$KG$20240628$$MD$TR$TR
240697601$24069760$1$I$$20240402$20240710$20240710$PER$$JP-ROCHE-3553667$ROCHE$$7$DEC$E$$Y$$$20240628$$MD$JP$JP
240697611$24069761$1$I$$20240201$20240710$20240710$PER$$PH-ROCHE-3502996$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$PH$PH
240697631$24069763$1$I$$20230809$20240710$20240710$PER$$IN-ROCHE-3403431$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$IN$IN
240697651$24069765$1$I$$20240326$20240710$20240710$PER$$JP-ROCHE-3550841$ROCHE$$61$YR$A$F$Y$$$20240628$$PH$JP$JP
240697661$24069766$1$I$$20240423$20240710$20240710$PER$$GB-ROCHE-3552107$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240697684$24069768$4$F$20230706$20240423$20240710$20240710$PER$$AU-ROCHE-3395187$ROCHE$$78$YR$E$F$Y$$$20240628$$MD$AU$AU
240697691$24069769$1$I$$20240411$20240710$20240710$PER$$US-ROCHE-3544936$ROCHE$$47$YR$A$M$Y$$$20240628$$CN$US$US
240697701$24069770$1$I$20240228$20240305$20240710$20240710$PER$$JP-ROCHE-3536691$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240697712$24069771$2$F$20230831$20231227$20240710$20240710$PER$$CO-ROCHE-3447734$ROCHE$$70$YR$E$M$Y$54.1$KG$20240628$$MD$CO$CO
240697721$24069772$1$I$20240424$20240426$20240710$20240710$PER$$US-ROCHE-3554622$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$US$US
240697731$24069773$1$I$$20231129$20240710$20240710$PER$$TH-ROCHE-3467859$ROCHE$$59$YR$A$F$Y$$$20240628$$HP$TH$TH
240697751$24069775$1$I$20220923$20240318$20240710$20240710$PER$$KR-ROCHE-3529651$ROCHE$$70$YR$E$M$Y$$$20240628$$HP$KR$KR
240697761$24069776$1$I$$20230920$20240710$20240710$PER$$IN-ROCHE-3428045$ROCHE$$58$YR$A$M$Y$$$20240628$$MD$IN$IN
240697771$24069777$1$I$20231105$20231107$20240710$20240710$PER$$CN-ROCHE-3453580$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$CN$CN
240697781$24069778$1$I$$20240130$20240710$20240710$PER$$US-ROCHE-3502067$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$US$US
240697801$24069780$1$I$$20240528$20240710$20240710$PER$$IN-ROCHE-3572285$ROCHE$$59$YR$A$M$Y$$$20240628$$CN$IN$IN
240697811$24069781$1$I$20240321$20240523$20240710$20240710$PER$$IN-ROCHE-3569984$ROCHE$$51$YR$A$F$Y$$$20240628$$CN$IN$IN
240697822$24069782$2$F$$20240610$20240710$20240710$PER$$ES-ROCHE-3571374$ROCHE$$$$$F$Y$$$20240628$$MD$ES$ES
240697831$24069783$1$I$$20240506$20240710$20240710$PER$$PE-ROCHE-3559722$ROCHE$$$$$F$Y$$$20240628$$CN$PE$PE
240697841$24069784$1$I$$20240222$20240710$20240710$PER$$JP-ROCHE-3522047$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240697851$24069785$1$I$$20240104$20240710$20240710$PER$$IN-ROCHE-3486556$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$IN$IN
240697871$24069787$1$I$$20230801$20240710$20240710$PER$$MX-ROCHE-3399535$ROCHE$$$$$F$Y$$$20240628$$CN$MX$MX
240697881$24069788$1$I$$20231229$20240710$20240710$PER$IT-MINISAL02-962171$IT-ROCHE-3483447$ROCHE$$60$YR$A$F$Y$$$20240628$$PH$IT$IT
240697891$24069789$1$I$$20240520$20240710$20240710$PER$$SE-ROCHE-3567938$ROCHE$$$$$$Y$$$20240628$$MD$SE$SE
240697902$24069790$2$F$20231219$20240103$20240710$20240710$PER$$US-ROCHE-3484372$ROCHE$$74$YR$E$F$Y$$$20240628$$MD$US$US
240697911$24069791$1$I$$20240226$20240710$20240710$PER$$JP-ROCHE-3524506$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$JP$JP
240697921$24069792$1$I$$20240415$20240710$20240710$PER$$IN-ROCHE-3548455$ROCHE$$71$YR$E$M$Y$$$20240628$$CN$IN$IN
240697931$24069793$1$I$20240115$20240130$20240710$20240710$PER$$JP-ROCHE-3509168$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240697941$24069794$1$I$$20240301$20240710$20240710$PER$$GB-ROCHE-3563094$ROCHE$$$$$$Y$$$20240628$$MD$GB$GB
240697951$24069795$1$I$$20240530$20240710$20240710$PER$$AU-ROCHE-3573346$ROCHE$$$$$$Y$$$20240628$$CN$AU$AU
240697961$24069796$1$I$20240101$20240327$20240710$20240710$PER$$CA-ROCHE-3534820$ROCHE$$78$YR$E$M$Y$$$20240628$$CN$CA$CA
240697982$24069798$2$F$20230217$20231201$20240710$20240710$PER$$IT-ROCHE-3469519$ROCHE$$67$YR$E$F$Y$68.4$KG$20240628$$MD$IT$IT
240697991$24069799$1$I$$20240529$20240710$20240710$PER$$KR-ROCHE-3573678$ROCHE$$50$YR$A$M$Y$$$20240628$$CN$KR$KR
240698001$24069800$1$I$$20240213$20240710$20240710$PER$$JP-ROCHE-3515546$ROCHE$$$$$F$Y$$$20240628$$CN$JP$JP
240698011$24069801$1$I$$20240327$20240710$20240710$PER$$IT-ROCHE-3535904$ROCHE$$$$$$Y$$$20240628$$MD$IT$IT
240698021$24069802$1$I$$20240119$20240710$20240710$PER$$JP-ROCHE-3500220$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240698031$24069803$1$I$$20240708$20240710$20240710$EXP$$US-UCBSA-2024034695$UCB$$$$$F$Y$$$20240710$$HP$US$US
240698041$24069804$1$I$$20230816$20240710$20240710$PER$$JP-ROCHE-3407564$ROCHE$$72$YR$E$F$Y$43$KG$20240628$$MD$JP$JP
240698052$24069805$2$F$20240412$20240418$20240710$20240710$PER$$IN-ROCHE-3547490$ROCHE$$57$YR$A$M$Y$$$20240628$$CN$IN$IN
240698061$24069806$1$I$$20240213$20240710$20240710$PER$$JP-ROCHE-3514083$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240698071$24069807$1$I$$20240513$20240710$20240710$PER$$KR-ROCHE-3563828$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$KR$KR
240698081$24069808$1$I$$20240401$20240710$20240710$PER$$JP-ROCHE-3552799$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240698091$24069809$1$I$20230503$20230911$20240710$20240710$PER$FR-AFSSAPS-CN2023000806$FR-ROCHE-3420202$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$FR$FR
240698101$24069810$1$I$20220512$20240227$20240710$20240710$PER$$AU-ROCHE-3173817$ROCHE$$73$YR$E$F$Y$83$KG$20240628$$MD$AU$AU
240698111$24069811$1$I$$20240322$20240710$20240710$PER$$JP-ROCHE-3548428$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240698121$24069812$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142296$NOVARTIS$$$$$M$Y$$$20240710$$PH$US$US
240698131$24069813$1$I$$20230906$20240710$20240710$PER$$CN-ROCHE-3418376$ROCHE$$79$YR$E$F$Y$$$20240628$$CN$CN$CN
240698141$24069814$1$I$20240118$20240119$20240710$20240710$PER$$JP-ROCHE-3499170$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240698151$24069815$1$I$$20240514$20240710$20240710$PER$$JP-ROCHE-3570615$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240698161$24069816$1$I$20240312$20240313$20240710$20240710$PER$$EG-ROCHE-3528062$ROCHE$$$$A$F$Y$$$20240628$$CN$EG$EG
240698171$24069817$1$I$$20240314$20240710$20240710$PER$$JP-ROCHE-3544749$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240698181$24069818$1$I$$20231104$20240710$20240710$PER$$IN-ROCHE-3452989$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$IN$IN
240698191$24069819$1$I$20240503$20240506$20240710$20240710$PER$$DE-ROCHE-3560258$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$DE$DE
240698201$24069820$1$I$$20230830$20240710$20240710$PER$$DK-ROCHE-3414935$ROCHE$$$$$$Y$$$20240628$$PH$DK$DK
240698211$24069821$1$I$$20240314$20240710$20240710$PER$$IN-ROCHE-3527377$ROCHE$$$$$F$Y$$$20240628$$MD$IN$IN
240698221$24069822$1$I$$20240405$20240710$20240710$PER$$US-ROCHE-3541555$ROCHE$$$$$F$Y$$$20240628$$PH$US$US
240698231$24069823$1$I$20240221$20240308$20240710$20240710$PER$$TR-ROCHE-3524709$ROCHE$$39$YR$A$M$Y$72$KG$20240628$$MD$TR$TR
240698241$24069824$1$I$20240322$20240410$20240710$20240710$PER$$JP-ROCHE-3559458$ROCHE$$$$E$$Y$$$20240628$$MD$JP$JP
240698251$24069825$1$I$20240514$20240514$20240710$20240710$PER$$IN-ROCHE-3564218$ROCHE$$46$YR$A$F$Y$$$20240628$$CN$IN$IN
240698262$24069826$2$F$$20240415$20240710$20240710$PER$$US-ROCHE-3546616$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240698271$24069827$1$I$$20230823$20240710$20240710$PER$$IN-ROCHE-3410922$ROCHE$$41$YR$A$F$Y$$$20240628$$MD$IN$IN
240698281$24069828$1$I$$20240531$20240710$20240710$PER$$US-ROCHE-3575407$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$US$US
240698291$24069829$1$I$$20231208$20240710$20240710$PER$$IN-ROCHE-3374990$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$IN$IN
240698301$24069830$1$I$$20231127$20240710$20240710$PER$$US-ROCHE-3465759$ROCHE$$36$YR$A$M$Y$$$20240628$$CN$US$US
240698312$24069831$2$F$$20240521$20240710$20240710$PER$$ES-ROCHE-3568699$ROCHE$$$$$$Y$$$20240628$$MD$ES$ES
240698322$24069832$2$F$$20240606$20240710$20240710$PER$$US-ROCHE-3578806$ROCHE$$49$YR$A$M$Y$$$20240628$$MD$US$US
240698333$24069833$3$F$$20230918$20240710$20240710$PER$$IN-ROCHE-3372787$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240698343$24069834$3$F$20230501$20230727$20240710$20240710$PER$$CN-ROCHE-3367861$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$CN$CN
240698351$24069835$1$I$20240530$20240603$20240710$20240710$PER$$CA-ROCHE-3576180$ROCHE$$80$YR$E$F$Y$$$20240628$$CN$CA$CA
240698361$24069836$1$I$$20231116$20240710$20240710$PER$$IN-ROCHE-3372603$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$IN$IN
240698371$24069837$1$I$$20231109$20240710$20240710$PER$$IL-ROCHE-3456355$ROCHE$$$$A$M$Y$$$20240628$$CN$IL$IL
240698381$24069838$1$I$$20240605$20240710$20240710$PER$$US-ROCHE-3578879$ROCHE$$$$E$F$Y$$$20240628$$HP$US$US
240698392$24069839$2$F$$20240514$20240710$20240710$PER$$US-ROCHE-3544817$ROCHE$$81$YR$E$M$Y$$$20240628$$MD$US$US
240698401$24069840$1$I$$20240429$20240710$20240710$PER$$US-ROCHE-3555866$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240698411$24069841$1$I$$20240528$20240710$20240710$PER$$ZA-ROCHE-3574208$ROCHE$$$$E$M$Y$$$20240628$$MD$ZA$ZA
240698422$24069842$2$F$$20240516$20240710$20240710$PER$$JP-ROCHE-3532900$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240698431$24069843$1$I$$20230803$20240710$20240710$PER$$US-ROCHE-3401765$ROCHE$$69$YR$E$F$Y$75.1$KG$20240628$$MD$US$US
240698441$24069844$1$I$20231019$20231229$20240710$20240710$PER$NO-NOMAADVRE-RELISSO-2023-V8dnaq$NO-ROCHE-3483411$ROCHE$$42$YR$A$F$Y$$$20240628$$HP$NO$NO
240698451$24069845$1$I$$20240315$20240710$20240710$PER$$RO-ROCHE-3528602$ROCHE$$42$YR$A$F$Y$60$KG$20240628$$CN$RO$RO
240698461$24069846$1$I$$20230911$20240710$20240710$PER$$JP-ROCHE-3421830$ROCHE$$7$DEC$E$M$Y$$$20240628$$MD$JP$JP
240698471$24069847$1$I$$20240219$20240710$20240710$PER$$ID-ROCHE-3512903$ROCHE$$43$YR$A$F$Y$$$20240628$$CN$ID$ID
240698481$24069848$1$I$20240220$20240227$20240710$20240710$PER$$TR-ROCHE-3517404$ROCHE$$78$YR$E$F$Y$$$20240628$$MD$TR$TR
240698501$24069850$1$I$$20240227$20240710$20240710$PER$$US-ROCHE-3517147$ROCHE$$81$YR$E$M$Y$$$20240628$$CN$US$US
240698511$24069851$1$I$$20230817$20240710$20240710$PER$$IN-ROCHE-3408344$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240698521$24069852$1$I$$20240522$20240710$20240710$PER$$IT-ROCHE-3571256$ROCHE$$$$$$Y$$$20240628$$MD$IT$IT
240698531$24069853$1$I$$20240202$20240710$20240710$PER$$ID-ROCHE-3503727$ROCHE$$52$YR$A$M$Y$$$20240628$$MD$ID$ID
240698541$24069854$1$I$$20240504$20240710$20240710$PER$$IN-ROCHE-3559855$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$IN$IN
240698551$24069855$1$I$20240319$20240321$20240710$20240710$PER$$JP-ROCHE-3549265$ROCHE$$9$DEC$E$F$Y$$$20240628$$HP$JP$JP
240698561$24069856$1$I$$20230705$20240710$20240710$PER$$CN-ROCHE-3383302$ROCHE$$$$$$Y$$$20240628$$CN$CN$CN
240698571$24069857$1$I$$20240105$20240710$20240710$PER$$CH-ROCHE-3487486$ROCHE$$$$A$$Y$$$20240628$$MD$CH$CH
240698581$24069858$1$I$$20240531$20240710$20240710$PER$$GB-ROCHE-3575466$ROCHE$$$$$$Y$$$20240628$$PH$GB$GB
240698591$24069859$1$I$$20231117$20240710$20240710$PER$$ES-ROCHE-3462194$ROCHE$$$$A$F$Y$51$KG$20240628$$MD$ES$ES
240698601$24069860$1$I$$20240525$20240710$20240710$PER$$PH-ROCHE-3573500$ROCHE$$80$YR$E$F$Y$$$20240628$$CN$PH$PH
240698611$24069861$1$I$$20240531$20240710$20240710$PER$$US-ROCHE-3575479$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$US$US
240698621$24069862$1$I$20240101$20240221$20240710$20240710$PER$$JP-ROCHE-3517944$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240698641$24069864$1$I$$20240314$20240710$20240710$PER$$US-ROCHE-3527821$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$US$US
240698651$24069865$1$I$$20240605$20240710$20240710$PER$$KR-ROCHE-3577638$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$KR$KR
240698661$24069866$1$I$$20231018$20240710$20240710$PER$$RO-ROCHE-3443863$ROCHE$$70$YR$E$M$Y$100$KG$20240628$$CN$RO$RO
240698671$24069867$1$I$$20240514$20240710$20240710$PER$$RO-ROCHE-3564706$ROCHE$$62$YR$A$F$Y$115$KG$20240628$$CN$RO$RO
240698681$24069868$1$I$$20240520$20240710$20240710$PER$$JP-ROCHE-3573183$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240698691$24069869$1$I$$20230810$20240710$20240710$PER$$US-ROCHE-3404409$ROCHE$$76$YR$E$F$Y$73.48$KG$20240628$$CN$US$US
240698701$24069870$1$I$$20230712$20240710$20240710$PER$$US-ROCHE-3387790$ROCHE$$$$E$F$Y$$$20240628$$CN$US$US
240698711$24069871$1$I$$20231121$20240710$20240710$PER$$ID-ROCHE-3464322$ROCHE$$$$$$Y$$$20240628$$MD$ID$ID
240698721$24069872$1$I$$20230814$20240710$20240710$PER$$CN-ROCHE-3228859$ROCHE$$34$YR$A$M$Y$72$KG$20240628$$CN$CN$CN
240698731$24069873$1$I$$20230807$20240710$20240710$PER$$PH-ROCHE-3404229$ROCHE$$62$YR$A$F$Y$64$KG$20240628$$CN$PH$PH
240698741$24069874$1$I$20230411$20230725$20240710$20240710$PER$FR-AFSSAPS-GR2023000999$FR-ROCHE-3393782$ROCHE$$70$YR$E$F$Y$70$KG$20240628$$MD$FR$FR
240698751$24069875$1$I$20240319$20240419$20240710$20240710$PER$$CN-ROCHE-3550235$ROCHE$$67$YR$E$M$Y$$$20240628$$CN$CN$CN
240698761$24069876$1$I$$20231028$20240710$20240710$PER$$IN-ROCHE-3451439$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240698771$24069877$1$I$$20240127$20240710$20240710$PER$$EG-ROCHE-3500412$ROCHE$$40$YR$A$M$Y$$$20240628$$CN$EG$EG
240698781$24069878$1$I$$20240221$20240710$20240710$PER$$AU-ROCHE-3513806$ROCHE$$12$YR$T$M$Y$42$KG$20240628$$MD$AU$AU
240698791$24069879$1$I$20240109$20240308$20240710$20240710$PER$$JP-ROCHE-3537621$ROCHE$$56$YR$A$F$Y$$$20240628$$MD$JP$JP
240698802$24069880$2$F$20240228$20240408$20240710$20240710$PER$$JP-ROCHE-3533096$ROCHE$$7$DEC$E$F$Y$$$20240628$$HP$JP$JP
240698811$24069881$1$I$$20240520$20240710$20240710$PER$$JP-ROCHE-3573119$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240698821$24069882$1$I$$20240507$20240710$20240710$PER$$CA-ROCHE-3560503$ROCHE$$$$E$M$Y$$$20240628$$CN$CA$CA
240698841$24069884$1$I$$20231229$20240710$20240710$PER$$US-ROCHE-3484070$ROCHE$$76$YR$E$M$Y$$$20240628$$CN$US$US
240698851$24069885$1$I$$20240408$20240710$20240710$PER$$JP-ROCHE-3559232$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240698861$24069886$1$I$$20240521$20240710$20240710$PER$$IN-ROCHE-3568517$ROCHE$$79$YR$E$F$Y$$$20240628$$CN$IN$IN
240698871$24069887$1$I$$20231031$20240710$20240710$PER$$US-ROCHE-3450487$ROCHE$$72$YR$E$F$Y$$$20240628$$HP$US$US
240698881$24069888$1$I$$20240429$20240710$20240710$PER$$PH-ROCHE-3555142$ROCHE$$69$YR$E$F$Y$48$KG$20240628$$CN$PH$PH
240698891$24069889$1$I$20231227$20240201$20240710$20240710$PER$$JP-ROCHE-3509801$ROCHE$$$$A$F$Y$$$20240628$$HP$JP$JP
240698901$24069890$1$I$$20240603$20240710$20240710$PER$$MX-ROCHE-3577563$ROCHE$$$$$$Y$$$20240628$$MD$MX$MX
240698911$24069891$1$I$$20240314$20240710$20240710$PER$$JP-ROCHE-3544108$ROCHE$$7$DEC$E$F$Y$$$20240628$$PH$JP$JP
240698921$24069892$1$I$20240419$20240422$20240710$20240710$PER$$JP-ROCHE-3561546$ROCHE$$7$DEC$E$F$Y$$$20240628$$HP$JP$JP
240698931$24069893$1$I$20220104$20240105$20240710$20240710$PER$$TR-ROCHE-2997891$ROCHE$$54$YR$A$F$Y$75$KG$20240628$$MD$TR$TR
240698941$24069894$1$I$$20240531$20240710$20240710$PER$$KR-ROCHE-3575278$ROCHE$$42$YR$A$F$Y$$$20240628$$CN$KR$KR
240698951$24069895$1$I$$20240518$20240710$20240710$PER$$US-ROCHE-3567041$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$US$US
240698962$24069896$2$F$20220610$20231127$20240710$20240710$PER$$CO-ROCHE-3465785$ROCHE$$66$YR$E$F$Y$64$KG$20240628$$MD$CO$CO
240698971$24069897$1$I$$20230831$20240710$20240710$PER$$US-ROCHE-3415745$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240698981$24069898$1$I$20240101$20240227$20240710$20240710$PER$$US-ROCHE-3518483$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240698991$24069899$1$I$$20240508$20240710$20240710$PER$$US-ROCHE-3561857$ROCHE$$$$A$F$Y$$$20240628$$HP$US$US
240699001$24069900$1$I$$20231207$20240710$20240710$PER$$IN-ROCHE-3473878$ROCHE$$41$YR$A$F$Y$$$20240628$$MD$IN$IN
240699011$24069901$1$I$$20240520$20240710$20240710$PER$$JP-ROCHE-3572973$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240699021$24069902$1$I$20240112$20240207$20240710$20240710$PER$$JP-ROCHE-3513305$ROCHE$$71$YR$E$M$Y$$$20240628$$PH$JP$JP
240699032$24069903$2$F$$20231028$20240710$20240710$PER$$IN-ROCHE-3355656$ROCHE$$55$YR$A$F$Y$66$KG$20240628$$MD$IN$IN
240699041$24069904$1$I$$20240424$20240710$20240710$PER$$RO-ROCHE-3555200$ROCHE$$$$A$M$Y$$$20240628$$MD$RO$RO
240699051$24069905$1$I$20231224$20240321$20240710$20240710$PER$$PT-ROCHE-3531291$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$PT$PT
240699071$24069907$1$I$$20240415$20240710$20240710$PER$$JP-ROCHE-3551619$ROCHE$$$$E$$Y$$$20240628$$MD$JP$JP
240699081$24069908$1$I$$20240524$20240710$20240710$PER$$RO-ROCHE-3571385$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240699091$24069909$1$I$20240522$20240524$20240710$20240710$PER$$IN-ROCHE-3570531$ROCHE$$62$YR$A$M$Y$$$20240628$$CN$IN$IN
240699102$24069910$2$F$$20230921$20240710$20240710$PER$$PH-ROCHE-3428371$ROCHE$$$$$$Y$$$20240628$$MD$PH$PH
240699111$24069911$1$I$20240124$20240124$20240710$20240710$PER$$JP-ROCHE-3503353$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240699121$24069912$1$I$$20240521$20240710$20240710$PER$$SE-ROCHE-3568423$ROCHE$$75$YR$E$F$Y$$$20240628$$CN$SE$SE
240699131$24069913$1$I$$20240426$20240710$20240710$PER$$IN-ROCHE-3556197$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$IN$IN
240699141$24069914$1$I$20230517$20231110$20240710$20240710$PER$$IT-ROCHE-3456726$ROCHE$$49$YR$A$F$Y$57$KG$20240628$$MD$IT$IT
240699151$24069915$1$I$$20240125$20240710$20240710$PER$$AE-ROCHE-3500493$ROCHE$$52$YR$A$F$Y$$$20240628$$HP$AE$AE
240699161$24069916$1$I$$20230718$20240710$20240710$PER$$IN-ROCHE-3391682$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$IN$IN
240699171$24069917$1$I$20150101$20240529$20240710$20240710$PER$$US-ROCHE-3500653$ROCHE$$68$YR$E$M$Y$127$KG$20240628$$CN$US$US
240699181$24069918$1$I$20240110$20240110$20240710$20240710$PER$$JP-ROCHE-3493975$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240699191$24069919$1$I$20240422$20240517$20240710$20240710$PER$$CN-ROCHE-3566818$ROCHE$$55$YR$A$M$Y$$$20240628$$CN$CN$CN
240699201$24069920$1$I$$20240517$20240710$20240710$PER$$JP-ROCHE-3573048$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240699212$24069921$2$F$$20230928$20240710$20240710$PER$$IN-ROCHE-3366410$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$IN$IN
240699221$24069922$1$I$$20240315$20240710$20240710$PER$$JP-ROCHE-3544893$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240699241$24069924$1$I$$20240417$20240710$20240710$PER$$JP-ROCHE-3559822$ROCHE$$9$DEC$E$F$Y$$$20240628$$MD$JP$JP
240699252$24069925$2$F$20240708$20240708$20240710$20240722$PER$$US-AMGEN-USASP2024135781$AMGEN$$70$YR$E$F$Y$$$20240722$$CN$US$US
240699261$24069926$1$I$$20231215$20240710$20240710$PER$$DE-ROCHE-3478561$ROCHE$$71$YR$E$F$Y$$$20240628$$PH$DE$DE
240699271$24069927$1$I$20200731$20231208$20240710$20240710$PER$$JP-ROCHE-3477436$ROCHE$$79$YR$E$M$Y$63$KG$20240628$$MD$JP$JP
240699281$24069928$1$I$$20240201$20240710$20240710$PER$$IN-ROCHE-3503616$ROCHE$$62$YR$A$F$Y$$$20240628$$CN$IN$IN
240699291$24069929$1$I$$20240603$20240710$20240710$PER$$IN-ROCHE-3578007$ROCHE$$$$$$Y$$$20240628$$CN$IN$IN
240699301$24069930$1$I$$20240417$20240710$20240710$PER$$US-ROCHE-3550691$ROCHE$$71$YR$E$M$Y$$$20240628$$CN$US$US
240699311$24069931$1$I$$20240321$20240710$20240710$PER$$JP-ROCHE-3548198$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240699321$24069932$1$I$20221124$20231124$20240710$20240710$PER$$RS-ROCHE-3354859$ROCHE$$69$YR$E$F$Y$66$KG$20240628$$MD$RS$RS
240699341$24069934$1$I$$20230703$20240710$20240710$PER$$IN-ROCHE-3257851$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$IN$IN
240699351$24069935$1$I$$20240415$20240710$20240710$PER$$JP-ROCHE-3560621$ROCHE$$$$E$$Y$$$20240628$$MD$JP$JP
240699362$24069936$2$F$$20230905$20240710$20240710$PER$$IN-ROCHE-3342246$ROCHE$$68$YR$E$F$Y$$$20240628$$MD$IN$IN
240699372$24069937$2$F$$20240318$20240710$20240710$PER$$HK-ROCHE-3528486$ROCHE$$$$A$F$Y$$$20240628$$CN$HK$HK
240699381$24069938$1$I$$20240515$20240710$20240710$PER$$CA-ROCHE-3564889$ROCHE$$$$$$Y$$$20240628$$MD$CA$CA
240699391$24069939$1$I$$20240525$20240710$20240710$PER$$IN-ROCHE-3573257$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$IN$IN
240699401$24069940$1$I$$20230825$20240710$20240710$PER$$US-ROCHE-3412337$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240699411$24069941$1$I$$20240404$20240710$20240710$PER$$JP-ROCHE-3557787$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240699422$24069942$2$F$$20231206$20240710$20240710$PER$$IT-ROCHE-3473157$ROCHE$$39$YR$A$F$Y$$$20240628$$MD$IT$IT
240699431$24069943$1$I$$20240226$20240710$20240710$PER$$IN-ROCHE-3518466$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$IN$IN
240699441$24069944$1$I$$20230721$20240710$20240710$PER$$IN-ROCHE-3393209$ROCHE$$60$YR$A$F$Y$$$20240628$$CN$IN$IN
240699451$24069945$1$I$$20230831$20240710$20240710$PER$$US-ROCHE-3352934$ROCHE$$75$YR$E$M$Y$$$20240628$$CN$US$US
240699463$24069946$3$F$20220920$20240423$20240710$20240710$PER$$AU-ROCHE-3210059$ROCHE$$44$YR$A$F$Y$127$KG$20240628$$MD$AU$AU
240699471$24069947$1$I$$20230703$20240710$20240710$PER$$IN-ROCHE-3382627$ROCHE$$39$YR$A$F$Y$$$20240628$$MD$IN$IN
240699481$24069948$1$I$$20240514$20240710$20240710$PER$$PH-ROCHE-3566463$ROCHE$$51$YR$A$F$Y$63$KG$20240628$$CN$PH$PH
240699491$24069949$1$I$$20230905$20240710$20240710$PER$$US-ROCHE-3417813$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240699501$24069950$1$I$20211224$20231122$20240710$20240710$PER$$IT-ROCHE-3463132$ROCHE$$45$YR$A$F$Y$63$KG$20240628$$MD$IT$IT
240699511$24069951$1$I$$20240526$20240710$20240710$PER$$GB-ROCHE-3571392$ROCHE$$32$YR$A$F$Y$$$20240628$$MD$GB$GB
240699521$24069952$1$I$$20240515$20240710$20240710$PER$$GB-ROCHE-3566496$ROCHE$$$$$$Y$$$20240628$$MD$GB$GB
240699531$24069953$1$I$20221101$20231018$20240710$20240710$PER$$CN-ROCHE-3328700$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$CN$CN
240699541$24069954$1$I$$20240408$20240710$20240710$PER$$JP-ROCHE-3559496$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240699561$24069956$1$I$$20240606$20240710$20240710$PER$$IN-ROCHE-3578214$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$IN$IN
240699571$24069957$1$I$$20240118$20240710$20240710$PER$$CH-ROCHE-3497123$ROCHE$$$$A$$Y$$$20240628$$MD$CH$CH
240699582$24069958$2$F$20230912$20240517$20240710$20240710$PER$$CA-ROCHE-3486633$ROCHE$$61$YR$A$F$Y$75$KG$20240628$$MD$CA$CA
240699591$24069959$1$I$$20230918$20240710$20240710$PER$$RO-ROCHE-3288261$ROCHE$$66$YR$E$F$Y$73$KG$20240628$$CN$RO$RO
240699601$24069960$1$I$$20230713$20240710$20240710$PER$$US-ROCHE-3388157$ROCHE$$$$$M$Y$$$20240628$$CN$US$US
240699611$24069961$1$I$20231020$20231024$20240710$20240710$PER$$CN-ROCHE-3445171$ROCHE$$80$YR$E$F$Y$$$20240628$$CN$CN$CN
240699621$24069962$1$I$$20240523$20240710$20240710$PER$$US-ROCHE-3571442$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240699632$24069963$2$F$$20230828$20240710$20240710$PER$$BR-ROCHE-3414996$ROCHE$$$$$F$Y$$$20240628$$MD$BR$BR
240699641$24069964$1$I$$20240425$20240710$20240710$PER$$IN-ROCHE-3554359$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IN$IN
240699651$24069965$1$I$20231007$20231103$20240710$20240710$PER$$CN-ROCHE-3452370$ROCHE$$54$YR$A$F$Y$$$20240628$$HP$CN$CN
240699671$24069967$1$I$$20230718$20240710$20240710$PER$$PH-ROCHE-3390914$ROCHE$$$$$$Y$$$20240628$$CN$PH$PH
240699681$24069968$1$I$$20240215$20240710$20240710$PER$$US-ROCHE-3511202$ROCHE$$$$A$M$Y$$$20240628$$CN$US$US
240699691$24069969$1$I$20211201$20230721$20240710$20240710$PER$$CN-ROCHE-3079508$ROCHE$$68$YR$E$M$Y$65$KG$20240628$$MD$CN$CN
240699701$24069970$1$I$$20231113$20240710$20240710$PER$$CN-ROCHE-3456882$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$CN$CN
240699712$24069971$2$F$$20230914$20240710$20240710$PER$$MX-ROCHE-3425315$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$MX$MX
240699721$24069972$1$I$$20231027$20240710$20240710$PER$$US-ROCHE-3448272$ROCHE$$58$YR$A$M$Y$$$20240628$$CN$US$US
240699731$24069973$1$I$$20231026$20240710$20240710$PER$$RO-ROCHE-3449969$ROCHE$$38$YR$A$F$Y$53$KG$20240628$$CN$RO$RO
240699741$24069974$1$I$20231026$20240302$20240710$20240710$PER$$HR-ROCHE-3519869$ROCHE$$57$YR$A$F$Y$74$KG$20240628$$MD$HR$HR
240699751$24069975$1$I$$20240530$20240710$20240710$PER$$IN-ROCHE-3574609$ROCHE$$66$YR$E$M$Y$$$20240628$$CN$IN$IN
240699761$24069976$1$I$$20231117$20240710$20240710$PER$$US-ROCHE-3460405$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$US$US
240699771$24069977$1$I$$20240517$20240710$20240710$PER$$JP-ROCHE-3573228$ROCHE$$$$$$Y$$$20240628$$MD$JP$JP
240699781$24069978$1$I$$20240301$20240710$20240710$PER$$US-ROCHE-3519880$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$US$US
240699791$24069979$1$I$$20230721$20240710$20240710$PER$$IN-ROCHE-3394715$ROCHE$$57$YR$A$F$Y$$$20240628$$CN$IN$IN
240699801$24069980$1$I$$20240129$20240710$20240710$PER$$JP-ROCHE-3506245$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$JP$JP
240699811$24069981$1$I$$20240430$20240710$20240710$PER$$IN-ROCHE-3557373$ROCHE$$74$YR$E$M$Y$$$20240628$$CN$IN$IN
240699821$24069982$1$I$$20240524$20240710$20240710$PER$$SG-ROCHE-3572582$ROCHE$$44$YR$A$F$Y$$$20240628$$CN$SG$SG
240699831$24069983$1$I$$20230705$20240710$20240710$PER$$FR-ROCHE-3382932$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$FR$FR
240699841$24069984$1$I$$20240424$20240710$20240710$PER$$CO-ROCHE-3554260$ROCHE$$56$YR$A$M$Y$$$20240628$$CN$CO$CO
240699851$24069985$1$I$$20240226$20240710$20240710$PER$$US-ROCHE-3517100$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$US$US
240699861$24069986$1$I$$20230720$20240710$20240710$PER$$TW-ROCHE-3395952$ROCHE$$64$YR$A$M$Y$$$20240628$$MD$TW$TW
240699871$24069987$1$I$$20240503$20240710$20240710$PER$$AU-ROCHE-3557769$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$AU$AU
240699881$24069988$1$I$20220228$20240108$20240710$20240710$PER$$ES-ROCHE-3068899$ROCHE$$70$YR$E$$Y$$$20240628$$MD$ES$ES
240699891$24069989$1$I$$20230821$20240710$20240710$PER$$RO-ROCHE-3359992$ROCHE$$45$YR$A$F$Y$91$KG$20240628$$CN$RO$RO
240699901$24069990$1$I$$20240508$20240710$20240710$PER$$CO-ROCHE-3561375$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$CO$CO
240699911$24069991$1$I$$20230928$20240710$20240710$PER$$IN-ROCHE-3320453$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$IN$IN
240699921$24069992$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3526150$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240699931$24069993$1$I$$20230711$20240710$20240710$PER$$IN-ROCHE-3387184$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$IN$IN
240699941$24069994$1$I$$20240529$20240710$20240710$PER$$KR-ROCHE-3573686$ROCHE$$64$YR$A$F$Y$$$20240628$$CN$KR$KR
240699951$24069995$1$I$$20231211$20240710$20240710$PER$$RO-ROCHE-3474352$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240699961$24069996$1$I$20240220$20240222$20240710$20240710$PER$$JP-ROCHE-3522767$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240699971$24069997$1$I$$20240527$20240710$20240710$PER$$IN-ROCHE-3572518$ROCHE$$$$$F$Y$$$20240628$$MD$IN$IN
240699981$24069998$1$I$$20230706$20240710$20240710$PER$$IN-ROCHE-3353783$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240699991$24069999$1$I$20230620$20230727$20240710$20240710$PER$PT-INFARMED-B202307-501$PT-ROCHE-3395210$ROCHE$$74$YR$E$M$Y$$$20240628$$MD$PT$PT
240700001$24070000$1$I$$20240606$20240710$20240710$PER$$GB-ROCHE-3578882$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240700012$24070001$2$F$$20240130$20240710$20240710$PER$$JP-ROCHE-3481668$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240700021$24070002$1$I$20230829$20240227$20240710$20240710$PER$$TR-ROCHE-3517449$ROCHE$$77$YR$E$F$Y$$$20240628$$MD$TR$TR
240700031$24070003$1$I$$20230906$20240710$20240710$PER$PL-URPL-DML-MLP.4401.1.301.2023$PL-ROCHE-3417300$ROCHE$$69$YR$E$M$Y$63$KG$20240628$$PH$PL$PL
240700041$24070004$1$I$$20230711$20240710$20240710$PER$$CU-ROCHE-3388766$ROCHE$$$$$$Y$$$20240628$$CN$CU$CU
240700051$24070005$1$I$$20240423$20240710$20240710$PER$$IN-ROCHE-3554125$ROCHE$$$$$$Y$$$20240628$$CN$IN$IN
240700061$24070006$1$I$$20240314$20240710$20240710$PER$$JP-ROCHE-3544072$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$JP$JP
240700071$24070007$1$I$20221214$20240520$20240710$20240710$PER$$JP-ROCHE-3573140$ROCHE$$76$YR$E$M$Y$$$20240628$$MD$JP$JP
240700081$24070008$1$I$$20240426$20240710$20240710$PER$$TH-ROCHE-3556064$ROCHE$$$$$F$Y$$$20240628$$CN$TH$TH
240700091$24070009$1$I$$20240523$20240710$20240710$PER$$US-ROCHE-3569808$ROCHE$$88$YR$E$F$Y$$$20240628$$MD$US$US
240700101$24070010$1$I$$20240427$20240710$20240710$PER$$GB-ROCHE-3557542$ROCHE$$$$A$F$Y$$$20240628$$MD$GB$GB
240700111$24070011$1$I$$20240514$20240710$20240710$PER$$CA-ROCHE-3564522$ROCHE$$$$E$M$Y$$$20240628$$CN$CA$CA
240700121$24070012$1$I$$20231226$20240710$20240710$PER$$IN-ROCHE-3482437$ROCHE$$34$YR$A$F$Y$$$20240628$$MD$IN$IN
240700131$24070013$1$I$$20240523$20240710$20240710$PER$$US-ROCHE-3454651$ROCHE$$68$YR$E$$Y$$$20240628$$MD$US$US
240700141$24070014$1$I$$20240119$20240710$20240710$PER$$NG-ROCHE-3496133$ROCHE$$$$A$F$Y$$$20240628$$PH$NG$NG
240700151$24070015$1$I$$20240304$20240710$20240710$PER$$SK-ROCHE-3521074$ROCHE$$$$$F$Y$$$20240628$$MD$SK$SK
240700162$24070016$2$F$20220722$20240116$20240710$20240710$PER$$RO-ROCHE-3148675$ROCHE$$74$YR$E$M$Y$71$KG$20240628$$MD$RO$RO
240700171$24070017$1$I$$20230822$20240710$20240710$PER$$IN-ROCHE-3410432$ROCHE$$33$YR$A$F$Y$$$20240628$$CN$IN$IN
240700181$24070018$1$I$$20230806$20240710$20240710$PER$$US-ROCHE-3401196$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240700191$24070019$1$I$$20240606$20240710$20240710$PER$$MX-ROCHE-3579044$ROCHE$$$$$$Y$$$20240628$$MD$MX$MX
240700201$24070020$1$I$$20240116$20240710$20240710$PER$$US-ROCHE-3493321$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$US$US
240700211$24070021$1$I$20240411$20240426$20240710$20240710$PER$$US-ROCHE-3554754$ROCHE$$$$E$F$Y$$$20240628$$CN$US$US
240700221$24070022$1$I$$20240605$20240710$20240710$PER$$GR-ROCHE-3577576$ROCHE$$$$$$Y$$$20240628$$MD$GR$GR
240700231$24070023$1$I$20220915$20240318$20240710$20240710$PER$$KR-ROCHE-3529693$ROCHE$$44$YR$A$F$Y$$$20240628$$PH$KR$KR
240700242$24070024$2$F$$20240508$20240710$20240710$PER$$JP-ROCHE-3567994$ROCHE$$57$YR$A$F$Y$$$20240628$$PH$JP$JP
240700251$24070025$1$I$20230701$20230830$20240710$20240710$PER$$US-ROCHE-3414835$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240700261$24070026$1$I$$20231203$20240710$20240710$PER$$LB-ROCHE-3472218$ROCHE$$$$$F$Y$$$20240628$$MD$LB$LB
240700271$24070027$1$I$20230301$20240103$20240710$20240710$PER$$US-ROCHE-3485928$ROCHE$$65$YR$E$F$Y$86.18$KG$20240628$$CN$US$US
240700281$24070028$1$I$20240312$20240420$20240710$20240710$PER$$IN-ROCHE-3553022$ROCHE$$84$YR$E$F$Y$$$20240628$$CN$IN$IN
240700291$24070029$1$I$20211101$20231124$20240710$20240710$PER$$CO-ROCHE-3218284$ROCHE$$56$YR$A$M$Y$77$KG$20240628$$MD$CO$CO
240700301$24070030$1$I$$20230907$20240710$20240710$PER$$CA-ROCHE-3419035$ROCHE$$$$A$F$Y$$$20240628$$CN$CA$CA
240700311$24070031$1$I$$20240523$20240710$20240710$PER$$ZA-ROCHE-3571798$ROCHE$$$$$F$Y$$$20240628$$MD$ZA$ZA
240700321$24070032$1$I$20240320$20240323$20240710$20240710$PER$$EG-ROCHE-3532539$ROCHE$$34$YR$A$F$Y$$$20240628$$CN$EG$EG
240700331$24070033$1$I$$20230926$20240710$20240710$PER$$TH-ROCHE-3431844$ROCHE$$$$$$Y$$$20240628$$PH$TH$TH
240700341$24070034$1$I$$20240521$20240710$20240710$PER$$US-ROCHE-3568010$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240700361$24070036$1$I$$20240223$20240710$20240710$PER$$IN-ROCHE-3515823$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$IN$IN
240700372$24070037$2$F$20200910$20240112$20240710$20240710$PER$PT-INFARMED-T202401-26$PT-ROCHE-3490905$ROCHE$$$$E$F$Y$48$KG$20240628$$MD$PT$PT
240700381$24070038$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186183$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240700391$24070039$1$I$$20240425$20240710$20240710$PER$$HR-ROCHE-3556024$ROCHE$$78$YR$E$F$Y$$$20240628$$MD$HR$HR
240700401$24070040$1$I$$20240529$20240710$20240710$PER$$IN-ROCHE-3573648$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240700411$24070041$1$I$20230601$20231023$20240710$20240710$PER$$CN-ROCHE-3283733$ROCHE$$47$YR$A$F$Y$55$KG$20240628$$CN$CN$CN
240700422$24070042$2$F$20240405$20240425$20240710$20240710$PER$$JP-ROCHE-3564185$ROCHE$$$$E$F$Y$$$20240628$$CN$JP$JP
240700431$24070043$1$I$$20240429$20240710$20240710$PER$$DE-ROCHE-3577974$ROCHE$$81$YR$E$F$Y$$$20240628$$MD$DE$DE
240700441$24070044$1$I$$20240523$20240710$20240710$PER$$US-ROCHE-3570224$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$US$US
240700451$24070045$1$I$$20240530$20240710$20240710$PER$$FR-ROCHE-3574661$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$FR$FR
240700461$24070046$1$I$$20240506$20240710$20240710$PER$$IN-ROCHE-3558868$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$IN$IN
240700471$24070047$1$I$$20240327$20240710$20240710$PER$$IT-ROCHE-3535905$ROCHE$$$$$$Y$$$20240628$$MD$IT$IT
240700481$24070048$1$I$$20240507$20240710$20240710$PER$$US-ROCHE-3561089$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240700491$24070049$1$I$20240419$20240511$20240710$20240710$PER$$CN-ROCHE-3562630$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$CN$CN
240700501$24070050$1$I$20240515$20240517$20240710$20240710$PER$$JP-ROCHE-3572618$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240700511$24070051$1$I$$20240213$20240710$20240710$PER$$IN-ROCHE-3511565$ROCHE$$41$YR$A$F$Y$$$20240628$$MD$IN$IN
240700521$24070052$1$I$$20231026$20240710$20240710$PER$$US-ROCHE-3447155$ROCHE$$56$YR$A$F$Y$$$20240628$$CN$US$US
240700531$24070053$1$I$$20240520$20240710$20240710$PER$$US-ROCHE-3567701$ROCHE$$77$YR$E$M$Y$$$20240628$$MD$US$US
240700541$24070054$1$I$$20240426$20240710$20240710$PER$$US-ROCHE-3554989$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$US$US
240700551$24070055$1$I$$20240517$20240710$20240710$PER$$IN-ROCHE-3567240$ROCHE$$41$YR$A$F$Y$$$20240628$$MD$IN$IN
240700561$24070056$1$I$20231227$20240110$20240710$20240710$PER$$JP-ROCHE-3493276$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240700571$24070057$1$I$20221201$20230814$20240710$20240710$PER$$CN-ROCHE-3405559$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$CN$CN
240700581$24070058$1$I$$20240516$20240710$20240710$PER$$SG-ROCHE-3567856$ROCHE$$52$YR$A$F$Y$$$20240628$$CN$SG$SG
240700591$24070059$1$I$$20240213$20240710$20240710$PER$$US-ROCHE-3510219$ROCHE$$76$YR$E$F$Y$$$20240628$$MD$US$US
240700601$24070060$1$I$$20240426$20240710$20240710$PER$$MY-ROCHE-3554216$ROCHE$$37$YR$A$F$Y$$$20240628$$CN$MY$MY
240700611$24070061$1$I$$20230828$20240710$20240710$PER$$BR-ROCHE-3414992$ROCHE$$$$$F$Y$$$20240628$$MD$BR$BR
240700621$24070062$1$I$$20240404$20240710$20240710$PER$$IN-ROCHE-3540930$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$IN$IN
240700631$24070063$1$I$$20240221$20240710$20240710$PER$$US-ROCHE-3514218$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240700652$24070065$2$F$20240423$20240526$20240710$20240710$PER$$CN-ROCHE-3571687$ROCHE$$71$YR$E$M$Y$$$20240628$$MD$CN$CN
240700661$24070066$1$I$$20231121$20240710$20240710$PER$$US-ROCHE-3462446$ROCHE$$44$YR$A$F$Y$$$20240628$$MD$US$US
240700671$24070067$1$I$$20240429$20240710$20240710$PER$$US-ROCHE-3555779$ROCHE$$82$YR$E$M$Y$$$20240628$$PH$US$US
240700681$24070068$1$I$$20231030$20240710$20240710$PER$$CH-ROCHE-3450134$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240700691$24070069$1$I$20230606$20231030$20240710$20240710$PER$IT-MINISAL02-951064$IT-ROCHE-3448812$ROCHE$$54$YR$A$F$Y$$$20240628$$HP$IT$IT
240700701$24070070$1$I$20240402$20240402$20240710$20240710$PER$$JP-ROCHE-3555709$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240700721$24070072$1$I$$20240523$20240710$20240710$PER$$US-ROCHE-3570350$ROCHE$$74$YR$E$M$Y$$$20240628$$MD$US$US
240700732$24070073$2$F$20240219$20240221$20240710$20240710$PER$$JP-ROCHE-3517292$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240700741$24070074$1$I$$20240426$20240710$20240710$PER$$JP-ROCHE-3565038$ROCHE$$$$A$F$Y$$$20240628$$HP$JP$JP
240700751$24070075$1$I$$20231219$20240710$20240710$PER$$IN-ROCHE-3479444$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$IN$IN
240700762$24070076$2$F$20240514$20240528$20240710$20240710$PER$$JP-ROCHE-3573079$ROCHE$$$$$M$Y$$$20240628$$MD$JP$JP
240700771$24070077$1$I$$20230926$20240710$20240710$PER$$US-ROCHE-3429554$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240700781$24070078$1$I$$20240410$20240710$20240710$PER$$JP-ROCHE-3559210$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$JP$JP
240700792$24070079$2$F$$20231123$20240710$20240710$PER$$IN-ROCHE-3431615$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$IN$IN
240700801$24070080$1$I$$20231023$20240710$20240710$PER$$US-ROCHE-3445217$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240700811$24070081$1$I$$20240227$20240710$20240710$PER$$DE-ROCHE-3517663$ROCHE$$$$$$Y$$$20240628$$PH$DE$DE
240700821$24070082$1$I$20240314$20240319$20240710$20240710$PER$GB-MHRA-MED-202403151003136060-MYHKR$GB-ROCHE-3530334$ROCHE$$42$YR$A$F$Y$$$20240628$$HP$GB$GB
240700831$24070083$1$I$$20230803$20240710$20240710$PER$$AR-ROCHE-3400452$ROCHE$$$$$F$Y$$$20240628$$MD$AR$AR
240700841$24070084$1$I$$20231114$20240710$20240710$PER$$US-ROCHE-3458436$ROCHE$$40$YR$A$M$Y$$$20240628$$HP$US$US
240700851$24070085$1$I$$20240515$20240710$20240710$PER$$US-ROCHE-3566521$ROCHE$$71$YR$E$F$Y$54$KG$20240628$$MD$US$US
240700861$24070086$1$I$20200101$20240208$20240710$20240710$PER$IT-MINISAL02-969068$IT-ROCHE-3507091$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$IT$IT
240700872$24070087$2$F$20221115$20240411$20240710$20240710$PER$$BE-ROCHE-3529745$ROCHE$$73$YR$E$M$Y$83$KG$20240628$$MD$BE$BE
240700881$24070088$1$I$$20230804$20240710$20240710$PER$$IN-ROCHE-3400836$ROCHE$$57$YR$A$F$Y$90.8$KG$20240628$$CN$IN$IN
240700891$24070089$1$I$$20231117$20240710$20240710$PER$$IN-ROCHE-3459916$ROCHE$$50$YR$A$F$Y$$$20240628$$MD$IN$IN
240700901$24070090$1$I$20240107$20240322$20240710$20240710$PER$$VN-ROCHE-3532630$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$VN$VN
240700911$24070091$1$I$$20240430$20240710$20240710$PER$$DE-ROCHE-3556839$ROCHE$$$$$F$Y$$$20240628$$MD$DE$DE
240700921$24070092$1$I$$20230828$20240710$20240710$PER$$IN-ROCHE-3413097$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
240700942$24070094$2$F$$20240415$20240710$20240710$PER$$JP-ROCHE-3513324$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240700951$24070095$1$I$$20240410$20240710$20240710$PER$$IN-ROCHE-3545698$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$IN$IN
240700962$24070096$2$F$$20231109$20240710$20240710$PER$$IN-ROCHE-3429656$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$IN$IN
240700972$24070097$2$F$20230417$20240408$20240710$20240710$PER$$IL-ROCHE-3532351$ROCHE$$71$YR$E$M$Y$83$KG$20240628$$MD$IL$IL
240700981$24070098$1$I$$20240216$20240710$20240710$PER$$US-ROCHE-3511848$ROCHE$$50$YR$A$M$Y$$$20240628$$CN$US$US
240700991$24070099$1$I$$20240105$20240710$20240710$PER$$JP-ROCHE-3488979$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240701001$24070100$1$I$$20240502$20240710$20240710$PER$$US-ROCHE-3557939$ROCHE$$74$YR$E$F$Y$58.97$KG$20240628$$CN$US$US
240701011$24070101$1$I$$20240605$20240710$20240710$PER$$FR-ROCHE-3579139$ROCHE$$$$$F$Y$$$20240628$$MD$FR$FR
240701021$24070102$1$I$20240503$20240529$20240710$20240710$PER$IT-MINISAL02-986975$IT-ROCHE-3572513$ROCHE$$66$YR$E$F$Y$65$KG$20240628$$PH$IT$IT
240701031$24070103$1$I$$20240314$20240710$20240710$PER$$US-ROCHE-3527254$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240701041$24070104$1$I$$20230925$20240710$20240710$PER$$US-ROCHE-3430211$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240701051$24070105$1$I$$20231215$20240710$20240710$PER$$IN-ROCHE-3478520$ROCHE$$74$YR$E$F$Y$$$20240628$$MD$IN$IN
240701061$24070106$1$I$20240510$20240524$20240710$20240710$PER$$JP-ROCHE-3576085$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240701071$24070107$1$I$$20230705$20240710$20240710$PER$$GE-ROCHE-3382939$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$GE$GE
240701082$24070108$2$F$$20230703$20240710$20240710$PER$$IN-ROCHE-3348163$ROCHE$$46$YR$A$F$Y$$$20240628$$CN$IN$IN
240701091$24070109$1$I$$20240319$20240710$20240710$PER$$ID-ROCHE-3531477$ROCHE$$43$YR$A$F$Y$$$20240628$$CN$ID$ID
240701101$24070110$1$I$$20240308$20240710$20240710$PER$$JP-ROCHE-3538678$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240701111$24070111$1$I$$20231023$20240710$20240710$PER$$US-ROCHE-3446088$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240701121$24070112$1$I$$20240505$20240710$20240710$PER$$FR-ROCHE-3561316$ROCHE$$$$$$Y$$$20240628$$MD$FR$FR
240701131$24070113$1$I$$20240117$20240710$20240710$PER$$JP-ROCHE-3496523$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240701141$24070114$1$I$$20240226$20240710$20240710$PER$$RU-ROCHE-3517685$ROCHE$$64$YR$A$M$Y$$$20240628$$HP$RU$RU
240701151$24070115$1$I$$20240319$20240710$20240710$PER$$CR-ROCHE-3530351$ROCHE$$77$YR$E$F$Y$$$20240628$$PH$CR$CR
240701161$24070116$1$I$$20240221$20240710$20240710$PER$IT-MINISAL02-970878$IT-ROCHE-3513522$ROCHE$$68$YR$E$M$Y$77$KG$20240628$$PH$IT$IT
240701171$24070117$1$I$$20240103$20240710$20240710$PER$$RO-ROCHE-3487700$ROCHE$$75$YR$E$F$Y$61$KG$20240628$$CN$RO$RO
240701182$24070118$2$F$$20240425$20240710$20240710$PER$$FR-ROCHE-3554268$ROCHE$$$$$M$Y$$$20240628$$MD$FR$FR
240701191$24070119$1$I$$20231215$20240710$20240710$PER$$US-ROCHE-3479245$ROCHE$$69$YR$E$F$Y$$$20240628$$HP$US$US
240701211$24070121$1$I$$20240319$20240710$20240710$PER$$JP-ROCHE-3547468$ROCHE$$7$DEC$E$M$Y$$$20240628$$MD$JP$JP
240701221$24070122$1$I$$20230713$20240710$20240710$PER$$MY-ROCHE-3388315$ROCHE$$50$YR$A$F$Y$$$20240628$$PH$MY$MY
240701231$24070123$1$I$20230624$20231225$20240710$20240710$PER$$JP-ROCHE-3484104$ROCHE$$5$DEC$A$$Y$$$20240628$$CN$JP$JP
240701241$24070124$1$I$$20240416$20240710$20240710$PER$$JP-ROCHE-3559990$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240701251$24070125$1$I$20240410$20240412$20240710$20240710$PER$$JP-ROCHE-3559403$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240701281$24070128$1$I$$20240502$20240710$20240710$PER$$AE-ROCHE-3557627$ROCHE$$$$$$Y$$$20240628$$MD$AE$AE
240701291$24070129$1$I$20240115$20240115$20240710$20240710$PER$$JP-ROCHE-3494640$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240701311$24070131$1$I$20240422$20240513$20240710$20240710$PER$$JP-ROCHE-3569648$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240701321$24070132$1$I$$20240426$20240710$20240710$PER$$RO-ROCHE-3554758$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240701331$24070133$1$I$$20240426$20240710$20240710$PER$$KR-ROCHE-3554770$ROCHE$$66$YR$E$M$Y$$$20240628$$CN$KR$KR
240701341$24070134$1$I$20240101$20240702$20240710$20240710$EXP$$US-UCBSA-2024017569$UCB$$$$$F$Y$$$20240710$$CN$US$US
240701351$24070135$1$I$20240531$20240708$20240710$20240710$EXP$$US-UCBSA-2024034722$UCB$$59$YR$$M$Y$$$20240710$$CN$US$US
240701361$24070136$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405091156004180-HMBTC$GB-UCBSA-2024034147$UCB$$$$$M$Y$$$20240710$$PH$GB$GB
240701372$24070137$2$F$20240607$20240718$20240710$20240724$EXP$$CO-UCBSA-2024034749$UCB$$89$YR$$F$Y$$$20240724$$CN$CO$CO
240701381$24070138$1$I$20240601$20240708$20240710$20240710$EXP$$US-UCBSA-2024034769$UCB$$45$YR$$F$Y$$$20240710$$HP$US$US
240701392$24070139$2$F$$20240709$20240710$20240722$EXP$$JP-UCBSA-2024034038$UCB$Nishioka A, et al. A case of epileptic encephalopathy with spike-wave activation in sleep (EE-SWAS) in which seizure aggravation due to lacosamide was suspected. The 18th Regional Meeting of the Japan Epilepsy Society$6$YR$$F$Y$30$KG$20240720$$MD$JP$JP
240701402$24070140$2$F$$20240712$20240710$20240726$EXP$$JP-UCBSA-2024033933$UCB$Nakamura Y., et. al.. The 18th Regional Meeting of the Japan Epilepsy Society in the Kanto-Koshinetsu District, oral/poster presentation D-4. A case of left chronic subdural hematoma with status epilepticus$8$DEC$$M$Y$$$20240726$$MD$JP$JP
240701412$24070141$2$F$20240126$20240428$20240710$20240710$PER$$RS-ROCHE-3556560$ROCHE$$53$YR$A$M$Y$83$KG$20240628$$MD$RS$RS
240701421$24070142$1$I$20240325$20240702$20240710$20240710$EXP$$AU-UCBSA-2024014594$UCB$$29$YR$$F$Y$$$20240710$$CN$AU$AU
240701442$24070144$2$F$$20240415$20240710$20240710$PER$$US-ROCHE-3546579$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$US$US
240701451$24070145$1$I$$20240524$20240710$20240710$PER$$US-ROCHE-3571190$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$US$US
240701461$24070146$1$I$$20240610$20240710$20240710$PER$$US-ROCHE-3580016$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240701471$24070147$1$I$$20240530$20240710$20240710$PER$$CH-ROCHE-3575699$ROCHE$$$$$$Y$$$20240628$$PH$CH$CH
240701482$24070148$2$F$$20240305$20240710$20240710$PER$$US-ROCHE-3400393$ROCHE$$76$YR$E$F$Y$$$20240628$$CN$US$US
240701491$24070149$1$I$$20230912$20240710$20240710$PER$$CA-ROCHE-3422133$ROCHE$$$$A$M$Y$$$20240628$$CN$CA$CA
240701501$24070150$1$I$20240419$20240425$20240710$20240710$PER$$JP-ROCHE-3564187$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240701521$24070152$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3526929$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240701531$24070153$1$I$20240202$20240403$20240710$20240710$PER$IT-MINISAL02-978201$IT-ROCHE-3538443$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$IT$IT
240701541$24070154$1$I$$20240426$20240710$20240710$PER$$SG-ROCHE-3555929$ROCHE$$50$YR$A$F$Y$$$20240628$$CN$SG$SG
240701551$24070155$1$I$20231214$20240111$20240710$20240710$PER$$JP-ROCHE-3493165$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240701561$24070156$1$I$$20240515$20240710$20240710$PER$$IN-ROCHE-3564638$ROCHE$$57$YR$A$F$Y$$$20240628$$CN$IN$IN
240701571$24070157$1$I$$20230821$20240710$20240710$PER$$DE-ROCHE-3410253$ROCHE$$$$$F$Y$$$20240628$$MD$DE$DE
240701581$24070158$1$I$$20230719$20240710$20240710$PER$$US-ROCHE-3392755$ROCHE$$65$YR$E$F$Y$$$20240628$$CN$US$US
240701591$24070159$1$I$20240424$20240507$20240710$20240710$PER$$JP-ROCHE-3565661$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$JP$JP
240701601$24070160$1$I$$20240502$20240710$20240710$PER$$IN-ROCHE-3558547$ROCHE$$74$YR$E$F$Y$$$20240628$$MD$IN$IN
240701611$24070161$1$I$20240419$20240421$20240710$20240710$PER$$EG-ROCHE-3553642$ROCHE$$$$$F$Y$$$20240628$$CN$EG$EG
240701621$24070162$1$I$$20231012$20240710$20240710$PER$$CH-ROCHE-3440977$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240701631$24070163$1$I$$20240222$20240710$20240710$PER$$JP-ROCHE-3521971$ROCHE$$10$DEC$E$$Y$$$20240628$$MD$JP$JP
240701641$24070164$1$I$20240219$20240314$20240710$20240710$PER$$JP-ROCHE-3544381$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240701651$24070165$1$I$$20230809$20240710$20240710$PER$$IN-ROCHE-3402878$ROCHE$$48$YR$A$M$Y$$$20240628$$CN$IN$IN
240701661$24070166$1$I$$20240514$20240710$20240710$PER$$IN-ROCHE-3563722$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$IN$IN
240701671$24070167$1$I$20231021$20231122$20240710$20240710$PER$IT-MINISAL02-955259$IT-ROCHE-3464037$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$IT$IT
240701681$24070168$1$I$20230529$20230809$20240710$20240710$PER$$US-ROCHE-3403024$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240701691$24070169$1$I$$20240513$20240710$20240710$PER$$US-ROCHE-3570133$ROCHE$$46$YR$A$F$Y$$$20240628$$PH$US$US
240701701$24070170$1$I$$20240315$20240710$20240710$PER$$US-ROCHE-3527961$ROCHE$$81$YR$E$F$Y$$$20240628$$CN$US$US
240701711$24070171$1$I$$20240221$20240710$20240710$PER$$US-ROCHE-3514327$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$US$US
240701721$24070172$1$I$$20240404$20240710$20240710$PER$$IN-ROCHE-3541494$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240701731$24070173$1$I$$20230714$20240710$20240710$PER$$CN-ROCHE-3388385$ROCHE$$$$$$Y$$$20240628$$CN$CN$CN
240701751$24070175$1$I$$20230824$20240710$20240710$PER$$RO-ROCHE-3411707$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240701761$24070176$1$I$$20240222$20240710$20240710$PER$$IT-ROCHE-3515304$ROCHE$$$$$F$Y$$$20240628$$MD$IT$IT
240701771$24070177$1$I$$20240529$20240710$20240710$PER$$CA-ROCHE-3573788$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$CA$CA
240701781$24070178$1$I$$20240108$20240710$20240710$PER$$US-ROCHE-3488160$ROCHE$$44$YR$A$F$Y$$$20240628$$CN$US$US
240701791$24070179$1$I$20231220$20240127$20240710$20240710$PER$$JP-ROCHE-3506091$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240701801$24070180$1$I$20240305$20240319$20240710$20240710$PER$$JP-ROCHE-3547485$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240701811$24070181$1$I$$20231013$20240710$20240710$PER$$CN-ROCHE-3440276$ROCHE$$$$$$Y$$$20240628$$MD$CN$CN
240701821$24070182$1$I$$20230629$20240710$20240710$PER$$US-ROCHE-3380405$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240701831$24070183$1$I$$20240115$20240710$20240710$PER$$US-ROCHE-3493507$ROCHE$Jang C, Sabari J. Combinatorial therapy is a safe and durable treatment option in ALK-rearranged nonsmall cell lung cancer with an acquired MET exon 14 skipping mutation mediated resistance to alectinib: a case report. DOI:10.21037/tlcr-23-613. Translational lung cancer research 2023 Dec 26;12 (12):2558-64.$72$YR$E$M$Y$$$20240628$$MD$US$US
240701841$24070184$1$I$20240117$20240124$20240710$20240710$PER$$JP-ROCHE-3503351$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240701851$24070185$1$I$20240327$20240402$20240710$20240710$PER$$JP-ROCHE-3553599$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240701861$24070186$1$I$$20240502$20240710$20240710$PER$$IN-ROCHE-3558210$ROCHE$$56$YR$A$M$Y$$$20240628$$CN$IN$IN
240701871$24070187$1$I$20240220$20240227$20240710$20240710$PER$$JP-ROCHE-3526128$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240701881$24070188$1$I$20200901$20240102$20240710$20240710$PER$$PT-ROCHE-3484655$ROCHE$Simoes F, Sequeira T, Rosa R, Desterro J, Almodovar MT Alectinib-induced anemia with acanthocytosis: To proceed or discontinue treatment in Non-Small Cell  Lung Cancer patients?. Revista GECP 2023;2:43-6.$72$YR$E$F$Y$$$20240628$$HP$PT$PT
240701891$24070189$1$I$$20240209$20240710$20240710$PER$$RU-ROCHE-3508772$ROCHE$$55$YR$A$M$Y$$$20240628$$MD$RU$RU
240701901$24070190$1$I$$20240530$20240710$20240710$PER$$CO-ROCHE-3575749$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$CO$CO
240701913$24070191$3$F$20211027$20240516$20240710$20240710$PER$$TR-ROCHE-3078592$ROCHE$$23$YR$A$F$Y$70$KG$20240628$$MD$TR$TR
240701921$24070192$1$I$$20230825$20240710$20240710$PER$$IN-ROCHE-3412396$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$IN$IN
240701931$24070193$1$I$20220920$20240108$20240710$20240710$PER$$ES-ROCHE-3488874$ROCHE$$53$YR$A$$Y$$$20240628$$MD$ES$ES
240701941$24070194$1$I$$20240227$20240710$20240710$PER$$TW-ROCHE-3521372$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$TW$TW
240701951$24070195$1$I$$20231231$20240710$20240710$PER$$IN-ROCHE-3484435$ROCHE$$41$YR$A$F$Y$$$20240628$$CN$IN$IN
240701962$24070196$2$F$$20240424$20240710$20240710$PER$$IN-ROCHE-3429738$ROCHE$$50$YR$A$F$Y$$$20240628$$MD$IN$IN
240701971$24070197$1$I$20240101$20240705$20240710$20240710$EXP$$US-UCBSA-2024034707$UCB$$$$$M$Y$$$20240710$$HP$US$US
240701981$24070198$1$I$$20240528$20240710$20240710$PER$$FR-ROCHE-3572866$ROCHE$$$$$$Y$$$20240628$$MD$FR$FR
240701991$24070199$1$I$20231220$20231227$20240710$20240710$PER$$CN-ROCHE-3482825$ROCHE$$63$YR$A$F$Y$64$KG$20240628$$HP$CN$CN
240702002$24070200$2$F$20230717$20240226$20240710$20240710$PER$$TR-ROCHE-3516334$ROCHE$$83$YR$E$F$Y$$$20240628$$MD$TR$TR
240702011$24070201$1$I$20190701$20240409$20240710$20240710$PER$$US-ROCHE-2674310$ROCHE$$81$YR$E$F$Y$39.92$KG$20240628$$CN$US$US
240702025$24070202$5$F$20240101$20240904$20240710$20240917$EXP$$US-UCBSA-2024034743$UCB$$$$$F$Y$64.9$KG$20240917$$HP$US$US
240702041$24070204$1$I$$20230908$20240710$20240710$PER$$IN-ROCHE-3420095$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$IN$IN
240702051$24070205$1$I$$20240304$20240710$20240710$PER$$PH-ROCHE-3521039$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$PH$PH
240702061$24070206$1$I$$20240510$20240710$20240710$PER$$GB-ROCHE-3563185$ROCHE$$$$$M$Y$$$20240628$$MD$GB$GB
240702072$24070207$2$F$$20231121$20240710$20240710$PER$$CN-ROCHE-3384304$ROCHE$$35$YR$A$F$Y$$$20240628$$CN$CN$CN
240702081$24070208$1$I$$20231220$20240710$20240710$PER$$IN-ROCHE-3480715$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$IN$IN
240702091$24070209$1$I$$20240426$20240710$20240710$PER$$JP-ROCHE-3564307$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240702101$24070210$1$I$$20240528$20240710$20240710$PER$$FR-ROCHE-3573756$ROCHE$$$$$F$Y$$$20240628$$MD$FR$FR
240702111$24070211$1$I$$20240313$20240710$20240710$PER$$RO-ROCHE-3527564$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240702121$24070212$1$I$$20240412$20240710$20240710$PER$$IN-ROCHE-3546076$ROCHE$$71$YR$E$F$Y$$$20240628$$CN$IN$IN
240702131$24070213$1$I$$20240328$20240710$20240710$PER$$JP-ROCHE-3551784$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240702141$24070214$1$I$$20230801$20240710$20240710$PER$$FI-ROCHE-3400328$ROCHE$$$$$$Y$$$20240628$$MD$FI$FI
240702151$24070215$1$I$$20240430$20240710$20240710$PER$$IN-ROCHE-3557370$ROCHE$$75$YR$E$M$Y$$$20240628$$CN$IN$IN
240702161$24070216$1$I$$20230725$20240710$20240710$PER$$US-ROCHE-3182802$ROCHE$$61$YR$A$M$Y$$$20240628$$MD$US$US
240702181$24070218$1$I$$20240517$20240710$20240710$PER$$US-ROCHE-3566157$ROCHE$$61$YR$A$M$Y$$$20240628$$MD$US$US
240702191$24070219$1$I$20240628$20240703$20240710$20240710$EXP$$GB-AUROBINDO-AUR-APL-2024-033229$AUROBINDO$$31$YR$$F$Y$$$20240710$$CN$GB$GB
240702201$24070220$1$I$20200201$20240125$20240710$20240710$PER$$US-ROCHE-2589882$ROCHE$$$$E$F$Y$51.71$KG$20240628$$CN$US$US
240702212$24070221$2$F$$20240523$20240710$20240710$PER$$CA-ROCHE-3560590$ROCHE$$$$$$Y$$$20240628$$HP$CA$CA
240702221$24070222$1$I$$20240327$20240710$20240710$PER$$US-ROCHE-3534951$ROCHE$$76$YR$E$M$Y$$$20240628$$CN$US$US
240702231$24070223$1$I$20221208$20230926$20240710$20240710$PER$$EG-ROCHE-3431407$ROCHE$$60$YR$A$F$Y$58$KG$20240628$$CN$EG$EG
240702241$24070224$1$I$$20240301$20240710$20240710$PER$$IN-ROCHE-3521205$ROCHE$$56$YR$A$F$Y$$$20240628$$CN$IN$IN
240702251$24070225$1$I$$20240607$20240710$20240710$PER$$CA-ROCHE-3579173$ROCHE$$86$YR$E$M$Y$$$20240628$$CN$CA$CA
240702261$24070226$1$I$$20240416$20240710$20240710$PER$$IN-ROCHE-3549089$ROCHE$$60$YR$A$M$Y$$$20240628$$CN$IN$IN
240702271$24070227$1$I$$20231228$20240710$20240710$PER$$HK-ROCHE-3483948$ROCHE$$$$A$F$Y$$$20240628$$CN$HK$HK
240702281$24070228$1$I$$20240326$20240710$20240710$PER$$US-ROCHE-3535744$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240702291$24070229$1$I$$20240529$20240710$20240710$PER$$KR-ROCHE-3573555$ROCHE$$80$YR$E$F$Y$$$20240628$$CN$KR$KR
240702311$24070231$1$I$$20231218$20240710$20240710$PER$$NL-ROCHE-3479482$ROCHE$$$$$$Y$$$20240628$$HP$NL$NL
240702321$24070232$1$I$$20240411$20240710$20240710$PER$$US-ROCHE-3545715$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240702331$24070233$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06333$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240702341$24070234$1$I$$20230823$20240710$20240710$PER$$SG-ROCHE-3412551$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$SG$SG
240702353$24070235$3$F$20230605$20240105$20240710$20240710$PER$$RS-ROCHE-3464144$ROCHE$$62$YR$A$F$Y$68$KG$20240628$$MD$RS$RS
240702361$24070236$1$I$$20231004$20240710$20240710$PER$$US-ROCHE-3434140$ROCHE$$$$E$M$Y$$$20240628$$CN$US$US
240702371$24070237$1$I$$20230918$20240710$20240710$PER$$US-ROCHE-3425139$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240702381$24070238$1$I$$20231115$20240710$20240710$PER$$JP-ROCHE-3246187$ROCHE$Kato M, Kato M, Yamaura T, Shio Y, Suzuki H. A Case of Pregnancy Complicated by Advanced Lung Cancer with ALK Fusion Gene Mutation. Japanese Journal of Lung Cancer. The 63rd Annual Meeting of the Japan Lung Cancer Society. 2022;62 (6):725-.$3$DEC$A$F$Y$$$20240628$$MD$JP$JP
240702391$24070239$1$I$$20240509$20240710$20240710$PER$$CO-ROCHE-3562293$ROCHE$$$$$F$Y$$$20240628$$CN$CO$CO
240702401$24070240$1$I$$20240531$20240710$20240710$PER$$KR-ROCHE-3575004$ROCHE$$56$YR$A$F$Y$$$20240628$$CN$KR$KR
240702411$24070241$1$I$$20231208$20240710$20240710$PER$$AE-ROCHE-3472625$ROCHE$$34$YR$A$F$Y$$$20240628$$CN$AE$AE
240702421$24070242$1$I$$20240207$20240710$20240710$PER$$AT-ROCHE-3506495$ROCHE$$$$$M$Y$$$20240628$$MD$AT$AT
240702431$24070243$1$I$$20240510$20240710$20240710$PER$$JP-ROCHE-3570748$ROCHE$$8$DEC$E$$Y$$$20240628$$MD$JP$JP
240702441$24070244$1$I$$20240103$20240710$20240710$PER$$US-ROCHE-3485810$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240702451$24070245$1$I$$20230727$20240710$20240710$PER$$CL-ROCHE-3398057$ROCHE$$$$$F$Y$$$20240628$$MD$CL$CL
240702461$24070246$1$I$$20240508$20240710$20240710$PER$$KR-ROCHE-3560585$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$KR$KR
240702471$24070247$1$I$$20240404$20240710$20240710$PER$$US-ROCHE-3540936$ROCHE$$$$A$F$Y$$$20240628$$HP$US$US
240702481$24070248$1$I$20230915$20230921$20240710$20240710$PER$$US-ROCHE-3427479$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240702491$24070249$1$I$$20230817$20240710$20240710$PER$$IN-ROCHE-3407917$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$IN$IN
240702501$24070250$1$I$$20240507$20240710$20240710$PER$$CA-ROCHE-3560693$ROCHE$$$$$$Y$$$20240628$$HP$CA$CA
240702511$24070251$1$I$20240709$20240709$20240709$20240709$DIR$709639$$FDA-CTU$$$$$UNK$N$$$20240709$N$CN$US$
240702521$24070252$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47774$$FDA-CTU$$$$$F$N$$$20240709$N$$US$
240702551$24070255$1$I$20240308$20240709$20240709$20240709$DIR$709563$$FDA-CTU$$68$YR$$F$N$56.25$KG$20240709$N$PH$US$
240702561$24070256$1$I$20240709$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47746$$FDA-CTU$$58$YR$$F$N$$$20240709$Y$PH$US$
240702571$24070257$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47677$$FDA-CTU$$78$YR$$F$N$$$20240709$N$$US$
240702592$24070259$2$F$$20230927$20240710$20240710$PER$$MX-ROCHE-3431748$ROCHE$$$$A$F$Y$70$KG$20240628$$CN$MX$MX
240702601$24070260$1$I$$20240506$20240710$20240710$PER$$IN-ROCHE-3558667$ROCHE$$47$YR$A$F$Y$$$20240628$$CN$IN$IN
240702611$24070261$1$I$$20240524$20240710$20240710$PER$$ID-ROCHE-3572675$ROCHE$$43$YR$A$F$Y$$$20240628$$CN$ID$ID
240702621$24070262$1$I$$20240409$20240710$20240710$PER$$IN-ROCHE-3544767$ROCHE$$78$YR$E$F$Y$$$20240628$$MD$IN$IN
240702631$24070263$1$I$20230201$20240429$20240710$20240710$PER$$US-ROCHE-3555313$ROCHE$$$$E$F$Y$56.7$KG$20240628$$CN$US$US
240702641$24070264$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47705$$FDA-CTU$$81$YR$$M$N$$$20240709$N$$US$
240702651$24070265$1$I$20221004$20240310$20240710$20240710$PER$$RO-ROCHE-3274923$ROCHE$$73$YR$E$F$Y$75$KG$20240628$$MD$RO$RO
240702671$24070267$1$I$20240114$20240314$20240710$20240710$PER$$JP-ROCHE-3543958$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$JP$JP
240702681$24070268$1$I$$20240709$20240709$20240709$DIR$709585$$FDA-CTU$$$$$UNK$N$$$20240709$$CN$US$
240702691$24070269$1$I$20240709$20240709$20240709$20240709$DIR$709632$$FDA-CTU$$54$YR$$F$N$$$20240709$N$$US$
240702701$24070270$1$I$20221201$20230919$20240710$20240710$PER$$CN-ROCHE-3425742$ROCHE$$49$YR$A$M$Y$$$20240628$$CN$CN$CN
240702711$24070271$1$I$$20240223$20240710$20240710$PER$$IN-ROCHE-3515795$ROCHE$$$$$$Y$$$20240628$$CN$IN$IN
240702721$24070272$1$I$20240703$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47767$$FDA-CTU$$57$YR$$M$N$$$20240708$N$HP$US$
240702731$24070273$1$I$20240620$20240709$20240709$20240709$DIR$709572$$FDA-CTU$$$$$F$N$69$KG$20240709$N$PH$US$
240702741$24070274$1$I$$20231009$20240710$20240710$PER$$IN-ROCHE-3437928$ROCHE$$75$YR$E$F$Y$$$20240628$$CN$IN$IN
240702752$24070275$2$F$$20230802$20240710$20240710$PER$$AU-ROCHE-3071224$ROCHE$$$$A$F$Y$$$20240628$$CN$AU$AU
240702771$24070277$1$I$$20240604$20240710$20240710$PER$$KR-ROCHE-3577107$ROCHE$$54$YR$A$M$Y$$$20240628$$CN$KR$KR
240702791$24070279$1$I$$20230717$20240710$20240710$PER$$CN-ROCHE-3389977$ROCHE$$50$YR$A$M$Y$$$20240628$$CN$CN$CN
240702801$24070280$1$I$$20240606$20240710$20240710$PER$$US-ROCHE-3578631$ROCHE$$75$YR$E$M$Y$$$20240628$$MD$US$US
240702811$24070281$1$I$$20240328$20240710$20240710$PER$$US-ROCHE-3535488$ROCHE$$74$YR$E$F$Y$$$20240628$$HP$US$US
240702821$24070282$1$I$20230614$20240227$20240710$20240710$PER$$TR-ROCHE-3517162$ROCHE$$50$YR$A$F$Y$71$KG$20240628$$MD$TR$TR
240702831$24070283$1$I$20230710$20231101$20240710$20240710$PER$$TR-ROCHE-3450997$ROCHE$$48$YR$A$F$Y$68$KG$20240628$$MD$TR$TR
240702841$24070284$1$I$20231013$20240313$20240710$20240710$PER$$US-ROCHE-3526487$ROCHE$$$$$M$Y$81.65$KG$20240628$$CN$US$US
240702851$24070285$1$I$20240510$20240530$20240710$20240710$PER$$JP-ROCHE-3579567$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240702861$24070286$1$I$$20230908$20240710$20240710$PER$$IN-ROCHE-3362377$ROCHE$$64$YR$A$F$Y$$$20240628$$MD$IN$IN
240702871$24070287$1$I$20230707$20230718$20240710$20240710$PER$IT-MINISAL02-935174$IT-ROCHE-3389960$ROCHE$$59$YR$A$F$Y$88$KG$20240628$$MD$IT$IT
240702881$24070288$1$I$$20240425$20240710$20240710$PER$$IN-ROCHE-3554384$ROCHE$$61$YR$A$M$Y$$$20240628$$CN$IN$IN
240702891$24070289$1$I$$20240514$20240710$20240710$PER$$IN-ROCHE-3565066$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$IN$IN
240702901$24070290$1$I$20231128$20231128$20240710$20240710$PER$$JP-ROCHE-3469963$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240702921$24070292$1$I$$20231207$20240710$20240710$PER$$IL-ROCHE-3472856$ROCHE$$$$E$F$Y$$$20240628$$CN$IL$IL
240702931$24070293$1$I$$20231023$20240710$20240710$PER$$JP-ROCHE-3448452$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240702941$24070294$1$I$$20240223$20240710$20240710$PER$$IN-ROCHE-3517525$ROCHE$$33$YR$A$F$Y$$$20240628$$CN$IN$IN
240702951$24070295$1$I$$20240606$20240710$20240710$PER$$US-ROCHE-3578694$ROCHE$$87$YR$E$F$Y$$$20240628$$MD$US$US
240702961$24070296$1$I$20240516$20240517$20240710$20240710$PER$$JP-ROCHE-3572145$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240702971$24070297$1$I$20231213$20231213$20240710$20240710$PER$$JP-ROCHE-3478769$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240702981$24070298$1$I$20240325$20240325$20240710$20240710$PER$$JP-ROCHE-3550057$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240702992$24070299$2$F$$20231103$20240710$20240710$PER$$GR-ROCHE-3445529$ROCHE$$$$$F$Y$$$20240628$$MD$GR$GR
240703003$24070300$3$F$20231106$20240527$20240710$20240710$PER$$CN-ROCHE-3490597$ROCHE$$63$YR$A$F$Y$72$KG$20240628$$MD$CN$CN
240703011$24070301$1$I$$20240308$20240710$20240710$PER$$JP-ROCHE-3539049$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240703021$24070302$1$I$$20240529$20240710$20240710$PER$$US-ROCHE-3573123$ROCHE$$64$YR$A$M$Y$$$20240628$$MD$US$US
240703031$24070303$1$I$$20230810$20240710$20240710$PER$$IN-ROCHE-3404793$ROCHE$$39$YR$A$F$Y$$$20240628$$CN$IN$IN
240703041$24070304$1$I$20230214$20231004$20240710$20240710$PER$$ES-ROCHE-3325736$ROCHE$$78$YR$E$$Y$$$20240628$$MD$ES$ES
240703051$24070305$1$I$$20230706$20240710$20240710$PER$$AT-ROCHE-3367975$ROCHE$$$$$M$Y$$$20240628$$MD$AT$AT
240703061$24070306$1$I$$20240429$20240710$20240710$PER$$KR-ROCHE-3555435$ROCHE$$75$YR$E$M$Y$$$20240628$$CN$KR$KR
240703071$24070307$1$I$$20240524$20240710$20240710$PER$$ZA-ROCHE-3571110$ROCHE$$$$E$F$Y$$$20240628$$MD$ZA$ZA
240703081$24070308$1$I$$20240514$20240710$20240710$PER$$IN-ROCHE-3565033$ROCHE$$79$YR$E$F$Y$$$20240628$$CN$IN$IN
240703091$24070309$1$I$20231219$20231220$20240710$20240710$PER$$JP-ROCHE-3481646$ROCHE$$$$$F$Y$$$20240628$$HP$JP$JP
240703101$24070310$1$I$20240425$20240517$20240710$20240710$PER$$JP-ROCHE-3572992$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240703111$24070311$1$I$20230307$20231004$20240710$20240710$PER$$ES-ROCHE-3325737$ROCHE$$69$YR$E$$Y$$$20240628$$MD$ES$ES
240703121$24070312$1$I$$20240419$20240710$20240710$PER$$JP-ROCHE-3561425$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240703131$24070313$1$I$$20230810$20240710$20240710$PER$$IN-ROCHE-3404360$ROCHE$$56$YR$A$F$Y$81.2$KG$20240628$$CN$IN$IN
240703141$24070314$1$I$$20240301$20240710$20240710$PER$$AM-ROCHE-3521057$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$AM$AM
240703151$24070315$1$I$$20240427$20240710$20240710$PER$$GB-ROCHE-3555334$ROCHE$$$$E$M$Y$$$20240628$$MD$GB$GB
240703161$24070316$1$I$$20240206$20240710$20240710$PER$$IN-ROCHE-3505487$ROCHE$$$$$$Y$$$20240628$$MD$IN$IN
240703171$24070317$1$I$$20231120$20240710$20240710$PER$$IN-ROCHE-3463559$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$IN$IN
240703181$24070318$1$I$$20231115$20240710$20240710$PER$$US-ROCHE-3457726$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240703191$24070319$1$I$$20240503$20240710$20240710$PER$$IN-ROCHE-3558650$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$IN$IN
240703221$24070322$1$I$20240422$20240507$20240710$20240710$PER$$US-ROCHE-3560707$ROCHE$$51$YR$A$F$Y$92.98$KG$20240628$$MD$US$US
240703231$24070323$1$I$$20240301$20240710$20240710$PER$$US-ROCHE-3519555$ROCHE$$30$YR$A$F$Y$$$20240628$$CN$US$US
240703241$24070324$1$I$$20240527$20240710$20240710$PER$$PH-ROCHE-3570991$ROCHE$$70$YR$E$F$Y$66.5$KG$20240628$$CN$PH$PH
240703251$24070325$1$I$$20240331$20240710$20240710$PER$$IL-ROCHE-3540454$ROCHE$$$$$F$Y$$$20240628$$MD$IL$IL
240703261$24070326$1$I$$20240329$20240710$20240710$PER$$JP-ROCHE-3551917$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240703271$24070327$1$I$$20240509$20240710$20240710$PER$$AU-ROCHE-3560840$ROCHE$$95$YR$E$F$Y$$$20240628$$MD$AU$AU
240703281$24070328$1$I$$20240423$20240710$20240710$PER$$CH-ROCHE-3553896$ROCHE$$$$$M$Y$$$20240628$$MD$CH$CH
240703292$24070329$2$F$20231101$20240213$20240710$20240710$PER$$PE-ROCHE-3509541$ROCHE$$36$YR$A$F$Y$49.7$KG$20240628$$MD$PE$PE
240703301$24070330$1$I$$20240411$20240710$20240710$PER$$US-ROCHE-3544773$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240703311$24070331$1$I$$20240513$20240710$20240710$PER$$JP-ROCHE-3569759$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240703331$24070333$1$I$20230301$20231102$20240710$20240710$PER$$TR-ROCHE-3452054$ROCHE$$39$YR$A$F$Y$$$20240628$$MD$TR$TR
240703341$24070334$1$I$20231011$20231225$20240710$20240710$PER$$JP-ROCHE-3484123$ROCHE$$32$YR$A$M$Y$$$20240628$$CN$JP$JP
240703351$24070335$1$I$$20240516$20240710$20240710$PER$$ES-ROCHE-3566299$ROCHE$$$$A$F$Y$68$KG$20240628$$MD$ES$ES
240703361$24070336$1$I$$20230711$20240710$20240710$PER$$CU-ROCHE-3388752$ROCHE$$$$$$Y$$$20240628$$CN$CU$CU
240703371$24070337$1$I$$20240108$20240710$20240710$PER$$US-ROCHE-3488345$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$US$US
240703381$24070338$1$I$$20240214$20240710$20240710$PER$$JP-ROCHE-3517148$ROCHE$$5$DEC$A$F$Y$$$20240628$$PH$JP$JP
240703391$24070339$1$I$20240208$20240228$20240710$20240710$PER$$JP-ROCHE-3528072$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240703401$24070340$1$I$$20230912$20240710$20240710$PER$$US-ROCHE-3422572$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240703411$24070341$1$I$$20240416$20240710$20240710$PER$$CO-ROCHE-3548990$ROCHE$$$$$F$Y$$$20240628$$MD$CO$CO
240703421$24070342$1$I$$20240520$20240710$20240710$PER$$US-ROCHE-3567794$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$US$US
240703431$24070343$1$I$$20240408$20240710$20240710$PER$$US-ROCHE-3542404$ROCHE$$62$YR$A$F$Y$$$20240628$$CN$US$US
240703442$24070344$2$F$$20230703$20240710$20240710$PER$$IN-ROCHE-3344709$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240703461$24070346$1$I$$20230719$20240710$20240710$PER$$IN-ROCHE-3392326$ROCHE$$$$$$Y$$$20240628$$HP$IN$IN
240703471$24070347$1$I$$20240411$20240710$20240710$PER$$CN-ROCHE-3544270$ROCHE$$$$$F$Y$$$20240628$$MD$CN$CN
240703481$24070348$1$I$$20230726$20240710$20240710$PER$$RO-ROCHE-3396185$ROCHE$$53$YR$A$F$Y$70$KG$20240628$$CN$RO$RO
240703491$24070349$1$I$20240326$20240329$20240710$20240710$PER$$CN-ROCHE-3536297$ROCHE$$68$YR$E$F$Y$$$20240628$$HP$CN$CN
240703511$24070351$1$I$$20230824$20240710$20240710$PER$$MX-ROCHE-3413364$ROCHE$$$$E$M$Y$56$KG$20240628$$CN$MX$MX
240703522$24070352$2$F$$20240903$20240710$20240913$EXP$$IN-ROCHE-3562932$ROCHE$$69$YR$E$M$Y$$$20240913$$CN$IN$IN
240703531$24070353$1$I$$20230825$20240710$20240710$PER$$AR-ROCHE-3413481$ROCHE$$$$$F$Y$$$20240628$$MD$AR$AR
240703542$24070354$2$F$$20240423$20240710$20240710$PER$$IN-ROCHE-3545119$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240703551$24070355$1$I$$20240321$20240710$20240710$PER$$US-ROCHE-3532652$ROCHE$$$$$M$Y$$$20240628$$HP$US$US
240703561$24070356$1$I$20231209$20231213$20240710$20240710$PER$$JP-ROCHE-3478721$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240703571$24070357$1$I$$20240115$20240710$20240710$PER$$PH-ROCHE-3492042$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$PH$PH
240703581$24070358$1$I$$20230711$20240710$20240710$PER$$CU-ROCHE-3388776$ROCHE$$$$$$Y$$$20240628$$CN$CU$CU
240703591$24070359$1$I$$20240430$20240710$20240710$PER$$IN-ROCHE-3557383$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$IN$IN
240703601$24070360$1$I$$20240315$20240710$20240710$PER$$JP-ROCHE-3544927$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240703611$24070361$1$I$$20240605$20240710$20240710$PER$$US-ROCHE-3578047$ROCHE$$28$YR$A$F$Y$$$20240628$$MD$US$US
240703621$24070362$1$I$20240101$20240221$20240710$20240710$PER$$JP-ROCHE-3517863$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240703631$24070363$1$I$$20240430$20240710$20240710$PER$$IN-ROCHE-3556533$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240703641$24070364$1$I$$20240222$20240710$20240710$PER$$US-ROCHE-2974657$ROCHE$$89$YR$E$F$Y$$$20240628$$HP$US$US
240703651$24070365$1$I$20231130$20240401$20240710$20240710$PER$$IL-ROCHE-3536695$ROCHE$$67$YR$E$M$Y$87$KG$20240628$$MD$IL$IL
240703661$24070366$1$I$20230619$20230918$20240710$20240710$PER$FR-AFSSAPS-TO2023001607$FR-ROCHE-3423987$ROCHE$$42$YR$A$F$Y$$$20240628$$PH$FR$FR
240703671$24070367$1$I$$20240506$20240710$20240710$PER$$CA-ROCHE-3558985$ROCHE$$$$$F$Y$$$20240628$$MD$CA$CA
240703681$24070368$1$I$$20240507$20240710$20240710$PER$$IN-ROCHE-3559197$ROCHE$$56$YR$A$M$Y$$$20240628$$CN$IN$IN
240703691$24070369$1$I$$20230808$20240710$20240710$PER$$VN-ROCHE-3403515$ROCHE$$63$YR$A$M$Y$$$20240628$$MD$VN$VN
240703711$24070371$1$I$$20230824$20240710$20240710$PER$$IN-ROCHE-3345937$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$IN$IN
240703721$24070372$1$I$20240430$20240507$20240710$20240710$PER$$JP-ROCHE-3563370$ROCHE$$7$DEC$E$F$Y$$$20240628$$PH$JP$JP
240703731$24070373$1$I$20231115$20240307$20240710$20240710$PER$$IT-ROCHE-3523698$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$IT$IT
240703741$24070374$1$I$$20240503$20240710$20240710$PER$$CA-ROCHE-3558788$ROCHE$$61$YR$A$M$Y$$$20240628$$CN$CA$CA
240703751$24070375$1$I$$20230915$20240710$20240710$PER$$FR-ROCHE-3425245$ROCHE$$$$$$Y$$$20240628$$PH$FR$FR
240703761$24070376$1$I$$20240205$20240710$20240710$PER$$IN-ROCHE-3505798$ROCHE$$$$$M$Y$$$20240628$$MD$IN$IN
240703771$24070377$1$I$20240226$20240318$20240710$20240710$PER$$LT-ROCHE-3529223$ROCHE$$71$YR$E$F$Y$69$KG$20240628$$MD$LT$LT
240703781$24070378$1$I$$20240215$20240710$20240710$PER$$US-ROCHE-3511253$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240703791$24070379$1$I$$20240315$20240710$20240710$PER$$US-ROCHE-3527934$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240703801$24070380$1$I$$20230824$20240710$20240710$PER$$IN-ROCHE-3412751$ROCHE$$50$YR$A$F$Y$$$20240628$$MD$IN$IN
240703821$24070382$1$I$$20240426$20240710$20240710$PER$$JP-ROCHE-3566967$ROCHE$$$$E$M$Y$$$20240628$$MD$JP$JP
240703831$24070383$1$I$20240315$20240709$20240709$20240709$DIR$709647$$FDA-CTU$$78$YR$$F$N$53.55$KG$20240709$N$CN$US$
240703851$24070385$1$I$20240623$20240709$20240709$20240709$DIR$709568$$FDA-CTU$$78$YR$$M$N$99.8$KG$20240709$N$HP$US$
240703861$24070386$1$I$20240708$20240709$20240709$20240709$DIR$709559$$FDA-CTU$$32$YR$$F$N$58.5$KG$20240709$N$CN$US$
240703872$24070387$2$F$$20240508$20240710$20240710$PER$$US-ROCHE-3560818$ROCHE$$51$YR$A$F$Y$$$20240628$$HP$US$US
240703881$24070388$1$I$$20240405$20240710$20240710$PER$$IN-ROCHE-3543153$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
240703891$24070389$1$I$$20231208$20240710$20240710$PER$$US-ROCHE-3474400$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240703901$24070390$1$I$20240402$20240426$20240710$20240710$PER$$JP-ROCHE-3564418$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240703912$24070391$2$F$$20240201$20240710$20240710$PER$$PL-ROCHE-3505720$ROCHE$$$$$F$Y$$$20240628$$MD$PL$PL
240703921$24070392$1$I$20240118$20240709$20240709$20240709$DIR$709623$$FDA-CTU$$62$YR$$F$N$84.15$KG$20240709$N$CN$US$
240703931$24070393$1$I$20240318$20240709$20240709$20240709$DIR$709604$$FDA-CTU$$68$YR$$M$N$87$KG$20240709$Y$HP$US$
240703941$24070394$1$I$$20230821$20240710$20240710$PER$$RO-ROCHE-3410271$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240703951$24070395$1$I$20240424$20240424$20240710$20240710$PER$$JP-ROCHE-3563298$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240703961$24070396$1$I$$20231206$20240710$20240710$PER$$CA-ROCHE-2887874$ROCHE$$$$E$M$Y$$$20240628$$CN$CA$CA
240703971$24070397$1$I$$20240129$20240710$20240710$PER$$IN-ROCHE-3501210$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$IN$IN
240703981$24070398$1$I$$20240403$20240710$20240710$PER$$US-ROCHE-3538384$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$US$US
240703991$24070399$1$I$$20240529$20240710$20240710$PER$$US-ROCHE-3573360$ROCHE$$59$YR$A$M$Y$$$20240628$$HP$US$US
240704001$24070400$1$I$20240201$20240205$20240710$20240710$PER$GB-MHRA-MED-202402021415101820-PYFMK$GB-ROCHE-3505136$ROCHE$$53$YR$A$F$Y$$$20240628$$HP$GB$GB
240704021$24070402$1$I$$20240418$20240710$20240710$PER$$JP-ROCHE-3560795$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240704031$24070403$1$I$$20230807$20240710$20240710$PER$$IN-ROCHE-3401860$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$IN$IN
240704041$24070404$1$I$$20240520$20240710$20240710$PER$$SE-ROCHE-3567869$ROCHE$$$$$$Y$$$20240628$$MD$SE$SE
240704051$24070405$1$I$$20240404$20240710$20240710$PER$$IN-ROCHE-3542139$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$IN$IN
240704061$24070406$1$I$$20240527$20240710$20240710$PER$$KR-ROCHE-3573025$ROCHE$$92$YR$E$F$Y$$$20240628$$CN$KR$KR
240704081$24070408$1$I$$20240321$20240710$20240710$PER$$US-ROCHE-3531265$ROCHE$$72$YR$E$M$Y$$$20240628$$CN$US$US
240704091$24070409$1$I$$20240226$20240710$20240710$PER$$JP-ROCHE-3524522$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240704101$24070410$1$I$$20240606$20240710$20240710$PER$$CA-ROCHE-3579116$ROCHE$$70$YR$E$M$Y$$$20240628$$HP$CA$CA
240704111$24070411$1$I$$20240116$20240710$20240710$PER$$RO-ROCHE-3494521$ROCHE$$52$YR$A$F$Y$52$KG$20240628$$CN$RO$RO
240704121$24070412$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3527062$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240704131$24070413$1$I$$20240606$20240710$20240710$PER$$US-ROCHE-3577929$ROCHE$Firoz W, Sen F, Kiuru M, Huang V and  Riess J A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation Developing Unusual Skin Metastasis.Doi:10.1016/j.cllc.2024.01.008. Clinical Lung Cancer 2024 Jun;25 (4):380-383.$54$YR$A$F$Y$$$20240628$$HP$US$US
240704151$24070415$1$I$$20240524$20240710$20240710$PER$$US-ROCHE-3571130$ROCHE$$80$YR$E$M$Y$$$20240628$$MD$US$US
240704161$24070416$1$I$$20231127$20240710$20240710$PER$$RO-ROCHE-3466894$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$RO$RO
240704171$24070417$1$I$20230827$20230828$20240710$20240710$PER$$FR-ROCHE-3414942$ROCHE$$77$YR$E$F$Y$$$20240628$$PH$FR$FR
240704182$24070418$2$F$$20240513$20240710$20240710$PER$$IN-ROCHE-3479002$ROCHE$$57$YR$A$F$Y$$$20240628$$MD$IN$IN
240704191$24070419$1$I$$20240524$20240710$20240710$PER$$US-ROCHE-3571137$ROCHE$$63$YR$A$$Y$$$20240628$$MD$US$US
240704201$24070420$1$I$$20240527$20240710$20240710$PER$$PT-ROCHE-3572015$ROCHE$$$$$$Y$$$20240628$$PH$PT$PT
240704211$24070421$1$I$20221219$20231103$20240710$20240710$PER$$CN-ROCHE-3263264$ROCHE$$41$YR$A$F$Y$67.5$KG$20240628$$CN$CN$CN
240704221$24070422$1$I$$20240606$20240710$20240710$PER$$SG-ROCHE-3580014$ROCHE$$54$YR$A$F$Y$$$20240628$$CN$SG$SG
240704231$24070423$1$I$$20240419$20240710$20240710$PER$$IN-ROCHE-3551714$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
240704241$24070424$1$I$$20240418$20240710$20240710$PER$$BR-ROCHE-3549847$ROCHE$$$$$$Y$$$20240628$$MD$BR$BR
240704251$24070425$1$I$20240401$20240518$20240710$20240710$PER$$IN-ROCHE-3566764$ROCHE$$73$YR$E$M$Y$$$20240628$$CN$IN$IN
240704261$24070426$1$I$$20240412$20240710$20240710$PER$$IN-ROCHE-3547560$ROCHE$$56$YR$A$M$Y$$$20240628$$CN$IN$IN
240704271$24070427$1$I$$20240410$20240710$20240710$PER$$JP-ROCHE-3559220$ROCHE$$$$E$F$Y$$$20240628$$HP$JP$JP
240704281$24070428$1$I$20240627$20240709$20240709$20240709$DIR$709613$$FDA-CTU$$62$YR$$F$N$96.75$KG$20240709$N$HP$US$
240704291$24070429$1$I$20240709$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47776$$FDA-CTU$$56$YR$$F$N$$$20240709$Y$PH$US$
240704301$24070430$1$I$$20240315$20240710$20240710$PER$$JP-ROCHE-3544905$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240704311$24070431$1$I$$20231014$20240710$20240710$PER$$IN-ROCHE-3441503$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$IN$IN
240704321$24070432$1$I$$20240507$20240710$20240710$PER$$JP-ROCHE-3563274$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240704331$24070433$1$I$20221016$20240709$20240709$20240709$DIR$709650$$FDA-CTU$$78$YR$$F$N$$$20240709$N$CN$US$
240704351$24070435$1$I$$20230828$20240710$20240710$PER$$CN-ROCHE-3412842$ROCHE$$$$$$Y$$$20240628$$CN$CN$CN
240704361$24070436$1$I$$20231122$20240710$20240710$PER$$US-ROCHE-3463623$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240704371$24070437$1$I$$20240404$20240710$20240710$PER$$IN-ROCHE-3540457$ROCHE$$32$YR$A$F$Y$$$20240628$$MD$IN$IN
240704381$24070438$1$I$$20231020$20240710$20240710$PER$$GB-ROCHE-3446165$ROCHE$$$$$$Y$$$20240628$$MD$GB$GB
240704391$24070439$1$I$$20230918$20240710$20240710$PER$$BR-ROCHE-3426129$ROCHE$$$$$F$Y$$$20240628$$CN$BR$BR
240704401$24070440$1$I$$20240528$20240710$20240710$PER$$JP-ROCHE-3577699$ROCHE$$82$YR$E$F$Y$$$20240628$$MD$JP$JP
240704411$24070441$1$I$20240118$20240314$20240710$20240710$PER$$JP-ROCHE-3544284$ROCHE$$62$YR$A$$Y$$$20240628$$MD$JP$JP
240704421$24070442$1$I$$20240426$20240710$20240710$PER$$ES-ROCHE-3555421$ROCHE$$$$$M$Y$$$20240628$$MD$ES$ES
240704431$24070443$1$I$20230705$20230710$20240710$20240710$PER$$JP-ROCHE-3387999$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240704441$24070444$1$I$$20240501$20240710$20240710$PER$$GB-ROCHE-3476209$ROCHE$$81$YR$E$M$Y$$$20240628$$CN$GB$GB
240704451$24070445$1$I$$20231116$20240710$20240710$PER$$IN-ROCHE-3460138$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$IN$IN
240704481$24070448$1$I$$20231214$20240710$20240710$PER$$CN-ROCHE-3476617$ROCHE$$$$$F$Y$$$20240628$$CN$CN$CN
240704491$24070449$1$I$$20240119$20240710$20240710$PER$$JP-ROCHE-3499177$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240704501$24070450$1$I$$20230711$20240710$20240710$PER$$CU-ROCHE-3388743$ROCHE$$$$$$Y$$$20240628$$CN$CU$CU
240704511$24070451$1$I$$20240401$20240710$20240710$PER$$JP-ROCHE-3553580$ROCHE$$$$$F$Y$$$20240628$$CN$JP$JP
240704521$24070452$1$I$$20240513$20240710$20240710$PER$$US-ROCHE-3563590$ROCHE$$77$YR$E$F$Y$68.04$KG$20240628$$CN$US$US
240704531$24070453$1$I$$20240307$20240710$20240710$PER$$IN-ROCHE-3524680$ROCHE$$42$YR$A$F$Y$$$20240628$$CN$IN$IN
240704542$24070454$2$F$20230301$20240605$20240710$20240710$PER$$CU-ROCHE-3350832$ROCHE$$53$YR$A$M$Y$83$KG$20240628$$MD$CU$CU
240704551$24070455$1$I$$20240601$20240710$20240710$PER$$BD-ROCHE-3577845$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$BD$BD
240704561$24070456$1$I$$20230918$20240710$20240710$PER$$CN-ROCHE-3424874$ROCHE$$62$YR$A$F$Y$$$20240628$$CN$CN$CN
240704571$24070457$1$I$20231017$20240327$20240710$20240710$PER$$CN-ROCHE-3534952$ROCHE$$65$YR$E$F$Y$51$KG$20240628$$MD$CN$CN
240704581$24070458$1$I$$20231214$20240710$20240710$PER$$CN-ROCHE-3476616$ROCHE$$$$$M$Y$$$20240628$$CN$CN$CN
240704591$24070459$1$I$$20240522$20240710$20240710$PER$$IT-ROCHE-3569308$ROCHE$$$$$$Y$$$20240628$$MD$IT$IT
240704601$24070460$1$I$20221005$20240424$20240710$20240710$PER$$TR-ROCHE-3553242$ROCHE$$68$YR$E$M$Y$$$20240628$$MD$TR$TR
240704611$24070461$1$I$$20240409$20240710$20240710$PER$$US-ROCHE-3447458$ROCHE$$63$YR$A$M$Y$$$20240628$$HP$US$US
240704621$24070462$1$I$$20240524$20240710$20240710$PER$$IN-ROCHE-3571223$ROCHE$$39$YR$A$F$Y$$$20240628$$MD$IN$IN
240704631$24070463$1$I$$20240205$20240710$20240710$PER$$JP-ROCHE-3511089$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240704641$24070464$1$I$$20230926$20240710$20240710$PER$$US-ROCHE-3429486$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$US$US
240704651$24070465$1$I$$20240320$20240710$20240710$PER$$IN-ROCHE-3531723$ROCHE$$40$YR$A$F$Y$$$20240628$$MD$IN$IN
240704661$24070466$1$I$$20231013$20240710$20240710$PER$$CN-ROCHE-3440085$ROCHE$$$$$$Y$$$20240628$$CN$CN$CN
240704671$24070467$1$I$20220509$20240105$20240710$20240710$PER$$IT-ROCHE-3165365$ROCHE$$70$YR$E$F$Y$50$KG$20240628$$MD$IT$IT
240704681$24070468$1$I$$20230920$20240710$20240710$PER$$IN-ROCHE-3428076$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$IN$IN
240704691$24070469$1$I$20231201$20240208$20240710$20240710$PER$$US-ROCHE-3507820$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$US$US
240704701$24070470$1$I$$20240111$20240710$20240710$PER$$US-ROCHE-3492139$ROCHE$$$$$$Y$$$20240628$$HP$US$US
240704711$24070471$1$I$$20231201$20240710$20240710$PER$$CA-ROCHE-3469609$ROCHE$$$$$F$Y$$$20240628$$CN$CA$CA
240704721$24070472$1$I$20231110$20231204$20240710$20240710$PER$$JP-ROCHE-3474716$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240704731$24070473$1$I$$20231221$20240710$20240710$PER$$US-ROCHE-3480597$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240704742$24070474$2$F$$20231117$20240710$20240710$PER$$DE-ROCHE-3461115$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$DE$DE
240704751$24070475$1$I$20230206$20240315$20240710$20240710$PER$$CZ-ROCHE-3347998$ROCHE$$42$YR$A$M$Y$92$KG$20240628$$MD$CZ$CZ
240704761$24070476$1$I$20231001$20231225$20240710$20240710$PER$$JP-ROCHE-3484036$ROCHE$$5$DEC$A$$Y$$$20240628$$CN$JP$JP
240704771$24070477$1$I$$20240423$20240710$20240710$PER$$CH-ROCHE-3554079$ROCHE$$$$$M$Y$$$20240628$$MD$CH$CH
240704782$24070478$2$F$20240129$20240528$20240710$20240710$PER$$TR-ROCHE-3500917$ROCHE$$64$YR$A$F$Y$65$KG$20240628$$MD$TR$TR
240704801$24070480$1$I$$20231030$20240710$20240710$PER$$CN-ROCHE-3453339$ROCHE$Xu J, Yao X, Wen Y, Lian H,  Han X and Xu Z. Alectinib In the Treatment of Systemic Juvenile Xanthogranuloma of Infancy With ALK Translocation. DOI : 10.1001/jamadermatol.2023.4027. JAMA dermatology 2023 Oct 25;:E1-3.$3$MON$I$F$Y$$$20240628$$MD$CN$CN
240704811$24070481$1$I$20240330$20240402$20240710$20240710$PER$$IN-ROCHE-3537669$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$IN$IN
240704821$24070482$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47780$$FDA-CTU$$60$YR$$M$N$$$20240709$N$$US$
240704831$24070483$1$I$20240629$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010385$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240704841$24070484$1$I$$20240507$20240710$20240710$PER$$US-ROCHE-3561077$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240704851$24070485$1$I$$20240405$20240710$20240710$PER$$IN-ROCHE-3543472$ROCHE$$39$YR$A$F$Y$$$20240628$$MD$IN$IN
240704861$24070486$1$I$$20240131$20240710$20240710$PER$$RO-ROCHE-3503230$ROCHE$$47$YR$A$F$Y$56$KG$20240628$$CN$RO$RO
240704871$24070487$1$I$$20231106$20240710$20240710$PER$$IN-ROCHE-3454733$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$IN$IN
240704881$24070488$1$I$20240521$20240709$20240709$20240709$DIR$709564$$FDA-CTU$$49$YR$$F$N$110.2$KG$20240709$N$$US$
240704891$24070489$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47784$$FDA-CTU$$48$YR$$F$N$$$20240709$N$$US$
240704901$24070490$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47694$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240704911$24070491$1$I$$20230904$20240710$20240710$PER$$PH-ROCHE-3417077$ROCHE$$46$YR$A$F$Y$48$KG$20240628$$CN$PH$PH
240704921$24070492$1$I$$20231013$20240710$20240710$PER$$US-ROCHE-3440528$ROCHE$$$$E$F$Y$$$20240628$$CN$US$US
240704932$24070493$2$F$$20231116$20240710$20240710$PER$$NO-ROCHE-3462069$ROCHE$$$$$F$Y$$$20240628$$HP$NO$NO
240704941$24070494$1$I$$20240301$20240710$20240710$PER$$GB-ROCHE-3562876$ROCHE$$$$$$Y$$$20240628$$MD$GB$GB
240704961$24070496$1$I$20240705$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47735$$FDA-CTU$$64$YR$$F$N$$$20240709$N$HP$US$
240704971$24070497$1$I$20240513$20240709$20240709$20240709$DIR$709656$$FDA-CTU$$49$YR$$M$N$83.25$KG$20240709$N$HP$US$
240704991$24070499$1$I$$20240404$20240710$20240710$PER$$IN-ROCHE-3539487$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$IN$IN
240705001$24070500$1$I$20240101$20240229$20240710$20240710$PER$$CN-ROCHE-3519077$ROCHE$$$$$M$Y$$$20240628$$CN$CN$CN
240705011$24070501$1$I$$20240508$20240710$20240710$PER$$JP-ROCHE-3567231$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240705021$24070502$1$I$$20240505$20240710$20240710$PER$$FR-ROCHE-3561313$ROCHE$$$$$$Y$$$20240628$$MD$FR$FR
240705031$24070503$1$I$$20231016$20240710$20240710$PER$$DE-ROCHE-3443839$ROCHE$$$$A$F$Y$$$20240628$$PH$DE$DE
240705041$24070504$1$I$20231201$20231226$20240710$20240710$PER$$JP-ROCHE-3483372$ROCHE$$5$DEC$A$F$Y$$$20240628$$MD$JP$JP
240705051$24070505$1$I$20240416$20240511$20240710$20240710$PER$$CN-ROCHE-3562625$ROCHE$$65$YR$E$M$Y$$$20240628$$MD$CN$CN
240705061$24070506$1$I$20231210$20231213$20240710$20240710$PER$$TR-ROCHE-3475685$ROCHE$$32$YR$A$M$Y$93$KG$20240628$$MD$TR$TR
240705071$24070507$1$I$20231102$20231128$20240710$20240710$PER$$VN-ROCHE-3468633$ROCHE$$$$A$F$Y$$$20240628$$MD$VN$VN
240705081$24070508$1$I$$20230905$20240710$20240710$PER$$US-ROCHE-3419362$ROCHE$Hunt A, Nutcharoen A, Randall J, Papazian A, Deeken J, Maxwell L, Bateman N, Petricoin E, Benyounes A, Conrads T and Cannon T. Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer. DOI: 10.1093/oncolo/oyad129. Oncologist 2023 Aug;28 (8):730-6.$49$YR$A$F$Y$$$20240628$$HP$US$US
240705091$24070509$1$I$$20240319$20240710$20240710$PER$$JP-ROCHE-3547540$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240705101$24070510$1$I$20220101$20240517$20240710$20240710$PER$$US-ROCHE-3566884$ROCHE$$52$YR$A$M$Y$92.99$KG$20240628$$CN$US$US
240705112$24070511$2$F$$20230926$20240710$20240710$PER$$TH-ROCHE-3431797$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$TH$TH
240705121$24070512$1$I$$20240118$20240710$20240710$PER$$US-ROCHE-3495165$ROCHE$$62$YR$A$F$Y$$$20240628$$CN$US$US
240705131$24070513$1$I$$20240516$20240710$20240710$PER$$ES-ROCHE-3566312$ROCHE$$$$A$F$Y$62$KG$20240628$$MD$ES$ES
240705141$24070514$1$I$20240131$20240314$20240710$20240710$PER$$JP-ROCHE-3544294$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240705151$24070515$1$I$20240101$20240306$20240710$20240710$PER$$JP-ROCHE-3536124$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240705161$24070516$1$I$$20240510$20240710$20240710$PER$$EC-ROCHE-3563890$ROCHE$$$$$F$Y$$$20240628$$MD$EC$EC
240705171$24070517$1$I$20240501$20240502$20240710$20240710$PER$$US-ROCHE-3558059$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240705182$24070518$2$F$20240305$20240430$20240710$20240710$PER$$IN-ROCHE-3556713$ROCHE$$63$YR$A$M$Y$$$20240628$$CN$IN$IN
240705191$24070519$1$I$$20240119$20240710$20240710$PER$$US-ROCHE-3497191$ROCHE$$44$YR$A$F$Y$$$20240628$$MD$US$US
240705201$24070520$1$I$$20240304$20240710$20240710$PER$$JP-ROCHE-3534418$ROCHE$$6$DEC$A$F$Y$$$20240628$$HP$JP$JP
240705211$24070521$1$I$$20230927$20240710$20240710$PER$$US-ROCHE-3431920$ROCHE$$$$A$M$Y$$$20240628$$CN$US$US
240705221$24070522$1$I$20230917$20231017$20240710$20240710$PER$$CN-ROCHE-3441735$ROCHE$$65$YR$E$M$Y$60$KG$20240628$$HP$CN$CN
240705231$24070523$1$I$$20240410$20240710$20240710$PER$$JP-ROCHE-3559415$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240705241$24070524$1$I$20240205$20240412$20240710$20240710$PER$$IT-ROCHE-3546163$ROCHE$$52$YR$A$F$Y$70$KG$20240628$$MD$IT$IT
240705251$24070525$1$I$$20230717$20240710$20240710$PER$$US-ROCHE-3391144$ROCHE$$80$YR$E$F$Y$$$20240628$$CN$US$US
240705261$24070526$1$I$20240205$20240227$20240710$20240710$PER$$CN-ROCHE-3517399$ROCHE$$63$YR$A$F$Y$$$20240628$$HP$CN$CN
240705271$24070527$1$I$$20240513$20240710$20240710$PER$$CA-ROCHE-3563823$ROCHE$$76$YR$E$M$Y$$$20240628$$HP$CA$CA
240705281$24070528$1$I$20231002$20231225$20240710$20240710$PER$$JP-ROCHE-3484183$ROCHE$$$$A$F$Y$$$20240628$$CN$JP$JP
240705291$24070529$1$I$$20240418$20240710$20240710$PER$$IN-ROCHE-3551389$ROCHE$$44$YR$A$F$Y$$$20240628$$MD$IN$IN
240705301$24070530$1$I$$20240515$20240710$20240710$PER$$GB-ROCHE-3566497$ROCHE$$$$$$Y$$$20240628$$MD$GB$GB
240705311$24070531$1$I$$20240312$20240710$20240710$PER$$RO-ROCHE-3526859$ROCHE$$77$YR$E$F$Y$60$KG$20240628$$CN$RO$RO
240705321$24070532$1$I$$20240208$20240710$20240710$PER$$CH-ROCHE-3508304$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240705331$24070533$1$I$20240118$20240124$20240710$20240710$PER$$JP-ROCHE-3504253$ROCHE$$54$YR$A$F$Y$44$KG$20240628$$MD$JP$JP
240705341$24070534$1$I$20231017$20231229$20240710$20240710$PER$NO-NOMAADVRE-RELISSO-2023-Vz5qwp$NO-ROCHE-3483498$ROCHE$$66$YR$E$F$Y$$$20240628$$HP$NO$NO
240705351$24070535$1$I$$20240402$20240710$20240710$PER$$IN-ROCHE-3539352$ROCHE$$38$YR$A$F$Y$$$20240628$$MD$IN$IN
240705361$24070536$1$I$$20240213$20240710$20240710$PER$$IN-ROCHE-3510687$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$IN$IN
240705371$24070537$1$I$$20240518$20240710$20240710$PER$$US-ROCHE-3567244$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240705381$24070538$1$I$$20240607$20240710$20240710$PER$$GB-ROCHE-3579848$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240705391$24070539$1$I$20240223$20240409$20240710$20240710$PER$$IT-ROCHE-3544028$ROCHE$$64$YR$A$F$Y$66$KG$20240628$$MD$IT$IT
240705401$24070540$1$I$$20230711$20240710$20240710$PER$$CU-ROCHE-3388771$ROCHE$$$$$$Y$$$20240628$$CN$CU$CU
240705411$24070541$1$I$20231220$20231225$20240710$20240710$PER$$VN-ROCHE-3483734$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$VN$VN
240705431$24070543$1$I$$20240528$20240710$20240710$PER$$FI-ROCHE-3572911$ROCHE$$$$$$Y$$$20240628$$MD$FI$FI
240705441$24070544$1$I$$20240506$20240710$20240710$PER$$IN-ROCHE-3559514$ROCHE$$49$YR$A$F$Y$$$20240628$$CN$IN$IN
240705451$24070545$1$I$$20231114$20240710$20240710$PER$$US-ROCHE-3458579$ROCHE$$79$YR$E$M$Y$$$20240628$$CN$US$US
240705471$24070547$1$I$$20240604$20240710$20240710$PER$$KR-ROCHE-3577006$ROCHE$$62$YR$A$M$Y$$$20240628$$CN$KR$KR
240705481$24070548$1$I$20240101$20240209$20240710$20240710$PER$$CA-ROCHE-3510128$ROCHE$$51$YR$A$M$Y$$$20240628$$CN$CA$CA
240705491$24070549$1$I$$20240709$20240709$20240709$DIR$709575$$FDA-CTU$$$$$UNK$N$$$20240709$$CN$US$
240705501$24070550$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47762$$FDA-CTU$$55$YR$$F$N$$$20240709$N$$US$
240705511$24070551$1$I$$20231204$20240710$20240710$PER$$IN-ROCHE-3360713$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240705521$24070552$1$I$$20240425$20240710$20240710$PER$$CL-ROCHE-3556109$ROCHE$$85$YR$E$M$Y$$$20240628$$CN$CL$CL
240705531$24070553$1$I$20220621$20240306$20240710$20240710$PER$$CU-ROCHE-3200408$ROCHE$$64$YR$A$F$Y$62$KG$20240628$$MD$CU$CU
240705541$24070554$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47739$$FDA-CTU$$74$YR$$M$N$$$20240709$N$$US$
240705551$24070555$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47666$$FDA-CTU$$53$YR$$F$N$$$20240709$N$HP$US$
240705571$24070557$1$I$$20240422$20240710$20240710$PER$$IN-ROCHE-3553847$ROCHE$$90$YR$E$M$Y$$$20240628$$CN$IN$IN
240705581$24070558$1$I$20231204$20231204$20240710$20240710$PER$$JP-ROCHE-3474818$ROCHE$$89$YR$E$F$Y$$$20240628$$PH$JP$JP
240705591$24070559$1$I$$20240709$20240709$20240709$DIR$709580$$FDA-CTU$$$$$UNK$N$$$20240709$$CN$US$
240705601$24070560$1$I$20240708$20240709$20240709$20240709$DIR$709590$$FDA-CTU$$$$$UNK$N$$$20240709$N$CN$US$
240705611$24070561$1$I$20240709$20240709$20240709$20240709$DIR$709619$$FDA-CTU$$73$YR$$M$N$$$20240709$$CN$US$
240705631$24070563$1$I$20230101$20240205$20240710$20240710$PER$$JP-ROCHE-3511123$ROCHE$$9$DEC$E$$Y$$$20240628$$MD$JP$JP
240705641$24070564$1$I$$20231228$20240710$20240710$PER$$IN-ROCHE-3483996$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$IN$IN
240705671$24070567$1$I$$20230727$20240710$20240710$PER$$IN-ROCHE-3396300$ROCHE$$54$YR$A$F$Y$$$20240628$$MD$IN$IN
240705681$24070568$1$I$20211230$20240416$20240710$20240710$PER$$TR-ROCHE-3028445$ROCHE$$29$YR$A$F$Y$58$KG$20240628$$MD$TR$TR
240705691$24070569$1$I$$20240601$20240710$20240710$PER$$MY-ROCHE-3580133$ROCHE$$$$$$Y$$$20240628$$CN$MY$MY
240705701$24070570$1$I$20230307$20231123$20240710$20240710$PER$$TR-ROCHE-3345471$ROCHE$$63$YR$A$F$Y$$$20240628$$MD$TR$TR
240705711$24070571$1$I$20240403$20240528$20240710$20240710$PER$$JP-ROCHE-3577835$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240705741$24070574$1$I$$20240411$20240710$20240710$PER$$JP-ROCHE-3559338$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240705761$24070576$1$I$$20240328$20240710$20240710$PER$$JP-ROCHE-3553729$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240705771$24070577$1$I$20240417$20240419$20240710$20240710$PER$$US-ROCHE-3550564$ROCHE$$52$YR$A$M$Y$$$20240628$$CN$US$US
240705782$24070578$2$F$20240708$20240718$20240710$20240731$PER$$US-JNJFOC-20240720010$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240731$$CN$US$US
240705791$24070579$1$I$20240226$20240409$20240710$20240710$PER$$JP-ROCHE-3559331$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240705811$24070581$1$I$$20240709$20240710$20240710$PER$$US-JNJFOC-20240723080$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$HP$US$US
240705821$24070582$1$I$20240323$20240418$20240710$20240710$PER$IT-MINISAL02-980671$IT-ROCHE-3548404$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$IT$IT
240705831$24070583$1$I$$20240214$20240710$20240710$PER$$JP-ROCHE-3517106$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240705841$24070584$1$I$$20240429$20240710$20240710$PER$$KR-ROCHE-3555446$ROCHE$$75$YR$E$M$Y$$$20240628$$CN$KR$KR
240705851$24070585$1$I$$20230919$20240710$20240710$PER$$CN-ROCHE-3425678$ROCHE$$53$YR$A$M$Y$$$20240628$$MD$CN$CN
240705861$24070586$1$I$$20231002$20240710$20240710$PER$$US-ROCHE-3432828$ROCHE$$71$YR$E$F$Y$$$20240628$$CN$US$US
240705881$24070588$1$I$20220511$20240318$20240710$20240710$PER$$KR-ROCHE-3529733$ROCHE$$68$YR$E$F$Y$$$20240628$$HP$KR$KR
240705891$24070589$1$I$$20240515$20240710$20240710$PER$$GB-ROCHE-3566487$ROCHE$$$$$$Y$$$20240628$$MD$GB$GB
240705901$24070590$1$I$$20230927$20240710$20240710$PER$$IN-ROCHE-3364249$ROCHE$$$$$$Y$$$20240628$$MD$IN$IN
240705911$24070591$1$I$20220715$20240222$20240710$20240710$PER$$AU-ROCHE-3149656$ROCHE$$59$YR$A$M$Y$86.7$KG$20240628$$MD$AU$AU
240705921$24070592$1$I$$20240206$20240710$20240710$PER$$JP-ROCHE-3512604$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240705931$24070593$1$I$$20230919$20240710$20240710$PER$$IN-ROCHE-3426032$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$IN$IN
240705941$24070594$1$I$$20240412$20240710$20240710$PER$$JP-ROCHE-3559136$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240705951$24070595$1$I$20240401$20240419$20240710$20240710$PER$$JP-ROCHE-3561501$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240705961$24070596$1$I$20230708$20230709$20240710$20240710$PER$$ID-ROCHE-3387936$ROCHE$$$$$$Y$$$20240628$$MD$ID$ID
240705971$24070597$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47689$$FDA-CTU$$$$$M$N$$$20240708$N$HP$US$
240705981$24070598$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47757$$FDA-CTU$$23$YR$$F$N$$$20240708$N$PH$US$
240705991$24070599$1$I$$20240307$20240710$20240710$PER$$US-ROCHE-3523618$ROCHE$$71$YR$E$M$Y$$$20240628$$MD$US$US
240706001$24070600$1$I$$20240207$20240710$20240710$PER$$SG-ROCHE-3507852$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$SG$SG
240706021$24070602$1$I$20240319$20240709$20240709$20240709$DIR$709611$$FDA-CTU$$82$YR$$F$N$53.55$KG$20240709$N$CN$US$
240706031$24070603$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47692$$FDA-CTU$$78$YR$$F$N$54.88$KG$20240709$N$$US$
240706041$24070604$1$I$20230622$20230928$20240710$20240710$PER$IT-MINISAL02-945623$IT-ROCHE-3430609$ROCHE$$80$YR$E$F$Y$105$KG$20240628$$MD$IT$IT
240706051$24070605$1$I$$20230918$20240710$20240710$PER$$IN-ROCHE-3424849$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
240706061$24070606$1$I$$20240513$20240710$20240710$PER$$IN-ROCHE-3562905$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$IN$IN
240706071$24070607$1$I$$20231108$20240710$20240710$PER$$US-ROCHE-3455505$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240706091$24070609$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47681$$FDA-CTU$$53$YR$$F$N$68.95$KG$20240709$N$$US$
240706101$24070610$1$I$20240630$20240709$20240709$20240709$DIR$709662$$FDA-CTU$$67$YR$$F$N$51.3$KG$20240709$N$CN$US$
240706111$24070611$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47709$$FDA-CTU$$76$YR$$F$N$$$20240709$N$$US$
240706121$24070612$1$I$$20240513$20240710$20240710$PER$$US-ROCHE-3563754$ROCHE$$58$YR$A$M$Y$$$20240628$$MD$US$US
240706131$24070613$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3526924$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240706141$24070614$1$I$$20240415$20240710$20240710$PER$$AU-ROCHE-3164933$ROCHE$$81$YR$E$F$Y$$$20240628$$CN$AU$AU
240706151$24070615$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47688$$FDA-CTU$$59$YR$$M$N$94.8$KG$20240709$N$$US$
240706171$24070617$1$I$20240707$20240709$20240709$20240709$DIR$709671$$FDA-CTU$$36$YR$$F$N$90$KG$20240709$N$CN$US$
240706182$24070618$2$F$$20240306$20240710$20240710$PER$$US-ROCHE-3522556$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$US$US
240706211$24070621$1$I$$20240319$20240710$20240710$PER$$JP-ROCHE-3547531$ROCHE$$$$A$F$Y$$$20240628$$PH$JP$JP
240706221$24070622$1$I$$20240529$20240710$20240710$PER$$US-ROCHE-3573465$ROCHE$$64$YR$A$M$Y$$$20240628$$MD$US$US
240706231$24070623$1$I$$20240426$20240710$20240710$PER$$FR-ROCHE-3555164$ROCHE$$88$YR$E$$Y$$$20240628$$MD$FR$FR
240706242$24070624$2$F$20240106$20240126$20240710$20240710$PER$$JP-ROCHE-3505197$ROCHE$$50$YR$A$F$Y$$$20240628$$MD$JP$JP
240706251$24070625$1$I$$20230923$20240710$20240710$PER$$IN-ROCHE-3428861$ROCHE$$34$YR$A$F$Y$$$20240628$$MD$IN$IN
240706261$24070626$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3526954$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240706281$24070628$1$I$$20240227$20240710$20240710$PER$$US-ROCHE-3517558$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$US$US
240706291$24070629$1$I$20240213$20240314$20240710$20240710$PER$$JP-ROCHE-3544080$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240706301$24070630$1$I$$20240425$20240710$20240710$PER$$FR-ROCHE-3554270$ROCHE$$$$$F$Y$$$20240628$$MD$FR$FR
240706311$24070631$1$I$$20230729$20240710$20240710$PER$$IN-ROCHE-3397227$ROCHE$$52$YR$A$F$Y$$$20240628$$CN$IN$IN
240706321$24070632$1$I$$20240523$20240710$20240710$PER$$US-ROCHE-3570135$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240706331$24070633$1$I$20240404$20240408$20240710$20240710$PER$GB-MHRA-MED-202404050947427930-RJFVL$GB-ROCHE-3542381$ROCHE$$53$YR$A$F$Y$$$20240628$$HP$GB$GB
240706341$24070634$1$I$$20240208$20240710$20240710$PER$$JP-ROCHE-3512621$ROCHE$$$$E$F$Y$$$20240628$$PH$JP$JP
240706351$24070635$1$I$$20240409$20240710$20240710$PER$$ZA-ROCHE-3543693$ROCHE$$32$YR$A$M$Y$$$20240628$$CN$ZA$ZA
240706361$24070636$1$I$20231006$20231228$20240710$20240710$PER$$RS-ROCHE-3483591$ROCHE$$55$YR$A$F$Y$91$KG$20240628$$MD$RS$RS
240706371$24070637$1$I$$20240514$20240710$20240710$PER$$TW-ROCHE-3563990$ROCHE$$$$$$Y$$$20240628$$MD$TW$TW
240706381$24070638$1$I$$20240322$20240710$20240710$PER$$IN-ROCHE-3533079$ROCHE$$36$YR$A$F$Y$$$20240628$$CN$IN$IN
240706391$24070639$1$I$$20240305$20240710$20240710$PER$$IN-ROCHE-3521863$ROCHE$$46$YR$A$F$Y$$$20240628$$CN$IN$IN
240706401$24070640$1$I$$20230831$20240710$20240710$PER$$US-ROCHE-3415127$ROCHE$$72$YR$E$F$Y$$$20240628$$CN$US$US
240706411$24070641$1$I$$20240423$20240710$20240710$PER$$SG-ROCHE-3553508$ROCHE$$56$YR$A$F$Y$$$20240628$$CN$SG$SG
240706421$24070642$1$I$$20231127$20240710$20240710$PER$$CO-ROCHE-3467776$ROCHE$$43$YR$A$M$Y$$$20240628$$CN$CO$CO
240706431$24070643$1$I$$20240502$20240710$20240710$PER$$US-ROCHE-3558286$ROCHE$$51$YR$A$F$Y$$$20240628$$HP$US$US
240706441$24070644$1$I$$20230812$20240710$20240710$PER$$PH-ROCHE-3406649$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$PH$PH
240706451$24070645$1$I$20240201$20240314$20240710$20240710$PER$$JP-ROCHE-3544113$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$JP$JP
240706461$24070646$1$I$$20231104$20240710$20240710$PER$$IN-ROCHE-3454003$ROCHE$$69$YR$E$F$Y$$$20240628$$MD$IN$IN
240706471$24070647$1$I$$20240508$20240710$20240710$PER$$IN-ROCHE-3561273$ROCHE$$75$YR$E$F$Y$$$20240628$$CN$IN$IN
240706481$24070648$1$I$$20231229$20240710$20240710$PER$$IN-ROCHE-3483825$ROCHE$$70$YR$E$F$Y$$$20240628$$CN$IN$IN
240706491$24070649$1$I$$20240403$20240710$20240710$PER$$JP-ROCHE-3556200$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240706501$24070650$1$I$$20240327$20240710$20240710$PER$$CN-ROCHE-3534930$ROCHE$$$$A$F$Y$$$20240628$$MD$CN$CN
240706511$24070651$1$I$$20240515$20240710$20240710$PER$$IN-ROCHE-3565374$ROCHE$$46$YR$A$F$Y$$$20240628$$MD$IN$IN
240706521$24070652$1$I$$20240503$20240710$20240710$PER$$US-ROCHE-3558688$ROCHE$$81$YR$E$F$Y$$$20240628$$HP$US$US
240706531$24070653$1$I$$20240513$20240710$20240710$PER$$IN-ROCHE-3563691$ROCHE$$43$YR$A$F$Y$$$20240628$$MD$IN$IN
240706541$24070654$1$I$20240501$20240508$20240710$20240710$PER$$JP-ROCHE-3566872$ROCHE$$8$DEC$E$$Y$$$20240628$$MD$JP$JP
240706551$24070655$1$I$$20240315$20240710$20240710$PER$$US-ROCHE-3527898$ROCHE$$57$YR$A$M$Y$$$20240628$$CN$US$US
240706561$24070656$1$I$$20240417$20240710$20240710$PER$$US-ROCHE-3549115$ROCHE$$66$YR$E$F$Y$$$20240628$$HP$US$US
240706571$24070657$1$I$$20240207$20240710$20240710$PER$$MX-ROCHE-3508177$ROCHE$$62$YR$A$F$Y$65$KG$20240628$$CN$MX$MX
240706591$24070659$1$I$$20240604$20240710$20240710$PER$$KR-ROCHE-3577213$ROCHE$$76$YR$E$M$Y$$$20240628$$CN$KR$KR
240706601$24070660$1$I$20201214$20240325$20240710$20240710$PER$$CN-ROCHE-3532437$ROCHE$$40$YR$A$F$Y$$$20240628$$CN$CN$CN
240706611$24070661$1$I$$20240419$20240710$20240710$PER$$JP-ROCHE-3561428$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240706621$24070662$1$I$20231117$20231120$20240710$20240710$PER$$NO-ROCHE-3463613$ROCHE$$$$$$Y$$$20240628$$PH$NO$NO
240706631$24070663$1$I$$20240423$20240710$20240710$PER$$FR-ROCHE-3553224$ROCHE$$$$$F$Y$$$20240628$$MD$FR$FR
240706641$24070664$1$I$20240427$20240521$20240710$20240710$PER$IT-MINISAL02-985348$IT-ROCHE-3567417$ROCHE$$78$YR$E$F$Y$$$20240628$$MD$IT$IT
240706651$24070665$1$I$$20240403$20240710$20240710$PER$$JP-ROCHE-3557679$ROCHE$$5$DEC$A$F$Y$$$20240628$$HP$JP$JP
240706661$24070666$1$I$$20240502$20240710$20240710$PER$$IN-ROCHE-3557328$ROCHE$$73$YR$E$M$Y$$$20240628$$CN$IN$IN
240706671$24070667$1$I$$20230811$20240710$20240710$PER$$IN-ROCHE-3405088$ROCHE$$45$YR$A$M$Y$$$20240628$$MD$IN$IN
240706681$24070668$1$I$20240101$20240502$20240710$20240710$PER$$US-ROCHE-3557591$ROCHE$$74$YR$E$F$Y$74.84$KG$20240628$$CN$US$US
240706691$24070669$1$I$$20240430$20240710$20240710$PER$$IN-ROCHE-3556767$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$IN$IN
240706701$24070670$1$I$$20231123$20240710$20240710$PER$$IN-ROCHE-3465833$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$IN$IN
240706711$24070671$1$I$$20231113$20240710$20240710$PER$$PH-ROCHE-3457049$ROCHE$$78$YR$E$F$Y$$$20240628$$CN$PH$PH
240706721$24070672$1$I$$20240411$20240710$20240710$PER$$JP-ROCHE-3559144$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240706731$24070673$1$I$$20240425$20240710$20240710$PER$$BE-ROCHE-3554238$ROCHE$$$$$F$Y$$$20240628$$MD$BE$BE
240706741$24070674$1$I$$20240110$20240710$20240710$PER$$EG-ROCHE-3489925$ROCHE$$75$YR$E$M$Y$$$20240628$$CN$EG$EG
240706751$24070675$1$I$$20231218$20240710$20240710$PER$$CZ-ROCHE-3480150$ROCHE$$$$$F$Y$$$20240628$$MD$CZ$CZ
240706761$24070676$1$I$$20240207$20240710$20240710$PER$$CO-ROCHE-3508025$ROCHE$$$$$F$Y$$$20240628$$MD$CO$CO
240706771$24070677$1$I$20240105$20240219$20240710$20240710$PER$$JP-ROCHE-3520416$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240706781$24070678$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47701$$FDA-CTU$$$$$M$N$$$20240708$N$HP$US$
240706791$24070679$1$I$$20240708$20240710$20240710$EXP$$CA-UCBSA-2024034529$UCB$$60$YR$$F$Y$67$KG$20240710$$HP$CA$CA
240706801$24070680$1$I$$20240501$20240710$20240710$PER$$IN-ROCHE-3557187$ROCHE$$64$YR$A$F$Y$$$20240628$$CN$IN$IN
240706811$24070681$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47782$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240706821$24070682$1$I$$20240522$20240710$20240710$PER$$US-ROCHE-3568985$ROCHE$$61$YR$A$F$Y$$$20240628$$HP$US$US
240706831$24070683$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47778$$FDA-CTU$$$$$M$N$$$20240708$N$HP$US$
240706841$24070684$1$I$$20230829$20240710$20240710$PER$$US-ROCHE-3413707$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$US$US
240706851$24070685$1$I$$20240129$20240710$20240710$PER$$IN-ROCHE-3501443$ROCHE$$77$YR$E$F$Y$$$20240628$$MD$IN$IN
240706861$24070686$1$I$20240630$20240709$20240709$20240709$DIR$709649$$FDA-CTU$$59$YR$$M$N$106$KG$20240709$N$MD$US$
240706881$24070688$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47788$$FDA-CTU$$41$YR$$F$N$$$20240709$N$$US$
240706901$24070690$1$I$$20231010$20240710$20240710$PER$$GB-ROCHE-3439919$ROCHE$$$$$$Y$$$20240628$$CN$GB$GB
240706911$24070691$1$I$$20230921$20240710$20240710$PER$$JP-ROCHE-3429419$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240706941$24070694$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47721$$FDA-CTU$$41$YR$$F$N$$$20240709$N$$US$
240706951$24070695$1$I$$20240122$20240710$20240710$PER$$JP-ROCHE-3501031$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240706961$24070696$1$I$$20240709$20240709$20240709$DIR$709589$$FDA-CTU$$$$$UNK$N$$$20240709$$CN$US$
240706971$24070697$1$I$20240703$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47732$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240706981$24070698$1$I$$20230725$20240710$20240710$PER$$US-ROCHE-3394687$ROCHE$$67$YR$E$F$Y$$$20240628$$MD$US$US
240706991$24070699$1$I$$20240307$20240710$20240710$PER$$US-ROCHE-3523798$ROCHE$$83$YR$E$F$Y$$$20240628$$MD$US$US
240707011$24070701$1$I$$20231204$20240710$20240710$PER$$CA-ROCHE-1959350$ROCHE$$$$A$M$Y$$$20240628$$CN$CA$CA
240707021$24070702$1$I$20240112$20240221$20240710$20240710$PER$$JP-ROCHE-3521229$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240707031$24070703$1$I$20240228$20240503$20240710$20240710$PER$$DE-ROCHE-3558845$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$DE$DE
240707041$24070704$1$I$$20240130$20240710$20240710$PER$$IN-ROCHE-3502251$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$IN$IN
240707052$24070705$2$F$$20240304$20240710$20240710$PER$$PH-ROCHE-3520155$ROCHE$$53$YR$A$F$Y$61.5$KG$20240628$$CN$PH$PH
240707061$24070706$1$I$20240201$20240221$20240710$20240710$PER$$JP-ROCHE-3517891$ROCHE$$82$YR$E$F$Y$$$20240628$$MD$JP$JP
240707071$24070707$1$I$$20240419$20240710$20240710$PER$$BR-ROCHE-3550803$ROCHE$$$$$$Y$$$20240628$$MD$BR$BR
240707081$24070708$1$I$20231005$20240104$20240710$20240710$PER$$MX-ROCHE-3487635$ROCHE$$$$$F$Y$62$KG$20240628$$CN$MX$MX
240707091$24070709$1$I$20240425$20240425$20240710$20240710$PER$$CN-ROCHE-3553643$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$CN$CN
240707101$24070710$1$I$20231004$20231225$20240710$20240710$PER$$JP-ROCHE-3484299$ROCHE$$$$A$$Y$$$20240628$$CN$JP$JP
240707111$24070711$1$I$$20240508$20240710$20240710$PER$$JP-ROCHE-3566570$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240707121$24070712$1$I$$20231122$20240710$20240710$PER$$CN-ROCHE-3239804$ROCHE$$66$YR$E$M$Y$$$20240628$$CN$CN$CN
240707132$24070713$2$F$$20240719$20240710$20240730$EXP$$BE-AUROBINDO-AUR-APL-2024-033218$AUROBINDO$$$$$M$Y$$$20240730$$PH$BE$BE
240707151$24070715$1$I$$20230711$20240710$20240710$PER$$CU-ROCHE-3388749$ROCHE$$$$$$Y$$$20240628$$CN$CU$CU
240707161$24070716$1$I$$20231005$20240710$20240710$PER$$AR-ROCHE-3435311$ROCHE$$$$$M$Y$$$20240628$$MD$AR$AR
240707171$24070717$1$I$$20240517$20240710$20240710$PER$$US-ROCHE-3566604$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240707181$24070718$1$I$$20240415$20240710$20240710$PER$$AU-ROCHE-3165002$ROCHE$$81$YR$E$F$Y$$$20240628$$CN$AU$AU
240707191$24070719$1$I$$20240415$20240710$20240710$PER$$RO-ROCHE-3547161$ROCHE$$79$YR$E$F$Y$95$KG$20240628$$CN$RO$RO
240707201$24070720$1$I$$20240425$20240710$20240710$PER$$US-ROCHE-3553681$ROCHE$$47$YR$A$F$Y$$$20240628$$MD$US$US
240707211$24070721$1$I$$20230705$20240710$20240710$PER$$US-ROCHE-3383730$ROCHE$$77$YR$E$F$Y$$$20240628$$MD$US$US
240707221$24070722$1$I$$20240220$20240710$20240710$PER$$US-ROCHE-3513812$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$US$US
240707231$24070723$1$I$$20240130$20240710$20240710$PER$$GB-ROCHE-3502114$ROCHE$$51$YR$A$F$Y$$$20240628$$HP$GB$GB
240707241$24070724$1$I$$20240313$20240710$20240710$PER$$JP-ROCHE-3543891$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240707251$24070725$1$I$$20240516$20240710$20240710$PER$$ZA-ROCHE-3567464$ROCHE$$$$$M$Y$$$20240628$$MD$ZA$ZA
240707261$24070726$1$I$$20240709$20240709$20240709$DIR$709574$$FDA-CTU$$$$$UNK$N$$$20240709$$CN$US$
240707281$24070728$1$I$20240212$20240709$20240709$20240709$DIR$709596$$FDA-CTU$$73$YR$$F$N$89.82$KG$20240709$N$MD$US$
240707291$24070729$1$I$20231001$20240709$20240709$20240709$DIR$709560$$FDA-CTU$$74$YR$$F$N$103.5$KG$20240709$N$CN$US$
240707301$24070730$1$I$20230511$20231124$20240710$20240710$PER$$IT-ROCHE-3357307$ROCHE$$67$YR$E$F$Y$77$KG$20240628$$MD$IT$IT
240707311$24070731$1$I$$20230817$20240710$20240710$PER$$TH-ROCHE-3408137$ROCHE$$65$YR$E$F$Y$$$20240628$$PH$TH$TH
240707321$24070732$1$I$$20240314$20240710$20240710$PER$$US-ROCHE-3527037$ROCHE$$60$YR$A$M$Y$$$20240628$$CN$US$US
240707331$24070733$1$I$20240616$20240709$20240709$20240709$DIR$709608$$FDA-CTU$$71$YR$$F$N$81.4$KG$20240709$N$$US$
240707341$24070734$1$I$20240709$20240709$20240709$20240709$DIR$709553$$FDA-CTU$$47$YR$$F$N$83.25$KG$20240709$N$CN$US$
240707351$24070735$1$I$20240707$20240709$20240709$20240709$DIR$709579$$FDA-CTU$$39$YR$$UNK$N$67.5$KG$20240709$N$HP$US$
240707361$24070736$1$I$20230101$20240426$20240710$20240710$PER$$US-ROCHE-3554643$ROCHE$$94$YR$E$F$Y$64.41$KG$20240628$$CN$US$US
240707371$24070737$1$I$$20240523$20240710$20240710$PER$$JP-ROCHE-3576055$ROCHE$$$$E$$Y$$$20240628$$MD$JP$JP
240707381$24070738$1$I$$20240509$20240710$20240710$PER$$RO-ROCHE-3562850$ROCHE$$65$YR$E$F$Y$58$KG$20240628$$CN$RO$RO
240707391$24070739$1$I$20240116$20240207$20240710$20240710$PER$$JP-ROCHE-3512627$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240707411$24070741$1$I$$20230818$20240710$20240710$PER$$IN-ROCHE-3357543$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240707421$24070742$1$I$$20230711$20240710$20240710$PER$$US-ROCHE-3387080$ROCHE$$$$$M$Y$$$20240628$$CN$US$US
240707441$24070744$1$I$$20240118$20240710$20240710$PER$$IN-ROCHE-3496178$ROCHE$$65$YR$E$F$Y$$$20240628$$MD$IN$IN
240707451$24070745$1$I$$20231103$20240710$20240710$PER$$GB-ROCHE-3453156$ROCHE$$$$$F$Y$$$20240628$$CN$GB$GB
240707461$24070746$1$I$$20240529$20240710$20240710$PER$$US-ROCHE-3572698$ROCHE$$54$YR$A$M$Y$$$20240628$$MD$US$US
240707471$24070747$1$I$$20240606$20240710$20240710$PER$$IN-ROCHE-3578734$ROCHE$$43$YR$A$F$Y$$$20240628$$MD$IN$IN
240707481$24070748$1$I$$20240215$20240710$20240710$PER$$US-ROCHE-3511369$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240707491$24070749$1$I$$20240517$20240710$20240710$PER$$JP-ROCHE-3573324$ROCHE$$9$DEC$E$F$Y$$$20240628$$PH$JP$JP
240707501$24070750$1$I$$20240227$20240710$20240710$PER$$US-ROCHE-3318401$ROCHE$$76$YR$E$M$Y$$$20240628$$CN$US$US
240707511$24070751$1$I$20230725$20240424$20240710$20240710$PER$$TR-ROCHE-3553139$ROCHE$$63$YR$A$M$Y$$$20240628$$MD$TR$TR
240707521$24070752$1$I$20240410$20240410$20240710$20240710$PER$$JP-ROCHE-3559277$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240707531$24070753$1$I$$20231222$20240710$20240710$PER$$IN-ROCHE-3482363$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240707541$24070754$1$I$$20240228$20240710$20240710$PER$$US-ROCHE-3518799$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$US$US
240707551$24070755$1$I$20240318$20240326$20240710$20240710$PER$$JP-ROCHE-3550346$ROCHE$$$$A$F$Y$$$20240628$$PH$JP$JP
240707561$24070756$1$I$20231217$20231225$20240710$20240710$PER$$JP-ROCHE-3483501$ROCHE$$$$A$$Y$$$20240628$$CN$JP$JP
240707571$24070757$1$I$$20240523$20240710$20240710$PER$$US-ROCHE-3570412$ROCHE$$88$YR$E$M$Y$$$20240628$$MD$US$US
240707581$24070758$1$I$20220816$20240318$20240710$20240710$PER$$KR-ROCHE-3529669$ROCHE$$82$YR$E$M$Y$$$20240628$$HP$KR$KR
240707591$24070759$1$I$20221201$20230731$20240710$20240710$PER$$US-ROCHE-3397803$ROCHE$$57$YR$A$F$Y$95.25$KG$20240628$$CN$US$US
240707601$24070760$1$I$20220901$20240314$20240710$20240710$PER$$PE-ROCHE-3528367$ROCHE$$35$YR$A$M$Y$74$KG$20240628$$MD$PE$PE
240707611$24070761$1$I$20240228$20240501$20240710$20240710$PER$$US-ROCHE-3557115$ROCHE$$77$YR$E$F$Y$76.3$KG$20240628$$MD$US$US
240707621$24070762$1$I$$20240418$20240710$20240710$PER$$US-ROCHE-3549606$ROCHE$$59$YR$A$M$Y$$$20240628$$MD$US$US
240707631$24070763$1$I$20240504$20240507$20240710$20240710$PER$$IN-ROCHE-3559398$ROCHE$$62$YR$A$M$Y$$$20240628$$CN$IN$IN
240707641$24070764$1$I$20230828$20231012$20240710$20240710$PER$$JP-ROCHE-3441526$ROCHE$$$$A$F$Y$$$20240628$$PH$JP$JP
240707651$24070765$1$I$$20240517$20240710$20240710$PER$$JP-ROCHE-3572118$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240707661$24070766$1$I$20220714$20240117$20240710$20240710$PER$$IT-ROCHE-3147151$ROCHE$$61$YR$A$M$Y$67$KG$20240628$$MD$IT$IT
240707671$24070767$1$I$$20240424$20240710$20240710$PER$$IN-ROCHE-3554554$ROCHE$$67$YR$E$M$Y$$$20240628$$CN$IN$IN
240707681$24070768$1$I$20231215$20240320$20240710$20240710$PER$ES-AEMPS-1498157$ES-ROCHE-3529872$ROCHE$$78$YR$E$F$Y$$$20240628$$PH$ES$ES
240707691$24070769$1$I$$20230928$20240710$20240710$PER$$IN-ROCHE-3431630$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$IN$IN
240707702$24070770$2$F$$20230703$20240710$20240710$PER$$HK-ROCHE-3382795$ROCHE$$$$A$F$Y$$$20240628$$CN$HK$HK
240707711$24070771$1$I$20240523$20240524$20240710$20240710$PER$$JP-ROCHE-3575818$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240707721$24070772$1$I$$20240229$20240710$20240710$PER$$GR-ROCHE-3521072$ROCHE$$$$$$Y$$$20240628$$MD$GR$GR
240707741$24070774$1$I$20240507$20240509$20240710$20240710$PER$$IN-ROCHE-3563209$ROCHE$$61$YR$A$M$Y$$$20240628$$CN$IN$IN
240707751$24070775$1$I$$20231113$20240710$20240710$PER$$US-ROCHE-3457982$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$US$US
240707761$24070776$1$I$$20231012$20240710$20240710$PER$$CH-ROCHE-3439730$ROCHE$$$$$$Y$$$20240628$$MD$CH$CH
240707771$24070777$1$I$$20240508$20240710$20240710$PER$$CH-ROCHE-3561209$ROCHE$$$$E$$Y$$$20240628$$MD$CH$CH
240707781$24070778$1$I$$20240510$20240710$20240710$PER$$US-ROCHE-3563604$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240707791$24070779$1$I$$20240213$20240710$20240710$PER$$JP-ROCHE-3515499$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240707801$24070780$1$I$$20230925$20240710$20240710$PER$$JP-ROCHE-3431973$ROCHE$$78$YR$E$M$Y$71.9$KG$20240628$$MD$JP$JP
240707821$24070782$1$I$20240101$20240112$20240710$20240710$PER$$JP-ROCHE-3493989$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240707831$24070783$1$I$20240329$20240329$20240710$20240710$PER$$JP-ROCHE-3551742$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$JP$JP
240707841$24070784$1$I$$20240603$20240710$20240710$PER$$EC-ROCHE-3578311$ROCHE$$$$$F$Y$$$20240628$$MD$EC$EC
240707851$24070785$1$I$$20231013$20240710$20240710$PER$$IN-ROCHE-3440844$ROCHE$$58$YR$A$F$Y$$$20240628$$MD$IN$IN
240707861$24070786$1$I$$20231227$20240710$20240710$PER$$RU-ROCHE-3482950$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$RU$RU
240707881$24070788$1$I$$20240528$20240710$20240710$PER$$US-ROCHE-3572638$ROCHE$$50$YR$A$M$Y$$$20240628$$MD$US$US
240707891$24070789$1$I$$20230713$20240710$20240710$PER$$IN-ROCHE-3389922$ROCHE$$59$YR$A$M$Y$$$20240628$$CN$IN$IN
240707901$24070790$1$I$$20231214$20240710$20240710$PER$$RO-ROCHE-3309134$ROCHE$$43$YR$A$F$Y$98$KG$20240628$$CN$RO$RO
240707911$24070791$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3526163$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240707921$24070792$1$I$$20240522$20240710$20240710$PER$$ES-ROCHE-3570262$ROCHE$$$$A$F$Y$67$KG$20240628$$MD$ES$ES
240707931$24070793$1$I$$20240424$20240710$20240710$PER$$JP-ROCHE-3564205$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240707942$24070794$2$F$20220217$20240604$20240710$20240710$PER$$TR-ROCHE-3092865$ROCHE$$51$YR$A$M$Y$70$KG$20240628$$MD$TR$TR
240707951$24070795$1$I$$20240213$20240710$20240710$PER$$US-ROCHE-3510141$ROCHE$$80$YR$E$M$Y$$$20240628$$CN$US$US
240707961$24070796$1$I$$20230803$20240710$20240710$PER$$IN-ROCHE-3400284$ROCHE$$33$YR$A$F$Y$$$20240628$$CN$IN$IN
240707971$24070797$1$I$$20240412$20240710$20240710$PER$$FR-ROCHE-3548054$ROCHE$$$$A$F$Y$$$20240628$$MD$FR$FR
240707981$24070798$1$I$20240216$20240301$20240710$20240710$PER$$JP-ROCHE-3533019$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240707991$24070799$1$I$$20240217$20240710$20240710$PER$$IN-ROCHE-3514299$ROCHE$$49$YR$A$F$Y$$$20240628$$CN$IN$IN
240708001$24070800$1$I$$20240122$20240710$20240710$PER$$RO-ROCHE-3498080$ROCHE$$50$YR$A$F$Y$70$KG$20240628$$CN$RO$RO
240708014$24070801$4$F$20220216$20240508$20240710$20240710$PER$$TR-ROCHE-3032575$ROCHE$$69$YR$E$M$Y$81$KG$20240628$$MD$TR$TR
240708021$24070802$1$I$20231021$20231024$20240710$20240710$PER$$IN-ROCHE-3447438$ROCHE$$56$YR$A$F$Y$$$20240628$$MD$IN$IN
240708031$24070803$1$I$20220512$20240329$20240710$20240710$PER$$CN-ROCHE-3146591$ROCHE$$53$YR$A$F$Y$55$KG$20240628$$MD$CN$CN
240708041$24070804$1$I$$20230711$20240710$20240710$PER$$CU-ROCHE-3388768$ROCHE$$$$$$Y$$$20240628$$CN$CU$CU
240708051$24070805$1$I$$20240310$20240710$20240710$PER$$IL-ROCHE-3526765$ROCHE$$$$E$M$Y$$$20240628$$MD$IL$IL
240708061$24070806$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3526197$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240708071$24070807$1$I$20240311$20240312$20240710$20240710$PER$$JP-ROCHE-3542083$ROCHE$$$$$F$Y$$$20240628$$HP$JP$JP
240708081$24070808$1$I$20240404$20240418$20240710$20240710$PER$$FR-ROCHE-3551565$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$FR$FR
240708091$24070809$1$I$$20240513$20240710$20240710$PER$$RO-ROCHE-3564720$ROCHE$$$$$F$Y$$$20240628$$MD$RO$RO
240708101$24070810$1$I$$20230925$20240710$20240710$PER$$US-ROCHE-3429089$ROCHE$$$$E$F$Y$$$20240628$$HP$US$US
240708111$24070811$1$I$$20240508$20240710$20240710$PER$$KR-ROCHE-3560603$ROCHE$$59$YR$A$M$Y$$$20240628$$CN$KR$KR
240708121$24070812$1$I$$20240529$20240710$20240710$PER$$US-ROCHE-3573075$ROCHE$$60$YR$A$M$Y$$$20240628$$MD$US$US
240708131$24070813$1$I$$20240219$20240710$20240710$PER$$GB-ROCHE-3513745$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240708141$24070814$1$I$20240423$20240426$20240710$20240710$PER$$JP-ROCHE-3565694$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240708151$24070815$1$I$$20240309$20240710$20240710$PER$$IN-ROCHE-3526094$ROCHE$$50$YR$A$F$Y$$$20240628$$CN$IN$IN
240708161$24070816$1$I$$20240223$20240710$20240710$PER$$IN-ROCHE-3515798$ROCHE$$$$$$Y$$$20240628$$CN$IN$IN
240708171$24070817$1$I$$20231221$20240710$20240710$PER$$IN-ROCHE-3480973$ROCHE$$69$YR$E$F$Y$$$20240628$$MD$IN$IN
240708182$24070818$2$F$$20240523$20240710$20240710$PER$$US-ROCHE-3569727$ROCHE$$$$$M$Y$99.79$KG$20240628$$CN$US$US
240708191$24070819$1$I$$20240605$20240710$20240710$PER$$BR-ROCHE-3579936$ROCHE$$$$$F$Y$$$20240628$$HP$BR$BR
240708202$24070820$2$F$20220619$20240525$20240710$20240710$PER$$TR-ROCHE-3550974$ROCHE$$75$YR$E$F$Y$$$20240628$$MD$TR$TR
240708211$24070821$1$I$20240311$20240313$20240710$20240710$PER$$JP-ROCHE-3543973$ROCHE$$57$YR$A$F$Y$$$20240628$$PH$JP$JP
240708231$24070823$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47665$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240708241$24070824$1$I$$20240515$20240710$20240710$PER$$JP-ROCHE-3570597$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240708261$24070826$1$I$20230501$20231024$20240710$20240710$PER$$CN-ROCHE-3350740$ROCHE$$53$YR$A$M$Y$65$KG$20240628$$CN$CN$CN
240708271$24070827$1$I$20240424$20240516$20240710$20240710$PER$IT-MINISAL02-984761$IT-ROCHE-3565107$ROCHE$$48$YR$A$F$Y$80$KG$20240628$$MD$IT$IT
240708281$24070828$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47686$$FDA-CTU$$57$YR$$F$N$63.5$KG$20240709$N$$US$
240708291$24070829$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47678$$FDA-CTU$$49$YR$$F$N$$$20240709$N$$US$
240708301$24070830$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47673$$FDA-CTU$$86$YR$$M$N$65.77$KG$20240709$N$HP$US$
240708311$24070831$1$I$20240311$20240312$20240710$20240710$PER$$JP-ROCHE-3543327$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240708321$24070832$1$I$$20240508$20240710$20240710$PER$$GE-ROCHE-3561067$ROCHE$$$$$F$Y$$$20240628$$MD$GE$GE
240708331$24070833$1$I$$20240501$20240710$20240710$PER$$US-ROCHE-3556996$ROCHE$$92$YR$E$M$Y$$$20240628$$MD$US$US
240708341$24070834$1$I$$20240425$20240710$20240710$PER$$IN-ROCHE-3554380$ROCHE$$59$YR$A$M$Y$$$20240628$$CN$IN$IN
240708351$24070835$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47697$$FDA-CTU$$62$YR$$M$N$83.46$KG$20240709$N$$US$
240708361$24070836$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47713$$FDA-CTU$$60$YR$$F$N$76.2$KG$20240709$N$$US$
240708371$24070837$1$I$$20230816$20240710$20240710$PER$$US-ROCHE-3407147$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240708381$24070838$1$I$$20231009$20240710$20240710$PER$$US-ROCHE-3436350$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$US$US
240708391$24070839$1$I$20240425$20240426$20240710$20240710$PER$$JP-ROCHE-3564213$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240708401$24070840$1$I$20240504$20240604$20240710$20240710$PER$$IN-ROCHE-3577469$ROCHE$$26$YR$A$F$Y$$$20240628$$CN$IN$IN
240708411$24070841$1$I$$20231217$20240710$20240710$PER$$GB-ROCHE-3480166$ROCHE$$$$$$Y$$$20240628$$PH$GB$GB
240708421$24070842$1$I$$20240605$20240710$20240710$PER$$US-ROCHE-3578180$ROCHE$$85$YR$E$M$Y$$$20240628$$MD$US$US
240708431$24070843$1$I$20210104$20230820$20240710$20240710$PER$$CN-ROCHE-3202508$ROCHE$$44$YR$A$M$Y$55$KG$20240628$$CN$CN$CN
240708441$24070844$1$I$$20240206$20240710$20240710$PER$$IN-ROCHE-3505885$ROCHE$$$$$$Y$$$20240628$$CN$IN$IN
240708451$24070845$1$I$20231110$20240201$20240710$20240710$PER$IT-MINISAL02-967694$IT-ROCHE-3502854$ROCHE$$83$YR$E$F$Y$$$20240628$$MD$IT$IT
240708461$24070846$1$I$$20240122$20240710$20240710$PER$$JP-ROCHE-3500820$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240708471$24070847$1$I$20240407$20240407$20240710$20240710$PER$$CN-ROCHE-3541580$ROCHE$$37$YR$A$F$Y$$$20240628$$CN$CN$CN
240708481$24070848$1$I$20231201$20231228$20240710$20240710$PER$$US-ROCHE-3355648$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$US$US
240708491$24070849$1$I$$20240223$20240710$20240710$PER$$IN-ROCHE-3515827$ROCHE$$$$$$Y$$$20240628$$CN$IN$IN
240708512$24070851$2$F$20231227$20240208$20240710$20240710$PER$$JP-ROCHE-3493940$ROCHE$$6$DEC$A$F$Y$$$20240628$$PH$JP$JP
240708521$24070852$1$I$20240409$20240411$20240710$20240710$PER$$CN-ROCHE-3544735$ROCHE$$46$YR$A$F$Y$$$20240628$$CN$CN$CN
240708531$24070853$1$I$$20240426$20240710$20240710$PER$$FR-ROCHE-3555157$ROCHE$$78$YR$E$$Y$$$20240628$$MD$FR$FR
240708541$24070854$1$I$$20230925$20240710$20240710$PER$$RO-ROCHE-3326481$ROCHE$$51$YR$A$F$Y$70$KG$20240628$$CN$RO$RO
240708551$24070855$1$I$$20240503$20240710$20240710$PER$$US-ROCHE-3558697$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240708561$24070856$1$I$20230426$20240404$20240710$20240710$PER$$US-ROCHE-3540487$ROCHE$$50$YR$A$F$Y$$$20240628$$CN$US$US
240708571$24070857$1$I$$20231024$20240710$20240710$PER$$US-ROCHE-3445699$ROCHE$$44$YR$A$M$Y$$$20240628$$CN$US$US
240708581$24070858$1$I$$20230713$20240710$20240710$PER$$US-ROCHE-3388876$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$US$US
240708591$24070859$1$I$$20240525$20240710$20240710$PER$$US-ROCHE-3572096$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240708601$24070860$1$I$$20230911$20240710$20240710$PER$$US-ROCHE-3421524$ROCHE$$62$YR$A$F$Y$$$20240628$$CN$US$US
240708611$24070861$1$I$$20230801$20240710$20240710$PER$$GB-ROCHE-3398562$ROCHE$$$$$F$Y$$$20240628$$CN$GB$GB
240708621$24070862$1$I$20220203$20240318$20240710$20240710$PER$$KR-ROCHE-3529712$ROCHE$$71$YR$E$F$Y$$$20240628$$HP$KR$KR
240708631$24070863$1$I$$20240604$20240710$20240710$PER$$US-ROCHE-3577335$ROCHE$$73$YR$E$F$Y$$$20240628$$MD$US$US
240708641$24070864$1$I$$20240417$20240710$20240710$PER$$US-ROCHE-3548508$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$US$US
240708651$24070865$1$I$$20240527$20240710$20240710$PER$$ZA-ROCHE-3573395$ROCHE$$$$E$F$Y$$$20240628$$MD$ZA$ZA
240708662$24070866$2$F$20240609$20240709$20240710$20240711$PER$$US-AMGEN-USASP2024135766$AMGEN$$23$YR$A$F$Y$$$20240711$$CN$US$US
240708681$24070868$1$I$20221201$20230810$20240710$20240710$PER$FR-AFSSAPS-PP2023001141$FR-ROCHE-3402870$ROCHE$$38$YR$A$F$Y$40$KG$20240628$$MD$FR$FR
240708691$24070869$1$I$20240212$20240228$20240710$20240710$PER$$DK-ROCHE-3520273$ROCHE$$70$YR$E$M$Y$$$20240628$$MD$DK$DK
240708701$24070870$1$I$$20230724$20240710$20240710$PER$$IN-ROCHE-3365838$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$IN$IN
240708711$24070871$1$I$20240408$20240410$20240710$20240710$PER$$JP-ROCHE-3559247$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240708721$24070872$1$I$20240301$20240329$20240710$20240710$PER$$JP-ROCHE-3553862$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240708731$24070873$1$I$20221208$20240506$20240710$20240710$PER$$TR-ROCHE-3329837$ROCHE$$73$YR$E$F$Y$70.5$KG$20240628$$MD$TR$TR
240708742$24070874$2$F$20240309$20240524$20240710$20240710$PER$$IN-ROCHE-3567818$ROCHE$$70$YR$E$M$Y$$$20240628$$CN$IN$IN
240708751$24070875$1$I$$20240705$20240710$20240710$EXP$$CA-ABBVIE-5831030$ABBVIE$$$$A$F$Y$$$20240710$$MD$CA$CA
240708762$24070876$2$F$20220919$20240530$20240710$20240710$PER$$TR-ROCHE-3194063$ROCHE$$48$YR$A$F$Y$116$KG$20240628$$MD$TR$TR
240708771$24070877$1$I$20231001$20240228$20240710$20240710$PER$$US-ROCHE-3518534$ROCHE$$$$E$F$Y$45.36$KG$20240628$$CN$US$US
240708781$24070878$1$I$$20231105$20240710$20240710$PER$$TH-ROCHE-3455185$ROCHE$$$$$$Y$$$20240628$$PH$TH$TH
240708791$24070879$1$I$20231025$20231229$20240710$20240710$PER$NO-NOMAADVRE-RELISSO-2023-Vpdjdq$NO-ROCHE-3483412$ROCHE$$51$YR$A$F$Y$$$20240628$$MD$NO$NO
240708801$24070880$1$I$20231101$20240222$20240710$20240710$PER$$RS-ROCHE-3515466$ROCHE$$74$YR$E$F$Y$84$KG$20240628$$MD$RS$RS
240708811$24070881$1$I$$20230814$20240710$20240710$PER$$CN-ROCHE-3409103$ROCHE$Wei L, Liu H,  Wang W, Tang Y, Zhao S, Zhang W, Yan J and Liu W Multisystem ALK-positive histiocytosis: a multi-case study and literature review. DOI: 10.1186/s13023-023-02649-x. Orphanet Journal of Rare Diseases 2023;18 (1):1-12.$38$YR$A$M$Y$$$20240628$$HP$CN$CN
240708821$24070882$1$I$$20240509$20240710$20240710$PER$$IN-ROCHE-3561204$ROCHE$$72$YR$E$M$Y$$$20240628$$CN$IN$IN
240708831$24070883$1$I$$20231121$20240710$20240710$PER$$RO-ROCHE-3462947$ROCHE$$58$YR$A$F$Y$60$KG$20240628$$CN$RO$RO
240708841$24070884$1$I$20230301$20240501$20240710$20240710$PER$$LT-ROCHE-3558247$ROCHE$$59$YR$A$F$Y$72$KG$20240628$$MD$LT$LT
240708851$24070885$1$I$$20240515$20240710$20240710$PER$$CA-ROCHE-3565404$ROCHE$$$$$$Y$$$20240628$$MD$CA$CA
240708861$24070886$1$I$$20230801$20240710$20240710$PER$$BR-ROCHE-3399584$ROCHE$$$$$F$Y$$$20240628$$HP$BR$BR
240708871$24070887$1$I$$20240123$20240710$20240710$PER$$JP-ROCHE-3501700$ROCHE$$74$YR$E$F$Y$$$20240628$$PH$JP$JP
240708881$24070888$1$I$$20230706$20240710$20240710$PER$$US-ROCHE-3384533$ROCHE$$$$E$F$Y$$$20240628$$MD$US$US
240708891$24070889$1$I$20240210$20240514$20240710$20240710$PER$$IN-ROCHE-3564011$ROCHE$$60$YR$A$F$Y$$$20240628$$CN$IN$IN
240708901$24070890$1$I$$20240527$20240710$20240710$PER$$RO-ROCHE-3572702$ROCHE$$$$$F$Y$$$20240628$$MD$RO$RO
240708911$24070891$1$I$$20240430$20240710$20240710$PER$$US-ROCHE-3556651$ROCHE$$38$YR$A$F$Y$$$20240628$$MD$US$US
240708921$24070892$1$I$20231020$20231101$20240710$20240710$PER$$CN-ROCHE-3451190$ROCHE$$80$YR$E$F$Y$$$20240628$$HP$CN$CN
240708931$24070893$1$I$$20231216$20240710$20240710$PER$$IN-ROCHE-3478190$ROCHE$$42$YR$A$F$Y$$$20240628$$MD$IN$IN
240708941$24070894$1$I$$20230707$20240710$20240710$PER$$IN-ROCHE-3386520$ROCHE$$49$YR$A$F$Y$$$20240628$$MD$IN$IN
240708951$24070895$1$I$$20240329$20240710$20240710$PER$$JP-ROCHE-3551767$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240708961$24070896$1$I$20240227$20240313$20240710$20240710$PER$$JP-ROCHE-3543923$ROCHE$$60$YR$A$F$Y$$$20240628$$PH$JP$JP
240708971$24070897$1$I$20240531$20240531$20240710$20240710$PER$$IN-ROCHE-3574853$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$IN$IN
240708981$24070898$1$I$$20240205$20240710$20240710$PER$$JP-ROCHE-3511228$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240708991$24070899$1$I$20230906$20230906$20240710$20240710$PER$$JP-ROCHE-3419923$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240709001$24070900$1$I$$20230908$20240710$20240710$PER$$US-ROCHE-3420463$ROCHE$$83$YR$E$M$Y$$$20240628$$CN$US$US
240709011$24070901$1$I$20240416$20240423$20240710$20240710$PER$$IN-ROCHE-3553401$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$IN$IN
240709021$24070902$1$I$$20231006$20240710$20240710$PER$$US-ROCHE-3435427$ROCHE$$$$$F$Y$$$20240628$$MD$US$US
240709031$24070903$1$I$$20240402$20240710$20240710$PER$$DE-ROCHE-3538941$ROCHE$$$$$$Y$$$20240628$$CN$DE$DE
240709041$24070904$1$I$20240708$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47672$$FDA-CTU$$62$YR$$M$N$$$20240708$N$HP$US$
240709061$24070906$1$I$$20240522$20240710$20240710$PER$$US-ROCHE-3570761$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$US$US
240709071$24070907$1$I$$20240513$20240710$20240710$PER$$MA-ROCHE-3564089$ROCHE$$$$$F$Y$$$20240628$$MD$MA$MA
240709081$24070908$1$I$$20240522$20240710$20240710$PER$$KR-ROCHE-3570159$ROCHE$$67$YR$E$M$Y$$$20240628$$CN$KR$KR
240709091$24070909$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47724$$FDA-CTU$$38$YR$$F$N$152.41$KG$20240709$N$$US$
240709101$24070910$1$I$$20230817$20240710$20240710$PER$$GB-ROCHE-3407522$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240709111$24070911$1$I$20230124$20231114$20240710$20240710$PER$$TR-ROCHE-3272807$ROCHE$$58$YR$A$F$Y$63$KG$20240628$$MD$TR$TR
240709141$24070914$1$I$$20240510$20240710$20240710$PER$$FR-ROCHE-3563841$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$FR$FR
240709151$24070915$1$I$20240517$20240521$20240710$20240710$PER$$IN-ROCHE-3568631$ROCHE$$68$YR$E$M$Y$$$20240628$$CN$IN$IN
240709161$24070916$1$I$20240112$20240112$20240710$20240710$PER$$JP-ROCHE-3494650$ROCHE$$68$YR$E$F$Y$$$20240628$$MD$JP$JP
240709171$24070917$1$I$20240702$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47680$$FDA-CTU$$55$YR$$F$N$$$20240709$Y$PH$US$
240709181$24070918$1$I$20210501$20240418$20240710$20240710$PER$$DK-ROCHE-3551478$ROCHE$$60$YR$A$M$Y$$$20240628$$MD$DK$DK
240709191$24070919$1$I$20240516$20240528$20240710$20240710$PER$$DE-ROCHE-3572647$ROCHE$$83$YR$E$F$Y$$$20240628$$MD$DE$DE
240709201$24070920$1$I$20220420$20240506$20240710$20240710$PER$$ES-ROCHE-3110725$ROCHE$$63$YR$A$$Y$$$20240628$$MD$ES$ES
240709211$24070921$1$I$$20230803$20240710$20240710$PER$$AT-ROCHE-3459095$ROCHE$$$$E$$Y$$$20240628$$MD$AT$AT
240709221$24070922$1$I$$20240315$20240710$20240710$PER$$IN-ROCHE-3530174$ROCHE$$44$YR$A$F$Y$$$20240628$$MD$IN$IN
240709231$24070923$1$I$$20230711$20240710$20240710$PER$$CU-ROCHE-3388738$ROCHE$$$$$$Y$$$20240628$$CN$CU$CU
240709241$24070924$1$I$20230406$20240111$20240710$20240710$PER$$RO-ROCHE-3341776$ROCHE$$43$YR$A$F$Y$63$KG$20240628$$MD$RO$RO
240709251$24070925$1$I$$20240605$20240710$20240710$PER$$DE-ROCHE-3578307$ROCHE$$$$$$Y$$$20240628$$MD$DE$DE
240709261$24070926$1$I$20240506$20240506$20240710$20240710$PER$$FR-ROCHE-3560479$ROCHE$$91$YR$E$F$Y$$$20240628$$PH$FR$FR
240709271$24070927$1$I$$20240503$20240710$20240710$PER$$IN-ROCHE-3559085$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$IN$IN
240709281$24070928$1$I$20220901$20240301$20240710$20240710$PER$$ES-ROCHE-3520275$ROCHE$$72$YR$E$$Y$$$20240628$$MD$ES$ES
240709291$24070929$1$I$$20240423$20240710$20240710$PER$$IT-ROCHE-3554404$ROCHE$$42$YR$A$F$Y$$$20240628$$MD$IT$IT
240709301$24070930$1$I$20240516$20240516$20240710$20240710$PER$$IN-ROCHE-3565814$ROCHE$$82$YR$E$M$Y$$$20240628$$CN$IN$IN
240709311$24070931$1$I$$20240513$20240710$20240710$PER$$JP-ROCHE-3569915$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240709321$24070932$1$I$$20240531$20240710$20240710$PER$$FR-ROCHE-3575743$ROCHE$$$$$$Y$$$20240628$$CN$FR$FR
240709331$24070933$1$I$20240510$20240514$20240710$20240710$PER$$JP-ROCHE-3570607$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240709341$24070934$1$I$20220902$20231127$20240710$20240710$PER$$CO-ROCHE-3465801$ROCHE$$68$YR$E$F$Y$43$KG$20240628$$MD$CO$CO
240709351$24070935$1$I$20220422$20240318$20240710$20240710$PER$$KR-ROCHE-3528998$ROCHE$$62$YR$A$M$Y$$$20240628$$HP$KR$KR
240709361$24070936$1$I$20231115$20240118$20240710$20240710$PER$$IT-ROCHE-3494106$ROCHE$$52$YR$A$F$Y$$$20240628$$MD$IT$IT
240709371$24070937$1$I$$20240417$20240710$20240710$PER$$IN-ROCHE-3548817$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$IN$IN
240709381$24070938$1$I$20240412$20240412$20240710$20240710$PER$$JP-ROCHE-3559462$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240709391$24070939$1$I$20230929$20231225$20240710$20240710$PER$$JP-ROCHE-3484071$ROCHE$$$$A$M$Y$$$20240628$$CN$JP$JP
240709401$24070940$1$I$$20240517$20240710$20240710$PER$$ID-ROCHE-3568726$ROCHE$$$$$$Y$$$20240628$$MD$ID$ID
240709411$24070941$1$I$$20240604$20240710$20240710$PER$$US-ROCHE-3578363$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$US$US
240709421$24070942$1$I$20231001$20231127$20240710$20240710$PER$IT-MINISAL02-955865$IT-ROCHE-3464870$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$IT$IT
240709431$24070943$1$I$$20230928$20240710$20240710$PER$$US-ROCHE-3431655$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$US$US
240709441$24070944$1$I$20231014$20240212$20240710$20240710$PER$IT-MINISAL02-969289$IT-ROCHE-3508759$ROCHE$$35$YR$A$F$Y$$$20240628$$MD$IT$IT
240709451$24070945$1$I$$20240117$20240710$20240710$PER$$RO-ROCHE-3494549$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240709461$24070946$1$I$$20240509$20240710$20240710$PER$$IN-ROCHE-3561159$ROCHE$$73$YR$E$F$Y$$$20240628$$CN$IN$IN
240709471$24070947$1$I$$20231031$20240710$20240710$PER$$US-ROCHE-3450653$ROCHE$$$$$F$Y$$$20240628$$HP$US$US
240709481$24070948$1$I$$20240105$20240710$20240710$PER$$TH-ROCHE-3487624$ROCHE$$$$$$Y$$$20240628$$PH$TH$TH
240709491$24070949$1$I$$20240226$20240710$20240710$PER$$JP-ROCHE-3524641$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240709501$24070950$1$I$$20240411$20240710$20240710$PER$$FR-ROCHE-3547107$ROCHE$$92$YR$E$F$Y$$$20240628$$MD$FR$FR
240709511$24070951$1$I$$20240521$20240710$20240710$PER$$JP-ROCHE-3571654$ROCHE$$81$YR$E$M$Y$$$20240628$$MD$JP$JP
240709531$24070953$1$I$$20240127$20240710$20240710$PER$$US-ROCHE-3501181$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240709541$24070954$1$I$$20240418$20240710$20240710$PER$$IN-ROCHE-3550997$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$IN$IN
240709551$24070955$1$I$20221108$20230706$20240710$20240710$PER$$CN-ROCHE-3225378$ROCHE$$51$YR$A$M$Y$75$KG$20240628$$CN$CN$CN
240709561$24070956$1$I$20240101$20240404$20240710$20240710$PER$$JP-ROCHE-3556284$ROCHE$$$$$F$Y$$$20240628$$HP$JP$JP
240709572$24070957$2$F$$20240515$20240710$20240710$PER$$NO-ROCHE-3566909$ROCHE$$$$$$Y$$$20240628$$PH$NO$NO
240709581$24070958$1$I$$20240401$20240710$20240710$PER$$US-ROCHE-3536666$ROCHE$$54$YR$A$M$Y$$$20240628$$PH$US$US
240709591$24070959$1$I$$20240529$20240710$20240710$PER$$US-ROCHE-3573571$ROCHE$$40$YR$A$M$Y$$$20240628$$MD$US$US
240709601$24070960$1$I$$20231109$20240710$20240710$PER$$IN-ROCHE-3457428$ROCHE$$47$YR$A$F$Y$$$20240628$$MD$IN$IN
240709611$24070961$1$I$$20240412$20240710$20240710$PER$$IN-ROCHE-3546565$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$IN$IN
240709621$24070962$1$I$20240115$20240116$20240710$20240710$PER$$JP-ROCHE-3496473$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240709631$24070963$1$I$20240124$20240217$20240710$20240710$PER$$BD-ROCHE-3513041$ROCHE$$58$YR$A$F$Y$74$KG$20240628$$CN$BD$BD
240709641$24070964$1$I$$20240411$20240710$20240710$PER$$US-ROCHE-3544857$ROCHE$$88$YR$E$F$Y$$$20240628$$CN$US$US
240709652$24070965$2$F$$20240503$20240710$20240711$PER$$GB-ROCHE-3558863$ROCHE$$$$$$Y$$$20240628$$CN$GB$GB
240709661$24070966$1$I$20211013$20240306$20240710$20240710$PER$$CN-ROCHE-3310232$ROCHE$$56$YR$A$F$Y$70$KG$20240628$$MD$CN$CN
240709671$24070967$1$I$20230318$20240306$20240710$20240710$PER$$RS-ROCHE-3522108$ROCHE$$74$YR$E$M$Y$71$KG$20240628$$MD$RS$RS
240709681$24070968$1$I$$20240118$20240710$20240710$PER$$US-ROCHE-3495351$ROCHE$$64$YR$A$F$Y$$$20240628$$CN$US$US
240709691$24070969$1$I$$20240522$20240710$20240710$PER$$US-ROCHE-3570249$ROCHE$$81$YR$E$F$Y$$$20240628$$CN$US$US
240709701$24070970$1$I$$20240418$20240710$20240710$PER$$KR-ROCHE-3549848$ROCHE$$67$YR$E$M$Y$$$20240628$$CN$KR$KR
240709711$24070971$1$I$$20240411$20240710$20240710$PER$$JP-ROCHE-3559174$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240709721$24070972$1$I$$20240508$20240710$20240710$PER$$KR-ROCHE-3560579$ROCHE$$65$YR$E$M$Y$$$20240628$$CN$KR$KR
240709731$24070973$1$I$20240603$20240604$20240710$20240710$PER$$IN-ROCHE-3577766$ROCHE$$79$YR$E$M$Y$$$20240628$$CN$IN$IN
240709741$24070974$1$I$20231105$20231229$20240710$20240710$PER$$IT-ROCHE-3484100$ROCHE$$59$YR$A$F$Y$63$KG$20240628$$PH$IT$IT
240709751$24070975$1$I$$20240423$20240710$20240710$PER$$JP-ROCHE-3565006$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240709761$24070976$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47676$$FDA-CTU$$74$YR$$M$N$$$20240709$N$$US$
240709771$24070977$1$I$$20231027$20240710$20240710$PER$$ZA-ROCHE-3450627$ROCHE$$31$YR$A$M$Y$$$20240628$$MD$ZA$ZA
240709781$24070978$1$I$20240111$20240709$20240709$20240709$DIR$709641$$FDA-CTU$$67$YR$$M$N$126$KG$20240709$N$CN$US$
240709791$24070979$1$I$20240617$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47682$$FDA-CTU$$88$YR$$F$N$$$20240709$N$HP$US$
240709801$24070980$1$I$20230804$20230824$20240710$20240710$PER$IT-MINISAL02-940996$IT-ROCHE-3410581$ROCHE$$85$YR$E$F$Y$60$KG$20240628$$MD$IT$IT
240709811$24070981$1$I$$20240528$20240710$20240710$PER$$IN-ROCHE-3572680$ROCHE$$48$YR$A$F$Y$$$20240628$$MD$IN$IN
240709821$24070982$1$I$20240620$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47737$$FDA-CTU$$55$YR$$M$N$$$20240709$Y$PH$US$
240709831$24070983$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47728$$FDA-CTU$$85$YR$$F$N$$$20240709$N$$US$
240709841$24070984$1$I$$20230705$20240710$20240710$PER$$US-ROCHE-3038423$ROCHE$$84$YR$E$F$Y$$$20240628$$MD$US$US
240709851$24070985$1$I$20240424$20240424$20240710$20240710$PER$$JP-ROCHE-3564182$ROCHE$$44$YR$A$F$Y$$$20240628$$MD$JP$JP
240709861$24070986$1$I$$20240515$20240710$20240710$PER$$US-ROCHE-3564413$ROCHE$$89$YR$E$F$Y$$$20240628$$MD$US$US
240709871$24070987$1$I$$20240604$20240710$20240710$PER$$FR-ROCHE-3577539$ROCHE$$84$YR$E$F$Y$$$20240628$$MD$FR$FR
240709881$24070988$1$I$$20240506$20240710$20240710$PER$$SK-ROCHE-3559707$ROCHE$$$$$F$Y$$$20240628$$MD$SK$SK
240709891$24070989$1$I$$20240125$20240710$20240710$PER$$US-ROCHE-3499693$ROCHE$$47$YR$A$F$Y$$$20240628$$CN$US$US
240709901$24070990$1$I$20220901$20230725$20240710$20240710$PER$$DK-ROCHE-3395979$ROCHE$$54$YR$A$M$Y$$$20240628$$MD$DK$DK
240709911$24070991$1$I$$20240206$20240710$20240710$PER$$RO-ROCHE-3507161$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240709921$24070992$1$I$$20231024$20240710$20240710$PER$$US-ROCHE-3446958$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240709931$24070993$1$I$$20231221$20240710$20240710$PER$$US-ROCHE-3245747$ROCHE$$82$YR$E$F$Y$$$20240628$$CN$US$US
240709941$24070994$1$I$$20240527$20240710$20240710$PER$$KR-ROCHE-3573039$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$KR$KR
240709951$24070995$1$I$$20230808$20240710$20240710$PER$$CA-ROCHE-3402223$ROCHE$$$$A$M$Y$$$20240628$$CN$CA$CA
240709961$24070996$1$I$$20240209$20240710$20240710$PER$$RO-ROCHE-3508390$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240709971$24070997$1$I$20240308$20240405$20240710$20240710$PER$$JP-ROCHE-3555880$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240709981$24070998$1$I$$20240422$20240710$20240710$PER$$US-ROCHE-3551932$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240709991$24070999$1$I$$20230918$20240710$20240710$PER$$IN-ROCHE-3327989$ROCHE$$44$YR$A$F$Y$$$20240628$$MD$IN$IN
240710003$24071000$3$F$20240423$20240812$20240710$20240822$PER$$US-ROCHE-3577536$ROCHE$$75$YR$E$M$Y$106.59$KG$20240822$$MD$US$US
240710011$24071001$1$I$$20231102$20240710$20240710$PER$$RO-ROCHE-3452082$ROCHE$$42$YR$A$F$Y$65$KG$20240628$$CN$RO$RO
240710021$24071002$1$I$$20240422$20240710$20240710$PER$$RO-ROCHE-3554148$ROCHE$$$$$M$Y$$$20240628$$MD$RO$RO
240710031$24071003$1$I$$20240415$20240710$20240710$PER$$IN-ROCHE-3549160$ROCHE$$53$YR$A$F$Y$$$20240628$$CN$IN$IN
240710041$24071004$1$I$$20240515$20240710$20240710$PER$$CA-ROCHE-3565244$ROCHE$$$$E$M$Y$$$20240628$$CN$CA$CA
240710051$24071005$1$I$$20231107$20240710$20240710$PER$$US-ROCHE-3339846$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$US$US
240710071$24071007$1$I$$20230913$20240710$20240710$PER$$TW-ROCHE-3426204$ROCHE$$72$YR$E$F$Y$$$20240628$$HP$TW$TW
240710082$24071008$2$F$20221201$20240517$20240710$20240710$PER$$PT-ROCHE-3531295$ROCHE$$70$YR$E$M$Y$83$KG$20240628$$MD$PT$PT
240710091$24071009$1$I$$20240209$20240710$20240710$PER$$IN-ROCHE-3509174$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$IN$IN
240710101$24071010$1$I$$20240129$20240710$20240710$PER$$JP-ROCHE-3507489$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240710121$24071012$1$I$$20240308$20240710$20240710$PER$$US-ROCHE-3304698$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$US$US
240710131$24071013$1$I$$20231102$20240710$20240710$PER$$IN-ROCHE-3452993$ROCHE$$66$YR$E$F$Y$$$20240628$$MD$IN$IN
240710141$24071014$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47679$$FDA-CTU$$38$YR$$M$N$$$20240709$N$$US$
240710151$24071015$1$I$20240701$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47741$$FDA-CTU$$66$YR$$M$N$65.3$KG$20240709$N$CN$US$
240710161$24071016$1$I$$20231107$20240710$20240710$PER$$US-ROCHE-3455550$ROCHE$$79$YR$E$M$Y$$$20240628$$PH$US$US
240710171$24071017$1$I$$20240520$20240710$20240710$PER$$US-ROCHE-3567397$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$US$US
240710181$24071018$1$I$$20231129$20240710$20240710$PER$$TH-ROCHE-3467861$ROCHE$$48$YR$A$F$Y$$$20240628$$HP$TH$TH
240710191$24071019$1$I$20240608$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47715$$FDA-CTU$$58$YR$$F$N$$$20240709$Y$PH$US$
240710201$24071020$1$I$20240707$20240709$20240709$20240709$DIR$709582$$FDA-CTU$$$$$UNK$N$$$20240709$N$CN$US$
240710211$24071021$1$I$$20240410$20240710$20240710$PER$$JP-ROCHE-3559271$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240710221$24071022$1$I$20240528$20240529$20240710$20240710$PER$$IN-ROCHE-3573719$ROCHE$$66$YR$E$F$Y$$$20240628$$CN$IN$IN
240710231$24071023$1$I$$20240105$20240710$20240710$PER$$JP-ROCHE-3489032$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240710241$24071024$1$I$20240112$20240117$20240710$20240710$PER$$JP-ROCHE-3497305$ROCHE$$6$DEC$A$$Y$$$20240628$$HP$JP$JP
240710251$24071025$1$I$$20240528$20240710$20240710$PER$$KR-ROCHE-3573112$ROCHE$$54$YR$A$M$Y$$$20240628$$CN$KR$KR
240710261$24071026$1$I$$20240220$20240710$20240710$PER$$JP-ROCHE-3521990$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240710271$24071027$1$I$$20231024$20240710$20240710$PER$$TH-ROCHE-3446495$ROCHE$$$$$F$Y$$$20240628$$CN$TH$TH
240710281$24071028$1$I$$20231120$20240710$20240710$PER$$US-ROCHE-3462059$ROCHE$$75$YR$E$F$Y$$$20240628$$CN$US$US
240710291$24071029$1$I$$20240523$20240710$20240710$PER$$US-ROCHE-3570244$ROCHE$$86$YR$E$M$Y$$$20240628$$MD$US$US
240710302$24071030$2$F$20240101$20240807$20240710$20240814$PER$$US-BIOGEN-2024BI01272338$BIOGEN$$$$$M$Y$$$20240814$$CN$US$US
240710311$24071031$1$I$20240101$20240118$20240710$20240710$PER$$JP-ROCHE-3498196$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240710321$24071032$1$I$$20240206$20240710$20240710$PER$$JP-ROCHE-3512700$ROCHE$$$$$F$Y$$$20240628$$MD$JP$JP
240710331$24071033$1$I$20230101$20230926$20240710$20240710$PER$$CN-ROCHE-3429539$ROCHE$$55$YR$A$M$Y$$$20240628$$CN$CN$CN
240710341$24071034$1$I$20240519$20240520$20240710$20240710$PER$$TH-ROCHE-3567691$ROCHE$$43$YR$A$F$Y$$$20240628$$CN$TH$TH
240710351$24071035$1$I$20240425$20240708$20240710$20240710$PER$$US-BIOGEN-2024BI01262201$BIOGEN$$62$YR$$M$Y$$$20240710$$CN$US$US
240710361$24071036$1$I$$20230719$20240710$20240710$PER$$IN-ROCHE-3315533$ROCHE$$38$YR$A$F$Y$$$20240628$$MD$IN$IN
240710371$24071037$1$I$$20240503$20240710$20240710$PER$$IN-ROCHE-3558105$ROCHE$$71$YR$E$F$Y$$$20240628$$CN$IN$IN
240710382$24071038$2$F$20211026$20240531$20240710$20240710$PER$$CL-ROCHE-2981125$ROCHE$$46$YR$A$M$Y$86.6$KG$20240628$$MD$CL$CL
240710391$24071039$1$I$$20231024$20240710$20240710$PER$$DE-ROCHE-3510961$ROCHE$$$$$F$Y$$$20240628$$MD$DE$DE
240710401$24071040$1$I$$20231020$20240710$20240710$PER$$PH-ROCHE-3446149$ROCHE$$49$YR$A$F$Y$46.6$KG$20240628$$CN$PH$PH
240710411$24071041$1$I$20220217$20231124$20240710$20240710$PER$$CN-ROCHE-3079489$ROCHE$$56$YR$A$F$Y$59$KG$20240628$$MD$CN$CN
240710421$24071042$1$I$$20240105$20240710$20240710$PER$$PH-ROCHE-3486725$ROCHE$$42$YR$A$F$Y$69$KG$20240628$$CN$PH$PH
240710431$24071043$1$I$$20240508$20240710$20240710$PER$$JP-ROCHE-3566676$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240710441$24071044$1$I$$20230906$20240710$20240710$PER$$US-ROCHE-3418381$ROCHE$$47$YR$A$M$Y$$$20240628$$CN$US$US
240710451$24071045$1$I$$20240425$20240710$20240710$PER$$IN-ROCHE-3554344$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$IN$IN
240710461$24071046$1$I$$20240422$20240710$20240710$PER$$US-ROCHE-3551200$ROCHE$$39$YR$A$F$Y$$$20240628$$CN$US$US
240710471$24071047$1$I$$20240524$20240710$20240710$PER$$AU-ROCHE-3571443$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240710481$24071048$1$I$$20240418$20240710$20240710$PER$$JP-ROCHE-3561426$ROCHE$$$$A$F$Y$$$20240628$$PH$JP$JP
240710491$24071049$1$I$20240308$20240311$20240710$20240710$PER$$JP-ROCHE-3538285$ROCHE$$65$YR$E$F$Y$$$20240628$$PH$JP$JP
240710501$24071050$1$I$$20240507$20240710$20240710$PER$$AU-ROCHE-3559361$ROCHE$$$$A$F$Y$$$20240628$$MD$AU$AU
240710511$24071051$1$I$$20240102$20240710$20240710$PER$$IN-ROCHE-3484710$ROCHE$$43$YR$A$F$Y$$$20240628$$MD$IN$IN
240710521$24071052$1$I$20240102$20240325$20240710$20240710$PER$$IL-ROCHE-3532490$ROCHE$$88$YR$E$M$Y$70$KG$20240628$$MD$IL$IL
240710531$24071053$1$I$$20231127$20240710$20240710$PER$$VN-ROCHE-3465879$ROCHE$$65$YR$E$M$Y$$$20240628$$MD$VN$VN
240710541$24071054$1$I$$20230728$20240710$20240710$PER$$IN-ROCHE-3396770$ROCHE$$28$YR$A$M$Y$$$20240628$$MD$IN$IN
240710551$24071055$1$I$20240509$20240509$20240710$20240710$PER$$JP-ROCHE-3567211$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240710561$24071056$1$I$$20240507$20240710$20240710$PER$$CH-ROCHE-3560777$ROCHE$$$$$F$Y$$$20240628$$MD$CH$CH
240710581$24071058$1$I$$20230907$20240710$20240710$PER$$US-ROCHE-3419725$ROCHE$$43$YR$A$F$Y$$$20240628$$CN$US$US
240710591$24071059$1$I$20230424$20240422$20240710$20240710$PER$$TR-ROCHE-3337468$ROCHE$$53$YR$A$M$Y$70$KG$20240628$$MD$TR$TR
240710601$24071060$1$I$$20240319$20240710$20240710$PER$$AU-ROCHE-3528954$ROCHE$$$$$$Y$$$20240628$$MD$AU$AU
240710611$24071061$1$I$$20231017$20240710$20240710$PER$$IN-ROCHE-3442717$ROCHE$$35$YR$A$F$Y$$$20240628$$MD$IN$IN
240710621$24071062$1$I$$20231226$20240710$20240710$PER$$IN-ROCHE-3482677$ROCHE$$44$YR$A$F$Y$$$20240628$$MD$IN$IN
240710631$24071063$1$I$$20231006$20240710$20240710$PER$$US-ROCHE-3435616$ROCHE$$73$YR$E$M$Y$$$20240628$$CN$US$US
240710641$24071064$1$I$20240527$20240527$20240710$20240710$PER$$IN-ROCHE-3573052$ROCHE$$69$YR$E$F$Y$$$20240628$$CN$IN$IN
240710651$24071065$1$I$$20230727$20240710$20240710$PER$$IN-ROCHE-3234372$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$IN$IN
240710661$24071066$1$I$$20240514$20240710$20240710$PER$$TW-ROCHE-3563916$ROCHE$$$$$$Y$$$20240628$$MD$TW$TW
240710671$24071067$1$I$$20230804$20240710$20240710$PER$$US-ROCHE-3400556$ROCHE$$85$YR$E$M$Y$$$20240628$$MD$US$US
240710681$24071068$1$I$$20240319$20240710$20240710$PER$$US-ROCHE-3530770$ROCHE$$57$YR$A$F$Y$$$20240628$$HP$US$US
240710691$24071069$1$I$$20230727$20240710$20240710$PER$$CN-ROCHE-3247917$ROCHE$$47$YR$A$M$Y$69$KG$20240628$$CN$CN$CN
240710701$24071070$1$I$$20231129$20240710$20240710$PER$$JP-ROCHE-3470634$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240710711$24071071$1$I$20240301$20240408$20240710$20240710$PER$$JP-ROCHE-3559384$ROCHE$$$$E$F$Y$$$20240628$$HP$JP$JP
240710721$24071072$1$I$$20240307$20240710$20240710$PER$$US-ROCHE-3524588$ROCHE$$$$$M$Y$$$20240628$$CN$US$US
240710731$24071073$1$I$20240501$20240523$20240710$20240710$PER$$US-ROCHE-3569734$ROCHE$$52$YR$A$F$Y$$$20240628$$CN$US$US
240710741$24071074$1$I$$20231020$20240710$20240710$PER$$RO-ROCHE-3446159$ROCHE$$$$$F$Y$$$20240628$$CN$RO$RO
240710751$24071075$1$I$20230713$20231003$20240710$20240710$PER$IT-MINISAL02-945839$IT-ROCHE-3432663$ROCHE$$84$YR$E$F$Y$$$20240628$$MD$IT$IT
240710761$24071076$1$I$$20240529$20240710$20240710$PER$$FI-ROCHE-3575449$ROCHE$$89$YR$E$F$Y$$$20240628$$MD$FI$FI
240710771$24071077$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47745$$FDA-CTU$$57$YR$$F$N$84.37$KG$20240709$N$$US$
240710781$24071078$1$I$20240116$20240124$20240710$20240710$PER$$JP-ROCHE-3503342$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240710791$24071079$1$I$$20231110$20240710$20240710$PER$$US-ROCHE-3507345$ROCHE$$39$YR$A$M$Y$$$20240628$$MD$US$US
240710801$24071080$1$I$$20231214$20240710$20240710$PER$$US-ROCHE-3477283$ROCHE$$61$YR$A$F$Y$$$20240628$$MD$US$US
240710811$24071081$1$I$$20240528$20240710$20240710$PER$$ZA-ROCHE-3574762$ROCHE$$$$A$F$Y$$$20240628$$MD$ZA$ZA
240710821$24071082$1$I$20240209$20240422$20240710$20240710$PER$$IN-ROCHE-3553553$ROCHE$$69$YR$E$M$Y$$$20240628$$CN$IN$IN
240710835$24071083$5$F$20240430$20240819$20240710$20240823$EXP$$FR-ROCHE-3577550$ROCHE$$73$YR$E$F$Y$$$20240823$$MD$FR$FR
240710841$24071084$1$I$$20240131$20240710$20240710$PER$$TH-ROCHE-3349352$ROCHE$$57$YR$A$F$Y$$$20240628$$HP$TH$TH
240710851$24071085$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47683$$FDA-CTU$$77$YR$$F$N$$$20240709$N$$US$
240710861$24071086$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47731$$FDA-CTU$$55$YR$$F$N$$$20240709$N$$US$
240710871$24071087$1$I$$20231112$20240710$20240710$PER$$KW-ROCHE-3459704$ROCHE$$$$E$F$Y$$$20240628$$HP$KW$KW
240710881$24071088$1$I$$20231011$20240710$20240710$PER$$US-ROCHE-3438460$ROCHE$$$$$$Y$$$20240628$$PH$US$US
240710891$24071089$1$I$$20240124$20240710$20240710$PER$$VN-ROCHE-3500423$ROCHE$$31$YR$A$F$Y$$$20240628$$MD$VN$VN
240710901$24071090$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47748$$FDA-CTU$$$$$M$N$$$20240709$N$HP$US$
240710911$24071091$1$I$20240601$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47691$$FDA-CTU$$19$YR$$M$N$$$20240709$N$HP$US$
240710921$24071092$1$I$$20240625$20240709$20240709$DIR$FDA-CDER-CTU-2024-47693$$FDA-CTU$$$$$M$N$$$20240625$N$HP$US$
240710951$24071095$1$I$$20240121$20240710$20240710$PER$$MX-ROCHE-3497226$ROCHE$$48$YR$A$F$Y$69$KG$20240628$$CN$MX$MX
240710973$24071097$3$F$$20240510$20240710$20240710$PER$$FR-ROCHE-3564633$ROCHE$$25$YR$A$M$Y$$$20240701$$PH$FR$FR
240710981$24071098$1$I$20240119$20240216$20240710$20240710$PER$$JP-ROCHE-3518814$ROCHE$$6$DEC$A$M$Y$$$20240628$$MD$JP$JP
240710991$24071099$1$I$20240131$20240201$20240710$20240710$PER$$JP-ROCHE-3509807$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240711001$24071100$1$I$$20240213$20240710$20240710$PER$$US-ROCHE-3511051$ROCHE$$72$YR$E$F$Y$$$20240628$$MD$US$US
240711011$24071101$1$I$$20240424$20240710$20240710$PER$$JP-ROCHE-3569839$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240711021$24071102$1$I$20230104$20240325$20240710$20240710$PER$$KR-ROCHE-3533238$ROCHE$$76$YR$E$F$Y$39$KG$20240628$$HP$KR$KR
240711031$24071103$1$I$$20240514$20240710$20240710$PER$$FI-ROCHE-3565206$ROCHE$$$$A$$Y$$$20240628$$MD$FI$FI
240711041$24071104$1$I$20240418$20240418$20240710$20240710$PER$$IN-ROCHE-3551038$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$IN$IN
240711051$24071105$1$I$$20230913$20240710$20240710$PER$$US-ROCHE-3422960$ROCHE$$42$YR$A$F$Y$$$20240628$$MD$US$US
240711061$24071106$1$I$$20240524$20240710$20240710$PER$$DE-ROCHE-3572590$ROCHE$$43$YR$A$F$Y$43$KG$20240701$$CN$DE$DE
240711071$24071107$1$I$$20230719$20240710$20240710$PER$$US-ROCHE-3392424$ROCHE$$71$YR$E$F$Y$$$20240628$$CN$US$US
240711081$24071108$1$I$$20240425$20240710$20240710$PER$$IN-ROCHE-3554385$ROCHE$$32$YR$A$F$Y$$$20240628$$MD$IN$IN
240711091$24071109$1$I$$20240313$20240710$20240710$PER$$VN-ROCHE-3526604$ROCHE$$79$YR$E$M$Y$$$20240628$$MD$VN$VN
240711101$24071110$1$I$20230930$20231205$20240710$20240710$PER$$BE-ROCHE-3471567$ROCHE$$60$YR$A$F$Y$105$KG$20240628$$MD$BE$BE
240711111$24071111$1$I$$20230705$20240710$20240710$PER$$GE-ROCHE-3385557$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$GE$GE
240711123$24071112$3$F$$20240301$20240710$20240710$PER$$US-ROCHE-3516441$ROCHE$$15$YR$T$F$Y$41.5$KG$20240701$$CN$US$US
240711131$24071113$1$I$$20240607$20240710$20240710$PER$$FR-ROCHE-3579234$ROCHE$$82$YR$E$F$Y$$$20240628$$MD$FR$FR
240711141$24071114$1$I$20240514$20240514$20240710$20240710$PER$$RS-ROCHE-3564631$ROCHE$$56$YR$A$F$Y$88$KG$20240628$$MD$RS$RS
240711151$24071115$1$I$$20230818$20240710$20240710$PER$$BE-ROCHE-3408804$ROCHE$$$$$$Y$$$20240628$$MD$BE$BE
240711162$24071116$2$F$20240226$20240228$20240710$20240710$PER$$US-ROCHE-3517420$ROCHE$$33$YR$A$M$Y$49.9$KG$20240701$$CN$US$US
240711171$24071117$1$I$$20240115$20240710$20240710$PER$$JP-ROCHE-3375124$ROCHE$Sakoda S, Koga Y, Mikumo H, Tsuchiya Y and Hadara E. A Case of Inflammatory Myofibroblastic Tumour in which Therapeutic Effect of Alectinib could be Confirmed by Bronchoscopy. The Journal of the Japan Society for Respiratory Endoscopy/The 46th Annual Meeting of the Japan Society for Respiratory Endoscopy. 2023;45(S):S333-.;, Tanaka K, Koga Y, Mikumo H, Tsuchiya- Kawano Y, Hadara E, Tamiya S and Okamoto I. A case of inflammatory myofibroblastic tumor harboring EML4-ALK fusion with a brain metasta$73$YR$E$F$Y$$$20240628$$MD$JP$JP
240711181$24071118$1$I$20230801$20240312$20240710$20240710$PER$$US-ROCHE-3525380$ROCHE$$34$YR$A$F$Y$$$20240701$$MD$US$US
240711191$24071119$1$I$$20240308$20240710$20240710$PER$$GB-ROCHE-3525115$ROCHE$$$$T$F$Y$$$20240701$$CN$GB$GB
240711201$24071120$1$I$$20230808$20240710$20240710$PER$$PT-ROCHE-3403716$ROCHE$$$$$$Y$$$20240628$$PH$PT$PT
240711221$24071122$1$I$$20231129$20240710$20240710$PER$$PH-ROCHE-3467735$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$PH$PH
240711231$24071123$1$I$$20230816$20240710$20240710$PER$$IN-ROCHE-3317059$ROCHE$$52$YR$A$F$Y$$$20240628$$CN$IN$IN
240711241$24071124$1$I$$20240308$20240710$20240710$PER$$CA-ROCHE-3335319$ROCHE$$$$C$M$Y$13.2$KG$20240701$$CN$CA$CA
240711251$24071125$1$I$$20240702$20240710$20240710$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001361$BLUEPRINT MEDICINES$$$$$F$Y$$$20240710$$CN$US$US
240711262$24071126$2$F$$20240214$20240710$20240710$PER$$US-ROCHE-3510741$ROCHE$$3$YR$C$M$Y$11.7$KG$20240701$$MD$US$US
240711281$24071128$1$I$$20240516$20240710$20240710$PER$$KR-ROCHE-3566259$ROCHE$$48$YR$A$M$Y$$$20240628$$CN$KR$KR
240711292$24071129$2$F$20240618$20240725$20240710$20240801$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001357$BLUEPRINT MEDICINES$$53$YR$A$F$Y$$$20240801$$CN$US$US
240711303$24071130$3$F$$20240522$20240710$20240710$PER$$US-ROCHE-3515723$ROCHE$$3$YR$C$F$Y$9.56$KG$20240701$$CN$US$US
240711311$24071131$1$I$$20240306$20240710$20240710$PER$$CA-ROCHE-3522009$ROCHE$$21$YR$A$M$Y$$$20240701$$HP$CA$CA
240711321$24071132$1$I$$20240514$20240710$20240710$PER$$AT-ROCHE-3565520$ROCHE$$$$$F$Y$$$20240628$$MD$AT$AT
240711331$24071133$1$I$$20240308$20240710$20240710$PER$$JP-ROCHE-3537960$ROCHE$$$$E$F$Y$$$20240628$$MD$JP$JP
240711341$24071134$1$I$$20240220$20240710$20240710$PER$$BR-ROCHE-3514731$ROCHE$$26$YR$A$M$Y$50$KG$20240701$$HP$BR$BR
240711351$24071135$1$I$$20240610$20240710$20240710$PER$$US-ROCHE-3579991$ROCHE$$$$A$M$Y$$$20240628$$PH$US$US
240711362$24071136$2$F$$20240507$20240710$20240710$PER$$IT-ROCHE-3560468$ROCHE$$$$$$Y$$$20240701$$MD$IT$IT
240711371$24071137$1$I$20210125$20231129$20240710$20240710$PER$$US-ROCHE-3467672$ROCHE$$43$YR$A$F$Y$$$20240628$$HP$US$US
240711383$24071138$3$F$$20240510$20240710$20240710$PER$$DE-ROCHE-3558920$ROCHE$$$$$F$Y$$$20240701$$MD$DE$DE
240711391$24071139$1$I$20240423$20240423$20240710$20240710$PER$$US-ROCHE-3552525$ROCHE$$4$YR$C$F$Y$10.7$KG$20240701$$CN$US$US
240711401$24071140$1$I$$20240529$20240710$20240710$PER$$US-ROCHE-3573515$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240711411$24071141$1$I$20220609$20231031$20240710$20240710$PER$$AT-ROCHE-3116095$ROCHE$$59$YR$A$F$Y$56$KG$20240628$$MD$AT$AT
240711421$24071142$1$I$20211028$20240311$20240710$20240710$PER$$DE-ROCHE-3525073$ROCHE$$14$YR$T$M$Y$120$KG$20240701$$MD$DE$DE
240711431$24071143$1$I$20220815$20240308$20240710$20240710$PER$$DE-ROCHE-3524433$ROCHE$$22$YR$A$M$Y$50$KG$20240701$$MD$DE$DE
240711441$24071144$1$I$$20231106$20240710$20240710$PER$$US-ROCHE-3454035$ROCHE$$26$YR$A$M$Y$$$20240628$$MD$US$US
240711451$24071145$1$I$20221001$20240426$20240710$20240710$PER$$DE-ROCHE-3555701$ROCHE$$10$YR$C$F$Y$27.6$KG$20240701$$MD$DE$DE
240711461$24071146$1$I$20240401$20240524$20240710$20240710$PER$$CN-ROCHE-3570651$ROCHE$$42$YR$A$F$Y$62$KG$20240628$$MD$CN$CN
240711473$24071147$3$F$$20240207$20240710$20240710$PER$$UY-ROCHE-3480193$ROCHE$$8$MON$I$F$Y$$$20240701$$CN$UY$UY
240711481$24071148$1$I$$20240426$20240710$20240710$PER$$JP-ROCHE-3565638$ROCHE$$9$DEC$E$F$Y$$$20240628$$MD$JP$JP
240711491$24071149$1$I$20230718$20240510$20240710$20240710$PER$$RS-ROCHE-3563741$ROCHE$$51$YR$A$F$Y$81$KG$20240628$$MD$RS$RS
240711502$24071150$2$F$20220818$20240321$20240710$20240710$PER$$JP-ROCHE-3169663$ROCHE$$51$YR$A$M$Y$58$KG$20240701$$MD$JP$JP
240711512$24071151$2$F$$20240328$20240710$20240710$PER$$US-ROCHE-3535431$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
240711521$24071152$1$I$20220411$20240320$20240710$20240710$PER$$DE-ROCHE-3292068$ROCHE$$43$YR$A$F$Y$43$KG$20240701$$MD$DE$DE
240711531$24071153$1$I$$20240522$20240710$20240710$PER$$AU-ROCHE-3569263$ROCHE$$$$A$F$Y$79$KG$20240628$$MD$AU$AU
240711541$24071154$1$I$$20240603$20240710$20240710$PER$$ID-ROCHE-3577412$ROCHE$$70$YR$E$M$Y$$$20240628$$CN$ID$ID
240711551$24071155$1$I$$20240327$20240710$20240710$PER$$US-ROCHE-3534525$ROCHE$$3$YR$C$M$Y$$$20240701$$CN$US$US
240711561$24071156$1$I$$20240607$20240710$20240710$PER$$US-ROCHE-3579602$ROCHE$$85$YR$E$M$Y$$$20240628$$CN$US$US
240711572$24071157$2$F$$20240415$20240710$20240710$PER$$US-ROCHE-3531550$ROCHE$$$$A$F$Y$$$20240701$$CN$US$US
240711581$24071158$1$I$20221119$20240510$20240710$20240710$PER$$DE-ROCHE-3448127$ROCHE$$3$YR$C$F$Y$15.8$KG$20240701$$MD$DE$DE
240711591$24071159$1$I$20220120$20240510$20240710$20240710$PER$$DE-ROCHE-3176408$ROCHE$$41$YR$A$M$Y$56$KG$20240701$$MD$DE$DE
240711601$24071160$1$I$$20240226$20240710$20240710$PER$$GB-ROCHE-3448113$ROCHE$$$$A$M$Y$$$20240701$$CN$GB$GB
240711611$24071161$1$I$$20240703$20240710$20240710$EXP$$BR-ALXN-202407SAM000328BR$ALEXION PHARMACEUTICALS$$23$YR$$M$Y$$$20240710$$HP$BR$BR
240711622$24071162$2$F$$20240218$20240710$20240710$PER$$CN-ROCHE-3512252$ROCHE$$8$YR$C$M$Y$$$20240701$$MD$CN$CN
240711632$24071163$2$F$20231201$20240405$20240710$20240710$PER$$BR-ROCHE-3533518$ROCHE$$30$YR$A$F$Y$38$KG$20240701$$CN$BR$BR
240711641$24071164$1$I$$20240430$20240710$20240710$PER$$US-ROCHE-3556735$ROCHE$$$$I$F$Y$8.6$KG$20240701$$MD$US$US
240711651$24071165$1$I$$20240118$20240710$20240710$PER$$US-ROCHE-3495174$ROCHE$$$$E$F$Y$$$20240628$$MD$US$US
240711661$24071166$1$I$20230301$20240510$20240710$20240710$PER$$DE-ROCHE-3374951$ROCHE$$31$YR$A$M$Y$60$KG$20240701$$MD$DE$DE
240711671$24071167$1$I$20220706$20240514$20240710$20240710$PER$$TR-ROCHE-3564643$ROCHE$$23$YR$A$F$Y$74$KG$20240628$$MD$TR$TR
240711682$24071168$2$F$20230330$20240430$20240710$20240710$PER$$SA-ROCHE-3324826$ROCHE$$6$YR$C$F$Y$42$KG$20240701$$CN$SA$SA
240711691$24071169$1$I$20221103$20231004$20240710$20240710$PER$$ES-ROCHE-3435263$ROCHE$$69$YR$E$$Y$$$20240628$$MD$ES$ES
240711702$24071170$2$F$20240101$20240228$20240710$20240710$PER$$US-ROCHE-3518203$ROCHE$$54$YR$A$M$Y$66.68$KG$20240701$$HP$US$US
240711711$24071171$1$I$20240401$20240605$20240710$20240710$PER$$PE-ROCHE-3578317$ROCHE$$5$YR$C$M$Y$18$KG$20240701$$CN$PE$PE
240711721$24071172$1$I$$20240606$20240710$20240710$PER$$US-ROCHE-3368785$ROCHE$$68$YR$E$F$Y$$$20240628$$CN$US$US
240711732$24071173$2$F$$20240307$20240710$20240710$PER$$BE-ROCHE-3518528$ROCHE$$$$$$Y$$$20240701$$PH$BE$BE
240711741$24071174$1$I$20231027$20240209$20240710$20240710$PER$$BR-ROCHE-3492037$ROCHE$$29$YR$A$M$Y$$$20240701$$CN$BR$BR
240711751$24071175$1$I$$20240529$20240710$20240710$PER$$GB-ROCHE-3573755$ROCHE$$$$T$F$Y$$$20240701$$HP$GB$GB
240711761$24071176$1$I$$20240528$20240710$20240710$PER$$AU-ROCHE-3574321$ROCHE$$$$$$Y$$$20240701$$MD$AU$AU
240711771$24071177$1$I$20240304$20240606$20240710$20240710$PER$$CN-ROCHE-3578982$ROCHE$$60$YR$A$M$Y$76$KG$20240628$$MD$CN$CN
240711781$24071178$1$I$$20240515$20240710$20240710$PER$$IN-ROCHE-3565561$ROCHE$$34$YR$A$F$Y$$$20240628$$MD$IN$IN
240711791$24071179$1$I$20230615$20240213$20240710$20240710$PER$$GB-ROCHE-3396361$ROCHE$$$$E$F$Y$$$20240701$$CN$GB$GB
240711801$24071180$1$I$$20240426$20240710$20240710$PER$$US-ROCHE-3555086$ROCHE$$86$YR$E$F$Y$$$20240628$$CN$US$US
240711811$24071181$1$I$20231201$20240222$20240710$20240710$PER$$JP-ROCHE-3522070$ROCHE$$$$A$F$Y$$$20240628$$MD$JP$JP
240711821$24071182$1$I$$20240507$20240710$20240710$PER$$CO-ROCHE-3560506$ROCHE$$56$YR$A$M$Y$75$KG$20240628$$CN$CO$CO
240711831$24071183$1$I$$20240516$20240710$20240710$PER$$JP-ROCHE-3577648$ROCHE$$27$YR$A$F$Y$$$20240701$$MD$JP$JP
240711841$24071184$1$I$$20240327$20240710$20240710$PER$$US-ROCHE-3534796$ROCHE$$$$I$M$Y$$$20240701$$MD$US$US
240711851$24071185$1$I$$20240531$20240710$20240710$PER$$US-ROCHE-3574968$ROCHE$$50$YR$A$F$Y$$$20240701$$CN$US$US
240711861$24071186$1$I$$20240503$20240710$20240710$PER$$US-ROCHE-3090352$ROCHE$$15$YR$T$M$Y$33.9$KG$20240701$$CN$US$US
240711872$24071187$2$F$$20240321$20240710$20240710$PER$$BR-ROCHE-3531842$ROCHE$$36$YR$A$F$Y$$$20240701$$CN$BR$BR
240711881$24071188$1$I$$20240523$20240710$20240710$PER$$US-ROCHE-3569846$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240711891$24071189$1$I$$20240405$20240710$20240710$PER$$CA-ROCHE-3541126$ROCHE$$$$$$Y$$$20240701$$MD$CA$CA
240711902$24071190$2$F$$20240403$20240710$20240710$PER$$AT-ROCHE-3540544$ROCHE$$$$A$F$Y$$$20240701$$MD$AT$AT
240711911$24071191$1$I$20230401$20240313$20240710$20240710$PER$$IN-ROCHE-3528508$ROCHE$$$$$M$Y$$$20240701$$MD$IN$IN
240711922$24071192$2$F$20220104$20240212$20240710$20240710$PER$$US-ROCHE-3053660$ROCHE$$1$YR$I$M$Y$8.1$KG$20240701$$CN$US$US
240711931$24071193$1$I$$20240327$20240710$20240710$PER$$JP-ROCHE-3551694$ROCHE$$$$A$M$Y$$$20240628$$MD$JP$JP
240711941$24071194$1$I$$20240301$20240710$20240710$PER$$JP-ROCHE-3533728$ROCHE$$73$YR$E$F$Y$$$20240628$$HP$JP$JP
240711952$24071195$2$F$20240201$20240522$20240710$20240710$PER$$PE-ROCHE-3566759$ROCHE$$69$YR$E$M$Y$69.5$KG$20240628$$MD$PE$PE
240711962$24071196$2$F$$20240320$20240710$20240710$PER$$EG-ROCHE-3532215$ROCHE$$14$YR$T$M$Y$45$KG$20240701$$CN$EG$EG
240711971$24071197$1$I$20240707$20240709$20240709$20240709$DIR$709631$$FDA-CTU$$72$YR$$M$N$72$KG$20240709$Y$CN$US$
240711981$24071198$1$I$$20240515$20240710$20240710$PER$$US-ROCHE-3565042$ROCHE$$81$YR$E$F$Y$$$20240628$$CN$US$US
240712005$24071200$5$F$$20240401$20240710$20240710$PER$$MY-ROCHE-3506367$ROCHE$$$$T$M$Y$17$KG$20240701$$PH$MY$MY
240712011$24071201$1$I$$20240411$20240710$20240710$PER$$IT-ROCHE-3545502$ROCHE$$$$$M$Y$$$20240628$$CN$IT$IT
240712021$24071202$1$I$20220613$20240606$20240710$20240710$PER$$AT-ROCHE-3219153$ROCHE$$74$YR$E$F$Y$84$KG$20240628$$MD$AT$AT
240712031$24071203$1$I$$20240610$20240710$20240710$PER$$US-ROCHE-10000000734$ROCHE$$47$YR$A$M$Y$$$20240701$$CN$US$US
240712041$24071204$1$I$$20240401$20240710$20240710$PER$$US-ROCHE-3537131$ROCHE$$8$YR$C$F$Y$$$20240701$$PH$US$US
240712051$24071205$1$I$20240417$20240506$20240710$20240710$PER$$PY-ROCHE-3560436$ROCHE$$2$YR$C$F$Y$10.55$KG$20240701$$CN$PY$PY
240712061$24071206$1$I$$20240303$20240710$20240710$PER$$EG-ROCHE-3522825$ROCHE$$20$MON$I$M$Y$12$KG$20240701$$CN$EG$EG
240712071$24071207$1$I$$20230719$20240710$20240710$PER$$IN-ROCHE-3391588$ROCHE$$59$YR$A$F$Y$$$20240628$$MD$IN$IN
240712082$24071208$2$F$20240501$20240531$20240710$20240710$PER$$DE-ROCHE-3569389$ROCHE$$$$$F$Y$$$20240701$$PH$DE$DE
240712092$24071209$2$F$20240612$20240820$20240710$20240903$EXP$$DE-OCTA-GAM21324$OCTAPHARMA$$50$YR$A$M$Y$$$20240903$$MD$EU$EU
240712102$24071210$2$F$$20240401$20240710$20240710$PER$$US-ROCHE-3537023$ROCHE$$1$YR$I$M$Y$6.3$KG$20240701$$CN$US$US
240712112$24071211$2$F$$20240419$20240710$20240710$PER$$DE-ROCHE-3552139$ROCHE$$4$WK$N$$Y$$$20240701$$CN$DE$DE
240712121$24071212$1$I$$20240501$20240710$20240710$PER$$US-ROCHE-3557117$ROCHE$$6$WK$I$M$Y$2.96$KG$20240701$$CN$US$US
240712132$24071213$2$F$$20240523$20240710$20240710$PER$$CA-ROCHE-3413308$ROCHE$$28$YR$A$F$Y$$$20240701$$CN$CA$CA
240712142$24071214$2$F$$20240506$20240710$20240710$PER$$US-ROCHE-3558383$ROCHE$$3$WK$N$F$Y$$$20240701$$MD$US$US
240712152$24071215$2$F$20240115$20240424$20240710$20240710$PER$$AR-ROCHE-3528616$ROCHE$$11$YR$C$F$Y$$$20240701$$MD$AR$AR
240712161$24071216$1$I$$20240219$20240710$20240710$PER$$GB-ROCHE-3513074$ROCHE$$$$$$Y$$$20240628$$HP$GB$GB
240712171$24071217$1$I$$20240607$20240710$20240710$PER$$CN-ROCHE-3579231$ROCHE$$51$YR$A$M$Y$$$20240628$$CN$CN$CN
240712181$24071218$1$I$$20231031$20240710$20240710$PER$$KR-ROCHE-3451036$ROCHE$Park S, Yoon H, Han E, Yoo I Clinical Challenge of Two Competing Targetable Mutations in Non-Small-Cell Lung Cancer: A Case Report. DOI:10.3390/diagnostics13193112. Diagnostics 2023 Oct;13(19):1-4.$74$YR$E$F$Y$$$20240628$$HP$KR$KR
240712191$24071219$1$I$$20240427$20240710$20240710$PER$$EG-ROCHE-3557090$ROCHE$$1$YR$I$F$Y$7$KG$20240701$$CN$EG$EG
240712201$24071220$1$I$20240527$20240529$20240710$20240710$PER$$CL-ROCHE-3575598$ROCHE$$1$YR$I$M$Y$11.3$KG$20240701$$CN$CL$CL
240712211$24071221$1$I$20231214$20240216$20240710$20240710$PER$$US-ROCHE-3489274$ROCHE$$13$YR$T$M$Y$22.7$KG$20240701$$CN$US$US
240712221$24071222$1$I$$20240415$20240710$20240710$PER$$GB-ROCHE-3548224$ROCHE$$$$A$M$Y$$$20240701$$CN$GB$GB
240712231$24071223$1$I$$20240409$20240710$20240710$PER$$RO-ROCHE-3545549$ROCHE$$80$YR$E$F$Y$70$KG$20240628$$CN$RO$RO
240712243$24071224$3$F$20231211$20240209$20240710$20240710$PER$$UY-ROCHE-3475946$ROCHE$$8$MON$I$F$Y$$$20240701$$CN$UY$UY
240712262$24071226$2$F$$20240209$20240710$20240710$PER$$US-ROCHE-3508634$ROCHE$$32$YR$A$M$Y$68.9$KG$20240701$$CN$US$US
240712271$24071227$1$I$$20231205$20240710$20240710$PER$$IN-ROCHE-3470396$ROCHE$$53$YR$A$F$Y$$$20240628$$MD$IN$IN
240712282$24071228$2$F$$20240305$20240710$20240710$PER$$NL-ROCHE-3498014$ROCHE$$22$YR$A$F$Y$$$20240701$$PH$NL$NL
240712303$24071230$3$F$$20240502$20240710$20240710$PER$$US-ROCHE-3557596$ROCHE$$$$I$F$Y$$$20240701$$CN$US$US
240712311$24071231$1$I$$20240227$20240710$20240710$PER$$IS-ROCHE-3517775$ROCHE$$$$A$M$Y$64.7$KG$20240701$$HP$IS$IS
240712321$24071232$1$I$20240412$20240412$20240710$20240710$PER$$JP-ROCHE-3556399$ROCHE$$11$YR$C$M$Y$30.2$KG$20240701$$MD$JP$JP
240712331$24071233$1$I$$20240221$20240710$20240710$PER$$AU-ROCHE-3513819$ROCHE$$$$$M$Y$$$20240701$$CN$AU$AU
240712342$24071234$2$F$$20240603$20240710$20240710$PER$$US-ROCHE-3576425$ROCHE$$27$YR$A$M$Y$$$20240701$$CN$US$US
240712352$24071235$2$F$$20240429$20240710$20240710$PER$$US-ROCHE-3533589$ROCHE$$19$YR$A$M$Y$40.7$KG$20240701$$CN$US$US
240712361$24071236$1$I$20240409$20240409$20240710$20240710$PER$$US-ROCHE-3543152$ROCHE$$69$YR$E$F$Y$99.79$KG$20240701$$CN$US$US
240712371$24071237$1$I$$20240502$20240710$20240710$PER$$US-ROCHE-3557885$ROCHE$$61$YR$A$F$Y$$$20240628$$CN$US$US
240712381$24071238$1$I$$20240418$20240710$20240710$PER$$US-ROCHE-3549215$ROCHE$$7$YR$C$F$Y$12.7$KG$20240701$$CN$US$US
240712392$24071239$2$F$20240327$20240402$20240710$20240710$PER$$AR-ROCHE-3540556$ROCHE$$35$YR$A$F$Y$54$KG$20240701$$CN$AR$AR
240712403$24071240$3$F$$20240514$20240710$20240710$PER$$US-ROCHE-3539083$ROCHE$$3$YR$C$M$Y$13.2$KG$20240701$$CN$US$US
240712411$24071241$1$I$20220401$20240605$20240710$20240710$PER$$CU-ROCHE-3238153$ROCHE$$52$YR$A$M$Y$80$KG$20240628$$MD$CU$CU
240712421$24071242$1$I$$20240521$20240710$20240710$PER$$US-ROCHE-3568234$ROCHE$$65$YR$E$M$Y$$$20240701$$CN$US$US
240712431$24071243$1$I$$20240517$20240710$20240710$PER$$IN-ROCHE-3567590$ROCHE$$51$YR$A$F$Y$$$20240628$$CN$IN$IN
240712441$24071244$1$I$$20240503$20240710$20240710$PER$$US-ROCHE-3558329$ROCHE$$56$YR$A$F$Y$$$20240628$$CN$US$US
240712452$24071245$2$F$$20240708$20240710$20240711$PER$$US-JNJFOC-20240718160$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240712461$24071246$1$I$$20240207$20240710$20240710$PER$$US-ROCHE-3507700$ROCHE$$53$YR$A$$Y$$$20240701$$MD$US$US
240712472$24071247$2$F$$20240209$20240710$20240710$PER$$BR-ROCHE-3417083$ROCHE$$13$YR$T$M$Y$28.6$KG$20240701$$CN$BR$BR
240712491$24071249$1$I$20230901$20240605$20240710$20240710$PER$$BR-ROCHE-3578347$ROCHE$$32$YR$A$M$Y$$$20240701$$CN$BR$BR
240712501$24071250$1$I$20240429$20240514$20240710$20240710$PER$$US-ROCHE-3564577$ROCHE$$2$MON$I$M$Y$3.93$KG$20240701$$CN$US$US
240712513$24071251$3$F$20230411$20240517$20240710$20240710$PER$$IT-ROCHE-3553117$ROCHE$$65$YR$E$M$Y$$$20240628$$MD$IT$IT
240712521$24071252$1$I$$20240222$20240710$20240710$PER$$US-ROCHE-3515612$ROCHE$$59$YR$A$F$Y$63.5$KG$20240701$$CN$US$US
240712543$24071254$3$F$$20240223$20240710$20240710$PER$$AR-ROCHE-3517019$ROCHE$$35$YR$A$F$Y$54$KG$20240701$$CN$AR$AR
240712551$24071255$1$I$$20240209$20240710$20240710$PER$$BR-ROCHE-3507736$ROCHE$$20$YR$A$M$Y$42$KG$20240701$$CN$BR$BR
240712562$24071256$2$F$$20240318$20240710$20240710$PER$$US-ROCHE-3528846$ROCHE$$5$YR$C$M$Y$$$20240701$$CN$US$US
240712571$24071257$1$I$$20240303$20240710$20240710$PER$$US-ROCHE-3519804$ROCHE$$$$A$$Y$$$20240701$$MD$US$US
240712582$24071258$2$F$20240101$20240305$20240710$20240710$PER$$GR-ROCHE-3522669$ROCHE$$53$YR$A$M$Y$100$KG$20240701$$CN$GR$GR
240712592$24071259$2$F$20240414$20240414$20240710$20240710$PER$$US-ROCHE-3546563$ROCHE$$1$MON$I$M$Y$2.2$KG$20240701$$CN$US$US
240712602$24071260$2$F$$20240304$20240710$20240710$PER$$US-ROCHE-3518994$ROCHE$$9$YR$C$F$Y$24.9$KG$20240701$$CN$US$US
240712612$24071261$2$F$20240212$20240213$20240710$20240710$PER$$US-ROCHE-3510157$ROCHE$$1$YR$I$M$Y$$$20240701$$CN$US$US
240712622$24071262$2$F$20230920$20240220$20240710$20240710$PER$$SA-ROCHE-3429078$ROCHE$$13$YR$T$M$Y$43.63$KG$20240701$$CN$SA$SA
240712641$24071264$1$I$$20240507$20240710$20240710$PER$$US-ROCHE-3560764$ROCHE$$68$YR$E$M$Y$$$20240701$$CN$US$US
240712652$24071265$2$F$20240201$20240314$20240710$20240710$PER$$EG-ROCHE-3528859$ROCHE$$8$YR$C$M$Y$32$KG$20240701$$CN$EG$EG
240712661$24071266$1$I$20240221$20240223$20240710$20240710$PER$$FR-ROCHE-3487710$ROCHE$$18$YR$A$$Y$$$20240701$$MD$FR$FR
240712671$24071267$1$I$20230601$20240229$20240710$20240710$PER$$DE-ROCHE-3450790$ROCHE$$41$YR$A$F$Y$39$KG$20240701$$MD$DE$DE
240712681$24071268$1$I$20240508$20240529$20240710$20240710$PER$$DK-ROCHE-3574413$ROCHE$$70$YR$E$M$Y$$$20240628$$MD$DK$DK
240712691$24071269$1$I$20240301$20240520$20240710$20240710$PER$CH-SM-2024-13193$CH-ROCHE-3567774$ROCHE$$40$YR$A$F$Y$$$20240701$$MD$CH$CH
240712701$24071270$1$I$$20240321$20240710$20240710$PER$$US-ROCHE-3532250$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240712711$24071271$1$I$$20240423$20240710$20240710$PER$$US-ROCHE-3552192$ROCHE$$79$YR$E$F$Y$$$20240628$$CN$US$US
240712722$24071272$2$F$20240217$20240219$20240710$20240710$PER$$US-ROCHE-3512601$ROCHE$$36$YR$A$M$Y$$$20240701$$CN$US$US
240712731$24071273$1$I$$20240424$20240710$20240710$PER$$GB-ROCHE-3552985$ROCHE$$$$$$Y$$$20240701$$HP$GB$GB
240712741$24071274$1$I$$20240321$20240710$20240710$PER$$US-ROCHE-3532349$ROCHE$$19$DY$N$M$Y$3.8$KG$20240701$$CN$US$US
240712751$24071275$1$I$$20240209$20240710$20240710$PER$$US-ROCHE-3421694$ROCHE$$31$YR$A$F$Y$38.56$KG$20240701$$CN$US$US
240712761$24071276$1$I$$20240510$20240710$20240710$PER$$US-ROCHE-3563757$ROCHE$$54$YR$A$M$Y$$$20240701$$CN$US$US
240712771$24071277$1$I$$20240219$20240710$20240710$PER$$DE-ROCHE-3514964$ROCHE$$21$YR$A$M$Y$$$20240701$$HP$DE$DE
240712783$24071278$3$F$$20240422$20240710$20240710$PER$$US-ROCHE-3551050$ROCHE$$$$N$F$Y$4.01$KG$20240701$$CN$US$US
240712791$24071279$1$I$$20240506$20240710$20240710$PER$$US-ROCHE-3559588$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240712801$24071280$1$I$$20240314$20240710$20240710$PER$$US-ROCHE-3530144$ROCHE$$3$YR$C$F$Y$16.9$KG$20240701$$MD$US$US
240712811$24071281$1$I$$20240304$20240710$20240710$PER$$GB-ROCHE-3102041$ROCHE$$$$A$F$Y$$$20240701$$CN$GB$GB
240712841$24071284$1$I$$20240506$20240710$20240710$PER$$US-ROCHE-3558990$ROCHE$$$$N$M$Y$$$20240701$$CN$US$US
240712851$24071285$1$I$$20240314$20240710$20240710$PER$$AU-ROCHE-3527191$ROCHE$$7$YR$C$F$Y$$$20240701$$CN$AU$AU
240712861$24071286$1$I$20231218$20240516$20240710$20240710$PER$$BE-ROCHE-3565838$ROCHE$$59$YR$A$F$Y$91.5$KG$20240628$$MD$BE$BE
240712871$24071287$1$I$$20240418$20240710$20240710$PER$$US-ROCHE-3549435$ROCHE$$4$YR$C$F$Y$$$20240701$$PH$US$US
240712882$24071288$2$F$$20240403$20240710$20240710$PER$$GB-ROCHE-3529464$ROCHE$$$$$$Y$$$20240701$$MD$GB$GB
240712891$24071289$1$I$$20240221$20240710$20240710$PER$$US-ROCHE-3514220$ROCHE$$35$YR$A$$Y$$$20240701$$CN$US$US
240712903$24071290$3$F$20231101$20240403$20240710$20240710$PER$$BR-ROCHE-3522661$ROCHE$$6$YR$C$M$Y$17$KG$20240701$$MD$BR$BR
240712911$24071291$1$I$20240305$20240426$20240710$20240710$PER$$JP-ROCHE-3564932$ROCHE$$8$DEC$E$M$Y$$$20240628$$MD$JP$JP
240712921$24071292$1$I$$20240529$20240710$20240710$PER$$US-ROCHE-3573268$ROCHE$$$$C$M$Y$$$20240701$$MD$US$US
240712931$24071293$1$I$20231201$20240223$20240710$20240710$PER$$CL-ROCHE-3516965$ROCHE$$$$$M$Y$62$KG$20240701$$CN$CL$CL
240712951$24071295$1$I$20240301$20240328$20240710$20240710$PER$$BR-ROCHE-3536636$ROCHE$$24$YR$A$F$Y$$$20240701$$CN$BR$BR
240712961$24071296$1$I$$20240412$20240710$20240710$PER$$US-ROCHE-3545792$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
240712972$24071297$2$F$20220501$20240322$20240710$20240710$PER$$JP-ROCHE-3123092$ROCHE$$15$YR$T$F$Y$$$20240701$$MD$JP$JP
240712981$24071298$1$I$20220523$20240415$20240710$20240710$PER$$DE-ROCHE-3289291$ROCHE$$43$YR$A$M$Y$71$KG$20240701$$MD$DE$DE
240712991$24071299$1$I$$20240606$20240710$20240710$PER$$RU-ROCHE-3578818$ROCHE$$57$YR$A$M$Y$$$20240628$$MD$RU$RU
240713001$24071300$1$I$$20240229$20240710$20240710$PER$$US-ROCHE-3519023$ROCHE$$$$C$F$Y$23.1$KG$20240701$$CN$US$US
240713021$24071302$1$I$20240322$20240517$20240710$20240710$PER$$IT-ROCHE-3566651$ROCHE$$59$YR$A$M$Y$102$KG$20240628$$MD$IT$IT
240713032$24071303$2$F$$20240327$20240710$20240710$PER$$US-ROCHE-3534449$ROCHE$$22$YR$A$F$Y$29.76$KG$20240701$$CN$US$US
240713041$24071304$1$I$$20240329$20240710$20240710$PER$$CA-ROCHE-3339194$ROCHE$$$$A$M$Y$$$20240701$$CN$CA$CA
240713051$24071305$1$I$$20240510$20240710$20240710$PER$$FR-ROCHE-3562947$ROCHE$$34$YR$A$F$Y$$$20240701$$PH$FR$FR
240713061$24071306$1$I$$20240422$20240710$20240710$PER$$US-ROCHE-3554288$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240713071$24071307$1$I$20220318$20240304$20240710$20240710$PER$$JP-ROCHE-3108936$ROCHE$$76$YR$E$M$Y$67.9$KG$20240701$$MD$JP$JP
240713081$24071308$1$I$$20240315$20240710$20240710$PER$$CA-ROCHE-3149377$ROCHE$$35$YR$A$M$Y$$$20240701$$CN$CA$CA
240713091$24071309$1$I$$20240229$20240710$20240710$PER$$DE-ROCHE-3519398$ROCHE$$10$YR$C$F$Y$53$KG$20240701$$MD$DE$DE
240713101$24071310$1$I$$20240516$20240710$20240710$PER$$GR-ROCHE-3422084$ROCHE$$$$A$M$Y$68$KG$20240701$$CN$GR$GR
240713111$24071311$1$I$20240101$20240419$20240710$20240710$PER$$CA-ROCHE-3551583$ROCHE$$63$YR$A$F$Y$$$20240628$$CN$CA$CA
240713121$24071312$1$I$$20240515$20240710$20240710$PER$$TH-ROCHE-3566274$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$TH$TH
240713131$24071313$1$I$$20240530$20240710$20240710$PER$$GB-ROCHE-3575575$ROCHE$$$$A$F$Y$$$20240701$$CN$GB$GB
240713142$24071314$2$F$$20240410$20240710$20240710$PER$$US-ROCHE-3543708$ROCHE$$10$YR$C$F$Y$$$20240701$$CN$US$US
240713161$24071316$1$I$20240401$20240425$20240710$20240710$PER$$US-ROCHE-3553378$ROCHE$$2$YR$C$F$Y$12.5$KG$20240701$$CN$US$US
240713171$24071317$1$I$20220801$20240528$20240710$20240710$PER$$DE-ROCHE-3300318$ROCHE$$16$YR$T$F$Y$55$KG$20240701$$MD$DE$DE
240713181$24071318$1$I$$20240227$20240710$20240710$PER$$US-ROCHE-3517229$ROCHE$$32$YR$A$$Y$$$20240701$$CN$US$US
240713191$24071319$1$I$20240617$20240626$20240710$20240710$EXP$$CN-OCTA-ALB10524$OCTAPHARMA$$$$A$M$Y$71$KG$20240709$$HP$CN$CN
240713201$24071320$1$I$$20240408$20240710$20240710$PER$$US-ROCHE-3542162$ROCHE$$79$YR$E$F$Y$$$20240701$$CN$US$US
240713211$24071321$1$I$$20240408$20240710$20240710$PER$$US-ROCHE-3543722$ROCHE$$$$$$Y$$$20240701$$MD$US$US
240713222$24071322$2$F$$20240321$20240710$20240710$PER$$CA-ROCHE-3529298$ROCHE$$29$YR$A$$Y$$$20240701$$CN$CA$CA
240713231$24071323$1$I$20230603$20240527$20240710$20240710$PER$$RU-ROCHE-3362155$ROCHE$$57$YR$A$M$Y$60$KG$20240628$$MD$RU$RU
240713242$24071324$2$F$20240501$20240501$20240710$20240710$PER$$CN-ROCHE-3556953$ROCHE$$13$YR$T$M$Y$$$20240701$$CN$CN$CN
240713252$24071325$2$F$20240502$20240508$20240710$20240710$PER$$UY-ROCHE-3562931$ROCHE$$16$YR$T$F$Y$$$20240701$$CN$UY$UY
240713261$24071326$1$I$$20240527$20240710$20240710$PER$$BR-ROCHE-3572925$ROCHE$$7$YR$C$F$Y$$$20240701$$CN$BR$BR
240713271$24071327$1$I$20240220$20240221$20240710$20240710$PER$$US-ROCHE-3514132$ROCHE$$2$YR$C$F$Y$$$20240701$$CN$US$US
240713281$24071328$1$I$$20240312$20240710$20240710$PER$$US-ROCHE-3525644$ROCHE$$13$DY$N$M$Y$$$20240701$$CN$US$US
240713291$24071329$1$I$$20240312$20240710$20240710$PER$$US-ROCHE-3525489$ROCHE$$$$I$M$Y$3.44$KG$20240701$$CN$US$US
240713302$24071330$2$F$20240328$20240328$20240710$20240710$PER$$US-ROCHE-3536196$ROCHE$$19$DY$N$M$Y$3.58$KG$20240701$$CN$US$US
240713311$24071331$1$I$20211121$20240313$20240710$20240710$PER$$JP-ROCHE-3086495$ROCHE$$44$YR$A$M$Y$25.7$KG$20240701$$PH$JP$JP
240713321$24071332$1$I$20221001$20240510$20240710$20240710$PER$$DE-ROCHE-3303049$ROCHE$$10$YR$C$F$Y$32$KG$20240701$$MD$DE$DE
240713332$24071333$2$F$20240419$20240430$20240710$20240710$PER$$US-ROCHE-3556288$ROCHE$$13$YR$T$M$Y$46.2$KG$20240701$$CN$US$US
240713342$24071334$2$F$$20240320$20240710$20240710$PER$$US-ROCHE-3530577$ROCHE$$4$YR$C$M$Y$14.97$KG$20240701$$CN$US$US
240713352$24071335$2$F$$20240318$20240710$20240710$PER$$US-ROCHE-3528091$ROCHE$$38$YR$A$M$Y$$$20240701$$CN$US$US
240713361$24071336$1$I$$20240403$20240710$20240710$PER$$GB-ROCHE-3538989$ROCHE$$$$C$M$Y$$$20240701$$MD$GB$GB
240713372$24071337$2$F$20231115$20240522$20240710$20240710$PER$$JP-ROCHE-3494838$ROCHE$$25$YR$A$F$Y$$$20240701$$MD$JP$JP
240713381$24071338$1$I$$20240509$20240710$20240710$PER$$GB-ROCHE-3561739$ROCHE$$$$$$Y$$$20240701$$MD$GB$GB
240713391$24071339$1$I$20240101$20240308$20240710$20240710$PER$$DE-ROCHE-3524417$ROCHE$$18$YR$A$F$Y$50$KG$20240701$$MD$DE$DE
240713401$24071340$1$I$$20240529$20240710$20240710$PER$$AU-ROCHE-3574356$ROCHE$$$$$$Y$$$20240701$$MD$AU$AU
240713411$24071341$1$I$$20240215$20240710$20240710$PER$$DE-ROCHE-3511677$ROCHE$$$$$M$Y$$$20240701$$MD$DE$DE
240713421$24071342$1$I$$20240305$20240710$20240710$PER$$SK-ROCHE-3523512$ROCHE$$$$T$M$Y$13$KG$20240701$$PH$SK$SK
240713432$24071343$2$F$$20240227$20240710$20240710$PER$$JP-ROCHE-3528095$ROCHE$$$$A$F$Y$$$20240701$$MD$JP$JP
240713441$24071344$1$I$$20240503$20240710$20240710$PER$$US-ROCHE-3558666$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240713451$24071345$1$I$$20240401$20240710$20240710$PER$$US-ROCHE-3537154$ROCHE$$8$YR$C$$Y$$$20240701$$CN$US$US
240713461$24071346$1$I$$20240315$20240710$20240710$PER$$GB-ROCHE-3528973$ROCHE$$$$A$M$Y$$$20240701$$CN$GB$GB
240713471$24071347$1$I$$20240516$20240710$20240710$PER$$JP-ROCHE-3572212$ROCHE$$$$E$$Y$$$20240628$$MD$JP$JP
240713491$24071349$1$I$$20240308$20240710$20240710$PER$$US-ROCHE-3524980$ROCHE$$9$YR$C$F$Y$$$20240701$$MD$US$US
240713501$24071350$1$I$20220928$20240528$20240710$20240710$PER$$DE-ROCHE-3460144$ROCHE$$8$YR$C$M$Y$15$KG$20240701$$MD$DE$DE
240713511$24071351$1$I$$20240603$20240710$20240710$PER$$US-ROCHE-3575856$ROCHE$$77$YR$E$M$Y$$$20240628$$CN$US$US
240713521$24071352$1$I$$20240327$20240710$20240710$PER$$US-ROCHE-3497381$ROCHE$$5$YR$C$M$Y$13.15$KG$20240701$$HP$US$US
240713532$24071353$2$F$$20240228$20240710$20240710$PER$$US-ROCHE-3518488$ROCHE$$33$YR$A$$Y$$$20240701$$CN$US$US
240713541$24071354$1$I$$20240313$20240710$20240710$PER$$US-ROCHE-3526820$ROCHE$$33$YR$A$F$Y$$$20240701$$CN$US$US
240713551$24071355$1$I$$20240513$20240710$20240710$PER$$US-ROCHE-3563128$ROCHE$$$$A$M$Y$$$20240701$$CN$US$US
240713562$24071356$2$F$20240116$20240418$20240710$20240710$PER$$CN-ROCHE-3532265$ROCHE$$2$YR$C$$Y$$$20240701$$MD$CN$CN
240713571$24071357$1$I$20231101$20240412$20240710$20240710$PER$$PY-ROCHE-3547194$ROCHE$$2$YR$C$F$Y$17$KG$20240701$$CN$PY$PY
240713582$24071358$2$F$$20240304$20240710$20240710$PER$$GB-ROCHE-3520860$ROCHE$$$$$$Y$$$20240701$$CN$GB$GB
240713591$24071359$1$I$$20240212$20240710$20240710$PER$$US-ROCHE-3509500$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240713611$24071361$1$I$20240519$20240521$20240710$20240710$PER$$FR-ROCHE-3568668$ROCHE$$32$YR$A$M$Y$$$20240701$$CN$FR$FR
240713621$24071362$1$I$20240528$20240528$20240710$20240710$PER$$JP-ROCHE-3577642$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240713631$24071363$1$I$$20240428$20240710$20240710$PER$$EG-ROCHE-3556962$ROCHE$$1$YR$I$M$Y$9.5$KG$20240701$$CN$EG$EG
240713641$24071364$1$I$$20240528$20240710$20240710$PER$$AU-ROCHE-3574303$ROCHE$$$$$$Y$$$20240701$$MD$AU$AU
240713652$24071365$2$F$20240201$20240513$20240710$20240710$PER$$AT-ROCHE-3541900$ROCHE$$6$YR$C$F$Y$21.6$KG$20240701$$HP$AT$AT
240713661$24071366$1$I$20221125$20240430$20240710$20240710$PER$$AT-ROCHE-3231110$ROCHE$$79$YR$E$F$Y$90$KG$20240628$$MD$AT$AT
240713671$24071367$1$I$20240124$20240223$20240710$20240710$PER$$US-ROCHE-3498594$ROCHE$$18$YR$A$F$Y$60$KG$20240701$$CN$US$US
240713681$24071368$1$I$20240601$20240604$20240710$20240710$PER$$CN-ROCHE-3577209$ROCHE$$4$YR$C$F$Y$11$KG$20240701$$CN$CN$CN
240713691$24071369$1$I$$20240521$20240710$20240710$PER$$US-ROCHE-3569663$ROCHE$$57$YR$A$M$Y$$$20240628$$MD$US$US
240713701$24071370$1$I$$20240219$20240710$20240710$PER$$DE-ROCHE-3514957$ROCHE$$34$YR$A$M$Y$$$20240701$$HP$DE$DE
240713711$24071371$1$I$20240117$20240326$20240710$20240710$PER$$JP-ROCHE-3550863$ROCHE$$5$DEC$A$M$Y$$$20240628$$PH$JP$JP
240713722$24071372$2$F$$20240212$20240710$20240710$PER$$US-ROCHE-3361112$ROCHE$$16$MON$I$F$Y$8.46$KG$20240701$$CN$US$US
240713732$24071373$2$F$$20240312$20240710$20240710$PER$$EG-ROCHE-3527002$ROCHE$$$$$M$Y$$$20240701$$CN$EG$EG
240713741$24071374$1$I$$20240221$20240710$20240710$PER$$BR-ROCHE-3487750$ROCHE$$40$YR$A$F$Y$19.5$KG$20240701$$HP$BR$BR
240713751$24071375$1$I$$20240220$20240710$20240710$PER$$CA-ROCHE-3513389$ROCHE$$$$$$Y$$$20240701$$MD$CA$CA
240713763$24071376$3$F$20230701$20240215$20240710$20240710$PER$$PT-ROCHE-3511019$ROCHE$$$$$M$Y$$$20240701$$MD$PT$PT
240713771$24071377$1$I$$20240209$20240710$20240710$PER$$CA-ROCHE-3509020$ROCHE$$$$A$M$Y$$$20240701$$MD$CA$CA
240713781$24071378$1$I$20240216$20240702$20240710$20240710$EXP$$JP-AstraZeneca-2024A156264$ASTRAZENECA$$76$YR$$M$Y$$$20240710$$MD$JP$
240713791$24071379$1$I$20240326$20240329$20240710$20240710$PER$$US-ROCHE-3535917$ROCHE$$13$YR$T$M$Y$46.6$KG$20240701$$CN$US$US
240713801$24071380$1$I$$20240524$20240710$20240710$PER$$US-ROCHE-3571210$ROCHE$$90$YR$E$F$Y$$$20240628$$CN$US$US
240713812$24071381$2$F$$20240906$20240710$20240916$EXP$$FR-CELLTRION INC.-2024FR016154$CELLTRION$Defrance C, Guicheney M, Toussaint C, Laharie D, Duport E, Beylot-Barry M.. Extremely serious perineal skin involvement of Crohn^s disease treated with risankizumab.. Annals of dermatology and venereology-FMC. 2023;3(8):A255-A256$$$$$Y$$$20240916$$MD$FR$FR
240713821$24071382$1$I$$20240522$20240710$20240710$PER$$US-ROCHE-2846969$ROCHE$$61$YR$A$F$Y$96.16$KG$20240628$$CN$US$US
240713831$24071383$1$I$$20240318$20240710$20240710$PER$$BR-ROCHE-3526017$ROCHE$$2$MON$I$F$Y$5.08$KG$20240701$$CN$BR$BR
240713841$24071384$1$I$$20240325$20240710$20240710$PER$$GB-ROCHE-3534899$ROCHE$$$$$F$Y$$$20240701$$HP$GB$GB
240713853$24071385$3$F$$20240508$20240710$20240710$PER$$US-ROCHE-3560701$ROCHE$$54$YR$A$F$Y$$$20240701$$HP$US$US
240713861$24071386$1$I$20240101$20240605$20240710$20240710$PER$$AU-ROCHE-3578069$ROCHE$$86$YR$E$F$Y$72.21$KG$20240628$$CN$AU$AU
240713871$24071387$1$I$$20240315$20240710$20240710$PER$$BR-ROCHE-3528675$ROCHE$$23$YR$A$F$Y$$$20240701$$HP$BR$BR
240713881$24071388$1$I$$20240219$20240710$20240710$PER$$US-ROCHE-3513012$ROCHE$$17$MON$I$F$Y$10.43$KG$20240701$$CN$US$US
240713901$24071390$1$I$20221001$20240311$20240710$20240710$PER$$DE-ROCHE-3330122$ROCHE$$13$YR$T$M$Y$53$KG$20240701$$MD$DE$DE
240713912$24071391$2$F$$20240216$20240710$20240710$PER$$BR-ROCHE-3513240$ROCHE$$$$$F$Y$$$20240701$$MD$BR$BR
240713932$24071393$2$F$20240410$20240412$20240710$20240710$PER$$PY-ROCHE-3547176$ROCHE$$10$MON$I$F$Y$7.2$KG$20240701$$CN$PY$PY
240713941$24071394$1$I$$20240213$20240710$20240710$PER$$FR-ROCHE-3510344$ROCHE$$35$YR$A$M$Y$$$20240701$$PH$FR$FR
240713951$24071395$1$I$$20240408$20240710$20240710$PER$$US-ROCHE-2812761$ROCHE$$3$YR$C$M$Y$14$KG$20240701$$CN$US$US
240713961$24071396$1$I$$20240422$20240710$20240710$PER$$US-ROCHE-3551404$ROCHE$$$$$M$Y$$$20240628$$HP$US$US
240713971$24071397$1$I$$20240208$20240710$20240710$PER$$BR-ROCHE-3506416$ROCHE$$29$YR$A$F$Y$56$KG$20240701$$CN$BR$BR
240713981$24071398$1$I$$20240308$20240710$20240710$PER$$JP-ROCHE-3539514$ROCHE$$$$C$M$Y$$$20240701$$MD$JP$JP
240713991$24071399$1$I$20240201$20240425$20240710$20240710$PER$$JP-ROCHE-3509782$ROCHE$$16$YR$T$F$Y$$$20240701$$MD$JP$JP
240714002$24071400$2$F$$20240321$20240710$20240710$PER$$GB-ROCHE-3532109$ROCHE$$$$A$M$Y$$$20240701$$CN$GB$GB
240714011$24071401$1$I$20230101$20240301$20240710$20240710$PER$SE-SEMPA-2023-012285$SE-ROCHE-3518985$ROCHE$$22$YR$A$F$Y$$$20240701$$MD$SE$SE
240714021$24071402$1$I$$20240308$20240710$20240710$PER$$FR-ROCHE-3525196$ROCHE$$24$YR$A$F$Y$$$20240701$$PH$FR$FR
240714032$24071403$2$F$$20240314$20240710$20240710$PER$$UY-ROCHE-3500730$ROCHE$$12$YR$T$F$Y$28$KG$20240701$$CN$UY$UY
240714043$24071404$3$F$$20240213$20240710$20240710$PER$$KR-ROCHE-3504692$ROCHE$$13$YR$T$M$Y$$$20240701$$CN$KR$KR
240714051$24071405$1$I$20240312$20240314$20240710$20240710$PER$$AR-ROCHE-3527738$ROCHE$$8$YR$C$M$Y$23.2$KG$20240701$$CN$AR$AR
240714061$24071406$1$I$$20240426$20240710$20240710$PER$$JP-ROCHE-3564983$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240714071$24071407$1$I$20240228$20240228$20240710$20240710$PER$$CA-ROCHE-3519370$ROCHE$$26$YR$A$M$Y$$$20240701$$CN$CA$CA
240714082$24071408$2$F$20221201$20240531$20240710$20240710$PER$$AT-ROCHE-3231891$ROCHE$$79$YR$E$F$Y$90$KG$20240628$$MD$AT$AT
240714091$24071409$1$I$$20240520$20240710$20240710$PER$$US-ROCHE-3567378$ROCHE$$75$YR$E$F$Y$$$20240628$$CN$US$US
240714101$24071410$1$I$$20240219$20240710$20240710$PER$$US-ROCHE-3513036$ROCHE$$23$YR$A$F$Y$$$20240701$$CN$US$US
240714111$24071411$1$I$20240201$20240409$20240710$20240710$PER$$DE-ROCHE-3543424$ROCHE$$1$YR$I$F$Y$9.8$KG$20240701$$MD$DE$DE
240714121$24071412$1$I$20240116$20240418$20240710$20240710$PER$$CN-ROCHE-3549298$ROCHE$$5$YR$C$$Y$$$20240701$$MD$CN$CN
240714131$24071413$1$I$$20240423$20240710$20240710$PER$$IT-ROCHE-3554280$ROCHE$$75$YR$E$$Y$$$20240628$$MD$IT$IT
240714141$24071414$1$I$$20240605$20240710$20240710$PER$$US-ROCHE-3578018$ROCHE$$83$YR$E$F$Y$$$20240628$$PH$US$US
240714151$24071415$1$I$20230928$20240502$20240710$20240710$PER$$DE-ROCHE-3453105$ROCHE$$37$YR$A$M$Y$100$KG$20240701$$CN$DE$DE
240714161$24071416$1$I$$20240306$20240710$20240710$PER$$BR-ROCHE-3521934$ROCHE$$$$$$Y$$$20240701$$MD$BR$BR
240714172$24071417$2$F$$20240410$20240710$20240710$PER$$IT-ROCHE-3538143$ROCHE$D^Amario G, Villa M, de Gioia A, De Biase M, Buchignani B, Leone D, Palermo C, Pane M and Mercuri E Tethered cord in SMA 3 patient. Smakers 2024;:-.$10$YR$C$F$Y$$$20240701$$HP$IT$IT
240714181$24071418$1$I$$20240602$20240710$20240710$PER$$CN-ROCHE-3575166$ROCHE$$$$I$$Y$$$20240701$$MD$CN$CN
240714192$24071419$2$F$$20240329$20240710$20240710$PER$$CN-ROCHE-3535393$ROCHE$$$$C$F$Y$$$20240701$$MD$CN$CN
240714202$24071420$2$F$20240322$20240322$20240710$20240710$PER$$US-ROCHE-3532950$ROCHE$$17$YR$T$F$Y$$$20240701$$CN$US$US
240714211$24071421$1$I$$20240429$20240710$20240710$PER$$CA-ROCHE-3555987$ROCHE$$$$C$M$Y$$$20240701$$CN$CA$CA
240714221$24071422$1$I$20220902$20240522$20240710$20240710$PER$$AU-ROCHE-3174403$ROCHE$$63$YR$A$F$Y$87.1$KG$20240628$$MD$AU$AU
240714231$24071423$1$I$20230727$20240528$20240710$20240710$PER$$TR-ROCHE-3552899$ROCHE$$69$YR$E$M$Y$87$KG$20240628$$MD$TR$TR
240714241$24071424$1$I$$20240528$20240710$20240710$PER$$AU-ROCHE-3574471$ROCHE$$$$$$Y$$$20240701$$MD$AU$AU
240714251$24071425$1$I$$20240325$20240710$20240710$PER$$US-ROCHE-3532862$ROCHE$$5$YR$C$M$Y$$$20240701$$CN$US$US
240714261$24071426$1$I$$20240227$20240710$20240710$PER$$DK-ROCHE-3517775$ROCHE$$$$A$M$Y$64.7$KG$20240701$$HP$DK$DK
240714271$24071427$1$I$$20240220$20240710$20240710$PER$$CH-ROCHE-3513891$ROCHE$$44$YR$A$M$Y$$$20240701$$HP$CH$CH
240714281$24071428$1$I$20231223$20240215$20240710$20240710$PER$$AR-ROCHE-3493800$ROCHE$$34$YR$A$F$Y$45$KG$20240701$$CN$AR$AR
240714291$24071429$1$I$$20240529$20240710$20240710$PER$$AU-ROCHE-3574351$ROCHE$$$$$$Y$$$20240701$$MD$AU$AU
240714312$24071431$2$F$20240124$20240306$20240710$20240710$PER$$GB-ROCHE-3520644$ROCHE$$30$YR$A$F$Y$94.7$KG$20240701$$MD$GB$GB
240714321$24071432$1$I$$20240426$20240710$20240710$PER$$US-ROCHE-3554855$ROCHE$$17$YR$T$F$Y$37$KG$20240701$$CN$US$US
240714331$24071433$1$I$20240619$20240627$20240710$20240710$EXP$$CN-OCTA-ALB10624$OCTAPHARMA$$$$A$F$Y$45$KG$20240709$$HP$CN$CN
240714361$24071436$1$I$20240219$20240221$20240710$20240710$PER$$US-ROCHE-3514237$ROCHE$$5$YR$C$F$Y$$$20240701$$CN$US$US
240714371$24071437$1$I$$20240320$20240710$20240710$PER$$US-ROCHE-3530816$ROCHE$$49$YR$A$M$Y$61.2$KG$20240701$$MD$US$US
240714381$24071438$1$I$$20240408$20240710$20240710$PER$$US-ROCHE-3542275$ROCHE$$64$YR$A$M$Y$$$20240701$$CN$US$US
240714391$24071439$1$I$20220916$20240322$20240710$20240710$PER$$DE-ROCHE-3275193$ROCHE$$54$YR$A$F$Y$60$KG$20240701$$MD$DE$DE
240714401$24071440$1$I$$20240423$20240710$20240710$PER$$CA-ROCHE-3469848$ROCHE$$4$YR$C$M$Y$$$20240701$$CN$CA$CA
240714411$24071441$1$I$$20240516$20240710$20240710$PER$$CA-ROCHE-3566405$ROCHE$$$$$$Y$$$20240701$$CN$CA$CA
240714421$24071442$1$I$$20240604$20240710$20240710$PER$$US-ROCHE-3576810$ROCHE$$9$YR$C$F$Y$$$20240701$$CN$US$US
240714431$24071443$1$I$20230612$20240320$20240710$20240710$PER$$DE-ROCHE-3383725$ROCHE$$26$YR$A$F$Y$23$KG$20240701$$MD$DE$DE
240714441$24071444$1$I$$20240509$20240710$20240710$PER$$TH-ROCHE-3563204$ROCHE$$$$$$Y$$$20240628$$CN$TH$TH
240714451$24071445$1$I$20240314$20240314$20240710$20240710$PER$$US-ROCHE-3527642$ROCHE$$59$YR$A$M$Y$$$20240701$$CN$US$US
240714462$24071446$2$F$$20240604$20240710$20240710$PER$$CH-ROCHE-3557419$ROCHE$$$$$F$Y$$$20240701$$CN$CH$CH
240714471$24071447$1$I$$20240419$20240710$20240710$PER$$FR-ROCHE-3552436$ROCHE$$$$A$$Y$$$20240701$$CN$FR$FR
240714482$24071448$2$F$20240501$20240514$20240710$20240710$PER$$JP-ROCHE-3569687$ROCHE$$3$DEC$A$F$Y$$$20240701$$HP$JP$JP
240714492$24071449$2$F$$20240328$20240710$20240710$PER$$US-ROCHE-3535328$ROCHE$$$$A$M$Y$$$20240701$$HP$US$US
240714501$24071450$1$I$20220429$20240321$20240710$20240710$PER$$DE-ROCHE-3275281$ROCHE$$23$YR$A$F$Y$85$KG$20240701$$MD$DE$DE
240714511$24071451$1$I$$20240219$20240710$20240710$PER$$DE-ROCHE-3514960$ROCHE$$27$YR$A$M$Y$$$20240701$$HP$DE$DE
240714521$24071452$1$I$20230306$20240213$20240710$20240710$PER$$DE-ROCHE-3427578$ROCHE$$56$YR$A$F$Y$52.8$KG$20240701$$MD$DE$DE
240714541$24071454$1$I$20240101$20240207$20240710$20240710$PER$$JP-ROCHE-3513326$ROCHE$$$$C$F$Y$$$20240701$$PH$JP$JP
240714551$24071455$1$I$20240514$20240516$20240710$20240710$PER$$US-ROCHE-3565881$ROCHE$$28$YR$A$M$Y$39.2$KG$20240701$$CN$US$US
240714561$24071456$1$I$$20240301$20240710$20240710$PER$$RU-ROCHE-3521076$ROCHE$$$$A$M$Y$$$20240701$$MD$RU$RU
240714571$24071457$1$I$20240509$20240510$20240710$20240710$PER$$US-ROCHE-3562540$ROCHE$$3$YR$C$M$Y$12.5$KG$20240701$$CN$US$US
240714581$24071458$1$I$$20240410$20240710$20240710$PER$$US-ROCHE-3544472$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240714591$24071459$1$I$$20240227$20240710$20240710$PER$$US-ROCHE-3517061$ROCHE$$9$YR$C$F$Y$26.2$KG$20240701$$CN$US$US
240714602$24071460$2$F$20240601$20240603$20240710$20240710$PER$$US-ROCHE-3575879$ROCHE$$1$MON$I$F$Y$$$20240701$$CN$US$US
240714611$24071461$1$I$20230801$20240212$20240710$20240710$PER$$DE-ROCHE-3428510$ROCHE$$14$YR$T$M$Y$67$KG$20240701$$MD$DE$DE
240714622$24071462$2$F$20220214$20240528$20240710$20240710$PER$$JP-ROCHE-3035541$ROCHE$$67$YR$E$M$Y$52$KG$20240701$$MD$JP$JP
240714632$24071463$2$F$$20240401$20240710$20240710$PER$$US-ROCHE-3537261$ROCHE$$23$YR$A$M$Y$$$20240701$$CN$US$US
240714642$24071464$2$F$20230801$20240409$20240710$20240710$PER$$DE-ROCHE-3524335$ROCHE$$33$YR$A$F$Y$95$KG$20240701$$MD$DE$DE
240714651$24071465$1$I$20220208$20240403$20240710$20240710$PER$$DE-ROCHE-3288276$ROCHE$$27$YR$A$F$Y$23.2$KG$20240701$$MD$DE$DE
240714661$24071466$1$I$$20240227$20240710$20240710$PER$$JP-ROCHE-3526186$ROCHE$$43$YR$A$F$Y$$$20240701$$MD$JP$JP
240714671$24071467$1$I$$20240416$20240710$20240710$PER$$FI-ROCHE-3549976$ROCHE$$$$$M$Y$$$20240701$$MD$FI$FI
240714681$24071468$1$I$20240405$20240325$20240710$20240710$PER$$BR-ROCHE-3562835$ROCHE$$7$YR$C$F$Y$$$20240701$$HP$BR$BR
240714691$24071469$1$I$20240216$20240228$20240710$20240710$PER$$DE-ROCHE-3518522$ROCHE$$3$YR$C$M$Y$15.2$KG$20240701$$MD$DE$DE
240714701$24071470$1$I$$20240427$20240710$20240710$PER$$EG-ROCHE-3556905$ROCHE$$13$YR$T$M$Y$$$20240701$$CN$EG$EG
240714711$24071471$1$I$20240526$20240528$20240710$20240710$PER$$SA-ROCHE-3574490$ROCHE$$6$YR$C$M$Y$20$KG$20240701$$CN$SA$SA
240714733$24071473$3$F$20240310$20240318$20240710$20240710$PER$$BR-ROCHE-3526793$ROCHE$$6$YR$C$M$Y$$$20240701$$CN$BR$BR
240714742$24071474$2$F$20231223$20240226$20240710$20240710$PER$$SA-ROCHE-3483543$ROCHE$$20$YR$A$M$Y$34$KG$20240701$$CN$SA$SA
240714751$24071475$1$I$20230816$20240403$20240710$20240710$PER$$DE-ROCHE-3538918$ROCHE$$8$YR$C$F$Y$24$KG$20240701$$MD$DE$DE
240714761$24071476$1$I$$20240515$20240710$20240710$PER$$CN-ROCHE-3565194$ROCHE$$8$YR$C$M$Y$24.6$KG$20240701$$CN$CN$CN
240714771$24071477$1$I$$20240524$20240710$20240710$PER$$RU-ROCHE-3571379$ROCHE$$55$YR$A$F$Y$$$20240628$$MD$RU$RU
240714781$24071478$1$I$20240708$20240709$20240709$20240709$DIR$709614$$FDA-CTU$$8$YR$$M$N$32.4$KG$20240709$N$MD$US$
240714791$24071479$1$I$20240317$20240318$20240710$20240710$PER$$US-ROCHE-3529675$ROCHE$$10$YR$C$F$Y$48$KG$20240701$$CN$US$US
240714801$24071480$1$I$20240201$20240226$20240710$20240710$PER$$US-ROCHE-3516651$ROCHE$$35$YR$A$M$Y$$$20240701$$CN$US$US
240714811$24071481$1$I$$20240305$20240710$20240710$PER$$US-ROCHE-3524994$ROCHE$$$$A$M$Y$$$20240701$$HP$US$US
240714821$24071482$1$I$$20240419$20240710$20240710$PER$$FR-ROCHE-3552458$ROCHE$$$$A$$Y$$$20240701$$CN$FR$FR
240714831$24071483$1$I$$20240422$20240710$20240710$PER$$US-ROCHE-3551296$ROCHE$$8$YR$C$M$Y$$$20240701$$CN$US$US
240714842$24071484$2$F$$20240508$20240710$20240710$PER$$AT-ROCHE-3551577$ROCHE$$31$YR$A$F$Y$68$KG$20240701$$MD$AT$AT
240714851$24071485$1$I$$20240531$20240710$20240710$PER$$US-ROCHE-3575026$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240714861$24071486$1$I$$20240603$20240710$20240710$PER$$CN-ROCHE-3575010$ROCHE$$$$A$F$Y$$$20240628$$MD$CN$CN
240714871$24071487$1$I$20230928$20240521$20240710$20240710$PER$$DE-ROCHE-3492886$ROCHE$$21$YR$A$F$Y$28$KG$20240701$$MD$DE$DE
240714881$24071488$1$I$$20240506$20240710$20240710$PER$$US-ROCHE-3559008$ROCHE$$34$YR$A$F$Y$26.7$KG$20240701$$CN$US$US
240714891$24071489$1$I$20211201$20240416$20240710$20240710$PER$$DE-ROCHE-3272247$ROCHE$$9$YR$C$M$Y$28.8$KG$20240701$$MD$DE$DE
240714901$24071490$1$I$20231201$20240415$20240710$20240710$PER$$AR-ROCHE-3548989$ROCHE$$2$YR$C$F$Y$8$KG$20240701$$CN$AR$AR
240714911$24071491$1$I$20231201$20240208$20240710$20240710$PER$$US-ROCHE-3507591$ROCHE$$$$A$F$Y$$$20240701$$CN$US$US
240714921$24071492$1$I$20211204$20240517$20240710$20240710$PER$$IT-ROCHE-3566644$ROCHE$$34$YR$A$F$Y$59$KG$20240628$$MD$IT$IT
240714931$24071493$1$I$$20240416$20240710$20240710$PER$$JP-ROCHE-3563065$ROCHE$$2$DEC$A$M$Y$$$20240701$$MD$JP$JP
240714941$24071494$1$I$20240125$20240209$20240710$20240710$PER$GB-MHRA-MED-202402071154053720-NRKVT$GB-ROCHE-3508821$ROCHE$$35$YR$A$M$Y$70$KG$20240701$$HP$GB$GB
240714953$24071495$3$F$20240204$20240327$20240710$20240710$PER$$US-ROCHE-3510414$ROCHE$$5$YR$C$F$Y$19.5$KG$20240701$$CN$US$US
240714962$24071496$2$F$20240501$20240607$20240710$20240710$PER$$AR-ROCHE-3576726$ROCHE$$36$YR$A$F$Y$$$20240701$$CN$AR$AR
240714971$24071497$1$I$$20240221$20240710$20240710$PER$$US-ROCHE-3514232$ROCHE$$21$YR$A$F$Y$135$KG$20240701$$CN$US$US
240714982$24071498$2$F$20240304$20240304$20240710$20240710$PER$$IN-ROCHE-3523227$ROCHE$$$$$$Y$$$20240701$$CN$IN$IN
240714991$24071499$1$I$20221115$20240516$20240710$20240710$PER$$RU-ROCHE-3334796$ROCHE$$32$YR$A$M$Y$90$KG$20240628$$MD$RU$RU
240715002$24071500$2$F$20231228$20240213$20240710$20240710$PER$$BE-ROCHE-3503175$ROCHE$$49$YR$A$F$Y$$$20240701$$HP$BE$BE
240715011$24071501$1$I$20211201$20240426$20240710$20240710$PER$$DE-ROCHE-3267291$ROCHE$$30$YR$A$M$Y$40$KG$20240701$$MD$DE$DE
240715022$24071502$2$F$$20240522$20240710$20240710$PER$$US-ROCHE-3568979$ROCHE$$$$I$M$Y$$$20240701$$CN$US$US
240715031$24071503$1$I$$20240403$20240710$20240710$PER$$GB-ROCHE-3538865$ROCHE$$$$$$Y$$$20240701$$MD$GB$GB
240715042$24071504$2$F$$20240214$20240710$20240710$PER$$BR-ROCHE-3471779$ROCHE$$19$YR$A$M$Y$45.55$KG$20240701$$CN$BR$BR
240715051$24071505$1$I$20230301$20240412$20240710$20240710$PER$$JP-ROCHE-3317077$ROCHE$$12$YR$T$F$Y$19.2$KG$20240701$$MD$JP$JP
240715061$24071506$1$I$20220831$20240529$20240710$20240710$PER$$JP-ROCHE-3198930$ROCHE$$17$YR$T$M$Y$28$KG$20240701$$MD$JP$JP
240715071$24071507$1$I$20240301$20240411$20240710$20240710$PER$$DE-ROCHE-3545504$ROCHE$$35$YR$A$M$Y$$$20240701$$CN$DE$DE
240715081$24071508$1$I$20240425$20240425$20240710$20240710$PER$$AE-ROCHE-3554965$ROCHE$$4$YR$C$F$Y$$$20240701$$CN$AE$AE
240715091$24071509$1$I$20240403$20240405$20240710$20240710$PER$$CL-ROCHE-3542703$ROCHE$$33$YR$A$M$Y$61$KG$20240701$$CN$CL$CL
240715101$24071510$1$I$$20240506$20240710$20240710$PER$$BE-ROCHE-3491119$ROCHE$$57$YR$A$F$Y$$$20240701$$MD$BE$BE
240715111$24071511$1$I$20240124$20240322$20240710$20240710$PER$$BR-ROCHE-3532763$ROCHE$$43$YR$A$M$Y$94$KG$20240701$$CN$BR$BR
240715121$24071512$1$I$20240401$20240702$20240710$20240710$EXP$SE-SEMPA-2024-005140$SE-TEVA-VS-3216678$TEVA$$35$YR$$M$Y$$$20240710$$MD$SE$SE
240715131$24071513$1$I$$20240229$20240710$20240710$PER$$EG-ROCHE-3520498$ROCHE$$9$MON$I$F$Y$9.5$KG$20240701$$CN$EG$EG
240715141$24071514$1$I$20220124$20240228$20240710$20240710$PER$$DE-ROCHE-3181715$ROCHE$$14$YR$T$F$Y$40$KG$20240701$$MD$DE$DE
240715151$24071515$1$I$$20240528$20240710$20240710$PER$$AU-ROCHE-3574336$ROCHE$$$$$$Y$$$20240701$$MD$AU$AU
240715161$24071516$1$I$$20240528$20240710$20240710$PER$$US-ROCHE-3573709$ROCHE$$37$YR$A$F$Y$$$20240628$$HP$US$US
240715171$24071517$1$I$$20240320$20240710$20240710$PER$$CN-ROCHE-3530659$ROCHE$$$$$F$Y$$$20240701$$MD$CN$CN
240715181$24071518$1$I$$20240509$20240710$20240710$PER$$US-ROCHE-3561794$ROCHE$$4$YR$C$M$Y$16$KG$20240701$$CN$US$US
240715191$24071519$1$I$20211113$20240314$20240710$20240710$PER$$JP-ROCHE-3002171$ROCHE$$13$YR$T$F$Y$18.1$KG$20240701$$MD$JP$JP
240715201$24071520$1$I$20230306$20240228$20240710$20240710$PER$$DE-ROCHE-3351073$ROCHE$$9$YR$C$F$Y$60$KG$20240701$$MD$DE$DE
240715212$24071521$2$F$$20240507$20240710$20240710$PER$$KR-ROCHE-3553439$ROCHE$$8$YR$C$M$Y$$$20240701$$CN$KR$KR
240715221$24071522$1$I$$20240304$20240710$20240710$PER$$US-ROCHE-3524172$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240715231$24071523$1$I$$20240219$20240710$20240710$PER$$DE-ROCHE-3514961$ROCHE$$47$YR$A$M$Y$$$20240701$$HP$DE$DE
240715242$24071524$2$F$$20240223$20240710$20240710$PER$$GB-ROCHE-3514347$ROCHE$$$$$M$Y$$$20240701$$HP$GB$GB
240715252$24071525$2$F$20230101$20240307$20240710$20240710$PER$$US-ROCHE-3522851$ROCHE$$35$YR$A$F$Y$73.48$KG$20240701$$CN$US$US
240715261$24071526$1$I$$20240415$20240710$20240710$PER$$US-ROCHE-3547005$ROCHE$$1$YR$I$M$Y$11.2$KG$20240701$$MD$US$US
240715271$24071527$1$I$20231201$20240502$20240710$20240710$PER$$DE-ROCHE-3558046$ROCHE$$9$YR$C$F$Y$14.9$KG$20240701$$MD$DE$DE
240715281$24071528$1$I$$20240509$20240710$20240710$PER$$US-ROCHE-3561490$ROCHE$$6$YR$C$M$Y$16.5$KG$20240701$$CN$US$US
240715292$24071529$2$F$$20240220$20240710$20240710$PER$$US-ROCHE-3514619$ROCHE$$14$YR$T$M$Y$$$20240701$$CN$US$US
240715301$24071530$1$I$20240201$20240510$20240710$20240710$PER$$DE-ROCHE-3562922$ROCHE$$5$YR$C$M$Y$20$KG$20240701$$MD$DE$DE
240715311$24071531$1$I$$20240516$20240710$20240710$PER$$TH-ROCHE-3338925$ROCHE$$77$YR$E$F$Y$$$20240628$$CN$TH$TH
240715322$24071532$2$F$20240101$20240409$20240710$20240710$PER$$JP-ROCHE-3559182$ROCHE$$4$DEC$A$F$Y$$$20240701$$PH$JP$JP
240715332$24071533$2$F$$20240208$20240710$20240710$PER$$JP-ROCHE-3515547$ROCHE$$9$YR$C$M$Y$$$20240701$$PH$JP$JP
240715341$24071534$1$I$20221102$20240517$20240710$20240710$PER$$IT-ROCHE-3566696$ROCHE$$35$YR$A$F$Y$61$KG$20240628$$MD$IT$IT
240715351$24071535$1$I$20220808$20240304$20240710$20240710$PER$$JP-ROCHE-3187552$ROCHE$$39$YR$A$M$Y$66.5$KG$20240701$$MD$JP$JP
240715361$24071536$1$I$$20240523$20240710$20240710$PER$$DE-ROCHE-3570201$ROCHE$$28$YR$A$F$Y$$$20240701$$CN$DE$DE
240715372$24071537$2$F$20240101$20240715$20240710$20240717$PER$$US-AMGEN-USASP2024135462$AMGEN$$76$YR$E$M$Y$$$20240717$$CN$US$US
240715381$24071538$1$I$$20240521$20240710$20240710$PER$$CA-ROCHE-3568635$ROCHE$$$$A$F$Y$$$20240628$$CN$CA$CA
240715391$24071539$1$I$$20240501$20240710$20240710$PER$$GB-ROCHE-3133476$ROCHE$$$$A$M$Y$$$20240701$$CN$GB$GB
240715401$24071540$1$I$$20240319$20240710$20240710$PER$$GB-ROCHE-3200687$ROCHE$$$$A$F$Y$$$20240701$$CN$GB$GB
240715411$24071541$1$I$20240518$20240528$20240710$20240710$PER$$US-ROCHE-3572163$ROCHE$$62$YR$A$M$Y$$$20240701$$CN$US$US
240715421$24071542$1$I$$20240522$20240710$20240710$PER$$US-ROCHE-3569218$ROCHE$$74$YR$E$F$Y$$$20240628$$CN$US$US
240715431$24071543$1$I$$20240220$20240710$20240710$PER$$BR-ROCHE-3493826$ROCHE$$36$YR$A$F$Y$$$20240701$$CN$BR$BR
240715441$24071544$1$I$20240621$20240709$20240709$20240709$DIR$709584$$FDA-CTU$$84$YR$$F$N$$$20240709$N$PH$US$
240715452$24071545$2$F$20220406$20240312$20240710$20240710$PER$$JP-ROCHE-3127602$ROCHE$$50$YR$A$F$Y$$$20240701$$MD$JP$JP
240715461$24071546$1$I$$20240520$20240710$20240710$PER$$PK-ROCHE-3567354$ROCHE$$11$YR$C$F$Y$39$KG$20240701$$CN$PK$PK
240715471$24071547$1$I$20231201$20240220$20240710$20240710$PER$$US-ROCHE-3513764$ROCHE$$1$YR$I$F$Y$10.6$KG$20240701$$CN$US$US
240715481$24071548$1$I$20230913$20240603$20240710$20240710$PER$CH-SM-2024-13275$CH-ROCHE-3576560$ROCHE$$49$YR$A$M$Y$94$KG$20240628$$MD$CH$CH
240715491$24071549$1$I$$20240329$20240710$20240710$PER$$CN-ROCHE-3537791$ROCHE$$6$YR$C$F$Y$$$20240701$$MD$CN$CN
240715501$24071550$1$I$$20240219$20240710$20240710$PER$$DE-ROCHE-3514958$ROCHE$$35$YR$A$M$Y$$$20240701$$HP$DE$DE
240715511$24071551$1$I$$20240311$20240710$20240710$PER$$CN-ROCHE-3525544$ROCHE$$30$YR$A$F$Y$$$20240701$$MD$CN$CN
240715521$24071552$1$I$$20240405$20240710$20240710$PER$$GB-ROCHE-3541618$ROCHE$$29$YR$A$$Y$$$20240701$$CN$GB$GB
240715531$24071553$1$I$$20240329$20240710$20240710$PER$$US-ROCHE-3536000$ROCHE$$65$YR$E$M$Y$89$KG$20240701$$CN$US$US
240715541$24071554$1$I$20191101$20240704$20240710$20240710$EXP$$GB-AUROBINDO-AUR-APL-2024-033300$AUROBINDO$$$$$M$Y$$$20240710$$CN$GB$GB
240715551$24071555$1$I$$20240215$20240710$20240710$PER$$BR-ROCHE-3415609$ROCHE$$40$YR$A$M$Y$74$KG$20240701$$CN$BR$BR
240715561$24071556$1$I$$20240428$20240710$20240710$PER$$EG-ROCHE-3557745$ROCHE$$8$MON$I$M$Y$7$KG$20240701$$CN$EG$EG
240715571$24071557$1$I$$20240521$20240710$20240710$PER$$JP-ROCHE-3573261$ROCHE$$6$DEC$A$F$Y$$$20240628$$MD$JP$JP
240715581$24071558$1$I$20230101$20240208$20240710$20240710$PER$$US-ROCHE-3505840$ROCHE$$11$YR$C$F$Y$24.6$KG$20240701$$CN$US$US
240715591$24071559$1$I$20240227$20240403$20240710$20240710$PER$$DE-ROCHE-3538874$ROCHE$$2$YR$C$F$Y$9.3$KG$20240701$$MD$DE$DE
240715601$24071560$1$I$20220420$20240209$20240710$20240710$PER$$JP-ROCHE-3202097$ROCHE$$29$YR$A$M$Y$29.6$KG$20240701$$MD$JP$JP
240715611$24071561$1$I$$20240326$20240710$20240710$PER$$BE-ROCHE-3535871$ROCHE$$$$$$Y$$$20240701$$MD$BE$BE
240715621$24071562$1$I$$20240510$20240710$20240710$PER$$DE-ROCHE-3563826$ROCHE$$$$A$F$Y$$$20240701$$CN$DE$DE
240715631$24071563$1$I$$20240223$20240710$20240710$PER$$BR-ROCHE-3516145$ROCHE$$6$YR$C$F$Y$14.7$KG$20240701$$HP$BR$BR
240715641$24071564$1$I$$20240528$20240710$20240710$PER$$AU-ROCHE-3574312$ROCHE$$$$$$Y$$$20240701$$MD$AU$AU
240715651$24071565$1$I$$20240419$20240710$20240710$PER$$GB-ROCHE-3549691$ROCHE$$$$T$M$Y$$$20240701$$CN$GB$GB
240715661$24071566$1$I$20221215$20240311$20240710$20240710$PER$$DE-ROCHE-3378973$ROCHE$$28$YR$A$F$Y$70$KG$20240701$$MD$DE$DE
240715672$24071567$2$F$20240302$20240303$20240710$20240710$PER$$US-ROCHE-3519682$ROCHE$$15$YR$T$F$Y$63.4$KG$20240701$$CN$US$US
240715681$24071568$1$I$20221223$20240510$20240710$20240710$PER$$DE-ROCHE-3481074$ROCHE$$7$YR$C$M$Y$23.2$KG$20240701$$MD$DE$DE
240715691$24071569$1$I$20211008$20240308$20240710$20240710$PER$$DE-ROCHE-3269986$ROCHE$$10$YR$C$F$Y$43.3$KG$20240701$$MD$DE$DE
240715701$24071570$1$I$20240428$20240428$20240710$20240710$PER$$FR-ROCHE-3556042$ROCHE$$24$YR$A$M$Y$$$20240701$$CN$FR$FR
240715711$24071571$1$I$$20240223$20240710$20240710$PER$$KR-ROCHE-3515877$ROCHE$$32$YR$A$M$Y$$$20240701$$CN$KR$KR
240715721$24071572$1$I$$20240501$20240710$20240710$PER$$MO-ROCHE-3557412$ROCHE$$$$$M$Y$$$20240701$$MD$MO$MO
240715731$24071573$1$I$20230120$20240216$20240710$20240710$PER$$BR-ROCHE-3369328$ROCHE$$17$YR$T$F$Y$34$KG$20240701$$CN$BR$BR
240715741$24071574$1$I$$20240417$20240710$20240710$PER$$CA-ROCHE-3549238$ROCHE$$69$YR$E$M$Y$$$20240701$$CN$CA$CA
240715751$24071575$1$I$$20240422$20240710$20240710$PER$$US-ROCHE-3550950$ROCHE$$54$DY$I$M$Y$$$20240701$$CN$US$US
240715761$24071576$1$I$20240201$20240403$20240710$20240710$PER$$DE-ROCHE-3538991$ROCHE$$16$YR$T$M$Y$23$KG$20240701$$MD$DE$DE
240715771$24071577$1$I$$20240227$20240710$20240710$PER$$EG-ROCHE-3519088$ROCHE$$18$YR$A$M$Y$52$KG$20240701$$CN$EG$EG
240715781$24071578$1$I$20220217$20240314$20240710$20240710$PER$$JP-ROCHE-3175042$ROCHE$$19$YR$A$M$Y$34.7$KG$20240701$$MD$JP$JP
240715792$24071579$2$F$20220124$20240212$20240710$20240710$PER$$US-ROCHE-3019788$ROCHE$$14$YR$T$M$Y$22.7$KG$20240701$$CN$US$US
240715801$24071580$1$I$20220124$20240213$20240710$20240710$PER$$JP-ROCHE-3020102$ROCHE$$4$YR$C$M$Y$11.6$KG$20240701$$MD$JP$JP
240715811$24071581$1$I$20240402$20240517$20240710$20240710$PER$$JP-ROCHE-3572199$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240715821$24071582$1$I$$20240603$20240710$20240710$PER$$US-ROCHE-3577276$ROCHE$$84$YR$E$F$Y$$$20240628$$CN$US$US
240715831$24071583$1$I$$20240531$20240710$20240710$PER$$US-ROCHE-3575635$ROCHE$$$$$M$Y$$$20240701$$CN$US$US
240715841$24071584$1$I$$20240411$20240710$20240710$PER$$US-ROCHE-3545312$ROCHE$$50$YR$A$M$Y$$$20240701$$CN$US$US
240715851$24071585$1$I$20220307$20240510$20240710$20240710$PER$$DE-ROCHE-3269094$ROCHE$$28$YR$A$M$Y$38$KG$20240701$$MD$DE$DE
240715872$24071587$2$F$20240313$20240531$20240710$20240710$PER$$LT-ROCHE-3567318$ROCHE$$50$YR$A$M$Y$124$KG$20240628$$MD$LT$LT
240715881$24071588$1$I$$20240328$20240710$20240710$PER$$US-ROCHE-3535866$ROCHE$$6$WK$I$M$Y$3.63$KG$20240701$$MD$US$US
240715891$24071589$1$I$20230526$20240321$20240710$20240710$PER$$DE-ROCHE-3372181$ROCHE$$21$YR$A$F$Y$35$KG$20240701$$MD$DE$DE
240715901$24071590$1$I$$20240603$20240710$20240710$PER$$US-ROCHE-3575965$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$US$US
240715911$24071591$1$I$$20240412$20240710$20240710$PER$$JP-ROCHE-3559213$ROCHE$$$$$F$Y$$$20240628$$CN$JP$JP
240715922$24071592$2$F$$20240415$20240710$20240710$PER$$FI-ROCHE-3542716$ROCHE$$16$YR$T$F$Y$$$20240701$$CN$FI$FI
240715932$24071593$2$F$$20240301$20240710$20240710$PER$$GB-ROCHE-3521140$ROCHE$$$$$F$Y$$$20240701$$CN$GB$GB
240715941$24071594$1$I$$20240304$20240710$20240710$PER$$GB-ROCHE-3521143$ROCHE$$$$A$F$Y$$$20240701$$CN$GB$GB
240715962$24071596$2$F$20231004$20240502$20240710$20240710$PER$$AT-ROCHE-3450776$ROCHE$$11$YR$C$M$Y$24.1$KG$20240701$$MD$AT$AT
240715972$24071597$2$F$20220703$20240223$20240710$20240710$PER$$DE-ROCHE-3350269$ROCHE$$39$YR$A$F$Y$77.3$KG$20240701$$MD$DE$DE
240715981$24071598$1$I$20240409$20240409$20240710$20240710$PER$$JP-ROCHE-3556396$ROCHE$$8$DEC$E$M$Y$$$20240701$$MD$JP$JP
240715991$24071599$1$I$$20240222$20240710$20240710$PER$$BR-ROCHE-3492830$ROCHE$$12$YR$T$F$Y$34$KG$20240701$$HP$BR$BR
240716002$24071600$2$F$20230723$20240516$20240710$20240710$PER$$RS-ROCHE-3566799$ROCHE$$44$YR$A$F$Y$69$KG$20240628$$MD$RS$RS
240716011$24071601$1$I$$20240308$20240710$20240710$PER$$BR-ROCHE-3524401$ROCHE$$3$YR$C$M$Y$$$20240701$$HP$BR$BR
240716021$24071602$1$I$$20240423$20240710$20240710$PER$$CN-ROCHE-3552049$ROCHE$$49$YR$A$M$Y$$$20240628$$CN$CN$CN
240716031$24071603$1$I$$20240605$20240710$20240710$PER$$PH-ROCHE-3579171$ROCHE$$47$YR$A$F$Y$$$20240628$$CN$PH$PH
240716042$24071604$2$F$$20240319$20240710$20240710$PER$$US-ROCHE-3525494$ROCHE$$$$A$M$Y$$$20240701$$HP$US$US
240716051$24071605$1$I$$20240528$20240710$20240710$PER$$AU-ROCHE-3574341$ROCHE$$$$$$Y$$$20240701$$MD$AU$AU
240716061$24071606$1$I$20230515$20240320$20240710$20240710$PER$$DE-ROCHE-3372783$ROCHE$$22$YR$A$M$Y$76$KG$20240701$$MD$DE$DE
240716071$24071607$1$I$$20240430$20240710$20240710$PER$$US-ROCHE-3556270$ROCHE$$59$YR$A$F$Y$$$20240628$$CN$US$US
240716082$24071608$2$F$$20240603$20240710$20240710$PER$$US-ROCHE-3575655$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240716091$24071609$1$I$20240624$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47722$$FDA-CTU$$55$YR$$F$N$$$20240709$Y$PH$US$
240716102$24071610$2$F$20240101$20240417$20240710$20240710$PER$$DE-ROCHE-3545453$ROCHE$$39$YR$A$F$Y$$$20240701$$CN$DE$DE
240716112$24071611$2$F$20240412$20240416$20240710$20240710$PER$$US-ROCHE-3547391$ROCHE$$62$YR$A$M$Y$47.67$KG$20240701$$CN$US$US
240716122$24071612$2$F$$20240222$20240710$20240710$PER$$BR-ROCHE-3516139$ROCHE$$19$YR$A$M$Y$50.7$KG$20240701$$HP$BR$BR
240716131$24071613$1$I$$20240425$20240710$20240710$PER$$NL-ROCHE-3556051$ROCHE$$$$A$F$Y$$$20240701$$MD$NL$NL
240716141$24071614$1$I$$20240603$20240710$20240710$PER$$US-ROCHE-3576430$ROCHE$$$$A$M$Y$$$20240701$$CN$US$US
240716171$24071617$1$I$20240410$20240411$20240710$20240710$PER$$CO-ROCHE-3546366$ROCHE$$1$YR$I$F$Y$8.1$KG$20240701$$CN$CO$CO
240716181$24071618$1$I$$20240525$20240710$20240710$PER$$BR-ROCHE-3572909$ROCHE$$$$$M$Y$$$20240701$$MD$BR$BR
240716191$24071619$1$I$20240308$20240308$20240710$20240710$PER$$JP-ROCHE-3540431$ROCHE$$2$DEC$A$M$Y$$$20240701$$MD$JP$JP
240716201$24071620$1$I$$20240528$20240710$20240710$PER$$US-ROCHE-3572310$ROCHE$$58$YR$A$F$Y$$$20240628$$CN$US$US
240716211$24071621$1$I$$20240321$20240710$20240710$PER$$JP-ROCHE-3549046$ROCHE$$58$YR$A$F$Y$$$20240701$$MD$JP$JP
240716221$24071622$1$I$20211213$20240313$20240710$20240710$PER$$JP-ROCHE-3038829$ROCHE$$25$YR$A$F$Y$43$KG$20240701$$MD$JP$JP
240716231$24071623$1$I$$20240514$20240710$20240710$PER$$HK-ROCHE-3566470$ROCHE$$60$YR$A$F$Y$$$20240628$$MD$HK$HK
240716241$24071624$1$I$20240101$20240508$20240710$20240710$PER$$CN-ROCHE-3560064$ROCHE$$10$YR$C$F$Y$$$20240701$$CN$CN$CN
240716251$24071625$1$I$20240423$20240424$20240710$20240710$PER$$JP-ROCHE-3563346$ROCHE$$7$DEC$E$F$Y$$$20240628$$MD$JP$JP
240716262$24071626$2$F$20240526$20240527$20240710$20240710$PER$$SA-ROCHE-3572289$ROCHE$$8$YR$C$F$Y$23.1$KG$20240701$$CN$SA$SA
240716271$24071627$1$I$20240116$20240314$20240710$20240710$PER$$CN-ROCHE-3527250$ROCHE$$30$YR$A$M$Y$58$KG$20240701$$CN$CN$CN
240716281$24071628$1$I$$20240520$20240710$20240710$PER$$US-ROCHE-3567283$ROCHE$$$$A$F$Y$$$20240701$$CN$US$US
240716291$24071629$1$I$20230101$20240426$20240710$20240710$PER$$US-ROCHE-3093935$ROCHE$$44$YR$A$F$Y$59.8$KG$20240628$$MD$US$US
240716301$24071630$1$I$20231201$20240226$20240710$20240710$PER$$DE-ROCHE-3498629$ROCHE$$9$YR$C$M$Y$31.1$KG$20240701$$MD$DE$DE
240716311$24071631$1$I$$20240415$20240710$20240710$PER$$US-ROCHE-3547050$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240716321$24071632$1$I$$20240419$20240710$20240710$PER$$US-ROCHE-3550610$ROCHE$$5$YR$C$F$Y$14.3$KG$20240701$$MD$US$US
240716331$24071633$1$I$$20240521$20240710$20240710$PER$$UY-ROCHE-3569507$ROCHE$$1$YR$I$F$Y$$$20240701$$MD$UY$UY
240716341$24071634$1$I$20231230$20240409$20240710$20240710$PER$$DE-ROCHE-3546250$ROCHE$$51$YR$A$M$Y$85$KG$20240701$$MD$DE$DE
240716351$24071635$1$I$$20240311$20240710$20240710$PER$$GB-ROCHE-3284232$ROCHE$$$$A$M$Y$$$20240701$$CN$GB$GB
240716361$24071636$1$I$$20240530$20240710$20240710$PER$$TH-ROCHE-3576522$ROCHE$$$$$$Y$$$20240628$$MD$TH$TH
240716371$24071637$1$I$20240606$20240606$20240710$20240710$PER$$AE-ROCHE-3156034$ROCHE$$2$YR$C$F$Y$$$20240701$$CN$AE$AE
240716381$24071638$1$I$$20240223$20240710$20240710$PER$$BR-ROCHE-3516141$ROCHE$$4$YR$C$F$Y$$$20240701$$MD$BR$BR
240716391$24071639$1$I$$20240219$20240710$20240710$PER$$JP-ROCHE-3520536$ROCHE$$$$$M$Y$$$20240701$$MD$JP$JP
240716401$24071640$1$I$$20240503$20240710$20240710$PER$$US-ROCHE-3558341$ROCHE$$28$YR$A$M$Y$$$20240701$$CN$US$US
240716411$24071641$1$I$20231101$20240228$20240710$20240710$PER$$DE-ROCHE-3518677$ROCHE$$64$YR$A$F$Y$59$KG$20240701$$MD$DE$DE
240716421$24071642$1$I$$20240228$20240710$20240710$PER$$US-ROCHE-3518285$ROCHE$$33$YR$A$$Y$$$20240701$$CN$US$US
240716431$24071643$1$I$$20240314$20240710$20240710$PER$$BR-ROCHE-3529478$ROCHE$$$$$M$Y$$$20240701$$MD$BR$BR
240716441$24071644$1$I$20230515$20240511$20240710$20240710$PER$$CN-ROCHE-3353942$ROCHE$$59$YR$A$F$Y$65$KG$20240628$$MD$CN$CN
240716452$24071645$2$F$$20240221$20240710$20240710$PER$$US-ROCHE-3514075$ROCHE$$1$YR$I$F$Y$8.46$KG$20240701$$CN$US$US
240716461$24071646$1$I$20240416$20240423$20240710$20240710$PER$$AR-ROCHE-3555228$ROCHE$$43$YR$A$F$Y$56$KG$20240701$$CN$AR$AR
240716471$24071647$1$I$$20240513$20240710$20240710$PER$$AE-ROCHE-3565005$ROCHE$$3$YR$C$F$Y$$$20240701$$CN$AE$AE
240716481$24071648$1$I$20240520$20240607$20240710$20240710$PER$$AU-ROCHE-3579615$ROCHE$$59$YR$A$F$Y$77.35$KG$20240628$$MD$AU$AU
240716491$24071649$1$I$20240328$20240415$20240710$20240710$PER$$AR-ROCHE-3548987$ROCHE$$34$YR$A$F$Y$45$KG$20240701$$CN$AR$AR
240716501$24071650$1$I$$20240305$20240710$20240710$PER$$CN-ROCHE-3521312$ROCHE$$$$$M$Y$$$20240701$$MD$CN$CN
240716511$24071651$1$I$20231001$20240213$20240710$20240710$PER$$DE-ROCHE-3510277$ROCHE$$36$YR$A$F$Y$53$KG$20240701$$MD$DE$DE
240716521$24071652$1$I$20230613$20240409$20240710$20240710$PER$$JP-ROCHE-3376218$ROCHE$$2$YR$C$M$Y$$$20240701$$MD$JP$JP
240716531$24071653$1$I$$20240517$20240710$20240710$PER$$GB-ROCHE-3567078$ROCHE$$$$$$Y$$$20240701$$HP$GB$GB
240716541$24071654$1$I$$20240523$20240710$20240710$PER$$US-ROCHE-3570025$ROCHE$$$$A$M$Y$$$20240628$$CN$US$US
240716551$24071655$1$I$20220815$20240415$20240710$20240710$PER$$DE-ROCHE-3460234$ROCHE$$48$YR$A$M$Y$120$KG$20240701$$MD$DE$DE
240716561$24071656$1$I$$20240422$20240710$20240710$PER$$RU-ROCHE-3552478$ROCHE$$$$$F$Y$$$20240701$$CN$RU$RU
240716571$24071657$1$I$$20240219$20240710$20240710$PER$$DE-ROCHE-3514959$ROCHE$$34$YR$A$F$Y$$$20240701$$HP$DE$DE
240716581$24071658$1$I$20240501$20240527$20240710$20240710$PER$$JP-ROCHE-3576827$ROCHE$$9$DEC$E$M$Y$$$20240628$$MD$JP$JP
240716591$24071659$1$I$20220301$20240320$20240710$20240710$PER$$DE-ROCHE-3272251$ROCHE$$42$YR$A$F$Y$40$KG$20240701$$MD$DE$DE
240716601$24071660$1$I$$20240510$20240710$20240710$PER$$US-ROCHE-3562725$ROCHE$$57$YR$A$F$Y$58.51$KG$20240628$$CN$US$US
240716611$24071661$1$I$$20240226$20240710$20240710$PER$$US-ROCHE-3516772$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240716621$24071662$1$I$$20240509$20240710$20240710$PER$$US-ROCHE-3432349$ROCHE$$28$YR$A$F$Y$32.7$KG$20240701$$CN$US$US
240716631$24071663$1$I$$20240306$20240710$20240710$PER$$AR-ROCHE-3457193$ROCHE$$$$C$$Y$$$20240701$$MD$AR$AR
240716641$24071664$1$I$20240301$20240403$20240710$20240710$PER$$PE-ROCHE-3538956$ROCHE$$$$$F$Y$$$20240701$$CN$PE$PE
240716651$24071665$1$I$$20240514$20240710$20240710$PER$$RO-ROCHE-3564694$ROCHE$$41$YR$A$F$Y$60$KG$20240628$$CN$RO$RO
240716661$24071666$1$I$20220601$20240604$20240710$20240710$PER$$DE-ROCHE-3300321$ROCHE$$7$YR$C$F$Y$54$KG$20240701$$MD$DE$DE
240716671$24071667$1$I$$20240425$20240710$20240710$PER$$US-ROCHE-3553392$ROCHE$$41$YR$A$F$Y$$$20240701$$MD$US$US
240716681$24071668$1$I$$20240610$20240710$20240710$PER$$IN-ROCHE-10000001013$ROCHE$$1$YR$I$M$Y$12$KG$20240701$$MD$IN$IN
240716692$24071669$2$F$$20240609$20240710$20240710$PER$$US-ROCHE-3579967$ROCHE$$$$$F$Y$$$20240701$$MD$US$US
240716701$24071670$1$I$$20240512$20240710$20240710$PER$$IL-ROCHE-3563838$ROCHE$$$$A$M$Y$$$20240628$$CN$IL$IL
240716711$24071671$1$I$20240322$20240401$20240710$20240710$PER$$PY-ROCHE-3537270$ROCHE$$2$YR$C$F$Y$17$KG$20240701$$CN$PY$PY
240716721$24071672$1$I$$20240221$20240710$20240710$PER$$IN-ROCHE-3514244$ROCHE$$3$YR$C$M$Y$8.95$KG$20240701$$MD$IN$IN
240716731$24071673$1$I$$20240531$20240710$20240710$PER$$US-ROCHE-3574927$ROCHE$$57$YR$A$F$Y$$$20240701$$CN$US$US
240716741$24071674$1$I$20240425$20240426$20240710$20240710$PER$$US-ROCHE-3556289$ROCHE$$5$YR$C$F$Y$30.3$KG$20240701$$PH$US$US
240716751$24071675$1$I$20240226$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47703$$FDA-CTU$$59$YR$$F$N$$$20240709$N$HP$US$
240716761$24071676$1$I$$20240709$20240709$20240709$DIR$709583$$FDA-CTU$$$$$UNK$N$$$20240709$$CN$US$
240716771$24071677$1$I$$20240514$20240710$20240710$PER$$US-ROCHE-3564759$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240716781$24071678$1$I$$20240313$20240710$20240710$PER$$US-ROCHE-3527369$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240716801$24071680$1$I$20220804$20240415$20240710$20240710$PER$$DE-ROCHE-3312116$ROCHE$$5$YR$C$M$Y$13.8$KG$20240701$$MD$DE$DE
240716811$24071681$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47690$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240716821$24071682$1$I$20240606$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47699$$FDA-CTU$$72$YR$$M$N$$$20240709$N$$US$
240716831$24071683$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47671$$FDA-CTU$$58$YR$$F$N$180$LBS$20240709$N$$US$
240716841$24071684$1$I$$20240419$20240710$20240710$PER$$US-ROCHE-3550382$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240716851$24071685$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47751$$FDA-CTU$$72$YR$$F$N$84$LBS$20240709$N$$US$
240716861$24071686$1$I$$20240226$20240710$20240710$PER$$JP-ROCHE-3049014$ROCHE$$23$YR$A$F$Y$25.8$KG$20240701$$MD$JP$JP
240716871$24071687$1$I$20221004$20240513$20240710$20240710$PER$$JP-ROCHE-3356225$ROCHE$$30$YR$A$F$Y$52$KG$20240701$$MD$JP$JP
240716882$24071688$2$F$20240309$20240820$20240710$20240822$EXP$$CN-ROCHE-3549348$ROCHE$$7$MON$I$$Y$$$20240822$$MD$CN$CN
240716891$24071689$1$I$$20240429$20240710$20240710$PER$$US-ROCHE-3555598$ROCHE$$$$$F$Y$$$20240628$$CN$US$US
240716902$24071690$2$F$$20240605$20240710$20240710$PER$$US-ROCHE-3578128$ROCHE$$1$YR$I$M$Y$10.3$KG$20240701$$MD$US$US
240716911$24071691$1$I$20240302$20240313$20240710$20240710$PER$$CL-ROCHE-3526867$ROCHE$$27$YR$A$F$Y$60$KG$20240701$$CN$CL$CL
240716921$24071692$1$I$20240516$20240517$20240710$20240710$PER$$CL-ROCHE-3567163$ROCHE$$6$YR$C$F$Y$15$KG$20240701$$CN$CL$CL
240716931$24071693$1$I$20240326$20240607$20240710$20240710$PER$$CN-ROCHE-3579333$ROCHE$$48$YR$A$M$Y$73$KG$20240628$$MD$CN$CN
240716941$24071694$1$I$$20240424$20240710$20240710$PER$$CN-ROCHE-3552048$ROCHE$$55$YR$A$F$Y$$$20240628$$CN$CN$CN
240716951$24071695$1$I$$20240315$20240710$20240710$PER$$CA-ROCHE-3529009$ROCHE$$$$C$F$Y$$$20240701$$CN$CA$CA
240716961$24071696$1$I$$20240422$20240710$20240710$PER$$CN-ROCHE-3551186$ROCHE$$11$YR$C$M$Y$52$KG$20240701$$CN$CN$CN
240716971$24071697$1$I$20230501$20240229$20240710$20240710$PER$$DE-ROCHE-3428449$ROCHE$$18$YR$A$M$Y$59.6$KG$20240701$$MD$DE$DE
240716981$24071698$1$I$20231121$20240604$20240710$20240710$PER$$PT-ROCHE-3577391$ROCHE$$75$YR$E$M$Y$$$20240628$$MD$PT$PT
240716991$24071699$1$I$$20240209$20240710$20240710$PER$$BR-ROCHE-3459603$ROCHE$$14$YR$T$F$Y$43$KG$20240701$$HP$BR$BR
240717001$24071700$1$I$$20240523$20240710$20240710$PER$$US-ROCHE-3569789$ROCHE$$64$YR$A$F$Y$$$20240628$$CN$US$US
240717012$24071701$2$F$$20240328$20240710$20240710$PER$$US-ROCHE-3535348$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240717021$24071702$1$I$$20240318$20240710$20240710$PER$$US-ROCHE-3529759$ROCHE$$46$DY$I$F$Y$3.97$KG$20240701$$CN$US$US
240717032$24071703$2$F$20240205$20240312$20240710$20240710$PER$$US-ROCHE-3523439$ROCHE$$38$YR$A$M$Y$$$20240701$$CN$US$US
240717051$24071705$1$I$$20240427$20240710$20240710$PER$$EG-ROCHE-3555824$ROCHE$$4$YR$C$M$Y$16$KG$20240701$$CN$EG$EG
240717061$24071706$1$I$$20240417$20240710$20240710$PER$$US-ROCHE-3548403$ROCHE$$55$YR$A$F$Y$$$20240701$$CN$US$US
240717071$24071707$1$I$20240301$20240517$20240710$20240710$PER$$BE-ROCHE-3566699$ROCHE$$86$YR$E$F$Y$48$KG$20240628$$MD$BE$BE
240717091$24071709$1$I$$20240502$20240710$20240710$PER$$IT-ROCHE-3559679$ROCHE$$$$$$Y$$$20240701$$MD$IT$IT
240717101$24071710$1$I$$20240423$20240710$20240710$PER$$JP-ROCHE-3565043$ROCHE$$9$DEC$E$$Y$$$20240628$$MD$JP$JP
240717111$24071711$1$I$20240412$20240521$20240710$20240710$PER$$RS-ROCHE-3568528$ROCHE$$45$YR$A$F$Y$69$KG$20240628$$MD$RS$RS
240717121$24071712$1$I$20240309$20240516$20240710$20240710$PER$$RS-ROCHE-3566557$ROCHE$$43$YR$A$F$Y$62$KG$20240628$$MD$RS$RS
240717131$24071713$1$I$$20240509$20240710$20240710$PER$$ES-ROCHE-3562821$ROCHE$$$$$$Y$$$20240701$$MD$ES$ES
240717141$24071714$1$I$20240207$20240207$20240710$20240710$PER$$AE-ROCHE-3507002$ROCHE$$3$YR$C$F$Y$$$20240701$$CN$AE$AE
240717152$24071715$2$F$$20240321$20240710$20240710$PER$$CA-ROCHE-3529290$ROCHE$$$$$$Y$$$20240701$$CN$CA$CA
240717171$24071717$1$I$$20240508$20240710$20240710$PER$$GB-ROCHE-3562798$ROCHE$$$$C$M$Y$$$20240701$$HP$GB$GB
240717191$24071719$1$I$20240410$20240410$20240710$20240710$PER$$JP-ROCHE-3561809$ROCHE$$5$MON$I$F$Y$$$20240701$$PH$JP$JP
240717202$24071720$2$F$$20240311$20240710$20240710$PER$$EG-ROCHE-3527154$ROCHE$$10$MON$I$F$Y$6$KG$20240701$$CN$EG$EG
240717211$24071721$1$I$$20240216$20240710$20240710$PER$$BR-ROCHE-3513170$ROCHE$$32$YR$A$F$Y$56$KG$20240701$$HP$BR$BR
240717252$24071725$2$F$$20240412$20240710$20240710$PER$$IT-ROCHE-3543610$ROCHE$$$$$$Y$$$20240701$$MD$IT$IT
240717261$24071726$1$I$20240117$20240329$20240710$20240710$PER$$JP-ROCHE-3551925$ROCHE$$5$DEC$A$M$Y$$$20240628$$MD$JP$JP
240717271$24071727$1$I$$20240510$20240710$20240710$PER$$US-ROCHE-3562565$ROCHE$$29$YR$A$F$Y$$$20240701$$CN$US$US
240717281$24071728$1$I$$20240412$20240710$20240710$PER$$JP-ROCHE-3559150$ROCHE$$8$DEC$E$F$Y$$$20240628$$MD$JP$JP
240717292$24071729$2$F$$20240209$20240710$20240710$PER$$BR-ROCHE-3416485$ROCHE$$32$YR$A$F$Y$39$KG$20240701$$CN$BR$BR
240717301$24071730$1$I$$20240521$20240710$20240710$PER$$JP-ROCHE-3575211$ROCHE$$3$YR$C$M$Y$12.5$KG$20240701$$PH$JP$JP
240717311$24071731$1$I$$20240213$20240710$20240710$PER$$FR-ROCHE-3492922$ROCHE$$35$YR$A$M$Y$$$20240701$$PH$FR$FR
240717321$24071732$1$I$$20240501$20240710$20240710$PER$$AT-ROCHE-3558889$ROCHE$$59$YR$A$M$Y$64$KG$20240701$$MD$AT$AT
240717331$24071733$1$I$$20240516$20240710$20240710$PER$$US-ROCHE-3567155$ROCHE$$$$$$Y$$$20240628$$CN$US$US
240717341$24071734$1$I$$20240410$20240710$20240710$PER$$GB-ROCHE-3385387$ROCHE$$$$A$M$Y$$$20240701$$CN$GB$GB
240717351$24071735$1$I$$20240207$20240710$20240710$PER$$US-ROCHE-3506790$ROCHE$$39$YR$A$M$Y$41.1$KG$20240701$$CN$US$US
240717361$24071736$1$I$20220401$20240207$20240710$20240710$PER$$JP-ROCHE-3093624$ROCHE$$49$YR$A$M$Y$$$20240701$$MD$JP$JP
240717371$24071737$1$I$$20240430$20240710$20240710$PER$$IE-ROCHE-3424533$ROCHE$$$$$$Y$$$20240701$$HP$IE$IE
240717381$24071738$1$I$$20240318$20240710$20240710$PER$$CA-ROCHE-3529055$ROCHE$$29$YR$A$$Y$$$20240701$$CN$CA$CA
240717391$24071739$1$I$20240212$20240320$20240710$20240710$PER$FR-AFSSAPS-MP2024000344$FR-ROCHE-3530148$ROCHE$$25$YR$A$F$Y$$$20240701$$MD$FR$FR
240717402$24071740$2$F$$20240326$20240710$20240710$PER$$US-ROCHE-3533634$ROCHE$$46$YR$A$F$Y$$$20240701$$CN$US$US
240717411$24071741$1$I$$20240603$20240710$20240710$PER$$FR-ROCHE-3579039$ROCHE$$$$$F$Y$$$20240628$$HP$FR$FR
240717421$24071742$1$I$$20240408$20240710$20240710$PER$$IT-ROCHE-3545678$ROCHE$$17$YR$T$M$Y$$$20240701$$MD$IT$IT
240717431$24071743$1$I$$20240313$20240710$20240710$PER$$IN-ROCHE-3528370$ROCHE$$28$YR$A$F$Y$44$KG$20240701$$CN$IN$IN
240717441$24071744$1$I$$20240229$20240710$20240710$PER$$US-ROCHE-3518781$ROCHE$$8$YR$C$M$Y$37.5$KG$20240701$$CN$US$US
240717451$24071745$1$I$$20240419$20240710$20240710$PER$$DE-ROCHE-3552135$ROCHE$$4$WK$N$$Y$$$20240701$$CN$DE$DE
240717461$24071746$1$I$$20240328$20240710$20240710$PER$$GB-ROCHE-3535663$ROCHE$$$$A$F$Y$$$20240701$$CN$GB$GB
240717471$24071747$1$I$$20240405$20240710$20240710$PER$$US-ROCHE-3273179$ROCHE$$31$YR$A$F$Y$$$20240701$$MD$US$US
240717481$24071748$1$I$20220221$20240313$20240710$20240710$PER$$JP-ROCHE-3038843$ROCHE$$23$YR$A$M$Y$22.1$KG$20240701$$MD$JP$JP
240717491$24071749$1$I$$20240606$20240710$20240710$PER$$US-ROCHE-3578452$ROCHE$$9$YR$C$F$Y$$$20240701$$PH$US$US
240717501$24071750$1$I$20240502$20240502$20240710$20240710$PER$$MX-ROCHE-3558194$ROCHE$$1$YR$I$F$Y$$$20240701$$MD$MX$MX
240717511$24071751$1$I$$20240306$20240710$20240710$PER$$US-ROCHE-3489511$ROCHE$$35$YR$A$F$Y$$$20240701$$CN$US$US
240717521$24071752$1$I$$20240510$20240710$20240710$PER$$US-ROCHE-3562582$ROCHE$$61$YR$A$F$Y$$$20240701$$CN$US$US
240717532$24071753$2$F$20240212$20240301$20240710$20240710$PER$$US-ROCHE-3519255$ROCHE$$20$YR$A$F$Y$46$KG$20240701$$CN$US$US
240717541$24071754$1$I$20231201$20240426$20240710$20240710$PER$$DE-ROCHE-3554890$ROCHE$$45$YR$A$F$Y$34$KG$20240701$$MD$DE$DE
240717551$24071755$1$I$$20240219$20240710$20240710$PER$$DE-ROCHE-3513003$ROCHE$$36$YR$A$M$Y$$$20240701$$HP$DE$DE
240717561$24071756$1$I$$20240515$20240710$20240710$PER$$US-ROCHE-3564808$ROCHE$$68$YR$E$M$Y$$$20240701$$CN$US$US
240717572$24071757$2$F$20240405$20240415$20240710$20240710$PER$$BR-ROCHE-3543867$ROCHE$$7$YR$C$F$Y$$$20240701$$HP$BR$BR
240717581$24071758$1$I$20240510$20240607$20240710$20240710$PER$$VN-ROCHE-3580034$ROCHE$$28$YR$A$F$Y$$$20240628$$MD$VN$VN
240717591$24071759$1$I$$20240522$20240710$20240710$PER$$US-ROCHE-3570070$ROCHE$$28$YR$A$M$Y$$$20240701$$CN$US$US
240717601$24071760$1$I$$20240423$20240710$20240710$PER$$US-ROCHE-3552527$ROCHE$$3$YR$C$M$Y$16.2$KG$20240701$$CN$US$US
240717611$24071761$1$I$$20240522$20240710$20240710$PER$$VN-ROCHE-3569441$ROCHE$$41$YR$A$M$Y$$$20240628$$MD$VN$VN
240717621$24071762$1$I$20221003$20240520$20240710$20240710$PER$$IL-ROCHE-3287713$ROCHE$$61$YR$A$M$Y$86.6$KG$20240628$$MD$IL$IL
240717631$24071763$1$I$$20240514$20240710$20240710$PER$$US-ROCHE-3148948$ROCHE$$68$YR$E$M$Y$$$20240628$$MD$US$US
240717641$24071764$1$I$20230101$20240522$20240710$20240710$PER$SE-SEMPA-2024-000093$SE-ROCHE-3568167$ROCHE$$3$YR$C$M$Y$$$20240701$$MD$SE$SE
240717651$24071765$1$I$$20240220$20240710$20240710$PER$$US-ROCHE-3513401$ROCHE$$19$YR$A$F$Y$$$20240701$$CN$US$US
240717661$24071766$1$I$$20240514$20240710$20240710$PER$$US-ROCHE-3564075$ROCHE$$50$YR$A$M$Y$29.9$KG$20240701$$CN$US$US
240717671$24071767$1$I$$20240405$20240710$20240710$PER$$US-ROCHE-3541325$ROCHE$$5$YR$C$F$Y$17.33$KG$20240701$$CN$US$US
240717681$24071768$1$I$20240129$20240226$20240710$20240710$PER$$DE-ROCHE-3516774$ROCHE$$15$YR$T$M$Y$97.2$KG$20240701$$MD$DE$DE
240717691$24071769$1$I$$20240301$20240710$20240710$PER$$CH-ROCHE-3445587$ROCHE$$23$YR$A$M$Y$$$20240701$$CN$CH$CH
240717701$24071770$1$I$$20240422$20240710$20240710$PER$$US-ROCHE-3552144$ROCHE$$29$YR$A$F$Y$57.9$KG$20240701$$CN$US$US
240717711$24071771$1$I$20210307$20240607$20240710$20240710$PER$$CN-ROCHE-3579578$ROCHE$$71$YR$E$M$Y$59.2$KG$20240628$$MD$CN$CN
240717731$24071773$1$I$$20240320$20240710$20240710$PER$$US-ROCHE-3530570$ROCHE$$$$$M$Y$$$20240701$$MD$US$US
240717741$24071774$1$I$20220127$20240308$20240710$20240710$PER$$DE-ROCHE-3380573$ROCHE$$4$YR$C$F$Y$21.5$KG$20240701$$MD$DE$DE
240717752$24071775$2$F$20240114$20240305$20240710$20240710$PER$$US-ROCHE-3505348$ROCHE$$45$YR$A$F$Y$34.02$KG$20240701$$CN$US$US
240717761$24071776$1$I$20240411$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47670$$FDA-CTU$$35$YR$$F$N$$$20240708$N$HP$US$
240717772$24071777$2$F$20240409$20240528$20240710$20240710$PER$$ES-ROCHE-3562844$ROCHE$$50$YR$A$F$Y$48$KG$20240701$$MD$ES$ES
240717781$24071778$1$I$20240330$20240419$20240710$20240710$PER$$US-ROCHE-3536946$ROCHE$$10$YR$C$F$Y$48$KG$20240701$$CN$US$US
240717791$24071779$1$I$20240415$20240424$20240710$20240710$PER$$US-ROCHE-3553217$ROCHE$$$$$F$Y$3.96$KG$20240701$$CN$US$US
240717801$24071780$1$I$$20240709$20240709$20240709$DIR$709637$$FDA-CTU$$$$$M$N$$$20240709$N$HP$US$
240717811$24071781$1$I$20220308$20240327$20240710$20240710$PER$$GB-ROCHE-3047040$ROCHE$$$$A$F$Y$$$20240701$$CN$GB$GB
240717821$24071782$1$I$$20240219$20240710$20240710$PER$$DE-ROCHE-3514963$ROCHE$$39$YR$A$F$Y$$$20240701$$HP$DE$DE
240717831$24071783$1$I$20240401$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024134381$AMGEN$$66$YR$E$F$Y$$$20240710$$CN$US$US
240717841$24071784$1$I$20240705$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024136025$AMGEN$$61$YR$A$F$Y$$$20240710$$CN$US$US
240717851$24071785$1$I$$20240422$20240710$20240710$PER$$CN-ROCHE-3551201$ROCHE$$9$YR$C$F$Y$60$KG$20240701$$CN$CN$CN
240717861$24071786$1$I$$20240228$20240710$20240710$PER$$DE-ROCHE-3518644$ROCHE$$19$YR$A$F$Y$$$20240701$$CN$DE$DE
240717871$24071787$1$I$20220601$20240705$20240710$20240710$EXP$$US-AMGEN-USASP2024134225$AMGEN$$$$A$F$Y$$$20240710$$CN$US$US
240717881$24071788$1$I$20230501$20240304$20240710$20240710$PER$$JP-ROCHE-3355400$ROCHE$$77$YR$E$M$Y$$$20240701$$MD$JP$JP
240717891$24071789$1$I$$20240420$20240710$20240710$PER$$BR-ROCHE-3552492$ROCHE$$22$YR$A$M$Y$$$20240701$$CN$BR$BR
240717901$24071790$1$I$$20240415$20240710$20240710$PER$$US-ROCHE-3547052$ROCHE$$$$$$Y$$$20240701$$CN$US$US
240717911$24071791$1$I$20240120$20240219$20240710$20240710$PER$$US-ROCHE-3505925$ROCHE$$1$MON$I$M$Y$2.8$KG$20240701$$CN$US$US
240717921$24071792$1$I$20231110$20240216$20240710$20240710$PER$$US-ROCHE-3457791$ROCHE$$5$MON$I$M$Y$3.6$KG$20240701$$CN$US$US
240717932$24071793$2$F$$20240329$20240710$20240710$PER$$CN-ROCHE-3519957$ROCHE$$12$YR$T$M$Y$$$20240701$$MD$CN$CN
240717941$24071794$1$I$$20240423$20240710$20240710$PER$$CN-ROCHE-3551190$ROCHE$$62$YR$A$M$Y$$$20240628$$CN$CN$CN
240717951$24071795$1$I$20220614$20240604$20240710$20240710$PER$$TR-ROCHE-3577334$ROCHE$$37$YR$A$M$Y$69$KG$20240628$$MD$TR$TR
240717961$24071796$1$I$$20240423$20240710$20240710$PER$$US-ROCHE-3552689$ROCHE$$2$WK$N$M$Y$3.3$KG$20240701$$CN$US$US
240717971$24071797$1$I$$20240516$20240710$20240710$PER$$US-ROCHE-3565866$ROCHE$$67$YR$E$F$Y$$$20240628$$CN$US$US
240717991$24071799$1$I$$20240509$20240710$20240710$PER$$GB-ROCHE-3561759$ROCHE$$$$$$Y$$$20240701$$MD$GB$GB
240718001$24071800$1$I$$20240403$20240710$20240710$PER$$DK-ROCHE-3541778$ROCHE$$$$C$$Y$$$20240701$$HP$DK$DK
240718011$24071801$1$I$20231201$20240416$20240710$20240710$PER$$DE-ROCHE-3547541$ROCHE$$1$YR$I$M$Y$9.75$KG$20240701$$MD$DE$DE
240718031$24071803$1$I$20231201$20240422$20240710$20240710$PER$$US-ROCHE-3551083$ROCHE$$50$YR$A$M$Y$106.59$KG$20240628$$CN$US$US
240718041$24071804$1$I$20240512$20240514$20240710$20240710$PER$$CA-ROCHE-3564580$ROCHE$$54$YR$A$M$Y$$$20240701$$CN$CA$CA
240718051$24071805$1$I$20240504$20240509$20240710$20240710$PER$$CN-ROCHE-3561600$ROCHE$$58$YR$A$F$Y$60$KG$20240628$$HP$CN$CN
240718061$24071806$1$I$$20240322$20240710$20240710$PER$$JP-ROCHE-3550128$ROCHE$$5$DEC$A$M$Y$$$20240701$$MD$JP$JP
240718071$24071807$1$I$$20240416$20240710$20240710$PER$$IT-ROCHE-3549643$ROCHE$$41$YR$A$$Y$$$20240701$$MD$IT$IT
240718081$24071808$1$I$$20240509$20240710$20240710$PER$$CN-ROCHE-3561526$ROCHE$Li D, Zhu Y, Song J, Yang D, Cui S, Liu X, Wang L, Zhang J, Pan E and Dai Z Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report. DOI:10.3389/fonc.2024.1339511. Frontiers in oncology 2024 Apr 18;14:1-5.$56$YR$A$M$Y$$$20240628$$HP$CN$CN
240718091$24071809$1$I$$20240606$20240710$20240710$PER$$CN-ROCHE-3578553$ROCHE$$$$T$$Y$$$20240701$$MD$CN$CN
240718101$24071810$1$I$$20240509$20240710$20240710$PER$$JP-ROCHE-3567293$ROCHE$$8$DEC$E$$Y$$$20240628$$MD$JP$JP
240718111$24071811$1$I$$20240503$20240710$20240710$PER$$CN-ROCHE-3557673$ROCHE$$60$YR$A$F$Y$$$20240701$$CN$CN$CN
240718121$24071812$1$I$$20240222$20240710$20240710$PER$$US-ROCHE-3514913$ROCHE$$$$A$M$Y$99.5$KG$20240701$$CN$US$US
240718131$24071813$1$I$$20240311$20240710$20240710$PER$$BR-ROCHE-3525234$ROCHE$$$$$M$Y$$$20240701$$CN$BR$BR
240718141$24071814$1$I$$20240216$20240710$20240710$PER$$BR-ROCHE-3450736$ROCHE$$33$YR$A$F$Y$47$KG$20240701$$CN$BR$BR
240718161$24071816$1$I$$20240215$20240710$20240710$PER$$BR-ROCHE-3420602$ROCHE$$28$YR$A$M$Y$60$KG$20240701$$CN$BR$BR
240718171$24071817$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47707$$FDA-CTU$$74$YR$$F$N$$$20240709$N$$US$
240718181$24071818$1$I$$20240510$20240710$20240710$PER$$US-ROCHE-3562873$ROCHE$$50$YR$A$F$Y$$$20240701$$CN$US$US
240718191$24071819$1$I$$20240708$20240709$20240709$DIR$FDA-CDER-CTU-2024-47674$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240718211$24071821$1$I$$20240709$20240709$20240709$DIR$709620$$FDA-CTU$$$$$M$N$102.4$KG$20240709$N$PH$US$
240718221$24071822$1$I$20221219$20240606$20240710$20240710$PER$$BG-ROCHE-3578786$ROCHE$$57$YR$A$F$Y$68$KG$20240628$$MD$BG$BG
240718231$24071823$1$I$20230218$20240308$20240710$20240710$PER$$DE-ROCHE-3391898$ROCHE$$4$YR$C$F$Y$20.9$KG$20240701$$MD$DE$DE
240718241$24071824$1$I$20240605$20240703$20240709$20240709$DIR$FDA-CDER-CTU-2024-47684$$FDA-CTU$$74$YR$$F$N$$$20240703$N$HP$US$
240718251$24071825$1$I$20231101$20240403$20240710$20240710$PER$$DE-ROCHE-3538879$ROCHE$$23$YR$A$F$Y$40$KG$20240701$$MD$DE$DE
240718261$24071826$1$I$$20240208$20240710$20240710$PER$$US-ROCHE-3507627$ROCHE$$5$YR$C$F$Y$10.8$KG$20240701$$CN$US$US
240718271$24071827$1$I$$20240524$20240710$20240710$PER$$GR-ROCHE-3572763$ROCHE$$$$$$Y$$$20240628$$MD$GR$GR
240718281$24071828$1$I$$20240218$20240710$20240710$PER$$CN-ROCHE-3512268$ROCHE$$8$YR$C$M$Y$$$20240701$$MD$CN$CN
240718291$24071829$1$I$$20240313$20240710$20240710$PER$$BG-ROCHE-3525984$ROCHE$$$$A$M$Y$$$20240701$$CN$BG$BG
240718301$24071830$1$I$$20240305$20240710$20240710$PER$$US-ROCHE-3521608$ROCHE$$$$A$M$Y$112.19$KG$20240701$$HP$US$US
240718312$24071831$2$F$$20240217$20240710$20240710$PER$$US-ROCHE-3513032$ROCHE$$$$I$F$Y$3.94$KG$20240701$$MD$US$US
240718321$24071832$1$I$20230221$20240308$20240710$20240710$PER$$DE-ROCHE-3391978$ROCHE$$7$YR$C$M$Y$32.6$KG$20240701$$MD$DE$DE
240718331$24071833$1$I$$20240218$20240710$20240710$PER$$CN-ROCHE-3511999$ROCHE$$12$MON$I$F$Y$$$20240701$$MD$CN$CN
240718342$24071834$2$F$$20240725$20240710$20240806$EXP$$RU-DEXPHARM-2024-2199$DEXCEL$Mukashev MSh, Turganbaev AE, Toktosun UuluB, Asanov BA, Kalybekova GM, Ibragimov AB. Acute poisoning with antiseptic of external application containing chlorohexidine in the case of accidental intravenous administration causing serious harm to health. Forensic Medical Expertise. 2024;67(3):50 53.$$$$F$Y$$$20240806$$HP$RU$RU
240718352$24071835$2$F$$20240319$20240710$20240710$PER$$US-ROCHE-3518845$ROCHE$$60$YR$A$F$Y$59.3$KG$20240701$$CN$US$US
240718361$24071836$1$I$$20240419$20240710$20240710$PER$$AT-ROCHE-3301468$ROCHE$$33$YR$A$M$Y$105$KG$20240701$$MD$AT$AT
240718371$24071837$1$I$$20240208$20240710$20240710$PER$$GB-ROCHE-3431927$ROCHE$$$$A$F$Y$$$20240701$$CN$GB$GB
240718381$24071838$1$I$20210111$20240315$20240710$20240710$PER$$US-ROCHE-2753557$ROCHE$$42$YR$A$M$Y$122.47$KG$20240701$$CN$US$US
240718391$24071839$1$I$$20240214$20240710$20240710$PER$$BR-ROCHE-3428459$ROCHE$$32$YR$A$F$Y$22.2$KG$20240701$$CN$BR$BR
240718401$24071840$1$I$$20240507$20240710$20240710$PER$$CA-ROCHE-3346231$ROCHE$$$$T$F$Y$22.5$KG$20240701$$MD$CA$CA
240718411$24071841$1$I$$20240215$20240710$20240710$PER$$AT-ROCHE-3504816$ROCHE$$20$YR$A$F$Y$$$20240701$$MD$AT$AT
240718421$24071842$1$I$20231222$20240425$20240710$20240710$PER$$CN-ROCHE-3553398$ROCHE$$55$YR$A$F$Y$55$KG$20240628$$MD$CN$CN
240718431$24071843$1$I$$20240404$20240710$20240710$PER$$US-ROCHE-3540294$ROCHE$$60$YR$A$F$Y$58.97$KG$20240701$$CN$US$US
240718441$24071844$1$I$$20240214$20240710$20240710$PER$$FR-ROCHE-3512511$ROCHE$$$$$F$Y$$$20240701$$MD$FR$FR
240718451$24071845$1$I$$20240513$20240710$20240710$PER$$RO-ROCHE-3563884$ROCHE$$$$$$Y$$$20240628$$PH$RO$RO
240718461$24071846$1$I$$20240516$20240710$20240710$PER$$CA-ROCHE-3566194$ROCHE$$$$C$M$Y$$$20240701$$CN$CA$CA
240718471$24071847$1$I$20240418$20240701$20240710$20240710$PER$$US-TEVA-VS-3217469$TEVA$$61$YR$$M$Y$$$20240710$$CN$US$US
240718481$24071848$1$I$20240311$20240314$20240710$20240710$PER$$US-ROCHE-3527617$ROCHE$$45$YR$A$M$Y$74.8$KG$20240701$$CN$US$US
240718491$24071849$1$I$20231215$20240409$20240710$20240710$PER$$DE-ROCHE-3543691$ROCHE$$17$YR$T$F$Y$83.9$KG$20240701$$MD$DE$DE
240718501$24071850$1$I$$20240401$20240710$20240710$PER$$US-ROCHE-3536710$ROCHE$$$$C$M$Y$10.43$KG$20240701$$CN$US$US
240718511$24071851$1$I$$20240322$20240710$20240710$PER$$BR-ROCHE-3563005$ROCHE$$3$YR$C$M$Y$$$20240701$$CN$BR$BR
240718521$24071852$1$I$$20240305$20240710$20240710$PER$$GB-ROCHE-3345084$ROCHE$$$$T$M$Y$$$20240701$$CN$GB$GB
240718531$24071853$1$I$$20240603$20240710$20240710$PER$$US-ROCHE-3575932$ROCHE$$34$YR$A$F$Y$92.5$KG$20240701$$HP$US$US
240718541$24071854$1$I$$20240531$20240710$20240710$PER$$IT-ROCHE-3576594$ROCHE$$36$YR$A$F$Y$$$20240628$$MD$IT$IT
240718551$24071855$1$I$$20240327$20240710$20240710$PER$$BE-ROCHE-3536601$ROCHE$$$$A$F$Y$$$20240701$$MD$BE$BE
240718562$24071856$2$F$$20240318$20240710$20240710$PER$$FR-ROCHE-3531045$ROCHE$$$$$$Y$$$20240701$$PH$FR$FR
240718571$24071857$1$I$20231129$20240311$20240710$20240710$PER$$DE-ROCHE-3525134$ROCHE$$2$YR$C$F$Y$12.4$KG$20240701$$MD$DE$DE
240718581$24071858$1$I$20231001$20240502$20240710$20240710$PER$$DE-ROCHE-3454839$ROCHE$$48$YR$A$F$Y$34$KG$20240701$$MD$DE$DE
240718591$24071859$1$I$$20240517$20240710$20240710$PER$$JP-ROCHE-3573090$ROCHE$$57$YR$A$F$Y$$$20240701$$MD$JP$JP
240718601$24071860$1$I$$20240405$20240710$20240710$PER$$US-ROCHE-3540722$ROCHE$$26$YR$A$F$Y$$$20240701$$CN$US$US
240718611$24071861$1$I$$20240306$20240710$20240710$PER$$BR-ROCHE-3522665$ROCHE$$$$$$Y$$$20240701$$MD$BR$BR
240718621$24071862$1$I$$20240516$20240710$20240710$PER$$US-ROCHE-3566383$ROCHE$$70$YR$E$F$Y$$$20240628$$CN$US$US
240718631$24071863$1$I$$20240509$20240710$20240710$PER$$US-ROCHE-3561536$ROCHE$$1$YR$I$F$Y$8.6$KG$20240701$$MD$US$US
240718641$24071864$1$I$$20240513$20240710$20240710$PER$$US-ROCHE-3563444$ROCHE$$$$N$F$Y$3.43$KG$20240701$$CN$US$US
240718651$24071865$1$I$20240426$20240510$20240710$20240710$PER$$US-ROCHE-3564082$ROCHE$$45$YR$A$F$Y$$$20240628$$MD$US$US
240718661$24071866$1$I$$20240228$20240710$20240710$PER$$US-ROCHE-3518517$ROCHE$$17$YR$T$F$Y$$$20240701$$CN$US$US
240718671$24071867$1$I$20240601$20240706$20240709$20240709$DIR$FDA-CDER-CTU-2024-47669$$FDA-CTU$$49$YR$$F$N$$$20240706$N$HP$US$
240718681$24071868$1$I$20220215$20240228$20240710$20240710$PER$$JP-ROCHE-3046232$ROCHE$$17$YR$T$M$Y$$$20240701$$MD$JP$JP
240718691$24071869$1$I$$20240319$20240710$20240710$PER$$CA-ROCHE-3529770$ROCHE$$$$T$F$Y$$$20240701$$CN$CA$CA
240718701$24071870$1$I$$20240326$20240710$20240710$PER$$US-ROCHE-3533695$ROCHE$$$$T$F$Y$$$20240701$$MD$US$US
240718711$24071871$1$I$$20240221$20240710$20240710$PER$$GR-ROCHE-3490271$ROCHE$$$$A$M$Y$85$KG$20240701$$CN$GR$GR
240718731$24071873$1$I$$20240709$20240709$20240709$DIR$709626$$FDA-CTU$$$$$F$N$88.9$KG$20240709$N$PH$US$
240718741$24071874$1$I$$20240703$20240710$20240710$EXP$$US-JNJFOC-20240712704$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$CN$US$US
240718751$24071875$1$I$$20240513$20240710$20240710$PER$$US-ROCHE-3562677$ROCHE$$$$$$Y$$$20240628$$MD$US$US
240718761$24071876$1$I$$20240528$20240710$20240710$PER$$IL-ROCHE-3574720$ROCHE$$$$C$M$Y$$$20240701$$CN$IL$IL
240718781$24071878$1$I$20220919$20240415$20240710$20240710$PER$$DE-ROCHE-3305496$ROCHE$$13$YR$T$F$Y$42.5$KG$20240701$$MD$DE$DE
240718791$24071879$1$I$$20240510$20240710$20240710$PER$$US-ROCHE-3562573$ROCHE$$51$YR$A$F$Y$$$20240628$$HP$US$US
240718801$24071880$1$I$$20240527$20240710$20240710$PER$$US-ROCHE-3571495$ROCHE$$$$A$F$Y$$$20240628$$CN$US$US
240718812$24071881$2$F$$20240425$20240710$20240710$PER$$US-ROCHE-3553355$ROCHE$$25$DY$N$M$Y$$$20240701$$CN$US$US
240718821$24071882$1$I$$20240604$20240710$20240710$PER$$DE-ROCHE-3578020$ROCHE$$9$YR$C$M$Y$$$20240701$$CN$DE$DE
240718831$24071883$1$I$20231116$20240229$20240710$20240710$PER$$CN-ROCHE-3519670$ROCHE$$7$MON$I$$Y$$$20240701$$MD$CN$CN
240718841$24071884$1$I$20240416$20240423$20240710$20240710$PER$$PY-ROCHE-3552499$ROCHE$$10$MON$I$F$Y$7.2$KG$20240701$$CN$PY$PY
240718851$24071885$1$I$20220418$20240425$20240710$20240710$PER$$JP-ROCHE-3138430$ROCHE$$11$YR$C$F$Y$21$KG$20240701$$PH$JP$JP
240718861$24071886$1$I$20220801$20240409$20240710$20240710$PER$$DE-ROCHE-3314065$ROCHE$$17$YR$T$M$Y$70.5$KG$20240701$$MD$DE$DE
240718871$24071887$1$I$$20240405$20240710$20240710$PER$$DE-ROCHE-3541723$ROCHE$$75$YR$E$F$Y$$$20240701$$CN$DE$DE
240718881$24071888$1$I$20240320$20240320$20240710$20240710$PER$$CN-ROCHE-3530686$ROCHE$$20$YR$A$M$Y$70$KG$20240701$$CN$CN$CN
240718891$24071889$1$I$$20240227$20240710$20240710$PER$$US-ROCHE-3517523$ROCHE$$29$YR$A$$Y$$$20240701$$CN$US$US
240718901$24071890$1$I$$20240219$20240710$20240710$PER$$JP-ROCHE-3520402$ROCHE$$6$DEC$A$M$Y$$$20240701$$MD$JP$JP
240718911$24071891$1$I$$20240312$20240710$20240710$PER$$GB-ROCHE-3074290$ROCHE$$$$T$F$Y$$$20240701$$HP$GB$GB
240718921$24071892$1$I$20220825$20240604$20240710$20240710$PER$$TR-ROCHE-3577356$ROCHE$$37$YR$A$M$Y$69$KG$20240628$$MD$TR$TR
240718931$24071893$1$I$$20240315$20240710$20240710$PER$$BE-ROCHE-3530215$ROCHE$$$$$$Y$$$20240701$$PH$BE$BE
240718941$24071894$1$I$$20240311$20240710$20240710$PER$$US-ROCHE-3519387$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
240718951$24071895$1$I$20240312$20240315$20240710$20240710$PER$$CL-ROCHE-3528509$ROCHE$$3$YR$C$F$Y$13.2$KG$20240701$$CN$CL$CL
240718961$24071896$1$I$20220723$20240222$20240710$20240710$PER$$US-ROCHE-3148055$ROCHE$$4$YR$C$F$Y$14$KG$20240701$$CN$US$US
240718971$24071897$1$I$20220824$20240523$20240710$20240710$PER$$AT-ROCHE-3570140$ROCHE$$72$YR$E$F$Y$67.3$KG$20240628$$MD$AT$AT
240718981$24071898$1$I$$20240521$20240710$20240710$PER$$US-ROCHE-3569326$ROCHE$$6$WK$I$M$Y$$$20240701$$CN$US$US
240718991$24071899$1$I$$20240410$20240710$20240710$PER$$GB-ROCHE-3184271$ROCHE$$$$C$M$Y$$$20240701$$CN$GB$GB
240719001$24071900$1$I$20210819$20240422$20240710$20240710$PER$$TR-ROCHE-3121090$ROCHE$$51$YR$A$M$Y$70$KG$20240628$$MD$TR$TR
240719011$24071901$1$I$$20240703$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01193$NOVITIUM PHARMA$$42$YR$A$F$Y$$$20240710$$HP$US$US
240719021$24071902$1$I$$20240522$20240710$20240710$PER$$US-ROCHE-3568889$ROCHE$$$$$M$Y$$$20240701$$CN$US$US
240719031$24071903$1$I$$20240528$20240710$20240710$PER$$JP-ROCHE-3578001$ROCHE$$52$YR$A$F$Y$$$20240628$$PH$JP$JP
240719041$24071904$1$I$$20240417$20240710$20240710$PER$$DK-ROCHE-3549842$ROCHE$$$$A$$Y$$$20240701$$HP$DK$DK
240719051$24071905$1$I$$20240508$20240710$20240710$PER$$US-ROCHE-3561593$ROCHE$$6$YR$C$M$Y$$$20240701$$MD$US$US
240719061$24071906$1$I$$20240410$20240710$20240710$PER$$FR-ROCHE-3546359$ROCHE$$17$YR$T$M$Y$$$20240701$$CN$FR$FR
240719071$24071907$1$I$20230313$20240415$20240710$20240710$PER$$DE-ROCHE-3460146$ROCHE$$16$YR$T$F$Y$37$KG$20240701$$MD$DE$DE
240719081$24071908$1$I$$20240524$20240710$20240710$PER$$JP-ROCHE-3576928$ROCHE$$$$A$$Y$$$20240628$$MD$JP$JP
240719101$24071910$1$I$$20240215$20240710$20240710$PER$$RU-ROCHE-3512502$ROCHE$$8$YR$C$M$Y$$$20240701$$MD$RU$RU
240719111$24071911$1$I$20240131$20240520$20240710$20240710$PER$$AU-ROCHE-3567315$ROCHE$$63$YR$A$M$Y$98.45$KG$20240628$$MD$AU$AU
240719121$24071912$1$I$$20240429$20240710$20240710$PER$$US-ROCHE-3555626$ROCHE$$$$A$M$Y$$$20240628$$CN$US$US
240719131$24071913$1$I$$20240429$20240710$20240710$PER$$US-ROCHE-3555563$ROCHE$$$$$F$Y$$$20240701$$CN$US$US
240719141$24071914$1$I$$20240303$20240710$20240710$PER$$US-ROCHE-3520397$ROCHE$$30$YR$A$$Y$$$20240701$$MD$US$US
240719151$24071915$1$I$20231101$20240521$20240710$20240710$PER$$RS-ROCHE-3568769$ROCHE$$26$YR$A$F$Y$63$KG$20240628$$MD$RS$RS
240719161$24071916$1$I$$20240422$20240710$20240710$PER$$TM-ROCHE-3552186$ROCHE$$8$MON$I$F$Y$$$20240701$$MD$TM$TM
240719171$24071917$1$I$20240611$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010392$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240719181$24071918$1$I$$20240704$20240710$20240710$EXP$$CA-ABBVIE-5831009$ABBVIE$$$$A$F$Y$$$20240710$$CN$CA$CA
240719191$24071919$1$I$20240430$20240704$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010451$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240719203$24071920$3$F$$20240801$20240710$20240805$EXP$$EC-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037714$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$99.8$KG$20240805$$LW$EC$EC
240719211$24071921$1$I$$20240704$20240710$20240710$EXP$$FR-EMD Serono-2024036632$EMD SERONO INC$$44$YR$A$M$Y$$$20240710$$CN$FR$FR
240719221$24071922$1$I$$20240708$20240710$20240710$PER$$US-ABBVIE-5831998$ABBVIE$$$$$$Y$$$20240710$$CN$US$US
240719231$24071923$1$I$20240408$20240705$20240710$20240710$EXP$$CA-UCBSA-2024017542$UCB$$59$YR$$F$Y$$$20240710$$CN$CA$CA
240719241$24071924$1$I$$20240703$20240710$20240710$EXP$$NVSC2024RU140234$NOVARTIS$$67$YR$$F$Y$$$20240710$$MD$RU$RU
240719251$24071925$1$I$$20240625$20240710$20240710$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06200$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240719261$24071926$1$I$$20240704$20240710$20240710$EXP$$IT-AMGEN-ITASP2024133199$AMGEN$Breda L.; Di Donato G.; Attanasi M. et al.. Associations of C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio with disease activity in patients with juvenile idiopathic arthritis. BMC Rheumatology. 2024;8 (1):1-10$$$$$Y$$$20240710$$HP$IT$IT
240719271$24071927$1$I$20240624$20240704$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010455$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240719281$24071928$1$I$$20240630$20240710$20240710$EXP$$US-JNJFOC-20240700791$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240719292$24071929$2$F$20240601$20240710$20240710$20240716$EXP$$CA-LEO Pharma-371704$LEO PHARM$$53$YR$$F$Y$$$20240716$$CN$CA$CA
240719301$24071930$1$I$20240706$20240708$20240710$20240710$PER$$US-JNJFOC-20240720332$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240710$$PH$US$US
240719311$24071931$1$I$$20240703$20240710$20240710$PER$$US-JNJFOC-20240712298$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240719322$24071932$2$F$$20240719$20240710$20240729$EXP$$FR-TEVA-VS-3216779$TEVA$Pardinhas C, Filipe R, Vergnaud P, Grapin M, Ferriere E, Jamet A, et al. Renal arcuate vein thrombosis-induced acute kidney injury: a rare multiple-Hit-mediated disease. Clin-Kidney-J 2023; 16 (2): 367-373.; Pardinhas C, Filipe R, Vergnaud P, Grapin M, Ferriere E, Jamet A, et al. Renal arcuate vein thrombosis-induced acute kidney injury: a rare multiple-Hit-mediated disease. Clin-Kidney-J 2023; 16 (2): 367-373.; Pardinhas C, Filipe R, Vergnaud P, Grapin M, Ferriere E, Jamet A, et al. Renal ar...$13$YR$$F$Y$$$20240729$$HP$FR$FR
240719331$24071933$1$I$$20240705$20240710$20240710$EXP$$JP-EMD Serono-2024037131$EMD SERONO INC$$$$$$Y$$$20240710$$PH$JP$JP
240719341$24071934$1$I$$20240708$20240710$20240710$PER$$US-AstraZeneca-2024A156400$ASTRAZENECA$$$$$F$Y$$$20240710$$PH$US$
240719351$24071935$1$I$20240709$20240709$20240709$20240709$DIR$709670$$FDA-CTU$$35$YR$$M$N$119.25$KG$20240709$N$CN$US$
240719361$24071936$1$I$20240501$20240627$20240709$20240709$DIR$FDA-CDER-CTU-2024-47653$$FDA-CTU$$79$YR$$F$N$34.93$KG$20240627$N$CN$US$
240719371$24071937$1$I$20240623$20240709$20240709$20240709$DIR$709635$$FDA-CTU$$47$YR$$F$N$78.75$KG$20240709$N$CN$US$
240719381$24071938$1$I$20240704$20240705$20240710$20240710$EXP$$US-AstraZeneca-2024A155432$ASTRAZENECA$$29871$DY$$F$Y$$$20240710$$CN$US$
240719391$24071939$1$I$$20240702$20240710$20240710$EXP$$IT-CELLTRION INC.-2024IT016283$CELLTRION$$$$$$Y$$$20240710$$MD$IT$IT
240719401$24071940$1$I$$20240703$20240710$20240710$EXP$GB-MHRA-MED-202407021645515840-LWBGM$GB-MSNLABS-2024MSNSPO01511$MSN LABORATORIES$$$$$$Y$$$20240710$$HP$GB$GB
240719411$24071941$1$I$$20240706$20240710$20240710$PER$$US-AMGEN-USASP2024134650$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240719431$24071943$1$I$$20240701$20240710$20240710$PER$$US-BIOGEN-2024BI01271972$BIOGEN$$$$$M$Y$64.8$KG$20240710$$MD$US$US
240719441$24071944$1$I$$20240702$20240710$20240710$PER$$US-BIOGEN-2024BI01272214$BIOGEN$$$$$$Y$$$20240710$$CN$US$US
240719451$24071945$1$I$$20240708$20240710$20240710$PER$$US-ABBVIE-5831826$ABBVIE$$$$$$Y$$$20240710$$CN$US$US
240719461$24071946$1$I$$20240701$20240710$20240710$PER$$US-MSNLABS-2024MSNSPO01461$MSN LABORATORIES$$$$$$Y$$$20240710$$PH$US$US
240719471$24071947$1$I$$20240703$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01213$NOVITIUM PHARMA$J Braat.Atypical Presentation of Central Serous Chorioretinopathy (CSCR) After Lung Transplantation.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;209:A5938$$$A$F$Y$$$20240710$$HP$US$US
240719481$24071948$1$I$$20240703$20240710$20240710$EXP$$US-EMD Serono-2024037139$EMD SERONO INC$$$$N$$Y$$$20240710$$CN$US$US
240719492$24071949$2$F$$20240711$20240710$20240712$PER$$PR-JNJFOC-20240722594$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$MD$PR$PR
240719501$24071950$1$I$$20240628$20240710$20240710$PER$$US-HALEON-2184510$Haleon PLC$$7$YR$$$Y$$$20240710$$CN$US$US
240719511$24071951$1$I$20240629$20240701$20240710$20240710$EXP$$CA-EMD Serono-2024036183$EMD SERONO INC$$33$YR$A$F$Y$$$20240710$$CN$CA$CA
240719521$24071952$1$I$$20240702$20240710$20240710$EXP$$IL-Stemline Therapeutics, Inc.-2024ST004095$STEMLINE THERAPEUTICS$$18$YR$A$M$Y$$$20240708$$MD$IL$IL
240719531$24071953$1$I$20240207$20240702$20240710$20240710$EXP$$US-Stemline Therapeutics, Inc.-2024ST001187$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240708$$CN$US$US
240719541$24071954$1$I$20240626$20240704$20240710$20240710$EXP$ES-AEMPS-1543557$ES-HETERO-AMR2024ES02137$HETERO$$43$YR$$M$Y$$$20240710$$PH$ES$ES
240719551$24071955$1$I$$20240703$20240710$20240710$EXP$$PL-NOVITIUMPHARMA-2024PLNVP01217$NOVITIUM PHARMA$Adam Plonski.Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review.International Journal of Environmental Research and Public Health.29-JUN-2023;20(13):1-14$45$YR$A$M$Y$$$20240710$$HP$PL$PL
240719561$24071956$1$I$$20240701$20240710$20240710$EXP$$US-MSNLABS-2024MSNLIT01478$MSN LABORATORIES$Lam C, Kioka M.A Critical Confluence: Acute Pulmonary Embolism Complicating Systemic Sclerosis- Associated Pulmonary Arterial Hypertension.American Journal of Respiratory and Critical Care Medicine.2024;209:A2211$$$$$Y$$$20240710$$HP$US$US
240719571$24071957$1$I$$20240703$20240710$20240710$EXP$$US-Stemline Therapeutics, Inc.-2024ST004111$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240709$$CN$US$US
240719582$24071958$2$F$$20240904$20240710$20240912$EXP$$US-ARGENX-2024-ARGX-US005095$ARGENX BVBA$$$$$$Y$$$20240912$$CN$US$US
240719601$24071960$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109242$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240710$$CN$US$US
240719612$24071961$2$F$$20240731$20240710$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109213$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$85.73$KG$20240801$$CN$US$US
240719622$24071962$2$F$$20240712$20240710$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108661$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240718$$CN$US$US
240719631$24071963$1$I$$20240702$20240710$20240710$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008144$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240710$$HP$CN$CN
240719642$24071964$2$F$$20240822$20240710$20240826$PER$$NVSC2024US142351$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
240719651$24071965$1$I$$20240701$20240710$20240710$EXP$$US-MSNLABS-2024MSNLIT01479$MSN LABORATORIES$Simone C, Axelband J.Levetiracetam-associated Rhabdomyolysis.American Journal of Respiratory and Critical Care Medicine.2024;209:A5704$$$$$Y$$$20240710$$HP$US$US
240719663$24071966$3$F$20240101$20240710$20240710$20240725$EXP$$CA-AKCEA THERAPEUTICS, INC.-2024IS005784$AKCEA THERAPEUTICS$$$$$$Y$$$20240724$$HP$CA$CA
240719671$24071967$1$I$20240601$20240615$20240710$20240710$PER$$US-JNJFOC-20240670617$JOHNSON AND JOHNSON$$5$YR$C$F$Y$$$20240710$$CN$US$US
240719681$24071968$1$I$$20240702$20240710$20240710$EXP$$US-JNJFOC-20240708397$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240719691$24071969$1$I$20240627$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024134398$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240719701$24071970$1$I$$20240708$20240710$20240710$PER$$US-AstraZeneca-2024A156637$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240719711$24071971$1$I$$20240705$20240710$20240710$EXP$$US-AstraZeneca-2024A154950$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240719721$24071972$1$I$20240201$20240702$20240710$20240710$EXP$FR-AFSSAPS-MA2024000810$FR-BIOCON BIOLOGICS LIMITED-BBL2024004939$BIOCON$$$$$$Y$$$20240710$$MD$FR$FR
240719731$24071973$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109106$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$60$YR$A$F$Y$$$20240710$$HP$US$US
240719741$24071974$1$I$$20240709$20240709$20240709$DIR$709573$$FDA-CTU$$$$$UNK$N$$$20240709$N$CN$US$
240719751$24071975$1$I$20240102$20240709$20240709$20240709$DIR$709659$$FDA-CTU$$84$YR$$F$N$58.5$KG$20240709$N$CN$US$
240719761$24071976$1$I$$20240703$20240710$20240710$EXP$$PL-NOVITIUMPHARMA-2024PLNVP01230$NOVITIUM PHARMA$Adam Plonski.Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review.International Journal of Environmental Research and Public Health.29-JUN-2023;20(13):1-14$38$YR$A$M$Y$$$20240710$$HP$PL$PL
240719771$24071977$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202407041756586250-ZYHDR$GB-SANDOZ INC.-SDZ2024GB063645$SANDOZ$$$$$F$Y$52$KG$20240710$$CN$GB$GB
240719783$24071978$3$F$20240629$20240717$20240710$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA063857$SANDOZ$$83$YR$$M$Y$$$20240723$$MD$CA$CA
240719791$24071979$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405071423293830-ZHTYS$GB-SANDOZ INC.-SDZ2024GB063868$SANDOZ$$$$$F$Y$$$20240710$$PH$GB$GB
240719801$24071980$1$I$20240608$20240701$20240710$20240710$PER$FR-AFSSAPS-MP2024001045$FR-PFM-2024-03813$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$PH$FR$FR
240719811$24071981$1$I$$20240630$20240710$20240710$PER$$BE-PFM-2024-03834$PIERRE FABRE MEDICAMENT$Pierman G, Vandermeeren Y, Jonas C, Delgrange E. Association of Graves^ disease and Moyamoya  syndrome in a Caucasian woman from Western  Europe: vascular effects of anti-TSH receptor  antibodies. vascular effects of anti-TSH receptor antibodies. 2024$$$$$Y$$$20240710$$HP$BE$BE
240719821$24071982$1$I$$20240603$20240710$20240710$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-12434$ALKEM$Zhang Q, Yu L, Wan L, Chen L, Chen J.. Ineffectiveness of apremilast in moderate-to-severe pemphigus: A case series of three patients. Australasian Journal Dermatology. 2024;00:1-2$74$YR$$M$Y$$$20240710$$HP$CN$CN
240719831$24071983$1$I$$20240603$20240710$20240710$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-11744$ALKEM$Zhang Q, Yu L, Wan L, Chen L, Chen J.. Ineffectiveness of apremilast in moderate-to-severe pemphigus: A case series of three patients. Australasian Journal Dermatology. 2024;00:1-2$56$YR$$F$Y$$$20240710$$HP$CN$CN
240719841$24071984$1$I$$20240603$20240710$20240710$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-12437$ALKEM$Zhang Q, Yu L, Wan L, Chen L, Chen J.. Ineffectiveness of apremilast in moderate-to-severe pemphigus: A case series of three patients. Australasian Journal Dermatol. 2024;00:1-2$26$YR$$F$Y$$$20240710$$HP$CN$CN
240719851$24071985$1$I$$20240613$20240710$20240710$EXP$$GR-ALKEM LABORATORIES LIMITED-GR-ALKEM-2024-13422$ALKEM$Tampouratzi E, Kanni T, Katsantonis J, et al.. Case report: treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches. F1000Research. 2019;8:2002$27$YR$$F$Y$$$20240710$$HP$GR$GR
240719871$24071987$1$I$20200303$20240706$20240709$20240709$DIR$FDA-CDER-CTU-2024-47643$$FDA-CTU$$61$YR$$M$N$122.47$KG$20240706$N$CN$US$
240719881$24071988$1$I$20240708$20240709$20240709$20240709$DIR$709593$$FDA-CTU$$$$$UNK$N$$$20240709$N$CN$US$
240719891$24071989$1$I$$20240515$20240710$20240710$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-10632$ALKEM$Yamauchi PS.. Management of scrotal pruritus with topical roflumilast 0.3% once daily treatment. JAAD Case Rep. 2024;47:4-5$41$YR$$M$Y$$$20240710$$MD$US$US
240719901$24071990$1$I$$20240702$20240710$20240710$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008145$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240710$$HP$CN$CN
240719911$24071991$1$I$$20240628$20240710$20240710$PER$$US-JNJFOC-20240704371$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240719921$24071992$1$I$20240601$20240709$20240710$20240710$PER$$US-JNJFOC-20240723344$JOHNSON AND JOHNSON$$34$YR$A$$Y$$$20240710$$HP$US$US
240719931$24071993$1$I$20240101$20240704$20240710$20240710$EXP$$BR-JNJFOC-20240715281$JOHNSON AND JOHNSON$$43$YR$A$M$Y$96$KG$20240710$$CN$BR$BR
2407199411$24071994$11$F$20240101$20240917$20240710$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-020714$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240925$$$US$US
240719951$24071995$1$I$20230715$20240709$20240709$20240709$DIR$709644$$FDA-CTU$$66$YR$$F$N$55.35$KG$20240709$N$CN$US$
240719963$24071996$3$F$20240107$20240822$20240710$20240827$EXP$$US-TAKEDA-2018TUS010543$TAKEDA$$42$YR$$F$Y$83$KG$20240827$$CN$US$US
240719972$24071997$2$F$$20240724$20240710$20240729$EXP$$CA-ABBVIE-5831637$ABBVIE$$$$A$F$Y$$$20240729$$CN$CA$CA
240719981$24071998$1$I$20240626$20240708$20240710$20240710$EXP$$CN-ABBVIE-5831849$ABBVIE$$71$YR$$F$Y$50$KG$20240710$$MD$CN$CN
240719992$24071999$2$F$$20240710$20240710$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-020841$UNITED THERAPEUTICS$$$$$M$Y$89.796$KG$20240713$$$US$US
240720001$24072000$1$I$$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024134655$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240720021$24072002$1$I$$20240702$20240710$20240710$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008062$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240710$$HP$CN$CN
240720031$24072003$1$I$20240401$20240703$20240710$20240710$EXP$$JP-SANDOZ INC.-SDZ2024JP042475$SANDOZ$$81$YR$$$Y$$$20240710$$MD$JP$JP
240720041$24072004$1$I$20240709$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024135848$AMGEN$$84$YR$E$M$Y$$$20240710$$CN$US$US
240720051$24072005$1$I$20221205$20240702$20240710$20240710$EXP$$ES-CELLTRION INC.-2024ES016306$CELLTRION$$$$$$Y$$$20240710$$MD$ES$ES
240720062$24072006$2$F$$20240916$20240710$20240924$EXP$$DK-CELLTRION INC.-2024DK016164$CELLTRION$Taudorf EH, Jensen MB, Bouazzi D. Tumor necrosis factor-alpha inhibitor treatment of acne fulminans - a clinical and literature review. Journal der Deutschen Dermatologischen Gesellschaft. 2024;22(1):23-28$$$$$Y$$$20240924$$MD$DK$DK
240720071$24072007$1$I$$20240703$20240710$20240710$EXP$$US-CIPLA LTD.-2024US07104$CIPLA$Rome N, Padala V, Pattoli M, Desai S, Krinock M, Durkin M et al.. BRASH Syndrome: A rare clinical phenomenon. CJC Open. 2024;6 (6):840 to 842$$$$$Y$$$20240710$$MD$US$US
240720081$24072008$1$I$$20240703$20240710$20240710$EXP$$PL-NOVITIUMPHARMA-2024PLNVP01231$NOVITIUM PHARMA$Adam Plonski.Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review.International Journal of Environmental Research and Public Health.29-JUN-2023;20(13):1-14$79$YR$E$M$Y$$$20240710$$HP$PL$PL
240720091$24072009$1$I$$20240702$20240710$20240710$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008063$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240710$$HP$CN$CN
240720103$24072010$3$F$$20240701$20240710$20240715$EXP$$NVSC2024CN140534$NOVARTIS$Zhang P, Yue Y, Gui D. Effectiveness of laparoscopic surgery combined with gonadotrophin - releasing hormone agonist therapy in the treatment of endometriosis and its  impact on recurrence and pregnancy status. JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. 2024;23(10):1064-7$$$$F$Y$$$20240715$$HP$CN$CN
240720113$24072011$3$F$$20240728$20240710$20240801$EXP$$NVSC2024JO141714$NOVARTIS$$$$A$M$Y$$$20240801$$PH$JO$JO
240720121$24072012$1$I$$20240701$20240710$20240710$EXP$$GB-CELLTRION INC.-2024GB010890$CELLTRION$$$$$$Y$$$20240710$$CN$GB$GB
240720132$24072013$2$F$20240101$20240715$20240710$20240718$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019249$UNITED THERAPEUTICS$$$$$M$Y$26.757$KG$20240718$$$US$US
240720141$24072014$1$I$20230101$20240626$20240710$20240710$EXP$$CN-IPCA LABORATORIES LIMITED-IPC-2024-CN-001676$IPCA$Fan Caixia, Guo Dequn, Li Zhengrong, et.al. Warfarin-related nephropathy due to excessive anticoagulation induced by combination of warfarin and amiodarone. ADRJ. 2024;26(5):318-320$$$$$Y$$$20240710$$HP$CN$CN
240720151$24072015$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186226$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240720161$24072016$1$I$$20240701$20240710$20240710$EXP$$SG-AMGEN-SGPSP2024131729$AMGEN$Nagarajan, C. BCMA Directed Bispecific Antibody Induced Tumor Flare in Multiple Myeloma. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(7):488-490$53$YR$A$M$Y$$$20240710$$HP$SG$SG
240720171$24072017$1$I$20210801$20240621$20240710$20240710$EXP$$DE-SANDOZ INC.-SDZ2024DE063903$SANDOZ$$72$YR$$F$Y$$$20240710$$MD$DE$DE
240720181$24072018$1$I$$20230728$20240710$20240710$PER$$US-AUROBINDO-AUR-APL-2023-043728$AUROBINDO$$59$YR$$F$Y$65$KG$20240710$$CN$US$US
240720191$24072019$1$I$$20240708$20240710$20240710$EXP$$CN-TAKEDA-2024TUS069761$TAKEDA$$$$$M$Y$$$20240710$$CN$CN$CN
240720201$24072020$1$I$$20240708$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063622$SANDOZ$$74$YR$$M$Y$$$20240710$$CN$CA$CA
240720211$24072021$1$I$20240629$20240701$20240710$20240710$EXP$$CN-CHIESI-2024CHF03955$CHIESI$$0$YR$$M$Y$1.17$KG$20240710$$HP$CN$CN
240720222$24072022$2$F$20240707$20240708$20240710$20240715$PER$$US-AMGEN-USASP2024135162$AMGEN$$62$YR$A$M$Y$$$20240714$$CN$US$US
240720241$24072024$1$I$$20240706$20240710$20240710$PER$$US-HALEON-2185811$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240720253$24072025$3$F$20240705$20240815$20240710$20240821$PER$$US-AMGEN-USASP2024136342$AMGEN$$66$YR$E$M$Y$$$20240820$$CN$US$US
240720261$24072026$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109122$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$43$YR$A$M$Y$$$20240710$$HP$US$US
240720271$24072027$1$I$$20240705$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063607$SANDOZ$$$$$F$Y$$$20240710$$HP$US$US
240720281$24072028$1$I$20240630$20240705$20240710$20240710$30DAY$$IT-SANDOZ INC.-SDZ2024IT063963$SANDOZ$$16$YR$$M$Y$57$KG$20240710$$CN$IT$IT
240720291$24072029$1$I$$20240702$20240710$20240710$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008064$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240710$$HP$CN$CN
240720301$24072030$1$I$20230703$20230815$20240710$20240710$PER$$US-AUROBINDO-AUR-APL-2023-047057$AUROBINDO$$$$$F$Y$$$20240710$$CN$US$US
240720311$24072031$1$I$$20231106$20240710$20240710$PER$$US-APOTEX-2023AP016474$APOTEX$Sambommatsu Y, Bruno DA, Imai D, Lee SD, Khan AA, Sharma A, Kumaran V, et al.. Domino Liver Transplantation for Unresectable Colon Cancer Liver Metastasis From a Donor With Heterozygous Familial Hyperlipidemia: A Case Report.. Transplantation Proceedings. 2023;55(8):1930-1933$30$YR$$F$Y$$$20240710$$HP$US$US
240720321$24072032$1$I$20240101$20240708$20240710$20240710$PER$$US-ABBVIE-5833059$ABBVIE$$$$$F$Y$$$20240710$$HP$US$US
240720332$24072033$2$F$20230501$20240702$20240710$20240722$EXP$$RU-ABBVIE-5832707$ABBVIE$$5$YR$$F$Y$$$20240719$$CN$RU$RU
240720341$24072034$1$I$$20240702$20240710$20240710$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008065$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240710$$HP$CN$CN
240720351$24072035$1$I$$20240703$20240710$20240710$EXP$$PL-NOVITIUMPHARMA-2024PLNVP01232$NOVITIUM PHARMA$Adam Plonski.Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review.International Journal of Environmental Research and Public Health.29-JUN-2023;20(13):1-14$30$YR$A$F$Y$$$20240710$$HP$PL$PL
240720361$24072036$1$I$$20230925$20240710$20240710$PER$$US-AUROBINDO-AUR-APL-2023-059140$AUROBINDO$$$$$F$Y$$$20240710$$CN$US$US
240720372$24072037$2$F$$20240717$20240710$20240719$30DAY$$GR-SANDOZ INC.-SDZ2024GR063806$SANDOZ$$5$YR$$M$Y$$$20240719$$CN$GR$GR
240720381$24072038$1$I$$20240708$20240710$20240710$30DAY$$FR-SANDOZ INC.-SDZ2024FR063906$SANDOZ$$10$YR$$M$Y$$$20240710$$CN$FR$FR
240720391$24072039$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A153148$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240720401$24072040$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405101415057720-NPTCZ$GB-SANDOZ INC.-SDZ2024GB063833$SANDOZ$$$$$F$Y$70$KG$20240710$$HP$GB$GB
240720411$24072041$1$I$20240613$20240702$20240710$20240710$EXP$$FR-AstraZeneca-2024A151720$ASTRAZENECA$$76$YR$$F$Y$99$KG$20240710$$MD$FR$
240720431$24072043$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005388$ELI LILLY AND CO$$$$$F$Y$$$20240710$$CN$US$US
240720441$24072044$1$I$20240708$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005695$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240710$$CN$US$US
240720451$24072045$1$I$$20240705$20240710$20240710$EXP$$PL-SANDOZ INC.-SDZ2023PL076622$SANDOZ$Tomasik J, Drozd-Sokolowska J, Kacprzyk P, Tomaszewska A, Machowicz R, Urbanowska E, et al.. Tisagenlecleucel CAR-T for relapsed/refractorydiffuse large B-cell lymphoma;one therapy, two clinical presentations:urgent need to design adverse event predictors. Acta Haematologica Polonica. 2023;54:100-103$38$YR$$F$Y$$$20240710$$HP$PL$PL
240720461$24072046$1$I$$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005941$ELI LILLY AND CO$$1$YR$I$M$Y$$$20240710$$CN$US$US
240720471$24072047$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005476$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240710$$CN$US$US
240720481$24072048$1$I$20240707$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005457$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240710$$CN$US$US
240720492$24072049$2$F$20240628$20240717$20240710$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407004547$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240723$$CN$US$US
240720501$24072050$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005478$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240710$$CN$US$US
240720511$24072051$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005658$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240710$$CN$US$US
240720521$24072052$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005670$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240710$$CN$US$US
240720531$24072053$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005263$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240710$$CN$US$US
240720541$24072054$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005086$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240710$$CN$US$US
240720551$24072055$1$I$20240707$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005124$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240710$$CN$US$US
240720561$24072056$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005739$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240710$$CN$US$US
240720571$24072057$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005212$ELI LILLY AND CO$$$$$$Y$$$20240710$$CN$US$US
240720581$24072058$1$I$20240705$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005131$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240710$$CN$US$US
240720591$24072059$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005532$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240710$$CN$US$US
240720601$24072060$1$I$$20240627$20240710$20240710$EXP$$AU-GSK-AU2024080231$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$AU$AU
240720611$24072061$1$I$$20240702$20240710$20240710$PER$$US-CHATTEMPRD-2024OHG023109$CHATTEM$$$$A$$Y$$$20240710$$CN$US$US
240720633$24072063$3$F$20230901$20240813$20240710$20240820$EXP$$GB-BIOGEN-2023BI01233743$BIOGEN$$33$YR$$F$Y$$$20240820$$HP$GB$GB
240720641$24072064$1$I$$20240702$20240710$20240710$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005005$BIOCON$$$$$$Y$$$20240710$$CN$CA$CA
240720651$24072065$1$I$20240101$20240705$20240710$20240710$EXP$FR-AFSSAPS-NT2024000825$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-107521$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$54$KG$20240710$$MD$FR$FR
240720662$24072066$2$F$20240601$20240717$20240710$20240724$EXP$$JP-009507513-2407JPN000598J$MERCK$$86$YR$$M$Y$$$20240724$$MD$JP$JP
240720671$24072067$1$I$$20240707$20240710$20240710$PER$$US-CHATTEMPRD-2024OHG023517$CHATTEM$$$$$$Y$$$20240710$$CN$US$US
240720681$24072068$1$I$$20240703$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008086$STRIDES$Marino-Nunez D, Chadha A, Onajin O.. A Fatal Case of Cryptococcoid Vasculopathy.. Am-J-Dermatopathol. 2024;46 (7):S7$$$$M$Y$$$20240710$$HP$US$US
240720691$24072069$1$I$$20240109$20240710$20240710$PER$$US-AUROBINDO-AUR-APL-2023-076242$AUROBINDO$$$$$M$Y$$$20240710$$CN$US$US
240720701$24072070$1$I$$20240703$20240710$20240710$EXP$$PL-NOVITIUMPHARMA-2024PLNVP01233$NOVITIUM PHARMA$Adam Plonski.Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review.International Journal of Environmental Research and Public Health.29-JUN-2023;20(13):1-14$73$YR$E$M$Y$$$20240710$$HP$PL$PL
240720711$24072071$1$I$$20240708$20240710$20240710$PER$$US-ABBVIE-5832348$ABBVIE$$$$$$Y$$$20240710$$CN$US$US
240720721$24072072$1$I$$20240617$20240710$20240710$PER$$US-JNJFOC-20240656868$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$HP$US$US
240720731$24072073$1$I$20240624$20240705$20240710$20240710$EXP$$CN-ABBVIE-5832793$ABBVIE$$57$YR$$F$Y$68$KG$20240710$$HP$CN$CN
240720741$24072074$1$I$20240626$20240709$20240709$20240709$DIR$709557$$FDA-CTU$$18$MON$$F$N$9$KG$20240709$N$HP$US$
240720751$24072075$1$I$$20240701$20240710$20240710$EXP$$AR-TAKEDA-2024TUS068384$TAKEDA$$$$$M$Y$$$20240710$$CN$AR$AR
240720761$24072076$1$I$$20240704$20240710$20240710$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008127$STRIDES$Sood A, Nayyar V, Roychoudhury A, Bhalla AS, Mishra D.. Post-COVID steroid induced avascular necrosis of the jaw: Emerging challenge in India.. Oral-Surg-Oral-Med-Oral-Pathol-Oral-Radiol. 2023;135 (4):e89-e93$65$YR$$M$Y$$$20240710$$HP$IN$IN
240720771$24072077$1$I$20240215$20240619$20240710$20240710$PER$$US-AUROBINDO-AUR-APL-2024-016958$AUROBINDO$$41$YR$$F$Y$99.7$KG$20240710$$CN$US$US
240720782$24072078$2$F$$20240822$20240710$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-033086$AUROBINDO$Bhatti A, Kalearasu A, Jayapalen V.. TACHYPHYLAXIS-INDUCED MYOCARDIAL INFARCTION IN A PATIENT WITH VASOSPASTIC ANGINA.. Heart. 2024;110 (Suppl. 3):A80-A81 abstr. 75$70$YR$$F$Y$$$20240827$$MD$GB$GB
240720791$24072079$1$I$20240115$20240305$20240710$20240710$PER$$US-AUROBINDO-AUR-APL-2024-004537$AUROBINDO$$45$YR$$F$Y$108.86$KG$20240710$$CN$US$US
240720802$24072080$2$F$$20240715$20240710$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-033280$AUROBINDO$Boris J, Al-Sudani H, Brophy A. Flecainide overdose-induced wide-complex tachyarrhythmia treated with sodium bicarbonate infusion. BMJ case reports.. 2024;17(6):e256391$5$DEC$$M$Y$$$20240724$$MD$US$US
240720811$24072081$1$I$20230814$20240709$20240709$20240709$DIR$709565$$FDA-CTU$$48$YR$$F$N$110.2$KG$20240709$N$$US$
240720823$24072082$3$F$20240706$20240821$20240710$20240823$PER$$US-AMGEN-USASP2024135559$AMGEN$$72$YR$E$M$Y$$$20240823$$CN$US$US
240720831$24072083$1$I$20240415$20240709$20240709$20240709$DIR$709595$$FDA-CTU$$94$YR$$F$N$61.65$KG$20240709$N$CN$US$
240720841$24072084$1$I$20240709$20240709$20240709$20240709$DIR$709630$$FDA-CTU$$87$YR$$F$N$$$20240709$N$$US$
240720851$24072085$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135804$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240720862$24072086$2$F$20240101$20240903$20240710$20240915$EXP$$US-UCBSA-2024034514$UCB$$$$$M$Y$$$20240915$$CN$US$US
240720871$24072087$1$I$$20240708$20240710$20240710$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-095665$REGENERON$$$$$M$Y$$$20240710$$CN$CA$CA
240720881$24072088$1$I$20240101$20240705$20240710$20240710$EXP$$US-009507513-2407USA003614$MERCK$$$$$F$Y$$$20240710$$CN$US$US
240720891$24072089$1$I$20230701$20240628$20240710$20240710$EXP$$JP-TAKEDA-2024TUS068923$TAKEDA$Ichikawa J. 17 clinical experience of using horse atg for aplastic anaemia which developed due to platelets decreased during treatment for colitis ulcerative. The 120th Kinki Hematology Local Meeting. 2024;31$62$YR$$M$Y$$$20240710$$MD$JP$JP
240720902$24072090$2$F$20230901$20240813$20240710$20240821$EXP$$GB-BIOGEN-2024BI01272863$BIOGEN$$0$YR$$$Y$$$20240821$$HP$GB$GB
240720911$24072091$1$I$20230801$20240703$20240710$20240710$EXP$$CA-CELLTRION INC.-2023CA010524$CELLTRION$$$$$$Y$$$20240710$$MD$CA$CA
240720922$24072092$2$F$20240601$20240821$20240710$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107722$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240826$$PH$JP$JP
240720931$24072093$1$I$$20240709$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038848$BOEHRINGER INGELHEIM$$$$$$Y$$$20240710$$CN$US$US
240720941$24072094$1$I$20231219$20240702$20240710$20240710$EXP$$CA-CELLTRION INC.-2023CA021419$CELLTRION$$$$$$Y$$$20240710$$MD$CA$CA
240720951$24072095$1$I$$20240419$20240710$20240710$PER$$US-AUROBINDO-AUR-APL-2024-017615$AUROBINDO$$$$$M$Y$$$20240710$$CN$US$US
240720971$24072097$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032949$AUROBINDO$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant. 2023;23(7):1048-1057$$$E$M$Y$$$20240710$$HP$US$US
240720991$24072099$1$I$$20240704$20240710$20240710$EXP$$CA-TAKEDA-2024TUS014524$TAKEDA$$$$$M$Y$$$20240710$$CN$CA$CA
240721001$24072100$1$I$$20240419$20240710$20240710$PER$$US-AUROBINDO-AUR-APL-2024-017891$AUROBINDO$$$$$F$Y$$$20240710$$HP$US$US
240721011$24072101$1$I$$20240701$20240710$20240710$EXP$$CA-APOTEX-2024AP007911$APOTEX$Spence S, Lee M, Tan Y, Wang P, Smyth L.. Reducing Peri-Procedural Complications Using Point-Of-Care Ultrasound: A Case of Intra-Abdominal Hemorrhage Post-Paracentesis. Canadian Journal of General Internal Medicine. 2023;18 (4):13$32$YR$$F$Y$$$20240710$$HP$CA$CA
240721021$24072102$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032946$AUROBINDO$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al.. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant. 2023;23(7):1048-1057$7$DEC$$M$Y$$$20240710$$HP$US$US
240721035$24072103$5$F$20240612$20240920$20240710$20240930$EXP$$US-UCBSA-2024031872$UCB$$81$YR$$F$Y$$$20240930$$CN$US$US
240721041$24072104$1$I$$20240629$20240710$20240710$PER$$US-AUROBINDO-AUR-APL-2024-024762$AUROBINDO$$60$YR$$$Y$$$20240710$$CN$US$US
240721051$24072105$1$I$$20240705$20240710$20240710$PER$$US-HALEON-2185777$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240721061$24072106$1$I$$20240627$20240710$20240710$EXP$$FR-IPCA LABORATORIES LIMITED-IPC-2024-FR-001694$IPCA$Guillaume Drevin,  Nicolas Picard, Antoine Baudriller et al.. Tramadol intoxication in children: An emerging issue. Therapie. 2024;xxx(xxxx)xxx-xx:1-5$$$$$Y$$$20240710$$HP$FR$FR
240721071$24072107$1$I$$20240706$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-020798$UNITED THERAPEUTICS$$$$$F$Y$48.073$KG$20240710$$$US$US
240721081$24072108$1$I$$20240706$20240710$20240710$PER$$NVSC2024US141042$NOVARTIS$$$$$$Y$$$20240710$$CN$US$US
240721091$24072109$1$I$20220126$20240704$20240710$20240710$EXP$$JP-EXELIXIS-CABO-22049402$EXELIXIS$$72$YR$$M$Y$$$20240710$$MD$JP$JP
240721101$24072110$1$I$20240520$20240702$20240710$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-032972$AUROBINDO$$11$YR$$F$Y$38$KG$20240710$$MD$FR$FR
240721112$24072111$2$F$$20240715$20240710$20240724$EXP$$AE-GILEAD-2024-0679739$GILEAD$$$$A$$Y$$$20240724$$MD$AE$AE
240721142$24072114$2$F$$20240910$20240710$20240918$EXP$$CA-AUROBINDO-AUR-APL-2024-032832$AUROBINDO$$3$YR$$M$Y$13$KG$20240918$$MD$CA$CA
240721161$24072116$1$I$20240626$20240709$20240709$20240709$DIR$709645$$FDA-CTU$$91$YR$$F$N$$$20240709$Y$HP$US$
240721171$24072117$1$I$20240701$20240709$20240709$20240709$DIR$709603$$FDA-CTU$$63$YR$$F$N$57$KG$20240709$N$$US$
240721181$24072118$1$I$20240619$20240709$20240709$20240709$DIR$709586$$FDA-CTU$$57$YR$$M$N$95$KG$20240709$Y$HP$US$
240721195$24072119$5$F$20240101$20240916$20240710$20240925$EXP$$AU-JNJFOC-20240602818$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240925$$CN$AU$AU
240721201$24072120$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A153312$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240721211$24072121$1$I$20240619$20240703$20240710$20240710$EXP$$CN-BEIGENE-BGN-2024-010393$BEIGENE$$$$$$Y$$$20240710$$HP$CN$CN
240721221$24072122$1$I$$20240702$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-033824$AUROBINDO$$68$YR$$F$Y$$$20240710$$HP$US$US
240721231$24072123$1$I$20240621$20240709$20240709$20240709$DIR$709591$$FDA-CTU$$70$YR$$F$N$49$KG$20240709$Y$HP$US$
240721241$24072124$1$I$20240708$20240709$20240709$20240709$DIR$709602$$FDA-CTU$$54$YR$$F$N$62$KG$20240709$Y$$US$
240721251$24072125$1$I$20240627$20240709$20240709$20240709$DIR$709597$$FDA-CTU$$82$YR$$F$N$91$KG$20240709$Y$HP$US$
240721262$24072126$2$F$$20240719$20240710$20240729$EXP$$BR-TEVA-VS-3216961$TEVA$Franco PDA, Araujo Neto CAD, da Silva SRL, Coelho Filho JC, Brites C, Pereira-Silva JL. Autochtonal case of chronic, unifocal, pulmonary paracoccidioidomycosis with methotrexate use, in Salvador - Brazil. Brazil-J-Infect-Dis 2024; 28 (3):.; Franco PDA, Araujo Neto CAD, da Silva SRL, Coelho Filho JC, Brites C, Pereira-Silva JL. Autochtonal case of chronic, unifocal, pulmonary paracoccidioidomycosis with methotrexate use, in Salvador - Brazil. Brazil-J-Infect-Dis 2024; 28 (3):.; Franco PDA, Ara...$48$YR$$F$Y$$$20240729$$HP$BR$BR
240721272$24072127$2$F$$20240911$20240710$20240913$EXP$$NVSC2024GB141903$NOVARTIS$$$$$$Y$$$20240913$$HP$GB$GB
240721281$24072128$1$I$$20240705$20240710$20240710$EXP$$IT-TAKEDA-2024TUS069432$TAKEDA$$$$$M$Y$$$20240710$$CN$IT$IT
240721292$24072129$2$F$$20240808$20240710$20240814$EXP$$US-TAKEDA-2021TUS029820$TAKEDA$$$$$F$Y$72$KG$20240814$$CN$US$US
240721302$24072130$2$F$$20240816$20240710$20240820$EXP$$GB-TAKEDA-2024TUS069139$TAKEDA$$$$$M$Y$$$20240820$$CN$GB$GB
240721311$24072131$1$I$$20240703$20240710$20240710$EXP$$US-GILEAD-2024-0679815$GILEAD$$$$A$M$Y$$$20240710$$CN$US$US
240721322$24072132$2$F$$20240722$20240710$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109025$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$PH$JP$JP
240721331$24072133$1$I$$20240702$20240710$20240710$PER$$US-ABBVIE-5827425$ABBVIE$$$$$$Y$$$20240709$$HP$US$US
240721344$24072134$4$F$20231001$20240727$20240710$20240802$EXP$$US-ABBVIE-5830890$ABBVIE$$59$YR$$F$Y$48.534$KG$20240802$$CN$US$US
240721353$24072135$3$F$20240301$20240807$20240710$20240810$EXP$$US-ABBVIE-5830054$ABBVIE$$63$YR$$M$Y$$$20240810$$CN$US$US
240721361$24072136$1$I$$20240705$20240710$20240710$EXP$$GB-SANDOZ INC.-NVSC2022GB182644$SANDOZ$$$$$F$Y$$$20240710$$CN$GB$GB
240721371$24072137$1$I$$20240704$20240710$20240710$EXP$$CA-ABBVIE-5830425$ABBVIE$$$$A$F$Y$$$20240709$$CN$CA$CA
240721391$24072139$1$I$$20231127$20240710$20240710$PER$$US-APOTEX-2023AP017622$APOTEX$Tran E, Ledbetter LE.. A retrospective evaluation of direct oral anticoagulant (DOAC) management strategies in patients with cancer on active chemotherapy. Journal of Thrombosis and Thrombolysis. 2023;55(4):721-728$73$YR$$M$Y$70.4$KG$20240710$$HP$US$US
240721401$24072140$1$I$20240626$20240701$20240710$20240710$EXP$$US-EMD Serono-2024036258$EMD SERONO INC$$58$YR$A$F$Y$$$20240710$$HP$US$US
240721411$24072141$1$I$20240401$20240704$20240710$20240710$EXP$$CA-ABBVIE-5830150$ABBVIE$$32$YR$$F$Y$$$20240710$$CN$CA$CA
240721421$24072142$1$I$20240301$20240704$20240710$20240710$EXP$SE-SEMPA-2024-005224$SE-AMGEN-SWESP2024133053$AMGEN$$73$YR$E$M$Y$$$20240710$$HP$SE$SE
240721431$24072143$1$I$20200429$20240708$20240710$20240710$EXP$PL-URPL-1-1560-2020$PL-AMGEN-POLSP2024134822$AMGEN$$73$YR$E$M$Y$77$KG$20240710$$MD$PL$PL
240721441$24072144$1$I$$20240615$20240710$20240710$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002890$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
240721452$24072145$2$F$$20240705$20240710$20240713$EXP$$CA-AMGEN-CANSP2024134429$AMGEN$Rajendran L.; Magyar C.J.; Li Z. et al.. Is liver transplantation a treatment option for unresectable colorectal liver metastases? Interim analysis of a phase ll trial. Annals of Oncology. 2024;35:S24-S25$$$$$Y$$$20240713$$HP$CA$CA
240721463$24072146$3$F$20240707$20240830$20240710$20240902$PER$$US-AMGEN-USASP2024135235$AMGEN$$75$YR$E$F$Y$$$20240902$$CN$US$US
240721472$24072147$2$F$$20240829$20240710$20240906$EXP$$AU-CELLTRION INC.-2024AU016408$CELLTRION$$$$$$Y$$$20240906$$MD$AU$AU
240721481$24072148$1$I$$20240625$20240710$20240710$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108963$ZYDUS PHARM$Yousaf Z, Jyothi Ramachandran Nair D, Kamel A.. Nystatin Induced Laryngeal Edema - First Reported Case.. Am-J-Respir-Crit-Care-Med. 2024;209:A1360$$$$$Y$$$20240710$$HP$US$US
240721491$24072149$1$I$$20240626$20240710$20240710$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109142$ZYDUS PHARM$Patel D, Chittal A, Malik KJ, Disilvio BE.. A ^Tail^ of Caution: Pioglitazone Induced Recurrent Pleural Effusion.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240710$$HP$US$US
240721501$24072150$1$I$$20240626$20240710$20240710$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109185$ZYDUS PHARM$Lavin L, Chefitz G, Patel D, Baek WK, Khattri S.. Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect.. JAAD-Case-Rep. 2024;49:40-43$$$$$Y$$$20240710$$HP$US$US
240721511$24072151$1$I$20240612$20240701$20240710$20240710$EXP$FR-AFSSAPS-PV2024000570$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109252$ZYDUS PHARM$$$$$$Y$$$20240710$$MD$FR$FR
240721521$24072152$1$I$$20240626$20240710$20240710$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109148$ZYDUS PHARM$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al.. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease.. Rheumatology. 2024;63(5):1291-1296$$$$$Y$$$20240710$$HP$US$US
240721531$24072153$1$I$$20240626$20240710$20240710$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109149$ZYDUS PHARM$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al.. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease.. Rheumatology. 2024;63(5):1291-1296$$$$$Y$$$20240710$$HP$US$US
240721541$24072154$1$I$$20240626$20240710$20240710$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109200$ZYDUS PHARM$Hu G, Hauk PJ, Zhang N, Elsegeiny W, Guardia CM, Kullas A, et al.. Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in ATG9A.. Autophagy. 2023;19 (2):678-691$$$$$Y$$$20240710$$HP$US$US
240721551$24072155$1$I$$20240628$20240710$20240710$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109260$ZYDUS PHARM$Braat J, Shacker M, Arjuna A.. Atypical presentation of central serous chorioretinopathy (CSCR) after lung transplantation.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240710$$HP$US$US
240721561$24072156$1$I$20240401$20240704$20240710$20240710$EXP$$CA-TAKEDA-2024TUS068867$TAKEDA$$80$YR$$F$Y$$$20240710$$CN$CA$CA
240721581$24072158$1$I$$20240703$20240710$20240710$PER$$US-ABBVIE-5830456$ABBVIE$$$$$F$Y$$$20240709$$HP$US$US
240721591$24072159$1$I$20240501$20240702$20240710$20240710$EXP$$US-ABBVIE-5826330$ABBVIE$$$$E$$Y$$$20240709$$CN$US$US
240721601$24072160$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005098$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240710$$CN$US$US
240721611$24072161$1$I$$20240705$20240710$20240710$EXP$$NVSC2024US140415$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
240721631$24072163$1$I$$20240708$20240710$20240710$PER$$US-ABBVIE-5832631$ABBVIE$$$$$$Y$$$20240710$$CN$US$US
240721641$24072164$1$I$$20240705$20240710$20240710$EXP$$US-GILEAD-2024-0679917$GILEAD$$$$C$M$Y$$$20240710$$CN$US$US
240721651$24072165$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405101722428740-NRBYG$GB-SANDOZ INC.-SDZ2024GB063865$SANDOZ$$$$$M$Y$$$20240710$$PH$GB$GB
240721661$24072166$1$I$$20240702$20240710$20240710$EXP$$IN-KOANAAP-SML-IN-2024-00686$Unknown Manufacturer$Debanjali D, Avanish S, Engineer R, Ashwin D, Baheti A, Kumar S. Non-operative management in low-lying rectal cancers undergoing chemoradiation. J-Cancer-Res-Ther. 2024;20(1): 417-422. doi:10.4103/jcrt.jcrt_189_23.$$$$$Y$$$20240710$$MD$IN$IN
240721681$24072168$1$I$$20240705$20240710$20240710$EXP$$FR-TAKEDA-2024TUS069852$TAKEDA$$$$A$F$Y$$$20240710$$CN$GB$FR
240721691$24072169$1$I$$20240702$20240710$20240710$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005008$BIOCON$$$$$$Y$$$20240710$$MD$CA$CA
240721701$24072170$1$I$20240415$20240709$20240709$20240709$DIR$709628$$FDA-CTU$$60$YR$$F$N$$$20240709$Y$HP$US$
240721711$24072171$1$I$$20240709$20240709$20240709$DIR$709640$$FDA-CTU$$$$$UNK$N$$$20240709$$CN$US$
240721722$24072172$2$F$20220301$20240703$20240710$20240712$EXP$$JP-TAKEDA-2024TUS069428$TAKEDA$$4$DEC$$M$Y$$$20240712$$MD$JP$JP
240721741$24072174$1$I$$20240702$20240710$20240710$EXP$$US-KOANAAP-SML-US-2024-00692$Unknown Manufacturer$Ravi S, Ravi SN, Ballam Nagaraj N, Upadhyay H. Acute Respiratory Compromise in the Context of COVID-19 and Gemcitabine. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5539. DOI: 10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5539.$48$YR$A$F$Y$$$20240710$$MD$US$US
240721751$24072175$1$I$20231002$20240701$20240710$20240710$EXP$IT-MINISAL02-991619$IT-TEVA-VS-3216152$TEVA$$38$YR$$F$Y$55$KG$20240710$$MD$IT$IT
240721761$24072176$1$I$20240624$20240703$20240710$20240710$EXP$$JP-AMGEN-JPNSP2024133130$AMGEN$$$$A$$Y$$$20240710$$HP$JP$JP
240721773$24072177$3$F$$20240822$20240710$20240823$EXP$$US-ALXN-202407USA000252US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240823$$HP$US$US
240721781$24072178$1$I$20240101$20240704$20240710$20240710$EXP$$BR-JNJFOC-20240715246$JOHNSON AND JOHNSON$$67$YR$E$F$Y$64$KG$20240710$$CN$BR$BR
240721791$24072179$1$I$20191002$20240703$20240710$20240710$EXP$$US-TAKEDA-2019TUS064301$TAKEDA$$68$YR$$M$Y$109$KG$20240710$$CN$US$US
240721811$24072181$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135930$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240721821$24072182$1$I$20240201$20240613$20240710$20240710$PER$$US-JNJFOC-20240641460$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240710$$CN$US$US
240721831$24072183$1$I$$20240705$20240710$20240710$EXP$$US-TAKEDA-2024TUS069589$TAKEDA$$$$$M$Y$111.11$KG$20240710$$MD$US$US
240721852$24072185$2$F$$20240807$20240710$20240814$EXP$$JP-AMGEN-JPNSP2024133900$AMGEN$$$$$$Y$$$20240814$$MD$JP$JP
240721861$24072186$1$I$20240704$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024134123$AMGEN$$74$YR$E$F$Y$$$20240710$$CN$US$US
240721872$24072187$2$F$20240620$20240709$20240710$20240712$EXP$$US-AMGEN-USASP2024134960$AMGEN$$82$YR$E$F$Y$$$20240712$$CN$US$US
240721881$24072188$1$I$$20240702$20240710$20240710$EXP$$CO-AstraZeneca-2024A154046$ASTRAZENECA$$23618$DY$$M$Y$$$20240710$$CN$CO$
240721891$24072189$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05858$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240721901$24072190$1$I$$20240709$20240710$20240710$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038830$BOEHRINGER INGELHEIM$$$$$$Y$$$20240710$$CN$US$US
240721911$24072191$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109080$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$74$YR$E$F$Y$$$20240710$$HP$US$US
240721921$24072192$1$I$20231110$20240628$20240710$20240710$EXP$$US-TAKEDA-2023TUS112056$TAKEDA$$64$YR$$F$Y$$$20240710$$MD$US$US
240721931$24072193$1$I$$20240703$20240710$20240710$EXP$$CA-AMGEN-CANSP2024132624$AMGEN$$$$$M$Y$$$20240710$$CN$CA$CA
240721943$24072194$3$F$20240601$20240912$20240710$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020369$UNITED THERAPEUTICS$$68$YR$$M$Y$$$20240920$$$US$US
240721951$24072195$1$I$20240101$20240708$20240710$20240710$EXP$$US-ABBVIE-5831843$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
240721961$24072196$1$I$$20240705$20240710$20240710$PER$$US-ABBVIE-5831307$ABBVIE$$37$YR$$M$Y$$$20240710$$CN$US$US
240721971$24072197$1$I$$20240704$20240710$20240710$EXP$$JP-EXELIXIS-CABO-24079213$EXELIXIS$$69$YR$$M$Y$$$20240710$$MD$JP$JP
240721981$24072198$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032873$AUROBINDO$Gilani S, Rifai Z, Singanallur P, Song M. Prolonged COVID-19 Pneumonia in a Patient on Obinutuzumab for Treatment of Follicular Lymphoma. Am-J-Respir-Crit-Care-Med. 2024;209:A5676$62$YR$$M$Y$$$20240710$$HP$US$US
240721991$24072199$1$I$$20240704$20240710$20240710$EXP$GB-MHRA-DEFECT-202406221311545970-BHSNJ$GB-CHEPLA-2024008389$CHEPLAPHARM$$$$A$$Y$$$20240710$$CN$COUNTRY NOT SPECIFIED$GB
240722002$24072200$2$F$$20240715$20240710$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05857$LUPIN$$$$$$Y$$$20240809$$CN$US$US
240722032$24072203$2$F$20240704$20240826$20240710$20240903$EXP$$JP-009507513-2407JPN000611J$MERCK$$53$YR$$F$Y$$$20240903$$PH$JP$JP
240722042$24072204$2$F$$20240808$20240710$20240808$PER$$US-ALXN-202407USA000242US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
240722051$24072205$1$I$$20240708$20240710$20240710$EXP$$US-ABBVIE-5831808$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
240722061$24072206$1$I$$20240702$20240710$20240710$EXP$$AU-CELLTRION INC.-2024AU016336$CELLTRION$$$$$$Y$$$20240710$$HP$AU$AU
240722071$24072207$1$I$20240628$20240708$20240710$20240710$PER$$US-ABBVIE-5832497$ABBVIE$$66$YR$$M$Y$104$KG$20240710$$CN$US$US
240722081$24072208$1$I$$20240708$20240710$20240710$PER$$US-TAKEDA-2024TUS069533$TAKEDA$$$$$M$Y$82$KG$20240710$$MD$US$US
240722091$24072209$1$I$20211130$20240704$20240710$20240710$EXP$$JP-EXELIXIS-CABO-24079215$EXELIXIS$$62$YR$$M$Y$$$20240710$$MD$JP$JP
240722101$24072210$1$I$$20240702$20240710$20240710$EXP$$US-CHEPLA-2024008344$CHEPLAPHARM$Ahdoot R, Rew J, Reynolds KA, Lowe L, Mervak JE. Violaceous scaly plaques of the dorsal hands. JAAD Case reports.2024;49:85-87. doi: 10.1016/j.jdcr.2024.05.007.$84$YR$$F$Y$$$20240710$$HP$COUNTRY NOT SPECIFIED$US
240722111$24072211$1$I$20240621$20240705$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108067$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$58.97$KG$20240710$$HP$US$US
240722121$24072212$1$I$$20240704$20240710$20240710$EXP$$AU-TAKEDA-2023TUS051807$TAKEDA$$$$$M$Y$$$20240710$$CN$AU$AU
240722131$24072213$1$I$$20240621$20240710$20240710$PER$$US-JNJFOC-20240661936$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
240722141$24072214$1$I$$20240629$20240710$20240710$PER$$US-JNJFOC-20240700927$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240722151$24072215$1$I$20240705$20240709$20240710$20240710$PER$$US-JNJFOC-20240722946$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240710$$PH$US$US
240722161$24072216$1$I$$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024134295$AMGEN$$$$$M$Y$$$20240710$$HP$US$US
240722171$24072217$1$I$20240601$20240705$20240710$20240710$EXP$$ZA-ABBVIE-5831188$ABBVIE$$42$YR$$F$Y$$$20240710$$CN$ZA$ZA
240722181$24072218$1$I$$20240621$20240710$20240710$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024078080$VIIV$$$$$M$Y$$$20240710$$PH$US$US
240722191$24072219$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135884$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240722201$24072220$1$I$20240101$20240705$20240710$20240710$EXP$FR-AFSSAPS-AN2024000833$FR-CHEPLA-2024008487$CHEPLAPHARM$$54$YR$$M$Y$80$KG$20240710$$PH$COUNTRY NOT SPECIFIED$FR
240722212$24072221$2$F$20240705$20240711$20240710$20240723$EXP$$JP-MALLINCKRODT-MNK202404406$MALLINCKRODT$$84$YR$E$F$Y$$$20240723$$PH$JP$JP
240722221$24072222$1$I$$20240701$20240710$20240710$EXP$$US-AMGEN-USASP2024132890$AMGEN$Cole E.D.; Dedania V.; Demirci H.. Occlusive Vasculitis Following Intravitreal Rituximab Injection for Primary Vitreoretinal Lymphoma. Ocular Immunology and Inflammation. 2024;1-5$50$YR$A$F$Y$$$20240710$$MD$US$US
240722232$24072223$2$F$20240628$20240710$20240710$20240716$PER$$US-ABBVIE-5832216$ABBVIE$$42$YR$$F$Y$82$KG$20240716$$CN$US$US
240722241$24072224$1$I$20240701$20240708$20240710$20240710$EXP$$US-ABBVIE-5832747$ABBVIE$$78$YR$$F$Y$$$20240710$$CN$US$US
240722252$24072225$2$F$20240701$20240712$20240710$20240801$PER$$US-AMGEN-USASP2024135778$AMGEN$$88$YR$E$F$Y$$$20240801$$CN$US$US
240722261$24072226$1$I$$20240703$20240710$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-108411$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$PH$JP$JP
240722271$24072227$1$I$20240702$20240702$20240710$20240710$EXP$$GB-AUROBINDO-AUR-APL-2024-033063$AUROBINDO$$38$YR$$M$Y$68$KG$20240710$$PH$GB$GB
240722281$24072228$1$I$20240520$20240708$20240710$20240710$EXP$FR-AFSSAPS-NC2024000792$FR-UCBSA-2024034454$UCB$$11$YR$$F$Y$38$KG$20240710$$MD$FR$FR
240722292$24072229$2$F$20240706$20240820$20240710$20240824$PER$$US-AMGEN-USASP2024135834$AMGEN$$56$YR$A$F$Y$$$20240823$$CN$US$US
240722312$24072231$2$F$20240201$20240708$20240710$20240722$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-20425$SAMSUNG BIOEPIS$$74$YR$E$F$Y$$$20240722$$CN$CA$CA
240722321$24072232$1$I$$20240702$20240710$20240710$EXP$$CA-CELLTRION INC.-2024CA016132$CELLTRION$$$$$$Y$$$20240710$$HP$CA$CA
240722331$24072233$1$I$20240603$20240702$20240710$20240710$EXP$$CN-TAKEDA-2024TUS066864$TAKEDA$$67$YR$$M$Y$70$KG$20240710$$HP$CN$CN
240722341$24072234$1$I$20240601$20240708$20240710$20240710$PER$$US-JNJFOC-20240720020$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240710$$CN$US$US
240722351$24072235$1$I$20240101$20240708$20240710$20240710$EXP$$SE-ABBVIE-5832686$ABBVIE$$$$$$Y$$$20240710$$HP$SE$SE
240722364$24072236$4$F$20240101$20240819$20240710$20240827$EXP$$CA-CELLTRION INC.-2023CA024023$CELLTRION$$$$$$Y$$$20240827$$MD$CA$CA
240722371$24072237$1$I$$20240703$20240710$20240710$PER$$US-JNJFOC-20240712609$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
240722381$24072238$1$I$$20240705$20240710$20240710$EXP$$US-JNJFOC-20240717624$JOHNSON AND JOHNSON$$91$YR$E$M$Y$$$20240710$$CN$US$US
240722401$24072240$1$I$$20240705$20240710$20240710$EXP$$US-AstraZeneca-2024A154949$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240722411$24072241$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06239$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240722421$24072242$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186062$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240722431$24072243$1$I$20240609$20240702$20240710$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-032922$AUROBINDO$$12$YR$$M$Y$$$20240710$$PH$FR$FR
240722442$24072244$2$F$20240402$20240709$20240710$20240716$EXP$$DE-ABBVIE-5832161$ABBVIE$$75$YR$$M$Y$$$20240716$$HP$DE$DE
240722452$24072245$2$F$20231026$20240717$20240710$20240726$EXP$$CA-CELLTRION INC.-2024CA001078$CELLTRION$$$$$$Y$$$20240726$$CN$CA$CA
240722462$24072246$2$F$$20240708$20240710$20240717$EXP$GB-MHRA-MED-202406281442341590-SCYTR$GB-AMAROX PHARMA-AMR2024GB02095$HETERO$$$$$$Y$$$20240717$$CN$GB$GB
240722482$24072248$2$F$$20240808$20240710$20240808$PER$$US-ALXN-202407USA000241US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
240722491$24072249$1$I$$20240704$20240710$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109061$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$PH$JP$JP
240722501$24072250$1$I$$20240705$20240710$20240710$EXP$$CA-UCBSA-2022026620$UCB$$$$$M$Y$$$20240710$$CN$CA$CA
240722521$24072252$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186200$Haleon PLC$$31$YR$$M$Y$$$20240710$$CN$US$US
240722531$24072253$1$I$$20240704$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063777$SANDOZ$$$$$$Y$$$20240710$$CN$US$US
240722541$24072254$1$I$$20240702$20240710$20240710$EXP$$US-VIIV HEALTHCARE LIMITED-US2024082121$VIIV$$$$$F$Y$$$20240710$$MD$US$US
240722552$24072255$2$F$20240101$20240821$20240710$20240826$EXP$$US-ABBVIE-5823343$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
240722562$24072256$2$F$20240709$20240709$20240710$20240730$PER$$US-AMGEN-USASP2024135825$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
240722572$24072257$2$F$20240707$20240708$20240710$20240715$PER$$US-AMGEN-USASP2024135422$AMGEN$$62$YR$A$F$Y$$$20240715$$CN$US$US
240722581$24072258$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063881$SANDOZ$$82$YR$$F$Y$72$KG$20240710$$HP$CA$CA
240722592$24072259$2$F$20240101$20240708$20240710$20240715$EXP$$US-AMGEN-USASP2024134747$AMGEN$$$$$F$Y$$$20240715$$HP$US$US
240722601$24072260$1$I$$20240619$20240710$20240710$PER$$US-JNJFOC-20240655386$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240722611$24072261$1$I$20240301$20240625$20240710$20240710$PER$$US-JNJFOC-20240673578$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240710$$CN$US$US
240722621$24072262$1$I$20211026$20240702$20240710$20240710$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02485$AMNEAL$$79$YR$$M$Y$$$20240710$$MD$US$US
240722631$24072263$1$I$$20240702$20240710$20240710$PER$$US-JNJFOC-20240706315$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$CN$US$US
240722641$24072264$1$I$20240607$20240628$20240710$20240710$EXP$BE-FAMHP-DHH-N2024-122286$BE-GSK-BE2024080599$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$BE$BE
240722652$24072265$2$F$$20240814$20240710$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06241$LUPIN$$$$$$Y$$$20240901$$CN$US$US
240722671$24072267$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104946$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$62$YR$A$F$Y$$$20240710$$HP$US$US
240722681$24072268$1$I$20240417$20240703$20240710$20240710$EXP$IT-MINISAL02-993354$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-106468$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240710$$PH$IT$IT
240722691$24072269$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109082$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$75$YR$E$F$Y$$$20240710$$HP$US$US
240722704$24072270$4$F$20240101$20240721$20240710$20240724$EXP$$IL-ABBVIE-5831004$ABBVIE$$$$$M$Y$$$20240724$$HP$IL$IL
240722721$24072272$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135857$AMGEN$$$$$$Y$$$20240710$$MD$US$US
240722731$24072273$1$I$20240705$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135562$AMGEN$$71$YR$E$M$Y$$$20240710$$PH$US$US
240722741$24072274$1$I$20240423$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405101435442930-CTHRF$GB-CHATTEMPRD-2024OHG023391$CHATTEM$$36$YR$A$M$Y$$$20240710$$PH$GB$GB
240722752$24072275$2$F$20220815$20240823$20240710$20240828$PER$$US-JAZZ PHARMACEUTICALS-2023-US-020749$JAZZ$$21$YR$$M$Y$$$20240827$$MD$US$US
240722761$24072276$1$I$$20240703$20240710$20240710$EXP$GB-MHRA-30925138$GB-AMAROX PHARMA-AMR2024GB02096$HETERO$$75$YR$$F$Y$$$20240710$$PH$GB$GB
240722781$24072278$1$I$$20240708$20240710$20240710$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038555$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240709$$MD$US$US
240722802$24072280$2$F$20240322$20240725$20240710$20240726$EXP$$FR-TAKEDA-2024TUS069841$TAKEDA$$67$YR$$M$Y$$$20240726$$HP$FR$FR
240722811$24072281$1$I$$20240627$20240710$20240710$PER$$US-TAKEDA-2024TUS064929$TAKEDA$$$$$$Y$$$20240710$$MD$US$US
240722821$24072282$1$I$20210101$20240709$20240710$20240710$EXP$GB-MHRA-MED-202407081641262170-TMSVK$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038571$BOEHRINGER INGELHEIM$$55$YR$A$M$Y$$$20240709$$CN$GB$GB
240722831$24072283$1$I$$20240513$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-028300$BOEHRINGER INGELHEIM$$52$YR$A$F$Y$$$20240709$$CN$US$US
240722841$24072284$1$I$$20240703$20240710$20240710$EXP$$US-NOVITIUMPHARMA-2024USNVP01214$NOVITIUM PHARMA$Madhumita Rao.Disseminated Scedosporium infection in the early post-kidney transplant period.Transplant Infectious Disease.20-FEB-2024;26(2):1-6$63$YR$A$F$Y$$$20240710$$HP$US$US
240722851$24072285$1$I$$20240513$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-028302$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240709$$CN$US$US
240722861$24072286$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06262$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240722872$24072287$2$F$$20240703$20240710$20240712$PER$$US-ABBVIE-5829122$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240722883$24072288$3$F$20240531$20240812$20240710$20240822$PER$$US-TRAVERE-2024TVT00560$TRAVERE THERAPEUTICS$$36$YR$A$F$Y$$$20240822$$CN$US$US
240722901$24072290$1$I$$20240703$20240710$20240710$PER$$US-ALXN-202407USA000312US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
240722911$24072291$1$I$20240101$20240703$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107109$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$85.28$KG$20240710$$HP$US$US
240722921$24072292$1$I$20210723$20240701$20240710$20240710$PER$DE-PEI-CADR2024327962$DE-IGSA-BIG0029465$GRIFOLS$$27$YR$$M$Y$100$KG$20240710$$CN$DE$DE
240722931$24072293$1$I$$20240703$20240710$20240710$PER$$US-ALXN-202407USA000233US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240710$$HP$US$US
240722941$24072294$1$I$$20240702$20240710$20240710$PER$$US-TAKEDA-2024TUS066859$TAKEDA$$$$A$F$Y$$$20240710$$CN$US$US
240722952$24072295$2$F$$20240801$20240710$20240805$PER$$US-ALXN-202407USA000324US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240722963$24072296$3$F$20240613$20240719$20240710$20240727$EXP$$BR-CELLTRION INC.-2024BR016369$CELLTRION$$$$$$Y$$$20240727$$CN$BR$BR
240722971$24072297$1$I$$20240701$20240710$20240710$EXP$$BG-BIOCON BIOLOGICS LIMITED-BBL2024005036$BIOCON$Valova S, Tilkiyan E, Kostyaneva S, Zdravkova I, Erkanyan I, Hristov B et al.,. Glomerulonephritis associated with anti -TNF- alpha therapy. Nephrology Dialysis Transplantation. 2024;39(1):i2073$$$$$Y$$$20240710$$HP$BG$BG
240722981$24072298$1$I$20240627$20240702$20240710$20240710$EXP$$IL-AstraZeneca-2024A154846$ASTRAZENECA$$27536$DY$$F$Y$$$20240710$$CN$IL$
240722991$24072299$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06278$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240723001$24072300$1$I$20240623$20240627$20240710$20240710$EXP$GB-MHRA-MED-202406270852281540-HWGRJ$GB-GLENMARK PHARMACEUTICALS-2024GMK091977$GLENMARK$$$$$$Y$$$20240710$$CN$GB$GB
240723011$24072301$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135813$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240723023$24072302$3$F$20240601$20240806$20240710$20240809$PER$$US-AMGEN-USASP2024135942$AMGEN$$85$YR$E$F$Y$$$20240809$$CN$US$US
240723031$24072303$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005577$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240710$$CN$US$US
240723041$24072304$1$I$20240707$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005397$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240710$$CN$US$US
240723051$24072305$1$I$$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407006130$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240710$$CN$US$US
240723061$24072306$1$I$$20240707$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005622$ELI LILLY AND CO$$10$YR$C$F$Y$$$20240710$$CN$US$US
240723071$24072307$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004689$ELI LILLY AND CO$$$$$F$Y$$$20240710$$CN$US$US
240723081$24072308$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005586$ELI LILLY AND CO$$18$YR$A$F$Y$$$20240710$$CN$US$US
240723091$24072309$1$I$20210101$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407006044$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240710$$CN$US$US
240723101$24072310$1$I$20240707$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005498$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240710$$CN$US$US
240723111$24072311$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005710$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240710$$CN$US$US
240723121$24072312$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005103$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240710$$CN$US$US
240723131$24072313$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005166$ELI LILLY AND CO$$24$YR$A$M$Y$$$20240710$$CN$US$US
240723141$24072314$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005510$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240710$$CN$US$US
240723151$24072315$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005245$ELI LILLY AND CO$$$$$M$Y$$$20240710$$CN$US$US
240723161$24072316$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005509$ELI LILLY AND CO$$$$A$F$Y$$$20240710$$CN$US$US
240723171$24072317$1$I$$20240707$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004941$ELI LILLY AND CO$$$$$$Y$$$20240710$$CN$US$US
240723181$24072318$1$I$20240709$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407006179$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240710$$CN$US$US
240723191$24072319$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004973$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240710$$CN$US$US
240723201$24072320$1$I$20240707$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005472$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240710$$PH$US$US
240723212$24072321$2$F$$20240712$20240710$20240715$PER$$NVSC2024US142276$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240723221$24072322$1$I$$20240704$20240710$20240710$PER$$NVSC2024US140437$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
240723232$24072323$2$F$20230101$20240729$20240710$20240731$PER$$US-AMGEN-USASP2024135474$AMGEN$$76$YR$E$M$Y$$$20240731$$CN$US$US
240723241$24072324$1$I$$20240704$20240710$20240710$EXP$$US-AMGEN-USASP2024133177$AMGEN$Verma K.; Hardy D.. Two Cases of Pediatric Leucine-Rich Glioma-inactivated Protein-1 Encephalitis: Clinical Course, Challenges, and Implications. Pediatric Neurology. 2024;157:96-99$16$YR$T$F$Y$$$20240710$$MD$US$US
240723262$24072326$2$F$$20240703$20240710$20240723$PER$$US-TEVA-VS-3217564$TEVA$$67$YR$$M$Y$$$20240723$$PH$US$US
240723272$24072327$2$F$20230901$20240704$20240710$20240714$EXP$GB-MHRA-MED-202407021235502260-VRZQL$GB-TEVA-VS-3216837$TEVA$$$$$M$Y$$$20240714$$MD$GB$GB
240723281$24072328$1$I$$20240703$20240710$20240710$EXP$$PK-NOVITIUMPHARMA-2024PKNVP01216$NOVITIUM PHARMA$R. Ahmed.Lung Hernia: An Uncommon Presentation After Chronic Obstructive Pulmonary Disease (COPD) Exacerbation.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;209(9):A5820$61$YR$A$F$Y$$$20240710$$HP$PK$PK
240723291$24072329$1$I$20240601$20240704$20240710$20240710$EXP$$CA-CELLTRION INC.-2024CA016713$CELLTRION$$$$$$Y$$$20240710$$HP$CA$CA
240723301$24072330$1$I$20240101$20240708$20240710$20240710$EXP$$GB-UCBSA-2024034584$UCB$$$$$M$Y$$$20240710$$CN$GB$GB
240723312$24072331$2$F$20240602$20240712$20240710$20240715$EXP$$TR-ABBVIE-5793218$ABBVIE$$36$YR$$F$Y$$$20240715$$MD$TR$TR
240723321$24072332$1$I$$20240705$20240710$20240710$PER$$US-JNJFOC-20240718059$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240723341$24072334$1$I$$20240703$20240710$20240710$PER$$US-ABBVIE-5830218$ABBVIE$$$$$$Y$$$20240710$$CN$US$US
240723352$24072335$2$F$20240709$20240710$20240710$20240716$PER$$US-AMGEN-USASP2024135935$AMGEN$$81$YR$E$F$Y$$$20240715$$MD$US$US
240723361$24072336$1$I$20240101$20240708$20240710$20240710$EXP$$US-UCBSA-2024034491$UCB$$$$$F$Y$$$20240710$$CN$US$US
240723373$24072337$3$F$20240627$20240812$20240710$20240820$EXP$$IL-TAKEDA-2024TUS065987$TAKEDA$$7$YR$$M$Y$$$20240820$$CN$IL$IL
240723381$24072338$1$I$$20240705$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063784$SANDOZ$$$$$M$Y$$$20240710$$CN$US$US
240723392$24072339$2$F$20240702$20240729$20240710$20240807$EXP$$US-LEO Pharma-371746$LEO PHARM$$84$YR$$F$Y$$$20240807$$CN$US$US
240723401$24072340$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06310$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240723411$24072341$1$I$20240708$20240708$20240710$20240710$EXP$$JP-009507513-2407JPN001076J$MERCK$$67$YR$$F$Y$$$20240710$$PH$JP$JP
240723421$24072342$1$I$$20240625$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101989$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240710$$HP$US$US
240723432$24072343$2$F$$20240731$20240710$20240805$EXP$$AU-TAKEDA-2024TUS068225$TAKEDA$$$$$$Y$$$20240805$$CN$AU$AU
240723441$24072344$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135302$AMGEN$$69$YR$E$F$Y$$$20240710$$CN$US$US
240723451$24072345$1$I$20230101$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135494$AMGEN$$52$YR$A$$Y$$$20240710$$CN$US$US
240723464$24072346$4$F$20240101$20240823$20240710$20240830$EXP$$CA-CELLTRION INC.-2024CA005869$CELLTRION$$$$$$Y$$$20240830$$MD$CA$CA
240723471$24072347$1$I$$20240702$20240710$20240710$EXP$$US-LUOXIN-LUX-2024-US-LIT-00036$LUOXIN AUROVITAS PHARMA(CHENGDU)$Bjork ST, Chen E..Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series..Am-J-Respir-Crit-Care-Med.2024;209:A7429$74$YR$E$F$Y$$$20240710$$HP$US$US
240723482$24072348$2$F$20240629$20240711$20240710$20240723$EXP$$CA-CELLTRION INC.-2024CA016345$CELLTRION$$$$$$Y$$$20240724$$PH$CA$CA
240723491$24072349$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06355$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240723503$24072350$3$F$$20240812$20240710$20240812$PER$$US-ALXN-202407USA000292US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
240723512$24072351$2$F$$20240708$20240710$20240711$PER$$US-JNJFOC-20240718223$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240723521$24072352$1$I$20240628$20240704$20240710$20240710$EXP$$AU-TAKEDA-2024TUS069132$TAKEDA$$33$YR$$F$Y$$$20240710$$CN$AU$AU
240723531$24072353$1$I$$20240708$20240710$20240710$PER$$US-ABBVIE-5832464$ABBVIE$$$$$$Y$$$20240710$$CN$US$US
240723543$24072354$3$F$$20240719$20240710$20240729$30DAY$$US-GSK-US2024083903$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
240723551$24072355$1$I$20240627$20240701$20240710$20240710$EXP$$CN-JNJFOC-20240704091$JOHNSON AND JOHNSON$$16$YR$T$M$Y$70$KG$20240710$$HP$CN$CN
240723561$24072356$1$I$$20240708$20240710$20240710$PER$$US-JNJFOC-20240719602$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240723571$24072357$1$I$20240101$20240703$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107005$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$63.05$KG$20240710$$PH$US$US
240723581$24072358$1$I$$20240702$20240710$20240710$EXP$$US-LUOXIN-LUX-2024-US-LIT-00029$LUOXIN AUROVITAS PHARMA(CHENGDU)$Fomeche J, Nor M, Wang Y, Carro M, Homayounrooz F, Hastrup F..Ketamine Chronicles: A Breath of Fresh Air in Status Asthmaticus..Am-J-Respir-Crit-Care-Med.2024;NA:NA$64$YR$A$M$Y$$$20240710$$HP$US$US
240723591$24072359$1$I$20240610$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024135889$AMGEN$$67$YR$E$F$Y$$$20240710$$PH$US$US
240723601$24072360$1$I$20240624$20240703$20240710$20240710$EXP$GB-MHRA-MED-202407021402321670-WCMBF$GB-TEVA-VS-3216841$TEVA$$13$YR$$M$Y$42$KG$20240710$$HP$GB$GB
240723611$24072361$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06276$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240723621$24072362$1$I$$20240703$20240710$20240710$EXP$GB-MHRA-MED-202406281042408830-QRLPK$GB-AMAROX PHARMA-AMR2024GB02098$HETERO$$$$$$Y$$$20240710$$CN$GB$GB
240723631$24072363$1$I$20210317$20240705$20240710$20240710$EXP$FR-AFSSAPS-MA2024001144$FR-SA-2024SA199069$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240710$$PH$FR$FR
240723641$24072364$1$I$20240601$20240708$20240710$20240710$EXP$$US-AMGEN-USASP2024134795$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240723651$24072365$1$I$$20240708$20240710$20240710$EXP$$US-AMGEN-USASP2024134964$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240723661$24072366$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108651$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240710$$CN$US$US
240723671$24072367$1$I$20240516$20240702$20240710$20240710$EXP$$GB-MALLINCKRODT-MNK202404408$MALLINCKRODT$$$$$M$Y$$$20240710$$HP$GB$GB
240723681$24072368$1$I$$20240705$20240710$20240710$EXP$$US-AMGEN-USASP2024134261$AMGEN$Afify Z. M.; Taj M. M.; Orjuela-grimm M. et al.. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders. Cancer. 2023;129 (5):780-789$$$$M$Y$$$20240710$$MD$US$US
240723691$24072369$1$I$$20240709$20240710$20240710$EXP$$US-GILEAD-2024-0680079$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240723711$24072371$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063885$SANDOZ$$65$YR$$F$Y$97$KG$20240710$$HP$CA$CA
240723721$24072372$1$I$20240707$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024134851$AMGEN$$78$YR$E$M$Y$$$20240710$$CN$US$US
240723731$24072373$1$I$$20240705$20240710$20240710$EXP$$US-AMGEN-USASP2024134268$AMGEN$Afify Z. M.; Taj M. M.; Orjuela-grimm M. et al.. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders. Cancer. 2023;129 (5):780-789$$$$M$Y$$$20240710$$MD$US$US
240723741$24072374$1$I$20240602$20240701$20240710$20240710$EXP$ES-AEMPS-1536359$ES-TEVA-VS-3216150$TEVA$$6$YR$$F$Y$23$KG$20240710$$MD$ES$ES
240723752$24072375$2$F$$20240814$20240710$20240822$30DAY$$US-JNJFOC-20240717698$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$PH$US$US
240723761$24072376$1$I$$20240626$20240710$20240710$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109193$ZYDUS PHARM$Benandi K, Sieving D, Wolf K.. A rare case of meloxicam-induced pseudoporphyria.. 2024;30(2):1-3$$$$$Y$$$20240710$$HP$US$US
240723771$24072377$1$I$$20240708$20240710$20240710$PER$$US-ALXN-202407USA000455US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240723781$24072378$1$I$$20240628$20240710$20240710$EXP$$US-AstraZeneca-2024A150112$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240723791$24072379$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A152288$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240723805$24072380$5$F$$20240828$20240710$20240902$PER$$US-ALXN-202407USA000229US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
240723811$24072381$1$I$$20240626$20240710$20240710$EXP$$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-06028$HIKMA$Gan YL, Bashir A, Sunni N.. Gan YL, Bashir A, Sunni N. The diversity of cardiac manifestations in rheumatological disorders: highlights on immunosuppression and cardiac complications. Heart. 2024;110(Supp3)A33-4$30$YR$$F$Y$$$20240710$$HP$GB$GB
240723821$24072382$1$I$20240219$20240708$20240710$20240710$EXP$IT-MINISAL02-993684$NVSC2024IT140498$NOVARTIS$$86$YR$$M$Y$75$KG$20240710$$MD$IT$IT
240723831$24072383$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05709$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240723841$24072384$1$I$20240613$20240702$20240710$20240710$EXP$GB-MHRA-MED-202407021025478080-SCGZW$GB-TEVA-VS-3216638$TEVA$$74$YR$$M$Y$77$KG$20240710$$CN$GB$GB
240723851$24072385$1$I$20211001$20240701$20240710$20240710$EXP$$US-BAUSCHBL-2024BNL029452$BAUSCH AND LOMB$Chaleff A, Gang A, Relich R, Lavik J. Utilizing confocal microscopy and topical natamycin in metarhizium keratitis of Caribbean origin. Diagnostic Microbiology + Infectious Disease. 2024 MAY 29;110 (2024):1-4. doi:10.1016/j.diagmicrobio.2024.116369$32$YR$$M$Y$$$20240710$$HP$US$US
240723872$24072387$2$F$20240601$20240815$20240710$20240820$PER$$US-JNJFOC-20240703639$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240820$$CN$US$US
240723881$24072388$1$I$$20240624$20240710$20240710$EXP$$PL-CHATTEMPRD-2023SA195448$CHATTEM$$$$$F$Y$$$20240710$$HP$PL$PL
240723891$24072389$1$I$$20240705$20240710$20240710$EXP$$US-AMGEN-USASP2024134271$AMGEN$Afify Z. M.; Taj. M. M.; Orjuela-grimm M. et. al.. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders. Cancer. 2023;129 (5):780-789$$$$$Y$$$20240710$$MD$US$US
240723901$24072390$1$I$$20240705$20240710$20240710$EXP$$US-AMGEN-USASP2024134274$AMGEN$Afify Z. M.; Taj. M. M.; Orjuela-grimm M. et. al.. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders. Cancer. 2023;129 (5):780-789$$$$$Y$$$20240710$$MD$US$US
240723912$24072391$2$F$$20240719$20240710$20240729$EXP$$IL-TEVA-VS-3217206$TEVA$Rahamimov R, Telem S, Davidovichi B, Bielopolski D, Steinmetz T, Nesher E, et al. The association between hydrochlorothiazide use and non-melanoma skin cancer in kidney transplant recipients. Clin-Kidney-J 2024; 17 (5):.; Rahamimov R, Telem S, Davidovichi B, Bielopolski D, Steinmetz T, Nesher E, et al. The association between hydrochlorothiazide use and non-melanoma skin cancer in kidney transplant recipients. Clin-Kidney-J 2024; 17 (5):.$$$A$$Y$$$20240729$$HP$IL$IL
240723921$24072392$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108978$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240710$$CN$US$US
240723931$24072393$1$I$20240510$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405131136421290-FRDBS$GB-BEH-2024175009$CSL BEHRING$$83$YR$E$F$Y$$$20240710$$HP$GB$GB
240723941$24072394$1$I$$20240625$20240710$20240710$EXP$$US-ENDO USA, INC.-2024-002824$ENDO$$$$$M$Y$$$20240710$$CN$US$US
240723951$24072395$1$I$$20240702$20240710$20240710$EXP$$US-LUOXIN-LUX-2024-US-LIT-00032$LUOXIN AUROVITAS PHARMA(CHENGDU)$Lodh A, Blankenship S, Minish-Pron J, Lalani I..Treatment of Acute Respiratory Failure Secondary to Chronic Graft-Versus-Host Disease With Fluticasone, Azithromycin, Montelukast, and High-Dose Glucocorticoids..Am-J-Respir-Crit-Care-Med.2024;209:A5898.$38$YR$A$M$Y$$$20240710$$HP$US$US
240723962$24072396$2$F$$20240710$20240710$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05796$LUPIN$$$$$$Y$$$20240805$$CN$US$US
240723971$24072397$1$I$20240101$20240628$20240710$20240710$EXP$$US-BAUSCHBL-2024BNL029456$BAUSCH AND LOMB$$78$YR$$M$Y$$$20240710$$CN$US$US
240723981$24072398$1$I$$20240709$20240710$20240710$EXP$$US-TAKEDA-2024TUS064853$TAKEDA$$$$$M$Y$$$20240710$$CN$US$US
240723991$24072399$1$I$$20240709$20240710$20240710$EXP$$NVSC2024US141833$NOVARTIS$$$$$$Y$$$20240710$$HP$US$US
240724001$24072400$1$I$$20240702$20240710$20240710$EXP$$US-LUOXIN-LUX-2024-US-LIT-00031$LUOXIN AUROVITAS PHARMA(CHENGDU)$Torelli VA, Ernest Jean R, Tran E.Rapidly Progressive Interstitial Lung Disease Due to Silicosis in an Otherwise Healthy Jeweler..Am-J-Respir-Crit-Care-Med.2024;209:A5985$83$YR$E$F$Y$$$20240710$$HP$US$US
240724013$24072401$3$F$20240604$20240717$20240710$20240725$30DAY$$US-AMGEN-USASL2024133469$AMGEN$$61$YR$A$M$Y$86.984$KG$20240725$$PH$US$US
240724022$24072402$2$F$$20240805$20240710$20240809$30DAY$$US-JNJFOC-20240716472$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$HP$US$US
240724031$24072403$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05869$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240724041$24072404$1$I$20060101$20240705$20240710$20240710$EXP$$US-ABBVIE-5825282$ABBVIE$$$$$M$Y$93$KG$20240710$$CN$US$US
240724051$24072405$1$I$20240626$20240628$20240710$20240710$PER$$US-AstraZeneca-2024A150658$ASTRAZENECA$$31498$DY$$F$Y$$$20240710$$CN$US$
240724061$24072406$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A152251$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240724091$24072409$1$I$20240101$20240708$20240710$20240710$EXP$$IL-ABBVIE-5831918$ABBVIE$$49$YR$$M$Y$$$20240710$$CN$IL$IL
240724101$24072410$1$I$$20240708$20240710$20240710$EXP$GB-MHRA-MED-202406281421496220-GBHVJ$GB-ORGANON-O2407GBR000042$ORGANON$$$$$$Y$$$20240710$$CN$GB$GB
240724111$24072411$1$I$$20240704$20240710$20240710$EXP$$BR-TAKEDA-2023TUS103265$TAKEDA$$$$$F$Y$$$20240710$$CN$BR$BR
240724122$24072412$2$F$20231226$20240925$20240710$20240927$EXP$$DE-TAKEDA-2024TUS069858$TAKEDA$$4$YR$$M$Y$$$20240927$$HP$DE$DE
240724131$24072413$1$I$$20240703$20240710$20240710$EXP$GB-MHRA-MED-202406281438310700-KPJBZ$GB-AMAROX PHARMA-AMR2024GB02102$HETERO$$$$$$Y$$$20240710$$CN$GB$GB
240724141$24072414$1$I$20200101$20240628$20240710$20240710$EXP$$CN-BAUSCHBL-2024BNL029555$BAUSCH AND LOMB$Xiang X, Lin W, Guan X, Zhou B, Yuan Y, Silva D, Wang Y. Corneal ulcer development due to sintilimab-anlotinib combination therapy-induced dry eye: a case report. Translational Cancer Research. 2024 APR 19;13(5):2571-2579. doi:10.21037/tcr-23-1952$65$YR$$F$Y$$$20240710$$HP$CN$CN
240724152$24072415$2$F$$20240710$20240710$20240715$PER$$US-JNJFOC-20240721424$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240724161$24072416$1$I$$20240706$20240710$20240710$PER$$US-JNJFOC-20240717697$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$HP$US$US
240724171$24072417$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05856$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240724181$24072418$1$I$$20240627$20240710$20240710$EXP$$IN-MACLEODS PHARMA-MAC2024048047$MACLEODS$The Unusual Adverse Effects of Antituberculosis Therapy in Kidney Patients.Int J Mycobacteriol$$$$$Y$$$20240710$$HP$IN$IN
240724193$24072419$3$F$$20240808$20240710$20240819$EXP$$GB-UCBSA-2024034547$UCB$$$$$F$Y$$$20240819$$PH$GB$GB
240724201$24072420$1$I$$20240627$20240710$20240710$EXP$$IN-MACLEODS PHARMA-MAC2024048051$MACLEODS$Behera MR, Kaul A, Agarwal V, Prasad P, Prasad N, Bhadauria DS, Patel MR, Sharma H..The Unusual Adverse Effects of Antituberculosis Therapy in Kidney Patients..The International Journal of Mycobacteriolog.01-APR-2024;13(2):183-90$$$$$Y$$$20240710$$HP$IN$IN
240724211$24072421$1$I$$20240705$20240710$20240710$EXP$$JP-ASTELLAS-2024JP004767$ASTELLAS$$67$YR$$M$Y$$$20240710$$MD$JP$JP
240724221$24072422$1$I$$20240626$20240710$20240710$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109141$ZYDUS PHARM$Tajfiroozeh D, Silva R, Otsuka KN, Wai A.. A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240710$$HP$US$US
240724231$24072423$1$I$20240520$20240702$20240710$20240710$EXP$$RU-TAKEDA-2024TUS068556$TAKEDA$$69$YR$$F$Y$62$KG$20240710$$HP$RU$RU
240724243$24072424$3$F$$20240710$20240710$20240715$PER$$NVSC2024US142282$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240724251$24072425$1$I$$20240705$20240710$20240710$EXP$$JP-ASTELLAS-2024JP004768$ASTELLAS$$36$YR$$F$Y$$$20240710$$PH$JP$JP
240724261$24072426$1$I$20240701$20240703$20240710$20240710$EXP$GB-MHRA-MED-202407031414194540-ZBJMR$GB-TEVA-VS-3216888$TEVA$$44$YR$$F$Y$54$KG$20240710$$PH$GB$GB
240724271$24072427$1$I$20240619$20240708$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108772$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240710$$CN$US$US
240724284$24072428$4$F$20240702$20240824$20240710$20240830$EXP$$CO-AMGEN-COLSL2024133092$AMGEN$$60$YR$A$F$Y$$$20240830$$CN$CO$CO
240724291$24072429$1$I$$20240626$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103190$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240710$$CN$US$US
240724301$24072430$1$I$$20240703$20240710$20240710$PER$$US-RDY-SPO/USA/24/0009938$DR REDDYS$$17$YR$T$F$Y$$$20240710$$MD$US$US
240724311$24072431$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133498$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31 (6):3529-3545$75$YR$E$F$Y$$$20240710$$HP$US$US
240724321$24072432$1$I$$20240703$20240710$20240710$PER$$US-AMGEN-USASP2024132515$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240724332$24072433$2$F$$20240710$20240710$20240712$EXP$$RO-ABBVIE-5833530$ABBVIE$Mustea TI, Morar MM, Muntean AM, Nistor S, Vasile Pop A. CHALLENGES IN MANAGING EARLY-ONSET CROHN^S DISEASE. Acta Medica Marisiensis, 2024;70(Suppl.3):188-189.; Mustea TI, Morar MM, Muntean AM, Nistor S, Vasile Pop A. CHALLENGES IN MANAGING EARLY-ONSET CROHN^S DISEASE. Acta Medica Marisiensis, 2024;70(Suppl.3):188-189.$41$YR$$M$Y$$$20240712$$MD$RO$RO
240724341$24072434$1$I$20240328$20240709$20240710$20240710$EXP$GB-MHRA-MED-202405031231580390-VSKJW$GB-UCBSA-2024034796$UCB$$37$YR$$M$Y$$$20240710$$PH$GB$GB
240724351$24072435$1$I$20240530$20240701$20240710$20240710$EXP$FR-AFSSAPS-LL2024001165$FR-TEVA-VS-3216149$TEVA$$47$YR$$F$Y$$$20240710$$MD$FR$FR
240724361$24072436$1$I$20230327$20240621$20240709$20240709$DIR$FDA-CDER-CTU-2024-47654$$FDA-CTU$$81$YR$$M$N$72.57$KG$20240621$N$CN$US$
240724371$24072437$1$I$$20240705$20240710$20240710$EXP$$CA-TEVA-VS-3207058$TEVA$$55$YR$$F$Y$$$20240710$$CN$CA$CA
240724391$24072439$1$I$20240618$20240709$20240709$20240709$DIR$709578$$FDA-CTU$$67$YR$$M$N$87.5$KG$20240709$N$HP$US$
240724401$24072440$1$I$$20240626$20240710$20240710$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05901$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240724411$24072441$1$I$$20240617$20240710$20240710$PER$$US-JNJFOC-20240652949$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240724422$24072442$2$F$$20240826$20240710$20240903$EXP$$US-AMGEN-USASP2024133264$AMGEN$$$$$F$Y$$$20240903$$LW$US$US
240724431$24072443$1$I$20240619$20240629$20240710$20240710$EXP$$CN-TAKEDA-2024TUS069462$TAKEDA$$68$YR$$M$Y$52$KG$20240710$$HP$CN$CN
240724442$24072444$2$F$20240203$20240904$20240710$20240912$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-02843$IPSEN$$70$YR$E$F$Y$95$KG$20240912$$CN$US$US
240724451$24072445$1$I$20231016$20240701$20240710$20240710$EXP$GB-MHRA-MED-202407011810395080-DZGKC$GB-TEVA-VS-3216259$TEVA$$47$YR$$F$Y$118$KG$20240710$$CN$GB$GB
240724461$24072446$1$I$20230307$20240703$20240710$20240710$EXP$$FR-TAKEDA-2024TUS069418$TAKEDA$$$$$$Y$$$20240710$$CN$FR$FR
240724471$24072447$1$I$$20240708$20240710$20240710$EXP$$CA-TAKEDA-2024TUS069922$TAKEDA$$$$$F$Y$$$20240710$$MD$CA$CA
240724481$24072448$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005157$ELI LILLY AND CO$$$$$M$Y$$$20240710$$CN$US$US
240724492$24072449$2$F$$20240712$20240710$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407006158$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240715$$CN$US$US
240724502$24072450$2$F$20240508$20240808$20240710$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202407005374$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240812$$CN$US$US
240724511$24072451$1$I$20231101$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004976$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240710$$CN$US$US
240724521$24072452$1$I$20240325$20240701$20240710$20240710$EXP$$GB-TEVA-VS-3216486$TEVA$$78$YR$$M$Y$85$KG$20240710$$MD$GB$GB
240724531$24072453$1$I$20240709$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005966$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240710$$CN$US$US
240724541$24072454$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109236$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240710$$CN$US$US
240724551$24072455$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109012$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$74.39$KG$20240710$$CN$US$US
240724561$24072456$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109200$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$102.06$KG$20240710$$CN$US$US
240724571$24072457$1$I$20240616$20240702$20240710$20240710$EXP$$CN-ALXN-202407CHN000098CN$ALEXION PHARMACEUTICALS$$60$YR$$F$Y$58$KG$20240710$$HP$CN$CN
240724581$24072458$1$I$$20240627$20240710$20240710$EXP$$US-MYLANLABS-2024M1061946$MYLAN$Razia D, Moin A, Arjuna A, Evans S. Vasculopathy and demyelinating complications of varicella in an immunocompromised patient. Crit-Care-Med 2024; 52 (Suppl.) (1): S228 abstr. 508.$42$YR$$F$Y$$$20240710$$HP$US$US
240724593$24072459$3$F$$20240920$20240710$20240920$PER$$NVSC2024US142466$NOVARTIS$$$$$F$Y$$$20240920$$MD$US$US
240724601$24072460$1$I$$20240702$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008150$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510.$$$$$Y$$$20240710$$HP$US$US
240724611$24072461$1$I$20231108$20240703$20240710$20240710$EXP$$CA-GSK-CA2023131695$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$HP$CA$CA
240724622$24072462$2$F$$20240709$20240710$20240712$PER$$US-JNJFOC-20240722084$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240724641$24072464$1$I$$20240628$20240710$20240710$PER$$US-TEVA-VS-3217787$TEVA$$$$$F$Y$$$20240710$$CN$US$US
240724651$24072465$1$I$20240601$20240702$20240710$20240710$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00710$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240724662$24072466$2$F$$20240715$20240710$20240722$PER$$US-LEO Pharma-371820$LEO PHARM$$41$YR$$F$Y$$$20240722$$PH$US$US
240724671$24072467$1$I$20240521$20240708$20240710$20240710$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038712$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240710$$HP$CO$CO
240724681$24072468$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A152195$ASTRAZENECA$$$$$F$Y$72.1$KG$20240710$$MD$US$
240724691$24072469$1$I$20240603$20240702$20240710$20240710$EXP$$ZA-AstraZeneca-2024A153329$ASTRAZENECA$$16436$DY$$M$Y$$$20240710$$CN$ZA$
240724701$24072470$1$I$$20240702$20240710$20240710$EXP$$ZA-AstraZeneca-2024A152249$ASTRAZENECA$$79$YR$$F$Y$$$20240710$$CN$ZA$
240724711$24072471$1$I$$20240709$20240710$20240710$PER$$US-TAKEDA-2024TUS069931$TAKEDA$$$$$F$Y$61$KG$20240710$$MD$US$US
240724721$24072472$1$I$20240304$20240701$20240710$20240710$EXP$FR-AFSSAPS-CN2024000594$FR-TEVA-VS-3216219$TEVA$$65$YR$$F$Y$56$KG$20240710$$MD$FR$FR
240724741$24072474$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133523$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31(6):3529-3545$85$YR$E$F$Y$$$20240710$$HP$US$US
240724752$24072475$2$F$20240625$20240816$20240710$20240821$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038713$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240821$$HP$CO$CO
240724763$24072476$3$F$20240521$20240918$20240710$20240925$EXP$$JP-AMGEN-JPNSP2024133689$AMGEN$$49$YR$A$M$Y$$$20240925$$MD$JP$JP
240724771$24072477$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133543$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of 1pilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31(6):3529-3545$62$YR$A$F$Y$$$20240710$$HP$US$US
240724781$24072478$1$I$20240301$20240703$20240710$20240710$EXP$$US-GSK-US2024083236$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$US$US
240724792$24072479$2$F$$20240814$20240710$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06428$LUPIN$$$$$$Y$$$20240901$$CN$US$US
240724801$24072480$1$I$20240401$20240626$20240710$20240710$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2024-05692$LUPIN$$$$$$Y$$$20240710$$MD$DE$DE
240724811$24072481$1$I$$20240703$20240710$20240710$EXP$GB-MHRA-MED-202406281336531360-CFMRD$GB-AMAROX PHARMA-AMR2024GB02107$HETERO$$$$$F$Y$$$20240710$$CN$GB$GB
240724823$24072482$3$F$$20240723$20240710$20240726$PER$$NVSC2024US142510$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
240724834$24072483$4$F$$20240816$20240710$20240818$PER$$US-JNJFOC-20240708773$JOHNSON AND JOHNSON$$$$$F$Y$$$20240818$$CN$US$US
240724841$24072484$1$I$$20240701$20240710$20240710$EXP$$US-MYLANLABS-2024M1063143$MYLAN$Celli S, Nash R, McMenamin C, Garza M, Von Geldern G, Georges G, et al. Successful Autologous Hematopoietic Stem Cell Transplant in a Case of Stiff Person Spectrum Disorder with a positive Glycine Receptor antibody. Neurology 2023; 100 (17):.$59$YR$$M$Y$$$20240710$$HP$US$US
240724851$24072485$1$I$20230510$20240412$20240710$20240710$EXP$$US-MYLANLABS-2024M1062837$MYLAN$$74$YR$$M$Y$86.18$KG$20240710$$CN$US$US
240724861$24072486$1$I$$20240701$20240710$20240710$EXP$$IT-MYLANLABS-2024M1062902$MYLAN$Fabozzi F, Palumbo G, Di Pastena M, Zangari P, Bernardi S. Prolonged neutropenia in patients with lymphoma treated with antiretroviral therapy: Raltegravir too? A single-case report. Pediatr-Blood-Cancer 2023; 70 (4).$6$YR$$F$Y$$$20240710$$HP$IT$IT
240724871$24072487$1$I$20240701$20240708$20240710$20240710$EXP$$US-ABBVIE-5832637$ABBVIE$$69$YR$$M$Y$$$20240710$$CN$US$US
240724883$24072488$3$F$20240101$20240722$20240710$20240726$PER$$US-AMGEN-USASP2024133164$AMGEN$$72$YR$E$F$Y$$$20240726$$CN$US$US
240724892$24072489$2$F$20240624$20240715$20240710$20240717$PER$$US-AMGEN-USASP2024134932$AMGEN$$58$YR$A$F$Y$$$20240716$$CN$US$US
240724902$24072490$2$F$20240624$20240711$20240710$20240720$EXP$$BR-CELLTRION INC.-2024BR016286$CELLTRION$$$$$$Y$$$20240720$$CN$BR$BR
240724921$24072492$1$I$$20240703$20240710$20240710$EXP$$GB-TEVA-VS-3216816$TEVA$$71$YR$$M$Y$96$KG$20240710$$MD$GB$GB
240724931$24072493$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133610$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31 (6):3529-3545$61$YR$A$M$Y$$$20240710$$HP$US$US
240724941$24072494$1$I$20240501$20240703$20240710$20240710$EXP$$CA-GSK-CA2024064034$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$CA$CA
240724961$24072496$1$I$$20240709$20240710$20240710$PER$$US-TAKEDA-2024TUS069880$TAKEDA$$$$$$Y$$$20240710$$CN$US$US
240724971$24072497$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109121$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$66$YR$E$F$Y$$$20240710$$HP$US$US
240724981$24072498$1$I$$20240703$20240710$20240710$PER$$US-009507513-2407USA001969$MERCK$Tarabay J, Rodriguez ED, Gates G. Pembrolizumab-Induced Lichen Planus Pemphigoides in a Patient With Metastatic Renal Cell Carcinoma. American Journal of Dermatopathology. 2024;46(7):S28$62$YR$$F$Y$$$20240710$$HP$US$US
240724992$24072499$2$F$20231130$20240911$20240710$20240920$EXP$$US-AMGEN-USASP2024132223$AMGEN$$$$E$M$Y$$$20240920$$CN$US$US
240725001$24072500$1$I$$20240708$20240710$20240710$EXP$$NVSC2024CA088143$NOVARTIS$$58$YR$$F$Y$61$KG$20240710$$CN$CA$CA
240725011$24072501$1$I$20240704$20240708$20240710$20240710$EXP$$IT-GILEAD-2024-0679627$GILEAD$$60$YR$A$F$Y$$$20240710$$MD$IT$IT
240725022$24072502$2$F$20240624$20240709$20240710$20240715$EXP$$CA-TAKEDA-2024TUS067476$TAKEDA$$57$YR$$F$Y$$$20240715$$CN$CA$CA
240725031$24072503$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186201$Haleon PLC$$54$YR$$M$Y$$$20240710$$CN$US$US
240725041$24072504$1$I$$20240626$20240710$20240710$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109147$ZYDUS PHARM$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al.. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease.. Rheumatology. 2024;63(5):1291-1296$$$$$Y$$$20240710$$HP$US$US
240725051$24072505$1$I$20240422$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405031303370180-SCPBV$GB-862174955-ML2024-03804$Unknown Manufacturer$$72$YR$E$F$Y$78$KG$20240710$$PH$GB$GB
240725062$24072506$2$F$$20240725$20240710$20240802$EXP$$GB-862174955-ML2024-03735$MICRO LABS$$15$YR$T$F$Y$$$20240802$$HP$GB$GB
240725071$24072507$1$I$20240401$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405021346199740-TWCQK$GB-862174955-ML2024-03787$Unknown Manufacturer$$$$$M$Y$100$KG$20240710$$CN$GB$GB
240725081$24072508$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405060721540350-JFMKW$GB-862174955-ML2024-03813$Unknown Manufacturer$$$$$M$Y$82$KG$20240710$$CN$GB$GB
240725092$24072509$2$F$$20240716$20240710$20240726$EXP$GB-MHRA-MED-202405101401069270-STKMW$GB-862174955-ML2024-03809$Unknown Manufacturer$$$$T$$Y$$$20240726$$MD$GB$GB
240725101$24072510$1$I$$20240709$20240709$20240709$DIR$709663$$FDA-CTU$$47$YR$$F$N$71.1$KG$20240709$N$CN$US$
240725121$24072512$1$I$20230710$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405031246208040-FRJDH$GB-862174955-ML2024-03800$Unknown Manufacturer$$67$YR$E$M$Y$83$KG$20240710$$CN$GB$GB
240725131$24072513$1$I$$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405011630278270-FQSZT$GB-862174955-ML2024-03794$Unknown Manufacturer$$$$$F$Y$$$20240710$$HP$GB$GB
240725141$24072514$1$I$$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405021803196890-NFPBC$GB-862174955-ML2024-03790$Unknown Manufacturer$$$$$$Y$44$KG$20240710$$CN$GB$GB
240725151$24072515$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05873$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240725171$24072517$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405101423535400-WTCJS$GB-SANDOZ INC.-SDZ2024GB063798$SANDOZ$$$$$$Y$$$20240710$$HP$GB$GB
240725181$24072518$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186249$Haleon PLC$$$$$M$Y$$$20240710$$CN$US$US
240725191$24072519$1$I$20240703$20240708$20240710$20240710$EXP$$GB-MYLANLABS-2024M1064467$MYLAN$$68$YR$$M$Y$$$20240710$$HP$GB$GB
240725201$24072520$1$I$$20240709$20240709$20240709$DIR$709642$$FDA-CTU$$$$$UNK$N$$$20240709$$CN$US$
240725211$24072521$1$I$20240708$20240709$20240709$20240709$DIR$709606$$FDA-CTU$$34$YR$$M$N$$$20240709$N$$US$
240725221$24072522$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405171305488340-NRGVL$GB-MYLANLABS-2024M1064004$MYLAN$$$$$F$Y$75$KG$20240710$$CN$GB$GB
240725231$24072523$1$I$$20240710$20240710$20240710$EXP$$AU-MYLANLABS-2024M1064476$MYLAN$$$$$F$Y$$$20240710$$HP$AU$AU
240725241$24072524$1$I$20240301$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405091258118410-JLBWZ$GB-MYLANLABS-2024M1064062$MYLAN$$$$$F$Y$57$KG$20240710$$CN$GB$GB
240725252$24072525$2$F$20240705$20240709$20240710$20240712$EXP$$NZ-MYLANLABS-2024M1064120$MYLAN$$41$YR$$F$Y$$$20240712$$HP$NZ$NZ
240725261$24072526$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A152258$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240725271$24072527$1$I$20210330$20240705$20240710$20240710$EXP$$CO-UCBSA-2024034806$UCB$$62$YR$$M$Y$$$20240710$$CN$CO$CO
240725281$24072528$1$I$$20240708$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063836$SANDOZ$$89$YR$$F$Y$52$KG$20240710$$PH$CA$CA
240725291$24072529$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A152763$ASTRAZENECA$$$$$F$Y$$$20240710$$HP$US$
240725301$24072530$1$I$20240430$20240702$20240710$20240710$EXP$$CO-AstraZeneca-2024A154466$ASTRAZENECA$$29581$DY$$M$Y$82$KG$20240710$$CN$CO$
240725311$24072531$1$I$20240601$20240702$20240710$20240710$EXP$$AT-AstraZeneca-2024A155055$ASTRAZENECA$$$$$F$Y$$$20240710$$MD$AT$
240725321$24072532$1$I$20201204$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157227$ASTRAZENECA$$60$YR$$M$Y$42.5$KG$20240710$$HP$FR$
240725331$24072533$1$I$20240303$20240709$20240709$20240709$DIR$709652$$FDA-CTU$$65$YR$$M$N$93.15$KG$20240709$N$CN$US$
240725341$24072534$1$I$20240621$20240702$20240710$20240710$EXP$$MX-JNJFOC-20240716919$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240710$$HP$MX$MX
240725351$24072535$1$I$19970501$20240701$20240710$20240710$PER$$US-JNJFOC-20240708965$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240710$$HP$US$US
240725363$24072536$3$F$$20240730$20240710$20240805$EXP$$US-JNJFOC-20240705639$JOHNSON AND JOHNSON$$$$$M$Y$$$20240804$$PH$US$US
240725371$24072537$1$I$$20240709$20240710$20240710$EXP$IT-MINISAL02-994086$IT-GILEAD-2024-0680029$GILEAD$$73$YR$E$F$Y$$$20240710$$MD$IT$IT
240725385$24072538$5$F$$20240812$20240710$20240813$PER$$US-JNJFOC-20240677848$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240813$$PH$US$US
240725392$24072539$2$F$20240706$20240808$20240710$20240809$PER$$US-AMGEN-USASP2024135216$AMGEN$$67$YR$E$F$Y$$$20240809$$CN$US$US
240725401$24072540$1$I$$20240703$20240710$20240710$EXP$$GB-TEVA-VS-3216901$TEVA$$56$YR$$F$Y$85$KG$20240710$$MD$GB$GB
240725411$24072541$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186272$Haleon PLC$$89$YR$$F$Y$$$20240710$$CN$US$US
240725421$24072542$1$I$$20240625$20240710$20240710$PER$$FR-APOTEX-2024AP007850$APOTEX$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al.. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. Journal of Clinical Immunology. 2023;43 (3):647-652$4$YR$$F$Y$$$20240710$$HP$FR$US
240725431$24072543$1$I$20120101$20240705$20240710$20240710$EXP$$US-ABBVIE-5821151$ABBVIE$$39$YR$$F$Y$82$KG$20240710$$CN$US$US
240725441$24072544$1$I$20240101$20240708$20240710$20240710$EXP$$US-ABBVIE-5832552$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
240725451$24072545$1$I$20240101$20240708$20240710$20240710$EXP$$CA-ABBVIE-5833033$ABBVIE$$62$YR$$F$Y$$$20240710$$CN$CA$CA
240725461$24072546$1$I$20240101$20240704$20240710$20240710$EXP$$BG-ABBVIE-5833037$ABBVIE$$81$YR$$M$Y$$$20240710$$CN$BG$BG
240725472$24072547$2$F$$20240916$20240710$20240926$PER$$US-GSK-US2024083230$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
240725481$24072548$1$I$20240101$20240706$20240710$20240710$EXP$$CA-ABBVIE-5833042$ABBVIE$$41$YR$$F$Y$$$20240710$$CN$CA$CA
240725491$24072549$1$I$20240703$20240703$20240710$20240710$PER$$US-ABBVIE-5832387$ABBVIE$$63$YR$$F$Y$$$20240710$$CN$US$US
240725501$24072550$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06297$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240725511$24072551$1$I$$20240705$20240710$20240710$EXP$$CA-TAKEDA-2024TUS069147$TAKEDA$$$$$F$Y$$$20240710$$HP$CA$CA
240725521$24072552$1$I$20240601$20240701$20240710$20240710$EXP$$AU-TAKEDA-2024TUS069488$TAKEDA$$84$YR$$M$Y$$$20240710$$HP$AU$AU
240725531$24072553$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109119$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$63$YR$A$M$Y$$$20240710$$HP$US$US
240725543$24072554$3$F$20230101$20240805$20240710$20240808$EXP$$JP-JNJFOC-20240723061$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240808$$MD$JP$JP
240725551$24072555$1$I$20240703$20240709$20240710$20240710$PER$$US-JNJFOC-20240722535$JOHNSON AND JOHNSON$$56$YR$A$$Y$$$20240710$$CN$US$US
240725561$24072556$1$I$$20240709$20240710$20240710$PER$$US-GILEAD-2024-0680104$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240725571$24072557$1$I$20240616$20240709$20240709$20240709$DIR$709643$$FDA-CTU$$46$YR$$M$N$99.9$KG$20240709$Y$$US$
240725581$24072558$1$I$20240709$20240709$20240709$20240709$DIR$709624$$FDA-CTU$$80$YR$$M$N$$$20240709$N$HP$US$
240725592$24072559$2$F$$20240812$20240710$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06047$LUPIN$$$$$$Y$$$20240828$$CN$US$US
240725601$24072560$1$I$20240101$20240705$20240710$20240710$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-026128$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240710$$CN$FR$FR
240725611$24072561$1$I$20240630$20240710$20240710$20240710$DIR$709676$$FDA-CTU$$29$YR$$F$N$74.25$KG$20240710$N$CN$US$
240725621$24072562$1$I$20240709$20240710$20240710$20240710$DIR$709689$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240725631$24072563$1$I$$20240710$20240710$20240710$DIR$709690$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240725641$24072564$1$I$20240101$20240708$20240710$20240710$EXP$$PR-ABBVIE-5828482$ABBVIE$$$$$F$Y$$$20240710$$CN$PR$PR
240725661$24072566$1$I$$20240709$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038764$BOEHRINGER INGELHEIM$$$$$$Y$$$20240710$$CN$US$US
240725681$24072568$1$I$$20240710$20240710$20240710$DIR$709692$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240725691$24072569$1$I$$20240708$20240710$20240710$EXP$$CA-ABBVIE-5832949$ABBVIE$$$$A$F$Y$$$20240710$$CN$CA$CA
240725701$24072570$1$I$20240407$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405072028331790-PRWGT$GB-ABBVIE-5829245$ABBVIE$$38$YR$$M$Y$70$KG$20240710$$CN$GB$GB
240725711$24072571$1$I$$20240704$20240710$20240710$EXP$$FR-ABBVIE-5833036$ABBVIE$$88$YR$$F$Y$$$20240710$$HP$FR$FR
240725721$24072572$1$I$$20240708$20240710$20240710$EXP$$IT-ABBVIE-5832664$ABBVIE$$75$YR$$F$Y$$$20240710$$CN$IT$IT
240725731$24072573$1$I$20240626$20240630$20240710$20240710$EXP$$CN-TEVA-VS-3215833$TEVA$$53$YR$$M$Y$$$20240710$$CN$CN$CN
240725741$24072574$1$I$$20240708$20240710$20240710$EXP$$US-ABBVIE-5832682$ABBVIE$$$$$M$Y$$$20240710$$HP$US$US
240725751$24072575$1$I$20240101$20240708$20240710$20240710$EXP$$RO-ABBVIE-5832687$ABBVIE$$62$YR$$M$Y$$$20240710$$CN$RO$RO
240725762$24072576$2$F$20231122$20240731$20240710$20240806$EXP$$CA-TAKEDA-2024TUS068146$TAKEDA$$38$YR$$F$Y$$$20240806$$MD$CA$CA
240725771$24072577$1$I$$20240705$20240710$20240710$EXP$$CA-TAKEDA-2024TUS069539$TAKEDA$$$$$F$Y$$$20240710$$MD$CA$CA
240725781$24072578$1$I$$20240605$20240710$20240710$EXP$$US-BAYER-2024A085963$BAYER$Zimmer Z; Hill R; Fratto V; Lutgendorf MA. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:e250664$$$N$$Y$$$20240710$$MD$US$US
240725801$24072580$1$I$$20240625$20240710$20240710$EXP$$US-MYLANLABS-2024M1060984$MYLAN$Jones AC, Tillman F3rd, Kahlon C, Seys R, Pepin M. Characterizing acute and postsurgical pain management in patients receiving buprenorphine or buprenorphine/naloxone. J-Am-Pharm-Assoc 2024; 64 (3).$$$A$$Y$$$20240710$$PH$US$US
240725811$24072581$1$I$20240101$20240701$20240710$20240710$EXP$DK-DKMA-30731630$DK-TEVA-VS-3216185$TEVA$$85$YR$$M$Y$64$KG$20240710$$MD$DK$DK
240725821$24072582$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135646$AMGEN$$$$A$M$Y$$$20240710$$HP$US$US
240725831$24072583$1$I$$20240702$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008081$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$19$YR$$F$Y$$$20240710$$HP$US$US
240725841$24072584$1$I$$20240702$20240710$20240710$EXP$$US-CHATTEMPRD-2024OHG023007$CHATTEM$$$$$M$Y$$$20240710$$LW$US$US
240725852$24072585$2$F$20240101$20240711$20240710$20240715$30DAY$$US-SANDOZ INC.-SDZ2024US064005$SANDOZ$$$$$$Y$$$20240715$$CN$US$US
240725861$24072586$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06000$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240725871$24072587$1$I$20240101$20240701$20240710$20240710$EXP$$US-Amarin Pharma, Inc-2024AMR000330$AMARIN$$58$YR$A$M$Y$$$20240710$$CN$US$US
240725882$24072588$2$F$20231201$20240812$20240710$20240823$EXP$$CH-BEH-2024175274$CSL BEHRING$$$$$F$Y$$$20240823$$MD$CH$CH
240725891$24072589$1$I$$20240625$20240710$20240710$PER$$US-APOTEX-2024AP007890$APOTEX$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316:279:1-5$49$YR$$F$Y$$$20240710$$HP$US$US
240725901$24072590$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133720$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31 (6):3529-3545$64$YR$A$M$Y$$$20240710$$HP$US$US
240725911$24072591$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186197$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240725921$24072592$1$I$$20240701$20240710$20240710$EXP$$CN-MSNLABS-2024MSNLIT01503$MSN LABORATORIES$$$$$$Y$$$20240710$$HP$CN$CN
240725931$24072593$1$I$$20240628$20240710$20240710$PER$$US-AstraZeneca-2024A151457$ASTRAZENECA$$$$$$Y$$$20240710$$MD$US$
240725941$24072594$1$I$$20240702$20240710$20240710$EXP$$DE-AstraZeneca-2024A152305$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$DE$
240725951$24072595$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05875$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240725962$24072596$2$F$20240705$20240710$20240710$20240712$PER$$US-AMGEN-USASP2024135963$AMGEN$$80$YR$E$M$Y$$$20240712$$CN$US$US
240725971$24072597$1$I$$20240702$20240710$20240710$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008091$STRIDES$Sallee L, Souchet L, Boutolleau D, Nguyen S.. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports.. Int-J-Antimicrob-Agents. 2024;63 (6):1-2.$54$YR$$F$Y$$$20240710$$HP$FR$FR
240725982$24072598$2$F$20240702$20240903$20240710$20240904$PER$$US-AMGEN-USASP2024135404$AMGEN$$73$YR$E$F$Y$$$20240904$$CN$US$US
240725991$24072599$1$I$$20240703$20240710$20240710$EXP$$US-MYLANLABS-2024M1064274$MYLAN$$$$$F$Y$$$20240710$$MD$US$US
240726001$24072600$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133510$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31(6):3529-3545$67$YR$E$M$Y$$$20240710$$HP$US$US
240726011$24072601$1$I$20240703$20240703$20240710$20240710$EXP$GB-MHRA-MED-202407032204148930-MRGNP$GB-RDY-SPO/GBR/24/0009790$DR REDDYS$$17$YR$T$$Y$$$20240710$$CN$GB$GB
240726022$24072602$2$F$$20240709$20240710$20240718$EXP$$NVSC2024US142233$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
240726031$24072603$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A153586$ASTRAZENECA$$$$$M$Y$61.2$KG$20240710$$CN$US$
240726041$24072604$1$I$20240604$20240702$20240710$20240710$EXP$SE-SEMPA-2024-005009$SE-TEVA-VS-3216667$TEVA$$67$YR$$F$Y$$$20240710$$MD$SE$SE
240726051$24072605$1$I$20240527$20240701$20240710$20240710$EXP$FR-AFSSAPS-PA2024001273$FR-TEVA-VS-3216192$TEVA$$62$YR$$F$Y$76$KG$20240710$$MD$FR$FR
240726061$24072606$1$I$$20240702$20240710$20240710$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008139$STRIDES$Okuzumi S, Suzuki H, Morinaga S, Tamura M, Minematsu N.. Mesenchymal-epithelial Transition Exon 14-skipping Mutation-positive Invasive Mucinous Adenocarcinoma of the Lung: First Case Treated with Mesenchymal-epithelial Transition-tyrosine Kinase Inhibitors.. Intern-Med. 2024;63 (12):1789-1795$8$DEC$$F$Y$$$20240710$$HP$JP$JP
240726071$24072607$1$I$$20240702$20240710$20240710$EXP$$US-MYLANLABS-2024M1063154$MYLAN$Beck OG, Hardesty MM. Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion. Gynecol-Oncol-Rep 2023; 47.$51$YR$$F$Y$$$20240710$$HP$US$US
240726081$24072608$1$I$$20240702$20240710$20240710$EXP$$US-MYLANLABS-2024M1063737$MYLAN$Alexander J, Soney H, Lopez D, Naik D, Azimi A. Rush to de-liver: a case of HSV hepatitis in pregnancy. J-Hosp-Med 2023; 18 S635-S636.$24$YR$$F$Y$$$20240710$$HP$US$US
240726091$24072609$1$I$$20240702$20240710$20240710$EXP$$GB-MYLANLABS-2024M1063739$MYLAN$Boontaveeyuwat E, Willis F, Fassihi H, Sarkany RPE. Successful serial plasmapheresis for solar urticaria, a case report and literature review. J-Dermatolog-Treat 2024; 35 (1):.$6$DEC$$F$Y$$$20240710$$HP$GB$GB
240726101$24072610$1$I$$20240702$20240710$20240710$EXP$$CN-MYLANLABS-2024M1063776$MYLAN$Zhai W, Liu H, Li J, Xin H. Pregabalin-induced rhabdomyolysis: a case series and literature analysis. J-Int-Med-Res 2024; 52 (6):.$10$DEC$$F$Y$$$20240710$$HP$CN$CN
240726121$24072612$1$I$$20240702$20240710$20240710$EXP$$US-MYLANLABS-2024M1063766$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$33$YR$$M$Y$$$20240710$$HP$US$US
240726131$24072613$1$I$20240627$20240705$20240710$20240710$PER$$US-JNJFOC-20240717908$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240710$$CN$US$US
240726142$24072614$2$F$20240531$20240731$20240710$20240808$EXP$$CO-JNJFOC-20240604164$JOHNSON AND JOHNSON$$64$YR$A$F$Y$55$KG$20240808$$HP$CO$CO
240726161$24072616$1$I$$20240702$20240710$20240710$EXP$$CA-MYLANLABS-2024M1063898$MYLAN$$40$YR$$M$Y$$$20240710$$CN$CA$CA
240726171$24072617$1$I$$20240702$20240710$20240710$EXP$$US-MYLANLABS-2024M1063722$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$44$YR$$F$Y$$$20240710$$HP$US$US
240726181$24072618$1$I$$20240709$20240710$20240710$EXP$$US-GILEAD-2024-0680105$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240726191$24072619$1$I$$20240702$20240710$20240710$EXP$$US-MYLANLABS-2024M1063730$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$58$YR$$M$Y$$$20240710$$HP$US$US
240726201$24072620$1$I$$20240707$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005295$ELI LILLY AND CO$$$$$$Y$$$20240710$$CN$US$US
240726211$24072621$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004979$ELI LILLY AND CO$$$$$F$Y$$$20240710$$HP$US$US
240726221$24072622$1$I$$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407006171$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240710$$CN$US$US
240726231$24072623$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005023$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240710$$CN$US$US
240726241$24072624$1$I$20240707$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005724$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240710$$CN$US$US
240726251$24072625$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005523$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240710$$CN$US$US
240726261$24072626$1$I$20240612$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005522$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240710$$CN$US$US
240726271$24072627$1$I$20240704$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005215$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240710$$CN$US$US
240726281$24072628$1$I$$20240705$20240710$20240710$PER$$US-CHATTEMPRD-2024OHG023537$CHATTEM$$$$A$$Y$$$20240710$$CN$US$US
240726291$24072629$1$I$$20240702$20240710$20240710$EXP$$US-MYLANLABS-2024M1063754$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$29$YR$$M$Y$$$20240710$$HP$US$US
240726301$24072630$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005154$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240710$$MD$US$US
240726311$24072631$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004978$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240710$$CN$US$US
240726321$24072632$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005741$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240710$$CN$US$US
240726331$24072633$1$I$$20240702$20240710$20240710$EXP$$US-MYLANLABS-2024M1063703$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$59$YR$$M$Y$$$20240710$$HP$US$US
240726341$24072634$1$I$20240101$20240705$20240710$20240710$EXP$$US-SA-2024SA201709$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240710$$MD$US$US
240726351$24072635$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05886$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240726361$24072636$1$I$$20240702$20240710$20240710$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008149$STRIDES$Horibe R, Yokota M, Uemura K, Hashimoto M, Kawagishi N, Nishiyama K.. De novo Hepatitis B Virus Reactivation during Treatment with an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Patient with Advanced Lung Cancer. Intern-Med 2024; 63 (12): 1797-1800.. Intern-Med. 2024;63 (12):1797-1800$71$YR$$F$Y$$$20240710$$HP$JP$JP
240726371$24072637$1$I$$20240708$20240710$20240710$EXP$$US-TAKEDA-2023TUS097486$TAKEDA$$$$$M$Y$$$20240710$$CN$US$US
240726381$24072638$1$I$$20240705$20240710$20240710$PER$$US-BIOVITRUM-2024-US-007120$BIOVITRUM$$25$YR$$F$Y$$$20240710$$CN$US$US
240726391$24072639$1$I$20240709$20240710$20240710$20240710$DIR$709693$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240726401$24072640$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06237$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240726411$24072641$1$I$$20240702$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008154$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510.$45$YR$$F$Y$$$20240710$$HP$US$US
240726431$24072643$1$I$20240401$20240709$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108995$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240710$$CN$US$US
240726441$24072644$1$I$$20240702$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008152$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$15$YR$$F$Y$$$20240710$$HP$US$US
240726451$24072645$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109118$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$65$YR$E$M$Y$$$20240710$$HP$US$US
240726461$24072646$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109113$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$66$YR$E$M$Y$$$20240710$$HP$US$US
240726471$24072647$1$I$$20240702$20240710$20240710$EXP$$JP-009507513-2406JPN004232J$MERCK$$66$YR$$F$Y$$$20240710$$PH$JP$JP
240726482$24072648$2$F$20240629$20240807$20240710$20240809$PER$$US-AMGEN-USASP2024135663$AMGEN$$60$YR$A$F$Y$$$20240809$$CN$US$US
240726491$24072649$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186262$Haleon PLC$$$$$F$Y$$$20240710$$CN$US$US
240726502$24072650$2$F$$20240910$20240710$20240919$EXP$$US-SPECGX-T202401499$SPECGX$Rice D, Yoshida H. Opioid-induced adrenal insufficiency. JAMA Internal Medicine. 2024;184(7):830-1$5$DEC$$F$Y$$$20240919$$MD$US$US
240726511$24072651$1$I$$20240702$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008155$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$35$YR$$M$Y$$$20240710$$HP$US$US
240726522$24072652$2$F$20240101$20240827$20240710$20240902$EXP$$JP-AMGEN-JPNSP2024133894$AMGEN$$$$E$F$Y$$$20240902$$HP$JP$JP
240726532$24072653$2$F$20240627$20240712$20240710$20240717$PER$$US-AMGEN-USASP2024135715$AMGEN$$64$YR$A$F$Y$$$20240716$$MD$US$US
240726541$24072654$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135441$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240726551$24072655$1$I$$20240702$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008156$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510.$50$YR$$M$Y$$$20240710$$HP$US$US
240726561$24072656$1$I$$20240702$20240710$20240710$EXP$GB-MHRA-MED-202407022217253260-ZVMGT$GB-TEVA-VS-3216753$TEVA$$$$$F$Y$$$20240710$$CN$GB$GB
240726571$24072657$1$I$20240628$20240630$20240710$20240710$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2158988$JIANGSU HANSOH PHARMACEUTICAL$$73$YR$$F$Y$70$KG$20240710$$MD$CN$CN
240726581$24072658$1$I$$20240702$20240710$20240710$EXP$$US-Ricola USA Inc.-2158996$RICOLA$$74$YR$$F$Y$$$20240710$$$US$US
240726591$24072659$1$I$$20240621$20240710$20240710$PER$$US-B.Braun Medical Inc.-2158987$B BRAUN$$80$YR$$F$Y$$$20240710$$$US$US
240726601$24072660$1$I$20240609$20240630$20240710$20240710$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2158985$JIANGSU HANSOH PHARMACEUTICAL$$42$YR$$F$Y$75$KG$20240710$$MD$CN$CN
240726621$24072662$1$I$$20240705$20240710$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010392$JAZZ$$$$$F$Y$$$20240710$$HP$US$US
240726631$24072663$1$I$20240613$20240630$20240710$20240710$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2158990$JIANGSU HANSOH PHARMACEUTICAL$$64$YR$$M$Y$$$20240710$$MD$CN$CN
240726641$24072664$1$I$20240627$20240702$20240710$20240710$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158993$JIANGSU HENGRUI MEDICINE$$62$YR$$M$Y$$$20240710$$MD$CN$CN
240726651$24072665$1$I$20240624$20240629$20240710$20240710$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158991$JIANGSU HENGRUI MEDICINE$$66$YR$$F$Y$$$20240710$$MD$CN$CN
240726661$24072666$1$I$20230613$20240627$20240710$20240710$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2158989$JIANGSU HENGRUI MEDICINE$Literature title: Coronary Artery Spasm induced by Tegafur, Gimeracil and Oteracil Potassium Combined with Oxaliplatin in Elderly Patients with Gastric Cancer: A Report of 2 Cases?Literature publication journal: Practical Geriatrics, 2024, 38(6): 646-648.?Literature authors: Jing Li.$73$YR$$M$Y$$$20240710$$MD$CN$CN
240726671$24072667$1$I$20240622$20240628$20240710$20240710$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2158995$JIANGSU HANSOH PHARMACEUTICAL$$72$YR$$F$Y$55.9$KG$20240710$$MD$CN$CN
240726681$24072668$1$I$$20240627$20240710$20240710$EXP$$US-B.Braun Medical Inc.-2158984$B BRAUN$Literature Article$78$YR$$F$Y$$$20240710$$$US$US
240726691$24072669$1$I$$20240703$20240710$20240710$EXP$GB-MHRA-MED-202407020643199960-VMKHF$GB-AMAROX PHARMA-AMR2024GB02106$HETERO$$$$$F$Y$95$KG$20240710$$CN$GB$GB
240726711$24072671$1$I$$20240708$20240710$20240710$EXP$$US-GSK-US2024AMR084789$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$US$US
240726721$24072672$1$I$$20240704$20240710$20240710$EXP$$GB-GSK-GB2024EME083673$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$HP$GB$GB
240726731$24072673$1$I$$20240702$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008163$STRIDES$Alexander J, Soney H, Lopez D, Naik D, Azimi A. RUSH TO DE-LIVER: A CASE OF HSV HEPATITIS IN PREGNANCY. J-Hosp-Med. 2023;18:S635-S636$24$YR$$F$Y$$$20240710$$HP$US$US
240726741$24072674$1$I$$20240702$20240710$20240710$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008158$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$62$YR$$F$Y$$$20240710$$HP$US$US
240726751$24072675$1$I$20230101$20240701$20240710$20240710$EXP$$US-AMGEN-USASL2024130287$AMGEN$$77$YR$E$F$Y$$$20240710$$CN$US$US
240726762$24072676$2$F$20240703$20240911$20240710$20240918$EXP$$US-JNJFOC-20240717604$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240918$$MD$US$US
240726771$24072677$1$I$$20240628$20240710$20240710$EXP$$KR-NOVAST LABORATORIES INC.-2024NOV000266$NOVAST$Kim J, Lee J, Lee S, Kim K. Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report.. Medicina. 2024;60$79$YR$$M$Y$$$20240710$$HP$KR$KR
240726781$24072678$1$I$$20240708$20240710$20240710$EXP$$NVSC2024US141968$NOVARTIS$$$$$M$Y$$$20240710$$HP$US$US
240726791$24072679$1$I$$20240703$20240710$20240710$EXP$$NVSC2024HN130208$NOVARTIS$$$$$F$Y$$$20240710$$CN$HN$HN
240726801$24072680$1$I$20240601$20240625$20240710$20240710$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01067$AVADEL CNS PHARMA$$58$YR$$F$Y$83.9$KG$20240710$$CN$US$US
240726811$24072681$1$I$20220809$20240625$20240710$20240710$EXP$$US-COOPERSURGICAL, INC.-2024CPS002009$COOPERSURGICAL$$$$$F$Y$$$20240710$$LW$US$US
240726821$24072682$1$I$20240101$20240625$20240710$20240710$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01065$INTRA-CELLULAR THERAPIES$$3$DEC$$F$Y$$$20240710$$HP$US$US
240726831$24072683$1$I$20240101$20240625$20240710$20240710$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01061$INTRA-CELLULAR THERAPIES$$51$YR$$F$Y$38.555$KG$20240710$$CN$US$US
240726841$24072684$1$I$$20240710$20240710$20240710$DIR$709694$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240726852$24072685$2$F$$20240820$20240710$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010373$JAZZ$$$$$M$Y$$$20240823$$HP$US$US
240726862$24072686$2$F$$20240709$20240710$20240711$PER$$US-HALEON-2186031$Haleon PLC$$63$YR$$F$Y$$$20240711$$CN$US$US
240726871$24072687$1$I$20240706$20240710$20240710$20240710$DIR$709697$$FDA-CTU$$36$YR$$M$N$96.75$KG$20240710$N$CN$US$
240726881$24072688$1$I$$20240702$20240710$20240710$EXP$$IE-STRIDES ARCOLAB LIMITED-2024SP008055$STRIDES$Mulkerrin G, Hennessy MJ.. Nonsense mutation in DEPDC5 gene in a patient with carbamazepine-responsive focal epilepsy.. Epilepsy-Behav-Rep. 2024;27:1-3$$$A$M$Y$$$20240710$$HP$IE$IE
240726891$24072689$1$I$$20240710$20240710$20240710$DIR$709695$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
240726901$24072690$1$I$20240614$20240630$20240710$20240710$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00548$PARATEK PHARMACEUTICALS$$36$YR$$M$Y$$$20240710$$HP$CN$CN
240726912$24072691$2$F$$20240711$20240710$20240719$EXP$$JP-AstraZeneca-2024A154185$ASTRAZENECA$$77$YR$$M$Y$$$20240719$$PH$JP$
240726921$24072692$1$I$$20240702$20240710$20240710$EXP$$ZA-AstraZeneca-2024A153484$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$ZA$
240726931$24072693$1$I$20230701$20240628$20240710$20240710$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-02209$AMNEAL$$$$$F$Y$$$20240710$$HP$JP$JP
240726952$24072695$2$F$$20240729$20240710$20240806$EXP$$IT-AstraZeneca-2024A154253$ASTRAZENECA$$$$$F$Y$$$20240806$$MD$IT$
240726961$24072696$1$I$20240102$20240703$20240710$20240710$EXP$$IE-TAKEDA-2024TUS069109$TAKEDA$$40$YR$$F$Y$$$20240710$$MD$IE$IE
240726972$24072697$2$F$20240729$20240729$20240710$20240806$EXP$$US-BAYER-2024A095884$BAYER$$53$YR$A$F$Y$87.528$KG$20240806$$CN$US$US
240726981$24072698$1$I$$20240702$20240710$20240710$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008061$STRIDES$Gan Y, Chen J, Wang M, Li Q, Wang A, Yang H.. The efficacy and safety of tacrolimus in treating refractory IgA vasculitis nephritis: a single-center retrospective study on 16 cases.  ;. Clin-Kidney-J. 2024;17 (5):.$7$YR$$F$Y$$$20240710$$HP$CN$CN
240726991$24072699$1$I$20240626$20240701$20240710$20240710$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020182$UNITED THERAPEUTICS$$49$YR$$M$Y$$$20240710$$$US$US
240727001$24072700$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109078$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$59$YR$A$M$Y$$$20240710$$HP$US$US
240727011$24072701$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109115$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$85$YR$E$M$Y$$$20240710$$HP$US$US
240727021$24072702$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109079$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$63$YR$A$M$Y$$$20240710$$HP$US$US
240727031$24072703$1$I$20240603$20240702$20240710$20240710$EXP$$TR-BAYER-2024A096723$BAYER$$47$YR$A$F$Y$59$KG$20240710$$PH$TR$TR
240727041$24072704$1$I$$20240703$20240710$20240710$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001365$BLUEPRINT MEDICINES$$$$$M$Y$$$20240710$$CN$US$US
240727052$24072705$2$F$$20240722$20240710$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001374$BLUEPRINT MEDICINES$$$$$F$Y$$$20240731$$CN$US$US
240727061$24072706$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109102$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$25$YR$A$M$Y$$$20240710$$HP$US$US
240727072$24072707$2$F$20240611$20240712$20240710$20240722$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001371$BLUEPRINT MEDICINES$$66$YR$E$F$Y$$$20240722$$CN$US$US
240727081$24072708$1$I$$20240708$20240710$20240710$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-108598$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240710$$PH$AU$AU
240727091$24072709$1$I$20240628$20240628$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104752$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$HP$US$US
240727101$24072710$1$I$$20240708$20240710$20240710$EXP$$GR-BRISTOL-MYERS SQUIBB COMPANY-2024-108953$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240710$$MD$GR$GR
240727111$24072711$1$I$$20240708$20240710$20240710$EXP$$US-ABBVIE-5832739$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
240727121$24072712$1$I$$20240628$20240710$20240710$EXP$$GR-NOVAST LABORATORIES INC.-2024NOV000267$NOVAST$Karmiris E, Chalkiadaki E, Tsiripidis K, Stavrakas P, Papakonstantinou E.. An Atypical Case of Severe Toxicity, Anterior Chamber Inflammation, and Transient Subretinal Fluid Formation Induced by the Subconjunctival Injection of 5-FU.. Ocular Immunology and Inflammation. 2024$40$YR$$M$Y$$$20240710$$HP$GR$GR
240727131$24072713$1$I$$20240702$20240710$20240710$30DAY$$US-GSK-US2024AMR082331$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
240727141$24072714$1$I$$20240703$20240710$20240710$EXP$$BE-STRIDES ARCOLAB LIMITED-2024SP008126$STRIDES$Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A, et al.. PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer.. Cold-Spring-Harb-Mol-Case-Stud. 2023;9 (2)::1-16.$30$YR$$F$Y$$$20240710$$HP$BE$BE
240727151$24072715$1$I$$20240704$20240710$20240710$EXP$$JP-VIATRISJAPAN-2024M1062587AA$MYLAN$Takemoto N, Sugimoto M, Sasaki A, Urushihara M. A case of drug-induced kidney injury suspected to be due to allergic mechanism. The Journal of the Japan Pediatric Society. 2024;128(6):870$14$YR$$M$Y$$$20240710$$MD$JP$JP
240727161$24072716$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109071$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$76$YR$E$M$Y$$$20240710$$HP$US$US
240727171$24072717$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109072$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$52$YR$A$M$Y$$$20240710$$HP$US$US
240727181$24072718$1$I$20240616$20240709$20240710$20240710$EXP$ES-AEMPS-1543588$ES-JNJFOC-20240722256$JOHNSON AND JOHNSON$$16$YR$T$F$Y$57.1$KG$20240710$$MD$ES$ES
240727191$24072719$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109088$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$42$YR$A$M$Y$$$20240710$$HP$US$US
240727201$24072720$1$I$$20240701$20240710$20240710$EXP$$AR-JNJFOC-20240705621$JOHNSON AND JOHNSON$$65$YR$E$M$Y$82$KG$20240710$$CN$AR$AR
240727211$24072721$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-033122$AUROBINDO$Timirau WM, Sari E, Boyd S, Khokhar H, Nabizadeh P, Huang D.. An Unusual Case of Arcanobacterium Haemolyticum Causing Acute Respiratory Distress Syndrome Requiring Extracorporeal Membrane Oxygenation. Am-J-Respir-Crit-Care-Med. 2024;209:A3556$18$YR$$F$Y$$$20240710$$HP$US$US
240727221$24072722$1$I$$20240703$20240710$20240710$EXP$$GB-TEVA-VS-3216861$TEVA$$60$YR$$M$Y$92$KG$20240710$$MD$GB$GB
240727232$24072723$2$F$20240625$20240708$20240710$20240714$PER$$US-AMGEN-USASP2024135488$AMGEN$$68$YR$E$M$Y$$$20240714$$CN$US$US
240727241$24072724$1$I$$20240405$20240710$20240710$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430733$RANBAXY$$$$E$F$Y$$$20240710$$CN$US$US
240727251$24072725$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-033078$AUROBINDO$Folkerth R, Jayakumar J, Manesh A, Pandurangan K, Perl D, Priemer D, et al.. Comparison of neuropathologies among rabies patients treated with standard, Milwaukee, and/or experimental AAV-RAB strategies.. J-Neuropathol-Exp-Neurol. 2024;83 (6):453$57$YR$$M$Y$$$20240710$$HP$US$US
240727261$24072726$1$I$$20240705$20240710$20240710$EXP$$US-GILEAD-2024-0679804$GILEAD$$$$$$Y$$$20240710$$HP$US$US
240727282$24072728$2$F$$20240708$20240710$20240712$EXP$$GB-UCBSA-2024034651$UCB$$$$$F$Y$$$20240712$$CN$GB$GB
240727291$24072729$1$I$20231110$20240703$20240710$20240710$EXP$GB-MHRA-MED-202407022337350880-HWTLS$GB-TEVA-VS-3216908$TEVA$$39$YR$$F$Y$$$20240710$$CN$GB$GB
240727301$24072730$1$I$$20240710$20240710$20240710$DIR$709705$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240727311$24072731$1$I$20110620$20240710$20240710$20240710$DIR$709686$$FDA-CTU$$27$YR$$M$N$112.5$KG$20240710$N$CN$US$
240727321$24072732$1$I$20240621$20240630$20240709$20240709$DIR$FDA-CDER-CTU-2024-47642$$FDA-CTU$$53$YR$$F$N$100.7$KG$20240630$N$CN$US$
240727331$24072733$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032868$AUROBINDO$Fomeche J, Nor M, Wang Y, Carro M, Homayounrooz F, Hastrup F. Ketamine Chronicles: A Breath of Fresh Air in Status Asthmaticus. Am-J-Respir-Crit-Care-Med. 2024;209:A5301$64$YR$$M$Y$$$20240710$$HP$US$US
240727341$24072734$1$I$$20240701$20240710$20240710$EXP$$DE-AUROBINDO-AUR-APL-2024-033230$AUROBINDO$Jori B, Vossing C, Pirngruber J, Willing EM, Arndt K, Falk M, et al.. The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations. Curr-Oncol. 2023;30(10):8805-8814$50$YR$$M$Y$$$20240710$$HP$DE$DE
240727351$24072735$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06259$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240727361$24072736$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032804$AUROBINDO$Deka A, Joseph E, Sharma N, Berhanu T, Kaplan J. Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature. JPsychiatr-Pract. 2024;30(3):234-241$78$YR$$F$Y$$$20240710$$HP$US$US
240727371$24072737$1$I$$20240709$20240710$20240710$EXP$$US-JNJFOC-20240721861$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
240727381$24072738$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005033$ELI LILLY AND CO$$$$$$Y$$$20240710$$CN$US$US
240727392$24072739$2$F$$20240723$20240710$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407005290$ELI LILLY AND CO$$59$YR$A$$Y$$$20240726$$CN$US$US
240727401$24072740$1$I$20210719$20240710$20240710$20240710$DIR$709708$$FDA-CTU$$59$YR$$M$N$72$KG$20240710$N$CN$US$
240727411$24072741$1$I$$20240710$20240710$20240710$DIR$709718$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240727421$24072742$1$I$$20240628$20240710$20240710$EXP$$US-PTA-005701$BANNER$$$$$F$Y$$$20240710$$CN$US$US
240727431$24072743$1$I$20240620$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005206$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240710$$CN$US$US
240727441$24072744$1$I$20240610$20240610$20240710$20240710$EXP$$US-PTA-005698$BANNER$$60$YR$A$F$Y$$$20240710$$CN$US$US
240727451$24072745$1$I$$20240710$20240710$20240710$DIR$709709$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240727461$24072746$1$I$$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407006381$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240710$$CN$US$US
240727471$24072747$1$I$$20240701$20240710$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-108125$BRISTOL MYERS SQUIBB$Kajikawa S, et al. A case of adult B-ALL without KMT2A reconstitution who developed AML due to lineage switch after administration of Blinatumomab. The 59th Spring Hokkaido Regional Meeting of the Japanese Society of Hematology.$81$YR$E$M$Y$$$20240710$$MD$JP$JP
240727481$24072748$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109069$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$61$YR$A$F$Y$$$20240710$$HP$US$US
240727491$24072749$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135655$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240727502$24072750$2$F$$20240715$20240710$20240724$EXP$$AE-GILEAD-2024-0679745$GILEAD$$$$A$$Y$$$20240724$$MD$AE$AE
240727512$24072751$2$F$$20240625$20240710$20240828$PER$$US-ROCHE-10000020574$ROCHE$$$$$$Y$$$20240828$$CN$US$US
240727523$24072752$3$F$20240529$20240806$20240710$20240808$PER$$US-ROCHE-10000019017$ROCHE$$41$YR$A$F$Y$80.74$KG$20240808$$CN$US$US
240727531$24072753$1$I$$20240629$20240710$20240710$EXP$AU-TGA-803446$AU-Accord-433035$ACCORD$$$$$$Y$$$20240710$$HP$AU$AU
240727541$24072754$1$I$$20240629$20240710$20240710$EXP$CA-MHPD-E2B_07068614$CA-Accord-433494$ACCORD$$62$YR$A$F$Y$$$20240710$$MD$CA$CA
240727551$24072755$1$I$$20240629$20240710$20240710$EXP$CA-MHPD-E2B_07071691$CA-Accord-433501$ACCORD$$69$YR$E$F$Y$$$20240710$$HP$CA$CA
240727561$24072756$1$I$20200209$20240629$20240710$20240710$EXP$GB-MHRA-MED-202406291153551960-YVRTB$GB-Accord-433704$ACCORD$$24$YR$A$M$Y$65$KG$20240710$$CN$GB$GB
240727572$24072757$2$F$20240513$20240711$20240710$20240722$EXP$IT-MINISAL02-992905$IT-Accord-433897$ACCORD$$69$YR$E$F$Y$60$KG$20240722$$MD$IT$IT
240727581$24072758$1$I$20240517$20240629$20240710$20240710$EXP$FR-AFSSAPS-LM2024000370$FR-Accord-433535$ACCORD$$89$YR$E$F$Y$77.8$KG$20240710$$MD$FR$FR
240727591$24072759$1$I$$20240629$20240710$20240710$EXP$CA-MHPD-E2B_07068950$CA-Accord-433500$ACCORD$$69$YR$E$F$Y$$$20240710$$HP$CA$CA
240727601$24072760$1$I$20240621$20240629$20240710$20240710$EXP$CN-HENLIUS-24CN015683$CN-Accord-434499$ACCORD$$52$YR$A$F$Y$72$KG$20240710$$MD$CN$CN
240727611$24072761$1$I$20240603$20240629$20240710$20240710$EXP$FR-AFSSAPS-PP2024000694$FR-Accord-433709$ACCORD$$75$YR$E$F$Y$75$KG$20240710$$MD$FR$FR
240727621$24072762$1$I$$20240629$20240710$20240710$EXP$CA-MHPD-E2B_07065326$CA-Accord-433492$ACCORD$$59$YR$A$F$Y$$$20240710$$MD$CA$CA
240727631$24072763$1$I$$20240626$20240710$20240710$PER$$US-ROCHE-10000020433$ROCHE$$$$E$F$Y$$$20240709$$CN$US$US
240727641$24072764$1$I$$20240613$20240710$20240710$EXP$$MY-ROCHE-10000016004$ROCHE$$$$$$Y$$$20240709$$MD$MY$MY
240727651$24072765$1$I$20240601$20240701$20240710$20240710$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700017$RIGEL PHARMACEUTICALS$$33$YR$$F$Y$102.51$KG$20240710$$CN$US$US
240727661$24072766$1$I$$20240621$20240710$20240710$EXP$$AU-ROCHE-10000006732$ROCHE$$65$YR$E$F$Y$$$20240709$$HP$AU$AU
240727671$24072767$1$I$$20240628$20240710$20240710$PER$$US-ROCHE-10000016481$ROCHE$$$$$F$Y$$$20240710$$CN$US$US
240727682$24072768$2$F$20240617$20240708$20240710$20240715$EXP$$CA-ROCHE-10000020356$ROCHE$$42$YR$A$F$Y$$$20240715$$HP$CA$CA
240727691$24072769$1$I$$20240629$20240710$20240710$PER$$US-ROCHE-10000020083$ROCHE$$$$E$F$Y$$$20240709$$CN$US$US
240727701$24072770$1$I$$20240702$20240710$20240710$EXP$$CH-ROCHE-3292940$ROCHE$$32$YR$A$F$Y$$$20240709$$MD$CH$CH
240727711$24072771$1$I$$20240625$20240710$20240710$PER$$US-ROCHE-10000021133$ROCHE$$$$$M$Y$$$20240710$$CN$US$US
240727722$24072772$2$F$$20240807$20240710$20240813$PER$$US-ROCHE-10000020417$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
240727732$24072773$2$F$$20240911$20240710$20240912$EXP$$GB-ROCHE-10000016841$ROCHE$$$$$$Y$$$20240912$$HP$GB$GB
240727741$24072774$1$I$$20240628$20240710$20240710$PER$$US-ROCHE-10000006880$ROCHE$$$$$F$Y$$$20240710$$CN$US$US
240727751$24072775$1$I$$20240627$20240710$20240710$EXP$$CA-ROCHE-3522033$ROCHE$$$$A$F$Y$$$20240710$$HP$CA$CA
240727761$24072776$1$I$$20240617$20240710$20240710$PER$$US-ROCHE-10000006759$ROCHE$$$$$M$Y$$$20240710$$CN$US$US
240727772$24072777$2$F$20220713$20240702$20240710$20240715$EXP$$CA-ROCHE-3140364$ROCHE$$78$YR$E$F$Y$76$KG$20240715$$HP$CA$CA
240727781$24072778$1$I$$20240617$20240710$20240710$EXP$$IL-ROCHE-10000015913$ROCHE$$69$YR$E$F$Y$$$20240709$$CN$IL$IL
240727791$24072779$1$I$20240422$20240628$20240710$20240710$PER$$US-ROCHE-3563949$ROCHE$$45$YR$A$F$Y$83.4$KG$20240709$$HP$US$US
240727801$24072780$1$I$$20240705$20240710$20240710$EXP$$IN-ASTELLAS-2024US019220$ASTELLAS$$32$YR$$M$Y$$$20240710$$HP$IN$IN
240727811$24072781$1$I$20231030$20240702$20240710$20240710$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240700028$RIGEL PHARMACEUTICALS$$86$YR$$F$Y$54$KG$20240710$$MD$JP$JP
240727822$24072782$2$F$$20240703$20240710$20240711$PER$$US-ROCHE-10000020527$ROCHE$$50$YR$A$F$Y$$$20240711$$MD$US$US
240727831$24072783$1$I$$20240702$20240710$20240710$PER$$US-EMD Serono-2024036404$EMD SERONO INC$$57$YR$A$M$Y$$$20240710$$CN$US$US
240727841$24072784$1$I$$20240702$20240710$20240710$EXP$$IT-AUROBINDO-AUR-APL-2024-033657$AUROBINDO$Del Fabro V, Pennisi C, Leotta S, Petronaci A, Longo L, Elia F, et al.. PRACTICAL CONSIDERATIONS ON MANAGEMENT OF INFECTION IN PATIENTS RECEIVING BISPECIFIC ANTIBODIES: A SINGLE CENTER EXPERIENCE.. Haematologica.. 2024;109 (Suppl.)33$$$$$Y$$$20240710$$HP$IT$IT
240727851$24072785$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05846$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240727863$24072786$3$F$$20240819$20240710$20240823$EXP$$AE-TAKEDA-2024TUS069763$TAKEDA$$$$$$Y$$$20240823$$CN$AE$AE
240727871$24072787$1$I$$20240703$20240710$20240710$EXP$GB-MHRA-DEFECT-202406221311545970-BHSNJ$GB-TEVA-VS-3216955$TEVA$$$$$$Y$$$20240710$$CN$GB$GB
240727881$24072788$1$I$20240708$20240708$20240710$20240710$EXP$$NVSC2024IN141609$NOVARTIS$$72$YR$$M$Y$$$20240710$$MD$IN$IN
240727891$24072789$1$I$20240511$20240626$20240710$20240710$EXP$$US-CIPLA LTD.-2024US06944$CIPLA$$$$$$Y$$$20240710$$MD$US$US
240727901$24072790$1$I$20221001$20240627$20240710$20240710$EXP$$FR-CIPLA LTD.-2024FR06865$CIPLA$$$$$$Y$$$20240710$$MD$FR$FR
240727921$24072792$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A152874$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240727931$24072793$1$I$20211025$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157061$ASTRAZENECA$$66$YR$$M$Y$84$KG$20240710$$HP$FR$
240727943$24072794$3$F$20240621$20240815$20240710$20240820$EXP$$CA-AstraZeneca-2024A153494$ASTRAZENECA$$23430$DY$$F$Y$$$20240820$$CN$CA$
240727951$24072795$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198854$SANOFI AVENTIS$$73$YR$E$F$Y$63.5$KG$20240710$$MD$US$US
240727961$24072796$1$I$20240615$20240703$20240710$20240710$EXP$GB-MHRA-MED-202406171146230370-MZGPH$GB-TEVA-VS-3216959$TEVA$$72$YR$$$Y$$$20240710$$CN$GB$GB
240727971$24072797$1$I$20240701$20240701$20240710$20240710$PER$$US-SA-2024SA198102$SANOFI AVENTIS$$72$YR$E$F$Y$71.21$KG$20240710$$MD$US$US
240727983$24072798$3$F$20240103$20240813$20240710$20240826$PER$$US-SA-2024SA200272$SANOFI AVENTIS$$2$YR$C$F$Y$14.4$KG$20240826$$MD$US$US
240727991$24072799$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197868$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240710$$MD$US$US
240728001$24072800$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA200527$SANOFI AVENTIS$$$$E$F$Y$99.79$KG$20240710$$MD$US$US
240728012$24072801$2$F$20240101$20240710$20240710$20240718$PER$$US-SA-2024SA200524$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240718$$MD$US$US
240728021$24072802$1$I$20240101$20240703$20240710$20240710$PER$$US-SA-2024SA199769$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240710$$MD$US$US
240728031$24072803$1$I$20240602$20240701$20240710$20240710$PER$$US-SA-2024SA198787$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240710$$MD$US$US
240728041$24072804$1$I$20240601$20240701$20240710$20240710$PER$$US-SA-2024SA197037$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240710$$CN$US$US
240728051$24072805$1$I$20240703$20240703$20240710$20240710$PER$$US-SA-2024SA200663$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240710$$MD$US$US
240728061$24072806$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198099$SANOFI AVENTIS$$$$C$F$Y$27.211$KG$20240710$$MD$US$US
240728071$24072807$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA199479$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240710$$CN$US$US
240728082$24072808$2$F$20240707$20240709$20240710$20240717$PER$$US-SA-2024SA197355$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240717$$MD$US$US
240728091$24072809$1$I$20240627$20240628$20240710$20240710$PER$$US-SA-2024SA193429$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240710$$MD$US$US
240728101$24072810$1$I$20240201$20240703$20240710$20240710$EXP$$US-EMD Serono-2024037153$EMD SERONO INC$$61$YR$A$F$Y$$$20240710$$CN$US$US
240728113$24072811$3$F$20240701$20240802$20240710$20240812$PER$$US-SA-2024SA198121$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240812$$CN$US$US
240728122$24072812$2$F$20240101$20240805$20240710$20240812$PER$$US-SA-2024SA196102$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240812$$MD$US$US
240728131$24072813$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA200961$SANOFI AVENTIS$$$$A$F$Y$64$KG$20240710$$MD$US$US
240728141$24072814$1$I$$20240702$20240710$20240710$PER$$US-SA-2024SA199292$SANOFI AVENTIS$$$$A$M$Y$117$KG$20240710$$MD$US$US
240728151$24072815$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA196976$SANOFI AVENTIS$$$$C$M$Y$38.6$KG$20240710$$MD$US$US
240728163$24072816$3$F$$20240809$20240710$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-033297$AUROBINDO$Liane D. Paul, Brueckner I, Welter-Luedeke J, Zangl A, Graw M. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$42$YR$$M$Y$$$20240821$$PH$DE$DE
240728171$24072817$1$I$$20240705$20240710$20240710$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107751$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240710$$HP$CA$CA
240728181$24072818$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109075$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$51$YR$A$F$Y$$$20240710$$HP$US$US
240728191$24072819$1$I$$20240708$20240710$20240710$PER$$US-HALEON-2186030$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240728201$24072820$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA199839$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240710$$MD$US$US
240728211$24072821$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA199310$SANOFI AVENTIS$$$$A$F$Y$63.5$KG$20240710$$MD$US$US
240728233$24072823$3$F$20240101$20240716$20240710$20240723$PER$$US-SA-2024SA199050$SANOFI AVENTIS$$62$YR$A$F$Y$68.03$KG$20240723$$MD$US$US
240728241$24072824$1$I$20240401$20240703$20240710$20240710$PER$$US-SA-2024SA199886$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240710$$MD$US$US
240728251$24072825$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA073271$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240710$$MD$US$US
240728271$24072827$1$I$20240501$20240701$20240710$20240710$PER$$US-SA-2024SA198504$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240710$$MD$US$US
240728281$24072828$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA197339$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240710$$MD$US$US
240728291$24072829$1$I$20240101$20240703$20240710$20240710$PER$$US-SA-2024SA200491$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240710$$CN$US$US
240728301$24072830$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA198254$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240710$$MD$US$US
240728312$24072831$2$F$$20240716$20240710$20240725$PER$$US-SA-2024SA170088$SANOFI AVENTIS$$31$YR$A$M$Y$82.1$KG$20240725$$MD$US$US
240728321$24072832$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA108251$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240710$$MD$US$US
240728332$24072833$2$F$$20240711$20240710$20240801$PER$$US-SA-2024SA196726$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240719$$MD$US$US
240728341$24072834$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA198146$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240710$$MD$US$US
240728351$24072835$1$I$20240401$20240703$20240710$20240710$PER$$US-SA-2024SA200975$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240710$$MD$US$US
240728361$24072836$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA196326$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240710$$MD$US$US
240728372$24072837$2$F$20240101$20240701$20240710$20240918$PER$$US-SA-2024SA197141$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240918$$MD$US$US
240728391$24072839$1$I$20240627$20240701$20240710$20240710$PER$$US-SA-2024SA198676$SANOFI AVENTIS$$65$YR$E$F$Y$63.5$KG$20240710$$MD$US$US
240728401$24072840$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198675$SANOFI AVENTIS$$$$A$M$Y$166$KG$20240710$$MD$US$US
240728411$24072841$1$I$$20240710$20240710$20240710$DIR$709715$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240728421$24072842$1$I$20240501$20240701$20240710$20240710$PER$$US-SA-2024SA198009$SANOFI AVENTIS$$44$YR$A$F$Y$99$KG$20240710$$MD$US$US
240728431$24072843$1$I$$20240704$20240710$20240710$EXP$$US-JNJFOC-20240718774$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240728441$24072844$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA201044$SANOFI AVENTIS$$$$E$F$Y$$$20240710$$MD$US$US
240728451$24072845$1$I$$20240313$20240710$20240710$PER$$US-AJANTA-2024AJA00053$AJANTA PHARMA$$80$YR$E$F$Y$140$KG$20240710$$CN$US$US
240728461$24072846$1$I$20240615$20240627$20240710$20240710$EXP$$GB-CIPLA LTD.-2024GB06950$CIPLA$$$$$$Y$$$20240710$$CN$GB$GB
240728471$24072847$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA198636$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240710$$MD$US$US
240728481$24072848$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198091$SANOFI AVENTIS$$$$A$F$Y$72$KG$20240710$$MD$US$US
240728491$24072849$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA196787$SANOFI AVENTIS$$72$YR$E$M$Y$83.9$KG$20240710$$MD$US$US
240728501$24072850$1$I$20240101$20240703$20240710$20240710$PER$$US-SA-2024SA198306$SANOFI AVENTIS$$$$$M$Y$$$20240710$$CN$US$US
240728511$24072851$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA198095$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240710$$MD$US$US
240728523$24072852$3$F$20240101$20240812$20240710$20240820$PER$$US-SA-2024SA197859$SANOFI AVENTIS$$37$YR$A$F$Y$99.32$KG$20240820$$MD$US$US
240728531$24072853$1$I$$20240710$20240710$20240710$DIR$709717$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240728541$24072854$1$I$$20240701$20240710$20240710$PER$$US-SA-2023SA226366$SANOFI AVENTIS$$$$A$F$Y$65.7$KG$20240710$$MD$US$US
240728553$24072855$3$F$20240801$20240911$20240710$20240920$PER$$US-SA-2024SA198064$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240920$$MD$US$US
240728561$24072856$1$I$$20240710$20240710$20240710$DIR$709711$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
240728571$24072857$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197542$SANOFI AVENTIS$$$$A$M$Y$112.9$KG$20240710$$MD$US$US
240728581$24072858$1$I$20230101$20240701$20240710$20240710$PER$$US-SA-2024SA197851$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240710$$MD$US$US
240728591$24072859$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198772$SANOFI AVENTIS$$$$A$F$Y$83$KG$20240710$$MD$US$US
240728602$24072860$2$F$$20240712$20240710$20240722$PER$$US-SA-2024SA199752$SANOFI AVENTIS$$73$YR$E$M$Y$64.8$KG$20240722$$MD$US$US
240728611$24072861$1$I$20231201$20240701$20240710$20240710$PER$$US-SA-2024SA198255$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240710$$MD$US$US
240728622$24072862$2$F$20240601$20240723$20240710$20240803$PER$$US-SA-2024SA198533$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240803$$MD$US$US
240728631$24072863$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA199146$SANOFI AVENTIS$$$$E$M$Y$$$20240710$$MD$US$US
240728642$24072864$2$F$20240707$20240716$20240710$20240722$PER$$US-AMGEN-USASP2024135849$AMGEN$$$$$M$Y$$$20240722$$CN$US$US
240728651$24072865$1$I$$20240702$20240710$20240710$PER$$US-SA-2024SA198924$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240710$$CN$US$US
240728662$24072866$2$F$20230601$20240808$20240710$20240816$PER$$US-SA-2024SA201037$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240817$$MD$US$US
240728671$24072867$1$I$$20240703$20240710$20240710$EXP$$AU-MYLANLABS-2024M1064167$MYLAN$Ali SB, Vembar P, Sukumaran S, Gunawardane D, Hughes T, Smith A. Tocilizumab in grade 4 hepatitis secondary to immune checkpoint inhibitor: a case report and review of the literature. Immunotherapy 2023; 15 (14): 1125-1132.$68$YR$$F$Y$52$KG$20240710$$HP$AU$AU
240728681$24072868$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA199837$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240710$$MD$US$US
240728692$24072869$2$F$$20240912$20240710$20240923$PER$$US-SA-2024SA197334$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240923$$MD$US$US
240728701$24072870$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197633$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240710$$MD$US$US
240728712$24072871$2$F$20240101$20240903$20240710$20240930$PER$$US-SA-2024SA197268$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240929$$MD$US$US
240728724$24072872$4$F$$20240904$20240710$20240912$EXP$$US-SA-2024SA199398$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240912$$PH$US$US
240728731$24072873$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA199641$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240710$$MD$US$US
240728741$24072874$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA199064$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240710$$MD$US$US
240728751$24072875$1$I$20240501$20240701$20240710$20240710$PER$$US-SA-2024SA200615$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240710$$MD$US$US
240728761$24072876$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA199297$SANOFI AVENTIS$$57$YR$A$M$Y$92.9$KG$20240710$$MD$US$US
240728771$24072877$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA199256$SANOFI AVENTIS$$34$YR$A$M$Y$117$KG$20240710$$MD$US$US
240728781$24072878$1$I$20240601$20240701$20240710$20240710$PER$$US-SA-2024SA197140$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240710$$MD$US$US
240728801$24072880$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA195966$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240710$$MD$US$US
240728811$24072881$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA195643$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240710$$MD$US$US
240728821$24072882$1$I$$20240702$20240710$20240710$PER$$US-SA-2024SA199835$SANOFI AVENTIS$$$$A$M$Y$85.72$KG$20240710$$MD$US$US
240728831$24072883$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198417$SANOFI AVENTIS$$$$A$M$Y$95.25$KG$20240710$$MD$US$US
240728841$24072884$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197942$SANOFI AVENTIS$$$$T$F$Y$63.5$KG$20240710$$MD$US$US
240728851$24072885$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197874$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240710$$MD$US$US
240728861$24072886$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA196194$SANOFI AVENTIS$$$$E$M$Y$$$20240710$$MD$US$US
240728871$24072887$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA195733$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240710$$MD$US$US
240728881$24072888$1$I$20240509$20240702$20240710$20240710$EXP$GB-MHRA-MED-202407021027329530-NMCPL$GB-TEVA-VS-3216274$TEVA$$43$YR$$M$Y$$$20240710$$MD$GB$GB
240728901$24072890$1$I$$20240702$20240710$20240710$EXP$$US-LUOXIN-LUX-2024-US-LIT-00034$LUOXIN AUROVITAS PHARMA(CHENGDU)$Shukla P.Cause and Effect: Long Covid and High-grade B-cell Lymphoma.Am-J-Respir-Crit- Care-Med.2024;209:A1714.$68$YR$A$M$Y$$$20240710$$HP$US$US
240728911$24072891$1$I$$20240629$20240710$20240710$EXP$GB-MHRA-MED-202406291156204580-GSRWB$GB-Accord-433706$ACCORD$$25$YR$A$M$Y$88$KG$20240710$$CN$GB$GB
240728921$24072892$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406280855400820-VQTNC$GB-Accord-433175$ACCORD$$$$$M$Y$$$20240710$$CN$GB$GB
240728931$24072893$1$I$20240603$20240628$20240710$20240710$EXP$CN-HENLIUS-24CN015665$CN-Accord-434497$ACCORD$$69$YR$E$F$Y$50$KG$20240710$$MD$CN$CN
240728941$24072894$1$I$20240509$20240628$20240710$20240710$EXP$GB-MHRA-MIDB-41044ecb-1347-4981-ac26-69141f820ea3$GB-Accord-433395$ACCORD$$59$YR$A$F$Y$$$20240710$$HP$GB$GB
240728951$24072895$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281437236830-WVLTH$GB-Accord-433479$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240728961$24072896$1$I$$20240629$20240710$20240710$EXP$GB-MHRA-MED-202406291149288680-KLQWZ$GB-Accord-433722$ACCORD$$$$$M$Y$78$KG$20240710$$CN$GB$GB
240728971$24072897$1$I$20220101$20240630$20240710$20240710$EXP$$JP-Accord-434147$ACCORD$Sawada K, Kawaji T, Yamana K, Matsuhashi K, Hara Y, Kuriyama N et al. Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory distress syndrome: a case report. J Cardiothorac Surg. 2024 Jun 24;19(1):358.$40$YR$A$F$Y$43$KG$20240710$$HP$JP$JP
240728981$24072898$1$I$$20240629$20240710$20240710$EXP$FR-AFSSAPS-RE2024000660$FR-Accord-433530$ACCORD$$87$YR$E$F$Y$72$KG$20240710$$MD$FR$FR
240728991$24072899$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281145082300-JSMBZ$GB-Accord-433393$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240729001$24072900$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281459532020-PFYZC$GB-Accord-433443$ACCORD$$$$$M$Y$$$20240710$$CN$GB$GB
240729011$24072901$1$I$$20221110$20240710$20240710$EXP$IT-MINISAL02-889353$IT-Accord-426735$ACCORD$$75$YR$E$F$Y$66$KG$20240710$$PH$IT$IT
240729021$24072902$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281143566360-GQMFV$GB-Accord-433378$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240729031$24072903$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281446000970-SKTYP$GB-Accord-433466$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240729041$24072904$1$I$$20240629$20240710$20240710$EXP$GB-MHRA-MED-202406291146576770-GMFCW$GB-Accord-433715$ACCORD$$$$$$Y$78$KG$20240710$$CN$GB$GB
240729061$24072906$1$I$$20240705$20240710$20240710$PER$$US-SA-2024SA200645$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240710$$CN$US$US
240729071$24072907$1$I$20230522$20240629$20240710$20240710$EXP$IT-MINISAL02-992833$IT-Accord-433471$ACCORD$$58$YR$A$M$Y$$$20240710$$MD$IT$IT
240729081$24072908$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281417420110-KQVHC$GB-Accord-433235$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240729091$24072909$1$I$$20240707$20240710$20240710$PER$$US-SA-2024SA200827$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240710$$CN$US$US
240729102$24072910$2$F$20240101$20240904$20240710$20240926$PER$$US-SA-2024SA201130$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240926$$CN$US$US
240729111$24072911$1$I$20240601$20240705$20240710$20240710$PER$$US-SA-2024SA200474$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240710$$MD$US$US
240729121$24072912$1$I$20240101$20240705$20240710$20240710$PER$$US-SA-2024SA200715$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240710$$MD$US$US
240729131$24072913$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198043$SANOFI AVENTIS$$$$A$F$Y$53$KG$20240710$$MD$US$US
240729141$24072914$1$I$20240101$20240705$20240710$20240710$PER$$US-SA-2024SA201032$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240710$$MD$US$US
240729151$24072915$1$I$$20240705$20240710$20240710$PER$$US-SA-2024SA200480$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240710$$CN$US$US
240729161$24072916$1$I$$20240705$20240710$20240710$PER$$US-SA-2024SA201105$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240710$$CN$US$US
240729182$24072918$2$F$20240101$20240802$20240710$20240813$PER$$US-SA-2024SA199008$SANOFI AVENTIS$$52$YR$A$F$Y$68.9$KG$20240814$$MD$US$US
240729191$24072919$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142297$NOVARTIS$$$$$F$Y$$$20240710$$HP$US$US
240729203$24072920$3$F$$20240912$20240710$20240923$PER$$US-ROCHE-10000021370$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
240729214$24072921$4$F$20240501$20240701$20240710$20240712$PER$$US-ROCHE-10000018456$ROCHE$$32$YR$A$F$Y$62.14$KG$20240712$$CN$US$US
240729221$24072922$1$I$20240501$20240627$20240710$20240710$EXP$$PK-ROCHE-10000015160$ROCHE$$50$YR$A$M$Y$$$20240710$$CN$PK$PK
240729231$24072923$1$I$20240626$20240703$20240710$20240710$PER$$US-ROCHE-10000021080$ROCHE$$51$YR$A$F$Y$$$20240710$$CN$US$US
240729252$24072925$2$F$20240625$20240726$20240710$20240805$EXP$$JP-ROCHE-10000014625$ROCHE$$52$YR$A$F$Y$$$20240805$$PH$JP$JP
240729263$24072926$3$F$$20240911$20240710$20240919$EXP$$US-ROCHE-10000015964$ROCHE$$82$YR$E$M$Y$$$20240919$$CN$US$US
240729281$24072928$1$I$$20240625$20240710$20240710$EXP$$MY-ROCHE-3423796$ROCHE$$82$YR$E$F$Y$$$20240710$$CN$MY$MY
240729301$24072930$1$I$$20240625$20240710$20240710$EXP$$CA-ROCHE-10000011609$ROCHE$$$$$F$Y$$$20240710$$HP$CA$CA
240729313$24072931$3$F$20210125$20240911$20240710$20240912$EXP$DE-CHEPLA-2024008279$DE-ROCHE-10000019133$ROCHE$$$$A$F$Y$$$20240912$$MD$DE$DE
240729321$24072932$1$I$20240622$20240627$20240710$20240710$EXP$$PK-ROCHE-10000017982$ROCHE$$52$YR$A$M$Y$$$20240710$$CN$PK$PK
240729331$24072933$1$I$20230511$20240626$20240710$20240710$EXP$ES-AEMPS-1393984$ES-ROCHE-10000016286$ROCHE$$49$YR$A$F$Y$46.9$KG$20240710$$MD$ES$ES
240729342$24072934$2$F$20240528$20240627$20240710$20240710$PER$$US-ROCHE-3573357$ROCHE$$67$YR$E$F$Y$69.4$KG$20240710$$CN$US$US
240729351$24072935$1$I$20240321$20240626$20240710$20240710$EXP$$PK-ROCHE-10000018309$ROCHE$$29$YR$A$M$Y$$$20240710$$CN$PK$PK
240729361$24072936$1$I$$20240703$20240710$20240710$PER$$US-ROCHE-10000021258$ROCHE$$58$YR$A$M$Y$$$20240710$$MD$US$US
240729381$24072938$1$I$$20240708$20240710$20240710$PER$$US-ROCHE-10000021390$ROCHE$$89$YR$E$F$Y$62.59$KG$20240710$$CN$US$US
240729392$24072939$2$F$20240831$20240909$20240710$20240916$EXP$$UY-ROCHE-10000012423$ROCHE$$74$YR$E$M$Y$$$20240916$$MD$UY$UY
240729403$24072940$3$F$20240509$20240827$20240710$20240827$EXP$DE-DCGMA-24203370$DE-ROCHE-10000015229$ROCHE$$73$YR$E$M$Y$100$KG$20240827$$MD$DE$DE
240729412$24072941$2$F$20230522$20240731$20240710$20240809$EXP$$IT-ROCHE-10000012436$ROCHE$$43$YR$A$F$Y$$$20240809$$MD$IT$IT
240729421$24072942$1$I$$20240626$20240710$20240710$EXP$$PK-ROCHE-10000018314$ROCHE$$50$YR$A$M$Y$$$20240710$$CN$PK$PK
240729431$24072943$1$I$$20240708$20240710$20240710$PER$$US-GILEAD-2024-0679932$GILEAD$$$$$M$Y$$$20240710$$CN$US$US
240729451$24072945$1$I$$20240708$20240710$20240710$PER$$US-GILEAD-2024-0679929$GILEAD$$$$E$F$Y$$$20240710$$CN$US$US
240729462$24072946$2$F$$20240726$20240710$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05850$LUPIN$$$$$$Y$$$20240814$$CN$US$US
240729471$24072947$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032931$AUROBINDO$Simpson M, Awuah KB, Patel D, Ogline O, Pratapneni S, Disilvio BE.. Early Extra Corporeal Membrane Oxygenation (ECMO) and Esophagogastroduodenoscopy (EGD) Implementation: A Timely Intervention in a Patient With Extended-Release Bupropion Overdose. Am-J-Respir-Crit-CareMed. 2024;209:A5672$41$YR$$M$Y$$$20240710$$HP$US$US
240729481$24072948$1$I$20230101$20240219$20240710$20240710$EXP$$US-RECORDATI RARE DISEASE INC.-2024001372$RECORDATI$$$$$$Y$$$20240710$$CN$US$US
240729491$24072949$1$I$$20240708$20240710$20240710$PER$$US-ROCHE-10000021391$ROCHE$$25$YR$A$F$Y$$$20240710$$HP$US$US
240729502$24072950$2$F$20240604$20240808$20240710$20240815$EXP$$JP-ROCHE-10000014629$ROCHE$$$$E$M$Y$$$20240815$$MD$JP$JP
240729511$24072951$1$I$$20240621$20240710$20240710$EXP$$PT-ROCHE-10000019926$ROCHE$$62$YR$A$M$Y$$$20240710$$MD$PT$PT
240729521$24072952$1$I$20240510$20240628$20240710$20240710$EXP$$RS-ROCHE-10000019619$ROCHE$$47$YR$A$F$Y$60$KG$20240710$$MD$RS$RS
240729531$24072953$1$I$20231110$20240703$20240710$20240710$EXP$$GB-AUROBINDO-AUR-APL-2024-033214$AUROBINDO$$39$YR$$F$Y$$$20240710$$CN$GB$GB
240729543$24072954$3$F$20240702$20240813$20240710$20240822$PER$$US-ROCHE-10000018444$ROCHE$$29$YR$A$F$Y$$$20240822$$CN$US$US
240729551$24072955$1$I$$20240708$20240710$20240710$EXP$$US-ROCHE-10000020910$ROCHE$$$$E$M$Y$$$20240710$$CN$US$US
240729561$24072956$1$I$$20240701$20240710$20240710$PER$$US-ROCHE-10000021895$ROCHE$$$$A$M$Y$$$20240710$$MD$US$US
240729581$24072958$1$I$$20240627$20240710$20240710$EXP$$IE-ROCHE-10000019996$ROCHE$$76$YR$E$F$Y$$$20240710$$PH$IE$IE
240729591$24072959$1$I$$20240703$20240710$20240710$EXP$GB-MHRA-MED-202406281437236830-WVLTH$GB-AMAROX PHARMA-AMR2024GB02100$HETERO$$$$$$Y$$$20240710$$CN$GB$GB
240729601$24072960$1$I$$20240707$20240710$20240710$PER$$US-ROCHE-10000021524$ROCHE$$$$$$Y$$$20240710$$CN$US$US
240729611$24072961$1$I$20240101$20240701$20240710$20240710$EXP$$US-SA-2024SA197549$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240710$$MD$US$US
240729621$24072962$1$I$$20240703$20240710$20240710$PER$$US-ROCHE-10000019896$ROCHE$$$$A$F$Y$$$20240710$$CN$US$US
240729635$24072963$5$F$20240616$20240827$20240710$20240903$EXP$$CA-ROCHE-10000021166$ROCHE$$43$YR$A$M$Y$$$20240903$$CN$CA$CA
240729644$24072964$4$F$20240626$20240723$20240710$20240731$EXP$$CA-ROCHE-10000021074$ROCHE$$50$YR$A$F$Y$$$20240731$$CN$CA$CA
240729651$24072965$1$I$20240703$20240709$20240710$20240710$EXP$$CN-ROCHE-10000021582$ROCHE$$33$YR$A$F$Y$57$KG$20240710$$HP$CN$CN
240729661$24072966$1$I$$20240628$20240710$20240710$PER$$US-ROCHE-10000016427$ROCHE$$$$E$F$Y$$$20240710$$CN$US$US
240729671$24072967$1$I$20240625$20240628$20240710$20240710$EXP$$PK-ROCHE-10000018352$ROCHE$$43$YR$A$M$Y$$$20240710$$CN$PK$PK
240729682$24072968$2$F$20240701$20240710$20240710$20240715$EXP$$NZ-Merz Pharmaceuticals GmbH-24-02369$MERZ$$43$YR$$F$Y$$$20240715$$PH$NZ$NZ
240729701$24072970$1$I$$20240610$20240710$20240710$EXP$$TH-ROCHE-10000017571$ROCHE$$75$YR$E$F$Y$$$20240710$$CN$TH$TH
240729721$24072972$1$I$$20240627$20240710$20240710$EXP$$US-ROCHE-10000021088$ROCHE$$83$YR$E$M$Y$$$20240710$$CN$US$US
240729732$24072973$2$F$$20240905$20240710$20240914$EXP$$TH-ROCHE-10000011002$ROCHE$$70$YR$E$F$Y$$$20240914$$CN$TH$TH
240729741$24072974$1$I$20240626$20240705$20240710$20240710$EXP$$US-ROCHE-10000019203$ROCHE$$78$YR$E$F$Y$$$20240710$$CN$US$US
240729754$24072975$4$F$20240627$20240710$20240710$20240712$PER$$US-ROCHE-10000018974$ROCHE$$50$YR$A$F$Y$$$20240712$$CN$US$US
240729762$24072976$2$F$$20240629$20240710$20240710$EXP$$US-ROCHE-10000014722$ROCHE$$$$$M$Y$$$20240710$$CN$US$US
240729773$24072977$3$F$$20240726$20240710$20240802$EXP$$KR-ROCHE-10000014086$ROCHE$$59$YR$A$M$Y$$$20240802$$MD$KR$KR
240729781$24072978$1$I$$20240708$20240710$20240710$PER$$US-ROCHE-10000021466$ROCHE$$16$YR$T$F$Y$$$20240710$$CN$US$US
240729791$24072979$1$I$20240607$20240628$20240710$20240710$EXP$$JP-ROCHE-10000016585$ROCHE$$56$YR$A$M$Y$$$20240710$$PH$JP$JP
240729801$24072980$1$I$20240626$20240702$20240710$20240710$EXP$$US-ROCHE-10000019439$ROCHE$$79$YR$E$F$Y$$$20240710$$CN$US$US
240729811$24072981$1$I$20240618$20240702$20240710$20240710$EXP$$CN-ROCHE-10000019151$ROCHE$$34$YR$A$M$Y$$$20240710$$HP$CN$CN
240729821$24072982$1$I$$20240705$20240710$20240710$PER$$US-ROCHE-10000020612$ROCHE$$$$E$M$Y$$$20240710$$CN$US$US
240729831$24072983$1$I$$20240709$20240710$20240710$PER$$US-ROCHE-10000022023$ROCHE$$$$A$F$Y$$$20240710$$HP$US$US
240729841$24072984$1$I$20240504$20240702$20240710$20240710$EXP$$US-ROCHE-10000018485$ROCHE$$55$YR$A$F$Y$$$20240710$$HP$US$US
240729851$24072985$1$I$$20240709$20240710$20240710$EXP$$US-GILEAD-2024-0680106$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240729862$24072986$2$F$$20240708$20240710$20240711$EXP$$US-ROCHE-10000020713$ROCHE$$47$YR$A$F$Y$$$20240711$$CN$US$US
240729871$24072987$1$I$20240530$20240708$20240710$20240710$EXP$$US-ROCHE-10000020899$ROCHE$$54$YR$A$F$Y$$$20240710$$MD$US$US
240729881$24072988$1$I$$20240701$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-032950$AUROBINDO$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al.. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant. 2023;23(7):1048-1057$$$A$M$Y$$$20240710$$HP$US$US
240729911$24072991$1$I$$20240703$20240710$20240710$EXP$$RU-ROCHE-10000018981$ROCHE$$39$YR$A$F$Y$$$20240710$$MD$RU$RU
240729922$24072992$2$F$$20240702$20240710$20240710$EXP$$US-ROCHE-10000018472$ROCHE$$$$A$F$Y$$$20240710$$CN$US$US
240729932$24072993$2$F$20171116$20240721$20240710$20240729$EXP$$CA-ROCHE-10000013896$ROCHE$$52$YR$A$F$Y$$$20240729$$CN$CA$CA
240729941$24072994$1$I$20240611$20240626$20240710$20240710$EXP$$IN-ROCHE-3373273$ROCHE$$88$YR$E$M$Y$$$20240710$$MD$IN$IN
240729951$24072995$1$I$$20240625$20240710$20240710$EXP$$US-ROCHE-10000013167$ROCHE$$52$YR$A$M$Y$$$20240710$$CN$US$US
240729981$24072998$1$I$20240427$20240703$20240710$20240710$EXP$$US-ROCHE-10000020342$ROCHE$$68$YR$E$F$Y$$$20240710$$CN$US$US
240729991$24072999$1$I$$20240625$20240710$20240710$PER$$US-ROCHE-10000014240$ROCHE$$$$$$Y$$$20240710$$CN$US$US
240730001$24073000$1$I$20231201$20240709$20240710$20240710$EXP$RO-AMGEN-ROUSP2024108468$RO-ROCHE-10000021462$ROCHE$$52$YR$A$M$Y$$$20240710$$MD$RO$RO
240730014$24073001$4$F$20240627$20240919$20240710$20240927$EXP$$CA-ROCHE-10000019441$ROCHE$$30$YR$A$F$Y$$$20240927$$CN$CA$CA
240730021$24073002$1$I$$20240703$20240710$20240710$PER$$US-ROCHE-10000020233$ROCHE$$37$YR$A$M$Y$$$20240710$$CN$US$US
240730033$24073003$3$F$20090206$20240712$20240710$20240722$EXP$DE-PVZIBE-JENA-10070$DE-ROCHE-10000016648$ROCHE$$66$YR$E$F$Y$70$KG$20240722$$MD$DE$DE
240730051$24073005$1$I$$20240702$20240710$20240710$PER$$US-APOTEX-2024AP007988$APOTEX$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation. American Journal of Transplantation. 2011;11 (3):500-510$51$YR$$M$Y$$$20240710$$HP$US$US
240730061$24073006$1$I$20230404$20240705$20240710$20240710$EXP$$CO-UCBSA-2024034849$UCB$$66$YR$$M$Y$$$20240710$$CN$CO$CO
240730071$24073007$1$I$20240328$20240701$20240710$20240710$PER$FR-AFSSAPS-LY2024000851$FR-PFM-2024-03814$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$MD$FR$FR
240730092$24073009$2$F$$20240814$20240710$20240819$PER$$US-ROCHE-10000021368$ROCHE$$$$A$F$Y$$$20240819$$CN$US$US
240730101$24073010$1$I$20240401$20240408$20240710$20240710$EXP$$US-RECORDATI RARE DISEASE INC.-2024002670$RECORDATI$$$$$$Y$$$20240710$$PH$US$US
240730111$24073011$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281502574640-CFGVW$GB-Accord-433486$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240730121$24073012$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281456410520-PYKZQ$GB-Accord-433481$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240730131$24073013$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281041575460-KYCFR$GB-Accord-433363$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240730141$24073014$1$I$20220322$20240629$20240710$20240710$EXP$IT-MINISAL02-992819$IT-Accord-433925$ACCORD$$57$YR$A$M$Y$$$20240710$$MD$IT$IT
240730152$24073015$2$F$$20240708$20240710$20240718$EXP$GB-MHRA-MED-202406281439120430-SHLWN$GB-Accord-433455$ACCORD$$$$$$Y$$$20240718$$CN$GB$GB
240730161$24073016$1$I$$20240629$20240710$20240710$EXP$GB-MHRA-MED-202406291352445690-FRSGZ$GB-Accord-433726$ACCORD$$$$$M$Y$$$20240710$$CN$GB$GB
240730171$24073017$1$I$20240620$20240629$20240710$20240710$EXP$IT-MINISAL02-992706$IT-Accord-433749$ACCORD$$59$YR$A$M$Y$$$20240710$$PH$IT$IT
240730181$24073018$1$I$$20240629$20240710$20240710$EXP$GB-MHRA-MED-202406291145190840-GJMRH$GB-Accord-433713$ACCORD$$$$$M$Y$$$20240710$$CN$GB$GB
240730192$24073019$2$F$$20240722$20240710$20240801$EXP$FR-AFSSAPS-AN2024000833$FR-Accord-433611$ACCORD$$54$YR$A$M$Y$80$KG$20240801$$PH$FR$FR
240730201$24073020$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281035540500-DRMKH$GB-Accord-433623$ACCORD$$$$$F$Y$$$20240710$$CN$GB$GB
240730211$24073021$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281443140430-YKFLG$GB-Accord-433469$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240730221$24073022$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281137402150-JMBTC$GB-Accord-433406$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240730232$24073023$2$F$20240531$20240805$20240710$20240814$EXP$$AU-Accord-433846$ACCORD$$$$$F$Y$$$20240814$$PH$AU$AU
240730242$24073024$2$F$20240605$20240805$20240710$20240814$EXP$$AU-Accord-433843$ACCORD$$$$$F$Y$$$20240814$$PH$AU$AU
240730251$24073025$1$I$$20240705$20240710$20240710$EXP$$US-GSK-US2024083801$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
240730261$24073026$1$I$$20240703$20240710$20240710$30DAY$$US-GSK-US2024083242$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
240730271$24073027$1$I$20220301$20240628$20240710$20240710$EXP$DE-EMA-DD-20240627-7482677-131330$DE-Accord-433248$ACCORD$$72$YR$E$F$Y$$$20240710$$MD$DE$DE
240730281$24073028$1$I$$20240630$20240710$20240710$EXP$$ET-Accord-433914$ACCORD$Gashawbeza B, Dereje B, Abubeker FA. Primary Dysgerminoma of the Uterine Cervix: A Rare Case Report. Case Rep Obstet Gynecol. 2024 May 31;2024:6465387.$18$YR$A$F$Y$$$20240710$$HP$ET$ET
240730291$24073029$1$I$$20240702$20240710$20240710$EXP$$US-AMERICAN REGENT INC-2024002588$AMERICAN REGENT$Epler KE, Crouch DR, Van Nostrand K. Serotonin-Like-Syndrome Resulting From Tranexamic Acid Applied to Airways During Flexible Bronchoscopy. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5805[abstract]$44$YR$$M$Y$$$20240710$$HP$US$US
240730301$24073030$1$I$$20240703$20240710$20240710$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR084556$VIIV$$$$$$Y$$$20240710$$HP$US$US
240730311$24073031$1$I$$20240704$20240710$20240710$EXP$$US-JNJFOC-20240718120$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240730321$24073032$1$I$$20240701$20240710$20240710$EXP$$US-FreseniusKabi-FK202410636$FRESENIUS KABI$Wong C, Ang G, Malik M, Iqbal S. From Tongue Swelling to Skin Sloughing: Azithromycin-induced SJS/TEN. American Journal of Respiratory and Critical Care Medicine. 2024 May 21;209:$71$YR$E$F$Y$$$20240710$$HP$US$US
240730331$24073033$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405132328117890-HTSGN$GB-FreseniusKabi-FK202410744$FRESENIUS KABI$$$$$M$Y$$$20240710$$CN$GB$GB
240730341$24073034$1$I$$20240709$20240710$20240710$30DAY$$US-SANDOZ INC.-SDZ2023US012670$SANDOZ$$$$$M$Y$$$20240710$$CN$US$US
240730351$24073035$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109391$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240710$$HP$US$US
240730362$24073036$2$F$$20240912$20240710$20240913$EXP$$NVSC2024US141108$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
240730371$24073037$1$I$$20240701$20240710$20240710$EXP$$US-AMAROX PHARMA-HET2024US02144$HETERO$Al-Moussally F, Thompson BM, Masarweh OM, Shah N, Gaudi S, Restrepo J.. Atorvastatin-Associated Eosinophilic Spongiosis: A Case Report and a Relevant Literature Review of Dermatological Manifestations. Cureus. 2024;16(5):1-5$72$YR$$M$Y$$$20240710$$HP$US$US
240730381$24073038$1$I$$20240626$20240710$20240710$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06027$HIKMA$Ali F, Arshad K, Latif R, Farooq A, Nanjundappa A.. Ali F, Arshad K, Latif R, Farooq A, Nanjundappa A. Spontaneous spinal epidural hematoma following IV heparin and catheter-directed thrombolysis for deep vein thrombosis.. Journal of Vascular Surgery Cases, Innovations and Techniques. 2024;10(4):/$$$$$Y$$$20240710$$MD$US$US
240730391$24073039$1$I$$20240703$20240710$20240710$EXP$GB-MHRA-MED-202406280855400820-VQTNC$GB-AMAROX PHARMA-AMR2024GB02093$HETERO$$$$$M$Y$$$20240710$$CN$GB$GB
240730401$24073040$1$I$$20240709$20240710$20240710$EXP$IT-MINISAL02-994087$IT-GILEAD-2024-0680043$GILEAD$$79$YR$E$M$Y$$$20240710$$MD$IT$IT
240730411$24073041$1$I$$20240708$20240710$20240710$PER$$US-GILEAD-2024-0679940$GILEAD$$$$$$Y$$$20240710$$CN$US$US
240730431$24073043$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05847$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240730443$24073044$3$F$20240101$20240805$20240710$20240816$EXP$$US-INSMED-2024-01604-USAA$INSMED$$$$$F$Y$$$20240816$$CN$US$US
240730451$24073045$1$I$$20240701$20240710$20240710$PER$$US-TEVA-VS-3217231$TEVA$$$$A$M$Y$$$20240710$$CN$US$US
240730461$24073046$1$I$$20240629$20240710$20240710$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000961$ALEMBIC$$$$$$Y$$$20240709$$CN$US$US
240730472$24073047$2$F$$20240719$20240710$20240729$EXP$$IT-TEVA-VS-3217289$TEVA$Berloffa S, Dosi C, Tascini B, Fossati B, Lupetti I, Masi G. Neuroleptic malignant syndrome in children with autism spectrum disorder (Asd): A case report and brief review of recent literature. Children-(Basel) 2021; 8 (12):.; Berloffa S, Dosi C, Tascini B, Fossati B, Lupetti I, Masi G. Neuroleptic malignant syndrome in children with autism spectrum disorder (Asd): A case report and brief review of recent literature. Children-(Basel) 2021; 8 (12):.; Berloffa S, Dosi C, Tascini B, Fossati B, L...$16$YR$$M$Y$$$20240729$$HP$IT$IT
240730481$24073048$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024136046$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240730491$24073049$1$I$$20240430$20240710$20240710$EXP$$US-RECORDATI RARE DISEASE INC.-2024000845$RECORDATI$$$$$$Y$$$20240710$$CN$US$US
240730502$24073050$2$F$20240701$20240813$20240710$20240816$EXP$$NVSC2024DE141871$NOVARTIS$$41$YR$$F$Y$$$20240816$$MD$DE$DE
240730521$24073052$1$I$$20240702$20240710$20240710$EXP$$ZA-AstraZeneca-2024A153343$ASTRAZENECA$$66$YR$$M$Y$$$20240710$$CN$ZA$
240730533$24073053$3$F$20240630$20240826$20240710$20240902$EXP$$JP-AstraZeneca-2024A154543$ASTRAZENECA$$47$YR$$F$Y$40$KG$20240902$$MD$JP$
240730543$24073054$3$F$20240101$20240815$20240710$20240819$EXP$$US-UCBSA-2024026884$UCB$$$$$F$Y$$$20240819$$CN$US$US
240730551$24073055$1$I$20240629$20240701$20240710$20240710$PER$$US-JNJFOC-20240701467$JOHNSON AND JOHNSON$$40$YR$A$M$Y$74.91$KG$20240710$$PH$US$US
240730561$24073056$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186281$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240730571$24073057$1$I$20110107$20240704$20240710$20240710$EXP$$KR-ASTELLAS-2024EU006687$ASTELLAS$$57$YR$$M$Y$$$20240710$$HP$GB$KR
240730581$24073058$1$I$$20240626$20240710$20240710$EXP$$AU-GENERIC HEALTH PTY. LTD.-2024-06449$LUPIN$Gerostamoulos D, Glowacki L, Pricone M, Crump K, Rago MD, Joubert S, et al. Fatal intoxications from a combination of 4-Fluoroamphetamine and 25C-NBOMe. Journal of Analytical Toxicology. 2022;47 (2):191-196$$$$F$Y$$$20240710$$HP$AU$AU
240730591$24073059$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198042$SANOFI AVENTIS$$$$E$M$Y$74.48$KG$20240710$$MD$US$US
240730601$24073060$1$I$$20240702$20240710$20240710$PER$$US-SA-2024SA199813$SANOFI AVENTIS$$$$E$F$Y$47.166$KG$20240710$$MD$US$US
240730611$24073061$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA200712$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240710$$MD$US$US
240730621$24073062$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA197648$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240710$$MD$US$US
240730631$24073063$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198158$SANOFI AVENTIS$$$$E$F$Y$$$20240710$$MD$US$US
240730641$24073064$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA198662$SANOFI AVENTIS$$61$YR$A$M$Y$68.9$KG$20240710$$HP$US$US
240730651$24073065$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA198470$SANOFI AVENTIS$$11$YR$C$M$Y$26.3$KG$20240710$$MD$US$US
240730661$24073066$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA196274$SANOFI AVENTIS$$$$$M$Y$$$20240710$$PH$US$US
240730671$24073067$1$I$20240601$20240705$20240710$20240710$PER$$US-SA-2024SA200774$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240710$$CN$US$US
240730681$24073068$1$I$20240703$20240703$20240710$20240710$PER$$US-SA-2024SA200699$SANOFI AVENTIS$$36$YR$A$M$Y$68.03$KG$20240710$$MD$US$US
240730691$24073069$1$I$20230101$20240703$20240710$20240710$PER$$US-SA-2024SA198693$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240710$$CN$US$US
240730702$24073070$2$F$$20240705$20240710$20240717$PER$$US-SA-2024SA198182$SANOFI AVENTIS$$$$A$M$Y$99$KG$20240717$$MD$US$US
240730711$24073071$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198036$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240710$$MD$US$US
240730721$24073072$1$I$$20240702$20240710$20240710$PER$$US-SA-2024SA199540$SANOFI AVENTIS$$$$A$M$Y$$$20240710$$MD$US$US
240730731$24073073$1$I$$20240705$20240710$20240710$EXP$$US-BIOGEN-2024BI01271966$BIOGEN$$$$$F$Y$$$20240710$$CN$US$US
240730741$24073074$1$I$20240410$20240701$20240710$20240710$EXP$ES-AEMPS-1538475$ES-TEVA-VS-3216167$TEVA$$56$YR$$F$Y$$$20240710$$MD$ES$ES
240730751$24073075$1$I$20240702$20240704$20240710$20240710$EXP$$CN-AMGEN-CHNSP2024133664$AMGEN$$64$YR$E$M$Y$$$20240710$$HP$CN$CN
240730761$24073076$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133581$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31 (6):3529-3545$49$YR$A$M$Y$$$20240710$$HP$US$US
240730771$24073077$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024136211$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240730781$24073078$1$I$$20240709$20240710$20240710$EXP$$NVSC2024US142046$NOVARTIS$$$$$$Y$$$20240710$$CN$US$US
240730791$24073079$1$I$20240512$20240705$20240710$20240710$EXP$$DE-BAYER-2024A072324$BAYER$$36$YR$A$F$Y$$$20240710$$CN$DE$DE
240730801$24073080$1$I$$20240704$20240710$20240710$EXP$$AU-ASTELLAS-2024US019156$ASTELLAS$Goradia S, Holper S, Lim YZ, Brady SR. Anti-melanoma differentiation-associated gene 5 (anti-MDA5) positive dermatomyositis: early detection is crucial. BMJ Case Reports. 2024;17(6):1-4$7$DEC$$F$Y$$$20240710$$HP$AU$AU
240730811$24073081$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06321$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240730821$24073082$1$I$$20240709$20240710$20240710$EXP$$US-GILEAD-2024-0680113$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240730831$24073083$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198022$SANOFI AVENTIS$$4$YR$C$F$Y$16$KG$20240710$$MD$US$US
240730841$24073084$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA197978$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240710$$MD$US$US
240730851$24073085$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA196842$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240710$$CN$US$US
240730861$24073086$1$I$20240320$20240702$20240710$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-032839$AUROBINDO$$59$YR$$F$Y$70$KG$20240710$$PH$FR$FR
240730871$24073087$1$I$20210101$20240701$20240710$20240710$PER$$US-SA-2024SA199580$SANOFI AVENTIS$$24$YR$A$F$Y$65.7$KG$20240710$$MD$US$US
240730882$24073088$2$F$20240101$20240917$20240710$20240926$PER$$US-SA-2024SA198033$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240926$$MD$US$US
240730891$24073089$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA110876$SANOFI AVENTIS$$$$A$F$Y$61.2$KG$20240710$$MD$US$US
240730901$24073090$1$I$20240425$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405052104531520-SZPJT$GB-ABBVIE-5832207$ABBVIE$$$$$$Y$$$20240710$$CN$GB$GB
240730911$24073091$1$I$$20240703$20240710$20240710$EXP$$US-ROCHE-10000018540$ROCHE$$$$$$Y$$$20240710$$CN$US$US
240730921$24073092$1$I$$20240701$20240710$20240710$30DAY$$US-GSK-US2024081619$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
240730931$24073093$1$I$$20240702$20240710$20240710$EXP$$BR-PFIZER INC-PV202400089206$PFIZER$$47$YR$$M$Y$$$20240710$$HP$BR$BR
240730941$24073094$1$I$$20240707$20240710$20240710$EXP$$IL-PFIZER INC-PV202400089220$PFIZER$$$$$F$Y$$$20240710$$CN$IL$IL
240730951$24073095$1$I$$20240703$20240710$20240710$EXP$GB-MHRA-MED-202406291228213970-KGHYM$GB-TEVA-VS-3216847$TEVA$$30$YR$$M$Y$$$20240710$$CN$GB$GB
240730961$24073096$1$I$$20240707$20240710$20240710$EXP$$RO-PFIZER INC-PV202400089238$PFIZER$$54$YR$$F$Y$$$20240710$$MD$RO$RO
240730973$24073097$3$F$20240704$20240925$20240710$20240930$EXP$$IN-PFIZER INC-PV202400089825$PFIZER$$66$YR$$M$Y$$$20240930$$CN$IN$IN
240730981$24073098$1$I$$20240703$20240710$20240710$EXP$$IE-PFIZER INC-PV202400087296$PFIZER$$80$YR$$F$Y$$$20240710$$HP$IE$IE
240730991$24073099$1$I$20240426$20240705$20240710$20240710$EXP$ES-AEMPS-1543141$ES-PFIZER INC-202400207467$PFIZER$$71$YR$$M$Y$$$20240710$$HP$ES$ES
240731002$24073100$2$F$20240621$20240726$20240710$20240731$EXP$$ES-PFIZER INC-PV202400089177$PFIZER$$49$YR$$F$Y$68.4$KG$20240731$$MD$ES$ES
240731012$24073101$2$F$20200101$20240712$20240710$20240718$EXP$$CA-PFIZER INC-PV202400063512$PFIZER$$65$YR$$F$Y$83$KG$20240718$$MD$CA$CA
240731031$24073103$1$I$20240704$20240705$20240710$20240710$EXP$$JP-PFIZER INC-PV202400088822$PFIZER$$84$YR$$M$Y$$$20240710$$PH$JP$JP
240731041$24073104$1$I$20231008$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405160812016360-QLCBY$GB-PFIZER INC-202400207412$PFIZER$$26$YR$$F$Y$54$KG$20240710$$CN$GB$GB
240731051$24073105$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405170907418370-BHNFM$GB-PFIZER INC-202400207552$PFIZER$$$$$F$Y$$$20240710$$HP$GB$GB
240731061$24073106$1$I$20231201$20240705$20240710$20240710$EXP$ES-AEMPS-1539101$ES-PFIZER INC-202400207486$PFIZER$$2$YR$$F$Y$12$KG$20240710$$MD$ES$ES
240731071$24073107$1$I$20240101$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405031624150060-GJKDW$GB-PFIZER INC-202400207336$PFIZER$$$$$M$Y$111$KG$20240710$$MD$GB$GB
240731081$24073108$1$I$20240429$20240705$20240710$20240710$EXP$FR-AFSSAPS-RS2024000652$FR-PFIZER INC-202400207396$PFIZER$$75$YR$$M$Y$87$KG$20240710$$MD$FR$FR
240731092$24073109$2$F$$20240716$20240710$20240724$EXP$$NO-PFIZER INC-2017SGN02884$PFIZER$$$$$M$Y$$$20240724$$CN$NO$NO
240731101$24073110$1$I$20240625$20240708$20240710$20240710$EXP$$CN-PFIZER INC-PV202400089420$PFIZER$$52$YR$$M$Y$$$20240710$$HP$CN$CN
240731112$24073111$2$F$$20240715$20240710$20240717$EXP$$PT-PFIZER INC-2021SGN03513$PFIZER$$58$YR$$F$Y$$$20240717$$MD$PT$PT
240731121$24073112$1$I$$20240702$20240710$20240710$EXP$$US-AUROBINDO-AUR-APL-2024-033504$AUROBINDO$Koga S, Pai E, Banihashemi A.. Diffuse lymphocytic encephalomyelitis with stiffperson- like syndrome in multiple myeloma after Teclistamab treatment. J-Neuropathol-Exp-Neurol. 2024;83(6):457-458 abstr. 5.$45$YR$$M$Y$$$20240710$$HP$US$US
240731131$24073113$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109373$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$87.54$KG$20240710$$CN$US$US
240731141$24073114$1$I$$20240705$20240710$20240710$EXP$$US-GSK-US2024083884$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
240731152$24073115$2$F$$20240808$20240710$20240817$30DAY$$US-GSK-US2024081600$GLAXOSMITHKLINE$$$$$F$Y$$$20240817$$CN$US$US
240731161$24073116$1$I$$20240701$20240710$20240710$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR084546$VIIV$$$$$$Y$$$20240710$$HP$US$US
240731171$24073117$1$I$20240630$20240702$20240710$20240710$EXP$$CN-FreseniusKabi-FK202410556$FRESENIUS KABI$$41$YR$A$F$Y$50$KG$20240710$$HP$CN$CN
240731191$24073119$1$I$$20240701$20240710$20240710$EXP$$IT-TEVA-VS-3217326$TEVA$Fattizzo B, Pasquale R, Croci GA, Pettine L, Cassanello G, Barcellini W. Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review. Blood-Transf 2024; 22 (3): 266-272.$43$YR$$M$Y$$$20240710$$HP$IT$IT
240731201$24073120$1$I$20240629$20240704$20240710$20240710$EXP$$FR-BIOGEN-2024BI01272698$BIOGEN$$41$YR$$F$Y$$$20240710$$MD$FR$FR
240731211$24073121$1$I$20240707$20240708$20240710$20240710$EXP$$CA-BIOGEN-2024BI01272894$BIOGEN$$61$YR$$F$Y$$$20240710$$CN$CA$CA
240731221$24073122$1$I$$20240702$20240710$20240710$PER$$US-ROCHE-10000022143$ROCHE$$$$$$Y$$$20240710$$CN$US$US
240731231$24073123$1$I$20240418$20240705$20240710$20240710$EXP$$GB-MYLANLABS-2024M1063746$MYLAN$$33$YR$$F$Y$83$KG$20240710$$CN$GB$GB
240731243$24073124$3$F$$20240916$20240710$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004956$BIOCON$$$$$$Y$$$20240926$$HP$CA$CA
240731251$24073125$1$I$20100101$20240705$20240710$20240710$EXP$GB-MHRA-MED-202406262240085340-WRQJG$GB-MYLANLABS-2024M1063774$MYLAN$$$$$F$Y$$$20240710$$CN$GB$GB
240731261$24073126$1$I$20240626$20240705$20240710$20240710$EXP$$GB-MYLANLABS-2024M1064018$MYLAN$$80$YR$$F$Y$108$KG$20240710$$MD$GB$GB
240731271$24073127$1$I$20240514$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405171141332930-KLCBG$GB-MYLANLABS-2024M1063503$MYLAN$$89$YR$$F$Y$$$20240710$$PH$GB$GB
240731281$24073128$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405161632105600-RFYBT$GB-MYLANLABS-2024M1063695$MYLAN$$$$$F$Y$$$20240710$$CN$GB$GB
240731291$24073129$1$I$20240511$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405111859298430-VKGCT$GB-MYLANLABS-2024M1063593$MYLAN$$3$YR$$F$Y$17$KG$20240710$$MD$GB$GB
240731301$24073130$1$I$20240307$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405162030425190-YNHGW$GB-MYLANLABS-2024M1063458$MYLAN$$33$YR$$F$Y$73$KG$20240710$$CN$GB$GB
240731311$24073131$1$I$20230915$20240705$20240710$20240710$EXP$$GB-MYLANLABS-2024M1063868$MYLAN$$70$YR$$$Y$83$KG$20240710$$CN$GB$GB
240731321$24073132$1$I$20230601$20240705$20240710$20240710$EXP$$GB-MYLANLABS-2024M1063812$MYLAN$$44$YR$$M$Y$108$KG$20240710$$CN$GB$GB
240731331$24073133$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405091618218170-JRLNH$GB-MYLANLABS-2024M1063580$MYLAN$$$$$M$Y$$$20240710$$CN$GB$GB
240731342$24073134$2$F$$20240918$20240710$20240920$EXP$GB-MHRA-MED-202406260950346500-CPFHT$GB-MYLANLABS-2024M1063761$MYLAN$$$$$M$Y$$$20240920$$CN$GB$GB
240731351$24073135$1$I$20240620$20240705$20240710$20240710$EXP$$GB-MYLANLABS-2024M1063716$MYLAN$$61$YR$$F$Y$60$KG$20240710$$MD$GB$GB
240731361$24073136$1$I$20240621$20240628$20240710$20240710$EXP$$CN-TETRAPHASE PHARMACEUTICALS, INC-2024-INNO-CN000046$PAREXEL$$$$$$Y$$$20240710$$HP$CN$CN
240731373$24073137$3$F$20240628$20240725$20240710$20240731$EXP$$US-LEO Pharma-371671$LEO PHARM$$75$YR$$M$Y$$$20240731$$CN$US$US
240731381$24073138$1$I$$20240702$20240710$20240710$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005004$BIOCON$$$$$$Y$$$20240710$$HP$CA$CA
240731392$24073139$2$F$$20240724$20240710$20240729$EXP$$IT-AMGEN-ITASP2024132876$AMGEN$Tursi A.; Nenna R.. Endoscopic appearance is not sufficient for a diagnosis of segmental colitis associated with diverticulosis. Annals of Gastroenterology. 2024;37:377-380$41$YR$A$F$Y$$$20240729$$MD$IT$IT
240731401$24073140$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05848$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240731413$24073141$3$F$$20240723$20240710$20240801$EXP$$BR-TEVA-VS-3216944$TEVA$$50$YR$$F$Y$102$KG$20240801$$PH$BR$BR
240731421$24073142$1$I$$20240703$20240710$20240710$EXP$NO-NOMAADVRE-PASRAPP-2024-Vp3xnn$NO-CHEPLA-2024008450$CHEPLAPHARM$$54$YR$$F$Y$76$KG$20240710$$CN$COUNTRY NOT SPECIFIED$NO
240731431$24073143$1$I$20240309$20240703$20240710$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-033289$AUROBINDO$$14$YR$$F$Y$60$KG$20240710$$PH$FR$FR
240731441$24073144$1$I$20240101$20240708$20240710$20240710$EXP$SE-SEMPA-2024-004013$SE-PFIZER INC-202400208405$PFIZER$$28$YR$$F$Y$73$KG$20240710$$MD$SE$SE
240731451$24073145$1$I$20240523$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47796$$FDA-CTU$$67$YR$$F$N$72.2$KG$20240709$N$$US$
240731461$24073146$1$I$$20240708$20240710$20240710$EXP$$CN-PFIZER INC-PV202400089088$PFIZER$$$$A$M$Y$$$20240710$$CN$CN$CN
240731472$24073147$2$F$20120801$20240715$20240710$20240717$EXP$DE-CADRBFARM-2024329126$DE-PFIZER INC-202400208347$PFIZER$$26$YR$$F$Y$75$KG$20240717$$CN$DE$DE
240731482$24073148$2$F$20240514$20240807$20240710$20240812$EXP$$CA-PFIZER INC-202400209021$PFIZER$$79$YR$$M$Y$75.283$KG$20240812$$MD$CA$CA
240731492$24073149$2$F$20240101$20240901$20240710$20240902$EXP$$CA-PFIZER INC-202300237601$PFIZER$$74$YR$$F$Y$$$20240902$$MD$CA$CA
240731501$24073150$1$I$20240624$20240709$20240710$20240710$EXP$$CN-PFIZER INC-PV202400090099$PFIZER$$7$YR$$F$Y$29$KG$20240710$$HP$CN$CN
240731511$24073151$1$I$20240601$20240708$20240710$20240710$EXP$$CA-PFIZER INC-202400197773$PFIZER$$64$YR$$F$Y$$$20240710$$HP$CA$CA
240731523$24073152$3$F$$20240801$20240710$20240806$EXP$$US-PFIZER INC-PV202400089749$PFIZER$$48$YR$$F$Y$$$20240806$$PH$US$US
240731531$24073153$1$I$$20240709$20240710$20240710$EXP$$ES-PFIZER INC-202201290999$PFIZER$$$$$F$Y$$$20240710$$MD$ES$ES
240731541$24073154$1$I$20240528$20240708$20240710$20240710$EXP$$CN-PFIZER INC-PV202400089417$PFIZER$$68$YR$$F$Y$80$KG$20240710$$HP$CN$CN
240731561$24073156$1$I$20240609$20240709$20240710$20240710$EXP$PT-INFARMED-R202407-59$PT-PFIZER INC-202400209345$PFIZER$$50$YR$$F$Y$100$KG$20240710$$MD$PT$PT
240731571$24073157$1$I$20240701$20240708$20240710$20240710$EXP$$CN-PFIZER INC-PV202400089411$PFIZER$$45$YR$$F$Y$62$KG$20240710$$HP$CN$CN
240731581$24073158$1$I$$20240708$20240710$20240710$EXP$$US-PFIZER INC-202400209380$PFIZER$$46$YR$$F$Y$$$20240710$$MD$US$US
240731591$24073159$1$I$20240705$20240708$20240710$20240710$EXP$$CN-PFIZER INC-PV202400089398$PFIZER$$29$YR$$F$Y$62$KG$20240710$$HP$CN$CN
240731601$24073160$1$I$20240630$20240708$20240710$20240710$EXP$$CN-PFIZER INC-PV202400089400$PFIZER$$30$YR$$F$Y$71$KG$20240710$$HP$CN$CN
240731611$24073161$1$I$20240626$20240708$20240710$20240710$EXP$$CN-PFIZER INC-PV202400089406$PFIZER$$34$YR$$F$Y$83$KG$20240710$$HP$CN$CN
240731621$24073162$1$I$$20240704$20240710$20240710$EXP$$KW-JNJFOC-20240714770$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$MD$KW$KW
240731631$24073163$1$I$20240402$20240708$20240710$20240710$EXP$$US-PFIZER INC-202400209285$PFIZER$$53$YR$$F$Y$73.03$KG$20240710$$CN$US$US
240731641$24073164$1$I$20240709$20240709$20240710$20240710$PER$$US-JNJFOC-20240722971$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240710$$CN$US$US
240731651$24073165$1$I$$20240625$20240710$20240710$EXP$$FI-BRAEBURN-FI-BRA-24-000631$BRAEBURN PHARMACEUTICALS$Claudia Mariottini. Buprenorphine deaths confirmed by toxicology reveal a low proportion of opioid agonist treatment before death in Finland.. International Journal of Legal Medicine. 2024;1-8$$$$$Y$$$20240710$$HP$FI$FI
240731661$24073166$1$I$$20240704$20240710$20240710$EXP$$DE-AMGEN-DEUSP2024132750$AMGEN$Pacis S.; Bolzani A.; Heuck A. et al.. Epidemiology and Real-World Treatment of Incident Diffuse Large B-cell Lymphoma (DLBCL)- A German Claims Data Analysis. Oncology and Therapy. 2024;12 (2):293-309$$$$$Y$$$20240710$$HP$DE$DE
240731671$24073167$1$I$$20240703$20240710$20240710$PER$$US-ROCHE-10000020441$ROCHE$$51$YR$A$F$Y$$$20240710$$CN$US$US
240731682$24073168$2$F$20240604$20240712$20240710$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024083885$VIIV$$31$YR$$M$Y$$$20240722$$CN$US$US
240731691$24073169$1$I$$20240703$20240710$20240710$EXP$$IT-MYLANLABS-2024M1064057$MYLAN$Scollo C, Rossi D, D^Andria R, Magnano R, Pezzi L, D^Alleva A, et al. Cardiovascular considerations in antidepressant therapy: sinus arrest due to sertraline. Eur-Heart-J-Suppl 2024; 26 (Suppl. 2) ii78.$39$YR$$F$Y$$$20240710$$HP$IT$IT
240731701$24073170$1$I$20240319$20240704$20240710$20240710$EXP$$DE-JNJFOC-20240713148$JOHNSON AND JOHNSON$$84$YR$E$F$Y$67$KG$20240710$$MD$DE$DE
240731711$24073171$1$I$$20240703$20240710$20240710$EXP$$CH-MYLANLABS-2024M1064073$MYLAN$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. Unhappy hearts with the antidepressant venlafaxine. Swiss-Med-Wkly 2024; 154 (Suppl.) (6): 63S-64S (plus Poster) abstr. P27.$51$YR$$F$Y$$$20240710$$HP$CH$CH
240731721$24073172$1$I$$20240703$20240710$20240710$EXP$$CH-MYLANLABS-2024M1064053$MYLAN$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. Unhappy Hearts With The Antidepressant Venlafaxine. Swiss-Med-Wkly 2024; 154 (Suppl.) (6): 63S-64S (plus Poster) abstr. P27.$77$YR$$F$Y$$$20240710$$HP$CH$CH
240731732$24073173$2$F$$20240731$20240710$20240805$EXP$$CA-MYLANLABS-2024M1064041$MYLAN$Lee J, Chopra N, Costa T, George TP. Treatment of ketamine use disorder with combined gabapentin and topiramate: two case reports. Am-J-Drug-Alcohol-Abuse 2024;.$28$YR$$F$Y$$$20240805$$HP$CA$CA
240731741$24073174$1$I$$20240703$20240710$20240710$EXP$$CH-MYLANLABS-2024M1064042$MYLAN$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. Unhappy hearts with the antidepressant venlafaxine. Swiss-Med-Wkly 2024; 154 (Suppl.) (6): 63S-64S (plus Poster) abstr. P27.$82$YR$$M$Y$$$20240710$$HP$CH$CH
240731751$24073175$1$I$$20240630$20240710$20240710$EXP$$CN-Accord-434134$ACCORD$He A, Xu L, Li S, Qiu J. Sertraline Hydrochloride Overdose Resulting in Diabetes Insipidus: A Case Report. Cureus. 2024 May 23;16(5):e60952.$17$YR$T$F$Y$$$20240710$$HP$CN$CN
240731761$24073176$1$I$$20240630$20240710$20240710$EXP$$CN-Accord-434114$ACCORD$Zhu P, Wang M, Sun Q, Dong W. Right eye metastasis of small-cell lung carcinoma: A case report. Exp Ther Med. 2024 Jun 14;28(2):318.$54$YR$A$M$Y$$$20240710$$HP$CN$CN
240731771$24073177$1$I$$20240630$20240710$20240710$EXP$$CN-Accord-434086$ACCORD$Wu J, Hu Y. A late-onset hyperammonemia syndrome caused by Ureaplasma parvum infection after kidney transplantation. Heliyon. 2024;10(11):e32134.$64$YR$A$M$Y$$$20240710$$HP$CN$CN
240731781$24073178$1$I$20240607$20240627$20240710$20240710$EXP$FR-AFSSAPS-MP2024001041$FR-Axellia-005261$XELLIA PHARMACEUTICALS$$82$YR$E$M$Y$85$KG$20240710$$PH$FR$FR
240731793$24073179$3$F$$20240805$20240710$20240806$PER$$US-ALXN-202407USA000392US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240731801$24073180$1$I$20240525$20240627$20240710$20240710$EXP$ES-AEMPS-1540602$ES-Axellia-005264$XELLIA PHARMACEUTICALS$$78$YR$E$M$Y$$$20240710$$MD$ES$ES
240731811$24073181$1$I$$20240702$20240710$20240710$PER$$US-ROCHE-10000021669$ROCHE$$$$E$M$Y$$$20240710$$CN$US$US
240731822$24073182$2$F$$20240805$20240710$20240806$EXP$$JP-BAYER-2024A097030$BAYER$$70$YR$E$M$Y$$$20240806$$PH$JP$JP
240731831$24073183$1$I$20240429$20240703$20240710$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-033268$AUROBINDO$$75$YR$$M$Y$87$KG$20240710$$MD$FR$FR
240731841$24073184$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06317$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240731851$24073185$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05853$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240731871$24073187$1$I$$20240703$20240710$20240710$EXP$$US-AMGEN-USASP2024132075$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240731881$24073188$1$I$$20240709$20240710$20240710$PER$$US-GILEAD-2024-0680088$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240731892$24073189$2$F$20240703$20240729$20240710$20240803$EXP$GB-MHRA-MED-202407032204148930-MRGNP$GB-TEVA-VS-3217153$TEVA$$17$YR$$$Y$$$20240803$$CN$GB$GB
240731901$24073190$1$I$$20240703$20240710$20240710$EXP$$IT-MYLANLABS-2024M1064100$MYLAN$Ferrara A, Di Fonzo R, Vigorito F, Galasso G, Vecchione C, Soriente L. Pulmonary hypertension and congenital heart disease: the clinic beyond the evidence. Eur-Heart-J-Suppl 2024; 26 (Suppl. 2) ii98.$44$YR$$$Y$$$20240710$$HP$IT$IT
240731911$24073191$1$I$20240701$20240702$20240710$20240710$EXP$GB-MHRA-MED-202407021200033630-CDZPF$GB-TEVA-VS-3217514$TEVA$$55$YR$$F$Y$$$20240710$$HP$GB$GB
240731921$24073192$1$I$20240513$20240703$20240710$20240710$EXP$NO-NOMAADVRE-RELISM-2024-Vrn35d$NO-REGENERON PHARMACEUTICALS, INC.-2024-093355$REGENERON$$73$YR$$F$Y$$$20240710$$MD$NO$NO
240731934$24073193$4$F$$20240717$20240710$20240729$PER$$US-ROCHE-10000020907$ROCHE$$$$$$Y$$$20240729$$CN$US$US
240731941$24073194$1$I$20240304$20240703$20240710$20240710$EXP$$FR-AUROBINDO-AUR-APL-2024-033266$AUROBINDO$$19$YR$$F$Y$55.8$KG$20240710$$MD$FR$FR
240731951$24073195$1$I$20240604$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47838$$FDA-CTU$$63$YR$$F$N$$$20240710$N$$US$
240731961$24073196$1$I$20240623$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47858$$FDA-CTU$$22$YR$$F$N$$$20240710$Y$PH$US$
240731971$24073197$1$I$$20240703$20240710$20240710$EXP$$US-GSK-US2024AMR083471$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$CN$US$US
240731981$24073198$1$I$$20240705$20240710$20240710$30DAY$$US-GSK-US2024083900$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240710$$CN$US$US
240731993$24073199$3$F$20240630$20240813$20240710$20240815$EXP$$CA-ROCHE-10000021506$ROCHE$$48$YR$A$F$Y$$$20240815$$CN$CA$CA
240732001$24073200$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05849$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240732011$24073201$1$I$20240626$20240628$20240710$20240710$DIR$FDA-CDER-CTU-2024-47795$$FDA-CTU$$$$$M$N$167.6$KG$20240628$N$$US$
240732021$24073202$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05863$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240732031$24073203$1$I$$20240709$20240710$20240710$PER$$US-GILEAD-2024-0680117$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240732041$24073204$1$I$$20240708$20240710$20240710$PER$$US-HALEON-2186208$Haleon PLC$$34$YR$$F$Y$$$20240710$$CN$US$US
240732054$24073205$4$F$$20240712$20240710$20240719$EXP$$US-AMGEN-USASP2024135892$AMGEN$$$$$M$Y$$$20240719$$CN$US$US
240732061$24073206$1$I$$20240709$20240710$20240710$PER$$US-ROCHE-10000021598$ROCHE$$$$$F$Y$$$20240710$$CN$US$US
240732072$24073207$2$F$20220518$20240821$20240710$20240830$EXP$$JP-ASTELLAS-2022JP009064$ASTELLAS$$56$YR$A$M$Y$49$KG$20240830$$MD$JP$JP
240732081$24073208$1$I$$20240708$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063487$SANDOZ$$71$YR$$M$Y$$$20240710$$HP$CA$CA
240732092$24073209$2$F$$20240812$20240710$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06343$LUPIN$$$$$$Y$$$20240906$$CN$US$US
240732101$24073210$1$I$$20240701$20240710$20240710$PER$$US-ROCHE-10000020554$ROCHE$$$$$$Y$$$20240710$$CN$US$US
240732111$24073211$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142488$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
240732131$24073213$1$I$$20240703$20240710$20240710$EXP$$CH-MYLANLABS-2024M1063873$MYLAN$Shai B, Morgane C, Guillaume M, Fabian S. An apple detergent a day doesn^t always keep the doctor away. Swiss-Med-Wkly 2024; 154 (Suppl. 277) 39S (plus Poster) abstr. P 56.$10$MON$$M$Y$$$20240710$$HP$CH$CH
240732141$24073214$1$I$$20240703$20240710$20240710$EXP$$IN-MYLANLABS-2024M1063861$MYLAN$Udupa ST, Vaidyanathan S, Munoli RN, Praharaj SK. Serotonin toxicity - A case report. Indian-J-Psychiatry 2024; 66 (Suppl. 1) S215.$31$YR$$M$Y$$$20240710$$HP$IN$IN
240732151$24073215$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06257$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240732165$24073216$5$F$20240601$20240809$20240710$20240820$EXP$$US-SA-2024SA197185$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240820$$CN$US$US
240732171$24073217$1$I$$20240709$20240710$20240710$EXP$$US-GILEAD-2024-0680091$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240732181$24073218$1$I$$20240703$20240710$20240710$EXP$$IT-MYLANLABS-2024M1064052$MYLAN$Vecchio C, Zuffada F, Bianchi M, Nassiacos D. Discovering palpitations. Eur-Heart-J-Suppl 2024; 26 (Suppl.) ii47.?$51$YR$$M$Y$$$20240710$$HP$IT$IT
240732191$24073219$1$I$$20240703$20240710$20240710$EXP$$US-MYLANLABS-2024M1064030$MYLAN$Franchini A, Fortugno A, Li C, Ahmed H, Pavlidakey P, Elston C. A Rare Presentation of Cutaneous Reactive Angiomatosis. Am-J-Dermatopathol 2024; 46 (7): S14.$50$YR$$F$Y$$$20240710$$HP$US$US
240732201$24073220$1$I$$20240703$20240710$20240710$EXP$$BE-MYLANLABS-2024M1063713$MYLAN$Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A, et al. PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer. Cold-Spring-Harb-Mol-Case-Stud 2023; 9 (2): 1-16.$31$YR$$F$Y$$$20240710$$HP$BE$BE
240732211$24073221$1$I$20180101$20240706$20240710$20240710$EXP$$US-ABBVIE-5792210$ABBVIE$$$$$F$Y$79$KG$20240710$$CN$US$US
240732221$24073222$1$I$20240628$20240701$20240710$20240710$PER$$US-AstraZeneca-2024A155916$ASTRAZENECA$$$$$$Y$$$20240710$$CN$US$
240732231$24073223$1$I$20240702$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A153433$ASTRAZENECA$$32711$DY$$M$Y$$$20240710$$CN$US$
240732241$24073224$1$I$$20240628$20240710$20240710$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202407000653$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240710$$CN$BE$BE
240732251$24073225$1$I$$20240628$20240710$20240710$EXP$$NL-ELI_LILLY_AND_COMPANY-NL202407000815$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240710$$CN$NL$NL
240732261$24073226$1$I$20240703$20240707$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005226$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240710$$CN$US$US
240732271$24073227$1$I$20240708$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005228$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240710$$CN$US$US
240732281$24073228$1$I$$20240628$20240710$20240710$EXP$$US-ELI_LILLY_AND_COMPANY-US202406019857$ELI LILLY AND CO$$$$$$Y$$$20240710$$CN$US$US
240732291$24073229$1$I$20240708$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005949$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240710$$CN$US$US
240732301$24073230$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005198$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240710$$CN$US$US
240732311$24073231$1$I$20240601$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005227$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240710$$CN$US$US
240732321$24073232$1$I$$20240627$20240710$20240710$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407000037$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240710$$CN$DE$DE
240732331$24073233$1$I$$20240708$20240710$20240710$PER$$US-AstraZeneca-2024A156396$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240732341$24073234$1$I$20240430$20240705$20240710$20240710$EXP$$US-AstraZeneca-2024A155585$ASTRAZENECA$$29698$DY$$F$Y$$$20240710$$MD$US$
240732351$24073235$1$I$20240707$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005136$ELI LILLY AND CO$$59$YR$A$$Y$$$20240710$$CN$US$US
240732361$24073236$1$I$20240319$20240705$20240710$20240710$EXP$$JP-AstraZeneca-2024A154437$ASTRAZENECA$$59$YR$$F$Y$52$KG$20240710$$MD$JP$
240732371$24073237$1$I$$20240701$20240710$20240710$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR084558$VIIV$$$$$$Y$$$20240710$$HP$US$US
240732382$24073238$2$F$20240101$20240815$20240710$20240819$EXP$$US-AMGEN-USASP2024134595$AMGEN$$$$A$F$Y$$$20240819$$MD$US$US
240732391$24073239$1$I$20231101$20240702$20240710$20240710$EXP$$JP-AstraZeneca-2024A155610$ASTRAZENECA$$73$YR$$M$Y$$$20240710$$MD$JP$
240732402$24073240$2$F$20240625$20240715$20240710$20240716$EXP$$GB-BAYER-2024A097713$BAYER$$$$$F$Y$$$20240716$$HP$GB$GB
240732412$24073241$2$F$$20240717$20240710$20240725$EXP$$GR-TAKEDA-2024TUS069419$TAKEDA$$65$YR$$M$Y$$$20240725$$CN$GR$GR
240732422$24073242$2$F$20230128$20240827$20240710$20240904$EXP$$TW-TAKEDA-2023TUS010905$TAKEDA$$53$YR$$M$Y$$$20240904$$CN$TW$TW
240732431$24073243$1$I$$20240706$20240710$20240710$PER$$US-HALEON-2185869$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240732441$24073244$1$I$$20240703$20240710$20240710$EXP$$CA-TAKEDA-2024TUS068428$TAKEDA$$$$$M$Y$$$20240710$$CN$CA$CA
240732451$24073245$1$I$$20240708$20240710$20240710$EXP$$CA-ORGANON-O2407CAN000897$ORGANON$Unknown. Unknown. Unknown. UNK$$$$M$Y$$$20240710$$HP$CA$CA
240732464$24073246$4$F$$20240724$20240710$20240806$EXP$$CA-ABBVIE-5828375$ABBVIE$$36$YR$$F$Y$$$20240806$$HP$CA$CA
240732471$24073247$1$I$20240401$20240709$20240710$20240710$EXP$ES-AEMPS-1541457$ES-ORGANON-O2407ESP000893$ORGANON$$76$YR$$F$Y$$$20240710$$MD$ES$ES
240732481$24073248$1$I$$20240705$20240710$20240710$EXP$$IN-TAKEDA-2024TUS006394$TAKEDA$$$$$M$Y$$$20240710$$CN$IN$IN
240732491$24073249$1$I$20240603$20240703$20240710$20240710$EXP$$CA-TAKEDA-2024TUS068199$TAKEDA$$68$YR$$F$Y$$$20240710$$MD$CA$CA
240732502$24073250$2$F$20230803$20240723$20240710$20240802$EXP$AT-EMA-2024626-AUTODUP-1719436556567$AT-Accord-433352$ACCORD$$60$YR$A$M$Y$$$20240802$$CN$AT$AT
240732511$24073251$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281438310700-KPJBZ$GB-Accord-433381$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240732521$24073252$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281436490710-YBJTK$GB-Accord-433475$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240732533$24073253$3$F$20240521$20240723$20240710$20240802$EXP$$CN-Accord-434101$ACCORD$$69$YR$E$F$Y$$$20240802$$CN$CN$CN
240732541$24073254$1$I$$20240629$20240710$20240710$EXP$CA-MHPD-E2B_07065946$CA-Accord-433371$ACCORD$$43$YR$A$F$Y$$$20240710$$HP$CA$CA
240732551$24073255$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281504408720-TKDCS$GB-Accord-433470$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240732561$24073256$1$I$20240323$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281122461890-DVTGF$GB-Accord-433370$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240732571$24073257$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281436108240-JYFTK$GB-Accord-433464$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240732581$24073258$1$I$20240701$20240708$20240710$20240710$EXP$$NVSC2024US141911$NOVARTIS$$61$YR$$F$Y$$$20240710$$CN$US$US
240732591$24073259$1$I$$20240629$20240710$20240710$EXP$AU-TGA-802149$AU-Accord-432947$ACCORD$$26$YR$A$F$Y$$$20240710$$HP$AU$AU
240732602$24073260$2$F$$20240905$20240710$20240909$EXP$$NVSJ2024JP008124$NOVARTIS$$89$YR$$$Y$$$20240909$$MD$JP$JP
240732612$24073261$2$F$$20240814$20240710$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05884$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240732621$24073262$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06069$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240732631$24073263$1$I$$20240708$20240710$20240710$EXP$$NVSC2024CA141811$NOVARTIS$$79$YR$$M$Y$$$20240710$$CN$CA$CA
240732641$24073264$1$I$20240601$20240704$20240710$20240710$EXP$$NVSC2024IL140190$NOVARTIS$$$$$M$Y$$$20240710$$MD$IL$IL
240732651$24073265$1$I$20240327$20240705$20240710$20240710$EXP$$NVSC2024FR019001$NOVARTIS$$$$C$F$Y$$$20240710$$MD$FR$FR
240732662$24073266$2$F$20240501$20240808$20240710$20240809$EXP$$NVSJ2024JP005620$NOVARTIS$$$$E$F$Y$$$20240809$$MD$JP$JP
240732671$24073267$1$I$20230701$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47791$$FDA-CTU$$$$$F$N$96.9$KG$20240709$N$$US$
240732681$24073268$1$I$20240418$20240703$20240710$20240710$EXP$$NVSC2024IN087766$NOVARTIS$$28$YR$$F$Y$$$20240710$$CN$IN$IN
240732691$24073269$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47818$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240732701$24073270$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47833$$FDA-CTU$$59$YR$$F$N$$$20240710$N$$US$
240732711$24073271$1$I$20240315$20240708$20240710$20240710$DIR$FDA-CDER-CTU-2024-47800$$FDA-CTU$$36$YR$$M$N$83.3$KG$20240708$N$$US$
240732721$24073272$1$I$20240601$20240703$20240710$20240710$EXP$$JP-009507513-2407JPN000595J$MERCK$$48$YR$$F$Y$$$20240710$$MD$JP$JP
240732731$24073273$1$I$$20240705$20240710$20240710$EXP$$CA-TAKEDA-2024TUS045664$TAKEDA$$$$$M$Y$$$20240710$$CN$CA$CA
240732741$24073274$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA196716$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240710$$CN$US$US
240732751$24073275$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA199041$SANOFI AVENTIS$$$$T$M$Y$131.08$KG$20240710$$MD$US$US
240732761$24073276$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA201246$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240710$$CN$US$US
240732771$24073277$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA198008$SANOFI AVENTIS$$13$YR$T$F$Y$57.78$KG$20240710$$MD$US$US
240732781$24073278$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197993$SANOFI AVENTIS$$$$A$F$Y$70$KG$20240710$$MD$US$US
240732791$24073279$1$I$20240619$20240704$20240710$20240710$EXP$FR-AFSSAPS-RN2024000735$FR-ASTELLAS-2024EU006677$ASTELLAS$$49$YR$$M$Y$$$20240710$$CN$FR$FR
240732802$24073280$2$F$$20240717$20240710$20240724$PER$$US-SA-2024SA199812$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$MD$US$US
240732811$24073281$1$I$20240626$20240705$20240710$20240710$EXP$$US-BAYER-2024A098351$BAYER$$78$YR$E$F$Y$73.469$KG$20240710$$CN$US$US
240732831$24073283$1$I$$20240705$20240710$20240710$PER$$US-SA-2024SA200985$SANOFI AVENTIS$$$$$F$Y$$$20240710$$CN$US$US
240732841$24073284$1$I$20240601$20240701$20240710$20240710$PER$$US-SA-2024SA198591$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240710$$MD$US$US
240732851$24073285$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198289$SANOFI AVENTIS$$$$C$F$Y$63.5$KG$20240710$$MD$US$US
240732861$24073286$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA199753$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240710$$CN$US$US
240732871$24073287$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05854$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240732881$24073288$1$I$$20240708$20240710$20240710$PER$$US-ROCHE-10000020872$ROCHE$$$$A$F$Y$$$20240710$$CN$US$US
240732891$24073289$1$I$20240628$20240701$20240710$20240710$PER$$US-ROCHE-10000017234$ROCHE$$$$$$Y$$$20240710$$HP$US$US
240732901$24073290$1$I$$20240627$20240710$20240710$PER$$US-ROCHE-10000014778$ROCHE$$$$$$Y$$$20240710$$MD$US$US
240732912$24073291$2$F$$20240708$20240710$20240711$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-043389$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240711$$CN$GB$GB
240732921$24073292$1$I$20230202$20240703$20240710$20240710$EXP$$BE-PFIZER INC-2023SGN00711$PFIZER$$$$$M$Y$65$KG$20240710$$MD$BE$BE
240732931$24073293$1$I$$20240701$20240710$20240710$EXP$$IT-TEVA-VS-3217038$TEVA$Sala A, Vitali A, Remelli F, Zurlo A, Volpato S. Delirium in hip fractured patients. J-gerontol-geriatr 2023; 71 (1): 8-14.; Sala A, Vitali A, Remelli F, Zurlo A, Volpato S. Delirium in hip fractured patients. J-gerontol-geriatr 2023; 71 (1): 8-14.$70$YR$$M$Y$$$20240710$$HP$IT$IT
240732952$24073295$2$F$20220131$20240808$20240710$20240813$EXP$$FR-PFIZER INC-2023SGN01847$PFIZER$$57$YR$$F$Y$$$20240813$$PH$FR$FR
240732962$24073296$2$F$$20240724$20240710$20240730$EXP$$CA-TAKEDA-2024TUS069554$TAKEDA$$$$$M$Y$$$20240730$$CN$CA$CA
240732971$24073297$1$I$20240101$20240708$20240710$20240710$EXP$$JP-ABBVIE-5832701$ABBVIE$$50$YR$$M$Y$$$20240710$$MD$JP$JP
240732981$24073298$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135819$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240732993$24073299$3$F$20230101$20240717$20240710$20240719$EXP$$US-AMGEN-USASP2024134968$AMGEN$$57$YR$A$F$Y$$$20240719$$CN$US$US
240733001$24073300$1$I$$20240701$20240710$20240710$EXP$$CN-ROCHE-10000015578$ROCHE$Pei F, He W, Duan Y, Yao Q, Zhao Y, Fan X, et al. PD-1 blockade enhances the effect of targeted chemotherapy on locally advanced pMMR/MSS colorectal cancer. Cancer Medicine. 2024-Jun;13 (12):1-12. doi:10.1002/cam4.7224.$$$$$Y$$$20240710$$HP$CN$CN
240733011$24073301$1$I$20240301$20240702$20240710$20240710$EXP$DK-DKMA-30729402$DK-TEVA-VS-3216553$TEVA$$52$YR$$M$Y$$$20240710$$MD$DK$DK
240733021$24073302$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05841$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240733031$24073303$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05876$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240733041$24073304$1$I$20210101$20240703$20240710$20240710$EXP$FR-AFSSAPS-AVCN2024000493$FR-MYLANLABS-2024M1062989$MYLAN$$55$YR$$F$Y$$$20240710$$PH$FR$FR
240733052$24073305$2$F$20240601$20240709$20240710$20240711$EXP$$US-UCBSA-2024034703$UCB$$32$YR$$F$Y$$$20240711$$HP$US$US
240733061$24073306$1$I$$20240705$20240710$20240710$PER$$US-SA-2024SA200210$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240710$$CN$US$US
240733073$24073307$3$F$$20240731$20240710$20240810$EXP$$AU-TEVA-VS-3216337$TEVA$$51$YR$$M$Y$$$20240810$$HP$AU$AU
240733091$24073309$1$I$20240310$20240703$20240710$20240710$EXP$FR-AFSSAPS-AVMA2024000275$FR-MYLANLABS-2024M1062581$MYLAN$$31$YR$$F$Y$$$20240710$$PH$FR$FR
240733121$24073312$1$I$20240521$20240701$20240710$20240710$EXP$IT-MINISAL02-992143$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06212$HIKMA$$49$YR$$F$Y$$$20240710$$PH$IT$IT
240733131$24073313$1$I$$20240708$20240710$20240710$PER$$US-JNJFOC-20240721343$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$HP$US$US
240733141$24073314$1$I$20240101$20240709$20240710$20240710$PER$$US-JNJFOC-20240723016$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
240733151$24073315$1$I$20240622$20240624$20240710$20240710$DIR$FDA-CDER-CTU-2024-47792$$FDA-CTU$$15$YR$$UNK$N$62.6$KG$20240624$N$$US$
240733161$24073316$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47862$$FDA-CTU$$67$YR$$F$N$80.29$KG$20240710$N$$US$
240733172$24073317$2$F$$20240831$20240710$20240903$30DAY$$CO-PFIZER INC-202400205931$PFIZER$$12$YR$$M$Y$$$20240903$$CN$CO$CO
240733184$24073318$4$F$20240704$20240906$20240710$20240910$30DAY$$AR-PFIZER INC-202400207724$PFIZER$$4$YR$$M$Y$$$20240910$$HP$AR$AR
240733191$24073319$1$I$$20240702$20240710$20240710$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005006$BIOCON$$$$$$Y$$$20240710$$CN$CA$CA
240733201$24073320$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05838$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240733212$24073321$2$F$$20240717$20240710$20240724$EXP$$CA-GSK-CA2024083949$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$CA$CA
240733223$24073322$3$F$$20240925$20240710$20240930$30DAY$$CO-PFIZER INC-PV202400083476$PFIZER$$9$YR$$M$Y$$$20240930$$CN$CO$CO
240733231$24073323$1$I$20210401$20240705$20240710$20240710$EXP$$GB-AstraZeneca-2024A154996$ASTRAZENECA$$$$$F$Y$$$20240710$$PH$GB$
240733241$24073324$1$I$$20240709$20240710$20240710$PER$$US-GILEAD-2024-0680118$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240733251$24073325$1$I$20240520$20240709$20240710$20240710$EXP$FR-AFSSAPS-NT2024000768$FR-JNJFOC-20240722195$JOHNSON AND JOHNSON$$87$YR$E$M$Y$88$KG$20240710$$HP$FR$FR
240733261$24073326$1$I$20240702$20240709$20240710$20240710$PER$$US-JNJFOC-20240723131$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240710$$CN$US$US
240733271$24073327$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405101722428740-NRBYG$GB-MYLANLABS-2024M1063448$MYLAN$$$$$M$Y$$$20240710$$PH$GB$GB
240733281$24073328$1$I$20240107$20240705$20240710$20240710$EXP$GB-MHRA-MED-202406251219224260-VPSWC$GB-MYLANLABS-2024M1063799$MYLAN$$21$YR$$F$Y$$$20240710$$MD$GB$GB
240733291$24073329$1$I$$20240705$20240710$20240710$EXP$$AU-MYLANLABS-2024M1063446$MYLAN$$$$$F$Y$$$20240710$$MD$AU$AU
240733301$24073330$1$I$$20240705$20240710$20240710$EXP$$CA-CHEPLA-2024008492$CHEPLAPHARM$$$$$F$Y$$$20240710$$HP$COUNTRY NOT SPECIFIED$CA
240733311$24073331$1$I$$20240702$20240710$20240710$EXP$$CN-MYLANLABS-2024M1063896$MYLAN$Zhai W, Liu H, Li J, Xin H. Pregabalin-induced rhabdomyolysis: a case series and literature analysis. J-Int-Med-Res 2024; 52 (6):.$10$DEC$$M$Y$$$20240710$$HP$CN$CN
240733322$24073332$2$F$20240707$20240715$20240710$20240717$PER$$US-AMGEN-USASP2024136345$AMGEN$$74$YR$E$F$Y$$$20240717$$CN$US$US
240733331$24073333$1$I$20230405$20240710$20240710$20240710$EXP$ES-AEMPS-1545539$NVSC2024ES142291$NOVARTIS$$55$YR$$F$Y$$$20240710$$MD$ES$ES
240733342$24073334$2$F$$20240814$20240710$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05923$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240733352$24073335$2$F$20240619$20240722$20240710$20240724$EXP$$JP-OTSUKA-2024_019147$OTSUKA$$54$YR$$M$Y$$$20240724$$MD$JP$JP
240733364$24073336$4$F$$20240829$20240710$20240904$EXP$$NVSC2024ES140577$NOVARTIS$Rubio-Mora E, Rodr?guez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection. TRANSPLANT INFECTIOUS DISEASE. 2024;26(3):1-3$5$MON$$M$Y$$$20240904$$HP$ES$ES
240733371$24073337$1$I$$20240701$20240710$20240710$EXP$$US-MYLANLABS-2024M1063701$MYLAN$Pien I, Mudgal CS. Osteonecrosis of Trapezium Occurring in Patient with History of Recurrent Carpometacarpal Corticosteroid Injection. J-Hand-Surg-Asian-Pac-Vol 2023; 28 (1): 129-133.$59$YR$$F$Y$$$20240710$$HP$US$US
240733383$24073338$3$F$20240101$20240711$20240710$20240711$EXP$$CA-PFIZER INC-202400185491$PFIZER$$40$YR$$M$Y$$$20240711$$HP$CA$CA
240733394$24073339$4$F$$20240904$20240710$20240909$30DAY$$CA-PFIZER INC-202400004365$PFIZER$$76$YR$$F$Y$$$20240909$$HP$CA$CA
240733412$24073341$2$F$$20240831$20240710$20240903$30DAY$$CO-PFIZER INC-PV202400083477$PFIZER$$$$$F$Y$$$20240903$$CN$CO$CO
240733422$24073342$2$F$$20240807$20240710$20240809$EXP$$AU-PFIZER INC-202400202660$PFIZER$$40$YR$$M$Y$$$20240809$$PH$AU$AU
240733434$24073343$4$F$$20240923$20240710$20240925$30DAY$$CO-PFIZER INC-202400205923$PFIZER$$8$YR$$F$Y$$$20240925$$CN$CO$CO
240733443$24073344$3$F$20240701$20240909$20240710$20240912$30DAY$$PT-PFIZER INC-202400205839$PFIZER$$$$$M$Y$$$20240912$$CN$PT$PT
240733464$24073346$4$F$20240601$20240806$20240710$20240809$EXP$$SE-PFIZER INC-202400209553$PFIZER$$79$YR$$F$Y$$$20240809$$PH$SE$SE
240733485$24073348$5$F$20240101$20240916$20240710$20240920$EXP$$CL-PFIZER INC-PV202400089239$PFIZER$$9$YR$$F$Y$$$20240920$$CN$CL$CL
240733493$24073349$3$F$20240601$20240909$20240710$20240918$EXP$$FR-TEVA-VS-3217918$TEVA$$42$YR$$F$Y$88$KG$20240918$$MD$FR$FR
240733511$24073351$1$I$$20240706$20240710$20240710$PER$$US-JNJFOC-20240717054$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
240733522$24073352$2$F$20240706$20240807$20240710$20240808$PER$$US-JNJFOC-20240719566$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240808$$HP$US$US
240733531$24073353$1$I$$20240703$20240710$20240710$EXP$US-MLMSERVICE-20240626-PI112507-00145-1$US-RDY-SPO/USA/24/0009847$DR REDDYS$Golparvar A, Nafeh O, Alzamani M, Singh V, Jennings M. The Development of Disinhibited Social Engagement Disorder: A Case Report on the Psychiatric Implications of Prenatal Fentanyl Use. Cureus. 2024;16(5):e61078. DOI:10.7759/cureus.61078.$$$$F$Y$$$20240710$$MD$US$US
240733542$24073354$2$F$20240101$20240717$20240710$20240723$EXP$$FR-OTSUKA-2024_018916$OTSUKA$$51$YR$$F$Y$$$20240723$$MD$FR$FR
240733551$24073355$1$I$$20240701$20240710$20240710$EXP$$US-TEVA-VS-3216301$TEVA$$$$E$M$Y$$$20240710$$HP$US$US
240733561$24073356$1$I$20240101$20240701$20240710$20240710$EXP$$US-TEVA-VS-3216784$TEVA$$24$YR$$F$Y$$$20240710$$MD$US$US
240733571$24073357$1$I$20240628$20240708$20240710$20240710$EXP$$US-AMGEN-USASP2024134999$AMGEN$$68$YR$E$M$Y$$$20240710$$CN$US$US
240733591$24073359$1$I$$20240701$20240710$20240710$EXP$$US-TEVA-VS-3218088$TEVA$$52$YR$$M$Y$$$20240710$$PH$US$US
240733601$24073360$1$I$20240708$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136466$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240733614$24073361$4$F$20240101$20240916$20240710$20240918$EXP$$CA-GILEAD-2024-0677874$GILEAD$$$$A$F$Y$$$20240918$$HP$CA$CA
240733621$24073362$1$I$20210702$20240702$20240710$20240710$EXP$$GB-TEVA-VS-3216766$TEVA$$25$YR$$F$Y$78$KG$20240710$$MD$GB$GB
240733631$24073363$1$I$20240603$20240627$20240710$20240710$EXP$GB-MHRA-MED-202406271047536950-MNTJK$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-06202$HIKMA$$21$YR$$F$Y$52$KG$20240710$$CN$GB$GB
240733641$24073364$1$I$$20240704$20240710$20240710$EXP$$DE-BAYER-2024A097597$BAYER$$71$YR$E$M$Y$$$20240710$$HP$DE$DE
240733672$24073367$2$F$20240701$20240724$20240710$20240802$PER$$US-SA-2024SA200879$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240802$$MD$US$US
240733681$24073368$1$I$$20240708$20240710$20240710$EXP$$US-ELI_LILLY_AND_COMPANY-US202407005882$ELI LILLY AND CO$$$$A$M$Y$$$20240710$$CN$US$US
240733691$24073369$1$I$$20240701$20240710$20240710$EXP$GB-MHRA-MED-202407011402475390-HWYFQ$GB-ELI_LILLY_AND_COMPANY-GB202407003211$ELI LILLY AND CO$$$$$F$Y$$$20240710$$CN$GB$GB
240733701$24073370$1$I$$20240704$20240710$20240710$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202407003781$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240710$$CN$IT$IT
240733711$24073371$1$I$20240401$20240703$20240710$20240710$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406013459$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240710$$CN$JP$JP
240733721$24073372$1$I$$20240701$20240710$20240710$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407001730$ELI LILLY AND CO$$$$$M$Y$$$20240710$$CN$KR$KR
240733731$24073373$1$I$$20240704$20240710$20240710$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407003613$ELI LILLY AND CO$$$$A$$Y$$$20240710$$CN$JP$JP
240733742$24073374$2$F$20240408$20240812$20240710$20240815$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407004824$ELI LILLY AND CO$$$$E$M$Y$90$KG$20240815$$CN$DE$DE
240733775$24073377$5$F$20240401$20240919$20240710$20240920$30DAY$$CO-PFIZER INC-202400207716$PFIZER$$9$YR$$F$Y$$$20240920$$CN$CO$CO
240733782$24073378$2$F$$20240812$20240710$20240814$30DAY$$AR-PFIZER INC-202400203197$PFIZER$$$$$$Y$$$20240814$$CN$AR$AR
240733792$24073379$2$F$$20240920$20240710$20240925$30DAY$$IE-PFIZER INC-PV202400085342$PFIZER$$57$YR$$M$Y$$$20240925$$CN$IE$IE
240733803$24073380$3$F$$20240814$20240710$20240814$30DAY$$CO-PFIZER INC-PV202400088539$PFIZER$$$$$$Y$$$20240814$$CN$CO$CO
240733811$24073381$1$I$$20240708$20240710$20240710$PER$$US-ROCHE-10000021377$ROCHE$$$$A$$Y$$$20240710$$CN$US$US
240733822$24073382$2$F$$20240719$20240710$20240725$EXP$$US-ABBVIE-5833097$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
240733841$24073384$1$I$$20240708$20240710$20240710$PER$$US-HALEON-2186051$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240733851$24073385$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05898$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240733862$24073386$2$F$$20240821$20240710$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05877$LUPIN$$$$$$Y$$$20240909$$CN$US$US
240733871$24073387$1$I$$20240625$20240710$20240710$EXP$$TR-RISINGPHARMA-TR-2024RISLIT00227$RISING PHARMACEUTICALS$Seza Ozen.Drug-induced lupus erythematosus in childhood: Case-based review.Lupus.2024;33(7):1-12$9$YR$C$M$Y$$$20240710$$HP$TR$TR
240733881$24073388$1$I$20240702$20240708$20240710$20240710$EXP$$US-GILEAD-2024-0677983$GILEAD$$72$YR$E$F$Y$$$20240710$$HP$US$US
240733892$24073389$2$F$$20240830$20240710$20240830$EXP$$US-PFIZER INC-2024SGN01400$PFIZER$$$$$F$Y$$$20240830$$MD$US$US
240733901$24073390$1$I$$20240625$20240710$20240710$EXP$$US-PFIZER INC-202400201054$PFIZER$$71$YR$$M$Y$$$20240710$$CN$US$US
240733911$24073391$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47856$$FDA-CTU$$$$$M$N$$$20240709$N$HP$US$
240733921$24073392$1$I$20221114$20240704$20240710$20240710$EXP$$BE-PFIZER INC-2022SGN12373$PFIZER$$66$YR$$F$Y$42$KG$20240710$$MD$BE$BE
240733971$24073397$1$I$20240705$20240705$20240710$20240710$EXP$$US-AMGEN-USASP2024134012$AMGEN$$75$YR$E$F$Y$$$20240710$$CN$US$US
240733981$24073398$1$I$20240609$20240705$20240710$20240710$EXP$$AU-AMGEN-AUSSP2024133744$AMGEN$$58$YR$A$F$Y$$$20240710$$HP$AU$AU
240734001$24073400$1$I$20240523$20240708$20240710$20240710$EXP$$US-ABBVIE-5832596$ABBVIE$$79$YR$$F$Y$$$20240710$$CN$US$US
240734011$24073401$1$I$20240620$20240708$20240710$20240710$EXP$IT-MINISAL02-993113$IT-FreseniusKabi-FK202410742$FRESENIUS KABI$$56$YR$A$M$Y$$$20240710$$MD$IT$IT
240734021$24073402$1$I$20240501$20240702$20240710$20240710$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003174$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240710$$HP$US$US
240734051$24073405$1$I$20231212$20240709$20240710$20240710$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038796$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240710$$HP$SG$SG
240734061$24073406$1$I$20240615$20240709$20240710$20240710$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038800$BOEHRINGER INGELHEIM$$43$YR$A$F$Y$$$20240710$$HP$SG$SG
240734071$24073407$1$I$$20240625$20240710$20240710$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05881$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240734081$24073408$1$I$20240630$20240705$20240710$20240710$EXP$$CN-BAYER-2024A097904$BAYER$$73$YR$E$F$Y$55$KG$20240710$$HP$CN$CN
240734091$24073409$1$I$$20240702$20240710$20240710$EXP$$US-RDY-OTH/USA/23/0175646$DR REDDYS$$$$$$Y$$$20240710$$MD$US$US
240734101$24073410$1$I$$20240704$20240710$20240710$PER$$US-MYLANLABS-2024M1064308$MYLAN$$$$$F$Y$$$20240710$$CN$US$US
240734111$24073411$1$I$20231201$20240702$20240710$20240710$EXP$DK-DKMA-30729591$DK-TEVA-VS-3216586$TEVA$$39$YR$$F$Y$141$KG$20240710$$MD$DK$DK
240734122$24073412$2$F$$20240814$20240710$20240903$PER$$US-AstraZeneca-2024A140632$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
240734131$24073413$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157129$ASTRAZENECA$$66$YR$$M$Y$$$20240710$$HP$FR$
240734141$24073414$1$I$$20240702$20240710$20240710$EXP$$VN-AstraZeneca-2024A155524$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$VN$
240734151$24073415$1$I$$20240702$20240710$20240710$EXP$$ZA-AstraZeneca-2024A153282$ASTRAZENECA$$49$YR$$F$Y$$$20240710$$CN$ZA$
240734161$24073416$1$I$20210101$20240625$20240710$20240710$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00311$Unknown Manufacturer$$$$$F$Y$61.235$KG$20240710$$CN$US$US
240734171$24073417$1$I$$20240709$20240710$20240710$EXP$$US-GILEAD-2024-0680123$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240734182$24073418$2$F$20240101$20240823$20240710$20240913$PER$$US-SA-2024SA199286$SANOFI AVENTIS$$67$YR$E$M$Y$93.424$KG$20240913$$MD$US$US
240734191$24073419$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA199106$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$MD$US$US
240734201$24073420$1$I$$20240625$20240710$20240710$EXP$$ES-RISINGPHARMA-ES-2024RISLIT00229$RISING PHARMACEUTICALS$Francisco J. Pelegrin Mateo.Capecitabine-Related Thrombotic Microangiopathy.Journal of Gastrointestinal Cancer.04-JAN-2024;55:965-968$82$YR$E$F$Y$$$20240710$$HP$ES$ES
240734211$24073421$1$I$20240601$20240701$20240710$20240710$PER$$US-SA-2024SA199319$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240710$$MD$US$US
240734221$24073422$1$I$20240501$20240708$20240710$20240710$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003788$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240734232$24073423$2$F$$20240703$20240710$20240712$EXP$$NVSC2024GR140181$NOVARTIS$$54$YR$$F$Y$$$20240712$$CN$GR$GR
240734244$24073424$4$F$20240101$20240722$20240710$20240731$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003428$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240731$$HP$CA$CA
240734251$24073425$1$I$$20240704$20240710$20240710$EXP$$GB-MYLANLABS-2024M1063574$MYLAN$$$$$M$Y$$$20240710$$MD$GB$GB
240734261$24073426$1$I$$20240701$20240710$20240710$EXP$$JP-ROCHE-10000020934$ROCHE$Yamamoto C, Furukawa K I. A study of COVID-19 cases receiving anti-CD20 antibody treatment in our hospital.. The Joint Congress of the 98th Annual Meeting of the Japanese Association for Infectious Diseases and the 72nd Annual Meeting of the Japanese Society of Chemotherapy. 2024-Jun;27-9.$$$$$Y$$$20240710$$MD$JP$JP
240734291$24073429$1$I$$20240703$20240710$20240710$EXP$$US-GSK-US2024082606$GLAXOSMITHKLINE$$4$DEC$$M$Y$$$20240710$$MD$US$US
240734301$24073430$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281441485000-MGTNK$GB-Accord-433451$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734322$24073432$2$F$$20240708$20240710$20240718$EXP$GB-MHRA-MED-202406281441057610-CBYGW$GB-Accord-433186$ACCORD$$$$$$Y$$$20240718$$CN$GB$GB
240734331$24073433$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281422291500-CTQJK$GB-Accord-433429$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734341$24073434$1$I$20240312$20240628$20240710$20240710$EXP$FR-AFSSAPS-AVMA2024000276$FR-Accord-433650$ACCORD$$26$YR$A$M$Y$$$20240710$$PH$FR$FR
240734352$24073435$2$F$$20240708$20240710$20240718$EXP$GB-MHRA-MED-202406281144360370-LSKWG$GB-Accord-433379$ACCORD$$$$$$Y$$$20240718$$CN$GB$GB
240734361$24073436$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281434234840-MKDNF$GB-Accord-433484$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734371$24073437$1$I$20240117$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281626497690-MPKWV$GB-Accord-433402$ACCORD$$52$YR$A$F$Y$$$20240710$$MD$GB$GB
240734381$24073438$1$I$20240614$20240628$20240710$20240710$EXP$IT-MINISAL02-992507$IT-Accord-433539$ACCORD$$50$YR$A$F$Y$$$20240710$$PH$IT$IT
240734391$24073439$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281414490710-DZNCP$GB-Accord-433240$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734401$24073440$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281421048380-HJCMP$GB-Accord-433224$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734411$24073441$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281417043890-YNTHC$GB-Accord-433233$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734421$24073442$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281437578480-ZYWPV$GB-Accord-433461$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734431$24073443$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281435349850-RDTKB$GB-Accord-433380$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734441$24073444$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281440345420-HKJBF$GB-Accord-433460$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734451$24073445$1$I$20240501$20240628$20240710$20240710$EXP$ES-AEMPS-1540247$ES-Accord-433271$ACCORD$$97$YR$E$$Y$$$20240710$$MD$ES$ES
240734461$24073446$1$I$20240416$20240628$20240710$20240710$EXP$FR-AFSSAPS-CN2024000636$FR-Accord-433128$ACCORD$$68$YR$E$M$Y$90.5$KG$20240710$$MD$FR$FR
240734471$24073447$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MIDB-413fe4c7-eba0-4c12-8b8e-714ae2981ff8$GB-Accord-433317$ACCORD$$73$YR$E$$Y$$$20240710$$PH$GB$GB
240734481$24073448$1$I$20240619$20240709$20240710$20240710$EXP$ES-AEMPS-1540420$ES-JNJFOC-20240722495$JOHNSON AND JOHNSON$$54$YR$A$M$Y$100$KG$20240710$$MD$ES$ES
240734491$24073449$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109098$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$80$YR$E$F$Y$$$20240710$$HP$US$US
240734501$24073450$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108383$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240710$$HP$US$US
240734511$24073451$1$I$20240418$20240705$20240710$20240710$EXP$$GB-ABBVIE-5832177$ABBVIE$$33$YR$$F$Y$$$20240710$$CN$GB$GB
240734522$24073452$2$F$20240708$20240911$20240710$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109302$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$78.47$KG$20240912$$PH$US$US
240734531$24073453$1$I$$20240626$20240710$20240710$EXP$$KR-Innogenix, LLC-2158998$INNOGENIX$Source document (Full text)$40$YR$$F$Y$$$20240710$$MD$KR$KR
240734541$24073454$1$I$$20240625$20240710$20240710$EXP$$AR-RISINGPHARMA-AR-2024RISLIT00230$RISING PHARMACEUTICALS$Jose G. Cervante.Liver transplantation as treatment for acetaminophen poisoning.Medicina.2024;84 (3):588-591$28$YR$A$F$Y$$$20240710$$HP$AR$AR
240734553$24073455$3$F$$20240719$20240710$20240809$PER$$AT-TOLMAR, INC.-24AT050411$TOLMAR$$$$$$Y$$$20240809$$MD$AT$AT
240734562$24073456$2$F$$20240717$20240710$20240809$PER$$AU-TOLMAR, INC.-24AU050450$TOLMAR$$$$$$Y$$$20240809$$HP$AU$AU
240734571$24073457$1$I$$20240619$20240710$20240710$PER$$AU-TOLMAR, INC.-24AU050419$TOLMAR$$$$$M$Y$$$20240709$$CN$AU$AU
240734581$24073458$1$I$$20240619$20240710$20240710$PER$$AU-TOLMAR, INC.-24AU050336$TOLMAR$$4$YR$$F$Y$$$20240709$$HP$AU$AU
240734591$24073459$1$I$20231213$20240619$20240710$20240710$PER$$BR-TOLMAR, INC.-24BR050362$TOLMAR$$9$YR$$F$Y$$$20240709$$CN$BR$BR
240734601$24073460$1$I$$20240620$20240710$20240710$PER$$BR-TOLMAR, INC.-24BR050417$TOLMAR$$$$$F$Y$$$20240709$$CN$BR$BR
240734611$24073461$1$I$20240516$20240619$20240710$20240710$PER$$BR-TOLMAR, INC.-24BR050367$TOLMAR$$9$YR$$F$Y$$$20240709$$CN$BR$BR
240734621$24073462$1$I$20240619$20240619$20240710$20240710$PER$$BR-TOLMAR, INC.-24BR050384$TOLMAR$$9$YR$$F$Y$$$20240709$$CN$BR$BR
240734631$24073463$1$I$20240101$20240708$20240710$20240710$EXP$$US-UCBSA-2024034758$UCB$$$$$F$Y$$$20240710$$HP$US$US
240734642$24073464$2$F$$20240906$20240710$20240906$EXP$$NVSC2024US141600$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
240734651$24073465$1$I$$20240701$20240710$20240710$EXP$$US-CLINIGEN-US-CLI-2024-010404$CLINIGEN$Tyler Legro, Brinda Mehta, Priti Patel. Incidental finding of atrial myxoma following curative treatment for paediatric neuroblastoma. Cardiology in the Young. 2024;34:1:192-193$7$YR$$M$Y$$$20240710$$MD$US$US
240734662$24073466$2$F$$20240711$20240710$20240711$EXP$$CA-BAYER-2024A098951$BAYER$$$$$F$Y$$$20240711$$HP$CA$CA
240734671$24073467$1$I$20240616$20240703$20240710$20240710$EXP$IT-MINISAL02-992734$IT-MYLANLABS-2024M1062799$MYLAN$$80$YR$$M$Y$$$20240710$$MD$IT$IT
240734681$24073468$1$I$20240708$20240709$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108974$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240710$$HP$US$US
240734701$24073470$1$I$$20240628$20240710$20240710$PER$$US-AMGEN-USASP2024130875$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240734711$24073471$1$I$20190602$20240708$20240710$20240710$EXP$FR-AFSSAPS-PC2024000530$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-108904$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$55$KG$20240710$$PH$FR$FR
240734721$24073472$1$I$20240201$20240708$20240710$20240710$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-029764$BOEHRINGER INGELHEIM$$58$YR$A$M$Y$77$KG$20240710$$MD$DE$DE
240734731$24073473$1$I$$20240627$20240710$20240710$PER$$US-RDY-SPO/USA/24/0009519$DR REDDYS$$$$$F$Y$$$20240710$$CN$US$US
240734741$24073474$1$I$$20240628$20240710$20240710$EXP$CA-MHPD-E2B_001084057$CA-Accord-433178$ACCORD$$76$YR$E$F$Y$$$20240710$$MD$CA$CA
240734751$24073475$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281425089800-RYTVB$GB-Accord-433453$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734761$24073476$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281040200250-ZJMNR$GB-Accord-433409$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734772$24073477$2$F$$20240708$20240710$20240718$EXP$GB-MHRA-MED-202406281415559760-KVNGH$GB-Accord-433456$ACCORD$$$$$$Y$$$20240718$$CN$GB$GB
240734781$24073478$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281435011580-DLRNY$GB-Accord-433227$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734791$24073479$1$I$20240323$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406271040542900-VDNJS$GB-Accord-433177$ACCORD$$$$$M$Y$78$KG$20240710$$CN$GB$GB
240734812$24073481$2$F$20240620$20240805$20240710$20240814$EXP$$AU-Accord-433847$ACCORD$$$$$F$Y$$$20240814$$PH$AU$AU
240734821$24073482$1$I$$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406281411346130-TDLKP$GB-Accord-433239$ACCORD$$$$$$Y$$$20240710$$CN$GB$GB
240734831$24073483$1$I$20230101$20240704$20240710$20240710$EXP$$CA-Orion Corporation ORION PHARMA-24_00030711$ORION$$67$YR$E$M$Y$75$KG$20240710$$HP$CA$
240734841$24073484$1$I$$20240628$20240710$20240710$PER$US-MLMSERVICE-20240627-PI109357-00128-1$US-RDY-SPO/USA/24/0009673$DR REDDYS$Sharma P, Tahiru M, Li H, Bansari A, Baskaran N. A case of ocular diffuse large B-cell lymphoma unveiled through Pars Plana Vitrectomy: surgical insight and multidisciplinary management. Journal of Surgical Case Reports. 2024;2024(6):rjae399. DOI:10.1093/jscr/rjae399.$74$YR$E$M$Y$$$20240710$$MD$US$US
240734851$24073485$1$I$$20240703$20240710$20240710$PER$$US-ALXN-202407USA000245US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240734861$24073486$1$I$20190101$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405151027377850-PNZRJ$GB-MYLANLABS-2024M1063717$MYLAN$$$$$F$Y$$$20240710$$CN$GB$GB
240734871$24073487$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405101423535400-WTCJS$GB-MYLANLABS-2024M1063404$MYLAN$$$$$$Y$$$20240710$$HP$GB$GB
240734881$24073488$1$I$20240513$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405140254114100-JSHRC$GB-MYLANLABS-2024M1063408$MYLAN$$41$YR$$F$Y$103$KG$20240710$$CN$GB$GB
240734891$24073489$1$I$20220101$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405071957286520-FKGWQ$GB-MYLANLABS-2024M1063398$MYLAN$$72$YR$$M$Y$64$KG$20240710$$CN$GB$GB
240734903$24073490$3$F$20220101$20240812$20240710$20240827$EXP$$US-ENDO USA, INC.-2024-002806$ENDO$$$$$$Y$$$20240827$$MD$US$US
240734911$24073491$1$I$20240508$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405100847300190-SGWYH$GB-MYLANLABS-2024M1063054$MYLAN$$45$YR$$F$Y$99$KG$20240710$$CN$GB$GB
240734921$24073492$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202402191603379640-YRNGP$GB-MYLANLABS-2024M1063351$MYLAN$$40$YR$$F$Y$$$20240710$$HP$GB$GB
240734931$24073493$1$I$20240418$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405071703163580-SFGKJ$GB-MYLANLABS-2024M1063415$MYLAN$$$$$M$Y$$$20240710$$HP$GB$GB
240734941$24073494$1$I$20240708$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136011$AMGEN$$44$YR$A$M$Y$$$20240710$$CN$US$US
240734951$24073495$1$I$$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136619$AMGEN$$$$$M$Y$$$20240710$$CN$US$US
240734961$24073496$1$I$20240410$20240705$20240710$20240710$EXP$HR-HALMED-300085892$HR-AMGEN-HRVSP2024135481$AMGEN$$63$YR$A$F$Y$70$KG$20240710$$MD$HR$HR
240734971$24073497$1$I$20240601$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004947$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240710$$CN$US$US
240734981$24073498$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005747$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240710$$CN$US$US
240734991$24073499$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005193$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240710$$CN$US$US
240735001$24073500$1$I$20240705$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005217$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240710$$CN$US$US
240735011$24073501$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004822$ELI LILLY AND CO$$$$$$Y$$$20240710$$CN$US$US
240735021$24073502$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005400$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240710$$CN$US$US
240735031$24073503$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005144$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240710$$CN$US$US
240735041$24073504$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005152$ELI LILLY AND CO$$$$$$Y$$$20240710$$CN$US$US
240735051$24073505$1$I$20240601$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005223$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240710$$HP$US$US
240735061$24073506$1$I$$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005916$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240710$$CN$US$US
240735071$24073507$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004194$ELI LILLY AND CO$$$$$M$Y$$$20240710$$CN$US$US
240735081$24073508$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005650$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240710$$CN$US$US
240735091$24073509$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005333$ELI LILLY AND CO$$50$YR$A$$Y$$$20240710$$CN$US$US
240735101$24073510$1$I$20240708$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005078$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240710$$CN$US$US
240735112$24073511$2$F$20240601$20240709$20240710$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407006155$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240725$$CN$US$US
240735121$24073512$1$I$20240705$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005200$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240710$$CN$US$US
240735131$24073513$1$I$$20240627$20240710$20240710$EXP$$DE-RICHTER-2024-GR-006676$MYOVANT SCIENCES$$$$A$F$Y$$$20240710$$MD$DE$DE
240735141$24073514$1$I$$20240702$20240710$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-108412$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240710$$MD$JP$JP
240735151$24073515$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109074$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$64$YR$A$M$Y$$$20240710$$HP$US$US
240735161$24073516$1$I$$20240707$20240710$20240710$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003791$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240735191$24073519$1$I$20240618$20240708$20240710$20240710$EXP$$TW-BAYER-2024A098617$BAYER$$58$YR$A$F$Y$$$20240710$$HP$TW$TW
240735201$24073520$1$I$$20240626$20240710$20240710$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2024-05691$LUPIN$$$$$$Y$$$20240710$$MD$DE$DE
240735211$24073521$1$I$20240214$20240704$20240710$20240710$EXP$$JP-009507513-2405JPN000759J$MERCK$$67$YR$$M$Y$$$20240710$$MD$JP$JP
240735221$24073522$1$I$20231003$20240708$20240710$20240710$EXP$$ES-GILEAD-2024-0679951$GILEAD$$$$$M$Y$$$20240710$$PH$ES$ES
240735232$24073523$2$F$$20240906$20240710$20240909$EXP$$NVSC2024US139715$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
240735241$24073524$1$I$20090301$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405121551375800-CVNQW$GB-MYLANLABS-2024M1063433$MYLAN$$18$YR$$M$Y$$$20240710$$CN$GB$GB
240735252$24073525$2$F$20240603$20240905$20240710$20240910$EXP$$US-OTSUKA-2024_015909$OTSUKA$$$$$F$Y$$$20240910$$CN$US$US
240735263$24073526$3$F$$20240715$20240710$20240716$PER$$US-GILEAD-2024-0679956$GILEAD$$77$YR$E$M$Y$$$20240716$$HP$US$US
240735273$24073527$3$F$$20240826$20240710$20240829$EXP$$CA-TAKEDA-2019TUS028665$TAKEDA$$$$$F$Y$$$20240829$$MD$CA$CA
240735281$24073528$1$I$$20240701$20240710$20240710$PER$$US-TEVA-VS-3216870$TEVA$$50$YR$$F$Y$$$20240710$$CN$US$US
240735291$24073529$1$I$$20240627$20240710$20240710$PER$$US-TEVA-VS-3216893$TEVA$$64$YR$$M$Y$$$20240710$$CN$US$US
240735312$24073531$2$F$20220901$20240712$20240710$20240723$PER$$US-SA-2024SA195401$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240723$$CN$US$US
240735321$24073532$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA196658$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240710$$MD$US$US
240735332$24073533$2$F$20230701$20240719$20240710$20240729$PER$$US-SA-2024SA201086$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240729$$HP$US$US
240735341$24073534$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109116$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$75$YR$E$M$Y$$$20240710$$HP$US$US
240735351$24073535$1$I$$20240708$20240710$20240710$EXP$$CA-FreseniusKabi-FK202410784$FRESENIUS KABI$$74$YR$E$M$Y$95$KG$20240710$$PH$CA$CA
240735361$24073536$1$I$20240501$20240701$20240710$20240710$EXP$ES-AEMPS-1540862$ES-FreseniusKabi-FK202410398$FRESENIUS KABI$$$$I$M$Y$$$20240710$$HP$ES$ES
240735381$24073538$1$I$$20240708$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063770$SANDOZ$$71$YR$$M$Y$$$20240710$$HP$CA$CA
240735411$24073541$1$I$20240701$20240708$20240710$20240710$EXP$$US-OTSUKA-2024_019287$OTSUKA$$$$$$Y$$$20240710$$CN$US$US
240735421$24073542$1$I$20170101$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405142045567050-ZYRQP$GB-OTSUKA-2024_019082$OTSUKA$$18$YR$$F$Y$55$KG$20240710$$CN$GB$GB
240735432$24073543$2$F$$20240717$20240710$20240726$PER$$US-BEH-2024173654$CSL BEHRING$$$$C$M$Y$$$20240726$$CN$US$US
240735441$24073544$1$I$20240101$20240704$20240710$20240710$EXP$CH-SM-2024-13229$CH-SANDOZ INC.-SDZ2024CH062920$SANDOZ$$52$YR$$F$Y$81.4$KG$20240710$$MD$CH$CH
240735451$24073545$1$I$$20240703$20240710$20240710$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037907$BOEHRINGER INGELHEIM$Khan O, Egbe A, Abbasi D. The failing watchman^: recurrent left atrial appendage occlusion device (LAAOD) thrombus after successful initial implantation. Cureus. 2024 May 30;16(5): e61368. doi:10.7759/cureus.61368.$79$YR$E$F$Y$$$20240710$$HP$US$US
240735461$24073546$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-NVSC2023CA028634$SANDOZ$$$$$F$Y$$$20240710$$HP$CA$CA
240735472$24073547$2$F$$20240708$20240710$20240718$PER$$US-ABBVIE-5832324$ABBVIE$$$$$$Y$$$20240718$$CN$US$US
240735481$24073548$1$I$20220101$20240703$20240710$20240710$PER$$US-SA-2024SA199762$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240710$$MD$US$US
240735491$24073549$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA196076$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240710$$HP$US$US
240735501$24073550$1$I$20240101$20240705$20240710$20240710$EXP$$US-SA-2024SA201012$SANOFI AVENTIS$$$$I$F$Y$$$20240710$$HP$US$US
240735511$24073551$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198242$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$MD$US$US
240735523$24073552$3$F$20240101$20240830$20240710$20240913$PER$$US-SA-2024SA197754$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240913$$MD$US$US
240735531$24073553$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA197791$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240710$$MD$US$US
240735541$24073554$1$I$20240101$20240705$20240710$20240710$PER$$US-SA-2024SA200716$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240710$$MD$US$US
240735551$24073555$1$I$20240101$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136664$AMGEN$$80$YR$E$F$Y$$$20240710$$CN$US$US
240735561$24073556$1$I$$20240702$20240710$20240710$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005007$BIOCON$$$$$$Y$$$20240710$$CN$CA$CA
240735571$24073557$1$I$$20240708$20240710$20240710$EXP$$NVSC2024SK141901$NOVARTIS$$14$YR$$M$Y$$$20240710$$MD$SK$SK
240735581$24073558$1$I$$20240708$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063523$SANDOZ$$$$$M$Y$$$20240710$$HP$US$US
240735591$24073559$1$I$20240616$20240708$20240710$20240710$EXP$IT-MINISAL02-993938$IT-DAIICHI SANKYO EUROPE GMBH-DSE-2024-134716$DAIICHI$$84$YR$$M$Y$65$KG$20240710$$MD$IT$IT
240735601$24073560$1$I$20231101$20240626$20240710$20240710$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2024-05690$LUPIN$$$$$$Y$$$20240710$$MD$DE$DE
240735611$24073561$1$I$20240701$20240701$20240710$20240710$PER$$US-TEVA-VS-3217454$TEVA$$27$YR$$M$Y$$$20240710$$CN$US$US
240735621$24073562$1$I$$20240702$20240710$20240710$EXP$$JP-ROCHE-10000019430$ROCHE$$8$DEC$E$M$Y$$$20240710$$MD$JP$JP
240735641$24073564$1$I$20240705$20240709$20240710$20240710$EXP$$CN-BAYER-2024A099064$BAYER$$69$YR$E$M$Y$$$20240710$$HP$CN$CN
240735652$24073565$2$F$20240101$20240702$20240710$20240712$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-080614$REGENERON$$80$YR$$F$Y$$$20240712$$CN$DE$DE
240735661$24073566$1$I$20230801$20240702$20240710$20240710$EXP$$GB-CELLTRION INC.-2024GB016297$CELLTRION$$$$$$Y$$$20240710$$CN$GB$GB
240735672$24073567$2$F$$20240715$20240710$20240718$EXP$$NVSC2024RU141530$NOVARTIS$Luchkina VK, Bratukhina MM, Aleshina OA, Volkov NV, Vasilyeva AN, Akhmerzaeva ZKH et al.. ?????? ????????? ?????????????????? ?? ???? ??????????  ????????????? ? ???????? ? ?????? ?????????? ????????, ??????????? ? ???????? FLT3-ITDA [Reversible Leukoencephalopathy With Gilteritinib In A Patient With Acute Myeloid Leukemia With Flt3-Itd Mutation]. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY. 2024;69(2):267-9$41$YR$$$Y$$$20240718$$HP$RU$RU
240735681$24073568$1$I$20240601$20240705$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108526$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240710$$CN$US$US
240735692$24073569$2$F$20240301$20240719$20240710$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109024$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240726$$MD$JP$JP
240735701$24073570$1$I$20230914$20240702$20240710$20240710$EXP$IE-HPRA-2024-113765$IE-TEVA-VS-3216606$TEVA$$45$YR$$F$Y$65$KG$20240710$$CN$IE$IE
240735711$24073571$1$I$$20240703$20240710$20240710$PER$$US-BAYER-2024A097649$BAYER$$$$$$Y$$$20240710$$CN$US$US
240735721$24073572$1$I$$20240703$20240710$20240710$PER$$US-APOTEX-2024AP007991$APOTEX$Halawi H, Harris JE, Goodarzi A, Yau S, Youssef JG, Botros M, et al. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy. 2024;44 (3):283-289$24$YR$$M$Y$$$20240710$$HP$US$US
240735731$24073573$1$I$$20240709$20240710$20240710$EXP$IT-MINISAL02-994120$IT-GILEAD-2024-0680032$GILEAD$$61$YR$A$M$Y$$$20240710$$MD$IT$IT
240735751$24073575$1$I$$20240705$20240710$20240710$EXP$$CN-RDY-LIT/CHN/24/0010151$DR REDDYS$Tang M, Zhang Z, Wang L, Qian H, Wu W, Liu Z, et al. Coronary artery ectasia associated with IgG4-related disease: a case report and literature review. BMC Cardiovascular Disorders. 2023 Dec;23(1): doi:10.1186/s12872-023-03369-7.$77$YR$E$M$Y$$$20240710$$HP$CN$CN
240735761$24073576$1$I$$20240703$20240710$20240710$PER$$US-ALXN-202407USA000283US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
240735771$24073577$1$I$20240624$20240708$20240710$20240710$EXP$GB-MHRA-MED-202407071634430990-SFRGM$GB-DSJP-DSE-2024-134766$DAIICHI$$69$YR$$M$Y$117$KG$20240710$$PH$GB$GB
240735781$24073578$1$I$20231101$20240625$20240710$20240710$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456090$RANBAXY$$63$YR$$M$Y$$$20240710$$MD$FR$FR
240735791$24073579$1$I$$20240625$20240710$20240710$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456158$RANBAXY$Veres M, Ustohal L. Malignant catatonia in a patient with undifferentiated schizophrenia. Psychiatrie pro praxi. 2024;25(2):99-102$46$YR$$M$Y$$$20240710$$MD$CZ$CZ
240735801$24073580$1$I$$20240709$20240710$20240710$EXP$$US-GILEAD-2024-0680098$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240735812$24073581$2$F$20240703$20240709$20240710$20240715$PER$$US-ABBVIE-5832523$ABBVIE$$61$YR$$F$Y$$$20240715$$CN$US$US
240735821$24073582$1$I$$20240625$20240710$20240710$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455964$RANBAXY$Zhang N, Li H, Wang D, Wang Z, Zhu J-S, Chen K, et al. Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children. Clin Epigenetics. 2024;16 (1):1-11$$$C$$Y$$$20240710$$HP$CN$CN
240735831$24073583$1$I$$20240705$20240710$20240710$PER$$NVSC2024US140865$NOVARTIS$$$$$M$Y$$$20240710$$CN$US$US
240735851$24073585$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024136589$AMGEN$$$$$F$Y$$$20240710$$PH$US$US
240735861$24073586$1$I$20240708$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136673$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240735871$24073587$1$I$20240507$20240705$20240710$20240710$EXP$FR-AFSSAPS-PC2024000558$FR-REGENERON PHARMACEUTICALS, INC.-2024-095708$REGENERON$$76$YR$$F$Y$$$20240710$$MD$FR$FR
240735881$24073588$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109109$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$56$YR$A$M$Y$$$20240710$$HP$US$US
240735891$24073589$1$I$$20240702$20240710$20240710$EXP$$US-PFIZER INC-07H-163-0313561-00$PFIZER$Francis, L.. Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin. Clinical Rheumatology. 2007;27(1):129-131$66$YR$$M$Y$$$20240710$$HP$US$US
240735901$24073590$1$I$20240101$20240627$20240710$20240710$PER$$US-SA-2024SA035455$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240710$$MD$US$US
240735951$24073595$1$I$$20240628$20240710$20240710$EXP$$US-PFIZER INC-202400203652$PFIZER$$$$$F$Y$$$20240710$$CN$US$US
240735971$24073597$1$I$20240401$20240701$20240710$20240710$PER$$US-SA-2024SA197777$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240710$$MD$US$US
240735982$24073598$2$F$20240101$20240807$20240710$20240814$PER$$US-SA-2024SA200098$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240814$$MD$US$US
240735992$24073599$2$F$$20240716$20240710$20240724$PER$$US-SA-2024SA200964$SANOFI AVENTIS$$47$YR$A$F$Y$68$KG$20240724$$MD$US$US
240736001$24073600$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47860$$FDA-CTU$$46$YR$$M$N$126.55$KG$20240710$N$$US$
240736011$24073601$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47880$$FDA-CTU$$43$YR$$F$N$$$20240710$N$$US$
240736023$24073602$3$F$20240101$20240829$20240710$20240911$PER$$US-SA-2024SA199890$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240911$$MD$US$US
240736031$24073603$1$I$$20240710$20240710$20240710$DIR$709703$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240736041$24073604$1$I$20240101$20240705$20240710$20240710$PER$$US-SA-2024SA201519$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240710$$MD$US$US
240736051$24073605$1$I$20240625$20240710$20240710$20240710$DIR$709683$$FDA-CTU$$49$YR$$F$N$57.6$KG$20240710$N$CN$US$
240736071$24073607$1$I$$20240708$20240710$20240710$PER$$US-BAYER-2024A098332$BAYER$$4$YR$C$F$Y$$$20240710$$CN$US$US
240736081$24073608$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA196723$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240710$$MD$US$US
240736091$24073609$1$I$20240522$20240710$20240710$20240710$DIR$709688$$FDA-CTU$$33$YR$$M$N$74.25$KG$20240710$$CN$US$
240736101$24073610$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47840$$FDA-CTU$$70$YR$$$N$78.93$KG$20240710$N$$US$
240736111$24073611$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47843$$FDA-CTU$$23$YR$$F$N$$$20240710$N$$US$
240736123$24073612$3$F$$20240814$20240710$20240816$PER$$US-JNJFOC-20240715113$JOHNSON AND JOHNSON$$11$YR$C$M$Y$35$KG$20240816$$PH$US$US
240736132$24073613$2$F$20240518$20240701$20240710$20240712$EXP$$CL-BEH-2024175076$CSL BEHRING$$32$YR$A$M$Y$$$20240712$$CN$CL$CL
240736141$24073614$1$I$$20240704$20240710$20240710$EXP$$AU-AMERICAN REGENT INC-2024002631$AMERICAN REGENT$$$$$$Y$$$20240710$$HP$AU$AU
240736152$24073615$2$F$20240510$20240828$20240710$20240903$EXP$$JP-009507513-2405JPN002723J$MERCK$$$$$M$Y$$$20240903$$MD$JP$JP
240736161$24073616$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109108$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$62$YR$A$F$Y$$$20240710$$HP$US$US
240736181$24073618$1$I$20211212$20240705$20240710$20240710$EXP$$IT-PFIZER INC-2022SGN01643$PFIZER$$49$YR$$M$Y$$$20240710$$MD$IT$IT
240736191$24073619$1$I$$20240705$20240710$20240710$EXP$$DE-PFIZER INC-2023SGN01799$PFIZER$$38$YR$$F$Y$$$20240710$$MD$DE$DE
240736201$24073620$1$I$$20240703$20240710$20240710$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR084555$VIIV$$$$$$Y$$$20240710$$HP$US$US
240736211$24073621$1$I$$20240705$20240710$20240710$EXP$$US-GSK-US2024AMR084532$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$US$US
240736223$24073622$3$F$$20240812$20240710$20240812$PER$$US-ALXN-202407USA000278US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
240736231$24073623$1$I$20240612$20240709$20240710$20240710$EXP$$AT-JNJFOC-20240722163$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$MD$AT$AT
240736251$24073625$1$I$20240208$20240702$20240710$20240710$EXP$FR-AFSSAPS-AVMA2024000249$FR-TEVA-VS-3216618$TEVA$$38$YR$$M$Y$$$20240710$$PH$FR$FR
240736261$24073626$1$I$$20240410$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000404$PAREXEL$$16$YR$$F$Y$$$20240710$$HP$US$US
240736271$24073627$1$I$$20240628$20240710$20240710$EXP$$SI-AMNEAL PHARMACEUTICALS-2024-AMRX-02492$AMNEAL$Bezeljak N, Jerman A, Grenc D, Zorman S.K.. Inadvertent Intoxication with Salbutamol, Treated with Hemodialysis: A Case Report and Brief Review of the Literature. Case Rep Nephrol Dial. 2024;14:88-96$69$YR$$M$Y$76$KG$20240710$$HP$SI$SI
240736281$24073628$1$I$20230109$20231128$20240710$20240710$EXP$$PL-SANDOZ INC.-NVSC2023PL037905$SANDOZ$$74$YR$$F$Y$$$20240710$$MD$PL$PL
240736291$24073629$1$I$$20240405$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000381$PAREXEL$$52$YR$$F$Y$$$20240710$$CN$US$US
240736301$24073630$1$I$$20240408$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000385$PAREXEL$$33$YR$$F$Y$$$20240710$$HP$US$US
240736311$24073631$1$I$$20240710$20240710$20240710$DIR$709719$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240736321$24073632$1$I$$20240411$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000414$PAREXEL$$24$YR$$F$Y$$$20240710$$HP$US$US
240736331$24073633$1$I$$20240710$20240710$20240710$DIR$709685$$FDA-CTU$$30$YR$$M$N$94.5$KG$20240710$N$CN$US$
240736341$24073634$1$I$20240101$20240326$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000169$PAREXEL$$$$$F$Y$81.188$KG$20240710$$HP$US$US
240736351$24073635$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47864$$FDA-CTU$$39$YR$$M$N$$$20240710$N$$US$
240736362$24073636$2$F$20240101$20240723$20240710$20240724$EXP$$US-UCBSA-2024034801$UCB$$$$$M$Y$$$20240724$$CN$US$US
240736371$24073637$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47885$$FDA-CTU$$56$YR$$F$N$$$20240710$N$$US$
240736381$24073638$1$I$20240602$20240710$20240710$20240710$DIR$709721$$FDA-CTU$$75$YR$$M$N$94.5$KG$20240710$N$CN$US$
240736391$24073639$1$I$$20240710$20240710$20240710$DIR$709713$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240736401$24073640$1$I$$20240702$20240710$20240710$EXP$$RU-ROCHE-10000016806$ROCHE$$54$YR$A$M$Y$$$20240710$$CN$RU$RU
240736411$24073641$1$I$20240501$20240702$20240710$20240710$EXP$DE-BFARM-24004252$DE-TEVA-VS-3216675$TEVA$$$$$F$Y$$$20240710$$CN$DE$DE
240736422$24073642$2$F$20240101$20240705$20240710$20240717$PER$$US-SA-2024SA194662$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240717$$MD$US$US
240736432$24073643$2$F$$20240709$20240710$20240715$EXP$$BD-BIOCON BIOLOGICS LIMITED-BBL2024005027$BIOCON$Ferdause J, Momtahena SJ, Karim R, Chowdhury AP, Hossain NT, Islam MA et al.,. Trastuzumab-induced toxic epidermal necrolysis in a HER-2-positive metastatic breast cancer patient - A rare case report. Clin Case Rep. 2024;12:e9103$$$$$Y$$$20240715$$HP$BD$BD
240736441$24073644$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47876$$FDA-CTU$$$$$M$N$$$20240709$N$HP$US$
240736451$24073645$1$I$$20240710$20240710$20240710$DIR$709712$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240736481$24073648$1$I$$20240705$20240710$20240710$EXP$$CA-TAKEDA-2022TUS028992$TAKEDA$$$$$M$Y$$$20240710$$MD$CA$CA
240736491$24073649$1$I$$20240708$20240710$20240710$EXP$$CA-TAKEDA-2024TUS069898$TAKEDA$$$$$F$Y$$$20240710$$CN$CA$CA
240736504$24073650$4$F$20240629$20240802$20240710$20240820$PER$$US-AMGEN-USASP2024135365$AMGEN$$75$YR$E$F$Y$$$20240820$$HP$US$US
240736511$24073651$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024136404$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240736522$24073652$2$F$20240301$20240712$20240710$20240723$EXP$$ES-BEH-2024174953$CSL BEHRING$$48$YR$A$F$Y$$$20240723$$PH$ES$ES
240736541$24073654$1$I$$20240422$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000468$PAREXEL$$$$$F$Y$$$20240710$$HP$US$US
240736561$24073656$1$I$$20240419$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000457$PAREXEL$$40$YR$$M$Y$$$20240710$$HP$US$US
240736573$24073657$3$F$20240522$20240910$20240710$20240924$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0501114$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
240736601$24073660$1$I$$20240509$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000544$PAREXEL$$$$A$F$Y$$$20240710$$HP$US$US
240736611$24073661$1$I$$20240425$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000487$PAREXEL$$40$YR$$F$Y$$$20240710$$HP$US$US
240736621$24073662$1$I$$20240510$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000549$PAREXEL$$$$$F$Y$$$20240710$$HP$US$US
240736631$24073663$1$I$$20240419$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000461$PAREXEL$$41$YR$$F$Y$$$20240710$$HP$US$US
240736651$24073665$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47863$$FDA-CTU$$68$YR$$F$N$92.99$KG$20240710$N$$US$
240736661$24073666$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47831$$FDA-CTU$$68$YR$$M$N$$$20240710$N$$US$
240736671$24073667$1$I$$20240417$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000450$PAREXEL$$$$$F$Y$$$20240710$$HP$US$US
240736701$24073670$1$I$$20240509$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000540$PAREXEL$$$$$F$Y$$$20240710$$HP$US$US
240736741$24073674$1$I$20240517$20240604$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000654$PAREXEL$$41$YR$$F$Y$88$KG$20240710$$HP$US$US
240736771$24073677$1$I$$20240430$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000514$PAREXEL$$59$YR$$F$Y$$$20240710$$CN$US$US
240736781$24073678$1$I$$20240419$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000459$PAREXEL$$45$YR$$M$Y$$$20240710$$HP$US$US
240736791$24073679$1$I$$20240603$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000644$PAREXEL$$53$YR$$F$Y$$$20240710$$HP$US$US
240736801$24073680$1$I$$20240619$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000737$PAREXEL$$$$$M$Y$$$20240710$$HP$US$US
240736821$24073682$1$I$20231201$20240430$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000501$PAREXEL$$39$YR$$F$Y$$$20240710$$CN$US$US
240736851$24073685$1$I$20240401$20240430$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000500$PAREXEL$$33$YR$$F$Y$$$20240710$$CN$US$US
240736861$24073686$1$I$20240501$20240503$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000520$PAREXEL$$35$YR$$M$Y$$$20240710$$CN$US$US
240736891$24073689$1$I$$20240510$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000552$PAREXEL$$$$$M$Y$$$20240710$$MD$US$US
240736901$24073690$1$I$$20240418$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000449$PAREXEL$$$$$M$Y$$$20240710$$MD$US$US
240736911$24073691$1$I$$20240409$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000398$PAREXEL$$$$$F$Y$48.526$KG$20240710$$CN$US$US
240736921$24073692$1$I$$20240613$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000720$PAREXEL$$36$YR$$F$Y$$$20240710$$HP$US$US
240736941$24073694$1$I$20240501$20240501$20240710$20240710$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000513$PAREXEL$$16$YR$$M$Y$$$20240710$$CN$US$US
240736951$24073695$1$I$20240508$20240708$20240710$20240710$EXP$FR-AFSSAPS-PB2024000724$FR-EMD Serono-2024037047$EMD SERONO INC$$77$YR$E$F$Y$48$KG$20240710$$MD$FR$FR
240736961$24073696$1$I$20240401$20240701$20240710$20240710$PER$$US-SA-2024SA197825$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240710$$MD$US$US
240736971$24073697$1$I$20240601$20240701$20240710$20240710$PER$$US-SA-2023SA130040$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240710$$MD$US$US
240736982$24073698$2$F$20240523$20240905$20240710$20240911$EXP$$JP-AMGEN-JPNSP2024127108$AMGEN$$$$$M$Y$$$20240911$$PH$JP$JP
240736993$24073699$3$F$20240709$20240719$20240710$20240724$PER$$US-AMGEN-USASP2024136016$AMGEN$$77$YR$E$F$Y$$$20240724$$CN$US$US
240737001$24073700$1$I$20240703$20240703$20240710$20240710$EXP$$IE-ROCHE-10000018686$ROCHE$$$$$F$Y$$$20240710$$CN$IE$IE
240737011$24073701$1$I$20240624$20240707$20240710$20240710$EXP$$CN-BAYER-2024A097653$BAYER$$44$YR$A$M$Y$88$KG$20240710$$HP$CN$CN
240737021$24073702$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405071912587540-GYZRT$GB-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2407GB05285$INSUD PHARMA$$$$$F$Y$$$20240710$$CN$GB$GB
240737033$24073703$3$F$$20240821$20240710$20240821$PER$$US-ALXN-202407USA000311US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
240737043$24073704$3$F$$20240916$20240710$20240925$PER$$US-GSK-US2024084318$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$PH$US$US
240737051$24073705$1$I$$20240703$20240710$20240710$30DAY$$US-GSK-US2024082603$GLAXOSMITHKLINE$$43$YR$$F$Y$$$20240710$$CN$US$US
240737061$24073706$1$I$20240601$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135440$AMGEN$$41$YR$A$F$Y$$$20240710$$CN$US$US
240737071$24073707$1$I$20240101$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136388$AMGEN$$69$YR$E$F$Y$$$20240710$$CN$US$US
240737081$24073708$1$I$20240702$20240703$20240710$20240710$PER$$US-ABBVIE-5829901$ABBVIE$$34$YR$$F$Y$$$20240710$$HP$US$US
240737091$24073709$1$I$$20240709$20240710$20240710$EXP$$NVSC2024US142454$NOVARTIS$$$$$M$Y$$$20240710$$HP$US$US
240737101$24073710$1$I$$20240701$20240710$20240710$EXP$$IT-TEVA-VS-3217334$TEVA$Fattizzo B, Pasquale R, Croci GA, Pettine L, Cassanello G, Barcellini W. Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review. Blood-Transf 2024; 22 (3): 266-272.$58$YR$$F$Y$$$20240710$$HP$IT$IT
240737111$24073711$1$I$20220519$20240708$20240710$20240710$EXP$$NVSC2022DE228292$NOVARTIS$$66$YR$$F$Y$73$KG$20240710$$MD$DE$DE
240737121$24073712$1$I$20240602$20240705$20240710$20240710$EXP$$CA-JNJFOC-20240721585$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240710$$HP$CA$CA
240737131$24073713$1$I$$20240709$20240710$20240710$PER$$PR-JNJFOC-20240723830$JOHNSON AND JOHNSON$$$$$$Y$72.64$KG$20240710$$CN$PR$PR
240737141$24073714$1$I$$20240627$20240710$20240710$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2024US000931$JUBILANT$Singh R, Patel D. R. Pejka S. Rhabdomyolysis in a Hospitalized 16-Year-Old Boy: A Rarely Reported Underlying Cause. Case Reports in Pediatrics. 2016;1-2$16$YR$$M$Y$$$20240710$$HP$US$US
240737151$24073715$1$I$20240701$20240704$20240710$20240710$EXP$$JP-OTSUKA-2024_019116$OTSUKA$$$$$M$Y$$$20240710$$MD$JP$JP
240737161$24073716$1$I$20230101$20240704$20240710$20240710$EXP$IT-MLMSERVICE-20240627-PI114604-00034-1$IT-JUBILANT CADISTA PHARMACEUTICALS-2024IT000929$JUBILANT$Malavasi M, Notarianni G, Pontillo D, Luciani M, Petrungaro M, Zampi G, et al.. THE CONUNDRUM OF DRUG INTERACTIONS AND HOLTER MONITORING: LAMIN GENE MUTATION DISCOVERED BY A TORSADE DE POINTES EPISODE FOLLOWED BY OUT-OF-THE-HOSPITAL RESUSCITATION.. European Heart Journal, Supplement.. 2024;26(Supplement 2:ii55-6$57$YR$$F$Y$$$20240710$$MD$IT$IT
240737171$24073717$1$I$20240101$20240627$20240710$20240710$PER$$US-SA-2024SA195039$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240710$$MD$US$US
240737182$24073718$2$F$20240101$20240715$20240710$20240723$EXP$$CN-SA-2024SA199516$SANOFI AVENTIS$$80$YR$E$M$Y$40$KG$20240723$$CN$CN$CN
240737193$24073719$3$F$20240101$20240812$20240710$20240821$PER$$US-SA-2024SA200977$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240821$$MD$US$US
240737201$24073720$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA196049$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$HP$US$US
240737211$24073721$1$I$$20240628$20240710$20240710$PER$$US-SA-2024SA195460$SANOFI AVENTIS$$$$$M$Y$$$20240710$$CN$US$US
240737221$24073722$1$I$20240101$20240705$20240710$20240710$EXP$$US-SA-2024SA133015$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240710$$CN$US$US
240737232$24073723$2$F$$20240709$20240710$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005123$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240712$$CN$US$US
240737241$24073724$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005207$ELI LILLY AND CO$$15$YR$T$M$Y$$$20240710$$CN$US$US
240737251$24073725$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005262$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240710$$CN$US$US
240737261$24073726$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005325$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240710$$CN$US$US
240737271$24073727$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005219$ELI LILLY AND CO$$$$$F$Y$$$20240710$$CN$US$US
240737291$24073729$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005106$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240710$$CN$US$US
240737301$24073730$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005082$ELI LILLY AND CO$$$$$M$Y$$$20240710$$CN$US$US
240737311$24073731$1$I$$20240703$20240710$20240710$EXP$$US-PFIZER INC-PV202400088360$PFIZER$Carozza, R.. Reversible cerebral vasoconstriction syndrome complicated by posterior reversible encephalopathy syndrome in a child triggered by systemic immunosuppression. Pediatr Stroke. 2024;8:16-32$10$YR$$M$Y$$$20240710$$MD$US$US
240737321$24073732$1$I$20240705$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005056$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240710$$CN$US$US
240737331$24073733$1$I$20230717$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47878$$FDA-CTU$$63$YR$$F$N$$$20240710$Y$PH$US$
240737351$24073735$1$I$20231216$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47877$$FDA-CTU$$71$YR$$F$N$$$20240710$Y$PH$US$
240737361$24073736$1$I$$20240708$20240710$20240710$EXP$$PT-PFIZER INC-2022SGN02192$PFIZER$$$$$F$Y$$$20240710$$CN$PT$PT
240737371$24073737$1$I$$20240629$20240710$20240710$PER$$US-TEVA-VS-3216827$TEVA$$$$$$Y$$$20240710$$CN$US$US
240737382$24073738$2$F$20230101$20240801$20240710$20240807$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2023CUR004375$CURRAX PHARMACEUTICALS$$65$YR$$F$Y$104.31$KG$20240807$$CN$CA$CA
240737391$24073739$1$I$20230601$20240702$20240710$20240710$EXP$$DE-TEVA-VS-3216603$TEVA$$$$$F$Y$2.94$KG$20240710$$MD$DE$DE
240737401$24073740$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186254$Haleon PLC$$33$YR$$$Y$$$20240710$$CN$US$US
240737411$24073741$1$I$$20240708$20240710$20240710$EXP$$CA-BAYER-2024A098730$BAYER$$77$YR$E$F$Y$$$20240710$$HP$CA$CA
240737431$24073743$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47859$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240737441$24073744$1$I$20240601$20240710$20240710$20240710$EXP$ES-AEMPS-1545536$NVSC2024ES142347$NOVARTIS$$73$YR$$M$Y$$$20240710$$PH$ES$ES
240737451$24073745$1$I$20240701$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024133907$AMGEN$$48$YR$A$F$Y$$$20240710$$CN$US$US
240737461$24073746$1$I$$20240708$20240710$20240710$EXP$$NVSC2024US141222$NOVARTIS$$$$$$Y$$$20240710$$CN$US$US
240737471$24073747$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024136597$AMGEN$$$$$F$Y$$$20240710$$PH$US$US
240737482$24073748$2$F$20240705$20240711$20240710$20240726$PER$$US-AMGEN-USASP2024136004$AMGEN$$64$YR$A$F$Y$$$20240726$$CN$US$US
240737502$24073750$2$F$$20240812$20240710$20240813$PER$$US-JNJFOC-20240709538$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$PH$US$US
240737511$24073751$1$I$$20240701$20240710$20240710$EXP$$US-AstraZeneca-2024A157199$ASTRAZENECA$$74$YR$$M$Y$$$20240710$$CN$US$
240737521$24073752$1$I$$20240705$20240710$20240710$PER$$US-SA-2024SA200219$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240710$$HP$US$US
240737531$24073753$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA196734$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240710$$CN$US$US
240737542$24073754$2$F$$20240801$20240710$20240810$PER$$US-SA-2024SA196708$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240810$$MD$US$US
240737561$24073756$1$I$$20240707$20240710$20240710$EXP$$US-GSK-US2024AMR084779$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$US$US
240737571$24073757$1$I$20180909$20210705$20240710$20240710$PER$$JP-PFM-2018-11476$PIERRE FABRE MEDICAMENT$$13$MON$$F$Y$3$KG$20240710$$MD$JP$JP
240737581$24073758$1$I$20240501$20240708$20240710$20240710$EXP$$US-BAYER-2024A098838$BAYER$$53$YR$A$M$Y$$$20240710$$HP$US$US
240737591$24073759$1$I$$20210505$20240710$20240710$PER$$CA-PFM-2020-16155$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$MD$CA$CA
240737601$24073760$1$I$$20210727$20240710$20240710$PER$$CA-PFM-2020-15565$PIERRE FABRE MEDICAMENT$$47$YR$$M$Y$$$20240710$$MD$CA$CA
240737611$24073761$1$I$$20211209$20240710$20240710$PER$$CA-PFM-2020-03676$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240710$$MD$CA$CA
240737621$24073762$1$I$20180101$20210505$20240710$20240710$PER$$CA-PFM-2020-15189$PIERRE FABRE MEDICAMENT$$48$YR$$F$Y$$$20240710$$MD$CA$CA
240737631$24073763$1$I$20230101$20240701$20240710$20240710$EXP$$CN-SA-2024SA197312$SANOFI AVENTIS$$$$$F$Y$$$20240710$$CN$CN$CN
240737641$24073764$1$I$$20240627$20240710$20240710$PER$$US-SA-2024SA194110$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240710$$PH$US$US
240737651$24073765$1$I$$20210505$20240710$20240710$PER$$CA-PFM-2020-17452$PIERRE FABRE MEDICAMENT$$68$YR$$F$Y$$$20240710$$MD$CA$CA
240737661$24073766$1$I$$20210505$20240710$20240710$PER$$CA-PFM-2020-16158$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240710$$MD$CA$CA
240737671$24073767$1$I$$20210505$20240710$20240710$PER$$CA-PFM-2020-18704$PIERRE FABRE MEDICAMENT$$40$YR$$F$Y$$$20240710$$MD$CA$CA
240737681$24073768$1$I$$20210505$20240710$20240710$PER$$CA-PFM-2020-18703$PIERRE FABRE MEDICAMENT$$19$YR$$F$Y$$$20240710$$MD$CA$CA
240737691$24073769$1$I$$20240626$20240710$20240710$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-06450$LUPIN$Gerostamoulos D, Glowacki L, Pricone M, Crump K, Rago MD, Joubert S, et al. Fatal intoxications from a combination of 4-Fluoroamphetamine and 25C-NBOMe. Journal of Analytical Toxicology. 2022;47 (2):191-196$$$$M$Y$$$20240710$$HP$AU$AU
240737701$24073770$1$I$20200101$20210505$20240710$20240710$PER$$CA-PFM-2020-17445$PIERRE FABRE MEDICAMENT$$63$YR$$F$Y$$$20240710$$MD$CA$CA
240737711$24073771$1$I$$20210505$20240710$20240710$PER$$CA-PFM-2020-17448$PIERRE FABRE MEDICAMENT$$33$YR$$F$Y$$$20240710$$MD$CA$CA
240737721$24073772$1$I$$20210518$20240710$20240710$PER$$CA-PFM-2020-20310$PIERRE FABRE MEDICAMENT$$53$YR$$F$Y$$$20240710$$MD$CA$CA
240737731$24073773$1$I$$20210518$20240710$20240710$PER$$CA-PFM-2020-19357$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240710$$MD$CA$CA
240737741$24073774$1$I$$20210518$20240710$20240710$PER$$CA-PFM-2020-16924$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240710$$MD$CA$CA
240737751$24073775$1$I$$20210518$20240710$20240710$PER$$CA-PFM-2020-17895$PIERRE FABRE MEDICAMENT$$68$YR$$M$Y$$$20240710$$MD$CA$CA
240737761$24073776$1$I$$20210802$20240710$20240710$PER$$CA-PFM-2020-17857$PIERRE FABRE MEDICAMENT$$19$YR$$F$Y$$$20240710$$MD$CA$CA
240737771$24073777$1$I$$20210802$20240710$20240710$PER$$CA-PFM-2020-18175$PIERRE FABRE MEDICAMENT$$20$YR$$F$Y$$$20240710$$MD$CA$CA
240737781$24073778$1$I$$20210923$20240710$20240710$PER$$FR-PFM-2021-00471$PIERRE FABRE MEDICAMENT$$$$I$F$Y$$$20240710$$CN$FR$FR
240737791$24073779$1$I$20191123$20211215$20240710$20240710$PER$$CA-PFM-2021-00443$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240710$$MD$CA$CA
240737811$24073781$1$I$$20210817$20240710$20240710$PER$$CA-PFM-2020-18227$PIERRE FABRE MEDICAMENT$$46$YR$$F$Y$$$20240710$$MD$CA$CA
240737821$24073782$1$I$$20211209$20240710$20240710$PER$$CA-PFM-2020-22588$PIERRE FABRE MEDICAMENT$$45$YR$$F$Y$$$20240710$$MD$CA$CA
240737831$24073783$1$I$$20211215$20240710$20240710$PER$$CA-PFM-2021-00444$PIERRE FABRE MEDICAMENT$$45$YR$$M$Y$$$20240710$$MD$CA$CA
240737841$24073784$1$I$$20210727$20240710$20240710$PER$$CA-PFM-2020-21891$PIERRE FABRE MEDICAMENT$$45$YR$$M$Y$$$20240710$$MD$CA$CA
240737851$24073785$1$I$20240201$20240628$20240710$20240710$PER$$US-SA-2024SA194880$SANOFI AVENTIS$$23$YR$A$F$Y$68.03$KG$20240710$$MD$US$US
240737861$24073786$1$I$$20210608$20240710$20240710$PER$$CA-PFM-2020-22511$PIERRE FABRE MEDICAMENT$$28$YR$$F$Y$$$20240710$$MD$CA$CA
240737871$24073787$1$I$20240101$20240705$20240710$20240710$EXP$$HN-DSJP-DSE-2024-126974$DAIICHI$$77$YR$$M$Y$$$20240710$$PH$HN$HN
240737881$24073788$1$I$$20240705$20240710$20240710$EXP$$US-INCYTE CORPORATION-2024IN007126$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240737891$24073789$1$I$$20211215$20240710$20240710$PER$$CA-PFM-2021-00445$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240710$$MD$CA$CA
240737902$24073790$2$F$$20240708$20240710$20240711$EXP$$US-PFIZER INC-202400206582$PFIZER$Khan, M.. Anaconda Right Coronary Artery. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(Suppl 1):10.1161/atvb.43.suppl_1.442$61$YR$$M$Y$$$20240711$$MD$US$US
240737911$24073791$1$I$20240411$20240704$20240710$20240710$EXP$$FR-DSJP-DSE-2024-134770$DAIICHI$$$$A$F$Y$$$20240710$$MD$FR$FR
240737921$24073792$1$I$20190423$20210426$20240710$20240710$PER$$JP-PFM-2019-04966$PIERRE FABRE MEDICAMENT$$2$MON$$F$Y$$$20240710$$MD$JP$JP
240737931$24073793$1$I$20181021$20210426$20240710$20240710$PER$$JP-PFM-2018-14367$PIERRE FABRE MEDICAMENT$$4$MON$$M$Y$7.2$KG$20240710$$PH$JP$JP
240737941$24073794$1$I$20190224$20210426$20240710$20240710$PER$$JP-PFM-2019-04508$PIERRE FABRE MEDICAMENT$$3$MON$$M$Y$$$20240710$$MD$JP$JP
240737951$24073795$1$I$20190329$20210531$20240710$20240710$PER$$JP-PFM-2019-04442$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$$$20240710$$MD$JP$JP
240737961$24073796$1$I$20190313$20210531$20240710$20240710$PER$$JP-PFM-2019-04487$PIERRE FABRE MEDICAMENT$$7$MON$$F$Y$$$20240710$$MD$JP$JP
240737971$24073797$1$I$$20211215$20240710$20240710$PER$$CA-PFM-2021-00472$PIERRE FABRE MEDICAMENT$$46$YR$$F$Y$$$20240710$$MD$CA$CA
240737981$24073798$1$I$$20240702$20240710$20240710$PER$$US-INCYTE CORPORATION-2024IN007028$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240737991$24073799$1$I$20180205$20230622$20240710$20240710$PER$$JP-PFM-2018-01979$PIERRE FABRE MEDICAMENT$$4$MON$$F$Y$$$20240710$$MD$JP$JP
240738001$24073800$1$I$$20240708$20240710$20240710$EXP$$CA-BAYER-2024A099311$BAYER$$45$YR$A$F$Y$$$20240710$$HP$CA$CA
240738011$24073801$1$I$$20240321$20240710$20240710$PER$$NL-PFM-2019-00403$PIERRE FABRE MEDICAMENT$$42$YR$$F$Y$$$20240710$$MD$NL$NL
240738021$24073802$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47881$$FDA-CTU$$68$YR$$F$N$167.38$KG$20240710$N$$US$
240738031$24073803$1$I$$20240321$20240710$20240710$PER$$BE-PFM-2019-04726$PIERRE FABRE MEDICAMENT$$26$YR$$M$Y$$$20240710$$MD$BE$BE
240738041$24073804$1$I$$20240321$20240710$20240710$PER$$BE-PFM-2019-06442$PIERRE FABRE MEDICAMENT$$41$YR$$M$Y$$$20240710$$MD$BE$BE
240738051$24073805$1$I$$20240321$20240710$20240710$PER$$NL-PFM-2019-01495$PIERRE FABRE MEDICAMENT$$66$YR$$F$Y$$$20240710$$MD$NL$NL
240738061$24073806$1$I$$20240321$20240710$20240710$PER$$BE-PFM-2019-04688$PIERRE FABRE MEDICAMENT$$59$YR$$F$Y$$$20240710$$MD$BE$BE
240738071$24073807$1$I$20240630$20240701$20240710$20240710$EXP$$TW-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00712$BIOCRYST PHARMACEUTICALS$$25$YR$$M$Y$$$20240710$$MD$TW$TW
240738081$24073808$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47886$$FDA-CTU$$15$YR$$F$N$81.19$KG$20240710$N$$US$
240738101$24073810$1$I$$20240321$20240710$20240710$PER$$BE-PFM-2019-01225$PIERRE FABRE MEDICAMENT$$44$YR$$F$Y$$$20240710$$MD$BE$BE
240738111$24073811$1$I$$20240321$20240710$20240710$PER$$BE-PFM-2019-03710$PIERRE FABRE MEDICAMENT$$48$YR$$F$Y$$$20240710$$MD$BE$BE
240738121$24073812$1$I$$20240321$20240710$20240710$PER$$NL-PFM-2019-01208$PIERRE FABRE MEDICAMENT$$66$YR$$F$Y$$$20240710$$MD$NL$NL
240738131$24073813$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47832$$FDA-CTU$$33$YR$$F$N$$$20240710$N$$US$
240738141$24073814$1$I$$20240328$20240710$20240710$PER$$HR-PFM-2019-00457$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240710$$MD$HR$HR
240738151$24073815$1$I$20240521$20240703$20240710$20240710$EXP$FR-AFSSAPS-TS2024000748$FR-Merck Healthcare KGaA-2024036384$MERCK KGAA$$68$YR$E$M$Y$$$20240709$$MD$FR$FR
240738161$24073816$1$I$$20240415$20240710$20240710$PER$$NL-PFM-2019-15729$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$MD$NL$NL
240738171$24073817$1$I$$20240321$20240710$20240710$PER$$BE-PFM-2019-10375$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240710$$MD$BE$BE
240738181$24073818$1$I$$20240321$20240710$20240710$PER$$BE-PFM-2019-13207$PIERRE FABRE MEDICAMENT$$$$A$M$Y$$$20240710$$MD$BE$BE
240738201$24073820$1$I$$20240702$20240710$20240710$EXP$$PT-TAKEDA-2024TUS068057$TAKEDA$Temido, MJ, Lopes S, Figueiredo P and Portela F. Case of autoimmune haemolytic anaemia, possibly secondary to vedolizumab in ulcerative colitis, successfully treated with rituxima. BMJ Case Reports. 2024;17(6):1-3$30$YR$$F$Y$$$20240710$$MD$PT$PT
240738212$24073821$2$F$$20240716$20240710$20240725$PER$$US-INCYTE CORPORATION-2024IN007010$INCYTE$$$$$$Y$$$20240725$$CN$US$US
240738221$24073822$1$I$$20240626$20240710$20240710$EXP$$KR-Eywa Pharma Inc.-2159000$EYWA PHARMA$Source document (Full text)$77$YR$$F$Y$$$20240710$$MD$KR$KR
240738231$24073823$1$I$$20240321$20240710$20240710$PER$$BE-PFM-2020-02258$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240710$$MD$BE$BE
240738241$24073824$1$I$20240627$20240628$20240710$20240710$PER$$US-JNJFOC-20240676613$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240710$$HP$US$US
240738261$24073826$1$I$20240501$20240627$20240710$20240710$PER$$US-SA-2024SA194572$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240710$$MD$US$US
240738271$24073827$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA199881$SANOFI AVENTIS$$$$A$M$Y$$$20240710$$MD$US$US
240738281$24073828$1$I$20240101$20240704$20240710$20240710$PER$$US-SA-2024SA200981$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240710$$MD$US$US
240738292$24073829$2$F$20210101$20240718$20240710$20240723$PER$$US-BAYER-2024A096250$BAYER$$34$YR$A$F$Y$$$20240723$$CN$US$US
240738301$24073830$1$I$20191201$20210503$20240710$20240710$PER$$ES-PFM-2020-19922$PIERRE FABRE MEDICAMENT$$$$E$F$Y$$$20240710$$PH$ES$ES
240738321$24073832$1$I$$20230622$20240710$20240710$PER$$JP-PFM-2020-17717$PIERRE FABRE MEDICAMENT$$2$MON$$F$Y$$$20240710$$PH$JP$JP
240738331$24073833$1$I$20240702$20240703$20240710$20240710$PER$$US-ALXN-202407USA000284US$ALEXION PHARMACEUTICALS$$80$YR$$M$Y$$$20240710$$CN$US$US
240738341$24073834$1$I$$20240708$20240710$20240710$EXP$$GR-PFIZER INC-2023SGN02290$PFIZER$$63$YR$$F$Y$$$20240710$$MD$GR$GR
240738351$24073835$1$I$$20240709$20240710$20240710$EXP$$ES-PFIZER INC-2022SGN10806$PFIZER$$$$$F$Y$$$20240710$$MD$ES$ES
240738361$24073836$1$I$$20240703$20240710$20240710$EXP$$US-ALXN-202407USA000270US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240738371$24073837$1$I$$20240610$20240710$20240710$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000122$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240738381$24073838$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47875$$FDA-CTU$$82$YR$$F$N$$$20240710$N$$US$
240738391$24073839$1$I$20180502$20211129$20240710$20240710$PER$$JP-PFM-2018-05370$PIERRE FABRE MEDICAMENT$Seguchi M. Propranolol therapy for infantile strawberry mark - a study of hypoglycaemia cases. The Journal of the Japan Pediatric Society. 2021;125(9):1358$5$MON$$F$Y$$$20240710$$MD$JP$JP
240738401$24073840$1$I$$20240529$20240710$20240710$DIR$FDA-CDER-CTU-2024-47834$$FDA-CTU$$$$$F$N$$$20240529$N$HP$US$
240738411$24073841$1$I$$20210719$20240710$20240710$PER$$GR-PFM-2019-11218$PIERRE FABRE MEDICAMENT$Polymerou I, Ojala T, Bonou P, Martelius L, Tzifa A. Successful treatment of cardiac haemangiomas with oral propranolol: a case series of two patients. European Heart Journal. 2019$2$MON$$F$Y$$$20240710$$HP$GR$GR
240738421$24073842$1$I$20240625$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47884$$FDA-CTU$$62$YR$$M$N$$$20240709$N$PH$US$
240738441$24073844$1$I$20201001$20230622$20240710$20240710$PER$$JP-PFM-2020-21045$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.28$KG$20240710$$MD$JP$JP
240738451$24073845$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47879$$FDA-CTU$$66$YR$$F$N$$$20240710$N$$US$
240738461$24073846$1$I$20201108$20240510$20240710$20240710$PER$$JP-PFM-2020-21384$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$4.54$KG$20240710$$MD$JP$JP
240738481$24073848$1$I$20240707$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135409$AMGEN$$77$YR$E$M$Y$$$20240710$$CN$US$US
240738491$24073849$1$I$$20240709$20240710$20240710$PER$$US-ROCHE-10000022356$ROCHE$$51$YR$A$F$Y$$$20240710$$HP$US$US
240738501$24073850$1$I$20240706$20240708$20240710$20240710$EXP$$DE-BAYER-2024A099394$BAYER$$52$YR$A$F$Y$$$20240710$$CN$DE$DE
240738511$24073851$1$I$$20240705$20240710$20240710$PER$$US-BAYER-2024A097568$BAYER$$33$YR$A$F$Y$$$20240710$$MD$US$US
240738523$24073852$3$F$20240514$20240725$20240710$20240802$PER$$US-RDY-CLI/USA/24/0009935$DR REDDYS$$30$YR$A$F$Y$$$20240802$$MD$US$US
240738532$24073853$2$F$$20240712$20240710$20240722$EXP$$US-RDY-OTH/USA/23/0175642$DR REDDYS$$$$$$Y$$$20240719$$HP$US$US
240738561$24073856$1$I$20210301$20210616$20240710$20240710$PER$QUALITY COMPLAINT 188237$IL-PFM-2021-03405$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$CN$IL$IL
240738571$24073857$1$I$$20210610$20240710$20240710$PER$$JP-PFM-2021-00972$PIERRE FABRE MEDICAMENT$$16$MON$$F$Y$$$20240710$$PH$JP$JP
240738581$24073858$1$I$$20210630$20240710$20240710$PER$$JP-PFM-2021-04101$PIERRE FABRE MEDICAMENT$$$$$M$Y$7$KG$20240710$$MD$JP$JP
240738591$24073859$1$I$20191025$20210909$20240710$20240710$PER$$JP-PFM-2020-17664$PIERRE FABRE MEDICAMENT$Yuki Matsushita et al. Evaluation of therapeutic effect of oral Hemangiol therapy for infantile haemangioma in our hospital. The 64th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery. 2021$1$YR$$F$Y$11$KG$20240710$$MD$JP$JP
240738602$24073860$2$F$20240421$20240709$20240710$20240712$EXP$CH-SM-2024-13975$CH-TAKEDA-2024TUS069885$TAKEDA$$78$YR$$F$Y$$$20240712$$HP$CH$CH
240738611$24073861$1$I$20240512$20240705$20240710$20240710$PER$$US-BAYER-2024A098048$BAYER$$21$YR$A$F$Y$$$20240710$$HP$US$US
240738621$24073862$1$I$20240702$20240703$20240710$20240710$EXP$$US-JNJFOC-20240717629$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240710$$HP$US$US
240738641$24073864$1$I$20240516$20240702$20240710$20240710$EXP$FR-AFSSAPS-NY2024000707$FR-TEVA-VS-3216614$TEVA$$76$YR$$M$Y$68$KG$20240710$$PH$FR$FR
240738651$24073865$1$I$$20210506$20240710$20240710$PER$$FR-PFM-2021-04523$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$MD$FR$FR
240738661$24073866$1$I$20210301$20210503$20240710$20240710$PER$FR-AFSSAPS-LL20211486$FR-PFM-2021-04320$PIERRE FABRE MEDICAMENT$$24$YR$$F$Y$$$20240710$$MD$FR$FR
240738671$24073867$1$I$20240501$20240703$20240710$20240710$PER$$US-SA-2024SA199909$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240710$$MD$US$US
240738683$24073868$3$F$$20240813$20240710$20240819$PER$$KR-OTSUKA-2024_019055$OTSUKA$$6$DEC$$F$Y$$$20240819$$MD$KR$KR
240738701$24073870$1$I$$20240708$20240710$20240710$PER$$US-TAKEDA-2024TUS069897$TAKEDA$$$$$$Y$$$20240710$$CN$US$US
240738711$24073871$1$I$$20240708$20240710$20240710$PER$$US-BAYER-2024A098316$BAYER$$22$YR$A$F$Y$$$20240710$$HP$US$US
240738731$24073873$1$I$20240202$20240708$20240710$20240710$PER$$US-PFIZER INC-202400209250$PFIZER$$83$YR$$F$Y$$$20240710$$CN$US$US
240738741$24073874$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-202400209503$PFIZER$$82$YR$$M$Y$73.016$KG$20240710$$HP$US$US
240738761$24073876$1$I$20240701$20240708$20240710$20240710$PER$$US-PFIZER INC-PV202400089801$PFIZER$$52$YR$$F$Y$$$20240710$$CN$US$US
240738771$24073877$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-PV202400090172$PFIZER$$64$YR$$F$Y$$$20240710$$CN$US$US
240738781$24073878$1$I$20240101$20240706$20240710$20240710$PER$$US-PFIZER INC-202400208052$PFIZER$$43$YR$$F$Y$$$20240710$$CN$US$US
240738791$24073879$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-PV202400089754$PFIZER$$19$YR$$F$Y$$$20240710$$HP$US$US
240738802$24073880$2$F$20240101$20240906$20240710$20240909$PER$$US-PFIZER INC-202400208148$PFIZER$$66$YR$$F$Y$$$20240909$$CN$US$US
240738811$24073881$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-PV202400089648$PFIZER$$$$$$Y$$$20240710$$HP$US$US
240738823$24073882$3$F$20240501$20240821$20240710$20240822$PER$$US-PFIZER INC-2024SGN05213$PFIZER$$79$YR$$F$Y$$$20240822$$CN$US$US
240738831$24073883$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-PV202400089802$PFIZER$$56$YR$$M$Y$$$20240710$$CN$US$US
240738841$24073884$1$I$20240705$20240706$20240710$20240710$PER$$US-PFIZER INC-202400208194$PFIZER$$31$YR$$F$Y$$$20240710$$HP$US$US
240738861$24073886$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-PV202400089950$PFIZER$$84$YR$$F$Y$55.3$KG$20240710$$MD$US$US
240738871$24073887$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47854$$FDA-CTU$$62$YR$$F$N$$$20240710$N$$US$
240738881$24073888$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-PV202400089622$PFIZER$$61$YR$$M$Y$$$20240710$$CN$US$US
240738891$24073889$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-202400209484$PFIZER$$$$T$$Y$$$20240710$$HP$US$US
240738901$24073890$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-202400209885$PFIZER$$51$YR$$F$Y$$$20240710$$HP$US$US
240738912$24073891$2$F$$20240911$20240710$20240913$PER$$US-PFIZER INC-PV202400049180$PFIZER$$84$YR$$F$Y$62.14$KG$20240913$$CN$US$US
240738921$24073892$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-202400027498$PFIZER$$56$YR$$M$Y$$$20240710$$CN$US$US
240738941$24073894$1$I$$20240620$20240710$20240710$PER$$US-PFIZER INC-PV202400089897$PFIZER$$69$YR$$F$Y$$$20240710$$CN$US$US
240738951$24073895$1$I$20240101$20240705$20240710$20240710$PER$$US-PFIZER INC-202400208873$PFIZER$$63$YR$$F$Y$$$20240710$$HP$US$US
240738961$24073896$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-PV202400047621$PFIZER$$51$YR$$M$Y$$$20240710$$HP$US$US
240738972$24073897$2$F$20240703$20240731$20240710$20240802$PER$$US-PFIZER INC-202400208233$PFIZER$$62$YR$$F$Y$63.492$KG$20240802$$CN$US$US
240738982$24073898$2$F$20240612$20240724$20240710$20240726$PER$$US-PFIZER INC-202400208133$PFIZER$$78$YR$$F$Y$49.887$KG$20240726$$CN$US$US
240738992$24073899$2$F$20240705$20240722$20240710$20240724$PER$$US-PFIZER INC-202400208887$PFIZER$$88$YR$$M$Y$76.19$KG$20240724$$CN$US$US
240739011$24073901$1$I$20240501$20240708$20240710$20240710$PER$$US-PFIZER INC-PV202400089945$PFIZER$$32$YR$$F$Y$$$20240710$$HP$US$US
240739021$24073902$1$I$20240101$20240708$20240710$20240710$PER$$US-PFIZER INC-202400208843$PFIZER$$76$YR$$F$Y$59.42$KG$20240710$$CN$US$US
240739032$24073903$2$F$$20240730$20240710$20240801$PER$$US-PFIZER INC-2024SGN01747$PFIZER$$74$YR$$F$Y$$$20240801$$CN$US$US
240739042$24073904$2$F$$20240809$20240710$20240809$PER$$US-PFIZER INC-PV202400088487$PFIZER$$25$YR$$F$Y$52.789$KG$20240809$$HP$US$US
240739061$24073906$1$I$20240705$20240709$20240710$20240710$EXP$$CN-BAYER-2024A098970$BAYER$$69$YR$E$M$Y$$$20240710$$MD$CN$CN
240739071$24073907$1$I$$20240704$20240710$20240710$EXP$$FR-DSJP-DSE-2024-134762$DAIICHI$$$$E$F$Y$62$KG$20240710$$MD$FR$FR
240739082$24073908$2$F$$20240810$20240710$20240812$PER$$US-PFIZER INC-PV202400089307$PFIZER$$12$YR$$M$Y$43$KG$20240812$$HP$US$US
240739091$24073909$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142031$NOVARTIS$$$$$$Y$$$20240710$$CN$US$US
240739101$24073910$1$I$20240628$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136212$AMGEN$$53$YR$A$M$Y$$$20240710$$CN$US$US
240739112$24073911$2$F$20240708$20240712$20240710$20240714$PER$$US-AMGEN-USASP2024136512$AMGEN$$58$YR$A$F$Y$$$20240714$$CN$US$US
240739122$24073912$2$F$$20240809$20240710$20240809$PER$$US-PFIZER INC-202400206316$PFIZER$$13$YR$$F$Y$54.42$KG$20240809$$CN$US$US
240739131$24073913$1$I$20240101$20240707$20240710$20240710$PER$$US-AMGEN-USASP2024135492$AMGEN$$$$A$M$Y$$$20240710$$MD$US$US
240739141$24073914$1$I$20210430$20210505$20240710$20240710$PER$$GR-PFM-2021-05441$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240710$$MD$GR$GR
240739151$24073915$1$I$20210509$20210524$20240710$20240710$PER$$JP-PFM-2021-05513$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240710$$PH$JP$JP
240739161$24073916$1$I$$20211215$20240710$20240710$PER$$CA-PFM-2021-00476$PIERRE FABRE MEDICAMENT$$63$YR$$F$Y$$$20240710$$MD$CA$CA
240739172$24073917$2$F$$20240712$20240710$20240715$EXP$$GB-MYLANLABS-2024M1064045$MYLAN$$$$$F$Y$$$20240715$$CN$GB$GB
240739181$24073918$1$I$$20211215$20240710$20240710$PER$$CA-PFM-2021-01786$PIERRE FABRE MEDICAMENT$$34$YR$$F$Y$$$20240710$$MD$CA$CA
240739191$24073919$1$I$$20211209$20240710$20240710$PER$$CA-PFM-2021-01773$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240710$$MD$CA$CA
240739201$24073920$1$I$20111028$20211209$20240710$20240710$PER$$CA-PFM-2021-02976$PIERRE FABRE MEDICAMENT$$12$YR$$M$Y$$$20240710$$MD$CA$CA
240739211$24073921$1$I$$20211215$20240710$20240710$PER$$CA-PFM-2021-01784$PIERRE FABRE MEDICAMENT$$51$YR$$M$Y$$$20240710$$MD$CA$CA
240739221$24073922$1$I$$20211215$20240710$20240710$PER$$CA-PFM-2021-01825$PIERRE FABRE MEDICAMENT$$52$YR$$M$Y$$$20240710$$MD$CA$CA
240739231$24073923$1$I$$20211215$20240710$20240710$PER$$CA-PFM-2021-01783$PIERRE FABRE MEDICAMENT$$21$YR$$F$Y$$$20240710$$MD$CA$CA
240739241$24073924$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109093$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$67$YR$E$M$Y$$$20240710$$HP$US$US
240739251$24073925$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109105$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$67$YR$E$M$Y$$$20240710$$HP$US$US
240739261$24073926$1$I$$20211215$20240710$20240710$PER$$CA-PFM-2021-01812$PIERRE FABRE MEDICAMENT$$27$YR$$F$Y$$$20240710$$MD$CA$CA
240739271$24073927$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109090$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$73$YR$E$F$Y$$$20240710$$HP$US$US
240739281$24073928$1$I$$20211206$20240710$20240710$PER$$CA-PFM-2021-01828$PIERRE FABRE MEDICAMENT$$50$YR$$F$Y$$$20240710$$MD$CA$CA
240739291$24073929$1$I$$20211215$20240710$20240710$PER$$CA-PFM-2021-01776$PIERRE FABRE MEDICAMENT$$40$YR$$F$Y$$$20240710$$HP$CA$CA
240739301$24073930$1$I$$20211215$20240710$20240710$PER$$CA-PFM-2021-01815$PIERRE FABRE MEDICAMENT$$50$YR$$F$Y$$$20240710$$MD$CA$CA
240739311$24073931$1$I$$20240705$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108064$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240710$$CN$US$US
240739321$24073932$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109099$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$71$YR$E$M$Y$$$20240710$$HP$US$US
240739331$24073933$1$I$$20210518$20240710$20240710$PER$E2B_03402948$CA-PFM-2021-05124$PIERRE FABRE MEDICAMENT$$26$YR$$F$Y$$$20240710$$MD$CA$CA
240739341$24073934$1$I$$20210518$20240710$20240710$PER$$CA-PFM-2021-05142$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240710$$MD$CA$CA
240739351$24073935$1$I$20190130$20210505$20240710$20240710$PER$BE-Insmed Incorporated-BE-INS-19-00311$BE-PFM-2021-04449$PIERRE FABRE MEDICAMENT$$$$$F$Y$46$KG$20240710$$MD$BE$BE
240739361$24073936$1$I$$20210518$20240710$20240710$PER$$CA-PFM-2021-05141$PIERRE FABRE MEDICAMENT$$44$YR$$F$Y$$$20240710$$MD$CA$CA
240739371$24073937$1$I$$20210518$20240710$20240710$PER$$CA-PFM-2021-05139$PIERRE FABRE MEDICAMENT$$50$YR$$F$Y$$$20240710$$MD$CA$CA
240739381$24073938$1$I$$20210518$20240710$20240710$PER$$CA-PFM-2021-05138$PIERRE FABRE MEDICAMENT$$61$YR$$F$Y$$$20240710$$MD$CA$CA
240739391$24073939$1$I$$20210518$20240710$20240710$PER$$CA-PFM-2021-05130$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240710$$MD$CA$CA
240739401$24073940$1$I$$20210518$20240710$20240710$PER$NVSC2020CA144149$CA-PFM-2021-05128$PIERRE FABRE MEDICAMENT$$21$YR$$F$Y$$$20240710$$MD$CA$CA
240739411$24073941$1$I$$20210518$20240710$20240710$PER$NVSC2020CA054399$CA-PFM-2021-05129$PIERRE FABRE MEDICAMENT$$19$YR$$F$Y$$$20240710$$MD$CA$CA
240739421$24073942$1$I$$20210518$20240710$20240710$PER$NVSC2020CA055709$CA-PFM-2021-05127$PIERRE FABRE MEDICAMENT$$18$YR$$F$Y$$$20240710$$MD$CA$CA
240739431$24073943$1$I$$20210518$20240710$20240710$PER$NVSC2020CA209041$CA-PFM-2021-05126$PIERRE FABRE MEDICAMENT$$43$YR$$F$Y$$$20240710$$MD$CA$CA
240739441$24073944$1$I$$20210518$20240710$20240710$PER$NVSC2020CA205033$CA-PFM-2021-05125$PIERRE FABRE MEDICAMENT$$55$YR$$F$Y$$$20240710$$MD$CA$CA
240739451$24073945$1$I$$20240705$20240710$20240710$EXP$$US-JNJFOC-20240716121$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
240739461$24073946$1$I$$20210518$20240710$20240710$PER$$CA-PFM-2021-05140$PIERRE FABRE MEDICAMENT$$20$YR$$M$Y$$$20240710$$MD$CA$CA
240739471$24073947$1$I$20200515$20210519$20240710$20240710$PER$ES-AEMPS-778035$ES-PFM-2021-05044$PIERRE FABRE MEDICAMENT$$10$MON$$F$Y$4.2$KG$20240710$$PH$ES$ES
240739481$24073948$1$I$$20211209$20240710$20240710$PER$$CA-PFM-2021-03076$PIERRE FABRE MEDICAMENT$$45$YR$$F$Y$$$20240710$$MD$CA$CA
240739491$24073949$1$I$$20210518$20240710$20240710$PER$NVSC2020CA044471$CA-PFM-2021-05137$PIERRE FABRE MEDICAMENT$$43$YR$$M$Y$$$20240710$$MD$CA$CA
240739501$24073950$1$I$$20211103$20240710$20240710$PER$E2B_04007947.$CA-PFM-2021-05131$PIERRE FABRE MEDICAMENT$$31$YR$$F$Y$$$20240710$$MD$CA$CA
240739511$24073951$1$I$$20210629$20240710$20240710$PER$$FR-PFM-2021-04418$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$CN$FR$FR
240739532$24073953$2$F$$20240812$20240710$20240827$PER$$US-SA-2024SA197295$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240827$$MD$US$US
240739541$24073954$1$I$$20240628$20240710$20240710$PER$$US-SA-2024SA194411$SANOFI AVENTIS$$$$$F$Y$$$20240710$$CN$US$US
240739551$24073955$1$I$$20210426$20240710$20240710$PER$$JP-PFM-2021-02046$PIERRE FABRE MEDICAMENT$Izumoto M et al. Oral propranolol therapy for infantile haemangioma in our department. The Nishinihon Journal of Dermatology. 2020;82(6):479$7$MON$$F$Y$$$20240710$$HP$JP$JP
240739561$24073956$1$I$$20210426$20240710$20240710$PER$$JP-PFM-2021-02045$PIERRE FABRE MEDICAMENT$Mamiko Izumoto et al. Oral propranolol therapy for infantile haemangioma in our department. The Nishinihon Journal of Dermatology. 2020;82(6):479$4$MON$$F$Y$$$20240710$$HP$JP$JP
240739571$24073957$1$I$$20210426$20240710$20240710$PER$$JP-PFM-2021-02050$PIERRE FABRE MEDICAMENT$Izumoto M et al. Oral propranolol therapy for infantile haemangioma in our department. The Nishinihon Journal of Dermatology. 2020;82 (6):479$1$MON$$F$Y$$$20240710$$HP$JP$JP
240739581$24073958$1$I$20190601$20211006$20240710$20240710$PER$$JP-PFM-2021-03995$PIERRE FABRE MEDICAMENT$Matsushita Y. Evaluation of therapeutic effect of oral Hemangiol therapy for infantile haemangioma in our hospital. The 64th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery. 2021$0$YR$$F$Y$$$20240710$$HP$JP$JP
240739591$24073959$1$I$$20210518$20240710$20240710$PER$$CA-PFM-2021-05143$PIERRE FABRE MEDICAMENT$$54$YR$$F$Y$$$20240710$$MD$CA$CA
240739601$24073960$1$I$20191004$20211220$20240710$20240710$PER$$JP-PFM-2021-00692$PIERRE FABRE MEDICAMENT$Miyazaki T, Sasai H, Ozeki M, Yasue S, Matsumoto H, Hori T et al. A neonatal case of multiple infantile hemangiomas and extrahepatic portosystemic shunt with hyperinsulinemic hypoglycemia. Journal of Japanese Society for Neonatal Screening. 2020;30:215$2$MON$$F$Y$$$20240710$$HP$JP$JP
240739611$24073961$1$I$$20210518$20240710$20240710$PER$$CA-PFM-2021-05158$PIERRE FABRE MEDICAMENT$$48$YR$$F$Y$$$20240710$$MD$CA$CA
240739631$24073963$1$I$$20210426$20240710$20240710$PER$$JP-PFM-2021-04046$PIERRE FABRE MEDICAMENT$Matsuoka R, Tanaka M. Hematidrosis in a Japanese girl: Treatment with propranolol and psychotherapy. Japan Pediatric Society. 2020;62:1001-2$11$YR$$F$Y$$$20240710$$MD$JP$JP
240739642$24073964$2$F$$20240708$20240710$20240718$EXP$$US-ABBVIE-5832566$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
240739651$24073965$1$I$$20240626$20240710$20240710$EXP$$KR-Eywa Pharma Inc.-2159001$EYWA PHARMA$Source document (Full text)$40$YR$$F$Y$$$20240710$$MD$KR$KR
240739661$24073966$1$I$$20210510$20240710$20240710$PER$$TR-PFM-2021-04637$PIERRE FABRE MEDICAMENT$Eris D, Pac FA, Sayin S, Sert DE, Pac M. Successful treatment of rejection-related atrial tachycardia with pulse steroid after heart transplantation. Anatol J Cardiol. 2021;25:205-8$9$YR$$M$Y$$$20240710$$HP$TR$TR
240739671$24073967$1$I$$20210525$20240710$20240710$PER$$ES-PFM-2021-05274$PIERRE FABRE MEDICAMENT$Alfonso JCM, Caballero AYM, Martinez AP, Montero JA, Ugarteche, Pascual CB. Cranio-facial-cervical and subglottic hemangioma with respiratory symptoms. A therapeutic emergency. Annals of the Health System of Navarra. 2021;44:113-7$41$DY$$F$Y$$$20240710$$HP$ES$ES
240739681$24073968$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108294$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240710$$CN$US$US
240739701$24073970$1$I$$20210525$20240710$20240710$PER$$KR-PFM-2021-05466$PIERRE FABRE MEDICAMENT$Yung-Ju Yoo, Hee Kyung Yang, Jeong-Yoon Choi, Ji-Soo Kim,  Jeong-Min Hwang. Neuro-ophthalmologic Findings in Visual Snow Syndrome. Neurological Association. 2020;16(4):646-52$$$$$Y$$$20240710$$HP$KR$KR
240739711$24073971$1$I$20180123$20210819$20240710$20240710$PER$$JP-PFM-2021-04037$PIERRE FABRE MEDICAMENT$Izumozaki A. Evaluation of the therapeutic effect of oral hemangiol therapy for infantile haemangioma using MRI. The 64th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery. 2021$0$YR$$M$Y$$$20240710$$MD$JP$JP
240739731$24073973$1$I$$20211101$20240710$20240710$PER$NL-LRB-00482058$NL-PFM-2021-04458$PIERRE FABRE MEDICAMENT$$$$C$F$Y$25$KG$20240710$$MD$NL$NL
240739741$24073974$1$I$20240521$20240708$20240710$20240710$EXP$FR-AFSSAPS-RE2024000674$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-109446$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$45$KG$20240710$$MD$FR$FR
240739751$24073975$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47855$$FDA-CTU$$89$YR$$F$N$50.8$KG$20240710$N$$US$
240739761$24073976$1$I$$20240402$20240710$20240710$PER$$US-PFM-2024-02113$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.8$KG$20240710$$CN$US$US
240739771$24073977$1$I$$20240401$20240710$20240710$PER$$US-PFM-2024-02112$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.866$KG$20240710$$HP$US$US
240739781$24073978$1$I$$20210525$20240710$20240710$PER$$IT-PFM-2021-05522$PIERRE FABRE MEDICAMENT$Fofi L, Egeo G, Aurilia C, Barbanti P. Erenumab during pregnancy: a case report in a atient with chronic migraine. Research Square. 2021;42:1-5$37$YR$$F$Y$$$20240710$$HP$IT$IT
240739791$24073979$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47857$$FDA-CTU$$$$$F$N$$$20240709$N$$US$
240739801$24073980$1$I$20240529$20240706$20240710$20240710$EXP$$NVSC2024CN142261$NOVARTIS$$47$YR$$M$Y$65$KG$20240710$$HP$CN$CN
240739811$24073981$1$I$$20240402$20240710$20240710$PER$$US-PFM-2024-02116$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.937$KG$20240710$$CN$US$US
240739821$24073982$1$I$$20240402$20240710$20240710$PER$$US-PFM-2024-02115$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.297$KG$20240710$$HP$US$US
240739831$24073983$1$I$20240710$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47887$$FDA-CTU$$52$YR$$F$N$$$20240710$N$HP$US$
240739841$24073984$1$I$$20240409$20240710$20240710$PER$$CA-PFM-2024-02327$PIERRE FABRE MEDICAMENT$$50$YR$$F$Y$$$20240710$$CN$CA$CA
240739851$24073985$1$I$$20240409$20240710$20240710$PER$$CA-PFM-2024-02330$PIERRE FABRE MEDICAMENT$$64$YR$$M$Y$$$20240710$$CN$CA$CA
240739861$24073986$1$I$$20240409$20240710$20240710$PER$$US-PFM-2024-02114$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.639$KG$20240710$$CN$US$US
240739871$24073987$1$I$$20240409$20240710$20240710$PER$$CA-PFM-2024-02343$PIERRE FABRE MEDICAMENT$$49$YR$$F$Y$$$20240710$$CN$CA$CA
240739881$24073988$1$I$20240222$20240403$20240710$20240710$PER$$US-PFM-2024-02153$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.6$KG$20240710$$PH$US$US
240739891$24073989$1$I$$20240403$20240710$20240710$PER$$US-PFM-2024-02154$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.367$KG$20240710$$HP$US$US
240739901$24073990$1$I$$20240404$20240710$20240710$PER$$US-PFM-2024-02155$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.141$KG$20240710$$HP$US$US
240739911$24073991$1$I$$20240402$20240710$20240710$PER$$JP-PFM-2024-02259$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$PH$JP$JP
240739921$24073992$1$I$$20240404$20240710$20240710$PER$$US-PFM-2024-02189$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.197$KG$20240710$$CN$US$US
240739931$24073993$1$I$20240101$20240405$20240710$20240710$PER$$US-PFM-2024-02191$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.64$KG$20240710$$PH$US$US
240739941$24073994$1$I$20240223$20240404$20240710$20240710$PER$$US-PFM-2024-02157$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.64$KG$20240710$$PH$US$US
240739951$24073995$1$I$$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136307$AMGEN$$$$$$Y$$$20240710$$HP$US$US
240739961$24073996$1$I$$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024135888$AMGEN$$$$$M$Y$$$20240710$$CN$US$US
240739972$24073997$2$F$20240630$20240710$20240710$20240712$PER$$US-AMGEN-USASP2024136145$AMGEN$$75$YR$E$F$Y$$$20240712$$CN$US$US
240739981$24073998$1$I$$20240408$20240710$20240710$PER$$US-PFM-2024-02278$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.122$KG$20240710$$CN$US$US
240739991$24073999$1$I$20231212$20240409$20240710$20240710$PER$$US-PFM-2024-02279$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240710$$MD$US$US
240740001$24074000$1$I$$20240405$20240710$20240710$PER$$FR-PFM-2024-02185$PIERRE FABRE MEDICAMENT$$27$YR$$M$Y$$$20240710$$CN$FR$FR
240740011$24074001$1$I$$20240709$20240710$20240710$EXP$IT-MINISAL02-994079$IT-GILEAD-2024-0680027$GILEAD$$86$YR$E$F$Y$$$20240710$$MD$IT$IT
240740021$24074002$1$I$$20240410$20240710$20240710$PER$$US-PFM-2024-02320$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.971$KG$20240710$$HP$US$US
240740031$24074003$1$I$$20240410$20240710$20240710$PER$$US-PFM-2024-02291$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.751$KG$20240710$$CN$US$US
240740042$24074004$2$F$$20240701$20240710$20240920$EXP$$NO-SA-2024SA197306$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$NO$NO
240740051$24074005$1$I$$20240408$20240710$20240710$PER$$US-PFM-2024-02280$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.778$KG$20240710$$HP$US$US
240740061$24074006$1$I$$20240409$20240710$20240710$PER$$US-PFM-2024-02290$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.71$KG$20240710$$CN$US$US
240740071$24074007$1$I$$20240410$20240710$20240710$PER$$US-PFM-2024-02292$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.651$KG$20240710$$CN$US$US
240740081$24074008$1$I$$20240410$20240710$20240710$PER$$US-PFM-2024-02293$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.125$KG$20240710$$CN$US$US
240740091$24074009$1$I$$20240410$20240710$20240710$PER$$US-PFM-2024-02294$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.907$KG$20240710$$HP$US$US
240740111$24074011$1$I$$20240411$20240710$20240710$PER$$US-PFM-2024-02319$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.8$KG$20240710$$CN$US$US
240740121$24074012$1$I$$20240411$20240710$20240710$PER$$US-PFM-2024-02322$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.497$KG$20240710$$CN$US$US
240740131$24074013$1$I$$20240510$20240710$20240710$PER$$US-PFM-2024-02295$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.9$KG$20240710$$CN$US$US
240740141$24074014$1$I$$20240604$20240710$20240710$PER$$US-PFM-2024-02321$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.62$KG$20240710$$CN$US$US
240740152$24074015$2$F$$20240715$20240710$20240722$EXP$$NVSC2024US141924$NOVARTIS$$$$$M$Y$$$20240722$$CN$US$US
240740171$24074017$1$I$20231201$20240406$20240710$20240710$PER$$JP-PFM-2024-02355$PIERRE FABRE MEDICAMENT$$13$MON$$$Y$$$20240710$$CN$JP$JP
240740181$24074018$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142676$NOVARTIS$$$$$$Y$$$20240710$$HP$US$US
240740191$24074019$1$I$$20240409$20240710$20240710$PER$$CA-PFM-2024-02326$PIERRE FABRE MEDICAMENT$$42$YR$$F$Y$$$20240710$$CN$CA$CA
240740201$24074020$1$I$$20240409$20240710$20240710$PER$$CA-PFM-2024-02341$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$CN$CA$CA
240740211$24074021$1$I$$20240412$20240710$20240710$PER$$US-PFM-2024-02373$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.399$KG$20240710$$HP$US$US
240740221$24074022$1$I$$20240411$20240710$20240710$PER$$US-PFM-2024-02374$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.499$KG$20240710$$CN$US$US
240740231$24074023$1$I$20240411$20240426$20240710$20240710$PER$$ES-PFM-2024-02404$PIERRE FABRE MEDICAMENT$$7$MON$$F$Y$8.06$KG$20240710$$CN$ES$ES
240740241$24074024$1$I$$20240517$20240710$20240710$PER$$US-PFM-2024-02375$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240710$$CN$US$US
240740251$24074025$1$I$$20240409$20240710$20240710$PER$$CA-PFM-2024-02342$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$HP$CA$CA
240740263$24074026$3$F$$20240829$20240710$20240910$PER$$US-INCYTE CORPORATION-2024IN006964$INCYTE$$$$$$Y$$$20240910$$MD$US$US
240740272$24074027$2$F$20240601$20240712$20240710$20240715$PER$$US-AMGEN-USASP2024136723$AMGEN$$89$YR$E$F$Y$$$20240715$$MD$US$US
240740281$24074028$1$I$$20240409$20240710$20240710$PER$$CA-PFM-2024-02328$PIERRE FABRE MEDICAMENT$$53$YR$$F$Y$$$20240710$$CN$CA$CA
240740291$24074029$1$I$20230828$20240703$20240710$20240710$EXP$$CO-UCBSA-2024034711$UCB$$73$YR$$M$Y$$$20240710$$CN$CO$CO
240740301$24074030$1$I$$20240415$20240710$20240710$PER$$US-PFM-2024-02433$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.957$KG$20240710$$HP$US$US
240740311$24074031$1$I$$20240412$20240710$20240710$PER$$US-PFM-2024-02405$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.039$KG$20240710$$CN$US$US
240740321$24074032$1$I$$20240412$20240710$20240710$PER$$US-PFM-2024-02438$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.567$KG$20240710$$CN$US$US
240740331$24074033$1$I$$20240412$20240710$20240710$PER$$US-PFM-2024-02432$PIERRE FABRE MEDICAMENT$$$$$F$Y$17.796$KG$20240710$$CN$US$US
240740341$24074034$1$I$$20240416$20240710$20240710$PER$$US-PFM-2024-02437$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.122$KG$20240710$$CN$US$US
240740351$24074035$1$I$$20240415$20240710$20240710$PER$$US-PFM-2024-02434$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.109$KG$20240710$$CN$US$US
240740361$24074036$1$I$$20240701$20240709$20240709$DIR$FDA-CDER-CTU-2024-47646$$FDA-CTU$$61$YR$$F$N$70.31$KG$20240701$N$CN$US$
240740371$24074037$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47896$$FDA-CTU$$65$YR$$M$N$$$20240710$N$$US$
240740381$24074038$1$I$$20240416$20240710$20240710$PER$$US-PFM-2024-02476$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.15$KG$20240710$$CN$US$US
240740391$24074039$1$I$$20240417$20240710$20240710$PER$$US-PFM-2024-02435$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240710$$HP$US$US
240740401$24074040$1$I$$20240417$20240710$20240710$PER$$US-PFM-2024-02473$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.71$KG$20240710$$HP$US$US
240740411$24074041$1$I$$20240417$20240710$20240710$PER$$US-PFM-2024-02474$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.73$KG$20240710$$CN$US$US
240740421$24074042$1$I$$20240419$20240710$20240710$PER$$US-PFM-2024-02574$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.027$KG$20240710$$CN$US$US
240740431$24074043$1$I$20240417$20240418$20240710$20240710$PER$$US-PFM-2024-02517$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.2$KG$20240710$$PH$US$US
240740441$24074044$1$I$$20240418$20240710$20240710$PER$$US-PFM-2024-02518$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.39$KG$20240710$$PH$US$US
240740451$24074045$1$I$20240301$20240419$20240710$20240710$PER$$US-PFM-2024-02436$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.537$KG$20240710$$CN$US$US
240740461$24074046$1$I$$20240419$20240710$20240710$PER$$US-PFM-2024-02519$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.088$KG$20240710$$CN$US$US
240740471$24074047$1$I$$20240423$20240710$20240710$PER$$US-PFM-2024-02576$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.163$KG$20240710$$HP$US$US
240740481$24074048$1$I$$20240423$20240710$20240710$PER$$US-PFM-2024-02577$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.499$KG$20240710$$HP$US$US
240740491$24074049$1$I$20230101$20240422$20240710$20240710$PER$SE-SEMPA-2023-015119$SE-PFM-2024-02526$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240710$$MD$SE$SE
240740501$24074050$1$I$20230501$20240422$20240710$20240710$PER$SE-SEMPA-2023-015090$SE-PFM-2024-02524$PIERRE FABRE MEDICAMENT$$66$YR$$M$Y$$$20240710$$MD$SE$SE
240740511$24074051$1$I$$20240515$20240710$20240710$PER$$US-PFM-2024-02557$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.18$KG$20240710$$CN$US$US
240740521$24074052$1$I$20240601$20240708$20240710$20240710$EXP$$US-UCBSA-2024034902$UCB$$65$YR$$F$Y$$$20240710$$HP$US$US
240740531$24074053$1$I$20231130$20240627$20240710$20240710$EXP$$FR-INCYTE CORPORATION-2024IN003965$INCYTE$$$$$$Y$$$20240710$$HP$FR$FR
240740541$24074054$1$I$20210101$20240704$20240710$20240710$EXP$$DE-MYLANLABS-2024M1063210$MYLAN$$72$YR$$F$Y$$$20240710$$MD$DE$DE
240740551$24074055$1$I$20240705$20240705$20240710$20240710$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-094647$REGENERON$$$$$M$Y$$$20240710$$CN$US$US
240740561$24074056$1$I$20240602$20240613$20240710$20240710$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-11949$IPSEN$$17$YR$T$F$Y$78$KG$20240710$$CN$US$US
240740571$24074057$1$I$$20240709$20240710$20240710$EXP$$US-GILEAD-2024-0680101$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240740581$24074058$1$I$20231101$20240703$20240710$20240710$PER$$US-ALXN-202407USA000272US$ALEXION PHARMACEUTICALS$$69$YR$$M$Y$$$20240710$$CN$US$US
240740591$24074059$1$I$$20240401$20240710$20240710$PER$$US-PFM-2024-02131$PIERRE FABRE MEDICAMENT$Ding K, Rosa A, Do D, Shah S. Uncommon CALM2 mutation in catecholaminergic polymorphic ventricular tachycardia. Journal of the American College of Cardiology. 2024;83 (13):2874$21$YR$$F$Y$$$20240710$$HP$US$US
240740601$24074060$1$I$$20240702$20240710$20240710$EXP$GB-MHRA-MED-202406291157398850-KGTCR$GB-TEVA-VS-3216567$TEVA$$30$YR$$M$Y$$$20240710$$CN$GB$GB
240740611$24074061$1$I$$20240401$20240710$20240710$PER$$US-PFM-2024-02133$PIERRE FABRE MEDICAMENT$Boampong A, Ayele G, Bhagwandeen S, Prempeh J, Brgdar A, Gebremariam B et al. Pericardial effusion as an infrequent complication of thyroid storm in graves disease. Journal of the American College of Cardiology. 2024;83 (13):4470$32$YR$$F$Y$$$20240710$$HP$US$US
240740621$24074062$1$I$$20240401$20240710$20240710$PER$$US-PFM-2024-02132$PIERRE FABRE MEDICAMENT$Rodriguez-Santiago A, Santiago G, Berrios G, Mesa-Paton A. Thyrotoxicosis and acute heart failure: to treat or not to treat. Journal of the American College of Cardiology. 2024;83(13):3222$38$YR$$F$Y$$$20240710$$HP$US$US
240740631$24074063$1$I$$20240401$20240710$20240710$PER$$TR-PFM-2024-02137$PIERRE FABRE MEDICAMENT$Ciftel S, Tuzun Z. SUBACUTE THYROIDITIS FOLLOWING SARS-COV-2 VACCINATION: AN AUTOIMMUNE/ INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS (ASIA SYNDROME). Acta Endocrinologica (Buc). 2023;XIX, no. 3:390-5$40$YR$$F$Y$$$20240710$$HP$TR$TR
240740641$24074064$1$I$$20240401$20240710$20240710$PER$$JP-PFM-2024-02211$PIERRE FABRE MEDICAMENT$Maki Y et al.. Treatment course of patients who had bradycardia after taking propranolol for infantile hemangioma. The journal of the Japan Pediatric Society. 2024;128(2):2-O-087$$$I$$Y$$$20240710$$MD$JP$JP
240740651$24074065$1$I$$20240401$20240710$20240710$PER$$JP-PFM-2024-02217$PIERRE FABRE MEDICAMENT$Yasuda M, et al. Clinical study of oral propranolol therapy in 148 cases of infantile haemangioma. The journal of the Japan Pediatric Society. 2024;128(2):2-O-085$$$I$$Y$$$20240710$$MD$JP$JP
240740661$24074066$1$I$$20240401$20240710$20240710$PER$$IT-PFM-2024-02129$PIERRE FABRE MEDICAMENT$Tornabene D, Bini P, Gastaldi M, Vegezzi E, Asteggiano C, Marchioni E et al. Neurological complications due to copper defciency in the context  of Wilson disease treatment: a case report with long-term follow-up  and review of the literature. Neurological Sciences. 2024;45:987-96$57$YR$$F$Y$$$20240710$$HP$IT$IT
240740671$24074067$1$I$$20240401$20240710$20240710$PER$$TR-PFM-2024-02135$PIERRE FABRE MEDICAMENT$Ciftel S, Tuzun Z. SUBACUTE THYROIDITIS FOLLOWING SARS-COV-2 VACCINATION: AN AUTOIMMUNE/ INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS (ASIA SYNDROME). Acta Endocrinologica (Buc). 2023;XIX, no. 3:390-5$54$YR$$F$Y$$$20240710$$HP$TR$TR
240740681$24074068$1$I$$20240401$20240710$20240710$PER$$TR-PFM-2024-02138$PIERRE FABRE MEDICAMENT$Ciftel S, Tuzun Z. SUBACUTE THYROIDITIS FOLLOWING SARS-COV-2 VACCINATION: AN AUTOIMMUNE/ INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS (ASIA SYNDROME). Acta Endocrinologica (Buc). 2023;XIX, no. 3:390-5$31$YR$$F$Y$$$20240710$$HP$TR$TR
240740691$24074069$1$I$$20240401$20240710$20240710$PER$$TR-PFM-2024-02139$PIERRE FABRE MEDICAMENT$Ciftel S, Tuzun Z. SUBACUTE THYROIDITIS FOLLOWING SARS-COV-2 VACCINATION: AN AUTOIMMUNE/ INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS (ASIA SYNDROME). Acta Endocrinologica. 2023;390-5$34$YR$$F$Y$$$20240710$$HP$TR$TR
240740701$24074070$1$I$$20240405$20240710$20240710$PER$$SE-PFM-2024-02166$PIERRE FABRE MEDICAMENT$Hosseini S, Seifert O, Jerkovic Gulin S. The effect of early systemic propranolol treatment on color improvement of infantile hemangiomas. A retrospective cohort study.. European Journal of Pediatric Dermatology. 2024;34(1):4-11$$$I$$Y$$$20240710$$HP$SE$SE
240740711$24074071$1$I$$20240702$20240710$20240710$EXP$GB-MHRA-MED-202407021734360860-QHKDY$GB-TEVA-VS-3216536$TEVA$$$$$M$Y$$$20240710$$HP$GB$GB
240740721$24074072$1$I$$20240423$20240710$20240710$PER$$US-PFM-2024-02637$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.048$KG$20240710$$HP$US$US
240740731$24074073$1$I$$20240401$20240710$20240710$PER$$TR-PFM-2024-02140$PIERRE FABRE MEDICAMENT$Ciftel S, Tuzun Z. subacute thyroiditis following sars-cov-2 vaccination: an autoimmune/ inflammatory syndrome induced by adjuvants (asia syndrome). Acta Endocrinologica. 2023;390-95$26$YR$$F$Y$$$20240710$$HP$TR$TR
240740741$24074074$1$I$$20240417$20240710$20240710$PER$$JP-PFM-2024-02445$PIERRE FABRE MEDICAMENT$Matsuo Y, Jo T, Watanabe H, Matsui H, Fushimi K, Yasunaga H. Clinical efficacy of beta-1 selective beta-blockers versus propranolol in patients with thyroid storm: A retrospective cohort study. Critical care medicine. 2024;52:1-10$$$$$Y$$$20240710$$MD$JP$JP
240740752$24074075$2$F$20240601$20240715$20240710$20240722$PER$$US-SA-2024SA197896$SANOFI AVENTIS$$16$YR$T$F$Y$40.1$KG$20240722$$MD$US$US
240740761$24074076$1$I$$20240423$20240710$20240710$PER$$US-PFM-2024-02643$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.578$KG$20240710$$HP$US$US
240740771$24074077$1$I$$20240423$20240710$20240710$PER$$US-PFM-2024-02579$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240710$$CN$US$US
240740781$24074078$1$I$$20240423$20240710$20240710$PER$$US-PFM-2024-02578$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.66$KG$20240710$$HP$US$US
240740791$24074079$1$I$$20240502$20240710$20240710$PER$$JP-PFM-2024-02590$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$$$20240710$$PH$JP$JP
240740801$24074080$1$I$$20240423$20240710$20240710$PER$$US-PFM-2024-02580$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.417$KG$20240710$$CN$US$US
240740811$24074081$1$I$$20240515$20240710$20240710$PER$$JP-PFM-2024-02223$PIERRE FABRE MEDICAMENT$Nishimura S. Study of 74 cases treated with propranolol oral therapy for infantile hemangioma. The journal of the Japan Pediatric Society. 2024;128(2):2-O-086$$$I$$Y$$$20240710$$MD$JP$JP
240740821$24074082$1$I$$20240401$20240710$20240710$PER$$US-PFM-2024-02143$PIERRE FABRE MEDICAMENT$McGeoch CLB, Steinberg RS, Bortfeld KS, Almuwaqqat Z, Rheudasil JM, Bhatia NK et al. Radiofrequency venous ablation for  symptomatic relief in postural orthostatic  tachycardia syndrome: a case series. European Heart Journal - Case Reports. 2024;8:1-5$54$YR$$F$Y$$$20240710$$HP$US$US
240740831$24074083$1$I$$20240401$20240710$20240710$PER$$JP-PFM-2024-02220$PIERRE FABRE MEDICAMENT$Koki N, et al. Infantile-onset congenital QT prolongation syndrome refractory to medical therapy. The journal of the Japan Pediatric Society. 2024;128(2):2-P-060$$$$M$Y$$$20240710$$MD$JP$JP
240740841$24074084$1$I$$20240401$20240710$20240710$PER$$US-PFM-2024-02141$PIERRE FABRE MEDICAMENT$Kahnauth A, Patel M, Alharash H, Desai N, Rao SM, Dubey S. Ventricular arrhythmia in a pediatric patient with active covid-19 infection. Journal of the American College of Cardiology. 2024;83(13):3053$9$MON$$F$Y$$$20240710$$HP$US$US
240740851$24074085$1$I$$20240401$20240710$20240710$PER$$US-PFM-2024-02142$PIERRE FABRE MEDICAMENT$Almasri M, Ayyad M, Sanders E, Orcutt JW, Mari A, Zakaria D. A rare case of neonatal ventricular tachycardia. Journal of the American College of Cardiology. 2024;83(13):3108$4$WK$$M$Y$$$20240710$$HP$US$US
240740861$24074086$1$I$$20240401$20240710$20240710$PER$$FR-PFM-2024-02159$PIERRE FABRE MEDICAMENT$JM L^Orphelin. An occurrence of eosinophilic folliculitis  and alopecia associated with a sustained  complete response to mogamulizumab in  S?zary syndrome: a case report. Therapeutic Advances in  Hematology. 2024;15:1-8$72$YR$$F$Y$$$20240710$$HP$FR$FR
240740871$24074087$1$I$$20240401$20240710$20240710$PER$$JP-PFM-2024-02318$PIERRE FABRE MEDICAMENT$Yoshimi A et al. Three cases of refractory vascular tumors that responded to everolimus. The journal of the Japan Pediatric Society. 2024;128(2):2-O-088$7$DY$$$Y$$$20240710$$MD$JP$JP
240740881$24074088$1$I$$20240408$20240710$20240710$PER$$JP-PFM-2024-02240$PIERRE FABRE MEDICAMENT$Nagatomo Y, Takase S, Sakamoto K, Nagata H, Yamamura K, Tsutsui H et al. Successful mapping and ablation of a pediatric-onset non-reentrant fascicular tachycardia. Journal of Cardiology Cases. 2024;29:165-9$10$YR$$M$Y$$$20240710$$HP$JP$JP
240740891$24074089$1$I$$20240405$20240710$20240710$PER$$KR-PFM-2024-02165$PIERRE FABRE MEDICAMENT$Kim MK, Lee WH, Yang X, Kim HJ, Choi JY, Kim JS. Opsoclonus Induced by Head-Shaking in Vestibular Migraine. The Cerebellum. 2024;23:856-60$47$YR$$F$Y$$$20240710$$HP$KR$KR
240740901$24074090$1$I$$20240401$20240710$20240710$PER$$JP-PFM-2024-02221$PIERRE FABRE MEDICAMENT$Kuroki R, et al.. Low-dose propranolol for infantile hemangiomas caused decreased blood glucose and blood pressure in preterm and low birth weight infants. The Journal of the Japanese Pediatric Society. 2024;128(2):3-P-134$113$DY$$F$Y$$$20240710$$MD$JP$JP
240740911$24074091$1$I$$20240408$20240710$20240710$PER$$US-PFM-2024-02287$PIERRE FABRE MEDICAMENT$Engineer M, Simone P, Patel S, Johnson A,. Ventricular tachycardia secondary to thyroid storm with adverse drug reactions. Complex Clinical Cases. 2024;83(13)$66$YR$$M$Y$$$20240710$$HP$US$US
240740921$24074092$1$I$$20240409$20240710$20240710$PER$$SI-PFM-2024-02333$PIERRE FABRE MEDICAMENT$Kitanovski T, Grzelja J, Plut D. Multifocal infantile hepatic hemangioma- a case report. Medicinski razgledi. 2024;63 (1):101-8$6$MON$$F$Y$$$20240710$$HP$SI$SI
240740931$24074093$1$I$$20240401$20240710$20240710$PER$$JP-PFM-2024-02317$PIERRE FABRE MEDICAMENT$Yoshimi A et al. Three cases of refractory vascular tumors that responded to everolimus. The journal of the Japan Pediatric Society. 2024;128(2):2-O-088$1$MON$$$Y$$$20240710$$MD$JP$JP
240740941$24074094$1$I$$20240415$20240710$20240710$PER$$US-PFM-2024-02408$PIERRE FABRE MEDICAMENT$Woods HB, Bharathidasan K, Yang M, Nichols J, Nugent K. Delayed onset graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency virus: a case series. The American journal of the medical sciences. 2024;9-10$49$YR$$M$Y$$$20240710$$HP$US$US
240740951$24074095$1$I$$20240704$20240710$20240710$EXP$$DE-BAYER-2024A096926$BAYER$$33$YR$A$F$Y$$$20240710$$MD$DE$DE
240740961$24074096$1$I$$20240701$20240710$20240710$PER$$US-BAYER-2024A099427$BAYER$$33$YR$A$F$Y$76$KG$20240710$$MD$US$US
240740971$24074097$1$I$$20240411$20240710$20240710$PER$$US-PFM-2024-02288$PIERRE FABRE MEDICAMENT$Koirala P, Tawfiq R, Raslau D. 22-Year-Old Man With Seizures. Mayo clinic proceedings. 2024;99(4):661-64$22$YR$$M$Y$$$20240710$$MD$US$US
240740981$24074098$1$I$$20240415$20240710$20240710$PER$$US-PFM-2024-02440$PIERRE FABRE MEDICAMENT$Cao T, Sadeghi S, Lulich V, LEnge Ll, Sanne S, Modica M. Severe abdominal pain secondary to celiac artery stenosis. The American journal of the medical sciences. 2024;89-90$45$YR$$M$Y$$$20240710$$HP$US$US
240740991$24074099$1$I$$20240415$20240710$20240710$PER$$US-PFM-2024-02441$PIERRE FABRE MEDICAMENT$Eftaiha E, Paladugula A, Thakkar A, Das D. Amlodipine-induced gingival hyperplasia: a rare but important side effect in hypertension management. The American journal of the medical sciences. 2024;51$40$YR$$F$Y$$$20240710$$HP$US$US
240741001$24074100$1$I$$20240415$20240710$20240710$PER$$US-PFM-2024-02412$PIERRE FABRE MEDICAMENT$Tuttle M, Ciampa D, Godena E, Kim B, Sakmar K, Vanwort-Meng L et al. The evaluation and treatment of somatic symptom disorder in primary care practices. The primary care Companion for CNS disorders. 2024;26(1)$40$YR$$F$Y$$$20240710$$MD$US$US
240741011$24074101$1$I$$20240417$20240710$20240710$PER$$JP-PFM-2024-02264$PIERRE FABRE MEDICAMENT$Shimoda K, Iwasaki H, Mizuno Y, Seki M, Mimaki M, Kato M et al. Case Report: tuberous sclerosis complex-associated hemihypertrophy successfully treated with mTOR inhibitor sirolimus. Frontiers in pediatrics. 2024;12$$$$F$Y$$$20240710$$HP$JP$JP
240741021$24074102$1$I$20220625$20240701$20240710$20240710$PER$$US-MYLANLABS-2024M1064334$MYLAN$$85$YR$$$Y$$$20240710$$HP$US$US
240741031$24074103$1$I$$20240415$20240710$20240710$PER$$RO-PFM-2024-02411$PIERRE FABRE MEDICAMENT$Vatasescu R, Deaconu S, Iorgulescu C, Marascu G, Oprita B, Deaconu A. Long QT Syndrome and WPW Syndrome: A Very Rare Association between Two Causes of Sudden Cardiac Death in a Young Patient. Journal of Clinical Medicine. 2024;13:1-8$26$YR$$F$Y$$$20240710$$HP$RO$RO
240741041$24074104$1$I$$20240417$20240710$20240710$PER$$US-PFM-2024-02443$PIERRE FABRE MEDICAMENT$Eberhard S, Jackman C. Pediatric cluster headache case series: symptomatic cases and the migraine relationship. Journal of child neurology. 2023;1-11$17$YR$$F$Y$$$20240710$$HP$US$US
240741051$24074105$1$I$$20240304$20240710$20240710$PER$$JP-PFM-2024-01585$PIERRE FABRE MEDICAMENT$$3$MON$$$Y$6.1$KG$20240710$$PH$JP$JP
240741061$24074106$1$I$20240301$20240306$20240710$20240710$PER$$US-PFM-2024-01561$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.01$KG$20240710$$PH$US$US
240741071$24074107$1$I$$20240305$20240710$20240710$PER$$US-PFM-2024-01559$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.297$KG$20240710$$CN$US$US
240741081$24074108$1$I$$20240305$20240710$20240710$PER$$US-PFM-2024-01554$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.8$KG$20240710$$CN$US$US
240741091$24074109$1$I$20240305$20240307$20240710$20240710$PER$$US-PFM-2024-01562$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.6$KG$20240710$$PH$US$US
240741101$24074110$1$I$$20240308$20240710$20240710$PER$$US-PFM-2024-01613$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.07$KG$20240710$$CN$US$US
240741111$24074111$1$I$20240228$20240314$20240710$20240710$PER$$US-PFM-2024-01691$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$9.977$KG$20240710$$PH$US$US
240741121$24074112$1$I$20240619$20240709$20240710$20240710$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038803$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$$$20240710$$HP$SG$SG
240741131$24074113$1$I$$20240423$20240710$20240710$PER$$US-PFM-2024-01557$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240710$$HP$US$US
240741141$24074114$1$I$$20240426$20240710$20240710$PER$$US-PFM-2024-02606$PIERRE FABRE MEDICAMENT$Webb J. ?-Blockers for the Treatment of Misophonia and  Misokinesia. Clin Neuropharmacol.. 2022;45(1):13-4$16$YR$$M$Y$$$20240710$$HP$US$US
240741151$24074115$1$I$$20240417$20240710$20240710$PER$$US-PFM-2024-02444$PIERRE FABRE MEDICAMENT$Eberhard S, Jackman C. Pediatric cluster headache case series: symptomatic cases and the migraine relationship. Journal of child neurology. 2023;1-11$14$YR$$F$Y$$$20240710$$HP$US$US
240741162$24074116$2$F$$20240731$20240710$20240807$30DAY$$CZ-JNJFOC-20240637204$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240807$$PH$CZ$CZ
240741174$24074117$4$F$20240604$20240820$20240710$20240822$PER$$US-AMGEN-USASP2024136003$AMGEN$$77$YR$E$M$Y$$$20240822$$CN$US$US
240741192$24074119$2$F$20240613$20240710$20240710$20240712$PER$$US-AMGEN-USASP2024136644$AMGEN$$80$YR$E$M$Y$$$20240712$$PH$US$US
240741201$24074120$1$I$$20240325$20240710$20240710$PER$$US-AMGEN-USASP2024131851$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240741211$24074121$1$I$$20240314$20240710$20240710$PER$$JP-PFM-2024-01788$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$PH$JP$JP
240741221$24074122$1$I$20230105$20230911$20240710$20240710$PER$FR-AFSSAPS-BR2023000803-1$FR-PFM-2024-01851$PIERRE FABRE MEDICAMENT$$57$YR$$M$Y$100$KG$20240710$$MD$FR$FR
240741231$24074123$1$I$20230421$20230515$20240710$20240710$PER$FR-AFSSAPS-ST2023000591-1$FR-PFM-2024-01853$PIERRE FABRE MEDICAMENT$$24$YR$$M$Y$77$KG$20240710$$CN$FR$FR
240741241$24074124$1$I$$20240320$20240710$20240710$PER$$US-PFM-2024-01808$PIERRE FABRE MEDICAMENT$$$$$M$Y$12.998$KG$20240710$$CN$US$US
240741251$24074125$1$I$$20240321$20240710$20240710$PER$$US-PFM-2024-01823$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240710$$PH$US$US
240741261$24074126$1$I$20240316$20240321$20240710$20240710$PER$$FR-PFM-2024-01848$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$8$KG$20240710$$MD$FR$FR
240741271$24074127$1$I$$20240419$20240710$20240710$PER$$US-PFM-2024-01822$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.9$KG$20240710$$HP$US$US
240741281$24074128$1$I$20220101$20230502$20240710$20240710$PER$FR-AFSSAPS-GR2023000575-1$FR-PFM-2024-01849$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240710$$PH$FR$FR
240741291$24074129$1$I$20240307$20240507$20240710$20240710$PER$$US-PFM-2024-01711$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$4.952$KG$20240710$$CN$US$US
240741301$24074130$1$I$$20240626$20240710$20240710$PER$$US-PFM-2024-01752$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.698$KG$20240710$$CN$US$US
240741311$24074131$1$I$20240601$20240703$20240710$20240710$PER$$US-SA-2024SA200586$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240710$$MD$US$US
240741331$24074133$1$I$$20240702$20240710$20240710$PER$$US-SA-2024SA199993$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$MD$US$US
240741341$24074134$1$I$20240625$20240704$20240710$20240710$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-095582$REGENERON$$$$$$Y$$$20240710$$MD$DE$DE
240741361$24074136$1$I$20240618$20240701$20240710$20240710$EXP$$CN-AstraZeneca-2024A153044$ASTRAZENECA$$17$YR$$F$Y$41.8$KG$20240710$$MD$CN$
240741371$24074137$1$I$$20240702$20240710$20240710$EXP$$JP-AstraZeneca-2024A153763$ASTRAZENECA$$69$YR$$M$Y$$$20240710$$MD$JP$
240741381$24074138$1$I$20240517$20240705$20240710$20240710$EXP$$CO-AstraZeneca-2024A155391$ASTRAZENECA$$12776$DY$$M$Y$$$20240710$$CN$CO$
240741401$24074140$1$I$$20240326$20240710$20240710$PER$$US-PFM-2024-01975$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.299$KG$20240710$$CN$US$US
240741411$24074141$1$I$$20231116$20240710$20240710$PER$$SI-PFM-2024-01990$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$CN$SI$SI
240741421$24074142$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005254$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240710$$CN$US$US
240741431$24074143$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004930$ELI LILLY AND CO$$$$$$Y$$$20240710$$HP$US$US
240741441$24074144$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005271$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240710$$CN$US$US
240741451$24074145$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005211$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240710$$CN$US$US
240741461$24074146$1$I$$20240628$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407000063$ELI LILLY AND CO$$$$$M$Y$$$20240710$$CN$US$US
240741471$24074147$1$I$20240122$20240122$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407006031$ELI LILLY AND CO$$$$A$M$Y$$$20240710$$CN$US$US
240741481$24074148$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004274$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240710$$CN$US$US
240741491$24074149$1$I$$20240322$20240710$20240710$PER$$US-PFM-2024-01958$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.998$KG$20240710$$CN$US$US
240741501$24074150$1$I$$20240326$20240710$20240710$PER$$US-PFM-2024-02042$PIERRE FABRE MEDICAMENT$$$$$F$Y$16.327$KG$20240710$$HP$US$US
240741511$24074151$1$I$20230721$20240202$20240710$20240710$PER$FR-AFSSAPS-AN2024000122-1$FR-PFM-2024-01894$PIERRE FABRE MEDICAMENT$$38$YR$$M$Y$$$20240710$$PH$FR$FR
240741521$24074152$1$I$$20240326$20240710$20240710$PER$$US-PFM-2024-02041$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.558$KG$20240710$$HP$US$US
240741531$24074153$1$I$$20240327$20240710$20240710$PER$$US-PFM-2024-02043$PIERRE FABRE MEDICAMENT$$$$$F$Y$15.986$KG$20240710$$CN$US$US
240741541$24074154$1$I$$20240328$20240710$20240710$PER$$US-PFM-2024-02040$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.458$KG$20240710$$HP$US$US
240741551$24074155$1$I$$20240416$20240710$20240710$PER$$JP-PFM-2024-01856$PIERRE FABRE MEDICAMENT$$$$I$F$Y$$$20240710$$PH$JP$JP
240741561$24074156$1$I$$20240605$20240710$20240710$PER$$US-PFM-2024-01972$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.297$KG$20240710$$CN$US$US
240741571$24074157$1$I$$20240705$20240710$20240710$EXP$$NVSC2023DE111628$NOVARTIS$Kloehn J, Kruchen A, Schutze K, Wustrau K, Schrum J, Muller I. Immune ablation and stem cell rescue in two pediatric patients with progressive severe chronic graft-versus-host disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022;23:15403$8$YR$$F$Y$$$20240710$$HP$DE$DE
240741591$24074159$1$I$$20240624$20240710$20240710$PER$$US-MYLANLABS-2024M1058457$MYLAN$$$$$F$Y$$$20240710$$CN$US$US
240741611$24074161$1$I$$20240625$20240710$20240710$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00522$Phathom Pharmaceuticals$$$$E$$Y$$$20240710$$CN$JP$JP
240741621$24074162$1$I$$20240626$20240710$20240710$PER$$US-MYLANLABS-2024M1061115$MYLAN$$$$$$Y$$$20240710$$CN$US$US
240741631$24074163$1$I$$20240327$20240710$20240710$PER$$US-PFM-2024-02049$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.07$KG$20240710$$CN$US$US
240741641$24074164$1$I$$20240327$20240710$20240710$PER$$US-PFM-2024-02044$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.737$KG$20240710$$CN$US$US
240741651$24074165$1$I$$20240327$20240710$20240710$PER$$US-PFM-2024-02047$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.44$KG$20240710$$CN$US$US
240741661$24074166$1$I$$20240305$20240710$20240710$PER$$US-PFM-2024-01517$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.197$KG$20240710$$CN$US$US
240741671$24074167$1$I$$20240329$20240710$20240710$PER$$US-PFM-2024-02087$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.297$KG$20240710$$HP$US$US
240741681$24074168$1$I$$20240401$20240710$20240710$PER$$JP-PFM-2024-02046$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$$$20240710$$PH$JP$JP
240741691$24074169$1$I$$20240329$20240710$20240710$PER$$US-PFM-2024-02059$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.989$KG$20240710$$CN$US$US
240741701$24074170$1$I$$20240402$20240710$20240710$PER$$DE-PFM-2024-02090$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240710$$CN$DE$DE
240741711$24074171$1$I$$20240701$20240710$20240710$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004891$BIOCON$$$$$$Y$$$20240710$$MD$CA$CA
240741721$24074172$1$I$20240329$20240425$20240710$20240710$PER$$US-PFM-2024-02086$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$4$KG$20240710$$HP$US$US
240741731$24074173$1$I$$20240401$20240710$20240710$PER$$US-PFM-2024-02111$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.878$KG$20240710$$HP$US$US
240741741$24074174$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186211$Haleon PLC$$93$YR$$M$Y$$$20240710$$CN$US$US
240741751$24074175$1$I$$20240702$20240710$20240710$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700095$MYOVANT SCIENCES$$$$$M$Y$$$20240710$$CN$US$US
240741761$24074176$1$I$20240526$20240703$20240710$20240710$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700109$MYOVANT SCIENCES$$81$YR$$M$Y$$$20240710$$CN$US$US
240741771$24074177$1$I$20240314$20240702$20240710$20240710$EXP$$US-Biofrontera-2024BIO00102$BIOFRONTERA BIOSCIENCE$$$$$F$Y$$$20240710$$CN$US$US
240741781$24074178$1$I$$20240305$20240710$20240710$PER$$US-PFM-2024-01556$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.297$KG$20240710$$CN$US$US
240741801$24074180$1$I$20240301$20240308$20240710$20240710$PER$$US-PFM-2024-01594$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.79$KG$20240710$$PH$US$US
240741811$24074181$1$I$$20240305$20240710$20240710$PER$$US-PFM-2024-01560$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.798$KG$20240710$$CN$US$US
240741821$24074182$1$I$$20240305$20240710$20240710$PER$$US-PFM-2024-01555$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.488$KG$20240710$$CN$US$US
240741831$24074183$1$I$$20240308$20240710$20240710$PER$$US-PFM-2024-01615$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240710$$CN$US$US
240741841$24074184$1$I$$20240308$20240710$20240710$PER$$US-PFM-2024-01611$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.399$KG$20240710$$CN$US$US
240741851$24074185$1$I$$20240308$20240710$20240710$PER$$US-PFM-2024-01612$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.719$KG$20240710$$CN$US$US
240741861$24074186$1$I$$20240311$20240710$20240710$PER$$US-PFM-2024-01646$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.658$KG$20240710$$HP$US$US
240741871$24074187$1$I$20221230$20240311$20240710$20240710$PER$ES-AEMPS-1495657$ES-PFM-2024-01601$PIERRE FABRE MEDICAMENT$$80$YR$$M$Y$$$20240710$$PH$ES$ES
240741881$24074188$1$I$$20240312$20240710$20240710$PER$$US-PFM-2024-01643$PIERRE FABRE MEDICAMENT$$$$$M$Y$15.896$KG$20240710$$HP$US$US
240741891$24074189$1$I$$20240312$20240710$20240710$PER$$US-PFM-2024-01644$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.61$KG$20240710$$CN$US$US
240741901$24074190$1$I$$20240312$20240710$20240710$PER$$US-PFM-2024-01645$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.918$KG$20240710$$CN$US$US
240741911$24074191$1$I$$20240313$20240710$20240710$PER$$US-PFM-2024-01686$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.698$KG$20240710$$CN$US$US
240741921$24074192$1$I$20240216$20240314$20240710$20240710$PER$$US-PFM-2024-01687$PIERRE FABRE MEDICAMENT$$1$YR$$M$Y$5.97$KG$20240710$$PH$US$US
240741931$24074193$1$I$$20240314$20240710$20240710$PER$$US-PFM-2024-01722$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.2$KG$20240710$$CN$US$US
240741941$24074194$1$I$$20240314$20240710$20240710$PER$$US-PFM-2024-01689$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.567$KG$20240710$$CN$US$US
240741953$24074195$3$F$20240616$20240731$20240710$20240803$PER$$US-AMGEN-USASP2024121708$AMGEN$$$$A$$Y$$$20240803$$PH$US$US
240741961$24074196$1$I$$20240314$20240710$20240710$PER$$US-PFM-2024-01690$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.44$KG$20240710$$HP$US$US
240741971$24074197$1$I$$20240314$20240710$20240710$PER$$US-PFM-2024-01688$PIERRE FABRE MEDICAMENT$$$$$F$Y$22.676$KG$20240710$$HP$US$US
240741981$24074198$1$I$$20240315$20240710$20240710$PER$$US-PFM-2024-01710$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.998$KG$20240710$$CN$US$US
240741991$24074199$1$I$20230101$20240315$20240710$20240710$PER$SE-SEMPA-2023-014492$SE-PFM-2024-01673$PIERRE FABRE MEDICAMENT$$76$YR$$F$Y$$$20240710$$MD$SE$SE
240742001$24074200$1$I$20240624$20240704$20240710$20240710$PER$$US-BAYER-2024A097706$BAYER$$$$$F$Y$$$20240710$$CN$US$US
240742011$24074201$1$I$20240619$20240704$20240710$20240710$EXP$PT-INFARMED-T202406-504$PT-MYLANLABS-2024M1063159$MYLAN$$68$YR$$F$Y$$$20240710$$MD$PT$PT
240742021$24074202$1$I$$20240701$20240710$20240710$EXP$$FR-TEVA-VS-3217185$TEVA$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$49$YR$$M$Y$$$20240710$$HP$FR$FR
240742031$24074203$1$I$$20240703$20240710$20240710$PER$$US-BIOGEN-2024BI01251349$BIOGEN$$$$$M$Y$$$20240710$$CN$US$US
240742041$24074204$1$I$$20240708$20240710$20240710$EXP$$US-ORGANON-O2407USA000886$ORGANON$$$$$F$Y$$$20240710$$CN$US$US
240742051$24074205$1$I$20240521$20240705$20240710$20240710$EXP$$NVSC2024CN141669$NOVARTIS$$24$YR$$M$Y$$$20240710$$HP$CN$CN
240742061$24074206$1$I$20240506$20240702$20240710$20240710$EXP$FR-AFSSAPS-LY2024000823$FR-TEVA-VS-3216613$TEVA$$2$YR$$M$Y$13.3$KG$20240710$$MD$FR$FR
240742071$24074207$1$I$20210420$20230613$20240710$20240710$PER$FR-AFSSAPS-MA2023001709-1$FR-PFM-2024-01873$PIERRE FABRE MEDICAMENT$$1$DY$$F$Y$$$20240710$$CN$FR$FR
240742081$24074208$1$I$20230331$20230616$20240710$20240710$PER$FR-AFSSAPS-TO2023001133-1$FR-PFM-2024-02018$PIERRE FABRE MEDICAMENT$$95$YR$$F$Y$62$KG$20240710$$PH$FR$FR
240742091$24074209$1$I$20230708$20231012$20240710$20240710$PER$FR-AFSSAPS-PA2023001581-1$FR-PFM-2024-01858$PIERRE FABRE MEDICAMENT$$31$YR$$F$Y$$$20240710$$CN$FR$FR
240742101$24074210$1$I$20230520$20230711$20240710$20240710$PER$FR-AFSSAPS-MP2023001200-1$FR-PFM-2024-01959$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240710$$CN$FR$FR
240742111$24074211$1$I$20230101$20231027$20240710$20240710$PER$$FR-PFM-2024-01861$PIERRE FABRE MEDICAMENT$$60$YR$$F$Y$$$20240710$$CN$FR$FR
240742121$24074212$1$I$20230315$20231222$20240710$20240710$PER$FR-AFSSAPS-TO2023002224-1$FR-PFM-2024-01885$PIERRE FABRE MEDICAMENT$$73$YR$$M$Y$$$20240710$$PH$FR$FR
240742131$24074213$1$I$$20240318$20240710$20240710$PER$$US-PFM-2024-01753$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.247$KG$20240710$$HP$US$US
240742141$24074214$1$I$$20240318$20240710$20240710$PER$$US-PFM-2024-01756$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.531$KG$20240710$$CN$US$US
240742151$24074215$1$I$20240313$20240318$20240710$20240710$PER$$US-PFM-2024-01757$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.67$KG$20240710$$PH$US$US
240742161$24074216$1$I$$20240320$20240710$20240710$PER$$US-PFM-2024-01802$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.381$KG$20240710$$HP$US$US
240742171$24074217$1$I$$20240320$20240710$20240710$PER$$US-PFM-2024-01807$PIERRE FABRE MEDICAMENT$$$$$M$Y$13.696$KG$20240710$$CN$US$US
240742181$24074218$1$I$$20240320$20240710$20240710$PER$$US-PFM-2024-01821$PIERRE FABRE MEDICAMENT$$$$$M$Y$12.798$KG$20240710$$CN$US$US
240742191$24074219$1$I$20240206$20240321$20240710$20240710$PER$$US-PFM-2024-01820$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6.803$KG$20240710$$HP$US$US
240742201$24074220$1$I$$20240322$20240710$20240710$PER$$US-PFM-2024-01868$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.029$KG$20240710$$CN$US$US
240742211$24074221$1$I$$20240322$20240710$20240710$PER$$US-PFM-2024-01869$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.299$KG$20240710$$HP$US$US
240742221$24074222$1$I$$20240325$20240710$20240710$PER$$US-PFM-2024-01971$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.866$KG$20240710$$CN$US$US
240742231$24074223$1$I$$20240321$20240710$20240710$PER$$BE-PFM-2024-01828$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240710$$MD$BE$BE
240742241$24074224$1$I$$20240325$20240710$20240710$PER$$US-PFM-2024-01973$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.51$KG$20240710$$HP$US$US
240742251$24074225$1$I$$20240325$20240710$20240710$PER$$US-PFM-2024-01974$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.2$KG$20240710$$CN$US$US
240742261$24074226$1$I$$20240325$20240710$20240710$PER$$US-PFM-2024-01970$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.166$KG$20240710$$HP$US$US
240742271$24074227$1$I$20240408$20240702$20240710$20240710$EXP$SE-SEMPA-2024-005083$SE-TEVA-VS-3216677$TEVA$$57$YR$$F$Y$$$20240710$$MD$SE$SE
240742283$24074228$3$F$20240703$20240718$20240710$20240729$PER$$US-AMGEN-USASP2024133948$AMGEN$$$$$$Y$$$20240729$$PH$US$US
240742293$24074229$3$F$$20240725$20240710$20240729$PER$$US-AMGEN-USASP2024136645$AMGEN$$$$$M$Y$$$20240728$$CN$US$US
240742301$24074230$1$I$20210420$20230614$20240710$20240710$PER$FR-AFSSAPS-MA2023001708-1$FR-PFM-2024-02022$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$CN$FR$FR
240742311$24074231$1$I$20230501$20230620$20240710$20240710$PER$FR-AFSSAPS-TS2023000761-1$FR-PFM-2024-02020$PIERRE FABRE MEDICAMENT$$$$$F$Y$1.895$KG$20240710$$MD$FR$FR
240742321$24074232$1$I$$20240701$20240710$20240710$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004925$BIOCON$$$$$$Y$$$20240710$$CN$CA$CA
240742331$24074233$1$I$$20240709$20240710$20240710$PER$$US-GILEAD-2024-0680064$GILEAD$$37$YR$A$$Y$$$20240710$$HP$US$US
240742343$24074234$3$F$$20240826$20240710$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109395$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240828$$CN$US$US
240742361$24074236$1$I$$20231011$20240710$20240710$PER$$IT-PFM-2024-01978$PIERRE FABRE MEDICAMENT$Cimmino AT, Sanginario P, Bentivoglio AR, Calabresi P, Petracca M, Di Lazzaro G. Botulinum neurotoxin in FXTAS-related tremor: A ^successful^ case report. INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE 2023. 2023$59$YR$$M$Y$$$20240710$$HP$IT$IT
240742371$24074237$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109086$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$52$YR$A$F$Y$$$20240710$$HP$US$US
240742381$24074238$1$I$20240614$20240704$20240710$20240710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099393$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$PH$JP$JP
240742391$24074239$1$I$$20240701$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105464$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240710$$CN$US$US
240742401$24074240$1$I$$20230524$20240710$20240710$PER$$AT-PFM-2024-01989$PIERRE FABRE MEDICAMENT$Haxhija$$$I$F$Y$$$20240710$$MD$AT$AT
240742411$24074241$1$I$$20230809$20240710$20240710$PER$$GR-PFM-2024-01988$PIERRE FABRE MEDICAMENT$Lazaridou E, Makri E, Angeliki F, Terzoudi A. Patient with migraine and history of sleepwalking. Case presentation and literature review. 34th Panhellenic Congress on Neurology. 2023$26$YR$$F$Y$$$20240710$$HP$GR$GR
240742421$24074242$1$I$20230727$20230831$20240710$20240710$PER$FR-AFSSAPS-RN2023000951-1$FR-PFM-2024-01850$PIERRE FABRE MEDICAMENT$$51$YR$$M$Y$55$KG$20240710$$HP$FR$FR
240742431$24074243$1$I$$20240304$20240710$20240710$PER$$JP-PFM-2024-01582$PIERRE FABRE MEDICAMENT$Fukuyama M. Calmodulinopathy in Japanese Children ? Their Cardiac Phenotypes Are Severe and Show Early Onset in Fetal Life and Infancy. Circulation Journal. 2023;87(12):1828-35$4$YR$$M$Y$$$20240710$$MD$JP$JP
240742441$24074244$1$I$$20240311$20240710$20240710$PER$$ES-PFM-2024-01635$PIERRE FABRE MEDICAMENT$Navarro-Bielsa A, Gil-Pallares P, Diago-Irache A, Martinez-Arnau N, Gracia-Cazana T, Gilaberte Y. Kaposi sarcoma of the penis successfully treated with oral propranolol. Clinical and Experimental Dermatology. 2023;48:1084-6$72$YR$$M$Y$$$20240710$$HP$ES$ES
240742451$24074245$1$I$$20240304$20240710$20240710$PER$$JP-PFM-2024-01584$PIERRE FABRE MEDICAMENT$Fukuyama M. Calmodulinopathy in Japanese Children ? Their Cardiac Phenotypes Are Severe and Show Early Onset in Fetal Life and Infancy. Circulation Journal. 2023;87(12):1828-35$$$I$M$Y$3.221$KG$20240710$$MD$JP$JP
240742461$24074246$1$I$$20240304$20240710$20240710$PER$$JP-PFM-2024-01583$PIERRE FABRE MEDICAMENT$Fukuyama M. Calmodulinopathy in Japanese Children ? Their Cardiac Phenotypes Are Severe and Show Early Onset in Fetal Life and Infancy. Circulation Journal. 2023;87(12):1828-35$5$YR$$M$Y$$$20240710$$MD$JP$JP
240742471$24074247$1$I$$20240313$20240710$20240710$PER$$JP-PFM-2024-01606$PIERRE FABRE MEDICAMENT$Imamura M, Shin C, Ozeki M, Matsuoka K, Saitoh A, Imai C. Regression of kaposiform lymphangiomatosis and chronic disseminated intravascular coagulation after inhaled budesonide-formoterol treatment. Pediatric Blood and Cancer. 2024;71:1-4$12$YR$$M$Y$$$20240710$$HP$JP$JP
240742481$24074248$1$I$$20240311$20240710$20240710$PER$$KR-PFM-2024-01605$PIERRE FABRE MEDICAMENT$Lee GH, Jung E, Jung NY, Mizuguchi T, Matsumoto N, Kim EJ. Case report: Neuronal intranuclear inclusion disease initially mimicking reversible cerebral vasoconstriction syndrome: serial neuroimaging findings during an 11-year follow-up. Frontiers in neurology. 2024;15$59$YR$$M$Y$$$20240710$$HP$KR$KR
240742491$24074249$1$I$$20240325$20240710$20240710$PER$$JP-PFM-2024-02081$PIERRE FABRE MEDICAMENT$Narita M. Four cases report of hypertrophic obstructive cardiomyopathy with underlying Noonan syndrome treated with high-dose?blocker medication from neonatal or early infantile period. The 32th meeting of the Japanese Society of Pediatric Myocardial Diseases. 2023;1-3$1$MON$$F$Y$$$20240710$$MD$JP$JP
240742501$24074250$1$I$$20240318$20240710$20240710$PER$$DE-PFM-2024-01731$PIERRE FABRE MEDICAMENT$Merbecks M, Carl L, Weissgerber T, Gorenflo M, Kovacevic A. Verapamil-sensitive fascicular left ventricular tachycardia in an 8-week-old infant: diagnosis and management. Thoracic and Cardiovascular Surgeon. 2024;72(2)$8$WK$$$Y$$$20240710$$HP$DE$DE
240742511$24074251$1$I$$20240318$20240710$20240710$PER$$DE-PFM-2024-01730$PIERRE FABRE MEDICAMENT$Rottermann K, Abu-Tair T, Purbujo A, Dewald O, Steinmetz M, Schirrmeister J et al. Transcatheter Device Closure of a Large Muscular VSD during  Neonatal Period: An Opt-out Strategy in a Complex Case. The Thoracic and Cardiovascular Surgeon. 2024$$$N$M$Y$$$20240710$$HP$DE$DE
240742521$24074252$1$I$$20240325$20240710$20240710$PER$$JP-PFM-2024-02080$PIERRE FABRE MEDICAMENT$Narita M. Four cases of hypertrophic obstructive cardiomyopathy with underlying Noonan syndrome treated with high-dose?blocker medication from neonatal or early infantile period. The 32th meeting of the Japanese Society of Pediatric Myocardial Diseases. 2023;1-3$6$DY$$M$Y$$$20240710$$MD$JP$JP
240742531$24074253$1$I$$20240311$20240710$20240710$PER$$IT-PFM-2024-01614$PIERRE FABRE MEDICAMENT$Falsaperla R, Scalia B, Collotta AD, Giacchi V, Cimino C, Ruggieri M. Treatment Options for Cyclic Vomiting Syndrome: A Real-World, Single-Center Experience with Systematic Literature Review and Meta-Analysis. Pediatric Pharmacology. 2024;64(2):227-39$$$$$Y$$$20240710$$HP$IT$IT
240742551$24074255$1$I$$20240325$20240710$20240710$PER$$JP-PFM-2024-02083$PIERRE FABRE MEDICAMENT$Narita M. Four cases report of hypertrophic obstructive cardiomyopathy with underlying Noonan syndrome treated with high-dose?blocker medication from neonatal or early infantile period. The 32th meeting of the Japanese Society of Pediatric Myocardial Diseases. 2023;1-3$1$MON$$F$Y$$$20240710$$MD$JP$JP
240742561$24074256$1$I$$20240325$20240710$20240710$PER$$JP-PFM-2024-02082$PIERRE FABRE MEDICAMENT$Narita M. Four cases report of hypertrophic obstructive cardiomyopathy with underlying Noonan syndrome treated with high-dose?blocker medication from neonatal or early infantile period. The 32th meeting of the Japanese Society of Pediatric Myocardial Diseases. 2023;1-3$5$MON$$F$Y$$$20240710$$MD$JP$JP
240742571$24074257$1$I$$20240708$20240710$20240710$EXP$$US-GSK-US2024084448$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$US$US
240742582$24074258$2$F$20240601$20240802$20240710$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000442$PAREXEL$$$$$$Y$$$20240930$$CN$US$US
240742592$24074259$2$F$20240101$20240719$20240710$20240725$EXP$$JP-009507513-2407JPN000589J$MERCK$$7$DEC$$M$Y$$$20240725$$MD$JP$JP
240742601$24074260$1$I$$20240318$20240710$20240710$PER$$HR-PFM-2024-01743$PIERRE FABRE MEDICAMENT$Lasic S, Marasanov S, Rozankovic M, Rozankovic P B. Gamma knife thalamotomy in treating refractory tremor: initial clinical experience in Croatia. Croat Med J. 2024;65:59-64$68$YR$$F$Y$$$20240710$$HP$HR$HR
240742611$24074261$1$I$$20240318$20240710$20240710$PER$$TR-PFM-2024-01741$PIERRE FABRE MEDICAMENT$Yilmaz GC, Anik A. Thyroid dysfunction caused by maternal autoimmune thyroiditis: Two different clinical pictures in two siblings. Acta Endocrinol (Buchar). 2023;19(3):386-9$34$DY$$M$Y$$$20240710$$HP$TR$TR
240742621$24074262$1$I$$20240708$20240710$20240710$PER$$US-BAYER-2024A098698$BAYER$$$$$F$Y$$$20240710$$CN$US$US
240742631$24074263$1$I$$20240627$20240710$20240710$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06150$HIKMA$$$$$$Y$$$20240710$$CN$US$US
240742641$24074264$1$I$$20240701$20240710$20240710$EXP$$US-ROCHE-10000017207$ROCHE$$69$YR$E$F$Y$$$20240710$$CN$US$US
240742651$24074265$1$I$$20240702$20240710$20240710$EXP$$US-SA-2024SA198948$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240710$$MD$US$US
240742662$24074266$2$F$$20240715$20240710$20240715$PER$$US-BAYER-2024A097715$BAYER$$$$$F$Y$$$20240715$$CN$US$US
240742681$24074268$1$I$20240401$20240701$20240710$20240710$EXP$$US-TG THERAPEUTICS INC.-TGT003761$TG THERAPEUTICS$$$$$$Y$$$20240710$$HP$US$US
240742691$24074269$1$I$20200427$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157056$ASTRAZENECA$$72$YR$$M$Y$78$KG$20240710$$HP$FR$
240742701$24074270$1$I$$20240702$20240710$20240710$EXP$$ZA-AstraZeneca-2024A152265$ASTRAZENECA$$23376$DY$$M$Y$$$20240710$$CN$ZA$
240742711$24074271$1$I$20240708$20240709$20240710$20240710$PER$$US-BAYER-2024A098944$BAYER$$29$YR$A$F$Y$$$20240710$$CN$US$US
240742721$24074272$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157100$ASTRAZENECA$$61$YR$$M$Y$$$20240710$$HP$FR$
240742731$24074273$1$I$20240423$20240702$20240710$20240710$EXP$FR-AFSSAPS-AM2024000532$FR-TEVA-VS-3216363$TEVA$$57$YR$$M$Y$$$20240710$$MD$FR$FR
240742741$24074274$1$I$20240619$20240702$20240710$20240710$EXP$LU-ALMPS-202404267$LU-TEVA-VS-3217015$TEVA$$48$YR$$F$Y$72$KG$20240710$$PH$LU$LU
240742751$24074275$1$I$$20240702$20240710$20240710$EXP$GB-MHRA-MED-202407020643199960-VMKHF$GB-TEVA-VS-3216504$TEVA$$$$$F$Y$95$KG$20240710$$CN$GB$GB
240742762$24074276$2$F$$20240729$20240710$20240808$30DAY$$US-GSK-US2024AMR084805$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
240742782$24074278$2$F$20240709$20240710$20240710$20240726$PER$$US-AMGEN-USASP2024135803$AMGEN$$49$YR$A$M$Y$$$20240726$$CN$US$US
240742794$24074279$4$F$20240624$20240911$20240710$20240912$PER$$US-AMGEN-USASP2024136735$AMGEN$$80$YR$E$F$Y$$$20240912$$CN$US$US
240742801$24074280$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024136559$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240742811$24074281$1$I$$20240702$20240710$20240710$EXP$$US-BAXTER-2024BAX021039$BAXTER$$$$$$Y$$$20240710$$CN$US$US
240742821$24074282$1$I$$20240705$20240710$20240710$EXP$$US-INCYTE CORPORATION-2024IN007124$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240742833$24074283$3$F$$20240830$20240710$20240904$EXP$$US-INCYTE CORPORATION-2024IN006968$INCYTE$$$$$$Y$$$20240904$$MD$US$US
240742841$24074284$1$I$$20240710$20240710$20240710$PER$$US-HALEON-2186304$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240742852$24074285$2$F$20240101$20240702$20240710$20240711$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020192$UNITED THERAPEUTICS$$$$$F$Y$$$20240711$$$US$US
240742861$24074286$1$I$20240201$20240702$20240710$20240710$EXP$IT-MINISAL02-992123$IT-TEVA-VS-3216583$TEVA$$69$YR$$M$Y$$$20240710$$MD$IT$IT
240742881$24074288$1$I$20240624$20240708$20240710$20240710$EXP$$CA-ABBVIE-5832743$ABBVIE$$52$YR$$F$Y$$$20240710$$CN$CA$CA
240742892$24074289$2$F$20240612$20240912$20240710$20240916$EXP$IT-MINISAL02-993030$IT-BIOCON BIOLOGICS LIMITED-BBL2024004901$BIOCON$$$$$$Y$$$20240916$$MD$IT$IT
240742902$24074290$2$F$$20240919$20240710$20240919$PER$$NVSC2024US142470$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
240742911$24074291$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47900$$FDA-CTU$$65$YR$$M$N$$$20240710$N$$US$
240742922$24074292$2$F$20240501$20240704$20240710$20240812$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003273$CURRAX PHARMACEUTICALS$$67$YR$$F$Y$$$20240812$$CN$CA$CA
240742932$24074293$2$F$$20240625$20240710$20240730$EXP$$CH-TEVA-VS-3218963$TEVA$$$$$$Y$$$20240730$$HP$CH$CH
240742942$24074294$2$F$$20240807$20240710$20240808$PER$$US-BAUSCH-BL-2024-010376$BAUSCH AND LOMB$$53$YR$$F$Y$$$20240808$$CN$US$US
240742951$24074295$1$I$$20240625$20240710$20240710$EXP$$ZA-ROCHE-10000019842$ROCHE$$$$$M$Y$$$20240710$$MD$ZA$ZA
240742962$24074296$2$F$20240628$20240724$20240710$20240731$EXP$$JP-GENMAB-2024-02351$GENMAB$$73$YR$$F$Y$$$20240731$$MD$JP$JP
240742973$24074297$3$F$$20240716$20240710$20240723$EXP$$GR-ABBVIE-5833848$ABBVIE$Giannias R, Alexandrou S, Ntoumou E, Adamidou S, Skafida E, Tzortzi M. A case of serotoninergic syndrome. Archives of Hellenic Medicine. 2024;41(4):555-557.; Giannias R, Alexandrou S, Ntoumou E, Adamidou S, Skafida E, Tzortzi M. A case of serotoninergic syndrome. Archives of Hellenic Medicine. 2024;41(4):555-557$$$$$Y$$$20240723$$HP$GR$GR
240742981$24074298$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186292$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240742991$24074299$1$I$$20240703$20240710$20240710$EXP$$US-VIIV HEALTHCARE LIMITED-US2024082571$VIIV$$$$$$Y$$$20240710$$HP$US$US
240743001$24074300$1$I$20240101$20240706$20240710$20240710$EXP$$US-ABBVIE-5831421$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240743011$24074301$1$I$$20240701$20240710$20240710$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004927$BIOCON$$$$$$Y$$$20240710$$HP$CA$CA
240743021$24074302$1$I$20240601$20240627$20240710$20240710$PER$$US-TEVA-VS-3214768$TEVA$$66$YR$$M$Y$104.33$KG$20240710$$CN$US$US
240743034$24074303$4$F$$20240922$20240710$20240925$30DAY$$US-PFIZER INC-202400206347$PFIZER$$14$YR$$M$Y$$$20240925$$CN$US$US
240743042$24074304$2$F$20220915$20240708$20240710$20240711$EXP$$CN-PFIZER INC-PV202400088205$PFIZER$Zhu, A.. Omadacycline for the treatment of patients with Legionella pneumophila pneumonia after experiencing liver dysfunction: case series. Frontiers in Microbiology. 2024;15:10.3389/fmicb.2024.1408443$59$YR$$M$Y$$$20240711$$HP$CN$CN
240743051$24074305$1$I$20240112$20240705$20240710$20240710$EXP$IT-MINISAL02-980290$IT-PFIZER INC-2024SGN04470$PFIZER$$59$YR$$F$Y$54$KG$20240710$$MD$IT$IT
240743071$24074307$1$I$$20240704$20240710$20240710$EXP$$US-PFIZER INC-2024SGN05831$PFIZER$$59$YR$$F$Y$$$20240710$$CN$US$US
240743082$24074308$2$F$$20240904$20240710$20240910$EXP$FR-AFSSAPS-PV20221513$FR-PFIZER INC-PV202400089084$PFIZER$COHEN, S.. Isolated conjugated hyperbilirubinemia with rifampicin and cross-reaction with rifabutin: A drug-endogenous substance interaction case report. Therapies. 2023;10.1016/j.therap.2023.09.006$73$YR$$F$Y$53$KG$20240910$$HP$FR$FR
240743111$24074311$1$I$$20240704$20240710$20240710$EXP$$US-PFIZER INC-2024SGN00105$PFIZER$$45$YR$$F$Y$$$20240710$$CN$US$US
240743121$24074312$1$I$20180103$20240708$20240710$20240710$EXP$$US-ABBVIE-5802006$ABBVIE$$72$YR$$F$Y$$$20240710$$CN$US$US
240743151$24074315$1$I$20210127$20240704$20240710$20240710$EXP$$FR-PFIZER INC-2021SGN03034$PFIZER$$50$YR$$F$Y$$$20240710$$HP$FR$FR
240743164$24074316$4$F$20230517$20240718$20240710$20240723$EXP$$CN-PFIZER INC-PV202400088834$PFIZER$Yan, L.. Hypotensive syncope induced by the combination of benidipine and nirmatrelvir/ritonavir. Adverse Drug Reactions Journal. 2024;26(6):376-379$67$YR$$M$Y$$$20240723$$HP$CN$CN
240743211$24074321$1$I$20230327$20240704$20240710$20240710$EXP$$FR-Hill Dermaceuticals, Inc.-2159002$HILL DERM$$68$YR$$M$Y$79.5$KG$20240710$$MD$FR$FR
240743222$24074322$2$F$$20240710$20240710$20240715$PER$$US-BIOVITRUM-2024-US-009625$BIOVITRUM$$63$YR$$F$Y$$$20240715$$CN$US$US
240743231$24074323$1$I$20220518$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157046$ASTRAZENECA$$65$YR$$M$Y$$$20240710$$HP$FR$
240743241$24074324$1$I$20210816$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157251$ASTRAZENECA$$56$YR$$F$Y$56$KG$20240710$$HP$FR$
240743251$24074325$1$I$20210205$20240705$20240710$20240710$EXP$$DE-PFIZER INC-2021SGN00523$PFIZER$$52$YR$$F$Y$82$KG$20240710$$MD$DE$DE
240743263$24074326$3$F$$20240810$20240710$20240812$30DAY$$US-PFIZER INC-202400205668$PFIZER$$7$YR$$M$Y$$$20240812$$CN$US$US
240743271$24074327$1$I$20210818$20240705$20240710$20240710$EXP$$IT-PFIZER INC-2021SGN04351$PFIZER$$69$YR$$F$Y$70$KG$20240710$$MD$IT$IT
240743283$24074328$3$F$20240501$20240805$20240710$20240816$PER$$US-MYLANLABS-2024M1060714$MYLAN$$71$YR$$F$Y$43.09$KG$20240816$$CN$US$US
240743291$24074329$1$I$20240705$20240705$20240710$20240710$EXP$$US-Stemline Therapeutics, Inc.-2024ST004134$STEMLINE THERAPEUTICS$$82$YR$E$F$Y$$$20240709$$CN$US$US
240743301$24074330$1$I$20240417$20240702$20240710$20240710$EXP$FR-AFSSAPS-DJ2024000806$FR-TEVA-VS-3216690$TEVA$$37$YR$$M$Y$92$KG$20240710$$MD$FR$FR
240743321$24074332$1$I$20240613$20240705$20240710$20240710$EXP$$CN-ROCHE-10000019490$ROCHE$$18$YR$A$M$Y$80$KG$20240710$$HP$CN$CN
240743331$24074333$1$I$20240101$20240702$20240710$20240710$EXP$$US-SA-2024SA198927$SANOFI AVENTIS$$64$YR$A$F$Y$53$KG$20240710$$MD$US$US
240743341$24074334$1$I$$20240705$20240710$20240710$EXP$$US-Stemline Therapeutics, Inc.-2024ST004131$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240710$$CN$US$US
240743351$24074335$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186279$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240743362$24074336$2$F$$20240904$20240710$20240927$PER$$US-SA-2024SA199087$SANOFI AVENTIS$$15$YR$T$M$Y$54.88$KG$20240927$$MD$US$US
240743371$24074337$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197934$SANOFI AVENTIS$$$$C$M$Y$$$20240710$$MD$US$US
240743381$24074338$1$I$20240601$20240705$20240710$20240710$PER$$US-SA-2024SA200730$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240710$$MD$US$US
240743391$24074339$1$I$20240601$20240702$20240710$20240710$EXP$$US-SA-2024SA198747$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240710$$MD$US$US
240743401$24074340$1$I$$20240701$20240710$20240710$EXP$$EG-DSJP-DSJ-2024-134760$DAIICHI$$$$A$F$Y$$$20240710$$MD$EG$EG
240743414$24074341$4$F$20240711$20240904$20240710$20240912$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004472$BIOCON$$$$$$Y$$$20240912$$CN$CA$CA
240743421$24074342$1$I$20240601$20240709$20240710$20240710$PER$$US-BIOVITRUM-2024-US-009674$BIOVITRUM$$5$MON$$F$Y$$$20240710$$CN$US$US
240743433$24074343$3$F$20240601$20240814$20240710$20240821$EXP$$CA-GSK-CA2024083915$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$CA$CA
240743441$24074344$1$I$$20240703$20240710$20240710$EXP$$US-GSK-US2024AMR084207$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$US$US
240743451$24074345$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197898$SANOFI AVENTIS$$$$A$F$Y$53.5$KG$20240710$$MD$US$US
240743461$24074346$1$I$$20240702$20240710$20240710$EXP$$JP-ABBVIE-5796364$ABBVIE$$$$E$M$Y$$$20240710$$CN$JP$JP
240743471$24074347$1$I$$20240625$20240710$20240710$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00446$GLAND PHARMA$Hitoshi Mori.Coronary vasospasms induced by a dexmedetomidine infusion for deep sedation during catheter ablation in a patient with negative findings of an acetylcholine provocation test.Journal of Arrhythmia.15-AUG-2023;39:819-821$68$YR$E$M$Y$80$KG$20240710$$MD$JP$JP
240743481$24074348$1$I$20240627$20240627$20240710$20240710$EXP$$CA-ROCHE-10000018838$ROCHE$$39$YR$A$F$Y$$$20240710$$HP$CA$CA
240743501$24074350$1$I$$20240629$20240710$20240710$PER$$US-TEVA-VS-3216490$TEVA$$$$$$Y$$$20240710$$CN$US$US
240743511$24074351$1$I$$20240702$20240710$20240710$EXP$FR-AFSSAPS-AVPO2024000118$FR-TEVA-VS-3216430$TEVA$$34$YR$$M$Y$$$20240710$$PH$FR$FR
240743521$24074352$1$I$20240529$20240701$20240710$20240710$EXP$IT-MINISAL02-991415$IT-TEVA-VS-3216169$TEVA$$89$YR$$F$Y$$$20240710$$PH$IT$IT
240743531$24074353$1$I$20240620$20240630$20240710$20240710$EXP$$CN-INCYTE CORPORATION-2024IN007092$INCYTE$$$$$$Y$$$20240710$$HP$CN$CN
240743541$24074354$1$I$$20240703$20240710$20240710$EXP$$US-MYLANLABS-2024M1064076$MYLAN$Almeida Da SilvaLC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. J-Pediatr-Orthop-B 2024; 33 (4): 407-410.$$$C$$Y$$$20240710$$MD$US$US
240743561$24074356$1$I$$20240625$20240710$20240710$EXP$$QA-GLANDPHARMA-QA-2024GLNLIT00431$GLAND PHARMA$Haidar Barjas.Metronidazole associated optic neuritis-induced irreversible vision loss: A  case report and literature review.IDCases.JAN-2024;36:1-4$30$YR$A$F$Y$$$20240710$$HP$QA$QA
240743572$24074357$2$F$$20240719$20240710$20240729$EXP$$GB-TEVA-VS-3217278$TEVA$Bhatti A, Kalearasu A, Jayapalen V. TACHYPHYLAXIS-INDUCED MYOCARDIAL INFARCTION IN A PATIENT WITH VASOSPASTIC ANGINA. Heart 2024; 110 (Suppl. 3) A80-A81 abstr. 75.; Bhatti A, Kalearasu A, Jayapalen V. TACHYPHYLAXIS-INDUCED MYOCARDIAL INFARCTION IN A PATIENT WITH VASOSPASTIC ANGINA. Heart 2024; 110 (Suppl. 3) A80-A81 abstr. 75.$70$YR$$F$Y$$$20240729$$HP$GB$GB
240743581$24074358$1$I$20240601$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024133993$AMGEN$$$$$M$Y$$$20240710$$CN$US$US
240743591$24074359$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA199513$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240710$$MD$US$US
240743601$24074360$1$I$20240704$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005232$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240710$$CN$US$US
240743615$24074361$5$F$20240101$20240906$20240710$20240917$PER$$US-SA-2024SA201734$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240918$$MD$US$US
240743621$24074362$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004574$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240710$$CN$US$US
240743632$24074363$2$F$$20240703$20240710$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407002416$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240711$$CN$US$US
240743641$24074364$1$I$$20240705$20240710$20240710$EXP$$NVSC2024PE141923$NOVARTIS$$56$YR$$M$Y$$$20240710$$CN$PE$PE
240743652$24074365$2$F$20240606$20240703$20240710$20240714$EXP$$US-ABBVIE-5832814$ABBVIE$$82$YR$$M$Y$$$20240714$$MD$US$US
240743661$24074366$1$I$20230730$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157409$ASTRAZENECA$$72$YR$$M$Y$$$20240710$$HP$FR$
240743671$24074367$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157246$ASTRAZENECA$$78$YR$$M$Y$85$KG$20240710$$HP$FR$
240743682$24074368$2$F$$20240725$20240710$20240726$PER$$US-ROCHE-10000020690$ROCHE$$$$$$Y$$$20240726$$CN$US$US
240743691$24074369$1$I$$20240705$20240710$20240710$EXP$$US-AstraZeneca-2024A155081$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240743701$24074370$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A117188$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240743711$24074371$1$I$$20240702$20240710$20240710$EXP$$GB-AstraZeneca-2024A153701$ASTRAZENECA$$$$$M$Y$$$20240710$$MD$GB$
240743721$24074372$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157406$ASTRAZENECA$$82$YR$$F$Y$53$KG$20240710$$HP$FR$
240743731$24074373$1$I$$20240701$20240710$20240710$PER$$US-TEVA-VS-3217362$TEVA$$55$YR$$M$Y$$$20240710$$CN$US$US
240743741$24074374$1$I$$20240702$20240710$20240710$EXP$$ZA-AstraZeneca-2024A153269$ASTRAZENECA$$82$YR$$F$Y$$$20240710$$CN$ZA$
240743751$24074375$1$I$20240612$20240613$20240710$20240710$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000495$PAREXEL$$$$$$Y$$$20240710$$CN$US$US
240743762$24074376$2$F$20240611$20240809$20240710$20240830$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000494$PAREXEL$$$$$$Y$$$20240830$$HP$US$US
240743771$24074377$1$I$$20240625$20240710$20240710$EXP$$US-GLANDPHARMA-US-2024GLNSPO00426$GLAND PHARMA$$$$$$Y$$$20240710$$CN$US$US
240743781$24074378$1$I$$20240709$20240710$20240710$PER$$US-JNJFOC-20240721453$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$CN$US$US
240743791$24074379$1$I$20240125$20240709$20240710$20240710$EXP$GB-MHRA-MED-202407081950377100-MCSQK$GB-ORGANON-O2407GBR000919$ORGANON$$4$YR$$M$Y$16$KG$20240710$$CN$GB$GB
240743803$24074380$3$F$20240101$20240722$20240710$20240726$PER$$US-BIOGEN-2024BI01269716$BIOGEN$$$$$F$Y$$$20240726$$CN$US$US
240743811$24074381$1$I$$20240709$20240710$20240710$PER$$US-JNJFOC-20240722267$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$HP$US$US
240743821$24074382$1$I$20240101$20240709$20240710$20240710$PER$$US-JNJFOC-20240722899$JOHNSON AND JOHNSON$$14$YR$T$M$Y$31.78$KG$20240710$$PH$US$US
240743831$24074383$1$I$$20240701$20240710$20240710$PER$$US-TEVA-VS-3217367$TEVA$$37$YR$$M$Y$$$20240710$$CN$US$US
240743842$24074384$2$F$20240520$20240710$20240710$20240718$EXP$$US-BIOCON BIOLOGICS LIMITED-BBL2024005022$BIOCON$$$$$$Y$$$20240718$$CN$US$US
240743861$24074386$1$I$20240701$20240703$20240710$20240710$PER$$US-GILEAD-2024-0679572$GILEAD$$$$$F$Y$$$20240710$$MD$US$US
240743871$24074387$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405071423293830-ZHTYS$GB-MYLANLABS-2024M1063427$MYLAN$$$$$F$Y$$$20240710$$PH$GB$GB
240743881$24074388$1$I$20240101$20240708$20240710$20240710$EXP$$US-ABBVIE-5832428$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
240743891$24074389$1$I$20240101$20240702$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-013416$UNITED THERAPEUTICS$$$$$F$Y$$$20240710$$$US$US
240743901$24074390$1$I$$20240708$20240710$20240710$EXP$$FR-FreseniusKabi-FK202410836$FRESENIUS KABI$$$$$F$Y$$$20240710$$MD$FR$FR
240743911$24074391$1$I$$20240705$20240710$20240710$PER$$NVSC2024US140904$NOVARTIS$$$$$$Y$$$20240710$$CN$US$US
240743921$24074392$1$I$$20240708$20240710$20240710$EXP$$US-UCBSA-2024034714$UCB$$$$$$Y$$$20240710$$CN$US$US
240743931$24074393$1$I$$20240625$20240710$20240710$PER$$US-GLANDPHARMA-US-2024GLNSPO00441$GLAND PHARMA$$$$$$Y$$$20240710$$CN$US$US
240743941$24074394$1$I$$20240701$20240710$20240710$EXP$$IT-TEVA-VS-3217329$TEVA$Fattizzo B, Pasquale R, Croci GA, Pettine L, Cassanello G, Barcellini W. Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review. Blood-Transf 2024; 22 (3): 266-272.$83$YR$$M$Y$$$20240710$$HP$IT$IT
240743951$24074395$1$I$20230101$20240703$20240710$20240710$EXP$$BR-TAKEDA-2023TUS014472$TAKEDA$$$$$F$Y$$$20240710$$CN$BR$BR
240743961$24074396$1$I$20240615$20240709$20240710$20240710$EXP$$MX-BAYER-2024A099445$BAYER$$61$YR$A$M$Y$$$20240710$$CN$MX$MX
240743971$24074397$1$I$20240620$20240705$20240710$20240710$EXP$$US-ABBVIE-5832064$ABBVIE$$62$YR$$F$Y$106$KG$20240710$$CN$US$US
240743981$24074398$1$I$$20240704$20240710$20240710$PER$$US-SA-2024SA200110$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240710$$MD$US$US
240743993$24074399$3$F$20240708$20240711$20240710$20240712$PER$$US-AMGEN-USASP2024136728$AMGEN$$78$YR$E$M$Y$$$20240712$$CN$US$US
240744001$24074400$1$I$$20240709$20240710$20240710$PER$$US-GILEAD-2024-0680139$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240744012$24074401$2$F$20240101$20240715$20240710$20240717$EXP$$US-BAYER-2024A098290$BAYER$$78$YR$E$M$Y$$$20240717$$CN$US$US
240744021$24074402$1$I$$20240710$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038946$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240710$$CN$US$US
240744031$24074403$1$I$$20240625$20240710$20240710$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06293$LUPIN$$$$$$Y$$$20240710$$CN$US$US
240744041$24074404$1$I$20240501$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405130012593890-VJCNG$GB-MYLANLABS-2024M1063413$MYLAN$$$$$F$Y$76$KG$20240710$$CN$GB$GB
240744051$24074405$1$I$$20240625$20240710$20240710$PER$$US-GLANDPHARMA-US-2024GLNSPO00448$GLAND PHARMA$$$$$$Y$$$20240710$$PH$US$US
240744061$24074406$1$I$20240604$20240702$20240710$20240710$EXP$$JP-009507513-2406JPN000592J$MERCK$$$$$F$Y$$$20240710$$MD$JP$JP
240744071$24074407$1$I$20240207$20240207$20240710$20240710$EXP$$US-FERRINGPH-2024FE00621$FERRING$$16$YR$$M$Y$$$20240710$$CN$US$US
240744081$24074408$1$I$$20231105$20240710$20240710$EXP$$US-FERRINGPH-2023FE05519$FERRING$$$$$M$Y$$$20240710$$CN$US$US
240744091$24074409$1$I$20240221$20240305$20240710$20240710$EXP$$US-FERRINGPH-2024FE01131$FERRING$$11$YR$$M$Y$30.35$KG$20240710$$CN$US$US
240744101$24074410$1$I$$20240702$20240710$20240710$EXP$$US-MYLANLABS-2024M1063743$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$61$YR$$M$Y$$$20240710$$HP$US$US
240744111$24074411$1$I$20240411$20240412$20240710$20240710$EXP$$US-FERRINGPH-2024FE01853$FERRING$$42$YR$$F$Y$68.027$KG$20240710$$CN$US$US
240744121$24074412$1$I$20240221$20240305$20240710$20240710$EXP$$US-FERRINGPH-2024FE01130$FERRING$$11$YR$$M$Y$29.5$KG$20240710$$CN$US$US
240744131$24074413$1$I$$20240625$20240710$20240710$PER$$US-TEVA-VS-3213830$TEVA$$$$$F$Y$$$20240710$$CN$US$US
240744141$24074414$1$I$$20240628$20240710$20240710$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI04110$NEUROCRINE BIOSCIENCES$$42$YR$$F$Y$$$20240710$$HP$US$US
240744151$24074415$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA195646$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240710$$MD$US$US
240744161$24074416$1$I$20240601$20240705$20240710$20240710$EXP$$GB-AstraZeneca-2024A154906$ASTRAZENECA$$784$MON$$F$Y$$$20240710$$CN$GB$
240744171$24074417$1$I$20231205$20240702$20240710$20240710$EXP$$FR-AstraZeneca-2024A155949$ASTRAZENECA$$1$MON$$M$Y$3.5$KG$20240710$$MD$FR$
240744181$24074418$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157034$ASTRAZENECA$$70$YR$$M$Y$81$KG$20240710$$HP$FR$
240744191$24074419$1$I$$20240205$20240710$20240710$PER$$US-PFM-2024-00845$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.599$KG$20240710$$CN$US$US
240744201$24074420$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47898$$FDA-CTU$$65$YR$$M$N$$$20240710$N$$US$
240744211$24074421$1$I$$20240206$20240710$20240710$PER$$US-PFM-2024-00848$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.998$KG$20240710$$CN$US$US
240744221$24074422$1$I$$20240207$20240710$20240710$PER$$US-PFM-2024-00849$PIERRE FABRE MEDICAMENT$$$$$F$Y$10$KG$20240710$$HP$US$US
240744231$24074423$1$I$$20240205$20240710$20240710$PER$$US-PFM-2024-00843$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.329$KG$20240710$$CN$US$US
240744241$24074424$1$I$$20240208$20240710$20240710$PER$$US-PFM-2024-00926$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.821$KG$20240710$$CN$US$US
240744251$24074425$1$I$$20240206$20240710$20240710$PER$$US-PFM-2024-00847$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.481$KG$20240710$$CN$US$US
240744261$24074426$1$I$$20240207$20240710$20240710$PER$$US-PFM-2024-00924$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.338$KG$20240710$$CN$US$US
240744271$24074427$1$I$$20240207$20240710$20240710$PER$$US-PFM-2024-00923$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.1$KG$20240710$$CN$US$US
240744281$24074428$1$I$$20240207$20240710$20240710$PER$$US-PFM-2024-00922$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.438$KG$20240710$$CN$US$US
240744291$24074429$1$I$$20240313$20240710$20240710$PER$$US-PFM-2024-00925$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.798$KG$20240710$$CN$US$US
240744301$24074430$1$I$20240126$20240209$20240710$20240710$PER$$US-PFM-2024-00981$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$4.44$KG$20240710$$PH$US$US
240744311$24074431$1$I$20240411$20240703$20240710$20240710$EXP$$CN-FreseniusKabi-FK202410629$FRESENIUS KABI$$71$YR$E$F$Y$$$20240710$$HP$CN$CN
240744321$24074432$1$I$$20240210$20240710$20240710$PER$$US-PFM-2024-00984$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.109$KG$20240710$$CN$US$US
240744331$24074433$1$I$20231128$20240209$20240710$20240710$PER$$US-PFM-2024-00983$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$4.73$KG$20240710$$CN$US$US
240744341$24074434$1$I$$20240209$20240710$20240710$PER$$US-PFM-2024-00982$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.161$KG$20240710$$HP$US$US
240744351$24074435$1$I$$20240212$20240710$20240710$PER$$US-PFM-2024-01023$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.551$KG$20240710$$HP$US$US
240744361$24074436$1$I$20240212$20240214$20240710$20240710$PER$$US-PFM-2024-01051$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$5.58$KG$20240710$$PH$US$US
240744371$24074437$1$I$$20240211$20240710$20240710$PER$$US-PFM-2024-00985$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.2$KG$20240710$$CN$US$US
240744381$24074438$1$I$$20240213$20240710$20240710$PER$$US-PFM-2024-01025$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.209$KG$20240710$$CN$US$US
240744391$24074439$1$I$$20240320$20240710$20240710$PER$$US-PFM-2024-01021$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.098$KG$20240710$$CN$US$US
240744401$24074440$1$I$$20240213$20240710$20240710$PER$$US-PFM-2024-01028$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.989$KG$20240710$$CN$US$US
240744411$24074441$1$I$20240613$20240614$20240710$20240710$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000504$PAREXEL$$$$$$Y$$$20240710$$HP$US$US
240744421$24074442$1$I$$20240625$20240710$20240710$PER$$US-LEADINGPHARMA-US-2024LEASPO00274$LEADING PHARMA$$$$$M$Y$$$20240710$$CN$US$US
240744432$24074443$2$F$$20240719$20240710$20240729$EXP$$GB-TEVA-VS-3216978$TEVA$Buckens G, Mahir G, Bapat A. 58 Antifungal resistance, a hot topic. A case report in co-infection of Mycobacterium avium-intracellulare and chronic cavitary pulmonary aspergillosis. Clin-Infect-Pract 2023; 20 (Suppl. 1) 23 abstr. 58.; Buckens G, Mahir G, Bapat A. 58 Antifungal resistance, a hot topic. A case report in co-infection of Mycobacterium avium-intracellulare and chronic cavitary pulmonary aspergillosis. Clin-Infect-Pract 2023; 20 (Suppl. 1) 23 abstr. 58.$53$YR$$M$Y$$$20240729$$HP$GB$GB
240744441$24074444$1$I$20240614$20240614$20240710$20240710$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000503$PAREXEL$$$$$$Y$$$20240710$$HP$US$US
240744461$24074446$1$I$$20240214$20240710$20240710$PER$$US-PFM-2024-01054$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.549$KG$20240710$$CN$US$US
240744471$24074447$1$I$$20240214$20240710$20240710$PER$$US-PFM-2024-01053$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.161$KG$20240710$$CN$US$US
240744481$24074448$1$I$$20240214$20240710$20240710$PER$$US-PFM-2024-01052$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.1$KG$20240710$$CN$US$US
240744491$24074449$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01057$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$CN$CA$CA
240744501$24074450$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01065$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240710$$MD$CA$CA
240744511$24074451$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01061$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$HP$CA$CA
240744521$24074452$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01060$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$CN$CA$CA
240744531$24074453$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01059$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240710$$CN$CA$CA
240744541$24074454$1$I$$20240305$20240710$20240710$PER$$US-PFM-2024-01055$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.837$KG$20240710$$CN$US$US
240744551$24074455$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01058$PIERRE FABRE MEDICAMENT$$54$YR$$F$Y$$$20240710$$HP$CA$CA
240744561$24074456$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47910$$FDA-CTU$$$$$M$N$$$20240709$N$HP$US$
240744571$24074457$1$I$$20240703$20240710$20240710$PER$$US-ROCHE-3527892$ROCHE$$36$YR$A$F$Y$$$20240710$$HP$US$US
240744581$24074458$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01068$PIERRE FABRE MEDICAMENT$$10$YR$$F$Y$$$20240710$$MD$CA$CA
240744591$24074459$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01074$PIERRE FABRE MEDICAMENT$$45$YR$$F$Y$$$20240710$$MD$CA$CA
240744601$24074460$1$I$$20240214$20240710$20240710$PER$$US-PFM-2024-01092$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.567$KG$20240710$$CN$US$US
240744611$24074461$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01069$PIERRE FABRE MEDICAMENT$$17$YR$$F$Y$$$20240710$$MD$CA$CA
240744621$24074462$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01076$PIERRE FABRE MEDICAMENT$$22$YR$$F$Y$$$20240710$$MD$CA$CA
240744631$24074463$1$I$$20240215$20240710$20240710$PER$$US-PFM-2024-01094$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.896$KG$20240710$$HP$US$US
240744641$24074464$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01075$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240710$$CN$CA$CA
240744651$24074465$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01123$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$CN$CA$CA
240744661$24074466$1$I$$20240216$20240710$20240710$PER$$US-PFM-2024-01162$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.891$KG$20240710$$CN$US$US
240744671$24074467$1$I$20231109$20240219$20240710$20240710$PER$$DE-PFM-2024-01155$PIERRE FABRE MEDICAMENT$$8$MON$$M$Y$9$KG$20240710$$MD$DE$DE
240744681$24074468$1$I$20230701$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005485$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240710$$CN$US$US
240744691$24074469$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA195641$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240710$$CN$US$US
240744701$24074470$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197108$SANOFI AVENTIS$$$$A$F$Y$77.38$KG$20240710$$CN$US$US
240744713$24074471$3$F$20221129$20240701$20240710$20240801$EXP$$FR-JNJFOC-20240712606$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240801$$MD$FR$FR
240744721$24074472$1$I$$20240216$20240710$20240710$PER$$US-PFM-2024-01163$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.42$KG$20240710$$HP$US$US
240744731$24074473$1$I$$20240219$20240710$20240710$PER$$US-PFM-2024-01166$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.868$KG$20240710$$CN$US$US
240744741$24074474$1$I$$20240219$20240710$20240710$PER$$US-PFM-2024-01165$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.299$KG$20240710$$HP$US$US
240744751$24074475$1$I$$20240220$20240710$20240710$PER$$US-PFM-2024-01200$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.399$KG$20240710$$CN$US$US
240744761$24074476$1$I$$20240216$20240710$20240710$PER$$US-PFM-2024-01164$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.889$KG$20240710$$HP$US$US
240744771$24074477$1$I$20240216$20240220$20240710$20240710$PER$$US-PFM-2024-01201$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.12$KG$20240710$$CN$US$US
240744781$24074478$1$I$$20240220$20240710$20240710$PER$$US-PFM-2024-01203$PIERRE FABRE MEDICAMENT$$$$$F$Y$16.195$KG$20240710$$CN$US$US
240744791$24074479$1$I$$20240220$20240710$20240710$PER$$US-PFM-2024-01202$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.358$KG$20240710$$CN$US$US
240744801$24074480$1$I$$20240222$20240710$20240710$PER$$US-PFM-2024-01308$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.209$KG$20240710$$CN$US$US
240744811$24074481$1$I$20240209$20240220$20240710$20240710$PER$$US-PFM-2024-01204$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.23$KG$20240710$$HP$US$US
240744821$24074482$1$I$$20240704$20240710$20240710$EXP$$CA-Orion Corporation ORION PHARMA-24_00030688$ORION$$59$YR$A$F$Y$$$20240710$$MD$CA$
240744831$24074483$1$I$$20240226$20240710$20240710$PER$$US-PFM-2024-01360$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.338$KG$20240710$$CN$US$US
240744841$24074484$1$I$$20240226$20240710$20240710$PER$$US-PFM-2024-01358$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.803$KG$20240710$$CN$US$US
240744851$24074485$1$I$$20240227$20240710$20240710$PER$$US-PFM-2024-01361$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.989$KG$20240710$$CN$US$US
240744861$24074486$1$I$$20240226$20240710$20240710$PER$$US-PFM-2024-01359$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.798$KG$20240710$$CN$US$US
240744871$24074487$1$I$$20240228$20240710$20240710$PER$$US-PFM-2024-01392$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.977$KG$20240710$$CN$US$US
240744891$24074489$1$I$$20240229$20240710$20240710$PER$$US-PFM-2024-01396$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.9$KG$20240710$$CN$US$US
240744901$24074490$1$I$$20240229$20240710$20240710$PER$$US-PFM-2024-01454$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.34$KG$20240710$$HP$US$US
240744911$24074491$1$I$$20240304$20240710$20240710$PER$$FR-PFM-2024-01434$PIERRE FABRE MEDICAMENT$$1$MON$$M$Y$4$KG$20240710$$CN$FR$FR
240744921$24074492$1$I$$20240304$20240710$20240710$PER$$FR-PFM-2024-01445$PIERRE FABRE MEDICAMENT$$4$MON$$M$Y$$$20240710$$CN$FR$FR
240744931$24074493$1$I$$20240304$20240710$20240710$PER$$FR-PFM-2024-01447$PIERRE FABRE MEDICAMENT$$8$MON$$M$Y$$$20240710$$CN$FR$FR
240744941$24074494$1$I$$20240229$20240710$20240710$PER$$US-PFM-2024-01394$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.698$KG$20240710$$HP$US$US
240744951$24074495$1$I$$20240229$20240710$20240710$PER$$US-PFM-2024-01395$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.397$KG$20240710$$HP$US$US
240744961$24074496$1$I$$20240206$20240710$20240710$PER$$US-PFM-2024-00846$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.68$KG$20240710$$CN$US$US
240744971$24074497$1$I$$20240301$20240710$20240710$PER$$US-PFM-2024-01480$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.874$KG$20240710$$HP$US$US
240744981$24074498$1$I$$20240301$20240710$20240710$PER$$US-PFM-2024-01482$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.959$KG$20240710$$CN$US$US
240744991$24074499$1$I$$20240301$20240710$20240710$PER$$US-PFM-2024-01485$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.533$KG$20240710$$CN$US$US
240745001$24074500$1$I$$20240301$20240710$20240710$PER$$US-PFM-2024-01487$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.261$KG$20240710$$CN$US$US
240745011$24074501$1$I$$20240227$20240710$20240710$PER$$MX-PFM-2024-01424$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$MD$MX$MX
240745021$24074502$1$I$$20240304$20240710$20240710$PER$$US-PFM-2024-01515$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.163$KG$20240710$$CN$US$US
240745031$24074503$1$I$$20240701$20240710$20240710$PER$$US-TEVA-VS-3217471$TEVA$$54$YR$$F$Y$$$20240710$$CN$US$US
240745041$24074504$1$I$20240218$20240305$20240710$20240710$PER$$FR-PFM-2024-01500$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$4.5$KG$20240710$$MD$FR$FR
240745051$24074505$1$I$$20240305$20240710$20240710$PER$$US-PFM-2024-01516$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.709$KG$20240710$$HP$US$US
240745061$24074506$1$I$$20240327$20240710$20240710$PER$$US-PFM-2024-01027$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.58$KG$20240710$$CN$US$US
240745071$24074507$1$I$$20240410$20240710$20240710$PER$$US-PFM-2024-01306$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.497$KG$20240710$$CN$US$US
240745081$24074508$1$I$$20240417$20240710$20240710$PER$$US-PFM-2024-01457$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.42$KG$20240710$$CN$US$US
240745091$24074509$1$I$$20240416$20240710$20240710$PER$$US-PFM-2024-01219$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.719$KG$20240710$$CN$US$US
240745101$24074510$1$I$$20240611$20240710$20240710$PER$$US-PFM-2024-01050$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.719$KG$20240710$$CN$US$US
240745111$24074511$1$I$$20240618$20240710$20240710$PER$$US-PFM-2024-01024$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.57$KG$20240710$$CN$US$US
240745121$24074512$1$I$$20240425$20240710$20240710$PER$$US-PFM-2024-01096$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.308$KG$20240710$$HP$US$US
240745131$24074513$1$I$$20240430$20240710$20240710$PER$$US-PFM-2024-01093$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.499$KG$20240710$$CN$US$US
240745141$24074514$1$I$20240413$20240705$20240710$20240710$EXP$SE-SEMPA-2024-003624$SE-AMGEN-SWESP2024134313$AMGEN$$61$YR$A$F$Y$$$20240710$$PH$SE$SE
240745151$24074515$1$I$$20240624$20240710$20240710$PER$$US-PFM-2024-01307$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.16$KG$20240710$$CN$US$US
240745162$24074516$2$F$$20240704$20240710$20240826$EXP$$CA-BAYER-2024A097726$BAYER$$$$$M$Y$176$KG$20240826$$HP$CA$CA
240745175$24074517$5$F$20240701$20240913$20240710$20240919$30DAY$$US-PFIZER INC-202400208965$PFIZER$$19$YR$$M$Y$$$20240919$$CN$US$US
240745184$24074518$4$F$$20240904$20240710$20240906$30DAY$$US-PFIZER INC-202400207987$PFIZER$$18$YR$$M$Y$73.03$KG$20240906$$CN$US$US
240745221$24074522$1$I$$20240703$20240710$20240710$EXP$$BE-VIIV HEALTHCARE LIMITED-BE2024EME083613$VIIV$$$$$$Y$$$20240710$$PH$BE$BE
240745231$24074523$1$I$$20240709$20240710$20240710$EXP$GB-MHRA-MED-202407082013362770-TYVSG$GB-GSK-GB2024084675$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$GB$GB
240745242$24074524$2$F$20240327$20240707$20240710$20240807$EXP$$NVSC2024AU077306$NOVARTIS$$66$YR$$F$Y$$$20240807$$CN$AU$AU
240745251$24074525$1$I$20240601$20240701$20240710$20240710$PER$$US-SA-2024SA197054$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240710$$MD$US$US
240745261$24074526$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198005$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240710$$MD$US$US
240745271$24074527$1$I$20240101$20240627$20240710$20240710$PER$$US-SA-2024SA194410$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240710$$CN$US$US
240745281$24074528$1$I$20240101$20240627$20240710$20240710$PER$$US-SA-2024SA194400$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240710$$MD$US$US
240745291$24074529$1$I$$20240212$20240710$20240710$PER$$NL-PFM-2024-01001$PIERRE FABRE MEDICAMENT$Willems JIA, Twist DJLV, Peeters RP, Mostard GJM, Wijngaarden RFATLV. Stress-Induced Graves Disease: Spontaneous Recovery  After Stress Relief. Journal of the Endocrine Society. 2024;8:1-4$67$YR$$F$Y$$$20240710$$MD$NL$NL
240745301$24074530$1$I$$20240212$20240710$20240710$PER$$NL-PFM-2024-01000$PIERRE FABRE MEDICAMENT$Willems J, Twist Daan, Peeters R, Mostard G, Wijngaarden R. Stress-Induced Graves Disease: Spontaneous Recovery After Stress Relief. Journal of the Endocrine Society. 2024;8:1-4$48$YR$$F$Y$$$20240710$$MD$NL$NL
240745311$24074531$1$I$$20240212$20240710$20240710$PER$$ES-PFM-2024-01041$PIERRE FABRE MEDICAMENT$Torres JA, Llamas-Velasco S, Martin CS, Guerrero AM. Postural tremor and sexual chromosome aneuploidies: case report and review of literature. International Journal of Neuroscience. 2024;1-7$18$YR$$M$Y$$$20240710$$HP$ES$ES
240745321$24074532$1$I$$20240215$20240710$20240710$PER$$CA-PFM-2024-01125$PIERRE FABRE MEDICAMENT$$66$YR$$F$Y$$$20240710$$CN$CA$CA
240745331$24074533$1$I$$20240215$20240710$20240710$PER$$US-PFM-2024-01042$PIERRE FABRE MEDICAMENT$Davis JL, Kurek JA, Morgan JC, Sethi KD. Tremor and Dystonia in Jacob^s Syndrome (47,XYY). MOVEMENT DISORDERS CLINICAL PRACTICE. 2020;7(1):107-8$61$YR$$M$Y$$$20240710$$HP$US$US
240745341$24074534$1$I$$20240219$20240710$20240710$PER$$ES-PFM-2024-01212$PIERRE FABRE MEDICAMENT$Sendra MC, Gonzalez JDB, Palacios JMS, Millan IV, Solana ME, Martin MDT. Nadolol for Infantile Hemangiomas Previously Treated with Propranolol. Actas Dermo-Sifiliogr?ficas. 2024;115:215-17$4$MON$$F$Y$$$20240710$$HP$ES$ES
240745351$24074535$1$I$$20240219$20240710$20240710$PER$$ES-PFM-2024-01216$PIERRE FABRE MEDICAMENT$Sendra MC, Gonzalez JDB, Palacios JMS, Millan IV, Solana ME, Martin MDT. Nadolol for Infantile Hemangiomas Previously Treated with Propranolol. Actas Dermo-Sifiliogr?ficas. 2024;115:215-17$3$MON$$F$Y$$$20240710$$HP$ES$ES
240745361$24074536$1$I$$20240219$20240710$20240710$PER$$ES-PFM-2024-01214$PIERRE FABRE MEDICAMENT$Sendra MC, Gonzalez J, Palacios JMS, Millan IV, Solana ME, Martin MDT. Nadolol for Infantile Hemangiomas Previously Treated with Propranolol. Actas Dermo-Sifiliogr?ficas. 2024;115:215-17$$$$F$Y$$$20240710$$HP$ES$ES
240745371$24074537$1$I$$20240207$20240710$20240710$PER$$BE-PFM-2024-00860$PIERRE FABRE MEDICAMENT$Wuyts SCM, Cappelle CAH, Verhaert M, Bravenboer B, Aspeslagh S. Immunosuppressive therapy management in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors: A case series and systematic literature review. Journal of Oncology Pharmacy Practice. 2024;30(1):55-66$55$YR$$F$Y$$$20240710$$HP$BE$BE
240745381$24074538$1$I$$20240219$20240710$20240710$PER$$ES-PFM-2024-01211$PIERRE FABRE MEDICAMENT$Sendra MC, Gonzalez J, Palacios JMS, Millan IV, Solana ME, Martin MDT. Nadolol for Infantile Hemangiomas Previously Treated with Propranolol. Actas Dermo-Sifiliogr?ficas. 2024;115:215-17$5$MON$$F$Y$$$20240710$$HP$ES$ES
240745391$24074539$1$I$$20240219$20240710$20240710$PER$$ES-PFM-2024-01215$PIERRE FABRE MEDICAMENT$Sendra MC, Gonzalez J, Palacios JMS, Millan IV, Solana ME, Martin MDT. Nadolol for Infantile Hemangiomas Previously Treated with Propranolol. Actas Dermo-Sifiliogr?ficas. 2024;115:215-17$2$MON$$F$Y$$$20240710$$HP$ES$ES
240745401$24074540$1$I$$20240219$20240710$20240710$PER$$ES-PFM-2024-01213$PIERRE FABRE MEDICAMENT$Sendra MC, Gonzalez J, Palacios JMS, Millan IV, Solana ME, Martin MDT. Nadolol for Infantile Hemangiomas Previously Treated with Propranolol. Actas Dermo-Sifiliogr?ficas. 2024;115:215-17$1$MON$$F$Y$$$20240710$$HP$ES$ES
240745411$24074541$1$I$$20240226$20240710$20240710$PER$$JP-PFM-2024-01350$PIERRE FABRE MEDICAMENT$Teshigawara A, Nishibe S, Horie S, Hakone M, Yamaji Y, Akasawa A et al. Fentanyl-associated anaphylaxis in an infant with tetralogy of Fallot: a case report. JA Clinical Reports. 2019;5:34$$$I$M$Y$$$20240710$$HP$JP$JP
240745421$24074542$1$I$$20240219$20240710$20240710$PER$$TR-PFM-2024-01180$PIERRE FABRE MEDICAMENT$Agyun B, Ustun NSG. Hematohydrosis and ocd in a male pediatric patient. Psychiatria Danubina. 2023;35:136-140$9$YR$$M$Y$$$20240710$$HP$TR$TR
240745431$24074543$1$I$$20240302$20240710$20240710$PER$$CH-PFM-2024-01486$PIERRE FABRE MEDICAMENT$Jurisic S, Medeiros-Domingo A, Berger F, Balmer C, Brunckhorst C, Ruschitzka F et al. Catecholaminergic Polymorphic Ventricular Tachycardia: Multiple Clinical Presentations of a Genetically Determined Disease. Journal of clinical medicine. 2024;13$22$YR$$M$Y$$$20240710$$HP$CH$CH
240745441$24074544$1$I$20210204$20240306$20240710$20240710$PER$$JP-PFM-2024-00941$PIERRE FABRE MEDICAMENT$Mitamura S et al. Propranolol Treatment for Facial Infantile Hemangiomas in Low-Birth-Weight Infants: Two Case Reports. Japanese Journal of Plastic Surgery. 2023;66(11):1336-45$43$DY$$M$Y$1.12$KG$20240710$$MD$JP$JP
240745451$24074545$1$I$$20240312$20240710$20240710$PER$$CH-PFM-2024-01479$PIERRE FABRE MEDICAMENT$Jurisic S, Domingo AM, Berger F, Balmer C, Brunckhorst C, Ruschitzka F et al. Catecholaminergic Polymorphic Ventricular Tachycardia: Multiple Clinical Presentations of a Genetically Determined Disease. Journal of clinical medicine. 2024;13(1):47$24$YR$$M$Y$$$20240710$$MD$CH$CH
240745461$24074546$1$I$20211013$20240306$20240710$20240710$PER$$JP-PFM-2024-00939$PIERRE FABRE MEDICAMENT$Mitamura S et al. Propranolol Treatment for Facial Infantile Hemangiomas in Low-Birth-Weight Infants: Two Case Reports. Japanese Journal of Plastic Surgery. 2023;66(11):1336-45$56$DY$$M$Y$2.15$KG$20240710$$MD$JP$JP
240745471$24074547$1$I$$20240304$20240710$20240710$PER$$TR-PFM-2024-01471$PIERRE FABRE MEDICAMENT$Yilmaz N, Kaypakl O, Acarturk H, Kartal S. Inappropriate sinus tachycardia in a child with wolf parkinson white syndrome after successful radiofrequency ablation treatment. Cardiology. 432$7$YR$$M$Y$$$20240710$$HP$TR$TR
240745484$24074548$4$F$$20240925$20240710$20240927$30DAY$$US-PFIZER INC-202400208790$PFIZER$$8$YR$$F$Y$$$20240927$$CN$US$US
240745491$24074549$1$I$20240625$20240626$20240710$20240710$PER$$US-TEVA-VS-3214881$TEVA$$65$YR$$F$Y$$$20240710$$CN$US$US
240745501$24074550$1$I$$20240104$20240710$20240710$PER$$US-PFM-2024-00119$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.957$KG$20240710$$CN$US$US
240745511$24074551$1$I$20230101$20240506$20240710$20240710$PER$$CA-PFM-2024-01124$PIERRE FABRE MEDICAMENT$$17$YR$$F$Y$$$20240710$$CN$CA$CA
240745521$24074552$1$I$20231005$20240104$20240710$20240710$PER$$US-PFM-2024-00102$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240710$$PH$US$US
240745531$24074553$1$I$20240104$20240105$20240710$20240710$PER$$US-PFM-2024-00106$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240710$$HP$US$US
240745541$24074554$1$I$$20240108$20240710$20240710$PER$$US-PFM-2024-00149$PIERRE FABRE MEDICAMENT$$$$$F$Y$14.998$KG$20240710$$CN$US$US
240745551$24074555$1$I$$20240108$20240710$20240710$PER$$US-PFM-2024-00150$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.07$KG$20240710$$CN$US$US
240745561$24074556$1$I$$20240103$20240710$20240710$PER$$US-PFM-2024-00104$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.098$KG$20240710$$CN$US$US
240745571$24074557$1$I$$20240109$20240710$20240710$PER$$US-PFM-2024-00152$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.995$KG$20240710$$CN$US$US
240745581$24074558$1$I$$20240109$20240710$20240710$PER$$US-PFM-2024-00186$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.721$KG$20240710$$HP$US$US
240745591$24074559$1$I$20230825$20240109$20240710$20240710$PER$$US-PFM-2024-00184$PIERRE FABRE MEDICAMENT$$1$YR$$M$Y$10.739$KG$20240710$$CN$US$US
240745601$24074560$1$I$$20240109$20240710$20240710$PER$$US-PFM-2024-00153$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.907$KG$20240710$$CN$US$US
240745611$24074561$1$I$$20240110$20240710$20240710$PER$$US-PFM-2024-00218$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.909$KG$20240710$$CN$US$US
240745621$24074562$1$I$$20240110$20240710$20240710$PER$$US-PFM-2024-00188$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.22$KG$20240710$$CN$US$US
240745631$24074563$1$I$$20240110$20240710$20240710$PER$$US-PFM-2024-00187$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.256$KG$20240710$$CN$US$US
240745641$24074564$1$I$$20240110$20240710$20240710$PER$$US-PFM-2024-00185$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.256$KG$20240710$$CN$US$US
240745651$24074565$1$I$$20240117$20240710$20240710$PER$$CA-PFM-2024-00359$PIERRE FABRE MEDICAMENT$$54$YR$$F$Y$$$20240710$$CN$CA$CA
240745661$24074566$1$I$$20240625$20240710$20240710$PER$$US-PFM-2024-00103$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$HP$US$US
240745671$24074567$1$I$$20240117$20240710$20240710$PER$$CA-PFM-2024-00361$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$CN$CA$CA
240745681$24074568$1$I$$20240404$20240710$20240710$PER$$US-PFM-2024-00154$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.66$KG$20240710$$CN$US$US
240745691$24074569$1$I$$20240207$20240710$20240710$PER$$US-PFM-2024-00107$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.639$KG$20240710$$CN$US$US
240745711$24074571$1$I$20230214$20240129$20240710$20240710$PER$IT-MINISAL02-966963$IT-PFM-2024-00570$PIERRE FABRE MEDICAMENT$$60$YR$$F$Y$$$20240710$$MD$IT$IT
240745721$24074572$1$I$$20240111$20240710$20240710$PER$$US-PFM-2024-00220$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.889$KG$20240710$$CN$US$US
240745731$24074573$1$I$$20240111$20240710$20240710$PER$$US-PFM-2024-00219$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.728$KG$20240710$$CN$US$US
240745741$24074574$1$I$$20240115$20240710$20240710$PER$$US-PFM-2024-00323$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.138$KG$20240710$$CN$US$US
240745751$24074575$1$I$$20240111$20240710$20240710$PER$$US-PFM-2024-00221$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.488$KG$20240710$$CN$US$US
240745761$24074576$1$I$$20240201$20240710$20240710$PER$$JP-PFM-2024-00301$PIERRE FABRE MEDICAMENT$$4$MON$$F$Y$$$20240710$$PH$JP$JP
240745771$24074577$1$I$$20240320$20240710$20240710$PER$$US-PFM-2024-00322$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.13$KG$20240710$$CN$US$US
240745781$24074578$1$I$$20240321$20240710$20240710$PER$$US-PFM-2024-00298$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.885$KG$20240710$$CN$US$US
240745791$24074579$1$I$20231101$20240701$20240710$20240710$EXP$DE-EMBRYOTOX-202303590$DE-TORRENT-00026959$TORRENT$$$$$M$Y$2$KG$20240710$$MD$DE$DE
240745801$24074580$1$I$20240111$20240115$20240710$20240710$PER$$US-PFM-2024-00325$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.1$KG$20240710$$PH$US$US
240745811$24074581$1$I$20231207$20240115$20240710$20240710$PER$$US-PFM-2024-00324$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$9.07$KG$20240710$$CN$US$US
240745821$24074582$1$I$$20240115$20240710$20240710$PER$$US-PFM-2024-00327$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.617$KG$20240710$$CN$US$US
240745831$24074583$1$I$20240531$20240630$20240710$20240710$EXP$GB-MHRA-MED-202406301749069030-FDMTJ$GB-TORRENT-00036973$TORRENT$$59$YR$A$M$Y$76$KG$20240710$$CN$GB$GB
240745841$24074584$1$I$$20240701$20240710$20240710$EXP$GB-MHRA-MED-202406281336531360-CFMRD$GB-TORRENT-00036979$TORRENT$$$$$F$Y$$$20240710$$CN$GB$GB
240745851$24074585$1$I$$20240116$20240710$20240710$PER$$US-PFM-2024-00329$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.698$KG$20240710$$CN$US$US
240745861$24074586$1$I$$20240116$20240710$20240710$PER$$US-PFM-2024-00331$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.297$KG$20240710$$CN$US$US
240745871$24074587$1$I$$20240115$20240710$20240710$PER$$US-PFM-2024-00328$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.061$KG$20240710$$CN$US$US
240745885$24074588$5$F$$20240805$20240710$20240809$EXP$$US-TORRENT-00013665$TORRENT$$85$YR$E$F$Y$54$KG$20240809$$PH$US$US
240745891$24074589$1$I$$20240117$20240710$20240710$PER$$CA-PFM-2024-00360$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240710$$MD$CA$CA
240745901$24074590$1$I$$20240117$20240710$20240710$PER$$US-PFM-2024-00373$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.798$KG$20240710$$CN$US$US
240745911$24074591$1$I$$20240117$20240710$20240710$PER$$US-PFM-2024-00372$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.619$KG$20240710$$CN$US$US
240745921$24074592$1$I$$20240118$20240710$20240710$PER$$US-PFM-2024-00374$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$MD$US$US
240745931$24074593$1$I$$20240119$20240710$20240710$PER$$US-PFM-2024-00416$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.27$KG$20240710$$CN$US$US
240745941$24074594$1$I$20240107$20240119$20240710$20240710$PER$$US-PFM-2024-00326$PIERRE FABRE MEDICAMENT$$0$YR$$$Y$2.9$KG$20240710$$HP$US$US
240745951$24074595$1$I$$20240617$20240710$20240710$PER$$US-PFM-2024-00330$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.426$KG$20240710$$CN$US$US
240745961$24074596$1$I$$20240702$20240710$20240710$EXP$$VN-AstraZeneca-2024A155447$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$VN$
240745983$24074598$3$F$20240701$20240724$20240710$20240730$PER$$US-AMGEN-USASP2024135835$AMGEN$$74$YR$E$F$Y$$$20240730$$CN$US$US
240745992$24074599$2$F$$20240722$20240710$20240724$EXP$GB-MHRA-MED-202405151353006080-KDBHY$GB-SANDOZ INC.-SDZ2024GB064106$SANDOZ$$93$YR$$M$Y$$$20240724$$MD$GB$GB
240746001$24074600$1$I$$20240709$20240710$20240710$PER$$US-JNJFOC-20240722913$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240710$$MD$US$US
240746011$24074601$1$I$$20240116$20240710$20240710$PER$$JP-PFM-2024-00450$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$MD$JP$JP
240746021$24074602$1$I$$20240122$20240710$20240710$PER$$US-PFM-2024-00455$PIERRE FABRE MEDICAMENT$$$$$F$Y$2.205$KG$20240710$$CN$US$US
240746031$24074603$1$I$$20240702$20240710$20240710$EXP$$CA-JNJFOC-20240715099$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$HP$CA$CA
240746041$24074604$1$I$20240118$20240118$20240710$20240710$PER$$JP-PFM-2024-00498$PIERRE FABRE MEDICAMENT$$4$YR$$$Y$$$20240710$$MD$JP$JP
240746051$24074605$1$I$$20240122$20240710$20240710$PER$$US-PFM-2024-00456$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.968$KG$20240710$$CN$US$US
240746061$24074606$1$I$$20240122$20240710$20240710$PER$$US-PFM-2024-00457$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.937$KG$20240710$$CN$US$US
240746071$24074607$1$I$$20240122$20240710$20240710$PER$$US-PFM-2024-00516$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.501$KG$20240710$$HP$US$US
240746081$24074608$1$I$$20240123$20240710$20240710$PER$$US-PFM-2024-00520$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$HP$US$US
240746091$24074609$1$I$$20240123$20240710$20240710$PER$$US-PFM-2024-00517$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.429$KG$20240710$$HP$US$US
240746101$24074610$1$I$$20240220$20240710$20240710$PER$$US-PFM-2024-00519$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.32$KG$20240710$$CN$US$US
240746111$24074611$1$I$$20240501$20240710$20240710$PER$$US-PFM-2024-00518$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.36$KG$20240710$$CN$US$US
240746121$24074612$1$I$$20240124$20240710$20240710$PER$$US-PFM-2024-00523$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240710$$CN$US$US
240746141$24074614$1$I$20240119$20240123$20240710$20240710$PER$$US-PFM-2024-00521$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.617$KG$20240710$$CN$US$US
240746151$24074615$1$I$$20240124$20240710$20240710$PER$$US-PFM-2024-00524$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.22$KG$20240710$$CN$US$US
240746161$24074616$1$I$$20240123$20240710$20240710$PER$$US-PFM-2024-00522$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.408$KG$20240710$$CN$US$US
240746171$24074617$1$I$$20240125$20240710$20240710$PER$$US-PFM-2024-00525$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.091$KG$20240710$$CN$US$US
240746181$24074618$1$I$$20240125$20240710$20240710$PER$$US-PFM-2024-00526$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$HP$US$US
240746191$24074619$1$I$$20240125$20240710$20240710$PER$$US-PFM-2024-00527$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.558$KG$20240710$$CN$US$US
240746201$24074620$1$I$20240706$20240708$20240710$20240710$EXP$$CN-TAKEDA-2024TUS069774$TAKEDA$$77$YR$$M$Y$$$20240710$$HP$CN$CN
240746211$24074621$1$I$$20240126$20240710$20240710$PER$$US-PFM-2024-00528$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.737$KG$20240710$$CN$US$US
240746221$24074622$1$I$$20240126$20240710$20240710$PER$$US-PFM-2024-00560$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.077$KG$20240710$$CN$US$US
240746231$24074623$1$I$$20240126$20240710$20240710$PER$$US-PFM-2024-00561$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.399$KG$20240710$$HP$US$US
240746241$24074624$1$I$$20240628$20240710$20240710$EXP$$CA-TEVA-VS-3218297$TEVA$$6$YR$$M$Y$$$20240710$$HP$CA$CA
240746251$24074625$1$I$$20240130$20240710$20240710$PER$$US-PFM-2024-00646$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.794$KG$20240710$$CN$US$US
240746261$24074626$1$I$$20240124$20240710$20240710$PER$$US-PFM-2024-00593$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.803$KG$20240710$$CN$US$US
240746271$24074627$1$I$20240529$20240626$20240710$20240710$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000562$PAREXEL$$$$$$Y$$$20240710$$HP$CN$CN
240746281$24074628$1$I$$20240129$20240710$20240710$PER$$US-PFM-2024-00645$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.88$KG$20240710$$CN$US$US
240746291$24074629$1$I$20240105$20240131$20240710$20240710$PER$$US-PFM-2024-00647$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.1$KG$20240710$$PH$US$US
240746301$24074630$1$I$$20240131$20240710$20240710$PER$$US-PFM-2024-00649$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.1$KG$20240710$$HP$US$US
240746311$24074631$1$I$20240119$20240131$20240710$20240710$PER$$US-PFM-2024-00650$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$5.9$KG$20240710$$PH$US$US
240746321$24074632$1$I$$20240201$20240710$20240710$PER$$US-PFM-2024-00690$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.016$KG$20240710$$CN$US$US
240746331$24074633$1$I$$20240129$20240710$20240710$PER$$US-PFM-2024-00644$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.918$KG$20240710$$HP$US$US
240746341$24074634$1$I$20240120$20240131$20240710$20240710$PER$$US-PFM-2024-00648$PIERRE FABRE MEDICAMENT$$1$YR$$M$Y$9.75$KG$20240710$$PH$US$US
240746351$24074635$1$I$$20240201$20240710$20240710$PER$$US-PFM-2024-00689$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.721$KG$20240710$$CN$US$US
240746361$24074636$1$I$$20240708$20240710$20240710$PER$$NVSC2024US142712$NOVARTIS$$60$YR$$F$Y$$$20240710$$HP$US$US
240746371$24074637$1$I$$20240129$20240710$20240710$PER$$JP-PFM-2024-00729$PIERRE FABRE MEDICAMENT$$3$YR$$$Y$$$20240710$$PH$JP$JP
240746381$24074638$1$I$20240708$20240709$20240710$20240710$EXP$$US-KYOWAKIRIN-2024KK016526$KYOWA$$$$$$Y$$$20240710$$HP$US$US
240746391$24074639$1$I$$20240202$20240710$20240710$PER$$US-PFM-2024-00794$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.9$KG$20240710$$CN$US$US
240746401$24074640$1$I$20240709$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136544$AMGEN$$69$YR$E$M$Y$$$20240710$$CN$US$US
240746411$24074641$1$I$$20240703$20240710$20240710$EXP$$IT-AMGEN-ITASP2024133211$AMGEN$Alberici F.; Salvarani C.; Morales E. et al.. Safety and effectiveness of avacopan beyond 52 weeks: experience to date in the Early Access Program (EAP). Nephrology Dialysis Transplantation. 2024;39:i2019-i2020$$$$$Y$$$20240710$$HP$IT$IT
240746421$24074642$1$I$20240708$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136675$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240746431$24074643$1$I$$20240202$20240710$20240710$PER$$US-PFM-2024-00791$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.397$KG$20240710$$HP$US$US
240746441$24074644$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133821$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$76$YR$E$M$Y$$$20240710$$HP$US$US
240746451$24074645$1$I$$20240202$20240710$20240710$PER$$US-PFM-2024-00793$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.701$KG$20240710$$HP$US$US
240746461$24074646$1$I$20240120$20240201$20240710$20240710$PER$$BG-PFM-2024-00746$PIERRE FABRE MEDICAMENT$$13$MON$$M$Y$7.7$KG$20240710$$MD$BG$BG
240746471$24074647$1$I$$20240202$20240710$20240710$PER$$US-PFM-2024-00792$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.018$KG$20240710$$HP$US$US
240746481$24074648$1$I$$20240205$20240710$20240710$PER$$US-PFM-2024-00797$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.098$KG$20240710$$CN$US$US
240746491$24074649$1$I$$20240205$20240710$20240710$PER$$US-PFM-2024-00798$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.497$KG$20240710$$HP$US$US
240746501$24074650$1$I$$20240217$20240710$20240710$PER$$US-PFM-2024-00795$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.989$KG$20240710$$CN$US$US
240746511$24074651$1$I$20231214$20240313$20240710$20240710$PER$$JP-PFM-2024-00728$PIERRE FABRE MEDICAMENT$$2$MON$$M$Y$6.19$KG$20240710$$MD$JP$JP
240746521$24074652$1$I$$20240708$20240710$20240710$PER$$US-JNJFOC-20240719462$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$MD$US$US
240746532$24074653$2$F$$20240919$20240710$20240926$EXP$$CA-GSK-CA2024021098$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CA$CA
240746541$24074654$1$I$$20240108$20240710$20240710$PER$$US-PFM-2024-00137$PIERRE FABRE MEDICAMENT$Zeman J, Pettinato AM, Ladha FA, Lico I, Crespo EM, Givertz MM. Recurrent premature ventricular complex-triggered idiopathic polymorphic ventricular arrhythmias in a patient with a structurally normal heart. Heart Rhythm Case Reports. 2023;9:888-92$31$YR$$M$Y$$$20240710$$HP$US$US
240746551$24074655$1$I$$20240105$20240710$20240710$PER$$TR-PFM-2024-00143$PIERRE FABRE MEDICAMENT$Yuksek T, Kartal SP, Onder E. Lichenoid Drug Eruption Induced By  COVID-19 mRNA Vaccine. Journal Of The Turkish Academy Of Dermatology. 2023;17(4):106-8)$57$YR$$M$Y$$$20240710$$MD$TR$TR
240746561$24074656$1$I$$20240108$20240710$20240710$PER$$FR-PFM-2024-00133$PIERRE FABRE MEDICAMENT$Piarroux J, Dimopoulou E, Taieb G, Souvannanorath S, Roze E, Lion-Fran?ois L et al. Clinical and Electrophysiological Characterization of Essential Tremor in 18 Children and Adolescents. Tremor and Other Hyperkinetic Movements. 2023;13(1): 46:1-14$$$$$Y$$$20240710$$HP$FR$FR
240746571$24074657$1$I$$20240108$20240710$20240710$PER$$FR-PFM-2024-00128$PIERRE FABRE MEDICAMENT$Piarroux J, Dimopoulou E, Taieb G, Souvannanorath S, Roze E, Lion-Fran?ois L et al. Clinical and Electrophysiological Characterization of Essential Tremor in 18 Children and Adolescents. Tremor and Other Hyperkinetic Movements. 2023;13(1): 46:1-14$$$$M$Y$$$20240710$$HP$FR$FR
240746581$24074658$1$I$$20240108$20240710$20240710$PER$$FR-PFM-2024-00132$PIERRE FABRE MEDICAMENT$Piarroux J, Dimopoulou E, Taieb G, Souvannanorath S, Roze E, Lion-Fran?ois L et al. Clinical and Electrophysiological Characterization of Essential Tremor in 18 Children and Adolescents. Tremor and Other Hyperkinetic Movements. 2023;13(1): 46:1-14$$$$$Y$$$20240710$$HP$FR$FR
240746591$24074659$1$I$$20240108$20240710$20240710$PER$$FR-PFM-2024-00130$PIERRE FABRE MEDICAMENT$Piarroux J, Dimopoulou E, Taieb G, Souvannanorath S, Roze E, Lion-Fran?ois L et al. Clinical and Electrophysiological Characterization of Essential Tremor in 18 Children and Adolescents. Tremor and Other Hyperkinetic Movements. 2023;13(1): 46:1-14$$$$$Y$$$20240710$$HP$FR$FR
240746601$24074660$1$I$$20240108$20240710$20240710$PER$$FR-PFM-2024-00129$PIERRE FABRE MEDICAMENT$Piarroux J, Dimopoulou E, Taieb G, Souvannanorath S, Roze E, Lion-Fran?ois L et al. Clinical and Electrophysiological Characterization of Essential Tremor in 18 Children and Adolescents. Tremor and Other Hyperkinetic Movements. 2023;13(1): 46:1-14$$$$$Y$$$20240710$$HP$FR$FR
240746611$24074661$1$I$$20240115$20240710$20240710$PER$$US-PFM-2024-00307$PIERRE FABRE MEDICAMENT$Sebastian WP, Parisa A, Pandy M, Anees A. Graves^ Disease Exacerbation with Impending Thyroid Storm After SARS-CoV-2 Infection: A Case Report. Am J Case Rep. 2024;25:e941311:1-4$42$YR$$F$Y$$$20240710$$HP$US$US
240746621$24074662$1$I$$20240108$20240710$20240710$PER$$FR-PFM-2024-00131$PIERRE FABRE MEDICAMENT$Piarroux J, Dimopoulou E, Taieb G, Souvannanorath S, Roze E, Lion-Fran?ois L et al. Clinical and Electrophysiological Characterization of Essential Tremor in 18 Children and Adolescents. Tremor and Other Hyperkinetic Movements. 2023;13(1): 46:1-14$$$$$Y$$$20240710$$HP$FR$FR
240746631$24074663$1$I$$20240119$20240710$20240710$PER$$CH-PFM-2024-00398$PIERRE FABRE MEDICAMENT$Fleury V, Romascano D, Schneider D, Tuleasca C, Lorton O, Chaoui ET et al. Successful MRI-Guided Focused Ultrasound Thalamotomy after Ipsilateral Gamma Knife Radiosurgery for Essential Tremor: A Case Report with Video. Stereotact Funct Neurosurg. 2023;101:380-6$$$A$F$Y$$$20240710$$HP$CH$CH
240746641$24074664$1$I$$20240131$20240710$20240710$PER$$JP-PFM-2024-00841$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240710$$PH$JP$JP
240746651$24074665$1$I$$20240122$20240710$20240710$PER$$ES-PFM-2024-00475$PIERRE FABRE MEDICAMENT$Gomez-Peralta F, Velasco-Martinez P, Abreu C, Cepeda M, Fernandez-Puente M. Hepatotoxicity in hyperthyroid patient after consecutive methimazole and propylthiouracil therapies. Endocrinol Diabetes Metab Case Rep. 2018;18$55$YR$$F$Y$$$20240710$$HP$ES$ES
240746661$24074666$1$I$20240202$20240205$20240710$20240710$PER$$US-PFM-2024-00801$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$5.2$KG$20240710$$PH$US$US
240746671$24074667$1$I$$20240205$20240710$20240710$PER$$US-PFM-2024-00802$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.9$KG$20240710$$CN$US$US
240746681$24074668$1$I$$20240207$20240710$20240710$PER$$US-PFM-2024-00805$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.9$KG$20240710$$CN$US$US
240746691$24074669$1$I$$20240209$20240710$20240710$PER$$IT-PFM-2024-00586$PIERRE FABRE MEDICAMENT$Compagnone M, Marinelli A, Dall^Ara G, Ziacchi M, Grotti S, Ciurlanti L et al. Prolactin Inhibition to Treat Postpartum Arrhythmic Storm. JACC : C ASE REPORTS. 2024;29:1-4$36$YR$$F$Y$$$20240710$$MD$IT$IT
240746701$24074670$1$I$$20240219$20240710$20240710$PER$$RO-PFM-2024-00212$PIERRE FABRE MEDICAMENT$Popa A, Sufana C, Pantelemon C, Kiss E, Cismaru G, Man O et al. An electrical storm hook the brain and the heart of a new born baby-case presentation. MEDICINE AND PHARMACY REPORTS. 2023;96(1):S33$4$DY$$$Y$3.89$KG$20240710$$HP$RO$RO
240746721$24074672$1$I$$20240105$20240710$20240710$PER$$US-PFM-2024-00810$PIERRE FABRE MEDICAMENT$Alzghoul H, Kadri F, Ismail MF, Youssef R, Shamaileh M, Al-Assi AR et al. Paraneoplastic NMDA encephalitis, a case report and an extensive review of available literature. Radiology Case Reports. 2024;19:1371-85$20$YR$$F$Y$$$20240710$$HP$US$US
240746731$24074673$1$I$$20231201$20240710$20240710$PER$$US-PFM-2023-06957$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.839$KG$20240710$$CN$US$US
240746741$24074674$1$I$$20240702$20240710$20240710$EXP$$LV-BAYER-2024A096266$BAYER$$75$YR$E$M$Y$$$20240710$$MD$LV$LV
240746751$24074675$1$I$$20231201$20240710$20240710$PER$$US-PFM-2023-06954$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.9$KG$20240710$$CN$US$US
240746761$24074676$1$I$$20231204$20240710$20240710$PER$$US-PFM-2023-06956$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.499$KG$20240710$$CN$US$US
240746771$24074677$1$I$$20231201$20240710$20240710$PER$$US-PFM-2023-06958$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.07$KG$20240710$$CN$US$US
240746781$24074678$1$I$$20231205$20240710$20240710$PER$$US-PFM-2023-07005$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.9$KG$20240710$$CN$US$US
240746791$24074679$1$I$$20231206$20240710$20240710$PER$$US-PFM-2023-07007$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.256$KG$20240710$$CN$US$US
240746801$24074680$1$I$$20231206$20240710$20240710$PER$$US-PFM-2023-07029$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.397$KG$20240710$$CN$US$US
240746811$24074681$1$I$$20231206$20240710$20240710$PER$$US-PFM-2023-07028$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.17$KG$20240710$$CN$US$US
240746821$24074682$1$I$20210126$20231206$20240710$20240710$PER$$US-PFM-2023-07027$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$17.687$KG$20240710$$CN$US$US
240746831$24074683$1$I$20231204$20231206$20240710$20240710$PER$$US-PFM-2023-07010$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240710$$PH$US$US
240746841$24074684$1$I$$20231206$20240710$20240710$PER$$US-PFM-2023-07009$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.238$KG$20240710$$CN$US$US
240746851$24074685$1$I$$20231206$20240710$20240710$PER$$US-PFM-2023-07011$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240710$$PH$US$US
240746861$24074686$1$I$20230703$20231206$20240710$20240710$PER$$US-PFM-2023-07008$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$9.27$KG$20240710$$HP$US$US
240746871$24074687$1$I$$20240112$20240710$20240710$PER$$US-PFM-2023-06955$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.46$KG$20240710$$CN$US$US
240746881$24074688$1$I$$20240129$20240710$20240710$PER$$JP-PFM-2023-06959$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240710$$PH$JP$JP
240746891$24074689$1$I$20240612$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47914$$FDA-CTU$$55$YR$$F$N$73.1$KG$20240709$Y$$US$
240746901$24074690$1$I$$20240312$20240710$20240710$PER$$US-PFM-2023-06982$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.118$KG$20240710$$CN$US$US
240746911$24074691$1$I$$20240115$20240710$20240710$PER$$US-PFM-2023-06979$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.87$KG$20240710$$CN$US$US
240746921$24074692$1$I$$20240408$20240710$20240710$PER$$US-PFM-2023-07006$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.62$KG$20240710$$CN$US$US
240746931$24074693$1$I$20230922$20240425$20240710$20240710$PER$$JP-PFM-2023-06972$PIERRE FABRE MEDICAMENT$$9$WK$$F$Y$6.1$KG$20240710$$MD$JP$JP
240746941$24074694$1$I$$20240521$20240710$20240710$PER$$US-PFM-2024-00799$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.7$KG$20240710$$HP$US$US
240746951$24074695$1$I$20240401$20240702$20240710$20240710$EXP$IT-MINISAL02-991904$IT-TEVA-VS-3216339$TEVA$$28$YR$$M$Y$$$20240710$$MD$IT$IT
240746971$24074697$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405081937521040-HGMFW$GB-SANDOZ INC.-SDZ2024GB063445$SANDOZ$$$$$F$Y$79$KG$20240710$$CN$GB$GB
240746981$24074698$1$I$20240101$20240627$20240710$20240710$PER$$US-SA-2024SA194494$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240710$$MD$US$US
240746991$24074699$1$I$20231208$20231207$20240710$20240710$PER$$US-PFM-2023-07092$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$8.127$KG$20240710$$CN$US$US
240747001$24074700$1$I$$20231211$20240710$20240710$PER$$US-PFM-2023-07100$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.34$KG$20240710$$CN$US$US
240747011$24074701$1$I$$20240105$20240710$20240710$PER$$US-PFM-2023-07030$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.256$KG$20240710$$CN$US$US
240747021$24074702$1$I$20240522$20240612$20240710$20240710$PER$$US-ROCHE-RCA5204041$ROCHE$$86$YR$E$M$Y$$$20240710$$CN$US$US
240747031$24074703$1$I$$20231207$20240710$20240710$PER$$US-PFM-2023-07036$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.397$KG$20240710$$CN$US$US
240747041$24074704$1$I$$20231207$20240710$20240710$PER$$US-PFM-2023-07061$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.844$KG$20240710$$CN$US$US
240747051$24074705$1$I$$20231208$20240710$20240710$PER$$US-PFM-2023-07093$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.163$KG$20240710$$CN$US$US
240747061$24074706$1$I$20230101$20231211$20240710$20240710$PER$FR-AFSSAPS-AVPO2023000240$FR-PFM-2023-07074$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240710$$PH$FR$FR
240747071$24074707$1$I$$20231218$20240710$20240710$PER$$US-PFM-2023-07094$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.998$KG$20240710$$CN$US$US
240747081$24074708$1$I$$20240412$20240710$20240710$PER$$US-PFM-2023-07060$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.549$KG$20240710$$CN$US$US
240747091$24074709$1$I$$20240301$20240710$20240710$PER$$US-PFM-2023-07035$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.256$KG$20240710$$CN$US$US
240747101$24074710$1$I$$20240708$20240710$20240710$EXP$$DZ-PFIZER INC-202400209865$PFIZER$$50$YR$$M$Y$$$20240710$$MD$DZ$DZ
240747111$24074711$1$I$20240429$20240707$20240710$20240710$EXP$$IN-PFIZER INC-202200501213$PFIZER$$66$YR$$F$Y$$$20240710$$CN$IN$IN
240747121$24074712$1$I$20240629$20240708$20240710$20240710$EXP$$CN-PFIZER INC-PV202400089475$PFIZER$$4$YR$$F$Y$17$KG$20240710$$HP$CN$CN
240747131$24074713$1$I$20240620$20240708$20240710$20240710$EXP$$US-ROCHE-10000021470$ROCHE$$81$YR$E$F$Y$$$20240710$$CN$US$US
240747141$24074714$1$I$20240119$20240705$20240710$20240710$EXP$FR-AFSSAPS-BX2024001301$FR-PFIZER INC-202400207359$PFIZER$$56$YR$$F$Y$$$20240710$$MD$FR$FR
240747151$24074715$1$I$20240630$20240708$20240710$20240710$EXP$$CN-PFIZER INC-PV202400089401$PFIZER$$28$YR$$F$Y$60$KG$20240710$$HP$CN$CN
240747161$24074716$1$I$20240630$20240708$20240710$20240710$EXP$$CN-PFIZER INC-PV202400089435$PFIZER$$19$MON$$M$Y$11$KG$20240710$$HP$CN$CN
240747172$24074717$2$F$$20240718$20240710$20240723$EXP$$IL-PFIZER INC-PV202400089822$PFIZER$$77$YR$$F$Y$$$20240723$$HP$IL$IL
240747186$24074718$6$F$20240624$20240731$20240710$20240806$EXP$$CA-PFIZER INC-PV202400084118$PFIZER$$58$YR$$F$Y$$$20240806$$HP$CA$CA
240747191$24074719$1$I$$20240704$20240710$20240710$EXP$$US-PFIZER INC-2024SGN05703$PFIZER$$60$YR$$F$Y$$$20240710$$CN$US$US
240747201$24074720$1$I$$20240709$20240710$20240710$EXP$$US-PFIZER INC-PV202400090193$PFIZER$$$$$F$Y$$$20240710$$HP$US$US
240747211$24074721$1$I$20240625$20240705$20240710$20240710$EXP$$CN-PFIZER INC-PV202400088714$PFIZER$$72$YR$$M$Y$60$KG$20240710$$HP$CN$CN
240747233$24074723$3$F$20240627$20240830$20240710$20240830$EXP$$JP-PFIZER INC-PV202400088813$PFIZER$$$$$$Y$$$20240830$$MD$JP$JP
240747241$24074724$1$I$20240101$20240709$20240710$20240710$EXP$DK-DKMA-30734677$DK-PFIZER INC-202400209337$PFIZER$$70$YR$$F$Y$59$KG$20240710$$MD$DK$DK
240747253$24074725$3$F$20240101$20240913$20240710$20240913$EXP$$JP-PFIZER INC-PV202400088695$PFIZER$$77$YR$$M$Y$55.7$KG$20240913$$MD$JP$JP
240747261$24074726$1$I$$20240708$20240710$20240710$EXP$$US-PFIZER INC-202400209755$PFIZER$$63$YR$$M$Y$$$20240710$$CN$US$US
240747271$24074727$1$I$20240530$20240708$20240710$20240710$EXP$FR-AFSSAPS-PV2024000604$FR-PFIZER INC-202400208321$PFIZER$$18$YR$$F$Y$67$KG$20240710$$MD$FR$FR
240747281$24074728$1$I$20240101$20240704$20240710$20240710$EXP$$IN-PFIZER INC-PV202400055601$PFIZER$$57$YR$$F$Y$$$20240710$$CN$IN$IN
240747291$24074729$1$I$$20240704$20240710$20240710$EXP$$US-PFIZER INC-2024SGN04480$PFIZER$$59$YR$$F$Y$$$20240710$$CN$US$US
240747311$24074731$1$I$$20240708$20240710$20240710$EXP$$PK-PFIZER INC-202400208798$PFIZER$$$$$$Y$$$20240710$$PH$PK$PK
240747321$24074732$1$I$20240708$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005548$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240710$$CN$US$US
240747331$24074733$1$I$$20231208$20240710$20240710$PER$$US-PFM-2023-07101$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.449$KG$20240710$$CN$US$US
240747341$24074734$1$I$20231201$20231211$20240710$20240710$PER$$GR-PFM-2023-07124$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$5.8$KG$20240710$$CN$GR$GR
240747351$24074735$1$I$$20231212$20240710$20240710$PER$$US-PFM-2023-07169$PIERRE FABRE MEDICAMENT$$$$$F$Y$2.558$KG$20240710$$CN$US$US
240747361$24074736$1$I$$20231212$20240710$20240710$PER$$US-PFM-2023-07163$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$MD$US$US
240747371$24074737$1$I$$20231212$20240710$20240710$PER$$US-PFM-2023-07167$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.129$KG$20240710$$CN$US$US
240747381$24074738$1$I$20231110$20240708$20240710$20240710$EXP$FR-AFSSAPS-LY2024001008$FR-PFIZER INC-202400208580$PFIZER$$62$YR$$M$Y$64$KG$20240710$$MD$FR$FR
240747391$24074739$1$I$20231213$20231213$20240710$20240710$PER$$HR-PFM-2023-07146$PIERRE FABRE MEDICAMENT$$11$MON$$F$Y$$$20240710$$CN$HR$HR
240747401$24074740$1$I$$20231212$20240710$20240710$PER$$US-PFM-2023-07164$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.748$KG$20240710$$CN$US$US
240747411$24074741$1$I$$20231211$20240710$20240710$PER$$CA-PFM-2023-07126$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$HP$CA$CA
240747421$24074742$1$I$$20240105$20240710$20240710$PER$$CZ-PFM-2023-07102$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$MD$CZ$CZ
240747431$24074743$1$I$$20240105$20240710$20240710$PER$$CZ-PFM-2023-07103$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$MD$CZ$CZ
240747441$24074744$1$I$$20231213$20240710$20240710$PER$$US-PFM-2023-07176$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.109$KG$20240710$$CN$US$US
240747451$24074745$1$I$$20231213$20240710$20240710$PER$$US-PFM-2023-07173$PIERRE FABRE MEDICAMENT$$$$$M$Y$14$KG$20240710$$CN$US$US
240747461$24074746$1$I$$20240618$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202406019878$ELI LILLY AND CO$$74$YR$E$F$Y$86.168$KG$20240710$$CN$US$US
240747471$24074747$1$I$20240412$20240704$20240710$20240710$EXP$FR-AFSSAPS-GR2024000778$FR-MYLANLABS-2024M1063110$MYLAN$$85$YR$$F$Y$$$20240710$$PH$FR$FR
240747481$24074748$1$I$$20231214$20240710$20240710$PER$$US-PFM-2023-07209$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240710$$CN$US$US
240747491$24074749$1$I$$20240702$20240710$20240710$PER$$US-AMGEN-USASP2024133637$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$42$YR$A$M$Y$$$20240710$$HP$US$US
240747501$24074750$1$I$$20231215$20240710$20240710$PER$$US-PFM-2023-07210$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.748$KG$20240710$$HP$US$US
240747511$24074751$1$I$$20231215$20240710$20240710$PER$$US-PFM-2023-07246$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.245$KG$20240710$$CN$US$US
240747521$24074752$1$I$$20231215$20240710$20240710$PER$$US-PFM-2023-07215$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.159$KG$20240710$$CN$US$US
240747531$24074753$1$I$$20231215$20240710$20240710$PER$$US-PFM-2023-07213$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.127$KG$20240710$$CN$US$US
240747541$24074754$1$I$20240419$20240708$20240710$20240710$EXP$GB-MHRA-TPP14955018C9703078YC1719417878808$GB-SANDOZ INC.-SDZ2024GB064046$SANDOZ$$64$YR$$M$Y$90$KG$20240710$$MD$GB$GB
240747551$24074755$1$I$20231211$20231218$20240710$20240710$PER$$US-PFM-2023-07266$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.9$KG$20240710$$PH$US$US
240747561$24074756$1$I$$20231218$20240710$20240710$PER$$US-PFM-2023-07264$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.8$KG$20240710$$CN$US$US
240747571$24074757$1$I$$20231218$20240710$20240710$PER$$US-PFM-2023-07262$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.9$KG$20240710$$CN$US$US
240747581$24074758$1$I$20230404$20231218$20240710$20240710$PER$IT-MINISAL02-960167$IT-PFM-2023-07211$PIERRE FABRE MEDICAMENT$$20$YR$$$Y$60$KG$20240710$$MD$IT$IT
240747591$24074759$1$I$$20240122$20240710$20240710$PER$$US-PFM-2023-07208$PIERRE FABRE MEDICAMENT$$$$$F$Y$14.698$KG$20240710$$HP$US$US
240747601$24074760$1$I$$20240110$20240710$20240710$PER$$US-PFM-2023-07170$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.707$KG$20240710$$HP$US$US
240747611$24074761$1$I$20231218$20240123$20240710$20240710$PER$$US-PFM-2023-07263$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.5$KG$20240710$$PH$US$US
240747621$24074762$1$I$$20240229$20240710$20240710$PER$$US-PFM-2023-07214$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.2$KG$20240710$$CN$US$US
240747631$24074763$1$I$$20240409$20240710$20240710$PER$$US-PFM-2023-07261$PIERRE FABRE MEDICAMENT$$$$$M$Y$12.2$KG$20240710$$CN$US$US
240747641$24074764$1$I$20240623$20240628$20240710$20240710$PER$$US-ROCHE-10000019626$ROCHE$$66$YR$E$M$Y$$$20240710$$CN$US$US
240747651$24074765$1$I$$20231218$20240710$20240710$PER$$US-PFM-2023-07267$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.297$KG$20240710$$CN$US$US
240747661$24074766$1$I$$20231219$20240710$20240710$PER$$US-PFM-2023-07269$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.399$KG$20240710$$HP$US$US
240747671$24074767$1$I$$20231218$20240710$20240710$PER$$US-PFM-2023-07268$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240710$$CN$US$US
240747681$24074768$1$I$$20231227$20240710$20240710$PER$$US-PFM-2023-07270$PIERRE FABRE MEDICAMENT$$$$$F$Y$5$KG$20240710$$CN$US$US
240747691$24074769$1$I$20240227$20240704$20240710$20240710$EXP$$ES-009507513-2407ESP002539$MERCK$$70$YR$$F$Y$70$KG$20240710$$MD$ES$ES
240747703$24074770$3$F$20240701$20240719$20240710$20240802$PER$$US-KARYOPHARM-2024KPT001285$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240802$$CN$US$US
240747711$24074771$1$I$$20231220$20240710$20240710$PER$$US-PFM-2023-07325$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.88$KG$20240710$$HP$US$US
240747722$24074772$2$F$20240620$20240723$20240710$20240805$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000560$PAREXEL$$$$$$Y$$$20240805$$HP$CN$CN
240747731$24074773$1$I$20240617$20240627$20240710$20240710$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000559$PAREXEL$$$$$$Y$$$20240710$$HP$CN$CN
240747741$24074774$1$I$$20231220$20240710$20240710$PER$$US-PFM-2023-07324$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.478$KG$20240710$$HP$US$US
240747751$24074775$1$I$$20231220$20240710$20240710$PER$$US-PFM-2023-07286$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240710$$PH$US$US
240747761$24074776$1$I$20230927$20231220$20240710$20240710$PER$$US-PFM-2023-07326$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.159$KG$20240710$$HP$US$US
240747771$24074777$1$I$$20231220$20240710$20240710$PER$$US-PFM-2023-07322$PIERRE FABRE MEDICAMENT$$$$$M$Y$25.397$KG$20240710$$HP$US$US
240747781$24074778$1$I$$20231223$20240710$20240710$PER$$US-PFM-2023-07405$PIERRE FABRE MEDICAMENT$$$$$F$Y$2.948$KG$20240710$$CN$US$US
240747791$24074779$1$I$$20231226$20240710$20240710$PER$$US-PFM-2023-07403$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.769$KG$20240710$$HP$US$US
240747801$24074780$1$I$20231114$20231226$20240710$20240710$PER$ES-AEMPS-1467278$ES-PFM-2023-07368$PIERRE FABRE MEDICAMENT$$78$YR$$F$Y$63$KG$20240710$$MD$ES$ES
240747811$24074781$1$I$20231201$20231227$20240710$20240710$PER$$US-PFM-2023-07421$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$3.007$KG$20240710$$HP$US$US
240747821$24074782$1$I$$20231227$20240710$20240710$PER$$US-PFM-2024-00015$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.868$KG$20240710$$CN$US$US
240747831$24074783$1$I$$20231227$20240710$20240710$PER$$US-PFM-2024-00014$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.669$KG$20240710$$HP$US$US
240747841$24074784$1$I$$20231227$20240710$20240710$PER$$US-PFM-2023-07422$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240710$$CN$US$US
240747851$24074785$1$I$$20231227$20240710$20240710$PER$$DE-PFM-2023-07425$PIERRE FABRE MEDICAMENT$$$$$F$Y$7$KG$20240710$$CN$DE$DE
240747861$24074786$1$I$$20231228$20240710$20240710$PER$$US-PFM-2024-00016$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.868$KG$20240710$$CN$US$US
240747871$24074787$1$I$$20240626$20240710$20240710$EXP$$QA-Innogenix, LLC-2159005$INNOGENIX$Source document (Full text)$30$YR$$F$Y$$$20240710$$$QA$QA
240747881$24074788$1$I$$20240228$20240710$20240710$PER$$US-PFM-2023-07404$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.408$KG$20240710$$CN$US$US
240747891$24074789$1$I$20231220$20240305$20240710$20240710$PER$$US-PFM-2023-07321$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$11.338$KG$20240710$$HP$US$US
240747901$24074790$1$I$$20240527$20240710$20240710$PER$$US-PFM-2023-07323$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.98$KG$20240710$$CN$US$US
240747911$24074791$1$I$20231201$20240112$20240710$20240710$PER$$JP-PFM-2024-00005$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$CN$JP$US
240747921$24074792$1$I$20240701$20240710$20240710$20240710$DIR$709728$$FDA-CTU$$73$YR$$F$N$57.6$KG$20240710$N$CN$US$
240747931$24074793$1$I$20240710$20240710$20240710$20240710$DIR$709731$$FDA-CTU$$58$YR$$F$N$$$20240710$N$PH$US$
240747941$24074794$1$I$20231228$20240201$20240710$20240710$PER$$US-PFM-2024-00004$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.669$KG$20240710$$HP$US$US
240747951$24074795$1$I$$20240614$20240710$20240710$PER$$US-PFM-2024-00017$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.2$KG$20240710$$CN$US$US
240747961$24074796$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157470$ASTRAZENECA$$68$YR$$M$Y$70$KG$20240710$$HP$FR$
240747971$24074797$1$I$20240630$20240710$20240710$20240710$DIR$709679$$FDA-CTU$$32$YR$$F$N$75.15$KG$20240710$N$CN$US$
240747981$24074798$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133391$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$74$YR$E$F$Y$$$20240710$$HP$US$US
240747991$24074799$1$I$$20240702$20240710$20240710$EXP$$CN-AstraZeneca-2024A153636$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$CN$
240748001$24074800$1$I$$20240702$20240710$20240710$EXP$$GB-AstraZeneca-2024A152106$ASTRAZENECA$$$$$F$Y$64$KG$20240710$$MD$GB$
240748011$24074801$1$I$$20240610$20240710$20240710$PER$$US-AstraZeneca-2024A126210$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240748021$24074802$1$I$20240624$20240708$20240710$20240710$EXP$$US-VANTIVE-2024VAN018199$Vantive US Healthcare$$65$YR$$F$Y$$$20240710$$CN$US$US
240748031$24074803$1$I$20240612$20240702$20240710$20240710$EXP$$CO-VANTIVE-2024VAN017767$Vantive US Healthcare$$56$YR$$F$Y$55.8$KG$20240710$$HP$CO$CO
240748041$24074804$1$I$20240412$20240702$20240710$20240710$EXP$$US-VANTIVE-2024VAN018120$Vantive US Healthcare$$60$YR$$M$Y$110$KG$20240710$$HP$US$US
240748052$24074805$2$F$$20240828$20240710$20240904$EXP$$US-AstraZeneca-2024A155262$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
240748071$24074807$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024136116$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240748081$24074808$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133457$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$56$YR$A$M$Y$$$20240710$$HP$US$US
240748091$24074809$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133321$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$62$YR$A$F$Y$$$20240710$$HP$US$US
240748101$24074810$1$I$$20240702$20240710$20240710$PER$$US-AMGEN-USASP2024133611$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$43$YR$A$M$Y$$$20240710$$HP$US$US
240748111$24074811$1$I$$20240703$20240710$20240710$EXP$$US-AMGEN-USASP2024132606$AMGEN$Dean E.A.; Fenton G.A.. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case Reports in Oncology. 2024;17 (1):75-81$64$YR$A$F$Y$$$20240710$$HP$US$US
240748121$24074812$1$I$$20231204$20240710$20240710$PER$$IL-PFM-2023-06969$PIERRE FABRE MEDICAMENT$Glowinsky S, Bergman H, Zarchi O, Fireman S, Reiner J, Tamir I. Electrophysiology-aided DBS targeting the ventral intermediate nucleus in an essential tremor patient with MRI-incompatible lead: A case report. Physiological Reports. 2023;11:e15730:1-7$75$YR$$M$Y$$$20240710$$HP$IL$IL
240748131$24074813$1$I$$20231226$20240710$20240710$PER$$ES-PFM-2023-07388$PIERRE FABRE MEDICAMENT$Gomez CG, Navarro E, Alcazar V,  Lopez-Guzman A, Arrieta F, Anda E et al. Therapeutic Management and Long-Term Outcome of Hyperthyroidism in Patients with Antithyroid-Induced Agranulocytosis: A Retrospective, Multicenter Study. Journal of clinical medicine. 2023;12:6556$$$A$$Y$$$20240710$$HP$ES$ES
240748141$24074814$1$I$$20231211$20240710$20240710$PER$$IT-PFM-2023-07112$PIERRE FABRE MEDICAMENT$Ceccanti S, Varrasso G, D^Avanzo M, Andreoli G, Masselli G, Tarani F et al. Female splenogonadal fusion: A PLEA for conservative management. Urology Case Reports. 2023;51:102620$6$MON$$F$Y$$$20240710$$HP$IT$IT
240748151$24074815$1$I$$20231207$20240710$20240710$PER$$KR-PFM-2023-07002$PIERRE FABRE MEDICAMENT$Ju H, Joo B, Pyun J, Kwon K. A rare and illustrated case of presumed essential tremor mimicking tremor-dominant Parkinson disease: More than meets the eye. Geriatr. Gerontol. Int. 2023;23:877-9$87$YR$$F$Y$$$20240710$$HP$KR$KR
240748161$24074816$1$I$20231024$20231229$20240710$20240710$PER$$US-PFM-2024-00035$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.197$KG$20240710$$CN$US$US
240748171$24074817$1$I$20231003$20231230$20240710$20240710$PER$$US-PFM-2024-00036$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$8.163$KG$20240710$$PH$US$US
240748181$24074818$1$I$$20231231$20240710$20240710$PER$$IL-PFM-2024-00037$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240710$$CN$IL$IL
240748191$24074819$1$I$$20240101$20240710$20240710$PER$$TR-PFM-2024-00066$PIERRE FABRE MEDICAMENT$Sicim H, Altunyuva K, Ozdemir F, Cicek M, Aydemir NA. Surgical Treatment of Pediatric Refractory Ventricular Tachycardia Originating From a Left Ventricular Rhabdomyoma. World Journal for Pediatric and Congenital Heart Surgery. 2023;15(1):114-5$6$YR$$$Y$$$20240710$$HP$TR$TR
240748201$24074820$1$I$$20231226$20240710$20240710$PER$$JP-PFM-2023-07389$PIERRE FABRE MEDICAMENT$Makino M, Koriyama N, Kojima N, Nishio Y. A Rare Case of Painless Destructive Thyroiditis Resulting in Thyroid Storm. Intern Med. 2023;62:3373-9$85$YR$$M$Y$50.7$KG$20240710$$HP$JP$JP
240748211$24074821$1$I$$20231226$20240710$20240710$PER$$IT-PFM-2023-07363$PIERRE FABRE MEDICAMENT$Oreto L, Briuglia S, Capra AP, Ruiz VG, Di Pino A. Bidirectional Ventricular Tachycardia and Prominent U Waves: Look at Fingers and Muscles and Use Flecainide. J Pediatr Pharmacol Ther. 2023;28(7):662-8$15$YR$$M$Y$50$KG$20240710$$HP$IT$IT
240748221$24074822$1$I$$20240101$20240710$20240710$PER$$CA-PFM-2024-00074$PIERRE FABRE MEDICAMENT$Albertini L, Ezekian J, Care M, Silversides C, Sermer M, Gollob MH et al. Assessment of Severity of Long QT Syndrome Phenotype and Risk of Fetal Death. Journal of the American Heart Association. 2023;12:1-8$$$$F$Y$$$20240710$$HP$CA$CA
240748232$24074823$2$F$20240626$20240712$20240710$20240723$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000014$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240719$$HP$US$US
240748241$24074824$1$I$$20240102$20240710$20240710$PER$$US-PFM-2024-00059$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.379$KG$20240710$$CN$US$US
240748251$24074825$1$I$$20240102$20240710$20240710$PER$$IT-PFM-2024-00073$PIERRE FABRE MEDICAMENT$Nora AD, Pizzo F, Testai M, Gulizia C, Pavone P. Beard neonatal hemangioma: report of a PHACE syndrome. Acta Neurologica Belgica. 2023$1$MON$$F$Y$$$20240710$$HP$IT$IT
240748261$24074826$1$I$$20240102$20240710$20240710$PER$$US-PFM-2024-00060$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.388$KG$20240710$$CN$US$US
240748271$24074827$1$I$$20240102$20240710$20240710$PER$$US-PFM-2024-00076$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.497$KG$20240710$$CN$US$US
240748281$24074828$1$I$$20240103$20240710$20240710$PER$$US-PFM-2024-00077$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.079$KG$20240710$$CN$US$US
240748291$24074829$1$I$$20240103$20240710$20240710$PER$$US-PFM-2024-00101$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.819$KG$20240710$$CN$US$US
240748301$24074830$1$I$$20240103$20240710$20240710$PER$$US-PFM-2024-00078$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.109$KG$20240710$$CN$US$US
240748311$24074831$1$I$$20240103$20240710$20240710$PER$$US-PFM-2024-00079$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.338$KG$20240710$$CN$US$US
240748321$24074832$1$I$20240101$20240703$20240710$20240710$PER$$US-Eisai-EC-2024-169815$EISAI$$73$YR$E$F$Y$$$20240710$$CN$US$US
240748331$24074833$1$I$20231103$20240609$20240710$20240710$PER$$US-PFM-2024-00058$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.58$KG$20240710$$HP$US$US
240748341$24074834$1$I$$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405011633482420-QSCHD$GB-BAXTER-2024BAX021284$BAXTER$$$$$$Y$$$20240710$$PH$GB$GB
240748351$24074835$1$I$$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405020933491240-GTSJB$GB-BAXTER-2024BAX021244$BAXTER$$$$$$Y$$$20240710$$PH$GB$GB
240748361$24074836$1$I$20231213$20240701$20240710$20240710$EXP$PL-URPL-DML-MLP.4401.1.801.2023$PL-BAXTER-2024BAX021042$BAXTER$$73$YR$$M$Y$84.5$KG$20240710$$MD$PL$PL
240748371$24074837$1$I$$20240708$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063880$SANDOZ$$$$$M$Y$$$20240710$$CN$US$US
240748381$24074838$1$I$20240624$20240626$20240710$20240710$PER$$US-APELLIS-2024-APL-0000379$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240748391$24074839$1$I$20240626$20240710$20240710$20240710$DIR$709734$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240748401$24074840$1$I$20240320$20240626$20240710$20240710$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000563$PAREXEL$$$$$$Y$$$20240710$$HP$CN$CN
240748411$24074841$1$I$20230901$20231101$20240710$20240710$PER$$US-PFM-2023-06326$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240710$$PH$US$US
240748421$24074842$1$I$$20240701$20240710$20240710$PER$$US-ROCHE-10000021222$ROCHE$$$$$F$Y$$$20240710$$HP$US$US
240748431$24074843$1$I$$20231101$20240710$20240710$PER$$US-PFM-2023-06328$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.546$KG$20240710$$CN$US$US
240748441$24074844$1$I$$20240628$20240710$20240710$PER$$US-ROCHE-10000021324$ROCHE$$$$A$F$Y$$$20240710$$CN$US$US
240748451$24074845$1$I$$20231101$20240710$20240710$PER$$US-PFM-2023-06297$PIERRE FABRE MEDICAMENT$$$$$M$Y$2.671$KG$20240710$$CN$US$US
240748471$24074847$1$I$$20240710$20240710$20240710$DIR$709684$$FDA-CTU$$51$YR$$F$N$$$20240710$Y$CN$IN$
240748482$24074848$2$F$20240101$20240730$20240710$20240806$EXP$$CA-KARYOPHARM-2024KPT000788$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240806$$CN$CA$CA
240748491$24074849$1$I$$20231101$20240710$20240710$PER$$US-PFM-2023-06295$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.102$KG$20240710$$CN$US$US
240748501$24074850$1$I$20231001$20231101$20240710$20240710$PER$$US-PFM-2023-06327$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240710$$PH$US$US
240748511$24074851$1$I$$20231101$20240710$20240710$PER$$US-PFM-2023-06298$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.399$KG$20240710$$CN$US$US
240748521$24074852$1$I$20231101$20231101$20240710$20240710$PER$$US-PFM-2023-06299$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.297$KG$20240710$$HP$US$US
240748531$24074853$1$I$$20231102$20240710$20240710$PER$$US-PFM-2023-06334$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.07$KG$20240710$$CN$US$US
240748541$24074854$1$I$$20231102$20240710$20240710$PER$$US-PFM-2023-06333$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.689$KG$20240710$$HP$US$US
240748551$24074855$1$I$20240530$20240710$20240710$20240710$DIR$709698$$FDA-CTU$$79$YR$$M$N$67.5$KG$20240710$N$PH$US$
240748561$24074856$1$I$$20231102$20240710$20240710$PER$$US-PFM-2023-06335$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.168$KG$20240710$$HP$US$US
240748571$24074857$1$I$$20231103$20240710$20240710$PER$$US-PFM-2023-06371$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.9$KG$20240710$$CN$US$US
240748581$24074858$1$I$$20231103$20240710$20240710$PER$$US-PFM-2023-06370$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.17$KG$20240710$$CN$US$US
240748591$24074859$1$I$$20231104$20240710$20240710$PER$$US-PFM-2023-06374$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.399$KG$20240710$$CN$US$US
240748601$24074860$1$I$$20231102$20240710$20240710$PER$$US-PFM-2023-06332$PIERRE FABRE MEDICAMENT$$$$$M$Y$12.698$KG$20240710$$CN$US$US
240748611$24074861$1$I$20231102$20231215$20240710$20240710$PER$$US-PFM-2023-06330$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.678$KG$20240710$$HP$US$US
240748621$24074862$1$I$20231001$20231103$20240710$20240710$PER$$US-PFM-2023-06343$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240710$$PH$US$US
240748631$24074863$1$I$$20231229$20240710$20240710$PER$$US-PFM-2023-06325$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.868$KG$20240710$$CN$US$US
240748641$24074864$1$I$20231001$20240305$20240710$20240710$PER$$US-PFM-2023-06342$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.95$KG$20240710$$CN$US$US
240748651$24074865$1$I$20231029$20240305$20240710$20240710$PER$$US-PFM-2023-06329$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$11.397$KG$20240710$$CN$US$US
240748661$24074866$1$I$$20240101$20240710$20240710$PER$$TR-PFM-2024-00094$PIERRE FABRE MEDICAMENT$Pamukcu O, Citli R. Ivabradine for congenital ectopic tachycardia in newborn. Cardiology in the Young. 2023;1-3$6$HR$$F$Y$$$20240710$$HP$TR$TR
240748671$24074867$1$I$$20240627$20240710$20240710$PER$$US-SA-2024SA194496$SANOFI AVENTIS$$$$A$M$Y$$$20240710$$MD$US$US
240748681$24074868$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA197719$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240710$$MD$US$US
240748692$24074869$2$F$20240101$20240905$20240710$20240917$PER$$US-SA-2024SA197690$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240918$$MD$US$US
240748702$24074870$2$F$20080101$20240719$20240710$20240729$EXP$$PL-TEVA-VS-3217035$TEVA$Razik M, Rozwadowska P, Koclega A, Helbig G. Double Malignancy and Double Transplant-A Bumpy Road to Success. Medicina-Kaunas 2023; 59 (7):.; Razik M, Rozwadowska P, Koclega A, Helbig G. Double Malignancy and Double Transplant-A Bumpy Road to Success. Medicina-Kaunas 2023; 59 (7):.$35$YR$$F$Y$$$20240729$$HP$PL$PL
240748711$24074871$1$I$$20231106$20240710$20240710$PER$$US-PFM-2023-06377$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.159$KG$20240710$$CN$US$US
240748721$24074872$1$I$20240617$20240703$20240710$20240710$EXP$$CA-JNJFOC-20240713198$JOHNSON AND JOHNSON$$73$YR$E$M$Y$97$KG$20240710$$HP$CA$CA
240748731$24074873$1$I$$20231107$20240710$20240710$PER$$US-PFM-2023-06415$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.358$KG$20240710$$CN$US$US
240748741$24074874$1$I$20231108$20231108$20240710$20240710$PER$$US-PFM-2023-06410$PIERRE FABRE MEDICAMENT$$5$YR$$F$Y$20.698$KG$20240710$$HP$US$US
240748751$24074875$1$I$$20231107$20240710$20240710$PER$$US-PFM-2023-06414$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.088$KG$20240710$$HP$US$US
240748761$24074876$1$I$$20231108$20240710$20240710$PER$$US-PFM-2023-06412$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.898$KG$20240710$$CN$US$US
240748771$24074877$1$I$$20231108$20240710$20240710$PER$$US-PFM-2023-06413$PIERRE FABRE MEDICAMENT$$$$$F$Y$15.42$KG$20240710$$HP$US$US
240748781$24074878$1$I$$20231108$20240710$20240710$PER$$US-PFM-2023-06411$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.698$KG$20240710$$HP$US$US
240748791$24074879$1$I$20240621$20240709$20240710$20240710$EXP$$NVSC2024US142582$NOVARTIS$$72$YR$$M$Y$$$20240710$$HP$US$US
240748801$24074880$1$I$$20231109$20240710$20240710$PER$$US-PFM-2023-06438$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.927$KG$20240710$$CN$US$US
240748811$24074881$1$I$$20231113$20240710$20240710$PER$$US-PFM-2023-06544$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.907$KG$20240710$$CN$US$US
240748821$24074882$1$I$$20231214$20240710$20240710$PER$$US-PFM-2023-06376$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.259$KG$20240710$$CN$US$US
240748831$24074883$1$I$$20240129$20240710$20240710$PER$$US-PFM-2023-06375$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.8$KG$20240710$$CN$US$US
240748841$24074884$1$I$20230901$20231110$20240710$20240710$PER$$US-PFM-2023-06439$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240710$$PH$US$US
240748851$24074885$1$I$$20231113$20240710$20240710$PER$$US-PFM-2023-06538$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.678$KG$20240710$$CN$US$US
240748861$24074886$1$I$$20231110$20240710$20240710$PER$$US-PFM-2023-06489$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.549$KG$20240710$$CN$US$US
240748871$24074887$1$I$$20231113$20240710$20240710$PER$$US-PFM-2023-06541$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.501$KG$20240710$$CN$US$US
240748881$24074888$1$I$$20231115$20240710$20240710$PER$$US-PFM-2023-06586$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.528$KG$20240710$$CN$US$US
240748891$24074889$1$I$$20231114$20240710$20240710$PER$$US-PFM-2023-06547$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.701$KG$20240710$$CN$US$US
240748901$24074890$1$I$$20231115$20240710$20240710$PER$$US-PFM-2023-06587$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.308$KG$20240710$$CN$US$US
240748911$24074891$1$I$$20231218$20240710$20240710$PER$$US-PFM-2023-06543$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.803$KG$20240710$$CN$US$US
240748921$24074892$1$I$$20240710$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038978$BOEHRINGER INGELHEIM$$$$$$Y$$$20240710$$CN$US$US
240748931$24074893$1$I$20240101$20240708$20240710$20240710$PER$$US-ABBVIE-5831892$ABBVIE$$$$$$Y$$$20240710$$CN$US$US
240748941$24074894$1$I$20240101$20240705$20240710$20240710$EXP$$CA-ABBVIE-5831187$ABBVIE$$$$E$F$Y$70$KG$20240710$$CN$CA$CA
240748951$24074895$1$I$20231109$20231116$20240710$20240710$PER$$US-PFM-2023-06588$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$$$20240710$$PH$US$US
240748961$24074896$1$I$$20231117$20240710$20240710$PER$$US-PFM-2023-06629$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.098$KG$20240710$$CN$US$US
240748971$24074897$1$I$$20231117$20240710$20240710$PER$$US-PFM-2023-06590$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.898$KG$20240710$$CN$US$US
240748981$24074898$1$I$$20231117$20240710$20240710$PER$$US-PFM-2023-06627$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.129$KG$20240710$$HP$US$US
240748991$24074899$1$I$$20231117$20240710$20240710$PER$$US-PFM-2023-06625$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.959$KG$20240710$$HP$US$US
240749001$24074900$1$I$20231001$20231117$20240710$20240710$PER$$US-PFM-2023-06591$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240710$$PH$US$US
240749011$24074901$1$I$$20231117$20240710$20240710$PER$$US-PFM-2023-06628$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.197$KG$20240710$$CN$US$US
240749021$24074902$1$I$$20231117$20240710$20240710$PER$NL-LRB-00925012$NL-PFM-2023-06614$PIERRE FABRE MEDICAMENT$$24$YR$$F$Y$60$KG$20240710$$MD$NL$NL
240749031$24074903$1$I$$20231130$20240710$20240710$PER$$JP-PFM-2023-06608$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$$$20240710$$MD$JP$JP
240749041$24074904$1$I$$20231204$20240710$20240710$PER$$JP-PFM-2023-06607$PIERRE FABRE MEDICAMENT$$6$MON$$F$Y$$$20240710$$PH$JP$JP
240749052$24074905$2$F$20240705$20240719$20240710$20240723$PER$$US-AMGEN-USASP2024134357$AMGEN$$79$YR$E$M$Y$$$20240722$$CN$US$US
240749061$24074906$1$I$$20240702$20240710$20240710$EXP$$GB-AMGEN-GBRSP2024133951$AMGEN$Crossley R.. Intermittent first-line anti-EGFR with chemotherapy improves the survival of patients with RAS and BRAF wild type metastatic colon cancer. Annals of Oncology. 2024;35 (S1):S47$$$$$Y$$$20240710$$HP$GB$GB
240749071$24074907$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133484$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$62$YR$A$F$Y$$$20240710$$HP$US$US
240749081$24074908$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133526$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$75$YR$E$M$Y$$$20240710$$HP$US$US
240749091$24074909$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133553$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$85$YR$E$M$Y$$$20240710$$HP$US$US
240749101$24074910$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133513$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$65$YR$E$M$Y$$$20240710$$HP$US$US
240749111$24074911$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133490$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$63$YR$A$M$Y$$$20240710$$HP$US$US
240749121$24074912$1$I$$20231119$20240710$20240710$PER$$US-PFM-2023-06631$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.998$KG$20240710$$CN$US$US
240749131$24074913$1$I$20231101$20231121$20240710$20240710$PER$$US-PFM-2023-06668$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240710$$PH$US$US
240749141$24074914$1$I$20240617$20240627$20240710$20240710$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000567$PAREXEL$$$$$$Y$$$20240710$$HP$CN$CN
240749151$24074915$1$I$$20231117$20240710$20240710$PER$$IT-PFM-2023-06632$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$PH$IT$IT
240749161$24074916$1$I$20210310$20231121$20240710$20240710$PER$$US-PFM-2023-06670$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$15.42$KG$20240710$$CN$US$US
240749171$24074917$1$I$20231120$20231122$20240710$20240710$PER$$US-PFM-2023-06712$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240710$$PH$US$US
240749181$24074918$1$I$$20231117$20240710$20240710$PER$$US-PFM-2023-06630$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.798$KG$20240710$$CN$US$US
240749191$24074919$1$I$$20231121$20240710$20240710$PER$$US-PFM-2023-06714$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.497$KG$20240710$$CN$US$US
240749201$24074920$1$I$$20231122$20240710$20240710$PER$$US-PFM-2023-06715$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.109$KG$20240710$$CN$US$US
240749221$24074922$1$I$$20231122$20240710$20240710$PER$$US-PFM-2023-06713$PIERRE FABRE MEDICAMENT$$$$$M$Y$3.741$KG$20240710$$HP$US$US
240749231$24074923$1$I$20230929$20240126$20240710$20240710$PER$$JP-PFM-2023-06674$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$8.3$KG$20240710$$PH$JP$JP
240749241$24074924$1$I$20240101$20240708$20240710$20240710$PER$$US-ABBVIE-5831900$ABBVIE$$$$$$Y$$$20240710$$CN$US$US
240749251$24074925$1$I$$20231120$20240710$20240710$PER$$JP-PFM-2023-06784$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240710$$CN$JP$JP
240749261$24074926$1$I$20240522$20240709$20240710$20240710$EXP$FR-AFSSAPS-BS2024000413$FR-GSK-FR2024084883$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$FR$FR
240749271$24074927$1$I$$20240708$20240710$20240710$PER$$US-HALEON-2185954$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240749281$24074928$1$I$20211027$20231127$20240710$20240710$PER$$US-PFM-2023-06770$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$12.798$KG$20240710$$CN$US$US
240749291$24074929$1$I$20231010$20231127$20240710$20240710$PER$ES-AEMPS-1453744$ES-PFM-2023-06787$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240710$$MD$ES$ES
240749301$24074930$1$I$$20231128$20240710$20240710$PER$$US-PFM-2023-06844$PIERRE FABRE MEDICAMENT$$$$$F$Y$18.998$KG$20240710$$CN$US$US
240749311$24074931$1$I$20230101$20231128$20240710$20240710$PER$$FR-PFM-2023-06838$PIERRE FABRE MEDICAMENT$$18$MON$$F$Y$$$20240710$$MD$FR$FR
240749321$24074932$1$I$$20231127$20240710$20240710$PER$$US-PFM-2023-06843$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.71$KG$20240710$$CN$US$US
240749331$24074933$1$I$$20231128$20240710$20240710$PER$$US-PFM-2023-06865$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.712$KG$20240710$$CN$US$US
240749341$24074934$1$I$$20231122$20240710$20240710$PER$$CA-PFM-2023-06734$PIERRE FABRE MEDICAMENT$$53$YR$$F$Y$$$20240710$$CN$CA$CA
240749351$24074935$1$I$$20231128$20240710$20240710$PER$$US-PFM-2023-06864$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.163$KG$20240710$$CN$US$US
240749361$24074936$1$I$20231101$20231129$20240710$20240710$PER$$US-PFM-2023-06868$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240710$$PH$US$US
240749371$24074937$1$I$$20231128$20240710$20240710$PER$$US-PFM-2023-06867$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.15$KG$20240710$$CN$US$US
240749381$24074938$1$I$$20231130$20240710$20240710$PER$$US-PFM-2023-06916$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.279$KG$20240710$$CN$US$US
240749391$24074939$1$I$$20231129$20240710$20240710$PER$$US-PFM-2023-06869$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.798$KG$20240710$$CN$US$US
240749401$24074940$1$I$20231122$20240126$20240710$20240710$PER$$JP-PFM-2023-06882$PIERRE FABRE MEDICAMENT$$3$MON$$$Y$$$20240710$$MD$JP$JP
240749411$24074941$1$I$$20240424$20240710$20240710$PER$$US-PFM-2023-06331$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240710$$CN$US$US
240749422$24074942$2$F$$20240711$20240710$20240715$EXP$$LB-PFIZER INC-2019SGN03298$PFIZER$Haidar, N.. Unusual side effect of brentuximab vedotin in a Hodgkin lymphoma. Clinical Lymphoma, Myeloma + Leukemia. 2019;9:supplement 1:S305-6$22$YR$$M$Y$$$20240715$$HP$LB$LB
240749431$24074943$1$I$$20240329$20240710$20240710$PER$$US-PFM-2023-06589$PIERRE FABRE MEDICAMENT$$$$$F$Y$14.6$KG$20240710$$CN$US$US
240749441$24074944$1$I$20240707$20240710$20240710$20240710$DIR$709742$$FDA-CTU$$58$YR$$F$N$68$KG$20240710$N$$US$
240749451$24074945$1$I$$20240327$20240710$20240710$PER$$US-PFM-2023-06296$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.4$KG$20240710$$HP$US$US
240749464$24074946$4$F$$20240715$20240710$20240722$EXP$$IE-ABBVIE-5830408$ABBVIE$$$$A$F$Y$$$20240719$$CN$IE$IE
240749471$24074947$1$I$20240710$20240710$20240710$20240710$DIR$709691$$FDA-CTU$$41$YR$$F$N$94.5$KG$20240710$N$CN$US$
240749481$24074948$1$I$$20231130$20240710$20240710$PER$$US-PFM-2023-06917$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.587$KG$20240710$$CN$US$US
240749491$24074949$1$I$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133596$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$59$YR$A$M$Y$$$20240710$$HP$US$US
240749501$24074950$1$I$$20240508$20240710$20240710$PER$$US-PFM-2023-06710$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.39$KG$20240710$$HP$US$US
240749511$24074951$1$I$20231120$20240521$20240710$20240710$PER$$US-PFM-2023-06669$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6.37$KG$20240710$$HP$US$US
240749522$24074952$2$F$20230101$20240723$20240710$20240731$EXP$$US-BAYER-2024A097628$BAYER$$63$YR$A$M$Y$$$20240731$$CN$US$US
240749534$24074953$4$F$20240628$20240805$20240710$20240809$EXP$$US-APELLIS-2024-APL-0000391$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240809$$CN$US$US
240749541$24074954$1$I$$20231106$20240710$20240710$PER$$IT-PFM-2023-06396$PIERRE FABRE MEDICAMENT$Nigris AD, Arenella M, Nardo GD, Marco GMD, Mormile A, Lauretta D et al. The diagnostic and therapeutic challenge  of atrial flutter in children: a case report. Italian Journal of Pediatrics. 2023;49:137$11$YR$$M$Y$$$20240710$$HP$IT$IT
240749551$24074955$1$I$$20231113$20240710$20240710$PER$$GR-PFM-2023-06531$PIERRE FABRE MEDICAMENT$Armeni AK, Markantes GK, Stathopoulou A, Saltiki K, Zampakis P, Assimakopoulos SF et al. Thyroid eye disease as initial manifestation of graves^ disease following viral vector SARS-CoV-2 vaccine: report of a case and review of the literature. Vaccines. 2023;11:1574$63$YR$$F$Y$$$20240710$$HP$GR$GR
240749561$24074956$1$I$$20231113$20240710$20240710$PER$$CA-PFM-2023-06530$PIERRE FABRE MEDICAMENT$Peloquin ID, St-Jean M. A Case of T3 Thyrotoxicosis. Journal of the Endocrine Society. 2020;4:A204-5$24$YR$$M$Y$$$20240710$$HP$CA$CA
240749571$24074957$1$I$$20231113$20240710$20240710$PER$$NL-PFM-2023-06532$PIERRE FABRE MEDICAMENT$Bergeman AT, Robyns T, Amin AS, Wilde AAM, Werf Cvd. Importance of exercise stress testing in evaluation of unexplained cardiac arrest survivor. Neth Heart J. 2023;31:444-51$40$YR$$F$Y$$$20240710$$HP$NL$NL
240749581$24074958$1$I$$20231116$20240710$20240710$PER$$JP-PFM-2023-06571$PIERRE FABRE MEDICAMENT$Takeyama M, Furukawa S, Ogiwara K, Nogami K. First case report of hematidrosis complicated with type 1 von Willebrand disease. Pediatrics International. 2023;65:e15615:1-2$14$YR$$F$Y$$$20240710$$HP$JP$JP
240749591$24074959$1$I$$20231113$20240710$20240710$PER$$KR-PFM-2023-06533$PIERRE FABRE MEDICAMENT$Kim SH, Baek CO, Kim JH, Song SK. A rare case of graves^ thyrotoxicosis with concomitant pulmonary alveolar proteinosis. Acta Endocrinologica (Buc). 2023;19(2):241-4$62$YR$$F$Y$$$20240710$$HP$KR$KR
240749601$24074960$1$I$$20231120$20240710$20240710$PER$$JP-PFM-2023-06780$PIERRE FABRE MEDICAMENT$Sasaoka D. A case of neonatal Basedow^s disease born to a mother with TRAb { 5 IU/L and Basedow^s disease. The Japanese journal of endocrinology. 2023;99(2):601$$$N$$Y$$$20240710$$MD$JP$JP
240749611$24074961$1$I$$20231121$20240710$20240710$PER$$US-PFM-2023-06711$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.9$KG$20240710$$HP$US$US
240749621$24074962$1$I$$20231120$20240710$20240710$PER$$JP-PFM-2023-06690$PIERRE FABRE MEDICAMENT$Kashima T, Ujita N, Igarashi M, Doi H, Yoshii K, Naiki Y et al. A Study Of 21 Cases Of Graves Disease In Childhood Presenting At Our Hospital For The First Time. Journal of the Endocrine Society. 2023;7(1):A794-5$$$$$Y$$$20240710$$HP$JP$JP
240749631$24074963$1$I$$20231121$20240710$20240710$PER$$JP-PFM-2023-06823$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240710$$PH$JP$JP
240749641$24074964$1$I$$20231122$20240710$20240710$PER$$TR-PFM-2023-06726$PIERRE FABRE MEDICAMENT$Erol N, Alpinar A, Kulcu NU. Infantile hemangiomatosis, a rare cause of high-output heart failure and pulmonary hypertension in the newborn baby: a case report. Cardiology in the Young. 2023;33:2133-35$36$DY$$F$Y$$$20240710$$HP$TR$TR
240749651$24074965$1$I$$20231124$20240710$20240710$PER$$TR-PFM-2023-06572$PIERRE FABRE MEDICAMENT$Sengul FS, Kafali HC, Ergul Y. Unmasking the uncommon: bidirectional ventricular tachycardia in two rare paediatric cardiomyopathies. Cardiology in the Young. 2023;33:2101-3$14$YR$$F$Y$$$20240710$$HP$TR$TR
240749661$24074966$1$I$$20231127$20240710$20240710$PER$$JP-PFM-2023-06911$PIERRE FABRE MEDICAMENT$Hiruta S. Case report of a neonatal female with diffuse neonatal haemangiomatosis complicated by fetomaternal hemorrhage. Journal of Japan Society for Neonatal Health and Development. 2023;35(3):608$16$DY$$F$Y$$$20240710$$MD$JP$JP
240749671$24074967$1$I$$20231120$20240710$20240710$PER$$HR-PFM-2023-06682$PIERRE FABRE MEDICAMENT$Mahovic D, Bracic M. Erenumab as treatment for recurrent painful ophthalmoplegic neuropathy. Progress in Neurology and Psychiatry. 2023;27(4):19-21$31$YR$$F$Y$$$20240710$$MD$HR$HR
240749681$24074968$1$I$20240501$20240514$20240710$20240710$PER$$US-PFM-2023-06866$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.9$KG$20240710$$CN$US$US
240749691$24074969$1$I$20240306$20240708$20240710$20240710$EXP$$US-UCBSA-2024034543$UCB$$81$YR$$F$Y$$$20240710$$HP$US$US
240749701$24074970$1$I$$20231204$20240710$20240710$PER$$JP-PFM-2023-06923$PIERRE FABRE MEDICAMENT$Ohtani S, Watanabe N, Ihara K, Takahashi N, Miyazaki N, Ishizuchi K et al. Real-world evidence of fremanezumab  for treating migraine in Japan: a retrospective study. BMC Neurology. 2023;23(404):1-11$$$$F$Y$$$20240710$$HP$JP$JP
240749711$24074971$1$I$$20231204$20240710$20240710$PER$$TR-PFM-2023-06930$PIERRE FABRE MEDICAMENT$Ozge A, Domac FM, Tekin N, Sunbul EA, Oksuz N, Atalar AC et al. One Patient, Three Providers: A Multidisciplinary Approach to Managing Common Neuropsychiatric Cases. Journal of Clinical Medicine. 2023;12:5754$28$YR$$F$Y$$$20240710$$HP$TR$TR
240749721$24074972$1$I$$20231204$20240710$20240710$PER$$TR-PFM-2023-06924$PIERRE FABRE MEDICAMENT$Nalcacioglu H, Onal H, Yucle B, Karali D, Erdeniz E, Tuncer G et al. Case report: Thrombotic microangiopathy in pediatric multisystem inflammatory syndrome associated with COVID-19: a case series. Frontiers in pediatrics. 2023;1-6$7$YR$$F$Y$$$20240710$$HP$TR$TR
240749731$24074973$1$I$$20231204$20240710$20240710$PER$$US-PFM-2023-06925$PIERRE FABRE MEDICAMENT$Hertz D, Scorza F, Fiorini A, Finsterer J. SARS-CoV-2 vaccination complicated by small fiber neuropathy, mast cell activation syndrome, and pericarditis. Clinics. 2023;1-2$66$YR$$F$Y$$$20240710$$HP$US$US
240749741$24074974$1$I$20170203$20231214$20240710$20240710$PER$$JP-PFM-2023-06913$PIERRE FABRE MEDICAMENT$Kudo K. Treatment of Infantile Haemangioma in our hospital. The Nishinihon Journal of Dermatology. 2023;85(5):416$$$I$F$Y$4.98$KG$20240710$$MD$JP$JP
240749752$24074975$2$F$$20240814$20240710$20240821$EXP$$BG-ABBVIE-5832869$ABBVIE$$62$YR$$M$Y$$$20240821$$CN$BG$BG
240749761$24074976$1$I$$20240708$20240710$20240710$PER$$US-ABBVIE-5832092$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
240749771$24074977$1$I$$20240625$20240710$20240710$PER$$US-TEVA-VS-3213895$TEVA$$$$$$Y$$$20240710$$HP$US$US
240749781$24074978$1$I$$20240702$20240710$20240710$EXP$$ES-AstraZeneca-2024A153252$ASTRAZENECA$$75$YR$$F$Y$$$20240710$$PH$ES$
240749791$24074979$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A152507$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240749802$24074980$2$F$$20240812$20240710$20240814$EXP$$US-PFIZER INC-202400209983$PFIZER$$88$YR$$F$Y$$$20240814$$CN$US$US
240749811$24074981$1$I$20240704$20240708$20240710$20240710$PER$$US-PFIZER INC-PV202400089752$PFIZER$$70$YR$$F$Y$$$20240710$$CN$US$US
240749822$24074982$2$F$$20240808$20240710$20240812$PER$$US-PFIZER INC-202400209411$PFIZER$$35$YR$$F$Y$$$20240812$$MD$US$US
240749833$24074983$3$F$$20240819$20240710$20240823$PER$$US-PFIZER INC-PV202400072164$PFIZER$$65$YR$$F$Y$57.15$KG$20240823$$CN$US$US
240749841$24074984$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-202400210077$PFIZER$$73$YR$$F$Y$$$20240710$$HP$US$US
240749851$24074985$1$I$20240625$20240708$20240710$20240710$PER$$US-PFIZER INC-202300373174$PFIZER$$47$YR$$M$Y$$$20240710$$HP$US$US
240749862$24074986$2$F$20240701$20240723$20240710$20240725$PER$$US-PFIZER INC-202400210203$PFIZER$$79$YR$$F$Y$90.703$KG$20240725$$CN$US$US
240749871$24074987$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-PV202400090132$PFIZER$$55$YR$$M$Y$$$20240710$$HP$US$US
240749881$24074988$1$I$20240101$20240709$20240710$20240710$PER$$US-PFIZER INC-202400209796$PFIZER$$79$YR$$F$Y$$$20240710$$CN$US$US
240749891$24074989$1$I$20240707$20240708$20240710$20240710$PER$$US-PFIZER INC-202400209126$PFIZER$$50$YR$$F$Y$$$20240710$$CN$US$US
240749901$24074990$1$I$$20240709$20240710$20240710$PER$$US-PFIZER INC-202400209990$PFIZER$$23$YR$$M$Y$$$20240710$$HP$US$US
240749911$24074991$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-202400209880$PFIZER$$27$YR$$F$Y$$$20240710$$MD$US$US
240749921$24074992$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-2024SGN01328$PFIZER$$52$YR$$F$Y$$$20240710$$CN$US$US
240749932$24074993$2$F$$20240916$20240710$20240919$PER$$US-PFIZER INC-202400209994$PFIZER$$65$YR$$F$Y$$$20240919$$MD$US$US
240749944$24074994$4$F$20240101$20240924$20240710$20240930$EXP$$US-PFIZER INC-202400209668$PFIZER$$87$YR$$F$Y$58.957$KG$20240929$$CN$US$US
240749952$24074995$2$F$20240708$20240816$20240710$20240821$PER$$US-PFIZER INC-202400201861$PFIZER$$15$YR$$F$Y$49.887$KG$20240821$$HP$US$US
240749961$24074996$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-PV202400089547$PFIZER$$79$YR$$F$Y$$$20240710$$CN$US$US
240749971$24074997$1$I$$20240626$20240710$20240710$PER$$US-SA-2024SA194715$SANOFI AVENTIS$$$$T$F$Y$$$20240710$$MD$US$US
240749981$24074998$1$I$$20240708$20240710$20240710$EXP$$US-ABBVIE-5832876$ABBVIE$$$$$F$Y$$$20240710$$HP$US$US
240749991$24074999$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198433$SANOFI AVENTIS$$$$A$F$Y$$$20240710$$MD$US$US
240750001$24075000$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198173$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240710$$MD$US$US
240750011$24075001$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198872$SANOFI AVENTIS$$$$A$M$Y$$$20240710$$MD$US$US
240750021$24075002$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA199276$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240710$$MD$US$US
240750031$24075003$1$I$20240330$20240701$20240710$20240710$PER$$US-SA-2024SA198644$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240710$$MD$US$US
240750041$24075004$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197674$SANOFI AVENTIS$$61$YR$A$F$Y$65.7$KG$20240710$$MD$US$US
240750051$24075005$1$I$20240301$20240701$20240710$20240710$PER$$US-SA-2024SA197812$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240710$$MD$US$US
240750061$24075006$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186290$Haleon PLC$$$$$F$Y$$$20240710$$CN$US$US
240750071$24075007$1$I$$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407006215$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240710$$PH$US$US
240750081$24075008$1$I$$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407006180$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240710$$CN$US$US
240750091$24075009$1$I$$20240703$20240710$20240710$EXP$$GB-JNJFOC-20240712833$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240710$$CN$GB$GB
240750101$24075010$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186268$Haleon PLC$$54$YR$$M$Y$$$20240710$$CN$US$US
240750112$24075011$2$F$$20240802$20240710$20240809$EXP$$US-GSK-US2024AMR083276$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$US$US
240750121$24075012$1$I$$20240627$20240710$20240710$EXP$$US-Avondale Pharmaceuticals, LLC-2159006$AVONDALE PHARMACEUTICALS$Initial$55$YR$$F$Y$$$20240710$$MD$US$US
240750141$24075014$1$I$20231117$20240710$20240710$20240710$EXP$IT-MINISAL02-994195$NVSC2024IT142295$NOVARTIS$$82$YR$$F$Y$$$20240710$$MD$IT$IT
240750151$24075015$1$I$$20240704$20240710$20240710$EXP$$GB-MYLANLABS-2024M1062948$MYLAN$$$$$F$Y$$$20240710$$PH$GB$GB
240750161$24075016$1$I$20240101$20240701$20240710$20240710$EXP$$US-TEVA-VS-3217316$TEVA$$$$$F$Y$$$20240710$$CN$US$US
240750171$24075017$1$I$20211101$20240709$20240710$20240710$EXP$GR-GREOF-202400745$GR-ORGANON-O2407GRC000869$ORGANON$$47$YR$$F$Y$80$KG$20240710$$MD$GR$GR
240750181$24075018$1$I$20240619$20240709$20240710$20240710$EXP$FR-AFSSAPS-GR2024000866$FR-EXELIXIS-CABO-24079273$EXELIXIS$$53$YR$$M$Y$72$KG$20240710$$PH$FR$FR
240750191$24075019$1$I$20240621$20240701$20240710$20240710$EXP$$CN-009507513-2407CHN002514$MERCK$$56$YR$$F$Y$$$20240710$$HP$CN$CN
240750201$24075020$1$I$20240601$20240704$20240710$20240710$EXP$$CN-009507513-2407CHN003627$MERCK$$82$YR$$M$Y$$$20240710$$HP$CN$CN
240750212$24075021$2$F$$20240710$20240710$20240712$PER$$US-PFIZER INC-PV202400090136$PFIZER$$$$$$Y$$$20240712$$HP$US$US
240750222$24075022$2$F$20240706$20240729$20240710$20240801$PER$$US-PFIZER INC-202400210531$PFIZER$$82$YR$$M$Y$81.633$KG$20240801$$CN$US$US
240750231$24075023$1$I$$20240709$20240710$20240710$PER$$US-PFIZER INC-202400209884$PFIZER$$77$YR$$F$Y$90.72$KG$20240710$$CN$US$US
240750245$24075024$5$F$20240708$20240804$20240710$20240806$PER$$US-PFIZER INC-202400209887$PFIZER$$27$YR$$F$Y$68.027$KG$20240806$$CN$US$US
240750251$24075025$1$I$$20240709$20240710$20240710$PER$$US-PFIZER INC-202400209822$PFIZER$$39$YR$$F$Y$$$20240710$$CN$US$US
240750261$24075026$1$I$20240101$20240709$20240710$20240710$PER$$US-PFIZER INC-202400209813$PFIZER$$44$YR$$M$Y$$$20240710$$CN$US$US
240750271$24075027$1$I$20240708$20240709$20240710$20240710$PER$$US-PFIZER INC-202400209555$PFIZER$$36$YR$$F$Y$$$20240710$$CN$US$US
240750281$24075028$1$I$20240501$20240709$20240710$20240710$PER$$US-PFIZER INC-202400209806$PFIZER$$81$YR$$F$Y$$$20240710$$CN$US$US
240750291$24075029$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186276$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240750301$24075030$1$I$20240630$20240703$20240710$20240710$EXP$$NVSC2024CN139799$NOVARTIS$$$$$M$Y$$$20240710$$CN$CN$CN
240750311$24075031$1$I$20240525$20240704$20240710$20240710$EXP$FR-AFSSAPS-PB2024000692$FR-009507513-2407FRA002552$MERCK$$52$YR$$F$Y$$$20240710$$MD$FR$FR
240750331$24075033$1$I$20240515$20240704$20240710$20240710$EXP$FR-AFSSAPS-AN2024000856$FR-MYLANLABS-2024M1063072$MYLAN$$58$YR$$M$Y$60$KG$20240710$$PH$FR$FR
240750341$24075034$1$I$$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136632$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240750352$24075035$2$F$20240704$20240711$20240710$20240713$PER$$US-AMGEN-USASP2024134314$AMGEN$$76$YR$E$F$Y$$$20240713$$CN$US$US
240750361$24075036$1$I$20240706$20240708$20240710$20240710$EXP$$US-ABBVIE-5833085$ABBVIE$$77$YR$$M$Y$$$20240710$$CN$US$US
240750371$24075037$1$I$20240501$20240703$20240710$20240710$EXP$$US-SA-2024SA199750$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240710$$MD$US$US
240750382$24075038$2$F$20230919$20240802$20240710$20240806$EXP$$JP-ABBVIE-5833320$ABBVIE$$47$YR$$M$Y$$$20240806$$MD$JP$JP
240750391$24075039$1$I$$20240710$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038945$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240710$$CN$US$US
240750401$24075040$1$I$$20240701$20240710$20240710$PER$$US-TEVA-VS-3218085$TEVA$$$$$$Y$$$20240710$$HP$US$US
240750421$24075042$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186271$Haleon PLC$$54$YR$$M$Y$$$20240710$$CN$US$US
240750432$24075043$2$F$20230710$20240802$20240710$20240809$EXP$$US-GSK-US2024AMR083278$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$US$US
240750451$24075045$1$I$20240611$20240704$20240710$20240710$EXP$$GB-MYLANLABS-2024M1061582$MYLAN$$$$$M$Y$$$20240710$$HP$GB$GB
240750461$24075046$1$I$$20240701$20240710$20240710$EXP$$US-RADIUS HEALTH INC.-2024US004848$RADIUS PHARM$$$$$F$Y$$$20240710$$CN$US$US
240750472$24075047$2$F$20240605$20240710$20240710$20240717$EXP$$GB-009507513-2407GBR003394$MERCK$$33$YR$$F$Y$71.5$KG$20240717$$HP$GB$GB
240750481$24075048$1$I$20240209$20240704$20240710$20240710$EXP$IT-MINISAL02-992875$IT-MYLANLABS-2024M1063419$MYLAN$$76$YR$$F$Y$$$20240710$$MD$IT$IT
240750491$24075049$1$I$$20240628$20240710$20240710$PER$$US-TEVA-VS-3216094$TEVA$$$$$F$Y$$$20240710$$CN$US$US
240750501$24075050$1$I$$20240528$20240710$20240710$PER$$US-Nostrum Laboratories, Inc.-2159007$NOSTRUM$$$$$$Y$$$20240710$$$US$US
240750522$24075052$2$F$20240601$20240816$20240710$20240830$PER$$US-SA-2024SA201225$SANOFI AVENTIS$$32$YR$A$M$Y$90.718$KG$20240830$$MD$US$US
240750531$24075053$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA199359$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240710$$MD$US$US
240750541$24075054$1$I$$20240627$20240710$20240710$PER$$US-SA-2024SA194549$SANOFI AVENTIS$$44$YR$A$F$Y$90.71$KG$20240710$$MD$US$US
240750551$24075055$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA199327$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240710$$MD$US$US
240750562$24075056$2$F$20240601$20240724$20240710$20240731$EXP$$JP-BAYER-2024A098310$BAYER$$$$$M$Y$$$20240731$$PH$JP$JP
240750571$24075057$1$I$$20240702$20240710$20240710$PER$$US-JNJFOC-20240708127$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240750581$24075058$1$I$20231020$20240708$20240710$20240710$EXP$FR-AFSSAPS-AM2023001020$FR-MYLANLABS-2023M1132366$MYLAN$$33$YR$$F$Y$79$KG$20240710$$MD$FR$FR
240750592$24075059$2$F$20240517$20240812$20240710$20240813$PER$$US-ROCHE-10000020659$ROCHE$$41$YR$A$M$Y$89.81$KG$20240813$$CN$US$US
240750601$24075060$1$I$20240401$20240703$20240710$20240710$EXP$$CO-GSK-CO2024AMR051678$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$CO$CO
240750611$24075061$1$I$$20240705$20240710$20240710$EXP$$JP-GSK-JP2024084521$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$JP$JP
240750631$24075063$1$I$$20240705$20240710$20240710$PER$$US-ROCHE-10000021314$ROCHE$$$$A$M$Y$$$20240710$$CN$US$US
240750641$24075064$1$I$20240615$20240705$20240710$20240710$PER$$US-ROCHE-10000020595$ROCHE$$42$YR$A$M$Y$$$20240710$$CN$US$US
240750651$24075065$1$I$20240701$20240705$20240710$20240710$PER$$US-ROCHE-10000020842$ROCHE$$29$YR$A$M$Y$$$20240710$$HP$US$US
240750661$24075066$1$I$$20240702$20240710$20240710$PER$$US-ROCHE-10000019245$ROCHE$$74$YR$E$F$Y$$$20240710$$CN$US$US
240750671$24075067$1$I$20240601$20240705$20240710$20240710$PER$$US-ROCHE-10000020986$ROCHE$$25$YR$A$M$Y$$$20240710$$CN$US$US
240750681$24075068$1$I$20240628$20240705$20240710$20240710$PER$$US-ROCHE-10000021382$ROCHE$$38$YR$A$M$Y$$$20240710$$CN$US$US
240750691$24075069$1$I$$20240705$20240710$20240710$PER$$US-ROCHE-10000021217$ROCHE$$$$A$M$Y$$$20240710$$CN$US$US
240750701$24075070$1$I$$20240703$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-020598$UNITED THERAPEUTICS$$$$$F$Y$59.864$KG$20240710$$$US$US
240750711$24075071$1$I$$20240513$20240710$20240710$PER$$US-Eisai-EC-2024-165702$EISAI$$$$$F$Y$$$20240710$$MD$US$US
240750722$24075072$2$F$20240708$20240711$20240710$20240713$PER$$US-AMGEN-USASP2024136652$AMGEN$$66$YR$E$M$Y$$$20240713$$CN$US$US
240750731$24075073$1$I$20240620$20240704$20240710$20240710$EXP$IT-MINISAL02-993113$IT-BAXTER-2024BAX021187$BAXTER$$56$YR$$M$Y$$$20240710$$MD$IT$IT
240750741$24075074$1$I$$20240705$20240710$20240710$PER$$US-ROCHE-10000021503$ROCHE$$$$T$M$Y$$$20240710$$CN$US$US
240750751$24075075$1$I$$20240705$20240710$20240710$PER$$US-ROCHE-10000020509$ROCHE$$$$A$M$Y$$$20240710$$CN$US$US
240750761$24075076$1$I$20240612$20240703$20240710$20240710$PER$$US-ROCHE-10000020347$ROCHE$$18$YR$A$M$Y$$$20240710$$CN$US$US
240750776$24075077$6$F$20240101$20240815$20240710$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-020885$UNITED THERAPEUTICS$$$$$M$Y$$$20240822$$$US$US
240750794$24075079$4$F$20240101$20240722$20240710$20240730$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020890$UNITED THERAPEUTICS$$$$$F$Y$$$20240730$$$US$US
240750802$24075080$2$F$$20240918$20240710$20240927$EXP$$US-PFIZER INC-202400200999$PFIZER$$71$YR$$M$Y$$$20240927$$CN$US$US
240750821$24075082$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005520$ELI LILLY AND CO$$$$$F$Y$$$20240710$$CN$US$US
240750831$24075083$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005525$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240710$$CN$US$US
240750842$24075084$2$F$$20240911$20240710$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202407004497$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240918$$CN$US$US
240750852$24075085$2$F$20231118$20240802$20240710$20240806$EXP$$JP-AstraZeneca-2023A272944$ASTRAZENECA$$69$YR$$M$Y$$$20240806$$MD$JP$
240750861$24075086$1$I$$20240702$20240710$20240710$EXP$$ZA-AstraZeneca-2024A153479$ASTRAZENECA$$67$YR$$M$Y$$$20240710$$CN$ZA$
240750871$24075087$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A152336$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240750891$24075089$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157676$ASTRAZENECA$$46$YR$$M$Y$67$KG$20240710$$HP$FR$
240750903$24075090$3$F$20240701$20240802$20240710$20240805$PER$$US-AMGEN-USASP2024136658$AMGEN$$74$YR$E$M$Y$$$20240805$$CN$US$US
240750911$24075091$1$I$$20240705$20240710$20240710$EXP$$IN-AstraZeneca-2024A155336$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$IN$
240750922$24075092$2$F$20221101$20240705$20240710$20240711$EXP$$CA-JNJFOC-20230515783$JOHNSON AND JOHNSON$$49$YR$A$M$Y$88$KG$20240711$$HP$CA$CA
240750931$24075093$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157183$ASTRAZENECA$$79$YR$$M$Y$87$KG$20240710$$HP$FR$
240750941$24075094$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109709$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240710$$CN$US$US
240750951$24075095$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109662$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$HP$US$US
240750961$24075096$1$I$$20240708$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108835$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240710$$MD$US$US
240750971$24075097$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109324$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240710$$CN$US$US
240750981$24075098$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109087$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$65$YR$E$M$Y$$$20240710$$HP$US$US
240751001$24075100$1$I$$20240704$20240710$20240710$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107326$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$85$KG$20240710$$PH$CA$CA
240751011$24075101$1$I$20240702$20240709$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109598$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240710$$CN$US$US
240751022$24075102$2$F$$20240807$20240710$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108501$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240808$$CN$US$US
240751031$24075103$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109112$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$49$YR$A$M$Y$$$20240710$$HP$US$US
240751042$24075104$2$F$$20240425$20240710$20240717$EXP$$JP-BIOVITRUM-2024-JP-009582$BIOVITRUM$$70$YR$$M$Y$$$20240717$$MD$JP$JP
240751061$24075106$1$I$20240613$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108617$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$87.09$KG$20240710$$HP$US$US
240751072$24075107$2$F$$20240704$20240710$20240716$EXP$$JP-BIOVITRUM-2024-JP-009520$BIOVITRUM$$8$DEC$$F$Y$$$20240716$$MD$JP$JP
240751092$24075109$2$F$20240611$20240703$20240710$20240711$EXP$$NVSC2024ES140160$NOVARTIS$$77$YR$$F$Y$$$20240711$$HP$ES$ES
240751101$24075110$1$I$$20240702$20240710$20240710$PER$$US-ROCHE-10000017545$ROCHE$$$$A$F$Y$$$20240710$$CN$US$US
240751111$24075111$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186321$Haleon PLC$$$$$M$Y$$$20240710$$CN$US$US
240751121$24075112$1$I$$20240704$20240710$20240710$PER$$US-SA-2024SA199596$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240710$$MD$US$US
240751131$24075113$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA196277$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240710$$CN$US$US
240751141$24075114$1$I$20240401$20240703$20240710$20240710$PER$$US-SA-2024SA199591$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240710$$MD$US$US
240751151$24075115$1$I$20240601$20240610$20240710$20240710$PER$$US-009507513-2406USA003429$MERCK$$90$YR$$F$Y$$$20240710$$CN$US$US
240751162$24075116$2$F$20240418$20240703$20240710$20240710$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-07612$IPSEN$$41$YR$A$F$Y$$$20240710$$HP$US$US
240751171$24075117$1$I$20240101$20240627$20240710$20240710$PER$$US-SA-2024SA194550$SANOFI AVENTIS$$70$YR$E$M$Y$73$KG$20240710$$MD$US$US
240751184$24075118$4$F$20240509$20240801$20240710$20240809$EXP$$DE-Ipsen Biopharmaceuticals, Inc.-2024-08209$IPSEN$$79$YR$E$M$Y$$$20240809$$HP$DE$DE
240751191$24075119$1$I$20240704$20240710$20240710$20240710$DIR$709743$$FDA-CTU$$72$YR$$M$N$78.3$KG$20240710$N$CN$US$
240751211$24075121$1$I$$20240710$20240710$20240710$DIR$709720$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240751231$24075123$1$I$$20240703$20240710$20240710$EXP$$CA-ANIPHARMA-2024-CA-003138$ANI$$55$YR$$F$Y$$$20240710$$HP$CA$CA
240751241$24075124$1$I$20240708$20240710$20240710$20240710$DIR$709724$$FDA-CTU$$69$YR$$F$N$72$KG$20240710$N$$US$
240751251$24075125$1$I$$20240703$20240710$20240710$PER$$NVSC2024US139850$NOVARTIS$$69$YR$$F$Y$$$20240710$$CN$US$US
240751262$24075126$2$F$$20240917$20240710$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109356$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$68.95$KG$20240925$$CN$US$US
240751271$24075127$1$I$$20240705$20240710$20240710$EXP$$US-GSK-US2024AMR084775$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$US$US
240751281$24075128$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109475$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$HP$US$US
240751292$24075129$2$F$$20240806$20240710$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109419$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240808$$CN$US$US
240751302$24075130$2$F$20240701$20240711$20240710$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109471$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$67.13$KG$20240715$$CN$US$US
240751311$24075131$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109101$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$55$YR$A$M$Y$$$20240710$$HP$US$US
240751321$24075132$1$I$$20240626$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109343$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240710$$CN$US$US
240751331$24075133$1$I$20240629$20240702$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105948$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240710$$CN$US$US
240751341$24075134$1$I$20240706$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108773$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240710$$CN$US$US
240751351$24075135$1$I$$20240706$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108557$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$CN$US$US
240751372$24075137$2$F$20230102$20240704$20240710$20240712$EXP$$JP-UCBSA-2024033919$UCB$$74$YR$$M$Y$$$20240712$$MD$JP$JP
240751385$24075138$5$F$$20240924$20240710$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109369$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240926$$CN$US$US
240751391$24075139$1$I$$20240705$20240710$20240710$PER$$US-ROCHE-10000021254$ROCHE$$$$A$M$Y$$$20240710$$CN$US$US
240751401$24075140$1$I$$20240703$20240710$20240710$PER$$US-ROCHE-10000021342$ROCHE$$76$YR$E$F$Y$$$20240710$$CN$US$US
240751411$24075141$1$I$$20240708$20240710$20240710$PER$$US-ROCHE-10000021203$ROCHE$$$$A$M$Y$$$20240710$$CN$US$US
240751421$24075142$1$I$$20240515$20240710$20240710$PER$$US-Eisai-EC-2024-165871$EISAI$$$$$$Y$$$20240710$$CN$US$US
240751434$24075143$4$F$20240626$20240912$20240710$20240924$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06513$NEUROCRINE BIOSCIENCES$$71$YR$$M$Y$$$20240924$$CN$US$US
240751441$24075144$1$I$20220101$20240521$20240710$20240710$PER$$US-Eisai-EC-2023-135325$EISAI$$$$$M$Y$$$20240710$$PH$US$US
240751452$24075145$2$F$$20240823$20240710$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109368$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240827$$CN$US$US
240751461$24075146$1$I$$20240703$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106402$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240710$$HP$US$US
240751471$24075147$1$I$20240616$20240708$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108977$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$72.12$KG$20240710$$HP$US$US
240751481$24075148$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109418$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240710$$CN$US$US
240751491$24075149$1$I$$20240703$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106605$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$94$KG$20240710$$CN$US$US
240751501$24075150$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109120$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$66$YR$E$M$Y$$$20240710$$HP$US$US
240751511$24075151$1$I$20240601$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109359$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240710$$CN$US$US
240751522$24075152$2$F$$20240805$20240710$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109198$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240812$$CN$US$US
240751532$24075153$2$F$$20240924$20240710$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109298$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240925$$CN$US$US
240751541$24075154$1$I$$20240705$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108368$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240710$$CN$US$US
240751551$24075155$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109032$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240710$$HP$US$US
240751561$24075156$1$I$$20240703$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107345$BRISTOL MYERS SQUIBB$Desai MY, Xu B, Rutkowski K, Ospina S, Smedira N, Thamilarasan M, et al. Right treatment for the right patient: mavacamten cannot fix everything. JACC: Cardiovascular Imaging. 2024 Jun 13;1-5. doi:10.1016/j.jcmg.2024.04.020.$71$YR$E$F$Y$$$20240710$$MD$US$US
240751572$24075157$2$F$$20240709$20240710$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109518$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240722$$PH$US$US
240751581$24075158$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109084$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$56$YR$A$M$Y$$$20240710$$HP$US$US
240751592$24075159$2$F$$20240924$20240710$20240925$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-107478$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240925$$MD$IL$IL
240751602$24075160$2$F$$20240813$20240710$20240819$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2023-106659$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240819$$CN$ES$ES
240751612$24075161$2$F$$20240708$20240710$20240711$EXP$$ZA-ABBVIE-5832189$ABBVIE$$74$YR$$M$Y$$$20240711$$CN$ZA$ZA
240751621$24075162$1$I$20240601$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108410$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240710$$HP$US$US
240751631$24075163$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109111$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$61$YR$A$M$Y$$$20240710$$HP$US$US
240751641$24075164$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109301$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$89.36$KG$20240710$$CN$US$US
240751652$24075165$2$F$$20240709$20240710$20240711$EXP$$GB-SANDOZ INC.-SDZ2024GB033690$SANDOZ$$$$E$F$Y$$$20240711$$CN$GB$GB
240751661$24075166$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A152243$ASTRAZENECA$$$$$M$Y$$$20240710$$HP$US$
240751691$24075169$1$I$20240401$20240702$20240710$20240710$EXP$$JP-AstraZeneca-2024A157865$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$JP$
240751702$24075170$2$F$$20240705$20240710$20240711$EXP$$US-AstraZeneca-2024A155506$ASTRAZENECA$$$$$M$Y$$$20240711$$CN$US$
240751711$24075171$1$I$20231205$20240702$20240710$20240710$EXP$$FR-AstraZeneca-2024A155998$ASTRAZENECA$$1$MON$$M$Y$5.2$KG$20240710$$MD$FR$
240751721$24075172$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A153412$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240751751$24075175$1$I$20220724$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47901$$FDA-CTU$$42$YR$$F$N$69.4$KG$20240709$N$CN$US$
240751761$24075176$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A152223$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240751771$24075177$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A153409$ASTRAZENECA$$$$$M$Y$99$KG$20240710$$CN$US$
240751781$24075178$1$I$20240501$20240705$20240710$20240710$EXP$$US-GSK-US2024083945$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$US$US
240751791$24075179$1$I$$20240705$20240710$20240710$EXP$$JP-AstraZeneca-2024A154894$ASTRAZENECA$$$$$F$Y$$$20240710$$MD$JP$
240751801$24075180$1$I$20240620$20240701$20240710$20240710$EXP$$IT-AstraZeneca-2024A147444$ASTRAZENECA$$70$YR$$M$Y$$$20240710$$MD$IT$
240751821$24075182$1$I$$20240703$20240710$20240710$EXP$$IE-TAKEDA-2024TUS068555$TAKEDA$$$$$F$Y$$$20240710$$CN$IE$IE
240751831$24075183$1$I$20240708$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47897$$FDA-CTU$$33$YR$$M$N$$$20240709$N$$US$
240751841$24075184$1$I$20240708$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47902$$FDA-CTU$$71$YR$$F$N$$$20240709$N$$US$
240751852$24075185$2$F$20240101$20240715$20240710$20240722$EXP$$CA-JNJFOC-20240648144$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$102$KG$20240721$$CN$CA$CA
240751861$24075186$1$I$$20240709$20240710$20240710$EXP$$US-JNJFOC-20240724080$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240710$$PH$US$US
240751871$24075187$1$I$$20240703$20240710$20240710$EXP$$BR-JNJFOC-20240714536$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240710$$CN$BR$BR
240751881$24075188$1$I$20240707$20240709$20240710$20240710$PER$$US-PFIZER INC-202400210334$PFIZER$$45$YR$$F$Y$$$20240710$$HP$US$US
240751891$24075189$1$I$$20240708$20240710$20240710$PER$$US-PFIZER INC-202400104214$PFIZER$$55$YR$$F$Y$$$20240710$$CN$US$US
240751901$24075190$1$I$$20240709$20240710$20240710$PER$$US-PFIZER INC-PV202400090330$PFIZER$$63$YR$$M$Y$$$20240710$$HP$US$US
240751911$24075191$1$I$20240705$20240709$20240710$20240710$PER$$US-PFIZER INC-202400210304$PFIZER$$58$YR$$F$Y$$$20240710$$MD$US$US
240751921$24075192$1$I$$20240709$20240710$20240710$PER$$US-PFIZER INC-202400210557$PFIZER$$$$$$Y$$$20240710$$MD$US$US
240751933$24075193$3$F$$20240903$20240710$20240905$PER$$US-PFIZER INC-PV202400089081$PFIZER$$20$YR$$F$Y$$$20240905$$HP$US$US
240751941$24075194$1$I$$20240709$20240710$20240710$PER$$US-PFIZER INC-202400210548$PFIZER$$$$$$Y$$$20240710$$MD$US$US
240751951$24075195$1$I$$20240710$20240710$20240710$PER$$US-PFIZER INC-202400211035$PFIZER$$43$YR$$F$Y$$$20240710$$CN$US$US
240751961$24075196$1$I$$20240709$20240710$20240710$EXP$$US-GILEAD-2024-0680174$GILEAD$$$$$$Y$$$20240710$$LW$US$US
240751971$24075197$1$I$20221028$20240626$20240710$20240710$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR006147$AEGERION$$$$$$Y$$$20240710$$MD$DE$DE
240751981$24075198$1$I$$20240708$20240710$20240710$EXP$$US-ABBVIE-5832620$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
240751991$24075199$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202407041609215930-WBTYK$GB-ABBVIE-5832176$ABBVIE$$$$$F$Y$$$20240710$$PH$GB$GB
240752002$24075200$2$F$20240101$20240718$20240710$20240724$PER$$US-VERTEX PHARMACEUTICALS-2024-002831$VERTEX$$$$$F$Y$$$20240724$$PH$US$US
240752022$24075202$2$F$20240101$20240801$20240710$20240806$EXP$$US-VERTEX PHARMACEUTICALS-2024-011182$VERTEX$$$$$F$Y$66$KG$20240806$$CN$US$US
240752031$24075203$1$I$20240308$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405021701577370-ZBMWG$GB-VERTEX PHARMACEUTICALS-2024-011234$VERTEX$$2$YR$$F$Y$12$KG$20240710$$MD$GB$GB
240752041$24075204$1$I$20190101$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405131421343420-PYVHS$GB-VERTEX PHARMACEUTICALS-2024-011216$VERTEX$$$$$F$Y$$$20240710$$PH$GB$GB
240752051$24075205$1$I$$20240703$20240710$20240710$PER$$US-VERTEX PHARMACEUTICALS-2024-011138$VERTEX$$$$$F$Y$$$20240710$$CN$US$US
240752061$24075206$1$I$$20240627$20240710$20240710$EXP$$US-P+L Developments of Newyork Corporation-2159008$PL DEVELOPMENTS$Initial$26$YR$$F$Y$$$20240710$$$US$US
240752072$24075207$2$F$$20240715$20240710$20240723$EXP$$FR-VERTEX PHARMACEUTICALS-2024-011240$VERTEX$Sermet-Gaudelus I, Benaboud S, Bui S, Bihouee T, Gautier S, Barboura M, et al.. Behavioural and sleep issues after initiation of elexacaftor-tezacaftor-ivacaftor in preschool-age children with cystic fibrosis. Lancet. 2024$$$C$$Y$$$20240723$$HP$FR$FR
240752081$24075208$1$I$20230601$20240706$20240710$20240710$EXP$$US-KYOWAKIRIN-2023BKK010312$KYOWA$$$$$$Y$$$20240710$$HP$US$US
240752091$24075209$1$I$$20240705$20240710$20240710$EXP$$CA-JNJFOC-20240716937$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240710$$HP$CA$CA
240752103$24075210$3$F$$20240822$20240710$20240826$PER$$NVSC2024US142724$NOVARTIS$$$$$F$Y$$$20240826$$MD$US$US
240752111$24075211$1$I$$20240709$20240710$20240710$EXP$IT-MINISAL02-994113$IT-GILEAD-2024-0680037$GILEAD$$84$YR$E$M$Y$$$20240710$$MD$IT$IT
240752121$24075212$1$I$$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136640$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240752141$24075214$1$I$$20240702$20240710$20240710$EXP$$IE-JNJFOC-20240707286$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240710$$HP$IE$IE
240752151$24075215$1$I$$20240412$20240710$20240710$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00357$UPSHER-SMITH$$$$$F$Y$52.608$KG$20240710$$MD$US$US
240752161$24075216$1$I$$20240528$20240710$20240710$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00448$UPSHER-SMITH$$$$$F$Y$$$20240710$$CN$US$US
240752171$24075217$1$I$$20240701$20240710$20240710$EXP$$US-RDY-LIT/USA/24/0009824$DR REDDYS$Laughter MR, Tegla CA, Pawar S, Moshir AS, Orlow SJ. Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C. JAAD Case Reports. 2024 Jul;49: 28-31. doi:10.1016/j.jdcr.2024.04.039.$37$YR$A$M$Y$$$20240710$$MD$US$US
240752191$24075219$1$I$$20240703$20240710$20240710$EXP$$US-MAYNE PHARMA-2024MYN000301$MAYNE$$$$$$Y$$$20240710$$CN$US$US
240752201$24075220$1$I$20240702$20240703$20240710$20240710$PER$$US-ROCHE-10000018661$ROCHE$$$$$$Y$$$20240710$$PH$US$US
240752212$24075221$2$F$$20240719$20240710$20240729$EXP$$SG-TEVA-VS-3217040$TEVA$Wong J, Samol J, Chai GT. Who^s to Blame? A Case of Drug-Induced Pneumonitis With Multiple Potential Culprits. Am-J-Respir-Crit-Care-Med 2024; 209 A2006.; Wong J, Samol J, Chai GT. Who^s to Blame? A Case of Drug-Induced Pneumonitis With Multiple Potential Culprits. Am-J-Respir-Crit-Care-Med 2024; 209 A2006.$62$YR$$M$Y$$$20240729$$HP$SG$SG
240752222$24075222$2$F$20231201$20240805$20240710$20240808$EXP$$NVSC2024GB135790$NOVARTIS$$49$YR$$F$Y$$$20240808$$HP$GB$GB
240752231$24075223$1$I$20210501$20240703$20240710$20240710$PER$$US-INCYTE CORPORATION-2024IN007089$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240752241$24075224$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA197929$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240710$$MD$US$US
240752252$24075225$2$F$20240601$20240723$20240710$20240729$EXP$$JP-AMGEN-JPNSP2024133390$AMGEN$$93$YR$E$F$Y$35$KG$20240729$$PH$JP$JP
240752261$24075226$1$I$20240201$20240312$20240710$20240710$PER$$US-BIOVITRUM-2024-US-004123$BIOVITRUM$$60$YR$A$M$Y$$$20240710$$CN$US$US
240752271$24075227$1$I$$20240703$20240710$20240710$PER$$US-ROCHE-10000017383$ROCHE$$$$$$Y$$$20240710$$CN$US$US
240752281$24075228$1$I$$20240703$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407003994$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240710$$CN$US$US
240752292$24075229$2$F$$20240715$20240710$20240718$PER$$US-ROCHE-10000019362$ROCHE$$$$A$F$Y$$$20240718$$CN$US$US
240752301$24075230$1$I$$20240626$20240710$20240710$EXP$$US-ALVOGEN-2024095012$ALVOGEN$Nwodim O, Karsalia R, Heslin ME, Lieberman AE, Wang SZ, Kalanuria AA, Elser HC, Driessen B, Caruso C, Anesi GL. Opioid-related xylazine toxicity manifesting as myonecrosis, rhabdomyolysis, multifocal ischemic cerebral infarcts, and cerebral edema. JACEP Open. 2024;5:e13187. doi:https://doi.org/10.1002/emp2.13187$27$YR$$F$Y$$$20240710$$MD$US$US
240752311$24075231$1$I$20240607$20240710$20240710$20240710$EXP$IT-MINISAL02-990147$IT-ROCHE-10000022442$ROCHE$$33$YR$A$M$Y$$$20240710$$MD$IT$IT
240752322$24075232$2$F$$20240815$20240710$20240823$EXP$$FR-TEVA-VS-3217499$TEVA$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.; Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-A...$26$YR$$M$Y$$$20240823$$HP$FR$FR
240752331$24075233$1$I$$20240703$20240710$20240710$PER$$US-INCYTE CORPORATION-2024IN007052$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240752342$24075234$2$F$$20240703$20240710$20240718$PER$$US-MYLANLABS-2024M1039039$MYLAN$$$$$M$Y$$$20240718$$PH$US$US
240752352$24075235$2$F$$20240919$20240710$20240924$PER$$US-ROCHE-10000021416$ROCHE$$$$A$F$Y$$$20240924$$CN$US$US
240752391$24075239$1$I$20240601$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024134023$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240752405$24075240$5$F$20240601$20240823$20240710$20240827$PER$$US-AMGEN-USASP2024135940$AMGEN$$73$YR$E$F$Y$$$20240827$$CN$US$US
240752411$24075241$1$I$$20240705$20240710$20240710$EXP$$TW-ABBVIE-5830058$ABBVIE$$10$YR$$F$Y$20$KG$20240710$$HP$TW$TW
240752421$24075242$1$I$20220606$20240710$20240710$20240710$EXP$$US-UCBSA-2024024483$UCB$$41$YR$$M$Y$$$20240710$$HP$US$US
240752431$24075243$1$I$20240101$20240709$20240710$20240710$EXP$$US-UCBSA-2024015553$UCB$$$$$F$Y$$$20240710$$CN$US$US
240752441$24075244$1$I$$20240708$20240710$20240710$PER$$US-ROCHE-10000020652$ROCHE$$$$A$F$Y$$$20240710$$CN$US$US
240752451$24075245$1$I$$20240701$20240710$20240710$EXP$$FR-TEVA-VS-3217500$TEVA$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$35$YR$$M$Y$$$20240710$$HP$FR$FR
240752481$24075248$1$I$$20240701$20240710$20240710$30DAY$$US-GSK-US2024083025$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240710$$CN$US$US
240752491$24075249$1$I$20240708$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47904$$FDA-CTU$$49$YR$$M$N$$$20240709$N$$US$
240752501$24075250$1$I$$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47889$$FDA-CTU$$51$YR$$F$N$$$20240709$N$$US$
240752511$24075251$1$I$20240707$20240709$20240709$20240709$DIR$FDA-CDER-CTU-2024-47895$$FDA-CTU$$55$YR$$F$N$104.33$KG$20240709$Y$PH$US$
240752522$24075252$2$F$$20240710$20240710$20240712$PER$$US-AMGEN-USASP2024136724$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240752532$24075253$2$F$20240708$20240710$20240710$20240712$PER$$US-AMGEN-USASP2024136709$AMGEN$$91$YR$E$M$Y$$$20240711$$CN$US$US
240752544$24075254$4$F$20240702$20240731$20240710$20240807$PER$$US-AMGEN-USASP2024134011$AMGEN$$77$YR$E$F$Y$63.6$KG$20240806$$PH$US$US
240752551$24075255$1$I$$20230811$20240710$20240710$PER$$US-Accord-374526$ACCORD$$$$$F$Y$$$20240710$$CN$US$US
240752561$24075256$1$I$20190101$20240626$20240710$20240710$EXP$$US-ALVOGEN-2024094989$ALVOGEN$Panjiyar BK, Changlani N, Medina C, Trevino LR. Cocaine, amphetamine, or titin: Unraveling the genetic underpinnings of dilated cardiomyopathy. Clinical Case Reports. 2024;12:e9069. doi:https://doi.org/10.1002/ccr3.9069$$$A$M$Y$$$20240710$$HP$US$US
240752571$24075257$1$I$$20240703$20240710$20240710$EXP$$NVSC2024BE139838$NOVARTIS$Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A et al.. PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer. COLD SPRING HARBOR MOLECULAR CASE STUDIES. 2023;9 (2):1-16$30$YR$$F$Y$$$20240710$$HP$BE$BE
240752581$24075258$1$I$$20231030$20240710$20240710$PER$$US-Accord-389309$ACCORD$$$$$F$Y$$$20240710$$CN$US$US
240752591$24075259$1$I$$20230626$20240710$20240710$PER$$US-Accord-365191$ACCORD$$$$$F$Y$$$20240710$$CN$US$US
240752601$24075260$1$I$$20230723$20240710$20240710$PER$$US-Accord-371175$ACCORD$$$$$F$Y$$$20240710$$CN$US$US
240752611$24075261$1$I$$20231127$20240710$20240710$PER$$US-Accord-394755$ACCORD$$$$$F$Y$$$20240710$$CN$US$US
240752621$24075262$1$I$$20230628$20240710$20240710$PER$$US-Accord-365782$ACCORD$$$$$F$Y$56.7$KG$20240710$$CN$US$US
240752631$24075263$1$I$$20240702$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106366$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240710$$HP$US$US
240752641$24075264$1$I$$20240702$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105918$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$$$20240710$$HP$US$US
240752651$24075265$1$I$$20240701$20240710$20240710$EXP$$FR-TEVA-VS-3217518$TEVA$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$33$YR$$M$Y$$$20240710$$HP$FR$FR
240752661$24075266$1$I$$20240702$20240710$20240710$EXP$$GB-AstraZeneca-2024A157500$ASTRAZENECA$$$$$F$Y$$$20240710$$MD$GB$
240752671$24075267$1$I$20231128$20240702$20240710$20240710$EXP$$FR-AstraZeneca-2024A155919$ASTRAZENECA$$1$MON$$M$Y$4.6$KG$20240710$$MD$FR$
240752686$24075268$6$F$20240601$20240917$20240710$20240923$30DAY$$US-PFIZER INC-202400205690$PFIZER$$13$YR$$F$Y$47.63$KG$20240923$$HP$US$US
240752693$24075269$3$F$$20240823$20240710$20240827$30DAY$$US-PFIZER INC-202400206858$PFIZER$$7$YR$$M$Y$$$20240827$$CN$US$US
240752704$24075270$4$F$$20240908$20240710$20240909$30DAY$$JP-PFIZER INC-PV202400086990$PFIZER$$13$YR$$M$Y$$$20240909$$MD$JP$JP
240752712$24075271$2$F$$20240902$20240710$20240904$30DAY$$JP-PFIZER INC-PV202400086998$PFIZER$$11$YR$$M$Y$$$20240904$$MD$JP$JP
240752722$24075272$2$F$$20240902$20240710$20240904$30DAY$$JP-PFIZER INC-PV202300136055$PFIZER$$13$YR$$M$Y$45$KG$20240904$$MD$JP$JP
240752731$24075273$1$I$20240101$20240702$20240710$20240710$EXP$$JP-AstraZeneca-2024A154167$ASTRAZENECA$$54$YR$$M$Y$$$20240710$$MD$JP$
240752741$24075274$1$I$20200519$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157492$ASTRAZENECA$$53$YR$$F$Y$$$20240710$$HP$FR$
240752751$24075275$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157356$ASTRAZENECA$$72$YR$$F$Y$$$20240710$$HP$FR$
240752761$24075276$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157035$ASTRAZENECA$$68$YR$$M$Y$$$20240710$$HP$FR$
240752771$24075277$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157695$ASTRAZENECA$$64$YR$$M$Y$$$20240710$$HP$FR$
240752781$24075278$1$I$$20240702$20240710$20240710$EXP$$ES-AstraZeneca-2024A154217$ASTRAZENECA$$$$$F$Y$$$20240710$$MD$ES$
240752791$24075279$1$I$$20240707$20240710$20240710$EXP$$US-TAKEDA-2024TUS070029$TAKEDA$$$$$M$Y$$$20240710$$MD$US$US
240752802$24075280$2$F$20230630$20240731$20240710$20240807$EXP$$CA-TAKEDA-2023TUS092593$TAKEDA$$44$YR$$M$Y$$$20240807$$HP$CA$CA
240752822$24075282$2$F$$20240708$20240710$20240713$EXP$$US-ABBVIE-5831935$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240752841$24075284$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063913$SANDOZ$$34$YR$$F$Y$75$KG$20240710$$MD$CA$CA
240752862$24075286$2$F$$20240701$20240710$20240913$EXP$$JP-BAYER-2024A095609$BAYER$Sumi H, Abe K, Endo S, Koseki K, Kato T, Michikami H, et al. A case of uterine myoma that rapidly enlarged after insertion of levonorgestrel-releasing IUS (LNG-IUS). Kanto Journal of Obstetrics and Gynecology. 2024;61(2):210$39$YR$A$F$Y$$$20240913$$HP$JP$JP
240752872$24075287$2$F$$20240719$20240710$20240729$EXP$$IT-TEVA-VS-3217664$TEVA$Celardo G, Scaffei E, Buchignani B, Donatelli G, Costagli M, Cristofani P, et al. Case report: Exploring chemoradiotherapy-induced leukoencephalopathy with 7T imaging and quantitative susceptibility mapping. Front-Neurol 2024; 15 1-6.; Celardo G, Scaffei E, Buchignani B, Donatelli G, Costagli M, Cristofani P, et al. Case report: Exploring chemoradiotherapy-induced leukoencephalopathy with 7T imaging and quantitative susceptibility mapping. Front-Neurol 2024; 15 1-6.; Celardo G, Scaffei E, Buc...$9$YR$$M$Y$$$20240729$$HP$IT$IT
240752881$24075288$1$I$20240509$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405171415438930-CKYNW$GB-MYLANLABS-2024M1063498$MYLAN$$$$N$M$Y$2$KG$20240710$$MD$GB$GB
240752891$24075289$1$I$20240101$20240701$20240710$20240710$PER$$US-SA-2024SA198791$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240710$$CN$US$US
240752901$24075290$1$I$20240101$20240702$20240710$20240710$PER$$US-SA-2024SA199116$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240710$$MD$US$US
240752911$24075291$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA199221$SANOFI AVENTIS$$62$YR$A$F$Y$77.11$KG$20240710$$MD$US$US
240752921$24075292$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA179113$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240710$$MD$US$US
240752931$24075293$1$I$$20240709$20240710$20240710$EXP$DE-PEI-202400012733$DE-ROCHE-10000021837$ROCHE$$$$A$$Y$$$20240710$$MD$DE$DE
240752941$24075294$1$I$$20240621$20240710$20240710$EXP$$KR-ROCHE-10000014458$ROCHE$$$$$$Y$$$20240710$$HP$KR$KR
240752951$24075295$1$I$20240627$20240703$20240710$20240710$PER$$US-SA-2024SA200743$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240710$$MD$US$US
240752961$24075296$1$I$20231220$20240704$20240710$20240710$EXP$$CA-TAKEDA-2024TUS001501$TAKEDA$$24$YR$$F$Y$54.4$KG$20240710$$HP$CA$CA
240752971$24075297$1$I$$20240708$20240710$20240710$EXP$$NVSC2024US141878$NOVARTIS$$$$$M$Y$$$20240710$$HP$US$US
240752981$24075298$1$I$$20240709$20240710$20240710$EXP$IT-MINISAL02-994116$IT-GILEAD-2024-0680046$GILEAD$$83$YR$E$F$Y$$$20240710$$MD$IT$IT
240752992$24075299$2$F$20240614$20240715$20240710$20240718$EXP$$US-JNJFOC-20240704900$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240718$$CN$US$US
240753001$24075300$1$I$$20240705$20240710$20240710$PER$$US-TAKEDA-2024TUS069291$TAKEDA$$$$$F$Y$$$20240710$$CN$US$US
240753011$24075301$1$I$$20240703$20240710$20240710$EXP$$US-GSK-US2024AMR082874$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$MD$US$US
240753021$24075302$1$I$20240601$20240621$20240710$20240710$PER$$US-TEVA-VS-3213494$TEVA$$67$YR$$F$Y$$$20240710$$CN$US$US
240753031$24075303$1$I$20240613$20240705$20240710$20240710$EXP$$NL-ABBVIE-5711089$ABBVIE$$$$E$M$Y$$$20240710$$CN$NL$NL
240753041$24075304$1$I$$20240703$20240710$20240710$EXP$$US-GILEAD-2024-0679600$GILEAD$$$$A$M$Y$$$20240710$$HP$US$US
240753051$24075305$1$I$20240626$20240710$20240710$20240710$PER$$US-BAYER-2024A099530$BAYER$$37$YR$A$F$Y$$$20240710$$CN$US$US
240753061$24075306$1$I$$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405130934371150-CKWVG$GB-SANDOZ INC.-SDZ2024GB063793$SANDOZ$$$$$$Y$$$20240710$$PH$GB$GB
240753072$24075307$2$F$20240705$20240710$20240710$20240713$EXP$$ES-ABBVIE-5833078$ABBVIE$$79$YR$$M$Y$$$20240713$$CN$ES$ES
240753081$24075308$1$I$20231228$20240701$20240710$20240710$EXP$$US-RADIUS HEALTH INC.-2024US004856$RADIUS PHARM$$67$YR$$F$Y$$$20240710$$CN$US$US
240753091$24075309$1$I$$20240708$20240710$20240710$EXP$$US-ABBVIE-5832076$ABBVIE$$$$$M$Y$$$20240710$$HP$US$US
240753102$24075310$2$F$20240101$20240727$20240710$20240801$EXP$$US-ABBVIE-5832531$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
240753111$24075311$1$I$$20240708$20240710$20240710$PER$$NVSC2024US142037$NOVARTIS$$48$YR$$F$Y$$$20240710$$HP$US$US
240753123$24075312$3$F$20240704$20240801$20240710$20240806$EXP$$BE-ABBVIE-5831732$ABBVIE$$43$YR$$F$Y$102$KG$20240806$$MD$BE$BE
240753133$24075313$3$F$20240601$20240822$20240710$20240827$EXP$$US-SANDOZ INC.-SDZ2024US064108$SANDOZ$$57$YR$$F$Y$$$20240827$$CN$US$US
240753141$24075314$1$I$20240101$20240708$20240710$20240710$EXP$$US-ABBVIE-5832017$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240753151$24075315$1$I$20240524$20240702$20240710$20240710$EXP$ES-AEMPS-1538966$ES-TEVA-VS-3216524$TEVA$$67$YR$$F$Y$$$20240710$$MD$ES$ES
240753161$24075316$1$I$$20240627$20240710$20240710$PER$$US-FARMAPROD-202407-2426$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240710$$CN$US$US
240753171$24075317$1$I$20240623$20240628$20240710$20240710$EXP$$US-FARMAPROD-202407-2442$DOMPE FARMACEUTICI$$93$YR$E$F$Y$$$20240710$$CN$US$US
240753181$24075318$1$I$$20240708$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063470$SANDOZ$$75$YR$$F$Y$$$20240710$$CN$CA$CA
240753191$24075319$1$I$20240626$20240627$20240710$20240710$PER$$US-FARMAPROD-202407-2414$DOMPE FARMACEUTICI$$72$YR$E$M$Y$$$20240710$$CN$US$US
240753201$24075320$1$I$$20240705$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063631$SANDOZ$$$$$$Y$$$20240710$$CN$US$US
240753211$24075321$1$I$$20240709$20240710$20240710$30DAY$$US-SANDOZ INC.-SDZ2024US063931$SANDOZ$$$$$M$Y$$$20240710$$CN$US$US
240753221$24075322$1$I$$20240703$20240710$20240710$PER$$DE-BRACCO-2024DE04072$BRACCO$$57$YR$$F$Y$$$20240710$$CN$DE$DE
240753231$24075323$1$I$$20240702$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-013227$UNITED THERAPEUTICS$$$$$M$Y$$$20240710$$$US$US
240753241$24075324$1$I$$20240702$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-014494$UNITED THERAPEUTICS$$$$$M$Y$83.9$KG$20240710$$$US$US
240753252$24075325$2$F$$20240715$20240710$20240717$EXP$$GB-MYLANLABS-2024M1063764$MYLAN$$$$$M$Y$$$20240717$$CN$GB$GB
240753261$24075326$1$I$$20240708$20240710$20240710$EXP$$US-PFIZER INC-202400209072$PFIZER$$68$YR$$F$Y$$$20240710$$CN$US$US
240753281$24075328$1$I$$20240708$20240710$20240710$EXP$PL-URPL-2-998-2019$PL-PFIZER INC-202400208455$PFIZER$$27$YR$$F$Y$$$20240710$$CN$PL$PL
240753291$24075329$1$I$20240528$20240708$20240710$20240710$EXP$$CN-PFIZER INC-PV202400089491$PFIZER$$75$YR$$M$Y$70$KG$20240710$$HP$CN$CN
240753302$24075330$2$F$$20240911$20240710$20240912$EXP$$NVSC2024GB141013$NOVARTIS$$$$$F$Y$$$20240912$$CN$GB$GB
240753312$24075331$2$F$20240629$20240806$20240710$20240815$EXP$$US-RADIUS HEALTH INC.-2024US004971$RADIUS PHARM$$79$YR$$M$Y$$$20240815$$MD$US$US
240753322$24075332$2$F$20240601$20240710$20240710$20240712$PER$$US-ABBVIE-5831842$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240753331$24075333$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004391$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240710$$CN$US$US
240753341$24075334$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004779$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240710$$CN$US$US
240753351$24075335$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004754$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240710$$MD$US$US
240753361$24075336$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407003940$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240710$$CN$US$US
240753371$24075337$1$I$20230601$20240702$20240710$20240710$EXP$FR-AFSSAPS-NT2024000747$FR-TEVA-VS-3216692$TEVA$$46$YR$$M$Y$$$20240710$$MD$FR$FR
240753381$24075338$1$I$$20240708$20240710$20240710$EXP$$GB-SANDOZ INC.-SDZ2024GB063882$SANDOZ$$$$$F$Y$$$20240710$$CN$GB$GB
240753391$24075339$1$I$$20240705$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063751$SANDOZ$$$$$$Y$$$20240710$$CN$US$US
240753401$24075340$1$I$20240708$20240708$20240710$20240710$EXP$$PT-ABBVIE-5832999$ABBVIE$$78$YR$$F$Y$$$20240710$$CN$PT$PT
240753411$24075341$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063898$SANDOZ$$63$YR$$M$Y$$$20240710$$CN$CA$CA
240753422$24075342$2$F$$20240730$20240710$20240802$EXP$$GB-SANDOZ INC.-SDZ2024GB034123$SANDOZ$$$$$M$Y$$$20240802$$CN$GB$GB
240753432$24075343$2$F$$20240730$20240710$20240731$EXP$$CA-ABBVIE-5833000$ABBVIE$$79$YR$$F$Y$$$20240731$$CN$CA$CA
240753442$24075344$2$F$$20240808$20240710$20240812$EXP$$NL-JNJFOC-20240717297$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$CN$NL$NL
240753451$24075345$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063854$SANDOZ$$43$YR$$F$Y$$$20240710$$HP$CA$CA
240753462$24075346$2$F$$20240719$20240710$20240729$EXP$$IT-TEVA-VS-3216992$TEVA$Galli E, Metafuni E, Gandi C, Limongiello MA, Giammarco S, Mattozzi A, et al. Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy. Eur-J-Haematol 2024; 112 (4): 577-584.; Galli E, Metafuni E, Gandi C, Limongiello MA, Giammarco S, Mattozzi A, et al. Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receivi...$$$$$Y$$$20240729$$HP$IT$IT
240753472$24075347$2$F$$20240917$20240710$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107942$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240923$$HP$US$US
240753481$24075348$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109607$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240710$$HP$US$US
240753491$24075349$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157101$ASTRAZENECA$$73$YR$$M$Y$110$KG$20240710$$HP$FR$
240753501$24075350$1$I$20230101$20240702$20240710$20240710$EXP$$JP-AstraZeneca-2024A154170$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$JP$
240753511$24075351$1$I$$20240701$20240710$20240710$EXP$$ES-AstraZeneca-2024A153566$ASTRAZENECA$Luisa, VR.; Veronica, RT.; Laura, FG.; Marta, SH.; Miireia, AG.; Lidica, FM.. SINDROME DE COMPRESION MEDULAR POR METASTASIS VERTEBRALES. 34th National Congress of the Spanish Society of Emergency Medicine (SEMES) 2024;$72$YR$$M$Y$$$20240710$$HP$ES$
240753521$24075352$1$I$$20240702$20240710$20240710$EXP$$JP-AstraZeneca-2024A154120$ASTRAZENECA$$$$$F$Y$$$20240710$$PH$JP$
240753532$24075353$2$F$$20240702$20240710$20240711$EXP$$FR-AstraZeneca-2024A128915$ASTRAZENECA$$$$$M$Y$115$KG$20240711$$MD$FR$
240753541$24075354$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A153024$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240753551$24075355$1$I$$20240701$20240710$20240710$PER$$US-AstraZeneca-2024A151778$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240753561$24075356$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157201$ASTRAZENECA$$76$YR$$F$Y$53$KG$20240710$$HP$FR$
240753571$24075357$1$I$20240626$20240702$20240710$20240710$EXP$$CN-AstraZeneca-2024A153976$ASTRAZENECA$$19256$DY$$M$Y$88$KG$20240710$$MD$CN$
240753581$24075358$1$I$20240701$20240708$20240710$20240710$EXP$$CN-SANDOZ INC.-SDZ2024CN063690$SANDOZ$$80$YR$$M$Y$60$KG$20240710$$HP$CN$CN
240753591$24075359$1$I$$20240708$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063531$SANDOZ$$73$YR$$F$Y$$$20240710$$CN$CA$CA
240753602$24075360$2$F$$20240924$20240710$20240926$PER$$US-BIOGEN-2024BI01272607$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
240753611$24075361$1$I$$20240705$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-020697$UNITED THERAPEUTICS$$$$$M$Y$$$20240710$$$US$US
240753622$24075362$2$F$20240101$20240830$20240710$20240905$PER$$US-AMGEN-USASP2024135251$AMGEN$$55$YR$A$M$Y$$$20240905$$CN$US$US
240753631$24075363$1$I$20240101$20240704$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-020606$UNITED THERAPEUTICS$$$$$F$Y$55.329$KG$20240710$$$US$US
240753642$24075364$2$F$20240704$20240809$20240710$20240816$EXP$$JP-AMGEN-JPNSP2024133435$AMGEN$$$$$$Y$$$20240816$$PH$JP$JP
240753651$24075365$1$I$20240630$20240707$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063746$SANDOZ$$59$YR$$F$Y$56.82$KG$20240710$$MD$US$US
240753661$24075366$1$I$20240619$20240704$20240710$20240710$EXP$IT-MINISAL02-993224$IT-MYLANLABS-2024M1063251$MYLAN$$$$$F$Y$$$20240710$$MD$IT$IT
240753671$24075367$1$I$$20240708$20240710$20240710$PER$$US-JNJFOC-20240720389$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$CN$US$US
240753681$24075368$1$I$$20240702$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-012967$UNITED THERAPEUTICS$$$$$F$Y$$$20240710$$$US$US
240753691$24075369$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108806$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240710$$CN$US$US
240753701$24075370$1$I$20240101$20240701$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-017524$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240710$$$US$US
240753712$24075371$2$F$20240401$20240822$20240710$20240823$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-026214$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240823$$CN$US$US
240753723$24075372$3$F$20240101$20240819$20240710$20240826$EXP$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000590$DECIPHERA PHARMACEUTICALS$$75$YR$E$M$Y$$$20240826$$CN$US$US
240753732$24075373$2$F$$20240717$20240710$20240724$EXP$$CA-ABBVIE-5832140$ABBVIE$$$$$F$Y$$$20240724$$HP$CA$CA
240753741$24075374$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA064089$SANDOZ$$60$YR$$F$Y$$$20240710$$HP$CA$CA
240753753$24075375$3$F$20240625$20240730$20240710$20240802$PER$$US-ROCHE-10000018544$ROCHE$$$$$$Y$$$20240802$$HP$US$US
240753762$24075376$2$F$$20240724$20240710$20240726$EXP$$CA-SANDOZ INC.-SDZ2023CA069381$SANDOZ$$$$$M$Y$$$20240726$$CN$CA$CA
240753771$24075377$1$I$$20240702$20240710$20240710$EXP$$US-TEVA-VS-3218018$TEVA$$70$YR$$F$Y$$$20240710$$CN$US$US
240753781$24075378$1$I$20240615$20240708$20240710$20240710$EXP$$US-ABBVIE-5832414$ABBVIE$$10$YR$$M$Y$$$20240710$$CN$US$US
240753792$24075379$2$F$20240709$20240722$20240710$20240729$PER$$US-AMGEN-USASP2024136634$AMGEN$$$$$$Y$$$20240729$$HP$US$US
240753802$24075380$2$F$20240101$20240807$20240710$20240814$EXP$$JP-AMGEN-JPNSP2024133773$AMGEN$$$$$$Y$$$20240814$$PH$JP$JP
240753811$24075381$1$I$$20240704$20240710$20240710$EXP$$JP-AMGEN-JPNSP2024134329$AMGEN$$$$$$Y$$$20240710$$MD$JP$JP
240753821$24075382$1$I$$20240708$20240710$20240710$EXP$$US-ABBVIE-5831944$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240753831$24075383$1$I$$20240708$20240710$20240710$EXP$$US-INCYTE CORPORATION-2024IN007178$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240753842$24075384$2$F$20240701$20240806$20240710$20240816$EXP$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000589$DECIPHERA PHARMACEUTICALS$$71$YR$E$M$Y$$$20240816$$CN$US$US
240753851$24075385$1$I$20240301$20240701$20240710$20240710$PER$$US-SA-2024SA198618$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240710$$MD$US$US
240753861$24075386$1$I$$20240701$20240710$20240710$PER$$US-SA-2024SA198296$SANOFI AVENTIS$$$$E$F$Y$52.163$KG$20240710$$MD$US$US
240753871$24075387$1$I$$20240708$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063688$SANDOZ$$$$$M$Y$$$20240710$$HP$US$US
240753881$24075388$1$I$$20240704$20240710$20240710$EXP$$US-PFIZER INC-2024SGN06245$PFIZER$$$$$$Y$$$20240710$$MD$US$US
240753891$24075389$1$I$20240101$20240321$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-004562$UNITED THERAPEUTICS$$$$$M$Y$$$20240710$$$US$US
240753901$24075390$1$I$$20240705$20240710$20240710$EXP$$IT-PFIZER INC-2024SGN03421$PFIZER$$22$YR$$F$Y$$$20240710$$MD$IT$IT
240753911$24075391$1$I$$20240704$20240710$20240710$EXP$$DE-PFIZER INC-2022SGN03979$PFIZER$$$$E$M$Y$$$20240710$$MD$DE$DE
240753921$24075392$1$I$20190418$20240704$20240710$20240710$EXP$DE-TAKEDA-2019TUS050551$DE-PFIZER INC-2019SGN03285$PFIZER$$41$YR$$F$Y$52$KG$20240710$$HP$DE$DE
240753931$24075393$1$I$$20240705$20240710$20240710$EXP$$SI-PFIZER INC-2023SGN00396$PFIZER$$21$YR$$M$Y$88$KG$20240710$$MD$SI$SI
240753941$24075394$1$I$20240701$20240709$20240710$20240710$EXP$$JP-PFIZER INC-202400209498$PFIZER$$$$E$F$Y$$$20240710$$MD$JP$JP
240753951$24075395$1$I$$20240707$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063720$SANDOZ$$$$$$Y$$$20240710$$CN$US$US
240753961$24075396$1$I$20240118$20240702$20240710$20240710$EXP$FR-AFSSAPS-TO2024001132$FR-TEVA-VS-3217571$TEVA$$63$YR$$F$Y$$$20240710$$PH$FR$FR
240753971$24075397$1$I$$20240709$20240710$20240710$EXP$$GB-SANDOZ INC.-SDZ2024GB063965$SANDOZ$$$$$F$Y$$$20240710$$CN$GB$GB
240753981$24075398$1$I$$20240705$20240710$20240710$30DAY$$US-SANDOZ INC.-SDZ2024US063843$SANDOZ$$$$$$Y$$$20240710$$CN$US$US
240753991$24075399$1$I$$20240705$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107899$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240710$$CN$US$US
240754001$24075400$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109095$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$80$YR$E$M$Y$$$20240710$$HP$US$US
240754011$24075401$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109651$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240710$$CN$US$US
240754021$24075402$1$I$20240130$20240621$20240710$20240710$PER$$BR-TOLMAR, INC.-24BR050448$TOLMAR$$8$YR$$F$Y$$$20240710$$CN$BR$BR
240754031$24075403$1$I$20240101$20240708$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-020837$UNITED THERAPEUTICS$$$$$F$Y$$$20240710$$$US$US
240754041$24075404$1$I$$20240703$20240710$20240710$EXP$$US-JNJFOC-20240718557$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240754052$24075405$2$F$$20240712$20240710$20240718$PER$$US-INCYTE CORPORATION-2024IN007103$INCYTE$$$$$$Y$$$20240718$$CN$US$US
240754061$24075406$1$I$$20240708$20240710$20240710$PER$$NVSC2024US142034$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
240754072$24075407$2$F$$20240711$20240710$20240718$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001356$BLUEPRINT MEDICINES$$$$$M$Y$$$20240718$$CN$US$US
240754081$24075408$1$I$20240609$20240629$20240710$20240710$EXP$$CN-TETRAPHASE PHARMACEUTICALS, INC-2024-INNO-CN000045$PAREXEL$$$$$$Y$$$20240710$$HP$CN$CN
240754091$24075409$1$I$$20240213$20240710$20240710$EXP$GB-MHRA-MED-202402121412305880-WSTCR$GB-TEVA-VS-3158575$TEVA$$70$YR$$M$Y$$$20240710$$HP$GB$GB
240754101$24075410$1$I$$20240708$20240710$20240710$EXP$GB-MHRA-TPP58375521C20988500YC1719398389246$GB-SANDOZ INC.-SDZ2024GB064052$SANDOZ$$7$YR$$M$Y$24$KG$20240710$$PH$GB$GB
240754112$24075411$2$F$20240601$20240909$20240710$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-020860$UNITED THERAPEUTICS$$76$YR$$F$Y$35.828$KG$20240914$$$US$US
240754121$24075412$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA064067$SANDOZ$$54$YR$$F$Y$$$20240710$$HP$CA$CA
240754131$24075413$1$I$$20240701$20240710$20240710$EXP$$CH-VANTIVE-2020BAX003707$Vantive US Healthcare$$74$YR$$M$Y$$$20240710$$HP$CH$CH
240754141$24075414$1$I$$20240621$20240710$20240710$EXP$$US-NOVOPROD-1251245$NOVO NORDISK$$$$A$F$Y$$$20240710$$CN$US$US
240754151$24075415$1$I$$20240701$20240710$20240710$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR084722$VIIV$$$$$$Y$$$20240710$$HP$US$US
240754161$24075416$1$I$$20240707$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063778$SANDOZ$$$$$$Y$$$20240710$$CN$US$US
240754171$24075417$1$I$20211201$20240703$20240710$20240710$EXP$$GB-JNJFOC-20240713872$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$HP$GB$GB
240754181$24075418$1$I$20240703$20240703$20240710$20240710$EXP$$US-JNJFOC-20240717608$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240710$$HP$US$US
240754191$24075419$1$I$$20240401$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-020874$UNITED THERAPEUTICS$$$$$F$Y$$$20240710$$$US$US
240754201$24075420$1$I$20231125$20240709$20240710$20240710$EXP$ES-AEMPS-1543378$ES-GILEAD-2024-0680045$GILEAD$$73$YR$E$F$Y$$$20240710$$PH$ES$ES
240754212$24075421$2$F$$20240709$20240710$20240711$PER$$NVSC2024US142702$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240754221$24075422$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024136078$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240754231$24075423$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A155099$ASTRAZENECA$$$$$F$Y$$$20240710$$CN$US$
240754241$24075424$1$I$20240618$20240702$20240710$20240710$EXP$$CN-AstraZeneca-2024A153982$ASTRAZENECA$$71$YR$$F$Y$45$KG$20240710$$MD$CN$
240754251$24075425$1$I$$20240701$20240710$20240710$EXP$$IT-TEVA-VS-3217325$TEVA$Fattizzo B, Pasquale R, Croci GA, Pettine L, Cassanello G, Barcellini W. Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review. Blood-Transf 2024; 22 (3): 266-272.$72$YR$$F$Y$$$20240710$$HP$IT$IT
240754262$24075426$2$F$20240611$20240710$20240710$20240715$EXP$$TW-ABBVIE-5832129$ABBVIE$$0$YR$$M$Y$3$KG$20240715$$HP$TW$TW
240754272$24075427$2$F$20240618$20240829$20240710$20240906$EXP$$US-AstraZeneca-2024A152139$ASTRAZENECA$$34630$DY$$F$Y$$$20240906$$CN$US$
240754282$24075428$2$F$20240415$20240703$20240710$20240819$EXP$$GB-AstraZeneca-2024A156068$ASTRAZENECA$$77$YR$$M$Y$$$20240819$$MD$GB$
240754291$24075429$1$I$$20240705$20240710$20240710$EXP$$IT-PFIZER INC-2023SGN12638$PFIZER$$$$A$F$Y$$$20240710$$MD$IT$IT
240754313$24075431$3$F$$20240712$20240710$20240717$EXP$$US-PFIZER INC-202400209278$PFIZER$Kraus, M.. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report. Case Reports in Neurology. 2024;16(1):142-147$38$YR$$F$Y$63.5$KG$20240717$$MD$US$US
240754322$24075432$2$F$20181203$20240819$20240710$20240828$EXP$$IT-PFIZER INC-2019SGN02839$PFIZER$$24$YR$$M$Y$$$20240828$$MD$IT$IT
240754331$24075433$1$I$$20240706$20240710$20240710$EXP$$CA-ABBVIE-5833040$ABBVIE$$$$$F$Y$$$20240710$$HP$CA$CA
240754342$24075434$2$F$$20240729$20240710$20240802$EXP$$CH-AstraZeneca-2024A157071$ASTRAZENECA$$$$$M$Y$$$20240802$$MD$CH$
240754351$24075435$1$I$20240613$20240704$20240710$20240710$EXP$FR-AFSSAPS-AVCN2024000462$FR-MYLANLABS-2024M1063467$MYLAN$$28$YR$$M$Y$$$20240710$$HP$FR$FR
240754361$24075436$1$I$20240523$20240704$20240710$20240710$EXP$FR-AFSSAPS-SE2024000529$FR-MYLANLABS-2024M1063337$MYLAN$$78$YR$$M$Y$68$KG$20240710$$MD$FR$FR
240754372$24075437$2$F$$20240719$20240710$20240729$EXP$$US-TEVA-VS-3218355$TEVA$Jagannathan P, Blough P, Morrison RJ, Taylor S. The Role of Plasmapheresis in Management of Thyroid Storm. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Jagannathan P, Blough P, Morrison RJ, Taylor S. The Role of Plasmapheresis in Management of Thyroid Storm. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$53$YR$$M$Y$$$20240729$$HP$US$US
240754381$24075438$1$I$$20240708$20240710$20240710$EXP$$US-ABBVIE-5833017$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240754391$24075439$1$I$$20240707$20240710$20240710$PER$$US-TAKEDA-2024TUS069633$TAKEDA$$$$$F$Y$$$20240710$$CN$US$US
240754401$24075440$1$I$20210101$20240704$20240710$20240710$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-006816$BRISTOL MYERS SQUIBB$Juarso AE, Entz S, Weissinger F. Durable response from fibroblast growth factor receptor inhibition in intrahepatic cholangiocarcinoma terminated by metachronous acute myeloid leukemia: a case report. Journal of Medical Case Reports. 2023 Dec 15;17:1-7. doi:10.1186/s13256-023-04231-2.$69$YR$E$M$Y$$$20240710$$HP$DE$DE
240754411$24075441$1$I$20240118$20240628$20240710$20240710$EXP$$US-ORG100022029-2024000143$TELIX PHARMACEUTICALS$$67$YR$E$M$Y$102.05$KG$20240710$$HP$US$US
240754423$24075442$3$F$20240201$20240719$20240710$20240723$30DAY$$CL-JNJFOC-20240422846$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240723$$CN$CL$CL
240754431$24075443$1$I$$20240705$20240710$20240710$EXP$$CO-ABBVIE-5834057$ABBVIE$Tabares B, Sarmiento-Suarez AD, Gil O, Hernandez-Pabon JC, Firacative C. Fatal co-infection by multiple pathogens in an indigenous woman with autoimmune hemolytic anemia and tuberculosis: a case report. BMC Infect Di.2024;24(1):645.$$$A$F$Y$$$20240710$$HP$CO$CO
240754441$24075444$1$I$20240601$20240702$20240710$20240710$PER$$US-MYLANLABS-2024M1062424$MYLAN$$80$YR$$F$Y$79.37$KG$20240710$$CN$US$US
240754491$24075449$1$I$$20240708$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-020962$UNITED THERAPEUTICS$$$$$F$Y$62.585$KG$20240710$$$US$US
240754501$24075450$1$I$$20240703$20240710$20240710$EXP$$CA-ABBVIE-5833089$ABBVIE$$84$YR$$F$Y$$$20240710$$CN$CA$CA
240754511$24075451$1$I$$20240705$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US064223$SANDOZ$$$$$F$Y$$$20240710$$CN$US$US
240754522$24075452$2$F$$20240716$20240710$20240717$EXP$$BR-WOODWARD-2024-BR-000072$WOODWARD PHARMA SERVICES$$$$$M$Y$$$20240716$$CN$BR$BR
240754531$24075453$1$I$20240321$20240704$20240710$20240710$EXP$PT-INFARMED-J202406-503$PT-MYLANLABS-2024M1063338$MYLAN$$27$YR$$M$Y$78$KG$20240710$$MD$PT$PT
240754541$24075454$1$I$$20240701$20240710$20240710$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-095232$REGENERON$Mika Nagai, Yuki Okuma, Nobuki Hayashi, Erina Matsuda, Kanoko Katoh, Osamu Kobayashi, Takahiro Nakajima, Aiko Aoki, Yuji Ikeda, Atsushi Komatsu, Keisuke Saito, Kei Kawana. A Case of Complete Response to Cemiplimab Monotherapy as Second-Line Therapy for Platinum-Refractory Cervical Cancer Recurring in the Irradiated Field.. 2024;61(2):199$68$YR$$F$Y$$$20240710$$MD$JP$JP
240754552$24075455$2$F$$20240704$20240710$20240712$EXP$$BR-JNJFOC-20240720790$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$BR$BR
240754561$24075456$1$I$$20240704$20240710$20240710$EXP$GB-MHRA-MED-202407041234462960-ZBJDK$GB-RDY-SPO/GBR/24/0009926$DR REDDYS$$$$$F$Y$$$20240710$$CN$GB$GB
240754571$24075457$1$I$20240418$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405071703163580-SFGKJ$GB-SANDOZ INC.-SDZ2024GB063855$SANDOZ$$$$$M$Y$$$20240710$$HP$GB$GB
240754581$24075458$1$I$$20240701$20240710$20240710$EXP$$US-RDY-LIT/USA/24/0009822$DR REDDYS$Khattar G, Sanayeh EB, Makram M, Rabah H, Baker SA, Khan S, et al. THE CONCOMITANT OCCURRENCE OF HIDRADENITIS SUPPURATIVA AND FOURNIER^S GANGRENE. European Journal of Case Reports in Internal Medicine. 2024;11(6): doi:10.12890/2024_004493.$42$YR$A$F$Y$$$20240710$$HP$US$US
240754593$24075459$3$F$20240223$20240827$20240710$20240903$EXP$FR-AFSSAPS-NC2024000785$FR-009507513-2407FRA003078$MERCK$$48$YR$$F$Y$77.6$KG$20240903$$HP$FR$FR
240754601$24075460$1$I$20240707$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136555$AMGEN$$67$YR$E$F$Y$$$20240710$$PH$US$US
240754611$24075461$1$I$20230902$20240709$20240710$20240710$EXP$$US-ROCHE-3417403$ROCHE$$57$YR$A$M$Y$94.35$KG$20240710$$CN$US$US
240754621$24075462$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A153840$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240754631$24075463$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157075$ASTRAZENECA$$62$YR$$M$Y$$$20240710$$HP$FR$
240754643$24075464$3$F$20230101$20240807$20240710$20240815$EXP$$JP-AstraZeneca-2024A154115$ASTRAZENECA$$74$YR$$M$Y$72$KG$20240815$$MD$JP$
240754651$24075465$1$I$20240704$20240705$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109015$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240710$$CN$US$US
240754661$24075466$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157515$ASTRAZENECA$$63$YR$$F$Y$$$20240710$$HP$FR$
240754675$24075467$5$F$20240704$20240801$20240710$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107398$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240808$$CN$JP$JP
240754681$24075468$1$I$$20240707$20240710$20240710$EXP$$PT-AstraZeneca-2024A156807$ASTRAZENECA$Lobato C.T., Castelo Branco S., Camoes J., Molinos E. Rhabdomyolysis secondary to a weight-loss prescription. BMJ Case Reports 2024;17(6):e258208-.$80$YR$$M$Y$$$20240710$$HP$PT$
240754691$24075469$1$I$$20240701$20240710$20240710$EXP$$PL-TEVA-VS-3216855$TEVA$Plonski A, Plonski AF, Glowinski J. Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review. Int-J-Environ-Res-Public-Health 2023; 20 (13): 1-14.$79$YR$$M$Y$$$20240710$$HP$PL$PL
240754703$24075470$3$F$20240622$20240909$20240710$20240911$EXP$$GB-PFIZER INC-202400207920$PFIZER$$71$YR$$M$Y$86$KG$20240911$$PH$GB$GB
240754712$24075471$2$F$20240710$20240710$20240710$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038992$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240814$$CN$US$US
240754721$24075472$1$I$$20240703$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106913$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240710$$HP$US$US
240754731$24075473$1$I$20240508$20240704$20240710$20240710$EXP$IT-MINISAL02-993159$IT-MYLANLABS-2024M1063217$MYLAN$$62$YR$$F$Y$$$20240710$$MD$IT$IT
240754743$24075474$3$F$$20240812$20240710$20240812$PER$$US-ALXN-202407USA000254US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
240754751$24075475$1$I$$20240701$20240710$20240710$EXP$$JP-PFIZER INC-PV202400086595$PFIZER$Miyata, Y.. A case in which switching to teneligliptin was able to be made after onset of platelets decreased caused by sitagliptin. Journal of Japanese Society of Hospital Pharmacists. 2024;60(6):599-603$73$YR$$M$Y$52.6$KG$20240710$$HP$JP$JP
240754761$24075476$1$I$$20240701$20240710$20240710$EXP$$FR-TEVA-VS-3217520$TEVA$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$38$YR$$M$Y$$$20240710$$HP$FR$FR
240754772$24075477$2$F$20240705$20240710$20240710$20240712$PER$$US-AMGEN-USASP2024136405$AMGEN$$76$YR$E$F$Y$$$20240712$$PH$US$US
240754782$24075478$2$F$20240709$20240710$20240710$20240712$PER$$US-AMGEN-USASP2024136001$AMGEN$$60$YR$A$F$Y$$$20240712$$CN$US$US
240754791$24075479$1$I$20240702$20240703$20240710$20240710$EXP$$IL-EMD Serono-2024036528$EMD SERONO INC$$35$YR$A$F$Y$57$KG$20240710$$CN$IL$IL
240754801$24075480$1$I$$20240701$20240710$20240710$EXP$$FR-TEVA-VS-3217519$TEVA$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$55$YR$$M$Y$$$20240710$$HP$FR$FR
240754811$24075481$1$I$$20240701$20240710$20240710$EXP$$GB-AVEO PHARMACEUTICALS, INC.-2024-AVEO-GB000517$PAREXEL$$$$$$Y$$$20240710$$CN$GB$GB
240754821$24075482$1$I$$20240626$20240710$20240710$PER$$US-Calliditas-2024CAL01194$CALLIDITAS THERAPEUTICS$$59$YR$A$F$Y$72.1$KG$20240710$$CN$US$US
240754831$24075483$1$I$20240710$20240710$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039009$BOEHRINGER INGELHEIM$$75$YR$E$$Y$$$20240710$$CN$US$US
240754841$24075484$1$I$$20240628$20240710$20240710$PER$$US-SA-2024SA196389$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240710$$MD$US$US
240754851$24075485$1$I$$20240702$20240710$20240710$PER$$US-SA-2024SA197094$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240710$$MD$US$US
240754861$24075486$1$I$20240628$20240628$20240710$20240710$PER$$US-SA-2024SA195463$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240710$$CN$US$US
240754871$24075487$1$I$$20240628$20240710$20240710$PER$$US-SA-2024SA196525$SANOFI AVENTIS$$52$YR$A$M$Y$79.8$KG$20240710$$MD$US$US
240754882$24075488$2$F$$20240801$20240710$20240802$EXP$GB-MHRA-TPP32770833C2677317YC1720440010522$GB-ORGANON-O2407GBR000923$ORGANON$$10$YR$$M$Y$28$KG$20240802$$HP$GB$GB
240754891$24075489$1$I$20240525$20240703$20240710$20240710$EXP$GB-MHRA-MED-202405281810247390-QJFSR$GB-ORGANON-O2407GBR000452$ORGANON$$72$YR$$M$Y$80$KG$20240710$$CN$GB$GB
240754901$24075490$1$I$$20240701$20240710$20240710$EXP$SI-JAZMP-NCPHV-2024SI0606_0606$SI-INCYTE CORPORATION-2024IN007044$INCYTE$$$$$$Y$$$20240710$$MD$SI$SI
240754911$24075491$1$I$20240610$20240704$20240710$20240710$EXP$IT-MINISAL02-992921$IT-MYLANLABS-2024M1063302$MYLAN$$84$YR$$F$Y$90$KG$20240710$$MD$IT$IT
240754922$24075492$2$F$20240402$20240725$20240710$20240730$EXP$FR-AFSSAPS-PC2024000513$FR-INCYTE CORPORATION-2024IN006999$INCYTE$$$$$$Y$$$20240730$$PH$FR$FR
240754931$24075493$1$I$$20240701$20240710$20240710$EXP$HU-EMA-DD-20240626-7482831-112214$HU-INCYTE CORPORATION-2024IN007018$INCYTE$Lakatos V, Gopcsa L, Balogh A, Fabian J, Remenyi P. Treatment and transplantation in T-cell prolymphocytic leukaemia: Presentation of two cases. HEMATOLOGY-TRANSFUSIOLOGY. 2024;65-6$$$$$Y$$$20240710$$HP$HU$HU
240754941$24075494$1$I$20210101$20240702$20240710$20240710$EXP$DK-DKMA-30730549$DK-TEVA-VS-3216552$TEVA$$8$DEC$$F$Y$$$20240710$$MD$DK$DK
240754961$24075496$1$I$$20240701$20240710$20240710$EXP$$PL-TEVA-VS-3216856$TEVA$Plonski A, Plonski AF, Glowinski J. Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review. Int-J-Environ-Res-Public-Health 2023; 20 (13): 1-14.$38$YR$$M$Y$$$20240710$$HP$PL$PL
240754971$24075497$1$I$$20240709$20240710$20240710$EXP$$NVSC2024AU141884$NOVARTIS$$75$YR$$M$Y$$$20240710$$MD$AU$AU
240754982$24075498$2$F$$20240919$20240710$20240919$PER$$NVSC2024US142773$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
240754991$24075499$1$I$$20240702$20240710$20240710$EXP$$GB-TEVA-VS-3216481$TEVA$$75$YR$$F$Y$55$KG$20240710$$MD$GB$GB
240755002$24075500$2$F$20240625$20240625$20240710$20240712$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038772$BOEHRINGER INGELHEIM$$41$YR$A$F$Y$$$20240712$$MD$JP$JP
240755011$24075501$1$I$$20240624$20240710$20240710$PER$$US-ROCHE-10000010299$ROCHE$$$$$$Y$$$20240710$$PH$US$US
240755021$24075502$1$I$$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024134014$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240755031$24075503$1$I$20240502$20240701$20240710$20240710$EXP$IT-MINISAL02-992927$IT-INCYTE CORPORATION-2024IN006998$INCYTE$$$$$$Y$$$20240710$$MD$IT$IT
240755041$24075504$1$I$20240418$20240704$20240710$20240710$EXP$FR-AFSSAPS-NC2024000773$FR-MYLANLABS-2024M1062937$MYLAN$$86$YR$$F$Y$$$20240710$$PH$FR$FR
240755051$24075505$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109484$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240710$$CN$US$US
240755061$24075506$1$I$20240619$20240704$20240710$20240710$EXP$$DE-MYLANLABS-2024M1063441$MYLAN$$81$YR$$F$Y$70$KG$20240710$$MD$DE$DE
240755073$24075507$3$F$20240101$20240802$20240710$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020276$UNITED THERAPEUTICS$$$$$F$Y$41.27$KG$20240810$$$US$US
240755081$24075508$1$I$$20240701$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109094$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$70$YR$E$M$Y$$$20240710$$HP$US$US
240755091$24075509$1$I$20240704$20240709$20240710$20240710$PER$$US-BAYER-2024A098953$BAYER$$75$YR$E$F$Y$$$20240710$$CN$US$US
240755101$24075510$1$I$$20240705$20240710$20240710$EXP$$US-BAUSCH-BL-2024-010018$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240710$$CN$US$US
240755111$24075511$1$I$$20240702$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108289$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240710$$HP$US$US
240755123$24075512$3$F$20240101$20240812$20240710$20240816$EXP$$NVSC2024DE142586$NOVARTIS$$$$A$F$Y$$$20240816$$CN$DE$DE
240755132$24075513$2$F$$20240801$20240710$20240805$PER$$US-ALXN-202407USA000295US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240755141$24075514$1$I$$20240702$20240710$20240710$EXP$$GB-TEVA-VS-3216454$TEVA$$65$YR$$F$Y$88$KG$20240710$$PH$GB$GB
240755151$24075515$1$I$$20240708$20240710$20240710$EXP$$CA-BAUSCH-BL-2024-010437$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240710$$CN$CA$CA
240755162$24075516$2$F$$20240625$20240710$20240807$EXP$$CH-TEVA-VS-3218308$TEVA$$$$$$Y$$$20240807$$HP$CH$CH
240755171$24075517$1$I$$20240704$20240710$20240710$EXP$$CZ-MYLANLABS-2024M1063235$MYLAN$$74$YR$$M$Y$$$20240710$$MD$CZ$CZ
240755182$24075518$2$F$$20240702$20240710$20240722$PER$$US-BIOGEN-2024BI01272184$BIOGEN$$$$$M$Y$$$20240722$$CN$US$US
240755191$24075519$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157631$ASTRAZENECA$$73$YR$$M$Y$$$20240710$$HP$FR$
240755201$24075520$1$I$$20240628$20240710$20240710$EXP$$US-TEVA-VS-3216443$TEVA$$$$A$M$Y$$$20240710$$CN$US$GB
240755211$24075521$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157062$ASTRAZENECA$$70$YR$$M$Y$$$20240710$$HP$FR$
240755221$24075522$1$I$$20240708$20240710$20240710$EXP$$CA-BAUSCH-BL-2024-010458$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240710$$MD$CA$CA
240755231$24075523$1$I$20230901$20240703$20240710$20240710$EXP$$IT-BAUSCH-BL-2024-010330$BAUSCH AND LOMB$Samperi S, Laura C, Trambaiolo P, D ^Ambrosi D, Mustilli M, Romano S, Granatelli A. A strange case of cardiotoxicity from antiblastic treatment: a high price to pay. European Heart Journal Supplements. 2024;26 (2):II178-II180. doi:10.1093/eurheartjsupp/suae036.431$58$YR$$F$Y$$$20240710$$HP$IT$IT
240755241$24075524$1$I$$20240704$20240710$20240710$EXP$$BR-AstraZeneca-2024A156260$ASTRAZENECA$Gomes L.B.M., Sandoval R.L., Xavier C.B., Correa T.S., Matuda R.M.K., De Souza Z.S., De Lima L.G.C.A., De Macedo M.P., Carvalho F.M., Suzuki D.A.. Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline BRCA2 Pathogenic Variant: Case Report. Case Reports in Oncology 2024;17(1):1-9.$37$YR$$F$Y$$$20240710$$HP$BR$
240755251$24075525$1$I$20240702$20240702$20240710$20240710$PER$$US-SA-2024SA197490$SANOFI AVENTIS$$$$$$Y$$$20240710$$CN$US$US
240755261$24075526$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA198611$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240710$$CN$US$US
240755273$24075527$3$F$20240101$20240808$20240710$20240814$PER$$US-SA-2024SA197283$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240814$$MD$US$US
240755282$24075528$2$F$20240702$20240709$20240710$20240715$PER$$US-SA-2024SA197936$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240715$$MD$US$US
240755291$24075529$1$I$20240101$20240703$20240710$20240710$EXP$$US-SA-2024SA200868$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240710$$MD$US$US
240755311$24075531$1$I$$20240701$20240710$20240710$EXP$$PL-TEVA-VS-3216865$TEVA$Plonski A, Plonski AF, Glowinski J. Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review. Int-J-Environ-Res-Public-Health 2023; 20 (13): 1-14.$30$YR$$F$Y$$$20240710$$HP$PL$PL
240755321$24075532$1$I$20240528$20240701$20240710$20240710$EXP$$US-EAGLE PHARMACEUTICALS, INC.-US-2024EAG000173$EAGLE$$55$YR$$F$Y$$$20240710$$MD$US$US
240755331$24075533$1$I$$20240703$20240710$20240710$PER$$US-BAYER-2024A096648$BAYER$$$$$M$Y$$$20240710$$CN$US$US
240755341$24075534$1$I$20240702$20240702$20240710$20240710$PER$$US-BAYER-2024A095612$BAYER$$27$YR$A$F$Y$$$20240710$$CN$US$US
240755351$24075535$1$I$$20240630$20240710$20240710$EXP$$US-JNJFOC-20240712947$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240710$$MD$US$US
240755361$24075536$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108429$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240710$$CN$US$US
240755372$24075537$2$F$20240101$20240730$20240710$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-108485$BRISTOL MYERS SQUIBB$$9$DEC$E$F$Y$$$20240802$$MD$JP$JP
240755383$24075538$3$F$20240101$20240719$20240710$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-020602$UNITED THERAPEUTICS$$$$$M$Y$99.773$KG$20240724$$$US$US
240755391$24075539$1$I$$20240528$20240710$20240710$PER$$US-Eisai-EC-2024-166739$EISAI$$$$$F$Y$$$20240710$$CN$US$US
240755401$24075540$1$I$20240509$20240704$20240710$20240710$EXP$IT-MINISAL02-993161$IT-MYLANLABS-2024M1063320$MYLAN$$45$YR$$M$Y$$$20240710$$MD$IT$IT
240755411$24075541$1$I$20240627$20240704$20240710$20240710$EXP$IT-MINISAL02-993029$IT-MYLANLABS-2024M1063237$MYLAN$$62$YR$$M$Y$$$20240710$$MD$IT$IT
240755421$24075542$1$I$$20240529$20240710$20240710$PER$$US-Eisai-EC-2024-166847$EISAI$$14$YR$T$F$Y$$$20240710$$MD$US$US
240755431$24075543$1$I$20240608$20240708$20240710$20240710$EXP$$DE-BAUSCH-BL-2024-010456$BAUSCH AND LOMB$$$$$M$Y$90$KG$20240710$$HP$DE$DE
240755441$24075544$1$I$20230801$20240702$20240710$20240710$PER$$US-SA-2024SA198407$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240710$$CN$US$US
240755451$24075545$1$I$$20240702$20240710$20240710$PER$$US-SA-2024SA198092$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240710$$MD$US$US
240755462$24075546$2$F$$20240715$20240710$20240722$EXP$$US-ABBVIE-5833261$ABBVIE$$$$$M$Y$$$20240719$$CN$US$US
240755471$24075547$1$I$20210701$20240703$20240710$20240710$EXP$$CH-BAUSCH-BL-2024-010484$BAUSCH AND LOMB$Sopi B, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, Hammer H, Jost C. Unhappy Hearts with the Antidepressant Venlafaxine. Swiss Medical Weekly. 2024 JUN;154 (SUPPL. 278):63S-64S.$52$YR$$F$Y$$$20240710$$HP$CH$CH
240755481$24075548$1$I$20240601$20240703$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-020623$UNITED THERAPEUTICS$$60$YR$$F$Y$131.52$KG$20240710$$$US$US
240755491$24075549$1$I$$20240708$20240710$20240710$EXP$$CA-BAUSCH-BL-2024-010447$BAUSCH AND LOMB$$8$YR$$M$Y$30$KG$20240710$$HP$CA$CA
240755501$24075550$1$I$$20240703$20240710$20240710$EXP$$CH-BAUSCH-BL-2024-010342$BAUSCH AND LOMB$Sopi B, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, Hammer H, Jost C. Unhappy Hearts with the Antidepressant Venlafaxine. Swiss Medical Weekly. 2024 JUN;154 (SUPPL. 278):63S-64S.$82$YR$$M$Y$$$20240710$$HP$CH$CH
240755511$24075551$1$I$$20240703$20240710$20240710$EXP$$CH-BAUSCH-BL-2024-010483$BAUSCH AND LOMB$Sopi B, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, Hammer H, Jost C. Unhappy Hearts with the Antidepressant Venlafaxine. Swiss Medical Weekly. 2024 JUN;154 (SUPPL. 278):63S-64S.$77$YR$$F$Y$$$20240710$$HP$CH$CH
240755521$24075552$1$I$20230501$20240703$20240710$20240710$EXP$$CH-BAUSCH-BL-2024-010485$BAUSCH AND LOMB$Sopi B, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, Hammer H, Jost C. Unhappy Hearts with the Antidepressant Venlafaxine. Swiss Medical Weekly. 2024 JUN;154 (SUPPL. 278):63S-64S.$51$YR$$F$Y$$$20240710$$HP$CH$CH
240755532$24075553$2$F$20240709$20240815$20240710$20240821$EXP$$US-Imprimis NJOF, LLC-2159016$IMPRIMIS CARES - COMPOUNDING$$86$YR$$F$Y$$$20240821$$MD$US$US
240755541$24075554$1$I$20240703$20240703$20240710$20240710$PER$$US-UNITED THERAPEUTICS-UNT-2024-020707$UNITED THERAPEUTICS$$86$YR$$F$Y$57.143$KG$20240710$$$US$US
240755553$24075555$3$F$$20240916$20240710$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108282$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240918$$HP$US$US
240755562$24075556$2$F$20240701$20240723$20240710$20240801$EXP$$BR-TEVA-VS-3217992$TEVA$$68$YR$$M$Y$76$KG$20240801$$PH$BR$BR
240755571$24075557$1$I$$20231113$20240710$20240710$PER$$US-Breckenridge Pharmaceutical, Inc.-2159017$BRECKENRIDGE$$69$YR$$F$Y$55.909$KG$20240710$$$US$US
240755581$24075558$1$I$20240701$20240704$20240710$20240710$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-095730$REGENERON$$$$$M$Y$$$20240710$$CN$CA$CA
240755592$24075559$2$F$20240701$20240710$20240710$20240717$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-095737$REGENERON$$74$YR$$F$Y$$$20240717$$CN$DE$DE
240755601$24075560$1$I$20240624$20240702$20240710$20240710$EXP$GB-MHRA-MED-202407021416012270-JCRSH$GB-TEVA-VS-3216643$TEVA$$72$YR$$F$Y$$$20240710$$MD$GB$GB
240755611$24075561$1$I$20220101$20240704$20240710$20240710$EXP$$BR-ORGANON-O2407BRA000765$ORGANON$$$$$F$Y$$$20240710$$CN$BR$BR
240755623$24075562$3$F$$20240912$20240710$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA063943$SANDOZ$$44$YR$$F$Y$$$20240916$$HP$CA$CA
240755632$24075563$2$F$$20240801$20240710$20240805$PER$$US-ALXN-202407USA000322US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240755643$24075564$3$F$$20240710$20240710$20240715$PER$$NVSC2024US142777$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240755651$24075565$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109580$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240710$$CN$US$US
240755661$24075566$1$I$20240405$20240628$20240710$20240710$PER$$US-JNJFOC-20240700851$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240710$$CN$US$US
240755671$24075567$1$I$$20240701$20240710$20240710$EXP$$PL-TEVA-VS-3216866$TEVA$Plonski A, Plonski AF, Glowinski J. Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review. Int-J-Environ-Res-Public-Health 2023; 20 (13): 1-14.$73$YR$$M$Y$$$20240710$$HP$PL$PL
240755681$24075568$1$I$$20240708$20240710$20240710$PER$$US-Mission Pharmacal Company-2159018$MISSION$$33$YR$$F$Y$$$20240710$$$US$US
240755691$24075569$1$I$20231218$20240702$20240710$20240710$EXP$SE-SEMPA-2024-005108$SE-TEVA-VS-3216683$TEVA$$50$YR$$F$Y$69$KG$20240710$$MD$SE$SE
240755701$24075570$1$I$$20240708$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US063922$SANDOZ$Elizabeth S. Mikhail, Matthew Jankowski, Dheeraj Alexander, Dhwani Pandya , Arvind Kunadi. Survival and Vision Restoration Following SevereMetformin-associated Metabolic Acidosis WithTransient Blindness: A Case Report and Review ofthe Literature. Journal of Community Hospital Internal Medicine Perspectives. 2024;14$72$YR$$F$Y$$$20240710$$HP$US$US
240755711$24075571$1$I$$20240709$20240710$20240710$EXP$$US-TAKEDA-2023TUS075087$TAKEDA$$$$$F$Y$$$20240710$$CN$US$US
240755721$24075572$1$I$20240519$20240709$20240710$20240710$EXP$$CN-BAYER-2024A099301$BAYER$$56$YR$A$M$Y$$$20240710$$HP$CN$CN
240755731$24075573$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157412$ASTRAZENECA$$71$YR$$M$Y$$$20240710$$HP$FR$
240755741$24075574$1$I$$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157222$ASTRAZENECA$$74$YR$$M$Y$61$KG$20240710$$HP$FR$
240755751$24075575$1$I$20210511$20240701$20240710$20240710$EXP$$FR-AstraZeneca-2024A157223$ASTRAZENECA$$64$YR$$F$Y$$$20240710$$HP$FR$
240755761$24075576$1$I$$20240702$20240710$20240710$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202407003416$ELI LILLY AND CO$$$$$M$Y$$$20240710$$MD$AE$AE
240755771$24075577$1$I$$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407006176$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240710$$CN$US$US
240755781$24075578$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004009$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240710$$CN$US$US
240755792$24075579$2$F$$20240910$20240710$20240919$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407000854$ELI LILLY AND CO$$$$$M$Y$$$20240919$$CN$JP$JP
240755801$24075580$1$I$20240613$20240628$20240710$20240710$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407000840$ELI LILLY AND CO$$44$YR$A$M$Y$93$KG$20240710$$CN$JP$JP
240755811$24075581$1$I$20240501$20240628$20240710$20240710$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000442$ELI LILLY AND CO$$$$$$Y$$$20240710$$CN$US$US
240755821$24075582$1$I$$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407004003$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240710$$CN$US$US
240755831$24075583$1$I$$20240704$20240710$20240710$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202407004515$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240710$$CN$TW$TW
240755842$24075584$2$F$$20240719$20240710$20240729$EXP$$PL-TEVA-VS-3216857$TEVA$Plonski A, Plonski AF, Glowinski J. Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review. Int-J-Environ-Res-Public-Health 2023; 20 (13): 1-14.; Plonski A, Plonski AF, Glowinski J. Surgical Management, Prevention and Outcomes for Aneurysms of Arteriovenous Dialysis Fistulas: A Case Series Study and Review. Int-J-Environ-Res-Public-Health 2023; 20 (13): 1-14.$45$YR$$M$Y$$$20240729$$HP$PL$PL
240755851$24075585$1$I$$20240605$20240710$20240710$PER$$US-ABBVIE-5834400$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240755861$24075586$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142661$NOVARTIS$$$$$M$Y$$$20240710$$MD$US$US
240755871$24075587$1$I$20240127$20240704$20240710$20240710$EXP$DE-CADRBFARM-2024329055$DE-MYLANLABS-2024M1063305$MYLAN$$69$YR$$M$Y$70$KG$20240710$$CN$DE$DE
240755881$24075588$1$I$20240517$20240704$20240710$20240710$EXP$FR-AFSSAPS-LM2024000370$FR-MYLANLABS-2024M1063346$MYLAN$$89$YR$$F$Y$77.8$KG$20240710$$MD$FR$FR
240755892$24075589$2$F$20240515$20240731$20240710$20240806$EXP$FR-AFSSAPS-GR2024000805$FR-009507513-2407FRA003186$MERCK$$56$YR$$M$Y$$$20240806$$PH$FR$FR
240755901$24075590$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063889$SANDOZ$$55$YR$$M$Y$$$20240710$$HP$CA$CA
240755911$24075591$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109586$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240710$$HP$US$US
240755921$24075592$1$I$20240601$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109643$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$161$KG$20240710$$HP$US$US
240755931$24075593$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024136401$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240755941$24075594$1$I$20230101$20240705$20240710$20240710$EXP$$CA-JNJFOC-20240228615$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240710$$HP$CA$CA
240755951$24075595$1$I$20240704$20240705$20240710$20240710$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-13667$IPSEN$$2$YR$C$F$Y$11.33$KG$20240710$$CN$US$US
240755971$24075597$1$I$$20240703$20240710$20240710$EXP$$US-MYLANLABS-2024M1064267$MYLAN$$$$$F$Y$$$20240710$$MD$US$US
240755981$24075598$1$I$20130401$20240704$20240710$20240710$EXP$$GR-PFIZER INC-2019SGN04921$PFIZER$Spathas, N.. Successful reversal of severe liver function impairment with brentuximab vedotin in multiply relapsed/refractory classical hodgkin lymphoma. Journal of B.U.ON. 2019;24(6):2483-2489$39$YR$$M$Y$$$20240710$$HP$GR$GR
240755991$24075599$1$I$20151021$20240705$20240710$20240710$EXP$$JP-PFIZER INC-2016SGN00225$PFIZER$Watanabe, K.. Two Cases of Pneumocystis Pneumonia during the Treatment with Brentuximab VedotinTwo Cases of Pneumocystis Pneumonia during the Treatment with Brentuximab Vedotin. The Japanese Journal of Clinical Hematology. 2016;57(9):1738-1738$28$YR$$F$Y$58$KG$20240710$$MD$JP$JP
240756002$24075600$2$F$$20240709$20240710$20240712$EXP$$AU-PFIZER INC-202400208624$PFIZER$Anstey, M.. Mucosal bleeding while on venovenous extracorporeal membrane oxygenation in the setting of vitamin C deficiency.. BMJ case reports. 2024;17(6):e259185$4$DEC$$F$Y$$$20240712$$MD$AU$AU
240756011$24075601$1$I$20240604$20240702$20240710$20240710$EXP$FR-AFSSAPS-NY2024000714$FR-TEVA-VS-3216694$TEVA$$53$YR$$F$Y$$$20240710$$PH$FR$FR
240756021$24075602$1$I$$20240702$20240710$20240710$EXP$$ES-GILEAD-2024-0679001$GILEAD$$55$YR$A$M$Y$$$20240710$$MD$ES$ES
240756031$24075603$1$I$$20240705$20240710$20240710$EXP$$US-JNJFOC-20240717924$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240756041$24075604$1$I$20240705$20240708$20240710$20240710$PER$$US-JNJFOC-20240718842$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240710$$HP$US$US
240756052$24075605$2$F$20240318$20240716$20240710$20240722$EXP$ES-AEMPS-1542523$ES-MYLANLABS-2024M1063450$MYLAN$$58$YR$$F$Y$$$20240722$$PH$ES$ES
240756061$24075606$1$I$20240624$20240704$20240710$20240710$EXP$FR-AFSSAPS-SE2024000533$FR-MYLANLABS-2024M1062976$MYLAN$$16$YR$$F$Y$58.3$KG$20240710$$PH$FR$FR
240756073$24075607$3$F$20240626$20240924$20240710$20240924$30DAY$$AR-PFIZER INC-202400203150$PFIZER$$$$$F$Y$$$20240924$$CN$AR$AR
240756091$24075609$1$I$20240525$20240708$20240710$20240710$EXP$FR-AFSSAPS-NC2024000801$FR-PFIZER INC-202400208330$PFIZER$$74$YR$$F$Y$$$20240710$$MD$FR$FR
240756102$24075610$2$F$$20240711$20240710$20240715$EXP$$US-PFIZER INC-202400209753$PFIZER$$32$YR$$F$Y$$$20240715$$HP$US$US
240756111$24075611$1$I$20220420$20240704$20240710$20240710$EXP$$CA-PFIZER INC-202400208246$PFIZER$$63$YR$$F$Y$$$20240710$$HP$CA$CA
240756121$24075612$1$I$20240306$20240708$20240710$20240710$EXP$$US-PFIZER INC-PV202400072255$PFIZER$$56$YR$$M$Y$111.1$KG$20240710$$CN$US$US
240756134$24075613$4$F$$20240921$20240710$20240925$30DAY$$US-PFIZER INC-202400206621$PFIZER$$10$YR$$M$Y$$$20240925$$CN$US$US
240756141$24075614$1$I$20240626$20240708$20240710$20240710$EXP$$CN-PFIZER INC-PV202400089399$PFIZER$$32$YR$$F$Y$65$KG$20240710$$HP$CN$CN
240756151$24075615$1$I$$20240708$20240710$20240710$30DAY$$CO-PFIZER INC-202400208827$PFIZER$$10$YR$$F$Y$$$20240710$$CN$CO$CO
240756161$24075616$1$I$$20240709$20240710$20240710$EXP$$TH-PFIZER INC-PV202400089731$PFIZER$$$$$$Y$$$20240710$$MD$TH$TH
240756182$24075618$2$F$$20240702$20240710$20240710$EXP$$US-AMGEN-USASP2024133899$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31(6):3529-3545$64$YR$A$F$Y$$$20240710$$HP$US$US
240756212$24075621$2$F$20231201$20240808$20240710$20240808$PER$$US-ALXN-202407USA000223US$ALEXION PHARMACEUTICALS$$10$YR$$M$Y$$$20240808$$CN$US$US
240756222$24075622$2$F$20230927$20240715$20240710$20240716$EXP$ES-AEMPS-1445215$ES-GILEAD-2024-0679893$GILEAD$$36$YR$A$M$Y$75$KG$20240716$$PH$ES$ES
240756231$24075623$1$I$$20240709$20240710$20240710$PER$$US-JNJFOC-20240723761$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$PH$US$US
240756273$24075627$3$F$20240101$20240905$20240710$20240905$EXP$$CA-PFIZER INC-202400208926$PFIZER$$64$YR$$M$Y$$$20240905$$MD$CA$CA
240756283$24075628$3$F$$20240916$20240710$20240919$30DAY$$US-PFIZER INC-202400202793$PFIZER$$12$YR$$M$Y$$$20240919$$CN$US$US
240756292$24075629$2$F$$20240711$20240710$20240715$PER$$US-PFIZER INC-202400209055$PFIZER$$59$YR$$F$Y$$$20240715$$HP$US$US
240756301$24075630$1$I$$20240705$20240710$20240710$EXP$$CA-TAKEDA-2024TUS069159$TAKEDA$$33$YR$$F$Y$$$20240710$$HP$CA$CA
240756311$24075631$1$I$$20240703$20240710$20240710$EXP$$IT-MYLANLABS-2024M1063866$MYLAN$Messina A, Rodolico A, Caraci F, Signorelli MS. Vortioxetine in Patients with Schizophrenia and Suicidal Ideation. System-Rev-Pharm 2023; 14 (6): 393-395.$19$YR$$F$Y$$$20240710$$HP$IT$IT
240756321$24075632$1$I$$20240709$20240710$20240710$30DAY$$US-SANDOZ INC.-SDZ2024US064009$SANDOZ$$$$$F$Y$$$20240710$$CN$US$US
240756334$24075633$4$F$$20240911$20240710$20240917$30DAY$$CO-PFIZER INC-PV202400084882$PFIZER$$6$YR$$F$Y$$$20240917$$CN$CO$CO
240756342$24075634$2$F$$20240816$20240710$20240816$30DAY$$CL-PFIZER INC-PV202400089277$PFIZER$$14$YR$$M$Y$$$20240816$$CN$CL$CL
240756352$24075635$2$F$$20240715$20240710$20240715$EXP$$US-PFIZER INC-PV202400088561$PFIZER$$$$$$Y$$$20240715$$CN$US$US
240756362$24075636$2$F$$20240710$20240710$20240718$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001381$BLUEPRINT MEDICINES$$$$$M$Y$$$20240718$$MD$US$US
240756371$24075637$1$I$$20240709$20240710$20240710$EXP$$US-JNJFOC-20240723258$JOHNSON AND JOHNSON$$$$$$Y$$$20240710$$CN$US$US
240756382$24075638$2$F$$20240715$20240710$20240723$EXP$$NVSC2024MX140281$NOVARTIS$Rivera-lizarraga DA, Jimenez-Gonzalez JC, Solis-Gamboa MI, Esoinosa-Padilla SE, Gutierrez-Hernandez JA, Yamazaki-Nakashimade MA et.al.. Guillain-barre syndrome as initial manifestation of systemic lupus erythematosus: case report. CASO CLINICO. 2024;33(1):27-32$13$YR$$F$Y$$$20240723$$HP$MX$MX
240756391$24075639$1$I$20240601$20240704$20240710$20240710$EXP$$FR-MYLANLABS-2024M1062968$MYLAN$$58$YR$$M$Y$61$KG$20240710$$HP$FR$FR
240756401$24075640$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47929$$FDA-CTU$$57$YR$$F$N$$$20240710$N$$US$
240756411$24075641$1$I$20240709$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47925$$FDA-CTU$$75$YR$$M$N$61.6$KG$20240710$N$$US$
240756431$24075643$1$I$$20240710$20240710$20240710$EXP$$US-ANIPHARMA-2024-US-036229$ANI$Haghparast P, Nadybal M, Yuan C.Treatment-resistant priapism in a 61-year-old male after combined use of trazodone, quetiapine, and fluoxetine..Journal of Clinical Psychopharmacology.2024;44(3):316-317.$61$YR$$M$Y$$$20240710$$PH$US$US
240756441$24075644$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135137$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240756451$24075645$1$I$$20240601$20240710$20240710$PER$$US-Eisai-EC-2024-167181$EISAI$$$$$M$Y$$$20240710$$MD$US$US
240756481$24075648$1$I$20240101$20240702$20240710$20240710$EXP$SE-SEMPA-2024-005135$SE-TEVA-VS-3216588$TEVA$$56$YR$$M$Y$$$20240710$$MD$SE$SE
240756491$24075649$1$I$20240401$20240617$20240710$20240710$PER$$US-TEVA-VS-3211523$TEVA$$21$YR$$F$Y$$$20240710$$MD$US$US
240756501$24075650$1$I$$20240704$20240710$20240710$EXP$$US-PFIZER INC-2024SGN02307$PFIZER$$$$$F$Y$$$20240710$$MD$US$US
240756511$24075651$1$I$$20240708$20240710$20240710$EXP$$GR-PFIZER INC-2022SGN05762$PFIZER$$28$YR$$F$Y$$$20240710$$MD$GR$GR
240756522$24075652$2$F$$20240705$20240710$20240711$EXP$$KR-PFIZER INC-PV202400089246$PFIZER$Kim, J.. Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report. Medicina. 2024;60:992$79$YR$$M$Y$$$20240711$$HP$KR$KR
240756531$24075653$1$I$$20240708$20240710$20240710$EXP$$GB-PFIZER INC-2021SGN01476$PFIZER$$72$YR$$F$Y$$$20240710$$MD$GB$GB
240756542$24075654$2$F$20171101$20240717$20240710$20240724$EXP$IE-HPRA-2017-032790$IE-PFIZER INC-2018SGN00231$PFIZER$$49$YR$$M$Y$$$20240724$$MD$IE$IE
240756551$24075655$1$I$$20240702$20240710$20240710$EXP$$CA-JNJFOC-20240714699$JOHNSON AND JOHNSON$$32$YR$A$M$Y$75$KG$20240710$$CN$CA$CA
240756561$24075656$1$I$$20240707$20240710$20240710$EXP$$CA-PFIZER INC-2019SGN03940$PFIZER$$35$YR$$M$Y$$$20240710$$HP$CA$CA
240756571$24075657$1$I$$20240709$20240710$20240710$EXP$IT-MINISAL02-994117$IT-GILEAD-2024-0680048$GILEAD$$61$YR$A$M$Y$$$20240710$$MD$IT$IT
240756582$24075658$2$F$20220526$20240705$20240710$20240717$EXP$$AR-BIOMARINAP-AR-2024-159019$BIOMARIN$$$$$$Y$$$20240717$$CN$AR$AR
240756593$24075659$3$F$20240702$20240715$20240710$20240722$EXP$$AR-BIOMARINAP-AR-2024-159004$BIOMARIN$$$$$$Y$$$20240722$$CN$AR$AR
240756603$24075660$3$F$20240101$20240916$20240710$20240918$EXP$$CA-BIOMARINAP-CA-2024-159027$BIOMARIN$$$$$$Y$$$20240918$$CN$CA$CA
240756611$24075661$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142717$NOVARTIS$$$$$M$Y$$$20240710$$MD$US$US
240756621$24075662$1$I$$20240619$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039002$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240710$$CN$US$US
240756631$24075663$1$I$20240702$20240705$20240710$20240710$PER$$US-JNJFOC-20240717612$JOHNSON AND JOHNSON$$29$YR$A$$Y$$$20240710$$CN$US$US
240756641$24075664$1$I$$20240701$20240710$20240710$PER$$US-INCYTE CORPORATION-2024IN006967$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240756651$24075665$1$I$20240507$20240702$20240710$20240710$EXP$FR-AFSSAPS-TO2024000823$FR-TEVA-VS-3216688$TEVA$$78$YR$$F$Y$$$20240710$$MD$FR$FR
240756661$24075666$1$I$20201101$20240708$20240710$20240710$EXP$$CA-PFIZER INC-2023SGN08878$PFIZER$$44$YR$$M$Y$88.6$KG$20240710$$MD$CA$CA
240756671$24075667$1$I$$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407006377$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240710$$CN$US$US
240756681$24075668$1$I$$20240709$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407006166$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240710$$CN$US$US
240756691$24075669$1$I$$20240705$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108249$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$61.23$KG$20240710$$CN$US$US
240756703$24075670$3$F$$20240830$20240710$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109667$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240904$$CN$US$US
240756711$24075671$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109529$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240710$$CN$US$US
240756721$24075672$1$I$$20240704$20240710$20240710$EXP$FR-AFSSAPS-MP2024001059$FR-MYLANLABS-2024M1063003$MYLAN$$$$N$F$Y$2.36$KG$20240710$$MD$FR$FR
240756732$24075673$2$F$20240625$20240808$20240710$20240809$EXP$$CL-AMERICAN REGENT INC-2024002661$AMERICAN REGENT$$49$YR$$F$Y$$$20240809$$MD$CL$CL
240756745$24075674$5$F$20240708$20240812$20240710$20240822$30DAY$$US-JNJFOC-20240720344$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240822$$PH$US$US
240756751$24075675$1$I$$20240628$20240710$20240710$PER$$US-PHARMING-PHAUS2024000545$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
240756761$24075676$1$I$$20240702$20240710$20240710$PER$$US-PHARMING-PHAUS2024000559$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
240756771$24075677$1$I$$20240708$20240710$20240710$PER$$US-PHARMING-PHAUS2024000577$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
240756781$24075678$1$I$$20240627$20240710$20240710$PER$$US-PHARMING-PHAUS2024000544$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
240756791$24075679$1$I$20240606$20240628$20240710$20240710$PER$$US-PHARMING-PHAUS2024000548$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
240756801$24075680$1$I$$20240703$20240710$20240710$PER$$US-PHARMING-PHAUS2024000573$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
240756811$24075681$1$I$$20240703$20240710$20240710$PER$$US-PHARMING-PHAUS2024000564$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
240756821$24075682$1$I$$20240703$20240710$20240710$PER$$US-PHARMING-PHAUS2024000565$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
240756831$24075683$1$I$20240601$20240702$20240710$20240710$PER$$US-PHARMING-PHAUS2024000561$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
240756842$24075684$2$F$$20240724$20240710$20240730$PER$$US-PHARMING-PHAUS2024000574$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
240756851$24075685$1$I$$20240709$20240710$20240710$PER$$US-PFIZER INC-202400209869$PFIZER$$$$$F$Y$136.05$KG$20240710$$MD$US$US
240756862$24075686$2$F$$20240802$20240710$20240828$PER$$US-PHARMING-PHAUS2024000563$PHARMING GROUP$$$$$$Y$$$20240806$$CN$US$US
240756872$24075687$2$F$$20240904$20240710$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109348$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240905$$CN$US$US
240756881$24075688$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109683$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240710$$CN$US$US
240756891$24075689$1$I$$20240703$20240710$20240710$PER$$US-PHARMING-PHAUS2024000572$PHARMING GROUP$$$$$$Y$$$20240710$$CN$US$US
240756903$24075690$3$F$20210101$20240919$20240710$20240925$EXP$$HU-MYLANLABS-2024M1060428$MYLAN$Gulyas A, Berzy K, Domotor MA, Santa H, Batai AL. High-grade transformation in a patient of ours treated for lymphoplasmacytic lymphoma - case presentation. Hematology -Transfusionology.. 2024;57(1):68-69$58$YR$$F$Y$$$20240925$$MD$HU$HU
240756912$24075691$2$F$$20240704$20240710$20240712$EXP$$AU-MYLANLABS-2024M1064229$MYLAN$Ninkov T, Chan J, Von Nida J. A Case of Terbinafine-Induced Subacute Cutaneous Lupus Erythematosus rapidly resolving with Upadacitinib. Clin-Exp-Dermatol 2024; 0 (0).$71$YR$$F$Y$$$20240712$$HP$AU$AU
240756922$24075692$2$F$20240501$20240718$20240710$20240802$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455799$RANBAXY$$76$YR$$F$Y$78$KG$20240802$$PH$BR$BR
240756931$24075693$1$I$20240525$20240708$20240710$20240710$EXP$$NVSC2024CN142463$NOVARTIS$$68$YR$$M$Y$$$20240710$$HP$CN$CN
240756941$24075694$1$I$$20240626$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455718$RANBAXY$Muhammad O, Munir K, Upadristra P, Jhaveri K, Sachdeva M. Diagnosis of Pheochromocytoma during first trimester pregnancy. Am J Kidney Dis. 2024;83 (Suppl.)(4):S155/504$32$YR$$F$Y$$$20240711$$HP$US$US
240756951$24075695$1$I$$20240626$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455661$RANBAXY$Vallabhajosyula S, Ukrani H, Wersinger D, Malik H, Obaji A.. Fighting the Recovering Heart While Drowning in Volume: Role of VA-V ECMO Configuration in Migrating Mixing Cloud Effect. Am J Respir Crit Care Med. 2024;209:A5582$43$YR$$F$Y$$$20240711$$HP$US$US
240756961$24075696$1$I$$20240626$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455618$RANBAXY$Puri C, Khan AA, Sher N. A Case of Emphysematous Gastritis With Septic Shock and Clostridioides Difficile. Am J Respir Crit Care Med. 2024;209(0):A43$72$YR$$F$Y$$$20240711$$HP$US$US
240756971$24075697$1$I$$20240626$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455612$RANBAXY$Rubannelsonkumar C, Hornak J. Treatment of Mucormycosis Infection With Combination Therapy Using Echinocandin and Amphotericin B. Am J Respir Crit Care Med. 2024;209 (0):A2389$46$YR$$M$Y$$$20240711$$HP$US$US
240756981$24075698$1$I$$20240626$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455650$RANBAXY$Koga S, Pai E, Banihashemi A. Diffuse lymphocytic encephalomyelitis with stiff person-like syndrome in multiple myeloma after Teclistamab treatment. J Neuropathol Exp Neurol. 2024;83 (6):457-458/5$45$YR$$$Y$$$20240711$$HP$US$US
240756991$24075699$1$I$$20240705$20240710$20240710$PER$$NVSC2024US142679$NOVARTIS$$$$$F$Y$$$20240710$$HP$US$US
240757001$24075700$1$I$$20240626$20240710$20240710$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455802$RANBAXY$Hammamia SB, Jabri FE, Belhadj A, Khefacha F, Saidani A, Chebbi F et al. Neurotoxicity Related to Multidrug Association: A Case Report. J Clin Psychopharmacol. 2024;May/Jun; 44(3):317-319$57$YR$$F$Y$$$20240711$$MD$TN$TN
240757011$24075701$1$I$$20240708$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US064155$SANDOZ$$$$$F$Y$$$20240710$$CN$US$US
240757021$24075702$1$I$20240520$20240705$20240710$20240710$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-005848$AURINIA PHARMACEUTICALS$$21$YR$$F$Y$$$20240710$$CN$US$US
240757031$24075703$1$I$20231104$20240709$20240710$20240710$EXP$ES-AEMPS-1543377$ES-GILEAD-2024-0680042$GILEAD$$19$YR$A$F$Y$$$20240710$$PH$ES$ES
240757041$24075704$1$I$20240619$20240702$20240710$20240710$EXP$$DE-PFIZER INC-202400209374$PFIZER$$$$E$F$Y$53$KG$20240710$$HP$DE$DE
240757051$24075705$1$I$$20240704$20240710$20240710$EXP$$US-PFIZER INC-2024SGN06279$PFIZER$$42$YR$$F$Y$$$20240710$$CN$US$US
240757071$24075707$1$I$$20240704$20240710$20240710$EXP$$US-PFIZER INC-2024SGN05841$PFIZER$$61$YR$$F$Y$$$20240710$$CN$US$US
240757083$24075708$3$F$20230413$20240827$20240710$20240902$EXP$$ES-PFIZER INC-202400207452$PFIZER$$80$YR$$F$Y$$$20240902$$MD$ES$ES
240757091$24075709$1$I$$20240704$20240710$20240710$EXP$$US-PFIZER INC-2024SGN05780$PFIZER$$52$YR$$M$Y$$$20240710$$CN$US$US
240757101$24075710$1$I$$20240704$20240710$20240710$EXP$$US-PFIZER INC-2024SGN05523$PFIZER$$68$YR$$F$Y$$$20240710$$CN$US$US
240757111$24075711$1$I$$20240704$20240710$20240710$EXP$$US-PFIZER INC-2024SGN05525$PFIZER$$53$YR$$F$Y$$$20240710$$CN$US$US
240757121$24075712$1$I$$20240704$20240710$20240710$EXP$$US-PFIZER INC-2024SGN05749$PFIZER$$67$YR$$M$Y$$$20240710$$CN$US$US
240757131$24075713$1$I$20210805$20240704$20240710$20240710$EXP$$US-PFIZER INC-2021SGN03466$PFIZER$$56$YR$$F$Y$$$20240710$$CN$US$US
240757141$24075714$1$I$$20240705$20240710$20240710$EXP$$US-GSK-US2024084025$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$CN$US$US
240757151$24075715$1$I$$20240709$20240710$20240710$EXP$$US-SANDOZ INC.-SDZ2024US064143$SANDOZ$$$$$F$Y$$$20240710$$CN$US$US
240757161$24075716$1$I$$20240626$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455419$RANBAXY$$$$E$M$Y$$$20240711$$HP$US$US
240757171$24075717$1$I$$20240708$20240710$20240710$EXP$IT-PFIZER INC-202400198684$IT-GSK-IT2024GSK084828$GLAXOSMITHKLINE$Antonello, R.. Antiviral combination regimens as rescue therapy in immunocompromised hosts with persistent COVID-19. Journal of Chemotherapy. 2024$$$$$Y$$$20240710$$HP$IT$IT
240757181$24075718$1$I$$20240626$20240710$20240710$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455188$RANBAXY$Levy DM, Arush OB, Carmi L, Wetzler AJ, Zohar J. Off-label higher doses of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Safety and tolerability. Compr Psychiatry. 2024;133 (0):152486;1-6$45$YR$$M$Y$$$20240711$$HP$IL$IL
240757191$24075719$1$I$$20240626$20240710$20240710$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455183$RANBAXY$Levy DM, Arush OB, Carmi L, Wetzler AJ, Zohar J. Off-label higher doses of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Safety and tolerability. Compr Psychiatry. 2024;133 (0):152486;1-6$$$A$$Y$$$20240711$$HP$IL$IL
240757201$24075720$1$I$$20240703$20240710$20240710$EXP$$DK-GSK-DK2024GSK083765$GLAXOSMITHKLINE$Pedersen OS, Barkholt TO, Madsen SH, Rudolf F. Tuberculosis immune reconstitution syndrome (TB-IRIS) followed by recurring lymphadenitis up to 8 years post-antituberculous treatment. BMJ Case Reports. 2024;17 (6)$$$$$Y$$$20240710$$HP$DK$DK
240757211$24075721$1$I$$20240703$20240710$20240710$EXP$$US-GSK-US2024GSK083696$GLAXOSMITHKLINE$Jimenez D, Rabe MS, Agarwal AN, Dalton SR, Anstead GM. An Exuberant Case of Ulceronodular-Rupioid (Malignant) Syphilis in an HIV Patient: A Proposal for New Diagnostic Criteria. Infectious Disease Reports. 2024;16 (3):499-518$$$$$Y$$$20240710$$HP$US$US
240757221$24075722$1$I$$20240626$20240710$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452320$RANBAXY$Benefield S. Case study: treatment-resistant schizophrenia. Pharm J. 2022;308 (7957):1-12$26$YR$$M$Y$$$20240711$$HP$GB$GB
240757231$24075723$1$I$$20240703$20240710$20240710$EXP$$US-VIIV HEALTHCARE LIMITED-US2024GSK083696$VIIV$Jimenez D, Rabe MS, Agarwal AN, Dalton SR, Anstead GM. An Exuberant Case of Ulceronodular-Rupioid (Malignant) Syphilis in an HIV Patient: A Proposal for New Diagnostic Criteria. Infectious Disease Reports. 2024;16 (3):499-518$$$$$Y$$$20240710$$HP$US$US
240757241$24075724$1$I$$20240626$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451233$RANBAXY$$$$$M$Y$$$20240711$$CN$US$US
240757252$24075725$2$F$$20240701$20240710$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455607$RANBAXY$Goudie MP, Khawam S, Levy JM, Hartfield R, Hassan S, Dawson M. A Storm is Brewing: A Case of Thyrotoxic Crisis. Am J Respir Crit Care Med. 2024;209(0):A3376$27$YR$$M$Y$$$20240716$$HP$US$US
240757261$24075726$1$I$$20240624$20240710$20240710$EXP$$CA-DSJP-DSJ-2024-134977AA$DAIICHI$$$$$F$Y$$$20240710$$MD$CA$CA
240757271$24075727$1$I$20240101$20240604$20240710$20240710$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0273$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240757281$24075728$1$I$$20240703$20240710$20240710$EXP$$DK-VIIV HEALTHCARE LIMITED-DK2024GSK083765$VIIV$Pedersen OS, Barkholt TO, Madsen SH, Rudolf F. Tuberculosis immune reconstitution syndrome (TB-IRIS) followed by recurring lymphadenitis up to 8 years post-antituberculous treatment. BMJ Case Reports. 2024;17 (6)$$$$$Y$$$20240710$$HP$DK$DK
240757293$24075729$3$F$$20240729$20240710$20240805$EXP$$IT-MYLANLABS-2024M1063380$MYLAN$Gunnellini M, Tornincasa A, Montedoro M, Caprodossi A, Prosperi E, Peverini M.. Neoadjuvant treatment for a cT4cN+ HER2+ breast cancer: case report of a therapeutic success.. Anticancer research. 2024;44(6):2755-2758$35$YR$$F$Y$$$20240805$$MD$IT$IT
240757301$24075730$1$I$20240614$20240702$20240710$20240710$PER$$CN-Eisai-EC-2024-169556$EISAI$$46$YR$A$F$Y$62$KG$20240710$$HP$CN$CN
240757311$24075731$1$I$20240601$20240702$20240710$20240710$PER$$JP-Eisai-EC-2024-169510$EISAI$$$$A$F$Y$$$20240710$$MD$JP$JP
240757321$24075732$1$I$$20240701$20240710$20240710$PER$$JP-Eisai-EC-2024-169407$EISAI$$39$YR$A$$Y$$$20240710$$MD$JP$JP
240757331$24075733$1$I$20230716$20240702$20240710$20240710$EXP$FR-AFSSAPS-PC2024000510$FR-TEVA-VS-3216616$TEVA$$23$YR$$F$Y$$$20240710$$MD$FR$FR
240757351$24075735$1$I$20240417$20240630$20240710$20240710$PER$$CN-Eisai-EC-2024-169273$EISAI$$59$YR$A$M$Y$55$KG$20240710$$HP$CN$CN
240757362$24075736$2$F$20240602$20240722$20240710$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-104755$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$124$KG$20240726$$HP$US$US
240757372$24075737$2$F$20240614$20240822$20240710$20240828$PER$IT-MINISAL02-992911$IT-Eisai-EC-2024-169186$EISAI$$86$YR$E$M$Y$75$KG$20240828$$MD$IT$IT
240757381$24075738$1$I$$20240709$20240710$20240710$EXP$$US-BAUSCH-BL-2024-010512$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240710$$CN$US$US
240757391$24075739$1$I$20240516$20240703$20240710$20240710$EXP$$US-Eisai-EC-2024-169484$EISAI$$67$YR$E$M$Y$$$20240710$$HP$US$US
240757402$24075740$2$F$$20240918$20240710$20240925$PER$$JP-Eisai-EC-2024-169529$EISAI$$$$E$M$Y$$$20240925$$MD$JP$JP
240757411$24075741$1$I$20200506$20240708$20240710$20240710$EXP$PL-URPL-1-3691-2020$PL-BAUSCH-BL-2024-010473$BAUSCH AND LOMB$$40$YR$$M$Y$80$KG$20240710$$MD$PL$PL
240757421$24075742$1$I$20240101$20240709$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039027$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240710$$CN$US$US
240757431$24075743$1$I$20230307$20240709$20240710$20240710$EXP$ES-AEMPS-1542764$ES-GILEAD-2024-0680047$GILEAD$$55$YR$A$M$Y$$$20240710$$PH$ES$ES
240757441$24075744$1$I$20240101$20240704$20240710$20240710$EXP$$CA-BAUSCH-BL-2024-010405$BAUSCH AND LOMB$$47$YR$$M$Y$$$20240710$$CN$CA$CA
240757453$24075745$3$F$20240704$20240710$20240710$20240717$EXP$$CA-HLS-202401702$HLS THERAPEUTICS$$46$YR$A$M$Y$81$KG$20240717$$PH$CA$CA
240757461$24075746$1$I$20230615$20240704$20240710$20240710$EXP$FR-AFSSAPS-PP2024000715$FR-MYLANLABS-2024M1063269$MYLAN$$96$YR$$M$Y$62$KG$20240710$$PH$FR$FR
240757471$24075747$1$I$$20240626$20240710$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456139$RANBAXY$Ozer A, Demirtas H, Tak S, Kocak B, Yigiter EN, Oktar GL, et al. Assessment of aspirin and clopidogrel resistance in patients undergoing cardiovascular surgery: a single-center cross sectional study. Turk J Haematol. 2024;41 (2):105-112$62$YR$$M$Y$$$20240711$$HP$TR$TR
240757481$24075748$1$I$$20240626$20240710$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456131$RANBAXY$Ozer A, Demirtas H, Tak S, Kocak B, Yigiter EN, Oktar GL, et al. Assessment of aspirin and clopidogrel resistance in patients undergoing cardiovascular surgery: a single-center cross sectional study. Turk J Haematol. 2024;41 (2):105-112$60$YR$$M$Y$$$20240711$$HP$TR$TR
240757491$24075749$1$I$$20240626$20240710$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456132$RANBAXY$Ozer A, Demirtas H, Tak S, Kocak B, Yigiter EN, Oktar GL, et al. Assessment of aspirin and clopidogrel resistance in patients undergoing cardiovascular surgery: a single-center cross sectional study. Turk J Haematol. 2024;41 (2):105-112$63$YR$$M$Y$$$20240711$$HP$TR$TR
240757501$24075750$1$I$$20240626$20240710$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456135$RANBAXY$Ozer A, Demirtas H, Tak S, Kocak B, Yigiter EN, Oktar GL, et al. Assessment of aspirin and clopidogrel resistance in patients undergoing cardiovascular surgery: a single-center cross sectional study. Turk J Haematol. 2024;41 (2):105-112$64$YR$$F$Y$$$20240711$$HP$TR$TR
240757511$24075751$1$I$$20240626$20240710$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456129$RANBAXY$Ozer A, Demirtas H, Tak S, Kocak B, Yigiter EN, Oktar GL, et al. Assessment of aspirin and clopidogrel resistance in patients undergoing cardiovascular surgery: a single-center cross sectional study. Turk J Haematol. 2024;41 (2):105-112$72$YR$$M$Y$$$20240711$$HP$TR$TR
240757521$24075752$1$I$$20240626$20240710$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456134$RANBAXY$Ozer A, Demirtas H, Tak S, Kocak B, Yigiter EN, Oktar GL, et al. Assessment of aspirin and clopidogrel resistance in patients undergoing cardiovascular surgery: a single-center cross sectional study. Turk J Haematol. 2024;41 (2):105-112$66$YR$$M$Y$$$20240711$$HP$TR$TR
240757531$24075753$1$I$20240201$20240626$20240710$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456096$RANBAXY$$67$YR$$M$Y$98$KG$20240711$$CN$GB$GB
240757541$24075754$1$I$$20240626$20240710$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456128$RANBAXY$Ozer A, Demirtas H, Tak S, Kocak B, Yigiter EN, Oktar GL, et al. Assessment of aspirin and clopidogrel resistance in patients undergoing cardiovascular surgery: a single-center cross sectional study. Turk J Haematol. 2024;41 (2):105-112$73$YR$$M$Y$$$20240711$$HP$TR$TR
240757551$24075755$1$I$$20240626$20240710$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456123$RANBAXY$Ozer A, Demirtas H, Tak S, Kocak B, Yigiter EN, Oktar GL, et al. Assessment of aspirin and clopidogrel resistance in patients undergoing cardiovascular surgery: a single-center cross sectional study. Turk J Haematol. 2024;41 (2):105-112$69$YR$$M$Y$$$20240711$$HP$TR$TR
240757561$24075756$1$I$$20240626$20240710$20240710$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456102$RANBAXY$Gerostamoulos D, Glowacki L, Pricone M, Crump K, Rago MD, Joubert S, et al. Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMe. J Anal Toxicol. 2023;47 (2):191-196$$$$F$Y$$$20240711$$HP$AU$AU
240757571$24075757$1$I$$20240626$20240710$20240710$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456121$RANBAXY$Gerostamoulos D, Glowacki L, Pricone M, Crump K, Rago MD, Joubert S, et al. Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMe. J Anal Toxicol. 2023;47 (2):191-196$$$$M$Y$$$20240711$$HP$AU$AU
240757581$24075758$1$I$$20240626$20240710$20240710$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456126$RANBAXY$Gerostamoulos D, Glowacki L, Pricone M, Crump K, Rago MD, Joubert S, et al. Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMe. J Anal Toxicol. 2023;47 (2):191-196$$$$M$Y$$$20240711$$HP$AU$AU
240757591$24075759$1$I$$20240626$20240710$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456118$RANBAXY$$56$YR$$$Y$$$20240711$$PH$GB$GB
240757601$24075760$1$I$$20240626$20240710$20240710$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455866$RANBAXY$Gao J, Wang Y, Zhang A, Pang H, Wang F. Old woman with Sheehan^s syndrome suffered severe hyponatremia following percutaneous coronary intervention: a case report and review of literature. Front Cardiovasc Med. 2024;11:1353392$70$YR$$F$Y$46$KG$20240711$$HP$CN$CN
240757611$24075761$1$I$20240619$20240626$20240710$20240710$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456153$RANBAXY$$67$YR$$F$Y$82$KG$20240711$$HP$NL$NL
240757621$24075762$1$I$$20240701$20240710$20240710$EXP$$US-SMPA-2024SPA000100$SUNOVION$$$$$$Y$$$20240710$$CN$US$US
240757631$24075763$1$I$20230824$20240701$20240710$20240710$EXP$$US-SMPA-2024SPA000117$SUNOVION$$$$$$Y$$$20240710$$CN$US$US
240757641$24075764$1$I$$20240705$20240710$20240710$EXP$CA-HEALTHCANVIG-07164590$CA-SMPA-2024SPA000122$SUNOVION$$$$$$Y$$$20240710$$CN$CA$CA
240757651$24075765$1$I$$20240626$20240710$20240710$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455920$RANBAXY$Majowicz D, Kostrzewa K, Gromek T, Sokolowska B, Hus M. Haemophagocytic lymphohistiocytosis:  case series. Serum ferritin level as an indicator  of treatment effectiveness. Hematol Clinic Pract. 2022;13 (3-4):130-137$46$YR$$M$Y$$$20240711$$HP$PL$PL
240757661$24075766$1$I$$20240626$20240710$20240710$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456082$RANBAXY$Li C, Zheng X, Zhang L, Wang Y, Hu R, Cui H-Y, et al. PLA2R-associated membranous nephropathy: a single-center cohort study. Nephrol Dial Transplant. 2024;39:i2064(Abs citation ID: gfae06)$$$A$$Y$$$20240711$$HP$CN$CN
240757671$24075767$1$I$$20240626$20240710$20240710$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456081$RANBAXY$Li C, Zheng X, Zhang L, Wang Y, Hu R, Cui H-Y, et al. PLA2R-associated membranous nephropathy: a single-center cohort study. Nephrol Dial Transplant. 2024;39:i2064(Abs citation ID: gfae06)$$$A$$Y$$$20240711$$HP$CN$CN
240757681$24075768$1$I$$20240626$20240710$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456011$RANBAXY$Gungor ES, Durmaz O. A case of psoriasis following clozapine treatment: Considerations for immunopsychiatry. Indian J Psychiatry. 2022;Apr; 66(4):407-408$47$YR$$F$Y$$$20240711$$HP$TR$TR
240757691$24075769$1$I$$20240626$20240710$20240710$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455917$RANBAXY$Majowicz D, Kostrzewa K, Gromek T, Sokolowska B, Hus M. Haemophagocytic lymphohistiocytosis: case series. Serum ferritin level as an indicator  of treatment effectiveness. Hematol Clinic Pract. 2022;13 (3-4):130-137$31$YR$$M$Y$$$20240711$$HP$PL$PL
240757701$24075770$1$I$$20240626$20240710$20240710$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455984$RANBAXY$Bours B, Barcena C, Cairoli A, De Leval L, Schaefer N, Segot A. Primary bone marrow lymphoma (PBML): a rare cause of chronic inflammation with diffuse bone marrow hypermetabolism. Swiss Med Wkly. 2023;Abs: 279; 69S-70S$81$YR$$F$Y$$$20240711$$HP$CH$CH
240757711$24075771$1$I$$20240626$20240710$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456004$RANBAXY$Erdal AE, Koylu OK, Ceylan AC, Kasapkara CS, Tuncez E, Topu M. Sepiapterin Reductase Deficiency Misdiagnosed as Neurological Sequelae of Meningitis. Mol Syndromol. 2024;15:130-135$19$YR$$M$Y$$$20240711$$HP$TR$TR
240757721$24075772$1$I$$20240703$20240710$20240710$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407005278$ELI LILLY AND CO$$61$YR$A$M$Y$62$KG$20240710$$CN$CN$CN
240757731$24075773$1$I$$20240626$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455963$RANBAXY$Mak K, Maleckar S, Strek ME, Adegunsoye AO, Lee CT. Improvement in Pulmonary Function in a Patient With ILD Following Semaglutide Therapy. Am J Respir Crit Care Med. 2024;May;209 (0):A2047; A53$65$YR$$F$Y$$$20240711$$HP$US$US
240757741$24075774$1$I$$20240626$20240710$20240710$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455967$RANBAXY$Bo Y, Zhong X, Xiang Y, Ren Q, Hao P. Death Caused by Disseminated Herpes Zoster in a Patient with Multiple Myeloma: A Case Report and Literature Review. Clin Cosmet Invest Dermatol. 2024;17 (0):941-951$58$YR$$M$Y$$$20240711$$HP$CN$CN
240757751$24075775$1$I$20240628$20240628$20240710$20240710$EXP$GB-MHRA-MED-202406282030124910-RZMFY$GB-ELI_LILLY_AND_COMPANY-GB202407000657$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240710$$CN$GB$GB
240757761$24075776$1$I$20240704$20240705$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407003969$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240710$$CN$US$US
240757771$24075777$1$I$$20240626$20240710$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455944$RANBAXY$Reid I, Sharma A, Gogbashian A, Kaur B, Fotopoulou C. Germ cell cancer in pregnancy ? Successfully treated with chemotherapy and surgery. Gynecol Oncol Rep. 2023;47:101185$$$N$F$Y$2.415$KG$20240711$$HP$GB$GB
240757781$24075778$1$I$$20240626$20240710$20240710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455939$RANBAXY$Reid I, Sharma A, Gogbashian A, Kaur B, Fotopoulou C. Germ cell cancer in pregnancy ? Successfully treated with chemotherapy and surgery. Gynecol Oncol Rep. 2023;47:101185$31$YR$$F$Y$$$20240711$$HP$GB$GB
240757791$24075779$1$I$$20240626$20240710$20240710$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456084$RANBAXY$Ozer A, Demirtas H, Tak S, Kocak B, Yigiter EN, Oktar GL, et al. Assessment of aspirin and clopidogrel resistance in patients undergoing cardiovascular surgery: a single-center cross sectional study. Turk J Haematol. 2024;41 (2):105-112$78$YR$$M$Y$$$20240711$$HP$TR$TR
240757801$24075780$1$I$$20240626$20240710$20240710$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455921$RANBAXY$Deanda S, Razia D, Zaidi W, Lee R, Arjuna A. Post-transplant Lymphoproliferative Disorder: A Nodular Area That Kept Growing. Am J Respir Crit Care Med. 2024;May;209:A5942 (C54)$79$YR$$F$Y$$$20240711$$HP$US$US
240757811$24075781$1$I$$20240708$20240710$20240710$PER$$US-SMPA-2024SPA000125$SUNOVION$$$$$$Y$$$20240710$$CN$US$US
240757833$24075783$3$F$20240804$20240817$20240710$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109385$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$68.04$KG$20240820$$CN$US$US
240757841$24075784$1$I$$20240703$20240710$20240710$PER$$US-ALXN-202407USA000276US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
240757851$24075785$1$I$$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136020$AMGEN$$$$$M$Y$$$20240710$$CN$US$US
240757861$24075786$1$I$$20240705$20240710$20240710$PER$$US-EMD Serono-2024037225$EMD SERONO INC$$53$YR$A$F$Y$$$20240710$$CN$US$US
240757871$24075787$1$I$20220901$20240708$20240710$20240710$EXP$FR-AFSSAPS-TO2024000745$FR-009507513-2404FRA012401$MERCK$$78$YR$$M$Y$85$KG$20240710$$PH$FR$FR
240757881$24075788$1$I$$20240626$20240710$20240710$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455875$RANBAXY$Yan C, Liu TT, Gao Li-T. Chronic inflammatory demyelinating polyneuropathy with pulmonary nocardiosis: A case report. Medicine. 2024;103(24):p e38544$65$YR$$M$Y$$$20240711$$MD$CN$CN
240757902$24075790$2$F$$20240717$20240710$20240724$PER$$US-AMGEN-USASP2024135393$AMGEN$$66$YR$E$M$Y$$$20240723$$CN$US$US
240757911$24075791$1$I$$20240611$20240710$20240710$PER$$US-Eisai-EC-2024-168137$EISAI$Soiffer JL. Durable partial response to pembrolizumab, lenvatinib, and letrozole in a case of recurrent uterine carcinosarcoma with ESR1 gene amplification. Gynecologic Oncology Reports. 2024 May 28;(54): doi:https://doi.org/10.1016/j.gore.2024.101426.$68$YR$E$F$Y$$$20240710$$MD$US$US
240757921$24075792$1$I$20240125$20240703$20240710$20240710$EXP$$CA-LUNDBECK-DKLU3073205$LUNDBECK$$$$$$Y$$$20240710$$HP$CA$CA
240757941$24075794$1$I$$20240705$20240710$20240710$PER$GB-MHRA-MED-202405091043499980-ZCLHQ$GB-Eisai-EC-2024-169643$EISAI$$$$$F$Y$$$20240710$$PH$GB$GB
240757951$24075795$1$I$20240601$20240703$20240710$20240710$EXP$$JP-Eisai-EC-2024-169571$EISAI$$$$A$F$Y$$$20240710$$MD$JP$JP
240757961$24075796$1$I$20240708$20240708$20240710$20240710$PER$$US-BAUSCH-BL-2024-010476$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240710$$CN$US$US
240757971$24075797$1$I$20240618$20240704$20240710$20240710$PER$$CN-Eisai-EC-2024-169619$EISAI$$61$YR$A$F$Y$48$KG$20240710$$HP$CN$CN
240757981$24075798$1$I$20231220$20240709$20240710$20240710$PER$$NVSC2024US142797$NOVARTIS$$76$YR$$M$Y$$$20240710$$CN$US$US
240757991$24075799$1$I$20240319$20240702$20240710$20240710$EXP$ES-AEMPS-1538852$ES-TEVA-VS-3216558$TEVA$$57$YR$$M$Y$$$20240710$$MD$ES$ES
240758011$24075801$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109673$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$83.3$KG$20240710$$CN$US$US
240758021$24075802$1$I$20240702$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109505$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240710$$PH$US$US
240758041$24075804$1$I$$20240708$20240710$20240710$PER$$US-009507513-2407USA003853$MERCK$$$$$M$Y$$$20240710$$CN$US$US
240758051$24075805$1$I$20240430$20240703$20240710$20240710$PER$$US-JNJFOC-20240724040$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$HP$US$US
240758061$24075806$1$I$$20240703$20240710$20240710$PER$$US-ALXN-202407USA000280US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
240758071$24075807$1$I$$20240627$20240710$20240710$PER$$US-SA-2024SA195705$SANOFI AVENTIS$$35$YR$A$F$Y$77$KG$20240710$$MD$US$US
240758083$24075808$3$F$$20240916$20240710$20240919$30DAY$$KR-PFIZER INC-202400209928$PFIZER$$10$YR$$$Y$$$20240919$$CN$KR$KR
240758091$24075809$1$I$20240610$20240708$20240710$20240710$EXP$FI-FIMEA-202402347$FI-PFIZER INC-202400208422$PFIZER$$60$YR$$F$Y$$$20240710$$CN$FI$FI
240758101$24075810$1$I$20240601$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109508$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$56.88$KG$20240710$$PH$US$US
240758111$24075811$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109689$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240710$$CN$US$US
240758121$24075812$1$I$$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405021803196890-NFPBC$GB-RDY-SPO/GBR/24/0009910$DR REDDYS$$$$$$Y$44$KG$20240710$$CN$GB$GB
240758131$24075813$1$I$$20240703$20240710$20240710$EXP$GB-MHRA-DEFECT-202406221311545970-BHSNJ$GB-RDY-SPO/GBR/24/0009794$DR REDDYS$$$$$$Y$$$20240710$$CN$GB$GB
240758141$24075814$1$I$$20240705$20240710$20240710$EXP$$ZA-AstraZeneca-2024A155812$ASTRAZENECA$$70$YR$$M$Y$$$20240710$$CN$ZA$
240758151$24075815$1$I$20240601$20240705$20240710$20240710$EXP$$US-MYLANLABS-2024M1064675$MYLAN$$66$YR$$M$Y$$$20240710$$CN$US$US
240758161$24075816$1$I$$20240625$20240710$20240710$EXP$$US-Calliditas-2024CAL01191$CALLIDITAS THERAPEUTICS$$67$YR$E$M$Y$$$20240710$$CN$US$US
240758172$24075817$2$F$20240404$20240708$20240710$20240717$EXP$FR-AFSSAPS-TO2024001135$FR-TEVA-VS-3216194$TEVA$$77$YR$$M$Y$79$KG$20240717$$MD$FR$FR
240758182$24075818$2$F$$20240903$20240710$20240910$EXP$$DE-Calliditas-2024CAL01226$CALLIDITAS THERAPEUTICS$$66$YR$E$M$Y$$$20240910$$MD$DE$DE
240758193$24075819$3$F$20240702$20240816$20240710$20240822$EXP$$JP-PFIZER INC-PV202400087484$PFIZER$$60$YR$$M$Y$57.4$KG$20240822$$MD$JP$JP
240758201$24075820$1$I$20240501$20240604$20240710$20240710$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0275$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240758211$24075821$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2023CA012898$SANDOZ$$$$$M$Y$$$20240710$$CN$CA$CA
240758221$24075822$1$I$$20240706$20240710$20240710$PER$$US-EMD Serono-2024037235$EMD SERONO INC$$$$A$M$Y$$$20240710$$HP$US$US
240758252$24075825$2$F$$20240922$20240710$20240924$EXP$$US-SA-2024SA201771$SANOFI AVENTIS$$$$E$M$Y$$$20240924$$MD$US$US
240758261$24075826$1$I$20240601$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109483$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240710$$HP$US$US
240758271$24075827$1$I$20240618$20240703$20240710$20240710$PER$$US-IDORSIA-008203-2024-US$IDORSIA PHARMACEUTICALS$$91$YR$$M$Y$$$20240710$$CN$US$US
240758282$24075828$2$F$20240701$20240711$20240710$20240724$PER$$US-IDORSIA-008221-2024-US$IDORSIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240724$$CN$US$US
240758291$24075829$1$I$20240628$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136242$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240758301$24075830$1$I$$20240704$20240710$20240710$EXP$$BE-AMGEN-BELSP2024132870$AMGEN$Van Den Brande R.; Van Den Kieboom M.; Peeters M et al.. Remineralization of lytic spinal metastases after radiation therapy - A retrospective cohort study comparing conventional external beam radiation therapy with stereotactic ablative body radiation. Clinical and Translational Radiation Oncology. 2024;48:1-8$$$$$Y$$$20240710$$HP$BE$BE
240758311$24075831$1$I$$20240706$20240710$20240710$PER$$US-PURDUE-USA-2024-0310646$PURDUE$$$$$$Y$$$20240708$$CN$US$US
240758321$24075832$1$I$20240628$20240703$20240710$20240710$EXP$$CN-PURDUE-USA-2024-0310632$PURDUE$$72$YR$$M$Y$40$KG$20240708$$HP$CN$CN
240758331$24075833$1$I$20240703$20240703$20240710$20240710$EXP$$CN-PURDUE-USA-2024-0310637$PURDUE$$79$YR$$M$Y$40$KG$20240708$$HP$CN$CN
240758341$24075834$1$I$$20240702$20240710$20240710$EXP$$US-PURDUE-USA-2024-0310626$PURDUE$Kraus M.J., Nguyen J.. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report. Case Reports in Neurology. 2024;16:1:142-147$38$YR$$F$Y$$$20240708$$HP$US$US
240758351$24075835$1$I$$20240702$20240710$20240710$EXP$$US-AstraZeneca-2024A152786$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240758371$24075837$1$I$20231201$20240705$20240710$20240710$EXP$GB-MHRA-MED-202405060341067210-TCMHK$GB-MYLANLABS-2024M1063586$MYLAN$$$$$F$Y$$$20240710$$CN$GB$GB
240758381$24075838$1$I$20231201$20240702$20240710$20240710$EXP$FR-AFSSAPS-BX2024001287$FR-TEVA-VS-3217100$TEVA$$66$YR$$M$Y$94$KG$20240710$$MD$FR$FR
240758392$24075839$2$F$$20240709$20240710$20240717$EXP$$NVSC2024RU141773$NOVARTIS$Ryazanov AS, Melnikova LV, Makarovskaya MV, Kechina OV. ????????????? ???????????/?????????? ?? ????????? ? ??????????? ?  ????????? ? ???????????? ???????????? [Efficacy of sacubitril/valsartan versus valsartan in patients with arterial hypertension]. ARTERIAL HYPERTENSION. 2024;30(2):198-206$$$$$Y$$$20240717$$HP$RU$RU
240758401$24075840$1$I$$20240708$20240710$20240710$EXP$$CA-SANDOZ INC.-NVSC2022CA013012$SANDOZ$$60$YR$$F$Y$$$20240710$$CN$CA$CA
240758411$24075841$1$I$20220204$20240703$20240710$20240710$EXP$$FR-MYLANLABS-2023M1107626$MYLAN$Arnould B, Miranda S, Mignon F, Camus V. G-CSF-induced TIPIC syndrome and large vessel vasculitis:  A case report. Clinical Case Reports. 2023;11(9):1-5$73$YR$$F$Y$$$20240710$$HP$FR$FR
240758421$24075842$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109461$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240710$$HP$US$US
240758451$24075845$1$I$$20240702$20240710$20240710$PER$$JP-Eisai-EC-2024-169416$EISAI$$$$$$Y$$$20240710$$MD$JP$JP
240758461$24075846$1$I$20240101$20240604$20240710$20240710$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0285$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$MD$US$US
240758471$24075847$1$I$$20240704$20240710$20240710$EXP$$US-AMGEN-USASP2024133026$AMGEN$Bhatt S.K.; Ashcherkin N.; Fanous J. et al.. Hepatitis and Vasodilatory Shock due to an Unsuspected Culprit: A Rare Presentation of Multisystem Langerhans Cell Histiocytosis. Case Reports in Gastroenterology. 2024;18 (1):286-292$71$YR$E$F$Y$$$20240710$$HP$US$US
240758481$24075848$1$I$20240708$20240708$20240710$20240710$30DAY$$US-SANDOZ INC.-SDZ2024US063754$SANDOZ$$27$YR$$F$Y$$$20240710$$CN$US$US
240758492$24075849$2$F$$20240913$20240710$20240916$EXP$$NVSC2024CA141245$NOVARTIS$$$$$F$Y$$$20240916$$CN$CA$CA
240758501$24075850$1$I$$20240707$20240710$20240710$EXP$GB-MHRA-MED-202407072116268200-GDLRZ$GB-MYLANLABS-2024M1063875$MYLAN$$73$YR$$F$Y$73$KG$20240710$$CN$GB$GB
240758511$24075851$1$I$$20240701$20240710$20240710$EXP$$US-LEX-000370$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
240758521$24075852$1$I$20240101$20240701$20240710$20240710$PER$$US-TEVA-VS-3217456$TEVA$$37$YR$$M$Y$$$20240710$$CN$US$US
240758541$24075854$1$I$20240601$20240701$20240710$20240710$EXP$$US-LEX-000371$LEXICON PHARMACEUTICALS$$85$YR$$M$Y$$$20240710$$CN$US$US
240758551$24075855$1$I$$20240702$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105751$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240710$$HP$US$US
240758562$24075856$2$F$20240502$20240722$20240710$20240729$PER$$JP-Eisai-EC-2024-169589$EISAI$$$$A$F$Y$$$20240729$$MD$JP$JP
240758571$24075857$1$I$20240704$20240705$20240710$20240710$PER$$JP-Eisai-EC-2024-169637$EISAI$$$$$M$Y$$$20240710$$MD$JP$JP
240758581$24075858$1$I$20240703$20240703$20240710$20240710$PER$$AT-Eisai-EC-2024-169610$EISAI$$$$$F$Y$$$20240710$$MD$AT$AT
240758591$24075859$1$I$20240623$20240702$20240710$20240710$PER$$CN-Eisai-EC-2024-169558$EISAI$$35$YR$A$F$Y$$$20240710$$HP$CN$CN
240758601$24075860$1$I$$20240702$20240710$20240710$EXP$PL-URPL-DML-MLP.4401.1.3347.2021$PL-TEVA-VS-3217012$TEVA$$24$YR$$F$Y$40$KG$20240710$$MD$PL$PL
240758611$24075861$1$I$$20240703$20240710$20240710$EXP$$US-LEX-000376$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240710$$CN$US$US
240758621$24075862$1$I$20240701$20240705$20240710$20240710$EXP$$JP-009507513-2407JPN001393J$MERCK$$84$YR$$$Y$$$20240710$$PH$JP$JP
240758631$24075863$1$I$20240229$20240704$20240710$20240710$EXP$IT-MINISAL02-993154$IT-MYLANLABS-2024M1063332$MYLAN$$48$YR$$F$Y$$$20240710$$MD$IT$IT
240758641$24075864$1$I$20240702$20240703$20240710$20240710$PER$$US-Millicent Holdings Ltd.-MILL20241015$MILLICENT HOLDINGS$$$$$F$Y$$$20240710$$CN$US$US
240758651$24075865$1$I$20240401$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135608$AMGEN$$68$YR$E$F$Y$$$20240710$$CN$US$US
240758661$24075866$1$I$20240601$20240623$20240710$20240710$PER$$US-JNJFOC-20240665888$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240710$$CN$US$US
240758671$24075867$1$I$$20240703$20240710$20240710$EXP$$NVSC2024BR119588$NOVARTIS$$$$$F$Y$$$20240710$$CN$BR$BR
240758681$24075868$1$I$20230701$20240705$20240710$20240710$EXP$$GB-PURDUE-USA-2024-0310679$PURDUE$$$$$M$Y$$$20240710$$CN$GB$GB
240758691$24075869$1$I$20240205$20240707$20240710$20240710$EXP$GB-MHRA-MED-202407071022568140-LDMWC$GB-MYLANLABS-2024M1063845$MYLAN$$41$YR$$M$Y$56$KG$20240710$$CN$GB$GB
240758701$24075870$1$I$$20240708$20240710$20240710$EXP$$US-PURDUE PHARMA-USA-2024-0310661$PURDUE$$$$A$M$Y$$$20240710$$CN$US$US
240758712$24075871$2$F$$20240702$20240710$20240711$EXP$$US-PURDUE-USA-2024-0310689$PURDUE$Creamer M.; Ranjan A.. Left Sixth Nerve Palsy and Subdural Hygroma Following Intrathecal Morphine Pump Placement: A Case Report. Pain Medicine Case Reports. 2023;7:8:385-387$59$YR$$M$Y$$$20240711$$HP$US$US
240758721$24075872$1$I$20240625$20240704$20240710$20240710$EXP$$CN-PURDUE-USA-2024-0310657$PURDUE$$76$YR$$M$Y$55$KG$20240710$$HP$CN$CN
240758731$24075873$1$I$$20240626$20240710$20240710$EXP$$JP-PURDUE-USA-2024-0310669$PURDUE$$$$$M$Y$$$20240710$$PH$JP$JP
240758741$24075874$1$I$20240704$20240704$20240710$20240710$EXP$$JP-PURDUE-USA-2024-0310681$PURDUE$$53$YR$$M$Y$$$20240710$$PH$JP$JP
240758751$24075875$1$I$$20240702$20240710$20240710$EXP$$MX-PURDUE-USA-2024-0310682$PURDUE$Medina A.R.; Hammerness P.; Ihyembe D.; Plummer S.; Diekroger E.; Fogler J... Complex ADHD Challenging Case: Managing Co-Occurring Attention-Deficit Hyperactivity Disorder and Congenital Heart Disease with a Limited Medication Formulary: A Case from Mexico.. Journal of developmental and behavioral pediatrics. 2024;45:3:e271-e273.$8$YR$$M$Y$$$20240710$$HP$MX$MX
240758761$24075876$1$I$$20240705$20240710$20240710$EXP$$US-PURDUE PHARMA-USA-2024-0308161$PURDUE$Ghalayni R, AI Kalaji B, Malik K.. From Friend to Foe: A Case of Naloxone - Induced Pulmonary Edema. Hospital Pharmacy. 2024;59(4):407-10$66$YR$$F$Y$$$20240710$$MD$US$US
240758773$24075877$3$F$20240101$20240801$20240710$20240808$EXP$$JP-RADIUS HEALTH, INC.-2024JP005072$RADIUS PHARM$$60$YR$$F$Y$$$20240808$$MD$JP$JP
240758781$24075878$1$I$$20240610$20240710$20240710$PER$$US-Nostrum Laboratories, Inc.-2159022$NOSTRUM$$$$$$Y$$$20240710$$$US$US
240758792$24075879$2$F$20240513$20240814$20240710$20240823$EXP$FR-AFSSAPS-BX2024001296$FR-TEVA-VS-3216806$TEVA$$30$YR$$F$Y$$$20240823$$PH$FR$FR
240758801$24075880$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109547$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240710$$CN$US$US
240758812$24075881$2$F$$20240730$20240710$20240802$EXP$$CA-PURDUE-USA-2024-0310654$PURDUE$$$$$F$Y$$$20240802$$HP$CA$CA
240758821$24075882$1$I$$20240705$20240710$20240710$EXP$$GB-PURDUE-USA-2024-0310664$PURDUE$$$$$F$Y$$$20240710$$HP$GB$GB
240758841$24075884$1$I$$20240703$20240710$20240710$PER$$US-ALXN-202407USA000318US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240710$$CN$US$US
240758851$24075885$1$I$20220821$20240708$20240710$20240710$PER$$US-PURDUE PHARMA-USA-2024-0310660$PURDUE$$$$$M$Y$$$20240710$$CN$US$US
240758861$24075886$1$I$20240604$20240708$20240710$20240710$PER$$US-PURDUE PHARMA-USA-2024-0310673$PURDUE$$33$YR$$M$Y$87.982$KG$20240710$$CN$US$US
240758871$24075887$1$I$20240501$20240708$20240710$20240710$PER$$US-PURDUE-USA-2024-0310647$PURDUE$$59$YR$$M$Y$120.2$KG$20240710$$CN$US$US
240758883$24075888$3$F$20240501$20240709$20240710$20240715$PER$$US-PURDUE PHARMA-USA-2024-0310672$PURDUE$$68$YR$$F$Y$45.36$KG$20240715$$CN$US$US
240758892$24075889$2$F$20240401$20240812$20240710$20240813$PER$$US-PURDUE-USA-2024-0310675$PURDUE$$$$$$Y$$$20240813$$CN$US$US
240758901$24075890$1$I$$20240708$20240710$20240710$PER$$US-PURDUE-USA-2024-0310648$PURDUE$$$$$M$Y$$$20240710$$PH$US$US
240758913$24075891$3$F$$20240711$20240710$20240715$PER$$US-PURDUE PHARMA-USA-2024-0310670$PURDUE$$$$$F$Y$68.95$KG$20240715$$CN$US$US
240758921$24075892$1$I$$20240709$20240710$20240710$PER$$US-PURDUE-USA-2024-0310674$PURDUE$$$$$$Y$$$20240710$$CN$US$US
240758931$24075893$1$I$20240505$20240702$20240710$20240710$EXP$$GB-AstraZeneca-2024A155969$ASTRAZENECA$$45$YR$$F$Y$$$20240710$$MD$GB$
240758941$24075894$1$I$20230426$20240705$20240710$20240710$PER$$US-PURDUE PHARMA-USA-2024-0310665$PURDUE$$35$YR$$M$Y$$$20240710$$CN$US$US
240758952$24075895$2$F$20240503$20240725$20240710$20240729$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010370$JAZZ$$58$YR$$M$Y$116$KG$20240729$$HP$US$US
240758971$24075897$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142822$NOVARTIS$$$$$M$Y$$$20240710$$CN$US$US
240758981$24075898$1$I$$20240620$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100403$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240710$$CN$US$US
240758991$24075899$1$I$$20240708$20240710$20240710$PER$$US-009507513-2407USA003857$MERCK$$$$$M$Y$$$20240710$$CN$US$US
240759001$24075900$1$I$20210314$20240702$20240710$20240710$EXP$$KR-Eisai-EC-2024-169426$EISAI$$20$YR$A$F$Y$$$20240710$$HP$KR$KR
240759021$24075902$1$I$$20240705$20240710$20240710$PER$$US-INCYTE CORPORATION-2024IN007163$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240759031$24075903$1$I$20240101$20240705$20240710$20240710$EXP$$DE-ABBVIE-5831049$ABBVIE$$43$YR$$F$Y$$$20240710$$MD$DE$DE
240759041$24075904$1$I$$20240705$20240710$20240710$PER$$US-INCYTE CORPORATION-2024IN007161$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240759051$24075905$1$I$20180830$20240705$20240710$20240710$PER$$US-INCYTE CORPORATION-2024IN007157$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240759061$24075906$1$I$$20240708$20240710$20240710$EXP$GB-MHRA-TPP11773167C7181661YC1719389954605$GB-SANDOZ INC.-SDZ2024GB064045$SANDOZ$$64$YR$$F$Y$77$KG$20240710$$PH$GB$GB
240759071$24075907$1$I$20240201$20240521$20240710$20240710$PER$$US-LUNDBECK-DKLU3078395$LUNDBECK$$$$$$Y$$$20240710$$CN$US$US
240759081$24075908$1$I$$20240705$20240710$20240710$PER$$US-INCYTE CORPORATION-2024IN007151$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240759111$24075911$1$I$$20240705$20240710$20240710$EXP$$CA-TAKEDA-2024TUS069261$TAKEDA$$$$$F$Y$$$20240710$$HP$CA$CA
240759121$24075912$1$I$20231101$20240705$20240710$20240710$PER$$US-INCYTE CORPORATION-2024IN007141$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240759131$24075913$1$I$20230101$20240521$20240710$20240710$PER$$US-LUNDBECK-DKLU3078335$LUNDBECK$$$$$$Y$$$20240710$$CN$US$US
240759141$24075914$1$I$$20240627$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109333$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240710$$CN$US$US
240759151$24075915$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109458$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240710$$HP$US$US
240759162$24075916$2$F$$20240814$20240710$20240930$PER$$US-LUNDBECK-DKLU3078437$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
240759172$24075917$2$F$20240101$20240701$20240710$20240718$EXP$DK-DKMA-30730760$DK-BEH-2024174804$CSL BEHRING$$61$YR$A$F$Y$$$20240718$$MD$DK$DK
240759183$24075918$3$F$20230901$20240821$20240710$20240823$EXP$NO-NOMAADVRE-PASRAPP-2024-Vw6846$NO-LUNDBECK-DKLU4001371$LUNDBECK$$$$$$Y$$$20240823$$CN$NO$NO
240759202$24075920$2$F$20230801$20240326$20240710$20240927$EXP$$EU-BAUSCHBL-2024BNL001210$BAUSCH AND LOMB$$80$YR$$M$Y$$$20240927$$CN$EU$EU
240759241$24075924$1$I$20240601$20240701$20240710$20240710$EXP$$US-BIOGEN-2024BI01272024$BIOGEN$$38$YR$$F$Y$$$20240710$$CN$US$US
240759251$24075925$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063891$SANDOZ$$$$$F$Y$$$20240710$$MD$CA$CA
240759261$24075926$1$I$$20240702$20240710$20240710$EXP$$US-RADIUS HEALTH INC.-2024US004959$RADIUS PHARM$$$$$F$Y$$$20240710$$CN$US$US
240759271$24075927$1$I$20240609$20240702$20240710$20240710$EXP$FR-AFSSAPS-BR2024000524$FR-TEVA-VS-3216700$TEVA$$77$YR$$F$Y$69$KG$20240710$$MD$FR$FR
240759281$24075928$1$I$$20240708$20240710$20240710$PER$$NVSC2024US142716$NOVARTIS$$$$$$Y$$$20240710$$MD$US$US
240759302$24075930$2$F$20240528$20240814$20240710$20240823$EXP$FR-AFSSAPS-BX2024001295$FR-TEVA-VS-3216609$TEVA$$50$YR$$M$Y$$$20240823$$PH$FR$FR
240759312$24075931$2$F$$20240709$20240710$20240716$EXP$$US-PFIZER INC-PV202400089265$PFIZER$Shihadeh, S.. Blinding Optic Neuropathy Associated With Carboplatin Therapy: A Case Report and Literature Review. Cureus. 2024;16:e52975$71$YR$$M$Y$$$20240716$$HP$US$US
240759321$24075932$1$I$$20240705$20240710$20240710$EXP$$CZ-PFIZER INC-202400208817$PFIZER$Lazanska, R.. Zkusenosti s lecbou AL amyloidozy s renalnim postizenim... Aktuality v nefrologii. 2024;30 Supp.1:26$55$YR$$F$Y$$$20240710$$MD$CZ$CZ
240759351$24075935$1$I$20200201$20240706$20240710$20240710$EXP$$EU-BAUSCHBL-2023BNL004552$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240710$$MD$EU$EU
240759361$24075936$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109603$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240710$$CN$US$US
240759382$24075938$2$F$$20240710$20240710$20240712$EXP$$JP-PFIZER INC-202400209970$PFIZER$$$$$$Y$$$20240712$$MD$JP$JP
240759391$24075939$1$I$20240621$20240701$20240710$20240710$EXP$$CN-009507513-2407CHN001907$MERCK$$64$YR$$M$Y$60$KG$20240710$$HP$CN$CN
240759401$24075940$1$I$20240428$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405011746117080-BKTGL$GB-LUNDBECK-DKLU4001374$LUNDBECK$$$$$$Y$$$20240710$$CN$GB$GB
240759411$24075941$1$I$20231122$20240706$20240710$20240710$EXP$$EU-BAUSCHBL-2024BNL002135$BAUSCH AND LOMB$$75$YR$$M$Y$57$KG$20240710$$MD$EU$EU
240759421$24075942$1$I$20240601$20240701$20240710$20240710$EXP$$CN-009507513-2407CHN002654$MERCK$$6$WK$$M$Y$2.7$KG$20240710$$HP$CN$CN
240759431$24075943$1$I$20240101$20240520$20240710$20240710$PER$$US-LUNDBECK-DKLU3078286$LUNDBECK$$$$$$Y$$$20240710$$CN$US$US
240759441$24075944$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142802$NOVARTIS$$$$$F$Y$$$20240710$$CN$US$US
240759451$24075945$1$I$20210401$20240703$20240710$20240710$EXP$$EU-BAUSCHBL-2024BNL029580$BAUSCH AND LOMB$Paulo N, Goncalves P, Cerqueira A, Araujo J, Sampaio S, Vasconcelos M. Recurrent parvovirus B19 infection-associated pure red cell aplasia in kidney transplantation. Nephrology Dialysis Transplantation. 2024 MAY 01;39 SUPPLEMENT 1:I2698. doi:10.1093/ndt/gfae069.1710$42$YR$$M$Y$$$20240710$$HP$EU$EU
240759461$24075946$1$I$$20240708$20240710$20240710$EXP$$DE-AstraZeneca-2024A157110$ASTRAZENECA$$$$$$Y$$$20240710$$MD$DE$
240759471$24075947$1$I$$20240703$20240710$20240710$EXP$US-MLMSERVICE-20240626-PI113150-00057-1$US-RDY-SPO/USA/24/0009858$DR REDDYS$Al-Moussally F, Thompson BM, Masarweh OM, Shah N, Gaudi S, Restrepo J. Atorvastatin-Associated Eosinophilic Spongiosis: A Case Report and a Relevant Literature Review of Dermatological Manifestations. Cureus. 2024;16(5):e61071. DOI:10.7759/cureus.61071.$72$YR$E$M$Y$$$20240710$$MD$US$US
240759481$24075948$1$I$20240601$20240606$20240710$20240710$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0289$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240759491$24075949$1$I$20240101$20240607$20240710$20240710$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0290$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240759502$24075950$2$F$20200401$20240820$20240710$20240828$EXP$$AU-BAUSCHBL-2024BNL029653$BAUSCH AND LOMB$Thorburn S, Majumdar A, Smibert O. Chronic hepatitis E masquerading as allograft rejection in a liver transplant recipient. Transplant Infectious Diseases. 2024;26:1-3. doi:10.1111/tid.14303$41$YR$$M$Y$$$20240828$$HP$AU$AU
240759511$24075951$1$I$20240501$20240610$20240710$20240710$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0299$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$MD$US$US
240759521$24075952$1$I$$20240704$20240710$20240710$EXP$$BR-BIOMARINAP-BR-2024-159068$BIOMARIN$$$$$$Y$$$20240710$$CN$BR$BR
240759533$24075953$3$F$$20240904$20240710$20240909$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033559$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240909$$CN$JP$JP
240759541$24075954$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109583$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240710$$MD$US$US
240759551$24075955$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109436$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240710$$CN$US$US
240759573$24075957$3$F$20240624$20240911$20240710$20240912$EXP$$NVSC2024US138117$NOVARTIS$$50$YR$$F$Y$$$20240912$$CN$US$US
240759581$24075958$1$I$$20240415$20240710$20240710$PER$$US-GE HEALTHCARE-2024CSU007837$GE HEALTHCARE$$$$$$Y$$$20240710$$HP$US$US
240759591$24075959$1$I$$20240415$20240710$20240710$PER$$US-GE HEALTHCARE-2024CSU003879$GE HEALTHCARE$$$$$$Y$$$20240710$$HP$US$US
240759601$24075960$1$I$$20240415$20240710$20240710$PER$$US-GE HEALTHCARE-2024CSU007838$GE HEALTHCARE$$$$$$Y$$$20240710$$HP$US$US
240759613$24075961$3$F$$20240812$20240710$20240812$PER$$US-ALXN-202407USA000083US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
240759621$24075962$1$I$$20240630$20240710$20240710$PER$$US-JNJFOC-20240712377$JOHNSON AND JOHNSON$$$$$M$Y$$$20240710$$CN$US$US
240759631$24075963$1$I$$20240419$20240710$20240710$PER$$US-INSUD PHARMA-2404US05332$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759641$24075964$1$I$$20240625$20240710$20240710$PER$$US-INSUD PHARMA-2406US05333$INSUD PHARMA$$$$$$Y$$$20240710$$HP$US$US
240759651$24075965$1$I$$20240627$20240710$20240710$EXP$$US-INSUD PHARMA-2406US05241$INSUD PHARMA$Mignone D, Shah K, Alawneh B, Papadakos SP, Michelakis N. A RUDE AWAKENING: A CASE OF SUGAMMADEX CAUSING TRANSIENT CARDIOMYOPATHY MIMICKING STEMI. JACC. 2024;83(13), Suppl A:3618$$$$$Y$$$20240710$$HP$US$US
240759661$24075966$1$I$20240101$20240701$20240710$20240710$PER$$US-INSUD PHARMA-2407US05245$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759671$24075967$1$I$20240701$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109599$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240710$$CN$US$US
240759681$24075968$1$I$20240101$20240702$20240710$20240710$PER$$US-INSUD PHARMA-2407US05337$INSUD PHARMA$$$$$$Y$$$20240710$$MD$US$US
240759691$24075969$1$I$20240101$20240628$20240710$20240710$PER$$US-INSUD PHARMA-2406US05148$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759701$24075970$1$I$20240601$20240627$20240710$20240710$PER$$US-INSUD PHARMA-2406US05190$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759711$24075971$1$I$20240101$20240701$20240710$20240710$PER$$US-INSUD PHARMA-2407US05201$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759721$24075972$1$I$20240401$20240628$20240710$20240710$PER$$US-INSUD PHARMA-2406US05145$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759731$24075973$1$I$20240601$20240628$20240710$20240710$PER$$US-INSUD PHARMA-2406US05142$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759741$24075974$1$I$20240601$20240701$20240710$20240710$PER$$US-INSUD PHARMA-2407US05200$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759751$24075975$1$I$$20240701$20240710$20240710$PER$$US-INSUD PHARMA-2407US05246$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759761$24075976$1$I$$20240630$20240710$20240710$PER$$US-INSUD PHARMA-2406US05191$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759771$24075977$1$I$20240701$20240701$20240710$20240710$PER$$US-INSUD PHARMA-2407US05248$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759781$24075978$1$I$20240501$20240701$20240710$20240710$PER$$US-INSUD PHARMA-2407US05195$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759791$24075979$1$I$20240101$20240630$20240710$20240710$PER$$US-INSUD PHARMA-2406US05189$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759801$24075980$1$I$20240701$20240701$20240710$20240710$PER$$US-INSUD PHARMA-2407US05197$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759811$24075981$1$I$20240601$20240630$20240710$20240710$PER$$US-INSUD PHARMA-2406US05194$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759822$24075982$2$F$20240101$20240702$20240710$20240731$PER$$US-INSUD PHARMA-2407US05338$INSUD PHARMA$$$$$$Y$$$20240731$$CN$US$US
240759832$24075983$2$F$20240601$20240813$20240710$20240826$PER$$US-INSUD PHARMA-2406US05193$INSUD PHARMA$$$$$$Y$$$20240826$$CN$US$US
240759841$24075984$1$I$20230101$20240701$20240710$20240710$PER$$US-INSUD PHARMA-2407US05250$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759852$24075985$2$F$20240101$20240708$20240710$20240725$PER$$US-INSUD PHARMA-2407US05198$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
240759861$24075986$1$I$20240601$20240701$20240710$20240710$PER$$US-INSUD PHARMA-2407US05199$INSUD PHARMA$$$$$$Y$$$20240710$$CN$US$US
240759871$24075987$1$I$$20240627$20240710$20240710$EXP$$AU-GILEAD-2024-0679309$GILEAD$$$$E$F$Y$$$20240710$$MD$AU$AU
240759881$24075988$1$I$20100101$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405011158072330-YRBMF$GB-RDY-SPO/GBR/24/0009894$DR REDDYS$$$$$$Y$$$20240710$$CN$GB$GB
240759892$24075989$2$F$20240510$20240828$20240710$20240905$PER$$JP-Eisai-EC-2024-166782$EISAI$$$$$M$Y$$$20240905$$MD$JP$JP
240759911$24075991$1$I$$20240704$20240710$20240710$EXP$GB-MHRA-MED-202407041350123850-LJDQC$GB-RDY-SPO/GBR/24/0009854$DR REDDYS$$$$$F$Y$66$KG$20240710$$CN$GB$GB
240759921$24075992$1$I$20240709$20240709$20240710$20240710$EXP$$US-ABBVIE-5834407$ABBVIE$$63$YR$$M$Y$$$20240710$$HP$US$US
240759931$24075993$1$I$$20240702$20240710$20240710$EXP$$US-GSK-US2024AMR082813$GLAXOSMITHKLINE$$$$$F$Y$$$20240710$$MD$US$US
240759942$24075994$2$F$20240101$20240705$20240710$20240712$EXP$$NVSC2024CA141001$NOVARTIS$$59$YR$$F$Y$$$20240712$$PH$CA$CA
240759951$24075995$1$I$20240618$20240627$20240710$20240710$PER$$US-APELLIS-2024-APL-0000376$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240759961$24075996$1$I$20240624$20240627$20240710$20240710$EXP$$CN-ROCHE-10000011762$ROCHE$$76$YR$E$M$Y$62$KG$20240710$$CN$CN$CN
240759971$24075997$1$I$20240705$20240709$20240710$20240710$EXP$$CN-SANDOZ INC.-SDZ2024CN064084$SANDOZ$$71$YR$$M$Y$75$KG$20240710$$HP$CN$CN
240759982$24075998$2$F$$20240905$20240710$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108499$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240906$$HP$US$US
240759991$24075999$1$I$$20240615$20240710$20240710$PER$$US-FMCRTG-FMC-2406-000727$FRESENIUS MEDICAL CARE$$53$YR$A$M$Y$69$KG$20240710$$HP$US$US
240760001$24076000$1$I$$20240617$20240710$20240710$PER$$US-FMCRTG-FMC-2406-000735$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240710$$HP$US$US
240760011$24076001$1$I$$20240617$20240710$20240710$PER$$US-FMCRTG-FMC-2406-000736$FRESENIUS MEDICAL CARE$$75$YR$E$M$Y$93$KG$20240710$$HP$US$US
240760021$24076002$1$I$$20240703$20240710$20240710$EXP$US-GLAXOSMITHKLINE-US2024GSK079428$US-RDY-SPO/USA/24/0009844$DR REDDYS$Roma N, Padala V, Pattoli M, Desai S, Krinock M, Durkin M, et al. BRASH Syndrome: A Rare Clinical Phenomenon. CJC Open. 2024;6(6):840-2. DOI: 10.1016/j.cjco.2024.03.013.$66$YR$E$F$Y$$$20240710$$MD$US$US
240760031$24076003$1$I$20240530$20240611$20240710$20240710$PER$$US-FMCRTG-FMC-2406-000724$FRESENIUS MEDICAL CARE$$80$YR$E$F$Y$62$KG$20240710$$HP$US$US
240760041$24076004$1$I$$20240527$20240710$20240710$PER$$US-FMCRTG-FMC-2407-000800$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240710$$CN$US$US
240760051$24076005$1$I$$20240613$20240710$20240710$PER$$US-FMCRTG-FMC-2406-000728$FRESENIUS MEDICAL CARE$$35$YR$A$M$Y$102$KG$20240710$$HP$US$US
240760061$24076006$1$I$$20240415$20240710$20240710$PER$$US-GE HEALTHCARE-2024CSU007839$GE HEALTHCARE$$$$$$Y$$$20240711$$HP$US$US
240760071$24076007$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109600$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240710$$CN$US$US
240760081$24076008$1$I$$20240612$20240710$20240710$PER$$GB-APELLIS-2024-APL-0000318$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240710$$MD$GB$GB
240760091$24076009$1$I$20240530$20240704$20240710$20240710$EXP$$JP-RADIUS HEALTH INC.-2024JP005070$RADIUS PHARM$$84$YR$$F$Y$$$20240710$$MD$JP$JP
240760101$24076010$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109357$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$51.26$KG$20240710$$CN$US$US
240760111$24076011$1$I$20240703$20240705$20240710$20240710$EXP$$US-INCYTE CORPORATION-2024IN007136$INCYTE$$$$$$Y$$$20240710$$CN$US$US
240760121$24076012$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109549$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240710$$CN$US$US
240760131$24076013$1$I$$20240617$20240710$20240710$PER$$US-AstraZeneca-2024A142174$ASTRAZENECA$$$$$M$Y$$$20240710$$CN$US$
240760141$24076014$1$I$$20240705$20240710$20240710$EXP$$CA-TAKEDA-2024TUS069245$TAKEDA$$$$$F$Y$$$20240710$$HP$CA$CA
240760151$24076015$1$I$20231127$20240709$20240710$20240710$PER$$US-DSJP-DSU-2024-135052$DAIICHI$$$$$F$Y$$$20240710$$CN$US$US
240760161$24076016$1$I$$20240625$20240710$20240710$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06393$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240710$$HP$US$US
240760171$24076017$1$I$20240423$20240701$20240710$20240710$EXP$DE-CADRBFARM-2024328899$DE-009507513-2407DEU000743$MERCK$$63$YR$$M$Y$152$KG$20240710$$MD$DE$DE
240760191$24076019$1$I$20240101$20240626$20240710$20240710$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06506$NEUROCRINE BIOSCIENCES$$68$YR$$F$Y$$$20240710$$HP$US$US
240760201$24076020$1$I$$20240626$20240710$20240710$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06467$NEUROCRINE BIOSCIENCES$$77$YR$$F$Y$$$20240710$$CN$US$US
240760211$24076021$1$I$$20240703$20240710$20240710$EXP$$US-RADIUS HEALTH, INC.-2024US005027$RADIUS PHARM$$$$$M$Y$$$20240710$$CN$US$US
240760221$24076022$1$I$20231122$20240706$20240710$20240710$EXP$$GB-TAKEDA-2023TUS118603$TAKEDA$$81$YR$$M$Y$$$20240710$$CN$GB$GB
240760231$24076023$1$I$20240401$20240709$20240710$20240710$PER$$US-JNJFOC-20240722471$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$HP$US$US
240760241$24076024$1$I$$20240625$20240710$20240710$EXP$$EU-ETHYPHARM-2024001113$ETHYPHARM$$$$$$Y$$$20240710$$CN$EU$EU
240760251$24076025$1$I$$20240705$20240710$20240710$EXP$$US-MTPC-MTDA2024-0014283$Unknown Manufacturer$$$$A$$Y$$$20240710$$HP$US$US
240760261$24076026$1$I$$20240709$20240710$20240710$PER$$US-JNJFOC-20240722118$JOHNSON AND JOHNSON$$$$$F$Y$$$20240710$$CN$US$US
240760272$24076027$2$F$$20240827$20240710$20240901$PER$$US-AstraZeneca-2024A157595$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
240760281$24076028$1$I$$20240617$20240710$20240710$PER$$US-AstraZeneca-2024A141088$ASTRAZENECA$$$$$$Y$$$20240711$$CN$US$
240760291$24076029$1$I$20240105$20240701$20240710$20240710$PER$$US-APELLIS-APL-2024-003904$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240760302$24076030$2$F$20240626$20240823$20240710$20240911$EXP$$US-BIOMARINAP-US-2024-159074$BIOMARIN$$$$$$Y$$$20240911$$CN$US$US
240760313$24076031$3$F$20240626$20240912$20240710$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106887$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$51$KG$20240920$$PH$JP$JP
240760321$24076032$1$I$$20240701$20240710$20240710$EXP$$BR-SANDOZ INC.-SDZ2024BR064038$SANDOZ$$$$$M$Y$$$20240710$$CN$BR$BR
240760334$24076033$4$F$20240401$20240807$20240710$20240809$EXP$$GB-SANDOZ INC.-SDZ2023GB056623$SANDOZ$$62$YR$$F$Y$$$20240809$$CN$GB$GB
240760341$24076034$1$I$$20240521$20240710$20240710$PER$$US-LUNDBECK-DKLU3078310$LUNDBECK$$$$$$Y$$$20240711$$HP$US$US
240760351$24076035$1$I$$20240704$20240710$20240710$EXP$$NVSC2024CA140743$NOVARTIS$$73$YR$$F$Y$$$20240711$$CN$CA$CA
240760361$24076036$1$I$$20240710$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039070$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240711$$CN$US$US
240760371$24076037$1$I$$20240710$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038943$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240711$$CN$US$US
240760384$24076038$4$F$$20240904$20240710$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109185$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240905$$CN$US$US
240760391$24076039$1$I$$20240704$20240710$20240710$EXP$$TH-JNJFOC-20240724917$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$MD$TH$TH
240760401$24076040$1$I$20240313$20240702$20240710$20240710$PER$$US-JNJFOC-20240706038$JOHNSON AND JOHNSON$$82$YR$$M$Y$$$20240711$$HP$US$US
240760422$24076042$2$F$20240709$20240711$20240710$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039031$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240715$$CN$US$US
240760441$24076044$1$I$20231207$20240704$20240710$20240710$EXP$$NVSC2024IN087657$NOVARTIS$$52$YR$$F$Y$$$20240711$$CN$IN$IN
240760453$24076045$3$F$20240705$20240725$20240710$20240729$PER$$US-AMGEN-USASP2024136692$AMGEN$$49$YR$A$M$Y$$$20240729$$HP$US$US
240760461$24076046$1$I$$20240708$20240710$20240710$EXP$$US-ABBVIE-5832470$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240760471$24076047$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109199$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240711$$HP$US$US
240760481$24076048$1$I$$20240708$20240710$20240710$EXP$$CA-JNJFOC-20240724579$JOHNSON AND JOHNSON$$95$YR$E$M$Y$$$20240711$$CN$CA$CA
240760491$24076049$1$I$$20240708$20240710$20240710$PER$$US-ELI_LILLY_AND_COMPANY-US202407005540$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240710$$CN$US$US
240760501$24076050$1$I$$20240617$20240710$20240710$30DAY$$US-JNJFOC-20240645068$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240760512$24076051$2$F$$20240813$20240710$20240813$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039039$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240814$$CN$CA$CA
240760521$24076052$1$I$20240705$20240705$20240710$20240710$EXP$$FR-ABBVIE-5833138$ABBVIE$$69$YR$$F$Y$$$20240710$$MD$FR$FR
240760531$24076053$1$I$20240601$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109064$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240711$$HP$US$US
240760541$24076054$1$I$20240601$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109133$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240711$$HP$US$US
240760552$24076055$2$F$$20240719$20240710$20240725$30DAY$$DE-JNJFOC-20240722503$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$PH$DE$DE
240760561$24076056$1$I$20240501$20240709$20240710$20240710$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038971$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$48$KG$20240711$$HP$CO$CO
240760571$24076057$1$I$20240522$20240626$20240710$20240710$PER$$US-009507513-2406USA009421$MERCK$$63$YR$$M$Y$$$20240710$$CN$US$US
240760581$24076058$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109089$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240711$$HP$US$US
240760592$24076059$2$F$20210714$20240823$20240710$20240827$EXP$$JP-ABBVIE-21K-087-4181361-00$ABBVIE$$79$YR$$F$Y$52$KG$20240827$$MD$JP$JP
240760601$24076060$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109067$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240711$$HP$US$US
240760611$24076061$1$I$20240628$20240708$20240710$20240710$EXP$$AR-ABBVIE-5833929$ABBVIE$$50$YR$$M$Y$$$20240710$$CN$AR$AR
240760621$24076062$1$I$20060719$20240708$20240710$20240710$PER$$US-JNJFOC-20240722788$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20240711$$LW$US$US
240760631$24076063$1$I$$20240704$20240710$20240710$EXP$$EG-AMGEN-EGYSP2024134545$AMGEN$$47$YR$A$F$Y$$$20240710$$CN$EG$EG
240760641$24076064$1$I$20240101$20240708$20240710$20240710$EXP$$US-ABBVIE-5832784$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240760652$24076065$2$F$$20240806$20240710$20240811$EXP$$US-ABBVIE-5831974$ABBVIE$$$$$F$Y$$$20240811$$CN$US$US
240760661$24076066$1$I$20240601$20240705$20240710$20240710$EXP$$US-ABBVIE-5824225$ABBVIE$$75$YR$$M$Y$$$20240710$$CN$US$US
240760671$24076067$1$I$$20240708$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063517$SANDOZ$$$$$M$Y$$$20240710$$CN$CA$CA
240760681$24076068$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063886$SANDOZ$$69$YR$$F$Y$$$20240710$$HP$CA$CA
240760691$24076069$1$I$20240629$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135412$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240760702$24076070$2$F$$20240722$20240710$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109319$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240723$$HP$US$US
240760711$24076071$1$I$$20240709$20240710$20240710$EXP$$CA-SANDOZ INC.-SDZ2024CA063933$SANDOZ$$$$$M$Y$$$20240710$$CN$CA$CA
240760721$24076072$1$I$20231201$20240701$20240710$20240710$PER$$US-TEVA-VS-3216281$TEVA$$56$YR$$F$Y$$$20240710$$CN$US$US
240760731$24076073$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135667$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240760741$24076074$1$I$20210428$20240705$20240710$20240710$EXP$$JP-SA-2021SA261698$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240711$$MD$JP$JP
240760751$24076075$1$I$$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405011129202000-PMHDY$GB-009507513-2407GBR002942$MERCK$$$$$F$Y$$$20240710$$MD$GB$GB
240760761$24076076$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109161$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240711$$CN$US$US
240760772$24076077$2$F$20240611$20240726$20240710$20240802$EXP$$JP-LUNDBECK-DKLU4001474$LUNDBECK$$$$$$Y$$$20240802$$PH$JP$JP
240760781$24076078$1$I$$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024135787$AMGEN$$$$$$Y$$$20240710$$HP$US$US
240760791$24076079$1$I$$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109100$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240711$$CN$US$US
240760802$24076080$2$F$$20240710$20240710$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109180$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240717$$HP$US$US
240760811$24076081$1$I$$20240703$20240710$20240710$EXP$$GB-JNJFOC-20240712637$JOHNSON AND JOHNSON$$70$YR$E$$Y$$$20240711$$PH$GB$GB
240760821$24076082$1$I$$20240709$20240710$20240710$EXP$$NVSC2024US142587$NOVARTIS$$$$$$Y$$$20240711$$CN$US$US
240760832$24076083$2$F$20240708$20240813$20240710$20240814$PER$$US-AMGEN-USASP2024135514$AMGEN$$48$YR$A$F$Y$$$20240814$$CN$US$US
240760841$24076084$1$I$$20240703$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106601$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240711$$CN$US$US
240760861$24076086$1$I$$20240708$20240710$20240710$EXP$$US-ABBVIE-5832097$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240760872$24076087$2$F$20240612$20240826$20240710$20240904$EXP$$CO-ABBVIE-5833117$ABBVIE$$81$YR$$F$Y$52$KG$20240904$$HP$CO$CO
240760881$24076088$1$I$20240705$20240708$20240710$20240710$EXP$$US-ABBVIE-5833153$ABBVIE$$82$YR$$F$Y$$$20240710$$CN$US$US
240760891$24076089$1$I$$20240709$20240710$20240710$EXP$$US-ABBVIE-5834393$ABBVIE$$$$$M$Y$$$20240710$$HP$US$US
240760902$24076090$2$F$$20240723$20240710$20240727$EXP$$GB-ABBVIE-5832089$ABBVIE$$$$A$M$Y$$$20240727$$CN$GB$GB
240760911$24076091$1$I$20240703$20240708$20240710$20240710$EXP$$CA-ABBVIE-5833811$ABBVIE$$75$YR$$F$Y$$$20240710$$CN$CA$CA
240760922$24076092$2$F$20240101$20240712$20240710$20240718$EXP$$US-ABBVIE-5832713$ABBVIE$$$$$M$Y$121$KG$20240718$$CN$US$US
240760931$24076093$1$I$20240616$20240708$20240710$20240710$EXP$$TR-ABBVIE-5833034$ABBVIE$$79$YR$$M$Y$80$KG$20240710$$CN$TR$TR
240760956$24076095$6$F$20240701$20240802$20240710$20240805$EXP$ES-AEMPS-1544294$ES-JNJFOC-20240725333$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240805$$MD$ES$ES
240760961$24076096$1$I$20240709$20240709$20240710$20240710$PER$$US-JNJFOC-20240723608$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240711$$CN$US$US
240760971$24076097$1$I$20240101$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024135208$AMGEN$$68$YR$E$F$Y$$$20240710$$CN$US$US
240760981$24076098$1$I$20240706$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024135998$AMGEN$$38$YR$A$$Y$$$20240710$$CN$US$US
240760991$24076099$1$I$$20240627$20240710$20240710$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-13384$SAMSUNG BIOEPIS$$79$YR$E$F$Y$$$20240709$$CN$GB$GB
240761011$24076101$1$I$$20240708$20240710$20240710$PER$$US-JNJFOC-20240721080$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240761021$24076102$1$I$$20240709$20240710$20240710$EXP$$US-ABBVIE-5833366$ABBVIE$$$$$M$Y$$$20240710$$CN$US$US
240761033$24076103$3$F$20170223$20240807$20240710$20240812$EXP$$CA-TAKEDA-2017TUS000776$TAKEDA$$67$YR$$M$Y$$$20240812$$CN$CA$CA
240761041$24076104$1$I$$20240702$20240710$20240710$PER$$US-BAUSCHBL-2024BNL029553$BAUSCH AND LOMB$$$$$F$Y$$$20240711$$MD$US$US
240761051$24076105$1$I$20240101$20240702$20240710$20240710$PER$$US-BAUSCHBL-2024BNL029498$BAUSCH AND LOMB$$76$YR$$F$Y$45.36$KG$20240711$$CN$US$US
240761063$24076106$3$F$20240605$20240820$20240710$20240823$EXP$$NVSC2024IL124467$NOVARTIS$$76$YR$$F$Y$50.9$KG$20240823$$HP$IL$IL
240761072$24076107$2$F$20240101$20240821$20240710$20240901$PER$$US-BAUSCHBL-2024BNL029543$BAUSCH AND LOMB$$84$YR$$F$Y$$$20240902$$CN$US$US
240761081$24076108$1$I$$20240701$20240710$20240710$PER$$US-BAUSCHBL-2024BNL029579$BAUSCH AND LOMB$$$$$F$Y$$$20240711$$CN$US$US
240761091$24076109$1$I$20191101$20240704$20240710$20240710$EXP$GB-MHRA-MED-202404301931392500-MGPHN$GB-ABBVIE-5832173$ABBVIE$$$$$$Y$$$20240710$$CN$GB$GB
240761101$24076110$1$I$$20240701$20240710$20240710$EXP$$FR-TEVA-VS-3217521$TEVA$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$44$YR$$M$Y$$$20240710$$HP$FR$FR
240761112$24076111$2$F$$20240731$20240710$20240802$EXP$$CA-TAKEDA-2024TUS068086$TAKEDA$$$$$F$Y$$$20240802$$MD$CA$CA
240761121$24076112$1$I$20240705$20240705$20240710$20240710$EXP$$NVSC2024US140189$NOVARTIS$$56$YR$$$Y$$$20240711$$CN$US$US
240761131$24076113$1$I$20240624$20240624$20240710$20240710$PER$$US-AMGEN-USASP2024135682$AMGEN$$$$$F$Y$$$20240710$$MD$US$US
240761141$24076114$1$I$$20240701$20240710$20240710$EXP$$FR-TEVA-VS-3217186$TEVA$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$33$YR$$M$Y$$$20240710$$HP$FR$FR
240761151$24076115$1$I$20240624$20240708$20240710$20240710$EXP$$US-ABBVIE-5832865$ABBVIE$$57$YR$$F$Y$$$20240710$$CN$US$US
240761164$24076116$4$F$20240702$20240917$20240710$20240924$EXP$$AU-TAKEDA-2024TUS070080$TAKEDA$$56$YR$$F$Y$$$20240924$$CN$AU$AU
240761171$24076117$1$I$$20240701$20240710$20240710$EXP$$FR-TEVA-VS-3217502$TEVA$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$47$YR$$M$Y$$$20240710$$HP$FR$FR
240761181$24076118$1$I$20240101$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136690$AMGEN$$62$YR$A$M$Y$$$20240710$$CN$US$US
240761192$24076119$2$F$$20240703$20240710$20240715$EXP$$CA-009507513-2407CAN002237$MERCK$Patton L, Monteitg B, Heffernan P, Herzinger T, Brooke EW. Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study. Frontiers in Oncology. 2024;14:1394543$40$YR$$F$Y$$$20240715$$HP$CA$CA
240761201$24076120$1$I$20240616$20240702$20240710$20240710$EXP$$CA-JNJFOC-20240711221$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240711$$HP$CA$CA
240761211$24076121$1$I$20240101$20240702$20240710$20240710$PER$$US-SA-2024SA199510$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240711$$MD$US$US
240761221$24076122$1$I$$20240708$20240710$20240710$PER$$US-AMGEN-USASP2024136446$AMGEN$$$$$$Y$$$20240710$$HP$US$US
240761231$24076123$1$I$20240423$20240627$20240710$20240710$EXP$GB-MHRA-MED-202406271249557900-BCMJH$GB-GLENMARK PHARMACEUTICALS-2024GMK091981$GLENMARK$$$$$$Y$$$20240711$$MD$GB$GB
240761241$24076124$1$I$$20231227$20240710$20240710$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00646$PRINSTON PHARMACEUTICAL$$$$$M$Y$58.06$KG$20240624$$CN$US$US
240761251$24076125$1$I$$20240105$20240710$20240710$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00005$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240624$$PH$US$US
240761262$24076126$2$F$20240624$20240821$20240710$20240829$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-106914$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240829$$HP$BR$BR
240761271$24076127$1$I$$20240704$20240710$20240710$EXP$$IL-ABBVIE-5833133$ABBVIE$$70$YR$$M$Y$$$20240710$$MD$IL$IL
240761281$24076128$1$I$$20240703$20240710$20240710$EXP$$KR-JNJFOC-20240714608$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240711$$HP$KR$KR
240761301$24076130$1$I$$20240708$20240710$20240710$EXP$$US-ABBVIE-5831882$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240761312$24076131$2$F$20240607$20240723$20240710$20240729$EXP$$NVSC2024AE142328$NOVARTIS$$64$YR$$M$Y$$$20240729$$CN$AE$AE
240761321$24076132$1$I$20240611$20240703$20240710$20240710$EXP$$US-JNJFOC-20240711091$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240711$$CN$US$US
240761332$24076133$2$F$20240715$20240715$20240710$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038964$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240716$$CN$US$US
240761341$24076134$1$I$20240707$20240708$20240710$20240710$PER$$US-JNJFOC-20240719564$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240711$$CN$US$US
240761351$24076135$1$I$$20240705$20240710$20240710$EXP$$CA-ABBVIE-5831005$ABBVIE$$$$A$M$Y$$$20240710$$CN$CA$CA
240761362$24076136$2$F$$20240702$20240710$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107573$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$84.37$KG$20240716$$CN$US$US
240761371$24076137$1$I$$20240708$20240710$20240710$PER$$US-HALEON-2186206$Haleon PLC$$26$YR$$F$Y$$$20240710$$CN$US$US
240761381$24076138$1$I$$20240709$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109358$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240711$$CN$US$US
240761392$24076139$2$F$$20240904$20240710$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108913$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$$$20240911$$HP$US$US
240761403$24076140$3$F$20240702$20240816$20240710$20240822$30DAY$$US-JNJFOC-20240709531$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240822$$CN$US$US
240761411$24076141$1$I$$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136679$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240761421$24076142$1$I$20240709$20240709$20240710$20240710$PER$$US-AMGEN-USASP2024136580$AMGEN$$72$YR$E$M$Y$$$20240710$$CN$US$US
240761432$24076143$2$F$20240708$20240710$20240710$20240711$PER$$US-AMGEN-USASP2024136708$AMGEN$$67$YR$E$F$Y$$$20240711$$HP$US$US
240761441$24076144$1$I$$20240704$20240710$20240710$EXP$GB-MHRA-MED-202405011700175730-BMCHD$GB-RDY-SPO/GBR/24/0009912$DR REDDYS$$6$YR$C$F$Y$$$20240711$$CN$GB$GB
240761451$24076145$1$I$20240703$20240703$20240710$20240710$EXP$$US-JNJFOC-20240717619$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240711$$HP$US$US
240761461$24076146$1$I$$20240709$20240710$20240710$PER$$US-HALEON-2186085$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240761471$24076147$1$I$20240529$20240702$20240710$20240710$PER$$US-RDY-SPO/USA/24/0009782$DR REDDYS$$15$WK$T$F$Y$$$20240711$$CN$US$US
240761481$24076148$1$I$$20240707$20240710$20240710$EXP$$US-ABBVIE-5831142$ABBVIE$$$$$F$Y$$$20240710$$CN$US$US
240761492$24076149$2$F$20240531$20240717$20240710$20240723$PER$$US-AMGEN-USASP2024132325$AMGEN$$$$$$Y$$$20240723$$HP$US$US
240761502$24076150$2$F$$20240812$20240710$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109123$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240813$$HP$US$US
240761512$24076151$2$F$$20240722$20240710$20240725$EXP$$JP-SA-2024SA199406$SANOFI AVENTIS$$$$$$Y$$$20240726$$MD$JP$JP
240761521$24076152$1$I$$20240705$20240710$20240710$EXP$$JP-GSK-JP2024083755$GLAXOSMITHKLINE$$$$$$Y$$$20240710$$PH$JP$JP
240761531$24076153$1$I$$20240706$20240710$20240710$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010390$JAZZ$$$$$M$Y$$$20240710$$CN$US$US
240761541$24076154$1$I$$20240705$20240710$20240710$PER$$US-BIOGEN-2024BI01272795$BIOGEN$$$$$F$Y$$$20240710$$HP$US$US
240761551$24076155$1$I$$20240703$20240710$20240710$EXP$$ES-NOVITIUMPHARMA-2024ESNVP01209$NOVITIUM PHARMA$Carla Marco.Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series.Journal of Clinical Medicine.24-DEC-2022;12:1-10$78$YR$E$M$Y$$$20240711$$HP$ES$ES
240761561$24076156$1$I$20240627$20240708$20240710$20240710$EXP$$US-ABBVIE-5831796$ABBVIE$$51$YR$$F$Y$$$20240710$$CN$US$US
240761571$24076157$1$I$$20240709$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109497$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$83.5$KG$20240711$$HP$US$US
240761581$24076158$1$I$$20240708$20240710$20240710$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109539$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240711$$CN$US$US
240761591$24076159$1$I$$20240708$20240710$20240710$EXP$$US-BIOGEN-2024BI01272914$BIOGEN$$$$$F$Y$$$20240710$$CN$US$US
240761601$24076160$1$I$20240521$20240708$20240710$20240710$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109516$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240711$$CN$US$US
240761611$24076161$1$I$20240703$20240708$20240710$20240710$EXP$$US-ABBVIE-5831955$ABBVIE$$67$YR$$F$Y$$$20240710$$CN$US$US
240761621$24076162$1$I$20240703$20240703$20240710$20240710$PER$$US-ROCHE-10000018193$ROCHE$$$$$$Y$$$20240711$$PH$US$US
240761631$24076163$1$I$20240611$20240708$20240710$20240710$EXP$$US-ABBVIE-5833122$ABBVIE$$76$YR$$F$Y$$$20240710$$CN$US$US
240761642$24076164$2$F$20240401$20240917$20240710$20240922$EXP$$US-BIOGEN-2024BI01272910$BIOGEN$$36$YR$$F$Y$$$20240922$$MD$US$US
240761651$24076165$1$I$$20240703$20240710$20240710$PER$$US-ROCHE-10000020658$ROCHE$$$$A$M$Y$$$20240711$$CN$US$US
240761662$24076166$2$F$20240601$20240711$20240710$20240715$EXP$$US-ABBVIE-5833264$ABBVIE$$73$YR$$F$Y$$$20240715$$CN$US$US
240761672$24076167$2$F$20240702$20240729$20240710$20240805$EXP$$JP-JNJFOC-20240724184$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240805$$MD$JP$JP
240761682$24076168$2$F$$20240731$20240710$20240801$EXP$$NVSJ2024JP008100$NOVARTIS$$81$YR$$F$Y$$$20240802$$MD$JP$JP
240761691$24076169$1$I$$20240708$20240710$20240710$EXP$$US-BIOGEN-2024BI01272928$BIOGEN$$$$$F$Y$$$20240710$$CN$US$US
240761703$24076170$3$F$$20240716$20240710$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039069$BOEHRINGER INGELHEIM$$$$$$Y$$$20240722$$MD$US$US
240761721$24076172$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142884$NOVARTIS$$$$$F$Y$$$20240711$$CN$US$US
240761731$24076173$1$I$20240624$20240708$20240710$20240710$PER$$US-ABBVIE-5833003$ABBVIE$$86$YR$$F$Y$$$20240710$$CN$US$US
240761741$24076174$1$I$20240606$20240701$20240710$20240710$PER$$US-SA-2024SA198137$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240711$$MD$US$US
240761751$24076175$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA199397$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240711$$MD$US$US
240761761$24076176$1$I$$20240703$20240710$20240710$PER$$US-SA-2024SA201273$SANOFI AVENTIS$$$$E$F$Y$$$20240711$$MD$US$US
240761772$24076177$2$F$$20240722$20240710$20240731$PER$$US-SA-2024SA200525$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240731$$MD$US$US
240761782$24076178$2$F$$20240731$20240710$20240803$EXP$$US-ABBVIE-5833216$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
240761791$24076179$1$I$$20240613$20240710$20240710$PER$$US-JNJFOC-20240638005$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240711$$CN$US$US
240761801$24076180$1$I$$20240703$20240710$20240710$PER$$US-JNJFOC-20240709977$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240761813$24076181$3$F$20240628$20240812$20240710$20240815$30DAY$$US-AMGEN-USASP2024131868$AMGEN$$41$YR$A$M$Y$89.796$KG$20240815$$PH$US$US
240761821$24076182$1$I$20220101$20240703$20240710$20240710$EXP$$IT-009507513-2407ITA002256$MERCK$Vitale MG, Nasso C, Ricco B, Bocconi A, Chiavelli C, Baldessari C, et al.. Pembrolizumab in Vaginal Carcinoma: A Case Report and Review of the Literature. Case Reports in Oncology. 2024;17:564-72$47$YR$$F$Y$$$20240710$$HP$IT$IT
240761831$24076183$1$I$$20240708$20240710$20240710$EXP$$US-ABBVIE-5832694$ABBVIE$$$$$F$Y$$$20240710$$HP$US$US
240761851$24076185$1$I$$20240706$20240710$20240710$PER$$US-ROCHE-10000021396$ROCHE$$65$YR$E$F$Y$$$20240711$$CN$US$US
240761861$24076186$1$I$$20240704$20240710$20240710$PER$$US-SA-2024SA200533$SANOFI AVENTIS$$$$E$F$Y$$$20240711$$MD$US$US
240761871$24076187$1$I$$20240709$20240710$20240710$PER$$NVSC2024US142921$NOVARTIS$$$$$M$Y$$$20240711$$CN$US$US
240761881$24076188$1$I$$20240703$20240710$20240710$EXP$$US-JNJFOC-20240709404$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$MD$US$US
240761891$24076189$1$I$$20240702$20240710$20240710$PER$$US-JNJFOC-20240706162$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$MD$US$US
240761902$24076190$2$F$$20240917$20240710$20240917$EXP$$AT-JNJFOC-20240429967$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240918$$MD$AT$AT
240761911$24076191$1$I$20240601$20240708$20240710$20240710$EXP$$US-ABBVIE-5832673$ABBVIE$$68$YR$$F$Y$$$20240710$$CN$US$US
240761931$24076193$1$I$$20240705$20240710$20240710$PER$$US-AMGEN-USASP2024133653$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240761953$24076195$3$F$20240101$20240730$20240710$20240831$EXP$$CA-ABBVIE-5828903$ABBVIE$$68$YR$$F$Y$$$20240831$$CN$CA$CA
240761961$24076196$1$I$$20240710$20240710$20240710$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039038$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240711$$CN$US$US
240761971$24076197$1$I$$20240703$20240710$20240710$EXP$$ES-NOVITIUMPHARMA-2024ESNVP01227$NOVITIUM PHARMA$Carla Marco.Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series.Journal of Clinical Medicine.24-DEC-2022;12:1-10$70$YR$E$M$Y$$$20240711$$HP$ES$ES
240761992$24076199$2$F$$20240807$20240710$20240808$PER$$NVSC2024US142977$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
240762001$24076200$1$I$$20240705$20240710$20240710$EXP$$KR-ASTELLAS-2024EU006708$ASTELLAS$$$$$$Y$$$20240711$$HP$GB$KR
240762011$24076201$1$I$$20240705$20240710$20240710$EXP$$IN-ASTELLAS-2024US019221$ASTELLAS$$17$YR$$F$Y$$$20240711$$HP$IN$IN
240762032$24076203$2$F$20240501$20240923$20240711$20240923$PER$$NVSC2024US142903$NOVARTIS$$70$YR$$F$Y$$$20240923$$MD$US$US
240762041$24076204$1$I$20240101$20240701$20240711$20240711$PER$$US-SA-2024SA198140$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240711$$MD$US$US
240762052$24076205$2$F$20240612$20240726$20240711$20240801$PER$$US-SA-2024SA201023$SANOFI AVENTIS$$64$YR$A$F$Y$83$KG$20240801$$MD$US$US
240762061$24076206$1$I$$20240705$20240711$20240711$PER$$US-ABBVIE-5830808$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240762071$24076207$1$I$20240601$20240701$20240711$20240711$PER$$US-SA-2024SA198141$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240711$$MD$US$US
240762082$24076208$2$F$$20240815$20240711$20240824$EXP$$US-GSK-US2024084086$GLAXOSMITHKLINE$$$$$F$Y$61.678$KG$20240824$$CN$US$US
240762091$24076209$1$I$20240101$20240701$20240711$20240711$PER$$US-SA-2024SA198139$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240711$$MD$US$US
240762102$24076210$2$F$$20240717$20240711$20240722$PER$$US-AMGEN-USASP2024136286$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
240762112$24076211$2$F$20240701$20240723$20240711$20240725$PER$$US-AMGEN-USASP2024135784$AMGEN$$37$YR$A$F$Y$$$20240725$$HP$US$US
240762121$24076212$1$I$20240613$20240628$20240711$20240711$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407001378$ELI LILLY AND CO$$66$YR$E$F$Y$60$KG$20240710$$CN$CN$CN
240762132$24076213$2$F$20240619$20240809$20240711$20240819$EXP$FR-AFSSAPS-TO2024001234$FR-ELI_LILLY_AND_COMPANY-FR202407003537$ELI LILLY AND CO$$63$YR$A$M$Y$92$KG$20240819$$CN$FR$FR
240762141$24076214$1$I$20240426$20240628$20240711$20240711$EXP$ES-AEMPS-1540625$ES-ELI_LILLY_AND_COMPANY-ES202407000717$ELI LILLY AND CO$$71$YR$E$F$Y$71$KG$20240710$$CN$ES$ES
240762151$24076215$1$I$$20240628$20240711$20240711$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407000560$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240710$$CN$BR$BR
240762161$24076216$1$I$$20240709$20240711$20240711$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407006022$ELI LILLY AND CO$$$$$$Y$$$20240710$$MD$JP$JP
240762172$24076217$2$F$20230301$20240712$20240711$20240719$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406001204$ELI LILLY AND CO$$63$YR$A$F$Y$76$KG$20240719$$CN$JP$JP
240762181$24076218$1$I$$20240704$20240711$20240711$EXP$$SG-ELI_LILLY_AND_COMPANY-SG202407006484$ELI LILLY AND CO$$$$$$Y$$$20240710$$CN$DE$SG
240762191$24076219$1$I$$20240628$20240711$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000884$ELI LILLY AND CO$$$$$F$Y$$$20240710$$CN$US$US
240762201$24076220$1$I$20240601$20240702$20240711$20240711$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407006483$ELI LILLY AND CO$$50$YR$A$F$Y$43$KG$20240710$$CN$DE$CN
240762211$24076221$1$I$$20240701$20240711$20240711$EXP$$US-ChurchDwight-2024-CDW-01114$CHURCH + DWIGHT$$97$YR$E$M$Y$$$20240709$$CN$US$US
240762222$24076222$2$F$20240708$20240829$20240711$20240901$EXP$$US-ROCHE-10000022548$ROCHE$$49$YR$A$F$Y$$$20240901$$MD$US$US
240762231$24076223$1$I$$20240627$20240711$20240711$PER$$US-SA-2024SA194540$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240711$$MD$US$US
240762241$24076224$1$I$20240201$20240701$20240711$20240711$PER$$US-SA-2024SA198175$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240711$$MD$US$US
240762251$24076225$1$I$$20240701$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033192$AUROBINDO$Huang J, Shehzad D, Ahmed I, Yu JC. Recognizing Veno-occlusive Disease After Inotuzumab Treatment: An Urgent Call to Physicians in Non-Transplant Centers.. Am-J-Respir-Crit-Care-Med. 2024$47$YR$$F$Y$$$20240711$$HP$US$US
240762261$24076226$1$I$$20240701$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-032736$AUROBINDO$Aslam Khan A, Anwar MS, Cherukuri PB, Abu-Shanab A, Fish PN. Community-Acquired Meningitis Complicated With Pyogenic Ventriculitis and Hydrocephalus in a Patient With Haematological Malignancy: A Case Report and Literature Review. Cureus. 2024;16(5):e60800$85$YR$$F$Y$$$20240711$$MD$US$US
240762271$24076227$1$I$$20240701$20240711$20240711$EXP$$US-ARDELYX-2024ARDX004832$ARDELYX$$$$$M$Y$$$20240711$$HP$US$US
240762281$24076228$1$I$20240101$20240705$20240711$20240711$EXP$$US-ABBVIE-5834423$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240762291$24076229$1$I$$20240701$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-032892$AUROBINDO$Peters AT, Case R, Kim SJ, McGregor M, Shifren A, Schroeder G, et al.. Single-Agent Oral Therapy of Granulomatous-Lymphocytic Interstitial Lung Disease: A Case Series. Am-J-Respir-Crit-Care-Med. 2024;209:A3739$$$$$Y$$$20240711$$HP$US$US
240762302$24076230$2$F$20240425$20240816$20240711$20240827$EXP$$US-ARDELYX-2024ARDX004870$ARDELYX$$67$YR$$F$Y$$$20240827$$HP$US$US
240762311$24076231$1$I$$20240702$20240711$20240711$EXP$$JP-ARDELYX-2024ARDX004982$ARDELYX$$6$DEC$$M$Y$$$20240711$$PH$JP$JP
240762321$24076232$1$I$$20240710$20240711$20240711$PER$$US-TAKEDA-2024TUS070148$TAKEDA$$32$YR$$F$Y$$$20240711$$CN$US$US
240762331$24076233$1$I$20240601$20240702$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105910$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240711$$HP$US$US
240762341$24076234$1$I$20240307$20240702$20240711$20240711$EXP$FR-AFSSAPS-AVMA2024000251$FR-TEVA-VS-3216352$TEVA$$27$YR$$M$Y$$$20240711$$PH$FR$FR
240762351$24076235$1$I$$20240701$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-032869$AUROBINDO$Basnet A, Sharma NR, Gautam S, Lamichhane S, Kansakar S, Tiwari K, et al. Immune checkpoint inhibitor-induced myasthenia gravis, myocarditis, and myositis: A case report. Clin-Case-Rep. 2024$76$YR$$M$Y$$$20240711$$HP$US$US
240762361$24076236$1$I$20221201$20240701$20240711$20240711$PER$$US-SA-2024SA198145$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240711$$MD$US$US
240762371$24076237$1$I$$20240613$20240711$20240711$PER$$US-JNJFOC-20240637477$JOHNSON AND JOHNSON$$8$YR$C$F$Y$$$20240711$$CN$US$US
240762384$24076238$4$F$$20240812$20240711$20240813$PER$$US-JNJFOC-20240678011$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240813$$PH$US$US
240762391$24076239$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5833253$ABBVIE$$$$$M$Y$$$20240711$$HP$US$US
240762402$24076240$2$F$20240606$20240725$20240711$20240801$EXP$$IE-JNJFOC-20240624638$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240802$$HP$IE$IE
240762411$24076241$1$I$$20240625$20240711$20240711$EXP$CA-ALLERGAN-2002222US$CA-ABBVIE-2002222US$ABBVIE$$72$YR$$M$Y$$$20240711$$HP$CA$CA
240762421$24076242$1$I$20161101$20240708$20240711$20240711$EXP$$US-ABBVIE-5826407$ABBVIE$$41$YR$$F$Y$$$20240711$$CN$US$US
240762431$24076243$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5832386$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240762441$24076244$1$I$20240624$20240708$20240711$20240711$EXP$$US-ABBVIE-5833282$ABBVIE$$33$YR$$M$Y$$$20240711$$CN$US$US
240762451$24076245$1$I$20231228$20240703$20240711$20240711$EXP$$CA-JNJFOC-20231280619$JOHNSON AND JOHNSON$$70$YR$E$F$Y$98$KG$20240711$$HP$CA$CA
240762461$24076246$1$I$20170815$20240704$20240711$20240711$EXP$$BE-ABBVIE-17K-013-3084891-00$ABBVIE$$67$YR$$M$Y$68$KG$20240711$$MD$BE$BE
240762471$24076247$1$I$20240601$20240702$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109193$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240711$$CN$US$US
240762481$24076248$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109314$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$93.44$KG$20240711$$HP$US$US
240762494$24076249$4$F$20240626$20240923$20240711$20240926$EXP$$AT-HALEON-2186111$Haleon PLC$$56$YR$$M$Y$$$20240926$$CN$AT$AT
240762501$24076250$1$I$20240522$20240709$20240711$20240711$EXP$$US-TAKEDA-2024TUS070055$TAKEDA$$957$YR$$M$Y$$$20240711$$CN$US$US
240762511$24076251$1$I$$20240705$20240711$20240711$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02489$AMNEAL$$$$$M$Y$$$20240711$$CN$US$US
240762521$24076252$1$I$$20240702$20240711$20240711$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024082202$VIIV$$$$$M$Y$$$20240711$$MD$US$US
240762531$24076253$1$I$20240101$20240708$20240711$20240711$EXP$$CA-ABBVIE-5833107$ABBVIE$$38$YR$$F$Y$$$20240711$$CN$CA$CA
240762541$24076254$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5833201$ABBVIE$$$$$F$Y$$$20240711$$HP$US$US
240762551$24076255$1$I$$20240703$20240711$20240711$EXP$$US-HALEON-2185526$Haleon PLC$Raza HS, Love JS, Mikolajczyk AE. Parvimonas micra Bacteremia: A Rare Complication After ?Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding. ACG Case Reports Journal . 2024 Jun 07;11(6).$38$YR$$M$Y$$$20240710$$HP$US$US
240762561$24076256$1$I$$20240702$20240711$20240711$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001355$BLUEPRINT MEDICINES$$$$$M$Y$$$20240711$$CN$US$US
240762572$24076257$2$F$20240501$20240731$20240711$20240801$EXP$$US-ABBVIE-5832892$ABBVIE$$28$YR$$M$Y$$$20240801$$CN$US$US
240762581$24076258$1$I$$20240701$20240711$20240711$PER$$US-SA-2024SA197371$SANOFI AVENTIS$$$$A$F$Y$154$KG$20240711$$MD$US$US
240762591$24076259$1$I$$20240701$20240711$20240711$PER$$US-SA-2024SA197578$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240711$$MD$US$US
240762602$24076260$2$F$20240101$20240904$20240711$20240913$PER$$US-SA-2024SA196119$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240913$$MD$US$US
240762611$24076261$1$I$$20240709$20240711$20240711$EXP$$NVSC2024US142662$NOVARTIS$$$$$M$Y$$$20240711$$CN$US$US
240762621$24076262$1$I$$20240705$20240711$20240711$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001372$BLUEPRINT MEDICINES$$$$$F$Y$$$20240711$$CN$US$US
240762641$24076264$1$I$20240709$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136718$AMGEN$$61$YR$A$F$Y$$$20240710$$HP$US$US
240762651$24076265$1$I$20240101$20240701$20240711$20240711$PER$$US-SA-2024SA199727$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240711$$MD$US$US
240762661$24076266$1$I$$20240701$20240711$20240711$PER$$US-SA-2024SA195983$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$CN$US$US
240762671$24076267$1$I$20240621$20240701$20240711$20240711$PER$$US-SA-2024SA198176$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240711$$MD$US$US
240762681$24076268$1$I$20240501$20240705$20240711$20240711$EXP$GB-MHRA-MED-202405061024440000-QGVMZ$GB-CHATTEMPRD-2024OHG023399$CHATTEM$$66$YR$E$$Y$$$20240711$$CN$GB$GB
240762692$24076269$2$F$$20240703$20240711$20240717$EXP$$US-CHATTEMPRD-2024OHG023119$CHATTEM$$$$E$F$Y$$$20240717$$LW$US$US
240762701$24076270$1$I$$20240709$20240711$20240711$PER$$US-JNJFOC-20240725040$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240762712$24076271$2$F$$20240917$20240711$20240919$EXP$$US-JNJFOC-20240715480$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$HP$US$US
240762721$24076272$1$I$$20240709$20240711$20240711$PER$$NVSC2024US142898$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240762731$24076273$1$I$$20240708$20240711$20240711$EXP$$US-JNJFOC-20240720213$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$PH$US$US
240762743$24076274$3$F$20240609$20240711$20240711$20240718$EXP$$BR-JNJFOC-20240719943$JOHNSON AND JOHNSON$$10$YR$C$M$Y$46$KG$20240718$$CN$BR$BR
240762752$24076275$2$F$20240703$20240807$20240711$20240807$PER$$US-JNJFOC-20240715376$JOHNSON AND JOHNSON$$41$YR$A$F$Y$101$KG$20240807$$PH$US$US
240762762$24076276$2$F$20230821$20240917$20240711$20240922$EXP$$US-JNJFOC-20240720421$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$PH$US$US
240762771$24076277$1$I$20201028$20240702$20240711$20240711$EXP$PL-URPL-1-3237-2020$PL-TEVA-VS-3216653$TEVA$$29$YR$$M$Y$80$KG$20240711$$MD$PL$PL
240762781$24076278$1$I$$20240703$20240711$20240711$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001366$BLUEPRINT MEDICINES$$$$$F$Y$$$20240711$$CN$US$US
240762791$24076279$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5833354$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240762802$24076280$2$F$$20240805$20240711$20240807$EXP$$US-TAKEDA-2024TUS057816$TAKEDA$$$$$M$Y$$$20240807$$MD$US$US
240762811$24076281$1$I$$20240705$20240711$20240711$PER$$US-ROCHE-10000017674$ROCHE$Yuen A, Suessman A. Stumped by a Case of Appendicitis After Appendectomy. Ochsner Journal. 2024;24 (2):147-50. doi:10.31486/toj.23.0098.$10$YR$C$M$Y$$$20240711$$MD$US$US
240762822$24076282$2$F$$20240711$20240711$20240718$EXP$$NL-ABBVIE-5833361$ABBVIE$$$$E$M$Y$$$20240718$$CN$NL$NL
240762831$24076283$1$I$20210101$20240702$20240711$20240711$EXP$$US-ABBVIE-5826394$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240762841$24076284$1$I$$20230725$20240711$20240711$PER$$US-STRIDES ARCOLAB LIMITED-2023SP012250$STRIDES$Khoury AL, Weiss K, Haithcock BE, Tessmann PB, Caranasos TG.. Bilateral Thoracoscopic Sympathectomy After Sternotomy for Left Ventricular Assist Device Insertion.. Ann-Thorac-Surg. 2022;114(5):e319-e320$73$YR$$M$Y$$$20240711$$MD$US$US
240762851$24076285$1$I$$20240117$20240711$20240711$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000729$STRIDES$$90$YR$$M$Y$$$20240711$$CN$US$US
240762861$24076286$1$I$$20240410$20240711$20240711$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004356$STRIDES$$$$$F$Y$$$20240711$$HP$US$US
240762871$24076287$1$I$$20240507$20240711$20240711$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005423$STRIDES$$$$$$Y$$$20240711$$HP$US$US
240762881$24076288$1$I$$20240526$20240711$20240711$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006386$STRIDES$Onuchic F, Trivedi R.. A CASE OF HYPONATREMIA IN AN ESRD PATIENT ON PERITONEAL DIALYSIS. Am-J-Kidney-Dis. 2024;83 (Suppl.) (4):S40 abstr. 135$58$YR$$M$Y$$$20240711$$HP$US$US
240762891$24076289$1$I$20220101$20240704$20240711$20240711$EXP$$CA-JNJFOC-20220107972$JOHNSON AND JOHNSON$$48$YR$A$F$Y$71$KG$20240711$$HP$CA$CA
240762901$24076290$1$I$$20240705$20240711$20240711$30DAY$$US-GSK-US2024AMR084143$GLAXOSMITHKLINE$$$$$M$Y$$$20240711$$CN$US$US
240762911$24076291$1$I$$20240705$20240711$20240711$EXP$$US-HALEON-2185733$Haleon PLC$$$$$$Y$$$20240710$$CN$US$US
240762921$24076292$1$I$20240415$20240628$20240711$20240711$EXP$$US-ABBVIE-5824924$ABBVIE$$37$YR$$F$Y$$$20240711$$CN$US$US
240762931$24076293$1$I$$20240708$20240711$20240711$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-109295$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240711$$MD$FR$FR
240762944$24076294$4$F$$20240905$20240711$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109311$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240909$$CN$US$US
240762951$24076295$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109176$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240711$$PH$US$US
240762961$24076296$1$I$$20240213$20240711$20240711$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002007$STRIDES$Marinescu A, Azam A.. A Rare Case of Pituitary Apoplexy in an Adolescent Male.. J-Endocr-Soc. 2020;4 (Suppl.):A894-A895 abstr. SAT-064$17$YR$$M$Y$$$20240711$$MD$US$US
240762971$24076297$1$I$$20231211$20240711$20240711$PER$$US-STRIDES ARCOLAB LIMITED-2023SP018680$STRIDES$$$$$M$Y$102.04$KG$20240711$$CN$US$US
240762981$24076298$1$I$$20240419$20240711$20240711$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004685$STRIDES$$$$$$Y$$$20240711$$HP$US$US
240762991$24076299$1$I$20230301$20230718$20240711$20240711$PER$$US-STRIDES ARCOLAB LIMITED-2023SP011762$STRIDES$$68$YR$$M$Y$86.168$KG$20240711$$CN$US$US
240763001$24076300$1$I$$20231012$20240711$20240711$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015839$STRIDES$$81$YR$$M$Y$$$20240711$$CN$US$US
240763011$24076301$1$I$20240601$20240627$20240711$20240711$PER$$US-SA-2024SA193427$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240711$$MD$US$US
240763021$24076302$1$I$$20230817$20240711$20240711$PER$$US-STRIDES ARCOLAB LIMITED-2023SP013431$STRIDES$Mathew A, Ramakrishna J, Kumar S, Asif J, Javaid U.. Abstract #1403021: HIV Status in a Patient on Testosterone Therapy: Confounder or Modifier to Venous Thromboembolism?. Endocr-Pract. 2023;29(5):S86-S87$60$YR$$M$Y$$$20240711$$MD$US$US
240763031$24076303$1$I$20240601$20240627$20240711$20240711$PER$$US-SA-2024SA195263$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240711$$MD$US$US
240763041$24076304$1$I$$20240708$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108281$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240709$$CN$US$US
240763051$24076305$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136452$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240763063$24076306$3$F$20240708$20240716$20240711$20240719$PER$$US-AMGEN-USASP2024136641$AMGEN$$87$YR$E$F$Y$$$20240719$$PH$US$US
240763072$24076307$2$F$20240701$20240724$20240711$20240805$PER$$US-AMGEN-USASP2024134941$AMGEN$$18$YR$A$F$Y$59.1$KG$20240804$$HP$US$US
240763083$24076308$3$F$20240718$20240718$20240711$20240731$PER$$US-AMGEN-USASP2024135941$AMGEN$$75$YR$E$M$Y$$$20240731$$CN$US$US
240763091$24076309$1$I$$20240705$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108837$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240709$$CN$US$US
240763101$24076310$1$I$$20240703$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108042$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240709$$CN$US$US
240763111$24076311$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108265$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240709$$CN$US$US
240763121$24076312$1$I$20240629$20240705$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107877$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240709$$CN$US$US
240763141$24076314$1$I$$20240708$20240711$20240711$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-108808$BRISTOL MYERS SQUIBB$$74$YR$E$$Y$65.32$KG$20240709$$CN$PR$PR
240763162$24076316$2$F$20240520$20240809$20240711$20240813$EXP$$US-ABBVIE-5832487$ABBVIE$$69$YR$$F$Y$$$20240813$$CN$US$US
240763171$24076317$1$I$20240601$20240708$20240711$20240711$EXP$$US-ABBVIE-5833310$ABBVIE$$54$YR$$F$Y$$$20240711$$CN$US$US
240763181$24076318$1$I$$20240628$20240711$20240711$PER$$US-SA-2024SA196369$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240711$$MD$US$US
240763192$24076319$2$F$20240703$20240909$20240711$20240910$PER$$US-BIOVITRUM-2024-US-009563$BIOVITRUM$$63$YR$$M$Y$$$20240910$$CN$US$US
240763202$24076320$2$F$$20240816$20240711$20240822$EXP$CZ-CZSUKL-24001824$CZ-SA-2024SA195303$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240822$$MD$CZ$CZ
240763213$24076321$3$F$20240705$20240730$20240711$20240805$EXP$$US-BIOGEN-2024BI01272918$BIOGEN$$59$YR$$F$Y$$$20240805$$CN$US$US
240763221$24076322$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008070$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11(3):500-510$64$YR$$M$Y$$$20240711$$HP$US$US
240763231$24076323$1$I$$20240627$20240711$20240711$EXP$$US-P+L Developments of Newyork Corporation-2159031$PL DEVELOPMENTS$Initial$55$YR$$M$Y$$$20240711$$$US$US
240763242$24076324$2$F$20240702$20240725$20240711$20240801$PER$$US-AMGEN-USASP2024134455$AMGEN$$59$YR$A$F$Y$137$KG$20240801$$PH$US$US
240763251$24076325$1$I$$20240701$20240711$20240711$EXP$$BR-NOVOPROD-1249230$NOVO NORDISK$$$$$F$Y$$$20240711$$CN$BR$BR
240763261$24076326$1$I$20240301$20240701$20240711$20240711$EXP$$CN-NOVOPROD-1248206$NOVO NORDISK$$46$YR$$M$Y$$$20240711$$CN$CN$CN
240763271$24076327$1$I$$20240702$20240711$20240711$EXP$$TR-NOVOPROD-1252711$NOVO NORDISK$$709$MON$$F$Y$80$KG$20240711$$CN$TR$TR
240763291$24076329$1$I$20240601$20240701$20240711$20240711$EXP$$US-NOVOPROD-1248858$NOVO NORDISK$$$$A$$Y$$$20240711$$HP$US$US
240763301$24076330$1$I$20240611$20240701$20240711$20240711$EXP$CN-NMPA-3411011513148202400354$CN-NOVOPROD-1248804$NOVO NORDISK$$24$YR$$F$Y$79$KG$20240711$$HP$CN$CN
240763311$24076331$1$I$20240621$20240701$20240711$20240711$EXP$$US-NOVOPROD-1249412$NOVO NORDISK$$72$YR$$F$Y$$$20240711$$CN$US$US
240763321$24076332$1$I$$20240702$20240711$20240711$EXP$GB-MHRA-MED-202407010839343690-HCZKJ$GB-NOVOPROD-1249866$NOVO NORDISK$$$$$F$Y$$$20240711$$CN$GB$GB
240763331$24076333$1$I$$20240701$20240711$20240711$EXP$AU-TGA-0000782502$AU-NOVOPROD-1249552$NOVO NORDISK$$$$$M$Y$$$20240711$$CN$AU$AU
240763341$24076334$1$I$20230704$20240701$20240711$20240711$EXP$AU-TGA-0000782136$AU-NOVOPROD-1249569$NOVO NORDISK$$68$YR$$F$Y$$$20240711$$CN$AU$AU
240763351$24076335$1$I$$20240629$20240711$20240711$EXP$$DE-NOVOPROD-1251231$NOVO NORDISK$$$$$M$Y$$$20240711$$CN$DE$DE
240763362$24076336$2$F$20240629$20240918$20240711$20240927$EXP$$ES-NOVOPROD-1220087$NOVO NORDISK$$54$YR$$F$Y$58$KG$20240927$$CN$ES$ES
240763371$24076337$1$I$20240701$20240702$20240711$20240711$EXP$$US-NOVOPROD-1250160$NOVO NORDISK$$41$YR$$F$Y$$$20240711$$CN$US$US
240763381$24076338$1$I$20200101$20240702$20240711$20240711$EXP$$US-NOVOPROD-1251815$NOVO NORDISK$$63$YR$$F$Y$$$20240711$$CN$US$US
240763391$24076339$1$I$20240101$20240702$20240711$20240711$EXP$$AT-NOVOPROD-1249587$NOVO NORDISK$$$$A$F$Y$$$20240711$$MD$AT$AT
240763402$24076340$2$F$$20240717$20240711$20240725$EXP$$GB-NOVOPROD-1248434$NOVO NORDISK$$52$YR$$M$Y$$$20240725$$HP$GB$GB
240763412$24076341$2$F$20240527$20240906$20240711$20240917$EXP$$US-NOVOPROD-1249485$NOVO NORDISK$$84$YR$$F$Y$$$20240917$$CN$US$US
240763421$24076342$1$I$20240501$20240702$20240711$20240711$EXP$$CN-NOVOPROD-1249243$NOVO NORDISK$$60$YR$$F$Y$50$KG$20240711$$CN$CN$CN
240763431$24076343$1$I$$20240630$20240711$20240711$EXP$$IL-NOVOPROD-1248921$NOVO NORDISK$$$$$M$Y$$$20240711$$MD$IL$IL
240763442$24076344$2$F$20230101$20240822$20240711$20240904$EXP$$US-NOVOPROD-1251755$NOVO NORDISK$$$$$M$Y$$$20240904$$CN$US$US
240763451$24076345$1$I$$20240702$20240711$20240711$EXP$$DE-NOVOPROD-1249246$NOVO NORDISK$$$$$F$Y$$$20240711$$CN$DE$DE
240763461$24076346$1$I$$20240702$20240711$20240711$EXP$$AU-NOVOPROD-1248145$NOVO NORDISK$$$$$F$Y$$$20240711$$CN$AU$AU
240763482$24076348$2$F$$20240717$20240711$20240718$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010456$JAZZ$$$$$M$Y$$$20240718$$MD$US$US
240763491$24076349$1$I$$20240705$20240711$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109209$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240711$$MD$JP$JP
240763501$24076350$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000022256$ROCHE$$42$YR$A$F$Y$47.2$KG$20240711$$HP$US$US
240763512$24076351$2$F$20240529$20240725$20240711$20240731$EXP$$US-BIOGEN-2024BI01272510$BIOGEN$$8$YR$$M$Y$$$20240731$$MD$US$US
240763521$24076352$1$I$20240705$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135511$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240763531$24076353$1$I$$20240702$20240711$20240711$EXP$$RU-AMGEN-RUSSP2024133579$AMGEN$Popov A. M; Rumyantseva Y. V; Mikhailova E. V et al.. The use of blinatumomab in children with de novo Ph-negative B-lineage acute lymphoblastic leukemia and slow clearance of minimal residual disease. Pediatric Hematology/Oncology and Immunopathology. 2024;23 (1):63-72$$$$$Y$$$20240710$$HP$RU$RU
240763541$24076354$1$I$$20240703$20240711$20240711$EXP$$US-GSK-US2024AMR084319$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240763551$24076355$1$I$$20240703$20240711$20240711$EXP$$US-GSK-US2024082584$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$MD$US$US
240763561$24076356$1$I$20240703$20240708$20240711$20240711$EXP$$US-AstraZeneca-2024A156033$ASTRAZENECA$$32261$DY$$M$Y$$$20240711$$CN$US$
240763581$24076358$1$I$20240101$20240626$20240711$20240711$PER$$US-Encube-000800$ENCUBE ETHICALS$$79$YR$E$F$Y$$$20240710$$CN$US$
240763591$24076359$1$I$$20240704$20240711$20240711$EXP$GB-MHRA-MED-202404301829409070-KFDHQ$GB-ABBVIE-5833906$ABBVIE$$$$$F$Y$$$20240711$$CN$GB$GB
240763601$24076360$1$I$$20240705$20240711$20240711$PER$$US-ROCHE-10000021373$ROCHE$$24$YR$A$F$Y$$$20240711$$CN$US$US
240763611$24076361$1$I$20240101$20240704$20240711$20240711$EXP$$DE-BIOGEN-2024BI01272674$BIOGEN$$37$YR$$M$Y$$$20240711$$MD$DE$DE
240763621$24076362$1$I$$20240708$20240711$20240711$EXP$$US-BIOGEN-2024BI01272912$BIOGEN$$$$$M$Y$$$20240711$$CN$US$US
240763631$24076363$1$I$$20240619$20240711$20240711$PER$$CA-TOLMAR, INC.-24CA049845$TOLMAR$$$$$M$Y$$$20240711$$CN$CA$CA
240763641$24076364$1$I$20231201$20240620$20240711$20240711$PER$$CA-TOLMAR, INC.-24CA050048$TOLMAR$$70$YR$$M$Y$$$20240711$$CN$CA$CA
240763652$24076365$2$F$$20240731$20240711$20240808$EXP$$US-BIOGEN-2024BI01272904$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
240763661$24076366$1$I$20240131$20240619$20240711$20240711$PER$$CA-TOLMAR, INC.-24CA049993$TOLMAR$$84$YR$$M$Y$$$20240711$$PH$CA$CA
240763671$24076367$1$I$20240101$20240620$20240711$20240711$PER$$CA-TOLMAR, INC.-24CA050128$TOLMAR$$$$$M$Y$$$20240711$$CN$CA$CA
240763684$24076368$4$F$20240612$20240812$20240711$20240905$PER$$CA-TOLMAR, INC.-24CA050211$TOLMAR$$10$YR$$F$Y$35$KG$20240905$$MD$CA$CA
240763691$24076369$1$I$$20240619$20240711$20240711$PER$$CA-TOLMAR, INC.-24CA050157$TOLMAR$$$$$M$Y$$$20240711$$CN$CA$CA
240763701$24076370$1$I$$20240619$20240711$20240711$PER$$CA-TOLMAR, INC.-24CA050339$TOLMAR$$$$$M$Y$$$20240711$$CN$CA$CA
240763712$24076371$2$F$20240101$20240913$20240711$20240927$PER$$CA-TOLMAR, INC.-24CA050249$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
240763731$24076373$1$I$$20240619$20240711$20240711$PER$$CA-TOLMAR, INC.-24CA050343$TOLMAR$$$$$M$Y$$$20240711$$CN$CA$CA
240763741$24076374$1$I$20240101$20240619$20240711$20240711$PER$$CA-TOLMAR, INC.-24CA050341$TOLMAR$$$$$M$Y$$$20240711$$CN$CA$CA
240763751$24076375$1$I$$20240703$20240711$20240711$EXP$$CA-CELLTRION INC.-2024CA016140$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
240763761$24076376$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136598$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240763771$24076377$1$I$$20240701$20240711$20240711$EXP$IT-MLMSERVICE-20240613-PI080629-00232-2$IT-STRIDES ARCOLAB LIMITED-2024SP007330$STRIDES$Favi E, Cresseri D, Perego M, Ikehata M, Iesari S, Campise MR, et al.. Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept.. Clinical Immunology. 2024;264:110240$50$YR$$M$Y$$$20240711$$MD$IT$IT
240763781$24076378$1$I$20230101$20240708$20240711$20240711$EXP$DK-DKMA-30734076$DK-AMGEN-DNKSP2024135515$AMGEN$$60$YR$A$F$Y$$$20240710$$MD$DK$DK
240763793$24076379$3$F$$20240819$20240711$20240821$EXP$$NVSC2024CA142861$NOVARTIS$$$$$F$Y$$$20240821$$HP$CA$CA
240763801$24076380$1$I$$20240701$20240711$20240711$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP008040$STRIDES$Kaazan P, Palmer AJ, Oliver K, Burger D, Segal J, Chao C-Y, et al.. Primary intestinal Cytomegalovirus infection in a patient with severe ulcerative colitis.. Intern-Med-J. 2023;53 (5):875-876$30$YR$$M$Y$$$20240711$$HP$AU$AU
240763812$24076381$2$F$$20240920$20240711$20240923$EXP$$JP-009507513-2407JPN001288J$MERCK$Yagi Y, Arakawa Y, Yamagishi Y.. [C-02 A Case of Prosthetic Vessel Infection Caused by MRSA with Difficulty in Selecting Antibiotics]. MRSA Forum 2024 IN SENDAI. 38$$$$M$Y$$$20240923$$MD$JP$JP
240763823$24076382$3$F$$20240724$20240711$20240802$EXP$$US-TEVA-VS-3218058$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.; May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240802$$PH$US$US
240763831$24076383$1$I$20240625$20240702$20240711$20240711$EXP$$CN-BEIGENE-BGN-2024-010286$BEIGENE$$$$$$Y$$$20240711$$HP$CN$CN
240763842$24076384$2$F$20240626$20240905$20240711$20240916$30DAY$$US-GSK-US2024083027$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240916$$CN$US$US
240763852$24076385$2$F$$20240807$20240711$20240809$PER$$US-AMGEN-USASP2024134576$AMGEN$$57$YR$A$M$Y$$$20240809$$CN$US$US
240763861$24076386$1$I$$20240528$20240711$20240711$PER$$US-CHATTEMPRD-2024OHG023525$CHATTEM$$$$$F$Y$$$20240711$$CN$US$US
240763871$24076387$1$I$$20240705$20240711$20240711$EXP$$US-GSK-US2024AMR084787$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$US$US
240763884$24076388$4$F$20240410$20240726$20240711$20240805$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-018831$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240805$$CN$JP$JP
240763891$24076389$1$I$$20240701$20240711$20240711$EXP$$SA-STRIDES ARCOLAB LIMITED-2024SP008090$STRIDES$Al-Juraibah F, Al Shaikh A, Al-Sagheir A, Babiker A, Al Nuaimi A, Al Enezi A, et al.. Experience of X-linked hypophosphatemic rickets in the Gulf Cooperation Council countries: case series.. Endocrinol-Diabetes-Metab-Case-Rep. 2024;2024 (2)$8$YR$$F$Y$$$20240711$$HP$SA$SA
240763901$24076390$1$I$$20240702$20240711$20240711$EXP$$CN-AUROBINDO-AUR-APL-2024-032903$AUROBINDO$He A, Xu L, Li S, Qiu J.. Sertraline Hydrochloride Overdose Resulting in Diabetes Insipidus: A Case Report.. Cureus. 2024;16(5):e60952$17$YR$$F$Y$$$20240711$$MD$CN$CN
240763911$24076391$1$I$20230101$20240708$20240711$20240711$EXP$$US-BIOGEN-2024BI01272919$BIOGEN$$$$$M$Y$$$20240711$$CN$US$US
240763921$24076392$1$I$20240530$20240703$20240711$20240711$EXP$$CN-BEIGENE-BGN-2024-010367$BEIGENE$$$$$$Y$$$20240711$$HP$CN$CN
240763931$24076393$1$I$$20240701$20240711$20240711$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008053$STRIDES$Bishnoi K, Agrawal K, Mishra SK, Purkait S.. Uncommon Site of Metastasis: A Case Report of Breast Carcinoma Spreading to the Pancreas.. Indian-J-Nucl-Med. 2024;39 (2):120-122$5$DEC$$F$Y$$$20240711$$MD$IN$IN
240763941$24076394$1$I$$20240702$20240711$20240711$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008129$STRIDES$Neacsu ED, Montalban EM, de Miguel BM.. Resolution of a rare case of hypercalcemia in a PTHrp-producing pancreatic neuroendocrine tumor using selective internal radiation therapy with 90Y microspheres.. Ann-Pancreat-Cancer. 2024;7$7$DEC$$F$Y$$$20240711$$HP$ES$ES
240763951$24076395$1$I$$20240703$20240711$20240711$EXP$$ES-NOVITIUMPHARMA-2024ESNVP01229$NOVITIUM PHARMA$Carla Marco.Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series.Journal of Clinical Medicine.24-DEC-2022;12:1-10$85$YR$E$M$Y$$$20240711$$HP$ES$ES
240763961$24076396$1$I$$20240702$20240711$20240711$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008146$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240711$$HP$CN$CN
240763971$24076397$1$I$$20240702$20240711$20240711$30DAY$$US-GSK-US2024082226$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240763981$24076398$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109460$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240711$$CN$US$US
240763991$24076399$1$I$$20240702$20240711$20240711$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008147$STRIDES$Zhan M, Liu T, Zhang Z, Wang G, Cao Z, Li X, et al.. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.. Front-Pediatr. 2023;11:1-12$$$C$$Y$$$20240711$$HP$CN$CN
240764011$24076401$1$I$$20240708$20240711$20240711$PER$$US-ROCHE-10000022009$ROCHE$$41$YR$A$M$Y$$$20240711$$HP$US$US
240764021$24076402$1$I$20240101$20240703$20240711$20240711$PER$$US-UNITED THERAPEUTICS-UNT-2024-020134$UNITED THERAPEUTICS$$$$$F$Y$63.946$KG$20240711$$$US$US
240764032$24076403$2$F$20220101$20240712$20240711$20240717$EXP$DE-SK LIFE SCIENCE, INC-SKPVG-2024-001322$DE-UCBSA-2024034450$UCB$$18$YR$$M$Y$$$20240717$$HP$DE$DE
240764041$24076404$1$I$20161129$20240705$20240711$20240711$EXP$$DE-TAKEDA-2016BLT008883$TAKEDA$$4$YR$$M$Y$$$20240711$$CN$DE$DE
240764051$24076405$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136648$AMGEN$$$$$$Y$$$20240710$$HP$US$US
240764061$24076406$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008098$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$33$YR$$M$Y$$$20240711$$HP$US$US
240764072$24076407$2$F$$20240920$20240711$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105693$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240924$$CN$US$US
240764081$24076408$1$I$$20240704$20240711$20240711$EXP$$BR-BEIGENE-BGN-2024-010546$BEIGENE$$$$$$Y$$$20240711$$HP$BR$BR
240764091$24076409$1$I$$20240705$20240711$20240711$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107741$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240711$$CN$CA$CA
240764101$24076410$1$I$$20240703$20240711$20240711$EXP$$CA-CELLTRION INC.-2024CA016225$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
240764111$24076411$1$I$20240707$20240708$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108870$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240711$$MD$US$US
240764121$24076412$1$I$$20240706$20240711$20240711$PER$$US-TAKEDA-2024TUS069818$TAKEDA$$$$$$Y$$$20240711$$CN$US$US
240764132$24076413$2$F$20240625$20240710$20240711$20240712$EXP$$US-ROCHE-10000022017$ROCHE$$84$YR$E$M$Y$$$20240712$$HP$US$US
240764141$24076414$1$I$$20240702$20240711$20240711$EXP$$JP-MALLINCKRODT-MNK202404436$MALLINCKRODT$$43$YR$A$$Y$$$20240711$$HP$JP$JP
240764151$24076415$1$I$20240309$20240628$20240711$20240711$EXP$FR-AFSSAPS-AVMA2024000274$FR-INDIVIOR US-INDV-145814-2024$RECKITT BENCKISER$$$$$$Y$$$20240711$$PH$FR$FR
240764161$24076416$1$I$$20240702$20240711$20240711$EXP$$JP-MALLINCKRODT-MNK202404437$MALLINCKRODT$$27$DY$N$$Y$$$20240711$$HP$JP$JP
240764171$24076417$1$I$$20240702$20240711$20240711$EXP$$JP-MALLINCKRODT-MNK202404435$MALLINCKRODT$$1$DY$N$$Y$$$20240711$$HP$JP$JP
240764181$24076418$1$I$$20240702$20240711$20240711$EXP$$JP-MALLINCKRODT-MNK202404438$MALLINCKRODT$$1$DY$N$$Y$$$20240711$$HP$JP$JP
240764191$24076419$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199577$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240711$$MD$US$US
240764201$24076420$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA200613$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$CN$US$US
240764211$24076421$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199739$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$MD$US$US
240764222$24076422$2$F$20240710$20240711$20240711$20240712$PER$$US-AMGEN-USASP2024137111$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240764231$24076423$1$I$$20240702$20240711$20240711$PER$$US-ROCHE-10000019249$ROCHE$$10$YR$C$F$Y$$$20240711$$HP$US$US
240764242$24076424$2$F$$20240730$20240711$20240801$EXP$$US-ROCHE-10000017018$ROCHE$$77$YR$E$M$Y$$$20240801$$CN$US$US
240764252$24076425$2$F$$20240716$20240711$20240726$EXP$$GB-TEVA-VS-3217286$TEVA$Phaw NA, Taha Y, Valappil M, McPherson S. IMPACT OF THE INTRODUCTION OF AN HBV TESTING AND TREATING POLICY IN PATIENTS BEING TREATED WITH IMMUNOSUPPRESSION. Gut 2023; 72 (Suppl.) A92-A93.; Phaw NA, Taha Y, Valappil M, McPherson S. IMPACT OF THE INTRODUCTION OF AN HBV TESTING AND TREATING POLICY IN PATIENTS BEING TREATED WITH IMMUNOSUPPRESSION. Gut 2023; 72 (Suppl.) A92-A93.$$$$$Y$$$20240726$$HP$GB$GB
240764261$24076426$1$I$$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109634$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240711$$CN$US$US
240764271$24076427$1$I$$20240703$20240711$20240711$EXP$$ES-NOVITIUMPHARMA-2024ESNVP01228$NOVITIUM PHARMA$Carla Marco.Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series.Journal of Clinical Medicine.24-DEC-2022;12:1-10$69$YR$E$M$Y$$$20240711$$HP$ES$ES
240764281$24076428$1$I$$20240706$20240711$20240711$PER$$US-AMGEN-USASP2024134608$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240764291$24076429$1$I$20240708$20240708$20240711$20240711$EXP$$NVSJ2024JP008292$NOVARTIS$$89$YR$$M$Y$$$20240711$$MD$JP$JP
240764302$24076430$2$F$$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024136000$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240764311$24076431$1$I$$20240708$20240711$20240711$EXP$$US-GSK-US2024084474$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$US$US
240764321$24076432$1$I$$20240702$20240711$20240711$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR084552$VIIV$$$$$$Y$$$20240711$$HP$US$US
240764331$24076433$1$I$20240503$20240705$20240711$20240711$EXP$FR-AFSSAPS-AN2024000803$FR-CHEPLA-2024008448$CHEPLAPHARM$$66$YR$$F$Y$65$KG$20240711$$PH$COUNTRY NOT SPECIFIED$FR
240764344$24076434$4$F$20240702$20240807$20240711$20240808$PER$$US-JNJFOC-20240708907$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240809$$CN$US$US
240764351$24076435$1$I$20240210$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109663$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240711$$CN$US$US
240764361$24076436$1$I$20240703$20240705$20240711$20240711$PER$$US-ORGANON-O2407USA000733$ORGANON$$39$YR$$F$Y$76.2$KG$20240711$$PH$US$US
240764372$24076437$2$F$20240611$20240712$20240711$20240722$30DAY$$US-GSK-US2024082204$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240722$$CN$US$US
240764382$24076438$2$F$20240628$20240726$20240711$20240805$30DAY$$US-GSK-US2024083226$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240805$$CN$US$US
240764391$24076439$1$I$$20240710$20240711$20240711$EXP$$JP-TAKEDA-2024TJP010402$TAKEDA$$6$YR$$$Y$$$20240711$$MD$JP$JP
240764401$24076440$1$I$$20240629$20240711$20240711$PER$$US-TEVA-VS-3217442$TEVA$$$$$$Y$$$20240711$$CN$US$US
240764411$24076441$1$I$$20240701$20240711$20240711$30DAY$$US-GSK-US2024AMR081751$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240764421$24076442$1$I$$20240703$20240711$20240711$EXP$$CL-HALEON-2185407$Haleon PLC$Ramirez RF, Bravo L, Toledo CT, Giovine S, Giadalah VM. Use of lipid emulsion for treatment of lipophilic non-local anesthetic drug intoxication. From theory to practice. Rev. Chil. Anest. 2024; 53 (3): 224-229. DOI: 10.25237/revchilanestv53n3-04; NA. Ramirez RF, Bravo L, Toledo CT, et al. Use of lipid emulsion for treatment of intoxication by lipophilic drugs, not local anesthetics. From theory to?practice.Revista chilena de anestesia (En l?nea).2024;53(3): 224-229_Chile_03-Jul-2024. #journa...$32$YR$$F$Y$$$20240710$$HP$CL$CL
240764431$24076443$1$I$20240401$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136306$AMGEN$$82$YR$$F$Y$$$20240710$$HP$US$US
240764441$24076444$1$I$20240707$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136884$AMGEN$$$$$M$Y$$$20240710$$CN$US$US
240764451$24076445$1$I$$20240703$20240711$20240711$EXP$$PT-ABBVIE-5830193$ABBVIE$$$$$$Y$$$20240711$$MD$PT$PT
240764461$24076446$1$I$$20240702$20240711$20240711$EXP$GB-MHRA-MED-202406191521210010-ZJBRL$GB-DEXPHARM-2024-2148$DEXCEL$$$$$F$Y$$$20240711$$HP$GB$GB
240764471$24076447$1$I$20170301$20240701$20240711$20240711$EXP$PL-URPL-1-2249-2019$PL-AMGEN-POLSP2024134475$AMGEN$$71$YR$E$F$Y$80$KG$20240710$$MD$PL$PL
240764481$24076448$1$I$20240707$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136933$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240764491$24076449$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136592$AMGEN$$$$$$Y$$$20240710$$PH$US$US
240764501$24076450$1$I$$20240703$20240711$20240711$PER$US-MLMSERVICE-20240626-PI113605-00034-1$US-RDY-SPO/USA/24/0009859$DR REDDYS$Lyon BA, Wynne D. Amiodarone-Induced Epididymitis: A Case Report and Review of the Literature. Cureus. 2024;16(6):e62861. DOI: 10.7759/cureus.62861.$78$YR$E$M$Y$88.904$KG$20240709$$MD$US$US
240764521$24076452$1$I$$20240628$20240711$20240711$EXP$$FR-NATCOUSA-2024-NATCOUSA-000215$NATCO PHARMA$Drevin G, Malbranque S, Jousset N, Ferec S, Zabet D, Baudriller A, Briet M, Abbara C. Pharmacobezoar-Related Fatalities: A Case Report and a Review of the Literature. Ther Drug Monit. 2024 Feb 1;46(1):1-5. doi: 10.1097/FTD.0000000000001150. Epub 2023 Nov 8. PMID: 37941108.$62$YR$$F$Y$$$20240711$$MD$FR$
240764531$24076453$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033461$AUROBINDO$Okura M, Sheikhan N, Thind GS.. First Case of Elizabethkingia Lung Infection Strikes Central Valley California. Am-J-Respir-Crit-Care-Med. 2024;209:A6009$24$YR$$F$Y$$$20240711$$HP$US$US
240764544$24076454$4$F$$20240806$20240711$20240807$30DAY$$US-JNJFOC-20240715765$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$PH$US$US
240764551$24076455$1$I$20240414$20240710$20240711$20240711$EXP$ES-AEMPS-1535351$ES-ROCHE-10000022411$ROCHE$$63$YR$A$F$Y$$$20240711$$MD$ES$ES
240764561$24076456$1$I$$20240703$20240711$20240711$EXP$$US-NOVITIUMPHARMA-2024USNVP01210$NOVITIUM PHARMA$F. J. Novoa.A Case of Symptomatic Hypercalcemia Secondary to Histoplasmosis.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;209:A6332 - A6332$57$YR$A$F$Y$$$20240711$$HP$US$US
240764571$24076457$1$I$20240219$20240704$20240711$20240711$EXP$FR-AFSSAPS-AN2024000874$FR-RDY-SPO/FRA/24/0009855$DR REDDYS$$15$YR$T$M$Y$38.1$KG$20240709$$MD$FR$FR
240764581$24076458$1$I$$20240708$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109536$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240711$$CN$US$US
240764591$24076459$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033558$AUROBINDO$Puri C, Khan AA, Sher N. Case of Emphysematous Gastritis With Septic Shock and Clostridioides Difficile. Am-J-Respir-Crit-Care-Med. 2024;209:A1630$72$YR$$F$Y$$$20240711$$HP$US$US
240764601$24076460$1$I$$20240703$20240711$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107960$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240711$$MD$JP$JP
240764611$24076461$1$I$$20240709$20240711$20240711$PER$$NVSC2024US142908$NOVARTIS$$65$YR$$F$Y$$$20240711$$HP$US$US
240764621$24076462$1$I$$20240703$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106414$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240711$$CN$US$US
240764631$24076463$1$I$$20240706$20240711$20240711$PER$$US-ROCHE-10000009341$ROCHE$Overman M, Gelsomino F, Aglietta M, Wong M, Miron M, Leonard G, et al. Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: The phase II CheckMate 142 study. Journal for ImmunoTherapy of Cancer. 2024;12 (5):1-8. doi:10.1136/jitc-2023-008689.$$$$$Y$$$20240711$$MD$US$US
240764641$24076464$1$I$$20240629$20240711$20240711$EXP$$US-RDY-LIT/USA/24/0009909$DR REDDYS$Abbas Z, Mahmood T, Bellman V, Koirala P, , Myers T. Relationship Between Pericallosal Lipoma and Neuropsychiatric Symptoms: A Case Report. Journal of Nervous and Mental Disease. 2023 Aug 01;211(8): 639-640. doi:10.1097/NMD.0000000000001633.$15$YR$T$M$Y$$$20240709$$HP$US$US
240764651$24076465$1$I$20231201$20240708$20240711$20240711$EXP$$NO-PFIZER INC-202400209583$PFIZER$$$$$F$Y$$$20240711$$CN$NO$NO
240764661$24076466$1$I$20230606$20240705$20240711$20240711$EXP$$CA-PFIZER INC-202300159808$PFIZER$$36$YR$$F$Y$$$20240711$$MD$CA$CA
240764671$24076467$1$I$$20240708$20240711$20240711$EXP$$CN-PFIZER INC-PV202400089567$PFIZER$$$$A$M$Y$$$20240711$$CN$CN$CN
240764681$24076468$1$I$20240617$20240708$20240711$20240711$EXP$$CA-PFIZER INC-202400209951$PFIZER$$65$YR$$M$Y$$$20240711$$CN$CA$CA
240764691$24076469$1$I$20240412$20240708$20240711$20240711$EXP$FR-AFSSAPS-LY2024000983$FR-PFIZER INC-202400208459$PFIZER$$83$YR$$M$Y$89.3$KG$20240711$$HP$FR$FR
240764701$24076470$1$I$$20240708$20240711$20240711$PER$$US-HALEON-2185958$Haleon PLC$$62$YR$$F$Y$$$20240711$$CN$US$US
240764711$24076471$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109691$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240711$$CN$US$US
240764721$24076472$1$I$20240703$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109626$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240711$$CN$US$US
240764731$24076473$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109857$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240711$$CN$US$US
240764742$24076474$2$F$$20240712$20240711$20240723$EXP$$DE-AUROBINDO-AUR-APL-2024-033234$AUROBINDO$Broecker S, Pragst F, Bakdash A, Herre S, Tsokos M. Combined use of liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) and high performance liquid chromatography with photodiode array detector (HPLC-DAD) in systematic toxicological analysis. Forensic Science International. 2011;215-226$69$YR$$M$Y$$$20240723$$HP$DE$DE
240764751$24076475$1$I$20240101$20240703$20240711$20240711$EXP$$BE-AUROBINDO-AUR-APL-2024-033242$AUROBINDO$$$$$M$Y$$$20240711$$PH$BE$BE
240764761$24076476$1$I$20240705$20240708$20240711$20240711$EXP$$CA-UCBSA-2024034883$UCB$$38$YR$$F$Y$$$20240711$$CN$CA$CA
240764771$24076477$1$I$20210811$20240701$20240711$20240711$30DAY$$US-GSK-US2021170376$GLAXOSMITHKLINE$$69$YR$$M$Y$$$20240711$$CN$US$US
240764792$24076479$2$F$$20240718$20240711$20240718$PER$$US-JNJFOC-20240725723$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$PH$US$US
240764801$24076480$1$I$$20240708$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109743$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240711$$CN$US$US
240764811$24076481$1$I$$20240701$20240711$20240711$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020035$UNITED THERAPEUTICS$Legro T, Mehta B, Patel P. Incidental finding of atrial myxoma following curative treatment for paediatric neuroblastoma. Cardiol Young. 2024;34(1):192-193$7$YR$$M$Y$$$20240711$$$US$US
240764824$24076482$4$F$$20240826$20240711$20240904$EXP$$DE-AUROBINDO-AUR-APL-2024-033314$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. Alpha-Pyrrolidinohexanophenone (alpha-PHP) vs. alpha-pyrrolidinoisohexanophenone (alpha-PiHP): A toxicological  investigation about plasma concentrations and behavior in  forensic routine cases. Journal of Analytical Toxicology. 2024;48:299?313$40$YR$$M$Y$$$20240904$$HP$DE$DE
240764831$24076483$1$I$$20240708$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA063456$SANDOZ$$65$YR$$F$Y$$$20240711$$MD$CA$CA
240764842$24076484$2$F$20240703$20240719$20240711$20240725$30DAY$$US-AMGEN-USASP2024134080$AMGEN$$$$$$Y$$$20240725$$PH$US$US
240764851$24076485$1$I$$20240702$20240711$20240711$PER$$US-AMGEN-USASP2024133585$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$25$YR$A$M$Y$$$20240710$$HP$US$US
240764863$24076486$3$F$20240704$20240903$20240711$20240904$EXP$$US-SANDOZ INC.-SDZ2024US064275$SANDOZ$$54$YR$$F$Y$$$20240904$$CN$US$US
240764872$24076487$2$F$$20240729$20240711$20240808$30DAY$$US-GSK-US2024084029$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
240764881$24076488$1$I$$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136729$AMGEN$$$$$F$Y$$$20240710$$CN$US$US
240764892$24076489$2$F$$20240708$20240711$20240712$EXP$$CN-SANDOZ INC.-SDZ2024CN063612$SANDOZ$Zhang Hongxia, Zou Fang, Wang Bu ,Li Maochen , Peng Xiaocui, Liu Jianhua ,Zhang Zhihua. Reports? Severe pneumonia caused by Trichosporon asahii: a report of 3 cases and a review of the literature. Chinese Journal of Mycology. 2024;19:161-172$60$YR$$M$Y$$$20240712$$MD$CN$CN
240764901$24076490$1$I$20240513$20240703$20240711$20240711$EXP$$DE-AUROBINDO-AUR-APL-2024-033237$AUROBINDO$$75$YR$$M$Y$65$KG$20240711$$MD$DE$DE
240764911$24076491$1$I$$20240709$20240711$20240711$PER$$US-GILEAD-2024-0680083$GILEAD$$$$A$M$Y$$$20240710$$CN$US$US
240764922$24076492$2$F$20240703$20240718$20240711$20240724$30DAY$$US-AMGEN-USASP2024134053$AMGEN$$69$YR$E$F$Y$58.8$KG$20240724$$PH$US$US
240764932$24076493$2$F$$20240829$20240711$20240907$EXP$$DE-AUROBINDO-AUR-APL-2024-033306$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Liane D. Paul. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$36$YR$$M$Y$$$20240907$$HP$DE$DE
240764941$24076494$1$I$20240513$20240708$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109710$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240711$$CN$US$US
240764952$24076495$2$F$$20240710$20240711$20240717$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024083215$VIIV$$$$$F$Y$$$20240717$$PH$US$US
240764961$24076496$1$I$20150101$20240710$20240711$20240711$EXP$DE-AMK-253746$DE-SANDOZ INC.-NVSC2021DE235062$SANDOZ$$73$YR$$F$Y$81.2$KG$20240711$$PH$DE$DE
240764973$24076497$3$F$$20240904$20240711$20240913$PER$$US-AstraZeneca-2024A157176$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
240764981$24076498$1$I$$20240708$20240711$20240711$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-029088$JAZZ$$$$$F$Y$$$20240710$$HP$US$US
240764991$24076499$1$I$$20240708$20240711$20240711$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-095576$REGENERON$$$$$M$Y$$$20240711$$CN$CA$CA
240765001$24076500$1$I$$20240707$20240711$20240711$EXP$$US-JNJFOC-20240718905$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$MD$US$US
240765012$24076501$2$F$20240517$20240712$20240711$20240723$EXP$$BR-CELLTRION INC.-2024BR016302$CELLTRION$$$$$$Y$$$20240723$$CN$BR$BR
240765021$24076502$1$I$$20240709$20240711$20240711$PER$$NVSC2024US142961$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240765031$24076503$1$I$$20240703$20240711$20240711$EXP$$CN-BEIGENE-BGN-2024-010433$BEIGENE$Gao Z, Jin L, Lv H, Duan N, Zhang G, Ran Y et al. Tislelizumab combined with sunitinib in the treatment of metastatic clear cell renal cell carcinoma with renal venous tumor thrombus: A case report and literature review. Elsevier. 2024;54:Epub ahead of print$$$$$Y$$$20240711$$MD$CN$CN
240765042$24076504$2$F$$20240717$20240711$20240722$PER$$US-ROCHE-10000017884$ROCHE$$77$YR$E$F$Y$$$20240719$$CN$US$US
240765051$24076505$1$I$$20240705$20240711$20240711$PER$$US-JNJFOC-20240716292$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240765062$24076506$2$F$$20240617$20240711$20240711$PER$$US-JNJFOC-20240645615$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240765073$24076507$3$F$$20240831$20240711$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-033516$AUROBINDO$Liane D. Paul, Brueckner I, Welter-Luedeke J, Zangl A, Graw M.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology.. 2024;48(5):299?313$44$YR$$M$Y$$$20240910$$HP$DE$DE
240765082$24076508$2$F$20240625$20240809$20240711$20240813$30DAY$$CA-JNJFOC-20240670799$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240813$$HP$CA$CA
240765092$24076509$2$F$$20240704$20240711$20240716$PER$$US-ROCHE-10000018341$ROCHE$$$$E$F$Y$$$20240716$$MD$US$US
240765101$24076510$1$I$20240612$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136771$AMGEN$$69$YR$E$F$Y$$$20240710$$CN$US$US
240765111$24076511$1$I$$20240626$20240711$20240711$EXP$$US-ROCHE-10000020193$ROCHE$$$$E$F$Y$$$20240711$$CN$US$US
240765122$24076512$2$F$$20240702$20240711$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455748$RANBAXY$Mignone D, Shah K, Alawneh B, Papadakos SP, Michelakis N. A RUDE AWAKENING: A CASE OF SUGAMMADEX CAUSING TRANSIENT CARDIOMYOPATHY MIMICKING STEMI. J Am Coll Cardiol. 2024;Apr; 83 (S.13):3618$43$YR$$M$Y$$$20240717$$HP$US$US
240765132$24076513$2$F$20240620$20240705$20240711$20240716$PER$$US-ROCHE-10000020606$ROCHE$$60$YR$A$F$Y$$$20240716$$CN$US$US
240765141$24076514$1$I$$20240707$20240711$20240711$EXP$$US-ABBVIE-5833657$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240765152$24076515$2$F$20240101$20240808$20240711$20240821$EXP$$US-UCBSA-2024034978$UCB$$$$$F$Y$$$20240821$$CN$US$US
240765162$24076516$2$F$$20240702$20240711$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455749$RANBAXY$Razia D, Moin A, Arjuna A, Evans S. VASCULOPATHY AND DEMYELINATING COMPLICATIONS OF VARICELLA IN AN IMMUNOCOMPROMISED PATIENT. Crit Care Med. 2024;52 (Suppl.) (1):S228;508$42$YR$$F$Y$$$20240717$$HP$US$US
240765181$24076518$1$I$$20240628$20240711$20240711$PER$$US-ROCHE-10000016288$ROCHE$$$$$$Y$$$20240711$$PH$US$US
240765191$24076519$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA197087$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240711$$MD$US$US
240765201$24076520$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA179906$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240711$$MD$US$US
240765211$24076521$1$I$20230101$20240703$20240711$20240711$PER$$US-SA-2024SA199467$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240711$$MD$US$US
240765221$24076522$1$I$20240601$20240702$20240711$20240711$PER$$US-SA-2024SA197743$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240711$$CN$US$US
240765232$24076523$2$F$20240101$20240703$20240711$20240713$PER$$US-SA-2024SA197256$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240713$$MD$US$US
240765242$24076524$2$F$20240101$20240911$20240711$20240917$PER$$US-SA-2024SA196524$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240918$$MD$US$US
240765251$24076525$1$I$20220501$20240702$20240711$20240711$PER$$US-SA-2024SA198248$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240711$$MD$US$US
240765262$24076526$2$F$20240620$20240717$20240711$20240722$EXP$$NVSJ2024JP008326$NOVARTIS$$80$YR$$M$Y$$$20240722$$MD$JP$JP
240765272$24076527$2$F$20240709$20240710$20240711$20240712$PER$$US-AMGEN-USASP2024136266$AMGEN$$75$YR$E$F$Y$$$20240712$$CN$US$US
240765281$24076528$1$I$$20240702$20240711$20240711$EXP$$US-KOANAAP-SML-US-2024-00695$Unknown Manufacturer$Singla A, Vashi M. Worsening Cavitary Lung Lesions in a Patient With Metastatic Colorectal Cancer on Stirvaga (Regorafenib). Am-J-Respir-Crit-Care-Med. 2024;209: A7478.$67$YR$E$M$Y$$$20240711$$MD$US$US
240765292$24076529$2$F$20180401$20240712$20240711$20240722$EXP$$ES-KOANAAP-SML-ES-2024-00715$Unknown Manufacturer$$78$YR$E$M$Y$$$20240722$$MD$ES$ES
240765301$24076530$1$I$$20240708$20240711$20240711$EXP$CA-LEO Pharma-371819$CA-LEO Pharma-371819$LEO PHARM$$19$YR$$M$Y$98$KG$20240711$$HP$CA$CA
240765311$24076531$1$I$$20240703$20240711$20240711$EXP$$TN-NOVITIUMPHARMA-2024TNNVP01194$NOVITIUM PHARMA$Aicha Ben Kahla.Cerebral venous thrombosis after first Methotrexate administration by lumbar puncture in a patient with large B cell lymphoma.La Tunisie Medicale.29-OCT-2023;101(7):648-650$24$YR$A$M$Y$$$20240711$$HP$TN$TN
240765321$24076532$1$I$$20240703$20240711$20240711$EXP$$CA-TOLMAR, INC.-24CA050790$TOLMAR$$$$$M$Y$$$20240711$$CN$CA$CA
240765333$24076533$3$F$20240703$20240826$20240711$20240903$PER$$CA-TOLMAR, INC.-24CA050788$TOLMAR$$73$YR$$M$Y$$$20240903$$CN$CA$CA
240765341$24076534$1$I$$20240703$20240711$20240711$EXP$$CA-TOLMAR, INC.-24CA050797$TOLMAR$$$$$M$Y$$$20240711$$CN$CA$CA
240765351$24076535$1$I$$20240703$20240711$20240711$EXP$$CA-TOLMAR, INC.-24CA050795$TOLMAR$$$$$M$Y$$$20240711$$PH$CA$CA
240765361$24076536$1$I$$20240703$20240711$20240711$EXP$$NL-TOLMAR, INC.-24NL050724$TOLMAR$$$$$M$Y$$$20240711$$CN$NL$NL
240765372$24076537$2$F$$20240718$20240711$20240722$EXP$$US-TOLMAR, INC.-24US050808$TOLMAR$$$$$$Y$$$20240722$$CN$US$US
240765381$24076538$1$I$$20240703$20240711$20240711$EXP$$FR-AUROBINDO-AUR-APL-2024-033317$AUROBINDO$$43$YR$$F$Y$$$20240711$$PH$FR$FR
240765394$24076539$4$F$20240517$20240716$20240711$20240723$EXP$$NVSC2024AT130588$NOVARTIS$$$$A$M$Y$$$20240723$$MD$AT$AT
240765411$24076541$1$I$20240601$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109665$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240711$$HP$US$US
240765421$24076542$1$I$20240703$20240703$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033253$AUROBINDO$$69$YR$$M$Y$83$KG$20240711$$PH$GB$GB
240765434$24076543$4$F$20240601$20240717$20240711$20240920$EXP$$AU-BEH-2024174536$CSL BEHRING$$74$YR$E$F$Y$54.96$KG$20240920$$HP$AU$AU
240765441$24076544$1$I$$20240709$20240711$20240711$PER$$NVSC2024US143155$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240765452$24076545$2$F$$20240813$20240711$20240829$PER$$US-AstraZeneca-2024A156838$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
240765461$24076546$1$I$$20240703$20240711$20240711$PER$$US-AstraZeneca-2024A153594$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240765473$24076547$3$F$20230101$20240724$20240711$20240801$EXP$$BR-CELLTRION INC.-2024BR016377$CELLTRION$$$$$$Y$$$20240801$$CN$BR$BR
240765481$24076548$1$I$20231007$20240703$20240711$20240711$EXP$$FR-AUROBINDO-AUR-APL-2024-033252$AUROBINDO$$87$YR$$M$Y$$$20240711$$PH$FR$FR
240765491$24076549$1$I$20240610$20240702$20240711$20240711$EXP$FR-AFSSAPS-BS2024000381$FR-TEVA-VS-3216419$TEVA$$45$YR$$F$Y$79$KG$20240711$$MD$FR$FR
240765502$24076550$2$F$20240601$20240726$20240711$20240808$PER$$US-SA-2024SA197914$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240808$$MD$US$US
240765511$24076551$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198172$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240711$$CN$US$US
240765521$24076552$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA198625$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240711$$MD$US$US
240765531$24076553$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA197853$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$MD$US$US
240765543$24076554$3$F$20220101$20240917$20240711$20240924$PER$$US-SA-2024SA198584$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240924$$MD$US$US
240765551$24076555$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198193$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240711$$MD$US$US
240765562$24076556$2$F$$20240729$20240711$20240807$PER$$US-SA-2024SA196261$SANOFI AVENTIS$$66$YR$E$M$Y$108$KG$20240807$$MD$US$US
240765571$24076557$1$I$20240601$20240705$20240711$20240711$PER$$US-SA-2024SA202331$SANOFI AVENTIS$$48$YR$A$F$Y$142$KG$20240711$$MD$US$US
240765581$24076558$1$I$20240101$20240628$20240711$20240711$PER$$US-SA-2024SA196338$SANOFI AVENTIS$$98$YR$E$M$Y$$$20240711$$MD$US$US
240765591$24076559$1$I$20240629$20240701$20240711$20240711$EXP$$US-VIIV HEALTHCARE LIMITED-US2024081534$VIIV$$34$YR$$M$Y$$$20240711$$CN$US$US
240765601$24076560$1$I$20240101$20240627$20240711$20240711$PER$$US-SA-2024SA194504$SANOFI AVENTIS$$$$A$M$Y$90.703$KG$20240711$$MD$US$US
240765611$24076561$1$I$$20240628$20240711$20240711$PER$$US-SA-2024SA196294$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240711$$MD$US$US
240765621$24076562$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA198535$SANOFI AVENTIS$$$$$$Y$$$20240711$$MD$US$US
240765631$24076563$1$I$20240601$20240701$20240711$20240711$PER$$US-SA-2024SA196268$SANOFI AVENTIS$$48$YR$A$F$Y$104.3$KG$20240711$$MD$US$US
240765641$24076564$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198290$SANOFI AVENTIS$$$$$F$Y$$$20240711$$MD$US$US
240765652$24076565$2$F$$20240717$20240711$20240724$PER$$US-SA-2024SA196230$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240725$$MD$US$US
240765661$24076566$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA198260$SANOFI AVENTIS$$40$YR$A$F$Y$77.098$KG$20240711$$MD$US$US
240765671$24076567$1$I$20240501$20240702$20240711$20240711$PER$$US-SA-2024SA197901$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240711$$MD$US$US
240765681$24076568$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA198375$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240711$$MD$US$US
240765691$24076569$1$I$$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024135936$AMGEN$$$$$$Y$$$20240710$$CN$US$US
240765701$24076570$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109013$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240711$$CN$US$US
240765711$24076571$1$I$20240501$20240702$20240711$20240711$EXP$$CO-JNJFOC-20240586424$JOHNSON AND JOHNSON$$77$YR$E$M$Y$75$KG$20240711$$HP$CO$CO
240765731$24076573$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143065$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240765743$24076574$3$F$$20240716$20240711$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039156$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$MD$US$US
240765751$24076575$1$I$$20240626$20240711$20240711$EXP$$US-ROCHE-10000012217$ROCHE$$73$YR$E$F$Y$68.04$KG$20240711$$CN$US$US
240765761$24076576$1$I$$20240710$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039119$BOEHRINGER INGELHEIM$$$$$$Y$$$20240711$$CN$US$US
240765771$24076577$1$I$20240101$20240706$20240711$20240711$EXP$$CA-UCBSA-2024032177$UCB$$$$$F$Y$$$20240711$$CN$CA$CA
240765782$24076578$2$F$20240701$20240729$20240711$20240731$PER$$US-AMGEN-USASP2024136967$AMGEN$$42$YR$A$F$Y$$$20240730$$PH$US$US
240765791$24076579$1$I$$20240704$20240711$20240711$EXP$$JP-ROCHE-10000000393$ROCHE$Fukushi K, Monna-Oiwa M, Kato S, Isobe M, Kuroda S, Nannya Y, et al. Influence of interruption of oral mycophenolate mofetil for graft-versus-host disease prophylaxis on outcomes after single cord blood transplantation. Blood cell therapy. 2024-Apr-19;7 (2):41-8. doi:10.31547/bct-2023-038.$$$$$Y$$$20240711$$HP$JP$JP
240765801$24076580$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14807$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765811$24076581$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14817$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765821$24076582$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14796$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA.. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765831$24076583$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14798$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765841$24076584$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14800$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA.. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765851$24076585$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14813$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765861$24076586$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14819$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765871$24076587$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14809$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765882$24076588$2$F$$20240704$20240711$20240718$EXP$$SE-ALKEM LABORATORIES LIMITED-SE-ALKEM-2024-14437$ALKEM$Ott M, Mannchen JK, Jamshidi F, Werneke U.. Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques. Therapeutic Advances in Psychopharmacology. 2019;9:1-32$73$YR$$F$Y$$$20240718$$HP$SE$SE
240765891$24076589$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14823$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765901$24076590$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14825$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765911$24076591$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14835$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765921$24076592$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109307$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240711$$HP$US$US
240765931$24076593$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14811$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA.. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765941$24076594$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14815$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765951$24076595$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14827$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA.. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765961$24076596$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14829$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA.. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765971$24076597$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14833$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765981$24076598$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14821$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA.. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240765991$24076599$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14831$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA.. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240766001$24076600$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14837$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA.. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240766011$24076601$1$I$$20240703$20240711$20240711$EXP$$CA-NOVITIUMPHARMA-2024CANVP01215$NOVITIUM PHARMA$A. S. Marwaha.Psyllium Husk (Metamucil) Induced Non-atopic Perennial Asthma: A Case Report.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;209:A5996$44$YR$A$F$Y$$$20240711$$HP$CA$CA
240766021$24076602$1$I$$20240627$20240711$20240711$EXP$$IN-ALKEM LABORATORIES LIMITED-CH-ALKEM-2024-14750$ALKEM$Swarnalata G, Shiradhonkar S, Jha R, Rao BS, Narayan G, Sinha S.. Acute cortical necrosis following renal transplantation in a case of sickle cell trait. Indian J. Nephrol. 2011;21(4):286-288$32$YR$$$Y$$$20240711$$HP$IN$IN
240766031$24076603$1$I$$20240627$20240711$20240711$EXP$$ES-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14755$ALKEM$Quintana LF, Cofan F, Reverte JC, Oppenheimer F, Campistol JM.. Renal cortical necrosis after kidney transplantation associated with the prothrombin 20210A mutation. Nephrol Dial Transplant. 2006;21(5):1455-1456$39$YR$$$Y$$$20240711$$HP$ES$ES
240766041$24076604$1$I$$20240627$20240711$20240711$EXP$$TR-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14757$ALKEM$Kocak B, Arpali E, Demiralp E, et al.,. Eculizumab for salvage treatment of refractory antibody-mediated rejection in kidney transplant patients: case reports. Proc. 2013;45(3):1022-1025$46$YR$$$Y$$$20240711$$HP$TR$TR
240766051$24076605$1$I$$20240627$20240711$20240711$EXP$$TR-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14759$ALKEM$Kocak B, Arpali E, Demiralp E, et al.,. Eculizumab for salvage treatment of refractory antibody-mediated rejection in kidney transplant patients: case reports. Proc. 2013;45(3):1022-1025$26$YR$$$Y$$$20240711$$HP$TR$TR
240766061$24076606$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14793$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240766071$24076607$1$I$$20240627$20240711$20240711$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-13772$ALKEM$Chen E, Ghannoum M, Elewski BE. Treatment-resistant tinea corporis, a potential public health issue. British Journal of Dermatology. 2021;184(1):164-165$45$YR$$M$Y$$$20240711$$HP$US$US
240766081$24076608$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14785$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240766091$24076609$1$I$$20240627$20240711$20240711$EXP$DE-BFARM-24004574$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14342$ALKEM$$$$$F$Y$$$20240711$$CN$DE$DE
240766102$24076610$2$F$$20240705$20240711$20240718$EXP$GB-MLMSERVICE-20240626-PI103883-00270-1$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14314$ALKEM$Gan YL, Bashir A, Sunni N.. The diversity of cardiac manifestations in rheumatological disorders: highlights on immunosuppression and cardiac complications. Heart. 2024;110(Suppl 3):A1-A297$30$YR$$F$Y$$$20240718$$HP$GB$GB
240766111$24076611$1$I$$20240627$20240711$20240711$EXP$DE-EMBRYOTOX-202301664-B$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14340$ALKEM$$$$$F$Y$3.41$KG$20240711$$MD$DE$DE
240766121$24076612$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14788$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240766131$24076613$1$I$$20240627$20240711$20240711$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-14790$ALKEM$Ramlakhan KP, Roos-Hesselink JW, Basso T, Greenslade J, Flint RB, Krieger EV, Shotan A, Budts W, De Backer J, Hall R, Johnson MR, Parsonage WA. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC). International Journal of Cardiology. 2024;410:132234$$$N$$Y$$$20240711$$HP$NL$NL
240766141$24076614$1$I$$20240708$20240711$20240711$EXP$$NVSC2024US141584$NOVARTIS$$$$$M$Y$$$20240711$$HP$US$US
240766151$24076615$1$I$20240422$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033800$AUROBINDO$$72$YR$$F$Y$78$KG$20240711$$PH$GB$GB
240766161$24076616$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA197989$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240711$$CN$US$US
240766171$24076617$1$I$$20240627$20240711$20240711$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14339$ALKEM$$$$$F$Y$$$20240711$$CN$DE$DE
240766181$24076618$1$I$$20240627$20240711$20240711$EXP$IT-MLMSERVICE-20240528-PI080629-00232-1$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-13434$ALKEM$Favi E, Cresseri D, Perego M, Ikehata M, Iesari S, Campise MR, Morello W, Testa S, Sioli V, Mattinzoli D, Longhi E, Del Gobbo A, Castellano G, Ferraresso M. Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20  obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept. Clinical Immunology. 2024;264:110240$50$YR$$M$Y$$$20240711$$MD$IT$IT
240766192$24076619$2$F$$20240705$20240711$20240718$EXP$US-MLMSERVICE-20240619-PI104961-00030-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14356$ALKEM$Postoll-Downs MA, Ozguc F, Vasudevan J, Stawinski PM, Wright R.. Breaking Patterns: A Case of Dieulafoy Lesion in a Young Patient Without Comorbid Conditions. Cureus. 2024;16(5):e60513$18$YR$$M$Y$$$20240718$$MD$US$US
240766202$24076620$2$F$$20240705$20240711$20240718$EXP$SI-MLMSERVICE-20240624-PI109519-00030-3$SI-ALKEM LABORATORIES LIMITED-SI-ALKEM-2024-14359$ALKEM$Trampuz BV. Electrolyte disorders in the emergency department clinical cases and emergency treatment. Urgentna Medicina - Izbrana Poglavja. 2024;Unk:142-146$$$$M$Y$$$20240718$$MD$SI$SI
240766211$24076621$1$I$20240625$20240627$20240711$20240711$EXP$GB-MHRA-TPP37044927C16176816YC1719306210825$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14341$ALKEM$$39$YR$$F$Y$$$20240711$$HP$GB$GB
240766221$24076622$1$I$$20240705$20240711$20240711$EXP$$JP-JNJFOC-20240727171$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240711$$PH$JP$JP
240766231$24076623$1$I$$20240709$20240711$20240711$PER$$US-JNJFOC-20240722530$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240766241$24076624$1$I$20240415$20240702$20240711$20240711$EXP$GB-MHRA-MED-202407021248095350-GNCRY$GB-TEVA-VS-3216641$TEVA$$77$YR$$M$Y$$$20240710$$CN$GB$GB
240766251$24076625$1$I$20240101$20240707$20240711$20240711$PER$$US-AMGEN-USASP2024134674$AMGEN$$66$YR$E$F$Y$$$20240710$$HP$US$US
240766262$24076626$2$F$$20240808$20240711$20240816$EXP$$US-VIIV HEALTHCARE LIMITED-US2024082213$VIIV$$$$$M$Y$$$20240816$$HP$US$US
240766271$24076627$1$I$20240101$20240628$20240711$20240711$PER$$US-SA-2024SA194537$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240711$$MD$US$US
240766282$24076628$2$F$20240101$20240802$20240711$20240816$PER$$US-SA-2024SA198523$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240816$$MD$US$US
240766291$24076629$1$I$20240701$20240702$20240711$20240711$PER$$US-SA-2024SA198579$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240711$$PH$US$US
240766302$24076630$2$F$$20240710$20240711$20240715$EXP$$US-JNJFOC-20240719596$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$MD$US$US
240766312$24076631$2$F$$20240808$20240711$20240813$PER$$US-JNJFOC-20240722765$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
240766321$24076632$1$I$$20240710$20240711$20240711$PER$$US-JNJFOC-20240725377$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$CN$US$US
240766331$24076633$1$I$$20240708$20240711$20240711$PER$$US-HALEON-2186386$Haleon PLC$$62$YR$$F$Y$$$20240711$$CN$US$US
240766341$24076634$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05792$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240766351$24076635$1$I$$20240709$20240711$20240711$PER$$NVSC2024US143168$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240766362$24076636$2$F$20240101$20240814$20240711$20240817$PER$$US-AMGEN-USASP2024136402$AMGEN$$70$YR$E$F$Y$$$20240817$$CN$US$US
240766371$24076637$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143164$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240766381$24076638$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA198014$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240711$$CN$US$US
240766391$24076639$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA201425$SANOFI AVENTIS$$$$$M$Y$$$20240711$$CN$US$US
240766401$24076640$1$I$$20240705$20240711$20240711$EXP$$NVSC2024US091359$NOVARTIS$$$$$F$Y$$$20240711$$CN$US$US
240766411$24076641$1$I$$20240706$20240711$20240711$EXP$$US-JNJFOC-20240721410$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240766421$24076642$1$I$20170101$20240705$20240711$20240711$EXP$GB-MHRA-MED-202405151454063910-JKLMF$GB-GSK-GB2024083614$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$GB$GB
240766431$24076643$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000022796$ROCHE$$61$YR$A$F$Y$$$20240711$$HP$US$US
240766443$24076644$3$F$20240501$20240826$20240711$20240830$EXP$$US-JNJFOC-20240721597$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240830$$HP$US$US
240766451$24076645$1$I$$20240701$20240711$20240711$EXP$$US-HALEON-2184824$Haleon PLC$$62$YR$$M$Y$$$20240709$$CN$US$US
240766461$24076646$1$I$20240627$20240627$20240711$20240711$PER$$US-Encube-000802$ENCUBE ETHICALS$$16$YR$T$F$Y$$$20240710$$CN$US$
240766471$24076647$1$I$20240704$20240705$20240711$20240711$PER$$US-SA-2023SA223704$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240711$$CN$US$US
240766481$24076648$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198077$SANOFI AVENTIS$$$$A$M$Y$$$20240711$$MD$US$US
240766491$24076649$1$I$$20240708$20240711$20240711$PER$$US-HALEON-2186063$Haleon PLC$$$$$$Y$$$20240711$$CN$US$US
240766502$24076650$2$F$$20240701$20240711$20240711$EXP$$US-ROCHE-10000015372$ROCHE$$64$YR$A$F$Y$$$20240711$$CN$US$US
240766512$24076651$2$F$20240706$20240715$20240711$20240717$PER$$US-AMGEN-USASP2024136750$AMGEN$$73$YR$E$F$Y$$$20240717$$CN$US$US
240766522$24076652$2$F$20240610$20240715$20240711$20240719$EXP$$AU-TAKEDA-2024TUS069489$TAKEDA$$81$YR$$M$Y$$$20240719$$HP$AU$AU
240766533$24076653$3$F$20240101$20240911$20240711$20240919$PER$$US-AMGEN-USASP2024136695$AMGEN$$37$YR$A$F$Y$$$20240918$$HP$US$US
240766541$24076654$1$I$20240617$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024137259$AMGEN$$$$A$F$Y$$$20240711$$CN$US$US
240766551$24076655$1$I$$20240702$20240711$20240711$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR084921$VIIV$$$$$$Y$$$20240711$$HP$US$US
240766561$24076656$1$I$$20240704$20240711$20240711$PER$$US-LEO Pharma-371826$LEO PHARM$$$$$M$Y$$$20240711$$CN$US$US
240766571$24076657$1$I$$20240628$20240711$20240711$EXP$$US-ROCHE-10000020469$ROCHE$$63$YR$A$F$Y$$$20240711$$CN$US$US
240766581$24076658$1$I$20210101$20240702$20240711$20240711$EXP$$US-UNITED THERAPEUTICS-UNT-2021-001421$UNITED THERAPEUTICS$$65$YR$$F$Y$$$20240711$$$US$US
240766591$24076659$1$I$$20240701$20240711$20240711$EXP$$US-APOTEX-2024AP007908$APOTEX$$$$A$M$Y$$$20240711$$HP$US$US
240766611$24076661$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109755$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240711$$HP$US$US
240766621$24076662$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109439$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240711$$CN$US$US
240766641$24076664$1$I$20240704$20240709$20240711$20240711$PER$$US-AMGEN-USASL2024135952$AMGEN$$89$YR$E$F$Y$$$20240711$$CN$US$US
240766651$24076665$1$I$$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136617$AMGEN$$$$$$Y$$$20240711$$MD$US$US
240766671$24076667$1$I$20240428$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033355$AUROBINDO$$78$YR$$$Y$$$20240711$$PH$GB$GB
240766681$24076668$1$I$$20240702$20240711$20240711$EXP$$US-RIGEL-20240700014$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240766692$24076669$2$F$20240702$20240709$20240711$20240716$EXP$$JP-RIGEL-20240700020$RIGEL PHARMACEUTICALS$$77$YR$$F$Y$37.8$KG$20240716$$MD$JP$JP
240766701$24076670$1$I$$20240709$20240711$20240711$EXP$$JP-TAKEDA-2024TJP008029$TAKEDA$$52$YR$$M$Y$$$20240711$$PH$JP$JP
240766711$24076671$1$I$$20240702$20240711$20240711$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700029$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240766721$24076672$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135599$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240766731$24076673$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198692$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240711$$MD$US$US
240766741$24076674$1$I$$20240702$20240711$20240711$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700024$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
240766751$24076675$1$I$20240101$20240702$20240711$20240711$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700030$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240766761$24076676$1$I$20240619$20240703$20240711$20240711$EXP$$FR-AUROBINDO-AUR-APL-2024-033267$AUROBINDO$$68$YR$$F$Y$57.4$KG$20240711$$PH$FR$FR
240766781$24076678$1$I$$20240703$20240711$20240711$PER$$US-ROCHE-3565776$ROCHE$$77$YR$E$F$Y$$$20240711$$CN$US$US
240766793$24076679$3$F$$20240812$20240711$20240815$PER$$US-ROCHE-10000017417$ROCHE$$$$$$Y$$$20240815$$HP$US$US
240766801$24076680$1$I$20230910$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033611$AUROBINDO$$$$$F$Y$$$20240711$$PH$GB$GB
240766811$24076681$1$I$20240324$20240703$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033103$AUROBINDO$$71$YR$$F$Y$$$20240711$$HP$GB$GB
240766821$24076682$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008068$STRIDES$Devine MN, Gordon SE, Press CA.. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series.. J-Pediatr-Pharmacol-Ther. 2023;28(2):161-166$52$DY$$$Y$$$20240711$$HP$US$US
240766831$24076683$1$I$$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033447$AUROBINDO$$$$$F$Y$$$20240711$$HP$GB$GB
240766841$24076684$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153160$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240766851$24076685$1$I$$20240703$20240711$20240711$EXP$$ZA-AstraZeneca-2024A154423$ASTRAZENECA$$10957$DY$$F$Y$$$20240711$$CN$ZA$
240766861$24076686$1$I$20240705$20240705$20240711$20240711$PER$$US-SA-2024SA201454$SANOFI AVENTIS$$59$YR$A$M$Y$95.25$KG$20240711$$CN$US$US
240766871$24076687$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA199674$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240711$$MD$US$US
240766881$24076688$1$I$20220101$20240703$20240711$20240711$EXP$$DE-AUROBINDO-AUR-APL-2024-033283$AUROBINDO$Alexander Witt J, Moskau-Hartmann S, Olaciregui Dague K, Surges R + Helmstaedter C. Severe memory decline along with unaffected executive functions under 400 mg/day of cenobamate leading to a collapse in school performance. Neurocase: Behavior, Cognition and Neuroscience- Taylor and Francis. 2024;30:1-6$18$YR$$M$Y$$$20240711$$HP$DE$DE
240766901$24076690$1$I$20240601$20240628$20240711$20240711$PER$$US-SA-2024SA196502$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240711$$MD$US$US
240766911$24076691$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA199626$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240711$$MD$US$US
240766922$24076692$2$F$20240425$20240708$20240711$20240722$EXP$$GB-SA-2024SA202107$SANOFI AVENTIS$$69$YR$E$F$Y$50$KG$20240722$$HP$GB$GB
240766931$24076693$1$I$$20240628$20240711$20240711$PER$$US-SA-2024SA196463$SANOFI AVENTIS$$$$A$$Y$$$20240711$$HP$US$US
240766951$24076695$1$I$20240301$20240703$20240711$20240711$EXP$$FR-AUROBINDO-AUR-APL-2024-033262$AUROBINDO$$57$YR$$F$Y$$$20240711$$MD$FR$FR
240766961$24076696$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000022245$ROCHE$$41$YR$A$F$Y$$$20240711$$HP$US$US
240766981$24076698$1$I$20240101$20240708$20240711$20240711$PER$$US-SA-2024SA202524$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240711$$MD$US$US
240766991$24076699$1$I$$20240702$20240711$20240711$EXP$CN-MLMSERVICE-20240625-PI111522-00097-1$CN-STRIDES ARCOLAB LIMITED-2024SP008261$STRIDES$Wu J, Hu Y.. A late-onset hyperammonemia syndrome caused by Ureaplasma parvum infection after kidney transplantation.. Heliyon. 2024;10(11):e32134$64$YR$$M$Y$$$20240711$$MD$CN$CN
240767002$24076700$2$F$20240706$20240722$20240711$20240725$PER$$US-AMGEN-USASP2024136076$AMGEN$$57$YR$A$F$Y$$$20240725$$CN$US$US
240767012$24076701$2$F$20240708$20240711$20240711$20240715$PER$$US-AMGEN-USASP2024135372$AMGEN$$63$YR$A$F$Y$$$20240715$$CN$US$US
240767023$24076702$3$F$20240101$20240715$20240711$20240722$PER$$US-BIOGEN-2024BI01272242$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
240767031$24076703$1$I$$20240705$20240711$20240711$PER$$US-BIOGEN-2024BI01272611$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240767041$24076704$1$I$20240704$20240704$20240711$20240711$EXP$$JP-VANTIVE-2024VAN018159$Vantive US Healthcare$$8$DEC$$M$Y$$$20240711$$MD$JP$JP
240767051$24076705$1$I$20240704$20240704$20240711$20240711$EXP$$JP-VANTIVE-2024VAN018158$Vantive US Healthcare$$6$DEC$$M$Y$$$20240711$$MD$JP$JP
240767061$24076706$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA201409$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240711$$MD$US$US
240767072$24076707$2$F$20240101$20240814$20240711$20240828$PER$$US-SA-2024SA195798$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240828$$MD$US$US
240767081$24076708$1$I$20240701$20240703$20240711$20240711$PER$$US-SA-2024SA198371$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240711$$CN$US$US
240767091$24076709$1$I$$20240613$20240711$20240711$PER$$US-BEIGENE-BGN-2024-009228$BEIGENE$$$$$$Y$$$20240711$$PH$US$US
240767103$24076710$3$F$$20240809$20240711$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-033481$AUROBINDO$Liane D. Paul, Brueckner I, Welter-Luedeke J, Zangl A, Graw M.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$39$YR$$F$Y$$$20240821$$HP$DE$DE
240767111$24076711$1$I$20240124$20240703$20240711$20240711$EXP$FR-AFSSAPS-AVMA2024000257$FR-TEVA-VS-3216923$TEVA$$45$YR$$F$Y$$$20240711$$PH$FR$FR
240767121$24076712$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008075$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$24$YR$$M$Y$$$20240711$$HP$US$US
240767131$24076713$1$I$$20240706$20240711$20240711$PER$$US-JNJFOC-20240718367$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$HP$US$US
240767141$24076714$1$I$$20240626$20240711$20240711$PER$$US-ROCHE-10000011961$ROCHE$$$$$$Y$$$20240711$$CN$US$US
240767151$24076715$1$I$20240624$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024131948$AMGEN$$66$YR$E$F$Y$$$20240711$$CN$US$US
240767161$24076716$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008076$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$61$YR$$M$Y$$$20240711$$HP$US$US
240767171$24076717$1$I$$20240705$20240711$20240711$EXP$GB-MHRA-MED-202407031106237230-CRTDW$GB-STRIDES ARCOLAB LIMITED-2024SP008165$STRIDES$$$$$F$Y$$$20240711$$HP$GB$GB
240767181$24076718$1$I$20240528$20240708$20240711$20240711$EXP$GB-MHRA-MED-202406251912063080-PNHML$GB-STRIDES ARCOLAB LIMITED-2024SP008199$STRIDES$$$$$M$Y$90$KG$20240711$$CN$GB$GB
240767191$24076719$1$I$20240619$20240704$20240711$20240711$EXP$$DE-AMGEN-USASP2024134254$AMGEN$$17$YR$T$F$Y$62.993$KG$20240711$$MD$DE$DE
240767211$24076721$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136462$AMGEN$$$$$$Y$$$20240711$$MD$US$US
240767222$24076722$2$F$20231101$20240730$20240711$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-033381$AUROBINDO$$78$YR$$F$Y$$$20240812$$MD$FR$FR
240767231$24076723$1$I$$20240709$20240711$20240711$PER$$NVSC2024US143188$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240767241$24076724$1$I$20240501$20240705$20240711$20240711$EXP$GB-MHRA-MED-202405171114400390-TPNYF$GB-CHATTEMPRD-2024OHG023397$CHATTEM$$$$$F$Y$$$20240711$$CN$GB$GB
240767252$24076725$2$F$$20240629$20240711$20240718$EXP$$TH-ROCHE-10000015244$ROCHE$$70$YR$E$F$Y$$$20240718$$CN$TH$TH
240767261$24076726$1$I$20240614$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109698$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240711$$PH$US$US
240767271$24076727$1$I$20240628$20240701$20240711$20240711$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000171$DENDREON$$$$$$Y$$$20240711$$CN$US$US
240767281$24076728$1$I$20240201$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033482$AUROBINDO$$59$YR$$M$Y$90$KG$20240711$$CN$GB$GB
240767292$24076729$2$F$20240617$20240703$20240711$20240910$EXP$$US-VANTIVE-2024VAN018144$Vantive US Healthcare$$$$$$Y$$$20240910$$HP$US$US
240767301$24076730$1$I$20240513$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033624$AUROBINDO$$45$YR$$F$Y$91$KG$20240711$$CN$GB$GB
240767311$24076731$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143190$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240767321$24076732$1$I$$20240704$20240711$20240711$EXP$$CA-APOTEX-2024AP007978$APOTEX$$$$A$F$Y$$$20240711$$HP$CA$CA
240767331$24076733$1$I$20240703$20240703$20240711$20240711$PER$$US-AstraZeneca-2024A153906$ASTRAZENECA$$17918$DY$$F$Y$$$20240711$$HP$US$
240767351$24076735$1$I$20240507$20240705$20240711$20240711$EXP$GB-MHRA-MED-202405111000550060-MSRDP$GB-CHATTEMPRD-2024OHG023377$CHATTEM$$40$YR$A$M$Y$$$20240711$$CN$GB$GB
240767361$24076736$1$I$20240112$20240704$20240711$20240711$EXP$$FR-AUROBINDO-AUR-APL-2024-033459$AUROBINDO$$78$YR$$F$Y$$$20240711$$PH$FR$FR
240767374$24076737$4$F$20240708$20240709$20240711$20240823$PER$$US-JNJFOC-20240719815$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240823$$CN$US$US
240767382$24076738$2$F$$20240716$20240711$20240725$EXP$$GB-AUROBINDO-AUR-APL-2024-033807$AUROBINDO$$$$$$Y$$$20240725$$MD$GB$GB
240767392$24076739$2$F$20240101$20240708$20240711$20240715$PER$$US-AMGEN-USASP2024135371$AMGEN$$79$YR$E$M$Y$$$20240715$$CN$US$US
240767401$24076740$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136467$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240767411$24076741$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008125$STRIDES$Fan J, Thanedar S, Ovechko V, Jana B.. Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers.. Case-Rep-Oncol. 2024;17(1):517-523$$$$$Y$$$20240711$$HP$US$US
240767422$24076742$2$F$$20240716$20240711$20240718$PER$$US-AMGEN-USASP2024135685$AMGEN$$$$$F$Y$$$20240718$$HP$US$US
240767431$24076743$1$I$$20240709$20240711$20240711$PER$$NVSC2024US142901$NOVARTIS$$$$$$Y$$$20240711$$MD$US$US
240767441$24076744$1$I$20240423$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033315$AUROBINDO$$64$YR$$M$Y$$$20240711$$MD$GB$GB
240767451$24076745$1$I$20230321$20240701$20240711$20240711$EXP$$CN-BEIGENE-BGN-2024-010164$BEIGENE$Li X; Mo Z; Yu Z. Comprehensive treatment of von Hippel?Lindau disease: A case report. Cancer Innovation. 2024;3(2):e94$$$$$Y$$$20240711$$MD$CN$CN
240767462$24076746$2$F$20240624$20240807$20240711$20240812$EXP$$JP-TAKEDA-2024TJP010329$TAKEDA$$54$YR$$F$Y$$$20240812$$MD$JP$JP
240767473$24076747$3$F$$20240731$20240711$20240806$PER$$US-LEO Pharma-371859$LEO PHARM$$38$YR$$M$Y$$$20240806$$CN$US$US
240767491$24076749$1$I$20240623$20240705$20240711$20240711$EXP$$US-ROCHE-10000019189$ROCHE$$48$YR$A$$Y$$$20240711$$HP$US$US
240767502$24076750$2$F$$20240808$20240711$20240813$PER$$US-JNJFOC-20240725207$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
240767511$24076751$1$I$$20240703$20240711$20240711$EXP$$BR-JNJFOC-20240714705$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240711$$CN$BR$BR
240767521$24076752$1$I$20240621$20240703$20240711$20240711$EXP$$TW-JNJFOC-20240711276$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240711$$CN$TW$TW
240767531$24076753$1$I$20240626$20240704$20240711$20240711$EXP$$IT-AUROBINDO-AUR-APL-2024-033323$AUROBINDO$$74$YR$$F$Y$$$20240711$$PH$IT$IT
240767543$24076754$3$F$20240101$20240916$20240711$20240924$EXP$$CA-CELLTRION INC.-2024CA016712$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
240767551$24076755$1$I$$20240705$20240711$20240711$30DAY$$US-GSK-US2024AMR084118$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240767561$24076756$1$I$20230901$20240703$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107221$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$87.23$KG$20240711$$PH$US$US
240767572$24076757$2$F$20240708$20240715$20240711$20240723$EXP$$US-JNJFOC-20240722398$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240724$$MD$US$US
240767581$24076758$1$I$20240623$20240628$20240711$20240711$EXP$$US-RECORDATI RARE DISEASE INC.-2024004976$RECORDATI$$$$$$Y$$$20240711$$CN$US$US
240767591$24076759$1$I$$20240703$20240711$20240711$EXP$FR-AFSSAPS-AVNT2024000423$FR-TEVA-VS-3217243$TEVA$$48$YR$$M$Y$$$20240711$$PH$FR$FR
240767601$24076760$1$I$$20240703$20240711$20240711$EXP$$IE-CELLTRION INC.-2024IE016510$CELLTRION$$$$$$Y$$$20240711$$MD$IE$IE
240767611$24076761$1$I$20230911$20240701$20240711$20240711$EXP$FR-AFSSAPS-TS2023001217$FR-TEVA-202310_00014549$TEVA$$65$YR$$M$Y$67$KG$20240711$$MD$FR$FR
240767624$24076762$4$F$20240703$20240718$20240711$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019582$UNITED THERAPEUTICS$$65$YR$$M$Y$78.912$KG$20240726$$$US$US
240767641$24076764$1$I$20171213$20190211$20240711$20240711$EXP$$IT-TEVA-VS-3217884$TEVA$$33$YR$$F$Y$$$20240711$$PH$IT$IT
240767651$24076765$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06238$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240767661$24076766$1$I$20240601$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109949$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240711$$HP$US$US
240767671$24076767$1$I$20240101$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108565$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240711$$CN$US$US
240767683$24076768$3$F$$20240808$20240711$20240813$PER$$US-JNJFOC-20240725245$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
240767703$24076770$3$F$20240101$20240808$20240711$20240821$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00643$CATALYST PHARMA$$$$$M$Y$87.528$KG$20240821$$CN$US$US
240767711$24076771$1$I$$20240708$20240711$20240711$PER$$US-BIOVITRUM-2024-US-009413$BIOVITRUM$$57$YR$$F$Y$$$20240711$$CN$US$US
240767733$24076773$3$F$20240709$20240812$20240711$20240814$PER$$US-BIOVITRUM-2024-US-009703$BIOVITRUM$$77$YR$$M$Y$$$20240814$$CN$US$US
240767741$24076774$1$I$$20240709$20240711$20240711$PER$$US-BIOVITRUM-2024-US-009722$BIOVITRUM$$60$YR$$M$Y$$$20240711$$CN$US$US
240767751$24076775$1$I$$20240708$20240711$20240711$PER$$US-ROCHE-10000021090$ROCHE$$56$YR$A$F$Y$$$20240711$$MD$US$US
240767761$24076776$1$I$$20240709$20240711$20240711$30DAY$$US-GSK-US2024084994$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240767771$24076777$1$I$20230118$20240703$20240711$20240711$EXP$$FR-CELLTRION INC.-2024FR016416$CELLTRION$$$$$$Y$$$20240711$$MD$FR$FR
240767782$24076778$2$F$$20240808$20240711$20240812$EXP$$US-ROCHE-10000022901$ROCHE$$36$YR$A$F$Y$$$20240812$$CN$US$US
240767791$24076779$1$I$20230303$20240107$20240711$20240711$EXP$GB-MHRA-MED-202401060646333030-KTLFZ$GB-TEVA-VS-3145855$TEVA$$$$$F$Y$$$20240711$$CN$GB$GB
240767801$24076780$1$I$$20240703$20240711$20240711$EXP$$JP-EMD Serono-2024037316$EMD SERONO INC$$$$$$Y$$$20240711$$MD$JP$JP
240767811$24076781$1$I$$20240702$20240711$20240711$EXP$$CA-EMD Serono-2024005406$EMD SERONO INC$$$$A$F$Y$$$20240711$$CN$CA$CA
240767821$24076782$1$I$$20240703$20240711$20240711$EXP$$JP-EMD Serono-2024037132$EMD SERONO INC$$$$$$Y$$$20240711$$MD$JP$JP
240767831$24076783$1$I$$20240701$20240711$20240711$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004913$BIOCON$$$$$$Y$$$20240711$$HP$CA$CA
240767841$24076784$1$I$20240704$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136280$AMGEN$$77$YR$E$F$Y$$$20240711$$CN$US$US
240767851$24076785$1$I$20240601$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135563$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240767862$24076786$2$F$20240101$20240805$20240711$20240810$EXP$$US-SA-2024SA200513$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240810$$MD$US$US
240767871$24076787$1$I$20240601$20240702$20240711$20240711$PER$$US-TEVA-VS-3217363$TEVA$$67$YR$$F$Y$$$20240711$$CN$US$US
240767881$24076788$1$I$$20240709$20240711$20240711$EXP$$CL-ROCHE-10000022804$ROCHE$$$$A$F$Y$$$20240711$$CN$CL$CL
240767891$24076789$1$I$20240625$20240705$20240711$20240711$EXP$$JP-ROCHE-10000022421$ROCHE$$7$DEC$E$$Y$$$20240711$$MD$JP$JP
240767902$24076790$2$F$20240321$20240709$20240711$20240712$PER$$NVSC2024US142900$NOVARTIS$$$$$F$Y$$$20240712$$HP$US$US
240767911$24076791$1$I$$20240702$20240711$20240711$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR084557$VIIV$$$$$$Y$$$20240711$$HP$US$US
240767921$24076792$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143234$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240767933$24076793$3$F$$20240814$20240711$20240820$EXP$$US-TAKEDA-2024TUS057481$TAKEDA$$$$$M$Y$$$20240820$$CN$US$US
240767941$24076794$1$I$20240323$20240708$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108944$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240711$$CN$US$US
240767951$24076795$1$I$$20240709$20240711$20240711$PER$$US-GILEAD-2024-0680086$GILEAD$$$$$F$Y$$$20240711$$HP$US$US
240767971$24076797$1$I$20240523$20240704$20240711$20240711$EXP$$DE-AMGEN-DEUSP2024136079$AMGEN$$34$YR$A$F$Y$$$20240711$$MD$DE$DE
240767981$24076798$1$I$$20240709$20240711$20240711$PER$$US-BIOVITRUM-2024-US-009680$BIOVITRUM$$77$YR$$M$Y$$$20240711$$CN$US$US
240767991$24076799$1$I$20240613$20240709$20240711$20240711$PER$$US-JNJFOC-20240722791$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240768001$24076800$1$I$$20240630$20240711$20240711$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-06090$HIKMA$Sharma NR, Basnet A, Lamichhane S, Tiwari K, Varghese J, Gautam S, et al.. Sharma NR, Basnet A, Lamichhane S, Tiwari K, Varghese J, Gautam S, et al. Sphincter of oddi dysfunction induced by ketamine: A case report.. Clin. Case Rep. 2024;12(6):1-4$29$YR$$F$Y$$$20240711$$MD$US$US
240768031$24076803$1$I$$20240627$20240711$20240711$EXP$$DE-INFO-20240193$INFORLIFE$Zugaj MR, Gutzeit O, Mayer VL, Ishak B, Gumbinger C, Weigand MA, et al. Incomplete sensorimotor paresis after upper abdominal surgery with TEA and spinal epidural lipomatosis: a case report. Regional Anesthesia and Pain Medicine. 2024;49(6):465-8. DOI: 10.1136/rapm-2024-105342.$60$YR$A$F$Y$$$20240628$$MD$DE$
240768041$24076804$1$I$20240622$20240703$20240711$20240711$EXP$$IN-AstraZeneca-2024A153069$ASTRAZENECA$$21938$DY$$F$Y$$$20240711$$CN$IN$
240768051$24076805$1$I$20230101$20240710$20240711$20240711$EXP$ES-EMA-DD-20240704-7482665-115009$ES-SANDOZ INC.-SDZ2024ES064124$SANDOZ$$72$YR$$F$Y$94$KG$20240711$$CN$ES$ES
240768062$24076806$2$F$20240611$20240718$20240711$20240726$EXP$$PT-AstraZeneca-2024A151801$ASTRAZENECA$$48$YR$$F$Y$78$KG$20240726$$MD$PT$
240768071$24076807$1$I$$20240702$20240711$20240711$EXP$$US-TAKEDA-2023TUS087691$TAKEDA$$$$$M$Y$$$20240711$$CN$US$US
240768081$24076808$1$I$$20240708$20240711$20240711$PER$$US-ABBVIE-5833336$ABBVIE$$$$$$Y$$$20240711$$CN$US$US
240768101$24076810$1$I$20240624$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135378$AMGEN$$74$YR$E$F$Y$$$20240711$$CN$US$US
240768111$24076811$1$I$$20240702$20240711$20240711$EXP$$US-GSK-US2024AMR083370$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$US$US
240768121$24076812$1$I$20240101$20240710$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039118$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240711$$CN$US$US
240768132$24076813$2$F$20240629$20240703$20240711$20240718$EXP$$JP-ALXN-202407JPN000167JP$ALEXION PHARMACEUTICALS$$61$YR$$F$Y$$$20240718$$MD$JP$JP
240768143$24076814$3$F$$20240812$20240711$20240812$PER$$US-ALXN-202407USA000508US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$PH$US$US
240768151$24076815$1$I$$20240702$20240711$20240711$PER$$US-RDY-SPO/USA/24/0009774$DR REDDYS$$$$$F$Y$$$20240711$$MD$US$US
240768162$24076816$2$F$$20240809$20240711$20240820$PER$$US-RDY-SPO/USA/24/0009775$DR REDDYS$$19$YR$A$M$Y$$$20240820$$MD$US$US
240768171$24076817$1$I$$20240628$20240711$20240711$EXP$$IT-ROCHE-10000022036$ROCHE$$40$YR$A$F$Y$$$20240711$$MD$IT$IT
240768182$24076818$2$F$$20240920$20240711$20240920$PER$$NVSC2024US142915$NOVARTIS$$$$$F$Y$$$20240920$$MD$US$US
240768191$24076819$1$I$$20240709$20240711$20240711$EXP$$US-ABBVIE-5757771$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240768201$24076820$1$I$$20240710$20240711$20240711$PER$$US-JNJFOC-20240726786$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240768211$24076821$1$I$20240701$20240701$20240711$20240711$PER$$US-JNJFOC-20240720058$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240711$$CN$US$US
240768221$24076822$1$I$20240603$20240705$20240711$20240711$EXP$$BR-JNJFOC-20240719812$JOHNSON AND JOHNSON$$17$YR$T$F$Y$59$KG$20240711$$CN$BR$BR
240768231$24076823$1$I$$20240701$20240711$20240711$PER$$US-IGSA-BIG0029705$GRIFOLS$Fleshman, Taylor. Subacute Cutaneous Lupus Erythematosus Secondary to Intravenous Immunoglobulin Infusions. Cureus. 2024;16:6$50$YR$$M$Y$$$20240711$$MD$US$US
240768241$24076824$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143232$NOVARTIS$$$$$$Y$$$20240711$$MD$US$US
240768251$24076825$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143238$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240768262$24076826$2$F$20240801$20240816$20240711$20240823$EXP$$BR-JNJFOC-20240714630$JOHNSON AND JOHNSON$$9$YR$C$M$Y$24$KG$20240823$$MD$BR$BR
240768271$24076827$1$I$$20240704$20240711$20240711$EXP$$JP-ROCHE-10000022100$ROCHE$$$$E$M$Y$$$20240711$$MD$JP$JP
240768291$24076829$1$I$$20240708$20240711$20240711$EXP$$JP-TAKEDA-2024TJP010267$TAKEDA$$$$$F$Y$$$20240711$$MD$JP$JP
240768301$24076830$1$I$$20240703$20240711$20240711$EXP$$JP-EMD Serono-2024037272$EMD SERONO INC$$$$$$Y$$$20240711$$MD$JP$JP
240768311$24076831$1$I$$20240703$20240711$20240711$EXP$$JP-EMD Serono-2024037352$EMD SERONO INC$$$$$$Y$$$20240711$$MD$JP$JP
240768322$24076832$2$F$$20240731$20240711$20240807$PER$$US-HETERO-HET2024US02146$HETERO$$$$$$Y$$$20240807$$CN$US$US
240768332$24076833$2$F$20230301$20240812$20240711$20240821$EXP$FR-AFSSAPS-AVCN2024000470$FR-TEVA-VS-3216703$TEVA$$42$YR$$M$Y$$$20240821$$MD$FR$FR
240768341$24076834$1$I$20230501$20240709$20240711$20240711$EXP$NO-NOMAADVRE-PASRAPP-2024-Vk8x9z$NO-ORGANON-O2407NOR000860$ORGANON$$44$YR$$M$Y$86$KG$20240711$$CN$NO$NO
240768351$24076835$1$I$$20240705$20240711$20240711$EXP$$ES-JNJFOC-20230956979$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240711$$CN$ES$ES
240768361$24076836$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143059$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240768383$24076838$3$F$20240627$20240904$20240711$20240908$EXP$$US-ABBVIE-5833134$ABBVIE$$61$YR$$M$Y$$$20240908$$CN$US$US
240768391$24076839$1$I$20240101$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136730$AMGEN$$58$YR$A$F$Y$$$20240711$$CN$US$US
240768401$24076840$1$I$20240525$20240702$20240711$20240711$EXP$$CO-VANTIVE-2024VAN017426$Vantive US Healthcare$$79$YR$$M$Y$55$KG$20240711$$HP$CO$CO
240768411$24076841$1$I$20240601$20240709$20240711$20240711$EXP$$US-UCBSA-2024034991$UCB$$32$YR$$F$Y$$$20240711$$HP$US$US
240768421$24076842$1$I$$20240612$20240711$20240711$30DAY$$SI-UCBSA-2024030875$UCB$$$$$M$Y$$$20240711$$CN$SI$SI
240768432$24076843$2$F$$20240814$20240711$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06236$LUPIN$$$$$$Y$$$20240901$$CN$US$US
240768441$24076844$1$I$20230113$20240702$20240711$20240711$EXP$$FR-CELLTRION INC.-2024FR016262$CELLTRION$$$$$$Y$$$20240711$$MD$FR$FR
240768452$24076845$2$F$$20240710$20240711$20240720$EXP$$AT-AMGEN-AUTSP2024134681$AMGEN$$42$YR$A$F$Y$$$20240720$$PH$AT$AT
240768461$24076846$1$I$20240601$20240703$20240711$20240711$EXP$IT-MINISAL02-991530$IT-TEVA-VS-3217172$TEVA$$92$YR$$M$Y$60$KG$20240711$$MD$IT$IT
240768471$24076847$1$I$20240101$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136763$AMGEN$$76$YR$E$F$Y$$$20240711$$CN$US$US
240768483$24076848$3$F$20240701$20240924$20240711$20240926$PER$$US-AMGEN-USASP2024136686$AMGEN$$79$YR$E$F$Y$$$20240926$$CN$US$US
240768492$24076849$2$F$20240708$20240715$20240711$20240718$PER$$US-AMGEN-USASP2024137034$AMGEN$$81$YR$E$F$Y$$$20240718$$CN$US$US
240768502$24076850$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3217821$TEVA$Gupta UD, Chowdhury T, Niriyan J, Bellamkonda A, Aryal B, Al-Ghuraibawi M. Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Gupta UD, Chowdhury T, Niriyan J, Bellamkonda A, Aryal B, Al-Ghuraibawi M. Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$43$YR$$F$Y$$$20240809$$HP$US$US
240768511$24076851$1$I$$20240626$20240711$20240711$EXP$$AU-GRANULES-AU-2024GRALIT00258$GRANULES INDIA$D. Roy.A rare instance of tardive dyskinesia with SSRI use: A case study.European Psychiatry.APR-2017;41 (Suppl. 1):S759$49$YR$A$F$Y$$$20240711$$HP$AU$AU
240768521$24076852$1$I$$20240705$20240711$20240711$PER$$NVSC2024US140305$NOVARTIS$$$$$$Y$$$20240711$$CN$US$US
240768531$24076853$1$I$20240625$20240708$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108937$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240711$$HP$US$US
240768541$24076854$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110004$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240711$$HP$US$US
240768561$24076856$1$I$20240501$20240709$20240711$20240711$EXP$ES-AEMPS-1542846$ES-ORGANON-O2407ESP000874$ORGANON$$67$YR$$M$Y$$$20240711$$PH$ES$ES
240768572$24076857$2$F$$20240807$20240711$20240812$30DAY$$AU-JNJFOC-20240716625$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$HP$AU$AU
240768581$24076858$1$I$$20240702$20240711$20240711$PER$$US-JNJFOC-20240721356$JOHNSON AND JOHNSON$$61$YR$A$M$Y$74.2$KG$20240711$$MD$US$US
240768591$24076859$1$I$$20240710$20240711$20240711$EXP$$US-UCBSA-2024034942$UCB$$$$$F$Y$$$20240711$$HP$US$US
240768601$24076860$1$I$$20231004$20240711$20240711$PER$$US-PFM-2023-05599$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.1$KG$20240711$$CN$US$US
240768611$24076861$1$I$20220701$20240704$20240711$20240711$EXP$$FR-AUROBINDO-AUR-APL-2024-033475$AUROBINDO$$75$YR$$F$Y$$$20240711$$PH$FR$FR
240768621$24076862$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5832877$ABBVIE$$$$$M$Y$$$20240711$$HP$US$US
240768631$24076863$1$I$$20231004$20240711$20240711$PER$$US-PFM-2023-05602$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.909$KG$20240711$$CN$US$US
240768641$24076864$1$I$$20231004$20240711$20240711$PER$$US-PFM-2023-05598$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.828$KG$20240711$$CN$US$US
240768651$24076865$1$I$$20231002$20240711$20240711$PER$$US-PFM-2023-05597$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.968$KG$20240711$$CN$US$US
240768661$24076866$1$I$$20240701$20240711$20240711$EXP$$JP-TAKEDA-2024TUS069128$TAKEDA$Sato Y, Sato Y, Irei K, Nanjo S, Hara S, Fujiwara S, et al. Successful intracranial response of lorlatinib after resistance with alectinib and brigatinib in patients with ALK- postitve lung adenocarcinoma: Implications of CNS penetration rate of brigatinib$34$YR$$M$Y$$$20240711$$MD$JP$JP
240768671$24076867$1$I$$20231027$20240711$20240711$PER$$US-PFM-2023-05604$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.2$KG$20240711$$CN$US$US
240768681$24076868$1$I$$20231003$20240711$20240711$PER$$US-PFM-2023-05596$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.376$KG$20240711$$HP$US$US
240768691$24076869$1$I$$20240703$20240711$20240711$EXP$$DE-NOVITIUMPHARMA-2024DENVP01201$NOVITIUM PHARMA$Karsten Heusser.Disconnected Cardiac Autonomic Nerves in Genetic Ganglionic Acetylcholine Receptor Alpha-3 Subunit Deficiency.Hypertension.10-MAY-2023;80(8):E137-E139$18$YR$T$F$Y$$$20240711$$HP$DE$DE
240768702$24076870$2$F$$20240726$20240711$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06256$LUPIN$$$$$$Y$$$20240814$$CN$US$US
240768711$24076871$1$I$$20240709$20240711$20240711$EXP$$US-ABBVIE-5834086$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240768721$24076872$1$I$$20231005$20240711$20240711$PER$$US-PFM-2023-05633$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.977$KG$20240711$$CN$US$US
240768731$24076873$1$I$$20231004$20240711$20240711$PER$$US-PFM-2023-05605$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.24$KG$20240711$$CN$US$US
240768741$24076874$1$I$$20231005$20240711$20240711$PER$$US-PFM-2023-05679$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.898$KG$20240711$$HP$US$US
240768751$24076875$1$I$$20231004$20240711$20240711$PER$$US-PFM-2023-05606$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.147$KG$20240711$$CN$US$US
240768761$24076876$1$I$$20231005$20240711$20240711$PER$$US-PFM-2023-05634$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.311$KG$20240711$$CN$US$US
240768771$24076877$1$I$$20231006$20240711$20240711$PER$$US-PFM-2023-05681$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.052$KG$20240711$$CN$US$US
240768781$24076878$1$I$$20231006$20240711$20240711$PER$$US-PFM-2023-05742$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.977$KG$20240711$$CN$US$US
240768791$24076879$1$I$20231005$20231009$20240711$20240711$PER$$US-PFM-2023-05743$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$8.44$KG$20240711$$CN$US$US
240768801$24076880$1$I$$20240702$20240711$20240711$EXP$$US-UCBSA-2024034878$UCB$$12$YR$$F$Y$$$20240711$$CN$US$US
240768818$24076881$8$F$20240101$20240825$20240711$20240903$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020488$UNITED THERAPEUTICS$$$$$F$Y$88.435$KG$20240903$$$US$US
240768821$24076882$1$I$20190101$20231009$20240711$20240711$PER$ES-AEMPS-579836$ES-PFM-2023-05705$PIERRE FABRE MEDICAMENT$$54$YR$$M$Y$$$20240711$$MD$ES$ES
240768831$24076883$1$I$$20231009$20240711$20240711$PER$$US-PFM-2023-05680$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.68$KG$20240711$$HP$US$US
240768841$24076884$1$I$$20231010$20240711$20240711$PER$$US-PFM-2023-05744$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.884$KG$20240711$$CN$US$US
240768851$24076885$1$I$$20231030$20240711$20240711$PER$$US-PFM-2023-05607$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.297$KG$20240711$$CN$US$US
240768861$24076886$1$I$$20231105$20240711$20240711$PER$$US-PFM-2023-05682$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.524$KG$20240711$$HP$US$US
240768871$24076887$1$I$$20240311$20240711$20240711$PER$$US-PFM-2023-05635$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.6$KG$20240711$$CN$US$US
240768891$24076889$1$I$$20240701$20240711$20240711$EXP$$US-RDY-LIT/USA/24/0009821$DR REDDYS$Ozueh P, Agogbuo O, Walnofer A, Umezurike I, John L, Hammond TC, et al. Breathtaking Intrathoracic Rhabdoid Tumor. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: A6559. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6559.$63$YR$A$M$Y$$$20240711$$HP$US$US
240768901$24076890$1$I$20240521$20240702$20240711$20240711$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-06252$HIKMA$$$$$$Y$$$20240711$$HP$EG$EG
240768911$24076891$1$I$$20231011$20240711$20240711$PER$$US-PFM-2023-05817$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.02$KG$20240711$$CN$US$US
240768921$24076892$1$I$$20231011$20240711$20240711$PER$$US-PFM-2023-05836$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.977$KG$20240711$$CN$US$US
240768931$24076893$1$I$$20231012$20240711$20240711$PER$$US-PFM-2023-05814$PIERRE FABRE MEDICAMENT$$$$$F$Y$31.293$KG$20240711$$CN$US$US
240768941$24076894$1$I$20231011$20231011$20240711$20240711$PER$$US-PFM-2023-05835$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.451$KG$20240711$$HP$US$US
240768951$24076895$1$I$20231011$20231012$20240711$20240711$PER$$US-PFM-2023-05816$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.488$KG$20240711$$HP$US$US
240768961$24076896$1$I$$20231012$20240711$20240711$PER$$US-PFM-2023-05818$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.898$KG$20240711$$CN$US$US
240768971$24076897$1$I$$20231011$20240711$20240711$PER$$US-PFM-2023-05820$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.302$KG$20240711$$CN$US$US
240768981$24076898$1$I$20221209$20231013$20240711$20240711$PER$$US-PFM-2023-05813$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$10.5$KG$20240711$$PH$US$US
240768991$24076899$1$I$20240512$20240627$20240711$20240711$EXP$$PK-ROCHE-10000018320$ROCHE$$81$YR$E$M$Y$$$20240711$$CN$PK$PK
240769001$24076900$1$I$$20231101$20240711$20240711$PER$$US-PFM-2023-05815$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.698$KG$20240711$$CN$US$US
240769012$24076901$2$F$$20240723$20240711$20240724$PER$$NVSC2024US143275$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
240769021$24076902$1$I$$20231016$20240711$20240711$PER$$US-PFM-2023-05936$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.658$KG$20240711$$CN$US$US
240769031$24076903$1$I$$20230906$20240711$20240711$PER$$US-PFM-2023-05992$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.098$KG$20240711$$CN$US$US
240769041$24076904$1$I$20230823$20231013$20240711$20240711$PER$$US-PFM-2023-05874$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.442$KG$20240711$$PH$US$US
240769051$24076905$1$I$20231017$20231016$20240711$20240711$PER$$US-PFM-2023-05938$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.587$KG$20240711$$HP$US$US
240769063$24076906$3$F$20240612$20240822$20240711$20240902$PER$$US-JNJFOC-20240641651$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240902$$CN$US$US
240769071$24076907$1$I$$20231017$20240711$20240711$PER$$US-PFM-2023-05944$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.39$KG$20240711$$CN$US$US
240769081$24076908$1$I$$20231017$20240711$20240711$PER$$US-PFM-2023-05942$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.85$KG$20240711$$CN$US$US
240769093$24076909$3$F$20240629$20240724$20240711$20240801$EXP$$US-JNJFOC-20240715131$JOHNSON AND JOHNSON$$44$YR$A$M$Y$87.07$KG$20240801$$HP$US$US
240769101$24076910$1$I$20230929$20231114$20240711$20240711$PER$$US-PFM-2023-05875$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$9.977$KG$20240711$$CN$US$US
240769111$24076911$1$I$20231001$20240117$20240711$20240711$PER$$FR-PFM-2023-05870$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$$$20240711$$CN$FR$FR
240769121$24076912$1$I$$20240315$20240711$20240711$PER$$US-PFM-2023-05933$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.15$KG$20240711$$CN$US$US
240769131$24076913$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136655$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240769143$24076914$3$F$20240702$20240717$20240711$20240727$PER$$US-AMGEN-USASP2024134142$AMGEN$$54$YR$A$F$Y$52.2$KG$20240727$$HP$US$US
240769151$24076915$1$I$$20240626$20240711$20240711$EXP$$US-GRANULES-US-2024GRALIT00259$GRANULES INDIA$Rebecca Perkins.Treating Polysubstance Ingestion with Continuous Renal Replacement Therapy and Total Plasma Exchange .Critical Care Medicine.JAN-2024;52:S342$16$YR$T$F$Y$$$20240711$$HP$US$US
240769162$24076916$2$F$$20240701$20240711$20240819$EXP$$GB-ROCHE-10000016111$ROCHE$$69$YR$E$M$Y$$$20240819$$HP$GB$GB
240769171$24076917$1$I$20231016$20231018$20240711$20240711$PER$$US-PFM-2023-06009$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$5.211$KG$20240711$$HP$US$US
240769181$24076918$1$I$$20231019$20240711$20240711$PER$$US-PFM-2023-06010$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.51$KG$20240711$$CN$US$US
240769191$24076919$1$I$20230801$20231018$20240711$20240711$PER$$US-PFM-2023-05994$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
240769201$24076920$1$I$$20231019$20240711$20240711$PER$$US-PFM-2023-06011$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.971$KG$20240711$$CN$US$US
240769211$24076921$1$I$$20231023$20240711$20240711$PER$$US-PFM-2023-06128$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.596$KG$20240711$$CN$US$US
240769221$24076922$1$I$20231017$20231017$20240711$20240711$PER$$US-PFM-2023-05993$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$2.989$KG$20240711$$HP$US$US
240769231$24076923$1$I$$20231023$20240711$20240711$PER$$US-PFM-2023-06129$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.596$KG$20240711$$CN$US$US
240769241$24076924$1$I$20230401$20231023$20240711$20240711$PER$FR-AFSSAPS-AN2023001347$FR-PFM-2023-06054$PIERRE FABRE MEDICAMENT$$49$YR$$F$Y$60.8$KG$20240711$$PH$FR$FR
240769251$24076925$1$I$$20231023$20240711$20240711$PER$$US-PFM-2023-06090$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.8$KG$20240711$$CN$US$US
240769261$24076926$1$I$$20231023$20240711$20240711$PER$$US-PFM-2023-06087$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.347$KG$20240711$$CN$US$US
240769271$24076927$1$I$$20231023$20240711$20240711$PER$$US-PFM-2023-06086$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.798$KG$20240711$$HP$US$US
240769281$24076928$1$I$$20231024$20240711$20240711$PER$$US-PFM-2023-06130$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.159$KG$20240711$$CN$US$US
240769291$24076929$1$I$$20231023$20240711$20240711$PER$$US-PFM-2023-06081$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.989$KG$20240711$$HP$US$US
240769301$24076930$1$I$$20231024$20240711$20240711$PER$$US-PFM-2023-06131$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.667$KG$20240711$$CN$US$US
240769311$24076931$1$I$$20231025$20240711$20240711$PER$$US-PFM-2023-06210$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.698$KG$20240711$$CN$US$US
240769321$24076932$1$I$$20231026$20240711$20240711$PER$$US-PFM-2023-06212$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.828$KG$20240711$$CN$US$US
240769331$24076933$1$I$$20231026$20240711$20240711$PER$$US-PFM-2023-06188$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240711$$CN$US$US
240769341$24076934$1$I$$20240110$20240711$20240711$PER$$US-PFM-2023-06209$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.75$KG$20240711$$CN$US$US
240769351$24076935$1$I$$20240117$20240711$20240711$PER$$US-PFM-2023-06046$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.89$KG$20240711$$HP$US$US
240769361$24076936$1$I$20220901$20240703$20240711$20240711$EXP$$ES-CELLTRION INC.-2024ES016402$CELLTRION$$$$$$Y$$$20240711$$MD$ES$ES
240769371$24076937$1$I$20240601$20240708$20240711$20240711$EXP$$US-UCBSA-2024034702$UCB$$38$YR$$F$Y$$$20240711$$HP$US$US
240769381$24076938$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109901$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$75.3$KG$20240711$$CN$US$US
240769391$24076939$1$I$20240624$20240709$20240711$20240711$EXP$$US-ABBVIE-5834003$ABBVIE$$78$YR$$M$Y$$$20240711$$CN$US$US
240769401$24076940$1$I$$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407090825557380-VYPZT$GB-SANDOZ INC.-SDZ2024GB064326$SANDOZ$$72$YR$$M$Y$$$20240711$$MD$GB$GB
240769412$24076941$2$F$$20240827$20240711$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06273$LUPIN$$$$$$Y$$$20240918$$CN$US$US
240769421$24076942$1$I$$20231026$20240711$20240711$PER$$US-PFM-2023-06213$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.948$KG$20240711$$CN$US$US
240769431$24076943$1$I$$20231009$20240711$20240711$PER$$NL-PFM-2023-06254$PIERRE FABRE MEDICAMENT$$67$YR$$F$Y$52$KG$20240711$$CN$NL$NL
240769441$24076944$1$I$20221024$20231023$20240711$20240711$PER$$JP-PFM-2023-06218$PIERRE FABRE MEDICAMENT$$7$MON$$F$Y$$$20240711$$MD$JP$JP
240769451$24076945$1$I$20230915$20231027$20240711$20240711$PER$$US-PFM-2023-06228$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$9.31$KG$20240711$$PH$US$US
240769461$24076946$1$I$$20231026$20240711$20240711$PER$$JP-PFM-2023-06289$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240711$$MD$JP$JP
240769471$24076947$1$I$$20231026$20240711$20240711$PER$$US-PFM-2023-06214$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.41$KG$20240711$$CN$US$US
240769481$24076948$1$I$20231015$20231027$20240711$20240711$PER$$US-PFM-2023-06234$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$8.32$KG$20240711$$PH$US$US
240769491$24076949$1$I$$20231027$20240711$20240711$PER$$US-PFM-2023-06230$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.701$KG$20240711$$CN$US$US
240769501$24076950$1$I$$20231027$20240711$20240711$PER$$US-PFM-2023-06229$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.501$KG$20240711$$HP$US$US
240769511$24076951$1$I$$20231030$20240711$20240711$PER$$US-PFM-2023-06262$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.71$KG$20240711$$CN$US$US
240769521$24076952$1$I$$20231030$20240711$20240711$PER$$US-PFM-2023-06263$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.481$KG$20240711$$CN$US$US
240769531$24076953$1$I$$20240709$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA063883$SANDOZ$$53$YR$$M$Y$$$20240711$$HP$CA$CA
240769541$24076954$1$I$$20231031$20240711$20240711$PER$$US-PFM-2023-06264$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.007$KG$20240711$$CN$US$US
240769551$24076955$1$I$20230820$20231031$20240711$20240711$PER$$US-PFM-2023-06294$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
240769561$24076956$1$I$$20231211$20240711$20240711$PER$$US-PFM-2023-06235$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.517$KG$20240711$$CN$US$US
240769571$24076957$1$I$20230901$20231208$20240711$20240711$PER$$US-PFM-2023-06227$PIERRE FABRE MEDICAMENT$$1$YR$$M$Y$12.1$KG$20240711$$PH$US$US
240769581$24076958$1$I$$20240208$20240711$20240711$PER$$US-PFM-2023-06261$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.71$KG$20240711$$CN$US$US
240769591$24076959$1$I$$20240618$20240711$20240711$PER$$US-PFM-2023-06207$PIERRE FABRE MEDICAMENT$$$$$F$Y$15$KG$20240711$$CN$US$US
240769601$24076960$1$I$$20240430$20240711$20240711$PER$$US-PFM-2023-05876$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$US$US
240769612$24076961$2$F$$20240729$20240711$20240801$EXP$$JP-JNJFOC-20240726945$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240801$$MD$JP$JP
240769621$24076962$1$I$$20240404$20240711$20240711$PER$$US-PFM-2023-05595$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.85$KG$20240711$$CN$US$US
240769633$24076963$3$F$20240707$20240822$20240711$20240830$30DAY$$US-JNJFOC-20240722322$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240830$$HP$US$US
240769641$24076964$1$I$$20240418$20240711$20240711$PER$$US-PFM-2023-05819$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.26$KG$20240711$$CN$US$US
240769651$24076965$1$I$$20240229$20240711$20240711$PER$$US-PFM-2023-06208$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.85$KG$20240711$$CN$US$US
240769661$24076966$1$I$$20240529$20240711$20240711$PER$$US-PFM-2023-06211$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.34$KG$20240711$$CN$US$US
240769671$24076967$1$I$$20231002$20240711$20240711$PER$$JP-PFM-2023-05670$PIERRE FABRE MEDICAMENT$$2$MON$$M$Y$$$20240711$$MD$JP$JP
240769681$24076968$1$I$$20231006$20240711$20240711$PER$$TR-PFM-2023-05752$PIERRE FABRE MEDICAMENT$Durantas S. Hypoxic Spell After Abdominal Surgery in  Tetralogy of Fallot Patient: From Being Asymptomatic to Symptomatic. Journal of The Cardiovascular Thoracic Anaesthesia and Intensive Care Society. 2023;29 (3):174-6$9$MON$$M$Y$9.5$KG$20240711$$HP$TR$TR
240769691$24076969$1$I$$20231006$20240711$20240711$PER$$TR-PFM-2023-05676$PIERRE FABRE MEDICAMENT$Turkmen H, Uysal F, Bostan OM. A rare and fatal cause of hypertrophic cardiomyopathy: Danon disease. Cardiology in the Young. 2023;33:1448-50$3$YR$$M$Y$$$20240711$$HP$TR$TR
240769701$24076970$1$I$$20231009$20240711$20240711$PER$$FR-PFM-2023-05764$PIERRE FABRE MEDICAMENT$Mauguen C,  Maruani A,  Barbarot S, Abasq C, Martin L, Herbert J et al. Factors associated with early relapse of infantile haemangioma in children treated for at least six months with oral propranolol: A case-control study using the 2014-2021 French Ouest DataHub. Annales de Dermatologie et de V?n?r?ologie. 2023;150:189-194$$$C$$Y$$$20240711$$HP$FR$FR
240769711$24076971$1$I$$20231010$20240711$20240711$PER$$JP-PFM-2023-05896$PIERRE FABRE MEDICAMENT$Minori Matsuzawa et al.. Infantile  hepatic hemangioma: A diagnostic challenge in the differentiation from malignancy. The Japanese Journal of Pediatric Hematology/Oncology (e- e-journal). 2023;60(4):359$82$DY$$M$Y$2.975$KG$20240711$$MD$JP$JP
240769721$24076972$1$I$$20231013$20240711$20240711$PER$$TR-PFM-2023-05918$PIERRE FABRE MEDICAMENT$Turan O, Koker S. Cardiac screening in patients with infantile  hemangiomas before propranolol treatment. Cukurova Medical Journal. 2023;48(3):1000-6$$$$$Y$$$20240711$$HP$TR$TR
240769731$24076973$1$I$$20231010$20240711$20240711$PER$$JP-PFM-2023-05891$PIERRE FABRE MEDICAMENT$Suzuki R, Fukushima H, Hosalca S, Inaba M, Yamaki Y, Takada H. Diffuse hepatic angiosarcoma with Kasabach-Merritt syndrome and pulmonary metastases could be controlled with paclitaxel and propranolol. The Japanese Journal of Pediatric Hematology/Oncology (e-journal). 2023;60(4):351$2$YR$$F$Y$$$20240711$$MD$JP$JP
240769741$24076974$1$I$$20231009$20240711$20240711$PER$$IT-PFM-2023-05777$PIERRE FABRE MEDICAMENT$Lovato A, Disco C, Frosolini A, Monzani D, Perini F. Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine. Medicina. 2023;59,1560:1-9$$$$$Y$$$20240711$$HP$IT$IT
240769751$24076975$1$I$$20231017$20240711$20240711$PER$$CA-PFM-2023-05937$PIERRE FABRE MEDICAMENT$$48$YR$$M$Y$$$20240711$$MD$CA$CA
240769761$24076976$1$I$20210525$20240510$20240711$20240711$PER$$JP-PFM-2023-06275$PIERRE FABRE MEDICAMENT$$2$MON$$M$Y$$$20240711$$MD$JP$JP
240769771$24076977$1$I$20200914$20240510$20240711$20240711$PER$$JP-PFM-2023-06276$PIERRE FABRE MEDICAMENT$$90$DY$$F$Y$$$20240711$$MD$JP$JP
240769781$24076978$1$I$$20231017$20240711$20240711$PER$$CA-PFM-2023-05934$PIERRE FABRE MEDICAMENT$$46$YR$$F$Y$$$20240711$$MD$CA$CA
240769791$24076979$1$I$$20231017$20240711$20240711$PER$$CA-PFM-2023-05943$PIERRE FABRE MEDICAMENT$$25$YR$$F$Y$$$20240711$$MD$CA$CA
240769801$24076980$1$I$$20231017$20240711$20240711$PER$$CA-PFM-2023-05941$PIERRE FABRE MEDICAMENT$$46$YR$$F$Y$$$20240711$$MD$CA$CA
240769813$24076981$3$F$20240101$20240809$20240711$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020647$UNITED THERAPEUTICS$$$$$F$Y$48.073$KG$20240817$$$US$US
240769821$24076982$1$I$20210324$20240510$20240711$20240711$PER$$JP-PFM-2023-06279$PIERRE FABRE MEDICAMENT$$105$DY$$F$Y$$$20240711$$MD$JP$JP
240769831$24076983$1$I$$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024137280$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240769841$24076984$1$I$20240708$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024137050$AMGEN$$80$YR$E$F$Y$$$20240711$$CN$US$US
240769851$24076985$1$I$$20231017$20240711$20240711$PER$$CA-PFM-2023-05935$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
240769861$24076986$1$I$$20231030$20240711$20240711$PER$$BE-PFM-2023-06268$PIERRE FABRE MEDICAMENT$Nathan T, Giulia C, Antoine B, Lise J, Frederic VE, Florence R. Case report: Serious unexpected vascular events in two patients with lymphocytic variant hypereosinophilic syndrome. Frontiers in Cardiovascular Medicine. 2023;10:1256862:1-5$62$YR$$F$Y$$$20240711$$HP$BE$BE
240769871$24076987$1$I$$20230911$20240711$20240711$PER$$CA-PFM-2023-05072$PIERRE FABRE MEDICAMENT$$41$YR$$M$Y$$$20240711$$MD$CA$CA
240769881$24076988$1$I$$20230911$20240711$20240711$PER$$CA-PFM-2023-05129$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
240769891$24076989$1$I$$20230911$20240711$20240711$PER$$CA-PFM-2023-05128$PIERRE FABRE MEDICAMENT$$32$YR$$F$Y$$$20240711$$MD$CA$CA
240769901$24076990$1$I$$20230911$20240711$20240711$PER$$CA-PFM-2023-05127$PIERRE FABRE MEDICAMENT$$$$A$M$Y$$$20240711$$MD$CA$CA
240769911$24076991$1$I$$20230911$20240711$20240711$PER$$CA-PFM-2023-05130$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240711$$MD$CA$CA
240769921$24076992$1$I$$20230911$20240711$20240711$PER$$CA-PFM-2023-05132$PIERRE FABRE MEDICAMENT$$59$YR$$F$Y$$$20240711$$MD$CA$CA
240769931$24076993$1$I$$20230911$20240711$20240711$PER$$CA-PFM-2023-05075$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240711$$MD$CA$CA
240769941$24076994$1$I$$20231010$20240711$20240711$PER$$JP-PFM-2023-06141$PIERRE FABRE MEDICAMENT$Saito K et al. Autosomal recessive polycystic kidney disease (ARPKD) with heart failure due to prolonged hypertension since neonatal period. Program and Abstracts of the 29th Annual Meeting of JSPH. 2023;13$3$MON$$F$Y$$$20240711$$MD$JP$JP
240769953$24076995$3$F$$20240729$20240711$20240806$EXP$$ZA-HETERO-HET2024ZA02145$HETERO$$$$I$F$Y$3.88$KG$20240806$$HP$ZA$ZA
240769961$24076996$1$I$$20230911$20240711$20240711$PER$$CA-PFM-2023-05073$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
240769971$24076997$1$I$$20230911$20240711$20240711$PER$$CA-PFM-2023-05074$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
240769981$24076998$1$I$20240625$20240626$20240711$20240711$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455909$RANBAXY$$79$YR$$F$Y$$$20240711$$MD$GB$GB
240769991$24076999$1$I$$20240626$20240711$20240711$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455856$RANBAXY$Ramirez SEC, Mateo MCG, Egea SER, Cepero MLM, Mugarza PG, Sanz SB. Spontaneous remission of a pulmonary sclerosing epithelioid fibrosarcoma: a case report of a possible abscopal effect. Trans Cancer Res. 2024;13(5):2564-2570$58$YR$$F$Y$$$20240711$$HP$ES$ES
240770001$24077000$1$I$$20230906$20240711$20240711$PER$$US-PFM-2023-05034$PIERRE FABRE MEDICAMENT$$$$$M$Y$18.195$KG$20240711$$HP$US$US
240770011$24077001$1$I$$20230906$20240711$20240711$PER$$JP-PFM-2023-05112$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$CN$JP$JP
240770021$24077002$1$I$20230811$20230907$20240711$20240711$PER$$US-PFM-2023-05058$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.442$KG$20240711$$PH$US$US
240770031$24077003$1$I$$20230908$20240711$20240711$PER$$US-PFM-2023-05076$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.989$KG$20240711$$CN$US$US
240770041$24077004$1$I$$20230911$20240711$20240711$PER$$US-PFM-2023-05141$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.02$KG$20240711$$CN$US$US
240770051$24077005$1$I$$20230911$20240711$20240711$PER$$US-PFM-2023-05140$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.696$KG$20240711$$CN$US$US
240770061$24077006$1$I$$20230913$20240711$20240711$PER$$JP-PFM-2023-05054$PIERRE FABRE MEDICAMENT$$10$MON$$M$Y$$$20240711$$PH$JP$JP
240770071$24077007$1$I$$20230911$20240711$20240711$PER$$CA-PFM-2023-05131$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
240770081$24077008$1$I$$20231006$20240711$20240711$PER$$US-PFM-2023-05057$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.39$KG$20240711$$CN$US$US
240770091$24077009$1$I$$20230911$20240711$20240711$PER$$CA-PFM-2023-05133$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240711$$MD$CA$CA
240770102$24077010$2$F$$20240701$20240711$20240711$EXP$$US-ROCHE-10000015435$ROCHE$Yuen C, Pekmezci M, Bao S, Kong X. Metastatic glioblastoma to the lungs: a case report and literature review. CNS Oncology. 2024;13 (1): doi:10.1080/20450907.2024.2351789.$63$YR$A$F$Y$$$20240711$$HP$US$US
240770111$24077011$1$I$20240101$20240704$20240711$20240711$EXP$$CA-CELLTRION INC.-2023CA017805$CELLTRION$$$$$$Y$$$20240711$$HP$CA$CA
240770121$24077012$1$I$20240516$20240704$20240711$20240711$EXP$FR-AFSSAPS-AN2024000726$FR-ABBVIE-5833985$ABBVIE$$$$$$Y$$$20240711$$MD$FR$FR
240770131$24077013$1$I$$20230912$20240711$20240711$PER$$US-PFM-2023-05142$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.018$KG$20240711$$HP$US$US
240770141$24077014$1$I$$20230912$20240711$20240711$PER$$US-PFM-2023-05144$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.361$KG$20240711$$CN$US$US
240770151$24077015$1$I$$20230912$20240711$20240711$PER$$US-PFM-2023-05146$PIERRE FABRE MEDICAMENT$$$$$M$Y$3.9$KG$20240711$$HP$US$US
240770161$24077016$1$I$$20230912$20240711$20240711$PER$$US-PFM-2023-05145$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.118$KG$20240711$$CN$US$US
240770171$24077017$1$I$$20230912$20240711$20240711$PER$$US-PFM-2023-05166$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.558$KG$20240711$$CN$US$US
240770181$24077018$1$I$$20230913$20240711$20240711$PER$$US-PFM-2023-05167$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.968$KG$20240711$$HP$US$US
240770191$24077019$1$I$$20230913$20240711$20240711$PER$$US-PFM-2023-05222$PIERRE FABRE MEDICAMENT$$$$$M$Y$3.66$KG$20240711$$HP$US$US
240770201$24077020$1$I$$20230913$20240711$20240711$PER$$US-PFM-2023-05171$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.188$KG$20240711$$HP$US$US
240770211$24077021$1$I$$20230913$20240711$20240711$PER$$US-PFM-2023-05170$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.757$KG$20240711$$CN$US$US
240770221$24077022$1$I$$20230913$20240711$20240711$PER$$US-PFM-2023-05169$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.317$KG$20240711$$CN$US$US
240770231$24077023$1$I$$20230914$20240711$20240711$PER$$US-PFM-2023-05223$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.161$KG$20240711$$HP$US$US
240770241$24077024$1$I$$20230915$20240711$20240711$PER$$US-PFM-2023-05235$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.388$KG$20240711$$HP$US$US
240770251$24077025$1$I$$20230915$20240711$20240711$PER$$US-PFM-2023-05237$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.751$KG$20240711$$CN$US$US
240770261$24077026$1$I$$20230918$20240711$20240711$PER$$US-PFM-2023-05262$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.977$KG$20240711$$CN$US$US
240770271$24077027$1$I$$20230918$20240711$20240711$PER$$US-PFM-2023-05261$PIERRE FABRE MEDICAMENT$$$$$F$Y$16.798$KG$20240711$$HP$US$US
240770281$24077028$1$I$20240101$20240626$20240711$20240711$PER$$US-GRANULES-US-2024GRASPO00255$GRANULES INDIA$$$$$F$Y$$$20240711$$CN$US$US
240770291$24077029$1$I$$20230927$20240711$20240711$PER$$JP-PFM-2023-05289$PIERRE FABRE MEDICAMENT$$1$MON$$F$Y$$$20240711$$MD$JP$JP
240770301$24077030$1$I$$20230919$20240711$20240711$PER$$US-PFM-2023-05291$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.161$KG$20240711$$CN$US$US
240770311$24077031$1$I$$20231010$20240711$20240711$PER$$US-PFM-2023-05168$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.22$KG$20240711$$CN$US$US
240770321$24077032$1$I$$20231109$20240711$20240711$PER$$US-PFM-2023-05238$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.558$KG$20240711$$HP$US$US
240770331$24077033$1$I$$20231023$20240711$20240711$PER$$US-PFM-2023-05236$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.9$KG$20240711$$CN$US$US
240770341$24077034$1$I$20240101$20240710$20240711$20240711$PER$$US-JNJFOC-20240726893$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240711$$CN$US$US
240770351$24077035$1$I$20240620$20240704$20240711$20240711$EXP$$CA-TAKEDA-2024TUS064933$TAKEDA$$55$YR$$M$Y$$$20240711$$CN$CA$CA
240770361$24077036$1$I$20240501$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136958$AMGEN$$69$YR$E$M$Y$$$20240711$$CN$US$US
240770371$24077037$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008097$STRIDES$Contag CA, Studemeister L, Bogler Y, Cooper JD.. Q fever presenting as splenic infarct without endocarditis. IDCases. 2024;37$44$YR$$M$Y$$$20240711$$HP$US$US
240770381$24077038$1$I$$20240708$20240711$20240711$EXP$$US-TAKEDA-2024TUS070110$TAKEDA$$$$$F$Y$$$20240711$$CN$US$US
240770391$24077039$1$I$$20240702$20240711$20240711$EXP$$IT-AUROBINDO-AUR-APL-2024-033622$AUROBINDO$Garbo V, Condemi A, Albano C, Polara VF, Parrino R, Colomba C, et al.. Dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients: a case series.. Infezioni-in-Medicina/Le Infezioni in Medicina. 2024;32(2):231-240$3$MON$$$Y$$$20240711$$HP$IT$IT
240770401$24077040$1$I$$20230920$20240711$20240711$PER$$US-PFM-2023-05320$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.2$KG$20240711$$HP$US$US
240770411$24077041$1$I$$20230922$20240711$20240711$PER$$US-PFM-2023-05385$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.354$KG$20240711$$CN$US$US
240770421$24077042$1$I$$20230918$20240711$20240711$PER$$US-PFM-2023-05292$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.524$KG$20240711$$CN$US$US
240770431$24077043$1$I$$20230919$20240711$20240711$PER$$US-PFM-2023-05293$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.58$KG$20240711$$CN$US$US
240770441$24077044$1$I$$20230922$20240711$20240711$PER$$US-PFM-2023-05386$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240711$$CN$US$US
240770451$24077045$1$I$$20230925$20240711$20240711$PER$$US-PFM-2023-05432$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.599$KG$20240711$$CN$US$US
240770461$24077046$1$I$$20230925$20240711$20240711$PER$$US-PFM-2023-05435$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.868$KG$20240711$$CN$US$US
240770471$24077047$1$I$$20230926$20240711$20240711$PER$$US-PFM-2023-05427$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.998$KG$20240711$$CN$US$US
240770481$24077048$1$I$$20230925$20240711$20240711$PER$$US-PFM-2023-05431$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.197$KG$20240711$$CN$US$US
240770491$24077049$1$I$$20230926$20240711$20240711$PER$$US-PFM-2023-05460$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.197$KG$20240711$$HP$US$US
240770501$24077050$1$I$$20230928$20240711$20240711$PER$$US-PFM-2023-05429$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.247$KG$20240711$$CN$US$US
240770511$24077051$1$I$$20230927$20240711$20240711$PER$$JP-PFM-2023-05326$PIERRE FABRE MEDICAMENT$$2$YR$$F$Y$$$20240711$$PH$JP$JP
240770521$24077052$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06279$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240770531$24077053$1$I$$20231019$20240711$20240711$PER$$US-PFM-2023-05437$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240711$$CN$US$US
240770541$24077054$1$I$20230801$20231025$20240711$20240711$PER$$SK-PFM-2023-05351$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$SK$SK
240770551$24077055$1$I$$20231025$20240711$20240711$PER$$SK-PFM-2023-05350$PIERRE FABRE MEDICAMENT$$$$I$M$Y$$$20240711$$MD$SK$SK
240770561$24077056$1$I$$20231025$20240711$20240711$PER$$US-PFM-2023-05323$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.213$KG$20240711$$HP$US$US
240770571$24077057$1$I$$20231127$20240711$20240711$PER$$US-PFM-2023-05321$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.8$KG$20240711$$CN$US$US
240770581$24077058$1$I$$20231229$20240711$20240711$PER$$US-PFM-2023-05430$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.71$KG$20240711$$CN$US$US
240770591$24077059$1$I$$20240125$20240711$20240711$PER$$US-PFM-2023-05436$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.54$KG$20240711$$CN$US$US
240770601$24077060$1$I$$20240229$20240711$20240711$PER$$US-PFM-2023-05434$PIERRE FABRE MEDICAMENT$$$$$M$Y$16.2$KG$20240711$$HP$US$US
240770611$24077061$1$I$20240429$20240705$20240711$20240711$EXP$$CN-BEIGENE-BGN-2024-010485$BEIGENE$$$$$$Y$$$20240711$$HP$CN$CN
240770621$24077062$1$I$20240628$20240708$20240711$20240711$EXP$$BE-ABBVIE-5833035$ABBVIE$$89$YR$$M$Y$68$KG$20240711$$HP$BE$BE
240770631$24077063$1$I$20231101$20240703$20240711$20240711$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024082587$VIIV$$48$YR$$M$Y$$$20240711$$HP$US$US
240770641$24077064$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5832769$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240770651$24077065$1$I$20240526$20240628$20240711$20240711$EXP$$CN-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000165-2024$QILU PHARMACEUTICAL$$70$YR$E$M$Y$66$KG$20240711$$HP$CN$CN
240770661$24077066$1$I$$20230926$20240711$20240711$PER$$US-PFM-2023-05461$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.02$KG$20240711$$CN$US$US
240770671$24077067$1$I$20230818$20230914$20240711$20240711$PER$$DE-PFM-2023-05218$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$8$KG$20240711$$CN$DE$DE
240770681$24077068$1$I$$20230925$20240711$20240711$PER$$US-PFM-2023-05433$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.689$KG$20240711$$CN$US$US
240770691$24077069$1$I$$20230925$20240711$20240711$PER$$JP-PFM-2023-05534$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240711$$HP$JP$JP
240770701$24077070$1$I$$20230926$20240711$20240711$PER$$JP-PFM-2023-05482$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240711$$MD$JP$JP
240770711$24077071$1$I$20210501$20230926$20240711$20240711$PER$$JP-PFM-2023-05566$PIERRE FABRE MEDICAMENT$$4$MON$$F$Y$$$20240711$$MD$JP$JP
240770721$24077072$1$I$$20240710$20240711$20240711$EXP$$GB-ABBVIE-5834996$ABBVIE$$$$E$F$Y$$$20240711$$HP$GB$GB
240770731$24077073$1$I$20240620$20240701$20240711$20240711$EXP$$CN-JNJFOC-20240704104$JOHNSON AND JOHNSON$$61$YR$A$M$Y$77$KG$20240711$$HP$CN$CN
240770741$24077074$1$I$$20230926$20240711$20240711$PER$$JP-PFM-2023-05565$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240711$$MD$JP$JP
240770751$24077075$1$I$$20230926$20240711$20240711$PER$$US-PFM-2023-05465$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.499$KG$20240711$$CN$US$US
240770761$24077076$1$I$$20230928$20240711$20240711$PER$$US-PFM-2023-05500$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.837$KG$20240711$$CN$US$US
240770771$24077077$1$I$$20230928$20240711$20240711$PER$$US-PFM-2023-05496$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.968$KG$20240711$$CN$US$US
240770781$24077078$1$I$$20230928$20240711$20240711$PER$$US-PFM-2023-05499$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.442$KG$20240711$$CN$US$US
240770791$24077079$1$I$$20230928$20240711$20240711$PER$$US-PFM-2023-05497$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.209$KG$20240711$$CN$US$US
240770801$24077080$1$I$$20231002$20240711$20240711$PER$$US-PFM-2023-05592$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.497$KG$20240711$$HP$US$US
240770811$24077081$1$I$$20231001$20240711$20240711$PER$$US-PFM-2023-05558$PIERRE FABRE MEDICAMENT$$4$YR$$F$Y$$$20240711$$CN$US$US
240770821$24077082$1$I$$20231002$20240711$20240711$PER$$US-PFM-2023-05593$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.2$KG$20240711$$CN$US$US
240770831$24077083$1$I$$20231002$20240711$20240711$PER$$US-PFM-2023-05463$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.701$KG$20240711$$HP$US$US
240770841$24077084$1$I$$20231128$20240711$20240711$PER$$US-PFM-2023-05462$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.34$KG$20240711$$CN$US$US
240770851$24077085$1$I$$20240311$20240711$20240711$PER$$US-PFM-2023-05464$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240711$$CN$US$US
240770861$24077086$1$I$$20240422$20240711$20240711$PER$$US-PFM-2023-05495$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.5$KG$20240711$$HP$US$US
240770871$24077087$1$I$$20231003$20240711$20240711$PER$$HR-PFM-2023-05480$PIERRE FABRE MEDICAMENT$$24$YR$$F$Y$$$20240711$$MD$HR$HR
240770881$24077088$1$I$$20240709$20240711$20240711$PER$$NVSC2024US143292$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240770891$24077089$1$I$$20240709$20240711$20240711$EXP$$CN-AMGEN-CHNSP2024136153$AMGEN$$$$$$Y$$$20240711$$MD$CN$CN
240770901$24077090$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06307$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240770911$24077091$1$I$$20230928$20240711$20240711$PER$$JP-PFM-2023-05589$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240711$$CN$JP$JP
240770921$24077092$1$I$$20230901$20240711$20240711$PER$$JP-PFM-2023-05052$PIERRE FABRE MEDICAMENT$Hori T. Practical use of oral propranolol therapy for infantile haemangioma$1$MON$$$Y$$$20240711$$HP$JP$JP
240770931$24077093$1$I$$20230901$20240711$20240711$PER$$JP-PFM-2023-05053$PIERRE FABRE MEDICAMENT$Hori T. Practical use of oral propranolol therapy for infantile haemangioma$3$MON$$$Y$$$20240711$$HP$JP$JP
240770941$24077094$1$I$$20230911$20240711$20240711$PER$$DE-PFM-2023-05111$PIERRE FABRE MEDICAMENT$Christidis G, Krawczyk M, Haberkorn B. Hepatopathy in graves thyrotoxicosi. The American Journal of Medicine. 2023;136(8):155-6$46$YR$$F$Y$$$20240711$$HP$DE$DE
240770951$24077095$1$I$$20231002$20240711$20240711$PER$$ES-PFM-2023-05573$PIERRE FABRE MEDICAMENT$Conthe A, Ibanez-Samaniego L, Munoz MF, Ortega V, Yunquera AF, Romero M et al. Pregnancy outcomes in patients with portal cavernoma: A case series study. Int J Gynecol Obstet. 2023;163(1):277-81$31$YR$$F$Y$$$20240711$$HP$ES$ES
240770961$24077096$1$I$$20230907$20240711$20240711$PER$$JP-PFM-2023-05150$PIERRE FABRE MEDICAMENT$Kuwahara k. A Case report of infant who experienced CK increased and gross motor development delay possibly due to propranolol. The 19th Annual Meeting of Japanese Society for the Study of Vascular Anomalies/. 2023;25$11$MON$$F$Y$$$20240711$$MD$JP$JP
240770971$24077097$1$I$$20230904$20240711$20240711$PER$$JP-PFM-2023-05084$PIERRE FABRE MEDICAMENT$Kobayashi F et al. A case of infantile hemangioma (IH) in a extremely low birth weight baby treated with propranolol (PPL) and laser therapy. Program and Abstracts of the 134th Annual Meeting of the JSPRS, Kansai. 2023;25$$$I$$Y$$$20240711$$MD$JP$JP
240770981$24077098$1$I$$20230913$20240711$20240711$PER$$TR-PFM-2023-05152$PIERRE FABRE MEDICAMENT$Babaoglu K, Dogan Y, Uzun O. Transplacental treatment of foetal supraventricular tachycardia with triple antiarrhythmic combination to avoid intra foetal intervention. Cardiology in the Young. 2022;32:1162-5$$$N$M$Y$$$20240711$$HP$TR$TR
240770991$24077099$1$I$$20230911$20240711$20240711$PER$$NL-PFM-2023-05115$PIERRE FABRE MEDICAMENT$Buijink A, Snijders A, Helmich C. Dystonic tremor disappearance after internal capsule stroke. Movement disorder. 2023;10(8):1203-06$64$YR$$F$Y$$$20240711$$MD$NL$NL
240771001$24077100$1$I$$20230918$20240711$20240711$PER$$DE-PFM-2023-05376$PIERRE FABRE MEDICAMENT$Pollmann K, Call D, Heinzmann T, Kovacevic A, Arnold R, Gille C. A rare case of left atrial thrombus mimicking cardiac tumor in a female neonate. Z Geburtshilfe Neonatol. 2023;227(03):e53$$$N$F$Y$$$20240711$$HP$DE$DE
240771011$24077101$1$I$$20230911$20240711$20240711$PER$$TR-PFM-2023-05113$PIERRE FABRE MEDICAMENT$Oksuz G, Ergelen M. High dose piracetam on alcoholic cerebellar degeneration: A case report. European Psychiatry. 2023;S376-7$57$YR$$M$Y$$$20240711$$HP$TR$TR
240771021$24077102$1$I$$20230918$20240711$20240711$PER$$JP-PFM-2023-05272$PIERRE FABRE MEDICAMENT$Konishi S, Kometani M, Aiga K, Aono D, Nohara T, Ikeda H et al. Using telemedicine to manage a patient with a hypertensive emergency due to pheochromocytoma. Endocrinology, Diabetes + Metabolism Case Reports. 2023;3:23-0033$18$YR$$F$Y$49$KG$20240711$$HP$JP$JP
240771031$24077103$1$I$$20230922$20240711$20240711$PER$$JP-PFM-2023-05419$PIERRE FABRE MEDICAMENT$Nakazono M, Kagimoto S, Nakamura S, Koike T, Maegawa J. Dermoscopy as a useful tool for short term monitoring of infantile hemangioma after oral propranolol onset. Eur. J. Pediat. Dermatol. 2022;32(4):204-8$3$MON$$F$Y$$$20240711$$HP$JP$JP
240771041$24077104$1$I$$20230922$20240711$20240711$PER$$JP-PFM-2023-05418$PIERRE FABRE MEDICAMENT$Nakazono M, Kagimoto S, Nakamura S, Koike T, Maegawa J. Dermoscopy as a useful tool for short term monitoring of infantile hemangioma after oral propranolol onset. Eur. J. Pediat. Dermatol. 2022;32(4):204-8$4$MON$$F$Y$$$20240711$$HP$JP$JP
240771051$24077105$1$I$$20230922$20240711$20240711$PER$$JP-PFM-2023-05421$PIERRE FABRE MEDICAMENT$Nakazono M, Kagimoto S, Nakamura S, Koike T, Maegawa J. Dermoscopy as a useful tool for short term monitoring of infantile hemangioma after oral propranolol onset. Eur. J. Pediat. Dermatol. 2022;32(4):204-8$2$MON$$F$Y$$$20240711$$HP$JP$JP
240771061$24077106$1$I$$20230922$20240711$20240711$PER$$JP-PFM-2023-05420$PIERRE FABRE MEDICAMENT$Nakazono M, Kagimoto S, Nakamura S, Koike T, Maegawa J. Dermoscopy as a useful tool for short term monitoring of infantile hemangioma after oral propranolol onset. Eur. J. Pediat. Dermatol. 2022;32(4):204-08$3$MON$$F$Y$$$20240711$$HP$JP$JP
240771071$24077107$1$I$$20231002$20240711$20240711$PER$$ES-PFM-2023-05574$PIERRE FABRE MEDICAMENT$Conthe A, Ibanez-Samaniego L, Munoz MF, Ortega V, Yunquera AF, Romero M et al. Pregnancy outcomes in patients with portal cavernoma: A case series study. Int J Gynecol Obstet. 2023;163(1):277-81$32$YR$$F$Y$$$20240711$$HP$ES$ES
240771081$24077108$1$I$$20231002$20240711$20240711$PER$$ES-PFM-2023-05575$PIERRE FABRE MEDICAMENT$Conthe A, Ibanez-Samaniego L, Munoz MF, Ortega V, Yunquera AF, Romero M et al. Pregnancy outcomes in patients with portal cavernoma: A case series study. Int J Gynecol Obstet. 2023;163(1):277-81$30$YR$$F$Y$$$20240711$$HP$ES$ES
240771091$24077109$1$I$$20230925$20240711$20240711$PER$$RU-PFM-2023-05423$PIERRE FABRE MEDICAMENT$Gandaeva L, Sonicheva-Paterson N, McKenna WJ, Savostyanov K, Myasnikov R, Pushkov A et al. Clinical features of pediatric Danon disease and the importance of early diagnosis. International Journal of Cardiology. 2023;389:1-8$9$YR$$F$Y$$$20240711$$HP$RU$RU
240771103$24077110$3$F$20240522$20240723$20240711$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-033261$AUROBINDO$$87$YR$$M$Y$82$KG$20240802$$HP$GB$GB
240771111$24077111$1$I$$20240603$20240711$20240711$PER$$JP-PFM-2023-05149$PIERRE FABRE MEDICAMENT$Kamiya R et al. A case of regrowth after discontinuing propranolol treatment for infantile haemangioma due to onset of bronchial asthma. Program of the 14th Annual Session of Society for the Study of Vascular Anomalie. 2023;54$6$MON$$M$Y$$$20240711$$MD$JP$JP
240771121$24077112$1$I$$20240709$20240711$20240711$30DAY$$GB-SANDOZ INC.-SDZ2024GB001089$SANDOZ$$$$$F$Y$$$20240711$$CN$GB$GB
240771131$24077113$1$I$$20240709$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA063967$SANDOZ$$48$YR$$F$Y$68$KG$20240711$$HP$CA$CA
240771142$24077114$2$F$$20240702$20240711$20240715$PER$$US-GRANULES-US-2024GRASPO00256$GRANULES INDIA$$$$$F$Y$$$20240715$$CN$US$US
240771151$24077115$1$I$$20230927$20240711$20240711$PER$$FR-PFM-2023-05503$PIERRE FABRE MEDICAMENT$Olivier C, Lamy J-C, Kosutzka Z, Van Hamme A, Cherif S, Lau B et al. Cerebellar Transcranial Alternating Current Stimulation in Essential Tremor Patients with Thalamic Stimulation: A Proof-of-Concept Study. Neurotherapeutics. 2023;20(4):1109 - 1119$$$$$Y$$$20240711$$HP$FR$FR
240771161$24077116$1$I$20190101$20240703$20240711$20240711$EXP$$AR-ROCHE-10000021763$ROCHE$$51$YR$A$M$Y$$$20240711$$CN$AR$AR
240771172$24077117$2$F$$20240802$20240711$20240808$EXP$$JP-CHEPLA-2024008461$CHEPLAPHARM$Masuda S. Lecture Slide. 2024.$$$N$$Y$$$20240808$$HP$COUNTRY NOT SPECIFIED$JP
240771181$24077118$1$I$$20240701$20240711$20240711$30DAY$$US-GSK-US2024083015$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240771192$24077119$2$F$20240601$20240709$20240711$20240720$30DAY$$US-GSK-US2024083220$GLAXOSMITHKLINE$$73$YR$$M$Y$78.458$KG$20240720$$CN$US$US
240771201$24077120$1$I$20240302$20240702$20240711$20240711$EXP$$US-GSK-US2024083079$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240711$$CN$US$US
240771211$24077121$1$I$$20240705$20240711$20240711$30DAY$$US-GSK-US2024084062$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240771222$24077122$2$F$20240602$20240709$20240711$20240723$EXP$$IT-AUROBINDO-AUR-APL-2024-033325$AUROBINDO$$74$YR$$F$Y$$$20240719$$MD$IT$IT
240771231$24077123$1$I$$20240702$20240711$20240711$EXP$FR-AFSSAPS-AVPO2024000119$FR-TEVA-VS-3216619$TEVA$$28$YR$$M$Y$$$20240711$$PH$FR$FR
240771242$24077124$2$F$$20240704$20240711$20240717$EXP$$CA-BIOGEN-2024BI01272621$BIOGEN$$$$$F$Y$$$20240717$$CN$CA$CA
240771251$24077125$1$I$20240707$20240707$20240711$20240711$EXP$$KR-VANTIVE-2024VAN018207$Vantive US Healthcare$$10$YR$$M$Y$$$20240711$$CN$KR$KR
240771261$24077126$1$I$20231220$20240705$20240711$20240711$EXP$FR-AFSSAPS-AVMA2024000261$FR-CHEPLA-2024008561$CHEPLAPHARM$$55$YR$$M$Y$$$20240711$$PH$COUNTRY NOT SPECIFIED$FR
240771272$24077127$2$F$20240601$20240725$20240711$20240805$EXP$$US-RECORDATI-2024005130$RECORDATI$$$$$$Y$$$20240805$$CN$US$US
240771283$24077128$3$F$$20240812$20240711$20240813$PER$$NVSC2024US143305$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
240771291$24077129$1$I$20240101$20240708$20240711$20240711$EXP$$US-ABBVIE-5832795$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240771301$24077130$1$I$$20240708$20240711$20240711$EXP$$US-ARGENX-2024-ARGX-US005250$ARGENX BVBA$$$$$$Y$$$20240711$$HP$US$US
240771311$24077131$1$I$20240702$20240704$20240711$20240711$EXP$$CA-APOTEX-2024AP008036$APOTEX$$67$YR$E$F$Y$$$20240711$$HP$CA$CA
240771321$24077132$1$I$20240619$20240708$20240711$20240711$EXP$$US-ABBVIE-5832265$ABBVIE$$53$YR$$F$Y$$$20240711$$CN$US$US
240771331$24077133$1$I$20240101$20240709$20240711$20240711$EXP$$US-UCBSA-2024034966$UCB$$65$YR$$F$Y$$$20240711$$PH$US$US
240771342$24077134$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3218281$TEVA$Geller A, Martinez Manzano J, Benzaquen S. An Exudative Enigma: Recurrent Pleural Effusions Following Drug-Eluting Bead Transarterial Chemoembolization With Percutaneous Ethanol Injection for Palliative Treatment of Hepatocellular Carcinoma. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Geller A, Martinez Manzano J, Benzaquen S. An Exudative Enigma: Recurrent Pleural Effusions Following Drug-Eluting Bead Transarterial Chemoembolization With Percutaneous Ethanol Injection for Palliative Treatment...$64$YR$$M$Y$$$20240809$$HP$US$US
240771351$24077135$1$I$$20240703$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033125$AUROBINDO$$60$YR$$M$Y$92$KG$20240711$$MD$GB$GB
240771361$24077136$1$I$$20240702$20240711$20240711$EXP$$GB-MSNLABS-2024MSNSPO01491$MSN LABORATORIES$$$$$$Y$$$20240711$$PH$GB$GB
240771371$24077137$1$I$$20240627$20240711$20240711$EXP$$DE-ROCHE-10000019662$ROCHE$$$$E$F$Y$$$20240711$$MD$DE$DE
240771381$24077138$1$I$$20240112$20240711$20240711$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429099$RANBAXY$$$$$F$Y$$$20240711$$CN$US$US
240771391$24077139$1$I$$20240627$20240711$20240711$EXP$$CA-AMGEN-CANSP2024134783$AMGEN$$40$YR$A$F$Y$$$20240711$$HP$CA$CA
240771402$24077140$2$F$20240303$20240806$20240711$20240809$EXP$$US-TAKEDA-2024TUS021999$TAKEDA$$14$YR$$M$Y$$$20240809$$CN$US$US
240771411$24077141$1$I$20230414$20240709$20240711$20240711$EXP$$US-ROCHE-10000021893$ROCHE$$53$YR$A$M$Y$$$20240711$$HP$US$US
240771421$24077142$1$I$20240405$20240705$20240711$20240711$EXP$$US-JNJFOC-20240715812$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240771431$24077143$1$I$20240708$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136701$AMGEN$$35$YR$A$F$Y$$$20240711$$CN$US$US
240771441$24077144$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06337$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240771452$24077145$2$F$20240701$20240723$20240711$20240724$PER$$US-AMGEN-USASP2024136372$AMGEN$$77$YR$E$F$Y$$$20240724$$HP$US$US
240771461$24077146$1$I$$20240701$20240711$20240711$EXP$$ES-ROCHE-10000021276$ROCHE$Fortuny M, Garcia-Calonge M, Arrabal O, Zamparelli M, Castano-Garciat A, Iserte G, et al. Networks in focus: profile of immune-related adverse events in first-line immunotherapy for hepatocellular carcinoma (abstract number: THU-500). Journal of Hepatology. 2024;80 (S1):S455.$$$$$Y$$$20240711$$HP$ES$ES
240771471$24077147$1$I$$20240703$20240711$20240711$EXP$$US-NOVITIUMPHARMA-2024USNVP01196$NOVITIUM PHARMA$Deanda S.Post-transplant Lymphoproliferative Disorder: A Nodular Area That Kept Growing!.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;209:A5942$79$YR$E$F$Y$$$20240711$$HP$US$US
240771481$24077148$1$I$$20240627$20240711$20240711$PER$$US-GRANULES-US-2024GRASPO00257$GRANULES INDIA$$$$$M$Y$$$20240711$$CN$US$US
240771491$24077149$1$I$$20240627$20240711$20240711$EXP$$ZA-ABBVIE-5833959$ABBVIE$$65$YR$$F$Y$$$20240711$$CN$ZA$ZA
240771501$24077150$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06312$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240771511$24077151$1$I$20171217$20240703$20240711$20240711$EXP$$CA-TAKEDA-2018MPI000323$TAKEDA$$63$YR$$M$Y$$$20240711$$MD$CA$CA
240771521$24077152$1$I$$20230808$20240711$20240711$PER$$US-PFM-2023-04527$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.868$KG$20240711$$HP$US$US
240771531$24077153$1$I$$20230808$20240711$20240711$PER$$US-PFM-2023-04529$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.918$KG$20240711$$HP$US$US
240771541$24077154$1$I$20240705$20240705$20240711$20240711$30DAY$$US-GSK-US2024083964$GLAXOSMITHKLINE$$$$$M$Y$$$20240711$$CN$US$US
240771551$24077155$1$I$$20240705$20240711$20240711$30DAY$$US-GSK-US2024AMR084621$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240771561$24077156$1$I$$20230808$20240711$20240711$PER$$US-PFM-2023-04530$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.977$KG$20240711$$HP$US$US
240771571$24077157$1$I$$20240702$20240711$20240711$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024082665$VIIV$$4$DEC$$$Y$$$20240711$$HP$US$US
240771581$24077158$1$I$$20230808$20240711$20240711$PER$$US-PFM-2023-04525$PIERRE FABRE MEDICAMENT$$$$$M$Y$3.968$KG$20240711$$HP$US$US
240771591$24077159$1$I$$20230809$20240711$20240711$PER$$US-PFM-2023-04581$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.299$KG$20240711$$CN$US$US
240771601$24077160$1$I$20230718$20230811$20240711$20240711$PER$$US-PFM-2023-04603$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.6$KG$20240711$$PH$US$US
240771611$24077161$1$I$$20230811$20240711$20240711$PER$$US-PFM-2023-04602$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.499$KG$20240711$$HP$US$US
240771621$24077162$1$I$20230701$20230814$20240711$20240711$PER$$US-PFM-2023-04604$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
240771631$24077163$1$I$$20230815$20240711$20240711$PER$$US-PFM-2023-04607$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.717$KG$20240711$$CN$US$US
240771641$24077164$1$I$$20230811$20240711$20240711$PER$$US-PFM-2023-04600$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.1$KG$20240711$$CN$US$US
240771651$24077165$1$I$$20230814$20240711$20240711$PER$$US-PFM-2023-04605$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.209$KG$20240711$$CN$US$US
240771661$24077166$1$I$20230815$20230816$20240711$20240711$PER$$US-PFM-2023-04654$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
240771671$24077167$1$I$$20230816$20240711$20240711$PER$$US-PFM-2023-04655$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.689$KG$20240711$$CN$US$US
240771681$24077168$1$I$20230809$20230907$20240711$20240711$PER$$DE-PFM-2023-04563$PIERRE FABRE MEDICAMENT$$1$YR$$M$Y$$$20240711$$MD$DE$DE
240771691$24077169$1$I$$20230920$20240711$20240711$PER$$US-PFM-2023-04606$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.599$KG$20240711$$HP$US$US
240771701$24077170$1$I$$20231205$20240711$20240711$PER$$US-PFM-2023-04601$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.26$KG$20240711$$HP$US$US
240771711$24077171$1$I$20230701$20231220$20240711$20240711$PER$$US-PFM-2023-04506$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.95$KG$20240711$$PH$US$US
240771721$24077172$1$I$$20231025$20240711$20240711$PER$$US-PFM-2023-04587$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.05$KG$20240711$$CN$US$US
240771731$24077173$1$I$20230525$20231130$20240711$20240711$PER$$JP-PFM-2023-04522$PIERRE FABRE MEDICAMENT$$1$MON$$M$Y$$$20240711$$MD$JP$JP
240771741$24077174$1$I$$20240312$20240711$20240711$PER$$US-PFM-2023-04586$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.3$KG$20240711$$CN$US$US
240771751$24077175$1$I$20230708$20240708$20240711$20240711$EXP$$US-ABBVIE-5832372$ABBVIE$$72$YR$$F$Y$$$20240711$$CN$US$US
240771763$24077176$3$F$$20240729$20240711$20240805$EXP$$US-BIOGEN-2024BI01273068$BIOGEN$$$$$F$Y$$$20240804$$HP$US$US
240771771$24077177$1$I$$20240705$20240711$20240711$PER$$US-CHATTEMPRD-2024OHG023630$CHATTEM$$$$A$$Y$$$20240711$$CN$US$US
240771785$24077178$5$F$20240701$20240805$20240711$20240808$EXP$$US-ABBVIE-5834611$ABBVIE$$25$YR$$M$Y$$$20240808$$CN$US$US
240771791$24077179$1$I$$20240709$20240711$20240711$PER$$US-JNJFOC-20240723437$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240771801$24077180$1$I$$20230816$20240711$20240711$PER$$US-PFM-2023-04656$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240711$$CN$US$US
240771811$24077181$1$I$$20230817$20240711$20240711$PER$$US-PFM-2023-04687$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.698$KG$20240711$$CN$US$US
240771821$24077182$1$I$$20230817$20240711$20240711$PER$$US-PFM-2023-04658$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.989$KG$20240711$$HP$US$US
240771831$24077183$1$I$$20230817$20240711$20240711$PER$$US-PFM-2023-04686$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.499$KG$20240711$$CN$US$US
240771842$24077184$2$F$$20240812$20240711$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06360$LUPIN$$$$$$Y$$$20240828$$CN$US$US
240771851$24077185$1$I$$20230817$20240711$20240711$PER$$US-PFM-2023-04659$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.499$KG$20240711$$CN$US$US
240771861$24077186$1$I$$20230818$20240711$20240711$PER$$US-PFM-2023-04726$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.338$KG$20240711$$CN$US$US
240771871$24077187$1$I$$20230818$20240711$20240711$PER$$US-PFM-2023-04718$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.698$KG$20240711$$HP$US$US
240771881$24077188$1$I$$20230818$20240711$20240711$PER$$US-PFM-2023-04724$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.299$KG$20240711$$CN$US$US
240771891$24077189$1$I$20230801$20230821$20240711$20240711$PER$$US-PFM-2023-04767$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
240771901$24077190$1$I$$20230821$20240711$20240711$PER$$US-PFM-2023-04768$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.467$KG$20240711$$HP$US$US
240771911$24077191$1$I$$20230822$20240711$20240711$PER$$US-PFM-2023-04796$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.297$KG$20240711$$HP$US$US
240771921$24077192$1$I$$20230822$20240711$20240711$PER$$US-PFM-2023-04795$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.211$KG$20240711$$HP$US$US
240771933$24077193$3$F$$20240730$20240711$20240808$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004889$BIOCON$$$$$$Y$$$20240808$$HP$CA$CA
240771941$24077194$1$I$$20230823$20240711$20240711$PER$$US-PFM-2023-04800$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.599$KG$20240711$$CN$US$US
240771951$24077195$1$I$$20230823$20240711$20240711$PER$$US-PFM-2023-04799$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.8$KG$20240711$$HP$US$US
240771961$24077196$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153241$ASTRAZENECA$$$$$M$Y$$$20240711$$MD$US$
240771971$24077197$1$I$$20231109$20240711$20240711$PER$$US-PFM-2023-04717$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.499$KG$20240711$$CN$US$US
240771982$24077198$2$F$$20240827$20240711$20240904$PER$$US-AstraZeneca-2024A156638$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
240771991$24077199$1$I$$20231128$20240711$20240711$PER$$US-PFM-2023-04727$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.89$KG$20240711$$HP$US$US
240772001$24077200$1$I$$20240105$20240711$20240711$PER$$US-PFM-2023-04798$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.16$KG$20240711$$CN$US$US
240772012$24077201$2$F$$20240823$20240711$20240903$PER$$US-AstraZeneca-2024A148765$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
240772021$24077202$1$I$20230817$20240202$20240711$20240711$PER$$JP-PFM-2023-04778$PIERRE FABRE MEDICAMENT$$7$MON$$M$Y$$$20240711$$PH$JP$JP
240772031$24077203$1$I$20151221$20240701$20240711$20240711$EXP$$JP-AMGEN-JPNCT2024040118$AMGEN$Tomie K, Tomomatsu A, Ogoshi H, Ideguchi R, Kato N, Kitazawa H, et al.. A study on cases of medication-related osteonecrosis of jaw at our hospital. The 68th Congress of the Japanese Society of Oral and Maxillofacial Surgeons. 2023;549$72$YR$E$F$Y$$$20240711$$MD$JP$JP
240772041$24077204$1$I$20240525$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109581$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240711$$CN$US$US
240772051$24077205$1$I$20240601$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109965$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240711$$HP$US$US
240772061$24077206$1$I$$20230824$20240711$20240711$PER$$US-PFM-2023-04809$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.76$KG$20240711$$CN$US$US
240772071$24077207$1$I$$20230823$20240711$20240711$PER$$US-PFM-2023-04801$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.989$KG$20240711$$CN$US$US
240772081$24077208$1$I$$20230825$20240711$20240711$PER$$US-PFM-2023-04881$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.49$KG$20240711$$HP$US$US
240772091$24077209$1$I$$20230825$20240711$20240711$PER$$US-PFM-2023-04885$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.082$KG$20240711$$CN$US$US
240772101$24077210$1$I$$20230824$20240711$20240711$PER$$US-PFM-2023-04802$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.34$KG$20240711$$CN$US$US
240772111$24077211$1$I$$20230825$20240711$20240711$PER$$US-PFM-2023-04883$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.399$KG$20240711$$CN$US$US
240772121$24077212$1$I$20230101$20230921$20240711$20240711$PER$$JP-PFM-2023-04887$PIERRE FABRE MEDICAMENT$$6$MON$$F$Y$$$20240711$$MD$JP$JP
240772131$24077213$1$I$$20231227$20240711$20240711$PER$$US-PFM-2023-04882$PIERRE FABRE MEDICAMENT$$$$$M$Y$14.51$KG$20240711$$CN$US$US
240772141$24077214$1$I$$20240703$20240711$20240711$EXP$$RU-ROCHE-10000018625$ROCHE$$69$YR$E$M$Y$$$20240711$$MD$RU$RU
240772151$24077215$1$I$$20240709$20240711$20240711$PER$$NVSC2024US143314$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240772165$24077216$5$F$20230504$20240805$20240711$20240807$EXP$$CA-ROCHE-3348579$ROCHE$$49$YR$A$F$Y$$$20240807$$CN$CA$CA
240772171$24077217$1$I$$20230830$20240711$20240711$PER$$US-PFM-2023-04966$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.399$KG$20240711$$CN$US$US
240772181$24077218$1$I$$20230825$20240711$20240711$PER$$US-PFM-2023-04895$PIERRE FABRE MEDICAMENT$$$$$M$Y$12$KG$20240711$$CN$US$US
240772191$24077219$1$I$$20230828$20240711$20240711$PER$$US-PFM-2023-04898$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.438$KG$20240711$$CN$US$US
240772201$24077220$1$I$20230829$20230829$20240711$20240711$PER$$US-PFM-2023-04935$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.27$KG$20240711$$CN$US$US
240772211$24077221$1$I$$20230831$20240711$20240711$PER$$US-PFM-2023-04975$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.043$KG$20240711$$CN$US$US
240772221$24077222$1$I$20230801$20230830$20240711$20240711$PER$$US-PFM-2023-04967$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
240772231$24077223$1$I$20221201$20230901$20240711$20240711$PER$FR-AFSSAPS-NY2023001223$FR-PFM-2023-04958$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.7$KG$20240711$$MD$FR$FR
240772241$24077224$1$I$$20230908$20240711$20240711$PER$$US-PFM-2023-05008$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.277$KG$20240711$$CN$US$US
240772251$24077225$1$I$20221109$20230927$20240711$20240711$PER$$JP-PFM-2023-05027$PIERRE FABRE MEDICAMENT$$6$MON$$M$Y$$$20240711$$MD$JP$JP
240772261$24077226$1$I$20221106$20231023$20240711$20240711$PER$$JP-PFM-2023-05003$PIERRE FABRE MEDICAMENT$$12$MON$$M$Y$$$20240711$$MD$JP$JP
240772271$24077227$1$I$$20240110$20240711$20240711$PER$$US-PFM-2023-04936$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.15$KG$20240711$$HP$US$US
240772281$24077228$1$I$$20240117$20240711$20240711$PER$$US-PFM-2023-04897$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.84$KG$20240711$$CN$US$US
240772292$24077229$2$F$$20240726$20240711$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06379$LUPIN$$$$$$Y$$$20240814$$CN$US$US
240772301$24077230$1$I$$20240708$20240711$20240711$PER$$US-ORGANON-O2407USA000875$ORGANON$$$$$$Y$$$20240711$$CN$US$US
240772311$24077231$1$I$20230701$20230803$20240711$20240711$PER$$US-PFM-2023-04461$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
240772321$24077232$1$I$$20230807$20240711$20240711$PER$$US-PFM-2023-04504$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.791$KG$20240711$$CN$US$US
240772331$24077233$1$I$$20230807$20240711$20240711$PER$$US-PFM-2023-04505$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.796$KG$20240711$$HP$US$US
240772341$24077234$1$I$20230406$20230808$20240711$20240711$PER$IT-MINISAL02-938355$IT-PFM-2023-04502$PIERRE FABRE MEDICAMENT$$49$YR$$F$Y$65$KG$20240711$$MD$IT$IT
240772351$24077235$1$I$20230701$20230803$20240711$20240711$PER$$US-PFM-2023-04460$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
240772361$24077236$1$I$$20230810$20240711$20240711$PER$$DE-PFM-2023-04545$PIERRE FABRE MEDICAMENT$Kosian P, Jansen C, Chang J, Praktiknjo M, Ayub TH, Gembruch U et al. Maternal and Perinatal Outcome in a Contemporary Cohort of Patients with Portal Hypertension: A Single-Center Experience. Journal of Clinical Medicine. 2023;12:3088$$$I$$Y$$$20240711$$HP$DE$DE
240772371$24077237$1$I$$20230810$20240711$20240711$PER$$DE-PFM-2023-04531$PIERRE FABRE MEDICAMENT$Kosian P, Jansen C, Chang J, Praktiknjo M, Ayub TH, Gembruch U et al. Maternal and Perinatal Outcome in a Contemporary Cohort of Patients with Portal Hypertension: A Single-Center Experience. Journal of Clinical Medicine. 2023;12:3088$44$YR$$F$Y$$$20240711$$HP$DE$DE
240772381$24077238$1$I$$20230810$20240711$20240711$PER$$DE-PFM-2023-04532$PIERRE FABRE MEDICAMENT$Kosian P, Jansen C, Chang J, Praktiknjo M, Ayub TH, Gembruch U et al. Maternal and Perinatal Outcome in a Contemporary Cohort of Patients with Portal Hypertension: A Single-Center Experience. Journal of Clinical Medicine. 2023;12:3088$38$YR$$F$Y$$$20240711$$HP$DE$DE
240772391$24077239$1$I$$20230828$20240711$20240711$PER$$IT-PFM-2023-04875$PIERRE FABRE MEDICAMENT$Volonte M, Codazzi AC, Davidovich S, Apicella A, Isoletta E, Barruscotti S et al. Propranolol for the treatment of infantile hemangiomas: a nine-year monocentric experience from a tertiary hospital. Eur J Dermatol. 2023;33(3):265-9$$$$$Y$$$20240711$$HP$IT$IT
240772401$24077240$1$I$$20230905$20240711$20240711$PER$$US-PFM-2023-05033$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.397$KG$20240711$$CN$US$US
240772411$24077241$1$I$$20240124$20240711$20240711$PER$$US-PFM-2023-04899$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.338$KG$20240711$$CN$US$US
240772421$24077242$1$I$$20240411$20240711$20240711$PER$$US-PFM-2023-04725$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.6$KG$20240711$$CN$US$US
240772431$24077243$1$I$$20240426$20240711$20240711$PER$$US-PFM-2023-04723$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.38$KG$20240711$$CN$US$US
240772441$24077244$1$I$$20240605$20240711$20240711$PER$$US-PFM-2023-04808$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.177$KG$20240711$$CN$US$US
240772453$24077245$3$F$20240101$20240911$20240711$20240912$PER$$US-AMGEN-USASP2024136842$AMGEN$$51$YR$A$F$Y$$$20240912$$CN$US$US
240772464$24077246$4$F$20240701$20240806$20240711$20240810$PER$$US-AMGEN-USASP2024136864$AMGEN$$72$YR$E$F$Y$$$20240810$$CN$US$US
240772471$24077247$1$I$20240705$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136833$AMGEN$$59$YR$A$F$Y$$$20240711$$CN$US$US
240772482$24077248$2$F$$20240917$20240711$20240923$EXP$$US-JNJFOC-20240722700$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$HP$US$US
240772492$24077249$2$F$$20240725$20240711$20240805$EXP$$DE-AUROBINDO-AUR-APL-2024-033322$AUROBINDO$$17$YR$$F$Y$$$20240805$$MD$DE$DE
240772501$24077250$1$I$$20230814$20240711$20240711$PER$$US-PFM-2023-04681$PIERRE FABRE MEDICAMENT$Luca DGD, Mohney NJ, Kottapally M. Paroxysmal Sympathetic Hyperactivity  with Dystonia Following Non-traumatic Bilateral  Thalamic and Cerebellar Hemorrhage. Neurocrit Care. 2019$53$YR$$M$Y$$$20240711$$HP$US$US
240772511$24077251$1$I$$20230814$20240711$20240711$PER$$US-PFM-2023-04653$PIERRE FABRE MEDICAMENT$Siefferman JW, Lai G. Propranolol for Paroxysmal Sympathetic Hyperactivity with Lateralizing Hyperhidrosis after Stroke. Case Reports in Neurological Medicine. 2015;1-3$41$YR$$M$Y$$$20240711$$HP$US$US
240772521$24077252$1$I$$20230814$20240711$20240711$PER$$TR-PFM-2023-04642$PIERRE FABRE MEDICAMENT$Kavgaci A, Incedere F, Terlemez S, Kula S. Successful treatment of two cases of acute myocarditis with colchicine. Cardiology in the Young. 2023;1-2$11$YR$$M$Y$$$20240711$$HP$TR$TR
240772531$24077253$1$I$$20230807$20240711$20240711$PER$$NL-PFM-2023-04546$PIERRE FABRE MEDICAMENT$Swinnen BEKS, Bergers M, Babeliowsky WA, Torres-Russotto D, Bie RMAde, Rootselaar AFV. Dutch translation, adaptation and validation of the OT-10 scale for orthostatic tremor. Clinical Parkinsonism + Related Disorders. 2023;9:1-4$$$$$Y$$$20240711$$HP$NL$NL
240772541$24077254$1$I$$20230822$20240711$20240711$PER$$RO-PFM-2023-04752$PIERRE FABRE MEDICAMENT$Sus I, Suteu C, Dobreanu D. Cardiac resynchronisation therapy in a pace-dependent infant with tetralogy of Fallot. Cardiology in the Young. 2022;32:849-52$5$MON$$F$Y$$$20240711$$HP$RO$RO
240772551$24077255$1$I$$20230814$20240711$20240711$PER$$JP-PFM-2023-04652$PIERRE FABRE MEDICAMENT$Yamada H, Kikuchi R, Katayama J, Nakamura A, Miyazaki H. Paroxysmal Sympathetic Hyperactivity after Surgery for Cerebral Hemorrhagic Arteriovenous Malformation: A Case Report. Journal of Stroke and Cerebrovascular Diseases. 2018;27:2768-9$17$YR$$M$Y$$$20240711$$HP$JP$JP
240772561$24077256$1$I$$20230817$20240711$20240711$PER$$US-PFM-2023-04715$PIERRE FABRE MEDICAMENT$Ezeh UC, Ben-Dov T, Taufique ZM, Gaffey MM, Blei F, April MM. A New Approach for Diagnosis and Surveillance of Infantile Subglottic Hemangioma in the Era of Propranolol Use: A Case Series. Annals of Otology, Rhinology + Laryngology. 2023;00(0):1-7$3$MON$$F$Y$$$20240711$$HP$US$US
240772571$24077257$1$I$$20230828$20240711$20240711$PER$$IT-PFM-2023-04872$PIERRE FABRE MEDICAMENT$Adorisio R, Cantarutti N, Ingrasciotta G, Mencarelli E, Bellettini E, Grandinetti M et al. High dosage of propranolol prolongs survival in newborns with hypertrophic cardiomyopathy associated to noonan syndrome and mitochondrial diseases. 56th Annual Meeting of the AEPC. 2023;S233$$$N$$Y$$$20240711$$HP$IT$IT
240772581$24077258$1$I$$20230828$20240711$20240711$PER$$DE-PFM-2023-04890$PIERRE FABRE MEDICAMENT$Forderer NM, Michel J, Bobrowski A, Akinturk H, Schlensak C, Mustafi M et al. Treatment and outcome in patients with congenital idiopathic dilatation of the right or left atrium a report of seven cases. Cardiology in the Young. Conference: 56th Annual Meeting of the AEPC. 2023;33 (Suppl 1):S137-8$$$$$Y$$$20240711$$HP$DE$DE
240772591$24077259$1$I$$20230828$20240711$20240711$PER$$PT-PFM-2023-04873$PIERRE FABRE MEDICAMENT$Pereira M, Almeida C, Sarmento J, Miranda J. Refractory fetal and neonatal supraventricular tachycardia associated with mitral valve mass: A case report. Cardiology in the Young. 2023;33(1):84$9$DY$$F$Y$$$20240711$$HP$PT$PT
240772601$24077260$1$I$$20230828$20240711$20240711$PER$$PT-PFM-2023-04879$PIERRE FABRE MEDICAMENT$Lourenco G, Laranjo S, Oliveira M, Trigo C, Pinto FF. Incessant post-operative arrhythmia in a toddler-when the usual therapy is not enough. Cardiology in the Young. Conference:56th Annual Meeting of the AEPC. 2023;33 (Suppl 1):S94$8$MON$$M$Y$8.35$KG$20240711$$HP$PT$PT
240772612$24077261$2$F$$20240801$20240711$20240805$PER$$US-ALXN-202407USA000351US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240772621$24077262$1$I$$20230901$20240711$20240711$PER$$HR-PFM-2023-04868$PIERRE FABRE MEDICAMENT$Gasparini D, Raljevic D, Pehar-Pejcinovic V, Gembic TK, Persic V, Wensveen TT. When amiodarone-induced thyroiditis meets cardiomyopathy with excessive trabeculation: a case report. Frontiers in Cardiovascular Medicine. 2023;10:1212965:1-7$36$YR$$$Y$$$20240711$$HP$HR$HR
240772631$24077263$1$I$$20230814$20240711$20240711$PER$$TR-PFM-2023-04644$PIERRE FABRE MEDICAMENT$Kavgaci A, Incedere F, Terlemez S, Kula S. Successful treatment of two cases of acute myocarditis with colchicine. Cardiology in the Young. 2023;1-2$12$YR$$F$Y$$$20240711$$HP$TR$TR
240772641$24077264$1$I$$20230817$20240711$20240711$PER$$TR-PFM-2023-04703$PIERRE FABRE MEDICAMENT$Gul O, Kafali HC, and Ergul Y. Successful treatment of the focal ectopic atrial tachycardia in an infant with a single dose of ivabradin. Cardiology in the Young. 2023;1-3$7$MON$$M$Y$$$20240711$$HP$TR$TR
240772651$24077265$1$I$$20230901$20240711$20240711$PER$$JP-PFM-2023-04987$PIERRE FABRE MEDICAMENT$Toshinari H. Practical use of oral propranolol therapy for infantile haemangioma$7$MON$$F$Y$$$20240711$$MD$JP$JP
240772661$24077266$1$I$$20230822$20240711$20240711$PER$$TR-PFM-2023-04754$PIERRE FABRE MEDICAMENT$Tasci O, Karadeniz C. Ivabradine in a 15-day-old male neonate with refractory focal atrial tachycardia. Pacing Clin Electrophysiol. 2023;46:924-7$15$DY$$M$Y$$$20240711$$HP$TR$TR
240772671$24077267$1$I$$20231106$20240711$20240711$PER$$BE-PFM-2023-04919$PIERRE FABRE MEDICAMENT$Claes L, Schil K, Dewals W, Beysen D. A Severe Form of Familial Desminopathy Due to a Homozygous Nonsense DES Variant in Two Siblings. Neuropediatrics. 2023;54:279-86$11$YR$$M$Y$$$20240711$$HP$BE$BE
240772681$24077268$1$I$$20230915$20240711$20240711$PER$$CA-PFM-2023-05012$PIERRE FABRE MEDICAMENT$Yoshida K, Muller DJ and Desarkar P. Psychiatric manifestations of Kleefstra syndrome: a case report. Frontiers in Psychiatry. 2023;14:1174195:1-6$9$YR$$M$Y$$$20240711$$MD$CA$CA
240772692$24077269$2$F$20240614$20240812$20240711$20240812$EXP$FR-AFSSAPS-NY2024000735$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039164$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240812$$PH$FR$FR
240772701$24077270$1$I$$20240704$20240711$20240711$EXP$$NVSC2024BR141485$NOVARTIS$$$$$F$Y$$$20240711$$HP$BR$BR
240772711$24077271$1$I$20160101$20240703$20240711$20240711$EXP$ES-AEMPS-1537765$ES-TEVA-VS-3216949$TEVA$$42$YR$$M$Y$83$KG$20240711$$CN$ES$ES
240772735$24077273$5$F$20240704$20240905$20240711$20240910$EXP$$KR-ABBVIE-5832966$ABBVIE$$74$YR$$M$Y$76$KG$20240910$$MD$KR$KR
240772741$24077274$1$I$20221201$20230703$20240711$20240711$PER$FR-AFSSAPS-NY2023000903$FR-PFM-2023-03810$PIERRE FABRE MEDICAMENT$$8$MON$$F$Y$5.1$KG$20240711$$MD$FR$FR
240772751$24077275$1$I$$20230703$20240711$20240711$PER$$US-PFM-2023-03837$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.299$KG$20240711$$CN$US$US
240772761$24077276$1$I$$20230703$20240711$20240711$PER$$US-PFM-2023-03838$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.1$KG$20240711$$CN$US$US
240772771$24077277$1$I$20230701$20230703$20240711$20240711$PER$$US-PFM-2023-03836$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.268$KG$20240711$$CN$US$US
240772781$24077278$1$I$$20230801$20240711$20240711$PER$$CA-PFM-2023-04382$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
240772791$24077279$1$I$$20230801$20240711$20240711$PER$$CA-PFM-2023-04388$PIERRE FABRE MEDICAMENT$$46$YR$$F$Y$$$20240711$$MD$CA$CA
240772801$24077280$1$I$$20230801$20240711$20240711$PER$$CA-PFM-2023-04387$PIERRE FABRE MEDICAMENT$$31$YR$$F$Y$$$20240711$$MD$CA$CA
240772811$24077281$1$I$$20230801$20240711$20240711$PER$$CA-PFM-2023-04386$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240711$$MD$CA$CA
240772821$24077282$1$I$20240101$20240703$20240711$20240711$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109490$ZYDUS PHARM$$$$$$Y$$$20240711$$CN$US$US
240772831$24077283$1$I$$20240708$20240711$20240711$EXP$$US-BIOGEN-2024BI01272891$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240772841$24077284$1$I$20240705$20240705$20240711$20240711$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109489$ZYDUS PHARM$$$$$$Y$$$20240711$$PH$US$US
240772851$24077285$1$I$20240601$20240709$20240711$20240711$EXP$$US-BIOGEN-2024BI01273064$BIOGEN$$67$YR$$M$Y$$$20240711$$CN$US$US
240772861$24077286$1$I$$20230803$20240711$20240711$PER$$US-PFM-2023-04451$PIERRE FABRE MEDICAMENT$Cegielski V, Gratton S. Case report: Left gaze and facial nerve palsies after ventral intermediate thalamic nucleus deep brain stimulation implantation. Frontiers in Neurology. 2023;14:1130087$69$YR$$F$Y$$$20240711$$MD$US$US
240772871$24077287$1$I$$20230817$20240711$20240711$PER$$US-PFM-2023-04713$PIERRE FABRE MEDICAMENT$Ezeh UC, Ben-Dov T, Taufique ZM, Gaffey MM, Blei F, April MM. A New Approach for Diagnosis and Surveillance of Infantile Subglottic Hemangioma in the Era of Propranolol Use: A Case Series. Annals of Otology, Rhinology and Laryngology. 2023;00(0):1-7$6$WK$$F$Y$$$20240711$$HP$US$US
240772881$24077288$1$I$$20230801$20240711$20240711$PER$$CA-PFM-2023-04383$PIERRE FABRE MEDICAMENT$$45$YR$$F$Y$$$20240711$$MD$CA$CA
240772891$24077289$1$I$$20230801$20240711$20240711$PER$$CA-PFM-2023-04385$PIERRE FABRE MEDICAMENT$$45$YR$$F$Y$$$20240711$$MD$CA$CA
240772901$24077290$1$I$$20230817$20240711$20240711$PER$$US-PFM-2023-04714$PIERRE FABRE MEDICAMENT$Ezeh UC, Ben-Dov T, Taufique ZM, Gaffey MM, Blei F, April MM. A New Approach for Diagnosis and Surveillance of Infantile Subglottic Hemangioma in the Era of Propranolol Use: A Case Series. Annals of Otology, Rhinology + Laryngology. 2023;00(0):1-7$2$MON$$M$Y$$$20240711$$HP$US$US
240772911$24077291$1$I$$20240103$20240711$20240711$PER$$US-PFM-2023-03856$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.99$KG$20240711$$CN$US$US
240772921$24077292$1$I$$20240628$20240711$20240711$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109367$ZYDUS PHARM$Aljbour Almajali D, Cherabuddi MR, Ayyad A, Fram F, Abu Sayf A.. Brivaracetam-related neurological decline in a patient with complex medical history.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240711$$HP$US$US
240772931$24077293$1$I$$20240628$20240711$20240711$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109349$ZYDUS PHARM$Sasidharan S, Ouyang J, Jatoi T, Mallappallil M, Puri I, Agarwal S.. Myxedema coma triggering BRASH syndrome.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240711$$HP$US$US
240772941$24077294$1$I$$20231018$20240711$20240711$PER$$CA-PFM-2023-04380$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240711$$MD$CA$CA
240772951$24077295$1$I$$20240606$20240711$20240711$PER$$JP-PFM-2023-04870$PIERRE FABRE MEDICAMENT$Watanabe K, Maruo Y, Takeda A. Efficacy of cibenzoline for hypertrophic obstructive cardiomyopathy in pediatric patients with RAS/MAPK pathway syndromes. 56th Annual Meeting of the AEPC. 2023;33:1007-9$5$MON$$M$Y$$$20240711$$HP$JP$JP
240772961$24077296$1$I$20240101$20240701$20240711$20240711$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109220$ZYDUS PHARM$$$$$$Y$$$20240711$$PH$US$US
240772972$24077297$2$F$$20240821$20240711$20240823$EXP$$CA-TAKEDA-2024TUS069969$TAKEDA$$$$$M$Y$$$20240823$$MD$CA$CA
240772981$24077298$1$I$$20240606$20240711$20240711$PER$$JP-PFM-2023-04869$PIERRE FABRE MEDICAMENT$Watanabe K, Maruo Y, Takeda A,. Efficacy of cibenzoline for hypertrophic obstructive cardiomyopathy in pediatric patients with RAS/MAPK pathway syndromes. 56th Annual Meeting of the AEPC. 2023;33:1007-9$1$YR$$M$Y$$$20240711$$HP$JP$JP
240772991$24077299$1$I$20200907$20240510$20240711$20240711$PER$$JP-PFM-2023-05007$PIERRE FABRE MEDICAMENT$Yasuda M et al. Clinical study of oral propranolol therapy in 136 cases of infantile haemangioma. Programme and abstracts of the 47th Annual Meeting of the JSPD. 2023;83$155$DY$$F$Y$$$20240711$$MD$JP$JP
240773001$24077300$1$I$20231101$20231130$20240711$20240711$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-101036$ZYDUS PHARM$$$$$$Y$$$20240711$$CN$US$US
240773011$24077301$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06346$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240773021$24077302$1$I$$20240701$20240711$20240711$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109224$ZYDUS PHARM$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM.. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.. Arch-Dermatol-Res. 2024;316 No. 6.$$$$$Y$$$20240711$$HP$US$US
240773031$24077303$1$I$$20240703$20240711$20240711$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109493$ZYDUS PHARM$$$$$$Y$$$20240711$$HP$US$US
240773041$24077304$1$I$20230626$20230814$20240711$20240711$PER$$US-PFM-2023-03860$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$5.44$KG$20240711$$PH$US$US
240773051$24077305$1$I$$20230705$20240711$20240711$PER$$US-PFM-2023-03857$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.977$KG$20240711$$CN$US$US
240773061$24077306$1$I$$20230727$20240711$20240711$PER$$US-PFM-2023-03858$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.599$KG$20240711$$CN$US$US
240773071$24077307$1$I$$20230706$20240711$20240711$PER$$US-PFM-2023-03859$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.458$KG$20240711$$HP$US$US
240773081$24077308$1$I$$20231020$20240711$20240711$PER$$US-PFM-2023-03887$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.236$KG$20240711$$CN$US$US
240773091$24077309$1$I$$20240620$20240711$20240711$PER$$US-JNJFOC-20240656555$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240711$$CN$US$US
240773103$24077310$3$F$$20240801$20240711$20240809$EXP$$US-AstraZeneca-2024A153514$ASTRAZENECA$$70$YR$$F$Y$68$KG$20240809$$CN$US$
240773111$24077311$1$I$$20240707$20240711$20240711$PER$$US-AstraZeneca-2024A156457$ASTRAZENECA$$$$$$Y$$$20240711$$CN$US$
240773122$24077312$2$F$20240705$20240729$20240711$20240806$PER$$US-AstraZeneca-2024A155230$ASTRAZENECA$$22289$DY$$F$Y$90$KG$20240806$$MD$US$
240773132$24077313$2$F$$20240711$20240711$20240723$PER$$US-AstraZeneca-2024A155257$ASTRAZENECA$$$$$F$Y$59$KG$20240723$$CN$US$
240773141$24077314$1$I$$20240705$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-034144$AUROBINDO$$$$$F$Y$$$20240711$$PH$GB$GB
240773151$24077315$1$I$$20230706$20240711$20240711$PER$$US-PFM-2023-03914$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.898$KG$20240711$$CN$US$US
240773161$24077316$1$I$$20230706$20240711$20240711$PER$$US-PFM-2023-03917$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.1$KG$20240711$$HP$US$US
240773171$24077317$1$I$$20230707$20240711$20240711$PER$$US-PFM-2023-03948$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.49$KG$20240711$$HP$US$US
240773181$24077318$1$I$$20230706$20240711$20240711$PER$$US-PFM-2023-03916$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.211$KG$20240711$$CN$US$US
240773191$24077319$1$I$20230601$20240703$20240711$20240711$EXP$$JP-ROCHE-10000020049$ROCHE$$$$A$$Y$$$20240711$$MD$JP$JP
240773201$24077320$1$I$$20230707$20240711$20240711$PER$$US-PFM-2023-03949$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.497$KG$20240711$$CN$US$US
240773211$24077321$1$I$20230710$20230710$20240711$20240711$PER$$US-PFM-2023-03952$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.54$KG$20240711$$PH$US$US
240773221$24077322$1$I$$20230710$20240711$20240711$PER$$US-PFM-2023-03951$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.163$KG$20240711$$CN$US$US
240773231$24077323$1$I$$20230710$20240711$20240711$PER$$US-PFM-2023-03950$PIERRE FABRE MEDICAMENT$$$$$M$Y$3.578$KG$20240711$$HP$US$US
240773241$24077324$1$I$$20230711$20240711$20240711$PER$$US-PFM-2023-04005$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240711$$MD$US$US
240773251$24077325$1$I$$20230711$20240711$20240711$PER$$US-PFM-2023-04009$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.388$KG$20240711$$CN$US$US
240773261$24077326$1$I$$20230711$20240711$20240711$PER$$US-PFM-2023-04010$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.66$KG$20240711$$CN$US$US
240773271$24077327$1$I$$20230711$20240711$20240711$PER$$US-PFM-2023-04007$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.771$KG$20240711$$CN$US$US
240773281$24077328$1$I$$20230711$20240711$20240711$PER$$US-PFM-2023-04006$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.68$KG$20240711$$CN$US$US
240773291$24077329$1$I$$20230711$20240711$20240711$PER$$US-PFM-2023-04008$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.878$KG$20240711$$CN$US$US
240773301$24077330$1$I$$20240215$20240711$20240711$PER$$US-PFM-2023-03915$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.68$KG$20240711$$CN$US$US
240773312$24077331$2$F$20240601$20240805$20240711$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106618$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240807$$CN$US$US
240773321$24077332$1$I$$20240701$20240711$20240711$PER$$US-ABBVIE-5833513$ABBVIE$$$$$$Y$$$20240711$$HP$US$US
240773331$24077333$1$I$$20230703$20240711$20240711$PER$$DE-PFM-2023-03831$PIERRE FABRE MEDICAMENT$Loeffler MA, Synofzik M, Cebi I, Klocke P, Hormozi M, Gasser T et al. Case Report: Deep brain stimulation improves tremor in FGF-14 associated spinocerebellar ataxia. Frontiers in Neurology. 2022;13:1-7$7$YR$$M$Y$$$20240711$$HP$DE$DE
240773341$24077334$1$I$$20230703$20240711$20240711$PER$$DE-PFM-2023-03826$PIERRE FABRE MEDICAMENT$Buchhorn R. Therapeutic Approaches to Dysautonomia in Childhood, with a Special Focus on Long COVID. Children. 2023;10:316$$$$$Y$$$20240711$$HP$DE$DE
240773351$24077335$1$I$$20230710$20240711$20240711$PER$$JP-PFM-2023-04073$PIERRE FABRE MEDICAMENT$Kurakazu K et al. A case successfully treated with early endovascular treatment for neonatal giant haemangioma of liver with hydrops foetalis (P-369). The 59th Japan Society of Perinatal and Neonatal Medicine. 2023;431$3$DY$$M$Y$4.023$KG$20240711$$HP$JP$JP
240773361$24077336$1$I$$20230710$20240711$20240711$PER$$KR-PFM-2023-03994$PIERRE FABRE MEDICAMENT$Hwang HW, Lee SB, Shin J, Choi GS, Byun JW. A Case of Perineal Hemangioma, External Genitalia  Malformations, Lipomyelomeningocele, Vesicorenal  Abnormalities, Imperforate Anus, and Skin Tag (PELVIS) Syndrome with Extensive Perineal Infantile Hemangioma. Annals of Dermatology. 2023;35(Suppl 1):S88-92$2$MON$$F$Y$$$20240711$$HP$KR$KR
240773371$24077337$1$I$$20230710$20240711$20240711$PER$$RO-PFM-2023-03996$PIERRE FABRE MEDICAMENT$Stanciulescu MC, Dorobantu FR, Boia ES, Popoiu MC, Cerbu S, Heredea R et al. ^Face(s)^ of a PHACE(S) Syndrome Patient before and after Therapy: Particular Case Report and Review of Literature. Children. 2022;9:1970$1$MON$$F$Y$$$20240711$$HP$RO$RO
240773381$24077338$1$I$$20230711$20240711$20240711$PER$$RO-PFM-2023-03999$PIERRE FABRE MEDICAMENT$Sasu AB, Serban DL, Ureche C. Anaphylaxis at minimal sensitization. Acta Medica Marisiensis. 2023;69(Suppl. 1):226$23$YR$$F$Y$$$20240711$$HP$RO$RO
240773391$24077339$1$I$$20230710$20240711$20240711$PER$$DE-PFM-2023-03997$PIERRE FABRE MEDICAMENT$Wilke PI, Biermann D, Grafmann M, Kozlik-Feldmann R, Papingi D et al. Siblings with Gorlin-Goltz syndrome  associated with cardiac tumors: a case report  and review of literature. Orphanet Journal of Rare Diseases. 2023;18(178):1-10$3$YR$$F$Y$$$20240711$$HP$DE$DE
240773401$24077340$1$I$20240628$20240703$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106724$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$68$KG$20240711$$PH$US$US
240773411$24077341$1$I$$20230711$20240711$20240711$PER$$US-PFM-2023-04011$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.147$KG$20240711$$HP$US$US
240773421$24077342$1$I$20230601$20230712$20240711$20240711$PER$$US-PFM-2023-04040$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
240773431$24077343$1$I$$20230712$20240711$20240711$PER$$US-PFM-2023-04013$PIERRE FABRE MEDICAMENT$$$$$F$Y$14.417$KG$20240711$$HP$US$US
240773441$24077344$1$I$$20230712$20240711$20240711$PER$$US-PFM-2023-04014$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.349$KG$20240711$$CN$US$US
240773451$24077345$1$I$$20230713$20240711$20240711$PER$$US-PFM-2023-04041$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.476$KG$20240711$$HP$US$US
240773461$24077346$1$I$$20240701$20240711$20240711$EXP$$JP-ROCHE-10000017690$ROCHE$Ando K, Ezawa K, Hoshino Y, Sato K, Uno S, Onuki Y et al.. 58 A case where persistent SARS-CoV-2 infection was cured by combination therapy with remdesivir and nirmatrelvir/ritonavir. The 696th Kanto Regional Meeting of the Japanese Society of Internal Medicine. 2024$69$YR$E$F$Y$$$20240711$$MD$JP$JP
240773471$24077347$1$I$$20230715$20240711$20240711$PER$$TR-PFM-2023-04110$PIERRE FABRE MEDICAMENT$Cetin S, Guven M, Bolayir B, Simsek M, Soylu H, Genes D et al. Can a novel drug dose be used for T3 suppression test?. Endocrine. 2023$$$A$$Y$$$20240711$$HP$TR$TR
240773481$24077348$1$I$$20230714$20240711$20240711$PER$$US-PFM-2023-04105$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.499$KG$20240711$$HP$US$US
240773491$24077349$1$I$$20230713$20240711$20240711$PER$$US-PFM-2023-04080$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.397$KG$20240711$$CN$US$US
240773501$24077350$1$I$$20230717$20240711$20240711$PER$$US-PFM-2023-04106$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.082$KG$20240711$$HP$US$US
240773511$24077351$1$I$$20230718$20240711$20240711$PER$$US-PFM-2023-04136$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.238$KG$20240711$$CN$US$US
240773521$24077352$1$I$20230601$20230718$20240711$20240711$PER$$US-PFM-2023-04164$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
240773531$24077353$1$I$$20230718$20240711$20240711$PER$$US-PFM-2023-04166$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.361$KG$20240711$$CN$US$US
240773541$24077354$1$I$$20230710$20240711$20240711$PER$$HR-PFM-2023-03992$PIERRE FABRE MEDICAMENT$Prlic MF, Jelakovic M, Brinar M, Grgic D, Romic I, Marusic Z et al. Case report: Sevelamer-associated colitis-a cause of pseudotumor formation with colon perforation and life-threatening bleeding. Frontiers in Medicine. 2023;10:1097469:1-6$74$YR$$F$Y$$$20240711$$HP$HR$HR
240773551$24077355$1$I$$20240705$20240711$20240711$EXP$$BR-BIOGEN-2024BI01272809$BIOGEN$$$$$F$Y$70$KG$20240711$$CN$BR$BR
240773571$24077357$1$I$$20230719$20240711$20240711$PER$$JP-PFM-2023-04251$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$PH$JP$JP
240773581$24077358$1$I$$20230719$20240711$20240711$PER$$US-PFM-2023-04167$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.057$KG$20240711$$CN$US$US
240773591$24077359$1$I$$20230720$20240711$20240711$PER$$US-PFM-2023-04205$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.798$KG$20240711$$HP$US$US
240773601$24077360$1$I$$20230719$20240711$20240711$PER$$US-PFM-2023-04168$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.329$KG$20240711$$CN$US$US
240773611$24077361$1$I$$20230720$20240711$20240711$PER$$US-PFM-2023-04203$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.2$KG$20240711$$CN$US$US
240773621$24077362$1$I$$20230720$20240711$20240711$PER$$US-PFM-2023-04204$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.478$KG$20240711$$HP$US$US
240773631$24077363$1$I$20230719$20230720$20240711$20240711$PER$$US-PFM-2023-04209$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$HP$US$US
240773641$24077364$1$I$$20230720$20240711$20240711$PER$$US-PFM-2023-04202$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.717$KG$20240711$$CN$US$US
240773651$24077365$1$I$$20230721$20240711$20240711$PER$$US-PFM-2023-04208$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.057$KG$20240711$$CN$US$US
240773661$24077366$1$I$$20230725$20240711$20240711$PER$$US-PFM-2023-04257$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.637$KG$20240711$$CN$US$US
240773671$24077367$1$I$20230703$20230726$20240711$20240711$PER$$US-PFM-2023-04297$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.349$KG$20240711$$PH$US$US
240773681$24077368$1$I$$20230726$20240711$20240711$PER$$US-PFM-2023-04300$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.388$KG$20240711$$CN$US$US
240773691$24077369$1$I$$20230727$20240711$20240711$PER$$US-PFM-2023-04303$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.567$KG$20240711$$HP$US$US
240773701$24077370$1$I$$20230727$20240711$20240711$PER$$US-PFM-2023-04302$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.884$KG$20240711$$CN$US$US
240773711$24077371$1$I$$20230828$20240711$20240711$PER$$US-PFM-2023-04079$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.977$KG$20240711$$CN$US$US
240773721$24077372$1$I$$20230809$20240711$20240711$PER$$US-PFM-2023-04015$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.29$KG$20240711$$CN$US$US
240773731$24077373$1$I$$20230908$20240711$20240711$PER$$US-PFM-2023-04012$PIERRE FABRE MEDICAMENT$$$$$M$Y$8$KG$20240711$$CN$US$US
240773741$24077374$1$I$$20231128$20240711$20240711$PER$$US-PFM-2023-04039$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.989$KG$20240711$$HP$US$US
240773751$24077375$1$I$$20231027$20240711$20240711$PER$$US-PFM-2023-04165$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.6$KG$20240711$$CN$US$US
240773762$24077376$2$F$$20240708$20240711$20240829$PER$$US-AMGEN-USASP2024135844$AMGEN$$83$YR$E$F$Y$$$20240829$$MD$US$US
240773771$24077377$1$I$$20240708$20240711$20240711$EXP$$US-TAKEDA-2024TUS069788$TAKEDA$$$$$M$Y$$$20240711$$MD$US$US
240773781$24077378$1$I$$20230727$20240711$20240711$PER$$US-PFM-2023-04301$PIERRE FABRE MEDICAMENT$$$$$F$Y$53.991$KG$20240711$$CN$US$US
240773791$24077379$1$I$20240101$20240702$20240711$20240711$PER$$US-TEVA-VS-3216770$TEVA$$$$$$Y$$$20240711$$CN$US$US
240773801$24077380$1$I$$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024137279$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240773811$24077381$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135213$AMGEN$$$$$M$Y$$$20240711$$CN$US$US
240773821$24077382$1$I$20230701$20230728$20240711$20240711$PER$$US-PFM-2023-04343$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
240773831$24077383$1$I$$20230731$20240711$20240711$PER$$US-PFM-2023-04369$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240711$$HP$US$US
240773841$24077384$1$I$$20230731$20240711$20240711$PER$$BE-PFM-2023-04415$PIERRE FABRE MEDICAMENT$Cortier J, Vandamme S, Vanhauwaert D, Maenhoudt W, Lerbeirghe J, Tack P et al. Deep brain stimulation in Bassen-Kornzweig syndrome: Still effective after 22 years. Brain and Spine. 2023;3:101762$17$YR$$M$Y$$$20240711$$HP$BE$BE
240773851$24077385$1$I$20240525$20240701$20240711$20240711$EXP$$JP-ROCHE-10000020674$ROCHE$$76$YR$E$F$Y$$$20240711$$MD$JP$JP
240773861$24077386$1$I$20240604$20240704$20240711$20240711$EXP$$CN-ROCHE-10000016917$ROCHE$$54$YR$A$M$Y$73$KG$20240711$$HP$CN$CN
240773871$24077387$1$I$$20230731$20240711$20240711$PER$$DE-PFM-2023-04419$PIERRE FABRE MEDICAMENT$Kosian P, Jansen C, Chang J, Praktiknjo M, Ayub TH, Gembruch U et al. Maternal and Perinatal Outcome in a Contemporary Cohort of Patients with Portal Hypertension: A Single-Center Experience. Journal of Clinical Medicine. 2023;12:3088$27$YR$$F$Y$$$20240711$$HP$DE$DE
240773881$24077388$1$I$$20230731$20240711$20240711$PER$$IT-PFM-2023-04414$PIERRE FABRE MEDICAMENT$Giuseppina D, Gabriele P, Clotilde S, Giulia R, Elena R, Serena M et al. Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/ paraganglioma a retrospective study. World Journal of Surgical Oncology. 2023;21:192$$$$$Y$$$20240711$$HP$IT$IT
240773891$24077389$1$I$$20230731$20240711$20240711$PER$$US-PFM-2023-04368$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.896$KG$20240711$$CN$US$US
240773901$24077390$1$I$$20230731$20240711$20240711$PER$$US-PFM-2023-04413$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.58$KG$20240711$$HP$US$US
240773911$24077391$1$I$$20230731$20240711$20240711$PER$$US-PFM-2023-04412$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.238$KG$20240711$$HP$US$US
240773921$24077392$1$I$20230601$20230731$20240711$20240711$PER$$US-PFM-2023-04411$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
240773931$24077393$1$I$$20230731$20240711$20240711$PER$$US-PFM-2023-04370$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.907$KG$20240711$$HP$US$US
240773941$24077394$1$I$$20230801$20240711$20240711$PER$$US-PFM-2023-04440$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240711$$CN$US$US
240773951$24077395$1$I$$20230801$20240711$20240711$PER$$US-PFM-2023-04416$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.059$KG$20240711$$HP$US$US
240773961$24077396$1$I$$20230801$20240711$20240711$PER$$US-PFM-2023-04418$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.596$KG$20240711$$CN$US$US
240773971$24077397$1$I$$20230801$20240711$20240711$PER$$US-PFM-2023-04417$PIERRE FABRE MEDICAMENT$$$$$M$Y$3.27$KG$20240711$$HP$US$US
240773981$24077398$1$I$$20230802$20240711$20240711$PER$$US-PFM-2023-04442$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.24$KG$20240711$$HP$US$US
240773991$24077399$1$I$$20230802$20240711$20240711$PER$$US-PFM-2023-04443$PIERRE FABRE MEDICAMENT$$$$$M$Y$13.796$KG$20240711$$CN$US$US
240774001$24077400$1$I$$20231031$20240711$20240711$PER$$US-PFM-2023-04299$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.07$KG$20240711$$CN$US$US
240774011$24077401$1$I$$20240320$20240711$20240711$PER$$US-PFM-2023-04304$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.89$KG$20240711$$CN$US$US
240774021$24077402$1$I$$20231113$20240711$20240711$PER$$US-PFM-2023-04256$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.44$KG$20240711$$CN$US$US
240774031$24077403$1$I$$20231128$20240711$20240711$PER$$US-PFM-2023-04298$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.76$KG$20240711$$HP$US$US
240774042$24077404$2$F$20171030$20240816$20240711$20240820$EXP$$US-UCBSA-2024035040$UCB$$60$YR$$F$Y$$$20240820$$CN$US$US
240774051$24077405$1$I$$20240710$20240711$20240711$EXP$$US-UCBSA-2024034927$UCB$$$$$M$Y$$$20240711$$HP$US$US
240774061$24077406$1$I$$20240705$20240711$20240711$EXP$$US-CHATTEMPRD-2024OHG023481$CHATTEM$$$$$F$Y$$$20240711$$CN$US$US
240774071$24077407$1$I$$20230605$20240711$20240711$PER$$AT-PFM-2023-03289$PIERRE FABRE MEDICAMENT$Mileder LP, Morris NM, Kurath-Koller S, Pansy J, Pichler G, Pocivalnik M et al. Successful Postnatal Cardiopulmonary Resuscitation Due to Defibrillation. Children. 2021;8:421$$$N$M$Y$$$20240711$$HP$AT$AT
240774081$24077408$1$I$$20240708$20240711$20240711$PER$$US-ABBVIE-5833901$ABBVIE$$$$$$Y$$$20240711$$MD$US$US
240774091$24077409$1$I$$20230605$20240711$20240711$PER$$ES-PFM-2023-03277$PIERRE FABRE MEDICAMENT$Moreno-Alfonso JC, San Basilio Berenguer M, Sarmiento Caldas MDC, Gonz?lez Cay?n J, de la Puente S, Triana P. Successful sirolimus treatment for recurrent pericardial effusion in a large cervicomediastinal provisionally unclassified vascular anomaly: A case report. European J Pediatr Surg Rep. 2023;11(1):20-4$12$HR$$F$Y$3$KG$20240711$$MD$ES$ES
240774101$24077410$1$I$$20230605$20240711$20240711$PER$$KR-PFM-2023-03293$PIERRE FABRE MEDICAMENT$Park H, Park H, Kang H, Lee E. Middle meningeal artery embolization for postoperative supratentorial chronic subdural hematoma occurring after posterior fossa neurosurgery. Journal of Cerebrovascular and Endovascular Neurosurgery. 2021;23(2):152-8$70$YR$$M$Y$$$20240711$$HP$KR$KR
240774111$24077411$1$I$$20220921$20240711$20240711$PER$$ES-PFM-2023-03496$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$MD$ES$ES
240774121$24077412$1$I$$20230606$20240711$20240711$PER$$US-PFM-2023-03273$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.163$KG$20240711$$CN$US$US
240774131$24077413$1$I$$20230605$20240711$20240711$PER$$KR-PFM-2023-03278$PIERRE FABRE MEDICAMENT$Kim SH, Han JY, Song MK, Choi IS, Park HK. Orthostatic tremor after knee contusion without head trauma:  A rare case report. Turk J Phys Med Rehab. 2023;69(1):111-5$18$YR$$M$Y$$$20240711$$HP$KR$KR
240774141$24077414$1$I$$20240703$20240711$20240711$EXP$$US-NOVITIUMPHARMA-2024USNVP01198$NOVITIUM PHARMA$Sneha Poondru.Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy.Case Reports in Oncology.08-NOV-2022;15(3):918-926$51$YR$A$F$Y$$$20240711$$HP$US$US
240774151$24077415$1$I$$20230607$20240711$20240711$PER$$ES-PFM-2023-03295$PIERRE FABRE MEDICAMENT$Delgado-Miguel C, Triana P, Miguel-Ferrero M, Diaz M, Hierro L, Jara P, Lopez-Gutierrez JC et al. Mortality predictive factors in congenital hepatic hemangioma: a case-control study. European Journal of Pediatrics. 2023;182:1657-63$$$$$Y$$$20240711$$HP$ES$ES
240774161$24077416$1$I$$20230607$20240711$20240711$PER$$TR-PFM-2023-03296$PIERRE FABRE MEDICAMENT$Imamoglu M,  Ekic H, Okmen F, Ergenoglu M. Cirrhosis and pregnancy: a single centre experience. Archives of Gynecology and Obstetrics. 2023;308:111-16$37$YR$$F$Y$$$20240711$$HP$TR$TR
240774171$24077417$1$I$$20230607$20240711$20240711$PER$$TR-PFM-2023-03297$PIERRE FABRE MEDICAMENT$Imamoglu M,  Ekic H, Okmen F, Ergenoglu M. Cirrhosis and pregnancy: a single centre experience. Archives of Gynecology and Obstetrics. 2023;308:111-16$26$YR$$F$Y$$$20240711$$HP$TR$TR
240774181$24077418$1$I$$20230607$20240711$20240711$PER$$TR-PFM-2023-03300$PIERRE FABRE MEDICAMENT$Imamoglu M,  Ekic H, Okmen F, Ergenoglu M. Cirrhosis and pregnancy: a single centre experience. Archives of Gynecology and Obstetrics. 2023;308:111-16$32$YR$$F$Y$$$20240711$$HP$TR$TR
240774191$24077419$1$I$$20230607$20240711$20240711$PER$$TR-PFM-2023-03302$PIERRE FABRE MEDICAMENT$Imamoglu M,  Ekici H, Okmen F, Ergenoglu M. Cirrhosis and pregnancy: a single centre experience. Archives of Gynecology and Obstetrics. 2023;308:111-16$22$YR$$F$Y$$$20240711$$HP$TR$TR
240774201$24077420$1$I$$20231218$20240711$20240711$PER$$US-PFM-2023-03855$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.483$KG$20240711$$CN$US$US
240774211$24077421$1$I$$20230607$20240711$20240711$PER$$TR-PFM-2023-03280$PIERRE FABRE MEDICAMENT$Taskaldiran I, Altay FP, Bozkus Y, Iyidir OT, Nar A, Tutuncu NB. A Case Report of Conversion from Hashimoto^s Thyroiditis to Graves^ Disease in Type 1 Diabetic Patient Following the COVID-19 Vaccination. Endocr Metab Immune Disord Drug Targets. 2023;23:405-9$31$YR$$F$Y$$$20240711$$MD$TR$TR
240774221$24077422$1$I$$20240422$20240711$20240711$PER$$US-PFM-2023-04367$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.17$KG$20240711$$CN$US$US
240774231$24077423$1$I$$20240514$20240711$20240711$PER$$US-PFM-2023-04042$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.617$KG$20240711$$CN$US$US
240774241$24077424$1$I$$20240501$20240711$20240711$PER$$US-PFM-2023-03886$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.93$KG$20240711$$HP$US$US
240774251$24077425$1$I$$20240621$20240711$20240711$PER$$US-PFM-2023-04255$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.2$KG$20240711$$CN$US$US
240774261$24077426$1$I$$20240528$20240711$20240711$PER$$US-PFM-2023-04201$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.15$KG$20240711$$CN$US$US
240774271$24077427$1$I$$20240617$20240711$20240711$PER$$US-PFM-2023-04200$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.3$KG$20240711$$CN$US$US
240774281$24077428$1$I$$20240704$20240711$20240711$PER$$US-JNJFOC-20240721313$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240774291$24077429$1$I$$20240708$20240711$20240711$PER$$US-JNJFOC-20240719594$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$MD$US$US
240774311$24077431$1$I$$20230608$20240711$20240711$PER$$US-PFM-2023-03326$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.696$KG$20240711$$HP$US$US
240774321$24077432$1$I$$20230607$20240711$20240711$PER$$US-PFM-2023-03276$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.141$KG$20240711$$CN$US$US
240774331$24077433$1$I$20220825$20230607$20240711$20240711$PER$FR-AFSSAPS-NY2023000732$FR-PFM-2023-03340$PIERRE FABRE MEDICAMENT$$9$MON$$F$Y$9.6$KG$20240711$$MD$FR$FR
240774341$24077434$1$I$$20230607$20240711$20240711$PER$$US-PFM-2023-03274$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.163$KG$20240711$$HP$US$US
240774351$24077435$1$I$$20230609$20240711$20240711$PER$$US-PFM-2023-03363$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.098$KG$20240711$$CN$US$US
240774361$24077436$1$I$20230601$20230609$20240711$20240711$PER$$US-PFM-2023-03365$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
240774371$24077437$1$I$$20230609$20240711$20240711$PER$$US-PFM-2023-03364$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.66$KG$20240711$$CN$US$US
240774381$24077438$1$I$20230513$20230612$20240711$20240711$PER$PT-INFARMED-J202305-597$PT-PFM-2023-03375$PIERRE FABRE MEDICAMENT$$3$YR$$F$Y$13.4$KG$20240711$$MD$PT$PT
240774391$24077439$1$I$$20230612$20240711$20240711$PER$$US-PFM-2023-03395$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.95$KG$20240711$$CN$US$US
240774401$24077440$1$I$$20230612$20240711$20240711$PER$$US-PFM-2023-03427$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.399$KG$20240711$$HP$US$US
240774411$24077441$1$I$$20230613$20240711$20240711$PER$$US-PFM-2023-03431$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.163$KG$20240711$$CN$US$US
240774421$24077442$1$I$$20230613$20240711$20240711$PER$$US-PFM-2023-03430$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.896$KG$20240711$$HP$US$US
240774431$24077443$1$I$$20230621$20240711$20240711$PER$$CA-PFM-2023-03557$PIERRE FABRE MEDICAMENT$$59$YR$$F$Y$$$20240711$$MD$CA$CA
240774441$24077444$1$I$$20230613$20240711$20240711$PER$$US-PFM-2023-03429$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$US$US
240774451$24077445$1$I$$20230611$20240711$20240711$PER$$US-PFM-2023-03396$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.213$KG$20240711$$CN$US$US
240774461$24077446$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109318$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240711$$CN$US$US
240774471$24077447$1$I$$20230612$20240711$20240711$PER$$US-PFM-2023-03394$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.803$KG$20240711$$CN$US$US
240774481$24077448$1$I$$20230719$20240711$20240711$PER$$US-PFM-2023-03275$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.587$KG$20240711$$HP$US$US
240774491$24077449$1$I$$20240520$20240711$20240711$PER$$US-PFM-2023-03428$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.7$KG$20240711$$CN$US$US
240774511$24077451$1$I$$20240708$20240711$20240711$EXP$$SG-SNT-000401$SINOTHERAPEUTICS$(Citation: Monteiro A.Y., Min A.W., See J.S., Pan J.Y. Cutaneous mucormycosis infection owing to Rhizomucor variabilis presenting as recurrent lower limb ulceration and cellulitis in a diabetic patient. Dermatol Online J. 2024 15;30(2). Doi: 10.5070/D330263579)$73$YR$E$M$Y$$$20240711$$HP$SG$SG
240774521$24077452$1$I$$20231218$20240711$20240711$PER$$CA-PFM-2023-03558$PIERRE FABRE MEDICAMENT$$42$YR$$M$Y$$$20240711$$MD$CA$CA
240774531$24077453$1$I$$20230621$20240711$20240711$PER$$CA-PFM-2023-03559$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
240774541$24077454$1$I$20000101$20240703$20240711$20240711$EXP$$ES-CELLTRION INC.-2024ES016453$CELLTRION$Alegre-bailo A, Sanchez-gilo A, Gonzalez IG, et al.. Combination treatment with monoclonal antibodies: Dupilumab and ustekinumab for the treatment of severe atopic dermatitis and Crohn disease. Australasian Journal of Dermatology. 2024;65 (1):63-66$$$$$Y$$$20240711$$MD$ES$ES
240774551$24077455$1$I$20200204$20230608$20240711$20240711$PER$$JP-PFM-2023-03477$PIERRE FABRE MEDICAMENT$$2$MON$$F$Y$$$20240711$$MD$JP$JP
240774561$24077456$1$I$$20240709$20240711$20240711$30DAY$$US-GSK-US2024084920$GLAXOSMITHKLINE$$$$$M$Y$$$20240711$$CN$US$US
240774571$24077457$1$I$$20240708$20240711$20240711$PER$$US-ABBVIE-5832488$ABBVIE$$$$$$Y$$$20240711$$CN$US$US
240774581$24077458$1$I$$20230608$20240711$20240711$PER$$US-PFM-2023-03382$PIERRE FABRE MEDICAMENT$Peterman CM, Gibson RS, Lillis AP, Fishman SJ, Liang MG. Clinical and radiological characteristics of patients with retroperitoneal infantile hemangiomas. Pediatric Dermatology. 2019;36(6):823-9$8$WK$$F$Y$$$20240711$$MD$US$US
240774591$24077459$1$I$$20230607$20240711$20240711$PER$$TR-PFM-2023-03298$PIERRE FABRE MEDICAMENT$Imamoglu M,  Ekic H, Okmen F, Ergenoglu M. Cirrhosis and pregnancy: a single centre experience. Archives of Gynecology and Obstetrics. 2023;308:111-16$30$YR$$F$Y$$$20240711$$HP$TR$TR
240774601$24077460$1$I$$20230607$20240711$20240711$PER$$TR-PFM-2023-03299$PIERRE FABRE MEDICAMENT$Imamoglu M,  Ekici H, Okmen F, Ergenoglu M. Cirrhosis and pregnancy: a single centre experience. Archives of Gynecology and Obstetrics. 2023;308:111-16$26$YR$$F$Y$$$20240711$$HP$TR$TR
240774611$24077461$1$I$20240101$20240705$20240711$20240711$EXP$$NL-ORGANON-O2407NLD000705$ORGANON$$$$$F$Y$$$20240711$$HP$NL$NL
240774621$24077462$1$I$$20230608$20240711$20240711$PER$$IT-PFM-2023-03371$PIERRE FABRE MEDICAMENT$Destro F, Maestri L, Vella C, Baraldini V, Riccipetitoni G. Infantile hemangioma as cause of neonatal gastrointestinal bleeding. Journal of Pediatric Surgery Case Reports. 2018;31:71-6$20$DY$$F$Y$$$20240711$$HP$IT$IT
240774631$24077463$1$I$$20230612$20240711$20240711$PER$$NL-PFM-2023-03435$PIERRE FABRE MEDICAMENT$Tibben M, Wensen E, Nijenhuis B, Zwerver J. Is Behavioural Therapy a New Treatment Option for Task-Specific Dystonia in Athletes? A Case Series. Tremor Other Hyperkinetic Movements. 2023;13(1):1-8$40$YR$$M$Y$$$20240711$$HP$NL$NL
240774641$24077464$1$I$$20230612$20240711$20240711$PER$$NL-PFM-2023-03436$PIERRE FABRE MEDICAMENT$Tibben MI, Van Wensen EV, Nijenhuis B, Zwerver J. Is Behavioural Therapy a New Treatment Option for Task-Specific Dystonia in Athletes? A Case Series. Tremor Other Hyperkinet Mov. 2023;13(1):16$53$YR$$M$Y$$$20240711$$HP$NL$NL
240774651$24077465$1$I$$20230608$20240711$20240711$PER$$US-PFM-2023-03377$PIERRE FABRE MEDICAMENT$Peterman CM, Gibson RS, Lillis AP, Fishman SJ, Liang MG. Clinical and radiological characteristics of patients with retroperitoneal infantile hemangiomas. Pediatric Dermatology. 2019;36(6):823-9$3$WK$$F$Y$$$20240711$$MD$US$US
240774661$24077466$1$I$$20230612$20240711$20240711$PER$$CA-PFM-2023-03437$PIERRE FABRE MEDICAMENT$Pastukhova E, Kanigsberg N. Segmental infantile hemangioma with milia:  A case report. JCMS Case Reports. 2023;11:1-3$5$MON$$F$Y$$$20240711$$HP$CA$CA
240774671$24077467$1$I$$20230612$20240711$20240711$PER$$JP-PFM-2023-03449$PIERRE FABRE MEDICAMENT$Morita M, Ochi H, Yano R, Amano M, Azemoto N, Mashiba T et al. A case of refractory chylous ascites associated with liver cirrhosis successfully treated with propranolol. The Japan Society of Hepatology. 2022;63:417-23$73$YR$$F$Y$$$20240711$$HP$JP$JP
240774681$24077468$1$I$$20230614$20240711$20240711$PER$$US-PFM-2023-03507$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.476$KG$20240711$$CN$US$US
240774691$24077469$1$I$$20230615$20240711$20240711$PER$$US-PFM-2023-03470$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.338$KG$20240711$$CN$US$US
240774701$24077470$1$I$$20230608$20240711$20240711$PER$$IT-PFM-2023-03310$PIERRE FABRE MEDICAMENT$Trimboli M, Marsico O, Troisi L, Fasano F. External trigeminal neurostimulation in patients with chronic migraine. Pain Management. 2023;13(3):185-92$$$$$Y$$$20240711$$HP$IT$IT
240774711$24077471$1$I$$20230614$20240711$20240711$PER$$US-PFM-2023-03469$PIERRE FABRE MEDICAMENT$$$$$M$Y$13.596$KG$20240711$$HP$US$US
240774721$24077472$1$I$$20230615$20240711$20240711$PER$$US-PFM-2023-03509$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.49$KG$20240711$$CN$US$US
240774731$24077473$1$I$$20230615$20240711$20240711$PER$$US-PFM-2023-03508$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.528$KG$20240711$$CN$US$US
240774741$24077474$1$I$$20230615$20240711$20240711$PER$$US-PFM-2023-03486$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.68$KG$20240711$$CN$US$US
240774751$24077475$1$I$20230612$20230802$20240711$20240711$PER$$JP-PFM-2023-03442$PIERRE FABRE MEDICAMENT$$2$MON$$M$Y$$$20240711$$MD$JP$JP
240774761$24077476$1$I$20230426$20230614$20240711$20240711$PER$FR-AFSSAPS-AN2023000775$FR-PFM-2023-03452$PIERRE FABRE MEDICAMENT$$55$YR$$F$Y$60$KG$20240711$$PH$FR$FR
240774771$24077477$1$I$$20240709$20240711$20240711$EXP$$US-ABBVIE-5834083$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240774781$24077478$1$I$20240101$20240708$20240711$20240711$EXP$$US-BIOGEN-2024BI01272929$BIOGEN$$$$$M$Y$$$20240711$$CN$US$US
240774791$24077479$1$I$$20240705$20240711$20240711$EXP$$US-TAKEDA-2024TUS069646$TAKEDA$$$$$F$Y$$$20240711$$CN$US$US
240774801$24077480$1$I$$20240703$20240711$20240711$EXP$$EU-BAUSCHBL-2024BNL029496$BAUSCH AND LOMB$Ros-Sanchez E, Oliver-Gutierrez D, Buck P, Goncharova T, Distefano L, Kirkegaard-Biosca E. Purpureocillium lilacinum-related endophthalmitis: case report. Journal of Ophthalmic Inflammation and Infection. 2024 JUN 12;14:27:1-5. doi:10.1186/s12348-024-00412-2$64$YR$$M$Y$$$20240711$$HP$EU$EU
240774811$24077481$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06427$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240774821$24077482$1$I$$20230616$20240711$20240711$PER$$US-PFM-2023-03513$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.998$KG$20240711$$CN$US$US
240774831$24077483$1$I$$20230616$20240711$20240711$PER$$US-PFM-2023-03514$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.528$KG$20240711$$CN$US$US
240774841$24077484$1$I$$20230615$20240711$20240711$PER$$US-PFM-2023-03510$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.077$KG$20240711$$CN$US$US
240774861$24077486$1$I$$20230615$20240711$20240711$PER$$US-PFM-2023-03512$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.619$KG$20240711$$CN$US$US
240774871$24077487$1$I$20230618$20230618$20240711$20240711$PER$$IT-PFM-2023-03522$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$9.6$KG$20240711$$HP$IT$IT
240774881$24077488$1$I$$20230619$20240711$20240711$PER$$US-PFM-2023-03535$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.048$KG$20240711$$HP$US$US
240774891$24077489$1$I$$20230619$20240711$20240711$PER$$US-PFM-2023-03537$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.71$KG$20240711$$CN$US$US
240774901$24077490$1$I$$20230621$20240711$20240711$PER$$US-PFM-2023-03567$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.605$KG$20240711$$CN$US$US
240774911$24077491$1$I$20230619$20230620$20240711$20240711$PER$$US-PFM-2023-03568$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$7.256$KG$20240711$$PH$US$US
240774921$24077492$1$I$$20230621$20240711$20240711$PER$$US-PFM-2023-03603$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.029$KG$20240711$$HP$US$US
240774931$24077493$1$I$20230501$20230621$20240711$20240711$PER$$US-PFM-2023-03576$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6.08$KG$20240711$$PH$US$US
240774941$24077494$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153259$ASTRAZENECA$$$$E$M$Y$104.8$KG$20240711$$CN$US$
240774951$24077495$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153313$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240774961$24077496$1$I$20230622$20240517$20240711$20240711$PER$$US-PFM-2023-03575$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$9.7$KG$20240711$$HP$US$US
240774971$24077497$1$I$$20240614$20240711$20240711$PER$$US-BEIGENE-BGN-2024-009271$BEIGENE$$$$$$Y$$$20240711$$HP$US$US
240774981$24077498$1$I$$20230621$20240711$20240711$PER$$US-PFM-2023-03604$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.41$KG$20240711$$CN$US$US
240774991$24077499$1$I$$20230620$20240711$20240711$PER$$JP-PFM-2023-03682$PIERRE FABRE MEDICAMENT$$6$MON$$M$Y$$$20240711$$MD$JP$JP
240775001$24077500$1$I$$20230621$20240711$20240711$PER$$US-PFM-2023-03605$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.297$KG$20240711$$HP$US$US
240775011$24077501$1$I$$20230622$20240711$20240711$PER$$US-PFM-2023-03634$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.22$KG$20240711$$HP$US$US
240775021$24077502$1$I$$20230623$20240711$20240711$PER$$US-PFM-2023-03681$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.839$KG$20240711$$CN$US$US
240775031$24077503$1$I$$20230627$20240711$20240711$PER$$US-PFM-2023-03708$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.807$KG$20240711$$HP$US$US
240775041$24077504$1$I$$20230920$20240711$20240711$PER$$JP-PFM-2023-03621$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$$$20240711$$MD$JP$JP
240775051$24077505$1$I$$20230925$20240711$20240711$PER$$US-PFM-2023-03606$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.6$KG$20240711$$CN$US$US
240775061$24077506$1$I$$20240709$20240711$20240711$EXP$$CN-TAKEDA-2024TUS070205$TAKEDA$$$$$M$Y$$$20240711$$CN$CN$CN
240775071$24077507$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136351$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240775082$24077508$2$F$20240707$20240723$20240711$20240726$PER$$US-AMGEN-USASP2024135451$AMGEN$$68$YR$E$M$Y$$$20240726$$CN$US$US
240775091$24077509$1$I$$20240701$20240711$20240711$EXP$$CA-ROCHE-10000017003$ROCHE$$61$YR$A$M$Y$86$KG$20240711$$HP$CA$CA
240775101$24077510$1$I$$20230626$20240711$20240711$PER$$US-PFM-2023-03709$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.449$KG$20240711$$CN$US$US
240775111$24077511$1$I$$20230626$20240711$20240711$PER$$JP-PFM-2023-03787$PIERRE FABRE MEDICAMENT$$4$MON$$$Y$$$20240711$$PH$JP$JP
240775121$24077512$1$I$$20230626$20240711$20240711$PER$$JP-PFM-2023-03786$PIERRE FABRE MEDICAMENT$$5$MON$$M$Y$$$20240711$$PH$JP$JP
240775131$24077513$1$I$$20230628$20240711$20240711$PER$$US-PFM-2023-03728$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.757$KG$20240711$$CN$US$US
240775141$24077514$1$I$20230501$20230628$20240711$20240711$PER$$US-PFM-2023-03772$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
240775151$24077515$1$I$$20230626$20240711$20240711$PER$$JP-PFM-2023-03788$PIERRE FABRE MEDICAMENT$$8$MON$$F$Y$$$20240711$$PH$JP$JP
240775161$24077516$1$I$$20240630$20240711$20240711$EXP$$US-ABBVIE-5833781$ABBVIE$Wede SL, Schultze MD, Reeves DJ. Evaluation of oral targeted anticancer drug interactions and their management by oncology pharmacists. J Am Coll Clin Pharm. 2024;7(6):535-543.$$$$$Y$$$20240711$$HP$US$US
240775171$24077517$1$I$$20230628$20240711$20240711$PER$$US-PFM-2023-03769$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.018$KG$20240711$$CN$US$US
240775181$24077518$1$I$$20230628$20240711$20240711$PER$$US-PFM-2023-03731$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.1$KG$20240711$$CN$US$US
240775191$24077519$1$I$$20230628$20240711$20240711$PER$$US-PFM-2023-03732$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.696$KG$20240711$$CN$US$US
240775201$24077520$1$I$$20230628$20240711$20240711$PER$$US-PFM-2023-03730$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.308$KG$20240711$$CN$US$US
240775211$24077521$1$I$$20230629$20240711$20240711$PER$$US-PFM-2023-03773$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.798$KG$20240711$$CN$US$US
240775221$24077522$1$I$$20230630$20240711$20240711$PER$$US-PFM-2023-03783$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.399$KG$20240711$$CN$US$US
240775231$24077523$1$I$$20230706$20240711$20240711$PER$$US-PFM-2023-03784$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.15$KG$20240711$$CN$US$US
240775241$24077524$1$I$$20230809$20240711$20240711$PER$$US-PFM-2023-03767$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.939$KG$20240711$$CN$US$US
240775251$24077525$1$I$$20230706$20240711$20240711$PER$$US-PFM-2023-03785$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.227$KG$20240711$$CN$US$US
240775261$24077526$1$I$$20230817$20240711$20240711$PER$$US-PFM-2023-03768$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.957$KG$20240711$$HP$US$US
240775271$24077527$1$I$20200921$20230726$20240711$20240711$PER$$JP-PFM-2023-03736$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$7.2$KG$20240711$$MD$JP$JP
240775281$24077528$1$I$$20240115$20240711$20240711$PER$$US-PFM-2023-03729$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.82$KG$20240711$$CN$US$US
240775291$24077529$1$I$$20230815$20240711$20240711$PER$$US-PFM-2023-03710$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.599$KG$20240711$$HP$US$US
240775301$24077530$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06294$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240775311$24077531$1$I$$20240705$20240711$20240711$EXP$$EU-BAUSCHBL-2024BNL026598$BAUSCH AND LOMB$$$$A$M$Y$$$20240711$$MD$EU$EU
240775323$24077532$3$F$$20240812$20240711$20240812$PER$$US-ALXN-202407USA000353US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
240775331$24077533$1$I$$20240705$20240711$20240711$PER$$US-ALXN-202407USA000368US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240775351$24077535$1$I$$20240708$20240711$20240711$EXP$$US-TAKEDA-2024TUS069622$TAKEDA$$$$$F$Y$$$20240711$$CN$US$US
240775361$24077536$1$I$20240601$20240702$20240711$20240711$PER$$US-UNITED THERAPEUTICS-UNT-2024-019339$UNITED THERAPEUTICS$$33$YR$$F$Y$58.957$KG$20240711$$$US$US
240775373$24077537$3$F$$20240801$20240711$20240807$EXP$$GB-TAKEDA-2024TUS069635$TAKEDA$$$$$M$Y$$$20240807$$CN$GB$GB
240775381$24077538$1$I$$20230630$20240711$20240711$PER$$US-PFM-2023-03793$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.898$KG$20240711$$CN$US$US
240775391$24077539$1$I$$20230619$20240711$20240711$PER$$DE-PFM-2023-03572$PIERRE FABRE MEDICAMENT$Mauritz MD, Hasan C, Schreiber L, Wegener-Panzer A, Barth S, Zernikow B. Differential diagnosis of cyclic vomiting and periodic headaches in a child with ventriculoperitoneal shunt: case report of chronic shunt overdrainage. Children. 2022;9(3):432$6$YR$$M$Y$$$20240711$$HP$DE$DE
240775401$24077540$1$I$$20230626$20240711$20240711$PER$$RO-PFM-2023-03684$PIERRE FABRE MEDICAMENT$Badan MI, Piciu D. Triple Metachronous Malignancies with Thyroid Involvement: A Brief Overview of Five Case Reports over 20 Years of Institutional Experience. Diagnostics. 2020;10:168$54$YR$$F$Y$$$20240711$$HP$RO$RO
240775411$24077541$1$I$$20230615$20240711$20240711$PER$$US-PFM-2023-03498$PIERRE FABRE MEDICAMENT$Lenka A, King C, Soni M, Hu N, Motamedi G. Tacrolimus-induced generalized tremor with excellent response to primidone. Annals of Movement Disorders. 2022;5(1):74-6$68$YR$$F$Y$$$20240711$$MD$US$US
240775421$24077542$1$I$$20230630$20240711$20240711$PER$$US-PFM-2023-03795$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.109$KG$20240711$$CN$US$US
240775431$24077543$1$I$20240701$20240704$20240711$20240711$EXP$$MX-JNJFOC-20240715868$JOHNSON AND JOHNSON$$66$YR$E$M$Y$75$KG$20240711$$CN$MX$MX
240775441$24077544$1$I$20230601$20230630$20240711$20240711$PER$$US-PFM-2023-03794$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
240775451$24077545$1$I$20210823$20230703$20240711$20240711$PER$FR-AFSSAPS-PA20212244$FR-PFM-2023-03805$PIERRE FABRE MEDICAMENT$$47$YR$$F$Y$57$KG$20240711$$CN$FR$FR
240775461$24077546$1$I$20240401$20240614$20240711$20240711$PER$$US-Vifor (International) Inc.-VIT-2024-05464$VIFOR$$32$YR$$M$Y$76$KG$20240711$$HP$US$US
240775471$24077547$1$I$20210330$20230926$20240711$20240711$PER$$JP-PFM-2023-03789$PIERRE FABRE MEDICAMENT$$9$MON$$F$Y$$$20240711$$MD$JP$JP
240775481$24077548$1$I$$20240219$20240711$20240711$PER$$ES-PFM-2023-03281$PIERRE FABRE MEDICAMENT$Sendra MC, Palacios JMS, Javier DBG, Solana ME, Millan IV, Martin MDT. Use of nadolol in the treatment of infant hemangiomas previously treated with propranolol: A group of 7 patients. Pediatric dermatology. 2023$6$MON$$M$Y$$$20240711$$HP$ES$ES
240775492$24077549$2$F$$20240719$20240711$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-020865$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240723$$$US$US
240775501$24077550$1$I$20240702$20240708$20240711$20240711$EXP$$US-ABBVIE-5832169$ABBVIE$$79$YR$$F$Y$$$20240711$$CN$US$US
240775511$24077551$1$I$$20240703$20240711$20240711$EXP$$GB-AMGEN-GBRSP2024134856$AMGEN$$80$YR$E$F$Y$$$20240711$$CN$GB$GB
240775523$24077552$3$F$20240706$20240717$20240711$20240723$PER$$US-AMGEN-USASP2024135790$AMGEN$$79$YR$E$F$Y$$$20240723$$CN$US$US
240775531$24077553$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06250$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240775541$24077554$1$I$20240505$20240508$20240711$20240711$EXP$$US-RECORDATI RARE DISEASE INC.-2024003499$RECORDATI$$$$$$Y$$$20240711$$CN$US$US
240775551$24077555$1$I$20240401$20240705$20240711$20240711$EXP$GB-MHRA-MED-202405132245101830-MHYZW$GB-TAKEDA-2024TUS069907$TAKEDA$$43$YR$$M$Y$$$20240711$$HP$GB$GB
240775561$24077556$1$I$$20240708$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108852$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240711$$HP$US$US
240775572$24077557$2$F$20240101$20240809$20240711$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-019464$UNITED THERAPEUTICS$$$$$M$Y$$$20240817$$$US$US
240775581$24077558$1$I$$20240705$20240711$20240711$PER$$US-UNITED THERAPEUTICS-UNT-2024-020925$UNITED THERAPEUTICS$$$$$F$Y$79.365$KG$20240711$$$US$US
240775591$24077559$1$I$$20240709$20240711$20240711$PER$$NVSC2024US142913$NOVARTIS$$$$$$Y$$$20240711$$CN$US$US
240775601$24077560$1$I$$20240520$20240711$20240711$EXP$$US-RECORDATI RARE DISEASE INC.-2024003877$RECORDATI$$$$$$Y$$$20240711$$CN$US$US
240775611$24077561$1$I$$20240705$20240711$20240711$EXP$$CN-TAKEDA-2024TUS069242$TAKEDA$$$$$M$Y$$$20240711$$CN$CN$CN
240775621$24077562$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05920$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240775631$24077563$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06283$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240775641$24077564$1$I$$20240710$20240711$20240711$EXP$GB-MHRA-MED-202407091327046950-KHLJW$GB-ORGANON-O2407GBR000927$ORGANON$$10$YR$$M$Y$$$20240711$$CN$GB$GB
240775651$24077565$1$I$$20240703$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033129$AUROBINDO$$56$YR$$F$Y$85$KG$20240711$$MD$GB$GB
240775661$24077566$1$I$$20240702$20240711$20240711$PER$$US-JNJFOC-20240707541$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240775672$24077567$2$F$$20240716$20240711$20240718$EXP$$US-TAKEDA-2024TUS070054$TAKEDA$$$$$M$Y$$$20240718$$CN$US$US
240775681$24077568$1$I$20200201$20240626$20240711$20240711$EXP$$US-COOPERSURGICAL, INC.-2024CPS002046$COOPERSURGICAL$$$$$F$Y$$$20240711$$LW$US$US
240775692$24077569$2$F$20240101$20240704$20240711$20240713$EXP$$CA-CELLTRION INC.-2024CA013436$CELLTRION$$$$$$Y$$$20240713$$HP$CA$CA
240775701$24077570$1$I$20240703$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033850$AUROBINDO$$$$$M$Y$$$20240711$$PH$GB$GB
240775711$24077571$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06254$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240775721$24077572$1$I$$20240701$20240711$20240711$EXP$$SE-ROCHE-10000015989$ROCHE$Piehl F, Alping P, Virtanen S, Englund S, Burman J, Fink K, et al. COMBAT-MS: A Population-Based Observational Cohort Study Addressing theBenefit-RiskBalance of Multiple Sclerosis Therapies Compared with Rituximab. Annals of neurology. 2024-Jun-25; doi:10.1002/ana.27012.$$$$$Y$$$20240711$$HP$SE$SE
240775731$24077573$1$I$$20240704$20240711$20240711$PER$$US-HETERO-HET2024US01748$HETERO$$$$$F$Y$$$20240711$$CN$US$US
240775741$24077574$1$I$20240503$20240704$20240711$20240711$EXP$FR-AFSSAPS-PV2024000498$FR-ROCHE-10000016725$ROCHE$$7$YR$C$M$Y$17$KG$20240711$$MD$FR$FR
240775751$24077575$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136697$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240775763$24077576$3$F$20240715$20240807$20240711$20240809$PER$$US-AMGEN-USASP2024136733$AMGEN$$81$YR$E$M$Y$$$20240809$$CN$US$US
240775772$24077577$2$F$20240708$20240710$20240711$20240712$PER$$US-AMGEN-USASP2024136249$AMGEN$$$$$M$Y$$$20240712$$CN$US$US
240775781$24077578$1$I$$20230508$20240711$20240711$PER$$IT-PFM-2023-02806$PIERRE FABRE MEDICAMENT$Ciriello G, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino M et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatric Cardiology. 2023$$$$F$Y$$$20240711$$HP$IT$IT
240775791$24077579$1$I$$20230508$20240711$20240711$PER$$IT-PFM-2023-02807$PIERRE FABRE MEDICAMENT$Ciriello G, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino M et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatric Cardiology. 2023$$$$F$Y$$$20240711$$HP$IT$IT
240775801$24077580$1$I$$20230508$20240711$20240711$PER$$IT-PFM-2023-02805$PIERRE FABRE MEDICAMENT$Ciriello G, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino M et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatric Cardiology. 2023$$$$M$Y$$$20240711$$HP$IT$IT
240775811$24077581$1$I$$20230509$20240711$20240711$PER$$US-PFM-2023-02810$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.299$KG$20240711$$HP$US$US
240775821$24077582$1$I$$20230508$20240711$20240711$PER$$IT-PFM-2023-02804$PIERRE FABRE MEDICAMENT$Ciriello G, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino M et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatric Cardiology. 2023$$$$M$Y$3.2$KG$20240711$$HP$IT$IT
240775831$24077583$1$I$$20230508$20240711$20240711$PER$$IT-PFM-2023-02808$PIERRE FABRE MEDICAMENT$Ciriello G, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino M et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatric Cardiology. 2023$$$$F$Y$$$20240711$$HP$IT$IT
240775841$24077584$1$I$$20230510$20240711$20240711$PER$$US-PFM-2023-02813$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.971$KG$20240711$$HP$US$US
240775851$24077585$1$I$$20230510$20240711$20240711$PER$$US-PFM-2023-02814$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.508$KG$20240711$$HP$US$US
240775861$24077586$1$I$$20230511$20240711$20240711$PER$$US-PFM-2023-02829$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.288$KG$20240711$$HP$US$US
240775871$24077587$1$I$20230511$20230511$20240711$20240711$PER$$IT-PFM-2023-02835$PIERRE FABRE MEDICAMENT$$10$MON$$M$Y$$$20240711$$CN$IT$IT
240775881$24077588$1$I$$20230511$20240711$20240711$PER$$US-PFM-2023-02830$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240711$$CN$US$US
240775891$24077589$1$I$$20240619$20240711$20240711$EXP$$US-ROCHE-RCA5153258$ROCHE$$$$$$Y$$$20240711$$CN$US$US
240775901$24077590$1$I$$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033629$AUROBINDO$$$$$F$Y$51$KG$20240711$$CN$GB$GB
240775911$24077591$1$I$$20230901$20240711$20240711$PER$$US-PFM-2023-02811$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.47$KG$20240711$$HP$US$US
240775921$24077592$1$I$$20230524$20240711$20240711$PER$$CA-PFM-2023-03080$PIERRE FABRE MEDICAMENT$$44$YR$$F$Y$$$20240711$$MD$CA$CA
240775931$24077593$1$I$$20230524$20240711$20240711$PER$$CA-PFM-2023-03083$PIERRE FABRE MEDICAMENT$$$$A$M$Y$$$20240711$$MD$CA$CA
240775941$24077594$1$I$$20230524$20240711$20240711$PER$$CA-PFM-2023-03084$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
240775951$24077595$1$I$20110816$20230724$20240711$20240711$PER$$CA-PFM-2023-03065$PIERRE FABRE MEDICAMENT$$$$A$M$Y$$$20240711$$MD$CA$CA
240775961$24077596$1$I$$20230724$20240711$20240711$PER$$CA-PFM-2023-03063$PIERRE FABRE MEDICAMENT$$63$YR$$F$Y$$$20240711$$CN$CA$CA
240775971$24077597$1$I$$20230524$20240711$20240711$PER$$CA-PFM-2023-03081$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240711$$MD$CA$CA
240775981$24077598$1$I$$20230911$20240711$20240711$PER$$CA-PFM-2023-03079$PIERRE FABRE MEDICAMENT$$$$A$F$Y$$$20240711$$MD$CA$CA
240775991$24077599$1$I$20240101$20240708$20240711$20240711$PER$$US-ABBVIE-5833919$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240776001$24077600$1$I$20240612$20240702$20240711$20240711$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-06254$HIKMA$$61$YR$$F$Y$89$KG$20240711$$HP$EG$EG
240776011$24077601$1$I$$20230524$20240711$20240711$PER$$CA-PFM-2023-03082$PIERRE FABRE MEDICAMENT$$44$YR$$F$Y$$$20240711$$MD$CA$CA
240776022$24077602$2$F$$20240724$20240711$20240731$EXP$$CA-TAKEDA-2024TUS070433$TAKEDA$$$$$F$Y$$$20240731$$CN$CA$CA
240776033$24077603$3$F$20230601$20240725$20240711$20240729$EXP$$FR-TAKEDA-2024TUS069156$TAKEDA$$60$YR$$F$Y$$$20240729$$HP$FR$FR
240776041$24077604$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05926$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240776052$24077605$2$F$20240624$20240710$20240711$20240718$EXP$$KR-ROCHE-10000019376$ROCHE$$41$YR$A$M$Y$$$20240718$$MD$KR$KR
240776061$24077606$1$I$$20230512$20240711$20240711$PER$$JP-PFM-2023-02882$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240711$$PH$JP$JP
240776071$24077607$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000022142$ROCHE$$67$YR$E$M$Y$$$20240711$$MD$US$US
240776081$24077608$1$I$$20230515$20240711$20240711$PER$$JP-PFM-2023-02888$PIERRE FABRE MEDICAMENT$Yamada S, Shimada S, Nakayama W, Sawamura S, Nishimura Y, Kajihara I et al. A study of 95 infantile hemangiomas treated with propranolol: A  potentially efficacious combination with laser therapy. Drug Discoveries + Therapeutics. 2023;17(1):70-2$4$MON$$$Y$$$20240711$$HP$JP$JP
240776091$24077609$1$I$$20230511$20240711$20240711$PER$$US-PFM-2023-02828$PIERRE FABRE MEDICAMENT$$$$$M$Y$$$20240711$$MD$US$US
240776101$24077610$1$I$$20230515$20240711$20240711$PER$$US-PFM-2023-02877$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.497$KG$20240711$$CN$US$US
240776111$24077611$1$I$$20230515$20240711$20240711$PER$$US-PFM-2023-02876$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.599$KG$20240711$$CN$US$US
240776121$24077612$1$I$20240101$20240705$20240711$20240711$PER$$US-BIOGEN-2024BI01272530$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240776131$24077613$1$I$$20230515$20240711$20240711$PER$$US-PFM-2023-02832$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.501$KG$20240711$$HP$US$US
240776142$24077614$2$F$$20240802$20240711$20240808$PER$$US-BIOGEN-2024BI01272635$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
240776151$24077615$1$I$$20230515$20240711$20240711$PER$$JP-PFM-2023-03013$PIERRE FABRE MEDICAMENT$Kawamura M. Current situation and selection of treatment methods of infant hemangioma treatment in our department. Practical Dermatology. 2023;45(4):315-20$2$MON$$M$Y$$$20240711$$HP$JP$JP
240776161$24077616$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153470$ASTRAZENECA$$$$$M$Y$$$20240711$$CN$US$
240776174$24077617$4$F$20240520$20240903$20240711$20240911$30DAY$$US-AstraZeneca-2024A156573$ASTRAZENECA$$31768$DY$$F$Y$$$20240911$$CN$US$
240776181$24077618$1$I$$20240702$20240711$20240711$PER$$US-AstraZeneca-2024A153597$ASTRAZENECA$$$$$$Y$$$20240711$$CN$US$
240776191$24077619$1$I$20240627$20240701$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407000777$ELI LILLY AND CO$$$$$$Y$$$20240711$$CN$US$US
240776201$24077620$1$I$20231201$20240702$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407001731$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240711$$CN$US$US
240776211$24077621$1$I$20240706$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005983$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240711$$CN$US$US
240776221$24077622$1$I$20240501$20240523$20240711$20240711$EXP$$US-RECORDATI RARE DISEASE INC.-2024003992$RECORDATI$$$$$$Y$$$20240711$$CN$US$US
240776231$24077623$1$I$$20240703$20240711$20240711$EXP$$CH-AstraZeneca-2024A154963$ASTRAZENECA$$$$$F$Y$$$20240711$$HP$CH$
240776243$24077624$3$F$20240614$20240913$20240711$20240923$EXP$$JP-LEO Pharma-371723$LEO PHARM$$44$YR$$M$Y$$$20240923$$MD$JP$JP
240776251$24077625$1$I$20240501$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033597$AUROBINDO$$$$$$Y$$$20240711$$CN$GB$GB
240776261$24077626$1$I$$20230515$20240711$20240711$PER$$JP-PFM-2023-02891$PIERRE FABRE MEDICAMENT$Yamada-Kanazawa S, Shimada S, Nakayama W, Sawamura S, Nishimura Y, Kajihara I et al. A study of 95 infantile hemangiomas treated with propranolol: A potentially efficacious combination with laser therapy. Drug Discoveries + Therapeutics. 2023;17(1):70-2$3$MON$$$Y$$$20240711$$HP$JP$JP
240776271$24077627$1$I$$20230515$20240711$20240711$PER$$DE-PFM-2023-02883$PIERRE FABRE MEDICAMENT$Schneider SA, Desai S, Phokaewvarangkul O, Rosca EC, Sringean J, Anand P et al. Journal of Neurology. COVID19-associated new-onset movement disorders: a follow-up study. 2023;270:2409-15$62$YR$$M$Y$$$20240711$$HP$DE$DE
240776281$24077628$1$I$$20230515$20240711$20240711$PER$$JP-PFM-2023-02890$PIERRE FABRE MEDICAMENT$Yamada S, Shimada S, Nakayama W, Sawamura S, Nishimura Y, Kajihara I et al. A study of 95 infantile hemangiomas treated with propranolol: A potentially efficacious combination with laser therapy. Drug Discoveries + Therapeutics. 2023;17(1):70-2$4$MON$$$Y$$$20240711$$HP$JP$JP
240776291$24077629$1$I$$20230515$20240711$20240711$PER$$JP-PFM-2023-02889$PIERRE FABRE MEDICAMENT$Yamada S, Shimada S, Nakayama W, Sawamura S, Nishimura Y, Kajihara I et al. A study of 95 infantile hemangiomas treated with propranolol: A potentially efficacious combination with laser therapy. Drug Discoveries + Therapeutics. 2023;17(1):70-2$2$MON$$$Y$$$20240711$$HP$JP$JP
240776301$24077630$1$I$$20230517$20240711$20240711$PER$$US-PFM-2023-02910$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.297$KG$20240711$$CN$US$US
240776311$24077631$1$I$$20230517$20240711$20240711$PER$$US-PFM-2023-02908$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.05$KG$20240711$$HP$US$US
240776321$24077632$1$I$$20230517$20240711$20240711$PER$$US-PFM-2023-02909$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.397$KG$20240711$$CN$US$US
240776331$24077633$1$I$$20230517$20240711$20240711$PER$$US-PFM-2023-02946$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.728$KG$20240711$$CN$US$US
240776341$24077634$1$I$$20230518$20240711$20240711$PER$$US-PFM-2023-02947$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.349$KG$20240711$$CN$US$US
240776351$24077635$1$I$$20230518$20240711$20240711$PER$$US-PFM-2023-02948$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.399$KG$20240711$$CN$US$US
240776361$24077636$1$I$$20230522$20240711$20240711$PER$$US-PFM-2023-03023$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.998$KG$20240711$$HP$US$US
240776371$24077637$1$I$$20230519$20240711$20240711$PER$$US-PFM-2023-03020$PIERRE FABRE MEDICAMENT$$$$$F$Y$30.898$KG$20240711$$CN$US$US
240776381$24077638$1$I$$20230519$20240711$20240711$PER$$US-PFM-2023-03018$PIERRE FABRE MEDICAMENT$$$$$F$Y$10.798$KG$20240711$$CN$US$US
240776391$24077639$1$I$$20230523$20240711$20240711$PER$$US-PFM-2023-03025$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.803$KG$20240711$$CN$US$US
240776401$24077640$1$I$$20230523$20240711$20240711$PER$$US-PFM-2023-03073$PIERRE FABRE MEDICAMENT$$$$$M$Y$6$KG$20240711$$HP$US$US
240776411$24077641$1$I$$20230522$20240711$20240711$PER$$US-PFM-2023-03021$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.499$KG$20240711$$CN$US$US
240776421$24077642$1$I$$20230523$20240711$20240711$PER$$US-PFM-2023-03072$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.76$KG$20240711$$HP$US$US
240776431$24077643$1$I$$20230523$20240711$20240711$PER$$US-PFM-2023-03026$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.42$KG$20240711$$CN$US$US
240776441$24077644$1$I$$20230523$20240711$20240711$PER$$US-PFM-2023-03027$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.871$KG$20240711$$HP$US$US
240776451$24077645$1$I$20230501$20230524$20240711$20240711$PER$$US-PFM-2023-03074$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
240776461$24077646$1$I$$20230524$20240711$20240711$PER$$US-PFM-2023-03075$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.349$KG$20240711$$CN$US$US
240776471$24077647$1$I$$20230526$20240711$20240711$PER$$US-PFM-2023-03099$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.535$KG$20240711$$CN$US$US
240776481$24077648$1$I$$20230526$20240711$20240711$PER$$US-PFM-2023-03112$PIERRE FABRE MEDICAMENT$$$$$M$Y$11.469$KG$20240711$$CN$US$US
240776491$24077649$1$I$$20230526$20240711$20240711$PER$$US-PFM-2023-03111$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.501$KG$20240711$$CN$US$US
240776501$24077650$1$I$20230429$20230615$20240711$20240711$PER$$US-PFM-2023-02827$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
240776511$24077651$1$I$$20230714$20240711$20240711$PER$$US-PFM-2023-02812$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.12$KG$20240711$$CN$US$US
240776521$24077652$1$I$$20230829$20240711$20240711$PER$$US-PFM-2023-03022$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.85$KG$20240711$$CN$US$US
240776531$24077653$1$I$$20230928$20240711$20240711$PER$$US-PFM-2023-02945$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.17$KG$20240711$$CN$US$US
240776541$24077654$1$I$$20240213$20240711$20240711$PER$$US-PFM-2023-02831$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.34$KG$20240711$$CN$US$US
240776551$24077655$1$I$$20231102$20240711$20240711$PER$$US-PFM-2023-03019$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.5$KG$20240711$$CN$US$US
240776561$24077656$1$I$$20240123$20240711$20240711$PER$$US-PFM-2023-03024$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.57$KG$20240711$$HP$US$US
240776571$24077657$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06274$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240776583$24077658$3$F$20200520$20240830$20240711$20240909$EXP$$JP-ROCHE-10000020766$ROCHE$Obuchi S, Yao C, Kidani K, Kano Y. A case of haemorrhage abnormal after tooth extraction in a patient with factor VIII inhibitor positive congenital haemophilia A (abstract number 3). The 53rd Chugoku and Shikoku Branch Annual Meeting of the Japanese Society of Or. 2024;14:$61$YR$A$M$Y$74.2$KG$20240909$$MD$JP$JP
240776591$24077659$1$I$$20240709$20240711$20240711$EXP$$US-TAKEDA-2024TUS049171$TAKEDA$$$$$F$Y$$$20240711$$CN$US$US
240776601$24077660$1$I$$20230728$20240711$20240711$PER$$US-PFM-2023-03134$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.211$KG$20240711$$CN$US$US
240776611$24077661$1$I$$20230530$20240711$20240711$PER$$US-PFM-2023-03176$PIERRE FABRE MEDICAMENT$$$$$M$Y$10$KG$20240711$$CN$US$US
240776621$24077662$1$I$$20230803$20240711$20240711$PER$$JP-PFM-2023-03168$PIERRE FABRE MEDICAMENT$$7$MON$$F$Y$$$20240711$$PH$JP$JP
240776631$24077663$1$I$$20230526$20240711$20240711$PER$$US-PFM-2023-03133$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.737$KG$20240711$$HP$US$US
240776641$24077664$1$I$20220101$20240710$20240711$20240711$EXP$$US-UCBSA-2024034941$UCB$$$$$F$Y$$$20240711$$HP$US$US
240776652$24077665$2$F$$20240911$20240711$20240913$EXP$$CA-ADIENNEP-2024AD000561$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240912$$HP$CA$
240776663$24077666$3$F$$20240827$20240711$20240828$EXP$$DE-SANDOZ INC.-SDZ2024DE064236$SANDOZ$$39$YR$$F$Y$$$20240828$$HP$DE$DE
240776671$24077667$1$I$$20240705$20240711$20240711$EXP$$US-ABBVIE-5832571$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240776681$24077668$1$I$$20240708$20240711$20240711$EXP$$CA-ADIENNEP-2024AD000557$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240708$$HP$CA$
240776691$24077669$1$I$$20230530$20240711$20240711$PER$$US-PFM-2023-03178$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.757$KG$20240711$$CN$US$US
240776701$24077670$1$I$$20230531$20240711$20240711$PER$$US-PFM-2023-03179$PIERRE FABRE MEDICAMENT$$$$$F$Y$30.993$KG$20240711$$HP$US$US
240776711$24077671$1$I$$20230531$20240711$20240711$PER$$US-PFM-2023-03201$PIERRE FABRE MEDICAMENT$$$$$F$Y$28.494$KG$20240711$$HP$US$US
240776721$24077672$1$I$$20230530$20240711$20240711$PER$$US-PFM-2023-03177$PIERRE FABRE MEDICAMENT$$$$$M$Y$5.442$KG$20240711$$CN$US$US
240776731$24077673$1$I$$20230531$20240711$20240711$PER$$US-PFM-2023-03183$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.302$KG$20240711$$HP$US$US
240776741$24077674$1$I$$20230531$20240711$20240711$PER$$US-PFM-2023-03181$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.821$KG$20240711$$CN$US$US
240776751$24077675$1$I$$20230602$20240711$20240711$PER$$US-PFM-2023-03240$PIERRE FABRE MEDICAMENT$$$$$M$Y$13.796$KG$20240711$$CN$US$US
240776761$24077676$1$I$$20230602$20240711$20240711$PER$$US-PFM-2023-03217$PIERRE FABRE MEDICAMENT$$$$$F$Y$12$KG$20240711$$CN$US$US
240776771$24077677$1$I$$20230605$20240711$20240711$PER$$US-PFM-2023-03239$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.803$KG$20240711$$CN$US$US
240776781$24077678$1$I$$20230605$20240711$20240711$PER$$US-PFM-2023-03244$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.617$KG$20240711$$CN$US$US
240776791$24077679$1$I$$20230605$20240711$20240711$PER$$US-PFM-2023-03242$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.091$KG$20240711$$HP$US$US
240776801$24077680$1$I$$20230605$20240711$20240711$PER$$US-PFM-2023-03241$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.596$KG$20240711$$HP$US$US
240776811$24077681$1$I$$20230621$20240711$20240711$PER$$US-PFM-2023-03218$PIERRE FABRE MEDICAMENT$$$$$F$Y$11.397$KG$20240711$$CN$US$US
240776821$24077682$1$I$$20230901$20240711$20240711$PER$$US-PFM-2023-03182$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.81$KG$20240711$$CN$US$US
240776841$24077684$1$I$$20240201$20240711$20240711$PER$$US-PFM-2023-03202$PIERRE FABRE MEDICAMENT$$$$$M$Y$13.6$KG$20240711$$HP$US$US
240776851$24077685$1$I$$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033797$AUROBINDO$$$$$F$Y$56$KG$20240711$$MD$GB$GB
240776862$24077686$2$F$$20240712$20240711$20240719$EXP$$US-TAKEDA-2024TUS056538$TAKEDA$$$$$F$Y$$$20240719$$CN$US$US
240776871$24077687$1$I$$20240705$20240711$20240711$EXP$$CA-TAKEDA-2024TUS069255$TAKEDA$$45$YR$$M$Y$84$KG$20240711$$HP$CA$CA
240776881$24077688$1$I$$20240629$20240711$20240711$PER$$US-JNJFOC-20240701041$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240776891$24077689$1$I$20240601$20240709$20240711$20240711$EXP$$US-ABBVIE-5833632$ABBVIE$$65$YR$$M$Y$$$20240711$$CN$US$US
240776901$24077690$1$I$20221201$20230525$20240711$20240711$PER$$GR-PFM-2023-03090$PIERRE FABRE MEDICAMENT$Koulouridis A, Kyriakidou A, Fotsitzoudis C, Lydaki D, Tzardi M, Mavroudis D. Case Report: Recurrent bone hemangioma, the example of bad malignancy. CLINICAL ONCOLOGY$23$YR$$F$Y$$$20240711$$HP$GR$GR
240776911$24077691$1$I$$20230530$20240711$20240711$PER$$RU-PFM-2023-03147$PIERRE FABRE MEDICAMENT$Kovalchuk ST, Kruchina TK, Tatarsky RB, Pervunina TM, Malyarova MS, Lebedev DS et al. Experience in the management of infants with multifocal atrial tachycardia. Journal of Arrhythmology. 2021;28(4):24-33$3$MON$$M$Y$$$20240711$$HP$RU$RU
240776921$24077692$1$I$$20240710$20240711$20240711$EXP$$PT-SANDOZ INC.-SDZ2024PT064336$SANDOZ$$54$YR$$M$Y$$$20240711$$HP$PT$PT
240776933$24077693$3$F$20240603$20240904$20240711$20240905$EXP$$ZA-SANDOZ INC.-SDZ2024ZA055770$SANDOZ$$77$YR$$F$Y$$$20240905$$HP$ZA$ZA
240776941$24077694$1$I$$20230530$20240711$20240711$PER$$RU-PFM-2023-03146$PIERRE FABRE MEDICAMENT$Kovalchuk ST, Kruchina TK, Tatarsky RB, Pervunina TM, Malyarova MS, Lebedev DS et al. Experience in the management of infants with multifocal atrial tachycardia. Journal of Arrhythmology. 2021;28(4):24-33$6$MON$$M$Y$$$20240711$$HP$RU$RU
240776951$24077695$1$I$$20230530$20240711$20240711$PER$$RU-PFM-2023-03136$PIERRE FABRE MEDICAMENT$Kovalchuk TS, Kruchina TK, Tatarsky RB, Pervunina TM, Malyarova MSh, Lebedev DS et al. Experience in the management of infants with multifocal atrial tachycardia. Journal of Arrhythmology. 2021;28(4):24-33$21$DY$$F$Y$$$20240711$$HP$RU$RU
240776961$24077696$1$I$$20240709$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA064007$SANDOZ$$72$YR$$F$Y$$$20240711$$HP$CA$CA
240776971$24077697$1$I$$20230530$20240711$20240711$PER$$RU-PFM-2023-03141$PIERRE FABRE MEDICAMENT$Kovalchuk TS, Kruchina TK, Tatarsky RB, Pervunina TM, Malyarova MS, Lebedev DS et al. Experience in the management of infants with multifocal atrial tachycardia. Journal of Arrhythmology. 2021;28(4):24-33$21$DY$$M$Y$$$20240711$$HP$RU$RU
240776981$24077698$1$I$$20230530$20240711$20240711$PER$$RU-PFM-2023-03145$PIERRE FABRE MEDICAMENT$Kovalchuk TS, Kruchina TK, Tatarsky RB, Pervunina TM, Malyarova MS, Lebedev DS et al. Experience in the management of infants with multifocal atrial tachycardia. Journal of Arrhythmology. 2021;28(4):24-33$1$DY$$F$Y$$$20240711$$HP$RU$RU
240776991$24077699$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06059$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240777001$24077700$1$I$$20230530$20240711$20240711$PER$$RU-PFM-2023-03140$PIERRE FABRE MEDICAMENT$Kovalchuk TS, Kruchina TK, Tatarsky RB, Pervunina TM, Malyarova MS, Lebedev DS et al. Experience in the management of infants with multifocal atrial tachycardia. Journal of Arrhythmology. 2021;28(4):24-33$2$MON$$F$Y$$$20240711$$HP$RU$RU
240777011$24077701$1$I$20230201$20230605$20240711$20240711$PER$$US-PFM-2023-03247$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$10.1$KG$20240711$$CN$US$US
240777021$24077702$1$I$$20230530$20240711$20240711$PER$$RU-PFM-2023-03139$PIERRE FABRE MEDICAMENT$Kovalchuk TS, Kruchina TK, Tatarsky RB, Pervunina TM, Malyarova MS, Lebedev DS et al. Experience in the management of infants with multifocal atrial tachycardia. Journal of Arrhythmology. 2021;28(4):24-33$1$MON$$M$Y$$$20240711$$HP$RU$RU
240777031$24077703$1$I$$20230530$20240711$20240711$PER$$RU-PFM-2023-03138$PIERRE FABRE MEDICAMENT$Kovalchuk TS, Kruchina TK, Tatarsky RB, Pervunina TM, Malyarova MSh, Lebedev DS et al. Experience in the management of infants with multifocal atrial tachycardia. Journal of Arrhythmology. 2021;28(4):24-33$2$MON$$F$Y$$$20240711$$HP$RU$RU
240777041$24077704$1$I$$20230530$20240711$20240711$PER$$RU-PFM-2023-03137$PIERRE FABRE MEDICAMENT$Kovalchuk ST, Kruchina TK, Tatarsky RB, Pervunina TM, Malyarova MS, Lebedev DS et al. Experience in the management of infants with multifocal atrial tachycardia. Journal of Arrhythmology. 2021;28(4):24-33$1$DY$$M$Y$$$20240711$$HP$RU$RU
240777052$24077705$2$F$20240101$20240716$20240711$20240722$EXP$$ES-ABBVIE-5682422$ABBVIE$$$$$M$Y$$$20240722$$CN$ES$ES
240777061$24077706$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5833009$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240777071$24077707$1$I$20240617$20240703$20240711$20240711$PER$$US-GILEAD-2024-0679678$GILEAD$$$$$M$Y$$$20240711$$MD$US$US
240777083$24077708$3$F$20240527$20240722$20240711$20240727$EXP$$IT-ABBVIE-5834723$ABBVIE$$65$YR$$M$Y$85$KG$20240727$$MD$IT$IT
240777091$24077709$1$I$$20240709$20240711$20240711$EXP$$CA-ABBVIE-5834397$ABBVIE$$$$A$F$Y$$$20240711$$CN$CA$CA
240777101$24077710$1$I$$20230605$20240711$20240711$PER$$US-PFM-2023-03248$PIERRE FABRE MEDICAMENT$$$$$F$Y$12.599$KG$20240711$$CN$US$US
240777111$24077711$1$I$$20230530$20240711$20240711$PER$$RU-PFM-2023-03143$PIERRE FABRE MEDICAMENT$Kovalchuk TS, Kruchina TK, Tatarsky RB, Pervunina TM, Malyarova MS, Lebedev DS et al. Experience in the management of infants with multifocal atrial tachycardia. Journal of Arrhythmology. 2021;28(4):24-33$1$DY$$F$Y$$$20240711$$HP$RU$RU
240777121$24077712$1$I$$20230530$20240711$20240711$PER$$RU-PFM-2023-03144$PIERRE FABRE MEDICAMENT$Kovalchuk TS, Kruchina TK, Tatarsky RB, Pervunina TM, Malyarova MS, Lebedev DS et al. Experience in the management of infants with multifocal atrial tachycardia. Journal of Arrhythmology. 2021;28(4):24-33$1$MON$$F$Y$$$20240711$$HP$RU$RU
240777131$24077713$1$I$$20230530$20240711$20240711$PER$$RU-PFM-2023-03142$PIERRE FABRE MEDICAMENT$Kovalchuk TS, Kruchina TK, Tatarsky RB, Pervunina TM, Malyarova MS, Lebedev DS et al. Experience in the management of infants with multifocal atrial tachycardia. Journal of Arrhythmology. 2021;28(4):24-33$8$MON$$F$Y$$$20240711$$HP$RU$RU
240777141$24077714$1$I$$20230605$20240711$20240711$PER$$AT-PFM-2023-03260$PIERRE FABRE MEDICAMENT$Marquart E, Weiss D, Weninger W, Kinaciyan T. Differential diagnosis and management of isolated ulcers in infants may be challenging. Pediatric dermatology. 2023;83-4$5$MON$$F$Y$$$20240711$$HP$AT$AT
240777151$24077715$1$I$$20230605$20240711$20240711$PER$$US-PFM-2023-03250$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.608$KG$20240711$$CN$US$US
240777161$24077716$1$I$$20230605$20240711$20240711$PER$$US-PFM-2023-03249$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.56$KG$20240711$$HP$US$US
240777171$24077717$1$I$$20230606$20240711$20240711$PER$$US-PFM-2023-03251$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.81$KG$20240711$$CN$US$US
240777181$24077718$1$I$$20240705$20240711$20240711$EXP$$DO-ABBVIE-5834733$ABBVIE$$$$$M$Y$70$KG$20240711$$CN$DO$DO
240777191$24077719$1$I$$20240708$20240711$20240711$EXP$$CA-ADIENNEP-2024AD000558$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240708$$HP$CA$
240777201$24077720$1$I$$20230606$20240711$20240711$PER$$DK-PFM-2023-03039$PIERRE FABRE MEDICAMENT$Heydorn A, Bertelsen B, Nolsoe RL, Eiken P, Kristensen PL. Thyrotoxic periodic paralysis in a Caucasian man without identifiable genetic predisposition: a case report. Thyroid research. 2023;16(10):1-5$19$YR$$M$Y$$$20240711$$HP$DK$DK
240777211$24077721$1$I$$20240710$20240711$20240711$EXP$NL-EMA-DD-20210216-kumarvn_p-091438$NL-SANDOZ INC.-SDZ2024NL064206$SANDOZ$$5$DEC$$F$Y$$$20240711$$MD$NL$NL
240777222$24077722$2$F$$20240911$20240711$20240913$EXP$$CA-ADIENNEP-2024AD000562$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240912$$HP$CA$
240777231$24077723$1$I$$20240709$20240711$20240711$EXP$$GB-NOVITIUMPHARMA-2024GBNVP01190$NOVITIUM PHARMA$Hannah Preston.Plasma exchange for the management of digoxin toxicity in an individual with an acute kidney injury: A case report.The Journal of the Royal College of Physicians of Edinburgh.18-MAR-2024;54(1):55-58$80$YR$E$M$Y$$$20240711$$HP$GB$GB
240777241$24077724$1$I$$20230605$20240711$20240711$PER$$GR-PFM-2023-03261$PIERRE FABRE MEDICAMENT$Louka M, Ntasi E, Petropoulou T, Valari M. An infant with PHACE syndrome and lower gastrointestinal bleeding. Pediatric dermatology. 2023;82-3$2$MON$$F$Y$$$20240711$$HP$GR$GR
240777251$24077725$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06253$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240777261$24077726$1$I$$20240708$20240711$20240711$EXP$$CA-ADIENNEP-2024AD000559$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240708$$HP$CA$
240777272$24077727$2$F$20240301$20240802$20240711$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-005992$JAZZ$$87$YR$$F$Y$$$20240806$$HP$US$US
240777281$24077728$1$I$20240430$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033616$AUROBINDO$$38$YR$$M$Y$48$KG$20240711$$PH$GB$GB
240777291$24077729$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000023182$ROCHE$$35$YR$A$F$Y$$$20240711$$CN$US$US
240777301$24077730$1$I$$20240703$20240711$20240711$EXP$$CN-ROCHE-10000014802$ROCHE$Jiang D, Rao Y, Zhang C, Wang D, Jiang X, Wang H. Efficacy andsafetyofbevacizumaband platinum-based chemotherapy as neoadjuvant regimen for stage-IIIA non-squamous non-small cell lung cancer: A retrospective study. Oncology letters. 2024-Jun-13;28 (2):1-9. doi:10.3892/ol.2024.14508.$$$$$Y$$$20240711$$HP$CN$CN
240777312$24077731$2$F$$20240911$20240711$20240913$EXP$$CA-ADIENNEP-2024AD000563$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240912$$HP$CA$
240777321$24077732$1$I$20240508$20240531$20240711$20240711$EXP$$US-RECORDATI RARE DISEASE INC.-2024004200$RECORDATI$$$$$$Y$$$20240711$$CN$US$US
240777331$24077733$1$I$$20240705$20240711$20240711$PER$$NVSC2024US140855$NOVARTIS$$$$$$Y$$$20240711$$CN$US$US
240777341$24077734$1$I$20240501$20240709$20240711$20240711$EXP$$US-GILEAD-2024-0680252$GILEAD$$46$YR$A$F$Y$$$20240711$$CN$US$US
240777354$24077735$4$F$20240703$20240830$20240711$20240904$EXP$$US-GILEAD-2024-0677183$GILEAD$$61$YR$A$F$Y$$$20240904$$CN$US$US
240777361$24077736$1$I$$20240708$20240711$20240711$EXP$$CA-ADIENNEP-2024AD000560$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240708$$HP$CA$
240777371$24077737$1$I$20240703$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033508$AUROBINDO$$58$YR$$F$Y$$$20240711$$HP$GB$GB
240777381$24077738$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5832903$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240777392$24077739$2$F$$20240905$20240711$20240909$EXP$$US-TAKEDA-2024TUS046751$TAKEDA$$$$$F$Y$63$KG$20240909$$HP$US$US
240777401$24077740$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109942$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$70.31$KG$20240711$$CN$US$US
240777411$24077741$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06371$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240777421$24077742$1$I$$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033403$AUROBINDO$$$$$$Y$$$20240711$$PH$GB$GB
240777432$24077743$2$F$20240704$20240711$20240711$20240712$PER$$US-AMGEN-USASP2024135376$AMGEN$$40$YR$A$F$Y$$$20240712$$CN$US$US
240777442$24077744$2$F$$20240709$20240711$20240712$PER$$US-AMGEN-USASP2024135186$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240777461$24077746$1$I$$20240702$20240711$20240711$EXP$$IE-TAKEDA-2024TUS069658$TAKEDA$$$$$$Y$$$20240711$$MD$IE$IE
240777471$24077747$1$I$20240101$20240709$20240711$20240711$EXP$$US-UCBSA-2024034868$UCB$$$$$M$Y$$$20240711$$CN$US$US
240777481$24077748$1$I$$20240708$20240711$20240711$EXP$$US-GILEAD-2024-0680013$GILEAD$$$$E$F$Y$$$20240711$$CN$US$US
240777491$24077749$1$I$$20230424$20240711$20240711$PER$$US-PFM-2023-02506$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.549$KG$20240711$$CN$US$US
240777501$24077750$1$I$$20230424$20240711$20240711$PER$$US-PFM-2023-02504$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.098$KG$20240711$$CN$US$US
240777511$24077751$1$I$$20230425$20240711$20240711$PER$$US-PFM-2023-02553$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.129$KG$20240711$$CN$US$US
240777521$24077752$1$I$20230417$20230425$20240711$20240711$PER$$US-PFM-2023-02521$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
240777531$24077753$1$I$$20230425$20240711$20240711$PER$$US-PFM-2023-02525$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.59$KG$20240711$$CN$US$US
240777541$24077754$1$I$20230401$20230425$20240711$20240711$PER$$US-PFM-2023-02523$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240711$$PH$US$US
240777551$24077755$1$I$$20230607$20240711$20240711$PER$$US-PFM-2023-02554$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.866$KG$20240711$$CN$US$US
240777561$24077756$1$I$$20230921$20240711$20240711$PER$$US-PFM-2023-02520$PIERRE FABRE MEDICAMENT$$$$$M$Y$9.098$KG$20240711$$CN$US$US
240777571$24077757$1$I$20240601$20240708$20240711$20240711$EXP$$NVSC2024GB061029$NOVARTIS$$$$$F$Y$$$20240711$$CN$GB$GB
240777581$24077758$1$I$$20240710$20240711$20240711$PER$$US-HALEON-2186458$Haleon PLC$$$$$$Y$$$20240711$$CN$US$US
240777591$24077759$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033492$AUROBINDO$Adegoke T, Subramanian S, Daunis D, Bick S, Ward HB.. Case of Treatment-Resistant Depression Complicated by Traumatic Brain Injury and Seizure. Harvard Review of Psychiatry. 2024;32 (3):117- 125$45$YR$$M$Y$$$20240711$$MD$US$US
240777601$24077760$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033554$AUROBINDO$Devault KF, Mudrakola HV. Hydralazine Induced Pleuropericarditis With Bilateral Eosinophilic Pleural Effusions. Am-J-Respir-Crit-Care-Med. 2024;209:A2029$81$YR$$M$Y$$$20240711$$HP$US$US
240777615$24077761$5$F$20231010$20240917$20240711$20240923$EXP$$AT-TEVA-VS-3219559$TEVA$$60$YR$$F$Y$80$KG$20240923$$HP$AT$AT
240777621$24077762$1$I$$20230427$20240711$20240711$PER$$US-PFM-2023-02567$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.678$KG$20240711$$CN$US$US
240777631$24077763$1$I$20230426$20230426$20240711$20240711$PER$$US-PFM-2023-02566$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$10.4$KG$20240711$$PH$US$US
240777641$24077764$1$I$$20230426$20240711$20240711$PER$$US-PFM-2023-02555$PIERRE FABRE MEDICAMENT$$$$$F$Y$3.628$KG$20240711$$HP$US$US
240777651$24077765$1$I$$20230501$20240711$20240711$PER$$AT-PFM-2023-02668$PIERRE FABRE MEDICAMENT$Beqo BP, Gasparella P, Flucher C, Spendel S, Quehenberger F, Haxhija EQ. Indications for surgical resection of complicated infantile hemangiomas in the ?-blocker^s era: a single-institution experience from a retrospective cohort study. International journal of surgery. 2023;109(4):829-40$$$I$$Y$$$20240711$$MD$AT$AT
240777661$24077766$1$I$$20230501$20240711$20240711$PER$$AT-PFM-2023-02669$PIERRE FABRE MEDICAMENT$Beqo BP, Gasparella P, Flucher C, Spendel S, Quehenberger F, Haxhija EQ. Indications for surgical resection of complicated infantile hemangiomas in the ?-blocker^s era: a single-institution experience from a retrospective cohort study. International journal of surgery. 2023;109(4):829-40$$$I$$Y$$$20240711$$MD$AT$AT
240777671$24077767$1$I$$20230501$20240711$20240711$PER$$AT-PFM-2023-02670$PIERRE FABRE MEDICAMENT$Beqo BP, Gasparella P, Flucher C, Spendel S, Quehenberger F, Haxhija EQ. Indications for surgical resection of complicated infantile hemangiomas in the ?-blocker^s era: a single-institution experience from a retrospective cohort study. International journal of surgery. 2023;109(4):829-40$2$MON$$$Y$$$20240711$$MD$AT$AT
240777682$24077768$2$F$$20240923$20240711$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05872$LUPIN$$$$$$Y$$$20240926$$CN$US$US
240777691$24077769$1$I$$20230501$20240711$20240711$PER$$TR-PFM-2023-02647$PIERRE FABRE MEDICAMENT$Aydin D, Dogan E and Levent E. Hypertrophic cardiomyopathy after Takeuchi procedure for anomalous origin of the left coronary artery from the pulmonary artery syndrome. Annals of Pediatric Cardiology. 2023;15:523-5$3$MON$$F$Y$$$20240711$$MD$TR$TR
240777701$24077770$1$I$$20230501$20240711$20240711$PER$$AT-PFM-2023-02671$PIERRE FABRE MEDICAMENT$Beqo BP, Gasparella P, Flucher C, Spendel S, Quehenberger F, Haxhija EQ. Indications for surgical resection of complicated infantile hemangiomas in the ?-blocker^s era: a single-institution experience from a retrospective cohort study. International journal of surgery. 2023;109(4):829-40$3$MON$$M$Y$$$20240711$$MD$AT$AT
240777711$24077771$1$I$$20230501$20240711$20240711$PER$$AT-PFM-2023-02672$PIERRE FABRE MEDICAMENT$Beqo BP, Gasparella P, Flucher C, Spendel S, Quehenberger F, Haxhija EQ. Indications for surgical resection of complicated infantile hemangiomas in the ?-blocker^s era: a single-institution experience from a retrospective cohort study. International journal of surgery. 2023;109(4):829-40$2$MON$$F$Y$$$20240711$$MD$AT$AT
240777721$24077772$1$I$$20230501$20240711$20240711$PER$$US-PFM-2023-02643$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.721$KG$20240711$$CN$US$US
240777731$24077773$1$I$$20230502$20240711$20240711$PER$$US-PFM-2023-02645$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.68$KG$20240711$$CN$US$US
240777741$24077774$1$I$$20230502$20240711$20240711$PER$$US-PFM-2023-02694$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.376$KG$20240711$$CN$US$US
240777751$24077775$1$I$$20230503$20240711$20240711$PER$$US-PFM-2023-02696$PIERRE FABRE MEDICAMENT$$$$$F$Y$9.977$KG$20240711$$CN$US$US
240777761$24077776$1$I$$20230503$20240711$20240711$PER$$US-PFM-2023-02695$PIERRE FABRE MEDICAMENT$$$$$F$Y$13.859$KG$20240711$$CN$US$US
240777771$24077777$1$I$$20230504$20240711$20240711$PER$$US-PFM-2023-02699$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.17$KG$20240711$$HP$US$US
240777781$24077778$1$I$$20230504$20240711$20240711$PER$$US-PFM-2023-02702$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.381$KG$20240711$$HP$US$US
240777791$24077779$1$I$$20230504$20240711$20240711$PER$$US-PFM-2023-02722$PIERRE FABRE MEDICAMENT$$$$$M$Y$4.989$KG$20240711$$HP$US$US
240777801$24077780$1$I$$20230504$20240711$20240711$PER$$US-PFM-2023-02700$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240711$$HP$US$US
240777811$24077781$1$I$$20230505$20240711$20240711$PER$$US-PFM-2023-02701$PIERRE FABRE MEDICAMENT$$$$$M$Y$7.261$KG$20240711$$CN$US$US
240777821$24077782$1$I$20240401$20240408$20240711$20240711$EXP$$US-RECORDATI RARE DISEASE INC.-2024002740$RECORDATI$$$$$$Y$$$20240711$$CN$US$US
240777831$24077783$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153301$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240777842$24077784$2$F$$20240905$20240711$20240913$PER$$US-AstraZeneca-2024A157359$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
240777851$24077785$1$I$$20240703$20240711$20240711$EXP$$RU-AstraZeneca-2024A155409$ASTRAZENECA$$62$YR$$F$Y$$$20240711$$HP$RU$
240777862$24077786$2$F$20240709$20240712$20240711$20240715$PER$$US-AMGEN-USASP2024137051$AMGEN$$59$YR$A$M$Y$$$20240715$$CN$US$US
240777871$24077787$1$I$$20240628$20240711$20240711$PER$$US-JNJFOC-20240700920$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240711$$CN$US$US
240777881$24077788$1$I$$20240702$20240711$20240711$EXP$$JP-ROCHE-10000021201$ROCHE$$74$YR$E$F$Y$49$KG$20240711$$MD$JP$JP
240777892$24077789$2$F$20240501$20240705$20240711$20240719$EXP$$NVSC2024TR127184$NOVARTIS$$$$$$Y$$$20240719$$MD$TR$TR
240777901$24077790$1$I$$20240709$20240711$20240711$EXP$$CA-UCBSA-2024035017$UCB$$72$YR$$M$Y$$$20240711$$HP$CA$CA
240777912$24077791$2$F$$20240813$20240711$20240821$EXP$$CA-ABBVIE-5833895$ABBVIE$$$$E$F$Y$$$20240821$$HP$CA$CA
240777921$24077792$1$I$20240625$20240709$20240711$20240711$EXP$$CN-GILEAD-2024-0680173$GILEAD$$46$YR$A$F$Y$44$KG$20240711$$HP$CN$CN
240777931$24077793$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033605$AUROBINDO$Torelli VA, Ernest Jean R, Tran E.. Rapidly Progressive Interstitial Lung Disease Due to Silicosis in an Otherwise Healthy Jeweler.. Am-J-Respir-Crit-Care-Med. 2024;209:A5985$83$YR$$F$Y$$$20240711$$HP$US$US
240777941$24077794$1$I$$20230508$20240711$20240711$PER$$US-PFM-2023-02751$PIERRE FABRE MEDICAMENT$$$$$F$Y$8.395$KG$20240711$$CN$US$US
240777951$24077795$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033551$AUROBINDO$Hirt PA, Gonzalez AM, Acosta AS, Price A, Elgart GW, Nousari CH, et al.. Cutaneous Mycobacterium avium-intracellulare infection masquerading as sarcoidosis. Pediatr-Dermatol. 2024;41(3):497-500$14$YR$$M$Y$$$20240711$$HP$US$US
240777961$24077796$1$I$$20230505$20240711$20240711$PER$$US-PFM-2023-02747$PIERRE FABRE MEDICAMENT$$$$$F$Y$7.007$KG$20240711$$CN$US$US
240777971$24077797$1$I$$20230508$20240711$20240711$PER$$US-PFM-2023-02749$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.288$KG$20240711$$CN$US$US
240777981$24077798$1$I$$20230508$20240711$20240711$PER$$IT-PFM-2023-02792$PIERRE FABRE MEDICAMENT$Ciriello G, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino M et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatric Cardiology. 2023$$$$F$Y$$$20240711$$HP$IT$IT
240777991$24077799$1$I$$20230508$20240711$20240711$PER$$US-PFM-2023-02750$PIERRE FABRE MEDICAMENT$$$$$F$Y$4.998$KG$20240711$$CN$US$US
240778001$24077800$1$I$$20230508$20240711$20240711$PER$$IT-PFM-2023-02793$PIERRE FABRE MEDICAMENT$Ciriello G, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino M et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatric Cardiology. 2023$$$$M$Y$$$20240711$$HP$IT$IT
240778011$24077801$1$I$$20230508$20240711$20240711$PER$$IT-PFM-2023-02796$PIERRE FABRE MEDICAMENT$Ciriello GD, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino MT et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatric Cardiology. 2023$$$$F$Y$$$20240711$$HP$IT$IT
240778021$24077802$1$I$$20230508$20240711$20240711$PER$$IT-PFM-2023-02801$PIERRE FABRE MEDICAMENT$Ciriello G, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino M et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatric Cardiology. 2023$$$$M$Y$$$20240711$$HP$IT$IT
240778031$24077803$1$I$$20230508$20240711$20240711$PER$$IT-PFM-2023-02795$PIERRE FABRE MEDICAMENT$Ciriello G, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino M et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatric Cardiology. 2023$$$$F$Y$$$20240711$$HP$IT$IT
240778041$24077804$1$I$20220528$20230509$20240711$20240711$PER$$US-PFM-2023-02770$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$10.431$KG$20240711$$PH$US$US
240778051$24077805$1$I$20230401$20230509$20240711$20240711$PER$$US-PFM-2023-02771$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240711$$PH$US$US
240778061$24077806$1$I$$20230526$20240711$20240711$PER$$US-PFM-2023-02698$PIERRE FABRE MEDICAMENT$$$$$M$Y$10$KG$20240711$$HP$US$US
240778071$24077807$1$I$$20230615$20240711$20240711$PER$$US-PFM-2023-02697$PIERRE FABRE MEDICAMENT$$$$$M$Y$6.168$KG$20240711$$CN$US$US
240778081$24077808$1$I$$20230508$20240711$20240711$PER$$IT-PFM-2023-02798$PIERRE FABRE MEDICAMENT$Ciriello G, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino M et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatric Cardiology. 2023$$$$F$Y$$$20240711$$HP$IT$IT
240778091$24077809$1$I$$20230619$20240711$20240711$PER$$US-PFM-2023-02642$PIERRE FABRE MEDICAMENT$$$$$F$Y$2.698$KG$20240711$$CN$US$US
240778101$24077810$1$I$$20230731$20240711$20240711$PER$$US-PFM-2023-02644$PIERRE FABRE MEDICAMENT$$$$$M$Y$8.091$KG$20240711$$HP$US$US
240778111$24077811$1$I$$20231114$20240711$20240711$PER$$US-PFM-2023-02556$PIERRE FABRE MEDICAMENT$$$$$F$Y$5.215$KG$20240711$$CN$US$US
240778121$24077812$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033669$AUROBINDO$Blankenship S, Lodh A, Minish-Pron JM, Morris PE.. Catastrophic Antiphospholipid Syndrome as a Cause for Multi-System Organ Failure and Death. Am-J-Respir-Crit-Care-Med. 2024;209:A3546$19$YR$$F$Y$$$20240711$$HP$US$US
240778131$24077813$1$I$$20240118$20240711$20240711$PER$$US-PFM-2023-02522$PIERRE FABRE MEDICAMENT$$$$$F$Y$14.8$KG$20240711$$HP$US$US
240778141$24077814$1$I$$20240709$20240711$20240711$EXP$$GB-SANDOZ INC.-NVSC2020GB124210$SANDOZ$$$$$M$Y$$$20240711$$CN$GB$GB
240778151$24077815$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06349$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240778161$24077816$1$I$$20240628$20240711$20240711$EXP$$IN-ROCHE-10000019124$ROCHE$$63$YR$A$F$Y$55$KG$20240711$$CN$IN$IN
240778181$24077818$1$I$$20230508$20240711$20240711$PER$$IT-PFM-2023-02803$PIERRE FABRE MEDICAMENT$Ciriello G, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino M et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatric Cardiology. 2023$$$$M$Y$$$20240711$$HP$IT$IT
240778191$24077819$1$I$$20240702$20240711$20240711$EXP$$BR-SA-2024SA199511$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240711$$CN$BR$BR
240778201$24077820$1$I$20210201$20240703$20240711$20240711$EXP$$CN-BEIGENE-BGN-2024-010422$BEIGENE$Yue X, Yang C, Cao D, Li Y. Niraparib for the treatment of metastatic ccRCC in a patient with CDK12 and RAD51C mutations: a case report. Frontiers in Parmacology. 2024;15:1396606$$$$$Y$$$20240711$$MD$CN$CN
240778211$24077821$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033614$AUROBINDO$Meland J, Bockerstett K, Desai N, Vaidyan N, Ferguson K.. A Rare Case of Candida Auris Fungemia Leading to Cardiac Arrest.. Am-J-Respir-Crit-Care-Med. 2024;209:A1662$83$YR$$M$Y$$$20240711$$HP$US$US
240778221$24077822$1$I$$20240709$20240711$20240711$PER$$NVSC2024US142942$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240778231$24077823$1$I$$20240701$20240711$20240711$EXP$$US-STERISCIENCE B.V.-2024-ST-000986$Steriscience PTE$Arnouk S, Huynh Q, Saric M, Papadopoulos J.. A Case Report of Cardiac Arrest After Intravenous Administration of Sulfur Hexafluoride (Lumason R) Ultrasound Enhancing Agent.. J-Pharm-Pract. 2024;37 (2):509-512$35$YR$$M$Y$$$20240711$$PH$US$US
240778241$24077824$1$I$20240501$20240506$20240711$20240711$EXP$$US-RECORDATI RARE DISEASE INC.-2024003449$RECORDATI$$$$$$Y$$$20240711$$CN$US$US
240778253$24077825$3$F$20240601$20240808$20240711$20240814$EXP$$BR-CELLTRION INC.-2024BR016555$CELLTRION$$$$$$Y$$$20240814$$CN$BR$BR
240778261$24077826$1$I$$20240701$20240711$20240711$EXP$$BH-STERISCIENCE B.V.-2024-ST-000992$Steriscience PTE$Ghanem H, Wilson PT, Gill DS. Intravenous magnesium sulphate for treatment of pediatric migraine: case series. Signa-Vitae. 2023;19:194-200$13$YR$$F$Y$$$20240711$$HP$BH$BH
240778271$24077827$1$I$$20240701$20240711$20240711$EXP$$BH-STERISCIENCE B.V.-2024-ST-000991$Steriscience PTE$Ghanem H, Wilson PT, Gill DS.. Intravenous magnesium sulphate for treatment of pediatric migraine: case series.. Signa-Vitae. 2023;19:194-200$16$YR$$M$Y$$$20240711$$HP$BH$BH
240778281$24077828$1$I$$20240701$20240711$20240711$EXP$$BH-STERISCIENCE B.V.-2024-ST-000996$Steriscience PTE$Ghanem H, Wilson PT, Gill DS. Intravenous magnesium sulphate for treatment of pediatric migraine: case series. Signa-Vitae. 2023;19:194-200$17$YR$$M$Y$$$20240711$$HP$BH$BH
240778291$24077829$1$I$$20240701$20240711$20240711$EXP$$BH-STERISCIENCE B.V.-2024-ST-000990$Steriscience PTE$Ghanem H, Wilson PT, Gill DS.. Intravenous magnesium sulphate for treatment of pediatric migraine: case series.. Signa-Vitae. 2023;19:194-200$17$YR$$F$Y$$$20240711$$HP$BH$BH
240778301$24077830$1$I$$20240701$20240711$20240711$EXP$$BH-STERISCIENCE B.V.-2024-ST-000994$Steriscience PTE$Ghanem H, Wilson PT, Gill DS.. Intravenous magnesium sulphate for treatment of pediatric migraine: case series.. Signa-Vitae. 2023;19:194-200$7$YR$$F$Y$$$20240711$$HP$BH$BH
240778311$24077831$1$I$$20240701$20240711$20240711$30DAY$$US-GSK-US2024083030$GLAXOSMITHKLINE$$$$$M$Y$$$20240711$$CN$US$US
240778321$24077832$1$I$20240201$20240705$20240711$20240711$EXP$$US-GSK-US2024084035$GLAXOSMITHKLINE$$86$YR$$M$Y$$$20240711$$CN$US$US
240778331$24077833$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05874$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240778341$24077834$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06359$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240778351$24077835$1$I$20240517$20240704$20240711$20240711$EXP$FR-AFSSAPS-LM2024000370$FR-TEVA-VS-3217937$TEVA$$89$YR$$F$Y$77.8$KG$20240711$$MD$FR$FR
240778362$24077836$2$F$$20240712$20240711$20240717$PER$$US-ROCHE-10000021742$ROCHE$$71$YR$E$F$Y$$$20240717$$MD$US$US
240778371$24077837$1$I$20240704$20240704$20240711$20240711$EXP$$JP-ROCHE-10000023186$ROCHE$$4$DEC$A$F$Y$$$20240711$$MD$JP$JP
240778381$24077838$1$I$$20240703$20240711$20240711$EXP$$US-JNJFOC-20240709960$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240778391$24077839$1$I$20240625$20240704$20240711$20240711$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-096082$REGENERON$$$$$$Y$$$20240711$$MD$DE$DE
240778402$24077840$2$F$20240601$20240816$20240711$20240830$PER$$US-GRANULES-US-2024GRASPO00261$GRANULES INDIA$$$$$$Y$$$20240830$$CN$US$US
240778411$24077841$1$I$20240101$20240703$20240711$20240711$EXP$$BE-AUROBINDO-AUR-APL-2024-033238$AUROBINDO$$63$YR$$F$Y$$$20240711$$PH$BE$BE
240778421$24077842$1$I$20240201$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136980$AMGEN$$36$YR$A$F$Y$$$20240711$$CN$US$US
240778432$24077843$2$F$20240101$20240816$20240711$20240821$PER$$US-AMGEN-USASP2024136858$AMGEN$$70$YR$E$F$Y$$$20240821$$CN$US$US
240778441$24077844$1$I$20220115$20240705$20240711$20240711$EXP$$CO-UCBSA-2024034777$UCB$$74$YR$$F$Y$$$20240711$$CN$CO$CO
240778451$24077845$1$I$20240614$20240704$20240711$20240711$EXP$$JP-ROCHE-10000022471$ROCHE$$8$DEC$E$M$Y$$$20240711$$MD$JP$JP
240778461$24077846$1$I$20240504$20240505$20240711$20240711$EXP$$US-RECORDATI RARE DISEASE INC.-2024003380$RECORDATI$$$$$$Y$$$20240711$$CN$US$US
240778471$24077847$1$I$20240401$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033553$AUROBINDO$$$$$M$Y$100$KG$20240711$$CN$GB$GB
240778481$24077848$1$I$$20240617$20240711$20240711$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002326$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240778491$24077849$1$I$$20240703$20240711$20240711$EXP$$US-SA-2024SA200873$SANOFI AVENTIS$$$$E$F$Y$54.43$KG$20240711$$MD$US$US
240778502$24077850$2$F$20240529$20240814$20240711$20240819$EXP$$ES-AUROBINDO-AUR-APL-2024-033884$AUROBINDO$$47$YR$$F$Y$$$20240819$$MD$ES$ES
240778521$24077852$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136049$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240778531$24077853$1$I$20240601$20240708$20240711$20240711$EXP$$US-ABBVIE-5832175$ABBVIE$$55$YR$$F$Y$$$20240711$$CN$US$US
240778541$24077854$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06118$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240778551$24077855$1$I$20240607$20240709$20240711$20240711$EXP$$IT-HALEON-2183955$Haleon PLC$$54$YR$$F$Y$$$20240711$$PH$IT$IT
240778562$24077856$2$F$$20240712$20240711$20240717$EXP$$US-ABBVIE-5832362$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
240778571$24077857$1$I$20240101$20240703$20240711$20240711$EXP$$US-SA-2024SA202649$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240711$$MD$US$US
240778581$24077858$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143281$NOVARTIS$$$$$F$Y$$$20240711$$HP$US$US
240778592$24077859$2$F$$20240725$20240711$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002880$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
240778601$24077860$1$I$$20240702$20240711$20240711$EXP$$IN-ROCHE-10000008096$ROCHE$$76$YR$E$M$Y$$$20240711$$MD$IN$IN
240778611$24077861$1$I$$20240704$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033309$AUROBINDO$$$$$F$Y$89$KG$20240711$$CN$GB$GB
240778623$24077862$3$F$$20240724$20240711$20240830$EXP$$FI-AUROBINDO-AUR-APL-2024-033690$AUROBINDO$$$$$F$Y$$$20240830$$CN$SE$SE
240778631$24077863$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06064$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240778641$24077864$1$I$$20240621$20240711$20240711$EXP$$SK-ROCHE-RCA5018580$ROCHE$Vitkova M,  Unknown. Unknown.$$$$$Y$$$20240711$$MD$SK$SK
240778651$24077865$1$I$20240101$20240708$20240711$20240711$EXP$$CN-JNJFOC-20240721899$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$MD$CN$CN
240778661$24077866$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153573$ASTRAZENECA$$$$$F$Y$$$20240711$$MD$US$
240778671$24077867$1$I$20240705$20240708$20240711$20240711$EXP$$US-AstraZeneca-2024A156118$ASTRAZENECA$$$$$M$Y$$$20240711$$CN$US$
240778681$24077868$1$I$$20240706$20240711$20240711$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-094851$REGENERON$$$$$M$Y$$$20240711$$CN$US$US
240778692$24077869$2$F$$20240721$20240711$20240723$PER$$NVSC2024US143060$NOVARTIS$$22$YR$$M$Y$77.11$KG$20240723$$CN$US$US
240778701$24077870$1$I$$20240625$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109228$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240711$$MD$US$US
240778723$24077872$3$F$$20240806$20240711$20240813$PER$$US-ROCHE-10000019117$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
240778731$24077873$1$I$$20240709$20240711$20240711$PER$$US-TAKEDA-2024TUS069912$TAKEDA$$$$$$Y$$$20240711$$CN$US$US
240778742$24077874$2$F$$20240829$20240711$20240906$EXP$$AU-CELLTRION INC.-2024AU016675$CELLTRION$$$$$$Y$$$20240906$$MD$AU$AU
240778752$24077875$2$F$$20240814$20240711$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06296$LUPIN$$$$$$Y$$$20240828$$CN$US$US
240778761$24077876$1$I$$20240626$20240711$20240711$PER$$US-ROCHE-10000013671$ROCHE$Papsun D.M, Chan-Hosokawal A, Lamb M.E, Logan B. Increasing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017 to 2021. Journal of Analytical Toxicology. 2023;47(8):668-679. DOI: https://doi.org/10.1093/jat/bkad036.$61$YR$A$F$Y$$$20240711$$HP$US$US
240778771$24077877$1$I$20230202$20240705$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-034186$AUROBINDO$$$$$F$Y$$$20240711$$CN$GB$GB
240778782$24077878$2$F$20240601$20240711$20240711$20240712$PER$$US-AMGEN-USASP2024137196$AMGEN$$63$YR$A$F$Y$$$20240712$$CN$US$US
240778791$24077879$1$I$20240625$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136920$AMGEN$$77$YR$E$F$Y$$$20240711$$CN$US$US
240778802$24077880$2$F$$20240726$20240711$20240808$EXP$$JP-AMGEN-JPNSP2024136515$AMGEN$$74$YR$E$F$Y$$$20240807$$MD$JP$JP
240778811$24077881$1$I$20240707$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135720$AMGEN$$65$YR$E$F$Y$$$20240711$$CN$US$US
240778822$24077882$2$F$$20240813$20240711$20240816$EXP$$US-AMGEN-USASL2024135722$AMGEN$$74$YR$E$M$Y$$$20240816$$HP$US$US
240778831$24077883$1$I$20240630$20240702$20240711$20240711$EXP$$UA-ROCHE-10000019308$ROCHE$$5$YR$C$M$Y$$$20240711$$MD$UA$UA
240778841$24077884$1$I$$20240704$20240711$20240711$PER$$US-ABBVIE-5834941$ABBVIE$$$$$M$Y$$$20240711$$CN$US$IL
240778851$24077885$1$I$$20240702$20240711$20240711$EXP$$IN-Unichem Pharmaceuticals (USA) Inc-UCM202407-000868$UNICHEM$$65$YR$E$M$Y$$$20240711$$HP$IN$
240778861$24077886$1$I$$20240628$20240711$20240711$EXP$$CN-Unichem Pharmaceuticals (USA) Inc-UCM202407-000837$UNICHEM$$47$YR$A$F$Y$$$20240711$$HP$CN$
240778872$24077887$2$F$$20240710$20240711$20240715$PER$$NVSC2024US142816$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240778881$24077888$1$I$$20240702$20240711$20240711$EXP$$IN-Unichem Pharmaceuticals (USA) Inc-UCM202407-000869$UNICHEM$$32$YR$A$F$Y$$$20240711$$HP$IN$
240778891$24077889$1$I$$20240628$20240711$20240711$EXP$$IT-Unichem Pharmaceuticals (USA) Inc-UCM202407-000835$UNICHEM$$15$YR$T$F$Y$48$KG$20240711$$HP$IT$
240778901$24077890$1$I$$20240627$20240711$20240711$EXP$$CH-Unichem Pharmaceuticals (USA) Inc-UCM202407-000859$UNICHEM$$7$YR$C$F$Y$$$20240711$$HP$CH$
240778911$24077891$1$I$20190314$20240703$20240711$20240711$EXP$$GB-BAUSCH-BL-2020-032093$BAUSCH AND LOMB$$84$YR$$F$Y$$$20240711$$CN$GB$GB
240778921$24077892$1$I$$20240703$20240711$20240711$EXP$$FR-Orion Corporation ORION PHARMA-TREX2024-0174$ORION$Solignac M, Cabrera N. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study. J Autoimmun. 2024 MAY 25;147 (2024):103248.$2$DEC$T$F$Y$$$20240711$$MD$FR$
240778932$24077893$2$F$20240101$20240725$20240711$20240731$EXP$$JP-JNJFOC-20240727481$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240731$$MD$JP$JP
240778941$24077894$1$I$$20240709$20240711$20240711$PER$$US-HALEON-2186267$Haleon PLC$$54$YR$$M$Y$$$20240711$$CN$US$US
240778951$24077895$1$I$20240101$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137059$AMGEN$$$$$M$Y$$$20240711$$CN$US$US
240778961$24077896$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033517$AUROBINDO$Zafar P, Nasrullah A, Patel D, Holden K, Balaan MR. Community Acquired Pneumonia or Hydralazine-Induced Vasculitis - A Clinical Dilemma. Am-J-Respir-Crit-Care-Med. 2024;209:A2014$82$YR$$F$Y$$$20240711$$HP$US$US
240778971$24077897$1$I$20240401$20240707$20240711$20240711$EXP$$SA-SANDOZ INC.-SDZ2024SA063718$SANDOZ$$40$YR$$F$Y$$$20240711$$CN$SA$SA
240778983$24077898$3$F$$20240829$20240711$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002884$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
240778991$24077899$1$I$$20240628$20240711$20240711$EXP$GB-MHRA-30949595$GB-JUBILANT CADISTA PHARMACEUTICALS-2024GB000895$JUBILANT$$75$YR$$$Y$$$20240711$$PH$GB$GB
240779001$24077900$1$I$20240605$20240702$20240711$20240711$EXP$$JP-ROCHE-10000020103$ROCHE$$76$YR$E$M$Y$$$20240711$$MD$JP$JP
240779011$24077901$1$I$$20230110$20240711$20240711$EXP$$US-RDY-LIT/USA/23/0159924$DR REDDYS$Souter J, Behbahani M, Sharma S, Cantrell D, Alden TD. Middle meningeal artery embolization in pediatric patient.. Childs Nerv Syst. 2022;38(10): 1861-6. doi:10.1007/s00381-022-05639-9.$15$MON$I$M$Y$$$20240711$$HP$US$US
240779021$24077902$1$I$$20240701$20240711$20240711$EXP$$GB-ROCHE-10000016931$ROCHE$Dhalla F, Murray S, Sadler R, Chaigne-Delalande B, Sadaoka T, Soilleux E, et al. Identification of a Novel Mutation in MAGT1 and Progressive Multifocal Leucoencephalopathy in a 58-Year-Old Man with XMEN Disease. Doi: 10.1007/s10875-014-0116-2. J Clin Immunol. 2015;35:112-8. doi:10.1007/s10875-014-0116-2.$58$YR$A$M$Y$$$20240711$$HP$GB$GB
240779051$24077905$1$I$20230327$20240703$20240711$20240711$EXP$ES-AEMPS-1539418$ES-TEVA-VS-3216952$TEVA$$74$YR$$F$Y$$$20240711$$MD$ES$ES
240779061$24077906$1$I$$20240617$20240711$20240711$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002885$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240711$$HP$US$US
240779071$24077907$1$I$$20240701$20240711$20240711$EXP$$JP-ROCHE-10000019429$ROCHE$Ono T, Horii T, Kanazawa J, Ikehara H, Yokoyama K, Kusano C.. 12 A case of a patient who received vedolizumab for colitis ulcerative that developed after living donor renal transplant. The 696th Kanto Regional Meeting of the Japanese Society of Internal Medicine. 2024$52$YR$A$M$Y$$$20240711$$MD$JP$JP
240779081$24077908$1$I$20240322$20240703$20240711$20240711$EXP$FR-AFSSAPS-GR2024000776$FR-TEVA-VS-3217198$TEVA$$56$YR$$M$Y$$$20240711$$PH$FR$FR
240779092$24077909$2$F$20240601$20240710$20240711$20240717$30DAY$$US-GSK-US2024083038$GLAXOSMITHKLINE$$26$YR$$F$Y$$$20240717$$CN$US$US
240779101$24077910$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5832734$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240779111$24077911$1$I$20240701$20240708$20240711$20240711$PER$$US-BAUSCH-BL-2024-010505$BAUSCH AND LOMB$$64$YR$$F$Y$63$KG$20240711$$CN$US$US
240779121$24077912$1$I$$20240617$20240711$20240711$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002886$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
240779131$24077913$1$I$$20240703$20240711$20240711$PER$$US-TAKEDA-2024TUS067926$TAKEDA$$68$YR$$M$Y$$$20240711$$CN$US$US
240779141$24077914$1$I$20240423$20240708$20240711$20240711$EXP$$US-ABBVIE-5833154$ABBVIE$$71$YR$$F$Y$$$20240711$$CN$US$US
240779151$24077915$1$I$$20240710$20240711$20240711$PER$$US-TAKEDA-2024TUS070251$TAKEDA$$28$YR$$F$Y$66$KG$20240711$$MD$US$US
240779161$24077916$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033599$AUROBINDO$Abdulelah M, McGee WT. Diagnostic Ambiguity in Brain Death. Am-J-Respir-Crit-Care-Med. 2024;209:A7048$40$YR$$M$Y$$$20240711$$HP$US$US
240779171$24077917$1$I$$20240627$20240711$20240711$EXP$$CA-ROCHE-10000015892$ROCHE$$16$YR$T$F$Y$$$20240711$$CN$CA$CA
240779181$24077918$1$I$$20240709$20240711$20240711$PER$$US-TAKEDA-2024TUS070376$TAKEDA$$$$$$Y$$$20240711$$CN$US$US
240779192$24077919$2$F$20171201$20240701$20240711$20240816$EXP$$IT-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00371$VELOXIS PHARMACEUTICALS$Perencin B, Zacchi A, Zanconati F, Tomietto P, Bianco F, Di Maso V.. COVID-19 and lupus nephritis flare in unvaccinated patients: a case report and literature review.. Italian Journal of Nephrology. 2024;3$28$YR$$F$Y$$$20240816$$HP$IT$IT
240779201$24077920$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033509$AUROBINDO$Treacy T, Taylor J, Philpotts YF.. A Case of Fatal Asthma Exacerbation Leading to Cardiac Arrest. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240711$$HP$US$US
240779211$24077921$1$I$$20240701$20240711$20240711$EXP$$US-ROCHE-10000013214$ROCHE$Martinez S, Sindu D, Nailor M, Cherrier L, Tokman S, Walia R, et al. Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. Doi: 10.1111/tid.14279. Transplant Infectious Disease. 2024-Jun;26 (3):1-8. doi:10.1111/tid.14279.$$$$$Y$$$20240711$$HP$US$US
240779221$24077922$1$I$$20240702$20240711$20240711$PER$$US-AMGEN-USASP2024133906$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31(6):3529-3545$$$$$Y$$$20240711$$HP$US$US
240779231$24077923$1$I$$20240702$20240711$20240711$EXP$$JP-AMGEN-JPNSP2024134445$AMGEN$Sawatsubashi T.; Sakakibara K.; Saitou K. et al.. O-37 A case of hormone-positive, HER2-negative breast cancer patient in whom multiple brain metastases disappeared with abemaciclib combination therapy.. The 46th Japanese Society for Local Cancer Therapy Research. 2024;92$$$$$Y$$$20240711$$MD$JP$JP
240779241$24077924$1$I$$20240701$20240711$20240711$EXP$$GB-TEVA-VS-3216921$TEVA$Hutton D, Kameda-Smith M, Afshari FT, Elawadly A, Hogg F, Mehta S, et al. Intracranial invasive group A streptococcus: a neurosurgical emergency in children. J-Neurosurg-Pediatr 2023; 32 (4): 478-487.; Hutton D, Kameda-Smith M, Afshari FT, Elawadly A, Hogg F, Mehta S, et al. Intracranial invasive group A streptococcus: a neurosurgical emergency in children. J-Neurosurg-Pediatr 2023; 32 (4): 478-487.$5$YR$$F$Y$$$20240711$$HP$GB$GB
240779251$24077925$1$I$20240617$20240709$20240711$20240711$EXP$DE-DCGMA-24203552$DE-ORGANON-O2407DEU000845$ORGANON$$79$YR$$F$Y$87$KG$20240711$$MD$DE$DE
240779261$24077926$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153270$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240779271$24077927$1$I$$20240703$20240711$20240711$EXP$$DE-AstraZeneca-2024A153518$ASTRAZENECA$$$$$M$Y$105$KG$20240711$$MD$DE$
240779281$24077928$1$I$20240703$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153635$ASTRAZENECA$$79$YR$$F$Y$$$20240711$$CN$US$
240779291$24077929$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153403$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240779301$24077930$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153704$ASTRAZENECA$$$$$$Y$$$20240711$$CN$US$
240779311$24077931$1$I$$20240703$20240711$20240711$EXP$$JP-AstraZeneca-2024A154116$ASTRAZENECA$$$$$$Y$$$20240711$$PH$JP$
240779321$24077932$1$I$$20240627$20240711$20240711$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05832$LUPIN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to prevent endotracheal intubation in adults with refractory non-convulsive status epilepticus: A case series. Neurocritical Care. 2024;40:976-983$61$YR$$M$Y$83$KG$20240711$$HP$US$US
240779332$24077933$2$F$$20240710$20240711$20240722$PER$$US-ROCHE-10000022981$ROCHE$$$$A$$Y$49.9$KG$20240722$$CN$US$US
240779341$24077934$1$I$$20240708$20240711$20240711$PER$$US-ABBVIE-5833239$ABBVIE$$$$$$Y$$$20240711$$CN$US$US
240779351$24077935$1$I$20240101$20240705$20240711$20240711$PER$$US-AMGEN-USASP2024134378$AMGEN$$57$YR$A$F$Y$$$20240711$$HP$US$US
240779371$24077937$1$I$20240401$20240702$20240711$20240711$EXP$$US-ROCHE-10000018891$ROCHE$$31$YR$A$F$Y$95.25$KG$20240711$$MD$US$US
240779381$24077938$1$I$20240203$20240704$20240711$20240711$EXP$GB-MHRA-MED-202405072005473960-BTSHV$GB-ABBVIE-5833677$ABBVIE$$$$$F$Y$$$20240711$$CN$GB$GB
240779402$24077940$2$F$20240620$20240731$20240711$20240807$EXP$CA-MMM-AU9LKWJ7$CA-GSK-CA2023133690$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$HP$CA$CA
240779411$24077941$1$I$$20240705$20240711$20240711$EXP$$CA-JNJFOC-20240717315$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240711$$HP$CA$CA
240779424$24077942$4$F$20240101$20240912$20240711$20240924$EXP$$US-INSMED, INC.-2024-02573-US$INSMED$$$$$M$Y$$$20240924$$CN$US$US
240779431$24077943$1$I$20240524$20240701$20240711$20240711$EXP$$JP-ROCHE-10000017464$ROCHE$$76$YR$E$F$Y$$$20240711$$MD$JP$JP
240779441$24077944$1$I$$20240701$20240711$20240711$EXP$$JP-ROCHE-10000019435$ROCHE$Iwama H, Takahara T, Mii S, Nishimura A, Uchida Y, Kojima M et al.. A case of living donor liver transplant after administration of immune checkpoint inhibitor. The 42nd Annual Meeting of the Japanese Liver Transplantation Society. 2024;104$65$YR$E$M$Y$$$20240711$$MD$JP$JP
240779452$24077945$2$F$$20240729$20240711$20240805$30DAY$$US-GSK-US2024AMR084213$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
240779461$24077946$1$I$$20240627$20240711$20240711$EXP$$US-LUPIN HEALTHCARE (UK) LIMITED-2024-05836$LUPIN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to prevent endotracheal intubation in adults with refractory non-convulsive status epilepticus: A case series. Neurocritical Care. 2024;40:976-983$45$YR$$M$Y$65$KG$20240711$$HP$US$US
240779471$24077947$1$I$20240507$20240614$20240711$20240711$PER$$US-Vifor (International) Inc.-VIT-2024-05458$VIFOR$$43$YR$$F$Y$65.5$KG$20240711$$HP$US$US
240779491$24077949$1$I$20240530$20240614$20240711$20240711$PER$$US-Vifor (International) Inc.-VIT-2024-05483$VIFOR$$64$YR$$M$Y$75.5$KG$20240711$$HP$US$US
240779512$24077951$2$F$20240708$20240709$20240711$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039093$BOEHRINGER INGELHEIM$$46$YR$A$M$Y$$$20240715$$PH$US$US
240779521$24077952$1$I$20231212$20240614$20240711$20240711$PER$$US-Vifor (International) Inc.-VIT-2024-05459$VIFOR$$75$YR$$F$Y$83.6$KG$20240711$$HP$US$US
240779531$24077953$1$I$20240517$20240614$20240711$20240711$PER$$US-Vifor (International) Inc.-VIT-2024-05486$VIFOR$$74$YR$$M$Y$103$KG$20240711$$HP$US$US
240779542$24077954$2$F$20240101$20240723$20240711$20240815$EXP$$US-Vifor (International) Inc.-VIT-2024-05480$VIFOR$$32$YR$$M$Y$75$KG$20240815$$HP$US$US
240779551$24077955$1$I$20240518$20240614$20240711$20240711$EXP$$US-Vifor (International) Inc.-VIT-2024-05484$VIFOR$$68$YR$$M$Y$71.5$KG$20240711$$HP$US$US
240779561$24077956$1$I$$20240702$20240711$20240711$EXP$$IT-AMNEAL PHARMACEUTICALS-2024-AMRX-02500$AMNEAL$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, et al.. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicol Rep.. 2024;13$15$YR$$F$Y$48$KG$20240711$$HP$IT$IT
240779571$24077957$1$I$20240507$20240614$20240711$20240711$EXP$$US-Vifor (International) Inc.-VIT-2024-05482$VIFOR$$68$YR$$M$Y$87$KG$20240711$$HP$US$US
240779581$24077958$1$I$$20240704$20240711$20240711$PER$$US-HETERO-HET2024US01717$HETERO$$$$$$Y$$$20240711$$CN$US$US
240779591$24077959$1$I$$20240614$20240711$20240711$PER$$US-P+L Developments of Newyork Corporation-2159032$PL DEVELOPMENTS$$$$$$Y$$$20240711$$$US$US
240779601$24077960$1$I$$20240624$20240711$20240711$EXP$$NL-AMGEN-NLDSP2024128955$AMGEN$Marcel A M Beijk, J. Woudstra, A Suzanne Vink, N R Bijsterveld, R A F de Lind van Wijngaarden, et al.. Myocardial Bridging as a Trigger in Angina With No Obstructive Coronary Artery Disease. JACC-Case-Rep. 2024;29:13. doi:10.1016/j.jaccas.2024.102382$59$YR$A$M$Y$$$20240711$$MD$NL$NL
240779611$24077961$1$I$$20240703$20240711$20240711$EXP$$GB-SANDOZ INC.-NVSC2022GB121373$SANDOZ$$$$E$F$Y$$$20240711$$CN$GB$GB
240779621$24077962$1$I$20240702$20240705$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033691$AUROBINDO$$39$YR$$F$Y$$$20240711$$MD$GB$GB
240779631$24077963$1$I$$20240705$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033779$AUROBINDO$$$$A$F$Y$54$KG$20240711$$CN$GB$GB
240779641$24077964$1$I$$20240702$20240711$20240711$PER$$US-TEVA-VS-3217104$TEVA$$$$$F$Y$$$20240711$$CN$US$US
240779651$24077965$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153166$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240779662$24077966$2$F$$20240711$20240711$20240715$PER$$US-TAKEDA-2024TUS070390$TAKEDA$$$$$$Y$$$20240715$$CN$US$US
240779672$24077967$2$F$20240404$20240829$20240711$20240905$EXP$$JP-GENMAB-2024-01328AA$GENMAB$$74$YR$$F$Y$$$20240905$$MD$JP$JP
240779681$24077968$1$I$20240409$20240409$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202404006111$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240711$$CN$US$US
240779691$24077969$1$I$$20240701$20240711$20240711$EXP$$CN-MSNLABS-2024MSNLIT01549$MSN LABORATORIES$Wu W, Liu C, Wang K, Wu P, Zhan S, Liu X..Non-Hodgkins lymphoma complicated with human coronavirus HKU1 pneumonia A case report and literature review.Journal of Jilin University (Medicine Edition).JAN-2023;49(1):187-192$$$$$Y$$$20240711$$HP$CN$CN
240779702$24077970$2$F$$20240906$20240711$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109567$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240916$$HP$US$US
240779711$24077971$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109429$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240711$$HP$US$US
240779721$24077972$1$I$20240601$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109349$BRISTOL MYERS SQUIBB$$3$DEC$A$F$Y$$$20240711$$MD$US$US
240779731$24077973$1$I$20240101$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109360$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240711$$CN$US$US
240779741$24077974$1$I$20240601$20240620$20240711$20240711$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000550$DECIPHERA PHARMACEUTICALS$$58$YR$A$M$Y$$$20240711$$CN$US$US
240779751$24077975$1$I$$20240701$20240711$20240711$EXP$$JP-ROCHE-10000019534$ROCHE$Yamada M, Inazu D, Takii M, Gyobu K, Oshima T, Mayumi K et al.. O-2 A case of palliative surgery for gastrointestinal obstruction caused by peritoneal dissemination after surgery for large intestine carcinoma. The 46th Annual Meeting of Japanese Society for Research of Loco-Regional Cancer. 2024;83$51$YR$A$F$Y$$$20240711$$MD$JP$JP
240779762$24077976$2$F$$20240709$20240711$20240712$EXP$$NVSC2024US142694$NOVARTIS$$$$$M$Y$$$20240712$$CN$US$US
240779781$24077978$1$I$20240401$20240423$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0079$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$MD$US$US
240779791$24077979$1$I$20240708$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136578$AMGEN$$71$YR$E$F$Y$$$20240711$$CN$US$US
240779801$24077980$1$I$20230905$20240701$20240711$20240711$EXP$$RO-ROCHE-10000016679$ROCHE$$32$YR$A$M$Y$$$20240711$$CN$RO$RO
240779811$24077981$1$I$20210527$20240627$20240711$20240711$EXP$$US-COOPERSURGICAL, INC.-2024CPS002042$COOPERSURGICAL$$$$$F$Y$$$20240711$$LW$US$US
240779821$24077982$1$I$$20240704$20240711$20240711$EXP$$IN-ROCHE-10000016378$ROCHE$Chhabra R, Dodagoudar C, Rajpurohit S, Vidushi A, Narwariya A. Trastuzumab in combination with gemcitabine and cisplatin for treatment-naive HER2/neu-positive metastatic adenocarcinoma of gall bladder [abstract number:  305 P].. Annals of Oncology. 2024-Jun;35:S129. doi:10.1016/j.annonc.2024.05.448.$$$$$Y$$$20240711$$HP$IN$IN
240779841$24077984$1$I$$20240703$20240711$20240711$EXP$$US-APOTEX-2024AP008050$APOTEX$Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN.. Relationship between the Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular Immunology and Inflammation. 2023;31(5):900-904$$$A$$Y$$$20240711$$HP$US$US
240779851$24077985$1$I$20210101$20240703$20240711$20240711$PER$$US-BIOGEN-2024BI01273111$BIOGEN$$$$$F$Y$$$20240711$$HP$US$US
240779861$24077986$1$I$20240101$20240705$20240711$20240711$PER$$US-BIOGEN-2024BI01272630$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240779871$24077987$1$I$$20240709$20240711$20240711$PER$$NVSC2024US142956$NOVARTIS$$35$YR$$$Y$$$20240711$$CN$US$US
240779881$24077988$1$I$20240601$20240701$20240711$20240711$EXP$$AU-ROCHE-10000023121$ROCHE$$65$YR$E$F$Y$$$20240711$$CN$AU$AU
240779892$24077989$2$F$20240501$20240904$20240711$20240916$EXP$$US-ACORDA-ACO_177483_2024$ACORDA$$84$YR$$M$Y$$$20240916$$HP$US$US
240779901$24077990$1$I$$20240708$20240711$20240711$PER$$US-JNJFOC-20240721362$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$HP$US$US
240779921$24077992$1$I$$20240627$20240711$20240711$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04913$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240779931$24077993$1$I$$20240627$20240711$20240711$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05833$LUPIN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to prevent endotracheal intubation in adults with refractory non-convulsive status epilepticus: A case series. Neurocritical Care. 2024;40:976-983$68$YR$$M$Y$60$KG$20240711$$HP$US$US
240779941$24077994$1$I$$20240709$20240711$20240711$PER$$NVSC2024US143385$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240779952$24077995$2$F$$20240913$20240711$20240916$EXP$$NVSC2024US030621$NOVARTIS$$$$$F$Y$58$KG$20240917$$CN$US$US
240779971$24077997$1$I$20220101$20240709$20240711$20240711$PER$$US-GILEAD-2024-0680138$GILEAD$$$$A$M$Y$$$20240711$$CN$US$US
240779982$24077998$2$F$$20240722$20240711$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA063495$SANDOZ$$15$YR$$F$Y$$$20240723$$HP$CA$CA
240779991$24077999$1$I$$20240701$20240711$20240711$EXP$$US-STERISCIENCE B.V.-2024-ST-000983$Steriscience PTE$Saleh A, D^Amico A, Hasnie A, Clarkson S, Heindl B.. Atrial arrhythmias and acute pericarditis triggered by bleach ingestion-associated oesophageal perforation: a case report.. Eur-Heart-J-Case-Rep. 2024;8(2):no pagination.$36$YR$$M$Y$$$20240711$$HP$US$US
240780001$24078000$1$I$20240626$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135284$AMGEN$$68$YR$E$M$Y$$$20240711$$CN$US$US
240780012$24078001$2$F$$20240716$20240711$20240726$EXP$$TR-TEVA-VS-3217347$TEVA$Varol F, Can YY, Kilic A, Kotcioglu AC, Durak C, Altas U, et al. Evaluation of Intoxication Cases Followed up in Pediatric Intensive Care Unit During COVID-19 Pandemic with Social Restrictions. Guncel-Pediatr 2022; 20 (3): 258-265.; Varol F, Can YY, Kilic A, Kotcioglu AC, Durak C, Altas U, et al. Evaluation of Intoxication Cases Followed up in Pediatric Intensive Care Unit During COVID-19 Pandemic with Social Restrictions. Guncel-Pediatr 2022; 20 (3): 258-265.$163$MON$$F$Y$$$20240726$$MD$TR$TR
240780021$24078002$1$I$$20240618$20240711$20240711$PER$$US-ABBVIE-5834306$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240780031$24078003$1$I$$20240626$20240711$20240711$EXP$$AT-ROCHE-10000021099$ROCHE$$$$A$$Y$$$20240711$$MD$AT$AT
240780044$24078004$4$F$20240630$20240806$20240711$20240816$EXP$$US-GSK-US2024AMR083487$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240816$$CN$US$US
240780051$24078005$1$I$20240709$20240709$20240711$20240711$EXP$$US-GSK-US2024084938$GLAXOSMITHKLINE$$69$YR$$M$Y$$$20240711$$MD$US$US
240780062$24078006$2$F$$20240809$20240711$20240813$30DAY$$JP-JNJFOC-20240722280$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$PH$JP$JP
240780071$24078007$1$I$20240101$20240702$20240711$20240711$EXP$$US-SA-2024SA198483$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240711$$CN$US$US
240780081$24078008$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143255$NOVARTIS$$$$$$Y$$$20240711$$CN$US$US
240780093$24078009$3$F$$20240729$20240711$20240802$EXP$$US-TAKEDA-2024TUS069886$TAKEDA$$$$$M$Y$$$20240802$$CN$US$US
240780102$24078010$2$F$20240101$20240808$20240711$20240809$EXP$$US-UCBSA-2024014729$UCB$$$$$F$Y$$$20240809$$CN$US$US
240780111$24078011$1$I$20240626$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109350$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240711$$HP$US$US
240780121$24078012$1$I$$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109491$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240711$$CN$US$US
240780131$24078013$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109450$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240711$$CN$US$US
240780141$24078014$1$I$20240401$20240424$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0080$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$HP$US$US
240780151$24078015$1$I$$20240703$20240711$20240711$EXP$$US-ROCHE-10000019620$ROCHE$$$$A$M$Y$$$20240711$$CN$US$US
240780161$24078016$1$I$20240615$20240703$20240711$20240711$EXP$GB-MHRA-MED-202407030846073730-WGDPS$GB-MSNLABS-2024MSNSPO01515$MSN LABORATORIES$$$$$$Y$$$20240711$$CN$GB$GB
240780171$24078017$1$I$20240402$20240627$20240711$20240711$EXP$ES-AEMPS-1540689$ES-Axellia-005265$XELLIA PHARMACEUTICALS$$77$YR$E$M$Y$$$20240711$$MD$ES$ES
240780181$24078018$1$I$20240625$20240703$20240711$20240711$PER$$US-AMGEN-USASP2024137594$AMGEN$$$$$$Y$$$20240711$$PH$US$US
240780191$24078019$1$I$$20240702$20240711$20240711$EXP$$US-AMGEN-USASP2024133627$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31 (6):3529-3545$80$YR$E$F$Y$$$20240711$$HP$US$US
240780201$24078020$1$I$$20240702$20240711$20240711$EXP$$US-AMGEN-USASP2024133558$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of 1pilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31(6):3529-3545$61$YR$A$F$Y$$$20240711$$HP$US$US
240780211$24078021$1$I$$20240703$20240711$20240711$EXP$$US-AMGEN-USASP2024133243$AMGEN$Goodlet K. J. ; Martinez S.; Sindu D. et al.. Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. Transplant Infectious disease. 2024;26 (3):1-8$$$$$Y$$$20240711$$HP$US$US
240780222$24078022$2$F$$20240724$20240711$20240730$EXP$$US-ABBVIE-5832390$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
240780231$24078023$1$I$$20240627$20240711$20240711$EXP$$NO-Jerome Stevens Pharmaceuticals, Inc.-2159033$JEROME STEVENS$Literature full text article$74$YR$$F$Y$$$20240711$$$NO$NO
240780251$24078025$1$I$$20231009$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US045630$SANDOZ$$$$$F$Y$$$20240711$$HP$US$US
240780261$24078026$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143390$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240780272$24078027$2$F$$20240712$20240711$20240717$EXP$$CA-TAKEDA-2024TUS070388$TAKEDA$$$$$F$Y$$$20240717$$CN$CA$CA
240780281$24078028$1$I$$20240709$20240711$20240711$PER$$NVSC2024US143388$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240780292$24078029$2$F$$20240710$20240711$20240711$PER$$NVSC2024US142974$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240780301$24078030$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05880$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240780312$24078031$2$F$20240101$20240817$20240711$20240822$EXP$$US-SA-2024SA201164$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240822$$CN$US$US
240780331$24078033$1$I$$20240627$20240711$20240711$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05835$LUPIN$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to prevent endotracheal intubation in adults with refractory non-convulsive status epilepticus: A case series. Neurocritical Care. 2024;40:976-983$70$YR$$M$Y$61.8$KG$20240711$$HP$US$US
240780342$24078034$2$F$$20240717$20240711$20240726$EXP$$JP-UCBSA-2024034204$UCB$$43$YR$$F$Y$$$20240726$$MD$JP$JP
240780352$24078035$2$F$$20240711$20240711$20240801$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2019-014964$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
240780361$24078036$1$I$$20240701$20240711$20240711$EXP$$JP-ROCHE-10000017904$ROCHE$Nozawa K, Tsunemi Y, Abe F, Deguchi Y, Taniguchi T, Takano T et al.. 10 A case of perforation of skin ulcer into hernial sac of parastomal hernia causing intestinal tract prolapse during the use of angiogenesis inhibitor as chemotherapy for unresectable rectal cancer. The 696th Kanto Regional Meeting of the Japanese Society of Internal Medicine. 2024$74$YR$E$M$Y$$$20240711$$MD$JP$JP
240780371$24078037$1$I$20240619$20240703$20240711$20240711$EXP$$CN-SA-2024SA200728$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240711$$CN$CN$CN
240780382$24078038$2$F$20230101$20240718$20240711$20240724$EXP$$NVSC2024AR141951$NOVARTIS$$$$$F$Y$$$20240724$$CN$AR$AR
240780391$24078039$1$I$20231201$20240703$20240711$20240711$EXP$FR-AFSSAPS-LY2024000922$FR-TEVA-VS-3216916$TEVA$$73$YR$$F$Y$76$KG$20240711$$PH$FR$FR
240780401$24078040$1$I$20240601$20240703$20240711$20240711$EXP$$US-SA-2024SA201085$SANOFI AVENTIS$$66$YR$E$F$Y$118$KG$20240711$$MD$US$US
240780411$24078041$1$I$$20240710$20240711$20240711$EXP$$PT-TAKEDA-2024TUS070216$TAKEDA$$10$YR$$M$Y$$$20240711$$HP$PT$PT
240780431$24078043$1$I$$20240628$20240711$20240711$PER$$US-ROCHE-10000016464$ROCHE$$$$$$Y$$$20240711$$HP$US$US
240780441$24078044$1$I$20240709$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137282$AMGEN$$$$$M$Y$$$20240711$$HP$US$US
240780451$24078045$1$I$$20240702$20240711$20240711$EXP$$US-AMGEN-USASP2024133710$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of pilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31(6):3529-3545$66$YR$E$F$Y$$$20240711$$HP$US$US
240780461$24078046$1$I$$20240703$20240711$20240711$PER$$US-AMGEN-USASP2024132846$AMGEN$$$$A$F$Y$$$20240711$$CN$US$US
240780471$24078047$1$I$$20240702$20240711$20240711$EXP$$US-AMGEN-USASP2024133774$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31 (6):3529-3545$80$YR$E$M$Y$$$20240711$$HP$US$US
240780481$24078048$1$I$$20240702$20240711$20240711$EXP$$US-AMGEN-USASP2024133802$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of lpilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31 (6):3529-3545$65$YR$E$F$Y$$$20240711$$HP$US$US
240780491$24078049$1$I$$20240702$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407002444$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240711$$CN$US$US
240780501$24078050$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005163$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240711$$CN$US$US
240780511$24078051$1$I$$20240710$20240711$20240711$EXP$$US-GSK-US2024085726$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240780521$24078052$1$I$$20240701$20240711$20240711$30DAY$$US-GSK-US2024081594$GLAXOSMITHKLINE$$$$$M$Y$$$20240711$$CN$US$US
240780531$24078053$1$I$$20240710$20240711$20240711$EXP$$US-GSK-US2024085627$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$HP$US$US
240780542$24078054$2$F$20240401$20240731$20240711$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202405017267$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240812$$CN$US$US
240780551$24078055$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006025$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240711$$CN$US$US
240780561$24078056$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005328$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240711$$CN$US$US
240780571$24078057$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006014$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240711$$CN$US$US
240780581$24078058$1$I$20240707$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005349$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240711$$CN$US$US
240780591$24078059$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005900$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240711$$CN$US$US
240780601$24078060$1$I$20240708$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005322$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240711$$CN$US$US
240780612$24078061$2$F$$20240729$20240711$20240808$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006046$ELI LILLY AND CO$$$$A$F$Y$$$20240808$$CN$US$US
240780621$24078062$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006453$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240711$$PH$US$US
240780631$24078063$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006600$ELI LILLY AND CO$$$$$F$Y$$$20240711$$CN$US$US
240780641$24078064$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005318$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240711$$CN$US$US
240780651$24078065$1$I$20240703$20240708$20240711$20240711$EXP$$CA-ABBVIE-5833112$ABBVIE$$$$A$M$Y$$$20240711$$CN$CA$CA
240780661$24078066$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135360$AMGEN$$$$$$Y$$$20240711$$PH$US$US
240780671$24078067$1$I$$20240701$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407002211$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240711$$CN$US$US
240780681$24078068$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109148$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240711$$HP$US$US
240780692$24078069$2$F$$20240816$20240711$20240820$PER$$US-AstraZeneca-2024A155326$ASTRAZENECA$$$$$F$Y$$$20240820$$HP$US$
240780701$24078070$1$I$$20230717$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US006801$SANDOZ$$$$$M$Y$95.25$KG$20240711$$MD$US$US
240780711$24078071$1$I$20240526$20240617$20240711$20240711$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002472$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240711$$CN$US$US
240780722$24078072$2$F$$20240701$20240711$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05893$LUPIN$$$$$$Y$$$20240719$$CN$US$US
240780731$24078073$1$I$$20240709$20240711$20240711$PER$$US-TAKEDA-2024TUS069929$TAKEDA$$$$$F$Y$$$20240711$$CN$US$US
240780741$24078074$1$I$20230124$20240703$20240711$20240711$EXP$$ES-CELLTRION INC.-2024ES016412$CELLTRION$$$$$$Y$$$20240711$$MD$ES$ES
240780752$24078075$2$F$20240101$20240709$20240711$20240717$PER$$US-AMGEN-USASP2024136925$AMGEN$$54$YR$A$F$Y$$$20240717$$HP$US$US
240780761$24078076$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06026$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240780771$24078077$1$I$$20240709$20240711$20240711$PER$$US-ABBVIE-5833299$ABBVIE$$$$$$Y$$$20240711$$HP$US$US
240780783$24078078$3$F$20240412$20240716$20240711$20240725$PER$$US-ROCHE-10000023023$ROCHE$$75$YR$E$M$Y$101.4$KG$20240725$$HP$US$US
240780791$24078079$1$I$20240101$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135358$AMGEN$$52$YR$A$F$Y$$$20240711$$HP$US$US
240780803$24078080$3$F$$20240814$20240711$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002893$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
240780812$24078081$2$F$20240517$20240917$20240711$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015593$UNITED THERAPEUTICS$$65$YR$$F$Y$98.413$KG$20240927$$$US$US
240780832$24078083$2$F$20240630$20240816$20240711$20240822$PER$$US-JNJFOC-20240708916$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240822$$HP$US$US
240780852$24078085$2$F$20240611$20240705$20240711$20240711$PER$$US-ROCHE-10000022308$ROCHE$$$$$F$Y$$$20240711$$CN$US$US
240780861$24078086$1$I$$20240701$20240711$20240711$PER$$US-ROCHE-10000014569$ROCHE$$$$$F$Y$$$20240711$$MD$US$US
240780891$24078089$1$I$20190901$20240708$20240711$20240711$PER$$US-ABBVIE-5832749$ABBVIE$$68$YR$$F$Y$$$20240711$$HP$US$US
240780901$24078090$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143408$NOVARTIS$$$$$$Y$$$20240711$$MD$US$US
240780911$24078091$1$I$20240601$20240703$20240711$20240711$EXP$$AU-AstraZeneca-2024A154271$ASTRAZENECA$$708$MON$$F$Y$$$20240711$$CN$AU$
240780921$24078092$1$I$20240614$20240703$20240711$20240711$EXP$$EG-AstraZeneca-2024A154343$ASTRAZENECA$$24911$DY$$F$Y$$$20240711$$CN$EG$
240780941$24078094$1$I$$20231024$20240711$20240711$30DAY$$US-SANDOZ INC.-SDZ2023US038210$SANDOZ$$$$$M$Y$$$20240711$$CN$US$US
240780951$24078095$1$I$20230101$20240701$20240711$20240711$EXP$$FR-ROCHE-10000019787$ROCHE$Pabst L, Lopes S, Mascaux C. Non-small cell lung cancer: the role of immune checkpoint inhibitors in elderly patients, Clinical case study. Cancer and the Immune System. 2024;8 (2):79-85.$72$YR$E$M$Y$$$20240711$$MD$FR$FR
240780971$24078097$1$I$20240531$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024135896$AMGEN$$61$YR$A$M$Y$$$20240711$$PH$US$US
240780982$24078098$2$F$$20240708$20240711$20240711$EXP$$US-AMGEN-USASL2024135616$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240780992$24078099$2$F$20240701$20240718$20240711$20240722$PER$$US-AMGEN-USASP2024136806$AMGEN$$61$YR$A$M$Y$$$20240722$$CN$US$US
240781001$24078100$1$I$20240621$20240705$20240711$20240711$EXP$$CN-AMGEN-CHNSP2024134170$AMGEN$$67$YR$E$F$Y$47$KG$20240711$$HP$CN$CN
240781012$24078101$2$F$20240626$20240822$20240711$20240904$PER$$US-APOTEX-2024AP007845$APOTEX$$$$$M$Y$$$20240904$$CN$US$US
240781021$24078102$1$I$20240701$20240708$20240711$20240711$PER$$US-ABBVIE-5832276$ABBVIE$$32$YR$$M$Y$$$20240711$$HP$US$US
240781041$24078104$1$I$$20240710$20240711$20240711$PER$$US-HALEON-2186463$Haleon PLC$$$$$$Y$$$20240711$$CN$US$US
240781052$24078105$2$F$20220101$20240821$20240711$20240831$EXP$$DE-TEVA-VS-3217609$TEVA$$54$YR$$F$Y$61$KG$20240831$$CN$DE$DE
240781061$24078106$1$I$$20240628$20240711$20240711$30DAY$$US-JNJFOC-20240717668$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240781072$24078107$2$F$20240101$20240709$20240711$20240715$EXP$$US-ABBVIE-5832131$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240781081$24078108$1$I$$20240623$20240711$20240711$PER$$US-P+L Developments of Newyork Corporation-2159034$PL DEVELOPMENTS$$$$$$Y$$$20240711$$$US$US
240781091$24078109$1$I$$20240701$20240711$20240711$EXP$$GB-TEVA-VS-3216234$TEVA$$86$YR$$F$Y$$$20240711$$MD$GB$GB
240781111$24078111$1$I$20240101$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136895$AMGEN$$$$A$M$Y$$$20240711$$HP$US$US
240781121$24078112$1$I$20231201$20240627$20240711$20240711$EXP$$US-ROCHE-3569890$ROCHE$$66$YR$E$M$Y$86.18$KG$20240711$$CN$US$US
240781132$24078113$2$F$20240708$20240731$20240711$20240801$PER$$US-AMGEN-USASP2024136561$AMGEN$$68$YR$E$F$Y$$$20240801$$CN$US$US
240781141$24078114$1$I$20240101$20240701$20240711$20240711$EXP$$US-TEVA-VS-3175495$TEVA$$68$YR$$F$Y$$$20240711$$CN$US$US
240781151$24078115$1$I$$20240702$20240711$20240711$EXP$$CA-MYLANLABS-2024M1062836$MYLAN$$72$YR$$F$Y$$$20240711$$CN$CA$CA
240781161$24078116$1$I$$20240702$20240711$20240711$PER$$US-TEVA-VS-3217078$TEVA$$$$$$Y$$$20240711$$CN$US$US
240781171$24078117$1$I$$20240710$20240711$20240711$EXP$$US-GSK-US2024085727$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240781181$24078118$1$I$20240101$20240709$20240711$20240711$PER$$US-JNJFOC-20240722983$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240711$$CN$US$US
240781192$24078119$2$F$$20240806$20240711$20240808$EXP$$JP-JNJFOC-20240727339$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20240808$$MD$JP$JP
240781231$24078123$1$I$$20240621$20240711$20240711$EXP$$SG-ROCHE-10000006929$ROCHE$$65$YR$E$F$Y$$$20240711$$CN$SG$SG
240781241$24078124$1$I$20230725$20240704$20240711$20240711$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038674$BOEHRINGER INGELHEIM$$17$YR$T$F$Y$47$KG$20240711$$CN$GB$GB
240781251$24078125$1$I$$20240709$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2024US064061$SANDOZ$$$$$F$Y$$$20240711$$CN$US$US
240781263$24078126$3$F$20240101$20240826$20240711$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US063902$SANDOZ$$$$$F$Y$$$20240829$$CN$US$US
240781282$24078128$2$F$$20240701$20240711$20240712$EXP$$US-TEVA-VS-3217542$TEVA$$$$$$Y$$$20240712$$CN$US$US
240781291$24078129$1$I$20240701$20240708$20240711$20240711$EXP$$CO-UCBSA-2024035081$UCB$$82$YR$$M$Y$$$20240711$$CN$CO$CO
240781301$24078130$1$I$20240529$20240705$20240711$20240711$EXP$$CN-ALCON LABORATORIES-ALC2024CN003283$ALCON$$70$YR$$F$Y$72$KG$20240711$$HP$CN$CN
240781311$24078131$1$I$$20240701$20240711$20240711$EXP$$US-GSK-US2024083039$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$PH$US$US
240781321$24078132$1$I$20231001$20240701$20240711$20240711$EXP$$US-NEURELIS-USNEU24000324$Unknown Manufacturer$$$$$$Y$$$20240710$$CN$US$US
240781331$24078133$1$I$20240620$20240628$20240711$20240711$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000566$PAREXEL$$$$$$Y$$$20240711$$HP$CN$CN
240781341$24078134$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000021630$ROCHE$$$$$F$Y$$$20240711$$HP$US$US
240781351$24078135$1$I$$20240708$20240711$20240711$EXP$$JP-AMGEN-JPNSP2024135816$AMGEN$$$$$$Y$$$20240711$$MD$JP$JP
240781362$24078136$2$F$20240514$20240708$20240711$20240715$PER$$US-AMGEN-USASP2024135526$AMGEN$$37$YR$A$M$Y$$$20240715$$CN$US$US
240781371$24078137$1$I$20240425$20240425$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0089$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240781381$24078138$1$I$20240601$20240701$20240711$20240711$PER$$US-ABBVIE-5832493$ABBVIE$$50$YR$$M$Y$$$20240711$$CN$US$US
240781391$24078139$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06240$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240781401$24078140$1$I$20240621$20240701$20240711$20240711$EXP$$US-ACORDA-ACO_177490_2024$ACORDA$$77$YR$$F$Y$$$20240711$$CN$US$US
240781412$24078141$2$F$$20240711$20240711$20240715$PER$$US-ROCHE-10000020462$ROCHE$$$$$F$Y$79.38$KG$20240715$$CN$US$US
240781421$24078142$1$I$$20240710$20240711$20240711$PER$$US-ROCHE-10000022436$ROCHE$$$$A$F$Y$$$20240711$$CN$US$US
240781431$24078143$1$I$$20240701$20240711$20240711$EXP$$CA-AUROBINDO-AUR-APL-2013-05945$AUROBINDO$Beliveau Alian. Oral fluoroquinolines and retinal detachment. CARN. 2013;23:1-6$52$YR$$F$Y$$$20240711$$HP$CA$CA
240781441$24078144$1$I$20240412$20240708$20240711$20240711$EXP$FR-AFSSAPS-NT2024000810$FR-ASTELLAS-2024EU006733$ASTELLAS$$61$YR$$M$Y$65.2$KG$20240711$$CN$FR$FR
240781451$24078145$1$I$$20240701$20240711$20240711$EXP$$US-MYLANLABS-2024M1062938$MYLAN$Natarajan S, Amjad M, Zaidi S, Shah A, Ochieng PO. Persistent Bilateral Spontaneous Pneumothorax in Combined Pulmonary Fibrosis and Emphysema. Am-J-Respir-Crit-Care-Med 2023; 207 (plus Poster).$72$YR$$M$Y$$$20240711$$HP$US$US
240781461$24078146$1$I$20240401$20240425$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0090$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$PH$US$US
240781473$24078147$3$F$20240601$20240823$20240711$20240911$PER$$US-APOTEX-2024AP007846$APOTEX$$$$$F$Y$$$20240911$$CN$US$US
240781481$24078148$1$I$20230814$20240628$20240711$20240711$EXP$$CO-MYLANLABS-2024M1064302$MYLAN$$11$YR$$F$Y$11$KG$20240711$$CN$CO$CO
240781492$24078149$2$F$$20240710$20240711$20240711$PER$$US-ROCHE-10000022936$ROCHE$$$$$F$Y$$$20240711$$CN$US$US
240781501$24078150$1$I$$20240708$20240711$20240711$EXP$$KR-ASTELLAS-2024EU006758$ASTELLAS$$$$$M$Y$$$20240711$$HP$GB$KR
240781511$24078151$1$I$20230104$20240708$20240711$20240711$EXP$$KR-SANDOZ INC.-SDZ2024KR063792$SANDOZ$$64$YR$$F$Y$$$20240711$$CN$KR$KR
240781521$24078152$1$I$20240604$20240628$20240711$20240711$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000572$PAREXEL$$$$$$Y$$$20240711$$HP$CN$CN
240781531$24078153$1$I$$20240705$20240711$20240711$EXP$$US-AMGEN-USASP2024133963$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240781551$24078155$1$I$$20240705$20240711$20240711$PER$$US-UNITED THERAPEUTICS-UNT-2024-020564$UNITED THERAPEUTICS$$$$$F$Y$99.773$KG$20240711$$$US$US
240781562$24078156$2$F$20240601$20240716$20240711$20240719$EXP$$US-ABBVIE-5808308$ABBVIE$$52$YR$$F$Y$$$20240719$$CN$US$US
240781572$24078157$2$F$$20240711$20240711$20240716$EXP$$JP-AstraZeneca-2024A154397$ASTRAZENECA$$62$YR$$F$Y$$$20240716$$MD$JP$
240781581$24078158$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A154058$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240781592$24078159$2$F$20240527$20240724$20240711$20240801$EXP$IT-MINISAL02-992166$IT-TEVA-VS-3217170$TEVA$$67$YR$$F$Y$$$20240801$$MD$IT$IT
240781601$24078160$1$I$$20240703$20240711$20240711$EXP$$IL-AstraZeneca-2024A154953$ASTRAZENECA$$$$$F$Y$$$20240711$$HP$IL$
240781611$24078161$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153926$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240781622$24078162$2$F$$20240726$20240711$20240801$PER$$US-ABBVIE-5835230$ABBVIE$$$$$$Y$$$20240801$$CN$US$US
240781631$24078163$1$I$20240710$20240710$20240711$20240711$PER$$US-JNJFOC-20240726476$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240711$$CN$US$US
240781641$24078164$1$I$$20240703$20240711$20240711$EXP$$US-JNJFOC-20240711861$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240781651$24078165$1$I$20240623$20240628$20240711$20240711$EXP$GB-MHRA-MED-202406270852281540-HWGRJ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14416$ALKEM$$78$YR$$M$Y$91$KG$20240711$$CN$GB$GB
240781661$24078166$1$I$$20240705$20240711$20240711$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000594$DECIPHERA PHARMACEUTICALS$$80$YR$E$F$Y$$$20240711$$CN$US$US
240781672$24078167$2$F$$20240719$20240711$20240802$EXP$GB-MHRA-MED-202406271102593100-MTLRW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14418$ALKEM$$37$YR$$$Y$$$20240802$$CN$GB$GB
240781681$24078168$1$I$$20240628$20240711$20240711$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14737$ALKEM$$$$$M$Y$$$20240711$$CN$US$US
240781691$24078169$1$I$$20240628$20240711$20240711$EXP$$CH-ALKEM LABORATORIES LIMITED-CH-ALKEM-2024-14448$ALKEM$Hosek N, Montani M, Mani LY.. Acute post-renal kidney graft dysfunction due to cytomegalovirus-positive nephrogenic adenoma- case report and review of the literature. Frontiers in Medicine. 2024;11:1394028$33$YR$$M$Y$$$20240711$$HP$CH$CH
240781702$24078170$2$F$20150101$20240726$20240711$20240809$EXP$PL-MLMSERVICE-20240620-PI107024-00232-2$PL-ALKEM LABORATORIES LIMITED-PL-ALKEM-2024-14459$ALKEM$Maciej S, Hanna AB, Letachowicz K, Dorota K, Miroslaw B, Oktawia M, Magdalena K.. Severe Bullous Erysipelas/Cellulitis, Atypically Caused by Escherichia coli, in Kidney Transplant Recipient- Case Report and Review of Literature. Transplantation Proceedings. 2024;56(4):976-980$57$YR$$F$Y$$$20240809$$HP$PL$PL
240781711$24078171$1$I$$20240628$20240711$20240711$EXP$US-MLMSERVICE-20240621-PI105671-00232-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14460$ALKEM$Singh AD, Kurin M. An Unusual Case of Refractory Esophagitis and Esophageal Diverticulum. Digestive Diseases and Sciences. 2024;69 (6):1913-1914$76$YR$$F$Y$$$20240711$$MD$US$US
240781721$24078172$1$I$$20240628$20240711$20240711$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-14802$ALKEM$Grifoni E, Paniccia R, Giusti B, Sticchi E, Padeletti L, Cavallini C, Marcucci R. Non-traumatic splenic rupture on dual antiplatelet therapy with aspirin and ticagrelor after stenting for acute coronary syndrome. Journal of Cardiology Cases. 2015;12:65-67$57$YR$$M$Y$$$20240711$$MD$IT$IT
240781731$24078173$1$I$$20240628$20240711$20240711$EXP$BD-MLMSERVICE-20240625-PI107440-00039-4$BD-ALKEM LABORATORIES LIMITED-BD-ALKEM-2024-14447$ALKEM$Bari A, Begum NA, Nobi F, Rashid HU, Akhter N, Islam S. Varicella zoster virus and cytomegalovirus coinfection in a live related kidney transplant recipient: A case report. Clinical case reports. 2024;12(6):e9089$32$YR$$F$Y$$$20240711$$MD$BD$BD
240781741$24078174$1$I$$20240628$20240711$20240711$EXP$GB-MHRA-MED-202406281035540500-DRMKH$GB-ROCHE-10000012852$ROCHE$$$$$F$Y$$$20240711$$CN$GB$GB
240781772$24078177$2$F$$20240812$20240711$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06251$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240781781$24078178$1$I$20240604$20240704$20240711$20240711$EXP$$JP-ROCHE-10000021994$ROCHE$$61$YR$A$F$Y$$$20240711$$PH$JP$JP
240781791$24078179$1$I$20240326$20240704$20240711$20240711$EXP$IT-MINISAL02-992686$IT-009507513-2407ITA002482$MERCK$$81$YR$$F$Y$57$KG$20240711$$MD$IT$IT
240781801$24078180$1$I$$20240701$20240711$20240711$PER$$US-ROCHE-10000018463$ROCHE$$$$$F$Y$$$20240711$$MD$US$US
240781812$24078181$2$F$$20240716$20240711$20240726$EXP$$JP-TEVA-VS-3216279$TEVA$Oguni K, Fukushima S, Otsuka Y, Soejima Y, Kawaguchi M, Sazumi Y, et al. Disseminated septic arthritis caused by Ureaplasma urealyticum in an immunocompromised patient with hypogammaglobulinemia after rituximab therapy. Infection 2024; 52 (3):.; Oguni K, Fukushima S, Otsuka Y, Soejima Y, Kawaguchi M, Sazumi Y, et al. Disseminated septic arthritis caused by Ureaplasma urealyticum in an immunocompromised patient with hypogammaglobulinemia after rituximab therapy. Infection 2024; 52 (3):.; Oguni...$23$YR$$F$Y$$$20240726$$HP$JP$JP
240781821$24078182$1$I$20220101$20220210$20240711$20240711$PER$$DE-PFM-2022-09256$PIERRE FABRE MEDICAMENT$$$$E$M$Y$$$20240711$$CN$DE$DE
240781831$24078183$1$I$20240101$20240702$20240711$20240711$PER$$US-TEVA-VS-3217261$TEVA$$$$$$Y$$$20240711$$$US$US
240781851$24078185$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109642$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240711$$HP$US$US
240781871$24078187$1$I$20240101$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109432$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240711$$CN$US$US
240781881$24078188$1$I$20240705$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109481$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240711$$CN$US$US
240781891$24078189$1$I$20240624$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109414$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240711$$PH$US$US
240781901$24078190$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06309$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240781911$24078191$1$I$$20240701$20240711$20240711$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR082052$VIIV$$$$$F$Y$$$20240711$$CN$US$US
240781932$24078193$2$F$$20240711$20240711$20240718$PER$$US-ROCHE-10000020386$ROCHE$$$$A$M$Y$$$20240718$$CN$US$US
240781951$24078195$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06284$LUPIN$$$$$F$Y$$$20240711$$CN$US$US
240781961$24078196$1$I$20240702$20240708$20240711$20240711$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-13704$IPSEN$$75$YR$E$F$Y$$$20240711$$HP$GB$GB
240781971$24078197$1$I$20210701$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137333$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240781981$24078198$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136444$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240781991$24078199$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135023$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240782001$24078200$1$I$20240710$20240710$20240711$20240711$EXP$$US-GSK-US2024085843$GLAXOSMITHKLINE$$45$YR$$F$Y$$$20240711$$CN$US$US
240782012$24078201$2$F$20230101$20240627$20240711$20240716$EXP$$US-ACORDA-ACO_177519_2024$ACORDA$$$$$M$Y$77.1$KG$20240716$$MD$US$US
240782022$24078202$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3217764$TEVA$Pandey M, Vallapu Reddy T, Khattri B, Hemmige A, Pujar S, Aashish A. Pneumocystis Pneumonia in a Patient With Prolonged Steroid Therapy. Am-J-Respir-Crit-Care-Med 2024; 209.; Pandey M, Vallapu Reddy T, Khattri B, Hemmige A, Pujar S, Aashish A. Pneumocystis Pneumonia in a Patient With Prolonged Steroid Therapy. Am-J-Respir-Crit-Care-Med 2024; 209.$65$YR$$M$Y$$$20240809$$HP$US$US
240782032$24078203$2$F$$20240802$20240711$20240806$PER$$US-JNJFOC-20240723274$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$US$US
240782041$24078204$1$I$20240101$20240627$20240711$20240711$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00519$UPSHER-SMITH$$$$$$Y$$$20240711$$HP$US$US
240782051$24078205$1$I$20240101$20240627$20240711$20240711$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00520$UPSHER-SMITH$$$$$F$Y$$$20240711$$HP$US$US
240782061$24078206$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06285$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240782071$24078207$1$I$20240629$20240705$20240711$20240711$EXP$$CN-ROCHE-10000019484$ROCHE$$25$YR$A$F$Y$$$20240711$$CN$CN$CN
240782112$24078211$2$F$$20240726$20240711$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06295$LUPIN$$$$$$Y$$$20240814$$CN$US$US
240782121$24078212$1$I$20240613$20240703$20240711$20240711$EXP$ES-AEMPS-1536377$ES-TEVA-VS-3217163$TEVA$$61$YR$$F$Y$$$20240711$$HP$ES$ES
240782131$24078213$1$I$$20240710$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA064323$SANDOZ$$$$$M$Y$$$20240711$$HP$CA$CA
240782141$24078214$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06361$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240782161$24078216$1$I$20240301$20240708$20240711$20240711$EXP$$US-UCBSA-2024034905$UCB$$29$YR$$F$Y$$$20240711$$HP$US$US
240782171$24078217$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109640$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240711$$CN$US$US
240782181$24078218$1$I$$20240709$20240711$20240711$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-109555$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240711$$MD$FR$FR
240782191$24078219$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110040$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240711$$HP$US$US
240782201$24078220$1$I$$20240703$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109745$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240711$$HP$US$US
240782212$24078221$2$F$$20240716$20240711$20240726$EXP$$US-TEVA-VS-3217674$TEVA$Khan A, Murag S, Chinchilla D. When Time Is of the Essence: Fatal Delay in Diagnosis and Surgical Management of Pulmonary Mucormycosis in a Renal Transplant Patient. Am-J-Respir-Crit-Care-Med 2024; 209.; Khan A, Murag S, Chinchilla D. When Time Is of the Essence: Fatal Delay in Diagnosis and Surgical Management of Pulmonary Mucormycosis in a Renal Transplant Patient. Am-J-Respir-Crit-Care-Med 2024; 209.$67$YR$$M$Y$$$20240726$$HP$US$US
240782231$24078223$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135296$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240782241$24078224$1$I$$20240708$20240711$20240711$EXP$$CA-ORGANON-O2407CAN000770$ORGANON$$72$YR$$M$Y$$$20240711$$HP$CA$CA
240782251$24078225$1$I$$20240709$20240711$20240711$PER$$US-JNJFOC-20240723302$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$MD$US$US
240782263$24078226$3$F$$20240917$20240711$20240919$EXP$$US-JNJFOC-20240720340$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$MD$US$US
240782271$24078227$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033681$AUROBINDO$Yegudkin I, Feng L, Manzouri S, Funnamark R, Ciurczak N, McKenzie ME, et al.. Neurogenic Pulmonary Edema in the Setting of Intracerebral Hemorrhage: A Case Report.. Am-J-Respir-Crit Care-Med.. 2024;209:A1157$40$YR$$M$Y$$$20240711$$HP$US$US
240782282$24078228$2$F$20190319$20240709$20240711$20240712$EXP$$US-ROCHE-10000023088$ROCHE$$63$YR$A$F$Y$50.34$KG$20240712$$CN$US$US
240782291$24078229$1$I$20200101$20240708$20240711$20240711$EXP$$US-ABBVIE-5832614$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240782311$24078231$1$I$$20240620$20240711$20240711$PER$$US-PHARMING-PHAUS2024000514$PHARMING GROUP$$$$$$Y$$$20240711$$CN$US$US
240782321$24078232$1$I$$20240621$20240711$20240711$PER$$US-PHARMING-PHAUS2024000523$PHARMING GROUP$$$$$$Y$$$20240711$$CN$US$US
240782331$24078233$1$I$$20240619$20240711$20240711$PER$$US-PHARMING-PHAUS2024000504$PHARMING GROUP$$$$$$Y$$$20240711$$CN$US$US
240782342$24078234$2$F$$20240717$20240711$20240726$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000578$DECIPHERA PHARMACEUTICALS$$48$YR$A$F$Y$$$20240726$$CN$US$US
240782353$24078235$3$F$20240705$20240727$20240711$20240801$EXP$$JP-GSK-JP2024085323$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$MD$JP$JP
240782361$24078236$1$I$$20240701$20240711$20240711$EXP$$IE-STERISCIENCE B.V.-2024-ST-000984$Steriscience PTE$Dinneen B, Stack J.. Atypical antinuclear matrix protein 2-positive dermatomyositis presenting with anasarca and bulbar weakness after COVID-19 infection requiring mechanical ventilation.. Arch-Rheumatol. 2024;39 (2):312-313$28$YR$$F$Y$$$20240711$$HP$IE$IE
240782371$24078237$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06348$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240782381$24078238$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06372$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240782394$24078239$4$F$$20240806$20240711$20240808$30DAY$$GB-JNJFOC-20240675201$JOHNSON AND JOHNSON$$70$YR$E$F$Y$89$KG$20240809$$CN$GB$GB
240782401$24078240$1$I$$20240709$20240711$20240711$PER$$US-JNJFOC-20240723197$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240782411$24078241$1$I$$20240701$20240711$20240711$EXP$$BH-STERISCIENCE B.V.-2024-ST-000997$Steriscience PTE$Ghanem H, Wilson PT, Gill DS.. Intravenous magnesium sulphate for treatment of pediatric migraine: case series.. Signa-Vitae. 2023;19:194-200.$11$YR$$M$Y$$$20240711$$HP$BH$BH
240782421$24078242$1$I$$20240628$20240711$20240711$EXP$$US-Axellia-005267$XELLIA PHARMACEUTICALS$Havill NL, Colandrea NA, Merwede J, Aniskiewicz MJ, Roberts SC, Patel K, Pseudo-outbreak of Parengyodontium album related to contaminated saline used in specimen processing in the microbiology laboratory. American journal of infection control. 2024.$65$YR$E$M$Y$$$20240711$$MD$US$US
240782442$24078244$2$F$20240101$20240828$20240711$20240905$EXP$$CA-CELLTRION INC.-2024CA009477$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
240782451$24078245$1$I$20240418$20240604$20240711$20240711$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-12705$SAMSUNG BIOEPIS$$54$YR$A$M$Y$79$KG$20240711$$MD$DE$DE
240782461$24078246$1$I$$20240708$20240711$20240711$EXP$$US-PFIZER INC-PV202400090381$PFIZER$$31$YR$$M$Y$$$20240711$$MD$US$US
240782471$24078247$1$I$$20240708$20240711$20240711$EXP$$US-PFIZER INC-PV202400090280$PFIZER$$34$YR$$F$Y$$$20240711$$MD$US$US
240782481$24078248$1$I$$20240708$20240711$20240711$EXP$$US-PFIZER INC-PV202400090369$PFIZER$$42$YR$$F$Y$$$20240711$$MD$US$US
240782491$24078249$1$I$$20240704$20240711$20240711$EXP$$CA-PFIZER INC-2019SGN02894$PFIZER$$15$YR$$F$Y$50$KG$20240711$$PH$CA$CA
240782501$24078250$1$I$$20240708$20240711$20240711$EXP$$US-PFIZER INC-PV202400090390$PFIZER$$68$YR$$M$Y$$$20240711$$MD$US$US
240782511$24078251$1$I$20240101$20240708$20240711$20240711$EXP$$CA-PFIZER INC-202400022500$PFIZER$$76$YR$$F$Y$74.4$KG$20240711$$HP$CA$CA
240782521$24078252$1$I$20240629$20240708$20240711$20240711$EXP$$CN-PFIZER INC-PV202400089423$PFIZER$$69$YR$$M$Y$42$KG$20240711$$HP$CN$CN
240782532$24078253$2$F$$20240712$20240711$20240716$EXP$$JP-PFIZER INC-202400208205$PFIZER$$$$$$Y$$$20240716$$PH$JP$JP
240782541$24078254$1$I$$20240708$20240711$20240711$EXP$$US-PFIZER INC-PV202400090167$PFIZER$$48$YR$$F$Y$$$20240711$$MD$US$US
240782551$24078255$1$I$20240101$20240708$20240711$20240711$EXP$$CA-PFIZER INC-202400090068$PFIZER$$65$YR$$M$Y$80$KG$20240711$$HP$CA$CA
240782561$24078256$1$I$20231107$20240708$20240711$20240711$EXP$$DE-PFIZER INC-202400208461$PFIZER$$5$YR$$M$Y$$$20240711$$MD$DE$DE
240782581$24078258$1$I$20240622$20240708$20240711$20240711$EXP$$CN-PFIZER INC-PV202400089419$PFIZER$$3$YR$$M$Y$14.5$KG$20240711$$HP$CN$CN
240782591$24078259$1$I$$20240707$20240711$20240711$EXP$$CA-PFIZER INC-202400209429$PFIZER$$77$YR$$M$Y$$$20240711$$CN$CA$CA
240782601$24078260$1$I$$20240708$20240711$20240711$EXP$$US-PFIZER INC-PV202400090180$PFIZER$$51$YR$$M$Y$$$20240711$$MD$US$US
240782611$24078261$1$I$20240616$20240708$20240711$20240711$EXP$GB-MHRA-MED-202406300231145930-SKJZD$GB-PFIZER INC-202400208870$PFIZER$$73$YR$$F$Y$120$KG$20240711$$CN$GB$GB
240782621$24078262$1$I$20240703$20240708$20240711$20240711$EXP$$CN-PFIZER INC-PV202400089495$PFIZER$$14$YR$$M$Y$45$KG$20240711$$HP$CN$CN
240782631$24078263$1$I$20240622$20240705$20240711$20240711$EXP$$CN-PFIZER INC-PV202400088713$PFIZER$$82$YR$$M$Y$51$KG$20240711$$HP$CN$CN
240782643$24078264$3$F$20240601$20240911$20240711$20240912$EXP$$US-PFIZER INC-202400209565$PFIZER$$16$YR$$M$Y$67.13$KG$20240912$$CN$US$US
240782651$24078265$1$I$20240626$20240708$20240711$20240711$EXP$NO-NOMAADVRE-RELISV-2024-V37g8d$NO-PFIZER INC-202400208466$PFIZER$$36$YR$$F$Y$$$20240711$$MD$NO$NO
240782661$24078266$1$I$20240507$20240708$20240711$20240711$EXP$$US-PFIZER INC-202400208920$PFIZER$$55$YR$$M$Y$$$20240711$$HP$US$US
240782674$24078267$4$F$20210101$20240913$20240711$20240913$EXP$$CA-PFIZER INC-202101332003$PFIZER$$27$YR$$F$Y$87.45$KG$20240913$$HP$CA$CA
240782681$24078268$1$I$20240112$20240708$20240711$20240711$EXP$FR-AFSSAPS-GR2024000808$FR-PFIZER INC-202400208573$PFIZER$$78$YR$$F$Y$$$20240711$$PH$FR$FR
240782691$24078269$1$I$20240622$20240708$20240711$20240711$EXP$$CN-PFIZER INC-PV202400089490$PFIZER$$9$YR$$M$Y$28$KG$20240711$$HP$CN$CN
240782702$24078270$2$F$20240305$20240829$20240711$20240904$EXP$$IN-PFIZER INC-PV202400089211$PFIZER$$74$YR$$F$Y$$$20240904$$CN$IN$IN
240782731$24078273$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5833233$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240782753$24078275$3$F$20240612$20240830$20240711$20240909$EXP$$JP-ASTELLAS-2024JP004788$ASTELLAS$$8$DEC$E$M$Y$$$20240909$$MD$JP$JP
240782771$24078277$1$I$20240709$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136770$AMGEN$$69$YR$E$F$Y$$$20240711$$CN$US$US
240782781$24078278$1$I$20240707$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024137063$AMGEN$$74$YR$E$M$Y$$$20240711$$CN$US$US
240782792$24078279$2$F$$20240716$20240711$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-033919$AUROBINDO$$$$$F$Y$$$20240725$$HP$US$US
240782801$24078280$1$I$$20240705$20240711$20240711$EXP$$NVSJ2023JP003143$NOVARTIS$$$$$$Y$$$20240711$$MD$JP$JP
240782811$24078281$1$I$$20240705$20240711$20240711$EXP$$NVSJ2023JP003161$NOVARTIS$$$$$$Y$$$20240711$$MD$JP$JP
240782823$24078282$3$F$20210607$20240923$20240711$20240925$EXP$$NVSC2024CH140104$NOVARTIS$$$$A$F$Y$$$20240925$$MD$CH$CH
240782831$24078283$1$I$$20240705$20240711$20240711$EXP$$NVSJ2023JP014391$NOVARTIS$$$$$$Y$$$20240711$$MD$JP$JP
240782842$24078284$2$F$20240703$20240708$20240711$20240716$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020684$UNITED THERAPEUTICS$$77$YR$$M$Y$94.331$KG$20240716$$$US$US
240782851$24078285$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063751$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$35$YR$$M$Y$$$20240711$$HP$US$US
240782861$24078286$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063753$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$24$YR$$M$Y$$$20240711$$HP$US$US
240782871$24078287$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063742$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$45$YR$$F$Y$$$20240711$$HP$US$US
240782881$24078288$1$I$$20240702$20240711$20240711$EXP$$FR-MYLANLABS-2024M1063715$MYLAN$Sallee L, Souchet L, Boutolleau D, Nguyen S. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports. Int-J-Antimicrob-Agents 2024; 63 (6): 1-2.$60$YR$$F$Y$$$20240711$$HP$FR$FR
240782891$24078289$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063725$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$40$YR$$F$Y$$$20240711$$HP$US$US
240782901$24078290$1$I$$20240702$20240711$20240711$EXP$$FR-MYLANLABS-2024M1063723$MYLAN$Sallee L, Souchet L, Boutolleau D, Nguyen S. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports. Int-J-Antimicrob-Agents 2024; 63 (6): 1-2.$54$YR$$F$Y$$$20240711$$HP$FR$FR
240782911$24078291$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063731$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$65$YR$$F$Y$$$20240711$$HP$US$US
240782921$24078292$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063747$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$61$YR$$M$Y$$$20240711$$HP$US$US
240782931$24078293$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063748$MYLAN$Devine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. J-Pediatr-Pharmacol-Ther 2023; 28 (2): 161-166.$60$DY$$$Y$$$20240711$$HP$US$US
240782941$24078294$1$I$20240601$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109784$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240711$$HP$US$US
240782951$24078295$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063780$MYLAN$Torrado C, Baysal MA, Chakraborty A, Norris BL, Khawaja F, Tsimberidou AM. Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy. Front-Immunol 2024; 15.$5$DEC$$M$Y$$$20240711$$HP$US$US
240782961$24078296$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063772$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$50$YR$$M$Y$$$20240711$$HP$US$US
240782971$24078297$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109900$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240711$$CN$US$US
240782981$24078298$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109744$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240711$$CN$US$US
240783001$24078300$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06367$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240783011$24078301$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06374$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240783021$24078302$1$I$20240709$20240709$20240711$20240711$PER$$US-JNJFOC-20240722691$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240711$$CN$US$US
240783031$24078303$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033436$AUROBINDO$Goldberg E, Syed A, Desai S, Franco R, Ali Z.. Diffuse Alveolar Hemorrhage Secondary to Hydralazine-induced Vasculitis Causing Pulmonary-renal Syndrome.. Am-J-Respir-Crit-Care-Med. 2024$80$YR$$F$Y$$$20240711$$HP$US$US
240783042$24078304$2$F$$20240710$20240711$20240722$EXP$$JP-MACLEODS PHARMA-MAC2024048104$MACLEODS$$$$$$Y$$$20240722$$MD$JP$JP
240783052$24078305$2$F$20240614$20240822$20240711$20240904$EXP$IT-MINISAL02-992911$IT-MACLEODS PHARMA-MAC2024048062$MACLEODS$$$$$$Y$$$20240904$$MD$IT$IT
240783061$24078306$1$I$20240321$20240629$20240711$20240711$EXP$PT-INFARMED-J202406-503$PT-MACLEODS PHARMA-MAC2024048063$MACLEODS$$$$$$Y$$$20240711$$MD$PT$PT
240783071$24078307$1$I$20240629$20240701$20240711$20240711$EXP$GB-MHRA-MED-202407011648125660-STYZG$GB-MACLEODS PHARMA-MAC2024048087$MACLEODS$$72$YR$E$F$Y$$$20240711$$CN$GB$GB
240783081$24078308$1$I$$20240614$20240711$20240711$EXP$$ZA-ROCHE-RCA5198373$ROCHE$$$$E$M$Y$$$20240711$$MD$ZA$ZA
240783091$24078309$1$I$$20240418$20240711$20240711$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00777$AMNEAL$$$$$M$Y$$$20240711$$CN$US$US
240783101$24078310$1$I$$20230816$20240711$20240711$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02503$AMNEAL$$$$$F$Y$$$20240711$$CN$US$US
240783111$24078311$1$I$$20240624$20240711$20240711$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01300$AMNEAL$$$$$M$Y$45.805$KG$20240711$$CN$US$US
240783121$24078312$1$I$20240506$20240629$20240711$20240711$EXP$ES-EMA-DD-20240628-7483181-074332$ES-MACLEODS PHARMA-MAC2024048065$MACLEODS$$67$YR$E$F$Y$69.1$KG$20240711$$MD$ES$ES
240783134$24078313$4$F$20240601$20240826$20240711$20240902$EXP$$CN-ROCHE-10000015015$ROCHE$$67$YR$E$F$Y$$$20240902$$MD$CN$CN
240783141$24078314$1$I$$20240705$20240711$20240711$EXP$$US-ASTELLAS-2023EU005067$ASTELLAS$$$$$M$Y$$$20240711$$CN$US$US
240783151$24078315$1$I$$20240703$20240711$20240711$EXP$$FR-AstraZeneca-2024A154983$ASTRAZENECA$$$$$M$Y$$$20240711$$MD$FR$
240783161$24078316$1$I$20221214$20240703$20240711$20240711$EXP$$RU-ROCHE-10000018528$ROCHE$$62$YR$A$M$Y$$$20240711$$MD$RU$RU
240783171$24078317$1$I$20240630$20240709$20240711$20240711$EXP$$US-PFIZER INC-PV202400090378$PFIZER$$75$YR$$M$Y$$$20240711$$CN$US$US
240783182$24078318$2$F$$20240830$20240711$20240830$EXP$$US-PFIZER INC-PV202400090561$PFIZER$$61$YR$$$Y$$$20240830$$MD$US$US
240783191$24078319$1$I$20240428$20240709$20240711$20240711$EXP$ES-AEMPS-1544923$ES-PFIZER INC-202400209403$PFIZER$$51$YR$$M$Y$130$KG$20240711$$MD$ES$ES
240783202$24078320$2$F$20240703$20240711$20240711$20240712$EXP$$US-PFIZER INC-202400211066$PFIZER$$12$YR$$M$Y$$$20240712$$HP$US$US
240783211$24078321$1$I$$20240709$20240711$20240711$EXP$$JP-PFIZER INC-PV202400090208$PFIZER$$$$$$Y$$$20240711$$MD$JP$JP
240783221$24078322$1$I$20220927$20240709$20240711$20240711$EXP$$ES-PFIZER INC-202201251704$PFIZER$$$$$F$Y$$$20240711$$MD$ES$ES
240783231$24078323$1$I$20240428$20240709$20240711$20240711$EXP$FR-AFSSAPS-RN2024000752$FR-PFIZER INC-202400209312$PFIZER$$7$YR$$M$Y$$$20240711$$MD$FR$FR
240783242$24078324$2$F$20230901$20240712$20240711$20240716$EXP$GB-MHRA-MED-202407091227303110-MKNVL$GB-PFIZER INC-202400209632$PFIZER$$55$YR$$M$Y$$$20240716$$CN$GB$GB
240783262$24078326$2$F$$20240808$20240711$20240813$EXP$$NVSJ2024JP008234$NOVARTIS$$$$$$Y$$$20240813$$MD$JP$JP
240783271$24078327$1$I$$20240709$20240711$20240711$EXP$$NVSJ2024JP007700$NOVARTIS$$$$$$Y$$$20240711$$MD$JP$JP
240783282$24078328$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3217721$TEVA$Hashmi N, Basaleli C, Gupta S, John G, Birnbaum B, Kim U, et al. Acute Eosinophilic Pneumonia in the Setting of Intramuscular Progesterone Usage. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A6397.; Hashmi N, Basaleli C, Gupta S, John G, Birnbaum B, Kim U, et al. Acute Eosinophilic Pneumonia in the Setting of Intramuscular Progesterone Usage. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A6397.$33$YR$$F$Y$$$20240809$$HP$US$US
240783293$24078329$3$F$$20240920$20240711$20240926$EXP$$AU-ROCHE-10000007537$ROCHE$$$$$F$Y$$$20240926$$MD$AU$AU
240783301$24078330$1$I$20240621$20240702$20240711$20240711$EXP$FR-AFSSAPS-PC2024000547$FR-BEH-2024174854$CSL BEHRING$$77$YR$E$M$Y$68.5$KG$20240711$$MD$FR$FR
240783312$24078331$2$F$20240524$20240809$20240711$20240813$EXP$$US-PFIZER INC-PV202400073155$PFIZER$$74$YR$$F$Y$98.3$KG$20240813$$CN$US$US
240783321$24078332$1$I$20240513$20240708$20240711$20240711$EXP$$DE-BIOCON-BCN-2024-000125$BIOCON$$75$YR$E$M$Y$65$KG$20240711$$MD$DE$DE
240783331$24078333$1$I$20240129$20240708$20240711$20240711$EXP$FR-AFSSAPS-LM2024000374$FR-PFIZER INC-202400208574$PFIZER$$68$YR$$F$Y$63$KG$20240711$$MD$FR$FR
240783342$24078334$2$F$$20240703$20240711$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06377$LUPIN$$$$$$Y$$$20240728$$CN$US$US
240783351$24078335$1$I$$20240709$20240711$20240711$EXP$$US-GILEAD-2024-0680246$GILEAD$$$$$$Y$$$20240711$$LW$US$US
240783361$24078336$1$I$20150101$20240703$20240711$20240711$EXP$NO-NOMAADVRE-PASRAPP-2024-Vp3x3q$NO-TEVA-VS-3217155$TEVA$$43$YR$$M$Y$100$KG$20240711$$CN$NO$NO
240783371$24078337$1$I$$20240703$20240711$20240711$PER$$US-JNJFOC-20240711977$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240783381$24078338$1$I$$20240702$20240711$20240711$EXP$$US-BAYER-2024A096486$BAYER$$89$YR$E$M$Y$69.388$KG$20240711$$CN$US$US
240783391$24078339$1$I$$20240704$20240711$20240711$EXP$$JP-009507513-2407JPN000775J$MERCK$$$$$F$Y$$$20240711$$MD$JP$JP
240783403$24078340$3$F$20240704$20240708$20240711$20240717$EXP$$NVSC2024US141088$NOVARTIS$$74$YR$$M$Y$$$20240717$$CN$US$US
240783412$24078341$2$F$20170101$20240807$20240711$20240813$EXP$$NVSC2024NO142923$NOVARTIS$$47$YR$$F$Y$$$20240813$$CN$NO$NO
240783421$24078342$1$I$$20240626$20240711$20240711$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01080$INTRA-CELLULAR THERAPIES$$32$YR$$F$Y$$$20240711$$HP$US$US
240783431$24078343$1$I$20240521$20240701$20240711$20240711$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00545$PARATEK PHARMACEUTICALS$$70$YR$$M$Y$85$KG$20240711$$HP$CN$CN
240783441$24078344$1$I$20240501$20240614$20240711$20240711$PER$$US-AJANTA-2024AJA00116$AJANTA PHARMA$$69$YR$E$F$Y$130$KG$20240711$$CN$US$US
240783451$24078345$1$I$$20240701$20240711$20240711$EXP$$BH-STRIDES ARCOLAB LIMITED-2024SP008018$STRIDES$Ghanem H, Wilson PT, Gill DS. Intravenous magnesium sulphate for treatment of pediatric migraine: case series. Signa-Vitae. 2023;19:194-200$11$YR$$M$Y$$$20240711$$HP$BH$BH
240783461$24078346$1$I$20240619$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006423$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240711$$CN$US$US
240783471$24078347$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005943$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240711$$CN$US$US
240783481$24078348$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005456$ELI LILLY AND CO$$$$$$Y$$$20240711$$CN$US$US
240783491$24078349$1$I$$20240626$20240711$20240711$EXP$$SI-VIRTUS PHARMACEUTICALS, LLC-2024VTS00016$VIRTUS PHARMACEUTICALS$Jerman A, Bezeljak N. Hemodialysis for salbutamol intoxication: patient case report.. Nephrol. Dial. Transplant. 2024;39:i2452$69$YR$$M$Y$76$KG$20240711$$HP$SI$SI
240783502$24078350$2$F$$20240709$20240711$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407005315$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240718$$CN$US$US
240783511$24078351$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006252$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240711$$CN$US$US
240783521$24078352$1$I$20240702$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005984$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240711$$CN$US$US
240783531$24078353$1$I$20240706$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005980$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240711$$CN$US$US
240783541$24078354$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006062$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240711$$CN$US$US
240783551$24078355$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47946$$FDA-CTU$$34$YR$$F$N$$$20240710$N$$US$
240783561$24078356$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005053$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240711$$MD$US$US
240783571$24078357$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005408$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240711$$CN$US$US
240783581$24078358$1$I$20240708$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005414$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240711$$CN$US$US
240783591$24078359$1$I$20240704$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006137$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240711$$CN$US$US
240783601$24078360$1$I$20240708$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005302$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240711$$CN$US$US
240783612$24078361$2$F$20240530$20240724$20240711$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407004256$ELI LILLY AND CO$$16$YR$T$F$Y$$$20240802$$CN$US$US
240783621$24078362$1$I$$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006771$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240711$$CN$US$US
240783631$24078363$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006518$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240711$$CN$US$US
240783641$24078364$1$I$20240708$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005340$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240711$$CN$US$US
240783651$24078365$1$I$20240706$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005601$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240711$$CN$US$US
240783661$24078366$1$I$20240601$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006538$ELI LILLY AND CO$$$$$M$Y$$$20240711$$CN$US$US
240783671$24078367$1$I$20240601$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006257$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240711$$PH$US$US
240783681$24078368$1$I$$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136892$AMGEN$$85$YR$E$F$Y$$$20240711$$CN$US$US
240783691$24078369$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005484$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240711$$CN$US$US
240783703$24078370$3$F$20240626$20240717$20240711$20240916$EXP$$US-SA-2024SA201749$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240916$$MD$US$US
240783711$24078371$1$I$$20240426$20240711$20240711$PER$$US-NOVAST LABORATORIES INC.-2024NOV000234$NOVAST$$$$$$Y$$$20240711$$CN$US$US
240783721$24078372$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110077$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$57.15$KG$20240711$$CN$US$US
240783731$24078373$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110025$BRISTOL MYERS SQUIBB$$24$YR$A$M$Y$$$20240711$$HP$US$US
240783741$24078374$1$I$$20240702$20240711$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-057728$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240711$$MD$JP$JP
240783751$24078375$1$I$20240703$20240710$20240711$20240711$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-109976$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240711$$CN$PR$PR
240783761$24078376$1$I$20240313$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109441$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240711$$CN$US$US
240783781$24078378$1$I$20100118$20240705$20240711$20240711$EXP$$IL-ASTELLAS-2024EU006706$ASTELLAS$$65$YR$$M$Y$$$20240711$$HP$GB$IL
240783801$24078380$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143440$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240783811$24078381$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033491$AUROBINDO$Le CT, Mahmoud A, Kurt O, Bangash H, Saad Eldin M, Ayaz S.. Advanced Care in Rheumatoid Arthritis With Biologic Agents: The Role of Pneumocystis Jirovecii Pneumonia Prophylaxis.. Am-JRespir-Crit-Care-Med. 2024;209:A2388$66$YR$$F$Y$$$20240711$$HP$US$US
240783821$24078382$1$I$20210601$20240710$20240711$20240711$EXP$$US-GILEAD-2024-0680242$GILEAD$$49$YR$A$M$Y$$$20240711$$CN$US$US
240783831$24078383$1$I$$20240701$20240711$20240711$EXP$GB-MHRA-MED-202407011411135000-YPNHD$GB-Accord-434265$ACCORD$$$$$$Y$$$20240711$$HP$GB$GB
240783842$24078384$2$F$$20240712$20240711$20240718$EXP$$NVSJ2024JP008313$NOVARTIS$$$$A$M$Y$$$20240718$$MD$JP$JP
240783851$24078385$1$I$20240630$20240630$20240711$20240711$EXP$GB-MHRA-MED-202406301736438520-HBFNL$GB-Accord-433766$ACCORD$$32$YR$A$F$Y$$$20240711$$CN$GB$GB
240783861$24078386$1$I$$20240701$20240711$20240711$EXP$AU-TGA-801557$AU-Accord-433155$ACCORD$$45$YR$A$F$Y$$$20240711$$HP$AU$AU
240783882$24078388$2$F$20240703$20240712$20240711$20240715$PER$$US-JNJFOC-20240710368$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240715$$HP$US$US
240783891$24078389$1$I$20230301$20240708$20240711$20240711$EXP$$EG-SANDOZ INC.-SDZ2024EG037479$SANDOZ$$8$YR$$M$Y$31$KG$20240711$$CN$EG$EG
240783901$24078390$1$I$$20240627$20240711$20240711$EXP$$IT-Long Grove-000058$Long Grove Pharmaceuticals$Di Trana A, Di Giorgi A, Carlier J, Serra F, Busard? FP, Pichini S. Tranq-dope: The first fatal intoxication due to xylazine-adulterated heroin in Italy. Clin Chim Acta. 2024 Jun 21; 561:119826$33$YR$A$M$Y$$$20240711$$HP$IT$IT
240783911$24078391$1$I$$20240628$20240711$20240711$EXP$$CA-Axellia-005266$XELLIA PHARMACEUTICALS$Salter B, Ge S, Tam A, Demczuk S, Butcher D, McCready E, Concurrent BCR-ABL1 and core binding factor beta rearrangement in de novo acute myeloid leukemia: A case report and review of literature. eJHaem. 2024;5(3):607-15.$62$YR$A$M$Y$$$20240711$$MD$CA$CA
240783921$24078392$1$I$$20240630$20240711$20240711$EXP$$GR-Accord-434058$ACCORD$Karmiris E, Chalkiadaki E, Tsiripidis K, Stavrakas P, Papakonstantinou E. An Atypical Case of Severe Toxicity, Anterior Chamber Inflammation, and Transient Subretinal Fluid Formation Induced by the Subconjunctival Injection of 5-FU. Ocul Immunol Inflamm. 2024 Jun 25:1-4.$40$YR$A$M$Y$$$20240711$$MD$GR$GR
240783935$24078393$5$F$20240617$20240816$20240711$20240828$EXP$$US-Accord-433782$ACCORD$$49$YR$A$M$Y$$$20240828$$MD$US$US
240783942$24078394$2$F$$20240709$20240711$20240716$EXP$$US-Accord-434001$ACCORD$$61$YR$A$F$Y$$$20240716$$HP$US$US
240783951$24078395$1$I$20230101$20240629$20240711$20240711$EXP$IT-MINISAL02-992968$IT-Accord-433606$ACCORD$$48$YR$A$M$Y$94$KG$20240711$$MD$IT$IT
240783965$24078396$5$F$20240101$20240826$20240711$20240906$EXP$$GB-UCBSA-2024029100$UCB$$$$$F$Y$$$20240906$$CN$GB$GB
240783971$24078397$1$I$20240101$20240709$20240711$20240711$EXP$$US-UCBSA-2024034929$UCB$$$$$M$Y$$$20240711$$HP$US$US
240783981$24078398$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47937$$FDA-CTU$$72$YR$$F$N$$$20240710$N$$US$
240783991$24078399$1$I$20240627$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47999$$FDA-CTU$$83$YR$$F$N$$$20240710$Y$PH$US$
240784001$24078400$1$I$20240608$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47963$$FDA-CTU$$57$YR$$M$N$$$20240710$Y$PH$US$
240784011$24078401$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47991$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240784031$24078403$1$I$$20240709$20240711$20240711$EXP$GR-GREOF-202400711$GR-ORGANON-O2407GRC000857$ORGANON$$65$YR$$F$Y$$$20240711$$MD$GR$GR
240784042$24078404$2$F$20240401$20240709$20240711$20240715$EXP$$US-ABBVIE-5832705$ABBVIE$$63$YR$$F$Y$$$20240715$$CN$US$US
240784051$24078405$1$I$20220101$20240701$20240711$20240711$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008314$STRIDES$Khan MF, Siddini V, Ballal S, Mathur A.. Posttransplant Thrombotic Microangiopathy: Unraveling a Mystery.. Indian-J-Transplant. 2024;18(1):78-80$24$YR$$F$Y$$$20240711$$HP$IN$IN
240784061$24078406$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008160$STRIDES$Torrado C, Baysal MA, Chakraborty A, Norris BL, Khawaja F, Tsimberidou AM. Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy.. Front-Immunol. 2024;15$$$$$Y$$$20240711$$HP$US$US
240784091$24078409$1$I$$20240703$20240711$20240711$EXP$$US-VIIV HEALTHCARE LIMITED-US2024083135$VIIV$$$$E$M$Y$$$20240711$$HP$US$US
240784102$24078410$2$F$$20240725$20240711$20240730$PER$$US-AMGEN-USASP2024135678$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
240784121$24078412$1$I$20240622$20240709$20240711$20240711$EXP$$NVSC2024EG142723$NOVARTIS$$33$YR$$M$Y$$$20240711$$CN$EG$EG
240784131$24078413$1$I$$20240702$20240711$20240711$EXP$$US-AUROBINDO-AUR-APL-2024-033596$AUROBINDO$Shapoo N, Poor A, Trenard N. Challenging Diagnosis of Myxedema Coma in an Elderly Patient. Am-J-Respir-Crit-Care-Med. 2024;209:A3392$86$YR$$M$Y$$$20240711$$HP$US$US
240784141$24078414$1$I$20240101$20240701$20240711$20240711$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017859$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240711$$$US$US
240784151$24078415$1$I$$20240702$20240711$20240711$EXP$$FR-MYLANLABS-2023M1090428$MYLAN$Gigante E, Bouattour M, Bedoya JU, Regnault H, Ziol M, Assenat E, et al. Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: a multicentric retrospective study. J-Hepatol 2023;78 (Suppl. 1):S577 (plus poster) abstr. THU-119.$66$YR$$M$Y$$$20240711$$HP$FR$FR
240784161$24078416$1$I$$20240621$20240711$20240711$EXP$$KR-ROCHE-10000013955$ROCHE$$$$$$Y$$$20240711$$HP$KR$KR
240784172$24078417$2$F$$20240716$20240711$20240726$EXP$$US-TEVA-VS-3217678$TEVA$Nasir S, Sedghian M, Khan Z, Roberge MR. IVDU, I Can^t Hear You: Sudden Hearing Loss After Fentanyl Use. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A2132.; Nasir S, Sedghian M, Khan Z, Roberge MR. IVDU, I Can^t Hear You: Sudden Hearing Loss After Fentanyl Use. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A2132.$36$YR$$M$Y$$$20240726$$HP$US$US
240784181$24078418$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063706$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$56$YR$$M$Y$$$20240711$$HP$US$US
240784191$24078419$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063705$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$62$YR$$F$Y$$$20240711$$HP$US$US
240784201$24078420$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063773$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$61$YR$$M$Y$$$20240711$$HP$US$US
240784211$24078421$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136447$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240784221$24078422$1$I$20240610$20240701$20240711$20240711$EXP$FR-AFSSAPS-PC2024000522$FR-BAXTER-2024BAX020927$BAXTER$$53$YR$$M$Y$87$KG$20240711$$PH$FR$FR
240784231$24078423$1$I$20240701$20240709$20240711$20240711$PER$$US-ROCHE-10000022377$ROCHE$$47$YR$A$M$Y$$$20240711$$CN$US$US
240784241$24078424$1$I$$20240704$20240711$20240711$EXP$GB-MHRA-MED-202405011654184450-TSCFD$GB-BAXTER-2024BAX021283$BAXTER$$$$$F$Y$42$KG$20240711$$PH$GB$GB
240784251$24078425$1$I$$20240702$20240711$20240711$EXP$$SA-STRIDES ARCOLAB LIMITED-2024SP008083$STRIDES$Alahwal HM, Alsharif MH, Almohammadi AT, Al-Marzouki AF, Barefah AS, Bahashwan SM, et al.. COVID-19-induced immune thrombocytopenia management approach: A case report and literature review.. Clin-Case-Rep. 2024;12 (6)$39$YR$$M$Y$$$20240711$$HP$SA$SA
240784261$24078426$1$I$20240613$20240628$20240711$20240711$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000564$PAREXEL$$$$$$Y$$$20240711$$HP$CN$CN
240784271$24078427$1$I$20240518$20240703$20240711$20240711$EXP$FR-AFSSAPS-RN2024000697$FR-TEVA-VS-3217224$TEVA$$69$YR$$M$Y$$$20240711$$MD$FR$FR
240784284$24078428$4$F$20240101$20240903$20240711$20240911$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000592$DECIPHERA PHARMACEUTICALS$$83$YR$E$M$Y$156.5$KG$20240911$$CN$US$US
240784291$24078429$1$I$$20240702$20240711$20240711$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP008088$STRIDES$Mutlu C, Gunes S, Turan S, Camli SE.. CLOZAPINE-INDUCED MYOCARDITIS: AN ADOLESCENT GIRL WITH VERY EARLY-ONSET SCHIZOPHRENIA.. Psychiatr-Danub. 2024;36 (1):123-125$13$YR$$F$Y$$$20240711$$HP$TR$TR
240784311$24078431$1$I$$20240705$20240711$20240711$PER$$US-ABBVIE-5832170$ABBVIE$$$$$M$Y$102$KG$20240711$$CN$US$US
240784321$24078432$1$I$$20240702$20240711$20240711$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008089$STRIDES$Bascuas Arribas M, Camino Serrano M, Sanz Santiago V, Lopez-Neyra A.. Severe asthma resistant to biological treatment?.. An-Pediatr. 2024;100(5):e9$11$YR$$F$Y$$$20240711$$HP$ES$ES
240784332$24078433$2$F$20240101$20240724$20240711$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108829$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240729$$CN$US$US
240784341$24078434$1$I$$20240701$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109092$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$49$YR$A$F$Y$$$20240711$$HP$US$US
240784353$24078435$3$F$20230101$20240802$20240711$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-108272$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$47$KG$20240806$$MD$JP$JP
240784371$24078437$1$I$$20240618$20240711$20240711$EXP$$ZA-ROCHE-10000016411$ROCHE$$$$A$M$Y$$$20240711$$CN$ZA$ZA
240784381$24078438$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108577$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240711$$CN$US$US
240784391$24078439$1$I$$20240703$20240711$20240711$EXP$$CN-ROCHE-10000015354$ROCHE$Yan Z, Dong Y, Qiao N, Zhang Y, Wu W, Zhu Y, et al. Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma. Nature Communications. 2024;15 (1):1-16. doi:10.1038/s41467-024-49495-4.$$$$$Y$$$20240711$$HP$CN$CN
240784403$24078440$3$F$20240706$20240726$20240711$20240730$PER$$US-AMGEN-USASP2024136909$AMGEN$$63$YR$A$F$Y$$$20240730$$CN$US$US
240784412$24078441$2$F$20240628$20240812$20240711$20240819$30DAY$$CL-JNJFOC-20240712807$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240819$$CN$CL$CL
240784421$24078442$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008084$STRIDES$Sharma S, Desai S, Leoni J, Paghdar S, Ruiz J, Goswami R.. Case report: eosinophilic myocarditis in hypereosinophilic syndrome: a journey to heart transplantation.. Front-Immunol. 2024;15.$51$YR$$F$Y$$$20240711$$HP$US$US
240784431$24078443$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008100$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$$$$$Y$$$20240711$$HP$US$US
240784441$24078444$1$I$20230520$20240703$20240711$20240711$EXP$ES-AEMPS-1539406$ES-TEVA-VS-3216940$TEVA$$64$YR$$F$Y$$$20240711$$MD$ES$ES
240784451$24078445$1$I$$20240704$20240711$20240711$EXP$$NL-CHEPLA-6000124524$CHEPLAPHARM$Boot E, Butcher NJ, van Amelsvoort TAMJ, Lang AE, Marras C, Pondal M, et al. Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome. American Journal of Medical Genetics, Part A. 2015;167A:639-645. doi:10.1002/ajmg.a.36928.$20$YR$$M$Y$$$20240711$$HP$COUNTRY NOT SPECIFIED$NL
240784461$24078446$1$I$20240613$20240628$20240711$20240711$EXP$$CN-EMD Serono-2024035748$EMD SERONO INC$$77$YR$E$F$Y$51$KG$20240711$$HP$CN$CN
240784471$24078447$1$I$$20240626$20240711$20240711$PER$$US-P+L Developments of Newyork Corporation-2159037$PL DEVELOPMENTS$$$$$F$Y$$$20240711$$$US$US
240784481$24078448$1$I$$20240626$20240711$20240711$PER$$US-P+L Developments of Newyork Corporation-2159038$PL DEVELOPMENTS$$$$$$Y$$$20240711$$$US$US
240784491$24078449$1$I$20230101$20240705$20240711$20240711$EXP$$CN-ASTELLAS-2024US019219$ASTELLAS$$32$YR$$M$Y$$$20240711$$HP$CN$CN
240784503$24078450$3$F$$20240720$20240711$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-032944$AUROBINDO$M. Chappuy, I. Merah, D. Ragonnet, J. de Ternay, B. Rolland. Le Centre ressource lyonnais des addictions m?dicamenteuses (CERLAM) -Lyon resource center for prescription drug use disorder. Le courrier des Addictions. 2024;XXVI(2):24-27$47$YR$$M$Y$$$20240731$$PH$FR$FR
240784511$24078451$1$I$$20240626$20240711$20240711$PER$$US-P+L Developments of Newyork Corporation-2159039$PL DEVELOPMENTS$$$$$$Y$$$20240711$$$US$US
240784521$24078452$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136215$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240784531$24078453$1$I$$20240701$20240711$20240711$EXP$$RO-EMD Serono-2024036501$EMD SERONO INC$Late-onset congenital adrenal hyperplasia-a low-key differential diagnosis. Acta medica marisiensis. 2024;70: 275-275.$31$YR$A$F$Y$$$20240711$$MD$RO$RO
240784541$24078454$1$I$20230930$20231018$20240711$20240711$EXP$$US-SANDOZ INC.-NVSC2023US097749$SANDOZ$$77$YR$$F$Y$$$20240711$$MD$US$US
240784551$24078455$1$I$$20240702$20240711$20240711$PER$$US-TEVA-VS-3217290$TEVA$$$$A$F$Y$$$20240711$$CN$US$US
240784561$24078456$1$I$20240101$20240708$20240711$20240711$PER$$US-ABBVIE-5832693$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240784571$24078457$1$I$$20240704$20240711$20240711$EXP$$IR-ASTELLAS-2024EU006700$ASTELLAS$$49$YR$$M$Y$$$20240711$$CN$NL$IR
240784581$24078458$1$I$$20240710$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039154$BOEHRINGER INGELHEIM$$$$$$Y$$$20240711$$MD$US$US
240784591$24078459$1$I$20240523$20240701$20240711$20240711$EXP$CH-SEPTODONT-2024018786$CH-SEPTODONT-2024018786$SEPTODONT$$75$YR$E$M$Y$$$20240711$$HP$CH$CH
240784601$24078460$1$I$$20240710$20240711$20240711$EXP$$IL-AMERICAN REGENT INC-2024002663$AMERICAN REGENT$$40$YR$$F$Y$$$20240711$$MD$IL$IL
240784611$24078461$1$I$$20240704$20240711$20240711$EXP$$US-ASTELLAS-2024EU006694$ASTELLAS$Shehzad D, Khan D, Huang J, Sitta EA. Mediastinal actinomycosis masquerading as a mass: a case of progressive dysphagia in an immunocompromised patient. BMJ Case Reports. 2024;17(6):1-4$7$DEC$$F$Y$$$20240711$$MD$US$US
240784621$24078462$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008101$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$34$YR$$M$Y$$$20240711$$HP$US$US
240784631$24078463$1$I$20220617$20240710$20240711$20240711$EXP$$AT-SANDOZ INC.-SDZ2024AT064165$SANDOZ$$29$YR$$M$Y$88.2$KG$20240711$$HP$AT$AT
240784651$24078465$1$I$$20240702$20240711$20240711$EXP$$JP-TAKEDA-2024TUS070506$TAKEDA$$$$$M$Y$$$20240711$$PH$JP$JP
240784661$24078466$1$I$20240415$20240704$20240711$20240711$EXP$$HR-ASTELLAS-2024US019249$ASTELLAS$$$$E$M$Y$$$20240711$$CN$HR$HR
240784671$24078467$1$I$$20240701$20240711$20240711$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-357485$RANBAXY$$$$A$F$Y$$$20240711$$HP$US$US
240784681$24078468$1$I$20221001$20240701$20240711$20240711$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389255$RANBAXY$$60$YR$$F$Y$70.748$KG$20240711$$CN$CA$CA
240784691$24078469$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000023635$ROCHE$$73$YR$E$F$Y$$$20240711$$MD$US$US
240784701$24078470$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008102$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$47$YR$$F$Y$$$20240711$$HP$US$US
240784711$24078471$1$I$20240529$20240704$20240711$20240711$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000571$PAREXEL$$73$YR$$M$Y$54.5$KG$20240711$$HP$CN$CN
240784722$24078472$2$F$20240626$20240809$20240711$20240812$EXP$$NZ-MYLANLABS-2024M1061232$MYLAN$$49$YR$$M$Y$$$20240812$$CN$NZ$NZ
240784731$24078473$1$I$$20240703$20240711$20240711$EXP$$US-MYLANLABS-2024M1063890$MYLAN$Gouda MA, Janku F, Somaiah N, Hunt KK, Yedururi S, Subbiah V. Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery. Oncoscience 2023; 10 38-43.$$$A$F$Y$$$20240711$$HP$US$US
240784741$24078474$1$I$$20240703$20240711$20240711$EXP$$US-MYLANLABS-2024M1064031$MYLAN$Henry PJ, Wen JH, Feldman EB, Vargas J. Minocycline Induced Parenchymal Lung Disease with Peripheral Eosinophilia. Am-J-Respir-Crit-Care-Med 2024; 209.$70$YR$$M$Y$$$20240711$$HP$US$US
240784751$24078475$1$I$$20240703$20240711$20240711$EXP$$US-MYLANLABS-2024M1064026$MYLAN$Almeida Da SilvaLC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. J-Pediatr-Orthop-B 2024; 33 (4): 407-410.$$$C$$Y$$$20240711$$MD$US$US
240784761$24078476$1$I$$20240703$20240711$20240711$EXP$$US-MYLANLABS-2024M1064090$MYLAN$Almeida Da SilvaLC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. J-Pediatr-Orthop-B 2024; 33 (4): 407-410.$$$C$$Y$$$20240711$$MD$US$US
240784771$24078477$1$I$$20240703$20240711$20240711$EXP$$US-MYLANLABS-2024M1064089$MYLAN$Almeida Da SilvaLC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. J-Pediatr-Orthop-B 2024; 33 (4): 407-410.$$$C$$Y$$$20240711$$MD$US$US
240784783$24078478$3$F$20240101$20240812$20240711$20240816$EXP$$US-PFIZER INC-202400211088$PFIZER$$66$YR$$M$Y$$$20240816$$HP$US$US
240784791$24078479$1$I$20240519$20240709$20240711$20240711$EXP$ES-AEMPS-1543851$ES-PFIZER INC-202400209434$PFIZER$$56$YR$$M$Y$$$20240711$$PH$ES$ES
240784801$24078480$1$I$20231201$20240709$20240711$20240711$EXP$$US-PFIZER INC-202400209787$PFIZER$$40$YR$$F$Y$$$20240711$$CN$US$US
240784811$24078481$1$I$20230101$20240709$20240711$20240711$EXP$$CA-PFIZER INC-PV202300140230$PFIZER$$68$YR$$F$Y$$$20240711$$PH$CA$CA
240784821$24078482$1$I$$20240710$20240711$20240711$EXP$$AU-PFIZER INC-PV202400090258$PFIZER$$84$YR$$M$Y$$$20240711$$CN$AU$AU
240784832$24078483$2$F$20210512$20240817$20240711$20240819$EXP$$ES-PFIZER INC-2021SGN02751$PFIZER$$$$A$F$Y$$$20240819$$MD$ES$ES
240784851$24078485$1$I$20240709$20240710$20240711$20240711$EXP$$US-PFIZER INC-PV202400090614$PFIZER$$69$YR$$F$Y$$$20240711$$CN$US$US
240784861$24078486$1$I$20220105$20240705$20240711$20240711$EXP$$IT-PFIZER INC-2022SGN00326$PFIZER$$45$YR$$F$Y$58$KG$20240711$$MD$IT$IT
240784871$24078487$1$I$20240119$20240705$20240711$20240711$EXP$IT-MINISAL02-993344$IT-PFIZER INC-202400207325$PFIZER$$83$YR$$F$Y$$$20240711$$MD$IT$IT
240784882$24078488$2$F$$20240821$20240711$20240823$EXP$$CA-PFIZER INC-202400209564$PFIZER$$82$YR$$M$Y$$$20240823$$CN$CA$CA
240784891$24078489$1$I$20240701$20240709$20240711$20240711$EXP$$US-PFIZER INC-202400210294$PFIZER$$73$YR$$F$Y$81.633$KG$20240711$$CN$US$US
240784901$24078490$1$I$$20240520$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2024US027792$SANDOZ$$72$YR$$F$Y$$$20240711$$CN$US$US
240784911$24078491$1$I$$20240628$20240711$20240711$PER$$US-P+L Developments of Newyork Corporation-2159040$PL DEVELOPMENTS$$$$$$Y$$$20240711$$$US$US
240784922$24078492$2$F$$20240716$20240711$20240717$EXP$$DE-PFIZER INC-202400209408$PFIZER$$4$MON$$F$Y$$$20240717$$MD$DE$DE
240784931$24078493$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008103$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$38$YR$$F$Y$$$20240711$$HP$US$US
240784942$24078494$2$F$20240509$20240715$20240711$20240718$EXP$$ES-PFIZER INC-202400207453$PFIZER$$72$YR$$F$Y$68.5$KG$20240718$$MD$ES$ES
240784951$24078495$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109340$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240711$$HP$US$US
240784961$24078496$1$I$$20240701$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109103$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$62$YR$A$F$Y$$$20240711$$HP$US$US
240784972$24078497$2$F$$20240711$20240711$20240718$EXP$$US-ABBVIE-5832775$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
240784982$24078498$2$F$20240708$20240715$20240711$20240717$EXP$$GB-ROCHE-10000022689$ROCHE$$$$$F$Y$115$KG$20240717$$HP$GB$GB
240784991$24078499$1$I$20240101$20240708$20240711$20240711$EXP$$US-PFIZER INC-202400049257$PFIZER$$87$YR$$M$Y$$$20240711$$HP$US$US
240785002$24078500$2$F$$20240802$20240711$20240812$EXP$$BR-ASTELLAS-2024US019524$ASTELLAS$$$$$M$Y$$$20240812$$CN$BR$BR
240785011$24078501$1$I$$20240705$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-033783$AUROBINDO$$$$$F$Y$87$KG$20240711$$PH$GB$GB
240785026$24078502$6$F$$20240829$20240711$20240909$30DAY$$US-ABBVIE-5832720$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
240785031$24078503$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008104$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$40$YR$$F$Y$$$20240711$$HP$US$US
240785041$24078504$1$I$$20240710$20240711$20240711$EXP$FI-EMA-DD-20180507-gdhingrap-153020$FI-SANDOZ INC.-SDZ2024FI064294$SANDOZ$$49$YR$$M$Y$$$20240711$$MD$FI$FI
240785051$24078505$1$I$$20240702$20240711$20240711$30DAY$$US-GSK-US2024083096$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240785061$24078506$1$I$20230809$20240627$20240711$20240711$EXP$$US-MIRUM PHARMACEUTICALS INTERNATIONAL B.V.-US-MIR-24-00549$Unknown Manufacturer$$$$$$Y$$$20240711$$CN$US$US
240785071$24078507$1$I$20240617$20240702$20240711$20240711$EXP$$IE-AMGEN-IRLSL2024132728$AMGEN$$51$YR$A$F$Y$$$20240711$$CN$IE$IE
240785082$24078508$2$F$$20240710$20240711$20240729$PER$$US-AMGEN-USASP2024136902$AMGEN$$70$YR$E$F$Y$$$20240729$$CN$US$US
240785091$24078509$1$I$20240101$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135010$AMGEN$$34$YR$A$F$Y$$$20240711$$CN$US$US
240785101$24078510$1$I$20240708$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135454$AMGEN$$73$YR$E$F$Y$$$20240711$$PH$US$US
240785111$24078511$1$I$$20240703$20240711$20240711$EXP$$CH-MYLANLABS-2024M1064054$MYLAN$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. Unhappy hearts with the antidepressant venlafaxine. Swiss-Med-Wkly 2024; 154 (Suppl.) (6): 63S-64S (plus Poster) abstr. P27.$52$YR$$F$Y$$$20240711$$HP$CH$CH
240785121$24078512$1$I$$20240703$20240711$20240711$EXP$$JP-ASTELLAS-2024JP004754$ASTELLAS$Nakamoto H, Ishikawa H, Shinno R, Hirosawa A, Sato M, Nagasawa A, et al.. Incarceration of a gravid uterus associated with intrusion of a posterolateral uterine diverticulum into the pouch of Douglas , in a woman with systemic lupus erythematosus. Kanto Journal of Obstetrics and Gynecology. 2023;60(4):573-9$$$N$M$Y$1.764$KG$20240711$$MD$JP$JP
240785131$24078513$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5835012$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240785151$24078515$1$I$20240120$20240209$20240711$20240711$EXP$GB-MHRA-TPP929740C5199652YC1707319101647$GB-TEVA-VS-3157153$TEVA$$53$YR$$F$Y$$$20240711$$MD$GB$GB
240785161$24078516$1$I$$20240626$20240711$20240711$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450801$RANBAXY$Cai J, Chen J, Gao L, Hu Y, Li M. Clinical and literature case analysis on duloxetine-related syndrome of inappropriate antidiuretic hormone secretion. [Chinese]. Advers Drug React J. 2022;Dec 24 (12):633-640$60$YR$$M$Y$$$20240711$$HP$CN$CN
240785174$24078517$4$F$20220325$20240729$20240711$20240819$EXP$$FR-BEH-2022144964$CSL BEHRING$$52$YR$A$M$Y$59$KG$20240819$$MD$FR$FR
240785181$24078518$1$I$$20231009$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US043503$SANDOZ$$$$$F$Y$$$20240711$$MD$US$US
240785201$24078520$1$I$$20240702$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008106$STRIDES$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al.. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.. Am-J-Transplant. 2011;11 (3):500-510$19$YR$$F$Y$$$20240711$$HP$US$US
240785211$24078521$1$I$20240623$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47956$$FDA-CTU$$77$YR$$F$N$$$20240710$Y$PH$US$
240785221$24078522$1$I$$20240702$20240711$20240711$EXP$PT-INFARMED-E202405-815$PT-TEVA-VS-3217771$TEVA$$$$$F$Y$$$20240711$$HP$PT$PT
240785241$24078524$1$I$$20240709$20240711$20240711$EXP$$BE-SANDOZ INC.-SDZ2024BE064193$SANDOZ$Micha Saad. Paracetamol overdose causing acute kidneyinjury without hepatotoxicity: a case report. International Journal of Emergency Medicine. 2024;17:81$15$YR$$F$Y$57$KG$20240711$$HP$BE$BE
240785252$24078525$2$F$$20240702$20240711$20240729$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008067$STRIDES$Sallee L, Souchet L, Boutolleau D, Nguyen S.. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports.. Int-J-Antimicrob-Agents. 2024;63 (6):1-2$60$YR$$F$Y$$$20240729$$HP$FR$FR
240785262$24078526$2$F$20240619$20240830$20240711$20240909$EXP$$CA-CELLTRION INC.-2024CA014384$CELLTRION$$$$$$Y$$$20240909$$MD$CA$CA
240785272$24078527$2$F$$20240807$20240711$20240811$EXP$$CA-ABBVIE-5833510$ABBVIE$$$$A$$Y$$$20240811$$CN$CA$CA
240785281$24078528$1$I$$20240703$20240711$20240711$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008048$STRIDES$De Waard A, Lefebvre L, Textoris J, Payen D.. Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?.. Front-Immunol. 2023;14$60$YR$$M$Y$$$20240711$$HP$FR$FR
240785291$24078529$1$I$20220301$20240703$20240711$20240711$EXP$PL-URPL-DML-MLP.4401.1.722.2022$PL-TEVA-VS-3216975$TEVA$$67$YR$$F$Y$80$KG$20240711$$HP$PL$PL
240785301$24078530$1$I$$20240702$20240711$20240711$EXP$$JP-862174955-ML2024-03877$Unknown Manufacturer$Hirooka A, Saijo N, Horiguchi Y. A Case of Penicillin Induced Acute Eosinophilic Pneumonia With Diverse Symptoms. American Journal of Respiratory and Critical Care Medicine. 2024;(209): A2017.$21$YR$A$M$Y$$$20240711$$HP$JP$JP
240785311$24078531$1$I$$20240705$20240711$20240711$EXP$GB-MHRA-MED-202405101415057720-NPTCZ$GB-862174955-ML2024-03827$Unknown Manufacturer$$$$$F$Y$70$KG$20240711$$HP$GB$GB
240785321$24078532$1$I$$20240710$20240711$20240711$EXP$$US-JNJFOC-20240726001$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$HP$US$US
240785331$24078533$1$I$$20240708$20240711$20240711$EXP$$IT-009507513-2407ITA004128$MERCK$$79$YR$$F$Y$$$20240711$$MD$IT$IT
240785341$24078534$1$I$20240703$20240709$20240711$20240711$EXP$$BR-SANDOZ INC.-SDZ2024BR064393$SANDOZ$$4$YR$$F$Y$$$20240711$$CN$BR$BR
240785351$24078535$1$I$$20240703$20240711$20240711$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008164$STRIDES$Xuan W, Wang Z, Lin J, Zou L, Yang X, Xu Y, et al.. Case report: Aggressive progression of acute heart failure due to juvenile tuberculosis-associated Takayasu arteritis with aortic stenosis and thrombosis.. Front-Cardiovasc-Med. 2023;10$10$YR$$M$Y$$$20240711$$HP$CN$CN
240785361$24078536$1$I$$20240627$20240711$20240711$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06166$HIKMA$$49$YR$$F$Y$59$KG$20240711$$MD$CA$CA
240785381$24078538$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47977$$FDA-CTU$$67$YR$$F$N$$$20240710$N$$US$
240785391$24078539$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000022610$ROCHE$$32$YR$A$M$Y$$$20240711$$CN$US$US
240785401$24078540$1$I$$20240708$20240711$20240711$PER$$US-ROCHE-10000022808$ROCHE$$48$YR$A$F$Y$$$20240711$$CN$US$US
240785413$24078541$3$F$$20240724$20240711$20240726$PER$$NVSC2024US143269$NOVARTIS$$$$$F$Y$$$20240726$$MD$US$US
240785422$24078542$2$F$$20240724$20240711$20240807$PER$$US-P+L Developments of Newyork Corporation-2159041$PL DEVELOPMENTS$$$$$F$Y$$$20240807$$$US$US
240785431$24078543$1$I$20240118$20240703$20240711$20240711$EXP$$FR-CELLTRION INC.-2024FR016422$CELLTRION$$$$$$Y$$$20240711$$MD$FR$FR
240785441$24078544$1$I$$20240710$20240710$20240710$DIR$709787$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240785451$24078545$1$I$20240415$20240627$20240711$20240711$EXP$FR-AFSSAPS-RS2024000398$FR-SAMSUNG BIOEPIS-SB-2024-20175$SAMSUNG BIOEPIS$$71$YR$E$F$Y$69.4$KG$20240711$$MD$FR$FR
240785461$24078546$1$I$$20231208$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US012658$SANDOZ$$$$$F$Y$$$20240711$$CN$US$US
240785472$24078547$2$F$$20240926$20240711$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109189$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240927$$HP$US$US
240785481$24078548$1$I$$20240703$20240711$20240711$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008202$STRIDES$Chillaron MM, Gonzalez A, Garcia-Herrera A, Larque AB, Olle Grau J, Morantes L, et al.. Factor B inhibition with iptacopan in C3 glomerulopathy recurrence after transplantation: a case presentation.. Nephrol-Dial-Transplant. 2024;39:i2677-i2678$38$YR$$M$Y$$$20240711$$HP$ES$ES
240785491$24078549$1$I$20240314$20240703$20240711$20240711$EXP$$CN-ROCHE-10000016043$ROCHE$$58$YR$A$F$Y$56$KG$20240711$$HP$CN$CN
240785501$24078550$1$I$20240524$20240705$20240711$20240711$EXP$$MX-VANTIVE-2024VAN017298$Vantive US Healthcare$$70$YR$$M$Y$79$KG$20240711$$CN$MX$MX
240785511$24078551$1$I$$20240703$20240711$20240711$EXP$JP-MLMSERVICE-20240626-PI112916-00270-1$JP-STRIDES ARCOLAB LIMITED-2024SP008262$STRIDES$Minamioka H, Tsukihashi Y, Yano T, Sano C, Ohta R.. Giant Cell Arteritis With Sepsis-Like Symptoms in an Elderly Man: A Case Report.. Cureus. 2024;16(5):e61074$88$YR$$M$Y$$$20240711$$MD$JP$JP
240785531$24078553$1$I$20240401$20240430$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0100$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240785541$24078554$1$I$20240614$20240702$20240711$20240711$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00556$PARATEK PHARMACEUTICALS$$81$YR$$M$Y$60$KG$20240711$$HP$CN$CN
240785553$24078555$3$F$$20240816$20240711$20240821$PER$$US-AMGEN-USASP2024137088$AMGEN$$73$YR$E$F$Y$$$20240821$$CN$US$US
240785562$24078556$2$F$20240626$20240821$20240711$20240823$PER$$US-AMGEN-USASP2024135392$AMGEN$$66$YR$E$F$Y$$$20240823$$CN$US$US
240785571$24078557$1$I$20220602$20240709$20240711$20240711$EXP$$NVSC2022AU130186$NOVARTIS$$53$YR$$F$Y$$$20240711$$CN$AU$AU
240785581$24078558$1$I$$20240506$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0115$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240785591$24078559$1$I$$20240702$20240711$20240711$PER$$US-TEVA-VS-3218594$TEVA$$$$$F$Y$$$20240711$$CN$US$US
240785601$24078560$1$I$$20240703$20240711$20240711$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008229$STRIDES$Li W, Chang Y, Liu X, Chen Z, Sun J, Geng Z, et al.. Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study.. Ann-Hematol. 2024;103 (6):2003-2012$$$$$Y$$$20240711$$HP$CN$CN
240785612$24078561$2$F$$20240812$20240711$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06362$LUPIN$$$$$$Y$$$20240828$$CN$US$US
240785621$24078562$1$I$$20240709$20240711$20240711$EXP$$CA-GILEAD-2024-0680128$GILEAD$$$$A$M$Y$$$20240711$$CN$CA$CA
240785631$24078563$1$I$$20230828$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US022503$SANDOZ$$$$$M$Y$$$20240711$$CN$US$US
240785661$24078566$1$I$$20240703$20240711$20240711$EXP$$IN-MYLANLABS-2024M1064039$MYLAN$Meenakshi R, Balamurali K, Anbazhagan G. A unique case of galactorrhea caused by tramadol dependency in a 32-year-old female- a case report. Indian-J-Psychiatry 2024; 66 S192.$$$$F$Y$$$20240711$$HP$IN$IN
240785671$24078567$1$I$$20240703$20240711$20240711$EXP$$IT-MYLANLABS-2024M1064049$MYLAN$Malavasi M, Notarianni G, Pontillo D, Luciani M, Petrungaro M, Zampi G, et al. The conundrum of drug interactions and holter monitoring: lamin gene mutation discovered by a torsade de pointes episode followed by out-of-the-hospital resuscitation. Eur-Heart-J-Suppl 2024; 26 (Suppl. 2) ii55-ii56 abstr. suae036.124.$57$YR$$F$Y$$$20240711$$HP$IT$IT
240785681$24078568$1$I$$20240703$20240711$20240711$EXP$$ES-MYLANLABS-2024M1063878$MYLAN$Garcia Ruiz PJ, Feliz LD, Feliz CE, Sanchez IL, Fernandez AA, Kelly FB, et al. The enduring enigma of sporadic chorea: A single center case series. Tremor-Other-Hyperkinet-Mov 2023; 13 (1): 1-10.$58$YR$$F$Y$$$20240711$$MD$ES$ES
240785691$24078569$1$I$$20240710$20240710$20240710$DIR$709783$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240785701$24078570$1$I$$20240703$20240711$20240711$EXP$$IT-MYLANLABS-2024M1064056$MYLAN$Morena A, Gravinese C, Frea S, Angelini F, Boretto P, Gallone G, et al. Percutaneous left stellate ganglion block to increase ventricular fibrillation threshold and defibrillation success rate in acute fulminant myocarditis with electrical storm. Eur-Heart-J-Suppl 2024; 26 (Suppl.) ii4.$57$YR$$M$Y$$$20240711$$HP$IT$IT
240785711$24078571$1$I$$20240703$20240711$20240711$EXP$$JP-MYLANLABS-2024M1063995$MYLAN$Kikkawa K, Wakamiya T, Kojima F, Kohjimoto Y, Hara I. Nephrectomy for emphysematous pyelonephritis in a nonfunctional renal allograft due to rejection after kidney transplantation. Afr-J-Urol 2024; 30 (1):.. 2023;30 (1)$71$YR$$M$Y$$$20240711$$HP$JP$JP
240785721$24078572$1$I$$20240507$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0116$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$PH$US$US
240785731$24078573$1$I$20240709$20240710$20240710$20240710$DIR$709828$$FDA-CTU$$71$YR$$F$N$58.05$KG$20240710$N$CN$US$
240785751$24078575$1$I$$20240703$20240711$20240711$EXP$$JP-MYE-2024M1063679AA$MYLAN$Nakamura S, Masuda S, Oda S, Yamakawa D, Yamaguchi S, Ishima T, et al. Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine. Intern-Med 2024; 63 (12): 1829-1835.. 2024;63 (12):1829-1835$72$YR$$F$Y$$$20240711$$HP$JP$JP
240785761$24078576$1$I$20240702$20240703$20240711$20240711$PER$$US-BAYER-2024A096659$BAYER$$$$$F$Y$$$20240711$$CN$US$US
240785771$24078577$1$I$$20240704$20240711$20240711$EXP$$CL-ROCHE-10000020284$ROCHE$$38$YR$A$M$Y$$$20240711$$HP$CL$CL
240785781$24078578$1$I$$20240710$20240710$20240710$DIR$709784$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240785791$24078579$1$I$$20240710$20240710$20240710$DIR$709749$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240785801$24078580$1$I$20240703$20240710$20240710$20240710$DIR$709814$$FDA-CTU$$51$YR$$F$N$74.7$KG$20240710$N$CN$US$
240785811$24078581$1$I$20231222$20240710$20240710$20240710$DIR$709810$$FDA-CTU$$65$YR$$F$N$52.2$KG$20240710$Y$CN$US$
240785823$24078582$3$F$20240722$20240722$20240711$20240726$EXP$$CA-TAKEDA-2024TUS067306$TAKEDA$$36$YR$$F$Y$$$20240726$$CN$CA$CA
240785831$24078583$1$I$20240509$20240628$20240711$20240711$EXP$GB-MHRA-MIDB-41044ecb-1347-4981-ac26-69141f820ea3$GB-USV-002530$USV PRIVATE$$59$YR$A$F$Y$$$20240711$$HP$GB$GB
240785843$24078584$3$F$$20240916$20240711$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110087$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240918$$CN$US$US
240785851$24078585$1$I$$20240701$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109104$BRISTOL MYERS SQUIBB$Ho C, Samlowski W. Outcome of an accelerated treatment algorithm for patients developing diarrhea as a complication of ipilimumab-based cancer immunotherapy in a community practice. Current Oncology. 2024 Jun 18;31(6):3529-45. doi:10.3390/curroncol31060260.$85$YR$E$F$Y$$$20240711$$HP$US$US
240785862$24078586$2$F$$20240703$20240711$20240726$EXP$$CA-CELLTRION INC.-2024CA016710$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
240785871$24078587$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109654$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240711$$CN$US$US
240785881$24078588$1$I$$20240701$20240711$20240711$EXP$$JP-ROCHE-10000019841$ROCHE$Kunimoto M, Watanabe O, Takahashi H, Koizumi A, Shigehara F, Soeda N. DP-58 Two cases of delayed anastomotic leakage due to bevacizumab. The 46th Annual Meeting of Japanese Society for Research of Loco-Regional Cancer. 2024;131.$78$YR$E$F$Y$$$20240711$$MD$JP$JP
240785891$24078589$1$I$$20240619$20240711$20240711$EXP$$DE-ROCHE-10000018934$ROCHE$$80$YR$E$M$Y$$$20240711$$CN$DE$DE
240785911$24078591$1$I$$20240709$20240711$20240711$EXP$GB-002147023-NVSC2023GB012168$GB-SANDOZ INC.-SDZ2024GB064376$SANDOZ$$6$YR$$F$Y$$$20240711$$MD$GB$GB
240785921$24078592$1$I$$20240510$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0138$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240785941$24078594$1$I$20210101$20240703$20240711$20240711$PER$US-MLMSERVICE-20240626-PI112410-00275-1$US-RDY-SPO/USA/24/0009845$DR REDDYS$Greenfield MJ, Fobian AD, Fargason RE, Birur B. Optimizing outcomes when treating functional neurological disorder in acute care settings: case reports depicting the value of diagnostic precision and timely and appropriate psychological interventions using an interdisciplinary framework. Frontiers in Psychiatry. 2024;15:1288828. DOI: 10.3389/fpsyt.2024.1288828.$49$YR$A$F$Y$$$20240711$$MD$US$US
240785954$24078595$4$F$20240719$20240920$20240711$20240927$EXP$$US-BEH-2024175156$CSL BEHRING$$23$YR$A$F$Y$$$20240927$$HP$US$US
240785971$24078597$1$I$$20240703$20240711$20240711$EXP$$US-MYLANLABS-2024M1063885$MYLAN$Memon R, Mehreen R, Mack MA, Okoyeze K, Shaikh A, Shan Ul Abedin M, et al. Biopsy of Thoracic Lymph Node Diagnosing Mystery of Distributive Shock Caused by Idiopathic Multicenteric Castleman Disease With TAFRO Syndrome. Am-J-Respir-Crit-Care-Med 2023; 207 (plus Poster).$36$YR$$M$Y$$$20240711$$HP$US$US
240785992$24078599$2$F$20240703$20240708$20240711$20240718$EXP$$US-Accord-434311$ACCORD$$19$YR$A$F$Y$$$20240718$$PH$US$US
240786001$24078600$1$I$20200903$20240629$20240711$20240711$EXP$PL-URPL-1-2925-2020$PL-Accord-433641$ACCORD$$70$YR$E$F$Y$$$20240711$$MD$PL$PL
240786011$24078601$1$I$$20240702$20240711$20240711$EXP$GB-MHRA-MIDB- 5c5977f1-7f26-4321-b456-1036d1661ac9$GB-Accord-433850$ACCORD$$88$YR$E$F$Y$$$20240711$$HP$GB$GB
240786021$24078602$1$I$$20240630$20240711$20240711$EXP$$US-Accord-433935$ACCORD$Reinsch N, Haq E, Ramakrishna K, et al. (June 21, 2024) Cardiovascular Collapse Requiring Veno-Arterial Extracorporeal Membrane Oxygenation?and Lidocaine: A Case of Massive Bupropion Overdose. Cureus 16(6): e62873. DOI 10.7759/cureus.62873$18$YR$A$F$Y$$$20240711$$HP$US$US
240786031$24078603$1$I$20240208$20240629$20240711$20240711$EXP$FR-AFSSAPS-NC2024000788$FR-Accord-433922$ACCORD$$72$YR$E$F$Y$55$KG$20240711$$HP$FR$FR
240786041$24078604$1$I$20240405$20240629$20240711$20240711$EXP$ES-AEMPS-1541918$ES-Accord-433891$ACCORD$$50$YR$A$M$Y$$$20240711$$PH$ES$ES
240786051$24078605$1$I$$20240627$20240711$20240711$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06020$HIKMA$Martin G, Narvaez-Guerra O, Aurigemma G, Kovell L.. Martin G, Narvaez-Guerra O, Aurigemma G, Kovell L. Peripartum ventricular tachycardia and PVC-induced cardiomyopathy: Delivering optimal care when it^s time to deliver.. BMJ Case Reports. 2024;17(6):e259075:5 pgs$3$DEC$$F$Y$$$20240711$$MD$US$US
240786061$24078606$1$I$20181219$20240708$20240711$20240711$EXP$$FR-AstraZeneca-2024A158094$ASTRAZENECA$$39$YR$$F$Y$$$20240711$$MD$FR$
240786071$24078607$1$I$$20220528$20240711$20240711$EXP$PL-EMA-2022408-AUTODUP-1649447024788$PL-Accord-426733$ACCORD$$78$YR$E$M$Y$$$20240711$$MD$PL$PL
240786081$24078608$1$I$$20240703$20240711$20240711$EXP$$PL-AstraZeneca-2024A134019$ASTRAZENECA$Buczek K.;  Suwalski P.;  Winkler A.;  Kowalewski M.;  Orski Z.;  Krzesi?ski P.; Kiliszek M.. Thoracic sympathectomy in patient with electrical storm. Kardiologia Polska, POLSTIM 2024. XXXV Conference of the Working Group on Heart Rhytm of the Polish Cardiac Society 2024;82(Supplement 1):71.$78$YR$$M$Y$$$20240711$$HP$PL$
240786091$24078609$1$I$20240101$20240708$20240711$20240711$EXP$$CA-Orion Corporation ORION PHARMA-24_00030329$ORION$$44$YR$A$F$Y$$$20240711$$MD$CA$
240786102$24078610$2$F$$20240708$20240711$20240711$EXP$$US-009507513-2407USA004127$MERCK$$$$$F$Y$$$20240711$$CN$US$US
240786111$24078611$1$I$$20230912$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US033090$SANDOZ$$$$$M$Y$$$20240711$$CN$US$US
240786121$24078612$1$I$$20240703$20240711$20240711$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008258$STRIDES$Henry PJ, Wen JH, Feldman EB, Vargas J.. Minocycline Induced Parenchymal Lung Disease with Peripheral Eosinophilia.. Am-J-Respir-Crit-Care-Med. 2024;209$70$YR$$M$Y$$$20240711$$HP$US$US
240786132$24078613$2$F$$20240712$20240711$20240723$PER$$US-ROCHE-10000022405$ROCHE$$$$$$Y$$$20240723$$CN$US$US
240786141$24078614$1$I$20240617$20240708$20240711$20240711$EXP$$US-BAYER-2024A098268$BAYER$$34$YR$A$M$Y$$$20240711$$CN$US$US
240786151$24078615$1$I$$20240705$20240711$20240711$EXP$$CA-Orion Corporation ORION PHARMA-24_00030737$ORION$$63$YR$A$F$Y$$$20240711$$HP$CA$
240786167$24078616$7$F$20240708$20240918$20240711$20240924$PER$$US-ROCHE-10000021725$ROCHE$$$$A$F$Y$$$20240924$$HP$US$US
240786171$24078617$1$I$$20240708$20240711$20240711$EXP$$CA-JNJFOC-20240725745$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$HP$CA$CA
240786181$24078618$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000022498$ROCHE$$42$YR$A$F$Y$$$20240711$$CN$US$US
240786192$24078619$2$F$20220101$20240729$20240711$20240807$EXP$JP-MLMSERVICE-20240627-PI112237-00117-1$JP-STRIDES ARCOLAB LIMITED-2024SP008334$STRIDES$Sawada K, Kawaji T, Yamana K, Matsuhashi K, Hara Y, Kuriyama N, et al.. Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory distress syndrome: a case report.. Journal of cardiothoracic surgery. 2024;19(1):358 (1-7)$4$DEC$$F$Y$$$20240807$$MD$JP$JP
240786201$24078620$1$I$$20240708$20240711$20240711$PER$$US-ROCHE-10000020761$ROCHE$$$$$$Y$$$20240711$$CN$US$US
240786211$24078621$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000022413$ROCHE$$60$YR$A$F$Y$$$20240711$$CN$US$US
240786221$24078622$1$I$$20240627$20240711$20240711$EXP$$AU-ROCHE-3571563$ROCHE$$38$YR$A$F$Y$$$20240711$$MD$AU$AU
240786231$24078623$1$I$$20240706$20240711$20240711$PER$$US-ROCHE-10000019876$ROCHE$$$$$$Y$$$20240711$$CN$US$US
240786242$24078624$2$F$20240619$20240903$20240711$20240906$EXP$$US-BEH-2024175298$CSL BEHRING$$66$YR$E$F$Y$140.59$KG$20240906$$CN$US$US
240786261$24078626$1$I$$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137103$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240786271$24078627$1$I$$20231219$20240711$20240711$EXP$$JP-MTPC-MTPC2023-0030171$Unknown Manufacturer$$$$A$$Y$$$20240711$$MD$JP$JP
240786281$24078628$1$I$$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024137147$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240786291$24078629$1$I$20240702$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136818$AMGEN$$60$YR$A$M$Y$$$20240711$$PH$US$US
240786301$24078630$1$I$20240708$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135019$AMGEN$$$$$M$Y$$$20240711$$CN$US$US
240786331$24078633$1$I$$20240705$20240711$20240711$EXP$$US-TAKEDA-2024TUS014152$TAKEDA$$$$$M$Y$$$20240711$$CN$US$US
240786342$24078634$2$F$20240101$20240702$20240711$20240724$EXP$$US-BEH-2024175166$CSL BEHRING$$$$$M$Y$$$20240724$$CN$US$US
240786351$24078635$1$I$20240703$20240706$20240711$20240711$PER$GB-MHRA-MED-202407060912107400-MPKVW$GB-BRACCO-2024GB04168$BRACCO$$41$YR$$F$Y$$$20240711$$CN$GB$GB
240786361$24078636$1$I$$20240705$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108492$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$66$KG$20240711$$PH$US$US
240786371$24078637$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47952$$FDA-CTU$$23$YR$$M$N$170$LBS$20240710$N$$US$
240786381$24078638$1$I$$20230926$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US036840$SANDOZ$$$$$M$Y$$$20240711$$CN$US$US
240786392$24078639$2$F$20240413$20240729$20240711$20240802$EXP$$IE-BEH-2024170830$CSL BEHRING$$77$YR$E$F$Y$$$20240802$$CN$IE$IE
240786401$24078640$1$I$20240113$20240701$20240711$20240711$EXP$GB-MHRA-MED-202406301130511070-FLYHN$GB-Accord-433827$ACCORD$$24$YR$A$M$Y$$$20240711$$CN$GB$GB
240786411$24078641$1$I$$20240629$20240711$20240711$EXP$GB-MHRA-MED-202406291148076400-HYSNB$GB-Accord-433717$ACCORD$$$$$M$Y$78$KG$20240711$$CN$GB$GB
240786421$24078642$1$I$$20240629$20240711$20240711$EXP$CA-MHPD-E2B_07071215$CA-Accord-433359$ACCORD$$38$YR$A$F$Y$73$KG$20240711$$HP$CA$CA
240786434$24078643$4$F$20240618$20240909$20240711$20240921$EXP$$ES-Accord-433738$ACCORD$$66$YR$E$F$Y$66$KG$20240921$$HP$ES$ES
240786441$24078644$1$I$$20240629$20240711$20240711$EXP$CA-MHPD-E2B_07065666$CA-Accord-433498$ACCORD$$69$YR$E$M$Y$$$20240711$$HP$CA$CA
240786451$24078645$1$I$20240617$20240629$20240711$20240711$EXP$FR-AFSSAPS-LY2024000927$FR-Accord-433533$ACCORD$$52$YR$A$F$Y$$$20240711$$PH$FR$FR
240786461$24078646$1$I$20240525$20240629$20240711$20240711$EXP$FR-AFSSAPS-AM2024000538$FR-Accord-433646$ACCORD$$78$YR$E$M$Y$88$KG$20240711$$MD$FR$FR
240786491$24078649$1$I$20240621$20240629$20240711$20240711$EXP$IT-MINISAL02-992812$IT-Accord-433768$ACCORD$$76$YR$E$M$Y$68$KG$20240711$$HP$IT$IT
240786501$24078650$1$I$20240215$20240704$20240711$20240711$EXP$$CA-GSK-CA2024020564$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$CA$CA
240786511$24078651$1$I$$20240708$20240711$20240711$EXP$GB-MHRA-MED-202407070025010300-VNFWD$GB-SANDOZ INC.-SDZ2024GB064042$SANDOZ$$20$YR$$F$Y$$$20240711$$CN$GB$GB
240786521$24078652$1$I$20240624$20240702$20240711$20240711$EXP$$US-Accord-433810$ACCORD$$43$YR$A$F$Y$$$20240711$$HP$US$US
240786531$24078653$1$I$20240629$20240701$20240711$20240711$EXP$$US-Accord-433817$ACCORD$$27$YR$A$F$Y$$$20240711$$HP$US$US
240786541$24078654$1$I$20240628$20240702$20240711$20240711$EXP$$US-Accord-433755$ACCORD$$38$YR$A$M$Y$$$20240711$$HP$US$US
240786551$24078655$1$I$20240701$20240702$20240711$20240711$EXP$$US-Accord-434008$ACCORD$$61$YR$A$F$Y$$$20240711$$HP$US$US
240786561$24078656$1$I$20240613$20240702$20240711$20240711$EXP$GB-MHRA-MED-202407021025478080-SCGZW$GB-Accord-434300$ACCORD$$74$YR$E$M$Y$77$KG$20240711$$CN$GB$GB
240786571$24078657$1$I$20240425$20240701$20240711$20240711$EXP$GB-MHRA-30958493$GB-Accord-433902$ACCORD$$74$YR$E$F$Y$$$20240711$$PH$GB$GB
240786581$24078658$1$I$20170101$20240701$20240711$20240711$EXP$$PL-Accord-433724$ACCORD$Storoniak H, Debska-Slizien A. Miliary Tuberculosis as Postmortem Diagnosis in Solid Organ Transplant Recipient: Case Report and Review of the Literature. Transplantation Proceedings. 2024;56(4):968-71. DOI: 10.1016/j.transproceed.2024.01.057.$70$YR$E$M$Y$$$20240711$$MD$PL$PL
240786591$24078659$1$I$20240628$20240702$20240711$20240711$EXP$$US-Accord-433795$ACCORD$$22$YR$A$M$Y$$$20240711$$HP$US$US
240786603$24078660$3$F$20240627$20240913$20240711$20240920$EXP$$JP-JNJFOC-20240728069$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240920$$MD$JP$JP
240786611$24078661$1$I$$20240704$20240711$20240711$EXP$$SE-SANOFI-AVENTIS-2010SA054602$Haleon PLC$Knudsen K, Jonsson U, Abrahamsson J.Twenty-three deaths with -hydroxybutyrate overdose in western Sweden between 2000 and 2007. Acta Anaesthesiologica Scandinavica 54: 987-992, Sep 2010. Available from: URL: http://dx.doi.org/10.1111/j.1399-6576.2010.02278.x - Sweden$30$YR$$M$Y$$$20240711$$HP$SE$SE
240786621$24078662$1$I$$20240701$20240711$20240711$EXP$$US-STERISCIENCE B.V.-2024-ST-000989$Steriscience PTE$Natarajan S, Amjad M, Zaidi S, Shah A, Ochieng PO.. Persistent Bilateral Spontaneous Pneumothorax in Combined Pulmonary Fibrosis and Emphysema.. Am-J-Respir-Crit-Care-Med. 2023;207$72$YR$$M$Y$$$20240711$$HP$US$US
240786651$24078665$1$I$$20240709$20240711$20240711$EXP$$CA-TAKEDA-2024TUS069913$TAKEDA$$$$$F$Y$$$20240711$$CN$CA$CA
240786661$24078666$1$I$$20240703$20240711$20240711$EXP$$JP-BAUSCHBL-2024BNL029599$BAUSCH AND LOMB$Tokuchi M, Yonishi H, Namba-Hamano T. Successful treatment of a renal allograft abscess with antimicrobial agents alone and appropriate follow-up imaging. Transplant Infectious Diseases. 2024;26:1-3. doi:10.1111/tid.14278$22$YR$$F$Y$$$20240711$$HP$JP$JP
240786671$24078667$1$I$$20240705$20240711$20240711$EXP$$EU-BAUSCHBL-2024BNL029705$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240711$$MD$EU$EU
240786682$24078668$2$F$$20240719$20240711$20240724$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039193$BOEHRINGER INGELHEIM$$87$YR$E$M$Y$$$20240724$$PH$JP$JP
240786691$24078669$1$I$$20240614$20240711$20240711$EXP$$TW-SANOFI-AVENTIS R+D-2024SA199323$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240711$$HP$TW$TW
240786711$24078671$1$I$$20231006$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US040450$SANDOZ$$$$$M$Y$$$20240711$$CN$US$US
240786721$24078672$1$I$$20240707$20240711$20240711$EXP$GB-MHRA-MED-202407071941537630-RTWMN$GB-MYLANLABS-2024M1063863$MYLAN$$33$YR$$M$Y$77$KG$20240711$$CN$GB$GB
240786731$24078673$1$I$$20240627$20240711$20240711$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06065$HIKMA$Singh AD, Kurin M.. Singh AD, Kurin M. An Unusual Case of Refractory Esophagitis and Esophageal Diverticulum. Digestive Diseases and Sciences. 2024;69(6):1913-14:4 pgs$76$YR$$F$Y$$$20240711$$MD$US$US
240786741$24078674$1$I$20240627$20240628$20240711$20240711$PER$$US-FARMAPROD-202407-2445$DOMPE FARMACEUTICI$$86$YR$E$F$Y$$$20240711$$CN$US$US
240786751$24078675$1$I$20240105$20240708$20240711$20240711$EXP$$EU-BAUSCHBL-2024BNL029755$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240711$$HP$EU$EU
240786762$24078676$2$F$20240709$20240710$20240711$20240712$PER$$US-JNJFOC-20240723206$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20240712$$CN$US$US
240786781$24078678$1$I$20240609$20240711$20240711$20240711$EXP$$AU-MYLANLABS-2024M1064933$MYLAN$$64$YR$$M$Y$$$20240711$$HP$AU$AU
240786791$24078679$1$I$20240630$20240701$20240711$20240711$30DAY$$US-GSK-US2024081657$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240711$$PH$US$US
240786801$24078680$1$I$$20240212$20240711$20240711$EXP$$CA-HALEON-2185155$Haleon PLC$$44$YR$$F$Y$97$KG$20240711$$HP$CA$CA
240786811$24078681$1$I$20240703$20240710$20240711$20240711$30DAY$$US-GSK-US2024085868$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240711$$CN$US$US
240786821$24078682$1$I$20231001$20240709$20240711$20240711$EXP$$US-UCBSA-2024028286$UCB$$72$YR$$F$Y$35.828$KG$20240711$$CN$US$US
240786831$24078683$1$I$20240624$20240703$20240711$20240711$EXP$$CN-SA-2024SA201304$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240711$$HP$CN$CN
240786851$24078685$1$I$$20240702$20240711$20240711$EXP$$PE-ROCHE-10000016863$ROCHE$$$$$$Y$$$20240711$$CN$PE$PE
240786861$24078686$1$I$$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136366$AMGEN$$$$$$Y$$$20240711$$PH$US$US
240786881$24078688$1$I$$20240628$20240711$20240711$EXP$$US-NAPO PHARMACEUTICALS-2024US002122$PAREXEL$$$$$$Y$$$20240711$$CN$US$US
240786891$24078689$1$I$$20240118$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US046516$SANDOZ$$$$$M$Y$$$20240711$$CN$US$US
240786901$24078690$1$I$$20240709$20240711$20240711$EXP$SE-SEMPA-2024-005345$SE-ORGANON-O2407SWE000888$ORGANON$$55$YR$$F$Y$$$20240711$$CN$SE$SE
240786921$24078692$1$I$20211101$20240710$20240711$20240711$EXP$$US-UCBSA-2024034932$UCB$$60$YR$$F$Y$$$20240711$$HP$US$US
240786931$24078693$1$I$20240301$20240709$20240711$20240711$EXP$FR-AFSSAPS-MP2024001122$FR-ORGANON-O2407FRA000891$ORGANON$$75$YR$$M$Y$$$20240711$$MD$FR$FR
240786941$24078694$1$I$$20221108$20240711$20240711$EXP$DE-BFARM-22006968$DE-Accord-419011$ACCORD$$84$YR$E$M$Y$74$KG$20240711$$PH$DE$DE
240786951$24078695$1$I$$20240701$20240711$20240711$EXP$$US-GSK-US2024AMR081834$GLAXOSMITHKLINE$$16$YR$$M$Y$$$20240711$$CN$US$US
240786961$24078696$1$I$$20240703$20240711$20240711$30DAY$$US-GSK-US2024083240$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240786971$24078697$1$I$$20240629$20240711$20240711$EXP$GB-MHRA-MED-202406290956091950-BTVGZ$GB-Accord-433710$ACCORD$$$$$M$Y$$$20240711$$CN$GB$GB
240786981$24078698$1$I$20240201$20240629$20240711$20240711$EXP$FR-AFSSAPS-TS2024000749$FR-Accord-433708$ACCORD$$79$YR$E$M$Y$107$KG$20240711$$MD$FR$FR
240786991$24078699$1$I$20240627$20240702$20240711$20240711$EXP$$US-Accord-433760$ACCORD$$55$YR$A$M$Y$$$20240711$$HP$US$US
240787001$24078700$1$I$$20240630$20240711$20240711$EXP$$CN-Accord-434150$ACCORD$Li T, Tang X, He X, Zhang L, Zhang Y, Wang L, Et al (2024) Case report: Clinical features of pediatric acute myeloid leukemia presenting with cardiac tamponade: a case series study and literature review. Front. Oncol. 14:1391768$1$YR$I$F$Y$$$20240711$$HP$CN$CN
240787011$24078701$1$I$$20240701$20240711$20240711$EXP$$IN-Accord-433716$ACCORD$Charitha SA, Sobhan SS, Jacob JA, Gopalakrishnan R, Kuruvilla A. Cariprazine Augmentation in Inadequate Clozapine Response: A Case Series. Journal of Clinical and Diagnostic Research. 2024;18(6):VR04-7. DOI:10.7860/JCDR/2024/69088.19525.$$$A$M$Y$$$20240711$$MD$IN$IN
240787022$24078702$2$F$20240626$20240708$20240711$20240722$EXP$$US-Accord-434005$ACCORD$$59$YR$A$M$Y$$$20240719$$HP$US$US
240787031$24078703$1$I$$20240701$20240711$20240711$EXP$CA-MHPD-E2B_07055322$CA-Accord-433784$ACCORD$$34$YR$A$F$Y$$$20240711$$HP$CA$CA
240787041$24078704$1$I$20240602$20240629$20240711$20240711$EXP$IT-MINISAL02-992904$IT-Accord-433629$ACCORD$$76$YR$E$F$Y$45$KG$20240711$$MD$IT$IT
240787051$24078705$1$I$$20240701$20240711$20240711$EXP$CA-MHPD-001081261$CA-Accord-433789$ACCORD$$70$YR$E$F$Y$160$KG$20240711$$CN$CA$CA
240787061$24078706$1$I$20240405$20240630$20240711$20240711$EXP$GB-MHRA-MED-202406301116153080-MDTRN$GB-Accord-433752$ACCORD$$$$$$Y$$$20240711$$CN$GB$GB
240787071$24078707$1$I$20240412$20240701$20240711$20240711$EXP$GB-MHRA-MED-202407010018118840-CQPRJ$GB-Accord-433830$ACCORD$$32$YR$A$F$Y$76$KG$20240711$$CN$GB$GB
240787081$24078708$1$I$$20240701$20240711$20240711$EXP$GB-MHRA-MED-202406281336531360-CFMRD$GB-Accord-434251$ACCORD$$$$$F$Y$$$20240711$$CN$GB$GB
240787091$24078709$1$I$$20240630$20240711$20240711$EXP$$CN-Accord-433693$ACCORD$Zhou Y, Xue H, Lu C, Zhang Y, Wu Q, Zhang J, Xie S, Xu X, Guo X. Treatment of Tislelizumab-Induced Toxic Epidermal Necrolysis and Agranulocytosis: A Case Report and Literature Review. Curr Drug Saf. 2024 Jun 20.$75$YR$E$M$Y$$$20240711$$HP$CN$CN
240787101$24078710$1$I$$20240701$20240711$20240711$EXP$$JP-Accord-433721$ACCORD$Ohtaka K, Ohtake S, Ishii YU, Kaku S, Takeuchi Y, Mizota T, et al. Spontaneous intercostal artery bleeding occurring simultaneously in numerous vessels during antithrombotic therapy with mechanical circulatory support: a case report. Journal of Medical Case Reports. 2024;18(1):280.$63$YR$A$M$Y$$$20240711$$MD$JP$JP
240787111$24078711$1$I$20240120$20240630$20240711$20240711$EXP$GB-MHRA-MED-202406302239302250-SFMJQ$GB-Accord-433779$ACCORD$$30$YR$A$F$Y$97$KG$20240711$$HP$GB$GB
240787121$24078712$1$I$20240501$20240630$20240711$20240711$EXP$GB-MHRA-MED-202406302222374210-PLJMT$GB-Accord-433776$ACCORD$$41$YR$A$F$Y$65$KG$20240711$$CN$GB$GB
240787131$24078713$1$I$20240629$20240701$20240711$20240711$EXP$GB-MHRA-MED-202407010145473670-FYPQD$GB-Accord-433915$ACCORD$$$$$F$Y$75$KG$20240711$$CN$GB$GB
240787141$24078714$1$I$$20240701$20240711$20240711$EXP$$IT-Accord-431439$ACCORD$Favi E, Cresseri D, Perego M, Ikehata M, Iesari S, Campise MR, et al. Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept. Clinical Immunology. 2024;264:110240. DOI:10.1016/j.clim.2024.110240.$50$YR$A$M$Y$$$20240711$$MD$IT$IT
240787151$24078715$1$I$$20240629$20240711$20240711$EXP$CA-MHPD-E2B_07071690$CA-Accord-433485$ACCORD$$53$YR$A$$Y$$$20240711$$MD$CA$CA
240787161$24078716$1$I$$20240630$20240711$20240711$EXP$$AT-Accord-433778$ACCORD$Finsterer J. Glofitamab-Associated Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Presenting as Serial Seizures and Responding Positively to Antiseizure Drugs and Anakinra: A Case Report. Cureus. 2024;16(5):e60833.$61$YR$A$M$Y$$$20240711$$MD$AT$AT
240787171$24078717$1$I$20240607$20240701$20240711$20240711$EXP$$US-Accord-433751$ACCORD$$25$YR$A$F$Y$$$20240711$$HP$US$US
240787181$24078718$1$I$$20240629$20240711$20240711$EXP$$GR-Accord-427949$ACCORD$Sgoura X, Karachalios X, Golemi N, Zafiris G, Tzouda V, Tzoudas F, et al. AA59: Targeting of rare c.2317 in exon 20 mutation of the epidermal growth factor receptor (EGFR) with amivantamab in a case of a patient with metastatic lung adenocarcinoma. 7th Hellenic oncology congress. 2024-Apr-24-27.$74$YR$E$F$Y$$$20240711$$HP$GR$GR
240787191$24078719$1$I$20240626$20240701$20240711$20240711$EXP$IT-MINISAL02-993086$IT-Accord-433678$ACCORD$$47$YR$A$F$Y$54$KG$20240711$$MD$IT$IT
240787201$24078720$1$I$$20240630$20240711$20240711$EXP$GB-MHRA-MED-202406302141532850-LTFKC$GB-Accord-433769$ACCORD$$$$$F$Y$$$20240711$$PH$GB$GB
240787211$24078721$1$I$20240628$20240701$20240711$20240711$EXP$$US-Accord-433748$ACCORD$$62$YR$A$M$Y$$$20240711$$HP$US$US
240787221$24078722$1$I$20240630$20240701$20240711$20240711$EXP$GB-MHRA-MED-202407010701487260-WFGHL$GB-Accord-433851$ACCORD$$41$YR$A$$Y$$$20240711$$CN$GB$GB
240787231$24078723$1$I$$20240702$20240711$20240711$EXP$$US-TEVA-VS-3217275$TEVA$$$$T$F$Y$$$20240711$$HP$US$US
240787251$24078725$1$I$$20240624$20240711$20240711$PER$$US-USAntibiotics-000321$USAntibiotics$$29$YR$A$F$Y$$$20240709$$CN$US$
240787261$24078726$1$I$$20240708$20240711$20240711$EXP$$US-LUNDBECK-DKLU4001359$LUNDBECK$$$$$$Y$$$20240711$$HP$US$US
240787273$24078727$3$F$20240705$20240801$20240711$20240808$30DAY$$JP-MYLANLABS-2024M1063758$MYLAN$$$$$$Y$$$20240808$$HP$JP$JP
240787281$24078728$1$I$$20240708$20240711$20240711$EXP$$AU-MYLANLABS-2024M1064070$MYLAN$$$$$M$Y$$$20240711$$HP$AU$AU
240787291$24078729$1$I$20240101$20240702$20240711$20240711$EXP$$US-ORPHANEU-2024005155$RECORDATI$$$$$$Y$$$20240711$$CN$US$US
240787301$24078730$1$I$$20240708$20240711$20240711$EXP$$AU-MYLANLABS-2024M1063820$MYLAN$$86$YR$$F$Y$$$20240711$$CN$AU$AU
240787311$24078731$1$I$20240616$20240627$20240711$20240711$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-20362$SAMSUNG BIOEPIS$$55$YR$A$F$Y$$$20240711$$CN$CA$CA
240787321$24078732$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000022578$ROCHE$$75$YR$E$M$Y$$$20240711$$CN$US$US
240787331$24078733$1$I$$20240710$20240711$20240711$PER$$US-ROCHE-10000023042$ROCHE$$$$$F$Y$$$20240711$$HP$US$US
240787341$24078734$1$I$$20240705$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407004238$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240711$$CN$US$US
240787351$24078735$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006048$ELI LILLY AND CO$$58$YR$A$$Y$$$20240711$$CN$US$US
240787361$24078736$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006242$ELI LILLY AND CO$$76$YR$E$$Y$$$20240711$$CN$US$US
240787372$24078737$2$F$20240101$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005273$ELI LILLY AND CO$$$$$F$Y$$$20240711$$CN$US$US
240787381$24078738$1$I$20240706$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005121$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240711$$CN$US$US
240787391$24078739$1$I$20240705$20240705$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005721$ELI LILLY AND CO$$$$$F$Y$$$20240711$$CN$US$US
240787401$24078740$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005624$ELI LILLY AND CO$$$$$$Y$$$20240711$$CN$US$US
240787411$24078741$1$I$20240704$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005308$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240711$$CN$US$US
240787421$24078742$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005979$ELI LILLY AND CO$$$$$F$Y$$$20240711$$HP$US$US
240787431$24078743$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005433$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240711$$CN$US$US
240787441$24078744$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006100$ELI LILLY AND CO$$$$$$Y$$$20240711$$CN$US$US
240787451$24078745$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005608$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240711$$CN$US$US
240787461$24078746$1$I$20240601$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005646$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240711$$CN$US$US
240787472$24078747$2$F$$20240716$20240711$20240726$EXP$$IT-TEVA-VS-3217332$TEVA$Fattizzo B, Pasquale R, Croci GA, Pettine L, Cassanello G, Barcellini W. Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review. Blood-Transf 2024; 22 (3): 266-272.; Fattizzo B, Pasquale R, Croci GA, Pettine L, Cassanello G, Barcellini W. Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review. Blood-Transf 2024; 22 (3): 266-272.$72$YR$$M$Y$$$20240726$$HP$IT$IT
240787484$24078748$4$F$20240625$20240806$20240711$20240813$PER$$US-ROCHE-10000021407$ROCHE$$40$YR$A$F$Y$$$20240813$$CN$US$US
240787491$24078749$1$I$$20240702$20240711$20240711$EXP$$CZ-ROCHE-10000019303$ROCHE$Ruzickova O,  Complicated osteoporosis - a case report. Pharmacotherapeutics review. 2024;9 (3):233-7.$$$E$F$Y$$$20240711$$MD$CZ$CZ
240787501$24078750$1$I$$20240702$20240711$20240711$EXP$$AU-CELLTRION INC.-2024AU016867$CELLTRION$$$$$$Y$$$20240711$$MD$AU$AU
240787522$24078752$2$F$$20240709$20240711$20240715$PER$$US-AMGEN-USASP2024137585$AMGEN$$$$A$M$Y$$$20240715$$MD$US$US
240787534$24078753$4$F$20240704$20240723$20240711$20240820$EXP$$JP-BAYER-2024A097846$BAYER$$31$YR$A$F$Y$$$20240820$$MD$JP$JP
240787541$24078754$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109621$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240711$$CN$US$US
240787551$24078755$1$I$$20240710$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039117$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240711$$CN$US$US
240787561$24078756$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000022481$ROCHE$$36$YR$A$F$Y$$$20240711$$CN$US$US
240787571$24078757$1$I$20240705$20240708$20240711$20240711$EXP$$GB-MYLANLABS-2024M1064340$MYLAN$$$$$M$Y$$$20240711$$MD$GB$GB
240787581$24078758$1$I$20240601$20240627$20240711$20240711$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01084$INTRA-CELLULAR THERAPIES$$30$YR$$F$Y$$$20240711$$HP$US$US
240787591$24078759$1$I$$20240708$20240711$20240711$EXP$GB-MHRA-MED-202407051007036090-WYDJT$GB-MYLANLABS-2024M1064065$MYLAN$$$$$M$Y$$$20240711$$PH$GB$GB
240787601$24078760$1$I$$20240703$20240711$20240711$EXP$$US-PADAGIS-2024PAD01099$PADAGIS$$$$$$Y$$$20240711$$CN$US$US
240787611$24078761$1$I$$20240625$20240711$20240711$EXP$$US-PADAGIS-2024PAD01101$PADAGIS$$$$$$Y$$$20240711$$CN$US$US
240787631$24078763$1$I$20240710$20240710$20240710$20240710$DIR$709747$$FDA-CTU$$84$YR$$M$N$$$20240710$N$$US$
240787643$24078764$3$F$$20240830$20240711$20240902$EXP$$US-SANDOZ INC.-SDZ2023US024478$SANDOZ$$$$$$Y$$$20240902$$CN$US$US
240787661$24078766$1$I$20240708$20240709$20240711$20240711$PER$$US-TAKEDA-2024TUS069950$TAKEDA$$75$YR$$M$Y$86$KG$20240711$$MD$US$US
240787671$24078767$1$I$20240630$20240709$20240711$20240711$EXP$$CN-HALEON-2186222$Haleon PLC$$54$YR$$F$Y$50$KG$20240711$$HP$CN$CN
240787681$24078768$1$I$20240621$20240628$20240711$20240711$EXP$$PK-ROCHE-10000013401$ROCHE$$66$YR$E$M$Y$$$20240711$$PH$PK$PK
240787692$24078769$2$F$$20240714$20240711$20240715$EXP$$AU-DEXPHARM-2024-2194$DEXCEL$Perucca, P.; Bourikas, D.; Voinescu, P. E.; Vadlamudi, L.; Chellun, D.; Kumke, T.; Werhahn, K. J.; Schmitz, B.  Lacosamide and pregnancy: Data from spontaneous and solicited reports. Epilepsia 2024, V65,P1275-1284$$$$$Y$$$20240715$$HP$AU$
240787702$24078770$2$F$20240501$20240708$20240711$20240712$PER$$US-ROCHE-10000015939$ROCHE$$51$YR$A$F$Y$52.16$KG$20240712$$CN$US$US
240787711$24078771$1$I$20240501$20240708$20240711$20240711$EXP$RU-RZN-2431027$RU-BIOGEN-2024BI01272898$BIOGEN$$44$YR$$F$Y$75$KG$20240711$$MD$RU$RU
240787722$24078772$2$F$$20240714$20240711$20240715$EXP$$AU-DEXPHARM-2024-2297$DEXCEL$Perucca, P.; Bourikas, D.; Voinescu, P. E.; Vadlamudi, L.; Chellun, D.; Kumke, T.; Werhahn, K. J.; Schmitz, B.  Lacosamide and pregnancy: Data from spontaneous and solicited reports. Epilepsia 2024, V65, P1275-1284$$$$$Y$$$20240715$$HP$AU$AU
240787742$24078774$2$F$$20240714$20240711$20240715$EXP$$AU-DEXPHARM-2024-2303$DEXCEL$Perucca, P.; Bourikas, D.; Voinescu, P. E.; Vadlamudi, L.; Chellun, D.; Kumke, T.; Werhahn, K. J.; Schmitz, B.  Lacosamide and pregnancy: Data from spontaneous and solicited reports. Epilepsia 2024, V65, P1275-1284$$$$$Y$$$20240715$$HP$AU$AU
240787751$24078775$1$I$$20240710$20240711$20240711$PER$$US-TAKEDA-2024TUS070525$TAKEDA$$4$YR$$$Y$$$20240711$$PH$US$US
240787761$24078776$1$I$$20240709$20240711$20240711$PER$$US-ORGANON-O2407USA000969$ORGANON$$$$$$Y$$$20240711$$CN$US$US
240787771$24078777$1$I$20151101$20240705$20240711$20240711$PER$$US-ROCHE-10000019096$ROCHE$$61$YR$A$F$Y$61.68$KG$20240711$$HP$US$US
240787782$24078778$2$F$$20240714$20240711$20240715$EXP$$AU-DEXPHARM-2024-2306$DEXCEL$Perucca, P.; Bourikas, D.; Voinescu, P. E.; Vadlamudi, L.; Chellun, D.; Kumke, T.; Werhahn, K. J.; Schmitz, B.  Lacosamide and pregnancy: Data from spontaneous and solicited reports. Epilepsia 2024, V65, P1275-1284$$$$$Y$$$20240715$$HP$AU$AU
240787791$24078779$1$I$$20240701$20240711$20240711$EXP$$JP-ROCHE-10000021746$ROCHE$Kunimoto M, Watanabe O, Takahashi H, Koizumi A, Shigehara F, Soeda N. DP-58: Two cases of delayed suture insufficiency due to bevacizumab. The 46th Annual Meeting of Japanese Society for Research of Loco-Regional Cancer. 2024;131.$77$YR$E$M$Y$$$20240711$$MD$JP$JP
240787803$24078780$3$F$20240707$20240722$20240711$20240819$EXP$$US-UCBSA-2024034957$UCB$$26$YR$$F$Y$$$20240819$$HP$US$US
240787811$24078781$1$I$$20240701$20240711$20240711$PER$$US-RDY-SPO/USA/24/0009839$DR REDDYS$$14$YR$T$F$Y$$$20240711$$MD$US$US
240787821$24078782$1$I$$20240701$20240711$20240711$PER$$US-RDY-SPO/USA/24/0009711$DR REDDYS$$24$YR$A$F$Y$$$20240711$$CN$US$US
240787831$24078783$1$I$$20240701$20240711$20240711$PER$$US-RDY-SPO/USA/24/0009714$DR REDDYS$$23$YR$A$F$Y$$$20240711$$HP$US$US
240787841$24078784$1$I$$20240709$20240711$20240711$EXP$$US-BAYER-2024A098954$BAYER$$$$$F$Y$$$20240711$$CN$US$US
240787851$24078785$1$I$$20240701$20240711$20240711$PER$$US-RDY-SPO/USA/24/0009840$DR REDDYS$$18$YR$A$F$Y$$$20240711$$MD$US$US
240787861$24078786$1$I$$20240710$20240710$20240710$DIR$709757$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240787871$24078787$1$I$20120501$20240701$20240711$20240711$PER$$US-RDY-SPO/USA/24/0009710$DR REDDYS$$34$YR$A$$Y$$$20240711$$CN$US$US
240787881$24078788$1$I$$20240701$20240711$20240711$PER$$US-RDY-LIT/USA/24/0009917$DR REDDYS$Merrill K, Davis A, Jackson E, Riker M, Kirk C, Yung D. Direct prostacyclin transition in pediatric patients with pulmonary hypertension. Pulmonary Circulation. 2024 Apr;14(2): 1-5. doi:10.1002/pul2.12373.$2$YR$C$M$Y$16$KG$20240711$$HP$US$US
240787911$24078791$1$I$20240702$20240710$20240710$20240710$DIR$709761$$FDA-CTU$$33$YR$$F$N$$$20240710$N$PH$US$
240787921$24078792$1$I$$20240710$20240710$20240710$DIR$709765$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
240787961$24078796$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143480$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240787973$24078797$3$F$20240327$20240723$20240711$20240730$EXP$$NVSC2024DE142782$NOVARTIS$$$$A$F$Y$60$KG$20240730$$MD$DE$DE
240787992$24078799$2$F$$20240710$20240711$20240712$PER$$NVSC2024US143243$NOVARTIS$$$$$M$Y$$$20240712$$CN$US$US
240788001$24078800$1$I$$20240709$20240711$20240711$PER$$NVSC2024US142914$NOVARTIS$$$$$$Y$$$20240711$$CN$US$US
240788011$24078801$1$I$$20240702$20240711$20240711$PER$$US-JNJFOC-20240727224$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$MD$US$US
240788021$24078802$1$I$20240607$20240709$20240711$20240711$EXP$$US-BAYER-2024A099070$BAYER$$12$YR$C$M$Y$$$20240711$$HP$US$US
240788032$24078803$2$F$$20240717$20240711$20240718$EXP$$AM-ROCHE-10000018960$ROCHE$$71$YR$E$M$Y$$$20240718$$HP$AM$AM
240788051$24078805$1$I$$20240710$20240711$20240711$PER$$US-ROCHE-10000023269$ROCHE$$$$$$Y$$$20240711$$CN$US$US
240788061$24078806$1$I$$20240626$20240711$20240711$EXP$$IN-ROCHE-10000022252$ROCHE$$$$A$F$Y$$$20240711$$MD$IN$IN
240788072$24078807$2$F$$20240704$20240711$20240712$EXP$$CN-ROCHE-3417469$ROCHE$$68$YR$E$M$Y$$$20240712$$CN$CN$CN
240788091$24078809$1$I$20240529$20240705$20240711$20240711$EXP$$RS-BRISTOL-MYERS SQUIBB COMPANY-2024-108117$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$132$KG$20240711$$MD$RS$RS
240788101$24078810$1$I$20210101$20240703$20240711$20240711$EXP$$DE-AstraZeneca-2024A152846$ASTRAZENECA$$72$YR$$F$Y$$$20240711$$MD$DE$
240788121$24078812$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109972$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240711$$CN$US$US
240788132$24078813$2$F$$20240813$20240711$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105784$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240822$$CN$US$US
240788141$24078814$1$I$$20240627$20240711$20240711$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06001$LUPIN$Mignone D, Shah K, Alawneh B, Papadakos SP, Michelakis N. A rude awakening: A case of sugammadex causing transient cardiomyopathy mimicking STEMI. Journal of the American College of Cardiology. 2024;83(13):3618$43$YR$$M$Y$$$20240711$$HP$US$US
240788151$24078815$1$I$20240609$20240703$20240711$20240711$EXP$$CN-AstraZeneca-2024A155342$ASTRAZENECA$$39$YR$$M$Y$$$20240711$$MD$CN$
240788171$24078817$1$I$$20240703$20240711$20240711$EXP$$CN-ROCHE-10000015389$ROCHE$Dai M, Chen Y, Qin J. Atrioventricular re-entrant tachycardia and atrioventricular node re-entrant tachycardia in a patient with cancer under chemotherapy: a case report and literature review. Frontiers in Cardiovascular Medicine. 2024;11:1-10. doi:10.3389/fcvm.2024.1367893.$65$YR$E$M$Y$$$20240711$$HP$CN$CN
240788183$24078818$3$F$20230101$20240815$20240711$20240822$EXP$$JP-009507513-2407JPN000185J$MERCK$$$$$F$Y$50$KG$20240822$$MD$JP$JP
240788191$24078819$1$I$$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024136907$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240788201$24078820$1$I$20240611$20240710$20240711$20240711$EXP$FR-AFSSAPS-BX2024001382$FR-SANDOZ INC.-SDZ2024FR064227$SANDOZ$$58$YR$$F$Y$60$KG$20240711$$MD$FR$FR
240788221$24078822$1$I$$20240704$20240711$20240711$EXP$$IN-MYLANLABS-2024M1064470$MYLAN$Gupta D, Sivaramakrishnan P, Layek A, Mishra M. Exudative pleural effusion during sunitinib treatment. BMJ-Case-Rep 2024; 17 (6).$4$DEC$$M$Y$$$20240711$$HP$IN$IN
240788232$24078823$2$F$$20240710$20240711$20240717$EXP$$LB-MYLANLABS-2024M1064474$MYLAN$Mikhael E, Slim R, El Helou S, Amer L, Khanfour M, Yaghi C. Sertraline-Induced Hypoglycemia in Drug-Induced Liver Injury. Hosp-Pharm 2024; 0 (0):.$22$YR$$M$Y$$$20240717$$HP$LB$LB
240788246$24078824$6$F$20240424$20240719$20240711$20240723$PER$$US-ROCHE-10000000644$ROCHE$$61$YR$A$F$Y$57.33$KG$20240723$$HP$US$US
240788251$24078825$1$I$$20240627$20240711$20240711$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-20360$SAMSUNG BIOEPIS$$42$YR$A$F$Y$$$20240711$$PH$CA$CA
240788261$24078826$1$I$$20240627$20240711$20240711$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-20359$SAMSUNG BIOEPIS$$$$$M$Y$$$20240711$$CN$CA$CA
240788271$24078827$1$I$20240617$20240704$20240711$20240711$EXP$FR-AFSSAPS-LY2024000927$FR-MYLANLABS-2024M1062791$MYLAN$$52$YR$$F$Y$$$20240711$$PH$FR$FR
240788282$24078828$2$F$$20240725$20240711$20240730$EXP$$SK-MYLANLABS-2024M1063247$MYLAN$$85$YR$$F$Y$$$20240730$$MD$SK$SK
240788292$24078829$2$F$$20240814$20240711$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06373$LUPIN$$$$$$Y$$$20240828$$CN$US$US
240788301$24078830$1$I$$20240625$20240711$20240711$PER$$US-LUPIN LIMITED-2024-06323$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240788311$24078831$1$I$20240101$20240704$20240711$20240711$EXP$$RO-MYLANLABS-2024M1063375$MYLAN$$64$YR$$M$Y$$$20240711$$MD$RO$RO
240788322$24078832$2$F$20240628$20240813$20240711$20240819$EXP$$JP-ROCHE-10000019547$ROCHE$$8$DEC$E$$Y$$$20240819$$MD$JP$JP
240788331$24078833$1$I$20240112$20240627$20240711$20240711$EXP$IT-MINISAL02-991677$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06036$HIKMA$$58$YR$$F$Y$$$20240711$$MD$IT$IT
240788341$24078834$1$I$$20240627$20240711$20240711$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-20353$SAMSUNG BIOEPIS$$$$A$F$Y$65$KG$20240711$$MD$DE$DE
240788352$24078835$2$F$20240101$20240821$20240711$20240823$EXP$$AU-ORGANON-O2407AUS000939$ORGANON$$$$$F$Y$$$20240823$$MD$AU$AU
240788361$24078836$1$I$20240101$20240706$20240711$20240711$PER$$US-UNITED THERAPEUTICS-UNT-2024-020855$UNITED THERAPEUTICS$$$$$F$Y$84.807$KG$20240711$$$US$US
240788371$24078837$1$I$$20240705$20240711$20240711$PER$$US-UNITED THERAPEUTICS-UNT-2024-020887$UNITED THERAPEUTICS$$$$$F$Y$53.515$KG$20240711$$$US$US
240788381$24078838$1$I$$20240707$20240711$20240711$PER$$US-UNITED THERAPEUTICS-UNT-2024-020770$UNITED THERAPEUTICS$$$$$F$Y$57.143$KG$20240711$$$US$US
240788391$24078839$1$I$$20240710$20240710$20240710$DIR$709760$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240788401$24078840$1$I$$20240710$20240710$20240710$DIR$709768$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
240788421$24078842$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109330$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240711$$CN$US$US
240788431$24078843$1$I$$20240707$20240711$20240711$PER$$US-ROCHE-10000023565$ROCHE$$52$YR$A$M$Y$$$20240711$$CN$US$US
240788441$24078844$1$I$20240512$20240705$20240711$20240711$EXP$GB-MHRA-MED-202405161319201970-NZKCF$GB-LUNDBECK-DKLU4001367$LUNDBECK$$$$$$Y$$$20240711$$CN$GB$GB
240788451$24078845$1$I$$20240710$20240710$20240710$DIR$709769$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240788461$24078846$1$I$$20230912$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US031810$SANDOZ$$$$$M$Y$$$20240711$$CN$US$US
240788471$24078847$1$I$20240703$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407081358055900-NCHJG$GB-MYLANLABS-2024M1064079$MYLAN$$61$YR$$F$Y$71$KG$20240711$$PH$GB$GB
240788482$24078848$2$F$20240612$20240722$20240711$20240725$EXP$$GB-MYLANLABS-2024M1064879$MYLAN$$$$$M$Y$146.5$KG$20240725$$HP$GB$GB
240788502$24078850$2$F$20240607$20240812$20240711$20240816$EXP$FR-AFSSAPS-BX2024001314$FR-CHEPLA-2024008594$CHEPLAPHARM$$68$YR$$F$Y$$$20240816$$PH$COUNTRY NOT SPECIFIED$FR
240788511$24078851$1$I$$20240703$20240711$20240711$EXP$$SG-ROCHE-10000017015$ROCHE$$62$YR$A$M$Y$$$20240711$$HP$SG$SG
240788521$24078852$1$I$$20240709$20240711$20240711$EXP$$AU-MYLANLABS-2024M1064512$MYLAN$$$$$M$Y$$$20240711$$HP$AU$AU
240788531$24078853$1$I$$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024137547$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240788545$24078854$5$F$20240720$20240808$20240711$20240812$PER$$US-AMGEN-USASP2024137461$AMGEN$$77$YR$E$F$Y$$$20240811$$CN$US$US
240788561$24078856$1$I$$20240708$20240711$20240711$EXP$$ZA-BAYER-2024A089185$BAYER$$16$YR$T$F$Y$$$20240711$$CN$ZA$ZA
240788571$24078857$1$I$20240601$20240624$20240711$20240711$PER$$US-ABBVIE-5832375$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240788581$24078858$1$I$$20230926$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US038650$SANDOZ$$$$$M$Y$131.5$KG$20240711$$HP$US$US
240788591$24078859$1$I$$20240701$20240711$20240711$PER$$US-TEVA-VS-3217511$TEVA$$75$YR$$F$Y$103.42$KG$20240711$$PH$US$US
240788601$24078860$1$I$$20240611$20240711$20240711$PER$$US-009507513-2406USA004931$MERCK$$85$YR$$F$Y$$$20240711$$CN$US$US
240788612$24078861$2$F$$20240809$20240711$20240910$PER$$US-LUNDBECK-DKLU3078325$LUNDBECK$$$$$$Y$$$20240910$$CN$US$US
240788622$24078862$2$F$$20240827$20240711$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06073$LUPIN$$$$$$Y$$$20240918$$CN$US$US
240788641$24078864$1$I$$20240705$20240711$20240711$PER$$US-ALXN-202407USA000383US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240788671$24078867$1$I$$20240705$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108709$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240711$$CN$US$US
240788681$24078868$1$I$$20240709$20240711$20240711$PER$$US-GILEAD-2024-0680276$GILEAD$$$$$$Y$$$20240711$$LW$US$US
240788692$24078869$2$F$$20240802$20240711$20240805$PER$$US-ALXN-202407USA000438US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240788701$24078870$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109338$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240711$$CN$US$US
240788711$24078871$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109346$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240711$$HP$US$US
240788721$24078872$1$I$$20240710$20240711$20240711$30DAY$$US-GSK-US2024085841$GLAXOSMITHKLINE$$$$$M$Y$$$20240711$$CN$US$US
240788733$24078873$3$F$20240630$20240906$20240711$20240916$30DAY$$US-GSK-US2024083010$GLAXOSMITHKLINE$$53$YR$$M$Y$$$20240916$$CN$US$US
240788741$24078874$1$I$$20240708$20240711$20240711$30DAY$$US-GSK-US2024084947$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240788751$24078875$1$I$$20240710$20240710$20240710$DIR$709776$$FDA-CTU$$$$$UNK$N$$$20240710$N$CN$US$
240788761$24078876$1$I$20240710$20240710$20240710$20240710$DIR$709774$$FDA-CTU$$54$YR$$M$N$$$20240710$N$HP$US$
240788771$24078877$1$I$20240701$20240710$20240710$20240710$DIR$709767$$FDA-CTU$$69$YR$$F$N$54.45$KG$20240710$N$$US$
240788791$24078879$1$I$20240710$20240710$20240710$20240710$DIR$709775$$FDA-CTU$$48$YR$$F$N$67.95$KG$20240710$N$HP$US$
240788811$24078881$1$I$$20240710$20240710$20240710$DIR$709779$$FDA-CTU$$$$$M$N$99.79$KG$20240710$N$HP$US$
240788821$24078882$1$I$$20240710$20240710$20240710$DIR$709781$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240788831$24078883$1$I$$20240710$20240710$20240710$DIR$709786$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240788841$24078884$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47955$$FDA-CTU$$61$YR$$F$N$$$20240710$N$$US$
240788861$24078886$1$I$$20240710$20240710$20240710$DIR$709780$$FDA-CTU$$$$$F$N$$$20240710$N$HP$US$
240788871$24078887$1$I$$20240705$20240711$20240711$EXP$GB-MHRA-MED-202405021346225070-FQBPR$NVSC2024GB142685$NOVARTIS$$80$YR$$F$Y$$$20240711$$HP$GB$GB
240788882$24078888$2$F$$20240710$20240711$20240715$PER$$NVSC2024US142897$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240788891$24078889$1$I$20240201$20240708$20240711$20240711$EXP$$NVSC2024BR142947$NOVARTIS$$50$YR$$F$Y$$$20240711$$CN$BR$BR
240788901$24078890$1$I$$20240710$20240711$20240711$EXP$$GB-MYLANLABS-2024M1064858$MYLAN$$$$$M$Y$$$20240711$$CN$GB$GB
240788911$24078891$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135618$AMGEN$$$$A$F$Y$$$20240711$$CN$US$US
240788921$24078892$1$I$20230915$20240522$20240711$20240711$PER$$US-LUNDBECK-DKLU3078432$LUNDBECK$$$$$$Y$$$20240711$$HP$US$US
240788931$24078893$1$I$$20240710$20240711$20240711$EXP$$US-BAYER-2024A099605$BAYER$$70$YR$E$M$Y$$$20240711$$CN$US$US
240788941$24078894$1$I$$20240708$20240711$20240711$EXP$$NL-ROCHE-10000023422$ROCHE$$$$$M$Y$$$20240711$$HP$NL$NL
240788952$24078895$2$F$$20240712$20240711$20240712$PER$$US-BAYER-2024A096143$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240788961$24078896$1$I$$20240705$20240711$20240711$PER$$NVSC2024US142971$NOVARTIS$$$$$M$Y$$$20240711$$CN$US$US
240788982$24078898$2$F$$20240711$20240711$20240725$EXP$$JP-ROCHE-10000017402$ROCHE$Tsukada M, Kawamata T, Yamauchi N, Osuka F, Endo G, Sato N. A case of colonic diverticulitis accompanied by retroperitoneal abscess due to administration of bevacizumab [Abstract number:  S3-3]. The 46th Meeting of the Japanese Society for Research of Loco-Regional Cancer Th. 2024;56.$56$YR$A$M$Y$$$20240725$$MD$JP$JP
240788992$24078899$2$F$20170101$20240808$20240711$20240813$EXP$$US-KAMADA LIMITED-2019US005720$TAKEDA$$$$$M$Y$$$20240813$$HP$US$US
240789001$24078900$1$I$$20240710$20240711$20240711$EXP$$US-PFIZER INC-PV202400090697$PFIZER$$64$YR$$M$Y$$$20240711$$CN$US$US
240789011$24078901$1$I$$20240705$20240711$20240711$EXP$$IT-PFIZER INC-PV202400089049$PFIZER$Attili, I.. Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences across ALEX and CROWN Phase 3 Trials. cancers. 2024;16:2457$$$$$Y$$$20240711$$HP$IT$IT
240789021$24078902$1$I$$20240705$20240711$20240711$EXP$$IT-PFIZER INC-202400209059$PFIZER$Attili, I.. Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences across ALEX and CROWN Phase 3 Trials. cancers. 2024;16:2457$$$A$$Y$$$20240711$$HP$IT$IT
240789032$24078903$2$F$20240702$20240910$20240711$20240920$30DAY$$US-GSK-US2024083074$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240920$$CN$US$US
240789041$24078904$1$I$20240705$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024134807$AMGEN$$$$$M$Y$$$20240711$$CN$US$US
240789051$24078905$1$I$20240630$20240710$20240711$20240711$EXP$$CN-BAYER-2024A099691$BAYER$$67$YR$E$F$Y$47.5$KG$20240711$$HP$CN$CN
240789061$24078906$1$I$$20240313$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US050446$SANDOZ$$64$YR$$F$Y$$$20240711$$CN$US$US
240789081$24078908$1$I$20230101$20240617$20240711$20240711$PER$$US-JNJFOC-20240645623$JOHNSON AND JOHNSON$$10$DEC$E$F$Y$$$20240711$$CN$US$US
240789091$24078909$1$I$$20240705$20240711$20240711$EXP$$GB-JNJFOC-20240721287$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$HP$GB$GB
240789102$24078910$2$F$$20240808$20240711$20240813$PER$$US-JNJFOC-20240725270$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
240789112$24078911$2$F$$20240916$20240711$20240920$EXP$$AU-MYLANLABS-2024M1064493$MYLAN$$$$$M$Y$$$20240920$$HP$AU$AU
240789121$24078912$1$I$$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407091039521900-GMQNV$GB-MYLANLABS-2024M1064647$MYLAN$$34$YR$$F$Y$$$20240711$$CN$GB$GB
240789132$24078913$2$F$$20240814$20240711$20240816$EXP$$CA-TAKEDA-2020TUS042705$TAKEDA$$$$$M$Y$$$20240816$$CN$CA$CA
240789141$24078914$1$I$20211225$20240603$20240711$20240711$EXP$$AU-JNJFOC-20240719580$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$HP$AU$AU
240789151$24078915$1$I$$20240705$20240711$20240711$PER$$US-ALXN-202407USA000489US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
240789163$24078916$3$F$20240601$20240904$20240711$20240913$EXP$$BR-TEVA-VS-3217448$TEVA$$61$YR$$F$Y$$$20240913$$CN$BR$BR
240789172$24078917$2$F$$20240905$20240711$20240905$EXP$$CA-PFIZER INC-202400196939$PFIZER$$29$YR$$M$Y$$$20240905$$HP$CA$CA
240789181$24078918$1$I$$20240710$20240711$20240711$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039128$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240711$$CN$US$US
240789193$24078919$3$F$$20240905$20240711$20240905$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037144$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240905$$CN$JP$JP
240789201$24078920$1$I$$20240708$20240711$20240711$EXP$$CA-FreseniusKabi-FK202410826$FRESENIUS KABI$$25$YR$A$M$Y$72$KG$20240711$$HP$CA$CA
240789211$24078921$1$I$$20240708$20240711$20240711$EXP$$CA-FreseniusKabi-FK202410772$FRESENIUS KABI$$73$YR$E$F$Y$$$20240711$$MD$CA$CA
240789221$24078922$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06358$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240789231$24078923$1$I$$20240624$20240711$20240711$PER$$US-FMCRTG-FMC-2406-000766$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240711$$HP$US$US
240789241$24078924$1$I$$20240617$20240711$20240711$PER$$US-FMCRTG-FMC-2406-000740$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240711$$HP$US$US
240789252$24078925$2$F$$20240904$20240711$20240904$EXP$$CA-PFIZER INC-202400209809$PFIZER$$46$YR$$M$Y$$$20240904$$PH$CA$CA
240789263$24078926$3$F$20240101$20240905$20240711$20240905$EXP$$CA-PFIZER INC-202400063995$PFIZER$$31$YR$$M$Y$$$20240905$$HP$CA$CA
240789271$24078927$1$I$20231201$20240126$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2024US011433$SANDOZ$$71$YR$$F$Y$$$20240711$$CN$US$US
240789291$24078929$1$I$20230322$20240626$20240711$20240711$EXP$$JP-ROCHE-10000013576$ROCHE$$47$YR$A$F$Y$48.6$KG$20240711$$PH$JP$JP
240789301$24078930$1$I$20240524$20240701$20240711$20240711$EXP$DE-PEI-CADR2024328342$DE-BEH-2024174823$CSL BEHRING$$28$YR$A$F$Y$65$KG$20240711$$CN$DE$DE
240789361$24078936$1$I$$20240705$20240711$20240711$EXP$$US-TAKEDA-2023TUS089302$TAKEDA$$$$$F$Y$$$20240711$$CN$US$US
240789371$24078937$1$I$20220101$20240708$20240711$20240711$EXP$$AU-AstraZeneca-2024A156902$ASTRAZENECA$$$$$F$Y$$$20240711$$MD$AU$
240789382$24078938$2$F$20240701$20240717$20240711$20240720$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010455$JAZZ$$15$YR$$M$Y$27.4$KG$20240720$$CN$US$US
240789391$24078939$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47960$$FDA-CTU$$65$YR$$F$N$$$20240710$N$$US$
240789401$24078940$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47983$$FDA-CTU$$65$YR$$F$N$$$20240710$N$$US$
240789411$24078941$1$I$$20240624$20240711$20240711$EXP$$US-MYLANLABS-2024M1060708$MYLAN$$$$$F$Y$$$20240711$$CN$US$US
240789421$24078942$1$I$$20230929$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US038246$SANDOZ$$$$$F$Y$$$20240711$$CN$US$US
240789431$24078943$1$I$20240711$20240711$20240711$20240711$EXP$$CN-BAYER-2024A099898$BAYER$$56$YR$A$M$Y$$$20240711$$HP$CN$CN
240789441$24078944$1$I$20240613$20240703$20240711$20240711$EXP$DE-CADRBFARM-2024328829$DE-TEVA-VS-3216982$TEVA$$37$YR$$F$Y$90$KG$20240711$$CN$DE$DE
240789451$24078945$1$I$$20240705$20240711$20240711$PER$$US-ALXN-202407USA000488US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240789462$24078946$2$F$20240501$20240802$20240711$20240805$PER$$US-ALXN-202407USA000361US$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240805$$CN$US$US
240789471$24078947$1$I$$20240705$20240711$20240711$EXP$$CN-ROCHE-10000003019$ROCHE$Li X, Zhang Y, Wei L, Wang Z, Yang M. SMARCA4-deficient uterine adnexal tumor with ascites: A case report and literature review. Oncology Letters. 2024;28 (2):1-8. doi:10.3892/ol.2024.14490.$64$YR$A$F$Y$$$20240711$$HP$CN$CN
240789481$24078948$1$I$$20240703$20240711$20240711$PER$$US-ALXN-202407USA000248US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240789491$24078949$1$I$20240709$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136838$AMGEN$$64$YR$A$M$Y$$$20240711$$PH$US$US
240789501$24078950$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136077$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240789531$24078953$1$I$$20240705$20240711$20240711$EXP$$US-GILEAD-2024-0679796$GILEAD$$36$YR$A$F$Y$$$20240711$$CN$US$US
240789541$24078954$1$I$20240601$20240710$20240711$20240711$PER$$US-JNJFOC-20240725908$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240711$$HP$US$US
240789551$24078955$1$I$20230928$20240704$20240711$20240711$EXP$$BY-JNJFOC-20240717281$JOHNSON AND JOHNSON$$71$YR$E$M$Y$44.7$KG$20240711$$MD$BY$BY
240789561$24078956$1$I$$20240703$20240711$20240711$EXP$$BR-TAKEDA-2023TUS088002$TAKEDA$$$$$M$Y$$$20240711$$CN$BR$BR
240789571$24078957$1$I$20240623$20240627$20240711$20240711$PER$$US-MYLANLABS-2024M1061139$MYLAN$$$$$F$Y$$$20240711$$CN$US$US
240789581$24078958$1$I$20240130$20240705$20240711$20240711$PER$FR-AFSSAPS-BX2024000604$FR-Waylis Therapeutics LLC-ATNAHS20240400941$Waylis$$41$YR$A$M$Y$92$KG$20240710$$PH$FR$FR
240789592$24078959$2$F$20240620$20240719$20240711$20240813$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000414$BECTON DICKINSON$$$$$$Y$$$20240812$$CN$GB$GB
240789601$24078960$1$I$20240706$20240710$20240711$20240711$30DAY$$US-GSK-US2024085815$GLAXOSMITHKLINE$$21$YR$$F$Y$$$20240711$$CN$US$US
240789612$24078961$2$F$$20240709$20240711$20240712$EXP$$US-GSK-US2024083863$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$CN$US$US
240789622$24078962$2$F$20240101$20240718$20240711$20240726$EXP$$US-009507513-2406USA005703$MERCK$$$$$F$Y$78.5$KG$20240726$$CN$US$US
240789641$24078964$1$I$$20240705$20240711$20240711$EXP$$US-Bion-013405$BIONPHARMA$$$$$F$Y$$$20240711$$CN$US$US
240789651$24078965$1$I$$20240703$20240711$20240711$EXP$$US-Bion-013407$BIONPHARMA$$$$$M$Y$$$20240711$$CN$US$US
240789661$24078966$1$I$$20240705$20240711$20240711$EXP$$US-Bion-013406$BIONPHARMA$$81$YR$E$F$Y$$$20240711$$CN$US$US
240789671$24078967$1$I$$20240708$20240711$20240711$EXP$$JP-AMGEN-JPNSP2024099367$AMGEN$$4$YR$C$F$Y$$$20240711$$MD$JP$JP
240789681$24078968$1$I$20240520$20240709$20240711$20240711$EXP$$US-TAKEDA-2024TUS070141$TAKEDA$$4$YR$$M$Y$$$20240711$$PH$US$US
240789692$24078969$2$F$$20240709$20240711$20240819$PER$$CA-TOLMAR, INC.-24CA050468$TOLMAR$$$$$M$Y$$$20240814$$CN$CA$CA
240789701$24078970$1$I$20240621$20240621$20240711$20240711$PER$$CA-TOLMAR, INC.-24CA050531$TOLMAR$$91$YR$$M$Y$$$20240710$$CN$CA$CA
240789711$24078971$1$I$20240621$20240621$20240711$20240711$PER$$CA-TOLMAR, INC.-24CA050519$TOLMAR$$60$YR$$M$Y$$$20240710$$CN$CA$CA
240789721$24078972$1$I$20240108$20240621$20240711$20240711$PER$$CO-TOLMAR, INC.-24CO050430$TOLMAR$$88$YR$$M$Y$$$20240710$$CN$CO$CO
240789731$24078973$1$I$$20240619$20240711$20240711$PER$$DO-TOLMAR, INC.-24DO050358$TOLMAR$$$$$M$Y$$$20240710$$CN$DO$DO
240789751$24078975$1$I$$20240702$20240711$20240711$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004953$BIOCON$$$$$$Y$$$20240711$$HP$CA$CA
240789761$24078976$1$I$20240626$20240710$20240710$20240710$DIR$709748$$FDA-CTU$$55$YR$$F$N$$$20240710$Y$HP$US$
240789772$24078977$2$F$20240615$20240718$20240711$20240812$PER$$FR-TOLMAR, INC.-24FR050364$TOLMAR$$70$YR$$M$Y$$$20240812$$PH$FR$FR
240789781$24078978$1$I$$20240627$20240711$20240711$EXP$$MX-SERVIER-S24008668$SERVIER$$$$$$Y$$$20240711$$MD$MX$MX
240789791$24078979$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47964$$FDA-CTU$$7$YR$$M$N$21.77$KG$20240710$N$$US$
240789801$24078980$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47942$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
240789811$24078981$1$I$20210101$20240709$20240711$20240711$EXP$$US-ROCHE-10000023345$ROCHE$$63$YR$A$F$Y$72.57$KG$20240711$$CN$US$US
240789821$24078982$1$I$$20240624$20240711$20240711$EXP$$US-MYLANLABS-2024M1058479$MYLAN$$$$$$Y$$$20240711$$CN$US$US
240789831$24078983$1$I$$20240626$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05802$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240789841$24078984$1$I$20230115$20240702$20240711$20240711$EXP$$RU-SA-2024SA197889$SANOFI AVENTIS$$43$YR$A$M$Y$86$KG$20240711$$MD$RU$RU
240789851$24078985$1$I$20210126$20240709$20240711$20240711$EXP$$CA-TAKEDA-2021TUS006804$TAKEDA$$83$YR$$M$Y$$$20240711$$CN$CA$CA
240789861$24078986$1$I$$20240701$20240711$20240711$EXP$$CN-SA-2024SA196030$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240711$$HP$CN$CN
240789871$24078987$1$I$20010222$20240710$20240710$20240710$DIR$709792$$FDA-CTU$$47$YR$$F$N$67.5$KG$20240710$N$CN$US$
240789881$24078988$1$I$20240325$20240701$20240711$20240711$EXP$$PK-ROCHE-10000022478$ROCHE$$41$YR$A$F$Y$$$20240711$$CN$PK$PK
240789891$24078989$1$I$20240101$20240703$20240711$20240711$EXP$$US-NEBO-663169$PHARMACOSMOS$$$$E$F$Y$$$20240711$$HP$US$US
240789901$24078990$1$I$20240213$20240711$20240711$20240711$EXP$SE-SEMPA-2024-005382$NVSC2024SE143295$NOVARTIS$$84$YR$$M$Y$$$20240711$$MD$SE$SE
240789913$24078991$3$F$20240101$20240917$20240711$20240924$EXP$$EG-SA-2024SA198835$SANOFI AVENTIS$$1$DY$N$M$Y$2.5$KG$20240924$$CN$EG$EG
240789921$24078992$1$I$$20240116$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2024US007023$SANDOZ$$$$$F$Y$$$20240711$$HP$US$US
240789931$24078993$1$I$$20240704$20240711$20240711$EXP$$CA-TAKEDA-2022TUS053668$TAKEDA$$$$$M$Y$$$20240711$$CN$CA$CA
240789942$24078994$2$F$20240703$20240912$20240711$20240916$EXP$$RO-ARGENX-2024-ARGX-RO005349$ARGENX BVBA$$$$$$Y$$$20240916$$MD$RO$RO
240789951$24078995$1$I$20240418$20240422$20240711$20240711$PER$$US-USWM, LLC-UWM202404-000031$US WORLDMEDS$$7$YR$$F$Y$$$20240711$$CN$US$
240789971$24078997$1$I$20240709$20240710$20240710$20240710$DIR$709753$$FDA-CTU$$31$YR$$F$N$74.7$KG$20240710$N$CN$US$
240789991$24078999$1$I$20240710$20240710$20240710$20240710$DIR$709790$$FDA-CTU$$46$YR$$M$N$108$KG$20240710$N$$US$
240790001$24079000$1$I$20240701$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47981$$FDA-CTU$$24$YR$$M$N$$$20240710$Y$PH$US$
240790011$24079001$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47989$$FDA-CTU$$41$YR$$M$N$$$20240710$N$$US$
240790041$24079004$1$I$20230101$20240701$20240711$20240711$EXP$$JP-ROCHE-10000019367$ROCHE$$$$A$$Y$$$20240711$$PH$JP$JP
240790055$24079005$5$F$20240729$20240729$20240711$20240805$EXP$$CA-TAKEDA-2024TUS069930$TAKEDA$$51$YR$$F$Y$68.03$KG$20240804$$CN$CA$CA
240790061$24079006$1$I$$20240708$20240711$20240711$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003794$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$US$US
240790071$24079007$1$I$$20240708$20240711$20240711$EXP$$US-TAKEDA-2022TUS057189$TAKEDA$$$$$F$Y$$$20240711$$MD$US$US
240790092$24079009$2$F$$20240802$20240711$20240805$PER$$US-ALXN-202407USA000371US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240790102$24079010$2$F$20150613$20240802$20240711$20240812$EXP$FR-AFSSAPS-AN2024000810$FR-TEVA-VS-3217047$TEVA$$50$YR$$F$Y$74$KG$20240812$$PH$FR$FR
240790111$24079011$1$I$$20240710$20240711$20240711$EXP$$US-TAKEDA-2024TUS070208$TAKEDA$$$$$F$Y$$$20240711$$CN$US$US
240790124$24079012$4$F$20240705$20240805$20240711$20240809$PER$$US-AMGEN-USASP2024134050$AMGEN$$78$YR$E$M$Y$$$20240808$$CN$US$US
240790131$24079013$1$I$20240601$20240705$20240711$20240711$PER$$US-JNJFOC-20240718140$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240711$$CN$US$US
240790141$24079014$1$I$20240702$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407081256567830-ZBRLH$GB-MYLANLABS-2024M1064178$MYLAN$$55$YR$$F$Y$$$20240711$$CN$GB$GB
240790151$24079015$1$I$20240612$20240703$20240711$20240711$EXP$IT-MINISAL02-991089$IT-TEVA-VS-3217213$TEVA$$50$YR$$F$Y$$$20240711$$PH$IT$IT
240790161$24079016$1$I$20240601$20240626$20240711$20240711$PER$$US-RISINGPHARMA-US-2024RISSPO00235$RISING PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240790171$24079017$1$I$$20240630$20240711$20240711$EXP$$US-RDY-LIT/USA/24/0009874$DR REDDYS$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. Journal of Maternal-Fetal and Neonatal Medicine. 2024;37(1): doi:10.1080/14767058.2024.2355293.$$$$F$Y$$$20240711$$HP$US$US
240790181$24079018$1$I$$20240630$20240711$20240711$EXP$$US-RDY-LIT/USA/24/0009908$DR REDDYS$Yeung SJ, Qdaisat A, Bischof JJ, Caterino JM, Kyriacou DN, Coyne MC. A case series of adrenal insufficiency (likely due to hypophysitis) in cancer patients treated with immune checkpoint inhibitors. American Journal of Emergency Medicine. 2024 Jun;80(0): 227. doi:10.1016/j.ajem.2024.04.046.$37$YR$A$F$Y$$$20240711$$HP$US$US
240790201$24079020$1$I$20240622$20240705$20240711$20240711$EXP$$PR-JNJFOC-20240717650$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20240711$$CN$PR$PR
240790211$24079021$1$I$$20240701$20240711$20240711$PER$$US-AMGEN-USASP2024132449$AMGEN$Chaisrimaneepan, N.. Neutrophilic eccrine hidradenitis from granulocyte- stimulating factor in a patient with ANCA vasculitis. Clinical Case Reports. 2024;12 (7):1-4$$$A$M$Y$$$20240711$$HP$US$US
240790231$24079023$1$I$20240101$20240701$20240711$20240711$PER$$US-AMGEN-USASP2024130266$AMGEN$$73$YR$E$F$Y$$$20240711$$CN$US$US
240790241$24079024$1$I$$20240701$20240711$20240711$PER$$US-ROCHE-10000017285$ROCHE$$36$YR$A$F$Y$$$20240711$$MD$US$US
240790251$24079025$1$I$20210101$20240708$20240711$20240711$EXP$$US-ROCHE-3040984$ROCHE$$73$YR$E$M$Y$97.52$KG$20240711$$CN$US$US
240790261$24079026$1$I$$20240702$20240711$20240711$EXP$$US-ROCHE-10000018508$ROCHE$$$$$$Y$$$20240711$$CN$US$US
240790281$24079028$1$I$20240315$20240711$20240711$20240711$EXP$FR-AFSSAPS-PP2024000768$NVSC2024FR143294$NOVARTIS$$40$YR$$M$Y$68$KG$20240711$$MD$FR$FR
240790291$24079029$1$I$$20240708$20240711$20240711$30DAY$$US-GSK-US2024084986$GLAXOSMITHKLINE$$$$$M$Y$$$20240711$$CN$US$US
240790301$24079030$1$I$20221110$20240705$20240711$20240711$EXP$$MX-SANDOZ INC.-NVSC2023MX040606$SANDOZ$$85$YR$$F$Y$$$20240711$$CN$MX$MX
240790313$24079031$3$F$$20240730$20240711$20240806$PER$$US-ALXN-202407USA000436US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240790321$24079032$1$I$$20240703$20240711$20240711$PER$$US-ALXN-202407USA000300US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
240790332$24079033$2$F$$20240630$20240711$20240711$EXP$$US-ROCHE-10000015645$ROCHE$$71$YR$E$F$Y$$$20240711$$MD$US$US
240790341$24079034$1$I$20240705$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47954$$FDA-CTU$$38$YR$$F$N$$$20240710$N$HP$US$
240790351$24079035$1$I$$20240701$20240711$20240711$EXP$$US-ROCHE-10000018177$ROCHE$$48$YR$A$M$Y$$$20240711$$HP$US$US
240790361$24079036$1$I$$20240705$20240711$20240711$PER$$US-JNJFOC-20240718179$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240790371$24079037$1$I$$20240710$20240711$20240711$PER$$US-HALEON-2186442$Haleon PLC$$$$$$Y$$$20240711$$CN$US$US
240790381$24079038$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47943$$FDA-CTU$$76$YR$$F$N$86.18$KG$20240710$N$HP$US$
240790391$24079039$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47957$$FDA-CTU$$73$YR$$F$N$$$20240710$N$HP$US$
240790401$24079040$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47969$$FDA-CTU$$68$YR$$F$N$90.26$KG$20240710$N$HP$US$
240790411$24079041$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47971$$FDA-CTU$$63$YR$$M$N$82.55$KG$20240710$N$$US$
240790421$24079042$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47966$$FDA-CTU$$56$YR$$F$N$$$20240709$N$$US$
240790431$24079043$1$I$$20240710$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA064357$SANDOZ$$71$YR$$F$Y$$$20240711$$HP$CA$CA
240790441$24079044$1$I$20240708$20240709$20240711$20240711$30DAY$$US-SANDOZ INC.-SDZ2024US064090$SANDOZ$$67$YR$$F$Y$$$20240711$$CN$US$US
240790451$24079045$1$I$20240630$20240703$20240711$20240711$EXP$$US-SERVIER-S24008600$SERVIER$$$$$$Y$$$20240711$$CN$US$US
240790476$24079047$6$F$20240601$20240906$20240711$20240910$PER$$US-BIOGEN-2024BI01268577$BIOGEN$$67$YR$$F$Y$$$20240910$$CN$US$US
240790482$24079048$2$F$$20240811$20240711$20240812$PER$$US-PFIZER INC-202400211149$PFIZER$$41$YR$$M$Y$$$20240812$$CN$US$US
240790491$24079049$1$I$20230720$20240703$20240711$20240711$EXP$FR-AFSSAPS-TO2024001177$FR-TEVA-VS-3216989$TEVA$$66$YR$$M$Y$$$20240711$$MD$FR$FR
240790501$24079050$1$I$$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137240$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240790511$24079051$1$I$20240601$20240627$20240711$20240711$PER$$US-AMGEN-USASP2024136696$AMGEN$$68$YR$E$F$Y$$$20240711$$CN$US$US
240790522$24079052$2$F$20240628$20240712$20240711$20240718$PER$$US-AMGEN-USASP2024132873$AMGEN$$55$YR$A$M$Y$62.6$KG$20240718$$HP$US$US
240790531$24079053$1$I$$20240705$20240711$20240711$EXP$$JP-AMGEN-JPNSP2024134718$AMGEN$$$$E$M$Y$$$20240711$$HP$JP$JP
240790544$24079054$4$F$20240709$20240919$20240711$20240923$PER$$US-AMGEN-USASP2024137518$AMGEN$$$$$F$Y$$$20240923$$HP$US$US
240790551$24079055$1$I$20240705$20240710$20240711$20240711$EXP$$US-TAKEDA-2024TUS070538$TAKEDA$$53$YR$$M$Y$$$20240711$$CN$US$US
240790561$24079056$1$I$$20240702$20240711$20240711$EXP$$US-AMGEN-USASP2024133769$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31(6):3529-3545$52$YR$A$F$Y$$$20240711$$HP$US$US
240790571$24079057$1$I$$20240702$20240711$20240711$EXP$$US-AMGEN-USASP2024133793$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31 (6):3529-3545$52$YR$A$M$Y$$$20240711$$HP$US$US
240790592$24079059$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3217978$TEVA$Khawam S, Goudie M, Hartfield R, Hassan S, Padder F. A Case of Trazadone and Omeprazole Associated Wenckebach Phenomenon Disguised as Second-degree Mobitz Type 2 AV Block. Am-J-Respir-Crit-Care-Med 2024; 209 A5664.; Khawam S, Goudie M, Hartfield R, Hassan S, Padder F. A Case of Trazadone and Omeprazole Associated Wenckebach Phenomenon Disguised as Second-degree Mobitz Type 2 AV Block. Am-J-Respir-Crit-Care-Med 2024; 209 A5664.$26$YR$$F$Y$$$20240809$$HP$US$US
240790602$24079060$2$F$20240702$20240809$20240711$20240813$30DAY$$US-AMGEN-USASP2024132547$AMGEN$$43$YR$A$F$Y$122.9$KG$20240813$$HP$US$US
240790611$24079061$1$I$$20240710$20240711$20240711$PER$$US-HALEON-2186518$Haleon PLC$$$$$$Y$$$20240711$$CN$US$US
240790621$24079062$1$I$$20231205$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US066169$SANDOZ$$$$$M$Y$$$20240711$$CN$US$US
240790631$24079063$1$I$$20240701$20240711$20240711$EXP$$US-AMGEN-USASP2024132486$AMGEN$Jameson G.S.. Phase II clinical trial of nab-paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer. Cancer Medicine. 2024;13 (12):1-10$$$$$Y$$$20240711$$HP$US$US
240790653$24079065$3$F$$20240724$20240711$20240726$EXP$$NVSC2024GR142711$NOVARTIS$$$$$$Y$$$20240726$$MD$GR$GR
240790661$24079066$1$I$$20230831$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US024102$SANDOZ$$$$$F$Y$$$20240711$$CN$US$US
240790671$24079067$1$I$$20240708$20240711$20240711$PER$$US-JNJFOC-20240719206$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$CN$US$US
240790692$24079069$2$F$$20240709$20240711$20240712$EXP$$GB-ROCHE-10000022744$ROCHE$$$$A$F$Y$$$20240713$$HP$GB$GB
240790702$24079070$2$F$20240709$20240715$20240711$20240717$PER$$US-AMGEN-USASP2024136822$AMGEN$$78$YR$E$F$Y$$$20240716$$PH$US$US
240790712$24079071$2$F$20240705$20240712$20240711$20240717$EXP$$US-JNJFOC-20240717673$JOHNSON AND JOHNSON$$73$YR$E$F$Y$99.88$KG$20240718$$MD$US$US
240790731$24079073$1$I$20240407$20240703$20240711$20240711$EXP$FR-AFSSAPS-NC2024000778$FR-LUNDBECK-DKLU4001380$LUNDBECK$$$$$$Y$$$20240711$$MD$FR$FR
240790741$24079074$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47938$$FDA-CTU$$$$$M$N$$$20240709$N$HP$US$
240790754$24079075$4$F$20240705$20240903$20240711$20240905$EXP$$NZ-MYLANLABS-2024M1063576$MYLAN$$26$YR$$M$Y$$$20240905$$CN$NZ$NZ
240790761$24079076$1$I$20240609$20240705$20240711$20240711$EXP$FR-AFSSAPS-LL2024001225$FR-MYLANLABS-2024M1063827$MYLAN$$12$YR$$M$Y$$$20240711$$PH$FR$FR
240790772$24079077$2$F$20240520$20240812$20240711$20240819$EXP$$DE-MYLANLABS-2024M1063630$MYLAN$$76$YR$$M$Y$$$20240819$$CN$DE$DE
240790781$24079078$1$I$$20240705$20240711$20240711$EXP$$JP-VIATRISJAPAN-2024M1063686AA$MYLAN$$84$YR$$$Y$$$20240711$$CN$JP$JP
240790801$24079080$1$I$20240706$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47944$$FDA-CTU$$82$YR$$M$N$$$20240710$N$$US$
240790811$24079081$1$I$$20240705$20240711$20240711$EXP$$AR-MYLANLABS-2024M1064176$MYLAN$$$$$F$Y$$$20240711$$MD$AR$AR
240790821$24079082$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063728$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$15$YR$$F$Y$$$20240711$$HP$US$US
240790831$24079083$1$I$$20240705$20240711$20240711$EXP$$IT-MYLANLABS-2024M1064629$MYLAN$Morena A, Matta M, Ferraris F, Frea S, Anselmino M, Berruquier P, et al. Continuous left stellate ganglion block during VT ablation to slow VT and improve ablation outcome. Eur-Heart-J-Suppl 2024; 26 (Suppl. 2) ii146.$71$YR$$M$Y$$$20240711$$HP$IT$IT
240790841$24079084$1$I$20240119$20240710$20240710$20240710$DIR$709771$$FDA-CTU$$43$YR$$F$N$81$KG$20240710$N$HP$US$
240790851$24079085$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47965$$FDA-CTU$$34$YR$$F$N$$$20240710$N$HP$US$
240790861$24079086$1$I$$20240703$20240711$20240711$PER$$US-ALXN-202407USA000323US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
240790871$24079087$1$I$$20240705$20240711$20240711$PER$$US-ALXN-202407USA000385US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240790883$24079088$3$F$20231001$20240924$20240711$20240927$EXP$$US-TAKEDA-2023TUS101677$TAKEDA$$52$YR$$F$Y$$$20240927$$CN$US$US
240790892$24079089$2$F$$20240802$20240711$20240805$PER$$US-ALXN-202407USA000378US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240790901$24079090$1$I$$20240705$20240711$20240711$EXP$$US-PFIZER INC-2021458218$PFIZER$Menegakis, N.. Case report of myocardial infarction in labor. American Journal of Obstetrics and Gynecology. 1991;165(5 I):1383-1384$37$YR$$F$Y$$$20240711$$MD$US$US
240790911$24079091$1$I$$20240708$20240711$20240711$EXP$$US-PFIZER INC-PV202400089942$PFIZER$Bayraktar, U.. Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas. Leukemia and Lymphoma. 2024;55(4):786-794$34$YR$$M$Y$$$20240711$$HP$US$US
240790922$24079092$2$F$$20240710$20240711$20240715$EXP$$US-PFIZER INC-202400209517$PFIZER$Ampomah, K.. Comprehensive Review for the Treatment of Multilevel Thoracic Compression Pain with a Case Report Demonstrating Use of Peripheral Stimulation. Pain Medicine Case Reports. 2024;8(3):95-101$20$YR$$F$Y$$$20240715$$MD$US$US
240790931$24079093$1$I$$20240705$20240711$20240711$EXP$$US-PFIZER INC-202400208497$PFIZER$Bulsara, K.. A Rare Case of Argatroban-Induced Anaphylaxis in a Patient With Intermediate-High Risk Pulmonary Embolism. Cureus. 2024;16(5):10.7759/cureus.61129$32$YR$$F$Y$$$20240711$$MD$US$US
240790942$24079094$2$F$$20240904$20240711$20240904$EXP$$CA-PFIZER INC-202400208993$PFIZER$$81$YR$$M$Y$$$20240904$$HP$CA$CA
240790951$24079095$1$I$$20240708$20240711$20240711$EXP$$US-PFIZER INC-PV202400089961$PFIZER$Suvar, T.. The Combined Use of Acute Regional and Interventional Pain Offers Superior Quality of Life in Palliative Care. Pain medicine case reports. 2024;8(1):25-29$29$YR$$F$Y$$$20240711$$MD$US$US
240790961$24079096$1$I$$20240705$20240711$20240711$EXP$$US-PFIZER INC-PV202400089048$PFIZER$Fine, P.. Cranial nerve block after test dose through an epidural catheter in a pre-eclamptic parturient. Canadian Anaesthetists Society Journal. 1984;31(5):565-567$44$YR$$F$Y$104$KG$20240711$$MD$US$US
240790971$24079097$1$I$$20240703$20240711$20240711$EXP$$GB-PFIZER INC-PV202400089261$PFIZER$Wilson, M.. ^ACOPP^ chemotherapy for older and less fit patients with Hodgkin lymphoma-A multicentre, retrospective study. British J Haematol. 2023;202(4):796-800$$$E$$Y$$$20240711$$HP$GB$GB
240790993$24079099$3$F$$20240712$20240711$20240725$EXP$$US-PFIZER INC-202400209825$PFIZER$Kraus, M.. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report. Case Reports in Neurology. 2024;16(1):142-147$38$YR$$F$Y$63.5$KG$20240725$$MD$US$US
240791001$24079100$1$I$$20240710$20240711$20240711$EXP$$DZ-PFIZER INC-202400212237$PFIZER$$60$YR$$M$Y$$$20240711$$MD$DZ$DZ
240791011$24079101$1$I$$20240709$20240711$20240711$EXP$$DO-PFIZER INC-PV202400090547$PFIZER$$42$YR$$F$Y$$$20240711$$CN$DO$DO
240791021$24079102$1$I$20240101$20240709$20240711$20240711$EXP$$US-PFIZER INC-202400211085$PFIZER$$64$YR$$M$Y$$$20240711$$HP$US$US
240791031$24079103$1$I$20230525$20240705$20240711$20240711$EXP$$DE-PFIZER INC-2023SGN05177$PFIZER$$44$YR$$F$Y$111$KG$20240711$$MD$DE$DE
240791041$24079104$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063744$MYLAN$Devine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. J-Pediatr-Pharmacol-Ther 2023; 28 (2): 161-166.$29$DY$$$Y$$$20240711$$HP$US$US
240791057$24079105$7$F$20240701$20240923$20240711$20240924$30DAY$$AR-PFIZER INC-202400205904$PFIZER$$20$YR$$F$Y$$$20240924$$HP$AR$AR
240791061$24079106$1$I$20240118$20240703$20240711$20240711$EXP$FR-AFSSAPS-AVMA2024000256$FR-TEVA-VS-3217057$TEVA$$60$YR$$F$Y$$$20240711$$PH$FR$FR
240791071$24079107$1$I$$20240709$20240711$20240711$PER$$US-JNJFOC-20240721853$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240791081$24079108$1$I$$20240706$20240711$20240711$EXP$$IT-JNJFOC-20240721257$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240711$$CN$IT$IT
240791101$24079110$1$I$20240702$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47974$$FDA-CTU$$61$YR$$M$N$$$20240710$Y$PH$US$
240791121$24079112$1$I$$20240710$20240710$20240710$DIR$709796$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240791141$24079114$1$I$$20240710$20240710$20240710$DIR$709797$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240791161$24079116$1$I$$20240708$20240711$20240711$EXP$$CA-FreseniusKabi-FK202410782$FRESENIUS KABI$$63$YR$A$M$Y$54$KG$20240711$$HP$CA$CA
240791171$24079117$1$I$20240614$20240708$20240711$20240711$EXP$LV-SAM-2024068270$LV-FreseniusKabi-FK202410796$FRESENIUS KABI$$17$YR$T$F$Y$$$20240711$$MD$LV$LV
240791181$24079118$1$I$20240702$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47976$$FDA-CTU$$76$YR$$M$N$$$20240710$Y$HP$US$
240791191$24079119$1$I$$20240708$20240711$20240711$EXP$$CA-FreseniusKabi-FK202410809$FRESENIUS KABI$$61$YR$A$M$Y$86$KG$20240711$$HP$CA$CA
240791201$24079120$1$I$$20240710$20240711$20240711$EXP$$CN-TAKEDA-2024TUS070575$TAKEDA$$$$$M$Y$$$20240711$$CN$CN$CN
240791221$24079122$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47962$$FDA-CTU$$77$YR$$M$N$$$20240710$N$$US$
240791231$24079123$1$I$$20240705$20240711$20240711$EXP$GB-MHRA-MED-202405091618218170-JRLNH$GB-RDY-SPO/GBR/24/0010018$DR REDDYS$$$$$M$Y$$$20240711$$CN$GB$GB
240791241$24079124$1$I$$20240627$20240711$20240711$EXP$$LB-ROCHE-10000019784$ROCHE$$$$$$Y$$$20240711$$MD$LB$LB
240791261$24079126$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47975$$FDA-CTU$$62$YR$$M$N$$$20240710$N$$US$
240791271$24079127$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47936$$FDA-CTU$$72$YR$$F$N$$$20240710$N$$US$
240791283$24079128$3$F$$20240906$20240711$20240912$30DAY$$CO-PFIZER INC-PV202400084883$PFIZER$$9$YR$$M$Y$$$20240912$$CN$CO$CO
240791291$24079129$1$I$20240629$20240710$20240710$20240710$DIR$709817$$FDA-CTU$$62$YR$$M$N$99$KG$20240710$Y$CN$US$
240791301$24079130$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47984$$FDA-CTU$$85$YR$$F$N$$$20240710$N$$US$
240791311$24079131$1$I$$20240710$20240711$20240711$EXP$$US-GILEAD-2024-0680302$GILEAD$$$$$$Y$$$20240711$$LW$US$US
240791322$24079132$2$F$20240704$20240710$20240711$20240715$EXP$$JP-009507513-2407JPN000768J$MERCK$$98$YR$$F$Y$$$20240715$$PH$JP$JP
240791331$24079133$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47982$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
240791341$24079134$1$I$20240331$20240710$20240710$20240710$DIR$709807$$FDA-CTU$$75$YR$$F$N$90$KG$20240710$N$CN$US$
240791353$24079135$3$F$20240101$20240903$20240711$20240914$PER$$US-SA-2024SA194521$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240914$$MD$US$US
240791363$24079136$3$F$20240624$20240718$20240711$20240718$PER$$US-JNJFOC-20240725131$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$US$US
240791371$24079137$1$I$$20240710$20240711$20240711$PER$$US-JNJFOC-20240724805$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240791381$24079138$1$I$20240702$20240703$20240711$20240711$PER$$US-SA-2024SA198570$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240711$$CN$US$US
240791391$24079139$1$I$20240501$20240628$20240711$20240711$PER$$US-SA-2024SA197233$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240711$$MD$US$US
240791401$24079140$1$I$20240601$20240702$20240711$20240711$PER$$US-SA-2024SA198247$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240711$$MD$US$US
240791411$24079141$1$I$20240101$20240628$20240711$20240711$PER$$US-SA-2024SA197410$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240711$$MD$US$US
240791421$24079142$1$I$20240601$20240702$20240711$20240711$PER$$US-SA-2024SA198061$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240711$$MD$US$US
240791431$24079143$1$I$20240412$20240703$20240711$20240711$PER$$US-SA-2024SA202931$SANOFI AVENTIS$$78$YR$E$M$Y$58.5$KG$20240711$$MD$US$US
240791441$24079144$1$I$$20240628$20240711$20240711$PER$$US-SA-2024SA197300$SANOFI AVENTIS$$$$A$F$Y$81.6$KG$20240711$$MD$US$US
240791452$24079145$2$F$20240101$20240708$20240711$20240716$PER$$US-SA-2024SA197805$SANOFI AVENTIS$$$$C$F$Y$12$KG$20240716$$MD$US$US
240791461$24079146$1$I$20240603$20240702$20240711$20240711$PER$$US-SA-2024SA197818$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240711$$MD$US$US
240791473$24079147$3$F$20240101$20240816$20240711$20240826$EXP$$JP-OTSUKA-2024_019462$OTSUKA$$89$YR$$M$Y$$$20240826$$PH$JP$JP
240791481$24079148$1$I$20210801$20240628$20240711$20240711$PER$$US-SA-2024SA199820$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240711$$MD$US$US
240791491$24079149$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199350$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240711$$MD$US$US
240791501$24079150$1$I$20150101$20240704$20240711$20240711$EXP$GB-MHRA-MED-202405110158043880-BNTCD$GB-OTSUKA-2024_019043$OTSUKA$$35$YR$$F$Y$55$KG$20240711$$CN$GB$GB
240791511$24079151$1$I$$20240628$20240711$20240711$PER$$US-SA-2024SA197302$SANOFI AVENTIS$$$$A$F$Y$86.1$KG$20240711$$MD$US$US
240791521$24079152$1$I$$20240627$20240711$20240711$PER$$US-SA-2024SA194811$SANOFI AVENTIS$$$$A$F$Y$57.15$KG$20240711$$MD$US$US
240791533$24079153$3$F$20240101$20240730$20240711$20240808$PER$$US-SA-2024SA196679$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240808$$MD$US$US
240791541$24079154$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198565$SANOFI AVENTIS$$$$E$M$Y$$$20240711$$MD$US$US
240791551$24079155$1$I$20190201$20240628$20240711$20240711$PER$$US-SA-2024SA153930$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240711$$MD$US$US
240791562$24079156$2$F$20240101$20240910$20240711$20240919$PER$$US-SA-2023SA265808$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240919$$MD$US$US
240791572$24079157$2$F$20240101$20240918$20240711$20240925$PER$$US-SA-2024SA196403$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240925$$MD$US$US
240791581$24079158$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198496$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240711$$MD$US$US
240791591$24079159$1$I$20240601$20240628$20240711$20240711$PER$$US-SA-2024SA197518$SANOFI AVENTIS$$26$YR$A$M$Y$65.7$KG$20240711$$MD$US$US
240791601$24079160$1$I$20240101$20240628$20240711$20240711$PER$$US-SA-2024SA196269$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240711$$MD$US$US
240791611$24079161$1$I$$20240628$20240711$20240711$PER$$US-SA-2024SA196407$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240711$$MD$US$US
240791621$24079162$1$I$20210929$20240703$20240711$20240711$PER$$US-SA-2024SA199400$SANOFI AVENTIS$$83$YR$E$F$Y$60.32$KG$20240711$$MD$US$US
240791631$24079163$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA197307$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240711$$MD$US$US
240791641$24079164$1$I$20240612$20240702$20240711$20240711$PER$$US-SA-2024SA199843$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240711$$CN$US$US
240791652$24079165$2$F$20240620$20240716$20240711$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407006116$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240718$$CN$US$US
240791661$24079166$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006388$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240711$$CN$US$US
240791671$24079167$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006214$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240711$$CN$US$US
240791681$24079168$1$I$20240626$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006566$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240711$$CN$US$US
240791691$24079169$1$I$20240706$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006135$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240711$$CN$US$US
240791701$24079170$1$I$20240707$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005310$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240711$$CN$US$US
240791711$24079171$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006108$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240711$$CN$US$US
240791721$24079172$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005986$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240711$$CN$US$US
240791731$24079173$1$I$20240708$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006070$ELI LILLY AND CO$$46$YR$A$$Y$$$20240711$$CN$US$US
240791741$24079174$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005600$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240711$$CN$US$US
240791751$24079175$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005382$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240711$$CN$US$US
240791761$24079176$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006093$ELI LILLY AND CO$$$$$$Y$$$20240711$$CN$US$US
240791771$24079177$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198598$SANOFI AVENTIS$$$$A$M$Y$$$20240711$$MD$US$US
240791781$24079178$1$I$20240601$20240702$20240711$20240711$PER$$US-SA-2024SA198274$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240711$$MD$US$US
240791791$24079179$1$I$20240708$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006259$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240711$$CN$US$US
240791801$24079180$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005320$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240711$$CN$US$US
240791811$24079181$1$I$20240703$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006104$ELI LILLY AND CO$$$$$M$Y$$$20240711$$CN$US$US
240791821$24079182$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006308$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240711$$CN$US$US
240791831$24079183$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006114$ELI LILLY AND CO$$$$$$Y$$$20240711$$CN$US$US
240791841$24079184$1$I$20240707$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005963$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240711$$CN$US$US
240791851$24079185$1$I$20240708$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006127$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240711$$CN$US$US
240791861$24079186$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006080$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240711$$CN$US$US
240791871$24079187$1$I$20240601$20240702$20240711$20240711$PER$$US-SA-2024SA198466$SANOFI AVENTIS$$63$YR$A$F$Y$63.5$KG$20240711$$MD$US$US
240791881$24079188$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA199184$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240711$$MD$US$US
240791891$24079189$1$I$20240701$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005918$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240711$$CN$US$US
240791901$24079190$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA200543$SANOFI AVENTIS$$$$C$M$Y$$$20240711$$MD$US$US
240791911$24079191$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA199386$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240711$$MD$US$US
240791921$24079192$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA199174$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240711$$MD$US$US
240791931$24079193$1$I$20240601$20240703$20240711$20240711$PER$$US-SA-2024SA201295$SANOFI AVENTIS$$19$YR$A$F$Y$88.4$KG$20240711$$MD$US$US
240791941$24079194$1$I$20240601$20240702$20240711$20240711$PER$$US-SA-2024SA198967$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240711$$MD$US$US
240791961$24079196$1$I$$20240709$20240711$20240711$EXP$$US-GILEAD-2024-0677166$GILEAD$$$$E$M$Y$$$20240711$$CN$US$US
240791972$24079197$2$F$$20240828$20240711$20240904$30DAY$$GR-PFIZER INC-PV202400088509$PFIZER$$11$YR$$F$Y$27$KG$20240904$$CN$GR$GR
240791981$24079198$1$I$$20240710$20240711$20240711$EXP$$IN-PFIZER INC-PV202400090596$PFIZER$$$$E$M$Y$$$20240711$$CN$IN$IN
240791991$24079199$1$I$20240606$20240708$20240711$20240711$EXP$ES-AEMPS-1542729$ES-PFIZER INC-202400208689$PFIZER$$78$YR$$F$Y$$$20240711$$MD$ES$ES
240792001$24079200$1$I$$20240710$20240710$20240710$DIR$709752$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240792021$24079202$1$I$$20240710$20240711$20240711$EXP$$JP-PFIZER INC-202400210408$PFIZER$$$$$$Y$$$20240711$$MD$JP$JP
240792031$24079203$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47945$$FDA-CTU$$$$$F$N$$$20240710$N$HP$US$
240792051$24079205$1$I$20240514$20240708$20240711$20240711$EXP$BE-FAMHP-DHH-N2024-122330$BE-PFIZER INC-202400208464$PFIZER$$67$YR$$F$Y$70$KG$20240711$$PH$BE$BE
240792061$24079206$1$I$$20240708$20240711$20240711$EXP$$US-PFIZER INC-PV202400090201$PFIZER$$27$YR$$F$Y$$$20240711$$MD$US$US
240792081$24079208$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47950$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240792091$24079209$1$I$20181214$20240710$20240710$20240710$DIR$709825$$FDA-CTU$$21$YR$$F$N$65.25$KG$20240710$N$CN$US$
240792111$24079211$1$I$20240620$20240710$20240711$20240711$EXP$$CN-PFIZER INC-PV202400090674$PFIZER$$26$YR$$F$Y$59$KG$20240711$$HP$CN$CN
240792121$24079212$1$I$$20240709$20240711$20240711$EXP$$EG-PFIZER INC-PV202400089850$PFIZER$$22$YR$$M$Y$$$20240711$$PH$EG$EG
240792131$24079213$1$I$20240625$20240708$20240711$20240711$EXP$$CN-PFIZER INC-PV202400089488$PFIZER$$9$YR$$M$Y$40$KG$20240711$$HP$CN$CN
240792141$24079214$1$I$20240702$20240710$20240711$20240711$EXP$ES-AEMPS-1545623$ES-PFIZER INC-202400210281$PFIZER$$78$YR$$M$Y$$$20240711$$MD$ES$ES
240792153$24079215$3$F$20240708$20240917$20240711$20240920$30DAY$$GB-PFIZER INC-PV202400089843$PFIZER$$5$YR$$M$Y$$$20240920$$CN$GB$GB
240792171$24079217$1$I$20240623$20240710$20240710$20240710$DIR$709819$$FDA-CTU$$57$YR$$F$N$90$KG$20240710$N$CN$US$
240792182$24079218$2$F$20240529$20240712$20240711$20240715$EXP$ES-AEMPS-1543650$ES-PFIZER INC-202400208488$PFIZER$$46$YR$$M$Y$$$20240715$$MD$ES$ES
240792191$24079219$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-48006$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240792201$24079220$1$I$20240628$20240710$20240710$20240710$DIR$709812$$FDA-CTU$$65$YR$$F$N$88.3$KG$20240710$Y$HP$US$
240792211$24079221$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198186$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240711$$CN$US$US
240792221$24079222$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198443$SANOFI AVENTIS$$$$A$M$Y$92.9$KG$20240711$$MD$US$US
240792231$24079223$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198031$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$MD$US$US
240792241$24079224$1$I$20240601$20240702$20240711$20240711$PER$$US-SA-2024SA199207$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240711$$MD$US$US
240792251$24079225$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA199352$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240711$$MD$US$US
240792261$24079226$1$I$20240601$20240702$20240711$20240711$PER$$US-SA-2024SA199036$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240711$$MD$US$US
240792272$24079227$2$F$20240101$20240709$20240711$20240716$PER$$US-AMGEN-USASP2024136564$AMGEN$$67$YR$E$F$Y$$$20240715$$HP$US$US
240792281$24079228$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA199228$SANOFI AVENTIS$$$$A$M$Y$113.3$KG$20240711$$MD$US$US
240792291$24079229$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA198278$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240711$$MD$US$US
240792301$24079230$1$I$20240101$20240701$20240711$20240711$PER$$US-SA-2024SA198609$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240711$$MD$US$US
240792311$24079231$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199222$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240711$$MD$US$US
240792321$24079232$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199334$SANOFI AVENTIS$$$$A$F$Y$74.84$KG$20240711$$MD$US$US
240792331$24079233$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198896$SANOFI AVENTIS$$$$A$M$Y$32.47$KG$20240711$$MD$US$US
240792341$24079234$1$I$20240601$20240703$20240711$20240711$PER$$US-SA-2024SA200044$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240711$$MD$US$US
240792351$24079235$1$I$20240601$20240703$20240711$20240711$PER$$US-SA-2024SA199799$SANOFI AVENTIS$$58$YR$A$F$Y$63.95$KG$20240711$$MD$US$US
240792361$24079236$1$I$20240410$20240702$20240711$20240711$PER$$US-SA-2024SA199168$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240711$$MD$US$US
240792371$24079237$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA198991$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240711$$CN$US$US
240792381$24079238$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA201027$SANOFI AVENTIS$$$$A$M$Y$75$KG$20240711$$MD$US$US
240792391$24079239$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA199362$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240711$$MD$US$US
240792401$24079240$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA198922$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240711$$MD$US$US
240792411$24079241$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199098$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240711$$CN$US$US
240792421$24079242$1$I$20240701$20240703$20240711$20240711$PER$$US-SA-2024SA198563$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240711$$CN$US$US
240792431$24079243$1$I$20240702$20240703$20240711$20240711$PER$$US-SA-2024SA198318$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240711$$MD$US$US
240792442$24079244$2$F$$20240819$20240711$20240830$PER$$US-SA-2024SA198977$SANOFI AVENTIS$$10$YR$C$F$Y$32.2$KG$20240830$$MD$US$US
240792451$24079245$1$I$$20230825$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2023US023793$SANDOZ$$77$YR$$F$Y$$$20240711$$HP$US$US
240792461$24079246$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA201002$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240711$$MD$US$US
240792471$24079247$1$I$20240601$20240702$20240711$20240711$PER$$US-SA-2024SA197772$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240711$$MD$US$US
240792481$24079248$1$I$20240601$20240702$20240711$20240711$PER$$US-SA-2024SA198148$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240711$$MD$US$US
240792491$24079249$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199083$SANOFI AVENTIS$$$$A$F$Y$77.1$KG$20240711$$MD$US$US
240792502$24079250$2$F$20240101$20240709$20240711$20240717$PER$$US-SA-2024SA198968$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240717$$MD$US$US
240792511$24079251$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA198475$SANOFI AVENTIS$$$$E$M$Y$$$20240711$$MD$PR$US
240792522$24079252$2$F$20240101$20240820$20240711$20240912$PER$$US-SA-2023SA274444$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240912$$MD$US$US
240792531$24079253$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA197766$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240711$$MD$US$US
240792541$24079254$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA198170$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240711$$MD$US$US
240792552$24079255$2$F$$20240814$20240711$20240828$PER$$US-SA-2024SA198985$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240828$$MD$US$US
240792561$24079256$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA198269$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240711$$MD$US$US
240792571$24079257$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199370$SANOFI AVENTIS$$$$A$F$Y$57.606$KG$20240711$$HP$US$US
240792581$24079258$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA199059$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240711$$MD$US$US
240792591$24079259$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199049$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240711$$MD$US$US
240792601$24079260$1$I$20240601$20240703$20240711$20240711$PER$$US-SA-2024SA201150$SANOFI AVENTIS$$46$YR$A$M$Y$90.71$KG$20240711$$MD$US$US
240792611$24079261$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA199361$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240711$$MD$US$US
240792632$24079263$2$F$$20240705$20240711$20240718$PER$$US-SA-2024SA198827$SANOFI AVENTIS$$20$YR$A$F$Y$68$KG$20240718$$MD$US$US
240792641$24079264$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA198932$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240711$$MD$US$US
240792651$24079265$1$I$20240619$20240703$20240711$20240711$PER$$US-SA-2024SA200566$SANOFI AVENTIS$$74$YR$E$M$Y$62.585$KG$20240711$$MD$US$US
240792662$24079266$2$F$$20240705$20240711$20240717$PER$$US-SA-2024SA198168$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240717$$CN$US$US
240792671$24079267$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA198830$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240711$$MD$US$US
240792682$24079268$2$F$$20240916$20240711$20240923$PER$$US-SA-2024SA198975$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240923$$MD$US$US
240792691$24079269$1$I$20240613$20240703$20240711$20240711$PER$$US-SA-2024SA201365$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240711$$MD$US$US
240792701$24079270$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA202820$SANOFI AVENTIS$$$$E$M$Y$$$20240711$$MD$US$US
240792711$24079271$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA201188$SANOFI AVENTIS$$$$A$M$Y$77$KG$20240711$$MD$US$US
240792721$24079272$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA198495$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240711$$CN$US$US
240792731$24079273$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA199558$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$MD$US$US
240792741$24079274$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199363$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240711$$MD$US$US
240792751$24079275$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA199983$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240711$$CN$US$US
240792761$24079276$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA198661$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240711$$MD$US$US
240792771$24079277$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198568$SANOFI AVENTIS$$$$A$M$Y$95.25$KG$20240711$$MD$US$US
240792781$24079278$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA198701$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240711$$HP$US$US
240792791$24079279$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA198558$SANOFI AVENTIS$$$$E$M$Y$$$20240711$$CN$US$US
240792801$24079280$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198953$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$MD$US$US
240792811$24079281$1$I$20180101$20240702$20240711$20240711$PER$$US-SA-2024SA197329$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240711$$CN$US$US
240792821$24079282$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199119$SANOFI AVENTIS$$$$E$F$Y$68.9$KG$20240711$$MD$US$US
240792831$24079283$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198585$SANOFI AVENTIS$$$$E$M$Y$$$20240711$$MD$US$US
240792841$24079284$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA198317$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240711$$MD$US$US
240792851$24079285$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA198356$SANOFI AVENTIS$$$$E$M$Y$$$20240711$$MD$US$US
240792862$24079286$2$F$$20240709$20240711$20240717$PER$$US-SA-2024SA200647$SANOFI AVENTIS$$1$YR$I$F$Y$12.2$KG$20240717$$MD$US$US
240792871$24079287$1$I$20240701$20240702$20240711$20240711$PER$$US-SA-2024SA198954$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240711$$MD$US$US
240792882$24079288$2$F$20240401$20240718$20240711$20240731$PER$$US-SA-2024SA199185$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240731$$CN$US$US
240792891$24079289$1$I$20240626$20240702$20240711$20240711$PER$$US-SA-2024SA197116$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240711$$MD$US$US
240792902$24079290$2$F$20240101$20240805$20240711$20240813$PER$$US-SA-2024SA198914$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240814$$MD$US$US
240792911$24079291$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA199141$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240711$$MD$US$US
240792931$24079293$1$I$20240702$20240702$20240711$20240711$PER$$US-SA-2024SA199461$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240711$$MD$US$US
240792941$24079294$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA198964$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240711$$MD$US$US
240792952$24079295$2$F$20240101$20240828$20240711$20240910$PER$$US-SA-2024SA199143$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240910$$MD$US$US
240792961$24079296$1$I$20240619$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47978$$FDA-CTU$$102$YR$$F$N$$$20240710$N$$US$
240792971$24079297$1$I$20240612$20240710$20240710$20240710$DIR$709793$$FDA-CTU$$26$YR$$F$N$117.45$KG$20240710$N$HP$US$
240792982$24079298$2$F$20240101$20240807$20240711$20240816$PER$$US-SA-2024SA199791$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240816$$MD$US$US
240792991$24079299$1$I$20240601$20240702$20240711$20240711$PER$$US-SA-2024SA199358$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240711$$MD$US$US
240793001$24079300$1$I$$20240705$20240711$20240711$PER$$US-ALXN-202407USA000382US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240793011$24079301$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47993$$FDA-CTU$$$$$M$N$$$20240709$N$HP$US$
240793031$24079303$1$I$20240710$20240710$20240710$20240710$DIR$709772$$FDA-CTU$$41$YR$$M$N$90$KG$20240710$N$HP$US$
240793041$24079304$1$I$20240501$20240709$20240711$20240711$EXP$$CA-ABBVIE-5834716$ABBVIE$$65$YR$$M$Y$$$20240711$$CN$CA$CA
240793051$24079305$1$I$20240619$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47953$$FDA-CTU$$87$YR$$M$N$$$20240710$Y$PH$US$
240793063$24079306$3$F$$20240905$20240711$20240913$EXP$$US-ALXN-202407USA000437US$ALEXION PHARMACEUTICALS$$$$$M$Y$62.585$KG$20240913$$CN$US$US
240793071$24079307$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA199899$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240711$$MD$US$US
240793082$24079308$2$F$20240101$20240813$20240711$20240826$PER$$US-SA-2024SA198874$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240826$$MD$US$US
240793091$24079309$1$I$$20240710$20240710$20240710$DIR$709756$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240793111$24079311$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA199441$SANOFI AVENTIS$$24$YR$A$$Y$$$20240711$$MD$US$US
240793121$24079312$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA198860$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240711$$MD$US$US
240793131$24079313$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA198613$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240711$$MD$US$US
240793141$24079314$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA197997$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240711$$CN$US$US
240793151$24079315$1$I$20240701$20240702$20240711$20240711$PER$$US-SA-2024SA199160$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240711$$MD$US$US
240793162$24079316$2$F$20240809$20240809$20240711$20240820$PER$$US-SA-2024SA198956$SANOFI AVENTIS$$14$YR$T$F$Y$102$KG$20240820$$MD$US$US
240793171$24079317$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199302$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240711$$MD$US$US
240793181$24079318$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA198955$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240711$$MD$US$US
240793191$24079319$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199177$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240711$$MD$US$US
240793201$24079320$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA197209$SANOFI AVENTIS$$$$$$Y$$$20240711$$MD$US$US
240793211$24079321$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198243$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240711$$CN$US$US
240793221$24079322$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199365$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240711$$MD$US$US
240793231$24079323$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199504$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$MD$US$US
240793241$24079324$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA198572$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240711$$HP$US$US
240793251$24079325$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA199875$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240711$$MD$US$US
240793261$24079326$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198251$SANOFI AVENTIS$$$$A$F$Y$114.29$KG$20240711$$MD$US$US
240793271$24079327$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA197886$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240711$$MD$US$US
240793291$24079329$1$I$$20240704$20240711$20240711$PER$$US-SA-2024SA198749$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240711$$MD$US$US
240793311$24079331$1$I$20240630$20240702$20240711$20240711$PER$$US-SA-2024SA199823$SANOFI AVENTIS$$40$YR$A$F$Y$195.95$KG$20240711$$MD$US$US
240793321$24079332$1$I$$20240704$20240711$20240711$PER$$US-SA-2024SA198619$SANOFI AVENTIS$$$$A$M$Y$$$20240711$$HP$US$US
240793331$24079333$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA201050$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240711$$MD$US$US
240793341$24079334$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA197796$SANOFI AVENTIS$$2$YR$C$M$Y$16.78$KG$20240711$$MD$US$US
240793352$24079335$2$F$$20240730$20240711$20240807$PER$$US-SA-2024SA201486$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240807$$MD$US$US
240793361$24079336$1$I$20240601$20240703$20240711$20240711$PER$$US-SA-2024SA199650$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240711$$MD$US$US
240793371$24079337$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA197501$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240711$$HP$US$US
240793381$24079338$1$I$$20240704$20240711$20240711$PER$$US-SA-2024SA200462$SANOFI AVENTIS$$$$$$Y$$$20240711$$PH$US$US
240793402$24079340$2$F$20181111$20240903$20240711$20240905$EXP$$CO-UCBSA-2024035070$UCB$$79$YR$$M$Y$$$20240905$$CN$CO$CO
240793411$24079341$1$I$20240708$20240708$20240711$20240711$PER$$US-SA-2024SA201977$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240711$$CN$US$US
240793421$24079342$1$I$20240701$20240708$20240711$20240711$PER$$US-SA-2024SA201851$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240711$$CN$US$US
240793431$24079343$1$I$$20240708$20240711$20240711$PER$$US-SA-2024SA201775$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240711$$CN$US$US
240793442$24079344$2$F$20240706$20240722$20240711$20240728$PER$$US-SA-2024SA201936$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240728$$CN$US$US
240793451$24079345$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA202040$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240711$$MD$US$US
240793461$24079346$1$I$20240601$20240705$20240711$20240711$PER$$US-SA-2024SA200518$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240711$$MD$US$US
240793471$24079347$1$I$$20240705$20240711$20240711$PER$$US-SA-2023SA253096$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240711$$CN$US$US
240793481$24079348$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA201428$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240711$$MD$US$US
240793491$24079349$1$I$$20240708$20240711$20240711$PER$$US-SA-2024SA203420$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240711$$CN$US$US
240793501$24079350$1$I$$20240708$20240711$20240711$PER$$US-SA-2024SA201603$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240711$$CN$US$US
240793511$24079351$1$I$20240703$20240705$20240711$20240711$PER$$US-SA-2024SA200992$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240711$$HP$US$US
240793521$24079352$1$I$20240501$20240706$20240711$20240711$PER$$US-SA-2024SA201743$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240711$$CN$US$US
240793531$24079353$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA202571$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240711$$MD$US$US
240793551$24079355$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA200725$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240711$$CN$US$US
240793571$24079357$1$I$$20240710$20240710$20240710$DIR$709782$$FDA-CTU$$$$$UNK$N$$$20240710$$CN$US$
240793581$24079358$1$I$20240201$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47980$$FDA-CTU$$39$YR$$F$N$236$LBS$20240710$Y$$US$
240793591$24079359$1$I$20240701$20240708$20240711$20240711$PER$$US-SA-2024SA202174$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240711$$CN$US$US
240793602$24079360$2$F$20220101$20240731$20240711$20240808$PER$$US-SA-2024SA202120$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240808$$MD$US$US
240793611$24079361$1$I$$20240709$20240711$20240711$PER$$US-SA-2024SA203436$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$CN$US$US
240793621$24079362$1$I$20240624$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47985$$FDA-CTU$$71$YR$$F$N$$$20240710$N$HP$US$
240793631$24079363$1$I$20240709$20240710$20240710$20240710$DIR$709821$$FDA-CTU$$45$YR$$F$N$109.35$KG$20240710$N$CN$US$
240793661$24079366$1$I$20240201$20240708$20240711$20240711$PER$$US-SA-2024SA202241$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240711$$CN$US$US
240793672$24079367$2$F$20240101$20240723$20240711$20240801$PER$$US-SA-2024SA200140$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240801$$MD$US$US
240793681$24079368$1$I$20240701$20240708$20240711$20240711$PER$$US-SA-2024SA201413$SANOFI AVENTIS$$$$A$M$Y$$$20240711$$HP$US$US
240793691$24079369$1$I$20240101$20240706$20240711$20240711$PER$$US-SA-2024SA201694$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240711$$MD$US$US
240793701$24079370$1$I$20240421$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47939$$FDA-CTU$$57$YR$$F$N$$$20240710$N$HP$US$
240793711$24079371$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47959$$FDA-CTU$$38$YR$$M$N$$$20240710$N$$US$
240793721$24079372$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA201702$SANOFI AVENTIS$$$$E$F$Y$$$20240711$$MD$US$US
240793731$24079373$1$I$20240101$20240708$20240711$20240711$PER$$US-SA-2024SA201988$SANOFI AVENTIS$$$$$M$Y$$$20240711$$CN$US$US
240793741$24079374$1$I$20240701$20240705$20240711$20240711$PER$$US-SA-2024SA202568$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240711$$MD$US$US
240793751$24079375$1$I$20240607$20240705$20240711$20240711$PER$$US-SA-2024SA202146$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240711$$MD$US$US
240793761$24079376$1$I$20240601$20240705$20240711$20240711$PER$$US-SA-2024SA201418$SANOFI AVENTIS$$$$C$F$Y$$$20240711$$MD$US$US
240793771$24079377$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA201481$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$CN$US$US
240793781$24079378$1$I$20240101$20240708$20240711$20240711$PER$$US-SA-2024SA201712$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240711$$CN$US$US
240793792$24079379$2$F$20240618$20240705$20240711$20240717$PER$$US-SA-2024SA200904$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240717$$MD$US$US
240793801$24079380$1$I$20240703$20240708$20240711$20240711$PER$$US-SA-2024SA201829$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240711$$CN$US$US
240793811$24079381$1$I$$20240708$20240711$20240711$PER$$US-SA-2024SA202650$SANOFI AVENTIS$$$$$F$Y$$$20240711$$HP$US$US
240793821$24079382$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA200560$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240711$$MD$US$US
240793831$24079383$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA201480$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240711$$CN$US$US
240793841$24079384$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA200514$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240711$$CN$US$US
240793851$24079385$1$I$20240619$20240705$20240711$20240711$PER$$US-SA-2024SA201913$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240711$$MD$US$US
240793862$24079386$2$F$$20240723$20240711$20240801$PER$$US-SA-2024SA200655$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240801$$MD$US$US
240793871$24079387$1$I$20240601$20240705$20240711$20240711$PER$$US-SA-2024SA201680$SANOFI AVENTIS$$55$YR$A$F$Y$56$KG$20240711$$MD$US$US
240793881$24079388$1$I$20240708$20240708$20240711$20240711$PER$$US-SA-2024SA202538$SANOFI AVENTIS$$74$YR$E$F$Y$79.3$KG$20240711$$CN$US$US
240793891$24079389$1$I$$20240708$20240711$20240711$PER$$US-SA-2024SA201926$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$MD$US$US
240793901$24079390$1$I$20230101$20240709$20240711$20240711$PER$$US-SA-2024SA202715$SANOFI AVENTIS$$92$YR$E$F$Y$$$20240711$$CN$US$US
240793911$24079391$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153615$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240793923$24079392$3$F$20240501$20240826$20240711$20240903$EXP$$MX-AstraZeneca-2024A140282$ASTRAZENECA$$691$MON$$F$Y$71$KG$20240903$$CN$MX$
240793942$24079394$2$F$20240701$20240708$20240711$20240711$PER$$US-ROCHE-10000020844$ROCHE$$57$YR$A$F$Y$$$20240711$$MD$US$US
240793951$24079395$1$I$20221201$20240703$20240711$20240711$EXP$$GB-UCBSA-2024002282$UCB$$$$$$Y$$$20240711$$MD$GB$GB
240793962$24079396$2$F$20240709$20240715$20240711$20240720$PER$$US-JNJFOC-20240725764$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240720$$HP$US$US
240793971$24079397$1$I$$20240708$20240711$20240711$EXP$$CA-FreseniusKabi-FK202410930$FRESENIUS KABI$$18$YR$A$F$Y$49$KG$20240711$$HP$CA$CA
240793981$24079398$1$I$20240101$20240710$20240711$20240711$EXP$$AU-ABBVIE-5834725$ABBVIE$$68$YR$$F$Y$$$20240711$$CN$AU$AU
240793991$24079399$1$I$$20240705$20240711$20240711$EXP$GB-MHRA-MED-202407052254347130-HGPBD$GB-LABORATORIOS LICONSA S.A.-2407GB05365$INSUD PHARMA$$23$YR$$F$Y$64$KG$20240711$$CN$GB$GB
240794001$24079400$1$I$20240101$20240529$20240711$20240711$EXP$FI-FIMEA-202401917$FI-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2405FI04300$INSUD PHARMA$$30$YR$$F$Y$$$20240711$$CN$FI$FI
240794011$24079401$1$I$20240613$20240702$20240711$20240711$EXP$$RU-SA-2024SA196957$SANOFI AVENTIS$$52$YR$A$F$Y$80$KG$20240711$$HP$RU$RU
240794021$24079402$1$I$20240101$20240629$20240711$20240711$EXP$$JP-INSMED, INC.-2024-00688-JP$INSMED$$78$YR$$F$Y$$$20240711$$CN$JP$JP
240794032$24079403$2$F$$20240711$20240711$20240724$EXP$$JP-INSMED, INC.-2024-02646-JP$INSMED$$71$YR$$F$Y$$$20240724$$MD$JP$JP
240794042$24079404$2$F$20240101$20240829$20240711$20240919$EXP$$US-SA-2024SA200701$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240919$$CN$US$US
240794051$24079405$1$I$20240522$20240708$20240711$20240711$EXP$AT-BASGAGES-2024-004870$AT-009507513-2407AUT003565$MERCK$$80$YR$$M$Y$90$KG$20240711$$PH$AT$AT
240794061$24079406$1$I$20240325$20240701$20240711$20240711$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-06294$HIKMA$$$$$$Y$$$20240711$$MD$GB$GB
240794071$24079407$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47973$$FDA-CTU$$60$YR$$F$N$$$20240710$N$$US$
240794081$24079408$1$I$$20240710$20240711$20240711$EXP$$US-GILEAD-2024-0680306$GILEAD$$$$$$Y$$$20240711$$LW$US$US
240794091$24079409$1$I$$20240704$20240711$20240711$PER$$US-JNJFOC-20240714062$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$CN$US$US
240794101$24079410$1$I$20240619$20240704$20240711$20240711$EXP$$CN-SA-2024SA200053$SANOFI AVENTIS$$80$YR$E$M$Y$75$KG$20240711$$HP$CN$CN
240794111$24079411$1$I$20240701$20240709$20240711$20240711$PER$$US-ABBVIE-5835185$ABBVIE$$$$A$F$Y$$$20240711$$HP$US$US
240794142$24079414$2$F$$20240810$20240711$20240812$30DAY$$US-PFIZER INC-202400208064$PFIZER$$11$YR$$F$Y$$$20240812$$CN$US$US
240794181$24079418$1$I$$20240703$20240711$20240711$EXP$$ZA-ABBVIE-5835023$ABBVIE$$50$YR$$M$Y$$$20240711$$CN$ZA$ZA
240794192$24079419$2$F$$20240716$20240711$20240718$EXP$$US-SA-2024SA201866$SANOFI AVENTIS$Pham S, Heigle B, Gibbs C, Gebrehiwot WG, Pannu P.. Complications of Infective Endocarditis: A Case Report of Intracerebral Hemorrhage Exacerbated by Enoxaparin.. Cureus.. 2024;16(5):1-5$76$YR$E$F$Y$$$20240718$$MD$US$US
240794201$24079420$1$I$$20240704$20240711$20240711$EXP$$CA-OTSUKA-2023_001539$OTSUKA$$$$$F$Y$$$20240711$$MD$CA$CA
240794211$24079421$1$I$$20240704$20240711$20240711$EXP$GB-MHRA-MED-202405011700175730-BMCHD$GB-TEVA-VS-3217818$TEVA$$6$YR$$F$Y$$$20240711$$CN$GB$GB
240794232$24079423$2$F$$20240810$20240711$20240812$30DAY$$US-PFIZER INC-202400205954$PFIZER$$16$YR$$M$Y$$$20240812$$CN$US$US
240794253$24079425$3$F$$20240813$20240711$20240815$30DAY$$BE-PFIZER INC-202400205910$PFIZER$$53$YR$$F$Y$$$20240815$$PH$BE$BE
240794282$24079428$2$F$20240503$20240713$20240711$20240718$EXP$$CO-GSK-CO2024AMR058900$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$CO$CO
240794291$24079429$1$I$$20240628$20240711$20240711$EXP$$AU-ACI HealthCare Limited-2159044$ACI HEALTHCARE$Source document (Full text)$49$YR$$F$Y$$$20240711$$$AU$AU
240794305$24079430$5$F$20230101$20240911$20240711$20240925$PER$$US-SA-2024SA194593$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240925$$CN$US$US
240794311$24079431$1$I$$20240614$20240711$20240711$PER$$US-BEIGENE-BGN-2024-009251$BEIGENE$$$$$$Y$$$20240711$$CN$US$US
240794321$24079432$1$I$20240101$20240627$20240711$20240711$PER$$US-SA-2024SA196172$SANOFI AVENTIS$$$$A$F$Y$59$KG$20240711$$MD$US$US
240794332$24079433$2$F$20240501$20240916$20240711$20240923$PER$$US-SA-2024SA196475$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240923$$MD$US$US
240794351$24079435$1$I$20230901$20240703$20240711$20240711$PER$$US-SA-2024SA201034$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240711$$MD$US$US
240794361$24079436$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA199216$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240711$$MD$US$US
240794371$24079437$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA201291$SANOFI AVENTIS$$$$A$F$Y$80$KG$20240711$$MD$US$US
240794381$24079438$1$I$20240601$20240703$20240711$20240711$PER$$US-SA-2024SA201107$SANOFI AVENTIS$$47$YR$A$M$Y$92$KG$20240711$$MD$US$US
240794391$24079439$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA199341$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240711$$MD$US$US
240794401$24079440$1$I$20230101$20240708$20240711$20240711$PER$$US-BIOGEN-2023BI01228402$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240794411$24079441$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA200487$SANOFI AVENTIS$$$$A$F$Y$53.5$KG$20240711$$MD$US$US
240794422$24079442$2$F$20240101$20240715$20240711$20240730$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00317$Unknown Manufacturer$$64$YR$$M$Y$73.923$KG$20240730$$CN$US$US
240794432$24079443$2$F$20240101$20240712$20240711$20240722$PER$$US-SA-2024SA198937$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240722$$CN$US$US
240794442$24079444$2$F$20240601$20240820$20240711$20240905$PER$$US-SA-2024SA200876$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240905$$MD$US$US
240794451$24079445$1$I$$20240702$20240711$20240711$PER$$US-JNJFOC-20240721782$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240711$$CN$US$US
240794461$24079446$1$I$20240601$20240628$20240711$20240711$EXP$$US-Nobelpharma America, LLC-NPA-2024-01159$NOBELPHARMA$$21$YR$A$M$Y$$$20240711$$HP$US$US
240794471$24079447$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA202392$SANOFI AVENTIS$$$$A$$Y$$$20240711$$CN$US$US
240794482$24079448$2$F$20240101$20240918$20240711$20240925$PER$$US-SA-2024SA200056$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240926$$MD$US$US
240794491$24079449$1$I$20240101$20240705$20240711$20240711$PER$$US-SA-2024SA201963$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240711$$MD$US$US
240794501$24079450$1$I$20240601$20240702$20240711$20240711$PER$$US-SA-2024SA159014$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240711$$MD$US$US
240794511$24079451$1$I$20240101$20240705$20240711$20240711$PER$$US-SA-2024SA201865$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240711$$MD$US$US
240794522$24079452$2$F$20240708$20240720$20240711$20240729$PER$$US-SA-2024SA202285$SANOFI AVENTIS$$93$YR$E$M$Y$$$20240729$$CN$US$US
240794531$24079453$1$I$$20240710$20240711$20240711$EXP$$US-GILEAD-2024-0680325$GILEAD$$$$$$Y$$$20240711$$LW$US$US
240794541$24079454$1$I$$20240707$20240711$20240711$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-135240$DAIICHI$$$$$M$Y$$$20240711$$CN$US$US
240794552$24079455$2$F$20240101$20240723$20240711$20240801$EXP$$JP-RADIUS HEALTH, INC.-2024JP004401$RADIUS PHARM$$82$YR$$M$Y$$$20240801$$MD$JP$JP
240794561$24079456$1$I$20240614$20240703$20240711$20240711$PER$$US-RDY-SPO/USA/24/0009944$DR REDDYS$$23$YR$A$F$Y$$$20240711$$MD$US$US
240794571$24079457$1$I$$20240704$20240711$20240711$EXP$US-MLMSERVICE-20240628-PI112447-00101-1$US-RDY-SPO/USA/24/0009954$DR REDDYS$Khosla H, Bhatt S, Wang M, Gignac G, Mittal K, Patel J. Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis. Journal of Oncology Pharmacy Practice. 2024;30(5):941-4. DOI: 10.1177/10781552241237752.$64$YR$A$M$Y$$$20240711$$MD$US$US
240794581$24079458$1$I$20230928$20231123$20240711$20240711$EXP$FI-FIMEA-202301632$FI-TEVA-VS-3137720$TEVA$$48$YR$$M$Y$$$20240711$$CN$FI$FI
240794591$24079459$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199806$SANOFI AVENTIS$$$$E$M$Y$73.95$KG$20240711$$MD$US$US
240794605$24079460$5$F$20240101$20240809$20240711$20240912$EXP$$US-RIGEL-20240700015$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240912$$MD$US$US
240794611$24079461$1$I$20240702$20240703$20240711$20240711$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700033$RIGEL PHARMACEUTICALS$$59$YR$$M$Y$$$20240711$$CN$US$US
240794621$24079462$1$I$20240701$20240701$20240711$20240711$EXP$$US-BEH-2024174877$CSL BEHRING$$69$YR$E$F$Y$63.492$KG$20240711$$CN$US$US
240794632$24079463$2$F$20240524$20240815$20240711$20240820$EXP$$US-SA-2024SA202828$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240820$$MD$US$US
240794641$24079464$1$I$$20240708$20240711$20240711$EXP$$CA-INDIVIOR US-INDV-145889-2024$RECKITT BENCKISER$$$$$$Y$$$20240711$$MD$CA$CA
240794652$24079465$2$F$$20240830$20240711$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05885$LUPIN$$$$$$Y$$$20240919$$CN$US$US
240794661$24079466$1$I$$20240709$20240711$20240711$PER$$US-HALEON-2186193$Haleon PLC$$$$$M$Y$$$20240711$$CN$US$US
240794672$24079467$2$F$$20240720$20240711$20240729$EXP$$US-OTSUKA-2024_019218$OTSUKA$$$$$M$Y$101.6$KG$20240729$$CN$US$US
240794681$24079468$1$I$$20240708$20240711$20240711$EXP$$GR-PFIZER INC-2023SGN01642$PFIZER$$63$YR$$F$Y$$$20240711$$MD$GR$GR
240794692$24079469$2$F$20240628$20240806$20240711$20240814$PER$$US-SA-2024SA199096$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240814$$MD$US$US
240794701$24079470$1$I$$20240703$20240711$20240711$PER$$US-SA-2022SA032487$SANOFI AVENTIS$$$$E$F$Y$$$20240711$$MD$US$US
240794711$24079471$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA201523$SANOFI AVENTIS$$18$YR$A$F$Y$54.43$KG$20240711$$HP$US$US
240794721$24079472$1$I$20240601$20240710$20240711$20240711$EXP$GB-MHRA-MED-202407101446515820-RMVTF$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039165$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$71$KG$20240711$$PH$GB$GB
240794731$24079473$1$I$$20240709$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038828$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240711$$CN$US$US
240794741$24079474$1$I$$20240704$20240711$20240711$EXP$$JP-AstraZeneca-2024A156933$ASTRAZENECA$$$$$M$Y$$$20240711$$PH$JP$
240794752$24079475$2$F$$20240703$20240711$20240712$EXP$$US-ABBVIE-5356035$ABBVIE$$$$$M$Y$$$20240712$$MD$US$US
240794761$24079476$1$I$$20240703$20240711$20240711$EXP$$CA-AstraZeneca-2024A154565$ASTRAZENECA$$$$$M$Y$$$20240711$$HP$CA$
240794771$24079477$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153327$ASTRAZENECA$$$$$M$Y$$$20240711$$CN$US$
240794781$24079478$1$I$$20240708$20240711$20240711$PER$$US-AstraZeneca-2024A156135$ASTRAZENECA$$$$$M$Y$$$20240711$$CN$US$
240794791$24079479$1$I$$20240703$20240711$20240711$EXP$$JP-AstraZeneca-2024A154516$ASTRAZENECA$$60$YR$$F$Y$$$20240711$$MD$JP$
240794802$24079480$2$F$20240101$20240718$20240711$20240727$EXP$$JP-TEVA-VS-3217753$TEVA$$7$YR$$F$Y$$$20240727$$PH$JP$JP
240794811$24079481$1$I$$20240705$20240711$20240711$EXP$$CN-JNJFOC-20240718528$JOHNSON AND JOHNSON$$15$YR$T$$Y$$$20240711$$CN$CN$CN
240794821$24079482$1$I$20231001$20240710$20240711$20240711$EXP$DK-DKMA-30729396$DK-JNJFOC-20240726171$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240711$$HP$DK$DK
240794831$24079483$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006136$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240711$$CN$US$US
240794841$24079484$1$I$20240615$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006248$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240711$$CN$US$US
240794854$24079485$4$F$$20240820$20240711$20240828$30DAY$$US-JNJFOC-20240722738$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240828$$CN$US$US
240794861$24079486$1$I$20240708$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006659$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240711$$CN$US$US
240794871$24079487$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006762$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240711$$CN$US$US
240794881$24079488$1$I$$20240515$20240711$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000968$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240711$$CN$US$US
240794891$24079489$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006239$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240711$$CN$US$US
240794901$24079490$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006061$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240711$$CN$US$US
240794911$24079491$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006168$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240711$$CN$US$US
240794921$24079492$1$I$20240701$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006256$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240711$$CN$US$US
240794931$24079493$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006003$ELI LILLY AND CO$$$$$M$Y$$$20240711$$CN$US$US
240794941$24079494$1$I$$20240703$20240711$20240711$PER$$US-MYLANLABS-2024M1063850$MYLAN$$$$$F$Y$$$20240711$$CN$US$US
240794951$24079495$1$I$20240624$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109931$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$61.69$KG$20240711$$HP$US$US
240794961$24079496$1$I$$20240704$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109335$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240711$$CN$US$US
240794971$24079497$1$I$$20240628$20240711$20240711$EXP$$CH-ROCHE-10000021480$ROCHE$$$$A$F$Y$$$20240711$$MD$CH$CH
240794982$24079498$2$F$20240703$20240712$20240711$20240717$PER$$US-ALXN-202407USA000374US$ALEXION PHARMACEUTICALS$$67$YR$$F$Y$$$20240718$$CN$US$US
240794991$24079499$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47948$$FDA-CTU$$56$YR$$F$N$$$20240710$N$$US$
240795001$24079500$1$I$$20240627$20240711$20240711$EXP$$US-PHARMAAND GMBH-2024PHR00400$pharmaAND$$$$$F$Y$$$20240711$$HP$US$US
240795011$24079501$1$I$20240301$20240708$20240711$20240711$EXP$$US-SA-2024SA200871$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240711$$CN$US$US
240795022$24079502$2$F$20240406$20240708$20240711$20240715$EXP$$NVSC2024CA075632$NOVARTIS$$39$YR$$F$Y$$$20240715$$CN$CA$CA
240795031$24079503$1$I$$20240705$20240711$20240711$PER$$US-ROCHE-10000021557$ROCHE$$57$YR$A$F$Y$$$20240711$$CN$US$US
240795041$24079504$1$I$20240517$20240522$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0172$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240795051$24079505$1$I$$20240701$20240711$20240711$EXP$$IL-BAXTER-2024BAX021060$BAXTER$$33$YR$$M$Y$$$20240711$$HP$IL$IL
240795061$24079506$1$I$$20240701$20240711$20240711$EXP$$CA-BAXTER-2024BAX021032$BAXTER$$$$$$Y$$$20240711$$LW$CA$CA
240795072$24079507$2$F$20231029$20240709$20240711$20240718$EXP$$ES-BAXTER-2023BAX037802$BAXTER$$77$YR$$M$Y$62$KG$20240718$$MD$ES$ES
240795082$24079508$2$F$$20240711$20240711$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039224$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240712$$MD$US$US
240795093$24079509$3$F$20240620$20240731$20240711$20240805$EXP$$AR-MYLANLABS-2024M1058221$MYLAN$$23$YR$$F$Y$$$20240805$$MD$AR$AR
240795101$24079510$1$I$20240307$20240705$20240711$20240711$EXP$FR-AFSSAPS-AVMA2024000280$FR-MYLANLABS-2024M1063785$MYLAN$$28$YR$$M$Y$$$20240711$$PH$FR$FR
240795111$24079511$1$I$20190523$20240705$20240711$20240711$EXP$PL-URPL-2-918-2019$PL-MYLANLABS-2024M1063919$MYLAN$$$$$M$Y$$$20240711$$CN$PL$PL
240795121$24079512$1$I$20240614$20240701$20240711$20240711$EXP$CN-NMPACDR-3708281020400202400521$CN-BAXTER-2024BAX021064$BAXTER$$41$YR$$F$Y$53$KG$20240711$$MD$CN$CN
240795131$24079513$1$I$20240626$20240702$20240711$20240711$EXP$$TW-BAXTER-2024BAX021035$BAXTER$$68$YR$$F$Y$55.2$KG$20240711$$MD$TW$TW
240795153$24079515$3$F$20240101$20240821$20240711$20240905$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0188$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240905$$MD$US$US
240795161$24079516$1$I$20210219$20240705$20240711$20240711$EXP$$DE-PFIZER INC-2021SGN02707$PFIZER$$$$$F$Y$$$20240711$$HP$DE$DE
240795173$24079517$3$F$$20240911$20240711$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109042$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240918$$HP$US$US
240795181$24079518$1$I$20240615$20240709$20240711$20240711$EXP$$US-AMGEN-USASP2024136587$AMGEN$$36$YR$A$F$Y$$$20240711$$PH$US$US
240795191$24079519$1$I$20240704$20240706$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107998$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240711$$CN$US$US
240795201$24079520$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110044$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240711$$CN$US$US
240795211$24079521$1$I$20240530$20240708$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109443$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240711$$CN$US$US
240795221$24079522$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109775$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$80$KG$20240711$$PH$US$US
240795231$24079523$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109156$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240711$$HP$US$US
240795241$24079524$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109733$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240711$$CN$US$US
240795251$24079525$1$I$$20240703$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109310$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240711$$CN$US$US
240795261$24079526$1$I$$20240703$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109219$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240711$$CN$US$US
240795271$24079527$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47967$$FDA-CTU$$$$$F$N$$$20240710$N$HP$US$
240795281$24079528$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109433$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240711$$MD$US$US
240795292$24079529$2$F$$20240829$20240711$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109633$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240903$$CN$US$US
240795301$24079530$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109487$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240711$$MD$US$US
240795312$24079531$2$F$$20240903$20240711$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108935$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$79.83$KG$20240904$$CN$US$US
240795322$24079532$2$F$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109528$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240711$$HP$US$US
240795331$24079533$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109740$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240711$$HP$US$US
240795343$24079534$3$F$$20240725$20240711$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109790$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240731$$CN$US$US
240795351$24079535$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109993$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$63.5$KG$20240711$$CN$US$US
240795361$24079536$1$I$20240702$20240705$20240711$20240711$PER$$US-EMD Serono-2024036975$EMD SERONO INC$$73$YR$E$F$Y$$$20240711$$HP$US$US
240795371$24079537$1$I$20240618$20240708$20240711$20240711$EXP$IT-MINISAL02-993484$IT-FreseniusKabi-FK202410793$FRESENIUS KABI$$60$YR$A$F$Y$55$KG$20240711$$MD$IT$IT
240795381$24079538$1$I$20240627$20240703$20240711$20240711$PER$$US-SA-2024SA203051$SANOFI AVENTIS$$45$YR$A$F$Y$99$KG$20240711$$MD$US$US
240795391$24079539$1$I$20240415$20240709$20240711$20240711$EXP$$JP-DSJP-DSJ-2024-134962$DAIICHI$$81$YR$$M$Y$$$20240711$$HP$JP$JP
240795401$24079540$1$I$$20240708$20240711$20240711$EXP$$US-OTSUKA-2024_019301$OTSUKA$$$$$$Y$$$20240711$$MD$US$US
240795412$24079541$2$F$20240701$20240731$20240711$20240809$PER$$US-SA-2024SA202605$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240809$$MD$US$US
240795422$24079542$2$F$20240101$20240730$20240711$20240808$PER$$US-SA-2024SA201532$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240808$$CN$US$US
240795432$24079543$2$F$20201007$20240912$20240711$20240920$EXP$$US-EMD Serono-2024036565$EMD SERONO INC$$58$YR$A$F$Y$87$KG$20240920$$MD$US$US
240795441$24079544$1$I$$20240709$20240711$20240711$PER$$US-BIOVITRUM-2024-US-009733$BIOVITRUM$$50$YR$$F$Y$$$20240711$$HP$US$US
240795452$24079545$2$F$$20240711$20240711$20240723$PER$$US-ROCHE-10000020569$ROCHE$$41$YR$A$F$Y$$$20240723$$CN$US$US
240795461$24079546$1$I$20240529$20240704$20240711$20240711$EXP$$FR-ABBVIE-5834997$ABBVIE$$40$YR$$M$Y$$$20240711$$CN$FR$FR
240795471$24079547$1$I$20240501$20240522$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0189$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240795484$24079548$4$F$20240707$20240923$20240711$20240926$30DAY$$US-PFIZER INC-202400209047$PFIZER$$46$YR$$F$Y$81.19$KG$20240926$$CN$US$US
240795501$24079550$1$I$$20240704$20240711$20240711$EXP$$CA-PFIZER INC-202400206980$PFIZER$$$$$F$Y$$$20240711$$PH$CA$CA
240795511$24079551$1$I$20180101$20240708$20240711$20240711$EXP$$AT-PFIZER INC-2018SGN00481$PFIZER$$$$A$F$Y$$$20240711$$MD$AT$AT
240795531$24079553$1$I$$20240703$20240711$20240711$EXP$$LB-PFIZER INC-2019SGN03150$PFIZER$Haidar N.A, AlChidiac J, Nassr F, Waked N. Unusual Side Effect of Brentuximab Vedotin in a Hodgkin Lymphoma. Clinical Lymphoma, Myeloma + Leukemia. 2019;19 supplement 1:S305-6$22$YR$$M$Y$$$20240711$$HP$LB$LB
240795544$24079554$4$F$20240630$20240906$20240711$20240910$30DAY$$US-PFIZER INC-202400208191$PFIZER$$14$YR$$M$Y$$$20240910$$CN$US$US
240795554$24079555$4$F$20240701$20240906$20240711$20240911$30DAY$$US-PFIZER INC-202400209248$PFIZER$$9$YR$$F$Y$$$20240911$$CN$US$US
240795562$24079556$2$F$$20240705$20240711$20240917$30DAY$$DE-PFIZER INC-202400207665$PFIZER$$41$YR$$F$Y$$$20240917$$CN$DE$DE
240795571$24079557$1$I$$20240709$20240711$20240711$EXP$$CA-PFIZER INC-202400194120$PFIZER$$8$YR$$M$Y$$$20240711$$MD$CA$CA
240795581$24079558$1$I$20221201$20240708$20240711$20240711$EXP$$MT-PFIZER INC-2023SGN05182$PFIZER$$27$YR$$F$Y$$$20240711$$MD$MT$MT
240795591$24079559$1$I$20240707$20240708$20240711$20240711$30DAY$$US-GSK-US2024084483$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240711$$CN$US$US
240795611$24079561$1$I$$20240702$20240711$20240711$PER$$US-ROCHE-10000018787$ROCHE$$6$YR$C$M$Y$$$20240711$$HP$US$US
240795621$24079562$1$I$20240101$20240701$20240711$20240711$PER$$US-INSUD PHARMA-2407US05247$INSUD PHARMA$$$$$$Y$$$20240711$$CN$US$US
240795631$24079563$1$I$20240501$20240522$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0191$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240795643$24079564$3$F$20240626$20240830$20240711$20240912$EXP$$CO-LUNDBECK-DKLU4000956$LUNDBECK$$$$$$Y$$$20240912$$CN$CO$CO
240795651$24079565$1$I$20240708$20240709$20240711$20240711$PER$$US-JNJFOC-20240727336$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240711$$PH$US$US
240795661$24079566$1$I$20240620$20240709$20240711$20240711$PER$$US-JNJFOC-20240727327$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240711$$PH$US$US
240795673$24079567$3$F$$20240814$20240711$20240815$EXP$$CA-TAKEDA-2024TUS069576$TAKEDA$$$$$F$Y$$$20240815$$MD$CA$CA
240795681$24079568$1$I$$20240703$20240711$20240711$PER$$US-ROCHE-10000021159$ROCHE$$51$YR$A$F$Y$$$20240711$$CN$US$US
240795692$24079569$2$F$$20240815$20240711$20240820$PER$$US-ROCHE-10000022324$ROCHE$$59$YR$A$F$Y$$$20240820$$MD$US$US
240795701$24079570$1$I$20240708$20240708$20240711$20240711$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-135037$DAIICHI$$69$YR$$F$Y$$$20240711$$CN$US$US
240795712$24079571$2$F$$20240717$20240711$20240724$EXP$$IL-TAKEDA-2024TUS034227$TAKEDA$$$$$M$Y$$$20240724$$CN$IL$IL
240795722$24079572$2$F$$20240801$20240711$20240809$PER$$US-SA-2024SA201498$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240809$$MD$US$US
240795733$24079573$3$F$20210602$20240904$20240711$20240909$EXP$$CA-TAKEDA-2018TUS005296$TAKEDA$$51$YR$$F$Y$$$20240909$$CN$CA$CA
240795741$24079574$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109678$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240711$$CN$US$US
240795751$24079575$1$I$20240630$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136427$AMGEN$$64$YR$A$F$Y$$$20240711$$CN$US$US
240795764$24079576$4$F$20240708$20240801$20240711$20240807$EXP$$CA-TAKEDA-2024TUS069921$TAKEDA$$69$YR$$F$Y$$$20240807$$CN$CA$CA
240795771$24079577$1$I$$20240503$20240711$20240711$PER$$US-USWM, LLC-UWM202405-000040$US WORLDMEDS$$7$YR$$F$Y$$$20240711$$CN$US$
240795781$24079578$1$I$$20240627$20240711$20240711$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05966$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240795792$24079579$2$F$$20240724$20240711$20240730$PER$$US-ROCHE-10000018333$ROCHE$$$$C$M$Y$$$20240730$$MD$US$US
240795802$24079580$2$F$$20240716$20240711$20240717$PER$$US-ROCHE-10000022288$ROCHE$$$$$$Y$$$20240717$$CN$US$US
240795811$24079581$1$I$20240617$20240703$20240711$20240711$PER$$US-BAYER-2024A096346$BAYER$$22$YR$A$F$Y$$$20240711$$MD$US$US
240795821$24079582$1$I$$20240708$20240711$20240711$PER$$US-ROCHE-10000020946$ROCHE$$$$A$F$Y$$$20240711$$CN$US$US
240795831$24079583$1$I$$20240705$20240711$20240711$PER$$US-ROCHE-10000021134$ROCHE$$54$YR$A$F$Y$$$20240711$$CN$US$US
240795841$24079584$1$I$$20240709$20240711$20240711$EXP$$US-GILEAD-2024-0677533$GILEAD$$$$E$F$Y$$$20240711$$CN$US$US
240795851$24079585$1$I$$20240611$20240711$20240711$PER$$US-009507513-2406USA003613$MERCK$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN.. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatric Blood and Cancer. 2024;71 (7)$$$$F$Y$$$20240711$$HP$US$US
240795861$24079586$1$I$$20240629$20240711$20240711$PER$$US-ROCHE-10000016359$ROCHE$$80$YR$E$F$Y$$$20240711$$CN$US$US
240795871$24079587$1$I$$20240702$20240711$20240711$PER$$US-ROCHE-10000019545$ROCHE$$80$YR$E$F$Y$$$20240711$$CN$US$US
240795881$24079588$1$I$$20240705$20240711$20240711$PER$$US-BAYER-2024A097480$BAYER$$38$YR$A$F$Y$$$20240711$$MD$US$US
240795891$24079589$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000022663$ROCHE$$$$E$F$Y$$$20240711$$CN$US$US
240795901$24079590$1$I$$20210705$20240711$20240711$PER$$IL-PFM-2022-06324$PIERRE FABRE MEDICAMENT$Pam N, Kridin K, Khamaysi Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatologic Therapy. 2021;34(3)$$$I$$Y$$$20240711$$MD$IL$IL
240795911$24079591$1$I$$20210705$20240711$20240711$PER$$IL-PFM-2022-06325$PIERRE FABRE MEDICAMENT$Pam N, Kridin K, Khamaysi Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatologic Therapy. 2021;34(3)$$$I$$Y$$$20240711$$MD$IL$IL
240795921$24079592$1$I$$20210705$20240711$20240711$PER$$IL-PFM-2022-06320$PIERRE FABRE MEDICAMENT$Pam N, Kridin K, Khamaysi Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatologic Therapy. 2021;34(3)$$$I$$Y$$$20240711$$MD$IL$IL
240795931$24079593$1$I$$20210705$20240711$20240711$PER$$IL-PFM-2022-06323$PIERRE FABRE MEDICAMENT$Pam N, Kridin K, Khamaysi Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatologic Therapy. 2021;34(3)$$$I$$Y$$$20240711$$MD$IL$IL
240795941$24079594$1$I$$20210705$20240711$20240711$PER$$IL-PFM-2022-06321$PIERRE FABRE MEDICAMENT$Pam N, Kridin K, Khamaysi Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatologic Therapy. 2021;34(3)$$$I$$Y$$$20240711$$MD$IL$IL
240795951$24079595$1$I$$20210705$20240711$20240711$PER$$IL-PFM-2022-06326$PIERRE FABRE MEDICAMENT$Pam N, Kridin K, Khamaysi Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatologic Therapy. 2021;34(3)$$$I$$Y$$$20240711$$MD$IL$IL
240795961$24079596$1$I$20220317$20240708$20240711$20240711$PER$$US-ORGANON-O2407USA000834$ORGANON$$$$$F$Y$$$20240711$$CN$US$US
240795974$24079597$4$F$20240702$20240912$20240711$20240917$30DAY$$US-PFIZER INC-202400209244$PFIZER$$6$YR$$M$Y$12.7$KG$20240917$$CN$US$US
240795991$24079599$1$I$$20240710$20240711$20240711$EXP$$US-UCBSA-2024035014$UCB$$$$$M$Y$$$20240711$$CN$US$US
240796011$24079601$1$I$$20240701$20240711$20240711$EXP$$DE-ROVI-20240665$ROVIPHARM SAS$$44$YR$A$F$Y$$$20240711$$MD$DE$DE
240796021$24079602$1$I$$20240626$20240711$20240711$PER$$US-COSETTE-CP2024US000147$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240711$$PH$US$US
240796033$24079603$3$F$20240917$20240919$20240711$20240926$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001376$BLUEPRINT MEDICINES$$75$YR$E$F$Y$$$20240926$$CN$US$US
240796041$24079604$1$I$20240618$20240709$20240711$20240711$PER$$US-JNJFOC-20240727304$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240711$$PH$US$US
240796052$24079605$2$F$20240617$20240801$20240711$20240805$PER$$US-JNJFOC-20240727321$JOHNSON AND JOHNSON$$87$YR$E$M$Y$$$20240805$$PH$US$US
240796061$24079606$1$I$$20240705$20240710$20240710$DIR$FDA-CDER-CTU-2024-47951$$FDA-CTU$$$$$M$N$$$20240705$N$HP$US$
240796072$24079607$2$F$$20240710$20240711$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407006157$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240714$$CN$US$US
240796081$24079608$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006175$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240711$$HP$US$US
240796091$24079609$1$I$20240702$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006148$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240711$$HP$US$US
240796101$24079610$1$I$20240604$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47940$$FDA-CTU$$3$YR$$F$N$$$20240710$Y$PH$US$
240796111$24079611$1$I$$20240709$20240710$20240710$DIR$FDA-CDER-CTU-2024-47986$$FDA-CTU$$$$$F$N$$$20240709$N$$US$
240796121$24079612$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006058$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240711$$CN$US$US
240796132$24079613$2$F$20240708$20240802$20240711$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407005410$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240806$$CN$US$US
240796141$24079614$1$I$20240710$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407007125$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240711$$CN$US$US
240796151$24079615$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006133$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240711$$CN$US$US
240796161$24079616$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005976$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240711$$CN$US$US
240796171$24079617$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006200$ELI LILLY AND CO$$$$$M$Y$$$20240711$$PH$US$US
240796181$24079618$1$I$20240708$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006211$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240711$$CN$US$US
240796191$24079619$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005161$ELI LILLY AND CO$$$$$$Y$$$20240711$$CN$US$US
240796201$24079620$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005964$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240711$$CN$US$US
240796211$24079621$1$I$$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-47949$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
240796221$24079622$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005968$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240711$$CN$US$US
240796231$24079623$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006795$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240711$$CN$US$US
240796242$24079624$2$F$$20240709$20240711$20240722$PER$$US-ALXN-202407USA000541US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
240796251$24079625$1$I$20240501$20240708$20240711$20240711$PER$$US-BIOGEN-2024BI01266978$BIOGEN$$31$YR$$M$Y$$$20240711$$CN$US$US
240796263$24079626$3$F$20240101$20240718$20240711$20240726$PER$$US-BIOGEN-2024BI01267082$BIOGEN$$$$$F$Y$$$20240726$$CN$US$US
240796291$24079629$1$I$20221001$20231129$20240711$20240711$EXP$FR-AFSSAPS-LY2023001623$FR-TEVA-VS-3138124$TEVA$$68$YR$$F$Y$$$20240711$$HP$FR$FR
240796301$24079630$1$I$$20240709$20240711$20240711$EXP$$AU-TAKEDA-2024TUS070486$TAKEDA$$$$$M$Y$$$20240711$$CN$AU$AU
240796311$24079631$1$I$$20240710$20240711$20240711$EXP$$NVSC2024GR142720$NOVARTIS$$$$$F$Y$$$20240711$$MD$GR$GR
240796321$24079632$1$I$$20240709$20240711$20240711$PER$$US-TAKEDA-2024TUS069957$TAKEDA$$$$$F$Y$75$KG$20240711$$HP$US$US
240796331$24079633$1$I$$20240701$20240711$20240711$EXP$$US-AMGEN-USASP2024137413$AMGEN$Jameson G.S;. Phase 2 clinical trial of nab-paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer. Cancer Medicine. 2024;13 (12):1-10$$$$$Y$$$20240711$$HP$US$US
240796343$24079634$3$F$20240528$20240731$20240711$20240805$EXP$$NVSC2024IL119024$NOVARTIS$$83$YR$$F$Y$$$20240805$$HP$IL$IL
240796351$24079635$1$I$20240227$20240709$20240711$20240711$EXP$$FR-AstraZeneca-2024A156268$ASTRAZENECA$$89$YR$$M$Y$77$KG$20240711$$MD$FR$
240796361$24079636$1$I$20240611$20240705$20240711$20240711$PER$$US-AMGEN-USASP2024134201$AMGEN$$$$$$Y$$$20240711$$PH$US$US
240796372$24079637$2$F$20240708$20240711$20240711$20240716$PER$$US-AMGEN-USASP2024137417$AMGEN$$63$YR$A$M$Y$$$20240716$$CN$US$US
240796381$24079638$1$I$20240508$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137447$AMGEN$$81$YR$E$M$Y$65.3$KG$20240711$$HP$US$US
240796391$24079639$1$I$20210801$20240703$20240711$20240711$EXP$$DE-AstraZeneca-2024A152835$ASTRAZENECA$$72$YR$$F$Y$$$20240711$$MD$DE$
240796401$24079640$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158279$ASTRAZENECA$$$$$F$Y$$$20240711$$HP$FR$
240796411$24079641$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A154848$ASTRAZENECA$$$$$F$Y$138.2$KG$20240711$$CN$US$
240796421$24079642$1$I$$20240709$20240711$20240711$PER$$US-TAKEDA-2024TUS070280$TAKEDA$$$$$M$Y$106.58$KG$20240711$$HP$US$US
240796432$24079643$2$F$20240518$20240709$20240711$20240724$PER$$US-COSETTE-CP2024US000148$COSETTE PHARMACEUTICALS$$61$YR$A$F$Y$115$KG$20240724$$HP$US$US
240796441$24079644$1$I$$20240624$20240711$20240711$PER$$US-MYLANLABS-2024M1058330$MYLAN$$$$$F$Y$$$20240711$$CN$US$US
240796451$24079645$1$I$20240520$20240709$20240711$20240711$PER$$US-JNJFOC-20240727286$JOHNSON AND JOHNSON$$88$YR$E$M$Y$$$20240711$$PH$US$US
240796461$24079646$1$I$20240704$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136241$AMGEN$$63$YR$A$M$Y$$$20240711$$CN$US$US
240796471$24079647$1$I$$20240702$20240711$20240711$EXP$GB-MHRA-MED-202407020643199960-VMKHF$GB-TORRENT-00036990$TORRENT$$$$$F$Y$95$KG$20240711$$CN$GB$GB
240796481$24079648$1$I$$20240701$20240711$20240711$EXP$GB-MHRA-WEBRADR-202407011543059420-YFVHP$GB-TORRENT-00036989$TORRENT$$15$YR$T$F$Y$$$20240711$$HP$GB$GB
240796491$24079649$1$I$$20240628$20240711$20240711$EXP$$US-TORRENT-00013667$TORRENT$$$$C$$Y$$$20240711$$CN$US$US
240796501$24079650$1$I$20240401$20240701$20240711$20240711$EXP$DE-EMBRYOTOX-202306375$DE-TORRENT-00026964$TORRENT$$1$DY$N$F$Y$3$KG$20240711$$MD$DE$DE
240796511$24079651$1$I$20240615$20240705$20240711$20240711$EXP$PT-INFARMED-R202406-546$PT-MYLANLABS-2024M1063627$MYLAN$$77$YR$$F$Y$$$20240711$$PH$PT$PT
240796521$24079652$1$I$$20240702$20240711$20240711$EXP$$US-MYLANLABS-2024M1063762$MYLAN$Contag CA, Studemeister L, Bogler Y, Cooper JD. Q fever presenting as splenic infarct without endocarditis. IDCases 2024; 37.$44$YR$$M$Y$$$20240711$$HP$US$US
240796531$24079653$1$I$$20240629$20240711$20240711$PER$$US-ROCHE-10000015984$ROCHE$$73$YR$E$F$Y$59$KG$20240711$$CN$US$US
240796541$24079654$1$I$20240201$20240708$20240711$20240711$PER$$US-ABBVIE-5832029$ABBVIE$$89$YR$$F$Y$65$KG$20240711$$CN$US$US
240796551$24079655$1$I$$20240627$20240711$20240711$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05958$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240796561$24079656$1$I$20240702$20240703$20240711$20240711$PER$$US-ROCHE-10000020390$ROCHE$$63$YR$A$F$Y$$$20240711$$CN$US$US
240796591$24079659$1$I$$20240709$20240711$20240711$EXP$$ES-PFIZER INC-2023SGN04999$PFIZER$$$$A$F$Y$51$KG$20240711$$MD$ES$ES
240796603$24079660$3$F$$20240719$20240711$20240725$EXP$$ES-PFIZER INC-202400208089$PFIZER$Lopez-Biga, N.. Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer Discovery. 2024;14(6):953-64$2$DEC$$F$Y$$$20240725$$MD$ES$ES
240796611$24079661$1$I$20211019$20240709$20240711$20240711$EXP$$AT-PFIZER INC-2022SGN03129$PFIZER$$59$YR$$F$Y$86$KG$20240711$$MD$AT$AT
240796621$24079662$1$I$20200501$20240708$20240711$20240711$EXP$$GB-PFIZER INC-2020SGN02076$PFIZER$$45$YR$$F$Y$$$20240711$$MD$GB$GB
240796631$24079663$1$I$$20240703$20240711$20240711$PER$$US-009507513-2407USA002281$MERCK$Pourali S, Dewan AK., Bahrani E.. Simultaneous Morphea and Vitiligo in a Patient on Immune Checkpoint Inhibition. American Journal of Dermatopathology. 2024;46(7):S24$71$YR$$F$Y$$$20240711$$MD$US$US
240796641$24079664$1$I$$20240708$20240711$20240711$EXP$$IE-PFIZER INC-2017SGN02916$PFIZER$$$$$$Y$$$20240711$$PH$IE$IE
240796651$24079665$1$I$20220601$20240704$20240711$20240711$EXP$$CN-PFIZER INC-202400209463$PFIZER$Wang, R.. Talaromyces marneffei: A challenging diagnosis in a kidney transplant patient. Clinical Case Reports. 2024;12(7):10.1002/ccr3.9028$68$YR$$M$Y$$$20240711$$MD$CN$CN
240796662$24079666$2$F$20220101$20240716$20240711$20240726$EXP$$DE-TEVA-VS-3217665$TEVA$Jori B, Vossing C, Pirngruber J, Willing EM, Arndt K, Falk M, et al. The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations. Curr-Oncol 2023; 30 (10): 8805-8814; Jori B, Vossing C, Pirngruber J, Willing EM, Arndt K, Falk M, et al. The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations. Curr-Oncol 2023; 30 (10)...$50$YR$$M$Y$$$20240726$$HP$DE$DE
240796671$24079667$1$I$$20240710$20240711$20240711$PER$$US-ABBVIE-5835245$ABBVIE$$$$$$Y$$$20240711$$CN$US$US
240796681$24079668$1$I$$20240709$20240711$20240711$EXP$$US-UCBSA-2024035159$UCB$$$$$M$Y$$$20240711$$HP$US$US
240796692$24079669$2$F$$20240711$20240711$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109339$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240712$$HP$US$US
240796701$24079670$1$I$20240427$20240710$20240711$20240711$EXP$$NVSC2024US142910$NOVARTIS$$54$YR$$F$Y$$$20240711$$CN$US$US
240796711$24079671$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA201553$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$MD$US$US
240796721$24079672$1$I$20240702$20240702$20240711$20240711$PER$$US-SA-2024SA196852$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240711$$MD$US$US
240796742$24079674$2$F$$20240702$20240711$20240807$EXP$$ES-Ipsen Biopharmaceuticals, Inc.-2024-13318$IPSEN$Guerrero-P?rez, Fernando, Peir?, Inmaculada, Vercher-Conejero, Jos? L., et al. ^Carcinoid crisis: The challenge is still there^, Endocrinologia, Diabetes y Nutricion, 01-Jan-2024, Vol. 71, Iss. 6, Pp. 263-270. doi: 10.1016/j.endinu.2024.03.003$65$YR$E$F$Y$$$20240807$$MD$ES$ES
240796751$24079675$1$I$$20240627$20240711$20240711$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2024-06423$LUPIN$$$$$$Y$$$20240711$$MD$DE$DE
240796761$24079676$1$I$$20240705$20240711$20240711$PER$$US-ROCHE-10000021873$ROCHE$$$$E$M$Y$$$20240711$$CN$US$US
240796771$24079677$1$I$20240604$20240701$20240711$20240711$EXP$$CN-009507513-2407CHN002101$MERCK$$81$YR$$M$Y$60.1$KG$20240711$$HP$CN$CN
240796781$24079678$1$I$20240601$20240626$20240711$20240711$PER$$US-EPICPHARMA-US-2024EPCSPO00810$EPIC PHARM$$62$YR$A$F$Y$210$KG$20240711$$CN$US$US
240796791$24079679$1$I$$20240307$20240711$20240711$PER$$US-ROCHE-3523432$ROCHE$$62$YR$A$F$Y$$$20240628$$MD$US$US
240796801$24079680$1$I$$20240604$20240711$20240711$PER$$DE-ROCHE-3578006$ROCHE$$8$YR$C$F$Y$$$20240701$$CN$DE$DE
240796821$24079682$1$I$$20240625$20240711$20240711$PER$$US-ROCHE-10000015780$ROCHE$$$$E$F$Y$$$20240705$$CN$US$US
240796831$24079683$1$I$$20240613$20240711$20240711$PER$$US-ROCHE-10000001367$ROCHE$Mark J, Gandhi R, Zaidan M, Murthy V. Rituximab for rapidly progressive MDA5 dermatomyositis-associated interstitial lung disease. American Journal of Respiratory and Critical Care Medicine. 2024-May;209:A1986.$41$YR$A$F$Y$$$20240618$$HP$US$US
240796842$24079684$2$F$$20240710$20240711$20240712$PER$$US-JNJFOC-20240724384$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$CN$US$US
240796851$24079685$1$I$$20240709$20240711$20240711$PER$$US-JNJFOC-20240723906$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$HP$US$US
240796862$24079686$2$F$$20240711$20240711$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110345$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240715$$MD$US$US
240796891$24079689$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199877$SANOFI AVENTIS$$$$A$F$Y$113$KG$20240711$$MD$US$US
240796901$24079690$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA201904$SANOFI AVENTIS$$$$C$F$Y$22.4$KG$20240711$$MD$US$US
240796911$24079691$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198200$SANOFI AVENTIS$$$$$F$Y$$$20240711$$MD$US$US
240796921$24079692$1$I$20220101$20240702$20240711$20240711$PER$$US-SA-2024SA200326$SANOFI AVENTIS$$$$A$$Y$$$20240711$$HP$US$US
240796931$24079693$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA198421$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240711$$MD$US$US
240796941$24079694$1$I$20240629$20240703$20240711$20240711$PER$$US-SA-2024SA198970$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240711$$MD$US$US
240796951$24079695$1$I$$20240620$20240711$20240711$PER$$US-AMGEN-USASP2024122791$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240796961$24079696$1$I$$20240705$20240711$20240711$EXP$$GB-AMGEN-GBRSL2024129295$AMGEN$$$$E$F$Y$$$20240711$$HP$GB$GB
240796971$24079697$1$I$$20240626$20240711$20240711$PER$$US-GLANDPHARMA-US-2024GLNSPO00450$GLAND PHARMA$$$$$F$Y$$$20240711$$CN$US$US
240796981$24079698$1$I$$20240708$20240711$20240711$PER$$US-JNJFOC-20240722193$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240711$$CN$US$US
240796991$24079699$1$I$20240709$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006267$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240711$$CN$US$US
240797001$24079700$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006264$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240711$$CN$US$US
240797013$24079701$3$F$20220818$20240702$20240711$20240920$PER$$US-JNJFOC-20240708587$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240920$$CN$US$US
240797021$24079702$1$I$$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407007066$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240711$$CN$US$US
240797031$24079703$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005978$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240711$$CN$US$US
240797041$24079704$1$I$20240401$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005973$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240711$$CN$US$US
240797051$24079705$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005787$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240711$$CN$US$US
240797061$24079706$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006611$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240711$$CN$US$US
240797071$24079707$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006833$ELI LILLY AND CO$$$$$$Y$$$20240711$$CN$US$US
240797081$24079708$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005783$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240711$$CN$US$US
240797091$24079709$1$I$20240708$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005502$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240711$$CN$US$US
240797101$24079710$1$I$$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006841$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240711$$CN$US$US
240797111$24079711$1$I$$20240705$20240711$20240711$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202407004560$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240711$$CN$TW$TW
240797121$24079712$1$I$$20240708$20240711$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202407005045$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240711$$CN$US$US
240797131$24079713$1$I$20240709$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407007006$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240711$$CN$US$US
240797141$24079714$1$I$20240626$20240702$20240711$20240711$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407004592$ELI LILLY AND CO$$46$YR$A$F$Y$68$KG$20240711$$CN$DE$CN
240797151$24079715$1$I$20240708$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006531$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240711$$CN$US$US
240797161$24079716$1$I$$20240616$20240711$20240711$EXP$$GR-ROCHE-10000001211$ROCHE$Dimou M, Bitsanis A, Chatzidimitriou C. The Combination Of Venetoclax-Obinutuzumab As 1st Line Treatment In Patients With Chronic Lymphocytic Leukemia - Daily Clinical Practice Data - A Site^s Experience. Haema (33rd Panhellenic Hematology Congress - Abstracts). 2022;13 (1):390-2.$$$$$Y$$$20240711$$MD$GR$GR
240797171$24079717$1$I$20240528$20240614$20240711$20240711$PER$$US-Vifor (International) Inc.-VIT-2024-05478$VIFOR$$66$YR$$M$Y$96$KG$20240711$$HP$US$US
240797182$24079718$2$F$20240601$20240724$20240711$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110121$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$90.91$KG$20240801$$CN$US$US
240797191$24079719$1$I$20240708$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109234$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240711$$HP$US$US
240797212$24079721$2$F$20240101$20240724$20240711$20240729$PER$$US-AMGEN-USASP2024137046$AMGEN$$79$YR$E$F$Y$$$20240729$$CN$US$US
240797222$24079722$2$F$$20240726$20240711$20240730$PER$$US-AMGEN-USASP2024137263$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
240797231$24079723$1$I$$20240710$20240711$20240711$EXP$$NVSC2024US143193$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240797241$24079724$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198961$SANOFI AVENTIS$$$$A$M$Y$127$KG$20240711$$HP$US$US
240797251$24079725$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198899$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240711$$MD$US$US
240797261$24079726$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA198998$SANOFI AVENTIS$$74$YR$E$M$Y$108$KG$20240711$$MD$US$US
240797271$24079727$1$I$$20240705$20240711$20240711$EXP$$CA-PUMA BIOTECHNOLOGY, LTD.-2024-PUM-CA000958$PUMA$$$$$$Y$$$20240711$$HP$CA$CA
240797281$24079728$1$I$$20240709$20240711$20240711$EXP$$US-GILEAD-2024-0680301$GILEAD$$$$A$M$Y$$$20240711$$CN$US$US
240797291$24079729$1$I$$20240709$20240711$20240711$EXP$$ES-PFIZER INC-2022SGN09691$PFIZER$$$$$F$Y$$$20240711$$MD$ES$ES
240797301$24079730$1$I$$20240704$20240711$20240711$EXP$$BE-PFIZER INC-PV202400089784$PFIZER$A. David-Cojocariu. Interet de l^ergospirometrie en cardio-oncologie. TIJDSCHRIJFT VOOR CARDIOLOGIE. 2024;(4):37-41$59$YR$$F$Y$$$20240711$$MD$BE$BE
240797311$24079731$1$I$$20240709$20240711$20240711$EXP$$ES-PFIZER INC-2022SGN10475$PFIZER$$$$$F$Y$$$20240711$$MD$ES$ES
240797321$24079732$1$I$20211001$20240709$20240711$20240711$EXP$$ES-PFIZER INC-2021SGN05858$PFIZER$$$$$F$Y$$$20240711$$MD$ES$ES
240797331$24079733$1$I$20210901$20240709$20240711$20240711$EXP$$PT-PFIZER INC-2022SGN04273$PFIZER$$59$YR$$F$Y$85$KG$20240711$$HP$PT$PT
240797341$24079734$1$I$20220301$20240708$20240711$20240711$EXP$$GB-PFIZER INC-2023SGN13486$PFIZER$$66$YR$$M$Y$$$20240711$$MD$GB$GB
240797351$24079735$1$I$20240706$20240710$20240711$20240711$EXP$$AR-PFIZER INC-202400211105$PFIZER$$47$YR$$M$Y$$$20240711$$CN$AR$AR
240797361$24079736$1$I$$20240709$20240711$20240711$EXP$$ES-PFIZER INC-2021SGN05491$PFIZER$$$$$F$Y$$$20240711$$MD$ES$ES
240797381$24079738$1$I$$20240709$20240711$20240711$EXP$$ES-PFIZER INC-2022SGN09096$PFIZER$$$$$F$Y$$$20240711$$MD$ES$ES
240797392$24079739$2$F$20210501$20240812$20240711$20240822$EXP$$RU-TEVA-VS-3217666$TEVA$Moiseev AA, Guriyanova AA, Suntsova MV, Buzdin AA, Sorokin MI. A case of whole-exome and transcriptome sequencing of tumor for personalized experimental treatment for metastatic mesothelioma. [Russian]. Onkol-Zhur-Imen-Gerc 2022; 11 (2): 62-67.; Moiseev AA, Guriyanova AA, Suntsova MV, Buzdin AA, Sorokin MI. A case of whole-exome and transcriptome sequencing of tumor for personalized experimental treatment for metastatic mesothelioma. [Russian]. Onkol-Zhur-Imen-Gerc 2022; 11 (2): 62-67.; Moise...$$$$M$Y$$$20240822$$HP$RU$RU
240797402$24079740$2$F$20240701$20240806$20240711$20240807$PER$$US-JNJFOC-20240726790$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240807$$HP$US$US
240797411$24079741$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A155516$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240797421$24079742$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158644$ASTRAZENECA$$67$YR$$M$Y$58$KG$20240711$$HP$FR$
240797431$24079743$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158322$ASTRAZENECA$$63$YR$$M$Y$$$20240711$$HP$FR$
240797441$24079744$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158454$ASTRAZENECA$$77$YR$$M$Y$100$KG$20240711$$HP$FR$
240797451$24079745$1$I$20240626$20240704$20240711$20240711$EXP$$US-MYLANLABS-2024M1064325$MYLAN$$74$YR$$F$Y$81.65$KG$20240711$$CN$US$US
240797461$24079746$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158477$ASTRAZENECA$$84$YR$$M$Y$72$KG$20240711$$HP$FR$
240797471$24079747$1$I$$20240709$20240711$20240711$PER$$AU-Eisai-EC-2024-169883$EISAI$$$$$M$Y$$$20240711$$MD$AU$AU
240797491$24079749$1$I$20210101$20240704$20240711$20240711$EXP$IT-EMA-DD-20240112-7482689-064006$IT-RDY-SPO/ITA/24/0001190$DR REDDYS$Zoli S, Pellegrini C, Casadei B, Broccoli A, Argnani L, Nanni L, Stefoni V, Zinzani PL. Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-cell Lymphoma, Leg-type: A Case Report. Chemotherapy. 2023 Nov 1. doi: 10.1159/000534784. Epub ahead of print. PMID: 37913761.$84$YR$E$F$Y$$$20240711$$MD$IT$IT
240797501$24079750$1$I$20150101$20240708$20240711$20240711$EXP$$US-ORGANON-O2407USA000814$ORGANON$$76$YR$$F$Y$$$20240711$$CN$US$US
240797511$24079751$1$I$$20240702$20240711$20240711$PER$$US-TEVA-VS-3217085$TEVA$$$$$$Y$$$20240711$$CN$US$US
240797521$24079752$1$I$$20240705$20240711$20240711$EXP$$US-ALXN-202407USA000544US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240797531$24079753$1$I$$20240709$20240711$20240711$EXP$$AU-MYLANLABS-2024M1064498$MYLAN$$$$$M$Y$$$20240711$$HP$AU$AU
240797542$24079754$2$F$$20240715$20240711$20240717$EXP$$GB-MYLANLABS-2024M1064517$MYLAN$$$$$M$Y$$$20240717$$PH$GB$GB
240797551$24079755$1$I$$20240701$20240711$20240711$30DAY$$US-GSK-US2024AMR082248$GLAXOSMITHKLINE$$$$$M$Y$$$20240711$$CN$US$US
240797571$24079757$1$I$$20240705$20240711$20240711$PER$$US-APELLIS-2024-APL-0000422$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$US$US
240797581$24079758$1$I$20240702$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108522$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240711$$HP$US$US
240797591$24079759$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110188$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$68.04$KG$20240711$$CN$US$US
240797601$24079760$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110186$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240711$$CN$US$US
240797612$24079761$2$F$20200801$20240710$20240711$20240718$EXP$$NVSC2024PL141789$NOVARTIS$$49$YR$$F$Y$$$20240718$$MD$PL$PL
240797622$24079762$2$F$$20240710$20240711$20240715$PER$$NVSC2024US142659$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240797631$24079763$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48087$$FDA-CTU$$63$YR$$F$N$89.81$KG$20240711$N$$US$
240797641$24079764$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48145$$FDA-CTU$$60$YR$$F$N$$$20240711$N$$US$
240797651$24079765$1$I$20240710$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48158$$FDA-CTU$$45$YR$$F$N$$$20240711$Y$PH$US$
240797661$24079766$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48122$$FDA-CTU$$54$YR$$M$N$$$20240711$N$$US$
240797671$24079767$1$I$20240609$20240701$20240711$20240711$DIR$FDA-CDER-CTU-2024-47994$$FDA-CTU$$$$$M$N$86$KG$20240701$N$$US$
240797681$24079768$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199301$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240711$$MD$US$US
240797691$24079769$1$I$20240401$20240614$20240711$20240711$PER$$US-ROCHE-10000023786$ROCHE$$32$YR$A$M$Y$76$KG$20240711$$HP$US$US
240797702$24079770$2$F$$20240711$20240711$20240716$PER$$US-AMGEN-USASP2024136845$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240797711$24079771$1$I$20240516$20240614$20240711$20240711$PER$$US-ROCHE-10000021722$ROCHE$$32$YR$A$M$Y$139$KG$20240711$$HP$US$US
240797721$24079772$1$I$$20240709$20240711$20240711$EXP$$GR-PFIZER INC-2023SGN04872$PFIZER$$37$YR$$F$Y$$$20240711$$MD$GR$GR
240797731$24079773$1$I$20230901$20240709$20240711$20240711$EXP$$AT-PFIZER INC-2023SGN10715$PFIZER$$61$YR$$F$Y$$$20240711$$MD$AT$AT
240797741$24079774$1$I$20220927$20240709$20240711$20240711$EXP$$ES-PFIZER INC-2022SGN10027$PFIZER$$$$$F$Y$$$20240711$$MD$ES$ES
240797752$24079775$2$F$$20240711$20240711$20240715$EXP$$PR-PFIZER INC-2024SGN05478$PFIZER$$59$YR$$F$Y$$$20240715$$PH$PR$PR
240797761$24079776$1$I$$20240709$20240711$20240711$EXP$$ES-PFIZER INC-2021SGN05857$PFIZER$$$$$F$Y$$$20240711$$MD$ES$ES
240797782$24079778$2$F$20240525$20240704$20240711$20240724$EXP$$DE-ROCHE-10000018842$ROCHE$$24$YR$A$F$Y$$$20240724$$MD$DE$DE
240797791$24079779$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199178$SANOFI AVENTIS$$66$YR$E$F$Y$122$KG$20240711$$MD$US$US
240797801$24079780$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199686$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240711$$MD$US$US
240797811$24079781$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA198938$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240711$$MD$US$US
240797821$24079782$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA201687$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240711$$MD$US$US
240797831$24079783$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199867$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240711$$MD$US$US
240797842$24079784$2$F$$20240628$20240711$20240715$PER$$US-ROCHE-10000021542$ROCHE$$$$E$M$Y$$$20240715$$MD$US$US
240797854$24079785$4$F$$20240903$20240711$20240909$PER$$US-ROCHE-3517284$ROCHE$$$$A$F$Y$$$20240909$$CN$US$US
240797861$24079786$1$I$20230101$20240705$20240711$20240711$PER$$US-ORGANON-O2407USA000808$ORGANON$$$$$F$Y$$$20240711$$CN$US$US
240797872$24079787$2$F$20240609$20240801$20240711$20240814$EXP$$US-BEH-2024175159$CSL BEHRING$$53$YR$A$F$Y$$$20240814$$HP$US$US
240797881$24079788$1$I$$20240515$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0148$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$HP$US$US
240797901$24079790$1$I$$20240708$20240711$20240711$PER$$US-ROCHE-10000022782$ROCHE$$$$A$F$Y$$$20240711$$CN$US$US
240797913$24079791$3$F$$20240715$20240711$20240722$EXP$$NVSC2024RU141536$NOVARTIS$Balaeva NI, Koroleva OM, Mikhaltsova ED, Vasilyeva VA, Kuzmina LA, Kuzmina EA et al.. ??????????? ?????? ?????????? ????-???? ? ???????? ?  ???, ?????????????? ? ??? [Clinical Case Of Allo-Hsct Performed In A Patient With CML Transformed Into MDS]. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY (GEMATOLOGIYA I TRANSFUSIOLOGIY. 2024;69 (2):169$$$$F$Y$$$20240722$$HP$RU$RU
240797921$24079792$1$I$$20240705$20240711$20240711$PER$$US-ROCHE-3540306$ROCHE$$$$E$F$Y$$$20240711$$CN$US$US
240797942$24079794$2$F$$20240820$20240711$20240827$PER$$CA-OTSUKA-2024_010267$OTSUKA$$$$$F$Y$$$20240827$$HP$CA$CA
240797951$24079795$1$I$$20240709$20240711$20240711$PER$$US-ABBVIE-5835102$ABBVIE$$$$$$Y$$$20240711$$CN$US$US
240797961$24079796$1$I$20240514$20240515$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0153$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240797971$24079797$1$I$20240518$20240617$20240711$20240711$PER$$US-BEH-2024174465$CSL BEHRING$$58$YR$A$F$Y$$$20240711$$MD$US$US
240797981$24079798$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48089$$FDA-CTU$$54$YR$$F$N$77.11$KG$20240711$N$$US$
240797991$24079799$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48141$$FDA-CTU$$22$YR$$F$N$$$20240711$N$$US$
240798001$24079800$1$I$$20240410$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202404007085$ELI LILLY AND CO$$$$$M$Y$$$20240711$$CN$US$US
240798011$24079801$1$I$$20240708$20240711$20240711$PER$$US-BIOGEN-2021BI01056145$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240798021$24079802$1$I$20240627$20240705$20240711$20240711$PER$$US-BIOGEN-2024BI01272643$BIOGEN$$57$YR$$F$Y$$$20240711$$CN$US$US
240798031$24079803$1$I$20240101$20240708$20240711$20240711$PER$$US-BIOGEN-2024BI01259511$BIOGEN$$$$$M$Y$$$20240711$$CN$US$US
240798042$24079804$2$F$20240707$20240710$20240711$20240717$PER$$US-BIOGEN-2024BI01272925$BIOGEN$$36$YR$$M$Y$$$20240717$$CN$US$US
240798051$24079805$1$I$$20240709$20240711$20240711$EXP$$US-JNJFOC-20240722996$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240798061$24079806$1$I$20240501$20240708$20240711$20240711$PER$$US-Millicent Holdings Ltd.-MILL20241018$MILLICENT HOLDINGS$$71$YR$E$$Y$$$20240711$$CN$US$US
240798071$24079807$1$I$$20240516$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0154$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$PH$US$US
240798081$24079808$1$I$$20240612$20240711$20240711$PER$$US-LEX-000340$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240798091$24079809$1$I$20230101$20240703$20240711$20240711$EXP$$TH-AstraZeneca-2023A054410$ASTRAZENECA$$78$YR$$F$Y$$$20240711$$CN$TH$
240798101$24079810$1$I$$20240703$20240711$20240711$EXP$$JP-AstraZeneca-2024A154393$ASTRAZENECA$$69$YR$$M$Y$$$20240711$$MD$JP$
240798111$24079811$1$I$20231220$20240703$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110187$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$86.18$KG$20240711$$CN$US$US
240798122$24079812$2$F$$20240731$20240711$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109270$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240802$$CN$US$US
240798131$24079813$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110098$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$85.28$KG$20240711$$CN$US$US
240798141$24079814$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109666$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240711$$CN$US$US
240798151$24079815$1$I$20240411$20240702$20240711$20240711$EXP$$US-AstraZeneca-2024A107704$ASTRAZENECA$$3347$WK$$M$Y$$$20240711$$MD$US$
240798161$24079816$1$I$20230905$20240702$20240711$20240711$EXP$$TW-AstraZeneca-2024A156064$ASTRAZENECA$$$$A$F$Y$71.2$KG$20240711$$HP$TW$
240798171$24079817$1$I$20201001$20240709$20240711$20240711$EXP$$NVSC2024US142894$NOVARTIS$$$$$F$Y$$$20240711$$CN$US$US
240798181$24079818$1$I$$20240703$20240711$20240711$EXP$$ZA-AstraZeneca-2024A154225$ASTRAZENECA$$81$YR$$F$Y$$$20240711$$CN$ZA$
240798191$24079819$1$I$20231214$20240703$20240711$20240711$EXP$$ES-AstraZeneca-2024A158042$ASTRAZENECA$$54$YR$$F$Y$$$20240711$$MD$ES$
240798201$24079820$1$I$$20240703$20240711$20240711$EXP$$ZA-AstraZeneca-2024A154278$ASTRAZENECA$$66$YR$$M$Y$$$20240711$$CN$ZA$
240798213$24079821$3$F$20240102$20240725$20240711$20240805$EXP$$US-ZENPEP LLC-2024AIMT01054$AIMMUNE$$$$$$Y$$$20240803$$HP$US$US
240798231$24079823$1$I$20240621$20240621$20240711$20240711$PER$$US-AMGEN-USASP2024123266$AMGEN$$57$YR$A$F$Y$$$20240711$$CN$US$US
240798241$24079824$1$I$$20240627$20240711$20240711$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06003$LUPIN$Habib A, Butt K, Ibrahim R, Shaaban A, Lee HS. BRASH syndrome: A rare but reversible cause of sinus node dysfunction. Heart Rhythm Case Reports. 2024;10:398-401$57$YR$$F$Y$$$20240711$$MD$US$US
240798264$24079826$4$F$$20240903$20240711$20240906$EXP$$US-BIOGEN-2024BI01272658$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
240798271$24079827$1$I$20240612$20240705$20240711$20240711$EXP$$GB-MYLANLABS-2024M1064225$MYLAN$$$$$F$Y$$$20240711$$CN$GB$GB
240798292$24079829$2$F$20240101$20240904$20240711$20240914$PER$$US-SA-2024SA197536$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240914$$MD$US$US
240798301$24079830$1$I$$20240708$20240711$20240711$EXP$$JP-OTSUKA-2024_017942$OTSUKA$$9$DEC$$F$Y$$$20240711$$PH$JP$JP
240798311$24079831$1$I$$20240627$20240711$20240711$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06002$LUPIN$Woodard VV, Ragland MF. A rare case of necrotizing pneumonia in an immunocompromised patient. American Journal of Respiratory and Critical Care Medicine. 2024;209$67$YR$$M$Y$$$20240711$$HP$US$US
240798321$24079832$1$I$$20240705$20240711$20240711$EXP$$US-PFIZER INC-202400196112$PFIZER$Schaeffer, A.. Refractory Covid-19-induced ITP Complicated by Secondary Hemophagocytic Lymphohistiocytosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3527$71$YR$$F$Y$$$20240711$$HP$US$US
240798332$24079833$2$F$20240611$20240720$20240711$20240723$EXP$$BR-PFIZER INC-202400208801$PFIZER$$67$YR$$M$Y$66$KG$20240723$$PH$BR$BR
240798341$24079834$1$I$$20240710$20240711$20240711$EXP$$GR-PFIZER INC-2023SGN11857$PFIZER$$$$$F$Y$$$20240711$$MD$GR$GR
240798351$24079835$1$I$20151101$20240707$20240711$20240711$EXP$$IL-PFIZER INC-202400209527$PFIZER$$65$YR$$M$Y$$$20240711$$MD$IL$IL
240798361$24079836$1$I$20240705$20240708$20240711$20240711$EXP$$GB-MYLANLABS-2024M1064497$MYLAN$$$$$M$Y$$$20240711$$CN$GB$GB
240798371$24079837$1$I$20220421$20240709$20240711$20240711$EXP$$US-UCBSA-2024020535$UCB$$28$YR$$F$Y$$$20240711$$HP$US$US
240798381$24079838$1$I$20240501$20240529$20240711$20240711$PER$$US-USWM, LLC-UWM202405-000052$US WORLDMEDS$$7$YR$$M$Y$$$20240711$$CN$US$
240798391$24079839$1$I$$20240701$20240711$20240711$30DAY$$US-GSK-US2024083036$GLAXOSMITHKLINE$$$$$F$Y$$$20240711$$CN$US$US
240798401$24079840$1$I$20240624$20240704$20240711$20240711$EXP$$IT-GSK-IT2024EME083748$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$IT$IT
240798412$24079841$2$F$20230601$20240718$20240711$20240723$PER$$US-ABBVIE-5834687$ABBVIE$$69$YR$$F$Y$$$20240723$$CN$US$US
240798421$24079842$1$I$20240701$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48168$$FDA-CTU$$45$YR$$M$N$$$20240711$N$HP$US$
240798431$24079843$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110061$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240711$$HP$US$US
240798441$24079844$1$I$20240628$20240708$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109899$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240711$$HP$US$US
240798451$24079845$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108548$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240711$$CN$US$US
240798461$24079846$1$I$20240709$20240710$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109761$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240711$$CN$US$US
240798471$24079847$1$I$20240710$20240711$20240711$20240711$DIR$709832$$FDA-CTU$$38$YR$$F$N$50.4$KG$20240711$N$CN$US$
240798481$24079848$1$I$20230710$20240704$20240711$20240711$EXP$GB-MHRA-MED-202405031246208040-FRJDH$GB-TEVA-VS-3217913$TEVA$$67$YR$$M$Y$83$KG$20240711$$CN$GB$GB
240798491$24079849$1$I$20231205$20240708$20240711$20240711$EXP$$GB-MYLANLABS-2023M1130844$MYLAN$$57$YR$$F$Y$$$20240711$$MD$GB$GB
240798501$24079850$1$I$20240704$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407091509566330-KSMBH$GB-MYLANLABS-2024M1064600$MYLAN$$71$YR$$M$Y$$$20240711$$PH$GB$GB
240798511$24079851$1$I$$20240708$20240711$20240711$EXP$$CA-EMD Serono-2024037331$EMD SERONO INC$$$$$F$Y$$$20240711$$HP$CA$CA
240798531$24079853$1$I$20240706$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48017$$FDA-CTU$$17$YR$$F$N$62.9$KG$20240710$N$$US$
240798541$24079854$1$I$20240709$20240711$20240711$20240711$DIR$709831$$FDA-CTU$$33$YR$$F$N$56$KG$20240711$N$CN$IN$
240798551$24079855$1$I$$20240706$20240711$20240711$EXP$$DE-JNJFOC-20240718941$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240711$$MD$DE$DE
240798561$24079856$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090277$PFIZER$$30$YR$$F$Y$$$20240711$$MD$US$US
240798572$24079857$2$F$$20240801$20240711$20240805$PER$$US-PFIZER INC-202400211051$PFIZER$$42$YR$$F$Y$$$20240805$$CN$US$US
240798581$24079858$1$I$$20240704$20240711$20240711$EXP$GB-MHRA-MED-202405012118279150-HZTMN$GB-TEVA-VS-3217924$TEVA$$$$$M$Y$78$KG$20240711$$CN$GB$GB
240798591$24079859$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-202400210341$PFIZER$$24$YR$$M$Y$$$20240711$$HP$US$US
240798602$24079860$2$F$20240708$20240904$20240711$20240906$PER$$US-PFIZER INC-202400208886$PFIZER$$46$YR$$F$Y$63.5$KG$20240906$$CN$US$US
240798611$24079861$1$I$20240708$20240709$20240711$20240711$PER$$US-PFIZER INC-202400210150$PFIZER$$70$YR$$M$Y$$$20240711$$CN$US$US
240798621$24079862$1$I$20240612$20240711$20240711$20240711$DIR$709842$$FDA-CTU$$26$YR$$F$N$53.55$KG$20240711$N$PH$US$
240798631$24079863$1$I$20240703$20240708$20240711$20240711$PER$$US-PFIZER INC-202400209291$PFIZER$$67$YR$$F$Y$$$20240711$$CN$US$US
240798641$24079864$1$I$20240630$20240703$20240711$20240711$DIR$FDA-CDER-CTU-2024-47988$$FDA-CTU$$$$$M$N$100.5$KG$20240703$N$$US$
240798652$24079865$2$F$20240707$20240711$20240711$20240715$PER$$US-PFIZER INC-202400209383$PFIZER$$53$YR$$F$Y$$$20240715$$CN$US$US
240798661$24079866$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090326$PFIZER$$7$YR$$F$Y$$$20240711$$MD$US$US
240798671$24079867$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090278$PFIZER$$40$YR$$M$Y$$$20240711$$MD$US$US
240798681$24079868$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090362$PFIZER$$7$YR$$M$Y$$$20240711$$MD$US$US
240798692$24079869$2$F$$20240715$20240711$20240716$PER$$US-PFIZER INC-PV202400089813$PFIZER$$62$YR$$F$Y$$$20240716$$HP$US$US
240798701$24079870$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400089615$PFIZER$$$$$$Y$$$20240711$$CN$US$US
240798711$24079871$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202300172100$PFIZER$$27$YR$$F$Y$$$20240711$$HP$US$US
240798722$24079872$2$F$$20240716$20240711$20240718$PER$$US-PFIZER INC-PV202400090022$PFIZER$$30$YR$$F$Y$$$20240718$$CN$US$US
240798732$24079873$2$F$$20240924$20240711$20240926$PER$$US-PFIZER INC-PV202400074466$PFIZER$$54$YR$$F$Y$$$20240926$$CN$US$US
240798741$24079874$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-202400209946$PFIZER$$1$YR$$F$Y$$$20240711$$CN$US$US
240798752$24079875$2$F$$20240910$20240711$20240912$PER$$US-PFIZER INC-PV202400076417$PFIZER$$55$YR$$M$Y$$$20240912$$HP$US$US
240798761$24079876$1$I$$20240509$20240711$20240711$PER$$US-PFIZER INC-202400104816$PFIZER$$$$A$F$Y$$$20240711$$CN$US$US
240798771$24079877$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090198$PFIZER$$22$YR$$F$Y$$$20240711$$MD$US$US
240798781$24079878$1$I$$20240709$20240711$20240711$PER$$US-PFIZER INC-202400209759$PFIZER$$37$YR$$M$Y$$$20240711$$MD$US$US
240798791$24079879$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090215$PFIZER$$9$YR$$F$Y$$$20240711$$MD$US$US
240798803$24079880$3$F$$20240731$20240711$20240802$PER$$US-PFIZER INC-PV202400090288$PFIZER$$59$YR$$F$Y$$$20240802$$HP$US$US
240798812$24079881$2$F$$20240916$20240711$20240918$PER$$US-PFIZER INC-PV202400089781$PFIZER$$81$YR$$F$Y$$$20240918$$HP$US$US
240798834$24079883$4$F$$20240911$20240711$20240913$PER$$US-PFIZER INC-2023SGN06963$PFIZER$$71$YR$$F$Y$$$20240913$$CN$US$US
240798841$24079884$1$I$20240709$20240709$20240711$20240711$PER$$US-PFIZER INC-202400210102$PFIZER$$62$YR$$M$Y$$$20240711$$CN$US$US
240798851$24079885$1$I$20240709$20240709$20240711$20240711$PER$$US-PFIZER INC-202400210082$PFIZER$$45$YR$$F$Y$63.5$KG$20240711$$CN$US$US
240798861$24079886$1$I$$20240709$20240711$20240711$PER$$US-PFIZER INC-PV202400090259$PFIZER$$34$YR$$M$Y$$$20240711$$CN$US$US
240798874$24079887$4$F$$20240918$20240711$20240920$PER$$US-PFIZER INC-PV202400090345$PFIZER$$48$YR$$M$Y$$$20240920$$CN$US$US
240798882$24079888$2$F$20240907$20240911$20240711$20240913$PER$$US-PFIZER INC-202400209959$PFIZER$$61$YR$$F$Y$$$20240913$$HP$US$US
240798891$24079889$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090366$PFIZER$$10$YR$$M$Y$$$20240711$$MD$US$US
240798901$24079890$1$I$20240601$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090146$PFIZER$$26$YR$$F$Y$$$20240711$$HP$US$US
240798911$24079891$1$I$$20240709$20240711$20240711$PER$$US-PFIZER INC-202400209800$PFIZER$$90$YR$$M$Y$$$20240711$$HP$US$US
240798921$24079892$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090287$PFIZER$$6$YR$$F$Y$$$20240711$$MD$US$US
240798932$24079893$2$F$$20240725$20240711$20240730$PER$$US-PFIZER INC-PV202400089770$PFIZER$$62$YR$$F$Y$$$20240730$$HP$US$US
240798941$24079894$1$I$20230509$20240709$20240711$20240711$PER$$US-PFIZER INC-202400210105$PFIZER$$64$YR$$F$Y$$$20240711$$MD$US$US
240798951$24079895$1$I$$20240709$20240711$20240711$PER$$US-ABBVIE-5834615$ABBVIE$$$$$$Y$$$20240711$$MD$US$US
240798963$24079896$3$F$$20240730$20240711$20240805$EXP$$US-TAKEDA-2023TUS041925$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
240798981$24079898$1$I$$20240702$20240711$20240711$PER$$US-AMGEN-USASP2024133782$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$57$YR$A$F$Y$$$20240711$$HP$US$US
240798991$24079899$1$I$20240524$20240711$20240711$20240711$EXP$FR-AFSSAPS-PO2024000754$NVSC2024FR143271$NOVARTIS$$65$YR$$F$Y$58$KG$20240711$$PH$FR$FR
240799002$24079900$2$F$20240615$20240815$20240711$20240822$EXP$$US-BAYER-2024A097644$BAYER$$6$YR$C$M$Y$$$20240822$$CN$US$US
240799021$24079902$1$I$$20240702$20240711$20240711$PER$$US-ROCHE-10000019007$ROCHE$$$$$$Y$$$20240711$$CN$US$US
240799031$24079903$1$I$$20240617$20240711$20240711$PER$$US-BEH-2024174463$CSL BEHRING$$$$$F$Y$$$20240711$$HP$US$US
240799041$24079904$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153963$ASTRAZENECA$$$$$M$Y$$$20240711$$CN$US$
240799051$24079905$1$I$20240416$20240416$20240711$20240711$EXP$$US-GUERBET / LLC-US-20240074$GUERBET$$67$YR$E$F$Y$$$20240711$$HP$US$US
240799061$24079906$1$I$$20240415$20240711$20240711$EXP$$US-GUERBET / LLC-US-20240067$GUERBET$$55$YR$A$$Y$$$20240711$$HP$US$US
240799071$24079907$1$I$20240417$20240418$20240711$20240711$EXP$$US-GUERBET / LLC-US-20240075$GUERBET$$39$YR$A$F$Y$66.4$KG$20240711$$HP$US$US
240799081$24079908$1$I$20240701$20240708$20240711$20240711$PER$$US-BIOGEN-2024BI01272868$BIOGEN$$52$YR$$F$Y$$$20240711$$CN$US$US
240799093$24079909$3$F$20240619$20240902$20240711$20240909$EXP$$US-BEH-2024175214$CSL BEHRING$$34$YR$A$F$Y$$$20240909$$HP$US$US
240799101$24079910$1$I$20240625$20240708$20240711$20240711$EXP$$JP-AMERICAN REGENT INC-2024002637$AMERICAN REGENT$$89$YR$$F$Y$21$KG$20240711$$MD$JP$JP
240799111$24079911$1$I$$20240704$20240711$20240711$EXP$$ES-INCYTE CORPORATION-2024IN007123$INCYTE$$$$$$Y$$$20240711$$MD$ES$ES
240799121$24079912$1$I$$20240422$20240711$20240711$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03596$HIKMA$$$$$$Y$$$20240710$$HP$US$US
240799131$24079913$1$I$$20240416$20240711$20240711$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03487$HIKMA$$$$$$Y$$$20240710$$HP$US$US
240799142$24079914$2$F$20240101$20240709$20240711$20240716$PER$$US-AMGEN-USASP2024136662$AMGEN$$$$$M$Y$$$20240716$$MD$US$US
240799151$24079915$1$I$20240703$20240710$20240711$20240711$EXP$IT-MINISAL02-994124$NVSC2024IT142308$NOVARTIS$$41$YR$$M$Y$$$20240711$$MD$IT$IT
240799161$24079916$1$I$$20240709$20240711$20240711$EXP$$NVSC2024BG143477$NOVARTIS$$71$YR$$F$Y$$$20240711$$MD$BG$BG
240799181$24079918$1$I$20240601$20240705$20240711$20240711$PER$$US-Eisai-EC-2024-169651$EISAI$$62$YR$A$M$Y$90.7$KG$20240711$$CN$US$US
240799191$24079919$1$I$20240522$20240705$20240711$20240711$EXP$FR-AFSSAPS-BS2024000398$FR-MYLANLABS-2024M1063817$MYLAN$$87$YR$$F$Y$$$20240711$$MD$FR$FR
240799201$24079920$1$I$20230909$20240703$20240711$20240711$EXP$DK-DKMA-30729568$DK-TEVA-VS-3216980$TEVA$$46$YR$$M$Y$$$20240711$$MD$DK$DK
240799211$24079921$1$I$20240520$20240705$20240711$20240711$EXP$FR-AFSSAPS-NC2024000792$FR-MYLANLABS-2024M1063553$MYLAN$$11$YR$$F$Y$38$KG$20240711$$MD$FR$FR
240799221$24079922$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06364$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240799231$24079923$1$I$$20240619$20240711$20240711$EXP$$FR-ROCHE-10000021103$ROCHE$$$$$$Y$$$20240711$$MD$FR$FR
240799243$24079924$3$F$$20240919$20240711$20240924$EXP$$US-TAKEDA-2024TUS053510$TAKEDA$$$$$F$Y$$$20240924$$CN$US$US
240799251$24079925$1$I$$20240131$20240711$20240711$EXP$NL-LRB-00933316$NL-TEVA-VS-3154130$TEVA$$57$YR$$M$Y$82$KG$20240711$$MD$NL$NL
240799261$24079926$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006588$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240711$$CN$US$US
240799271$24079927$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006263$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240711$$CN$US$US
240799281$24079928$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005398$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240711$$CN$US$US
240799291$24079929$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006243$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240711$$CN$US$US
240799301$24079930$1$I$20240628$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005629$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240711$$CN$US$US
240799311$24079931$1$I$20240708$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006558$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240711$$CN$US$US
240799321$24079932$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006017$ELI LILLY AND CO$$$$$M$Y$$$20240711$$HP$US$US
240799331$24079933$1$I$20230901$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006182$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240711$$CN$US$US
240799341$24079934$1$I$20240101$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006207$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240711$$CN$US$US
240799351$24079935$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006296$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240711$$CN$US$US
240799361$24079936$1$I$20240119$20240701$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407001899$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240711$$CN$US$US
240799371$24079937$1$I$$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006928$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240711$$CN$US$US
240799381$24079938$1$I$20240708$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005482$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240711$$CN$US$US
240799391$24079939$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006187$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240711$$CN$US$US
240799401$24079940$1$I$$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006880$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240711$$CN$US$US
240799421$24079942$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006866$ELI LILLY AND CO$$12$YR$C$$Y$$$20240711$$CN$US$US
240799431$24079943$1$I$20240708$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005655$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240711$$CN$US$US
240799441$24079944$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006153$ELI LILLY AND CO$$56$YR$A$$Y$$$20240711$$PH$US$US
240799451$24079945$1$I$20240708$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48123$$FDA-CTU$$55$YR$$F$N$$$20240710$N$HP$US$
240799471$24079947$1$I$20240501$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48085$$FDA-CTU$$8$YR$$M$N$$$20240710$N$HP$US$
240799482$24079948$2$F$$20240823$20240711$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202407005147$ELI LILLY AND CO$$29$YR$A$F$Y$93.424$KG$20240903$$CN$US$US
240799491$24079949$1$I$20240708$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005995$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240711$$CN$US$US
240799502$24079950$2$F$20240708$20240715$20240711$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407005939$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240718$$CN$US$US
240799512$24079951$2$F$$20240711$20240711$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407006274$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240715$$CN$US$US
240799521$24079952$1$I$20240601$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006111$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240711$$CN$US$US
240799541$24079954$1$I$$20240708$20240711$20240711$EXP$$NVSC2024CA142016$NOVARTIS$$49$YR$$F$Y$$$20240711$$CN$CA$CA
240799551$24079955$1$I$20240306$20240711$20240711$20240711$DIR$709841$$FDA-CTU$$19$YR$$F$N$72.45$KG$20240711$N$PH$US$
240799561$24079956$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48104$$FDA-CTU$$68$YR$$F$N$$$20240711$N$$US$
240799571$24079957$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48167$$FDA-CTU$$58$YR$$F$N$118.84$KG$20240711$N$$US$
240799582$24079958$2$F$20190101$20240712$20240711$20240718$EXP$$US-ABBVIE-5833303$ABBVIE$$$$$F$Y$68$KG$20240718$$CN$US$US
240799592$24079959$2$F$$20240722$20240711$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110135$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$84.82$KG$20240723$$CN$US$US
240799601$24079960$1$I$20231115$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110415$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240711$$MD$US$US
240799611$24079961$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108836$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240711$$CN$US$US
240799621$24079962$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110308$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240711$$HP$US$US
240799631$24079963$1$I$$20240711$20240711$20240711$DIR$709839$$FDA-CTU$$17$YR$$F$N$$$20240711$N$$US$
240799651$24079965$1$I$$20240708$20240711$20240711$PER$$US-JNJFOC-20190729330$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$LW$US$US
240799661$24079966$1$I$20240705$20240709$20240711$20240711$PER$$US-JNJFOC-20240723152$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240711$$PH$US$US
240799671$24079967$1$I$$20230721$20240711$20240711$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-63829$HIKMA$$$$$$Y$$$20240710$$HP$US$US
240799681$24079968$1$I$20201110$20231025$20240711$20240711$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66591$HIKMA$$$$$$Y$$$20240710$$MD$US$US
240799692$24079969$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3217773$TEVA$Bhatia S, Jamil A, Sharif M, Skenderi S. Cardiovascular Collapse Shortly After Beta Blockers in Atrial Fibrillationcomplicated Thyroid Storm. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.; Bhatia S, Jamil A, Sharif M, Skenderi S. Cardiovascular Collapse Shortly After Beta Blockers in Atrial Fibrillationcomplicated Thyroid Storm. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.$49$YR$$M$Y$$$20240809$$HP$US$US
240799701$24079970$1$I$$20230928$20240711$20240711$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65788$HIKMA$$$$$$Y$$$20240710$$HP$US$US
240799711$24079971$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199354$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240711$$MD$US$US
240799721$24079972$1$I$$20230715$20240711$20240711$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-63712$HIKMA$$$$$$Y$$$20240710$$CN$US$US
240799731$24079973$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA200722$SANOFI AVENTIS$$8$YR$C$M$Y$28$KG$20240711$$CN$US$US
240799741$24079974$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199767$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$MD$US$US
240799751$24079975$1$I$20240101$20240703$20240711$20240711$PER$$US-SA-2024SA203002$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240711$$MD$US$US
240799761$24079976$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199532$SANOFI AVENTIS$$15$YR$T$F$Y$84.8$KG$20240711$$MD$US$US
240799771$24079977$1$I$$20240411$20240711$20240711$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03396$HIKMA$$$$$M$Y$$$20240710$$MD$US$US
240799782$24079978$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3217907$TEVA$Barsoum A, Huang J, Kazemi M, Price J, Chakrabarty I. Hydroxychloroquine Induced Hypoglycemia. Am-J-Respir-Crit-Care-Med 2024; 209.; Barsoum A, Huang J, Kazemi M, Price J, Chakrabarty I. Hydroxychloroquine Induced Hypoglycemia. Am-J-Respir-Crit-Care-Med 2024; 209.$31$YR$$F$Y$$$20240809$$HP$US$US
240799791$24079979$1$I$20240424$20240705$20240711$20240711$EXP$$GB-AUROBINDO-AUR-APL-2024-034040$AUROBINDO$$60$YR$$M$Y$$$20240711$$MD$GB$GB
240799801$24079980$1$I$20230101$20231125$20240711$20240711$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67827$HIKMA$$$$$F$Y$91.6$KG$20240710$$CN$US$US
240799811$24079981$1$I$$20240607$20240711$20240711$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05585$HIKMA$$$$$$Y$$$20240710$$HP$US$US
240799821$24079982$1$I$20240418$20240501$20240711$20240711$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-04080$HIKMA$$$$$M$Y$$$20240710$$CN$US$US
240799832$24079983$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3219215$TEVA$Okura M, Sheikhan N, Thind GS. First Case of Elizabethkingia Lung Infection Strikes Central Valley California. Am-J-Respir-Crit-Care-Med 2024; 209 A6009 (plus Poster).; Okura M, Sheikhan N, Thind GS. First Case of Elizabethkingia Lung Infection Strikes Central Valley California. Am-J-Respir-Crit-Care-Med 2024; 209 A6009 (plus Poster).$24$YR$$F$Y$$$20240809$$HP$US$US
240799851$24079985$1$I$20240110$20240703$20240711$20240711$EXP$FR-AFSSAPS-GR2024000784$FR-TEVA-VS-3217156$TEVA$$60$YR$$M$Y$95$KG$20240711$$PH$FR$FR
240799861$24079986$1$I$20240501$20240523$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0195$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240799871$24079987$1$I$$20240705$20240711$20240711$PER$$US-AMGEN-USASP2024134686$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240799881$24079988$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143425$NOVARTIS$$$$$$Y$$$20240711$$HP$US$US
240799891$24079989$1$I$$20240708$20240711$20240711$EXP$$AT-PFIZER INC-2020SGN01377$PFIZER$Wagner, S.. Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas. European Journal of Haematology. 2019;1-8$$$$$Y$$$20240711$$HP$AT$AT
240799901$24079990$1$I$$20240614$20240711$20240711$PER$$US-009507513-2406USA005123$MERCK$$$$$F$Y$72.562$KG$20240711$$HP$US$US
240799911$24079991$1$I$$20240710$20240711$20240711$EXP$$IN-PFIZER INC-PV202400091017$PFIZER$$38$YR$$M$Y$$$20240711$$CN$IN$IN
240799922$24079992$2$F$$20240712$20240711$20240716$EXP$$US-PFIZER INC-202400211376$PFIZER$$34$YR$$F$Y$$$20240716$$HP$US$US
240799931$24079993$1$I$20240508$20240704$20240711$20240711$EXP$IT-MINISAL02-993159$IT-PFIZER INC-202400212246$PFIZER$$62$YR$$F$Y$$$20240711$$MD$IT$IT
240799941$24079994$1$I$20230807$20240703$20240711$20240711$EXP$$RU-ABBVIE-5835018$ABBVIE$$5$YR$$F$Y$18$KG$20240711$$MD$RU$RU
240799951$24079995$1$I$20240524$20240528$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0210$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240799962$24079996$2$F$20231130$20240905$20240711$20240909$EXP$$US-GSK-US2024084390$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$MD$US$US
240799971$24079997$1$I$$20240705$20240711$20240711$PER$$US-ALXN-202407USA000347US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240799981$24079998$1$I$20191101$20240704$20240711$20240711$EXP$GB-MHRA-MED-202404301931392500-MGPHN$GB-TEVA-VS-3217966$TEVA$$$$$M$Y$$$20240711$$CN$GB$GB
240799991$24079999$1$I$20230101$20240710$20240711$20240711$PER$$US-BAYER-2024A099503$BAYER$$33$YR$A$F$Y$$$20240711$$CN$US$US
240800001$24080000$1$I$$20240702$20240711$20240711$EXP$$US-RDY-LIT/USA/24/0009988$DR REDDYS$Gullapalli D, Raza A, Khan A, Ganti SS, Pervaiz A. Battling the breath-stealers: Blastomyces and Pseudomonas triggering acute respiratory distress syndrome (ARDS). Medical Mycology Case Reports. 45: doi:10.1016/j.mmcr.2024.100655.$46$YR$A$M$Y$$$20240711$$HP$US$US
240800011$24080001$1$I$20240524$20240528$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0212$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240800021$24080002$1$I$20240401$20240704$20240711$20240711$EXP$GB-MHRA-MED-202405021349419550-JDVKB$GB-TEVA-VS-3218016$TEVA$$7$YR$$F$Y$$$20240711$$MD$GB$GB
240800031$24080003$1$I$$20240703$20240711$20240711$PER$$US-AMGEN-USASP2024133204$AMGEN$Ezeani C.; Ugochukwu O.; Johnson A. et.al. Checkpoint Inhibitor Induced Acute Liver Failure. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-3$72$YR$E$M$Y$$$20240711$$MD$US$US
240800041$24080004$1$I$20240709$20240710$20240711$20240711$PER$$US-BAYER-2024A099600$BAYER$$25$YR$A$F$Y$$$20240711$$HP$US$US
240800051$24080005$1$I$20240423$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48125$$FDA-CTU$$40$YR$$M$N$$$20240710$N$$US$
240800061$24080006$1$I$20240501$20240528$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0213$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240800071$24080007$1$I$$20240709$20240711$20240711$PER$$US-ABBVIE-5835059$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240800081$24080008$1$I$$20240710$20240711$20240711$PER$$US-BAYER-2024A099620$BAYER$$31$YR$A$F$Y$$$20240711$$MD$US$US
240800091$24080009$1$I$$20240710$20240711$20240711$EXP$$US-ROCHE-10000022976$ROCHE$$$$A$F$Y$$$20240711$$HP$US$US
240800101$24080010$1$I$$20240702$20240711$20240711$PER$$US-TEVA-VS-3218577$TEVA$$$$$$Y$$$20240711$$PH$US$US
240800111$24080011$1$I$$20240711$20240711$20240711$DIR$709847$$FDA-CTU$$$$$F$N$$$20240711$Y$HP$US$
240800121$24080012$1$I$20240117$20240711$20240711$20240711$DIR$709850$$FDA-CTU$$26$YR$$F$N$$$20240711$N$PH$US$
240800131$24080013$1$I$20240529$20240530$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0225$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240800141$24080014$1$I$20240607$20240612$20240711$20240711$PER$$US-LEX-000341$LEXICON PHARMACEUTICALS$$58$YR$$M$Y$$$20240711$$CN$US$US
240800151$24080015$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA115787$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240711$$MD$US$US
240800161$24080016$1$I$20240601$20240708$20240711$20240711$PER$$US-SA-2024SA202097$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240711$$HP$US$US
240800171$24080017$1$I$$20240710$20240711$20240711$PER$$US-BAYER-2024A099623$BAYER$$31$YR$A$F$Y$$$20240711$$HP$US$US
240800192$24080019$2$F$$20240722$20240711$20240731$PER$$US-SA-2024SA199583$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240731$$MD$US$US
240800212$24080021$2$F$$20240712$20240711$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110172$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240715$$CN$US$US
240800221$24080022$1$I$$20240708$20240711$20240711$EXP$$CA-ORGANON-O2407CAN000747$ORGANON$$61$YR$$F$Y$$$20240711$$HP$CA$CA
240800231$24080023$1$I$20240611$20240711$20240711$20240711$DIR$709851$$FDA-CTU$$74$YR$$F$N$64$KG$20240711$N$MD$US$
240800241$24080024$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108503$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$63.41$KG$20240711$$CN$US$US
240800251$24080025$1$I$$20240711$20240711$20240711$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039240$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240711$$CN$US$US
240800261$24080026$1$I$20231003$20240711$20240711$20240711$DIR$709855$$FDA-CTU$$38$YR$$M$N$106$KG$20240711$N$MD$US$
240800291$24080029$1$I$$20240709$20240711$20240711$PER$$US-TAKEDA-2024TUS070546$TAKEDA$$$$$$Y$$$20240711$$PH$US$US
240800301$24080030$1$I$$20240710$20240711$20240711$EXP$$US-INCYTE CORPORATION-2024IN007260$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240800321$24080032$1$I$$20230127$20240711$20240711$EXP$$FR-INCYTE CORPORATION-2023IN001044$INCYTE$$$$$$Y$$$20240711$$MD$FR$FR
240800331$24080033$1$I$$20240710$20240711$20240711$EXP$$US-PURDUE PHARMA-USA-2024-0310696$PURDUE$$$$$F$Y$$$20240711$$CN$US$US
240800341$24080034$1$I$$20240710$20240711$20240711$PER$$US-BAYER-2024A099642$BAYER$$$$$F$Y$$$20240711$$CN$US$US
240800351$24080035$1$I$20240612$20240708$20240711$20240711$EXP$$CN-PURDUE-USA-2024-0310703$PURDUE$$71$YR$$M$Y$60$KG$20240711$$HP$CN$CN
240800361$24080036$1$I$$20240703$20240711$20240711$PER$$US-BAYER-2024A097669$BAYER$$38$YR$A$F$Y$$$20240711$$HP$US$US
240800371$24080037$1$I$20240601$20240610$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0308$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$MD$US$US
240800381$24080038$1$I$20240501$20240531$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0233$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240800391$24080039$1$I$20240702$20240704$20240711$20240711$EXP$$AU-GE HEALTHCARE-2024CSU007582$GE HEALTHCARE$$63$YR$$M$Y$85$KG$20240711$$HP$AU$AU
240800401$24080040$1$I$$20240703$20240711$20240711$EXP$$US-MYLANLABS-2024M1064024$MYLAN$Almeida Da SilvaLC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. J-Pediatr-Orthop-B 2024; 33 (4): 407-410.$$$C$$Y$$$20240711$$MD$US$US
240800411$24080041$1$I$$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407092212033490-KTPGJ$GB-MYLANLABS-2024M1064479$MYLAN$$$$$F$Y$$$20240711$$CN$GB$GB
240800431$24080043$1$I$20240520$20240702$20240711$20240711$EXP$IT-MINISAL02-992465$IT-PFIZER INC-202400211233$PFIZER$$17$YR$$M$Y$37$KG$20240711$$PH$IT$IT
240800441$24080044$1$I$$20240710$20240711$20240711$EXP$$US-INCYTE CORPORATION-2024IN007259$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240800451$24080045$1$I$20240601$20240610$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0311$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240800461$24080046$1$I$20240101$20240611$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0331$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240800471$24080047$1$I$$20240708$20240711$20240711$PER$$US-BAYER-2024A098296$BAYER$$27$YR$A$F$Y$$$20240711$$MD$US$US
240800483$24080048$3$F$$20240801$20240711$20240805$PER$$US-AMGEN-USASP2024135925$AMGEN$$$$$F$Y$$$20240804$$CN$US$US
240800501$24080050$1$I$$20240704$20240711$20240711$EXP$$US-AMGEN-USASP2024133743$AMGEN$Melica G.; Abia A L.; Corona M. et. al.. From Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T- Cell Therapy: Less Is Better. Blood. 2023;142 (SUPPL_1):3514-3516$$$$$Y$$$20240711$$MD$US$US
240800521$24080052$1$I$20240704$20240709$20240711$20240711$EXP$$US-INCYTE CORPORATION-2024IN007210$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240800531$24080053$1$I$$20240704$20240711$20240711$EXP$$US-AMGEN-USASP2024133876$AMGEN$Nunes S Z.; Mehta P.; Angell T.et.al.. Long-Term Follow-Up of a Case of Severe Hyperglycemia Requiring Hospitalization after Third Dose of Teprotumumab: A Case Report. Case Reports in Ophthalmology. 2024;15:115-121$67$YR$E$M$Y$$$20240711$$HP$US$US
240800551$24080055$1$I$$20240709$20240711$20240711$PER$$US-TAKEDA-2024TUS070424$TAKEDA$$8$DEC$$F$Y$$$20240711$$CN$US$US
240800561$24080056$1$I$20240611$20240611$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0333$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240800572$24080057$2$F$20240601$20240712$20240711$20240716$PER$$US-BAYER-2024A099002$BAYER$$40$YR$A$F$Y$$$20240716$$HP$US$US
240800581$24080058$1$I$20240501$20240521$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0270$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240800591$24080059$1$I$$20240612$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0338$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240800611$24080061$1$I$$20240711$20240711$20240711$DIR$709857$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240800621$24080062$1$I$20240710$20240711$20240711$20240711$DIR$709859$$FDA-CTU$$74$YR$$UNK$N$$$20240711$N$HP$US$
240800651$24080065$1$I$$20240711$20240711$20240711$DIR$709858$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240800661$24080066$1$I$$20240711$20240711$20240711$DIR$709860$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240800721$24080072$1$I$$20240711$20240711$20240711$DIR$709867$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240800731$24080073$1$I$20240601$20240705$20240711$20240711$EXP$$GB-JNJFOC-20240721255$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240711$$CN$GB$GB
240800741$24080074$1$I$20240601$20240613$20240711$20240711$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0349$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240710$$CN$US$US
240800771$24080077$1$I$20240710$20240711$20240711$20240711$DIR$709838$$FDA-CTU$$68$YR$$M$N$87.75$KG$20240711$N$CN$US$
240800791$24080079$1$I$$20240705$20240711$20240711$EXP$$US-AMGEN-USASP2024134219$AMGEN$Afify Z.M.; Taj M.M.; Orjuela-grimm M. et.al.. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders. Cancer. 2023;129 (5):780-789$$$$F$Y$$$20240711$$MD$US$US
240800801$24080080$1$I$$20240705$20240711$20240711$EXP$$US-AMGEN-USASP2024134241$AMGEN$Afify Z.M.; Taj M.M.; Orjuela-grimm M. et.al.. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders. Cancer. 2023;129 (5):780-789$$$$M$Y$$$20240711$$MD$US$US
240800811$24080081$1$I$$20240705$20240711$20240711$EXP$$US-AMGEN-USASP2024134502$AMGEN$Major A.; Weisse C.; Melekis K. et al.. Mixed-Methods Study of End-of-Life Experiences of Patients With Hematologic Malignancies in Social Hospice Residential Home Care Settings. JCO oncology practice. 2024;20 (6):779-786$$$$$Y$$$20240711$$MD$US$US
240800823$24080082$3$F$20230601$20240805$20240711$20240809$EXP$$US-INCYTE CORPORATION-2024IN007152$INCYTE$$$$$$Y$$$20240809$$HP$US$US
240800831$24080083$1$I$$20240705$20240711$20240711$EXP$$US-AMGEN-USASP2024134263$AMGEN$Afify Z. M.; Taj M. M.; Orjuela-grimm M. et al.. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders. Cancer. 2023;129 (5):780-789$$$$F$Y$$$20240711$$MD$US$US
240800842$24080084$2$F$$20240815$20240711$20240816$PER$$US-TAKEDA-2024TUS069943$TAKEDA$$$$$F$Y$64$KG$20240816$$MD$US$US
240800854$24080085$4$F$20240628$20240822$20240711$20240829$EXP$JP-MMM-3HT7MDZV$JP-ABBVIE-5835430$ABBVIE$$82$YR$$F$Y$35$KG$20240829$$MD$JP$JP
240800862$24080086$2$F$20230214$20240731$20240711$20240805$PER$$US-BAYER-2024A099007$BAYER$$19$YR$A$F$Y$$$20240805$$HP$US$US
240800871$24080087$1$I$$20240704$20240711$20240711$EXP$GB-MHRA-MED-202405020930463390-BMKSH$GB-TEVA-VS-3217945$TEVA$$$$$$Y$$$20240711$$PH$GB$GB
240800881$24080088$1$I$20240501$20240704$20240711$20240711$EXP$$JO-EMD Serono-2024036796$EMD SERONO INC$$44$YR$A$F$Y$$$20240711$$CN$JO$JO
240800901$24080090$1$I$$20240702$20240711$20240711$EXP$$US-AMERICAN REGENT INC-2024002587$AMERICAN REGENT$Leiser A, Virdee R, Kinniry P. Severe Epinephrine-Induced Lactic Acidosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3414[abstract]$69$YR$$M$Y$$$20240711$$HP$US$US
240800911$24080091$1$I$20240512$20240709$20240711$20240711$PER$$US-BAYER-2024A099302$BAYER$$$$$F$Y$$$20240711$$MD$US$US
240800921$24080092$1$I$20201203$20240703$20240711$20240711$EXP$$US-SA-2024SA202901$SANOFI AVENTIS$$10$YR$C$F$Y$33$KG$20240711$$MD$US$US
240800931$24080093$1$I$$20240705$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108930$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240711$$CN$US$US
240800941$24080094$1$I$$20240702$20240711$20240711$PER$$US-AMGEN-USASP2024133605$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$55$YR$A$M$Y$$$20240711$$HP$US$US
240800961$24080096$1$I$$20240709$20240711$20240711$PER$$US-BAYER-2024A099326$BAYER$$$$$F$Y$$$20240711$$CN$US$US
240800971$24080097$1$I$20240621$20240703$20240711$20240711$EXP$$GB-TAKEDA-2024TUS069744$TAKEDA$$71$YR$$F$Y$$$20240711$$CN$GB$GB
240800981$24080098$1$I$$20240708$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA063819$SANDOZ$$10$YR$$M$Y$$$20240711$$HP$CA$CA
240800991$24080099$1$I$20240101$20240628$20240711$20240711$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000138$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$US$US
240801001$24080100$1$I$$20240702$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN007040$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240801011$24080101$1$I$20240101$20240705$20240711$20240711$EXP$$US-INDIVIOR US-INDV-145898-2024$RECKITT BENCKISER$$$$$$Y$$$20240711$$PH$US$US
240801021$24080102$1$I$20240606$20240607$20240711$20240711$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000479$PAREXEL$$$$$$Y$$$20240711$$PH$US$US
240801031$24080103$1$I$$20240703$20240711$20240711$EXP$$GB-AstraZeneca-2024A152802$ASTRAZENECA$$63$YR$$F$Y$70$KG$20240711$$MD$GB$
240801041$24080104$1$I$20240530$20240607$20240711$20240711$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000466$PAREXEL$$$$$$Y$$$20240711$$HP$US$US
240801051$24080105$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158605$ASTRAZENECA$$47$YR$$M$Y$$$20240711$$HP$FR$
240801062$24080106$2$F$$20240710$20240711$20240715$EXP$$DE-AstraZeneca-2024A157016$ASTRAZENECA$$88$YR$$M$Y$$$20240715$$MD$DE$
240801071$24080107$1$I$20240627$20240701$20240711$20240711$EXP$$US-ROCHE-10000018917$ROCHE$$3$YR$C$M$Y$$$20240711$$CN$US$US
240801081$24080108$1$I$$20240710$20240711$20240711$PER$$US-BAYER-2024A099762$BAYER$$18$YR$A$F$Y$$$20240711$$MD$US$US
240801091$24080109$1$I$20240322$20240702$20240711$20240711$EXP$FR-AFSSAPS-GR2024000776$FR-009507513-2407FRA001377$MERCK$$56$YR$$M$Y$$$20240711$$PH$FR$FR
240801101$24080110$1$I$20240601$20240614$20240711$20240711$PER$$US-LEX-000343$LEXICON PHARMACEUTICALS$$67$YR$$M$Y$$$20240711$$CN$US$US
240801111$24080111$1$I$20240101$20240705$20240711$20240711$PER$$US-Eisai-EC-2024-168171$EISAI$$66$YR$E$F$Y$74.45$KG$20240711$$CN$US$US
240801121$24080112$1$I$$20240710$20240711$20240711$PER$$US-BAYER-2024A099775$BAYER$$44$YR$A$F$Y$$$20240711$$MD$US$US
240801132$24080113$2$F$$20240802$20240711$20240805$PER$$US-ALXN-202407USA000356US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240801141$24080114$1$I$20230328$20240706$20240711$20240711$EXP$$AU-Ipsen Biopharmaceuticals, Inc.-2023-15418$IPSEN$$13$MON$I$M$Y$9.3$KG$20240711$$CN$AU$AU
240801152$24080115$2$F$20240621$20240701$20240711$20240711$PER$$US-ROCHE-10000019688$ROCHE$$20$YR$A$M$Y$$$20240711$$CN$US$US
240801161$24080116$1$I$$20240710$20240711$20240711$EXP$$GB-JNJFOC-20240726711$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240711$$PH$GB$GB
240801171$24080117$1$I$$20240710$20240711$20240711$PER$$US-JNJFOC-20240723952$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240801181$24080118$1$I$20240704$20240709$20240711$20240711$EXP$$DE-BAYER-2024A099545$BAYER$$81$YR$E$F$Y$$$20240711$$CN$DE$DE
240801192$24080119$2$F$20240517$20240715$20240711$20240723$EXP$$MX-BIOVITRUM-2024-MX-008324$BIOVITRUM$$53$DY$$F$Y$2.9$KG$20240719$$CN$MX$MX
240801201$24080120$1$I$$20240709$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA064172$SANDOZ$$50$YR$$M$Y$$$20240711$$HP$CA$CA
240801221$24080122$1$I$20240711$20240711$20240711$20240711$DIR$709864$$FDA-CTU$$44$YR$$F$N$$$20240711$N$MD$US$
240801231$24080123$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48160$$FDA-CTU$$52$YR$$F$N$$$20240711$N$$US$
240801241$24080124$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48092$$FDA-CTU$$55$YR$$F$N$71.67$KG$20240711$N$$US$
240801251$24080125$1$I$20240703$20240711$20240711$20240711$DIR$709843$$FDA-CTU$$54$YR$$F$N$$$20240711$N$$US$
240801271$24080127$1$I$$20240711$20240711$20240711$DIR$709868$$FDA-CTU$$$$$UNK$N$66.15$KG$20240711$N$PH$US$
240801281$24080128$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48086$$FDA-CTU$$65$YR$$$N$79.38$KG$20240711$N$$US$
240801291$24080129$1$I$20240430$20240711$20240711$20240711$DIR$709848$$FDA-CTU$$25$YR$$F$N$77.4$KG$20240711$N$PH$US$
240801301$24080130$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48121$$FDA-CTU$$46$YR$$F$N$$$20240711$N$$US$
240801311$24080131$1$I$$20240711$20240711$20240711$DIR$709846$$FDA-CTU$$$$$F$N$69.16$KG$20240711$N$PH$US$
240801321$24080132$1$I$20240701$20240711$20240711$20240711$DIR$709871$$FDA-CTU$$83$YR$$F$N$59.4$KG$20240711$N$CN$US$
240801331$24080133$1$I$$20240711$20240711$20240711$DIR$709873$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240801341$24080134$1$I$20240417$20240711$20240711$20240711$DIR$709872$$FDA-CTU$$28$YR$$M$N$97.2$KG$20240711$N$PH$US$
240801361$24080136$1$I$20240709$20240711$20240711$20240711$DIR$709874$$FDA-CTU$$84$YR$$F$N$$$20240711$N$PH$US$
240801391$24080139$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48144$$FDA-CTU$$52$YR$$F$N$$$20240711$N$$US$
240801401$24080140$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48124$$FDA-CTU$$61$YR$$M$N$132.9$KG$20240711$N$$US$
240801431$24080143$1$I$$20240709$20240711$20240711$EXP$$NVSC2024US142817$NOVARTIS$$$$$$Y$$$20240711$$CN$US$US
240801441$24080144$1$I$20220101$20240703$20240711$20240711$EXP$$TW-BAYER-2024A097974$BAYER$Lin HW; Cheng CY. Painful annular skin rash on both legs in a patient with rectal cancer. The Lancet Oncology. 2024;25:7:(e331)$62$YR$A$F$Y$$$20240711$$MD$TW$TW
240801451$24080145$1$I$$20240702$20240711$20240711$PER$$US-AMGEN-USASP2024133749$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$66$YR$E$M$Y$$$20240711$$HP$US$US
240801461$24080146$1$I$20240509$20240703$20240711$20240711$EXP$DK-DKMA-30730569$DK-TEVA-VS-3217129$TEVA$$75$YR$$F$Y$$$20240711$$MD$DK$DK
240801471$24080147$1$I$$20240627$20240711$20240711$EXP$$VN-INCYTE CORPORATION-2024IN006973$INCYTE$$$$$$Y$$$20240711$$MD$VN$VN
240801481$24080148$1$I$20200102$20240701$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN006981$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240801491$24080149$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA201233$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240711$$MD$US$US
240801501$24080150$1$I$20200312$20240610$20240711$20240711$EXP$$ZA-GILEAD-2023-0640318$GILEAD$$33$YR$A$F$Y$$$20240711$$HP$ZA$ZA
240801511$24080151$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199142$SANOFI AVENTIS$$$$A$F$Y$111.58$KG$20240711$$MD$US$US
240801521$24080152$1$I$20240101$20240701$20240711$20240711$EXP$$MX-BAYER-2024A100085$BAYER$$$$$F$Y$$$20240711$$CN$MX$MX
240801531$24080153$1$I$$20240709$20240711$20240711$EXP$$US-BAYER-2024A099704$BAYER$$53$YR$A$M$Y$$$20240711$$CN$US$US
240801541$24080154$1$I$$20240705$20240711$20240711$PER$$US-BIOGEN-2020BI00923921$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240801551$24080155$1$I$$20240708$20240711$20240711$PER$$US-BIOGEN-2024BI01272827$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240801564$24080156$4$F$$20240916$20240711$20240918$PER$$US-BIOGEN-2024BI01246564$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
240801571$24080157$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110342$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$110.22$KG$20240711$$CN$US$US
240801591$24080159$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110278$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240711$$HP$US$US
240801601$24080160$1$I$$20240703$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106646$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240711$$CN$US$US
240801611$24080161$1$I$$20240710$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109974$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$67.59$KG$20240711$$CN$US$US
240801621$24080162$1$I$20230810$20240710$20240711$20240711$30DAY$$US-SANDOZ INC.-SDZ2023US014103$SANDOZ$$72$YR$$F$Y$$$20240711$$CN$US$US
240801631$24080163$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110192$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240711$$CN$US$US
240801641$24080164$1$I$$20240703$20240711$20240711$EXP$$CO-SANDOZ INC.-NVSC2022CO075219$SANDOZ$$$$$M$Y$68$KG$20240711$$CN$CO$CO
240801651$24080165$1$I$20240610$20240705$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2024US063118$SANDOZ$$0$YR$$F$Y$9.9$KG$20240711$$CN$US$US
240801661$24080166$1$I$$20240701$20240711$20240711$EXP$$CN-ROCHE-10000012952$ROCHE$Li C, Zheng X, Zhang L, Wang Y, Hu R, Cui H, et al. Obinutuzumab for the treatment of refractory PLA2R-associated membranous nephropathy: a single-center cohort study (Abstract number :#932). Nephrology Dialysis Transplantation. 2024-May;39 (Sup 1):i2064. doi:10.1093/ndt/gfae069.1276.$$$$$Y$$$20240711$$HP$CN$CN
240801672$24080167$2$F$20231101$20240802$20240711$20240815$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001468$SK LIFE SCIENCE$$$$$$Y$$$20240815$$CN$US$US
240801681$24080168$1$I$20230101$20240702$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN006971$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240801692$24080169$2$F$20240601$20240708$20240711$20240711$30DAY$$US-SANDOZ INC.-SDZ2024US063890$SANDOZ$$$$$F$Y$$$20240711$$CN$US$US
240801701$24080170$1$I$$20240701$20240711$20240711$EXP$DE-EMBRYOTOX-202301664$DE-TORRENT-00026961$TORRENT$$$$A$F$Y$73$KG$20240711$$MD$DE$DE
240801721$24080172$1$I$$20240701$20240711$20240711$EXP$$JP-BAXTER-2024BAX021174$BAXTER$$$$N$F$Y$1.98$KG$20240711$$HP$JP$JP
240801732$24080173$2$F$20240701$20240822$20240711$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110253$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$75.75$KG$20240826$$CN$US$US
240801741$24080174$1$I$$20240701$20240711$20240711$EXP$$US-VERTEX PHARMACEUTICALS-2024-011036$VERTEX$Holtrop M, Cosmich S, Lee M, Keller A, Jain R.. Sex differences persist after treatment with ivacaftor in people with cystic fibrosis. Chest. 2024$$$$$Y$$$20240711$$MD$US$US
240801771$24080177$1$I$20240511$20240708$20240711$20240711$EXP$$US-VERTEX PHARMACEUTICALS-2024-011317$VERTEX$$6$YR$$M$Y$$$20240711$$CN$US$US
240801781$24080178$1$I$$20240704$20240711$20240711$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011191$VERTEX$$$$A$M$Y$$$20240711$$CN$GB$GB
240801791$24080179$1$I$20240101$20240705$20240711$20240711$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011281$VERTEX$$$$$M$Y$$$20240711$$CN$GB$GB
240801811$24080181$1$I$$20240705$20240711$20240711$PER$$US-VERTEX PHARMACEUTICALS-2024-011270$VERTEX$$$$$M$Y$$$20240711$$CN$US$US
240801822$24080182$2$F$$20240723$20240711$20240801$PER$$US-VERTEX PHARMACEUTICALS-2024-011312$VERTEX$$4$YR$$F$Y$$$20240801$$HP$US$US
240801831$24080183$1$I$$20240705$20240711$20240711$PER$$US-VERTEX PHARMACEUTICALS-2024-011287$VERTEX$$11$YR$$F$Y$$$20240711$$CN$US$US
240801841$24080184$1$I$$20240709$20240711$20240711$EXP$$NVSC2024US142886$NOVARTIS$$70$YR$$F$Y$$$20240711$$HP$US$US
240801853$24080185$3$F$$20240823$20240711$20240829$PER$$NVSC2024US143541$NOVARTIS$$$$$F$Y$$$20240829$$HP$US$US
240801861$24080186$1$I$20240601$20240710$20240711$20240711$PER$$US-JNJFOC-20240727094$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240711$$CN$US$US
240801871$24080187$1$I$20240711$20240711$20240711$20240711$DIR$709878$$FDA-CTU$$88$YR$$F$N$$$20240711$N$$US$
240801891$24080189$1$I$$20240704$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2024US062848$SANDOZ$Sean J. Iwamoto, Micol S. Rothman, Guy T^Sjoen, and Justine Defreyne. Approach to the Patient: Hormonal Therapy in Transgender Adults With Complex Medical Histories. The Journal of Clinical Endocrinology + Metabolism$58$YR$$F$Y$$$20240711$$CN$US$US
240801911$24080191$1$I$20240206$20240711$20240711$20240711$DIR$709877$$FDA-CTU$$18$YR$$F$N$54.45$KG$20240711$N$PH$US$
240801931$24080193$1$I$$20240710$20240711$20240711$EXP$$US-JNJFOC-20240726630$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$HP$US$US
240801941$24080194$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5833157$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240801951$24080195$1$I$20240101$20240702$20240711$20240711$EXP$$US-SA-2024SA197073$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240711$$CN$US$US
240801961$24080196$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA200483$SANOFI AVENTIS$$18$YR$A$F$Y$29$KG$20240711$$MD$US$US
240801971$24080197$1$I$20240702$20240702$20240711$20240711$PER$$US-SA-2024SA198169$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240711$$MD$US$US
240801981$24080198$1$I$$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48090$$FDA-CTU$$$$$F$N$$$20240710$N$HP$US$
240801991$24080199$1$I$20240709$20240711$20240711$20240711$DIR$709875$$FDA-CTU$$78$YR$$F$N$$$20240711$N$PH$US$
240802001$24080200$1$I$$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48119$$FDA-CTU$$$$$F$N$$$20240710$N$HP$US$
240802013$24080201$3$F$20240601$20240716$20240711$20240724$EXP$$CR-SA-2024SA199545$SANOFI AVENTIS$$57$YR$A$F$Y$77.1$KG$20240724$$CN$CR$CR
240802022$24080202$2$F$$20240712$20240711$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA064532$SANDOZ$$$$$$Y$$$20240717$$CN$CA$CA
240802031$24080203$1$I$$20240709$20240711$20240711$EXP$$US-SANDOZ INC.-NVSC2019US081695$SANDOZ$$$$$F$Y$44.218$KG$20240711$$CN$US$US
240802041$24080204$1$I$20200101$20240708$20240711$20240711$EXP$$US-ABBVIE-5832584$ABBVIE$$$$$$Y$$$20240711$$CN$US$US
240802051$24080205$1$I$20240601$20240710$20240711$20240711$EXP$FR-AFSSAPS-PB2024000734$FR-SANDOZ INC.-SDZ2024FR064271$SANDOZ$$41$YR$$F$Y$$$20240711$$MD$FR$FR
240802061$24080206$1$I$20130101$20240707$20240711$20240711$EXP$$US-UCBSA-2024029748$UCB$$$$$M$Y$$$20240711$$CN$US$US
240802071$24080207$1$I$20231201$20240711$20240711$20240711$DIR$709861$$FDA-CTU$$41$YR$$M$N$85$KG$20240711$N$MD$US$
240802081$24080208$1$I$20240626$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48120$$FDA-CTU$$55$YR$$F$N$$$20240711$N$$US$
240802091$24080209$1$I$$20240711$20240711$20240711$DIR$709885$$FDA-CTU$$$$$UNK$N$$$20240711$$CN$US$
240802101$24080210$1$I$20240108$20240711$20240711$20240711$DIR$709853$$FDA-CTU$$65$YR$$M$N$85.5$KG$20240711$Y$CN$US$
240802111$24080211$1$I$$20240624$20240711$20240711$EXP$$US-MYLANLABS-2024M1063982$MYLAN$$$$$M$Y$85.28$KG$20240711$$CN$US$US
240802122$24080212$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3218279$TEVA$Deiss T, Harper A, Sanne S, Imsais W. Delayed clostridium difficile diagnosis in a patient with chronic constipation and diarrhea. Am-J-Med-Sci 2024; 367 (Suppl. 1) S47-S48 abstr. 80.; Deiss T, Harper A, Sanne S, Imsais W. Delayed clostridium difficile diagnosis in a patient with chronic constipation and diarrhea. Am-J-Med-Sci 2024; 367 (Suppl. 1) S47-S48 abstr. 80.$77$YR$$F$Y$$$20240809$$HP$US$US
240802131$24080213$1$I$$20240701$20240711$20240711$PER$$US-ALXN-202407USA000616US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$US$US
240802141$24080214$1$I$20240613$20240704$20240711$20240711$EXP$FR-AFSSAPS-LL2024001195$FR-009507513-2407FRA002474$MERCK$$47$YR$$M$Y$$$20240711$$MD$FR$FR
240802151$24080215$1$I$$20240701$20240711$20240711$PER$$US-BAYER-2024A095212$BAYER$$$$$$Y$$$20240711$$CN$US$US
240802161$24080216$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158366$ASTRAZENECA$$59$YR$$M$Y$54$KG$20240711$$HP$FR$
240802171$24080217$1$I$$20240703$20240711$20240711$EXP$$AU-AstraZeneca-2024A153084$ASTRAZENECA$$68$YR$$M$Y$$$20240711$$CN$AU$
240802191$24080219$1$I$$20240703$20240711$20240711$EXP$$FR-AstraZeneca-2024A152642$ASTRAZENECA$$$$N$F$Y$2.4$KG$20240711$$MD$FR$
240802201$24080220$1$I$$20240708$20240711$20240711$EXP$$GB-AstraZeneca-2024A156917$ASTRAZENECA$$$$$F$Y$62$KG$20240711$$MD$GB$
240802211$24080221$1$I$$20240702$20240711$20240711$PER$$US-AMGEN-USASP2024133847$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current Oncology. 2024;31 (6):3529-3545$73$YR$E$F$Y$$$20240711$$HP$US$US
240802221$24080222$1$I$20240701$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006269$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240711$$CN$US$US
240802231$24080223$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006112$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240711$$CN$US$US
240802241$24080224$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A154624$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240802252$24080225$2$F$$20240813$20240711$20240819$EXP$$IE-PFIZER INC-2020SGN03869$PFIZER$Keane, N.. A Surviving Case of Acanthamoeba Granulomatous Amebic Encephalitis in a Hematopoietic Stem Cell Transplant Recipient.. Am J Case Rep.. 2020;21:e923219-1 e923219-6$32$YR$$M$Y$$$20240819$$HP$IE$IE
240802262$24080226$2$F$20240415$20240705$20240711$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407004935$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240717$$PH$US$US
240802271$24080227$1$I$20240709$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006129$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240711$$CN$US$US
240802281$24080228$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005993$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240711$$CN$US$US
240802301$24080230$1$I$$20240711$20240711$20240711$DIR$709887$$FDA-CTU$$$$$UNK$N$$$20240711$$CN$US$
240802311$24080231$1$I$$20240711$20240711$20240711$DIR$709884$$FDA-CTU$$$$$UNK$N$$$20240711$$CN$US$
240802321$24080232$1$I$$20240710$20240711$20240711$EXP$$US-GILEAD-2024-0680320$GILEAD$$$$$$Y$$$20240711$$LW$US$US
240802331$24080233$1$I$20240711$20240711$20240711$20240711$DIR$709886$$FDA-CTU$$47$YR$$F$N$103.95$KG$20240711$N$PH$US$
240802362$24080236$2$F$$20240715$20240711$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-098149$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240717$$MD$US$US
240802382$24080238$2$F$$20240715$20240711$20240722$EXP$$NVSC2024RU142680$NOVARTIS$Chelysheva EY, Turkina AG, Polushkina ES, Shmakov RG. ??????????? ???????????, ??????? ?????????? ?? ????? ????????????: ??????? ???????, ?????????? ??????? ? ?????? ???????????? [Chronic myeloid leukemia first diagnosed during pregnancy: management tactics, treatment results and pregnancy outcomes]. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY (GEMATOLOGIYA I TRANSFUSIOLOGI). 2024;69(2):361$$$N$$Y$$$20240722$$HP$RU$RU
240802391$24080239$1$I$$20240710$20240711$20240711$PER$$US-ABBVIE-5835251$ABBVIE$$$$$$Y$$$20240711$$CN$US$US
240802421$24080242$1$I$20200101$20240705$20240711$20240711$EXP$$FR-MYLANLABS-2024M1063837$MYLAN$$31$YR$$F$Y$$$20240711$$MD$FR$FR
240802432$24080243$2$F$$20240813$20240711$20240821$EXP$$NVSC2024US142623$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
240802441$24080244$1$I$20240528$20240702$20240711$20240711$EXP$$CN-009507513-2407CHN002896$MERCK$$42$YR$$F$Y$56$KG$20240711$$HP$CN$CN
240802451$24080245$1$I$$20240711$20240711$20240711$PER$$US-BAYER-2024A100073$BAYER$$$$$$Y$$$20240711$$CN$US$US
240802461$24080246$1$I$20240703$20240705$20240711$20240711$30DAY$$US-GSK-US2024083996$GLAXOSMITHKLINE$$45$YR$$M$Y$$$20240711$$CN$US$US
240802471$24080247$1$I$20240101$20240701$20240711$20240711$PER$$US-TEVA-VS-3219136$TEVA$$27$YR$$M$Y$$$20240711$$CN$US$US
240802481$24080248$1$I$$20240705$20240711$20240711$PER$$US-HETERO-HET2024US01745$HETERO$$$$$$Y$$$20240711$$CN$US$US
240802492$24080249$2$F$20240101$20240726$20240711$20240801$EXP$$JP-009507513-2407JPN001014J$MERCK$$79$YR$$M$Y$$$20240801$$MD$JP$JP
240802501$24080250$1$I$20240305$20240705$20240711$20240711$EXP$$CN-009507513-2407CHN004034$MERCK$$73$YR$$M$Y$$$20240711$$HP$CN$CN
240802511$24080251$1$I$20240601$20240704$20240711$20240711$EXP$$CA-JNJFOC-20240716882$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240711$$HP$CA$CA
240802521$24080252$1$I$20240429$20240710$20240711$20240711$EXP$FR-AFSSAPS-RS2024000652$FR-SANDOZ INC.-SDZ2024FR064222$SANDOZ$$75$YR$$M$Y$87$KG$20240711$$MD$FR$FR
240802531$24080253$1$I$$20240705$20240711$20240711$PER$$US-BAYER-2024A099216$BAYER$$28$YR$A$F$Y$$$20240711$$CN$US$US
240802541$24080254$1$I$20240701$20240704$20240711$20240711$EXP$$NVSC2024FR102048$NOVARTIS$$$$E$M$Y$72$KG$20240711$$MD$FR$FR
240802561$24080256$1$I$$20240708$20240711$20240711$PER$$US-BAYER-2024A098303$BAYER$$48$YR$A$F$Y$$$20240711$$MD$US$US
240802572$24080257$2$F$$20240717$20240711$20240720$PER$$US-HETERO-HET2024US02183$HETERO$$$$$M$Y$$$20240720$$CN$US$US
240802581$24080258$1$I$20240401$20240709$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2024US064203$SANDOZ$$$$$$Y$$$20240711$$CN$US$US
240802591$24080259$1$I$$20240613$20240711$20240711$PER$$US-Vifor (International) Inc.-VIT-2024-05415$VIFOR$$$$$F$Y$$$20240711$$CN$US$US
240802601$24080260$1$I$$20240705$20240711$20240711$PER$$US-ALXN-202407USA000387US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240802613$24080261$3$F$20240201$20240917$20240711$20240920$30DAY$$KR-PFIZER INC-PV202400090239$PFIZER$$9$YR$$F$Y$$$20240920$$HP$KR$KR
240802621$24080262$1$I$20240625$20240701$20240711$20240711$DIR$FDA-CDER-CTU-2024-47990$$FDA-CTU$$$$$F$N$100$KG$20240701$N$$US$
240802631$24080263$1$I$20240708$20240711$20240711$20240711$DIR$709866$$FDA-CTU$$41$YR$$UNK$N$112$KG$20240711$N$$US$
240802641$24080264$1$I$20240709$20240709$20240711$20240711$PER$$US-BAYER-2024A099263$BAYER$$27$YR$A$F$Y$$$20240711$$HP$US$US
240802651$24080265$1$I$$20240701$20240711$20240711$EXP$$US-RDY-LIT/USA/24/0009918$DR REDDYS$Merrill K, Davis A, Jackson E, Riker M, Kirk M, Yung D. Direct prostacyclin transition in pediatric patients with pulmonary hypertension. Pulmonary Circulation. 2024 Apr;14(2): 1-5. doi:10.1002/pul2.12373.$14$YR$T$M$Y$85$KG$20240711$$HP$US$US
240802661$24080266$1$I$20231115$20240709$20240711$20240711$DIR$FDA-CDER-CTU-2024-48013$$FDA-CTU$$47$YR$$F$N$77$KG$20240709$N$$US$
240802681$24080268$1$I$$20240711$20240711$20240711$EXP$$US-GILEAD-2024-0680401$GILEAD$$$$A$F$Y$$$20240711$$HP$US$US
240802692$24080269$2$F$$20240715$20240711$20240722$EXP$$NVSC2024RU142447$NOVARTIS$Chelysheva EY, Turkina AG, Polushkina ES, Shmakov RG. ??????????? ???????????, ??????? ?????????? ?? ?????  ????????????: ??????? ???????, ?????????? ??????? ? ?????? ???????????? [Chronic myeloid leukemia first detected during pregnancy: management strategy, treatment results, and pregnancy outcomes]. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY (GEMATOLOGIYA I TRANSFUSIOLOGI). 2024;69(2):361$$$N$$Y$1.7$KG$20240722$$HP$RU$RU
240802711$24080271$1$I$20240119$20240709$20240711$20240711$DIR$FDA-CDER-CTU-2024-47998$$FDA-CTU$$$$$F$N$77$KG$20240709$N$$US$
240802721$24080272$1$I$$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48140$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
240802732$24080273$2$F$20240627$20240917$20240711$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109808$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240924$$CN$US$US
240802742$24080274$2$F$20240709$20240711$20240711$20240813$PER$$US-AMGEN-USASP2024137424$AMGEN$$75$YR$E$F$Y$$$20240813$$CN$US$US
240802751$24080275$1$I$$20240710$20240711$20240711$PER$$US-BAYER-2024A099613$BAYER$$23$YR$A$F$Y$$$20240711$$MD$US$US
240802761$24080276$1$I$20240422$20240703$20240711$20240711$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0600065$MYOVANT SCIENCES$$70$YR$$M$Y$$$20240711$$MD$US$US
240802771$24080277$1$I$20240619$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48142$$FDA-CTU$$39$YR$$M$N$$$20240710$N$HP$US$
240802781$24080278$1$I$20240501$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48083$$FDA-CTU$$8$YR$$M$N$$$20240710$N$HP$US$
240802791$24080279$1$I$20240710$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48185$$FDA-CTU$$74$YR$$F$N$$$20240710$N$HP$US$
240802801$24080280$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48099$$FDA-CTU$$64$YR$$F$N$170$LBS$20240711$N$$US$
240802811$24080281$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48193$$FDA-CTU$$55$YR$$F$N$196$LBS$20240711$N$$US$
240802821$24080282$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48165$$FDA-CTU$$63$YR$$F$N$$$20240711$N$$US$
240802831$24080283$1$I$$20240710$20240711$20240711$EXP$$US-GILEAD-2024-0680321$GILEAD$$$$$$Y$$$20240711$$LW$US$US
240802841$24080284$1$I$20240702$20240710$20240711$20240711$PER$$US-BAYER-2024A099701$BAYER$$22$YR$A$F$Y$$$20240711$$MD$US$US
240802851$24080285$1$I$20240710$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137141$AMGEN$$66$YR$E$F$Y$$$20240711$$CN$US$US
240802861$24080286$1$I$20240601$20240703$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN007087$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240802871$24080287$1$I$20240606$20240705$20240711$20240711$EXP$$DE-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003803$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240711$$HP$DE$DE
240802881$24080288$1$I$$20240705$20240711$20240711$EXP$$US-TAKEDA-2024TUS001773$TAKEDA$$$$$M$Y$$$20240711$$CN$US$US
240802891$24080289$1$I$$20240702$20240711$20240711$PER$$US-SA-2023SA201180$SANOFI AVENTIS$$$$A$F$Y$$$20240711$$MD$US$US
240802903$24080290$3$F$20240603$20240725$20240711$20240801$EXP$$EU-SEPTODONT-2024018708$SEPTODONT$$$$A$$Y$$$20240801$$HP$EU$EU
240802911$24080291$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06380$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240802921$24080292$1$I$$20240628$20240711$20240711$PER$$NVSC2024US137200$NOVARTIS$$$$$$Y$$$20240711$$MD$US$US
240802932$24080293$2$F$$20240712$20240711$20240726$EXP$$JP-JNJFOC-20240728464$JOHNSON AND JOHNSON$Miura M. Multicenter, cross sectional, observational study on Epstein Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study). J Gastroenterol..2021.$16$YR$T$F$Y$$$20240726$$HP$JP$JP
240802941$24080294$1$I$$20240710$20240711$20240711$PER$$US-BAYER-2024A099615$BAYER$$25$YR$A$F$Y$$$20240711$$HP$US$US
240802951$24080295$1$I$20230924$20240708$20240711$20240711$PER$$US-ORGANON-O2407USA000804$ORGANON$$19$YR$$F$Y$45.805$KG$20240711$$CN$US$US
240802961$24080296$1$I$$20240708$20240711$20240711$EXP$$GB-MYLANLABS-2024M1064242$MYLAN$$$$$M$Y$$$20240711$$CN$GB$GB
240802971$24080297$1$I$$20240708$20240711$20240711$EXP$$CA-TAKEDA-2024TUS058072$TAKEDA$$$$$M$Y$$$20240711$$CN$CA$CA
240802981$24080298$1$I$$20240710$20240711$20240711$PER$$US-HALEON-2186492$Haleon PLC$$$$$$Y$$$20240711$$CN$US$US
240802991$24080299$1$I$$20240625$20240711$20240711$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06417$LUPIN$$$$$$Y$$$20240711$$CN$US$US
240803001$24080300$1$I$$20240709$20240711$20240711$PER$$US-PFIZER INC-202400209866$PFIZER$$77$YR$$M$Y$$$20240711$$CN$US$US
240803011$24080301$1$I$20240709$20240709$20240711$20240711$PER$$US-PFIZER INC-202400210486$PFIZER$$68$YR$$F$Y$$$20240711$$HP$US$US
240803021$24080302$1$I$$20240709$20240711$20240711$PER$$US-PFIZER INC-202400211171$PFIZER$$80$YR$$M$Y$$$20240711$$HP$US$US
240803031$24080303$1$I$$20240709$20240711$20240711$PER$$US-PFIZER INC-202400211267$PFIZER$$59$YR$$F$Y$$$20240711$$HP$US$US
240803041$24080304$1$I$$20240709$20240711$20240711$PER$$US-PFIZER INC-PV202400090731$PFIZER$$$$$$Y$$$20240711$$HP$US$US
240803052$24080305$2$F$$20240715$20240711$20240717$PER$$US-PFIZER INC-PV202400090737$PFIZER$$$$$$Y$$$20240717$$HP$US$US
240803062$24080306$2$F$$20240715$20240711$20240719$PER$$US-PFIZER INC-PV202400090396$PFIZER$$73$YR$$F$Y$$$20240719$$CN$US$US
240803071$24080307$1$I$$20240704$20240711$20240711$EXP$$NVSC2024JP139808$NOVARTIS$Sakurazawa C, Habuka M, Hoshino Y, Sakamaki Y, Ogawa A, Yamamoto S, et al.. A case of multiorgan failure due to carbamazepine intoxication successfully treated with multimodal blood purification therapy. CEN CASE REPORTS. 2024;1-5$47$YR$$F$Y$$$20240711$$HP$JP$JP
240803081$24080308$1$I$$20240709$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA063941$SANDOZ$$$$$F$Y$$$20240711$$HP$CA$CA
240803092$24080309$2$F$$20240712$20240711$20240715$PER$$US-PFIZER INC-202400211061$PFIZER$$$$$$Y$$$20240715$$PH$US$US
240803101$24080310$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090359$PFIZER$$6$YR$$M$Y$$$20240711$$MD$US$US
240803121$24080312$1$I$$20240709$20240711$20240711$PER$$JP-PFIZER INC-202400209338$PFIZER$$$$$$Y$$$20240711$$PH$JP$JP
240803131$24080313$1$I$$20240709$20240711$20240711$PER$$US-PFIZER INC-202400209761$PFIZER$$64$YR$$F$Y$$$20240711$$CN$US$US
240803142$24080314$2$F$$20240710$20240711$20240715$PER$$US-PFIZER INC-202400211308$PFIZER$$78$YR$$F$Y$$$20240715$$HP$US$US
240803152$24080315$2$F$20240601$20240715$20240711$20240716$PER$$US-PFIZER INC-202400210166$PFIZER$$$$A$F$Y$$$20240716$$CN$US$US
240803163$24080316$3$F$20240101$20240711$20240711$20240716$PER$$US-PFIZER INC-202400209854$PFIZER$$74$YR$$M$Y$73.48$KG$20240716$$CN$US$US
240803172$24080317$2$F$$20240806$20240711$20240809$PER$$US-PFIZER INC-PV202400090157$PFIZER$$56$YR$$F$Y$$$20240809$$CN$US$US
240803181$24080318$1$I$$20240709$20240711$20240711$PER$$US-PFIZER INC-202400209853$PFIZER$$$$A$F$Y$$$20240711$$HP$US$US
240803192$24080319$2$F$20240708$20240723$20240711$20240725$PER$$US-PFIZER INC-PV202400090301$PFIZER$$83$YR$$M$Y$87.982$KG$20240725$$CN$US$US
240803202$24080320$2$F$$20240828$20240711$20240904$PER$$US-PFIZER INC-PV202400088825$PFIZER$$52$YR$$F$Y$$$20240904$$CN$US$US
240803211$24080321$1$I$$20240705$20240711$20240711$EXP$$FR-GENMAB-2024-02464$GENMAB$$67$YR$$M$Y$$$20240711$$HP$FR$FR
240803221$24080322$1$I$20240710$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006937$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240711$$CN$US$US
240803231$24080323$1$I$$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006905$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240711$$CN$US$US
240803241$24080324$1$I$$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006876$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240711$$CN$US$US
240803251$24080325$1$I$20240101$20240709$20240711$20240711$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038836$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240711$$CN$US$US
240803271$24080327$1$I$20240601$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109919$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$57.61$KG$20240711$$CN$US$US
240803281$24080328$1$I$$20240702$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106733$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240711$$HP$US$US
240803292$24080329$2$F$20230831$20240729$20240711$20240808$EXP$$JP-TEVA-VS-3219273$TEVA$$51$YR$$F$Y$56$KG$20240808$$MD$JP$JP
240803302$24080330$2$F$20240708$20240715$20240711$20240723$EXP$$US-GSK-US2024084415$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240723$$HP$US$US
240803311$24080331$1$I$$20240710$20240711$20240711$EXP$$AU-GSK-AU2024APC085675$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$AU$AU
240803321$24080332$1$I$20231016$20240708$20240711$20240711$EXP$$AU-GSK-AU2024APC084565$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$HP$AU$AU
240803331$24080333$1$I$20230517$20240708$20240711$20240711$EXP$GB-MHRA-MED-202405041058488200-KBNZJ$GB-MYLANLABS-2024M1064038$MYLAN$$70$YR$$F$Y$120$KG$20240711$$CN$GB$GB
240803341$24080334$1$I$20240619$20240703$20240711$20240711$EXP$$CN-AstraZeneca-2024A155337$ASTRAZENECA$$$$$M$Y$76$KG$20240711$$MD$CN$
240803351$24080335$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158491$ASTRAZENECA$$74$YR$$M$Y$62$KG$20240711$$HP$FR$
240803362$24080336$2$F$20240201$20240819$20240711$20240823$EXP$$US-009507513-2407USA003870$MERCK$$74$YR$$M$Y$$$20240823$$CN$US$US
240803371$24080337$1$I$$20240703$20240711$20240711$EXP$$BE-AstraZeneca-2024A154955$ASTRAZENECA$$60$YR$$M$Y$63$KG$20240711$$MD$BE$
240803381$24080338$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158624$ASTRAZENECA$$75$YR$$M$Y$$$20240711$$HP$FR$
240803391$24080339$1$I$20240626$20240701$20240711$20240711$EXP$$US-JNJFOC-20240707682$JOHNSON AND JOHNSON$$$$I$M$Y$$$20240711$$HP$US$US
240803401$24080340$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090237$PFIZER$$40$YR$$F$Y$$$20240711$$MD$US$US
240803411$24080341$1$I$$20240708$20240711$20240711$PER$$JP-PFIZER INC-202400208618$PFIZER$$$$$$Y$$$20240711$$PH$JP$JP
240803421$24080342$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090285$PFIZER$$66$YR$$M$Y$$$20240711$$MD$US$US
240803432$24080343$2$F$$20240823$20240711$20240828$PER$$US-PFIZER INC-202400211119$PFIZER$$$$A$F$Y$61$KG$20240828$$MD$US$US
240803441$24080344$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090209$PFIZER$$29$YR$$F$Y$$$20240711$$MD$US$US
240803451$24080345$1$I$20240706$20240709$20240711$20240711$PER$$US-PFIZER INC-202400209776$PFIZER$$82$YR$$F$Y$70$KG$20240711$$HP$US$US
240803462$24080346$2$F$$20240810$20240711$20240812$PER$$US-PFIZER INC-PV202400089953$PFIZER$$14$YR$$M$Y$59.6$KG$20240812$$MD$US$US
240803481$24080348$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-202400212403$PFIZER$$$$$F$Y$$$20240711$$CN$US$US
240803492$24080349$2$F$$20240701$20240711$20240715$EXP$$JP-TAKEDA-2024TUS070603$TAKEDA$$47$YR$$F$Y$$$20240715$$MD$JP$JP
240803501$24080350$1$I$$20240704$20240711$20240711$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003290$CURRAX PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$CA$CA
240803521$24080352$1$I$$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48080$$FDA-CTU$$$$$F$N$$$20240710$N$HP$US$
240803532$24080353$2$F$$20240909$20240711$20240913$EXP$$JP-009507513-2407JPN000769J$MERCK$$$$E$$Y$$$20240913$$MD$JP$JP
240803541$24080354$1$I$20210101$20240708$20240711$20240711$EXP$$US-ABBVIE-5831919$ABBVIE$$$$$$Y$$$20240711$$CN$US$US
240803552$24080355$2$F$20240409$20240705$20240711$20240717$PER$$US-PFIZER INC-202400208899$PFIZER$$59$YR$$F$Y$$$20240717$$HP$US$US
240803561$24080356$1$I$$20240710$20240711$20240711$PER$$US-HALEON-2186495$Haleon PLC$$$$$$Y$$$20240711$$CN$US$US
240803571$24080357$1$I$20240702$20240704$20240711$20240711$EXP$GB-MHRA-MED-202407031126019580-QRGTF$GB-GSK-GB2024082912$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$HP$GB$GB
240803581$24080358$1$I$20240101$20240708$20240711$20240711$EXP$$US-ABBVIE-5833651$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240803592$24080359$2$F$20240301$20240806$20240711$20240806$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-012079$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240806$$CN$JP$JP
240803601$24080360$1$I$20240101$20240703$20240711$20240711$PER$$US-MYLANLABS-2024M1062452$MYLAN$$$$$F$Y$63.49$KG$20240711$$CN$US$US
240803612$24080361$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3219026$TEVA$Rabah AK, Ahmed R, Duarte A, Wang-kocik C. A Rare Cause of Toxic Shock Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209.; Rabah AK, Ahmed R, Duarte A, Wang-kocik C. A Rare Cause of Toxic Shock Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209.$38$YR$$M$Y$$$20240809$$HP$US$US
240803621$24080362$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48196$$FDA-CTU$$30$YR$$F$N$349$LBS$20240711$N$$US$
240803632$24080363$2$F$$20240705$20240711$20240718$PER$$US-RDY-CLI/USA/24/0009546$DR REDDYS$$18$YR$A$M$Y$68.04$KG$20240718$$CN$US$US
240803641$24080364$1$I$$20240627$20240711$20240711$PER$$US-RDY-SPO/USA/24/0009470$DR REDDYS$$$$$F$Y$$$20240711$$CN$US$US
240803662$24080366$2$F$$20240717$20240711$20240724$EXP$$KR-TAKEDA-2024TUS069784$TAKEDA$$60$YR$$$Y$$$20240724$$CN$KR$KR
240803672$24080367$2$F$20240629$20240703$20240711$20240806$EXP$$CO-AstraZeneca-2024A154276$ASTRAZENECA$$3069$WK$$F$Y$$$20240806$$CN$CO$
240803681$24080368$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A154249$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240803691$24080369$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158689$ASTRAZENECA$$75$YR$$F$Y$60$KG$20240711$$HP$FR$
240803701$24080370$1$I$$20240705$20240711$20240711$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001375$BLUEPRINT MEDICINES$$$$$F$Y$$$20240711$$CN$US$US
240803711$24080371$1$I$20240101$20240708$20240711$20240711$EXP$$JP-AstraZeneca-2024A157392$ASTRAZENECA$$$$$F$Y$$$20240711$$PH$JP$
240803722$24080372$2$F$$20240729$20240711$20240807$PER$$US-SA-2024SA201236$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240807$$MD$US$US
240803731$24080373$1$I$20240101$20240704$20240711$20240711$PER$$US-SA-2024SA201292$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240711$$MD$US$US
240803742$24080374$2$F$20240101$20240810$20240711$20240819$PER$$US-SA-2024SA200538$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240819$$MD$US$US
240803751$24080375$1$I$$20240626$20240711$20240711$PER$$US-MYLANLABS-2024M1061135$MYLAN$$$$$F$Y$$$20240711$$CN$US$US
240803771$24080377$1$I$$20240710$20240711$20240711$PER$$JP-PFIZER INC-202400209955$PFIZER$$$$$$Y$$$20240711$$PH$JP$JP
240803781$24080378$1$I$$20240710$20240711$20240711$PER$$US-PFIZER INC-202400211304$PFIZER$$65$YR$$F$Y$$$20240711$$CN$US$US
240803791$24080379$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-202400209343$PFIZER$$81$YR$$M$Y$85.28$KG$20240711$$CN$US$US
240803801$24080380$1$I$$20240710$20240711$20240711$PER$$US-PFIZER INC-PV202400090588$PFIZER$$$$$$Y$$$20240711$$CN$US$US
240803811$24080381$1$I$$20240710$20240711$20240711$PER$$US-PFIZER INC-202400211127$PFIZER$$$$A$$Y$$$20240711$$MD$US$US
240803822$24080382$2$F$20240709$20240717$20240711$20240722$PER$$US-PFIZER INC-202400211991$PFIZER$$59$YR$$M$Y$92.971$KG$20240722$$CN$US$US
240803831$24080383$1$I$$20240710$20240711$20240711$PER$$US-PFIZER INC-202400211313$PFIZER$$81$YR$$F$Y$$$20240711$$MD$US$US
240803841$24080384$1$I$20240601$20240710$20240711$20240711$PER$$US-PFIZER INC-PV202300151393$PFIZER$$67$YR$$F$Y$$$20240711$$CN$US$US
240803851$24080385$1$I$20240710$20240710$20240711$20240711$PER$$US-PFIZER INC-202400211573$PFIZER$$71$YR$$M$Y$$$20240711$$CN$US$US
240803862$24080386$2$F$20240710$20240710$20240711$20240716$PER$$US-PFIZER INC-202400211237$PFIZER$$73$YR$$F$Y$$$20240716$$CN$US$US
240803871$24080387$1$I$$20240708$20240711$20240711$PER$$US-PFIZER INC-PV202400090037$PFIZER$$$$$$Y$$$20240711$$CN$US$US
240803882$24080388$2$F$$20240904$20240711$20240905$PER$$US-PFIZER INC-PV202400090856$PFIZER$$59$YR$$F$Y$$$20240905$$HP$US$US
240803895$24080389$5$F$20240101$20240924$20240711$20240927$PER$$US-PFIZER INC-202400209993$PFIZER$$71$YR$$F$Y$81.65$KG$20240927$$CN$US$US
240803901$24080390$1$I$20240710$20240710$20240711$20240711$PER$$US-PFIZER INC-202400211618$PFIZER$$66$YR$$F$Y$$$20240711$$CN$US$US
240803911$24080391$1$I$20240710$20240710$20240711$20240711$PER$$US-PFIZER INC-202400212243$PFIZER$$66$YR$$F$Y$$$20240711$$CN$US$US
240803921$24080392$1$I$$20240710$20240711$20240711$PER$$US-PFIZER INC-PV202400090839$PFIZER$$57$YR$$F$Y$$$20240711$$HP$US$US
240803931$24080393$1$I$$20240710$20240711$20240711$PER$$US-PFIZER INC-202400211695$PFIZER$$$$$M$Y$$$20240711$$HP$US$US
240803941$24080394$1$I$$20240709$20240711$20240711$PER$$US-PFIZER INC-202200335125$PFIZER$$75$YR$$F$Y$$$20240711$$CN$US$US
240803952$24080395$2$F$$20240826$20240711$20240828$PER$$US-PFIZER INC-PV202400090716$PFIZER$$48$YR$$F$Y$$$20240828$$CN$US$US
240803961$24080396$1$I$$20240709$20240711$20240711$PER$$US-PFIZER INC-PV202400090353$PFIZER$$$$$M$Y$$$20240711$$CN$US$US
240803974$24080397$4$F$$20240821$20240711$20240826$PER$$US-PFIZER INC-202400211170$PFIZER$$81$YR$$F$Y$$$20240826$$CN$US$US
240803981$24080398$1$I$$20240710$20240711$20240711$PER$$US-PFIZER INC-PV202400090848$PFIZER$$69$YR$$F$Y$$$20240711$$CN$US$US
240803991$24080399$1$I$$20240710$20240711$20240711$PER$$US-PFIZER INC-202400211107$PFIZER$$$$$F$Y$$$20240711$$CN$US$US
240804001$24080400$1$I$$20240621$20240711$20240711$PER$$US-JNJFOC-20240662438$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$CN$US$US
240804012$24080401$2$F$$20240910$20240711$20240918$EXP$$US-VANTIVE-2024VAN018177$Vantive US Healthcare$$$$$F$Y$$$20240918$$HP$US$US
240804022$24080402$2$F$20240701$20240703$20240711$20240910$EXP$$US-VANTIVE-2024VAN018143$Vantive US Healthcare$$$$$$Y$$$20240910$$HP$US$US
240804041$24080404$1$I$$20240709$20240711$20240711$EXP$$US-VANTIVE-2024VAN018238$Vantive US Healthcare$$$$$F$Y$$$20240711$$HP$US$US
240804051$24080405$1$I$$20240630$20240711$20240711$EXP$$US-RDY-LIT/USA/24/0009877$DR REDDYS$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. Journal of Maternal-Fetal and Neonatal Medicine. 2024;37(1): doi:10.1080/14767058.2024.2355293.$$$$F$Y$$$20240711$$HP$US$US
240804061$24080406$1$I$$20240630$20240711$20240711$PER$$US-RDY-LIT/USA/24/0009875$DR REDDYS$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. Journal of Maternal-Fetal and Neonatal Medicine. 2024;37(1): doi:10.1080/14767058.2024.2355293.$$$$F$Y$$$20240711$$HP$US$US
240804081$24080408$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48194$$FDA-CTU$$44$YR$$M$N$220$LBS$20240711$N$$US$
240804091$24080409$1$I$$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48199$$FDA-CTU$$$$$F$N$$$20240710$N$HP$US$
240804101$24080410$1$I$20240630$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48091$$FDA-CTU$$71$YR$$M$N$$$20240711$N$$US$
240804132$24080413$2$F$$20240815$20240711$20240828$PER$$US-SA-2024SA202137$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240828$$CN$US$US
240804141$24080414$1$I$$20240708$20240711$20240711$EXP$$CA-FreseniusKabi-FK202410778$FRESENIUS KABI$$5$YR$C$F$Y$$$20240711$$HP$CA$CA
240804151$24080415$1$I$$20240710$20240711$20240711$PER$$US-BIOGEN-2024BI01272757$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240804163$24080416$3$F$20240617$20240806$20240711$20240813$PER$$US-FreseniusKabi-FK202410538$FRESENIUS KABI$$68$YR$E$F$Y$$$20240813$$MD$US$US
240804171$24080417$1$I$20210317$20240708$20240711$20240711$EXP$FR-AFSSAPS-MA2024001144$FR-FreseniusKabi-FK202410842$FRESENIUS KABI$$70$YR$E$F$Y$$$20240711$$PH$FR$FR
240804191$24080419$1$I$$20240708$20240711$20240711$PER$$US-BIOGEN-2024BI01272733$BIOGEN$$$$E$F$Y$$$20240711$$MD$US$US
240804202$24080420$2$F$20240703$20240718$20240711$20240725$30DAY$$US-AMGEN-USASP2024134131$AMGEN$$18$YR$A$M$Y$63.7$KG$20240725$$HP$US$US
240804211$24080421$1$I$20240601$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135109$AMGEN$$22$YR$A$F$Y$$$20240711$$CN$US$US
240804223$24080422$3$F$$20240716$20240711$20240723$EXP$$NO-GSK-NO2024EME082976$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$NO$NO
240804231$24080423$1$I$20230925$20240705$20240711$20240711$EXP$$BR-GSK-BR2023AMR119839$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$BR$BR
240804241$24080424$1$I$20240101$20240708$20240711$20240711$EXP$$NVSC2024BR143161$NOVARTIS$$$$$M$Y$75$KG$20240711$$CN$BR$BR
240804251$24080425$1$I$$20240705$20240711$20240711$PER$$US-JNJFOC-20240715897$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$MD$US$US
240804261$24080426$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48143$$FDA-CTU$$55$YR$$F$N$$$20240711$N$$US$
240804273$24080427$3$F$20240702$20240717$20240711$20240725$EXP$$CA-JNJFOC-20240713930$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20240725$$HP$CA$CA
240804281$24080428$1$I$$20240708$20240711$20240711$PER$$US-JNJFOC-20240720159$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$HP$US$US
240804291$24080429$1$I$$20240627$20240711$20240711$EXP$$US-NOVOPROD-1248075$NOVO NORDISK$$$$$M$Y$$$20240711$$HP$US$US
240804302$24080430$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3217882$TEVA$Zaidi W, Saeed AI, Lundquist N, Nelson AR, Razia D, Lee R, et al. Bronchoscopic Debridement of Endobronchial Rhizopus With 1.1 Mm Cryoprobe in Lung Transplant Recipient. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Zaidi W, Saeed AI, Lundquist N, Nelson AR, Razia D, Lee R, et al. Bronchoscopic Debridement of Endobronchial Rhizopus With 1.1 Mm Cryoprobe in Lung Transplant Recipient. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$67$YR$$M$Y$$$20240809$$HP$US$US
240804312$24080431$2$F$$20240806$20240711$20240816$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI06731$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240816$$PH$JP$JP
240804321$24080432$1$I$20240703$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006139$ELI LILLY AND CO$$$$A$F$Y$$$20240711$$CN$US$US
240804331$24080433$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006788$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240711$$CN$US$US
240804341$24080434$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006281$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240711$$CN$US$US
240804351$24080435$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006415$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240711$$CN$US$US
240804361$24080436$1$I$20240708$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006105$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240711$$CN$US$US
240804371$24080437$1$I$20240625$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006291$ELI LILLY AND CO$$$$A$F$Y$$$20240711$$CN$US$US
240804381$24080438$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006085$ELI LILLY AND CO$$81$YR$E$$Y$$$20240711$$CN$US$US
240804391$24080439$1$I$$20240710$20240711$20240711$EXP$$NVSC2024US143427$NOVARTIS$$72$YR$$$Y$$$20240711$$MD$US$US
240804411$24080441$1$I$$20240708$20240711$20240711$PER$$US-TAKEDA-2024TUS069917$TAKEDA$$40$YR$$F$Y$$$20240711$$CN$US$US
240804422$24080442$2$F$20240415$20240704$20240711$20240713$EXP$FR-AFSSAPS-PC2024000499$FR-TEVA-VS-3216705$TEVA$$63$YR$$M$Y$86$KG$20240713$$MD$FR$FR
240804441$24080444$1$I$20240704$20240705$20240711$20240711$PER$$US-UNITED THERAPEUTICS-UNT-2024-020972$UNITED THERAPEUTICS$$65$YR$$M$Y$107.03$KG$20240711$$$US$US
240804451$24080445$1$I$20230816$20240627$20240711$20240711$PER$$US-APELLIS-2024-APL-0000288$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$HP$US$US
240804461$24080446$1$I$$20240703$20240711$20240711$EXP$$US-ALXN-202407USA000315US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
240804473$24080447$3$F$$20240909$20240711$20240930$30DAY$$IT-JNJFOC-20240668263$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$IT$IT
240804481$24080448$1$I$$20240705$20240711$20240711$PER$$US-JNJFOC-20240718145$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240804491$24080449$1$I$20240410$20240705$20240711$20240711$EXP$FR-AFSSAPS-TO2024000975$FR-EMD Serono-2024031709$EMD SERONO INC$$86$YR$E$M$Y$70$KG$20240711$$PH$FR$FR
240804503$24080450$3$F$20230101$20240826$20240711$20240905$EXP$$CA-UCBSA-2023048499$UCB$$$$$F$Y$$$20240905$$CN$CA$CA
240804511$24080451$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158354$ASTRAZENECA$$73$YR$$F$Y$56$KG$20240711$$HP$FR$
240804521$24080452$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158448$ASTRAZENECA$$64$YR$$M$Y$70$KG$20240711$$HP$FR$
240804533$24080453$3$F$$20240718$20240711$20240723$EXP$$JP-JNJFOC-20240726832$JOHNSON AND JOHNSON$$72$YR$E$F$Y$51$KG$20240723$$MD$JP$JP
240804541$24080454$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199832$SANOFI AVENTIS$$5$YR$C$F$Y$19.9$KG$20240711$$MD$US$US
240804551$24080455$1$I$$20240706$20240711$20240711$PER$$NVSC2024US141055$NOVARTIS$$$$$$Y$$$20240711$$CN$US$US
240804561$24080456$1$I$$20240603$20240711$20240711$PER$$US-Eisai-EC-2024-167243$EISAI$Ogunderu A, Pollack A, Milekic B. DOUBLE JEOPARDY: IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYASTHENIA GRAVIS AND HEMORRHAGIC STROKE. Critical Care Medicine 52 (Suppl.): S271 abstr. 596, No. 1. 2024 Jan;304-304. doi:https://dx.doi.org/10.1097/01.ccm.0001000560.01975.fb.$70$YR$E$M$Y$$$20240711$$MD$US$US
240804571$24080457$1$I$$20240703$20240711$20240711$EXP$$GB-AstraZeneca-2024A153937$ASTRAZENECA$Patel M.; Cernova J.; Harwood C.. Severe photosensitivity complicating anti-PDL1 checkpoint inhibitor treatment: An emerging immunotherapy-related skin toxicity. 104th Annual Meeting of the British Association of Dermatologists (BAD)$73$YR$$M$Y$$$20240711$$HP$GB$
240804581$24080458$1$I$$20240704$20240711$20240711$EXP$$US-AstraZeneca-2024A156745$ASTRAZENECA$Marsh J., Logan A.T., Bilgili E.P., Bowman L.J., Webb A.R.. Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion. Am J Health-Syst Pharm 2024;81(13):e345-e352.$53$YR$$M$Y$73$KG$20240711$$HP$US$
240804592$24080459$2$F$$20240820$20240711$20240827$EXP$$BR-AstraZeneca-2024A155398$ASTRAZENECA$$77$YR$$F$Y$$$20240827$$MD$BR$
240804601$24080460$1$I$$20240706$20240711$20240711$EXP$$IN-AstraZeneca-2024A156444$ASTRAZENECA$Paturu R., Lingaiah R., Singh S., Kumari N., Krishnani N.. A Case of Dynamic Molecular Profile in Metastatic Lung Adenocarcinoma and the Significance of Multiple-site Testing. Asia Pacific Journal of Cancer Biology 2024;9(2):247-250.$30$YR$$M$Y$$$20240711$$HP$IN$
240804611$24080461$1$I$20230101$20240704$20240711$20240711$EXP$$PL-AstraZeneca-2024A153710$ASTRAZENECA$Krawczyk M, Chajec J.. Pneumothorax as a complication of respiratory failure ? two case reports and literature review. J Pre Clin Clin Res. 2024;18(2):139-46.$28$YR$$M$Y$$$20240711$$MD$PL$
240804621$24080462$1$I$$20240709$20240711$20240711$PER$$US-HALEON-2186217$Haleon PLC$$$$$F$Y$$$20240711$$CN$US$US
240804631$24080463$1$I$$20240702$20240711$20240711$PER$$US-TEVA-VS-3216777$TEVA$$55$YR$$M$Y$$$20240711$$HP$US$US
240804651$24080465$1$I$20240528$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48201$$FDA-CTU$$97$YR$$F$N$$$20240711$N$PH$US$
240804681$24080468$1$I$$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48170$$FDA-CTU$$$$$F$N$$$20240710$N$HP$US$
240804701$24080470$1$I$20240624$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48157$$FDA-CTU$$67$YR$$F$N$$$20240710$N$HP$US$
240804721$24080472$1$I$$20240702$20240711$20240711$PER$$US-TEVA-VS-3217287$TEVA$$$$$$Y$$$20240711$$CN$US$US
240804731$24080473$1$I$$20240628$20240711$20240711$PER$$US-Calliditas-2024CAL01208$CALLIDITAS THERAPEUTICS$$41$YR$A$F$Y$$$20240711$$CN$US$US
240804741$24080474$1$I$20240706$20240709$20240711$20240711$EXP$$JP-ABBVIE-5834010$ABBVIE$$50$YR$$M$Y$$$20240711$$MD$JP$JP
240804751$24080475$1$I$$20240708$20240711$20240711$PER$$US-ABBVIE-5832337$ABBVIE$$$$$$Y$$$20240711$$HP$US$US
240804761$24080476$1$I$$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407091039521900-GMQNV$GB-TEVA-VS-3219603$TEVA$$34$YR$$F$Y$$$20240711$$CN$GB$GB
240804771$24080477$1$I$$20240620$20240711$20240711$PER$$US-APELLIS-APL-2023-002217$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$US$US
240804782$24080478$2$F$20231011$20240723$20240711$20240730$EXP$$JP-ARGENX-2024-ARGX-JP001551AA$ARGENX BVBA$$$$$$Y$$$20240730$$CN$JP$JP
240804792$24080479$2$F$$20240709$20240711$20240716$PER$$US-PFIZER INC-202400209740$PFIZER$$62$YR$$F$Y$52.62$KG$20240716$$CN$US$US
240804802$24080480$2$F$20231222$20240811$20240711$20240812$PER$$US-PFIZER INC-PV202400089348$PFIZER$$12$YR$$F$Y$45.1$KG$20240812$$MD$US$US
240804811$24080481$1$I$20240101$20240708$20240711$20240711$EXP$$US-KYOWAKIRIN-2024KK016462$KYOWA$$$$$$Y$$$20240711$$CN$US$US
240804821$24080482$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109805$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240711$$CN$US$US
240804831$24080483$1$I$$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110336$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240711$$CN$US$US
240804842$24080484$2$F$$20240821$20240711$20240821$PER$$NVSC2024US143482$NOVARTIS$$$$$$Y$$$20240821$$MD$US$US
240804851$24080485$1$I$$20240603$20240711$20240711$PER$$US-Eisai-EC-2024-167383$EISAI$Kolesnik M, Chaudhry N, Libbon R, Spitz M. Perampanel and Postictal Agitation. Epileptic Disord. 2024 May 30;00: 1-3. doi:https://doi.org/10.1002/epd2.20249.$34$YR$A$M$Y$$$20240711$$MD$US$US
240804871$24080487$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48203$$FDA-CTU$$64$YR$$F$N$140$LBS$20240711$N$$US$
240804881$24080488$1$I$$20240614$20240711$20240711$PER$$US-Eisai-EC-2024-168409$EISAI$$57$YR$A$M$Y$$$20240711$$CN$US$US
240804891$24080489$1$I$$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137027$AMGEN$$$$$M$Y$$$20240711$$CN$US$US
240804901$24080490$1$I$$20240705$20240711$20240711$EXP$$US-JNJFOC-20240721298$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240804911$24080491$1$I$$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48186$$FDA-CTU$$$$$F$N$$$20240710$N$PH$US$
240804922$24080492$2$F$$20240628$20240711$20240712$EXP$$AU-BIOVITRUM-2024-AU-006443$ADC THERAPEUTICS$$$$A$$Y$$$20240712$$MD$AU$AU
240804932$24080493$2$F$$20240805$20240711$20240828$PER$$US-PHARMING-PHAUS2024000532$PHARMING GROUP$$$$$$Y$$$20240807$$CN$US$US
240804961$24080496$1$I$$20240624$20240711$20240711$PER$$US-PHARMING-PHAUS2024000526$PHARMING GROUP$$$$$$Y$$$20240711$$CN$US$US
240804973$24080497$3$F$$20240826$20240711$20240902$PER$$US-PHARMING-PHAUS2024000530$PHARMING GROUP$$$$$$Y$$$20240902$$CN$US$US
240804981$24080498$1$I$$20240701$20240711$20240711$PER$$US-PHARMING-PHAUS2024000562$PHARMING GROUP$$$$$$Y$$$20240711$$CN$US$US
240804991$24080499$1$I$20240619$20240626$20240711$20240711$PER$$US-PHARMING-PHAUS2024000537$PHARMING GROUP$$$$$$Y$$$20240711$$CN$US$US
240805001$24080500$1$I$$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006923$ELI LILLY AND CO$$$$$F$Y$$$20240711$$CN$US$US
240805011$24080501$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48202$$FDA-CTU$$82$YR$$M$N$$$20240711$N$$US$
240805021$24080502$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006041$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240711$$CN$US$US
240805031$24080503$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006060$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240711$$CN$US$US
240805041$24080504$1$I$20240622$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48162$$FDA-CTU$$62$YR$$M$N$$$20240711$N$HP$US$
240805051$24080505$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48084$$FDA-CTU$$78$YR$$F$N$62.6$KG$20240711$N$$US$
240805061$24080506$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48204$$FDA-CTU$$43$YR$$F$N$236$LBS$20240711$N$$US$
240805071$24080507$1$I$$20240709$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA064088$SANDOZ$$72$YR$$F$Y$$$20240711$$CN$CA$CA
240805081$24080508$1$I$$20240709$20240711$20240711$PER$$US-HALEON-2186247$Haleon PLC$$$$$$Y$$$20240711$$CN$US$US
240805092$24080509$2$F$20240609$20240719$20240711$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110176$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240725$$CN$US$US
240805101$24080510$1$I$$20240703$20240711$20240711$PER$$US-PHARMING-PHAUS2024000575$PHARMING GROUP$$$$$$Y$$$20240711$$CN$US$US
240805111$24080511$1$I$$20240705$20240711$20240711$PER$$US-BAYER-2024A097549$BAYER$$84$YR$E$F$Y$$$20240711$$CN$US$US
240805121$24080512$1$I$20240705$20240705$20240711$20240711$EXP$$GT-BAYER-2024A098444$BAYER$$59$YR$A$F$Y$$$20240711$$CN$GT$GT
240805141$24080514$1$I$$20240701$20240711$20240711$EXP$$FR-Merck Healthcare KGaA-2024033284$MERCK KGAA$$33$YR$A$F$Y$$$20240709$$CN$FR$FR
240805151$24080515$1$I$$20240708$20240711$20240711$EXP$$FR-PFIZER INC-202400208540$PFIZER$$$$$F$Y$$$20240711$$PH$FR$FR
240805171$24080517$1$I$20240607$20240708$20240711$20240711$EXP$FR-AFSSAPS-GR2024000832$FR-PFIZER INC-202400208565$PFIZER$$10$YR$$M$Y$35$KG$20240711$$PH$FR$FR
240805181$24080518$1$I$$20240708$20240711$20240711$EXP$GB-MHRA-MED-202407081259418950-GBKPD$GB-PFIZER INC-202400209005$PFIZER$$39$YR$$F$Y$$$20240711$$HP$GB$GB
240805195$24080519$5$F$20240701$20240816$20240711$20240819$EXP$$CA-ALXN-202407CAN000274CA$ALEXION PHARMACEUTICALS$$70$YR$$M$Y$81$KG$20240819$$MD$CA$CA
240805201$24080520$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA201243$SANOFI AVENTIS$$$$E$F$Y$88.45$KG$20240711$$MD$US$US
240805211$24080521$1$I$20240630$20240702$20240711$20240711$EXP$GB-MHRA-MED-202407021519292830-RKTQF$GB-TEVA-VS-3216531$TEVA$$67$YR$$F$Y$$$20240711$$HP$GB$GB
240805221$24080522$1$I$20170101$20240708$20240711$20240711$EXP$$AT-PFIZER INC-2021533268$PFIZER$$58$YR$$M$Y$$$20240711$$MD$AT$AT
240805231$24080523$1$I$$20240710$20240711$20240711$PER$$US-BIOGEN-2024BI01272616$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240805241$24080524$1$I$$20240701$20240711$20240711$EXP$$US-B.Braun Medical Inc.-2159051$B BRAUN$Literatue Article$65$YR$$M$Y$$$20240711$$$US$US
240805251$24080525$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA199960$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240711$$MD$US$US
240805261$24080526$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA201109$SANOFI AVENTIS$$$$A$F$Y$104$KG$20240711$$MD$US$US
240805271$24080527$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA199340$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240711$$MD$US$US
240805291$24080529$1$I$$20240619$20240711$20240711$PER$$US-Eisai-EC-2024-168497$EISAI$Tu BH, Khalyfa A, Bellizzi AM, Tanaka T. Hepatocellular Carcinoma With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Absence of Cirrhosis. ACG Case Report Journal. 2024 May 09;e01348(11(5)): 1-3. doi:10.14309/crj.0000000000001348.$77$YR$E$M$Y$$$20240711$$MD$US$US
240805301$24080530$1$I$$20240619$20240711$20240711$PER$$US-Eisai-EC-2024-168566$EISAI$$67$YR$E$M$Y$$$20240711$$MD$US$US
240805314$24080531$4$F$$20240827$20240711$20240830$30DAY$$CL-PFIZER INC-PV202400089281$PFIZER$$12$YR$$F$Y$$$20240830$$CN$CL$CL
240805322$24080532$2$F$20240626$20240913$20240711$20240918$30DAY$$AR-PFIZER INC-202400204356$PFIZER$$8$YR$$M$Y$$$20240918$$HP$AR$AR
240805331$24080533$1$I$$20240709$20240711$20240711$30DAY$$US-PFIZER INC-202400209858$PFIZER$$35$YR$$F$Y$$$20240711$$CN$US$US
240805345$24080534$5$F$$20240913$20240711$20240917$30DAY$$ES-PFIZER INC-202400200171$PFIZER$$15$YR$$M$Y$50.8$KG$20240917$$PH$ES$ES
240805353$24080535$3$F$20240705$20240923$20240711$20240925$30DAY$$US-PFIZER INC-202400209266$PFIZER$$7$YR$$M$Y$$$20240925$$CN$US$US
240805361$24080536$1$I$20240701$20240710$20240711$20240711$PER$$US-JNJFOC-20240726352$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$CN$US$US
240805372$24080537$2$F$$20240711$20240711$20240716$EXP$$FR-PFIZER INC-202400202364$PFIZER$$6$YR$$F$Y$$$20240716$$PH$FR$FR
240805381$24080538$1$I$20240708$20240709$20240711$20240711$PER$$US-JNJFOC-20240725984$JOHNSON AND JOHNSON$$16$YR$T$$Y$$$20240711$$MD$US$US
240805391$24080539$1$I$$20240710$20240711$20240711$PER$$US-JNJFOC-20240728449$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240805412$24080541$2$F$$20240724$20240711$20240730$EXP$$SA-SANDOZ INC.-SDZ2024SA064160$SANDOZ$$$$$M$Y$$$20240730$$HP$SA$SA
240805421$24080542$1$I$20240210$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48206$$FDA-CTU$$36$YR$$F$N$$$20240711$N$$US$
240805431$24080543$1$I$20240705$20240705$20240711$20240711$EXP$$GB-SANDOZ INC.-SDZ2024GB063567$SANDOZ$$$$A$M$Y$$$20240711$$CN$GB$GB
240805441$24080544$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA198416$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240711$$MD$US$US
240805451$24080545$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA200578$SANOFI AVENTIS$$$$E$M$Y$95.25$KG$20240711$$MD$US$US
240805461$24080546$1$I$$20240701$20240711$20240711$EXP$$CA-TEVA-VS-3216726$TEVA$$14$YR$$M$Y$84$KG$20240711$$PH$CA$CA
240805471$24080547$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA201299$SANOFI AVENTIS$$$$A$F$Y$104.32$KG$20240711$$MD$US$US
240805481$24080548$1$I$$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48210$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
240805491$24080549$1$I$$20240703$20240711$20240711$PER$$US-SA-2024SA199241$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240711$$MD$US$US
240805501$24080550$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110252$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240711$$HP$US$US
240805511$24080551$1$I$20240629$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110323$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240711$$CN$US$US
240805521$24080552$1$I$20240701$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48205$$FDA-CTU$$63$YR$$F$N$$$20240711$Y$PH$US$
240805543$24080554$3$F$20231227$20240821$20240711$20240828$EXP$$CA-GSK-CA2024014426$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$CA$CA
240805551$24080555$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48103$$FDA-CTU$$66$YR$$F$N$114$LBS$20240711$N$$US$
240805561$24080556$1$I$$20240705$20240711$20240711$EXP$$NVSC2024TR141490$NOVARTIS$Babaoglu K, Basar EZ, Usta E, Yllmaz EH, Gunlemez A. Effect of different dose regimens of everolimus in a series of neonates with giant cardiac rhabdomyomas. CARDIOLOGY IN THE YOUNG. 2023;33(11):2291-6$$$N$F$Y$$$20240711$$HP$TR$TR
240805572$24080557$2$F$20201007$20240906$20240711$20240910$EXP$$DE-SANDOZ INC.-NVSC2020DE273972$SANDOZ$$$$E$F$Y$87$KG$20240910$$MD$DE$DE
240805581$24080558$1$I$20240501$20240509$20240711$20240711$PER$$US-KARYOPHARM-2024KPT001060$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240711$$CN$US$US
240805591$24080559$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48192$$FDA-CTU$$69$YR$$M$N$$$20240711$N$$US$
240805601$24080560$1$I$20240702$20240711$20240711$20240711$DIR$709900$$FDA-CTU$$47$YR$$M$N$99$KG$20240711$N$HP$US$
240805611$24080561$1$I$20240622$20240711$20240711$20240711$DIR$709898$$FDA-CTU$$50$YR$$F$N$$$20240711$Y$HP$US$
240805621$24080562$1$I$20240702$20240708$20240711$20240711$EXP$$CN-BAYER-2024A098523$BAYER$$77$YR$E$M$Y$56$KG$20240711$$HP$CN$CN
240805631$24080563$1$I$$20240709$20240711$20240711$EXP$$US-TAKEDA-2024TUS070509$TAKEDA$$$$$F$Y$$$20240711$$MD$US$US
240805641$24080564$1$I$$20240708$20240711$20240711$EXP$$CN-FERRINGPH-2024FE03771$FERRING$$$$$$Y$$$20240711$$CN$CN$CN
240805651$24080565$1$I$20240617$20240705$20240711$20240711$EXP$GB-MHRA-MED-202406261258482140-RYNVF$GB-FERRINGPH-2024FE03763$FERRING$$$$$$Y$$$20240711$$HP$GB$GB
240805661$24080566$1$I$$20240708$20240711$20240711$EXP$$CN-FERRINGPH-2024FE03776$FERRING$$$$$$Y$$$20240711$$CN$CN$CN
240805671$24080567$1$I$$20240708$20240711$20240711$EXP$$CN-FERRINGPH-2024FE03773$FERRING$$$$$$Y$$$20240711$$CN$CN$CN
240805682$24080568$2$F$$20240709$20240711$20240711$30DAY$$US-SANDOZ INC.-SDZ2024US064481$SANDOZ$$$$$F$Y$$$20240711$$CN$US$US
240805691$24080569$1$I$20240701$20240710$20240711$20240711$PER$$US-JNJFOC-20240726802$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240711$$CN$US$US
240805701$24080570$1$I$20230301$20240703$20240711$20240711$EXP$$VN-SANDOZ INC.-SDZ2024VN064290$SANDOZ$$64$YR$$F$Y$$$20240711$$MD$VN$VN
240805711$24080571$1$I$$20240708$20240711$20240711$EXP$$CN-OTSUKA-2024_019388$OTSUKA$Li Y, Hu G, Xu L, Zhang X, Liu K, Cheng YF, et.al.. CAR-T Therapy Followed by Hematopoietic Stem Cell Transplantation Can Improve Survival in Children Relapsed/Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2024;46(5):241-47$13$YR$$M$Y$$$20240711$$MD$CN$CN
240805731$24080573$1$I$20220205$20240711$20240711$20240711$EXP$PT-INFARMED-A202406-731$NVSC2024PT143270$NOVARTIS$$56$YR$$F$Y$$$20240711$$MD$PT$PT
240805741$24080574$1$I$$20240709$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA063914$SANDOZ$$$$$M$Y$$$20240711$$MD$CA$CA
240805761$24080576$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199929$SANOFI AVENTIS$$$$C$F$Y$52.1$KG$20240711$$MD$US$US
240805771$24080577$1$I$20231105$20240708$20240711$20240711$EXP$$KR-SANDOZ INC.-SDZ2024KR063802$SANDOZ$$$$$M$Y$53$KG$20240711$$HP$KR$KR
240805781$24080578$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA020301$SANOFI AVENTIS$$$$E$F$Y$59.8$KG$20240711$$MD$US$US
240805791$24080579$1$I$20240609$20240708$20240711$20240711$EXP$$US-ABBVIE-5834489$ABBVIE$$72$YR$$F$Y$$$20240711$$HP$US$US
240805801$24080580$1$I$20240709$20240709$20240711$20240711$EXP$$JP-PFIZER INC-PV202400089708$PFIZER$$83$YR$$M$Y$$$20240711$$PH$JP$JP
240805811$24080581$1$I$20240708$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407081333031060-LQDMN$GB-PFIZER INC-202400209736$PFIZER$$76$YR$$M$Y$115$KG$20240711$$HP$GB$GB
240805821$24080582$1$I$20240707$20240709$20240711$20240711$EXP$$CN-PFIZER INC-PV202400090053$PFIZER$$58$YR$$F$Y$65$KG$20240711$$HP$CN$CN
240805832$24080583$2$F$$20240711$20240711$20240715$PER$$US-JNJFOC-20240728386$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240805841$24080584$1$I$$20240708$20240711$20240711$EXP$$GB-PFIZER INC-2024SGN04559$PFIZER$$51$YR$$F$Y$$$20240711$$MD$GB$GB
240805852$24080585$2$F$20230525$20240709$20240711$20240716$EXP$CA-GSK-CA2024082630$CA-GSK-CA2023086852$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$CA$CA
240805861$24080586$1$I$$20240710$20240711$20240711$30DAY$$US-SANDOZ INC.-SDZ2024US064563$SANDOZ$$$$$F$Y$$$20240711$$HP$US$US
240805871$24080587$1$I$20240625$20240711$20240711$20240711$DIR$709893$$FDA-CTU$$67$YR$$F$N$75.6$KG$20240711$N$CN$US$
240805883$24080588$3$F$20231101$20240805$20240711$20240806$EXP$FR-AFSSAPS-TS2024000765$FR-SANDOZ INC.-SDZ2024FR064324$SANDOZ$$78$YR$$F$Y$$$20240806$$MD$FR$FR
240805891$24080589$1$I$$20240708$20240711$20240711$EXP$$AT-PFIZER INC-2021SGN02677$PFIZER$$58$YR$$M$Y$$$20240711$$MD$AT$AT
240805901$24080590$1$I$$20240710$20240711$20240711$EXP$$DE-SANDOZ INC.-SDZ2024DE064150$SANDOZ$$54$YR$$M$Y$$$20240711$$HP$DE$DE
240805911$24080591$1$I$20240707$20240708$20240711$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202407005385$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240711$$CN$US$US
240805923$24080592$3$F$20240219$20240830$20240711$20240910$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407003621$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240910$$CN$JP$JP
240805932$24080593$2$F$20240608$20240711$20240711$20240724$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407006595$ELI LILLY AND CO$$$$$F$Y$88$KG$20240724$$CN$GB$GB
240805941$24080594$1$I$20240128$20240705$20240711$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004278$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240711$$CN$US$US
240805951$24080595$1$I$20240519$20240701$20240711$20240711$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407001534$ELI LILLY AND CO$$$$$M$Y$$$20240711$$CN$BR$BR
240805961$24080596$1$I$20150101$20240628$20240711$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000363$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240711$$CN$US$US
240805971$24080597$1$I$$20240705$20240711$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202407005174$ELI LILLY AND CO$$$$$M$Y$$$20240711$$CN$US$US
240805981$24080598$1$I$20230701$20240702$20240711$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002459$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240711$$CN$US$US
240805991$24080599$1$I$$20240628$20240711$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202407000302$ELI LILLY AND CO$$$$$$Y$$$20240711$$CN$US$US
240806001$24080600$1$I$20240703$20240705$20240711$20240711$EXP$$CN-DSJP-DSJ-2024-131032$DAIICHI$$88$YR$$M$Y$$$20240711$$HP$CN$CN
240806011$24080601$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA201580$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240711$$MD$US$US
240806022$24080602$2$F$$20240731$20240711$20240802$EXP$$US-ROCHE-10000011555$ROCHE$$78$YR$E$F$Y$$$20240802$$CN$US$US
240806031$24080603$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199465$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240711$$MD$US$US
240806041$24080604$1$I$20230101$20240702$20240711$20240711$PER$$US-SA-2023SA218029$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240711$$CN$US$US
240806055$24080605$5$F$$20240806$20240711$20240812$EXP$$US-TAKEDA-2024TUS066903$TAKEDA$$$$$F$Y$$$20240812$$CN$US$US
240806061$24080606$1$I$$20240710$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA064402$SANDOZ$$73$YR$$F$Y$$$20240711$$CN$CA$CA
240806071$24080607$1$I$20240129$20240701$20240711$20240711$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024081596$VIIV$$66$YR$$M$Y$$$20240711$$CN$US$US
240806081$24080608$1$I$20240710$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137100$AMGEN$$64$YR$A$F$Y$$$20240711$$CN$US$US
240806101$24080610$1$I$$20240709$20240711$20240711$30DAY$$US-SANDOZ INC.-SDZ2024US064587$SANDOZ$$34$YR$$F$Y$$$20240711$$CN$US$US
240806121$24080612$1$I$$20240710$20240711$20240711$EXP$$US-TAKEDA-2024TUS070555$TAKEDA$$$$$F$Y$$$20240711$$MD$US$US
240806133$24080613$3$F$20240612$20240925$20240711$20240930$EXP$$US-TAKEDA-2024TUS059974$TAKEDA$$38$YR$$F$Y$64$KG$20240930$$CN$US$US
240806141$24080614$1$I$20240701$20240704$20240711$20240711$PER$$GR-KARYOPHARM-2024KPT001282$KARYOPHARM THERAPEUTICS$$79$YR$$F$Y$$$20240711$$HP$GR$GR
240806162$24080616$2$F$$20240712$20240711$20240720$PER$$US-JNJFOC-20240721342$JOHNSON AND JOHNSON$$61$YR$A$M$Y$74.2$KG$20240719$$MD$US$US
240806181$24080618$1$I$20240615$20240711$20240711$20240711$DIR$709901$$FDA-CTU$$36$YR$$F$N$63$KG$20240711$N$CN$US$
240806191$24080619$1$I$20240423$20240702$20240711$20240711$EXP$$NVSC2024IN097761$NOVARTIS$$53$YR$$M$Y$$$20240711$$CN$IN$IN
240806201$24080620$1$I$$20240709$20240711$20240711$30DAY$$US-SANDOZ INC.-SDZ2023US014135$SANDOZ$$$$$F$Y$$$20240711$$HP$US$US
240806221$24080622$1$I$$20240710$20240711$20240711$EXP$$US-GILEAD-2024-0680313$GILEAD$$$$$$Y$$$20240711$$LW$US$US
240806231$24080623$1$I$$20240710$20240711$20240711$EXP$$US-GILEAD-2024-0680316$GILEAD$$$$$$Y$$$20240711$$LW$US$US
240806241$24080624$1$I$20240125$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407081950377100-MCSQK$GB-SANDOZ INC.-SDZ2024GB064191$SANDOZ$$4$YR$$M$Y$16$KG$20240711$$CN$GB$GB
240806252$24080625$2$F$$20240711$20240711$20240712$EXP$$US-SANDOZ INC.-SDZ2024US064564$SANDOZ$$$$$F$Y$$$20240712$$CN$US$US
240806265$24080626$5$F$$20240829$20240711$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA034251$SANDOZ$$$$$M$Y$$$20240902$$MD$CA$CA
240806271$24080627$1$I$20240401$20240704$20240711$20240711$EXP$$US-GSK-US2024049412$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$HP$US$US
240806281$24080628$1$I$$20240705$20240711$20240711$PER$$US-Millicent Holdings Ltd.-MILL20241019$MILLICENT HOLDINGS$$$$$F$Y$$$20240711$$CN$US$US
240806291$24080629$1$I$20240101$20240708$20240711$20240711$EXP$BE-FAMHP-DHH-N2024-122338$BE-MYLANLABS-2024M1064300$MYLAN$$63$YR$$F$Y$$$20240711$$PH$BE$BE
240806301$24080630$1$I$20240626$20240709$20240711$20240711$EXP$$AT-PFIZER INC-PV202400090502$PFIZER$$84$YR$$F$Y$65$KG$20240711$$MD$AT$AT
240806313$24080631$3$F$$20240722$20240711$20240725$EXP$$ZA-PFIZER INC-PV202400090393$PFIZER$$$$$$Y$$$20240725$$CN$ZA$ZA
240806322$24080632$2$F$20240707$20240715$20240711$20240717$EXP$$US-KARYOPHARM-2024KPT001284$KARYOPHARM THERAPEUTICS$$53$YR$$M$Y$89.7$KG$20240717$$MD$US$US
240806341$24080634$1$I$20220201$20240708$20240711$20240711$EXP$$FR-PFIZER INC-202400208577$PFIZER$$72$YR$$M$Y$82$KG$20240711$$MD$FR$FR
240806362$24080636$2$F$$20240814$20240711$20240822$EXP$$US-AstraZeneca-2024A149231$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
240806371$24080637$1$I$$20240708$20240711$20240711$PER$$US-JNJFOC-20240721767$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240711$$HP$US$US
240806381$24080638$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153417$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240806391$24080639$1$I$$20240704$20240711$20240711$EXP$$CN-AstraZeneca-2024A157476$ASTRAZENECA$ZHANG X, YANG N, ZHANG Y, et al.. Immunotherapy combined with chemotherapy reversed MET D1228E and EGFR L858R-mediated drug resistance of lung adenocarcinoma with MET 14 exon skipping mutation. Anti-tumor Pharmacy 2024;14(2):252-255.$66$YR$$F$Y$$$20240711$$MD$CN$
240806402$24080640$2$F$$20240806$20240711$20240814$EXP$$JP-AstraZeneca-2024A154581$ASTRAZENECA$Kugiyama Y, et al.. OS3-5 A case of advanced hepatocellular carcinoma that developed thyroid crisis during durvalumab + tremelimumab combination therapy.. The 30th Japan Association of Systemic Therapy for HCC 2024;96-.$71$YR$$M$Y$$$20240814$$MD$JP$
240806411$24080641$1$I$20240101$20240708$20240711$20240711$EXP$$JP-AstraZeneca-2024A157441$ASTRAZENECA$$$$$M$Y$$$20240711$$PH$JP$
240806431$24080643$1$I$$20240708$20240711$20240711$PER$$US-BAYER-2024A098556$BAYER$$$$$F$Y$$$20240711$$MD$US$US
240806441$24080644$1$I$$20240703$20240711$20240711$EXP$$CA-AstraZeneca-2024A153831$ASTRAZENECA$$$$$F$Y$$$20240711$$HP$CA$
240806453$24080645$3$F$20240621$20240821$20240711$20240827$EXP$$NVSC2024GB136674$NOVARTIS$$$$$F$Y$$$20240827$$CN$GB$GB
240806461$24080646$1$I$$20240709$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2024US064611$SANDOZ$$$$$$Y$$$20240711$$HP$US$US
240806471$24080647$1$I$$20240615$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN006416$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240806481$24080648$1$I$$20240702$20240711$20240711$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR084559$VIIV$$$$$$Y$$$20240711$$HP$US$US
240806492$24080649$2$F$$20240924$20240711$20240927$30DAY$$FR-PFIZER INC-PV202400089886$PFIZER$$13$YR$$M$Y$$$20240927$$MD$FR$FR
240806504$24080650$4$F$$20240924$20240711$20240926$30DAY$$IL-PFIZER INC-202400204700$PFIZER$$$$$F$Y$$$20240926$$CN$IL$IL
240806511$24080651$1$I$20240701$20240708$20240711$20240711$30DAY$$AR-PFIZER INC-202400206132$PFIZER$$8$YR$$M$Y$$$20240711$$CN$AR$AR
240806521$24080652$1$I$$20240627$20240711$20240711$30DAY$$SA-PFIZER INC-202400211128$PFIZER$$$$$M$Y$$$20240711$$CN$SA$SA
240806531$24080653$1$I$20240101$20240709$20240711$20240711$PER$$US-BAUSCH-BL-2024-010510$BAUSCH AND LOMB$$18$YR$$M$Y$$$20240711$$CN$US$US
240806541$24080654$1$I$$20240618$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN006532$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240806552$24080655$2$F$20240401$20240716$20240711$20240723$EXP$$US-ABBVIE-5832575$ABBVIE$$66$YR$$F$Y$84$KG$20240723$$CN$US$US
240806561$24080656$1$I$20240531$20240708$20240711$20240711$EXP$$US-ABBVIE-5832225$ABBVIE$$71$YR$$M$Y$$$20240711$$CN$US$US
240806572$24080657$2$F$20240101$20240723$20240711$20240725$PER$$US-AMGEN-USASP2024134903$AMGEN$$69$YR$E$F$Y$$$20240725$$MD$US$US
240806582$24080658$2$F$20240101$20240731$20240711$20240820$PER$$US-TEVA-VS-3216790$TEVA$$58$YR$$F$Y$61.23$KG$20240820$$CN$US$US
240806601$24080660$1$I$$20240709$20240711$20240711$PER$$US-ABBVIE-5835526$ABBVIE$$$$$$Y$$$20240711$$CN$US$US
240806611$24080661$1$I$20210101$20240701$20240711$20240711$EXP$$RO-EMD Serono-2024035975$EMD SERONO INC$Late-onset congenital adrenal hyperplasia - a low-key differential diagnosis. Acta medica marisiensis. 2024;70: 275-275.$31$YR$A$F$Y$$$20240711$$MD$RO$RO
240806622$24080662$2$F$20240604$20240710$20240711$20240712$EXP$$US-KARYOPHARM-2024KPT000617$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240712$$CN$US$US
240806632$24080663$2$F$$20240710$20240711$20240718$EXP$$IT-BAUSCH-BL-2024-010500$BAUSCH AND LOMB$Muggeo P, Sinisi C, Angarano R, Daniele R, Grassi M, Ingravallo G, Santoro N. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports.. Journal of pediatric hematology/oncology. 2024;1-4. doi:10.1097/MPH.0000000000002904.$13$YR$$M$Y$$$20240718$$MD$IT$IT
240806641$24080664$1$I$$20240710$20240711$20240711$PER$$US-BAUSCH-BL-2024-010539$BAUSCH AND LOMB$$37$YR$$F$Y$$$20240711$$CN$US$US
240806651$24080665$1$I$20240601$20240702$20240711$20240711$EXP$$US-TRAVERE-2024TVT00671$TRAVERE THERAPEUTICS$$38$YR$A$F$Y$$$20240711$$CN$US$US
240806661$24080666$1$I$$20240710$20240711$20240711$EXP$$US-BAUSCH-BL-2024-010585$BAUSCH AND LOMB$$84$YR$$M$Y$$$20240711$$CN$US$US
240806671$24080667$1$I$$20240702$20240711$20240711$EXP$$CA-ALCON LABORATORIES-ALC2024CA003209$ALCON$$71$YR$$F$Y$77$KG$20240711$$HP$CA$CA
240806682$24080668$2$F$20240101$20240714$20240711$20240722$EXP$$EG-009507513-2407EGY003477$MERCK$$$$A$F$Y$$$20240719$$CN$EG$EG
240806691$24080669$1$I$20240628$20240702$20240711$20240711$PER$$US-MYLANLABS-2024M1062441$MYLAN$$55$YR$$F$Y$$$20240711$$CN$US$US
240806701$24080670$1$I$20240501$20240705$20240711$20240711$EXP$$US-MYLANLABS-2024M1064716$MYLAN$$23$YR$$F$Y$$$20240711$$MD$US$US
240806711$24080671$1$I$20240617$20240705$20240711$20240711$EXP$FR-AFSSAPS-RN2024000728$FR-MYLANLABS-2024M1063636$MYLAN$$68$YR$$F$Y$$$20240711$$MD$FR$FR
240806722$24080672$2$F$$20240711$20240711$20240718$PER$$US-MYLANLABS-2024M1064347$MYLAN$$$$$$Y$$$20240718$$CN$US$US
240806733$24080673$3$F$$20240822$20240711$20240828$EXP$$IT-MYLANLABS-2024M1063624$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology.. European Journal of Haematology. 2024;113 (1):90-8$11$YR$$M$Y$$$20240828$$HP$IT$IT
240806741$24080674$1$I$20240101$20240708$20240711$20240711$EXP$BE-FAMHP-DHH-N2024-122339$BE-MYLANLABS-2024M1064193$MYLAN$$$$$M$Y$$$20240711$$PH$BE$BE
240806752$24080675$2$F$20230515$20240722$20240711$20240725$EXP$$DE-MYLANLABS-2024M1063897$MYLAN$$$$A$F$Y$$$20240725$$MD$DE$DE
240806761$24080676$1$I$20240708$20240710$20240711$20240711$EXP$GB-MHRA-MED-202407091447195470-LPKSN$GB-GILEAD-2024-0680177$GILEAD$$65$YR$E$M$Y$$$20240711$$HP$GB$GB
240806771$24080677$1$I$20240101$20240708$20240711$20240711$EXP$$US-ABBVIE-5833686$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240806782$24080678$2$F$20240709$20240716$20240711$20240801$PER$$US-AMGEN-USASP2024137475$AMGEN$$80$YR$E$F$Y$$$20240801$$CN$US$US
240806811$24080681$1$I$$20240709$20240711$20240711$EXP$$US-ABBVIE-5834450$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240806821$24080682$1$I$20240625$20240705$20240711$20240711$EXP$$CN-AMERICAN REGENT INC-2024002612$AMERICAN REGENT$$35$YR$$F$Y$50$KG$20240711$$HP$CN$CN
240806831$24080683$1$I$20240101$20240709$20240711$20240711$EXP$$US-ABBVIE-5834359$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240806841$24080684$1$I$20240101$20240709$20240711$20240711$EXP$$US-BAUSCH-BL-2024-010538$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240711$$CN$US$US
240806854$24080685$4$F$$20240731$20240711$20240828$EXP$$NVSC2024IT115046$NOVARTIS$$53$YR$$M$Y$$$20240828$$MD$IT$IT
240806861$24080686$1$I$20240430$20240513$20240711$20240711$PER$$US-KARYOPHARM-2024KPT001062$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240711$$CN$US$US
240806871$24080687$1$I$$20240701$20240711$20240711$EXP$$JP-ANIPHARMA-2024-JP-000182$ANI$$$$$F$Y$$$20240711$$PH$JP$JP
240806881$24080688$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005401$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240711$$CN$US$US
240806891$24080689$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006134$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240711$$CN$US$US
240806901$24080690$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005474$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240711$$CN$US$US
240806911$24080691$1$I$20240708$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006427$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240711$$CN$US$US
240806921$24080692$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006225$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240711$$CN$US$US
240806931$24080693$1$I$20240620$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006304$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240711$$CN$US$US
240806941$24080694$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006119$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240711$$CN$US$US
240806951$24080695$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006838$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240711$$CN$US$US
240806961$24080696$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006380$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240711$$CN$US$US
240806971$24080697$1$I$$20240703$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407002979$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240711$$CN$US$US
240806981$24080698$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006329$ELI LILLY AND CO$$44$YR$A$$Y$$$20240711$$CN$US$US
240806991$24080699$1$I$20240522$20240702$20240711$20240711$PER$$US-SA-2023SA303557$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240711$$CN$US$US
240807001$24080700$1$I$20240323$20240628$20240711$20240711$EXP$$GB-CIPLA LTD.-2024GB06958$CIPLA$$$$$$Y$$$20240711$$CN$GB$GB
240807011$24080701$1$I$20240323$20240628$20240711$20240711$EXP$$GB-CIPLA LTD.-2024GB07003$CIPLA$$$$$$Y$$$20240711$$CN$GB$GB
240807022$24080702$2$F$20220801$20240628$20240711$20240712$EXP$$GB-GE HEALTHCARE-2024CSU007334$GE HEALTHCARE$$61$YR$$F$Y$61.2$KG$20240712$$PH$GB$GB
240807031$24080703$1$I$20211026$20240628$20240711$20240711$EXP$$GB-GE HEALTHCARE-2024CSU007489$GE HEALTHCARE$$75$YR$$M$Y$91.6$KG$20240711$$PH$GB$GB
240807041$24080704$1$I$$20240702$20240711$20240711$PER$$US-TEVA-VS-3218454$TEVA$$82$YR$$F$Y$$$20240711$$CN$US$US
240807051$24080705$1$I$$20240628$20240711$20240711$EXP$$GB-CIPLA LTD.-2024GB06971$CIPLA$$$$$$Y$$$20240711$$CN$GB$GB
240807062$24080706$2$F$$20240708$20240711$20240722$EXP$$GB-CIPLA LTD.-2024GB06963$CIPLA$$$$$$Y$$$20240722$$CN$GB$GB
240807071$24080707$1$I$20240323$20240628$20240711$20240711$EXP$$GB-CIPLA LTD.-2024GB07012$CIPLA$$$$$$Y$$$20240711$$CN$GB$GB
240807082$24080708$2$F$$20240718$20240711$20240801$EXP$$GB-CIPLA LTD.-2024GB06980$CIPLA$$$$$$Y$$$20240801$$CN$GB$GB
240807092$24080709$2$F$20240323$20240708$20240711$20240722$EXP$$GB-CIPLA LTD.-2024GB06959$CIPLA$$$$$$Y$$$20240722$$CN$GB$GB
240807101$24080710$1$I$$20240628$20240711$20240711$EXP$$GB-CIPLA LTD.-2024GB06962$CIPLA$$$$$$Y$$$20240711$$CN$GB$GB
240807111$24080711$1$I$20240604$20240708$20240711$20240711$EXP$$CN-MYLANLABS-2024M1064434$MYLAN$$74$YR$$M$Y$77$KG$20240711$$HP$CN$CN
240807121$24080712$1$I$20240626$20240708$20240711$20240711$EXP$$RU-AMERICAN REGENT INC-2024002636$AMERICAN REGENT$$30$YR$$F$Y$42$KG$20240711$$HP$RU$RU
240807132$24080713$2$F$20240707$20240801$20240711$20240805$PER$$US-AMGEN-USASP2024136028$AMGEN$$41$YR$A$F$Y$$$20240805$$CN$US$US
240807141$24080714$1$I$20220301$20240703$20240711$20240711$EXP$$JP-AstraZeneca-2022A199803$ASTRAZENECA$$74$YR$$F$Y$$$20240711$$MD$JP$
240807152$24080715$2$F$$20240801$20240711$20240812$30DAY$$TW-JNJFOC-20240727437$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$PH$TW$TW
240807161$24080716$1$I$$20240708$20240711$20240711$EXP$$JP-BAYER-2024A099322$BAYER$$71$YR$E$M$Y$$$20240711$$MD$JP$JP
240807171$24080717$1$I$$20240708$20240711$20240711$EXP$$TW-AstraZeneca-2024A157327$ASTRAZENECA$$$$$M$Y$$$20240711$$MD$TW$
240807182$24080718$2$F$$20240724$20240711$20240801$EXP$$US-AstraZeneca-2024A155142$ASTRAZENECA$$62$YR$$F$Y$81.6$KG$20240801$$MD$US$
240807191$24080719$1$I$20231203$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A155058$ASTRAZENECA$$75$YR$$M$Y$$$20240711$$CN$US$
240807211$24080721$1$I$$20240703$20240711$20240711$EXP$$ZA-AstraZeneca-2024A154465$ASTRAZENECA$$84$YR$$M$Y$$$20240711$$CN$ZA$
240807232$24080723$2$F$$20240802$20240711$20240809$EXP$$US-AstraZeneca-2024A153528$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
240807241$24080724$1$I$$20240703$20240711$20240711$EXP$$JP-AstraZeneca-2024A033902$ASTRAZENECA$$$$$F$Y$$$20240711$$MD$JP$
240807251$24080725$1$I$20240320$20240703$20240711$20240711$EXP$$CN-AstraZeneca-2024A155316$ASTRAZENECA$$15614$DY$$M$Y$65$KG$20240711$$MD$CN$
240807261$24080726$1$I$$20240703$20240711$20240711$EXP$$JP-AstraZeneca-2024A154391$ASTRAZENECA$$70$YR$$F$Y$$$20240711$$MD$JP$
240807272$24080727$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3218677$TEVA$Bagheri S, Sivanandham R, Barsoum A, Hussain M, Adial A. Hyperacute Presentation of Amiodarone Induced Pulmonary Toxicity. Am-J-Respir-Crit-Care-Med 2024; 209 A2026.; Bagheri S, Sivanandham R, Barsoum A, Hussain M, Adial A. Hyperacute Presentation of Amiodarone Induced Pulmonary Toxicity. Am-J-Respir-Crit-Care-Med 2024; 209 A2026.$45$YR$$M$Y$$$20240809$$HP$US$US
240807282$24080728$2$F$$20240805$20240711$20240916$EXP$$BR-AstraZeneca-2024A155405$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$BR$
240807291$24080729$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A153418$ASTRAZENECA$$$$$M$Y$$$20240711$$CN$US$
240807301$24080730$1$I$20240628$20240708$20240711$20240711$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010491$JAZZ$$74$YR$$M$Y$$$20240711$$HP$US$US
240807312$24080731$2$F$20240701$20240820$20240711$20240824$PER$$US-AMGEN-USASP2024137569$AMGEN$$64$YR$A$F$Y$$$20240824$$CN$US$US
240807323$24080732$3$F$20180509$20240806$20240711$20240816$EXP$$DE-EMD Serono-2024036638$EMD SERONO INC$$61$YR$A$M$Y$71$KG$20240816$$CN$DE$DE
240807341$24080734$1$I$$20240704$20240711$20240711$EXP$$US-GSK-US2024AMR083726$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$US$US
240807351$24080735$1$I$$20240708$20240711$20240711$EXP$$US-GSK-US2024084322$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$US$US
240807361$24080736$1$I$$20240708$20240711$20240711$EXP$$US-GSK-US2024AMR085515$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$US$US
240807372$24080737$2$F$20220805$20240708$20240711$20240715$EXP$$CN-PFIZER INC-202400207557$PFIZER$Zhu, A.. Omadacycline for the treatment of patients with Legionella pneumophila pneumonia after experiencing liver dysfunction: case series. Frontiers in Microbiology. 2024;15:10.3389/fmicb.2024.1408443$45$YR$$M$Y$$$20240715$$HP$CN$CN
240807381$24080738$1$I$20240618$20240709$20240711$20240711$EXP$$CN-PFIZER INC-PV202400090117$PFIZER$$3$YR$$M$Y$17$KG$20240711$$HP$CN$CN
240807393$24080739$3$F$20230401$20240709$20240711$20240723$EXP$$RS-PFIZER INC-202400209933$PFIZER$Andrej, A.. UNIQUE PRESENTATION OF T-CELL/HISTIOCYTE-RICH LARGE B CELL LYMPHOMA COMPLICATED WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: CASE REPORT AND REVIEW OF THE LITERATURE. Journal of Medical Biochemistry. 2024;43(4):631-7$32$YR$$M$Y$$$20240723$$MD$RS$RS
240807402$24080740$2$F$20230217$20240704$20240711$20240712$EXP$$CN-PFIZER INC-202400204694$PFIZER$Song, Y.. Pharmaceutical practice of proton pump inhibitors causing gout recurrence in cancer patients during chemotherapy. Chinese Journal of Hospital Pharmacy. 2024$70$YR$$M$Y$75$KG$20240712$$PH$CN$CN
240807411$24080741$1$I$20230419$20240709$20240711$20240711$EXP$FR-AFSSAPS-TS2024000773$FR-PFIZER INC-202400209462$PFIZER$$42$YR$$F$Y$77$KG$20240711$$MD$FR$FR
240807421$24080742$1$I$20221001$20240708$20240711$20240711$EXP$$US-ORGANON-O2407USA000882$ORGANON$$$$$F$Y$$$20240711$$MD$US$US
240807434$24080743$4$F$20210701$20240826$20240711$20240828$EXP$$US-ORGANON-O2407USA000892$ORGANON$$27$YR$$F$Y$102.95$KG$20240828$$HP$US$US
240807441$24080744$1$I$$20240614$20240711$20240711$PER$$US-SMPA-2024SPA000059$SUNOVION$$$$$$Y$$$20240711$$CN$US$US
240807451$24080745$1$I$$20240701$20240711$20240711$EXP$$US-RDY-LIT/USA/24/0010095$DR REDDYS$Merrill K, Davis A, Jackson E, Riker M, Kirk C, Yung D. Direct prostacyclin transition in pediatric patients with pulmonary hypertension. Pulmonary Circulation. 2024 Apr;14(2): 1-5. doi:10.1002/pul2.12373.$12$YR$T$M$Y$38$KG$20240711$$HP$US$US
240807461$24080746$1$I$$20240704$20240711$20240711$EXP$GB-MHRA-MED-202407041332334290-KQCNF$GB-RDY-SPO/GBR/24/0009868$DR REDDYS$$$$$M$Y$$$20240711$$CN$GB$GB
240807481$24080748$1$I$20240101$20240702$20240711$20240711$PER$$US-SA-2024SA199331$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240711$$MD$US$US
240807501$24080750$1$I$$20240710$20240711$20240711$EXP$$US-TAKEDA-2024TUS070227$TAKEDA$$27$YR$$F$Y$$$20240711$$HP$US$US
240807511$24080751$1$I$20240417$20240709$20240711$20240711$EXP$$JP-EMD Serono-2024037651$EMD SERONO INC$$78$YR$E$F$Y$64$KG$20240711$$PH$JP$JP
240807521$24080752$1$I$20240701$20240708$20240711$20240711$EXP$$US-ABBVIE-5834132$ABBVIE$$87$YR$$F$Y$$$20240711$$CN$US$US
240807532$24080753$2$F$$20240702$20240711$20240722$EXP$$BE-DSJP-DSJ-2024-135030$DAIICHI$$$$E$F$Y$64$KG$20240722$$MD$BE$BE
240807541$24080754$1$I$$20240709$20240711$20240711$EXP$$NVSC2024EG142668$NOVARTIS$$64$YR$$F$Y$$$20240711$$CN$EG$EG
240807551$24080755$1$I$$20240708$20240711$20240711$EXP$$AT-PFIZER INC-2019SGN02646$PFIZER$Piribauer, M.. Case presentation of alkaline negative anaplastic large cell lymphoma. Spectrum Oncology. 2019;94-95$72$YR$$M$Y$$$20240711$$MD$AT$AT
240807571$24080757$1$I$$20240704$20240711$20240711$EXP$$FR-009507513-2407FRA002808$MERCK$Wirbel C, Breton AL, Donzier L, Tartas S, Curings P, Pariset C, et al.. Multi-system involvement?including purpura fulminans?as an adverse effects of immune checkpoint inhibitor therapy for clear cell renal cell carcinoma. The Lancet. 2024;403:2818-9$61$YR$$F$Y$$$20240711$$MD$FR$FR
240807581$24080758$1$I$$20240627$20240711$20240711$EXP$$US-RECKITT-2024-US-038100$RECKITT BENCKISER$$65$YR$$F$Y$$$20240711$$CN$US$US
240807591$24080759$1$I$$20240704$20240711$20240711$EXP$GB-MHRA-MED-202405020930463390-BMKSH$GB-BAXTER-2024BAX021270$BAXTER$$$$$$Y$$$20240711$$PH$GB$GB
240807602$24080760$2$F$20230803$20240722$20240711$20240801$EXP$$AT-BAXTER-2024BAX020950$BAXTER$$60$YR$$M$Y$$$20240801$$CN$AT$AT
240807611$24080761$1$I$$20240704$20240711$20240711$EXP$$CA-EMD Serono-2024036808$EMD SERONO INC$$$$A$F$Y$$$20240711$$CN$CA$CA
240807621$24080762$1$I$20230616$20240710$20240711$20240711$EXP$$US-GILEAD-2024-0680336$GILEAD$$32$YR$A$M$Y$$$20240711$$CN$US$US
240807632$24080763$2$F$$20240715$20240711$20240722$EXP$$NVSC2024RU142687$NOVARTIS$Chelusheva EY, Turkina AG, Polushkina ES, Shmakov RG. ??????????? ???????????, ??????? ?????????? ?? ????? ????????????: ??????? ???????, ?????????? ??????? ? ?????? ???????????? [Chronic Myeloid Leukemia First Detected During Pregnancy: Management Strategy, Treatment Results, And Pregnancy Outcomes]. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY (GEMATOLOGIYA I TRANSFUSIOLOGI). 2024;69(2):361$$$$F$Y$$$20240722$$HP$RU$RU
240807641$24080764$1$I$$20240708$20240711$20240711$EXP$$GB-SANDOZ INC.-SDZ2024GB044964$SANDOZ$$$$$M$Y$$$20240711$$CN$GB$GB
240807651$24080765$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158375$ASTRAZENECA$$82$YR$$M$Y$74$KG$20240711$$HP$FR$
240807661$24080766$1$I$20240701$20240710$20240711$20240711$PER$$US-JNJFOC-20240726232$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240711$$PH$US$US
240807671$24080767$1$I$20240701$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137429$AMGEN$$$$$M$Y$$$20240711$$CN$US$US
240807682$24080768$2$F$20230201$20240711$20240711$20240722$EXP$$MX-AstraZeneca-2023A097403$ASTRAZENECA$$1053$MON$$F$Y$64$KG$20240722$$CN$MX$
240807691$24080769$1$I$$20240701$20240711$20240711$EXP$$CA-BAXTER-2023BAX027835$BAXTER$$37$YR$$F$Y$$$20240711$$HP$CA$CA
240807701$24080770$1$I$20220101$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A154986$ASTRAZENECA$$70$YR$$M$Y$75.3$KG$20240711$$HP$US$
240807711$24080771$1$I$$20240701$20240711$20240711$EXP$$FR-AstraZeneca-2024A158440$ASTRAZENECA$$$$$M$Y$65$KG$20240711$$HP$FR$
240807721$24080772$1$I$$20240703$20240711$20240711$EXP$$US-AstraZeneca-2024A155688$ASTRAZENECA$$$$$F$Y$$$20240711$$CN$US$
240807731$24080773$1$I$$20240703$20240711$20240711$EXP$$ZA-AstraZeneca-2024A153507$ASTRAZENECA$$55$YR$$F$Y$$$20240711$$CN$ZA$
240807741$24080774$1$I$$20240703$20240711$20240711$EXP$$LK-AstraZeneca-2024A153778$ASTRAZENECA$Abeyagunawardena I, Madurapperuma C, Thuvarakan P, Thowfeek Z, Sujeewa N, Katulanda G. Uncommon triggers of insulin autoimmune syndrome: a case report. Journal of Medical Case Reports 2024;18(1):Art nr 292.$67$YR$$M$Y$$$20240711$$HP$LK$
240807752$24080775$2$F$20240628$20240826$20240711$20240903$EXP$$FR-AstraZeneca-2024A157533$ASTRAZENECA$$750$MON$$M$Y$66$KG$20240903$$MD$FR$
240807761$24080776$1$I$20240318$20240711$20240711$20240711$DIR$709854$$FDA-CTU$$27$YR$$M$N$$$20240711$N$CN$US$
240807781$24080778$1$I$$20240708$20240711$20240711$EXP$$KR-009507513-2407KOR003707$MERCK$$$$$M$Y$$$20240711$$CN$KR$KR
240807791$24080779$1$I$$20240704$20240711$20240711$EXP$GB-MHRA-MED-202407041136045490-HKLQD$GB-RDY-SPO/GBR/24/0009923$DR REDDYS$$$$$M$Y$70$KG$20240711$$CN$GB$GB
240807804$24080780$4$F$20240101$20240902$20240711$20240906$EXP$$JP-ABBVIE-5733561$ABBVIE$$74$YR$$F$Y$$$20240906$$HP$JP$JP
240807811$24080781$1$I$20240601$20240703$20240711$20240711$EXP$$US-RDY-SPO/USA/24/0009948$DR REDDYS$$$$$F$Y$$$20240711$$CN$US$US
240807821$24080782$1$I$20240528$20240629$20240711$20240711$EXP$$US-RVL_Pharmaceuticals-USA-POI1255202400146$RVL PHARMACEUTICALS$$78$YR$E$M$Y$$$20240711$$$US$US
240807831$24080783$1$I$20240101$20240708$20240711$20240711$EXP$$US-ABBVIE-5719539$ABBVIE$$59$YR$$F$Y$$$20240711$$CN$US$US
240807841$24080784$1$I$20240101$20240709$20240711$20240711$EXP$$US-ABBVIE-5834847$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240807851$24080785$1$I$$20240705$20240711$20240711$EXP$$US-GSK-US2024AMR085009$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$US$US
240807861$24080786$1$I$20240326$20240705$20240711$20240711$EXP$FR-AFSSAPS-CN2024000635$FR-MYLANLABS-2024M1063634$MYLAN$$15$DY$$M$Y$4.4$KG$20240711$$MD$FR$FR
240807871$24080787$1$I$20240511$20240705$20240711$20240711$EXP$FR-AFSSAPS-LY2024000827$FR-MYLANLABS-2024M1063551$MYLAN$$88$YR$$F$Y$67.7$KG$20240711$$PH$FR$FR
240807881$24080788$1$I$20240530$20240705$20240711$20240711$EXP$PL-URPL-DML-MLP.4401.1.148.2024$PL-MYLANLABS-2024M1063915$MYLAN$$36$YR$$M$Y$64$KG$20240711$$PH$PL$PL
240807894$24080789$4$F$20231010$20240918$20240711$20240920$EXP$$AT-MYLANLABS-2024M1063798$MYLAN$$60$YR$$F$Y$80$KG$20240920$$HP$AT$AT
240807901$24080790$1$I$20240620$20240704$20240711$20240711$EXP$FR-AFSSAPS-RE2024000660$FR-MYLANLABS-2024M1062959$MYLAN$$87$YR$$F$Y$72$KG$20240711$$MD$FR$FR
240807911$24080791$1$I$20240614$20240710$20240711$20240711$EXP$FR-AFSSAPS-LL2024001248$FR-SANDOZ INC.-SDZ2024FR064276$SANDOZ$$93$YR$$M$Y$64.4$KG$20240711$$PH$FR$FR
240807921$24080792$1$I$$20240705$20240711$20240711$EXP$$US-009507513-2407USA003173$MERCK$$$$$M$Y$$$20240711$$CN$US$US
240807932$24080793$2$F$$20240723$20240711$20240806$PER$$US-Calliditas-2024CAL01235$CALLIDITAS THERAPEUTICS$$29$YR$A$F$Y$39.9$KG$20240806$$CN$US$US
240807942$24080794$2$F$20220120$20240730$20240711$20240802$EXP$$BE-ABBVIE-5443784$ABBVIE$$77$YR$$M$Y$81$KG$20240802$$MD$BE$BE
240807953$24080795$3$F$20240607$20240815$20240711$20240826$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002891$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$50$KG$20240826$$CN$US$US
240807961$24080796$1$I$$20240615$20240711$20240711$PER$$US-HALEON-2182391$Haleon PLC$$39$YR$$F$Y$$$20240711$$CN$US$US
240807971$24080797$1$I$$20240704$20240711$20240711$EXP$$JP-Eisai-EC-2024-169579$EISAI$$$$E$$Y$$$20240711$$MD$JP$JP
240807983$24080798$3$F$20240101$20240913$20240711$20240923$EXP$$US-MYLANLABS-2024M1064621$MYLAN$$$$$F$Y$88.89$KG$20240923$$CN$US$US
240807991$24080799$1$I$$20240709$20240711$20240711$PER$$US-ABBVIE-5834777$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240808001$24080800$1$I$20240601$20240701$20240711$20240711$EXP$$US-Eisai-EC-2024-170020$EISAI$$60$YR$A$F$Y$$$20240711$$CN$US$US
240808012$24080801$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3218493$TEVA$Bjork ST, Chen E. Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series. Am-J-Respir-Crit-Care-Med 2024; 209.; Bjork ST, Chen E. Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series. Am-J-Respir-Crit-Care-Med 2024; 209.$74$YR$$F$Y$$$20240809$$HP$US$US
240808021$24080802$1$I$20240709$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-48212$$FDA-CTU$$68$YR$$M$N$$$20240710$N$$US$
240808031$24080803$1$I$20240706$20240710$20240711$20240711$EXP$$US-GILEAD-2024-0680264$GILEAD$$36$YR$A$M$Y$$$20240711$$CN$US$US
240808041$24080804$1$I$$20240708$20240711$20240711$EXP$$FR-DSJP-DSE-2024-134777$DAIICHI$$$$$F$Y$69$KG$20240711$$HP$FR$FR
240808051$24080805$1$I$$20240708$20240711$20240711$PER$$US-ABBVIE-5831785$ABBVIE$$$$$$Y$$$20240711$$CN$US$US
240808061$24080806$1$I$20240705$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-48214$$FDA-CTU$$78$YR$$M$N$95.25$KG$20240710$N$CN$US$
240808071$24080807$1$I$$20240708$20240711$20240711$30DAY$$US-SANDOZ INC.-SDZ2024US064451$SANDOZ$$$$$M$Y$$$20240711$$CN$US$US
240808082$24080808$2$F$$20240916$20240711$20240924$EXP$$US-JNJFOC-20240709881$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240924$$MD$US$US
240808091$24080809$1$I$20211213$20240705$20240711$20240711$EXP$IT-MINISAL02-849712$IT-PFIZER INC-2022SGN02666$PFIZER$Dubbini, M.. Apoptotic colitis secondary to brentuximab vedotin: an immune mediated adverse event responsive to steroid treatment. Leukemia + Lymphoma. 2023;1-3$49$YR$$M$Y$95$KG$20240711$$HP$IT$IT
240808101$24080810$1$I$$20240708$20240711$20240711$EXP$$US-TAKEDA-2024TUS069717$TAKEDA$$$$$F$Y$$$20240711$$CN$US$US
240808121$24080812$1$I$$20240708$20240711$20240711$EXP$$IN-TAKEDA-2024TUS070630$TAKEDA$$$$$M$Y$$$20240711$$MD$IN$IN
240808134$24080813$4$F$$20240904$20240711$20240906$EXP$$US-TAKEDA-2024TUS069287$TAKEDA$$$$$M$Y$$$20240906$$CN$US$US
240808141$24080814$1$I$20240101$20240617$20240711$20240711$PER$$US-009507513-2406USA005838$MERCK$$$$$M$Y$$$20240711$$CN$US$US
240808151$24080815$1$I$$20240702$20240711$20240711$PER$$US-SA-2024SA199348$SANOFI AVENTIS$$$$T$F$Y$53$KG$20240711$$MD$US$US
240808161$24080816$1$I$20240401$20240703$20240711$20240711$PER$$US-SA-2024SA199364$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240711$$MD$US$US
240808173$24080817$3$F$$20240905$20240711$20240911$EXP$$CA-TAKEDA-2024TUS069811$TAKEDA$$$$$F$Y$$$20240911$$CN$CA$CA
240808191$24080819$1$I$20240625$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-48211$$FDA-CTU$$72$YR$$F$N$62.6$KG$20240710$N$HP$US$
240808211$24080821$1$I$$20240710$20240711$20240711$EXP$$US-TAKEDA-2023TUS100950$TAKEDA$$$$$M$Y$70.29$KG$20240711$$HP$US$US
240808221$24080822$1$I$$20240705$20240711$20240711$EXP$$GB-MYLANLABS-2024M1063813$MYLAN$$$$$M$Y$$$20240711$$MD$GB$GB
240808231$24080823$1$I$20211015$20240705$20240711$20240711$EXP$FR-AFSSAPS-MA2024001148$FR-MYLANLABS-2024M1063507$MYLAN$$67$YR$$F$Y$$$20240711$$PH$FR$FR
240808241$24080824$1$I$20231230$20240707$20240711$20240711$EXP$$BD-SANDOZ INC.-SDZ2024BD064559$SANDOZ$$80$YR$$F$Y$56$KG$20240711$$CN$BD$BD
240808251$24080825$1$I$20240711$20240711$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039258$BOEHRINGER INGELHEIM$$$$$$Y$$$20240711$$CN$US$US
240808262$24080826$2$F$20210701$20240802$20240711$20240808$EXP$DE-BFARM-23009796$DE-MYLANLABS-2023M1138963$MYLAN$$35$YR$$F$Y$$$20240808$$MD$DE$DE
240808271$24080827$1$I$20240606$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109753$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240711$$CN$US$US
240808281$24080828$1$I$$20240710$20240711$20240711$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110223$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240711$$HP$CA$CA
240808291$24080829$1$I$20240101$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108414$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240711$$CN$US$US
240808301$24080830$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110319$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240711$$HP$US$US
240808321$24080832$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110312$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240711$$HP$US$US
240808331$24080833$1$I$$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109563$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240711$$HP$US$US
240808341$24080834$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109880$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240711$$CN$US$US
240808361$24080836$1$I$$20240708$20240711$20240711$EXP$$IT-PFIZER INC-202400209882$PFIZER$Tondulli, L.. A RARE CASE OF PULMONARY VASCULITIS DUE TO NEW ANTIANGIOGENIC DRUGS. Annals of Oncology. 2009;20 (Suppl 5):10.1093/annonc/mdp218$67$YR$$F$Y$$$20240711$$HP$IT$IT
240808371$24080837$1$I$20240623$20240708$20240711$20240711$EXP$$US-ABBVIE-5832451$ABBVIE$$62$YR$$F$Y$$$20240711$$CN$US$US
240808381$24080838$1$I$$20240703$20240711$20240711$EXP$$US-PFIZER INC-2021SGN01565$PFIZER$$$$$$Y$$$20240711$$MD$US$US
240808391$24080839$1$I$$20240701$20240711$20240711$EXP$$US-TEVA-VS-3218494$TEVA$Bjork ST, Chen E. Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series. Am-J-Respir-Crit-Care-Med 2024; 209.$76$YR$$F$Y$$$20240711$$HP$US$US
240808411$24080841$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5831926$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240808421$24080842$1$I$$20240710$20240711$20240711$PER$$US-PURDUE PHARMA-USA-2024-0310694$PURDUE$$$$$M$Y$$$20240711$$CN$US$US
240808441$24080844$1$I$$20240709$20240711$20240711$EXP$$NVSC2024CA143032$NOVARTIS$$$$$M$Y$$$20240711$$CN$CA$CA
240808451$24080845$1$I$20240701$20240709$20240711$20240711$PER$$US-PURDUE PHARMA-USA-2024-0310677$PURDUE$$47$YR$$M$Y$151.95$KG$20240711$$CN$US$US
240808461$24080846$1$I$$20240709$20240711$20240711$PER$$US-PURDUE-USA-2024-0310697$PURDUE$$$$$F$Y$$$20240711$$PH$US$US
240808471$24080847$1$I$20240525$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110133$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240711$$CN$US$US
240808481$24080848$1$I$20240401$20240704$20240711$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109125$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240711$$MD$JP$JP
240808491$24080849$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110288$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240711$$HP$US$US
240808501$24080850$1$I$20240101$20240705$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108975$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240711$$CN$US$US
240808511$24080851$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110291$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240711$$HP$US$US
240808531$24080853$1$I$$20240708$20240711$20240711$EXP$$UA-BRISTOL-MYERS SQUIBB COMPANY-2024-109246$BRISTOL MYERS SQUIBB$$$$$M$Y$140$KG$20240711$$MD$UA$UA
240808542$24080854$2$F$$20240903$20240711$20240912$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-071962$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240912$$MD$IT$IT
240808552$24080855$2$F$$20240716$20240711$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110307$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240717$$HP$US$US
240808561$24080856$1$I$20240601$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110379$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240711$$HP$US$US
240808571$24080857$1$I$$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110229$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240711$$CN$US$US
240808582$24080858$2$F$20240701$20240805$20240711$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110279$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240807$$HP$US$US
240808591$24080859$1$I$20240709$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-48219$$FDA-CTU$$60$YR$$F$N$$$20240710$N$$US$
240808601$24080860$1$I$20240504$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110052$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240711$$HP$US$US
240808611$24080861$1$I$$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109751$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240711$$CN$US$US
240808621$24080862$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110418$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240711$$CN$US$US
240808631$24080863$1$I$$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110148$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240711$$CN$US$US
240808641$24080864$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110463$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240711$$CN$US$US
240808651$24080865$1$I$$20240709$20240711$20240711$EXP$$US-ABBVIE-5833670$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240808662$24080866$2$F$20240301$20240708$20240711$20240820$EXP$IT-MINISAL02-987048$IT-DSJP-DSE-2024-123546$DAIICHI$$49$YR$$F$Y$75$KG$20240820$$MD$IT$IT
240808671$24080867$1$I$$20240628$20240711$20240711$EXP$$US-INSMED, INC.-2024-02679-US$INSMED$$$$$F$Y$$$20240711$$CN$US$US
240808683$24080868$3$F$20240101$20240729$20240711$20240809$EXP$$US-INSMED-2024-00333-USAA$INSMED$$$$$M$Y$$$20240809$$CN$US$US
240808692$24080869$2$F$$20240712$20240711$20240724$EXP$$US-INSMED, INC.-2024-02690-US$INSMED$$$$$M$Y$$$20240724$$CN$US$US
240808702$24080870$2$F$20240101$20240711$20240711$20240723$EXP$$US-INSMED, INC.-2024-02736-US$INSMED$$$$$F$Y$$$20240723$$CN$US$US
240808711$24080871$1$I$$20240701$20240711$20240711$EXP$$US-INSMED, INC.-2023-02904-US$INSMED$$$$$F$Y$$$20240711$$CN$US$US
240808722$24080872$2$F$20240301$20240715$20240711$20240726$EXP$$US-INSMED, INC.-2024-02244-US$INSMED$$75$YR$$M$Y$$$20240726$$CN$US$US
240808731$24080873$1$I$20240503$20240709$20240711$20240711$EXP$$CA-PFIZER INC-202400209810$PFIZER$$77$YR$$F$Y$90.703$KG$20240711$$HP$CA$CA
240808741$24080874$1$I$$20240704$20240711$20240711$EXP$$US-PFIZER INC-2021SGN01820$PFIZER$$$$$F$Y$$$20240711$$MD$US$US
240808751$24080875$1$I$$20240708$20240711$20240711$EXP$$AT-PFIZER INC-2020SGN01610$PFIZER$Ozsvath, B.. Brentuximab vedotin (Adcetris) high-risk patient with advanced Hodgkin lymphoma.. Spectrum Onkologie. 2020;01:96$61$YR$$M$Y$$$20240711$$MD$AT$AT
240808761$24080876$1$I$20240613$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407081335013570-NFGKM$GB-PFIZER INC-202400209742$PFIZER$$58$YR$$M$Y$$$20240711$$HP$GB$GB
240808771$24080877$1$I$$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407081626102540-JWCDR$GB-PFIZER INC-202400209020$PFIZER$$$$$$Y$$$20240711$$HP$GB$GB
240808781$24080878$1$I$20240709$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-48224$$FDA-CTU$$68$YR$$F$N$$$20240710$N$$US$
240808791$24080879$1$I$20240710$20240710$20240710$20240710$DIR$FDA-CDER-CTU-2024-48226$$FDA-CTU$$42$YR$$M$N$86.18$KG$20240710$Y$$US$
240808801$24080880$1$I$20240624$20240702$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109202$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240711$$CN$US$US
240808811$24080881$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109657$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240711$$CN$US$US
240808831$24080883$1$I$20240423$20240706$20240711$20240711$EXP$$CN-SA-2024SA201679$SANOFI AVENTIS$$30$YR$A$M$Y$77$KG$20240711$$HP$CN$CN
240808842$24080884$2$F$$20240709$20240711$20240712$EXP$$US-ABBVIE-5834473$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240808852$24080885$2$F$20230127$20240911$20240711$20240918$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-006071$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240918$$MD$JP$JP
240808861$24080886$1$I$20211225$20240708$20240711$20240711$EXP$$AU-WOODWARD-2024-AU-000302$WOODWARD PHARMA SERVICES$$$$$M$Y$$$20240711$$HP$AU$AU
240808872$24080887$2$F$$20240715$20240711$20240722$EXP$$US-ABBVIE-5834438$ABBVIE$$$$$$Y$$$20240722$$CN$US$US
240808881$24080888$1$I$$20240709$20240711$20240711$PER$$US-JNJFOC-20240727215$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$HP$US$US
240808892$24080889$2$F$$20240715$20240711$20240722$EXP$$FI-BAUSCH-BL-2024-010402$BAUSCH AND LOMB$Karajamaki A, Lauri T, Ebeling T. Psykoosilaakkeiden aiheuttama hypoglykemia ja hypotermia. Duodecim. 2017;133(3):301-304.$49$YR$$M$Y$$$20240722$$MD$FI$FI
240808901$24080890$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110144$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240711$$CN$US$US
240808911$24080891$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110343$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240711$$HP$US$US
240808921$24080892$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110521$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240711$$CN$US$US
240808931$24080893$1$I$$20240701$20240711$20240711$EXP$$FR-TEVA-VS-3217501$TEVA$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique 2023; 35 (3): 175-197.$43$YR$$M$Y$$$20240711$$HP$FR$FR
240808952$24080895$2$F$$20240710$20240711$20240715$PER$$NVSC2024US142472$NOVARTIS$$$$$F$Y$$$20240715$$HP$US$US
240808962$24080896$2$F$20240708$20240708$20240711$20240716$EXP$$FR-ABBVIE-5835034$ABBVIE$$74$YR$$M$Y$$$20240716$$CN$FR$FR
240808971$24080897$1$I$20240708$20240709$20240711$20240711$EXP$$US-KYOWAKIRIN-2024KK016528$KYOWA$$$$$$Y$$$20240711$$HP$US$US
240808983$24080898$3$F$20240521$20240925$20240711$20240927$EXP$$JP-BAYER-2024A099402$BAYER$$74$YR$E$M$Y$$$20240927$$MD$JP$JP
240808992$24080899$2$F$$20240705$20240711$20240716$PER$$US-TRAVERE-2024TVT00681$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240716$$CN$US$US
240809001$24080900$1$I$$20240628$20240711$20240711$PER$$US-ROCHE-10000021427$ROCHE$$$$E$F$Y$$$20240711$$CN$US$US
240809011$24080901$1$I$$20240702$20240711$20240711$PER$$US-TEVA-VS-3217967$TEVA$$72$YR$$M$Y$$$20240711$$CN$US$US
240809021$24080902$1$I$$20240705$20240711$20240711$PER$$US-ROCHE-10000022161$ROCHE$$$$A$F$Y$$$20240711$$CN$US$US
240809031$24080903$1$I$$20240703$20240711$20240711$PER$$US-ROCHE-10000022350$ROCHE$$68$YR$E$M$Y$$$20240711$$CN$US$US
240809041$24080904$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110516$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240711$$CN$US$US
240809051$24080905$1$I$20231001$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110116$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240711$$CN$US$US
240809062$24080906$2$F$$20240725$20240711$20240801$EXP$$US-RADIUS HEALTH, INC.-2024US005026$RADIUS PHARM$$$$$F$Y$$$20240801$$MD$US$US
240809071$24080907$1$I$$20240710$20240711$20240711$EXP$$US-BAYER-2024A099674$BAYER$$70$YR$E$M$Y$$$20240711$$CN$US$US
240809081$24080908$1$I$20240711$20240711$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039267$BOEHRINGER INGELHEIM$$63$YR$A$$Y$$$20240711$$CN$US$US
240809091$24080909$1$I$20240703$20240708$20240711$20240711$EXP$$DE-ABBVIE-5833162$ABBVIE$$48$YR$$M$Y$$$20240711$$MD$DE$DE
240809101$24080910$1$I$20240701$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407082115360830-TWYZS$GB-ABBVIE-5832700$ABBVIE$$30$YR$$F$Y$66$KG$20240711$$CN$GB$GB
240809112$24080911$2$F$$20240711$20240711$20240711$EXP$$CA-PFIZER INC-202400211044$PFIZER$$38$YR$$M$Y$$$20240711$$HP$CA$CA
240809141$24080914$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000021842$ROCHE$$$$A$F$Y$$$20240711$$CN$US$US
240809151$24080915$1$I$$20240708$20240711$20240711$PER$$US-ROCHE-10000022242$ROCHE$$$$A$F$Y$$$20240711$$CN$US$US
240809161$24080916$1$I$$20240710$20240711$20240711$PER$$US-JNJFOC-20240725567$JOHNSON AND JOHNSON$$$$$M$Y$$$20240711$$CN$US$US
240809171$24080917$1$I$20240401$20240619$20240711$20240711$EXP$$JP-ASTELLAS-2024US017097$ASTELLAS$$62$YR$$F$Y$$$20240711$$CN$CH$JP
240809181$24080918$1$I$20240101$20240709$20240711$20240711$EXP$GB-MHRA-MED-202407031343476760-WYCPJ$GB-ABBVIE-5833252$ABBVIE$$59$YR$$M$Y$103$KG$20240711$$MD$GB$GB
240809191$24080919$1$I$20240630$20240630$20240711$20240711$EXP$GB-MHRA-MED-202406302106497910-HDVJY$GB-PERRIGO-24GB006159$PERRIGO$$60$YR$$F$Y$65$KG$20240711$$CN$GB$GB
240809202$24080920$2$F$20240531$20240712$20240711$20240722$EXP$GB-MHRA-MED-202406301749069030-FDMTJ$GB-PERRIGO-24GB006160$PERRIGO$$59$YR$$M$Y$76$KG$20240722$$CN$GB$GB
240809213$24080921$3$F$20240701$20240816$20240711$20240823$PER$$US-AMGEN-USASP2024136279$AMGEN$$79$YR$E$F$Y$$$20240823$$CN$US$US
240809221$24080922$1$I$20240622$20240711$20240711$20240711$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039269$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$$$20240711$$CN$US$US
240809232$24080923$2$F$$20240724$20240711$20240726$PER$$US-Taiho Oncology Inc-2024-006719$TAIHO ONCOLOGY INC$$62$YR$A$M$Y$88$KG$20240726$$CN$US$US
240809241$24080924$1$I$$20240711$20240711$20240711$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039266$BOEHRINGER INGELHEIM$$$$$$Y$$$20240711$$CN$US$US
240809251$24080925$1$I$20240601$20240709$20240711$20240711$EXP$$US-GILEAD-2024-0680116$GILEAD$$57$YR$A$M$Y$$$20240711$$CN$US$US
240809262$24080926$2$F$20210112$20240910$20240711$20240918$EXP$$IT-BIOGEN-2024BI01272177$BIOGEN$Zanetta C, Viti V, Sorino J, Memoli M, Rubin M, Moiola L, Rocca M, Pedica F, Filippi M. Drug-induced liver injury in patients with multiple sclerosis: a case series. 10th Congress of the European Academy of Neurology Helsinki 2024. 2024;.$36$YR$$F$Y$$$20240918$$MD$IT$IT
240809271$24080927$1$I$$20240704$20240711$20240711$EXP$GB-MHRA-MED-202405030852197980-SBFKV$GB-TEVA-VS-3218142$TEVA$$$$$$Y$$$20240711$$HP$GB$GB
240809292$24080929$2$F$$20240807$20240711$20240813$EXP$$DE-PFIZER INC-PV202400089714$PFIZER$Bakhtiar, S.. The incidence and type of cancer in patients with ataxia-telangiectasia via a retrospective single-centre study. British Journal of Haematology. 2021;194 (5):887-879$11$YR$$M$Y$$$20240813$$MD$DE$DE
240809301$24080930$1$I$20240530$20240701$20240711$20240711$EXP$$NL-PERRIGO-24NL006170$PERRIGO$$83$YR$$F$Y$$$20240711$$CN$NL$NL
240809312$24080931$2$F$20240425$20240712$20240711$20240722$EXP$GB-MHRA-30958493$GB-PERRIGO-24GB006210$PERRIGO$$74$YR$$F$Y$$$20240722$$MD$COUNTRY NOT SPECIFIED$GB
240809331$24080933$1$I$$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109795$BRISTOL MYERS SQUIBB$$100$YR$E$F$Y$$$20240711$$CN$US$US
240809341$24080934$1$I$20240624$20240701$20240711$20240711$EXP$$GB-PERRIGO-24GB006205$PERRIGO$$63$YR$$F$Y$57$KG$20240711$$PH$GB$GB
240809351$24080935$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110417$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$83.01$KG$20240711$$CN$US$US
240809361$24080936$1$I$20240601$20240710$20240711$20240711$PER$$US-JNJFOC-20240725931$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240711$$CN$US$US
240809371$24080937$1$I$$20240710$20240711$20240711$PER$$US-TAKEDA-2024TUS070429$TAKEDA$$$$$$Y$$$20240711$$CN$US$US
240809391$24080939$1$I$$20240701$20240711$20240711$EXP$IE-EMA-DD-20190204-jain_h1-093606$IE-PERRIGO-19IE000001$PERRIGO$$$$N$F$Y$1.5$KG$20240711$$MD$IE$IE
240809401$24080940$1$I$$20240703$20240711$20240711$EXP$$GB-PERRIGO-24GB006301$PERRIGO$$$$$F$Y$$$20240711$$CN$GB$GB
240809411$24080941$1$I$20240522$20240709$20240711$20240711$EXP$FR-AFSSAPS-AVTO2024000104$FR-MYLANLABS-2024M1064196$MYLAN$$25$YR$$F$Y$$$20240711$$MD$FR$FR
240809432$24080943$2$F$20170201$20240910$20240711$20240918$EXP$$IT-BIOGEN-2024BI01272178$BIOGEN$Zanetta C, Viti V, Sorino J, Memoli M, Rubin M, Moiola L, Rocca M, Pedica F, Filippi M. Drug-induced liver injury in patients with multiple sclerosis: a case series. 10th Congress of the European Academy of Neurology Helsinki 2024. 2024;.$17$YR$$F$Y$$$20240918$$MD$IT$IT
240809441$24080944$1$I$20230101$20240611$20240711$20240711$PER$$US-009507513-2406USA003782$MERCK$$$$$F$Y$$$20240711$$CN$US$US
240809452$24080945$2$F$$20240626$20240711$20240730$EXP$$CH-TEVA-VS-3218336$TEVA$$$$$M$Y$$$20240730$$HP$CH$CH
240809461$24080946$1$I$20240514$20240530$20240711$20240711$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000066$UROGEN PHARMA$$$$$$Y$$$20240712$$MD$US$US
240809471$24080947$1$I$$20240514$20240711$20240711$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000063$UROGEN PHARMA$$$$$$Y$$$20240712$$CN$US$US
240809481$24080948$1$I$$20240612$20240711$20240711$PER$$BE-APELLIS-2024-APL-0000306$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$BE$BE
240809491$24080949$1$I$$20240709$20240711$20240711$PER$$US-ABBVIE-5833400$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240809501$24080950$1$I$20240601$20240705$20240711$20240711$EXP$FR-AFSSAPS-BR2024000537$FR-MYLANLABS-2024M1063862$MYLAN$$54$YR$$F$Y$98$KG$20240711$$PH$FR$FR
240809511$24080951$1$I$20240101$20240705$20240711$20240711$PER$$US-SA-2024SA201978$SANOFI AVENTIS$$36$YR$A$M$Y$95$KG$20240711$$MD$US$US
240809521$24080952$1$I$$20240522$20240711$20240711$PER$$US-LUNDBECK-DKLU3078465$LUNDBECK$$$$$$Y$$$20240711$$CN$US$US
240809531$24080953$1$I$$20240705$20240711$20240711$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004671$JAZZ$$$$$F$Y$$$20240711$$HP$US$US
240809541$24080954$1$I$$20240708$20240711$20240711$PER$$US-ABBVIE-5833426$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240809552$24080955$2$F$$20240802$20240711$20240808$EXP$$JP-RADIUS HEALTH, INC.-2024JP005073$RADIUS PHARM$Aizawa J.. Cases of Ostabalo injector use (in Japanese). Self-injection instructions web seminar$95$YR$$F$Y$$$20240808$$HP$JP$JP
240809561$24080956$1$I$$20240709$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA063997$SANDOZ$$65$YR$$M$Y$$$20240711$$HP$CA$CA
240809571$24080957$1$I$20240501$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407007061$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240711$$CN$US$US
240809581$24080958$1$I$20240501$20240701$20240711$20240711$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407000834$ELI LILLY AND CO$$82$YR$E$M$Y$52$KG$20240711$$CN$JP$JP
240809591$24080959$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006647$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240711$$CN$US$US
240809601$24080960$1$I$20240706$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005216$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240711$$CN$US$US
240809612$24080961$2$F$20240601$20240722$20240711$20240724$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407007035$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240724$$CN$JP$JP
240809622$24080962$2$F$20230117$20240913$20240711$20240918$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407004889$ELI LILLY AND CO$$68$YR$E$M$Y$48.7$KG$20240918$$CN$JP$JP
240809631$24080963$1$I$$20240709$20240711$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006339$ELI LILLY AND CO$$$$$F$Y$$$20240711$$CN$US$US
240809641$24080964$1$I$20240708$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006147$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240711$$CN$US$US
240809651$24080965$1$I$$20240703$20240711$20240711$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202407005469$ELI LILLY AND CO$$$$$F$Y$$$20240711$$MD$MX$MX
240809661$24080966$1$I$20240706$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006113$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240711$$CN$US$US
240809672$24080967$2$F$$20240718$20240711$20240731$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407006355$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240731$$CN$JP$JP
240809691$24080969$1$I$$20240708$20240711$20240711$EXP$$GB-SANDOZ INC.-SDZ2024GB008443$SANDOZ$$$$$M$Y$$$20240711$$CN$GB$GB
240809701$24080970$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110398$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240711$$CN$US$US
240809711$24080971$1$I$20240621$20240710$20240711$20240711$EXP$$RU-AMERICAN REGENT INC-2024002667$AMERICAN REGENT$$33$YR$$F$Y$66$KG$20240711$$HP$RU$RU
240809722$24080972$2$F$20240702$20240906$20240711$20240909$EXP$$NVSC2024US141762$NOVARTIS$$48$YR$$M$Y$$$20240909$$HP$US$US
240809731$24080973$1$I$20210317$20240705$20240711$20240711$EXP$FR-AFSSAPS-MA2024001144$FR-MYLANLABS-2024M1063510$MYLAN$$70$YR$$F$Y$$$20240711$$PH$FR$FR
240809741$24080974$1$I$20240319$20240705$20240711$20240711$EXP$FR-AFSSAPS-RE2024000646$FR-MYLANLABS-2024M1063633$MYLAN$$84$YR$$M$Y$92$KG$20240711$$MD$FR$FR
240809752$24080975$2$F$$20240710$20240711$20240715$EXP$$US-PFIZER INC-202400209516$PFIZER$Pham, S.. Complications of Infective Endocarditis: A Case Report of Intracerebral Hemorrhage Exacerbated by Enoxaparin. Cureus. 2024;16(5):10.7759/cureus.61235$76$YR$$F$Y$$$20240715$$MD$US$US
240809761$24080976$1$I$$20240704$20240711$20240711$EXP$$BE-JAZZ PHARMACEUTICALS-2024-BE-009854$JAZZ$$$$$$Y$$$20240711$$HP$BE$BE
240809772$24080977$2$F$$20240726$20240711$20240805$PER$$US-ABBVIE-5836290$ABBVIE$$$$$F$Y$$$20240805$$MD$US$US
240809781$24080978$1$I$20240524$20240705$20240711$20240711$EXP$FR-AFSSAPS-ST2024001119$FR-MYLANLABS-2024M1063516$MYLAN$$37$YR$$M$Y$79.9$KG$20240711$$MD$FR$FR
240809791$24080979$1$I$20240417$20240704$20240711$20240711$EXP$FR-AFSSAPS-LL2024001009$FR-ABBVIE-5833910$ABBVIE$$24$YR$$F$Y$$$20240711$$CN$FR$FR
240809802$24080980$2$F$20170101$20240715$20240711$20240722$EXP$$US-ABBVIE-5834434$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
240809811$24080981$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109906$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$109.32$KG$20240711$$CN$US$US
240809821$24080982$1$I$20230801$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110216$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$70.31$KG$20240711$$CN$US$US
240809841$24080984$1$I$20240101$20240628$20240711$20240711$PER$$US-MYLANLABS-2024M1061700$MYLAN$$$$$F$Y$92.99$KG$20240711$$CN$US$US
240809851$24080985$1$I$$20240610$20240711$20240711$PER$$AT-APELLIS-2024-APL-0000284$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$PH$AT$AT
240809861$24080986$1$I$20231109$20240705$20240711$20240711$EXP$FR-AFSSAPS-NY2024000741$FR-MYLANLABS-2024M1063635$MYLAN$$38$YR$$F$Y$69.5$KG$20240711$$MD$FR$FR
240809871$24080987$1$I$$20240624$20240711$20240711$PER$$US-MYLANLABS-2024M1060508$MYLAN$$$$$$Y$$$20240711$$CN$US$US
240809881$24080988$1$I$$20240628$20240711$20240711$PER$$US-MYLANLABS-2024M1062787$MYLAN$$$$$M$Y$74.9$KG$20240711$$MD$US$US
240809892$24080989$2$F$20240707$20240830$20240711$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US064626$SANDOZ$$57$YR$$F$Y$$$20240902$$CN$US$US
240809901$24080990$1$I$$20240708$20240711$20240711$EXP$$US-SANDOZ INC.-SDZ2024US064318$SANDOZ$$$$$$Y$$$20240711$$HP$US$US
240809921$24080992$1$I$$20240704$20240711$20240711$EXP$$ES-AMGEN-ESPSP2024134139$AMGEN$Ivorra-cortes J.; Leal S.; Rubia-navarro M.D. et al.. JAK inhibitors in combination with anti-TNF drugs on difficult-to-treat chronic polyarthritis: a case series. Clinical and Experimental Rheumatology. 2024;1135-1136$35$YR$A$F$Y$$$20240711$$MD$ES$ES
240809931$24080993$1$I$20240401$20240702$20240711$20240711$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002081$ELI LILLY AND CO$$$$$$Y$$$20240711$$CN$US$US
240809941$24080994$1$I$$20240702$20240711$20240711$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407002248$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240711$$CN$GB$GB
240809951$24080995$1$I$$20240701$20240711$20240711$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202407000471$ELI LILLY AND CO$$$$$M$Y$$$20240711$$CN$AE$AE
240809961$24080996$1$I$20240501$20240704$20240711$20240711$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202406010936$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240711$$CN$AU$AU
240809971$24080997$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109000$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240711$$CN$US$US
240809981$24080998$1$I$$20240522$20240711$20240711$PER$$US-LUNDBECK-DKLU3078487$LUNDBECK$$$$$$Y$$$20240711$$CN$US$US
240809992$24080999$2$F$20240701$20240712$20240711$20240716$PER$$US-PFIZER INC-202400209980$PFIZER$$63$YR$$F$Y$$$20240716$$HP$US$US
240810001$24081000$1$I$$20240708$20240711$20240711$EXP$$JP-PFIZER INC-PV202400089634$PFIZER$Kawahata, T.. A case of multiple renal cysts and multiple hepatic cysts while receiving crizotinib. Japanese Journal of Lung Cancer. 2024;64 (3):256$64$YR$$M$Y$$$20240711$$HP$JP$JP
240810011$24081001$1$I$20240101$20240705$20240711$20240711$PER$$US-PFIZER INC-202400211196$PFIZER$$29$YR$$F$Y$$$20240711$$CN$US$US
240810031$24081003$1$I$$20240522$20240711$20240711$PER$$US-LUNDBECK-DKLU3078441$LUNDBECK$$$$$$Y$$$20240711$$HP$US$US
240810041$24081004$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110046$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240711$$HP$US$US
240810051$24081005$1$I$$20240705$20240711$20240711$EXP$$JP-AstraZeneca-2024A154399$ASTRAZENECA$$$$$$Y$$$20240711$$PH$JP$
240810071$24081007$1$I$$20240705$20240711$20240711$PER$$US-BAYER-2024A098580$BAYER$Lam K.; Gates G.A.; Bach D.Q.; Cheng K.. Eruptive Melanocytic Nevi in the Setting of Encorafenib, Cetuximab, and Binimetinib Combination Therapy: A Case Report. Case Reports in Dermatology ()  (). 2024;16:1$39$YR$A$F$Y$$$20240711$$HP$US$US
240810092$24081009$2$F$20240702$20240731$20240711$20240806$EXP$$JP-Eisai-EC-2024-169507$EISAI$$67$YR$E$M$Y$$$20240806$$MD$JP$JP
240810102$24081010$2$F$20240704$20240723$20240711$20240730$EXP$$CA-RDY-CLI/CAN/24/0009922$DR REDDYS$$78$YR$E$F$Y$$$20240730$$PH$CA$CA
240810112$24081011$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3217767$TEVA$Cooper J, Patel K, Richardson C. A Case of Severe Herpes Simplex Virus Pneumonitis. Am-J-Respir-Crit-Care-Med 2024; 209 A3584.; Cooper J, Patel K, Richardson C. A Case of Severe Herpes Simplex Virus Pneumonitis. Am-J-Respir-Crit-Care-Med 2024; 209 A3584.$71$YR$$F$Y$$$20240809$$HP$US$US
240810121$24081012$1$I$20210901$20240703$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN007064$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240810132$24081013$2$F$$20240730$20240711$20240806$EXP$$CA-MYLANLABS-2024M1062478$MYLAN$$44$YR$$F$Y$68$KG$20240806$$HP$CA$CA
240810141$24081014$1$I$$20240626$20240711$20240711$PER$$US-TEVA-VS-3215058$TEVA$$$$A$F$Y$$$20240711$$MD$US$US
240810152$24081015$2$F$20240206$20240715$20240711$20240718$EXP$$NVSC2024GB036003$NOVARTIS$$57$YR$$F$Y$$$20240718$$CN$GB$GB
240810161$24081016$1$I$20240612$20240703$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN007062$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240810171$24081017$1$I$20240101$20240709$20240711$20240711$PER$$US-ABBVIE-5833967$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240810181$24081018$1$I$$20240703$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN007061$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240810191$24081019$1$I$$20240708$20240711$20240711$EXP$$AU-MYLANLABS-2024M1064028$MYLAN$$$$$M$Y$$$20240711$$HP$AU$AU
240810201$24081020$1$I$20240601$20240703$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN007060$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240810211$24081021$1$I$$20240708$20240711$20240711$EXP$$AU-MYLANLABS-2024M1064084$MYLAN$$$$$F$Y$100$KG$20240711$$HP$AU$AU
240810221$24081022$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006236$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240711$$CN$US$US
240810231$24081023$1$I$20240601$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006335$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240711$$CN$US$US
240810241$24081024$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006441$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240711$$CN$US$US
240810251$24081025$1$I$20240601$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006150$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240711$$CN$US$US
240810261$24081026$1$I$20240708$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006489$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240711$$CN$US$US
240810271$24081027$1$I$20240708$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006464$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240711$$CN$US$US
240810281$24081028$1$I$20240705$20240705$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407004868$ELI LILLY AND CO$$49$YR$A$$Y$$$20240711$$CN$US$US
240810291$24081029$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006383$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240711$$CN$US$US
240810301$24081030$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006387$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240711$$CN$US$US
240810311$24081031$1$I$20240705$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006528$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240711$$CN$US$US
240810321$24081032$1$I$20240501$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407007042$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240711$$CN$US$US
240810331$24081033$1$I$20240101$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109575$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240711$$CN$US$US
240810341$24081034$1$I$20230701$20230728$20240711$20240711$PER$$US-JOURNEY MEDICAL CORPORATION-2023JNY00155$JOURNEY MEDICAL CORPORATION$$45$YR$$F$Y$81.633$KG$20240711$$CN$US$US
240810351$24081035$1$I$20230101$20240223$20240711$20240711$PER$$US-JOURNEY MEDICAL CORPORATION-2024JNY00044$JOURNEY MEDICAL CORPORATION$$$$$F$Y$77.111$KG$20240711$$CN$US$US
240810361$24081036$1$I$20220101$20231003$20240711$20240711$PER$$US-JOURNEY MEDICAL CORPORATION-2023JNY00215$JOURNEY MEDICAL CORPORATION$$59$YR$$F$Y$83.9$KG$20240711$$CN$US$US
240810371$24081037$1$I$$20240708$20240711$20240711$EXP$$US-ROCHE-10000020680$ROCHE$$$$A$F$Y$$$20240711$$CN$US$US
240810381$24081038$1$I$$20240703$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN007055$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240810393$24081039$3$F$20240308$20240726$20240711$20240808$EXP$$CN-009507513-2407CHN002810$MERCK$$75$YR$$M$Y$55$KG$20240808$$HP$CN$CN
240810401$24081040$1$I$20180313$20240710$20240711$20240711$EXP$$IT-BAUSCH-BL-2024-010584$BAUSCH AND LOMB$$$$$$Y$$$20240711$$MD$IT$IT
240810411$24081041$1$I$20190223$20240710$20240711$20240711$EXP$$IT-BAUSCH-BL-2024-010589$BAUSCH AND LOMB$$$$$$Y$$$20240711$$MD$IT$IT
240810421$24081042$1$I$20171114$20240710$20240711$20240711$EXP$$IT-BAUSCH-BL-2024-010591$BAUSCH AND LOMB$$$$$$Y$$$20240711$$MD$IT$IT
240810431$24081043$1$I$$20240709$20240711$20240711$EXP$$US-BAUSCH-BL-2024-010464$BAUSCH AND LOMB$Moallem N, Condit D, Bahgat J, Perez M. A Case of Steroid Unresponsive Bortezomib-induced Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 2023;207:1-2.$63$YR$$F$Y$$$20240711$$HP$US$US
240810451$24081045$1$I$$20240617$20240711$20240711$PER$$HR-APELLIS-2024-APL-0000331$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$MD$HR$HR
240810461$24081046$1$I$20220801$20240710$20240711$20240711$EXP$$AT-BAUSCH-BL-2024-010594$BAUSCH AND LOMB$$53$YR$$M$Y$$$20240711$$MD$AT$AT
240810471$24081047$1$I$$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109596$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$75.6$KG$20240711$$CN$US$US
240810481$24081048$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110348$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240711$$HP$US$US
240810491$24081049$1$I$20240411$20240707$20240711$20240711$EXP$$EU-BAUSCHBL-2024BNL029766$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240711$$HP$EU$EU
240810501$24081050$1$I$$20240707$20240711$20240711$EXP$$EU-BAUSCHBL-2024BNL029780$BAUSCH AND LOMB$Henrik H, Huovinen S, Uusitalo T. Autoimmune myopathy is a rare muscle disease associated with statin therapy. 2024;11343-1148.$$$A$M$Y$$$20240711$$HP$EU$EU
240810511$24081051$1$I$$20240702$20240711$20240711$PER$$US-TEVA-VS-3218718$TEVA$$$$$F$Y$$$20240711$$CN$US$US
240810521$24081052$1$I$20230101$20240709$20240711$20240711$PER$$US-ABBVIE-5834288$ABBVIE$$$$$F$Y$91$KG$20240711$$CN$US$US
240810531$24081053$1$I$$20240704$20240711$20240711$PER$$US-PFIZER INC-2024SGN02269$PFIZER$$$$$F$Y$$$20240711$$MD$US$US
240810541$24081054$1$I$20240529$20240701$20240711$20240711$EXP$$JP-Eisai-EC-2024-169417$EISAI$$73$YR$E$M$Y$66$KG$20240711$$PH$JP$JP
240810551$24081055$1$I$$20240704$20240711$20240711$PER$US-MLMSERVICE-20240627-PI115226-00175-1$US-RDY-SPO/USA/24/0009952$DR REDDYS$Bulsara KG, Patel H, Goldstein A, Mathew M. A Rare Case of Argatroban-Induced Anaphylaxis in a Patient With Intermediate-High Risk Pulmonary Embolism. Cureus. 2024;16(5):e61129. DOI: 10.7759/cureus.61129.$32$YR$A$F$Y$$$20240711$$MD$US$US
240810561$24081056$1$I$20240629$20240706$20240711$20240711$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407006676$ELI LILLY AND CO$$58$YR$A$M$Y$55$KG$20240711$$CN$DE$CN
240810571$24081057$1$I$20240101$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006907$ELI LILLY AND CO$$$$$M$Y$$$20240711$$HP$US$US
240810581$24081058$1$I$$20240702$20240711$20240711$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202407002846$ELI LILLY AND CO$$$$$F$Y$$$20240711$$MD$AE$AE
240810591$24081059$1$I$20240704$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006493$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240711$$CN$US$US
240810601$24081060$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006468$ELI LILLY AND CO$$61$YR$A$$Y$$$20240711$$CN$US$US
240810611$24081061$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006499$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240711$$CN$US$US
240810621$24081062$1$I$20240615$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006240$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240711$$CN$US$US
240810631$24081063$1$I$$20240704$20240711$20240711$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202406015644$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240711$$CN$CA$CA
240810641$24081064$1$I$$20240705$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407004884$ELI LILLY AND CO$$10$YR$C$M$Y$$$20240711$$CN$US$US
240810651$24081065$1$I$20240707$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006255$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240711$$CN$US$US
240810661$24081066$1$I$20240601$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006328$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240711$$CN$US$US
240810671$24081067$1$I$$20240708$20240711$20240711$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202407004667$ELI LILLY AND CO$$15$YR$T$F$Y$48$KG$20240711$$CN$NL$IT
240810681$24081068$1$I$20240704$20240705$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407004004$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240711$$CN$US$US
240810691$24081069$1$I$$20240709$20240711$20240711$PER$$US-Prasco Laboratories-PRAS20241021$PRASCO$$$$$F$Y$$$20240711$$CN$US$US
240810701$24081070$1$I$$20240626$20240711$20240711$PER$$US-EMD Serono-2024035017$EMD SERONO INC$$$$A$F$Y$$$20240711$$CN$US$US
240810711$24081071$1$I$20240709$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136739$AMGEN$$89$YR$E$F$Y$$$20240711$$CN$US$US
240810724$24081072$4$F$20231106$20240909$20240711$20240917$EXP$$JP-APELLIS-APL-2023-003303$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240917$$CN$JP$JP
240810731$24081073$1$I$20210127$20240702$20240711$20240711$PER$$KR-Eisai-EC-2024-169427$EISAI$$83$YR$E$F$Y$$$20240711$$PH$KR$KR
240810741$24081074$1$I$20230803$20240701$20240711$20240711$PER$$DE-Eisai-EC-2024-169923$EISAI$$78$YR$E$M$Y$74$KG$20240711$$MD$DE$DE
240810751$24081075$1$I$20240101$20240701$20240711$20240711$EXP$$US-BIOGEN-2024BI01272023$BIOGEN$$$$$F$Y$$$20240711$$HP$US$US
240810761$24081076$1$I$$20240701$20240711$20240711$EXP$$US-RDY-LIT/USA/24/0009906$DR REDDYS$Hogan KO. Preventative plasmapheresis in a diabetic pregnant patient with hypertriglyceridemia and distal pancreatectomy. Transfusion Medicine. 2023 Oct;33(5): 413-415. doi:10.1111/tme.12985.$23$YR$A$F$Y$$$20240711$$HP$US$US
240810771$24081077$1$I$20211022$20240709$20240711$20240711$EXP$FR-AFSSAPS-AM2024000546$FR-ORGANON-O2407FRA000854$ORGANON$$91$YR$$F$Y$45.4$KG$20240711$$MD$FR$FR
240810781$24081078$1$I$20240101$20240703$20240711$20240711$PER$$US-BAUSCHBL-2024BNL029596$BAUSCH AND LOMB$$85$YR$$F$Y$91$KG$20240711$$CN$US$US
240810791$24081079$1$I$20240708$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110458$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240711$$CN$US$US
240810812$24081081$2$F$20240101$20240811$20240711$20240812$PER$$US-JNJFOC-20240707101$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240812$$CN$US$US
240810821$24081082$1$I$20240417$20240611$20240711$20240711$PER$$JP-APELLIS-APL-2023-003420$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$JP$JP
240810831$24081083$1$I$20240711$20240711$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039273$BOEHRINGER INGELHEIM$$$$$$Y$$$20240711$$CN$US$US
240810841$24081084$1$I$$20240705$20240711$20240711$PER$$US-ALXN-202407USA000375US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240711$$CN$US$US
240810851$24081085$1$I$$20240701$20240711$20240711$EXP$$US-SABAL THERAPEUTICS LLC-2024-ATH-000057$ATHENA$Khan S, Reggio C, Shoukat U, et al.. Avoiding Premature Brain Death Declaration in Patients With Suspected Baclofen Overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7027$$$$$Y$$$20240711$$MD$US$US
240810861$24081086$1$I$20240601$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110368$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240711$$HP$US$US
240810871$24081087$1$I$$20240701$20240711$20240711$EXP$$US-SABAL THERAPEUTICS LLC-2024-ATH-000028$ATHENA$Hamad HM, Miett T, Kopec S. Statin and Feno?brate-Induced Rhabdomyolysis in Liver Transplant; A Case of Multiple Organ Dysfunction.. American Journal of Respiratory and Critical Care Medicine. 2024;209:No pagination$$$$$Y$$$20240711$$MD$US$US
240810881$24081088$1$I$$20240530$20240711$20240711$PER$$US-NOVOPROD-1236401$NOVO NORDISK$$$$$F$Y$$$20240711$$MD$US$US
240810891$24081089$1$I$$20240702$20240711$20240711$EXP$$AU-TAKEDA-2024TUS024782$TAKEDA$Nguyen KM, BBMed, MD and Wright EK. Vancomycin and Ustekinumab Combination Therapy in Acute Ulcerative Colitis. ACG CASE REPORTS JOURNAL. 2024;Volume 11:3$25$YR$$F$Y$$$20240711$$MD$AU$AU
240810901$24081090$1$I$20240101$20240711$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039263$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$$$20240711$$CN$US$US
240810911$24081091$1$I$20240701$20240705$20240711$20240711$PER$$US-ALXN-202407USA000548US$ALEXION PHARMACEUTICALS$$55$YR$$F$Y$108.84$KG$20240711$$CN$US$US
240810932$24081093$2$F$$20240903$20240711$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001377$BLUEPRINT MEDICINES$$$$$M$Y$$$20240911$$MD$US$US
240810942$24081094$2$F$$20240802$20240711$20240809$EXP$$US-AstraZeneca-2024A153172$ASTRAZENECA$$76$YR$$M$Y$$$20240809$$CN$US$
240810951$24081095$1$I$$20240708$20240711$20240711$EXP$$PT-PFIZER INC-202400208671$PFIZER$Vasconcelos, A. Complications and Relapse in a Mantle Cell Lymphoma Patient: A Case report. Medicina Interna. 2024;31(2):66-72$73$YR$$M$Y$$$20240711$$MD$PT$PT
240810961$24081096$1$I$$20240708$20240711$20240711$EXP$$IT-PFIZER INC-PV202400089808$PFIZER$Tondulli, L.. Po a rare case of pulmonary vasculitis due to new antiangiogenic drugs. Annals of Oncology. 2009;20 (Suppl 5):10.1093/annonc/mdp218$67$YR$$F$Y$$$20240711$$HP$IT$IT
240810971$24081097$1$I$$20240708$20240711$20240711$EXP$$IE-PFIZER INC-2017SGN02395$PFIZER$Glavey, S.. Emergence of Bruton^s tyrosine kinase-negative Hodgkin lymphoma during ibrutinib treatment of chronic lymphocytic leukaemia... European Journal of Haematology. 2017;99 (4):378-80$67$YR$$F$Y$$$20240711$$HP$IE$IE
240810997$24081099$7$F$$20240903$20240711$20240906$EXP$$IT-PFIZER INC-202400210394$PFIZER$Sinisi, C.. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports. Journal of pediatric hematology/oncology. 2024;0(0):1-4$13$YR$$M$Y$$$20240906$$MD$IT$IT
240811002$24081100$2$F$$20240716$20240711$20240812$PER$$US-JNJFOC-20240711332$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
240811012$24081101$2$F$$20240731$20240711$20240809$EXP$$US-TEVA-VS-3218347$TEVA$Hourigan EK, Rattan M, Olsen ML. The Right Side of Cardiogenic Shock: A Case of Beta-Blocker Induced Cardiogenic Shock in a Female With Suspected Pulmonary Hypertension. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Hourigan EK, Rattan M, Olsen ML. The Right Side of Cardiogenic Shock: A Case of Beta-Blocker Induced Cardiogenic Shock in a Female With Suspected Pulmonary Hypertension. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$41$YR$$F$Y$$$20240809$$HP$US$US
240811021$24081102$1$I$20240122$20240703$20240711$20240711$EXP$FR-AFSSAPS-CN2024000625$FR-009507513-2407FRA001910$MERCK$$59$YR$$M$Y$$$20240711$$MD$FR$FR
240811032$24081103$2$F$$20240916$20240711$20240926$EXP$$AU-009507513-2407AUS003290$MERCK$Gardiner BJ, Ivulich SP, Snell GI. Voriconazole inhalation powder: A novel therapeutic alternative for invasive pulmonary fungal infections. Transplant Infectious Disease. 2024;26 (3):1-4$50$YR$$M$Y$$$20240926$$HP$AU$AU
240811041$24081104$1$I$$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110281$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240711$$CN$US$US
240811051$24081105$1$I$$20240701$20240711$20240711$PER$$US-JNJFOC-20240728609$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240711$$CN$US$US
240811061$24081106$1$I$20240709$20240709$20240711$20240711$PER$$PR-JNJFOC-20240724689$JOHNSON AND JOHNSON$$$$$F$Y$$$20240711$$HP$PR$PR
240811072$24081107$2$F$$20240710$20240711$20240717$PER$$US-JNJFOC-20240727601$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$PH$US$US
240811081$24081108$1$I$20240502$20240705$20240711$20240711$EXP$$FR-DSJP-DSE-2024-135046$DAIICHI$$$$E$F$Y$59$KG$20240711$$MD$FR$FR
240811091$24081109$1$I$$20240710$20240711$20240711$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110199$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240711$$PH$CA$CA
240811101$24081110$1$I$$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109579$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240711$$CN$US$US
240811111$24081111$1$I$$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109650$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240711$$CN$US$US
240811121$24081112$1$I$$20240709$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110376$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240711$$HP$US$US
240811151$24081115$1$I$20240703$20240704$20240711$20240711$EXP$GB-MHRA-MED-202407041459345310-HBWCZ$GB-RDY-SPO/GBR/24/0009886$DR REDDYS$$58$YR$A$F$Y$$$20240711$$HP$GB$GB
240811161$24081116$1$I$20240627$20240705$20240711$20240711$PER$$US-ALXN-202407USA000388US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$US$US
240811172$24081117$2$F$20240702$20240802$20240711$20240805$PER$$US-ALXN-202407USA000451US$ALEXION PHARMACEUTICALS$$68$YR$$F$Y$$$20240805$$CN$US$US
240811181$24081118$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407004723$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240711$$CN$US$US
240811201$24081120$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006318$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240711$$CN$US$US
240811211$24081121$1$I$$20240708$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407004863$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240711$$CN$US$US
240811221$24081122$1$I$$20240709$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005825$ELI LILLY AND CO$$41$YR$A$$Y$$$20240711$$CN$US$US
240811231$24081123$1$I$$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407006966$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240711$$CN$US$US
240811241$24081124$1$I$20240711$20240711$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407007473$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240711$$CN$US$US
240811251$24081125$1$I$$20240708$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109556$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240711$$CN$US$US
240811261$24081126$1$I$20240707$20240709$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109566$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240711$$CN$US$US
240811271$24081127$1$I$$20240708$20240711$20240711$EXP$$US-INCYTE CORPORATION-2024IN007232$INCYTE$$$$$$Y$$$20240711$$MD$US$US
240811281$24081128$1$I$$20240705$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN007169$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240811291$24081129$1$I$$20240627$20240711$20240711$EXP$$US-OTTER-US-2024AST000259$Unknown Manufacturer$Javadi T, Morales B, Olson JJ, Kothari S, Zhang L,  Abedalthagafi M. Extracavitar y primar y e?usion lymphoma presenting as a solitary brain mass. CNS Oncology. 2023;13(1):2357535$62$YR$$M$Y$$$20240711$$HP$US$US
240811301$24081130$1$I$$20240705$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN007165$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240811331$24081133$1$I$$20240704$20240711$20240711$PER$$US-INCYTE CORPORATION-2024IN007101$INCYTE$$$$$$Y$$$20240711$$CN$US$US
240811341$24081134$1$I$20240628$20240702$20240711$20240711$EXP$GB-MHRA-MED-202407021452412110-QMLCG$GB-GE HEALTHCARE-2024CSU007486$GE HEALTHCARE$$76$YR$$F$Y$65$KG$20240711$$HP$GB$GB
240811365$24081136$5$F$20240523$20240912$20240711$20240924$EXP$$IT-BIOGEN-2024BI01272195$BIOGEN$$44$YR$$F$Y$65$KG$20240924$$MD$IT$IT
240811372$24081137$2$F$20240610$20240719$20240711$20240729$EXP$FR-AFSSAPS-RN2024000699$FR-TEVA-VS-3217084$TEVA$$23$YR$$M$Y$$$20240729$$MD$FR$FR
240811383$24081138$3$F$20240618$20240724$20240711$20240730$EXP$$JP-BIOMARINAP-JP-2024-158990$BIOMARIN$$$$$$Y$$$20240730$$CN$JP$JP
240811391$24081139$1$I$$20240704$20240711$20240711$PER$$JP-Eisai-EC-2024-169580$EISAI$$$$$F$Y$$$20240711$$MD$JP$JP
240811405$24081140$5$F$20240629$20240730$20240711$20240906$EXP$$US-BEH-2024174943$CSL BEHRING$$43$YR$A$F$Y$55$KG$20240906$$CN$US$US
240811411$24081141$1$I$$20240708$20240711$20240711$PER$$US-ALXN-202407USA000588US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240711$$CN$US$US
240811422$24081142$2$F$20230101$20240715$20240711$20240723$EXP$$US-BIOMARINAP-US-2024-159111$BIOMARIN$$$$$$Y$$$20240723$$CN$US$US
240811435$24081143$5$F$20240601$20240828$20240711$20240905$EXP$$US-BIOGEN-2024BI01272006$BIOGEN$$22$YR$$F$Y$$$20240905$$CN$US$US
240811441$24081144$1$I$20231226$20240704$20240711$20240711$EXP$FR-AFSSAPS-DJ2024000693$FR-Blueprint Medicines Corporation-SP-FR-2024-001368$BLUEPRINT MEDICINES$$68$YR$A$M$Y$114$KG$20240711$$MD$FR$FR
240811451$24081145$1$I$$20240703$20240711$20240711$PER$$US-JNJFOC-20240711496$JOHNSON AND JOHNSON$$$$$$Y$$$20240711$$CN$US$US
240811471$24081147$1$I$20160301$20240308$20240711$20240711$EXP$$US-GSK-US2016GSK173114$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$US$US
240811481$24081148$1$I$$20230606$20240711$20240711$PER$$US-KRAMERLABS-2023-US-015775$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811491$24081149$1$I$$20230607$20240711$20240711$PER$$US-KRAMERLABS-2023-US-016404$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240811501$24081150$1$I$20230501$20230612$20240711$20240711$PER$$US-KRAMERLABS-2023-US-016633$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240811511$24081151$1$I$$20230610$20240711$20240711$PER$$US-KRAMERLABS-2023-US-016637$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811521$24081152$1$I$$20230622$20240711$20240711$PER$$US-KRAMERLABS-2023-US-018036$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240811531$24081153$1$I$$20230714$20240711$20240711$PER$$US-KRAMERLABS-2023-US-021195$KRAMER LABORATORIES$$$$$UNK$Y$$$20240711$$CN$US$US
240811541$24081154$1$I$$20230721$20240711$20240711$PER$$US-KRAMERLABS-2023-US-022559$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811551$24081155$1$I$$20230814$20240711$20240711$PER$$US-KRAMERLABS-2023-US-024989$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811561$24081156$1$I$$20230822$20240711$20240711$PER$$US-KRAMERLABS-2023-US-026214$KRAMER LABORATORIES$$$$$UNK$Y$$$20240711$$CN$US$US
240811571$24081157$1$I$$20230903$20240711$20240711$PER$$US-KRAMERLABS-2023-US-027870$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811581$24081158$1$I$20230914$20230914$20240711$20240711$PER$$US-KRAMERLABS-2023-US-029568$KRAMER LABORATORIES$$59$YR$$M$Y$77.11$KG$20240711$$CN$US$US
240811591$24081159$1$I$$20230913$20240711$20240711$PER$$US-KRAMERLABS-2023-US-029583$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811601$24081160$1$I$20230912$20230916$20240711$20240711$PER$$US-KRAMERLABS-2023-US-029981$KRAMER LABORATORIES$$42$YR$$F$Y$44.45$KG$20240711$$CN$US$US
240811611$24081161$1$I$20230819$20230918$20240711$20240711$PER$$US-KRAMERLABS-2023-US-029993$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240811621$24081162$1$I$20230914$20230922$20240711$20240711$PER$$US-KRAMERLABS-2023-US-030715$KRAMER LABORATORIES$$55$YR$$F$Y$60.33$KG$20240711$$CN$US$US
240811631$24081163$1$I$$20231016$20240711$20240711$PER$$US-KRAMERLABS-2023-US-033912$KRAMER LABORATORIES$$67$YR$$F$Y$45.36$KG$20240711$$CN$US$US
240811641$24081164$1$I$$20231012$20240711$20240711$PER$$US-KRAMERLABS-2023-US-034060$KRAMER LABORATORIES$$29$YR$$F$Y$$$20240711$$MD$US$US
240811651$24081165$1$I$$20231014$20240711$20240711$PER$$US-KRAMERLABS-2023-US-034086$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811661$24081166$1$I$20230918$20231025$20240711$20240711$PER$$US-KRAMERLABS-2023-US-035632$KRAMER LABORATORIES$$21$YR$$M$Y$86.18$KG$20240711$$CN$US$US
240811671$24081167$1$I$$20231103$20240711$20240711$PER$$US-KRAMERLABS-2023-US-037152$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240811681$24081168$1$I$20230525$20230920$20240711$20240711$PER$$US-KRAMERLABS-2023-US-034515$KRAMER LABORATORIES$$64$YR$$F$Y$77.11$KG$20240711$$CN$US$US
240811691$24081169$1$I$$20231107$20240711$20240711$PER$$US-KRAMERLABS-2023-US-037406$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811701$24081170$1$I$20230801$20231108$20240711$20240711$PER$$US-KRAMERLABS-2023-US-037623$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240811711$24081171$1$I$20230101$20231109$20240711$20240711$PER$$US-KRAMERLABS-2023-US-037688$KRAMER LABORATORIES$$60$YR$$F$Y$50.8$KG$20240711$$CN$US$US
240811721$24081172$1$I$20231025$20231122$20240711$20240711$PER$$US-KRAMERLABS-2023-US-039597$KRAMER LABORATORIES$$39$YR$$M$Y$167.83$KG$20240711$$CN$US$US
240811731$24081173$1$I$$20231122$20240711$20240711$PER$$US-KRAMERLABS-2023-US-039643$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240811741$24081174$1$I$20230813$20231019$20240711$20240711$PER$$US-KRAMERLABS-2023-US-040204$KRAMER LABORATORIES$$76$YR$$F$Y$47.63$KG$20240711$$CN$US$US
240811751$24081175$1$I$20230920$20231205$20240711$20240711$PER$$US-KRAMERLABS-2023-US-041445$KRAMER LABORATORIES$$77$YR$$F$Y$51.26$KG$20240711$$CN$US$US
240811761$24081176$1$I$$20231207$20240711$20240711$PER$$US-KRAMERLABS-2023-US-041737$KRAMER LABORATORIES$$76$YR$$F$Y$56.7$KG$20240711$$CN$US$US
240811771$24081177$1$I$$20231211$20240711$20240711$PER$$US-KRAMERLABS-2023-US-042263$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811781$24081178$1$I$20230801$20231009$20240711$20240711$PER$$US-KRAMERLABS-2023-US-032999$KRAMER LABORATORIES$$30$YR$$F$Y$$$20240711$$CN$US$US
240811791$24081179$1$I$$20231215$20240711$20240711$PER$$US-KRAMERLABS-2023-US-043115$KRAMER LABORATORIES$$$$$UNK$Y$$$20240711$$CN$US$US
240811801$24081180$1$I$$20231225$20240711$20240711$PER$$US-KRAMERLABS-2023-US-044589$KRAMER LABORATORIES$$65$YR$$M$Y$$$20240711$$HP$US$US
240811811$24081181$1$I$$20231227$20240711$20240711$PER$$US-KRAMERLABS-2023-US-044590$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240811821$24081182$1$I$$20231227$20240711$20240711$PER$$US-KRAMERLABS-2023-US-044877$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811831$24081183$1$I$$20240119$20240711$20240711$PER$$US-KRAMERLABS-2024-US-003394$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240811841$24081184$1$I$$20240126$20240711$20240711$PER$$US-KRAMERLABS-2024-US-005401$KRAMER LABORATORIES$$37$YR$$F$Y$$$20240711$$CN$US$US
240811851$24081185$1$I$20240101$20240202$20240711$20240711$PER$$US-KRAMERLABS-2024-US-006741$KRAMER LABORATORIES$$15$YR$$F$Y$52.16$KG$20240711$$CN$US$US
240811861$24081186$1$I$$20240221$20240711$20240711$PER$$US-KRAMERLABS-2024-US-010707$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811871$24081187$1$I$20240206$20240221$20240711$20240711$PER$$US-KRAMERLABS-2024-US-010734$KRAMER LABORATORIES$$65$YR$$M$Y$97.52$KG$20240711$$CN$US$US
240811881$24081188$1$I$20231101$20240222$20240711$20240711$PER$$US-KRAMERLABS-2024-US-011013$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240811891$24081189$1$I$20231115$20240301$20240711$20240711$PER$$US-KRAMERLABS-2024-US-012830$KRAMER LABORATORIES$$60$YR$$M$Y$88.45$KG$20240711$$CN$US$US
240811901$24081190$1$I$$20240305$20240711$20240711$PER$$US-KRAMERLABS-2024-US-013500$KRAMER LABORATORIES$$$$$UNK$Y$$$20240711$$CN$US$US
240811911$24081191$1$I$$20240305$20240711$20240711$PER$$US-KRAMERLABS-2024-US-013650$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811921$24081192$1$I$$20240227$20240711$20240711$PER$$US-KRAMERLABS-2024-US-013681$KRAMER LABORATORIES$$$$$UNK$Y$$$20240711$$HP$US$US
240811931$24081193$1$I$20240302$20240306$20240711$20240711$PER$$US-KRAMERLABS-2024-US-013690$KRAMER LABORATORIES$$87$YR$$F$Y$81.65$KG$20240711$$CN$US$US
240811941$24081194$1$I$$20240226$20240711$20240711$PER$$US-KRAMERLABS-2024-US-013691$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240811951$24081195$1$I$$20240306$20240711$20240711$PER$$US-KRAMERLABS-2024-US-013800$KRAMER LABORATORIES$$$$$UNK$Y$$$20240711$$CN$US$US
240811961$24081196$1$I$20230101$20240318$20240711$20240711$PER$$US-KRAMERLABS-2024-US-016387$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240811971$24081197$1$I$$20240321$20240711$20240711$PER$$US-KRAMERLABS-2024-US-017339$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240811981$24081198$1$I$20240120$20240320$20240711$20240711$PER$$US-KRAMERLABS-2024-US-016970$KRAMER LABORATORIES$$80$YR$$M$Y$74.84$KG$20240711$$CN$US$US
240811991$24081199$1$I$20240301$20240325$20240711$20240711$PER$$US-KRAMERLABS-2024-US-017719$KRAMER LABORATORIES$$74$YR$$M$Y$81.65$KG$20240711$$CN$US$US
240812001$24081200$1$I$$20240322$20240711$20240711$PER$$US-KRAMERLABS-2024-US-018046$KRAMER LABORATORIES$$48$YR$$M$Y$$$20240711$$CN$US$US
240812011$24081201$1$I$$20240326$20240711$20240711$PER$$US-KRAMERLABS-2024-US-018086$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240812021$24081202$1$I$$20240326$20240711$20240711$PER$$US-KRAMERLABS-2024-US-018442$KRAMER LABORATORIES$$$$$UNK$Y$$$20240711$$CN$US$US
240812031$24081203$1$I$20240301$20240328$20240711$20240711$PER$$US-KRAMERLABS-2024-US-018567$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240812041$24081204$1$I$20240316$20240327$20240711$20240711$PER$$US-KRAMERLABS-2024-US-018679$KRAMER LABORATORIES$$29$YR$$F$Y$46.27$KG$20240711$$CN$US$US
240812051$24081205$1$I$$20240402$20240711$20240711$PER$$US-KRAMERLABS-2024-US-019659$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240812061$24081206$1$I$$20240410$20240711$20240711$PER$$US-KRAMERLABS-2024-US-021294$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240812071$24081207$1$I$$20240418$20240711$20240711$PER$$US-KRAMERLABS-2024-US-023535$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240812081$24081208$1$I$$20240206$20240711$20240711$PER$$US-KRAMERLABS-2024-US-007657$KRAMER LABORATORIES$$58$YR$$F$Y$$$20240711$$CN$US$US
240812091$24081209$1$I$20240201$20240430$20240711$20240711$PER$$US-KRAMERLABS-2024-US-025228$KRAMER LABORATORIES$$$$$M$Y$$$20240711$$CN$US$US
240812101$24081210$1$I$20240415$20240501$20240711$20240711$PER$$US-KRAMERLABS-2024-US-025446$KRAMER LABORATORIES$$$$$F$Y$77.11$KG$20240711$$CN$US$US
240812111$24081211$1$I$$20240502$20240711$20240711$PER$$US-KRAMERLABS-2024-US-025830$KRAMER LABORATORIES$$$$$F$Y$$$20240711$$CN$US$US
240812121$24081212$1$I$$20240507$20240711$20240711$PER$$US-KRAMERLABS-2024-US-026608$KRAMER LABORATORIES$$$$$UNK$Y$$$20240711$$CN$US$US
240812131$24081213$1$I$20240412$20240510$20240711$20240711$PER$$US-KRAMERLABS-2024-US-027409$KRAMER LABORATORIES$$90$YR$$F$Y$77.11$KG$20240711$$CN$US$US
240812141$24081214$1$I$$20240512$20240711$20240711$PER$$US-KRAMERLABS-2024-US-028100$KRAMER LABORATORIES$$$$$UNK$Y$$$20240711$$CN$US$US
240812151$24081215$1$I$20240201$20240514$20240711$20240711$PER$$US-KRAMERLABS-2024-US-028109$KRAMER LABORATORIES$$29$YR$$M$Y$97.52$KG$20240711$$CN$US$US
240812161$24081216$1$I$20240520$20240521$20240711$20240711$PER$$US-KRAMERLABS-2024-US-029427$KRAMER LABORATORIES$$77$YR$$F$Y$56.7$KG$20240711$$CN$US$US
240812171$24081217$1$I$20240515$20240523$20240711$20240711$PER$$US-KRAMERLABS-2024-US-030435$KRAMER LABORATORIES$$44$YR$$F$Y$78$KG$20240711$$CN$US$US
240812181$24081218$1$I$20171027$20240614$20240711$20240711$EXP$$FR-GSK-FR2017GSK165390$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$MD$FR$FR
240812191$24081219$1$I$$20240521$20240711$20240711$PER$$IT-APELLIS-APL-2023-003489$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$MD$IT$IT
240812211$24081221$1$I$$20240710$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109913$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$88.45$KG$20240711$$CN$US$US
240812221$24081222$1$I$20240601$20240708$20240711$20240711$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110337$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240711$$HP$US$US
240812232$24081223$2$F$$20240711$20240711$20240716$PER$$US-Taiho Oncology Inc-2024-006674$TAIHO ONCOLOGY INC$$82$YR$E$F$Y$$$20240716$$CN$US$US
240812241$24081224$1$I$$20240705$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407004005$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240711$$CN$US$US
240812253$24081225$3$F$20240628$20240718$20240711$20240725$PER$$US-ALXN-202407USA000380US$ALEXION PHARMACEUTICALS$$57$YR$$F$Y$$$20240725$$CN$US$US
240812261$24081226$1$I$$20240703$20240711$20240711$EXP$FR-AFSSAPS-AVNT2024000458$FR-TEVA-VS-3217137$TEVA$$62$YR$$M$Y$$$20240711$$PH$FR$FR
240812271$24081227$1$I$$20240514$20240711$20240711$PER$$JP-APELLIS-APL-2023-003502$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$CN$JP$JP
240812281$24081228$1$I$20231215$20240517$20240711$20240711$PER$$JP-APELLIS-APL-2024-003839$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240711$$MD$JP$JP
240812292$24081229$2$F$$20240630$20240711$20240723$PER$$US-GILEAD-2024-0679827$GILEAD$$55$YR$A$M$Y$$$20240723$$CN$US$US
240812302$24081230$2$F$$20240801$20240711$20240806$EXP$$US-TAKEDA-2024TUS019484$TAKEDA$$$$$F$Y$57$KG$20240806$$MD$US$US
240812323$24081232$3$F$$20240822$20240711$20240828$EXP$$NVSC2024VE142952$NOVARTIS$$37$YR$$M$Y$$$20240828$$CN$VE$VE
240812341$24081234$1$I$$20240708$20240711$20240711$EXP$$NVSC2024IL143229$NOVARTIS$$44$YR$$F$Y$$$20240712$$HP$IL$IL
240812351$24081235$1$I$20240410$20240704$20240711$20240711$EXP$ES-AEMPS-1540138$ES-TEVA-VS-3217547$TEVA$$77$YR$$F$Y$52.4$KG$20240711$$MD$ES$ES
240812371$24081237$1$I$$20240708$20240711$20240711$EXP$$US-MTPC-MTDA2024-0014297$Unknown Manufacturer$$$$A$$Y$$$20240711$$MD$US$US
240812382$24081238$2$F$$20240802$20240711$20240805$PER$$US-ALXN-202407USA000428US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240812391$24081239$1$I$20240622$20240704$20240711$20240711$EXP$$CN-AstraZeneca-2024A155782$ASTRAZENECA$$21827$DY$$F$Y$60$KG$20240711$$MD$CN$
240812401$24081240$1$I$20240619$20240708$20240711$20240711$EXP$$JP-AstraZeneca-2024A146057$ASTRAZENECA$$53$YR$$M$Y$54$KG$20240711$$MD$JP$
240812411$24081241$1$I$$20240627$20240711$20240711$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06502$NEUROCRINE BIOSCIENCES$$74$YR$$M$Y$$$20240711$$MD$US$US
240812431$24081243$1$I$$20240628$20240711$20240711$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06562$NEUROCRINE BIOSCIENCES$$$$E$F$Y$$$20240711$$MD$US$US
240812441$24081244$1$I$$20240627$20240711$20240711$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06565$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240711$$HP$US$US
240812451$24081245$1$I$$20240628$20240711$20240711$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06593$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240711$$HP$US$US
240812461$24081246$1$I$20240627$20240701$20240711$20240711$EXP$$US-BEIGENE-BGN-2024-010829$BEIGENE$$$$$$Y$$$20240711$$CN$US$US
240812471$24081247$1$I$20240703$20240708$20240711$20240711$EXP$$MX-JNJFOC-20240729524$JOHNSON AND JOHNSON$$88$YR$E$F$Y$52$KG$20240711$$CN$MX$MX
240812481$24081248$1$I$20240626$20240703$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407004008$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240711$$CN$US$US
240812493$24081249$3$F$$20240826$20240711$20240830$PER$$US-ALXN-202407USA000431US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
240812512$24081251$2$F$$20240802$20240711$20240805$PER$$US-ALXN-202407USA000433US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240812522$24081252$2$F$20240701$20240812$20240711$20240820$EXP$$KR-SAMSUNG BIOEPIS-SB-2024-20560$SAMSUNG BIOEPIS$$40$YR$A$M$Y$$$20240820$$HP$KR$KR
240812542$24081254$2$F$$20240712$20240711$20240718$PER$$US-ALXN-202407USA000500US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$HP$US$US
240812552$24081255$2$F$20240516$20240715$20240711$20240717$EXP$$US-BIOMARINAP-US-2024-159051$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
240812561$24081256$1$I$$20240703$20240711$20240711$PER$$US-BIOMARINAP-US-2024-159018$BIOMARIN$$$$$$Y$$$20240711$$CN$US$US
240812611$24081261$1$I$$20240626$20240711$20240711$PER$$US-PHARMING-PHAUS2024000538$PHARMING GROUP$$$$$$Y$$$20240712$$CN$US$US
240812622$24081262$2$F$20240501$20240802$20240711$20240805$PER$$US-ALXN-202407USA000505US$ALEXION PHARMACEUTICALS$$63$YR$$M$Y$$$20240805$$CN$US$US
240812631$24081263$1$I$$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407007526$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240711$$CN$US$US
240812641$24081264$1$I$$20240709$20240711$20240711$EXP$$US-009507513-2407USA004317$MERCK$$$$$F$Y$$$20240711$$CN$US$US
240812652$24081265$2$F$$20240821$20240711$20240902$PER$$US-PHARMING-PHAUS2024000536$PHARMING GROUP$$$$$$Y$$$20240902$$CN$US$US
240812661$24081266$1$I$$20240611$20240711$20240711$PER$$US-009507513-2406USA003970$MERCK$$$$$F$Y$$$20240711$$CN$US$US
240812671$24081267$1$I$20230101$20240704$20240711$20240711$PER$$US-009507513-2407USA002822$MERCK$Chalker C, Yilmaz B, Trone K, Parecki G, Chen A, Lim JY, et al. Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule. NPJ precision oncology. 2024;8(1): 132$70$YR$$M$Y$$$20240711$$HP$US$US
240812681$24081268$1$I$20240101$20240711$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039303$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$$$20240712$$CN$US$US
240812691$24081269$1$I$$20240709$20240711$20240711$EXP$$CA-SANDOZ INC.-SDZ2024CA064170$SANDOZ$$59$YR$$F$Y$$$20240711$$CN$CA$CA
240812701$24081270$1$I$$20240711$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039313$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240712$$CN$US$US
240812711$24081271$1$I$$20240709$20240711$20240711$EXP$$US-JNJFOC-20240723153$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240812731$24081273$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024135763$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240812741$24081274$1$I$$20240710$20240711$20240711$EXP$$JP-TAKEDA-2024TJP010435$TAKEDA$$8$DEC$$M$Y$$$20240711$$MD$JP$JP
240812751$24081275$1$I$$20240628$20240711$20240711$PER$$US-PHARMING-PHAUS2024000541$PHARMING GROUP$$$$$$Y$$$20240712$$CN$US$US
240812761$24081276$1$I$$20240707$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407005859$ELI LILLY AND CO$$$$$F$Y$$$20240711$$CN$US$US
240812771$24081277$1$I$$20240708$20240711$20240711$30DAY$$US-ELI_LILLY_AND_COMPANY-US202407007605$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240711$$CN$US$US
240812781$24081278$1$I$20240626$20240627$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202406019829$ELI LILLY AND CO$$10$YR$C$M$Y$$$20240711$$CN$US$US
240812791$24081279$1$I$20240101$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136738$AMGEN$$52$YR$A$F$Y$$$20240711$$HP$US$US
240812801$24081280$1$I$20141029$20240710$20240711$20240711$EXP$$DE-SANDOZ INC.-SDZ2024DE064196$SANDOZ$$9$YR$$F$Y$28$KG$20240711$$MD$DE$DE
240812811$24081281$1$I$$20240611$20240711$20240711$PER$$US-009507513-2406USA003877$MERCK$Dias E Silva D, Mambetsariev I, Fricke J, Babikian R, Dingal ST, Mazdisnian F, et al. A novel HLA-DQB2:MET gene fusion variant in lung adenocarcinoma with prolonged response to tepotinib: a case report. Translational Lung Cancer Research. 2024;13(5):1163-8$73$YR$$F$Y$$$20240711$$HP$US$US
240812821$24081282$1$I$20240101$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136674$AMGEN$$60$YR$A$F$Y$$$20240711$$HP$US$US
240812831$24081283$1$I$20150724$20240710$20240711$20240711$PER$$US-JNJFOC-20240728870$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240712$$HP$US$US
240812841$24081284$1$I$$20240703$20240711$20240711$EXP$$KR-JNJFOC-20240713580$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$HP$KR$KR
240812852$24081285$2$F$20240101$20240712$20240711$20240715$PER$$US-JNJFOC-20240722832$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240715$$CN$US$US
240812864$24081286$4$F$20211213$20240909$20240711$20240913$EXP$$JP-TAKEDA-2024TJP010349$TAKEDA$$15$YR$$M$Y$$$20240913$$MD$JP$JP
240812871$24081287$1$I$$20240710$20240711$20240711$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039287$BOEHRINGER INGELHEIM$$$$$$Y$$$20240712$$HP$CO$CO
240812881$24081288$1$I$20240529$20240708$20240711$20240711$EXP$$US-JNJFOC-20240719161$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240712$$HP$US$US
240812901$24081290$1$I$$20240709$20240711$20240711$PER$$NVSC2024US143697$NOVARTIS$$$$$$Y$$$20240712$$HP$US$US
240812911$24081291$1$I$$20240709$20240711$20240711$EXP$$JP-TAKEDA-2024TJP010356$TAKEDA$$5$DEC$$F$Y$$$20240711$$MD$JP$JP
240812922$24081292$2$F$20240321$20240725$20240711$20240731$EXP$$JP-009507513-2405JPN001059J$MERCK$$7$DEC$$M$Y$$$20240731$$MD$JP$JP
240812931$24081293$1$I$$20240701$20240711$20240711$EXP$$IT-PRINSTON PHARMACEUTICAL INC.-2024PRN00269$PRINSTON PHARMACEUTICAL$Malavasi M, Notarianni G, Pontillo D. et.al.. THE CONUNDRUM OF DRUG INTERACTIONS AND HOLTER MONITORING: LAMIN GENE MUTATION DISCOVERED BY A TORSADE DE POINTES EPISODE FOLLOWED BY OUT-OF-THE-HOSPITAL RESUSCITATION. Eur. Heart J. Suppl. 2024;26:ii55-ii56$57$YR$$F$Y$$$20240711$$HP$IT$IT
240812942$24081294$2$F$$20240916$20240711$20240918$EXP$$AU-009507513-2407AUS004576$MERCK$Gardiner BJ, Ivulich SP, Snell GI. Voriconazole inhalation powder: A novel therapeutic alternative for invasive pulmonary fungal infections. Transplant Infectious Disease. 2024;26 (3):1-4$54$YR$$F$Y$$$20240918$$HP$AU$AU
240812951$24081295$1$I$$20240708$20240711$20240711$EXP$$MX-NOVEN PHARMACEUTICALS, INC.-2024-NOV-MX000842$PAREXEL$Medina A.R., Hammerness P., Ihyembe D., Plummer S., Diekroger E., Fogler J.. Complex ADHD Challenging Case: Managing Co-Occurring Attention-Deficit Hyperactivity Disorder and Congenital Heart Disease with a Limited Medication Formulary: A Case from Mexico. Journal of Developmental + Behavioral Pediatrics. 2024;45:3:e271-e273$8$YR$$M$Y$$$20240712$$MD$MX$MX
240812961$24081296$1$I$20240601$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136234$AMGEN$$$$$F$Y$$$20240711$$HP$US$US
240812971$24081297$1$I$$20240711$20240711$20240711$EXP$GB-MHRA-30950590$GB-JNJFOC-20240729553$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240712$$PH$GB$GB
240812981$24081298$1$I$20240623$20240708$20240711$20240711$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109707$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240712$$HP$US$US
240812991$24081299$1$I$20240601$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137338$AMGEN$$63$YR$A$M$Y$$$20240711$$CN$US$US
240813001$24081300$1$I$$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024137588$AMGEN$$$$$$Y$$$20240711$$PH$US$US
240813021$24081302$1$I$$20240614$20240711$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-098668$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240712$$MD$JP$JP
240813031$24081303$1$I$$20240709$20240711$20240711$EXP$$GB-SANDOZ INC.-SDZ2024GB040360$SANDOZ$$$$$F$Y$$$20240711$$CN$GB$GB
240813041$24081304$1$I$$20240703$20240711$20240711$EXP$$PT-JNJFOC-20240722628$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240712$$MD$PT$PT
240813051$24081305$1$I$20240710$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137112$AMGEN$$60$YR$A$F$Y$$$20240711$$CN$US$US
240813071$24081307$1$I$$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137467$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240813086$24081308$6$F$20240708$20240913$20240711$20240923$EXP$$US-JNJFOC-20240722695$JOHNSON AND JOHNSON$$48$YR$A$F$Y$56.8$KG$20240923$$HP$US$US
240813101$24081310$1$I$20240528$20240709$20240711$20240711$EXP$$US-ABBVIE-5833545$ABBVIE$$66$YR$$F$Y$$$20240711$$CN$US$US
240813112$24081311$2$F$20240601$20240718$20240711$20240723$EXP$$US-ABBVIE-5831963$ABBVIE$$77$YR$$F$Y$56$KG$20240723$$CN$US$US
240813121$24081312$1$I$$20240709$20240711$20240711$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-109400$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$91.17$KG$20240712$$CN$PR$PR
240813132$24081313$2$F$20240708$20240712$20240711$20240718$EXP$$US-ABBVIE-5832503$ABBVIE$$66$YR$$F$Y$90.718$KG$20240718$$CN$US$US
240813156$24081315$6$F$$20240805$20240711$20240808$30DAY$$BR-JNJFOC-20240664041$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240808$$CN$BR$BR
240813161$24081316$1$I$20240301$20240704$20240711$20240711$EXP$GB-MHRA-MED-202405070900558150-WHPQJ$GB-RDY-SPO/GBR/24/0009848$DR REDDYS$$67$YR$E$M$Y$77$KG$20240712$$CN$GB$GB
240813171$24081317$1$I$20240101$20240708$20240711$20240711$EXP$$CA-ABBVIE-5833098$ABBVIE$$37$YR$$F$Y$$$20240711$$CN$CA$CA
240813181$24081318$1$I$20240222$20240709$20240711$20240711$EXP$$JP-TAKEDA-2024TJP010348$TAKEDA$$6$YR$$M$Y$$$20240711$$MD$JP$JP
240813192$24081319$2$F$$20240826$20240711$20240903$PER$$US-BAUSCHBL-2024BNL029607$BAUSCH AND LOMB$$$$$F$Y$$$20240904$$CN$US$US
240813201$24081320$1$I$$20240701$20240711$20240711$EXP$$JP-SIMCERE OF AMERICA, INC.-2024PRN00265$Jiangsu Simcere Pharmaceutical$Shionoya K, Kobayashi M, Kako M, Masuda S, Makazu M, Koizumi K.. Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct Syndrome. Internal Medicine. 2024;63 (12):1719-1723$70$YR$$M$Y$$$20240711$$HP$JP$JP
240813211$24081321$1$I$$20240709$20240711$20240711$EXP$$GB-BIOGEN-2024BI01273117$BIOGEN$$$$A$F$Y$$$20240711$$CN$GB$GB
240813221$24081322$1$I$20230710$20240702$20240711$20240711$EXP$$US-ABBVIE-5835270$ABBVIE$$81$YR$$M$Y$82.9$KG$20240711$$MD$US$US
240813231$24081323$1$I$$20240710$20240711$20240711$PER$$US-JNJFOC-20240726086$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240813241$24081324$1$I$20240708$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136970$AMGEN$$52$YR$A$F$Y$$$20240711$$CN$US$US
240813251$24081325$1$I$$20240709$20240711$20240711$EXP$$US-BIOGEN-2024BI01273043$BIOGEN$$$$$F$Y$$$20240711$$HP$US$US
240813261$24081326$1$I$20230101$20240708$20240711$20240711$EXP$$US-BIOGEN-2024BI01244972$BIOGEN$$$$$F$Y$47.243$KG$20240711$$CN$US$US
240813271$24081327$1$I$20230101$20240703$20240711$20240711$PER$$US-BAUSCHBL-2024BNL029614$BAUSCH AND LOMB$$$$$$Y$$$20240712$$HP$US$US
240813282$24081328$2$F$$20240703$20240711$20240722$PER$$US-JNJFOC-20240725034$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240722$$CN$US$US
240813291$24081329$1$I$20240710$20240710$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039306$BOEHRINGER INGELHEIM$$$$$$Y$$$20240712$$CN$US$US
240813301$24081330$1$I$20240701$20240710$20240711$20240711$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039255$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240712$$CN$US$US
240813311$24081331$1$I$$20240703$20240711$20240711$PER$$US-BAUSCHBL-2024BNL029610$BAUSCH AND LOMB$$30$YR$$F$Y$$$20240712$$MD$US$US
240813321$24081332$1$I$20240627$20240702$20240711$20240711$PER$$US-BAUSCHBL-2024BNL029693$BAUSCH AND LOMB$$$$$F$Y$$$20240712$$CN$US$US
240813331$24081333$1$I$$20240704$20240711$20240711$PER$$US-AMGEN-USASP2024133183$AMGEN$$$$A$F$Y$$$20240711$$CN$US$US
240813341$24081334$1$I$20240703$20240703$20240711$20240711$PER$$US-JNJFOC-20240723771$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240712$$CN$US$US
240813351$24081335$1$I$20240101$20240708$20240711$20240711$PER$$US-ABBVIE-5832164$ABBVIE$$$$$$Y$$$20240711$$CN$US$US
240813361$24081336$1$I$$20240707$20240711$20240711$EXP$$US-JNJFOC-20240718819$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240712$$HP$US$US
240813371$24081337$1$I$$20240701$20240711$20240711$EXP$$US-JNJFOC-20240717597$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$MD$US$US
240813381$24081338$1$I$$20240628$20240711$20240711$EXP$$SI-ALTHERA Pharmaceuticals, LLC-ALT202407-000001$ALTHERA LIFE SCIENCES$$79$YR$E$F$Y$$$20240711$$HP$SI$
240813391$24081339$1$I$$20240708$20240711$20240711$PER$$US-SA-2024SA202498$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240712$$CN$US$US
240813401$24081340$1$I$20240531$20240710$20240711$20240711$EXP$$CA-ABBVIE-5836341$ABBVIE$$77$YR$$M$Y$$$20240711$$CN$CA$CA
240813411$24081341$1$I$$20240709$20240711$20240711$PER$$US-JNJFOC-20240723019$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$HP$US$US
240813423$24081342$3$F$20240419$20240903$20240711$20240906$EXP$$CA-JNJFOC-20240526761$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240906$$HP$CA$CA
240813431$24081343$1$I$20240101$20240709$20240711$20240711$EXP$$US-BIOGEN-2024BI01273116$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240813441$24081344$1$I$20190101$20240709$20240711$20240711$EXP$$US-BIOGEN-2024BI01273121$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240813451$24081345$1$I$$20240701$20240711$20240711$EXP$$ES-JNJFOC-20240712645$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240712$$HP$ES$ES
240813461$24081346$1$I$$20240709$20240711$20240711$EXP$$US-BIOGEN-2024BI01273239$BIOGEN$$$$$F$Y$$$20240711$$CN$US$US
240813481$24081348$1$I$20240101$20240703$20240711$20240711$PER$$US-BAUSCHBL-2024BNL029724$BAUSCH AND LOMB$$$$$F$Y$$$20240712$$CN$US$US
240813491$24081349$1$I$$20240701$20240711$20240711$PER$$US-TEVA-VS-3218031$TEVA$LaCava AF, Fadugba OO. Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases. Allerg-Asth-Clin-Immunol 2023; 19.$39$YR$$M$Y$$$20240711$$HP$US$US
240813505$24081350$5$F$20240601$20240906$20240711$20240912$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032656$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240912$$CN$US$US
240813511$24081351$1$I$20240605$20240627$20240711$20240711$EXP$$PK-ROCHE-RCA5137690$ROCHE$$57$YR$A$M$Y$$$20240712$$CN$PK$PK
240813521$24081352$1$I$20240615$20240708$20240711$20240711$EXP$$CO-ABBVIE-5835528$ABBVIE$$81$YR$$F$Y$68$KG$20240711$$HP$CO$CO
240813531$24081353$1$I$20240101$20240628$20240711$20240711$EXP$$SE-GLENMARK PHARMACEUTICALS-2024GMK092020$GLENMARK$$$$$$Y$$$20240712$$MD$SE$SE
240813541$24081354$1$I$20240601$20240705$20240711$20240711$PER$$US-SA-2024SA200574$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240712$$CN$US$US
240813551$24081355$1$I$$20240702$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407002321$ELI LILLY AND CO$$$$$M$Y$$$20240711$$CN$US$US
240813561$24081356$1$I$$20240710$20240711$20240711$PER$$US-ELI_LILLY_AND_COMPANY-US202407007250$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240711$$CN$US$US
240813571$24081357$1$I$$20240708$20240711$20240711$PER$$US-ABBVIE-5833808$ABBVIE$$$$$$Y$$$20240711$$CN$US$US
240813584$24081358$4$F$20240515$20240827$20240711$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-101595$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240903$$MD$JP$JP
240813591$24081359$1$I$$20240708$20240711$20240711$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-110006$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240712$$MD$JP$JP
240813601$24081360$1$I$20240711$20240711$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039304$BOEHRINGER INGELHEIM$$$$$F$Y$227$KG$20240712$$HP$US$US
240813611$24081361$1$I$$20240710$20240711$20240711$PER$$US-AMGEN-USASP2024137621$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240813632$24081363$2$F$20240730$20240803$20240711$20240810$PER$$US-SA-2024SA201071$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240810$$MD$US$US
240813641$24081364$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA201171$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240712$$MD$US$US
240813651$24081365$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA200990$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240712$$MD$US$US
240813661$24081366$1$I$$20240711$20240711$20240711$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039302$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240712$$CN$US$US
240813672$24081367$2$F$20240705$20240710$20240711$20240715$EXP$$JP-JNJFOC-20240727547$JOHNSON AND JOHNSON$$13$YR$T$M$Y$51$KG$20240715$$MD$JP$JP
240813682$24081368$2$F$$20240710$20240711$20240712$PER$$NVSC2024US143621$NOVARTIS$$$$$F$Y$$$20240712$$CN$US$US
240813692$24081369$2$F$$20240709$20240711$20240712$EXP$$US-ROCHE-10000001905$ROCHE$$67$YR$E$F$Y$$$20240712$$MD$US$US
240813701$24081370$1$I$$20240711$20240711$20240711$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039300$BOEHRINGER INGELHEIM$$88$YR$E$F$Y$$$20240712$$CN$US$US
240813711$24081371$1$I$$20240703$20240711$20240711$PER$$US-JNJFOC-20240720631$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240813721$24081372$1$I$20240704$20240705$20240711$20240711$EXP$$IL-009507513-2407ISR004457$MERCK$$84$YR$$M$Y$$$20240711$$CN$IL$IL
240813731$24081373$1$I$$20240708$20240711$20240711$PER$$US-AMGEN-USASP2024136440$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240813741$24081374$1$I$$20240703$20240711$20240711$EXP$$US-NOVITIUMPHARMA-2024USNVP01200$NOVITIUM PHARMA$Penelope A. Hirt.Cutaneous Mycobacterium avium-intracellulare infection masquerading as sarcoidosis.Pediatric Dermatology.03-JAN-2024;41(3):497-500$14$YR$T$M$Y$$$20240712$$HP$US$US
240813753$24081375$3$F$$20240823$20240711$20240828$PER$$NVSC2024US143652$NOVARTIS$$$$$M$Y$$$20240828$$CN$US$US
240813763$24081376$3$F$20240601$20240806$20240711$20240808$EXP$$US-ROCHE-10000021916$ROCHE$$83$YR$E$F$Y$$$20240808$$MD$US$US
240813771$24081377$1$I$20230901$20240703$20240711$20240711$EXP$$GB-JNJFOC-20240713863$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$HP$GB$GB
240813781$24081378$1$I$$20240705$20240711$20240711$PER$$US-SA-2024SA201252$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240813791$24081379$1$I$$20240709$20240711$20240711$PER$$US-SA-2024SA202584$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240712$$CN$US$US
240813802$24081380$2$F$20230101$20240712$20240711$20240722$EXP$$US-ABBVIE-5832327$ABBVIE$$$$$M$Y$131.08$KG$20240719$$CN$US$US
240813811$24081381$1$I$20240529$20240708$20240711$20240711$EXP$$US-ABBVIE-5833645$ABBVIE$$66$YR$$F$Y$$$20240711$$CN$US$US
240813821$24081382$1$I$$20240628$20240711$20240711$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092043$GLENMARK$Sharma P, Tahiru M, Li H, Bansari A, Baskaran N.. A case of ocular diffuse large B-cell lymphoma unveiled through Pars Plana Vitrectomy: SJournal of Surgical Case Reportsurgical insight and multidisciplinary management.. Journal of surgical case reports.. 2024;2024(6):rjae399$$$$$Y$$$20240712$$MD$US$US
240813831$24081383$1$I$20230901$20240628$20240711$20240711$EXP$$US-ABBVIE-5833152$ABBVIE$$35$YR$$F$Y$97$KG$20240711$$MD$US$US
240813842$24081384$2$F$$20240710$20240711$20240720$PER$$US-ABBVIE-5836497$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
240813851$24081385$1$I$$20240708$20240711$20240711$EXP$$US-ABBVIE-5832473$ABBVIE$$$$$F$Y$$$20240711$$HP$US$US
240813862$24081386$2$F$20240101$20240724$20240711$20240731$EXP$$US-ABBVIE-5834043$ABBVIE$$$$$F$Y$83$KG$20240731$$CN$US$US
240813871$24081387$1$I$$20240705$20240711$20240711$EXP$$CN-BEIGENE-BGN-2024-010504$BEIGENE$Li M.; Yue J.; Zhang B.; Shi X.; Cui K.; Liu J. et al. Interim report of Notable-HCC: A phase Ib study of neoadjuvant PD-1 with stereotactic body radiotherapy in patients with resectable hepatocellular carcinoma (HCC). Annals of Oncology. 2023;34 Supplement 2:S598-S599$$$$$Y$$$20240711$$MD$CN$CN
240813881$24081388$1$I$20240708$20240708$20240711$20240711$EXP$$CN-GSK-CN2024APC084765$GLAXOSMITHKLINE$$$$$$Y$$$20240711$$CN$CN$CN
240813891$24081389$1$I$$20240705$20240711$20240711$PER$$US-AMGEN-USASP2024134709$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240813912$24081391$2$F$$20240805$20240711$20240808$EXP$$BE-TAKEDA-2024TUS068823$TAKEDA$$14$YR$$M$Y$$$20240808$$CN$BE$BE
240813921$24081392$1$I$20240708$20240709$20240711$20240711$EXP$$US-AstraZeneca-2024A157767$ASTRAZENECA$$$$$F$Y$$$20240712$$HP$US$
240813932$24081393$2$F$20240601$20240909$20240711$20240916$EXP$$CA-ABBVIE-5834390$ABBVIE$$59$YR$$F$Y$$$20240916$$CN$CA$CA
240813941$24081394$1$I$$20240705$20240711$20240711$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107847$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240712$$HP$CA$CA
240813951$24081395$1$I$20240627$20240709$20240711$20240711$EXP$$GB-ABBVIE-5833081$ABBVIE$$65$YR$$F$Y$$$20240711$$CN$GB$GB
240813961$24081396$1$I$20240101$20240709$20240711$20240711$EXP$$US-ABBVIE-5834596$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240813971$24081397$1$I$$20240709$20240711$20240711$PER$$US-ROCHE-10000023750$ROCHE$$$$A$F$Y$113$KG$20240712$$CN$US$US
240813982$24081398$2$F$$20240723$20240711$20240727$EXP$$US-ABBVIE-5833566$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
240813991$24081399$1$I$$20240710$20240711$20240711$EXP$$US-JNJFOC-20240727525$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$MD$US$US
240814001$24081400$1$I$20240301$20240705$20240711$20240711$PER$$US-BEIGENE-BGN-2024-010563$BEIGENE$$$$$$Y$$$20240711$$CN$US$US
240814022$24081402$2$F$20240625$20240718$20240711$20240724$EXP$JP-MMM-J63K9ZSN$JP-GSK-JP2024084300$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$JP$JP
240814032$24081403$2$F$$20240708$20240711$20240718$EXP$$US-GSK-US2024084328$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$US$US
240814041$24081404$1$I$20240101$20240709$20240711$20240711$EXP$$US-ABBVIE-5834307$ABBVIE$$$$$M$Y$$$20240711$$CN$US$US
240814051$24081405$1$I$$20240708$20240711$20240711$PER$$US-JNJFOC-20240719098$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240712$$HP$US$US
240814071$24081407$1$I$20240101$20240709$20240711$20240711$EXP$$US-JNJFOC-20240724227$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240712$$HP$US$US
240814081$24081408$1$I$$20240708$20240711$20240711$EXP$$GB-ABBVIE-5833902$ABBVIE$$$$E$F$Y$$$20240711$$CN$GB$GB
240814091$24081409$1$I$20240101$20240708$20240711$20240711$EXP$$US-ABBVIE-5833228$ABBVIE$$$$$F$Y$$$20240711$$CN$US$US
240814103$24081410$3$F$20240702$20240802$20240711$20240807$EXP$$US-ABBVIE-5834059$ABBVIE$$54$YR$$F$Y$$$20240807$$CN$US$US
240814112$24081411$2$F$20240625$20240801$20240711$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110154$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$54.88$KG$20240808$$CN$US$US
240814121$24081412$1$I$$20240703$20240711$20240711$EXP$$US-NOVITIUMPHARMA-2024USNVP01220$NOVITIUM PHARMA$Marlise R. Luskin.A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL and Blast Phase CML in Adults.Blood.02-NOV-2023;142:965$85$YR$E$M$Y$$$20240712$$HP$US$US
240814132$24081413$2$F$$20240823$20240711$20240823$PER$$NVSC2024US143620$NOVARTIS$$$$$F$Y$$$20240823$$HP$US$US
240814141$24081414$1$I$$20240710$20240711$20240711$PER$$NVSC2024US143689$NOVARTIS$$$$$F$Y$$$20240712$$CN$US$US
240814151$24081415$1$I$20240705$20240709$20240711$20240711$PER$$US-AMGEN-USASP2024136985$AMGEN$$78$YR$E$M$Y$$$20240711$$CN$US$US
240814162$24081416$2$F$20240601$20240708$20240711$20240725$30DAY$$US-AMGEN-USASP2024134125$AMGEN$$77$YR$E$F$Y$92.5$KG$20240725$$PH$US$US
240814171$24081417$1$I$20240209$20240709$20240712$20240712$EXP$$US-AstraZeneca-2024A157352$ASTRAZENECA$$25725$DY$$M$Y$$$20240712$$CN$US$
240814181$24081418$1$I$20240621$20240708$20240712$20240712$EXP$$US-AstraZeneca-2024A155898$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$US$
240814192$24081419$2$F$20240709$20240724$20240712$20240729$EXP$$JP-ASTELLAS-2024JP004833$ASTELLAS$$83$YR$$M$Y$$$20240729$$MD$JP$JP
240814201$24081420$1$I$$20240617$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002896$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240814211$24081421$1$I$20240616$20240705$20240712$20240712$EXP$DE-Eisai-EC-2024-168662$DE-GSK-DE2024GSK084594$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$PH$DE$DE
240814221$24081422$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASL2024136793$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240814231$24081423$1$I$$20240703$20240712$20240712$EXP$$JP-ROCHE-10000019911$ROCHE$$$$A$F$Y$$$20240712$$MD$JP$JP
240814242$24081424$2$F$20240706$20240716$20240712$20240718$PER$$US-AMGEN-USASP2024137634$AMGEN$$61$YR$A$F$Y$$$20240718$$CN$US$US
240814252$24081425$2$F$20240501$20240802$20240712$20240802$PER$$US-ALXN-202407USA000403US$ALEXION PHARMACEUTICALS$$59$YR$$M$Y$$$20240802$$CN$US$US
240814261$24081426$1$I$20240701$20240708$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005294$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240711$$CN$US$US
240814272$24081427$2$F$$20240823$20240712$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002899$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
240814281$24081428$1$I$$20240617$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002900$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240814291$24081429$1$I$$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109995$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240712$$PH$US$US
240814301$24081430$1$I$20240709$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110387$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240712$$PH$US$US
240814311$24081431$1$I$20240621$20240709$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110022$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$46.72$KG$20240712$$CN$US$US
240814321$24081432$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834719$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240814331$24081433$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA202729$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240712$$CN$US$US
240814352$24081435$2$F$$20240710$20240712$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002902$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
240814361$24081436$1$I$20240101$20240702$20240712$20240712$PER$$US-SA-2024SA199278$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240712$$MD$US$US
240814372$24081437$2$F$20240101$20240910$20240712$20240924$PER$$US-SA-2024SA202781$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240924$$CN$US$US
240814381$24081438$1$I$20240616$20240617$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002903$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240712$$CN$US$US
240814391$24081439$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA201585$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240712$$MD$US$US
240814401$24081440$1$I$20240620$20240705$20240712$20240712$PER$$US-SA-2024SA201458$SANOFI AVENTIS$$59$YR$A$F$Y$136$KG$20240712$$MD$US$US
240814411$24081441$1$I$$20240617$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002877$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$HP$US$US
240814421$24081442$1$I$20240515$20240701$20240712$20240712$EXP$$EG-ROCHE-10000018157$ROCHE$$24$YR$A$F$Y$$$20240712$$CN$EG$EG
240814431$24081443$1$I$$20240617$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002905$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240814441$24081444$1$I$$20240617$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003362$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240814451$24081445$1$I$$20240702$20240712$20240712$PER$$US-RDY-SPO/USA/24/0009702$DR REDDYS$$85$YR$E$F$Y$$$20240712$$CN$US$US
240814461$24081446$1$I$$20240703$20240712$20240712$EXP$$CA-AMGEN-CANNI2024136981$AMGEN$$12$MON$I$$Y$10.21$KG$20240711$$MD$CA$CA
240814471$24081447$1$I$20240621$20240709$20240712$20240712$EXP$$US-AstraZeneca-2024A157202$ASTRAZENECA$$$$$M$Y$$$20240712$$HP$US$
240814481$24081448$1$I$$20240701$20240712$20240712$EXP$$JP-ABBVIE-5834331$ABBVIE$$74$YR$$M$Y$$$20240712$$MD$JP$JP
240814491$24081449$1$I$$20240708$20240712$20240712$EXP$$IT-ALXN-202407EEA000465IT$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240712$$MD$IT$IT
240814522$24081452$2$F$20240708$20240731$20240712$20240802$30DAY$$GR-SANDOZ INC.-SDZ2024GR064297$SANDOZ$$13$YR$$F$Y$$$20240802$$CN$GR$GR
240814531$24081453$1$I$20240220$20240702$20240712$20240712$EXP$$CN-ABBVIE-5836530$ABBVIE$$76$YR$$M$Y$54$KG$20240712$$HP$CN$CN
240814541$24081454$1$I$$20240404$20240712$20240712$PER$$US-AJANTA-2024AJA00076$AJANTA PHARMA$$$$$$Y$$$20240712$$CN$US$US
240814551$24081455$1$I$$20240709$20240712$20240712$EXP$$BR-HALEON-2186128$Haleon PLC$$$$$M$Y$$$20240711$$CN$BR$BR
240814561$24081456$1$I$20240301$20240708$20240712$20240712$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010444$JAZZ$$7$YR$$M$Y$26.1$KG$20240711$$CN$US$US
240814571$24081457$1$I$$20240710$20240712$20240712$30DAY$$US-GSK-US2024AMR086080$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$MD$US$US
240814581$24081458$1$I$20240618$20240708$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108767$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240712$$HP$US$US
240814591$24081459$1$I$20240101$20240709$20240712$20240712$EXP$FR-AFSSAPS-TS2024000716$FR-HALEON-2186293$Haleon PLC$$17$YR$$F$Y$51$KG$20240711$$MD$FR$FR
240814601$24081460$1$I$20240612$20240710$20240712$20240712$EXP$$US-TAKEDA-2024TUS038310$TAKEDA$$58$YR$$F$Y$$$20240712$$CN$US$US
240814611$24081461$1$I$$20240710$20240712$20240712$PER$$US-ABBVIE-5836456$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240814622$24081462$2$F$$20240806$20240712$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002658$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
240814631$24081463$1$I$$20240711$20240712$20240712$EXP$$US-UCBSA-2024035181$UCB$$$$$F$Y$$$20240712$$PH$US$US
240814641$24081464$1$I$20231020$20231023$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2023US049218$SANDOZ$$0$YR$$F$Y$$$20240712$$CN$US$US
240814651$24081465$1$I$20240614$20240709$20240712$20240712$EXP$$US-AstraZeneca-2024A156927$ASTRAZENECA$$26626$DY$$M$Y$$$20240712$$CN$US$
240814661$24081466$1$I$20240612$20240709$20240712$20240712$EXP$$US-AstraZeneca-2024A157018$ASTRAZENECA$$24621$DY$$F$Y$$$20240712$$CN$US$
240814671$24081467$1$I$20240507$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405090234004530-TSGYV$GB-ABBVIE-5836345$ABBVIE$$26$YR$$M$Y$$$20240712$$CN$GB$GB
240814681$24081468$1$I$$20240617$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002910$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240814691$24081469$1$I$20240101$20240710$20240712$20240712$EXP$$US-UCBSA-2024035222$UCB$$$$$F$Y$$$20240712$$HP$US$US
240814701$24081470$1$I$$20240709$20240712$20240712$EXP$$US-JNJFOC-20240724231$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240712$$HP$US$US
240814713$24081471$3$F$20220401$20240805$20240712$20240808$EXP$DE-BFARM-24004401$DE-VIIV HEALTHCARE LIMITED-DE2024080553$VIIV$$$$$$Y$$$20240808$$MD$DE$DE
240814721$24081472$1$I$20240604$20240627$20240712$20240712$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000553$PAREXEL$$$$$$Y$$$20240712$$HP$CN$CN
240814731$24081473$1$I$20230201$20240701$20240712$20240712$EXP$DE-PEI-CADR2024328551$DE-BEH-2024174819$CSL BEHRING$$74$YR$E$M$Y$92$KG$20240712$$CN$DE$DE
240814741$24081474$1$I$20240702$20240708$20240712$20240712$EXP$$JP-HALEON-2186144$Haleon PLC$$6$DEC$$F$Y$$$20240711$$CN$JP$JP
240814751$24081475$1$I$$20230927$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2023US039875$SANDOZ$$$$$F$Y$$$20240712$$CN$US$US
240814761$24081476$1$I$20240101$20240708$20240712$20240712$EXP$$US-AMGEN-USASP2024136984$AMGEN$$86$YR$E$F$Y$$$20240711$$CN$US$US
240814773$24081477$3$F$20240101$20240723$20240712$20240730$EXP$$US-ABBVIE-5834789$ABBVIE$$$$$F$Y$55$KG$20240730$$PH$US$US
240814782$24081478$2$F$20240710$20240711$20240712$20240713$PER$$US-AMGEN-USASP2024137607$AMGEN$$$$$$Y$$$20240713$$PH$CA$CA
240814791$24081479$1$I$$20240701$20240712$20240712$EXP$$BH-STERISCIENCE B.V.-2024-ST-000993$Steriscience PTE$Ghanem H, Wilson PT, Gill DS.. Intravenous magnesium sulphate for treatment of pediatric migraine: case series.. Signa-Vitae. 2023;19:194-200.$17$YR$$M$Y$$$20240712$$HP$BH$BH
240814801$24081480$1$I$20240101$20240705$20240712$20240712$PER$$US-SA-2024SA201759$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240712$$MD$US$US
240814811$24081481$1$I$20240101$20240702$20240712$20240712$PER$$US-SA-2024SA197062$SANOFI AVENTIS$$$$$F$Y$$$20240712$$MD$US$US
240814821$24081482$1$I$$20240701$20240712$20240712$EXP$$TR-MSNLABS-2024MSNLIT01480$MSN LABORATORIES$Ozkan E, Aydogan E.A Report of a Case with Status Epilepticus Associated Rhabdomyolisis: Status Epilepticus Associated Rhabdomyolisis..International Journal of Current Medical and Biological Sciences.2024;4 (1):5-7$$$$$Y$$$20240712$$HP$TR$TR
240814842$24081484$2$F$20240101$20240702$20240712$20240717$EXP$$CN-SA-2024SA199240$SANOFI AVENTIS$$54$YR$A$F$Y$50.5$KG$20240717$$HP$CN$CN
240814851$24081485$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA200081$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240712$$CN$US$US
240814861$24081486$1$I$$20240627$20240712$20240712$PER$$US-SA-2024SA194746$SANOFI AVENTIS$$70$YR$E$F$Y$57$KG$20240712$$MD$US$US
240814872$24081487$2$F$20240101$20240924$20240712$20240930$PER$$US-SA-2024SA201575$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
240814881$24081488$1$I$20240101$20240708$20240712$20240712$EXP$$US-ABBVIE-5833149$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240814891$24081489$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834350$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240814901$24081490$1$I$$20231117$20240712$20240712$PER$$US-NOVAST LABORATORIES INC.-2023NOV000345$NOVAST$$$$$$Y$$$20240712$$PH$US$US
240814911$24081491$1$I$20210408$20240409$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2023US066061$SANDOZ$$$$C$F$Y$$$20240712$$MD$US$US
240814922$24081492$2$F$$20240801$20240712$20240805$PER$$US-JAZZ PHARMACEUTICALS-2022-US-038539$JAZZ$$$$$M$Y$$$20240804$$HP$US$US
240814931$24081493$1$I$$20240710$20240712$20240712$30DAY$$US-SANDOZ INC.-SDZ2023US024194$SANDOZ$$$$$M$Y$$$20240712$$PH$US$US
240814941$24081494$1$I$20240507$20240710$20240712$20240712$EXP$$US-AstraZeneca-2024A158344$ASTRAZENECA$$26349$DY$$F$Y$$$20240712$$CN$US$
240814951$24081495$1$I$20240630$20240708$20240712$20240712$EXP$$US-AstraZeneca-2024A156024$ASTRAZENECA$$27679$DY$$M$Y$$$20240712$$CN$US$
240814961$24081496$1$I$$20240704$20240712$20240712$PER$$US-LEO Pharma-371847$LEO PHARM$$36$YR$$F$Y$$$20240712$$PH$US$US
240814972$24081497$2$F$$20240711$20240712$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407004903$ELI LILLY AND CO$$90$YR$E$F$Y$$$20240723$$CN$US$US
240814981$24081498$1$I$20210401$20240708$20240712$20240712$EXP$GB-MHRA-MED-202407080925242930-VTSLR$GB-ABBVIE-5836258$ABBVIE$$29$YR$$M$Y$$$20240712$$CN$GB$GB
240814992$24081499$2$F$$20240730$20240712$20240808$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001363$BLUEPRINT MEDICINES$$$$$M$Y$$$20240808$$CN$US$US
240815001$24081500$1$I$20240311$20240314$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US031382$SANDOZ$$0$YR$$F$Y$$$20240712$$CN$US$US
240815012$24081501$2$F$20240630$20240719$20240712$20240802$EXP$$CA-HLS-202401655$HLS THERAPEUTICS$$37$YR$A$F$Y$$$20240802$$PH$CA$CA
240815021$24081502$1$I$$20240703$20240712$20240712$EXP$$PT-HALEON-2186350$Haleon PLC$Teixeira CM, Amaro AM, Dias A, Brito A, Duarte A. Drug-induced injury secondary to terbinafine. Gazzetta Medica Italiana Archivio per le Scienze Mediche. 2024;183(4):364-366$$$E$$Y$$$20240711$$HP$PT$PT
240815041$24081504$1$I$20240614$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110430$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240712$$HP$US$US
240815051$24081505$1$I$20240101$20240708$20240712$20240712$EXP$$US-ABBVIE-5832232$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240815061$24081506$1$I$20240403$20240621$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US039262$SANDOZ$$0$YR$$F$Y$$$20240712$$CN$US$US
240815071$24081507$1$I$$20240702$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033473$AUROBINDO$Malik T, Gordon B, Ramanathan R, Mcguire EL. A Tale of Broken Hearts: Cardiac Aspergillosis in an Immunocompromised Patient. Am-J-Respir-Crit-Care-Med. 2023;207:A 1 8 0 1$27$YR$$M$Y$$$20240712$$HP$US$US
240815081$24081508$1$I$$20240706$20240712$20240712$PER$$US-LEO Pharma-371867$LEO PHARM$$28$YR$$M$Y$$$20240712$$PH$US$US
240815091$24081509$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024136533$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240815101$24081510$1$I$20230901$20240701$20240712$20240712$EXP$$US-NOVOPROD-1249104$NOVO NORDISK$$59$YR$$F$Y$$$20240712$$CN$US$US
240815111$24081511$1$I$$20240702$20240712$20240712$EXP$$US-NOVOPROD-1250141$NOVO NORDISK$$$$$F$Y$$$20240712$$CN$US$US
240815121$24081512$1$I$$20240311$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US052564$SANDOZ$$$$$M$Y$$$20240712$$CN$US$US
240815131$24081513$1$I$20231212$20240701$20240712$20240712$EXP$$US-NOVOPROD-1215834$NOVO NORDISK$$76$YR$$$Y$$$20240712$$CN$US$US
240815141$24081514$1$I$$20240701$20240712$20240712$EXP$$JP-NOVOPROD-1253099$NOVO NORDISK$Ayana Sueki et al,. A Case of Secondary Growth Hormone Deficiency that Developed into Cirrhosis after Several Years of Interrupted Growth Hormone Replacement Therapy. Internal Medicine, The Japenese Society of Internal Medicine. 2024$49$YR$$M$Y$112$KG$20240712$$HP$JP$JP
240815151$24081515$1$I$20240701$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110100$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240712$$PH$US$US
240815162$24081516$2$F$20240620$20240805$20240712$20240814$EXP$$US-NOVOPROD-1249728$NOVO NORDISK$$77$YR$$F$Y$$$20240814$$CN$US$US
240815171$24081517$1$I$$20240702$20240712$20240712$EXP$GB-MHRA-MED-202407021246456500-HTWSK$GB-NOVOPROD-1250027$NOVO NORDISK$$$$$F$Y$$$20240712$$MD$GB$GB
240815181$24081518$1$I$$20240628$20240712$20240712$EXP$$US-NOVOPROD-1248672$NOVO NORDISK$$$$$F$Y$$$20240712$$CN$US$US
240815191$24081519$1$I$$20240702$20240712$20240712$EXP$IE-HPRA-2024-113844$IE-NOVOPROD-1247972$NOVO NORDISK$$61$YR$$F$Y$70$KG$20240712$$MD$IE$IE
240815202$24081520$2$F$20240518$20240816$20240712$20240827$EXP$$US-NOVOPROD-1238142$NOVO NORDISK$$38$YR$$F$Y$$$20240827$$MD$US$US
240815211$24081521$1$I$$20240630$20240712$20240712$EXP$$IL-NOVOPROD-1248997$NOVO NORDISK$$$$$M$Y$$$20240712$$MD$IL$IL
240815221$24081522$1$I$20240629$20240701$20240712$20240712$EXP$$US-NOVOPROD-1248829$NOVO NORDISK$$72$YR$$F$Y$$$20240712$$CN$US$US
240815231$24081523$1$I$$20240628$20240712$20240712$EXP$$US-NOVOPROD-1248507$NOVO NORDISK$$81$YR$$F$Y$$$20240712$$CN$US$US
240815241$24081524$1$I$20240501$20240701$20240712$20240712$EXP$DK-DKMA-30733865$DK-NOVOPROD-1247526$NOVO NORDISK$$72$YR$$F$Y$115$KG$20240712$$MD$DK$DK
240815251$24081525$1$I$$20240702$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033435$AUROBINDO$Peters JD, Shastri D, Hajjar S, York J, Erpenwar S, Vanlandingham A. A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage. Am-J-Respir-Crit-Care-Med. 2024$85$YR$$F$Y$$$20240712$$HP$US$US
240815261$24081526$1$I$$20240702$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033700$AUROBINDO$Suthar PP, Hughes K, Mafraji M, Akyuz M, Jhaveri M, Dua SG. Case 324: CHANTER Syndrome. Radiology. 2020;311(1):1-4, e222748$69$YR$$M$Y$$$20240712$$MD$US$US
240815271$24081527$1$I$20190101$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405151027377850-PNZRJ$GB-ABBVIE-5836091$ABBVIE$$$$$F$Y$$$20240712$$CN$GB$GB
240815281$24081528$1$I$20240101$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024138001$AMGEN$$69$YR$E$F$Y$$$20240711$$PH$US$US
240815301$24081530$1$I$$20240702$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033449$AUROBINDO$Adeniran JF,Ustaoglu M, Eagle RJ, Bloom SM, Wang W, Barr CC. UNILATERAL, SECTORAL RETINAL METASTASIS OF SMALL-CELL LUNG CANCER MIMICKING VIRAL RETINITIS. Retin Cases Brief Rep. 2024;18(4):481?485$48$YR$$F$Y$$$20240712$$MD$US$US
240815311$24081531$1$I$$20240709$20240712$20240712$PER$$US-ROCHE-10000022557$ROCHE$$13$YR$T$M$Y$47$KG$20240712$$HP$US$US
240815321$24081532$1$I$$20240702$20240712$20240712$EXP$$US-NOVOPROD-1251487$NOVO NORDISK$$$$$F$Y$$$20240712$$CN$US$US
240815331$24081533$1$I$20230501$20240702$20240712$20240712$EXP$$US-NOVOPROD-1250234$NOVO NORDISK$$59$YR$$F$Y$$$20240712$$CN$US$US
240815341$24081534$1$I$$20240702$20240712$20240712$EXP$$US-NOVOPROD-1251389$NOVO NORDISK$$$$$F$Y$$$20240712$$CN$US$US
240815351$24081535$1$I$$20240702$20240712$20240712$EXP$$US-NOVOPROD-1250462$NOVO NORDISK$$$$$F$Y$$$20240712$$CN$US$US
240815361$24081536$1$I$$20240708$20240712$20240712$EXP$$CA-ABBVIE-5836611$ABBVIE$$65$YR$$F$Y$$$20240712$$HP$CA$CA
240815371$24081537$1$I$$20240704$20240712$20240712$EXP$$US-JNJFOC-20240722681$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240815381$24081538$1$I$$20240704$20240712$20240712$PER$$US-SA-2024SA200979$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240815391$24081539$1$I$20230101$20240702$20240712$20240712$PER$$US-SA-2024SA199031$SANOFI AVENTIS$$32$YR$A$F$Y$88.435$KG$20240712$$MD$US$US
240815401$24081540$1$I$$20240707$20240712$20240712$PER$$US-SA-2024SA201556$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240712$$MD$US$US
240815422$24081542$2$F$$20240828$20240712$20240910$PER$$US-SA-2024SA197403$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240910$$MD$US$US
240815431$24081543$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA201118$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240712$$MD$US$US
240815443$24081544$3$F$$20240809$20240712$20240826$PER$$US-SA-2024SA197735$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240826$$MD$US$US
240815461$24081546$1$I$$20240703$20240712$20240712$PER$$US-ABBVIE-5834363$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240815472$24081547$2$F$20240101$20240810$20240712$20240814$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039285$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$$$20240814$$MD$CA$CA
240815483$24081548$3$F$20240501$20240815$20240712$20240819$PER$$US-ABBVIE-5834502$ABBVIE$$40$YR$$F$Y$$$20240819$$HP$US$US
240815491$24081549$1$I$20210101$20240708$20240712$20240712$EXP$$US-ABBVIE-5703266$ABBVIE$$52$YR$$M$Y$$$20240712$$CN$US$US
240815503$24081550$3$F$20240619$20240807$20240712$20240826$30DAY$$MX-JNJFOC-20240701865$JOHNSON AND JOHNSON$$55$YR$A$F$Y$70$KG$20240826$$CN$MX$MX
240815511$24081551$1$I$20240415$20240628$20240712$20240712$EXP$$IN-CIPLA LTD.-2024IN06760$CIPLA$$$$$$Y$$$20240712$$CN$IN$IN
240815521$24081552$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005985$ELI LILLY AND CO$$$$$$Y$$$20240712$$MD$US$US
240815531$24081553$1$I$$20240711$20240712$20240712$PER$$US-JNJFOC-20240730121$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$HP$US$US
240815541$24081554$1$I$$20240706$20240712$20240712$PER$$US-HETERO-HET2024US01757$HETERO$$$$$$Y$$$20240712$$CN$US$US
240815551$24081555$1$I$20240323$20240628$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB06961$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240815561$24081556$1$I$$20240628$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB06992$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240815571$24081557$1$I$$20240628$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB06990$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240815581$24081558$1$I$20240605$20240710$20240712$20240712$EXP$FR-AFSSAPS-MP2024001084$FR-JNJFOC-20240724704$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240712$$PH$FR$FR
240815592$24081559$2$F$$20240814$20240712$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06430$LUPIN$$$$$$Y$$$20240903$$CN$US$US
240815601$24081560$1$I$20240323$20240628$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB06977$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240815611$24081561$1$I$20240101$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024136748$AMGEN$$64$YR$A$F$Y$$$20240711$$CN$US$US
240815621$24081562$1$I$20211006$20230712$20240712$20240712$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00343$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240624$$MD$US$US
240815631$24081563$1$I$$20231130$20240712$20240712$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00619$PRINSTON PHARMACEUTICAL$$26$YR$$F$Y$$$20240624$$CN$US$US
240815641$24081564$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024135881$AMGEN$$$$$F$Y$$$20240711$$MD$US$US
240815652$24081565$2$F$20240601$20240917$20240712$20240924$PER$$US-JNJFOC-20240727346$JOHNSON AND JOHNSON$$49$YR$A$F$Y$127$KG$20240925$$CN$US$US
240815661$24081566$1$I$$20240222$20240712$20240712$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00092$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240624$$CN$US$US
240815671$24081567$1$I$20240701$20240701$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407002888$ELI LILLY AND CO$$49$YR$A$F$Y$75.737$KG$20240712$$CN$US$US
240815681$24081568$1$I$$20240625$20240712$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06493$LUPIN$$$$$$Y$$$20240712$$CN$US$US
240815691$24081569$1$I$20240628$20240709$20240712$20240712$EXP$GB-MHRA-MED-202407091127004480-HRMQC$GB-JNJFOC-20240721918$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$MD$GB$GB
240815701$24081570$1$I$$20231025$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2023US049939$SANDOZ$$$$$F$Y$$$20240712$$MD$US$US
240815711$24081571$1$I$20240613$20240710$20240712$20240712$EXP$$AU-ABBVIE-5836649$ABBVIE$$$$$M$Y$$$20240712$$CN$AU$AU
240815721$24081572$1$I$$20240708$20240712$20240712$PER$$US-BEIGENE-BGN-2024-010586$BEIGENE$$$$$$Y$$$20240712$$CN$US$US
240815731$24081573$1$I$$20240627$20240712$20240712$PER$$US-CASPERPHARMA-US-2024RISSPO00232$CASPER PHARMA$$35$YR$A$F$Y$$$20240712$$CN$US$US
240815741$24081574$1$I$20240625$20240618$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002912$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240712$$CN$US$US
240815752$24081575$2$F$20240619$20240801$20240712$20240829$PER$$PR-TOLMAR, INC.-24PR050321$TOLMAR$$64$YR$$M$Y$$$20240829$$HP$PR$PR
240815761$24081576$1$I$20240610$20240620$20240712$20240712$PER$$TR-TOLMAR, INC.-24TR050266$TOLMAR$$79$YR$$M$Y$$$20240712$$PH$TR$TR
240815771$24081577$1$I$$20240620$20240712$20240712$PER$$US-TOLMAR, INC.-24US048137$TOLMAR$$$$$$Y$$$20240712$$HP$US$US
240815781$24081578$1$I$20240507$20240620$20240712$20240712$PER$$US-TOLMAR, INC.-24US049172$TOLMAR$$$$$M$Y$$$20240712$$HP$US$US
240815791$24081579$1$I$20240101$20240703$20240712$20240712$PER$$US-SA-2024SA199870$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240815801$24081580$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA198804$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240712$$MD$US$US
240815811$24081581$1$I$20240702$20240703$20240712$20240712$PER$$US-SA-2024SA199984$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240712$$MD$US$US
240815821$24081582$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA200484$SANOFI AVENTIS$$94$YR$E$M$Y$$$20240712$$CN$US$US
240815831$24081583$1$I$$20240703$20240712$20240712$EXP$$FR-TAKEDA-2024TUS069976$TAKEDA$$$$$M$Y$$$20240712$$CN$FR$FR
240815841$24081584$1$I$$20240704$20240712$20240712$EXP$$US-AMAROX PHARMA-HET2024US01746$HETERO$$$$$$Y$$$20240712$$CN$US$US
240815851$24081585$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA202586$SANOFI AVENTIS$$$$E$F$Y$68$KG$20240712$$MD$US$US
240815861$24081586$1$I$20240501$20240627$20240712$20240712$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000556$PAREXEL$$$$$$Y$$$20240712$$HP$CN$CN
240815871$24081587$1$I$20240101$20240708$20240712$20240712$PER$$US-SA-2024SA201769$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240712$$CN$US$US
240815881$24081588$1$I$$20240706$20240712$20240712$PER$$US-SA-2024SA201564$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240712$$MD$US$US
240815891$24081589$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA199120$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240815903$24081590$3$F$$20240920$20240712$20240925$EXP$$US-TAKEDA-2024TUS055805$TAKEDA$$$$$M$Y$$$20240925$$MD$US$US
240815911$24081591$1$I$$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405080830444070-RFMTN$GB-TAKEDA-2024TUS068538$TAKEDA$$$$$F$Y$91$KG$20240712$$HP$GB$GB
240815922$24081592$2$F$20240101$20240808$20240712$20240812$EXP$$US-ABBVIE-5834443$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
240815931$24081593$1$I$20240707$20240709$20240712$20240712$EXP$$US-ABBVIE-5833762$ABBVIE$$56$YR$$F$Y$$$20240712$$CN$US$US
240815943$24081594$3$F$20240601$20240814$20240712$20240820$EXP$$US-ABBVIE-5834843$ABBVIE$$57$YR$$F$Y$81.646$KG$20240820$$CN$US$US
240815951$24081595$1$I$$20240628$20240712$20240712$EXP$$AU-QUAGEN-2024QUALIT00202$QUAGEN PHARMACEUTICALS$Isha Gupta.Diagnosis of an unusual orbital abscess following sub-Tenon^s steroid injection: a case report.Journal of Surgical Case Reports.08-MAY-2024;5:1-4$83$YR$E$M$Y$$$20240712$$HP$AU$AU
240815961$24081596$1$I$$20240702$20240712$20240712$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008087$STRIDES$Beltra-Pico I, Diaz-Gonzalez M, Nalda-Molina R, Ramon-Lopez A, Pascual-Bartolome S, Miralles-Macia CF, et al.. Cassia angustifolia and tacrolimus interaction in a liver transplant patient, a case report.. Br-J-Clin-Pharmacol. 2024;90 (7):1745-1750.$60$YR$$M$Y$59$KG$20240712$$HP$ES$ES
240815972$24081597$2$F$$20240826$20240712$20240901$EXP$$JP-AMGEN-JPNSP2024137195$AMGEN$$$$$$Y$$$20240901$$PH$JP$JP
240815982$24081598$2$F$$20240722$20240712$20240729$30DAY$$US-AMGEN-USASP2024134193$AMGEN$$$$$$Y$$$20240729$$HP$US$US
240815991$24081599$1$I$20240708$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137319$AMGEN$$73$YR$E$F$Y$$$20240711$$CN$US$US
240816002$24081600$2$F$$20240911$20240712$20240926$PER$$US-SA-2024SA203050$SANOFI AVENTIS$$52$YR$A$F$Y$95.25$KG$20240926$$MD$US$US
240816011$24081601$1$I$20240619$20240703$20240712$20240712$PER$$US-SA-2024SA199666$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240712$$MD$US$US
240816021$24081602$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA198589$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240816041$24081604$1$I$$20240702$20240712$20240712$EXP$CA-MLMSERVICE-20240624-PI109610-00329-1$CA-STRIDES ARCOLAB LIMITED-2024SP007920$STRIDES$Salter B, Ge S, Tam A, Demczuk S, Butcher D, McCready E, et al.. Concurrent BCR-ABL1 and core binding factor beta rearrangement in de novo acute myeloid leukemia: A case report and review of literature.. eJHaem.. 2024;5(3):607-615$62$YR$$M$Y$$$20240712$$MD$CA$CA
240816056$24081605$6$F$$20240826$20240712$20240904$EXP$$DE-AUROBINDO-AUR-APL-2024-033490$AUROBINDO$Paul LD, Brueckner I, Welter-Luedeke J, Zangl A, Graw M.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$44$YR$$M$Y$$$20240904$$HP$DE$DE
240816061$24081606$1$I$$20240703$20240712$20240712$EXP$$MX-STRIDES ARCOLAB LIMITED-2024SP008161$STRIDES$Parmentier C, Cruz-Martinez R, Quintero-Quintero MJ, Vilatoba M.. Mucormycosis in Liver Allograft Following Transplant for Secondary Biliary Cirrhosis. Exp-Clin-Transplant. 2024;22 (4):314-317$57$YR$$M$Y$$$20240712$$HP$MX$MX
240816071$24081607$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834817$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240816083$24081608$3$F$20240710$20240712$20240712$20240718$EXP$$ES-ABBVIE-5835089$ABBVIE$$80$YR$$M$Y$$$20240718$$CN$ES$ES
240816091$24081609$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834873$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240816101$24081610$1$I$20240501$20240703$20240712$20240712$PER$$US-SA-2024SA202904$SANOFI AVENTIS$$32$YR$A$F$Y$61.23$KG$20240712$$MD$US$US
240816111$24081611$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA202597$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240816123$24081612$3$F$$20240808$20240712$20240814$30DAY$$IT-JNJFOC-20240640644$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240814$$PH$IT$IT
240816131$24081613$1$I$20240501$20240709$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110436$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240712$$CN$US$US
240816141$24081614$1$I$20190703$20240624$20240712$20240712$EXP$$DE-ROCHE-2370623$ROCHE$$33$YR$A$F$Y$$$20240712$$CN$DE$DE
240816151$24081615$1$I$$20240605$20240712$20240712$PER$$US-AMGEN-USASP2024136742$AMGEN$$$$$$Y$$$20240711$$MD$US$US
240816161$24081616$1$I$$20240618$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002915$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240816171$24081617$1$I$$20240703$20240712$20240712$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008207$STRIDES$Matthews BJ, Froehlich A, Goicochea L, Levinson K.. Postmenopausal mixed gestational trophoblastic neoplasia with complete response to immunotherapy - A case report.. Gynecol-Oncol-Rep. 2023;46$66$YR$$F$Y$$$20240712$$HP$US$US
240816181$24081618$1$I$$20240703$20240712$20240712$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008216$STRIDES$Inoue S, Tachibana K, Masunaga N, Shinoda Y, Minamisaka T, Inui H, et al. A case of acute purulent pericarditis due to MRSA treated with daily pericardial lavage for one month followed by pericardial fenestration.. J-Cardiol-Cases. 2024;29 (5):231-233$54$YR$$M$Y$$$20240712$$MD$JP$JP
240816191$24081619$1$I$20240708$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137828$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240816201$24081620$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024136810$AMGEN$$61$YR$A$M$Y$$$20240711$$CN$US$US
240816211$24081621$1$I$$20240708$20240712$20240712$EXP$$FR-ABBVIE-5834994$ABBVIE$$67$YR$$M$Y$$$20240712$$MD$FR$FR
240816222$24081622$2$F$$20240708$20240712$20240718$EXP$IN-STRIDES ARCOLAB LIMITED-2024SP008278$IN-STRIDES ARCOLAB LIMITED-2024SP008278$STRIDES$Parmar S, Shatadal P, Mehta R.. Diagnostic dilemma: Systemic Lupus Erythematosus (SLE) induced psychosis vs Steroid-induced psychosis- A case report.. Indian Journal of Psychiatry. 2024;66 (Suppl. 1):S167 (plus Poster).$$$$F$Y$$$20240718$$MD$IN$IN
240816234$24081623$4$F$20240101$20240915$20240712$20240927$EXP$$NL-ABBVIE-5835002$ABBVIE$$$$E$F$Y$$$20240927$$CN$NL$NL
240816241$24081624$1$I$$20240708$20240712$20240712$EXP$$CA-ABBVIE-5832073$ABBVIE$$46$YR$$F$Y$$$20240712$$CN$CA$CA
240816252$24081625$2$F$$20240813$20240712$20240815$PER$$US-AstraZeneca-2024A150404$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
240816261$24081626$1$I$20240413$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033610$AUROBINDO$$58$YR$$F$Y$$$20240712$$CN$GB$GB
240816271$24081627$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA198562$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240712$$HP$US$US
240816281$24081628$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA202562$SANOFI AVENTIS$$$$A$F$Y$61.23$KG$20240712$$MD$US$US
240816291$24081629$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA201287$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240816302$24081630$2$F$20240101$20240805$20240712$20240810$PER$$US-SA-2021SA096497$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240810$$CN$US$US
240816311$24081631$1$I$$20240701$20240712$20240712$EXP$DE-EMBRYOTOX-202301664-B$DE-TORRENT-00026974$TORRENT$$$$$F$Y$3$KG$20240712$$MD$DE$DE
240816321$24081632$1$I$20230428$20240618$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-001657$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240712$$CN$US$US
240816332$24081633$2$F$$20240813$20240712$20240826$PER$$US-SA-2024SA198313$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240826$$MD$US$US
240816341$24081634$1$I$$20240703$20240712$20240712$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008282$STRIDES$Bhalla K, Mittal K, Gupta A, Nehra D.. Acute disulfiram poisoning in a child: A case report and review of literature. Indian-J-Crit-Care-Med. 2020;24 (3):203-205$4$YR$$F$Y$$$20240712$$HP$IN$IN
240816351$24081635$1$I$20191201$20240705$20240712$20240712$EXP$$ZA-ABBVIE-5835274$ABBVIE$$65$YR$$M$Y$$$20240712$$CN$ZA$ZA
240816361$24081636$1$I$20240101$20240705$20240712$20240712$PER$$US-UNITED THERAPEUTICS-UNT-2024-020924$UNITED THERAPEUTICS$$$$$F$Y$74.376$KG$20240712$$$US$US
240816371$24081637$1$I$$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033780$AUROBINDO$$$$$M$Y$82$KG$20240712$$CN$GB$GB
240816382$24081638$2$F$$20240820$20240712$20240830$30DAY$$US-GSK-US2024084026$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$CN$US$US
240816394$24081639$4$F$20230623$20240830$20240712$20240906$EXP$$NVSC2024KR143622$NOVARTIS$$75$YR$$M$Y$$$20240906$$MD$KR$KR
240816403$24081640$3$F$20240520$20240820$20240712$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002543$ACADIA PHARMACEUTICALS$$63$YR$$F$Y$$$20240912$$CN$US$US
240816411$24081641$1$I$20230301$20240704$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-033392$AUROBINDO$$46$YR$$F$Y$$$20240712$$PH$FR$FR
240816421$24081642$1$I$20230710$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-034030$AUROBINDO$$67$YR$$M$Y$83$KG$20240712$$CN$GB$GB
240816432$24081643$2$F$$20240708$20240712$20240716$EXP$IN-STRIDES ARCOLAB LIMITED-2024SP008249$IN-STRIDES ARCOLAB LIMITED-2024SP008249$STRIDES$Khanna P, Singh VV, Parveen.. Fluoxetine-induced SVT: A Case Report.. Indian Journal of Psychiatry. 2024;66(Supplement1):S203$35$YR$$M$Y$$$20240716$$MD$IN$IN
240816441$24081644$1$I$$20240703$20240712$20240712$PER$$US-ROCHE-10000020212$ROCHE$$25$YR$A$F$Y$$$20240712$$CN$US$US
240816451$24081645$1$I$$20240703$20240712$20240712$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008255$STRIDES$Khanam A, Ahmad Wani Z, Ahmad S, Nazir N.. CYPROHEPTADINE AND DEXAMETHASONE INDUCED SUICIDALITY AND OBSESSIONS PRESENTING TO LIASON PSYCHIATRY- A CASE REPORT.. Indian-J-Psychiatry. 2024;66 (Suppl. 1):S177$20$YR$$M$Y$$$20240712$$HP$IN$IN
240816461$24081646$1$I$$20240704$20240712$20240712$EXP$$CA-TOLMAR, INC.-24CA050799$TOLMAR$$$$$M$Y$$$20240712$$CN$CA$CA
240816471$24081647$1$I$$20240704$20240712$20240712$EXP$$CA-TOLMAR, INC.-24CA050796$TOLMAR$$$$$M$Y$$$20240712$$CN$CA$CA
240816481$24081648$1$I$20240401$20240704$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050800$TOLMAR$$81$YR$$M$Y$$$20240712$$CN$CA$CA
240816492$24081649$2$F$20240515$20240719$20240712$20240726$PER$$CA-TOLMAR, INC.-24CA050849$TOLMAR$$79$YR$$M$Y$$$20240726$$CN$CA$CA
240816501$24081650$1$I$$20240706$20240712$20240712$EXP$$CA-TOLMAR, INC.-24CA050864$TOLMAR$$$$$M$Y$$$20240712$$CN$CA$CA
240816511$24081651$1$I$$20240704$20240712$20240712$EXP$$NL-TOLMAR, INC.-24NL050758$TOLMAR$$$$$M$Y$$$20240712$$CN$NL$NL
240816531$24081653$1$I$$20240704$20240712$20240712$EXP$$US-TOLMAR, INC.-24US050870$TOLMAR$Ravi S.N., Cheema K.P., Taylor G.E.. 52-Year-Old Woman With Recurrent Unexplained Syncope. Mayo Clinic Proceedings. 2024;99:7:1173-1177$52$YR$$F$Y$$$20240712$$MD$US$US
240816541$24081654$1$I$$20240704$20240712$20240712$EXP$$US-TOLMAR, INC.-24US050874$TOLMAR$Lam K., Gates G.A., Bach D.Q., Cheng K.. Eruptive Melanocytic Nevi in the Setting of Encorafenib, Cetuximab, and Binimetinib Combination Therapy: A Case Report. Case Reports in Dermatology. 2024;16:1:133-139$39$YR$$F$Y$$$20240712$$MD$US$US
240816551$24081655$1$I$20240101$20240703$20240712$20240712$PER$$US-SA-2024SA201247$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240712$$MD$US$US
240816561$24081656$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110528$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240712$$CN$US$US
240816571$24081657$1$I$$20240704$20240712$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-107787$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240712$$PH$JP$JP
240816581$24081658$1$I$20240606$20240708$20240712$20240712$EXP$$CN-TAKEDA-2024TUS070132$TAKEDA$$67$YR$$M$Y$65$KG$20240712$$HP$CN$CN
240816592$24081659$2$F$$20240719$20240712$20240730$EXP$$JP-ROCHE-10000019541$ROCHE$Deguchi K,Deguchi S,Kinoshita A,Ihoriya H,Nakano Y,Tokunaga K. B-01 A case of multiple cerebral lesions after coil embolisation for unruptured cerebral aneurysm during administration of satralizumab for neuromyelitis optica spectrum disorder. The 115th Chugoku-Shikoku Regional Meeting of the Japanese Society of Neurology. 2024;47$57$YR$A$F$Y$77$KG$20240730$$MD$JP$JP
240816601$24081660$1$I$$20240618$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000209$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$HP$US$US
240816611$24081661$1$I$$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033765$AUROBINDO$$$$A$M$Y$70$KG$20240712$$CN$GB$GB
240816621$24081662$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024136614$AMGEN$$$$$M$Y$$$20240711$$CN$US$US
240816631$24081663$1$I$$20240703$20240712$20240712$PER$$US-APOTEX-2024AP008159$APOTEX$Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN.. Relationship between the Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular Immunology and Inflammation. 2023;31(5):900-904$$$A$$Y$$$20240712$$HP$US$US
240816641$24081664$1$I$$20240707$20240712$20240712$PER$$US-UNITED THERAPEUTICS-UNT-2024-020827$UNITED THERAPEUTICS$$$$$F$Y$137.87$KG$20240712$$$US$US
240816651$24081665$1$I$20230202$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405152358098260-JGDRY$GB-AMAROX PHARMA-AMR2024GB02154$HETERO$$$$$F$Y$$$20240712$$CN$GB$GB
240816661$24081666$1$I$$20240703$20240712$20240712$EXP$PT-MLMSERVICE-20240626-PI112609-00057-1$PT-STRIDES ARCOLAB LIMITED-2024SP008335$STRIDES$Lobato CT, Castelo Branco S, Cam?es J, Molinos E.. Rhabdomyolysis secondary to a weight-loss prescription.. BMJ Case Reports.. 2024;17(6):e258208$8$DEC$$M$Y$$$20240712$$MD$PT$PT
240816671$24081667$1$I$$20240702$20240712$20240712$EXP$$DK-ENDO USA, INC.-2024-002837$ENDO$Nordal T, Burcharth J, Cordtz AC, Storm N, Jensen TK.. Cholestyramine crystal deposits as possible cause of small bowel perforation. Danish Medical Journal. 2024;186 (V02240109):1-5$70$YR$$F$Y$$$20240712$$HP$DK$DK
240816681$24081668$1$I$$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033550$AUROBINDO$$$$$$Y$$$20240712$$PH$GB$GB
240816691$24081669$1$I$$20240617$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002854$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$HP$US$US
240816701$24081670$1$I$$20240701$20240712$20240712$EXP$$BH-STERISCIENCE B.V.-2024-ST-000995$Steriscience PTE$Ghanem H, Wilson PT, Gill DS.. Intravenous magnesium sulphate for treatment of pediatric migraine: case series.. Signa-Vitae. 2023;19:194-200$11$YR$$F$Y$$$20240712$$HP$BH$BH
240816711$24081671$1$I$$20240702$20240712$20240712$EXP$$US-NOVOPROD-1251501$NOVO NORDISK$$$$$F$Y$$$20240712$$CN$US$US
240816721$24081672$1$I$$20240702$20240712$20240712$EXP$$TR-NOVOPROD-1252721$NOVO NORDISK$$885$MON$$F$Y$70$KG$20240712$$CN$TR$TR
240816731$24081673$1$I$$20240702$20240712$20240712$EXP$$US-ENDO USA, INC.-2024-002855$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240816741$24081674$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006998$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240712$$CN$US$US
240816751$24081675$1$I$20240703$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006315$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240712$$CN$US$US
240816761$24081676$1$I$20240709$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006636$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240816771$24081677$1$I$20240501$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006188$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240712$$CN$US$US
240816781$24081678$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007534$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240712$$CN$US$US
240816791$24081679$1$I$$20240709$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110522$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240712$$CN$US$US
240816801$24081680$1$I$20240703$20240703$20240712$20240712$EXP$$US-ENDO USA, INC.-2024-002866$ENDO$$$$$M$Y$$$20240712$$HP$US$US
240816812$24081681$2$F$20240601$20240708$20240712$20240723$EXP$$JP-GSK-JP2024JPN084128$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$PH$JP$JP
240816821$24081682$1$I$$20240708$20240712$20240712$EXP$$CA-APOTEX-2024AP008145$APOTEX$$59$YR$$F$Y$$$20240712$$CN$CA$CA
240816831$24081683$1$I$$20240710$20240712$20240712$PER$$NVSC2024US143821$NOVARTIS$$27$YR$$$Y$$$20240712$$CN$US$US
240816843$24081684$3$F$$20240705$20240712$20240716$EXP$TR-MLMSERVICE-20240626-PI112309-00120-1$TR-STRIDES ARCOLAB LIMITED-2024SP008336$STRIDES$Boyaci F, Arslan U.. Causation or Coincidence? A Case of Coexisting Spontaneous Coronary Artery Dissection and Coronary Thrombosis in a Patient with Kounis Syndrome.. International Journal of the Cardiovascular Academy.. 2023;9(2):48-51$39$YR$$M$Y$$$20240716$$MD$TR$TR
240816851$24081685$1$I$20240531$20240708$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010621$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240816862$24081686$2$F$20240609$20240826$20240712$20240905$EXP$$US-NOVOPROD-1252661$NOVO NORDISK$$$$$F$Y$$$20240905$$CN$US$US
240816871$24081687$1$I$$20240703$20240712$20240712$EXP$$NL-NOVOPROD-1249734$NOVO NORDISK$$$$A$F$Y$$$20240712$$HP$NL$NL
240816881$24081688$1$I$20240529$20240703$20240712$20240712$EXP$$JP-NOVOPROD-1231438$NOVO NORDISK$$70$YR$$M$Y$$$20240712$$MD$JP$JP
240816891$24081689$1$I$$20240704$20240712$20240712$EXP$GB-MHRA-MED-202405021839073040-MHRPN$GB-NOVOPROD-1252380$NOVO NORDISK$$51$YR$$F$Y$$$20240712$$HP$GB$GB
240816901$24081690$1$I$$20240703$20240712$20240712$EXP$$CN-NOVOPROD-1249879$NOVO NORDISK$$90$YR$$M$Y$65$KG$20240712$$CN$CN$CN
240816911$24081691$1$I$$20240703$20240712$20240712$EXP$GB-MHRA-MED-202407031613269750-SKYTM$GB-NOVOPROD-1250041$NOVO NORDISK$$$$$M$Y$$$20240712$$MD$GB$GB
240816921$24081692$1$I$$20240703$20240712$20240712$EXP$$CH-NOVOPROD-1248930$NOVO NORDISK$$$$$F$Y$$$20240712$$MD$CH$CH
240816931$24081693$1$I$$20240703$20240712$20240712$EXP$GB-MHRA-MED-202407031246144830-TQCNG$GB-NOVOPROD-1250043$NOVO NORDISK$$$$$F$Y$$$20240712$$HP$GB$GB
240816941$24081694$1$I$20240626$20240703$20240712$20240712$EXP$$US-NOVOPROD-1251802$NOVO NORDISK$$$$A$F$Y$$$20240712$$CN$US$US
240816951$24081695$1$I$20190801$20240703$20240712$20240712$EXP$ES-AEMPS-1426145$ES-NOVOPROD-1249460$NOVO NORDISK$$50$YR$$M$Y$105$KG$20240712$$CN$ES$ES
240816961$24081696$1$I$20240604$20240703$20240712$20240712$EXP$CN-NMPA-4403041004400202400292$CN-NOVOPROD-1249622$NOVO NORDISK$$35$YR$$M$Y$72$KG$20240712$$HP$CN$CN
240816971$24081697$1$I$20230610$20240703$20240712$20240712$EXP$$US-NOVOPROD-1251785$NOVO NORDISK$$49$YR$$M$Y$$$20240712$$CN$US$US
240816981$24081698$1$I$$20240703$20240712$20240712$EXP$$JP-EMD Serono-2024037282$EMD SERONO INC$$$$$$Y$$$20240712$$MD$JP$JP
240816991$24081699$1$I$20240505$20240705$20240712$20240712$EXP$$CN-ROCHE-10000022485$ROCHE$$62$YR$A$M$Y$65$KG$20240712$$HP$CN$CN
240817002$24081700$2$F$20230101$20240731$20240712$20240805$EXP$$US-JNJFOC-20240723699$JOHNSON AND JOHNSON$$61$YR$A$F$Y$72.64$KG$20240805$$CN$US$US
240817011$24081701$1$I$$20240703$20240712$20240712$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008316$STRIDES$Li W, Chang Y, Liu X, Chen Z, Sun J, Geng Z, et al.. Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study.. Ann-Hematol. 2024;103(6):2003-2012$$$$$Y$$$20240712$$HP$CN$CN
240817022$24081702$2$F$20240623$20240731$20240712$20240806$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010528$JAZZ$$13$YR$$F$Y$28.6$KG$20240805$$CN$US$US
240817041$24081704$1$I$20240701$20240708$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010633$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240817051$24081705$1$I$$20240709$20240712$20240712$EXP$$US-JNJFOC-20240721852$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240817061$24081706$1$I$$20240703$20240712$20240712$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008326$STRIDES$Qu F-J, Kong Y, Yan X, Wang H.. Elderly patients with advanced HER2-positive breast cancer with liver metastases benefit from low dose disitamab vedotin (RC48): case series and literature review.. Anticancer-Drugs. 2024$81$YR$$F$Y$$$20240712$$MD$CN$CN
240817071$24081707$1$I$20240419$20240704$20240712$20240712$EXP$ES-AEMPS-1543970$ES-AMAROX PHARMA-AMR2024ES02136$HETERO$$70$YR$$M$Y$$$20240712$$MD$ES$ES
240817082$24081708$2$F$$20240720$20240712$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-033576$AUROBINDO$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al.. national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique. 2023;35(3):175-197$35$YR$$M$Y$$$20240731$$HP$FR$FR
240817091$24081709$1$I$$20240703$20240712$20240712$EXP$$US-APOTEX-2024AP008124$APOTEX$Chu AF, Sagi V, Amin AK, Rajagopal G, Shantanu S, Pederson KS. Continuous QT interval monitoring using insertable cardiac monitors during antiarrhythmic loading hospitalization: Results from the ^LINQ QT^ Study. Europace. 2024;26(1):i43-i45$$$$$Y$$$20240712$$HP$US$US
240817101$24081710$1$I$20240609$20240708$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010634$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240817121$24081712$1$I$20240707$20240708$20240712$20240712$PER$$US-SA-2024SA202019$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240712$$HP$US$US
240817132$24081713$2$F$20240101$20240806$20240712$20240815$PER$$US-SA-2024SA202616$SANOFI AVENTIS$$90$YR$E$F$Y$$$20240815$$CN$US$US
240817141$24081714$1$I$$20240709$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110456$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240712$$CN$US$US
240817151$24081715$1$I$$20240709$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110056$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$62.14$KG$20240712$$CN$US$US
240817161$24081716$1$I$$20240710$20240712$20240712$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110206$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240712$$HP$CA$CA
240817171$24081717$1$I$20240319$20240702$20240712$20240712$EXP$$JP-ROCHE-10000020747$ROCHE$$73$YR$E$F$Y$$$20240712$$MD$JP$JP
240817181$24081718$1$I$$20240702$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-033941$AUROBINDO$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al.. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).. Toxic-Analyt-Clinique.. 2023;35(3):175-197.$38$YR$$M$Y$$$20240712$$HP$FR$FR
240817191$24081719$1$I$$20240702$20240712$20240712$EXP$$US-AMGEN-USASP2024133814$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31 (6):3529-3545$70$YR$E$M$Y$$$20240711$$HP$US$US
240817201$24081720$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024136375$AMGEN$$$$$$Y$$$20240711$$PH$US$US
240817211$24081721$1$I$$20240702$20240712$20240712$EXP$$US-AMGEN-USASP2024133822$AMGEN$Samlowski W.; Ho C.. Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice. Current oncology. 2024;31 (6):3529-3545$61$YR$A$M$Y$$$20240711$$HP$US$US
240817221$24081722$1$I$$20240709$20240712$20240712$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010575$JAZZ$$$$$M$Y$$$20240711$$CN$US$US
240817231$24081723$1$I$20240624$20240709$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010702$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240817241$24081724$1$I$$20240702$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-034035$AUROBINDO$Chang J-H, Kudose S, Droubi S, Verduzco HA, Awori J, Ratner LE, et al.. Four Cases of Kidney Transplants With Donor HCV-Derived Immune Complex Glomerulonephritis.. Kidney International Reports. 2024;9(6):1903-1907$60$YR$$M$Y$73$KG$20240712$$HP$US$US
240817251$24081725$1$I$$20240624$20240712$20240712$PER$$US-AstraZeneca-2024A147527$ASTRAZENECA$$$$$F$Y$$$20240712$$HP$US$
240817263$24081726$3$F$20240101$20240805$20240712$20240815$PER$$US-AstraZeneca-2024A156518$ASTRAZENECA$$821$MON$$M$Y$$$20240815$$CN$US$
240817271$24081727$1$I$$20240709$20240712$20240712$EXP$$NVSC2024GT143603$NOVARTIS$$$$$M$Y$$$20240712$$CN$GT$GT
240817282$24081728$2$F$$20240822$20240712$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002926$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
240817291$24081729$1$I$$20240701$20240712$20240712$EXP$$US-ROCHE-10000018923$ROCHE$$77$YR$E$F$Y$$$20240712$$CN$US$US
240817301$24081730$1$I$20240324$20240326$20240712$20240712$PER$$US-USWM, LLC-UWM202403-000018$US WORLDMEDS$$52$YR$$M$Y$$$20240712$$HP$US$
240817311$24081731$1$I$$20240710$20240712$20240712$EXP$$CN-TAKEDA-2024TUS070633$TAKEDA$$$$$M$Y$$$20240712$$CN$CN$CN
240817321$24081732$1$I$20240220$20240705$20240712$20240712$EXP$$DE-TAKEDA-2024TUS070160$TAKEDA$$9$DEC$$M$Y$$$20240712$$MD$DE$DE
240817331$24081733$1$I$$20240619$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002925$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$HP$US$US
240817341$24081734$1$I$$20230913$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2023US031188$SANDOZ$$$$$F$Y$$$20240712$$CN$US$US
240817351$24081735$1$I$20240708$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007022$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240712$$HP$US$US
240817361$24081736$1$I$20240501$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007234$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240712$$CN$US$US
240817371$24081737$1$I$20240708$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006816$ELI LILLY AND CO$$$$$M$Y$$$20240712$$CN$US$US
240817383$24081738$3$F$20240101$20240719$20240712$20240727$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019119$UNITED THERAPEUTICS$$$$$F$Y$113.38$KG$20240727$$$US$US
240817391$24081739$1$I$20240709$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006688$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240817401$24081740$1$I$20240706$20240709$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110115$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240712$$CN$US$US
240817411$24081741$1$I$20240501$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110349$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240712$$HP$US$US
240817421$24081742$1$I$$20240709$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110475$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240712$$CN$US$US
240817431$24081743$1$I$20240523$20240705$20240712$20240712$EXP$$PE-AMGEN-PERSP2024136164$AMGEN$$$$$F$Y$$$20240711$$CN$PE$PE
240817441$24081744$1$I$20240705$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024135031$AMGEN$$$$$$Y$$$20240711$$PH$US$US
240817451$24081745$1$I$$20240619$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002929$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240817471$24081747$1$I$20160522$20240705$20240712$20240712$EXP$FR-AUROBINDO-AUR-APL-2018-049422$FR-GSK-FR2024083659$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$LW$FR$FR
240817481$24081748$1$I$$20240703$20240712$20240712$EXP$$JP-EMD Serono-2024037688$EMD SERONO INC$$$$$$Y$$$20240712$$MD$JP$JP
240817501$24081750$1$I$$20240711$20240712$20240712$PER$$US-JNJFOC-20240728993$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$HP$US$US
240817511$24081751$1$I$20240618$20240708$20240712$20240712$EXP$$US-ABBVIE-5833155$ABBVIE$$62$YR$$F$Y$$$20240712$$CN$US$US
240817521$24081752$1$I$$20240710$20240712$20240712$PER$$US-ROCHE-10000023408$ROCHE$$36$YR$A$F$Y$$$20240712$$MD$US$US
240817541$24081754$1$I$20240705$20240705$20240712$20240712$PER$$US-CHATTEMPRD-2024OHG023389$CHATTEM$$$$$F$Y$$$20240712$$CN$US$US
240817551$24081755$1$I$$20240705$20240712$20240712$PER$$US-CHATTEMPRD-2024OHG023477$CHATTEM$$$$$$Y$$$20240712$$CN$US$US
240817572$24081757$2$F$20240227$20240815$20240712$20240819$EXP$$US-SA-2024SA203627$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240819$$MD$US$US
240817581$24081758$1$I$$20240703$20240712$20240712$EXP$$US-GSK-US2024082659$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$MD$US$US
240817591$24081759$1$I$20240410$20240710$20240712$20240712$EXP$FR-AFSSAPS-NC2024000816$FR-JNJFOC-20240725291$JOHNSON AND JOHNSON$$9$YR$C$M$Y$26$KG$20240712$$MD$FR$FR
240817601$24081760$1$I$20240626$20240617$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002438$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240712$$CN$US$US
240817611$24081761$1$I$$20240708$20240712$20240712$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019310$VALIDUS$$$$$$Y$$$20240712$$CN$US$US
240817622$24081762$2$F$$20240822$20240712$20240826$EXP$$US-ROCHE-10000023890$ROCHE$$86$YR$E$F$Y$$$20240826$$CN$US$US
240817631$24081763$1$I$$20240705$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110484$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$24.49$KG$20240712$$PH$US$US
240817641$24081764$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110037$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240712$$CN$US$US
240817651$24081765$1$I$$20240710$20240712$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039137$BOEHRINGER INGELHEIM$$$$$$Y$$$20240712$$CN$US$US
240817662$24081766$2$F$20240101$20240731$20240712$20240803$PER$$US-AMGEN-USASP2024136855$AMGEN$$84$YR$E$F$Y$$$20240803$$CN$US$US
240817672$24081767$2$F$20240516$20240722$20240712$20240725$EXP$$DE-ABBVIE-5836523$ABBVIE$$68$YR$$F$Y$75$KG$20240725$$MD$DE$DE
240817681$24081768$1$I$$20230724$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2023US008935$SANDOZ$$$$$M$Y$$$20240712$$MD$US$US
240817692$24081769$2$F$20240606$20240715$20240712$20240726$PER$$US-ABBVIE-5835139$ABBVIE$$29$YR$$F$Y$$$20240726$$MD$BE$US
240817701$24081770$1$I$20240618$20240705$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010543$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240817711$24081771$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024136526$AMGEN$$$$$$Y$$$20240711$$PH$US$US
240817721$24081772$1$I$20240628$20240628$20240712$20240712$PER$$US-AMGEN-USASP2024129783$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240817731$24081773$1$I$$20240702$20240712$20240712$PER$$US-AMGEN-USASP2024131649$AMGEN$$$$A$M$Y$$$20240711$$HP$US$US
240817741$24081774$1$I$19890901$20240708$20240712$20240712$EXP$$US-ABBVIE-5833247$ABBVIE$$34$YR$$M$Y$$$20240712$$CN$US$US
240817751$24081775$1$I$$20240711$20240712$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039341$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240712$$CN$US$US
240817761$24081776$1$I$$20240708$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006151$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240817771$24081777$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007271$ELI LILLY AND CO$$26$YR$A$$Y$$$20240712$$CN$US$US
240817781$24081778$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006984$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240712$$CN$US$US
240817791$24081779$1$I$20240625$20240709$20240712$20240712$EXP$$US-ABBVIE-5834310$ABBVIE$$48$YR$$F$Y$$$20240712$$CN$US$US
240817801$24081780$1$I$$20240701$20240712$20240712$EXP$$US-HALEON-2185144$Haleon PLC$RefID 415206: AndersonM, BrozziN, RosenthalR, et al. Panel Discussion: Non-cardiac Surgery Interventions on Patients Receiving Impella Support. Interventional?Cardiology: Reviews, Research, Resources. #PY#;19(Supplement 1):31. https://dx.doi.org/10.15420/icr.2024.19.S1$66$YR$$F$Y$$$20240709$$HP$US$US
240817811$24081781$1$I$20230101$20240705$20240712$20240712$EXP$$CH-AMGEN-CHESP2024135313$AMGEN$$$$$$Y$$$20240711$$MD$CH$CH
240817821$24081782$1$I$20240506$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137179$AMGEN$$74$YR$E$M$Y$$$20240711$$CN$US$US
240817831$24081783$1$I$20240201$20240710$20240712$20240712$EXP$BE-FAMHP-DHH-N2024-122242$BE-ROCHE-10000022118$ROCHE$$$$E$F$Y$68$KG$20240712$$CN$BE$BE
240817841$24081784$1$I$$20240619$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002932$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240817851$24081785$1$I$20240530$20240617$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002856$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240712$$CN$US$US
240817861$24081786$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA201223$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240712$$MD$US$US
240817871$24081787$1$I$20240704$20240705$20240712$20240712$PER$$US-SA-2024SA200108$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240712$$HP$US$US
240817881$24081788$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA202563$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240712$$MD$US$US
240817891$24081789$1$I$20240101$20240703$20240712$20240712$PER$$US-SA-2024SA200706$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240712$$MD$US$US
240817901$24081790$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA203307$SANOFI AVENTIS$$$$E$F$Y$81.64$KG$20240712$$MD$US$US
240817911$24081791$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA202451$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240817921$24081792$1$I$20240703$20240703$20240712$20240712$PER$$US-SA-2024SA201231$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240712$$CN$US$US
240817932$24081793$2$F$20240101$20240712$20240712$20240722$PER$$US-SA-2024SA202357$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240720$$CN$US$US
240817941$24081794$1$I$20240201$20240705$20240712$20240712$PER$$US-SA-2024SA202158$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240712$$MD$US$US
240817951$24081795$1$I$20240401$20240705$20240712$20240712$PER$$US-SA-2024SA201837$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240712$$MD$US$US
240817962$24081796$2$F$20240701$20240801$20240712$20240808$PER$$US-SA-2024SA201681$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240808$$MD$US$US
240817971$24081797$1$I$$20240701$20240712$20240712$EXP$$JP-ROCHE-10000019464$ROCHE$Kunimoto M, Watanabe O, Takahashi H, Koizumi A, Shigehara F, Soeda N et al.. DP-58 Two cases of delayed anastomotic leakage due to bevacizumab. The 46th Annual Meeting of Japanese Society for Research of Loco-Regional Cancer. 2024;131$77$YR$E$M$Y$$$20240712$$MD$JP$JP
240817982$24081798$2$F$$20240715$20240712$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110526$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240716$$CN$US$US
240817992$24081799$2$F$$20240807$20240712$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106253$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240812$$CN$US$US
240818001$24081800$1$I$$20240619$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002928$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240818011$24081801$1$I$20240101$20240710$20240712$20240712$EXP$$US-ABBVIE-5835753$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240818021$24081802$1$I$$20240704$20240712$20240712$EXP$$EC-ROCHE-10000018182$ROCHE$$$$$$Y$$$20240712$$MD$EC$EC
240818031$24081803$1$I$20240701$20240705$20240712$20240712$EXP$$JP-009507513-2407JPN001013J$MERCK$$$$$F$Y$$$20240712$$MD$JP$JP
240818041$24081804$1$I$$20240617$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002873$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240818051$24081805$1$I$20240626$20240705$20240712$20240712$EXP$GB-MHRA-MED-202406260823074440-ZTJLM$GB-ABBVIE-5836240$ABBVIE$$58$YR$$M$Y$$$20240712$$CN$GB$GB
240818062$24081806$2$F$$20240809$20240712$20240816$EXP$JP-MLMSERVICE-20240628-PI112935-00232-1$JP-STRIDES ARCOLAB LIMITED-2024SP008179$STRIDES$Tokuchi M, Yonishi H, Namba-Hamano T.. Successful treatment of a renal allograft abscess with antimicrobial agents alone and appropriate follow-up imaging.. Transplant Infectious Disease. 2024;26(3):e14278$22$YR$$F$Y$$$20240816$$MD$JP$JP
240818071$24081807$1$I$$20240710$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US064623$SANDOZ$$$$$$Y$$$20240712$$HP$US$US
240818081$24081808$1$I$20240617$20240708$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010616$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240818091$24081809$1$I$20231001$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024136321$AMGEN$$57$YR$A$M$Y$$$20240711$$CN$US$US
240818102$24081810$2$F$$20240712$20240712$20240718$EXP$$MX-AMAROX PHARMA-HET2024MX02185$HETERO$Bautista-Sanchez CD, Martinez-Bravo LE, Hidalgo-Diaz DA. Pancytopenia in neuromyelitis optica spectrum disorder induced by azathioprine-allopurinol interaction. Neuroimmunology  Reports. 2024;6:100219$63$YR$$F$Y$50$KG$20240719$$MD$MX$MX
240818111$24081811$1$I$$20240710$20240712$20240712$PER$$US-GILEAD-2024-0680322$GILEAD$$$$$M$Y$$$20240711$$HP$US$US
240818121$24081812$1$I$$20240704$20240712$20240712$EXP$IR-MLMSERVICE-20240704-PI092975-00329-4$IR-STRIDES ARCOLAB LIMITED-2024SP008180$STRIDES$Shahbazi F, Shojaei L.. Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases.. Current drug safety. 2024$52$YR$$F$Y$$$20240712$$PH$IR$IR
240818131$24081813$1$I$20240507$20240705$20240712$20240712$EXP$$CA-JNJFOC-20240520905$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240712$$HP$CA$CA
240818141$24081814$1$I$$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137756$AMGEN$$$$$$Y$$$20240711$$MD$US$US
240818151$24081815$1$I$20240501$20240705$20240712$20240712$EXP$$RO-AMGEN-ROUSP2024135171$AMGEN$$72$YR$E$F$Y$$$20240711$$MD$RO$RO
240818161$24081816$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137478$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240818171$24081817$1$I$$20240619$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001841$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240818182$24081818$2$F$$20240719$20240712$20240725$EXP$$JP-GSK-JP2024JPN084547$GLAXOSMITHKLINE$Kageyama Y, Tsunakake M, Kozawa M, Hirano F, Tomono M, Nakashima Y, Shiroyama Y, Miyoshi H. Six cases of syphilis in pregnancy in the past five years at our hospital. Modern Trends in Obstetrics + Gynecology. 2024;72:315-319$$$$$Y$$$20240725$$MD$JP$JP
240818191$24081819$1$I$$20240705$20240712$20240712$PER$$US-ROCHE-10000023994$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240818211$24081821$1$I$$20240704$20240712$20240712$EXP$$EC-ROCHE-10000018247$ROCHE$$$$$$Y$$$20240712$$HP$EC$EC
240818221$24081822$1$I$$20240704$20240712$20240712$EXP$$EC-ROCHE-10000018248$ROCHE$$$$$$Y$$$20240712$$HP$EC$EC
240818231$24081823$1$I$20240514$20240709$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010686$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240818242$24081824$2$F$$20240712$20240712$20240801$EXP$$BE-ROCHE-3580138$ROCHE$$74$YR$E$M$Y$$$20240801$$MD$BE$BE
240818251$24081825$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281414140760-PYGTQ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14684$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818262$24081826$2$F$$20240709$20240712$20240723$EXP$GB-MHRA-MED-202406281415559760-KVNGH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14687$ALKEM$$$$$$Y$$$20240723$$CN$GB$GB
240818271$24081827$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281418165880-YWTHP$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14690$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818281$24081828$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281417420110-KQVHC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14689$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818291$24081829$1$I$20240323$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281136243400-GYCWK$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14642$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818301$24081830$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281438310700-KPJBZ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14657$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818312$24081831$2$F$$20240709$20240712$20240723$EXP$GB-MHRA-MED-202406281144360370-LSKWG$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14673$ALKEM$$$$$$Y$$$20240723$$CN$GB$GB
240818321$24081832$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281145082300-JSMBZ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14674$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818331$24081833$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281412466070-YKBNQ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14680$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818341$24081834$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281437578480-ZYWPV$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14632$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818351$24081835$1$I$20240323$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281137402150-JMBTC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14644$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818361$24081836$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281143566360-GQMFV$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14672$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818371$24081837$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281412107900-RNBWT$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14679$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818381$24081838$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281413365890-NGPDS$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14682$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818391$24081839$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281435011580-DLRNY$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14614$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818401$24081840$1$I$20240323$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281122461890-DVTGF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14624$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818411$24081841$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281432464540-VLDZP$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14606$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818421$24081842$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281433366540-CNLMB$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14608$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818431$24081843$1$I$20240323$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281053549520-RCDFK$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14621$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818441$24081844$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281436108240-JYFTK$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14622$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818451$24081845$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281435349850-RDTKB$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14617$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818461$24081846$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281437236830-WVLTH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14628$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818471$24081847$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281042408830-QRLPK$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14616$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818481$24081848$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281436490710-YBJTK$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14625$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818491$24081849$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281040200250-ZJMNR$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14597$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818501$24081850$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281423022780-LSYQG$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14577$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818511$24081851$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281425089800-RYTVB$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14579$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818521$24081852$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406280855400820-VQTNC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14589$ALKEM$$$$$M$Y$$$20240712$$CN$GB$GB
240818532$24081853$2$F$20240323$20240709$20240712$20240723$EXP$GB-MHRA-MED-202406281038502460-PFVRS$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14593$ALKEM$$$$$$Y$$$20240723$$CN$GB$GB
240818542$24081854$2$F$$20240709$20240712$20240723$EXP$GB-MHRA-MED-202406281431213880-YGRFD$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14596$ALKEM$$$$$$Y$$$20240723$$CN$GB$GB
240818551$24081855$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281432323530-HKSTC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14603$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818561$24081856$1$I$20240323$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406271040542900-VDNJS$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14580$ALKEM$$$$$M$Y$78$KG$20240712$$CN$GB$GB
240818571$24081857$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281423510310-QYSNJ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14578$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818581$24081858$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281432034530-LJZCK$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14599$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818591$24081859$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281419074630-BMTGL$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14563$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818601$24081860$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281504408720-TKDCS$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14566$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818611$24081861$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281502574640-CFGVW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14565$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818621$24081862$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281422291500-CTQJK$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14576$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818631$24081863$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281457303540-MZPCV$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14560$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818641$24081864$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281459532020-PFYZC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14561$ALKEM$$$$$M$Y$$$20240712$$CN$GB$GB
240818651$24081865$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281503492060-NTSCD$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14562$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818661$24081866$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281421048380-HJCMP$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14571$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818671$24081867$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281444339100-ZPDRB$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14547$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818681$24081868$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281440345420-HKJBF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14528$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818691$24081869$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281441485000-MGTNK$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14534$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818701$24081870$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281446000970-SKTYP$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14556$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818712$24081871$2$F$$20240709$20240712$20240723$EXP$GB-MHRA-MED-202406281439120430-SHLWN$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14524$ALKEM$$$$$$Y$$$20240723$$CN$GB$GB
240818721$24081872$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-30925138$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14553$ALKEM$$75$YR$$F$Y$$$20240712$$PH$GB$GB
240818732$24081873$2$F$$20240709$20240712$20240723$EXP$GB-MHRA-MED-202406281442341590-SCYTR$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14538$ALKEM$$$$$$Y$$$20240723$$CN$GB$GB
240818742$24081874$2$F$$20240709$20240712$20240723$EXP$GB-MHRA-MED-202406281441057610-CBYGW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14531$ALKEM$$$$$$Y$$$20240723$$CN$GB$GB
240818751$24081875$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281443140430-YKFLG$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14542$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818761$24081876$1$I$$20240710$20240712$20240712$EXP$$CA-JNJFOC-20240727994$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240712$$HP$CA$CA
240818771$24081877$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MIDB-b13c9216-0236-4bf2-b228-6b20ef976515$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14568$ALKEM$$74$YR$$M$Y$$$20240712$$PH$GB$GB
240818781$24081878$1$I$20240626$20240629$20240712$20240712$EXP$GB-MHRA-TPP60256840C4211929YC1719390337047$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14573$ALKEM$$24$YR$$F$Y$89$KG$20240712$$HP$GB$GB
240818791$24081879$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281456410520-PYKZQ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14557$ALKEM$$$$$$Y$$$20240712$$CN$GB$GB
240818801$24081880$1$I$20240601$20240703$20240712$20240712$PER$$US-SA-2024SA200043$SANOFI AVENTIS$$57$YR$A$F$Y$60$KG$20240712$$MD$US$US
240818812$24081881$2$F$20240101$20240712$20240712$20240722$PER$$US-SA-2024SA202977$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240722$$MD$US$US
240818821$24081882$1$I$$20240709$20240712$20240712$PER$$US-SA-2024SA203770$SANOFI AVENTIS$$$$A$M$Y$$$20240712$$CN$US$US
240818832$24081883$2$F$20240101$20240806$20240712$20240820$PER$$US-SA-2024SA200314$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240820$$CN$US$US
240818842$24081884$2$F$20240101$20240712$20240712$20240725$PER$$US-SA-2024SA202339$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240725$$MD$US$US
240818851$24081885$1$I$20240702$20240705$20240712$20240712$PER$$US-SA-2024SA201943$SANOFI AVENTIS$$54$YR$A$F$Y$65.8$KG$20240712$$MD$US$US
240818861$24081886$1$I$20240301$20240705$20240712$20240712$PER$$US-SA-2024SA201882$SANOFI AVENTIS$$63$YR$A$M$Y$86.6$KG$20240712$$MD$US$US
240818871$24081887$1$I$20240101$20240702$20240712$20240712$PER$$US-SA-2024SA199072$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240712$$MD$US$US
240818882$24081888$2$F$20240314$20240711$20240712$20240723$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001671$Alvotech$$37$YR$$F$Y$56.8$KG$20240723$$HP$CA$CA
240818891$24081889$1$I$$20240704$20240712$20240712$EXP$$EC-ROCHE-10000018180$ROCHE$$$$$$Y$$$20240712$$MD$EC$EC
240818901$24081890$1$I$20240628$20240705$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010491$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240818911$24081891$1$I$20240710$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137596$AMGEN$$59$YR$A$F$Y$$$20240711$$CN$US$US
240818921$24081892$1$I$20240709$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137605$AMGEN$$$$$F$Y$$$20240711$$CN$US$US
240818931$24081893$1$I$$20240617$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002874$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240818941$24081894$1$I$$20240709$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109812$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240712$$CN$US$US
240818951$24081895$1$I$$20240708$20240712$20240712$EXP$$US-ABBVIE-5833195$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240818961$24081896$1$I$20240518$20240709$20240712$20240712$EXP$$EC-ROCHE-10000018173$ROCHE$$$$$$Y$$$20240712$$MD$EC$EC
240818981$24081898$1$I$20200401$20240704$20240712$20240712$EXP$AU-MLMSERVICE-20240628-PI112925-00232-1$AU-STRIDES ARCOLAB LIMITED-2024SP008239$STRIDES$Thorburn S, Majumdar A, Smibert O.. Chronic hepatitis E masquerading as allograft rejection in a liver transplant recipient. Transplant Infectious Disease. 2024;26(3):e14303$41$YR$$M$Y$$$20240712$$MD$AU$AU
240818991$24081899$1$I$$20240704$20240712$20240712$EXP$ES-MLMSERVICE-20240628-PI112247-00097-2$ES-STRIDES ARCOLAB LIMITED-2024SP008241$STRIDES$Rubio-Mora E, Rodriguez JG, Carrascoso GR.. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transplant Infectious Disease. 2024;26(3):e14276$5$MON$$M$Y$$$20240712$$MD$ES$ES
240819001$24081900$1$I$$20240704$20240712$20240712$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP008384$STRIDES$Ninkov T, Chan J, Von Nida J.. A Case of Terbinafine-Induced Subacute Cutaneous Lupus Erythematosus rapidly resolving with Upadacitinib.. Clin-Exp-Dermatol. 2024;0(0)$71$YR$$F$Y$$$20240712$$HP$AU$AU
240819011$24081901$1$I$$20240705$20240712$20240712$EXP$$HR-AMGEN-HRVSP2024135943$AMGEN$$$$$F$Y$$$20240711$$MD$HR$HR
240819022$24081902$2$F$$20240822$20240712$20240826$PER$$US-AMGEN-USASP2024136937$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
240819032$24081903$2$F$$20240821$20240712$20240904$PER$$US-AstraZeneca-2024A157617$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
240819041$24081904$1$I$20240608$20240708$20240712$20240712$EXP$$US-AstraZeneca-2024A157344$ASTRAZENECA$$$$$F$Y$$$20240712$$HP$US$
240819053$24081905$3$F$20240101$20240718$20240712$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-013868$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240725$$$US$US
240819061$24081906$1$I$$20230816$20240712$20240712$PER$$US-USWM, LLC-UWM202308-000027$US WORLDMEDS$$$$$M$Y$$$20240712$$PH$US$
240819071$24081907$1$I$$20240710$20240712$20240712$PER$$US-ABBVIE-5835223$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240819081$24081908$1$I$$20230829$20240712$20240712$EXP$$US-SANDOZ INC.-NVSC2023US139879$SANDOZ$$$$$M$Y$90.72$KG$20240712$$MD$US$US
240819091$24081909$1$I$$20240628$20240712$20240712$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109264$ZYDUS PHARM$Gutierrez L, Ramanujam D, Patel D, Modugula S, Disilvio BE.. The Downside of Your Uppers: Venlafaxine-induced Hypertriglyceridemia Causing Acute Pancreatitis.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240712$$HP$US$US
240819101$24081910$1$I$$20240628$20240712$20240712$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109289$ZYDUS PHARM$Samuel S, Li W, Dunn K, Cortes J, Nguyen T, Moussa D, et al.. Unfractionated heparin versus enoxaparin for venous thromboembolism prophylaxis in intensive care units: a propensity score adjusted analysis.. J-Thromb-Thrombolysis. 2023;55(4):617-625$$$$$Y$$$20240712$$HP$US$US
240819111$24081911$1$I$$20240628$20240712$20240712$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109286$ZYDUS PHARM$Khawam S, Goudie M, Hartfield R, Hassan S, Padder F.. A Case of Trazadone and Omeprazole Associated Wenckebach Phenomenon Disguised as Second-degree Mobitz Type 2 AV Block.. Am-J-Respir- Crit-Care-Med. 2024$$$$$Y$$$20240712$$HP$US$US
240819121$24081912$1$I$$20240628$20240712$20240712$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109242$ZYDUS PHARM$Nasir S, Sedghian M, Khan Z, Roberge MR.. IVDU, I Can^t Hear You: Sudden Hearing Loss After Fentanyl Use.. Am-J-Respir-Crit-Care-Med. 2024;209:A2132$$$$$Y$$$20240712$$HP$US$US
240819131$24081913$1$I$$20240628$20240712$20240712$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109235$ZYDUS PHARM$Seetharaman K, Clarke J, Achamallah N, Fried JC.. Fentanyl Induced Chest Wall Rigidity Syndrome.. Am-J-Respir-Crit-Care-Med. 2024;209:A1150$$$$$Y$$$20240712$$HP$US$US
240819141$24081914$1$I$$20240628$20240712$20240712$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109239$ZYDUS PHARM$Manjunath S, Khandhar PB.. Atrial Fibrillation With Rapid Ventricular Response in Pediatric Lupus Carditis Following Pulse Steroid Therapy.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240712$$HP$US$US
240819151$24081915$1$I$$20240701$20240712$20240712$EXP$GB-MHRA-MED-202407011411135000-YPNHD$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-109217$ZYDUS PHARM$$$$$$Y$$$20240712$$HP$GB$GB
240819161$24081916$1$I$$20240628$20240712$20240712$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109253$ZYDUS PHARM$Epler KE, Crouch DR, Van Nostrand K.. Serotonin- Like- Syndrome Resulting From Tranexamic Acid Applied to Airways During Flexible Bronchoscopy.. Am-J-Respir-Crit-Care-Med. 2024;209:A5805$$$$$Y$$$20240712$$HP$US$US
240819171$24081917$1$I$20240626$20240708$20240712$20240712$EXP$$US-ABBVIE-5834765$ABBVIE$$73$YR$$F$Y$$$20240712$$CN$US$US
240819181$24081918$1$I$$20240708$20240712$20240712$PER$$US-BIOGEN-2024BI01272941$BIOGEN$$$$$F$Y$$$20240712$$CN$US$US
240819192$24081919$2$F$20240603$20240812$20240712$20240816$PER$$US-BIOGEN-2024BI01272970$BIOGEN$$57$YR$$F$Y$$$20240816$$CN$US$US
240819201$24081920$1$I$$20240708$20240712$20240712$PER$$US-BIOGEN-2024BI01272808$BIOGEN$$$$$F$Y$$$20240712$$CN$US$US
240819211$24081921$1$I$$20240627$20240712$20240712$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109198$ZYDUS PHARM$Huang J, Shehzad D, Ahmed I, Yu JC.. Recognizing Veno-occlusive Disease After Inotuzu Treatment: An Urgent Call to Physicians in Non-Transplant Centers.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240712$$HP$US$US
240819221$24081922$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007312$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240712$$HP$US$US
240819231$24081923$1$I$20240703$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202406018477$ELI LILLY AND CO$$86$YR$E$F$Y$$$20240712$$CN$US$US
240819241$24081924$1$I$$20240711$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007700$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240712$$CN$US$US
240819251$24081925$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006226$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240712$$CN$US$US
240819261$24081926$1$I$20240101$20240708$20240712$20240712$PER$$US-UNITED THERAPEUTICS-UNT-2024-021035$UNITED THERAPEUTICS$$$$$F$Y$95.238$KG$20240712$$$US$US
240819271$24081927$1$I$20240710$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007143$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240712$$CN$US$US
240819281$24081928$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006895$ELI LILLY AND CO$$$$A$F$Y$$$20240712$$CN$US$US
240819291$24081929$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007304$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240712$$HP$US$US
240819301$24081930$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007062$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240712$$CN$US$US
240819311$24081931$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007063$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240712$$CN$US$US
240819321$24081932$1$I$$20240708$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007157$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240819331$24081933$1$I$20240601$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007292$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240712$$CN$US$US
240819342$24081934$2$F$$20240710$20240712$20240712$PER$$US-JNJFOC-20240720759$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240819351$24081935$1$I$20240601$20240705$20240712$20240712$30DAY$$US-GSK-US2024083845$GLAXOSMITHKLINE$$72$YR$$M$Y$$$20240712$$CN$US$US
240819361$24081936$1$I$20240709$20240709$20240712$20240712$PER$$NVSC2024US143049$NOVARTIS$$30$YR$$F$Y$86.168$KG$20240712$$PH$US$US
240819372$24081937$2$F$$20240712$20240712$20240809$PER$$US-SA-2024SA203784$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240809$$HP$US$US
240819382$24081938$2$F$20240101$20240911$20240712$20240923$PER$$US-SA-2024SA200998$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240923$$MD$US$US
240819391$24081939$1$I$20240401$20240708$20240712$20240712$PER$$US-SA-2024SA201795$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240712$$MD$US$US
240819401$24081940$1$I$20240628$20240704$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010461$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240819411$24081941$1$I$$20240708$20240712$20240712$EXP$$US-ABBVIE-5833283$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240819421$24081942$1$I$$20240626$20240712$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05806$LUPIN$$$$$$Y$$$20240712$$PH$US$US
240819432$24081943$2$F$$20240917$20240712$20240921$EXP$$US-ABBVIE-5833440$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
240819441$24081944$1$I$20230802$20240701$20240712$20240712$EXP$$JP-ROCHE-10000019877$ROCHE$Itaya A, Okano K, Urata F, Matsumoto S, Suzuki T, Hakamada K. O-46 A case of severe CTRCD which occurred during preoperative chemotherapy for cancer. The 46th Annual Meeting of Japanese Society for Research of Loco-Regional Cancer. 2024;94$7$DEC$E$F$Y$$$20240712$$MD$JP$JP
240819452$24081945$2$F$$20240918$20240712$20240923$EXP$$PT-ROCHE-10000017854$ROCHE$$62$YR$A$M$Y$$$20240923$$HP$PT$PT
240819462$24081946$2$F$20240101$20240826$20240712$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-021063$UNITED THERAPEUTICS$$$$$M$Y$80.726$KG$20240829$$$US$US
240819471$24081947$1$I$$20230602$20240712$20240712$PER$$US-ENDO USA, INC.-2023-002747$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240819481$24081948$1$I$$20230607$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003057$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240819493$24081949$3$F$$20240820$20240712$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002875$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
240819501$24081950$1$I$$20230604$20240712$20240712$PER$$US-ENDO USA, INC.-2023-002924$ENDO$$$$$$Y$$$20240712$$$US$US
240819513$24081951$3$F$$20240507$20240712$20240916$PER$$US-ENDO USA, INC.-2024-002144$ENDO$$$$$M$Y$$$20240916$$CN$US$US
240819523$24081952$3$F$$20240514$20240712$20240917$PER$$US-ENDO USA, INC.-2024-002246$ENDO$$$$$F$Y$$$20240917$$CN$US$US
240819531$24081953$1$I$20231107$20240704$20240712$20240712$EXP$$NL-ABBVIE-5485676$ABBVIE$$25$YR$$F$Y$95$KG$20240712$$MD$NL$NL
240819541$24081954$1$I$$20240708$20240712$20240712$EXP$$GB-AMGEN-GBRSP2024136568$AMGEN$$$$$M$Y$$$20240711$$HP$GB$GB
240819553$24081955$3$F$$20240808$20240712$20240812$PER$$US-AMGEN-USASP2024137658$AMGEN$$$$$F$Y$$$20240812$$HP$US$US
240819563$24081956$3$F$20240620$20240725$20240712$20240727$PER$$US-AMGEN-USASP2024137982$AMGEN$$86$YR$E$F$Y$$$20240727$$CN$US$US
240819571$24081957$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024136451$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240819583$24081958$3$F$20240628$20240820$20240712$20240822$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039176$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240822$$MD$JP$JP
240819592$24081959$2$F$$20231219$20240712$20240916$PER$$US-ENDO USA, INC.-2024-000210$ENDO$$$$$M$Y$$$20240916$$CN$US$US
240819603$24081960$3$F$$20240319$20240712$20240916$PER$$US-ENDO USA, INC.-2024-001465$ENDO$$$$$$Y$$$20240916$$CN$US$US
240819611$24081961$1$I$$20240220$20240712$20240712$PER$$US-ENDO USA, INC.-2024-001147$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240819621$24081962$1$I$$20231219$20240712$20240712$PER$$US-ENDO USA, INC.-2024-000218$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240819632$24081963$2$F$$20231219$20240712$20240805$PER$$US-ENDO USA, INC.-2024-000101$ENDO$$$$$F$Y$$$20240805$$CN$US$US
240819641$24081964$1$I$20240630$20240705$20240712$20240712$EXP$$EC-EMD Serono-2024036971$EMD SERONO INC$$14$YR$T$M$Y$$$20240712$$CN$EC$EC
240819651$24081965$1$I$$20240708$20240712$20240712$EXP$$IE-UCBSA-2024035149$UCB$$$$$F$Y$$$20240712$$CN$IE$IE
240819661$24081966$1$I$20240101$20240708$20240712$20240712$PER$$US-SA-2024SA201855$SANOFI AVENTIS$$33$YR$A$F$Y$54$KG$20240712$$MD$US$US
240819672$24081967$2$F$$20240806$20240712$20240813$EXP$$JP-GSK-JP2024085551$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$PH$JP$JP
240819683$24081968$3$F$$20240206$20240712$20240918$PER$$US-ENDO USA, INC.-2024-000958$ENDO$$$$$M$Y$$$20240918$$CN$US$US
240819691$24081969$1$I$20221116$20240711$20240712$20240712$EXP$$US-UCBSA-2024035180$UCB$$64$YR$$F$Y$$$20240712$$HP$US$US
240819701$24081970$1$I$$20240709$20240712$20240712$PER$$US-ROCHE-10000023982$ROCHE$$26$YR$A$F$Y$$$20240712$$HP$US$US
240819711$24081971$1$I$$20240703$20240712$20240712$EXP$$US-APOTEX-2024AP008043$APOTEX$Chu AF, Sagi V, Amin AK, Rajagopal G, Shantanu S, Pederson KS. Continuous QT interval monitoring using insertable cardiac monitors during antiarrhythmic loading hospitalization: Results from the ^LINQ QT^ Study. Europace. 2024;26(1):i43-i45$$$$$Y$$$20240712$$HP$US$US
240819721$24081972$1$I$20240101$20240709$20240712$20240712$PER$$US-UNITED THERAPEUTICS-UNT-2024-021092$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240712$$$US$US
240819731$24081973$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024135011$AMGEN$$$$A$F$Y$$$20240711$$CN$US$US
240819741$24081974$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024136454$AMGEN$$$$$$Y$$$20240711$$HP$US$US
240819752$24081975$2$F$$20240729$20240712$20240731$30DAY$$US-AMGEN-USASP2024134188$AMGEN$$$$$$Y$$$20240731$$HP$US$US
240819761$24081976$1$I$20221101$20240702$20240712$20240712$PER$$US-UNITED THERAPEUTICS-UNT-2024-014600$UNITED THERAPEUTICS$$76$YR$$M$Y$$$20240712$$$US$US
240819771$24081977$1$I$$20240618$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002904$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240819781$24081978$1$I$$20231004$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2023US040580$SANDOZ$$$$$M$Y$$$20240712$$HP$US$US
240819791$24081979$1$I$$20240704$20240712$20240712$EXP$$EC-ROCHE-10000018246$ROCHE$$$$$$Y$$$20240712$$HP$EC$EC
240819801$24081980$1$I$20240708$20240708$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010636$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240819811$24081981$1$I$20231101$20240703$20240712$20240712$PER$$US-SA-2024SA199669$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240712$$MD$US$US
240819821$24081982$1$I$$20240709$20240712$20240712$PER$$US-SA-2024SA203817$SANOFI AVENTIS$$$$$F$Y$$$20240712$$CN$US$US
240819831$24081983$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024136456$AMGEN$$$$$$Y$$$20240711$$CN$US$US
240819842$24081984$2$F$20240709$20240711$20240712$20240715$PER$$US-AMGEN-USASP2024137758$AMGEN$$61$YR$A$F$Y$$$20240715$$CN$US$US
240819851$24081985$1$I$20230601$20240708$20240712$20240712$EXP$$US-ABBVIE-5832141$ABBVIE$$63$YR$$M$Y$$$20240712$$CN$US$US
240819861$24081986$1$I$20240706$20240709$20240712$20240712$EXP$$BR-BEIGENE-BGN-2024-010697$BEIGENE$$$$$$Y$$$20240712$$MD$BR$BR
240819881$24081988$1$I$$20240709$20240712$20240712$PER$$US-JNJFOC-20240725545$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$HP$US$US
240819891$24081989$1$I$$20240702$20240712$20240712$EXP$$IT-AUROBINDO-AUR-APL-2022-050684$AUROBINDO$De Giorgi F, Greco P, Spadaro S, Scutiero G, Mari M, Santi E, et al. Recurrent pneumothorax after cesarean delivery in the critically ill pregnant with severe COVID-19 ARDS: a case report. Eur-RevMed-Pharmacol-Sci. 2022;26(5):1765-1769$34$YR$$F$Y$$$20240712$$HP$IT$IT
240819901$24081990$1$I$$20240702$20240712$20240712$EXP$$US-ARGENX-2024-ARGX-US005222$ARGENX BVBA$$$$$$Y$$$20240712$$HP$US$US
240819911$24081991$1$I$$20240703$20240712$20240712$EXP$$US-HALEON-2182016$Haleon PLC$$$$$$Y$$$20240711$$CN$US$US
240819921$24081992$1$I$$20240610$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US058085$SANDOZ$$$$$F$Y$$$20240712$$HP$US$US
240819931$24081993$1$I$$20240705$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033831$AUROBINDO$$$$$M$Y$$$20240712$$MD$GB$GB
240819943$24081994$3$F$20240701$20240830$20240712$20240913$PER$$US-AMGEN-USASP2024135532$AMGEN$$68$YR$E$F$Y$113$KG$20240913$$PH$US$US
240819951$24081995$1$I$$20240627$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103744$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240704$$CN$US$US
240819971$24081997$1$I$20231202$20240703$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107054$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240704$$MD$US$US
240819982$24081998$2$F$$20240726$20240712$20240730$EXP$$CA-ABBVIE-5833393$ABBVIE$$$$A$F$Y$$$20240730$$CN$CA$CA
240819992$24081999$2$F$20110101$20240711$20240712$20240715$EXP$$US-ABBVIE-5833257$ABBVIE$$$$$M$Y$84.368$KG$20240715$$CN$US$US
240820001$24082000$1$I$$20240702$20240712$20240712$PER$$US-RDY-SPO/USA/24/0009779$DR REDDYS$$42$YR$A$F$Y$$$20240712$$MD$US$US
240820012$24082001$2$F$$20240813$20240712$20240815$PER$$US-AstraZeneca-2024A157561$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
240820021$24082002$1$I$20240510$20240511$20240712$20240712$PER$$US-USWM, LLC-UWM202405-000047$US WORLDMEDS$$$$$F$Y$$$20240712$$CN$US$
240820031$24082003$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024136459$AMGEN$$$$$$Y$$$20240712$$CN$US$US
240820041$24082004$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006540$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240820051$24082005$1$I$$20240701$20240712$20240712$EXP$$IN-STERISCIENCE B.V.-2024-ST-000987$Steriscience PTE$Batra S, Tandon R, Nigam S. Progressive multifocal leukoencephalopathy successfully treated with intravenous immunoglobulin. Neuroimmunol-Rep. 2024;5$52$YR$$F$Y$$$20240712$$HP$IN$IN
240820061$24082006$1$I$20240101$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006874$ELI LILLY AND CO$$$$$M$Y$$$20240712$$CN$US$US
240820071$24082007$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007011$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240820081$24082008$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006964$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240712$$CN$US$US
240820091$24082009$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007003$ELI LILLY AND CO$$66$YR$E$$Y$$$20240712$$CN$US$US
240820102$24082010$2$F$20240710$20240808$20240712$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202407007171$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240811$$CN$US$US
240820112$24082011$2$F$$20240710$20240712$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007174$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240715$$HP$US$US
240820121$24082012$1$I$20240710$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006979$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240712$$CN$US$US
240820131$24082013$1$I$$20240706$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006629$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240712$$CN$US$US
240820142$24082014$2$F$$20240729$20240712$20240731$PER$$US-AMGEN-USASP2024136012$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
240820152$24082015$2$F$20240710$20240717$20240712$20240720$PER$$US-AMGEN-USASP2024137045$AMGEN$$$$$F$Y$$$20240720$$CN$US$US
240820161$24082016$1$I$$20230604$20240712$20240712$PER$$US-ENDO USA, INC.-2023-002931$ENDO$$$$$$Y$$$20240712$$CN$US$US
240820173$24082017$3$F$$20240430$20240712$20240916$PER$$US-ENDO USA, INC.-2024-002078$ENDO$$$$$M$Y$$$20240916$$CN$US$US
240820181$24082018$1$I$$20230607$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003149$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240820191$24082019$1$I$$20230606$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003015$ENDO$$$$$$Y$$$20240712$$CN$US$US
240820201$24082020$1$I$$20230609$20240712$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003067$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240820211$24082021$1$I$$20231017$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2023US045199$SANDOZ$$$$$F$Y$$$20240712$$CN$US$US
240820221$24082022$1$I$20240101$20240701$20240712$20240712$PER$$US-SA-2024SA199802$SANOFI AVENTIS$$$$C$$Y$$$20240712$$MD$US$US
240820231$24082023$1$I$20240601$20240707$20240712$20240712$PER$$US-SA-2024SA202443$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240712$$MD$US$US
240820242$24082024$2$F$$20240829$20240712$20240913$PER$$US-SA-2024SA202496$SANOFI AVENTIS$$11$YR$C$M$Y$40.45$KG$20240913$$MD$US$US
240820252$24082025$2$F$20240615$20240729$20240712$20240731$PER$$US-AMGEN-USASP2024136335$AMGEN$$83$YR$E$M$Y$$$20240731$$CN$US$US
240820261$24082026$1$I$$20240708$20240712$20240712$EXP$$US-GSK-US2024AMR085714$GLAXOSMITHKLINE$$$$$F$Y$83.9$KG$20240712$$CN$US$US
240820271$24082027$1$I$20240501$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137091$AMGEN$$54$YR$A$F$Y$$$20240712$$CN$US$US
240820281$24082028$1$I$$20240711$20240712$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039301$BOEHRINGER INGELHEIM$$$$$$Y$$$20240712$$MD$US$US
240820292$24082029$2$F$20240523$20240812$20240712$20240816$PER$$US-ROCHE-3570757$ROCHE$$64$YR$A$F$Y$$$20240816$$CN$US$US
240820301$24082030$1$I$$20240617$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002879$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240820311$24082031$1$I$$20240705$20240712$20240712$EXP$$US-JNJFOC-20240715337$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240712$$CN$US$US
240820321$24082032$1$I$20240625$20240708$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010637$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240820334$24082033$4$F$20230904$20240901$20240712$20240909$EXP$$JP-009507513-2407JPN005379$MERCK$$75$YR$$M$Y$39.2$KG$20240909$$MD$JP$JP
240820341$24082034$1$I$$20240618$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US059894$SANDOZ$$$$$F$Y$$$20240712$$CN$US$US
240820361$24082036$1$I$$20230606$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003274$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240820372$24082037$2$F$$20240705$20240712$20240712$PER$$US-ROCHE-10000019271$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240820382$24082038$2$F$$20240809$20240712$20240816$PER$$US-ROCHE-10000022963$ROCHE$$$$A$F$Y$$$20240816$$CN$US$US
240820391$24082039$1$I$$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405101510545020-SPZMK$GB-AMAROX PHARMA-AMR2024GB02156$HETERO$$$$$M$Y$$$20240712$$MD$GB$GB
240820405$24082040$5$F$20240701$20240730$20240712$20240806$EXP$$US-GSK-US2024AMR082718$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$US$US
240820411$24082041$1$I$$20240704$20240712$20240712$EXP$$US-JNJFOC-20240724370$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240820421$24082042$1$I$$20240708$20240712$20240712$PER$$US-ALXN-202407USA000529US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240820433$24082043$3$F$$20240812$20240712$20240812$PER$$US-ALXN-202407USA000408US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
240820441$24082044$1$I$$20240705$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-034071$AUROBINDO$$$$$F$Y$$$20240712$$PH$GB$GB
240820451$24082045$1$I$$20240702$20240712$20240712$30DAY$$US-GSK-US2024083089$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$CN$US$US
240820461$24082046$1$I$20230101$20240708$20240712$20240712$PER$$US-ROCHE-10000020732$ROCHE$$74$YR$E$$Y$$$20240712$$CN$US$US
240820473$24082047$3$F$20230405$20240822$20240712$20240829$EXP$$KR-TAKEDA-2024TUS068333$TAKEDA$$68$YR$$F$Y$51$KG$20240829$$MD$KR$KR
240820482$24082048$2$F$20240726$20240731$20240712$20240805$EXP$$NVSC2024GB142062$NOVARTIS$$$$$F$Y$$$20240805$$CN$GB$GB
240820491$24082049$1$I$20240708$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137660$AMGEN$$55$YR$A$F$Y$$$20240712$$CN$US$US
240820502$24082050$2$F$$20240726$20240712$20240807$EXP$$JP-AMGEN-JPNSP2024137777$AMGEN$$8$DEC$E$M$Y$$$20240807$$PH$JP$JP
240820511$24082051$1$I$20240710$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137508$AMGEN$$$$$$Y$$$20240712$$HP$US$US
240820521$24082052$1$I$$20240708$20240712$20240712$PER$$US-ROCHE-10000022495$ROCHE$$36$YR$A$M$Y$$$20240712$$CN$US$US
240820531$24082053$1$I$$20240702$20240712$20240712$PER$$US-ROCHE-3567571$ROCHE$$$$A$M$Y$$$20240712$$CN$US$US
240820541$24082054$1$I$20240317$20240708$20240712$20240712$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019312$VALIDUS$$$$$$Y$$$20240712$$MD$US$US
240820551$24082055$1$I$$20240709$20240712$20240712$PER$$US-ROCHE-10000022004$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240820561$24082056$1$I$$20240630$20240712$20240712$EXP$$AU-IHL-000590$INVENTIA HEALTHCARE$$52$YR$A$F$Y$$$20240705$$HP$AU$AU
240820571$24082057$1$I$$20230609$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003183$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240820581$24082058$1$I$$20230607$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003335$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240820591$24082059$1$I$$20240709$20240712$20240712$PER$$US-ROCHE-10000022681$ROCHE$$$$E$F$Y$$$20240712$$CN$US$US
240820611$24082061$1$I$$20240702$20240712$20240712$PER$$US-TEVA-VS-3217276$TEVA$$59$YR$$F$Y$$$20240712$$CN$US$US
240820621$24082062$1$I$20230101$20240628$20240712$20240712$EXP$$AU-ROCHE-10000021522$ROCHE$$37$YR$A$F$Y$$$20240712$$HP$AU$AU
240820631$24082063$1$I$$20240709$20240712$20240712$EXP$$US-SNT-000399$SINOTHERAPEUTICS$$$$$F$Y$$$20240712$$CN$US$US
240820641$24082064$1$I$$20240617$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002878$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240820651$24082065$1$I$20240401$20240704$20240712$20240712$PER$$US-SA-2024SA200723$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240712$$MD$US$US
240820661$24082066$1$I$$20240710$20240712$20240712$PER$$US-JNJFOC-20240727163$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240820671$24082067$1$I$20240507$20240703$20240712$20240712$EXP$$US-JNJFOC-20240709838$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240712$$CN$US$US
240820681$24082068$1$I$20240514$20240628$20240712$20240712$PER$$US-ROCHE-3569017$ROCHE$$$$$M$Y$$$20240712$$CN$US$US
240820691$24082069$1$I$$20240628$20240712$20240712$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-20496$SAMSUNG BIOEPIS$$60$YR$A$M$Y$$$20240712$$CN$GB$GB
240820701$24082070$1$I$$20240709$20240712$20240712$PER$$US-SA-2024SA203894$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240712$$CN$US$US
240820711$24082071$1$I$20240101$20240709$20240712$20240712$PER$$US-SA-2024SA203875$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240712$$CN$US$US
240820721$24082072$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA202569$SANOFI AVENTIS$$$$E$F$Y$$$20240712$$MD$US$US
240820731$24082073$1$I$$20240709$20240712$20240712$PER$$US-SA-2024SA203676$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240712$$CN$US$US
240820741$24082074$1$I$20240101$20240708$20240712$20240712$PER$$US-SA-2024SA202531$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240712$$MD$US$US
240820751$24082075$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024136885$AMGEN$$$$$$Y$$$20240712$$HP$US$US
240820763$24082076$3$F$20240705$20240711$20240712$20240724$PER$$US-SA-2024SA200035$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240724$$HP$US$US
240820772$24082077$2$F$$20240716$20240712$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-033912$AUROBINDO$$$$$M$Y$$$20240725$$HP$US$US
240820781$24082078$1$I$$20240702$20240712$20240712$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024083063$VIIV$$56$YR$$F$Y$$$20240712$$PH$US$US
240820791$24082079$1$I$$20240627$20240712$20240712$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455891$RANBAXY$Pereira JT, Ribeiro A, Tonel C. VISCERAL LEISHMANIASIS AND IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME. Eur J Case Rep Intern Med. 2022;9 (Suppl.):413/1805 (EV0820)$40$YR$$M$Y$$$20240712$$HP$PT$PT
240820801$24082080$1$I$$20240627$20240712$20240712$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455898$RANBAXY$Struys I, Velazquez C, Ubels J, Van Leeuwen A, Ghosh M, Geurts J, et al. CHEMOTHERAPY DURING PREGNANCY IS ASSOCIATED WITH INCREASED GENOTOXICITY AND MUTATIONAL LOAD IN THE FETAL HEMATOPOIETIC COMPARTMENT. Int J Gynecol Cancer. 2023;33 (Suppl.3):A210-A211/506$$$$F$Y$$$20240712$$HP$BE$BE
240820811$24082081$1$I$$20240627$20240712$20240712$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455901$RANBAXY$Struys I, Velazquez C, Ubels J, Van Leeuwen A, Ghosh M, Geurts J, et al. CHEMOTHERAPY DURING PREGNANCY IS ASSOCIATED WITH INCREASED GENOTOXICITY AND MUTATIONAL LOAD IN THE FETAL HEMATOPOIETIC COMPARTMENT. Int J Gynecol Cancer. 2023;33 (Suppl.3):A210-A211/506$$$$F$Y$$$20240712$$HP$BE$BE
240820822$24082082$2$F$20231201$20240708$20240712$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455424$RANBAXY$$87$YR$$F$Y$52.16$KG$20240723$$HP$US$US
240820831$24082083$1$I$$20240627$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455863$RANBAXY$Jaggernauth S, Waack A, Hoyt A, Schroeder J. Disseminated mycobacterium avium complex spinal osteomyelitis in a patient with interferon gamma receptor deficiency: A case report. Radiol Case Rep. 2024;19 (8):3070-3075$21$YR$$M$Y$$$20240712$$HP$US$US
240820841$24082084$1$I$$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455860$RANBAXY$Chimenti G, Magli A, Njandjo L, Fois A, Santagati G, Piccoli G, et al. New onset proteinuria in two pregnancies: glomerulopathy or preeclampsia?. Nephrol Dial Transplant. 2024;39 (Suppl.):i2048-i2049;1728;gfae069.1265$44$YR$$F$Y$$$20240712$$HP$FR$FR
240820861$24082086$1$I$$20240627$20240712$20240712$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455906$RANBAXY$Suzuki K, Aizawa M, Tamazawa K, Ueda K, Wada J, Nakajima Y, et al. Relapse of Ulcerative Colitis with Immune Thrombocytopenia and Pyoderma Gangrenosum Subsequent to Receiving COVID-19 Vaccination. Intern med. 2024;63 (5):665-669$22$YR$$M$Y$$$20240712$$HP$JP$JP
240820871$24082087$1$I$$20240627$20240712$20240712$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455874$RANBAXY$Tortosa-Cabanas M, Acosta-Battle J, Perna C, Andreu-Suarez A, Corral-Bote A, Bachiller-Corral J.. Regression of amyloid deposits after treatment with tocilizumab. Nephrol Dial Transplant. 2024;39 (S):i2103 (#2698)$61$YR$$F$Y$$$20240712$$HP$ES$ES
240820881$24082088$1$I$$20240627$20240712$20240712$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455885$RANBAXY$Tan N, Ouyang Z, Duan X, Zhou X, Zhu Y, Chu J, et al. Case report: Pulmonary artery sarcoma diagnosed through rare brain metastases. Front Oncol. 2024;May 15; 14 (0):1394708; 1-6$33$YR$$M$Y$$$20240712$$HP$CN$CN
240820891$24082089$1$I$$20240627$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455888$RANBAXY$Habib A, Butt K, Ibrahim R, Shaaban A, Lee HS. BRASH syndrome: A rare but reversible cause of sinus node dysfunction. Heart Rhythm Case Rep. 2024;Jun; 10 (6):398-401$57$YR$$F$Y$$$20240712$$MD$US$US
240820901$24082090$1$I$20240429$20240704$20240712$20240712$EXP$GB-MHRA-MED-202405021613108220-GFLBS$GB-TEVA-VS-3217841$TEVA$$$$$F$Y$$$20240712$$HP$GB$GB
240820911$24082091$1$I$$20240710$20240712$20240712$PER$$US-ABBVIE-5835237$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240820921$24082092$1$I$$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455837$RANBAXY$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper?IgE Syndrome. J Clin Immunol. 2023;Dec;43 (3):647-652$11$YR$$M$Y$$$20240712$$HP$FR$FR
240820931$24082093$1$I$$20240627$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455721$RANBAXY$Flathers EB, Cecchini A, Ori T. Decades of Hiding: Adenosquamous Carcinoma Masquerading as Sarcoidosis. Am J Respir Crit Care Med. 2024;209 (0):A4658$79$YR$$F$Y$$$20240712$$HP$US$US
240820942$24082094$2$F$$20240709$20240712$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455769$RANBAXY$Devraj S, Bhuyan B. Short Term Outcomes of Hyper-CVAD/MA Protocol in Newly Diagnosed Cases of ALL/LBL in a Resource Limited Setting. Indian J Hematol Blood Transf. 2023;39:S9$$$A$$Y$$$20240724$$HP$IN$IN
240820952$24082095$2$F$$20240709$20240712$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455767$RANBAXY$Devraj S, Bhuyan B. Short Term Outcomes of Hyper-CVAD/MA Protocol in Newly Diagnosed Cases of ALL/LBL in a Resource Limited Setting. Indian J Hematol Blood Transf. 2023;39:S9$$$A$$Y$$$20240724$$HP$IN$IN
240820962$24082096$2$F$$20240709$20240712$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455768$RANBAXY$Devraj S, Bhuyan B. Short Term Outcomes of Hyper-CVAD/MA Protocol in Newly Diagnosed Cases of ALL/LBL in a Resource Limited Setting. Indian J Hematol Blood Transf. 2023;39:S9$$$A$$Y$$$20240724$$HP$IN$IN
240820971$24082097$1$I$$20240627$20240712$20240712$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455847$RANBAXY$Dhalla N, Gopal L, Palwankar P.. Drug induced gingival enlargement-phenytoin: an overview and case report. J Surg Case Rep. 2024;2024 (5):rjae304(1-4)$20$YR$$F$Y$$$20240712$$HP$IN$IN
240820981$24082098$1$I$$20240627$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455810$RANBAXY$Sharp JA, Jones D, Rotow JK, Fidias PM, Bertino E, Owen DH. Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2024;Apr; 22 (3):e247009; 1-5$79$YR$$F$Y$$$20240712$$MD$US$US
240820991$24082099$1$I$$20240627$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455703$RANBAXY$Goldschmidt-clermont PJ, Khan A, Jimsheleishvili G, Graham P, Brooks A, Silvera R , et al. Treating amyotrophic lateral sclerosis with allogeneic Schwann cell-derived exosomal vesicles: a case report. Neural Regen Res. 2024;-:Online ahead of print$81$YR$$M$Y$$$20240712$$HP$US$US
240821002$24082100$2$F$$20240709$20240712$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455765$RANBAXY$Devraj S, Bhuyan B. Short Term Outcomes of Hyper-CVAD/MA Protocol in Newly Diagnosed Cases of ALL/LBL in a Resource Limited Setting. Indian J Hematol Blood Transf. 2023;39:S9$$$A$$Y$$$20240724$$HP$IN$IN
240821011$24082101$1$I$$20240627$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455719$RANBAXY$$$$$M$Y$104.76$KG$20240712$$CN$US$US
240821021$24082102$1$I$$20240627$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455850$RANBAXY$Chan W, Park S, Shirkhoda L, O^Connell R, Houshyar R. Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells: a case report. J Med Case Rep. 2023;17:477; 1-7$54$YR$$M$Y$$$20240712$$HP$US$US
240821032$24082103$2$F$$20240711$20240712$20240718$EXP$$CA-JNJFOC-20230300522$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$93.2$KG$20240719$$CN$CA$CA
240821042$24082104$2$F$20170924$20240907$20240712$20240912$EXP$$PHHY2017IN143547$NOVARTIS$$51$YR$$F$Y$48$KG$20240912$$CN$IN$IN
240821051$24082105$1$I$20240708$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137769$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240821061$24082106$1$I$$20230623$20240712$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-003796$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240821071$24082107$1$I$$20230716$20240712$20240712$PER$$US-ENDO USA, INC.-2023-004436$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240821081$24082108$1$I$$20230703$20240712$20240712$PER$$US-ENDO USA, INC.-2023-004149$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240821091$24082109$1$I$$20230710$20240712$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2023-004268$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240821101$24082110$1$I$$20230622$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003841$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240821111$24082111$1$I$$20230608$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003542$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240821121$24082112$1$I$$20240711$20240712$20240712$PER$$US-ROCHE-10000023596$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240821131$24082113$1$I$$20240702$20240712$20240712$EXP$$US-SPECGX-T202401503$SPECGX$Ross RG. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry. 2006;163(7):1149-52$6$YR$$M$Y$$$20240712$$MD$US$US
240821141$24082114$1$I$$20240702$20240712$20240712$EXP$$US-SPECGX-T202401491$SPECGX$$$$$F$Y$$$20240712$$CN$US$US
240821151$24082115$1$I$$20240702$20240712$20240712$EXP$$US-SPECGX-T202401483$SPECGX$Gontkovsky ST, Nevels R, McDonald NB, Winkelmann MH. Decreased serum glucose levels after initiation of methylphenidate in a patient status post-cerebellar tumour resection: A potential interaction with glipizide. Clin Drug Invest. 2007;27(10):719-25$38$YR$$F$Y$$$20240712$$HP$US$US
240821161$24082116$1$I$$20240709$20240712$20240712$EXP$$US-VIIV HEALTHCARE LIMITED-US2024085129$VIIV$$$$A$M$Y$$$20240712$$CN$US$US
240821171$24082117$1$I$$20240702$20240712$20240712$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004976$BIOCON$$$$$$Y$$$20240712$$HP$CA$CA
240821181$24082118$1$I$$20240704$20240712$20240712$EXP$$CA-CELLTRION INC.-2024CA007907$CELLTRION$$$$$$Y$$$20240712$$MD$CA$CA
240821191$24082119$1$I$20200101$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033035$AUROBINDO$Yan A, Gallardo M, Savu A, Kaffenberger B.. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management.. Archives of Dermatological Research. 2024;316(7):397$59$YR$$M$Y$$$20240712$$MD$US$US
240821201$24082120$1$I$$20240704$20240712$20240712$EXP$$US-NOVITIUMPHARMA-2024USNVP01238$NOVITIUM PHARMA$Maryam J. Syed.Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series.Neurocrit Care.03-OCT-2023;40:976-983$58$YR$A$M$Y$71$KG$20240712$$HP$US$US
240821211$24082121$1$I$$20240703$20240712$20240712$EXP$$US-CHATTEMPRD-2024OHG023464$CHATTEM$Idowu D., Ezema K., Corcoran J., Farkas A., The predictive value of heart rate in determining clinical course after a bupropion overdose., CLINICAL TOXICOLOGY., 2024, VOL. 62, NO. 5, 296-302$21$YR$A$F$Y$$$20240712$$HP$US$US
240821225$24082122$5$F$20240725$20240916$20240712$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002876$ACADIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240926$$CN$US$US
240821231$24082123$1$I$$20240702$20240712$20240712$EXP$$IN-ENDO USA, INC.-2024-002838$ENDO$Ike IM, PK J, Raju R.. A case of Risperidone monotherapy causing serotonin syndrome in one of the monozygotic twins. Indian Journal of Psychiatry. 2024;66(Suppl 1):S52-S53$15$YR$$M$Y$$$20240712$$MD$IN$IN
240821242$24082124$2$F$20210101$20240715$20240712$20240718$EXP$$PT-SA-2024SA198524$SANOFI AVENTIS$Paulo N, Goncalves PL, Cerqueira A, Araujo J, Sampaio S, Vasconcelos MP.. Recurrent parvovirus B19 infection-associated pure red cell aplasia in kidney transplantation.. Nephrology Dialysis Transplantation.. 2024;39(SUPPL1):i2698$42$YR$A$M$Y$$$20240718$$MD$PT$PT
240821251$24082125$1$I$$20230607$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003444$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240821261$24082126$1$I$$20230706$20240712$20240712$PER$$US-ENDO USA, INC.-2023-004250$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240821271$24082127$1$I$20230101$20240702$20240712$20240712$EXP$$US-UNITED THERAPEUTICS-UNT-2023-035748$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240712$$$US$US
240821281$24082128$1$I$$20230703$20240712$20240712$PER$$US-ENDO USA, INC.-2023-004187$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240821291$24082129$1$I$$20230620$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003750$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240821301$24082130$1$I$$20230623$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003871$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240821311$24082131$1$I$20240101$20240709$20240712$20240712$EXP$$HR-ABBVIE-5833163$ABBVIE$$21$YR$$F$Y$$$20240712$$MD$HR$HR
240821321$24082132$1$I$$20230621$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003820$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240821331$24082133$1$I$20240623$20240704$20240712$20240712$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2159067$JIANGSU HENGRUI MEDICINE$$78$YR$$M$Y$60$KG$20240712$$MD$CN$CN
240821341$24082134$1$I$$20240710$20240712$20240712$EXP$$US-BIOGEN-2024BI01271810$BIOGEN$$$$$F$Y$$$20240712$$HP$US$US
240821351$24082135$1$I$$20230607$20240712$20240712$PER$$US-ENDO USA, INC.-2023-005594$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240821363$24082136$3$F$$20231219$20240712$20240918$PER$$US-ENDO USA, INC.-2024-000174$ENDO$$$$$M$Y$$$20240918$$CN$US$US
240821371$24082137$1$I$$20231218$20240712$20240712$PER$$US-ENDO USA, INC.-2024-000078$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240821383$24082138$3$F$20211001$20231218$20240712$20240916$PER$$US-ENDO USA, INC.-2023-006349$ENDO$$$$$F$Y$$$20240916$$CN$US$US
240821393$24082139$3$F$$20231218$20240712$20240918$PER$$US-ENDO USA, INC.-2023-006353$ENDO$$$$$F$Y$$$20240918$$CN$US$US
240821402$24082140$2$F$$20240701$20240712$20240712$PER$$US-ROCHE-10000017451$ROCHE$$79$YR$E$M$Y$$$20240712$$CN$US$US
240821411$24082141$1$I$20240709$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137771$AMGEN$$46$YR$A$F$Y$$$20240712$$CN$US$US
240821421$24082142$1$I$$20240708$20240712$20240712$PER$$US-ABBVIE-5832941$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240821431$24082143$1$I$$20240705$20240712$20240712$EXP$$US-JNJFOC-20240716006$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240821441$24082144$1$I$$20240628$20240712$20240712$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-20503$SAMSUNG BIOEPIS$$69$YR$E$M$Y$$$20240712$$CN$GB$GB
240821451$24082145$1$I$20240705$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137706$AMGEN$$55$YR$A$M$Y$$$20240712$$CN$US$US
240821462$24082146$2$F$20240709$20240718$20240712$20240723$PER$$US-AMGEN-USASP2024136856$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
240821471$24082147$1$I$20240704$20240708$20240712$20240712$EXP$$US-ARGENX-2024-ARGX-US005271$ARGENX BVBA$$$$$$Y$$$20240712$$CN$US$US
240821481$24082148$1$I$$20240708$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006419$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240712$$CN$US$US
240821491$24082149$1$I$20240612$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007040$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240712$$CN$US$US
240821501$24082150$1$I$20240601$20240708$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005359$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240712$$CN$US$US
240821511$24082151$1$I$$20240704$20240712$20240712$EXP$$DE-CELLTRION INC.-2024DE016517$CELLTRION$$$$$$Y$$$20240712$$CN$DE$DE
240821521$24082152$1$I$$20230807$20240712$20240712$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404841$RANBAXY$$$$$M$Y$$$20240712$$CN$US$US
240821531$24082153$1$I$$20240508$20240712$20240712$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446433$RANBAXY$$$$$F$Y$$$20240712$$CN$US$US
240821541$24082154$1$I$$20240510$20240712$20240712$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447201$RANBAXY$$$$$M$Y$$$20240712$$HP$US$US
240821551$24082155$1$I$20230901$20240607$20240712$20240712$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408418$RANBAXY$$83$YR$E$M$Y$$$20240712$$CN$US$US
240821561$24082156$1$I$$20240702$20240712$20240712$EXP$$IN-ROCHE-10000003261$ROCHE$$64$YR$A$M$Y$$$20240712$$CN$IN$IN
240821571$24082157$1$I$$20240710$20240712$20240712$PER$$US-ROCHE-10000023988$ROCHE$$57$YR$A$M$Y$$$20240712$$HP$US$US
240821582$24082158$2$F$20240625$20240807$20240712$20240814$EXP$$GB-CELLTRION INC.-2024GB011468$CELLTRION$$$$$$Y$$$20240814$$CN$GB$GB
240821592$24082159$2$F$$20240805$20240712$20240805$PER$$US-ALXN-202407USA000575US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$MD$US$US
240821601$24082160$1$I$$20231006$20240712$20240712$PER$$US-USWM, LLC-UWM202310-000030$US WORLDMEDS$$2$DEC$$M$Y$$$20240712$$HP$US$
240821611$24082161$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186613$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240821621$24082162$1$I$20240705$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137686$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240821631$24082163$1$I$$20240628$20240712$20240712$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-20574$SAMSUNG BIOEPIS$$$$$F$Y$$$20240712$$HP$CA$CA
240821641$24082164$1$I$$20240705$20240712$20240712$EXP$$TW-ROCHE-10000001334$ROCHE$Lan T, Chang T, Tseng T, Lee T, Kao J, Cheng C, et al. Risk of rituximab-induced hepatitis B flare after antiviral discontinuation in rheumatic patients with chronic hepatitis B virus. Clinical and experimental rheumatology. 2024-Jun-04;1-8. doi:10.55563/clinexprheumatol/qh1gj3.$$$$$Y$$$20240712$$HP$TW$TW
240821651$24082165$1$I$20240328$20240627$20240712$20240712$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451476$RANBAXY$$65$YR$$M$Y$65$KG$20240712$$MD$IN$IN
240821661$24082166$1$I$$20240627$20240712$20240712$EXP$$TZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455927$RANBAXY$Wilfred ZI, Magitta NF. Sirenomelia or mermaid syndrome with a cleft lip in a Tanzanian newborn: a case report. J Med Case Rep. 2024;18 (1):224$22$YR$$F$Y$$$20240712$$HP$TZ$TZ
240821671$24082167$1$I$$20240627$20240712$20240712$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455941$RANBAXY$Marasco E, Bracaglia C, Merli P, Alvarez PM, Nicolai R, Algeri M, et al. ANTI-CD19 CAR-T CELL THERAPY FOR REFRACTORY CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus Sci Med. 2024;11 (Suppl.):A113$15$YR$$F$Y$$$20240712$$HP$IT$IT
240821681$24082168$1$I$$20240627$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456047$RANBAXY$Lee B, Vipparthy SC Brider J, Mahtani AU, Doty B, Gabrah K, et al. A Unique Case Of Repetitive Non-Reentrant Ventriculoatrial Synchrony Inducing Recurrent Atrial Fibrillation. Heart Rhythm. 2024;21(Suppl.) (5):S600-S601(PO-05-064)$45$YR$$M$Y$$$20240712$$HP$US$US
240821691$24082169$1$I$$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455857$RANBAXY$Chimenti G, Magli A, Njandjo L, Fois A, Santagati G, Piccoli G, et al. New onset proteinuria in two pregnancies: glomerulopathy or preeclampsia?. Nephrol Dial Transplant. 2024;39(S):i2048-i2049/1728$27$YR$$F$Y$$$20240712$$HP$FR$FR
240821701$24082170$1$I$20220901$20240627$20240712$20240712$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455934$RANBAXY$Jori B, Vossing C, Pirngruber J, Willing EM, Arndt K, Falk M, et al. The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations. Curr Oncol. 2023;Sep 27; 30:8805-8814$50$YR$$M$Y$$$20240712$$HP$DE$DE
240821711$24082171$1$I$$20240627$20240712$20240712$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424490$RANBAXY$Ben Kahla A, Kassar O, Moalla K, Fakhfakh Y, Hentati Y, Elloumi M. Cerebral venous thrombosis after first Methotrexate administration by lumbar puncture in a patient with large B cell lymphoma. Tunis Med. 2023;101 (07):648-650$24$YR$$M$Y$$$20240712$$HP$TN$TN
240821721$24082172$1$I$$20240627$20240712$20240712$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455870$RANBAXY$Zhao Y, Zuo Y. Anesthesia management for a child with the Koolen-de Vries syndrome: a case report. BMC Anesthesiol. 2024;24(1):143/1-4$21$MON$$M$Y$11$KG$20240712$$HP$CN$CN
240821732$24082173$2$F$$20240913$20240712$20240919$EXP$$US-LEO Pharma-371824$LEO PHARM$$78$YR$$M$Y$$$20240919$$CN$US$US
240821741$24082174$1$I$20240326$20240705$20240712$20240712$EXP$$US-CHIESI-2024CHF04099$CHIESI$$14$YR$$M$Y$46$KG$20240712$$HP$US$US
240821771$24082177$1$I$$20240706$20240712$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038184$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240712$$MD$US$US
240821782$24082178$2$F$$20240724$20240712$20240726$PER$$NVSC2024US144007$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
240821792$24082179$2$F$20221205$20240902$20240712$20240911$EXP$$JP-AKEBIA EUROPE LIMITED-JP-AKEB-23-000229$AKEBIA THERAPEUTICS$$75$YR$$M$Y$72.5$KG$20240911$$MD$JP$JP
240821801$24082180$1$I$$20240702$20240712$20240712$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004964$BIOCON$$$$$$Y$$$20240712$$HP$CA$CA
240821811$24082181$1$I$20240615$20240618$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002906$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240712$$CN$US$US
240821821$24082182$1$I$20240612$20240618$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002881$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240712$$CN$US$US
240821832$24082183$2$F$$20240627$20240712$20240722$EXP$$DE-ROCHE-10000022062$ROCHE$$$$E$M$Y$$$20240719$$MD$DE$DE
240821842$24082184$2$F$$20240715$20240712$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-033579$AUROBINDO$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique. 2023;35(3):175-197$38$YR$$M$Y$$$20240723$$MD$FR$FR
240821851$24082185$1$I$20221101$20240629$20240712$20240712$EXP$$US-CIPLA LTD.-2024US07099$CIPLA$$$$$$Y$$$20240712$$LW$US$US
240821861$24082186$1$I$20240616$20240709$20240712$20240712$EXP$$ES-AstraZeneca-2024A156359$ASTRAZENECA$$58$YR$$M$Y$57.2$KG$20240712$$MD$ES$
240821872$24082187$2$F$$20240802$20240712$20240805$PER$$US-ALXN-202407USA000426US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240821881$24082188$1$I$$20240708$20240712$20240712$PER$$US-ALXN-202407USA000512US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240821894$24082189$4$F$20240531$20240710$20240712$20240723$PER$$NVSC2024US142310$NOVARTIS$$$$$M$Y$$$20240723$$HP$US$US
240821901$24082190$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186608$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240821911$24082191$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033805$AUROBINDO$Cooper J, Patel K, Richardson C.. A Case of Severe Herpes Simplex Virus Pneumonitis.. Am-JRespir-Crit-Care-Med. 2024;209:A3584$71$YR$$F$Y$$$20240712$$HP$US$US
240821921$24082192$1$I$$20240703$20240712$20240712$PER$$US-TEVA-VS-3217293$TEVA$$57$YR$$F$Y$$$20240712$$CN$US$US
240821931$24082193$1$I$20240521$20240712$20240712$20240712$EXP$SE-SEMPA-2024-005444$SE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039380$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$71$KG$20240712$$MD$SE$SE
240821941$24082194$1$I$20240710$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137682$AMGEN$$$$$$Y$$$20240712$$CN$US$US
240821961$24082196$1$I$20240705$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137693$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240821974$24082197$4$F$20220101$20240827$20240712$20240911$EXP$$HK-AMGEN-HKGSP2024137264$AMGEN$$84$YR$E$M$Y$$$20240911$$MD$HK$HK
240821981$24082198$1$I$$20230607$20240712$20240712$PER$$US-ENDO USA, INC.-2023-002973$ENDO$$$$$$Y$$$20240712$$CN$US$US
240821991$24082199$1$I$$20230607$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003039$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240822001$24082200$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007310$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240712$$CN$US$US
240822011$24082201$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006529$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240822022$24082202$2$F$$20240710$20240712$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007184$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240715$$HP$US$US
240822031$24082203$1$I$$20240704$20240712$20240712$EXP$$US-NOVITIUMPHARMA-2024USNVP01243$NOVITIUM PHARMA$Maryam J. Syed.Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series.Neurocrit Care.03-OCT-2023;40:976-983$72$YR$E$F$Y$86$KG$20240712$$HP$US$US
240822041$24082204$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007203$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240712$$HP$US$US
240822051$24082205$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005924$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240712$$CN$US$US
240822061$24082206$1$I$20240710$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007228$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240712$$CN$US$US
240822071$24082207$1$I$20240626$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007163$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240712$$CN$US$US
240822081$24082208$1$I$20240201$20240708$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005527$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240712$$CN$US$US
240822102$24082210$2$F$$20240801$20240712$20240805$EXP$$CA-ROCHE-10000021129$ROCHE$$$$A$M$Y$$$20240805$$CN$CA$CA
240822111$24082211$1$I$$20240628$20240712$20240712$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-19654$SAMSUNG BIOEPIS$$65$YR$E$F$Y$$$20240712$$PH$CA$CA
240822122$24082212$2$F$20240617$20240729$20240712$20240803$EXP$$JP-ROCHE-10000022674$ROCHE$$8$DEC$E$F$Y$$$20240803$$MD$JP$JP
240822131$24082213$1$I$20240101$20240619$20240712$20240712$PER$$US-FDC-2024USSPO00482$FDC LIMITED$$$$$F$Y$$$20240712$$PH$US$US
240822147$24082214$7$F$20240701$20240815$20240712$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020991$UNITED THERAPEUTICS$$35$YR$$F$Y$181.36$KG$20240823$$$US$US
240822152$24082215$2$F$20240602$20240705$20240712$20240716$PER$$US-SA-2024SA199841$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240716$$MD$US$US
240822161$24082216$1$I$20240410$20240627$20240712$20240712$EXP$$RU-SERVIER-S24008182$SERVIER$$$$$$Y$$$20240712$$MD$RU$RU
240822173$24082217$3$F$20240601$20240717$20240712$20240913$EXP$$US-Axsome Therapeutics, Inc.-AXS202406-000868$AXSOME THERAPEUTICS$$72$YR$E$F$Y$$$20240913$$CN$US$
240822181$24082218$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186611$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240822191$24082219$1$I$$20240709$20240712$20240712$EXP$$JP-GSK-JP2024084665$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$JP$JP
240822201$24082220$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186617$Haleon PLC$$$$$M$Y$$$20240712$$CN$US$US
240822211$24082221$1$I$$20240709$20240712$20240712$PER$$US-SA-2024SA203466$SANOFI AVENTIS$$$$E$F$Y$$$20240712$$CN$US$US
240822221$24082222$1$I$$20240705$20240712$20240712$EXP$$JP-ROCHE-10000002982$ROCHE$Tamura K, Okuma Y, Nomura S, Fukuda A, Masuda K, Matsumoto Y, et al. Efficacy and safety of chemoimmunotherapy in advanced non-small cell lung cancer patients with antibiotics-induced dysbiosis: a propensity-matched real-world analysis. Journal of Cancer Research and Clinical Oncology.150 (216):1-11. doi:10.1007/s00432-024-05649-x.$$$$$Y$$$20240712$$HP$JP$US
240822231$24082223$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA201773$SANOFI AVENTIS$$$$A$$Y$$$20240712$$PH$US$US
240822241$24082224$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA204033$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240712$$CN$US$US
240822251$24082225$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA202624$SANOFI AVENTIS$$$$T$F$Y$38.5$KG$20240712$$MD$US$US
240822261$24082226$1$I$20240703$20240705$20240712$20240712$PER$$US-SA-2024SA201953$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240712$$MD$US$US
240822271$24082227$1$I$20210101$20240709$20240712$20240712$PER$$US-SA-2024SA203471$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240712$$CN$US$US
240822281$24082228$1$I$$20240711$20240712$20240712$PER$$US-ROCHE-10000024254$ROCHE$$$$E$F$Y$$$20240712$$CN$US$US
240822293$24082229$3$F$$20240827$20240712$20240903$EXP$$US-TAKEDA-2024TUS066853$TAKEDA$$$$$M$Y$$$20240903$$CN$US$US
240822301$24082230$1$I$20231001$20240703$20240712$20240712$EXP$$RS-EMD Serono-2023489467$EMD SERONO INC$$38$YR$A$F$Y$$$20240712$$CN$RS$RS
240822311$24082231$1$I$20200101$20240704$20240712$20240712$EXP$$DE-EMD Serono-2024036962$EMD SERONO INC$$$$$M$Y$$$20240712$$CN$DE$DE
240822321$24082232$1$I$$20240708$20240712$20240712$EXP$$US-BIOGEN-2024BI01273094$BIOGEN$$$$$F$Y$$$20240712$$CN$US$US
240822341$24082234$1$I$$20240709$20240712$20240712$PER$$NVSC2024US143938$NOVARTIS$$34$YR$$F$Y$$$20240712$$CN$US$US
240822352$24082235$2$F$$20240719$20240712$20240725$EXP$$JP-EMD Serono-2024036714$EMD SERONO INC$$90$YR$E$F$Y$$$20240725$$MD$JP$JP
240822361$24082236$1$I$20230101$20240704$20240712$20240712$EXP$$CO-EMD Serono-2024036802$EMD SERONO INC$$11$YR$C$M$Y$$$20240712$$CN$CO$CO
240822371$24082237$1$I$20240626$20240703$20240712$20240712$EXP$$RS-EMD Serono-2024037669$EMD SERONO INC$$0$DY$N$F$Y$2$KG$20240712$$CN$RS$RS
240822381$24082238$1$I$20231001$20240710$20240712$20240712$EXP$GB-MHRA-MED-202407101221271600-BQCKL$GB-ORGANON-O2407GBR001019$ORGANON$$75$YR$$M$Y$90$KG$20240712$$CN$GB$GB
240822391$24082239$1$I$$20240709$20240712$20240712$EXP$$US-TAKEDA-2024TUS070016$TAKEDA$$$$$M$Y$$$20240712$$MD$US$US
240822401$24082240$1$I$$20240630$20240712$20240712$EXP$$US-RDY-LIT/USA/24/0009876$DR REDDYS$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. Journal of Maternal-Fetal and Neonatal Medicine. 2024;37(1): doi:10.1080/14767058.2024.2355293.$$$$F$Y$$$20240712$$HP$US$US
240822411$24082241$1$I$$20240630$20240712$20240712$EXP$$US-RDY-LIT/USA/24/0010074$DR REDDYS$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. Journal of Maternal-Fetal and Neonatal Medicine. 2024;37(1): doi:10.1080/14767058.2024.2355293.$$$$F$Y$$$20240712$$HP$US$US
240822421$24082242$1$I$$20240630$20240712$20240712$EXP$$US-RDY-LIT/USA/24/0010078$DR REDDYS$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. Journal of Maternal-Fetal and Neonatal Medicine. 2024;37(1): doi:10.1080/14767058.2024.2355293.$$$$F$Y$$$20240712$$HP$US$US
240822431$24082243$1$I$$20240630$20240712$20240712$EXP$$US-RDY-LIT/USA/24/0010069$DR REDDYS$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. Journal of Maternal-Fetal and Neonatal Medicine. 2024;37(1): doi:10.1080/14767058.2024.2355293.$$$$F$Y$$$20240712$$HP$US$US
240822441$24082244$1$I$$20240630$20240712$20240712$PER$$US-RDY-LIT/USA/24/0009878$DR REDDYS$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. Journal of Maternal-Fetal and Neonatal Medicine. 2024;37(1): doi:10.1080/14767058.2024.2355293.$$$$F$Y$$$20240712$$HP$US$US
240822451$24082245$1$I$$20240630$20240712$20240712$EXP$$US-RDY-LIT/USA/24/0010071$DR REDDYS$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. Journal of Maternal-Fetal and Neonatal Medicine. 2024;37(1): doi:10.1080/14767058.2024.2355293.$$$$F$Y$$$20240712$$HP$US$US
240822461$24082246$1$I$$20240630$20240712$20240712$EXP$$US-RDY-LIT/USA/24/0010067$DR REDDYS$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. Journal of Maternal-Fetal and Neonatal Medicine. 2024;37(1): doi:10.1080/14767058.2024.2355293.$$$$F$Y$$$20240712$$HP$US$US
240822471$24082247$1$I$$20240630$20240712$20240712$EXP$$US-RDY-LIT/USA/24/0010076$DR REDDYS$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. Journal of Maternal-Fetal and Neonatal Medicine. 2024;37(1): doi:10.1080/14767058.2024.2355293.$$$$F$Y$$$20240712$$HP$US$US
240822481$24082248$1$I$20240626$20240702$20240712$20240712$EXP$CN-HENLIUS-24CN015721$CN-Accord-434792$ACCORD$$55$YR$A$F$Y$$$20240712$$HP$CN$CN
240822491$24082249$1$I$$20240704$20240712$20240712$EXP$$US-NOVITIUMPHARMA-2024USNVP01244$NOVITIUM PHARMA$Maryam J. Syed.Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series.Neurocrit Care.03-OCT-2023;40:976-983$67$YR$E$M$Y$70$KG$20240712$$HP$US$US
240822503$24082250$3$F$20240503$20240809$20240712$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-033248$AUROBINDO$$28$YR$$F$Y$108$KG$20240821$$CN$DE$DE
240822511$24082251$1$I$$20240227$20240712$20240712$PER$$US-ENDO USA, INC.-2024-001217$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240822523$24082252$3$F$$20240213$20240712$20240916$PER$$US-ENDO USA, INC.-2024-001044$ENDO$$$$$M$Y$$$20240916$$MD$US$US
240822533$24082253$3$F$$20240412$20240712$20240916$PER$$US-ENDO USA, INC.-2024-001856$ENDO$$$$$F$Y$$$20240916$$CN$US$US
240822543$24082254$3$F$$20240514$20240712$20240917$PER$$US-ENDO USA, INC.-2024-002239$ENDO$$$$$M$Y$$$20240917$$CN$US$US
240822554$24082255$4$F$$20240326$20240712$20240916$PER$$US-ENDO USA, INC.-2024-001561$ENDO$$$$$F$Y$$$20240916$$CN$US$US
240822561$24082256$1$I$$20231219$20240712$20240712$PER$$US-ENDO USA, INC.-2024-000213$ENDO$$$$$$Y$$$20240712$$CN$US$US
240822571$24082257$1$I$20230413$20240703$20240712$20240712$EXP$$ES-AUROBINDO-AUR-APL-2024-033269$AUROBINDO$$80$YR$$F$Y$$$20240712$$MD$ES$ES
240822583$24082258$3$F$$20240430$20240712$20240917$PER$$US-ENDO USA, INC.-2024-002119$ENDO$$$$$$Y$$$20240917$$CN$US$US
240822591$24082259$1$I$$20240628$20240712$20240712$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-20577$SAMSUNG BIOEPIS$$56$YR$A$M$Y$$$20240712$$CN$CA$CA
240822601$24082260$1$I$$20240705$20240712$20240712$EXP$$CN-VANTIVE-2024VAN018198$Vantive US Healthcare$$$$$M$Y$$$20240712$$CN$CN$CN
240822622$24082262$2$F$20240601$20240711$20240712$20240801$PER$$US-FDC-2024USSPO00486$FDC LIMITED$$52$YR$A$F$Y$$$20240801$$CN$US$US
240822631$24082263$1$I$$20240621$20240712$20240712$PER$$US-JNJFOC-20240662261$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240822642$24082264$2$F$20240708$20240722$20240712$20240725$EXP$$JP-JNJFOC-20240726822$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240726$$PH$JP$JP
240822651$24082265$1$I$20240501$20240708$20240712$20240712$EXP$$US-BIOGEN-2024BI01273102$BIOGEN$$34$YR$$F$Y$$$20240712$$CN$US$US
240822661$24082266$1$I$$20240701$20240712$20240712$EXP$$IT-TWI PHARMACEUTICAL, INC-20240700003$TWI PHARMACEUTICALS$Marano M., Goffredo B.M., Faraci S., Torroni F., Gowda S.H., Perdichizzi S, et al.. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicol. Rep.. 2024;13 (101683)$15$YR$$F$Y$48$KG$20240709$$$IT$IT
240822671$24082267$1$I$$20240618$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002882$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$HP$US$US
240822683$24082268$3$F$20240101$20240815$20240712$20240817$PER$$US-AMGEN-USASP2024137811$AMGEN$$29$YR$A$F$Y$$$20240817$$HP$US$US
240822691$24082269$1$I$$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137791$AMGEN$$$$$$Y$$$20240712$$CN$US$US
240822702$24082270$2$F$20240101$20240710$20240712$20240717$PER$$US-AMGEN-USASP2024137704$AMGEN$$$$A$M$Y$$$20240717$$MD$US$US
240822711$24082271$1$I$20240709$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137073$AMGEN$$57$YR$A$M$Y$$$20240712$$CN$US$US
240822721$24082272$1$I$20240709$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137730$AMGEN$$42$YR$A$F$Y$$$20240712$$CN$US$US
240822731$24082273$1$I$$20240705$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107682$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240712$$CN$US$US
240822741$24082274$1$I$20240301$20240708$20240712$20240712$EXP$SI-JAZMP-NCPHV-2024SI0650_0650$SI-BRISTOL-MYERS SQUIBB COMPANY-2024-108295$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240712$$MD$SI$SI
240822751$24082275$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110555$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240712$$HP$US$US
240822764$24082276$4$F$$20240806$20240712$20240813$EXP$$SG-CHATTEMPRD-2024OHG023473$CHATTEM$$$$$F$Y$$$20240813$$CN$SG$SG
240822771$24082277$1$I$$20240628$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455922$RANBAXY$Butensky AM, Patten WF, Silver ES, Liberman L. Oral Albuterol Treatment in Three Pediatric Patients with Bradycardia: A Novel Therapy. Pediatr Cardiol. 2024;45:441-445$3$YR$$M$Y$16.5$KG$20240712$$HP$US$US
240822781$24082278$1$I$$20240708$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109428$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240712$$CN$US$US
240822791$24082279$1$I$$20240628$20240712$20240712$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456006$RANBAXY$Gao Q, Luo H. Successful diagnosis of asymptomatic choriocarcinoma by ultrasonography during a viable pregnancy: A rare case report. Medicine. 2024;103(9):E37334(1-8)$$$N$M$Y$$$20240712$$MD$CN$CN
240822801$24082280$1$I$$20240628$20240712$20240712$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455947$RANBAXY$Mu W, Zhang M, Hu G, Han Y, Mao X, Chen C, et al. Case report: Differential diagnosis of highly amplified anti-CD5 CAR T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma. Front Immunol. 2023;8 Dec;14:1280007(1-7)$17$YR$$M$Y$$$20240712$$HP$CN$CN
240822811$24082281$1$I$$20240628$20240712$20240712$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456065$RANBAXY$Klotzka A, Iwanczyk S, Ropacka-Lesiak M, Misan N, Lesiak M. Anthracycline-Induced Microcirculation disorders: AIM PILOT Study. Kardiol Pol. 2023;81:766-768$57$YR$$F$Y$$$20240712$$MD$PL$PL
240822821$24082282$1$I$$20240628$20240712$20240712$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456048$RANBAXY$Chabova CV. DRUG-INDUCED KIDNEY INJURY. aktuality v nefrologii. 2020;26(4):134-138$75$YR$$F$Y$$$20240712$$MD$CZ$CZ
240822831$24082283$1$I$$20240628$20240712$20240712$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456067$RANBAXY$Klotzka A, Iwanczyk S, Ropacka-Lesiak M, Misan N, Lesiak M. Anthracycline-Induced Microcirculation disorders: AIM PILOT Study. Kardiol Pol. 2023;81:766-768$59$YR$$F$Y$$$20240712$$MD$PL$PL
240822841$24082284$1$I$$20240628$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455908$RANBAXY$Deka A, Joseph E, Sharma N, Berhanu T, Kaplan J. Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature. J Psychiatr Pract. 2024;May; 30 (3):234-241$78$YR$$F$Y$$$20240712$$MD$US$US
240822851$24082285$1$I$$20240628$20240712$20240712$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456005$RANBAXY$Gao Q, Luo H. Successful diagnosis of asymptomatic choriocarcinoma by ultrasonography during a viable pregnancy: A rare case report. Medicine. 2024;103(9):E37334(1-8)$27$YR$$F$Y$$$20240712$$MD$CN$CN
240822861$24082286$1$I$$20240628$20240712$20240712$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456007$RANBAXY$Zhang J, Zhang R. Megalosplenia as an initial manifestation of multiple myeloma with a novel CYLD gene mutation: A case report and literature review. Medicine. 2024;103(14):E37624$65$YR$$F$Y$$$20240712$$HP$CN$CN
240822871$24082287$1$I$$20240628$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456080$RANBAXY$Malik T, Gordon B, Ramanathan R, Mcguire EL. A Tale of Broken Hearts: Cardiac Aspergillosis in an Immunocompromised Patient. Am J Respir Crit Care Med. 2024;207(0):A1801$27$YR$$M$Y$$$20240712$$HP$US$US
240822881$24082288$1$I$$20240709$20240712$20240712$PER$$US-JNJFOC-20240722881$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240822891$24082289$1$I$$20240628$20240712$20240712$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456051$RANBAXY$Chabova CV. DRUG-INDUCED KIDNEY INJURY. aktuality v nefrologii. 2020;26(4):134-138$33$YR$$F$Y$$$20240712$$MD$CZ$CZ
240822901$24082290$1$I$$20240629$20240712$20240712$EXP$$US-ROCHE-10000017265$ROCHE$$$$$F$Y$$$20240712$$CN$US$US
240822911$24082291$1$I$20240405$20240705$20240712$20240712$EXP$$JP-ROCHE-10000022466$ROCHE$$65$YR$E$M$Y$56.7$KG$20240712$$PH$JP$JP
240822921$24082292$1$I$20240501$20240704$20240712$20240712$EXP$GB-MHRA-MED-202405030516536190-FNSTD$GB-GE HEALTHCARE-2024CSU007648$GE HEALTHCARE$$46$YR$$$Y$$$20240712$$HP$GB$GB
240822932$24082293$2$F$20240627$20240712$20240712$20240718$EXP$$DE-EMD Serono-2024036964$EMD SERONO INC$$61$YR$A$M$Y$71$KG$20240718$$CN$DE$DE
240822941$24082294$1$I$20240601$20240710$20240712$20240712$EXP$$US-UCBSA-2024035245$UCB$$44$YR$$F$Y$$$20240712$$HP$US$US
240822951$24082295$1$I$$20240703$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106591$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240712$$CN$US$US
240822961$24082296$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110330$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240712$$HP$US$US
240822971$24082297$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110429$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240712$$CN$US$US
240822981$24082298$1$I$20240601$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110457$BRISTOL MYERS SQUIBB$$76$YR$E$$Y$$$20240712$$PH$US$US
240822991$24082299$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110477$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240712$$CN$US$US
240823002$24082300$2$F$$20240728$20240712$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110241$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240729$$MD$US$US
240823012$24082301$2$F$20240616$20240712$20240712$20240722$EXP$$BR-CELLTRION INC.-2022BR014625$CELLTRION$$$$$$Y$$$20240722$$CN$BR$BR
240823021$24082302$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110428$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240712$$CN$US$US
240823035$24082303$5$F$20240531$20240806$20240712$20240812$EXP$$FR-ABBVIE-5835624$ABBVIE$$61$YR$$M$Y$74$KG$20240812$$PH$FR$FR
240823041$24082304$1$I$$20240709$20240712$20240712$PER$$US-ALXN-202407USA000553US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240712$$CN$US$US
240823052$24082305$2$F$$20240711$20240712$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107399$BRISTOL MYERS SQUIBB$LeBlanc FR, Grier DD, Myers KC, Shimamura A, Pommert L. A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome. Pediatric Blood and Cancer. 2024;71(8):1-4. doi:10.1002/pbc.31137.$27$YR$A$M$Y$$$20240718$$HP$US$US
240823062$24082306$2$F$20240701$20240711$20240712$20240712$PER$$US-AMGEN-USASP2024137448$AMGEN$$62$YR$A$F$Y$$$20240712$$CN$US$US
240823081$24082308$1$I$$20240620$20240712$20240712$30DAY$$US-JNJFOC-20240678512$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$HP$US$US
240823091$24082309$1$I$$20240618$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002883$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240823101$24082310$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007245$ELI LILLY AND CO$$36$YR$A$$Y$$$20240712$$CN$US$US
240823112$24082311$2$F$20240706$20240826$20240712$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202407006794$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240829$$CN$US$US
240823121$24082312$1$I$$20240708$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005635$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240712$$CN$US$US
240823131$24082313$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006757$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240712$$HP$US$US
240823141$24082314$1$I$20240707$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006811$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240712$$CN$US$US
240823151$24082315$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007435$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240712$$CN$US$US
240823161$24082316$1$I$20240705$20240708$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005628$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240712$$CN$US$US
240823171$24082317$1$I$20240101$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005989$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240712$$CN$US$US
240823181$24082318$1$I$20240601$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006985$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240712$$CN$US$US
240823191$24082319$1$I$20231201$20240702$20240712$20240712$EXP$$JP-ALK-ABELLO A/S-2024AA001446$ALK-ABELLO$$$$$$Y$$$20240712$$HP$JP$JP
240823202$24082320$2$F$$20240913$20240712$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110556$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240916$$HP$US$US
240823211$24082321$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007568$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240712$$CN$US$US
240823231$24082323$1$I$20240629$20240703$20240712$20240712$PER$$US-RDY-SPO/USA/24/0009770$DR REDDYS$$54$YR$A$F$Y$$$20240712$$CN$US$US
240823241$24082324$1$I$$20240704$20240712$20240712$EXP$$US-NOVITIUMPHARMA-2024USNVP01245$NOVITIUM PHARMA$Maryam J. Syed.Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series.Neurocrit Care.03-OCT-2023;40:976-983$59$YR$A$F$Y$85$KG$20240712$$HP$US$US
240823252$24082325$2$F$$20240808$20240712$20240813$PER$$US-AMGEN-USASP2024137079$AMGEN$$35$YR$A$F$Y$$$20240813$$MD$US$US
240823261$24082326$1$I$20230601$20240627$20240712$20240712$EXP$$DE-AZURITY PHARMACEUTICALS, INC.-AZR202406-000072$AZURITY PHARMACEUTICALS$$$$$F$Y$2.94$KG$20240712$$MD$DE$DE
240823271$24082327$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110661$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240712$$HP$US$US
240823281$24082328$1$I$$20240710$20240712$20240712$PER$$US-ABBVIE-5836436$ABBVIE$$$$$$Y$$$20240712$$HP$US$US
240823292$24082329$2$F$20240701$20240712$20240712$20240715$PER$$US-AMGEN-USASP2024137899$AMGEN$$41$YR$A$F$Y$$$20240714$$CN$US$US
240823331$24082333$1$I$20231208$20240704$20240712$20240712$EXP$$JO-EMD Serono-2024004654$EMD SERONO INC$$35$YR$A$F$Y$$$20240712$$CN$JO$JO
240823342$24082334$2$F$$20240812$20240712$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002909$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
240823352$24082335$2$F$$20240514$20240712$20240916$PER$$US-ENDO USA, INC.-2024-002229$ENDO$$$$$M$Y$$$20240916$$$US$US
240823362$24082336$2$F$$20240528$20240712$20240805$PER$$US-ENDO USA, INC.-2024-002472$ENDO$$$$A$F$Y$$$20240805$$CN$US$US
240823371$24082337$1$I$$20230605$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003035$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240823384$24082338$4$F$$20240528$20240712$20240916$PER$$US-ENDO USA, INC.-2024-002463$ENDO$$$$$$Y$$$20240916$$CN$US$US
240823393$24082339$3$F$$20240528$20240712$20240917$PER$$US-ENDO USA, INC.-2024-002454$ENDO$$$$$F$Y$$$20240917$$CN$US$US
240823404$24082340$4$F$$20240521$20240712$20240917$PER$$US-ENDO USA, INC.-2024-002388$ENDO$$$$$F$Y$$$20240917$$CN$US$US
240823411$24082341$1$I$$20240528$20240712$20240712$PER$$US-ENDO USA, INC.-2024-002455$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240823424$24082342$4$F$$20240528$20240712$20240917$PER$$US-ENDO USA, INC.-2024-002464$ENDO$$$$$$Y$$$20240917$$CN$US$US
240823434$24082343$4$F$$20240528$20240712$20240917$PER$$US-ENDO USA, INC.-2024-002461$ENDO$$$$A$F$Y$$$20240917$$CN$US$US
240823442$24082344$2$F$$20240730$20240712$20240806$EXP$$JP-AMGEN-JPNSP2024133920$AMGEN$$$$$$Y$$$20240806$$MD$JP$JP
240823451$24082345$1$I$$20240704$20240712$20240712$EXP$$US-NOVITIUMPHARMA-2024USNVP01246$NOVITIUM PHARMA$Maryam J. Syed.Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series.Neurocrit Care.03-OCT-2023;40:976-983$26$YR$A$M$Y$76.5$KG$20240712$$HP$US$US
240823461$24082346$1$I$20240623$20240709$20240712$20240712$PER$$US-ALXN-202407USA000561US$ALEXION PHARMACEUTICALS$$67$YR$$F$Y$$$20240712$$CN$US$US
240823471$24082347$1$I$$20240705$20240712$20240712$EXP$$GB-JNJFOC-20240717104$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240712$$CN$GB$GB
240823483$24082348$3$F$20240606$20240923$20240712$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US056046$SANDOZ$$13$YR$$M$Y$$$20240926$$CN$US$US
240823492$24082349$2$F$$20230926$20240712$20240805$PER$$US-ENDO USA, INC.-2023-005308$ENDO$$$$$M$Y$$$20240805$$CN$US$US
240823501$24082350$1$I$$20231218$20240712$20240712$PER$$US-ENDO USA, INC.-2024-000037$ENDO$$$$$M$Y$$$20240712$$LW$US$US
240823511$24082351$1$I$$20231218$20240712$20240712$PER$$US-ENDO USA, INC.-2023-006351$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240823523$24082352$3$F$$20231218$20240712$20240917$PER$$US-ENDO USA, INC.-2023-006328$ENDO$$$$$M$Y$$$20240917$$CN$US$US
240823531$24082353$1$I$$20231218$20240712$20240712$PER$$US-ENDO USA, INC.-2024-000002$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240823541$24082354$1$I$$20230703$20240712$20240712$PER$$US-ENDO USA, INC.-2023-004406$ENDO$$$$$$Y$$$20240712$$CN$US$US
240823551$24082355$1$I$20240520$20240701$20240712$20240712$EXP$$PK-ROCHE-10000022502$ROCHE$$60$YR$A$M$Y$$$20240712$$CN$PK$PK
240823562$24082356$2$F$20240703$20240821$20240712$20240826$PER$$US-ROCHE-10000019369$ROCHE$$$$$$Y$$$20240826$$PH$US$US
240823571$24082357$1$I$20240601$20240710$20240712$20240712$PER$$US-ABBVIE-5835775$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240823581$24082358$1$I$$20240705$20240712$20240712$PER$$US-ROCHE-10000022428$ROCHE$$$$$F$Y$$$20240712$$CN$US$US
240823591$24082359$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137584$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240823602$24082360$2$F$20240703$20240805$20240712$20240812$EXP$$US-AMGEN-USASP2024136548$AMGEN$$60$YR$A$F$Y$45.125$KG$20240811$$CN$US$US
240823611$24082361$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024136313$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240823621$24082362$1$I$$20240704$20240712$20240712$EXP$$CN-AMGEN-CHNSP2024134281$AMGEN$Zhang P. Low-dose pegylated recombinant human granulocyte-colony stimulating factor as hematopoietic support for adjuvant chemotherapy in Chinese patients with breast cancer: An open-label, randomized, non-inferiority trial. British Journal of Clinical Pharmacology. 2024;1-9$$$$$Y$$$20240712$$HP$CN$CN
240823631$24082363$1$I$$20240702$20240712$20240712$EXP$$GR-Encube-000808$ENCUBE ETHICALS$Karmiris E, Chalkiadaki E, Tsiripidis K, Stavrakas P, Papakonstantinou E. An Atypical Case of Severe Toxicity, Anterior Chamber Inflammation, and Transient Subretinal Fluid Formation Induced by the Subconjunctival Injection of 5-FU. Ocul Immunol Inflamm. 2024 Jun 25:1-4. doi: 10.1080/09273948.2024.2369661. Epub ahead of print. PMID: 38916626.$40$YR$A$M$Y$$$20240711$$MD$GR$
240823641$24082364$1$I$$20240628$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456091$RANBAXY$Torelli VA, Ernest Jean R, Tran E. Rapidly Progressive Interstitial Lung Disease Due to Silicosis in an Otherwise Healthy Jeweler. Am J Respir Crit Care Med. 2024;209 (0):A5985$83$YR$$F$Y$$$20240712$$HP$US$US
240823652$24082365$2$F$$20240712$20240712$20240726$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456244$RANBAXY$Wong R, Neo A, Chua J. Unravelling the Unexplained: Cancer of Unknown Origin Presenting as Interstitial Lung Disease. Am J Respir Crit Care Med. 2024;209 (0):A2052$66$YR$$F$Y$$$20240726$$HP$BR$BR
240823661$24082366$1$I$20240618$20240629$20240712$20240712$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455165$RANBAXY$-. A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination with Chemotherapy with or without Tislelizumab in Subjects with HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA). -. -;-:-$75$YR$$M$Y$58$KG$20240712$$HP$CN$CN
240823671$24082367$1$I$$20240628$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456117$RANBAXY$Razia D, Saeed AI, Khokar A. A Flurry of Pulmonary Nodules: Recurrent Metastatic Pancreatic Cancer, or Just Mineral Oil. Am J Respir Crit Care Med. 2024;209 (0):A4823$77$YR$$M$Y$$$20240712$$HP$US$US
240823681$24082368$1$I$$20240628$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456201$RANBAXY$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. Rheumatol. 2024;63:1291-1296$68$YR$$M$Y$$$20240712$$HP$US$US
240823691$24082369$1$I$$20240628$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456227$RANBAXY$Grimm ZZ, Canter CJ. Gender-affirming Care via HRT and Difficult Anesthetization, a Critical Care Transport Consideration. Air Med J. 2024;43 (4):368$56$YR$$F$Y$$$20240712$$HP$US$US
240823701$24082370$1$I$$20240628$20240712$20240712$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456077$RANBAXY$Woron J, Siwek M. The use of sertraline and perazine as the cause of pneumonia in a patient suffering from chronic obstructive pulmonary disease. Psychiatria. 2024;3:19-21$67$YR$$F$Y$$$20240712$$HP$PL$PL
240823711$24082371$1$I$$20240628$20240712$20240712$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454675$RANBAXY$Magro CM, Kalomeris T, Shreve CR, Geyer JT, Patel SS. Subcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administration. Leuk Lymphoma. 2024;65 (5):638-646$61$YR$$F$Y$$$20240712$$HP$US$US
240823721$24082372$1$I$$20240628$20240712$20240712$EXP$$PS-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456209$RANBAXY$Arafat H, Khaldy M, AbuMunshar A, Zughayyer A. Hirsutism as the initial presentation of malignant ovarian Leydig cell tumor: A case report. Clin Case Rep. 2023;11:1-6$24$YR$$F$Y$65$KG$20240712$$HP$PS$PS
240823731$24082373$1$I$$20240708$20240712$20240712$PER$$US-ROCHE-10000021516$ROCHE$$$$A$F$Y$$$20240712$$CN$US$US
240823741$24082374$1$I$$20240704$20240712$20240712$EXP$$US-NOVITIUMPHARMA-2024USNVP01247$NOVITIUM PHARMA$Maryam J. Syed.Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series.Neurocrit Care.03-OCT-2023;40:976-983$45$YR$A$M$Y$65$KG$20240712$$HP$US$US
240823752$24082375$2$F$$20240717$20240712$20240724$PER$$US-ROCHE-10000022536$ROCHE$$74$YR$E$F$Y$$$20240724$$CN$US$US
240823771$24082377$1$I$$20240702$20240712$20240712$EXP$$US-APOTEX-2024AP007950$APOTEX$Contag CA, Studemeister L, Bogler Y, Cooper JD.. Q fever presenting as splenic infarct without endocarditis. IDCases. 2024;37: e02012:1-3$44$YR$$M$Y$$$20240712$$HP$US$US
240823782$24082378$2$F$20240619$20240813$20240712$20240816$EXP$$NVSC2024US141445$NOVARTIS$$12$YR$$F$Y$$$20240816$$MD$US$US
240823791$24082379$1$I$20240301$20240703$20240712$20240712$PER$$US-SA-2024SA199383$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240712$$HP$US$US
240823802$24082380$2$F$$20240708$20240712$20240717$EXP$$IN-TORRENT-00003577$TORRENT$$15$YR$T$M$Y$$$20240717$$MD$IN$IN
240823811$24082381$1$I$$20240710$20240712$20240712$PER$$US-ROCHE-10000024205$ROCHE$$$$$F$Y$$$20240712$$CN$US$US
240823821$24082382$1$I$20240703$20240706$20240712$20240712$EXP$$US-AstraZeneca-2024A156115$ASTRAZENECA$$28005$DY$$F$Y$$$20240712$$CN$US$
240823831$24082383$1$I$$20240710$20240712$20240712$PER$$US-ROCHE-RCA5088617$ROCHE$$68$YR$E$F$Y$$$20240712$$CN$US$US
240823841$24082384$1$I$$20240703$20240712$20240712$PER$$US-TEVA-VS-3217384$TEVA$$$$A$F$Y$$$20240712$$CN$US$US
240823851$24082385$1$I$$20240627$20240712$20240712$EXP$$GB-SA-2024SA201029$SANOFI AVENTIS$$$$$F$Y$$$20240712$$MD$GB$GB
240823871$24082387$1$I$20240501$20240701$20240712$20240712$EXP$$US-JNJFOC-20240705740$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240712$$MD$US$US
240823883$24082388$3$F$$20240718$20240712$20240824$PER$$US-ABBVIE-5832570$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
240823891$24082389$1$I$$20240711$20240712$20240712$PER$$US-JNJFOC-20240729462$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$HP$US$US
240823901$24082390$1$I$$20240709$20240712$20240712$PER$$US-ALXN-202407USA000564US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240823911$24082391$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006639$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240823921$24082392$1$I$$20240417$20240712$20240712$PER$$US-STERISCIENCE B.V.-2024-ST-000487$Steriscience PTE$Feeney L, Ripley K, Herre J, Yehya A. Early Onset Pancytopenia Post Heart Transplant: Calcineurin Inhibitor-Induced Thrombotic Microangiopathy versus Cytomegalovirus Infection. J-Heart-Lung-Transplant. 2024;43 (Suppl.) (4):S534 abstr. 1151$66$YR$$F$Y$$$20240712$$HP$US$US
240823931$24082393$1$I$20240710$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007158$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240712$$CN$US$US
240823941$24082394$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006974$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240712$$CN$US$US
240823951$24082395$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006882$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240712$$HP$US$US
240823961$24082396$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007224$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240712$$CN$US$US
240823971$24082397$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007007$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240712$$CN$US$US
240823991$24082399$1$I$20240601$20240702$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407002141$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240712$$CN$US$US
240824001$24082400$1$I$20240710$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006922$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240712$$CN$US$US
240824011$24082401$1$I$20240710$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006842$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240712$$CN$US$US
240824021$24082402$1$I$20240710$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007289$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240712$$CN$US$US
240824032$24082403$2$F$$20240711$20240712$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407006992$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240718$$CN$US$US
240824041$24082404$1$I$20240710$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007360$ELI LILLY AND CO$$$$$F$Y$$$20240712$$CN$US$US
240824051$24082405$1$I$$20240705$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007015$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240824061$24082406$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007354$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240712$$CN$US$US
240824071$24082407$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455436$RANBAXY$$41$YR$$F$Y$$$20240712$$MD$CA$CA
240824081$24082408$1$I$$20230621$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003896$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240824091$24082409$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455547$RANBAXY$$43$YR$$F$Y$$$20240712$$MD$CA$CA
240824101$24082410$1$I$$20230607$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003056$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240824111$24082411$1$I$$20240501$20240712$20240712$PER$$US-ENDO USA, INC.-2024-002069$ENDO$$$$$$Y$$$20240712$$CN$US$US
240824121$24082412$1$I$$20230609$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003405$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240824131$24082413$1$I$$20240304$20240712$20240712$PER$$US-ENDO PHARMACEUTICALS INC-2024-001135$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240824141$24082414$1$I$$20230629$20240712$20240712$PER$$US-ENDO USA, INC.-2023-004073$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240824151$24082415$1$I$$20230620$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003746$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240824161$24082416$1$I$20240401$20240703$20240712$20240712$EXP$$ES-AUROBINDO-AUR-APL-2024-033301$AUROBINDO$$29$YR$$F$Y$$$20240712$$MD$ES$ES
240824171$24082417$1$I$$20240704$20240712$20240712$EXP$$US-NOVITIUMPHARMA-2024USNVP01248$NOVITIUM PHARMA$Maryam J. Syed.Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series.Neurocrit Care.03-OCT-2023;40:976-983$68$YR$E$M$Y$60$KG$20240712$$HP$US$US
240824181$24082418$1$I$$20230927$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2023US039861$SANDOZ$$$$$M$Y$$$20240712$$MD$US$US
240824201$24082420$1$I$20200211$20240710$20240712$20240712$EXP$$ES-SANDOZ INC.-NVSC2020ES173510$SANDOZ$$58$YR$$M$Y$$$20240712$$MD$ES$ES
240824211$24082421$1$I$20240618$20240702$20240712$20240712$PER$$US-ROCHE-10000014755$ROCHE$$$$$F$Y$$$20240712$$MD$US$US
240824221$24082422$1$I$20160101$20240703$20240712$20240712$EXP$$DE-AUROBINDO-AUR-APL-2024-033060$AUROBINDO$$$$A$M$Y$$$20240712$$CN$DE$DE
240824231$24082423$1$I$$20240705$20240712$20240712$EXP$$US-SA-2024SA201014$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240712$$MD$US$US
240824251$24082425$1$I$$20240705$20240712$20240712$EXP$$US-SA-2024SA202012$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240712$$MD$US$US
240824261$24082426$1$I$$20240710$20240712$20240712$EXP$$ZA-ABBVIE-5836502$ABBVIE$$77$YR$$F$Y$$$20240712$$CN$ZA$ZA
240824271$24082427$1$I$20240425$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033573$AUROBINDO$$29$YR$$$Y$80$KG$20240712$$CN$GB$GB
240824281$24082428$1$I$20240501$20240705$20240712$20240712$EXP$$US-SA-2024SA202768$SANOFI AVENTIS$$61$YR$A$M$Y$70$KG$20240712$$MD$US$US
240824291$24082429$1$I$20240701$20240705$20240712$20240712$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159068$JIANGSU HANSOH PHARMACEUTICAL$$70$YR$$M$Y$70$KG$20240712$$MD$CN$CN
240824301$24082430$1$I$20240708$20240709$20240712$20240712$EXP$$GB-SANDOZ INC.-NVSC2022GB239614$SANDOZ$$81$YR$$M$Y$$$20240712$$CN$GB$GB
240824313$24082431$3$F$20240505$20240705$20240712$20240826$PER$$US-SA-2024SA202139$SANOFI AVENTIS$$74$YR$E$F$Y$50$KG$20240826$$MD$US$US
240824321$24082432$1$I$20240621$20240709$20240712$20240712$EXP$$GB-ABBVIE-5825995$ABBVIE$$71$YR$$F$Y$$$20240712$$CN$GB$GB
240824331$24082433$1$I$20240701$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137647$AMGEN$$76$YR$E$$Y$$$20240712$$CN$US$US
240824341$24082434$1$I$$20240708$20240712$20240712$EXP$$US-ABBVIE-5832843$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240824351$24082435$1$I$20221117$20240704$20240712$20240712$EXP$$FR-CELLTRION INC.-2024FR016518$CELLTRION$$$$$$Y$$$20240712$$MD$FR$FR
240824361$24082436$1$I$20240629$20240706$20240712$20240712$EXP$$EG-AMGEN-EGYSP2024130633$AMGEN$$31$YR$A$M$Y$$$20240712$$MD$EG$EG
240824371$24082437$1$I$20240201$20240710$20240712$20240712$EXP$$EG-SANDOZ INC.-SDZ2024EG007127$SANDOZ$$16$YR$$M$Y$38$KG$20240712$$CN$EG$EG
240824381$24082438$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5833835$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240824391$24082439$1$I$20240101$20240709$20240712$20240712$EXP$$US-ABBVIE-5669939$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240824401$24082440$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5833515$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240824411$24082441$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5835110$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240824421$24082442$1$I$20240622$20240705$20240712$20240712$EXP$$CN-ROCHE-10000019283$ROCHE$$48$YR$A$M$Y$50$KG$20240712$$HP$CN$CN
240824431$24082443$1$I$20240101$20240710$20240712$20240712$EXP$$CA-ABBVIE-5836758$ABBVIE$$61$YR$$M$Y$$$20240712$$CN$CA$CA
240824441$24082444$1$I$$20240703$20240712$20240712$PER$$US-BIOGEN-2024BI01272376$BIOGEN$$$$$M$Y$$$20240712$$CN$US$US
240824451$24082445$1$I$$20240510$20240712$20240712$PER$$US-STERISCIENCE B.V.-2024-ST-000655$Steriscience PTE$Mehrabyan A, Traub RE.. Retrospective review of patients with myasthenia gravis switched from plasma exchange therapy to efgartigimod treatment.. Muscle-Nerve. 2024;69 (4):467-471$71$YR$$F$Y$90$KG$20240712$$MD$US$US
240824461$24082446$1$I$$20240515$20240712$20240712$PER$$US-STERISCIENCE B.V.-2024-ST-000687$Steriscience PTE$Noree W, Rodsom K, Kookanok C, Thiravetyan B, Jariyayothin I, Tantisattamo E. ZERO-A-B-DR MISMATCHED ANTIGEN KIDNEY TRANSPLANTATION: PERFECT MATCHED BUT IMPERFECT OUTCOMES. Am-J-Kidney-Dis. 2024;83 (Suppl.2)(4):S147 abstr. 44 77 4 4 77 477.$26$YR$$F$Y$$$20240712$$HP$US$US
240824471$24082447$1$I$$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033608$AUROBINDO$$$$$M$Y$$$20240712$$CN$GB$GB
240824481$24082448$1$I$20230511$20240703$20240712$20240712$EXP$ES-AEMPS-1393984$ES-TEVA-VS-3217065$TEVA$$49$YR$$F$Y$46.9$KG$20240712$$MD$ES$ES
240824491$24082449$1$I$$20240708$20240712$20240712$EXP$$US-ABBVIE-5834195$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240824501$24082450$1$I$$20240704$20240712$20240712$EXP$$US-NOVITIUMPHARMA-2024USNVP01249$NOVITIUM PHARMA$Maryam J. Syed.Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series.Neurocrit Care.03-OCT-2023;40:976-983$70$YR$E$M$Y$61.8$KG$20240712$$HP$US$US
240824511$24082451$1$I$20240313$20240701$20240712$20240712$EXP$$EG-ROCHE-10000020635$ROCHE$$23$YR$A$M$Y$$$20240712$$CN$EG$EG
240824521$24082452$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456010$RANBAXY$$43$YR$$F$Y$$$20240712$$HP$CA$CA
240824531$24082453$1$I$$20240619$20240712$20240712$PER$$US-STERISCIENCE B.V.-2024-ST-000924$Steriscience PTE$Patel L, Lyons J, Scarola D, Warrior K. Mycophenolate-induced Colitis in Lung Transplant Recipients.. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster).$$$$$Y$$$20240712$$HP$US$US
240824541$24082454$1$I$$20240620$20240712$20240712$PER$$US-STERISCIENCE B.V.-2024-ST-000935$Steriscience PTE$Zaidi W, Saeed AI, Lundquist N, Nelson AR, Razia D, Lee R, et al.. Bronchoscopic Debridement of Endobronchial Rhizopus With 1.1 Mm Cryoprobe in Lung Transplant Recipient.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$67$YR$$M$Y$$$20240712$$HP$US$US
240824551$24082455$1$I$20240101$20240710$20240712$20240712$EXP$$JP-SANDOZ INC.-SDZ2024JP064537$SANDOZ$$87$YR$$F$Y$$$20240712$$CN$JP$JP
240824561$24082456$1$I$20240504$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033340$AUROBINDO$$63$YR$$F$Y$$$20240712$$HP$GB$GB
240824571$24082457$1$I$20240507$20240708$20240712$20240712$EXP$$US-BEIGENE-BGN-2024-010691$BEIGENE$$$$$$Y$$$20240712$$HP$US$US
240824581$24082458$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110374$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240712$$HP$US$US
240824592$24082459$2$F$20240622$20240711$20240712$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109907$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$62.3$KG$20240715$$PH$US$US
240824601$24082460$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110327$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240712$$HP$US$US
240824611$24082461$1$I$$20240709$20240712$20240712$PER$$US-ALXN-202407USA000584US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240824621$24082462$1$I$$20240708$20240712$20240712$PER$$US-BIOGEN-2024BI01272855$BIOGEN$$$$$$Y$$$20240712$$PH$US$US
240824631$24082463$1$I$20240705$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109922$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$105.33$KG$20240712$$HP$US$US
240824641$24082464$1$I$20210514$20240628$20240712$20240712$EXP$FR-AFSSAPS-PC2024000348$FR-SAMSUNG BIOEPIS-SB-2024-20262$SAMSUNG BIOEPIS$$36$YR$A$F$Y$$$20240712$$MD$FR$FR
240824651$24082465$1$I$20150601$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033542$AUROBINDO$$38$YR$$F$Y$$$20240712$$CN$GB$GB
240824661$24082466$1$I$20240615$20240704$20240712$20240712$EXP$$JO-EMD Serono-2024037033$EMD SERONO INC$$0$YR$N$F$Y$$$20240712$$CN$JO$JO
240824671$24082467$1$I$20240215$20240710$20240712$20240712$EXP$$US-BIOVITRUM-2024-US-009723$BIOVITRUM$$82$YR$$M$Y$$$20240712$$HP$US$US
240824681$24082468$1$I$$20240706$20240712$20240712$EXP$$CO-GSK-CO2024AMR084724$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$CO$CO
240824691$24082469$1$I$$20240710$20240712$20240712$PER$$NVSC2024US143904$NOVARTIS$$67$YR$$M$Y$$$20240712$$CN$US$US
240824703$24082470$3$F$20240709$20240726$20240712$20240729$PER$$NVSC2024US144090$NOVARTIS$$63$YR$$M$Y$$$20240729$$HP$US$US
240824712$24082471$2$F$20240612$20240710$20240712$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002870$ACADIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240731$$CN$US$US
240824721$24082472$1$I$20240101$20240701$20240712$20240712$PER$$US-ROCHE-10000020688$ROCHE$$$$$F$Y$$$20240712$$MD$US$US
240824731$24082473$1$I$20220427$20240628$20240712$20240712$EXP$FR-AFSSAPS-PC2024000350$FR-SAMSUNG BIOEPIS-SB-2024-20254$SAMSUNG BIOEPIS$$43$YR$A$M$Y$$$20240712$$MD$FR$FR
240824741$24082474$1$I$20210713$20240628$20240712$20240712$EXP$FR-AFSSAPS-PC2024000351$FR-SAMSUNG BIOEPIS-SB-2024-20257$SAMSUNG BIOEPIS$$50$YR$A$M$Y$$$20240712$$MD$FR$FR
240824751$24082475$1$I$20210830$20240628$20240712$20240712$EXP$FR-AFSSAPS-PC2024000352$FR-SAMSUNG BIOEPIS-SB-2024-20255$SAMSUNG BIOEPIS$$25$YR$A$M$Y$$$20240712$$MD$FR$FR
240824761$24082476$1$I$20180418$20240628$20240712$20240712$EXP$FR-AFSSAPS-PC2024000349$FR-SAMSUNG BIOEPIS-SB-2024-20231$SAMSUNG BIOEPIS$$49$YR$A$F$Y$$$20240712$$MD$FR$FR
240824771$24082477$1$I$$20240702$20240712$20240712$EXP$$US-AstraZeneca-2024A153083$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$US$
240824781$24082478$1$I$20240514$20240711$20240712$20240712$EXP$FR-AFSSAPS-BX2024001210$FR-ROCHE-10000024177$ROCHE$$34$YR$A$M$Y$57.7$KG$20240712$$MD$FR$FR
240824791$24082479$1$I$$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033655$AUROBINDO$$$$$F$Y$$$20240712$$PH$GB$GB
240824801$24082480$1$I$20240705$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024136774$AMGEN$$57$YR$A$F$Y$$$20240712$$CN$US$US
240824811$24082481$1$I$20240416$20240705$20240712$20240712$EXP$$GB-AstraZeneca-2024A154012$ASTRAZENECA$$51$YR$$F$Y$151$KG$20240712$$MD$GB$
240824821$24082482$1$I$$20240704$20240712$20240712$EXP$$US-NOVITIUMPHARMA-2024USNVP01250$NOVITIUM PHARMA$Maryam J. Syed.Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series.Neurocrit Care.03-OCT-2023;40:976-983$61$YR$A$M$Y$83$KG$20240712$$HP$US$US
240824831$24082483$1$I$20230101$20240708$20240712$20240712$EXP$DK-DKMA-30734085$DK-AMGEN-DNKSP2024135956$AMGEN$$70$YR$E$F$Y$$$20240712$$MD$DK$DK
240824842$24082484$2$F$20240709$20240726$20240712$20240731$PER$$US-AMGEN-USASP2024137773$AMGEN$$47$YR$A$F$Y$$$20240731$$CN$US$US
240824851$24082485$1$I$$20240710$20240712$20240712$EXP$$CN-TAKEDA-2024TUS070716$TAKEDA$$$$$M$Y$$$20240712$$CN$CN$CN
240824861$24082486$1$I$20240708$20240710$20240712$20240712$EXP$$CN-TAKEDA-2024TUS070704$TAKEDA$$74$YR$$M$Y$$$20240712$$CN$CN$CN
240824871$24082487$1$I$$20240710$20240712$20240712$EXP$$US-ROCHE-10000023244$ROCHE$$$$A$M$Y$113.39$KG$20240712$$CN$US$US
240824881$24082488$1$I$20240322$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405161416520420-JKQYG$GB-AMAROX PHARMA-AMR2024GB02176$HETERO$$44$YR$$M$Y$$$20240712$$CN$GB$GB
240824891$24082489$1$I$$20240710$20240712$20240712$EXP$$CA-SANDOZ INC.-SDZ2024CA064408$SANDOZ$$68$YR$$F$Y$$$20240712$$CN$CA$CA
240824901$24082490$1$I$20240425$20240705$20240712$20240712$EXP$ES-AEMPS-1530324$ES-ROCHE-10000017709$ROCHE$$60$YR$A$M$Y$$$20240712$$PH$ES$ES
240824911$24082491$1$I$20240421$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033575$AUROBINDO$$49$YR$$F$Y$75$KG$20240712$$CN$GB$GB
240824921$24082492$1$I$20240520$20240702$20240712$20240712$EXP$$US-GSK-US2024AMR082724$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240712$$CN$US$US
240824931$24082493$1$I$20240101$20240703$20240712$20240712$EXP$$US-INTERCEPT-PM2024001360$INTERCEPT PHARMACEUTICALS$$$$$F$Y$106.58$KG$20240712$$CN$US$US
240824942$24082494$2$F$$20240712$20240712$20240717$PER$$US-ROCHE-10000023179$ROCHE$Chowdhury R, Neychev V. Localized Colitis Associated With Cholecystectomy in Multiple Sclerosis Patient Treated With Ocrelizumab. Cureus. 2024-May-30;16 (5): doi:10.7759/cureus.61353.$47$YR$A$F$Y$$$20240717$$HP$US$US
240824951$24082495$1$I$$20240702$20240712$20240712$EXP$$US-INTERCEPT-PM2024001385$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240712$$HP$US$US
240824961$24082496$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456040$RANBAXY$$$$$F$Y$$$20240712$$MD$CA$CA
240824971$24082497$1$I$20240709$20240709$20240712$20240712$EXP$$IE-AMGEN-IRLSL2024136123$AMGEN$$89$YR$E$M$Y$$$20240712$$CN$IE$IE
240824981$24082498$1$I$20240101$20240701$20240712$20240712$PER$$US-TEVA-VS-3216193$TEVA$$75$YR$$F$Y$$$20240712$$CN$US$US
240824992$24082499$2$F$20240101$20240913$20240712$20240920$EXP$$JP-009507513-2407JPN000778J$MERCK$$8$DEC$$M$Y$$$20240920$$MD$JP$JP
240825001$24082500$1$I$20230101$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024135584$AMGEN$$9$YR$C$M$Y$$$20240712$$CN$US$US
240825011$24082501$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07060$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825021$24082502$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07037$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825031$24082503$1$I$$20240703$20240712$20240712$EXP$$US-NOVITIUMPHARMA-2024USNVP01221$NOVITIUM PHARMA$Marlise R. Luskin.A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL and Blast Phase CML in Adults.Blood.02-NOV-2023;142:965$57$YR$A$F$Y$$$20240712$$HP$US$US
240825041$24082504$1$I$$20240701$20240712$20240712$EXP$$US-ROCHE-10000020608$ROCHE$$19$YR$A$F$Y$$$20240712$$MD$US$US
240825051$24082505$1$I$20231209$20240709$20240712$20240712$EXP$$PH-009507513-2407PHL005381$MERCK$$62$YR$$F$Y$$$20240712$$HP$PH$PH
240825061$24082506$1$I$$20240709$20240712$20240712$EXP$$US-GSK-US2024AMR085609$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$HP$US$US
240825071$24082507$1$I$20210709$20240708$20240712$20240712$EXP$$ES-ABBVIE-5833821$ABBVIE$$40$YR$$M$Y$$$20240712$$MD$ES$ES
240825092$24082509$2$F$$20240711$20240712$20240726$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456112$RANBAXY$$50$YR$$F$Y$$$20240726$$MD$CA$CA
240825101$24082510$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456018$RANBAXY$$$$$F$Y$$$20240712$$MD$CA$CA
240825111$24082511$1$I$$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406291149288680-KLQWZ$GB-CIPLA LTD.-2024GB07001$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825121$24082512$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07059$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825131$24082513$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07002$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825141$24082514$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB06999$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825151$24082515$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07063$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825161$24082516$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07090$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825171$24082517$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07005$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825181$24082518$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB06998$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825191$24082519$1$I$20240528$20240702$20240712$20240712$EXP$DK-DKMA-30733584$DK-BEH-2024174858$CSL BEHRING$$72$YR$E$F$Y$$$20240712$$MD$DK$DK
240825202$24082520$2$F$$20240708$20240712$20240722$EXP$$GB-CIPLA LTD.-2024GB07056$CIPLA$$$$$$Y$$$20240722$$CN$GB$GB
240825211$24082521$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07025$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825221$24082522$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07021$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825232$24082523$2$F$$20240708$20240712$20240722$EXP$$GB-CIPLA LTD.-2024GB07078$CIPLA$$$$$$Y$$$20240722$$CN$GB$GB
240825241$24082524$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07081$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825251$24082525$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07040$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825261$24082526$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07013$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825271$24082527$1$I$$20240704$20240712$20240712$EXP$GB-MHRA-MED-202405030841217640-RCGSB$GB-ADVANZ PHARMA-202407005541$ADVANZ PHARMA$$$$$$Y$$$20240712$$HP$GB$GB
240825281$24082528$1$I$$20240709$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110303$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240712$$CN$US$US
240825291$24082529$1$I$20240501$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110414$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240712$$CN$US$US
240825301$24082530$1$I$$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110538$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240712$$CN$US$US
240825312$24082531$2$F$$20240715$20240712$20240720$EXP$$CA-ABBVIE-5833837$ABBVIE$$$$A$F$Y$$$20240720$$CN$CA$CA
240825321$24082532$1$I$$20240619$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002661$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240825331$24082533$1$I$20240630$20240709$20240712$20240712$EXP$CZ-CZSUKL-24001964$CZ-ORGANON-O2407CZE000916$ORGANON$$3$YR$$F$Y$12$KG$20240712$$CN$CZ$CZ
240825341$24082534$1$I$$20240704$20240712$20240712$EXP$$IT-CELLTRION INC.-2024IT016544$CELLTRION$$$$$$Y$$$20240712$$MD$IT$IT
240825351$24082535$1$I$20231025$20240709$20240712$20240712$EXP$AT-BASGAGES-2024-005011$AT-ORGANON-O2407AUT000924$ORGANON$$75$YR$$M$Y$90$KG$20240712$$MD$AT$AT
240825361$24082536$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456014$RANBAXY$$$$$F$Y$$$20240712$$HP$CA$CA
240825371$24082537$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456013$RANBAXY$$44$YR$$F$Y$$$20240712$$HP$CA$CA
240825383$24082538$3$F$20240709$20240729$20240712$20240731$PER$$US-AMGEN-USASP2024136606$AMGEN$$70$YR$E$M$Y$$$20240731$$HP$US$US
240825391$24082539$1$I$$20240614$20240712$20240712$PER$$US-JNJFOC-20240703931$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$MD$US$US
240825401$24082540$1$I$$20240705$20240712$20240712$EXP$$ZA-AstraZeneca-2024A155700$ASTRAZENECA$$66$YR$$M$Y$$$20240712$$CN$ZA$
240825415$24082541$5$F$20240606$20240822$20240712$20240828$EXP$$US-ROCHE-10000023065$ROCHE$$50$YR$A$M$Y$108.86$KG$20240828$$CN$US$US
240825421$24082542$1$I$20240616$20240620$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002920$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240712$$CN$US$US
240825433$24082543$3$F$20230101$20240726$20240712$20240802$PER$$US-AMGEN-USASP2024135390$AMGEN$$$$$M$Y$$$20240802$$LW$US$US
240825442$24082544$2$F$20240707$20240715$20240712$20240722$PER$$US-AMGEN-USASP2024135589$AMGEN$$68$YR$E$F$Y$$$20240721$$CN$US$US
240825451$24082545$1$I$20240701$20240710$20240712$20240712$PER$$US-ABBVIE-5836387$ABBVIE$$$$A$F$Y$$$20240712$$MD$US$US
240825461$24082546$1$I$$20240619$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002731$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240825471$24082547$1$I$$20240620$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050395$TOLMAR$$$$$M$Y$$$20240712$$CN$CA$CA
240825481$24082548$1$I$20240501$20240708$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050392$TOLMAR$$87$YR$$M$Y$$$20240712$$CN$CA$CA
240825491$24082549$1$I$20240401$20240620$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050396$TOLMAR$$69$YR$$M$Y$$$20240712$$CN$CA$CA
240825501$24082550$1$I$20240620$20240620$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050421$TOLMAR$$79$YR$$M$Y$$$20240712$$CN$CA$CA
240825511$24082551$1$I$$20240705$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050400$TOLMAR$$$$$M$Y$$$20240712$$CN$CA$CA
240825521$24082552$1$I$20240620$20240620$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050398$TOLMAR$$76$YR$$M$Y$$$20240712$$CN$CA$CA
240825531$24082553$1$I$20240620$20240704$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050424$TOLMAR$$79$YR$$M$Y$$$20240712$$CN$CA$CA
240825541$24082554$1$I$$20240620$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050432$TOLMAR$$$$$M$Y$$$20240712$$CN$CA$CA
240825551$24082555$1$I$$20240703$20240712$20240712$EXP$$US-NOVITIUMPHARMA-2024USNVP01222$NOVITIUM PHARMA$Marlise R. Luskin.A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL and Blast Phase CML in Adults.Blood.02-NOV-2023;142:965$65$YR$E$M$Y$$$20240712$$HP$US$US
240825561$24082556$1$I$$20240620$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050437$TOLMAR$$$$$M$Y$$$20240712$$CN$CA$CA
240825572$24082557$2$F$$20240715$20240712$20240805$PER$$CA-TOLMAR, INC.-24CA050438$TOLMAR$$$$$M$Y$$$20240805$$CN$CA$CA
240825581$24082558$1$I$20240620$20240620$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050440$TOLMAR$$65$YR$$M$Y$$$20240712$$CN$CA$CA
240825601$24082560$1$I$20240620$20240620$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050449$TOLMAR$$72$YR$$M$Y$$$20240712$$CN$CA$CA
240825611$24082561$1$I$20230726$20240703$20240712$20240712$EXP$$PL-AUROBINDO-AUR-APL-2024-033070$AUROBINDO$$70$YR$$F$Y$108$KG$20240712$$MD$PL$PL
240825622$24082562$2$F$$20240709$20240712$20240716$PER$$US-ALXN-202407USA000581US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
240825632$24082563$2$F$$20240724$20240712$20240806$EXP$$JP-AMGEN-JPNSP2024135847$AMGEN$$$$$$Y$$$20240805$$PH$JP$JP
240825641$24082564$1$I$$20240711$20240712$20240712$PER$$US-ROCHE-10000024514$ROCHE$$61$YR$A$M$Y$$$20240712$$CN$US$US
240825651$24082565$1$I$$20240628$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB06973$CIPLA$$$$$$Y$$$20240712$$HP$GB$GB
240825662$24082566$2$F$$20240718$20240712$20240725$EXP$$US-ABBVIE-5833975$ABBVIE$$$$$F$Y$58.967$KG$20240725$$CN$US$US
240825671$24082567$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456069$RANBAXY$$73$YR$$F$Y$$$20240712$$CN$CA$CA
240825681$24082568$1$I$$20240703$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033124$AUROBINDO$$79$YR$$$Y$$$20240712$$PH$GB$GB
240825691$24082569$1$I$$20240705$20240712$20240712$EXP$$CN-ROCHE-10000002801$ROCHE$Wei R, Wu Y, Jiang S, Zhang A, Zhang L, Liu L, et al. Efficacy and safety of Orelabrutinib-based regimens in diffuse large B-cell lymphoma: a single-center retrospective analysis.. Clinical and Experimental Medicine. 2023;23 (8):4609-21. doi:10.1007/s10238-023-01231-w.$$$$$Y$$$20240712$$HP$CN$CN
240825702$24082570$2$F$$20240711$20240712$20240726$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455803$RANBAXY$$$$$F$Y$$$20240726$$HP$CA$CA
240825711$24082571$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455590$RANBAXY$$44$YR$$F$Y$$$20240712$$HP$CA$CA
240825722$24082572$2$F$$20240711$20240712$20240726$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455796$RANBAXY$$44$YR$$F$Y$$$20240726$$MD$CA$CA
240825731$24082573$1$I$$20240704$20240712$20240712$EXP$$IR-NOVITIUMPHARMA-2024IRNVP01235$NOVITIUM PHARMA$Shirin Shamel.Acyclovir extravasation in a newborn: a case report.Journal of Medical Case Reports.07-JUN-2024;18(1):271$$$N$F$Y$$$20240712$$HP$IR$IR
240825742$24082574$2$F$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455601$RANBAXY$$48$YR$$F$Y$$$20240712$$HP$CA$CA
240825751$24082575$1$I$$20240703$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456016$RANBAXY$$53$YR$$M$Y$$$20240712$$HP$CA$CA
240825761$24082576$1$I$20220915$20240705$20240712$20240712$EXP$$US-TAKEDA-2022TUS066118$TAKEDA$$57$YR$$F$Y$$$20240712$$MD$US$US
240825771$24082577$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07015$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825781$24082578$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07050$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240825791$24082579$1$I$20240101$20240709$20240712$20240712$PER$$US-ROCHE-10000022039$ROCHE$$5$YR$C$M$Y$$$20240712$$HP$US$US
240825801$24082580$1$I$20240210$20240628$20240712$20240712$EXP$$SE-CIPLA LTD.-2024SE06940$CIPLA$$$$$$Y$$$20240712$$HP$SE$SE
240825812$24082581$2$F$$20240723$20240712$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407001590$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240730$$CN$US$US
240825821$24082582$1$I$$20240705$20240712$20240712$EXP$$DE-ROCHE-10000005988$ROCHE$Goerdt L, Schnaubelt R, Tiefenbacher U, Bruck V, Bauer L, Dinges S, et al. Acute and Long-Term Toxicity after Planned Intraoperative Boost and Whole Breast Irradiation in High-Risk Patients with Breast Cancer-Results from the Targeted Intraoperative Radiotherapy Boost Quality Registry (TARGIT BQR). Cancers. 2024-Jun;16 (11):1-16. doi:10.3390/cancers16112067.$$$$$Y$$$20240712$$HP$DE$DE
240825831$24082583$1$I$20240710$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007002$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240712$$CN$US$US
240825841$24082584$1$I$$20240711$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007861$ELI LILLY AND CO$$$$$F$Y$$$20240712$$CN$US$US
240825851$24082585$1$I$20240101$20240710$20240712$20240712$PER$$US-JNJFOC-20240726917$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240712$$HP$US$US
240825861$24082586$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834636$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240825871$24082587$1$I$$20240709$20240712$20240712$EXP$$CA-TAKEDA-2024TUS070548$TAKEDA$$43$YR$$F$Y$$$20240712$$HP$CA$CA
240825881$24082588$1$I$20090301$20240703$20240712$20240712$EXP$$AU-TAKEDA-2024TUS069779$TAKEDA$$47$YR$$F$Y$$$20240712$$MD$AU$AU
240825891$24082589$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033038$AUROBINDO$Al-Moussally F, Thompson BM, Masarweh OM, Shah N, Gaudi S, Restrepo J. Atorvastatin-Associated Eosinophilic Spongiosis: A Case Report and a Relevant Literature Review of Dermatological Manifestations. Cureus. 2024;16(5):e61071$73$YR$$M$Y$$$20240712$$MD$US$US
240825901$24082590$1$I$20230302$20240628$20240712$20240712$EXP$IT-MINISAL02-983967$IT-SAMSUNG BIOEPIS-SB-2024-20330$SAMSUNG BIOEPIS$$31$YR$A$F$Y$$$20240712$$MD$IT$IT
240825911$24082591$1$I$20240403$20240628$20240712$20240712$EXP$ES-AEMPS-1516665$ES-SAMSUNG BIOEPIS-SB-2024-20280$SAMSUNG BIOEPIS$$43$YR$A$M$Y$$$20240712$$MD$ES$ES
240825932$24082593$2$F$$20240628$20240712$20240718$EXP$$FR-SAMSUNG BIOEPIS-SB-2024-20348$SAMSUNG BIOEPIS$Sztejkowski C, Scherlinger M. Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event. Rheumatology. 2024;63:E185-E187. doi:10.1093/rheumatology/kead672$52$YR$A$F$Y$$$20240718$$HP$FR$FR
240825942$24082594$2$F$20240707$20240806$20240712$20240808$EXP$$JP-TAKEDA-2024TJP010369$TAKEDA$$43$YR$$M$Y$$$20240808$$PH$JP$JP
240825951$24082595$1$I$$20240710$20240712$20240712$EXP$$BE-ABBVIE-5836631$ABBVIE$$$$E$M$Y$$$20240712$$HP$BE$BE
240825962$24082596$2$F$$20240807$20240712$20240809$PER$$US-AMGEN-USASP2024137768$AMGEN$$$$$F$Y$$$20240809$$HP$US$US
240825971$24082597$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455801$RANBAXY$$56$YR$$F$Y$43$KG$20240712$$HP$CA$CA
240825981$24082598$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455812$RANBAXY$$55$YR$$M$Y$$$20240712$$PH$CA$CA
240825991$24082599$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455816$RANBAXY$$64$YR$$M$Y$57$KG$20240712$$HP$CA$CA
240826001$24082600$1$I$20231201$20240126$20240712$20240712$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00122$TARO$$$$$$Y$$$20240712$$CN$US$US
240826013$24082601$3$F$20240201$20240912$20240712$20240913$EXP$$NVSC2024GB093792$NOVARTIS$$43$YR$$F$Y$$$20240913$$CN$GB$GB
240826021$24082602$1$I$20240405$20240708$20240712$20240712$EXP$ES-AEMPS-1541918$ES-UCBSA-2024034452$UCB$$50$YR$$M$Y$$$20240712$$PH$ES$ES
240826031$24082603$1$I$$20240705$20240712$20240712$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-096546$REGENERON$$70$YR$$M$Y$$$20240712$$CN$CA$CA
240826043$24082604$3$F$20230101$20240916$20240712$20240925$EXP$$US-INSMED, INC.-2023-03824-US$INSMED$$$$$F$Y$$$20240925$$CN$US$US
240826051$24082605$1$I$$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033379$AUROBINDO$$$$$M$Y$$$20240712$$HP$GB$GB
240826061$24082606$1$I$$20240705$20240712$20240712$PER$$US-AstraZeneca-2024A156217$ASTRAZENECA$$$$$$Y$$$20240712$$CN$US$
240826071$24082607$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455806$RANBAXY$$52$YR$$F$Y$$$20240712$$HP$CA$CA
240826081$24082608$1$I$20231107$20240703$20240712$20240712$EXP$$JP-ROCHE-3537710$ROCHE$$58$YR$A$M$Y$78.7$KG$20240712$$MD$JP$JP
240826092$24082609$2$F$$20240711$20240712$20240726$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456009$RANBAXY$$52$YR$$F$Y$$$20240726$$CN$CA$CA
240826101$24082610$1$I$$20240629$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455779$RANBAXY$$40$YR$$F$Y$$$20240712$$MD$CA$CA
240826111$24082611$1$I$20240629$20240704$20240712$20240712$EXP$$ES-AUROBINDO-AUR-APL-2024-033375$AUROBINDO$$26$YR$$F$Y$$$20240712$$MD$ES$ES
240826121$24082612$1$I$$20240708$20240712$20240712$EXP$$US-JNJFOC-20240721966$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240712$$CN$US$US
240826131$24082613$1$I$$20240711$20240712$20240712$EXP$$US-JNJFOC-20240730948$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240712$$HP$US$US
240826141$24082614$1$I$$20240708$20240712$20240712$PER$$US-ROCHE-10000021310$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240826152$24082615$2$F$$20240710$20240712$20240723$PER$$US-ROCHE-10000022210$ROCHE$$$$$M$Y$$$20240723$$CN$US$US
240826161$24082616$1$I$$20240630$20240712$20240712$EXP$$DE-MPL-000045$MLV PHARMA$$57$YR$A$M$Y$$$20240703$$MD$DE$DE
240826171$24082617$1$I$$20240630$20240712$20240712$EXP$$DE-GTI-000255$Granulation Technology, INC$$57$YR$A$M$Y$$$20240703$$MD$DE$DE
240826181$24082618$1$I$$20240630$20240712$20240712$EXP$$US-GTI-000253$Granulation Technology, INC$$48$YR$A$M$Y$$$20240703$$MD$US$US
240826191$24082619$1$I$$20240630$20240712$20240712$EXP$$CN-GTI-000254$Granulation Technology, INC$$1$YR$C$$Y$$$20240703$$MD$CN$CN
240826201$24082620$1$I$$20240630$20240712$20240712$EXP$$CN-GTI-000251$Granulation Technology, INC$$32$YR$A$M$Y$$$20240703$$HP$CN$CN
240826211$24082621$1$I$$20240630$20240712$20240712$EXP$$PH-GTI-000252$Granulation Technology, INC$$$$N$M$Y$3$KG$20240703$$MD$PH$PH
240826221$24082622$1$I$$20240703$20240712$20240712$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456159$RANBAXY$$43$YR$$F$Y$68$KG$20240712$$HP$CA$CA
240826241$24082624$1$I$$20240711$20240712$20240712$PER$$US-JNJFOC-20240730141$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$HP$US$US
240826251$24082625$1$I$$20240708$20240712$20240712$EXP$$IE-JNJFOC-20240721445$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240712$$HP$IE$IE
240826262$24082626$2$F$20231201$20240814$20240712$20240828$PER$$US-SA-2024SA196246$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240828$$MD$US$US
240826271$24082627$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA202922$SANOFI AVENTIS$$$$A$M$Y$117.93$KG$20240712$$MD$US$US
240826281$24082628$1$I$$20240709$20240712$20240712$PER$$US-SA-2024SA203499$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240712$$CN$US$US
240826291$24082629$1$I$$20240702$20240712$20240712$PER$$US-SA-2024SA199852$SANOFI AVENTIS$$$$C$M$Y$13.517$KG$20240712$$MD$US$US
240826301$24082630$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA199658$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240712$$CN$US$US
240826311$24082631$1$I$20240101$20240705$20240712$20240712$PER$$US-SA-2024SA200083$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240712$$CN$US$US
240826321$24082632$1$I$20240531$20240708$20240712$20240712$PER$$US-SA-2024SA201290$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240712$$CN$US$US
240826332$24082633$2$F$$20240819$20240712$20240829$PER$$US-SA-2024SA199111$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240829$$CN$US$US
240826341$24082634$1$I$20240703$20240709$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110271$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$81.19$KG$20240712$$HP$US$US
240826361$24082636$1$I$$20240710$20240712$20240712$EXP$$US-UCBSA-2024035230$UCB$$$$$$Y$$$20240712$$CN$US$US
240826371$24082637$1$I$20240415$20240704$20240712$20240712$EXP$$IT-BIOGEN-2024BI01271647$BIOGEN$$49$YR$$M$Y$$$20240712$$MD$IT$IT
240826382$24082638$2$F$$20240725$20240712$20240731$EXP$$JP-SA-2024SA190729$SANOFI AVENTIS$$6$DEC$A$M$Y$$$20240731$$HP$JP$JP
240826391$24082639$1$I$$20240711$20240712$20240712$PER$$US-ROCHE-10000023709$ROCHE$$$$A$F$Y$$$20240712$$HP$US$US
240826401$24082640$1$I$20230901$20240708$20240712$20240712$EXP$$US-ABBVIE-5832289$ABBVIE$$22$YR$$F$Y$$$20240712$$CN$US$US
240826411$24082641$1$I$$20240708$20240712$20240712$EXP$$US-ABBVIE-5834900$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240826421$24082642$1$I$20240605$20240703$20240712$20240712$EXP$$ES-AUROBINDO-AUR-APL-2024-033080$AUROBINDO$$2$YR$$M$Y$17$KG$20240712$$MD$ES$ES
240826431$24082643$1$I$$20240627$20240712$20240712$EXP$$GB-SA-2024SA200470$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240712$$MD$GB$GB
240826441$24082644$1$I$20230401$20240704$20240712$20240712$EXP$$ES-CELLTRION INC.-2024ES016570$CELLTRION$$$$$$Y$$$20240712$$MD$ES$ES
240826471$24082647$1$I$20240622$20240703$20240712$20240712$EXP$$CN-AUROBINDO-AUR-APL-2024-034245$AUROBINDO$$55$YR$$M$Y$$$20240712$$HP$CN$CN
240826481$24082648$1$I$20230518$20240705$20240712$20240712$EXP$$US-RDY-CLI/USA/23/0165929$DR REDDYS$$21$YR$A$F$Y$$$20240712$$CN$US$US
240826501$24082650$1$I$$20240705$20240712$20240712$EXP$$US-SA-2024SA202661$SANOFI AVENTIS$$$$A$F$Y$64.41$KG$20240712$$MD$US$US
240826511$24082651$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033770$AUROBINDO$Kollasch-McGarvey A, Moore S, Eschbacher K. Gross and microscopic manifestations of Wernicke encephalopathy in a 67-year-old female. J-Neuropathol-Exp-Neurol. 2024;83(6):487$67$YR$$F$Y$$$20240712$$HP$US$US
240826531$24082653$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033801$AUROBINDO$Hodson EL, Kranyak A, Salem I, Buckey JC.. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases. J-Tissue-Viability. 2024$54$YR$$F$Y$$$20240712$$HP$US$US
240826541$24082654$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07089$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240826552$24082655$2$F$$20240708$20240712$20240722$EXP$$GB-CIPLA LTD.-2024GB07044$CIPLA$$$$$$Y$$$20240722$$CN$GB$GB
240826561$24082656$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07049$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240826571$24082657$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07018$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240826581$24082658$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07051$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240826591$24082659$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07022$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240826601$24082660$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07016$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240826611$24082661$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07058$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240826621$24082662$1$I$20240703$20240708$20240712$20240712$EXP$$DE-ABBVIE-5831740$ABBVIE$$49$YR$$M$Y$88$KG$20240712$$MD$DE$DE
240826631$24082663$1$I$$20240710$20240712$20240712$PER$$NVSC2024US143884$NOVARTIS$$$$$$Y$$$20240712$$CN$US$US
240826641$24082664$1$I$$20240705$20240712$20240712$EXP$$GB-AstraZeneca-2024A154235$ASTRAZENECA$$$$$F$Y$$$20240712$$MD$GB$
240826651$24082665$1$I$$20240706$20240712$20240712$EXP$$IN-AstraZeneca-2024A156232$ASTRAZENECA$$67$YR$$F$Y$64$KG$20240712$$CN$IN$
240826662$24082666$2$F$$20240723$20240712$20240731$EXP$$JP-AstraZeneca-2024A154903$ASTRAZENECA$$52$YR$$F$Y$$$20240731$$MD$JP$
240826671$24082667$1$I$$20240705$20240712$20240712$EXP$$US-AstraZeneca-2024A157554$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
240826682$24082668$2$F$$20240808$20240712$20240812$EXP$$IN-ROCHE-10000021278$ROCHE$$58$YR$A$F$Y$$$20240812$$CN$IN$IN
240826691$24082669$1$I$20240707$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007121$ELI LILLY AND CO$$42$YR$A$$Y$$$20240712$$CN$US$US
240826701$24082670$1$I$$20240619$20240712$20240712$PER$$US-STERISCIENCE B.V.-2024-ST-000922$Steriscience PTE$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients.. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster)$$$$$Y$$$20240712$$HP$US$US
240826711$24082671$1$I$$20240619$20240712$20240712$PER$$US-STERISCIENCE B.V.-2024-ST-000923$Steriscience PTE$Patel L, Lyons J, Scarola D, Warrior K. Mycophenolate-induced Colitis in Lung Transplant Recipients.. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster)$$$$$Y$$$20240712$$HP$US$US
240826721$24082672$1$I$$20240620$20240712$20240712$PER$$US-STERISCIENCE B.V.-2024-ST-000934$Steriscience PTE$Maldarelli ME, Grier WR. A Noxious Mimic - Pulmonary Nocardiosis Presenting as a Lung Mass in an Orthotopic Liver Transplant Patient. Am-J-Respir-Crit-Care-Med. 2024;209:A2434$72$YR$$M$Y$$$20240712$$HP$US$US
240826731$24082673$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07080$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240826741$24082674$1$I$20180718$20240708$20240712$20240712$EXP$$AU-GSK-AU2024APC085289$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$MD$AU$AU
240826751$24082675$1$I$$20240708$20240712$20240712$PER$$US-ABBVIE-5834344$ABBVIE$$16$YR$$F$Y$$$20240712$$MD$US$US
240826762$24082676$2$F$20240527$20240710$20240712$20240725$EXP$FR-AFSSAPS-PP2024000732$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-108867$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$60$KG$20240725$$MD$FR$FR
240826771$24082677$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110393$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240712$$CN$US$US
240826781$24082678$1$I$20240627$20240704$20240712$20240712$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159069$JIANGSU HANSOH PHARMACEUTICAL$$51$YR$$M$Y$59$KG$20240712$$MD$CN$CN
240826791$24082679$1$I$20240624$20240702$20240712$20240712$EXP$$US-ROCHE-10000018970$ROCHE$$60$YR$A$F$Y$$$20240712$$CN$US$US
240826801$24082680$1$I$$20240710$20240712$20240712$PER$$US-TAKEDA-2024TUS070751$TAKEDA$$$$$$Y$$$20240712$$CN$US$US
240826811$24082681$1$I$20240325$20240704$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-033397$AUROBINDO$$64$YR$$F$Y$$$20240712$$MD$FR$FR
240826821$24082682$1$I$$20240711$20240712$20240712$PER$$NVSC2024US144099$NOVARTIS$$$$$$Y$$$20240712$$MD$US$US
240826833$24082683$3$F$$20240710$20240712$20240722$PER$$NVSC2024US143910$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
240826841$24082684$1$I$20240601$20240709$20240712$20240712$PER$$US-ABBVIE-5835911$ABBVIE$$$$A$$Y$$$20240712$$MD$US$US
240826851$24082685$1$I$20240601$20240702$20240712$20240712$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-017610$UNITED THERAPEUTICS$$68$YR$$F$Y$$$20240712$$$JP$JP
240826861$24082686$1$I$$20240703$20240712$20240712$PER$$US-APOTEX-2024AP008162$APOTEX$Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN.. Relationship between the Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular Immunology and Inflammation. 2023;31(5):900-904$$$A$$Y$$$20240712$$HP$US$US
240826871$24082687$1$I$$20240708$20240712$20240712$PER$$US-ABBVIE-5834700$ABBVIE$$$$$F$Y$$$20240712$$MD$US$US
240826882$24082688$2$F$20240501$20240704$20240712$20240716$EXP$$GB-CELLTRION INC.-2024GB016686$CELLTRION$$$$$$Y$$$20240716$$HP$GB$GB
240826891$24082689$1$I$$20240704$20240712$20240712$EXP$GB-MHRA-MED-202405021617124220-NDSPQ$GB-TEVA-VS-3217833$TEVA$$$$$$Y$$$20240712$$PH$GB$GB
240826911$24082691$1$I$$20240709$20240712$20240712$PER$$US-TAKEDA-2024TUS070430$TAKEDA$$$$$$Y$$$20240712$$CN$US$US
240826921$24082692$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033970$AUROBINDO$Faris M, Saad E, Abdulrahman A, Albanna M, Friedman H. Life-threatening Bradyarrhythmia in the ICU:Beware of Phenytoin Loading!. Am-J-Respir-Crit-Care-Med. 2024$75$YR$$F$Y$$$20240712$$HP$US$US
240826931$24082693$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033768$AUROBINDO$Patel MH, Brumfiel CM, Breen I, Glembocki D, Luber A. Granulomatous Panniculitis as a Complication of Subcutaneous Testosterone Pellet Therapy. Skinmed. 2023;21(3):203-204$51$YR$$M$Y$$$20240712$$HP$US$US
240826941$24082694$1$I$$20240703$20240712$20240712$EXP$$US-INSMED, INC.-2024-02780-US$INSMED$$$$$F$Y$$$20240712$$MD$US$US
240826952$24082695$2$F$$20240716$20240712$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038795$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240717$$CN$US$US
240826961$24082696$1$I$20220127$20240709$20240712$20240712$EXP$$CA-TAKEDA-2024TUS070221$TAKEDA$$65$YR$$F$Y$$$20240712$$CN$CA$CA
240826971$24082697$1$I$20240301$20240710$20240712$20240712$EXP$$US-ROCHE-10000023616$ROCHE$$60$YR$A$M$Y$$$20240712$$CN$US$US
240826981$24082698$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186679$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240826991$24082699$1$I$20240628$20240705$20240712$20240712$EXP$$CN-ROCHE-10000019311$ROCHE$$75$YR$E$F$Y$43$KG$20240712$$HP$CN$CN
240827001$24082700$1$I$20240708$20240708$20240712$20240712$EXP$$US-ABBVIE-5833773$ABBVIE$$23$YR$$F$Y$$$20240712$$CN$US$US
240827011$24082701$1$I$$20240708$20240712$20240712$EXP$$NVSC2024US141439$NOVARTIS$$$$$F$Y$$$20240712$$CN$US$US
240827021$24082702$1$I$20240401$20240710$20240712$20240712$PER$$US-TAKEDA-2024TUS070701$TAKEDA$$50$YR$$F$Y$63$KG$20240712$$MD$US$US
240827031$24082703$1$I$$20240710$20240712$20240712$EXP$$US-ABBVIE-5836437$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240827041$24082704$1$I$$20240626$20240712$20240712$PER$$US-ABBVIE-5835554$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240827051$24082705$1$I$$20240705$20240712$20240712$EXP$$BR-JNJFOC-20240719469$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$HP$BR$BR
240827061$24082706$1$I$$20231024$20240712$20240712$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086113$GLENMARK$$$$$$Y$$$20240712$$CN$US$US
240827071$24082707$1$I$$20240703$20240712$20240712$30DAY$$US-GSK-US2024AMR083466$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$CN$US$US
240827081$24082708$1$I$$20240710$20240712$20240712$EXP$$US-GILEAD-2024-0680333$GILEAD$$$$$$Y$$$20240712$$LW$US$US
240827091$24082709$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110623$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240712$$CN$US$US
240827101$24082710$1$I$$20240703$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106954$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240712$$HP$US$US
240827111$24082711$1$I$20240708$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110095$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240712$$HP$US$US
240827121$24082712$1$I$$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110621$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240712$$CN$US$US
240827131$24082713$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110618$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240712$$CN$US$US
240827142$24082714$2$F$20240523$20240703$20240712$20240717$EXP$$CN-ROCHE-10000016107$ROCHE$$49$YR$A$F$Y$60$KG$20240717$$HP$CN$CN
240827151$24082715$1$I$20240101$20240712$20240712$20240712$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039422$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240712$$MD$RU$RU
240827161$24082716$1$I$$20240711$20240712$20240712$PER$$US-TAKEDA-2024TUS070841$TAKEDA$$$$$$Y$$$20240712$$MD$US$US
240827171$24082717$1$I$$20240702$20240712$20240712$EXP$$CA-AUROBINDO-AUR-APL-2024-033627$AUROBINDO$Mccoy J, Lobos A, De Nanassy J, Perrem L.. A Novel Mutation in Pulmonary Alveolar Microlithiasis With Disseminated Pseudomonas Infection. Am-J-Respir-Crit-Care-Med. 2024;209:A2304$6$MON$$F$Y$$$20240712$$HP$CA$CA
240827183$24082718$3$F$20240710$20240719$20240712$20240722$PER$$US-AMGEN-USASP2024137507$AMGEN$$67$YR$E$F$Y$$$20240722$$CN$US$US
240827191$24082719$1$I$$20240701$20240712$20240712$EXP$$IN-ROCHE-10000022180$ROCHE$$$$E$F$Y$$$20240712$$MD$IN$IN
240827201$24082720$1$I$$20240708$20240712$20240712$EXP$$US-ABBVIE-5834691$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240827221$24082722$1$I$$20240705$20240712$20240712$EXP$$US-AstraZeneca-2024A155462$ASTRAZENECA$$$$$F$Y$$$20240712$$MD$US$
240827231$24082723$1$I$$20240705$20240712$20240712$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01240$NOVITIUM PHARMA$Maojiang Yang.Reversible blindness after stellate ganglion block.Quantitative Imaging in Medicine and Surgery.26-APR-2024;14(5):3744-3750$53$YR$A$M$Y$$$20240712$$HP$CN$CN
240827241$24082724$1$I$$20240710$20240712$20240712$EXP$$CA-GSK-CA2024085784$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$HP$CA$CA
240827252$24082725$2$F$20240101$20240904$20240712$20240904$EXP$$CA-PFIZER INC-202300423364$PFIZER$$58$YR$$F$Y$62$KG$20240904$$MD$CA$CA
240827261$24082726$1$I$$20240708$20240712$20240712$EXP$$US-PFIZER INC-PV202400090243$PFIZER$$22$YR$$F$Y$$$20240712$$MD$US$US
240827272$24082727$2$F$$20240711$20240712$20240719$EXP$$IT-PFIZER INC-202400212188$PFIZER$$58$YR$$F$Y$$$20240719$$MD$IT$IT
240827282$24082728$2$F$20231226$20240823$20240712$20240830$EXP$$CA-GSK-CA2024001605$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$HP$CA$CA
240827292$24082729$2$F$20230104$20240719$20240712$20240726$EXP$$ES-ROCHE-3532321$ROCHE$$67$YR$E$M$Y$75$KG$20240726$$MD$ES$ES
240827302$24082730$2$F$$20240724$20240712$20240731$EXP$BE-FAMHP-DHH-N2024-122326$BE-PFIZER INC-202400211378$PFIZER$$$$$M$Y$$$20240731$$PH$BE$BE
240827311$24082731$1$I$$20240704$20240712$20240712$EXP$$AU-PFIZER INC-202400210536$PFIZER$$71$YR$$F$Y$$$20240712$$MD$AU$AU
240827321$24082732$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137148$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240827331$24082733$1$I$20240709$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137278$AMGEN$$49$YR$A$M$Y$$$20240712$$CN$US$US
240827341$24082734$1$I$$20240705$20240712$20240712$PER$$US-ROCHE-10000021313$ROCHE$$$$A$F$Y$$$20240712$$CN$US$US
240827351$24082735$1$I$20240704$20240708$20240712$20240712$EXP$$JP-AMGEN-JPNSP2024137244$AMGEN$$50$YR$A$F$Y$$$20240712$$MD$JP$JP
240827361$24082736$1$I$20240610$20240624$20240712$20240712$PER$$US-JNJFOC-20240669900$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240827371$24082737$1$I$$20240704$20240712$20240712$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008387$STRIDES$Amano K, Oda Y, Seki Y, Yamashita K, Bokuda K, Ichihara A, et al.. Reconsideration of Surgical Indication for Prolactin-producing Pituitary Tumor Focusing on Visual Impairment.. Neurol-Med-Chir-(Tokyo). 2024;64(4):160-167$35$YR$$M$Y$$$20240712$$MD$JP$JP
240827381$24082738$1$I$20240330$20240614$20240712$20240712$PER$$US-Vifor (International) Inc.-VIT-2024-05477$VIFOR$$65$YR$$F$Y$69.4$KG$20240712$$HP$US$US
240827391$24082739$1$I$20240201$20240704$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-033342$AUROBINDO$$68$YR$$F$Y$63$KG$20240712$$MD$FR$FR
240827402$24082740$2$F$$20240802$20240712$20240805$PER$$US-ALXN-202407USA000522US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240827411$24082741$1$I$20240701$20240709$20240712$20240712$PER$$US-ABBVIE-5835181$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240827421$24082742$1$I$20231101$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455631$RANBAXY$$31$YR$$M$Y$$$20240712$$MD$FR$FR
240827431$24082743$1$I$20230101$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455566$RANBAXY$$49$YR$$M$Y$$$20240712$$PH$FR$FR
240827441$24082744$1$I$20240206$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455545$RANBAXY$$34$YR$$M$Y$82$KG$20240712$$MD$FR$FR
240827451$24082745$1$I$$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455605$RANBAXY$$25$YR$$M$Y$$$20240712$$MD$FR$FR
240827461$24082746$1$I$20240219$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455764$RANBAXY$$84$YR$$F$Y$$$20240712$$PH$FR$FR
240827471$24082747$1$I$20240406$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455659$RANBAXY$$71$YR$$F$Y$55$KG$20240712$$PH$FR$FR
240827481$24082748$1$I$20230101$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455416$RANBAXY$$49$YR$$M$Y$$$20240712$$PH$FR$FR
240827491$24082749$1$I$20240322$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455654$RANBAXY$$62$YR$$M$Y$96$KG$20240712$$MD$FR$FR
240827501$24082750$1$I$20221223$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455555$RANBAXY$$85$YR$$F$Y$69$KG$20240712$$MD$FR$FR
240827511$24082751$1$I$20240127$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455693$RANBAXY$$43$YR$$M$Y$$$20240712$$MD$FR$FR
240827521$24082752$1$I$20240325$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455393$RANBAXY$$55$YR$$M$Y$105$KG$20240712$$MD$FR$FR
240827531$24082753$1$I$20240118$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455401$RANBAXY$$80$YR$$M$Y$$$20240712$$MD$FR$FR
240827541$24082754$1$I$20210301$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455355$RANBAXY$$23$YR$$F$Y$110$KG$20240712$$CN$FR$FR
240827551$24082755$1$I$20150901$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455400$RANBAXY$$73$YR$$M$Y$96$KG$20240712$$MD$FR$FR
240827561$24082756$1$I$20240312$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455334$RANBAXY$$60$YR$$M$Y$80$KG$20240712$$MD$FR$FR
240827571$24082757$1$I$20240308$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455361$RANBAXY$$50$YR$$M$Y$75$KG$20240712$$PH$FR$FR
240827581$24082758$1$I$$20240704$20240712$20240712$EXP$$BR-TAKEDA-2023TUS117724$TAKEDA$$$$$M$Y$$$20240712$$CN$BR$BR
240827591$24082759$1$I$20240709$20240709$20240712$20240712$EXP$$CA-TAKEDA-2024TUS054740$TAKEDA$$66$YR$$M$Y$$$20240712$$CN$CA$CA
240827601$24082760$1$I$20240627$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024136422$AMGEN$$$$$$Y$$$20240712$$HP$US$US
240827611$24082761$1$I$$20240627$20240712$20240712$PER$$US-ROCHE-10000014952$ROCHE$$41$YR$A$M$Y$$$20240712$$CN$US$US
240827621$24082762$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5833740$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240827631$24082763$1$I$20230915$20240704$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-033478$AUROBINDO$$44$YR$$M$Y$$$20240712$$MD$FR$FR
240827641$24082764$1$I$$20240704$20240712$20240712$EXP$$TW-STRIDES ARCOLAB LIMITED-2024SP008375$STRIDES$Chang H-Y, Hsu C-C, Hu L-F, Chou C-Y, Chang Y-L, Lu C-C, et al.. Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center.. Ann-Med 2024;. 2024;56 (1)$$$A$$Y$$$20240712$$HP$TW$TW
240827651$24082765$1$I$$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455548$RANBAXY$$70$YR$$M$Y$56$KG$20240712$$PH$FR$FR
240827661$24082766$1$I$20240401$20240710$20240712$20240712$30DAY$$US-SANDOZ INC.-SDZ2024US064580$SANDOZ$$28$YR$$$Y$$$20240712$$CN$US$US
240827671$24082767$1$I$$20240709$20240712$20240712$30DAY$$CA-SANDOZ INC.-SDZ2024CA064529$SANDOZ$$$$$F$Y$$$20240712$$MD$CA$CA
240827681$24082768$1$I$$20240628$20240712$20240712$EXP$$CA-APOTEX-2024AP007897$APOTEX$$$$A$M$Y$$$20240712$$PH$CA$CA
240827701$24082770$1$I$$20240705$20240712$20240712$EXP$$NVSC2024US143116$NOVARTIS$$$$$$Y$$$20240712$$CN$US$US
240827711$24082771$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006785$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240712$$CN$US$US
240827721$24082772$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007137$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240712$$CN$US$US
240827731$24082773$1$I$$20240628$20240712$20240712$PER$$US-JNJFOC-20240729444$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240827743$24082774$3$F$20240710$20240820$20240712$20240821$PER$$US-JNJFOC-20240730568$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240821$$CN$US$US
240827751$24082775$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033812$AUROBINDO$Luskin MR, Murakami MA, Keating J, Winer ES, Garcia JS, Stahl M, et al. A Phase IStudy of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL and Blast Phase CML in Adults.. Blood. 2023;142 (Suppl. 1):965-967$65$YR$$M$Y$$$20240712$$MD$US$US
240827761$24082776$1$I$$20240710$20240712$20240712$PER$$US-JNJFOC-20240730101$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240827772$24082777$2$F$$20240703$20240712$20240723$EXP$$IT-ASTELLAS-2024EU006762$ASTELLAS$Mandi O, Silverii M, Fattiroli F, Burgisser C, Valoti P, Orso F. PARTIALLY REVERSIBLE DILATED CARDIOMYOPATHY ASSOCIATED WITH AMPHOTERICIN B THERAPY. 55th Congress of the Italian Association of Hospital Cardiologists, ANMCO. 2024;26(2):181$41$YR$$M$Y$$$20240723$$HP$IT$IT
240827781$24082778$1$I$$20230621$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003816$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240827792$24082779$2$F$$20240722$20240712$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA063970$SANDOZ$$50$YR$$F$Y$68$KG$20240723$$HP$CA$CA
240827801$24082780$1$I$$20231219$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003616$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240827811$24082781$1$I$$20230607$20240712$20240712$PER$$US-ENDO USA, INC.-2023-003336$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240827821$24082782$1$I$$20240705$20240712$20240712$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008331$STRIDES$Wang D, Ye W, Chen D, Shi Q, Ma D. Transformation of Lung Squamous Cell Carcinoma to Small Cell Lung Cancer After Immunotherapy Resistance: A Case Report.. Cancer-Manag-Res. 2023;15:803-808$56$YR$$M$Y$$$20240712$$HP$CN$CN
240827831$24082783$1$I$20240630$20240709$20240712$20240712$EXP$$CN-SANDOZ INC.-SDZ2024CN064087$SANDOZ$$61$YR$$F$Y$54$KG$20240712$$HP$CN$CN
240827851$24082785$1$I$20190325$20240704$20240712$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-056118$BRISTOL MYERS SQUIBB$Aoki Y, Nagata M, Horie S. ???????????????????Nivolumab+Iplimumab????????????????.$58$YR$A$F$Y$42.4$KG$20240712$$MD$JP$JP
240827861$24082786$1$I$20240521$20240709$20240712$20240712$EXP$$CA-SANDOZ INC.-SDZ2024CA060632$SANDOZ$$56$YR$$F$Y$60$KG$20240712$$PH$CA$CA
240827872$24082787$2$F$20240101$20240708$20240712$20240726$PER$$US-TEVA-VS-3217923$TEVA$$90$YR$$F$Y$$$20240726$$CN$US$US
240827881$24082788$1$I$$20240709$20240712$20240712$EXP$$CA-SANDOZ INC.-SDZ2024CA063895$SANDOZ$$61$YR$$F$Y$$$20240712$$HP$CA$CA
240827893$24082789$3$F$$20240724$20240712$20240729$EXP$$DE-TAKEDA-2024TUS065669$TAKEDA$$45$YR$$M$Y$$$20240729$$CN$DE$DE
240827911$24082791$1$I$$20230710$20240712$20240712$PER$$US-ENDO USA, INC.-2023-004305$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240827921$24082792$1$I$$20231218$20240712$20240712$PER$$US-ENDO USA, INC.-2023-006350$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240827931$24082793$1$I$$20230627$20240712$20240712$PER$$US-ENDO USA, INC.-2023-004004$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240827941$24082794$1$I$$20230706$20240712$20240712$PER$$US-ENDO USA, INC.-2023-004239$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240827951$24082795$1$I$$20230703$20240712$20240712$PER$$US-ENDO USA, INC.-2023-004185$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240827961$24082796$1$I$$20240702$20240712$20240712$EXP$$CA-ROCHE-10000020246$ROCHE$$53$YR$A$M$Y$$$20240712$$CN$CA$CA
240827971$24082797$1$I$$20240703$20240712$20240712$EXP$$US-APOTEX-2024AP008156$APOTEX$Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN.. Relationship between the Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular Immunology and Inflammation. 2023;31(5):900-904$$$A$$Y$$$20240712$$HP$US$US
240827982$24082798$2$F$$20240812$20240712$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-033870$AUROBINDO$$$$$M$Y$89$KG$20240822$$CN$GB$GB
240827991$24082799$1$I$$20231219$20240712$20240712$PER$$US-ENDO USA, INC.-2024-000216$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240828001$24082800$1$I$$20231219$20240712$20240712$PER$$US-ENDO USA, INC.-2024-000096$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240828011$24082801$1$I$$20231218$20240712$20240712$PER$$US-ENDO USA, INC.-2023-006409$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240828021$24082802$1$I$$20240710$20240712$20240712$EXP$$CA-SANDOZ INC.-SDZ2024CA064495$SANDOZ$$51$YR$$F$Y$$$20240712$$CN$CA$CA
240828031$24082803$1$I$$20240711$20240712$20240712$EXP$$CA-SANDOZ INC.-SDZ2024CA064664$SANDOZ$$6$DEC$$F$Y$$$20240712$$HP$CA$CA
240828043$24082804$3$F$20240301$20240710$20240712$20240718$PER$$US-SA-2024SA176844$SANOFI AVENTIS$$65$YR$E$F$Y$82.553$KG$20240718$$MD$US$US
240828051$24082805$1$I$$20240628$20240712$20240712$PER$$US-SA-2023SA392684$SANOFI AVENTIS$$$$E$M$Y$$$20240712$$MD$US$US
240828061$24082806$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA201244$SANOFI AVENTIS$$$$C$F$Y$$$20240712$$MD$US$US
240828071$24082807$1$I$20210101$20240708$20240712$20240712$PER$$US-SA-2024SA202914$SANOFI AVENTIS$$$$$F$Y$$$20240712$$CN$US$US
240828083$24082808$3$F$20240701$20240812$20240712$20240816$PER$$US-SA-2024SA203623$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240816$$MD$US$US
240828091$24082809$1$I$20240201$20240705$20240712$20240712$PER$$US-SA-2024SA203091$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240712$$MD$US$US
240828101$24082810$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA201968$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240828111$24082811$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA201300$SANOFI AVENTIS$$$$E$F$Y$58$KG$20240712$$MD$US$US
240828121$24082812$1$I$20240101$20240708$20240712$20240712$PER$$US-SA-2024SA202760$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240712$$CN$US$US
240828131$24082813$1$I$20240401$20240703$20240712$20240712$PER$$US-SA-2024SA199643$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240712$$MD$US$US
240828141$24082814$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA202442$SANOFI AVENTIS$$$$A$M$Y$$$20240712$$MD$US$US
240828151$24082815$1$I$20240601$20240703$20240712$20240712$PER$$US-SA-2024SA199396$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240712$$MD$US$US
240828161$24082816$1$I$$20240619$20240712$20240712$PER$$US-STERISCIENCE B.V.-2024-ST-000920$Steriscience PTE$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients.. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster)$$$$$Y$$$20240712$$HP$US$US
240828171$24082817$1$I$$20240430$20240712$20240712$PER$$US-ENDO USA, INC.-2024-002074$ENDO$$$$$F$Y$$$20240712$$CN$US$US
240828183$24082818$3$F$$20240206$20240712$20240916$PER$$US-ENDO USA, INC.-2024-000955$ENDO$$$$$F$Y$$$20240916$$CN$US$US
240828191$24082819$1$I$$20240227$20240712$20240712$PER$$US-ENDO USA, INC.-2024-001219$ENDO$$$$$M$Y$$$20240712$$CN$US$US
240828202$24082820$2$F$$20231219$20240712$20240916$PER$$US-ENDO USA, INC.-2024-001277$ENDO$$$$$M$Y$$$20240916$$CN$US$US
240828213$24082821$3$F$$20240326$20240712$20240916$PER$$US-ENDO USA, INC.-2024-001564$ENDO$$$$$F$Y$$$20240916$$CN$US$US
240828223$24082822$3$F$$20240220$20240712$20240916$PER$$US-ENDO USA, INC.-2024-001134$ENDO$$$$$M$Y$$$20240916$$CN$US$US
240828231$24082823$1$I$$20240705$20240712$20240712$EXP$$JP-ROCHE-10000021221$ROCHE$Yamaguchi T, Shimizu J, Shigematsu F, Watanabe N, Hasegawa T, Horio Y, et al. Atezolizumab and nintedanib in patients with non-small cell lung cancer and interstitial lung disease. Journal of Thoracic Disease. 2024-May-31;16 (5):3371-80. doi:10.21037/jtd-24-45.$78$YR$E$M$Y$$$20240712$$MD$JP$JP
240828242$24082824$2$F$20240703$20240903$20240712$20240906$30DAY$$IT-SANDOZ INC.-SDZ2024IT064593$SANDOZ$$14$YR$$M$Y$52$KG$20240906$$CN$IT$IT
240828251$24082825$1$I$$20240709$20240712$20240712$PER$$US-TAKEDA-2024TUS069956$TAKEDA$$$$$M$Y$$$20240712$$CN$US$US
240828261$24082826$1$I$20240516$20240710$20240712$20240712$EXP$FR-AFSSAPS-CF2024000306$FR-TAKEDA-2024TUS070862$TAKEDA$$57$YR$$F$Y$$$20240712$$HP$FR$FR
240828271$24082827$1$I$$20240710$20240712$20240712$EXP$$US-TAKEDA-2024TUS070133$TAKEDA$$$$$M$Y$$$20240712$$MD$US$US
240828281$24082828$1$I$20240101$20240708$20240712$20240712$EXP$$US-JNJFOC-20240718458$JOHNSON AND JOHNSON$$68$YR$E$F$Y$69.4$KG$20240712$$CN$US$US
240828291$24082829$1$I$$20240708$20240712$20240712$EXP$$US-JNJFOC-20240718916$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240828301$24082830$1$I$$20240703$20240712$20240712$EXP$$US-APOTEX-2024AP008157$APOTEX$Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN.. Relationship between the Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular Immunology and Inflammation. 2023;31(5):900-904$$$A$$Y$$$20240712$$HP$US$US
240828311$24082831$1$I$20231007$20240708$20240712$20240712$EXP$$US-JNJFOC-20240720403$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$PH$US$US
240828321$24082832$1$I$20240701$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024136986$AMGEN$$$$$$Y$$$20240712$$HP$US$US
240828331$24082833$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186669$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240828341$24082834$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA202060$SANOFI AVENTIS$$92$YR$E$F$Y$$$20240712$$CN$US$US
240828351$24082835$1$I$$20240709$20240712$20240712$PER$$US-SA-2024SA203080$SANOFI AVENTIS$$$$$$Y$$$20240712$$CN$US$US
240828361$24082836$1$I$20230401$20240708$20240712$20240712$PER$$US-SA-2024SA201973$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240712$$MD$US$US
240828371$24082837$1$I$20230101$20240705$20240712$20240712$PER$$US-SA-2024SA202807$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240712$$MD$US$US
240828381$24082838$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA202652$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240712$$MD$US$US
240828391$24082839$1$I$$20240703$20240712$20240712$PER$$US-TAKEDA-2024TUS067875$TAKEDA$$$$$$Y$$$20240712$$HP$US$US
240828401$24082840$1$I$20220101$20240705$20240712$20240712$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008332$STRIDES$Tang M, Zhang Z, Wang L, Qian H, Wu W, Liu Z, et al.. Coronary artery ectasia associated with IgG4-related disease: a case report and literature review.. BMC-Cardiovasc-Disord. 2023;23 (1)$77$YR$$M$Y$$$20240712$$HP$CN$CN
240828412$24082841$2$F$$20240906$20240712$20240912$EXP$$CA-TAKEDA-2024TUS070001$TAKEDA$$$$$M$Y$$$20240912$$MD$CA$CA
240828421$24082842$1$I$$20240710$20240712$20240712$PER$$NVSC2024US143650$NOVARTIS$$$$$F$Y$$$20240712$$CN$US$US
240828431$24082843$1$I$$20240704$20240712$20240712$EXP$$AU-TAKEDA-2024TUS037922$TAKEDA$$20$YR$$F$Y$$$20240712$$HP$AU$AU
240828441$24082844$1$I$$20240626$20240712$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06436$LUPIN$$$$$$Y$$$20240712$$CN$US$US
240828451$24082845$1$I$$20240704$20240712$20240712$EXP$$CA-CELLTRION INC.-2023CA006006$CELLTRION$$$$$$Y$$$20240712$$HP$CA$CA
240828461$24082846$1$I$$20240708$20240712$20240712$PER$$US-ALXN-202407USA000518US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240828481$24082848$1$I$20240101$20240703$20240712$20240712$EXP$$KR-SA-2024SA198280$SANOFI AVENTIS$$$$$M$Y$$$20240712$$CN$KR$KR
240828491$24082849$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024136740$AMGEN$$$$$$Y$$$20240712$$MD$US$US
240828501$24082850$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137193$AMGEN$$$$$$Y$$$20240712$$HP$US$US
240828511$24082851$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137764$AMGEN$$$$A$$Y$$$20240712$$HP$US$US
240828521$24082852$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137761$AMGEN$$$$A$$Y$$$20240712$$HP$US$US
240828531$24082853$1$I$$20240708$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109494$BRISTOL MYERS SQUIBB$$14$YR$T$M$Y$$$20240712$$HP$US$US
240828541$24082854$1$I$20191101$20240705$20240712$20240712$EXP$$HU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038151$BOEHRINGER INGELHEIM$Gaspar E, Papay J, Agocs L, Galffy G. Journey of a patient with EGFR mutation. Medicina Thoracalis. 2024 May;3: 190-191.$71$YR$E$F$Y$$$20240712$$MD$HU$HU
240828551$24082855$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110535$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240712$$CN$US$US
240828561$24082856$1$I$$20240705$20240712$20240712$EXP$$US-AstraZeneca-2024A156182$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
240828572$24082857$2$F$$20240718$20240712$20240724$EXP$US-MLMSERVICE-20240613-PI099841-00232-1$US-STRIDES ARCOLAB LIMITED-2024SP008383$STRIDES$Rozenbaum Lerner G, Villamizar JP, Pelaez A, Salgado JC.. Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis.. American Journal of Respiratory and Critical Care Medicine.. 2024;209(plusPoster):A3531$68$YR$$M$Y$84$KG$20240724$$MD$US$US
240828582$24082858$2$F$$20240718$20240712$20240722$EXP$GB-MHRA-MED-202405101401069270-STKMW$GB-STRIDES ARCOLAB LIMITED-2024SP008183$STRIDES$$$$$$Y$$$20240722$$MD$GB$GB
240828591$24082859$1$I$$20240705$20240712$20240712$EXP$$US-JNJFOC-20240718237$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240828602$24082860$2$F$$20240726$20240712$20240807$EXP$$US-AUROBINDO-AUR-APL-2024-033463$AUROBINDO$Patel P, Turbin RE, Husain S, Wang S. Neurosyphilis Mimicking Connective Tissue Disease. BMJCase-Rep. 2023;16No:9$7$DEC$$M$Y$$$20240807$$MD$US$US
240828611$24082861$1$I$$20240709$20240712$20240712$PER$$NVSC2024US143769$NOVARTIS$$$$$$Y$$$20240712$$CN$US$US
240828621$24082862$1$I$$20240708$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2017-08460$AUROBINDO$Obada EN, Level G, Mathieu P, Parent X, Gilson B.. [Acute renal failure following a treatment with acyclovir.]. Nephrologie and Therapeutique. 2010;6(2):125-127$30$YR$$F$Y$$$20240712$$HP$FR$FR
240828631$24082863$1$I$$20240705$20240712$20240712$EXP$$TW-ROCHE-10000019334$ROCHE$$57$YR$A$F$Y$$$20240712$$MD$TW$TW
240828641$24082864$1$I$20240418$20240706$20240712$20240712$EXP$GB-MHRA-MED-202405071703163580-SFGKJ$GB-CHEPLA-2024008607$CHEPLAPHARM$$$$$M$Y$$$20240711$$HP$COUNTRY NOT SPECIFIED$GB
240828651$24082865$1$I$$20240628$20240712$20240712$EXP$$US-MACLEODS PHARMA-MAC2024048032$MACLEODS$$$$$$Y$$$20240712$$CN$US$US
240828661$24082866$1$I$$20240708$20240712$20240712$EXP$$NL-GILEAD-2024-0680125$GILEAD$Brakenhoff SM, Chi H., Friederich P., Doukas M., Hoed CD, Flink HJ, et al.. A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report.. Case Reports in Gastroenterology. 2024;18(1):252-259. doi:10.1159/000538342$68$YR$E$M$Y$$$20240712$$MD$NL$NL
240828671$24082867$1$I$$20240704$20240712$20240712$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-108432$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240712$$HP$CA$CA
240828683$24082868$3$F$20240628$20240823$20240712$20240902$EXP$$AT-JNJFOC-20240717232$JOHNSON AND JOHNSON$$39$YR$A$M$Y$117$KG$20240902$$MD$AT$AT
240828692$24082869$2$F$$20240715$20240712$20240722$PER$$US-BIOGEN-2024BI01272870$BIOGEN$$$$$M$Y$$$20240722$$CN$US$US
240828701$24082870$1$I$$20240705$20240712$20240712$PER$$US-BIOGEN-2024BI01271880$BIOGEN$$$$$F$Y$$$20240712$$CN$US$US
240828711$24082871$1$I$$20240708$20240712$20240712$PER$$US-BIOGEN-2024BI01272802$BIOGEN$$$$$M$Y$$$20240712$$CN$US$US
240828731$24082873$1$I$20240626$20240708$20240712$20240712$EXP$$CO-VANTIVE-2024VAN018155$Vantive US Healthcare$$85$YR$$F$Y$55$KG$20240712$$HP$CO$CO
240828742$24082874$2$F$$20240711$20240712$20240717$EXP$$IN-VANTIVE-2024VAN018250$Vantive US Healthcare$$51$YR$$M$Y$$$20240717$$CN$IN$IN
240828751$24082875$1$I$$20240708$20240712$20240712$PER$$US-EMD Serono-2024037467$EMD SERONO INC$$$$A$F$Y$$$20240712$$HP$US$US
240828761$24082876$1$I$20240702$20240702$20240712$20240712$PER$$US-RDY-SPO/USA/24/0009783$DR REDDYS$$20$YR$A$F$Y$$$20240712$$PH$US$US
240828772$24082877$2$F$20240710$20240711$20240712$20240715$PER$$US-AMGEN-USASP2024137818$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240828781$24082878$1$I$$20240709$20240712$20240712$EXP$CA-HPFB-001017610$CA-SERVIER-S23000831$SERVIER$$$$$$Y$$$20240712$$PH$CA$CA
240828791$24082879$1$I$20230824$20230911$20240712$20240712$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408548$RANBAXY$$17$YR$T$M$Y$$$20240712$$MD$US$US
240828801$24082880$1$I$20240707$20240709$20240712$20240712$EXP$$CO-EMD Serono-2024037633$EMD SERONO INC$$61$YR$A$F$Y$$$20240712$$CN$CO$CO
240828812$24082881$2$F$$20240814$20240712$20240821$PER$$US-EMD Serono-2024037475$EMD SERONO INC$$68$YR$E$F$Y$$$20240821$$CN$US$US
240828822$24082882$2$F$20240307$20240708$20240712$20240712$EXP$GB-MHRA-MED-202405161110176040-VBSDZ$GB-STRIDES ARCOLAB LIMITED-2024SP008187$STRIDES$$68$YR$$F$Y$$$20240712$$CN$GB$GB
240828832$24082883$2$F$$20240913$20240712$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002908$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
240828851$24082885$1$I$20240708$20240710$20240712$20240712$EXP$$CA-HALEON-2186480$Haleon PLC$$68$YR$$F$Y$$$20240712$$CN$CA$CA
240828861$24082886$1$I$$20240709$20240712$20240712$PER$$US-LEO Pharma-371884$LEO PHARM$$53$YR$$F$Y$$$20240712$$CN$US$US
240828871$24082887$1$I$$20240704$20240712$20240712$EXP$$NL-CELLTRION INC.-2024NL016545$CELLTRION$$$$$$Y$$$20240712$$HP$NL$NL
240828883$24082888$3$F$20230420$20240708$20240712$20240717$EXP$$US-CHATTEMPRD-2024OHG023635$CHATTEM$$76$YR$E$M$Y$$$20240717$$LW$US$US
240828891$24082889$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006065$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240828913$24082891$3$F$20240708$20240812$20240712$20240812$PER$$US-ALXN-202407USA000530US$ALEXION PHARMACEUTICALS$$73$YR$$M$Y$60.317$KG$20240812$$CN$US$US
240828921$24082892$1$I$$20240705$20240712$20240712$PER$$US-AMGEN-USASP2024134605$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240828931$24082893$1$I$20220501$20240705$20240712$20240712$EXP$$CN-ROCHE-10000002949$ROCHE$Zhang J, He W, Zhang Z, Dong H, Deng X, Wen Q, et al. Skin metastasis from ovarian cancer with somatic BRCA1 mutation: A case report and literature review. Oncology Letters. 2024;28 (2):1-10. doi:10.3892/ol.2024.14481.$49$YR$A$F$Y$$$20240712$$HP$CN$CN
240828941$24082894$1$I$$20240705$20240712$20240712$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000075$Unknown Manufacturer$$$$$$Y$$$20240712$$CN$US$US
240828951$24082895$1$I$20240621$20240703$20240712$20240712$EXP$$CN-ROCHE-10000015908$ROCHE$$65$YR$E$M$Y$70$KG$20240712$$HP$CN$CN
240828961$24082896$1$I$20240703$20240708$20240712$20240712$EXP$GB-MHRA-MED-202407041235375950-QYHNL$GB-STRIDES ARCOLAB LIMITED-2024SP008267$STRIDES$$$$$M$Y$$$20240712$$PH$GB$GB
240828971$24082897$1$I$20240101$20240705$20240712$20240712$EXP$$US-JNJFOC-20240717636$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240712$$CN$US$US
240828981$24082898$1$I$$20240627$20240712$20240712$PER$$US-JNJFOC-20240703261$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$CN$US$US
240828991$24082899$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834122$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240829001$24082900$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186682$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240829011$24082901$1$I$20240524$20240619$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050347$TOLMAR$$85$YR$$M$Y$$$20240712$$CN$CA$CA
240829021$24082902$1$I$20240616$20240619$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050349$TOLMAR$$84$YR$$M$Y$$$20240712$$CN$CA$CA
240829031$24082903$1$I$20240301$20240705$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050348$TOLMAR$$80$YR$$M$Y$$$20240712$$CN$CA$CA
240829041$24082904$1$I$20240401$20240704$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050385$TOLMAR$$68$YR$$M$Y$$$20240712$$CN$CA$CA
240829051$24082905$1$I$$20240708$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050356$TOLMAR$$$$$M$Y$$$20240712$$CN$CA$CA
240829071$24082907$1$I$20240619$20240619$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050390$TOLMAR$$69$YR$$M$Y$$$20240712$$CN$CA$CA
240829081$24082908$1$I$$20240619$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050391$TOLMAR$$$$$M$Y$$$20240712$$CN$CA$CA
240829091$24082909$1$I$$20240708$20240712$20240712$PER$$US-ROCHE-10000021478$ROCHE$$$$A$F$Y$$$20240712$$CN$US$US
240829101$24082910$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186730$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240829111$24082911$1$I$$20240627$20240712$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456130$RANBAXY$$83$YR$$F$Y$$$20240712$$PH$GB$GB
240829121$24082912$1$I$20240301$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455985$RANBAXY$$77$YR$$M$Y$90$KG$20240712$$MD$FR$FR
240829133$24082913$3$F$$20240725$20240712$20240809$EXP$$FI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456160$RANBAXY$$7$DEC$$F$Y$$$20240809$$HP$FI$FI
240829141$24082914$1$I$$20240627$20240712$20240712$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456182$RANBAXY$Mihaila ZA, Branea OE, Branea IA, Lazar A. Acute muscle toxicity following an olanzapine overdose: a case report. Acta Medica Marisiensis. 2024;70(2):42$31$YR$$F$Y$$$20240712$$HP$RO$RO
240829155$24082915$5$F$$20240911$20240712$20240926$EXP$$FI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456229$RANBAXY$$60$YR$$M$Y$$$20240926$$HP$FI$FI
240829162$24082916$2$F$20240509$20240712$20240712$20240723$EXP$$ES-AUROBINDO-AUR-APL-2024-033327$AUROBINDO$$72$YR$$F$Y$68.5$KG$20240723$$MD$ES$ES
240829171$24082917$1$I$20230101$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455981$RANBAXY$$23$YR$$M$Y$$$20240712$$PH$FR$FR
240829181$24082918$1$I$$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456017$RANBAXY$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. J Clin Immunol. 2023;43 (3):647-652$4$YR$$F$Y$$$20240712$$HP$FR$FR
240829191$24082919$1$I$20221114$20240711$20240712$20240712$EXP$$US-UCBSA-2024035175$UCB$$29$YR$$F$Y$$$20240712$$HP$US$US
240829201$24082920$1$I$20240101$20240708$20240712$20240712$EXP$$DE-ABBVIE-5835105$ABBVIE$$$$$M$Y$$$20240712$$MD$DE$DE
240829211$24082921$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186627$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240829221$24082922$1$I$$20240624$20240712$20240712$PER$$US-APOTEX-2024AP007750$APOTEX$$$$E$M$Y$$$20240712$$CN$US$US
240829231$24082923$1$I$$20240708$20240712$20240712$EXP$$CA-ASTELLAS-2024US019649$ASTELLAS$$84$YR$$F$Y$$$20240712$$CN$CA$CA
240829241$24082924$1$I$$20240705$20240712$20240712$EXP$$ZA-AstraZeneca-2024A155770$ASTRAZENECA$$80$YR$$F$Y$$$20240712$$CN$ZA$
240829251$24082925$1$I$$20240704$20240712$20240712$EXP$$VN-AstraZeneca-2024A155613$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$VN$
240829263$24082926$3$F$20240301$20240725$20240712$20240801$EXP$$US-ABBVIE-5833828$ABBVIE$$19$YR$$F$Y$54.431$KG$20240801$$CN$US$US
240829271$24082927$1$I$$20240708$20240712$20240712$EXP$GB-MHRA-MED-202405021803196890-NFPBC$GB-STRIDES ARCOLAB LIMITED-2024SP008271$STRIDES$$$$$$Y$44$KG$20240712$$CN$GB$GB
240829281$24082928$1$I$$20240704$20240712$20240712$EXP$$ES-CELLTRION INC.-2024ES016547$CELLTRION$$$$$$Y$$$20240712$$MD$ES$ES
240829291$24082929$1$I$20101102$20240703$20240712$20240712$EXP$$DE-AUROBINDO-AUR-APL-2024-033185$AUROBINDO$$12$YR$$F$Y$35.5$KG$20240712$$MD$DE$DE
240829301$24082930$1$I$$20240709$20240712$20240712$EXP$$CA-ABBVIE-5835062$ABBVIE$$$$A$F$Y$$$20240712$$CN$CA$CA
240829311$24082931$1$I$$20240705$20240712$20240712$EXP$$BE-ASTELLAS-2024EU006723$ASTELLAS$Meganck S, Raevens S, Ferdinande K, Verhelst X, Hoorens A, Degroote H et al. Recurrent rejections after liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient. Acta clinica Belgica. 2024;No information:1-8$32$YR$$F$Y$$$20240712$$HP$BE$BE
240829321$24082932$1$I$20150101$20240704$20240712$20240712$EXP$$DE-CELLTRION INC.-2024DE016568$CELLTRION$$$$$$Y$$$20240712$$MD$DE$DE
240829331$24082933$1$I$20240101$20240709$20240712$20240712$EXP$$BG-ABBVIE-5835093$ABBVIE$$60$YR$$M$Y$$$20240712$$CN$BG$BG
240829351$24082935$1$I$$20240709$20240712$20240712$EXP$$NVSC2024DE143623$NOVARTIS$$$$$M$Y$$$20240712$$MD$DE$DE
240829362$24082936$2$F$$20240723$20240712$20240724$EXP$$CA-SANDOZ INC.-SDZ2024CA063961$SANDOZ$$40$YR$$F$Y$96$KG$20240724$$HP$CA$CA
240829371$24082937$1$I$20240308$20240708$20240712$20240712$EXP$GB-MHRA-MED-202405051658493230-QSLNK$GB-STRIDES ARCOLAB LIMITED-2024SP008215$STRIDES$$51$YR$$M$Y$113$KG$20240712$$CN$GB$GB
240829381$24082938$1$I$$20240213$20240712$20240712$EXP$$CA-TEVA-VS-3160015$TEVA$$87$YR$$F$Y$$$20240712$$PH$CA$CA
240829401$24082940$1$I$$20240708$20240712$20240712$PER$$US-LEO Pharma-371888$LEO PHARM$$17$YR$$M$Y$40$KG$20240712$$CN$US$US
240829414$24082941$4$F$20240101$20240808$20240712$20240817$EXP$$CA-TEVA-VS-3217760$TEVA$$46$YR$$F$Y$$$20240817$$MD$CA$CA
240829421$24082942$1$I$$20240710$20240712$20240712$EXP$GB-MEN-2024-104908$GB-MEN-2024-104908$MENARINI$$$$$F$Y$$$20240712$$HP$GB$GB
240829431$24082943$1$I$20240101$20240626$20240712$20240712$PER$$US-ABBVIE-5836593$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240829441$24082944$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024136867$AMGEN$$$$$F$Y$$$20240712$$MD$US$US
240829451$24082945$1$I$$20240704$20240712$20240712$EXP$$CN-AMGEN-CHNSP2024134594$AMGEN$Caiguang X.; Lingyan L.; Yuemin Y. et al.. Effects of Evolocumab in the Treatment of Acute Myocardial Infarction After Percutaneous Coronary Intervention. Evaluation and analysis of drug-use in hospitals of China. 2024;24 (5):553-559$$$$$Y$$$20240712$$MD$CN$CN
240829461$24082946$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137359$AMGEN$$$$$$Y$$$20240712$$CN$US$US
240829471$24082947$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA198921$SANOFI AVENTIS$$$$C$M$Y$$$20240712$$MD$US$US
240829481$24082948$1$I$20240101$20240628$20240712$20240712$PER$$US-SA-2024SA094959$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240712$$MD$US$US
240829493$24082949$3$F$20240101$20240802$20240712$20240816$PER$$US-SA-2024SA197464$SANOFI AVENTIS$$44$YR$A$F$Y$106$KG$20240816$$CN$US$US
240829501$24082950$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA079101$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240712$$MD$US$US
240829511$24082951$1$I$20230101$20240705$20240712$20240712$PER$$US-SA-2024SA203293$SANOFI AVENTIS$$63$YR$A$F$Y$68.583$KG$20240712$$MD$US$US
240829521$24082952$1$I$$20240708$20240712$20240712$EXP$GB-MHRA-MED-202405030841217640-RCGSB$GB-STRIDES ARCOLAB LIMITED-2024SP008287$STRIDES$$$$$F$Y$$$20240712$$HP$GB$GB
240829531$24082953$1$I$20240401$20240706$20240712$20240712$EXP$GB-MHRA-MED-202405060910388660-LGKDY$GB-CHEPLA-2024008662$CHEPLAPHARM$$61$YR$$F$Y$116$KG$20240712$$CN$COUNTRY NOT SPECIFIED$GB
240829542$24082954$2$F$$20240707$20240712$20240724$EXP$$JP-009507513-2407JPN001598J$MERCK$Araki M, Matsui K, Ohsawa S, Yoshida T, Hori R, Fujii T.. EP-0522 Experience of immune-related adverse events occurring during preoperative chemotherapy at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 308$4$DEC$$F$Y$$$20240724$$MD$JP$JP
240829551$24082955$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186716$Haleon PLC$$$$$F$Y$$$20240712$$CN$US$US
240829561$24082956$1$I$$20240710$20240712$20240712$EXP$$GB-SANDOZ INC.-SDZ2024GB039438$SANDOZ$$$$$F$Y$$$20240712$$CN$GB$GB
240829571$24082957$1$I$$20240708$20240712$20240712$EXP$$JP-CHEPLA-2024008558$CHEPLAPHARM$Noda Y, Hamada M, Minowa K. A case of cooperation between a hospital and pharmacy for a patient with large intestine carcinoma which prevented adverse reactions from being aggravated and led to maintenance of treatment (Abstract number:P-145). Journal of Japanese Society of Pharmaceutical Oncology/Annual Meeting of Japanes.2024;36:370.$8$DEC$$M$Y$$$20240712$$PH$COUNTRY NOT SPECIFIED$JP
240829581$24082958$1$I$$20240619$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002851$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240829601$24082960$1$I$20240626$20240703$20240712$20240712$EXP$$US-BEH-2024175168$CSL BEHRING$$8$YR$C$M$Y$$$20240712$$HP$US$US
240829611$24082961$1$I$$20240708$20240712$20240712$EXP$$CA-SANDOZ INC.-SDZ2024CA063521$SANDOZ$$83$YR$$F$Y$87$KG$20240712$$HP$CA$CA
240829621$24082962$1$I$20240709$20240710$20240712$20240712$EXP$$ES-ABBVIE-5836698$ABBVIE$$78$YR$$F$Y$57$KG$20240712$$HP$ES$ES
240829631$24082963$1$I$20240324$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455044$RANBAXY$$56$YR$$F$Y$$$20240712$$PH$FR$FR
240829641$24082964$1$I$20240601$20240710$20240712$20240712$EXP$$NVSC2024DE143627$NOVARTIS$$25$YR$$F$Y$$$20240712$$MD$DE$DE
240829651$24082965$1$I$$20240627$20240712$20240712$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454883$RANBAXY$$$$E$M$Y$$$20240712$$CN$DE$DE
240829662$24082966$2$F$$20240723$20240712$20240731$PER$$US-ABBVIE-5834549$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
240829671$24082967$1$I$$20240708$20240712$20240712$EXP$GB-MHRA-MED-202405030852197980-SBFKV$GB-STRIDES ARCOLAB LIMITED-2024SP008288$STRIDES$$$$$$Y$$$20240712$$HP$GB$GB
240829681$24082968$1$I$$20240709$20240712$20240712$EXP$$AU-009507513-2407AUS004847$MERCK$$$$$F$Y$$$20240712$$MD$AU$AU
240829691$24082969$1$I$20240101$20240628$20240712$20240712$PER$$US-SA-2024SA199940$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240712$$MD$US$US
240829702$24082970$2$F$20240101$20240805$20240712$20240812$PER$$US-SA-2024SA168239$SANOFI AVENTIS$$77$YR$E$F$Y$79.02$KG$20240812$$MD$US$US
240829711$24082971$1$I$20240201$20240627$20240712$20240712$EXP$$DE-LUPIN HEALTHCARE (UK) LIMITED-2024-05719$LUPIN$$$$$F$Y$3.58$KG$20240712$$MD$DE$DE
240829722$24082972$2$F$$20240823$20240712$20240830$EXP$$FI-AMGEN-FINSP2024136407$AMGEN$Kolho K.; Raisanen L.; Nikkonen A. et al.. Liver enzyme profiles after initiating biological treatment in children with inflammatory bowel diseases. Journal of Pediatric Gastroenterology and Nutrition. 2024;1-9$$$$$Y$$$20240830$$HP$FI$FI
240829731$24082973$1$I$20240617$20240619$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002911$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240712$$CN$US$US
240829741$24082974$1$I$20220822$20240628$20240712$20240712$EXP$IT-MINISAL02-892668$IT-SERVIER-S22011413$SERVIER$$$$$$Y$$$20240712$$PH$IT$IT
240829751$24082975$1$I$$20240708$20240712$20240712$EXP$GB-MHRA-MED-202405091156004180-HMBTC$GB-STRIDES ARCOLAB LIMITED-2024SP008295$STRIDES$$$$$M$Y$$$20240712$$PH$GB$GB
240829761$24082976$1$I$$20240701$20240712$20240712$EXP$$US-RDY-LIT/USA/24/0009919$DR REDDYS$Merrill K, Davis A, Jackson E, Riker M, Kirk C, Yung D. Direct prostacyclin transition in pediatric patients with pulmonary hypertension. Pulmonary Circulation. 2024 Apr;14(2): 1-5. doi:10.1002/pul2.12373.$12$YR$T$F$Y$41$KG$20240712$$HP$US$US
240829771$24082977$1$I$$20240708$20240712$20240712$EXP$GB-MHRA-MED-202405081127236150-GTRHJ$GB-STRIDES ARCOLAB LIMITED-2024SP008296$STRIDES$$$$$F$Y$$$20240712$$HP$GB$GB
240829781$24082978$1$I$$20240704$20240712$20240712$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01236$NOVITIUM PHARMA$Claudia Maniezzi.Electrophysiological effects of estrogen on hiPSC-derived cardiomyocytes of a patient affected by estrogen-sensitive Long-QT Syndrome Type 2.Vascular Pharmacology.18-JUN-2024;155:1-4$$$$F$Y$$$20240712$$HP$IT$IT
240829791$24082979$1$I$$20240711$20240712$20240712$PER$$US-AMGEN-USASP2024138051$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240829801$24082980$1$I$$20240705$20240712$20240712$EXP$$CA-AMGEN-CANSP2024134436$AMGEN$Rajendran L.; Magyar C.; Li Z. et al.. Is liver transplantation a treatment option for unresectable colorectal liver metastases? Interim analysis of a phase II trial. Annals of Oncology. 2024;35 (SUPPL_1):S24-S25$$$$$Y$$$20240712$$HP$CA$CA
240829812$24082981$2$F$20240101$20240808$20240712$20240812$PER$$US-ROCHE-10000023406$ROCHE$$11$YR$C$M$Y$54.43$KG$20240813$$CN$US$US
240829821$24082982$1$I$20240614$20240704$20240712$20240712$EXP$SE-SEMPA-2024-005166$SE-TEVA-VS-3217593$TEVA$$46$YR$$F$Y$$$20240712$$MD$SE$SE
240829831$24082983$1$I$20240501$20240704$20240712$20240712$EXP$$RU-AstraZeneca-2024A156165$ASTRAZENECA$$72$YR$$M$Y$$$20240712$$MD$RU$
240829841$24082984$1$I$$20240704$20240712$20240712$EXP$$GB-AstraZeneca-2024A153946$ASTRAZENECA$$67$YR$$M$Y$133$KG$20240712$$MD$GB$
240829851$24082985$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006655$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240712$$CN$US$US
240829861$24082986$1$I$20240710$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007527$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240712$$CN$US$US
240829872$24082987$2$F$20240709$20240709$20240712$20240713$PER$$US-ELI_LILLY_AND_COMPANY-US202407006190$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240713$$CN$US$US
240829881$24082988$1$I$$20240711$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007819$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240712$$CN$US$US
240829892$24082989$2$F$20240611$20240809$20240712$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202406010779$ELI LILLY AND CO$$52$YR$A$M$Y$109.8$KG$20240816$$MD$US$US
240829901$24082990$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007159$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240829912$24082991$2$F$$20240722$20240712$20240802$EXP$$JP-TAKEDA-2024TUS070503$TAKEDA$$28$YR$$M$Y$$$20240802$$MD$JP$JP
240829931$24082993$1$I$20240705$20240706$20240712$20240712$EXP$$AU-TAKEDA-2024TUS070717$TAKEDA$$75$YR$$F$Y$$$20240712$$CN$AU$AU
240829941$24082994$1$I$$20240701$20240712$20240712$EXP$$MX-NOVAST LABORATORIES INC.-2024NOV000268$NOVAST$Ledesma GJ, Gurr?a QLU.. Transient cataract and permanent atrophy of the iris after the application  of subconjunctival 5-fluorouracil.. An Med (Mex).. 2020;65 (4):301-304$49$YR$$F$Y$$$20240712$$HP$MX$MX
240829961$24082996$1$I$20240618$20240701$20240712$20240712$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000271$NOVAST$$$$$$Y$$$20240712$$HP$CN$CN
240829971$24082997$1$I$$20240708$20240712$20240712$EXP$$JP-AMGEN-JPNSP2024135067$AMGEN$$$$$$Y$$$20240712$$PH$JP$JP
240829981$24082998$1$I$20240101$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024136820$AMGEN$$69$YR$E$M$Y$$$20240712$$CN$US$US
240830012$24083001$2$F$$20240806$20240712$20240807$EXP$$JP-BEH-2024175451$CSL BEHRING$$5$DEC$A$$Y$$$20240807$$MD$JP$JP
240830032$24083003$2$F$$20240814$20240712$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05904$LUPIN$$$$$$Y$$$20240828$$CN$US$US
240830041$24083004$1$I$20240101$20240711$20240712$20240712$EXP$GB-MHRA-MED-202407101019534010-STLFR$GB-UCBSA-2024035283$UCB$$63$YR$$F$Y$44$KG$20240712$$CN$GB$GB
240830051$24083005$1$I$$20240701$20240712$20240712$EXP$$CH-ROCHE-10000023189$ROCHE$$64$YR$A$M$Y$$$20240712$$MD$CH$CH
240830061$24083006$1$I$$20240401$20240712$20240712$PER$$US-AJANTA-2024AJA00066$AJANTA PHARMA$$75$YR$E$M$Y$176$KG$20240712$$CN$US$US
240830071$24083007$1$I$20240709$20240709$20240712$20240712$EXP$$US-ABBVIE-5833521$ABBVIE$$49$YR$$M$Y$$$20240712$$CN$US$US
240830081$24083008$1$I$20240101$20240709$20240712$20240712$EXP$$US-ABBVIE-5834060$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240830092$24083009$2$F$$20240905$20240712$20240911$EXP$$US-ABBVIE-5833583$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
240830101$24083010$1$I$20240621$20240701$20240712$20240712$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000584$PAREXEL$$$$$$Y$$$20240712$$HP$CN$CN
240830112$24083011$2$F$$20240913$20240712$20240923$PER$$US-SA-2024SA199780$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240923$$MD$US$US
240830121$24083012$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA199934$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240712$$MD$US$US
240830131$24083013$1$I$20240101$20240706$20240712$20240712$PER$$US-SA-2024SA202890$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240712$$CN$US$US
240830141$24083014$1$I$20240101$20240708$20240712$20240712$PER$$US-SA-2024SA202032$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240712$$MD$US$US
240830151$24083015$1$I$20240707$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137485$AMGEN$$79$YR$E$F$Y$$$20240712$$CN$US$US
240830162$24083016$2$F$20240709$20240710$20240712$20240716$EXP$$US-AMGEN-USASP2024136253$AMGEN$$80$YR$E$M$Y$$$20240716$$CN$US$US
240830172$24083017$2$F$20240601$20240724$20240712$20240727$EXP$$PT-ABBVIE-5834814$ABBVIE$$32$YR$$F$Y$$$20240727$$CN$PT$PT
240830182$24083018$2$F$$20240718$20240712$20240725$EXP$$CA-TAKEDA-2024TUS058560$TAKEDA$$$$$F$Y$$$20240725$$CN$CA$CA
240830191$24083019$1$I$$20240710$20240712$20240712$EXP$$US-GILEAD-2024-0680323$GILEAD$$$$A$M$Y$$$20240712$$CN$US$US
240830201$24083020$1$I$$20240709$20240712$20240712$PER$$US-ABBVIE-5836100$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240830211$24083021$1$I$$20240708$20240712$20240712$EXP$$US-ABBVIE-5834954$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240830222$24083022$2$F$$20240909$20240712$20240913$EXP$$US-ABBVIE-5835246$ABBVIE$$$$$M$Y$90.1$KG$20240913$$MD$US$US
240830231$24083023$1$I$20240709$20240711$20240712$20240712$PER$$US-JNJFOC-20240729163$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240712$$HP$US$US
240830243$24083024$3$F$20240706$20240716$20240712$20240724$EXP$$US-Taiho Oncology Inc-2024-006092$TAIHO ONCOLOGY INC$$73$YR$E$M$Y$$$20240724$$CN$US$US
240830251$24083025$1$I$$20240704$20240712$20240712$EXP$$US-RDY-LIT/USA/24/0009997$DR REDDYS$Shukla P, Lubrin SI, Subramanian R, Joshi H. SEVERE ARDS AND IMMUNE RECONSTITUTION SYNDROME IN A RARE CASE OF MULTIDRUG-RESISTANT TUBERCULOSIS: A CASE REPORT AND REVIEW. Chest. 2023 Oct 01;164(4): A1514. doi:10.1016/j.chest.2023.07.1041.$42$YR$A$F$Y$$$20240712$$HP$US$US
240830281$24083028$1$I$20240701$20240705$20240712$20240712$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00642$CATALYST PHARMA$$63$YR$$F$Y$100.23$KG$20240712$$CN$US$US
240830312$24083031$2$F$20240709$20240709$20240712$20240808$EXP$$US-VANTIVE-2024VAN018241$Vantive US Healthcare$$$$$$Y$$$20240808$$HP$US$US
240830321$24083032$1$I$$20240617$20240712$20240712$EXP$$VN-ROCHE-10000017670$ROCHE$$19$YR$A$M$Y$$$20240712$$MD$VN$VN
240830331$24083033$1$I$$20240708$20240712$20240712$PER$$US-ABBVIE-5834179$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240830341$24083034$1$I$20240626$20240702$20240712$20240712$EXP$CN-NMPACDR-3704011509867202400606$CN-BAXTER-2024BAX021121$BAXTER$$41$YR$$F$Y$62$KG$20240712$$MD$CN$CN
240830351$24083035$1$I$20240101$20240428$20240712$20240712$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-106924$ZYDUS PHARM$$$$$$Y$$$20240712$$CN$US$US
240830361$24083036$1$I$20240619$20240704$20240712$20240712$EXP$LU-ALMPS-202404270$LU-TEVA-VS-3217470$TEVA$$74$YR$$F$Y$49$KG$20240712$$PH$LU$LU
240830371$24083037$1$I$$20240711$20240712$20240712$PER$$US-ROCHE-10000024499$ROCHE$$73$YR$E$M$Y$$$20240712$$MD$US$US
240830381$24083038$1$I$$20240626$20240712$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05843$LUPIN$$$$$$Y$$$20240712$$CN$US$US
240830394$24083039$4$F$$20240905$20240712$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002866$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
240830401$24083040$1$I$$20240619$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002913$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240830412$24083041$2$F$20240301$20240716$20240712$20240730$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000586$PAREXEL$$$$$$Y$$$20240730$$MD$CN$CN
240830421$24083042$1$I$$20240711$20240712$20240712$EXP$$TW-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039190$BOEHRINGER INGELHEIM$$$$$M$Y$116$KG$20240712$$MD$TW$TW
240830431$24083043$1$I$$20240708$20240712$20240712$EXP$$US-ABBVIE-5834809$ABBVIE$$$$$F$Y$$$20240712$$MD$US$US
240830441$24083044$1$I$20240627$20240705$20240712$20240712$EXP$$CA-ROCHE-10000023772$ROCHE$$79$YR$E$M$Y$$$20240712$$CN$CA$CA
240830451$24083045$1$I$20240708$20240711$20240712$20240712$PER$$US-AMGEN-USASP2024138277$AMGEN$$42$YR$A$M$Y$$$20240712$$CN$US$US
240830461$24083046$1$I$$20240710$20240712$20240712$PER$$US-ABBVIE-5835357$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240830471$24083047$1$I$$20240620$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002930$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240830482$24083048$2$F$$20240820$20240712$20240821$PER$$US-ALXN-202407USA000415US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
240830491$24083049$1$I$$20240703$20240712$20240712$EXP$$PL-ROCHE-10000023648$ROCHE$$55$YR$A$M$Y$$$20240712$$MD$PL$PL
240830511$24083051$1$I$$20240706$20240712$20240712$EXP$$CL-EMD Serono-2024037112$EMD SERONO INC$$$$A$M$Y$$$20240712$$CN$CL$CL
240830521$24083052$1$I$20240520$20240628$20240712$20240712$EXP$IT-MINISAL02-992157$IT-SERVIER-S24008253$SERVIER$$$$$$Y$$$20240712$$PH$IT$IT
240830531$24083053$1$I$20240705$20240708$20240712$20240712$EXP$$CA-ABBVIE-5834964$ABBVIE$$$$A$F$Y$$$20240712$$CN$CA$CA
240830541$24083054$1$I$20240201$20240701$20240712$20240712$EXP$DE-EMBRYOTOX-202309591$DE-TORRENT-00026978$TORRENT$$$$$F$Y$3$KG$20240712$$MD$DE$DE
240830551$24083055$1$I$$20240702$20240712$20240712$EXP$$ES-TEVA-VS-3217550$TEVA$$72$YR$$F$Y$$$20240712$$CN$ES$ES
240830561$24083056$1$I$20240618$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110421$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$59.42$KG$20240712$$CN$US$US
240830571$24083057$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110438$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240712$$CN$US$US
240830582$24083058$2$F$$20240722$20240712$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109967$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240725$$CN$US$US
240830591$24083059$1$I$$20240709$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110385$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240712$$CN$US$US
240830601$24083060$1$I$$20240710$20240712$20240712$EXP$$US-ABBVIE-5836094$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240830611$24083061$1$I$20240501$20240703$20240712$20240712$PER$$US-SA-2024SA200579$SANOFI AVENTIS$$52$YR$A$M$Y$89.811$KG$20240712$$MD$US$US
240830621$24083062$1$I$$20240706$20240712$20240712$PER$$US-SA-2024SA202825$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240712$$CN$US$US
240830632$24083063$2$F$20240516$20240814$20240712$20240910$PER$$US-SA-2024SA200938$SANOFI AVENTIS$$5$YR$C$F$Y$19.955$KG$20240910$$MD$US$US
240830651$24083065$1$I$20240101$20240702$20240712$20240712$PER$$US-TEVA-VS-3218110$TEVA$$$$$F$Y$$$20240712$$CN$US$US
240830661$24083066$1$I$$20240620$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-001795$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240830671$24083067$1$I$$20240709$20240712$20240712$PER$$US-TAKEDA-2024TUS070484$TAKEDA$$34$YR$$M$Y$56$KG$20240712$$MD$US$US
240830681$24083068$1$I$$20240705$20240712$20240712$EXP$$CA-AMGEN-CANSP2024134412$AMGEN$Rajendran L.. Is liver transplantation a treatment option for unresectable colorectal liver metastases? Interim analysis of a phase ll trial. Annals of Oncology. 2024;35 (S1):S24-S25$$$$$Y$$$20240712$$HP$CA$CA
240830691$24083069$1$I$20230501$20240710$20240712$20240712$EXP$NO-NOMAADVRE-PASRAPP-2024-Vk8x9z$NO-ORGANON-O2407NOR001021$ORGANON$$44$YR$$M$Y$86$KG$20240712$$CN$NO$NO
240830711$24083071$1$I$$20240618$20240712$20240712$PER$$US-JNJFOC-20240655710$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240830721$24083072$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006878$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240712$$CN$US$US
240830731$24083073$1$I$20240619$20240710$20240712$20240712$EXP$$US-HALEON-2186445$Haleon PLC$$31$YR$$F$Y$97.069$KG$20240712$$HP$US$US
240830741$24083074$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007043$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240712$$CN$US$US
240830751$24083075$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007140$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240712$$CN$US$US
240830761$24083076$1$I$20240626$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007033$ELI LILLY AND CO$$$$$F$Y$$$20240712$$CN$US$US
240830771$24083077$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007325$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240712$$CN$US$US
240830781$24083078$1$I$20240709$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006791$ELI LILLY AND CO$$$$$F$Y$$$20240712$$CN$US$US
240830791$24083079$1$I$20240612$20240617$20240712$20240712$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000505$PAREXEL$$$$$$Y$$$20240712$$PH$US$US
240830801$24083080$1$I$20240601$20240705$20240712$20240712$EXP$$US-BEH-2024175152$CSL BEHRING$$11$MON$I$M$Y$$$20240712$$HP$US$US
240830811$24083081$1$I$$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110533$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240712$$CN$US$US
240830821$24083082$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110324$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240712$$CN$US$US
240830841$24083084$1$I$$20240709$20240712$20240712$EXP$$US-AstraZeneca-2024A156975$ASTRAZENECA$$$$$$Y$$$20240712$$CN$US$
240830851$24083085$1$I$20240703$20240709$20240712$20240712$EXP$$US-AstraZeneca-2024A158261$ASTRAZENECA$$29609$DY$$M$Y$$$20240712$$HP$US$
240830862$24083086$2$F$20240101$20240827$20240712$20240905$PER$$US-APOTEX-2024AP007865$APOTEX$$$$E$F$Y$$$20240905$$CN$US$US
240830871$24083087$1$I$$20240706$20240712$20240712$EXP$$MY-AstraZeneca-2024A156816$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$MY$
240830884$24083088$4$F$20240101$20240905$20240712$20240911$EXP$$JP-GSK-JP2024JPN084115$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$PH$JP$JP
240830891$24083089$1$I$20240101$20240708$20240712$20240712$EXP$$US-ABBVIE-5832744$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240830901$24083090$1$I$20240101$20240709$20240712$20240712$EXP$$US-ABBVIE-5834516$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240830911$24083091$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834551$ABBVIE$$$$$F$Y$$$20240712$$HP$US$US
240830921$24083092$1$I$20240408$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455873$RANBAXY$$89$YR$$F$Y$49$KG$20240712$$PH$FR$FR
240830931$24083093$1$I$20240518$20240628$20240712$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456207$RANBAXY$$58$YR$$F$Y$73$KG$20240712$$PH$GB$GB
240830941$24083094$1$I$$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455867$RANBAXY$$53$YR$$M$Y$$$20240712$$PH$FR$FR
240830951$24083095$1$I$20240301$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455971$RANBAXY$$52$YR$$F$Y$77$KG$20240712$$PH$FR$FR
240830961$24083096$1$I$$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455959$RANBAXY$$23$YR$$F$Y$$$20240712$$MD$FR$FR
240830972$24083097$2$F$20240305$20240719$20240712$20240802$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455729$RANBAXY$$69$YR$$F$Y$58$KG$20240802$$HP$IT$IT
240830981$24083098$1$I$$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455948$RANBAXY$$67$YR$$M$Y$$$20240712$$PH$FR$FR
240830993$24083099$3$F$20240615$20240726$20240712$20240730$EXP$$CN-JNJFOC-20240724536$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240731$$MD$CN$CN
240831005$24083100$5$F$$20231219$20240712$20240916$PER$$US-ENDO USA, INC.-2024-000163$ENDO$$$$$M$Y$$$20240916$$CN$US$US
240831011$24083101$1$I$$20240628$20240712$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456194$RANBAXY$$75$YR$$F$Y$$$20240712$$PH$GB$GB
240831021$24083102$1$I$$20240629$20240712$20240712$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456515$RANBAXY$Minami S, Shoshihara N. Long-term responders to erlotinib for pulmonary adenocarcinoma with wildtype epidermal growth factor receptor: two case reports and a single-institutional retrospective study. World J Oncol. 2023;14 (1):101-107$58$YR$$M$Y$$$20240712$$HP$JP$JP
240831031$24083103$1$I$$20240629$20240712$20240712$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456488$RANBAXY$Minami S, Shoshihara N. Long-term responders to erlotinib for pulmonary adenocarcinoma with wildtype epidermal growth factor receptor: two case reports and a single-institutional retrospective study. World J Oncol. 2023;14 (1):101-107$60$YR$$F$Y$$$20240712$$HP$JP$JP
240831041$24083104$1$I$20240430$20240709$20240712$20240712$EXP$$CO-UCBSA-2024035362$UCB$$6$YR$$F$Y$$$20240712$$CN$CO$CO
240831061$24083106$1$I$20240216$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455846$RANBAXY$$74$YR$$F$Y$68$KG$20240712$$MD$FR$FR
240831071$24083107$1$I$$20240628$20240712$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456101$RANBAXY$$75$YR$$$Y$$$20240712$$PH$GB$GB
240831091$24083109$1$I$20230830$20240627$20240712$20240712$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455951$RANBAXY$$91$YR$$M$Y$94$KG$20240712$$HP$DE$DE
240831102$24083110$2$F$$20240722$20240712$20240729$PER$$US-ABBVIE-5835796$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
240831111$24083111$1$I$20240101$20240709$20240712$20240712$PER$$US-SA-2024SA203509$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240712$$CN$US$US
240831123$24083112$3$F$20240101$20240802$20240712$20240810$PER$$US-SA-2024SA195988$SANOFI AVENTIS$$54$YR$A$F$Y$123.2$KG$20240810$$MD$US$US
240831131$24083113$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA202668$SANOFI AVENTIS$$$$A$F$Y$70.3$KG$20240712$$MD$US$US
240831141$24083114$1$I$20090201$20240614$20240712$20240712$EXP$$JP-SA-2024SA198883$SANOFI AVENTIS$Matsuzakia T, Eguchib K, Nagaob N, Tsujib S, Aramakib T, Teradab K et al.. Hepatitis B virus reactivation in patients with rheumatoid arthritis: A singlecenter study.. Modern rheumatology.. 2018;28(5):808-13$60$YR$A$M$Y$$$20240712$$HP$JP$JP
240831161$24083116$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA201842$SANOFI AVENTIS$$$$C$F$Y$$$20240712$$MD$US$US
240831173$24083117$3$F$20240630$20240730$20240712$20240806$PER$$US-SA-2024SA201267$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240806$$MD$US$US
240831181$24083118$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA202822$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240712$$MD$US$US
240831191$24083119$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA200996$SANOFI AVENTIS$$81$YR$E$M$Y$72.16$KG$20240712$$MD$US$US
240831201$24083120$1$I$$20240705$20240712$20240712$EXP$$IT-AMGEN-ITASP2024134518$AMGEN$Conca V.. Negative hyperselection and mechanisms of acquired resistance to first-line chemotherapy plus anti-EGFR in pMMR RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts): A translational analysis of the TRIPLETE trial. Annals of Oncology. 2024;35 (S1):S50$$$$$Y$$$20240712$$HP$IT$IT
240831211$24083121$1$I$$20240702$20240712$20240712$EXP$$US-ROCHE-10000018535$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240831222$24083122$2$F$$20240806$20240712$20240807$PER$$US-ALXN-202407USA000580US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
240831231$24083123$1$I$20240524$20240617$20240712$20240712$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000506$PAREXEL$$$$$$Y$$$20240712$$PH$US$US
240831241$24083124$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834385$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240831251$24083125$1$I$20240214$20240704$20240712$20240712$EXP$FR-AFSSAPS-AVMA2024000271$FR-TEVA-VS-3217476$TEVA$$26$YR$$M$Y$$$20240712$$PH$FR$FR
240831261$24083126$1$I$20230412$20240711$20240712$20240712$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-231428$BOEHRINGER INGELHEIM$$84$YR$E$F$Y$$$20240712$$CN$CA$CA
240831272$24083127$2$F$$20240724$20240712$20240802$EXP$$US-TEVA-VS-3218283$TEVA$Blankenship S, Lodh A, Minish-Pron JM, Morris PE. Catastrophic Antiphospholipid Syndrome as a Cause for Multi-System Organ Failure and Death. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A3546.; Blankenship S, Lodh A, Minish-Pron JM, Morris PE. Catastrophic Antiphospholipid Syndrome as a Cause for Multi-System Organ Failure and Death. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A3546.$19$YR$$F$Y$$$20240802$$HP$US$US
240831281$24083128$1$I$20240711$20240711$20240712$20240712$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039425$BOEHRINGER INGELHEIM$$7$DEC$E$M$Y$$$20240712$$MD$JP$JP
240831291$24083129$1$I$20240601$20240709$20240712$20240712$EXP$$JP-ASTELLAS-2024JP004839$ASTELLAS$$7$DEC$$F$Y$$$20240712$$MD$JP$JP
240831301$24083130$1$I$20240401$20240708$20240712$20240712$PER$$US-ABBVIE-5836192$ABBVIE$$$$A$$Y$$$20240712$$HP$US$US
240831312$24083131$2$F$20240708$20240709$20240712$20240717$PER$$US-AMGEN-USASP2024136746$AMGEN$$67$YR$E$M$Y$$$20240717$$HP$US$US
240831321$24083132$1$I$20240627$20240628$20240712$20240712$PER$$US-ROCHE-10000023413$ROCHE$$45$YR$A$F$Y$$$20240712$$CN$US$US
240831331$24083133$1$I$20221101$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455648$RANBAXY$$83$YR$$M$Y$$$20240712$$MD$FR$FR
240831341$24083134$1$I$20240120$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455332$RANBAXY$$31$YR$$M$Y$$$20240712$$MD$FR$FR
240831351$24083135$1$I$20240222$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455726$RANBAXY$$74$YR$$M$Y$68$KG$20240712$$MD$FR$FR
240831361$24083136$1$I$20240315$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455652$RANBAXY$$73$YR$$M$Y$106$KG$20240712$$MD$FR$FR
240831371$24083137$1$I$20230101$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455638$RANBAXY$$63$YR$$M$Y$$$20240712$$PH$FR$FR
240831381$24083138$1$I$20240211$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455698$RANBAXY$$14$YR$$F$Y$49$KG$20240712$$MD$FR$FR
240831403$24083140$3$F$20240623$20240815$20240712$20240826$PER$$US-ROCHE-10000022049$ROCHE$$37$YR$A$F$Y$$$20240826$$CN$US$US
240831411$24083141$1$I$20240702$20240702$20240712$20240712$PER$$US-EMD Serono-2024036138$EMD SERONO INC$$58$YR$A$F$Y$$$20240712$$HP$US$US
240831422$24083142$2$F$20240629$20240722$20240712$20240725$EXP$$NVSC2024DE139179$NOVARTIS$$44$YR$$F$Y$71$KG$20240725$$HP$DE$DE
240831441$24083144$1$I$$20240704$20240712$20240712$EXP$$ZA-AstraZeneca-2024A155346$ASTRAZENECA$$70$YR$$M$Y$$$20240712$$CN$ZA$
240831451$24083145$1$I$$20240704$20240712$20240712$EXP$$ZA-AstraZeneca-2024A154277$ASTRAZENECA$$86$YR$$M$Y$$$20240712$$CN$ZA$
240831462$24083146$2$F$$20240910$20240712$20240913$PER$$US-ROCHE-10000024067$ROCHE$$9$YR$C$M$Y$$$20240913$$HP$US$US
240831472$24083147$2$F$20240628$20240904$20240712$20240911$PER$$US-Vifor (International) Inc.-VIT-2024-06041$VIFOR$$20$YR$$M$Y$75$KG$20240911$$HP$US$US
240831481$24083148$1$I$$20240708$20240712$20240712$EXP$$JP-ASTELLAS-2024JP004830$ASTELLAS$Kumata D, Yamae M, Ide C, Nakano M. Two cases of bullous toxic erythema of chemotherapy (TEC) due to enfortumab vedotin. The 910th Tokyo regional meeting (four district meetings) of the Japanese Dermat. 2024;2-3$79$YR$$M$Y$$$20240712$$MD$JP$JP
240831492$24083149$2$F$$20240802$20240712$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110631$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240808$$CN$US$US
240831501$24083150$1$I$$20240709$20240712$20240712$EXP$$JP-ASTELLAS-2024JP004832$ASTELLAS$$8$DEC$$M$Y$$$20240712$$HP$JP$JP
240831511$24083151$1$I$$20240708$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109519$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$$$20240712$$CN$US$US
240831521$24083152$1$I$20240601$20240709$20240712$20240712$EXP$$JP-ASTELLAS-2024JP004841$ASTELLAS$$77$YR$$M$Y$$$20240712$$HP$JP$JP
240831532$24083153$2$F$20191101$20240718$20240712$20240726$EXP$$HR-BIOCON BIOLOGICS LIMITED-BBL2024005009$BIOCON$$$$$$Y$$$20240726$$MD$HR$HR
240831541$24083154$1$I$$20240704$20240712$20240712$EXP$$PT-AJANTA-2024AJA00126$AJANTA PHARMA$Mendonca MD, Barahona-Correa JB.Tetrabenazine-induced acute dystonic reaction during the treatment of comorbid tics in a young woman with autism spectrum disorder.Psychiatry and Clinical Neurosciences.28-JUN-2024$18$YR$A$F$Y$$$20240712$$MD$PT$PT
240831563$24083156$3$F$$20240703$20240712$20240802$EXP$$CA-BEH-2024175332$CSL BEHRING$$$$A$F$Y$60.8$KG$20240802$$CN$CA$CA
240831571$24083157$1$I$20240117$20240628$20240712$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456095$RANBAXY$$52$YR$$F$Y$$$20240712$$MD$GB$GB
240831581$24083158$1$I$$20240707$20240712$20240712$PER$$US-ABBVIE-5835022$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240831591$24083159$1$I$$20240703$20240712$20240712$EXP$$ES-AMGEN-ESPSP2024134106$AMGEN$$61$YR$A$M$Y$$$20240712$$MD$ES$ES
240831601$24083160$1$I$20240629$20240710$20240712$20240712$PER$$US-BAYER-2024A099621$BAYER$$57$YR$A$F$Y$$$20240712$$CN$US$US
240831611$24083161$1$I$$20240708$20240712$20240712$EXP$$QA-AMGEN-QATSP2024134840$AMGEN$Elsabah, H.. Relapsed IgA Multiple Myeloma as Testicular Plasmacytoma after Quadrable Novel Therapy and Autologous Stem Cell Transplant: A Rare Case Report and Literature Review. Case Reports in Oncology. 2024;17 (1):291-297$39$YR$A$M$Y$$$20240712$$HP$QA$QA
240831621$24083162$1$I$$20240707$20240712$20240712$EXP$$IL-AMGEN-ISRSP2024134741$AMGEN$$85$YR$E$F$Y$$$20240712$$PH$IL$IL
240831631$24083163$1$I$$20240630$20240712$20240712$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-20467$SAMSUNG BIOEPIS$$47$YR$A$M$Y$$$20240712$$HP$GB$GB
240831641$24083164$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07054$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831651$24083165$1$I$$20240628$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07004$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831662$24083166$2$F$$20240708$20240712$20240722$EXP$$GB-CIPLA LTD.-2024GB07057$CIPLA$$$$$$Y$$$20240722$$CN$GB$GB
240831672$24083167$2$F$20240101$20240722$20240712$20240724$PER$$US-ABBVIE-5835008$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
240831711$24083171$1$I$$20240620$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002949$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240831722$24083172$2$F$20230505$20240829$20240712$20240906$EXP$$AU-CELLTRION INC.-2024AU017034$CELLTRION$$$$$$Y$$$20240906$$MD$AU$AU
240831751$24083175$1$I$$20240709$20240712$20240712$PER$$US-JNJFOC-20240727110$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$MD$US$US
240831771$24083177$1$I$$20240709$20240712$20240712$EXP$$JP-ORGANON-O2407JPN001024$ORGANON$Kanai A, Yokohama Y, Yoshizawa A, Nakanishi K, Ishikawa Y, Sakai M, et al.. O42-7 A case of a woman who had been taking angiotensin II receptor blocker until the second trimester of pregnancy and had a live fetus with hydrops fetalis after discontinuation of the drug. Journal of Japan Society of Perinatal and Neonatal Medicine/ The 60th Annual Con. 2024;60(S1):252$$$$F$Y$$$20240712$$MD$JP$JP
240831784$24083178$4$F$$20240819$20240712$20240828$EXP$$US-ROCHE-10000015688$ROCHE$$$$E$F$Y$$$20240828$$CN$US$US
240831791$24083179$1$I$$20240705$20240712$20240712$EXP$$CN-ROCHE-10000005859$ROCHE$Jiang C, Huang J, Shao J, Yang T, Zhao Y, Huang M, et al. T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: case series and systemic review. Cell Transplantation. 2024-Jan;33:1-9. doi:10.1177/09636897241259722.$21$YR$A$M$Y$$$20240712$$HP$CN$CN
240831801$24083180$1$I$$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137491$AMGEN$$66$YR$E$F$Y$$$20240712$$HP$US$US
240831811$24083181$1$I$$20240711$20240712$20240712$PER$$US-BAYER-2024A100253$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240831821$24083182$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033711$AUROBINDO$Yasir M, Gelaye AE. Rare Case of Resistant Aspergillus Niger Invasive Pulmonary Aspergillosis.. Am-J-Respir-Crit-Care-Med. 2024;209:A3586$70$YR$$F$Y$$$20240712$$HP$US$US
240831831$24083183$1$I$$20240626$20240712$20240712$PER$$US-APOTEX-2024AP007891$APOTEX$$$$$F$Y$$$20240712$$CN$US$US
240831841$24083184$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033058$AUROBINDO$Roma N, Padala V, Pattoli M, Desai S, Krinock M, Durkin M, et al. BRASH Syndrome: A Rare Clinical Phenomenon. CJC Open. 2024;6(6):840-2$66$YR$$F$Y$$$20240712$$MD$US$US
240831851$24083185$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07024$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831861$24083186$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07053$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831871$24083187$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07048$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831881$24083188$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07088$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831891$24083189$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07023$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831901$24083190$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07041$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831912$24083191$2$F$$20240709$20240712$20240722$EXP$$GB-CIPLA LTD.-2024GB07091$CIPLA$$$$$$Y$$$20240722$$CN$GB$GB
240831921$24083192$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07046$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831931$24083193$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB06996$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831941$24083194$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07011$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831951$24083195$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07064$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831961$24083196$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07055$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240831981$24083198$1$I$$20240711$20240712$20240712$PER$$US-BAYER-2024A100282$BAYER$$$$$$Y$$$20240712$$CN$US$US
240831991$24083199$1$I$$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405091230085770-TBQVG$GB-862174955-ML2024-03885$Unknown Manufacturer$$$$$M$Y$$$20240712$$PH$GB$GB
240832001$24083200$1$I$20220906$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405111227472190-RWVFM$GB-862174955-ML2024-03889$Unknown Manufacturer$$71$YR$E$M$Y$70$KG$20240712$$CN$GB$GB
240832012$24083201$2$F$$20240824$20240712$20240829$EXP$$TH-ASTELLAS-2024US012211$ASTELLAS$$$$A$F$Y$50$KG$20240829$$MD$TH$TH
240832021$24083202$1$I$$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405091156004180-HMBTC$GB-862174955-ML2024-03816$Unknown Manufacturer$$$$$M$Y$$$20240712$$PH$GB$GB
240832033$24083203$3$F$$20240903$20240712$20240913$EXP$$JP-BEH-2024175046$CSL BEHRING$$54$YR$A$M$Y$$$20240913$$MD$JP$JP
240832041$24083204$1$I$$20240711$20240712$20240712$PER$$US-BAYER-2024A100406$BAYER$$$$$$Y$$$20240712$$CN$US$US
240832051$24083205$1$I$$20240703$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033224$AUROBINDO$$$$$$Y$$$20240712$$CN$GB$GB
240832061$24083206$1$I$20240506$20240709$20240712$20240712$EXP$$CO-UCBSA-2024035311$UCB$$60$YR$$M$Y$$$20240712$$CN$CO$CO
240832072$24083207$2$F$20240814$20240913$20240712$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002946$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240923$$CN$US$US
240832081$24083208$1$I$20240610$20240628$20240712$20240712$EXP$GB-MHRA-MED-202406281346577850-VNFCP$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-06286$HIKMA$$$$$$Y$$$20240712$$PH$GB$GB
240832092$24083209$2$F$$20240816$20240712$20240826$EXP$$US-ROCHE-10000018442$ROCHE$$75$YR$E$F$Y$$$20240826$$MD$US$US
240832101$24083210$1$I$$20240709$20240712$20240712$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-13820$IPSEN$$$$$M$Y$$$20240712$$PH$GB$GB
240832111$24083211$1$I$$20240702$20240712$20240712$EXP$$US-BEH-2024174961$CSL BEHRING$$$$E$F$Y$$$20240712$$HP$US$US
240832122$24083212$2$F$20240101$20240724$20240712$20240730$EXP$$US-ABBVIE-5835216$ABBVIE$$82$YR$$F$Y$$$20240730$$CN$US$US
240832131$24083213$1$I$$20240709$20240712$20240712$EXP$$IN-AstraZeneca-2024A158044$ASTRAZENECA$$16801$DY$$F$Y$97$KG$20240712$$CN$IN$
240832141$24083214$1$I$20240307$20240701$20240712$20240712$EXP$DE-CADRBFARM-2024328896$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-06211$HIKMA$$31$YR$$F$Y$67$KG$20240712$$CN$DE$DE
240832151$24083215$1$I$20230901$20240702$20240712$20240712$EXP$$US-MSNLABS-2024MSNSPO01475$MSN LABORATORIES$$$$$$Y$$$20240712$$CN$US$US
240832162$24083216$2$F$20230101$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110525$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240712$$CN$US$US
240832172$24083217$2$F$$20240715$20240712$20240724$EXP$$BR-CELLTRION INC.-2024BR016589$CELLTRION$$$$$$Y$$$20240724$$HP$BR$BR
240832192$24083219$2$F$$20240910$20240712$20240910$EXP$$FR-JNJFOC-20240712463$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240910$$PH$FR$FR
240832201$24083220$1$I$$20240705$20240712$20240712$EXP$$BR-JNJFOC-20240719762$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$HP$BR$BR
240832211$24083221$1$I$$20240704$20240712$20240712$EXP$$FR-ALK-ABELLO A/S-2024AA002810$ALK-ABELLO$$$$$$Y$$$20240712$$MD$FR$FR
240832271$24083227$1$I$20240301$20240709$20240712$20240712$EXP$FR-AFSSAPS-LL2024001238$FR-ORGANON-O2407FRA000907$ORGANON$$57$YR$$F$Y$$$20240712$$MD$FR$FR
240832283$24083228$3$F$$20240718$20240712$20240820$EXP$$BE-TEVA-VS-3216778$TEVA$Hendrickx T, Peetermans M, D^hoore A, Claes K, Van Hootegem A, Sabino J. STEC colitis mimicking acute severe colitis with life-threatening consequences: a case report. Acta-Gastroenterol-Belg 2024; 87 (1): 37-39.; Hendrickx T, Peetermans M, D^hoore A, Claes K, Van Hootegem A, Sabino J. STEC colitis mimicking acute severe colitis with life-threatening consequences: a case report. Acta-Gastroenterol-Belg 2024; 87 (1): 37-39.; Hendrickx T, Peetermans M, D^hoore A, Claes K, Van Hootegem A, Sabino...$18$YR$$M$Y$$$20240820$$MD$BE$BE
240832291$24083229$1$I$20240515$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405151322554580-JFDSQ$GB-ABBVIE-5836124$ABBVIE$$30$YR$$F$Y$$$20240712$$CN$GB$GB
240832311$24083231$1$I$$20240701$20240712$20240712$EXP$$IR-MSNLABS-2024MSNLIT01562$MSN LABORATORIES$Shahbazi F, Shojaei L.Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases.Current Drug Safety.2024;1-6$$$$$Y$$$20240712$$HP$IR$IR
240832321$24083232$1$I$$20240425$20240712$20240712$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-09399$ALKEM$$$$$$Y$79.6$KG$20240712$$CN$US$US
240832331$24083233$1$I$20240301$20240314$20240712$20240712$EXP$GB-MHRA-ADR 28600851$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05213$ALKEM$$$$$M$Y$$$20240712$$PH$GB$GB
240832341$24083234$1$I$20230701$20231019$20240712$20240712$EXP$GB-MHRA-ADR 28254231$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-12954$ALKEM$$41$YR$$F$Y$$$20240712$$HP$GB$GB
240832351$24083235$1$I$$20231114$20240712$20240712$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2023-13997$ALKEM$Bondanelli M, Aliberti L, Gagliardi I, Ambrosio MR, Zatelli MC. Long-term low-dose tolvaptan efficacy and safety in SIADH. Endocrine. 2023;82 (2):390-398$69$YR$$F$Y$$$20240712$$HP$IT$IT
240832361$24083236$1$I$20201208$20230810$20240712$20240712$EXP$GB-MHRA-ADR 24586896$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09100$ALKEM$$$$A$F$Y$69.2$KG$20240712$$MD$GB$GB
240832371$24083237$1$I$20210622$20230901$20240712$20240712$EXP$GB-MHRA-ADR 25695197$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10202$ALKEM$$$$A$F$Y$$$20240712$$MD$GB$GB
240832381$24083238$1$I$20180627$20240228$20240712$20240712$EXP$GB-MHRA-ADR 28150523$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10179$ALKEM$$43$YR$$F$Y$116.5$KG$20240712$$MD$GB$GB
240832391$24083239$1$I$20200107$20230807$20240712$20240712$EXP$GB-MHRA-ADR 28096503$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-08944$ALKEM$$$$A$M$Y$74.8$KG$20240712$$MD$GB$GB
240832401$24083240$1$I$20221122$20230710$20240712$20240712$EXP$GB-MHRA-ADR 28027766$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-07925$ALKEM$$$$A$F$Y$64$KG$20240712$$MD$GB$GB
240832411$24083241$1$I$20201201$20230710$20240712$20240712$EXP$GB-MHRA-ADR 24724673$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-07872$ALKEM$$$$$F$Y$71.1$KG$20240712$$MD$GB$GB
240832421$24083242$1$I$20210301$20230904$20240712$20240712$EXP$GB-MHRA-ADR 25140528$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10257$ALKEM$$$$A$F$Y$83.2$KG$20240712$$MD$GB$GB
240832431$24083243$1$I$20181024$20230602$20240712$20240712$EXP$GB-MHRA-ADR 27946863$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-06372$ALKEM$$65$YR$$M$Y$107.2$KG$20240712$$MD$GB$GB
240832441$24083244$1$I$20240620$20240709$20240712$20240712$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-13858$IPSEN$$75$YR$E$F$Y$$$20240712$$HP$US$US
240832451$24083245$1$I$20180912$20230703$20240712$20240712$EXP$GB-MHRA-ADR 28009452$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-07627$ALKEM$$50$YR$$F$Y$74.7$KG$20240712$$MD$GB$GB
240832461$24083246$1$I$20180705$20230911$20240712$20240712$EXP$GB-MHRA-ADR 28172560$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10549$ALKEM$$33$YR$$F$Y$55.4$KG$20240712$$MD$GB$GB
240832471$24083247$1$I$20180921$20230811$20240712$20240712$EXP$GB-MHRA-ADR 28108451$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09139$ALKEM$$47$YR$$F$Y$104$KG$20240712$$MD$GB$GB
240832481$24083248$1$I$$20240321$20240712$20240712$EXP$GB-MHRA-ADR 28517780$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-02834$ALKEM$$60$YR$$F$Y$63$KG$20240712$$CN$GB$GB
240832491$24083249$1$I$20211216$20230602$20240712$20240712$EXP$GB-MHRA-ADR 27944100$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-06366$ALKEM$$$$A$F$Y$67$KG$20240712$$MD$GB$GB
240832501$24083250$1$I$$20240126$20240712$20240712$EXP$GB-MHRA-ADR 28484521$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-01721$ALKEM$$$$$F$Y$$$20240712$$HP$GB$GB
240832511$24083251$1$I$20210302$20230814$20240712$20240712$EXP$GB-MHRA-ADR 25228131$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09233$ALKEM$$$$A$F$Y$68.5$KG$20240712$$MD$GB$GB
240832521$24083252$1$I$20190501$20230706$20240712$20240712$EXP$GB-MHRA-ADR 28021970$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-07804$ALKEM$$$$A$M$Y$70$KG$20240712$$MD$GB$GB
240832531$24083253$1$I$20180307$20230814$20240712$20240712$EXP$GB-MHRA-ADR 28112294$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09216$ALKEM$$64$YR$$M$Y$91.2$KG$20240712$$MD$GB$GB
240832541$24083254$1$I$$20230530$20240712$20240712$EXP$GB-MHRA-ADR 27932748$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-06218$ALKEM$$37$YR$$F$Y$64$KG$20240712$$PH$GB$GB
240832551$24083255$1$I$20180215$20230925$20240712$20240712$EXP$GB-MHRA-ADR 28198082$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-11562$ALKEM$$38$YR$$M$Y$64.4$KG$20240712$$MD$GB$GB
240832561$24083256$1$I$$20201202$20240712$20240712$EXP$$CA-CELLTRION INC.-2020CA035359$CELLTRION$$$$$$Y$$$20240712$$CN$CA$CA
240832571$24083257$1$I$20201101$20240325$20240712$20240712$EXP$GB-MHRA-ADR 28096499$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-08943$ALKEM$$$$A$F$Y$87.4$KG$20240712$$MD$GB$GB
240832583$24083258$3$F$$20240711$20240712$20240720$EXP$$PL-AUROBINDO-AUR-APL-2024-034049$AUROBINDO$Chrz?stek A. Dziwne? rany u pacjenta z oty?o?ci? olbrzymi? (Strange wounds in a  morbidly obese patient). MEDYCYNA PALIATYWNA (Palliative Medicine). 2024;16(2):129-130$71$YR$$M$Y$200$KG$20240720$$MD$PL$PL
240832591$24083259$1$I$20180406$20230803$20240712$20240712$EXP$GB-MHRA-ADR 28090907$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-08886$ALKEM$$53$YR$$F$Y$97.6$KG$20240712$$MD$GB$GB
240832601$24083260$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA201154$SANOFI AVENTIS$$$$E$F$Y$54.422$KG$20240712$$MD$US$US
240832612$24083261$2$F$20240101$20240805$20240712$20240810$PER$$US-SA-2024SA198656$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240810$$MD$US$US
240832621$24083262$1$I$$20231114$20240712$20240712$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2023-14365$ALKEM$Bondanelli M, Aliberti L, Gagliardi I, Ambrosio MR, Zatelli MC. Long-term low-dose tolvaptan efficacy and safety in SIADH. Endocrine. 2023;82:390-398$28$YR$$M$Y$$$20240712$$HP$IT$IT
240832631$24083263$1$I$$20240405$20240712$20240712$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-07932$ALKEM$Banks PN, Omar A, Walia R, Bhalla S, Chong Y, Tokman S.. Tacrolimus-Induced Hyponatremia in Lung Transplant Recipients: A Case Series. Transplantation Direct. 2018;4:e359$42$YR$$F$Y$$$20240712$$HP$US$US
240832641$24083264$1$I$20180703$20230711$20240712$20240712$EXP$GB-MHRA-ADR 28032773$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-07976$ALKEM$$34$YR$$F$Y$$$20240712$$MD$GB$GB
240832651$24083265$1$I$$20231114$20240712$20240712$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2023-14363$ALKEM$Bondanelli M, Aliberti L, Gagliardi I, Ambrosio MR, Zatelli MC. Long-term low-dose tolvaptan efficacy and safety in SIADH. Endocrine. 2023;82:390-398$52$YR$$F$Y$$$20240712$$HP$IT$IT
240832661$24083266$1$I$20220528$20230905$20240712$20240712$EXP$GB-MHRA-ADR 28155477$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10276$ALKEM$$$$$F$Y$34.2$KG$20240712$$MD$GB$GB
240832671$24083267$1$I$20181106$20230824$20240712$20240712$EXP$GB-MHRA-ADR 28135413$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09889$ALKEM$$43$YR$$F$Y$$$20240712$$MD$GB$GB
240832681$24083268$1$I$20230124$20230706$20240712$20240712$EXP$GB-MHRA-ADR 28021782$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-07802$ALKEM$$$$A$F$Y$83.9$KG$20240712$$MD$GB$GB
240832691$24083269$1$I$20190501$20230608$20240712$20240712$EXP$GB-MHRA-ADR 27954882$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-06538$ALKEM$$45$YR$$F$Y$71.8$KG$20240712$$MD$GB$GB
240832701$24083270$1$I$20180828$20230626$20240712$20240712$EXP$GB-MHRA-ADR 25168798$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-07282$ALKEM$$40$YR$$M$Y$$$20240712$$MD$GB$GB
240832711$24083271$1$I$20240101$20240705$20240712$20240712$PER$$US-SA-2024SA200465$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240712$$MD$US$US
240832721$24083272$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA199345$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240712$$CN$US$US
240832731$24083273$1$I$20240101$20240703$20240712$20240712$PER$$US-SA-2024SA202103$SANOFI AVENTIS$$5$YR$C$F$Y$18.6$KG$20240712$$MD$US$US
240832741$24083274$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110433$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240712$$CN$US$US
240832751$24083275$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110371$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240712$$HP$US$US
240832761$24083276$1$I$$20240710$20240712$20240712$PER$$US-ABBVIE-5836167$ABBVIE$$$$$$Y$$$20240712$$HP$US$US
240832771$24083277$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA201999$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240712$$PH$US$US
240832781$24083278$1$I$$20240709$20240712$20240712$PER$$US-JNJFOC-20240724014$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240832792$24083279$2$F$$20240716$20240712$20240718$PER$$US-JNJFOC-20240729730$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$US$US
240832801$24083280$1$I$$20240708$20240712$20240712$EXP$$US-JNJFOC-20240718685$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240832821$24083282$1$I$20190401$20240701$20240712$20240712$EXP$$DE-MACLEODS PHARMA-MAC2024048095$MACLEODS$$$$$$Y$$$20240712$$LW$DE$DE
240832831$24083283$1$I$$20240702$20240712$20240712$EXP$$ZA-MACLEODS PHARMA-MAC2024048102$MACLEODS$$$$$$Y$$$20240712$$CN$ZA$ZA
240832841$24083284$1$I$20240101$20240705$20240712$20240712$EXP$FR-AFSSAPS-NT2024000825$FR-RDY-SPO/FRA/24/0009946$DR REDDYS$$67$YR$E$F$Y$54$KG$20240712$$MD$FR$FR
240832861$24083286$1$I$$20240626$20240712$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06281$LUPIN$$$$$$Y$$$20240712$$CN$US$US
240832871$24083287$1$I$20230424$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405012323128620-MKJZV$GB-ROCHE-10000019672$ROCHE$$58$YR$A$F$Y$87$KG$20240712$$HP$GB$GB
240832881$24083288$1$I$$20240703$20240712$20240712$EXP$GB-MHRA-MED-202407021702084410-SYWHN$GB-MSNLABS-2024MSNSPO01512$MSN LABORATORIES$$$$$$Y$$$20240712$$HP$GB$GB
240832891$24083289$1$I$$20240701$20240712$20240712$PER$$US-RDY-LIT/USA/24/0009903$DR REDDYS$Bengio M, Goodwin G, Roka A, Marin M. Pediatric headache patient with cerebral abscesses: a brief review of the literature and case report. Journal of International Medical Research. 2023 Nov;51: doi:10.1177/03000605231213751.$12$YR$T$M$Y$$$20240712$$HP$US$US
240832901$24083290$1$I$$20240708$20240712$20240712$EXP$$US-ABBVIE-5834818$ABBVIE$$$$$$Y$$$20240712$$HP$US$US
240832921$24083292$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033814$AUROBINDO$Luskin MR, Murakami MA, Keating J, Winer ES, Garcia JS, Stahl M, et al. A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL and Blast Phase CML in Adults. Blood. 2023;142 (Suppl. 1):965-967$57$YR$$F$Y$$$20240712$$MD$US$US
240832931$24083293$1$I$$20240620$20240712$20240712$EXP$$FR-ROCHE-10000022527$ROCHE$$82$YR$E$F$Y$$$20240712$$HP$FR$FR
240832941$24083294$1$I$20240620$20240702$20240712$20240712$PER$$US-BEH-2024175047$CSL BEHRING$$74$YR$E$F$Y$63.492$KG$20240712$$CN$US$US
240832951$24083295$1$I$20220118$20240627$20240712$20240712$EXP$FR-AFSSAPS-MP2024000727$FR-SAMSUNG BIOEPIS-SB-2024-20137$SAMSUNG BIOEPIS$$53$YR$A$F$Y$68$KG$20240712$$MD$FR$FR
240832962$24083296$2$F$20240502$20240718$20240712$20240724$EXP$$US-ABBVIE-5757543$ABBVIE$$53$YR$$F$Y$$$20240724$$CN$US$US
240832971$24083297$1$I$$20240627$20240712$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05896$LUPIN$$$$$$Y$$$20240712$$CN$US$US
240832982$24083298$2$F$20230818$20240715$20240712$20240723$EXP$DE-CADRBFARM-2024329058$DE-TORRENT-00026960$TORRENT$$34$YR$A$F$Y$68$KG$20240723$$CN$DE$DE
240832991$24083299$1$I$$20240703$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-033751$AUROBINDO$Chimenti G, Magli A, Njandjo L, Fois A, Santagati G, Piccoli G, et al. New onset proteinuria in two pregnancies: glomerulopathy or preeclampsia. Nephrol-Dial-Transplant. 2024;39 (Suppl. 1):i2048- i2049$27$YR$$F$Y$$$20240712$$HP$FR$FR
240833001$24083300$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110712$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240712$$CN$US$US
240833013$24083301$3$F$20230301$20240903$20240712$20240906$EXP$$US-ABBVIE-5833619$ABBVIE$$75$YR$$F$Y$83$KG$20240906$$CN$US$US
240833021$24083302$1$I$20240608$20240710$20240712$20240712$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010522$JAZZ$$16$YR$$M$Y$$$20240712$$CN$US$US
240833034$24083303$4$F$20240214$20240818$20240712$20240902$EXP$FR-AFSSAPS-AN2024000610$FR-SAMSUNG BIOEPIS-SB-2024-20223$SAMSUNG BIOEPIS$$83$YR$E$F$Y$$$20240902$$MD$FR$FR
240833041$24083304$1$I$$20240703$20240712$20240712$EXP$GB-MHRA-MED-202407021657439190-VBJZM$GB-MSNLABS-2024MSNSPO01513$MSN LABORATORIES$$$$$$Y$$$20240712$$HP$GB$GB
240833052$24083305$2$F$20240101$20240724$20240712$20240725$EXP$$NVSC2024DE143663$NOVARTIS$$29$YR$$F$Y$$$20240725$$MD$DE$DE
240833061$24083306$1$I$$20240703$20240712$20240712$EXP$$LK-AMNEAL PHARMACEUTICALS-2024-AMRX-02504$AMNEAL$Abeyagunawardena I, Madurapperuma C, Thuvarakan P, Thowfeek Z, Sujeewa N, et al.. Uncommon triggers of insulin autoimmune syndrome: a case report.. J Med Case Rep.. 2024;18(1):292$67$YR$$M$Y$$$20240712$$HP$LK$LK
240833071$24083307$1$I$$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033810$AUROBINDO$$$$$F$Y$66$KG$20240712$$CN$GB$GB
240833082$24083308$2$F$$20240705$20240712$20240729$EXP$$GB-ROCHE-10000018125$ROCHE$$$$$$Y$$$20240729$$MD$GB$GB
240833091$24083309$1$I$$20240710$20240712$20240712$PER$$US-JNJFOC-20240727108$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$CN$US$US
240833111$24083311$1$I$19850730$20240709$20240712$20240712$EXP$$SE-JNJFOC-20240724730$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240712$$CN$SE$SE
240833121$24083312$1$I$20160701$20240620$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002933$ACADIA PHARMACEUTICALS$$67$YR$$F$Y$$$20240712$$CN$US$US
240833131$24083313$1$I$20240604$20240708$20240712$20240712$EXP$$US-AstraZeneca-2024A155993$ASTRAZENECA$$27987$DY$$F$Y$$$20240712$$CN$US$
240833141$24083314$1$I$$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405141126261270-YJVWZ$GB-ASPEN-GLO2024GB004576$ASPEN$$$$$$Y$$$20240712$$CN$GB$GB
240833151$24083315$1$I$20240601$20240708$20240712$20240712$EXP$GB-MHRA-MED-202407081013031350-FPMLC$GB-ASPEN-GLO2024GB004658$ASPEN$$$$$$Y$$$20240712$$PH$GB$GB
240833163$24083316$3$F$20240624$20240708$20240712$20240722$EXP$$US-ROCHE-10000021948$ROCHE$$77$YR$E$M$Y$82.64$KG$20240722$$MD$US$US
240833171$24083317$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006999$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240712$$CN$US$US
240833181$24083318$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007457$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240712$$MD$US$US
240833191$24083319$1$I$20240708$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006976$ELI LILLY AND CO$$$$A$F$Y$$$20240712$$CN$US$US
240833201$24083320$1$I$$20240711$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007703$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240712$$CN$US$US
240833211$24083321$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007095$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240712$$CN$US$US
240833222$24083322$2$F$$20240809$20240712$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202407007307$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240814$$CN$US$US
240833231$24083323$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006668$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240712$$CN$US$US
240833241$24083324$1$I$20240601$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007464$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240833261$24083326$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137628$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240833271$24083327$1$I$20240613$20240704$20240712$20240712$EXP$ES-AEMPS-1536573$ES-TEVA-VS-3217507$TEVA$$71$YR$$M$Y$$$20240712$$PH$ES$ES
240833292$24083329$2$F$20240329$20240716$20240712$20240722$EXP$$US-JNJFOC-20240527429$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240722$$CN$US$US
240833302$24083330$2$F$$20240716$20240712$20240718$EXP$$AU-ROCHE-10000023501$ROCHE$$72$YR$E$F$Y$$$20240718$$MD$AU$AU
240833311$24083331$1$I$20240627$20240702$20240712$20240712$EXP$$CN-ROCHE-10000015732$ROCHE$$81$YR$E$F$Y$39.7$KG$20240712$$HP$CN$CN
240833321$24083332$1$I$20240624$20240708$20240712$20240712$EXP$GB-MHRA-MED-202407080935173920-RWYQD$GB-TAKEDA-2024TUS069440$TAKEDA$$42$YR$$F$Y$55$KG$20240712$$HP$GB$GB
240833331$24083333$1$I$$20240709$20240712$20240712$EXP$$CA-ABBVIE-5835071$ABBVIE$$$$A$F$Y$$$20240712$$CN$CA$CA
240833341$24083334$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024136265$AMGEN$$$$$$Y$$$20240712$$HP$US$US
240833351$24083335$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137629$AMGEN$$$$$$Y$$$20240712$$CN$US$US
240833361$24083336$1$I$$20240711$20240712$20240712$PER$$US-GILEAD-2024-0680434$GILEAD$$$$$F$Y$$$20240712$$HP$US$US
240833371$24083337$1$I$20240604$20240704$20240712$20240712$EXP$ES-AEMPS-1540252$ES-TEVA-VS-3217538$TEVA$$68$YR$$M$Y$68$KG$20240712$$HP$ES$ES
240833381$24083338$1$I$$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033464$AUROBINDO$$6$YR$$F$Y$$$20240712$$CN$GB$GB
240833391$24083339$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108950$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240712$$HP$US$US
240833401$24083340$1$I$20240601$20240709$20240712$20240712$EXP$$US-UCBSA-2024034983$UCB$$38$YR$$F$Y$$$20240712$$HP$US$US
240833411$24083341$1$I$$20240704$20240712$20240712$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008201$STRIDES$Chen Q, Chen X, Zhu Y, Yu X.. A relatively rare traditional Chinese medicine pattern of primary Sj?gren syndrome: A case report. Medicine (Baltimore). 2024;103(15):e37744$56$YR$$F$Y$$$20240712$$MD$CN$CN
240833421$24083342$1$I$$20240702$20240712$20240712$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR082789$VIIV$$$$$M$Y$$$20240712$$HP$US$US
240833431$24083343$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186624$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240833441$24083344$1$I$$20240626$20240712$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05887$LUPIN$$$$$$Y$$$20240712$$CN$US$US
240833462$24083346$2$F$20240129$20240701$20240712$20240712$PER$$US-JNJFOC-20240729905$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240712$$CN$US$US
240833472$24083347$2$F$20240613$20240813$20240712$20240819$EXP$$DE-TAKEDA-2024TUS067648$TAKEDA$$77$YR$$M$Y$65$KG$20240819$$HP$DE$DE
240833481$24083348$1$I$$20240703$20240712$20240712$EXP$$IT-MYLANLABS-2024M1064067$MYLAN$Sanna S, Lampus M. a particular case of cardiac arrest. Eur-Heart-J-Suppl 2024; 26 (Suppl.) ii70-ii71.$88$YR$$M$Y$$$20240712$$HP$IT$IT
240833501$24083350$1$I$$20240702$20240712$20240712$EXP$$US-MYLANLABS-2024M1063734$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$34$YR$$M$Y$$$20240712$$HP$US$US
240833511$24083351$1$I$$20240703$20240712$20240712$EXP$$US-MYLANLABS-2024M1064025$MYLAN$Halawi H, Harris JE, Goodarzi A, Yau S, Youssef JG, Botros M, et al. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy 2024; 44 (3): 283-289.$29$YR$$M$Y$$$20240712$$HP$US$US
240833521$24083352$1$I$$20240704$20240712$20240712$EXP$$CN-MYLANLABS-2024M1064575$MYLAN$Wu H, Iqbal J, Li L, Jiang H, Chao C, Zhang M, et al. SGLT2 inhibitor monotherapy alleviates hyperglycemia in heredity severe insulin resistance syndrome. Chin-Med-J-Engl 2024; 137 (11): 1372-1374.$16$YR$$F$Y$$$20240712$$HP$CN$CN
240833531$24083353$1$I$$20240703$20240712$20240712$EXP$$US-MYLANLABS-2024M1064088$MYLAN$Halawi H, Harris JE, Goodarzi A, Yau S, Youssef JG, Botros M, et al. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy 2024; 44 (3): 283-289.$24$YR$$M$Y$$$20240712$$HP$US$US
240833541$24083354$1$I$$20240702$20240712$20240712$EXP$$US-MYLANLABS-2024M1063775$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$19$YR$$F$Y$$$20240712$$HP$US$US
240833551$24083355$1$I$$20240702$20240712$20240712$EXP$$US-MYLANLABS-2024M1063770$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$41$YR$$F$Y$$$20240712$$HP$US$US
240833561$24083356$1$I$$20240702$20240712$20240712$EXP$$US-MYLANLABS-2024M1063760$MYLAN$Devine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. J-Pediatr-Pharmacol-Ther 2023; 28 (2): 161-166.$52$DY$$$Y$$$20240712$$HP$US$US
240833571$24083357$1$I$$20240704$20240712$20240712$EXP$$US-MYLANLABS-2024M1064463$MYLAN$McMullan P, Brown R, Bibb L, Ferenczi K. Cutaneous CD30 positive anaplastic large cell lymphoma mimicking breast carcinoma en cuirasse. JAAD-Case-Rep 2023; 40 37-40.$80$YR$$F$Y$$$20240712$$MD$US$US
240833581$24083358$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA199657$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240712$$MD$US$US
240833591$24083359$1$I$$20240704$20240712$20240712$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008393$STRIDES$Martin-Aguilar S, Lopez-Rodriguez E, Puentes-Zarzuela MC.. Complete response to switch immunodepression of late-onset post-transplant lymphoproliferative disease (PTLD). Med-Clin-Barc. 2023;161 (2):86-87$$$A$M$Y$$$20240712$$HP$ES$ES
240833601$24083360$1$I$20240601$20240703$20240712$20240712$PER$$US-SA-2024SA201380$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240712$$MD$US$US
240833611$24083361$1$I$$20240709$20240712$20240712$PER$$US-SA-2024SA203201$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240712$$CN$US$US
240833631$24083363$1$I$20240601$20240703$20240712$20240712$PER$$US-SA-2024SA201510$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240712$$MD$US$US
240833642$24083364$2$F$$20240805$20240712$20240812$PER$$US-SA-2024SA203476$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240812$$CN$US$US
240833654$24083365$4$F$20240101$20240815$20240712$20240826$PER$$US-SA-2024SA201527$SANOFI AVENTIS$$84$YR$E$F$Y$89.8$KG$20240826$$MD$US$US
240833664$24083366$4$F$20240703$20240812$20240712$20240820$EXP$$CA-JNJFOC-20240554213$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240820$$HP$CA$CA
240833731$24083373$1$I$$20240711$20240712$20240712$PER$$US-GILEAD-2024-0680471$GILEAD$$23$YR$A$F$Y$$$20240712$$CN$US$US
240833742$24083374$2$F$$20240711$20240712$20240712$EXP$$US-ROCHE-10000024345$ROCHE$$$$E$F$Y$$$20240712$$CN$US$US
240833751$24083375$1$I$20240606$20240701$20240712$20240712$EXP$IT-MINISAL02-992470$IT-SERVIER-S24008404$SERVIER$$$$$$Y$$$20240712$$PH$IT$IT
240833763$24083376$3$F$20240501$20240906$20240712$20240912$EXP$$DE-SANDOZ INC.-SDZ2024DE064646$SANDOZ$$$$A$F$Y$$$20240912$$MD$DE$DE
240833781$24083378$1$I$$20240703$20240712$20240712$EXP$$IT-MYLANLABS-2024M1064046$MYLAN$Di Marino M, Galanti K, Testa S, Ricci M, Magnano R, Pezzi L, et al. Autoimmune myocarditis in melanoma immunotherapy-complex clinica presentation and adverse therapeutic response. Eur-Heart-J-Suppl 2024; 26 (Suppl.) ii172.$68$YR$$F$Y$$$20240712$$HP$IT$IT
240833791$24083379$1$I$$20240702$20240712$20240712$EXP$$US-MYLANLABS-2024M1063702$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$71$YR$$M$Y$$$20240712$$HP$US$US
240833801$24083380$1$I$$20240702$20240712$20240712$EXP$$US-ROCHE-10000017611$ROCHE$$$$$M$Y$$$20240712$$CN$US$US
240833812$24083381$2$F$$20240709$20240712$20240717$PER$$US-ROCHE-3572517$ROCHE$$65$YR$E$F$Y$56.7$KG$20240717$$CN$US$US
240833821$24083382$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137625$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240833831$24083383$1$I$20240707$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024136244$AMGEN$$63$YR$A$M$Y$$$20240712$$CN$US$US
240833841$24083384$1$I$$20240702$20240712$20240712$EXP$$US-MACLEODS PHARMA-MAC2024048123$MACLEODS$Pathan S.Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage..Hospital Pharmacy.2024;59(4):394-406$$$$$Y$$$20240712$$HP$US$US
240833851$24083385$1$I$$20240705$20240712$20240712$EXP$$GB-AstraZeneca-2024A154486$ASTRAZENECA$$$$A$F$Y$$$20240712$$MD$GB$
240833861$24083386$1$I$$20240624$20240712$20240712$PER$$US-AstraZeneca-2024A150854$ASTRAZENECA$$44$YR$$F$Y$$$20240712$$CN$US$
240833871$24083387$1$I$$20240704$20240712$20240712$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008395$STRIDES$Dehade A, Chakrabarti SS, Reddy NTS, Kaur U.. Dopaminergic Drugs and Valproate-associated Refractory Hyponatremia Over Levosulpiride-induced Parkinsonism in an Elderly Female Patient When Deprescribing was the Only Therapy.. Curr-Drug-Saf. 2024;0 (0):no pagination$74$YR$$F$Y$$$20240712$$MD$IN$IN
240833881$24083388$1$I$$20240709$20240712$20240712$EXP$$CA-TAKEDA-2024TUS070222$TAKEDA$$$$$M$Y$$$20240712$$MD$CA$CA
240833891$24083389$1$I$20221222$20240709$20240712$20240712$EXP$$AU-TAKEDA-2022TUS101641$TAKEDA$$35$YR$$F$Y$$$20240712$$CN$AU$AU
240833901$24083390$1$I$$20240705$20240712$20240712$EXP$$ZA-AstraZeneca-2024A155667$ASTRAZENECA$$79$YR$$M$Y$$$20240712$$CN$ZA$
240833921$24083392$1$I$$20240711$20240712$20240712$PER$$US-ROCHE-10000024288$ROCHE$$$$A$F$Y$$$20240712$$HP$US$AS
240833931$24083393$1$I$$20240711$20240712$20240712$PER$$US-ROCHE-10000024598$ROCHE$$$$T$F$Y$$$20240712$$MD$US$US
240833941$24083394$1$I$$20240703$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-034270$AUROBINDO$Buckens G, Mahir G, Bapat A.. 58 Antifungal resistance, a hot topic. A case report in co-infection of Mycobacterium avium-intracellulare and chronic cavitary pulmonary aspergillosis. Clin-Infect-Pract. 2023;20 (Suppl. 1)23:58$53$YR$$M$Y$$$20240712$$HP$GB$GB
240833951$24083395$1$I$$20240704$20240712$20240712$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008380$STRIDES$Rashid AM, Cheung TP, Paracha R, Vitale GC, Vyce SD.. Minocycline-Induced Black Bone Disease in Foot and Ankle Surgery: A Case Report.. J-Am-Podiatr-Med-Assoc. 2024;114 (2):no pagination$51$YR$$M$Y$$$20240712$$MD$US$US
240833962$24083396$2$F$$20240717$20240712$20240725$EXP$$FR-TAKEDA-2024TUS070830$TAKEDA$$55$YR$$F$Y$$$20240725$$MD$FR$FR
240833971$24083397$1$I$$20240626$20240712$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06339$LUPIN$$$$$$Y$$$20240712$$CN$US$US
240833981$24083398$1$I$$20240711$20240712$20240712$PER$$US-GILEAD-2024-0680432$GILEAD$$$$$F$Y$$$20240712$$HP$US$US
240833991$24083399$1$I$$20240710$20240712$20240712$EXP$SI-JAZMP-NCPHV-2024SI0606_0606$SI-CHEPLA-2024008722$CHEPLAPHARM$$80$YR$$F$Y$$$20240712$$MD$COUNTRY NOT SPECIFIED$SI
240834001$24083400$1$I$$20240701$20240712$20240712$PER$$NL-ROCHE-10000023528$ROCHE$Riel S, Thunnissen E, Heideman D, Smit E, Biesma B. A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation. Doi: 10.1093/annonc/mds525. Annals of Oncology. 2012-Oct-18;23 (12):3188-89. doi:10.1093/annonc/mds525.$42$YR$A$F$Y$$$20240712$$HP$NL$US
240834011$24083401$1$I$$20240710$20240712$20240712$PER$$US-ROCHE-10000023763$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240834021$24083402$1$I$$20240708$20240712$20240712$PER$$US-ROCHE-10000021214$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240834031$24083403$1$I$$20240710$20240712$20240712$PER$$US-ROCHE-10000023390$ROCHE$$$$A$F$Y$$$20240712$$CN$US$US
240834041$24083404$1$I$$20240707$20240712$20240712$EXP$$GB-GSK-GB2024EME084305$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$GB$GB
240834051$24083405$1$I$20240104$20240701$20240712$20240712$EXP$FR-AFSSAPS-GR2024000783$FR-MYLANLABS-2024M1061988$MYLAN$$20$YR$$F$Y$37$KG$20240712$$MD$FR$FR
240834071$24083407$1$I$20240605$20240705$20240712$20240712$EXP$$CN-JNJFOC-20240715116$JOHNSON AND JOHNSON$$24$YR$A$F$Y$$$20240712$$HP$CN$CN
240834082$24083408$2$F$$20240715$20240712$20240719$EXP$$ES-JNJFOC-20240725787$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$CN$ES$ES
240834091$24083409$1$I$$20240704$20240712$20240712$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP008367$STRIDES$Singh K, Taylor J, Nelson A, Mitchell R, Shon IH.. Cerebral hypometabolism in a pediatric patient with clinically resolved posterior reversible encephalopathy syndrome.. Radiol-Case-Rep. 2024;19 (9):3653-3655$4$YR$$M$Y$$$20240712$$MD$AU$AU
240834102$24083410$2$F$20200108$20240729$20240712$20240801$PER$$US-ORGANON-O2407USA001058$ORGANON$$22$YR$$F$Y$60.771$KG$20240801$$MD$US$US
240834111$24083411$1$I$$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216910$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240834122$24083412$2$F$20240611$20240921$20240712$20240926$EXP$$CN-CHEPLA-2024008070$CHEPLAPHARM$$65$YR$$M$Y$62$KG$20240926$$MD$COUNTRY NOT SPECIFIED$CN
240834131$24083413$1$I$$20240704$20240712$20240712$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008368$STRIDES$Carrillo I, Lopez De Las Heras M, Martinez SC, Prieto-Perez L, Alvarez Alvarez B, Waleed Al-Hayani A, et al.. Characteristics and rates of infection by HIV in people receiving non-occupational post-exposure prophylaxis (nPEP) against HIV.. Sex-Transmit-Infect. 2024;100 (4):231-235$$$$$Y$$$20240712$$HP$ES$ES
240834141$24083414$1$I$$20240701$20240712$20240712$EXP$$HR-PBT-009503$PANACEA BIOTEC$Basic-Jukic N, Androvic A, Beck D, Radunovic D, Juric I, Furic-Cunko V, et al. Exploring Acute Pancreatitis in Kidney Transplant Recipients: A Multicentre Retrospective Cohort Analysis of Incidence, Causes, and Clinical Outcomes. J Clin Med. 2024 Jun 7;13(12):3366. doi: 10.3390/jcm13123366.$31$YR$A$M$Y$$$20240712$$HP$HR$HR
240834151$24083415$1$I$$20240701$20240712$20240712$EXP$$HR-PBT-009501$PANACEA BIOTEC$Basic-Jukic N, Androvic A, Beck D, Radunovic D, Juric I, Furic-Cunko V, et al. Exploring Acute Pancreatitis in Kidney Transplant Recipients: A Multicentre Retrospective Cohort Analysis of Incidence, Causes, and Clinical Outcomes. J Clin Med. 2024 Jun 7;13(12):3366. doi: 10.3390/jcm13123366.$53$YR$A$M$Y$$$20240712$$HP$HR$HR
240834162$24083416$2$F$$20240709$20240712$20240718$EXP$$BE-AUROBINDO-AUR-APL-2024-033334$AUROBINDO$Spapen HD, Honore PM, Gregoire N, Gobin P, de Regt J, Martens GA. et al.. Convulsion and apnoea in a patient infected with New Delhi metallo-beta-lactamase-1 Escherichia coli treated with colistin. Journal of Infection. 2011;63 (6):468-470$51$YR$$M$Y$80$KG$20240718$$MD$BE$BE
240834171$24083417$1$I$$20240701$20240712$20240712$EXP$$HR-PBT-009504$PANACEA BIOTEC$Basic-Jukic N, Androvic A, Beck D, Radunovic D, Juric I, Furic-Cunko V, et al. Exploring Acute Pancreatitis in Kidney Transplant Recipients: A Multicentre Retrospective Cohort Analysis of Incidence, Causes, and Clinical Outcomes. J Clin Med. 2024 Jun 7;13(12):3366. doi: 10.3390/jcm13123366.$33$YR$A$F$Y$$$20240712$$HP$HR$HR
240834181$24083418$1$I$20230502$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216929$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240834191$24083419$1$I$$20240701$20240712$20240712$EXP$$HR-PBT-009509$PANACEA BIOTEC$Basic-Jukic N, Androvic A, Beck D, Radunovic D, Juric I, Furic-Cunko V, et al. Exploring Acute Pancreatitis in Kidney Transplant Recipients: A Multicentre Retrospective Cohort Analysis of Incidence, Causes, and Clinical Outcomes. J Clin Med. 2024 Jun 7;13(12):3366. doi: 10.3390/jcm13123366.$69$YR$E$M$Y$$$20240712$$HP$HR$HR
240834201$24083420$1$I$20240101$20240706$20240712$20240712$EXP$$IN-PBT-009512$PANACEA BIOTEC$Mohan V, Jain S, Naithani R. Low-dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe-BIRD) in a child with relapsed/refractory B-cell acute lymphoblastic leukemia with TP53 mutation. Pediatr Blood Cancer. 2024 Jul 2:e31152. doi: 10.1002/pbc.31152.$12$YR$T$M$Y$$$20240712$$HP$IN$IN
240834212$24083421$2$F$$20240701$20240712$20240712$EXP$$US-ROCHE-10000020605$ROCHE$$39$YR$A$F$Y$$$20240712$$MD$US$US
240834221$24083422$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006869$ELI LILLY AND CO$$$$A$F$Y$$$20240712$$CN$US$US
240834231$24083423$1$I$20240709$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007421$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240712$$CN$US$US
240834242$24083424$2$F$$20240722$20240712$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407007025$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240724$$HP$US$US
240834251$24083425$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007073$ELI LILLY AND CO$$32$YR$A$$Y$$$20240712$$CN$US$US
240834261$24083426$1$I$20240710$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007382$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240712$$CN$US$US
240834271$24083427$1$I$$20240704$20240712$20240712$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008372$STRIDES$Amano K, Oda Y, Seki Y, Yamashita K, Bokuda K, Ichihara A, et al.. Reconsideration of Surgical Indication for Prolactin-producing Pituitary Tumor Focusing on Visual Impairment.. Neurol-Med-Chir-(Tokyo). 2024;64 (4):160-167$54$YR$$M$Y$$$20240712$$MD$JP$JP
240834281$24083428$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033837$AUROBINDO$Grossman J, Amdo TD, Mercado JM, Moreira A, Adelman MH.. Case Report: Subtle Perilymphatic Sarcoidosis Mimicking Miliary Tuberculosis. Am-J-Respir-Crit-Care-Med. 2024;209:A5907$38$YR$$M$Y$$$20240712$$HP$US$US
240834292$24083429$2$F$$20240731$20240712$20240802$EXP$$IE-MYLANLABS-2024M1064653$MYLAN$$$$$M$Y$$$20240802$$HP$IE$IE
240834301$24083430$1$I$20240602$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110446$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240712$$CN$US$US
240834311$24083431$1$I$$20240709$20240712$20240712$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-095780$REGENERON$$$$$F$Y$$$20240712$$CN$US$US
240834322$24083432$2$F$20210101$20240905$20240712$20240918$EXP$$PT-AUROBINDO-AUR-APL-2024-033039$AUROBINDO$Paulo N, Goncalves PL, Cerqueira A, Araujo J, Sampaio S, Vasconcelos MP. Recurrent parvovirus B19 infection-associated pure red cell aplasia in kidney transplantation. Nephrology Dialysis Transplantation. 2024;39(Supple1):i2698$42$YR$$M$Y$$$20240918$$MD$PT$PT
240834331$24083433$1$I$20240501$20240708$20240712$20240712$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-110606$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240712$$MD$JP$JP
240834341$24083434$1$I$20240708$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110549$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240712$$HP$US$US
240834351$24083435$1$I$20240708$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137506$AMGEN$$$$$$Y$$$20240712$$HP$US$US
240834362$24083436$2$F$20230502$20240709$20240712$20240722$EXP$$US-CHIESI-2024CHF04148$CHIESI$$20$YR$$M$Y$94$KG$20240719$$CN$US$US
240834372$24083437$2$F$$20240710$20240712$20240718$EXP$IT-MLMSERVICE-20240628-PI115611-00275-1$IT-STRIDES ARCOLAB LIMITED-2024SP008364$STRIDES$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et al.. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars.. Toxicology Reports. 2024;13:101683$15$YR$$F$Y$48$KG$20240718$$MD$IT$IT
240834382$24083438$2$F$20231001$20240725$20240712$20240808$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06218$HIKMA$$35$YR$$F$Y$126.53$KG$20240808$$CN$US$US
240834392$24083439$2$F$$20240924$20240712$20240926$PER$$US-JNJFOC-20240723511$JOHNSON AND JOHNSON$$$$$M$Y$69.7$KG$20240927$$MD$US$US
240834401$24083440$1$I$$20240701$20240712$20240712$EXP$$CN-IPCA LABORATORIES LIMITED-IPC-2024-CN-001724$IPCA$Hong Cheng, Fengbo Xu, Guoqin Wang et al.. Warfarin-related nephropathy in two patients with mechanical valves. Kidney International Reports. 2024;9:S576$$$$$Y$$$20240712$$HP$CN$CN
240834411$24083441$1$I$$20240708$20240712$20240712$EXP$GB-MHRA-MED-202407041215189050-SRPKJ$GB-STRIDES ARCOLAB LIMITED-2024SP008266$STRIDES$$$$$M$Y$$$20240712$$CN$GB$GB
240834421$24083442$1$I$20180601$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033056$AUROBINDO$Omotosho YB, McGlotten R, Pacak K, Wierman ME, Nieman LK.. A Rare Cyclic Cushing Syndrome Mystery Illustrates Diagnostic Principles.. JCEM case reports.. 2024;2(6):luae094$71$YR$$F$Y$62.1$KG$20240712$$MD$US$US
240834431$24083443$1$I$$20240117$20240712$20240712$EXP$$US-BAYER-2024A095478$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240834441$24083444$1$I$$20240707$20240712$20240712$EXP$$JP-009507513-2407JPN001597J$MERCK$Araki M, Matsui K, Ohsawa S, Yoshida T, Hori R, Fujii T. EP-0522 Experience of immune-related adverse events occurring during preoperative chemotherapy at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 308$5$DEC$$F$Y$$$20240712$$MD$JP$JP
240834451$24083445$1$I$20240617$20240703$20240712$20240712$EXP$$DE-AUROBINDO-AUR-APL-2024-033194$AUROBINDO$$79$YR$$F$Y$87$KG$20240712$$MD$DE$DE
240834461$24083446$1$I$$20240703$20240712$20240712$EXP$$PT-AUROBINDO-AUR-APL-2024-033054$AUROBINDO$Lobato CT, Castelo Branco S, Cam?es J, Molinos E.. Rhabdomyolysis secondary to a weight-loss prescription.. BMJ Case Reports. 2024;17(6):e258208$8$DEC$$M$Y$$$20240712$$MD$PT$PT
240834491$24083449$1$I$20230904$20240708$20240712$20240712$EXP$$CN-JNJFOC-20240721707$JOHNSON AND JOHNSON$$38$YR$A$M$Y$90$KG$20240712$$HP$CN$CN
240834501$24083450$1$I$$20240708$20240712$20240712$EXP$GB-MHRA-MED-202405081535377470-TPYSN$GB-STRIDES ARCOLAB LIMITED-2024SP008346$STRIDES$$$$$F$Y$87$KG$20240712$$PH$GB$GB
240834511$24083451$1$I$20240612$20240709$20240712$20240712$PER$$US-JNJFOC-20240725537$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$HP$US$US
240834521$24083452$1$I$20240612$20240628$20240712$20240712$EXP$$CN-SA-2024SA198652$SANOFI AVENTIS$$71$YR$E$F$Y$60$KG$20240712$$HP$CN$CN
240834531$24083453$1$I$$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48279$$FDA-CTU$$$$$F$N$$$20240710$N$HP$US$
240834541$24083454$1$I$20240101$20240615$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050234$TOLMAR$$$$$M$Y$$$20240712$$CN$CA$CA
240834551$24083455$1$I$$20240615$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050236$TOLMAR$$$$$M$Y$$$20240712$$CN$CA$CA
240834561$24083456$1$I$20240626$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48290$$FDA-CTU$$88$YR$$M$N$$$20240710$N$PH$US$
240834571$24083457$1$I$$20240705$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050260$TOLMAR$$$$$M$Y$$$20240712$$CN$CA$CA
240834581$24083458$1$I$20240615$20240615$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050285$TOLMAR$$86$YR$$M$Y$$$20240712$$CN$CA$CA
240834591$24083459$1$I$$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48263$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
240834602$24083460$2$F$20240424$20240704$20240712$20240718$EXP$$GB-CELLTRION INC.-2024GB016606$CELLTRION$$$$$$Y$$$20240718$$HP$GB$GB
240834611$24083461$1$I$20090301$20240708$20240712$20240712$EXP$GB-MHRA-MED-202405121551375800-CVNQW$GB-STRIDES ARCOLAB LIMITED-2024SP008348$STRIDES$$18$YR$$M$Y$$$20240712$$CN$GB$GB
240834621$24083462$1$I$20240308$20240703$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-033241$AUROBINDO$$35$YR$$F$Y$$$20240712$$MD$FR$FR
240834631$24083463$1$I$$20240124$20240712$20240712$PER$$US-BAYER-2024A095524$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240834641$24083464$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48285$$FDA-CTU$$63$YR$$F$N$$$20240711$N$$US$
240834651$24083465$1$I$20240601$20240703$20240712$20240712$PER$$US-SA-2024SA201102$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240712$$MD$US$US
240834661$24083466$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA202906$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240712$$MD$US$US
240834671$24083467$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA203677$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240834681$24083468$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA201931$SANOFI AVENTIS$$54$YR$A$F$Y$55$KG$20240712$$MD$US$US
240834701$24083470$1$I$$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137951$AMGEN$$$$$M$Y$$$20240712$$CN$US$US
240834712$24083471$2$F$$20240809$20240712$20240812$PER$$US-AMGEN-USASP2024137047$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
240834722$24083472$2$F$20240709$20240710$20240712$20240717$PER$$US-AMGEN-USASP2024137853$AMGEN$$60$YR$A$M$Y$$$20240717$$PH$US$US
240834731$24083473$1$I$20240701$20240708$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109687$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240712$$PH$US$US
240834741$24083474$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033036$AUROBINDO$Javadi T, Morales B, Olson JJ, Kothari S, Zhang L, Abedalthagafi M.. Extracavitary primary effusion lymphoma presenting as a solitary brain mass.. CNS Oncology. 2024;13(1):2357535$62$YR$$M$Y$$$20240712$$MD$US$US
240834761$24083476$1$I$20240702$20240702$20240712$20240712$PER$$US-RDY-SPO/USA/24/0009947$DR REDDYS$$42$YR$A$F$Y$$$20240712$$MD$US$US
240834773$24083477$3$F$20240101$20240819$20240712$20240827$EXP$$JP-ALK-ABELLO A/S-2024AA002818$ALK-ABELLO$$$$$$Y$$$20240827$$HP$JP$JP
240834781$24083478$1$I$20240201$20240705$20240712$20240712$EXP$$DE-862174955-ML2024-03796$Unknown Manufacturer$$$$$F$Y$3.58$KG$20240712$$MD$DE$DE
240834791$24083479$1$I$20240617$20240701$20240712$20240712$EXP$SK-SUKLSK-20240412$SK-SERVIER-S24008421$SERVIER$$$$$$Y$$$20240712$$MD$SK$SK
240834801$24083480$1$I$$20240702$20240712$20240712$EXP$$US-JNJFOC-20240720741$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240834811$24083481$1$I$20240619$20240703$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-033281$AUROBINDO$$24$YR$$M$Y$133$KG$20240712$$MD$FR$FR
240834821$24083482$1$I$$20240704$20240712$20240712$EXP$$ZA-AstraZeneca-2024A155374$ASTRAZENECA$$81$YR$$M$Y$$$20240712$$CN$ZA$
240834831$24083483$1$I$$20240705$20240712$20240712$EXP$$GB-VANTIVE-2024VAN018240$Vantive US Healthcare$$$$$F$Y$54.2$KG$20240712$$CN$GB$GB
240834841$24083484$1$I$20230801$20240703$20240712$20240712$PER$$US-SA-2024SA201897$SANOFI AVENTIS$$63$YR$A$M$Y$65$KG$20240712$$MD$US$US
240834851$24083485$1$I$20240606$20240705$20240712$20240712$PER$$US-IDORSIA-008229-2024-US$IDORSIA PHARMACEUTICALS$$61$YR$$M$Y$$$20240712$$CN$US$US
240834861$24083486$1$I$$20240704$20240712$20240712$EXP$$US-BEH-2024175169$CSL BEHRING$$$$$M$Y$$$20240712$$MD$US$US
240834881$24083488$1$I$20240613$20240701$20240712$20240712$EXP$FR-AFSSAPS-BX2024001270$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-06205$HIKMA$$36$YR$$M$Y$123$KG$20240712$$PH$FR$FR
240834891$24083489$1$I$20240413$20240704$20240712$20240712$EXP$$ES-AUROBINDO-AUR-APL-2024-033422$AUROBINDO$$95$YR$$M$Y$$$20240712$$MD$ES$ES
240834901$24083490$1$I$$20240701$20240712$20240712$EXP$$CN-IPCA LABORATORIES LIMITED-IPC-2024-CN-001725$IPCA$Hong Cheng, Fengbo Xu, Guoqin Wang et al. Warfarin-related nephropathy in two patients with mechanical valves. Kidney International Reports. 2024;9:S576$$$$$Y$$$20240712$$HP$CN$CN
240834911$24083491$1$I$$20240619$20240712$20240712$PER$$US-BEH-2024172561$CSL BEHRING$$$$A$F$Y$$$20240712$$HP$US$US
240834921$24083492$1$I$20211215$20240709$20240712$20240712$EXP$$CO-UCBSA-2024035336$UCB$$57$YR$$F$Y$$$20240712$$CN$CO$CO
240834931$24083493$1$I$$20240702$20240712$20240712$PER$$US-ROCHE-10000017792$ROCHE$$$$A$M$Y$$$20240712$$CN$US$US
240834942$24083494$2$F$20230611$20240716$20240712$20240724$EXP$$BR-CELLTRION INC.-2023BR012605$CELLTRION$$$$$$Y$$$20240724$$CN$BR$BR
240834951$24083495$1$I$20240416$20240702$20240712$20240712$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024082203$VIIV$$34$YR$$M$Y$$$20240712$$HP$US$US
240834961$24083496$1$I$$20240708$20240712$20240712$EXP$$TR-MYLANLABS-2024M1065282$MYLAN$Gurbanov A, Kandemir H, Gurbanova L, Gun E, Botan E, Balaban B, et al. Antidepressant Poisoning Trends in Pediatric Intensive Care: A Comparative Study of New- and Old-Generation Antidepressants. J-Clin-Psychopharmacol 2023; 43 (2): 139-144.$$$$M$Y$$$20240712$$MD$TR$TR
240834971$24083497$1$I$$20240628$20240712$20240712$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06121$HIKMA$Contag CA, Studemeister L, Bogler Y, Cooper JD. Q. Contag CA, Studemeister L, Bogler Y, Cooper JD. Q fever presenting as splenic infarct without endocarditis.. IDCases. 2024;37:e02012$44$YR$$M$Y$$$20240712$$MD$US$US
240834981$24083498$1$I$$20240708$20240712$20240712$EXP$$IT-MYLANLABS-2024M1064106$MYLAN$Piscione M, Dajana P, Crispino E, Frau L, Halasz G, Ussi G, et al. If you want to go fast, go alone. If you want to go far, ablate AF: a case report. Eur-Heart-J-Suppl 2024; 26 (Suppl. 2) ii195.$70$YR$$F$Y$$$20240712$$HP$IT$IT
240834991$24083499$1$I$$20240708$20240712$20240712$EXP$$TR-MYLANLABS-2024M1065242$MYLAN$Gul EE, Bektasoglu G, Dogan Z. Brugada phenocopy associated with multiple psychotic drugs. J-Electrocardiol 2023; 81 156-158.$17$YR$$F$Y$$$20240712$$MD$TR$TR
240835001$24083500$1$I$$20240704$20240712$20240712$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008391$STRIDES$McMullan P, Brown R, Bibb L, Ferenczi K.. Cutaneous CD30 positive anaplastic large cell lymphoma mimicking breast carcinoma en cuirasse.. JAAD-Case-Rep. 2023;40:37-40$$$$$Y$$$20240712$$MD$US$US
240835011$24083501$1$I$$20240703$20240712$20240712$PER$$US-ROCHE-10000021033$ROCHE$$$$A$F$Y$$$20240712$$HP$US$US
240835021$24083502$1$I$$20240701$20240712$20240712$PER$$US-ROCHE-10000014228$ROCHE$Xu Z, Khalil S, Ponge-Wilson I, Moshiri A. Benign fibrous histiocytoma and cutaneous amyloidosis in a patient receiving enfuvirtide injections. JAAD Case Reports. 2024;(50):19-21. doi:10.1016/j.jdcr.2024.04.047.$55$YR$A$M$Y$$$20240712$$MD$US$US
240835032$24083503$2$F$20231123$20240821$20240712$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-004839$AUROBINDO$$43$YR$$F$Y$92$KG$20240831$$MD$FR$FR
240835052$24083505$2$F$20240625$20240710$20240712$20240725$EXP$$ES-SERVIER-S24008402$SERVIER$$$$$$Y$$$20240725$$HP$ES$ES
240835061$24083506$1$I$20220425$20240710$20240712$20240712$EXP$$CA-AMGEN-CANSL2022046910$AMGEN$$58$YR$A$F$Y$$$20240712$$HP$CA$CA
240835071$24083507$1$I$$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024138595$AMGEN$$$$$$Y$$$20240712$$CN$US$US
240835111$24083511$1$I$20230701$20240704$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-033395$AUROBINDO$$66$YR$$M$Y$$$20240712$$MD$FR$FR
240835124$24083512$4$F$$20240709$20240712$20240725$EXP$$US-GSK-US2024085051$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
240835131$24083513$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186692$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240835141$24083514$1$I$$20240709$20240712$20240712$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038912$BOEHRINGER INGELHEIM$Makihara Kan, Minamoto Toshiko, Nakagawa Kyoko, Haraga Hikaru, Nonomura Yuki, Okada Hiroe, Ishikawa Masako, Oride Aki, Kanasaki Haruhiko, Kyo Satoru ; A case of pregnancy complicated by scleroderma with marked renal failure after childbirth;Journal of Japan Society of Perinatal and Neonatal Medicine; 2024.6.22;60;S1;303$35$YR$A$F$Y$$$20240712$$MD$JP$JP
240835151$24083515$1$I$$20240704$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033286$AUROBINDO$Fink NS, Abubshait L, Deshisky A. Anti-HMGCR (Hydroxy-3-Methylglutaryl-CoA Reductase) Myopathy: A Rare Cause of Proximal Muscle Weakness. Cureus. 2024;16(5):e61094$65$YR$$F$Y$$$20240712$$MD$US$US
240835161$24083516$1$I$20240101$20240708$20240712$20240712$EXP$$DE-ABBVIE-5835070$ABBVIE$$$$$M$Y$71$KG$20240712$$HP$DE$DE
240835171$24083517$1$I$20240101$20240612$20240712$20240712$PER$$US-009507513-2406USA004032$MERCK$$$$$F$Y$$$20240712$$HP$US$US
240835182$24083518$2$F$$20240715$20240712$20240717$PER$$NVSC2024US144311$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
240835191$24083519$1$I$20240101$20240709$20240712$20240712$EXP$$US-ABBVIE-5835834$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240835211$24083521$1$I$$20240625$20240712$20240712$EXP$$TH-BLUEPRINT MEDICINES CORPORATION-2024BUS000134$Unknown Manufacturer$$$$$$Y$$$20240710$$CN$TH$TH
240835221$24083522$1$I$$20240708$20240712$20240712$EXP$$JP-JNJFOC-20240727479$JOHNSON AND JOHNSON$$14$YR$T$$Y$$$20240712$$CN$JP$JP
240835231$24083523$1$I$20240708$20240708$20240712$20240712$PER$$US-JNJFOC-20240718839$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$MD$US$US
240835241$24083524$1$I$20230201$20240708$20240712$20240712$EXP$$AU-JNJFOC-20240724933$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240712$$CN$AU$AU
240835251$24083525$1$I$20240618$20240705$20240712$20240712$EXP$$PR-JNJFOC-20240717623$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240712$$CN$PR$PR
240835271$24083527$1$I$$20240709$20240712$20240712$PER$$US-AGIOS-2407US03828$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240835281$24083528$1$I$$20240708$20240712$20240712$PER$$US-AGIOS-2407US03825$AGIOS PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240835292$24083529$2$F$$20240722$20240712$20240730$PER$$US-AGIOS-2407US03827$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
240835302$24083530$2$F$20240701$20240730$20240712$20240806$30DAY$$US-AMGEN-USASP2024135382$AMGEN$$58$YR$A$F$Y$85.7$KG$20240806$$PH$US$US
240835311$24083531$1$I$$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137382$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240835321$24083532$1$I$20220103$20240628$20240712$20240712$EXP$$KR-BLUEPRINT MEDICINES CORPORATION-2024BUS000136$Unknown Manufacturer$$$$$$Y$$$20240711$$HP$KR$KR
240835332$24083533$2$F$20240625$20240717$20240712$20240801$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0517$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240801$$HP$US$US
240835341$24083534$1$I$20240710$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006908$ELI LILLY AND CO$$$$$M$Y$$$20240712$$CN$US$US
240835351$24083535$1$I$20240705$20240705$20240712$20240712$PER$$US-HETERO-HET2024US02235$HETERO$$64$YR$$F$Y$$$20240712$$CN$US$US
240835361$24083536$1$I$20240706$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006987$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240712$$CN$US$US
240835371$24083537$1$I$$20240701$20240712$20240712$EXP$$US-TEVA-VS-3218674$TEVA$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch-Dermatol-Res 2024; 316 (6):.; Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch-Dermatol-Res 2024; 316 (6):.$63$YR$$F$Y$$$20240712$$HP$US$US
240835381$24083538$1$I$20240526$20240703$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-032991$AUROBINDO$$52$YR$$M$Y$79.8$KG$20240712$$MD$FR$FR
240835393$24083539$3$F$$20240722$20240712$20240724$EXP$$FI-ABBVIE-5837795$ABBVIE$Helin H, Huovinen S, Uusitalo T. Autoimmune myopathy is a rare muscle disease associated with statin therapy. 2024;11343-1148$60$YR$$M$Y$$$20240724$$HP$FI$FI
240835401$24083540$1$I$20240517$20240628$20240712$20240712$EXP$FR-AFSSAPS-AN2024000798$FR-SA-2024SA196899$SANOFI AVENTIS$$69$YR$E$F$Y$68$KG$20240712$$PH$FR$FR
240835411$24083541$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007126$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240712$$CN$US$US
240835421$24083542$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA202928$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240835432$24083543$2$F$20240601$20240730$20240712$20240805$PER$$US-SA-2024SA197391$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240804$$CN$US$US
240835441$24083544$1$I$20240101$20240709$20240712$20240712$PER$$US-SA-2024SA202917$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240712$$CN$US$US
240835451$24083545$1$I$20100101$20240705$20240712$20240712$EXP$GB-MHRA-MED-202406262240085340-WRQJG$GB-ABBVIE-5836329$ABBVIE$$$$$F$Y$$$20240712$$CN$GB$GB
240835461$24083546$1$I$$20240703$20240712$20240712$EXP$$US-APOTEX-2024AP008126$APOTEX$Chu AF, Sagi V, Amin AK, Rajagopal G, Shantanu S, Pederson KS. Continuous QT interval monitoring using insertable cardiac monitors during antiarrhythmic loading hospitalization: Results from the ^LINQ QT^ Study. Europace. 2024;26(1):i43-i45$$$$$Y$$$20240712$$HP$US$US
240835471$24083547$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186505$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240835481$24083548$1$I$$20240702$20240712$20240712$EXP$$US-THEA-2024001505$Thea Pharma$$$$$F$Y$$$20240712$$CN$US$US
240835491$24083549$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033954$AUROBINDO$Liu J, Rosenfeld PJ, Dubovy SR. Branch retinal artery occlusion in a 49-year-Old woman taking phentermine. American Journal of Ophthalmology Case Reports. 2024;35:102013$49$YR$$F$Y$$$20240712$$HP$US$US
240835501$24083550$1$I$$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033430$AUROBINDO$$$$$$Y$44$KG$20240712$$CN$GB$GB
240835511$24083551$1$I$$20240702$20240712$20240712$PER$$US-TEVA-VS-3217327$TEVA$$$$$$Y$$$20240712$$CN$US$US
240835521$24083552$1$I$$20240215$20240712$20240712$PER$$US-BAYER-2024A095460$BAYER$$$$$F$Y$$$20240712$$MD$US$US
240835531$24083553$1$I$20240617$20240620$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002934$ACADIA PHARMACEUTICALS$$91$YR$$M$Y$$$20240712$$CN$US$US
240835541$24083554$1$I$$20240628$20240712$20240712$PER$$US-ROCHE-10000022750$ROCHE$$$$$F$Y$$$20240712$$CN$US$US
240835551$24083555$1$I$20240530$20240708$20240712$20240712$EXP$$US-JNJFOC-20240719047$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240835561$24083556$1$I$$20240629$20240712$20240712$EXP$$GB-CIPLA LTD.-2024GB07043$CIPLA$$$$$$Y$$$20240712$$CN$GB$GB
240835571$24083557$1$I$20230501$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455287$RANBAXY$$55$YR$$F$Y$69$KG$20240712$$MD$FR$FR
240835582$24083558$2$F$20231215$20240729$20240712$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454781$RANBAXY$$74$YR$$F$Y$42$KG$20240813$$PH$IT$IT
240835591$24083559$1$I$20240403$20240627$20240712$20240712$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454766$RANBAXY$$72$YR$$F$Y$$$20240712$$PH$IT$IT
240835603$24083560$3$F$20240701$20240717$20240712$20240930$EXP$$NZ-BEH-2024175288$CSL BEHRING$$6$YR$C$M$Y$21$KG$20240930$$HP$NZ$NZ
240835611$24083561$1$I$$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455309$RANBAXY$$71$YR$$M$Y$$$20240712$$PH$FR$FR
240835621$24083562$1$I$$20240628$20240712$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455884$RANBAXY$$$$$$Y$$$20240712$$CN$GB$GB
240835634$24083563$4$F$$20240828$20240712$20240902$PER$$US-JNJFOC-20240729614$JOHNSON AND JOHNSON$$26$YR$A$M$Y$60.836$KG$20240903$$HP$US$US
240835651$24083565$1$I$20220510$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455317$RANBAXY$$13$YR$$F$Y$60$KG$20240712$$MD$FR$FR
240835662$24083566$2$F$20240313$20240805$20240712$20240820$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454862$RANBAXY$$58$YR$$M$Y$$$20240820$$MD$IT$IT
240835671$24083567$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033079$AUROBINDO$Yuen CA, Pekmezci M, Bao S, Kong X.. Metastatic glioblastoma to the lungs: a case report and literature review. CNS Oncology. 2024;13 (1):2351789$63$YR$$F$Y$$$20240712$$MD$US$US
240835682$24083568$2$F$20231201$20240717$20240712$20240801$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455365$RANBAXY$$85$YR$$M$Y$67$KG$20240801$$MD$FR$FR
240835691$24083569$1$I$$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455404$RANBAXY$$76$YR$$F$Y$$$20240712$$PH$FR$FR
240835701$24083570$1$I$$20240628$20240712$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456093$RANBAXY$$$$$F$Y$$$20240712$$CN$GB$GB
240835711$24083571$1$I$20240213$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455356$RANBAXY$$26$YR$$F$Y$$$20240712$$HP$FR$FR
240835721$24083572$1$I$20240301$20240627$20240712$20240712$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456358$RANBAXY$$66$YR$$F$Y$$$20240712$$MD$SE$SE
240835731$24083573$1$I$20230620$20240627$20240712$20240712$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454839$RANBAXY$$32$YR$$F$Y$$$20240712$$MD$IT$IT
240835741$24083574$1$I$20231031$20240627$20240712$20240712$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455492$RANBAXY$$38$YR$$M$Y$76$KG$20240712$$MD$IT$IT
240835751$24083575$1$I$20230101$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455116$RANBAXY$$47$YR$$M$Y$$$20240712$$PH$FR$FR
240835761$24083576$1$I$20230919$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455330$RANBAXY$$22$YR$$F$Y$$$20240712$$MD$FR$FR
240835771$24083577$1$I$20231001$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454738$RANBAXY$$69$YR$$M$Y$83.5$KG$20240712$$MD$FR$FR
240835781$24083578$1$I$20240131$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455061$RANBAXY$$88$YR$$F$Y$$$20240712$$PH$FR$FR
240835791$24083579$1$I$$20240628$20240712$20240712$PER$$US-MYLANLABS-2024M1062450$MYLAN$$$$$F$Y$$$20240712$$CN$US$US
240835801$24083580$1$I$$20240708$20240712$20240712$EXP$$ZA-AstraZeneca-2024A156964$ASTRAZENECA$$76$YR$$F$Y$$$20240712$$CN$ZA$
240835811$24083581$1$I$20240312$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455246$RANBAXY$$21$YR$$F$Y$53$KG$20240712$$PH$FR$FR
240835821$24083582$1$I$20240131$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455117$RANBAXY$$49$YR$$M$Y$$$20240712$$MD$FR$FR
240835831$24083583$1$I$20240501$20240705$20240712$20240712$EXP$$FR-AstraZeneca-2024A154474$ASTRAZENECA$$78$YR$$M$Y$$$20240712$$MD$FR$
240835841$24083584$1$I$$20240205$20240712$20240712$PER$$US-BAYER-2024A095445$BAYER$$30$YR$A$F$Y$$$20240712$$CN$US$US
240835851$24083585$1$I$20240322$20240627$20240712$20240712$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455387$RANBAXY$$72$YR$$M$Y$$$20240712$$PH$FR$FR
240835861$24083586$1$I$$20240611$20240712$20240712$EXP$$US-GSK-US2024085806$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$HP$US$US
240835871$24083587$1$I$$20240705$20240712$20240712$EXP$$RU-ABBVIE-5837436$ABBVIE$Merinov AV, Shiskova IM, Emec NA, Novichkova AS, Kosy^reva AV. Suicide and psychiatry: the suicidal person is more likely to be ill or rather healthy. Reflections on the psychiatric qualification of suicide, awareness of actions and the truth of intentions. Suicidology. 2024;15 (54):105-142.$$$$$Y$$$20240712$$HP$RU$RU
240835891$24083589$1$I$$20240704$20240712$20240712$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2023-05105$IPSEN$$$$$M$Y$$$20240712$$CN$GB$GB
240835902$24083590$2$F$$20240722$20240712$20240726$EXP$$US-AMGEN-USASP2024136752$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
240835911$24083591$1$I$20230214$20240701$20240712$20240712$EXP$FR-AFSSAPS-AM2023000635$FR-STRIDES ARCOLAB LIMITED-2024SP007854$STRIDES$$73$YR$$F$Y$$$20240712$$MD$FR$FR
240835921$24083592$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137389$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240835931$24083593$1$I$$20240205$20240712$20240712$PER$$US-BAYER-2024A095525$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240835941$24083594$1$I$20230417$20240702$20240712$20240712$EXP$FR-AFSSAPS-LM2024000369$FR-STRIDES ARCOLAB LIMITED-2024SP008033$STRIDES$$39$YR$$F$Y$$$20240712$$MD$FR$FR
240835972$24083597$2$F$20070101$20240628$20240712$20240805$EXP$$US-JNJFOC-20240723828$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$US$US
240835981$24083598$1$I$$20240708$20240712$20240712$EXP$$TR-JNJFOC-20240722625$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$MD$TR$TR
240835991$24083599$1$I$$20240206$20240712$20240712$PER$$US-BAYER-2024A095448$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240836001$24083600$1$I$20240707$20240711$20240712$20240712$EXP$$NVSC2024CN143863$NOVARTIS$$82$YR$$F$Y$$$20240712$$HP$CN$CN
240836011$24083601$1$I$20240202$20240708$20240712$20240712$EXP$BE-FAMHP-DHH-N2024-122327$BE-EMD Serono-2024037155$EMD SERONO INC$$61$YR$A$M$Y$68$KG$20240712$$PH$BE$BE
240836022$24083602$2$F$$20240705$20240712$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456896$RANBAXY$Chappuy M, Merah I, Ragonnet D, Ternay J, Rolland B. Lyon resource center for prescription drug use disorder (Use of a magistral preparation). The Addiction Letter. 2024;May-Jun 20(2):24-7$47$YR$$M$Y$$$20240719$$PH$FR$FR
240836031$24083603$1$I$20191101$20240704$20240712$20240712$EXP$GB-MHRA-MED-202404301931392500-MGPHN$GB-TORRENT-00037011$TORRENT$$$$$M$Y$$$20240712$$CN$GB$GB
240836043$24083604$3$F$$20240725$20240712$20240802$PER$$US-SA-2024SA202724$SANOFI AVENTIS$$72$YR$E$F$Y$60.781$KG$20240802$$MD$US$US
240836051$24083605$1$I$$20240223$20240712$20240712$PER$$US-BAYER-2024A095464$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240836061$24083606$1$I$$20240618$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002887$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240836072$24083607$2$F$$20240910$20240712$20240918$EXP$$CA-TAKEDA-2024TUS070371$TAKEDA$$$$$M$Y$$$20240918$$CN$CA$CA
240836081$24083608$1$I$$20240703$20240712$20240712$EXP$$US-AUROBINDO-AUR-APL-2024-033818$AUROBINDO$Luskin MR, Murakami MA, Keating J, Winer ES, Garcia JS, Stahl M, et al. A Phase IStudy of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL and Blast Phase CML in Adults.. Blood. 2023;142 (Suppl. 1):965-967$53$YR$$F$Y$$$20240712$$MD$US$US
240836091$24083609$1$I$20240222$20240304$20240712$20240712$PER$$US-BAYER-2024A095574$BAYER$$36$YR$A$F$Y$65.77$KG$20240712$$HP$US$US
240836101$24083610$1$I$$20240628$20240712$20240712$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05954$LUPIN$Torelli VA, Ernest Jean R, Tran E. Rapidly progressive interstitial lung disease due to silicosis in an otherwise healthy jeweler. American Journal of Respiratory and Critical Care Medicine. 2024;209$83$YR$$F$Y$$$20240712$$HP$US$US
240836111$24083611$1$I$$20240704$20240712$20240712$EXP$$NVSC2024RU142732$NOVARTIS$Aleshina OA. ???? ??????? ????????? ? ??????????????/???????????? ??????  ????????????? ???????? ???????????? ? ??????????? 7-? ????????? [Experience in treating patients with relapsed/refractory acute myeloblastic leukemia involving chromosome 7]. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY (GEMATOLOGIYA I TRANSFUSIOLOGIY. 2024;69 (2):159-61$25$YR$$$Y$$$20240712$$HP$RU$RU
240836122$24083612$2$F$$20240717$20240712$20240724$EXP$$NVSC2024MX142338$NOVARTIS$Perez Castaneda H, Gonzalez Luna RH. Sindrome de Blau; presentacion atipica de un caso [Blau Syndrome, atypical presentation of clinical case]. ALERGIA ASMA INMUNOL PEDIA. 2024;33 (1):48-9$2$YR$$M$Y$$$20240724$$HP$MX$MX
240836131$24083613$1$I$$20240708$20240712$20240712$EXP$GB-MHRA-MED-202407081207019380-BKMVG$GB-MYLANLABS-2024M1064168$MYLAN$$$$$M$Y$76$KG$20240712$$CN$GB$GB
240836141$24083614$1$I$20240624$20240708$20240712$20240712$EXP$$GB-MYLANLABS-2024M1064040$MYLAN$$76$YR$$F$Y$67$KG$20240712$$MD$GB$GB
240836151$24083615$1$I$20240617$20240618$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002888$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240712$$CN$US$US
240836161$24083616$1$I$20240305$20240305$20240712$20240712$PER$$US-BAYER-2024A095540$BAYER$$54$YR$A$F$Y$$$20240712$$CN$US$US
240836171$24083617$1$I$$20240628$20240712$20240712$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456284$RANBAXY$$73$YR$$M$Y$$$20240712$$PH$GB$GB
240836181$24083618$1$I$$20240709$20240712$20240712$PER$$US-JNJFOC-20240723899$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$HP$US$US
240836191$24083619$1$I$20240101$20240613$20240712$20240712$PER$$US-009507513-2406USA004758$MERCK$$$$$F$Y$$$20240712$$CN$US$US
240836201$24083620$1$I$$20240702$20240712$20240712$EXP$$CN-Merck Healthcare KGaA-2024036031$MERCK KGAA$$$$$F$Y$$$20240710$$CN$CN$CN
240836224$24083622$4$F$20240101$20240729$20240712$20240802$EXP$$US-009507513-2407USA003447$MERCK$$$$$M$Y$$$20240802$$CN$US$US
240836231$24083623$1$I$$20240328$20240712$20240712$PER$$US-BAYER-2024A095573$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240836241$24083624$1$I$$20240710$20240712$20240712$EXP$$NVSJ2024JP008360$NOVARTIS$$77$YR$$M$Y$$$20240712$$PH$JP$JP
240836251$24083625$1$I$20240401$20240704$20240712$20240712$EXP$GB-MHRA-MED-202405021349419550-JDVKB$GB-TORRENT-00037026$TORRENT$$7$YR$C$F$Y$$$20240712$$MD$GB$GB
240836261$24083626$1$I$20240703$20240703$20240712$20240712$PER$$US-RDY-SPO/USA/24/0009939$DR REDDYS$$15$YR$T$F$Y$$$20240712$$MD$US$US
240836271$24083627$1$I$$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033802$AUROBINDO$$$$$F$Y$$$20240712$$HP$GB$GB
240836291$24083629$1$I$20240601$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137426$AMGEN$$74$YR$E$F$Y$$$20240712$$CN$US$US
240836303$24083630$3$F$20240626$20240816$20240712$20240826$EXP$$CA-CELLTRION INC.-2024CA016288$CELLTRION$$$$$$Y$$$20240826$$CN$CA$CA
240836311$24083631$1$I$$20240328$20240712$20240712$PER$$US-BAYER-2024A095554$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240836321$24083632$1$I$$20240705$20240712$20240712$EXP$$US-AstraZeneca-2024A155002$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$US$
240836331$24083633$1$I$$20240708$20240712$20240712$EXP$$NL-MYLANLABS-2024M1064688$MYLAN$$$$$M$Y$$$20240712$$CN$NL$NL
240836343$24083634$3$F$$20240712$20240712$20240726$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456837$RANBAXY$Boutari C, Zarkada E, Vyzantiadis A, Vlachaki E, Mantzou G, Karipidou C et al. A hematoma in the anterior abdominal muscle in a woman receivingvenlafaxine. A literature review of the reports on similar cases. Acta Haematol. 2024;Apr 17; 0 (0):1-6$54$YR$$$Y$$$20240726$$HP$GR$GR
240836351$24083635$1$I$$20240708$20240712$20240712$EXP$$IE-MYLANLABS-2024M1064221$MYLAN$$$$$$Y$$$20240712$$PH$IE$IE
240836361$24083636$1$I$20240430$20240704$20240712$20240712$EXP$$GB-AstraZeneca-2024A153987$ASTRAZENECA$$63$YR$$F$Y$78$KG$20240712$$MD$GB$
240836371$24083637$1$I$$20240702$20240712$20240712$EXP$$FR-Merck Healthcare KGaA-2024036120$MERCK KGAA$$$$$F$Y$$$20240710$$CN$FR$FR
240836381$24083638$1$I$$20240618$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002889$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240836401$24083640$1$I$$20240701$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407001217$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240712$$CN$US$US
240836411$24083641$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007019$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240712$$CN$US$US
240836421$24083642$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007096$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240712$$CN$US$US
240836431$24083643$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007387$ELI LILLY AND CO$$$$$F$Y$$$20240712$$CN$US$US
240836441$24083644$1$I$$20240708$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005192$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240712$$CN$US$US
240836451$24083645$1$I$20240710$20240711$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007845$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240712$$CN$US$US
240836461$24083646$1$I$20240707$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007132$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240712$$CN$US$US
240836481$24083648$1$I$20240628$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48293$$FDA-CTU$$57$YR$$M$N$$$20240711$Y$PH$US$
240836491$24083649$1$I$20240620$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48249$$FDA-CTU$$45$YR$$F$N$$$20240711$Y$PH$US$
240836501$24083650$1$I$20190317$20240708$20240712$20240712$EXP$$US-TAKEDA-US201909193$TAKEDA$$34$YR$$F$Y$$$20240712$$CN$US$US
240836511$24083651$1$I$$20240620$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002936$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240836522$24083652$2$F$20240305$20240905$20240712$20240916$EXP$$JP-AMGEN-JPNSP2024137005$AMGEN$$82$YR$E$F$Y$$$20240916$$MD$JP$JP
240836531$24083653$1$I$20240702$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110666$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240712$$CN$US$US
240836541$24083654$1$I$$20240411$20240712$20240712$PER$$US-BAYER-2024A095489$BAYER$$$$$F$Y$$$20240712$$HP$US$US
240836552$24083655$2$F$20240709$20240709$20240712$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-021040$UNITED THERAPEUTICS$$53$YR$$M$Y$$$20240718$$$US$US
240836571$24083657$1$I$20180601$20240705$20240712$20240712$EXP$$NVSC2024SI139922$NOVARTIS$$45$YR$$F$Y$$$20240712$$MD$SI$SI
240836583$24083658$3$F$20240701$20240718$20240712$20240814$EXP$$GB-CELLTRION INC.-2024GB016666$CELLTRION$$$$$$Y$$$20240814$$CN$GB$GB
240836591$24083659$1$I$$20240703$20240712$20240712$PER$$US-APOTEX-2024AP008158$APOTEX$Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN. Relationship between the Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular Immunology and Inflammation. 2023;31(5):900-904$$$A$$Y$$$20240712$$HP$US$US
240836601$24083660$1$I$$20240628$20240712$20240712$EXP$$US-LEADINGPHARMA-US-2024LEASPO00271$LEADING PHARMA$$$$$F$Y$68$KG$20240712$$CN$US$US
240836611$24083661$1$I$$20240427$20240712$20240712$PER$$US-BAYER-2024A095556$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240836621$24083662$1$I$$20240626$20240712$20240712$PER$$US-ABBVIE-5835248$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240836632$24083663$2$F$$20240710$20240712$20240717$PER$$US-LEO Pharma-371846$LEO PHARM$$71$YR$$F$Y$$$20240717$$CN$US$US
240836641$24083664$1$I$20231119$20240704$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-033391$AUROBINDO$$62$YR$$M$Y$64$KG$20240712$$MD$FR$FR
240836651$24083665$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137623$AMGEN$$$$$$Y$$$20240712$$HP$US$US
240836671$24083667$1$I$20230625$20240701$20240712$20240712$EXP$$AU-009507513-2407AUS001807$MERCK$$79$YR$$M$Y$$$20240712$$MD$AU$AU
240836683$24083668$3$F$20240620$20240904$20240712$20240910$EXP$$US-BAYER-2024A095593$BAYER$$44$YR$A$F$Y$$$20240910$$MD$US$US
240836691$24083669$1$I$$20240702$20240712$20240712$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004975$BIOCON$$$$$$Y$$$20240712$$HP$CA$CA
240836706$24083670$6$F$20240601$20240916$20240712$20240920$EXP$$GB-MYLANLABS-2024M1064223$MYLAN$$59$YR$$F$Y$$$20240920$$MD$GB$GB
240836711$24083671$1$I$$20240705$20240712$20240712$EXP$$IT-MYLANLABS-2024M1064631$MYLAN$Lamaida N, Cerciello A. Cardiac contractility modulation: an option for chronic heart failure; a case report. Eur-Heart-J-Suppl 2024; 26 (Suppl. 2) ii134 abstr. 338.$72$YR$$$Y$$$20240712$$HP$IT$IT
240836722$24083672$2$F$$20240712$20240712$20240716$EXP$$GR-MYLANLABS-2024M1064005$MYLAN$$72$YR$$M$Y$$$20240716$$CN$GR$GR
240836731$24083673$1$I$$20240705$20240712$20240712$EXP$$AU-MYLANLABS-2024M1064925$MYLAN$Huynh A, Siggs OM, Wainstein BK, Gray PE. Infliximab Reverses Symptoms and May Protect from Developing Chronic Restrictive Ophthalmopathy in Children with Familial Orbital Myositis: A Case Report. Ocular-Immunol-Inflamm 2023; 31 (5): 1097-1100.$9$YR$$F$Y$$$20240712$$MD$AU$AU
240836741$24083674$1$I$$20240705$20240712$20240712$EXP$$US-MYLANLABS-2024M1064924$MYLAN$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatr-Blood-Cancer 2024; 71 (7): e31004.$31$YR$$M$Y$$$20240712$$HP$US$US
240836751$24083675$1$I$$20240705$20240712$20240712$EXP$$IT-MYLANLABS-2024M1064087$MYLAN$Grimaudo MS, Laffi A, Gennaro N, Fazio R, D^Orazio F, Sama L, et al. Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule. Front-Oncol 2023; 13.$53$YR$$M$Y$$$20240712$$HP$IT$IT
240836761$24083676$1$I$$20240705$20240712$20240712$EXP$$TR-MYLANLABS-2024M1064634$MYLAN$Herdi O. A combination of fluoxetine and olanzapine for the treatment of an adolescent with severe misophonia. Dusunen-Adam 2024; 37 (1): 57-58.$12$YR$$M$Y$$$20240712$$HP$TR$TR
240836771$24083677$1$I$$20240705$20240712$20240712$EXP$$US-MYLANLABS-2024M1064873$MYLAN$Baker M, Thakker S, Cardis M, DeSimone J, Larson A. A Vexing Case of a Treatment-Refractory, Idiopathic Rash Resembling Histiocytoid Sweet Syndrome: Insights into the Diagnostic Challenge of Vexas Syndrome. Am-J-Dermatopathol 2024; 46 (7) S1-S2.$71$YR$$M$Y$$$20240712$$HP$US$US
240836802$24083680$2$F$$20240709$20240712$20240712$PER$$US-ALXN-202407USA000621US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240712$$MD$US$US
240836811$24083681$1$I$$20240705$20240712$20240712$EXP$$US-MYLANLABS-2024M1064892$MYLAN$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatr-Blood-Cancer 2024; 71 (7): e31004.$6$YR$$F$Y$$$20240712$$HP$US$US
240836822$24083682$2$F$$20240730$20240712$20240808$EXP$$US-FARMAPROD-202407-2459$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240808$$MD$US$US
240836832$24083683$2$F$$20240705$20240712$20240717$EXP$$US-MYLANLABS-2024M1064917$MYLAN$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep 2023; 40 14-18.$$$$F$Y$$$20240717$$MD$US$US
240836841$24083684$1$I$20240101$20240705$20240712$20240712$PER$$US-SA-2024SA201394$SANOFI AVENTIS$$65$YR$E$F$Y$93.8$KG$20240712$$MD$US$US
240836851$24083685$1$I$$20240705$20240712$20240712$EXP$$US-MYLANLABS-2024M1064861$MYLAN$Bradshaw S, Oertling E, Rezigh A. Synchronous visceral Kaposi sarcoma and extracavitary primary effusion lymphoma in a patient with AIDS. BMJ-Case-Rep 2022; 15 (3):.$3$DEC$$M$Y$$$20240712$$MD$US$US
240836882$24083688$2$F$$20240820$20240712$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109370$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240826$$PH$JP$JP
240836892$24083689$2$F$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110679$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240712$$HP$US$US
240836901$24083690$1$I$20240613$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48295$$FDA-CTU$$66$YR$$F$N$$$20240711$Y$PH$US$
240836911$24083691$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110427$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240712$$CN$US$US
240836921$24083692$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109799$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240712$$CN$US$US
240836931$24083693$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110741$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240712$$CN$US$US
240836941$24083694$1$I$20240528$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48298$$FDA-CTU$$48$YR$$M$N$$$20240711$Y$PH$US$
240836951$24083695$1$I$$20240701$20240712$20240712$EXP$$US-MSNLABS-2024MSNSPO01460$MSN LABORATORIES$$$$$$Y$$$20240712$$PH$US$US
240836961$24083696$1$I$$20240710$20240712$20240712$EXP$$CN-TAKEDA-2024TUS070642$TAKEDA$$$$$M$Y$$$20240712$$CN$CN$CN
240836971$24083697$1$I$$20240704$20240712$20240712$EXP$$VN-TAKEDA-2024TUS069801$TAKEDA$$68$YR$$M$Y$$$20240712$$CN$VN$VN
240836991$24083699$1$I$$20240710$20240712$20240712$EXP$$US-TAKEDA-2023TUS122032$TAKEDA$$$$$F$Y$73$KG$20240712$$HP$US$US
240837001$24083700$1$I$20180101$20240705$20240712$20240712$EXP$$CA-TAKEDA-2018TUS022878$TAKEDA$$$$$F$Y$$$20240712$$CN$CA$CA
240837011$24083701$1$I$20240603$20240620$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002937$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240712$$CN$US$US
240837021$24083702$1$I$$20240702$20240712$20240712$EXP$$US-GSK-US2024AMR082453$GLAXOSMITHKLINE$$$$$M$Y$$$20240712$$CN$US$US
240837041$24083704$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48244$$FDA-CTU$$36$YR$$F$N$68.49$KG$20240711$N$HP$US$
240837051$24083705$1$I$20240710$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48305$$FDA-CTU$$26$YR$$M$N$$$20240711$N$$US$
240837071$24083707$1$I$20240622$20240710$20240712$20240712$EXP$$ZA-ABBVIE-5836588$ABBVIE$$11$YR$$M$Y$$$20240712$$MD$ZA$ZA
240837082$24083708$2$F$$20240715$20240712$20240720$EXP$$ES-JNJFOC-20240724363$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240719$$MD$ES$ES
240837091$24083709$1$I$$20240620$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002938$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$HP$US$US
240837102$24083710$2$F$20240601$20240906$20240712$20240911$EXP$$US-ROCHE-10000024959$ROCHE$$42$YR$A$F$Y$77.11$KG$20240911$$CN$US$US
240837121$24083712$1$I$20210512$20240711$20240712$20240712$EXP$$US-ROCHE-10000024655$ROCHE$$47$YR$A$F$Y$76.2$KG$20240712$$CN$US$US
240837131$24083713$1$I$$20240710$20240712$20240712$PER$$US-ROCHE-10000024301$ROCHE$$$$$$Y$$$20240712$$MD$US$US
240837141$24083714$1$I$20240517$20240628$20240712$20240712$EXP$IT-MINISAL02-992160$IT-SERVIER-S24008252$SERVIER$$$$$$Y$$$20240712$$PH$IT$IT
240837161$24083716$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA202962$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240712$$MD$US$US
240837171$24083717$1$I$20240601$20240709$20240712$20240712$PER$$US-SA-2024SA204694$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240712$$MD$US$US
240837181$24083718$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA201535$SANOFI AVENTIS$$$$E$F$Y$$$20240712$$CN$US$US
240837201$24083720$1$I$$20240628$20240712$20240712$EXP$$IN-ROCHE-10000019504$ROCHE$$67$YR$E$M$Y$$$20240712$$MD$IN$IN
240837211$24083721$1$I$$20240628$20240712$20240712$PER$$US-LEADINGPHARMA-US-2024LEASPO00278$LEADING PHARMA$$75$YR$E$F$Y$104.78$KG$20240712$$CN$US$US
240837221$24083722$1$I$$20240710$20240712$20240712$PER$$US-ROCHE-10000023547$ROCHE$$63$YR$A$F$Y$$$20240712$$CN$US$US
240837231$24083723$1$I$$20211115$20240712$20240712$PER$$PT-PFM-2022-05254$PIERRE FABRE MEDICAMENT$Mota R, Rodrigues E, Baptista M, Teles E, Farinha N. Langerhans Cells Histiocytosis in A Child with Barth Syndrome. Pediatric Blood and Cancer. 2021;68(5)$8$YR$$M$Y$$$20240712$$HP$PT$PT
240837241$24083724$1$I$$20240711$20240712$20240712$PER$$US-ROCHE-10000024482$ROCHE$$$$$M$Y$$$20240712$$CN$US$US
240837251$24083725$1$I$$20240703$20240712$20240712$PER$$US-APOTEX-2024AP008160$APOTEX$Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN. Relationship between the Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular Immunology and Inflammation. 2023;31(5):900-904$$$A$$Y$$$20240712$$HP$US$US
240837261$24083726$1$I$$20240705$20240712$20240712$EXP$$PL-ROCHE-10000002842$ROCHE$Pazyra A, Kusak N, Zak N, Jaworska B. Intraocular metastasis of small cell lung cancer: a case report. OnCOReview. 2023;13 (4):99-102. doi:10.24292/01.OR.134322223.$62$YR$A$M$Y$$$20240712$$HP$PL$PL
240837271$24083727$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110650$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240712$$MD$US$US
240837281$24083728$1$I$20240601$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110829$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240712$$HP$US$US
240837292$24083729$2$F$20240803$20240805$20240712$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107688$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$55.79$KG$20240809$$CN$US$US
240837301$24083730$1$I$$20240710$20240712$20240712$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110249$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$60$KG$20240712$$PH$CA$CA
240837311$24083731$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110110$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240712$$CN$US$US
240837321$24083732$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110033$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240712$$CN$US$US
240837332$24083733$2$F$$20240826$20240712$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110576$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240829$$CN$US$US
240837341$24083734$1$I$$20240709$20240712$20240712$PER$$US-ABBVIE-5836070$ABBVIE$$28$YR$$F$Y$$$20240712$$MD$US$US
240837351$24083735$1$I$$20211118$20240712$20240712$PER$$TR-PFM-2022-05256$PIERRE FABRE MEDICAMENT$Islek A, Ilhan D, Ozturk N, Guven B, Sag E. Altered von Willebrand Factor and ADAMTS13 Levels in Children with Cirrhosis and Extrahepatic Portal Hypertension. Journal of Pediatric Hematology Oncology. 2021;43(7):e951-6$$$$$Y$$$20240712$$HP$TR$TR
240837371$24083737$1$I$20231219$20240704$20240712$20240712$EXP$IT-MINISAL02-992456$IT-TEVA-VS-3217554$TEVA$$89$YR$$F$Y$$$20240712$$MD$IT$IT
240837381$24083738$1$I$20240601$20240709$20240712$20240712$DIR$FDA-CDER-CTU-2024-48394$$FDA-CTU$$20$YR$$M$N$$$20240709$N$HP$US$
240837392$24083739$2$F$20240701$20240722$20240712$20240729$PER$$US-ABBVIE-5834411$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
240837401$24083740$1$I$20240628$20240702$20240712$20240712$EXP$CN-NMPACDR-3704011509867202400607$CN-BAXTER-2024BAX021111$BAXTER$$54$YR$$F$Y$64$KG$20240712$$MD$CN$CN
240837411$24083741$1$I$$20240710$20240712$20240712$EXP$$US-LUNDBECK-DKLU4001525$LUNDBECK$$$$$$Y$$$20240712$$CN$US$US
240837421$24083742$1$I$$20240709$20240712$20240712$EXP$$CA-TAKEDA-2024TUS070410$TAKEDA$$$$$F$Y$$$20240712$$CN$CA$CA
240837431$24083743$1$I$20240623$20240702$20240712$20240712$EXP$CN-NMPACDR-3704011509867202400604$CN-BAXTER-2024BAX021113$BAXTER$$55$YR$$F$Y$51$KG$20240712$$MD$CN$CN
240837451$24083745$1$I$$20240708$20240712$20240712$EXP$$GB-MYLANLABS-2024M1064111$MYLAN$$$$$F$Y$$$20240712$$CN$GB$GB
240837461$24083746$1$I$20240701$20240708$20240712$20240712$EXP$$AU-MYLANLABS-2024M1064260$MYLAN$$84$YR$$F$Y$$$20240712$$HP$AU$AU
240837471$24083747$1$I$20240530$20240705$20240712$20240712$EXP$$GB-MYLANLABS-2024M1051541$MYLAN$$$$$M$Y$$$20240712$$MD$GB$GB
240837481$24083748$1$I$20240508$20240708$20240712$20240712$EXP$FR-AFSSAPS-PB2024000724$FR-MYLANLABS-2024M1063929$MYLAN$$77$YR$$F$Y$48$KG$20240712$$MD$FR$FR
240837491$24083749$1$I$20240701$20240708$20240712$20240712$EXP$$GB-MYLANLABS-2024M1064506$MYLAN$$$$$M$Y$$$20240712$$PH$GB$GB
240837501$24083750$1$I$$20240708$20240712$20240712$EXP$$GB-MYLANLABS-2024M1064941$MYLAN$$$$$M$Y$$$20240712$$HP$GB$GB
240837511$24083751$1$I$$20240704$20240712$20240712$EXP$$CA-ROCHE-2845146$ROCHE$$$$A$F$Y$$$20240712$$CN$CA$CA
240837521$24083752$1$I$$20240711$20240712$20240712$PER$$US-AMGEN-USASP2024138266$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240837531$24083753$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024136610$AMGEN$$$$$$Y$$$20240712$$HP$US$US
240837541$24083754$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137150$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240837551$24083755$1$I$20240611$20240618$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002892$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240712$$CN$US$US
240837563$24083756$3$F$$20240729$20240712$20240731$EXP$$CA-TAKEDA-2024TUS070534$TAKEDA$$$$$M$Y$$$20240731$$CN$CA$CA
240837571$24083757$1$I$20240101$20240710$20240712$20240712$EXP$$US-ROCHE-10000023302$ROCHE$$59$YR$A$F$Y$$$20240712$$CN$US$US
240837584$24083758$4$F$20240701$20240805$20240712$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-021105$UNITED THERAPEUTICS$$18$YR$$F$Y$49.887$KG$20240813$$$US$US
240837601$24083760$1$I$$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110801$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240712$$HP$US$US
240837611$24083761$1$I$20240524$20240705$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108973$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240712$$MD$US$US
240837621$24083762$1$I$20240628$20240703$20240712$20240712$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-106895$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240712$$MD$BR$BR
240837631$24083763$1$I$$20240710$20240712$20240712$PER$$NVSC2024US144351$NOVARTIS$$$$$$Y$$$20240712$$HP$US$US
240837642$24083764$2$F$$20240715$20240712$20240723$EXP$$NVSC2024RU143444$NOVARTIS$Luchkina VK, Bratukhina MM, Aleshina OA, Volkov NV, Vasilyeva AN, Akhmerzaeva ZKH et al.. ?????? ????????? ?????????????????? ?? ???? ??????????  ????????????? ? ???????? ? ?????? ?????????? ????????, ??????????? ? ???????? FLT3-ITD [A case of reversible leukoencephalopathy during the  use of gilteritinib in a patient with acute myeloid leukemia with the FLT3-ITD mutation]. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY. 2024;69(2):267-9$41$YR$$$Y$$$20240723$$HP$RU$RU
240837661$24083766$1$I$$20240710$20240712$20240712$PER$$US-ROCHE-10000023913$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240837671$24083767$1$I$20240616$20240618$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002894$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240712$$CN$US$US
240837681$24083768$1$I$$20240703$20240712$20240712$PER$$US-RDY-SPO/USA/24/0009942$DR REDDYS$$$$$F$Y$$$20240712$$CN$US$US
240837691$24083769$1$I$20240708$20240708$20240712$20240712$PER$$US-ABBVIE-5834894$ABBVIE$$59$YR$$F$Y$$$20240712$$CN$US$US
240837711$24083771$1$I$$20240703$20240712$20240712$EXP$$FR-RDY-LIT/FRA/24/0010127$DR REDDYS$Rocanieres P, Lamure S, Geny C, Hillaire-Buys D, Faillie J, Bres V. Parkinsonian Patients Requiring Proteasome Inhibitors for Multiple Myeloma: Exceptional Circumstances Call for Extra Caution. Journal of Parkinson^s Disease. 2022;12(8): 2601-2603. doi:10.3233/JPD-223496.$68$YR$E$M$Y$$$20240712$$HP$FR$FR
240837721$24083772$1$I$$20240702$20240712$20240712$PER$$US-APOTEX-2024AP007986$APOTEX$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation. American Journal of Transplantation. 2011;11 (3):500-510$47$YR$$F$Y$$$20240712$$HP$US$US
240837731$24083773$1$I$20240619$20240628$20240712$20240712$EXP$$IN-ROCHE-3441157$ROCHE$$44$YR$A$F$Y$$$20240712$$MD$IN$IN
240837762$24083776$2$F$20240710$20240802$20240712$20240805$PER$$US-AMGEN-USASP2024137038$AMGEN$$47$YR$A$M$Y$$$20240805$$CN$US$US
240837772$24083777$2$F$$20240716$20240712$20240724$EXP$$CA-TAKEDA-2024TUS070907$TAKEDA$$$$$F$Y$$$20240724$$CN$CA$CA
240837782$24083778$2$F$$20240712$20240712$20240718$30DAY$$US-GSK-US2024AMR085109$GLAXOSMITHKLINE$$$$$M$Y$$$20240718$$CN$US$US
240837792$24083779$2$F$20240201$20240812$20240712$20240821$EXP$$CL-JNJFOC-20240719861$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240821$$CN$CL$CL
240837802$24083780$2$F$$20240905$20240712$20240910$EXP$$US-ROCHE-10000024204$ROCHE$$62$YR$A$F$Y$81.19$KG$20240910$$MD$US$US
240837811$24083781$1$I$$20240701$20240712$20240712$EXP$$IN-ROCHE-10000020585$ROCHE$$45$YR$A$F$Y$$$20240712$$CN$IN$IN
240837821$24083782$1$I$20240429$20240705$20240712$20240712$EXP$$US-JNJFOC-20240715491$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$CN$US$US
240837833$24083783$3$F$20240617$20240806$20240712$20240816$EXP$$US-BAXTER-2024BAX021048$BAXTER$$68$YR$$F$Y$$$20240816$$MD$US$US
240837841$24083784$1$I$20240625$20240708$20240712$20240712$EXP$$US-009507513-2407USA003552$MERCK$$23$YR$$M$Y$103.4$KG$20240712$$PH$US$US
240837851$24083785$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006918$ELI LILLY AND CO$$56$YR$A$$Y$$$20240712$$CN$US$US
240837861$24083786$1$I$$20240625$20240712$20240712$EXP$$NVSC2024CA142728$NOVARTIS$$44$YR$$F$Y$$$20240712$$HP$CA$CA
240837871$24083787$1$I$$20240702$20240712$20240712$PER$$US-APOTEX-2024AP007987$APOTEX$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation. American Journal of Transplantation. 2011;11 (3):500-510$67$YR$$F$Y$$$20240712$$HP$US$US
240837881$24083788$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110976$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240712$$CN$US$US
240837891$24083789$1$I$$20240628$20240712$20240712$PER$$US-SA-2024SA196485$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240712$$CN$US$US
240837913$24083791$3$F$20240607$20240807$20240712$20240814$EXP$$CA-PUMA BIOTECHNOLOGY, LTD.-2024-PUM-CA000950$PUMA$$$$$$Y$$$20240814$$MD$CA$CA
240837921$24083792$1$I$20240629$20240708$20240712$20240712$EXP$$US-AstraZeneca-2024A156020$ASTRAZENECA$$24488$DY$$F$Y$$$20240712$$CN$US$
240837931$24083793$1$I$$20240704$20240712$20240712$EXP$$IT-AstraZeneca-2024A156130$ASTRAZENECA$$$$$M$Y$$$20240712$$MD$IT$
240837942$24083794$2$F$20240623$20240716$20240712$20240724$EXP$$JP-AstraZeneca-2024A156142$ASTRAZENECA$$$$E$M$Y$$$20240724$$MD$JP$
240837951$24083795$1$I$20240512$20240618$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002897$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240712$$CN$US$US
240837963$24083796$3$F$20240101$20240729$20240712$20240805$PER$$US-SA-2024SA199389$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240805$$MD$US$US
240837971$24083797$1$I$20240601$20240708$20240712$20240712$PER$$US-SA-2024SA204688$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240712$$MD$US$US
240837981$24083798$1$I$20240101$20240705$20240712$20240712$PER$$US-SA-2024SA202093$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240712$$MD$US$US
240837991$24083799$1$I$$20240704$20240712$20240712$EXP$$VN-AstraZeneca-2024A155078$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$VN$
240838001$24083800$1$I$20240628$20240709$20240712$20240712$EXP$$US-AstraZeneca-2024A157073$ASTRAZENECA$$29919$DY$$M$Y$$$20240712$$CN$US$
240838011$24083801$1$I$20240101$20240702$20240712$20240712$PER$$US-AMGEN-USASP2024137857$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240838022$24083802$2$F$$20240911$20240712$20240918$EXP$$CA-TAKEDA-2024TUS070382$TAKEDA$$$$$F$Y$$$20240918$$MD$CA$CA
240838031$24083803$1$I$$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033514$AUROBINDO$$$$$F$Y$42$KG$20240712$$PH$GB$GB
240838041$24083804$1$I$$20240627$20240712$20240712$EXP$$IN-ROCHE-10000022268$ROCHE$$$$A$F$Y$$$20240712$$MD$IN$IN
240838052$24083805$2$F$$20240715$20240712$20240720$EXP$$NVSC2024US143513$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
240838061$24083806$1$I$$20240709$20240712$20240712$PER$$US-TAKEDA-2024TUS070637$TAKEDA$$54$YR$$F$Y$$$20240712$$CN$US$US
240838071$24083807$1$I$20231001$20240710$20240712$20240712$EXP$GB-MHRA-MED-202407101221271600-BQCKL$GB-MYLANLABS-2024M1064943$MYLAN$$75$YR$$M$Y$90$KG$20240712$$CN$GB$GB
240838081$24083808$1$I$$20240708$20240712$20240712$PER$$US-ROCHE-10000022909$ROCHE$$$$A$M$Y$$$20240712$$CN$US$US
240838092$24083809$2$F$$20240711$20240712$20240712$EXP$$US-ROCHE-10000024402$ROCHE$$$$A$F$Y$$$20240712$$CN$US$US
240838101$24083810$1$I$$20240627$20240712$20240712$PER$$US-GLANDPHARMA-US-2024GLNSPO00438$GLAND PHARMA$$$$$$Y$$$20240712$$HP$US$US
240838111$24083811$1$I$20230601$20240705$20240712$20240712$PER$$US-ROCHE-10000021076$ROCHE$$47$YR$A$M$Y$$$20240712$$HP$US$US
240838121$24083812$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48247$$FDA-CTU$$72$YR$$F$N$$$20240711$N$$US$
240838131$24083813$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48287$$FDA-CTU$$63$YR$$M$N$$$20240711$N$$US$
240838141$24083814$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48275$$FDA-CTU$$77$YR$$M$N$$$20240711$N$$US$
240838151$24083815$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48271$$FDA-CTU$$23$YR$$M$N$$$20240711$N$$US$
240838161$24083816$1$I$20240710$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48235$$FDA-CTU$$13$YR$$F$N$$$20240711$N$$US$
240838181$24083818$1$I$20240510$20240710$20240712$20240712$DIR$FDA-CDER-CTU-2024-48397$$FDA-CTU$$24$YR$$F$N$$$20240710$N$HP$US$
240838191$24083819$1$I$20240709$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48242$$FDA-CTU$$66$YR$$M$N$126.1$KG$20240711$Y$MD$US$
240838221$24083822$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48274$$FDA-CTU$$75$YR$$F$N$$$20240711$N$$US$
240838241$24083824$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48245$$FDA-CTU$$$$$M$N$$$20240711$N$HP$US$
240838251$24083825$1$I$20240703$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48228$$FDA-CTU$$53$YR$$F$N$104.33$KG$20240711$N$CN$US$
240838273$24083827$3$F$$20240713$20240712$20240717$PER$$US-JNJFOC-20240727403$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$CN$US$US
240838281$24083828$1$I$$20240710$20240712$20240712$EXP$$US-GILEAD-2024-0680416$GILEAD$$$$E$F$Y$$$20240712$$CN$US$US
240838292$24083829$2$F$$20240711$20240712$20240718$EXP$$CH-PFIZER INC-202400211322$PFIZER$Lamoth, F.. Antifungal drug penetration in soft tissue abscesses: a comparative analysis. The Journal of antimicrobial chemotherapy. 2024;79(7):1668-1672$61$YR$$M$Y$$$20240718$$MD$CH$CH
240838302$24083830$2$F$20230101$20240830$20240712$20240910$EXP$$JP-ROCHE-10000023442$ROCHE$$47$YR$A$$Y$$$20240910$$MD$JP$JP
240838311$24083831$1$I$$20240704$20240712$20240712$EXP$$DE-AUROBINDO-AUR-APL-2024-033511$AUROBINDO$$$$$F$Y$$$20240712$$CN$DE$DE
240838322$24083832$2$F$$20240724$20240712$20240730$30DAY$$BE-PFIZER INC-202400208678$PFIZER$$58$YR$$F$Y$$$20240730$$PH$BE$BE
240838331$24083833$1$I$20240610$20240708$20240712$20240712$PER$$US-ROCHE-10000020584$ROCHE$$56$YR$A$F$Y$$$20240712$$CN$US$US
240838341$24083834$1$I$$20240710$20240712$20240712$PER$$NVSC2024US144346$NOVARTIS$$$$$$Y$$$20240712$$HP$US$US
240838351$24083835$1$I$$20240705$20240712$20240712$PER$$US-APOTEX-2024AP008131$APOTEX$Sancillo R., Wickham J., DeMasters D.. A CASE OF RITUXIMAB RESCUE THERAPY IN CLASS V LUPUS NEPHRITIS WITH SEVERE HEMATOLOGICAL MANIFESTATIONS. American Journal of Kidney Diseases. 2023;81 (4):S42- S43$20$YR$$F$Y$$$20240712$$HP$US$US
240838362$24083836$2$F$20220601$20240716$20240712$20240719$EXP$$NVSC2024PL140619$NOVARTIS$Kucharczyk-Foltyn AM, Bijak DE. Fragmented QRS comlex the clue to recognition spongy cardiomyopathy at 33-year woman case report. FOLIA CARDIOLOGICA. 2024;19:104-8$33$YR$$F$Y$$$20240719$$HP$PL$PL
240838372$24083837$2$F$20221206$20240723$20240712$20240805$EXP$$US-UCBSA-2024035209$UCB$$44$YR$$F$Y$$$20240805$$HP$US$US
240838381$24083838$1$I$$20240711$20240712$20240712$EXP$$US-UCBSA-2024035182$UCB$$$$$F$Y$$$20240712$$HP$US$US
240838402$24083840$2$F$$20240707$20240712$20240812$PER$$US-ROCHE-10000023212$ROCHE$$$$$$Y$$$20240812$$CN$US$US
240838411$24083841$1$I$$20240709$20240712$20240712$PER$$US-ROCHE-10000023685$ROCHE$$47$YR$A$F$Y$$$20240712$$CN$US$US
240838421$24083842$1$I$20220801$20240709$20240712$20240712$EXP$$US-ROCHE-10000022487$ROCHE$$53$YR$A$F$Y$61.23$KG$20240712$$CN$US$US
240838441$24083844$1$I$20231201$20240712$20240712$20240712$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039437$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$$$20240712$$MD$RU$RU
240838461$24083846$1$I$20200601$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033299$AUROBINDO$$29$YR$$M$Y$90$KG$20240712$$CN$GB$GB
240838471$24083847$1$I$$20240704$20240712$20240712$EXP$$JP-HBP-2024JP030719$HELSINN HEALTHCARE$$75$YR$$M$Y$$$20240712$$PH$JP$JP
240838481$24083848$1$I$20240601$20240619$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002914$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240712$$CN$US$US
240838491$24083849$1$I$20230301$20240710$20240712$20240712$EXP$GB-MHRA-MED-202407101640133760-ZJFLB$GB-SANDOZ INC.-SDZ2024GB064492$SANDOZ$$62$YR$$M$Y$$$20240712$$CN$GB$GB
240838501$24083850$1$I$20200501$20240709$20240712$20240712$EXP$GR-GREOF-202400710$GR-ORGANON-O2407GRC000908$ORGANON$$65$YR$$M$Y$$$20240712$$MD$GR$GR
240838511$24083851$1$I$$20240709$20240712$20240712$PER$$US-TAKEDA-2024TUS069995$TAKEDA$$$$$$Y$$$20240712$$CN$US$US
240838521$24083852$1$I$$20240710$20240712$20240712$EXP$$NVSC2024BR143632$NOVARTIS$$45$YR$$F$Y$$$20240712$$MD$BR$BR
240838531$24083853$1$I$$20240703$20240712$20240712$PER$$US-APOTEX-2024AP008161$APOTEX$Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN.. Relationship between the Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular Immunology and Inflammation. 2023;31(5):900-904$$$A$$Y$$$20240712$$HP$US$US
240838542$24083854$2$F$20240704$20240729$20240712$20240808$EXP$$JP-ROCHE-10000022588$ROCHE$$7$DEC$E$M$Y$$$20240808$$MD$JP$JP
240838551$24083855$1$I$$20240708$20240712$20240712$PER$$US-LEO Pharma-371882$LEO PHARM$$63$YR$$M$Y$$$20240712$$PH$US$US
240838562$24083856$2$F$20240525$20240906$20240712$20240906$EXP$$CA-PFIZER INC-202400191638$PFIZER$$62$YR$$F$Y$$$20240906$$MD$CA$CA
240838583$24083858$3$F$20240705$20240911$20240712$20240912$EXP$$US-PFIZER INC-202400198009$PFIZER$$78$YR$$M$Y$$$20240912$$CN$US$US
240838591$24083859$1$I$20230622$20240710$20240712$20240712$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-020206$BOEHRINGER INGELHEIM$$88$YR$E$F$Y$47$KG$20240712$$PH$JP$JP
240838604$24083860$4$F$$20240912$20240712$20240912$EXP$$CA-PFIZER INC-202400106645$PFIZER$$31$YR$$M$Y$$$20240912$$HP$CA$CA
240838612$24083861$2$F$20240101$20240905$20240712$20240905$EXP$$CA-PFIZER INC-202400209867$PFIZER$$62$YR$$M$Y$$$20240905$$HP$CA$CA
240838622$24083862$2$F$20220101$20240905$20240712$20240905$EXP$$CA-PFIZER INC-202200951229$PFIZER$$60$YR$$F$Y$$$20240905$$MD$CA$CA
240838632$24083863$2$F$20230101$20240830$20240712$20240903$EXP$$CA-PFIZER INC-202300452259$PFIZER$$73$YR$$F$Y$$$20240903$$HP$CA$CA
240838641$24083864$1$I$$20240709$20240712$20240712$EXP$$ZA-AstraZeneca-2024A157104$ASTRAZENECA$$87$YR$$M$Y$$$20240712$$CN$ZA$
240838651$24083865$1$I$20240607$20240702$20240712$20240712$EXP$CN-NMPACDR-6530011512366202400111$CN-BAXTER-2024BAX021126$BAXTER$$57$YR$$F$Y$61$KG$20240712$$MD$CN$CN
240838661$24083866$1$I$$20240709$20240712$20240712$EXP$$CN-AstraZeneca-2024A158604$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$CN$
240838671$24083867$1$I$$20240704$20240712$20240712$EXP$$JP-AstraZeneca-2024A155931$ASTRAZENECA$$80$YR$$M$Y$$$20240712$$PH$JP$
240838681$24083868$1$I$$20240630$20240712$20240712$EXP$$CN-GTI-000250$Granulation Technology, INC$$76$YR$E$F$Y$$$20240703$$MD$CN$CN
240838691$24083869$1$I$$20240704$20240712$20240712$EXP$$VN-AstraZeneca-2024A155621$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$VN$
240838701$24083870$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48246$$FDA-CTU$$74$YR$$F$N$$$20240711$N$$US$
240838721$24083872$1$I$$20240705$20240712$20240712$EXP$$GB-AstraZeneca-2024A154069$ASTRAZENECA$$$$$M$Y$$$20240712$$MD$GB$
240838741$24083874$1$I$20240624$20240703$20240712$20240712$EXP$$CN-SA-2024SA199515$SANOFI AVENTIS$$77$YR$E$M$Y$70$KG$20240712$$HP$CN$CN
240838751$24083875$1$I$20240418$20240704$20240712$20240712$EXP$$AU-AMERICAN REGENT INC-2024002633$AMERICAN REGENT$$86$YR$$$Y$$$20240712$$HP$AU$AU
240838761$24083876$1$I$20240101$20240627$20240712$20240712$PER$$US-GLANDPHARMA-US-2024GLNSPO00454$GLAND PHARMA$$$$$$Y$$$20240712$$CN$US$US
240838771$24083877$1$I$$20240704$20240712$20240712$EXP$$IT-AstraZeneca-2024A156220$ASTRAZENECA$$$$$$Y$$$20240712$$MD$IT$
240838781$24083878$1$I$20100101$20240704$20240712$20240712$EXP$$GB-AUROBINDO-AUR-APL-2024-033350$AUROBINDO$$$$$$Y$$$20240712$$CN$GB$GB
240838791$24083879$1$I$20240117$20240629$20240712$20240712$EXP$GB-MHRA-MED-202406281626497690-MPKWV$GB-LUPIN PHARMACEUTICALS INC.-2024-05941$LUPIN$$52$YR$$F$Y$$$20240712$$MD$GB$GB
240838811$24083881$1$I$20240708$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137856$AMGEN$$81$YR$E$F$Y$$$20240712$$CN$US$US
240838821$24083882$1$I$$20240520$20240712$20240712$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-04872$HIKMA$$$$$F$Y$$$20240711$$CN$US$US
240838831$24083883$1$I$$20240705$20240712$20240712$30DAY$$US-GSK-US2024084031$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$CN$US$US
240838842$24083884$2$F$20240707$20240802$20240712$20240805$PER$$US-ALXN-202407USA000430US$ALEXION PHARMACEUTICALS$$77$YR$$M$Y$$$20240805$$CN$US$US
240838852$24083885$2$F$$20240805$20240712$20240805$PER$$US-ALXN-202407USA000623US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$MD$US$US
240838861$24083886$1$I$$20240708$20240712$20240712$EXP$$JP-ASTELLAS-2024JP004829$ASTELLAS$Kumata D, Yamae M, Ide C, Nakano M. Two cases of bullous toxic erythema of chemotherapy (TEC) due to enfortumab vedotin. The 910th Tokyo regional meeting (four district meetings) of the Japanese Dermat. 2024;2-3$76$YR$$M$Y$$$20240712$$MD$JP$JP
240838871$24083887$1$I$$20240709$20240712$20240712$PER$$US-LEO Pharma-371911$LEO PHARM$$67$YR$$F$Y$$$20240712$$CN$US$US
240838881$24083888$1$I$20240326$20240704$20240712$20240712$EXP$$FR-AUROBINDO-AUR-APL-2024-033394$AUROBINDO$$13$YR$$F$Y$40$KG$20240712$$PH$FR$FR
240838891$24083889$1$I$$20240710$20240712$20240712$PER$$US-ROCHE-10000024429$ROCHE$$67$YR$E$F$Y$$$20240712$$CN$US$US
240838911$24083891$1$I$20240707$20240709$20240712$20240712$EXP$GB-MHRA-MED-202407091830464470-WZBFD$GB-ABBVIE-5836259$ABBVIE$$$$$$Y$$$20240712$$CN$GB$GB
240838921$24083892$1$I$20240617$20240709$20240712$20240712$EXP$$CN-ABBVIE-5833926$ABBVIE$$72$YR$$M$Y$$$20240712$$MD$CN$CN
240838932$24083893$2$F$$20240725$20240712$20240819$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002916$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
240838952$24083895$2$F$20240628$20240809$20240712$20240816$PER$$US-ROCHE-10000023603$ROCHE$$25$YR$A$F$Y$77.11$KG$20240816$$CN$US$US
240838961$24083896$1$I$$20230821$20240712$20240712$PER$$US-HIKMA PHARMACEUTICALS-US-H14001-23-64759$HIKMA$$$$$$Y$$$20240711$$CN$US$US
240838972$24083897$2$F$20240501$20240722$20240712$20240727$EXP$$US-ABBVIE-5832658$ABBVIE$$68$YR$$M$Y$$$20240727$$CN$US$US
240838982$24083898$2$F$$20240724$20240712$20240802$EXP$$US-TEVA-VS-3218547$TEVA$Crawford M, Trinh JM, Chaudhary S. A Case Report of Statin-induced Necrotizing Autoimmune Myopathy With Extramuscular Involvement. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A1363.; Crawford M, Trinh JM, Chaudhary S. A Case Report of Statin-induced Necrotizing Autoimmune Myopathy With Extramuscular Involvement. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A1363.$75$YR$$F$Y$$$20240802$$HP$US$US
240838991$24083899$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834417$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240839001$24083900$1$I$20110103$20240708$20240712$20240712$EXP$$BR-ASTELLAS-2024US019413$ASTELLAS$$59$YR$$M$Y$$$20240712$$HP$GB$BR
240839011$24083901$1$I$20240101$20240709$20240712$20240712$PER$$US-SA-2024SA204800$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240712$$MD$US$US
240839021$24083902$1$I$$20240702$20240712$20240712$PER$$US-SA-2024SA199882$SANOFI AVENTIS$$$$A$F$Y$95.254$KG$20240712$$MD$US$US
240839051$24083905$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA201452$SANOFI AVENTIS$$$$E$M$Y$58.05$KG$20240712$$MD$US$US
240839061$24083906$1$I$20210101$20240705$20240712$20240712$EXP$$CA-SA-2024SA202221$SANOFI AVENTIS$$$$$F$Y$$$20240712$$CN$CA$CA
240839073$24083907$3$F$20240101$20240711$20240712$20240722$PER$$US-SA-2024SA202194$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240721$$MD$US$US
240839081$24083908$1$I$20240624$20240710$20240712$20240712$EXP$DE-BFARM-24004784$DE-INSUD PHARMA-2407DE05505$INSUD PHARMA$$27$YR$$F$Y$$$20240712$$MD$DE$DE
240839093$24083909$3$F$20240101$20240824$20240712$20240828$EXP$$US-ABBVIE-5834838$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
240839101$24083910$1$I$$20240701$20240712$20240712$EXP$$IT-ROCHE-10000014768$ROCHE$Rossari F, Tada T, Suda G, Shimose S, Kudo M, Yoo C, et al. Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study. Liver Cancer. 2024-Apr-10;1-15. doi:10.1159/000537915.$$$$$Y$$$20240712$$HP$IT$IT
240839111$24083911$1$I$20240701$20240712$20240712$20240712$EXP$FR-AFSSAPS-AN2024000911$NVSC2024FR144085$NOVARTIS$$51$YR$$F$Y$$$20240712$$MD$FR$FR
240839122$24083912$2$F$$20240821$20240712$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002853$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
240839131$24083913$1$I$$20240708$20240712$20240712$PER$$US-MYLANLABS-2024M1064398$MYLAN$$$$$M$Y$81.64$KG$20240712$$CN$US$US
240839141$24083914$1$I$20240401$20240709$20240712$20240712$EXP$$US-ABBVIE-5833801$ABBVIE$$47$YR$$M$Y$$$20240712$$CN$US$US
240839151$24083915$1$I$$20240614$20240712$20240712$PER$$US-TEVA-VS-3217611$TEVA$$$$A$F$Y$$$20240712$$CN$US$US
240839161$24083916$1$I$$20240702$20240712$20240712$EXP$$FR-STERISCIENCE B.V.-2024-ST-001006$Steriscience PTE$Sallee L, Souchet L, Boutolleau D, Nguyen S. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports.. Int-J-Antimicrob-Agents. 2024;63 (6):1-2$54$YR$$F$Y$$$20240712$$HP$FR$FR
240839171$24083917$1$I$20240517$20240619$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002636$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240712$$CN$US$US
240839182$24083918$2$F$$20240705$20240712$20240717$EXP$$IT-CELLTRION INC.-2024IT005723$CELLTRION$$$$$$Y$$$20240717$$MD$IT$IT
240839191$24083919$1$I$$20240709$20240712$20240712$EXP$$US-STERISCIENCE B.V.-2024-ST-000897$Steriscience PTE$Pokhriyal SC, Tan EF, Bhatt PK, Khan AA, Pasha MN, Pierre L, Panigrahi K.. Assay Interference Causing Persistently Elevated Vancomycin Levels Ultimately Leading to Treatment Failure and Fatal Outcome.. Cureus. 2024;16(6):e61943$69$YR$$F$Y$$$20240712$$HP$US$US
240839201$24083920$1$I$$20240702$20240712$20240712$EXP$$CN-STERISCIENCE B.V.-2024-ST-001000$Steriscience PTE$Lin F, Dong X, Zhang Y, Cheng Y, Han T, Mo X, et al.. Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia.. Ann-Hematol. 2023;102 (9):2589-2598.$$$$$Y$$$20240712$$HP$CN$CN
240839211$24083921$1$I$$20240702$20240712$20240712$EXP$$US-STERISCIENCE B.V.-2024-ST-001003$Steriscience PTE$Gullapalli D, Raza A, Khan A, Ganti SS, Pervaiz A. Battling the breath-stealers: Blastomyces and Pseudomonas triggering acute respiratory distress syndrome (ARDS).. Med-Mycol-Case-Reports. 2024;45$46$YR$$M$Y$$$20240712$$HP$US$US
240839221$24083922$1$I$$20240702$20240712$20240712$EXP$$CN-STERISCIENCE B.V.-2024-ST-000999$Steriscience PTE$Lin F, Dong X, Zhang Y, Cheng Y, Han T, Mo X, et al.. Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia. Ann-Hematol. 2023;102 (9):2589-2598$$$$$Y$$$20240712$$HP$CN$CN
240839231$24083923$1$I$$20240701$20240712$20240712$EXP$$OM-STERISCIENCE B.V.-2024-ST-000985$Steriscience PTE$Al Madhani SAM.. PERITONEAL DIALYSIS FOR TREATING REFRACTORY ACIDOSIS IN A CHILD WITH DIABETIC KETOACIDOSIS A CASE REPORT.. BMJ-Paediatr-Open. 2024;8 (Suppl.):A21$2$YR$$M$Y$$$20240712$$HP$OM$OM
240839241$24083924$1$I$$20240702$20240712$20240712$EXP$$CN-STERISCIENCE B.V.-2024-ST-000998$Steriscience PTE$Lin F, Dong X, Zhang Y, Cheng Y, Han T, Mo X, et al. Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia.. Ann-Hematol. 2023;102 (9):2589-2598$$$$$Y$$$20240712$$HP$CN$CN
240839251$24083925$1$I$20171114$20240710$20240712$20240712$EXP$$EU-BAUSCHBL-2024BNL029974$BAUSCH AND LOMB$$$$$$Y$$$20240712$$MD$EU$EU
240839262$24083926$2$F$20240101$20240819$20240712$20240826$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700041$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
240839271$24083927$1$I$$20240701$20240712$20240712$EXP$$US-STERISCIENCE B.V.-2024-ST-000982$Steriscience PTE$Stratman S, Zhou L, Kim RH, Phelps RG, Glickman J, Mikhaylov D, et al.. Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic symptoms. JAAD-Case-Rep. 2024;49:36-39$77$YR$$F$Y$$$20240712$$MD$US$US
240839281$24083928$1$I$$20240705$20240712$20240712$PER$$US-MYLANLABS-2024M1064391$MYLAN$$$$$M$Y$$$20240712$$CN$US$US
240839291$24083929$1$I$20240630$20240701$20240712$20240712$PER$$US-MYLANLABS-2024M1062037$MYLAN$$68$YR$$F$Y$$$20240712$$CN$US$US
240839302$24083930$2$F$20240710$20240813$20240712$20240827$EXP$$US-UCBSA-2024035266$UCB$$27$YR$$F$Y$$$20240827$$CN$US$US
240839311$24083931$1$I$$20211102$20240712$20240712$PER$$GR-PFM-2022-03915$PIERRE FABRE MEDICAMENT$Papantonaki S, Lappa A, Dragatsiki A,Gavrilaki E. Sphenopalatine Ganglion Block (SPG) for the treatment of migraine. Signa Vitae. 2021;17(1)$$$$F$Y$$$20240712$$HP$GR$GR
240839321$24083932$1$I$$20211021$20240712$20240712$PER$$HR-PFM-2022-03886$PIERRE FABRE MEDICAMENT$Katic J, Katic A, Katic K, Duplancic D, Lozo M. Concurrent deep vein thrombosis and pulmonary embolism associated with hyperthyroidism: a case report. Acta Clin Croat. 2021;60(2):314-16$43$YR$$F$Y$$$20240712$$HP$HR$HR
240839331$24083933$1$I$$20211011$20240712$20240712$PER$$KR-PFM-2022-03908$PIERRE FABRE MEDICAMENT$Shin JA, Choi YU, Kim KM, Yoon JH, Lee JY. Congenital long QT syndrome type 2 with symptomatic 2:1 atrioventricular block and ventricular arrhythmia in a preterm baby who presented with fetal ventricular tachycardia and hydrops. Korean Circulation Journal. 2021;51(9):792-6$87$DY$$$Y$$$20240712$$HP$KR$KR
240839341$24083934$1$I$$20211025$20240712$20240712$PER$$CH-PFM-2022-03887$PIERRE FABRE MEDICAMENT$Stoller F, Glockler M, Kadner A, Widenka H. The ^Cauliflower Heart^: a case report of congenital bi-atrial aneurysms causing non-controllable arrhythmia. European Heart Journal. 2020;1-4$$$$F$Y$$$20240712$$HP$CH$CH
240839351$24083935$1$I$$20211102$20240712$20240712$PER$$JP-PFM-2022-03923$PIERRE FABRE MEDICAMENT$Takahashi K, Yamashita M, Sakaue T, Enomoto D, Uemura S, Okura T et al. Premature atrial contractions with multiple patterns of aberrant conduction followed by torsade de pointes in a patient with polymyalgia rheumatica. Medicine (Baltimore). 2021;100(37):1-9$85$YR$$F$Y$$$20240712$$HP$JP$JP
240839361$24083936$1$I$$20211108$20240712$20240712$PER$$TR-PFM-2022-03989$PIERRE FABRE MEDICAMENT$Yuksel H, Yasar A, Gurbuz N, Bizbirlik ZI, Yilmaz O. Infantile Glottic Hemangioma: Bronchoscopic Evaluation and Propranolol Treatment. J Bronchol Intervent Pulmonol. 2021;28(4):e69-e73$11$MON$$F$Y$$$20240712$$HP$TR$TR
240839371$24083937$1$I$$20211102$20240712$20240712$PER$$GR-PFM-2022-03918$PIERRE FABRE MEDICAMENT$Liatsos GD, Tsiriga A, Dourakis SP. Fatal Streptococcus pseudoporcinus disseminated infection in decompensated liver  cirrhosis: a case report. Journal of Medical Case Reports. 2021;15(1):1-6$56$YR$$M$Y$$$20240712$$HP$GR$GR
240839381$24083938$1$I$$20211109$20240712$20240712$PER$$CA-PFM-2022-03952$PIERRE FABRE MEDICAMENT$Tole S, Fantauzzi M, Cottingham D, Amaral JG, John PR, Lara-Corrales I et al. The use of rapamycin to treat vascular tumours and malformations: A single-centre experience. Paediatrics and Child Health. 2021;26(1):e25-e32$3$MON$$$Y$$$20240712$$HP$CA$CA
240839391$24083939$1$I$$20211109$20240712$20240712$PER$$CA-PFM-2022-03953$PIERRE FABRE MEDICAMENT$Tole S, Fantauzzi M, Cottingham D, Amaral JG, John PR, Lara-Corrales I, et al. The use of rapamycin to treat vascular tumours and malformations: A single-centre experience. Paediatrics and Child Health. 2021;26(1):e25-e32$2$YR$$$Y$$$20240712$$HP$CA$CA
240839401$24083940$1$I$$20220422$20240712$20240712$PER$$AU-PFM-2022-03869$PIERRE FABRE MEDICAMENT$$82$YR$$F$Y$$$20240712$$HP$AU$AU
240839411$24083941$1$I$$20211102$20240712$20240712$PER$$CA-PFM-2022-03987$PIERRE FABRE MEDICAMENT$McCuaig C, Elysia R. An unusual vascular Tumor KHE or RICH. J Cutan Med Surg. 59S$18$MON$$M$Y$$$20240712$$HP$CA$CA
240839421$24083942$1$I$20180313$20240710$20240712$20240712$EXP$$EU-BAUSCHBL-2024BNL029980$BAUSCH AND LOMB$$$$$$Y$$$20240712$$MD$EU$EU
240839431$24083943$1$I$$20240705$20240712$20240712$PER$$US-ALXN-202407USA000363US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240839441$24083944$1$I$$20240630$20240712$20240712$EXP$$DE-Accord-434059$ACCORD$Hans FP, Benning L, Pooth JS, Busch HJ. A potentially lifesaving error: unintentional high-dose adrenaline administration in anaphylaxis-induced cardiac arrest; a case report. Int J Emerg Med. 2024 Jun 28;17(1):78. doi: 10.1186/s12245-024-00663-9.$66$YR$E$F$Y$$$20240712$$HP$DE$DE
240839451$24083945$1$I$20211222$20240702$20240712$20240712$EXP$FR-AFSSAPS-MA2024001138$FR-Accord-434056$ACCORD$$72$YR$E$F$Y$$$20240712$$PH$FR$FR
240839461$24083946$1$I$20240530$20240702$20240712$20240712$EXP$PL-URPL-DML-MLP.4401.1.148.2024$PL-Accord-434015$ACCORD$$36$YR$A$M$Y$64$KG$20240712$$PH$PL$PL
240839471$24083947$1$I$$20240702$20240712$20240712$EXP$AU-TGA-803900$AU-Accord-433444$ACCORD$$68$YR$E$$Y$$$20240712$$HP$AU$AU
240839481$24083948$1$I$$20240701$20240712$20240712$EXP$AU-TGA-801548$AU-Accord-433159$ACCORD$$28$YR$A$M$Y$$$20240712$$HP$AU$AU
240839491$24083949$1$I$$20240702$20240712$20240712$EXP$AU-TGA-803769$AU-Accord-433450$ACCORD$$42$YR$A$F$Y$$$20240712$$HP$AU$AU
240839501$24083950$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48297$$FDA-CTU$$70$YR$$F$N$62.14$KG$20240711$N$HP$US$
240839511$24083951$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48276$$FDA-CTU$$67$YR$$F$N$$$20240711$N$$US$
240839521$24083952$1$I$20240708$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48303$$FDA-CTU$$87$YR$$M$N$$$20240711$Y$PH$US$
240839532$24083953$2$F$20220819$20240730$20240712$20240806$EXP$$US-AMGEN-USASP2024136472$AMGEN$$76$YR$E$M$Y$$$20240806$$LW$US$US
240839541$24083954$1$I$$20240701$20240712$20240712$EXP$$US-TEYRO-2024-TY-000357$Teyro Labs$Kim H, Hong B, Kim S, Kang SM, Park J.Chemotherapy-related cardiotoxicity and its symptoms in patients with breast cancer: a scoping review.Systematic Reviews.2024;13:167$66$YR$E$M$Y$$$20240712$$HP$US$US
240839551$24083955$1$I$20240703$20240710$20240712$20240712$PER$$US-ABBVIE-5836203$ABBVIE$$17$YR$$F$Y$$$20240712$$MD$US$US
240839561$24083956$1$I$$20211115$20240712$20240712$PER$$CH-PFM-2022-04065$PIERRE FABRE MEDICAMENT$Trimboli P, Cappelli C, Croce L, Scappaticcio L, Chiovato L, Rotondi M. Covid-19-associated subacute thyroiditis: evidence-based data from a systematic review. Frontiers in Endocrinology. 2021;12:1-11$37$YR$$M$Y$$$20240712$$HP$CH$CH
240839571$24083957$1$I$$20211115$20240712$20240712$PER$$CH-PFM-2022-04066$PIERRE FABRE MEDICAMENT$Trimboli P, Cappelli C, Croce L, Scappaticcio L, Chiovato L, Rotondi M. Covid-19-associated subacute thyroiditis: evidence-based data from a systematic review. Frontiers in Endocrinology. 2021;12$28$YR$$F$Y$$$20240712$$HP$CH$CH
240839581$24083958$1$I$$20211115$20240712$20240712$PER$$CH-PFM-2022-04064$PIERRE FABRE MEDICAMENT$Trimboli P, Cappelli C, Croce L, Scappaticcio L, Chiovato L, Rotondi M. Covid-19-associated subacute thyroiditis: evidence-based data from a systematic review. Frontiers in Endocrinology. 2021;12:1-11$58$YR$$M$Y$$$20240712$$HP$CH$CH
240839591$24083959$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48288$$FDA-CTU$$69$YR$$F$N$$$20240711$N$$US$
240839621$24083962$1$I$$20211115$20240712$20240712$PER$$TR-PFM-2022-03889$PIERRE FABRE MEDICAMENT$Oktay BK, Kacar AG, Ozel SC, Ocak S, Celkan T. Clinical course of pediatric large vascular anomalies located in the extremities. Turkish archives of pediatrics. 2021;56(3):213-18$$$$$Y$$$20240712$$HP$TR$TR
240839631$24083963$1$I$$20240703$20240712$20240712$EXP$$JP-Accord-433936$ACCORD$Nakamura S, Masuda S, Oda S, Yamakawa D, Yamaguchi S, Ishima T, et al. Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine. Internal Medicine. 2024;63(12):1829-35.$72$YR$E$F$Y$$$20240712$$MD$JP$JP
240839641$24083964$1$I$$20211122$20240712$20240712$PER$$PT-PFM-2022-03899$PIERRE FABRE MEDICAMENT$Ledo LM, Martins TA, Silva AS, Lucas MS, Pereira EC. Pheochromocytoma and c-section - is regional anaesthesia the solution for this dangerous combination?. Reg Anesth Pain Med. 2021;70(1):A59$$$$F$Y$$$20240712$$HP$PT$PT
240839651$24083965$1$I$$20211122$20240712$20240712$PER$$IT-PFM-2022-03927$PIERRE FABRE MEDICAMENT$Garbarino F, Vagelli G, Musso V, Pessano S, Minghetti D, Derchi M, et al. Perinatal tachyarrhythmia in preterm newborns. The journal of maternal-fetal and neonatal medicine. 2021$1$DY$$F$Y$$$20240712$$HP$IT$IT
240839661$24083966$1$I$$20211109$20240712$20240712$PER$$CA-PFM-2022-03954$PIERRE FABRE MEDICAMENT$Tole S, RN MF, Cottingham D,Amaral JG ,John PR, Lara-Corrales I et al. The use of rapamycin to treat vascular tumours and malformations: A single-centre experience. Paediatrics + Child Health. 2021;26(1):e25-e32$15$YR$$$Y$$$20240712$$HP$CA$CA
240839671$24083967$1$I$$20211115$20240712$20240712$PER$$CH-PFM-2022-03892$PIERRE FABRE MEDICAMENT$Trimboli P, Cappelli C, Croce L, Scappaticcio L, Chiovato L, Rotondi M. Covid-19-associated subacute thyroiditis: evidence-based data from a systematic review. Frontiers in Endocrinology. 2021;12$29$YR$$F$Y$$$20240712$$HP$CH$CH
240839681$24083968$1$I$$20211122$20240712$20240712$PER$$IT-PFM-2022-03926$PIERRE FABRE MEDICAMENT$Garbarino F, Vagelli G, Musso V, Pessano S, Minghetti D, Derchi M et al.. Perinatal tachyarrhythmia in preterm newborns. The journal of maternal-fetal and neonatal medicine. 2021$14$DY$$M$Y$$$20240712$$HP$IT$IT
240839691$24083969$1$I$$20211124$20240712$20240712$PER$$CH-PFM-2022-03901$PIERRE FABRE MEDICAMENT$Degabriel D, Cerutti A, Caramanica L, Vigano A, Fusi-Schmidhauser T. Association of hashimoto^s thyroiditis and burkitt lymphoma: A rare condition to be considered. Praxis. 2021;10(14):812-5$72$YR$$F$Y$$$20240712$$HP$CH$CH
240839701$24083970$1$I$20240626$20240702$20240712$20240712$EXP$$US-Accord-434450$ACCORD$$46$YR$A$F$Y$$$20240712$$HP$US$US
240839713$24083971$3$F$20240618$20240813$20240712$20240827$EXP$$US-Accord-433762$ACCORD$$76$YR$E$F$Y$$$20240824$$HP$US$US
240839721$24083972$1$I$20240323$20240701$20240712$20240712$EXP$$US-Accord-434104$ACCORD$$74$YR$E$M$Y$$$20240712$$CN$US$US
240839733$24083973$3$F$20240612$20240807$20240712$20240809$EXP$FR-AFSSAPS-BX2024001402$FR-JNJFOC-20240728482$JOHNSON AND JOHNSON$$77$YR$E$F$Y$58$KG$20240809$$PH$FR$FR
240839751$24083975$1$I$$20240709$20240712$20240712$EXP$$US-JNJFOC-20240722309$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$HP$US$US
240839761$24083976$1$I$$20240709$20240712$20240712$PER$$US-JNJFOC-20240723384$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240712$$HP$US$US
240839771$24083977$1$I$$20240709$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US064257$SANDOZ$Abdelhadi Farouji , Ahmad W. Haddad , Mohammad Kloub , Amy Paige , Richard Miller. A Case of Metformin-Associated Lactic AcidosisComplicated by Acute Liver Failure, Acute RenalFailure, and Shock. Cureus. 2024;1-5$63$YR$$F$Y$$$20240712$$HP$US$US
240839782$24083978$2$F$$20240718$20240712$20240723$EXP$$PT-BAUSCH-BL-2024-010398$BAUSCH AND LOMB$Maia S, Xavier B, Sa M, Antunes E, Morais D, Sampaio J. Edema Pulmonar por Pressao Negativa : Uma Intercorrencia Inesperada. Revista da sociedade portuguesa de anestesiologia. 2024;33(1):49. doi:10.25751/rspa.35116$19$YR$$M$Y$$$20240723$$HP$PT$PT
240839791$24083979$1$I$$20240619$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002917$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240839801$24083980$1$I$20240101$20240703$20240712$20240712$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-009890$JAZZ$$75$YR$$M$Y$$$20240712$$MD$JP$JP
240839811$24083981$1$I$20230601$20240703$20240712$20240712$EXP$$IT-CELLTRION INC.-2024IT016423$CELLTRION$$$$$$Y$$$20240712$$MD$IT$IT
240839821$24083982$1$I$$20240621$20240712$20240712$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-12588$IPSEN$$$$$F$Y$5.39$KG$20240712$$MD$US$US
240839831$24083983$1$I$$20220103$20240712$20240712$PER$$IT-PFM-2022-03929$PIERRE FABRE MEDICAMENT$Corbeddu M, Meucci D, Diociaiuti A, Giancristoforo S, Rotunno R, Gonfiantini MV et al. Management of upper airway infantile hemangiomas: experience of one Italian multidisciplinary center. Frontiers in Pediatrics. 2021;9:1-7$2$MON$$F$Y$$$20240712$$HP$IT$IT
240839841$24083984$1$I$$20211206$20240712$20240712$PER$$IT-PFM-2022-03913$PIERRE FABRE MEDICAMENT$Acquaro M, Breviario F, Greco A, Ghio S. Acute pericarditis, Graves^ disease, and thymic hyperplasia: A case report. European heart journal. 2021;5(10):1-5$18$YR$$F$Y$$$20240712$$HP$IT$IT
240839851$24083985$1$I$$20211206$20240712$20240712$PER$$ES-PFM-2022-03916$PIERRE FABRE MEDICAMENT$Ruano R, Zorzano-Martinez M, Campos A, Rius F, Hernandez M. Subacute thyroiditis might be a complication triggered by SARS-CoV-2. Endocrinol Diabetes Nutr (Engl Ed). 2020;68(10):755-6$28$YR$$F$Y$$$20240712$$HP$ES$ES
240839861$24083986$1$I$$20220103$20240712$20240712$PER$$IT-PFM-2022-03932$PIERRE FABRE MEDICAMENT$Corbeddu M, Meucci D, Diociaiuti A, Giancristoforo S, Rotunno R, Gonfiantini MV et al. Management of Upper Airway Infantile Hemangiomas: Experience of One Italian Multidisciplinary Center. Frontiers in pediatrics. 2021;9:1-7$1$MON$$M$Y$$$20240712$$HP$IT$IT
240839871$24083987$1$I$$20220103$20240712$20240712$PER$$IT-PFM-2022-03930$PIERRE FABRE MEDICAMENT$Corbeddu M, Meucci D, Diociaiuti A, Giancristoforo S, Rotunno R, Gonfiantini MV et al. Management of upper airway infantile hemangiomas: experience of one Italian multidisciplinary center. Frontiers in Pediatrics. 2021;9:1-7$15$DY$$F$Y$$$20240712$$HP$IT$IT
240839881$24083988$1$I$$20220103$20240712$20240712$PER$$IT-PFM-2022-03931$PIERRE FABRE MEDICAMENT$Corbeddu M, Meucci D, Diociaiuti A, Giancristoforo S, Rotunno R, Gonfiantini MV et al. Management of upper airway infantile hemangiomas: experience of one Italian multidisciplinary center. Frontiers in Pediatrics. 2021;9:1-7$1$MON$$M$Y$$$20240712$$HP$IT$IT
240839891$24083989$1$I$$20220110$20240712$20240712$PER$$GR-PFM-2022-03924$PIERRE FABRE MEDICAMENT$Bagkaki A, Tsoutsinos A, Hatzidaki E, Tzatzarakis M, Parthenakis F, Germanakis I. Mexiletine treatment for neonatal LQT3 syndrome: Case report and literature review. Frontiers in Pediatrics. 2021;9$2$DY$$F$Y$3.4$KG$20240712$$HP$GR$GR
240839901$24083990$1$I$$20220103$20240712$20240712$PER$$IT-PFM-2022-03933$PIERRE FABRE MEDICAMENT$Corbeddu M, Meucci D, Diociaiuti A, Giancristoforo S, Rotunno R, Gonfiantini MV et al. Management of upper airway infantile hemangiomas: experience of one Italian multidisciplinary center. Frontiers in Pediatrics. 2021;9:1-7$3$MON$$F$Y$$$20240712$$HP$IT$IT
240839911$24083991$1$I$$20240415$20240712$20240712$PER$$US-BAYER-2024A095565$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240839922$24083992$2$F$$20240704$20240712$20240717$EXP$$US-AstraZeneca-2024A154188$ASTRAZENECA$$$$$$Y$$$20240717$$CN$US$
240839931$24083993$1$I$$20240710$20240712$20240712$EXP$$NVSC2024US143433$NOVARTIS$$$$$M$Y$$$20240712$$MD$US$US
240839941$24083994$1$I$20240703$20240710$20240712$20240712$EXP$$CA-MYLANLABS-2024M1065191$MYLAN$$60$YR$$F$Y$$$20240712$$CN$CA$CA
240839951$24083995$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA202088$SANOFI AVENTIS$$$$$$Y$$$20240712$$CN$US$US
240839961$24083996$1$I$$20240711$20240712$20240712$30DAY$$DE-ABBVIE-5423496$ABBVIE$$$$$$Y$$$20240712$$MD$DE$DE
240839972$24083997$2$F$$20240708$20240712$20240716$EXP$$NZ-AstraZeneca-2024A159601$ASTRAZENECA$Not Provided. Medicine-induced hyponatraemia: increased risks in older people. Prescriber Update 2024;45(2):34-6.$88$YR$$F$Y$$$20240716$$MD$NZ$
240839981$24083998$1$I$$20240705$20240712$20240712$PER$$US-ROCHE-10000019701$ROCHE$$$$$F$Y$$$20240712$$CN$US$US
240839991$24083999$1$I$20240707$20240711$20240711$20240711$DIR$709917$$FDA-CTU$$$$$UNK$N$$$20240711$N$PH$US$
240840021$24084002$1$I$$20240711$20240711$20240711$DIR$709936$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240840031$24084003$1$I$$20240711$20240711$20240711$DIR$709923$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240840042$24084004$2$F$$20240710$20240712$20240828$EXP$$DE-GILEAD-2024-0680293$GILEAD$$70$YR$E$F$Y$$$20240828$$MD$DE$DE
240840051$24084005$1$I$20240101$20240708$20240712$20240712$PER$$US-SA-2024SA203792$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240712$$MD$US$US
240840061$24084006$1$I$20240524$20240711$20240711$20240711$DIR$709928$$FDA-CTU$$56$YR$$F$N$83.25$KG$20240711$Y$HP$US$
240840071$24084007$1$I$20240219$20240705$20240712$20240712$EXP$FI-FIMEA-202402421$FI-ALKABELLO A/S-2024AA002788$ALK-ABELLO$$$$$$Y$$$20240712$$HP$FI$FI
240840081$24084008$1$I$$20240628$20240712$20240712$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06157$HIKMA$$$$$$Y$$$20240712$$PH$CA$CA
240840091$24084009$1$I$20240423$20240704$20240712$20240712$EXP$SE-SEMPA-2024-004709$SE-ROCHE-10000016623$ROCHE$$49$YR$A$M$Y$$$20240712$$MD$SE$SE
240840101$24084010$1$I$$20240704$20240712$20240712$EXP$$CA-TEVA-VS-3219131$TEVA$$70$YR$$F$Y$$$20240712$$MD$CA$CA
240840113$24084011$3$F$20240810$20240906$20240712$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002918$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240916$$CN$US$US
240840121$24084012$1$I$$20240709$20240712$20240712$EXP$$GB-MYLANLABS-2024M1054472$MYLAN$$$$$M$Y$$$20240712$$MD$GB$GB
240840131$24084013$1$I$20240125$20240709$20240712$20240712$EXP$GB-MHRA-MED-202407081950377100-MCSQK$GB-MYLANLABS-2024M1064538$MYLAN$$4$YR$$M$Y$16$KG$20240712$$CN$GB$GB
240840141$24084014$1$I$20240702$20240709$20240712$20240712$EXP$GB-MHRA-TPP32770833C2677317YC1720440010522$GB-MYLANLABS-2024M1064681$MYLAN$$10$YR$$M$Y$28$KG$20240712$$HP$GB$GB
240840151$24084015$1$I$20240520$20240709$20240712$20240712$EXP$$UA-MYLANLABS-2024M1064836$MYLAN$$61$YR$$F$Y$$$20240712$$HP$UA$UA
240840162$24084016$2$F$20240612$20240806$20240712$20240812$EXP$FR-AFSSAPS-AN2024000835$FR-MYLANLABS-2024M1064199$MYLAN$$74$YR$$M$Y$87$KG$20240812$$MD$FR$FR
240840171$24084017$1$I$20240709$20240709$20240712$20240712$EXP$$GB-MYLANLABS-2024M1064540$MYLAN$$$$$M$Y$$$20240712$$CN$GB$GB
240840181$24084018$1$I$$20240709$20240712$20240712$EXP$GB-MHRA-MED-202407091042262220-KWDTG$GB-MYLANLABS-2024M1064660$MYLAN$$31$YR$$F$Y$34$KG$20240712$$CN$GB$GB
240840192$24084019$2$F$$20240722$20240712$20240731$EXP$$US-TEVA-VS-3217727$TEVA$Sherman M, Holden K, Sweeney R, Dumont TL, Appiah-Kubi E. A Case of Babesiosis Induced Sepsis Hemophagocytic Lymphohistiocytosis Overlap Syndrome in Pennsylvania. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A7336.; Sherman M, Holden K, Sweeney R, Dumont TL, Appiah-Kubi E. A Case of Babesiosis Induced Sepsis Hemophagocytic Lymphohistiocytosis Overlap Syndrome in Pennsylvania. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A7336.$74$YR$$F$Y$$$20240731$$HP$US$US
240840202$24084020$2$F$$20240821$20240712$20240824$PER$$US-JNJFOC-20240726228$JOHNSON AND JOHNSON$$$$$$Y$$$20240824$$HP$US$US
240840211$24084021$1$I$20240711$20240711$20240712$20240712$PER$$US-JNJFOC-20240730832$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240712$$CN$US$US
240840222$24084022$2$F$20240101$20240822$20240712$20240827$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-090751$REGENERON$$$$$M$Y$$$20240827$$CN$US$US
240840231$24084023$1$I$$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137024$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240840241$24084024$1$I$20240401$20240705$20240712$20240712$EXP$$NVSC2024US140126$NOVARTIS$$75$YR$$M$Y$87.08$KG$20240712$$CN$US$US
240840251$24084025$1$I$20240101$20240703$20240712$20240712$PER$$US-SA-2024SA200884$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240712$$MD$US$US
240840273$24084027$3$F$20240101$20240802$20240712$20240808$PER$$US-UNITED THERAPEUTICS-UNT-2024-020385$UNITED THERAPEUTICS$$$$$M$Y$85.714$KG$20240808$$$US$US
240840281$24084028$1$I$20240625$20240627$20240712$20240712$PER$$US-SA-2024SA189269$SANOFI AVENTIS$$80$YR$E$F$Y$88.4$KG$20240712$$MD$US$US
240840291$24084029$1$I$20220101$20240709$20240712$20240712$PER$$US-SA-2024SA203614$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240712$$PH$US$US
240840301$24084030$1$I$20240601$20240705$20240712$20240712$PER$$US-SA-2024SA204181$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240712$$CN$US$US
240840311$24084031$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA203199$SANOFI AVENTIS$$$$A$M$Y$$$20240712$$MD$US$US
240840321$24084032$1$I$20240629$20240703$20240712$20240712$PER$$US-SA-2024SA203506$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240712$$MD$US$US
240840333$24084033$3$F$$20240820$20240712$20240821$PER$$US-ALXN-202407USA000427US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240821$$CN$US$US
240840341$24084034$1$I$$20240709$20240712$20240712$EXP$$ES-ABBVIE-5834120$ABBVIE$$$$$F$Y$$$20240712$$PH$ES$ES
240840352$24084035$2$F$$20240702$20240712$20240717$EXP$$CH-009507513-2407CHE004724$MERCK$$$$$F$Y$$$20240717$$MD$CH$CH
240840361$24084036$1$I$$20240628$20240712$20240712$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06156$HIKMA$$21$MON$$F$Y$10$KG$20240712$$PH$CA$CA
240840381$24084038$1$I$$20240705$20240712$20240712$30DAY$$US-GSK-US2024084032$GLAXOSMITHKLINE$$$$E$M$Y$$$20240712$$CN$US$US
240840411$24084041$1$I$$20240710$20240712$20240712$EXP$$GB-GILEAD-2024-0680355$GILEAD$$$$A$M$Y$$$20240712$$HP$GB$GB
240840422$24084042$2$F$20240101$20240724$20240712$20240729$PER$$US-AMGEN-USASP2024137525$AMGEN$$72$YR$E$F$Y$$$20240728$$CN$US$US
240840431$24084043$1$I$$20240708$20240712$20240712$EXP$$CA-ABBVIE-5833110$ABBVIE$$65$YR$$$Y$85$KG$20240712$$HP$CA$CA
240840441$24084044$1$I$20100318$20240708$20240712$20240712$EXP$$AU-ASTELLAS-2024US019419$ASTELLAS$$63$YR$$F$Y$$$20240712$$HP$AU$AU
240840451$24084045$1$I$$20240708$20240712$20240712$EXP$$CN-OTSUKA-2024_019383$OTSUKA$Shen Y, Cao J, Hu T, Yang X, Zhao Y, Shen Y et al.. Successful Treatment of an AML Patient Infected with Hypervirulent ST463 Pseudomonas Aeruginosa Harboring Rare Carbapenem-Resistant Genes blaAFM-1 and blaKPC-2 Following Allogeneic Hematopoietic Stem Cell Transplantation. Infection and Drug Resistance. 2024;17:1357-1365$32$YR$$M$Y$$$20240712$$HP$CN$CN
240840462$24084046$2$F$20240301$20240716$20240712$20240719$EXP$$US-ABBVIE-5834153$ABBVIE$$45$YR$$M$Y$$$20240719$$CN$US$US
240840471$24084047$1$I$$20240424$20240712$20240712$PER$$US-BAYER-2024A095569$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240840481$24084048$1$I$$20240708$20240712$20240712$EXP$$TW-ASTELLAS-2024US019748$ASTELLAS$$$$$M$Y$$$20240712$$CN$TW$TW
240840491$24084049$1$I$20240606$20240701$20240712$20240712$EXP$GB-MHRA-MED-202406281442381420-RNWGQ$GB-LUPIN PHARMACEUTICALS INC.-2024-05975$LUPIN$$$$$$Y$$$20240712$$PH$GB$GB
240840501$24084050$1$I$$20240628$20240712$20240712$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06429$LUPIN$$$$$$Y$$$20240712$$CN$US$US
240840511$24084051$1$I$$20240705$20240712$20240712$EXP$DE-EMA-DD-20240704-7482653-200727$DE-RDY-SPO/DEU/24/0009964$DR REDDYS$$82$YR$E$M$Y$$$20240712$$CN$DE$DE
240840522$24084052$2$F$$20240724$20240712$20240802$EXP$$US-TEVA-VS-3218595$TEVA$Simone C, Axelband J. Levetiracetam-associated Rhabdomyolysis. Am-J-Respir-Crit-Care-Med 2024; 209 1.; Simone C, Axelband J. Levetiracetam-associated Rhabdomyolysis. Am-J-Respir-Crit-Care-Med 2024; 209 1.$20$YR$$M$Y$$$20240802$$HP$US$US
240840532$24084053$2$F$$20240724$20240712$20240802$EXP$$US-TEVA-VS-3217814$TEVA$Patel D, Chittal A, Malik KJ, Disilvio BE. A ^Tail^ of Caution: Pioglitazone Induced Recurrent Pleural Effusion. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Patel D, Chittal A, Malik KJ, Disilvio BE. A ^Tail^ of Caution: Pioglitazone Induced Recurrent Pleural Effusion. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$68$YR$$F$Y$$$20240802$$HP$US$US
240840552$24084055$2$F$20240624$20240705$20240712$20240716$EXP$$JP-ROCHE-10000020772$ROCHE$$9$DEC$E$M$Y$50$KG$20240716$$MD$JP$JP
240840561$24084056$1$I$$20240708$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005561$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240712$$CN$US$US
240840571$24084057$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007138$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240840581$24084058$1$I$20240709$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007173$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240712$$CN$US$US
240840591$24084059$1$I$$20240611$20240712$20240712$EXP$$MA-ROCHE-10000016697$ROCHE$El Idrissi F, Taouch A, Khibri H, Chhih Y, Mouatassim N, Ammouri W. Description of the complications and challenges with biologics: experiences of an internal medicine department [Abstract: CA191]. La Revue de medecine interne. 2024;45:A245-6. doi:10.1016/j.revmed.2024.04.207.$$$$$Y$$$20240712$$HP$MA$MA
240840601$24084060$1$I$$20240711$20240711$20240711$DIR$709946$$FDA-CTU$$$$$UNK$N$$$20240711$$CN$US$
240840621$24084062$1$I$$20210929$20240712$20240712$EXP$$GB-SANDOZ INC.-NVSC2021GB167202$SANDOZ$$37$YR$$M$Y$$$20240712$$MD$GB$GB
240840631$24084063$1$I$20230112$20240704$20240712$20240712$EXP$$FR-CELLTRION INC.-2024FR016514$CELLTRION$$$$$$Y$$$20240712$$PH$FR$FR
240840641$24084064$1$I$20240201$20240710$20240711$20240711$DIR$FDA-CDER-CTU-2024-48251$$FDA-CTU$$58$YR$$M$N$$$20240710$N$HP$US$
240840651$24084065$1$I$$20240711$20240711$20240711$DIR$709952$$FDA-CTU$$$$$UNK$N$$$20240711$$CN$US$
240840661$24084066$1$I$20240101$20240710$20240712$20240712$PER$$PR-JNJFOC-20240726881$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240712$$CN$PR$PR
240840671$24084067$1$I$20240706$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48306$$FDA-CTU$$59$YR$$F$N$$$20240711$N$CN$US$
240840681$24084068$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48294$$FDA-CTU$$61$YR$$F$N$$$20240711$N$$US$
240840701$24084070$1$I$20240622$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48273$$FDA-CTU$$54$YR$$F$N$$$20240711$N$HP$US$
240840711$24084071$1$I$20230715$20240711$20240711$20240711$DIR$709925$$FDA-CTU$$78$YR$$M$N$74.25$KG$20240711$Y$CN$US$
240840721$24084072$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48270$$FDA-CTU$$$$$M$N$$$20240711$N$HP$US$
240840741$24084074$1$I$$20240711$20240711$20240711$DIR$709905$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240840751$24084075$1$I$$20240711$20240711$20240711$DIR$709907$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240840761$24084076$1$I$$20240711$20240711$20240711$DIR$709912$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240840771$24084077$1$I$$20240711$20240711$20240711$DIR$709913$$FDA-CTU$$$$$F$N$$$20240711$N$PH$US$
240840801$24084080$1$I$$20240711$20240711$20240711$DIR$709918$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240840811$24084081$1$I$$20240711$20240711$20240711$DIR$709914$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240840841$24084084$1$I$$20240711$20240711$20240711$DIR$709919$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240840851$24084085$1$I$$20240711$20240711$20240711$DIR$709932$$FDA-CTU$$$$$UNK$N$$$20240711$N$CN$US$
240840861$24084086$1$I$20240711$20240711$20240711$20240711$DIR$709943$$FDA-CTU$$65$YR$$F$N$$$20240711$Y$HP$US$
240840871$24084087$1$I$$20240711$20240711$20240711$DIR$709949$$FDA-CTU$$$$$UNK$N$$$20240711$$CN$US$
240840891$24084089$1$I$$20240702$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106066$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240712$$HP$US$US
240840901$24084090$1$I$$20240703$20240712$20240712$EXP$$US-APOTEX-2024AP008155$APOTEX$Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN.. Relationship between the Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular Immunology and Inflammation. 2023;31(5):900-904$$$A$$Y$$$20240712$$HP$US$US
240840922$24084092$2$F$$20240820$20240712$20240821$EXP$$CA-TAKEDA-2024TUS069691$TAKEDA$$$$$F$Y$$$20240821$$MD$CA$CA
240840931$24084093$1$I$$20240629$20240712$20240712$EXP$$ZA-ROCHE-10000023473$ROCHE$$$$$M$Y$$$20240712$$CN$ZA$ZA
240840941$24084094$1$I$20240101$20240613$20240712$20240712$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000132$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240712$$CN$US$US
240840951$24084095$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186671$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240840961$24084096$1$I$20240101$20240709$20240712$20240712$EXP$$CA-ABBVIE-5836614$ABBVIE$$63$YR$$M$Y$$$20240712$$CN$CA$CA
240840971$24084097$1$I$20230101$20240708$20240712$20240712$EXP$$IT-AstraZeneca-2024A159414$ASTRAZENECA$$48$YR$$M$Y$94$KG$20240712$$MD$IT$
240840981$24084098$1$I$$20240705$20240712$20240712$EXP$$ZA-AstraZeneca-2024A155474$ASTRAZENECA$$42$YR$$F$Y$$$20240712$$CN$ZA$
240840992$24084099$2$F$$20240806$20240712$20240807$PER$$US-ALXN-202407USA000576US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240841002$24084100$2$F$20240708$20240717$20240712$20240722$EXP$$US-MYLANLABS-2024M1064801$MYLAN$$87$YR$$F$Y$$$20240722$$CN$US$US
240841011$24084101$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA202216$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$HP$US$US
240841022$24084102$2$F$$20240715$20240712$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06444$LUPIN$$$$$$Y$$$20240809$$CN$US$US
240841031$24084103$1$I$20231107$20240704$20240712$20240712$EXP$GB-MHRA-MED-202404301844192370-MVJFK$GB-TEVA-VS-3218134$TEVA$$71$YR$$F$Y$$$20240712$$HP$GB$GB
240841041$24084104$1$I$$20240619$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002919$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240841052$24084105$2$F$$20240716$20240712$20240725$EXP$$MA-INSUD PHARMA-2407MA05506$INSUD PHARMA$Nedday S, Naji Y, Laadami S, Adali N. Une toxicite cerebelleuse au metronidazole: a propos d^un cas. Revue Neurologique. 2024;180 (Suppl):S77$$$$$Y$$$20240725$$HP$MA$MA
240841061$24084106$1$I$$20240614$20240712$20240712$PER$$-MARINUS PHARMACEUTICALS, INC.-MAR2024000129$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240712$$CN$COUNTRY NOT SPECIFIED$
240841072$24084107$2$F$20240709$20240730$20240712$20240801$PER$$US-JNJFOC-20240729199$JOHNSON AND JOHNSON$$50$YR$A$$Y$$$20240801$$HP$US$US
240841081$24084108$1$I$$20240623$20240712$20240712$PER$$US-JNJFOC-20240721076$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240841095$24084109$5$F$20240802$20240905$20240712$20240910$EXP$$GB-MYLANLABS-2024M1062906$MYLAN$$$$$M$Y$$$20240910$$CN$GB$GB
240841101$24084110$1$I$$20240704$20240712$20240712$EXP$$JP-OTSUKA-2024_019117$OTSUKA$$$$$M$Y$$$20240712$$CN$JP$JP
240841113$24084111$3$F$20240630$20240710$20240712$20240717$EXP$$CA-ROCHE-10000022360$ROCHE$$34$YR$A$F$Y$$$20240717$$MD$CA$CA
240841121$24084112$1$I$$20240705$20240712$20240712$EXP$$US-BAYER-2024A097848$BAYER$$48$YR$A$F$Y$$$20240712$$CN$US$US
240841131$24084113$1$I$20240601$20240703$20240712$20240712$EXP$$DE-SA-2024SA199218$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$DE$DE
240841141$24084114$1$I$20240101$20240708$20240712$20240712$PER$$US-ABBVIE-5835881$ABBVIE$$40$YR$$$Y$$$20240712$$CN$US$US
240841152$24084115$2$F$$20240920$20240712$20240930$EXP$$GB-EMD Serono-2024036533$EMD SERONO INC$$$$A$M$Y$$$20240930$$CN$GB$GB
240841161$24084116$1$I$$20240708$20240712$20240712$EXP$$US-GSK-US2024084383$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$CN$US$US
240841171$24084117$1$I$$20240701$20240712$20240712$EXP$$US-VKT-000565$VKT PHARMA PRIVATE LIMITED$$9$YR$C$F$Y$$$20240704$$MD$US$US
240841181$24084118$1$I$$20240619$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002921$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240841191$24084119$1$I$20240604$20240711$20240712$20240712$EXP$$US-INCYTE CORPORATION-2024IN007307$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240841201$24084120$1$I$$20240710$20240712$20240712$EXP$$US-PFIZER INC-202400211125$PFIZER$$49$YR$$F$Y$$$20240712$$CN$US$US
240841213$24084121$3$F$$20240811$20240712$20240812$30DAY$$US-PFIZER INC-202400210019$PFIZER$$10$YR$$M$Y$29.94$KG$20240812$$MD$US$US
240841233$24084123$3$F$20240101$20240811$20240712$20240812$30DAY$$US-PFIZER INC-202400209146$PFIZER$$12$YR$$M$Y$$$20240812$$CN$US$US
240841244$24084124$4$F$20240708$20240911$20240712$20240913$30DAY$$US-PFIZER INC-202400209764$PFIZER$$10$YR$$M$Y$$$20240913$$CN$US$US
240841271$24084127$1$I$20220101$20240710$20240712$20240712$EXP$$US-PFIZER INC-PV202400090849$PFIZER$$58$YR$$F$Y$$$20240712$$HP$US$US
240841283$24084128$3$F$$20240828$20240712$20240829$EXP$$US-PFIZER INC-202400212738$PFIZER$$21$YR$$M$Y$84.354$KG$20240829$$CN$US$US
240841292$24084129$2$F$20240501$20240904$20240712$20240904$EXP$$CA-PFIZER INC-202400210204$PFIZER$$79$YR$$F$Y$$$20240904$$HP$CA$CA
240841301$24084130$1$I$$20240701$20240712$20240712$EXP$$US-VKT-000567$VKT PHARMA PRIVATE LIMITED$$14$YR$T$M$Y$$$20240708$$MD$US$US
240841312$24084131$2$F$20200101$20240723$20240712$20240725$EXP$$US-PFIZER INC-PV202400090509$PFIZER$$73$YR$$M$Y$$$20240725$$MD$US$US
240841321$24084132$1$I$20240709$20240710$20240712$20240712$EXP$GB-MHRA-MED-202407100753275870-LHPVW$GB-PFIZER INC-202400210332$PFIZER$$27$YR$$F$Y$72$KG$20240712$$CN$GB$GB
240841332$24084133$2$F$$20240814$20240712$20240815$30DAY$$US-PFIZER INC-202400208998$PFIZER$$86$YR$$F$Y$$$20240815$$CN$US$US
240841341$24084134$1$I$20240701$20240711$20240712$20240712$EXP$$AR-PFIZER INC-202400212536$PFIZER$$60$YR$$F$Y$$$20240712$$CN$AR$AR
240841351$24084135$1$I$20231214$20240709$20240712$20240712$EXP$$CA-PFIZER INC-202300449777$PFIZER$$43$YR$$F$Y$$$20240712$$HP$CA$CA
240841361$24084136$1$I$20240101$20240709$20240712$20240712$EXP$$CA-PFIZER INC-202400212169$PFIZER$$48$YR$$M$Y$$$20240712$$HP$CA$CA
240841372$24084137$2$F$20231201$20240716$20240712$20240725$EXP$$US-TAKEDA-2024TUS070206$TAKEDA$$52$YR$$F$Y$$$20240725$$PH$US$US
240841381$24084138$1$I$$20210809$20240712$20240712$PER$$KR-PFM-2022-03530$PIERRE FABRE MEDICAMENT$Ha D, Lee G, Shin K, Ko H, Kim B, Kim M, et al.. Deeply located infantile hemangioma with rapid growth resembles malignancy. Annals of dermatology. 2021;33(4):390-91$6$MON$$F$Y$$$20240712$$HP$KR$KR
240841391$24084139$1$I$20240605$20240702$20240712$20240712$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-06190$HIKMA$$$$$$Y$$$20240712$$HP$EG$EG
240841401$24084140$1$I$20231201$20240711$20240712$20240712$EXP$$US-INCYTE CORPORATION-2024IN007176$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240841411$24084141$1$I$$20210809$20240712$20240712$PER$$TR-PFM-2022-03525$PIERRE FABRE MEDICAMENT$Ayhan M, Guner R. A subacute thyroiditis case after SARS-CoV-2 infection: A case report and current literature review. Med Bull Haseki. 2021;59:54-6$39$YR$$M$Y$$$20240712$$HP$TR$TR
240841421$24084142$1$I$$20210823$20240712$20240712$PER$$IT-PFM-2022-03535$PIERRE FABRE MEDICAMENT$Correra A, Merola A, Palma M, Romeo E, Colonna D, Passariello A et al. A frightening giant QRS complex in a 3-months-old infant. Journal of Electrocardiology. 2021;66:16-17$3$MON$$$Y$$$20240712$$HP$IT$IT
240841431$24084143$1$I$$20240614$20240712$20240712$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000131$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240712$$CN$US$US
240841441$24084144$1$I$$20210901$20240712$20240712$PER$$IL-PFM-2022-03542$PIERRE FABRE MEDICAMENT$Tal R, Yakov G, Lorber A. When answers cannot be found in the texbooks: Making ethical decisions regarding children with profound disabilities. Progress in pediatric cardiology. 2021;61$3$MON$$M$Y$$$20240712$$HP$IL$IL
240841451$24084145$1$I$$20210823$20240712$20240712$PER$$BE-PFM-2022-03537$PIERRE FABRE MEDICAMENT$Geeurickx M, Labarque V. A narrative review of the role of sirolimus in the treatment of congenital vascular malformations. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2021;9(5):1321-32$$$$$Y$$$20240712$$HP$BE$BE
240841461$24084146$1$I$$20220324$20240712$20240712$PER$$JP-PFM-2022-02851$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$MD$JP$JP
240841472$24084147$2$F$20240710$20240826$20240712$20240829$PER$$US-JNJFOC-20240726557$JOHNSON AND JOHNSON$$64$YR$A$$Y$$$20240829$$CN$US$US
240841481$24084148$1$I$$20240709$20240712$20240712$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038942$BOEHRINGER INGELHEIM$Nishioka Y, Miyamoto K, Ogino H, Kakimoto T, Matsumura Y, Haji K. Transformation of epidermal growth factor receptor mutated lung adenocarcinoma to small-cell carcinoma long after the cessation of tyrosine kinase inhibitor treatment: a case series and literature review. Respiratory Medicine Case Reports. 2024;51: 102076. doi:10.1016/j.rmc r.2024.102076.$26$YR$A$F$Y$$$20240712$$HP$JP$JP
240841491$24084149$1$I$$20210901$20240712$20240712$PER$$IL-PFM-2022-03541$PIERRE FABRE MEDICAMENT$Tal R, Yakov G, Lorber A. When answers cannot be found in the texbooks: Making ethical decisions regarding children with profound disabilities. Progress in pediatric cardiology. 2021;61:1-6$$$I$F$Y$$$20240712$$HP$IL$IL
240841501$24084150$1$I$$20210809$20240712$20240712$PER$$ES-PFM-2022-03528$PIERRE FABRE MEDICAMENT$Rodriguez-Gonzalez M, P?rez-Reviriego AA, G?mez-Guzm?n E, Tejero-Hern?ndez MA, Sanz AZ, Valverde I. Primary cardiac fibroma in infants: A case report and review of cases of cardiac fibroma managed through orthotopic heart transplant. Annals of Pediatric Cardiology. 2021;14(2):224-7$7$MON$$F$Y$$$20240712$$HP$ES$ES
240841511$24084151$1$I$$20240703$20240712$20240712$EXP$$PL-MYLANLABS-2024M1050463$MYLAN$Chrobak J, Rodek P and Kucia K. Multiple-Monitored Electroconvulsive  Therapy (MMECT) ? does it really just belong in psychiatry?s past. A case report. POLISH PSYCHIATRY. 2024;58 (2):343?349$49$YR$$F$Y$$$20240712$$HP$PL$PL
240841521$24084152$1$I$$20240709$20240712$20240712$EXP$GB-MHRA-MED-202407082013362770-TYVSG$GB-MYLANLABS-2024M1064531$MYLAN$$26$YR$$F$Y$$$20240712$$CN$GB$GB
240841531$24084153$1$I$20240510$20240619$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002922$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240712$$CN$US$US
240841543$24084154$3$F$20201101$20240917$20240712$20240923$EXP$$DE-AMGEN-DEUSP2024135175$AMGEN$$42$YR$A$M$Y$44.444$KG$20240923$$MD$DE$DE
240841551$24084155$1$I$$20240702$20240712$20240712$PER$$US-TEVA-VS-3218000$TEVA$$$$$F$Y$$$20240712$$CN$US$US
240841561$24084156$1$I$20230127$20240703$20240712$20240712$PER$$US-SA-2024SA197842$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240712$$MD$US$US
240841571$24084157$1$I$$20240708$20240712$20240712$PER$$US-ROCHE-10000020261$ROCHE$Krawczyk K, Kwak A, Kujalowicz C, Truszkowska K. Primary Mediastinal Large B-Cell Lymphoma Presentingas Acute Pancreatitis. ACG CASE REPORTS JOURNAL. 2024-Jun-21;11 (6):1-3. doi:10.14309/crj.0000000000001394.$16$YR$T$F$Y$$$20240712$$MD$US$US
240841581$24084158$1$I$$20240710$20240712$20240712$PER$$US-ROCHE-10000023698$ROCHE$$$$$$Y$$$20240712$$CN$US$US
240841592$24084159$2$F$20240523$20240711$20240712$20240717$EXP$IT-MINISAL02-993696$IT-REGENERON PHARMACEUTICALS, INC.-2024-096625$REGENERON$$81$YR$$F$Y$$$20240717$$MD$IT$IT
240841601$24084160$1$I$$20210916$20240712$20240712$PER$$IT-PFM-2022-03484$PIERRE FABRE MEDICAMENT$Milano A. SUPRAUMBILICAL MIDLINE RAPHE AND INFANTILE HEMANGIOMA. Eur. J. Pediat. Dermatol. 2021;31(3):166-8$$$I$$Y$$$20240712$$HP$IT$IT
240841611$24084161$1$I$$20210902$20240712$20240712$PER$$GR-PFM-2022-03554$PIERRE FABRE MEDICAMENT$Karatza AA, Gkentzi D, Loukopoulou S, Dimitriou G. Supraventricular tachycardia in a 5-month-old infant with tuberous sclerosis complex. Japan Pediatric Society. 2021;63(3):342-3$5$MON$$M$Y$$$20240712$$HP$GR$GR
240841621$24084162$1$I$$20210916$20240712$20240712$PER$$IT-PFM-2022-03717$PIERRE FABRE MEDICAMENT$Milano A. SUPRAUMBILICAL MIDLINE RAPHE AND INFANTILE HEMANGIOMA. Eur. J. Pediat. Dermatol. 2021;31(3):166-8$7$DY$$F$Y$$$20240712$$HP$IT$IT
240841631$24084163$1$I$$20210922$20240712$20240712$PER$$KR-PFM-2022-03522$PIERRE FABRE MEDICAMENT$Yoo SW, Kim JS. Task-specifc dystonic tremor and the Korean traditional woodwind instrument, the Piri. Neurological Sciences. 2021;42:3923-5$33$YR$$M$Y$$$20240712$$HP$KR$KR
240841641$24084164$1$I$$20210906$20240712$20240712$PER$$CA-PFM-2022-03424$PIERRE FABRE MEDICAMENT$P?ttgen K, Hansen L, Lauren C, Stefanko N, Mathes E, Olsen G, et al. Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma. J AM ACAD DERMATOL. 2021;85(2):345-52$$$I$$Y$$$20240712$$HP$CA$CA
240841651$24084165$1$I$$20210922$20240712$20240712$PER$$CA-PFM-2022-03529$PIERRE FABRE MEDICAMENT$Al-Shorafat D, Bhowmick S, Espay A, Fasano A. B-blockers-Induced Tremor. Movement disorders clinical practice. 2021;8(3):449-52$38$YR$$M$Y$$$20240712$$HP$CA$CA
240841661$24084166$1$I$$20210929$20240712$20240712$PER$$IT-PFM-2022-03531$PIERRE FABRE MEDICAMENT$De Berardis D, Fornaro M, Ventriglio A, Pettorruso M, Vellante F, Napoletano C. Case of aripiprazole Case of aripiprazole successfully managed with carvedilol: A case report. Psychiatry and Clinical Neurosciences. 2021;75(3):114-5$27$YR$$F$Y$$$20240712$$HP$IT$IT
240841671$24084167$1$I$$20211004$20240712$20240712$PER$$JP-PFM-2022-03538$PIERRE FABRE MEDICAMENT$Suzuki A, Kobayashi R, Shirata T, Komoriya H, Kanoto M, and Otani K. Case Report: Changes in Regional Cerebral Blood Flow in Chronic Akathisia of a Depressed Patient Before and After Electroconvulsive Therapy Treatment. rCBF in Chronic Akathisia. 2021;12$66$YR$$F$Y$$$20240712$$HP$JP$JP
240841681$24084168$1$I$$20240620$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002939$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240841691$24084169$1$I$$20240705$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN007138$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240841701$24084170$1$I$20231201$20240703$20240712$20240712$EXP$$HR-TAKEDA-2024TUS070074$TAKEDA$$$$$F$Y$$$20240712$$CN$HR$HR
240841713$24084171$3$F$$20240918$20240712$20240924$30DAY$$JP-PFIZER INC-202400210419$PFIZER$$$$C$$Y$$$20240924$$MD$JP$JP
240841722$24084172$2$F$20240701$20240731$20240712$20240814$EXP$$US-UCBSA-2024034772$UCB$$36$YR$$F$Y$70.567$KG$20240814$$HP$US$US
240841731$24084173$1$I$$20240619$20240712$20240712$PER$$US-BAYER-2024A099133$BAYER$Siddiqui S.; Cheema M.; Iftikhar A. A Case of Herpetic Whitlow, Complicated by Osteomyelitis. American Journal of Respiratory and Critical Care Medicine () , American. 2024;209$19$YR$A$F$Y$$$20240712$$HP$US$US
240841743$24084174$3$F$$20240916$20240712$20240919$30DAY$$US-PFIZER INC-PV202400044843$PFIZER$$16$YR$$M$Y$$$20240919$$HP$US$US
240841763$24084176$3$F$$20240814$20240712$20240814$30DAY$$US-PFIZER INC-202400208088$PFIZER$$12$YR$$F$Y$$$20240814$$CN$US$US
240841773$24084177$3$F$$20240916$20240712$20240919$30DAY$$US-PFIZER INC-PV202400046941$PFIZER$$14$YR$$F$Y$$$20240919$$CN$US$US
240841781$24084178$1$I$$20240709$20240712$20240712$EXP$$US-PFIZER INC-202400210001$PFIZER$$77$YR$$F$Y$$$20240712$$CN$US$US
240841814$24084181$4$F$20240705$20240923$20240712$20240925$30DAY$$US-PFIZER INC-202400209089$PFIZER$$9$YR$$M$Y$19.5$KG$20240925$$MD$US$US
240841824$24084182$4$F$$20240911$20240712$20240912$30DAY$$US-PFIZER INC-202400208659$PFIZER$$10$YR$$M$Y$$$20240912$$CN$US$US
240841844$24084184$4$F$20240701$20240912$20240712$20240917$30DAY$$US-PFIZER INC-202400209433$PFIZER$$11$YR$$F$Y$$$20240917$$CN$US$US
240841862$24084186$2$F$20240706$20240821$20240712$20240821$30DAY$$US-PFIZER INC-202400209744$PFIZER$$22$MON$$F$Y$$$20240821$$CN$US$US
240841871$24084187$1$I$$20240708$20240712$20240712$30DAY$$SE-PFIZER INC-202400209568$PFIZER$$79$YR$$F$Y$$$20240712$$CN$SE$SE
240841883$24084188$3$F$$20240814$20240712$20240814$30DAY$$US-PFIZER INC-202400201911$PFIZER$$$$$$Y$$$20240814$$CN$US$US
240841904$24084190$4$F$$20240911$20240712$20240913$30DAY$$US-PFIZER INC-202400209268$PFIZER$$14$YR$$M$Y$$$20240913$$CN$US$US
240841911$24084191$1$I$$20240702$20240712$20240712$EXP$$AU-INCYTE CORPORATION-2024IN007099$INCYTE$$$$$$Y$$$20240712$$MD$AU$AU
240841931$24084193$1$I$$20211004$20240712$20240712$PER$$TR-PFM-2022-03539$PIERRE FABRE MEDICAMENT$Emekli AS, Parlak A, Gocen NY, Kurtuncu M. Anti-GAD associated post-infectious cerebellitis after COVID-19. Neurological Sciences. 2021$54$YR$$M$Y$$$20240712$$HP$TR$TR
240841941$24084194$1$I$$20211011$20240712$20240712$PER$$TR-PFM-2022-03551$PIERRE FABRE MEDICAMENT$Iremli BG, Sendur SN, Unluturk U. Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Post vaccination ASIA Syndrome. Oxford University Press on behalf of the Endocrine Society. 1-18$35$YR$$F$Y$$$20240712$$HP$TR$TR
240841951$24084195$1$I$$20211011$20240712$20240712$PER$$TR-PFM-2022-03697$PIERRE FABRE MEDICAMENT$Iremli B, Sendur S, Unluturk U. Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Post vaccination ASIA Syndrome$34$YR$$F$Y$$$20240712$$HP$TR$TR
240841961$24084196$1$I$$20211007$20240712$20240712$PER$$BE-PFM-2022-03548$PIERRE FABRE MEDICAMENT$Devos J, Nysten C, Buyse G, Cassiman C, Demaerel P. Neuro-image: recurrent painful ophthalmoplegic neuropathy. Acta Neurologica Belgica. 2021;121:1331-333$12$YR$$F$Y$$$20240712$$HP$BE$BE
240841981$24084198$1$I$$20211007$20240712$20240712$PER$$BE-PFM-2022-03545$PIERRE FABRE MEDICAMENT$Fameree L, Van Lier C, Borbath I, Yildiz H, Lemaire J, Baeck M, et al. Misleading clinical presentation of carcinoid syndrome. Acta Gastro-Enterologica Belgica. 2021;84:501-03$25$YR$$F$Y$$$20240712$$HP$BE$BE
240841991$24084199$1$I$$20211011$20240712$20240712$PER$$KR-PFM-2022-03563$PIERRE FABRE MEDICAMENT$Shin JA, Choi YU, Kim KM, Yoon HJ, Lee JY et al. Congenital Long QT Syndrome Type 2 with Symptomatic 2:1 Atrioventricular Block and Ventricular Arrhythmia in a Preterm Baby Who Presented with Fetal Ventricular Tachycardia and Hydrops. Korean Circ J. 2021;51(9):792-96$16$MON$$$Y$1$KG$20240712$$HP$KR$KR
240842001$24084200$1$I$$20211013$20240712$20240712$PER$$ES-PFM-2022-03672$PIERRE FABRE MEDICAMENT$Lesmes Heredia C, Comas Rovira M, Moreno Baro A, Pina Perez S, Zamora Lapiedra M, Corona Martinez M. Elevated fetal middle cerebral artery peak systolic velocity in diabetes type 1 patient: a case report. Case Rep. Perinat. Med. 2021;10(1)$$$N$F$Y$$$20240712$$HP$ES$ES
240842011$24084201$1$I$$20211206$20240712$20240712$PER$$JP-PFM-2022-03483$PIERRE FABRE MEDICAMENT$Mine T, Koike Y, Ehara D, Murota H. A case of bilateral plantar pseudo-Kaposi sarcoma successfully treated with propranolol. JAAD Case Reports. 2021;18:74-8$57$YR$$M$Y$$$20240712$$HP$JP$JP
240842026$24084202$6$F$20240101$20240925$20240712$20240930$30DAY$$US-PFIZER INC-202400205129$PFIZER$$16$YR$$M$Y$58.957$KG$20240930$$CN$US$US
240842031$24084203$1$I$$20220413$20240712$20240712$PER$$FR-PFM-2022-03447$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240712$$PH$FR$FR
240842041$24084204$1$I$$20211018$20240712$20240712$PER$$IT-PFM-2022-03564$PIERRE FABRE MEDICAMENT$Pezzini D, Labella B, Poli L, Costa A, Magoni M, and Padovani A. An uncommon cause of paraparesis: Thyrotoxic hypokalemic periodic paralysis. Journal of the Neurological Sciences. 2021;429:150$56$YR$$M$Y$$$20240712$$HP$IT$IT
240842051$24084205$1$I$20240625$20240711$20240711$20240711$DIR$709951$$FDA-CTU$$31$YR$$F$N$64.35$KG$20240711$N$HP$US$
240842061$24084206$1$I$$20211206$20240712$20240712$PER$$TR-PFM-2022-03482$PIERRE FABRE MEDICAMENT$Oguzturk G, Mahmuti SO, Demirkol EY, Fener N, Seyhan EC, Cetinkaya E, et al. Hemangiolymphangioma with Accompanying Interstitial Lung Disease: A Rare Case. Respir Case Rep. 2021;10(3):180-5$17$YR$$M$Y$65$KG$20240712$$HP$TR$TR
240842071$24084207$1$I$$20240701$20240712$20240712$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-20527$SAMSUNG BIOEPIS$$82$YR$E$F$Y$$$20240712$$CN$AU$AU
240842081$24084208$1$I$$20240702$20240712$20240712$EXP$$IN-INCYTE CORPORATION-2024IN007097$INCYTE$$$$$$Y$$$20240712$$CN$IN$IN
240842091$24084209$1$I$20220401$20220422$20240712$20240712$PER$$JP-PFM-2022-03235$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$3$KG$20240712$$MD$JP$JP
240842103$24084210$3$F$$20240806$20240712$20240814$PER$$US-ROCHE-10000022157$ROCHE$$38$YR$A$F$Y$$$20240814$$CN$US$US
240842111$24084211$1$I$20240703$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110195$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240712$$CN$US$US
240842121$24084212$1$I$$20240711$20240712$20240712$EXP$$AT-TAKEDA-2023TUS103899$TAKEDA$Otto F, Seiberl M, Bieler L, Moser T, Kleindienst W, Wallner-Essl W, et al... Beyond t cell toxicity - intrathecal chemokine cxcl13 indicating b cell involvement in immune-related adverse events following checkpoint inhibition: a two-case series and literature review. European Journal of Neurology. 2024;31(7)$75$YR$$F$Y$$$20240712$$HP$AT$AT
240842131$24084213$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110607$BRISTOL MYERS SQUIBB$$$$A$M$Y$$$20240712$$HP$US$US
240842141$24084214$1$I$$20240709$20240712$20240712$PER$$US-ROCHE-10000022788$ROCHE$$12$YR$T$F$Y$$$20240712$$CN$US$US
240842151$24084215$1$I$$20240705$20240712$20240712$EXP$$JP-ROCHE-10000006947$ROCHE$Matsukane R, Oyama T, Tatsuta R, Kimura S, Hata K, Urata S. Real-World Prevalence and Tolerability of Immune-Related Adverse Events in Older Adults with Non-Small Cell Lung Cancer: A Multi-Institutional Retrospective Study. Cancers. 2024-Jun-06;16 (11):1-13. doi:10.3390/cancers16112159.$$$$$Y$$$20240712$$HP$JP$JP
240842161$24084216$1$I$20230901$20240628$20240712$20240712$EXP$$US-ROCHE-10000020236$ROCHE$$36$YR$A$F$Y$96.84$KG$20240712$$MD$US$US
240842172$24084217$2$F$20240701$20240827$20240712$20240906$EXP$$US-Accord-433998$ACCORD$$64$YR$A$M$Y$$$20240906$$HP$US$US
240842182$24084218$2$F$$20240726$20240712$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110031$BRISTOL MYERS SQUIBB$$$$E$M$Y$68.95$KG$20240805$$CN$US$US
240842192$24084219$2$F$20240627$20240708$20240712$20240722$EXP$$US-Accord-434000$ACCORD$$53$YR$A$M$Y$$$20240719$$HP$US$US
240842201$24084220$1$I$20240701$20240703$20240712$20240712$EXP$$US-Accord-434027$ACCORD$$33$YR$A$M$Y$$$20240712$$HP$US$US
240842211$24084221$1$I$20230401$20240702$20240712$20240712$EXP$FR-AFSSAPS-NT2023000939$FR-Accord-434051$ACCORD$$66$YR$E$F$Y$105$KG$20240712$$PH$FR$FR
240842221$24084222$1$I$20201210$20240701$20240712$20240712$EXP$DE-EMA-20231103-AUTODUP-1699042384674$DE-Accord-393128$ACCORD$$$$E$F$Y$73$KG$20240712$$HP$DE$DE
240842231$24084223$1$I$20231211$20240702$20240712$20240712$EXP$SE-SEMPA-2023-016715$SE-Accord-434031$ACCORD$$79$YR$E$M$Y$$$20240712$$MD$SE$SE
240842241$24084224$1$I$$20240702$20240712$20240712$EXP$AU-TGA-805115$AU-Accord-433328$ACCORD$$84$YR$E$M$Y$$$20240712$$HP$AU$AU
240842252$24084225$2$F$$20240812$20240712$20240819$EXP$GB-002147023-NVSC2024GB135507$GB-RDY-SPO/GBR/24/0010075$DR REDDYS$$$$A$F$Y$$$20240819$$MD$GB$GB
240842261$24084226$1$I$$20240702$20240712$20240712$EXP$$US-Accord-434041$ACCORD$$$$$F$Y$154.22$KG$20240712$$PH$US$US
240842271$24084227$1$I$$20220119$20240712$20240712$PER$$JP-PFM-2022-03452$PIERRE FABRE MEDICAMENT$Shimozono T, Ueno K,  Shiokawa N, Ohno S, Kawano Y. Early diagnosis of infantile Danon disease complicated by tetralogy of fallot. Japan Pediatric Society. 2021;63(8):988-90$$$$M$Y$$$20240712$$HP$JP$JP
240842281$24084228$1$I$$20220106$20240712$20240712$PER$$JP-PFM-2022-03440$PIERRE FABRE MEDICAMENT$Fuke N, Nishisho S, Tanaka A, Shimono R, Kusaka T. Peritoneovenous shunt as a palliative option in generalized lymphatic anomaly. Japan Pediatric Society. 2021;63(12):1532-534$13$YR$$F$Y$$$20240712$$HP$JP$JP
240842301$24084230$1$I$$20240629$20240712$20240712$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06056$LUPIN$Abbas Z, Mahmood T, Bellman V, Koirala P, Myers T. Relationship between pericallosal lipoma and neuropsychiatric symptoms: a case report. The Journal of Nervous and Mental Disease. 2023;211:639-640$15$YR$$M$Y$$$20240712$$MD$US$US
240842311$24084231$1$I$$20211220$20240712$20240712$PER$$IT-PFM-2022-03485$PIERRE FABRE MEDICAMENT$Bona I, Marino C, Cavallaro C, Di Pasquale L, Genco M, Alaimo A et al. A case report of refractory Kawasaki disease. Pediatric Rheumatology. Conference: 27th European Paediatric Rheumatology Congre. 2021;19(SUPPL 1)$4$MON$$$Y$$$20240712$$HP$IT$IT
240842321$24084232$1$I$$20220117$20240712$20240712$PER$$SE-PFM-2022-03445$PIERRE FABRE MEDICAMENT$Rodriguez Cruz J, Sahlsten Scholin J, Hjorth S. Case report: Cariprazine in a patient With schizophrenia, substance abuse, and cognitive dysfunction. Frontiers in psychiatry. 2021;12:727666$30$YR$$M$Y$$$20240712$$HP$SE$SE
240842331$24084233$1$I$$20220328$20240712$20240712$PER$$DE-PFM-2022-02833$PIERRE FABRE MEDICAMENT$Violano M, Poller WC, Abraham MR, Huemer M, Scheinman MM, Landmesser U et al. A deadly emotional argument: prevention of sudden cardiac death in catecholaminergic polymorphic ventricular tachycardia (CPVT). Journal of the American College of Cardiology. 2022;79(9):2518$41$YR$$F$Y$$$20240712$$HP$DE$DE
240842341$24084234$1$I$$20220328$20240712$20240712$PER$$KR-PFM-2022-02768$PIERRE FABRE MEDICAMENT$Jang Y, Moon J, Kim N, Kim J, Jun S, Shin W et al. A new rapid titration protocol for lamotrigine that reduces the risk of skin rash. Epilepsia Open. 2021;6:394-1$20$YR$$M$Y$$$20240712$$HP$KR$KR
240842351$24084235$1$I$$20220328$20240712$20240712$PER$$IT-PFM-2022-02819$PIERRE FABRE MEDICAMENT$Marco GMD, Nigris AD,  Pepe A,  Pagano A, Nardo GD, Tipo V. Ivabradine-Flecainide as Breakthrough Drug Combination for Congenital Junctional Ectopic Tachycardia: A Case Report and Literature Review. Pediatric Report. 2021;13:624-31$1$YR$$F$Y$$$20240712$$HP$IT$IT
240842361$24084236$1$I$$20220328$20240712$20240712$PER$$ES-PFM-2022-02820$PIERRE FABRE MEDICAMENT$Pujol A, G?mez A, Gallegos C, Nicolau J, Sanch?s P, Gonz?lez M et.al. Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves^ disease to silent thyroiditis. Journal of Endocrinological Investigation. 2021;1-8$38$YR$$F$Y$$$20240712$$HP$ES$ES
240842371$24084237$1$I$$20220328$20240712$20240712$PER$$IT-PFM-2022-02773$PIERRE FABRE MEDICAMENT$Bleve C, Conighi ML, Valerio E, Cutrone M, Iannucci G, Segna A et al. Surgical management of large scalp infantile hemangioma in 30-month-old infant. La Pediatria Medica e Chirurgica. 2022;44(279)$30$MON$$F$Y$$$20240712$$HP$IT$IT
240842381$24084238$1$I$$20220330$20240712$20240712$PER$$CA-PFM-2022-02822$PIERRE FABRE MEDICAMENT$Asad I, Lee M, Banihani R, Wong P, Etoom Y. Coarctation of the Aorta in Adolescence Significance of Detailed Cardiac Examination in Pediatric Hypertension. Pediatric Emergency Care. 2021;37(12):e1724-5$15$YR$$M$Y$$$20240712$$HP$CA$CA
240842391$24084239$1$I$$20220331$20240712$20240712$PER$$IL-PFM-2022-02855$PIERRE FABRE MEDICAMENT$Tejman-Yarden S, Katz U, Rubinstein M, Attias Y, Yahia R, Mishali D et al. Inappropriate Shocks and Power Delivery Using Adult Automatic External Defibrillator Pads in a Pediatric Patient. Pediatric Emergency Care. 2021;37(12):e1708-10$2$WK$$M$Y$4$KG$20240712$$HP$IL$IL
240842401$24084240$1$I$$20220328$20240712$20240712$PER$$TR-PFM-2022-02772$PIERRE FABRE MEDICAMENT$Saglam C, Acarbulut I , Celik K. Fatal Blue Rubber Bleb Nevus Syndrome in a Newborn. Erciyes Med J. 2022;44(2):229-31$$$N$F$Y$4.2$KG$20240712$$HP$TR$TR
240842411$24084241$1$I$$20220404$20240712$20240712$PER$$PT-PFM-2022-03012$PIERRE FABRE MEDICAMENT$Magro P, Carvalho N, Anjos R, Neves J. Coronary artery bypass grafting in a child with Kawasaki disease. Revista Portuguesa de Cardiologia 40. 2021;519.e1-519.e4$23$MON$$M$Y$$$20240712$$HP$PT$PT
240842421$24084242$1$I$$20220404$20240712$20240712$PER$$GR-PFM-2022-03061$PIERRE FABRE MEDICAMENT$Papagiannis J, Yang T, Glazer AM, Tisma-Dupanovic S, Avramidis D, Kannankeril PJ et al. Incessant atrial and ventricular tachycardias associated with an SCN5A mutation. Heart Rhythm Case Reports. 2021;7(12):806-11$20$YR$$M$Y$$$20240712$$HP$GR$GR
240842431$24084243$1$I$20240711$20240711$20240712$20240712$PER$$US-TAKEDA-2024TUS070880$TAKEDA$$51$YR$$F$Y$55$KG$20240712$$HP$US$US
240842441$24084244$1$I$$20220331$20240712$20240712$PER$$IT-PFM-2022-02866$PIERRE FABRE MEDICAMENT$Tommaso MD, Delussi M, Gentile E, Ricci K, Quitadamo SG, Libro G. Effect of single dose Erenumab on cortical responses evoked by cutaneous a-delta fibers: A pilot study in migraine patients. Cephalalgia. 2021;41(9):1004-14$42$YR$$M$Y$$$20240712$$HP$IT$IT
240842451$24084245$1$I$$20220331$20240712$20240712$PER$$IT-PFM-2022-02867$PIERRE FABRE MEDICAMENT$Tommaso M, Delussi M, Gentile E, Ricci K, Quitadamo SG, Libro G. Effect of single dose Erenumab on cortical responses evoked by cutaneous a-delta fibers: A pilot study in migraine patients. Cephalalgia. 2021;41(9):1004-014$42$YR$$F$Y$$$20240712$$HP$IT$IT
240842461$24084246$1$I$$20220404$20240712$20240712$PER$$TR-PFM-2022-03078$PIERRE FABRE MEDICAMENT$Demiral M, Kiraz Z, Alatas I, Cetin N, Kirel B. Pseudo-hyperthyroidism: Biotine interference in a case with renal failure. Acta Endocrinologica (Buc). 2021;17(3):319-22$7$MON$$M$Y$6$KG$20240712$$HP$TR$TR
240842471$24084247$1$I$$20240710$20240712$20240712$PER$$US-TAKEDA-2024TUS070675$TAKEDA$$25$YR$$M$Y$86$KG$20240712$$CN$US$US
240842481$24084248$1$I$20240710$20240711$20240711$20240711$DIR$709903$$FDA-CTU$$54$YR$$F$N$89.55$KG$20240711$N$PH$US$
240842491$24084249$1$I$$20220404$20240712$20240712$PER$$TR-PFM-2022-03072$PIERRE FABRE MEDICAMENT$Cetin M, Aydin AA, Karaman K. Everolimus treatment in a 3-month-old infant with tuberous sclerosis complex cardiac rhabdomyoma, severe leftventricular outflow tract obstruction, and hearing loss. Cardiology in the Young. 2021;31:1359-62$3$MON$$M$Y$7$KG$20240712$$HP$TR$TR
240842501$24084250$1$I$$20220407$20240712$20240712$PER$$CA-PFM-2022-03126$PIERRE FABRE MEDICAMENT$De Vloo P, Boutet A, Elias GJB, Gramer RM, Joel SE, Llinas M et al. Dysgeusia induced and resolved by focused ultrasound thalamotomy: case report. J Neurosurg. 2022;136(1):215-20$75$YR$$M$Y$$$20240712$$HP$CA$CA
240842511$24084251$1$I$20231201$20240703$20240712$20240712$EXP$$AT-ROCHE-10000024117$ROCHE$$40$YR$A$F$Y$$$20240712$$MD$AT$AT
240842531$24084253$1$I$20240208$20240705$20240712$20240712$EXP$GB-MHRA-MED-202402201506028870-TZHML$GB-ROCHE-10000019416$ROCHE$$78$YR$E$M$Y$59$KG$20240712$$HP$GB$GB
240842542$24084254$2$F$20240707$20240814$20240712$20240826$EXP$$US-AstraZeneca-2024A156034$ASTRAZENECA$$34641$DY$$F$Y$$$20240826$$CN$US$
240842551$24084255$1$I$20220131$20240703$20240712$20240712$EXP$$JP-EMD Serono-2024036906$EMD SERONO INC$Kimura N, Miyamoto S, Bamba D, Kurozumi A, Amiya Y, Shima T. The 74th Annual Meeting of West Japan Urological Association Abstracts. 2022;11-197.$77$YR$E$M$Y$54$KG$20240712$$MD$JP$JP
240842561$24084256$1$I$$20240619$20240712$20240712$PER$$US-BAYER-2024A099245$BAYER$VuTicar N.Gupta M. Chryseobacterium: A Critical Conundrum. American Journal of Respiratory and Critical Care Medicine. 2024;209$50$YR$A$F$Y$$$20240712$$HP$US$US
240842573$24084257$3$F$$20240707$20240712$20240716$30DAY$$US-PFIZER INC-PV202400090156$PFIZER$$26$YR$$F$Y$$$20240716$$CN$US$US
240842581$24084258$1$I$20220101$20240702$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407003073$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240712$$CN$US$US
240842601$24084260$1$I$20240624$20240630$20240712$20240712$EXP$GB-MHRA-MED-202406301351350370-QLPGZ$GB-ELI_LILLY_AND_COMPANY-GB202407003154$ELI LILLY AND CO$$37$YR$A$F$Y$87$KG$20240712$$CN$GB$GB
240842621$24084262$1$I$$20240701$20240712$20240712$EXP$GB-MHRA-MED-202407011500551400-PZCRF$GB-ELI_LILLY_AND_COMPANY-GB202407003200$ELI LILLY AND CO$$$$$F$Y$$$20240712$$CN$GB$GB
240842631$24084263$1$I$$20240709$20240712$20240712$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407007130$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240712$$CN$JP$JP
240842641$24084264$1$I$$20240705$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004819$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240712$$CN$US$US
240842651$24084265$1$I$20240628$20240701$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407001426$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240712$$CN$US$US
240842662$24084266$2$F$20240517$20240830$20240712$20240910$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407001864$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240910$$CN$JP$JP
240842671$24084267$1$I$$20240709$20240712$20240712$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202407005864$ELI LILLY AND CO$$$$$F$Y$$$20240712$$PH$ES$ES
240842681$24084268$1$I$$20240702$20240712$20240712$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407002958$ELI LILLY AND CO$$78$YR$E$F$Y$60$KG$20240712$$CN$CN$CN
240842691$24084269$1$I$$20240702$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407001917$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240712$$CN$US$US
240842701$24084270$1$I$$20240702$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002517$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240712$$HP$US$US
240842721$24084272$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007248$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240712$$CN$US$US
240842731$24084273$1$I$20240619$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007315$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240712$$CN$US$US
240842751$24084275$1$I$$20220411$20240712$20240712$PER$$ES-PFM-2022-03282$PIERRE FABRE MEDICAMENT$Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves^ disease after COVID-19. Journal of Endocrinological Investigation. 2020;43 (10):1527-8$60$YR$$F$Y$$$20240712$$HP$ES$ES
240842761$24084276$1$I$$20220411$20240712$20240712$PER$$ES-PFM-2022-03283$PIERRE FABRE MEDICAMENT$Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves^ disease after COVID-19. Journal of Endocrinological Investigation. 2020;43:1527-528$53$YR$$F$Y$$$20240712$$HP$ES$ES
240842771$24084277$1$I$$20220411$20240712$20240712$PER$$JP-PFM-2022-03302$PIERRE FABRE MEDICAMENT$Suzuki T, Saito K, Yoshikawa T, Hirono K, Hata Y, Nishida N et al. A double heterozygous variant in MYH6 and MYH7 associated with hypertrophic cardiomyopathy in a Japanese Family. Journal of Cardiology Cases. 2022;25:213-17$7$YR$$M$Y$$$20240712$$HP$JP$JP
240842781$24084278$1$I$$20220411$20240712$20240712$PER$$JP-PFM-2022-03300$PIERRE FABRE MEDICAMENT$Suzuki T, Saito K, Yoshikawa T, Hirono K, Hata Y, Nishida N et al. A double heterozygous variant in MYH6 and MYH7 associated with hypertrophic cardiomyopathy in a Japanese Family. Journal of Cardiology Cases. 2022;25:213-7$13$YR$$M$Y$$$20240712$$HP$JP$JP
240842791$24084279$1$I$$20220419$20240712$20240712$PER$$PT-PFM-2022-03745$PIERRE FABRE MEDICAMENT$Santos M, Mendes GJ, Pinto AN, Coutinho MB, Sousa CA. Hemangioma of the Internal Auditory Canal and PHACES Syndrome: A Rare Finding in a Rare Syndrome. Imaging Clinic. 2020;99(3):192-3$1$YR$$F$Y$$$20240712$$HP$PT$PT
240842801$24084280$1$I$$20220419$20240712$20240712$PER$$CA-PFM-2022-03746$PIERRE FABRE MEDICAMENT$Kost K, Parham K, Tewfik M, AlSuliman YA. In-office sinonasal procedures in the elderly. Ear Nose Throat J. 2018;97(12):392-3$75$YR$$F$Y$$$20240712$$HP$CA$CA
240842811$24084281$1$I$$20220419$20240712$20240712$PER$$TR-PFM-2022-03738$PIERRE FABRE MEDICAMENT$Guvenc O, Karaer K, Haydin S, Guzeltas A, Ergul Y. Implantation of cardiac defibrillator in an infant with hypertrophic cardiomyopathy and newly identified mybp3 mutation. Turk Pediatri Ars. 2020;55(3):304-08$1$YR$$M$Y$$$20240712$$HP$TR$TR
240842821$24084282$1$I$20230516$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217149$TEVA$$$$A$M$Y$$$20240712$$HP$KR$KR
240842831$24084283$1$I$$20220419$20240712$20240712$PER$$NL-PFM-2022-03736$PIERRE FABRE MEDICAMENT$Swinnen BE, Boeree T, Rootselaar AFV. Steam train sign in slow orthostatic tremor. Mov Disord Clin Pract. 2022;9(3):410$57$YR$$F$Y$$$20240712$$HP$NL$NL
240842841$24084284$1$I$$20220419$20240712$20240712$PER$$CA-PFM-2022-03728$PIERRE FABRE MEDICAMENT$Aly S, Aguet J, Dragulescu A, Grosse-Wortmann L. Neonatal Myocardial Infarction in Association With Gestational Diabetes. Canadian Journal of Cardiology. 2021;37:2083-86$7$DY$$F$Y$$$20240712$$HP$CA$CA
240842851$24084285$1$I$$20220419$20240712$20240712$PER$$JP-PFM-2022-03735$PIERRE FABRE MEDICAMENT$Suzuki A, Kobayashi R, Shirata T, Komoriya H, Kanoto M, Otani K. Case Report: Changes in Regional Cerebral Blood Flow in Chronic Akathisia of a Depressed Patient Before and After Electroconvulsive Therapy Treatment. Frontiers in Psychiatry. 2021;12$66$YR$$F$Y$$$20240712$$HP$JP$JP
240842861$24084286$1$I$$20220419$20240712$20240712$PER$$JP-PFM-2022-03719$PIERRE FABRE MEDICAMENT$Ishida M, Yukawa J, Taniyama K, Ogawa S, Shibutani T. Case report of an autism patient who was diagnosed as having basedow^s disease because of tachycardia during general anesthesia. Journal of Japanese Dental Society of Anesthesiology. 2018;46(1):46-8$7$YR$$F$Y$$$20240712$$HP$JP$JP
240842871$24084287$1$I$$20220419$20240712$20240712$PER$$CA-PFM-2022-03715$PIERRE FABRE MEDICAMENT$Cheung CC, Roston TM, Davies B, Grewal J, Laksman ZW, Krahn AD. Process of Care and a Practical Toolkit for Evaluating and Managing Arrhythmic Risk in the Cardiogenetic Pregnant Patient. Canadian Journal of Cardiology. 2021;37(12):2001-013$21$YR$$F$Y$$$20240712$$HP$CA$CA
240842883$24084288$3$F$20240628$20240801$20240712$20240806$EXP$$LB-AMERICAN REGENT INC-2024002647$AMERICAN REGENT$$38$YR$$F$Y$$$20240806$$MD$LB$LB
240842891$24084289$1$I$$20240620$20240712$20240712$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001012$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240842901$24084290$1$I$$20240710$20240712$20240712$PER$$US-JNJFOC-20240729190$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$MD$US$US
240842911$24084291$1$I$$20240708$20240712$20240712$EXP$$US-JNJFOC-20240660593$JOHNSON AND JOHNSON$$$$$F$Y$57.3$KG$20240712$$HP$US$US
240842921$24084292$1$I$20240602$20240704$20240712$20240712$EXP$$IT-EMD Serono-2024037569$EMD SERONO INC$$74$YR$E$F$Y$$$20240712$$MD$IT$IT
240842931$24084293$1$I$20240629$20240702$20240712$20240712$EXP$$EG-HIKMA PHARMACEUTICALS USA INC.-EG-H14001-24-06184$HIKMA$$$$$$Y$$$20240712$$PH$EG$EG
240842942$24084294$2$F$$20240703$20240712$20240716$PER$$CA-BEH-2024175129$CSL BEHRING$$64$YR$A$M$Y$84$KG$20240716$$CN$CA$CA
240842961$24084296$1$I$20231108$20240711$20240711$20240711$DIR$709955$$FDA-CTU$$41$YR$$M$N$$$20240711$N$HP$US$
240842971$24084297$1$I$20240711$20240711$20240711$20240711$DIR$709956$$FDA-CTU$$$$$UNK$N$$$20240711$N$HP$US$
240842981$24084298$1$I$20240711$20240711$20240711$20240711$DIR$709957$$FDA-CTU$$69$YR$$F$N$$$20240711$N$HP$US$
240842991$24084299$1$I$20240503$20240711$20240711$20240711$DIR$709960$$FDA-CTU$$50$YR$$M$N$63$KG$20240711$N$CN$US$
240843021$24084302$1$I$20221230$20240711$20240711$20240711$DIR$709958$$FDA-CTU$$46$YR$$F$N$68.6$KG$20240711$N$$US$
240843031$24084303$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48277$$FDA-CTU$$$$$F$N$$$20240711$N$HP$US$
240843041$24084304$1$I$20240515$20240711$20240711$20240711$DIR$709969$$FDA-CTU$$71$YR$$M$N$81$KG$20240711$N$MD$US$
240843051$24084305$1$I$20240703$20240711$20240711$20240711$DIR$709967$$FDA-CTU$$64$YR$$M$N$$$20240711$N$PH$US$
240843081$24084308$1$I$20230703$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217386$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240843091$24084309$1$I$$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137775$AMGEN$$$$E$F$Y$$$20240712$$CN$US$US
240843101$24084310$1$I$20221229$20240701$20240712$20240712$EXP$FR-AFSSAPS-AM2023000272$FR-ROCHE-10000020067$ROCHE$$46$YR$A$F$Y$73$KG$20240712$$MD$FR$FR
240843111$24084311$1$I$$20240708$20240712$20240712$EXP$$US-AMGEN-USASP2024135456$AMGEN$$$$A$F$Y$$$20240712$$CN$US$US
240843121$24084312$1$I$20230629$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217079$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240843131$24084313$1$I$20230502$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217050$TEVA$$$$E$F$Y$$$20240712$$HP$KR$KR
240843141$24084314$1$I$20240101$20240706$20240712$20240712$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-096426$REGENERON$$78$YR$$F$Y$$$20240712$$HP$CO$CO
240843152$24084315$2$F$20240629$20240712$20240712$20240731$PER$$CN-Blueprint Medicines Corporation-SP-CN-2024-001405$BLUEPRINT MEDICINES$$67$YR$E$F$Y$$$20240731$$CN$CN$CN
240843161$24084316$1$I$$20240705$20240712$20240712$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001380$BLUEPRINT MEDICINES$$$$$F$Y$$$20240712$$CN$US$US
240843171$24084317$1$I$$20240710$20240712$20240712$PER$$US-JNJFOC-20240727278$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$CN$US$US
240843181$24084318$1$I$20240409$20240711$20240711$20240711$DIR$709968$$FDA-CTU$$27$YR$$F$N$42.75$KG$20240711$N$CN$US$
240843191$24084319$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48253$$FDA-CTU$$74$YR$$M$N$$$20240711$N$$US$
240843211$24084321$1$I$$20240628$20240712$20240712$EXP$$IN-ROCHE-10000014225$ROCHE$$44$YR$A$M$Y$$$20240712$$CN$IN$IN
240843231$24084323$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48260$$FDA-CTU$$50$YR$$F$N$0$KG$20240711$N$HP$US$
240843241$24084324$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48255$$FDA-CTU$$51$YR$$F$N$97.98$KG$20240711$N$$US$
240843251$24084325$1$I$$20240711$20240712$20240712$PER$$US-TAKEDA-2024TUS070910$TAKEDA$$$$$F$Y$86$KG$20240712$$MD$US$US
240843261$24084326$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48266$$FDA-CTU$$69$YR$$F$N$74.84$KG$20240711$N$$US$
240843271$24084327$1$I$$20240703$20240712$20240712$EXP$PT-EMA-DD-20240627-7482689-103215$PT-EMD Serono-2024036228$EMD SERONO INC$Alexandre I, Carvalho J, Anselmo M, Freitas P, Coelho S. it possible to survive 1.9 bicarbonate -A case of lactic acidosis associated with metformin. Portuguese Kidney Journal. 2024 Jan;38(Supp 1): 180-190.$80$YR$E$M$Y$$$20240712$$MD$PT$PT
240843291$24084329$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48248$$FDA-CTU$$72$YR$$F$N$$$20240711$N$$US$
240843302$24084330$2$F$20240610$20240710$20240712$20240718$EXP$$JP-UROVANT SCIENCES GMBH-202407-URV-000995$UROVANT SCIENCES$$82$YR$$M$Y$$$20240718$$MD$JP$JP
240843311$24084331$1$I$$20240703$20240712$20240712$PER$$US-UROVANT SCIENCES GMBH-202406-URV-000820$UROVANT SCIENCES$$$$$M$Y$$$20240712$$CN$US$US
240843321$24084332$1$I$20240614$20240703$20240712$20240712$EXP$$US-BEH-2024175291$CSL BEHRING$$77$YR$E$M$Y$$$20240712$$HP$US$US
240843332$24084333$2$F$$20240711$20240712$20240724$EXP$$JP-UCBSA-2024034045$UCB$Isahaya K, et al. A Female Case of Anti-NMDA Receptor Encephalitis with Marked Psychiatric Symptoms. The 18th Regional Meeting of the Japan Epilepsy Society in the Kanto-Koshinetsu. 2024$31$YR$$F$Y$$$20240724$$MD$JP$JP
240843341$24084334$1$I$20240627$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48267$$FDA-CTU$$1$YR$$M$N$$$20240711$N$PH$US$
240843351$24084335$1$I$$20240709$20240712$20240712$PER$$US-HALEON-2186651$Haleon PLC$$$$$F$Y$$$20240712$$CN$US$US
240843361$24084336$1$I$$20240705$20240712$20240712$EXP$$US-UROVANT SCIENCES GMBH-202407-URV-000993$UROVANT SCIENCES$$$$$F$Y$74.83$KG$20240712$$CN$US$US
240843371$24084337$1$I$20240518$20240711$20240711$20240711$DIR$709934$$FDA-CTU$$62$YR$$F$N$100.8$KG$20240711$Y$CN$US$
240843381$24084338$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48268$$FDA-CTU$$76$YR$$F$N$144$LBS$20240711$N$$US$
240843391$24084339$1$I$$20240703$20240712$20240712$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR082896$VIIV$$$$A$F$Y$$$20240712$$CN$US$US
240843401$24084340$1$I$$20240702$20240712$20240712$PER$$US-MYLANLABS-2024M1064638$MYLAN$$$$$F$Y$$$20240712$$CN$US$US
240843411$24084341$1$I$$20240701$20240712$20240712$EXP$$US-VKT-000564$VKT PHARMA PRIVATE LIMITED$$18$DY$N$M$Y$$$20240703$$MD$US$US
240843421$24084342$1$I$20240414$20240702$20240712$20240712$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0600931$MYOVANT SCIENCES$$67$YR$$M$Y$$$20240712$$CN$US$US
240843431$24084343$1$I$20240601$20240702$20240712$20240712$EXP$DE-BFARM-24004656$DE-Accord-433775$ACCORD$$89$YR$E$F$Y$$$20240712$$MD$DE$DE
240843441$24084344$1$I$$20240703$20240712$20240712$EXP$$PL-EXELIXIS-CABO-24079365$EXELIXIS$Lompart, J.. Long-term efficacy of cabozantinib in second-line palliative systemic therapy for an elderly patient with hepatocellular carcinoma.$79$YR$$M$Y$$$20240712$$MD$PL$PL
240843452$24084345$2$F$$20240812$20240712$20240816$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000599$PAREXEL$$$$$$Y$$$20240816$$MD$CN$CN
240843461$24084346$1$I$$20240709$20240712$20240712$PER$$US-ALXN-202407USA000545US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240712$$PH$US$US
240843471$24084347$1$I$20210317$20240702$20240712$20240712$EXP$FR-AFSSAPS-MA2024001144$FR-Accord-434080$ACCORD$$70$YR$E$F$Y$$$20240712$$PH$FR$FR
240843481$24084348$1$I$20240701$20240702$20240712$20240712$EXP$GB-MHRA-MED-202407021541570960-BRCNP$GB-Accord-434295$ACCORD$$48$YR$A$F$Y$$$20240712$$HP$GB$GB
240843492$24084349$2$F$$20240715$20240712$20240724$EXP$$JP-Accord-433933$ACCORD$Nakamoto K, Horimasu Y, Yamaguchi K, Sakamoto S, Masuda T, Miyamoto S, et al. Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases. Internal Medicine. 2024;63(12):1783-87. DOI: 10.2169/internalmedicine.2387-23.$63$YR$A$M$Y$70$KG$20240724$$MD$JP$JP
240843501$24084350$1$I$20240620$20240701$20240712$20240712$EXP$IT-MINISAL02-993015$IT-Accord-433996$ACCORD$$69$YR$E$F$Y$$$20240712$$MD$IT$IT
240843512$24084351$2$F$20240703$20240809$20240712$20240814$PER$$US-JNJFOC-20240726155$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240814$$PH$US$US
240843522$24084352$2$F$$20240710$20240712$20240717$EXP$$IQ-TAKEDA-2024TUS070472$TAKEDA$$3$YR$$M$Y$18$KG$20240717$$CN$IQ$IQ
240843531$24084353$1$I$20240101$20240711$20240712$20240712$PER$$US-ABBVIE-5836880$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240843541$24084354$1$I$20210101$20240704$20240712$20240712$EXP$$RO-EMD Serono-2024036849$EMD SERONO INC$Chioveanu ZI. ENDOGENOUS HYPERINSULINISM DUE TO A PANCREATIC TUMOR MANIFESTED AS SEVERE RECURRENT HYPOGLYCEMIA - A CASE REPORT.. ACTA MEDICA MARISIENSIS. 2024;70(Supplem 3): 308.$66$YR$E$F$Y$$$20240712$$MD$RO$RO
240843552$24084355$2$F$$20240913$20240712$20240916$EXP$$NVSC2024US142912$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
240843561$24084356$1$I$20240319$20240704$20240712$20240712$EXP$FR-AFSSAPS-AVPA2024000621$FR-Waylis Therapeutics LLC-ATNAHS20240701917$Waylis$$47$YR$A$M$Y$$$20240711$$MD$FR$FR
240843571$24084357$1$I$$20240708$20240712$20240712$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13832$IPSEN$$$$$$Y$$$20240712$$HP$US$US
240843581$24084358$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186739$Haleon PLC$$$$$M$Y$$$20240712$$CN$US$US
240843592$24084359$2$F$$20240710$20240712$20240717$EXP$$US-AMGEN-USASP2024137497$AMGEN$$61$YR$A$F$Y$47.25$KG$20240717$$CN$US$US
240843601$24084360$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA201356$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240712$$MD$US$US
240843612$24084361$2$F$$20240709$20240712$20240718$PER$$US-SA-2024SA203495$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240718$$CN$US$US
240843623$24084362$3$F$$20240918$20240712$20240923$30DAY$$JP-PFIZER INC-202400213374$PFIZER$$$$$M$Y$$$20240923$$MD$JP$JP
240843633$24084363$3$F$$20240918$20240712$20240924$30DAY$$JP-PFIZER INC-202400213370$PFIZER$$$$$M$Y$$$20240924$$MD$JP$JP
240843643$24084364$3$F$$20240918$20240712$20240920$30DAY$$JP-PFIZER INC-202400213378$PFIZER$$$$$F$Y$$$20240920$$MD$JP$JP
240843653$24084365$3$F$$20240918$20240712$20240923$30DAY$$JP-PFIZER INC-202400213373$PFIZER$$$$$M$Y$$$20240923$$MD$JP$JP
240843663$24084366$3$F$$20240918$20240712$20240920$30DAY$$JP-PFIZER INC-202400213379$PFIZER$$$$C$$Y$$$20240920$$MD$JP$JP
240843673$24084367$3$F$$20240918$20240712$20240923$30DAY$$JP-PFIZER INC-202400213376$PFIZER$$$$$F$Y$$$20240923$$MD$JP$JP
240843683$24084368$3$F$$20240918$20240712$20240920$30DAY$$JP-PFIZER INC-202400213377$PFIZER$$$$$F$Y$$$20240920$$MD$JP$JP
240843691$24084369$1$I$$20240709$20240712$20240712$EXP$$AT-PFIZER INC-2023SGN05599$PFIZER$Leser, C.. For HER2-low tumours: new option in a large patient population. Haematology + Oncology. 2023;24-27$43$YR$$F$Y$$$20240712$$MD$AT$AT
240843703$24084370$3$F$$20240918$20240712$20240923$30DAY$$JP-PFIZER INC-202400213375$PFIZER$$$$$F$Y$$$20240923$$MD$JP$JP
240843711$24084371$1$I$20210701$20240702$20240712$20240712$EXP$$CH-ENDO USA, INC.-2024-002853$ENDO$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al.. Unhappy Hearts with the Antidepressant Venlafaxine. Swiss Medical Weekly. 2024;154 (Suppl 278):63S-64S$52$YR$$F$Y$$$20240712$$HP$CH$CH
240843721$24084372$1$I$$20240702$20240712$20240712$EXP$$CH-ENDO USA, INC.-2024-002851$ENDO$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al.. Unhappy Hearts with the Antidepressant Venlafaxine. Swiss Medical Weekly. 2024;154 (Suppl 278):63S-64S$82$YR$$M$Y$$$20240712$$HP$CH$CH
240843731$24084373$1$I$20230501$20240702$20240712$20240712$EXP$$CH-ENDO USA, INC.-2024-002854$ENDO$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al.. Unhappy Hearts with the Antidepressant Venlafaxine. Swiss Medical Weekly. 2024;154 (Suppl 278):63S-64S$51$YR$$F$Y$$$20240712$$HP$CH$CH
240843741$24084374$1$I$$20240702$20240712$20240712$EXP$$CH-ENDO USA, INC.-2024-002852$ENDO$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al.. Unhappy Hearts with the Antidepressant Venlafaxine. Swiss Medical Weekly. 2024;154 (Suppl 278):63S-64S$77$YR$$F$Y$$$20240712$$HP$CH$CH
240843753$24084375$3$F$$20240918$20240712$20240923$30DAY$$JP-PFIZER INC-202400213380$PFIZER$$$$C$$Y$$$20240923$$MD$JP$JP
240843763$24084376$3$F$$20240918$20240712$20240923$30DAY$$JP-PFIZER INC-202400213371$PFIZER$$$$$M$Y$$$20240923$$MD$JP$JP
240843773$24084377$3$F$$20240918$20240712$20240923$30DAY$$JP-PFIZER INC-202400210261$PFIZER$$$$$M$Y$$$20240923$$MD$JP$JP
240843783$24084378$3$F$$20240918$20240712$20240923$30DAY$$JP-PFIZER INC-202400213372$PFIZER$$$$$M$Y$$$20240923$$MD$JP$JP
240843791$24084379$1$I$20240620$20240620$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001713$ACADIA PHARMACEUTICALS$$60$YR$$F$Y$$$20240712$$CN$US$US
240843801$24084380$1$I$20240711$20240711$20240712$20240712$PER$$US-JNJFOC-20240730225$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240712$$PH$US$US
240843813$24084381$3$F$$20240904$20240712$20240913$EXP$$IT-CELLTRION INC.-2024IT005013$CELLTRION$$$$$$Y$$$20240913$$MD$IT$IT
240843821$24084382$1$I$20240404$20240710$20240712$20240712$EXP$FR-AFSSAPS-LM2024000300$FR-TAKEDA-2024TUS070934$TAKEDA$$61$YR$$F$Y$$$20240712$$HP$FR$FR
240843831$24084383$1$I$$20240710$20240712$20240712$PER$$US-JNJFOC-20240726973$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240843841$24084384$1$I$$20240710$20240712$20240712$EXP$$CO-SERVIER-S24008765$SERVIER$$$$$$Y$$$20240712$$MD$CO$CO
240843851$24084385$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111045$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$99.34$KG$20240712$$CN$US$US
240843861$24084386$1$I$$20240701$20240712$20240712$EXP$$US-VKT-000563$VKT PHARMA PRIVATE LIMITED$$3$DY$N$F$Y$$$20240703$$MD$US$US
240843882$24084388$2$F$20231214$20240805$20240712$20240813$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-096311$REGENERON$$65$YR$$F$Y$$$20240813$$MD$CH$CH
240843891$24084389$1$I$20240614$20240709$20240712$20240712$EXP$$US-BIOGEN-2024BI01272992$BIOGEN$$65$YR$$M$Y$$$20240712$$CN$US$US
240843902$24084390$2$F$$20240724$20240712$20240730$EXP$$FR-BIOGEN-2024BI01273303$BIOGEN$S F, L A. TYSABRI,PLEGRIDY (natalizumab ((MAMMIFERE/SOURIS/CELLULES NSO)),p?ginterf?ron b?ta-1a ((MAMMIFERE/HAMSTER/CELLULES CHO))) Splenic marginal zone lymphoma. ANSM.$$$$F$Y$$$20240730$$HP$FR$FR
240843911$24084391$1$I$20240605$20240704$20240712$20240712$EXP$FR-AFSSAPS-AVTO2024000103$FR-Waylis Therapeutics LLC-ATNAHS20240701916$Waylis$$31$YR$A$M$Y$$$20240711$$MD$FR$FR
240843921$24084392$1$I$20240418$20240419$20240712$20240712$PER$$US-AMGEN-USASP2024137952$AMGEN$$67$YR$E$F$Y$$$20240712$$CN$US$US
240843931$24084393$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834826$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240843951$24084395$1$I$$20240712$20240712$20240712$EXP$$GR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039478$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240712$$MD$GR$GR
240843961$24084396$1$I$20240101$20240705$20240712$20240712$EXP$$US-009507513-2407USA003252$MERCK$$$$$F$Y$$$20240712$$CN$US$US
240843981$24084398$1$I$20240603$20240704$20240712$20240712$EXP$IT-MINISAL02-992405$IT-TEVA-VS-3217565$TEVA$$69$YR$$M$Y$69$KG$20240712$$MD$IT$IT
240843991$24084399$1$I$$20240711$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007818$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240712$$CN$US$US
240844001$24084400$1$I$20240527$20240702$20240712$20240712$EXP$$EG-HIKMA PHARMACEUTICALS USA INC.-EG-H14001-24-06180$HIKMA$$$$$$Y$$$20240712$$HP$EG$EG
240844021$24084402$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA200965$SANOFI AVENTIS$$$$$F$Y$$$20240712$$MD$US$US
240844031$24084403$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006861$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240712$$CN$US$US
240844041$24084404$1$I$$20240709$20240712$20240712$PER$$US-SA-2024SA203988$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240712$$MD$US$US
240844051$24084405$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA198612$SANOFI AVENTIS$$$$$F$Y$$$20240712$$CN$US$US
240844061$24084406$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA202547$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240712$$CN$US$US
240844071$24084407$1$I$20240101$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110660$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240712$$CN$US$US
240844081$24084408$1$I$20240530$20240703$20240712$20240712$EXP$PT-INFARMED-T202405-1013$PT-Atnahs Limited-ATNAHS20240701990$Atnahs Healthcare$$42$YR$A$F$Y$70$KG$20240712$$MD$PT$PT
240844091$24084409$1$I$$20240710$20240712$20240712$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-110697$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240712$$CN$PR$PR
240844101$24084410$1$I$20240601$20240710$20240712$20240712$PER$$US-JNJFOC-20240726751$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240712$$CN$US$US
240844112$24084411$2$F$$20240729$20240712$20240802$PER$$US-JNJFOC-20240727637$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$CN$US$US
240844121$24084412$1$I$$20211213$20240712$20240712$PER$$ES-PFM-2022-02213$PIERRE FABRE MEDICAMENT$Duarte Torres, J, Marschall A, Fraile Sanz C, Rod?l BB, Del Castillo Carnevali H, Sanchez DM. Ventricular tachycardia secondary to thyrotoxic periodic paralysis: A case report. Journal of Electrocardiology. 2021;67:107-09$32$YR$$M$Y$$$20240712$$HP$ES$ES
240844131$24084413$1$I$20240320$20240709$20240712$20240712$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-13763$IPSEN$$12$YR$T$F$Y$24$KG$20240712$$MD$US$US
240844141$24084414$1$I$$20240710$20240712$20240712$EXP$$AU-GILEAD-2024-0680352$GILEAD$$$$E$M$Y$$$20240712$$HP$AU$AU
240844151$24084415$1$I$$20240627$20240712$20240712$EXP$$IN-ROCHE-10000024611$ROCHE$$$$$$Y$$$20240712$$MD$IN$IN
240844161$24084416$1$I$$20211217$20240712$20240712$PER$$IT-PFM-2022-02211$PIERRE FABRE MEDICAMENT$Pique M, Brasili L, Putoto G, Lughetti L. Children with tetralogy of fallot exhibit bluish skin during episodes of crying or feeding. Supplied by british library. 2021;527-8$1$YR$$F$Y$$$20240712$$HP$IT$IT
240844171$24084417$1$I$$20211220$20240712$20240712$PER$$ES-PFM-2022-02215$PIERRE FABRE MEDICAMENT$Casanova OB, Gomez FN, Quesada JI, De Anda RM, Pena RD, Rey MF et al. Application of infrared thermography as a complementary technique to conventional imaging techniques in paediatrics: case studies. Computer Methods in Biomechanics and Biomedical Engineering. 2019;7:643-50$6$MON$$F$Y$$$20240712$$HP$ES$ES
240844181$24084418$1$I$20220101$20220210$20240712$20240712$PER$$FR-PFM-2022-01211$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$$$20240712$$MD$FR$FR
240844191$24084419$1$I$$20220214$20240712$20240712$PER$$PT-PFM-2022-01386$PIERRE FABRE MEDICAMENT$Verissimo D, Fernandes AC, Duarte AF, Lopes L. Graves Ophthalmopathy in Pediatric Age: Different Severities, Different Approaches. The 56th annual meeting online. 2021$7$YR$$M$Y$$$20240712$$HP$PT$PT
240844201$24084420$1$I$$20220214$20240712$20240712$PER$$TR-PFM-2022-01387$PIERRE FABRE MEDICAMENT$F. Kilci, J. Jones, FM. Cizmecioglu Jones. Recurrent fractures in a child with Graves^ disease. ESPE 59th annual meeting online. 2021$10$YR$$M$Y$45$KG$20240712$$HP$TR$TR
240844211$24084421$1$I$$20220214$20240712$20240712$PER$$TR-PFM-2022-01434$PIERRE FABRE MEDICAMENT$Demircioglu D, Durmaz EO. ^Polka dot^ appearance on the face. J Dtsch Dermatol Ges. 2022;20(1):114-6$41$YR$$M$Y$$$20240712$$HP$TR$TR
240844221$24084422$1$I$$20240704$20240712$20240712$EXP$$CA-TEVA-VS-3219614$TEVA$$87$YR$$M$Y$91$KG$20240712$$PH$CA$CA
240844231$24084423$1$I$20210701$20220217$20240712$20240712$PER$FR-AFSSAPS-SE20220219$FR-PFM-2022-01437$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240712$$MD$FR$FR
240844241$24084424$1$I$20220206$20220225$20240712$20240712$PER$$JP-PFM-2022-01185$PIERRE FABRE MEDICAMENT$$5$MON$$F$Y$$$20240712$$PH$JP$JP
240844251$24084425$1$I$20240229$20240701$20240712$20240712$EXP$IT-MINISAL02-983708$IT-SAMSUNG BIOEPIS-SB-2024-20283$SAMSUNG BIOEPIS$$8$YR$C$M$Y$$$20240712$$MD$IT$IT
240844261$24084426$1$I$$20240621$20240712$20240712$EXP$$BE-INCYTE CORPORATION-2024IN007263$INCYTE$$$$$$Y$$$20240712$$HP$BE$BE
240844272$24084427$2$F$$20240703$20240712$20240726$EXP$$US-BEH-2024175356$CSL BEHRING$$$$A$F$Y$$$20240726$$MD$US$US
240844281$24084428$1$I$$20220214$20240712$20240712$PER$$KR-PFM-2022-01390$PIERRE FABRE MEDICAMENT$Yang HJ, Kim SG, Seo EH, Yoon HJ. Amisulpride withdrawal akathisia responding to aripiprazole with propranolol in frst-onset psychosis: a case report. BMC Psychiatry. 2022;21(1):74$24$YR$$F$Y$$$20240712$$HP$KR$KR
240844291$24084429$1$I$$20220215$20240712$20240712$PER$$CA-PFM-2022-01420$PIERRE FABRE MEDICAMENT$$40$YR$$F$Y$$$20240712$$MD$CA$CA
240844301$24084430$1$I$$20220215$20240712$20240712$PER$$CA-PFM-2022-01421$PIERRE FABRE MEDICAMENT$$60$YR$$M$Y$$$20240712$$MD$CA$CA
240844311$24084431$1$I$$20220215$20240712$20240712$PER$$CA-PFM-2022-01423$PIERRE FABRE MEDICAMENT$$23$YR$$F$Y$$$20240712$$MD$CA$CA
240844321$24084432$1$I$$20220215$20240712$20240712$PER$$CA-PFM-2022-01422$PIERRE FABRE MEDICAMENT$$29$YR$$F$Y$$$20240712$$MD$CA$CA
240844331$24084433$1$I$$20220215$20240712$20240712$PER$$CA-PFM-2022-01425$PIERRE FABRE MEDICAMENT$$36$YR$$F$Y$$$20240712$$MD$CA$CA
240844341$24084434$1$I$$20220215$20240712$20240712$PER$$CA-PFM-2022-01424$PIERRE FABRE MEDICAMENT$$66$YR$$F$Y$$$20240712$$MD$CA$CA
240844351$24084435$1$I$20240501$20240708$20240712$20240712$EXP$SE-SEMPA-2024-005253$SE-BAYER-2024A098189$BAYER$$25$YR$A$F$Y$$$20240712$$MD$SE$SE
240844361$24084436$1$I$$20220224$20240712$20240712$PER$$JP-PFM-2022-01547$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$PH$JP$JP
240844371$24084437$1$I$$20220302$20240712$20240712$PER$$JP-PFM-2022-02030$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240712$$MD$JP$JP
240844381$24084438$1$I$20220208$20220406$20240712$20240712$PER$$JP-PFM-2022-01771$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240712$$PH$JP$JP
240844401$24084440$1$I$$20220217$20240712$20240712$PER$$TR-PFM-2022-01445$PIERRE FABRE MEDICAMENT$Kavurt AV, Ece I, Bagrul D. Transcatheter closure of post-operative type 1 Gerbode defect by Amplatzer Duct Occluder 2. Cardiology in the Young. 2021;31:1545-547$7$YR$$F$Y$$$20240712$$HP$TR$TR
240844411$24084441$1$I$$20240704$20240712$20240712$EXP$$DE-ABBVIE-5837211$ABBVIE$$$$A$F$Y$$$20240712$$PH$DE$DE
240844422$24084442$2$F$$20240725$20240712$20240731$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-132714$DAIICHI$$9$DEC$$F$Y$$$20240731$$MD$JP$JP
240844431$24084443$1$I$$20220303$20240712$20240712$PER$$JP-PFM-2022-02041$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240712$$MD$JP$JP
240844441$24084444$1$I$20240319$20240708$20240712$20240712$EXP$FR-AFSSAPS-RE2024000646$FR-009507513-2407FRA003461$MERCK$$84$YR$$M$Y$92$KG$20240712$$MD$FR$FR
240844451$24084445$1$I$$20240630$20240712$20240712$PER$$US-JNJFOC-20240706687$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240844464$24084446$4$F$20240710$20240812$20240712$20240813$PER$$US-AMGEN-USASP2024137806$AMGEN$$$$$F$Y$$$20240813$$PH$US$US
240844471$24084447$1$I$20230327$20240704$20240712$20240712$EXP$FR-AFSSAPS-NY2024000745$FR-AMGEN-FRASP2024133029$AMGEN$$57$YR$A$M$Y$107$KG$20240712$$MD$FR$FR
240844481$24084448$1$I$20240328$20240701$20240712$20240712$EXP$IT-MINISAL02-983606$IT-SAMSUNG BIOEPIS-SB-2024-20419$SAMSUNG BIOEPIS$$57$YR$$F$Y$$$20240712$$MD$IT$IT
240844491$24084449$1$I$20240408$20240708$20240712$20240712$EXP$$AE-BAYER-2024A098455$BAYER$$38$YR$A$F$Y$$$20240712$$CN$AE$AE
240844501$24084450$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48262$$FDA-CTU$$36$YR$$F$N$$$20240711$N$$US$
240844511$24084451$1$I$$20240703$20240712$20240712$EXP$$DE-ABBVIE-5835141$ABBVIE$$$$$F$Y$$$20240712$$CN$DE$DE
240844521$24084452$1$I$20211219$20220304$20240712$20240712$PER$FR-AFSSAPS-DJ20220498$FR-PFM-2022-01894$PIERRE FABRE MEDICAMENT$$9$MON$$F$Y$9$KG$20240712$$MD$FR$FR
240844531$24084453$1$I$$20220307$20240712$20240712$PER$$PT-PFM-2022-02044$PIERRE FABRE MEDICAMENT$Neves JS, Teles L, Oliveira SC, Souteiro P, Varela A, Oliveira AI, et al. Thyrotoxic hypokalemic periodic paralysis as presentation of graves disease in a caucasian male patient. European Thyroid Journal. 2017;6(1):89$25$YR$$M$Y$$$20240712$$HP$PT$PT
240844541$24084454$1$I$$20220307$20240712$20240712$PER$$IT-PFM-2022-02012$PIERRE FABRE MEDICAMENT$Codazzi CA, Ippolito R, Novara C, Tondina E, Cerbo RM, Tzialla C. Hypertrophic cardiomyopathy in infant newborns of diabetic mother: a heterogeneous condition, the importance of anamnesis, physical examination and follow-up. Italian Journal of Pediatrics. 2021;47(197):1-6$$$I$F$Y$$$20240712$$HP$IT$IT
240844551$24084455$1$I$20240711$20240711$20240711$20240711$DIR$709980$$FDA-CTU$$45$YR$$F$N$57.6$KG$20240711$N$CN$US$
240844571$24084457$1$I$20220128$20220307$20240712$20240712$PER$FR-AFSSAPS-MP20221261$FR-PFM-2022-02065$PIERRE FABRE MEDICAMENT$$43$YR$$F$Y$$$20240712$$MD$FR$FR
240844581$24084458$1$I$$20240711$20240711$20240711$DIR$709971$$FDA-CTU$$79$YR$$M$N$90$KG$20240711$N$CN$US$
240844591$24084459$1$I$20240301$20240711$20240711$20240711$DIR$709979$$FDA-CTU$$27$YR$$F$N$38.25$KG$20240711$N$CN$PR$
240844601$24084460$1$I$20220109$20220308$20240712$20240712$PER$FR-AFSSAPS-AM20220560$FR-PFM-2022-01981$PIERRE FABRE MEDICAMENT$$68$YR$$M$Y$66$KG$20240712$$PH$FR$FR
240844611$24084461$1$I$$20220307$20240712$20240712$PER$$PT-PFM-2022-02046$PIERRE FABRE MEDICAMENT$Rodrigues P, Correia S, Oliveira MJ. Invasive complete hydatidiform mole as an unsual cause of the hyperthyroidism. European Thyroid Journal. 2019;8 (suppl 1):85-6$53$YR$$F$Y$$$20240712$$HP$PT$PT
240844621$24084462$1$I$20240619$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48308$$FDA-CTU$$93$YR$$F$N$$$20240711$N$$US$
240844631$24084463$1$I$$20220307$20240712$20240712$PER$$CH-PFM-2022-02045$PIERRE FABRE MEDICAMENT$Papadakis G, Lamine F, Christinefi MF, Moschour E, Schneider A, Francois-Regis D et al. Rapid remission of severe graves^ disease without thionamides under glucocorticoid treatment for concomitant autoimmune hepatitis. European Thyroid Journal. 2017;6(1):88$28$YR$$F$Y$$$20240712$$HP$CH$CH
240844641$24084464$1$I$20220221$20220412$20240712$20240712$PER$$JP-PFM-2022-02168$PIERRE FABRE MEDICAMENT$$3$MON$$M$Y$$$20240712$$MD$JP$JP
240844651$24084465$1$I$$20220307$20240712$20240712$PER$$IT-PFM-2022-02014$PIERRE FABRE MEDICAMENT$Codazzi AC, Ippolito R, Novara C, Tondina E, Cerbo RM, Tzialla C. Hypertrophic cardiomyopathy in infant newborns of diabetic mother: a heterogeneous condition, the importance of anamnesis, physical examination and follow-up. Italian Journal of Pediatrics. 2021;47(197):1-6$$$I$F$Y$$$20240712$$HP$IT$IT
240844661$24084466$1$I$$20240709$20240711$20240711$DIR$FDA-CDER-CTU-2024-48257$$FDA-CTU$$$$$F$N$$$20240709$N$HP$US$
240844671$24084467$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48286$$FDA-CTU$$$$$F$N$$$20240711$N$HP$US$
240844681$24084468$1$I$20240711$20240711$20240711$20240711$DIR$709929$$FDA-CTU$$70$YR$$F$N$$$20240711$N$$US$
240844691$24084469$1$I$20240711$20240711$20240711$20240711$DIR$709972$$FDA-CTU$$81$YR$$M$N$$$20240711$Y$$US$
240844711$24084471$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186738$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240844722$24084472$2$F$$20240708$20240712$20240718$EXP$$UY-BAYER-2024A099339$BAYER$$$$$F$Y$$$20240718$$CN$UY$UY
240844731$24084473$1$I$$20240705$20240712$20240712$EXP$$NVSC2024CA141646$NOVARTIS$$$$A$F$Y$$$20240712$$CN$CA$CA
240844741$24084474$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48280$$FDA-CTU$$44$YR$$F$N$$$20240711$N$HP$US$
240844751$24084475$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48264$$FDA-CTU$$70$YR$$M$N$$$20240711$N$HP$US$
240844761$24084476$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48254$$FDA-CTU$$49$YR$$M$N$122.47$KG$20240711$N$HP$US$
240844771$24084477$1$I$$20220309$20240712$20240712$PER$$JP-PFM-2022-02332$PIERRE FABRE MEDICAMENT$$8$MON$$F$Y$$$20240712$$MD$JP$JP
240844781$24084478$1$I$$20220309$20240712$20240712$PER$$JP-PFM-2022-02325$PIERRE FABRE MEDICAMENT$$5$YR$$F$Y$$$20240712$$MD$JP$JP
240844791$24084479$1$I$$20220309$20240712$20240712$PER$$JP-PFM-2022-02322$PIERRE FABRE MEDICAMENT$$4$MON$$F$Y$$$20240712$$MD$JP$JP
240844801$24084480$1$I$$20240711$20240711$20240711$DIR$709974$$FDA-CTU$$27$YR$$M$N$$$20240711$N$MD$US$
240844811$24084481$1$I$20220420$20240711$20240711$20240711$DIR$709950$$FDA-CTU$$47$YR$$F$N$84.9$KG$20240711$N$$US$
240844821$24084482$1$I$$20220314$20240712$20240712$PER$$TR-PFM-2022-02286$PIERRE FABRE MEDICAMENT$Bor M, Ilhan O, Gumus E, Ozkan S, Karaca M. A Newborn with Infantile-Onset Pompe Disease Improving after Administration of Enzyme Replacement Therapy: Case Report. Journal of Pediatric Intensive Care. 2022;11:62-6$$$I$M$Y$$$20240712$$HP$TR$TR
240844831$24084483$1$I$$20220308$20240712$20240712$PER$$FR-PFM-2022-01985$PIERRE FABRE MEDICAMENT$$7$MON$$F$Y$$$20240712$$CN$FR$FR
240844851$24084485$1$I$$20220317$20240712$20240712$PER$$JP-PFM-2022-02642$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$CN$JP$JP
240844861$24084486$1$I$20240601$20240702$20240712$20240712$PER$$US-TEVA-VS-3218005$TEVA$$71$YR$$F$Y$$$20240712$$PH$US$US
240844871$24084487$1$I$$20240710$20240712$20240712$PER$$US-BAYER-2024A099629$BAYER$$47$YR$A$F$Y$$$20240712$$MD$US$US
240844882$24084488$2$F$20240601$20240820$20240712$20240823$PER$$US-AMGEN-USASP2024137557$AMGEN$$73$YR$E$F$Y$$$20240823$$CN$US$US
240844891$24084489$1$I$$20240708$20240712$20240712$PER$$US-ALXN-202407USA000453US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240844901$24084490$1$I$20240601$20240705$20240712$20240712$EXP$$AR-BEH-2024175401$CSL BEHRING$$37$YR$A$F$Y$$$20240712$$CN$AR$AR
240844911$24084491$1$I$$20240710$20240712$20240712$EXP$$CA-UCBSA-2024034956$UCB$$$$$F$Y$$$20240712$$HP$CA$CA
240844921$24084492$1$I$20240708$20240710$20240712$20240712$PER$$US-ABBVIE-5835503$ABBVIE$$35$YR$$F$Y$$$20240712$$HP$US$US
240844936$24084493$6$F$20240516$20240823$20240712$20240830$EXP$$CA-GSK-CA2024042608$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$CA$CA
240844942$24084494$2$F$$20240715$20240712$20240718$EXP$$AU-MYLANLABS-2024M1064903$MYLAN$$$$$M$Y$$$20240718$$PH$AU$AU
240844951$24084495$1$I$20240430$20240704$20240712$20240712$EXP$ES-AEMPS-1540249$ES-TEVA-VS-3217504$TEVA$$83$YR$$F$Y$$$20240712$$HP$ES$ES
240844971$24084497$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111006$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240712$$CN$US$US
240844991$24084499$1$I$$20240711$20240712$20240712$PER$$US-BAYER-2024A100271$BAYER$$19$YR$A$F$Y$$$20240712$$HP$US$US
240845011$24084501$1$I$$20240621$20240712$20240712$EXP$$BE-INCYTE CORPORATION-2024IN007264$INCYTE$$$$$$Y$$$20240712$$HP$BE$BE
240845021$24084502$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186745$Haleon PLC$$$$$F$Y$$$20240712$$CN$US$US
240845033$24084503$3$F$20240710$20240715$20240712$20240723$PER$$US-BAYER-2024A100280$BAYER$$20$YR$A$F$Y$$$20240723$$HP$US$US
240845043$24084504$3$F$$20240725$20240712$20240801$PER$$US-ROCHE-10000020559$ROCHE$$$$E$$Y$$$20240801$$CN$US$US
240845051$24084505$1$I$$20240627$20240712$20240712$EXP$$TH-ROCHE-10000024124$ROCHE$$65$YR$E$M$Y$$$20240712$$CN$TH$TH
240845065$24084506$5$F$20240628$20240902$20240712$20240906$PER$$US-ROCHE-10000024304$ROCHE$$52$YR$A$F$Y$90.72$KG$20240906$$CN$US$US
240845074$24084507$4$F$$20240812$20240712$20240821$PER$$US-ROCHE-10000023410$ROCHE$$$$$F$Y$$$20240821$$CN$US$US
240845081$24084508$1$I$$20220106$20240712$20240712$PER$$JP-PFM-2021-12648$PIERRE FABRE MEDICAMENT$$15$MON$$F$Y$$$20240712$$PH$JP$JP
240845091$24084509$1$I$20200327$20211227$20240712$20240712$PER$ES-AEMPS-1074725$ES-PFM-2021-12657$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$$$20240712$$MD$ES$ES
240845101$24084510$1$I$$20240702$20240712$20240712$EXP$$CH-009507513-2407CHE004719$MERCK$$$$$M$Y$$$20240712$$MD$CH$CH
240845111$24084511$1$I$$20220126$20240712$20240712$PER$$CA-PFM-2022-00793$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240712$$MD$CA$CA
240845121$24084512$1$I$$20220126$20240712$20240712$PER$$CA-PFM-2022-00802$PIERRE FABRE MEDICAMENT$$66$YR$$F$Y$$$20240712$$MD$CA$CA
240845131$24084513$1$I$$20220126$20240712$20240712$PER$$CA-PFM-2022-00805$PIERRE FABRE MEDICAMENT$$65$YR$$F$Y$$$20240712$$MD$CA$CA
240845151$24084515$1$I$$20220126$20240712$20240712$PER$$CA-PFM-2022-00804$PIERRE FABRE MEDICAMENT$$43$YR$$F$Y$$$20240712$$MD$CA$CA
240845161$24084516$1$I$$20220126$20240712$20240712$PER$$CA-PFM-2022-00801$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240712$$MD$CA$CA
240845171$24084517$1$I$$20220126$20240712$20240712$PER$$CA-PFM-2022-00800$PIERRE FABRE MEDICAMENT$$30$YR$$F$Y$$$20240712$$MD$CA$CA
240845181$24084518$1$I$$20220126$20240712$20240712$PER$$CA-PFM-2022-00799$PIERRE FABRE MEDICAMENT$$58$YR$$F$Y$$$20240712$$MD$CA$CA
240845191$24084519$1$I$$20220126$20240712$20240712$PER$$CA-PFM-2022-00797$PIERRE FABRE MEDICAMENT$$45$YR$$F$Y$$$20240712$$MD$CA$CA
240845201$24084520$1$I$$20220126$20240712$20240712$PER$$CA-PFM-2022-00798$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240712$$MD$CA$CA
240845211$24084521$1$I$$20220126$20240712$20240712$PER$$CA-PFM-2022-00796$PIERRE FABRE MEDICAMENT$$42$YR$$F$Y$$$20240712$$MD$CA$CA
240845221$24084522$1$I$$20220126$20240712$20240712$PER$$CA-PFM-2022-00794$PIERRE FABRE MEDICAMENT$$51$YR$$F$Y$$$20240712$$MD$CA$CA
240845231$24084523$1$I$$20220126$20240712$20240712$PER$$CA-PFM-2022-00795$PIERRE FABRE MEDICAMENT$$57$YR$$F$Y$$$20240712$$MD$CA$CA
240845241$24084524$1$I$$20240711$20240712$20240712$PER$$US-BAYER-2024A100448$BAYER$$$$$M$Y$$$20240712$$CN$US$US
240845251$24084525$1$I$$20220215$20240712$20240712$PER$$CA-PFM-2022-00803$PIERRE FABRE MEDICAMENT$$30$YR$$F$Y$$$20240712$$MD$CA$CA
240845261$24084526$1$I$$20240710$20240712$20240712$EXP$$US-GSK-US2024086329$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$CN$US$US
240845271$24084527$1$I$20240709$20240709$20240712$20240712$PER$$US-BAYER-2024A098916$BAYER$$$$$F$Y$$$20240712$$MD$US$US
240845281$24084528$1$I$20240512$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48281$$FDA-CTU$$63$YR$$M$N$$$20240711$N$HP$US$
240845291$24084529$1$I$20240629$20240711$20240711$20240711$DIR$709924$$FDA-CTU$$70$YR$$F$N$78.75$KG$20240711$Y$CN$US$
240845301$24084530$1$I$20240515$20240711$20240711$20240711$DIR$709920$$FDA-CTU$$52$YR$$F$N$$$20240711$Y$CN$US$
240845311$24084531$1$I$$20211018$20240712$20240712$PER$$IT-PFM-2022-01161$PIERRE FABRE MEDICAMENT$Labella B, Pezzini D, Costa A, Poli L, Magoni M, Padovani A et al. An uncommon cause of paraparesis: Thyrotoxic hypokalemic periodic paralysis. Journal of the Neurological Sciences. 2021;429:150$56$YR$$M$Y$$$20240712$$HP$IT$IT
240845321$24084532$1$I$20211201$20211231$20240712$20240712$PER$$FR-PFM-2022-00072$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$$$20240712$$CN$FR$FR
240845331$24084533$1$I$20240704$20240711$20240711$20240711$DIR$709927$$FDA-CTU$$37$YR$$F$N$123.75$KG$20240711$Y$CN$US$
240845351$24084535$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48296$$FDA-CTU$$$$$M$N$$$20240711$N$HP$US$
240845361$24084536$1$I$$20240711$20240711$20240711$DIR$709954$$FDA-CTU$$$$$UNK$N$$$20240711$$CN$US$
240845381$24084538$1$I$$20220103$20240712$20240712$PER$$FR-PFM-2022-00068$PIERRE FABRE MEDICAMENT$Le Tanno P,  Folacci M, Revilloud J,  Faivre L,  Laurent  G,  Pinson L et al. Characterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen. Frontiers in Genetics. 2021;12$16$YR$$F$Y$$$20240712$$HP$FR$FR
240845391$24084539$1$I$20230126$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216344$TEVA$$$$A$M$Y$$$20240712$$HP$KR$KR
240845401$24084540$1$I$20240628$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48269$$FDA-CTU$$81$YR$$M$N$$$20240711$N$$US$
240845411$24084541$1$I$20240510$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48283$$FDA-CTU$$57$YR$$F$N$$$20240711$N$HP$US$
240845421$24084542$1$I$$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48256$$FDA-CTU$$67$YR$$F$N$$$20240711$N$$US$
240845431$24084543$1$I$20211201$20220408$20240712$20240712$PER$$TR-PFM-2022-00033$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$9.5$KG$20240712$$CN$TR$TR
240845441$24084544$1$I$$20240708$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108551$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$$$20240712$$HP$US$US
240845451$24084545$1$I$$20240708$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108628$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240712$$CN$US$US
240845462$24084546$2$F$20240627$20240710$20240712$20240720$EXP$$US-Accord-433756$ACCORD$$64$YR$A$M$Y$$$20240720$$PH$US$US
240845471$24084547$1$I$$20240702$20240712$20240712$EXP$AU-TGA-805122$AU-Accord-433336$ACCORD$$51$YR$A$M$Y$$$20240712$$HP$AU$AU
240845481$24084548$1$I$$20240702$20240712$20240712$EXP$AU-TGA-804411$AU-Accord-433448$ACCORD$$$$$F$Y$$$20240712$$HP$AU$AU
240845491$24084549$1$I$$20240702$20240712$20240712$EXP$CA-MHPD-E2B_001081894$CA-Accord-433905$ACCORD$$83$YR$E$M$Y$85$KG$20240712$$PH$CA$CA
240845501$24084550$1$I$$20240702$20240712$20240712$EXP$AU-TGA-804290$AU-Accord-433452$ACCORD$$$$$F$Y$$$20240712$$HP$AU$AU
240845511$24084551$1$I$$20240703$20240712$20240712$EXP$$CN-Accord-432091$ACCORD$Zhai W, Liu H, Li J, Xin H. Pregabalin-induced rhabdomyolysis: a case series and literature analysis. J Int Med Res. 2024 Jun;52(6):3000605241257776.$9$DEC$E$M$Y$$$20240712$$HP$CN$CN
240845521$24084552$1$I$$20240702$20240712$20240712$EXP$$IN-TORRENT-00003579$TORRENT$$30$YR$A$M$Y$$$20240712$$HP$IN$IN
240845531$24084553$1$I$$20220110$20240712$20240712$PER$$RO-PFM-2022-00222$PIERRE FABRE MEDICAMENT$Gozar L, Suteu CC, Gabor-Miklosi D, Cerghit-Paler A, Fagarasan A. Diagnostic difficulties in a case of fetal ventricular tachycardia associated with neonatal COVID infection: Case report. International journal of environmental research and public heath. 2021;18:1-8$3$DY$$F$Y$3.37$KG$20240712$$HP$RO$RO
240845541$24084554$1$I$20231110$20240703$20240712$20240712$EXP$GB-MHRA-MED-202407022337350880-HWTLS$GB-TORRENT-00037048$TORRENT$$39$YR$A$F$Y$$$20240712$$CN$GB$GB
240845551$24084555$1$I$20240628$20240708$20240712$20240712$PER$$US-BIOGEN-2024BI01272835$BIOGEN$$59$YR$$F$Y$$$20240712$$CN$US$US
240845561$24084556$1$I$20240617$20240703$20240712$20240712$EXP$$US-Accord-434318$ACCORD$$65$YR$E$M$Y$$$20240712$$HP$US$US
240845571$24084557$1$I$$20240703$20240712$20240712$EXP$$DE-Accord-434469$ACCORD$Riedhammer C, Dull J, Kestle C, Kadel S, Franz J, Weis P, et al. Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma. Annals of Hematology. 2024 Apr;103(4): 1327-1332.$60$YR$A$M$Y$$$20240712$$HP$DE$DE
240845581$24084558$1$I$$20240630$20240712$20240712$EXP$$US-Accord-434809$ACCORD$Pathan S. Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage. Hosp Pharm. 2024 Aug;59(4):394-406.$82$YR$E$M$Y$$$20240712$$HP$US$US
240845591$24084559$1$I$20240320$20240702$20240712$20240712$EXP$FR-AFSSAPS-NY2024000727$FR-Accord-433772$ACCORD$$59$YR$A$F$Y$70$KG$20240712$$PH$FR$FR
240845601$24084560$1$I$$20240630$20240712$20240712$EXP$$US-Accord-434810$ACCORD$Pathan S. Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage. Hosp Pharm. 2024 Aug;59(4):394-406.$67$YR$E$F$Y$$$20240712$$HP$US$US
240845611$24084561$1$I$20240615$20240702$20240712$20240712$EXP$FR-AFSSAPS-PO2024000732$FR-Accord-434078$ACCORD$$66$YR$E$F$Y$54.5$KG$20240712$$MD$FR$FR
240845621$24084562$1$I$$20240630$20240712$20240712$EXP$$JP-Accord-433340$ACCORD$Manabe M, Nagano Y, Okuno T, Inoue T, Koh KR. Methotrexate associated B cell lymphoproliferative disease that exhibits hematuria due to urinary bladder lesions: A case report. Medicine international. 2024;4(4):44.$75$YR$E$F$Y$$$20240712$$MD$JP$JP
240845631$24084563$1$I$$20240702$20240712$20240712$EXP$$IN-TORRENT-00003582$TORRENT$$18$YR$A$M$Y$$$20240712$$HP$IN$IN
240845641$24084564$1$I$$20220113$20240712$20240712$PER$$PT-PFM-2022-00310$PIERRE FABRE MEDICAMENT$Monteiro C, Dias B, Vaz-Patto M. Headache as an adverse reaction to the use of medication in the elderly: A pharmacovigilance study. Int J Environ Res Public Health. 2021;18(5):1-11$$$E$$Y$$$20240712$$HP$PT$PT
240845651$24084565$1$I$$20220110$20240712$20240712$PER$$PT-PFM-2022-00256$PIERRE FABRE MEDICAMENT$Almeida D, Marinho G, Maia T. Withdrawal akathisia as a subtype of akathisia: a case report. European Neuropsychopharmacology. 2021;53:S310-S311$37$YR$$M$Y$$$20240712$$HP$PT$PT
240845661$24084566$1$I$$20220119$20240712$20240712$PER$$CA-PFM-2022-00566$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$MD$CA$CA
240845671$24084567$1$I$$20220121$20240712$20240712$PER$$JP-PFM-2022-00817$PIERRE FABRE MEDICAMENT$$6$MON$$F$Y$$$20240712$$PH$JP$JP
240845681$24084568$1$I$$20220124$20240712$20240712$PER$$JP-PFM-2022-00819$PIERRE FABRE MEDICAMENT$Misako Nakazono et al. Treatment of Infantile Hemangioma with Low-dose Propranolol. Journal of Japan Society of Plastic and Reconstructive Surgery. 2021;41(10):569-575$4$MON$$F$Y$$$20240712$$HP$JP$JP
240845691$24084569$1$I$$20220124$20240712$20240712$PER$$JP-PFM-2022-00822$PIERRE FABRE MEDICAMENT$Misako Nakazono et al. Treatment of Infantile Hemangioma with Low-dose Propranolol. Journal of Japan Society of Plastic and Reconstructive Surgery. 2021;41(10):569-75$4$MON$$F$Y$$$20240712$$HP$JP$JP
240845701$24084570$1$I$$20220124$20240712$20240712$PER$$JP-PFM-2022-00820$PIERRE FABRE MEDICAMENT$Nakazono M, Ko S, Nakamura S, Tsunoda Y, Koike T, Hirotomi K et al. Treatment of Infantile Hemangioma with Low-dose Propranolol. Journal of Japan Society of Plastic and Reconstructive Surgery. 2021;41(10):569-575$2$MON$$M$Y$$$20240712$$HP$JP$JP
240845711$24084571$1$I$$20220125$20240712$20240712$PER$$KR-PFM-2022-00710$PIERRE FABRE MEDICAMENT$$$$$F$Y$8$KG$20240712$$CN$KR$KR
240845721$24084572$1$I$$20220124$20240712$20240712$PER$$FR-PFM-2022-00809$PIERRE FABRE MEDICAMENT$Letertre O, Boccara O, Prey S, Pedespan JM, Boralevi F, Leaute Labreze. Segmental facial infantile haemangiomas in the era of propranolol: evaluation at 6 years of age. JEADV. 2022$$$$$Y$$$20240712$$HP$FR$FR
240845731$24084573$1$I$20240324$20240703$20240712$20240712$EXP$GB-MHRA-MED-202404191502598390-GLWNT$GB-TORRENT-00037008$TORRENT$$71$YR$E$F$Y$$$20240712$$HP$GB$GB
240845741$24084574$1$I$20240619$20240709$20240712$20240712$PER$$US-BAYER-2024A098809$BAYER$$30$YR$A$F$Y$$$20240712$$CN$US$US
240845761$24084576$1$I$$20220131$20240712$20240712$PER$$JP-PFM-2022-01021$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$MD$JP$JP
240845771$24084577$1$I$20240703$20240703$20240712$20240712$PER$$US-SA-2024SA198910$SANOFI AVENTIS$$$$$F$Y$$$20240712$$CN$US$US
240845781$24084578$1$I$$20220131$20240712$20240712$PER$NO-NOMAADVRE-RELISSO-2022-00069$NO-PFM-2022-00851$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$$$20240712$$MD$NO$NO
240845791$24084579$1$I$$20220128$20240712$20240712$PER$$IT-PFM-2022-00934$PIERRE FABRE MEDICAMENT$Iannone LF, Fattori D, Geppetti P, Cesaris FD. Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series. Neurological Sciences. 2022;43:697-703$48$YR$$F$Y$$$20240712$$HP$IT$IT
240845801$24084580$1$I$$20220202$20240712$20240712$PER$$JP-PFM-2022-00883$PIERRE FABRE MEDICAMENT$$1$YR$$$Y$$$20240712$$MD$JP$JP
240845811$24084581$1$I$$20220203$20240712$20240712$PER$$IT-PFM-2022-01029$PIERRE FABRE MEDICAMENT$di Filippo L, Castellino L, Giustina A et al. Occurrence and response to treatment of Graves^ disease after COVID vaccination in two male patients. Endocrine. 2022;75(1):19-21$35$YR$$M$Y$$$20240712$$HP$IT$IT
240845821$24084582$1$I$$20220203$20240712$20240712$PER$$IT-PFM-2022-01028$PIERRE FABRE MEDICAMENT$Filippo LD, Castellino L, Giustina A. Occurrence and response to treatment of Graves disease after COVID vaccination in two male patients. Endocrine. 2022;75(1):19-21$32$YR$$M$Y$$$20240712$$HP$IT$IT
240845831$24084583$1$I$$20220204$20240712$20240712$PER$$NL-PFM-2022-01039$PIERRE FABRE MEDICAMENT$Nieuwhof F., Toni I., Dirkx M.F., Gallea C., Vidailhet M., Buijink A.W.G et al. Cerebello-thalamic activity drives an abnormal motor network into dystonic tremor. NeuroImage: Clinical. 2022;33$$$A$$Y$$$20240712$$HP$NL$NL
240845851$24084585$1$I$$20240705$20240712$20240712$EXP$$US-BEH-2024175408$CSL BEHRING$$61$YR$A$F$Y$$$20240712$$HP$US$US
240845861$24084586$1$I$$20220128$20240712$20240712$PER$$IT-PFM-2022-00935$PIERRE FABRE MEDICAMENT$Iannone LF, Fattori D, Geppetti P, Cesaris FD. Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series. Neurological Sciences. 2022;43:697-703$27$YR$$M$Y$$$20240712$$HP$IT$IT
240845871$24084587$1$I$20211220$20220203$20240712$20240712$PER$FR-AFSSAPS-NY20220090$FR-PFM-2022-01136$PIERRE FABRE MEDICAMENT$$52$YR$$M$Y$97$KG$20240712$$MD$FR$FR
240845881$24084588$1$I$$20220204$20240712$20240712$PER$$DE-PFM-2022-01030$PIERRE FABRE MEDICAMENT$Pitarokoili K, Maier A, de Moya Rubio EC, Hahn K, Wallukat G, Athanasopoulos D et al. Maintenance therapy with subcutaneous immunoglobulin in a patient with immune-mediated neuropathic postural tachycardia syndrome. Journal of Translational Autoimmunity. 2021;4$35$YR$$F$Y$$$20240712$$HP$DE$DE
240845891$24084589$1$I$$20240709$20240712$20240712$PER$$US-BAYER-2024A098847$BAYER$$41$YR$A$F$Y$$$20240712$$HP$US$US
240845921$24084592$1$I$$20240705$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN006784$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240845931$24084593$1$I$$20240628$20240712$20240712$EXP$$IN-ROCHE-10000023719$ROCHE$$$$$$Y$$$20240712$$MD$IN$IN
240845941$24084594$1$I$20240604$20240709$20240712$20240712$EXP$$CO-BAYER-2024A099810$BAYER$$48$YR$A$M$Y$$$20240712$$CN$CO$CO
240845962$24084596$2$F$$20240904$20240712$20240906$EXP$$CA-PFIZER INC-202400212272$PFIZER$$40$YR$$F$Y$$$20240906$$HP$CA$CA
240845981$24084598$1$I$20240710$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48413$$FDA-CTU$$$$$F$N$$$20240711$Y$CN$US$
240846002$24084600$2$F$$20240717$20240712$20240718$EXP$$US-UCBSA-2024035125$UCB$$$$$M$Y$$$20240718$$CN$US$US
240846011$24084601$1$I$$20240615$20240712$20240712$30DAY$$US-VEROBIOTECH-2024USVEROSPO00140$VERO BIOTECH$$$$A$M$Y$$$20240712$$HP$US$US
240846021$24084602$1$I$$20220207$20240712$20240712$PER$$KR-PFM-2022-01106$PIERRE FABRE MEDICAMENT$Lee JY, Lee SH, Kim WH. Reversible severe tricuspid regurgitation associated with Graves disease A case report. Medicine Baltimore. 2021;100(51):1-4$41$YR$$F$Y$$$20240712$$HP$KR$KR
240846031$24084603$1$I$$20220209$20240712$20240712$PER$$JP-PFM-2022-00281$PIERRE FABRE MEDICAMENT$Takahashi H. Two very low birth weight infants of infantile hemangioma treated with propranolol from early infancy$$$$M$Y$$$20240712$$HP$JP$JP
240846041$24084604$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110419$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240712$$CN$US$US
240846051$24084605$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110636$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240712$$HP$US$US
240846061$24084606$1$I$20220101$20220302$20240712$20240712$PER$$JP-PFM-2022-01041$PIERRE FABRE MEDICAMENT$$$$I$$Y$8$KG$20240712$$MD$JP$JP
240846071$24084607$1$I$20170419$20220401$20240712$20240712$PER$$JP-PFM-2022-00431$PIERRE FABRE MEDICAMENT$Sugimoto A, Aoki R,Toyohara E, Ogawa R et al. Infantile Hemangiomas Cleared by Combined Therapy with Pulsed Dye Laser and Propranolol. American Society for Dermatologic Surgery. 2021;47(8):1052-57$$$I$F$Y$$$20240712$$HP$JP$JP
240846081$24084608$1$I$20170830$20220401$20240712$20240712$PER$$JP-PFM-2022-00434$PIERRE FABRE MEDICAMENT$Sugimoto A, Aoki R, Toyohara E, Ogawa R. Infantile Hemangiomas Cleared by Combined Therapy with Pulsed Dye Laser and Propranolol. Dermatologic surgery : official publication for American Society for Dermatologi. 2021;47(8):1052-57$$$I$M$Y$$$20240712$$HP$JP$JP
240846091$24084609$1$I$$20220228$20240712$20240712$PER$$JP-PFM-2022-00430$PIERRE FABRE MEDICAMENT$Sugimoto A, Aoki R,Toyohara E,  Ogawa R et al. Infantile Hemangiomas Cleared by Combined Therapy with Pulsed Dye Laser and Propranolol. American Society for Dermatologic Surgery. 2021;47(8):1052-7$$$I$$Y$$$20240712$$HP$JP$JP
240846101$24084610$1$I$20171120$20220405$20240712$20240712$PER$$JP-PFM-2022-00435$PIERRE FABRE MEDICAMENT$Sugimoto A, Aoki R, Toyohara E, Ogawa R. Infantile Hemangiomas Cleared by Combined Therapy with Pulsed Dye Laser and Propranolol. American Society for Dermatologic Surgery. 2021;47(8):1052-057$8$MON$$F$Y$$$20240712$$MD$JP$JP
240846111$24084611$1$I$$20240709$20240712$20240712$PER$$US-BAYER-2024A099169$BAYER$$55$YR$A$F$Y$$$20240712$$CN$US$US
240846121$24084612$1$I$20180910$20220405$20240712$20240712$PER$$JP-PFM-2022-00453$PIERRE FABRE MEDICAMENT$Atsuko Sugimoto, et al. Infantile Hemangiomas Cleared by Combined Therapy with Pulsed Dye Laser and Propranolol. Dermatologic surgery:official publication for American Society for Dermatologic. 2021;47(8):1052-7$10$MON$$M$Y$$$20240712$$MD$JP$JP
240846131$24084613$1$I$20180320$20220405$20240712$20240712$PER$$JP-PFM-2022-00436$PIERRE FABRE MEDICAMENT$Sugimoto A, Aoki R, Toyohara E, Ogawa R et al. Infantile Hemangiomas Cleared by Combined Therapy with Pulsed Dye Laser and Propranolol. American Society for Dermatologic Surgery. 2021;47(8):1052-7$10$MON$$F$Y$$$20240712$$MD$JP$JP
240846151$24084615$1$I$$20240627$20240712$20240712$PER$$US-SA-2024SA195062$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240712$$MD$US$US
240846161$24084616$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA199086$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$CN$US$US
240846171$24084617$1$I$20240101$20240703$20240712$20240712$PER$$US-SA-2024SA198629$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240712$$CN$US$US
240846181$24084618$1$I$20170705$20220401$20240712$20240712$PER$$JP-PFM-2022-00432$PIERRE FABRE MEDICAMENT$Sugimoto A, Aoki R, Toyohara E, Ogawa R. Infantile Hemangiomas Cleared by Combined Therapy with Pulsed Dye Laser and Propranolol. American Society for Dermatologic Surgery. 2021;47(8):1052-7$$$I$F$Y$$$20240712$$HP$JP$JP
240846191$24084619$1$I$20230708$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217402$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240846201$24084620$1$I$$20240704$20240712$20240712$EXP$$IN-ROCHE-3553595$ROCHE$$51$YR$A$M$Y$$$20240712$$MD$IN$IN
240846211$24084621$1$I$$20240703$20240712$20240712$EXP$$US-APOTEX-2024AP008125$APOTEX$Chu AF, Sagi V, Amin AK, Rajagopal G, Shantanu S, Pederson KS. Continuous QT interval monitoring using insertable cardiac monitors during antiarrhythmic loading hospitalization: Results from the ^LINQ QT^ Study. Europace. 2024;26(1):i43-i45$$$$$Y$$$20240712$$HP$US$US
240846221$24084622$1$I$$20240709$20240712$20240712$EXP$$CO-BAYER-2024A100672$BAYER$$61$YR$A$F$Y$$$20240712$$CN$CO$CO
240846234$24084623$4$F$20230101$20240904$20240712$20240914$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-029866$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240914$$CN$US$US
240846241$24084624$1$I$20230623$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217503$TEVA$$$$E$F$Y$$$20240712$$HP$KR$KR
240846251$24084625$1$I$20230703$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217512$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240846261$24084626$1$I$$20240702$20240712$20240712$EXP$CA-MHPD-E2B_001083766$CA-Accord-433900$ACCORD$$58$YR$A$F$Y$$$20240712$$HP$CA$CA
240846273$24084627$3$F$20240702$20240802$20240712$20240814$EXP$$US-Accord-433993$ACCORD$$46$YR$A$M$Y$$$20240814$$HP$US$US
240846281$24084628$1$I$20240701$20240702$20240712$20240712$EXP$$US-Accord-433988$ACCORD$$53$YR$A$F$Y$$$20240712$$HP$US$US
240846291$24084629$1$I$$20240702$20240712$20240712$EXP$GB-MHRA-MED-202407020643199960-VMKHF$GB-Accord-433853$ACCORD$$$$$F$Y$95$KG$20240712$$CN$GB$GB
240846301$24084630$1$I$20220501$20240703$20240712$20240712$EXP$$CN-Accord-433928$ACCORD$Zhang Q, Xie P, Hou X, Zhao C, Duan L, Qiao H. Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report. Journal of Chemotherapy. 2024;36(4):334-42.$52$YR$A$M$Y$$$20240712$$MD$CN$CN
240846311$24084631$1$I$$20240703$20240712$20240712$EXP$$US-Accord-433942$ACCORD$Roma N, Padala V, Pattoli M, Desai S, Krinock M, Durkin M, et al. BRASH Syndrome: A Rare Clinical Phenomenon. CJC Open. 2024;6(6):840-2.$66$YR$E$F$Y$$$20240712$$MD$US$US
240846321$24084632$1$I$20240701$20240702$20240712$20240712$EXP$$US-Accord-434017$ACCORD$$32$YR$$M$Y$$$20240712$$HP$US$US
240846331$24084633$1$I$20190106$20240702$20240712$20240712$EXP$GB-MHRA-MED-202407022222049650-KTBQJ$GB-Accord-433826$ACCORD$$21$YR$A$F$Y$$$20240712$$CN$GB$GB
240846341$24084634$1$I$20240710$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48417$$FDA-CTU$$48$YR$$F$N$$$20240711$N$CN$US$
240846351$24084635$1$I$20240710$20240711$20240711$20240711$DIR$FDA-CDER-CTU-2024-48432$$FDA-CTU$$73$YR$$F$N$$$20240711$N$$US$
240846371$24084637$1$I$20120101$20231213$20240712$20240712$EXP$GB-MHRA-TPP27230551C9671391YC1702373718909$GB-TEVA-VS-3139196$TEVA$$68$YR$$F$Y$61$KG$20240712$$MD$GB$GB
240846381$24084638$1$I$$20240703$20240712$20240712$EXP$$PT-Accord-433938$ACCORD$Lobato CT, Castelo Branco S, Camoes J, Molinos E. Rhabdomyolysis secondary to a weight-loss prescription. BMJ Case Reports. 2024;17(6):e258208. DOI:10.1136/bcr-2023-258208.$8$DEC$E$M$Y$$$20240712$$MD$PT$PT
240846391$24084639$1$I$$20240709$20240712$20240712$PER$$US-BAYER-2024A099235$BAYER$$30$YR$A$F$Y$$$20240712$$MD$US$US
240846401$24084640$1$I$$20240709$20240712$20240712$PER$$US-PFIZER INC-PV202400090718$PFIZER$$$$$$Y$$$20240712$$HP$US$US
240846411$24084641$1$I$$20240710$20240712$20240712$EXP$$US-PFIZER INC-202400212260$PFIZER$$62$YR$$F$Y$$$20240712$$HP$US$US
240846422$24084642$2$F$20240707$20240715$20240712$20240717$EXP$$US-PFIZER INC-202400210054$PFIZER$$67$YR$$F$Y$$$20240717$$CN$US$US
240846431$24084643$1$I$$20240708$20240712$20240712$PER$$US-PFIZER INC-PV202400090275$PFIZER$$33$YR$$F$Y$$$20240712$$MD$US$US
240846442$24084644$2$F$$20240805$20240712$20240808$PER$$US-PFIZER INC-PV202400071512$PFIZER$$51$YR$$F$Y$$$20240808$$CN$US$US
240846451$24084645$1$I$$20240710$20240712$20240712$EXP$$US-PFIZER INC-202400212026$PFIZER$$34$YR$$F$Y$$$20240712$$HP$US$US
240846461$24084646$1$I$$20240709$20240712$20240712$EXP$$CA-PFIZER INC-202400211236$PFIZER$Gourmel, A.. Multimodal therapeutic approach for a severe case of kaposiform lymphangiomatosis from procedural interventions to targeted therapies. Pediatric Blood and Cancer. 2024;71(8):10.1002/pbc.31079$10$YR$$F$Y$$$20240712$$HP$CA$CA
240846471$24084647$1$I$$20240708$20240712$20240712$PER$$US-PFIZER INC-PV202400090368$PFIZER$$33$YR$$M$Y$$$20240712$$MD$US$US
240846482$24084648$2$F$$20240717$20240712$20240718$EXP$$US-PFIZER INC-PV202400090998$PFIZER$$73$YR$$F$Y$$$20240718$$CN$US$US
240846491$24084649$1$I$$20240710$20240712$20240712$EXP$$CA-PFIZER INC-202400211330$PFIZER$$62$YR$$M$Y$$$20240712$$HP$CA$CA
240846511$24084651$1$I$$20240708$20240712$20240712$EXP$$IE-PFIZER INC-2017SGN03335$PFIZER$Glavey S. Quinn J. McCloy M. Sargent J. McCartney Y. Catherwood M. Emergence of Bruton^s tyrosine kinase-negative Hodgkin lymphoma during ibrutinib tretment of chronic lymphocytic leaukaemia.. European Journal of Haematology. 2017;99 (4):378-80$67$YR$$F$Y$$$20240712$$HP$IE$IE
240846521$24084652$1$I$$20240711$20240712$20240712$EXP$$GB-PFIZER INC-PV202400091682$PFIZER$$77$YR$$F$Y$$$20240712$$CN$GB$GB
240846531$24084653$1$I$$20240709$20240712$20240712$PER$$US-PFIZER INC-202400212520$PFIZER$$59$YR$$F$Y$67.59$KG$20240712$$CN$US$US
240846541$24084654$1$I$$20240709$20240712$20240712$EXP$$CA-PFIZER INC-PV202400089989$PFIZER$Gourmel, A.. Multimodal therapeutic approach for a severe case of kaposiform lymphangiomatosis from procedural interventions to targeted therapies. Pediatric Blood and Cancer. 2024;71(8):10.1002/pbc.31079$10$YR$$F$Y$$$20240712$$HP$CA$CA
240846551$24084655$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-PV202400090860$PFIZER$$52$YR$$F$Y$$$20240712$$CN$US$US
240846563$24084656$3$F$$20240723$20240712$20240724$EXP$$JP-PFIZER INC-202400212190$PFIZER$Sakai, Y.. Concomitant Administration of Vancomycin with a High Dose of Meropenem May Cause Acute Kidney Injury. Case reports in infectious diseases. 2024;2024:10.1155/2024/7956014$65$YR$$F$Y$58.3$KG$20240724$$PH$JP$JP
240846572$24084657$2$F$20240101$20240712$20240712$20240715$EXP$$US-PFIZER INC-202400211059$PFIZER$$80$YR$$F$Y$61.23$KG$20240715$$CN$US$US
240846582$24084658$2$F$$20240729$20240712$20240801$PER$$US-PFIZER INC-202400212042$PFIZER$$70$YR$$F$Y$$$20240801$$HP$US$US
240846591$24084659$1$I$20240410$20240709$20240712$20240712$PER$$US-PFIZER INC-2024SGN04812$PFIZER$$50$YR$$F$Y$$$20240712$$CN$US$US
240846601$24084660$1$I$$20240709$20240712$20240712$PER$$US-PFIZER INC-PV202400091014$PFIZER$$73$YR$$F$Y$$$20240712$$CN$US$US
240846622$24084662$2$F$20230801$20240712$20240712$20240717$EXP$$CN-PFIZER INC-PV202400090397$PFIZER$Jiang, C.. Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus. Frontiers in Pharmacology. 2024;15:10.3389/fphar.2024.1364121$32$YR$$M$Y$70$KG$20240717$$HP$CN$CN
240846641$24084664$1$I$20240709$20240709$20240712$20240712$PER$$US-PFIZER INC-202400211112$PFIZER$$65$YR$$M$Y$$$20240712$$CN$US$US
240846651$24084665$1$I$$20240711$20240712$20240712$EXP$$CA-PFIZER INC-PV202400091127$PFIZER$$60$YR$$F$Y$$$20240712$$HP$CA$CA
240846661$24084666$1$I$$20240710$20240712$20240712$EXP$$US-PFIZER INC-202400212767$PFIZER$$91$YR$$F$Y$$$20240712$$HP$US$US
240846671$24084667$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-202400211295$PFIZER$$68$YR$$F$Y$$$20240712$$CN$US$US
240846681$24084668$1$I$$20240709$20240712$20240712$PER$$US-PFIZER INC-202400211234$PFIZER$$47$YR$$F$Y$$$20240712$$HP$US$US
240846691$24084669$1$I$$20240709$20240712$20240712$PER$$US-PFIZER INC-202400211135$PFIZER$$54$YR$$F$Y$$$20240712$$HP$US$US
240846702$24084670$2$F$20240116$20240831$20240712$20240904$PER$$US-PFIZER INC-202400209965$PFIZER$$36$YR$$F$Y$$$20240904$$CN$US$US
240846713$24084671$3$F$$20240801$20240712$20240807$EXP$$CN-PFIZER INC-202400208627$PFIZER$Chen, W.. Electroacupuncture for oculomotor nerve palsy after chemotherapy: A case report. Medicine (United States). 2024;103(24):e38547$56$YR$$F$Y$$$20240807$$MD$CN$CN
240846721$24084672$1$I$$20240708$20240712$20240712$PER$$US-PFIZER INC-PV202400090388$PFIZER$$37$YR$$F$Y$$$20240712$$MD$US$US
240846732$24084673$2$F$$20240714$20240712$20240715$EXP$$US-PFIZER INC-202400212697$PFIZER$$61$YR$$F$Y$$$20240715$$HP$US$US
240846742$24084674$2$F$$20240711$20240712$20240715$EXP$$US-PFIZER INC-202400211336$PFIZER$$73$YR$$F$Y$$$20240715$$HP$US$US
240846751$24084675$1$I$20240614$20240711$20240712$20240712$EXP$FR-AFSSAPS-PP2024000767$FR-PFIZER INC-202400212105$PFIZER$$79$YR$$F$Y$$$20240712$$MD$FR$FR
240846761$24084676$1$I$$20240709$20240712$20240712$PER$$US-PFIZER INC-PV202400089931$PFIZER$$71$YR$$F$Y$$$20240712$$MD$US$US
240846771$24084677$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111206$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$103.87$KG$20240712$$CN$US$US
240846781$24084678$1$I$$20240711$20240712$20240712$EXP$GB-MHRA-MED-202407111342256210-LTCDW$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-110837$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240712$$HP$GB$GB
240846791$24084679$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110055$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$45.81$KG$20240712$$CN$US$US
240846801$24084680$1$I$$20240704$20240712$20240712$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005105$BIOCON$$$$$$Y$$$20240712$$HP$CA$CA
240846814$24084681$4$F$20240101$20240919$20240712$20240919$PER$$US-BAYER-2024A099320$BAYER$$53$YR$A$F$Y$$$20240919$$CN$US$US
240846821$24084682$1$I$20240305$20240705$20240712$20240712$EXP$GB-MHRA-MED-202406260926267920-QLDBR$GB-BAXTER-2024BAX021272$BAXTER$$$$$F$Y$$$20240712$$CN$GB$GB
240846831$24084683$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137826$AMGEN$$$$$$Y$$$20240712$$HP$US$US
240846841$24084684$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024135818$AMGEN$$$$$M$Y$$$20240712$$CN$US$US
240846851$24084685$1$I$20240701$20240704$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010456$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240846862$24084686$2$F$$20240806$20240712$20240807$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039415$BOEHRINGER INGELHEIM$$91$YR$E$F$Y$$$20240807$$CN$US$US
240846871$24084687$1$I$20240513$20240708$20240712$20240712$EXP$$DE-AstraZeneca-2024A159085$ASTRAZENECA$$75$YR$$M$Y$65$KG$20240712$$MD$DE$
240846881$24084688$1$I$$20240708$20240712$20240712$PER$$US-ABBVIE-5832491$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240846891$24084689$1$I$$20240703$20240712$20240712$EXP$$FR-DSJP-DSE-2024-134776$DAIICHI$$37$YR$$F$Y$$$20240712$$MD$FR$FR
240846902$24084690$2$F$$20240911$20240712$20240919$EXP$$CA-CELLTRION INC.-2024CA016274$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
240846911$24084691$1$I$20230101$20240702$20240712$20240712$EXP$FR-AFSSAPS-NC2024000752$FR-TEVA-VS-3216691$TEVA$$33$YR$$F$Y$$$20240712$$MD$FR$FR
240846921$24084692$1$I$$20240705$20240712$20240712$EXP$$US-AstraZeneca-2024A157624$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
240846931$24084693$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159522$ASTRAZENECA$$64$YR$$M$Y$$$20240712$$HP$FR$
240846941$24084694$1$I$$20240708$20240712$20240712$EXP$$US-TAKEDA-2023TUS116337$TAKEDA$$$$$F$Y$$$20240712$$HP$US$US
240846951$24084695$1$I$$20240711$20240712$20240712$EXP$$US-TAKEDA-2024TUS070763$TAKEDA$$$$$M$Y$$$20240712$$CN$US$US
240846961$24084696$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-PV202400090901$PFIZER$$28$YR$$M$Y$$$20240712$$CN$US$US
240846971$24084697$1$I$20240705$20240705$20240712$20240712$PER$$US-PFIZER INC-202400208232$PFIZER$$10$YR$$M$Y$$$20240712$$HP$US$US
240846981$24084698$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-202400211994$PFIZER$$$$$F$Y$$$20240712$$CN$US$US
240846993$24084699$3$F$$20240916$20240712$20240919$PER$$US-PFIZER INC-202400209227$PFIZER$$17$YR$$F$Y$$$20240919$$CN$US$US
240847003$24084700$3$F$$20240718$20240712$20240722$EXP$$US-PFIZER INC-202400212446$PFIZER$$94$YR$$F$Y$$$20240722$$CN$US$US
240847011$24084701$1$I$$20240709$20240712$20240712$EXP$$IN-AstraZeneca-2024A159687$ASTRAZENECA$$73$YR$$M$Y$$$20240712$$CN$IN$
240847022$24084702$2$F$20240601$20240912$20240712$20240918$EXP$$US-BEH-2024175296$CSL BEHRING$$7$YR$C$F$Y$37.19$KG$20240918$$CN$US$US
240847032$24084703$2$F$$20240710$20240712$20240720$PER$$NVSC2024US144350$NOVARTIS$$$$$M$Y$$$20240719$$CN$US$US
240847041$24084704$1$I$$20240704$20240712$20240712$EXP$$GB-AMGEN-FRASL2024138016$AMGEN$$27$YR$A$F$Y$$$20240712$$CN$GB$FR
240847052$24084705$2$F$20240509$20240729$20240712$20240731$PER$$US-JNJFOC-20240729428$JOHNSON AND JOHNSON$$66$YR$E$F$Y$70.5$KG$20240731$$HP$US$US
240847061$24084706$1$I$20221004$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405131608051290-BGYVH$GB-SEPTODONT-2024018793$SEPTODONT$$$$$M$Y$$$20240712$$HP$GB$GB
240847071$24084707$1$I$$20240709$20240712$20240712$PER$$US-BAYER-2024A099420$BAYER$$53$YR$A$F$Y$$$20240712$$CN$US$US
240847081$24084708$1$I$20240708$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137871$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240847091$24084709$1$I$$20240703$20240712$20240712$EXP$$AR-Accord-433906$ACCORD$Rotondaro JC, Maya M, Gutierrez M, Echavarria GL, Badariotti GH. Neumatosis intestinal y neumoperitoneo: no siempre una indicacion quirurgica (Intestinal pneumatosis and pneumoperitonum: not always a surgical indication). Medicina (B Aires). 2024;84(3):574-578. Spanish.$80$YR$E$F$Y$$$20240712$$HP$AR$AR
240847102$24084710$2$F$20240701$20240807$20240712$20240812$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-093384$REGENERON$$$$$M$Y$$$20240812$$MD$US$US
240847121$24084712$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA202849$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240712$$MD$US$US
240847131$24084713$1$I$$20240704$20240712$20240712$EXP$$MA-HIKMA PHARMACEUTICALS-MA-H14001-24-06379$HIKMA$$$$$F$Y$$$20240712$$PH$MA$MA
240847141$24084714$1$I$$20240708$20240712$20240712$EXP$$JP-PFIZER INC-PV202400088978$PFIZER$$67$YR$$F$Y$$$20240712$$MD$JP$JP
240847154$24084715$4$F$20240625$20240806$20240712$20240812$EXP$PT-INFARMED-R202406-732$PT-OTSUKA-2024_019228$OTSUKA$$37$YR$$M$Y$$$20240812$$PH$PT$PT
240847181$24084718$1$I$20230811$20240711$20240712$20240712$EXP$GB-MHRA-MED-202407111639412240-DPQHK$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039390$BOEHRINGER INGELHEIM$$56$YR$A$M$Y$86$KG$20240712$$MD$GB$GB
240847193$24084719$3$F$20240702$20240807$20240712$20240813$PER$$US-BAYER-2024A097844$BAYER$$52$YR$A$F$Y$$$20240813$$CN$US$US
240847201$24084720$1$I$$20240709$20240712$20240712$EXP$$IT-PFIZER INC-202400209663$PFIZER$Celardo, G.. Case report: Exploring chemoradiotherapy-induced leukoencephalopathy with 7T imaging and quantitative susceptibility mapping. Front-Neurol. 2024;15:1-6$6$YR$$M$Y$$$20240712$$HP$IT$IT
240847211$24084721$1$I$20240101$20240702$20240712$20240712$EXP$$NL-TEVA-VS-3217943$TEVA$$62$YR$$F$Y$$$20240712$$CN$NL$NL
240847224$24084722$4$F$20240701$20240806$20240712$20240812$PER$$US-BIOGEN-2024BI01272943$BIOGEN$$49$YR$$F$Y$$$20240812$$CN$US$US
240847231$24084723$1$I$$20240708$20240712$20240712$PER$$US-BIOGEN-2024BI01272915$BIOGEN$$$$$M$Y$$$20240712$$CN$US$US
240847241$24084724$1$I$20240519$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48406$$FDA-CTU$$73$YR$$F$N$$$20240711$N$HP$US$
240847251$24084725$1$I$$20240704$20240712$20240712$EXP$$ZA-AstraZeneca-2024A155891$ASTRAZENECA$$60$YR$$M$Y$$$20240712$$CN$ZA$
240847261$24084726$1$I$20240704$20240708$20240712$20240712$EXP$$JP-009507513-2407JPN001081J$MERCK$$91$YR$$F$Y$$$20240712$$PH$JP$JP
240847271$24084727$1$I$$20240709$20240712$20240712$EXP$$US-AstraZeneca-2024A157131$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$US$
240847281$24084728$1$I$20240422$20240703$20240712$20240712$EXP$$JP-009507513-2407JPN000416J$MERCK$$87$YR$$M$Y$50$KG$20240712$$PH$JP$JP
240847291$24084729$1$I$$20240705$20240712$20240712$EXP$$US-AstraZeneca-2024A155650$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
240847302$24084730$2$F$20240601$20240703$20240712$20240906$EXP$$US-FARMAPROD-202406-2210$DOMPE FARMACEUTICI$$92$YR$E$F$Y$$$20240904$$CN$US$US
240847311$24084731$1$I$$20240710$20240712$20240712$PER$$US-BAYER-2024A099771$BAYER$$$$$$Y$$$20240712$$HP$US$US
240847321$24084732$1$I$20210412$20240710$20240712$20240712$EXP$$NVSC2024US143843$NOVARTIS$$81$YR$$$Y$$$20240712$$CN$US$US
240847331$24084733$1$I$$20240708$20240712$20240712$EXP$$CA-AstraZeneca-2024A156811$ASTRAZENECA$$$$$F$Y$$$20240712$$HP$CA$
240847341$24084734$1$I$$20240708$20240712$20240712$EXP$$US-AstraZeneca-2024A156818$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
240847351$24084735$1$I$20240529$20240708$20240712$20240712$EXP$$CN-PFIZER INC-PV202400089416$PFIZER$$42$YR$$M$Y$$$20240712$$HP$CN$CN
240847361$24084736$1$I$$20240708$20240712$20240712$EXP$$GB-ORGANON-O2407GBR000928$ORGANON$$64$YR$$F$Y$77$KG$20240712$$PH$GB$GB
240847371$24084737$1$I$20240706$20240710$20240712$20240712$EXP$$CN-PFIZER INC-PV202400090642$PFIZER$$57$YR$$F$Y$88$KG$20240712$$HP$CN$CN
240847381$24084738$1$I$20220901$20240708$20240712$20240712$EXP$$CN-PFIZER INC-202400207559$PFIZER$Zhu, A.. Omadacycline for the treatment of patients with Legionella pneumophila pneumonia after experiencing liver dysfunction: case series. Frontiers in Microbiology. 2024;15:10.3389/fmicb.2024.1408443$65$YR$$F$Y$$$20240712$$HP$CN$CN
240847391$24084739$1$I$$20240708$20240712$20240712$EXP$$JP-PFIZER INC-PV202400089575$PFIZER$Murakami, S.. Periaortitis associated with anti-neutrophil cytoplasmic antibodies induced by bevacizumab combination therapy. Internal Medicine. 2013;52:589-591$57$YR$$F$Y$$$20240712$$HP$JP$JP
240847411$24084741$1$I$20240630$20240710$20240712$20240712$EXP$$CN-PFIZER INC-PV202400090650$PFIZER$$71$YR$$M$Y$69$KG$20240712$$HP$CN$CN
240847421$24084742$1$I$20220101$20240708$20240712$20240712$EXP$FR-AFSSAPS-GR2024000823$FR-PFIZER INC-202400208567$PFIZER$$44$YR$$F$Y$$$20240712$$PH$FR$FR
240847432$24084743$2$F$$20240904$20240712$20240905$30DAY$$CO-PFIZER INC-202400205007$PFIZER$$11$YR$$F$Y$$$20240905$$CN$CO$CO
240847451$24084745$1$I$20231012$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48309$$FDA-CTU$$$$$F$N$54$KG$20240711$N$$US$
240847461$24084746$1$I$20231220$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48307$$FDA-CTU$$$$$F$N$56.4$KG$20240711$N$$US$
240847471$24084747$1$I$20240702$20240710$20240712$20240712$EXP$$CN-PFIZER INC-PV202400090620$PFIZER$$75$YR$$M$Y$$$20240712$$HP$CN$CN
240847481$24084748$1$I$$20240704$20240712$20240712$EXP$$GB-AstraZeneca-2024A153960$ASTRAZENECA$$81$YR$$F$Y$57$KG$20240712$$MD$GB$
240847492$24084749$2$F$20230130$20240709$20240712$20240724$EXP$$JP-PFIZER INC-PV202400089548$PFIZER$$66$YR$$F$Y$53$KG$20240724$$PH$JP$JP
240847501$24084750$1$I$20240219$20240708$20240712$20240712$EXP$FR-AFSSAPS-AN2024000874$FR-PFIZER INC-202400208583$PFIZER$$15$YR$$M$Y$38.1$KG$20240712$$MD$FR$FR
240847511$24084751$1$I$20240501$20240709$20240712$20240712$EXP$FR-AFSSAPS-AM2024000551$FR-PFIZER INC-202400209465$PFIZER$$66$YR$$M$Y$79$KG$20240712$$MD$FR$FR
240847521$24084752$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48386$$FDA-CTU$$$$$F$N$$$20240711$N$HP$US$
240847532$24084753$2$F$$20240710$20240712$20240716$EXP$$LB-PFIZER INC-202400209521$PFIZER$Mouawad, J.. Index finger acrometastasis: A unique lung cancer case report.. International Journal of Surgery Case Reports. 2024;121:10.1016/j.ijscr.2024.109903$70$YR$$M$Y$$$20240716$$MD$LB$LB
240847541$24084754$1$I$$20240709$20240712$20240712$EXP$$FR-PFIZER INC-PV202400089819$PFIZER$$$$$M$Y$$$20240712$$HP$FR$FR
240847551$24084755$1$I$$20240708$20240712$20240712$EXP$$JP-PFIZER INC-PV202400089550$PFIZER$Yoshikawa, A.. Two cases of methotrexate-associated lymphoproliferative disorder that remitted spontaneously. The 132nd Shikoku Branch Meeting of the Japan Gastroenterological Endoscopy. 2024;132nd:59$71$YR$$F$Y$$$20240712$$HP$JP$JP
240847562$24084756$2$F$20240401$20240916$20240712$20240918$30DAY$$CO-PFIZER INC-PV202400086146$PFIZER$$12$YR$$M$Y$$$20240918$$CN$CO$CO
240847571$24084757$1$I$$20240708$20240712$20240712$EXP$$US-PFIZER INC-PV202400090267$PFIZER$$28$YR$$F$Y$$$20240712$$MD$US$US
240847581$24084758$1$I$20240618$20240709$20240712$20240712$EXP$FR-AFSSAPS-NC2024000815$FR-PFIZER INC-202400209479$PFIZER$$57$YR$$F$Y$$$20240712$$MD$FR$FR
240847591$24084759$1$I$$20240710$20240712$20240712$EXP$$CA-PFIZER INC-202400212459$PFIZER$$46$YR$$M$Y$96$KG$20240712$$HP$CA$CA
240847612$24084761$2$F$$20240817$20240712$20240819$30DAY$$US-PFIZER INC-202400209805$PFIZER$$5$YR$$M$Y$$$20240819$$CN$US$US
240847622$24084762$2$F$$20240805$20240712$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407007683$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240808$$CN$US$US
240847631$24084763$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007686$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240712$$MD$US$US
240847641$24084764$1$I$20240507$20240709$20240712$20240712$EXP$$EG-PFIZER INC-PV202400089858$PFIZER$$60$YR$$F$Y$75$KG$20240712$$PH$EG$EG
240847651$24084765$1$I$20240705$20240705$20240712$20240712$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00722$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240712$$CN$US$US
240847661$24084766$1$I$20240629$20240709$20240712$20240712$EXP$$CN-PFIZER INC-PV202400090105$PFIZER$$80$YR$$M$Y$54$KG$20240712$$HP$CN$CN
240847671$24084767$1$I$20240708$20240709$20240712$20240712$EXP$$GB-PFIZER INC-202400209543$PFIZER$$52$YR$$M$Y$$$20240712$$HP$GB$GB
240847681$24084768$1$I$20221217$20240710$20240712$20240712$EXP$$GB-GSK-GB2024GSK086156$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$MD$GB$GB
240847691$24084769$1$I$20200429$20240708$20240712$20240712$EXP$PL-URPL-1-1560-2020$PL-PFIZER INC-202400208486$PFIZER$$73$YR$$M$Y$77$KG$20240712$$MD$PL$PL
240847701$24084770$1$I$20231228$20240709$20240712$20240712$EXP$GB-MHRA-MED-202406241300397730-GKZMW$GB-PFIZER INC-202400209625$PFIZER$$69$YR$$F$Y$$$20240712$$MD$GB$GB
240847711$24084771$1$I$20240627$20240708$20240712$20240712$EXP$GB-MHRA-MED-202407081144285530-HQCRV$GB-PFIZER INC-202400209009$PFIZER$$46$YR$$F$Y$68$KG$20240712$$HP$GB$GB
240847721$24084772$1$I$$20240708$20240712$20240712$EXP$$JP-PFIZER INC-PV202400089514$PFIZER$Kijima, M.. A case of transient myocardial ischaemia in early postnatal period triggered by poor neonatal adaptation syndrome due to maternal antidepressants. Journal of Japan Society of Perinatal and Neonatal Medicine. 2024;60(S1):408$$$N$$Y$2.746$KG$20240712$$HP$JP$JP
240847731$24084773$1$I$20231014$20240709$20240712$20240712$EXP$FR-AFSSAPS-PA2024000835$FR-PFIZER INC-202400209480$PFIZER$$50$YR$$F$Y$93$KG$20240712$$MD$FR$FR
240847741$24084774$1$I$20240703$20240710$20240712$20240712$EXP$$CN-PFIZER INC-PV202400090649$PFIZER$$39$YR$$F$Y$55.8$KG$20240712$$HP$CN$CN
240847751$24084775$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110884$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$122.92$KG$20240712$$CN$US$US
240847761$24084776$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110460$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240712$$HP$US$US
240847771$24084777$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110578$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240712$$CN$US$US
240847781$24084778$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110497$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240712$$CN$US$US
240847801$24084780$1$I$$20240712$20240712$20240712$PER$$US-HALEON-2186796$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240847811$24084781$1$I$20240706$20240711$20240712$20240712$EXP$$NVSC2024CN144276$NOVARTIS$$83$YR$$F$Y$$$20240712$$HP$CN$CN
240847831$24084783$1$I$$20240523$20240712$20240712$PER$$US-LUNDBECK-DKLU3078543$LUNDBECK$$$$$$Y$$$20240712$$PH$US$US
240847842$24084784$2$F$$20240717$20240712$20240718$PER$$US-JNJFOC-20240723070$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$CN$US$US
240847852$24084785$2$F$$20240812$20240712$20240816$EXP$$IE-JNJFOC-20240723620$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240816$$HP$IE$IE
240847861$24084786$1$I$$20240710$20240712$20240712$PER$$US-JNJFOC-20240725726$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240847872$24084787$2$F$$20240710$20240712$20240822$PER$$US-LUNDBECK-DKLU4000360$LUNDBECK$$$$$$Y$$$20240822$$CN$US$US
240847882$24084788$2$F$20231106$20240712$20240712$20240723$EXP$GB-MHRA-MED-202405151732009310-VMTYH$GB-SA-2024SA204606$SANOFI AVENTIS$$70$YR$E$M$Y$85$KG$20240723$$CN$GB$GB
240847891$24084789$1$I$$20240708$20240712$20240712$PER$$US-BAYER-2024A099195$BAYER$$71$YR$E$M$Y$$$20240712$$CN$US$US
240847911$24084791$1$I$20240704$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48416$$FDA-CTU$$53$YR$$M$N$$$20240711$N$HP$US$
240847921$24084792$1$I$$20240710$20240712$20240712$DIR$FDA-CDER-CTU-2024-48430$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
240847992$24084799$2$F$20240606$20240802$20240712$20240807$EXP$$CA-TAKEDA-2024TUS070516$TAKEDA$$38$YR$$M$Y$87$KG$20240807$$CN$CA$CA
240848001$24084800$1$I$$20240705$20240712$20240712$EXP$$BR-AMGEN-BRASP2024134173$AMGEN$$63$YR$A$F$Y$$$20240712$$PH$BR$BR
240848011$24084801$1$I$$20240708$20240712$20240712$EXP$$US-GSK-US2024AMR085760$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$US$US
240848021$24084802$1$I$20240701$20240708$20240712$20240712$EXP$$SG-FreseniusKabi-FK202410686$FRESENIUS KABI$$24$YR$A$F$Y$$$20240712$$HP$SG$SG
240848033$24084803$3$F$20240101$20240730$20240712$20240807$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-11804$IPSEN$$65$YR$E$F$Y$$$20240807$$CN$US$US
240848041$24084804$1$I$20240704$20240704$20240712$20240712$EXP$$CN-BEIGENE-BGN-2024-010450$BEIGENE$$$$$$Y$$$20240712$$HP$CN$CN
240848055$24084805$5$F$20240701$20240725$20240712$20240731$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003780$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
240848062$24084806$2$F$$20240718$20240712$20240724$EXP$$JP-BAYER-2024A100011$BAYER$$$$$M$Y$$$20240724$$MD$JP$JP
240848081$24084808$1$I$20240503$20240704$20240712$20240712$EXP$FR-AFSSAPS-RS2024000627$FR-TEVA-VS-3217614$TEVA$$70$YR$$F$Y$$$20240712$$MD$FR$FR
240848092$24084809$2$F$$20240805$20240712$20240828$PER$$US-JNJFOC-20240670520$JOHNSON AND JOHNSON$$$$$F$Y$117.3$KG$20240828$$CN$US$US
240848101$24084810$1$I$$20240524$20240712$20240712$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-029783$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$$$20240712$$PH$GB$GB
240848121$24084812$1$I$$20240705$20240712$20240712$EXP$$TW-RDY-LIT/TWN/24/0010282$DR REDDYS$Tang S, Peng C, Lin T, Chang F, Hung S. Palbociclib-associated nephrotoxicity in a patient with breast cancer. Journal of Onco-Nephrology. 2024;8(1): 31-34. doi:10.1177/23993693241232733.$68$YR$E$F$Y$$$20240712$$HP$TW$TW
240848131$24084813$1$I$$20240708$20240712$20240712$EXP$$US-LUNDBECK-DKLU4001463$LUNDBECK$$$$$$Y$$$20240712$$CN$US$US
240848141$24084814$1$I$20240618$20240703$20240712$20240712$EXP$$CN-009507513-2407CHN002913$MERCK$$34$YR$$M$Y$69.5$KG$20240712$$HP$CN$CN
240848151$24084815$1$I$$20240703$20240712$20240712$EXP$$RO-RDY-LIT/ROU/24/0009996$DR REDDYS$Nechita L, Niculet E, Baroiu L, Stefania Balta AA, Nechita A, Voinescu DC, et al. Acute Myocardial Infarction in COVID-19 Patients-A Review of Literature Data and Two-Case Report Series. Journal of Clinical Medicine. 2024;13(10): 1-2. doi:10.3390/jcm13102936.$57$YR$A$M$Y$$$20240712$$HP$RO$RO
240848162$24084816$2$F$20240708$20240806$20240712$20240807$PER$$US-ALXN-202407USA000563US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240848171$24084817$1$I$20240311$20240711$20240712$20240712$EXP$$JP-BAYER-2024A080175$BAYER$$74$YR$E$M$Y$$$20240712$$MD$JP$JP
240848182$24084818$2$F$20240706$20240829$20240712$20240906$EXP$$PK-AMRYT PHARMACEUTICALS DAC-AEGR007241$AEGERION$$$$$$Y$$$20240906$$MD$PK$PK
240848191$24084819$1$I$$20240702$20240712$20240712$EXP$$US-TEVA-VS-3216728$TEVA$$65$YR$$M$Y$$$20240712$$CN$US$US
240848201$24084820$1$I$20240610$20240709$20240712$20240712$EXP$FR-AFSSAPS-GR2024000858$FR-ORGANON-O2407FRA000905$ORGANON$$42$YR$$F$Y$62$KG$20240712$$PH$FR$FR
240848212$24084821$2$F$$20240704$20240712$20240806$EXP$$CN-AstraZeneca-2024A156535$ASTRAZENECA$$$$$$Y$$$20240806$$CN$CN$
240848221$24084822$1$I$20240628$20240704$20240712$20240712$EXP$$CN-AstraZeneca-2024A155777$ASTRAZENECA$$18463$DY$$M$Y$80$KG$20240712$$MD$CN$
240848231$24084823$1$I$$20240709$20240712$20240712$EXP$$ZA-AstraZeneca-2024A157267$ASTRAZENECA$$62$YR$$F$Y$$$20240712$$CN$ZA$
240848241$24084824$1$I$$20240708$20240712$20240712$EXP$$US-TAKEDA-US202018606$TAKEDA$$$$$M$Y$$$20240712$$HP$US$US
240848252$24084825$2$F$20240501$20240705$20240712$20240805$EXP$$JP-AstraZeneca-2024A155954$ASTRAZENECA$$65$YR$$M$Y$$$20240805$$MD$JP$
240848261$24084826$1$I$$20240709$20240712$20240712$EXP$$US-AstraZeneca-2024A158504$ASTRAZENECA$$$$$F$Y$$$20240712$$MD$US$
240848271$24084827$1$I$$20240702$20240712$20240712$EXP$$US-AstraZeneca-2024A152870$ASTRAZENECA$$79$YR$$F$Y$75.8$KG$20240712$$CN$US$
240848281$24084828$1$I$20230825$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216392$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240848291$24084829$1$I$20230726$20240705$20240712$20240712$EXP$$PL-AstraZeneca-2024A154609$ASTRAZENECA$$70$YR$$F$Y$108$KG$20240712$$MD$PL$
240848301$24084830$1$I$$20240708$20240712$20240712$EXP$$GR-AstraZeneca-2024A158079$ASTRAZENECA$$49$YR$$F$Y$75$KG$20240712$$MD$GR$
240848311$24084831$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110714$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$99.34$KG$20240712$$PH$US$US
240848322$24084832$2$F$20240617$20240903$20240712$20240904$EXP$FR-AFSSAPS-TS2024000793$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-109694$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240905$$MD$FR$FR
240848331$24084833$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110957$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$59.42$KG$20240712$$CN$US$US
240848341$24084834$1$I$20240101$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110638$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240712$$HP$US$US
240848351$24084835$1$I$20240101$20240704$20240712$20240712$EXP$$CA-APOTEX-2024AP008038$APOTEX$$$$E$F$Y$$$20240712$$CN$CA$CA
240848361$24084836$1$I$$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024138373$AMGEN$$$$$$Y$$$20240712$$CN$US$US
240848372$24084837$2$F$$20240724$20240712$20240806$EXP$$JP-AMGEN-JPNSP2024135854$AMGEN$$$$$$Y$$$20240805$$PH$JP$JP
240848382$24084838$2$F$20240703$20240705$20240712$20240718$EXP$$GR-TAKEDA-2024TUS070372$TAKEDA$$70$YR$$M$Y$$$20240718$$CN$GR$GR
240848392$24084839$2$F$20240523$20240719$20240712$20240725$EXP$$IT-JNJFOC-20240720833$JOHNSON AND JOHNSON$$72$YR$E$M$Y$70$KG$20240725$$MD$IT$IT
240848411$24084841$1$I$$20240708$20240712$20240712$EXP$$AT-PFIZER INC-2019SGN03641$PFIZER$Melchardt, T.. Brentuximab Vedotin (Adcetris) New first-line option for advanced Hodgkin^s lymphoma. Spectrum Onkologie. 2019;05:89$67$YR$$M$Y$$$20240712$$HP$AT$AT
240848421$24084842$1$I$$20240710$20240712$20240712$PER$$US-ABBVIE-5835195$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240848431$24084843$1$I$20240125$20240705$20240712$20240712$EXP$$US-009507513-2407USA003321$MERCK$$52$YR$$F$Y$$$20240712$$CN$US$US
240848441$24084844$1$I$20240705$20240708$20240712$20240712$EXP$GB-MHRA-MED-202407060208043660-HWCTR$GB-009507513-2407GBR003515$MERCK$$61$YR$$F$Y$79$KG$20240712$$CN$GB$GB
240848451$24084845$1$I$20240201$20240710$20240712$20240712$EXP$$FR-GSK-FR2024GSK030295$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$MD$FR$FR
240848461$24084846$1$I$$20240710$20240712$20240712$EXP$$US-GSK-US2024085837$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$US$US
240848471$24084847$1$I$$20240610$20240712$20240712$PER$$US-BEH-2024173900$CSL BEHRING$$$$$$Y$$$20240712$$PH$US$US
240848481$24084848$1$I$$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110699$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240712$$CN$US$US
240848491$24084849$1$I$20200101$20240701$20240712$20240712$PER$$US-FreseniusKabi-FK202410413$FRESENIUS KABI$$62$YR$A$F$Y$$$20240712$$CN$US$US
240848501$24084850$1$I$$20240708$20240712$20240712$EXP$$CA-FreseniusKabi-FK202410776$FRESENIUS KABI$$66$YR$E$F$Y$$$20240712$$HP$CA$CA
240848511$24084851$1$I$$20240708$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109797$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240712$$CN$US$US
240848522$24084852$2$F$20240627$20240916$20240712$20240917$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-110964$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$71.21$KG$20240917$$CN$PR$PR
240848534$24084853$4$F$20240401$20240917$20240712$20240927$EXP$$CO-EXELIXIS-CABO-24078548$EXELIXIS$$69$YR$$F$Y$53$KG$20240926$$CN$CO$CO
240848541$24084854$1$I$20240401$20240704$20240712$20240712$EXP$$RU-EXELIXIS-CABO-24079366$EXELIXIS$$52$YR$$F$Y$40$KG$20240712$$HP$RU$RU
240848551$24084855$1$I$$20240709$20240712$20240712$EXP$$US-JNJFOC-20240723221$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240712$$HP$US$US
240848562$24084856$2$F$20221101$20240719$20240712$20240725$EXP$$DE-EXELIXIS-CABO-24079306$EXELIXIS$$67$YR$$M$Y$90$KG$20240725$$MD$DE$DE
240848571$24084857$1$I$20240701$20240708$20240712$20240712$EXP$$JP-Eisai-EC-2024-169847$EISAI$$65$YR$E$F$Y$$$20240712$$MD$JP$JP
240848581$24084858$1$I$$20240620$20240712$20240712$PER$$US-BEH-2024174626$CSL BEHRING$$$$A$F$Y$$$20240712$$HP$US$US
240848591$24084859$1$I$20240101$20240703$20240712$20240712$EXP$$CN-BAYER-2024A097285$BAYER$$$$$M$Y$$$20240712$$CN$CN$CN
240848603$24084860$3$F$20220101$20240814$20240712$20240821$EXP$$US-ROCHE-3314515$ROCHE$$64$YR$A$M$Y$$$20240821$$CN$US$US
240848612$24084861$2$F$$20240722$20240712$20240731$EXP$$US-TEVA-VS-3217675$TEVA$Peters JD, Shastri D, Hajjar S, York J, Erpenwar S, Vanlandingham A. A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage. Am-J-Respir-Crit-Care-Med 2024; 209.; Peters JD, Shastri D, Hajjar S, York J, Erpenwar S, Vanlandingham A. A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage. Am-J-Respir-Crit-Care-Med 2024; 209.$85$YR$$F$Y$$$20240731$$HP$US$US
240848621$24084862$1$I$$20240711$20240712$20240712$PER$$US-TAKEDA-2024TUS070969$TAKEDA$$70$YR$$F$Y$$$20240712$$CN$US$US
240848632$24084863$2$F$20240705$20240726$20240712$20240731$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-096583$REGENERON$$$$$M$Y$$$20240731$$CN$CA$CA
240848641$24084864$1$I$20240616$20240703$20240712$20240712$PER$$US-SA-2024SA198809$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240712$$MD$US$US
240848651$24084865$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA203092$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240712$$MD$US$US
240848661$24084866$1$I$20230223$20240709$20240712$20240712$EXP$$IE-TAKEDA-2023TUS021392$TAKEDA$$21$YR$$F$Y$$$20240712$$CN$IE$IE
240848671$24084867$1$I$$20240703$20240712$20240712$EXP$$IN-SA-2024SA200301$SANOFI AVENTIS$$$$$F$Y$$$20240712$$HP$IN$IN
240848681$24084868$1$I$20240405$20240702$20240712$20240712$EXP$FR-AFSSAPS-NC2024000743$FR-TEVA-VS-3216693$TEVA$$84$YR$$F$Y$52$KG$20240712$$CN$FR$FR
240848692$24084869$2$F$20240701$20240820$20240712$20240823$EXP$$US-OTSUKA-2024_019453$OTSUKA$$56$YR$$F$Y$$$20240823$$MD$US$US
240848701$24084870$1$I$$20240705$20240712$20240712$EXP$$AE-Amarin Pharma, Inc-2024AMR000335$AMARIN$$$$$M$Y$$$20240712$$MD$AE$AE
240848711$24084871$1$I$20240707$20240708$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109994$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240712$$CN$US$US
240848721$24084872$1$I$20240610$20240709$20240712$20240712$EXP$$US-OTSUKA-2024_019440$OTSUKA$$$$$M$Y$$$20240712$$CN$US$US
240848731$24084873$1$I$20240708$20240708$20240712$20240712$PER$$US-JNJFOC-20240720325$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$MD$US$US
240848741$24084874$1$I$$20211108$20240712$20240712$PER$$CA-PFM-2021-11174$PIERRE FABRE MEDICAMENT$$23$YR$$F$Y$$$20240712$$MD$CA$CA
240848751$24084875$1$I$20240601$20240620$20240712$20240712$PER$$US-BEH-2024174630$CSL BEHRING$$64$YR$A$F$Y$$$20240712$$HP$US$US
240848761$24084876$1$I$$20211108$20240712$20240712$PER$$CA-PFM-2021-11177$PIERRE FABRE MEDICAMENT$$58$YR$$F$Y$$$20240712$$MD$CA$CA
240848771$24084877$1$I$$20211108$20240712$20240712$PER$$CA-PFM-2021-11179$PIERRE FABRE MEDICAMENT$$28$YR$$F$Y$$$20240712$$MD$CA$CA
240848781$24084878$1$I$$20211108$20240712$20240712$PER$$CA-PFM-2021-11176$PIERRE FABRE MEDICAMENT$$25$YR$$F$Y$$$20240712$$MD$CA$CA
240848791$24084879$1$I$$20211108$20240712$20240712$PER$$CA-PFM-2021-11175$PIERRE FABRE MEDICAMENT$$54$YR$$F$Y$$$20240712$$MD$CA$CA
240848801$24084880$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11477$PIERRE FABRE MEDICAMENT$$58$YR$$F$Y$$$20240712$$MD$CA$CA
240848811$24084881$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11500$PIERRE FABRE MEDICAMENT$$53$YR$$M$Y$$$20240712$$MD$CA$CA
240848821$24084882$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11497$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240712$$MD$CA$CA
240848831$24084883$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11496$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240712$$MD$CA$CA
240848841$24084884$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11493$PIERRE FABRE MEDICAMENT$$31$YR$$F$Y$$$20240712$$MD$CA$CA
240848851$24084885$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11495$PIERRE FABRE MEDICAMENT$$57$YR$$F$Y$$$20240712$$MD$CA$CA
240848861$24084886$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11492$PIERRE FABRE MEDICAMENT$$27$YR$$F$Y$$$20240712$$MD$CA$CA
240848871$24084887$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11479$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240712$$MD$CA$CA
240848881$24084888$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11480$PIERRE FABRE MEDICAMENT$$24$YR$$F$Y$$$20240712$$MD$CA$CA
240848891$24084889$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11491$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240712$$MD$CA$CA
240848901$24084890$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11488$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240712$$MD$CA$CA
240848911$24084891$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11499$PIERRE FABRE MEDICAMENT$$65$YR$$F$Y$$$20240712$$MD$CA$CA
240848921$24084892$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11494$PIERRE FABRE MEDICAMENT$$36$YR$$F$Y$$$20240712$$MD$CA$CA
240848931$24084893$1$I$20230615$20240711$20240712$20240712$EXP$$US-ABBVIE-5837718$ABBVIE$$66$YR$$M$Y$61$KG$20240712$$HP$US$US
240848941$24084894$1$I$20210101$20211123$20240712$20240712$PER$$FR-PFM-2021-11607$PIERRE FABRE MEDICAMENT$$15$MON$$F$Y$$$20240712$$CN$FR$FR
240848951$24084895$1$I$$20240709$20240712$20240712$EXP$$GB-MYLANLABS-2024M1051672$MYLAN$$$$$F$Y$$$20240712$$MD$GB$GB
240848961$24084896$1$I$20211101$20211124$20240712$20240712$PER$$FR-PFM-2021-11680$PIERRE FABRE MEDICAMENT$$4$MON$$F$Y$$$20240712$$CN$FR$FR
240848971$24084897$1$I$$20211201$20240712$20240712$PER$$CA-PFM-2021-11909$PIERRE FABRE MEDICAMENT$$53$YR$$F$Y$$$20240712$$MD$CA$CA
240848981$24084898$1$I$$20240701$20240712$20240712$EXP$$US-VKT-000560$VKT PHARMA PRIVATE LIMITED$$3$DY$N$M$Y$$$20240703$$MD$US$US
240848991$24084899$1$I$$20240701$20240712$20240712$EXP$$US-VKT-000557$VKT PHARMA PRIVATE LIMITED$$3$DY$N$M$Y$$$20240703$$MD$US$US
240849001$24084900$1$I$$20211201$20240712$20240712$PER$$CA-PFM-2021-11908$PIERRE FABRE MEDICAMENT$$19$YR$$F$Y$$$20240712$$MD$CA$CA
240849011$24084901$1$I$$20240701$20240712$20240712$EXP$$US-VKT-000561$VKT PHARMA PRIVATE LIMITED$$3$DY$N$M$Y$$$20240703$$MD$US$US
240849021$24084902$1$I$$20240701$20240712$20240712$EXP$$US-VKT-000562$VKT PHARMA PRIVATE LIMITED$$9$DY$N$F$Y$$$20240703$$MD$US$US
240849031$24084903$1$I$$20240701$20240712$20240712$EXP$$US-VKT-000555$VKT PHARMA PRIVATE LIMITED$$3$DY$N$F$Y$$$20240703$$MD$US$US
240849041$24084904$1$I$$20211118$20240712$20240712$PER$$CA-PFM-2021-11498$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240712$$MD$CA$CA
240849052$24084905$2$F$20230101$20240709$20240712$20240716$EXP$$GB-PFIZER INC-202400209512$PFIZER$Teoh, P.. Invasive Trichoderma longibrachiatum infection in a neutropaenic patient.. Medical Mycology Case Reports.. 2024;45:10.1016/j.mmcr.2024.100656$51$YR$$F$Y$$$20240716$$MD$GB$GB
240849061$24084906$1$I$$20240701$20240712$20240712$EXP$$US-VKT-000559$VKT PHARMA PRIVATE LIMITED$$4$DY$N$M$Y$$$20240703$$MD$US$US
240849071$24084907$1$I$$20240701$20240712$20240712$EXP$$US-VKT-000558$VKT PHARMA PRIVATE LIMITED$$1$DY$N$F$Y$$$20240703$$MD$US$US
240849081$24084908$1$I$$20240701$20240712$20240712$EXP$$US-VKT-000556$VKT PHARMA PRIVATE LIMITED$$3$DY$N$F$Y$$$20240703$$MD$US$US
240849091$24084909$1$I$20240626$20240628$20240712$20240712$EXP$$CN-EAGLE PHARMACEUTICALS, INC.-CN-2024EAG000175$EAGLE$$35$YR$$M$Y$$$20240712$$HP$CN$CN
240849103$24084910$3$F$$20240715$20240712$20240715$EXP$$US-PFIZER INC-PV202400090424$PFIZER$Fenton, G.. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case Reports in Oncology. 2024;17(1):75-81$64$YR$$F$Y$$$20240715$$HP$US$US
240849111$24084911$1$I$$20240708$20240712$20240712$EXP$$US-PFIZER INC-202400210581$PFIZER$Fenton, G.. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case Reports in Oncology. 2024;17(1):75-81$64$YR$$F$Y$$$20240712$$HP$US$US
240849121$24084912$1$I$20201119$20211115$20240712$20240712$PER$$BE-PFM-2021-11339$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240712$$MD$BE$BE
240849131$24084913$1$I$$20211115$20240712$20240712$PER$$BE-PFM-2021-11332$PIERRE FABRE MEDICAMENT$Gaudioa ND, Vaz G, Duprezb T, Raftopoulosa C. Holmes tremor in a monocentric series of resected brainstem cavernomas. Neurochirurgie. 2021;67:315-24$56$YR$$M$Y$$$20240712$$HP$BE$BE
240849142$24084914$2$F$$20240724$20240712$20240802$EXP$$US-TEVA-VS-3217867$TEVA$Alsheimer K, Burgei JW, Lantry J, Shah H, Lamichhane B. Genitourinary Tuberculosis Resulting in Hydronephrosis. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Alsheimer K, Burgei JW, Lantry J, Shah H, Lamichhane B. Genitourinary Tuberculosis Resulting in Hydronephrosis. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$$$$M$Y$$$20240802$$HP$US$US
240849151$24084915$1$I$$20211115$20240712$20240712$PER$$BE-PFM-2021-11331$PIERRE FABRE MEDICAMENT$Del Gaudio N, Vaz G, Duprez T, Raftopoulos C. Holmes tremor in a monocentric series of resected brainstem cavernomas. Neurochirurgie. 2021;67:315-24$59$YR$$F$Y$$$20240712$$HP$BE$BE
240849161$24084916$1$I$$20211201$20240712$20240712$PER$$CA-PFM-2021-11910$PIERRE FABRE MEDICAMENT$$58$YR$$M$Y$$$20240712$$MD$CA$CA
240849171$24084917$1$I$$20211201$20240712$20240712$PER$$CA-PFM-2021-11913$PIERRE FABRE MEDICAMENT$$46$YR$$F$Y$$$20240712$$MD$CA$CA
240849181$24084918$1$I$$20211201$20240712$20240712$PER$$CA-PFM-2021-11911$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240712$$MD$CA$CA
240849201$24084920$1$I$$20211201$20240712$20240712$PER$$CA-PFM-2021-11912$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240712$$MD$CA$CA
240849211$24084921$1$I$20240610$20240704$20240712$20240712$EXP$$FR-AstraZeneca-2024A155785$ASTRAZENECA$$87$YR$$F$Y$56.6$KG$20240712$$MD$FR$
240849222$24084922$2$F$$20240712$20240712$20240727$PER$$US-AstraZeneca-2024A156821$ASTRAZENECA$$$$$F$Y$$$20240727$$CN$US$
240849231$24084923$1$I$20240605$20240626$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107849$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240712$$MD$US$US
240849241$24084924$1$I$$20240708$20240712$20240712$EXP$$CA-FreseniusKabi-FK202410820$FRESENIUS KABI$$72$YR$E$M$Y$79$KG$20240712$$HP$CA$CA
240849253$24084925$3$F$$20240815$20240712$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109354$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$71.67$KG$20240823$$CN$US$US
240849261$24084926$1$I$$20240708$20240712$20240712$EXP$$CA-FreseniusKabi-FK202410828$FRESENIUS KABI$$2$YR$C$M$Y$14$KG$20240712$$HP$CA$CA
240849271$24084927$1$I$20231001$20240705$20240712$20240712$EXP$$US-Amarin Pharma, Inc-2024AMR000337$AMARIN$$66$YR$E$M$Y$$$20240712$$CN$US$US
240849281$24084928$1$I$$20240708$20240712$20240712$EXP$$CA-FreseniusKabi-FK202410878$FRESENIUS KABI$$50$YR$A$M$Y$$$20240712$$HP$CA$CA
240849291$24084929$1$I$20240622$20240622$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050464$TOLMAR$$62$YR$$M$Y$$$20240711$$CN$CA$CA
240849311$24084931$1$I$$20240704$20240712$20240712$EXP$$CA-TEVA-VS-3219934$TEVA$$88$YR$$M$Y$77$KG$20240712$$PH$CA$CA
240849321$24084932$1$I$20240622$20240622$20240712$20240712$PER$$CA-TOLMAR, INC.-24CA050493$TOLMAR$$10$YR$$M$Y$$$20240711$$CN$CA$CA
240849331$24084933$1$I$$20240620$20240712$20240712$PER$$US-TOLMAR, INC.-24US050378$TOLMAR$$$$A$F$Y$$$20240711$$HP$US$US
240849341$24084934$1$I$$20240620$20240712$20240712$PER$$US-TOLMAR, INC.-24US050379$TOLMAR$$$$A$F$Y$$$20240711$$HP$US$US
240849351$24084935$1$I$$20240620$20240712$20240712$PER$$US-TOLMAR, INC.-24US050380$TOLMAR$$$$A$F$Y$$$20240711$$HP$US$US
240849362$24084936$2$F$$20240801$20240712$20240827$PER$$US-TOLMAR, INC.-24US050382$TOLMAR$$$$$$Y$$$20240827$$HP$US$US
240849371$24084937$1$I$$20240620$20240712$20240712$PER$$US-TOLMAR, INC.-24US050381$TOLMAR$$$$A$F$Y$$$20240711$$HP$US$US
240849381$24084938$1$I$$20240619$20240712$20240712$PER$$US-TOLMAR, INC.-24US050404$TOLMAR$$$$$M$Y$89.342$KG$20240711$$HP$US$US
240849392$24084939$2$F$20240101$20240816$20240712$20240906$PER$$US-TOLMAR, INC.-24US050409$TOLMAR$$82$YR$$M$Y$$$20240906$$CN$US$US
240849401$24084940$1$I$20240620$20240620$20240712$20240712$PER$$US-TOLMAR, INC.-24US050387$TOLMAR$$77$YR$$M$Y$$$20240711$$HP$US$US
240849412$24084941$2$F$20240621$20240712$20240712$20240801$PER$$US-TOLMAR, INC.-24US050410$TOLMAR$$$$$$Y$$$20240731$$HP$US$US
240849422$24084942$2$F$20240621$20240712$20240712$20240801$PER$$US-TOLMAR, INC.-24US050416$TOLMAR$$63$YR$$M$Y$$$20240731$$HP$US$US
240849431$24084943$1$I$20231101$20240621$20240712$20240712$PER$$US-TOLMAR, INC.-24US050420$TOLMAR$$72$YR$$M$Y$$$20240711$$CN$US$US
240849461$24084946$1$I$20211115$20211116$20240712$20240712$PER$$DE-PFM-2021-11483$PIERRE FABRE MEDICAMENT$$9$MON$$M$Y$$$20240712$$HP$DE$DE
240849471$24084947$1$I$$20240710$20240712$20240712$EXP$$IT-ABBVIE-5836724$ABBVIE$$$$$F$Y$$$20240712$$MD$IT$IT
240849481$24084948$1$I$$20211119$20240712$20240712$PER$$JP-PFM-2021-11737$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$PH$JP$JP
240849491$24084949$1$I$20210816$20211129$20240712$20240712$PER$FR-AFSSAPS-LY202112701$FR-PFM-2021-11782$PIERRE FABRE MEDICAMENT$$40$YR$$M$Y$$$20240712$$HP$FR$FR
240849501$24084950$1$I$$20211122$20240712$20240712$PER$$ES-PFM-2021-11598$PIERRE FABRE MEDICAMENT$Abilduaa M, Gutierrezb V, Garciac J, Barreroa F, Garciab B, Lopezc C. Central apnea-hypopnea syndrome and Chiari malformation type 1: pre and post-surgical studies. Sleep Medicine. 2021;88:25-8$47$YR$$M$Y$$$20240712$$HP$ES$ES
240849511$24084951$1$I$$20211201$20240712$20240712$PER$$JP-PFM-2021-12177$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240712$$MD$JP$JP
240849521$24084952$1$I$$20211130$20240712$20240712$PER$$JP-PFM-2021-12124$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240712$$PH$JP$JP
240849531$24084953$1$I$20220524$20240708$20240712$20240712$EXP$$CN-RDY-LIT/CHN/24/0010281$DR REDDYS$Zhang J, Fan L, Li J, Wen H, Su Y, Lu N, et al. A case of primary pancreatic lymphoma and review of the literature. J Int Oncol. 2024 May;5(51):$79$YR$E$F$Y$$$20240712$$HP$CN$CN
240849541$24084954$1$I$$20240711$20240712$20240712$EXP$$NVSC2024US144080$NOVARTIS$$$$$$Y$$$20240712$$HP$US$US
240849551$24084955$1$I$$20240708$20240712$20240712$PER$$US-ABBVIE-5835332$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240849562$24084956$2$F$20240701$20240803$20240712$20240813$EXP$$US-BAYER-2024A097891$BAYER$$75$YR$E$M$Y$$$20240813$$CN$US$US
240849571$24084957$1$I$20240523$20240709$20240712$20240712$EXP$$US-INCYTE CORPORATION-2024IN006352$INCYTE$$$$$$Y$$$20240712$$HP$US$US
240849581$24084958$1$I$$20211202$20240712$20240712$PER$$JP-PFM-2021-12223$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$PH$JP$JP
240849591$24084959$1$I$$20211206$20240712$20240712$PER$$CA-PFM-2021-12161$PIERRE FABRE MEDICAMENT$$40$YR$$F$Y$$$20240712$$MD$CA$CA
240849601$24084960$1$I$$20211206$20240712$20240712$PER$$CA-PFM-2021-12160$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240712$$MD$CA$CA
240849611$24084961$1$I$$20211206$20240712$20240712$PER$$CA-PFM-2021-12158$PIERRE FABRE MEDICAMENT$$58$YR$$F$Y$$$20240712$$MD$CA$CA
240849621$24084962$1$I$$20211206$20240712$20240712$PER$$CA-PFM-2021-12159$PIERRE FABRE MEDICAMENT$$59$YR$$F$Y$$$20240712$$MD$CA$CA
240849631$24084963$1$I$$20211206$20240712$20240712$PER$$CA-PFM-2021-12155$PIERRE FABRE MEDICAMENT$$44$YR$$F$Y$$$20240712$$MD$CA$CA
240849641$24084964$1$I$$20211206$20240712$20240712$PER$$CA-PFM-2021-12156$PIERRE FABRE MEDICAMENT$$51$YR$$F$Y$$$20240712$$MD$CA$CA
240849651$24084965$1$I$$20211206$20240712$20240712$PER$$CA-PFM-2021-12157$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240712$$MD$CA$CA
240849661$24084966$1$I$$20211206$20240712$20240712$PER$$CA-PFM-2021-12154$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240712$$MD$CA$CA
240849671$24084967$1$I$20240520$20240711$20240712$20240712$EXP$$DE-BAYER-2024A100184$BAYER$$72$YR$E$F$Y$$$20240712$$CN$DE$DE
240849681$24084968$1$I$$20211206$20240712$20240712$PER$$CA-PFM-2021-12153$PIERRE FABRE MEDICAMENT$$30$YR$$F$Y$$$20240712$$MD$CA$CA
240849691$24084969$1$I$$20211206$20240712$20240712$PER$$IT-PFM-2021-12273$PIERRE FABRE MEDICAMENT$Pique M, Brasili L, Putoto G, Iughetti L. Fallot^s tetralogy and squatting position. Medico e Bambino. 2021;40(8):527-8$1$YR$$F$Y$$$20240712$$HP$IT$IT
240849701$24084970$1$I$$20211216$20240712$20240712$PER$$FR-PFM-2021-12499$PIERRE FABRE MEDICAMENT$$2$YR$$F$Y$$$20240712$$CN$FR$FR
240849711$24084971$1$I$20211126$20220112$20240712$20240712$PER$$JP-PFM-2021-11792$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$6$KG$20240712$$MD$JP$JP
240849721$24084972$1$I$20240101$20240709$20240712$20240712$PER$$US-SA-2024SA205355$SANOFI AVENTIS$$30$YR$A$F$Y$65.77$KG$20240712$$MD$US$US
240849731$24084973$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA204628$SANOFI AVENTIS$$40$YR$A$F$Y$68.03$KG$20240712$$MD$US$US
240849741$24084974$1$I$$20240709$20240712$20240712$EXP$$JP-ORGANON-O2407JPN001044$ORGANON$Mizutani N, Goda K, Kenzaka T.. A Case of Milk-Alkali Syndrome Caused by Diuretic-Induced Alkalosis and Polypharmacy.. Medicina.. 2023;59(7):1345$85$YR$$F$Y$$$20240712$$HP$JP$JP
240849752$24084975$2$F$$20240807$20240712$20240813$EXP$$IN-ROCHE-3578243$ROCHE$$68$YR$E$M$Y$$$20240813$$CN$IN$IN
240849761$24084976$1$I$20221104$20240702$20240712$20240712$30DAY$$US-GSK-US2024083049$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240712$$CN$US$US
240849771$24084977$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110974$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$79.38$KG$20240712$$CN$US$US
240849781$24084978$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110963$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$66.68$KG$20240712$$HP$US$US
240849791$24084979$1$I$$20211214$20240712$20240712$PER$$JP-PFM-2021-12553$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$PH$JP$JP
240849801$24084980$1$I$$20211215$20240712$20240712$PER$$FR-PFM-2021-12426$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240712$$MD$FR$FR
240849811$24084981$1$I$$20211220$20240712$20240712$PER$$RU-PFM-2021-12567$PIERRE FABRE MEDICAMENT$Belysheva TS, Kotlukova NP, Valiev TT, Konstantinova NK, Telezhnikova ND, Lavrova TR et al. Results of Infantile Hemangioma Laser Therapy in Children with Persistent Residual Signs after Systemic Propranolol Therapy: Clinical Cases. Voprosy sovremennoi pediatrii-Current Pediatrics. 2021;20(5):418-25$3$YR$$$Y$$$20240712$$HP$RU$RU
240849821$24084982$1$I$$20211220$20240712$20240712$PER$$GR-PFM-2021-12558$PIERRE FABRE MEDICAMENT$Tsinti M, Dermentzoglou V, Ntokou A, Tsitsami E. Spondyloenchondrodysplasia in a female toddler presenting as systemic lupus erythematosus. Pediatric Rheumatology. 2021;19$14$MON$$F$Y$$$20240712$$HP$GR$GR
240849831$24084983$1$I$$20211220$20240712$20240712$PER$$CA-PFM-2021-12556$PIERRE FABRE MEDICAMENT$Cyr A, Frehlick R, Stammers D, Crone M. Case Report: Propranolol Therapy for Infantile Tremor Syndrome in a Child With Vitamin B12 Deficiency. Frontiers in Pediatrics. 2021;9:1-4$13$MON$$F$Y$$$20240712$$HP$CA$CA
240849841$24084984$1$I$$20211220$20240712$20240712$PER$$GR-PFM-2021-12510$PIERRE FABRE MEDICAMENT$Athanasiou L, Kostoglou-Athanasiou I 2, Nikolakopoulou S 3, Konstantinou A 3, Masha O, Samaras C, et al. Thyroid Gland Affection by SARS-COV-2 Virus. E-Poster at 24th Panhellenic Conference of Internal Medicine, Athens 03-06 Novem. 2021$52$YR$$F$Y$$$20240712$$MD$GR$GR
240849851$24084985$1$I$$20211220$20240712$20240712$PER$$TR-PFM-2021-12570$PIERRE FABRE MEDICAMENT$Ergul Y, Kafali HC, Cilsal E,Yukcu B, Yaman I, Isik FC et al. Prevalence of Jervell-Lange Nielsen syndrome in children with congenital bilateral sensorineural hearing loss. Turk Kardiyol Dern Ars. 2021;49(5):368-76$16$YR$$M$Y$$$20240712$$HP$TR$TR
240849861$24084986$1$I$$20211231$20240712$20240712$PER$$RU-PFM-2021-12562$PIERRE FABRE MEDICAMENT$Belysheva Tatyana S, Kotlukova Natalya P, Valiev Timur T, Konstantinova Nataliya K, Telezhnikova Natalya D, Lavrova Tatyana R et al. Results of Infantile Hemangioma Laser Therapy in Children with Persistent Residual Signs after Systemic Propranolol Therapy: Clinical Cases. Voprosy sovremennoi pediatrii-Current Pediatrics. 2021;20(5):418-25$8$MON$$$Y$$$20240712$$HP$RU$RU
240849871$24084987$1$I$$20211231$20240712$20240712$PER$$RU-PFM-2021-12566$PIERRE FABRE MEDICAMENT$Belysheva TS, Kotlukova NP, Valiev TT, Konstantinova NK, Telezhnikova ND, Lavrova TR et al. Results of Infantile Hemangioma Laser Therapy in Children with Persistent Residual Signs after Systemic Propranolol Therapy: Clinical Cases. Voprosy sovremennoi pediatrii - Current Pediatrics. 2021;20(5):418-25$11$MON$$$Y$$$20240712$$HP$RU$RU
240849881$24084988$1$I$$20211231$20240712$20240712$PER$$RU-PFM-2021-12565$PIERRE FABRE MEDICAMENT$Belysheva TS, Kotlukova NP, Valiev TT, Konstantinova NK,Telezhnikova ND, Lavrova TR et al. Results of Infantile Hemangioma Laser Therapy in Children with Persistent Residual Signs after Systemic Propranolol Therapy: Clinical Cases. Voprosy sovremennoi pediatrii-Current Pediatrics. 2021;20(5):418-25$2$YR$$$Y$$$20240712$$HP$RU$RU
240849891$24084989$1$I$$20220106$20240712$20240712$PER$$JP-PFM-2021-12629$PIERRE FABRE MEDICAMENT$$11$MON$$F$Y$$$20240712$$PH$JP$JP
240849901$24084990$1$I$$20240705$20240712$20240712$EXP$$AE-Amarin Pharma, Inc-2024AMR000340$AMARIN$$$$$M$Y$$$20240712$$MD$AE$AE
240849911$24084991$1$I$$20240704$20240712$20240712$PER$$US-JNJFOC-20240713940$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240849922$24084992$2$F$$20240911$20240712$20240912$EXP$$NVSC2024US143802$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
240849931$24084993$1$I$$20240626$20240712$20240712$PER$$US-MYLANLABS-2024M1061122$MYLAN$$$$$F$Y$$$20240712$$CN$US$US
240849941$24084994$1$I$$20211002$20240712$20240712$PER$$JP-PFM-2021-10103$PIERRE FABRE MEDICAMENT$Takemoto J. A case of forearm hemangioma successfully treated with sirolimus. The 17th Annual Meeting of Japanese Society for the Study of Vascular Anomalies. 2021;02-1$5$MON$$M$Y$$$20240712$$HP$JP$JP
240849951$24084995$1$I$$20211002$20240712$20240712$PER$$JP-PFM-2021-10104$PIERRE FABRE MEDICAMENT$Saori Endo et al. Successful sirolimus treatment of giant neck Kaposiform haemangioendothelioma with KMP in an infant. The 17th Annual Meeting of Japanese Society for the Study of Vascular Anomalies. 2021;02-2$2$MON$$M$Y$$$20240712$$HP$JP$JP
240849961$24084996$1$I$$20211002$20240712$20240712$PER$$JP-PFM-2021-10107$PIERRE FABRE MEDICAMENT$$3$MON$$$Y$$$20240712$$MD$JP$JP
240849971$24084997$1$I$$20211002$20240712$20240712$PER$$JP-PFM-2021-10106$PIERRE FABRE MEDICAMENT$Kawaguchi K. Treatment-resistant kaposiform heamangioendothelioma with involvement of the spinal infiltration successfully treated with sirolimus. The 17th Annual Meeting of Japanese Society for the Study of Vascular Anomalies. 2021;02-3$25$DY$$F$Y$$$20240712$$HP$JP$JP
240849981$24084998$1$I$$20211002$20240712$20240712$PER$$JP-PFM-2021-10102$PIERRE FABRE MEDICAMENT$Fukuda M. A case of haemangioma/vascular malformation with NICH and AVM as differential diagnoses. The 17th Annual Meeting of Japanese Society for the Study of Vascular Anomalies. 2021;01-3$10$DY$$F$Y$$$20240712$$HP$JP$JP
240849991$24084999$1$I$$20211002$20240712$20240712$PER$$JP-PFM-2021-10108$PIERRE FABRE MEDICAMENT$$5$MON$$$Y$$$20240712$$MD$JP$JP
240850001$24085000$1$I$$20211004$20240712$20240712$PER$$CA-PFM-2021-10055$PIERRE FABRE MEDICAMENT$$32$YR$$F$Y$$$20240712$$MD$CA$CA
240850011$24085001$1$I$$20211004$20240712$20240712$PER$$CA-PFM-2021-10058$PIERRE FABRE MEDICAMENT$$51$YR$$F$Y$$$20240712$$MD$CA$CA
240850021$24085002$1$I$$20211004$20240712$20240712$PER$$CA-PFM-2021-10054$PIERRE FABRE MEDICAMENT$$47$YR$$F$Y$$$20240712$$MD$CA$CA
240850031$24085003$1$I$$20211004$20240712$20240712$PER$$CA-PFM-2021-10059$PIERRE FABRE MEDICAMENT$$23$YR$$F$Y$$$20240712$$MD$CA$CA
240850041$24085004$1$I$$20211004$20240712$20240712$PER$$CA-PFM-2021-10056$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240712$$MD$CA$CA
240850051$24085005$1$I$$20211004$20240712$20240712$PER$$CA-PFM-2021-10060$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240712$$MD$CA$CA
240850061$24085006$1$I$$20211004$20240712$20240712$PER$$CA-PFM-2021-10061$PIERRE FABRE MEDICAMENT$$32$YR$$F$Y$$$20240712$$MD$CA$CA
240850081$24085008$1$I$$20211007$20240712$20240712$PER$$JP-PFM-2021-10253$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240712$$CN$JP$JP
240850091$24085009$1$I$$20211004$20240712$20240712$PER$$CA-PFM-2021-10062$PIERRE FABRE MEDICAMENT$$58$YR$$F$Y$$$20240712$$MD$CA$CA
240850101$24085010$1$I$$20240701$20240712$20240712$EXP$$GB-B.Braun Medical Inc.-2159078$B BRAUN$$34$YR$$F$Y$$$20240712$$PH$GB$GB
240850111$24085011$1$I$20210925$20211011$20240712$20240712$PER$FR-AFSSAPS-RE20212725$FR-PFM-2021-10129$PIERRE FABRE MEDICAMENT$$29$YR$$F$Y$79$KG$20240712$$CN$FR$FR
240850121$24085012$1$I$20210401$20211013$20240712$20240712$PER$ES-AEMPS-1025318$ES-PFM-2021-10266$PIERRE FABRE MEDICAMENT$$48$YR$$F$Y$$$20240712$$PH$ES$ES
240850131$24085013$1$I$$20211018$20240712$20240712$PER$$BE-PFM-2021-10461$PIERRE FABRE MEDICAMENT$$23$YR$$M$Y$$$20240712$$MD$BE$BE
240850141$24085014$1$I$$20211018$20240712$20240712$PER$$BE-PFM-2021-10462$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$MD$BE$BE
240850151$24085015$1$I$$20211018$20240712$20240712$PER$$BE-PFM-2021-10482$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240712$$MD$BE$BE
240850161$24085016$1$I$$20211020$20240712$20240712$PER$$CA-PFM-2021-10541$PIERRE FABRE MEDICAMENT$$46$YR$$F$Y$$$20240712$$MD$CA$CA
240850171$24085017$1$I$$20211020$20240712$20240712$PER$$CA-PFM-2021-10540$PIERRE FABRE MEDICAMENT$$27$YR$$F$Y$$$20240712$$MD$CA$CA
240850182$24085018$2$F$20240709$20240718$20240712$20240723$EXP$$JP-GSK-JP2024085973$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$JP$JP
240850191$24085019$1$I$20240627$20240708$20240712$20240712$PER$$US-FreseniusKabi-FK202410854$FRESENIUS KABI$$$$$M$Y$$$20240712$$CN$US$US
240850202$24085020$2$F$$20240724$20240712$20240802$EXP$$US-TEVA-VS-3217903$TEVA$Ibrar M, Saber H, Iftikhar M, Shakir M, Waqas M, Chaudhary T, et al. A Rapidly Progressive Case: From Radiation Pneumonitis, to End Stage Radiation-induced Pulmonary Fibrosis in Less Than 3 Months. Am-J-Respir-Crit-Care-Med 2024; 209 A6409.; Ibrar M, Saber H, Iftikhar M, Shakir M, Waqas M, Chaudhary T, et al. A Rapidly Progressive Case: From Radiation Pneumonitis, to End Stage Radiation-induced Pulmonary Fibrosis in Less Than 3 Months. Am-J-Respir-Crit-Care-Med 2024; 209 A6409.$70$YR$$M$Y$$$20240802$$HP$US$US
240850211$24085021$1$I$20240615$20240708$20240712$20240712$EXP$FR-AFSSAPS-PO2024000732$FR-FreseniusKabi-FK202410888$FRESENIUS KABI$$66$YR$E$F$Y$54.5$KG$20240712$$MD$FR$FR
240850221$24085022$1$I$$20211020$20240712$20240712$PER$$CA-PFM-2021-10550$PIERRE FABRE MEDICAMENT$$33$YR$$M$Y$$$20240712$$MD$CA$CA
240850231$24085023$1$I$$20211020$20240712$20240712$PER$$CA-PFM-2021-10542$PIERRE FABRE MEDICAMENT$$43$YR$$F$Y$$$20240712$$MD$CA$CA
240850241$24085024$1$I$$20211020$20240712$20240712$PER$$CA-PFM-2021-10549$PIERRE FABRE MEDICAMENT$$56$YR$$M$Y$$$20240712$$MD$CA$CA
240850251$24085025$1$I$$20211020$20240712$20240712$PER$$CA-PFM-2021-10552$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240712$$MD$CA$CA
240850261$24085026$1$I$$20211020$20240712$20240712$PER$$CA-PFM-2021-10551$PIERRE FABRE MEDICAMENT$$37$YR$$F$Y$$$20240712$$MD$CA$CA
240850271$24085027$1$I$$20211020$20240712$20240712$PER$$CA-PFM-2021-10553$PIERRE FABRE MEDICAMENT$$22$YR$$M$Y$$$20240712$$MD$CA$CA
240850281$24085028$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111015$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240712$$HP$US$US
240850301$24085030$1$I$$20240705$20240712$20240712$EXP$$AE-Amarin Pharma, Inc-2024AMR000341$AMARIN$$$$$M$Y$$$20240712$$MD$AE$AE
240850312$24085031$2$F$20240704$20240712$20240712$20240716$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-110639$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$58.97$KG$20240716$$CN$PR$PR
240850321$24085032$1$I$$20211020$20240712$20240712$PER$$CA-PFM-2021-10554$PIERRE FABRE MEDICAMENT$$50$YR$$F$Y$$$20240712$$MD$CA$CA
240850331$24085033$1$I$20240101$20240711$20240712$20240712$PER$$US-JNJFOC-20240730821$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240712$$CN$US$US
240850341$24085034$1$I$$20240711$20240712$20240712$PER$$US-JNJFOC-20240730660$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240850351$24085035$1$I$20240610$20240624$20240712$20240712$PER$$US-FMCRTG-FMC-2406-000752$FRESENIUS MEDICAL CARE$$64$YR$A$F$Y$71$KG$20240712$$HP$US$US
240850362$24085036$2$F$20240612$20240703$20240712$20240715$EXP$$US-FMCRTG-FMC-2406-000761$FRESENIUS MEDICAL CARE$$78$YR$E$M$Y$$$20240715$$HP$US$US
240850371$24085037$1$I$20240620$20240620$20240712$20240712$PER$$US-FMCRTG-FMC-2406-000747$FRESENIUS MEDICAL CARE$$21$YR$A$M$Y$77$KG$20240712$$HP$US$US
240850382$24085038$2$F$$20240625$20240712$20240715$EXP$$CA-AMGEN-CANSP2024135809$AMGEN$$43$YR$A$F$Y$96$KG$20240714$$HP$CA$CA
240850391$24085039$1$I$$20211020$20240712$20240712$PER$$JP-PFM-2021-10249$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240712$$PH$JP$JP
240850401$24085040$1$I$$20211025$20240712$20240712$PER$$JP-PFM-2021-10923$PIERRE FABRE MEDICAMENT$Ogaki T. Investigation of 33 Cases of Infantile Hemangioma Who Underwent Oral Propranolol Administration Combined with Dye Laser at Our Department. Journal of Japan Society of Plastic and Reconstructive Surgery. 2021;41(8):439-45$$$I$$Y$$$20240712$$HP$JP$JP
240850411$24085041$1$I$$20211103$20240712$20240712$PER$$CA-PFM-2021-11044$PIERRE FABRE MEDICAMENT$$25$YR$$F$Y$$$20240712$$MD$CA$CA
240850421$24085042$1$I$$20211103$20240712$20240712$PER$$CA-PFM-2021-11045$PIERRE FABRE MEDICAMENT$$51$YR$$F$Y$$$20240712$$MD$CA$CA
240850431$24085043$1$I$$20211103$20240712$20240712$PER$$CA-PFM-2021-11047$PIERRE FABRE MEDICAMENT$$28$YR$$F$Y$$$20240712$$MD$CA$CA
240850441$24085044$1$I$$20211103$20240712$20240712$PER$$CA-PFM-2021-11046$PIERRE FABRE MEDICAMENT$$36$YR$$F$Y$$$20240712$$MD$CA$CA
240850451$24085045$1$I$$20211103$20240712$20240712$PER$$CA-PFM-2021-11048$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240712$$MD$CA$CA
240850461$24085046$1$I$$20211103$20240712$20240712$PER$$CA-PFM-2021-11049$PIERRE FABRE MEDICAMENT$$30$YR$$M$Y$$$20240712$$MD$CA$CA
240850471$24085047$1$I$20240614$20240704$20240712$20240712$EXP$$TW-009507513-2407TWN003153$MERCK$$$$$F$Y$57.4$KG$20240712$$PH$TW$TW
240850481$24085048$1$I$$20211108$20240712$20240712$PER$$CA-PFM-2021-11163$PIERRE FABRE MEDICAMENT$$28$YR$$F$Y$$$20240712$$MD$CA$CA
240850491$24085049$1$I$$20211108$20240712$20240712$PER$$CA-PFM-2021-11164$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240712$$MD$CA$CA
240850501$24085050$1$I$$20211108$20240712$20240712$PER$$CA-PFM-2021-11165$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240712$$MD$CA$CA
240850511$24085051$1$I$$20211108$20240712$20240712$PER$$CA-PFM-2021-11167$PIERRE FABRE MEDICAMENT$$37$YR$$M$Y$$$20240712$$MD$CA$CA
240850521$24085052$1$I$$20211025$20240712$20240712$PER$$JP-PFM-2021-10893$PIERRE FABRE MEDICAMENT$Tomoe O, Yoshioka N. Investigation of 33 Cases of Infantile Hemangioma Who Underwent Oral Propranolol Administration Combined with Dye Laser at Our Department. Journal of Japan Society of Plastic and Reconstructive Surgery. 2021;41(8):439-45$$$I$$Y$$$20240712$$HP$JP$JP
240850531$24085053$1$I$$20211025$20240712$20240712$PER$$JP-PFM-2021-10894$PIERRE FABRE MEDICAMENT$Tomoe O. Investigation of 33 Cases of Infantile Hemangioma Who Underwent Oral Propranolol Administration Combined with Dye Laser at Our Department. Journal of Japan Society of Plastic and Reconstructive Surgery. 2021;41(8):439-45$$$I$$Y$$$20240712$$HP$JP$JP
240850551$24085055$1$I$$20211025$20240712$20240712$PER$$JP-PFM-2021-10895$PIERRE FABRE MEDICAMENT$Tomoe O. Investigation of 33 Cases of Infantile Hemangioma Who Underwent Oral Propranolol Administration Combined with Dye Laser at Our Department. Journal of Japan Society of Plastic and Reconstructive Surgery. 2021;41(8):439-45$$$I$$Y$$$20240712$$HP$JP$JP
240850573$24085057$3$F$$20240916$20240712$20240918$30DAY$$CO-PFIZER INC-PV202400086168$PFIZER$$9$YR$$F$Y$$$20240918$$CN$CO$CO
240850583$24085058$3$F$20240201$20240731$20240712$20240806$EXP$$US-PFIZER INC-2024SGN01305$PFIZER$$78$YR$$F$Y$$$20240806$$CN$US$US
240850603$24085060$3$F$20220901$20240813$20240712$20240819$EXP$$JP-PFIZER INC-202300355807$PFIZER$$55$YR$$F$Y$52.5$KG$20240819$$MD$JP$JP
240850611$24085061$1$I$20230802$20240710$20240712$20240712$30DAY$$US-PFIZER INC-PV202400044408$PFIZER$$$$$$Y$$$20240712$$HP$US$US
240850621$24085062$1$I$20230829$20240709$20240712$20240712$EXP$$ES-PFIZER INC-202400209398$PFIZER$$63$YR$$F$Y$$$20240712$$MD$ES$ES
240850631$24085063$1$I$$20211025$20240712$20240712$PER$$JP-PFM-2021-10896$PIERRE FABRE MEDICAMENT$Tomoe O. Investigation of 33 Cases of Infantile Hemangioma Who Underwent Oral Propranolol Administration Combined with Dye Laser at Our Department. Journal of Japan Society of Plastic and Reconstructive Surgery. 2021;41(8):439-45$$$I$$Y$$$20240712$$HP$JP$JP
240850641$24085064$1$I$$20240627$20240712$20240712$30DAY$$BR-PFIZER INC-202400069602$PFIZER$$$$$F$Y$$$20240712$$PH$BR$BR
240850651$24085065$1$I$$20211108$20240712$20240712$PER$$CA-PFM-2021-11169$PIERRE FABRE MEDICAMENT$$50$YR$$F$Y$$$20240712$$MD$CA$CA
240850661$24085066$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006954$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240712$$CN$US$US
240850671$24085067$1$I$20211007$20211118$20240712$20240712$PER$$JP-PFM-2021-10366$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240712$$MD$JP$JP
240850681$24085068$1$I$$20211108$20240712$20240712$PER$$CA-PFM-2021-11168$PIERRE FABRE MEDICAMENT$$45$YR$$M$Y$$$20240712$$MD$CA$CA
240850691$24085069$1$I$$20211108$20240712$20240712$PER$$CA-PFM-2021-11173$PIERRE FABRE MEDICAMENT$$40$YR$$F$Y$$$20240712$$MD$CA$CA
240850712$24085071$2$F$20230918$20240719$20240712$20240729$EXP$IT-MINISAL02-992332$IT-TEVA-VS-3217568$TEVA$$44$YR$$$Y$74$KG$20240729$$PH$IT$IT
240850723$24085072$3$F$20240707$20240805$20240712$20240812$PER$$US-SA-2024SA203268$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240812$$CN$US$US
240850731$24085073$1$I$20240401$20240705$20240712$20240712$PER$$US-SA-2024SA202148$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240712$$MD$US$US
240850741$24085074$1$I$$20240702$20240712$20240712$30DAY$$US-GSK-US2024083060$GLAXOSMITHKLINE$$$$$M$Y$$$20240712$$CN$US$US
240850751$24085075$1$I$$20240709$20240712$20240712$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135229$DAIICHI$$$$$F$Y$$$20240712$$CN$US$US
240850775$24085077$5$F$20240611$20240812$20240712$20240814$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135235$DAIICHI$$44$YR$$F$Y$$$20240814$$CN$US$US
240850781$24085078$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110479$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240712$$CN$US$US
240850791$24085079$1$I$20211225$20240603$20240712$20240712$EXP$$AU-BAYER-2024A100283$BAYER$$$$$M$Y$$$20240712$$HP$AU$AU
240850801$24085080$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159446$ASTRAZENECA$$71$YR$$M$Y$74$KG$20240712$$HP$FR$
240850812$24085081$2$F$20240617$20240705$20240712$20240716$EXP$$CN-AstraZeneca-2024A157509$ASTRAZENECA$$28781$DY$$F$Y$90$KG$20240716$$MD$CN$
240850821$24085082$1$I$20240604$20240705$20240712$20240712$EXP$$DE-AstraZeneca-2024A154597$ASTRAZENECA$$29$YR$$M$Y$68$KG$20240712$$MD$DE$
240850831$24085083$1$I$$20240708$20240712$20240712$EXP$$US-AstraZeneca-2024A155995$ASTRAZENECA$$$$$F$Y$$$20240712$$MD$US$
240850841$24085084$1$I$$20240708$20240712$20240712$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011149$VERTEX$$$$$M$Y$$$20240712$$CN$GB$GB
240850851$24085085$1$I$$20240708$20240712$20240712$PER$$US-VERTEX PHARMACEUTICALS-2024-011364$VERTEX$$$$$$Y$$$20240712$$CN$US$US
240850861$24085086$1$I$20240601$20240708$20240712$20240712$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011332$VERTEX$$$$A$M$Y$$$20240712$$CN$GB$GB
240850871$24085087$1$I$20240401$20240708$20240712$20240712$EXP$$US-VERTEX PHARMACEUTICALS-2023-007274$VERTEX$$30$YR$$F$Y$52$KG$20240712$$CN$US$US
240850884$24085088$4$F$20240424$20240823$20240712$20240829$EXP$$US-VERTEX PHARMACEUTICALS-2024-009393$VERTEX$$30$YR$$F$Y$53$KG$20240829$$HP$US$US
240850891$24085089$1$I$20240618$20240708$20240712$20240712$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011357$VERTEX$$47$YR$$M$Y$$$20240712$$CN$GB$GB
240850901$24085090$1$I$20240101$20240705$20240712$20240712$EXP$$US-VERTEX PHARMACEUTICALS-2024-011269$VERTEX$$$$$M$Y$$$20240712$$CN$US$US
240850912$24085091$2$F$$20240812$20240712$20240816$PER$$US-VERTEX PHARMACEUTICALS-2024-011271$VERTEX$$32$YR$$F$Y$$$20240816$$CN$US$US
240850921$24085092$1$I$$20240705$20240712$20240712$PER$$US-VERTEX PHARMACEUTICALS-2024-011265$VERTEX$$$$$M$Y$$$20240712$$CN$US$US
240850931$24085093$1$I$20211101$20211124$20240712$20240712$PER$$ES-PFM-2021-11051$PIERRE FABRE MEDICAMENT$$3$MON$$M$Y$$$20240712$$CN$ES$ES
240850941$24085094$1$I$20211019$20211111$20240712$20240712$PER$$JP-PFM-2021-10779$PIERRE FABRE MEDICAMENT$$6$MON$$M$Y$$$20240712$$MD$JP$JP
240850951$24085095$1$I$20201201$20211208$20240712$20240712$PER$FR-AFSSAPS-PS20212392$FR-PFM-2021-10985$PIERRE FABRE MEDICAMENT$$17$YR$$F$Y$53$KG$20240712$$CN$FR$FR
240850961$24085096$1$I$20210924$20211215$20240712$20240712$PER$$JP-PFM-2021-10780$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$4$KG$20240712$$HP$JP$JP
240850971$24085097$1$I$20240605$20240708$20240712$20240712$EXP$ES-AEMPS-1543146$ES-MYLANLABS-2024M1064140$MYLAN$$2$YR$$M$Y$17$KG$20240712$$MD$ES$ES
240850982$24085098$2$F$$20240710$20240712$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011347$VERTEX$$$$$$Y$$$20240722$$CN$US$US
240850991$24085099$1$I$$20240705$20240712$20240712$PER$$US-VERTEX PHARMACEUTICALS-2023-016404$VERTEX$$$$$F$Y$$$20240712$$CN$US$US
240851001$24085100$1$I$20231007$20240708$20240712$20240712$EXP$FR-AFSSAPS-TO2024000947$FR-MYLANLABS-2024M1064165$MYLAN$$87$YR$$M$Y$$$20240712$$PH$FR$FR
240851011$24085101$1$I$$20240705$20240712$20240712$PER$$US-VERTEX PHARMACEUTICALS-2024-011266$VERTEX$$5$YR$$M$Y$$$20240712$$CN$US$US
240851021$24085102$1$I$$20240705$20240712$20240712$PER$$US-VERTEX PHARMACEUTICALS-2022-011379$VERTEX$$$$$M$Y$$$20240712$$CN$US$US
240851031$24085103$1$I$20210101$20240705$20240712$20240712$PER$$US-VERTEX PHARMACEUTICALS-2021-016772$VERTEX$$$$$F$Y$$$20240712$$CN$US$US
240851041$24085104$1$I$20240517$20240614$20240712$20240712$PER$$US-ROCHE-10000024342$ROCHE$$74$YR$E$M$Y$103$KG$20240712$$HP$US$US
240851051$24085105$1$I$20240507$20240614$20240712$20240712$PER$$US-ROCHE-10000024325$ROCHE$$68$YR$E$M$Y$87$KG$20240712$$HP$US$US
240851062$24085106$2$F$20240621$20240813$20240712$20240816$PER$$US-BIOVITRUM-2024-US-009715$BIOVITRUM$$59$YR$$F$Y$$$20240816$$HP$US$US
240851071$24085107$1$I$20240503$20240614$20240712$20240712$PER$$US-ROCHE-10000024625$ROCHE$$32$YR$A$M$Y$75$KG$20240712$$HP$US$US
240851081$24085108$1$I$20240530$20240614$20240712$20240712$PER$$US-ROCHE-10000024317$ROCHE$$64$YR$A$M$Y$75.5$KG$20240712$$HP$US$US
240851091$24085109$1$I$20240518$20240614$20240712$20240712$PER$$US-ROCHE-10000024545$ROCHE$$68$YR$E$M$Y$71.5$KG$20240712$$HP$US$US
240851101$24085110$1$I$20240507$20240614$20240712$20240712$PER$$US-ROCHE-10000024375$ROCHE$$43$YR$A$F$Y$65.5$KG$20240712$$HP$US$US
240851111$24085111$1$I$20240528$20240614$20240712$20240712$PER$$US-ROCHE-10000024305$ROCHE$$66$YR$E$M$Y$96$KG$20240712$$HP$US$US
240851121$24085112$1$I$20240508$20240614$20240712$20240712$PER$$US-ROCHE-10000024583$ROCHE$$55$YR$A$M$Y$51.5$KG$20240712$$HP$US$US
240851131$24085113$1$I$20231212$20240614$20240712$20240712$PER$$US-ROCHE-10000024360$ROCHE$$75$YR$E$F$Y$83.6$KG$20240712$$HP$US$US
240851141$24085114$1$I$$20240709$20240712$20240712$EXP$$NL-GSK-NL2024EME002595$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$MD$NL$NL
240851151$24085115$1$I$$20240704$20240712$20240712$EXP$$CO-GSK-CO2024AMR057678$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$HP$CO$CO
240851161$24085116$1$I$20240101$20240708$20240712$20240712$EXP$$EE-FreseniusKabi-FK202410798$FRESENIUS KABI$$57$YR$A$F$Y$$$20240712$$MD$EE$EE
240851171$24085117$1$I$$20240708$20240712$20240712$EXP$$CA-FreseniusKabi-FK202410940$FRESENIUS KABI$$66$YR$E$M$Y$92$KG$20240712$$HP$CA$CA
240851181$24085118$1$I$20240101$20240710$20240712$20240712$EXP$$DE-ABBVIE-5836723$ABBVIE$$79$YR$$F$Y$65$KG$20240712$$CN$DE$DE
240851191$24085119$1$I$20240308$20240708$20240712$20240712$EXP$FR-AFSSAPS-LL2024001220$FR-FreseniusKabi-FK202410896$FRESENIUS KABI$$35$YR$A$F$Y$$$20240712$$MD$FR$FR
240851201$24085120$1$I$20240101$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024136717$AMGEN$$66$YR$E$F$Y$$$20240712$$CN$US$US
240851211$24085121$1$I$$20240711$20240712$20240712$EXP$$CN-TAKEDA-2024TUS070997$TAKEDA$$$$$F$Y$$$20240712$$CN$CN$CN
240851226$24085122$6$F$20240701$20240826$20240712$20240903$EXP$$US-TAKEDA-2024TUS069154$TAKEDA$$55$YR$$F$Y$121.99$KG$20240903$$CN$US$US
240851231$24085123$1$I$20240619$20240708$20240712$20240712$EXP$FR-AFSSAPS-RE2024000650$FR-FreseniusKabi-FK202410902$FRESENIUS KABI$$24$YR$A$M$Y$133$KG$20240712$$MD$FR$FR
240851251$24085125$1$I$20240101$20240711$20240712$20240712$PER$$US-JNJFOC-20240730786$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240712$$CN$US$US
240851261$24085126$1$I$$20240711$20240712$20240712$PER$$US-JNJFOC-20240730956$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$CN$US$US
240851272$24085127$2$F$$20240710$20240712$20240717$PER$$US-BIOGEN-2024BI01273228$BIOGEN$$$$$F$Y$$$20240717$$CN$US$US
240851281$24085128$1$I$$20240605$20240712$20240712$EXP$$US-BAYER-2024A085942$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240712$$MD$US$US
240851291$24085129$1$I$$20240703$20240712$20240712$EXP$$IN-SA-2024SA200286$SANOFI AVENTIS$$$$$F$Y$$$20240712$$HP$IN$IN
240851301$24085130$1$I$20240623$20240710$20240712$20240712$EXP$GB-MHRA-MED-202407101218237110-KJPCV$GB-MYLANLABS-2024M1064792$MYLAN$$36$YR$$M$Y$83$KG$20240712$$CN$GB$GB
240851311$24085131$1$I$$20240709$20240712$20240712$PER$$US-BIOVITRUM-2024-US-009734$BIOVITRUM$$61$YR$$F$Y$$$20240712$$CN$US$US
240851321$24085132$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186806$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240851331$24085133$1$I$20230101$20240704$20240712$20240712$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2023-25897$IPSEN$$72$YR$E$M$Y$$$20240712$$CN$GB$GB
240851342$24085134$2$F$$20240819$20240712$20240822$PER$$US-ROCHE-10000024434$ROCHE$$$$A$F$Y$$$20240822$$MD$US$US
240851351$24085135$1$I$$20240527$20240712$20240712$PER$$US-LUNDBECK-DKLU4000060$LUNDBECK$$$$$$Y$$$20240712$$CN$US$US
240851362$24085136$2$F$20160713$20240801$20240712$20240807$EXP$$CA-TAKEDA-2024TUS046872$TAKEDA$$32$YR$$F$Y$$$20240807$$MD$CA$CA
240851371$24085137$1$I$$20240708$20240712$20240712$EXP$$HK-TAKEDA-2024TUS070196$TAKEDA$$$$$$Y$$$20240712$$CN$HK$HK
240851381$24085138$1$I$20240709$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137330$AMGEN$$70$YR$E$F$Y$$$20240712$$CN$US$US
240851391$24085139$1$I$20240519$20240708$20240712$20240712$EXP$$US-JNJFOC-20240720823$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240712$$CN$US$US
240851401$24085140$1$I$20240401$20240708$20240712$20240712$PER$$US-JNJFOC-20240720416$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240712$$CN$US$US
240851411$24085141$1$I$20230830$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216422$TEVA$$$$E$M$Y$$$20240712$$HP$KR$KR
240851422$24085142$2$F$$20240711$20240712$20240716$PER$$US-BIOVITRUM-2024-US-009762$BIOVITRUM$Kolios A, Schmauch E, Severin Y, Xing X, Mangold A, Conrad C, et al. Targeting IL-1 controls refractory pityriasis rubra pilaris. Science advances. 2024 Jul 03;10(27): 1-13. doi:10.1126/sciadv.ado2365.$53$YR$$M$Y$113$KG$20240716$$HP$US$US
240851431$24085143$1$I$20240704$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48310$$FDA-CTU$$79$YR$$M$N$103.7$KG$20240711$N$$US$
240851441$24085144$1$I$20240711$20240712$20240712$20240712$DIR$709988$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240851451$24085145$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48453$$FDA-CTU$$66$YR$$F$N$65.77$KG$20240712$N$HP$US$
240851461$24085146$1$I$20240615$20240705$20240712$20240712$DIR$FDA-CDER-CTU-2024-48443$$FDA-CTU$$69$YR$$F$N$$$20240705$N$HP$US$
240851471$24085147$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48411$$FDA-CTU$$80$YR$$M$N$$$20240712$N$$US$
240851481$24085148$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48455$$FDA-CTU$$67$YR$$F$N$86.64$KG$20240712$N$$US$
240851491$24085149$1$I$20230315$20240709$20240712$20240712$EXP$$KR-009507513-2407KOR003524$MERCK$$$$A$F$Y$$$20240712$$PH$KR$KR
240851501$24085150$1$I$20230503$20240704$20240712$20240712$EXP$$AU-TAKEDA-2024TUS069520$TAKEDA$$34$YR$$F$Y$$$20240712$$HP$AU$AU
240851511$24085151$1$I$$20240705$20240712$20240712$EXP$$NVSC2024CN143376$NOVARTIS$Xie L, Sun X, Xu J, Liang X, Liu K, Sun K, et al. The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma. BMC CANCER. 2024;24:172$$$$F$Y$$$20240712$$HP$CN$CN
240851521$24085152$1$I$20240710$20240710$20240712$20240712$PER$$US-PFIZER INC-202400212291$PFIZER$$39$YR$$F$Y$$$20240712$$CN$US$US
240851531$24085153$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-202400212830$PFIZER$$59$YR$$F$Y$$$20240712$$HP$US$US
240851541$24085154$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-202400211143$PFIZER$$$$$F$Y$$$20240712$$MD$US$US
240851553$24085155$3$F$$20240917$20240712$20240918$PER$$US-PFIZER INC-PV202400090842$PFIZER$$23$YR$$F$Y$$$20240918$$HP$US$US
240851561$24085156$1$I$20240201$20240710$20240712$20240712$PER$$US-PFIZER INC-202400212288$PFIZER$$$$$$Y$$$20240712$$CN$US$US
240851571$24085157$1$I$$20240710$20240712$20240712$PER$$JP-PFIZER INC-202400210385$PFIZER$$$$$$Y$$$20240712$$PH$JP$JP
240851583$24085158$3$F$$20240906$20240712$20240910$EXP$$US-PFIZER INC-202200785315$PFIZER$$50$YR$$F$Y$$$20240910$$CN$US$US
240851592$24085159$2$F$20240709$20240715$20240712$20240717$PER$$US-PFIZER INC-202400212256$PFIZER$$66$YR$$F$Y$$$20240717$$HP$US$US
240851601$24085160$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-202400211535$PFIZER$$65$YR$$M$Y$$$20240712$$MD$US$US
240851612$24085161$2$F$$20240712$20240712$20240716$PER$$US-PFIZER INC-202400212286$PFIZER$$52$YR$$F$Y$$$20240716$$HP$US$US
240851621$24085162$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-202400211710$PFIZER$$67$YR$$M$Y$$$20240712$$MD$US$US
240851632$24085163$2$F$$20240715$20240712$20240719$PER$$US-PFIZER INC-PV202400091163$PFIZER$$$$$F$Y$$$20240719$$MD$US$US
240851641$24085164$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-202400211266$PFIZER$$8$DEC$$F$Y$$$20240712$$MD$US$US
240851651$24085165$1$I$20240709$20240710$20240712$20240712$PER$$US-PFIZER INC-202400212025$PFIZER$$71$YR$$M$Y$$$20240712$$CN$US$US
240851661$24085166$1$I$20230701$20240710$20240712$20240712$PER$$US-PFIZER INC-202400212809$PFIZER$$74$YR$$F$Y$$$20240712$$HP$US$US
240851671$24085167$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-PV202400090743$PFIZER$$51$YR$$F$Y$$$20240712$$HP$US$US
240851681$24085168$1$I$20240101$20240710$20240712$20240712$PER$$US-PFIZER INC-PV202400090819$PFIZER$$65$YR$$F$Y$$$20240712$$HP$US$US
240851691$24085169$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-PV202400090896$PFIZER$$$$A$F$Y$$$20240712$$CN$US$US
240851711$24085171$1$I$20240710$20240710$20240712$20240712$PER$$US-PFIZER INC-202400211032$PFIZER$$$$$M$Y$$$20240712$$CN$US$US
240851721$24085172$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186690$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240851731$24085173$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-PV202400090752$PFIZER$$$$$F$Y$$$20240712$$CN$US$US
240851742$24085174$2$F$20220101$20240918$20240712$20240930$EXP$$CA-UCBSA-2022042818$UCB$$$$$M$Y$$$20241001$$CN$CA$CA
240851751$24085175$1$I$20210325$20240708$20240712$20240712$EXP$FR-AFSSAPS-LY2024001020$FR-FreseniusKabi-FK202410946$FRESENIUS KABI$$49$YR$A$F$Y$116$KG$20240712$$MD$FR$FR
240851761$24085176$1$I$20240601$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110936$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240712$$HP$US$US
240851771$24085177$1$I$20210521$20240701$20240712$20240712$EXP$$US-BAYER-2024A095716$BAYER$$$$E$F$Y$$$20240712$$CN$US$US
240851781$24085178$1$I$$20240708$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110365$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$75.3$KG$20240712$$CN$US$US
240851791$24085179$1$I$$20240708$20240712$20240712$PER$$US-ROCHE-10000020546$ROCHE$$$$$$Y$$$20240712$$PH$US$US
240851802$24085180$2$F$$20240724$20240712$20240726$EXP$$US-Taiho Oncology Inc-2024-006781$TAIHO ONCOLOGY INC$$57$YR$A$M$Y$60.96$KG$20240726$$CN$US$US
240851811$24085181$1$I$20240530$20240704$20240712$20240712$EXP$HR-HALMED-300085785$HR-TEVA-VS-3217578$TEVA$$60$YR$$F$Y$$$20240712$$MD$HR$HR
240851821$24085182$1$I$$20240708$20240712$20240712$EXP$$FR-JNJFOC-20230255715$JOHNSON AND JOHNSON$$78$YR$E$M$Y$60$KG$20240712$$MD$FR$FR
240851832$24085183$2$F$20240603$20240912$20240712$20240917$EXP$$US-NEBO-661574$PHARMACOSMOS$$54$YR$$F$Y$95$KG$20240917$$HP$US$US
240851841$24085184$1$I$20240711$20240712$20240712$20240712$DIR$709995$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240851851$24085185$1$I$$20240709$20240712$20240712$PER$$US-ABBVIE-5834000$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240851861$24085186$1$I$20231127$20240709$20240712$20240712$EXP$$CO-UCBSA-2024035305$UCB$$64$YR$$M$Y$$$20240712$$CN$CO$CO
240851881$24085188$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006038$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240712$$CN$US$US
240851891$24085189$1$I$$20240711$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007815$ELI LILLY AND CO$$21$YR$A$M$Y$$$20240712$$CN$US$US
240851901$24085190$1$I$$20240703$20240712$20240712$EXP$$IN-SA-2024SA200295$SANOFI AVENTIS$$$$$F$Y$$$20240712$$HP$IN$IN
240851911$24085191$1$I$20230329$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216414$TEVA$$$$E$F$Y$$$20240712$$HP$KR$KR
240851922$24085192$2$F$$20240708$20240712$20240720$EXP$$ALC2024IT003305$ALCON$$$$$$Y$$$20240720$$MD$IT$IT
240851931$24085193$1$I$$20231129$20240712$20240712$PER$$US-PFIZER INC-PV202400091183$PFIZER$$59$YR$$F$Y$$$20240712$$CN$US$US
240851941$24085194$1$I$$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216394$TEVA$$63$YR$$M$Y$$$20240712$$MD$KR$KR
240851951$24085195$1$I$20230830$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216413$TEVA$$$$$M$Y$$$20240712$$HP$KR$KR
240851961$24085196$1$I$20240626$20240705$20240712$20240712$PER$$US-SA-2024SA202090$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240712$$MD$US$US
240851971$24085197$1$I$20240701$20240702$20240712$20240712$EXP$GB-MHRA-MED-202407021200033630-CDZPF$GB-Accord-433837$ACCORD$$55$YR$A$F$Y$$$20240712$$HP$GB$GB
240851981$24085198$1$I$$20240702$20240712$20240712$EXP$CA-MHPD-001084799$CA-Accord-433886$ACCORD$$79$YR$E$F$Y$$$20240712$$PH$CA$CA
240851991$24085199$1$I$20240422$20240628$20240712$20240712$EXP$IT-MINISAL02-992619$IT-Accord-433476$ACCORD$$53$YR$A$F$Y$$$20240712$$MD$IT$IT
240852001$24085200$1$I$20240523$20240702$20240712$20240712$EXP$$US-Accord-433911$ACCORD$$47$YR$A$M$Y$$$20240712$$HP$US$US
240852011$24085201$1$I$$20240702$20240712$20240712$EXP$GB-MHRA-EMIS-3831-f1ebf208-ad70-49fe-9e22-72ebf57f5e83$GB-Accord-433844$ACCORD$$65$YR$E$F$Y$88$KG$20240712$$PH$GB$GB
240852022$24085202$2$F$20240629$20240719$20240712$20240730$EXP$$US-Accord-433790$ACCORD$$68$YR$E$F$Y$$$20240730$$HP$US$US
240852034$24085203$4$F$20240401$20240826$20240712$20240830$PER$$US-ROCHE-10000019891$ROCHE$$73$YR$E$F$Y$99.79$KG$20240830$$CN$US$US
240852042$24085204$2$F$$20240724$20240712$20240802$EXP$$US-TEVA-VS-3218673$TEVA$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch-Dermatol-Res 2024; 316 (6):.; Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch-Dermatol-Res 2024; 316 (6):.; Kirven ...$26$YR$$F$Y$$$20240802$$HP$US$US
240852052$24085205$2$F$20240618$20240717$20240712$20240727$EXP$GB-MHRA-TPP61840023C11097060YC1719228836778$GB-Accord-433912$ACCORD$$86$YR$E$F$Y$$$20240727$$MD$GB$GB
240852061$24085206$1$I$20240520$20240702$20240712$20240712$EXP$FR-AFSSAPS-NC2024000792$FR-Accord-433822$ACCORD$$11$YR$C$F$Y$38$KG$20240712$$MD$FR$FR
240852071$24085207$1$I$20240704$20240705$20240712$20240712$EXP$$CN-JNJFOC-20240722085$JOHNSON AND JOHNSON$$12$YR$T$M$Y$51$KG$20240712$$HP$CN$CN
240852082$24085208$2$F$20240206$20240712$20240712$20240717$EXP$$JP-AstraZeneca-2024A158069$ASTRAZENECA$$87$YR$$M$Y$$$20240717$$MD$JP$
240852091$24085209$1$I$20240630$20240704$20240712$20240712$EXP$$CO-AstraZeneca-2024A155675$ASTRAZENECA$$21201$DY$$F$Y$$$20240712$$CN$CO$
240852102$24085210$2$F$$20240730$20240712$20240807$EXP$$ES-AstraZeneca-2024A155882$ASTRAZENECA$$$$$$Y$$$20240807$$MD$ES$
240852111$24085211$1$I$$20240708$20240712$20240712$EXP$$GB-AstraZeneca-2024A157994$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$GB$
240852122$24085212$2$F$$20240709$20240712$20240716$PER$$US-AMGEN-USASP2024136927$AMGEN$$$$$$Y$$$20240716$$HP$US$US
240852132$24085213$2$F$20210714$20240729$20240712$20240805$EXP$$CO-UCBSA-2024035392$UCB$$71$YR$$F$Y$$$20240805$$CN$CO$CO
240852141$24085214$1$I$20240613$20240705$20240712$20240712$PER$$US-ROCHE-10000020548$ROCHE$$9$YR$C$M$Y$$$20240712$$CN$US$US
240852161$24085216$1$I$$20240710$20240712$20240712$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135434$DAIICHI$$$$$F$Y$$$20240712$$MD$US$US
240852171$24085217$1$I$$20240710$20240712$20240712$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135236$DAIICHI$$$$$F$Y$$$20240712$$CN$US$US
240852181$24085218$1$I$$20240701$20240712$20240712$EXP$$US-TEVA-VS-3218675$TEVA$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch-Dermatol-Res 2024; 316 (6):.; Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch-Dermatol-Res 2024; 316 (6):.$49$YR$$F$Y$$$20240712$$HP$US$US
240852192$24085219$2$F$$20240809$20240712$20240813$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135244$DAIICHI$$$$$F$Y$$$20240813$$CN$US$US
240852201$24085220$1$I$20210312$20240303$20240712$20240712$EXP$GB-MHRA-MED-202403020709396140-TQSHJ$GB-TEVA-VS-3167006$TEVA$$49$YR$$M$Y$$$20240712$$CN$GB$GB
240852211$24085221$1$I$20240101$20240701$20240712$20240712$PER$$US-ABBVIE-5835298$ABBVIE$$40$YR$$M$Y$$$20240712$$MD$US$US
240852223$24085222$3$F$20240628$20240918$20240712$20240921$PER$$US-ROCHE-10000021981$ROCHE$$70$YR$E$M$Y$78.02$KG$20240921$$CN$US$US
240852251$24085225$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48460$$FDA-CTU$$85$YR$$M$N$$$20240712$N$$US$
240852272$24085227$2$F$$20240821$20240712$20240822$PER$$NVSC2024US144322$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
240852281$24085228$1$I$$20240711$20240712$20240712$EXP$$US-UCBSA-2024035347$UCB$$$$$M$Y$$$20240712$$CN$US$US
240852291$24085229$1$I$20240612$20240710$20240712$20240712$PER$$US-ROCHE-10000023324$ROCHE$$43$YR$A$M$Y$$$20240712$$CN$US$US
240852301$24085230$1$I$20240530$20240711$20240712$20240712$PER$$US-ROCHE-3575195$ROCHE$$57$YR$A$F$Y$$$20240712$$CN$US$US
240852311$24085231$1$I$$20240702$20240712$20240712$PER$$US-ROCHE-10000020241$ROCHE$$47$YR$A$F$Y$$$20240712$$HP$US$US
240852321$24085232$1$I$20240711$20240711$20240712$20240712$PER$$US-ROCHE-10000024381$ROCHE$$$$$F$Y$$$20240712$$HP$US$US
240852331$24085233$1$I$$20240709$20240712$20240712$PER$$US-PURDUE PHARMA-USA-2024-0310720$PURDUE$$$$$M$Y$$$20240712$$CN$US$US
240852341$24085234$1$I$$20240711$20240712$20240712$PER$$US-ROCHE-10000024661$ROCHE$$$$A$F$Y$$$20240712$$CN$US$US
240852351$24085235$1$I$20240429$20240708$20240712$20240712$EXP$FR-AFSSAPS-RS2024000652$FR-FreseniusKabi-FK202410900$FRESENIUS KABI$$75$YR$E$M$Y$87$KG$20240712$$MD$FR$FR
240852361$24085236$1$I$20240612$20240708$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108312$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240712$$HP$US$US
240852371$24085237$1$I$20240626$20240708$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109145$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240712$$PH$US$US
240852381$24085238$1$I$$20240705$20240712$20240712$EXP$$IT-MYLANLABS-2024M1064937$MYLAN$Ricciardulli S, Lattanzi L, Barbuti M, Ceravolo R, Perugi G. Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report. Int-Clin-Psychopharmacol 2023; 38 (2): 117-120.$69$YR$$F$Y$$$20240712$$HP$IT$IT
240852391$24085239$1$I$20231015$20240705$20240712$20240712$EXP$$US-GSK-US2024084052$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$US$US
240852401$24085240$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48456$$FDA-CTU$$75$YR$$F$N$73.48$KG$20240712$N$$US$
240852421$24085242$1$I$20240306$20240707$20240712$20240712$EXP$$EG-Taiho Oncology Inc-2024-002866$TAIHO ONCOLOGY INC$$60$YR$A$F$Y$75$KG$20240712$$MD$EG$EG
240852432$24085243$2$F$20211110$20240718$20240712$20240725$EXP$$NL-TAKEDA-2021TUS078979$TAKEDA$$$$E$M$Y$66$KG$20240725$$CN$NL$NL
240852441$24085244$1$I$$20240522$20240712$20240712$PER$$US-LUNDBECK-DKLU3078462$LUNDBECK$$$$$$Y$$$20240712$$HP$US$US
240852451$24085245$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48422$$FDA-CTU$$62$YR$$F$N$87.09$KG$20240712$N$$US$
240852461$24085246$1$I$$20240711$20240712$20240712$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135439$DAIICHI$$$$$F$Y$$$20240712$$CN$US$US
240852471$24085247$1$I$$20240710$20240712$20240712$PER$$US-DSJP-DSU-2024-135446$DAIICHI$$$$$F$Y$$$20240712$$MD$US$US
240852481$24085248$1$I$20240613$20240704$20240712$20240712$EXP$$CN-AstraZeneca-2024A155868$ASTRAZENECA$$38$YR$$F$Y$60$KG$20240712$$MD$CN$
240852491$24085249$1$I$$20240705$20240712$20240712$EXP$$VN-AstraZeneca-2024A155854$ASTRAZENECA$$$$$M$Y$$$20240712$$MD$VN$
240852501$24085250$1$I$20240402$20240705$20240712$20240712$EXP$$FR-AstraZeneca-2024A154463$ASTRAZENECA$$61$YR$$F$Y$60$KG$20240712$$MD$FR$
240852511$24085251$1$I$$20240702$20240712$20240712$EXP$$US-ROCHE-10000017675$ROCHE$$83$YR$E$F$Y$$$20240712$$CN$US$US
240852521$24085252$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48379$$FDA-CTU$$76$YR$$F$N$$$20240712$N$HP$US$
240852531$24085253$1$I$20240401$20240708$20240712$20240712$EXP$$DE-AstraZeneca-2024A156032$ASTRAZENECA$$54$YR$$F$Y$$$20240712$$PH$DE$
240852541$24085254$1$I$20240710$20240712$20240712$20240712$DIR$709998$$FDA-CTU$$46$YR$$F$N$$$20240712$N$$US$
240852552$24085255$2$F$20240101$20240722$20240712$20240731$EXP$$US-SA-2024SA199498$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240731$$MD$US$US
240852562$24085256$2$F$20240801$20240830$20240712$20240906$EXP$$CO-GSK-CO2024AMR054997$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$CO$CO
240852581$24085258$1$I$$20240704$20240712$20240712$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR083333$VIIV$$$$$M$Y$$$20240712$$MD$US$US
240852591$24085259$1$I$$20240709$20240712$20240712$EXP$$IT-009507513-2407ITA005426$MERCK$$42$YR$$M$Y$$$20240712$$MD$IT$IT
240852601$24085260$1$I$20240319$20240711$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110944$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240712$$CN$US$US
240852611$24085261$1$I$$20240708$20240712$20240712$PER$$US-JNJFOC-20240718630$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240852621$24085262$1$I$$20240711$20240712$20240712$PER$$NVSC2024US144319$NOVARTIS$$$$$$Y$$$20240712$$HP$US$US
240852631$24085263$1$I$$20240705$20240712$20240712$EXP$$IT-MYLANLABS-2024M1064055$MYLAN$Grimaudo MS, Laffi A, Gennaro N, Fazio R, D^Orazio F, Sama L, et al. Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule. Front-Oncol 2023; 13.$63$YR$$M$Y$$$20240712$$HP$IT$IT
240852642$24085264$2$F$$20240716$20240712$20240719$PER$$US-AMGEN-USASP2024138215$AMGEN$$$$$F$Y$$$20240719$$CN$US$US
240852651$24085265$1$I$$20240708$20240712$20240712$EXP$$KR-BAYER-2024A099201$BAYER$$$$$$Y$$$20240712$$MD$KR$KR
240852662$24085266$2$F$$20240805$20240712$20240813$EXP$$US-ALXN-202407USA000543US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
240852671$24085267$1$I$20220715$20240709$20240712$20240712$EXP$$AT-PFIZER INC-2022SGN08363$PFIZER$$60$YR$$F$Y$86$KG$20240712$$MD$AT$AT
240852683$24085268$3$F$20170101$20240806$20240712$20240813$EXP$$FR-PFIZER INC-2017SGN02994$PFIZER$$62$YR$$M$Y$65$KG$20240813$$MD$FR$FR
240852691$24085269$1$I$20200101$20240708$20240712$20240712$EXP$$AT-PFIZER INC-2021SGN01410$PFIZER$$59$YR$$F$Y$$$20240712$$MD$AT$AT
240852701$24085270$1$I$20220315$20240709$20240712$20240712$EXP$$AT-PFIZER INC-2023SGN03272$PFIZER$$60$YR$$F$Y$86$KG$20240712$$MD$AT$AT
240852712$24085271$2$F$$20240913$20240712$20240918$EXP$$CA-PFIZER INC-202400212390$PFIZER$$41$YR$$F$Y$$$20240918$$CN$CA$CA
240852731$24085273$1$I$20211123$20240709$20240712$20240712$EXP$$AT-PFIZER INC-2022SGN08362$PFIZER$$47$YR$$F$Y$$$20240712$$HP$AT$AT
240852741$24085274$1$I$$20240708$20240712$20240712$EXP$$GB-PFIZER INC-2021SGN05204$PFIZER$$27$YR$$M$Y$$$20240712$$MD$GB$GB
240852751$24085275$1$I$20180724$20240711$20240712$20240712$EXP$$FR-PFIZER INC-2018SGN03328$PFIZER$$57$YR$$F$Y$64$KG$20240712$$HP$FR$FR
240852762$24085276$2$F$20160101$20240718$20240712$20240724$EXP$$FR-PFIZER INC-2016SGN01807$PFIZER$$85$YR$$F$Y$60$KG$20240724$$MD$FR$FR
240852771$24085277$1$I$20200412$20240708$20240712$20240712$EXP$$AT-PFIZER INC-2020SGN04117$PFIZER$$$$E$M$Y$111$KG$20240712$$HP$AT$AT
240852791$24085279$1$I$$20240708$20240712$20240712$EXP$$CA-FreseniusKabi-FK202410944$FRESENIUS KABI$$11$YR$C$M$Y$34$KG$20240712$$HP$CA$CA
240852811$24085281$1$I$$20240703$20240712$20240712$EXP$$GB-Covis Pharma GmbH-2024COV00869$COVIS PHARMA$$63$YR$A$F$Y$70$KG$20240712$$MD$GB$GB
240852822$24085282$2$F$20240401$20240905$20240712$20240911$EXP$$JP-OTSUKA-2024_019446$OTSUKA$$3$DEC$$F$Y$$$20240911$$MD$JP$JP
240852831$24085283$1$I$$20240703$20240712$20240712$EXP$$US-FreseniusKabi-FK202410875$FRESENIUS KABI$Levinson K, Matthews BJ, Froehlich A, Goicochea L. Postmenopausal mixed gestational trophoblastic neoplasia with complete response to immunotherapy ? A case report. Gynecologic Oncology Reports. 2023 Apr;46: doi:https://doi.org/10.1016/j.gore.2023.101168.$66$YR$E$F$Y$$$20240712$$HP$US$US
240852841$24085284$1$I$$20240604$20240712$20240712$PER$$US-LUNDBECK-DKLU4000291$LUNDBECK$$$$$$Y$$$20240712$$CN$US$US
240852851$24085285$1$I$20240401$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110968$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240712$$CN$US$US
240852861$24085286$1$I$20240629$20240707$20240712$20240712$EXP$$GB-FreseniusKabi-FK202410723$FRESENIUS KABI$$56$YR$A$M$Y$$$20240712$$CN$GB$GB
240852881$24085288$1$I$20240711$20240712$20240712$20240712$DIR$709987$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240852901$24085290$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48461$$FDA-CTU$$32$YR$$F$N$$$20240712$N$$US$
240852941$24085294$1$I$19740920$20240712$20240712$20240712$DIR$710000$$FDA-CTU$$49$YR$$F$N$74.25$KG$20240712$N$PH$US$
240852951$24085295$1$I$20240501$20240704$20240712$20240712$EXP$$BR-TAKEDA-2024TUS042580$TAKEDA$$47$YR$$F$Y$$$20240712$$CN$BR$BR
240852961$24085296$1$I$20230604$20230815$20240712$20240712$PER$$US-PERRIGO-23US009267$PERRIGO$$21$YR$$F$Y$$$20240712$$CN$US$US
240852971$24085297$1$I$20221201$20230710$20240712$20240712$PER$$US-PERRIGO-23US007985$PERRIGO$$$$A$$Y$$$20240712$$CN$US$US
240852991$24085299$1$I$20200101$20230830$20240712$20240712$PER$$US-PERRIGO-23US009671$PERRIGO$$$$$M$Y$$$20240712$$CN$US$US
240853001$24085300$1$I$20230726$20230728$20240712$20240712$PER$$US-PERRIGO-23US008825$PERRIGO$$$$$M$Y$$$20240712$$CN$US$US
240853011$24085301$1$I$20200101$20230830$20240712$20240712$PER$$US-PERRIGO-23US009674$PERRIGO$$$$A$$Y$$$20240712$$CN$US$US
240853021$24085302$1$I$20230522$20230710$20240712$20240712$PER$$US-PERRIGO-23US007902$PERRIGO$$$$$M$Y$$$20240712$$LW$US$US
240853031$24085303$1$I$20230801$20230831$20240712$20240712$PER$$US-PERRIGO-23US010541$PERRIGO$$$$A$$Y$$$20240712$$CN$US$US
240853041$24085304$1$I$20230824$20230825$20240712$20240712$PER$$US-PERRIGO-23US009596$PERRIGO$$22$YR$$F$Y$$$20240712$$CN$US$US
240853051$24085305$1$I$20240630$20240703$20240712$20240712$EXP$CN-NMPACDR-4205831541489202400190$CN-BAXTER-2024BAX021217$BAXTER$$60$YR$$F$Y$$$20240712$$MD$CN$CN
240853061$24085306$1$I$20230601$20230627$20240712$20240712$PER$$US-PERRIGO-23US007600$PERRIGO$$$$$F$Y$$$20240712$$CN$US$US
240853071$24085307$1$I$20230501$20230808$20240712$20240712$PER$$US-PERRIGO-23US009032$PERRIGO$$55$YR$$F$Y$$$20240712$$CN$US$US
240853081$24085308$1$I$20230829$20230829$20240712$20240712$PER$$US-PERRIGO-23US010883$PERRIGO$$$$$F$Y$$$20240712$$CN$US$US
240853091$24085309$1$I$20230623$20230707$20240712$20240712$PER$$US-PERRIGO-23US007723$PERRIGO$$57$YR$$M$Y$117.91$KG$20240712$$CN$US$US
240853101$24085310$1$I$20230726$20230728$20240712$20240712$PER$$US-PERRIGO-23US008830$PERRIGO$$$$$F$Y$$$20240712$$CN$US$US
240853123$24085312$3$F$20240101$20240807$20240712$20240812$EXP$$CA-UCBSA-2024035411$UCB$$$$$F$Y$$$20240812$$CN$CA$CA
240853131$24085313$1$I$20231001$20231023$20240712$20240712$PER$$US-PERRIGO-23US012371$PERRIGO$$$$A$$Y$$$20240712$$CN$US$US
240853141$24085314$1$I$20230901$20230920$20240712$20240712$PER$$US-PERRIGO-23US011311$PERRIGO$$$$$F$Y$$$20240712$$CN$US$US
240853151$24085315$1$I$20231115$20231115$20240712$20240712$PER$$US-PERRIGO-23US013262$PERRIGO$$$$$M$Y$$$20240712$$CN$US$US
240853161$24085316$1$I$20230101$20240103$20240712$20240712$PER$$US-PERRIGO-24US000106$PERRIGO$$$$$M$Y$$$20240712$$CN$US$US
240853171$24085317$1$I$$20240709$20240712$20240712$PER$$US-TAKEDA-2024TUS069977$TAKEDA$$$$$F$Y$$$20240712$$MD$US$US
240853181$24085318$1$I$20230101$20240103$20240712$20240712$PER$$US-PERRIGO-24US000104$PERRIGO$$$$$F$Y$$$20240712$$CN$US$US
240853191$24085319$1$I$20200101$20231227$20240712$20240712$PER$$US-PERRIGO-23US014934$PERRIGO$$$$$F$Y$80.726$KG$20240712$$CN$US$US
240853211$24085321$1$I$20231205$20231226$20240712$20240712$PER$$US-PERRIGO-23US014936$PERRIGO$$79$YR$$F$Y$$$20240712$$CN$US$US
240853221$24085322$1$I$20231029$20231031$20240712$20240712$PER$$US-PERRIGO-23US012630$PERRIGO$$64$YR$$F$Y$$$20240712$$CN$US$US
240853231$24085323$1$I$20231018$20231018$20240712$20240712$PER$$US-PERRIGO-23US012145$PERRIGO$$$$$F$Y$$$20240712$$CN$US$US
240853241$24085324$1$I$20231030$20231030$20240712$20240712$PER$$US-PERRIGO-23US012545$PERRIGO$$93$YR$$M$Y$88.435$KG$20240712$$CN$US$US
240853251$24085325$1$I$20231026$20231026$20240712$20240712$PER$$US-PERRIGO-23US012549$PERRIGO$$75$YR$$F$Y$$$20240712$$CN$US$US
240853261$24085326$1$I$20240413$20240415$20240712$20240712$PER$$US-PERRIGO-24US003770$PERRIGO$$55$YR$$F$Y$$$20240712$$CN$US$US
240853271$24085327$1$I$20240101$20240124$20240712$20240712$PER$$US-PERRIGO-24US000903$PERRIGO$$61$YR$$M$Y$$$20240712$$CN$US$US
240853281$24085328$1$I$20240402$20240402$20240712$20240712$PER$$US-PERRIGO-24US003382$PERRIGO$$78$YR$$F$Y$$$20240712$$CN$US$US
240853291$24085329$1$I$$20240229$20240712$20240712$PER$$US-PERRIGO-24US002109$PERRIGO$$$$A$F$Y$$$20240712$$CN$US$US
240853301$24085330$1$I$$20240109$20240712$20240712$PER$$US-PERRIGO-24US000387$PERRIGO$$$$$M$Y$$$20240712$$CN$US$US
240853311$24085331$1$I$20240301$20240307$20240712$20240712$PER$$US-PERRIGO-24US002569$PERRIGO$$29$YR$$F$Y$$$20240712$$CN$US$US
240853321$24085332$1$I$$20240320$20240712$20240712$PER$$US-PERRIGO-24US002932$PERRIGO$$$$$F$Y$$$20240712$$CN$US$US
240853331$24085333$1$I$$20240502$20240712$20240712$PER$$US-PERRIGO-24US004406$PERRIGO$$$$$M$Y$$$20240712$$CN$US$US
240853341$24085334$1$I$20231201$20240213$20240712$20240712$PER$$US-PERRIGO-24US001642$PERRIGO$$78$YR$$M$Y$$$20240712$$CN$US$US
240853351$24085335$1$I$$20240507$20240712$20240712$PER$$US-PERRIGO-24US004493$PERRIGO$$$$$M$Y$$$20240712$$CN$US$US
240853361$24085336$1$I$20240501$20240531$20240712$20240712$PER$$US-PERRIGO-24US005336$PERRIGO$$$$$F$Y$$$20240712$$CN$US$US
240853371$24085337$1$I$20240409$20240416$20240712$20240712$PER$$US-PERRIGO-24US003841$PERRIGO$$66$YR$$F$Y$$$20240712$$CN$US$US
240853381$24085338$1$I$20240604$20240605$20240712$20240712$PER$$US-PERRIGO-24US005542$PERRIGO$$$$$M$Y$$$20240712$$CN$US$US
240853391$24085339$1$I$$20240702$20240712$20240712$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407007211$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240712$$CN$DE$BR
240853401$24085340$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006971$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240712$$CN$US$US
240853411$24085341$1$I$$20240710$20240712$20240712$EXP$$GB-PFIZER INC-202400210432$PFIZER$$86$YR$$F$Y$57$KG$20240712$$MD$GB$GB
240853421$24085342$1$I$20240704$20240710$20240712$20240712$EXP$$DZ-PFIZER INC-202400212238$PFIZER$$$$$M$Y$$$20240712$$MD$DZ$DZ
240853431$24085343$1$I$20221001$20240710$20240712$20240712$EXP$IT-MINISAL02-994088$IT-PFIZER INC-202400210368$PFIZER$$45$YR$$M$Y$92$KG$20240712$$MD$IT$IT
240853441$24085344$1$I$20240707$20240710$20240712$20240712$EXP$$CN-PFIZER INC-PV202400090622$PFIZER$$62$YR$$M$Y$65$KG$20240712$$HP$CN$CN
240853451$24085345$1$I$20240701$20240710$20240712$20240712$EXP$GB-MHRA-MED-202407101114394590-WQBHF$GB-PFIZER INC-202400210559$PFIZER$$79$YR$$M$Y$$$20240712$$HP$GB$GB
240853461$24085346$1$I$$20240708$20240712$20240712$EXP$BE-FAMHP-DHH-N2024-122325$BE-PFIZER INC-202400212306$PFIZER$$$$$F$Y$$$20240712$$PH$BE$BE
240853471$24085347$1$I$20210702$20240709$20240712$20240712$EXP$$US-PFIZER INC-US-GBT-21-02312$PFIZER$$77$YR$$F$Y$$$20240712$$CN$US$US
240853491$24085349$1$I$20240621$20240710$20240712$20240712$EXP$$CN-PFIZER INC-PV202400090663$PFIZER$$78$YR$$M$Y$$$20240712$$HP$CN$CN
240853501$24085350$1$I$20240702$20240703$20240712$20240712$EXP$$MX-PFIZER INC-202400206014$PFIZER$$22$YR$$M$Y$$$20240712$$MD$MX$MX
240853511$24085351$1$I$20240702$20240709$20240712$20240712$EXP$IT-MINISAL02-993866$IT-PFIZER INC-202400209356$PFIZER$$63$YR$$M$Y$$$20240712$$MD$IT$IT
240853521$24085352$1$I$20210224$20240705$20240712$20240712$EXP$$DE-PFIZER INC-202400212504$PFIZER$$$$A$F$Y$$$20240712$$MD$DE$DE
240853531$24085353$1$I$20240601$20240709$20240712$20240712$EXP$$CA-OTSUKA-2024_019501$OTSUKA$$69$YR$$M$Y$$$20240712$$CN$CA$CA
240853541$24085354$1$I$20240601$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110955$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240712$$HP$US$US
240853561$24085356$1$I$20240710$20240710$20240712$20240712$EXP$$PT-GSK-PT2024EME086082$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$MD$PT$PT
240853571$24085357$1$I$20171101$20240709$20240712$20240712$PER$$US-BAYER-2024A099294$BAYER$$66$YR$E$F$Y$$$20240712$$CN$US$US
240853581$24085358$1$I$$20240705$20240712$20240712$PER$$US-BAYER-2024A097571$BAYER$$$$$F$Y$$$20240712$$MD$US$US
240853591$24085359$1$I$$20240705$20240712$20240712$EXP$$US-JNJFOC-20240715426$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$CN$US$US
240853601$24085360$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159510$ASTRAZENECA$$60$YR$$F$Y$$$20240712$$HP$FR$
240853611$24085361$1$I$20240527$20240704$20240712$20240712$EXP$$CN-AstraZeneca-2024A156312$ASTRAZENECA$$22313$DY$$F$Y$$$20240712$$MD$CN$
240853621$24085362$1$I$20240702$20240712$20240712$20240712$DIR$710001$$FDA-CTU$$43$YR$$F$N$74.7$KG$20240712$N$CN$US$
240853631$24085363$1$I$20240101$20240709$20240712$20240712$EXP$$CA-PFIZER INC-202400053588$PFIZER$$32$YR$$F$Y$111$KG$20240712$$CN$CA$CA
240853641$24085364$1$I$20240423$20240705$20240712$20240712$EXP$$GB-AstraZeneca-2024A154223$ASTRAZENECA$$$$$M$Y$$$20240712$$MD$GB$
240853651$24085365$1$I$$20240709$20240712$20240712$EXP$$ID-AstraZeneca-2024A158974$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$ID$
240853671$24085367$1$I$20240711$20240712$20240712$20240712$DIR$710003$$FDA-CTU$$24$YR$$M$N$76.5$KG$20240712$N$HP$US$
240853681$24085368$1$I$$20240704$20240712$20240712$PER$$US-BAYER-2024A097825$BAYER$$$$$F$Y$$$20240712$$CN$US$US
240853691$24085369$1$I$$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110994$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240712$$CN$US$US
240853701$24085370$1$I$$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111053$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240712$$CN$US$US
240853711$24085371$1$I$$20240712$20240712$20240712$DIR$710009$$FDA-CTU$$$$$M$N$$$20240712$N$HP$US$
240853722$24085372$2$F$$20240722$20240712$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099577$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240725$$CN$US$US
240853742$24085374$2$F$20240311$20240812$20240712$20240818$EXP$GB-MHRA-MED-202405090912582800-FMHRG$GB-RDY-SPO/GBR/24/0010029$DR REDDYS$$73$YR$E$M$Y$101$KG$20240818$$PH$GB$GB
240853752$24085375$2$F$20240501$20240710$20240712$20240717$PER$$US-AMGEN-USASP2024137808$AMGEN$$48$YR$A$F$Y$$$20240717$$CN$US$US
240853761$24085376$1$I$$20240710$20240712$20240712$EXP$$US-TAKEDA-2023TUS038703$TAKEDA$$$$$M$Y$$$20240712$$MD$US$US
240853771$24085377$1$I$20240705$20240712$20240712$20240712$DIR$710007$$FDA-CTU$$33$YR$$F$N$126.45$KG$20240712$N$CN$US$
240853781$24085378$1$I$20240710$20240712$20240712$20240712$DIR$709990$$FDA-CTU$$33$YR$$F$N$73.35$KG$20240712$N$CN$US$
240853791$24085379$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA200251$SANOFI AVENTIS$$$$$F$Y$$$20240712$$CN$US$US
240853801$24085380$1$I$$20240702$20240712$20240712$EXP$$GB-PHARMAESSENTIA CORPORATION-GB-2024-PEC-004126$PHARMAESSENTIA$$$$$F$Y$$$20240712$$CN$GB$GB
240853812$24085381$2$F$$20240716$20240712$20240722$EXP$$US-ABBVIE-5832939$ABBVIE$$$$$$Y$$$20240722$$CN$US$US
240853822$24085382$2$F$$20240709$20240712$20240827$EXP$$NVSC2024CZ143746$NOVARTIS$$60$YR$$F$Y$$$20240827$$MD$CZ$CZ
240853832$24085383$2$F$20231001$20240924$20240712$20240927$EXP$$IN-GSK-IN2023APC136591$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$IN$IN
240853841$24085384$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186694$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240853851$24085385$1$I$20240215$20240704$20240712$20240712$EXP$FR-AFSSAPS-LY2024000867$FR-TEVA-VS-3217598$TEVA$$67$YR$$F$Y$50$KG$20240712$$PH$FR$FR
240853861$24085386$1$I$20240101$20240709$20240712$20240712$EXP$$US-DSJP-DSU-2024-135241$DAIICHI$$$$$F$Y$$$20240712$$PH$US$US
240853871$24085387$1$I$20240626$20240708$20240712$20240712$EXP$GB-MHRA-TPP4111031C9498820YC1719390227235$GB-DSJP-DSE-2024-134778$DAIICHI$$66$YR$$F$Y$114$KG$20240712$$PH$GB$GB
240853891$24085389$1$I$$20240705$20240712$20240712$EXP$$DE-AMGEN-DEUSP2024134590$AMGEN$Topp M.S.; Tani M.; Dickinson M. et al.. Glofitamab Plus R-CHOP Induces High Response Rates with a Manageable Safety Profile in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A 12-Month Analysis from a Phase lb Study. Blood. 2023;142 (SUPPL 1):3085$$$$$Y$$$20240712$$MD$DE$DE
240853902$24085390$2$F$20240101$20240719$20240712$20240724$EXP$$US-AMGEN-USASP2024137084$AMGEN$$$$$$Y$$$20240724$$MD$US$US
240853911$24085391$1$I$$20240704$20240712$20240712$EXP$$TR-AMGEN-TURSP2024133892$AMGEN$Akcay O.F.; Yeter H.H.; Guz G.. Utility of cinacalcet treatment in kidney transplant recipients with persistent hyperparathyroidism. Nephrology Dialysis Transplantation. 2024;39:i1603-i1605$$$$$Y$$$20240712$$HP$TR$TR
240853921$24085392$1$I$$20240711$20240712$20240712$PER$$US-AMGEN-USASP2024138360$AMGEN$$$$$F$Y$$$20240712$$HP$US$US
240853931$24085393$1$I$20240422$20240704$20240712$20240712$EXP$IT-MINISAL02-992397$IT-TEVA-VS-3217577$TEVA$$69$YR$$M$Y$69$KG$20240712$$MD$IT$IT
240853942$24085394$2$F$$20240820$20240712$20240821$PER$$US-ALXN-202407USA000481US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
240853951$24085395$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48481$$FDA-CTU$$63$YR$$F$N$$$20240712$N$$US$
240853961$24085396$1$I$$20240708$20240712$20240712$PER$$US-ALXN-202407USA000636US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240853971$24085397$1$I$$20240710$20240712$20240712$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-134636$DAIICHI$$7$DEC$$F$Y$$$20240712$$MD$JP$JP
240853981$24085398$1$I$$20240709$20240712$20240712$EXP$$IL-BAYER-2024A099378$BAYER$$$$$$Y$$$20240712$$CN$IL$IL
240853991$24085399$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108999$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240712$$CN$US$US
240854001$24085400$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48476$$FDA-CTU$$59$YR$$F$N$$$20240712$N$$US$
240854011$24085401$1$I$$20240702$20240712$20240712$EXP$$ES-RDY-LIT/ESP/24/0009984$DR REDDYS$Neacsu ED, Montalban EM, Miguel BM. Resolution of a rare case of hypercalcemia in a PTHrp-producing pancreatic neuroendocrine tumor using selective internal radiation therapy with 90Y microspheres. Annals of Pancreatic Cancer. 2024 Jun 30;7: doi:10.21037/apc-23-19.$7$DEC$E$F$Y$$$20240712$$HP$ES$ES
240854021$24085402$1$I$$20240704$20240712$20240712$PER$$US-AMGEN-USASP2024132898$AMGEN$Hutchinson A.; Eskens D.; Chan A. et. al. Managing suspected myasthenia gravis and myositis induced by pembrolizumab in a Jehovah^s Witness sarcoma patient. Journal of Oncology Pharmacy Practice. 2024;30 (5):950-953$73$YR$E$M$Y$$$20240712$$HP$US$US
240854032$24085403$2$F$$20240827$20240712$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002940$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
240854042$24085404$2$F$20240629$20240704$20240712$20240715$EXP$$CN-JNJFOC-20240718224$JOHNSON AND JOHNSON$$69$YR$E$F$Y$69$KG$20240715$$HP$CN$CN
240854052$24085405$2$F$20240614$20240812$20240712$20240812$EXP$FR-AFSSAPS-NY2024000735$FR-JNJFOC-20240728773$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240813$$PH$FR$FR
240854061$24085406$1$I$20240101$20240709$20240712$20240712$EXP$$US-ABBVIE-5834116$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240854072$24085407$2$F$20240426$20240728$20240712$20240801$EXP$$JP-BAYER-2024A099672$BAYER$$82$YR$E$M$Y$$$20240801$$MD$JP$JP
240854081$24085408$1$I$$20240708$20240712$20240712$PER$$US-AMGEN-USASP2024138271$AMGEN$$$$$M$Y$$$20240712$$CN$US$US
240854091$24085409$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48480$$FDA-CTU$$63$YR$$F$N$$$20240712$N$$US$
240854111$24085411$1$I$20110901$20240704$20240712$20240712$EXP$GB-MHRA-MED-202405021518569640-TZGLF$GB-OTSUKA-2024_019060$OTSUKA$$38$YR$$F$Y$$$20240712$$CN$GB$GB
240854122$24085412$2$F$20240529$20240807$20240712$20240809$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-135042$DAIICHI$$59$YR$$M$Y$$$20240809$$CN$US$US
240854131$24085413$1$I$20240626$20240703$20240712$20240712$EXP$$JP-009507513-2407JPN000581J$MERCK$$6$DEC$$F$Y$$$20240712$$MD$JP$JP
240854141$24085414$1$I$20240610$20240710$20240712$20240712$PER$$US-009507513-2407USA005054$MERCK$$57$YR$$F$Y$$$20240712$$CN$US$US
240854151$24085415$1$I$$20240704$20240712$20240712$EXP$$ZA-AstraZeneca-2024A155528$ASTRAZENECA$$52$YR$$M$Y$$$20240712$$CN$ZA$
240854161$24085416$1$I$$20240709$20240712$20240712$EXP$$CN-AstraZeneca-2024A157952$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$CN$
240854172$24085417$2$F$20240601$20240923$20240712$20240927$EXP$$CO-UCBSA-2024035394$UCB$$49$YR$$F$Y$$$20240927$$CN$CO$CO
240854181$24085418$1$I$$20240704$20240712$20240712$EXP$$ZA-AstraZeneca-2024A155781$ASTRAZENECA$$83$YR$$F$Y$$$20240712$$CN$ZA$
240854191$24085419$1$I$$20240704$20240712$20240712$EXP$$FR-AstraZeneca-2024A011419$ASTRAZENECA$$$$$F$Y$72$KG$20240712$$MD$FR$
240854201$24085420$1$I$20230928$20240705$20240712$20240712$EXP$$JP-009507513-2407JPN004291$MERCK$$71$YR$$M$Y$59.4$KG$20240712$$MD$JP$JP
240854211$24085421$1$I$20240504$20240705$20240712$20240712$EXP$$GB-AstraZeneca-2024A154324$ASTRAZENECA$$65$YR$$M$Y$70$KG$20240712$$MD$GB$
240854221$24085422$1$I$$20240708$20240712$20240712$EXP$$US-AstraZeneca-2024A155909$ASTRAZENECA$$$$$M$Y$$$20240712$$HP$US$
240854231$24085423$1$I$20230208$20240708$20240712$20240712$EXP$$GB-PFIZER INC-2023SGN02473$PFIZER$$19$YR$$F$Y$$$20240712$$MD$GB$GB
240854241$24085424$1$I$$20240711$20240712$20240712$EXP$$IN-AstraZeneca-2024A159564$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$IN$
240854251$24085425$1$I$$20240708$20240712$20240712$EXP$$IE-PFIZER INC-2022SGN06020$PFIZER$$$$$F$Y$$$20240712$$MD$IE$IE
240854261$24085426$1$I$20100201$20240704$20240712$20240712$EXP$$DE-PFIZER INC-2020SGN05123$PFIZER$$70$YR$$M$Y$66$KG$20240712$$MD$DE$DE
240854271$24085427$1$I$20240124$20240705$20240712$20240712$EXP$$DE-PFIZER INC-2024SGN01516$PFIZER$$$$$F$Y$$$20240712$$MD$DE$DE
240854281$24085428$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159352$ASTRAZENECA$$68$YR$$M$Y$93$KG$20240712$$HP$FR$
240854292$24085429$2$F$$20240920$20240712$20240925$EXP$$DE-PFIZER INC-2024SGN00172$PFIZER$$34$YR$$F$Y$$$20240925$$MD$DE$DE
240854301$24085430$1$I$$20240705$20240712$20240712$EXP$$HU-AstraZeneca-2024A157229$ASTRAZENECA$Horv?th L, S?t?r Sz,Temesi G, Bogos K.. EGFR-szenzitiz?l? mut?ci?val rendelkez? adenocarcinoma kissejtes t?d?r?kk? val? transzform?ci?ja-esetbemutat?s. Medicina Thoracalis 2024;3:190-191..$26$YR$$M$Y$$$20240712$$HP$HU$
240854311$24085431$1$I$20210513$20240709$20240712$20240712$EXP$$AT-PFIZER INC-2024SGN01129$PFIZER$$47$YR$$F$Y$$$20240712$$MD$AT$AT
240854321$24085432$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48385$$FDA-CTU$$39$YR$$F$N$113.4$KG$20240712$N$$US$
240854331$24085433$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110956$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240712$$CN$US$US
240854341$24085434$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48470$$FDA-CTU$$61$YR$$F$N$$$20240712$N$$US$
240854352$24085435$2$F$20240710$20240711$20240712$20240715$PER$$US-HALEON-2186767$Haleon PLC$$77$YR$$F$Y$$$20240715$$CN$US$US
240854361$24085436$1$I$20221114$20240710$20240712$20240712$EXP$$ZA-ABBVIE-5836589$ABBVIE$$9$YR$$M$Y$$$20240712$$MD$ZA$ZA
240854371$24085437$1$I$20240618$20240702$20240712$20240712$PER$$US-MYLANLABS-2024M1062115$MYLAN$$49$YR$$F$Y$$$20240712$$CN$US$US
240854381$24085438$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48382$$FDA-CTU$$$$$UNK$N$$$20240711$N$HP$US$
240854393$24085439$3$F$$20240801$20240712$20240805$PER$$NVSC2024US144182$NOVARTIS$$$$$F$Y$$$20240805$$CN$US$US
240854402$24085440$2$F$20240702$20240705$20240712$20240716$EXP$$CN-BAYER-2024A098309$BAYER$$64$YR$E$M$Y$63$KG$20240716$$HP$CN$CN
240854413$24085441$3$F$20240701$20240722$20240712$20240726$EXP$ES-AEMPS-1544294$ES-VIIV HEALTHCARE LIMITED-ES2024086129$VIIV$$$$$$Y$$$20240726$$MD$ES$ES
240854421$24085442$1$I$20240601$20240709$20240712$20240712$PER$$US-KARYOPHARM-2024KPT001301$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240712$$CN$US$US
240854431$24085443$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48424$$FDA-CTU$$61$YR$$F$N$$$20240712$N$$US$
240854441$24085444$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48439$$FDA-CTU$$46$YR$$F$N$$$20240712$N$$US$
240854461$24085446$1$I$20240711$20240712$20240712$20240712$DIR$710011$$FDA-CTU$$75$YR$$F$N$$$20240712$N$HP$US$
240854482$24085448$2$F$20200501$20240730$20240712$20240805$PER$$US-PFIZER INC-PV202400087138$PFIZER$$12$YR$$F$Y$31.746$KG$20240805$$CN$US$US
240854511$24085451$1$I$20240516$20240708$20240712$20240712$EXP$FR-AFSSAPS-TS2024000761$FR-MYLANLABS-2024M1063889$MYLAN$$70$YR$$M$Y$63$KG$20240712$$MD$FR$FR
240854521$24085452$1$I$$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024138347$AMGEN$$$$$$Y$$$20240712$$CN$US$US
240854531$24085453$1$I$20240709$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137659$AMGEN$$58$YR$A$F$Y$$$20240712$$CN$US$US
240854541$24085454$1$I$$20240701$20240712$20240712$PER$$US-AMGEN-USASP2024133734$AMGEN$Katyal N.; Govindarajan R.; Goyal N. et.al.. Ravulizumab use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice. Frontiers in Neurology. 2024;15:1-6$$$$$Y$$$20240712$$HP$US$US
240854552$24085455$2$F$$20240704$20240712$20240712$EXP$$US-AMGEN-USASP2024133779$AMGEN$Mudireddy M.; Dvergsten E.; Karovic S. et al.. R-CHOP Versus CHOP-R: Influence of Rituximab Timing on Real-World Outcomes in Patients with Diffuse Large B Cell Lymphoma. Blood. 2023;142 (SUPPL 1):3711$$$$$Y$$$20240712$$HP$US$US
240854561$24085456$1$I$$20240704$20240712$20240712$EXP$$US-AMGEN-USASP2024133679$AMGEN$Jacobs S.E..; Ibrahim U.; Vega A.B. et. al. Dynamics of cytomegalovirus-specific T-cell recovery in allogeneic hematopoietic cell transplant recipients using a commercially available flow cytometry assay: A pilot study. Transplant Infectious Disease. 2024;26 (3):1-6$$$A$$Y$$$20240712$$HP$US$US
240854571$24085457$1$I$$20240705$20240712$20240712$EXP$$US-AMGEN-USASP2024134584$AMGEN$Falchi L.; Carlo-Stella C.; Morschhauser F.et.al. Dexamethasone is Associated with a Lower Incidence and Severity of Cytokine Release Syndrome Compared with Other Corticosteroid Regimens When Given as Premedication for Glofitamab Monotherapy in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL). Blood. 2023;142 (SUPPL_1):3130-3133$$$$$Y$$$20240712$$MD$US$US
240854581$24085458$1$I$$20240704$20240712$20240712$EXP$$US-AMGEN-USASP2024133902$AMGEN$Carpenter T.;Ye C.;Wolff A et al. Another link between adult orbital xanthogranulomatous disease and IgG4-related disease. Annals of Allergy, Asthma and Immunology. 2024;133 (1):101-115$64$YR$A$F$Y$$$20240712$$HP$US$US
240854593$24085459$3$F$$20240904$20240712$20240905$30DAY$$CL-PFIZER INC-202400205060$PFIZER$$9$YR$$$Y$$$20240905$$CN$CL$CL
240854602$24085460$2$F$20100101$20240722$20240712$20240725$EXP$$FR-INDIVIOR UK LIMITED-INDV-145895-2024$RECKITT BENCKISER$$$$$$Y$$$20240725$$CN$FR$FR
240854611$24085461$1$I$$20240705$20240712$20240712$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-107508$BRISTOL MYERS SQUIBB$Zaccheddu E, Zappu A, Barella S, Clemente MG, Orecchia V, Pilia MP, et al. Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept. British Journal of Haematology 2024;204(6):2505-7. doi:10.1111/bjh.19480.$1$DY$N$F$Y$2.46$KG$20240712$$HP$IT$IT
240854621$24085462$1$I$$20240704$20240712$20240712$EXP$$US-AMGEN-USASP2024133704$AMGEN$Lehanka A.M.; Kebede A.; Amirmokhtari N. et.al.. Differences in Observed Toxicities for Adolescent and Young Adult Patients with Aggressive Mature B-Cell Lymphomas Treated at Adult Versus Pediatric Cancer Center -a Comparative Cohort Study. Blood. 2023;142 (SUPPL_1):3116-3117$$$$$Y$$$20240712$$HP$US$US
240854632$24085463$2$F$$20240923$20240712$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110932$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240924$$CN$US$US
240854641$24085464$1$I$$20240703$20240712$20240712$EXP$$US-GSK-US2024AMR082731$GLAXOSMITHKLINE$$$$A$M$Y$$$20240712$$HP$US$US
240854651$24085465$1$I$$20240711$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US064790$SANDOZ$$$$$F$Y$$$20240712$$MD$US$US
240854661$24085466$1$I$$20240711$20240712$20240712$EXP$$CA-SANDOZ INC.-SDZ2024CA064625$SANDOZ$$$$$F$Y$$$20240712$$HP$CA$CA
240854681$24085468$1$I$20240705$20240709$20240712$20240712$EXP$$CN-SANDOZ INC.-SDZ2024CN064097$SANDOZ$$68$YR$$M$Y$61$KG$20240712$$HP$CN$CN
240854691$24085469$1$I$$20240705$20240712$20240712$EXP$$US-BAYER-2024A098240$BAYER$$68$YR$E$M$Y$$$20240712$$CN$US$US
240854711$24085471$1$I$$20240712$20240712$20240712$DIR$710015$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240854721$24085472$1$I$20240613$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48391$$FDA-CTU$$48$YR$$F$N$$$20240711$N$HP$US$
240854741$24085474$1$I$20240712$20240712$20240712$20240712$DIR$710016$$FDA-CTU$$70$YR$$M$N$69.75$KG$20240712$Y$HP$US$
240854751$24085475$1$I$20240624$20240712$20240712$20240712$DIR$709984$$FDA-CTU$$30$YR$$F$N$45.36$KG$20240712$N$HP$US$
240854761$24085476$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48454$$FDA-CTU$$$$$M$N$$$20240711$N$HP$US$
240854771$24085477$1$I$20240711$20240712$20240712$20240712$DIR$709991$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240854811$24085481$1$I$20240309$20240712$20240712$20240712$DIR$709993$$FDA-CTU$$81$YR$$F$N$72$KG$20240712$N$HP$US$
240854821$24085482$1$I$20240709$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137798$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240854831$24085483$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48380$$FDA-CTU$$$$$F$N$$$20240711$N$HP$US$
240854841$24085484$1$I$$20240711$20240712$20240712$PER$$US-BIOVITRUM-2024-US-009790$BIOVITRUM$$$$A$$Y$$$20240712$$CN$US$US
240854851$24085485$1$I$20240329$20240709$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US064096$SANDOZ$$36$YR$$F$Y$81$KG$20240712$$MD$US$US
240854871$24085487$1$I$$20240703$20240712$20240712$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02511$AMNEAL$Ghalayni R, Al Kalaji B, Malik K.. From Friend to Foe: A Case of Naloxone-Induced Pulmonary Edema. Hosp Pharm.. 2024;59:4:407-410$66$YR$$$Y$$$20240712$$HP$US$US
240854901$24085490$1$I$$20240701$20240712$20240712$PER$$US-AMGEN-USASP2024134636$AMGEN$Plante E.. R.; Ekwunwa C.;  Maciag M. C. et. al. Serum sickness-like reaction to D-supplement: a case report. BMC Pediatrics. 2024;24 (1):1-4$16$YR$T$F$Y$$$20240712$$HP$US$US
240854923$24085492$3$F$20240629$20240812$20240712$20240815$EXP$$DE-BIOMARINAP-DE-2024-158985$BIOMARIN$$$$$$Y$$$20240815$$HP$DE$DE
240854931$24085493$1$I$20240702$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48482$$FDA-CTU$$72$YR$$F$N$$$20240711$N$HP$US$
240854941$24085494$1$I$20240708$20240710$20240712$20240712$EXP$$GB-TAKEDA-2024TUS071054$TAKEDA$$77$YR$$M$Y$$$20240712$$CN$GB$GB
240854953$24085495$3$F$20230119$20240724$20240712$20240820$EXP$$GB-ORGANON-O2407GBR001148$ORGANON$$24$YR$$F$Y$$$20240820$$MD$GB$GB
240854981$24085498$1$I$$20240709$20240712$20240712$EXP$$CA-HLS-202401712$HLS THERAPEUTICS$$$$A$M$Y$$$20240712$$MD$CA$CA
240854991$24085499$1$I$20240601$20240705$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108114$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240712$$CN$US$US
240855001$24085500$1$I$$20240701$20240712$20240712$EXP$$SA-BRISTOL-MYERS SQUIBB COMPANY-2024-105247$BRISTOL MYERS SQUIBB$Sanai FM, Odah HO, Alshammari K, Alzanbagi A, Alsubhi M, Tamim H, et al. Nivolumab as second-line therapy improves survival in patients with unresectable hepatocellular carcinoma. Cancers. 2024 Jun 11;16(12):1-13. doi:10.3390/cancers16122196.$$$$$Y$$$20240712$$HP$SA$SA
240855011$24085501$1$I$$20240703$20240712$20240712$30DAY$$US-GSK-US2024AMR083699$GLAXOSMITHKLINE$$$$$M$Y$$$20240712$$CN$US$US
240855022$24085502$2$F$20240706$20240731$20240712$20240806$EXP$$CA-OTSUKA-2024_019229$OTSUKA$$20$YR$$F$Y$$$20240806$$HP$CA$CA
240855031$24085503$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48400$$FDA-CTU$$$$$F$N$$$20240711$N$HP$US$
240855041$24085504$1$I$$20240709$20240712$20240712$EXP$$CA-SANDOZ INC.-SDZ2024CA064021$SANDOZ$$53$YR$$M$Y$$$20240712$$CN$CA$CA
240855052$24085505$2$F$20240701$20240801$20240712$20240821$PER$$US-TEVA-VS-3217318$TEVA$$49$YR$$F$Y$$$20240821$$MD$US$US
240855064$24085506$4$F$20240520$20240815$20240712$20240816$EXP$GB-MHRA-MED-202406061521357780-YMSVH$GB-SANDOZ INC.-SDZ2024GB055629$SANDOZ$$56$YR$$M$Y$$$20240816$$PH$GB$GB
240855071$24085507$1$I$20200101$20240711$20240712$20240712$EXP$$GB-SANDOZ INC.-SDZ2024GB064730$SANDOZ$$$$E$F$Y$$$20240712$$MD$GB$GB
240855081$24085508$1$I$$20240618$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN006580$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240855091$24085509$1$I$$20240710$20240712$20240712$DIR$FDA-CDER-CTU-2024-48384$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
240855101$24085510$1$I$$20240301$20240712$20240712$EXP$GB-MHRA-MED-202402291639350760-BHGQW$GB-TEVA-VS-3166856$TEVA$$$$$$Y$$$20240712$$CN$GB$GB
240855111$24085511$1$I$20240326$20240710$20240712$20240712$EXP$ES-AEMPS-1521335$ES-MYLANLABS-2024M1045216$MYLAN$$67$YR$$F$Y$$$20240712$$MD$ES$ES
240855121$24085512$1$I$20240617$20240708$20240712$20240712$EXP$$DE-MYLANLABS-2024M1063971$MYLAN$$79$YR$$F$Y$87$KG$20240712$$MD$DE$DE
240855131$24085513$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48396$$FDA-CTU$$$$$M$N$$$20240711$N$HP$US$
240855141$24085514$1$I$$20240703$20240712$20240712$EXP$$GB-INCYTE CORPORATION-2024IN007120$INCYTE$$$$$$Y$$$20240712$$MD$GB$GB
240855151$24085515$1$I$20240501$20240620$20240712$20240712$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002944$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240712$$CN$US$US
240855161$24085516$1$I$$20240711$20240712$20240712$PER$$US-BIOVITRUM-2024-US-008052$BIOVITRUM$$44$YR$$F$Y$$$20240712$$CN$US$US
240855171$24085517$1$I$20240527$20240710$20240712$20240712$EXP$$SG-ABBVIE-5836389$ABBVIE$$72$YR$$F$Y$$$20240712$$HP$SG$SG
240855181$24085518$1$I$20230307$20240712$20240712$20240712$EXP$$NVSC2024FR144098$NOVARTIS$$$$$$Y$$$20240712$$MD$FR$FR
240855201$24085520$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48488$$FDA-CTU$$$$$F$N$$$20240711$N$HP$US$
240855211$24085521$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48395$$FDA-CTU$$84$YR$$F$N$$$20240712$N$$US$
240855222$24085522$2$F$$20240719$20240712$20240724$EXP$$GB-TAKEDA-2024TUS070028$TAKEDA$$$$$M$Y$$$20240724$$CN$GB$GB
240855231$24085523$1$I$$20240711$20240712$20240712$PER$$NVSC2024US144324$NOVARTIS$$$$$M$Y$$$20240712$$HP$US$US
240855241$24085524$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48388$$FDA-CTU$$71$YR$$F$N$77.11$KG$20240712$N$$US$
240855251$24085525$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110853$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240712$$HP$US$US
240855271$24085527$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48409$$FDA-CTU$$50$YR$$M$N$$$20240712$N$$US$
240855281$24085528$1$I$$20240710$20240712$20240712$PER$$US-BIOVITRUM-2024-US-009775$BIOVITRUM$$$$I$M$Y$10.4$KG$20240712$$CN$US$US
240855291$24085529$1$I$$20240712$20240712$20240712$DIR$710019$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240855301$24085530$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110397$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240712$$CN$US$US
240855311$24085531$1$I$20240626$20240710$20240712$20240712$EXP$FR-AFSSAPS-TS2024000790$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-110483$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240712$$MD$FR$FR
240855322$24085532$2$F$$20240717$20240712$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110593$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$110.22$KG$20240726$$HP$US$US
240855331$24085533$1$I$20240620$20240708$20240712$20240712$EXP$$ES-AstraZeneca-2024A155237$ASTRAZENECA$$73$YR$$F$Y$$$20240712$$MD$ES$
240855341$24085534$1$I$20240609$20240705$20240712$20240712$EXP$$US-AstraZeneca-2024A157438$ASTRAZENECA$$26223$DY$$F$Y$$$20240712$$CN$US$
240855351$24085535$1$I$$20240705$20240712$20240712$EXP$$ZA-AstraZeneca-2024A155069$ASTRAZENECA$$77$YR$$F$Y$$$20240712$$CN$ZA$
240855361$24085536$1$I$$20240708$20240712$20240712$EXP$$IN-AstraZeneca-2024A156077$ASTRAZENECA$$$$$M$Y$$$20240712$$HP$IN$
240855371$24085537$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159460$ASTRAZENECA$$61$YR$$F$Y$45$KG$20240712$$HP$FR$
240855381$24085538$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159369$ASTRAZENECA$$60$YR$$F$Y$$$20240712$$HP$FR$
240855391$24085539$1$I$$20240704$20240712$20240712$EXP$$CA-AstraZeneca-2024A155225$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$CA$
240855401$24085540$1$I$$20240709$20240712$20240712$PER$$JP-Eisai-EC-2024-164338$EISAI$$$$A$M$Y$$$20240712$$HP$JP$JP
240855411$24085541$1$I$$20240703$20240712$20240712$EXP$$IE-INCYTE CORPORATION-2024IN007121$INCYTE$$$$$$Y$$$20240712$$HP$IE$IE
240855421$24085542$1$I$$20240703$20240712$20240712$30DAY$$US-GSK-US2024083247$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$CN$US$US
240855431$24085543$1$I$20230919$20240711$20240712$20240712$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039392$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$93$KG$20240712$$HP$GB$GB
240855441$24085544$1$I$$20240710$20240712$20240712$30DAY$$US-SANDOZ INC.-SDZ2024US064420$SANDOZ$$$$$F$Y$$$20240712$$CN$US$US
240855452$24085545$2$F$20240603$20240715$20240712$20240723$EXP$$AR-TAKEDA-2024TUS059197$TAKEDA$$71$YR$$F$Y$$$20240723$$CN$AR$AR
240855461$24085546$1$I$20240301$20240710$20240712$20240712$EXP$$FR-SANDOZ INC.-SDZ2024FR064373$SANDOZ$$87$YR$$F$Y$$$20240712$$PH$FR$FR
240855472$24085547$2$F$$20240821$20240712$20240827$EXP$$US-INCYTE CORPORATION-2024IN007159$INCYTE$$$$$$Y$$$20240827$$MD$US$US
240855481$24085548$1$I$$20240708$20240712$20240712$PER$$US-EMD Serono-2024037301$EMD SERONO INC$$65$YR$E$F$Y$$$20240712$$CN$US$US
240855491$24085549$1$I$$20240707$20240712$20240712$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13709$IPSEN$$$$$F$Y$98$KG$20240712$$CN$US$US
240855501$24085550$1$I$20240614$20240710$20240712$20240712$EXP$$CN-BAYER-2024A099822$BAYER$$57$YR$A$M$Y$62$KG$20240712$$HP$CN$CN
240855511$24085551$1$I$$20240710$20240712$20240712$EXP$$US-INCYTE CORPORATION-2024IN007231$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240855521$24085552$1$I$20240618$20240702$20240712$20240712$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202406019803$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240712$$CN$DE$KR
240855531$24085553$1$I$20240709$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006622$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240855541$24085554$1$I$20231201$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007110$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240712$$CN$US$US
240855551$24085555$1$I$$20240704$20240712$20240712$EXP$$JP-ARGENX-2024-ARGX-JP004448$ARGENX BVBA$$$$$$Y$$$20240712$$PH$JP$JP
240855561$24085556$1$I$20240101$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006576$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240712$$CN$US$US
240855571$24085557$1$I$20240101$20240626$20240712$20240712$EXP$$US-UCBSA-2024022283$UCB$$$$$M$Y$86$KG$20240712$$CN$US$US
240855581$24085558$1$I$$20240702$20240712$20240712$EXP$$GB-TEVA-VS-3219874$TEVA$$$$E$M$Y$$$20240712$$CN$GB$GB
240855591$24085559$1$I$20240701$20240709$20240712$20240712$EXP$$US-GSK-US2024085762$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$US$US
240855601$24085560$1$I$20240626$20240710$20240712$20240712$EXP$GB-MHRA-MED-202407101249558670-TKDZM$GB-GSK-GB2024085662$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$MD$GB$GB
240855611$24085561$1$I$$20240704$20240712$20240712$EXP$GB-MHRA-MED-202405021617124220-NDSPQ$GB-BAXTER-2024BAX021271$BAXTER$$$$$$Y$$$20240712$$PH$GB$GB
240855621$24085562$1$I$$20240703$20240712$20240712$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407002252$ELI LILLY AND CO$$$$I$M$Y$$$20240712$$CN$AU$AU
240855631$24085563$1$I$20190101$20240604$20240712$20240712$EXP$$DE-UCBSA-2024030162$UCB$$$$A$F$Y$$$20240712$$MD$DE$DE
240855651$24085565$1$I$$20240708$20240712$20240712$EXP$$CO-VANTIVE-2024VAN018182$Vantive US Healthcare$$$$$F$Y$36.3$KG$20240712$$HP$CO$CO
240855661$24085566$1$I$$20240712$20240712$20240712$DIR$710018$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240855671$24085567$1$I$20240712$20240712$20240712$20240712$DIR$710017$$FDA-CTU$$60$YR$$F$N$$$20240712$N$HP$US$
240855711$24085571$1$I$20240712$20240712$20240712$20240712$DIR$710002$$FDA-CTU$$81$YR$$F$N$70.2$KG$20240712$N$CN$US$
240855731$24085573$1$I$20240101$20240706$20240712$20240712$PER$$US-SA-2024SA202899$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240712$$MD$US$US
240855741$24085574$1$I$$20240703$20240712$20240712$PER$$US-SA-2024SA199590$SANOFI AVENTIS$$$$E$F$Y$86.182$KG$20240712$$MD$US$US
240855751$24085575$1$I$$20240709$20240712$20240712$EXP$$US-GILEAD-2024-0680150$GILEAD$$56$YR$A$F$Y$$$20240712$$HP$US$US
240855761$24085576$1$I$20240601$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110339$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240712$$HP$US$US
240855771$24085577$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110423$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240712$$CN$US$US
240855791$24085579$1$I$$20240710$20240712$20240712$PER$$NVSC2024US144539$NOVARTIS$$$$$$Y$$$20240712$$HP$US$US
240855801$24085580$1$I$$20240704$20240712$20240712$EXP$$NVSC2024ES141774$NOVARTIS$Martin-Aguilar S, Lopez-Rodriguez E, Puentes-Zarzuela MC. Complete response to switch immunodepression of late-onset post-transplant lymphoproliferative disease (PTLD). MEDICINA CLINICA. 2023;161(2):86-91$46$YR$$M$Y$$$20240712$$HP$ES$ES
240855811$24085581$1$I$$20240709$20240712$20240712$PER$$US-ABBVIE-5835189$ABBVIE$$$$$F$Y$$$20240712$$MD$US$US
240855821$24085582$1$I$$20240712$20240712$20240712$EXP$$US-BAYER-2024A100704$BAYER$$$$$$Y$$$20240712$$CN$US$US
240855832$24085583$2$F$20240710$20240809$20240712$20240811$PER$$US-JNJFOC-20240727073$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240811$$CN$US$US
240855851$24085585$1$I$$20240709$20240712$20240712$PER$$US-JNJFOC-20240725587$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$HP$US$US
240855861$24085586$1$I$20240301$20240703$20240712$20240712$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02487$AMNEAL$$68$YR$$M$Y$72.562$KG$20240712$$CN$US$US
240855882$24085588$2$F$$20240806$20240712$20240809$30DAY$$CA-MYLANLABS-2024M1062459$MYLAN$$$$$$Y$$$20240809$$CN$CA$CA
240855891$24085589$1$I$20231101$20240704$20240712$20240712$EXP$$GB-AstraZeneca-2024A159579$ASTRAZENECA$$$$$M$Y$2.6$KG$20240712$$MD$DE$
240855911$24085591$1$I$$20240709$20240712$20240712$EXP$$ES-PFIZER INC-2021SGN05505$PFIZER$$$$$F$Y$$$20240712$$HP$ES$ES
240855921$24085592$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A158993$ASTRAZENECA$$78$YR$$M$Y$$$20240712$$HP$FR$
240855931$24085593$1$I$$20240709$20240712$20240712$EXP$$ES-PFIZER INC-2021SGN05804$PFIZER$$$$$F$Y$$$20240712$$MD$ES$ES
240855941$24085594$1$I$$20240709$20240712$20240712$EXP$$GR-PFIZER INC-2023SGN07031$PFIZER$$$$$F$Y$$$20240712$$MD$GR$GR
240855951$24085595$1$I$20231226$20240709$20240712$20240712$EXP$$AT-PFIZER INC-2024SGN00634$PFIZER$$43$YR$$F$Y$$$20240712$$MD$AT$AT
240855961$24085596$1$I$$20240710$20240712$20240712$EXP$$GR-PFIZER INC-2023SGN10111$PFIZER$$$$$F$Y$$$20240712$$MD$GR$GR
240855972$24085597$2$F$20240709$20240920$20240712$20240925$30DAY$$GR-PFIZER INC-PV202400090436$PFIZER$$12$YR$$F$Y$33$KG$20240925$$CN$GR$GR
240855981$24085598$1$I$$20240709$20240712$20240712$EXP$$ES-PFIZER INC-2021SGN06301$PFIZER$$$$A$F$Y$$$20240712$$MD$ES$ES
240855991$24085599$1$I$$20240710$20240712$20240712$PER$$US-ROCHE-10000023194$ROCHE$$75$YR$E$F$Y$$$20240712$$HP$US$US
240856001$24085600$1$I$$20240708$20240712$20240712$EXP$$SI-AstraZeneca-2024A158272$ASTRAZENECA$$$$$M$Y$$$20240712$$MD$SI$
240856011$24085601$1$I$$20240708$20240712$20240712$PER$$US-AstraZeneca-2024A156454$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
240856022$24085602$2$F$20240401$20240723$20240712$20240726$EXP$$LT-AstraZeneca-2024A155332$ASTRAZENECA$$74$YR$$F$Y$$$20240726$$MD$LT$
240856031$24085603$1$I$20240612$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48492$$FDA-CTU$$70$YR$$M$N$$$20240712$N$PH$US$
240856041$24085604$1$I$20240512$20240610$20240712$20240712$EXP$$US-AstraZeneca-2024A159173$ASTRAZENECA$$23403$DY$$M$Y$$$20240712$$CN$US$
240856051$24085605$1$I$20230726$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217553$TEVA$$8$DEC$$M$Y$$$20240712$$HP$KR$KR
240856061$24085606$1$I$20240625$20240627$20240712$20240712$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000568$PAREXEL$$$$$$Y$$$20240712$$HP$CN$CN
240856071$24085607$1$I$$20240710$20240712$20240712$PER$$US-TAKEDA-2024TUS070800$TAKEDA$$$$$M$Y$$$20240712$$CN$US$US
240856082$24085608$2$F$$20240715$20240712$20240719$EXP$$NVSC2024RU143568$NOVARTIS$Zorina NA, Minaeva NV, Khorobrykh MN, Lagunova MV, Tselousova OM, Vaskina EA, et al.. ?????????? ?????????? ?????????????? ??????????????? ?????????  ?????? ? ????? ? ????????????? ????????????? ??????? (Results of allogeneic hematopoietic stem cell transplantation in children with acquired aplastic anemia). RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY (GEMATOLOGIYA I TRANSFUSIOLOGIY. 2024;69(2):221-3$$$$$Y$$$20240719$$HP$RU$RU
240856092$24085609$2$F$20240101$20240809$20240712$20240813$EXP$$JP-ABBVIE-5836777$ABBVIE$$78$YR$$F$Y$$$20240813$$MD$JP$JP
240856101$24085610$1$I$$20240709$20240712$20240712$EXP$$US-009507513-2407USA004365$MERCK$Webb L, Webb M, Campian J, Caron S, Ruff M, Uhm J, et al. A case series of osseous metastases in patients with glioblastoma. Medicine. 2024;103(27):e38794$20$YR$$M$Y$$$20240712$$MD$US$US
240856111$24085611$1$I$20240620$20240710$20240712$20240712$PER$$US-JNJFOC-20240727161$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240712$$CN$US$US
240856121$24085612$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110410$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240712$$HP$US$US
240856131$24085613$1$I$$20240708$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110454$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240712$$CN$US$US
240856141$24085614$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834292$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240856151$24085615$1$I$$20240701$20240712$20240712$EXP$$CN-B.Braun Medical Inc.-2159082$B BRAUN$$4$YR$$F$Y$2.5$KG$20240712$$$CN$CN
240856161$24085616$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110900$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240712$$CN$US$US
240856171$24085617$1$I$$20240708$20240712$20240712$DIR$FDA-CDER-CTU-2024-48498$$FDA-CTU$$$$$F$N$$$20240708$N$HP$US$
240856181$24085618$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48496$$FDA-CTU$$$$$F$N$$$20240712$N$HP$US$
240856191$24085619$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48493$$FDA-CTU$$$$$M$N$$$20240711$N$HP$US$
240856201$24085620$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48490$$FDA-CTU$$66$YR$$F$N$74.84$KG$20240712$N$HP$US$
240856211$24085621$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48414$$FDA-CTU$$57$YR$$F$N$98.43$KG$20240712$N$$US$
240856221$24085622$1$I$20240501$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48495$$FDA-CTU$$87$YR$$M$N$76.2$KG$20240712$N$PH$US$
240856231$24085623$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48494$$FDA-CTU$$37$YR$$F$N$$$20240712$N$$US$
240856241$24085624$1$I$20240615$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48499$$FDA-CTU$$94$YR$$M$N$$$20240711$N$HP$US$
240856252$24085625$2$F$20070618$20240711$20240712$20240716$EXP$$GXKR2007DE06957$NOVARTIS$$58$YR$$F$Y$60$KG$20240716$$MD$DE$DE
240856261$24085626$1$I$$20240705$20240712$20240712$EXP$$JP-Eisai-EC-2024-167343$EISAI$$69$YR$E$F$Y$$$20240712$$PH$JP$JP
240856271$24085627$1$I$20220101$20240704$20240712$20240712$EXP$$JP-Eisai-EC-2024-169541$EISAI$$80$YR$E$M$Y$$$20240712$$HP$JP$JP
240856281$24085628$1$I$20220101$20240704$20240712$20240712$EXP$$JP-Eisai-EC-2024-169989$EISAI$$79$YR$E$M$Y$$$20240712$$HP$JP$JP
240856302$24085630$2$F$$20240710$20240712$20240712$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-13747$IPSEN$$72$YR$E$M$Y$59.8$KG$20240712$$HP$US$US
240856311$24085631$1$I$20230111$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216441$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240856321$24085632$1$I$20230303$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216436$TEVA$$$$E$M$Y$$$20240712$$HP$KR$KR
240856332$24085633$2$F$$20240724$20240712$20240802$EXP$$US-TEVA-VS-3217742$TEVA$Yasmin M, Rojas LJ, Marshall SH, Hujer AM, Cmolik A, Marshall E, et al. Characterization of a Novel Pathogen in Immunocompromised Patients: Elizabethkingia anophelis-Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and beta-lactamase Inhibitors. Open-Forum-Infect-Dis 2023; 10 (2): no pagination.; Yasmin M, Rojas LJ, Marshall SH, Hujer AM, Cmolik A, Marshall E, et al. Characterization of a Novel Pathogen in Immunocompromised Patients: Elizabethkingia anophelis-Exploring t...$60$YR$$F$Y$$$20240802$$HP$US$US
240856341$24085634$1$I$20240707$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006369$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240712$$CN$US$US
240856351$24085635$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006627$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240856361$24085636$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110970$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240712$$CN$US$US
240856371$24085637$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110126$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240712$$PH$US$US
240856382$24085638$2$F$$20240731$20240712$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-053907$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240807$$MD$US$US
240856392$24085639$2$F$20230727$20240712$20240712$20240717$EXP$ES-AEMPS-1541438$ES-OTSUKA-2024_019227$OTSUKA$$61$YR$$F$Y$$$20240717$$MD$ES$ES
240856401$24085640$1$I$20240613$20240705$20240712$20240712$EXP$$CN-009507513-2407CHN004046$MERCK$$60$YR$$M$Y$65.2$KG$20240712$$HP$CN$CN
240856411$24085641$1$I$$20240701$20240712$20240712$EXP$$EE-B.Braun Medical Inc.-2159083$B BRAUN$$85$YR$$F$Y$87$KG$20240712$$$EE$EE
240856431$24085643$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48467$$FDA-CTU$$70$YR$$M$N$109.77$KG$20240712$N$HP$US$
240856441$24085644$1$I$20230814$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216431$TEVA$$69$YR$$F$Y$$$20240712$$MD$KR$KR
240856452$24085645$2$F$$20240820$20240712$20240823$EXP$$US-009507513-2407USA008472$MERCK$Webb L, Webb M, Campian J, Caron S, Ruff M, Uhm J, et al. A case series of osseous metastases in patients with glioblastoma. Medicine. 2024;103(27):e38794$84$YR$$M$Y$$$20240823$$MD$US$US
240856461$24085646$1$I$20240101$20240708$20240712$20240712$EXP$$US-009507513-2405USA007320$MERCK$$88$YR$$M$Y$$$20240712$$CN$US$US
240856472$24085647$2$F$$20240724$20240712$20240805$EXP$$US-BAYER-2024A099036$BAYER$$75$YR$E$F$Y$$$20240805$$CN$US$US
240856481$24085648$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48412$$FDA-CTU$$66$YR$$F$N$$$20240712$N$$US$
240856491$24085649$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48458$$FDA-CTU$$65$YR$$F$N$$$20240712$N$$US$
240856501$24085650$1$I$20240628$20240703$20240712$20240712$DIR$FDA-CDER-CTU-2024-48311$$FDA-CTU$$62$YR$$F$N$56.2$KG$20240703$N$$US$
240856511$24085651$1$I$$20240710$20240712$20240712$EXP$$GB-ABBVIE-5836736$ABBVIE$$$$$$Y$$$20240712$$HP$GB$GB
240856525$24085652$5$F$20240708$20240905$20240712$20240924$PER$$US-JNJFOC-20240726044$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240924$$CN$US$US
240856531$24085653$1$I$20240709$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48447$$FDA-CTU$$62$YR$$M$N$$$20240712$N$HP$US$
240856541$24085654$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48428$$FDA-CTU$$$$$F$N$$$20240711$N$HP$US$
240856551$24085655$1$I$$20240709$20240712$20240712$EXP$$US-009507513-2407USA008468$MERCK$Webb L, Webb M, Campian J, Caron S, Ruff M, Uhm J, et al. A case series of osseous metastases in patients with glioblastoma. Medicine. 2024;103(27):e38794$69$YR$$M$Y$$$20240712$$MD$US$US
240856561$24085656$1$I$$20240709$20240712$20240712$EXP$$US-009507513-2407USA008470$MERCK$Webb L, Webb M, Campian J, Caron S, Ruff M, Uhm J, et al. A case series of osseous metastases in patients with glioblastoma. Medicine. 2024;103(27):e38794$51$YR$$F$Y$$$20240712$$MD$US$US
240856571$24085657$1$I$$20240709$20240712$20240712$EXP$$US-009507513-2407USA008471$MERCK$Webb L, Webb M, Campian J, Caron S, Ruff M, Uhm J, et al. A case series of osseous metastases in patients with glioblastoma. Medicine. 2024;103(27):e38794$37$YR$$M$Y$$$20240712$$MD$US$US
240856581$24085658$1$I$$20240709$20240712$20240712$EXP$$US-009507513-2407USA008469$MERCK$Webb L, Webb M, Campian J, Caron S, Ruff M, Uhm J, et al. A case series of osseous metastases in patients with glioblastoma. Medicine. 2024;103(27):e38794$41$YR$$M$Y$$$20240712$$MD$US$US
240856591$24085659$1$I$$20240711$20240712$20240712$EXP$$NVSC2024ET144341$NOVARTIS$$$$$M$Y$$$20240712$$MD$ET$ET
240856603$24085660$3$F$20240627$20240723$20240712$20240802$EXP$$US-BAYER-2024A098360$BAYER$$62$YR$A$F$Y$46.712$KG$20240802$$PH$US$US
240856611$24085661$1$I$$20240710$20240712$20240712$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110219$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240712$$HP$CA$CA
240856621$24085662$1$I$20210629$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159289$ASTRAZENECA$$47$YR$$M$Y$$$20240712$$HP$FR$
240856631$24085663$1$I$$20240704$20240712$20240712$EXP$$DE-AstraZeneca-2024A159526$ASTRAZENECA$$29$YR$$F$Y$73.8$KG$20240712$$MD$DE$
240856642$24085664$2$F$$20240909$20240712$20240924$EXP$$CA-BAXTER-2024BAX021165$BAXTER$$44$YR$$F$Y$$$20240924$$HP$CA$CA
240856651$24085665$1$I$$20240705$20240712$20240712$EXP$$ZA-AstraZeneca-2024A156088$ASTRAZENECA$$86$YR$$F$Y$$$20240712$$CN$ZA$
240856661$24085666$1$I$20240501$20240708$20240712$20240712$EXP$$ES-AstraZeneca-2024A158111$ASTRAZENECA$$67$YR$$M$Y$$$20240712$$MD$ES$
240856671$24085667$1$I$20240601$20240710$20240712$20240712$EXP$FR-AFSSAPS-AVNT2024000506$FR-INDIVIOR UK LIMITED-INDV-145914-2024$RECKITT BENCKISER$$$$$$Y$$$20240712$$PH$FR$FR
240856681$24085668$1$I$20240101$20240705$20240712$20240712$EXP$$JP-AstraZeneca-2024A155977$ASTRAZENECA$$$$E$M$Y$$$20240712$$MD$JP$
240856691$24085669$1$I$20240118$20240704$20240712$20240712$EXP$$FR-AstraZeneca-2024A158579$ASTRAZENECA$$60$YR$$F$Y$$$20240712$$MD$FR$
240856702$24085670$2$F$$20240828$20240712$20240905$EXP$$JP-AstraZeneca-2024A154889$ASTRAZENECA$$90$YR$$M$Y$$$20240905$$MD$JP$
240856711$24085671$1$I$$20240706$20240712$20240712$EXP$$US-AstraZeneca-2024A157728$ASTRAZENECA$Greenfield M.J.;  Fobian A.D.;  Fargason R.E.;  Birur B.. Optimizing outcomes when treating functional neurological disorder in acute care settings: case reports depicting the value of diagnostic precision and timely and appropriate psychological interventions using an interdisciplinary framework. Frontiers in Psychiatry 2024;15:1288828.$49$YR$$F$Y$$$20240712$$HP$US$
240856721$24085672$1$I$$20240704$20240712$20240712$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005107$BIOCON$$$$$$Y$$$20240712$$HP$CA$CA
240856741$24085674$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48445$$FDA-CTU$$30$YR$$F$N$$$20240712$N$$US$
240856751$24085675$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48501$$FDA-CTU$$55$YR$$F$N$205$LBS$20240712$N$$US$
240856761$24085676$1$I$$20240704$20240712$20240712$EXP$$IT-AstraZeneca-2024A156188$ASTRAZENECA$$$$$$Y$$$20240712$$MD$IT$
240856771$24085677$1$I$$20240710$20240712$20240712$PER$$US-BIOVITRUM-2024-US-009743$BIOVITRUM$$64$YR$$M$Y$$$20240712$$CN$US$US
240856781$24085678$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48503$$FDA-CTU$$81$YR$$F$N$$$20240712$N$$US$
240856791$24085679$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48507$$FDA-CTU$$75$YR$$F$N$104.33$KG$20240712$N$$US$
240856803$24085680$3$F$20240703$20240906$20240712$20240916$EXP$$US-GSK-US2024AMR084785$GLAXOSMITHKLINE$$48$YR$$F$Y$63.492$KG$20240916$$CN$US$US
240856813$24085681$3$F$$20240805$20240712$20240812$30DAY$$US-GSK-US2024082577$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
240856822$24085682$2$F$20211201$20240704$20240712$20240724$EXP$$US-APELLIS-APL-2021-000270$APELLIS PHARMACEUTICALS$Du, Wei, Mei, Lin. A case report of pegcetacoplan use for a pregnant woman with paroxysmal nocturnal hemoglobinuria.Research and practice in thrombosis and haemostasis . 2024;8(4):102435:1-4. doi:https://dx.doi.org/10.1016/j.rpth.2024.102435$$$$$Y$$$20240724$$CN$US$US
240856851$24085685$1$I$20240703$20240710$20240712$20240712$EXP$$CA-BAYER-2024A100521$BAYER$$38$YR$A$M$Y$$$20240712$$CN$CA$CA
240856865$24085686$5$F$20240701$20240905$20240712$20240916$EXP$$CA-GSK-CA2024082562$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$PH$CA$CA
240856871$24085687$1$I$$20240710$20240712$20240712$EXP$$CA-009507513-2407CAN005258$MERCK$$$$$M$Y$$$20240712$$PH$CA$CA
240856881$24085688$1$I$$20240711$20240712$20240712$PER$$US-ROCHE-10000024247$ROCHE$$45$YR$A$F$Y$$$20240712$$HP$US$US
240856892$24085689$2$F$20240101$20240717$20240712$20240729$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00177$XERIS PHARMACEUTICALS$$$$$M$Y$109.3$KG$20240726$$CN$US$US
240856901$24085690$1$I$20240601$20240710$20240712$20240712$EXP$$TR-JNJFOC-20240725650$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240712$$HP$TR$TR
240856911$24085691$1$I$$20240703$20240712$20240712$EXP$$FR-JNJFOC-20240708707$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$MD$FR$FR
240856921$24085692$1$I$20240711$20240711$20240712$20240712$PER$$US-JNJFOC-20240729399$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240712$$CN$US$US
240856931$24085693$1$I$$20240711$20240712$20240712$PER$$NVSC2024US144540$NOVARTIS$$$$$$Y$$$20240712$$HP$US$US
240856941$24085694$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137151$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240856951$24085695$1$I$$20240618$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN006530$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240856961$24085696$1$I$20240703$20240710$20240712$20240712$EXP$$CA-ABBVIE-5836701$ABBVIE$$81$YR$$F$Y$$$20240712$$HP$CA$CA
240856982$24085698$2$F$$20240726$20240712$20240805$EXP$$US-GSK-US2024085875$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$HP$US$US
240856991$24085699$1$I$20240617$20240618$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN006519$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240857002$24085700$2$F$20240521$20240704$20240712$20240717$EXP$$NVSC2024MX123738$NOVARTIS$$53$YR$$F$Y$75$KG$20240717$$CN$MX$MX
240857011$24085701$1$I$20240710$20240711$20240712$20240712$PER$$US-JNJFOC-20240729969$JOHNSON AND JOHNSON$$50$YR$A$$Y$$$20240712$$CN$US$US
240857022$24085702$2$F$$20240715$20240712$20240716$PER$$US-PFIZER INC-202400212567$PFIZER$$76$YR$$F$Y$67.483$KG$20240716$$MD$US$US
240857033$24085703$3$F$20240613$20240716$20240712$20240726$EXP$$AR-JNJFOC-20240715441$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240726$$MD$AR$AR
240857041$24085704$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-PV202400091483$PFIZER$$57$YR$$F$Y$$$20240712$$HP$US$US
240857051$24085705$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-202400211620$PFIZER$$$$$$Y$$$20240712$$CN$US$US
240857061$24085706$1$I$20240711$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212495$PFIZER$$62$YR$$F$Y$$$20240712$$CN$US$US
240857071$24085707$1$I$20240710$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212515$PFIZER$$75$YR$$F$Y$$$20240712$$CN$US$US
240857081$24085708$1$I$20240707$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212855$PFIZER$$51$YR$$F$Y$$$20240712$$CN$US$US
240857092$24085709$2$F$20240806$20240910$20240712$20240912$PER$$US-PFIZER INC-PV202400090746$PFIZER$$66$YR$$F$Y$$$20240912$$HP$US$US
240857101$24085710$1$I$$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212772$PFIZER$$$$$$Y$$$20240712$$CN$US$US
240857111$24085711$1$I$$20240710$20240712$20240712$PER$$PR-PFIZER INC-202400211615$PFIZER$$54$YR$$F$Y$$$20240712$$HP$PR$PR
240857123$24085712$3$F$20240706$20240918$20240712$20240920$EXP$$US-PFIZER INC-PV202400091283$PFIZER$$68$YR$$F$Y$$$20240920$$HP$US$US
240857131$24085713$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-PV202400091645$PFIZER$$$$$$Y$$$20240712$$HP$US$US
240857141$24085714$1$I$$20240709$20240712$20240712$PER$$US-PFIZER INC-PV202400090757$PFIZER$$62$YR$$F$Y$$$20240712$$HP$US$US
240857151$24085715$1$I$$20240711$20240712$20240712$PER$$US-PFIZER INC-PV202400091499$PFIZER$$60$YR$$F$Y$$$20240712$$PH$US$US
240857161$24085716$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-PV202400091426$PFIZER$$78$YR$$F$Y$$$20240712$$CN$US$US
240857172$24085717$2$F$20240709$20240710$20240712$20240715$PER$$US-PFIZER INC-202400211140$PFIZER$$76$YR$$F$Y$$$20240715$$CN$US$US
240857181$24085718$1$I$20240402$20240708$20240712$20240712$PER$$US-PFIZER INC-PV202400079703$PFIZER$$64$YR$$F$Y$$$20240712$$CN$US$US
240857191$24085719$1$I$$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212557$PFIZER$$$$$M$Y$$$20240712$$MD$US$US
240857201$24085720$1$I$$20240709$20240712$20240712$PER$$US-PFIZER INC-202400212040$PFIZER$$$$$M$Y$$$20240712$$MD$US$US
240857211$24085721$1$I$20240710$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212945$PFIZER$$31$YR$$F$Y$$$20240712$$CN$US$US
240857221$24085722$1$I$20240703$20240711$20240712$20240712$EXP$$CN-PFIZER INC-PV202400091352$PFIZER$$59$YR$$F$Y$61$KG$20240712$$HP$CN$CN
240857232$24085723$2$F$$20240717$20240712$20240717$PER$$US-PFIZER INC-PV202400091561$PFIZER$$$$$$Y$$$20240717$$HP$US$US
240857242$24085724$2$F$$20240809$20240712$20240812$PER$$US-PFIZER INC-202400212414$PFIZER$$40$YR$$M$Y$88.435$KG$20240812$$CN$US$US
240857251$24085725$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-PV202400090320$PFIZER$$70$YR$$M$Y$$$20240712$$HP$US$US
240857262$24085726$2$F$$20240801$20240712$20240805$PER$$US-PFIZER INC-PV202400091448$PFIZER$$56$YR$$M$Y$$$20240805$$HP$US$US
240857272$24085727$2$F$20240709$20240814$20240712$20240814$PER$$US-PFIZER INC-202400208033$PFIZER$$56$YR$$F$Y$$$20240814$$MD$US$US
240857281$24085728$1$I$$20240711$20240712$20240712$PER$$US-PFIZER INC-PV202400091578$PFIZER$$68$YR$$F$Y$$$20240712$$CN$US$US
240857292$24085729$2$F$20240708$20240801$20240712$20240806$PER$$US-PFIZER INC-202400212903$PFIZER$$59$YR$$F$Y$72.562$KG$20240806$$CN$US$US
240857302$24085730$2$F$$20240717$20240712$20240722$PER$$US-PFIZER INC-PV202400091445$PFIZER$$58$YR$$F$Y$$$20240722$$HP$US$US
240857311$24085731$1$I$$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212735$PFIZER$$68$YR$$M$Y$$$20240712$$MD$US$US
240857321$24085732$1$I$$20240708$20240712$20240712$PER$$US-PFIZER INC-PV202400090196$PFIZER$$18$YR$$F$Y$$$20240712$$MD$US$US
240857331$24085733$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-202400211921$PFIZER$$$$$M$Y$$$20240712$$CN$US$US
240857341$24085734$1$I$$20240711$20240712$20240712$PER$$US-PFIZER INC-202400213083$PFIZER$$73$YR$$F$Y$$$20240712$$CN$US$US
240857351$24085735$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-PV202400070818$PFIZER$$63$YR$$F$Y$$$20240712$$HP$US$US
240857362$24085736$2$F$20240701$20240809$20240712$20240813$PER$$US-PFIZER INC-202400211157$PFIZER$$50$YR$$F$Y$$$20240813$$PH$US$US
240857372$24085737$2$F$$20240712$20240712$20240716$PER$$US-PFIZER INC-202400212872$PFIZER$$43$YR$$F$Y$$$20240716$$MD$US$US
240857381$24085738$1$I$$20240711$20240712$20240712$PER$$US-PFIZER INC-PV202400091597$PFIZER$$$$$$Y$$$20240712$$HP$US$US
240857391$24085739$1$I$20240101$20240709$20240712$20240712$PER$$US-PFIZER INC-PV202400090310$PFIZER$$51$YR$$M$Y$$$20240712$$HP$US$US
240857401$24085740$1$I$20240710$20240711$20240712$20240712$PER$$US-PFIZER INC-202400213324$PFIZER$$30$YR$$F$Y$$$20240712$$CN$US$US
240857412$24085741$2$F$20240710$20240730$20240712$20240801$PER$$US-PFIZER INC-202400211358$PFIZER$$52$YR$$F$Y$$$20240801$$HP$US$US
240857421$24085742$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-PV202400091632$PFIZER$$$$$$Y$$$20240712$$HP$US$US
240857432$24085743$2$F$20240710$20240730$20240712$20240802$PER$$US-PFIZER INC-202400212305$PFIZER$$59$YR$$M$Y$95.238$KG$20240802$$CN$US$US
240857441$24085744$1$I$$20240708$20240712$20240712$PER$$US-PFIZER INC-PV202400090324$PFIZER$$$$$M$Y$$$20240712$$HP$US$US
240857451$24085745$1$I$$20240711$20240712$20240712$PER$$US-PFIZER INC-PV202400091543$PFIZER$$60$YR$$F$Y$$$20240712$$CN$US$US
240857462$24085746$2$F$20240401$20240716$20240712$20240717$PER$$US-PFIZER INC-202400212293$PFIZER$$50$YR$$F$Y$$$20240717$$HP$US$US
240857471$24085747$1$I$$20240711$20240712$20240712$PER$$US-PFIZER INC-2021425352$PFIZER$$68$YR$$F$Y$$$20240712$$CN$US$US
240857483$24085748$3$F$$20240912$20240712$20240916$PER$$US-PFIZER INC-202400212452$PFIZER$$27$YR$$F$Y$$$20240916$$MD$US$US
240857491$24085749$1$I$$20240710$20240712$20240712$PER$$US-PFIZER INC-202400212650$PFIZER$$73$YR$$F$Y$$$20240712$$HP$US$US
240857503$24085750$3$F$20240701$20240828$20240712$20240904$PER$$US-PFIZER INC-202400212514$PFIZER$$76$YR$$F$Y$74.376$KG$20240904$$CN$US$US
240857511$24085751$1$I$$20240708$20240712$20240712$PER$$US-PFIZER INC-202400209845$PFIZER$$54$YR$$F$Y$$$20240712$$CN$US$US
240857521$24085752$1$I$20240711$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212948$PFIZER$$73$YR$$M$Y$$$20240712$$HP$US$US
240857531$24085753$1$I$20240708$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212579$PFIZER$$48$YR$$F$Y$$$20240712$$MD$US$US
240857541$24085754$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5835455$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240857551$24085755$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110917$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$96.16$KG$20240712$$CN$US$US
240857561$24085756$1$I$$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110923$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240712$$CN$US$US
240857571$24085757$1$I$$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110854$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240712$$CN$US$US
240857581$24085758$1$I$20240710$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110131$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240712$$CN$US$US
240857592$24085759$2$F$$20240830$20240712$20240903$EXP$$US-ABBVIE-5835472$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
240857601$24085760$1$I$20230131$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216434$TEVA$$4$DEC$$F$Y$$$20240712$$HP$KR$KR
240857612$24085761$2$F$20231001$20240717$20240712$20240723$EXP$$DE-Ipsen Biopharmaceuticals, Inc.-2024-13833$IPSEN$$70$YR$E$F$Y$$$20240723$$CN$DE$DE
240857622$24085762$2$F$$20240903$20240712$20240904$30DAY$$CO-PFIZER INC-202400211060$PFIZER$$10$YR$$M$Y$$$20240904$$CN$CO$CO
240857631$24085763$1$I$20240614$20240709$20240712$20240712$PER$$US-PFIZER INC-202400211475$PFIZER$$49$YR$$M$Y$$$20240712$$HP$US$US
240857641$24085764$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005823$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240712$$CN$US$US
240857651$24085765$1$I$$20240708$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005432$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240712$$CN$US$US
240857661$24085766$1$I$20240611$20240704$20240712$20240712$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202407003782$ELI LILLY AND CO$$61$YR$A$M$Y$63$KG$20240712$$MD$IT$IT
240857675$24085767$5$F$20240708$20240821$20240712$20240826$EXP$$ES-JNJFOC-20240725253$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240826$$MD$ES$ES
240857681$24085768$1$I$20240601$20240710$20240712$20240712$PER$$US-JNJFOC-20240726029$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240712$$CN$US$US
240857691$24085769$1$I$$20240703$20240712$20240712$EXP$$BR-JNJFOC-20240718176$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$BR$BR
240857701$24085770$1$I$$20240705$20240712$20240712$PER$$US-ADVANZ PHARMA-202407005820$ADVANZ PHARMA$$$$$$Y$$$20240712$$CN$US$US
240857711$24085771$1$I$$20240705$20240712$20240712$EXP$$GB-AstraZeneca-2024A155567$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$GB$
240857721$24085772$1$I$$20240703$20240712$20240712$EXP$$US-AstraZeneca-2024A153410$ASTRAZENECA$$$$$M$Y$$$20240712$$MD$US$
240857731$24085773$1$I$$20240711$20240712$20240712$EXP$$CN-AstraZeneca-2024A159946$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$CN$
240857742$24085774$2$F$$20240709$20240712$20240717$EXP$$JP-AstraZeneca-2024A155943$ASTRAZENECA$$$$$$Y$$$20240717$$PH$JP$
240857751$24085775$1$I$$20240703$20240712$20240712$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001088$AKEBIA THERAPEUTICS$$9$DEC$$M$Y$46.7$KG$20240712$$MD$JP$JP
240857761$24085776$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159536$ASTRAZENECA$$70$YR$$M$Y$$$20240712$$HP$FR$
240857771$24085777$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159488$ASTRAZENECA$$83$YR$$M$Y$$$20240712$$HP$FR$
240857781$24085778$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159696$ASTRAZENECA$$53$YR$$M$Y$$$20240712$$HP$FR$
240857791$24085779$1$I$20230117$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216187$TEVA$$6$DEC$$F$Y$$$20240712$$HP$KR$KR
240857801$24085780$1$I$20230303$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159620$ASTRAZENECA$$76$YR$$F$Y$69$KG$20240712$$HP$FR$
240857811$24085781$1$I$20240704$20240710$20240712$20240712$EXP$$IN-AstraZeneca-2024A159166$ASTRAZENECA$$17666$DY$$M$Y$$$20240712$$CN$IN$
240857822$24085782$2$F$20240626$20240724$20240712$20240802$30DAY$$US-GSK-US2024084059$GLAXOSMITHKLINE$$69$YR$$M$Y$$$20240802$$CN$US$US
240857832$24085783$2$F$20240627$20240719$20240712$20240724$PER$$US-ABBVIE-5837273$ABBVIE$$76$YR$$$Y$$$20240724$$CN$US$US
240857841$24085784$1$I$$20240702$20240712$20240712$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004977$BIOCON$$$$$$Y$$$20240712$$HP$CA$CA
240857852$24085785$2$F$$20240801$20240712$20240810$PER$$US-SA-2024SA202810$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$MD$US$US
240857861$24085786$1$I$20240628$20240702$20240712$20240712$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000582$PAREXEL$$$$$$Y$$$20240712$$HP$CN$CN
240857871$24085787$1$I$$20240710$20240712$20240712$PER$$US-ABBVIE-5835983$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240857881$24085788$1$I$20230724$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216476$TEVA$$$$E$M$Y$$$20240712$$HP$KR$KR
240857891$24085789$1$I$20230816$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216407$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240857901$24085790$1$I$20230224$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216482$TEVA$$$$A$M$Y$$$20240712$$HP$KR$KR
240857912$24085791$2$F$20240708$20240807$20240712$20240809$PER$$US-AMGEN-USASP2024137423$AMGEN$$77$YR$E$F$Y$$$20240809$$CN$US$US
240857921$24085792$1$I$$20240701$20240712$20240712$PER$$US-TEVA-VS-3219670$TEVA$$42$YR$$F$Y$$$20240712$$PH$US$US
240857931$24085793$1$I$20230701$20240705$20240712$20240712$EXP$GB-MHRA-MED-202407051918202680-JGMVB$GB-ABBVIE-5836412$ABBVIE$$35$YR$$$Y$$$20240712$$CN$GB$GB
240857941$24085794$1$I$$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216513$TEVA$$67$YR$$F$Y$$$20240712$$MD$KR$KR
240857951$24085795$1$I$20240707$20240708$20240712$20240712$EXP$$KR-BAYER-2024A099204$BAYER$$$$$$Y$$$20240712$$MD$KR$KR
240857961$24085796$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48515$$FDA-CTU$$27$YR$$F$N$$$20240712$N$$US$
240857971$24085797$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48511$$FDA-CTU$$46$YR$$F$N$98$LBS$20240712$N$$US$
240857981$24085798$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48459$$FDA-CTU$$35$YR$$F$N$$$20240712$N$$US$
240857991$24085799$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48472$$FDA-CTU$$57$YR$$F$N$$$20240712$N$$US$
240858001$24085800$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48489$$FDA-CTU$$$$$F$N$$$20240711$N$HP$US$
240858011$24085801$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48457$$FDA-CTU$$44$YR$$M$N$$$20240712$N$$US$
240858021$24085802$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48478$$FDA-CTU$$58$YR$$F$N$$$20240712$N$$US$
240858031$24085803$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48421$$FDA-CTU$$46$YR$$F$N$$$20240712$N$$US$
240858071$24085807$1$I$20230222$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216593$TEVA$$$$A$M$Y$$$20240712$$HP$KR$KR
240858081$24085808$1$I$20240703$20240709$20240712$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039198$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240712$$CN$US$US
240858092$24085809$2$F$$20240919$20240712$20240924$EXP$$US-TAKEDA-2022TUS002396$TAKEDA$$$$$M$Y$77$KG$20240924$$MD$US$US
240858101$24085810$1$I$$20240705$20240712$20240712$PER$$US-SA-2024SA204636$SANOFI AVENTIS$$$$A$M$Y$70.3$KG$20240712$$MD$US$US
240858111$24085811$1$I$$20240703$20240712$20240712$EXP$$AU-AMGEN-AUSSP2024132068$AMGEN$$$$$M$Y$$$20240712$$HP$AU$AU
240858122$24085812$2$F$20240626$20240717$20240712$20240717$EXP$$GB-BAYER-2024A097718$BAYER$$$$$F$Y$$$20240717$$CN$GB$GB
240858141$24085814$1$I$20240516$20240708$20240712$20240712$PER$$US-JNJFOC-20240724317$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$PH$US$US
240858155$24085815$5$F$20240611$20240807$20240712$20240819$30DAY$$US-JNJFOC-20240725417$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$HP$US$US
240858161$24085816$1$I$$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110861$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$107.05$KG$20240712$$CN$US$US
240858171$24085817$1$I$$20240708$20240712$20240712$EXP$$CN-OTSUKA-2024_019395$OTSUKA$Li Y, Hu G, Xu L, Zhang X, Liu K, Cheng YF, et.al.. CAR-T Therapy Followed by Hematopoietic Stem Cell Transplantation Can Improve Survival in Children Relapsed/Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2024;46(5):241-47$9$YR$$M$Y$$$20240712$$MD$CN$CN
240858182$24085818$2$F$$20240710$20240712$20240720$PER$$NVSC2024US142527$NOVARTIS$$$$$M$Y$$$20240720$$HP$US$US
240858191$24085819$1$I$20240608$20240705$20240712$20240712$EXP$$CN-ABBVIE-5835351$ABBVIE$$44$YR$$M$Y$$$20240712$$HP$CN$CN
240858201$24085820$1$I$20231017$20240708$20240712$20240712$EXP$FR-AFSSAPS-ST2024001103$FR-009507513-2407FRA003452$MERCK$$71$YR$$M$Y$73$KG$20240712$$MD$FR$FR
240858211$24085821$1$I$$20240709$20240712$20240712$EXP$$CN-JNJFOC-20240726925$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$MD$CN$CN
240858221$24085822$1$I$20240401$20240705$20240712$20240712$PER$$US-SA-2024SA202894$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240712$$MD$US$US
240858234$24085823$4$F$20240612$20240806$20240712$20240815$30DAY$$US-JNJFOC-20240725431$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$HP$US$US
240858241$24085824$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110060$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240712$$CN$US$US
240858251$24085825$1$I$$20240702$20240712$20240712$PER$$US-RDY-LIT/USA/24/0009979$DR REDDYS$Torrado C, Baysal MA, Chakraborty A, Norris BL, Khawaja F, Tsimberidou AM. Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy. Frontiers in Immunology. 2024;15: doi:10.3389/fimmu.2024.1366271.$5$DEC$A$M$Y$$$20240712$$HP$US$US
240858261$24085826$1$I$$20240708$20240712$20240712$PER$$US-MYLANLABS-2024M1065164$MYLAN$$$$$F$Y$$$20240712$$MD$US$US
240858271$24085827$1$I$20240219$20240710$20240712$20240712$EXP$FR-AFSSAPS-AN2024000874$FR-SANDOZ INC.-SDZ2024FR064229$SANDOZ$$15$YR$$M$Y$38.1$KG$20240712$$MD$FR$FR
240858281$24085828$1$I$$20240708$20240712$20240712$30DAY$$US-GSK-US2024084407$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$CN$US$US
240858291$24085829$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159458$ASTRAZENECA$$76$YR$$M$Y$$$20240712$$HP$FR$
240858301$24085830$1$I$20240530$20240709$20240712$20240712$EXP$$ID-AstraZeneca-2024A158973$ASTRAZENECA$$25872$DY$$M$Y$$$20240712$$CN$ID$
240858313$24085831$3$F$20240601$20240723$20240712$20240731$EXP$$JP-AstraZeneca-2024A155979$ASTRAZENECA$$$$E$F$Y$$$20240731$$MD$JP$
240858321$24085832$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159508$ASTRAZENECA$$62$YR$$M$Y$$$20240712$$HP$FR$
240858332$24085833$2$F$20240701$20240716$20240712$20240717$30DAY$$US-PFIZER INC-PV202400089317$PFIZER$$$$$F$Y$$$20240717$$CN$US$US
240858342$24085834$2$F$20240707$20240710$20240712$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407004867$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240715$$HP$US$US
240858351$24085835$1$I$$20240708$20240712$20240712$EXP$$ZA-AstraZeneca-2024A157168$ASTRAZENECA$$70$YR$$F$Y$$$20240712$$CN$ZA$
240858363$24085836$3$F$20240701$20240816$20240712$20240821$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407006363$ELI LILLY AND CO$$42$YR$A$F$Y$43$KG$20240821$$CN$JP$JP
240858371$24085837$1$I$$20240704$20240712$20240712$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407007626$ELI LILLY AND CO$$$$$F$Y$$$20240712$$CN$JP$JP
240858381$24085838$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159459$ASTRAZENECA$$79$YR$$F$Y$59$KG$20240712$$HP$FR$
240858391$24085839$1$I$$20240705$20240712$20240712$EXP$$HU-AstraZeneca-2024A157442$ASTRAZENECA$Gaspar E, Papay J, Agocs L, Galffy G.. Egy EGFR mut?ns beteg ?let?tja. Medicina Thoracalis 2024;3:190 - 191..$71$YR$$F$Y$$$20240712$$HP$HU$
240858401$24085840$1$I$20240610$20240709$20240712$20240712$EXP$$EG-AstraZeneca-2024A158256$ASTRAZENECA$$52$YR$$F$Y$58$KG$20240712$$MD$EG$
240858411$24085841$1$I$20240101$20240711$20240712$20240712$PER$$US-JNJFOC-20240730152$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240712$$HP$US$US
240858421$24085842$1$I$20230101$20240701$20240712$20240712$EXP$$AU-JNJFOC-20240703553$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240712$$HP$AU$AU
240858432$24085843$2$F$$20240709$20240712$20240813$EXP$$PL-AstraZeneca-2024A159053$ASTRAZENECA$$52$YR$$M$Y$$$20240813$$MD$PL$
240858441$24085844$1$I$$20240705$20240712$20240712$EXP$$US-AstraZeneca-2024A157331$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
240858451$24085845$1$I$$20240705$20240712$20240712$EXP$$BR-JNJFOC-20240720292$JOHNSON AND JOHNSON$$75$YR$E$F$Y$60$KG$20240712$$CN$BR$BR
240858471$24085847$1$I$20240410$20240709$20240712$20240712$EXP$ES-AEMPS-1545274$ES-PFIZER INC-202400209414$PFIZER$$49$YR$$M$Y$$$20240712$$HP$ES$ES
240858481$24085848$1$I$$20240710$20240712$20240712$PER$$US-ABBVIE-5837886$ABBVIE$$$$$$Y$$$20240712$$HP$US$US
240858491$24085849$1$I$$20240711$20240712$20240712$PER$$US-HALEON-2186760$Haleon PLC$$$$$$Y$$$20240712$$CN$US$US
240858501$24085850$1$I$$20240628$20240712$20240712$EXP$$CA-HLS-202401648$HLS THERAPEUTICS$$$$E$F$Y$$$20240712$$PH$CA$CA
240858511$24085851$1$I$20240116$20240705$20240712$20240712$EXP$$US-APELLIS-APL-2024-003826$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240712$$CN$US$US
240858521$24085852$1$I$20230821$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216210$TEVA$$5$DEC$$F$Y$$$20240712$$HP$KR$KR
240858531$24085853$1$I$$20240709$20240712$20240712$30DAY$$GB-SANDOZ INC.-SDZ2024GB030074$SANDOZ$$$$$F$Y$$$20240712$$CN$GB$GB
240858541$24085854$1$I$$20240710$20240712$20240712$EXP$$IT-JNJFOC-20240731584$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$PH$IT$IT
240858551$24085855$1$I$20240508$20240709$20240712$20240712$EXP$$US-KYOWAKIRIN-2024KK016763$KYOWA$$$$$$Y$$$20240712$$HP$US$US
240858564$24085856$4$F$20240601$20240827$20240712$20240830$EXP$$DE-SANDOZ INC.-SDZ2024DE064621$SANDOZ$$$$E$F$Y$$$20240830$$MD$DE$DE
240858571$24085857$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110959$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$66.22$KG$20240712$$CN$US$US
240858582$24085858$2$F$$20240712$20240712$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110888$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$83.01$KG$20240716$$CN$US$US
240858601$24085860$1$I$$20240703$20240712$20240712$PER$$US-RDY-SPO/USA/24/0009769$DR REDDYS$$73$YR$E$F$Y$$$20240712$$CN$US$US
240858611$24085861$1$I$$20240710$20240712$20240712$EXP$$GB-SANDOZ INC.-SDZ2024GB064547$SANDOZ$$78$YR$$F$Y$46$KG$20240712$$HP$GB$GB
240858621$24085862$1$I$$20240710$20240712$20240712$EXP$$GR-BAUSCH-BL-2024-010583$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240712$$MD$GR$GR
240858631$24085863$1$I$20180701$20240710$20240712$20240712$PER$$US-Millicent Holdings Ltd.-MILL20241023$MILLICENT HOLDINGS$$$$$F$Y$$$20240712$$CN$US$US
240858641$24085864$1$I$$20240711$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US064661$SANDOZ$$$$$F$Y$$$20240712$$CN$US$US
240858651$24085865$1$I$20240617$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48404$$FDA-CTU$$38$YR$$M$N$$$20240712$N$PH$US$
240858661$24085866$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48491$$FDA-CTU$$77$YR$$F$N$212$LBS$20240712$N$$US$
240858671$24085867$1$I$$20240711$20240712$20240712$PER$$NVSC2024US144554$NOVARTIS$$$$$F$Y$$$20240712$$HP$US$US
240858691$24085869$1$I$20240101$20240708$20240712$20240712$PER$$US-JNJFOC-20240720906$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240712$$HP$US$US
240858701$24085870$1$I$20231223$20240705$20240712$20240712$EXP$$FR-BAUSCH-BL-2024-010617$BAUSCH AND LOMB$$30$YR$$F$Y$50$KG$20240712$$MD$FR$FR
240858711$24085871$1$I$20240101$20240704$20240712$20240712$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010633$JAZZ$$$$$$Y$$$20240712$$MD$JP$JP
240858721$24085872$1$I$$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212846$PFIZER$$64$YR$$M$Y$$$20240712$$MD$US$US
240858732$24085873$2$F$$20240711$20240712$20240716$PER$$US-PFIZER INC-202400212859$PFIZER$$$$$$Y$$$20240716$$CN$US$US
240858742$24085874$2$F$20240616$20240729$20240712$20240802$PER$$US-PFIZER INC-PV202400091577$PFIZER$$59$YR$$M$Y$$$20240802$$CN$US$US
240858761$24085876$1$I$20240711$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212777$PFIZER$$$$$F$Y$$$20240712$$CN$US$US
240858774$24085877$4$F$$20240819$20240712$20240821$EXP$$GB-SANDOZ INC.-SDZ2023GB055724$SANDOZ$$56$YR$$F$Y$$$20240821$$CN$GB$GB
240858782$24085878$2$F$20240711$20240731$20240712$20240805$PER$$US-PFIZER INC-202400212956$PFIZER$$66$YR$$M$Y$90.703$KG$20240805$$CN$US$US
240858791$24085879$1$I$20240711$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212934$PFIZER$$$$$$Y$$$20240712$$CN$US$US
240858801$24085880$1$I$20240601$20240711$20240712$20240712$PER$$US-PFIZER INC-202400212827$PFIZER$$81$YR$$F$Y$$$20240712$$CN$US$US
240858811$24085881$1$I$$20240711$20240712$20240712$PER$$US-PFIZER INC-202400213320$PFIZER$$33$YR$$F$Y$$$20240712$$CN$US$US
240858821$24085882$1$I$20240710$20240711$20240712$20240712$PER$$US-PFIZER INC-202400213342$PFIZER$$70$YR$$F$Y$$$20240712$$MD$US$US
240858831$24085883$1$I$20240708$20240711$20240712$20240712$PER$$US-PFIZER INC-202400213100$PFIZER$$59$YR$$F$Y$$$20240712$$CN$US$US
240858842$24085884$2$F$$20240716$20240712$20240717$PER$$US-PFIZER INC-202400212458$PFIZER$$21$YR$$M$Y$$$20240717$$CN$US$US
240858851$24085885$1$I$20200110$20220125$20240712$20240712$EXP$$DE-SANDOZ INC.-NVSC2020DE045426$SANDOZ$$47$YR$$F$Y$$$20240712$$MD$DE$DE
240858862$24085886$2$F$20240619$20240711$20240712$20240715$EXP$$US-SANDOZ INC.-SDZ2024US064548$SANDOZ$$61$YR$$M$Y$$$20240715$$HP$US$US
240858872$24085887$2$F$20240616$20240816$20240712$20240820$EXP$$US-SANDOZ INC.-SDZ2024US064202$SANDOZ$$70$YR$$F$Y$$$20240820$$HP$US$US
240858881$24085888$1$I$$20240710$20240712$20240712$EXP$$ZA-ABBVIE-5838166$ABBVIE$$$$$$Y$$$20240712$$PH$ZA$ZA
240858891$24085889$1$I$$20240709$20240712$20240712$EXP$$NVSC2024BR143816$NOVARTIS$$$$$M$Y$$$20240712$$CN$BR$BR
240858901$24085890$1$I$$20240704$20240712$20240712$EXP$$AU-TAKEDA-2024TUS067797$TAKEDA$$$$$F$Y$$$20240712$$HP$AU$AU
240858922$24085892$2$F$$20240712$20240712$20240718$EXP$$FR-SANDOZ INC.-SDZ2024FR064246$SANDOZ$$4$YR$$F$Y$$$20240718$$HP$FR$FR
240858932$24085893$2$F$$20240709$20240712$20240828$EXP$$NVSC2024CZ143713$NOVARTIS$$$$$F$Y$$$20240828$$MD$CZ$CZ
240858945$24085894$5$F$$20240925$20240712$20240927$EXP$GB-MHRA-ADR 28480998$XI-TEVA-VS-3216579$TEVA$$38$YR$$M$Y$104$KG$20240927$$HP$GB$GB
240858951$24085895$1$I$$20240709$20240712$20240712$PER$$US-GILEAD-2024-0680491$GILEAD$$$$$$Y$$$20240712$$HP$US$US
240858961$24085896$1$I$20220701$20240709$20240712$20240712$EXP$GB-BAXTER-2022BAX017429$GB-SANDOZ INC.-SDZ2024GB064335$SANDOZ$$64$YR$$F$Y$59$KG$20240712$$MD$GB$GB
240858972$24085897$2$F$$20240717$20240712$20240718$EXP$$CN-AstraZeneca-2024A159367$ASTRAZENECA$Ge T, Xie X, Liu J. A rare case of pheochromocytoma in a pregnant woman presenting with chest pain: extraordinary management.. BMC Cardiovascular Disorders 2024;24(261):1-5.$31$WK$$$Y$0.9$KG$20240718$$HP$CN$
240858981$24085898$1$I$20240629$20240705$20240712$20240712$EXP$$IT-AstraZeneca-2024A154502$ASTRAZENECA$$80$YR$$M$Y$$$20240712$$MD$IT$
240858991$24085899$1$I$20240703$20240706$20240712$20240712$EXP$$CN-AstraZeneca-2024A157245$ASTRAZENECA$$19351$DY$$M$Y$70$KG$20240712$$MD$CN$
240859001$24085900$1$I$20220913$20240704$20240712$20240712$EXP$$JP-AstraZeneca-2024A156093$ASTRAZENECA$$67$YR$$F$Y$$$20240712$$MD$JP$
240859011$24085901$1$I$$20240705$20240712$20240712$EXP$$JP-AstraZeneca-2024A155946$ASTRAZENECA$$$$$$Y$$$20240712$$PH$JP$
240859021$24085902$1$I$20240401$20240704$20240712$20240712$EXP$$DE-AstraZeneca-2024A149413$ASTRAZENECA$$38$YR$$F$Y$3.2$KG$20240712$$MD$DE$
240859031$24085903$1$I$20240705$20240706$20240712$20240712$EXP$$GB-AstraZeneca-2024A154796$ASTRAZENECA$$$$A$M$Y$98$KG$20240712$$MD$GB$
240859041$24085904$1$I$20210415$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159438$ASTRAZENECA$$64$YR$$M$Y$$$20240712$$HP$FR$
240859055$24085905$5$F$20240710$20240910$20240712$20240917$EXP$$CO-GSK-CO2024AMR084786$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$CO$CO
240859061$24085906$1$I$$20240711$20240712$20240712$EXP$$CA-SANDOZ INC.-SDZ2024CA064630$SANDOZ$$$$$F$Y$$$20240712$$HP$CA$CA
240859074$24085907$4$F$20240201$20240725$20240712$20240729$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-108918$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240730$$MD$DE$DE
240859081$24085908$1$I$20220325$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216416$TEVA$$61$YR$$F$Y$$$20240712$$PH$KR$KR
240859091$24085909$1$I$$20240709$20240712$20240712$EXP$$CA-SANDOZ INC.-SDZ2024CA064111$SANDOZ$$53$YR$$M$Y$$$20240712$$CN$CA$CA
240859111$24085911$1$I$20240709$20240712$20240712$20240712$DIR$710030$$FDA-CTU$$34$YR$$F$N$68$KG$20240712$Y$CN$US$
240859121$24085912$1$I$20240405$20240712$20240712$20240712$DIR$710031$$FDA-CTU$$42$YR$$M$N$119.25$KG$20240712$N$CN$US$
240859141$24085914$1$I$20240712$20240712$20240712$20240712$DIR$710024$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240859151$24085915$1$I$20240619$20240712$20240712$20240712$DIR$710032$$FDA-CTU$$73$YR$$F$N$58.05$KG$20240712$N$CN$US$
240859171$24085917$1$I$20231010$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216426$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240859181$24085918$1$I$$20240712$20240712$20240712$DIR$710033$$FDA-CTU$$$$$M$N$$$20240712$Y$HP$US$
240859191$24085919$1$I$20211201$20240702$20240712$20240712$EXP$$CN-HQ-20240042$HQ SPECIALTY$Zhang L, Wang L, Umar Z, Huang Y, Gu B. Weathering the storm: diagnosis and treatment of a life-threatening disseminated Nocardia otitidiscaviarum infection. Frontiers in Cellular and Infection Microbiology. 2024;14:1397847. DOI:10.3389/fcimb.2024.1397847.$68$YR$A$M$Y$$$20240703$$MD$CN$
240859201$24085920$1$I$$20240710$20240712$20240712$PER$$US-DSJP-DSU-2024-135435$DAIICHI$$$$$F$Y$$$20240712$$HP$US$US
240859211$24085921$1$I$$20240711$20240712$20240712$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135436$DAIICHI$$$$$F$Y$$$20240712$$CN$US$US
240859221$24085922$1$I$20230615$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216679$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240859241$24085924$1$I$$20240712$20240712$20240712$DIR$710029$$FDA-CTU$$$$$UNK$N$$$20240712$$CN$US$
240859251$24085925$1$I$$20240712$20240712$20240712$DIR$710025$$FDA-CTU$$$$$UNK$N$$$20240712$$CN$US$
240859261$24085926$1$I$20230422$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216711$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240859272$24085927$2$F$$20240715$20240712$20240718$PER$$US-AMGEN-USASP2024135858$AMGEN$$$$E$F$Y$$$20240718$$PH$US$US
240859281$24085928$1$I$20230530$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216880$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240859291$24085929$1$I$20240701$20240702$20240712$20240712$30DAY$$US-GSK-US2024082093$GLAXOSMITHKLINE$$84$YR$$F$Y$$$20240712$$CN$US$US
240859302$24085930$2$F$$20240718$20240712$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002947$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
240859311$24085931$1$I$$20240710$20240712$20240712$PER$$US-DSJP-DSU-2024-135551$DAIICHI$$$$$F$Y$$$20240712$$MD$US$US
240859321$24085932$1$I$20240711$20240711$20240712$20240712$PER$$US-JNJFOC-20240729943$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240712$$PH$US$US
240859331$24085933$1$I$$20240702$20240712$20240712$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202407003043$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240712$$CN$MX$MX
240859341$24085934$1$I$$20240701$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407001302$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240712$$CN$US$US
240859351$24085935$1$I$$20240703$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002881$ELI LILLY AND CO$$$$$M$Y$$$20240712$$CN$US$US
240859361$24085936$1$I$$20240702$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002290$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240712$$CN$US$US
240859371$24085937$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006542$ELI LILLY AND CO$$$$$F$Y$$$20240712$$CN$US$US
240859381$24085938$1$I$20240405$20240702$20240712$20240712$EXP$PT-INFARMED-B202406-564$PT-ELI_LILLY_AND_COMPANY-PT202407002358$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240712$$CN$PT$PT
240859391$24085939$1$I$$20240702$20240712$20240712$EXP$GB-MHRA-MED-202407021610082680-VSNRJ$GB-ELI_LILLY_AND_COMPANY-GB202407003401$ELI LILLY AND CO$$$$$F$Y$$$20240712$$CN$GB$GB
240859401$24085940$1$I$$20240701$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407001234$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240712$$CN$US$US
240859411$24085941$1$I$20240630$20240630$20240712$20240712$EXP$GB-MHRA-MED-202406301737348660-VLKDZ$GB-ELI_LILLY_AND_COMPANY-GB202407002387$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240712$$CN$GB$GB
240859421$24085942$1$I$$20240701$20240712$20240712$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407002184$ELI LILLY AND CO$$42$YR$A$F$Y$78$KG$20240712$$CN$CN$CN
240859431$24085943$1$I$$20240701$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407001483$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240712$$CN$US$US
240859441$24085944$1$I$20240612$20240701$20240712$20240712$EXP$GB-MHRA-MED-202406300036038400-YVSCZ$GB-ELI_LILLY_AND_COMPANY-GB202407002367$ELI LILLY AND CO$$29$YR$A$F$Y$79$KG$20240712$$CN$GB$GB
240859451$24085945$1$I$20240401$20240702$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002225$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240712$$PH$US$US
240859461$24085946$1$I$$20240702$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002101$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240712$$CN$US$US
240859471$24085947$1$I$20240703$20240703$20240712$20240712$EXP$GB-MHRA-MED-202407022323462230-KMVFC$GB-ELI_LILLY_AND_COMPANY-GB202407003403$ELI LILLY AND CO$$$$$F$Y$$$20240712$$CN$GB$GB
240859481$24085948$1$I$$20240711$20240712$20240712$EXP$$DE-SANDOZ INC.-SDZ2024DE064695$SANDOZ$$80$YR$$M$Y$$$20240712$$CN$DE$DE
240859491$24085949$1$I$20240422$20240705$20240712$20240712$EXP$$US-AMERICAN REGENT INC-2024002608$AMERICAN REGENT$$45$YR$$F$Y$83.4$KG$20240712$$HP$US$US
240859501$24085950$1$I$$20240710$20240712$20240712$EXP$$NVSC2024HR094675$NOVARTIS$$30$YR$$F$Y$$$20240712$$MD$HR$HR
240859511$24085951$1$I$$20240708$20240712$20240712$PER$$US-ROCHE-10000021364$ROCHE$$53$YR$A$F$Y$$$20240712$$CN$US$US
240859521$24085952$1$I$20240711$20240711$20240712$20240712$PER$$US-HALEON-2186675$Haleon PLC$$$$$M$Y$$$20240712$$CN$US$US
240859531$24085953$1$I$$20240705$20240712$20240712$PER$$US-JNJFOC-20240721055$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240859541$24085954$1$I$20230211$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216412$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240859552$24085955$2$F$$20240822$20240712$20240827$EXP$$GB-SANDOZ INC.-SDZ2024GB018704$SANDOZ$$$$$M$Y$$$20240827$$CN$GB$GB
240859561$24085956$1$I$$20240705$20240712$20240712$EXP$$US-AstraZeneca-2024A156592$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
240859571$24085957$1$I$20240605$20240705$20240712$20240712$EXP$$FR-AstraZeneca-2024A154473$ASTRAZENECA$$57$YR$$F$Y$50.8$KG$20240712$$MD$FR$
240859581$24085958$1$I$$20240711$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US064832$SANDOZ$$$$$F$Y$$$20240712$$CN$US$US
240859591$24085959$1$I$$20240710$20240712$20240712$EXP$$PL-AstraZeneca-2024A157739$ASTRAZENECA$Krawczyk M. Pneumothorax as a complication of respiratory failure a two case reports and literature. JOURNAL OF PRE-CLINICAL AND CLINICAL RESEARCH 2024;2:139-146..$28$YR$$M$Y$$$20240712$$MD$PL$
240859601$24085960$1$I$20191204$20240708$20240712$20240712$EXP$$JP-AstraZeneca-2024A099585$ASTRAZENECA$$755$MON$$F$Y$41$KG$20240712$$MD$JP$
240859611$24085961$1$I$20230813$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216326$TEVA$$7$DEC$$F$Y$$$20240712$$HP$KR$KR
240859622$24085962$2$F$20240601$20240727$20240712$20240730$PER$$US-BELCHER PHARMACEUTICALS, LLC-2024US002131$PAREXEL$$$$$$Y$$$20240730$$PH$US$US
240859631$24085963$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834264$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240859641$24085964$1$I$20231001$20240710$20240712$20240712$EXP$$GR-PFIZER INC-2023SGN12423$PFIZER$$67$YR$$F$Y$$$20240712$$MD$GR$GR
240859651$24085965$1$I$$20240710$20240712$20240712$EXP$$ES-PFIZER INC-2019SGN04364$PFIZER$$$$$F$Y$$$20240712$$MD$ES$ES
240859661$24085966$1$I$$20240711$20240712$20240712$EXP$$PT-PFIZER INC-2024SGN03104$PFIZER$$$$$$Y$$$20240712$$MD$PT$PT
240859671$24085967$1$I$$20240710$20240712$20240712$EXP$$GR-PFIZER INC-2023SGN13186$PFIZER$$$$$F$Y$$$20240712$$MD$GR$GR
240859691$24085969$1$I$$20240710$20240712$20240712$EXP$$ES-PFIZER INC-2023SGN02413$PFIZER$$$$$F$Y$$$20240712$$CN$ES$ES
240859701$24085970$1$I$$20240710$20240712$20240712$EXP$$GR-PFIZER INC-2023SGN11900$PFIZER$$$$$F$Y$$$20240712$$MD$GR$GR
240859711$24085971$1$I$$20240710$20240712$20240712$EXP$$ES-PFIZER INC-2022SGN05862$PFIZER$$72$YR$$M$Y$$$20240712$$MD$ES$ES
240859721$24085972$1$I$$20240710$20240712$20240712$EXP$$GR-PFIZER INC-2023SGN11095$PFIZER$$$$$F$Y$$$20240712$$MD$GR$GR
240859731$24085973$1$I$$20240711$20240712$20240712$EXP$$FR-PFIZER INC-2022SGN04030$PFIZER$$$$$F$Y$$$20240712$$MD$FR$FR
240859745$24085974$5$F$20230526$20240830$20240712$20240904$EXP$FR-AFSSAPS-TS2023001354$FR-PFIZER INC-2023SGN11970$PFIZER$$20$YR$$F$Y$$$20240904$$MD$FR$FR
240859751$24085975$1$I$$20240710$20240712$20240712$EXP$$GR-PFIZER INC-2023SGN13222$PFIZER$$$$$F$Y$$$20240712$$MD$GR$GR
240859761$24085976$1$I$$20240626$20240712$20240712$PER$$US-ABBVIE-5836276$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240859771$24085977$1$I$20240710$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48451$$FDA-CTU$$$$$$N$$$20240712$N$$US$
240859781$24085978$1$I$$20240709$20240712$20240712$EXP$$US-ABBVIE-5834602$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240859791$24085979$1$I$$20240711$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US064731$SANDOZ$$$$$F$Y$$$20240712$$CN$US$US
240859801$24085980$1$I$$20240703$20240712$20240712$PER$$US-RDY-LIT/USA/24/0010136$DR REDDYS$Rorex J, Nelson S, DiCaudo D, Swanson L. Fulvestrant Associated Chromhidrosis. American Journal of Dermatopathology. 2024 Jul;46(7): S25. doi:10.1097/DAD.0000000000002757.$61$YR$A$F$Y$$$20240712$$HP$US$US
240859811$24085981$1$I$20240619$20240704$20240712$20240712$EXP$$IT-ABBVIE-5837384$ABBVIE$$56$YR$$F$Y$$$20240712$$MD$IT$IT
240859821$24085982$1$I$$20220321$20240712$20240712$EXP$$CA-SANDOZ INC.-NVSC2022CA068094$SANDOZ$$58$YR$$M$Y$$$20240712$$CN$CA$CA
240859832$24085983$2$F$$20240730$20240712$20240802$30DAY$$GB-SANDOZ INC.-SDZ2023GB070817$SANDOZ$$$$$M$Y$$$20240802$$CN$GB$GB
240859853$24085985$3$F$20240707$20240812$20240712$20240812$PER$$US-ALXN-202407USA000503US$ALEXION PHARMACEUTICALS$$69$YR$$M$Y$$$20240812$$CN$US$US
240859861$24085986$1$I$20240423$20240704$20240712$20240712$EXP$GB-MHRA-MED-202405071650060600-GRTYL$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-06389$HIKMA$$75$YR$$M$Y$$$20240712$$MD$GB$GB
240859871$24085987$1$I$$20240705$20240712$20240712$EXP$$GB-TEVA-VS-3218590$TEVA$$74$YR$$M$Y$68$KG$20240712$$MD$GB$GB
240859881$24085988$1$I$$20240711$20240712$20240712$30DAY$$US-SANDOZ INC.-SDZ2024US064864$SANDOZ$$$$$$Y$$$20240712$$CN$US$US
240859891$24085989$1$I$20240703$20240705$20240712$20240712$EXP$$CN-SA-2024SA204434$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240712$$HP$CN$CN
240859901$24085990$1$I$20240601$20240705$20240712$20240712$PER$$US-SA-2024SA202948$SANOFI AVENTIS$$49$YR$A$M$Y$67.5$KG$20240712$$MD$US$US
240859913$24085991$3$F$20240101$20240904$20240712$20240910$EXP$$JP-009507513-2407JPN001017J$MERCK$$77$YR$$M$Y$$$20240910$$MD$JP$JP
240859922$24085992$2$F$20210701$20240712$20240712$20240729$PER$$US-JNJFOC-20240733182$JOHNSON AND JOHNSON$$43$YR$A$$Y$$$20240729$$CN$US$US
240859931$24085993$1$I$$20240709$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN007247$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240859941$24085994$1$I$20230219$20240708$20240712$20240712$PER$$US-APELLIS-APL-2023-002067$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240712$$CN$US$US
240859951$24085995$1$I$$20240703$20240712$20240712$EXP$$CN-009507513-2407CHN002567$MERCK$Wang X, Wang W, Zou S, Xu Z, Cao D, Zhang S, et al. Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors. Cell research. 2024;1-4$69$YR$$M$Y$$$20240712$$HP$CN$CN
240859962$24085996$2$F$$20240826$20240712$20240830$EXP$$US-SA-2024SA202576$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240830$$MD$US$US
240859971$24085997$1$I$20240617$20240705$20240712$20240712$EXP$$FR-ASTELLAS-2024EU006856$ASTELLAS$$68$YR$$M$Y$48.7$KG$20240712$$PH$FR$FR
240859981$24085998$1$I$$20240618$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN006527$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240859991$24085999$1$I$20240301$20240708$20240712$20240712$PER$$US-EMD Serono-2024037248$EMD SERONO INC$$48$YR$A$F$Y$$$20240712$$HP$US$US
240860002$24086000$2$F$$20240710$20240712$20240801$PER$$US-SA-2024SA203503$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240719$$CN$US$US
240860011$24086001$1$I$$20240626$20240712$20240712$PER$$US-PHARMING-PHAUS2024000534$PHARMING GROUP$$$$$$Y$$$20240712$$CN$US$US
240860021$24086002$1$I$$20240709$20240712$20240712$EXP$$US-PHARMING-PHAUS2024000583$PHARMING GROUP$$$$$$Y$$$20240712$$CN$US$US
240860031$24086003$1$I$$20240626$20240712$20240712$PER$$US-PHARMING-PHAUS2024000539$PHARMING GROUP$$$$$$Y$$$20240712$$CN$US$US
240860041$24086004$1$I$$20240710$20240712$20240712$PER$$US-PHARMING-PHAUS2024000580$PHARMING GROUP$$$$$$Y$$$20240712$$CN$US$US
240860051$24086005$1$I$$20240705$20240712$20240712$EXP$$US-AstraZeneca-2024A155361$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
240860061$24086006$1$I$$20240708$20240712$20240712$EXP$$ZA-AstraZeneca-2024A157136$ASTRAZENECA$$30681$DY$$F$Y$$$20240712$$CN$ZA$
240860071$24086007$1$I$$20240710$20240712$20240712$PER$$US-JNJFOC-20240731120$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240860081$24086008$1$I$$20240712$20240712$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039532$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240712$$CN$US$US
240860091$24086009$1$I$20240626$20240709$20240712$20240712$EXP$$ID-AstraZeneca-2024A158996$ASTRAZENECA$$31662$DY$$F$Y$$$20240712$$CN$ID$
240860101$24086010$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159539$ASTRAZENECA$$74$YR$$M$Y$80$KG$20240712$$HP$FR$
240860112$24086011$2$F$20240625$20240714$20240712$20240722$EXP$$UY-AstraZeneca-2024A156992$ASTRAZENECA$$24186$DY$$F$Y$75$KG$20240722$$MD$UY$
240860121$24086012$1$I$$20240710$20240712$20240712$EXP$$US-PHARMING-PHAUS2024000581$PHARMING GROUP$$$$$$Y$$$20240712$$CN$US$US
240860131$24086013$1$I$20240510$20240709$20240712$20240712$EXP$$ZA-AstraZeneca-2024A157205$ASTRAZENECA$$73$YR$$F$Y$$$20240712$$CN$ZA$
240860141$24086014$1$I$20230728$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159537$ASTRAZENECA$$55$YR$$F$Y$44$KG$20240712$$HP$FR$
240860151$24086015$1$I$$20240706$20240712$20240712$EXP$$GB-AstraZeneca-2024A159381$ASTRAZENECA$$$$$F$Y$62$KG$20240712$$MD$GB$
240860161$24086016$1$I$$20240704$20240712$20240712$EXP$$GB-AstraZeneca-2024A153869$ASTRAZENECA$$$$$F$Y$$$20240712$$MD$GB$
240860171$24086017$1$I$$20240705$20240712$20240712$EXP$$ZA-AstraZeneca-2024A155630$ASTRAZENECA$$63$YR$$F$Y$$$20240712$$CN$ZA$
240860181$24086018$1$I$20240628$20240709$20240712$20240712$EXP$$GB-AstraZeneca-2024A156739$ASTRAZENECA$$64$YR$$M$Y$86$KG$20240712$$MD$GB$
240860191$24086019$1$I$$20240705$20240712$20240712$EXP$$VN-AstraZeneca-2024A155792$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$VN$
240860201$24086020$1$I$20240704$20240709$20240712$20240712$EXP$$CN-AstraZeneca-2024A157988$ASTRAZENECA$$91$YR$$M$Y$60$KG$20240712$$MD$CN$
240860211$24086021$1$I$$20240705$20240712$20240712$EXP$$JP-AstraZeneca-2024A155956$ASTRAZENECA$$84$YR$$F$Y$$$20240712$$PH$JP$
240860221$24086022$1$I$20230524$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217011$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240860232$24086023$2$F$$20240717$20240712$20240725$EXP$$JP-AstraZeneca-2024A155971$ASTRAZENECA$$84$YR$$M$Y$$$20240725$$MD$JP$
240860241$24086024$1$I$20230707$20240705$20240712$20240712$EXP$$GB-AstraZeneca-2024A154777$ASTRAZENECA$$55$YR$$M$Y$82$KG$20240712$$MD$GB$
240860251$24086025$1$I$20240412$20240708$20240712$20240712$EXP$$US-AstraZeneca-2024A156010$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$US$
240860261$24086026$1$I$$20240704$20240712$20240712$EXP$$ZA-AstraZeneca-2024A154261$ASTRAZENECA$$$$$F$Y$$$20240712$$CN$ZA$
240860271$24086027$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110318$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240712$$HP$US$US
240860281$24086028$1$I$20240702$20240709$20240712$20240712$EXP$$ZA-AstraZeneca-2024A157991$ASTRAZENECA$$80$YR$$F$Y$$$20240712$$CN$ZA$
240860291$24086029$1$I$20240709$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110081$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240712$$CN$US$US
240860301$24086030$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159375$ASTRAZENECA$$69$YR$$M$Y$$$20240712$$HP$FR$
240860311$24086031$1$I$20240202$20240711$20240712$20240712$EXP$$KR-AstraZeneca-2024A159957$ASTRAZENECA$$661$MON$$M$Y$$$20240712$$CN$KR$
240860333$24086033$3$F$20220426$20240814$20240712$20240826$EXP$$US-GSK-US2024082530$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$HP$US$US
240860341$24086034$1$I$$20240703$20240712$20240712$30DAY$$US-GSK-US2024083232$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$HP$US$US
240860351$24086035$1$I$$20240703$20240712$20240712$30DAY$$US-GSK-US2024083248$GLAXOSMITHKLINE$$$$$M$Y$$$20240712$$CN$US$US
240860362$24086036$2$F$20240707$20240830$20240712$20240909$30DAY$$US-GSK-US2024085131$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240909$$CN$US$US
240860381$24086038$1$I$20230721$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217426$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240860401$24086040$1$I$20230926$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216338$TEVA$$6$DEC$$F$Y$$$20240712$$HP$KR$KR
240860411$24086041$1$I$20230531$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217077$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240860424$24086042$4$F$20240708$20240716$20240712$20240722$EXP$$US-AMGEN-USASP2024135802$AMGEN$$$$$M$Y$$$20240722$$HP$US$US
240860431$24086043$1$I$$20240709$20240712$20240712$EXP$$US-AMGEN-USASP2024137677$AMGEN$$$$$$Y$$$20240712$$MD$US$US
240860442$24086044$2$F$$20240716$20240712$20240719$PER$$US-AMGEN-USASP2024138104$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
240860452$24086045$2$F$20240701$20240729$20240712$20240807$EXP$$US-AMGEN-USASP2024137672$AMGEN$$68$YR$E$F$Y$85.1$KG$20240806$$HP$US$US
240860462$24086046$2$F$$20240731$20240712$20240805$PER$$NVSC2024US144514$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
240860471$24086047$1$I$$20240706$20240712$20240712$EXP$$AU-CURRAX PHARMACEUTICALS LLC-AU-2024CUR001558$CURRAX PHARMACEUTICALS$$$$$F$Y$113$KG$20240712$$CN$AU$AU
240860481$24086048$1$I$$20240705$20240712$20240712$EXP$$US-AMGEN-USASP2024134522$AMGEN$Fiskea H. W.; Saeed F.; Ward C. et al.. Coexisting Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Overlapping Challenges in Diagnosis and Treatment. Case Rep Gastroenterol. 2024;18:167-175$30$YR$A$F$Y$$$20240712$$HP$US$US
240860491$24086049$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111228$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240712$$CN$US$US
240860501$24086050$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111276$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240712$$CN$US$US
240860511$24086051$1$I$20240701$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111290$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240712$$PH$US$US
240860521$24086052$1$I$$20240711$20240712$20240712$PER$$US-JNJFOC-20240729833$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$HP$US$US
240860531$24086053$1$I$20240308$20240708$20240712$20240712$EXP$FR-AFSSAPS-LL2024001220$FR-MYLANLABS-2024M1063895$MYLAN$$35$YR$$F$Y$$$20240712$$MD$FR$FR
240860541$24086054$1$I$20240619$20240708$20240712$20240712$EXP$FR-AFSSAPS-AN2024000834$FR-MYLANLABS-2024M1063948$MYLAN$$68$YR$$F$Y$57.4$KG$20240712$$PH$FR$FR
240860552$24086055$2$F$$20240710$20240712$20240722$EXP$$PL-MYLANLABS-2024M1064760$MYLAN$Gazolyszyn N., Pragnacy K.. Diagnostics of comorbidities in a non-binary person - a study case.. Psychiatry after diploma. 2024;3$23$YR$$M$Y$$$20240722$$HP$PL$PL
240860561$24086056$1$I$$20240330$20240712$20240712$EXP$$US-TAKEDA-2024TUS070857$TAKEDA$$$$$F$Y$$$20240712$$CN$US$US
240860572$24086057$2$F$20240621$20240724$20240712$20240808$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0555$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240808$$MD$US$US
240860584$24086058$4$F$$20240829$20240712$20240903$EXP$$DE-MYLANLABS-2024M1063901$MYLAN$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology.. 2024;48:299?313$39$YR$$F$Y$$$20240903$$HP$DE$DE
240860604$24086060$4$F$20240627$20240913$20240712$20240920$EXP$$US-TAKEDA-2024TUS068910$TAKEDA$$64$YR$$M$Y$97.52$KG$20240920$$MD$US$US
240860611$24086061$1$I$20240514$20240708$20240712$20240712$EXP$$CA-TAKEDA-2024TUS069942$TAKEDA$$77$YR$$F$Y$$$20240712$$CN$CA$CA
240860622$24086062$2$F$$20240716$20240712$20240726$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001087$AKEBIA THERAPEUTICS$$9$DEC$$M$Y$$$20240726$$MD$JP$JP
240860631$24086063$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110945$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$66.68$KG$20240712$$CN$US$US
240860642$24086064$2$F$$20240906$20240712$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110926$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$69.4$KG$20240910$$CN$US$US
240860661$24086066$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110982$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$58.97$KG$20240712$$CN$US$US
240860671$24086067$1$I$20240512$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110975$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240712$$CN$US$US
240860682$24086068$2$F$$20240814$20240712$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110913$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240819$$CN$US$US
240860691$24086069$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110979$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240712$$CN$US$US
240860701$24086070$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110973$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$86.18$KG$20240712$$CN$US$US
240860711$24086071$1$I$20240502$20240708$20240712$20240712$EXP$FR-AFSSAPS-RS2024000657$FR-MYLANLABS-2024M1064206$MYLAN$$23$YR$$F$Y$$$20240712$$MD$FR$FR
240860721$24086072$1$I$$20240708$20240712$20240712$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006228$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240712$$CN$US$US
240860731$24086073$1$I$$20240710$20240712$20240712$PER$$US-ABBVIE-5837884$ABBVIE$$$$$F$Y$$$20240712$$HP$US$US
240860753$24086075$3$F$$20240909$20240712$20240912$EXP$$US-TAKEDA-2024TUS069252$TAKEDA$$$$$M$Y$$$20240912$$CN$US$US
240860761$24086076$1$I$20230426$20240701$20240712$20240712$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-011562$JAZZ$$44$YR$$F$Y$115$KG$20240712$$CN$US$US
240860771$24086077$1$I$20240301$20240708$20240712$20240712$EXP$FR-AFSSAPS-LL2024001238$FR-MYLANLABS-2024M1064213$MYLAN$$57$YR$$F$Y$$$20240712$$MD$FR$FR
240860785$24086078$5$F$$20240903$20240712$20240905$30DAY$$US-PFIZER INC-202400197907$PFIZER$$$$$$Y$$$20240905$$HP$US$US
240860792$24086079$2$F$$20240818$20240712$20240819$30DAY$$CL-PFIZER INC-PV202400090481$PFIZER$$11$YR$$M$Y$$$20240819$$CN$CL$CL
240860801$24086080$1$I$20240708$20240709$20240712$20240712$EXP$$KR-PFIZER INC-202400210407$PFIZER$$78$YR$$M$Y$$$20240712$$MD$KR$KR
240860815$24086081$5$F$20240705$20240916$20240712$20240920$30DAY$$US-PFIZER INC-202400209754$PFIZER$$13$YR$$F$Y$$$20240920$$CN$US$US
240860821$24086082$1$I$20240624$20240703$20240712$20240712$EXP$GB-MHRA-MED-202407031533046540-FZVDC$GB-BAUSCH-BL-2024-010661$BAUSCH AND LOMB$$42$YR$$M$Y$$$20240712$$HP$GB$GB
240860831$24086083$1$I$20230920$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216498$TEVA$$54$YR$$F$Y$$$20240712$$HP$KR$KR
240860841$24086084$1$I$$20240705$20240712$20240712$EXP$$JP-BAUSCH-BL-2024-010663$BAUSCH AND LOMB$$$$$$Y$$$20240712$$MD$JP$JP
240860852$24086085$2$F$$20240805$20240712$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109711$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240807$$CN$US$US
240860861$24086086$1$I$20231022$20240709$20240712$20240712$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-111237$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240712$$MD$CA$CA
240860871$24086087$1$I$20221229$20240710$20240712$20240712$EXP$$CA-TAKEDA-2024TUS071037$TAKEDA$$45$YR$$M$Y$$$20240712$$CN$CA$CA
240860881$24086088$1$I$20160920$20240709$20240712$20240712$EXP$$CA-TAKEDA-2016TUS020725$TAKEDA$$75$YR$$M$Y$$$20240712$$CN$CA$CA
240860892$24086089$2$F$$20240715$20240712$20240722$EXP$$NVSC2024RU143472$NOVARTIS$Eroshenkov DY, Aleshina OA, Vasilyeva AN, Terekhova EO, Bogolyubova AV, Serdyuk YV et al.. CAR-T-????????? ??????? ??? ????????????????? ???????? PH-??????????? ??????? ?????????????? ??????? ????? ????????????? ?????????????? [Car-T-Cell Therapy For Extramedullary Relapse Of R-Positive Acute Lymphoblastic Leukemia After Blinatumomab Immunotherapy]. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY(GEMATOLOGIYA I TRANSFUSIOLOGIY). 2024;69:215$28$YR$$$Y$$$20240722$$HP$RU$RU
240860901$24086090$1$I$20240702$20240709$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN007223$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240860911$24086091$1$I$$20240712$20240712$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039527$BOEHRINGER INGELHEIM$$$$$$Y$$$20240712$$CN$US$US
240860921$24086092$1$I$$20240710$20240712$20240712$EXP$$JP-LUNDBECK-DKLU4001640$LUNDBECK$$$$$$Y$$$20240712$$PH$JP$JP
240860933$24086093$3$F$20240426$20240816$20240712$20240902$PER$$US-AMGEN-USASP2024128115$AMGEN$$76$YR$E$M$Y$$$20240902$$PH$US$US
240860941$24086094$1$I$$20240710$20240712$20240712$EXP$$US-TAKEDA-2024TUS070707$TAKEDA$$$$$F$Y$$$20240712$$CN$US$US
240860951$24086095$1$I$$20240709$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN007221$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240860961$24086096$1$I$20240101$20240708$20240712$20240712$PER$$US-SA-2024SA203421$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240712$$MD$US$US
240860971$24086097$1$I$$20240705$20240712$20240712$EXP$$CA-INCYTE CORPORATION-2024IN007219$INCYTE$$$$$$Y$$$20240712$$PH$CA$CA
240860983$24086098$3$F$20210101$20240723$20240712$20240726$EXP$$US-ZENPEP LLC-2022AIMT01949$AIMMUNE$$$$$$Y$$$20240726$$HP$US$US
240860992$24086099$2$F$20231213$20240701$20240712$20240717$EXP$GB-MHRA-MED-202407011209211620-QRBJH$GB-BAYER-2024A100728$BAYER$$72$YR$E$F$Y$70$KG$20240717$$CN$GB$GB
240861002$24086100$2$F$20230710$20240703$20240712$20240715$EXP$$US-JNJFOC-20240718109$JOHNSON AND JOHNSON$$0$YR$$M$Y$$$20240715$$HP$US$US
240861011$24086101$1$I$20240709$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007532$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240712$$CN$US$US
240861021$24086102$1$I$20231211$20240709$20240712$20240712$EXP$$CA-PFIZER INC-202300442832$PFIZER$$30$YR$$F$Y$97$KG$20240712$$MD$CA$CA
240861031$24086103$1$I$$20240710$20240712$20240712$EXP$$GR-PFIZER INC-2023SGN12065$PFIZER$$$$$F$Y$$$20240712$$MD$GR$GR
240861042$24086104$2$F$20230101$20240905$20240712$20240905$EXP$$CA-PFIZER INC-202300322196$PFIZER$$52$YR$$M$Y$$$20240905$$CN$CA$CA
240861071$24086107$1$I$$20240702$20240712$20240712$EXP$$US-PFIZER INC-2021SGN00165$PFIZER$$33$YR$$M$Y$$$20240712$$MD$US$US
240861081$24086108$1$I$20211026$20240705$20240712$20240712$EXP$$JP-PFIZER INC-2021SGN06837$PFIZER$$24$YR$$F$Y$50$KG$20240712$$PH$JP$JP
240861091$24086109$1$I$$20240710$20240712$20240712$EXP$$GR-PFIZER INC-2023SGN10213$PFIZER$$$$$F$Y$$$20240712$$MD$GR$GR
240861101$24086110$1$I$20240621$20240708$20240712$20240712$EXP$HR-HALMED-300086012$HR-MYLANLABS-2024M1064208$MYLAN$$83$YR$$F$Y$55$KG$20240712$$PH$HR$HR
240861113$24086111$3$F$$20240909$20240712$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109685$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240910$$CN$US$US
240861121$24086112$1$I$$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110969$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$78.93$KG$20240712$$CN$US$US
240861141$24086114$1$I$20240601$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110883$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240712$$HP$US$US
240861152$24086115$2$F$20240711$20240711$20240712$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111348$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240716$$CN$US$US
240861161$24086116$1$I$$20240708$20240712$20240712$PER$$US-ALXN-202407USA000496US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240712$$CN$US$US
240861171$24086117$1$I$$20240707$20240712$20240712$EXP$$ID-AstraZeneca-2024A157970$ASTRAZENECA$$65$YR$$F$Y$$$20240712$$MD$ID$
240861181$24086118$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A159677$ASTRAZENECA$$70$YR$$F$Y$53$KG$20240712$$HP$FR$
240861191$24086119$1$I$$20240705$20240712$20240712$EXP$$ZA-AstraZeneca-2024A156043$ASTRAZENECA$$72$YR$$M$Y$$$20240712$$CN$ZA$
240861201$24086120$1$I$$20240709$20240712$20240712$EXP$$US-AstraZeneca-2024A157346$ASTRAZENECA$$$$$F$Y$88$KG$20240712$$CN$US$
240861211$24086121$1$I$$20240704$20240712$20240712$EXP$$JP-MALLINCKRODT-MNK202404439$MALLINCKRODT$$$$$$Y$$$20240712$$HP$JP$JP
240861221$24086122$1$I$$20240704$20240712$20240712$EXP$$JP-MALLINCKRODT-MNK202404442$MALLINCKRODT$$$$$$Y$$$20240712$$HP$JP$JP
240861231$24086123$1$I$20230623$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217529$TEVA$$66$YR$$F$Y$$$20240712$$HP$KR$KR
240861241$24086124$1$I$$20240704$20240712$20240712$EXP$$JP-MALLINCKRODT-MNK202404441$MALLINCKRODT$$$$$$Y$$$20240712$$HP$JP$JP
240861251$24086125$1$I$$20240704$20240712$20240712$EXP$$JP-MALLINCKRODT-MNK202404443$MALLINCKRODT$$$$$$Y$$$20240712$$HP$JP$JP
240861261$24086126$1$I$$20240704$20240712$20240712$EXP$$JP-MALLINCKRODT-MNK202404444$MALLINCKRODT$$$$$$Y$$$20240712$$HP$JP$JP
240861271$24086127$1$I$$20240704$20240712$20240712$EXP$$JP-MALLINCKRODT-MNK202404440$MALLINCKRODT$$$$$$Y$$$20240712$$HP$JP$JP
240861281$24086128$1$I$$20240704$20240712$20240712$EXP$$JP-MALLINCKRODT-MNK202404446$MALLINCKRODT$$$$$$Y$$$20240712$$HP$JP$JP
240861291$24086129$1$I$$20240704$20240712$20240712$EXP$$JP-MALLINCKRODT-MNK202404447$MALLINCKRODT$$$$$$Y$$$20240712$$HP$JP$JP
240861301$24086130$1$I$$20240704$20240712$20240712$EXP$$JP-MALLINCKRODT-MNK202404448$MALLINCKRODT$$$$$$Y$$$20240712$$HP$JP$JP
240861311$24086131$1$I$20240701$20240709$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN007213$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240861321$24086132$1$I$$20240704$20240712$20240712$EXP$$JP-MALLINCKRODT-MNK202404449$MALLINCKRODT$$$$$$Y$$$20240712$$HP$JP$JP
240861331$24086133$1$I$$20240704$20240712$20240712$EXP$$JP-MALLINCKRODT-MNK202404445$MALLINCKRODT$$$$$$Y$$$20240712$$HP$JP$JP
240861341$24086134$1$I$20230918$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216433$TEVA$$52$YR$$F$Y$$$20240712$$HP$KR$KR
240861351$24086135$1$I$20230706$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217552$TEVA$$8$DEC$$F$Y$$$20240712$$HP$KR$KR
240861361$24086136$1$I$20230816$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216364$TEVA$$5$DEC$$F$Y$$$20240712$$HP$KR$KR
240861371$24086137$1$I$$20240708$20240712$20240712$EXP$CZ-EMA-DD-20240319-7482705-141837$CZ-MYLANLABS-2024M1064279$MYLAN$Koristek Z. Treatment of relapsed B-acute lymphoblastic leukemia with inotuzumab ozogamicin. ACTA MEDICINAE. 2023;13(4 - Ext 2/3):46-47$27$YR$$M$Y$$$20240712$$HP$CZ$CZ
240861391$24086139$1$I$$20240709$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN007212$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240861401$24086140$1$I$20240703$20240712$20240712$20240712$30DAY$$AR-PFIZER INC-202400206978$PFIZER$$12$YR$$M$Y$$$20240712$$HP$AR$AR
240861414$24086141$4$F$20231116$20240810$20240712$20240814$30DAY$$US-PFIZER INC-PV202400044145$PFIZER$$$$$$Y$$$20240814$$HP$US$US
240861432$24086143$2$F$$20240718$20240712$20240725$EXP$$GB-TAKEDA-2024TUS070125$TAKEDA$$$$A$F$Y$$$20240725$$CN$GB$GB
240861441$24086144$1$I$20230901$20240708$20240712$20240712$PER$$US-Eisai-EC-2024-169988$EISAI$$69$YR$E$M$Y$$$20240712$$CN$US$US
240861451$24086145$1$I$20240108$20240708$20240712$20240712$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-004600$AURINIA PHARMACEUTICALS$$26$YR$$F$Y$$$20240712$$HP$US$US
240861463$24086146$3$F$$20240723$20240712$20240803$PER$$US-AMGEN-USASP2024138322$AMGEN$$56$YR$A$F$Y$$$20240803$$CN$US$US
240861472$24086147$2$F$$20240812$20240712$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110999$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240814$$CN$US$US
240861481$24086148$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110811$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240712$$HP$US$US
240861491$24086149$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110924$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240712$$HP$US$US
240861501$24086150$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111074$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$91.17$KG$20240712$$CN$US$US
240861512$24086151$2$F$20240622$20240708$20240712$20240807$EXP$$CO-BAYER-2024A100188$BAYER$$34$YR$A$M$Y$62$KG$20240807$$HP$CO$CO
240861522$24086152$2$F$20240704$20240712$20240712$20240717$EXP$$GB-MYLANLABS-2024M1064891$MYLAN$$$$$F$Y$$$20240717$$HP$GB$GB
240861531$24086153$1$I$$20240702$20240712$20240712$EXP$$US-MYLANLABS-2024M1063767$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$38$YR$$F$Y$$$20240712$$HP$US$US
240861541$24086154$1$I$20240428$20240709$20240712$20240712$EXP$FR-AFSSAPS-BX2024001374$FR-MYLANLABS-2024M1064275$MYLAN$$79$YR$$M$Y$89$KG$20240712$$PH$FR$FR
240861551$24086155$1$I$20240626$20240705$20240712$20240712$EXP$$CN-009507513-2407CHN004018$MERCK$$41$YR$$M$Y$85$KG$20240712$$HP$CN$CN
240861561$24086156$1$I$20240101$20240705$20240712$20240712$EXP$$DE-INCYTE CORPORATION-2024IN007208$INCYTE$$$$$$Y$$$20240712$$CN$DE$DE
240861571$24086157$1$I$20240705$20240711$20240712$20240712$EXP$$US-BAYER-2024A100792$BAYER$$72$YR$E$F$Y$$$20240712$$CN$US$US
240861581$24086158$1$I$$20240708$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN007205$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240861591$24086159$1$I$$20240710$20240712$20240712$EXP$$US-GSK-US2024086385$GLAXOSMITHKLINE$$$$$$Y$$$20240712$$CN$US$US
240861601$24086160$1$I$20240607$20240702$20240712$20240712$EXP$$TR-GE HEALTHCARE-2024CSU007491$GE HEALTHCARE$$60$YR$$M$Y$$$20240712$$HP$TR$TR
240861613$24086161$3$F$$20240903$20240712$20240909$PER$$US-AstraZeneca-2024A156886$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
240861625$24086162$5$F$20240601$20240807$20240712$20240816$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010366$JAZZ$$69$YR$$F$Y$$$20240816$$CN$US$US
240861631$24086163$1$I$$20240707$20240712$20240712$EXP$$US-Saptalis Pharmaceuticals LLC-2159084$SAPTALIS PHARMACEUTICALS$Here present a domestic (Literature; source) case of a female in her early 70s who arrived at the emergency department with altered mental status and new-onset blindness, later diagnosed with severe acidosis (pH 6.607). She was intubated for hemodynamic instability and continuous renal replacement therapy (CRRT).Her metformin concentration was found to be exceptionally high at 34 mcg/ml; Fortunately, the patient survived and was subsequently transferred to the medical floors in stable condition.$72$YR$$F$Y$$$20240712$$$US$US
240861641$24086164$1$I$20230501$20240612$20240712$20240712$PER$$US-009507513-2406USA004270$MERCK$Utpat N, Dikengil C, Utpat K. Puzzling encounter of idiopathic pasteurella bacteraemia. BMJ Case Reports. 2024;17 (5)$$$E$M$Y$$$20240712$$HP$US$US
240861652$24086165$2$F$20240706$20240821$20240712$20240828$EXP$$US-GSK-US2024084952$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
240861661$24086166$1$I$20230127$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216496$TEVA$$5$DEC$$M$Y$$$20240712$$HP$KR$KR
240861671$24086167$1$I$$20240709$20240712$20240712$PER$$US-MYLANLABS-2024M1065121$MYLAN$$$$$$Y$$$20240712$$CN$US$US
240861681$24086168$1$I$20230523$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216836$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240861691$24086169$1$I$20230913$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216503$TEVA$$8$DEC$$M$Y$$$20240712$$HP$KR$KR
240861701$24086170$1$I$20240530$20240708$20240712$20240712$EXP$FR-AFSSAPS-ST2024001125$FR-009507513-2407FRA003626$MERCK$$49$YR$$M$Y$$$20240712$$MD$FR$FR
240861711$24086171$1$I$20230727$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216507$TEVA$$7$DEC$$M$Y$$$20240712$$HP$KR$KR
240861721$24086172$1$I$20240620$20240702$20240712$20240712$PER$$CN-Eisai-EC-2024-169557$EISAI$$30$YR$A$M$Y$$$20240712$$HP$CN$CN
240861731$24086173$1$I$20240308$20240710$20240712$20240712$EXP$FR-AFSSAPS-LL2024001220$FR-PURDUE-USA-2024-0310713$PURDUE$$35$YR$$F$Y$$$20240712$$MD$FR$FR
240861741$24086174$1$I$20230904$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216515$TEVA$$8$DEC$$F$Y$$$20240712$$HP$KR$KR
240861751$24086175$1$I$$20240628$20240712$20240712$EXP$$US-ABBVIE-5834033$ABBVIE$$$$$M$Y$$$20240712$$MD$US$US
240861761$24086176$1$I$$20240629$20240712$20240712$EXP$$CA-HLS-202401654$HLS THERAPEUTICS$$$$E$F$Y$$$20240712$$PH$CA$CA
240861771$24086177$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006609$ELI LILLY AND CO$$$$$$Y$$$20240712$$CN$US$US
240861782$24086178$2$F$20240621$20240716$20240712$20240725$EXP$GB-MHRA-MED-202407011132109340-KPBJW$GB-ELI_LILLY_AND_COMPANY-GB202407002398$ELI LILLY AND CO$$50$YR$A$M$Y$105$KG$20240725$$CN$GB$GB
240861791$24086179$1$I$$20240704$20240712$20240712$EXP$$CA-TEVA-VS-3219573$TEVA$$45$YR$$F$Y$$$20240712$$CN$CA$CA
240861801$24086180$1$I$$20240708$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407005827$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240712$$CN$US$US
240861811$24086181$1$I$20230605$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216875$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240861821$24086182$1$I$$20240711$20240712$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039544$BOEHRINGER INGELHEIM$$$$$$Y$$$20240712$$HP$US$US
240861831$24086183$1$I$20230911$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216462$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240861841$24086184$1$I$$20240711$20240712$20240712$PER$$NVSC2024US144622$NOVARTIS$$$$$$Y$$$20240712$$HP$US$US
240861851$24086185$1$I$20231201$20240708$20240712$20240712$EXP$$CI-PERRIGO-24CI006335$PERRIGO$$32$YR$$F$Y$$$20240712$$HP$CI$CI
240861862$24086186$2$F$$20240722$20240712$20240731$EXP$$GB-TEVA-VS-3216384$TEVA$Kafagi AH, Li AS, Jayne D, Brix SR. Anti-GBM disease in pregnancy. BMJ Case Reports . 2024 Apr 30;17(4).$$$N$F$Y$1$KG$20240731$$MD$GB$GB
240861871$24086187$1$I$$20240702$20240712$20240712$30DAY$$US-GSK-US2024083084$GLAXOSMITHKLINE$$$$$M$Y$$$20240712$$CN$US$US
240861881$24086188$1$I$$20240621$20240712$20240712$PER$$US-BEH-2024174585$CSL BEHRING$$$$A$M$Y$$$20240712$$HP$US$US
240861891$24086189$1$I$20240701$20240710$20240712$20240712$EXP$$CN-PFIZER INC-PV202400090635$PFIZER$$27$YR$$F$Y$53.5$KG$20240712$$HP$CN$CN
240861901$24086190$1$I$$20240710$20240712$20240712$EXP$$US-PFIZER INC-202400212017$PFIZER$$42$YR$$F$Y$$$20240712$$MD$US$US
240861912$24086191$2$F$20100101$20240806$20240712$20240812$PER$$US-JAZZ-2019-US-012544$JAZZ$$41$YR$$F$Y$$$20240812$$CN$US$US
240861921$24086192$1$I$$20240710$20240712$20240712$EXP$$CN-009507513-2407CHN007930$MERCK$Jin S, Shen Z, Li J, Liu X, Zhu Q, Li F, et al.. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. Journal of Clinical Pathology. 2024;77(7):471-7$$$E$M$Y$$$20240712$$HP$CN$CN
240861932$24086193$2$F$$20240827$20240712$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111051$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240828$$CN$US$US
240861941$24086194$1$I$$20240708$20240712$20240712$EXP$$US-UROVANT SCIENCES GMBH-202407-URV-001010$UROVANT SCIENCES$$$$$F$Y$$$20240712$$CN$US$US
240861951$24086195$1$I$$20240710$20240712$20240712$EXP$$GR-JAZZ PHARMACEUTICALS-2024-GR-010562$JAZZ$$$$$$Y$$$20240712$$MD$GR$GR
240861961$24086196$1$I$$20240704$20240712$20240712$EXP$$CA-TEVA-VS-3219553$TEVA$$74$YR$$M$Y$$$20240712$$PH$CA$CA
240861971$24086197$1$I$$20240708$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN007203$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240861981$24086198$1$I$20230829$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216587$TEVA$$54$YR$$F$Y$$$20240712$$HP$KR$KR
240861991$24086199$1$I$20231026$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216542$TEVA$$50$YR$$F$Y$$$20240712$$HP$KR$KR
240862001$24086200$1$I$20230418$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216709$TEVA$$69$YR$$F$Y$$$20240712$$HP$KR$KR
240862011$24086201$1$I$20240301$20240708$20240712$20240712$EXP$$US-JNJFOC-20240720578$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$PH$US$US
240862021$24086202$1$I$20240708$20240708$20240712$20240712$EXP$GB-MHRA-MED-202407080851433390-DGCJK$GB-ABBVIE-5838070$ABBVIE$$$$$$Y$$$20240712$$MD$GB$GB
240862032$24086203$2$F$$20240909$20240712$20240911$PER$$NVSC2024US144619$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
240862041$24086204$1$I$$20240705$20240712$20240712$EXP$$CA-AMGEN-CANSP2024134421$AMGEN$Rajendran L.; Magyar C.J.; Li Z. et al.. Is liver transplantation a treatment option for unresectable colorectal liver metastases? Interim analysis of a phase ll trial. Annals of Oncology. 2024;35:S24-S25$$$$$Y$$$20240712$$HP$CA$CA
240862051$24086205$1$I$20231115$20240710$20240712$20240712$EXP$$US-ABBVIE-5836683$ABBVIE$$69$YR$$F$Y$$$20240712$$CN$US$US
240862061$24086206$1$I$20170623$20240708$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN007199$INCYTE$$$$$$Y$$$20240712$$HP$US$US
240862071$24086207$1$I$$20240711$20240712$20240712$EXP$$NVSC2024US143946$NOVARTIS$$$$$F$Y$$$20240712$$LW$US$US
240862081$24086208$1$I$20211017$20240624$20240712$20240712$EXP$$US-MYLANLABS-2024M1063979$MYLAN$$77$YR$$M$Y$82.55$KG$20240712$$CN$US$US
240862091$24086209$1$I$20240708$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137644$AMGEN$$62$YR$A$F$Y$$$20240712$$CN$US$US
240862101$24086210$1$I$20240624$20240710$20240712$20240712$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010597$JAZZ$$45$YR$$M$Y$$$20240712$$CN$US$US
240862113$24086211$3$F$$20240708$20240712$20240812$PER$$US-INCYTE CORPORATION-2024IN007195$INCYTE$$$$$$Y$$$20240812$$CN$US$US
240862121$24086212$1$I$$20240704$20240712$20240712$EXP$$CA-TEVA-VS-3219835$TEVA$$85$YR$$F$Y$45$KG$20240712$$PH$CA$CA
240862131$24086213$1$I$20240525$20240703$20240712$20240712$EXP$$CN-009507513-2407CHN002830$MERCK$$70$YR$$F$Y$58$KG$20240712$$HP$CN$CN
240862141$24086214$1$I$20240320$20240703$20240712$20240712$EXP$PT-INFARMED-R202406-412$PT-SA-2024SA199259$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240712$$PH$PT$PT
240862151$24086215$1$I$$20240709$20240712$20240712$EXP$$SE-PAIPHARMA-2024-SE-000017$PHARMACEUTICAL ASSOC$Ott M, Mannchen JK, Jamshidi F, Werneke U.Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques..Therapeutic Advances in Psychopharmacology.2019;91-32.$73$YR$$F$Y$$$20240712$$HP$SE$SE
240862161$24086216$1$I$$20240709$20240712$20240712$EXP$$BR-PAIPHARMA-2024-BR-000073$PHARMACEUTICAL ASSOC$Cavalcante Neto PM, Luz LC, Pereira LLS, et al.Non-eosinophilic exudative pleural effusion induced by valproic acid..American Journal of Respiratory and Critical Care Medicine.2024;209A1924.$55$YR$$M$Y$$$20240712$$HP$BR$BR
240862181$24086218$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111151$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240712$$HP$US$US
240862191$24086219$1$I$$20240711$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111056$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240712$$CN$US$US
240862201$24086220$1$I$20230602$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216935$TEVA$$$$E$F$Y$$$20240712$$HP$KR$KR
240862211$24086221$1$I$$20240708$20240712$20240712$EXP$$TN-PAIPHARMA-2024-TN-000010$PHARMACEUTICAL ASSOC$Ben Hammamia S, Jabri FE, Belhadj A, et al.Neurotoxicity related to multidrug association: a case report..Journal of Clinical Psychopharmacology.2024;44(3):317-319.$57$YR$$F$Y$$$20240712$$MD$TN$TN
240862221$24086222$1$I$20230425$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216877$TEVA$$$$E$M$Y$$$20240712$$HP$KR$KR
240862231$24086223$1$I$20230428$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216917$TEVA$$$$A$M$Y$$$20240712$$HP$KR$KR
240862241$24086224$1$I$20230418$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216724$TEVA$$70$YR$$M$Y$$$20240712$$HP$KR$KR
240862251$24086225$1$I$20240101$20240620$20240712$20240712$EXP$SE-SEMPA-2024-002890$SE-SAMSUNG BIOEPIS-SB-2024-19273$SAMSUNG BIOEPIS$$68$YR$E$F$Y$$$20240712$$MD$SE$SE
240862261$24086226$1$I$$20240710$20240712$20240712$EXP$GB-MHRA-MED-202407101636401910-FZYVH$GB-MYLANLABS-2024M1064965$MYLAN$$32$YR$$M$Y$$$20240712$$MD$GB$GB
240862271$24086227$1$I$20230920$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216589$TEVA$$5$DEC$$F$Y$$$20240712$$HP$KR$KR
240862281$24086228$1$I$$20240710$20240712$20240712$EXP$$CN-009507513-2407CHN006361$MERCK$Jin S, Shen Z, Li J, Liu X, Zhu Q, Li F, et al.. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. Journal of Clinical Pathology. 2024;77(7):471-7$$$E$M$Y$$$20240712$$HP$CN$CN
240862291$24086229$1$I$$20240705$20240712$20240712$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107904$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240712$$HP$CA$CA
240862301$24086230$1$I$20240603$20240702$20240712$20240712$EXP$$MX-ELI_LILLY_AND_COMPANY-BR202407007858$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240712$$CN$DE$BR
240862311$24086231$1$I$20240708$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006692$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240712$$CN$US$US
240862322$24086232$2$F$$20240729$20240712$20240730$EXP$$DE-ABBVIE-5835867$ABBVIE$$$$$M$Y$$$20240730$$MD$DE$DE
240862331$24086233$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A158984$ASTRAZENECA$$64$YR$$M$Y$64$KG$20240712$$HP$FR$
240862341$24086234$1$I$20230307$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216519$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240862351$24086235$1$I$20230909$20240709$20240712$20240712$EXP$ES-AEMPS-1543140$ES-MYLANLABS-2024M1064307$MYLAN$$59$YR$$M$Y$$$20240712$$MD$ES$ES
240862362$24086236$2$F$20240401$20240806$20240712$20240815$EXP$$CA-LUNDBECK-DKLU4001642$LUNDBECK$$$$$$Y$$$20240815$$CN$CA$CA
240862371$24086237$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA203067$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240712$$CN$US$US
240862381$24086238$1$I$$20240703$20240712$20240712$PER$$US-009507513-2407USA003202$MERCK$Abboud Y, Richter B, Malhotra R, Vossough-Teehan S. Treating Helicobacter pylori and Recurrent Clostridioides difficile Coinfection: A Delicate Balance in Management and a Need for Guidelines. ACG Case Reports Journal. 2024;11(11)$80$YR$$M$Y$$$20240712$$MD$US$US
240862391$24086239$1$I$$20240703$20240712$20240712$30DAY$$US-GSK-US2024083146$GLAXOSMITHKLINE$$$$$F$Y$$$20240712$$CN$US$US
240862401$24086240$1$I$$20240701$20240712$20240712$EXP$$US-HLS-202400194$HLS THERAPEUTICS$$53$YR$A$F$Y$$$20240712$$MD$US$US
240862411$24086241$1$I$$20240703$20240712$20240712$EXP$$US-BAUSCHBL-2024BNL029639$BAUSCH AND LOMB$$$$$M$Y$$$20240712$$CN$US$US
240862421$24086242$1$I$$20240707$20240712$20240712$EXP$$CN-Prasco Laboratories-PRAS20241024$PRASCO$Shen K, Gao Y, Chang L, Zhang L, Cao X, Tian Z, Wang Y, Zhou D, Li J. Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA and IIIB light-chain amyloidosis: a prospective phase II study. Haematologica. 2024 JUL;109:2355-2358. doi:10.3324/haematol.2024.285145$$$$$Y$$$20240712$$HP$CN$CN
240862431$24086243$1$I$20230518$20240702$20240712$20240712$EXP$ES-AEMPS-1541091$ES-TEVA-VS-3219866$TEVA$$32$YR$$F$Y$$$20240712$$PH$ES$ES
240862441$24086244$1$I$20150101$20240705$20240712$20240712$EXP$DE-AMK-253746$DE-RDY-SPO/GER/21/0142874$DR REDDYS$$73$YR$E$F$Y$81.2$KG$20240712$$PH$DE$DE
240862451$24086245$1$I$$20240710$20240712$20240712$EXP$$AU-MYLANLABS-2024M1064949$MYLAN$$$$$M$Y$$$20240712$$PH$AU$AU
240862461$24086246$1$I$20240112$20240620$20240712$20240712$EXP$FR-AFSSAPS-LL2024000581$FR-SAMSUNG BIOEPIS-SB-2024-19347$SAMSUNG BIOEPIS$$57$YR$A$F$Y$65$KG$20240712$$MD$FR$FR
240862471$24086247$1$I$$20240705$20240712$20240712$PER$$US-BAUSCHBL-2024BNL029754$BAUSCH AND LOMB$$$$$F$Y$$$20240712$$CN$US$US
240862481$24086248$1$I$$20240710$20240712$20240712$EXP$$US-PAIPHARMA-2024-US-037917$PHARMACEUTICAL ASSOC$Haghparast P, Nadybal M, Yuan C.Treatment-resistant priapism in a 61-year-old male after combined use of trazodone, quetiapine, and fluoxetine..Journal of Clinical Psychopharmacology.2024;44(3):316-317.$61$YR$$M$Y$$$20240712$$PH$US$US
240862502$24086250$2$F$20211221$20240723$20240712$20240826$EXP$$HU-LUNDBECK-DKLU4001387$LUNDBECK$Bodor A; Benczur B. Club of broken-hearted women: myth or reality? Minoca takotsubo syndrome - case study. LAM. 2024;34(4):205-211$$$$$Y$$$20240826$$MD$HU$HU
240862511$24086251$1$I$$20240620$20240712$20240712$EXP$$IT-SAMSUNG BIOEPIS-SB-2024-19449$SAMSUNG BIOEPIS$Discontinuation of Infliximab leading to auditory loss in a patient with Cogan syndrome: a case report. Joint Bone Spine. 91:. doi:10.1016/j.jbspin.2024.105747$22$YR$A$F$Y$$$20240712$$HP$IT$IT
240862522$24086252$2$F$$20240904$20240712$20240912$EXP$$US-GSK-US2024AMR084283$GLAXOSMITHKLINE$$$$$F$Y$82.086$KG$20240912$$CN$US$US
240862531$24086253$1$I$20240623$20240710$20240712$20240712$EXP$$NVSC2024CN144293$NOVARTIS$$35$YR$$F$Y$46$KG$20240712$$HP$CN$CN
240862541$24086254$1$I$20240506$20240708$20240712$20240712$EXP$$US-MYLANLABS-2024M1064365$MYLAN$$81$YR$$M$Y$73.02$KG$20240712$$CN$US$US
240862551$24086255$1$I$$20240705$20240712$20240712$EXP$$UA-009507513-2407UKR003260$MERCK$$29$YR$$F$Y$$$20240712$$MD$UA$UA
240862561$24086256$1$I$$20240418$20240712$20240712$PER$$US-AGEPHA PHARMA FZ LLC-AGP202404-000006$Agepha Pharmaceuticals$$47$YR$$M$Y$$$20240712$$CN$US$US
240862581$24086258$1$I$20240501$20240708$20240712$20240712$PER$$US-Eisai-EC-2024-169993$EISAI$$70$YR$E$M$Y$$$20240712$$CN$US$US
240862591$24086259$1$I$20240101$20240607$20240712$20240712$PER$$US-AGEPHA PHARMA FZ LLC-AGP202406-000010$Agepha Pharmaceuticals$$51$YR$$M$Y$$$20240712$$CN$US$US
240862601$24086260$1$I$$20240701$20240712$20240712$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000241$Unknown Manufacturer$$$$$$Y$$$20240712$$CN$US$US
240862612$24086261$2$F$20240101$20240708$20240712$20240722$EXP$$CA-BAUSCH-BL-2024-010528$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240722$$CN$CA$CA
240862621$24086262$1$I$$20240708$20240712$20240712$EXP$$US-BAUSCH-BL-2024-010451$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240712$$CN$US$US
240862631$24086263$1$I$$20240711$20240712$20240712$EXP$$US-BAUSCH-BL-2024-010612$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240712$$CN$US$US
240862642$24086264$2$F$$20240731$20240712$20240802$EXP$$US-BAUSCH-BL-2024-010552$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240802$$CN$US$US
240862651$24086265$1$I$20181206$20240711$20240712$20240712$EXP$$IT-BAUSCH-BL-2024-010605$BAUSCH AND LOMB$$$$$$Y$$$20240712$$MD$IT$IT
240862661$24086266$1$I$20220203$20240711$20240712$20240712$EXP$$IT-BAUSCH-BL-2024-010604$BAUSCH AND LOMB$$$$$$Y$$$20240712$$MD$IT$IT
240862672$24086267$2$F$20240614$20240711$20240712$20240918$EXP$FR-AFSSAPS-NT2024000812$FR-BAUSCH-BL-2024-010670$BAUSCH AND LOMB$$44$YR$$F$Y$$$20240918$$PH$FR$FR
240862681$24086268$1$I$20230530$20240711$20240712$20240712$EXP$$DE-BAUSCH-BL-2024-010655$BAUSCH AND LOMB$$60$YR$$M$Y$67$KG$20240712$$HP$DE$DE
240862691$24086269$1$I$20230601$20240701$20240712$20240712$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202407001250$ELI LILLY AND CO$$$$$F$Y$$$20240712$$CN$ES$ES
240862702$24086270$2$F$20140101$20240904$20240712$20240911$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407005819$ELI LILLY AND CO$$$$A$M$Y$73$KG$20240911$$CN$GB$GB
240862711$24086271$1$I$20240201$20240705$20240712$20240712$EXP$$JP-SMPA-2024SMP010400$SUNOVION$$$$$$Y$$$20240712$$CN$JP$JP
240862721$24086272$1$I$$20240703$20240712$20240712$EXP$$CA-BEH-2024175295$CSL BEHRING$$52$YR$A$M$Y$70$KG$20240712$$CN$CA$CA
240862742$24086274$2$F$20240101$20240709$20240712$20240722$EXP$$DE-VERTEX PHARMACEUTICALS-2024-011375$VERTEX$$$$$F$Y$$$20240722$$CN$DE$DE
240862751$24086275$1$I$$20231024$20240712$20240712$PER$$US-ANIPHARMA-2023-US-035674$ANI$$$$$UNK$Y$$$20240712$$CN$US$US
240862761$24086276$1$I$20230305$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216548$TEVA$$$$E$M$Y$$$20240712$$HP$KR$KR
240862771$24086277$1$I$20240622$20240711$20240712$20240712$EXP$$CN-PFIZER INC-PV202400091311$PFIZER$$68$YR$$M$Y$63$KG$20240712$$HP$CN$CN
240862781$24086278$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110354$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$69.85$KG$20240712$$MD$US$US
240862792$24086279$2$F$$20240711$20240712$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111305$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240716$$CN$US$US
240862801$24086280$1$I$$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217056$TEVA$$61$YR$$F$Y$$$20240712$$MD$KR$KR
240862821$24086282$1$I$$20240705$20240712$20240712$EXP$$ES-AstraZeneca-2024A156304$ASTRAZENECA$$$$$F$Y$$$20240712$$MD$ES$
240862841$24086284$1$I$$20240711$20240712$20240712$EXP$$US-PFIZER INC-202400212546$PFIZER$$$$$$Y$$$20240712$$CN$US$US
240862851$24086285$1$I$$20240701$20240712$20240712$EXP$$FR-AstraZeneca-2024A158988$ASTRAZENECA$$58$YR$$M$Y$76$KG$20240712$$HP$FR$
240862861$24086286$1$I$$20240702$20240712$20240712$EXP$$DE-TEVA-VS-3217364$TEVA$$$$$M$Y$$$20240712$$CN$DE$DE
240862871$24086287$1$I$20230724$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217403$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240862881$24086288$1$I$20230720$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3217404$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240862893$24086289$3$F$20240831$20240903$20240712$20240904$EXP$$GB-MYLANLABS-2024M1057743$MYLAN$$$$$M$Y$$$20240904$$MD$GB$GB
240862901$24086290$1$I$20240301$20240709$20240712$20240712$EXP$$NVSC2024US142543$NOVARTIS$$65$YR$$F$Y$$$20240712$$CN$US$US
240862911$24086291$1$I$$20240708$20240712$20240712$EXP$$NVSC2024CR143731$NOVARTIS$$$$$F$Y$$$20240712$$CN$CR$CR
240862921$24086292$1$I$$20240708$20240712$20240712$PER$$US-EMD Serono-2024037249$EMD SERONO INC$$$$A$F$Y$$$20240712$$HP$US$US
240862931$24086293$1$I$20230802$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216314$TEVA$$$$A$F$Y$$$20240712$$PH$KR$KR
240862941$24086294$1$I$$20240710$20240712$20240712$EXP$$US-MYLANLABS-2024M1064817$MYLAN$$$$$F$Y$$$20240712$$HP$US$US
240862951$24086295$1$I$$20240704$20240712$20240712$EXP$$CA-TEVA-VS-3219288$TEVA$$73$YR$$F$Y$$$20240712$$PH$CA$CA
240862971$24086297$1$I$$20240710$20240712$20240712$EXP$$US-Taiho Oncology Inc-2024-003309$TAIHO ONCOLOGY INC$$49$YR$A$M$Y$$$20240712$$CN$US$US
240862981$24086298$1$I$$20240708$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN007186$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240862991$24086299$1$I$$20240704$20240712$20240712$EXP$$CA-TEVA-VS-3219652$TEVA$$68$YR$$M$Y$$$20240712$$PH$CA$CA
240863001$24086300$1$I$20230301$20240704$20240712$20240712$EXP$$HK-INCYTE CORPORATION-2024IN007096$INCYTE$$$$$$Y$$$20240712$$MD$HK$HK
240863012$24086301$2$F$20240101$20240830$20240712$20240911$EXP$$US-BIOGEN-2024BI01272393$BIOGEN$$40$YR$$F$Y$$$20240911$$HP$US$US
240863031$24086303$1$I$20240101$20240702$20240712$20240712$EXP$$CH-CARA THERAPEUTICS, INC.-2024-00345-CH$CARA THERAPEUTICS$$68$YR$$F$Y$$$20240712$$MD$CH$CH
240863042$24086304$2$F$$20240621$20240712$20240924$PER$$US-INCYTE CORPORATION-2024IN006709$INCYTE$$$$$$Y$$$20240924$$CN$US$US
240863051$24086305$1$I$$20240621$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN006708$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240863061$24086306$1$I$20240601$20240709$20240712$20240712$EXP$FR-AFSSAPS-PB2024000734$FR-009507513-2407FRA004165$MERCK$$41$YR$$F$Y$$$20240712$$MD$FR$FR
240863071$24086307$1$I$$20240621$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN006707$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240863081$24086308$1$I$$20240621$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN006676$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240863101$24086310$1$I$$20240621$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN006675$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240863121$24086312$1$I$20240704$20240711$20240712$20240712$EXP$GB-MHRA-TPP17576274C5652396YC1720102731260$GB-ORGANON-O2407GBR001113$ORGANON$$55$YR$$F$Y$149$KG$20240712$$HP$GB$GB
240863131$24086313$1$I$$20240621$20240712$20240712$PER$$US-INCYTE CORPORATION-2024IN006674$INCYTE$$$$$$Y$$$20240712$$CN$US$US
240863151$24086315$1$I$20230829$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216329$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240863161$24086316$1$I$20230303$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216357$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240863171$24086317$1$I$20230927$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216390$TEVA$$$$A$F$Y$$$20240712$$HP$KR$KR
240863181$24086318$1$I$20240628$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110447$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240712$$CN$US$US
240863191$24086319$1$I$$20240708$20240712$20240712$PER$$US-ALXN-202407USA000463US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240712$$CN$US$US
240863201$24086320$1$I$$20240702$20240712$20240712$PER$$US-JNJFOC-20240731916$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240712$$PH$US$US
240863211$24086321$1$I$20230427$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216871$TEVA$$$$E$F$Y$$$20240712$$HP$KR$KR
240863221$24086322$1$I$$20240702$20240712$20240712$PER$$US-JNJFOC-20240733156$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$HP$US$US
240863231$24086323$1$I$20240101$20240709$20240712$20240712$PER$$US-SA-2024SA205437$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240712$$MD$US$US
240863241$24086324$1$I$20240612$20240711$20240712$20240712$PER$$US-JNJFOC-20240729985$JOHNSON AND JOHNSON$$$$$M$Y$$$20240712$$PH$US$US
240863252$24086325$2$F$20240601$20240826$20240712$20240829$EXP$$JP-GILEAD-2024-0680268$GILEAD$$7$DEC$E$M$Y$$$20240829$$MD$JP$JP
240863261$24086326$1$I$$20240703$20240712$20240712$PER$$US-JNJFOC-20240733251$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240712$$CN$US$US
240863271$24086327$1$I$20240101$20240629$20240712$20240712$PER$$US-009507513-2407USA001475$MERCK$$$$$F$Y$$$20240712$$CN$US$US
240863282$24086328$2$F$$20240822$20240712$20240827$EXP$$NVSC2024PT144163$NOVARTIS$Teixeira CM, Amaro AM, Dias A, Brito A, Duarte A. Drug-induced injury secondary to terbinafine. GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE. 2024;183(4):364-6$92$YR$$M$Y$$$20240827$$HP$PT$PT
240863292$24086329$2$F$20240605$20240814$20240712$20240821$EXP$FR-AFSSAPS-AN2024000831$FR-009507513-2407FRA002438$MERCK$$86$YR$$M$Y$60$KG$20240821$$PH$FR$FR
240863301$24086330$1$I$$20240708$20240712$20240712$EXP$$NVSC2023TR087081$NOVARTIS$Ozek G, Aksoylar S, Ucar SK, Canda E, Akcan M, Carti O et al.. Hematopoietic stem cell transplantation with reduced toxicity conditioning regimen in mitochondrial neurogastrointestinal encephalopathy syndrome. PEDIATRIC BLOOD AND CANCER. 2023;e30334(1-7)$20$YR$$M$Y$$$20240712$$HP$TR$TR
240863312$24086331$2$F$$20240801$20240712$20240805$PER$$US-PURDUE PHARMA-USA-2024-0310711$PURDUE$$$$A$M$Y$$$20240805$$CN$US$US
240863322$24086332$2$F$$20240709$20240712$20240717$EXP$$CA-AstraZeneca-2024A157087$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$CA$
240863341$24086334$1$I$20240603$20240704$20240712$20240712$EXP$$CN-009507513-2407CHN003459$MERCK$$94$YR$$F$Y$$$20240712$$HP$CN$CN
240863352$24086335$2$F$$20240715$20240712$20240724$EXP$$NVSC2024RU143453$NOVARTIS$Paneva MA, Kirillova EG, German KV. Evolution in the treatment of chronic myeloid leukemia by clinical example: 20-year follow-up experience. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY (GEMATOLOGIYA I TRANSFUSIOLOGIY. 2024;69(2):289-90$$$$F$Y$$$20240724$$HP$RU$RU
240863361$24086336$1$I$20240623$20240705$20240712$20240712$PER$$CN-Eisai-EC-2024-169700$EISAI$$44$YR$A$F$Y$49$KG$20240712$$HP$CN$CN
240863391$24086339$1$I$20230531$20240702$20240712$20240712$EXP$$KR-TEVA-VS-3216964$TEVA$$79$YR$$F$Y$$$20240712$$HP$KR$KR
240863412$24086341$2$F$$20240722$20240712$20240731$EXP$$US-TEVA-VS-3217669$TEVA$Kramkowski J, Rath S. Efficacious retrial of electroconvulsive therapy for major depressive disorder after a prolonged seizure in an older adult. BMJ-Case-Rep 2023; 16 (5): 1-4.; Kramkowski J, Rath S. Efficacious retrial of electroconvulsive therapy for major depressive disorder after a prolonged seizure in an older adult. BMJ-Case-Rep 2023; 16 (5): 1-4.$$$E$F$Y$$$20240731$$MD$US$US
240863431$24086343$1$I$20240601$20240627$20240712$20240712$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0524$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240712$$CN$US$US
240863441$24086344$1$I$$20240705$20240712$20240712$EXP$$ZA-AstraZeneca-2024A155839$ASTRAZENECA$$62$YR$$F$Y$$$20240712$$CN$ZA$
240863451$24086345$1$I$20240704$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110390$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240712$$HP$US$US
240863462$24086346$2$F$$20240724$20240712$20240802$EXP$$US-TEVA-VS-3217731$TEVA$Hossain S, Patten E, Anigbogu J. Daptomycin-induced Lung Injury. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Hossain S, Patten E, Anigbogu J. Daptomycin-induced Lung Injury. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$55$YR$$M$Y$$$20240802$$HP$US$US
240863472$24086347$2$F$20240703$20240724$20240712$20240802$EXP$$CN-BEIGENE-BGN-2024-010880$BEIGENE$$$$$$Y$$$20240802$$MD$CN$CN
240863491$24086349$1$I$$20240702$20240712$20240712$30DAY$$US-GSK-US2024AMR082208$GLAXOSMITHKLINE$$3$YR$$F$Y$$$20240712$$CN$US$US
240863502$24086350$2$F$20240628$20240712$20240712$20240716$PER$$US-AMGEN-USASP2024138253$AMGEN$$87$YR$E$M$Y$$$20240715$$CN$US$US
240863511$24086351$1$I$$20240709$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407006608$ELI LILLY AND CO$$40$YR$A$$Y$$$20240712$$CN$US$US
240863522$24086352$2$F$$20240724$20240712$20240802$EXP$$US-TEVA-VS-3217730$TEVA$Alpert M, Chu DC. Solving a Paradox: Use of Biologic Monotherapy in an Unusual Case of Asthma With Paradoxical Bronchospasm. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A6398.; Alpert M, Chu DC. Solving a Paradox: Use of Biologic Monotherapy in an Unusual Case of Asthma With Paradoxical Bronchospasm. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A6398.$24$YR$$F$Y$$$20240802$$HP$US$US
240863531$24086353$1$I$20230421$20240708$20240712$20240712$EXP$$GB-GILEAD-2024-0672034$GILEAD$$26$YR$A$F$Y$45$KG$20240712$$MD$GB$GB
240863542$24086354$2$F$20240701$20240716$20240712$20240724$EXP$$CN-Eisai-EC-2024-169559$EISAI$$62$YR$A$F$Y$75$KG$20240724$$MD$CN$CN
240863553$24086355$3$F$20240709$20240711$20240712$20240717$PER$$US-AMGEN-USASP2024137939$AMGEN$$72$YR$E$F$Y$$$20240717$$CN$US$US
240863561$24086356$1$I$$20240703$20240712$20240712$EXP$$IT-CARA THERAPEUTICS, INC.-2024-00348-IT$CARA THERAPEUTICS$$$$A$$Y$$$20240712$$MD$IT$IT
240863571$24086357$1$I$$20240703$20240712$20240712$EXP$$DE-TEVA-VS-3217175$TEVA$$$$A$F$Y$73$KG$20240712$$MD$DE$DE
240863581$24086358$1$I$20240309$20240710$20240712$20240712$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110940$BRISTOL MYERS SQUIBB$$104$YR$E$M$Y$$$20240712$$CN$US$US
240863592$24086359$2$F$20240709$20240711$20240712$20240829$EXP$$DE-GILEAD-2024-0679997$GILEAD$$42$YR$A$F$Y$$$20240829$$CN$DE$DE
240863601$24086360$1$I$20230413$20240705$20240712$20240712$EXP$$US-RDY-CLI/USA/23/0164262$DR REDDYS$$32$YR$A$F$Y$$$20240712$$MD$US$US
240863611$24086361$1$I$20240709$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137786$AMGEN$$63$YR$A$F$Y$$$20240712$$CN$US$US
240863621$24086362$1$I$$20240711$20240712$20240712$PER$$NVSC2024US144654$NOVARTIS$$$$$$Y$$$20240712$$HP$US$US
240863701$24086370$1$I$$20240709$20240712$20240712$EXP$$US-GILEAD-2024-0680290$GILEAD$$64$YR$A$M$Y$$$20240712$$CN$US$US
240863711$24086371$1$I$$20240707$20240712$20240712$PER$$US-SA-2024SA205444$SANOFI AVENTIS$$$$A$F$Y$$$20240712$$MD$US$US
240863721$24086372$1$I$20240621$20240703$20240712$20240712$EXP$IT-MINISAL02-992395$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-06487$HIKMA$$$$$$Y$$$20240712$$MD$IT$IT
240863732$24086373$2$F$20240401$20240805$20240712$20240805$EXP$$CN-PFIZER INC-202400210406$PFIZER$$$$E$$Y$$$20240805$$MD$CN$CN
240863745$24086374$5$F$20240601$20240826$20240712$20240826$EXP$$JP-PFIZER INC-PV202400082879$PFIZER$$62$YR$$M$Y$57$KG$20240826$$MD$JP$JP
240863751$24086375$1$I$20221001$20240710$20240712$20240712$EXP$$GR-PFIZER INC-2023SGN12424$PFIZER$$47$YR$$F$Y$$$20240712$$MD$GR$GR
240863761$24086376$1$I$20240606$20240703$20240712$20240712$EXP$$CN-PFIZER INC-202400211003$PFIZER$$30$YR$$F$Y$65$KG$20240712$$MD$CN$CN
240863771$24086377$1$I$20160811$20240711$20240712$20240712$EXP$$FR-PFIZER INC-2016SGN01991$PFIZER$$41$YR$$M$Y$83$KG$20240712$$MD$FR$FR
240863781$24086378$1$I$20151215$20240711$20240712$20240712$EXP$$FR-PFIZER INC-2016SGN01005$PFIZER$$56$YR$$F$Y$61$KG$20240712$$MD$FR$FR
240863791$24086379$1$I$20230517$20240710$20240712$20240712$EXP$$ES-PFIZER INC-2023SGN05123$PFIZER$$69$YR$$M$Y$$$20240712$$MD$ES$ES
240863801$24086380$1$I$$20240710$20240712$20240712$EXP$$CA-PFIZER INC-202400212393$PFIZER$$38$YR$$M$Y$$$20240712$$HP$CA$CA
240863811$24086381$1$I$$20240711$20240712$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039374$BOEHRINGER INGELHEIM$$$$$$Y$$$20240712$$HP$US$US
240863821$24086382$1$I$20240417$20240418$20240712$20240712$PER$$US-GE HEALTHCARE-2024CSU004050$GE HEALTHCARE$$30$YR$$F$Y$$$20240712$$HP$US$US
240863831$24086383$1$I$20240710$20240711$20240712$20240712$PER$$US-JNJFOC-20240730404$JOHNSON AND JOHNSON$$$$$$Y$$$20240712$$CN$US$US
240863841$24086384$1$I$$20240705$20240712$20240712$EXP$GB-MHRA-MED-202405151902076100-FZBVM$GB-RDY-SPO/GBR/24/0010005$DR REDDYS$$$$$F$Y$54$KG$20240712$$CN$GB$GB
240863851$24086385$1$I$20220727$20240703$20240712$20240712$EXP$IT-MINISAL02-891204$IT-TEVA-VS-3217075$TEVA$$9$YR$$M$Y$29$KG$20240712$$PH$IT$IT
240863861$24086386$1$I$20240628$20240702$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002866$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240712$$CN$US$US
240863871$24086387$1$I$$20240704$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159062$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240863881$24086388$1$I$20240606$20240620$20240712$20240712$PER$$US-009507513-2406USA007447$MERCK$$59$YR$$F$Y$$$20240712$$CN$US$US
240863892$24086389$2$F$20240223$20240814$20240712$20240814$PER$$US-PFIZER INC-2024SGN06270$PFIZER$$29$YR$$M$Y$$$20240814$$HP$US$US
240863901$24086390$1$I$20240301$20240320$20240712$20240712$EXP$$CN-PFIZER INC-PV202400038238$PFIZER$$84$YR$$M$Y$45$KG$20240712$$HP$CN$CN
240863911$24086391$1$I$20090101$20240702$20240712$20240712$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002307$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240712$$CN$US$US
240863922$24086392$2$F$20231201$20240923$20240712$20240925$PER$$US-PFIZER INC-PV202400091664$PFIZER$$46$YR$$F$Y$$$20240925$$HP$US$US
240863931$24086393$1$I$20210112$20240708$20240712$20240712$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110073$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240712$$MD$CA$CA
240863941$24086394$1$I$$20240701$20240712$20240712$EXP$$US-FMCRTG-FMC-2407-000798$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240712$$HP$US$US
240863951$24086395$1$I$20200901$20240704$20240712$20240712$EXP$$CN-INCYTE CORPORATION-2024IN007287$INCYTE$Zhang W, Xiao L, Zhou G, Zhu H, Bi Y, Du J, et al.. Secondary adrenocortical insuf?ciency after treatment with retifanlimab: a case report. Frontiers in Immunology. 2024;15:1371527$$$$$Y$$$20240712$$MD$CN$CN
240863961$24086396$1$I$$20240702$20240712$20240712$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001354$BLUEPRINT MEDICINES$$$$$F$Y$$$20240709$$CN$US$US
240863972$24086397$2$F$20240721$20240722$20240712$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001364$BLUEPRINT MEDICINES$$75$YR$E$F$Y$$$20240731$$CN$US$US
240863982$24086398$2$F$$20240708$20240712$20240716$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001367$BLUEPRINT MEDICINES$$$$$F$Y$$$20240716$$CN$US$US
240863991$24086399$1$I$20240520$20240701$20240712$20240712$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001344$BLUEPRINT MEDICINES$$60$YR$A$F$Y$$$20240709$$CN$US$US
240864001$24086400$1$I$20220701$20240703$20240712$20240712$PER$$GR-Blueprint Medicines Corporation-SP-GR-2024-001369$BLUEPRINT MEDICINES$$58$YR$A$M$Y$$$20240709$$MD$GR$GR
240864011$24086401$1$I$$20240702$20240712$20240712$EXP$$ES-Blueprint Medicines Corporation-SP-ES-2024-001351$BLUEPRINT MEDICINES$$$$$$Y$$$20240709$$MD$ES$ES
240864021$24086402$1$I$20240709$20240712$20240712$20240712$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039552$BOEHRINGER INGELHEIM$$88$YR$E$M$Y$$$20240712$$CN$US$US
240864031$24086403$1$I$$20240711$20240712$20240712$PER$$NVSC2024US144581$NOVARTIS$$$$$$Y$$$20240712$$MD$US$US
240864041$24086404$1$I$$20240705$20240712$20240712$EXP$$FR-AstraZeneca-2023A213529$ASTRAZENECA$$$$$F$Y$84$KG$20240712$$MD$FR$
240864061$24086406$1$I$20231101$20240703$20240712$20240712$EXP$$DE-TEVA-VS-3216966$TEVA$$$$$M$Y$2.59$KG$20240712$$MD$DE$DE
240864071$24086407$1$I$20230821$20240703$20240712$20240712$EXP$IT-MINISAL02-947954$IT-TEVA-VS-3216859$TEVA$$7$YR$$F$Y$23$KG$20240712$$PH$IT$IT
240864211$24086421$1$I$$20240712$20240712$20240712$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039539$BOEHRINGER INGELHEIM$$$$$$Y$$$20240712$$MD$US$US
240864221$24086422$1$I$$20240711$20240712$20240712$EXP$$KR-AstraZeneca-2024A159961$ASTRAZENECA$$$$$M$Y$$$20240712$$CN$KR$
240864232$24086423$2$F$$20240812$20240712$20240828$PER$$US-AstraZeneca-2024A157479$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
240864251$24086425$1$I$20240227$20240703$20240712$20240712$EXP$IT-MINISAL02-992247$IT-TEVA-VS-3216844$TEVA$$46$YR$$F$Y$49$KG$20240712$$PH$IT$IT
240864261$24086426$1$I$20240101$20240712$20240712$20240712$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039454$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240712$$MD$RU$RU
240864271$24086427$1$I$20240520$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137460$AMGEN$$67$YR$E$M$Y$83.6$KG$20240712$$HP$US$US
240864281$24086428$1$I$$20240709$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109152$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240712$$HP$US$US
240864291$24086429$1$I$20240710$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137534$AMGEN$$48$YR$A$F$Y$$$20240712$$CN$US$US
240864301$24086430$1$I$$20240710$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407007474$ELI LILLY AND CO$$$$A$M$Y$$$20240712$$CN$US$US
240864311$24086431$1$I$20240626$20240710$20240712$20240712$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110534$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$56.25$KG$20240712$$HP$US$US
240864321$24086432$1$I$$20240618$20240712$20240712$PER$$US-JNJFOC-20240650333$JOHNSON AND JOHNSON$$$$$F$Y$$$20240712$$CN$US$US
240864331$24086433$1$I$$20240711$20240712$20240712$PER$$NVSC2024US144644$NOVARTIS$$$$$$Y$$$20240713$$HP$US$US
240864342$24086434$2$F$20220801$20240909$20240712$20240914$EXP$$US-TAKEDA-US202030146$TAKEDA$$18$YR$$M$Y$135$KG$20240914$$HP$US$US
240864351$24086435$1$I$$20240705$20240712$20240712$PER$$GB-Eisai-EC-2024-169901$EISAI$$$$E$F$Y$$$20240712$$MD$GB$GB
240864361$24086436$1$I$20240702$20240708$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159034$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240864371$24086437$1$I$20240707$20240708$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159056$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240864381$24086438$1$I$$20240708$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159031$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240864391$24086439$1$I$$20240705$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159053$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240864401$24086440$1$I$20230701$20240710$20240712$20240712$EXP$$DE-GILEAD-2024-0680199$GILEAD$$63$YR$A$M$Y$$$20240712$$HP$DE$DE
240864411$24086441$1$I$20240326$20240707$20240712$20240712$EXP$$ID-AstraZeneca-2024A159008$ASTRAZENECA$$36$YR$$M$Y$$$20240713$$MD$ID$
240864422$24086442$2$F$$20240802$20240712$20240805$PER$$US-ALXN-202407USA000429US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240864431$24086443$1$I$20240122$20240704$20240712$20240712$EXP$FR-AFSSAPS-CN2024000625$FR-TEVA-VS-3217692$TEVA$$59$YR$$M$Y$$$20240712$$MD$FR$FR
240864441$24086444$1$I$20240612$20240708$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159057$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240864451$24086445$1$I$20240703$20240708$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159061$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240864461$24086446$1$I$$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024138343$AMGEN$$$$A$F$Y$$$20240712$$HP$US$US
240864471$24086447$1$I$20240615$20240710$20240712$20240712$EXP$$PR-ABBVIE-5835108$ABBVIE$$57$YR$$M$Y$$$20240712$$CN$PR$PR
240864481$24086448$1$I$20240706$20240711$20240712$20240712$EXP$$US-ABBVIE-5837909$ABBVIE$$79$YR$$M$Y$$$20240712$$CN$US$US
240864491$24086449$1$I$20240707$20240708$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159063$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240864502$24086450$2$F$$20240718$20240712$20240723$PER$$US-BIOMARINAP-US-2024-159106$BIOMARIN$$$$$$Y$$$20240723$$CN$US$US
240864511$24086451$1$I$$20240709$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159079$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240864521$24086452$1$I$$20240709$20240712$20240712$PER$$US-GILEAD-2024-0680489$GILEAD$$$$$$Y$$$20240712$$HP$US$US
240864531$24086453$1$I$20240707$20240708$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159060$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240864541$24086454$1$I$$20240628$20240712$20240712$EXP$$CA-HLS-202401644$HLS THERAPEUTICS$$$$A$F$Y$$$20240712$$MD$CA$CA
240864551$24086455$1$I$20240630$20240709$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159107$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240864561$24086456$1$I$$20240710$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159117$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240864571$24086457$1$I$$20240709$20240712$20240712$PER$$US-BIOMARINAP-US-2024-159112$BIOMARIN$$$$$$Y$$$20240712$$CN$US$US
240864581$24086458$1$I$20240101$20240705$20240712$20240712$PER$$US-009507513-2407USA003480$MERCK$$68$YR$$F$Y$$$20240712$$CN$US$US
240864591$24086459$1$I$$20240624$20240712$20240712$PER$$US-PHARMING-PHAUS2024000518$PHARMING GROUP$$$$$$Y$$$20240713$$MD$US$US
240864601$24086460$1$I$20240709$20240710$20240712$20240712$PER$$US-AMGEN-USASP2024137946$AMGEN$$48$YR$A$F$Y$$$20240712$$CN$US$US
240864611$24086461$1$I$$20240612$20240712$20240712$PER$$US-009507513-2406USA006071$MERCK$Chiu AK, Amatya B, Amin I, Ratanpal AS, Lutz AB, Shear BM, et al.. Superinfections of the Spine: A Single-Institution Experience. Journal of Clinical Medicine. 2024;13(2739)$57$YR$$M$Y$$$20240712$$HP$US$US
240864621$24086462$1$I$20240101$20240709$20240712$20240712$EXP$$US-ABBVIE-5811583$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240864631$24086463$1$I$$20240709$20240712$20240712$PER$$US-AMGEN-USASP2024137474$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240864641$24086464$1$I$20240702$20240708$20240712$20240712$EXP$$NL-ABBVIE-5693676$ABBVIE$$$$E$F$Y$$$20240712$$CN$NL$NL
240864651$24086465$1$I$$20240612$20240712$20240712$PER$$US-009507513-2407USA008704$MERCK$Chiu AK, Amatya B, Amin I, Ratanpal AS, Lutz AB, Shear BM, et al.. Superinfections of the Spine: A Single-Institution Experience. Journal of Clinical Medicine. 2024;13(2739)$62$YR$$F$Y$$$20240712$$HP$US$US
240864661$24086466$1$I$20240101$20240710$20240712$20240712$EXP$$CA-ABBVIE-5836976$ABBVIE$$92$YR$$F$Y$$$20240712$$CN$CA$CA
240864672$24086467$2$F$20240101$20240830$20240712$20240905$EXP$$CO-ABBVIE-5836923$ABBVIE$$$$$M$Y$67$KG$20240905$$CN$CO$CO
240864681$24086468$1$I$$20240701$20240712$20240712$PER$$US-ELI_LILLY_AND_COMPANY-US202407002516$ELI LILLY AND CO$$14$YR$T$F$Y$$$20240712$$CN$US$US
240864694$24086469$4$F$$20240912$20240712$20240919$EXP$$NVSC2024US128545$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
240864701$24086470$1$I$20240101$20240710$20240712$20240712$EXP$$AR-ABBVIE-5835078$ABBVIE$$$$$F$Y$$$20240712$$CN$AR$AR
240864711$24086471$1$I$20240707$20240710$20240712$20240712$EXP$$CZ-ABBVIE-5836682$ABBVIE$$73$YR$$M$Y$$$20240712$$HP$CZ$CZ
240864721$24086472$1$I$20230101$20240710$20240712$20240712$EXP$$CO-ABBVIE-5837100$ABBVIE$$$$$F$Y$62$KG$20240712$$CN$CO$CO
240864731$24086473$1$I$20240708$20240708$20240712$20240712$EXP$$JP-ABBVIE-5809133$ABBVIE$$40$YR$$F$Y$$$20240712$$PH$JP$JP
240864744$24086474$4$F$20240101$20240917$20240712$20240924$PER$$US-SA-2024SA153841$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240924$$MD$US$US
240864752$24086475$2$F$20240501$20240711$20240712$20240715$EXP$$US-ROCHE-10000024966$ROCHE$$43$YR$A$F$Y$70.3$KG$20240715$$CN$US$US
240864761$24086476$1$I$$20240710$20240712$20240712$PER$$US-ABBVIE-5835213$ABBVIE$$$$$$Y$$$20240712$$CN$US$US
240864771$24086477$1$I$20200803$20240711$20240712$20240712$EXP$PL-URPL-1-2812-2020$PL-ROCHE-10000023476$ROCHE$$81$YR$E$F$Y$77$KG$20240713$$MD$PL$PL
240864781$24086478$1$I$$20240618$20240712$20240712$EXP$$TH-ROCHE-10000023642$ROCHE$$70$YR$E$F$Y$$$20240713$$CN$TH$TH
240864791$24086479$1$I$20240101$20240710$20240712$20240712$EXP$$CA-ABBVIE-5831127$ABBVIE$$69$YR$$M$Y$$$20240712$$CN$CA$CA
240864801$24086480$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA204232$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240713$$MD$US$US
240864811$24086481$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA204194$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240713$$MD$US$US
240864821$24086482$1$I$$20240703$20240712$20240712$EXP$$IN-ROCHE-10000020767$ROCHE$$71$YR$E$M$Y$$$20240713$$CN$IN$IN
240864831$24086483$1$I$20240101$20240705$20240712$20240712$PER$$US-SA-2024SA204090$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240713$$MD$US$US
240864841$24086484$1$I$20240620$20240709$20240712$20240712$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000174$DENDREON$$$$$$Y$$$20240712$$CN$US$US
240864851$24086485$1$I$$20240707$20240712$20240712$EXP$$US-SANDOZ INC.-SDZ2024US064797$SANDOZ$$$$$F$Y$51$KG$20240712$$CN$US$US
240864861$24086486$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA204255$SANOFI AVENTIS$$$$A$M$Y$$$20240713$$MD$US$US
240864871$24086487$1$I$$20240705$20240712$20240712$EXP$$CN-ROCHE-10000004637$ROCHE$Ding J, Gu H, Yang Z, Lu Y, Guo G. Breast metastasis from lung adenocarcinoma: a case report and review of the literature. Frontiers in Oncology. 2024;14:1-5. doi:10.3389/fonc.2024.1370453.$52$YR$A$F$Y$$$20240713$$HP$CN$CN
240864881$24086488$1$I$$20240709$20240712$20240712$EXP$$GB-SANDOZ INC.-SDZ2024GB064595$SANDOZ$$$$$F$Y$$$20240712$$CN$GB$GB
240864894$24086489$4$F$20240101$20240819$20240712$20240826$EXP$$CA-CELLTRION INC.-2024CA014075$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
240864902$24086490$2$F$20240131$20240725$20240712$20240730$EXP$$PL-ABBVIE-5833038$ABBVIE$$65$YR$$F$Y$65$KG$20240730$$MD$PL$PL
240864912$24086491$2$F$$20240705$20240712$20240716$EXP$$US-ABBVIE-5837637$ABBVIE$$$$$M$Y$$$20240716$$MD$US$US
240864921$24086492$1$I$20240617$20240710$20240712$20240712$EXP$$US-ABBVIE-5837567$ABBVIE$$84$YR$$F$Y$$$20240712$$CN$US$US
240864931$24086493$1$I$20240301$20240708$20240712$20240712$PER$$US-SA-2024SA204084$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240713$$MD$US$US
240864941$24086494$1$I$20240401$20240704$20240712$20240712$EXP$GB-MHRA-MED-202405061455541680-ZSDVW$GB-TEVA-VS-3218663$TEVA$$25$YR$$M$Y$$$20240712$$MD$GB$GB
240864951$24086495$1$I$20240319$20240705$20240712$20240712$EXP$FR-AFSSAPS-RE2024000646$FR-SA-2024SA198848$SANOFI AVENTIS$$84$YR$E$M$Y$92$KG$20240713$$MD$FR$FR
240864961$24086496$1$I$20230520$20240710$20240712$20240712$EXP$FR-EMA-DD-20240703-7482665-082803$FR-SANDOZ INC.-SDZ2024FR064249$SANDOZ$$73$YR$$M$Y$100$KG$20240712$$MD$FR$FR
240864972$24086497$2$F$$20240724$20240712$20240805$EXP$$JP-ABBVIE-5837092$ABBVIE$$84$YR$$M$Y$$$20240804$$PH$JP$JP
240864981$24086498$1$I$$20240710$20240712$20240712$EXP$$US-ABBVIE-5837975$ABBVIE$$$$$M$Y$$$20240712$$CN$US$US
240864991$24086499$1$I$20240619$20240710$20240712$20240712$EXP$$US-ABBVIE-5835936$ABBVIE$$69$YR$$M$Y$$$20240712$$CN$US$US
240865001$24086500$1$I$$20240709$20240712$20240712$PER$$US-ABBVIE-5836830$ABBVIE$$$$$F$Y$$$20240712$$CN$US$US
240865021$24086502$1$I$$20240708$20240712$20240712$PER$$US-SA-2024SA202718$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240713$$HP$US$US
240865033$24086503$3$F$20230416$20240708$20240712$20240724$EXP$$RU-ABBVIE-5836506$ABBVIE$$8$YR$$M$Y$13.3$KG$20240724$$MD$RU$RU
240865041$24086504$1$I$20240401$20240710$20240712$20240712$EXP$$CA-SANDOZ INC.-SDZ2024CA044719$SANDOZ$$68$YR$$F$Y$$$20240712$$MD$CA$CA
240865051$24086505$1$I$$20240709$20240712$20240712$EXP$$BR-ROCHE-10000022893$ROCHE$$$$$F$Y$$$20240713$$MD$BR$BR
240865061$24086506$1$I$$20240705$20240712$20240712$EXP$$RU-ROCHE-10000019867$ROCHE$$$$A$F$Y$$$20240713$$MD$RU$RU
240865073$24086507$3$F$$20240715$20240712$20240801$EXP$$CA-SANDOZ INC.-SDZ2024CA064242$SANDOZ$$40$YR$$F$Y$$$20240801$$HP$CA$CA
240865081$24086508$1$I$20240101$20240626$20240713$20240713$EXP$$US-ABBVIE-5835267$ABBVIE$$$$$$Y$$$20240713$$CN$US$US
240865091$24086509$1$I$20240101$20240708$20240713$20240713$PER$$US-SA-2024SA204182$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240713$$MD$US$US
240865101$24086510$1$I$20240101$20240704$20240712$20240712$EXP$GB-MHRA-MED-202405011943502680-MHYWC$GB-TEVA-VS-3217788$TEVA$$66$YR$$F$Y$$$20240712$$HP$GB$GB
240865111$24086511$1$I$$20240710$20240713$20240713$EXP$$US-ABBVIE-5837887$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240865121$24086512$1$I$20240422$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405031303370180-SCPBV$GB-TEVA-VS-3218265$TEVA$$72$YR$$F$Y$78$KG$20240713$$PH$GB$GB
240865131$24086513$1$I$$20240704$20240712$20240712$EXP$GB-MHRA-MED-202407041215189050-SRPKJ$GB-TEVA-VS-3217740$TEVA$$$$$M$Y$$$20240712$$CN$GB$GB
240865141$24086514$1$I$$20240711$20240713$20240713$EXP$$US-SANDOZ INC.-SDZ2024US064793$SANDOZ$$$$$F$Y$$$20240713$$CN$US$US
240865151$24086515$1$I$$20240708$20240713$20240713$PER$$US-ABBVIE-5834676$ABBVIE$$50$YR$$M$Y$$$20240713$$MD$US$US
240865162$24086516$2$F$20240710$20240823$20240713$20240826$PER$$US-AMGEN-USASP2024137449$AMGEN$$80$YR$E$F$Y$$$20240826$$PH$US$US
240865172$24086517$2$F$20240528$20240718$20240713$20240722$EXP$$NVSC2024CO053911$NOVARTIS$$71$YR$$F$Y$60$KG$20240722$$CN$CO$CO
240865181$24086518$1$I$$20240704$20240713$20240713$EXP$$DE-TEVA-VS-3217584$TEVA$$$$$F$Y$3.41$KG$20240713$$MD$DE$DE
240865201$24086520$1$I$20240517$20240704$20240713$20240713$EXP$HR-HALMED-300085743$HR-TEVA-VS-3217586$TEVA$$65$YR$$M$Y$$$20240713$$MD$HR$HR
240865211$24086521$1$I$$20240711$20240713$20240713$PER$$US-ABBVIE-5837387$ABBVIE$$$$$$Y$$$20240713$$MD$US$US
240865221$24086522$1$I$20240201$20240704$20240713$20240713$EXP$FR-AFSSAPS-MA2024001109$FR-TEVA-VS-3217608$TEVA$$48$YR$$M$Y$$$20240713$$PH$FR$FR
240865231$24086523$1$I$20231224$20240704$20240713$20240713$EXP$FR-AFSSAPS-AVMA2024000263$FR-TEVA-VS-3217625$TEVA$$51$YR$$F$Y$$$20240713$$PH$FR$FR
240865241$24086524$1$I$20240523$20240704$20240713$20240713$EXP$FR-AFSSAPS-NC2024000755$FR-TEVA-VS-3217603$TEVA$$56$YR$$M$Y$$$20240713$$MD$FR$FR
240865251$24086525$1$I$20240709$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137944$AMGEN$$30$YR$A$F$Y$$$20240712$$CN$US$US
240865261$24086526$1$I$20240621$20240704$20240713$20240713$EXP$IT-MINISAL02-992420$IT-TEVA-VS-3217555$TEVA$$71$YR$$F$Y$84$KG$20240713$$MD$IT$IT
240865271$24086527$1$I$20240611$20240704$20240713$20240713$EXP$IT-MINISAL02-992508$IT-TEVA-VS-3217573$TEVA$$63$YR$$M$Y$$$20240713$$MD$IT$IT
240865281$24086528$1$I$$20240709$20240713$20240713$EXP$$AU-ABBVIE-5835035$ABBVIE$$61$YR$$F$Y$$$20240713$$MD$AU$AU
240865291$24086529$1$I$20240401$20240703$20240713$20240713$EXP$$DE-TEVA-VS-3217178$TEVA$$1$DY$$F$Y$3.18$KG$20240713$$MD$DE$DE
240865301$24086530$1$I$$20240703$20240713$20240713$EXP$$US-ROCHE-10000018818$ROCHE$$79$YR$E$F$Y$$$20240713$$CN$US$US
240865311$24086531$1$I$$20240705$20240713$20240713$PER$$US-AMGEN-USASP2024137772$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240865321$24086532$1$I$20240603$20240704$20240713$20240713$EXP$ES-AEMPS-1540003$ES-TEVA-VS-3217543$TEVA$$77$YR$$M$Y$57$KG$20240713$$MD$ES$ES
240865331$24086533$1$I$$20240705$20240713$20240713$EXP$$PT-CELLTRION INC.-2024PT016580$CELLTRION$Mariana F.D.M.. BIOLOGIC THERAPIES AND TUBERCULOSIS: KEEP IT IN MIND.. Europe an Journal of Case Reports in Internal Medicine.. 2021;8 (Supplement1):343$$$$$Y$$$20240713$$HP$PT$PT
240865341$24086534$1$I$20210605$20240704$20240713$20240713$EXP$$DE-TEVA-VS-3217628$TEVA$$$$A$F$Y$$$20240713$$MD$DE$DE
240865351$24086535$1$I$20240619$20240704$20240713$20240713$EXP$FR-AFSSAPS-TO2024001184$FR-TEVA-VS-3217590$TEVA$$33$YR$$F$Y$51$KG$20240713$$MD$FR$FR
240865361$24086536$1$I$20240630$20240708$20240713$20240713$PER$$US-AMGEN-USASP2024138501$AMGEN$$63$YR$A$F$Y$$$20240712$$CN$US$US
240865371$24086537$1$I$20240608$20240704$20240713$20240713$EXP$FR-AFSSAPS-MP2024001045$FR-TEVA-VS-3217610$TEVA$$32$YR$$F$Y$48$KG$20240713$$PH$FR$FR
240865384$24086538$4$F$20240503$20240913$20240713$20240923$EXP$IT-MINISAL02-992155$IT-TEVA-VS-3217119$TEVA$$9$YR$$F$Y$29$KG$20240923$$PH$IT$IT
240865391$24086539$1$I$20240614$20240704$20240713$20240713$EXP$FR-AFSSAPS-AM2024000542$FR-TEVA-VS-3217695$TEVA$$10$YR$$M$Y$35.5$KG$20240713$$PH$FR$FR
240865401$24086540$1$I$20240525$20240704$20240713$20240713$EXP$FR-AFSSAPS-TS2024000745$FR-TEVA-VS-3217617$TEVA$$49$YR$$F$Y$89$KG$20240713$$MD$FR$FR
240865411$24086541$1$I$$20240711$20240713$20240713$PER$$US-ABBVIE-5838219$ABBVIE$$$$$$Y$$$20240713$$HP$US$US
240865421$24086542$1$I$$20240709$20240713$20240713$EXP$$US-NOVITIUMPHARMA-2024USNVP01264$NOVITIUM PHARMA$V. V. Woodard.A Rare Case of Necrotizing Pneumonia in an Immunocompromised Patient.American Journal of Respiratory and Critical Care Medicine.19-MAY-2024;209:A2444-A2444$67$YR$A$M$Y$$$20240713$$HP$US$US
240865431$24086543$1$I$20240708$20240708$20240713$20240713$PER$$US-ABBVIE-5834951$ABBVIE$$89$YR$$F$Y$$$20240713$$CN$US$US
240865442$24086544$2$F$20231103$20240716$20240713$20240726$EXP$FR-AFSSAPS-MP2024001063$FR-TEVA-VS-3217594$TEVA$$70$YR$$F$Y$$$20240726$$PH$FR$FR
240865452$24086545$2$F$20231218$20240820$20240713$20240829$EXP$FR-AFSSAPS-AVMA2024000264$FR-TEVA-VS-3217478$TEVA$$39$YR$$F$Y$$$20240829$$PH$FR$FR
240865461$24086546$1$I$19920101$20240704$20240713$20240713$EXP$FR-AFSSAPS-RN2024000715$FR-TEVA-VS-3217688$TEVA$$28$YR$$F$Y$$$20240713$$MD$FR$FR
240865471$24086547$1$I$20240610$20240704$20240713$20240713$EXP$FR-AFSSAPS-BS2024000384$FR-TEVA-VS-3217355$TEVA$$83$YR$$F$Y$$$20240713$$MD$FR$FR
240865481$24086548$1$I$20190101$20240704$20240713$20240713$EXP$FR-AFSSAPS-RE2024000629$FR-TEVA-VS-3217690$TEVA$$23$YR$$F$Y$64$KG$20240713$$MD$FR$FR
240865491$24086549$1$I$20240705$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137849$AMGEN$$85$YR$E$M$Y$$$20240712$$CN$US$US
240865501$24086550$1$I$20240701$20240708$20240713$20240713$PER$$US-ABBVIE-5833725$ABBVIE$$46$YR$$M$Y$$$20240713$$MD$US$US
240865512$24086551$2$F$$20240724$20240713$20240802$EXP$$US-TEVA-VS-3217983$TEVA$Locke M, Kohn N, Seetharamu N. Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas. Clin-Otolaryngol 2023; 48 (6): 915-919.; Locke M, Kohn N, Seetharamu N. Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas. Clin-Otolaryngol 2023; 48 (6): 915-919.$$$$$Y$$$20240802$$HP$US$US
240865521$24086552$1$I$$20240701$20240713$20240713$EXP$$US-TEVA-VS-3217971$TEVA$Locke M, Kohn N, Seetharamu N. Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas. Clin-Otolaryngol 2023; 48 (6): 915-919.$$$$$Y$$$20240713$$HP$US$US
240865531$24086553$1$I$20240115$20240708$20240713$20240713$EXP$$NVSC2024IN019623$NOVARTIS$$57$YR$$M$Y$$$20240713$$CN$IN$IN
240865543$24086554$3$F$20240303$20240812$20240713$20240821$EXP$FR-AFSSAPS-AVMA2024000266$FR-TEVA-VS-3217704$TEVA$$44$YR$$F$Y$$$20240821$$PH$FR$FR
240865551$24086555$1$I$20240501$20240704$20240713$20240713$EXP$FR-AFSSAPS-AVNT2024000484$FR-TEVA-VS-3217624$TEVA$$59$YR$$M$Y$$$20240713$$PH$FR$FR
240865561$24086556$1$I$20240423$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405011152303220-GPJSV$GB-TEVA-VS-3218052$TEVA$$64$YR$$M$Y$$$20240713$$MD$GB$GB
240865571$24086557$1$I$20240507$20240705$20240713$20240713$EXP$$CH-ABBVIE-5835327$ABBVIE$$29$YR$$F$Y$$$20240713$$MD$CH$CH
240865581$24086558$1$I$$20240711$20240713$20240713$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039318$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240713$$MD$AU$AU
240865591$24086559$1$I$$20240708$20240713$20240713$PER$$US-ELI_LILLY_AND_COMPANY-US202407007350$ELI LILLY AND CO$$20$YR$A$M$Y$$$20240713$$CN$US$US
240865601$24086560$1$I$$20240710$20240713$20240713$PER$$US-ELI_LILLY_AND_COMPANY-US202407007276$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240713$$CN$US$US
240865613$24086561$3$F$20240101$20240802$20240713$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-019865$UNITED THERAPEUTICS$$$$$F$Y$58.957$KG$20240807$$$US$US
240865621$24086562$1$I$$20240710$20240713$20240713$EXP$$GB-ABBVIE-5837716$ABBVIE$$$$A$F$Y$$$20240713$$CN$GB$GB
240865631$24086563$1$I$$20240708$20240713$20240713$PER$$US-ABBVIE-5836658$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240865641$24086564$1$I$$20240709$20240713$20240713$PER$$US-JNJFOC-20240723784$JOHNSON AND JOHNSON$$$$$F$Y$$$20240713$$CN$US$US
240865661$24086566$1$I$$20240709$20240713$20240713$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01265$NOVITIUM PHARMA$Emiliano Marasco.ANTI-CD19 CAR-T CELL THERAPY FOR REFRACTORY CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS.Lupus Science + Medicine.14-MAR-2024;11:A113$15$YR$T$F$Y$$$20240713$$HP$IT$IT
240865671$24086567$1$I$20200101$20240709$20240713$20240713$EXP$$ES-ABBVIE-5838413$ABBVIE$$$$N$$Y$$$20240713$$MD$ES$ES
240865682$24086568$2$F$$20240715$20240713$20240718$PER$$US-AMGEN-USASP2024138917$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
240865691$24086569$1$I$$20240712$20240713$20240713$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039513$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240713$$CN$CA$CA
240865701$24086570$1$I$20240418$20240709$20240713$20240713$EXP$$US-ABBVIE-5834858$ABBVIE$$58$YR$$M$Y$$$20240713$$CN$US$US
240865711$24086571$1$I$20240709$20240709$20240713$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-021115$UNITED THERAPEUTICS$$78$YR$$F$Y$69.841$KG$20240713$$$US$US
240865721$24086572$1$I$$20240708$20240713$20240713$EXP$$JP-AMGEN-JPNSP2024136032$AMGEN$$$$E$F$Y$$$20240712$$MD$JP$JP
240865731$24086573$1$I$20240711$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138364$AMGEN$$$$$$Y$$$20240712$$MD$US$US
240865741$24086574$1$I$$20240711$20240713$20240713$PER$$US-ABBVIE-5837536$ABBVIE$$$$$$Y$$$20240713$$CN$US$US
240865752$24086575$2$F$20150101$20240708$20240713$20240909$PER$$US-ABBVIE-5832210$ABBVIE$$$$$F$Y$47$KG$20240909$$CN$US$US
240865765$24086576$5$F$20240514$20240812$20240713$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202407006935$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240815$$CN$US$US
240865771$24086577$1$I$$20240706$20240713$20240713$EXP$$US-JNJFOC-20240717241$JOHNSON AND JOHNSON$$$$$M$Y$$$20240713$$CN$US$US
240865781$24086578$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5838126$ABBVIE$$$$E$$Y$$$20240713$$CN$US$US
240865792$24086579$2$F$$20240719$20240713$20240730$EXP$$JP-ROCHE-10000024373$ROCHE$$76$YR$E$F$Y$$$20240730$$PH$JP$JP
240865801$24086580$1$I$20240413$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405051200506980-WGNQK$GB-TEVA-VS-3218642$TEVA$$58$YR$$F$Y$$$20240713$$CN$GB$GB
240865813$24086581$3$F$20240101$20240805$20240713$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-021291$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240814$$$US$US
240865821$24086582$1$I$20240613$20240708$20240713$20240713$EXP$$JP-AMGEN-JPNSP2024136308$AMGEN$$12$YR$T$$Y$$$20240712$$MD$JP$JP
240865831$24086583$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405012114026240-TJVGZ$GB-TEVA-VS-3218044$TEVA$$$$$$Y$$$20240713$$MD$GB$GB
240865841$24086584$1$I$$20240709$20240713$20240713$PER$$US-AstraZeneca-2024A158695$ASTRAZENECA$$$$$F$Y$$$20240713$$MD$US$
240865855$24086585$5$F$20240621$20240911$20240713$20240919$EXP$$CA-CELLTRION INC.-2024CA016983$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
240865871$24086587$1$I$20240704$20240709$20240713$20240713$EXP$$CN-ROCHE-10000021596$ROCHE$$40$YR$A$F$Y$56$KG$20240713$$HP$CN$CN
240865881$24086588$1$I$20240704$20240708$20240713$20240713$PER$$US-AMGEN-USASP2024135719$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240865891$24086589$1$I$$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138084$AMGEN$$$$$$Y$$$20240712$$CN$US$US
240865901$24086590$1$I$$20240709$20240713$20240713$EXP$$US-NOVITIUMPHARMA-2024USNVP01266$NOVITIUM PHARMA$Dedeepya Gullapalli.Battling the breath-stealers: Blastomyces and Pseudomonas triggering acute respiratory distress syndrome (ARDS).Medical Mycology Case Reports.19-JUN-2024;45:1-3$46$YR$A$M$Y$$$20240713$$HP$US$US
240865912$24086591$2$F$$20240724$20240713$20240802$EXP$$US-TEVA-VS-3218035$TEVA$Xiong J, Prasad S, Embry E, Singh K, Singh M. Resistant Pneumocystis Jiroveci Pneumonia in Patients With ANCAAssociated Vasculitis. Am-J-Respir-Crit-Care-Med 2024; 209.; Xiong J, Prasad S, Embry E, Singh K, Singh M. Resistant Pneumocystis Jiroveci Pneumonia in Patients With ANCAAssociated Vasculitis. Am-J-Respir-Crit-Care-Med 2024; 209.$68$YR$$M$Y$$$20240802$$HP$US$US
240865922$24086592$2$F$$20240708$20240713$20240715$PER$$US-ABBVIE-5834952$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240865931$24086593$1$I$$20240708$20240713$20240713$EXP$$US-COSETTE-CP2024US000160$COSETTE PHARMACEUTICALS$$68$YR$E$F$Y$$$20240713$$CN$US$US
240865941$24086594$1$I$20240708$20240702$20240713$20240713$PER$$US-AMGEN-USASP2024138753$AMGEN$$83$YR$E$F$Y$$$20240712$$PH$US$US
240865951$24086595$1$I$$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024138976$AMGEN$$$$$$Y$$$20240712$$PH$US$US
240865961$24086596$1$I$$20240630$20240713$20240713$EXP$$SA-ROCHE-10000017247$ROCHE$$30$YR$A$F$Y$$$20240713$$MD$SA$SA
240865972$24086597$2$F$$20240905$20240713$20240906$EXP$$NVSC2024US142979$NOVARTIS$$$$$M$Y$$$20240906$$CN$US$US
240865981$24086598$1$I$$20240710$20240713$20240713$PER$$US-AstraZeneca-2024A159866$ASTRAZENECA$$$$A$M$Y$$$20240713$$HP$US$
240865991$24086599$1$I$$20240710$20240713$20240713$EXP$$US-AstraZeneca-2024A158177$ASTRAZENECA$$$$$M$Y$$$20240713$$CN$US$
240866001$24086600$1$I$20220101$20240702$20240713$20240713$PER$$US-TEVA-VS-3217447$TEVA$$59$YR$$F$Y$$$20240713$$CN$US$US
240866011$24086601$1$I$$20240708$20240713$20240713$PER$$US-ELI_LILLY_AND_COMPANY-US202407006859$ELI LILLY AND CO$$$$$F$Y$$$20240713$$MD$US$US
240866021$24086602$1$I$20231229$20240628$20240713$20240713$PER$$US-COSETTE-CP2024US000151$COSETTE PHARMACEUTICALS$$31$YR$A$F$Y$$$20240713$$HP$US$US
240866032$24086603$2$F$$20240821$20240713$20240905$EXP$$AU-COSETTE-CP2024AU000157$COSETTE PHARMACEUTICALS$$43$YR$A$F$Y$$$20240905$$HP$AU$AU
240866041$24086604$1$I$$20240705$20240713$20240713$EXP$$NL-ABBVIE-5835031$ABBVIE$$$$E$M$Y$$$20240713$$CN$NL$NL
240866051$24086605$1$I$20240619$20240710$20240713$20240713$EXP$$US-ABBVIE-5837059$ABBVIE$$71$YR$$M$Y$$$20240713$$CN$US$US
240866061$24086606$1$I$$20240709$20240713$20240713$EXP$$IN-NOVITIUMPHARMA-2024INNVP01254$NOVITIUM PHARMA$Aaliya Khanam.CYPROHEPTADINE AND DEXAMETHASONE INDUCED SUICIDALITY AND OBSESSIONS PRESENTING TO LIASON PSYCHIATRY- A CASE REPORT.Indian Journal of Psychiatry.2024;66(1):S167-S222$20$YR$A$M$Y$$$20240713$$HP$IN$IN
240866071$24086607$1$I$20240701$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024137991$AMGEN$$$$$F$Y$$$20240712$$CN$US$US
240866081$24086608$1$I$20240710$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137790$AMGEN$$$$$M$Y$$$20240712$$CN$US$US
240866091$24086609$1$I$$20240711$20240713$20240713$PER$$US-ABBVIE-5837679$ABBVIE$$$$$$Y$$$20240713$$CN$US$US
240866101$24086610$1$I$$20240710$20240713$20240713$EXP$$US-SANDOZ INC.-SDZ2024US064895$SANDOZ$$$$$M$Y$$$20240713$$HP$US$US
240866111$24086611$1$I$$20240701$20240713$20240713$PER$$US-COSETTE-CP2024US000152$COSETTE PHARMACEUTICALS$$63$YR$A$F$Y$$$20240713$$HP$US$US
240866121$24086612$1$I$$20240712$20240713$20240713$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039575$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240713$$CN$US$US
240866134$24086613$4$F$20240627$20240723$20240713$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015078$UNITED THERAPEUTICS$$62$YR$$F$Y$46.712$KG$20240725$$$US$US
240866141$24086614$1$I$20240709$20240711$20240713$20240713$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039337$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$$$20240713$$CN$US$US
240866151$24086615$1$I$20240630$20240701$20240713$20240713$PER$$US-COSETTE-CP2024US000153$COSETTE PHARMACEUTICALS$$38$YR$A$M$Y$185$KG$20240713$$PH$US$US
240866161$24086616$1$I$20240711$20240711$20240713$20240713$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039340$BOEHRINGER INGELHEIM$$58$YR$A$F$Y$$$20240713$$CN$US$US
240866181$24086618$1$I$$20240708$20240713$20240713$EXP$$US-JNJFOC-20240721039$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240713$$HP$US$US
240866191$24086619$1$I$20240705$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024138830$AMGEN$$88$YR$E$M$Y$$$20240713$$CN$US$US
240866201$24086620$1$I$$20240709$20240713$20240713$PER$$US-AMGEN-USASP2024137767$AMGEN$$$$A$M$Y$$$20240713$$MD$US$US
240866211$24086621$1$I$20240524$20240708$20240713$20240713$EXP$HU-OGYI-0072824$HU-ROCHE-10000019736$ROCHE$$56$YR$A$F$Y$50$KG$20240713$$MD$HU$HU
240866222$24086622$2$F$20240617$20240801$20240713$20240808$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018808$UNITED THERAPEUTICS$$70$YR$$F$Y$69.841$KG$20240808$$$US$US
240866232$24086623$2$F$20240705$20240708$20240713$20240719$EXP$$CA-ABBVIE-5834987$ABBVIE$$78$YR$$$Y$$$20240719$$MD$CA$CA
240866241$24086624$1$I$20231028$20240709$20240713$20240713$EXP$$CA-BIOGEN-2023BI01234183$BIOGEN$$32$YR$$F$Y$$$20240713$$CN$CA$CA
240866251$24086625$1$I$$20240701$20240713$20240713$PER$$US-GLANDPHARMA-US-2024GLNSPO00449$GLAND PHARMA$$$$$F$Y$$$20240713$$HP$US$US
240866262$24086626$2$F$20240709$20240812$20240713$20240814$PER$$US-AMGEN-USASP2024137646$AMGEN$$70$YR$E$M$Y$$$20240814$$CN$US$US
240866271$24086627$1$I$$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137835$AMGEN$$$$$M$Y$$$20240713$$PH$US$US
240866281$24086628$1$I$$20240701$20240713$20240713$EXP$$US-GLANDPHARMA-US-2024GLNLIT00447$GLAND PHARMA$K. Holbert.Multiorgan Failure From Heat Stroke in a Person Taking Glycopyrrolate.Am J Respir Crit Care Med.2024;209:A7329$24$YR$A$M$Y$$$20240713$$HP$US$US
240866291$24086629$1$I$20240509$20240710$20240713$20240713$EXP$$US-AMGEN-USASP2024137501$AMGEN$$75$YR$E$M$Y$$$20240713$$HP$US$US
240866301$24086630$1$I$$20240704$20240713$20240713$EXP$$CA-TEVA-VS-3219651$TEVA$$78$YR$$F$Y$$$20240713$$HP$CA$CA
240866313$24086631$3$F$20240703$20240812$20240713$20240819$EXP$$RU-JNJFOC-20240721602$JOHNSON AND JOHNSON$$$$$M$Y$55$KG$20240819$$MD$RU$RU
240866322$24086632$2$F$$20240814$20240713$20240821$EXP$$CA-BIOGEN-2024BI01273462$BIOGEN$$$$$M$Y$$$20240821$$CN$CA$CA
240866332$24086633$2$F$20240708$20240715$20240713$20240717$PER$$US-AMGEN-USASP2024137589$AMGEN$$37$YR$A$F$Y$$$20240717$$CN$US$US
240866341$24086634$1$I$20240605$20240709$20240713$20240713$EXP$GB-MHRA-MED-202407091459342620-MKFBZ$GB-ROCHE-10000021991$ROCHE$$55$YR$A$F$Y$$$20240713$$HP$GB$GB
240866351$24086635$1$I$20240101$20240708$20240713$20240713$PER$$US-ABBVIE-5837344$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240866371$24086637$1$I$$20240704$20240713$20240713$EXP$$CA-TEVA-VS-3219123$TEVA$$80$YR$$M$Y$$$20240713$$PH$CA$CA
240866382$24086638$2$F$20240601$20240715$20240713$20240718$PER$$US-AMGEN-USASP2024137455$AMGEN$$76$YR$E$M$Y$$$20240718$$CN$US$US
240866391$24086639$1$I$20240416$20240702$20240713$20240713$PER$$US-JNJFOC-20240732878$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240713$$HP$US$US
240866401$24086640$1$I$20240708$20240710$20240713$20240713$EXP$$DO-ABBVIE-5838489$ABBVIE$$77$YR$$M$Y$57$KG$20240713$$HP$DO$DO
240866411$24086641$1$I$20240305$20240626$20240713$20240713$PER$$US-ABBVIE-5835902$ABBVIE$$52$YR$$F$Y$$$20240713$$CN$US$US
240866421$24086642$1$I$20240623$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137102$AMGEN$$70$YR$E$F$Y$$$20240713$$CN$US$US
240866431$24086643$1$I$20240101$20240708$20240713$20240713$EXP$$US-ABBVIE-5803283$ABBVIE$$$$$F$Y$56.699$KG$20240713$$CN$US$US
240866442$24086644$2$F$$20240708$20240713$20240723$PER$$US-GRANULES-US-2024GRASPO00260$GRANULES INDIA$$$$$F$Y$$$20240723$$PH$US$US
240866451$24086645$1$I$$20240708$20240713$20240713$EXP$$US-ABBVIE-5781691$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240866461$24086646$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5835326$ABBVIE$$$$$$Y$$$20240713$$HP$US$US
240866471$24086647$1$I$$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138803$AMGEN$$$$$$Y$$$20240713$$PH$US$US
240866483$24086648$3$F$20240701$20240811$20240713$20240820$EXP$$IL-UNITED THERAPEUTICS-UNT-2024-020741$UNITED THERAPEUTICS$$54$YR$$F$Y$85$KG$20240820$$$IL$IL
240866491$24086649$1$I$$20240701$20240713$20240713$PER$$US-GRANULES-US-2024GRASPO00273$GRANULES INDIA$$$$$F$Y$$$20240713$$CN$US$US
240866501$24086650$1$I$20230502$20240712$20240713$20240713$EXP$FR-AFSSAPS-NC2024000713$FR-ROCHE-10000025285$ROCHE$$79$YR$E$M$Y$98$KG$20240713$$MD$FR$FR
240866511$24086651$1$I$20240601$20240709$20240713$20240713$EXP$$AE-ABBVIE-5830107$ABBVIE$$71$YR$$M$Y$$$20240713$$CN$AE$AE
240866524$24086652$4$F$20240525$20240729$20240713$20240805$EXP$$US-ROCHE-10000007903$ROCHE$$67$YR$E$F$Y$86.18$KG$20240805$$CN$US$US
240866531$24086653$1$I$$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138771$AMGEN$$$$$$Y$$$20240713$$PH$US$US
240866541$24086654$1$I$20240710$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137057$AMGEN$$72$YR$E$F$Y$$$20240713$$CN$US$US
240866552$24086655$2$F$20240709$20240718$20240713$20240723$PER$$US-AMGEN-USASP2024137604$AMGEN$$$$$$Y$$$20240722$$CN$US$US
240866562$24086656$2$F$20180601$20240711$20240713$20240717$EXP$$US-ABBVIE-5833209$ABBVIE$$39$YR$$F$Y$$$20240717$$CN$US$US
240866571$24086657$1$I$20240630$20240701$20240713$20240713$PER$$US-LEADINGPHARMA-US-2024LEASPO00276$LEADING PHARMA$$74$YR$E$M$Y$178$KG$20240713$$CN$US$US
240866581$24086658$1$I$20240623$20240708$20240713$20240713$EXP$$US-ABBVIE-5833144$ABBVIE$$51$YR$$F$Y$$$20240713$$CN$US$US
240866591$24086659$1$I$20240101$20240709$20240713$20240713$EXP$$US-ABBVIE-5833913$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240866602$24086660$2$F$20240820$20240919$20240713$20240924$EXP$$US-ABBVIE-5835308$ABBVIE$$74$YR$$M$Y$81.3$KG$20240924$$CN$US$US
240866611$24086661$1$I$20240612$20240711$20240713$20240713$EXP$$CO-ABBVIE-5836924$ABBVIE$$67$YR$$M$Y$98$KG$20240713$$CN$CO$CO
240866621$24086662$1$I$$20240705$20240713$20240713$PER$$US-ABBVIE-5835609$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240866632$24086663$2$F$20240709$20240819$20240713$20240822$PER$$US-AMGEN-USASP2024137094$AMGEN$$89$YR$E$F$Y$$$20240822$$CN$US$US
240866641$24086664$1$I$20240705$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137787$AMGEN$$$$$F$Y$$$20240713$$CN$US$US
240866652$24086665$2$F$20240201$20240918$20240713$20240923$EXP$$CO-ABBVIE-5837419$ABBVIE$$55$YR$$M$Y$86$KG$20240923$$CN$CO$CO
240866661$24086666$1$I$20240708$20240709$20240713$20240713$EXP$$AU-ABBVIE-5834305$ABBVIE$$75$YR$$M$Y$$$20240713$$CN$AU$AU
240866671$24086667$1$I$20240611$20240708$20240713$20240713$EXP$$US-ABBVIE-5833072$ABBVIE$$47$YR$$F$Y$$$20240713$$CN$US$US
240866681$24086668$1$I$$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024138545$AMGEN$$$$$$Y$$$20240713$$HP$US$US
240866691$24086669$1$I$20240101$20240708$20240713$20240713$EXP$$CA-ABBVIE-5833094$ABBVIE$$$$A$M$Y$$$20240713$$CN$CA$CA
240866701$24086670$1$I$20231229$20240708$20240713$20240713$EXP$$JP-ROCHE-10000025107$ROCHE$$9$DEC$E$F$Y$$$20240713$$MD$JP$JP
240866712$24086671$2$F$20240706$20240717$20240713$20240720$EXP$$US-ABBVIE-5835487$ABBVIE$$84$YR$$M$Y$78.471$KG$20240720$$CN$US$US
240866722$24086672$2$F$20240615$20240829$20240713$20240904$EXP$$CA-CELLTRION INC.-2024CA003897$CELLTRION$$$$$$Y$$$20240905$$MD$CA$CA
240866731$24086673$1$I$20240701$20240710$20240713$20240713$EXP$$US-ABBVIE-5837056$ABBVIE$$71$YR$$M$Y$$$20240713$$CN$US$US
240866741$24086674$1$I$$20240602$20240713$20240713$PER$$JP-WT-2024-064908$Waylis$$7$DEC$$M$Y$$$20240713$$CN$JP$JP
240866751$24086675$1$I$20240607$20240709$20240713$20240713$EXP$$CN-AMGEN-CHNSP2024136188$AMGEN$$72$YR$E$F$Y$52$KG$20240713$$HP$CN$CN
240866763$24086676$3$F$20240628$20240725$20240713$20240731$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020603$UNITED THERAPEUTICS$$74$YR$$F$Y$54.422$KG$20240731$$PH$US$US
240866772$24086677$2$F$$20240723$20240713$20240726$EXP$$US-ABBVIE-5833114$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
240866782$24086678$2$F$20240701$20240716$20240713$20240720$EXP$$US-ABBVIE-5833807$ABBVIE$$41$YR$$F$Y$86$KG$20240720$$CN$US$US
240866792$24086679$2$F$$20240904$20240713$20240913$EXP$$JP-ROCHE-10000023200$ROCHE$$51$YR$A$F$Y$$$20240913$$PH$JP$JP
240866801$24086680$1$I$$20240705$20240713$20240713$EXP$$TW-AMGEN-TWNSP2024134371$AMGEN$Liu C.; Liu C.. Combined Dacomitinib and Selpercatinib Treatment for a Patient with EGFR-Mutant Non-Small Cell Lung Cancer and Acquired CCDC6-RET Fusion. OncoTargets and Therapy. 2024;17:499-506$68$YR$E$M$Y$$$20240713$$HP$TW$TW
240866811$24086681$1$I$20240417$20240709$20240713$20240713$EXP$$US-ABBVIE-5834496$ABBVIE$$80$YR$$M$Y$$$20240713$$CN$US$US
240866821$24086682$1$I$$20240701$20240713$20240713$EXP$$US-TEVA-VS-3217968$TEVA$Locke M, Kohn N, Seetharamu N. Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas. Clin-Otolaryngol 2023; 48 (6): 915-919.$$$$$Y$$$20240713$$HP$US$US
240866831$24086683$1$I$$20240710$20240713$20240713$PER$$US-ABBVIE-5837930$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240866841$24086684$1$I$$20240706$20240713$20240713$EXP$$US-JNJFOC-20240717667$JOHNSON AND JOHNSON$$62$YR$A$M$Y$100.7$KG$20240713$$CN$US$US
240866851$24086685$1$I$$20240708$20240713$20240713$EXP$$US-ABBVIE-5833244$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240866861$24086686$1$I$20240101$20240709$20240713$20240713$EXP$$US-ABBVIE-5834678$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240866871$24086687$1$I$20240710$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138792$AMGEN$$$$$$Y$$$20240713$$PH$US$US
240866891$24086689$1$I$20240630$20240705$20240713$20240713$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020867$UNITED THERAPEUTICS$$56$YR$$F$Y$100.23$KG$20240713$$$US$US
240866902$24086690$2$F$20240701$20240723$20240713$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-020802$UNITED THERAPEUTICS$$73$YR$$F$Y$90.703$KG$20240731$$$US$US
240866911$24086691$1$I$20240201$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405040555034480-WJKLS$GB-TEVA-VS-3217763$TEVA$$59$YR$$M$Y$90$KG$20240713$$CN$GB$GB
240866921$24086692$1$I$$20240709$20240713$20240713$EXP$$US-AMGEN-USASL2024137039$AMGEN$$$$$$Y$$$20240713$$CN$US$US
240866932$24086693$2$F$20240704$20240827$20240713$20240915$PER$$US-AstraZeneca-2024A157699$ASTRAZENECA$$22855$DY$$M$Y$$$20240915$$CN$US$
240866941$24086694$1$I$$20240711$20240713$20240713$PER$$US-ABBVIE-5837041$ABBVIE$$$$$$Y$$$20240713$$CN$US$US
240866951$24086695$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5834828$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240866961$24086696$1$I$$20240710$20240713$20240713$EXP$$CA-ABBVIE-5836743$ABBVIE$$$$A$F$Y$$$20240713$$CN$CA$CA
240866971$24086697$1$I$20240101$20240709$20240713$20240713$EXP$$US-ABBVIE-5805573$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240866981$24086698$1$I$20240618$20240710$20240713$20240713$EXP$IT-MINISAL02-994407$IT-ABBVIE-5835000$ABBVIE$$67$YR$$M$Y$$$20240713$$MD$IT$IT
240866991$24086699$1$I$20240701$20240710$20240713$20240713$EXP$$US-SANDOZ INC.-SDZ2024US064856$SANDOZ$$66$YR$$F$Y$$$20240713$$CN$US$US
240867001$24086700$1$I$20240219$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405041418106620-QDMKV$GB-TEVA-VS-3218461$TEVA$$31$YR$$F$Y$$$20240713$$CN$GB$GB
240867011$24086701$1$I$20240101$20240709$20240713$20240713$EXP$$US-ABBVIE-5835212$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240867021$24086702$1$I$20240606$20240709$20240713$20240713$EXP$$US-ABBVIE-5834428$ABBVIE$$62$YR$$$Y$$$20240713$$CN$US$US
240867031$24086703$1$I$$20240708$20240713$20240713$EXP$$ZA-ABBVIE-5836241$ABBVIE$$50$YR$$F$Y$$$20240713$$CN$ZA$ZA
240867041$24086704$1$I$$20240705$20240713$20240713$EXP$GB-MHRA-MED-202405071621301260-MVSYT$GB-TEVA-VS-3218353$TEVA$$$$$F$Y$57$KG$20240713$$CN$GB$GB
240867053$24086705$3$F$20240101$20240802$20240713$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-021018$UNITED THERAPEUTICS$$$$$F$Y$73.469$KG$20240810$$$US$US
240867062$24086706$2$F$20240703$20240705$20240713$20240716$EXP$$JP-UCBSA-2024034043$UCB$$34$YR$$F$Y$$$20240716$$PH$JP$JP
240867071$24086707$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5834883$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240867081$24086708$1$I$20240620$20240708$20240713$20240713$EXP$$ZA-ABBVIE-5836375$ABBVIE$$82$YR$$M$Y$$$20240713$$CN$ZA$ZA
240867091$24086709$1$I$20240507$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405071423209150-ZYQNK$GB-TEVA-VS-3218625$TEVA$$46$YR$$F$Y$58$KG$20240713$$CN$GB$GB
240867101$24086710$1$I$20240101$20240709$20240713$20240713$EXP$$JP-ABBVIE-5834884$ABBVIE$$30$YR$$F$Y$$$20240713$$MD$JP$JP
240867111$24086711$1$I$$20240705$20240713$20240713$EXP$GB-MHRA-MED-202405091852538820-HNZMT$GB-TEVA-VS-3218366$TEVA$$1$YR$$$Y$$$20240713$$HP$GB$GB
240867131$24086713$1$I$20231224$20240701$20240713$20240713$EXP$FR-AFSSAPS-AVNY2024000190$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109283$ZYDUS PHARM$$$$$$Y$$$20240713$$MD$FR$FR
240867141$24086714$1$I$20240611$20240709$20240713$20240713$EXP$$US-ABBVIE-5835393$ABBVIE$$38$YR$$M$Y$$$20240713$$CN$US$US
240867152$24086715$2$F$20240629$20240819$20240713$20240827$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020150$UNITED THERAPEUTICS$$67$YR$$F$Y$90.703$KG$20240827$$PH$US$US
240867161$24086716$1$I$20240610$20240701$20240713$20240713$EXP$FR-AFSSAPS-MP2024001013$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109234$ZYDUS PHARM$$$$$$Y$$$20240713$$MD$FR$FR
240867181$24086718$1$I$20240101$20240709$20240713$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-017143$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240713$$$US$US
240867191$24086719$1$I$$20240711$20240713$20240713$EXP$$US-ABBVIE-5838591$ABBVIE$$$$$$Y$$$20240713$$CN$US$US
240867211$24086721$1$I$$20240708$20240713$20240713$EXP$$AU-ABBVIE-5833128$ABBVIE$$$$$M$Y$$$20240713$$CN$AU$AU
240867221$24086722$1$I$$20240705$20240713$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-020880$UNITED THERAPEUTICS$$$$$F$Y$86.168$KG$20240713$$$US$US
240867233$24086723$3$F$20181001$20240919$20240713$20240926$EXP$$US-ABBVIE-5834303$ABBVIE$$78$YR$$M$Y$71.214$KG$20240926$$CN$US$US
240867241$24086724$1$I$$20240709$20240713$20240713$EXP$$CA-ABBVIE-5835092$ABBVIE$$63$YR$$F$Y$$$20240713$$CN$CA$CA
240867251$24086725$1$I$20240101$20240709$20240713$20240713$EXP$$US-ABBVIE-5835555$ABBVIE$$$$$F$Y$70$KG$20240713$$CN$US$US
240867261$24086726$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5834424$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240867281$24086728$1$I$20240101$20240709$20240713$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-017728$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240713$$$US$US
240867291$24086729$1$I$$20240710$20240713$20240713$EXP$$GB-ABBVIE-5835081$ABBVIE$$$$E$F$Y$$$20240713$$CN$GB$GB
240867301$24086730$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5833557$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240867312$24086731$2$F$20231201$20240812$20240713$20240819$EXP$$US-ABBVIE-5750960$ABBVIE$$42$YR$$M$Y$$$20240819$$CN$US$US
240867321$24086732$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405081127236150-GTRHJ$GB-TEVA-VS-3218589$TEVA$$$$$F$Y$$$20240713$$HP$GB$GB
240867333$24086733$3$F$20240201$20240710$20240713$20240723$PER$$US-SA-2024SA204970$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240723$$CN$US$US
240867341$24086734$1$I$20240101$20240708$20240713$20240713$PER$$US-SA-2024SA204915$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240713$$MD$US$US
240867351$24086735$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA205275$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240713$$MD$US$US
240867363$24086736$3$F$20240101$20240802$20240713$20240812$PER$$US-SA-2024SA200504$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240812$$CN$US$US
240867371$24086737$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA205434$SANOFI AVENTIS$$$$A$F$Y$66.67$KG$20240713$$MD$US$US
240867391$24086739$1$I$$20240705$20240713$20240713$PER$$US-SA-2024SA201448$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240713$$MD$US$US
240867403$24086740$3$F$20240101$20240711$20240713$20240717$PER$$US-SA-2024SA204038$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240717$$MD$US$US
240867411$24086741$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204243$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240713$$MD$US$US
240867421$24086742$1$I$20240401$20240708$20240713$20240713$PER$$US-SA-2024SA205290$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240713$$MD$US$US
240867431$24086743$1$I$20240601$20240705$20240713$20240713$PER$$US-SA-2024SA201466$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240713$$MD$US$US
240867441$24086744$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA202764$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240713$$MD$US$US
240867451$24086745$1$I$20240701$20240708$20240713$20240713$PER$$US-SA-2024SA205283$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240713$$MD$US$US
240867462$24086746$2$F$$20240726$20240713$20240805$PER$$US-SA-2024SA203211$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
240867481$24086748$1$I$20240522$20240704$20240713$20240713$EXP$IT-MINISAL02-993100$IT-SA-2024SA199266$SANOFI AVENTIS$$91$YR$E$M$Y$$$20240713$$MD$IT$IT
240867491$24086749$1$I$20240619$20240704$20240713$20240713$EXP$IT-MINISAL02-993224$IT-SA-2024SA199260$SANOFI AVENTIS$$$$$F$Y$$$20240713$$MD$IT$IT
240867502$24086750$2$F$20240101$20240901$20240713$20240910$PER$$US-SA-2024SA204032$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240910$$MD$US$US
240867511$24086751$1$I$20240101$20240710$20240713$20240713$PER$$US-SA-2024SA204723$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240713$$MD$US$US
240867521$24086752$1$I$20240424$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405022233422160-QCRDZ$GB-SA-2024SA199261$SANOFI AVENTIS$$59$YR$A$F$Y$80$KG$20240713$$CN$GB$GB
240867531$24086753$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204930$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240713$$MD$US$US
240867541$24086754$1$I$$20240703$20240713$20240713$PER$$US-SA-2024SA202011$SANOFI AVENTIS$$$$A$F$Y$72.57$KG$20240713$$MD$US$US
240867552$24086755$2$F$20240708$20240905$20240713$20240914$PER$$US-SA-2024SA204709$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240914$$MD$US$US
240867561$24086756$1$I$$20240707$20240713$20240713$PER$$US-SA-2024SA201195$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240713$$MD$US$US
240867572$24086757$2$F$20240101$20240717$20240713$20240725$PER$$US-SA-2024SA200506$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240725$$CN$US$US
240867581$24086758$1$I$$20240704$20240713$20240713$PER$$US-SA-2024SA198338$SANOFI AVENTIS$$$$$M$Y$$$20240713$$HP$US$US
240867591$24086759$1$I$20240601$20240708$20240713$20240713$PER$$US-SA-2024SA205291$SANOFI AVENTIS$$50$YR$A$M$Y$133.8$KG$20240713$$MD$US$US
240867601$24086760$1$I$$20240705$20240713$20240713$PER$$US-SA-2024SA204140$SANOFI AVENTIS$$60$YR$A$F$Y$98.8$KG$20240713$$MD$US$US
240867611$24086761$1$I$20240705$20240708$20240713$20240713$EXP$$US-SA-2024SA202153$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240713$$PH$US$US
240867621$24086762$1$I$20240531$20240708$20240713$20240713$EXP$$CO-SA-2024SA202663$SANOFI AVENTIS$$75$YR$E$F$Y$66$KG$20240713$$HP$CO$CO
240867631$24086763$1$I$20230101$20240709$20240713$20240713$PER$$US-SA-2024SA204036$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240713$$CN$US$US
240867641$24086764$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA203975$SANOFI AVENTIS$$$$A$F$Y$$$20240713$$MD$US$US
240867653$24086765$3$F$$20240716$20240713$20240723$PER$$US-SA-2024SA204261$SANOFI AVENTIS$$$$A$F$Y$66$KG$20240723$$MD$US$US
240867661$24086766$1$I$20240101$20240705$20240713$20240713$PER$$US-SA-2024SA201217$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240713$$MD$US$US
240867671$24086767$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA203225$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240713$$MD$US$US
240867682$24086768$2$F$20240101$20240719$20240713$20240729$PER$$US-SA-2024SA201192$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240729$$CN$US$US
240867691$24086769$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA204720$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240713$$MD$US$US
240867702$24086770$2$F$20240709$20240806$20240713$20240815$PER$$US-SA-2024SA204344$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240815$$CN$US$US
240867711$24086771$1$I$$20240705$20240713$20240713$PER$$US-SA-2024SA200549$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240713$$MD$US$US
240867721$24086772$1$I$20240625$20240708$20240713$20240713$PER$$US-SA-2024SA204322$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240713$$MD$US$US
240867741$24086774$1$I$$20240705$20240713$20240713$PER$$US-SA-2024SA202990$SANOFI AVENTIS$$$$A$F$Y$$$20240713$$MD$US$US
240867751$24086775$1$I$$20240705$20240713$20240713$PER$$US-SA-2024SA203119$SANOFI AVENTIS$$$$I$F$Y$$$20240713$$MD$US$US
240867761$24086776$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204165$SANOFI AVENTIS$$$$A$M$Y$$$20240713$$MD$US$US
240867771$24086777$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA204275$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240713$$MD$US$US
240867781$24086778$1$I$$20240705$20240713$20240713$PER$$US-SA-2023SA283080$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240713$$MD$US$US
240867791$24086779$1$I$20240701$20240708$20240713$20240713$PER$$US-SA-2024SA203805$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240713$$MD$US$US
240867801$24086780$1$I$$20240705$20240713$20240713$EXP$$CO-JNJFOC-20240720104$JOHNSON AND JOHNSON$$18$YR$A$M$Y$60$KG$20240713$$HP$CO$CO
240867812$24086781$2$F$20240601$20240905$20240713$20240913$PER$$US-SA-2024SA201412$SANOFI AVENTIS$$55$YR$A$F$Y$118$KG$20240913$$MD$US$US
240867821$24086782$1$I$$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138807$AMGEN$$$$$$Y$$$20240713$$CN$US$US
240867831$24086783$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204137$SANOFI AVENTIS$$$$C$M$Y$$$20240713$$MD$US$US
240867841$24086784$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5834110$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240867855$24086785$5$F$20240101$20240920$20240713$20240928$EXP$$FR-ABBVIE-5834963$ABBVIE$$64$YR$$M$Y$$$20240928$$HP$FR$FR
240867861$24086786$1$I$$20240709$20240713$20240713$PER$$US-ABBVIE-5834394$ABBVIE$$$$$M$Y$$$20240713$$HP$US$US
240867872$24086787$2$F$20240603$20240712$20240713$20240722$PER$$US-SA-2024SA203122$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240722$$MD$US$US
240867881$24086788$1$I$$20240708$20240713$20240713$EXP$$JP-ROCHE-10000025173$ROCHE$Fujii N, Nishimoto Y, Miwa I, Ito M, Asada H, Sanai H. Two cases of peritoneal cancer in which half-dose bevacizumab therapy was effective in controlling ascites accumulation at the terminal phase. Modern Trends in Obstetrics + Gynecology. 2023;72 (2):267-71.$66$YR$E$F$Y$$$20240713$$MD$JP$JP
240867892$24086789$2$F$20240101$20240813$20240713$20240816$EXP$$US-ABBVIE-5834541$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
240867901$24086790$1$I$$20240708$20240713$20240713$EXP$$US-ABBVIE-5833696$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240867912$24086791$2$F$$20240715$20240713$20240719$EXP$$US-ABBVIE-5834294$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
240867921$24086792$1$I$20230915$20240709$20240713$20240713$EXP$$US-ABBVIE-5833978$ABBVIE$$57$YR$$M$Y$$$20240713$$CN$US$US
240867931$24086793$1$I$20231211$20240704$20240713$20240713$EXP$FR-AFSSAPS-TO2024000762$FR-TEVA-VS-3217601$TEVA$$65$YR$$F$Y$$$20240713$$MD$FR$FR
240867942$24086794$2$F$$20240830$20240713$20240906$EXP$$CA-ABBVIE-5809878$ABBVIE$$$$E$M$Y$$$20240906$$HP$CA$CA
240867951$24086795$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5835325$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240867961$24086796$1$I$20240501$20240704$20240713$20240713$EXP$FR-AFSSAPS-RS2024000636$FR-TEVA-VS-3217689$TEVA$$51$YR$$F$Y$$$20240713$$MD$FR$FR
240867971$24086797$1$I$$20240710$20240713$20240713$EXP$$US-ABBVIE-5835770$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240867981$24086798$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5835147$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240867991$24086799$1$I$20240510$20240709$20240713$20240713$EXP$$US-ABBVIE-5835857$ABBVIE$$61$YR$$F$Y$$$20240713$$CN$US$US
240868011$24086801$1$I$20240601$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137666$AMGEN$$72$YR$E$F$Y$$$20240713$$CN$US$US
240868022$24086802$2$F$20240201$20240729$20240713$20240731$EXP$$US-ABBVIE-5632453$ABBVIE$$80$YR$$F$Y$73.481$KG$20240731$$CN$US$US
240868031$24086803$1$I$$20240606$20240713$20240713$PER$$BR-WT-2024-AMR-067511$Waylis$$$$$F$Y$$$20240713$$MD$BR$BR
240868041$24086804$1$I$20240101$20240709$20240713$20240713$EXP$$CA-ABBVIE-5835014$ABBVIE$$79$YR$$F$Y$$$20240713$$CN$CA$CA
240868051$24086805$1$I$20231220$20240704$20240713$20240713$EXP$FR-AFSSAPS-AVMA2024000261$FR-TEVA-VS-3217626$TEVA$$55$YR$$M$Y$$$20240713$$PH$FR$FR
240868061$24086806$1$I$20240525$20240701$20240713$20240713$EXP$FR-AFSSAPS-TS2024000745$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109302$ZYDUS PHARM$$$$$$Y$$$20240713$$MD$FR$FR
240868071$24086807$1$I$$20240628$20240713$20240713$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109329$ZYDUS PHARM$Patel S, Prajapati V, Patel P.. Culture Negative Infective Endocarditis Secondary to Septic Emboli of Lung.. Am-J-Respir-Crit-Care-Med. 2024;209:A2414$$$$$Y$$$20240713$$HP$US$US
240868081$24086808$1$I$20240610$20240701$20240713$20240713$EXP$FR-AFSSAPS-AN2024000823$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109299$ZYDUS PHARM$$$$$$Y$$$20240713$$MD$FR$FR
240868091$24086809$1$I$20240610$20240704$20240713$20240713$EXP$FR-AFSSAPS-RE2024000631$FR-TEVA-VS-3217607$TEVA$$63$YR$$M$Y$103$KG$20240713$$MD$FR$FR
240868102$24086810$2$F$20240528$20240812$20240713$20240821$EXP$FR-AFSSAPS-BX2024001295$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109228$ZYDUS PHARM$$$$$$Y$$$20240821$$PH$FR$FR
240868111$24086811$1$I$20240501$20240701$20240713$20240713$EXP$FR-AFSSAPS-AVNT2024000484$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109314$ZYDUS PHARM$$$$$$Y$$$20240713$$PH$FR$FR
240868121$24086812$1$I$20240415$20240701$20240713$20240713$EXP$FR-AFSSAPS-PC2024000499$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109313$ZYDUS PHARM$$$$$$Y$$$20240713$$MD$FR$FR
240868131$24086813$1$I$$20240628$20240713$20240713$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109255$ZYDUS PHARM$Almazan EP, Ellaicy O, Carter DJ, Kaleka K, Faruqi M.. Another case of the blues, methylene blue as adjunctive therapy in calcium-channel blocker induced vasoplegia.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240713$$HP$US$US
240868142$24086814$2$F$20240705$20240705$20240713$20240722$EXP$$BR-JNJFOC-20240719465$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240722$$HP$BR$BR
240868151$24086815$1$I$$20240704$20240713$20240713$EXP$$JP-ABBVIE-5838041$ABBVIE$$$$$F$Y$$$20240713$$HP$JP$JP
240868171$24086817$1$I$$20240611$20240713$20240713$PER$$BR-WT-2024-AMR-069874$Waylis$$$$$F$Y$$$20240713$$CN$BR$BR
240868181$24086818$1$I$20240601$20240708$20240713$20240713$PER$$US-SA-2024SA204950$SANOFI AVENTIS$$16$YR$T$M$Y$161.9$KG$20240713$$MD$US$US
240868191$24086819$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204074$SANOFI AVENTIS$$$$E$M$Y$$$20240713$$MD$US$US
240868202$24086820$2$F$20240101$20240722$20240713$20240805$EXP$FR-AFSSAPS-AN2024000833$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109330$ZYDUS PHARM$$$$$$Y$$$20240805$$PH$FR$FR
240868221$24086822$1$I$20240704$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137800$AMGEN$$67$YR$E$F$Y$$$20240713$$CN$US$US
240868231$24086823$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5834927$ABBVIE$$$$$$Y$$$20240713$$CN$US$US
240868242$24086824$2$F$$20240820$20240713$20240824$EXP$$US-ABBVIE-5835032$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
240868251$24086825$1$I$$20240709$20240713$20240713$EXP$$CA-ABBVIE-5834879$ABBVIE$$$$A$M$Y$$$20240713$$CN$CA$CA
240868273$24086827$3$F$20240706$20240712$20240713$20240727$PER$$US-AMGEN-USASP2024138648$AMGEN$$73$YR$E$M$Y$$$20240727$$CN$US$US
240868282$24086828$2$F$20240710$20240712$20240713$20240715$PER$$US-AMGEN-USASP2024138841$AMGEN$$65$YR$E$F$Y$$$20240715$$CN$US$US
240868292$24086829$2$F$$20240716$20240713$20240724$PER$$US-SA-2024SA200978$SANOFI AVENTIS$$$$E$F$Y$$$20240724$$MD$US$US
240868301$24086830$1$I$20240511$20240704$20240713$20240713$EXP$FR-AFSSAPS-RE2024000625$FR-TEVA-VS-3217618$TEVA$$76$YR$$M$Y$57.5$KG$20240713$$MD$FR$FR
240868312$24086831$2$F$20240101$20240731$20240713$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-020884$UNITED THERAPEUTICS$$$$$F$Y$62.585$KG$20240806$$$US$US
240868322$24086832$2$F$$20240711$20240713$20240718$PER$$US-SA-2024SA204999$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240718$$CN$US$US
240868331$24086833$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204245$SANOFI AVENTIS$$7$YR$C$M$Y$20$KG$20240713$$HP$US$US
240868341$24086834$1$I$20231001$20240704$20240713$20240713$EXP$FR-AFSSAPS-AVGR2024000118$FR-TEVA-VS-3217653$TEVA$$47$YR$$$Y$85$KG$20240713$$MD$FR$FR
240868351$24086835$1$I$$20240703$20240713$20240713$EXP$$JP-ROCHE-10000022075$ROCHE$$8$DEC$E$F$Y$$$20240713$$MD$JP$JP
240868361$24086836$1$I$20240101$20240708$20240713$20240713$PER$$US-SA-2024SA204184$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240713$$MD$US$US
240868381$24086838$1$I$$20240613$20240713$20240713$PER$$BR-WT-2024-AMR-071001$Waylis$$41$YR$$F$Y$$$20240713$$CN$BR$BR
240868393$24086839$3$F$20240701$20240805$20240713$20240807$EXP$$US-JNJFOC-20240724207$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240807$$HP$US$US
240868401$24086840$1$I$$20240709$20240713$20240713$EXP$$JP-AMGEN-JPNSP2024138283$AMGEN$$$$$$Y$$$20240713$$MD$JP$JP
240868411$24086841$1$I$$20240603$20240713$20240713$PER$$KR-WT-2024-APC-065151$Waylis$$$$$M$Y$$$20240713$$CN$KR$KR
240868421$24086842$1$I$20240618$20240704$20240713$20240713$EXP$FR-AFSSAPS-RS2024000626$FR-TEVA-VS-3217691$TEVA$$73$YR$$M$Y$70$KG$20240713$$MD$FR$FR
240868431$24086843$1$I$20191226$20240704$20240713$20240713$EXP$FR-AFSSAPS-RS2024000614$FR-TEVA-VS-3217694$TEVA$$62$YR$$M$Y$$$20240713$$MD$FR$FR
240868442$24086844$2$F$$20240625$20240713$20240724$PER$$GB-WT-2024-068335$Waylis$$28$YR$$M$Y$$$20240724$$MD$GB$GB
240868452$24086845$2$F$$20240716$20240713$20240722$PER$$US-SA-2024SA205011$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240722$$CN$US$US
240868461$24086846$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA204346$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240713$$MD$US$US
240868481$24086848$1$I$$20240711$20240713$20240713$EXP$$US-ABBVIE-5837357$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240868492$24086849$2$F$$20240724$20240713$20240802$EXP$$US-TEVA-VS-3218351$TEVA$Blohm JE, Choi H, Jakharia K. No-lax-zone: Side Effects That Can Steal Your Breath Away. Am-J-Respir-Crit-Care-Med 2024; 209 (0): (plus Poster).; Blohm JE, Choi H, Jakharia K. No-lax-zone: Side Effects That Can Steal Your Breath Away. Am-J-Respir-Crit-Care-Med 2024; 209 (0): (plus Poster).$24$YR$$M$Y$$$20240802$$HP$US$US
240868501$24086850$1$I$20231221$20240704$20240713$20240713$EXP$FR-AFSSAPS-AVMA2024000262$FR-TEVA-VS-3217705$TEVA$$29$YR$$F$Y$$$20240713$$PH$FR$FR
240868511$24086851$1$I$20240627$20240702$20240713$20240713$EXP$$GR-BAXTER-2024BAX020848$BAXTER$$$$$F$Y$$$20240713$$HP$GR$GR
240868522$24086852$2$F$$20240712$20240713$20240722$EXP$GB-TEVA-2023-GB-2901265$GB-BAXTER-2024BAX021198$BAXTER$$5$DEC$$F$Y$$$20240722$$HP$GB$GB
240868531$24086853$1$I$$20240708$20240713$20240713$EXP$$CA-BAXTER-2024BAX021329$BAXTER$$$$$$Y$$$20240713$$CN$CA$CA
240868541$24086854$1$I$20221201$20240701$20240713$20240713$EXP$IT-MINISAL02-904527$IT-BAXTER-2024BAX021470$BAXTER$$10$YR$$M$Y$30$KG$20240713$$PH$IT$IT
240868551$24086855$1$I$$20240702$20240713$20240713$EXP$ES-AEMPS-1540862$ES-BAXTER-2024BAX021149$BAXTER$$$$I$M$Y$$$20240713$$HP$ES$ES
240868561$24086856$1$I$20240706$20240708$20240713$20240713$EXP$$US-ABBVIE-5832890$ABBVIE$$68$YR$$M$Y$$$20240713$$CN$US$US
240868582$24086858$2$F$20240701$20240912$20240713$20240919$EXP$$CA-AMGEN-CANNI2024136994$AMGEN$$41$YR$A$F$Y$$$20240919$$CN$CA$CA
240868601$24086860$1$I$20240704$20240705$20240713$20240713$PER$$US-SA-2024SA201501$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240713$$MD$US$US
240868611$24086861$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA202791$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240713$$MD$US$US
240868622$24086862$2$F$$20240717$20240713$20240722$PER$$US-ROCHE-10000023768$ROCHE$$$$$M$Y$$$20240719$$CN$US$US
240868632$24086863$2$F$20240710$20240711$20240713$20240717$PER$$US-AMGEN-USASP2024138547$AMGEN$$68$YR$E$F$Y$$$20240716$$CN$US$US
240868643$24086864$3$F$$20240821$20240713$20240831$EXP$$FI-UNITED THERAPEUTICS-UNT-2024-020710$UNITED THERAPEUTICS$$32$YR$$$Y$$$20240831$$$FI$FI
240868651$24086865$1$I$$20240701$20240713$20240713$EXP$$JP-SA-2024SA199570$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240713$$HP$JP$JP
240868662$24086866$2$F$$20240722$20240713$20240731$EXP$$US-TEVA-VS-3217687$TEVA$Devault KF, Mudrakola HV. Hydralazine Induced Pleuropericarditis With Bilateral Eosinophilic Pleural Effusions. Am-J-Respir-Crit-Care-Med 2024; 209 A2029.; Devault KF, Mudrakola HV. Hydralazine Induced Pleuropericarditis With Bilateral Eosinophilic Pleural Effusions. Am-J-Respir-Crit-Care-Med 2024; 209 A2029.$81$YR$$M$Y$$$20240731$$HP$US$US
240868671$24086867$1$I$$20240705$20240713$20240713$EXP$$US-SA-2024SA201920$SANOFI AVENTIS$$76$YR$E$F$Y$47.699$KG$20240713$$CN$US$US
240868682$24086868$2$F$20240710$20240820$20240713$20240823$PER$$US-AMGEN-USASP2024138520$AMGEN$$63$YR$A$M$Y$$$20240823$$CN$US$US
240868691$24086869$1$I$20240124$20240125$20240713$20240713$PER$$US-AMGEN-USASP2024138959$AMGEN$$76$YR$E$M$Y$$$20240713$$CN$US$US
240868711$24086871$1$I$$20240705$20240713$20240713$EXP$$FR-ABBVIE-5838592$ABBVIE$$67$YR$$M$Y$65$KG$20240713$$CN$FR$FR
240868721$24086872$1$I$20240618$20240706$20240713$20240713$EXP$$MX-ROCHE-10000018249$ROCHE$$82$YR$E$F$Y$$$20240713$$MD$MX$MX
240868731$24086873$1$I$$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024138602$AMGEN$$$$$$Y$$$20240713$$HP$US$US
240868741$24086874$1$I$$20240703$20240713$20240713$EXP$$US-TEVA-VS-3217372$TEVA$$52$YR$$F$Y$$$20240713$$PH$US$US
240868751$24086875$1$I$$20240710$20240713$20240713$PER$$US-ABBVIE-5835895$ABBVIE$$$$$$Y$$$20240713$$CN$US$US
240868764$24086876$4$F$20240101$20240904$20240713$20240911$EXP$$CA-CELLTRION INC.-2024CA016908$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
240868771$24086877$1$I$20240707$20240711$20240713$20240713$PER$$US-AMGEN-USASL2024138620$AMGEN$$$$$$Y$$$20240713$$CN$US$US
240868782$24086878$2$F$$20240722$20240713$20240724$PER$$US-ABBVIE-5834326$ABBVIE$$18$YR$$M$Y$$$20240724$$CN$US$US
240868791$24086879$1$I$20240401$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405021346199740-TWCQK$GB-TEVA-VS-3218020$TEVA$$$$$M$Y$100$KG$20240713$$CN$GB$GB
240868801$24086880$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405032025487950-WVPBQ$GB-TEVA-VS-3217933$TEVA$$$$$M$Y$90$KG$20240713$$CN$GB$GB
240868813$24086881$3$F$20240101$20240905$20240713$20240914$EXP$$CA-CELLTRION INC.-2024CA016904$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
240868821$24086882$1$I$$20240708$20240713$20240713$EXP$$CN-ABBVIE-5836887$ABBVIE$$68$YR$$M$Y$$$20240713$$CN$CN$CN
240868831$24086883$1$I$20100101$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405011158072330-YRBMF$GB-TEVA-VS-3217856$TEVA$$$$$$Y$$$20240713$$CN$GB$GB
240868841$24086884$1$I$20240710$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138644$AMGEN$$36$YR$A$M$Y$$$20240713$$CN$US$US
240868851$24086885$1$I$20240101$20240708$20240713$20240713$PER$$US-SA-2024SA204171$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240713$$MD$US$US
240868861$24086886$1$I$20150601$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405021518569640-TZGLF$GB-TEVA-VS-3217900$TEVA$$38$YR$$F$Y$$$20240713$$CN$GB$GB
240868871$24086887$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405011630278270-FQSZT$GB-TEVA-VS-3217842$TEVA$$$$$F$Y$$$20240713$$HP$GB$GB
240868882$24086888$2$F$20240101$20240911$20240713$20240918$EXP$$US-ABBVIE-5834416$ABBVIE$$$$$F$Y$60.3$KG$20240918$$CN$US$US
240868891$24086889$1$I$20240101$20240709$20240713$20240713$EXP$$US-ABBVIE-5835260$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240868902$24086890$2$F$$20240711$20240713$20240716$PER$$US-AMGEN-USASP2024138583$AMGEN$$$$$F$Y$$$20240716$$CN$US$US
240868911$24086891$1$I$$20240705$20240713$20240713$EXP$$US-ROCHE-10000001941$ROCHE$$74$YR$E$F$Y$$$20240713$$MD$US$US
240868921$24086892$1$I$20240101$20240708$20240713$20240713$PER$$US-SA-2024SA204242$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240713$$MD$US$US
240868931$24086893$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA205269$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240713$$MD$US$US
240868941$24086894$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA204883$SANOFI AVENTIS$$$$T$F$Y$$$20240713$$MD$US$US
240868951$24086895$1$I$20240709$20240710$20240713$20240713$PER$$US-SA-2024SA204491$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240713$$CN$US$US
240868961$24086896$1$I$20240708$20240708$20240713$20240713$PER$$US-AMGEN-USASP2024135588$AMGEN$$41$YR$A$F$Y$$$20240713$$CN$US$US
240868971$24086897$1$I$20230801$20240709$20240713$20240713$EXP$$US-ABBVIE-5834173$ABBVIE$$76$YR$$F$Y$$$20240713$$CN$US$US
240868981$24086898$1$I$20240708$20240708$20240713$20240713$PER$$US-ALXN-202407USA000454US$ALEXION PHARMACEUTICALS$$82$YR$$F$Y$$$20240713$$CN$US$US
240868991$24086899$1$I$20240601$20240710$20240713$20240713$PER$$US-ELI_LILLY_AND_COMPANY-US202407007057$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240713$$CN$US$US
240869001$24086900$1$I$$20240708$20240713$20240713$PER$$US-ELI_LILLY_AND_COMPANY-US202407005991$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240713$$CN$US$US
240869011$24086901$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5835799$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240869021$24086902$1$I$$20240709$20240713$20240713$PER$$US-ROCHE-10000022302$ROCHE$$45$YR$A$M$Y$$$20240713$$HP$US$US
240869031$24086903$1$I$20220404$20240705$20240713$20240713$EXP$$JP-ABBVIE-5834895$ABBVIE$$62$YR$$M$Y$$$20240713$$MD$JP$JP
240869041$24086904$1$I$20240101$20240709$20240713$20240713$EXP$$US-ABBVIE-5836058$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240869051$24086905$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5835176$ABBVIE$$$$$F$Y$$$20240713$$HP$US$US
240869061$24086906$1$I$$20240701$20240713$20240713$EXP$$RO-TEVA-VS-3216569$TEVA$Literature Reference: Adelina-Maria Z, Valentina P O, Florin S, Andreea M, Adel V, Lorena G, Adriana M. ANTIPARKINSONIAN MEDICATION-INDUCED DELIRIUM - A CASE REPORT. Medical Journal of Mariensis. Vol. 70, Suppl. 3, 2024. 253-254.$80$YR$$F$Y$$$20240713$$HP$RO$RO
240869071$24086907$1$I$20240709$20240711$20240713$20240713$EXP$$US-ABBVIE-5837118$ABBVIE$$71$YR$$M$Y$$$20240713$$HP$US$US
240869091$24086909$1$I$20240418$20240704$20240713$20240713$EXP$FR-AFSSAPS-PB2024000707$FR-TEVA-VS-3217604$TEVA$$34$YR$$F$Y$$$20240713$$MD$FR$FR
240869101$24086910$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204189$SANOFI AVENTIS$$$$A$M$Y$$$20240713$$MD$US$US
240869111$24086911$1$I$$20240710$20240713$20240713$PER$$US-SA-2024SA204714$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240713$$HP$US$US
240869121$24086912$1$I$$20240709$20240713$20240713$EXP$$CA-ABBVIE-5834155$ABBVIE$$$$A$F$Y$$$20240713$$CN$CA$CA
240869131$24086913$1$I$$20240703$20240713$20240713$EXP$$KR-ROCHE-10000020371$ROCHE$Kim SK, Jeong DH, Hong JH, Pak CY. Hyperintense Acute Reperfusion Marker on FLAIR after Thrombolysis Therapy in Acute Ischemic Stroke Patient Without Occlusive Arterial Lesions. Cerebrovascular Diseases. 2015;40: 51-52. doi:10.1159/000441068.$69$YR$E$M$Y$$$20240713$$HP$KR$KR
240869151$24086915$1$I$20240611$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138650$AMGEN$$82$YR$E$M$Y$$$20240713$$CN$US$US
240869161$24086916$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5834601$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240869177$24086917$7$F$20000101$20240923$20240713$20240926$EXP$$US-ABBVIE-5834404$ABBVIE$$$$$F$Y$78.017$KG$20240926$$CN$US$US
240869192$24086919$2$F$20240709$20240712$20240713$20240731$PER$$US-AMGEN-USASP2024138653$AMGEN$$89$YR$E$F$Y$$$20240731$$PH$US$US
240869201$24086920$1$I$20240701$20240703$20240713$20240713$EXP$$CL-TEVA-VS-3218038$TEVA$$45$YR$$M$Y$$$20240713$$CN$CL$CL
240869211$24086921$1$I$20240703$20240703$20240713$20240713$EXP$$GB-TEVA-VS-3216925$TEVA$$69$YR$$M$Y$83$KG$20240713$$PH$GB$GB
240869221$24086922$1$I$$20240703$20240713$20240713$EXP$$CA-TEVA-VS-3219201$TEVA$$62$YR$$F$Y$$$20240713$$CN$CA$CA
240869231$24086923$1$I$20240324$20240703$20240713$20240713$EXP$GB-MHRA-MED-202404191502598390-GLWNT$GB-TEVA-VS-3217023$TEVA$$71$YR$$F$Y$$$20240713$$HP$GB$GB
240869241$24086924$1$I$20240201$20240704$20240713$20240713$EXP$$DE-TEVA-VS-3217581$TEVA$$$$$F$Y$3.58$KG$20240713$$MD$DE$DE
240869251$24086925$1$I$$20240710$20240713$20240713$PER$$US-ABBVIE-5835194$ABBVIE$$$$$$Y$$$20240713$$CN$US$US
240869261$24086926$1$I$$20240709$20240713$20240713$PER$$US-JNJFOC-20240724590$JOHNSON AND JOHNSON$$$$$$Y$$$20240713$$CN$US$US
240869273$24086927$3$F$20240124$20240705$20240713$20240723$EXP$$JP-ALXN-202403JPN000540JPAA$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240723$$MD$JP$JP
240869281$24086928$1$I$$20240703$20240713$20240713$EXP$GB-MHRA-MED-202407031106237230-CRTDW$GB-TEVA-VS-3216833$TEVA$$$$$F$Y$$$20240713$$HP$GB$GB
240869291$24086929$1$I$20240607$20240703$20240713$20240713$EXP$BE-FAMHP-DHH-N2024-122286$BE-TEVA-VS-3216987$TEVA$$23$YR$$F$Y$97$KG$20240713$$CN$BE$BE
240869301$24086930$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204229$SANOFI AVENTIS$$$$E$F$Y$$$20240713$$MD$US$US
240869311$24086931$1$I$20240401$20240708$20240713$20240713$PER$$US-SA-2024SA205142$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240713$$MD$US$US
240869321$24086932$1$I$20240218$20240704$20240713$20240713$EXP$FR-AFSSAPS-AVMA2024000267$FR-TEVA-VS-3217361$TEVA$$26$YR$$M$Y$$$20240713$$PH$FR$FR
240869332$24086933$2$F$20240710$20240719$20240713$20240724$EXP$$RO-ABBVIE-5835090$ABBVIE$$70$YR$$M$Y$$$20240724$$CN$RO$RO
240869341$24086934$1$I$$20240710$20240713$20240713$EXP$$US-ABBVIE-5836007$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240869351$24086935$1$I$$20240709$20240713$20240713$PER$$US-AMGEN-USASP2024136882$AMGEN$$$$$$Y$$$20240713$$HP$US$US
240869371$24086937$1$I$20240301$20240709$20240713$20240713$EXP$$CA-ABBVIE-5835004$ABBVIE$$$$A$M$Y$$$20240713$$CN$CA$CA
240869381$24086938$1$I$$20240625$20240713$20240713$PER$$US-JNJFOC-20240669962$JOHNSON AND JOHNSON$$$$$F$Y$$$20240713$$CN$US$US
240869392$24086939$2$F$20240101$20240828$20240713$20240830$EXP$$CA-ABBVIE-5734887$ABBVIE$$83$YR$$M$Y$$$20240830$$HP$CA$CA
240869401$24086940$1$I$20240101$20240709$20240713$20240713$EXP$$CA-ABBVIE-5835036$ABBVIE$$52$YR$$F$Y$$$20240713$$MD$CA$CA
240869411$24086941$1$I$20210101$20240709$20240713$20240713$EXP$$US-ABBVIE-5835128$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240869421$24086942$1$I$20210101$20240709$20240713$20240713$EXP$$US-ABBVIE-5835198$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240869431$24086943$1$I$20240611$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138232$AMGEN$$$$$$Y$$$20240713$$CN$US$US
240869441$24086944$1$I$20240711$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138546$AMGEN$$68$YR$E$F$Y$$$20240713$$CN$US$US
240869451$24086945$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA204635$SANOFI AVENTIS$$$$C$M$Y$14.014$KG$20240713$$MD$US$US
240869461$24086946$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204225$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240713$$MD$US$US
240869471$24086947$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA205073$SANOFI AVENTIS$$$$A$F$Y$$$20240713$$MD$US$US
240869482$24086948$2$F$20240401$20240731$20240713$20240810$EXP$GB-MHRA-MED-202405060000030850-KHQNL$GB-TEVA-VS-3218669$TEVA$$36$YR$$F$Y$52$KG$20240810$$CN$GB$GB
240869491$24086949$1$I$20240101$20240711$20240713$20240713$PER$$US-ABBVIE-5837469$ABBVIE$$$$A$F$Y$$$20240713$$MD$US$US
240869501$24086950$1$I$20240711$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138655$AMGEN$$79$YR$E$$Y$$$20240713$$CN$US$US
240869511$24086951$1$I$20240626$20240711$20240713$20240713$EXP$$CA-ABBVIE-5838520$ABBVIE$$43$YR$$M$Y$$$20240713$$CN$CA$CA
240869523$24086952$3$F$20240701$20240718$20240713$20240723$EXP$$US-ABBVIE-5835933$ABBVIE$$46$YR$$M$Y$$$20240723$$CN$US$US
240869531$24086953$1$I$$20240711$20240713$20240713$EXP$$GB-ABBVIE-5838822$ABBVIE$$$$A$F$Y$$$20240713$$HP$GB$GB
240869541$24086954$1$I$$20240708$20240713$20240713$EXP$$US-ABBVIE-5832785$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240869551$24086955$1$I$$20240711$20240713$20240713$EXP$$GB-ABBVIE-5839001$ABBVIE$$$$A$M$Y$$$20240713$$HP$GB$GB
240869561$24086956$1$I$$20240705$20240713$20240713$PER$$US-SA-2024SA203358$SANOFI AVENTIS$$$$A$M$Y$$$20240713$$MD$US$US
240869571$24086957$1$I$$20240703$20240713$20240713$EXP$FR-AFSSAPS-AVPO2024000121$FR-TEVA-VS-3217230$TEVA$$$$$M$Y$$$20240713$$PH$FR$FR
240869582$24086958$2$F$$20240822$20240713$20240902$PER$$US-JNJFOC-20240672766$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240902$$CN$US$US
240869592$24086959$2$F$$20240821$20240713$20240902$PER$$US-SA-2024SA204650$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240902$$MD$US$US
240869602$24086960$2$F$$20240728$20240713$20240807$PER$$US-TAKEDA-2024TUS070435$TAKEDA$$$$$F$Y$59$KG$20240807$$MD$US$US
240869611$24086961$1$I$$20240711$20240713$20240713$EXP$$CA-ABBVIE-5838417$ABBVIE$$$$E$M$Y$$$20240713$$MD$CA$CA
240869622$24086962$2$F$$20240802$20240713$20240810$PER$$US-ABBVIE-5837583$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
240869631$24086963$1$I$20240101$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137675$AMGEN$$$$$M$Y$$$20240713$$CN$US$US
240869641$24086964$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA155488$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240713$$MD$US$US
240869651$24086965$1$I$20240101$20240709$20240713$20240713$EXP$$US-ABBVIE-5835328$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240869661$24086966$1$I$$20240703$20240713$20240713$PER$$US-TEVA-VS-3217522$TEVA$$74$YR$$M$Y$$$20240713$$HP$US$US
240869671$24086967$1$I$20240101$20240710$20240713$20240713$EXP$$US-ABBVIE-5836967$ABBVIE$$78$YR$$M$Y$$$20240713$$CN$US$US
240869681$24086968$1$I$20090101$20240710$20240713$20240713$EXP$$US-ABBVIE-5835519$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240869691$24086969$1$I$$20240708$20240713$20240713$PER$$US-AMGEN-USASP2024136341$AMGEN$$$$$$Y$$$20240713$$HP$US$US
240869701$24086970$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204445$SANOFI AVENTIS$$$$A$F$Y$99.79$KG$20240713$$MD$US$US
240869714$24086971$4$F$20240101$20240912$20240713$20240920$EXP$$CA-CELLTRION INC.-2024CA012369$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
240869722$24086972$2$F$20230701$20240808$20240713$20240812$EXP$$US-TAKEDA-2024TUS022258$TAKEDA$$75$YR$$F$Y$$$20240812$$CN$US$US
240869731$24086973$1$I$$20240708$20240713$20240713$PER$$US-AMGEN-USASP2024136346$AMGEN$$$$$$Y$$$20240713$$HP$US$US
240869741$24086974$1$I$20240501$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405031127033190-YRLGM$GB-TEVA-VS-3218030$TEVA$$79$YR$$M$Y$$$20240713$$CN$GB$GB
240869751$24086975$1$I$20240427$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405021141582620-BCQHN$GB-TEVA-VS-3218075$TEVA$$39$YR$$F$Y$105$KG$20240713$$CN$GB$GB
240869762$24086976$2$F$20240701$20240723$20240713$20240731$PER$$US-SA-2024SA204010$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240731$$MD$US$US
240869771$24086977$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA202046$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240713$$MD$US$US
240869781$24086978$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA204281$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240713$$MD$US$US
240869791$24086979$1$I$$20240710$20240713$20240713$EXP$$GB-ABBVIE-5835045$ABBVIE$$$$A$F$Y$$$20240713$$CN$GB$GB
240869801$24086980$1$I$20240501$20240705$20240713$20240713$EXP$$US-ABBVIE-5835299$ABBVIE$$86$YR$$F$Y$$$20240713$$CN$US$US
240869813$24086981$3$F$20220101$20240801$20240713$20240806$EXP$$US-ABBVIE-5819239$ABBVIE$$$$$M$Y$118$KG$20240806$$CN$US$US
240869822$24086982$2$F$$20240808$20240713$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202407005736$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240812$$CN$US$US
240869831$24086983$1$I$20240711$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138499$AMGEN$$91$YR$E$F$Y$$$20240713$$CN$US$US
240869841$24086984$1$I$20240711$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138669$AMGEN$$70$YR$E$F$Y$$$20240713$$CN$US$US
240869851$24086985$1$I$$20240708$20240713$20240713$EXP$$US-ABBVIE-5761012$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240869862$24086986$2$F$$20240710$20240713$20240718$EXP$$US-ABBVIE-5835869$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
240869871$24086987$1$I$$20240708$20240713$20240713$EXP$$US-SA-2024SA202123$SANOFI AVENTIS$$$$A$$Y$$$20240713$$MD$US$US
240869881$24086988$1$I$$20240710$20240713$20240713$PER$$US-SA-2024SA204957$SANOFI AVENTIS$$$$A$M$Y$$$20240713$$CN$US$US
240869891$24086989$1$I$20240707$20240709$20240713$20240713$PER$$US-SA-2024SA204266$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240713$$MD$US$US
240869902$24086990$2$F$20240101$20240805$20240713$20240813$EXP$$US-ABBVIE-5832616$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
240869913$24086991$3$F$20240701$20240822$20240713$20240827$PER$$US-AMGEN-USASP2024138358$AMGEN$$78$YR$E$M$Y$$$20240826$$CN$US$US
240869922$24086992$2$F$20240101$20240717$20240713$20240723$EXP$$US-ABBVIE-5833618$ABBVIE$$$$$F$Y$50$KG$20240723$$CN$US$US
240869931$24086993$1$I$20240101$20240705$20240713$20240713$PER$$US-SA-2024SA203353$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240713$$MD$US$US
240869941$24086994$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204285$SANOFI AVENTIS$$$$C$M$Y$31.6$KG$20240713$$MD$US$US
240869952$24086995$2$F$20240101$20240821$20240713$20240911$PER$$US-SA-2024SA203090$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240911$$MD$US$US
240869961$24086996$1$I$$20240705$20240713$20240713$PER$$US-SA-2024SA202192$SANOFI AVENTIS$$52$YR$A$F$Y$79$KG$20240713$$MD$US$US
240869971$24086997$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA202966$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240713$$MD$US$US
240869981$24086998$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204304$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240713$$MD$US$US
240869991$24086999$1$I$$20240710$20240713$20240713$PER$$US-UNITED THERAPEUTICS-UNT-2024-020434$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240713$$$US$US
240870001$24087000$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA204248$SANOFI AVENTIS$$$$A$M$Y$95.25$KG$20240713$$MD$US$US
240870011$24087001$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA202633$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240713$$CN$US$US
240870021$24087002$1$I$20240101$20240709$20240713$20240713$PER$$US-SA-2024SA204654$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240713$$MD$US$US
240870031$24087003$1$I$20240601$20240709$20240713$20240713$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038823$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$$$20240713$$CN$US$US
240870041$24087004$1$I$$20240618$20240713$20240713$EXP$$US-ABBVIE-5837596$ABBVIE$$$$$M$Y$$$20240713$$CN$US$US
240870053$24087005$3$F$20240401$20240906$20240713$20240916$EXP$$US-JNJFOC-20240723461$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240916$$HP$US$US
240870061$24087006$1$I$20230101$20240705$20240713$20240713$EXP$$CO-ABBVIE-5838357$ABBVIE$$$$$M$Y$80$KG$20240713$$HP$CO$CO
240870071$24087007$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA203345$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240713$$MD$US$US
240870081$24087008$1$I$20240710$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138573$AMGEN$$64$YR$A$M$Y$$$20240713$$CN$US$US
240870091$24087009$1$I$$20240709$20240713$20240713$EXP$$US-ABBVIE-5835142$ABBVIE$$$$$F$Y$$$20240713$$CN$US$US
240870101$24087010$1$I$$20240711$20240713$20240713$EXP$$US-ABBVIE-5838634$ABBVIE$$$$$F$Y$$$20240713$$HP$US$US
240870111$24087011$1$I$20200425$20240612$20240713$20240713$EXP$$GB-AUROBINDO-AUR-APL-2024-034428$AUROBINDO$$70$YR$$M$Y$$$20240713$$CN$GB$GB
240870121$24087012$1$I$$20240703$20240713$20240713$EXP$$US-AUROBINDO-AUR-APL-2024-034099$AUROBINDO$Grace Kim, Kate E Lee, Anand Shah, Jessica Seidelman, Kevin A Wu, Diana M Cardona, et al.. Tuberculosis Osteomyelitis of the Wrist. THE PERMANENTE JOURNAL. 2024$56$YR$$M$Y$$$20240713$$HP$US$US
240870131$24087013$1$I$$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138673$AMGEN$$84$YR$E$F$Y$$$20240713$$CN$US$US
240870141$24087014$1$I$20240101$20240708$20240713$20240713$PER$$US-SA-2024SA203218$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240713$$MD$US$US
240870151$24087015$1$I$$20240703$20240713$20240713$EXP$$US-AUROBINDO-AUR-APL-2024-033880$AUROBINDO$Patel S, Seibert AM, Murray NM, Arizmendez N, Lanspa MJ, Beesley SJ.. West Nile Virus Meningoencephalitis in Liver Transplantation. Am-J-Respir-Crit-Care-Med. 2024;209A7041$69$YR$$M$Y$$$20240713$$HP$US$US
240870161$24087016$1$I$$20240704$20240713$20240713$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005109$BIOCON$$$$$$Y$$$20240713$$HP$CA$CA
240870171$24087017$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204289$SANOFI AVENTIS$$$$A$F$Y$72$KG$20240713$$MD$US$US
240870181$24087018$1$I$20240101$20240709$20240713$20240713$PER$$US-SA-2024SA204663$SANOFI AVENTIS$$62$YR$A$F$Y$74.842$KG$20240713$$MD$US$US
240870192$24087019$2$F$$20240814$20240713$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06415$LUPIN$$$$$$Y$$$20240828$$CN$US$US
240870201$24087020$1$I$$20240703$20240713$20240713$EXP$$US-AUROBINDO-AUR-APL-2024-034012$AUROBINDO$Ward SA, Shankar M, Viswanathan P, Suku S. Pulmonary Histoplasmosis in a 60-Year-Old Male With Ulcerative Colitis on Tofacitinib. Am-J-Respir-Crit-Care-Med. 2024;209:A6310$60$YR$$M$Y$$$20240713$$HP$US$US
240870211$24087021$1$I$20240615$20240709$20240713$20240713$PER$$US-AMGEN-USASP2024136216$AMGEN$$57$YR$A$F$Y$$$20240713$$CN$US$US
240870221$24087022$1$I$20240625$20240705$20240713$20240713$EXP$$CA-CELLTRION INC.-2024CA016984$CELLTRION$$$$$$Y$$$20240713$$CN$CA$CA
240870231$24087023$1$I$$20240703$20240713$20240713$EXP$$US-AUROBINDO-AUR-APL-2024-033977$AUROBINDO$Rainone M, Ngo D, Baird JH, Budde LE, Htut M, Pullarkat V, et al.. Interferon-gamma blockade in CAR T-cell therapy-associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis. Blood Advances. 2023;7(4):533-536$19$YR$$M$Y$$$20240713$$HP$US$US
240870241$24087024$1$I$20110103$20240703$20240713$20240713$EXP$$DE-AUROBINDO-AUR-APL-2024-033181$AUROBINDO$$12$YR$$F$Y$39.8$KG$20240713$$MD$DE$DE
240870251$24087025$1$I$$20240710$20240713$20240713$PER$$US-SA-2024SA205492$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240713$$MD$US$US
240870261$24087026$1$I$20240620$20240709$20240713$20240713$PER$$US-SA-2024SA204582$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240713$$MD$US$US
240870272$24087027$2$F$$20240709$20240713$20240718$PER$$US-SA-2024SA203742$SANOFI AVENTIS$$16$YR$T$M$Y$50.34$KG$20240718$$MD$US$US
240870281$24087028$1$I$$20240704$20240713$20240713$EXP$$GB-AUROBINDO-AUR-APL-2024-033405$AUROBINDO$$$$$$Y$$$20240713$$PH$GB$GB
240870291$24087029$1$I$$20240706$20240713$20240713$PER$$US-SA-2024SA203017$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240713$$MD$US$US
240870301$24087030$1$I$20240706$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138681$AMGEN$$80$YR$E$F$Y$$$20240713$$CN$US$US
240870311$24087031$1$I$20240615$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138662$AMGEN$$72$YR$E$M$Y$$$20240713$$CN$US$US
240870321$24087032$1$I$20240704$20240704$20240713$20240713$EXP$$GB-AUROBINDO-AUR-APL-2024-033847$AUROBINDO$$54$YR$$M$Y$73$KG$20240713$$CN$GB$GB
240870331$24087033$1$I$20240424$20240704$20240713$20240713$EXP$$GB-AUROBINDO-AUR-APL-2024-033413$AUROBINDO$$59$YR$$F$Y$80$KG$20240713$$CN$GB$GB
240870341$24087034$1$I$$20240709$20240713$20240713$PER$$US-AstraZeneca-2024A157115$ASTRAZENECA$$$$$F$Y$$$20240713$$CN$US$
240870352$24087035$2$F$20240612$20240909$20240713$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-033349$AUROBINDO$$$$A$F$Y$72$KG$20240920$$MD$FR$FR
240870363$24087036$3$F$$20240905$20240713$20240919$EXP$$ES-AUROBINDO-AUR-APL-2024-033228$AUROBINDO$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transplant Infectious Disease. 2024;26(3):e14276$6$MON$$M$Y$$$20240919$$MD$ES$ES
240870371$24087037$1$I$20240701$20240709$20240713$20240713$PER$$US-SA-2024SA204343$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240713$$PH$US$US
240870382$24087038$2$F$20240101$20240722$20240713$20240731$PER$$US-SA-2024SA202641$SANOFI AVENTIS$$$$A$F$Y$$$20240731$$MD$US$US
240870391$24087039$1$I$$20240705$20240713$20240713$EXP$$US-AMGEN-USASP2024134632$AMGEN$Afify Z.; Orjuela-Grimm M.; Smith C.M. et. al.. Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative. British Journal of Haematology. 2023;200 (3):297-305$$$$$Y$$$20240713$$HP$US$US
240870402$24087040$2$F$$20240710$20240713$20240720$EXP$$IT-AUROBINDO-AUR-APL-2024-033232$AUROBINDO$Scollo C, Rossi D, D^Andria R, Magnano R, Pezzi L, D^Alleva A, et al.. Cardiovascular considerations in antidepressant therapy: sinus arrest due to sertraline.. European Heart Journal Supplements.. 2024;26(Supplement 2:ii78$39$YR$$F$Y$$$20240720$$MD$IT$IT
240870412$24087041$2$F$$20240716$20240713$20240726$EXP$$IT-AUROBINDO-AUR-APL-2024-033257$AUROBINDO$Sanna S, Lampus M.. A PARTICULAR CASE OF CARDIAC ARREST.. European Heart Journal, Supplement.. 2024;26(Supplement 2:ii70-1$88$YR$$M$Y$$$20240726$$MD$IT$IT
240870421$24087042$1$I$$20240704$20240713$20240713$EXP$$ES-AUROBINDO-AUR-APL-2024-033294$AUROBINDO$Sanchez-Guixe M, Muinos F, Pinheiro-Santin M, Gonzalez-Huici V, Rodriguez-Hernandez CJ, Lopez-Biga N, et al.. Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer Discovery. 2024;14(6):953-64$2$DEC$$F$Y$$$20240713$$MD$ES$ES
240870431$24087043$1$I$$20240711$20240713$20240713$PER$$US-ELI_LILLY_AND_COMPANY-US202407007805$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240713$$CN$US$US
240870441$24087044$1$I$20240601$20240704$20240713$20240713$EXP$GB-MHRA-MED-202407040829504800-CHNDY$GB-TEVA-VS-3217343$TEVA$$62$YR$$F$Y$58$KG$20240713$$CN$GB$GB
240870452$24087045$2$F$$20240912$20240713$20240916$EXP$$NVSC2024GB143784$NOVARTIS$$$$A$F$Y$$$20240916$$CN$GB$GB
240870462$24087046$2$F$$20240709$20240713$20240717$EXP$$NVSC2024GB141979$NOVARTIS$$$$$F$Y$$$20240717$$CN$GB$GB
240870471$24087047$1$I$20240612$20240704$20240713$20240713$EXP$$FR-AUROBINDO-AUR-APL-2024-033337$AUROBINDO$$65$YR$$M$Y$$$20240713$$PH$FR$FR
240870481$24087048$1$I$$20240704$20240713$20240713$EXP$$GB-AUROBINDO-AUR-APL-2024-033440$AUROBINDO$$5$YR$$F$Y$$$20240713$$HP$GB$GB
240870491$24087049$1$I$20240703$20240704$20240713$20240713$EXP$GB-MHRA-MED-202407041235375950-QYHNL$GB-TEVA-VS-3217353$TEVA$$$$$M$Y$$$20240713$$PH$GB$GB
240870501$24087050$1$I$20240515$20240704$20240713$20240713$EXP$GB-MHRA-MED-202407040004224820-KYDQB$GB-TEVA-VS-3217656$TEVA$$82$YR$$$Y$64$KG$20240713$$CN$GB$GB
240870511$24087051$1$I$20240401$20240708$20240713$20240713$PER$$US-SA-2024SA205491$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240713$$MD$US$US
240870521$24087052$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202407041156036650-BMCRP$GB-TEVA-VS-3217663$TEVA$$$$$F$Y$85$KG$20240713$$PH$GB$GB
240870531$24087053$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405021717599450-VQTKM$GB-TEVA-VS-3217793$TEVA$$$$$M$Y$120$KG$20240713$$PH$GB$GB
240870541$24087054$1$I$$20240709$20240713$20240713$PER$$US-AstraZeneca-2024A158315$ASTRAZENECA$$$$A$F$Y$$$20240713$$CN$US$
240870552$24087055$2$F$$20240813$20240713$20240820$PER$$US-AstraZeneca-2024A156441$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
240870561$24087056$1$I$$20240710$20240713$20240713$EXP$$US-AstraZeneca-2024A158206$ASTRAZENECA$$$$$M$Y$$$20240713$$CN$US$
240870572$24087057$2$F$20240706$20240904$20240713$20240912$PER$$US-AstraZeneca-2024A157648$ASTRAZENECA$$15977$DY$$F$Y$$$20240912$$CN$US$
240870581$24087058$1$I$20110101$20240704$20240713$20240713$EXP$$ES-AUROBINDO-AUR-APL-2018-002194$AUROBINDO$De Arriba G, Fiallos RA, de Lorenzo A, Rodriguez-Palomares JR, Perna C.. Glomerulonefritis extracapilar y lepra: una asociaci?n infrecuente (Extracapillary glomerulonephritis and leprosy: An uncommon association.). Nefrologia. 2016;36(3):313-314$79$YR$$M$Y$$$20240713$$MD$ES$ES
240870591$24087059$1$I$20240404$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405031412135180-KYPGB$GB-TEVA-VS-3217819$TEVA$$63$YR$$F$Y$$$20240713$$PH$GB$GB
240870601$24087060$1$I$20240707$20240708$20240713$20240713$PER$$US-AMGEN-USASP2024135264$AMGEN$$$$$$Y$$$20240713$$HP$US$US
240870611$24087061$1$I$$20240703$20240713$20240713$EXP$$US-AUROBINDO-AUR-APL-2024-033815$AUROBINDO$Luskin MR, Murakami MA, Keating J, Winer ES, Garcia JS, Stahl M, et al.. A Phase IStudy of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL and Blast Phase CML in Adults.. Blood. 2023;142 (Suppl. 1):965$65$YR$$M$Y$$$20240713$$MD$US$US
240870621$24087062$1$I$20240711$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138241$AMGEN$$75$YR$E$F$Y$$$20240713$$CN$US$US
240870631$24087063$1$I$$20240703$20240713$20240713$EXP$$US-AUROBINDO-AUR-APL-2024-033816$AUROBINDO$Luskin MR, Murakami MA, Keating J, Winer ES, Garcia JS, Stahl M, et al. A Phase IStudy of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL and Blast Phase CML in Adults. Blood. 2023;142 (Suppl. 1):965$62$YR$$M$Y$$$20240713$$MD$US$US
240870641$24087064$1$I$20240711$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138684$AMGEN$$78$YR$E$F$Y$$$20240713$$CN$US$US
240870651$24087065$1$I$20240706$20240708$20240713$20240713$PER$$US-ALXN-202407USA000477US$ALEXION PHARMACEUTICALS$$46$YR$$M$Y$$$20240713$$CN$US$US
240870661$24087066$1$I$20240601$20240710$20240713$20240713$EXP$$NVSC2024CA143493$NOVARTIS$$43$YR$$M$Y$$$20240713$$CN$CA$CA
240870671$24087067$1$I$$20240703$20240713$20240713$EXP$$FR-AUROBINDO-AUR-APL-2024-034587$AUROBINDO$Chappuy M, Merah I, Ragonnet D, de Ternay J, Rolland B.. Le Centre ressource lyonnais des addictions m?dicamenteuses (CERLAM) (Lyon resource center for prescription drug use disorder).. Le Courrier des Addictions. 2024;26 (2):24-27$33$YR$$F$Y$$$20240713$$PH$FR$FR
240870681$24087068$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA204357$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240713$$CN$US$US
240870691$24087069$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204869$SANOFI AVENTIS$$$$C$F$Y$$$20240713$$MD$US$US
240870701$24087070$1$I$$20240703$20240713$20240713$EXP$$US-AUROBINDO-AUR-APL-2024-033468$AUROBINDO$Rao M, Casias M, Abidi MZ. Disseminated Scedosporium infection in the early post-kidney transplant period. Transpl-Infect-Dis. 2024;26No. 2$63$YR$$F$Y$$$20240713$$HP$US$US
240870711$24087071$1$I$$20240705$20240713$20240713$EXP$GB-MHRA-MED-202405091248557750-GJRVT$GB-BAXTER-2024BAX021246$BAXTER$$$$$F$Y$$$20240713$$PH$GB$GB
240870721$24087072$1$I$$20240705$20240713$20240713$EXP$GB-MHRA-MED-202405091047170220-LSYRH$GB-BAXTER-2024BAX021249$BAXTER$$$$$F$Y$$$20240713$$PH$GB$GB
240870731$24087073$1$I$$20240705$20240713$20240713$EXP$GB-MHRA-MED-202405081659194210-LKFVD$GB-BAXTER-2024BAX021251$BAXTER$$$$$F$Y$$$20240713$$PH$GB$GB
240870741$24087074$1$I$20240630$20240703$20240713$20240713$EXP$CN-NMPACDR-4205831541489202400189$CN-BAXTER-2024BAX021227$BAXTER$$91$YR$$F$Y$45$KG$20240713$$MD$CN$CN
240870751$24087075$1$I$20240201$20240708$20240713$20240713$PER$$US-ELI_LILLY_AND_COMPANY-US202407006492$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240713$$CN$US$US
240870761$24087076$1$I$$20240705$20240713$20240713$EXP$$US-AMGEN-USASP2024134489$AMGEN$Stan M.N.; Rachmasari K.N.; Toro-tobon D. et al.. Impact of Teprotumumab on Clinical Practice in Thyroid Eye Disease. American Association of Clinical endocrinologists. 2024;1-20$$$$$Y$$$20240713$$MD$US$US
240870771$24087077$1$I$$20240705$20240713$20240713$EXP$$US-AMGEN-USASP2024134630$AMGEN$Dileep A.; Digiuseppe J.A.. Primary Cutaneous Follicle Center Lymphoma (PCFCL) Arising in the Setting of Anti-TNF-Alpha Therapy. American Journal of Dermatopathology. 2024;46 (SUPPL_7):S13$21$YR$A$M$Y$$$20240713$$HP$US$US
240870781$24087078$1$I$20240703$20240703$20240713$20240713$EXP$$US-UROGEN PHARMA LTD.-2024-UGN-000094$UROGEN PHARMA$$$$$$Y$$$20240713$$MD$US$US
240870791$24087079$1$I$$20240704$20240713$20240713$EXP$$DE-AMGEN-DEUSP2024133828$AMGEN$Mauz-Koerholz C.; Beishuizen A.; Vinti L. et al.. Pembrolizumab (pembro) in Children and Young Adults with High-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Updated Results from the Phase 2 Keynote-667 Study. Blood. 2023;142(SUPPL 1):3063-3064$$$$$Y$$$20240713$$MD$DE$DE
240870801$24087080$1$I$$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024139039$AMGEN$$$$$$Y$$$20240713$$HP$US$US
240870823$24087082$3$F$20240710$20240712$20240713$20240805$PER$$US-AMGEN-USASP2024138696$AMGEN$$81$YR$E$F$Y$$$20240805$$CN$US$US
240870831$24087083$1$I$$20240708$20240713$20240713$EXP$$US-JNJFOC-20240718755$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240713$$CN$US$US
240870842$24087084$2$F$20240101$20240921$20240713$20240930$PER$$US-SA-2024SA205096$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240930$$MD$US$US
240870851$24087085$1$I$$20240705$20240713$20240713$EXP$$US-AMGEN-USASP2024134649$AMGEN$Afify Z.; Orjuela-Grimm M.; Smith C.M. et. al.. Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative. British Journal of Haematology. 2023;200 (3):297-305$$$$$Y$$$20240713$$HP$US$US
240870861$24087086$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA205469$SANOFI AVENTIS$$$$A$F$Y$83.91$KG$20240713$$MD$US$US
240870871$24087087$1$I$$20240711$20240713$20240713$PER$$US-ELI_LILLY_AND_COMPANY-US202407007811$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240713$$CN$US$US
240870882$24087088$2$F$$20240723$20240713$20240727$EXP$$JP-AMGEN-JPNSP2024136969$AMGEN$$$$$$Y$$$20240727$$MD$JP$JP
240870896$24087089$6$F$20240401$20240913$20240713$20240916$EXP$$NVSC2024US142425$NOVARTIS$$64$YR$$F$Y$$$20240916$$CN$US$US
240870901$24087090$1$I$$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137343$AMGEN$$39$YR$A$F$Y$$$20240713$$CN$US$US
240870911$24087091$1$I$20240710$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138747$AMGEN$$71$YR$E$M$Y$$$20240713$$CN$US$US
240870921$24087092$1$I$$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138945$AMGEN$$$$$$Y$$$20240713$$PH$US$US
240870931$24087093$1$I$$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137348$AMGEN$$37$YR$A$F$Y$$$20240713$$CN$US$US
240870941$24087094$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202407041136045490-HKLQD$GB-TEVA-VS-3217333$TEVA$$$$$M$Y$70$KG$20240713$$CN$GB$GB
240870951$24087095$1$I$20231101$20240704$20240713$20240713$EXP$GB-MHRA-MED-202407041053066220-FWYTH$GB-TEVA-VS-3217324$TEVA$$41$YR$$M$Y$65$KG$20240713$$CN$GB$GB
240870961$24087096$1$I$$20240705$20240713$20240713$EXP$$US-AMGEN-USASP2024134607$AMGEN$Wede S. L.; Schultze M. D.; Reeves D. J. et al.. Evaluation of oral targeted anticancer drug interactions and their management by oncology pharmacists. Journal of the American College of Clinical Pharmacy - JACCP. 2024;7 (6):535-543$$$$$Y$$$20240713$$PH$US$US
240870971$24087097$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405091629111830-LNCQR$GB-BAXTER-2024BAX021250$BAXTER$$$$$F$Y$$$20240713$$CN$GB$GB
240870991$24087099$1$I$20240101$20240709$20240713$20240713$PER$$US-SA-2024SA204271$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240713$$CN$US$US
240871001$24087100$1$I$20240601$20240710$20240713$20240713$PER$$US-ELI_LILLY_AND_COMPANY-US202407006913$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240713$$CN$US$US
240871011$24087101$1$I$20240101$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138922$AMGEN$$$$$F$Y$$$20240713$$CN$US$US
240871032$24087103$2$F$20240710$20240726$20240713$20240730$PER$$US-AMGEN-USASP2024138709$AMGEN$$74$YR$E$F$Y$$$20240730$$MD$US$US
240871041$24087104$1$I$20240101$20240708$20240713$20240713$EXP$$US-SA-2024SA202755$SANOFI AVENTIS$$65$YR$E$F$Y$64$KG$20240713$$MD$US$US
240871052$24087105$2$F$20240627$20240813$20240713$20240822$EXP$$US-ARDELYX-2024ARDX005028$ARDELYX$$75$YR$$F$Y$$$20240822$$CN$US$US
240871061$24087106$1$I$$20240705$20240713$20240713$EXP$$US-AMGEN-USASP2024133964$AMGEN$$80$YR$E$F$Y$$$20240713$$HP$US$US
240871071$24087107$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA201998$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240713$$CN$US$US
240871081$24087108$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA202919$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240713$$CN$US$US
240871092$24087109$2$F$20240101$20240705$20240713$20240722$PER$$US-SA-2024SA200038$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240722$$CN$US$US
240871102$24087110$2$F$20240101$20240802$20240713$20240813$PER$$US-SA-2024SA201148$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240814$$MD$US$US
240871111$24087111$1$I$20240101$20240705$20240713$20240713$PER$$US-SA-2024SA201504$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240713$$MD$US$US
240871121$24087112$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA202412$SANOFI AVENTIS$$$$A$M$Y$$$20240713$$CN$US$US
240871131$24087113$1$I$$20240704$20240713$20240713$PER$$US-SA-2024SA199610$SANOFI AVENTIS$$$$$F$Y$$$20240713$$CN$US$US
240871143$24087114$3$F$20230601$20240913$20240713$20240916$EXP$$NVSC2024US143772$NOVARTIS$$44$YR$$F$Y$$$20240916$$CN$US$US
240871151$24087115$1$I$$20240705$20240713$20240713$PER$$US-SA-2024SA201528$SANOFI AVENTIS$$$$$F$Y$$$20240713$$CN$US$US
240871162$24087116$2$F$20240601$20240916$20240713$20240923$PER$$US-SA-2024SA201506$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240923$$MD$US$US
240871173$24087117$3$F$20180830$20240821$20240713$20240919$EXP$$AU-AMGEN-USASP2024133577$AMGEN$$22$YR$A$F$Y$$$20240919$$MD$AU$AU
240871181$24087118$1$I$20230101$20240705$20240713$20240713$PER$$US-SA-2024SA203176$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240713$$MD$US$US
240871192$24087119$2$F$$20240717$20240713$20240724$PER$$US-SA-2024SA201546$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$HP$US$US
240871201$24087120$1$I$$20240705$20240713$20240713$EXP$$GB-TAKEDA-2024TUS070144$TAKEDA$$$$$F$Y$$$20240713$$CN$GB$GB
240871211$24087121$1$I$$20240710$20240713$20240713$EXP$$CA-TAKEDA-2024TUS071098$TAKEDA$$$$$M$Y$$$20240713$$CN$CA$CA
240871221$24087122$1$I$$20240705$20240713$20240713$EXP$$US-SA-2024SA201155$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240713$$CN$US$US
240871231$24087123$1$I$20240401$20240708$20240713$20240713$PER$$US-SA-2024SA130829$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240713$$MD$US$US
240871241$24087124$1$I$20240101$20240704$20240713$20240713$PER$$US-SA-2024SA201179$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240713$$CN$US$US
240871251$24087125$1$I$20240101$20240710$20240713$20240713$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020146$UNITED THERAPEUTICS$$$$$M$Y$$$20240713$$$US$US
240871262$24087126$2$F$$20240710$20240713$20240717$EXP$$NVSC2024US143832$NOVARTIS$$$$$M$Y$$$20240717$$CN$US$US
240871271$24087127$1$I$20240702$20240708$20240713$20240713$EXP$$PE-JNJFOC-20240720393$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240713$$CN$PE$PE
240871281$24087128$1$I$20240619$20240709$20240713$20240713$PER$$US-AMGEN-USASP2024136749$AMGEN$$$$$$Y$$$20240713$$PH$US$US
240871304$24087130$4$F$20240806$20240901$20240713$20240903$EXP$$IL-TAKEDA-2024TUS070128$TAKEDA$$$$A$F$Y$$$20240903$$CN$GB$IL
240871311$24087131$1$I$20240101$20240708$20240713$20240713$EXP$$US-SA-2024SA182335$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240713$$MD$US$US
240871321$24087132$1$I$$20240626$20240713$20240713$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06447$LUPIN$$$$$M$Y$$$20240713$$CN$US$US
240871341$24087134$1$I$$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138946$AMGEN$$$$$$Y$$$20240713$$PH$US$US
240871351$24087135$1$I$$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138964$AMGEN$$$$$$Y$$$20240713$$PH$US$US
240871362$24087136$2$F$20240702$20240731$20240713$20240806$EXP$$US-JNJFOC-20240709503$JOHNSON AND JOHNSON$$80$YR$E$F$Y$66.1$KG$20240806$$PH$US$US
240871371$24087137$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204087$SANOFI AVENTIS$$$$A$$Y$$$20240713$$MD$US$US
240871381$24087138$1$I$20240101$20240709$20240713$20240713$PER$$US-SA-2024SA204352$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240713$$MD$US$US
240871392$24087139$2$F$20240627$20240807$20240713$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202407006445$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240812$$CN$US$US
240871401$24087140$1$I$$20240708$20240713$20240713$EXP$$US-JNJFOC-20240725500$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240713$$HP$US$US
240871421$24087142$1$I$$20240702$20240713$20240713$EXP$AU-TGA-804714$AU-Accord-433434$ACCORD$$48$YR$A$F$Y$$$20240713$$HP$AU$AU
240871431$24087143$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405011621428480-LFNSC$GB-TEVA-VS-3218025$TEVA$$$$$$Y$$$20240713$$PH$GB$GB
240871441$24087144$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405060334504350-VGMLK$GB-TORRENT-00037045$TORRENT$$$$$M$Y$$$20240713$$CN$GB$GB
240871451$24087145$1$I$20200101$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405061709515560-TKWQZ$GB-TORRENT-00037049$TORRENT$$$$$M$Y$69$KG$20240713$$CN$GB$GB
240871461$24087146$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405050006115470-JBWFT$GB-TORRENT-00037073$TORRENT$$$$$M$Y$42$KG$20240713$$CN$GB$GB
240871471$24087147$1$I$$20240701$20240713$20240713$EXP$$US-TORRENT-00013668$TORRENT$$86$YR$E$F$Y$$$20240713$$CN$US$US
240871481$24087148$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202407041136045490-HKLQD$GB-TORRENT-00037063$TORRENT$$$$$M$Y$70$KG$20240713$$CN$GB$GB
240871491$24087149$1$I$$20240703$20240713$20240713$EXP$GB-MHRA-DEFECT-202406221311545970-BHSNJ$GB-TORRENT-00037047$TORRENT$$$$$F$Y$$$20240713$$CN$GB$GB
240871501$24087150$1$I$$20240701$20240713$20240713$EXP$CA-MHPD-E2B_06684153$CA-Accord-399647$ACCORD$$44$YR$A$F$Y$97$KG$20240713$$HP$CA$CA
240871511$24087151$1$I$20100101$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405011158072330-YRBMF$GB-TORRENT-00037017$TORRENT$$$$$$Y$$$20240713$$CN$GB$GB
240871521$24087152$1$I$20240424$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405022233422160-QCRDZ$GB-TORRENT-00037038$TORRENT$$59$YR$A$F$Y$80$KG$20240713$$CN$GB$GB
240871531$24087153$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA203360$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240713$$MD$US$US
240871541$24087154$1$I$20240710$20240710$20240713$20240713$PER$$US-SA-2024SA204773$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240713$$CN$US$US
240871551$24087155$1$I$20240101$20240708$20240713$20240713$EXP$$US-SA-2024SA204735$SANOFI AVENTIS$$50$YR$A$F$Y$63.5$KG$20240713$$MD$US$US
240871561$24087156$1$I$20240703$20240704$20240713$20240713$EXP$GB-MHRA-MED-202407041459345310-HBWCZ$GB-TEVA-VS-3218027$TEVA$$58$YR$$F$Y$$$20240713$$HP$GB$GB
240871571$24087157$1$I$20240127$20240709$20240713$20240713$EXP$$AU-TAKEDA-2024TUS008718$TAKEDA$$42$YR$$M$Y$$$20240713$$CN$AU$AU
240871581$24087158$1$I$$20240704$20240713$20240713$EXP$$GR-TEVA-VS-3219029$TEVA$$78$YR$$F$Y$$$20240713$$MD$GR$GR
240871592$24087159$2$F$$20240730$20240713$20240808$EXP$$US-SA-2024SA203547$SANOFI AVENTIS$$$$A$F$Y$106.59$KG$20240808$$MD$US$US
240871602$24087160$2$F$$20240808$20240713$20240812$EXP$$CN-TAKEDA-2024TUS070680$TAKEDA$$$$$F$Y$$$20240812$$CN$CN$CN
240871612$24087161$2$F$20240101$20240806$20240713$20240813$PER$$US-SA-2024SA204749$SANOFI AVENTIS$$39$YR$A$M$Y$102.05$KG$20240814$$MD$US$US
240871621$24087162$1$I$$20240709$20240713$20240713$EXP$$DE-SA-2024SA205080$SANOFI AVENTIS$$$$A$M$Y$$$20240713$$MD$DE$DE
240871632$24087163$2$F$20240905$20240919$20240713$20240926$EXP$$US-SA-2024SA204880$SANOFI AVENTIS$$79$YR$E$F$Y$77.1$KG$20240926$$MD$US$US
240871641$24087164$1$I$20240607$20240703$20240713$20240713$EXP$CN-NMPACDR-3412261024136202400368$CN-BAXTER-2024BAX021229$BAXTER$$54$YR$$F$Y$60$KG$20240713$$MD$CN$CN
240871651$24087165$1$I$$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138039$AMGEN$$$$$F$Y$$$20240713$$CN$US$US
240871661$24087166$1$I$20240710$20240711$20240713$20240713$PER$$US-AMGEN-USASP2024138863$AMGEN$$$$$$Y$$$20240713$$HP$US$US
240871671$24087167$1$I$$20240704$20240713$20240713$EXP$$LT-TEVA-VS-3219214$TEVA$$48$YR$$M$Y$$$20240713$$MD$LT$LT
240871681$24087168$1$I$20240403$20240708$20240713$20240713$EXP$DE-BFARM-24002570$DE-RDY-SPO/DEU/24/0010152$DR REDDYS$$42$YR$A$M$Y$64$KG$20240713$$MD$DE$DE
240871691$24087169$1$I$$20240702$20240713$20240713$EXP$$US-RDY-LIT/USA/24/0009970$DR REDDYS$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. American Journal of Transplantation. 2011 Mar;11(3): 500-510. doi:10.1111/j.1600-6143.2010.03414.x.$47$YR$A$F$Y$$$20240713$$HP$US$US
240871702$24087170$2$F$$20240715$20240713$20240722$PER$$NVSC2024US143618$NOVARTIS$$$$$F$Y$$$20240722$$CN$US$US
240871711$24087171$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405060721540350-JFMKW$GB-TEVA-VS-3218274$TEVA$$$$$M$Y$82$KG$20240713$$CN$GB$GB
240871721$24087172$1$I$$20240702$20240713$20240713$EXP$$US-RDY-LIT/USA/24/0009973$DR REDDYS$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. American Journal of Transplantation. 2011 Mar;11(3): 500-510. doi:10.1111/j.1600-6143.2010.03414.x.$58$YR$A$M$Y$$$20240713$$HP$US$US
240871731$24087173$1$I$$20240702$20240713$20240713$EXP$$US-RDY-LIT/USA/24/0009972$DR REDDYS$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. American Journal of Transplantation. 2011 Mar;11(3): 500-510. doi:10.1111/j.1600-6143.2010.03414.x.$61$YR$A$M$Y$$$20240713$$HP$US$US
240871742$24087174$2$F$20240711$20240711$20240713$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008157$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240715$$CN$US$US
240871751$24087175$1$I$20240422$20240704$20240713$20240713$EXP$FR-AFSSAPS-RE2024000621$FR-TEVA-VS-3217621$TEVA$$67$YR$$M$Y$85$KG$20240713$$MD$FR$FR
240871761$24087176$1$I$20240613$20240710$20240713$20240713$EXP$$US-TAKEDA-2023TUS068766$TAKEDA$$80$YR$$M$Y$$$20240713$$CN$US$US
240871771$24087177$1$I$$20240704$20240713$20240713$EXP$GB-MHRA-MED-202405071551083640-FNBDP$GB-TEVA-VS-3218617$TEVA$$$$$M$Y$85$KG$20240713$$CN$GB$GB
240871781$24087178$1$I$20240505$20240704$20240713$20240713$EXP$FR-AFSSAPS-AVCF2024000416$FR-TEVA-VS-3217474$TEVA$$32$YR$$M$Y$$$20240713$$MD$FR$FR
240871791$24087179$1$I$20240528$20240704$20240713$20240713$EXP$ES-AEMPS-1540696$ES-TEVA-VS-3217541$TEVA$$56$YR$$F$Y$75$KG$20240713$$MD$ES$ES
240871801$24087180$1$I$$20240702$20240713$20240713$EXP$$US-RDY-LIT/USA/24/0009983$DR REDDYS$Fan J, Thanedar S, Ovechko V, Jana B. Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers. Case Reports in Oncology. 2024;17(1): 517-523. doi:10.1159/000536571.$56$YR$A$M$Y$$$20240713$$HP$US$US
240871811$24087181$1$I$$20240620$20240713$20240713$PER$$US-JNJFOC-20240665972$JOHNSON AND JOHNSON$$$$$$Y$$$20240713$$CN$US$US
240871821$24087182$1$I$$20240703$20240713$20240713$EXP$$US-TEVA-VS-3217857$TEVA$$65$YR$$F$Y$$$20240713$$CN$US$US
240871831$24087183$1$I$20240706$20240708$20240713$20240713$EXP$$NVSC2024IN142890$NOVARTIS$$77$YR$$M$Y$$$20240713$$CN$IN$IN
240871841$24087184$1$I$20221220$20240710$20240713$20240713$EXP$$CA-TAKEDA-2024TUS070993$TAKEDA$$51$YR$$F$Y$$$20240713$$CN$CA$CA
240871851$24087185$1$I$20240623$20240711$20240713$20240713$EXP$$CN-TAKEDA-2024TUS036605$TAKEDA$$57$YR$$F$Y$$$20240713$$CN$CN$CN
240871862$24087186$2$F$$20240722$20240713$20240731$EXP$$PT-TEVA-VS-3217352$TEVA$Sousa BSGC, de Sa ZC, Ramos J. Decoding the enigma: Valproate encephalopathy in a bipolar affective disorder without hyperammonemia. Bipolar-Disord 2024;.; Sousa BSGC, de Sa ZC, Ramos J. Decoding the enigma: Valproate encephalopathy in a bipolar affective disorder without hyperammonemia. Bipolar-Disord 2024;.$63$YR$$F$Y$$$20240731$$HP$PT$PT
240871871$24087187$1$I$$20240708$20240713$20240713$PER$$US-ALXN-202407USA000479US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240713$$CN$US$US
240871881$24087188$1$I$20240625$20240705$20240713$20240713$PER$$US-SA-2024SA204013$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240713$$MD$US$US
240871892$24087189$2$F$$20240722$20240713$20240731$EXP$$US-TEVA-VS-3217681$TEVA$Yeates AC, Monroe IA, Ahmad F. Fungal Duo: A Case of Disseminated Histoplasmosis and Pneumocystis Pneumonia Competing for the Spotlight. Am-J-Respir-Crit-Care-Med 2024; 209.; Yeates AC, Monroe IA, Ahmad F. Fungal Duo: A Case of Disseminated Histoplasmosis and Pneumocystis Pneumonia Competing for the Spotlight. Am-J-Respir-Crit-Care-Med 2024; 209.$66$YR$$M$Y$$$20240731$$HP$US$US
240871901$24087190$1$I$20240401$20240708$20240713$20240713$PER$$US-SA-2024SA203214$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240713$$MD$US$US
240871911$24087191$1$I$20240101$20240708$20240713$20240713$PER$$US-SA-2024SA204198$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240713$$MD$US$US
240871921$24087192$1$I$$20240708$20240713$20240713$PER$$US-ALXN-202407USA000535US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240713$$CN$US$US
240871932$24087193$2$F$$20240722$20240713$20240731$EXP$$US-TEVA-VS-3217729$TEVA$Mahmoud A, Le C, Kurt O, Zoarob D, Ayaz S. An Unsettling Twist: Unveiling Acute Hyponatremia Induced by Linezolid: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209.; Mahmoud A, Le C, Kurt O, Zoarob D, Ayaz S. An Unsettling Twist: Unveiling Acute Hyponatremia Induced by Linezolid: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209.$88$YR$$F$Y$$$20240731$$HP$US$US
240871942$24087194$2$F$$20240722$20240713$20240731$EXP$$US-TEVA-VS-3217725$TEVA$Shah S, OSullivan MM. Psoriasiform Dermatitis During Dupilumab Treatment in Asthma and Allergic Bronchopulmonary Aspergillosis (ABPA). Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.; Shah S, OSullivan MM. Psoriasiform Dermatitis During Dupilumab Treatment in Asthma and Allergic Bronchopulmonary Aspergillosis (ABPA). Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.$68$YR$$F$Y$$$20240731$$HP$US$US
240871951$24087195$1$I$20240101$20240708$20240713$20240713$EXP$$AU-JNJFOC-20240720456$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240713$$CN$AU$AU
240871961$24087196$1$I$20240703$20240710$20240713$20240713$PER$$US-AMGEN-USASP2024137377$AMGEN$$66$YR$E$F$Y$$$20240713$$CN$US$US
240871971$24087197$1$I$$20240618$20240713$20240713$PER$$US-JNJFOC-20240653278$JOHNSON AND JOHNSON$$$$$M$Y$$$20240713$$CN$US$US
240871992$24087199$2$F$$20240722$20240713$20240731$EXP$$CN-TEVA-VS-3216312$TEVA$Bo Y, Zhong X, Xiang Y, Ren Q, Hao P. Death Caused by Disseminated Herpes Zoster in a Patient with Multiple Myeloma: A Case Report and Literature Review. Clin-Cosmet-Invest-Dermatol 2024; 17 941-951.; Bo Y, Zhong X, Xiang Y, Ren Q, Hao P. Death Caused by Disseminated Herpes Zoster in a Patient with Multiple Myeloma: A Case Report and Literature Review. Clin-Cosmet-Invest-Dermatol 2024; 17 941-951.; Bo Y, Zhong X, Xiang Y, Ren Q, Hao P. Death Caused by Disseminated Herpes Zoster in a Patient w...$58$YR$$M$Y$$$20240731$$HP$CN$CN
240872002$24087200$2$F$$20240724$20240713$20240802$EXP$$US-TEVA-VS-3218679$TEVA$Williams LA, Adamski J, Kinard TN, Ertz-Archambault NM, Lu Q, Gray K, et al. The first reported use of red blood cell exchange to treat hemoglobin Evans with secondary methemoglobinemia. J-Clin-Apheresis 2023; 38 755-759.; Williams LA, Adamski J, Kinard TN, Ertz-Archambault NM, Lu Q, Gray K, et al. The first reported use of red blood cell exchange to treat hemoglobin Evans with secondary methemoglobinemia. J-Clin-Apheresis 2023; 38 755-759.$60$YR$$M$Y$$$20240802$$MD$US$US
240872012$24087201$2$F$$20240722$20240713$20240731$EXP$$IT-TEVA-VS-3216922$TEVA$Costantini I, Mantelli G, Carollo M, Losso L, Morando E, Bacchion M, et al. Not only Van Gogh: a case of BRASH syndrome with concomitant digoxin toxicity. J-Med-Case-Rep 2024; 18 (1): 273.; Costantini I, Mantelli G, Carollo M, Losso L, Morando E, Bacchion M, et al. Not only Van Gogh: a case of BRASH syndrome with concomitant digoxin toxicity. J-Med-Case-Rep 2024; 18 (1): 273.; Costantini I, Mantelli G, Carollo M, Losso L, Morando E, Bacchion M, et al. Not only Van Gogh: a case of BRASH syndro...$66$YR$$F$Y$$$20240731$$HP$IT$IT
240872021$24087202$1$I$$20240709$20240713$20240713$EXP$$US-ALXN-202407USA000578US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240713$$CN$US$US
240872031$24087203$1$I$$20240621$20240713$20240713$PER$$US-JNJFOC-20240661909$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240713$$CN$US$US
240872042$24087204$2$F$$20240722$20240713$20240731$EXP$$US-TEVA-VS-3217686$TEVA$Baik D, Alghanim F, Bird K. Status Asthmaticus: Impact of Abrupt Cessation of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis Management. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster) abstr. A5997.; Baik D, Alghanim F, Bird K. Status Asthmaticus: Impact of Abrupt Cessation of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis Management. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster) abstr. A5997.$28$YR$$M$Y$$$20240731$$HP$US$US
240872051$24087205$1$I$$20240709$20240713$20240713$PER$$US-AstraZeneca-2024A157633$ASTRAZENECA$$$$$M$Y$$$20240713$$HP$US$
240872066$24087206$6$F$20240122$20240918$20240713$20240925$EXP$$DE-SA-2024SA120295$SANOFI AVENTIS$$76$YR$E$M$Y$65$KG$20240925$$MD$DE$DE
240872072$24087207$2$F$$20240724$20240713$20240802$EXP$$US-TEVA-VS-3218680$TEVA$Treacy T, Taylor J, Philpotts YF. A Case of Fatal Asthma Exacerbation Leading to Cardiac Arrest. Am-J-Respir-Crit-Care-Med 2024; 209.; Treacy T, Taylor J, Philpotts YF. A Case of Fatal Asthma Exacerbation Leading to Cardiac Arrest. Am-J-Respir-Crit-Care-Med 2024; 209.$38$YR$$F$Y$$$20240802$$HP$US$US
240872081$24087208$1$I$$20240709$20240713$20240713$PER$$US-SA-2024SA203830$SANOFI AVENTIS$$$$$$Y$$$20240713$$CN$US$US
240872091$24087209$1$I$20240701$20240710$20240713$20240713$PER$$US-ALXN-202407USA000611US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240713$$CN$US$US
240872101$24087210$1$I$20240623$20240710$20240713$20240713$EXP$$US-ABBVIE-5836858$ABBVIE$$83$YR$$M$Y$$$20240713$$CN$US$US
240872111$24087211$1$I$$20240623$20240713$20240713$PER$$US-JNJFOC-20240665909$JOHNSON AND JOHNSON$$$$$$Y$$$20240713$$CN$US$US
240872121$24087212$1$I$$20240623$20240713$20240713$PER$$US-JNJFOC-20240665042$JOHNSON AND JOHNSON$$$$$$Y$$$20240713$$CN$US$US
240872132$24087213$2$F$$20240806$20240713$20240807$PER$$US-ALXN-202407USA000592US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
240872141$24087214$1$I$$20240708$20240713$20240713$PER$$US-AstraZeneca-2024A156713$ASTRAZENECA$$$$$$Y$$$20240714$$CN$US$
240872153$24087215$3$F$$20240805$20240713$20240806$PER$$US-ALXN-202407USA000617US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240872161$24087216$1$I$$20240709$20240713$20240713$PER$$US-ALXN-202407USA000631US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240713$$CN$US$US
240872171$24087217$1$I$$20240710$20240713$20240713$PER$$US-AstraZeneca-2024A158594$ASTRAZENECA$$$$$F$Y$$$20240714$$CN$US$
240872181$24087218$1$I$20240601$20240709$20240713$20240713$PER$$US-SA-2024SA204531$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240714$$MD$US$US
240872201$24087220$1$I$$20240710$20240713$20240713$EXP$$NVSC2024US143759$NOVARTIS$$$$$M$Y$$$20240714$$MD$US$US
240872212$24087221$2$F$20240101$20240724$20240713$20240801$PER$$US-SA-2024SA204808$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240801$$MD$US$US
240872221$24087222$1$I$$20240708$20240713$20240713$PER$$US-SA-2024SA204573$SANOFI AVENTIS$$$$E$M$Y$$$20240714$$MD$US$US
240872232$24087223$2$F$20240101$20240809$20240713$20240820$PER$$US-SA-2024SA204607$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240820$$MD$US$US
240872242$24087224$2$F$20240101$20240730$20240713$20240808$PER$$US-SA-2024SA204548$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240808$$MD$US$US
240872251$24087225$1$I$20230101$20240708$20240713$20240713$PER$$US-SA-2024SA204737$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240714$$MD$US$US
240872261$24087226$1$I$20240615$20240701$20240714$20240714$EXP$GB-MHRA-MED-202406290731408350-JDBNM$GB-GLENMARK PHARMACEUTICALS-2024GMK092080$GLENMARK$$$$$$Y$$$20240714$$CN$GB$GB
240872271$24087227$1$I$$20240710$20240714$20240714$PER$$US-SA-2024SA204804$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240714$$MD$US$US
240872281$24087228$1$I$20240101$20240709$20240714$20240714$PER$$US-SA-2024SA205107$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240714$$MD$US$US
240872291$24087229$1$I$$20240709$20240714$20240714$PER$$US-AstraZeneca-2024A158431$ASTRAZENECA$$90$YR$$M$Y$$$20240714$$HP$US$
240872301$24087230$1$I$$20240711$20240714$20240714$PER$$US-AMGEN-USASP2024138722$AMGEN$$$$$F$Y$$$20240713$$CN$US$US
240872313$24087231$3$F$20240707$20240802$20240714$20240806$PER$$US-AMGEN-USASP2024138728$AMGEN$$58$YR$A$M$Y$$$20240806$$CN$US$US
240872321$24087232$1$I$$20240711$20240714$20240714$PER$$US-AMGEN-USASP2024138913$AMGEN$$$$$$Y$$$20240713$$PH$US$US
240872331$24087233$1$I$$20240701$20240714$20240714$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092128$GLENMARK$$$$$$Y$$$20240714$$CN$US$US
240872343$24087234$3$F$20240621$20240815$20240714$20240829$PER$$US-SA-2024SA204994$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240829$$MD$US$US
240872351$24087235$1$I$$20240710$20240714$20240714$PER$$US-SA-2024SA204706$SANOFI AVENTIS$$$$A$M$Y$$$20240714$$MD$US$US
240872362$24087236$2$F$20240703$20240722$20240714$20240724$EXP$$US-JNJFOC-20240721488$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240724$$MD$US$US
240872371$24087237$1$I$20240328$20240704$20240714$20240714$EXP$FR-AFSSAPS-LY2024000851$FR-TEVA-VS-3217612$TEVA$$62$YR$$F$Y$63$KG$20240714$$MD$FR$FR
240872381$24087238$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA203987$SANOFI AVENTIS$$$$A$M$Y$$$20240714$$MD$US$US
240872391$24087239$1$I$20240301$20240708$20240714$20240714$PER$$US-SA-2024SA204816$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240714$$MD$US$US
240872401$24087240$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA201263$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240714$$MD$US$US
240872411$24087241$1$I$$20240702$20240714$20240714$EXP$$LK-DEXPHARM-2024-2191$DEXCEL$Abeyagunawardena I; Madurapperuma C; Thuvarakan P; Thowfeek Z; Sujeewa N; Katulanda G; Karunatilake H. Uncommon triggers of insulin autoimmune syndrome: a case report. Journal of medical case reports, (2024 Jun 27) Vol. 18, No. 1, pp. 292. Electronic Publication Date: 27 Jun 2024 Journal code: 101293382. E-ISSN: 1752-1947. L-ISSN: 1752-1947. Report No.: PMC-PMC11210015. DOI  http://dx.doi.org/10.1186/s13256-024-04616-x$67$YR$E$M$Y$$$20240714$$HP$LK$LK
240872422$24087242$2$F$$20240821$20240714$20240830$PER$$US-AstraZeneca-2024A158410$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
240872431$24087243$1$I$20240328$20240712$20240714$20240714$EXP$IT-MINISAL02-991345$IT-ROCHE-10000025446$ROCHE$$32$YR$A$F$Y$$$20240714$$MD$IT$IT
240872441$24087244$1$I$$20240710$20240714$20240714$PER$$US-SA-2024SA204619$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240714$$MD$US$US
240872451$24087245$1$I$$20240704$20240714$20240714$EXP$GB-MHRA-MED-202407031223555360-VGDJB$GB-DEXPHARM-2024-2197$DEXCEL$$$$$$Y$$$20240714$$HP$GB$GB
240872461$24087246$1$I$20240601$20240709$20240714$20240714$PER$$US-SA-2024SA205009$SANOFI AVENTIS$$7$MON$I$M$Y$$$20240714$$MD$US$US
240872471$24087247$1$I$20210201$20240707$20240714$20240714$EXP$GB-MHRA-MED-202407051337161390-LVTDW$GB-DEXPHARM-2024-2263$DEXCEL$$84$YR$E$F$Y$66$KG$20240714$$PH$GB$GB
240872481$24087248$1$I$$20240708$20240714$20240714$PER$$US-ALXN-202407USA000591US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240714$$CN$US$US
240872491$24087249$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA205150$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240714$$MD$US$US
240872511$24087251$1$I$$20240705$20240714$20240714$PER$$US-SA-2024SA200517$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240714$$MD$US$US
240872521$24087252$1$I$20240301$20240710$20240714$20240714$PER$$US-SA-2024SA205185$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240714$$CN$US$US
240872531$24087253$1$I$20240617$20240701$20240714$20240714$EXP$DE-AMK-276934$DE-DEXPHARM-2024-2321$DEXCEL$$68$YR$E$M$Y$73$KG$20240714$$PH$DE$DE
240872541$24087254$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA204870$SANOFI AVENTIS$$$$A$M$Y$$$20240714$$MD$US$US
240872551$24087255$1$I$20240101$20240709$20240714$20240714$PER$$US-SA-2024SA205021$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240714$$MD$US$US
240872561$24087256$1$I$20240101$20240708$20240714$20240714$PER$$US-SA-2024SA205018$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240714$$MD$US$US
240872573$24087257$3$F$20220301$20240726$20240714$20240730$PER$$US-AMGEN-USASP2024135625$AMGEN$$3$YR$C$M$Y$$$20240730$$MD$US$US
240872581$24087258$1$I$$20240709$20240714$20240714$PER$$US-ALXN-202407USA000590US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240714$$CN$US$US
240872591$24087259$1$I$20220101$20240703$20240714$20240714$EXP$$JP-AMGEN-JPNSP2024139539$AMGEN$$69$YR$E$M$Y$$$20240713$$MD$JP$JP
240872601$24087260$1$I$$20240705$20240714$20240714$PER$$US-SA-2024SA203115$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240714$$CN$US$US
240872611$24087261$1$I$$20240710$20240714$20240714$EXP$$US-ROCHE-10000023167$ROCHE$$$$A$M$Y$$$20240714$$CN$US$US
240872621$24087262$1$I$20240704$20240710$20240714$20240714$EXP$$US-ROCHE-10000023960$ROCHE$$57$YR$A$M$Y$$$20240714$$MD$US$US
240872633$24087263$3$F$20240101$20240815$20240714$20240827$EXP$$JP-AMGEN-JPNSP2024139529$AMGEN$$58$YR$A$M$Y$70.8$KG$20240827$$MD$JP$JP
240872641$24087264$1$I$20240101$20240705$20240714$20240714$PER$$US-SA-2024SA204234$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240714$$MD$US$US
240872651$24087265$1$I$20240625$20240709$20240714$20240714$PER$$US-SA-2024SA203737$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240714$$CN$US$US
240872661$24087266$1$I$$20240709$20240714$20240714$PER$$US-ALXN-202407USA000586US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240714$$CN$US$US
240872672$24087267$2$F$$20240729$20240714$20240805$PER$$US-ALXN-202407USA000619US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
240872682$24087268$2$F$20240628$20240823$20240714$20240902$PER$$US-AstraZeneca-2024A158329$ASTRAZENECA$$28978$DY$$F$Y$$$20240902$$CN$US$
240872691$24087269$1$I$20231110$20240704$20240714$20240714$EXP$GB-MHRA-MED-202407022337350880-HWTLS$GB-DEXPHARM-2024-2168$DEXCEL$$39$YR$A$F$Y$$$20240714$$CN$GB$GB
240872701$24087270$1$I$20240601$20240709$20240714$20240714$PER$$US-SA-2024SA204653$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240714$$MD$US$US
240872711$24087271$1$I$$20240709$20240714$20240714$EXP$$US-ROCHE-10000022756$ROCHE$$79$YR$E$F$Y$$$20240714$$CN$US$US
240872721$24087272$1$I$20220101$20240709$20240714$20240714$PER$$US-SA-2024SA205112$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240714$$MD$US$US
240872731$24087273$1$I$$20240704$20240714$20240714$EXP$$IL-ROCHE-10000021535$ROCHE$$$$E$F$Y$$$20240714$$CN$IL$IL
240872751$24087275$1$I$20240101$20240708$20240714$20240714$PER$$US-SA-2024SA203448$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240714$$MD$US$US
240872761$24087276$1$I$20240101$20240708$20240714$20240714$PER$$US-SA-2024SA205103$SANOFI AVENTIS$$85$YR$E$F$Y$48.5$KG$20240714$$MD$US$US
240872771$24087277$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA205171$SANOFI AVENTIS$$$$A$F$Y$91.62$KG$20240714$$MD$US$US
240872782$24087278$2$F$20191210$20240731$20240714$20240807$EXP$$JP-ROCHE-10000022757$ROCHE$$5$DEC$A$F$Y$$$20240807$$MD$JP$JP
240872792$24087279$2$F$$20240730$20240714$20240806$EXP$$JP-ROCHE-10000019834$ROCHE$$$$A$$Y$$$20240806$$MD$JP$JP
240872801$24087280$1$I$$20240703$20240714$20240714$EXP$$JP-ROCHE-10000019459$ROCHE$$8$DEC$E$F$Y$$$20240714$$PH$JP$JP
240872811$24087281$1$I$$20240710$20240714$20240714$PER$$US-SA-2024SA205074$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240714$$HP$US$US
240872821$24087282$1$I$20240404$20240707$20240714$20240714$EXP$GB-MHRA-MED-202405082112016330-ZDTVB$GB-DEXPHARM-2024-2232$DEXCEL$$24$YR$A$F$Y$65$KG$20240714$$CN$GB$GB
240872832$24087283$2$F$$20240724$20240714$20240730$EXP$$US-JNJFOC-20240664672$JOHNSON AND JOHNSON$$$$$M$Y$62.7$KG$20240730$$HP$US$US
240872841$24087284$1$I$$20240709$20240714$20240714$EXP$$US-JNJFOC-20240723082$JOHNSON AND JOHNSON$$$$$F$Y$$$20240714$$CN$US$US
240872851$24087285$1$I$20240101$20240708$20240714$20240714$EXP$$US-SA-2024SA196833$SANOFI AVENTIS$$65$YR$E$M$Y$111.13$KG$20240714$$MD$US$US
240872861$24087286$1$I$20240501$20240708$20240714$20240714$PER$$US-SA-2024SA205213$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240714$$CN$US$US
240872871$24087287$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA205070$SANOFI AVENTIS$$$$$$Y$$$20240714$$MD$US$US
240872881$24087288$1$I$20240601$20240708$20240714$20240714$EXP$$CA-JNJFOC-20240724287$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240714$$HP$CA$CA
240872891$24087289$1$I$20240101$20240708$20240714$20240714$PER$$US-SA-2024SA205035$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240714$$MD$US$US
240872901$24087290$1$I$20240101$20240705$20240714$20240714$PER$$US-SA-2024SA203070$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240714$$MD$US$US
240872911$24087291$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA205031$SANOFI AVENTIS$$$$I$M$Y$$$20240714$$MD$US$US
240872921$24087292$1$I$20240101$20240705$20240714$20240714$PER$$US-SA-2024SA201268$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240714$$MD$US$US
240872931$24087293$1$I$$20240705$20240714$20240714$PER$$US-JNJFOC-20240717613$JOHNSON AND JOHNSON$$$$$F$Y$$$20240714$$CN$US$US
240872941$24087294$1$I$20240706$20240708$20240714$20240714$PER$$US-SA-2024SA203490$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240714$$CN$US$US
240872951$24087295$1$I$$20240705$20240714$20240714$PER$$US-SA-2024SA204056$SANOFI AVENTIS$$$$A$F$Y$73.48$KG$20240714$$MD$US$US
240872961$24087296$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA201683$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240714$$MD$US$US
240872972$24087297$2$F$20240601$20240710$20240714$20240723$EXP$$SE-AUROBINDO-AUR-APL-2024-033428$AUROBINDO$$43$YR$$M$Y$$$20240719$$HP$SE$SE
240872991$24087299$1$I$$20240705$20240714$20240714$EXP$$US-JNJFOC-20240715167$JOHNSON AND JOHNSON$$$$$M$Y$$$20240714$$CN$US$US
240873001$24087300$1$I$20240303$20240704$20240714$20240714$EXP$$FR-AUROBINDO-AUR-APL-2024-033399$AUROBINDO$$77$YR$$F$Y$80$KG$20240714$$PH$FR$FR
240873011$24087301$1$I$$20240626$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06292$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240873021$24087302$1$I$20231030$20240704$20240714$20240714$EXP$$IT-AUROBINDO-AUR-APL-2024-033250$AUROBINDO$$67$YR$$F$Y$$$20240714$$MD$IT$IT
240873031$24087303$1$I$$20240626$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06275$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240873041$24087304$1$I$$20240704$20240714$20240714$EXP$$GB-AUROBINDO-AUR-APL-2024-033273$AUROBINDO$$$$A$F$Y$$$20240714$$CN$GB$GB
240873051$24087305$1$I$$20240626$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06416$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240873061$24087306$1$I$20240627$20240704$20240714$20240714$EXP$$FR-AUROBINDO-AUR-APL-2024-033451$AUROBINDO$$50$YR$$M$Y$82$KG$20240714$$HP$FR$FR
240873071$24087307$1$I$20240319$20240704$20240714$20240714$EXP$$FR-AUROBINDO-AUR-APL-2024-033455$AUROBINDO$$47$YR$$M$Y$$$20240714$$MD$FR$FR
240873083$24087308$3$F$$20240826$20240714$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06454$LUPIN$$$$$$Y$$$20240916$$CN$US$US
240873091$24087309$1$I$$20240627$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06460$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240873101$24087310$1$I$$20240705$20240714$20240714$PER$$US-JNJFOC-20240715051$JOHNSON AND JOHNSON$$$$$$Y$$$20240714$$CN$US$US
240873111$24087311$1$I$$20240701$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06492$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240873122$24087312$2$F$$20240716$20240714$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05860$LUPIN$$$$$$Y$$$20240806$$CN$US$US
240873131$24087313$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA202939$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240714$$HP$US$US
240873141$24087314$1$I$20240601$20240708$20240714$20240714$PER$$US-SA-2024SA205020$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240714$$MD$US$US
240873151$24087315$1$I$$20240710$20240714$20240714$PER$$US-SA-2024SA203781$SANOFI AVENTIS$$$$A$M$Y$$$20240714$$HP$US$US
240873161$24087316$1$I$$20240626$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05810$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240873172$24087317$2$F$20240601$20240730$20240714$20240801$EXP$$US-JNJFOC-20240723364$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240801$$CN$US$US
240873191$24087319$1$I$$20240708$20240714$20240714$EXP$$US-SA-2024SA202445$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240714$$CN$US$US
240873202$24087320$2$F$$20240814$20240714$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06370$LUPIN$$$$$$Y$$$20240901$$CN$US$US
240873211$24087321$1$I$$20240626$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06453$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240873222$24087322$2$F$20230321$20240812$20240714$20240821$PER$$US-SA-2024SA204942$SANOFI AVENTIS$$73$YR$E$M$Y$63.5$KG$20240821$$CN$US$US
240873232$24087323$2$F$$20240826$20240714$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06326$LUPIN$$$$$$Y$$$20240913$$CN$US$US
240873242$24087324$2$F$$20240709$20240714$20240718$EXP$$CA-JNJFOC-20240630392$JOHNSON AND JOHNSON$$18$YR$A$M$Y$57$KG$20240718$$HP$CA$CA
240873251$24087325$1$I$20240708$20240711$20240714$20240714$PER$$US-AMGEN-USASP2024139232$AMGEN$$68$YR$E$F$Y$$$20240714$$CN$US$US
240873261$24087326$1$I$$20240626$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06305$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240873271$24087327$1$I$$20240626$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05808$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240873282$24087328$2$F$$20240710$20240714$20240718$PER$$US-SA-2024SA204568$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240718$$MD$US$US
240873292$24087329$2$F$20240630$20240911$20240714$20240919$PER$$US-SA-2024SA201550$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240919$$MD$US$US
240873302$24087330$2$F$$20240716$20240714$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05864$LUPIN$$$$$$Y$$$20240806$$CN$US$US
240873311$24087331$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA204922$SANOFI AVENTIS$$$$E$F$Y$$$20240714$$MD$US$US
240873322$24087332$2$F$$20240731$20240714$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05865$LUPIN$$$$$$Y$$$20240818$$CN$US$US
240873331$24087333$1$I$$20240710$20240714$20240714$PER$$US-AMGEN-USASP2024138365$AMGEN$$$$$$Y$$$20240714$$HP$US$US
240873341$24087334$1$I$$20240711$20240714$20240714$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039322$BOEHRINGER INGELHEIM$$60$YR$A$M$Y$$$20240714$$HP$US$US
240873351$24087335$1$I$20240711$20240711$20240714$20240714$PER$$US-AMGEN-USASP2024139242$AMGEN$$72$YR$E$F$Y$$$20240714$$CN$US$US
240873362$24087336$2$F$$20240823$20240714$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05811$LUPIN$$$$$$Y$$$20240905$$CN$US$US
240873371$24087337$1$I$$20240626$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05895$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240873381$24087338$1$I$$20240711$20240714$20240714$EXP$$US-AstraZeneca-2024A159109$ASTRAZENECA$$$$$$Y$$$20240714$$MD$US$
240873392$24087339$2$F$20240101$20240906$20240714$20240928$PER$$US-SA-2024SA200648$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240928$$MD$US$US
240873402$24087340$2$F$20240506$20240709$20240714$20240716$EXP$FR-AFSSAPS-AN2024000875$FR-SA-2024SA201811$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240716$$PH$FR$FR
240873411$24087341$1$I$20240618$20240704$20240714$20240714$EXP$$DE-AUROBINDO-AUR-APL-2024-033427$AUROBINDO$$85$YR$$F$Y$52$KG$20240714$$MD$DE$DE
240873421$24087342$1$I$$20240708$20240714$20240714$PER$$US-JNJFOC-20240720286$JOHNSON AND JOHNSON$$$$$F$Y$$$20240714$$CN$US$US
240873432$24087343$2$F$20221201$20240720$20240714$20240730$EXP$$ES-AUROBINDO-AUR-APL-2024-033378$AUROBINDO$$82$YR$$F$Y$$$20240730$$MD$ES$ES
240873441$24087344$1$I$20240101$20240705$20240714$20240714$PER$$US-SA-2024SA201826$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240714$$MD$US$US
240873451$24087345$1$I$20250101$20240708$20240714$20240714$PER$$US-SA-2024SA203588$SANOFI AVENTIS$$$$A$F$Y$$$20240714$$MD$US$US
240873461$24087346$1$I$20240710$20240711$20240714$20240714$PER$$US-AMGEN-USASP2024139257$AMGEN$$63$YR$A$F$Y$$$20240714$$CN$US$US
240873471$24087347$1$I$$20240704$20240714$20240714$EXP$$PL-AUROBINDO-AUR-APL-2024-033543$AUROBINDO$BoroWczyk ZM, Pyszczorska M. Nursing management and care on an adolescent patient with pulmonary embolism - A case study. Pielegniarstwo polskie NR. 2024;2 (92):54-88$15$YR$$F$Y$$$20240714$$HP$PL$PL
240873481$24087348$1$I$20240707$20240709$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407006347$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240714$$CN$US$US
240873491$24087349$1$I$20240502$20240704$20240714$20240714$EXP$$ES-AUROBINDO-AUR-APL-2024-033410$AUROBINDO$$70$YR$$M$Y$$$20240714$$MD$ES$ES
240873501$24087350$1$I$20240705$20240709$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407006670$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240714$$CN$US$US
240873511$24087351$1$I$$20240704$20240714$20240714$EXP$$GB-AUROBINDO-AUR-APL-2024-033401$AUROBINDO$$$$$$Y$$$20240714$$PH$GB$GB
240873521$24087352$1$I$$20240711$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407007893$ELI LILLY AND CO$$$$$$Y$$$20240714$$HP$US$US
240873531$24087353$1$I$20240101$20240708$20240714$20240714$EXP$$US-SA-2024SA201717$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240714$$MD$US$US
240873541$24087354$1$I$20240626$20240704$20240714$20240714$EXP$$IT-AUROBINDO-AUR-APL-2024-033321$AUROBINDO$$74$YR$$F$Y$$$20240714$$PH$IT$IT
240873551$24087355$1$I$20240709$20240709$20240714$20240714$PER$$US-SA-2024SA205483$SANOFI AVENTIS$$$$$F$Y$$$20240714$$MD$US$US
240873561$24087356$1$I$$20240705$20240714$20240714$PER$$US-SA-2024SA200859$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240714$$CN$US$US
240873571$24087357$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA204231$SANOFI AVENTIS$$$$T$M$Y$$$20240714$$MD$US$US
240873581$24087358$1$I$$20240710$20240714$20240714$PER$$US-SA-2024SA205485$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240714$$MD$US$US
240873591$24087359$1$I$20240101$20240627$20240714$20240714$PER$$US-JNJFOC-20240676267$JOHNSON AND JOHNSON$$$$$F$Y$$$20240714$$CN$US$US
240873601$24087360$1$I$20240320$20240704$20240714$20240714$EXP$$IT-AUROBINDO-AUR-APL-2024-033619$AUROBINDO$$32$YR$$F$Y$$$20240714$$PH$IT$IT
240873611$24087361$1$I$$20240704$20240714$20240714$EXP$$GB-AUROBINDO-AUR-APL-2024-033522$AUROBINDO$$$$$$Y$$$20240714$$PH$GB$GB
240873621$24087362$1$I$20220712$20240708$20240714$20240714$EXP$$ES-JNJFOC-20240724085$JOHNSON AND JOHNSON$$34$YR$A$F$Y$66.9$KG$20240714$$MD$ES$ES
240873631$24087363$1$I$20240101$20240702$20240714$20240714$EXP$$DE-ACORDA-ACO_177136_2024$ACORDA$$$$$M$Y$$$20240714$$CN$DE$DE
240873641$24087364$1$I$20240101$20240705$20240714$20240714$PER$$US-SA-2024SA203652$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240714$$MD$US$US
240873651$24087365$1$I$$20240705$20240714$20240714$PER$$US-SA-2024SA201093$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240714$$CN$US$US
240873661$24087366$1$I$$20240711$20240714$20240714$PER$$US-AMGEN-USASP2024139286$AMGEN$$$$$$Y$$$20240714$$CN$US$US
240873671$24087367$1$I$20240101$20240704$20240714$20240714$EXP$$IL-JNJFOC-20240717648$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240714$$HP$IL$IL
240873681$24087368$1$I$20240601$20240708$20240714$20240714$PER$$US-SA-2024SA205255$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240714$$MD$US$US
240873691$24087369$1$I$$20240705$20240714$20240714$PER$$US-SA-2024SA201116$SANOFI AVENTIS$$$$$M$Y$$$20240714$$CN$US$US
240873701$24087370$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA205246$SANOFI AVENTIS$$$$E$M$Y$$$20240714$$CN$US$US
240873711$24087371$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA201899$SANOFI AVENTIS$$$$E$M$Y$$$20240714$$MD$US$US
240873722$24087372$2$F$20240710$20240819$20240714$20240822$PER$$US-AMGEN-USASP2024139290$AMGEN$$47$YR$A$M$Y$$$20240821$$CN$US$US
240873731$24087373$1$I$$20240711$20240714$20240714$EXP$GR-GREOF-202400648$GR-ROCHE-10000025519$ROCHE$$58$YR$A$M$Y$$$20240714$$MD$GR$GR
240873741$24087374$1$I$20240501$20240705$20240714$20240714$PER$$US-SA-2024SA201370$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240714$$CN$US$US
240873751$24087375$1$I$20240101$20240707$20240714$20240714$PER$$US-SA-2024SA201949$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240714$$MD$US$US
240873761$24087376$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA204481$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240714$$MD$US$US
240873771$24087377$1$I$20240710$20240711$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407007943$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240714$$CN$US$US
240873781$24087378$1$I$$20240701$20240714$20240714$PER$$US-SA-2024SA201793$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240714$$CN$US$US
240873791$24087379$1$I$$20240705$20240714$20240714$PER$$US-SA-2024SA201950$SANOFI AVENTIS$$$$A$M$Y$85.27$KG$20240714$$MD$US$US
240873803$24087380$3$F$20240101$20240830$20240714$20240906$PER$$US-SA-2024SA204070$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240906$$MD$US$US
240873811$24087381$1$I$20240601$20240705$20240714$20240714$PER$$US-SA-2024SA202222$SANOFI AVENTIS$$93$YR$E$F$Y$$$20240714$$MD$US$US
240873821$24087382$1$I$$20240711$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407008041$ELI LILLY AND CO$$90$YR$E$F$Y$$$20240714$$CN$US$US
240873833$24087383$3$F$$20240801$20240714$20240813$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06300$LUPIN$$$$$$Y$$$20240813$$MD$US$US
240873841$24087384$1$I$20240201$20240709$20240714$20240714$EXP$$HR-ROCHE-10000022182$ROCHE$$69$YR$E$F$Y$$$20240714$$MD$HR$HR
240873852$24087385$2$F$$20240708$20240714$20240721$EXP$$RU-ROCHE-10000022190$ROCHE$$28$YR$A$F$Y$$$20240721$$MD$RU$RU
240873862$24087386$2$F$20240619$20240802$20240714$20240806$PER$$US-AMGEN-USASP2024137513$AMGEN$$75$YR$E$M$Y$$$20240805$$HP$US$US
240873871$24087387$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA204176$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240714$$MD$US$US
240873881$24087388$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA202982$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240714$$MD$US$US
240873891$24087389$1$I$20240710$20240711$20240714$20240714$PER$$US-AMGEN-USASP2024138385$AMGEN$$$$$F$Y$$$20240714$$CN$US$US
240873901$24087390$1$I$20240101$20240705$20240714$20240714$PER$$US-SA-2024SA201074$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240714$$CN$US$US
240873911$24087391$1$I$20240706$20240712$20240714$20240714$PER$$US-BAYER-2024A100867$BAYER$$60$YR$A$F$Y$$$20240714$$CN$US$US
240873921$24087392$1$I$$20240626$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05807$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240873931$24087393$1$I$$20240705$20240714$20240714$EXP$GB-MHRA-MED-202405101722428740-NRBYG$GB-TORRENT-00037104$TORRENT$$$$$M$Y$$$20240714$$PH$GB$GB
240873942$24087394$2$F$$20240716$20240714$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05812$LUPIN$$$$$$Y$$$20240806$$CN$US$US
240873951$24087395$1$I$$20240704$20240714$20240714$EXP$GB-MHRA-MED-202405011700175730-BMCHD$GB-TORRENT-00037020$TORRENT$$6$YR$C$F$Y$$$20240714$$CN$GB$GB
240873961$24087396$1$I$20150601$20240704$20240714$20240714$EXP$GB-MHRA-MED-202405021518569640-TZGLF$GB-TORRENT-00037090$TORRENT$$38$YR$A$F$Y$$$20240714$$CN$GB$GB
240873971$24087397$1$I$20240415$20240705$20240714$20240714$EXP$GB-MHRA-MED-202405091555219880-GCYSP$GB-TORRENT-00037100$TORRENT$$7$YR$C$M$Y$63$KG$20240714$$HP$GB$GB
240873981$24087398$1$I$$20240705$20240714$20240714$EXP$GB-MHRA-MED-202405101423535400-WTCJS$GB-TORRENT-00037103$TORRENT$$$$$$Y$$$20240714$$HP$GB$GB
240873991$24087399$1$I$20240201$20240704$20240714$20240714$EXP$GB-MHRA-MED-202405040555034480-WJKLS$GB-TORRENT-00037076$TORRENT$$59$YR$A$M$Y$90$KG$20240714$$CN$GB$GB
240874001$24087400$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA203597$SANOFI AVENTIS$$$$T$M$Y$$$20240714$$CN$US$US
240874012$24087401$2$F$20240101$20240729$20240714$20240807$PER$$US-SA-2024SA202991$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240807$$MD$US$US
240874021$24087402$1$I$$20240704$20240714$20240714$EXP$$BE-TEVA-VS-3218057$TEVA$$60$YR$$M$Y$$$20240714$$MD$BE$BE
240874031$24087403$1$I$$20240627$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05963$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240874041$24087404$1$I$$20240626$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06439$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240874051$24087405$1$I$$20240701$20240714$20240714$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06137$LUPIN$Goudie MP, Khawam S, Levy JM, Hartfield R, Hassan S, Dawson M. A storm is brewing: a case of thyrotoxic crisis. American Journal of Respiratory and Critical Care Medicine. 2024;209: A3376:1-2$27$YR$$M$Y$$$20240714$$HP$US$US
240874061$24087406$1$I$20240501$20240702$20240714$20240714$EXP$$US-ACORDA-ACO_177501_2024$ACORDA$$71$YR$$M$Y$$$20240714$$CN$US$US
240874072$24087407$2$F$$20240814$20240714$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06467$LUPIN$$$$$$Y$$$20240901$$CN$US$US
240874081$24087408$1$I$$20240627$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05959$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240874091$24087409$1$I$20240621$20240712$20240714$20240714$PER$$US-AMGEN-USASP2024139395$AMGEN$$63$YR$A$F$Y$$$20240714$$CN$US$US
240874101$24087410$1$I$$20240627$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06498$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240874111$24087411$1$I$$20240627$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06519$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240874121$24087412$1$I$$20240704$20240714$20240714$EXP$$US-AUROBINDO-AUR-APL-2024-033407$AUROBINDO$Yan A, Gallardo M, Savu A, Kaffenberger B.. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management.. Archives of Dermatological Research.. 2024;316(7):397$47$YR$$M$Y$$$20240714$$HP$US$US
240874131$24087413$1$I$$20240627$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06501$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240874143$24087414$3$F$$20240820$20240714$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-033254$AUROBINDO$Peters MG, Apte N, Kalra DK. Wide Complex Tachycardia in a Middle-Aged Woman with Diarrhea. JAMA Cardiology Clinical Challenge. 2024;9 (6):582-3$7$DEC$$F$Y$$$20240902$$MD$US$US
240874151$24087415$1$I$$20240627$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06530$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240874161$24087416$1$I$$20240701$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06594$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240874171$24087417$1$I$20240701$20240708$20240714$20240714$PER$$US-SA-2024SA201918$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240714$$CN$US$US
240874182$24087418$2$F$20240712$20240715$20240714$20240716$PER$$US-AMGEN-USASP2024139399$AMGEN$$59$YR$A$M$Y$$$20240716$$CN$US$US
240874191$24087419$1$I$20240611$20240704$20240714$20240714$EXP$CN-NMPACDR-1410011048596202402633$CN-BAXTER-2024BAX021304$BAXTER$$59$YR$$F$Y$58$KG$20240714$$MD$CN$CN
240874201$24087420$1$I$20240626$20240704$20240714$20240714$EXP$CN-NMPACDR-3305231059403202400128$CN-BAXTER-2024BAX021291$BAXTER$$75$YR$$F$Y$54$KG$20240714$$MD$CN$CN
240874211$24087421$1$I$$20240704$20240714$20240714$EXP$$CA-BAXTER-2024BAX021166$BAXTER$$$$$$Y$$$20240714$$PH$CA$CA
240874221$24087422$1$I$20240629$20240704$20240714$20240714$EXP$CN-NMPACDR-4417811006654202400113$CN-BAXTER-2024BAX021295$BAXTER$$54$YR$$M$Y$61$KG$20240714$$MD$CN$CN
240874231$24087423$1$I$$20240704$20240714$20240714$EXP$$FR-AUROBINDO-AUR-APL-2024-033098$AUROBINDO$$87$YR$$M$Y$$$20240714$$MD$FR$FR
240874241$24087424$1$I$20240424$20240704$20240714$20240714$EXP$CN-NMPACDR-4602001068793202400094$CN-BAXTER-2024BAX021293$BAXTER$$45$YR$$F$Y$41$KG$20240714$$MD$CN$CN
240874252$24087425$2$F$20180830$20240821$20240714$20240830$EXP$$AU-BAXTER-2024BAX021342$BAXTER$$22$YR$$F$Y$$$20240830$$MD$AU$AU
240874261$24087426$1$I$$20240711$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407007957$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240714$$CN$US$US
240874271$24087427$1$I$20240710$20240712$20240714$20240714$PER$$US-AMGEN-USASP2024139407$AMGEN$$78$YR$E$M$Y$$$20240714$$CN$US$US
240874281$24087428$1$I$20240701$20240708$20240714$20240714$PER$$US-SA-2024SA202780$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240714$$MD$US$US
240874291$24087429$1$I$$20240705$20240714$20240714$PER$$US-SA-2024SA200249$SANOFI AVENTIS$$$$E$F$Y$$$20240714$$CN$US$US
240874304$24087430$4$F$20240708$20240809$20240714$20240812$PER$$US-JNJFOC-20240726946$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240812$$PH$US$US
240874311$24087431$1$I$$20240627$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06036$LUPIN$$$$$$Y$$$20240714$$PH$US$US
240874321$24087432$1$I$$20240708$20240714$20240714$PER$$US-AstraZeneca-2024A157134$ASTRAZENECA$$$$$$Y$$$20240714$$CN$US$
240874331$24087433$1$I$20240712$20240712$20240714$20240714$PER$$US-AMGEN-USASP2024139431$AMGEN$$67$YR$E$M$Y$$$20240714$$CN$US$US
240874341$24087434$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA202247$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240714$$CN$US$US
240874351$24087435$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA204269$SANOFI AVENTIS$$$$A$F$Y$90.7$KG$20240714$$MD$US$US
240874362$24087436$2$F$20240101$20240708$20240714$20240716$PER$$US-SA-2024SA202293$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240716$$CN$US$US
240874371$24087437$1$I$20240707$20240708$20240714$20240714$EXP$$US-ARGENX-2024-ARGX-US005301$ARGENX BVBA$$$$$$Y$$$20240714$$CN$US$US
240874381$24087438$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA202168$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240714$$CN$US$US
240874391$24087439$1$I$20140101$20240708$20240714$20240714$PER$$US-SA-2024SA202131$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240714$$CN$US$US
240874401$24087440$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA202533$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240714$$CN$US$US
240874411$24087441$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA202722$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240714$$CN$US$US
240874421$24087442$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA203574$SANOFI AVENTIS$$$$E$F$Y$$$20240714$$CN$US$US
240874432$24087443$2$F$20240706$20240819$20240714$20240829$PER$$US-JNJFOC-20240727974$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240829$$CN$US$US
240874442$24087444$2$F$$20240731$20240714$20240806$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06304$LUPIN$$$$$M$Y$$$20240806$$HP$US$US
240874451$24087445$1$I$$20240708$20240714$20240714$EXP$$US-JNJFOC-20240721725$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240714$$CN$US$US
240874462$24087446$2$F$$20240712$20240714$20240722$PER$$US-SA-2024SA203074$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240720$$CN$US$US
240874471$24087447$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA203014$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240714$$CN$US$US
240874483$24087448$3$F$$20240814$20240714$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05899$LUPIN$$$$$$Y$$$20240901$$CN$US$US
240874491$24087449$1$I$$20240626$20240714$20240714$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05902$LUPIN$$$$$$Y$$$20240714$$CN$US$US
240874512$24087451$2$F$$20240716$20240714$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05903$LUPIN$$$$$$Y$$$20240806$$CN$US$US
240874521$24087452$1$I$$20240701$20240714$20240714$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06302$LUPIN$$$$$$Y$$$20240714$$MD$US$US
240874531$24087453$1$I$$20240702$20240714$20240714$EXP$$GR-B.Braun Medical Inc.-2159102$B BRAUN$Literature Article$44$YR$$M$Y$0.81$KG$20240714$$$GR$GR
240874541$24087454$1$I$$20240702$20240714$20240714$EXP$$GB-B.Braun Medical Inc.-2159103$B BRAUN$$58$YR$$M$Y$65$KG$20240714$$$GB$GB
240874551$24087455$1$I$$20240710$20240714$20240714$PER$$US-JNJFOC-20240727076$JOHNSON AND JOHNSON$$$$$$Y$$$20240714$$MD$US$US
240874562$24087456$2$F$20240701$20240722$20240714$20240724$EXP$$JP-JNJFOC-20240731203$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240724$$PH$JP$JP
240874571$24087457$1$I$20240701$20240705$20240714$20240714$PER$$US-SA-2024SA202935$SANOFI AVENTIS$$33$YR$A$F$Y$70.3$KG$20240714$$MD$US$US
240874581$24087458$1$I$$20240705$20240714$20240714$PER$$US-SA-2024SA202893$SANOFI AVENTIS$$$$A$F$Y$$$20240714$$MD$US$US
240874591$24087459$1$I$20240101$20240708$20240714$20240714$PER$$US-SA-2024SA203094$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240714$$MD$US$US
240874601$24087460$1$I$$20240709$20240714$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110701$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240714$$CN$US$US
240874611$24087461$1$I$$20240708$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407006037$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240714$$CN$US$US
240874622$24087462$2$F$$20240717$20240714$20240718$EXP$$AU-ROCHE-10000024203$ROCHE$$$$$$Y$$$20240718$$MD$AU$AU
240874631$24087463$1$I$20240705$20240711$20240714$20240714$PER$$US-JNJFOC-20240730683$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240714$$CN$US$US
240874641$24087464$1$I$20240225$20240705$20240714$20240714$EXP$$CN-ROCHE-3568038$ROCHE$$49$YR$A$M$Y$$$20240714$$MD$CN$CN
240874651$24087465$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA204353$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240714$$MD$US$US
240874661$24087466$1$I$$20240707$20240714$20240714$PER$$US-SA-2024SA204284$SANOFI AVENTIS$$$$A$F$Y$$$20240714$$MD$US$US
240874672$24087467$2$F$20240620$20240806$20240714$20240819$EXP$$JP-ROCHE-10000022670$ROCHE$$82$YR$E$M$Y$55$KG$20240819$$MD$JP$JP
240874681$24087468$1$I$$20240701$20240714$20240714$EXP$GB-MHRA-MED-202406281336531360-CFMRD$GB-GLENMARK PHARMACEUTICALS-2024GMK092079$GLENMARK$$$$$$Y$$$20240714$$CN$GB$GB
240874691$24087469$1$I$20240619$20240711$20240714$20240714$PER$$US-JNJFOC-20240730052$JOHNSON AND JOHNSON$$17$YR$T$$Y$$$20240714$$PH$US$US
240874703$24087470$3$F$20240101$20240821$20240714$20240918$PER$$US-SA-2024SA204417$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240918$$MD$US$US
240874721$24087472$1$I$20240101$20240705$20240714$20240714$PER$$US-SA-2024SA203118$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240714$$MD$US$US
240874731$24087473$1$I$$20240710$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407007793$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240714$$MD$US$US
240874741$24087474$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA203252$SANOFI AVENTIS$$$$$F$Y$$$20240714$$MD$US$US
240874751$24087475$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA203196$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240714$$MD$US$US
240874761$24087476$1$I$$20240703$20240714$20240714$PER$$US-JNJFOC-20240711747$JOHNSON AND JOHNSON$$$$$F$Y$$$20240714$$CN$US$US
240874771$24087477$1$I$20240301$20240709$20240714$20240714$PER$$US-JNJFOC-20240723163$JOHNSON AND JOHNSON$$$$$M$Y$77.18$KG$20240714$$PH$US$US
240874781$24087478$1$I$$20240711$20240714$20240714$PER$$US-JNJFOC-20240728988$JOHNSON AND JOHNSON$$$$$F$Y$$$20240714$$CN$US$US
240874791$24087479$1$I$20240410$20240704$20240714$20240714$EXP$GB-MHRA-MED-202405011750000060-NVGMH$GB-TEVA-VS-3218039$TEVA$$7$YR$$F$Y$29$KG$20240714$$CN$GB$GB
240874801$24087480$1$I$$20240704$20240714$20240714$EXP$GB-MHRA-MED-202405071428426630-ZQHTY$GB-TEVA-VS-3218267$TEVA$$$$$M$Y$97$KG$20240714$$CN$GB$GB
240874811$24087481$1$I$20230101$20240704$20240714$20240714$EXP$GB-MHRA-MED-202405061310423740-GYPZW$GB-TEVA-VS-3218289$TEVA$$$$$F$Y$75$KG$20240714$$CN$GB$GB
240874821$24087482$1$I$20240701$20240708$20240714$20240714$PER$$US-SA-2024SA205302$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240714$$MD$US$US
240874831$24087483$1$I$20240505$20240704$20240714$20240714$EXP$GB-MHRA-MED-202405080121008850-CJYVS$GB-TEVA-VS-3218290$TEVA$$16$YR$$F$Y$60$KG$20240714$$CN$GB$GB
240874841$24087484$1$I$$20240703$20240714$20240714$EXP$$IN-ROCHE-3530138$ROCHE$$75$YR$E$F$Y$$$20240714$$MD$IN$IN
240874852$24087485$2$F$20231201$20240712$20240714$20240716$EXP$$FR-JNJFOC-20240723192$JOHNSON AND JOHNSON$$56$YR$A$M$Y$76$KG$20240716$$MD$FR$FR
240874861$24087486$1$I$$20240711$20240714$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111016$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240714$$CN$US$US
240874871$24087487$1$I$$20240710$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407006980$ELI LILLY AND CO$$$$A$F$Y$$$20240714$$CN$US$US
240874881$24087488$1$I$20240709$20240709$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407006376$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240714$$CN$US$US
240874891$24087489$1$I$$20240710$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407007438$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240714$$CN$US$US
240874902$24087490$2$F$$20240829$20240714$20240906$EXP$$CR-ROCHE-10000025396$ROCHE$$68$YR$E$F$Y$$$20240906$$MD$CR$CR
240874911$24087491$1$I$$20240712$20240714$20240714$PER$$US-JNJFOC-20240734082$JOHNSON AND JOHNSON$$$$$$Y$$$20240714$$MD$US$US
240874922$24087492$2$F$20240101$20240709$20240714$20240718$EXP$$CR-ROCHE-10000024200$ROCHE$$$$A$M$Y$$$20240718$$MD$CR$CR
240874931$24087493$1$I$20240430$20240704$20240714$20240714$EXP$GB-MHRA-MED-202405012015382740-NWRQP$GB-TEVA-VS-3218149$TEVA$$63$YR$$F$Y$78$KG$20240714$$CN$GB$GB
240874941$24087494$1$I$$20240704$20240714$20240714$EXP$$IL-TEVA-VS-3219350$TEVA$$80$YR$$M$Y$$$20240714$$CN$IL$IL
240874952$24087495$2$F$20200701$20240708$20240714$20240723$EXP$$JP-ROCHE-10000020004$ROCHE$Fukui M, Chihara Y, Takahashi Y, Sai N, Doi H, Nakakubo Y, et al. Biological Agents for Treating Atezolizumab-Induced Psoriasis in Small-Cell Lung Cancer: A Case Report. Cureus. 2024-May-30;16 (5):1-7. doi:10.7759/cureus.61395.$55$YR$A$M$Y$$$20240723$$HP$JP$JP
240874961$24087496$1$I$20240627$20240708$20240714$20240714$EXP$$CN-ROCHE-10000020689$ROCHE$$61$YR$A$M$Y$75$KG$20240714$$HP$CN$CN
240874971$24087497$1$I$20240617$20240710$20240714$20240714$PER$$US-JNJFOC-20240727815$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240714$$CN$US$US
240874981$24087498$1$I$20240501$20240710$20240714$20240714$PER$$US-JNJFOC-20240726396$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240714$$CN$US$US
240874991$24087499$1$I$$20240710$20240714$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110724$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240714$$CN$US$US
240875001$24087500$1$I$$20240710$20240714$20240714$PER$$US-JNJFOC-20240731130$JOHNSON AND JOHNSON$$$$$$Y$$$20240714$$CN$US$US
240875012$24087501$2$F$20240709$20240903$20240714$20240904$PER$$US-AMGEN-USASP2024137250$AMGEN$$82$YR$E$F$Y$$$20240904$$CN$US$US
240875021$24087502$1$I$$20240708$20240714$20240714$PER$$US-SA-2023SA300023$SANOFI AVENTIS$$$$E$M$Y$$$20240714$$MD$US$US
240875031$24087503$1$I$20240707$20240708$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407005167$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240714$$CN$US$US
240875041$24087504$1$I$$20240703$20240714$20240714$EXP$$DE-AIMMUNE THERAPEUTICS, INC.-2024AIMT01066$AIMMUNE$$$$$$Y$$$20240714$$MD$DE$DE
240875051$24087505$1$I$$20240708$20240714$20240714$EXP$$JP-ROCHE-10000025142$ROCHE$Kawabata T, Inoe H, Nakao A, Igata F, Ebi N, Hamada N et al.. 19 A case of EGFR gene mutation-positive lung adenocarcinoma that responded to the sixth-line treatment with atezolizumab. Japanese Journal of Lung Cancer / The 64th Kyushu Branch Scientific Meeting of t. 2024;64(3):213$61$YR$A$F$Y$$$20240714$$MD$JP$JP
240875061$24087506$1$I$20240508$20240709$20240714$20240714$EXP$$JP-ROCHE-10000025420$ROCHE$$73$YR$E$M$Y$$$20240714$$MD$JP$JP
240875071$24087507$1$I$$20240709$20240714$20240714$EXP$$CA-AVEVACA-000024$AVEVA$Adamo A, Marshall K, Woodall KL. Fentanyl-Related Deaths in Ontario, Canada: Toxicological Findings and Circumstances of Death in 4395 Cases (2020-2022). J Anal Toxicol. 2024, bkae061. doi: 10.1093/jat/bkae061. PMID: 38966926.$27$YR$$M$Y$$$20240715$$HP$CA$CA
240875081$24087508$1$I$$20240709$20240714$20240714$EXP$$CA-AVEVACA-000026$AVEVA$Adamo A, Marshall K, Woodall KL. Fentanyl-Related Deaths in Ontario, Canada: Toxicological Findings and Circumstances of Death in 4395 Cases (2020-2022). J Anal Toxicol. 2024, bkae061. doi: 10.1093/jat/bkae061. PMID: 38966926.$62$YR$$F$Y$$$20240715$$HP$CA$CA
240875091$24087509$1$I$$20240709$20240714$20240714$EXP$$CA-AVEVACA-000025$AVEVA$Adamo A, Marshall K, Woodall KL. Fentanyl-Related Deaths in Ontario, Canada: Toxicological Findings and Circumstances of Death in 4395 Cases (2020-2022). J Anal Toxicol. 2024, bkae061. doi: 10.1093/jat/bkae061. PMID: 38966926.$38$YR$$M$Y$$$20240715$$HP$CA$CA
240875101$24087510$1$I$$20240709$20240714$20240714$EXP$$CA-AVEVACA-000023$AVEVA$Adamo A, Marshall K, Woodall KL. Fentanyl-Related Deaths in Ontario, Canada: Toxicological Findings and Circumstances of Death in 4395 Cases (2020-2022). J Anal Toxicol. 2024, bkae061. doi: 10.1093/jat/bkae061. PMID: 38966926.$$$$F$Y$$$20240715$$HP$CA$CA
240875111$24087511$1$I$$20240709$20240714$20240714$EXP$$CA-AVEVACA-000022$AVEVA$Adamo A, Marshall K, Woodall KL. Fentanyl-Related Deaths in Ontario, Canada: Toxicological Findings and Circumstances of Death in 4395 Cases (2020-2022). J Anal Toxicol. 2024, bkae061. doi: 10.1093/jat/bkae061. PMID: 38966926.$21$YR$$F$Y$$$20240715$$HP$CA$CA
240875121$24087512$1$I$20240709$20240710$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407007666$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240714$$CN$US$US
240875131$24087513$1$I$$20240709$20240714$20240714$EXP$$US-AVEVA-000697$AVEVA$Ballotari M, Truver MT, Dhoble LR, Kinsey AM, Hoyer JL, Chronister CW, Goldberger BA. A Postmortem Case Report involving Fentanyl, Desalkylgidazepam and Bromazolam. J Anal Toxicol. 2024, bkae059. doi: 10.1093/jat/bkae059. PMID: 38966933.$24$YR$$M$Y$$$20240715$$HP$US$US
240875141$24087514$1$I$$20240708$20240714$20240714$EXP$$JP-ROCHE-10000024555$ROCHE$Komiya K, Takao D, Nakatomi K, Sasaki E. 47 A case of a patient with small cell lung cancer extensive stage who had the onset of severe irAE myositis. Japanese Journal of Lung cancer/The 64th Kyushu Branch Scientific Meeting of the Japan Lung Cancer Society. 2024;64 (3):219.$47$YR$A$F$Y$$$20240714$$MD$JP$JP
240875151$24087515$1$I$20240530$20240708$20240714$20240714$EXP$$JP-ROCHE-10000024601$ROCHE$$7$DEC$E$$Y$$$20240714$$HP$JP$JP
240875172$24087517$2$F$20240628$20240724$20240714$20240801$EXP$$JP-ROCHE-10000023467$ROCHE$$77$YR$E$M$Y$57$KG$20240801$$MD$JP$JP
240875181$24087518$1$I$20240529$20240703$20240714$20240714$EXP$$FR-JNJFOC-20240711438$JOHNSON AND JOHNSON$$53$YR$A$M$Y$90$KG$20240714$$MD$FR$FR
240875192$24087519$2$F$20240626$20240712$20240714$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111057$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240715$$PH$US$US
240875202$24087520$2$F$20240101$20240822$20240714$20240917$PER$$US-SA-2024SA203963$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240918$$CN$US$US
240875211$24087521$1$I$$20240710$20240714$20240714$PER$$US-ALXN-A202307662$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240714$$CN$US$US
240875223$24087522$3$F$$20240730$20240714$20240801$EXP$$NVSC2024IT142722$NOVARTIS$Carpenedo M, Zappaterra A, Ferrari B, Cotilli G. Sequential use of efgartigimod and romiplostim restored platelet response in two multi-refractory thrombocytopenic patients, previously treated with thrombopoietin receptor agonists. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES. 2023;15(1):e2023021$80$YR$$M$Y$$$20240801$$HP$IT$IT
240875231$24087523$1$I$$20240711$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407008441$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240714$$CN$US$US
240875241$24087524$1$I$$20240712$20240714$20240714$EXP$$NVSC2024BE144330$NOVARTIS$Boland L. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19. TRANSPLANT INTERNATIONAL. 2024;37$$$A$$Y$$$20240714$$HP$BE$BE
240875252$24087525$2$F$20240307$20240708$20240714$20240717$EXP$$NVSC2024US141113$NOVARTIS$$65$YR$$F$Y$$$20240717$$CN$US$US
240875261$24087526$1$I$20150510$20240710$20240714$20240714$EXP$$PHHY2015CA054782$NOVARTIS$$69$YR$$F$Y$100$KG$20240714$$HP$CA$CA
240875271$24087527$1$I$$20240703$20240714$20240714$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01057$AIMMUNE$$$$$$Y$$$20240714$$CN$US$US
240875281$24087528$1$I$$20240710$20240714$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110933$BRISTOL MYERS SQUIBB$$$$A$F$Y$$$20240714$$MD$US$US
240875291$24087529$1$I$$20240708$20240714$20240714$EXP$$TW-ALXN-202407ASI000346TW$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240714$$HP$TW$TW
240875303$24087530$3$F$$20240808$20240714$20240815$EXP$$GB-AMGEN-GBRSP2024137943$AMGEN$$77$YR$E$F$Y$$$20240815$$CN$GB$GB
240875311$24087531$1$I$20240706$20240710$20240714$20240714$EXP$$NVSC2024ZA143431$NOVARTIS$$$$$M$Y$$$20240714$$CN$ZA$ZA
240875321$24087532$1$I$$20240711$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407008443$ELI LILLY AND CO$$86$YR$E$F$Y$$$20240714$$CN$US$US
240875331$24087533$1$I$$20240711$20240714$20240714$PER$$US-ROCHE-10000024831$ROCHE$$9$YR$C$M$Y$$$20240714$$MD$US$US
240875341$24087534$1$I$20231115$20240523$20240714$20240714$EXP$FR-AFSSAPS-RS2024000197$FR-SAMSUNG BIOEPIS-SB-2024-16088$SAMSUNG BIOEPIS$$39$YR$A$F$Y$$$20240714$$MD$FR$FR
240875351$24087535$1$I$20240621$20240627$20240714$20240714$PER$$US-JNJFOC-20240676059$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240714$$CN$US$US
240875362$24087536$2$F$$20240709$20240714$20240716$EXP$$NVSC2024DE143422$NOVARTIS$$$$$F$Y$$$20240716$$CN$DE$DE
240875371$24087537$1$I$$20240709$20240714$20240714$PER$$US-SA-2024SA203528$SANOFI AVENTIS$$$$A$F$Y$$$20240715$$MD$US$US
240875383$24087538$3$F$20240710$20240919$20240714$20240925$EXP$$JP-009507513-2407JPN002082J$MERCK$$86$YR$$F$Y$$$20240925$$MD$JP$JP
240875391$24087539$1$I$20240601$20240703$20240714$20240714$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01063$AIMMUNE$$$$$$Y$$$20240714$$CN$US$US
240875403$24087540$3$F$20230101$20240821$20240714$20240912$EXP$$FI-JNJFOC-20240731855$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240912$$CN$FI$FI
240875411$24087541$1$I$20240310$20240709$20240714$20240714$EXP$$LV-JNJFOC-20240731621$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240715$$CN$LV$LV
240875421$24087542$1$I$$20240710$20240714$20240714$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010312$JAZZ$$$$$M$Y$59.4$KG$20240714$$CN$US$US
240875432$24087543$2$F$20240619$20240715$20240714$20240718$PER$FR-AFSSAPS-NY2024000762$FR-Eisai-EC-2024-169964$EISAI$$63$YR$A$F$Y$94.6$KG$20240718$$PH$FR$FR
240875442$24087544$2$F$$20240714$20240714$20240718$EXP$$BD-SANDOZ INC.-SDZ2024BD064749$SANDOZ$$70$YR$$F$Y$$$20240718$$CN$BD$BD
240875451$24087545$1$I$$20240709$20240714$20240714$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010529$JAZZ$$$$$F$Y$28$KG$20240714$$CN$US$US
240875461$24087546$1$I$$20240703$20240714$20240714$PER$$US-ELI_LILLY_AND_COMPANY-US202407002826$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240714$$CN$US$US
240875471$24087547$1$I$$20240710$20240714$20240714$EXP$$US-JNJFOC-20240728139$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240715$$HP$US$US
240875481$24087548$1$I$$20240705$20240714$20240714$EXP$$US-ZENPEP LLC-2024AIMT01069$AIMMUNE$$$$$$Y$$$20240715$$HP$US$US
240875492$24087549$2$F$20240609$20240712$20240714$20240715$EXP$GB-MHRA-MED-202406281229432610-VWLMF$GB-JNJFOC-20240733828$JOHNSON AND JOHNSON$$45$YR$A$F$Y$59$KG$20240716$$PH$GB$GB
240875501$24087550$1$I$$20240703$20240714$20240714$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00271$PRINSTON PHARMACEUTICAL$Nagi T, Barnes S, Weiss A.. Rare Case of Endoscopically Diagnosed Ischemic Colitis Secondary to Chronic Phentermine Use.. ACG CASEREPORTS JOURNAL. 2024;(11) 6:e01363$48$YR$$F$Y$$$20240712$$MD$US$US
240875511$24087551$1$I$20240301$20240702$20240714$20240714$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00263$PRINSTON PHARMACEUTICAL$$79$YR$$F$Y$58.967$KG$20240712$$CN$US$US
240875521$24087552$1$I$$20240710$20240714$20240714$EXP$$US-JNJFOC-20240726866$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240715$$CN$US$US
240875531$24087553$1$I$$20240703$20240714$20240714$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00270$PRINSTON PHARMACEUTICAL$Sanjeevi A, Clark B.L, Aguirre A, Verghese B.G. Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature. Clinical Immunology Communications. 2024;6:1-4$65$YR$$F$Y$$$20240712$$HP$US$US
240875541$24087554$1$I$20240201$20240708$20240714$20240714$EXP$$CA-JNJFOC-20240203612$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240715$$HP$CA$CA
240875551$24087555$1$I$20240701$20240709$20240714$20240714$EXP$$CN-BEIGENE-BGN-2024-010711$BEIGENE$$$$$$Y$$$20240714$$HP$CN$CN
240875561$24087556$1$I$$20240709$20240714$20240714$EXP$$US-ABBVIE-5833520$ABBVIE$$$$$M$Y$$$20240714$$CN$US$US
240875571$24087557$1$I$$20240710$20240714$20240714$EXP$$US-JNJFOC-20240724288$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$US$US
240875591$24087559$1$I$20240506$20240708$20240714$20240714$EXP$$CA-JNJFOC-20240534182$JOHNSON AND JOHNSON$$63$YR$A$F$Y$45$KG$20240715$$HP$CA$CA
240875601$24087560$1$I$20240705$20240712$20240714$20240714$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039603$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$$$20240715$$CN$US$US
240875612$24087561$2$F$20240101$20240903$20240714$20240906$EXP$$US-ABBVIE-5807387$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
240875621$24087562$1$I$$20240711$20240714$20240714$PER$$NVSC2024US144738$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240875632$24087563$2$F$$20240717$20240714$20240718$EXP$$US-ABBVIE-5838601$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
240875642$24087564$2$F$$20240904$20240714$20240910$EXP$$ZA-ABBVIE-5838498$ABBVIE$$55$YR$$F$Y$$$20240910$$CN$ZA$ZA
240875661$24087566$1$I$$20240711$20240714$20240714$PER$$NVSC2024US144739$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240875672$24087567$2$F$$20240815$20240714$20240818$PER$$US-JNJFOC-20240723434$JOHNSON AND JOHNSON$$$$$$Y$$$20240818$$HP$US$US
240875681$24087568$1$I$$20240711$20240714$20240714$EXP$$US-JNJFOC-20240729481$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240875691$24087569$1$I$$20240709$20240714$20240714$PER$$US-BIOGEN-2024BI01271836$BIOGEN$$$$$F$Y$$$20240714$$CN$US$US
240875701$24087570$1$I$$20240708$20240714$20240714$PER$$US-BIOGEN-2024BI01262819$BIOGEN$$$$$M$Y$$$20240714$$CN$US$US
240875712$24087571$2$F$20240508$20240712$20240714$20240715$EXP$GB-MHRA-MED-202405121817323260-NJPZB$GB-JNJFOC-20240733922$JOHNSON AND JOHNSON$$43$YR$A$M$Y$95$KG$20240716$$MD$GB$GB
240875724$24087572$4$F$20240530$20240815$20240714$20240819$EXP$GB-MHRA-MED-202406061545377790-RFMPL$GB-SANDOZ INC.-SDZ2024GB055784$SANDOZ$$32$YR$$M$Y$$$20240819$$PH$GB$GB
240875732$24087573$2$F$$20240813$20240714$20240819$30DAY$$US-JNJFOC-20240723264$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
240875741$24087574$1$I$20240705$20240705$20240714$20240714$EXP$$CN-BEIGENE-BGN-2024-010539$BEIGENE$$$$$$Y$$$20240714$$HP$CN$CN
240875751$24087575$1$I$20240628$20240702$20240714$20240714$EXP$$CN-ROCHE-10000019180$ROCHE$$59$YR$A$M$Y$40$KG$20240715$$HP$CN$CN
240875762$24087576$2$F$20240705$20240712$20240714$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110797$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240722$$PH$US$US
240875771$24087577$1$I$$20240709$20240714$20240714$EXP$$CA-SANDOZ INC.-SDZ2024CA064157$SANDOZ$$44$YR$$F$Y$$$20240714$$HP$CA$CA
240875784$24087578$4$F$20230801$20240730$20240714$20240802$EXP$$US-ROCHE-10000021926$ROCHE$$70$YR$E$F$Y$67.58$KG$20240802$$CN$US$US
240875793$24087579$3$F$$20240712$20240714$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109488$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240717$$CN$JP$JP
240875801$24087580$1$I$$20240708$20240714$20240714$EXP$$US-ABBVIE-5833761$ABBVIE$$$$$F$Y$$$20240714$$CN$US$US
240875811$24087581$1$I$20240617$20240709$20240714$20240714$EXP$$CN-BEIGENE-BGN-2024-010712$BEIGENE$$$$$$Y$$$20240714$$HP$CN$CN
240875821$24087582$1$I$20240509$20240708$20240714$20240714$EXP$FR-AFSSAPS-NT2024000811$FR-BIOGEN-2024BI01273100$BIOGEN$$50$YR$$M$Y$90$KG$20240714$$MD$FR$FR
240875831$24087583$1$I$$20240710$20240714$20240714$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110878$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240715$$HP$CA$CA
240875841$24087584$1$I$20240617$20240709$20240714$20240714$EXP$$CN-BEIGENE-BGN-2024-010685$BEIGENE$$$$$$Y$$$20240714$$HP$CN$CN
240875851$24087585$1$I$$20240709$20240714$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110013$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240715$$HP$US$US
240875861$24087586$1$I$20240415$20240709$20240714$20240714$EXP$$CN-BEIGENE-BGN-2024-010713$BEIGENE$$$$$$Y$$$20240714$$HP$CN$CN
240875871$24087587$1$I$$20240711$20240714$20240714$PER$$US-ABBVIE-5836860$ABBVIE$$$$$F$Y$$$20240714$$CN$US$US
240875881$24087588$1$I$$20240709$20240714$20240714$EXP$$US-ABBVIE-5835136$ABBVIE$$$$$F$Y$$$20240714$$CN$US$US
240875891$24087589$1$I$20230101$20240705$20240714$20240714$EXP$$US-ABBVIE-5837264$ABBVIE$$$$$M$Y$76$KG$20240714$$CN$US$US
240875903$24087590$3$F$$20240826$20240714$20240904$PER$$US-ROCHE-10000023775$ROCHE$$$$$$Y$$$20240904$$HP$US$US
240875911$24087591$1$I$20220526$20240708$20240714$20240714$EXP$$EG-SANDOZ INC.-SDZ2024EG027470$SANDOZ$$10$YR$$F$Y$$$20240714$$CN$EG$EG
240875921$24087592$1$I$20240601$20240712$20240714$20240714$EXP$$JP-SANDOZ INC.-SDZ2024JP064873$SANDOZ$$88$YR$$M$Y$$$20240714$$CN$JP$JP
240875931$24087593$1$I$$20240711$20240714$20240714$PER$$US-AMGEN-USASP2024138748$AMGEN$$$$$F$Y$$$20240714$$CN$US$US
240875943$24087594$3$F$$20240909$20240714$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110841$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$86.18$KG$20240919$$CN$US$US
240875951$24087595$1$I$20240624$20240709$20240714$20240714$EXP$$RO-ABBVIE-5835026$ABBVIE$$39$YR$$M$Y$$$20240714$$MD$RO$RO
240875961$24087596$1$I$20240626$20240712$20240714$20240714$EXP$$DE-SANDOZ INC.-SDZ2024DE064879$SANDOZ$$71$YR$$F$Y$53$KG$20240714$$MD$DE$DE
240875971$24087597$1$I$20190205$20240710$20240714$20240714$EXP$$CA-TAKEDA-2024TUS069883$TAKEDA$$51$YR$$M$Y$$$20240714$$CN$CA$CA
240875981$24087598$1$I$$20240711$20240714$20240714$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-111164$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240715$$HP$CA$CA
240875992$24087599$2$F$$20240724$20240714$20240802$EXP$$US-TEVA-VS-3219047$TEVA$Abdalla AA, Ali RF, Zamora-Martinez AC, Wesselius LJ. Vexas Syndrome Presenting as Recurrent Relapses of Organizing Pneumonia- A Case Series. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A5321.; Abdalla AA, Ali RF, Zamora-Martinez AC, Wesselius LJ. Vexas Syndrome Presenting as Recurrent Relapses of Organizing Pneumonia- A Case Series. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A5321.$69$YR$$M$Y$$$20240802$$HP$US$US
240876001$24087600$1$I$$20240701$20240714$20240714$EXP$$US-TEVA-VS-3219046$TEVA$Abdalla AA, Ali RF, Zamora-Martinez AC, Wesselius LJ. Vexas Syndrome Presenting as Recurrent Relapses of Organizing Pneumonia- A Case Series. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A5321.$70$YR$$M$Y$$$20240714$$HP$US$US
240876011$24087601$1$I$$20240709$20240714$20240714$EXP$$DE-SANDOZ INC.-SDZ2024DE064388$SANDOZ$$$$$F$Y$$$20240714$$CN$DE$DE
240876031$24087603$1$I$$20240703$20240714$20240714$EXP$$JP-TAKEDA-2024TUS071093$TAKEDA$$74$YR$$M$Y$$$20240714$$MD$JP$JP
240876043$24087604$3$F$20240604$20240801$20240714$20240807$EXP$$DE-SANDOZ INC.-SDZ2024DE064802$SANDOZ$$$$A$F$Y$$$20240807$$HP$DE$DE
240876051$24087605$1$I$20240608$20240708$20240714$20240714$EXP$$CN-BEIGENE-BGN-2024-010614$BEIGENE$$$$$$Y$$$20240714$$HP$CN$CN
240876061$24087606$1$I$$20240710$20240714$20240714$EXP$$JP-ABBVIE-5837998$ABBVIE$Toya Y, Matsumoto A, Kanno N, Abe S, Akasaka M, Tsuchiya S et al. P70-3 A case of extremely low birth weight baby developed giant warts due to infective endocarditis. Journal of Japan Society of Perinatal and Neonatal Medicine/The 60th General Meeting and Academic Conference of the Japan Society of Perinatal and Neonatal Medicine (2024). 2024;60(S1):415.$31$YR$$F$Y$$$20240714$$MD$JP$JP
240876073$24087607$3$F$20240708$20240819$20240714$20240914$30DAY$$US-AMGEN-USASP2024135093$AMGEN$$$$$F$Y$$$20240914$$CN$US$US
240876081$24087608$1$I$$20240710$20240714$20240714$30DAY$$FR-SANDOZ INC.-SDZ2024FR064962$SANDOZ$$10$YR$$F$Y$$$20240714$$CN$FR$FR
240876091$24087609$1$I$20240708$20240710$20240714$20240714$EXP$$CO-ABBVIE-5838818$ABBVIE$$45$YR$$F$Y$$$20240714$$CN$CO$CO
240876101$24087610$1$I$$20240711$20240714$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110997$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$73.48$KG$20240715$$CN$US$US
240876111$24087611$1$I$20240101$20240709$20240714$20240714$EXP$$US-ABBVIE-5835413$ABBVIE$$$$$M$Y$$$20240714$$CN$US$US
240876121$24087612$1$I$$20240710$20240714$20240714$EXP$$US-ABBVIE-5836901$ABBVIE$$$$$F$Y$$$20240714$$CN$US$US
240876131$24087613$1$I$20240710$20240710$20240714$20240714$EXP$$US-ABBVIE-5837353$ABBVIE$$57$YR$$F$Y$$$20240714$$CN$US$US
240876142$24087614$2$F$20240708$20240820$20240714$20240829$30DAY$$US-AMGEN-USASP2024136757$AMGEN$$52$YR$A$F$Y$128.8$KG$20240829$$PH$US$US
240876151$24087615$1$I$20240531$20240708$20240714$20240714$PER$$US-AMGEN-USASP2024134870$AMGEN$$76$YR$E$F$Y$$$20240714$$CN$US$US
240876161$24087616$1$I$20040101$20240710$20240714$20240714$EXP$$US-ABBVIE-5837057$ABBVIE$$64$YR$$F$Y$$$20240714$$CN$US$US
240876171$24087617$1$I$20240706$20240710$20240714$20240714$EXP$$CN-ABBVIE-5835360$ABBVIE$$72$YR$$M$Y$60$KG$20240714$$MD$CN$CN
240876181$24087618$1$I$20240701$20240710$20240714$20240714$EXP$$BE-ABBVIE-5839000$ABBVIE$$64$YR$$M$Y$$$20240714$$HP$BE$BE
240876191$24087619$1$I$20231214$20240710$20240714$20240714$EXP$DE-SA-SAC20240630000033$DE-SANDOZ INC.-SDZ2024DE064148$SANDOZ$$5$YR$$M$Y$$$20240714$$MD$DE$DE
240876202$24087620$2$F$$20240809$20240714$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110939$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240812$$CN$US$US
240876211$24087621$1$I$$20240711$20240714$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110871$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$80.29$KG$20240715$$CN$US$US
240876221$24087622$1$I$$20240711$20240714$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110988$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$77.56$KG$20240715$$CN$US$US
240876231$24087623$1$I$$20240710$20240714$20240714$EXP$$US-ABBVIE-5836835$ABBVIE$$$$$F$Y$$$20240714$$CN$US$US
240876243$24087624$3$F$20240101$20240814$20240714$20240820$EXP$$US-ABBVIE-5835593$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
240876251$24087625$1$I$20240101$20240708$20240714$20240714$PER$$US-SA-2024SA074769$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240715$$MD$US$US
240876261$24087626$1$I$20240501$20240710$20240714$20240714$EXP$$CA-ABBVIE-5836921$ABBVIE$$$$A$M$Y$$$20240714$$CN$CA$CA
240876272$24087627$2$F$20240501$20240716$20240714$20240719$EXP$$US-ABBVIE-5836623$ABBVIE$$59$YR$$F$Y$92$KG$20240719$$CN$US$US
240876281$24087628$1$I$$20240711$20240714$20240714$PER$$US-HALEON-2186773$Haleon PLC$$$$$$Y$$$20240714$$CN$US$US
240876291$24087629$1$I$20240707$20240708$20240714$20240714$PER$$US-AMGEN-USASL2024136471$AMGEN$$$$$M$Y$$$20240714$$CN$US$US
240876303$24087630$3$F$20240704$20240912$20240714$20240923$EXP$$JP-AMGEN-JPNSP2024139542$AMGEN$$9$DEC$E$F$Y$$$20240922$$PH$JP$JP
240876311$24087631$1$I$20240705$20240706$20240714$20240714$PER$$US-SA-2024SA202846$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240715$$CN$US$US
240876321$24087632$1$I$$20240709$20240714$20240714$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01261$NOVITIUM PHARMA$Dorela Lame.Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis.Hematology Reports.04-MAR-2024;16(1):125-131$34$YR$A$M$Y$$$20240715$$HP$IT$IT
240876331$24087633$1$I$$20240708$20240714$20240714$PER$$US-SA-2024SA203205$SANOFI AVENTIS$$$$E$M$Y$$$20240715$$MD$US$US
240876341$24087634$1$I$20240709$20240709$20240714$20240714$PER$$US-SA-2024SA205205$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240715$$CN$US$US
240876353$24087635$3$F$20240624$20240716$20240714$20240722$EXP$$KR-ABBVIE-5835086$ABBVIE$$63$YR$$F$Y$78$KG$20240722$$MD$KR$KR
240876361$24087636$1$I$$20240708$20240714$20240714$EXP$$US-ABBVIE-5833184$ABBVIE$$$$$F$Y$$$20240714$$CN$US$US
240876371$24087637$1$I$20170801$20240620$20240714$20240714$EXP$$CA-UCBSA-2024034353$UCB$$40$YR$$F$Y$73$KG$20240715$$MD$CA$CA
240876381$24087638$1$I$$20240712$20240714$20240714$EXP$$GB-ABBVIE-5838692$ABBVIE$$$$E$M$Y$$$20240714$$CN$GB$GB
240876392$24087639$2$F$$20240711$20240714$20240716$EXP$$US-ABBVIE-5835815$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240876402$24087640$2$F$20240509$20240712$20240714$20240715$EXP$GB-MHRA-MED-202405131406578450-DLPQM$GB-JNJFOC-20240733899$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240716$$CN$GB$GB
240876413$24087641$3$F$20240101$20240725$20240714$20240729$EXP$$CA-ABBVIE-5835816$ABBVIE$$69$YR$$F$Y$$$20240729$$CN$CA$CA
240876421$24087642$1$I$20240709$20240710$20240714$20240714$EXP$$US-ABBVIE-5836690$ABBVIE$$40$YR$$F$Y$$$20240714$$CN$US$US
240876431$24087643$1$I$$20240710$20240714$20240714$PER$$US-AMGEN-USASP2024138524$AMGEN$$$$$$Y$$$20240714$$CN$US$US
240876441$24087644$1$I$20240101$20240710$20240714$20240714$EXP$$US-ABBVIE-5835381$ABBVIE$$$$$M$Y$$$20240714$$CN$US$US
240876451$24087645$1$I$$20240705$20240714$20240714$PER$$US-SA-2024SA201332$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240715$$CN$US$US
240876462$24087646$2$F$20240405$20240719$20240714$20240723$EXP$$JP-JNJFOC-20240733588$JOHNSON AND JOHNSON$$9$DEC$E$M$Y$$$20240724$$PH$JP$JP
240876471$24087647$1$I$20240625$20240705$20240714$20240714$EXP$$CN-JNJFOC-20240715178$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240715$$HP$CN$CN
240876482$24087648$2$F$20240307$20240801$20240714$20240805$EXP$$JP-JNJFOC-20240733563$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240805$$MD$JP$JP
240876492$24087649$2$F$$20240729$20240714$20240814$30DAY$$DE-JNJFOC-20240709143$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$PH$DE$DE
240876501$24087650$1$I$$20240711$20240714$20240714$PER$$US-HALEON-2186802$Haleon PLC$$$$$$Y$$$20240714$$CN$US$US
240876511$24087651$1$I$$20240712$20240714$20240714$PER$US-MLMSERVICE-20240626-PI112900-00306-1$US-ROCHE-10000025305$ROCHE$Youssefian L, Saeidian AH S, Ariamanesh M, Abdollahimajd F, Molkara S, Et al.. Whole-Transcriptome Sequencing-Based Profiling of the Cutaneous Virome in Patients with Secondary Immunodeficiency. JID Innovations. 2024;4 (4): doi:10.1016/j.xjidi.2024.100278..$29$YR$A$F$Y$$$20240715$$HP$US$US
240876521$24087652$1$I$$20240710$20240714$20240714$PER$$US-ABBVIE-5835307$ABBVIE$$$$$F$Y$$$20240714$$MD$US$US
240876531$24087653$1$I$$20240711$20240714$20240714$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111084$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240715$$CN$US$US
240876542$24087654$2$F$$20240716$20240714$20240723$EXP$$US-ABBVIE-5835995$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
240876551$24087655$1$I$$20240710$20240714$20240714$PER$$US-ALXN-202407USA000615US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240715$$HP$US$US
240876561$24087656$1$I$$20240711$20240714$20240714$EXP$$JP-JNJFOC-20240732517$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$MD$JP$JP
240876571$24087657$1$I$$20240711$20240714$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110846$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$55.34$KG$20240715$$CN$US$US
240876581$24087658$1$I$$20240710$20240714$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110960$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$121.11$KG$20240715$$CN$US$US
240876591$24087659$1$I$$20240709$20240714$20240714$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01260$NOVITIUM PHARMA$Francesco Fabozzi.Prolonged neutropenia in patients with lymphoma treated with antiretroviral therapy: Raltegravir too? A single-case report.Pediatric Blood + Cancer.03-NOV-2022;70:e30086$6$YR$C$F$Y$$$20240715$$HP$IT$IT
240876611$24087661$1$I$$20240710$20240714$20240714$EXP$$US-ABBVIE-5836010$ABBVIE$$$$$F$Y$$$20240714$$CN$US$US
240876621$24087662$1$I$$20240711$20240714$20240714$30DAY$$US-SANDOZ INC.-SDZ2024US063820$SANDOZ$$$$$F$Y$$$20240714$$HP$US$US
240876632$24087663$2$F$20240701$20240718$20240714$20240722$EXP$$CO-ABBVIE-5837113$ABBVIE$$59$YR$$M$Y$72$KG$20240722$$CN$CO$CO
240876641$24087664$1$I$20200715$20240710$20240714$20240714$EXP$$AT-ABBVIE-20K-009-3494822-00$ABBVIE$$81$YR$$M$Y$106$KG$20240714$$MD$AT$AT
240876651$24087665$1$I$$20240711$20240714$20240714$PER$$US-ABBVIE-5837944$ABBVIE$$$$$$Y$$$20240714$$CN$US$US
240876661$24087666$1$I$$20240710$20240714$20240714$EXP$$NVSC2024US122125$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240876671$24087667$1$I$$20240711$20240714$20240714$PER$$NVSC2024US144737$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240876681$24087668$1$I$$20240710$20240714$20240714$EXP$$US-SANDOZ INC.-SDZ2024US048596$SANDOZ$$$$$F$Y$$$20240714$$CN$US$US
240876692$24087669$2$F$20240612$20240807$20240714$20240812$EXP$$US-ABBVIE-5836017$ABBVIE$$66$YR$$F$Y$$$20240812$$CN$US$US
240876701$24087670$1$I$$20240710$20240714$20240714$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111081$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240715$$CN$US$US
240876712$24087671$2$F$20240619$20240716$20240714$20240720$EXP$$US-ABBVIE-5837035$ABBVIE$$79$YR$$M$Y$$$20240720$$CN$US$US
240876721$24087672$1$I$$20240711$20240714$20240714$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111136$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240715$$CN$US$US
240876731$24087673$1$I$$20240705$20240714$20240714$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-108307$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240715$$HP$CA$CA
240876741$24087674$1$I$$20240710$20240714$20240714$EXP$$US-ABBVIE-5836896$ABBVIE$$$$$F$Y$$$20240714$$CN$US$US
240876752$24087675$2$F$$20240718$20240715$20240720$EXP$$JP-ABBVIE-5837963$ABBVIE$Toya Y, Matsumoto A, Kanno N, Abe S, Akasaka M, Tsuchiya S et al. P70-3 A case of extremely low birth weight baby developed giant warts due to infective endocarditis. Journal of Japan Society of Perinatal and Neonatal Medicine/The 60th General Meeting and Academic Conference of the Japan Society of Perinatal and Neonatal Medicine (2024). 2024; 60 (S1) 415-415.; Toya Y, Matsumoto A, Kanno N, Abe S, Akasaka M, Tsuchiya S et al. P70-3 A case of extremely low birth weight baby developed giant war...$$$N$F$Y$$$20240720$$MD$JP$JP
240876761$24087676$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144736$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240876771$24087677$1$I$20240601$20240626$20240715$20240715$PER$$US-AstraZeneca-2024A148114$ASTRAZENECA$$34663$DY$$F$Y$$$20240715$$CN$US$
240876781$24087678$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5837851$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240876791$24087679$1$I$20240708$20240712$20240715$20240715$EXP$$RO-ABBVIE-5838424$ABBVIE$$79$YR$$M$Y$$$20240715$$CN$RO$RO
240876801$24087680$1$I$20240702$20240709$20240715$20240715$EXP$$CN-ABBVIE-5838380$ABBVIE$$48$YR$$M$Y$74.7$KG$20240715$$HP$CN$CN
240876811$24087681$1$I$$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111364$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240715$$HP$US$US
240876821$24087682$1$I$$20240707$20240715$20240715$EXP$$AU-JNJFOC-20240723946$JOHNSON AND JOHNSON$$12$MON$I$F$Y$$$20240715$$HP$AU$AU
240876832$24087683$2$F$20240801$20240812$20240715$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039629$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240814$$CN$US$US
240876842$24087684$2$F$20240611$20240722$20240715$20240729$EXP$$CA-BIOGEN-2024BI01270034$BIOGEN$$53$YR$$M$Y$$$20240729$$HP$CA$CA
240876861$24087686$1$I$$20240708$20240715$20240715$EXP$$US-BIOGEN-2024BI01273096$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240876871$24087687$1$I$$20240710$20240715$20240715$EXP$$US-BIOGEN-2024BI01273344$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240876881$24087688$1$I$20240101$20240708$20240715$20240715$EXP$$US-ABBVIE-5834152$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240876891$24087689$1$I$$20240712$20240715$20240715$EXP$GB-MHRA-MED-202405171231228440-PDMQJ$GB-ASTELLAS-2024US019863$ASTELLAS$$$$$M$Y$$$20240715$$CN$GB$GB
240876901$24087690$1$I$20240101$20240708$20240715$20240715$EXP$$BR-ABBVIE-5832598$ABBVIE$$$$$M$Y$88$KG$20240715$$CN$BR$BR
240876912$24087691$2$F$$20240717$20240715$20240723$EXP$$US-ABBVIE-5833673$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
240876922$24087692$2$F$$20240829$20240715$20240830$EXP$$US-SANDOZ INC.-SDZ2023US004477$SANDOZ$$$$$M$Y$90.72$KG$20240830$$HP$US$US
240876931$24087693$1$I$$20240701$20240715$20240715$EXP$$FR-AMGEN-FRASP2024138091$AMGEN$$$$$F$Y$$$20240714$$PH$FR$FR
240876941$24087694$1$I$20240401$20240710$20240715$20240715$EXP$$US-ASTELLAS-2024US016026$ASTELLAS$$24$YR$$M$Y$$$20240715$$CN$US$US
240876951$24087695$1$I$$20240708$20240715$20240715$EXP$$US-ABBVIE-5832589$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240876961$24087696$1$I$20240101$20240709$20240715$20240715$EXP$$US-ABBVIE-5835627$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240876971$24087697$1$I$$20240704$20240715$20240715$EXP$$BR-RDY-SPO/BRA/24/0008627$DR REDDYS$$$$$M$Y$$$20240715$$PH$BR$BR
240876981$24087698$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5837148$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240876991$24087699$1$I$$20240711$20240715$20240715$EXP$$US-AstraZeneca-2024A159052$ASTRAZENECA$$$$$$Y$$$20240715$$MD$US$
240877001$24087700$1$I$$20240709$20240715$20240715$EXP$$US-ABBVIE-5834806$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240877011$24087701$1$I$20240624$20240705$20240715$20240715$EXP$BE-FAMHP-DHH-N2024-122316$BE-ESPERIONTHERAPEUTICS-2024BEL01051$ESPERION THERAPEUTICS$$$$E$M$Y$$$20240715$$MD$BE$BE
240877021$24087702$1$I$20240301$20240705$20240715$20240715$EXP$BE-FAMHP-DHH-N2024-122303$BE-ESPERIONTHERAPEUTICS-2024BEL01053$ESPERION THERAPEUTICS$$75$YR$$F$Y$55$KG$20240715$$CN$BE$BE
240877031$24087703$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202406250204569350-DMTSB$GB-ESPERIONTHERAPEUTICS-2024GBR01063$ESPERION THERAPEUTICS$$71$YR$$F$Y$67$KG$20240715$$CN$GB$GB
240877041$24087704$1$I$20240514$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405161033260680-VTDQZ$GB-ESPERIONTHERAPEUTICS-2024GBR01054$ESPERION THERAPEUTICS$$$$$$Y$$$20240715$$MD$GB$GB
240877051$24087705$1$I$20240501$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405161000125770-LYFNQ$GB-ESPERIONTHERAPEUTICS-2024GBR01058$ESPERION THERAPEUTICS$$$$$F$Y$$$20240715$$PH$GB$GB
240877062$24087706$2$F$$20240811$20240715$20240813$EXP$$US-ABBVIE-5835123$ABBVIE$$$$$M$Y$83$KG$20240813$$CN$US$US
240877071$24087707$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5835362$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240877081$24087708$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5836892$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240877091$24087709$1$I$$20240709$20240715$20240715$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01259$NOVITIUM PHARMA$Vincenzo Maria Perriello.CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma.American Journal of Hematology.08-NOV-2022;98:212-219$63$YR$A$M$Y$$$20240715$$HP$IT$IT
240877101$24087710$1$I$$20240710$20240715$20240715$PER$$US-TAKEDA-2024TUS071149$TAKEDA$$64$YR$$F$Y$$$20240715$$CN$US$US
240877111$24087711$1$I$20240101$20240709$20240715$20240715$EXP$$US-ABBVIE-5832187$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240877121$24087712$1$I$20240229$20240710$20240715$20240715$EXP$$US-ABBVIE-5836816$ABBVIE$$33$YR$$M$Y$$$20240715$$CN$US$US
240877131$24087713$1$I$$20240412$20240715$20240715$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-08273$ALKEM$Sun D, Yu CH, Liu ZS, He XL, Hu JS, Wu GF, Mao B, Wu SH, Xiang HH.. Association of HLAB* 1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China. Huazhong Univ. Sci. Technolog. Med. Sci. 2014;34(1):146-150$6$YR$$F$Y$$$20240715$$HP$CN$CN
240877141$24087714$1$I$$20240416$20240715$20240715$EXP$$SA-ALKEM LABORATORIES LIMITED-SA-ALKEM-2024-08808$ALKEM$Muthaffar OY, Alqarni A, Shafei JA, Bahowarth SY, Alyazidi AS, Naseer MI.. Childhood-related neural genotype-phenotype in ATP1A3 mutations: comprehensive analysis. Genes + Genomics. 2024;46:475-487$2$YR$$$Y$$$20240715$$HP$SA$SA
240877151$24087715$1$I$$20240419$20240715$20240715$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-08838$ALKEM$Shankarkumar U, Shah KN, Ghosh K. Letter: HLA B*15:02 allele association with oxcarbamazepine-induced skin reactions in epilepsy patient from India. Epilepsia. 2009;50(7):1837-8$$$$$Y$$$20240715$$HP$IN$IN
240877161$24087716$1$I$$20240412$20240715$20240715$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-08274$ALKEM$Sun D, Yu CH, Liu ZS, He XL, Hu JS, Wu GF, Mao B, Wu SH, Xiang HH.. Association of HLAB* 1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China. J Huazhong Univ. Sci. Technolog. (Med. Sci). 2014;34(1):146-150$1$YR$$M$Y$$$20240715$$HP$CN$CN
240877171$24087717$1$I$$20240412$20240715$20240715$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-08275$ALKEM$Sun D, Yu CH, Liu ZS, He XL, Hu JS, Wu GF, Mao B, Wu SH, Xiang HH. Association of HLAB* 1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China. J Huazhong Univ. Sci. Technolog. (Med. Sci). 2014;34(1):146-150$3$YR$$F$Y$$$20240715$$HP$CN$CN
240877181$24087718$1$I$$20240528$20240715$20240715$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-12086$ALKEM$Ruppert E et al.. Characterization of periodic upper limb movement disorder in a patient with restless arms syndrome. Movement Disorders: Official J. Movement Disorder Society. 2012;27:1459-1461$40$YR$$F$Y$$$20240715$$HP$FR$FR
240877191$24087719$1$I$$20240424$20240715$20240715$EXP$$AT-ALKEM LABORATORIES LIMITED-AT-ALKEM-2024-09374$ALKEM$Windhaber J, Maierhofer D and Dantendorfer K. Oxcarbazepine for panic disorder occurring after two grand mal seizures: a case report. J Clin Psychiatry. 1997;58:404-405$23$YR$$M$Y$$$20240715$$HP$AT$AT
240877201$24087720$1$I$$20240412$20240715$20240715$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-07442$ALKEM$Sun D, Yu CH, Liu ZS, He XL, Hu JS, Wu GF, Mao B, Wu SH, Xiang HH. Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2014;34(1):146-150$8$YR$$M$Y$$$20240715$$HP$CN$CN
240877212$24087721$2$F$20240613$20240808$20240715$20240822$PER$$US-AstraZeneca-2024A138141$ASTRAZENECA$$28907$DY$$F$Y$$$20240822$$CN$US$
240877221$24087722$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA200970$SANOFI AVENTIS$$$$A$F$Y$$$20240715$$MD$US$US
240877232$24087723$2$F$20240614$20240723$20240715$20240729$PER$$US-AMGEN-USASP2024135626$AMGEN$$64$YR$A$F$Y$81.542$KG$20240729$$HP$US$US
240877241$24087724$1$I$20240316$20240708$20240715$20240715$EXP$GB-MHRA-MED-202405081234168730-VGBQC$GB-STRIDES ARCOLAB LIMITED-2024SP008299$STRIDES$$8$YR$$M$Y$22$KG$20240715$$CN$GB$GB
240877251$24087725$1$I$$20240704$20240715$20240715$EXP$$CO-STRIDES ARCOLAB LIMITED-2024SP008366$STRIDES$Mejia-Salgado G, Cardozo-Perez C, Cifuentes-Gonzalez C, Duran-Merino C, de-la-Torre A.. Coinfection Suspicion is Imperative in Immunosuppressed Patients with Suspected Infectious Uveitis and Inadequate Treatment Response: A Case Report.. Ocular-Immunol-Inflamm. 2024;0 (0)$70$YR$$F$Y$$$20240715$$MD$CO$CO
240877261$24087726$1$I$$20240703$20240715$20240715$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008230$STRIDES$Kikkawa K, Wakamiya T, Kojima F, Kohjimoto Y, Hara I.. Nephrectomy for emphysematous pyelonephritis in a nonfunctional renal allograft due to rejection after kidney transplantation.. Afr-J-Urol. 2024;30 (1)$71$YR$$M$Y$$$20240715$$HP$JP$JP
240877271$24087727$1$I$20220301$20240710$20240715$20240715$EXP$$US-ABBVIE-5836063$ABBVIE$$76$YR$$F$Y$$$20240715$$CN$US$US
240877281$24087728$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA203082$SANOFI AVENTIS$$$$$M$Y$$$20240715$$MD$US$US
240877291$24087729$1$I$$20240620$20240715$20240715$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002923$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240715$$HP$US$US
240877302$24087730$2$F$20240705$20240805$20240715$20240808$30DAY$$US-AMGEN-USASP2024136694$AMGEN$$39$YR$A$F$Y$97.5$KG$20240808$$PH$US$US
240877311$24087731$1$I$20240523$20240711$20240715$20240715$EXP$SE-SEMPA-2024-004551$SE-JNJFOC-20240728496$JOHNSON AND JOHNSON$$45$YR$A$F$Y$63$KG$20240715$$CN$SE$SE
240877331$24087733$1$I$$20240708$20240715$20240715$EXP$GB-MHRA-MED-202405060721540350-JFMKW$GB-STRIDES ARCOLAB LIMITED-2024SP008344$STRIDES$$$$$M$Y$82$KG$20240715$$CN$GB$GB
240877341$24087734$1$I$20240617$20240620$20240715$20240715$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002924$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240715$$CN$US$US
240877351$24087735$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA204174$SANOFI AVENTIS$$$$A$M$Y$$$20240715$$MD$US$US
240877361$24087736$1$I$$20240708$20240715$20240715$EXP$GB-MHRA-MED-202405020930463390-BMKSH$GB-STRIDES ARCOLAB LIMITED-2024SP008338$STRIDES$$$$$$Y$$$20240715$$PH$GB$GB
240877372$24087737$2$F$20240626$20240710$20240715$20240725$EXP$$US-MDD US Operations-MDD202407-002363$MDD OPERATIONS$$61$YR$$M$Y$$$20240725$$HP$US$
240877381$24087738$1$I$20240630$20240705$20240715$20240715$PER$$US-SA-2024SA202816$SANOFI AVENTIS$$64$YR$A$F$Y$117$KG$20240715$$MD$US$US
240877391$24087739$1$I$$20240711$20240715$20240715$PER$$US-JNJFOC-20240729693$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240877401$24087740$1$I$20020101$20240705$20240715$20240715$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008435$STRIDES$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN.. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series.. Pediatr-Blood-Cancer. 2024;71 (7):e31004$21$YR$$M$Y$$$20240715$$HP$US$US
240877412$24087741$2$F$20240101$20240722$20240715$20240725$EXP$$US-ABBVIE-5838947$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
240877421$24087742$1$I$$20240705$20240715$20240715$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008434$STRIDES$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN.. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series.. Pediatr-Blood-Cancer. 2024;71 (7):e31004$3$DEC$$M$Y$$$20240715$$HP$US$US
240877431$24087743$1$I$20100101$20240705$20240715$20240715$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008429$STRIDES$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN.. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series.. Pediatr-Blood-Cancer. 2024;71 (7):e31004$10$YR$$F$Y$$$20240715$$HP$US$US
240877441$24087744$1$I$20240629$20240704$20240715$20240715$EXP$$BR-SA-2024SA200529$SANOFI AVENTIS$$31$YR$A$F$Y$62.8$KG$20240715$$PH$BR$BR
240877451$24087745$1$I$$20240702$20240715$20240715$EXP$US-MLMSERVICE-20240624-PI111373-00128-1$US-RDY-SPO/USA/24/0009748$DR REDDYS$Aslam Khan A, Anwar MS, Cherukuri PB, Abu-Shanab A, Fish PN. Community-Acquired Meningitis Complicated With Pyogenic Ventriculitis and Hydrocephalus in a Patient With Haematological Malignancy: A Case Report and Literature Review. Cureus. 2024;16(5):e60800. DOI:10.7759/cureus.60800.$85$YR$E$F$Y$$$20240715$$MD$US$US
240877471$24087747$1$I$20060101$20240705$20240715$20240715$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008418$STRIDES$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN.. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series.. Pediatr-Blood-Cancer. 2024;71 (7):e31004$1$YR$$F$Y$$$20240715$$HP$US$US
240877481$24087748$1$I$$20240708$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407005537$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240715$$CN$US$US
240877491$24087749$1$I$$20240705$20240715$20240715$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP008419$STRIDES$Carpenedo M, Zappaterra A, Ferrari B, Cotilli G.. Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists.. Mediterr-J-Hematol-Infect-Dis. 2023;15 (1)$80$YR$$M$Y$$$20240715$$HP$IT$IT
240877501$24087750$1$I$20240627$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024137689$AMGEN$$39$YR$A$F$Y$$$20240714$$HP$US$US
240877511$24087751$1$I$$20240705$20240715$20240715$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP008425$STRIDES$Kwon H-J, Kim K-H, Yoon J-H.. Refractory Bullous Pemphigoid Successfully Treated with Reslizumab: A Possible Novel Therapeutic Modality.. Ann-Dermatol. 2023;35 (Suppl. 1):S103-S106$69$YR$$M$Y$$$20240715$$HP$KR$KR
240877522$24087752$2$F$20240708$20240814$20240715$20240819$EXP$$ES-ABBVIE-5835438$ABBVIE$$58$YR$$M$Y$75.9$KG$20240819$$MD$ES$ES
240877531$24087753$1$I$$20240705$20240715$20240715$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP008408$STRIDES$Morena A, Matta M, Ferraris F, Frea S, Anselmino M, Berruquier P, et al.. CONTINUOUS LEFT STELLATE GANGLION BLOCK DURING VT ABLATION TO SLOW VT AND IMPROVE ABLATION OUTCOME.. Eur-Heart-J-Suppl. 2024;26 (Suppl. 2):ii146.$71$YR$$M$Y$$$20240715$$HP$IT$IT
240877542$24087754$2$F$20240213$20240716$20240715$20240720$EXP$$CN-AMGEN-CHNNI2024135641$AMGEN$$84$YR$E$F$Y$72$KG$20240720$$MD$CN$CN
240877551$24087755$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111141$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240715$$CN$US$US
240877561$24087756$1$I$$20240619$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110091$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$84.37$KG$20240715$$HP$US$US
240877571$24087757$1$I$20240603$20240712$20240715$20240715$EXP$$US-ABBVIE-5838961$ABBVIE$$88$YR$$M$Y$$$20240715$$CN$US$US
240877581$24087758$1$I$$20240613$20240715$20240715$PER$$US-STERISCIENCE B.V.-2024-ST-000842$Steriscience PTE$Sanz M, Chernet S, Shymansky J, Mandel A, Chitrakar A, Kaminski HJ et al.. Mycophenolate mofetil for the long-term treatment of HTLV-1 associated myelopathy: A case report.. Journal of Neuroimmunology. 2024;388:578294$$$$F$Y$$$20240715$$HP$US$US
240877591$24087759$1$I$20240624$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111225$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$63.5$KG$20240715$$HP$US$US
240877601$24087760$1$I$$20240619$20240715$20240715$PER$$US-STERISCIENCE B.V.-2024-ST-000916$Steriscience PTE$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients.. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster)$$$$$Y$$$20240715$$HP$US$US
240877611$24087761$1$I$$20240619$20240715$20240715$PER$$US-STERISCIENCE B.V.-2024-ST-000918$Steriscience PTE$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients.. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster)$$$$$Y$$$20240715$$HP$US$US
240877621$24087762$1$I$$20240620$20240715$20240715$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002927$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
240877631$24087763$1$I$$20240619$20240715$20240715$PER$$US-STERISCIENCE B.V.-2024-ST-000919$Steriscience PTE$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster)$$$$$Y$$$20240715$$HP$US$US
240877641$24087764$1$I$$20240704$20240715$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107178$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240715$$HP$CA$CA
240877651$24087765$1$I$20240625$20240710$20240715$20240715$EXP$$CO-ABBVIE-5838672$ABBVIE$$82$YR$$M$Y$$$20240715$$CN$CO$CO
240877661$24087766$1$I$$20240710$20240715$20240715$PER$$US-JNJFOC-20240731113$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240877671$24087767$1$I$$20240710$20240715$20240715$EXP$$IN-NOVITIUMPHARMA-2024INNVP01287$NOVITIUM PHARMA$Nathi D.Unraveling Ibrutinib Resistance in Chronic Lymphocytic Leukemia: A Case Study on the Role of Bruton Tyrosine Kinase Mutation. Indian Journal of Hematology and Blood Transfusion.19-OCT-2023;39:S185-S186$67$YR$A$F$Y$$$20240715$$HP$IN$IN
240877681$24087768$1$I$20180101$20240710$20240715$20240715$EXP$$CL-ABBVIE-5837199$ABBVIE$$$$$F$Y$$$20240715$$CN$CL$CL
240877691$24087769$1$I$20170101$20240710$20240715$20240715$EXP$$PR-ABBVIE-5835158$ABBVIE$$$$$F$Y$102.05$KG$20240715$$CN$PR$PR
240877701$24087770$1$I$$20240708$20240715$20240715$EXP$$CA-EMD Serono-2024033115$EMD SERONO INC$$$$A$F$Y$$$20240715$$CN$CA$CA
240877711$24087771$1$I$$20240710$20240715$20240715$EXP$$BR-GENMAB-2024-02484$GENMAB$$$$$F$Y$$$20240715$$MD$BR$BR
240877721$24087772$1$I$$20240711$20240715$20240715$EXP$$US-SANDOZ INC.-SDZ2024US064844$SANDOZ$$$$$F$Y$$$20240715$$MD$US$US
240877731$24087773$1$I$$20240704$20240715$20240715$PER$$US-AstraZeneca-2024A152500$ASTRAZENECA$$81$YR$$F$Y$65.3$KG$20240715$$CN$US$
240877741$24087774$1$I$20220501$20240709$20240715$20240715$EXP$$GB-TAKEDA-2022TUS071322$TAKEDA$$71$YR$$M$Y$$$20240715$$CN$GB$GB
240877752$24087775$2$F$20240115$20240917$20240715$20240919$EXP$$BR-TAKEDA-2022TUS081847$TAKEDA$$58$YR$$F$Y$$$20240919$$CN$BR$BR
240877771$24087777$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007189$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240715$$CN$US$US
240877781$24087778$1$I$20240601$20240708$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407005008$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240715$$CN$US$US
240877791$24087779$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007079$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240715$$CN$US$US
240877801$24087780$1$I$$20240704$20240715$20240715$EXP$$DE-AUROBINDO-AUR-APL-2024-033426$AUROBINDO$$29$YR$$F$Y$$$20240715$$MD$DE$DE
240877811$24087781$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218572$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240877821$24087782$1$I$20240712$20240712$20240715$20240715$EXP$GB-MHRA-MED-202407121432555930-TMPSL$GB-JNJFOC-20240733568$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$PH$GB$GB
240877832$24087783$2$F$$20240709$20240715$20240718$EXP$$US-JNJFOC-20240723037$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240719$$MD$US$US
240877842$24087784$2$F$20160901$20240724$20240715$20240802$EXP$$US-AMGEN-USASP2024136406$AMGEN$$69$YR$E$M$Y$112.5$KG$20240802$$LW$US$US
240877852$24087785$2$F$20240101$20240920$20240715$20240926$PER$$US-ABBVIE-5833736$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
240877861$24087786$1$I$$20240711$20240715$20240715$EXP$$US-TAKEDA-2023TUS114235$TAKEDA$$$$$F$Y$$$20240715$$MD$US$US
240877871$24087787$1$I$20240523$20240704$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-033339$AUROBINDO$$63$YR$$F$Y$32$KG$20240715$$HP$FR$FR
240877881$24087788$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3219186$TEVA$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.; Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.$45$YR$$M$Y$$$20240715$$HP$US$US
240877892$24087789$2$F$20240701$20240701$20240715$20240909$EXP$$CN-EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD.-EVI-CN-2024-000021$Evive Biotechnology$$$$$M$Y$$$20240909$$MD$CN$CN
240877901$24087790$1$I$$20240705$20240715$20240715$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000601$DECIPHERA PHARMACEUTICALS$$85$YR$E$F$Y$77.279$KG$20240715$$CN$US$US
240877912$24087791$2$F$20240610$20240802$20240715$20240826$PER$$BR-TOLMAR, INC.-24BR050361$TOLMAR$$53$YR$$M$Y$$$20240826$$PH$BR$BR
240877921$24087792$1$I$$20240624$20240715$20240715$PER$$AU-TOLMAR, INC.-24AU050532$TOLMAR$$$$$M$Y$$$20240715$$CN$AU$AU
240877941$24087794$1$I$20240620$20240624$20240715$20240715$PER$$BR-TOLMAR, INC.-24BR050444$TOLMAR$$12$YR$$M$Y$$$20240715$$PH$BR$BR
240877951$24087795$1$I$20240708$20240710$20240715$20240715$30DAY$$FR-SANDOZ INC.-SDZ2024FR064871$SANDOZ$$$$$M$Y$$$20240715$$CN$FR$FR
240877961$24087796$1$I$20240301$20240624$20240715$20240715$PER$$CA-TOLMAR, INC.-24CA050342$TOLMAR$$81$YR$$M$Y$$$20240715$$CN$CA$CA
240877971$24087797$1$I$20240610$20240624$20240715$20240715$PER$$CA-TOLMAR, INC.-24CA050186$TOLMAR$$60$YR$$M$Y$$$20240715$$HP$CA$CA
240877981$24087798$1$I$20240619$20240624$20240715$20240715$PER$$CA-TOLMAR, INC.-24CA050320$TOLMAR$$77$YR$$M$Y$$$20240715$$CN$CA$CA
240878002$24087800$2$F$20240101$20240916$20240715$20240925$PER$$CA-TOLMAR, INC.-24CA050462$TOLMAR$$$$$M$Y$$$20240924$$CN$CA$CA
240878011$24087801$1$I$20240501$20240709$20240715$20240715$EXP$$US-JNJFOC-20240540779$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240715$$HP$US$US
240878021$24087802$1$I$20240702$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109715$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240715$$PH$US$US
240878032$24087803$2$F$20240501$20240820$20240715$20240828$30DAY$$US-GSK-US2024084051$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240828$$MD$US$US
240878041$24087804$1$I$$20240704$20240715$20240715$EXP$$ES-AUROBINDO-AUR-APL-2024-033506$AUROBINDO$$62$YR$$F$Y$$$20240715$$CN$ES$ES
240878051$24087805$1$I$$20240710$20240715$20240715$EXP$$GB-AstraZeneca-2024A157799$ASTRAZENECA$$56$YR$$M$Y$78$KG$20240715$$MD$GB$
240878071$24087807$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA203261$SANOFI AVENTIS$$$$E$M$Y$$$20240715$$CN$US$US
240878081$24087808$1$I$$20240711$20240715$20240715$EXP$$US-SANDOZ INC.-SDZ2024US064891$SANDOZ$$$$$F$Y$$$20240715$$HP$US$US
240878102$24087810$2$F$$20240722$20240715$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111369$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240724$$CN$US$US
240878111$24087811$1$I$$20240708$20240715$20240715$EXP$$US-JNJFOC-20240720295$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240878122$24087812$2$F$20240607$20240808$20240715$20240811$PER$$US-JNJFOC-20240725502$JOHNSON AND JOHNSON$$$$$$Y$$$20240811$$HP$US$US
240878132$24087813$2$F$20240711$20240715$20240715$20240717$PER$$US-AMGEN-USASP2024139668$AMGEN$$69$YR$E$F$Y$$$20240717$$CN$US$US
240878141$24087814$1$I$$20240710$20240715$20240715$EXP$$SY-NOVITIUMPHARMA-2024SYNVP01276$NOVITIUM PHARMA$Khalayli, Naram.Antineutrophil cytoplasmic antibody-associated vasculitis with systemic sclerosis: A fatal case report.Annals of Medicine and Surgery.04-OCT-2023;85(11):5770-5775$81$YR$E$F$Y$$$20240715$$HP$SY$SY
240878151$24087815$1$I$20230901$20240701$20240715$20240715$EXP$$DE-PHARMAESSENTIA-DE-2024-PEC-004002$PHARMAESSENTIA$$36$YR$$F$Y$$$20240715$$CN$DE$DE
240878161$24087816$1$I$20240619$20240625$20240715$20240715$EXP$CN-GUERBET / FUNDTRIP PHARMACEUTICALS-CN-20240177$CN-GUERBET / LLC-CN-20240177$GUERBET$$15$YR$T$M$Y$50$KG$20240709$$HP$CN$CN
240878171$24087817$1$I$$20240702$20240715$20240715$PER$$US-CHATTEMPRD-2024OHG023008$CHATTEM$$72$YR$E$F$Y$$$20240715$$CN$US$US
240878181$24087818$1$I$20240301$20240710$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110531$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240715$$CN$US$US
240878192$24087819$2$F$$20240711$20240715$20240722$EXP$$CA-TAKEDA-2024TUS070106$TAKEDA$$$$$F$Y$$$20240722$$CN$CA$CA
240878202$24087820$2$F$20210801$20240711$20240715$20240724$EXP$$US-ABBVIE-5836225$ABBVIE$$81$YR$$M$Y$$$20240724$$CN$US$US
240878212$24087821$2$F$20240101$20240723$20240715$20240730$EXP$$US-BIOGEN-2024BI01273408$BIOGEN$$$$$M$Y$$$20240730$$CN$US$US
240878222$24087822$2$F$20240701$20240808$20240715$20240810$PER$$US-AMGEN-USASP2024139673$AMGEN$$87$YR$E$F$Y$$$20240810$$CN$US$US
240878231$24087823$1$I$20240611$20240709$20240715$20240715$PER$$US-JNJFOC-20240725410$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$HP$US$US
240878243$24087824$3$F$20240601$20240823$20240715$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002898$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240916$$CN$US$US
240878251$24087825$1$I$20240416$20240619$20240715$20240715$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000515$PAREXEL$$$$$$Y$$$20240715$$HP$US$US
240878262$24087826$2$F$$20240730$20240715$20240802$PER$$US-LEO Pharma-371885$LEO PHARM$$18$YR$$F$Y$$$20240802$$PH$US$US
240878271$24087827$1$I$20240619$20240620$20240715$20240715$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000526$PAREXEL$$$$$$Y$$$20240715$$MD$US$US
240878281$24087828$1$I$$20240709$20240715$20240715$PER$$US-ABBVIE-5835471$ABBVIE$$$$E$$Y$$$20240715$$CN$US$US
240878293$24087829$3$F$20240920$20240920$20240715$20240926$EXP$$CA-TAKEDA-2024TUS070653$TAKEDA$$72$YR$$F$Y$$$20240926$$CN$CA$CA
240878301$24087830$1$I$20240221$20240705$20240715$20240715$EXP$$CN-BEIGENE-BGN-2024-010487$BEIGENE$$$$$$Y$$$20240715$$HP$CN$CN
240878311$24087831$1$I$20240628$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111370$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240715$$CN$US$US
240878321$24087832$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218613$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240878331$24087833$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218514$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240878341$24087834$1$I$$20240710$20240715$20240715$EXP$$US-NOVITIUMPHARMA-2024USNVP01281$NOVITIUM PHARMA$Janet Fan.Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers.Case Reports in Oncology.28-MAR-2024;17(1):517-523$56$YR$A$M$Y$$$20240715$$HP$US$US
240878351$24087835$1$I$$20240710$20240715$20240715$PER$$US-BIOVITRUM-2024-US-009785$BIOVITRUM$$84$YR$$M$Y$$$20240715$$CN$US$US
240878361$24087836$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218530$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240878371$24087837$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218532$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240878381$24087838$1$I$20230725$20240624$20240715$20240715$EXP$$DE-ROCHE-3396319$ROCHE$$26$YR$A$M$Y$$$20240715$$CN$DE$DE
240878391$24087839$1$I$$20240708$20240715$20240715$PER$$US-LEO Pharma-371883$LEO PHARM$$51$YR$$M$Y$$$20240715$$PH$US$US
240878402$24087840$2$F$20240101$20240821$20240715$20240912$PER$$US-SA-2024SA049010$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240912$$CN$US$US
240878411$24087841$1$I$20240601$20240703$20240715$20240715$PER$$US-SA-2024SA182045$SANOFI AVENTIS$$65$YR$E$F$Y$91.98$KG$20240715$$MD$US$US
240878421$24087842$1$I$$20240709$20240715$20240715$PER$$US-JNJFOC-20240727273$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$PH$US$US
240878433$24087843$3$F$$20240812$20240715$20240813$EXP$$US-JNJFOC-20240725696$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240814$$CN$US$US
240878442$24087844$2$F$$20240715$20240715$20240717$PER$$US-JNJFOC-20240723993$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$CN$US$US
240878452$24087845$2$F$$20240819$20240715$20240823$EXP$$CA-ABBVIE-5837268$ABBVIE$$$$A$F$Y$$$20240823$$CN$CA$CA
240878462$24087846$2$F$20240628$20240715$20240715$20240717$PER$$US-AMGEN-USASP2024139687$AMGEN$$79$YR$E$M$Y$$$20240717$$CN$US$US
240878472$24087847$2$F$$20240820$20240715$20240828$EXP$$JP-AMGEN-JPNSP2024135523$AMGEN$$8$DEC$E$$Y$$$20240828$$MD$JP$JP
240878481$24087848$1$I$20240301$20240710$20240715$20240715$EXP$$US-ABBVIE-5835507$ABBVIE$$47$YR$$M$Y$$$20240715$$CN$US$US
240878491$24087849$1$I$$20240709$20240715$20240715$PER$$US-JNJFOC-20240727062$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$HP$US$US
240878501$24087850$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218536$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240878521$24087852$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218559$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240878534$24087853$4$F$$20240808$20240715$20240816$EXP$BE-FAMHP-DHH-N2024-122326$BE-SA-2024SA201503$SANOFI AVENTIS$$$$$M$Y$$$20240816$$PH$BE$BE
240878541$24087854$1$I$20230501$20240708$20240715$20240715$EXP$$US-SA-2024SA204743$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240715$$MD$US$US
240878551$24087855$1$I$20230101$20240710$20240715$20240715$EXP$$US-ABBVIE-5837127$ABBVIE$$87$YR$$F$Y$$$20240715$$CN$US$US
240878561$24087856$1$I$20240415$20240702$20240715$20240715$EXP$GB-MHRA-MED-202407021248095350-GNCRY$GB-DEXPHARM-2024-2195$DEXCEL$$77$YR$E$M$Y$$$20240715$$CN$GB$GB
240878572$24087857$2$F$$20240828$20240715$20240828$PER$$NVSC2024US144817$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
240878581$24087858$1$I$20240601$20240708$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407005551$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240715$$CN$US$US
240878591$24087859$1$I$$20240703$20240715$20240715$PER$$US-SA-2024SA200572$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240715$$MD$US$US
240878601$24087860$1$I$20240425$20240708$20240715$20240715$PER$$US-SA-2024SA203997$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240715$$MD$US$US
240878611$24087861$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA204233$SANOFI AVENTIS$$$$E$F$Y$$$20240715$$MD$US$US
240878621$24087862$1$I$20240101$20240710$20240715$20240715$PER$$US-SA-2024SA205095$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240715$$MD$US$US
240878631$24087863$1$I$20240708$20240710$20240715$20240715$PER$$US-SA-2024SA205132$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240715$$MD$US$US
240878641$24087864$1$I$20240512$20240711$20240715$20240715$EXP$$US-ABBVIE-5838362$ABBVIE$$78$YR$$F$Y$$$20240715$$CN$US$US
240878651$24087865$1$I$$20240708$20240715$20240715$PER$$US-AMGEN-USASP2024136174$AMGEN$$$$$$Y$$$20240714$$CN$US$US
240878664$24087866$4$F$$20240812$20240715$20240813$PER$$US-AMGEN-USASP2024139538$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
240878671$24087867$1$I$20240101$20240711$20240715$20240715$EXP$$US-ABBVIE-5838331$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240878681$24087868$1$I$20240101$20240710$20240715$20240715$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-096603$REGENERON$$$$$$Y$$$20240715$$CN$US$US
240878692$24087869$2$F$20240601$20240731$20240715$20240808$EXP$$CN-BEIGENE-BGN-2024-010559$BEIGENE$$$$$$Y$$$20240808$$CN$CN$CN
240878701$24087870$1$I$20240601$20240709$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110026$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240715$$HP$US$US
240878711$24087871$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111013$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$73.03$KG$20240715$$CN$US$US
240878722$24087872$2$F$$20240801$20240715$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111325$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$65.77$KG$20240805$$CN$US$US
240878731$24087873$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110408$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$88.45$KG$20240715$$CN$US$US
240878741$24087874$1$I$$20240712$20240715$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039576$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240715$$CN$US$US
240878751$24087875$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000025704$ROCHE$$$$$$Y$$$20240715$$MD$US$US
240878762$24087876$2$F$20240101$20240715$20240715$20240724$EXP$$CA-TAKEDA-2024TUS040572$TAKEDA$$$$$M$Y$$$20240724$$CN$CA$CA
240878771$24087877$1$I$$20240709$20240715$20240715$EXP$$DE-BIOVITRUM-2024-DE-009645$BIOVITRUM$$88$YR$$F$Y$$$20240715$$MD$DE$DE
240878781$24087878$1$I$20110101$20240709$20240715$20240715$PER$$US-ABBVIE-5836703$ABBVIE$$$$$M$Y$106.59$KG$20240715$$CN$US$US
240878791$24087879$1$I$$20240704$20240715$20240715$EXP$GB-MHRA-MED-202405020930463390-BMKSH$GB-RDY-SPO/GBR/24/0009887$DR REDDYS$$$$$$Y$$$20240715$$PH$GB$GB
240878801$24087880$1$I$$20240702$20240715$20240715$EXP$$US-ALVOGEN-2024095024$ALVOGEN$$$$$$Y$$$20240715$$HP$US$US
240878811$24087881$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3219206$TEVA$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.; Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.$61$YR$$M$Y$$$20240715$$HP$US$US
240878821$24087882$1$I$$20240710$20240715$20240715$EXP$$ES-NOVITIUMPHARMA-2024ESNVP01284$NOVITIUM PHARMA$Sara Martin-Aguilar.Complete response to switch immunodepression of late-onset post-transplant lymphoproliferative disease (PTLD).Medicina Clinica.21-JUL-2023;161(2):86-87$$$A$M$Y$$$20240715$$HP$ES$ES
240878831$24087883$1$I$$20240706$20240715$20240715$EXP$$CN-BEIGENE-BGN-2024-010613$BEIGENE$$$$$$Y$$$20240715$$CN$CN$CN
240878843$24087884$3$F$20240701$20240717$20240715$20240722$PER$$US-AMGEN-USASP2024139088$AMGEN$$58$YR$A$F$Y$$$20240722$$CN$US$US
240878851$24087885$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138745$AMGEN$$$$$M$Y$$$20240714$$CN$US$US
240878861$24087886$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218620$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240878871$24087887$1$I$$20240707$20240715$20240715$EXP$GB-MHRA-MED-202407051358551410-MLWKF$GB-CHEPLA-2024008615$CHEPLAPHARM$$$$$M$Y$$$20240712$$MD$COUNTRY NOT SPECIFIED$GB
240878881$24087888$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000025673$ROCHE$$$$$$Y$$$20240715$$MD$US$US
240878891$24087889$1$I$20240626$20240703$20240715$20240715$EXP$$US-ALVOGEN-2024095040$ALVOGEN$$$$$F$Y$$$20240715$$CN$US$US
240878901$24087890$1$I$$20240705$20240715$20240715$EXP$$BR-TAKEDA-2024TUS070420$TAKEDA$$$$$F$Y$$$20240715$$CN$BR$BR
240878911$24087891$1$I$20240101$20240710$20240715$20240715$EXP$$US-ABBVIE-5836602$ABBVIE$$46$YR$$M$Y$$$20240715$$CN$US$US
240878921$24087892$1$I$20240601$20240710$20240715$20240715$EXP$$US-ABBVIE-5836984$ABBVIE$$78$YR$$M$Y$$$20240715$$CN$US$US
240878932$24087893$2$F$20240101$20240713$20240715$20240718$EXP$$GR-ABBVIE-5836906$ABBVIE$$$$$F$Y$$$20240718$$CN$GR$GR
240878951$24087895$1$I$20240201$20240705$20240715$20240715$EXP$$DE-CHEPLA-2024008723$CHEPLAPHARM$$$$$M$Y$$$20240714$$CN$COUNTRY NOT SPECIFIED$DE
240878961$24087896$1$I$$20240708$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110292$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240715$$HP$US$US
240878971$24087897$1$I$20240704$20240710$20240715$20240715$EXP$$US-ABBVIE-5836395$ABBVIE$$73$YR$$F$Y$$$20240715$$CN$US$US
240878981$24087898$1$I$20240501$20240705$20240715$20240715$EXP$FR-AFSSAPS-PB2024000736$FR-TEVA-VS-3218238$TEVA$$38$YR$$F$Y$$$20240715$$MD$FR$FR
240878991$24087899$1$I$$20240704$20240715$20240715$EXP$GB-MHRA-MED-202404302151369050-KRZFG$GB-RDY-SPO/GBR/24/0009914$DR REDDYS$$$$$M$Y$$$20240715$$CN$GB$GB
240879001$24087900$1$I$20240703$20240710$20240715$20240715$EXP$$US-ABBVIE-5836965$ABBVIE$$72$YR$$F$Y$$$20240715$$CN$US$US
240879011$24087901$1$I$$20240702$20240715$20240715$EXP$$US-MDD US Operations-MDD202407-002374$MDD OPERATIONS$$61$YR$$M$Y$$$20240715$$HP$US$
240879022$24087902$2$F$20240607$20240823$20240715$20240827$EXP$$DE-JNJFOC-20240631204$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240827$$HP$DE$DE
240879031$24087903$1$I$20240703$20240712$20240715$20240715$PER$$US-JNJFOC-20240734586$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240715$$CN$US$US
240879061$24087906$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218208$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240879071$24087907$1$I$$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007018$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240715$$CN$US$US
240879081$24087908$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008084$ELI LILLY AND CO$$$$$F$Y$$$20240715$$CN$US$US
240879091$24087909$1$I$$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407006213$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240715$$CN$US$US
240879101$24087910$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007699$ELI LILLY AND CO$$$$A$M$Y$$$20240715$$CN$US$US
240879112$24087911$2$F$20240708$20240730$20240715$20240805$EXP$$PT-ABBVIE-5836917$ABBVIE$$88$YR$$F$Y$$$20240805$$CN$PT$PT
240879122$24087912$2$F$20240701$20240722$20240715$20240813$EXP$$US-AMGEN-USASP2024137198$AMGEN$$64$YR$A$M$Y$$$20240813$$CN$US$US
240879131$24087913$1$I$20240525$20240709$20240715$20240715$EXP$$JP-SA-2024SA202373$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240715$$HP$JP$JP
240879141$24087914$1$I$20240710$20240710$20240715$20240715$EXP$$US-ABBVIE-5837165$ABBVIE$$19$YR$$F$Y$$$20240715$$CN$US$US
240879151$24087915$1$I$20240411$20240709$20240715$20240715$EXP$$CA-JNJFOC-20240456054$JOHNSON AND JOHNSON$$17$YR$T$M$Y$61.7$KG$20240715$$CN$CA$CA
240879162$24087916$2$F$20231230$20240801$20240715$20240805$EXP$$JP-JNJFOC-20240732327$JOHNSON AND JOHNSON$$87$YR$E$M$Y$$$20240805$$MD$JP$JP
240879171$24087917$1$I$20240529$20240705$20240715$20240715$EXP$$CO-BIOVITRUM-2024-CO-009811$BIOVITRUM$$205$DY$$M$Y$2.8$KG$20240715$$MD$CO$CO
240879181$24087918$1$I$20240701$20240708$20240715$20240715$EXP$$IT-EMD Serono-2024037647$EMD SERONO INC$$71$YR$E$M$Y$$$20240715$$PH$IT$IT
240879191$24087919$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218210$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240879201$24087920$1$I$$20240704$20240715$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-108430$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240715$$HP$CA$CA
240879211$24087921$1$I$$20240711$20240715$20240715$EXP$$JP-ABBVIE-5837792$ABBVIE$$$$$$Y$$$20240715$$PH$JP$JP
240879221$24087922$1$I$20240624$20240705$20240715$20240715$EXP$$CN-BEIGENE-BGN-2024-010494$BEIGENE$$$$$$Y$$$20240715$$HP$CN$CN
240879231$24087923$1$I$$20240708$20240715$20240715$EXP$BE-FAMHP-DHH-N2024-122325$BE-SA-2024SA201545$SANOFI AVENTIS$$$$$F$Y$$$20240715$$PH$BE$BE
240879241$24087924$1$I$$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111250$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240715$$HP$US$US
240879261$24087926$1$I$20240625$20240702$20240715$20240715$EXP$$CN-Hisun Pharmaceuticals-2159108$HISUN PHARMACEUTICALS$$74$YR$$F$Y$57$KG$20240715$$$CN$CN
240879271$24087927$1$I$$20240711$20240715$20240715$30DAY$$US-SANDOZ INC.-SDZ2024US064641$SANDOZ$$$$$F$Y$$$20240715$$CN$US$US
240879281$24087928$1$I$20240701$20240706$20240715$20240715$EXP$$CN-BEIGENE-BGN-2024-010540$BEIGENE$$$$$$Y$$$20240715$$HP$CN$CN
240879291$24087929$1$I$$20240709$20240715$20240715$EXP$$CH-AMGEN-CHESP2024136785$AMGEN$$$$E$F$Y$$$20240714$$MD$CH$CH
240879301$24087930$1$I$20240601$20240712$20240715$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039616$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240715$$CN$US$US
240879311$24087931$1$I$20240701$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139467$AMGEN$$$$$M$Y$$$20240714$$CN$US$US
240879321$24087932$1$I$$20240710$20240715$20240715$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01282$NOVITIUM PHARMA$Seigi Oshima.Cutaneous involvement in diffuse large B-cell lymphoma.Oxford Medical Case Reports.07-JUN-2024;6:266-267$85$YR$E$M$Y$$$20240715$$HP$JP$JP
240879331$24087933$1$I$$20240626$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06431$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240879342$24087934$2$F$20240101$20240801$20240715$20240808$EXP$$US-ABBVIE-5836676$ABBVIE$$$$$M$Y$109$KG$20240808$$CN$US$US
240879351$24087935$1$I$20240601$20240708$20240715$20240715$PER$$US-BIOGEN-2024BI01270903$BIOGEN$$38$YR$$$Y$$$20240715$$CN$US$US
240879361$24087936$1$I$20220517$20240709$20240715$20240715$PER$$US-BIOGEN-2022BI01130420$BIOGEN$$60$YR$$F$Y$$$20240715$$CN$US$US
240879382$24087938$2$F$$20240812$20240715$20240816$PER$$US-BIOGEN-2024BI01273002$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
240879391$24087939$1$I$$20240709$20240715$20240715$PER$$US-BIOGEN-2024BI01273089$BIOGEN$$$$$M$Y$$$20240715$$MD$US$US
240879401$24087940$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138701$AMGEN$$$$$F$Y$$$20240714$$CN$US$US
240879411$24087941$1$I$$20240708$20240715$20240715$EXP$$US-GSK-US2024084488$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$MD$US$US
240879431$24087943$1$I$$20240626$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06448$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240879441$24087944$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111085$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240715$$CN$US$US
240879451$24087945$1$I$20240630$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139600$AMGEN$$66$YR$E$F$Y$$$20240714$$CN$US$US
240879461$24087946$1$I$$20240709$20240715$20240715$EXP$$US-JNJFOC-20240723067$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$US$US
240879471$24087947$1$I$$20240709$20240715$20240715$PER$$US-BIOGEN-2022BI01118571$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240879482$24087948$2$F$20240319$20240712$20240715$20240718$EXP$FR-AFSSAPS-RE2024000646$FR-EMD Serono-2024036842$EMD SERONO INC$$84$YR$E$M$Y$92$KG$20240718$$MD$FR$FR
240879491$24087949$1$I$$20240703$20240715$20240715$EXP$$ES-SA-2024SA200205$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240715$$MD$ES$ES
240879512$24087951$2$F$20240501$20240918$20240715$20240927$PER$$US-SA-2024SA092091$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240927$$MD$US$US
240879521$24087952$1$I$20240513$20240705$20240715$20240715$EXP$FR-AFSSAPS-PC2024000498$FR-TEVA-VS-3218248$TEVA$$49$YR$$F$Y$$$20240715$$PH$FR$FR
240879531$24087953$1$I$20230101$20240710$20240715$20240715$EXP$$US-ABBVIE-5835348$ABBVIE$$$$$M$Y$70$KG$20240715$$CN$US$US
240879541$24087954$1$I$$20240711$20240715$20240715$PER$$US-GILEAD-2024-0680485$GILEAD$$$$$M$Y$$$20240714$$CN$US$US
240879551$24087955$1$I$20240710$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024139418$AMGEN$$79$YR$E$F$Y$$$20240714$$CN$US$US
240879562$24087956$2$F$20240306$20240802$20240715$20240812$EXP$FR-AFSSAPS-AVMA2024000272$FR-TEVA-VS-3218119$TEVA$$74$YR$$F$Y$$$20240812$$PH$FR$FR
240879571$24087957$1$I$$20240708$20240715$20240715$EXP$$US-GSK-US2024AMR085612$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$US$US
240879581$24087958$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138682$AMGEN$$$$$$Y$$$20240714$$PH$US$US
240879592$24087959$2$F$20240712$20240715$20240715$20240716$PER$$US-AMGEN-USASP2024139442$AMGEN$$81$YR$E$F$Y$$$20240716$$CN$US$US
240879601$24087960$1$I$20100101$20240711$20240715$20240715$EXP$FI-FIMEA-202402462$FI-JNJFOC-20240728477$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240715$$CN$FI$FI
240879611$24087961$1$I$$20240705$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108027$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240715$$CN$US$US
240879621$24087962$1$I$$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110120$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240715$$CN$US$US
240879631$24087963$1$I$20190201$20240708$20240715$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038596$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$$$20240715$$MD$US$US
240879641$24087964$1$I$20240601$20240703$20240715$20240715$EXP$$US-NOVOPROD-1252183$NOVO NORDISK$$60$YR$$F$Y$$$20240715$$CN$US$US
240879651$24087965$1$I$$20240703$20240715$20240715$EXP$$EE-NOVOPROD-1253600$NOVO NORDISK$$76$YR$$M$Y$$$20240715$$HP$EE$EE
240879661$24087966$1$I$$20240703$20240715$20240715$EXP$$US-NOVOPROD-1252032$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
240879672$24087967$2$F$$20240902$20240715$20240910$EXP$$US-NOVOPROD-1249340$NOVO NORDISK$$$$$M$Y$$$20240910$$CN$US$US
240879681$24087968$1$I$20240618$20240701$20240715$20240715$EXP$$BR-NOVOPROD-1249237$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$BR$BR
240879691$24087969$1$I$$20240703$20240715$20240715$EXP$$DE-NOVOPROD-1252988$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$DE$DE
240879701$24087970$1$I$20240701$20240703$20240715$20240715$EXP$$GB-NOVOPROD-1251519$NOVO NORDISK$$60$YR$$M$Y$120$KG$20240715$$HP$GB$GB
240879711$24087971$1$I$$20240702$20240715$20240715$EXP$$TR-NOVOPROD-1252717$NOVO NORDISK$$911$MON$$M$Y$75$KG$20240715$$CN$TR$TR
240879721$24087972$1$I$20240518$20240703$20240715$20240715$EXP$$GB-NOVOPROD-1249241$NOVO NORDISK$$50$YR$$F$Y$70$KG$20240715$$PH$GB$GB
240879732$24087973$2$F$$20240724$20240715$20240730$EXP$$CA-JNJFOC-20240489165$JOHNSON AND JOHNSON$$61$YR$A$F$Y$23.154$KG$20240730$$HP$CA$CA
240879741$24087974$1$I$$20240708$20240715$20240715$PER$$US-AMGEN-USASP2024137600$AMGEN$$$$E$F$Y$$$20240714$$CN$US$US
240879752$24087975$2$F$20240712$20240715$20240715$20240716$PER$$US-AMGEN-USASP2024139471$AMGEN$$87$YR$E$M$Y$$$20240716$$HP$US$US
240879761$24087976$1$I$$20240711$20240715$20240715$EXP$$US-ABBVIE-5838068$ABBVIE$$$$$$Y$$$20240715$$CN$US$US
240879772$24087977$2$F$20240101$20240716$20240715$20240725$PER$$US-SA-2024SA205465$SANOFI AVENTIS$$63$YR$A$F$Y$61.68$KG$20240725$$MD$US$US
240879781$24087978$1$I$$20240711$20240715$20240715$EXP$$CA-ABBVIE-5838518$ABBVIE$$$$E$M$Y$$$20240715$$CN$CA$CA
240879792$24087979$2$F$$20240715$20240715$20240722$EXP$$CA-GSK-CA2024084936$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$HP$CA$CA
240879801$24087980$1$I$$20240704$20240715$20240715$EXP$$JP-NOVOPROD-1251252$NOVO NORDISK$$62$YR$$M$Y$$$20240715$$CN$JP$JP
240879811$24087981$1$I$20180101$20240711$20240715$20240715$EXP$$US-ABBVIE-5837141$ABBVIE$$$$$F$Y$108$KG$20240715$$CN$US$US
240879823$24087982$3$F$20240101$20240828$20240715$20240911$EXP$$CA-UCBSA-2024035452$UCB$$$$$F$Y$$$20240911$$CN$CA$CA
240879831$24087983$1$I$20220321$20240704$20240715$20240715$EXP$FR-AFSSAPS-LY2024000977$FR-NOVOPROD-1250373$NOVO NORDISK$$47$YR$$F$Y$165$KG$20240715$$MD$FR$FR
240879844$24087984$4$F$20240301$20240717$20240715$20240725$EXP$$MX-NOVOPROD-1252347$NOVO NORDISK$$38$YR$$F$Y$85.3$KG$20240725$$CN$MX$MX
240879851$24087985$1$I$$20240704$20240715$20240715$EXP$$GB-NOVOPROD-1119244$NOVO NORDISK$$39$YR$$F$Y$92.1$KG$20240715$$MD$GB$GB
240879861$24087986$1$I$20240105$20240704$20240715$20240715$EXP$$HR-NOVOPROD-1249855$NOVO NORDISK$$58$YR$$M$Y$$$20240715$$CN$HR$HR
240879871$24087987$1$I$$20240704$20240715$20240715$EXP$$JP-NOVOPROD-1246232$NOVO NORDISK$A. Kosugi et al.. A case of pancreatogenous diabetes with irreversible bilateral lower limb muscle weakness due to frequent episodes of hypoglycemia. The 97th Annual Congress of the Japan Endocrine Society. 2024;100:384$69$YR$$F$Y$$$20240715$$MD$JP$JP
240879881$24087988$1$I$20240301$20240704$20240715$20240715$EXP$GB-MHRA-MED-202405021124210840-VTWND$GB-NOVOPROD-1252438$NOVO NORDISK$$57$YR$$F$Y$$$20240715$$PH$GB$GB
240879891$24087989$1$I$20240220$20240704$20240715$20240715$EXP$SE-SEMPA-2024-005319$SE-NOVOPROD-1250388$NOVO NORDISK$$71$YR$$F$Y$$$20240715$$MD$SE$SE
240879901$24087990$1$I$$20240704$20240715$20240715$EXP$$AZ-NOVOPROD-1251852$NOVO NORDISK$$50$YR$$F$Y$$$20240715$$MD$AZ$AZ
240879911$24087991$1$I$$20240704$20240715$20240715$EXP$$DE-NOVOPROD-1251323$NOVO NORDISK$$56$YR$$F$Y$$$20240715$$MD$DE$DE
240879921$24087992$1$I$20240702$20240703$20240715$20240715$EXP$$US-NOVOPROD-1251428$NOVO NORDISK$$72$YR$$F$Y$$$20240715$$CN$US$US
240879931$24087993$1$I$20240608$20240703$20240715$20240715$EXP$DE-CADRBFARM-2024329091$DE-NOVOPROD-1251334$NOVO NORDISK$$46$YR$$F$Y$106$KG$20240715$$CN$DE$DE
240879941$24087994$1$I$20240630$20240704$20240715$20240715$EXP$CN-NMPA-3702131013825202400251$CN-NOVOPROD-1251431$NOVO NORDISK$$65$YR$$M$Y$$$20240715$$HP$CN$CN
240879951$24087995$1$I$$20240710$20240715$20240715$EXP$$US-UCBSA-2024035186$UCB$$$$$F$Y$$$20240715$$MD$US$US
240879961$24087996$1$I$20240411$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405161500236480-MVFTR$GB-NOVOPROD-1254235$NOVO NORDISK$$41$YR$$M$Y$130$KG$20240715$$CN$GB$GB
240879971$24087997$1$I$20220101$20240705$20240715$20240715$EXP$$US-NOVOPROD-1253668$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
240879981$24087998$1$I$$20240708$20240715$20240715$EXP$$CN-NOVOPROD-1254353$NOVO NORDISK$Fang Tonga. Forensic aspects of homicides by insulin overdose. Forensic Science International. 2017$55$YR$$M$Y$$$20240715$$HP$CN$CN
240879991$24087999$1$I$$20240701$20240715$20240715$EXP$AU-TGA-0000782721$AU-NOVOPROD-1249783$NOVO NORDISK$$$$$M$Y$$$20240715$$HP$AU$AU
240880001$24088000$1$I$$20240705$20240715$20240715$EXP$$US-NOVOPROD-1252686$NOVO NORDISK$$66$YR$$$Y$$$20240715$$CN$US$US
240880011$24088001$1$I$$20240708$20240715$20240715$EXP$$CA-JNJFOC-20240729855$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240715$$HP$CA$CA
240880021$24088002$1$I$20210316$20240710$20240715$20240715$EXP$$CA-ABBVIE-5819920$ABBVIE$$$$A$M$Y$$$20240715$$CN$CA$CA
240880031$24088003$1$I$20230501$20240709$20240715$20240715$PER$$US-ROCHE-10000024691$ROCHE$$$$A$F$Y$$$20240715$$CN$US$US
240880042$24088004$2$F$20240301$20240812$20240715$20240821$EXP$$US-ROCHE-10000023271$ROCHE$$55$YR$A$F$Y$70.3$KG$20240821$$CN$US$US
240880051$24088005$1$I$20240629$20240709$20240715$20240715$EXP$$CN-SA-2024SA203260$SANOFI AVENTIS$$43$YR$A$M$Y$72$KG$20240715$$HP$CN$CN
240880061$24088006$1$I$20240416$20240705$20240715$20240715$EXP$FR-AFSSAPS-CN2024000636$FR-TEVA-VS-3218241$TEVA$$68$YR$$M$Y$90.5$KG$20240715$$MD$FR$FR
240880071$24088007$1$I$$20240704$20240715$20240715$EXP$$ES-ALVOGEN-2024095095$ALVOGEN$S?nchez-Sellero I, Cabarcos-Fern?ndez P, Jauregu?zar-Rodr?guez ME, Alvarez-Freire I, Tabernero-Duque MJ and Bermejo-Barrera AM. Development and Validation of a Sonication-Assisted Dispersive Liquid?Liquid Microextraction Procedure and an HPLC-PDA Method for Quantitative Determination of Zolpidem in Human Plasma and Its Application to Forensic Samples. Molecules. 2024 May 24;29:2490. doi:https://doi.org/10.3390/molecules29112490$50$YR$$M$Y$$$20240715$$HP$ES$ES
240880081$24088008$1$I$$20240709$20240715$20240715$PER$$US-AstraZeneca-2024A157125$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
240880092$24088009$2$F$$20240821$20240715$20240904$PER$$US-AstraZeneca-2024A158126$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
240880101$24088010$1$I$$20240709$20240715$20240715$PER$$US-AMGEN-USASP2024136525$AMGEN$$$$$$Y$$$20240714$$MD$US$US
240880111$24088011$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000025494$ROCHE$$$$$$Y$$$20240715$$MD$US$US
240880121$24088012$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007668$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240715$$CN$US$US
240880131$24088013$1$I$$20240708$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407006501$ELI LILLY AND CO$$$$$F$Y$$$20240715$$CN$US$US
240880142$24088014$2$F$20240708$20240805$20240715$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202407007048$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240815$$CN$US$US
240880151$24088015$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007663$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240715$$HP$US$US
240880161$24088016$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007721$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240715$$CN$US$US
240880171$24088017$1$I$20240710$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007719$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240715$$CN$US$US
240880181$24088018$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5836496$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240880191$24088019$1$I$$20240711$20240715$20240715$PER$$US-ABBVIE-5836933$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240880203$24088020$3$F$20230101$20240904$20240715$20240912$EXP$$CA-CELLTRION INC.-2022CA006842$CELLTRION$$$$$$Y$$$20240912$$MD$CA$CA
240880211$24088021$1$I$20240614$20240705$20240715$20240715$EXP$$CN-BEIGENE-BGN-2024-010544$BEIGENE$$$$$$Y$$$20240715$$HP$CN$CN
240880221$24088022$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144634$NOVARTIS$$$$$$Y$$$20240715$$CN$US$US
240880231$24088023$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218212$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240880244$24088024$4$F$20190101$20240802$20240715$20240805$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039595$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$$$20240805$$CN$US$US
240880251$24088025$1$I$20240708$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139674$AMGEN$$$$$$Y$$$20240714$$PH$US$US
240880261$24088026$1$I$20230701$20240709$20240715$20240715$PER$$US-SA-2024SA204595$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240715$$MD$US$US
240880271$24088027$1$I$$20240706$20240715$20240715$PER$$US-SA-2024SA203702$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240715$$MD$US$US
240880281$24088028$1$I$20240501$20240708$20240715$20240715$PER$$US-SA-2024SA204315$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240715$$MD$US$US
240880291$24088029$1$I$$20240710$20240715$20240715$EXP$$BE-ABBVIE-5838007$ABBVIE$$26$YR$$M$Y$$$20240715$$MD$BE$BE
240880301$24088030$1$I$20190801$20240704$20240715$20240715$EXP$$DE-AUROBINDO-AUR-APL-2024-033474$AUROBINDO$$33$YR$$F$Y$$$20240715$$MD$DE$DE
240880311$24088031$1$I$20240101$20240710$20240715$20240715$EXP$$US-JNJFOC-20240728039$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240715$$CN$US$US
240880321$24088032$1$I$$20240625$20240715$20240715$PER$$US-JNJFOC-20240670060$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240880331$24088033$1$I$20240701$20240705$20240715$20240715$30DAY$$US-GSK-US2024084011$GLAXOSMITHKLINE$$76$YR$$M$Y$$$20240715$$CN$US$US
240880341$24088034$1$I$20240701$20240710$20240715$20240715$EXP$$GB-ABBVIE-5838439$ABBVIE$$$$E$F$Y$$$20240715$$CN$GB$GB
240880353$24088035$3$F$20240703$20240801$20240715$20240809$EXP$$US-GSK-US2024AMR085654$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240809$$CN$US$US
240880361$24088036$1$I$20240419$20240704$20240715$20240715$EXP$IT-MINISAL02-993263$IT-AMGEN-ITANI2024133041$AMGEN$$60$YR$A$M$Y$$$20240714$$MD$IT$IT
240880371$24088037$1$I$$20240709$20240715$20240715$EXP$$CA-APOTEX-2024AP008141$APOTEX$$68$YR$$F$Y$$$20240715$$CN$CA$CA
240880381$24088038$1$I$20240614$20240704$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-033363$AUROBINDO$$53$YR$$M$Y$$$20240715$$PH$FR$FR
240880391$24088039$1$I$$20240617$20240715$20240715$PER$$BR-WT-2024-AMR-071589$Waylis$$$$$F$Y$$$20240715$$CN$BR$BR
240880402$24088040$2$F$20230101$20240724$20240715$20240803$EXP$$IT-AUROBINDO-AUR-APL-2024-033279$AUROBINDO$Malavasi M, Notarianni G, Pontillo D, Luciani M, Petrungaro M, Zampi G, et al.. THE CONUNDRUM OF DRUG INTERACTIONS AND HOLTER MONITORING: LAMIN GENE MUTATION DISCOVERED BY A TORSADE DE POINTES EPISODE FOLLOWED BY OUT-OF-THE-HOSPITAL RESUSCITATION. European Heart Journal. 2024;26(Supplement 2:55-56$57$YR$$F$Y$$$20240803$$MD$IT$IT
240880411$24088041$1$I$20240701$20240705$20240715$20240715$EXP$$CN-BEIGENE-BGN-2024-010489$BEIGENE$$$$$$Y$$$20240715$$HP$CN$CN
240880421$24088042$1$I$20240416$20240709$20240715$20240715$PER$$US-JNJFOC-20240723064$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240715$$CN$US$US
240880431$24088043$1$I$20240101$20240709$20240715$20240715$EXP$$US-JNJFOC-20240723541$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240715$$HP$US$US
240880442$24088044$2$F$$20240716$20240715$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05909$LUPIN$$$$$$Y$$$20240805$$CN$US$US
240880451$24088045$1$I$20230101$20240704$20240715$20240715$EXP$$DE-AUROBINDO-AUR-APL-2024-033329$AUROBINDO$$53$YR$$M$Y$67$KG$20240715$$CN$DE$DE
240880461$24088046$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218215$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240880472$24088047$2$F$20240101$20240913$20240715$20240923$PER$$US-SA-2024SA204270$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240923$$MD$US$US
240880481$24088048$1$I$20240601$20240704$20240715$20240715$PER$$US-SA-2024SA202666$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240715$$MD$US$US
240880491$24088049$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA204785$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240715$$HP$US$US
240880502$24088050$2$F$20240626$20240730$20240715$20240809$EXP$$ES-AUROBINDO-AUR-APL-2024-033673$AUROBINDO$$41$YR$$F$Y$$$20240809$$CN$ES$ES
240880511$24088051$1$I$20230101$20240708$20240715$20240715$EXP$$DE-SANDOZ INC.-SDZ2024DE061342$SANDOZ$$$$A$M$Y$121$KG$20240715$$HP$DE$DE
240880521$24088052$1$I$$20240627$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05892$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240880532$24088053$2$F$20240708$20240715$20240715$20240715$PER$$US-AMGEN-USASP2024139603$AMGEN$$75$YR$E$F$Y$$$20240715$$CN$US$US
240880541$24088054$1$I$$20240710$20240715$20240715$EXP$$US-JNJFOC-20240726850$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$US$US
240880551$24088055$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3219202$TEVA$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.; Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.$70$YR$$M$Y$$$20240715$$HP$US$US
240880561$24088056$1$I$$20240705$20240715$20240715$EXP$$OM-AMGEN-OMNSP2024134612$AMGEN$Al Mughairy A.; Abla D.; Al Habsi H. et al.. Trilineage hematopoietic recovery with romiplostim in a child with down syndrome and aplastic anemia- A case report and review of literature. Pediatric Hematology Oncology Journal. 2024;9 (3):180-183$7$YR$C$F$Y$$$20240715$$HP$OM$OM
240880571$24088057$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007658$ELI LILLY AND CO$$$$A$F$Y$$$20240715$$CN$US$US
240880581$24088058$1$I$20240601$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007798$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240715$$CN$US$US
240880591$24088059$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007733$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240715$$CN$US$US
240880602$24088060$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3219196$TEVA$Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.; Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Neurocrit-Care 2024; 40 976-983.; Syed MJ, Zutshi D, Muzammil SM, Mohamed W. Ketamine to Prevent Endotracheal Intubation in Adults with R...$68$YR$$M$Y$$$20240802$$HP$US$US
240880611$24088061$1$I$$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007710$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240715$$CN$US$US
240880621$24088062$1$I$$20240709$20240715$20240715$PER$$US-ABBVIE-5834318$ABBVIE$$$$$$Y$$$20240715$$HP$US$US
240880631$24088063$1$I$20240710$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007716$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240715$$CN$US$US
240880641$24088064$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144552$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240880651$24088065$1$I$20240426$20240705$20240715$20240715$EXP$FR-AFSSAPS-AVPA2024000609$FR-TEVA-VS-3218244$TEVA$$25$YR$$M$Y$$$20240715$$MD$FR$FR
240880661$24088066$1$I$$20240613$20240715$20240715$PER$$US-STERISCIENCE B.V.-2024-ST-000844$Steriscience PTE$Peringeth G, Abbi B, Mahmood S.. Treatment of myopathy and cutaneous ulcers in anti-MDA5- positive dermatomyositis with triple therapy.. BMJ Case Rep. 2024;17(3):e253960$3$DEC$$M$Y$$$20240715$$MD$US$US
240880671$24088067$1$I$$20240619$20240715$20240715$PER$$US-STERISCIENCE B.V.-2024-ST-000915$Steriscience PTE$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients.. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster).$$$$$Y$$$20240715$$HP$US$US
240880681$24088068$1$I$$20240619$20240715$20240715$PER$$US-STERISCIENCE B.V.-2024-ST-000895$Steriscience PTE$Huang L, Ellis TJ, Bagavathy K.. The Unfortunate Trifecta: Tuberculosis, EBV, and CMV Induced Hemophagocytic Lymphohistiocytosis. Am-J-Respir-Crit-Care-Med. 2024;209:1$52$YR$$M$Y$$$20240715$$HP$US$US
240880691$24088069$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033986$AUROBINDO$$$$$F$Y$70$KG$20240715$$HP$GB$GB
240880711$24088071$1$I$$20240627$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05912$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240880721$24088072$1$I$$20240711$20240715$20240715$EXP$$NVSC2024US144604$NOVARTIS$$$$$F$Y$$$20240715$$HP$US$US
240880731$24088073$1$I$20240623$20240705$20240715$20240715$EXP$$CN-BEIGENE-BGN-2024-010488$BEIGENE$$$$$$Y$$$20240715$$HP$CN$CN
240880741$24088074$1$I$$20240613$20240715$20240715$PER$$US-STERISCIENCE B.V.-2024-ST-000734$Steriscience PTE$Evbuomwan M O, Ingram T, Saleem N. A Case of Overlapping Autoimmune Syndrome. Cureus. 2024;16(5):e59714$44$YR$$F$Y$$$20240715$$HP$US$US
240880751$24088075$1$I$$20240712$20240715$20240715$PER$$US-JNJFOC-20240733509$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240880761$24088076$1$I$20240710$20240712$20240715$20240715$PER$$US-JNJFOC-20240734227$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240880771$24088077$1$I$$20240617$20240715$20240715$PER$$BR-WT-2024-AMR-073816$Waylis$$$$$F$Y$$$20240715$$CN$BR$BR
240880781$24088078$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA205076$SANOFI AVENTIS$$$$A$F$Y$80$KG$20240715$$MD$US$US
240880792$24088079$2$F$20240101$20240717$20240715$20240811$PER$$US-SA-2024SA200071$SANOFI AVENTIS$$90$YR$E$M$Y$$$20240811$$PH$US$US
240880803$24088080$3$F$20240710$20240814$20240715$20240819$PER$$US-AMGEN-USASP2024139666$AMGEN$$71$YR$E$F$Y$$$20240819$$PH$US$US
240880811$24088081$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA202670$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240715$$MD$US$US
240880821$24088082$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA205493$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240715$$MD$US$US
240880831$24088083$1$I$$20240708$20240715$20240715$PER$$US-ABBVIE-5832896$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240880851$24088085$1$I$20240622$20240705$20240715$20240715$EXP$FR-AFSSAPS-PB2024000740$FR-TEVA-VS-3218231$TEVA$$22$YR$$F$Y$76.5$KG$20240715$$MD$FR$FR
240880861$24088086$1$I$20240605$20240613$20240715$20240715$PER$$BR-WT-2024-AMR-070978$Waylis$$61$YR$$M$Y$$$20240715$$CN$BR$BR
240880872$24088087$2$F$20240625$20240708$20240715$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110090$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$60.33$KG$20240716$$CN$US$US
240880881$24088088$1$I$$20240708$20240715$20240715$PER$$US-CHATTEMPRD-2024OHG023651$CHATTEM$$$$$F$Y$$$20240715$$CN$US$US
240880891$24088089$1$I$$20240712$20240715$20240715$PER$$US-JNJFOC-20240733986$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240880901$24088090$1$I$20240709$20240709$20240715$20240715$PER$$US-JNJFOC-20240723083$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240715$$MD$US$US
240880911$24088091$1$I$20200101$20240712$20240715$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039670$BOEHRINGER INGELHEIM$$52$YR$A$F$Y$$$20240715$$CN$US$US
240880921$24088092$1$I$$20240705$20240715$20240715$30DAY$$US-GSK-US2024083009$GLAXOSMITHKLINE$$$$$M$Y$$$20240715$$CN$US$US
240880932$24088093$2$F$20240704$20240816$20240715$20240905$PER$$US-SA-2024SA203920$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240905$$MD$US$US
240880941$24088094$1$I$20240216$20240703$20240715$20240715$PER$$US-SA-2024SA200835$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240715$$MD$US$US
240880951$24088095$1$I$$20240708$20240715$20240715$PER$$US-CHATTEMPRD-2024OHG023593$CHATTEM$$$$$F$Y$$$20240715$$CN$US$US
240880961$24088096$1$I$20230601$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033487$AUROBINDO$$44$YR$$M$Y$108$KG$20240715$$CN$GB$GB
240880971$24088097$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5836912$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240880981$24088098$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218206$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240880992$24088099$2$F$20200101$20240702$20240715$20240715$PER$$US-ROCHE-10000021805$ROCHE$$$$$F$Y$$$20240715$$CN$US$US
240881001$24088100$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034062$AUROBINDO$$$$$F$Y$$$20240715$$PH$GB$GB
240881011$24088101$1$I$$20240709$20240715$20240715$PER$$US-JNJFOC-20240723233$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240881021$24088102$1$I$$20240711$20240715$20240715$PER$$US-JNJFOC-20240730610$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240881031$24088103$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218592$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240881041$24088104$1$I$$20240705$20240715$20240715$PER$$NVSC2024US141649$NOVARTIS$$$$$$Y$$$20240715$$CN$US$US
240881051$24088105$1$I$$20240701$20240715$20240715$EXP$$IN-ROCHE-10000011905$ROCHE$$67$YR$E$M$Y$$$20240715$$MD$IN$IN
240881061$24088106$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3218609$TEVA$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit-Care 2024; 40 (1): 262-271.$$$$$Y$$$20240715$$PH$US$US
240881071$24088107$1$I$20240611$20240705$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-033716$AUROBINDO$$58$YR$$F$Y$60$KG$20240715$$MD$FR$FR
240881081$24088108$1$I$$20240711$20240715$20240715$EXP$$NVSC2024KR144426$NOVARTIS$$$$$$Y$$$20240715$$MD$KR$KR
240881091$24088109$1$I$20210727$20240606$20240715$20240715$EXP$$DE-AMGEN-DEUNI2024135522$AMGEN$$68$YR$E$F$Y$$$20240715$$MD$DE$DE
240881101$24088110$1$I$20240709$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139650$AMGEN$$$$$$Y$$$20240715$$HP$US$US
240881111$24088111$1$I$$20240711$20240715$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110839$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$73$KG$20240715$$HP$CA$CA
240881122$24088112$2$F$20240601$20240903$20240715$20240904$PER$$US-AMGEN-USASP2024138436$AMGEN$$53$YR$A$F$Y$$$20240904$$HP$US$US
240881131$24088113$1$I$$20240711$20240715$20240715$EXP$$US-JNJFOC-20240729714$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$US$US
240881141$24088114$1$I$20240601$20240708$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407005545$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240715$$CN$US$US
240881151$24088115$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007233$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240715$$CN$US$US
240881161$24088116$1$I$20240701$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007583$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240715$$CN$US$US
240881171$24088117$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007706$ELI LILLY AND CO$$$$A$M$Y$$$20240715$$CN$US$US
240881182$24088118$2$F$$20240709$20240715$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407007803$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240723$$CN$US$US
240881191$24088119$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007749$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240715$$CN$US$US
240881202$24088120$2$F$$20240718$20240715$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407007891$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240728$$CN$US$US
240881211$24088121$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007807$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240715$$CN$US$US
240881221$24088122$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007830$ELI LILLY AND CO$$$$A$F$Y$$$20240715$$CN$US$US
240881231$24088123$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034042$AUROBINDO$$$$$M$Y$$$20240715$$PH$GB$GB
240881241$24088124$1$I$20240101$20240703$20240715$20240715$EXP$$US-INSMED, INC.-2024-01530-US$INSMED$$$$$F$Y$$$20240715$$CN$US$US
240881253$24088125$3$F$20240101$20240724$20240715$20240727$PER$$US-AMGEN-USASP2024137816$AMGEN$$59$YR$A$M$Y$85.1$KG$20240727$$PH$US$US
240881261$24088126$1$I$20240610$20240709$20240715$20240715$PER$$US-JNJFOC-20240727325$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240715$$PH$US$US
240881273$24088127$3$F$$20240805$20240715$20240829$PER$$US-AstraZeneca-2024A157619$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
240881281$24088128$1$I$$20240705$20240715$20240715$EXP$$EG-ROCHE-10000004217$ROCHE$Elbeltagi Y, Kersh M, Fathy H. Study of steroid-resistant nephrotic syndrome: a single center experience.. Egyptian Pediatric Association Gazette. 2024;72 (1):1-9. doi:10.1186/s43054-024-00267-1.$$$$$Y$$$20240715$$HP$EG$EG
240881292$24088129$2$F$$20240818$20240715$20240822$EXP$$JP-ABBVIE-5837764$ABBVIE$$$$$$Y$$$20240822$$PH$JP$JP
240881302$24088130$2$F$$20240814$20240715$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06409$LUPIN$$$$$$Y$$$20240903$$CN$US$US
240881311$24088131$1$I$$20240621$20240715$20240715$PER$$BR-WT-2024-AMR-074099$Waylis$$$$$F$Y$$$20240715$$CN$BR$BR
240881321$24088132$1$I$20240517$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034121$AUROBINDO$$84$YR$$F$Y$46$KG$20240715$$PH$GB$GB
240881331$24088133$1$I$20240101$20240705$20240715$20240715$PER$$US-SA-2024SA202541$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240715$$CN$US$US
240881341$24088134$1$I$20230427$20240710$20240715$20240715$EXP$ES-AEMPS-1541314$ES-SA-2024SA203851$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240715$$MD$ES$ES
240881351$24088135$1$I$$20240705$20240715$20240715$30DAY$$US-GSK-US2024AMR084235$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
240881361$24088136$1$I$20240515$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033785$AUROBINDO$$30$YR$$F$Y$110$KG$20240715$$CN$GB$GB
240881371$24088137$1$I$20240101$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024137586$AMGEN$$68$YR$E$F$Y$$$20240715$$CN$US$US
240881381$24088138$1$I$20230101$20240710$20240715$20240715$PER$$US-SA-2024SA205094$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240715$$HP$US$US
240881391$24088139$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5838012$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240881401$24088140$1$I$$20240701$20240715$20240715$EXP$$DE-RDY-LIT/DEU/24/0009825$DR REDDYS$Muller F, Boeltz S, Knitza J, Aigner M, Volkl S, Kharboutli S, et al. CD19-targeted CAR T cells in refractory antisynthetase syndrome. Lancet. 2023 Mar 11;401(10379): 815-818. doi:10.1016/S0140-6736%2823%2900023-5.$41$YR$A$M$Y$$$20240715$$HP$DE$DE
240881411$24088141$1$I$20170106$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034179$AUROBINDO$$18$YR$$F$Y$55$KG$20240715$$CN$GB$GB
240881421$24088142$1$I$20130812$20240712$20240715$20240715$EXP$$CA-SANDOZ INC.-PHHY2013CA089586$SANDOZ$$64$YR$$F$Y$$$20240715$$HP$CA$CA
240881442$24088144$2$F$$20240814$20240715$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05961$LUPIN$$$$$$Y$$$20240901$$CN$US$US
240881452$24088145$2$F$$20240801$20240715$20240802$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038609$BOEHRINGER INGELHEIM$$57$YR$A$M$Y$85$KG$20240802$$PH$DE$DE
240881461$24088146$1$I$20240501$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033530$AUROBINDO$$$$A$F$Y$76$KG$20240715$$CN$GB$GB
240881471$24088147$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033925$AUROBINDO$$$$$F$Y$$$20240715$$PH$GB$GB
240881481$24088148$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034109$AUROBINDO$$$$$M$Y$17$KG$20240715$$CN$GB$GB
240881491$24088149$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5839152$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240881502$24088150$2$F$20230920$20240813$20240715$20240823$EXP$IT-MINISAL02-992676$IT-TEVA-VS-3218199$TEVA$$47$YR$$M$Y$95$KG$20240823$$CN$IT$IT
240881511$24088151$1$I$$20240708$20240715$20240715$EXP$$AU-SANDOZ INC.-SDZ2024AU064120$SANDOZ$$$$A$F$Y$$$20240715$$MD$AU$AU
240881521$24088152$1$I$$20240627$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05964$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240881531$24088153$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144422$NOVARTIS$$$$$$Y$$$20240715$$CN$US$US
240881541$24088154$1$I$20240708$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138592$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240881552$24088155$2$F$20240101$20240730$20240715$20240801$PER$$US-AMGEN-USASP2024138687$AMGEN$$$$A$M$Y$98.2$KG$20240801$$PH$US$US
240881562$24088156$2$F$$20240716$20240715$20240718$PER$$US-JNJFOC-20240732750$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$US$US
240881571$24088157$1$I$$20240627$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06506$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240881581$24088158$1$I$$20240711$20240715$20240715$EXP$$CA-SANDOZ INC.-SDZ2024CA064798$SANDOZ$$$$$F$Y$$$20240715$$CN$CA$CA
240881591$24088159$1$I$20240509$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034122$AUROBINDO$$64$YR$$F$Y$75$KG$20240715$$HP$GB$GB
240881602$24088160$2$F$$20240703$20240715$20240717$PER$$US-IMP-2024000402$Harrow Health$$$$$F$Y$$$20240717$$CN$US$US
240881611$24088161$1$I$$20240703$20240715$20240715$EXP$$IN-ROCHE-10000020816$ROCHE$$60$YR$A$F$Y$$$20240715$$CN$IN$IN
240881621$24088162$1$I$$20240708$20240715$20240715$EXP$$US-PFIZER INC-PV202400090271$PFIZER$$34$YR$$M$Y$$$20240715$$MD$US$US
240881631$24088163$1$I$$20240708$20240715$20240715$EXP$$US-PFIZER INC-PV202400090227$PFIZER$$6$YR$$M$Y$$$20240715$$MD$US$US
240881641$24088164$1$I$$20240705$20240715$20240715$EXP$$AU-PFIZER INC-202400212193$PFIZER$$$$$F$Y$$$20240715$$CN$AU$AU
240881653$24088165$3$F$20240709$20240722$20240715$20240725$EXP$$CA-PFIZER INC-PV202400080810$PFIZER$$43$YR$$F$Y$$$20240725$$MD$CA$CA
240881662$24088166$2$F$20240619$20240906$20240715$20240910$EXP$$JP-PFIZER INC-PV202400088919$PFIZER$$74$YR$$M$Y$54.4$KG$20240910$$HP$JP$JP
240881671$24088167$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA204598$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240715$$CN$US$US
240881681$24088168$1$I$$20240708$20240715$20240715$EXP$$US-SA-2024SA202234$SANOFI AVENTIS$$$$$M$Y$$$20240715$$CN$US$US
240881692$24088169$2$F$20240601$20240723$20240715$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110981$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240731$$HP$US$US
240881701$24088170$1$I$$20240701$20240715$20240715$EXP$$JP-ROCHE-10000023909$ROCHE$Nishino H, Anazawa T, Nishio T. Indication for liver transplant learned from a case developed septic shock early after ABO-incompatible living donor liver transplant for acute liver failure. The 42nd Annual Meeting of the Japanese Liver Transplantation Society. 2024;$60$YR$A$M$Y$$$20240715$$MD$JP$JP
240881711$24088171$1$I$20240610$20240705$20240715$20240715$EXP$IS-IMA-8735$IS-TEVA-VS-3217914$TEVA$$57$YR$$F$Y$$$20240715$$PH$IS$IS
240881721$24088172$1$I$20230915$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034148$AUROBINDO$$70$YR$$$Y$83$KG$20240715$$CN$GB$GB
240881735$24088173$5$F$20240101$20240819$20240715$20240822$EXP$$US-AMGEN-USASP2024139295$AMGEN$$54$YR$A$F$Y$$$20240822$$CN$US$US
240881751$24088175$1$I$20240101$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033899$AUROBINDO$$$$A$F$Y$53$KG$20240715$$CN$GB$GB
240881771$24088177$1$I$20230131$20240712$20240715$20240715$EXP$$US-JNJFOC-20240731978$JOHNSON AND JOHNSON$$56$YR$A$F$Y$79$KG$20240715$$HP$US$US
240881781$24088178$1$I$$20240712$20240715$20240715$PER$$US-JNJFOC-20240733303$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$HP$US$US
240881791$24088179$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008298$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240715$$CN$US$US
240881801$24088180$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008079$ELI LILLY AND CO$$$$$$Y$$$20240715$$HP$US$US
240881811$24088181$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007711$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240715$$CN$US$US
240881821$24088182$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407006946$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240715$$CN$US$US
240881831$24088183$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007570$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240715$$CN$US$US
240881841$24088184$1$I$20231001$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007633$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240715$$CN$US$US
240881851$24088185$1$I$$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407006422$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240715$$CN$US$US
240881861$24088186$1$I$$20240619$20240715$20240715$PER$$BR-WT-2024-AMR-073001$Waylis$$$$$F$Y$$$20240715$$CN$BR$BR
240881871$24088187$1$I$20240622$20240708$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407005565$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240715$$CN$US$US
240881881$24088188$1$I$20240628$20240711$20240715$20240715$EXP$$US-UCBSA-2024002671$UCB$$8$YR$$M$Y$$$20240715$$CN$US$US
240881891$24088189$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA202709$SANOFI AVENTIS$$$$A$M$Y$$$20240715$$MD$US$US
240881901$24088190$1$I$$20240703$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106947$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240715$$CN$US$US
240881911$24088191$1$I$$20240618$20240715$20240715$PER$$BR-WT-2024-AMR-074476$Waylis$$42$YR$$F$Y$$$20240715$$CN$BR$BR
240881922$24088192$2$F$20240301$20240705$20240715$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456491$RANBAXY$$70$YR$$M$Y$$$20240719$$MD$FR$FR
240881931$24088193$1$I$20240710$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138459$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240881941$24088194$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144327$NOVARTIS$$$$$$Y$$$20240715$$CN$US$US
240881951$24088195$1$I$20240517$20240705$20240715$20240715$PER$$US-SA-2024SA202713$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240715$$MD$US$US
240881961$24088196$1$I$$20240708$20240715$20240715$PER$$US-SA-2022SA336396$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240715$$MD$US$US
240881971$24088197$1$I$$20240707$20240715$20240715$EXP$$BR-SANDOZ INC.-SDZ2024BR064379$SANDOZ$$$$$M$Y$$$20240715$$CN$BR$BR
240881981$24088198$1$I$$20240702$20240715$20240715$EXP$$CA-RDY-CLI/CAN/24/0009771$DR REDDYS$$74$YR$E$F$Y$$$20240715$$HP$CA$CA
240881991$24088199$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA202682$SANOFI AVENTIS$$$$E$M$Y$79$KG$20240715$$MD$US$US
240882001$24088200$1$I$$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111372$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$69.4$KG$20240715$$HP$US$US
240882011$24088201$1$I$20070616$20240704$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-033333$AUROBINDO$$$$$F$Y$3.76$KG$20240715$$MD$FR$FR
240882021$24088202$1$I$$20240702$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0009986$DR REDDYS$Lopez D, Naik D, Azimi A, Soney H, Alexander J. RUSH TO DE-LIVER: A CASE OF HSV HEPATITIS IN PREGNANCY. Journal of Hospital Medicine. 2023 Mar 01;18: S635-S636. doi:10.1002/jhm.13090.$24$YR$A$F$Y$$$20240715$$MD$US$US
240882031$24088203$1$I$$20240705$20240715$20240715$EXP$GB-MYLANLABS-2024M1062700$GB-RDY-SPO/GBR/24/0009959$DR REDDYS$$$$$F$Y$$$20240715$$CN$GB$GB
240882041$24088204$1$I$$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139516$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240882051$24088205$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407051358551410-MLWKF$GB-RDY-SPO/GBR/24/0010059$DR REDDYS$$$$$M$Y$$$20240715$$MD$GB$GB
240882061$24088206$1$I$$20240710$20240715$20240715$EXP$$CN-Bion-013433$BIONPHARMA$$53$YR$A$M$Y$$$20240715$$HP$CN$CN
240882071$24088207$1$I$$20240710$20240715$20240715$EXP$$IN-Bion-013434$BIONPHARMA$$20$YR$A$M$Y$$$20240715$$HP$IN$IN
240882081$24088208$1$I$$20240711$20240715$20240715$EXP$$JP-Bion-013443$BIONPHARMA$$47$YR$A$F$Y$$$20240715$$HP$JP$JP
240882091$24088209$1$I$$20240710$20240715$20240715$EXP$$PE-Bion-013431$BIONPHARMA$$34$YR$A$F$Y$$$20240715$$HP$PE$PE
240882101$24088210$1$I$$20240709$20240715$20240715$EXP$$US-Bion-013410$BIONPHARMA$$31$YR$A$M$Y$$$20240715$$HP$US$US
240882111$24088211$1$I$20240708$20240712$20240715$20240715$PER$$US-JNJFOC-20240733722$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240715$$CN$US$US
240882121$24088212$1$I$$20240709$20240715$20240715$EXP$$CA-JNJFOC-20240724249$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240715$$HP$CA$CA
240882131$24088213$1$I$$20240712$20240715$20240715$PER$$NVSC2024US144923$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240882144$24088214$4$F$20240702$20240805$20240715$20240812$EXP$$US-GSK-US2024AMR084311$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240812$$CN$US$US
240882152$24088215$2$F$$20240819$20240715$20240828$EXP$$CA-GLAXOSMITHKLINE-CACH2024009362$Haleon PLC$$$$A$F$Y$$$20240827$$HP$CA$CA
240882161$24088216$1$I$$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024138647$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240882171$24088217$1$I$$20240704$20240715$20240715$EXP$$GB-AMGEN-GBRSP2024136054$AMGEN$$$$$F$Y$$$20240715$$CN$GB$GB
240882181$24088218$1$I$$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024137642$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240882191$24088219$1$I$$20240703$20240715$20240715$EXP$$NL-AMGEN-NLDSP2024132578$AMGEN$Jalink M.; Jacobs C.F.; Khwaja J. et al.. Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood Advances. 2024;8 (11):2622-2634$62$YR$A$M$Y$$$20240715$$HP$NL$NL
240882202$24088220$2$F$$20240716$20240715$20240722$EXP$$US-TAKEDA-2024TUS070547$TAKEDA$$$$$M$Y$$$20240722$$CN$US$US
240882211$24088221$1$I$$20240707$20240715$20240715$EXP$$US-Bion-013436$BIONPHARMA$$$$$$Y$$$20240715$$CN$US$US
240882221$24088222$1$I$20240429$20240705$20240715$20240715$EXP$ES-AEMPS-1540865$ES-TEVA-VS-3218114$TEVA$$87$YR$$F$Y$$$20240715$$HP$ES$ES
240882231$24088223$1$I$$20240626$20240715$20240715$EXP$$PH-ROCHE-10000023981$ROCHE$$$$$F$Y$$$20240715$$MD$PH$PH
240882242$24088224$2$F$$20240715$20240715$20240719$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2024AMR086248$VIIV$$$$$$Y$$$20240719$$PH$CA$CA
240882251$24088225$1$I$$20240711$20240715$20240715$PER$$US-TAKEDA-2024TUS071005$TAKEDA$$$$$$Y$$$20240715$$CN$US$US
240882261$24088226$1$I$$20240709$20240715$20240715$EXP$$US-TAKEDA-2024TUS070741$TAKEDA$$$$$M$Y$18.594$KG$20240715$$HP$US$US
240882272$24088227$2$F$20240701$20240715$20240715$20240717$PER$$US-AMGEN-USASP2024139679$AMGEN$$53$YR$A$F$Y$$$20240716$$CN$US$US
240882282$24088228$2$F$20240606$20240726$20240715$20240808$EXP$$JP-AMGEN-JPNSP2024138112$AMGEN$$82$YR$E$F$Y$$$20240808$$HP$JP$JP
240882291$24088229$1$I$20240101$20240705$20240715$20240715$PER$$US-SA-2024SA202716$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240715$$MD$US$US
240882301$24088230$1$I$20230801$20240708$20240715$20240715$EXP$$US-EXELIXIS-CABO-23068513$EXELIXIS$$70$YR$$M$Y$$$20240715$$CN$US$US
240882311$24088231$1$I$20240708$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007765$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240715$$CN$US$US
240882321$24088232$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007959$ELI LILLY AND CO$$$$$M$Y$$$20240715$$CN$US$US
240882331$24088233$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008220$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240715$$CN$US$US
240882341$24088234$1$I$$20240703$20240715$20240715$PER$$US-TEVA-VS-3218808$TEVA$$$$$$Y$$$20240715$$HP$US$US
240882351$24088235$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007757$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240715$$CN$US$US
240882372$24088237$2$F$20240711$20240715$20240715$20240716$PER$$US-AMGEN-USASP2024138762$AMGEN$$$$$F$Y$$$20240716$$CN$US$US
240882381$24088238$1$I$20240709$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024137526$AMGEN$$62$YR$A$M$Y$$$20240715$$CN$US$US
240882401$24088240$1$I$$20240626$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06441$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240882424$24088242$4$F$20240701$20240814$20240715$20240816$PER$$US-AMGEN-USASP2024139466$AMGEN$$74$YR$E$F$Y$$$20240816$$CN$US$US
240882431$24088243$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144520$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240882442$24088244$2$F$20240614$20240826$20240715$20240909$EXP$$IT-JUBILANT CADISTA PHARMACEUTICALS-2024IT000912$JUBILANT$$86$YR$$M$Y$$$20240909$$HP$IT$IT
240882451$24088245$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091043499980-ZCLHQ$GB-JUBILANT PHARMA LTD-2024GB000944$JUBILANT$$$$A$F$Y$$$20240715$$PH$GB$GB
240882463$24088246$3$F$$20240828$20240715$20240828$PER$$NVSC2024US144425$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
240882471$24088247$1$I$$20240703$20240715$20240715$EXP$GB-MHRA-DEFECT-202406221311545970-BHSNJ$GB-JUBILANT PHARMA LTD-2024GB000915$JUBILANT$$$$A$$Y$$$20240715$$CN$GB$GB
240882481$24088248$1$I$$20240703$20240715$20240715$EXP$$PT-JUBILANT CADISTA PHARMACEUTICALS-2024PT000921$JUBILANT$Lobato CT, Castelo Branco S, Camoes J, Molinos E. Rhabdomyolysis secondary to a weight-loss prescription.. BMJ Case Reports.. 2024;17(6):e258208$8$DEC$$M$Y$$$20240715$$MD$PT$PT
240882501$24088250$1$I$$20240703$20240715$20240715$EXP$$RU-ROCHE-10000018662$ROCHE$$25$YR$A$$Y$$$20240715$$MD$RU$RU
240882521$24088252$1$I$$20240702$20240715$20240715$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR082598$VIIV$$$$A$$Y$$$20240715$$CN$US$US
240882531$24088253$1$I$$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111179$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240715$$HP$US$US
240882552$24088255$2$F$$20240814$20240715$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06455$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240882562$24088256$2$F$$20240711$20240715$20240722$EXP$$CO-TAKEDA-2024TUS070983$TAKEDA$$$$$F$Y$56$KG$20240722$$CN$CO$CO
240882571$24088257$1$I$$20240710$20240715$20240715$EXP$$US-AstraZeneca-2024A158436$ASTRAZENECA$$$$$M$Y$$$20240715$$MD$US$
240882581$24088258$1$I$20240708$20240710$20240715$20240715$EXP$$US-AstraZeneca-2024A158587$ASTRAZENECA$$$$$M$Y$$$20240715$$MD$US$
240882591$24088259$1$I$20240530$20240710$20240715$20240715$EXP$GB-MHRA-MED-202407101658218760-JDSFK$GB-UCBSA-2024035041$UCB$$69$YR$$M$Y$75$KG$20240715$$CN$GB$GB
240882603$24088260$3$F$20240711$20240731$20240715$20240802$PER$$US-AMGEN-USASP2024139478$AMGEN$$76$YR$E$M$Y$$$20240802$$HP$US$US
240882611$24088261$1$I$$20240708$20240715$20240715$EXP$$BG-AMGEN-BGRSP2024134828$AMGEN$Sapundzhieva T.; Sapundzhieva L.; Klinkanov K. et al.. Severe Acro-osteolysis Mimicking Arthritis Mutilans in a Patient with Primary Hyperparathyroidism: A Case Report. Current Rheumatology Reviews. 2024;20 (5):574-585$55$YR$A$F$Y$65$KG$20240715$$HP$BG$BG
240882621$24088262$1$I$20240101$20240708$20240715$20240715$EXP$$US-JNJFOC-20240719884$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240882641$24088264$1$I$20240518$20240709$20240715$20240715$EXP$FR-AFSSAPS-BX2024001312$FR-ORGANON-O2407FRA000904$ORGANON$$86$YR$$F$Y$58$KG$20240715$$PH$FR$FR
240882651$24088265$1$I$20240101$20240708$20240715$20240715$PER$$US-AMGEN-USASP2024135556$AMGEN$$69$YR$E$F$Y$80.726$KG$20240715$$CN$US$US
240882661$24088266$1$I$$20240708$20240715$20240715$EXP$$GB-TAKEDA-2024TUS070696$TAKEDA$$$$$M$Y$$$20240715$$CN$GB$GB
240882671$24088267$1$I$$20240705$20240715$20240715$EXP$$CA-CELLTRION INC.-2024CA016424$CELLTRION$$$$$$Y$$$20240715$$MD$CA$CA
240882681$24088268$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138837$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240882691$24088269$1$I$20240101$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138697$AMGEN$$70$YR$E$F$Y$$$20240715$$CN$US$US
240882702$24088270$2$F$$20240709$20240715$20240716$PER$$NVSC2024US144304$NOVARTIS$$$$$M$Y$$$20240716$$CN$US$US
240882713$24088271$3$F$$20240822$20240715$20240822$EXP$$US-TAKEDA-2024TUS059562$TAKEDA$$$$$M$Y$117$KG$20240822$$HP$US$US
240882722$24088272$2$F$$20240916$20240715$20240918$PER$$US-BIOGEN-2024BI01273090$BIOGEN$$$$$M$Y$$$20240918$$MD$US$US
240882731$24088273$1$I$20240101$20240708$20240715$20240715$PER$$US-BIOGEN-2024BI01272859$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240882741$24088274$1$I$$20240708$20240715$20240715$PER$$US-BIOGEN-2024BI01272986$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240882751$24088275$1$I$20240301$20240709$20240715$20240715$PER$$US-BIOGEN-2024BI01258437$BIOGEN$$47$YR$$F$Y$65.7$KG$20240715$$CN$US$US
240882761$24088276$1$I$20240701$20240702$20240715$20240715$EXP$$PK-ROCHE-10000019968$ROCHE$$42$YR$A$F$Y$$$20240715$$CN$PK$PK
240882772$24088277$2$F$$20240822$20240715$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05889$LUPIN$$$$$$Y$$$20240910$$CN$US$US
240882781$24088278$1$I$20240703$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407051154084370-RLBMZ$GB-TEVA-VS-3217861$TEVA$$21$YR$$M$Y$$$20240715$$PH$GB$GB
240882791$24088279$1$I$$20240710$20240715$20240715$EXP$$US-UCBSA-2024035011$UCB$$$$$F$Y$$$20240715$$CN$US$US
240882801$24088280$1$I$$20240710$20240715$20240715$EXP$$US-UCBSA-2024034998$UCB$$$$$M$Y$$$20240715$$CN$US$US
240882811$24088281$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110831$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$68.04$KG$20240715$$CN$US$US
240882821$24088282$1$I$$20240708$20240715$20240715$EXP$GB-MHRA-MED-202407051440050980-KRQWM$GB-RDY-SPO/GBR/24/0010180$DR REDDYS$$83$YR$E$F$Y$62$KG$20240715$$MD$GB$GB
240882831$24088283$1$I$20240503$20240705$20240715$20240715$EXP$FR-AFSSAPS-AN2024000803$FR-TEVA-VS-3218229$TEVA$$66$YR$$F$Y$65$KG$20240715$$PH$FR$FR
240882841$24088284$1$I$20240415$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091555219880-GCYSP$GB-TEVA-VS-3218435$TEVA$$7$YR$$M$Y$63$KG$20240715$$HP$GB$GB
240882851$24088285$1$I$$20240711$20240715$20240715$EXP$$US-HALEON-2186718$Haleon PLC$$$$$$Y$$$20240715$$CN$US$US
240882861$24088286$1$I$20240620$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007355$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240715$$CN$US$US
240882871$24088287$1$I$$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008603$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240715$$CN$US$US
240882881$24088288$1$I$$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407006152$ELI LILLY AND CO$$55$YR$A$$Y$$$20240715$$CN$US$US
240882891$24088289$1$I$20240710$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007982$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240715$$CN$US$US
240882901$24088290$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007767$ELI LILLY AND CO$$$$A$F$Y$$$20240715$$CN$US$US
240882911$24088291$1$I$20240711$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008222$ELI LILLY AND CO$$$$A$F$Y$$$20240715$$CN$US$US
240882921$24088292$1$I$20240706$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007058$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240715$$CN$US$US
240882931$24088293$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008232$ELI LILLY AND CO$$$$A$M$Y$$$20240715$$CN$US$US
240882941$24088294$1$I$20240707$20240708$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007281$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240715$$CN$US$US
240882951$24088295$1$I$$20240705$20240715$20240715$EXP$$CA-CELLTRION INC.-2024CA016485$CELLTRION$$$$$$Y$$$20240715$$HP$CA$CA
240882961$24088296$1$I$20240603$20240705$20240715$20240715$EXP$DE-BFARM-24004637$DE-SA-2024SA200126$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240715$$MD$DE$DE
240882971$24088297$1$I$20240708$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024137840$AMGEN$$68$YR$E$F$Y$$$20240715$$CN$US$US
240882982$24088298$2$F$$20240711$20240715$20240717$PER$$US-AMGEN-USASP2024139107$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
240883002$24088300$2$F$20240704$20240731$20240715$20240809$PER$$US-SA-2024SA203077$SANOFI AVENTIS$$13$YR$T$F$Y$53.5$KG$20240809$$MD$US$US
240883011$24088301$1$I$20240701$20240708$20240715$20240715$PER$$US-SA-2024SA202284$SANOFI AVENTIS$$$$$M$Y$$$20240715$$CN$US$US
240883021$24088302$1$I$20240101$20240705$20240715$20240715$PER$$US-SA-2024SA203060$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240715$$MD$US$US
240883031$24088303$1$I$$20240705$20240715$20240715$EXP$$PT-AUROBINDO-AUR-APL-2024-033668$AUROBINDO$$$$A$F$Y$$$20240715$$MD$PT$PT
240883041$24088304$1$I$20240709$20240711$20240715$20240715$PER$$US-JNJFOC-20240731379$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240715$$HP$US$US
240883051$24088305$1$I$20240701$20240703$20240715$20240715$PER$$US-JNJFOC-20240711544$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240883061$24088306$1$I$20240414$20240618$20240715$20240715$PER$$US-BEIGENE-BGN-2024-009467$BEIGENE$$$$$$Y$$$20240715$$CN$US$US
240883071$24088307$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA205361$SANOFI AVENTIS$$$$$M$Y$$$20240715$$MD$US$US
240883081$24088308$1$I$20190301$20240705$20240715$20240715$PER$$US-SA-2024SA202799$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240715$$MD$US$US
240883091$24088309$1$I$20220906$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034127$AUROBINDO$$71$YR$$M$Y$70$KG$20240715$$CN$GB$GB
240883101$24088310$1$I$20240626$20240705$20240715$20240715$EXP$$CN-SA-2024SA202714$SANOFI AVENTIS$$81$YR$E$F$Y$45$KG$20240715$$HP$CN$CN
240883111$24088311$1$I$20240702$20240708$20240715$20240715$EXP$$US-MTPC-MTDA2024-0014303$Unknown Manufacturer$$58$YR$$F$Y$$$20240715$$CN$US$US
240883121$24088312$1$I$$20240625$20240715$20240715$EXP$$CA-002147023-NVSC2024CA031637$Haleon PLC$$44$YR$$F$Y$97$KG$20240715$$HP$CA$CA
240883131$24088313$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033589$AUROBINDO$$12$YR$$M$Y$$$20240715$$HP$GB$GB
240883141$24088314$1$I$20240701$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109034$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240715$$HP$US$US
240883151$24088315$1$I$$20240704$20240715$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107300$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240715$$PH$CA$CA
240883161$24088316$1$I$$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110942$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$69.85$KG$20240715$$CN$US$US
240883171$24088317$1$I$$20240708$20240715$20240715$PER$$US-BAUSCHBL-2024BNL029805$BAUSCH AND LOMB$$$$$F$Y$$$20240715$$CN$US$US
240883181$24088318$1$I$20240101$20240708$20240715$20240715$PER$$US-BAUSCHBL-2024BNL029813$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240715$$CN$US$US
240883191$24088319$1$I$20240601$20240704$20240715$20240715$PER$$US-SA-2024SA201874$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240715$$MD$US$US
240883202$24088320$2$F$$20240813$20240715$20240815$PER$$US-JNJFOC-20240721700$JOHNSON AND JOHNSON$$$$$F$Y$$$20240815$$HP$US$US
240883211$24088321$1$I$20240703$20240705$20240715$20240715$PER$$US-SA-2024SA202752$SANOFI AVENTIS$$54$YR$A$F$Y$68$KG$20240715$$MD$US$US
240883221$24088322$1$I$20240101$20240706$20240715$20240715$PER$$US-SA-2024SA202689$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240715$$MD$US$US
240883231$24088323$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033756$AUROBINDO$$$$A$F$Y$$$20240715$$CN$GB$GB
240883241$24088324$1$I$$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024137915$AMGEN$$$$$$Y$$$20240715$$HP$US$US
240883251$24088325$1$I$20240710$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024139462$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240883261$24088326$1$I$20240710$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138827$AMGEN$$67$YR$E$F$Y$$$20240715$$CN$US$US
240883271$24088327$1$I$20240601$20240711$20240715$20240715$PER$$NVSC2024US144921$NOVARTIS$$83$YR$$F$Y$$$20240715$$MD$US$US
240883282$24088328$2$F$$20240729$20240715$20240731$PER$$NVSC2024US145139$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
240883294$24088329$4$F$20240101$20240829$20240715$20240910$EXP$$US-INSMED-2024-02444-USAA$INSMED$$$$$M$Y$$$20240910$$HP$US$US
240883312$24088331$2$F$20240601$20240730$20240715$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111365$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240801$$CN$US$US
240883323$24088332$3$F$20240601$20240627$20240715$20240730$PER$$US-TRAVERE-2024TVT00563$TRAVERE THERAPEUTICS$$81$YR$$M$Y$$$20240730$$CN$US$US
240883332$24088333$2$F$$20240812$20240715$20240820$PER$$US-JNJFOC-20240720994$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240820$$CN$US$US
240883342$24088334$2$F$$20240809$20240715$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111329$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240812$$CN$US$US
240883351$24088335$1$I$$20240705$20240715$20240715$30DAY$$US-GSK-US2024084045$GLAXOSMITHKLINE$$$$A$F$Y$$$20240715$$CN$US$US
240883361$24088336$1$I$$20240702$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0009980$DR REDDYS$Rehman A, Olayiwola A, Vu CA, Bhatt P, Joseph J, Ayoade F. Nocardia brasiliensis Pyomyositis in an Immunocompetent Patient Following Gardening Activity. Journal of Investigative Medicine High Impact Case Reports. 2024 Jan;12(0): doi:10.1177/23247096241261508.$48$YR$A$M$Y$$$20240715$$MD$US$US
240883371$24088337$1$I$$20240702$20240715$20240715$PER$$US-RDY-LIT/USA/24/0009991$DR REDDYS$Sablaban IM, Gautam M. Kratom and Stimulant Co-Addiction: A Case Series and Brief Review. Journal of Addictive Diseases: The Official Journal of the ASAM, American Society of Addiction Medicine. 2023 Jan;41(2): 181-184. doi:10.1080/10550887.2022.2066459.$44$YR$A$M$Y$$$20240715$$HP$US$US
240883382$24088338$2$F$$20240802$20240715$20240806$PER$$NVSC2024US145153$NOVARTIS$$$$$$Y$$$20240806$$HP$US$US
240883392$24088339$2$F$20240501$20240711$20240715$20240731$PER$$US-TEVA-VS-3219095$TEVA$$69$YR$$F$Y$$$20240731$$CN$US$US
240883401$24088340$1$I$$20240702$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0009968$DR REDDYS$Devine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. Journal of Pediatric Pharmacology and Therapeutics. 2023;28(2): 161-166. doi:10.5863/1551-6776-28.2.161.$29$DY$I$$Y$$$20240715$$PH$US$US
240883411$24088341$1$I$$20240702$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0009993$DR REDDYS$Suresh S, Chaitanya G, Kachhvah AD, Vashin V, Saranathan M, Pati S. Case report: Nocturnal low-frequency stimulation of the centromedian thalamic nucleus improves sleep quality and seizure control. Frontiers in Human Neuroscience. 2024 Jun 04;18: doi:10.3389/fnhum.2024.1392100.$39$YR$A$M$Y$$$20240715$$HP$US$US
240883422$24088342$2$F$20231001$20240908$20240715$20240918$EXP$$CA-AMGEN-CANNI2024139716$AMGEN$$58$YR$A$M$Y$$$20240917$$CN$CA$CA
240883431$24088343$1$I$20240501$20240705$20240715$20240715$PER$$US-SA-2024SA202819$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240715$$MD$US$US
240883441$24088344$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA203727$SANOFI AVENTIS$$$$$F$Y$$$20240715$$CN$US$US
240883451$24088345$1$I$20240101$20240705$20240715$20240715$PER$$US-SA-2024SA202802$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240715$$MD$US$US
240883461$24088346$1$I$20170101$20240708$20240715$20240715$EXP$$BR-BIOGEN-2024BI01273132$BIOGEN$$$$$F$Y$80$KG$20240715$$CN$BR$BR
240883471$24088347$1$I$$20240702$20240715$20240715$EXP$$JP-AMGEN-JPNSP2024138856$AMGEN$$$$$$Y$$$20240715$$MD$JP$JP
240883481$24088348$1$I$20240101$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139479$AMGEN$$59$YR$A$F$Y$$$20240715$$CN$US$US
240883491$24088349$1$I$20240706$20240708$20240715$20240715$PER$$US-BAUSCHBL-2024BNL029908$BAUSCH AND LOMB$$$$$M$Y$$$20240715$$CN$US$US
240883501$24088350$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034038$AUROBINDO$$$$$F$Y$$$20240715$$PH$GB$GB
240883511$24088351$1$I$20240707$20240710$20240715$20240715$EXP$$US-AstraZeneca-2024A159329$ASTRAZENECA$$17730$DY$$F$Y$$$20240715$$CN$US$
240883521$24088352$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034275$AUROBINDO$$$$$F$Y$$$20240715$$CN$GB$GB
240883531$24088353$1$I$20240601$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007072$ELI LILLY AND CO$$61$YR$A$$Y$$$20240715$$CN$US$US
240883541$24088354$1$I$20240707$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007824$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240715$$CN$US$US
240883551$24088355$1$I$20240401$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007671$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240715$$CN$US$US
240883561$24088356$1$I$20240707$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008230$ELI LILLY AND CO$$$$$$Y$$$20240715$$CN$US$US
240883571$24088357$1$I$$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008609$ELI LILLY AND CO$$$$$F$Y$$$20240715$$CN$US$US
240883581$24088358$1$I$$20240711$20240715$20240715$EXP$$NVSC2024US144212$NOVARTIS$$$$$M$Y$$$20240715$$MD$US$US
240883591$24088359$1$I$20240101$20240703$20240715$20240715$EXP$$US-TWI PHARMACEUTICAL, INC-20240700005$TWI PHARMACEUTICALS$$66$YR$$M$Y$$$20240712$$$US$US
240883601$24088360$1$I$20221001$20240703$20240715$20240715$EXP$$US-TWI PHARMACEUTICAL, INC-20240700006$TWI PHARMACEUTICALS$$64$YR$$F$Y$$$20240712$$CN$US$US
240883611$24088361$1$I$20170101$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033737$AUROBINDO$$$$$F$Y$$$20240715$$HP$GB$GB
240883621$24088362$1$I$$20240711$20240715$20240715$PER$$US-GILEAD-2024-0680484$GILEAD$$$$$M$Y$$$20240715$$CN$US$US
240883642$24088364$2$F$20240616$20240704$20240715$20240729$EXP$$CN-ROCHE-10000019065$ROCHE$$40$YR$A$M$Y$$$20240729$$HP$CN$CN
240883653$24088365$3$F$$20240807$20240715$20240815$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-20832$SAMSUNG BIOEPIS$$64$YR$A$M$Y$$$20240815$$CN$CA$CA
240883661$24088366$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033458$AUROBINDO$$$$$M$Y$$$20240715$$CN$GB$GB
240883673$24088367$3$F$20240311$20240812$20240715$20240823$EXP$$GB-AUROBINDO-AUR-APL-2024-033750$AUROBINDO$$73$YR$$M$Y$101$KG$20240823$$PH$GB$GB
240883681$24088368$1$I$20240620$20240708$20240715$20240715$EXP$PT-INFARMED-R202406-545$PT-REGENERON PHARMACEUTICALS, INC.-2024-097566$REGENERON$$58$YR$$M$Y$$$20240715$$PH$PT$PT
240883691$24088369$1$I$20240527$20240705$20240715$20240715$EXP$IT-MINISAL02-992631$IT-TEVA-VS-3218154$TEVA$$53$YR$$F$Y$58$KG$20240715$$MD$IT$IT
240883701$24088370$1$I$20240323$20240705$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-034327$AUROBINDO$$52$YR$$M$Y$84$KG$20240715$$PH$FR$FR
240883732$24088373$2$F$20240601$20240708$20240715$20240726$EXP$$US-CIPLA LTD.-2024US07196$CIPLA$$$$$$Y$$$20240719$$CN$US$US
240883741$24088374$1$I$$20240708$20240715$20240715$EXP$$US-GSK-US2024AMR085757$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$US$US
240883752$24088375$2$F$$20240812$20240715$20240814$PER$$US-JNJFOC-20240714558$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240814$$CN$US$US
240883761$24088376$1$I$20240113$20240701$20240715$20240715$EXP$$GB-CIPLA LTD.-2024GB07106$CIPLA$$$$$$Y$$$20240715$$CN$GB$GB
240883771$24088377$1$I$$20240705$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-033641$AUROBINDO$$$$$F$Y$$$20240715$$PH$FR$FR
240883782$24088378$2$F$$20240807$20240715$20240820$EXP$$US-CIPLA LTD.-2024US07239$CIPLA$Morcate L, Sanders I, Chen Chen K, Galavis YS, Villarroya-Marquina I, Makkoukdji N et al.. Nonsexual genital ulcers secondary to Epstein-Barr virus in a pediatric patient.. Journal of Pediatric Health Care. 2024;1 to 7$$$$$Y$$$20240820$$MD$US$US
240883791$24088379$1$I$20231201$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034175$AUROBINDO$$$$$F$Y$$$20240715$$CN$GB$GB
240883801$24088380$1$I$$20240701$20240715$20240715$EXP$$US-CIPLA LTD.-2024US07151$CIPLA$Guzman A.. Should severe hypertriglyceridemia also be considered as a contraindication for use of glucagon like peptide 1 (GLP-1) agonists?. J-Endocr-Soc. 2020;4:A122$$$$$Y$$$20240715$$HP$US$US
240883811$24088381$1$I$$20240702$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0009969$DR REDDYS$Devine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. Journal of Pediatric Pharmacology and Therapeutics. 2023;28(2): 161-166. doi:10.5863/1551-6776-28.2.161.$52$DY$I$$Y$$$20240715$$PH$US$US
240883822$24088382$2$F$$20240708$20240715$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05914$LUPIN$$$$$$Y$$$20240806$$CN$US$US
240883831$24088383$1$I$$20240701$20240715$20240715$EXP$$US-CIPLA LTD.-2024US07166$CIPLA$Khan AA, Anwar MS, Cherukuri PB, Abu-Shanab A, Fish PN.. Community-acquired meningitis complicated with pyogenic ventriculitis and hydrocephalus in a patient with haematological malignancy: A case report and literature review.. Cureus. 2024;16 (5):e60800$$$$$Y$$$20240715$$HP$US$US
240883841$24088384$1$I$$20240709$20240715$20240715$EXP$$US-ABBVIE-5832408$ABBVIE$$69$YR$$F$Y$$$20240715$$CN$US$US
240883852$24088385$2$F$20240529$20240725$20240715$20240725$EXP$IT-MINISAL02-988934$IT-ROCHE-10000014988$ROCHE$$21$YR$A$M$Y$$$20240726$$PH$IT$IT
240883862$24088386$2$F$20240401$20240910$20240715$20240914$EXP$IT-MINISAL02-989623$IT-ROCHE-10000020272$ROCHE$$67$YR$E$F$Y$$$20240914$$CN$IT$IT
240883871$24088387$1$I$$20240708$20240715$20240715$EXP$$GB-TAKEDA-2024TUS059126$TAKEDA$$$$$F$Y$$$20240715$$CN$GB$GB
240883881$24088388$1$I$20151201$20240708$20240715$20240715$EXP$$BR-BIOGEN-2024BI01273157$BIOGEN$$50$YR$$F$Y$71$KG$20240715$$HP$BR$BR
240883892$24088389$2$F$$20240715$20240715$20240716$PER$$US-AMGEN-USASP2024139568$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240883902$24088390$2$F$$20240711$20240715$20240718$PER$$US-AMGEN-USASL2024071512$AMGEN$$38$YR$A$F$Y$$$20240717$$CN$US$US
240883911$24088391$1$I$20240705$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139525$AMGEN$$82$YR$E$M$Y$$$20240715$$CN$US$US
240883921$24088392$1$I$$20240712$20240715$20240715$EXP$GB-MHRA-MED-202407111454382940-HMYKC$GB-ORGANON-O2407GBR001120$ORGANON$$78$YR$$F$Y$$$20240715$$PH$GB$GB
240883932$24088393$2$F$$20240814$20240715$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05965$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240883941$24088394$1$I$$20240703$20240715$20240715$PER$$US-JNJFOC-20240718178$JOHNSON AND JOHNSON$$$$$F$Y$58.2$KG$20240715$$CN$US$US
240883954$24088395$4$F$20240704$20240807$20240715$20240819$30DAY$$US-JNJFOC-20240726619$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240820$$PH$US$US
240883962$24088396$2$F$20240520$20240716$20240715$20240726$EXP$CZ-CZSUKL-24001785$CZ-GLENMARK PHARMACEUTICALS-2024GMK092052$GLENMARK$$$$$$Y$$$20240726$$CN$CZ$CZ
240883973$24088397$3$F$20240101$20240717$20240715$20240723$EXP$$US-JNJFOC-20240724312$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240722$$CN$US$US
240883981$24088398$1$I$20240626$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110887$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$87.09$KG$20240715$$CN$US$US
240883991$24088399$1$I$20240101$20240710$20240715$20240715$EXP$$US-ABBVIE-5836854$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240884001$24088400$1$I$20240702$20240702$20240715$20240715$EXP$$US-CIPLA LTD.-2024US07251$CIPLA$$$$$$Y$$$20240715$$CN$US$US
240884011$24088401$1$I$20210304$20240708$20240715$20240715$EXP$$US-SA-2024SA204457$SANOFI AVENTIS$$$$$M$Y$$$20240715$$HP$US$US
240884021$24088402$1$I$20240709$20240710$20240715$20240715$EXP$$US-ABBVIE-5836867$ABBVIE$$72$YR$$M$Y$$$20240715$$CN$US$US
240884031$24088403$1$I$$20240708$20240715$20240715$EXP$$US-BEIGENE-BGN-2024-010596$BEIGENE$$$$$$Y$$$20240715$$CN$US$US
240884051$24088405$1$I$20240101$20240703$20240715$20240715$PER$$US-SA-2024SA199680$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240715$$CN$US$US
240884062$24088406$2$F$$20240910$20240715$20240924$EXP$$US-CIPLA LTD.-2024US07280$CIPLA$Dogrul BN, Park C.. Hydralazine induced visual and auditory hallucinations in a kidney transplant patient: Case report. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;1 to 2$$$$$Y$$$20240925$$MD$US$US
240884081$24088408$1$I$$20240710$20240715$20240715$EXP$$US-AstraZeneca-2024A158400$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$US$
240884091$24088409$1$I$20240619$20240702$20240715$20240715$EXP$$FR-CIPLA LTD.-2024FR07188$CIPLA$$$$$$Y$$$20240715$$MD$FR$FR
240884111$24088411$1$I$$20240711$20240715$20240715$EXP$$TW-ABBVIE-5837772$ABBVIE$$$$$F$Y$$$20240715$$CN$TW$TW
240884121$24088412$1$I$$20240711$20240715$20240715$EXP$$GB-GILEAD-2024-0680529$GILEAD$$$$A$M$Y$$$20240715$$HP$GB$GB
240884131$24088413$1$I$$20240710$20240715$20240715$PER$$US-HALEON-2186720$Haleon PLC$Shah D. Diagnostic Challenges of Psoriasis: A Multifaceted Case of Triple-Drug Interaction and Literature Review. ?Consultant . 2024 Jun 01;64(6).$37$YR$$F$Y$$$20240715$$HP$US$US
240884142$24088414$2$F$$20240915$20240715$20240926$EXP$$EG-ROCHE-10000023219$ROCHE$Elshony H, Al-Ghamdi A. Acute Motor Conduction Block Neuropathy After Initiation of Omalizumab: Case Report and Literature Review for Possible Causality. ENEUROLOGICALSCI. 2024;(36):1-5. doi:1016/j.ensci.2024.100512.$45$YR$A$M$Y$$$20240926$$HP$EG$EG
240884151$24088415$1$I$20240101$20240710$20240715$20240715$EXP$$TN-ABBVIE-5836934$ABBVIE$$42$YR$$M$Y$$$20240715$$CN$TN$TN
240884161$24088416$1$I$$20240703$20240715$20240715$PER$$US-JNJFOC-20240713597$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240884171$24088417$1$I$$20240702$20240715$20240715$EXP$$US-CIPLA LTD.-2024US07263$CIPLA$Marino-Nunez D, Chadha A, Onajin O.. A fatal case of cryptococcoid vasculopathy.. American Journal of Dermatopathology.. 2024;46 (7):1 to 3$$$$$Y$$$20240715$$HP$US$US
240884181$24088418$1$I$$20240703$20240715$20240715$PER$$US-JNJFOC-20240713697$JOHNSON AND JOHNSON$$$$$F$Y$85.9$KG$20240715$$CN$US$US
240884192$24088419$2$F$$20240712$20240715$20240724$PER$$US-ABBVIE-5836998$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
240884201$24088420$1$I$20240706$20240712$20240715$20240715$EXP$$CA-JNJFOC-20240735875$JOHNSON AND JOHNSON$$16$YR$T$F$Y$52$KG$20240715$$HP$CA$CA
240884211$24088421$1$I$$20240702$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010098$DR REDDYS$Faircloth JM, Bhatt ND, Chartan CA, Coleman RD, Villafranco N, Ruiz FE, et al. Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration. Frontiers in Pediatrics. 2023 Jan 01;11: doi:10.3389/fped.2023.1050508.$5$YR$C$F$Y$$$20240715$$HP$US$US
240884221$24088422$1$I$20230701$20240705$20240715$20240715$PER$$US-SA-2024SA203068$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240715$$MD$US$US
240884233$24088423$3$F$20240628$20240820$20240715$20240828$EXP$$VN-TAKEDA-2024TUS067959$TAKEDA$$62$YR$$F$Y$55$KG$20240828$$CN$VN$VN
240884241$24088424$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA203747$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240715$$MD$US$US
240884251$24088425$1$I$20240601$20240705$20240715$20240715$PER$$US-SA-2024SA202988$SANOFI AVENTIS$$24$YR$A$M$Y$99$KG$20240715$$MD$US$US
240884261$24088426$1$I$20240101$20240705$20240715$20240715$PER$$US-SA-2024SA202898$SANOFI AVENTIS$$$$A$F$Y$$$20240715$$MD$US$US
240884271$24088427$1$I$$20240702$20240715$20240715$EXP$$US-CIPLA LTD.-2024US07273$CIPLA$Fenton GA, Dean EA.. Exacerbations of persistent neurotoxicity following Axicabtagene Ciloleucel in a patient with relapsed/refractory diffuse large B-cell lymphoma: A case report. Case Reports in Oncology. 2024;17:75 to 81$$$$$Y$$$20240715$$HP$US$US
240884281$24088428$1$I$20240517$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033760$AUROBINDO$$78$YR$$M$Y$$$20240715$$PH$GB$GB
240884291$24088429$1$I$20240101$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024137323$AMGEN$$59$YR$A$F$Y$$$20240715$$CN$US$US
240884311$24088431$1$I$$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024138717$AMGEN$$$$$$Y$$$20240715$$MD$US$US
240884322$24088432$2$F$$20240712$20240715$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407002179$ELI LILLY AND CO$$$$$F$Y$$$20240805$$CN$US$US
240884331$24088433$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007186$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240715$$CN$US$US
240884341$24088434$1$I$$20240708$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407004940$ELI LILLY AND CO$$64$YR$A$$Y$$$20240715$$CN$US$US
240884351$24088435$1$I$20240603$20240703$20240715$20240715$EXP$$US-ROCHE-3577909$ROCHE$$96$YR$E$M$Y$72.57$KG$20240715$$CN$US$US
240884361$24088436$1$I$20240709$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007913$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240715$$CN$US$US
240884371$24088437$1$I$$20240703$20240715$20240715$PER$$US-JNJFOC-20240711112$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240715$$CN$US$US
240884401$24088440$1$I$$20240711$20240715$20240715$30DAY$$US-GSK-US2024086594$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$HP$US$US
240884411$24088441$1$I$20240502$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405071035174850-GHKVL$GB-TEVA-VS-3218296$TEVA$$$$$F$Y$$$20240715$$PH$GB$GB
240884421$24088442$1$I$20240320$20240705$20240715$20240715$EXP$FR-AFSSAPS-NY2024000727$FR-SA-2024SA200319$SANOFI AVENTIS$$59$YR$A$F$Y$70$KG$20240715$$PH$FR$FR
240884431$24088443$1$I$$20240705$20240715$20240715$EXP$$ES-AUROBINDO-AUR-APL-2024-033945$AUROBINDO$Pomares H, Arribas I, Quinones T, Hernandez JV, Amoros JR, Artigal CM, et al. Long-term outcomes after venetoclax-hypomethylating agent combination therapy discontinuation, in patients with acute myeloid leukemia. Experience of a single center.. Blood. 2023;142(Suppl. 1):4225?4226$$$A$$Y$$$20240715$$MD$ES$ES
240884441$24088444$1$I$20231101$20240709$20240715$20240715$PER$$US-SA-2024SA204021$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240715$$CN$US$US
240884451$24088445$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA202657$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240715$$MD$US$US
240884461$24088446$1$I$20240709$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139605$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240884471$24088447$1$I$20240515$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405151322554580-JFDSQ$GB-TEVA-VS-3218498$TEVA$$30$YR$$F$Y$110$KG$20240715$$CN$GB$GB
240884482$24088448$2$F$20240101$20240710$20240715$20240718$EXP$$US-SA-2024SA204860$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240718$$MD$US$US
240884491$24088449$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407051358551410-MLWKF$GB-TEVA-VS-3218583$TEVA$$$$$M$Y$$$20240715$$MD$GB$GB
240884501$24088450$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033915$AUROBINDO$$$$$M$Y$97$KG$20240715$$PH$GB$GB
240884512$24088451$2$F$$20240703$20240715$20240814$EXP$$US-ROCHE-10000019639$ROCHE$$74$YR$E$F$Y$$$20240814$$CN$US$US
240884532$24088453$2$F$$20240916$20240715$20240926$PER$$US-GSK-US2024084057$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
240884544$24088454$4$F$20240701$20240826$20240715$20240902$EXP$$US-GSK-US2024AMR084304$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240902$$CN$US$US
240884551$24088455$1$I$20240701$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111432$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240715$$CN$US$US
240884564$24088456$4$F$20240101$20240916$20240715$20240924$EXP$$CA-CELLTRION INC.-2024CA017025$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
240884572$24088457$2$F$$20240808$20240715$20240812$PER$$US-JNJFOC-20240700362$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240812$$CN$US$US
240884581$24088458$1$I$$20240702$20240715$20240715$PER$$US-JNJFOC-20240707601$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240715$$CN$US$US
240884592$24088459$2$F$$20240712$20240715$20240717$PER$$NVSC2024US145198$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
240884602$24088460$2$F$20240501$20240710$20240715$20240717$EXP$$US-SA-2024SA204442$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240717$$MD$US$US
240884611$24088461$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA204686$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240715$$MD$US$US
240884621$24088462$1$I$20240503$20240709$20240715$20240715$EXP$$US-UCBSA-2024034874$UCB$$50$YR$$F$Y$$$20240715$$CN$US$US
240884631$24088463$1$I$$20240703$20240715$20240715$PER$$US-TEVA-VS-3217291$TEVA$$33$YR$$M$Y$$$20240715$$HP$US$US
240884641$24088464$1$I$20230701$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138038$AMGEN$$74$YR$E$F$Y$$$20240715$$CN$US$US
240884652$24088465$2$F$$20240715$20240715$20240715$PER$$US-AMGEN-USASP2024139580$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240884661$24088466$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034141$AUROBINDO$$$$$F$Y$56$KG$20240715$$HP$GB$GB
240884671$24088467$1$I$$20240711$20240715$20240715$EXP$$TW-ABBVIE-5837794$ABBVIE$$$$A$$Y$$$20240715$$CN$TW$TW
240884681$24088468$1$I$$20240703$20240715$20240715$EXP$$US-APOTEX-2024AP008127$APOTEX$Chu AF, Sagi V, Amin AK, Rajagopal G, Shantanu S, Pederson KS. Continuous QT interval monitoring using insertable cardiac monitors during antiarrhythmic loading hospitalization: Results from the ^LINQ QT^ Study. Europace. 2024;26(1):i43-i45$75$YR$$M$Y$$$20240715$$HP$US$US
240884691$24088469$1$I$20240602$20240710$20240715$20240715$EXP$$US-AstraZeneca-2024A158483$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$US$
240884701$24088470$1$I$20240701$20240710$20240715$20240715$EXP$$GB-AstraZeneca-2024A158546$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$GB$
240884711$24088471$1$I$20240709$20240710$20240715$20240715$EXP$$ES-AstraZeneca-2024A159364$ASTRAZENECA$$23608$DY$$F$Y$$$20240715$$CN$ES$
240884721$24088472$1$I$$20240705$20240715$20240715$EXP$$US-KERYX BIOPHARMACEUTICALS INC.-US-AKEB-24-001073$AKEBIA THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240884734$24088473$4$F$20240617$20240828$20240715$20240904$PER$$US-ROCHE-10000023517$ROCHE$$81$YR$E$M$Y$61.2$KG$20240904$$CN$US$US
240884741$24088474$1$I$20240422$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110572$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240715$$CN$US$US
240884751$24088475$1$I$20240101$20240711$20240715$20240715$EXP$$CA-ABBVIE-5838030$ABBVIE$$56$YR$$F$Y$$$20240715$$CN$CA$CA
240884761$24088476$1$I$20240701$20240711$20240715$20240715$EXP$$US-UCBSA-2024035451$UCB$$49$YR$$F$Y$$$20240715$$HP$US$US
240884771$24088477$1$I$20240101$20240708$20240715$20240715$PER$$US-SA-2024SA203117$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240715$$MD$US$US
240884781$24088478$1$I$$20240709$20240715$20240715$PER$$US-CHATTEMPRD-2024OHG023731$CHATTEM$$$$$F$Y$$$20240715$$CN$US$US
240884791$24088479$1$I$$20240708$20240715$20240715$PER$$US-CHATTEMPRD-2024OHG023550$CHATTEM$$$$$M$Y$$$20240715$$CN$US$US
240884801$24088480$1$I$20180517$20240710$20240715$20240715$EXP$$CO-UCBSA-2024035536$UCB$$73$YR$$M$Y$$$20240715$$CN$CO$CO
240884812$24088481$2$F$$20240729$20240715$20240730$PER$$NVSC2024US145188$NOVARTIS$$$$$$Y$$$20240730$$HP$US$US
240884821$24088482$1$I$20240101$20240705$20240715$20240715$EXP$$CA-CELLTRION INC.-2024CA017028$CELLTRION$$$$$$Y$$$20240715$$HP$CA$CA
240884831$24088483$1$I$20240614$20240705$20240715$20240715$EXP$IT-MINISAL02-992507$IT-TEVA-VS-3218172$TEVA$$50$YR$$F$Y$$$20240715$$PH$IT$IT
240884841$24088484$1$I$20240702$20240715$20240715$20240715$EXP$FR-AFSSAPS-AN2024000909$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039667$BOEHRINGER INGELHEIM$$86$YR$E$F$Y$$$20240715$$MD$FR$FR
240884852$24088485$2$F$$20240717$20240715$20240724$PER$$US-JNJFOC-20240700682$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
240884871$24088487$1$I$$20231027$20240715$20240715$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415610$RANBAXY$$$$$M$Y$$$20240715$$CN$US$US
240884881$24088488$1$I$$20230725$20240715$20240715$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403069$RANBAXY$$$$E$F$Y$$$20240715$$CN$US$US
240884891$24088489$1$I$$20240708$20240715$20240715$EXP$$CA-APOTEX-2024AP008093$APOTEX$$61$YR$$F$Y$$$20240715$$CN$CA$CA
240884901$24088490$1$I$20240501$20240705$20240715$20240715$EXP$IT-MINISAL02-992595$IT-TEVA-VS-3218181$TEVA$$52$YR$$F$Y$$$20240715$$MD$IT$IT
240884921$24088492$1$I$$20240709$20240715$20240715$PER$$US-ABBVIE-5836270$ABBVIE$$$$$M$Y$$$20240715$$HP$US$US
240884931$24088493$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034104$AUROBINDO$$$$$$Y$$$20240715$$CN$GB$GB
240884941$24088494$1$I$20240101$20240709$20240715$20240715$EXP$$US-ABBVIE-5835827$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240884951$24088495$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007804$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240715$$CN$US$US
240884962$24088496$2$F$20240709$20240826$20240715$20240830$EXP$$US-ABBVIE-5835010$ABBVIE$$77$YR$$F$Y$$$20240830$$CN$US$US
240884971$24088497$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033791$AUROBINDO$$$$$F$Y$$$20240715$$CN$GB$GB
240884981$24088498$1$I$20240707$20240708$20240715$20240715$EXP$$US-SA-2024SA203844$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240715$$MD$US$US
240884991$24088499$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138798$AMGEN$$$$$M$Y$$$20240715$$CN$US$US
240885001$24088500$1$I$$20240707$20240715$20240715$PER$$US-JNJFOC-20240721175$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240885016$24088501$6$F$20240310$20240925$20240715$20240930$EXP$$CA-JNJFOC-20240368096$JOHNSON AND JOHNSON$$15$YR$T$F$Y$56$KG$20240930$$HP$CA$CA
240885021$24088502$1$I$$20240708$20240715$20240715$EXP$$CA-JNJFOC-20240729863$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240715$$HP$CA$CA
240885031$24088503$1$I$$20240710$20240715$20240715$EXP$$CA-TAKEDA-2019TUS010398$TAKEDA$$$$$F$Y$$$20240715$$CN$CA$CA
240885042$24088504$2$F$$20240829$20240715$20240909$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13831$IPSEN$$37$YR$A$F$Y$104.3$KG$20240909$$CN$US$US
240885051$24088505$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145183$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240885061$24088506$1$I$20190101$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033840$AUROBINDO$$$$A$F$Y$$$20240715$$CN$GB$GB
240885071$24088507$1$I$$20240702$20240715$20240715$EXP$$US-ROCHE-10000017804$ROCHE$$70$YR$E$F$Y$$$20240715$$CN$US$US
240885084$24088508$4$F$$20240909$20240715$20240916$EXP$$IE-ABBVIE-5837032$ABBVIE$$$$E$M$Y$$$20240916$$HP$IE$IE
240885091$24088509$1$I$20180910$20190830$20240715$20240715$EXP$$US-AstraZeneca-2018SF18736$ASTRAZENECA$$31495$DY$$F$Y$$$20240715$$CN$US$
240885101$24088510$1$I$$20191210$20240715$20240715$EXP$$US-AstraZeneca-2019SE23921$ASTRAZENECA$$81$YR$$M$Y$$$20240715$$CN$US$
240885111$24088511$1$I$$20240710$20240715$20240715$EXP$$CA-TAKEDA-2024TUS014965$TAKEDA$$$$$F$Y$$$20240715$$MD$CA$CA
240885121$24088512$1$I$$20240625$20240715$20240715$PER$$JP-WT-2024-074894$Waylis$$62$YR$$M$Y$$$20240715$$MD$JP$JP
240885131$24088513$1$I$$20240705$20240715$20240715$EXP$$US-APOTEX-2024AP008076$APOTEX$Oomrigar S.C, Fernandez J, Rivera Ortiz C, Rajen H, Toll A, Perez Colome E, et al.. The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-3$$$$F$Y$$$20240715$$HP$US$US
240885141$24088514$1$I$$20240710$20240715$20240715$PER$$US-HALEON-2186636$Haleon PLC$$$$$$Y$$$20240715$$CN$US$US
240885151$24088515$1$I$20230904$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034260$AUROBINDO$$17$YR$$M$Y$$$20240715$$MD$GB$GB
240885161$24088516$1$I$$20240708$20240715$20240715$EXP$$CA-APOTEX-2024AP008146$APOTEX$$59$YR$$F$Y$$$20240715$$CN$CA$CA
240885171$24088517$1$I$20240101$20240623$20240715$20240715$PER$$US-SERVIER-S24008038$SERVIER$$$$$$Y$$$20240715$$MD$US$US
240885181$24088518$1$I$20240707$20240711$20240715$20240715$EXP$GB-MHRA-MED-202407091352085410-HRCLP$GB-SANDOZ INC.-SDZ2024GB064965$SANDOZ$$71$YR$$F$Y$88$KG$20240715$$CN$GB$GB
240885191$24088519$1$I$20231101$20240708$20240715$20240715$EXP$$CN-RDY-LIT/CHN/24/0010279$DR REDDYS$CAO J, WANG K, CAO G, HUANG G, HE X. Comprehensive Treatment of Metastatic Prostate Cancer: a Case Report and Literature Review.$74$YR$E$M$Y$$$20240715$$HP$CN$CN
240885201$24088520$1$I$20240314$20240708$20240715$20240715$EXP$ES-AEMPS-1542313$ES-ALXN-202407GLO000402ES$ALEXION PHARMACEUTICALS$$42$YR$$F$Y$$$20240715$$PH$ES$ES
240885211$24088521$1$I$20240509$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033766$AUROBINDO$$62$YR$$M$Y$78$KG$20240715$$MD$GB$GB
240885221$24088522$1$I$$20240709$20240715$20240715$EXP$$CA-TAKEDA-2022TUS077006$TAKEDA$$$$$F$Y$$$20240715$$MD$CA$CA
240885232$24088523$2$F$$20240911$20240715$20240916$EXP$$CA-TAKEDA-2024TUS070879$TAKEDA$$$$$F$Y$$$20240916$$CN$CA$CA
240885244$24088524$4$F$$20240806$20240715$20240821$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-04122$IPSEN$$$$$F$Y$$$20240821$$HP$GB$GB
240885251$24088525$1$I$$20240620$20240715$20240715$PER$$JP-WT-2024-074157$Waylis$$77$YR$$M$Y$$$20240715$$PH$JP$JP
240885262$24088526$2$F$$20240722$20240715$20240806$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-096538$REGENERON$$$$$F$Y$$$20240806$$CN$CA$CA
240885271$24088527$1$I$20240706$20240710$20240715$20240715$EXP$$US-GILEAD-2024-0680452$GILEAD$$52$YR$A$M$Y$$$20240715$$HP$US$US
240885281$24088528$1$I$20240401$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034108$AUROBINDO$$62$YR$$F$Y$87$KG$20240715$$PH$GB$GB
240885291$24088529$1$I$20240626$20240705$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-034158$AUROBINDO$$$$E$F$Y$$$20240715$$MD$FR$FR
240885301$24088530$1$I$$20240709$20240715$20240715$EXP$$NVSC2024US143975$NOVARTIS$$$$$$Y$$$20240715$$CN$US$US
240885311$24088531$1$I$$20240710$20240715$20240715$EXP$$CA-TAKEDA-2024TUS070999$TAKEDA$$$$$M$Y$$$20240715$$CN$CA$CA
240885321$24088532$1$I$20240514$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033734$AUROBINDO$$61$YR$$M$Y$82$KG$20240715$$MD$GB$GB
240885331$24088533$1$I$20240513$20240705$20240715$20240715$PER$$US-ROCHE-10000023953$ROCHE$$62$YR$A$M$Y$67.5$KG$20240715$$PH$US$US
240885341$24088534$1$I$$20240708$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108777$BRISTOL MYERS SQUIBB$Idogun PO, Hafez-Khayyata S, Ezekwudo D. Immune checkpoint inhibitor-induced guillain barre syndrome: a single-institution case report and narrative review. Cureus. 2024 Jun 01;16(6):1-11. doi:10.7759/cureus.61489.$67$YR$E$F$Y$$$20240715$$HP$US$US
240885353$24088535$3$F$20240101$20240820$20240715$20240827$EXP$$CA-ABBVIE-5838433$ABBVIE$$56$YR$$M$Y$70$KG$20240827$$CN$CA$CA
240885361$24088536$1$I$$20240703$20240715$20240715$EXP$$HU-SPC-000456$SOLARIS PHARMA$Nagy KI, Pribelszki E, Sira A, Fullajtar B, Racz T, Major T. Francisella tularensis Infection Causing Parinaud Oculoglandular Syndrome. Am J Case Rep. 2024 Jun 28;25:e943915. doi: 10.12659/AJCR.943915.$66$YR$E$M$Y$$$20240715$$HP$HU$HU
240885371$24088537$1$I$20240711$20240711$20240715$20240715$30DAY$$US-SANDOZ INC.-SDZ2024US064836$SANDOZ$$$$$$Y$$$20240715$$CN$US$US
240885382$24088538$2$F$$20240816$20240715$20240820$EXP$$US-TAKEDA-2023TUS053284$TAKEDA$$$$$F$Y$$$20240820$$CN$US$US
240885392$24088539$2$F$20240606$20240718$20240715$20240726$EXP$$CA-TAKEDA-2024TUS052835$TAKEDA$$19$YR$$M$Y$$$20240726$$CN$CA$CA
240885402$24088540$2$F$$20240719$20240715$20240723$PER$$NVSC2024US145117$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
240885411$24088541$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144840$NOVARTIS$$$$$$Y$$$20240715$$CN$US$US
240885421$24088542$1$I$$20240703$20240715$20240715$EXP$$US-INSMED-2024-00197-USAA$INSMED$$$$$F$Y$$$20240715$$CN$US$US
240885433$24088543$3$F$20240101$20240724$20240715$20240805$EXP$$NVSC2024DE133155$NOVARTIS$$67$YR$$F$Y$63$KG$20240805$$MD$DE$DE
240885442$24088544$2$F$20231201$20240820$20240715$20240822$EXP$$CO-ABBVIE-5838896$ABBVIE$$65$YR$$M$Y$43$KG$20240822$$CN$CO$CO
240885451$24088545$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034128$AUROBINDO$$$$$$Y$$$20240715$$HP$GB$GB
240885462$24088546$2$F$$20240802$20240715$20240812$EXP$$GB-AUROBINDO-AUR-APL-2024-034261$AUROBINDO$$$$$M$Y$$$20240812$$CN$GB$GB
240885471$24088547$1$I$20240620$20240705$20240715$20240715$EXP$IT-MINISAL02-992701$IT-TEVA-VS-3218167$TEVA$$84$YR$$F$Y$$$20240715$$PH$IT$IT
240885481$24088548$1$I$20240307$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034274$AUROBINDO$$33$YR$$F$Y$73$KG$20240715$$CN$GB$GB
240885492$24088549$2$F$20240712$20240715$20240715$20240715$PER$$US-AMGEN-USASP2024139188$AMGEN$$87$YR$E$M$Y$$$20240715$$MD$US$US
240885501$24088550$1$I$$20240708$20240715$20240715$EXP$$IN-ROCHE-10000019532$ROCHE$Kamtalwar S, Mirgh S, More A, Sharma P, Patkar N, Rajpal S, et al. Recurrent Cytokine Storm in SARS-CoV-2 Infected Patients with Hematolymphoid Malignancy: A New Perspective. South Asian Journal of Cancer. 2024;13 (2):157-162. doi:10.1055/s-0043-1761443.$72$YR$E$M$Y$$$20240715$$MD$IN$IN
240885513$24088551$3$F$20221231$20240906$20240715$20240910$EXP$$US-ROCHE-10000016241$ROCHE$$84$YR$E$F$Y$$$20240910$$CN$US$US
240885521$24088552$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144809$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240885531$24088553$1$I$20220201$20240705$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2022-009814$AUROBINDO$$72$YR$$M$Y$82$KG$20240715$$MD$FR$FR
240885541$24088554$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111284$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240715$$HP$US$US
240885551$24088555$1$I$20240421$20240710$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110314$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240715$$CN$US$US
240885563$24088556$3$F$20240701$20240815$20240715$20240816$EXP$$US-TAKEDA-2024TUS071024$TAKEDA$$21$YR$$M$Y$$$20240816$$PH$US$US
240885571$24088557$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405071205522550-YWQRT$GB-RDY-SPO/GBR/24/0010062$DR REDDYS$$$$$$Y$$$20240715$$PH$GB$GB
240885581$24088558$1$I$20240416$20240701$20240715$20240715$EXP$FR-AFSSAPS-CN2024000636$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109338$ZYDUS PHARM$$$$$$Y$$$20240715$$MD$FR$FR
240885591$24088559$1$I$20240309$20240701$20240715$20240715$EXP$FR-AFSSAPS-AVMA2024000274$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109343$ZYDUS PHARM$$$$$$Y$$$20240715$$PH$FR$FR
240885601$24088560$1$I$20240511$20240701$20240715$20240715$EXP$FR-AFSSAPS-RE2024000625$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109304$ZYDUS PHARM$$$$$$Y$$$20240715$$MD$FR$FR
240885611$24088561$1$I$20240430$20240701$20240715$20240715$EXP$FR-AFSSAPS-AN2024000825$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109244$ZYDUS PHARM$$$$$$Y$$$20240715$$PH$FR$FR
240885621$24088562$1$I$20231220$20240701$20240715$20240715$EXP$FR-AFSSAPS-AVMA2024000261$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109321$ZYDUS PHARM$$$$$$Y$$$20240715$$PH$FR$FR
240885631$24088563$1$I$20240101$20240709$20240715$20240715$EXP$$CA-SANDOZ INC.-SDZ2024CA064483$SANDOZ$$$$$F$Y$$$20240715$$MD$CA$CA
240885641$24088564$1$I$20240507$20240701$20240715$20240715$EXP$FR-AFSSAPS-TO2024000823$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109243$ZYDUS PHARM$$$$$$Y$$$20240715$$MD$FR$FR
240885651$24088565$1$I$20240326$20240705$20240715$20240715$EXP$$ES-AUROBINDO-AUR-APL-2024-033634$AUROBINDO$$88$YR$$M$Y$62.4$KG$20240715$$MD$ES$ES
240885661$24088566$1$I$$20240710$20240715$20240715$EXP$$US-AstraZeneca-2024A158330$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
240885671$24088567$1$I$$20240710$20240715$20240715$EXP$$US-AstraZeneca-2024A158260$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$US$
240885682$24088568$2$F$$20240709$20240715$20240718$PER$$US-ABBVIE-5835171$ABBVIE$$$$$M$Y$$$20240718$$HP$US$US
240885691$24088569$1$I$20190601$20240703$20240715$20240715$EXP$$CO-ROCHE-2975016$ROCHE$$30$YR$A$M$Y$100$KG$20240715$$CN$CO$CO
240885701$24088570$1$I$20240501$20240710$20240715$20240715$EXP$$US-AMGEN-USASP2024137601$AMGEN$$81$YR$E$F$Y$$$20240715$$HP$US$US
240885711$24088571$1$I$$20240710$20240715$20240715$EXP$$GR-ABBVIE-5839623$ABBVIE$$$$$M$Y$$$20240715$$MD$GR$GR
240885721$24088572$1$I$20240710$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007949$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240715$$CN$US$US
240885731$24088573$1$I$$20240712$20240715$20240715$PER$$US-ABBVIE-5839826$ABBVIE$$$$$$Y$$$20240715$$HP$US$US
240885752$24088575$2$F$20240709$20240723$20240715$20240726$EXP$$BE-ABBVIE-5835420$ABBVIE$$57$YR$$F$Y$57$KG$20240726$$MD$BE$BE
240885762$24088576$2$F$$20240913$20240715$20240919$EXP$$NVSC2024US144305$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
240885771$24088577$1$I$20240509$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405171415438930-CKYNW$GB-AMAROX PHARMA-AMR2024GB02155$HETERO$$$$$M$Y$2$KG$20240715$$MD$GB$GB
240885781$24088578$1$I$20231010$20240712$20240715$20240715$EXP$$AT-SANDOZ INC.-SDZ2024AT064838$SANDOZ$$60$YR$$F$Y$80$KG$20240715$$MD$AT$AT
240885792$24088579$2$F$20240620$20240823$20240715$20240909$PER$$US-BEH-2024175113$CSL BEHRING$$20$YR$A$M$Y$75$KG$20240909$$MD$US$US
240885801$24088580$1$I$20240521$20240705$20240715$20240715$EXP$IT-MINISAL02-992625$IT-TEVA-VS-3218168$TEVA$$74$YR$$F$Y$55$KG$20240715$$MD$IT$IT
240885811$24088581$1$I$$20240710$20240715$20240715$EXP$$US-JNJFOC-20240727217$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$US$US
240885823$24088582$3$F$$20240923$20240715$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108132$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240925$$CN$US$US
240885831$24088583$1$I$20240101$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138193$AMGEN$$65$YR$E$M$Y$$$20240715$$CN$US$US
240885841$24088584$1$I$20240601$20240711$20240715$20240715$PER$$US-JNJFOC-20240730581$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240715$$CN$US$US
240885851$24088585$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034264$AUROBINDO$$$$$$Y$$$20240715$$PH$GB$GB
240885871$24088587$1$I$$20240705$20240715$20240715$EXP$$US-GSK-US2024AMR084819$GLAXOSMITHKLINE$$$$$M$Y$$$20240715$$CN$US$US
240885881$24088588$1$I$$20240710$20240715$20240715$PER$$US-ROCHE-10000023795$ROCHE$$$$$F$Y$$$20240715$$HP$US$US
240885891$24088589$1$I$$20240702$20240715$20240715$EXP$$JP-ROCHE-3557266$ROCHE$Kawashima A, Kondo Y, Sugita N, et al. The efficacy of rituximab for microscopic polyangiitis and granulomatosis with polyangiitis in our department. The 68th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology 2024 Apr;2024:754-.$68$YR$E$M$Y$$$20240715$$MD$JP$JP
240885901$24088590$1$I$$20240708$20240715$20240715$PER$$US-ABBVIE-5836822$ABBVIE$$$$$$Y$$$20240715$$CN$US$US
240885911$24088591$1$I$20240521$20240705$20240715$20240715$EXP$FR-AFSSAPS-TS2024000748$FR-TEVA-VS-3218236$TEVA$$68$YR$$M$Y$$$20240715$$MD$FR$FR
240885921$24088592$1$I$$20240701$20240715$20240715$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0245$GRAVITI PHARMACEUTICALS$Guzman A.Should Severe Hypertriglyceridemia Also Be Considered as a Contraindication for Use of Glucagon like Peptide 1 (GLP-1) Agonists?.Journal of the Endocrine Societ.2020;4:A122$46$YR$A$M$Y$$$20240715$$MD$US$US
240885932$24088593$2$F$$20240712$20240715$20240716$PER$$NVSC2024US145116$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240885941$24088594$1$I$$20240630$20240715$20240715$EXP$$US-Indoco-000577$INDOCO$Pathan S. Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage. Hosp Pharm. 2024 Aug;59(4):394-406.$67$YR$E$F$Y$$$20240715$$HP$US$US
240885951$24088595$1$I$$20240708$20240715$20240715$EXP$GB-MHRA-TPP11773167C7181661YC1719389954605$GB-ESPERIONTHERAPEUTICS-2024GBR01074$ESPERION THERAPEUTICS$$64$YR$$F$Y$77$KG$20240715$$PH$GB$GB
240885972$24088597$2$F$$20240730$20240715$20240801$PER$$US-LEO Pharma-371932$LEO PHARM$$68$YR$$M$Y$119$KG$20240801$$CN$US$US
240885981$24088598$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111277$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240715$$HP$US$US
240885991$24088599$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024137985$AMGEN$$$$$M$Y$$$20240715$$CN$US$US
240886003$24088600$3$F$20240614$20240830$20240715$20240903$PER$$US-AMGEN-USASP2024137066$AMGEN$$69$YR$E$F$Y$$$20240903$$HP$US$US
240886013$24088601$3$F$20240710$20240828$20240715$20240829$PER$$US-AMGEN-USASP2024139642$AMGEN$$77$YR$E$F$Y$$$20240829$$CN$US$US
240886022$24088602$2$F$20230520$20240717$20240715$20240720$EXP$$US-ABBVIE-5837826$ABBVIE$$27$YR$$M$Y$52.163$KG$20240720$$CN$US$US
240886031$24088603$1$I$20240509$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034153$AUROBINDO$$$DY$$M$Y$2$KG$20240715$$MD$GB$GB
240886042$24088604$2$F$20040703$20240715$20240715$20240715$PER$$US-AMGEN-USASP2024139648$AMGEN$$55$YR$A$F$Y$$$20240715$$CN$US$US
240886051$24088605$1$I$20240101$20240711$20240715$20240715$PER$$US-JNJFOC-20240730868$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240715$$CN$US$US
240886062$24088606$2$F$$20240802$20240715$20240812$EXP$GB-MHRA-MED-202405162318157690-FNGQT$GB-TEVA-VS-3218520$TEVA$$$$$M$Y$$$20240812$$CN$GB$GB
240886071$24088607$1$I$$20240705$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-033985$AUROBINDO$M. Chappuy, I. Merah, D. Ragonnet, J. de Ternay, B. Rolland.. Clinical illustrations of specific care requirements. Le Courrier des addictions. 2024;2:26$33$YR$$F$Y$$$20240715$$PH$FR$FR
240886081$24088608$1$I$$20240702$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010347$DR REDDYS$Faircloth JM, Bhatt ND, Chartan CA, Coleman RD, Villafranco N, Ruiz FE, et al. Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration. Frontiers in Pediatrics. 2023 Jan 01;11: doi:10.3389/fped.2023.1050508.$2$YR$C$M$Y$$$20240715$$HP$US$US
240886091$24088609$1$I$$20240702$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010336$DR REDDYS$Devine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. Journal of Pediatric Pharmacology and Therapeutics. 2023;28(2): 161-166. doi:10.5863/1551-6776-28.2.161.$60$DY$I$$Y$$$20240715$$PH$US$US
240886101$24088610$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145141$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240886111$24088611$1$I$20240626$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033580$AUROBINDO$$58$YR$$M$Y$72$KG$20240715$$CN$GB$GB
240886121$24088612$1$I$20240620$20240709$20240715$20240715$EXP$$CN-BEIGENE-BGN-2024-010688$BEIGENE$$$$$$Y$$$20240715$$HP$CN$CN
240886131$24088613$1$I$$20240703$20240715$20240715$EXP$JP-MLMSERVICE-20240626-PI113028-00174-1$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP000920$JUBILANT$Nakamura S, Masuda S, Oda S, Yamakawa D, Yamaguchi S, Ishima T, et al. Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine. Internal Medicine. 2024;63(12):1829-35.$72$YR$$F$Y$$$20240715$$MD$JP$JP
240886141$24088614$1$I$$20240709$20240715$20240715$EXP$$JP-AMGEN-JPNSP2024138254$AMGEN$$$$$$Y$$$20240715$$MD$JP$JP
240886151$24088615$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110817$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240715$$HP$US$US
240886161$24088616$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110718$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240715$$HP$US$US
240886171$24088617$1$I$$20240710$20240715$20240715$EXP$$CA-TAKEDA-2024TUS070932$TAKEDA$$$$$F$Y$$$20240715$$CN$CA$CA
240886181$24088618$1$I$20231115$20240709$20240715$20240715$EXP$$FR-TAKEDA-2024TUS065894$TAKEDA$$$$A$M$Y$$$20240715$$CN$FR$FR
240886191$24088619$1$I$$20240701$20240715$20240715$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0247$GRAVITI PHARMACEUTICALS$Simpson M, Awuah KB, Patel D, Ogline O, Pratapneni S, Disilvio BE.Early Extra Corporeal Membrane Oxygenation (ECMO) and Esophagogastroduodenoscopy (EGD) Implementation: A Timely Intervention in a Patient With Extended-Release Bupropion Overdose.Am-J-Respir-Crit-Care-Med.MAY-2024;209:A5672$41$YR$A$M$Y$$$20240715$$HP$US$US
240886201$24088620$1$I$$20240712$20240715$20240715$PER$$US-ROCHE-10000025780$ROCHE$$$$$$Y$$$20240715$$CN$US$US
240886211$24088621$1$I$$20240704$20240715$20240715$EXP$$US-APOTEX-2024AP008039$APOTEX$Zardoost P, Buckman Z, Weaver J, Elston S, Prouty A, Stuart R, Wehrum L. H.. Continuous renal replacement therapy for lithium toxicity: A worthy treatment to avoid intradialytic hypotension and vasopressors. Clinical Case Reports. 2024;12 (4):e8775 (1-4)$54$YR$$F$Y$$$20240715$$HP$US$US
240886221$24088622$1$I$$20240708$20240715$20240715$PER$$US-ROCHE-10000022305$ROCHE$$75$YR$E$F$Y$$$20240715$$CN$US$US
240886231$24088623$1$I$20240322$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034208$AUROBINDO$$44$YR$$M$Y$$$20240715$$CN$GB$GB
240886241$24088624$1$I$20240101$20240708$20240715$20240715$EXP$$LU-SA-2024SA203263$SANOFI AVENTIS$$$$A$$Y$$$20240715$$CN$BE$LU
240886251$24088625$1$I$$20240627$20240715$20240715$PER$$US-BEIGENE-BGN-2024-010064$BEIGENE$$$$$$Y$$$20240715$$CN$US$US
240886272$24088627$2$F$$20240802$20240715$20240805$PER$$NVSC2024US144811$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
240886281$24088628$1$I$20240101$20240709$20240715$20240715$EXP$$US-SA-2024SA203309$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240715$$HP$US$US
240886302$24088630$2$F$$20240724$20240715$20240727$EXP$$US-ABBVIE-5836715$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
240886311$24088631$1$I$$20240711$20240715$20240715$EXP$$US-JNJFOC-20240729781$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240886322$24088632$2$F$20240101$20240807$20240715$20240812$EXP$$US-ABBVIE-5836455$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
240886332$24088633$2$F$20240625$20240724$20240715$20240802$EXP$$PT-AUROBINDO-AUR-APL-2024-033828$AUROBINDO$$37$YR$$M$Y$$$20240802$$PH$PT$PT
240886341$24088634$1$I$20240701$20240710$20240715$20240715$EXP$$US-ABBVIE-5836954$ABBVIE$$69$YR$$M$Y$$$20240715$$CN$US$US
240886352$24088635$2$F$20240301$20240710$20240715$20240726$EXP$$US-GILEAD-2024-0678315$GILEAD$$63$YR$A$F$Y$$$20240726$$CN$US$US
240886361$24088636$1$I$$20240618$20240715$20240715$PER$$JP-WT-2024-072373$Waylis$$$$$$Y$$$20240715$$PH$JP$JP
240886371$24088637$1$I$$20240702$20240715$20240715$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0248$GRAVITI PHARMACEUTICALS$Yegudkin I, Feng L, Manzouri S, Funnamark R, Ciurczak N, McKenzie ME, et al.Neurogenic Pulmonary Edema in the Setting of Intracerebral Hemorrhage: A Case Report..Am-J-Respir-Crit-Care-Med.2024;209:A1157$40$YR$A$M$Y$$$20240715$$HP$US$US
240886381$24088638$1$I$$20240709$20240715$20240715$EXP$$ZA-SA-2024SA203570$SANOFI AVENTIS$$$$A$F$Y$$$20240715$$HP$ZA$ZA
240886391$24088639$1$I$20240701$20240709$20240715$20240715$EXP$GB-MHRA-MED-202407081628097880-VKQWR$GB-ESPERIONTHERAPEUTICS-2024GBR01069$ESPERION THERAPEUTICS$$$$$$Y$$$20240715$$PH$GB$GB
240886402$24088640$2$F$$20240711$20240715$20240719$EXP$$CA-AstraZeneca-2024A159934$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$CA$
240886413$24088641$3$F$20231201$20240729$20240715$20240805$EXP$$US-ABBVIE-5821416$ABBVIE$$65$YR$$M$Y$83.914$KG$20240805$$CN$US$US
240886432$24088643$2$F$20240101$20240813$20240715$20240816$EXP$$US-ABBVIE-5836853$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
240886441$24088644$1$I$$20190722$20240715$20240715$EXP$$US-AstraZeneca-2019SE73673$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
240886451$24088645$1$I$20190611$20190702$20240715$20240715$EXP$$US-AstraZeneca-2019SE90126$ASTRAZENECA$$24774$DY$$F$Y$$$20240715$$CN$US$
240886461$24088646$1$I$20240101$20240711$20240715$20240715$EXP$$US-ABBVIE-5837016$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240886472$24088647$2$F$20240101$20240710$20240715$20240722$EXP$$US-ABBVIE-5836262$ABBVIE$$60$YR$$M$Y$$$20240722$$CN$US$US
240886481$24088648$1$I$20181004$20190827$20240715$20240715$EXP$$US-AstraZeneca-2018SF30739$ASTRAZENECA$$27011$DY$$M$Y$83.9$KG$20240715$$CN$US$
240886492$24088649$2$F$$20240718$20240715$20240722$EXP$$IE-SA-2024SA204708$SANOFI AVENTIS$O?Reilly M, Krstic A, Iglesias-Martinez LF, Ryan ?J, Moran B, Winter D, et al.. Genomic and Transcriptomic Analysis of a Patient with Early-Onset Colorectal Cancer and Therapy-Induced Focal Nodular Hyperplasia: A Case Report.. J Pers Med.. 2024;14(6):1-8$26$YR$A$F$Y$$$20240722$$HP$IE$IE
240886502$24088650$2$F$20240606$20240807$20240715$20240812$EXP$IT-MINISAL02-993711$IT-SA-2024SA204806$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240812$$MD$IT$IT
240886512$24088651$2$F$20240110$20240802$20240715$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-034181$AUROBINDO$$13$YR$$M$Y$$$20240809$$CN$GB$GB
240886521$24088652$1$I$20240515$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034077$AUROBINDO$$37$YR$$F$Y$$$20240715$$CN$GB$GB
240886531$24088653$1$I$$20240708$20240715$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039158$BOEHRINGER INGELHEIM$$$$$$Y$$$20240715$$CN$US$US
240886543$24088654$3$F$20240630$20240718$20240715$20240723$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039452$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$55$KG$20240719$$CN$PL$PL
240886551$24088655$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5837933$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240886561$24088656$1$I$$20240712$20240715$20240715$PER$$US-ABBVIE-5839829$ABBVIE$$$$$$Y$$$20240715$$HP$US$US
240886571$24088657$1$I$$20240710$20240715$20240715$EXP$$US-GILEAD-2024-0678030$GILEAD$$61$YR$A$M$Y$$$20240715$$HP$US$US
240886582$24088658$2$F$20231017$20240725$20240715$20240731$EXP$$US-ABBVIE-5836443$ABBVIE$$59$YR$$M$Y$$$20240731$$CN$US$US
240886591$24088659$1$I$20231130$20240710$20240715$20240715$EXP$$US-ABBVIE-5836413$ABBVIE$$59$YR$$F$Y$$$20240715$$CN$US$US
240886602$24088660$2$F$20240701$20240717$20240715$20240722$PER$$US-AMGEN-USASP2024138042$AMGEN$$76$YR$E$F$Y$$$20240722$$CN$US$US
240886611$24088661$1$I$$20240710$20240715$20240715$EXP$$CA-TAKEDA-2024TUS070839$TAKEDA$$$$$M$Y$$$20240715$$CN$CA$CA
240886621$24088662$1$I$$20240709$20240715$20240715$EXP$$CL-JNJFOC-20240726095$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240715$$CN$CL$CL
240886631$24088663$1$I$$20240711$20240715$20240715$PER$$US-JNJFOC-20240729767$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$US$US
240886641$24088664$1$I$20240712$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139145$AMGEN$$54$YR$A$F$Y$$$20240715$$CN$US$US
240886652$24088665$2$F$20240610$20240715$20240715$20240715$PER$$US-AMGEN-USASP2024139512$AMGEN$$88$YR$E$F$Y$$$20240715$$CN$US$US
240886661$24088666$1$I$$20240626$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05928$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240886671$24088667$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA203064$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240715$$MD$US$US
240886681$24088668$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA203721$SANOFI AVENTIS$$$$$F$Y$$$20240715$$CN$US$US
240886691$24088669$1$I$$20240712$20240715$20240715$EXP$DE-ROCHE-3363312$DE-ROCHE-10000026006$ROCHE$$$$A$F$Y$$$20240715$$MD$DE$DE
240886701$24088670$1$I$20240627$20240709$20240715$20240715$EXP$$CN-BEIGENE-BGN-2024-010704$BEIGENE$$$$$$Y$$$20240715$$HP$CN$CN
240886711$24088671$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA204838$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240715$$MD$US$US
240886723$24088672$3$F$20240601$20240710$20240715$20240801$PER$$US-SA-2024SA202920$SANOFI AVENTIS$$60$YR$A$F$Y$65.77$KG$20240719$$MD$US$US
240886731$24088673$1$I$20240101$20240710$20240715$20240715$PER$$US-SA-2024SA205370$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240715$$MD$US$US
240886741$24088674$1$I$20240401$20240703$20240715$20240715$PER$$US-SA-2024SA201248$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240715$$MD$US$US
240886751$24088675$1$I$20240601$20240709$20240715$20240715$PER$$US-SA-2024SA204885$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240715$$MD$US$US
240886761$24088676$1$I$20230903$20240702$20240715$20240715$EXP$$DE-Rhythm Pharmaceuticals, Inc.-2023RHM000456$RHYTHM PHARMACEUTICALS$$23$YR$A$F$Y$$$20240711$$CN$DE$DE
240886771$24088677$1$I$20240401$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405130901596960-PHMJQ$GB-TEVA-VS-3218852$TEVA$$52$YR$$F$Y$85$KG$20240715$$CN$GB$GB
240886781$24088678$1$I$$20240702$20240715$20240715$EXP$$US-Sprout Pharmaceuticals, Inc.-2024SP000210$SPROUT PHARMACEUTICALS$$34$YR$A$F$Y$53.118$KG$20240711$$CN$US$US
240886791$24088679$1$I$20240621$20240705$20240715$20240715$EXP$$US-SA-2024SA201984$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240715$$MD$US$US
240886801$24088680$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144928$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240886811$24088681$1$I$$20240708$20240715$20240715$EXP$$US-SA-2024SA201952$SANOFI AVENTIS$Jiang SY, Yeh J, Novoa R, Wang E, Chen M.. Folliculocentric Mycosis Fungoides Masquerading as Angioedema and Allergic Contact Dermatitis.. J Allergy Clin Immunol Pract.. 2024;12(7):1905-6$60$YR$A$F$Y$$$20240715$$MD$US$US
240886822$24088682$2$F$$20240911$20240715$20240912$EXP$$NVSC2024US141216$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
240886841$24088684$1$I$$20240709$20240715$20240715$PER$$US-AMGEN-USASP2024137308$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240886851$24088685$1$I$$20240710$20240715$20240715$EXP$$US-SA-2024SA204778$SANOFI AVENTIS$$$$$$Y$$$20240715$$MD$US$US
240886861$24088686$1$I$20231101$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405160929377240-YBTNR$GB-TEVA-VS-3218523$TEVA$$70$YR$$M$Y$96$KG$20240715$$MD$GB$GB
240886871$24088687$1$I$20240501$20240705$20240715$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST003309$STEMLINE THERAPEUTICS$$49$YR$A$F$Y$$$20240711$$CN$US$US
240886891$24088689$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008022$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240715$$CN$US$US
240886901$24088690$1$I$$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008652$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240715$$CN$US$US
240886911$24088691$1$I$20240109$20240705$20240715$20240715$EXP$FR-AFSSAPS-ST2024001087$FR-TEVA-VS-3218222$TEVA$$78$YR$$F$Y$45.8$KG$20240715$$MD$FR$FR
240886921$24088692$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007134$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240715$$CN$US$US
240886931$24088693$1$I$20240601$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008009$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240715$$CN$US$US
240886942$24088694$2$F$20240710$20240815$20240715$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202407007194$ELI LILLY AND CO$$43$YR$A$M$Y$126.98$KG$20240821$$CN$US$US
240886952$24088695$2$F$$20240830$20240715$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06445$LUPIN$$$$$$Y$$$20240919$$CN$US$US
240886961$24088696$1$I$$20240710$20240715$20240715$EXP$$US-GILEAD-2024-0680454$GILEAD$$$$A$F$Y$$$20240715$$CN$US$US
240886971$24088697$1$I$20240405$20240703$20240715$20240715$EXP$$FR-Rhythm Pharmaceuticals, Inc.-2024RHM000253$RHYTHM PHARMACEUTICALS$$42$YR$A$F$Y$91.2$KG$20240712$$MD$FR$FR
240886981$24088698$1$I$20240628$20240710$20240715$20240715$EXP$$US-SA-2024SA204757$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240715$$MD$US$US
240886991$24088699$1$I$$20240708$20240715$20240715$EXP$$US-ROCHE-10000020990$ROCHE$$68$YR$E$M$Y$$$20240715$$CN$US$US
240887001$24088700$1$I$20240610$20240702$20240715$20240715$EXP$$PK-ROCHE-10000008230$ROCHE$$37$YR$A$F$Y$$$20240715$$CN$PK$PK
240887011$24088701$1$I$$20240702$20240715$20240715$EXP$$US-Sprout Pharmaceuticals, Inc.-2024SP000208$SPROUT PHARMACEUTICALS$$$$A$F$Y$$$20240709$$CN$US$US
240887021$24088702$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110671$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240715$$CN$US$US
240887032$24088703$2$F$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110577$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240715$$CN$US$US
240887041$24088704$1$I$$20240708$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-094717$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240715$$CN$US$US
240887052$24088705$2$F$20240528$20240710$20240715$20240718$PER$$US-SA-2024SA203066$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240718$$MD$US$US
240887071$24088707$1$I$20240616$20240705$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108229$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$72.57$KG$20240715$$PH$US$US
240887081$24088708$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA204259$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240715$$MD$US$US
240887091$24088709$1$I$20240301$20240711$20240715$20240715$EXP$$US-TAKEDA-2024TUS041137$TAKEDA$$42$YR$$M$Y$$$20240715$$CN$US$US
240887101$24088710$1$I$$20240704$20240715$20240715$EXP$$AR-AKCEA THERAPEUTICS, INC.-2024IS005916$AKCEA THERAPEUTICS$$$$$$Y$$$20240710$$CN$AR$AR
240887111$24088711$1$I$20240401$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033693$AUROBINDO$$$$$F$Y$$$20240715$$PH$GB$GB
240887121$24088712$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-TPP21296320C7742597YC1720085903712$GB-ESPERIONTHERAPEUTICS-2024GBR01068$ESPERION THERAPEUTICS$$55$YR$$F$Y$83$KG$20240715$$PH$GB$GB
240887131$24088713$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033921$AUROBINDO$$$$$F$Y$$$20240715$$CN$GB$GB
240887141$24088714$1$I$20230401$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034214$AUROBINDO$$64$YR$$F$Y$67$KG$20240715$$CN$GB$GB
240887151$24088715$1$I$$20240710$20240715$20240715$EXP$BE-JNJFOC-20240619068$BE-ROCHE-10000022855$ROCHE$$87$YR$E$F$Y$$$20240715$$MD$BE$BE
240887161$24088716$1$I$$20240709$20240715$20240715$EXP$$US-SA-2024SA203459$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240715$$MD$US$US
240887171$24088717$1$I$20240630$20240704$20240715$20240715$EXP$$CN-TAKEDA-2024TUS069821$TAKEDA$$59$YR$$F$Y$46$KG$20240715$$HP$CN$CN
240887181$24088718$1$I$$20240705$20240715$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST004137$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240711$$CN$US$US
240887192$24088719$2$F$$20240912$20240715$20240921$EXP$$CN-ROCHE-10000016307$ROCHE$$72$YR$E$F$Y$$$20240921$$CN$CN$CN
240887211$24088721$1$I$$20240710$20240715$20240715$EXP$$CA-ABBVIE-5837286$ABBVIE$$$$A$F$Y$$$20240715$$CN$CA$CA
240887221$24088722$1$I$20240624$20240708$20240715$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST004153$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240711$$CN$US$US
240887232$24088723$2$F$20240601$20240718$20240715$20240723$EXP$$IT-ABBVIE-5813744$ABBVIE$$71$YR$$M$Y$$$20240723$$CN$IT$IT
240887241$24088724$1$I$$20240708$20240715$20240715$EXP$$US-LEO Pharma-371855$LEO PHARM$$46$YR$$M$Y$98$KG$20240715$$HP$US$US
240887254$24088725$4$F$$20240821$20240715$20240824$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110582$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240824$$MD$US$US
240887261$24088726$1$I$$20240708$20240715$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST004154$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240711$$CN$US$US
240887271$24088727$1$I$20240506$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034164$AUROBINDO$$68$YR$$M$Y$85$KG$20240715$$CN$GB$GB
240887281$24088728$1$I$$20240706$20240715$20240715$EXP$$US-ABBVIE-5640210$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240887291$24088729$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033894$AUROBINDO$$$$$F$Y$75$KG$20240715$$CN$GB$GB
240887311$24088731$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111282$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240715$$HP$US$US
240887321$24088732$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110980$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240715$$HP$US$US
240887331$24088733$1$I$$20240711$20240715$20240715$EXP$$US-GILEAD-2024-0680480$GILEAD$$$$A$M$Y$$$20240715$$HP$US$US
240887341$24088734$1$I$20240628$20240705$20240715$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST004138$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240711$$CN$US$US
240887351$24088735$1$I$$20240627$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05915$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240887364$24088736$4$F$20240601$20240909$20240715$20240919$EXP$$US-INSMED, INC.-2024-02499-US$INSMED$$79$YR$$F$Y$$$20240919$$CN$US$US
240887371$24088737$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033733$AUROBINDO$$$$$F$Y$$$20240715$$PH$GB$GB
240887381$24088738$1$I$$20240705$20240715$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST004144$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240711$$CN$US$US
240887392$24088739$2$F$20240101$20240719$20240715$20240724$PER$$US-AMGEN-USASP2024138019$AMGEN$$72$YR$E$F$Y$$$20240723$$CN$US$US
240887401$24088740$1$I$20230910$20240704$20240715$20240715$EXP$GB-MHRA-MED-202405031033527580-SZPTF$GB-RDY-SPO/GBR/24/0009916$DR REDDYS$$$$$F$Y$$$20240715$$PH$GB$GB
240887413$24088741$3$F$20240702$20240731$20240715$20240802$PER$$US-AMGEN-USASP2024139637$AMGEN$$71$YR$E$M$Y$$$20240802$$CN$US$US
240887422$24088742$2$F$$20240916$20240715$20240918$EXP$$NVSC2024CO144771$NOVARTIS$$$$$$Y$$$20240918$$MD$CO$CO
240887432$24088743$2$F$$20240726$20240715$20240731$EXP$$NVSC2024US142965$NOVARTIS$$$$$M$Y$$$20240731$$CN$US$US
240887441$24088744$1$I$$20240712$20240715$20240715$EXP$$US-ABBVIE-5838913$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240887452$24088745$2$F$$20240918$20240715$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-033562$AUROBINDO$$$$$M$Y$$$20240927$$CN$GB$GB
240887472$24088747$2$F$$20240821$20240715$20240828$EXP$$US-ROCHE-10000020776$ROCHE$$86$YR$E$M$Y$$$20240828$$CN$US$US
240887481$24088748$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033692$AUROBINDO$$$$$F$Y$$$20240715$$CN$GB$GB
240887491$24088749$1$I$$20240626$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06452$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240887501$24088750$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034140$AUROBINDO$$$$$$Y$$$20240715$$PH$GB$GB
240887511$24088751$1$I$20240201$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033930$AUROBINDO$$36$YR$$M$Y$$$20240715$$CN$GB$GB
240887523$24088752$3$F$20240101$20240812$20240715$20240819$PER$$US-SA-2024SA203355$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240819$$MD$US$US
240887531$24088753$1$I$20240709$20240710$20240715$20240715$PER$$US-SA-2024SA204562$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240715$$MD$US$US
240887541$24088754$1$I$20240601$20240709$20240715$20240715$PER$$US-SA-2024SA204617$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240715$$MD$US$US
240887551$24088755$1$I$20240507$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405131348578650-VJQWD$GB-TEVA-VS-3218881$TEVA$$32$YR$$F$Y$65$KG$20240715$$CN$GB$GB
240887561$24088756$1$I$$20190729$20240715$20240715$EXP$$US-AstraZeneca-2019SE93000$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$US$
240887571$24088757$1$I$$20240625$20240715$20240715$EXP$$NL-NEBO-664000$PHARMACOSMOS$Philips C. Patil A. A case of non-immune haemolytic anaemia in the context of severe haematinic deficiency in pregnancy. Int J Obstet Anesth 58S1 2024 76-77. doi10.1016 j.ijoa.2024.104157.pdf$25$YR$$F$Y$$$20240715$$HP$NL$NL
240887581$24088758$1$I$$20240710$20240715$20240715$PER$$US-AstraZeneca-2024A158630$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$US$
240887591$24088759$1$I$20240705$20240707$20240715$20240715$EXP$$EG-AstraZeneca-2024A157171$ASTRAZENECA$$28782$DY$$F$Y$$$20240715$$MD$EG$
240887602$24088760$2$F$20240314$20240715$20240715$20240717$EXP$FR-AFSSAPS-NY2024000658$FR-ROCHE-10000021108$ROCHE$$76$YR$E$M$Y$65$KG$20240717$$MD$FR$FR
240887621$24088762$1$I$20240412$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034063$AUROBINDO$$55$YR$$F$Y$$$20240715$$HP$GB$GB
240887631$24088763$1$I$$20240708$20240715$20240715$EXP$$US-ROCHE-10000021024$ROCHE$$74$YR$E$M$Y$$$20240715$$CN$US$US
240887641$24088764$1$I$$20240630$20240715$20240715$PER$$US-APOTEX-2024AP008016$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240715$$HP$US$US
240887651$24088765$1$I$$20240627$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05910$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240887661$24088766$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034199$AUROBINDO$$$$$F$Y$62$KG$20240715$$CN$GB$GB
240887671$24088767$1$I$$20240708$20240715$20240715$EXP$$CA-SPECGX-T202401511$SPECGX$$34$YR$$M$Y$$$20240715$$MD$CA$CA
240887681$24088768$1$I$20240517$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405171053306570-DYQVC$GB-TEVA-VS-3218612$TEVA$$78$YR$$M$Y$$$20240715$$PH$GB$GB
240887691$24088769$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033745$AUROBINDO$$$$$M$Y$$$20240715$$CN$GB$GB
240887701$24088770$1$I$$20240709$20240715$20240715$PER$$US-BIOGEN-2024BI01273030$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240887713$24088771$3$F$20240601$20240821$20240715$20240828$EXP$$CN-GSK-CN2024APC084745$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$PH$CN$CN
240887721$24088772$1$I$$20240704$20240715$20240715$PER$$US-JNJFOC-20240733602$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$MD$US$US
240887731$24088773$1$I$$20240710$20240715$20240715$PER$$US-JNJFOC-20240727806$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240715$$HP$US$US
240887741$24088774$1$I$20240508$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034147$AUROBINDO$$35$YR$$F$Y$$$20240715$$CN$GB$GB
240887751$24088775$1$I$$20240701$20240715$20240715$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06227$HIKMA$$$$$M$Y$$$20240715$$MD$US$US
240887761$24088776$1$I$$20240703$20240715$20240715$EXP$$RS-ROCHE-10000018828$ROCHE$$10$YR$C$M$Y$27$KG$20240715$$MD$RS$RS
240887771$24088777$1$I$$20240626$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06509$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240887781$24088778$1$I$$20240627$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05957$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240887792$24088779$2$F$20240701$20240709$20240715$20240723$PER$$US-ABBVIE-5837382$ABBVIE$$$$$F$Y$54$KG$20240723$$HP$US$US
240887803$24088780$3$F$20240601$20240926$20240715$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111086$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240927$$HP$US$US
240887811$24088781$1$I$20240628$20240712$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111357$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240715$$CN$US$US
240887821$24088782$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111104$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240715$$HP$US$US
240887832$24088783$2$F$$20240821$20240715$20240904$EXP$$US-UCBSA-2024035504$UCB$$$$$F$Y$37.2$KG$20240904$$MD$US$US
240887841$24088784$1$I$$20240712$20240715$20240715$EXP$$US-UCBSA-2024035465$UCB$$$$$M$Y$$$20240715$$HP$US$US
240887871$24088787$1$I$$20240630$20240715$20240715$PER$$US-APOTEX-2024AP008017$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240715$$HP$US$US
240887881$24088788$1$I$20200429$20240705$20240715$20240715$EXP$$PL-AUROBINDO-AUR-APL-2024-033701$AUROBINDO$$18$YR$$M$Y$$$20240715$$MD$PL$PL
240887892$24088789$2$F$20240708$20240807$20240715$20240812$PER$$US-JNJFOC-20240722894$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240812$$CN$US$US
240887901$24088790$1$I$20240418$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034154$AUROBINDO$$$$$M$Y$$$20240715$$HP$GB$GB
240887911$24088791$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405101415057720-NPTCZ$GB-TEVA-VS-3218803$TEVA$$$$$F$Y$70$KG$20240715$$HP$GB$GB
240887921$24088792$1$I$$20240702$20240715$20240715$EXP$$US-ROCHE-RCA5162451$ROCHE$$$$$$Y$$$20240715$$CN$US$US
240887931$24088793$1$I$$20240709$20240715$20240715$PER$$US-ABBVIE-5836742$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240887941$24088794$1$I$$20240707$20240715$20240715$PER$$US-SA-2024SA203062$SANOFI AVENTIS$$$$A$F$Y$$$20240715$$MD$US$US
240887951$24088795$1$I$20240201$20240709$20240715$20240715$EXP$FR-AFSSAPS-LM2024000374$FR-SA-2024SA201832$SANOFI AVENTIS$$68$YR$E$F$Y$63$KG$20240715$$MD$FR$FR
240887961$24088796$1$I$20240501$20240703$20240715$20240715$PER$$US-ROCHE-10000022328$ROCHE$$50$YR$A$F$Y$$$20240715$$CN$US$US
240887971$24088797$1$I$$20240703$20240715$20240715$EXP$$IN-ROCHE-10000020788$ROCHE$$74$YR$E$M$Y$$$20240715$$CN$IN$IN
240887981$24088798$1$I$20240129$20240220$20240715$20240715$EXP$GB-MHRA-TPP14470433C7577969YC1708001704701$GB-TEVA-VS-3161560$TEVA$$31$YR$$F$Y$127$KG$20240715$$HP$GB$GB
240887991$24088799$1$I$$20240703$20240715$20240715$EXP$$JP-TAKEDA-2024TUS071122$TAKEDA$$7$DEC$$M$Y$$$20240715$$MD$JP$JP
240888001$24088800$1$I$20240501$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007932$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240715$$CN$US$US
240888011$24088801$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007779$ELI LILLY AND CO$$$$$F$Y$$$20240715$$MD$US$US
240888021$24088802$1$I$20240401$20240702$20240715$20240715$EXP$IT-MINISAL02-984433$IT-SAMSUNG BIOEPIS-SB-2024-20490$SAMSUNG BIOEPIS$$54$YR$$M$Y$$$20240715$$MD$IT$IT
240888031$24088803$1$I$$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007439$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240715$$CN$US$US
240888041$24088804$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007814$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240715$$CN$US$US
240888051$24088805$1$I$20140515$20240702$20240715$20240715$EXP$FR-AFSSAPS-MA2024000785$FR-SAMSUNG BIOEPIS-SB-2024-20485$SAMSUNG BIOEPIS$$38$YR$A$F$Y$$$20240715$$MD$FR$FR
240888061$24088806$1$I$20240602$20240709$20240715$20240715$EXP$$CN-ROCHE-10000021913$ROCHE$$38$YR$A$M$Y$62.5$KG$20240715$$HP$CN$CN
240888073$24088807$3$F$20240426$20240809$20240715$20240813$EXP$$US-ORGANON-O2407USA001175$ORGANON$$25$YR$$F$Y$$$20240813$$HP$US$US
240888081$24088808$1$I$20240508$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033859$AUROBINDO$$60$YR$$M$Y$70$KG$20240715$$CN$GB$GB
240888091$24088809$1$I$$20240626$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06438$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240888101$24088810$1$I$$20240702$20240715$20240715$EXP$$US-DEXPHARM-2024-2357$DEXCEL$Simone, C.; Axelband, J.  Levetiracetam-associated Rhabdomyolysis. American Journal of Respiratory and Critical Care Medicine 2024, V209, P1$20$YR$A$M$Y$$$20240715$$HP$US$US
240888112$24088811$2$F$20240614$20240808$20240715$20240816$EXP$SI-JAZMP-NCPHV-2024SI0609_0609$SI-TEVA-VS-3218211$TEVA$$39$YR$$M$Y$81$KG$20240816$$MD$SI$SI
240888121$24088812$1$I$20240710$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138476$AMGEN$$74$YR$E$F$Y$$$20240715$$CN$US$US
240888131$24088813$1$I$20230101$20240705$20240715$20240715$EXP$$FR-CELLTRION INC.-2024FR016653$CELLTRION$$$$$$Y$$$20240715$$MD$FR$FR
240888141$24088814$1$I$$20240709$20240715$20240715$PER$$US-BIOGEN-2024BI01273049$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240888151$24088815$1$I$20191101$20240705$20240715$20240715$EXP$FR-AFSSAPS-LY2024000888$FR-TEVA-VS-3218225$TEVA$$78$YR$$F$Y$63$KG$20240715$$MD$FR$FR
240888162$24088816$2$F$$20240829$20240715$20240905$EXP$$US-ROCHE-10000018501$ROCHE$$$$$F$Y$$$20240905$$CN$US$US
240888171$24088817$1$I$20180101$20190703$20240715$20240715$EXP$$CO-AstraZeneca-2019SE97443$ASTRAZENECA$$17307$DY$$M$Y$$$20240715$$CN$CO$
240888181$24088818$1$I$$20200703$20240715$20240715$EXP$$IT-AstraZeneca-2020SE86461$ASTRAZENECA$$$$$F$Y$$$20240715$$MD$IT$
240888191$24088819$1$I$$20190713$20240715$20240715$EXP$$US-AstraZeneca-2019SF02578$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$US$
240888201$24088820$1$I$20240619$20240705$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-033935$AUROBINDO$$56$YR$$F$Y$53$KG$20240715$$PH$FR$FR
240888211$24088821$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111157$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$79.83$KG$20240715$$HP$US$US
240888221$24088822$1$I$$20240709$20240715$20240715$EXP$$CA-TAKEDA-2024TUS070537$TAKEDA$$63$YR$$F$Y$$$20240715$$HP$CA$CA
240888231$24088823$1$I$20240305$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033525$AUROBINDO$$$$$F$Y$$$20240715$$CN$GB$GB
240888241$24088824$1$I$$20240706$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108019$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240715$$HP$US$US
240888252$24088825$2$F$$20240807$20240715$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05956$LUPIN$$$$$$Y$$$20240822$$CN$US$US
240888262$24088826$2$F$$20240716$20240715$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05894$LUPIN$$$$$$Y$$$20240814$$CN$US$US
240888271$24088827$1$I$$20240708$20240715$20240715$EXP$$CA-SPECGX-T202401512$SPECGX$$34$YR$$M$Y$$$20240715$$MD$CA$CA
240888301$24088830$1$I$$20240705$20240715$20240715$30DAY$$US-GSK-US2024084037$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
240888312$24088831$2$F$$20240918$20240715$20240928$PER$$US-GSK-US2024084027$GLAXOSMITHKLINE$$$$$F$Y$$$20240928$$CN$US$US
240888322$24088832$2$F$20240101$20240809$20240715$20240817$EXP$$JP-AMGEN-JPNSP2024136792$AMGEN$$77$YR$E$F$Y$$$20240817$$MD$JP$JP
240888331$24088833$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5835675$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240888342$24088834$2$F$$20240812$20240715$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05960$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240888351$24088835$1$I$$20240709$20240715$20240715$PER$$US-ABBVIE-5835192$ABBVIE$$$$$F$Y$$$20240715$$HP$US$US
240888361$24088836$1$I$20231201$20240715$20240715$20240715$EXP$HR-HALMED-300086037$HR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039671$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$80$KG$20240715$$MD$HR$HR
240888371$24088837$1$I$$20240712$20240715$20240715$PER$$US-HALEON-2186994$Haleon PLC$$$$$M$Y$$$20240715$$CN$US$US
240888382$24088838$2$F$20221024$20240710$20240715$20240718$EXP$$IT-CELLTRION INC.-2024IT016599$CELLTRION$$$$$$Y$$$20240718$$MD$IT$IT
240888392$24088839$2$F$$20240809$20240715$20240812$EXP$$CA-JNJFOC-20240731603$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240812$$HP$CA$CA
240888401$24088840$1$I$$20240625$20240715$20240715$PER$$US-JNJFOC-20240669589$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240888411$24088841$1$I$$20240709$20240715$20240715$EXP$$JP-AMGEN-JPNSP2024138784$AMGEN$$$$$$Y$$$20240715$$MD$JP$JP
240888432$24088843$2$F$$20240729$20240715$20240802$EXP$$JP-AMGEN-JPNSP2024136809$AMGEN$$$$$F$Y$$$20240802$$MD$JP$JP
240888441$24088844$1$I$$20240627$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05955$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240888451$24088845$1$I$$20240708$20240715$20240715$PER$$US-ABBVIE-5834388$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240888461$24088846$1$I$20240617$20240705$20240715$20240715$EXP$GB-MHRA-MED-202406261258482140-RYNVF$GB-TEVA-VS-3218970$TEVA$$84$YR$$F$Y$$$20240715$$HP$GB$GB
240888471$24088847$1$I$20240423$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405082008401580-VCBNZ$GB-TEVA-VS-3218827$TEVA$$67$YR$$F$Y$$$20240715$$CN$GB$GB
240888481$24088848$1$I$20221206$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405081411386720-PQLBG$GB-ROCHE-10000019501$ROCHE$$$$$M$Y$$$20240715$$CN$GB$GB
240888491$24088849$1$I$$20240623$20240715$20240715$EXP$$MY-ROCHE-10000023936$ROCHE$$$$$$Y$$$20240715$$MD$MY$MY
240888501$24088850$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110931$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$122.92$KG$20240715$$CN$US$US
240888512$24088851$2$F$20240610$20240814$20240715$20240823$EXP$SI-JAZMP-NCPHV-2024SI0610_0610$SI-TEVA-VS-3218219$TEVA$$49$YR$$M$Y$130.5$KG$20240823$$MD$SI$SI
240888521$24088852$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110688$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240715$$HP$US$US
240888541$24088854$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033905$AUROBINDO$$$$A$M$Y$69$KG$20240715$$CN$GB$GB
240888551$24088855$1$I$20240625$20240701$20240715$20240715$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-20902$SAMSUNG BIOEPIS$$$$$M$Y$79$KG$20240715$$MD$DE$DE
240888561$24088856$1$I$20240403$20240411$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01279$AMNEAL$$$$$$Y$$$20240715$$CN$US$US
240888571$24088857$1$I$20230915$20240705$20240715$20240715$EXP$$GB-TEVA-VS-3218717$TEVA$$70$YR$$$Y$83$KG$20240715$$CN$GB$GB
240888581$24088858$1$I$20230101$20240110$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00195$AMNEAL$$$$$M$Y$$$20240715$$CN$US$US
240888591$24088859$1$I$20240628$20240705$20240715$20240715$EXP$$CN-ROCHE-10000019123$ROCHE$$59$YR$A$M$Y$76$KG$20240715$$HP$CN$CN
240888601$24088860$1$I$20240101$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139278$AMGEN$$57$YR$A$F$Y$$$20240715$$CN$US$US
240888612$24088861$2$F$$20240719$20240715$20240727$PER$$US-AMGEN-USASP2024133417$AMGEN$$$$$$Y$$$20240727$$HP$US$US
240888631$24088863$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033577$AUROBINDO$$30$YR$$F$Y$69$KG$20240715$$CN$GB$GB
240888641$24088864$1$I$20240626$20240709$20240715$20240715$EXP$$GB-JNJFOC-20240731498$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240715$$CN$GB$GB
240888651$24088865$1$I$$20231113$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03984$AMNEAL$$54$YR$$F$Y$78.02$KG$20240715$$CN$US$US
240888662$24088866$2$F$20240624$20240716$20240715$20240730$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-20903$SAMSUNG BIOEPIS$$62$YR$A$M$Y$$$20240730$$MD$DE$DE
240888672$24088867$2$F$$20240807$20240715$20240812$EXP$$US-ABBVIE-5836343$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
240888681$24088868$1$I$$20200703$20240715$20240715$EXP$$IT-AstraZeneca-2020SE86418$ASTRAZENECA$$$$$F$Y$$$20240715$$MD$IT$
240888691$24088869$1$I$$20190708$20240715$20240715$EXP$$CA-AstraZeneca-2019SE98922$ASTRAZENECA$$$$$M$Y$$$20240715$$HP$CA$
240888701$24088870$1$I$$20240627$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06505$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240888711$24088871$1$I$20240626$20240707$20240715$20240715$EXP$$IL-AstraZeneca-2024A156189$ASTRAZENECA$$17708$DY$$F$Y$$$20240715$$HP$IL$
240888721$24088872$1$I$20240229$20240710$20240715$20240715$EXP$$ES-AstraZeneca-2024A157747$ASTRAZENECA$$70$YR$$F$Y$$$20240715$$MD$ES$
240888732$24088873$2$F$$20240712$20240715$20240718$EXP$$CA-AstraZeneca-2020SE60742$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$CA$
240888741$24088874$1$I$$20240710$20240715$20240715$EXP$$US-AstraZeneca-2024A158586$ASTRAZENECA$$$$$F$Y$$$20240715$$HP$US$
240888751$24088875$1$I$$20240710$20240715$20240715$EXP$$US-AstraZeneca-2024A158554$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$US$
240888761$24088876$1$I$20240601$20240708$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407005727$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240715$$CN$US$US
240888771$24088877$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008059$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240715$$CN$US$US
240888781$24088878$1$I$20240710$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007630$ELI LILLY AND CO$$$$$M$Y$$$20240715$$PH$US$US
240888792$24088879$2$F$20240530$20240712$20240715$20240718$EXP$IT-MINISAL02-994221$IT-EXELIXIS-CABO-24079379$EXELIXIS$$84$YR$$M$Y$$$20240718$$MD$IT$IT
240888802$24088880$2$F$$20240716$20240715$20240802$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05916$LUPIN$$$$$$Y$$$20240802$$CN$US$US
240888821$24088882$1$I$$20240627$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06499$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240888841$24088884$1$I$20240613$20240705$20240715$20240715$30DAY$$US-GSK-US2024078082$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240715$$CN$US$US
240888851$24088885$1$I$$20240705$20240715$20240715$30DAY$$US-GSK-US2024AMR084164$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
240888862$24088886$2$F$20231201$20240816$20240715$20240822$PER$$US-AMGEN-USASP2024138073$AMGEN$$69$YR$E$F$Y$$$20240821$$CN$US$US
240888871$24088887$1$I$20240706$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138577$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240888892$24088889$2$F$$20240820$20240715$20240826$EXP$$NVSC2024CH143750$NOVARTIS$$14$YR$$F$Y$$$20240826$$MD$CH$CH
240888902$24088890$2$F$$20240717$20240715$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05890$LUPIN$$$$$$Y$$$20240808$$CN$US$US
240888911$24088891$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111087$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240715$$CN$US$US
240888921$24088892$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA204937$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240715$$CN$US$US
240888931$24088893$1$I$$20240710$20240715$20240715$EXP$$CA-UCBSA-2024004029$UCB$$$$$F$Y$$$20240715$$CN$CA$CA
240888941$24088894$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA205475$SANOFI AVENTIS$$$$A$F$Y$$$20240715$$MD$US$US
240888951$24088895$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA203723$SANOFI AVENTIS$$$$A$M$Y$$$20240715$$CN$US$US
240888961$24088896$1$I$20240101$20240709$20240715$20240715$EXP$$US-SA-2024SA204923$SANOFI AVENTIS$$65$YR$E$F$Y$77$KG$20240715$$MD$US$US
240888971$24088897$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA203210$SANOFI AVENTIS$$$$A$F$Y$99.773$KG$20240715$$MD$US$US
240888982$24088898$2$F$20240614$20240710$20240715$20240718$EXP$FR-AFSSAPS-LL2024001248$FR-SA-2024SA203869$SANOFI AVENTIS$$93$YR$E$M$Y$64.4$KG$20240718$$PH$FR$FR
240888991$24088899$1$I$$20240701$20240715$20240715$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06369$HIKMA$$7$MON$$M$Y$7$KG$20240715$$PH$CA$CA
240889002$24088900$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3217794$TEVA$Gans A, Taylor J, Goel NN. A Case of Drug-Induced Stevens-Johnson Syndrome With Primarily Visceral Involvement. Am-J-Respir-Crit-Care-Med 2024; 209 A5678.; Gans A, Taylor J, Goel NN. A Case of Drug-Induced Stevens-Johnson Syndrome With Primarily Visceral Involvement. Am-J-Respir-Crit-Care-Med 2024; 209 A5678.$76$YR$$F$Y$$$20240802$$HP$US$US
240889011$24088901$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033483$AUROBINDO$$$$$$Y$$$20240715$$HP$GB$GB
240889021$24088902$1$I$20240601$20240703$20240715$20240715$PER$$US-RDY-SPO/USA/24/0009949$DR REDDYS$$20$YR$A$F$Y$$$20240715$$CN$US$US
240889031$24088903$1$I$$20240708$20240715$20240715$PER$$US-RDY-SPO/USA/24/0010179$DR REDDYS$$69$YR$E$$Y$$$20240715$$HP$US$US
240889041$24088904$1$I$$20240705$20240715$20240715$PER$$US-RDY-SPO/USA/24/0010173$DR REDDYS$$$$$F$Y$$$20240715$$CN$US$US
240889051$24088905$1$I$20240708$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024137958$AMGEN$$70$YR$E$M$Y$$$20240715$$PH$US$US
240889061$24088906$1$I$$20240711$20240715$20240715$EXP$$US-ABBVIE-5837957$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240889071$24088907$1$I$$20240711$20240715$20240715$EXP$$US-JNJFOC-20240729291$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240889081$24088908$1$I$20230601$20230626$20240715$20240715$PER$$US-PERRIGO-23US007549$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889091$24088909$1$I$20230601$20230626$20240715$20240715$PER$$US-PERRIGO-23US007572$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889101$24088910$1$I$20230601$20230629$20240715$20240715$PER$$US-PERRIGO-23US007575$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889111$24088911$1$I$20230601$20230623$20240715$20240715$PER$$US-PERRIGO-23US007547$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889121$24088912$1$I$20230601$20230626$20240715$20240715$PER$$US-PERRIGO-23US007551$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889131$24088913$1$I$20230605$20230630$20240715$20240715$PER$$US-PERRIGO-23US007568$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889141$24088914$1$I$20230601$20230628$20240715$20240715$PER$$US-PERRIGO-23US007541$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889151$24088915$1$I$20230616$20230630$20240715$20240715$PER$$US-PERRIGO-23US007571$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240889161$24088916$1$I$20230601$20230629$20240715$20240715$PER$$US-PERRIGO-23US007574$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889171$24088917$1$I$$20240712$20240715$20240715$PER$$US-HALEON-2186975$Haleon PLC$$$$$$Y$$$20240715$$CN$US$US
240889181$24088918$1$I$20230601$20230623$20240715$20240715$PER$$US-PERRIGO-23US007537$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889191$24088919$1$I$$20240710$20240715$20240715$EXP$$US-BIOGEN-2024BI01273298$BIOGEN$$$$$F$Y$$$20240715$$HP$US$US
240889201$24088920$1$I$$20240703$20240715$20240715$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008085$STRIDES$Nakamura S, Masuda S, Oda S, Yamakawa D, Yamaguchi S, Ishima T, et al.. Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine. Intern-Med. 2024;63 (12):1829-1835.$72$YR$$F$Y$$$20240715$$HP$JP$JP
240889213$24088921$3$F$$20240802$20240715$20240806$EXP$$US-ABBVIE-5837994$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
240889221$24088922$1$I$20230601$20230628$20240715$20240715$PER$$US-PERRIGO-23US007601$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889231$24088923$1$I$20230601$20230629$20240715$20240715$PER$$US-PERRIGO-23US007602$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889241$24088924$1$I$20230601$20230703$20240715$20240715$PER$$US-PERRIGO-23US007645$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889251$24088925$1$I$20230601$20230629$20240715$20240715$PER$$US-PERRIGO-23US007654$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889261$24088926$1$I$20230601$20230630$20240715$20240715$PER$$US-PERRIGO-23US007597$PERRIGO$$39$YR$$M$Y$74.83$KG$20240715$$CN$US$US
240889271$24088927$1$I$20230201$20230705$20240715$20240715$PER$$US-PERRIGO-23US007648$PERRIGO$$73$YR$$F$Y$81.633$KG$20240715$$CN$US$US
240889281$24088928$1$I$20230401$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405061512172570-ZNVKL$GB-TEVA-VS-3218661$TEVA$$64$YR$$F$Y$67$KG$20240715$$CN$GB$GB
240889291$24088929$1$I$20230601$20230704$20240715$20240715$PER$$US-PERRIGO-23US007684$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889301$24088930$1$I$20230601$20230629$20240715$20240715$PER$$US-PERRIGO-23US007655$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889311$24088931$1$I$$20240703$20240715$20240715$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP008248$STRIDES$Chrobak J, Rodek P, Kucia K.. Multiple-Monitored Electroconvulsive Therapy (MMECT) - does it really just belong in psychiatry^s past? A case report.. Psychiatr-Pol. 2024;58 (2):343-349$5$DEC$$F$Y$$$20240715$$HP$PL$PL
240889321$24088932$1$I$20230701$20230707$20240715$20240715$PER$$US-PERRIGO-23US007818$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889331$24088933$1$I$20230601$20230706$20240715$20240715$PER$$US-PERRIGO-23US007799$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889341$24088934$1$I$20230601$20230704$20240715$20240715$PER$$US-PERRIGO-23US007744$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889351$24088935$1$I$20230701$20230707$20240715$20240715$PER$$US-PERRIGO-23US007817$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889361$24088936$1$I$20230601$20230630$20240715$20240715$PER$$US-PERRIGO-23US007656$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889371$24088937$1$I$20230601$20230703$20240715$20240715$PER$$US-PERRIGO-23US007661$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889381$24088938$1$I$20230601$20230704$20240715$20240715$PER$$US-PERRIGO-23US007689$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889391$24088939$1$I$20230701$20230707$20240715$20240715$PER$$US-PERRIGO-23US007820$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889401$24088940$1$I$20230601$20230701$20240715$20240715$PER$$US-PERRIGO-23US007657$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889411$24088941$1$I$20230601$20230703$20240715$20240715$PER$$US-PERRIGO-23US007662$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889421$24088942$1$I$20230601$20230704$20240715$20240715$PER$$US-PERRIGO-23US007695$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889431$24088943$1$I$20230601$20230703$20240715$20240715$PER$$US-PERRIGO-23US007660$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889441$24088944$1$I$20230601$20230703$20240715$20240715$PER$$US-PERRIGO-23US007658$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889451$24088945$1$I$20230601$20230705$20240715$20240715$PER$$US-PERRIGO-23US007747$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889461$24088946$1$I$20230601$20230630$20240715$20240715$PER$$US-PERRIGO-23US007659$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889471$24088947$1$I$$20240711$20240715$20240715$PER$$US-TAKEDA-2024TUS071198$TAKEDA$$27$YR$$M$Y$$$20240715$$CN$US$US
240889481$24088948$1$I$20230701$20230709$20240715$20240715$PER$$US-PERRIGO-23US007825$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889491$24088949$1$I$20230701$20230708$20240715$20240715$PER$$US-PERRIGO-23US007823$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889501$24088950$1$I$20230601$20230703$20240715$20240715$PER$$US-PERRIGO-23US007663$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889511$24088951$1$I$20230701$20230707$20240715$20240715$PER$$US-PERRIGO-23US007819$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889521$24088952$1$I$20230601$20230703$20240715$20240715$PER$$US-PERRIGO-23US007741$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889531$24088953$1$I$20230601$20230706$20240715$20240715$PER$$US-PERRIGO-23US007815$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889541$24088954$1$I$20230701$20230707$20240715$20240715$PER$$US-PERRIGO-23US007816$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889551$24088955$1$I$20240101$20240710$20240715$20240715$EXP$$US-ABBVIE-5837943$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240889561$24088956$1$I$$20240704$20240715$20240715$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008377$STRIDES$Zardoost P, Buckman Z, Weaver J, Elston S, Prouty A, Stuart R, et al.. Continuous renal replacement therapy for lithium toxicity: A worthy treatment to avoid intradialytic hypotension and vasopressors.. Clin-Case-Rep. 2024;12 (4):.$54$YR$$F$Y$$$20240715$$HP$US$US
240889573$24088957$3$F$$20240912$20240715$20240917$EXP$$JP-ABBVIE-5838519$ABBVIE$$$$$$Y$$$20240917$$HP$JP$JP
240889582$24088958$2$F$20240311$20240812$20240715$20240822$EXP$GB-MHRA-MED-202405090912582800-FMHRG$GB-TEVA-VS-3218733$TEVA$$73$YR$$M$Y$101$KG$20240822$$PH$GB$GB
240889631$24088963$1$I$20230701$20230708$20240715$20240715$PER$$US-PERRIGO-23US007826$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889641$24088964$1$I$20230701$20230711$20240715$20240715$PER$$US-PERRIGO-23US007950$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889651$24088965$1$I$20230601$20230706$20240715$20240715$PER$$US-PERRIGO-23US007874$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889661$24088966$1$I$20230701$20230710$20240715$20240715$PER$$US-PERRIGO-23US007918$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889671$24088967$1$I$20240605$20240705$20240715$20240715$EXP$FR-AFSSAPS-AN2024000831$FR-TEVA-VS-3218227$TEVA$$86$YR$$M$Y$60$KG$20240715$$PH$FR$FR
240889681$24088968$1$I$20230701$20230710$20240715$20240715$PER$$US-PERRIGO-23US007917$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889691$24088969$1$I$20230701$20230708$20240715$20240715$PER$$US-PERRIGO-23US007832$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889701$24088970$1$I$20230701$20230710$20240715$20240715$PER$$US-PERRIGO-23US007876$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889711$24088971$1$I$20230601$20230706$20240715$20240715$PER$$US-PERRIGO-23US007875$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889721$24088972$1$I$20230701$20230707$20240715$20240715$PER$$US-PERRIGO-23US007831$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889731$24088973$1$I$20230701$20230709$20240715$20240715$PER$$US-PERRIGO-23US007863$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889741$24088974$1$I$20230701$20230707$20240715$20240715$PER$$US-PERRIGO-23US007829$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889751$24088975$1$I$20230601$20230706$20240715$20240715$PER$$US-PERRIGO-23US007872$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889761$24088976$1$I$20230701$20230710$20240715$20240715$PER$$US-PERRIGO-23US007915$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889771$24088977$1$I$20230701$20230707$20240715$20240715$PER$$US-PERRIGO-23US007830$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889781$24088978$1$I$20200701$20230711$20240715$20240715$PER$$US-PERRIGO-23US007868$PERRIGO$$74$YR$$F$Y$63.492$KG$20240715$$CN$US$US
240889791$24088979$1$I$20230701$20230705$20240715$20240715$PER$$US-PERRIGO-23US007828$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889801$24088980$1$I$20230701$20230710$20240715$20240715$PER$$US-PERRIGO-23US007916$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889811$24088981$1$I$20230701$20230709$20240715$20240715$PER$$US-PERRIGO-23US007851$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889821$24088982$1$I$20240628$20240705$20240715$20240715$EXP$$PR-JNJFOC-20240717607$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240715$$CN$PR$PR
240889831$24088983$1$I$20230701$20230712$20240715$20240715$PER$$US-PERRIGO-23US008024$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889841$24088984$1$I$20230701$20230714$20240715$20240715$PER$$US-PERRIGO-23US008074$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889861$24088986$1$I$20230701$20230715$20240715$20240715$PER$$US-PERRIGO-23US008075$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889871$24088987$1$I$20230701$20230712$20240715$20240715$PER$$US-PERRIGO-23US008012$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889881$24088988$1$I$20230701$20230713$20240715$20240715$PER$$US-PERRIGO-23US008027$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889891$24088989$1$I$20230701$20230710$20240715$20240715$PER$$US-PERRIGO-23US007967$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889901$24088990$1$I$20230701$20230712$20240715$20240715$PER$$US-PERRIGO-23US008011$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889911$24088991$1$I$20230701$20230710$20240715$20240715$PER$$US-PERRIGO-23US007965$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889921$24088992$1$I$20230701$20230714$20240715$20240715$PER$$US-PERRIGO-23US008073$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889931$24088993$1$I$20230701$20230716$20240715$20240715$PER$$US-PERRIGO-23US008067$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889941$24088994$1$I$20230701$20230711$20240715$20240715$PER$$US-PERRIGO-23US007951$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889951$24088995$1$I$20230701$20230713$20240715$20240715$PER$$US-PERRIGO-23US008028$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889963$24088996$3$F$20240705$20240822$20240715$20240827$EXP$$IE-MYLANLABS-2024M1063692$MYLAN$$$$$M$Y$$$20240827$$HP$IE$IE
240889971$24088997$1$I$20240615$20240708$20240715$20240715$EXP$ES-AEMPS-1542654$ES-ASTELLAS-2024EU006810$ASTELLAS$$61$YR$$F$Y$$$20240715$$CN$ES$ES
240889981$24088998$1$I$20230701$20230713$20240715$20240715$PER$$US-PERRIGO-23US008140$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240889991$24088999$1$I$20230701$20230718$20240715$20240715$PER$$US-PERRIGO-23US008231$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890001$24089000$1$I$20230701$20230713$20240715$20240715$PER$$US-PERRIGO-23US008167$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890011$24089001$1$I$20230701$20230719$20240715$20240715$PER$$US-PERRIGO-23US008272$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890021$24089002$1$I$20230701$20230713$20240715$20240715$PER$$US-PERRIGO-23US008166$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890031$24089003$1$I$20150101$20230721$20240715$20240715$PER$$US-PERRIGO-23US008276$PERRIGO$$$$$F$Y$57.143$KG$20240715$$CN$US$US
240890041$24089004$1$I$20230701$20230718$20240715$20240715$PER$$US-PERRIGO-23US008233$PERRIGO$$79$YR$$M$Y$$$20240715$$CN$US$US
240890051$24089005$1$I$20230701$20230718$20240715$20240715$PER$$US-PERRIGO-23US008232$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890061$24089006$1$I$20230701$20230719$20240715$20240715$PER$$US-PERRIGO-23US008270$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890071$24089007$1$I$20230701$20230718$20240715$20240715$PER$$US-PERRIGO-23US008143$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890081$24089008$1$I$20230701$20230711$20240715$20240715$PER$$US-PERRIGO-23US008183$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890101$24089010$1$I$20230701$20230715$20240715$20240715$PER$$US-PERRIGO-23US008178$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890111$24089011$1$I$20230701$20230717$20240715$20240715$PER$$US-PERRIGO-23US008185$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890121$24089012$1$I$20230701$20230718$20240715$20240715$PER$$US-PERRIGO-23US008230$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890131$24089013$1$I$20230701$20230717$20240715$20240715$PER$$US-PERRIGO-23US008134$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890141$24089014$1$I$20230701$20230717$20240715$20240715$PER$$US-PERRIGO-23US008173$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890151$24089015$1$I$20230701$20230713$20240715$20240715$PER$$US-PERRIGO-23US008184$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890161$24089016$1$I$20230701$20230712$20240715$20240715$PER$$US-PERRIGO-23US008163$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890171$24089017$1$I$20231201$20240705$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-033786$AUROBINDO$$60$YR$$F$Y$81$KG$20240715$$MD$FR$FR
240890181$24089018$1$I$$20240705$20240715$20240715$EXP$$IT-AUROBINDO-AUR-APL-2024-034124$AUROBINDO$Zaccheddu E, Zappu A, Barella S, Clemente MG, Orecchia V, Pilia MP, et al.. Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept.. Br-J-Haematol. 2024;204(6):2505-2507$$$N$F$Y$2.5$KG$20240715$$HP$IT$IT
240890191$24089019$1$I$20230701$20230725$20240715$20240715$PER$$US-PERRIGO-23US008421$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890201$24089020$1$I$20230701$20230722$20240715$20240715$PER$$US-PERRIGO-23US008401$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890211$24089021$1$I$20230701$20230721$20240715$20240715$PER$$US-PERRIGO-23US008335$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890221$24089022$1$I$20230701$20230721$20240715$20240715$PER$$US-PERRIGO-23US008400$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890231$24089023$1$I$20230701$20230725$20240715$20240715$PER$$US-PERRIGO-23US008484$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890241$24089024$1$I$20230701$20230724$20240715$20240715$PER$$US-PERRIGO-23US008403$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890251$24089025$1$I$20230701$20230724$20240715$20240715$PER$$US-PERRIGO-23US008402$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890261$24089026$1$I$20230701$20230724$20240715$20240715$PER$$US-PERRIGO-23US008407$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890271$24089027$1$I$20230701$20230724$20240715$20240715$PER$$US-PERRIGO-23US008418$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890281$24089028$1$I$20230701$20230720$20240715$20240715$PER$$US-PERRIGO-23US008333$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890291$24089029$1$I$20230701$20230725$20240715$20240715$PER$$US-PERRIGO-23US008464$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890302$24089030$2$F$20240712$20240715$20240715$20240715$PER$$US-AMGEN-USASP2024139616$AMGEN$$73$YR$E$F$Y$$$20240715$$CN$US$US
240890311$24089031$1$I$20230701$20230724$20240715$20240715$PER$$US-PERRIGO-23US008420$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890322$24089032$2$F$$20240829$20240715$20240902$EXP$$CA-ABBVIE-5839360$ABBVIE$$$$E$F$Y$$$20240902$$CN$CA$CA
240890332$24089033$2$F$20231201$20240726$20240715$20240802$EXP$$US-ASTELLAS-2024US019941$ASTELLAS$$85$YR$$M$Y$$$20240802$$CN$US$US
240890351$24089035$1$I$$20240705$20240715$20240715$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008403$STRIDES$Salar T, Al-Hosainat N, Subedi R, Hameed M, Brodsky S, Dahhan A.. A CASE OF HYDRALAZINE INDUCED SEVERE RENAL- LIMITED ANCA VASCULITIS LEADING TO ESRD IN A 63-YEAR-OLD MAN.. Am-J-Kidney-Dis. 2023;81 (Suppl.1)(4):S42 abstr. 142$63$YR$$M$Y$$$20240715$$HP$US$US
240890361$24089036$1$I$20230701$20230726$20240715$20240715$PER$$US-PERRIGO-23US008537$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890371$24089037$1$I$20230101$20240709$20240715$20240715$EXP$$GB-UCBSA-2024035439$UCB$$$$$F$Y$$$20240715$$CN$GB$GB
240890381$24089038$1$I$20230701$20230726$20240715$20240715$PER$$US-PERRIGO-23US008528$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890391$24089039$1$I$20230701$20230726$20240715$20240715$PER$$US-PERRIGO-23US008493$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890401$24089040$1$I$20230701$20230729$20240715$20240715$PER$$US-PERRIGO-23US008548$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890411$24089041$1$I$20230701$20230728$20240715$20240715$PER$$US-PERRIGO-23US008547$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890421$24089042$1$I$20230701$20230725$20240715$20240715$PER$$US-PERRIGO-23US008496$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890431$24089043$1$I$20230701$20230725$20240715$20240715$PER$$US-PERRIGO-23US008500$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890441$24089044$1$I$20230701$20230726$20240715$20240715$PER$$US-PERRIGO-23US008538$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890451$24089045$1$I$20230701$20230725$20240715$20240715$PER$$US-PERRIGO-23US008497$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890461$24089046$1$I$20230701$20230726$20240715$20240715$PER$$US-PERRIGO-23US008501$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890471$24089047$1$I$20240525$20240712$20240715$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032689$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240715$$CN$US$US
240890481$24089048$1$I$$20240705$20240715$20240715$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP008405$STRIDES$Gianmarco A, Cerini M, Calvi E, Falco R, Curnis A.. A RARE COMPLICATION OF LEAD EXTRACTION: THE A-V FISTULA.. Eur-Heart-J-Suppl. 2024;26 (Suppl. 2):ii36$59$YR$$M$Y$$$20240715$$HP$IT$IT
240890491$24089049$1$I$20230701$20230801$20240715$20240715$PER$$US-PERRIGO-23US008754$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890511$24089051$1$I$20230701$20230727$20240715$20240715$PER$$US-PERRIGO-23US008575$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890521$24089052$1$I$20230701$20230727$20240715$20240715$PER$$US-PERRIGO-23US008567$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890531$24089053$1$I$20230701$20230804$20240715$20240715$PER$$US-PERRIGO-23US008805$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890541$24089054$1$I$20230701$20230803$20240715$20240715$PER$$US-PERRIGO-23US008802$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890551$24089055$1$I$20230701$20230802$20240715$20240715$PER$$US-PERRIGO-23US008797$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240890561$24089056$1$I$20230701$20230727$20240715$20240715$PER$$US-PERRIGO-23US008584$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890571$24089057$1$I$20230701$20230731$20240715$20240715$PER$$US-PERRIGO-23US008747$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890581$24089058$1$I$20230701$20230727$20240715$20240715$PER$$US-PERRIGO-23US008573$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890591$24089059$1$I$20230701$20230729$20240715$20240715$PER$$US-PERRIGO-23US008566$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890601$24089060$1$I$20190101$20230803$20240715$20240715$PER$$US-PERRIGO-23US008726$PERRIGO$$$$$F$Y$61.224$KG$20240715$$CN$US$US
240890611$24089061$1$I$20230701$20230729$20240715$20240715$PER$$US-PERRIGO-23US008581$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890621$24089062$1$I$20230701$20230801$20240715$20240715$PER$$US-PERRIGO-23US008741$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890631$24089063$1$I$20230701$20230801$20240715$20240715$PER$$US-PERRIGO-23US008750$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890641$24089064$1$I$20230701$20230728$20240715$20240715$PER$$US-PERRIGO-23US008576$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890651$24089065$1$I$20230701$20230731$20240715$20240715$PER$$US-PERRIGO-23US008692$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890661$24089066$1$I$20230801$20230801$20240715$20240715$PER$$US-PERRIGO-23US008613$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240890671$24089067$1$I$20230701$20230803$20240715$20240715$PER$$US-PERRIGO-23US008804$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890681$24089068$1$I$20230701$20230727$20240715$20240715$PER$$US-PERRIGO-23US008577$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890691$24089069$1$I$20230701$20230727$20240715$20240715$PER$$US-PERRIGO-23US008585$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890704$24089070$4$F$20240627$20240816$20240715$20240823$PER$$US-ROCHE-10000022809$ROCHE$$54$YR$A$F$Y$63.5$KG$20240823$$CN$US$US
240890711$24089071$1$I$20240118$20240705$20240715$20240715$EXP$$TW-ROCHE-10000020313$ROCHE$$64$YR$A$M$Y$$$20240715$$MD$TW$TW
240890722$24089072$2$F$$20240701$20240715$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05891$LUPIN$$$$$$Y$$$20240719$$CN$US$US
240890732$24089073$2$F$20240101$20240814$20240715$20240816$EXP$$US-UCBSA-2024035354$UCB$$$$$M$Y$$$20240816$$CN$US$US
240890741$24089074$1$I$$20240701$20240715$20240715$EXP$$US-CIPLA (EU) LIMITED-2024US04429$CIPLA$$$$$$Y$$$20240715$$CN$US$US
240890751$24089075$1$I$20230626$20230807$20240715$20240715$PER$$US-PERRIGO-23US008882$PERRIGO$$64$YR$$F$Y$65.76$KG$20240715$$CN$US$US
240890761$24089076$1$I$20230201$20230807$20240715$20240715$PER$$US-PERRIGO-23US008922$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240890771$24089077$1$I$20230701$20230802$20240715$20240715$PER$$US-PERRIGO-23US008816$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890781$24089078$1$I$20230806$20230807$20240715$20240715$PER$$US-PERRIGO-23US008833$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240890791$24089079$1$I$$20240705$20240715$20240715$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP008406$STRIDES$Abete R, Iacovoni A, Vittori C, Candiago E, Gianatti A, Terzi A, et al.. NAVIGATING THE UNCHARTED WATERS: MANAGING CONCURRENT CYTOMEGALOVIRUS MYOCARDITIS AND ALLOGRAFT REJECTION IN A PATIENT WITH HEART TRANSPLANTATION. Eur-Heart-J-Suppl. 2024;26 (Suppl. 2):ii39$49$YR$$F$Y$$$20240715$$HP$IT$IT
240890801$24089080$1$I$20230701$20230806$20240715$20240715$PER$$US-PERRIGO-23US008915$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890811$24089081$1$I$20230723$20230804$20240715$20240715$PER$$US-PERRIGO-23US008818$PERRIGO$$26$YR$$$Y$72.562$KG$20240715$$CN$US$US
240890821$24089082$1$I$20230701$20230802$20240715$20240715$PER$$US-PERRIGO-23US008824$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890831$24089083$1$I$20230701$20230731$20240715$20240715$PER$$US-PERRIGO-23US008839$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890841$24089084$1$I$20230701$20230802$20240715$20240715$PER$$US-PERRIGO-23US008823$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890851$24089085$1$I$20230801$20230805$20240715$20240715$PER$$US-PERRIGO-23US008822$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890861$24089086$1$I$$20240709$20240715$20240715$PER$$US-EMD Serono-2024037646$EMD SERONO INC$$50$YR$A$F$Y$$$20240715$$CN$US$US
240890875$24089087$5$F$20240514$20240820$20240715$20240826$PER$$US-ROCHE-10000022201$ROCHE$$57$YR$A$F$Y$89.81$KG$20240826$$CN$US$US
240890881$24089088$1$I$20240312$20240705$20240715$20240715$EXP$FR-AFSSAPS-AVMA2024000276$FR-TEVA-VS-3218250$TEVA$$26$YR$$M$Y$$$20240715$$PH$FR$FR
240890901$24089090$1$I$20240101$20240703$20240715$20240715$PER$$US-TEVA-VS-3217962$TEVA$$$$$F$Y$$$20240715$$HP$US$US
240890911$24089091$1$I$20230801$20230807$20240715$20240715$PER$$US-PERRIGO-23US008984$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890921$24089092$1$I$20230801$20230807$20240715$20240715$PER$$US-PERRIGO-23US008986$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890931$24089093$1$I$20230801$20230809$20240715$20240715$PER$$US-PERRIGO-23US009008$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240890941$24089094$1$I$$20240705$20240715$20240715$EXP$$IT-STRIDES ARCOLAB LIMITED-2023SP011051$STRIDES$Ricciardulli S, Lattanzi L, Barbuti M, Ceravolo R, Perugi G.. Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report.. Int-Clin-Psychopharmacol. 2023;38(2):117-120$69$YR$$F$Y$$$20240715$$HP$IT$IT
240890951$24089095$1$I$20230801$20230815$20240715$20240715$PER$$US-PERRIGO-23US009172$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240890961$24089096$1$I$20230801$20230809$20240715$20240715$PER$$US-PERRIGO-23US009045$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890971$24089097$1$I$20230801$20230809$20240715$20240715$PER$$US-PERRIGO-23US009051$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890981$24089098$1$I$20230801$20230807$20240715$20240715$PER$$US-PERRIGO-23US008989$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240890991$24089099$1$I$20230301$20230815$20240715$20240715$PER$$US-PERRIGO-23US009175$PERRIGO$$49$YR$$M$Y$82.993$KG$20240715$$CN$US$US
240891001$24089100$1$I$20230801$20230807$20240715$20240715$PER$$US-PERRIGO-23US008990$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891011$24089101$1$I$20230801$20230808$20240715$20240715$PER$$US-PERRIGO-23US009046$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891021$24089102$1$I$20230801$20230810$20240715$20240715$PER$$US-PERRIGO-23US009050$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891031$24089103$1$I$20230801$20230809$20240715$20240715$PER$$US-PERRIGO-23US009062$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891041$24089104$1$I$20230611$20230811$20240715$20240715$PER$$US-PERRIGO-23US009052$PERRIGO$$67$YR$$M$Y$79.365$KG$20240715$$CN$US$US
240891051$24089105$1$I$20230801$20230809$20240715$20240715$PER$$US-PERRIGO-23US009066$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891061$24089106$1$I$20230801$20230805$20240715$20240715$PER$$US-PERRIGO-23US008979$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891071$24089107$1$I$20230801$20230810$20240715$20240715$PER$$US-PERRIGO-23US009114$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891081$24089108$1$I$20230801$20230808$20240715$20240715$PER$$US-PERRIGO-23US009063$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891091$24089109$1$I$20230801$20230810$20240715$20240715$PER$$US-PERRIGO-23US009115$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891101$24089110$1$I$20230801$20230807$20240715$20240715$PER$$US-PERRIGO-23US008987$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891111$24089111$1$I$20230801$20230807$20240715$20240715$PER$$US-PERRIGO-23US008985$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891121$24089112$1$I$$20240703$20240715$20240715$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS003530$TERSERA THERAPEUTICS$$$$$$Y$$$20240715$$PH$NL$NL
240891131$24089113$1$I$$20240704$20240715$20240715$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003553$TERSERA THERAPEUTICS$$$$$$Y$$$20240715$$CN$AU$AU
240891141$24089114$1$I$$20240705$20240715$20240715$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008409$STRIDES$Matsuyama T, Tomioka Y, Matsuyama H, Kamenohara Y, Tanigawa K, Dotake Y, et al.. Severe asthma remaining well-controlled after mepolizumab discontinuation: A case report and literature review.. Respirol-Case-Rep. 2023;11 (6)$62$YR$$M$Y$$$20240715$$HP$JP$JP
240891151$24089115$1$I$20230801$20230814$20240715$20240715$PER$$US-PERRIGO-23US009202$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891161$24089116$1$I$$20240708$20240715$20240715$EXP$$CA-APOTEX-2024AP008058$APOTEX$$$$$M$Y$$$20240715$$HP$CA$CA
240891171$24089117$1$I$20230801$20230810$20240715$20240715$PER$$US-PERRIGO-23US009213$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891181$24089118$1$I$20230801$20230814$20240715$20240715$PER$$US-PERRIGO-23US009203$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891191$24089119$1$I$20230801$20230814$20240715$20240715$PER$$US-PERRIGO-23US009201$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891201$24089120$1$I$20240528$20240703$20240715$20240715$EXP$$PK-ROCHE-10000020711$ROCHE$$58$YR$A$F$Y$$$20240715$$CN$PK$PK
240891211$24089121$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008175$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240715$$CN$US$US
240891221$24089122$1$I$20240501$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007849$ELI LILLY AND CO$$$$A$F$Y$$$20240715$$CN$US$US
240891231$24089123$1$I$$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008570$ELI LILLY AND CO$$$$$F$Y$$$20240715$$CN$US$US
240891241$24089124$1$I$20240701$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007801$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240715$$CN$US$US
240891251$24089125$1$I$20240710$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007744$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240715$$CN$US$US
240891261$24089126$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008098$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240715$$CN$US$US
240891271$24089127$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008182$ELI LILLY AND CO$$89$YR$E$M$Y$$$20240715$$CN$US$US
240891281$24089128$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007902$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240715$$CN$US$US
240891292$24089129$2$F$$20240730$20240715$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407008344$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240801$$CN$US$US
240891302$24089130$2$F$20240601$20240711$20240715$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407008343$ELI LILLY AND CO$$66$YR$E$$Y$$$20240719$$CN$US$US
240891314$24089131$4$F$20240709$20240820$20240715$20240826$PER$$NVSC2024US144375$NOVARTIS$$23$YR$$F$Y$$$20240826$$HP$US$US
240891321$24089132$1$I$20240710$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007900$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240715$$CN$US$US
240891341$24089134$1$I$20230801$20230812$20240715$20240715$PER$$US-PERRIGO-23US009216$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891351$24089135$1$I$20230801$20230815$20240715$20240715$PER$$US-PERRIGO-23US009264$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891361$24089136$1$I$20230801$20230815$20240715$20240715$PER$$US-PERRIGO-23US009263$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891371$24089137$1$I$$20240705$20240715$20240715$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008423$STRIDES$Mukherjee A.. Combined Cyproheptadine and Dexamethasone dependence, a rare dependence syndrome or underreported? - A case series.. Indian-J-Psychiatry. 2024;66 (Suppl. 1):S91$3$DEC$$M$Y$$$20240715$$HP$IN$IN
240891381$24089138$1$I$20230801$20230814$20240715$20240715$PER$$US-PERRIGO-23US009268$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891391$24089139$1$I$20230801$20230816$20240715$20240715$PER$$US-PERRIGO-23US009271$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891401$24089140$1$I$20230701$20230816$20240715$20240715$PER$$US-PERRIGO-23US009237$PERRIGO$$67$YR$$M$Y$81.633$KG$20240715$$CN$US$US
240891411$24089141$1$I$20230801$20230812$20240715$20240715$PER$$US-PERRIGO-23US009214$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891431$24089143$1$I$20230801$20230815$20240715$20240715$PER$$US-PERRIGO-23US009284$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891441$24089144$1$I$20230801$20230815$20240715$20240715$PER$$US-PERRIGO-23US009326$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240891451$24089145$1$I$20230216$20230814$20240715$20240715$PER$$US-PERRIGO-23US009215$PERRIGO$$71$YR$$M$Y$81.633$KG$20240715$$CN$US$US
240891461$24089146$1$I$20230801$20230817$20240715$20240715$PER$$US-PERRIGO-23US009296$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240891471$24089147$1$I$20230701$20230814$20240715$20240715$PER$$US-PERRIGO-23US009297$PERRIGO$$85$YR$$F$Y$56.236$KG$20240715$$CN$US$US
240891481$24089148$1$I$20230801$20230814$20240715$20240715$PER$$US-PERRIGO-23US009270$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891491$24089149$1$I$20230801$20230814$20240715$20240715$PER$$US-PERRIGO-23US009257$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891501$24089150$1$I$20230801$20230814$20240715$20240715$PER$$US-PERRIGO-23US009269$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891511$24089151$1$I$20230801$20230816$20240715$20240715$PER$$US-PERRIGO-23US009319$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891521$24089152$1$I$$20240705$20240715$20240715$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008427$STRIDES$Mukherjee A.. Combined Cyproheptadine and Dexamethasone dependence, a rare dependence syndrome or underreported? - A case series.. Indian-J-Psychiatry. 2024;66 (Suppl. 1):S91$3$DEC$$M$Y$$$20240715$$HP$IN$IN
240891531$24089153$1$I$20230801$20230819$20240715$20240715$PER$$US-PERRIGO-23US009376$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891541$24089154$1$I$20230801$20230818$20240715$20240715$PER$$US-PERRIGO-23US009373$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891551$24089155$1$I$20230801$20230821$20240715$20240715$PER$$US-PERRIGO-23US009418$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891561$24089156$1$I$20230820$20230821$20240715$20240715$PER$$US-PERRIGO-23US009383$PERRIGO$$43$YR$$M$Y$81.633$KG$20240715$$CN$US$US
240891573$24089157$3$F$20240330$20240731$20240715$20240802$EXP$$US-ROCHE-10000023315$ROCHE$$19$YR$A$F$Y$34.5$KG$20240802$$CN$US$US
240891581$24089158$1$I$20230801$20230817$20240715$20240715$PER$$US-PERRIGO-23US009363$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891591$24089159$1$I$20230801$20230821$20240715$20240715$PER$$US-PERRIGO-23US009433$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891601$24089160$1$I$20230801$20230820$20240715$20240715$PER$$US-PERRIGO-23US009421$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891611$24089161$1$I$20230801$20230817$20240715$20240715$PER$$US-PERRIGO-23US009364$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891621$24089162$1$I$20190717$20190722$20240715$20240715$EXP$$CO-AstraZeneca-2019SF06486$ASTRAZENECA$$28912$DY$$F$Y$$$20240715$$CN$CO$
240891631$24089163$1$I$20230810$20230819$20240715$20240715$PER$$US-PERRIGO-23US009384$PERRIGO$$72$YR$$M$Y$88.435$KG$20240715$$CN$US$US
240891641$24089164$1$I$$20240710$20240715$20240715$EXP$$CA-AstraZeneca-2024A158455$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$CA$
240891651$24089165$1$I$$20190808$20240715$20240715$EXP$$US-AstraZeneca-2019SF15784$ASTRAZENECA$$$$$F$Y$$$20240715$$HP$US$
240891664$24089166$4$F$20240708$20240909$20240715$20240912$EXP$GB-MHRA-MED-202407081623476080-TCFKN$GB-STRIDES ARCOLAB LIMITED-2024SP008416$STRIDES$$77$YR$$M$Y$116$KG$20240912$$MD$GB$GB
240891671$24089167$1$I$$20240705$20240715$20240715$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008428$STRIDES$Mukherjee A.. Combined Cyproheptadine and Dexamethasone dependence, a rare dependence syndrome or underreported? - A case series.. Indian-J-Psychiatry. 2024;66 (Suppl. 1):S91$4$DEC$$F$Y$$$20240715$$HP$IN$IN
240891681$24089168$1$I$$20190806$20240715$20240715$EXP$$US-AstraZeneca-2019SF13754$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
240891691$24089169$1$I$20240601$20240710$20240715$20240715$EXP$$US-AstraZeneca-2024A159530$ASTRAZENECA$$23879$DY$$F$Y$$$20240715$$CN$US$
240891701$24089170$1$I$20230601$20230615$20240715$20240715$PER$$US-PERRIGO-23US007085$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891711$24089171$1$I$20230330$20230619$20240715$20240715$PER$$US-PERRIGO-23US007126$PERRIGO$$71$YR$$F$Y$52.154$KG$20240715$$CN$US$US
240891721$24089172$1$I$20230601$20230614$20240715$20240715$PER$$US-PERRIGO-23US007061$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891731$24089173$1$I$20230601$20230615$20240715$20240715$PER$$US-PERRIGO-23US007094$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891741$24089174$1$I$20230601$20230616$20240715$20240715$PER$$US-PERRIGO-23US007134$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891751$24089175$1$I$20230601$20230616$20240715$20240715$PER$$US-PERRIGO-23US007133$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891761$24089176$1$I$20230601$20230617$20240715$20240715$PER$$US-PERRIGO-23US007132$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891771$24089177$1$I$20230601$20230615$20240715$20240715$PER$$US-PERRIGO-23US007106$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891791$24089179$1$I$20230601$20230619$20240715$20240715$PER$$US-PERRIGO-23US007165$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891801$24089180$1$I$$20240709$20240715$20240715$EXP$$US-TAKEDA-2024TUS070457$TAKEDA$$$$$M$Y$$$20240715$$CN$US$US
240891811$24089181$1$I$20230601$20230619$20240715$20240715$PER$$US-PERRIGO-23US007176$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891821$24089182$1$I$20230601$20230619$20240715$20240715$PER$$US-PERRIGO-23US007164$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891831$24089183$1$I$20230601$20230619$20240715$20240715$PER$$US-PERRIGO-23US007160$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891841$24089184$1$I$20240709$20240710$20240715$20240715$EXP$$AU-TAKEDA-2024TUS070966$TAKEDA$$29$YR$$F$Y$$$20240715$$CN$AU$AU
240891851$24089185$1$I$20230601$20230615$20240715$20240715$PER$$US-PERRIGO-23US007135$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891861$24089186$1$I$20170101$20230615$20240715$20240715$PER$$US-PERRIGO-23US007066$PERRIGO$$$$$F$Y$53.515$KG$20240715$$CN$US$US
240891871$24089187$1$I$20190626$20190708$20240715$20240715$EXP$$BR-AstraZeneca-2019SE99642$ASTRAZENECA$$16472$DY$$F$Y$$$20240715$$CN$BR$
240891881$24089188$1$I$20230606$20230619$20240715$20240715$PER$$US-PERRIGO-23US007113$PERRIGO$$84$YR$$M$Y$63.492$KG$20240715$$CN$US$US
240891892$24089189$2$F$20190924$20240717$20240715$20240723$EXP$$CA-TAKEDA-2024TUS071030$TAKEDA$$38$YR$$F$Y$$$20240723$$CN$CA$CA
240891901$24089190$1$I$20240711$20240706$20240715$20240715$PER$$US-SA-2024SA205689$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240715$$CN$US$US
240891911$24089191$1$I$20230401$20240707$20240715$20240715$PER$$US-SA-2024SA202903$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240715$$MD$US$US
240891921$24089192$1$I$20190704$20190807$20240715$20240715$EXP$$CA-AstraZeneca-2019SF01803$ASTRAZENECA$$17946$DY$$F$Y$$$20240715$$CN$CA$
240891931$24089193$1$I$20210131$20210426$20240715$20240715$EXP$$BR-AstraZeneca-2021A367033$ASTRAZENECA$$19112$DY$$F$Y$50$KG$20240715$$MD$BR$
240891942$24089194$2$F$$20240705$20240715$20240801$PER$$US-SA-2024SA201251$SANOFI AVENTIS$$$$A$M$Y$74.84$KG$20240719$$MD$US$US
240891961$24089196$1$I$20230601$20230616$20240715$20240715$PER$$US-PERRIGO-23US007179$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240891971$24089197$1$I$$20240705$20240715$20240715$EXP$$PL-AUROBINDO-AUR-APL-2024-033678$AUROBINDO$$66$YR$$M$Y$80$KG$20240715$$MD$PL$PL
240891981$24089198$1$I$$20240708$20240715$20240715$PER$$US-BIOGEN-2024BI01272927$BIOGEN$$$$$F$Y$78.088$KG$20240715$$HP$US$US
240891991$24089199$1$I$20230601$20230618$20240715$20240715$PER$$US-PERRIGO-23US007178$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892001$24089200$1$I$20230601$20230619$20240715$20240715$PER$$US-PERRIGO-23US007187$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892011$24089201$1$I$20230601$20230621$20240715$20240715$PER$$US-PERRIGO-23US007270$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892021$24089202$1$I$20230601$20230621$20240715$20240715$PER$$US-PERRIGO-23US007267$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892031$24089203$1$I$20230601$20230620$20240715$20240715$PER$$US-PERRIGO-23US007230$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892041$24089204$1$I$20220201$20230622$20240715$20240715$PER$$US-PERRIGO-23US007266$PERRIGO$$44$YR$$M$Y$74.83$KG$20240715$$CN$US$US
240892051$24089205$1$I$20230420$20230620$20240715$20240715$PER$$US-PERRIGO-23US007199$PERRIGO$$57$YR$$M$Y$72.562$KG$20240715$$CN$US$US
240892061$24089206$1$I$20230601$20230620$20240715$20240715$PER$$US-PERRIGO-23US007225$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892071$24089207$1$I$20230601$20230617$20240715$20240715$PER$$US-PERRIGO-23US007221$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240892082$24089208$2$F$$20240715$20240715$20240717$PER$$US-AMGEN-USASP2024139659$AMGEN$$$$$$Y$$$20240717$$HP$US$US
240892091$24089209$1$I$20230601$20230626$20240715$20240715$PER$$US-PERRIGO-23US007450$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892101$24089210$1$I$20230601$20230622$20240715$20240715$PER$$US-PERRIGO-23US007344$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892111$24089211$1$I$20230601$20230621$20240715$20240715$PER$$US-PERRIGO-23US007314$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892121$24089212$1$I$20230601$20230623$20240715$20240715$PER$$US-PERRIGO-23US007349$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892131$24089213$1$I$20230601$20230621$20240715$20240715$PER$$US-PERRIGO-23US007286$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892141$24089214$1$I$20230601$20230623$20240715$20240715$PER$$US-PERRIGO-23US007367$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892153$24089215$3$F$20240802$20240802$20240715$20240807$EXP$$US-TAKEDA-2024TUS071050$TAKEDA$$76$YR$$M$Y$$$20240807$$CN$US$US
240892161$24089216$1$I$20230601$20230622$20240715$20240715$PER$$US-PERRIGO-23US007311$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892181$24089218$1$I$20230601$20230623$20240715$20240715$PER$$US-PERRIGO-23US007348$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892191$24089219$1$I$20230601$20230626$20240715$20240715$PER$$US-PERRIGO-23US007452$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892201$24089220$1$I$20230601$20230627$20240715$20240715$PER$$US-PERRIGO-23US007521$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892211$24089221$1$I$20230601$20230624$20240715$20240715$PER$$US-PERRIGO-23US007366$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892221$24089222$1$I$20230601$20230623$20240715$20240715$PER$$US-PERRIGO-23US007351$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892231$24089223$1$I$20230601$20230622$20240715$20240715$PER$$US-PERRIGO-23US007363$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892241$24089224$1$I$20230601$20230621$20240715$20240715$PER$$US-PERRIGO-23US007289$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892251$24089225$1$I$20230601$20230626$20240715$20240715$PER$$US-PERRIGO-23US007451$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892261$24089226$1$I$20230601$20230626$20240715$20240715$PER$$US-PERRIGO-23US007464$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892271$24089227$1$I$20230101$20230627$20240715$20240715$PER$$US-PERRIGO-23US007421$PERRIGO$$$$$F$Y$58.957$KG$20240715$$CN$US$US
240892281$24089228$1$I$20230601$20230622$20240715$20240715$PER$$US-PERRIGO-23US007347$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892291$24089229$1$I$20230601$20230622$20240715$20240715$PER$$US-PERRIGO-23US007345$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892301$24089230$1$I$20230601$20230620$20240715$20240715$PER$$US-PERRIGO-23US007285$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892321$24089232$1$I$$20240705$20240715$20240715$EXP$$GB-ROCHE-10000004842$ROCHE$Gan Y, Bashir A, Sunni N. The diversity of cardiac manifestations in rheumatological disorders: Highlights on immunosuppression and cardiac complications.. Heart. 2024-Jun;110 (3):A33-4. doi:10.1136/heartjnl-2024-BCS.29.$30$YR$A$F$Y$$$20240715$$HP$GB$GB
240892331$24089233$1$I$20240710$20240710$20240715$20240715$PER$$NVSC2024US143688$NOVARTIS$$45$YR$$$Y$$$20240715$$CN$US$US
240892341$24089234$1$I$20230628$20230629$20240715$20240715$PER$$US-PERRIGO-23US007532$PERRIGO$$49$YR$$F$Y$61.224$KG$20240715$$CN$US$US
240892351$24089235$1$I$20230601$20230627$20240715$20240715$PER$$US-PERRIGO-23US007529$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892361$24089236$1$I$20230601$20230626$20240715$20240715$PER$$US-PERRIGO-23US007531$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892371$24089237$1$I$20230601$20230627$20240715$20240715$PER$$US-PERRIGO-23US007527$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892382$24089238$2$F$$20240821$20240715$20240826$PER$$US-TAKEDA-2024TUS071287$TAKEDA$$$$$F$Y$$$20240826$$CN$US$US
240892391$24089239$1$I$20230601$20230627$20240715$20240715$PER$$US-PERRIGO-23US007523$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892401$24089240$1$I$20240523$20240715$20240715$20240715$EXP$FR-AFSSAPS-RE2024000682$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039698$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$114$KG$20240715$$PH$FR$FR
240892411$24089241$1$I$20230601$20230626$20240715$20240715$PER$$US-PERRIGO-23US007534$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240892421$24089242$1$I$20240319$20240701$20240715$20240715$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06422$HIKMA$$$$$$Y$$$20240715$$HP$US$US
240892441$24089244$1$I$$20240710$20240715$20240715$PER$$US-LEO Pharma-371322$LEO PHARM$$68$YR$$F$Y$$$20240715$$MD$US$US
240892451$24089245$1$I$$20240708$20240715$20240715$EXP$$US-AUROBINDO-AUR-APL-2019-087791$AUROBINDO$Wang E, Boswell E, Siddiqi I, Lu CM, Sebastian S, Rehder C et al.,. Pseudo?Pelger-Hu?t anomaly induced by medications: a clinicopathologic study in comparison with myelodysplastic syndrome?related Pseudo?Pelger-Hu?t anomaly. American journal of clinical pathology. 2011;135(2):291-303$71$YR$$M$Y$$$20240715$$MD$US$US
240892461$24089246$1$I$20240531$20240701$20240715$20240715$EXP$$GB-CIPLA LTD.-2024GB07115$CIPLA$$$$$$Y$$$20240715$$CN$GB$GB
240892473$24089247$3$F$20240621$20240812$20240715$20240812$PER$$US-ALXN-202407USA000547US$ALEXION PHARMACEUTICALS$$67$YR$$M$Y$118.82$KG$20240812$$CN$US$US
240892483$24089248$3$F$$20240723$20240715$20240803$EXP$$US-TEVA-VS-3218382$TEVA$Jain T, Choudhary M, Grover P. Severe Lactic Acidosis Following Epinephrine Use in Anaphylaxis. Am-J-Respir-Crit-Care-Med 2024; 209 A3413.; Jain T, Choudhary M, Grover P. Severe Lactic Acidosis Following Epinephrine Use in Anaphylaxis. Am-J-Respir-Crit-Care-Med 2024; 209 A3413.$57$YR$$M$Y$$$20240803$$HP$US$US
240892494$24089249$4$F$20240101$20240812$20240715$20240813$PER$$US-AMGEN-USASP2024139609$AMGEN$$69$YR$E$F$Y$$$20240813$$CN$US$US
240892501$24089250$1$I$$20240711$20240715$20240715$PER$$US-JNJFOC-20240729838$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$MD$US$US
240892512$24089251$2$F$20240401$20240909$20240715$20240916$EXP$$US-BIOGEN-2024BI01273271$BIOGEN$$52$YR$$M$Y$$$20240916$$CN$US$US
240892521$24089252$1$I$$20240710$20240715$20240715$EXP$$US-BIOGEN-2024BI01273290$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240892531$24089253$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144896$NOVARTIS$$56$YR$$F$Y$$$20240715$$MD$US$US
240892542$24089254$2$F$$20240705$20240715$20240902$EXP$$GB-AUROBINDO-AUR-APL-2024-034105$AUROBINDO$$67$YR$$F$Y$$$20240902$$CN$GB$GB
240892551$24089255$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405012341446720-KTSFY$GB-TEVA-VS-3218662$TEVA$$$$$$Y$$$20240715$$CN$GB$GB
240892561$24089256$1$I$20190401$20190807$20240715$20240715$EXP$$FR-AstraZeneca-2019SE85383$ASTRAZENECA$$19720$DY$$F$Y$48$KG$20240715$$MD$FR$
240892571$24089257$1$I$$20190718$20240715$20240715$EXP$$RU-AstraZeneca-2019SF05208$ASTRAZENECA$$81$YR$$M$Y$90$KG$20240715$$CN$RU$
240892582$24089258$2$F$20240702$20240909$20240715$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110462$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240913$$HP$US$US
240892591$24089259$1$I$$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110823$BRISTOL MYERS SQUIBB$$65$YR$E$$Y$87.09$KG$20240715$$HP$US$US
240892601$24089260$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111204$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240715$$CN$US$US
240892611$24089261$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110993$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240715$$HP$US$US
240892621$24089262$1$I$$20240708$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110096$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$75.3$KG$20240715$$CN$US$US
240892631$24089263$1$I$20240408$20240712$20240715$20240715$EXP$FR-AFSSAPS-RN2024000536$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-074763$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240715$$MD$FR$FR
240892641$24089264$1$I$$20190717$20240715$20240715$EXP$$US-AstraZeneca-2019SF03666$ASTRAZENECA$$$$$F$Y$72.1$KG$20240715$$CN$US$
240892651$24089265$1$I$$20240710$20240715$20240715$EXP$$US-TAKEDA-US201815555$TAKEDA$$$$$F$Y$64.853$KG$20240715$$HP$US$US
240892661$24089266$1$I$$20190918$20240715$20240715$EXP$$US-AstraZeneca-2019SF16954$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
240892671$24089267$1$I$$20190722$20240715$20240715$EXP$$US-AstraZeneca-2019SF06461$ASTRAZENECA$$$$$F$Y$61.2$KG$20240715$$CN$US$
240892681$24089268$1$I$20190101$20191017$20240715$20240715$EXP$$CO-AstraZeneca-2019SF08679$ASTRAZENECA$$2681$WK$$F$Y$$$20240715$$CN$CO$
240892691$24089269$1$I$20240602$20240702$20240715$20240715$EXP$$IN-ROCHE-3478032$ROCHE$$61$YR$A$F$Y$$$20240715$$MD$IN$IN
240892711$24089271$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405060340208450-NZPQH$GB-TEVA-VS-3218795$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240892731$24089273$1$I$$20240712$20240715$20240715$EXP$$US-TAKEDA-2024TUS023875$TAKEDA$$$$$F$Y$$$20240715$$CN$US$US
240892741$24089274$1$I$$20240627$20240715$20240715$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05971$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240892761$24089276$1$I$$20240712$20240715$20240715$EXP$$US-ROCHE-10000025898$ROCHE$$$$A$M$Y$$$20240715$$CN$US$US
240892773$24089277$3$F$20221230$20240812$20240715$20240812$EXP$$DE-TAKEDA-2024TUS070889$TAKEDA$$$$A$M$Y$$$20240812$$HP$DE$DE
240892781$24089278$1$I$$20240712$20240715$20240715$PER$$US-ROCHE-10000025908$ROCHE$$62$YR$A$F$Y$$$20240715$$HP$US$US
240892791$24089279$1$I$20240101$20240705$20240715$20240715$EXP$FR-AFSSAPS-AN2024000833$FR-TEVA-VS-3218233$TEVA$$54$YR$$M$Y$80$KG$20240715$$PH$FR$FR
240892801$24089280$1$I$20160906$20240709$20240715$20240715$EXP$$CA-BIOGEN-2022BI01124836$BIOGEN$$56$YR$$F$Y$$$20240715$$HP$CA$CA
240892813$24089281$3$F$20240416$20240909$20240715$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007167$JAZZ$$67$YR$$F$Y$$$20240912$$HP$US$US
240892821$24089282$1$I$$20240705$20240715$20240715$EXP$$GB-CELLTRION INC.-2024GB016610$CELLTRION$$$$$$Y$$$20240715$$PH$GB$GB
240892831$24089283$1$I$$20240708$20240715$20240715$PER$$US-ABBVIE-5834588$ABBVIE$$$$$M$Y$$$20240715$$HP$US$US
240892841$24089284$1$I$20240615$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138711$AMGEN$$66$YR$E$F$Y$$$20240715$$CN$US$US
240892851$24089285$1$I$20240709$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139329$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240892871$24089287$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110832$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$39.01$KG$20240715$$CN$US$US
240892881$24089288$1$I$20240601$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111328$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240715$$PH$US$US
240892901$24089290$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111754$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240715$$CN$US$US
240892911$24089291$1$I$20240601$20240711$20240715$20240715$EXP$$US-UCBSA-2024035497$UCB$$34$YR$$F$Y$$$20240715$$HP$US$US
240892923$24089292$3$F$20240301$20240723$20240715$20240801$EXP$$US-TAKEDA-2024TUS069951$TAKEDA$$32$YR$$M$Y$$$20240801$$HP$US$US
240892931$24089293$1$I$$20240711$20240715$20240715$EXP$$PR-ABBVIE-5839386$ABBVIE$$45$YR$$F$Y$$$20240715$$MD$PR$PR
240892941$24089294$1$I$$20240702$20240715$20240715$EXP$$US-ROCHE-10000018603$ROCHE$$62$YR$A$F$Y$$$20240715$$CN$US$US
240892951$24089295$1$I$$20240709$20240715$20240715$PER$$US-LEO Pharma-371935$LEO PHARM$$59$YR$$M$Y$$$20240715$$CN$US$US
240892961$24089296$1$I$20240417$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405100734032630-LHWQT$GB-TEVA-VS-3218844$TEVA$$50$YR$$M$Y$116$KG$20240715$$CN$GB$GB
240892971$24089297$1$I$20231201$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405060341067210-TCMHK$GB-TEVA-VS-3218866$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240892981$24089298$1$I$20231101$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405160812016360-QLCBY$GB-TEVA-VS-3218884$TEVA$$26$YR$$F$Y$54$KG$20240715$$CN$GB$GB
240893001$24089300$1$I$20240503$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405130822311460-KYBWF$GB-TEVA-VS-3218903$TEVA$$38$YR$$M$Y$80$KG$20240715$$CN$GB$GB
240893011$24089301$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405082345420790-DRFMC$GB-TEVA-VS-3218894$TEVA$$$$$F$Y$62$KG$20240715$$CN$GB$GB
240893021$24089302$1$I$20240530$20240708$20240715$20240715$EXP$PT-INFARMED-T202405-1013$PT-SA-2024SA201574$SANOFI AVENTIS$$42$YR$A$F$Y$70$KG$20240715$$MD$PT$PT
240893041$24089304$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA119960$SANOFI AVENTIS$$$$$F$Y$$$20240715$$MD$US$US
240893051$24089305$1$I$$20240705$20240715$20240715$30DAY$$US-GSK-US2024084064$GLAXOSMITHKLINE$$$$$M$Y$$$20240715$$CN$US$US
240893061$24089306$1$I$$20240709$20240715$20240715$PER$$US-BIOGEN-2024BI01273006$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240893071$24089307$1$I$20240101$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139508$AMGEN$$55$YR$A$F$Y$$$20240715$$CN$US$US
240893081$24089308$1$I$20240407$20240705$20240715$20240715$EXP$SE-SEMPA-2024-003385$SE-TEVA-VS-3218186$TEVA$$6$YR$$M$Y$29$KG$20240715$$HP$SE$SE
240893091$24089309$1$I$20240624$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007977$ELI LILLY AND CO$$$$$$Y$$$20240715$$CN$US$US
240893101$24089310$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007800$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240715$$CN$US$US
240893111$24089311$1$I$20230101$20240708$20240715$20240715$EXP$$US-ABBVIE-5834375$ABBVIE$$$$$$Y$$$20240715$$MD$US$US
240893121$24089312$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007969$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240715$$CN$US$US
240893131$24089313$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007390$ELI LILLY AND CO$$$$A$F$Y$$$20240715$$CN$US$US
240893141$24089314$1$I$20240701$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007730$ELI LILLY AND CO$$$$A$F$Y$$$20240715$$HP$US$US
240893151$24089315$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007888$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240715$$CN$US$US
240893162$24089316$2$F$20230101$20240805$20240715$20240809$EXP$$JP-TAKEDA-2024TUS070173$TAKEDA$$69$YR$$M$Y$$$20240809$$MD$JP$JP
240893171$24089317$1$I$$20240703$20240715$20240715$EXP$$RU-ROCHE-10000018654$ROCHE$$25$YR$A$$Y$$$20240715$$MD$RU$RU
240893181$24089318$1$I$20240309$20240705$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-034330$AUROBINDO$$82$YR$$F$Y$$$20240715$$PH$FR$FR
240893191$24089319$1$I$$20240709$20240715$20240715$PER$$US-ABBVIE-5835749$ABBVIE$$$$$$Y$$$20240715$$CN$US$US
240893201$24089320$1$I$20170101$20240708$20240715$20240715$PER$$US-AMGEN-USASP2024136450$AMGEN$Wang Y. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):1-8$$$$$Y$$$20240715$$HP$US$US
240893211$24089321$1$I$20240617$20240618$20240715$20240715$PER$$US-JNJFOC-20240649211$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$US$US
240893221$24089322$1$I$$20230602$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02023$AMNEAL$$$$$$Y$$$20240715$$PH$US$US
240893231$24089323$1$I$20220401$20230817$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02924$AMNEAL$$40$YR$$$Y$$$20240715$$CN$US$US
240893241$24089324$1$I$$20230719$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02584$AMNEAL$$80$YR$$$Y$$$20240715$$CN$US$US
240893251$24089325$1$I$$20240710$20240715$20240715$PER$$US-ROCHE-10000023939$ROCHE$$70$YR$E$F$Y$$$20240715$$CN$US$US
240893261$24089326$1$I$$20240710$20240715$20240715$PER$$US-ROCHE-10000024475$ROCHE$$72$YR$E$M$Y$$$20240715$$CN$US$US
240893281$24089328$1$I$$20240711$20240715$20240715$EXP$$AU-GSK-AU2024085970$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$MD$AU$AU
240893291$24089329$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000024887$ROCHE$$$$A$F$Y$$$20240715$$CN$US$US
240893301$24089330$1$I$20240506$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034115$AUROBINDO$$$$$F$Y$93$KG$20240715$$CN$GB$GB
240893311$24089331$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000024834$ROCHE$$$$A$F$Y$$$20240715$$CN$US$US
240893321$24089332$1$I$$20240703$20240715$20240715$EXP$$IN-ROCHE-10000021215$ROCHE$$73$YR$E$M$Y$$$20240715$$CN$IN$IN
240893331$24089333$1$I$20190507$20190801$20240715$20240715$EXP$$CO-AstraZeneca-2019SF12224$ASTRAZENECA$$26372$DY$$F$Y$$$20240715$$CN$CO$
240893342$24089334$2$F$$20240903$20240715$20240909$PER$$US-ROCHE-10000021566$ROCHE$$43$YR$A$M$Y$$$20240909$$HP$US$US
240893351$24089335$1$I$20170301$20190816$20240715$20240715$EXP$$US-AstraZeneca-2019SF19460$ASTRAZENECA$$677$MON$$F$Y$51.3$KG$20240715$$CN$US$
240893361$24089336$1$I$20190801$20190816$20240715$20240715$EXP$$CO-AstraZeneca-2019SF20295$ASTRAZENECA$$31384$DY$$F$Y$$$20240715$$CN$CO$
240893371$24089337$1$I$$20190807$20240715$20240715$EXP$$RU-AstraZeneca-2019SF15132$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$RU$
240893381$24089338$1$I$20180101$20201105$20240715$20240715$EXP$$BR-AstraZeneca-2018SF61271$ASTRAZENECA$$57$YR$$F$Y$$$20240715$$CN$BR$
240893391$24089339$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111320$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240715$$CN$US$US
240893401$24089340$1$I$20240621$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110967$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240715$$CN$US$US
240893411$24089341$1$I$20240708$20240708$20240715$20240715$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-109948$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240715$$CN$PR$PR
240893422$24089342$2$F$$20240814$20240715$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111019$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240820$$HP$US$US
240893441$24089344$1$I$$20240705$20240715$20240715$EXP$$GB-CELLTRION INC.-2024GB016628$CELLTRION$$$$$$Y$$$20240715$$CN$GB$GB
240893451$24089345$1$I$$20240701$20240715$20240715$EXP$$US-SAMSUNG BIOEPIS-SB-2024-21324$SAMSUNG BIOEPIS$Dileep A. Primary Cutaneous Follicle Center Lymphoma (PCFCL) Arising in the Setting of Anti-TNF-Alpha Therapy. American Journal of Dermatopathology. 46(7):. doi:10.1097/DAD.0000000000002757$21$YR$A$M$Y$$$20240715$$HP$US$US
240893461$24089346$1$I$$20240711$20240715$20240715$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-13889$IPSEN$$$$$M$Y$$$20240715$$CN$GB$GB
240893472$24089347$2$F$$20240726$20240715$20240801$EXP$$FR-BIOCON BIOLOGICS LIMITED-BBL2024005108$BIOCON$$$$$$Y$$$20240801$$PH$FR$FR
240893483$24089348$3$F$$20240731$20240715$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06414$LUPIN$$$$$$Y$$$20240820$$PH$US$US
240893492$24089349$2$F$$20240917$20240715$20240927$EXP$$JP-009507513-2407JPN001578J$MERCK$Furukawa J, Tsukahara D. EP-0516 A study of eight cases of triple-negative breast cancer preoperatively treated with pembrolizumab. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 306$59$YR$$$Y$$$20240927$$MD$JP$JP
240893501$24089350$1$I$$20240705$20240715$20240715$EXP$$PL-AUROBINDO-AUR-APL-2024-033911$AUROBINDO$$33$YR$$F$Y$72$KG$20240715$$MD$PL$PL
240893551$24089355$1$I$20240603$20240705$20240715$20240715$EXP$FR-AFSSAPS-PP2024000704$FR-TEVA-VS-3218239$TEVA$$84$YR$$M$Y$65.3$KG$20240715$$PH$FR$FR
240893561$24089356$1$I$$20240704$20240715$20240715$EXP$$RO-ROCHE-3563755$ROCHE$$61$YR$A$F$Y$76$KG$20240715$$CN$RO$RO
240893571$24089357$1$I$20240429$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405081150567380-PJVCF$GB-TEVA-VS-3218668$TEVA$$29$YR$$F$Y$74$KG$20240715$$CN$GB$GB
240893581$24089358$1$I$$20240618$20240715$20240715$PER$$US-JNJFOC-20240648935$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$US$US
240893591$24089359$1$I$20230326$20240705$20240715$20240715$EXP$FR-AFSSAPS-PP2024000709$FR-TEVA-VS-3218237$TEVA$$97$YR$$M$Y$65$KG$20240715$$PH$FR$FR
240893601$24089360$1$I$$20240707$20240715$20240715$EXP$$IT-JNJFOC-20240721635$JOHNSON AND JOHNSON$$$$A$$Y$$$20240715$$MD$IT$IT
240893611$24089361$1$I$20230101$20240709$20240715$20240715$EXP$CH-SM-2024-13707$CH-SA-2024SA203594$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240715$$PH$CH$CH
240893621$24089362$1$I$$20240710$20240715$20240715$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-13796$IPSEN$$$$$F$Y$$$20240715$$CN$GB$GB
240893631$24089363$1$I$$20240715$20240715$20240715$EXP$$CZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039696$BOEHRINGER INGELHEIM$Oulehle K, Vachek J. Malnutrice u pacientu s chronickym onemocnenim ledvin. Postgradualni nefrologie. 2024;22(2): 13-16.$74$YR$E$M$Y$$$20240715$$MD$CZ$CZ
240893641$24089364$1$I$$20240705$20240715$20240715$EXP$$GB-TEVA-VS-3218977$TEVA$$12$YR$$M$Y$$$20240715$$HP$GB$GB
240893651$24089365$1$I$$20240701$20240715$20240715$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109386$ZYDUS PHARM$Prabhu S, Malempati S, Markowitz D.. Amlodipine: Not an Ace in the Hole.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240715$$HP$US$US
240893661$24089366$1$I$$20240701$20240715$20240715$EXP$FR-AFSSAPS-MP2024001059$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109346$ZYDUS PHARM$$$$$$Y$$$20240715$$MD$FR$FR
240893671$24089367$1$I$$20240708$20240715$20240715$EXP$$US-GSK-US2024AMR085755$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$US$US
240893681$24089368$1$I$$20240705$20240715$20240715$30DAY$$US-GSK-US2024084038$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
240893691$24089369$1$I$20240118$20240701$20240715$20240715$EXP$FR-AFSSAPS-AVMA2024000256$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109280$ZYDUS PHARM$$$$$$Y$$$20240715$$PH$FR$FR
240893701$24089370$1$I$$20240701$20240715$20240715$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109387$ZYDUS PHARM$Bhatia S, Jamil A, Sharif M, Skenderi S.. Cardiovascular Collapse Shortly After Beta Blockers in Atrial Fibrillationcomplicated Thyroid Storm.. Am-J-Respir-Crit-Care-Med. 2024;209:A3637$$$$$Y$$$20240715$$HP$US$US
240893711$24089371$1$I$20240510$20240703$20240715$20240715$EXP$$FR-ROCHE-10000022552$ROCHE$$64$YR$A$F$Y$$$20240715$$MD$FR$FR
240893721$24089372$1$I$20240101$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111395$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240715$$CN$US$US
240893731$24089373$1$I$20240710$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138589$AMGEN$$72$YR$E$F$Y$$$20240715$$CN$US$US
240893741$24089374$1$I$20240702$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033702$AUROBINDO$$85$YR$$F$Y$$$20240715$$PH$GB$GB
240893751$24089375$1$I$20240711$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138781$AMGEN$$60$YR$A$M$Y$$$20240715$$CN$US$US
240893761$24089376$1$I$$20240705$20240715$20240715$EXP$$GR-CELLTRION INC.-2024GR016733$CELLTRION$$$$$$Y$$$20240715$$MD$GR$GR
240893773$24089377$3$F$$20240808$20240715$20240821$EXP$$FR-AUROBINDO-AUR-APL-2024-034145$AUROBINDO$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique. 2023;35:376-394$55$YR$$M$Y$$$20240821$$MD$FR$FR
240893781$24089378$1$I$$20240711$20240715$20240715$EXP$$NVSC2024US144606$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240893791$24089379$1$I$20240701$20240710$20240715$20240715$EXP$$EG-SA-2024SA204552$SANOFI AVENTIS$$48$YR$A$F$Y$70$KG$20240715$$HP$EG$EG
240893801$24089380$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405161632105600-RFYBT$GB-TEVA-VS-3218835$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240893811$24089381$1$I$20220101$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034129$AUROBINDO$$72$YR$$M$Y$64$KG$20240715$$CN$GB$GB
240893821$24089382$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000025701$ROCHE$$$$$$Y$$$20240715$$MD$US$US
240893832$24089383$2$F$$20240729$20240715$20240808$30DAY$$US-GSK-US2024084033$GLAXOSMITHKLINE$$$$$M$Y$$$20240808$$CN$US$US
240893841$24089384$1$I$20240522$20240704$20240715$20240715$EXP$SE-SEMPA-2024-004579$SE-ROCHE-10000016553$ROCHE$$76$YR$E$M$Y$$$20240715$$MD$SE$SE
240893852$24089385$2$F$20221111$20240903$20240715$20240905$EXP$$US-UCBSA-2024035470$UCB$$60$YR$$M$Y$$$20240905$$HP$US$US
240893861$24089386$1$I$$20240630$20240715$20240715$EXP$$US-CPL-004434$CADILA$Al-Moussally F, Thompson B M, Masarweh O M, et al. (May 25, 2024) Atorvastatin-Associated Eosinophilic Spongiosis: A Case Report and a Relevant Literature Review of Dermatological Manifestations. Cureus 16(5): e61071$73$YR$E$M$Y$$$20240715$$HP$US$US
240893871$24089387$1$I$$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033875$AUROBINDO$$$$$M$Y$$$20240715$$CN$GB$GB
240893881$24089388$1$I$$20240708$20240715$20240715$EXP$$US-GSK-US2024AMR085759$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$US$US
240893891$24089389$1$I$20240501$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111734$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240715$$CN$US$US
240893901$24089390$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145324$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240893911$24089391$1$I$$20240711$20240715$20240715$PER$$NVSC2024US145253$NOVARTIS$$$$$$Y$$$20240715$$MD$US$US
240893921$24089392$1$I$20240101$20240712$20240715$20240715$PER$$US-ABBVIE-5838660$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240893931$24089393$1$I$20240622$20240705$20240715$20240715$EXP$CN-NMPACDR-3302121039157202400307$CN-BAXTER-2024BAX021366$BAXTER$$54$YR$$M$Y$70$KG$20240715$$MD$CN$CN
240893941$24089394$1$I$20240327$20240705$20240715$20240715$EXP$FR-AFSSAPS-TO2024001134$FR-BAXTER-2024BAX021196$BAXTER$$77$YR$$M$Y$88$KG$20240715$$PH$FR$FR
240893951$24089395$1$I$20240418$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033445$AUROBINDO$$33$YR$$F$Y$83$KG$20240715$$CN$GB$GB
240893961$24089396$1$I$20240417$20240710$20240715$20240715$PER$$US-TAKEDA-2024TUS070428$TAKEDA$$23$MON$$F$Y$8$KG$20240715$$HP$US$US
240893971$24089397$1$I$$20240702$20240715$20240715$EXP$$US-862174955-ML2024-03892$Unknown Manufacturer$Bjork ST, Chen E. Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series. Am J Respir Crit Care Med. 2024;(209):$76$YR$E$F$Y$$$20240715$$HP$US$US
240893981$24089398$1$I$$20240702$20240715$20240715$EXP$$US-862174955-ML2024-03883$Unknown Manufacturer$Bjork ST, Chen E. Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series. Am-J-Respir-Crit-Care-Med. 2024;209:$74$YR$E$F$Y$$$20240715$$HP$US$US
240893991$24089399$1$I$$20240702$20240715$20240715$EXP$$US-862174955-ML2024-03876$Unknown Manufacturer$Simpson M, Awuah KB, Patel D, Ogline O, Pratapneni S, Disilvio BE. Early Extra Corporeal Membrane Oxygenation (ECMO) and Esophagogastroduodenoscopy (EGD) Implementation: A Timely Intervention in a Patient With Extended-Release Bupropion Overdose. Am J Respir Crit Care Med. 2024 May 21;209:$41$YR$A$M$Y$$$20240715$$HP$US$US
240894001$24089400$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405141236543910-PFYNT$GB-862174955-ML2024-03918$Unknown Manufacturer$$$$$F$Y$69$KG$20240715$$HP$GB$GB
240894011$24089401$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405171305488340-NRGVL$GB-862174955-ML2024-03915$Unknown Manufacturer$$$$$F$Y$75$KG$20240715$$CN$GB$GB
240894021$24089402$1$I$$20240703$20240715$20240715$EXP$$US-862174955-ML2024-03872$Unknown Manufacturer$Al-Moussally F, Thompson BM, Masarweh OM, Shah N, Gaudi S, Restrepo J. Atorvastatin-Associated Eosinophilic Spongiosis: A Case Report and a Relevant Literature Review of Dermatological Manifestations. Cureus. 2024;16(5): 1-5. doi:10.7759/cureus.61071.$72$YR$E$M$Y$$$20240715$$MD$US$US
240894031$24089403$1$I$$20240702$20240715$20240715$EXP$$US-862174955-ML2024-03880$Unknown Manufacturer$Epler KE, Crouch DR, Nostrand KV. Serotonin- Like- Syndrome Resulting From Tranexamic Acid Applied to Airways During Flexible Bronchoscopy. American Journal of Respiratory and Critical Care Medicine. 2024;(209):$44$YR$A$M$Y$$$20240715$$HP$US$US
240894041$24089404$1$I$$20210817$20240715$20240715$PER$$CA-PFM-2021-08359$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240715$$MD$CA$CA
240894051$24089405$1$I$$20240702$20240715$20240715$EXP$$IR-862174955-ML2024-03875$Unknown Manufacturer$Shahbazi F, Shojaei L. Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases. Curr-Drug-Saf. 2024;$52$YR$A$F$Y$$$20240715$$HP$IR$IR
240894061$24089406$1$I$$20210817$20240715$20240715$PER$$CA-PFM-2021-08356$PIERRE FABRE MEDICAMENT$$46$YR$$M$Y$$$20240715$$MD$CA$CA
240894071$24089407$1$I$$20210817$20240715$20240715$PER$$CA-PFM-2021-08357$PIERRE FABRE MEDICAMENT$$25$YR$$F$Y$$$20240715$$MD$CA$CA
240894081$24089408$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405140857136860-LVHKT$GB-862174955-ML2024-03902$Unknown Manufacturer$$$$$F$Y$$$20240715$$HP$GB$GB
240894091$24089409$1$I$$20210817$20240715$20240715$PER$$CA-PFM-2021-08361$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240715$$MD$CA$CA
240894101$24089410$1$I$$20210817$20240715$20240715$PER$$CA-PFM-2021-08362$PIERRE FABRE MEDICAMENT$$39$YR$$M$Y$$$20240715$$MD$CA$CA
240894111$24089411$1$I$$20210817$20240715$20240715$PER$$CA-PFM-2021-08358$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240715$$MD$CA$CA
240894121$24089412$1$I$$20210817$20240715$20240715$PER$$CA-PFM-2021-08363$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240715$$MD$CA$CA
240894131$24089413$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09743$PIERRE FABRE MEDICAMENT$$45$YR$$F$Y$$$20240715$$MD$CA$CA
240894141$24089414$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09747$PIERRE FABRE MEDICAMENT$$31$YR$$F$Y$$$20240715$$MD$CA$CA
240894151$24089415$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09734$PIERRE FABRE MEDICAMENT$$25$YR$$F$Y$$$20240715$$MD$CA$CA
240894161$24089416$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09745$PIERRE FABRE MEDICAMENT$$33$YR$$F$Y$$$20240715$$MD$CA$CA
240894171$24089417$1$I$$20210817$20240715$20240715$PER$$CA-PFM-2021-08360$PIERRE FABRE MEDICAMENT$$45$YR$$M$Y$$$20240715$$MD$CA$CA
240894181$24089418$1$I$$20220316$20240715$20240715$PER$$CA-PFM-2021-09404$PIERRE FABRE MEDICAMENT$$62$YR$$M$Y$$$20240715$$MD$CA$CA
240894191$24089419$1$I$$20240710$20240715$20240715$PER$$US-TAKEDA-2024TUS071196$TAKEDA$$23$MON$$$Y$$$20240715$$HP$US$US
240894203$24089420$3$F$20240701$20240821$20240715$20240827$EXP$$CA-JNJFOC-20240727633$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240827$$HP$CA$CA
240894211$24089421$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09746$PIERRE FABRE MEDICAMENT$$24$YR$$F$Y$$$20240715$$MD$CA$CA
240894221$24089422$1$I$$20220316$20240715$20240715$PER$$CA-PFM-2021-09402$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240715$$MD$CA$CA
240894231$24089423$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09741$PIERRE FABRE MEDICAMENT$$25$YR$$F$Y$$$20240715$$MD$CA$CA
240894241$24089424$1$I$$20220316$20240715$20240715$PER$$CA-PFM-2021-09401$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240715$$MD$CA$CA
240894251$24089425$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09742$PIERRE FABRE MEDICAMENT$$60$YR$$F$Y$$$20240715$$MD$CA$CA
240894261$24089426$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09735$PIERRE FABRE MEDICAMENT$$30$YR$$F$Y$$$20240715$$MD$CA$CA
240894271$24089427$1$I$$20240709$20240715$20240715$EXP$$CA-UCBSA-2024035588$UCB$$6$MON$$M$Y$$$20240715$$HP$CA$CA
240894281$24089428$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09733$PIERRE FABRE MEDICAMENT$$19$YR$$F$Y$$$20240715$$MD$CA$CA
240894291$24089429$1$I$$20240708$20240715$20240715$EXP$$US-SA-2024SA203518$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240715$$MD$US$US
240894301$24089430$1$I$$20190815$20240715$20240715$EXP$$CA-AstraZeneca-2019SF18485$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$CA$
240894312$24089431$2$F$$20240712$20240715$20240716$PER$$NVSC2024US145331$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240894321$24089432$1$I$$20190729$20240715$20240715$EXP$$US-AstraZeneca-2019SF10033$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$US$
240894331$24089433$1$I$20181023$20190809$20240715$20240715$EXP$$RU-AstraZeneca-2019SF16347$ASTRAZENECA$$58$YR$$M$Y$83$KG$20240715$$CN$RU$
240894341$24089434$1$I$$20200408$20240715$20240715$EXP$$US-AstraZeneca-2020SE49336$ASTRAZENECA$$63$YR$$F$Y$$$20240715$$CN$US$
240894352$24089435$2$F$20240101$20240729$20240715$20240805$EXP$$US-SA-2024SA204775$SANOFI AVENTIS$$57$YR$A$F$Y$65.77$KG$20240805$$MD$US$US
240894361$24089436$1$I$$20190805$20240715$20240715$EXP$$US-AstraZeneca-2019SF13339$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
240894371$24089437$1$I$$20190729$20240715$20240715$EXP$$RU-AstraZeneca-2019SF10747$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$RU$
240894391$24089439$1$I$$20240710$20240715$20240715$EXP$$ZA-AstraZeneca-2024A159368$ASTRAZENECA$$83$YR$$F$Y$$$20240715$$HP$ZA$
240894401$24089440$1$I$20190519$20190808$20240715$20240715$EXP$$CO-AstraZeneca-2019SF15666$ASTRAZENECA$$21669$DY$$M$Y$$$20240715$$CN$CO$
240894411$24089441$1$I$20190806$20190813$20240715$20240715$EXP$$US-AstraZeneca-2019SF17521$ASTRAZENECA$$2475$WK$$F$Y$$$20240715$$CN$US$
240894421$24089442$1$I$20240601$20240709$20240715$20240715$PER$$US-SA-2024SA204111$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240715$$CN$US$US
240894431$24089443$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA203822$SANOFI AVENTIS$$$$$M$Y$$$20240715$$CN$US$US
240894441$24089444$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA202944$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240715$$MD$US$US
240894451$24089445$1$I$$20240702$20240715$20240715$PER$$CA-SA-2024SA196032$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240715$$CN$US$US
240894461$24089446$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA202026$SANOFI AVENTIS$$$$A$M$Y$$$20240715$$MD$US$US
240894471$24089447$1$I$20240629$20240701$20240715$20240715$EXP$GB-MHRA-MED-202407010145473670-FYPQD$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001679$IPCA$$$$$$Y$$$20240715$$CN$GB$GB
240894481$24089448$1$I$20210601$20210824$20240715$20240715$PER$FR-AFSSAPS-AVCN20211291$FR-PFM-2021-08563$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240715$$PH$FR$FR
240894491$24089449$1$I$$20210824$20240715$20240715$PER$$FR-PFM-2021-08657$PIERRE FABRE MEDICAMENT$$10$YR$$F$Y$$$20240715$$PH$FR$FR
240894501$24089450$1$I$$20210830$20240715$20240715$PER$$FR-PFM-2021-08757$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240715$$PH$FR$FR
240894511$24089451$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09749$PIERRE FABRE MEDICAMENT$$65$YR$$F$Y$$$20240715$$MD$CA$CA
240894521$24089452$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09750$PIERRE FABRE MEDICAMENT$$22$YR$$F$Y$$$20240715$$MD$CA$CA
240894531$24089453$1$I$20240705$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007822$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240715$$CN$US$US
240894551$24089455$1$I$20240704$20240708$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407005496$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240715$$CN$US$US
240894561$24089456$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007981$ELI LILLY AND CO$$45$YR$A$$Y$$$20240715$$CN$US$US
240894571$24089457$1$I$20210727$20210903$20240715$20240715$PER$FR-AFSSAPS-MP20216672$FR-PFM-2021-08884$PIERRE FABRE MEDICAMENT$$35$YR$$M$Y$60.7$KG$20240715$$PH$FR$FR
240894581$24089458$1$I$20240119$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008216$ELI LILLY AND CO$$43$YR$A$F$Y$81.633$KG$20240715$$CN$US$US
240894591$24089459$1$I$20230101$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008051$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240715$$CN$US$US
240894601$24089460$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09751$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240715$$MD$CA$CA
240894611$24089461$1$I$20210208$20211018$20240715$20240715$PER$$JP-PFM-2021-08743$PIERRE FABRE MEDICAMENT$$6$MON$$F$Y$8$KG$20240715$$MD$JP$JP
240894621$24089462$1$I$20240708$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139664$AMGEN$$85$YR$E$F$Y$$$20240715$$CN$US$US
240894631$24089463$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024139292$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240894641$24089464$1$I$20230101$20231010$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03588$AMNEAL$$$$$F$Y$$$20240715$$CN$US$US
240894651$24089465$1$I$$20240129$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00314$AMNEAL$$$$$F$Y$$$20240715$$CN$US$US
240894661$24089466$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09748$PIERRE FABRE MEDICAMENT$$41$YR$$M$Y$$$20240715$$MD$CA$CA
240894671$24089467$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09752$PIERRE FABRE MEDICAMENT$$54$YR$$F$Y$$$20240715$$MD$CA$CA
240894681$24089468$1$I$20201021$20230328$20240715$20240715$EXP$$DE-SANDOZ INC.-NVSC2020DE302222$SANDOZ$$44$YR$$F$Y$47.4$KG$20240715$$MD$DE$DE
240894691$24089469$1$I$$20230807$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02478$AMNEAL$$$$$F$Y$$$20240715$$CN$US$US
240894701$24089470$1$I$$20240709$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01464$AMNEAL$$$$$F$Y$$$20240715$$CN$US$US
240894711$24089471$1$I$$20230626$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02277$AMNEAL$$$$$F$Y$$$20240715$$CN$US$US
240894721$24089472$1$I$$20230728$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02573$AMNEAL$$55$YR$$F$Y$$$20240715$$CN$US$US
240894731$24089473$1$I$$20230718$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02209$AMNEAL$$$$$F$Y$$$20240715$$PH$US$US
240894741$24089474$1$I$20240321$20240509$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00981$AMNEAL$$61$YR$$F$Y$64.399$KG$20240715$$CN$US$US
240894751$24089475$1$I$$20240322$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00525$AMNEAL$$$$$F$Y$$$20240715$$CN$US$US
240894761$24089476$1$I$20231001$20240115$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00048$AMNEAL$$57$YR$$F$Y$63.492$KG$20240715$$CN$US$US
240894771$24089477$1$I$$20231215$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03350$AMNEAL$$$$$$Y$$$20240715$$CN$US$US
240894781$24089478$1$I$$20230814$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03256$AMNEAL$$$$$F$Y$$$20240715$$CN$US$US
240894791$24089479$1$I$$20240216$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00042$AMNEAL$$$$$F$Y$$$20240715$$PH$US$US
240894801$24089480$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144405$NOVARTIS$$$$$$Y$$$20240715$$CN$US$US
240894811$24089481$1$I$$20210707$20240715$20240715$PER$$DE-PFM-2021-08920$PIERRE FABRE MEDICAMENT$$47$MON$$M$Y$$$20240715$$MD$DE$DE
240894821$24089482$1$I$20230101$20240711$20240715$20240715$EXP$$NVSC2024BR144746$NOVARTIS$$$$$F$Y$$$20240715$$CN$BR$BR
240894831$24089483$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145328$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240894841$24089484$1$I$20170628$20210909$20240715$20240715$PER$$JP-PFM-2021-09251$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240715$$MD$JP$JP
240894851$24089485$1$I$20170403$20210909$20240715$20240715$PER$$JP-PFM-2021-09243$PIERRE FABRE MEDICAMENT$$45$MON$$M$Y$$$20240715$$MD$JP$JP
240894861$24089486$1$I$20191031$20210909$20240715$20240715$PER$$JP-PFM-2021-09232$PIERRE FABRE MEDICAMENT$$4$MON$$F$Y$$$20240715$$MD$JP$JP
240894871$24089487$1$I$20210901$20210902$20240715$20240715$PER$$DE-PFM-2021-08905$PIERRE FABRE MEDICAMENT$$2$YR$$M$Y$13$KG$20240715$$HP$DE$DE
240894881$24089488$1$I$20170419$20210909$20240715$20240715$PER$$JP-PFM-2021-09242$PIERRE FABRE MEDICAMENT$$13$MON$$F$Y$$$20240715$$MD$JP$JP
240894891$24089489$1$I$20210910$20210913$20240715$20240715$PER$$FR-PFM-2021-09127$PIERRE FABRE MEDICAMENT$$9$MON$$M$Y$$$20240715$$CN$FR$FR
240894901$24089490$1$I$20210408$20210913$20240715$20240715$PER$FR-AFSSAPS-GR20213736$FR-PFM-2021-09160$PIERRE FABRE MEDICAMENT$$$$I$F$Y$6$KG$20240715$$PH$FR$FR
240894911$24089491$1$I$20210908$20210911$20240715$20240715$PER$$FR-PFM-2021-09099$PIERRE FABRE MEDICAMENT$$$$I$F$Y$$$20240715$$CN$FR$FR
240894921$24089492$1$I$$20210930$20240715$20240715$PER$$JP-PFM-2021-09254$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240715$$MD$JP$JP
240894931$24089493$1$I$$20211008$20240715$20240715$PER$$JP-PFM-2021-08975$PIERRE FABRE MEDICAMENT$$5$MON$$$Y$$$20240715$$PH$JP$JP
240894941$24089494$1$I$$20240711$20240715$20240715$PER$$US-TAKEDA-2024TUS070970$TAKEDA$$$$E$F$Y$$$20240715$$CN$US$US
240894951$24089495$1$I$20210405$20210914$20240715$20240715$PER$FR-AFSSAPS-LY20219808$FR-PFM-2021-09162$PIERRE FABRE MEDICAMENT$$62$YR$$M$Y$64$KG$20240715$$MD$FR$FR
240894962$24089496$2$F$$20240709$20240715$20240721$EXP$$JP-INSMED, INC.-2024-02729-JP$INSMED$$81$YR$$F$Y$$$20240719$$HP$JP$JP
240894971$24089497$1$I$$20240621$20240715$20240715$PER$$US-BEH-2024174691$CSL BEHRING$$65$YR$E$M$Y$$$20240715$$CN$US$US
240894992$24089499$2$F$20240312$20240708$20240715$20240717$EXP$$US-CHATTEMPRD-2024OHG023599$CHATTEM$$66$YR$E$$Y$$$20240717$$LW$US$US
240895011$24089501$1$I$$20210920$20240715$20240715$PER$$FR-PFM-2021-09414$PIERRE FABRE MEDICAMENT$$1$YR$$M$Y$$$20240715$$MD$FR$FR
240895021$24089502$1$I$$20240624$20240715$20240715$PER$$US-JNJFOC-20240669829$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240895033$24089503$3$F$20240709$20240911$20240715$20240918$EXP$$JP-JNJFOC-20240731554$JOHNSON AND JOHNSON$$73$YR$E$F$Y$40$KG$20240918$$MD$JP$JP
240895041$24089504$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA201059$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240715$$MD$US$US
240895051$24089505$1$I$$20210920$20240715$20240715$PER$$FR-PFM-2021-09674$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$$$20240715$$MD$FR$FR
240895061$24089506$1$I$$20210928$20240715$20240715$PER$$CA-PFM-2021-09736$PIERRE FABRE MEDICAMENT$$53$YR$$F$Y$$$20240715$$HP$CA$CA
240895071$24089507$1$I$$20211014$20240715$20240715$PER$$JP-PFM-2021-09726$PIERRE FABRE MEDICAMENT$$$$I$F$Y$$$20240715$$MD$JP$JP
240895081$24089508$1$I$20210101$20211207$20240715$20240715$PER$$JP-PFM-2021-09408$PIERRE FABRE MEDICAMENT$$$$$F$Y$6$KG$20240715$$PH$JP$JP
240895091$24089509$1$I$$20211014$20240715$20240715$PER$$JP-PFM-2021-09729$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240715$$MD$JP$JP
240895101$24089510$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145340$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240895112$24089511$2$F$$20240710$20240715$20240717$EXP$$US-CHATTEMPRD-2024OHG023816$CHATTEM$$$$$M$Y$$$20240717$$LW$US$US
240895121$24089512$1$I$20190121$20210909$20240715$20240715$PER$$JP-PFM-2021-09252$PIERRE FABRE MEDICAMENT$Matsushita Y. Evaluation of therapeutic effect of oral Hemangiol therapy for infantile haemangioma. The 64th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery. 2021$0$YR$$F$Y$$$20240715$$MD$JP$JP
240895131$24089513$1$I$$20210823$20240715$20240715$PER$$CA-PFM-2021-08482$PIERRE FABRE MEDICAMENT$Alexander K. C. Leung, Kin Fon Leong, Joseph M Lam. An ulcerated giant segmental hemangioma resulting in contracture of the left elbow. Paediatrics + Child Health. 2021;26:e70-e72$4$MON$$M$Y$$$20240715$$HP$CA$CO
240895141$24089514$1$I$$20210902$20240715$20240715$PER$$FR-PFM-2021-08838$PIERRE FABRE MEDICAMENT$Asselah T, Loureiro D, Le Gal F, Narguet S, Brichler S, Bouton V et al. Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real-life. Liver international. 2021;41:1509-1517$53$YR$$M$Y$$$20240715$$HP$FR$FR
240895151$24089515$1$I$20210926$20210929$20240715$20240715$PER$$RU-PFM-2021-09753$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$$$20240715$$MD$RU$RU
240895161$24089516$1$I$20240603$20240704$20240715$20240715$EXP$FR-AFSSAPS-PP2024000704$FR-INSMED, INC.-2024-02751-FR$INSMED$$84$YR$$M$Y$65.3$KG$20240715$$PH$FR$FR
240895171$24089517$1$I$$20210921$20240715$20240715$PER$$TR-PFM-2021-09372$PIERRE FABRE MEDICAMENT$Bostan H. U?an B. Kizilg?l M. D?ger H. Akhanli P, Cakal E. A rare presentation of Graves^ disease: bilateral pitting edema of the legs. Journal of Medicine Palliative Care. 2021;2:95-97$35$YR$$F$Y$$$20240715$$HP$TR$TR
240895181$24089518$1$I$$20210930$20240715$20240715$PER$$JP-PFM-2021-10030$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240715$$MD$JP$JP
240895191$24089519$1$I$$20210930$20240715$20240715$PER$$JP-PFM-2021-10018$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240715$$MD$JP$JP
240895201$24089520$1$I$$20240221$20240715$20240715$EXP$NL-LRB-00944075$NL-TEVA-VS-3162746$TEVA$$33$YR$$F$Y$80$KG$20240715$$CN$NL$NL
240895211$24089521$1$I$$20210922$20240715$20240715$PER$$SK-PFM-2021-09441$PIERRE FABRE MEDICAMENT$Necpal J, Zech M, Winkelmann J, Jech R. Trisomy X syndrome with dystonia and a pathogenic SATB1 variant. Neurological Sciences. 2021;42:3883-4$18$YR$$F$Y$$$20240715$$HP$SK$SK
240895221$24089522$1$I$$20210924$20240715$20240715$PER$$AT-PFM-2021-09395$PIERRE FABRE MEDICAMENT$Gasparella P, Singer G, Arneitz C, Benesch M, Sorantin E, Kampelm?hler E et al. Rapidly involuting congenital hemangioma of the liver in a newborn with incomplete Pentalogy of Cantrell: description of a new association. Journal of Surgical Case Reports. 2021;3:1-3$59$DY$$M$Y$$$20240715$$MD$AT$AT
240895231$24089523$1$I$$20210927$20240715$20240715$PER$$IT-PFM-2021-09651$PIERRE FABRE MEDICAMENT$Moscatelli S, Trocchio G, Stagnaro N, Derchi M, Tuo G, et al. An unexpected case of pediatric myocardial ischemia. European Heart Journal. 2019;J84-J85$9$YR$$F$Y$$$20240715$$HP$IT$IT
240895251$24089525$1$I$$20240701$20240715$20240715$EXP$GB-MHRA-MED-202406291352445690-FRSGZ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14643$ALKEM$$$$$M$Y$$$20240715$$CN$GB$GB
240895261$24089526$1$I$$20240701$20240715$20240715$EXP$GB-MHRA-MED-202406291149288680-KLQWZ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14630$ALKEM$$$$$M$Y$78$KG$20240715$$CN$GB$GB
240895271$24089527$1$I$$20240701$20240715$20240715$EXP$GB-MHRA-MED-202406291148076400-HYSNB$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14727$ALKEM$$$$$M$Y$78$KG$20240715$$CN$GB$GB
240895281$24089528$1$I$$20240701$20240715$20240715$EXP$GB-MHRA-MED-202406291145190840-GJMRH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14722$ALKEM$$$$$M$Y$$$20240715$$CN$GB$GB
240895291$24089529$1$I$$20240701$20240715$20240715$EXP$GB-MHRA-MED-202406291146576770-GMFCW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14724$ALKEM$$$$$$Y$78$KG$20240715$$CN$GB$GB
240895301$24089530$1$I$$20240701$20240715$20240715$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14564$ALKEM$Osmanodja B et al.. Donor-Derived Cell-Free DNA for Diagnosis and Monitoring of Antibody Mediated Rejection after Kidney Transplantation. Transfusionsmedizin. 2023;13 (04):196-200$49$YR$$$Y$$$20240715$$MD$DE$DE
240895312$24089531$2$F$$20240717$20240715$20240731$EXP$US-MLMSERVICE-20240627-PI109357-00232-4$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14734$ALKEM$Sharma P, Tahiru M, Li H, Bansari A, Baskaran N.. A case of ocular diffuse large B-cell lymphoma unveiled through Pars Plana Vitrectomy: surgical insight and multidisciplinary management. Journal of Surgical Case Reports. 2024;2024(6):rjae399$74$YR$$M$Y$$$20240731$$MD$US$US
240895321$24089532$1$I$20240509$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405171234445070-ZJYPQ$GB-TEVA-VS-3218854$TEVA$$39$YR$$M$Y$$$20240715$$MD$GB$GB
240895332$24089533$2$F$20240710$20240820$20240715$20240821$PER$$US-JNJFOC-20240728163$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$MD$US$US
240895341$24089534$1$I$$20210929$20240715$20240715$PER$$FR-PFM-2021-09977$PIERRE FABRE MEDICAMENT$Borius P-Y, Valade D. A new treatment option for child with refractory chronic paroxysmal hemicranias: occipital nerve stimulation. Pediatric Neurology. 2021$13$YR$$F$Y$$$20240715$$MD$FR$FR
240895352$24089535$2$F$$20240717$20240715$20240731$EXP$TW-MLMSERVICE-20240624-PI107138-00030-1$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-14729$ALKEM$Chang-Chieh L, Shen-Han C, Yu-Han F, Chi-Ta H. Eczema herpeticum in an immunocompetent man. Diagnostic Microbiology and Infectious Disease. 2024;110(1):116304$40$YR$$M$Y$$$20240731$$MD$TW$TW
240895361$24089536$1$I$$20240711$20240715$20240715$PER$$US-JNJFOC-20240504398$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240715$$MD$US$US
240895372$24089537$2$F$$20240729$20240715$20240807$EXP$PT-INFARMED-V202406-672$PT-TEVA-VS-3218221$TEVA$$82$YR$$F$Y$$$20240807$$PH$PT$PT
240895381$24089538$1$I$$20240701$20240715$20240715$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-001731$IPCA$Maria Menezes, Vwaire Orhurhu, Raissa Quezado, et al. Hematoma after a fluoroscopically guided sacroiliac joint injection: a case report. Pain Medicine Case Reports. 2021;5(2):63-66$$$$$Y$$$20240715$$MD$US$US
240895391$24089539$1$I$20240310$20240705$20240715$20240715$EXP$FR-AFSSAPS-AVMA2024000275$FR-TEVA-VS-3218247$TEVA$$31$YR$$F$Y$$$20240715$$PH$FR$FR
240895431$24089543$1$I$$20240708$20240715$20240715$EXP$$US-ROCHE-10000020369$ROCHE$$$$$$Y$$$20240715$$CN$US$US
240895442$24089544$2$F$$20240801$20240715$20240802$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06504$LUPIN$$$$$$Y$$$20240802$$CN$US$US
240895483$24089548$3$F$$20240820$20240715$20240827$EXP$$CA-GSK-CA2024084926$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$CA$CA
240895491$24089549$1$I$20240419$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405071334285430-VTKJN$GB-TEVA-VS-3218316$TEVA$$37$YR$$F$Y$58$KG$20240715$$PH$GB$GB
240895501$24089550$1$I$$20240709$20240715$20240715$EXP$$JP-TAKEDA-2024TUS071107$TAKEDA$$$$E$$Y$$$20240715$$MD$JP$JP
240895511$24089551$1$I$20230101$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024137649$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240895521$24089552$1$I$$20240701$20240715$20240715$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06185$HIKMA$Aslam Khan A, Anwar MS, Cherukuri PB, Abu-Shanab A, Fish PN.. Aslam Khan A, Anwar MS, Cherukuri PB, Abu-Shanab A, Fish PN. Community-Acquired Meningitis Complicated With Pyogenic Ventriculitis and Hydrocephalus in a Patient With Haematological Malignancy: A Case Report and Literature Review. Cureus. 2024;2024;16(5):1-7$85$YR$$F$Y$$$20240715$$MD$US$US
240895532$24089553$2$F$20240705$20240807$20240715$20240808$30DAY$$US-AMGEN-USASP2024135549$AMGEN$$79$YR$E$F$Y$$$20240808$$PH$US$US
240895541$24089554$1$I$$20240710$20240715$20240715$EXP$$DE-ASTELLAS-2024US019827$ASTELLAS$$$$$M$Y$$$20240715$$PH$DE$DE
240895551$24089555$1$I$20240216$20240705$20240715$20240715$EXP$IT-MINISAL02-992628$IT-TEVA-VS-3218135$TEVA$$42$YR$$F$Y$$$20240715$$MD$IT$IT
240895561$24089556$1$I$20230622$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405061547088210-QNHVK$GB-TEVA-VS-3218722$TEVA$$0$DY$$M$Y$1$KG$20240715$$CN$GB$GB
240895571$24089557$1$I$20240101$20240711$20240715$20240715$EXP$$CA-UCBSA-2024035533$UCB$$$$$F$Y$$$20240715$$CN$CA$CA
240895582$24089558$2$F$$20240805$20240715$20240806$PER$$US-ALXN-202407USA000605US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240895591$24089559$1$I$$20240710$20240715$20240715$EXP$$CA-TAKEDA-2024TUS070747$TAKEDA$$$$$M$Y$$$20240715$$CN$CA$CA
240895601$24089560$1$I$$20240711$20240715$20240715$EXP$$CA-JNJFOC-20240733284$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$HP$CA$CA
240895611$24089561$1$I$$20210423$20240715$20240715$EXP$$PL-AstraZeneca-2021A351615$ASTRAZENECA$$$$$$Y$$$20240715$$MD$PL$
240895621$24089562$1$I$$20200428$20240715$20240715$EXP$$US-AstraZeneca-2020SE52060$ASTRAZENECA$$$$$M$Y$50.8$KG$20240715$$CN$US$
240895631$24089563$1$I$20190101$20190812$20240715$20240715$EXP$$US-AstraZeneca-2019SF16928$ASTRAZENECA$$505$MON$$M$Y$$$20240715$$CN$US$
240895641$24089564$1$I$$20190924$20240715$20240715$EXP$$IT-AstraZeneca-2019SF38592$ASTRAZENECA$$$$$$Y$$$20240715$$MD$IT$
240895651$24089565$1$I$20180801$20190819$20240715$20240715$EXP$$US-AstraZeneca-2019SF20483$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
240895661$24089566$1$I$20190619$20190808$20240715$20240715$EXP$$CO-AstraZeneca-2019SF15788$ASTRAZENECA$$26385$DY$$M$Y$$$20240715$$CN$CO$
240895671$24089567$1$I$$20240705$20240715$20240715$30DAY$$US-GSK-US2024084068$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
240895681$24089568$1$I$20160814$20190814$20240715$20240715$EXP$$MX-AstraZeneca-2019SF18115$ASTRAZENECA$$22210$DY$$M$Y$68$KG$20240715$$CN$MX$
240895691$24089569$1$I$20181128$20190817$20240715$20240715$EXP$$RU-AstraZeneca-2019SF19472$ASTRAZENECA$$71$YR$$F$Y$78$KG$20240715$$CN$RU$
240895701$24089570$1$I$20190820$20190821$20240715$20240715$EXP$$US-AstraZeneca-2019SF20827$ASTRAZENECA$$29773$DY$$M$Y$$$20240715$$HP$US$
240895711$24089571$1$I$20190601$20191029$20240715$20240715$EXP$$BR-AstraZeneca-2019SF17099$ASTRAZENECA$$3309$WK$$F$Y$$$20240715$$CN$BR$
240895721$24089572$1$I$$20240708$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110971$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240715$$CN$US$US
240895731$24089573$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111793$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240715$$CN$US$US
240895751$24089575$1$I$$20240701$20240715$20240715$EXP$$US-VKT-000553$VKT PHARMA PRIVATE LIMITED$$22$DY$N$M$Y$$$20240703$$MD$US$US
240895761$24089576$1$I$$20240701$20240715$20240715$EXP$$US-VKT-000551$VKT PHARMA PRIVATE LIMITED$$2$DY$N$M$Y$$$20240703$$MD$US$US
240895771$24089577$1$I$$20240701$20240715$20240715$EXP$$US-VKT-000554$VKT PHARMA PRIVATE LIMITED$$1$DY$N$F$Y$$$20240703$$MD$US$US
240895781$24089578$1$I$$20240701$20240715$20240715$EXP$$US-VKT-000550$VKT PHARMA PRIVATE LIMITED$$1$DY$N$F$Y$$$20240703$$MD$US$US
240895791$24089579$1$I$20240219$20240626$20240715$20240715$PER$$US-ABBVIE-5836785$ABBVIE$$39$YR$$F$Y$$$20240715$$CN$US$US
240895801$24089580$1$I$20240419$20240512$20240715$20240715$EXP$$KW-ULTRAGENYX PHARMACEUTICAL INC.-KW-UGX-24-00945$ULTRAGENYX PHARMACEUTICAL$$21$YR$$F$Y$$$20240715$$MD$KW$KW
240895811$24089581$1$I$$20240701$20240715$20240715$EXP$$US-VKT-000552$VKT PHARMA PRIVATE LIMITED$$1$DY$N$F$Y$$$20240703$$MD$US$US
240895821$24089582$1$I$$20240703$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010329$DR REDDYS$Berry M, Wang AM, Lahham RF, Zhang X, Pacheco LD. Ischemic Hepatitis and Septic Shock Secondary to Murine Typhus Infection in Pregnancy. AJP Reports. 2024 Jun 10;14(2): E185-E187. doi:10.1055/a-2330-4249.$$$N$$Y$$$20240715$$MD$US$US
240895831$24089583$1$I$20240101$20240712$20240715$20240715$PER$$US-JNJFOC-20240733108$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240715$$CN$US$US
240895843$24089584$3$F$$20240709$20240715$20240724$30DAY$$US-JNJFOC-20240731596$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$HP$US$US
240895854$24089585$4$F$20240620$20240909$20240715$20240909$PER$$US-AMGEN-USASP2024139661$AMGEN$$89$YR$E$F$Y$$$20240909$$CN$US$US
240895862$24089586$2$F$$20240711$20240715$20240718$PER$$US-AMGEN-USASP2024139245$AMGEN$$$$A$F$Y$$$20240717$$CN$US$US
240895881$24089588$1$I$20240501$20240708$20240715$20240715$EXP$$US-SA-2024SA204062$SANOFI AVENTIS$$64$YR$A$M$Y$81.64$KG$20240715$$MD$US$US
240895891$24089589$1$I$$20240703$20240715$20240715$EXP$$US-MYLANLABS-2024M1064010$MYLAN$Matthews BJ, Froehlich A, Goicochea L, Levinson K. Postmenopausal mixed gestational trophoblastic neoplasia with complete response to immunotherapy - A case report. Gynecol-Oncol-Rep 2023; 46.$66$YR$$F$Y$$$20240715$$HP$US$US
240895901$24089590$1$I$$20240703$20240715$20240715$EXP$$IT-MYLANLABS-2024M1064077$MYLAN$Sorvillo G, Olivieri F, Rainone A, Quercia E, Violante A, Mazza A, et al. A very complex clinical case of acute coronary syndrome complicated by thrombosis and intracranial haemorrhage. Eur-Heart-J-Suppl 2024; 26 (Suppl. 2) ii127.$62$YR$$F$Y$$$20240715$$HP$IT$IT
240895911$24089591$1$I$20240618$20240701$20240715$20240715$EXP$$GB-MYLANLABS-2024M1065405$MYLAN$$86$YR$$F$Y$$$20240715$$MD$GB$GB
240895921$24089592$1$I$$20240702$20240715$20240715$EXP$$US-MYLANLABS-2024M1063729$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$52$YR$$F$Y$$$20240715$$HP$US$US
240895932$24089593$2$F$20240101$20240730$20240715$20240731$EXP$$NVSC2024DE144509$NOVARTIS$$$$A$M$Y$70$KG$20240731$$MD$DE$DE
240895941$24089594$1$I$$20240702$20240715$20240715$EXP$$US-MYLANLABS-2024M1063749$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$64$YR$$M$Y$$$20240715$$HP$US$US
240895951$24089595$1$I$$20240702$20240715$20240715$EXP$$US-MYLANLABS-2024M1063735$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$19$YR$$F$Y$$$20240715$$HP$US$US
240895961$24089596$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007816$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240715$$CN$US$US
240895971$24089597$1$I$20240601$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407006209$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240715$$CN$US$US
240895981$24089598$1$I$20240705$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007302$ELI LILLY AND CO$$44$YR$A$$Y$$$20240715$$CN$US$US
240895991$24089599$1$I$20220101$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007323$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240715$$CN$US$US
240896001$24089600$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008154$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240715$$CN$US$US
240896011$24089601$1$I$$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007028$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240715$$CN$US$US
240896022$24089602$2$F$20240514$20240717$20240715$20240718$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-111510$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240718$$HP$CH$CH
240896031$24089603$1$I$$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111035$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240715$$CN$US$US
240896041$24089604$1$I$20240701$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110890$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240715$$HP$US$US
240896051$24089605$1$I$$20240620$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-100461$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240715$$HP$US$US
240896071$24089607$1$I$20220101$20240712$20240715$20240715$EXP$FR-AFSSAPS-RS2024000688$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-111327$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$58$KG$20240715$$PH$FR$FR
240896081$24089608$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111388$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240715$$CN$US$US
240896092$24089609$2$F$$20240723$20240715$20240802$EXP$$ES-TEVA-VS-3217464$TEVA$Melgosa Ramos FJ, Garcia Ruiz R, Mateu Puchades A. Olmesartan Associated Enteropathy as an Inflammatory Bowel Disease Mimicker in a Patient With Hidradenitis Suppurativa. Actas-Dermosifiliogr 2024; 115 (6): 607-608.; Melgosa Ramos FJ, Garcia Ruiz R, Mateu Puchades A. Olmesartan Associated Enteropathy as an Inflammatory Bowel Disease Mimicker in a Patient With Hidradenitis Suppurativa. Actas-Dermosifiliogr 2024; 115 (6): 607-608.$65$YR$$M$Y$$$20240802$$HP$ES$ES
240896101$24089610$1$I$20231122$20240701$20240715$20240715$EXP$FR-AFSSAPS-AVNY2024000165$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109269$ZYDUS PHARM$$$$$$Y$$$20240715$$MD$FR$FR
240896111$24089611$1$I$$20240703$20240715$20240715$EXP$$CN-PADAGIS-2024PAD01122$PADAGIS$Luo S., Yan P., Wang X., Ren X., Sun K., Guo L.,et.al. Talaromyces marneffei: A challenging diagnosis in a kidney transplant patient. Clinical Case Reports. 2024;12(7):e9028$$$$$Y$$$20240715$$HP$CN$CN
240896122$24089612$2$F$$20240802$20240715$20240806$EXP$$CA-ABBVIE-5835860$ABBVIE$$$$E$M$Y$$$20240806$$CN$CA$CA
240896131$24089613$1$I$20240101$20240707$20240715$20240715$PER$$US-SA-2024SA203694$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240715$$MD$US$US
240896141$24089614$1$I$20240101$20240705$20240715$20240715$PER$$US-SA-2024SA201582$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240715$$MD$US$US
240896151$24089615$1$I$$20240702$20240715$20240715$EXP$GB-MHRA-MED-202407020643199960-VMKHF$GB-MACLEODS PHARMA-MAC2024048113$MACLEODS$$$$$$Y$$$20240715$$CN$GB$GB
240896171$24089617$1$I$$20240703$20240715$20240715$EXP$$US-MACLEODS PHARMA-MAC2024048133$MACLEODS$Khan MS, Ahmed O, Nwaedozie S.Anaconda Right Coronary Artery. Arteriosclerosis.Arteriosclerosis, Thrombosis, and Vascular Biology.2023;43(Suppl 1)$$$$$Y$$$20240715$$MD$US$US
240896181$24089618$1$I$20191101$20240704$20240715$20240715$EXP$GB-MHRA-MED-202404301931392500-MGPHN$GB-MACLEODS PHARMA-MAC2024048139$MACLEODS$$$$$$Y$$$20240715$$CN$GB$GB
240896191$24089619$1$I$$20240711$20240715$20240715$EXP$$CA-UCBSA-2024015258$UCB$$$$$F$Y$$$20240715$$CN$CA$CA
240896201$24089620$1$I$$20240703$20240715$20240715$EXP$GB-MHRA-DEFECT-202406221311545970-BHSNJ$GB-MACLEODS PHARMA-MAC2024048119$MACLEODS$$$$$$Y$$$20240715$$CN$GB$GB
240896214$24089621$4$F$20240619$20240725$20240715$20240729$EXP$$DE-AMGEN-DEUSP2024136769$AMGEN$$17$YR$T$F$Y$65$KG$20240729$$MD$DE$DE
240896221$24089622$1$I$$20240703$20240715$20240715$EXP$$PT-MACLEODS PHARMA-MAC2024048132$MACLEODS$Lobato CT, Castelo Branco S, Camoes J, Molinos E..Rhabdomyolysis secondary to a weight-loss prescription.BMJ Case Reports.2024;17(6):e258208.$$$$$Y$$$20240715$$MD$PT$PT
240896234$24089623$4$F$20240706$20240819$20240715$20240828$30DAY$$US-GSK-US2024086371$GLAXOSMITHKLINE$$40$YR$$M$Y$$$20240828$$CN$US$US
240896241$24089624$1$I$20240704$20240708$20240715$20240715$EXP$$US-LEO Pharma-371854$LEO PHARM$$90$YR$$F$Y$$$20240715$$CN$US$US
240896261$24089626$1$I$$20240703$20240715$20240715$EXP$$JP-MACLEODS PHARMA-MAC2024048134$MACLEODS$Nakamura S, Masuda S, Oda S, Yamakawa D, Yamaguchi S, Ishima T, et al..Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine..Internal Medicine.2024;63(12):1829-35$$$$$Y$$$20240715$$MD$JP$JP
240896291$24089629$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48524$$FDA-CTU$$46$YR$$F$N$200$LBS$20240712$N$$US$
240896321$24089632$1$I$$20240711$20240715$20240715$PER$$US-JNJFOC-20240730919$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$HP$US$US
240896333$24089633$3$F$20240101$20240812$20240715$20240821$PER$$US-SA-2024SA201011$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240821$$MD$US$US
240896341$24089634$1$I$20240501$20240705$20240715$20240715$PER$$US-SA-2024SA201581$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240715$$MD$US$US
240896353$24089635$3$F$20240101$20240729$20240715$20240807$PER$$US-SA-2024SA202073$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240807$$CN$US$US
240896361$24089636$1$I$20240101$20240708$20240715$20240715$PER$$US-SA-2024SA203270$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240715$$MD$US$US
240896371$24089637$1$I$20240101$20240708$20240715$20240715$PER$$US-SA-2024SA203537$SANOFI AVENTIS$$$$A$F$Y$77.11$KG$20240715$$MD$US$US
240896381$24089638$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5836918$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240896391$24089639$1$I$$20240710$20240715$20240715$EXP$$NVSC2024BR144794$NOVARTIS$$$$$F$Y$$$20240715$$CN$BR$BR
240896401$24089640$1$I$20210601$20240715$20240715$20240715$EXP$ES-AEMPS-1547680$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039714$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$69$KG$20240715$$MD$ES$ES
240896412$24089641$2$F$20231201$20240830$20240715$20240912$EXP$$US-UCBSA-2024029563$UCB$$34$YR$$F$Y$$$20240912$$HP$US$US
240896421$24089642$1$I$$20240709$20240715$20240715$EXP$$JP-AMGEN-JPNSP2024138919$AMGEN$$$$$$Y$$$20240715$$MD$JP$JP
240896431$24089643$1$I$$20240709$20240715$20240715$EXP$$JP-AMGEN-JPNSP2024138932$AMGEN$$$$$$Y$$$20240715$$MD$JP$JP
240896442$24089644$2$F$20240710$20240813$20240715$20240814$PER$$US-AMGEN-USASP2024137453$AMGEN$$77$YR$E$F$Y$$$20240814$$CN$US$US
240896451$24089645$1$I$20240626$20240704$20240715$20240715$EXP$$CN-SA-2024SA200956$SANOFI AVENTIS$$75$YR$E$F$Y$54$KG$20240715$$HP$CN$CN
240896461$24089646$1$I$$20240704$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010099$DR REDDYS$McMullan P, Brown R, Bibb L, Ferenczi K. Cutaneous CD30 positive anaplastic large cell lymphoma mimicking breast carcinoma en cuirasse. JAAD Case Reports. 2023 Oct;40: 37-40. doi:10.1016/j.jdcr.2023.07.023.$80$YR$E$F$Y$$$20240715$$HP$US$US
240896471$24089647$1$I$20240405$20240708$20240715$20240715$EXP$IT-MINISAL02-989760$IT-ROCHE-10000020268$ROCHE$$59$YR$A$F$Y$$$20240715$$MD$IT$IT
240896481$24089648$1$I$$20240702$20240715$20240715$EXP$$US-862174955-ML2024-03887$Unknown Manufacturer$Barrows C, Horton M, Allaham A, Israel HP. A Case of Acute Hypoxic Respiratory Failure After Administration of Rituximab. American Journal of Respiratory and Critical Care Medicine. 2024;209: A6326$61$YR$A$M$Y$$$20240715$$HP$US$US
240896491$24089649$1$I$20240708$20240709$20240715$20240715$PER$$US-SA-2024SA202554$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240715$$PH$US$US
240896502$24089650$2$F$20240101$20240805$20240715$20240814$PER$$US-SA-2024SA205366$SANOFI AVENTIS$$12$YR$T$M$Y$44.45$KG$20240814$$MD$US$US
240896511$24089651$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA201718$SANOFI AVENTIS$$$$E$M$Y$87$KG$20240715$$MD$US$US
240896521$24089652$1$I$20240101$20240709$20240715$20240715$PER$$US-SA-2024SA204782$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240715$$MD$US$US
240896531$24089653$1$I$20240101$20240711$20240715$20240715$PER$$US-SA-2024SA205612$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240715$$MD$US$US
240896541$24089654$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48531$$FDA-CTU$$$$$F$N$$$20240712$N$HP$US$
240896551$24089655$1$I$20240101$20240701$20240715$20240715$EXP$FR-AFSSAPS-RS2024000609$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109248$ZYDUS PHARM$$$$$$Y$$$20240715$$MD$FR$FR
240896562$24089656$2$F$20150613$20240729$20240715$20240810$EXP$FR-AFSSAPS-AN2024000810$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109271$ZYDUS PHARM$$$$$$Y$$$20240810$$PH$FR$FR
240896571$24089657$1$I$20240712$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48615$$FDA-CTU$$49$YR$$F$N$$$20240712$Y$PH$US$
240896581$24089658$1$I$20240122$20240701$20240715$20240715$EXP$FR-AFSSAPS-CN2024000625$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109305$ZYDUS PHARM$$$$$$Y$$$20240715$$MD$FR$FR
240896591$24089659$1$I$20240310$20240701$20240715$20240715$EXP$FR-AFSSAPS-AVMA2024000275$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109342$ZYDUS PHARM$$$$$$Y$$$20240715$$PH$FR$FR
240896601$24089660$1$I$20240520$20240701$20240715$20240715$EXP$FR-AFSSAPS-AN2024000826$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109238$ZYDUS PHARM$$$$$$Y$$$20240715$$PH$FR$FR
240896611$24089661$1$I$20240521$20240701$20240715$20240715$EXP$FR-AFSSAPS-TS2024000748$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109332$ZYDUS PHARM$$$$$$Y$$$20240715$$MD$FR$FR
240896621$24089662$1$I$20240610$20240701$20240715$20240715$EXP$FR-AFSSAPS-RE2024000631$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109303$ZYDUS PHARM$$$$$$Y$$$20240715$$MD$FR$FR
240896631$24089663$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48546$$FDA-CTU$$$$$F$N$$$20240712$N$HP$US$
240896642$24089664$2$F$20240306$20240729$20240715$20240810$EXP$FR-AFSSAPS-AVMA2024000272$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109345$ZYDUS PHARM$$$$$$Y$$$20240810$$PH$FR$FR
240896651$24089665$1$I$$20240701$20240715$20240715$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109395$ZYDUS PHARM$Simone C, Axelband J.. Levetiracetam-associated Rhabdomyolysis.. Am-J-Respir-Crit-Care-Med. 2024;2091:A5704$$$$$Y$$$20240715$$HP$US$US
240896661$24089666$1$I$$20240701$20240715$20240715$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109402$ZYDUS PHARM$Renzetti M, Potnis K, Vemmou E, Hansen B, Lin D, Yaggi HK.. Salty, Sweet, and Severe: A Case of Linagliptin-induced Severe Hyponatremia.. Am-J-Respir-Crit-Care-Med. 2024;209$$$$$Y$$$20240715$$HP$US$US
240896671$24089667$1$I$20240517$20240701$20240715$20240715$EXP$FR-AFSSAPS-LM2024000370$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109357$ZYDUS PHARM$$$$$$Y$$$20240715$$MD$FR$FR
240896681$24089668$1$I$20240503$20240701$20240715$20240715$EXP$FR-AFSSAPS-AN2024000803$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109446$ZYDUS PHARM$$$$$$Y$$$20240715$$PH$FR$FR
240896691$24089669$1$I$20230701$20240703$20240715$20240715$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109441$ZYDUS PHARM$$$$$$Y$$$20240715$$CN$US$US
240896702$24089670$2$F$20240101$20240729$20240715$20240731$EXP$$CA-UCBSA-2024027424$UCB$$$$$F$Y$$$20240731$$CN$CA$CA
240896711$24089671$1$I$20190101$20190820$20240715$20240715$EXP$$US-AstraZeneca-2019SF20742$ASTRAZENECA$$790$MON$$F$Y$$$20240715$$HP$US$
240896721$24089672$1$I$20240625$20240705$20240715$20240715$EXP$FR-AFSSAPS-CN2024000648$FR-AMGEN-FRASP2024133923$AMGEN$$59$YR$A$F$Y$79$KG$20240715$$MD$FR$FR
240896731$24089673$1$I$20181001$20190814$20240715$20240715$EXP$$CO-AstraZeneca-2019SE97590$ASTRAZENECA$$29667$DY$$F$Y$$$20240715$$CN$CO$
240896741$24089674$1$I$$20190827$20240715$20240715$EXP$$RU-AstraZeneca-2019SF23280$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$RU$
240896751$24089675$1$I$$20190830$20240715$20240715$EXP$$US-AstraZeneca-2019SF25256$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
240896771$24089677$1$I$20240621$20240708$20240715$20240715$EXP$IT-MINISAL02-993228$IT-CHEPLA-2024008604$CHEPLAPHARM$$$$$M$Y$$$20240715$$MD$COUNTRY NOT SPECIFIED$IT
240896781$24089678$1$I$$20240708$20240715$20240715$EXP$$US-CHEPLA-2024008598$CHEPLAPHARM$Manalac A E, Lytle E, Khan L, et al. Lissencephaly and Advanced-Stage Congenital Cytomegalovirus Infection in a Neonate. Cureus. 2024. 16(6): e61576. DOI 10.7759/cureus.61576.$24$WK$$F$Y$0.3549$KG$20240715$$HP$COUNTRY NOT SPECIFIED$US
240896791$24089679$1$I$$20190826$20240715$20240715$EXP$$US-AstraZeneca-2019SF23154$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
240896802$24089680$2$F$20240301$20240809$20240715$20240814$EXP$DK-DKMA-30733850$DK-GSK-DK2024086151$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$DK$DK
240896811$24089681$1$I$$20240708$20240715$20240715$EXP$$CA-ROCHE-10000026230$ROCHE$$$$A$F$Y$$$20240715$$CN$CA$CA
240896823$24089682$3$F$$20240805$20240715$20240809$EXP$$US-ROCHE-10000022943$ROCHE$$$$$$Y$$$20240809$$CN$US$US
240896832$24089683$2$F$$20240904$20240715$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-090843$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$MD$JP$JP
240896851$24089685$1$I$$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111227$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240715$$CN$US$US
240896861$24089686$1$I$$20240708$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110720$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240715$$HP$US$US
240896871$24089687$1$I$$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110352$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240715$$HP$US$US
240896881$24089688$1$I$$20240702$20240715$20240715$EXP$$US-MYLANLABS-2024M1063709$MYLAN$Sharma S, Desai S, Leoni J, Paghdar S, Ruiz J, Goswami R. Case report: eosinophilic myocarditis in hypereosinophilic syndrome: a journey to heart transplantation. Front-Immunol 2024; 15.$51$YR$$F$Y$$$20240715$$HP$US$US
240896901$24089690$1$I$$20240702$20240715$20240715$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008148$STRIDES$Iimori M, Sonomura K, Ueyama Y, Oobayashi Y, Adachi H, Nakayama M.. Minimal Change Nephrotic Syndrome Secondary to Methotrexate-associated Hodgkin Lymphoma. Intern-Med. 2024;63(12):1771-1776$64$YR$$M$Y$80$KG$20240715$$HP$JP$JP
240896911$24089691$1$I$20240711$20240711$20240715$20240715$PER$$US-ROCHE-10000026121$ROCHE$$80$YR$E$F$Y$$$20240715$$CN$US$US
240896921$24089692$1$I$$20240702$20240715$20240715$EXP$$MY-STRIDES ARCOLAB LIMITED-2024SP008143$STRIDES$Liew KC, O^Keeffe J, Rajandas H, Lee YP, Harris O, Parimannan S, et al.. Insights into the Evolution of P. aeruginosa Antimicrobial Resistance in a Patient Undergoing Intensive Therapy.. Antibiotics-(Basel). 2023;12 (3):1-6$51$YR$$M$Y$$$20240715$$HP$MY$MY
240896931$24089693$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000024329$ROCHE$$$$E$F$Y$$$20240715$$CN$US$US
240896943$24089694$3$F$20221001$20240906$20240715$20240916$EXP$$DE-ROCHE-3237809$ROCHE$$26$YR$A$M$Y$67$KG$20240916$$MD$DE$DE
240896951$24089695$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000024946$ROCHE$$5$YR$C$F$Y$$$20240715$$CN$US$US
240896961$24089696$1$I$20230701$20240711$20240715$20240715$PER$$US-ROCHE-10000025123$ROCHE$$76$YR$E$F$Y$110.67$KG$20240715$$CN$US$US
240896971$24089697$1$I$$20240710$20240715$20240715$EXP$$NVSC2024US143686$NOVARTIS$$$$$$Y$$$20240715$$MD$US$US
240896981$24089698$1$I$$20240710$20240715$20240715$PER$$NVSC2024US144570$NOVARTIS$$$$$F$Y$$$20240715$$HP$US$US
240896991$24089699$1$I$20190807$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003803$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240897001$24089700$1$I$$20220908$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2022M1092724$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240897011$24089701$1$I$$20220908$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2022M1092882$BIOCON$$$$$M$Y$$$20240715$$PH$US$US
240897021$24089702$1$I$$20221212$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2022M1139554$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240897031$24089703$1$I$$20230406$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1039763$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240897041$24089704$1$I$20230607$20230607$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1061548$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240897051$24089705$1$I$$20230705$20240715$20240715$PER$$US-MYLANLABS-2023M1073140$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240897061$24089706$1$I$$20230718$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1077709$BIOCON$$$$$M$Y$$$20240715$$$US$US
240897071$24089707$1$I$$20230808$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1085026$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240897081$24089708$1$I$20230811$20230814$20240715$20240715$PER$$US-MYLANLABS-2023M1086832$BIOCON$$$$$$Y$$$20240715$$$US$US
240897091$24089709$1$I$$20240105$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1112004$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240897101$24089710$1$I$20231031$20231031$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1117100$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240897111$24089711$1$I$$20231127$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1127290$BIOCON$$$$$M$Y$$$20240715$$PH$US$US
240897121$24089712$1$I$$20240207$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000877$BIOCON$$$$$$Y$$$20240715$$CN$US$US
240897131$24089713$1$I$$20240705$20240715$20240715$30DAY$$US-GSK-US2024083946$GLAXOSMITHKLINE$$83$YR$$M$Y$$$20240715$$CN$US$US
240897141$24089714$1$I$$20240710$20240715$20240715$PER$$US-ROCHE-10000024056$ROCHE$$$$$$Y$$$20240715$$MD$US$US
240897152$24089715$2$F$20240711$20240711$20240715$20240717$PER$$US-ROCHE-10000025756$ROCHE$$$$$F$Y$$$20240717$$CN$US$US
240897161$24089716$1$I$$20240125$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000556$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240897171$24089717$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000012950$ROCHE$Uhlenhopp R, Taylor C, Tomlinson H, McManus M, Burke M. Alleviation of COVID-19 Parosmia with Stellate Ganglion Block: A Case Report. Pain Medicine Case Reports. 2023-May;7 (3):101-4.$68$YR$E$F$Y$$$20240715$$HP$US$US
240897182$24089718$2$F$20240101$20240710$20240715$20240720$EXP$$US-ABBVIE-5836349$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
240897191$24089719$1$I$20240509$20240706$20240715$20240715$EXP$GB-MHRA-MED-202405171234445070-ZJYPQ$GB-CHEPLA-2024008596$CHEPLAPHARM$$39$YR$$M$Y$$$20240715$$MD$COUNTRY NOT SPECIFIED$GB
240897201$24089720$1$I$$20240702$20240715$20240715$EXP$$ZA-STRIDES ARCOLAB LIMITED-2024SP008069$STRIDES$Khan A, Pillay M, Chimukangara B, Gounder L, Manyana S, Francois K-L, et al.. Identification of HIV-1 subtype CRF18_cpx in a patient with multidrug resistance in KwaZulu-Natal, South Africa: An epidemiological worry?.. J-Clin-Virol-Plus. 2023;3 (2)$31$YR$$F$Y$$$20240715$$HP$ZA$ZA
240897211$24089721$1$I$20240101$20240711$20240715$20240715$EXP$DK-DKMA-30729554$DK-JNJFOC-20240728518$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240715$$PH$DK$DK
240897221$24089722$1$I$$20240711$20240715$20240715$EXP$$US-ABBVIE-5839611$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240897231$24089723$1$I$$20240708$20240715$20240715$EXP$$ES-JNJFOC-20240727877$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240715$$HP$ES$ES
240897241$24089724$1$I$20200818$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003800$BIOCON$$$$$$Y$$$20240715$$CN$US$US
240897251$24089725$1$I$$20240708$20240715$20240715$EXP$$US-CHEPLA-2024008690$CHEPLAPHARM$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J et al. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy. Experimental and Clinical Transplantatio.2024;22(5):392-395. doi:10.6002/ect.2024.0029.$68$YR$$F$Y$$$20240715$$MD$COUNTRY NOT SPECIFIED$US
240897261$24089726$1$I$20240328$20240328$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003445$TG THERAPEUTICS$$44$YR$$F$Y$$$20240715$$CN$US$US
240897271$24089727$1$I$20240222$20240328$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003439$TG THERAPEUTICS$$29$YR$$M$Y$$$20240715$$HP$US$US
240897281$24089728$1$I$20240313$20240401$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003448$TG THERAPEUTICS$$61$YR$$F$Y$$$20240715$$CN$US$US
240897301$24089730$1$I$20240328$20240328$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003442$TG THERAPEUTICS$$$$$F$Y$$$20240715$$HP$US$US
240897311$24089731$1$I$20240214$20240328$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003444$TG THERAPEUTICS$$45$YR$$F$Y$73.923$KG$20240715$$CN$US$US
240897321$24089732$1$I$20240710$20240711$20240715$20240715$30DAY$$IT-SANDOZ INC.-SDZ2024IT064923$SANDOZ$$12$YR$$F$Y$31$KG$20240715$$CN$IT$IT
240897331$24089733$1$I$20240325$20240401$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003450$TG THERAPEUTICS$$51$YR$$F$Y$$$20240715$$CN$US$US
240897341$24089734$1$I$20240330$20240401$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003449$TG THERAPEUTICS$$53$YR$$F$Y$83.9$KG$20240715$$CN$US$US
240897351$24089735$1$I$$20240401$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003447$TG THERAPEUTICS$$$$$F$Y$83.9$KG$20240715$$CN$US$US
240897361$24089736$1$I$$20240703$20240715$20240715$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP008047$STRIDES$Perriello VM, Falini L, Ruggeri L, Innocente A, Ballanti S, Costa C, et al.. CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma.. Am-J-Hematol. 2023;98:212-219$63$YR$$M$Y$$$20240715$$HP$IT$IT
240897371$24089737$1$I$$20230718$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BCN-2023-001406$BIOCON$$$$$M$Y$$$20240715$$CN$US$US
240897391$24089739$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48614$$FDA-CTU$$70$YR$$M$N$$$20240712$N$$US$
240897411$24089741$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48545$$FDA-CTU$$36$YR$$F$N$$$20240712$N$$US$
240897452$24089745$2$F$20240709$20240725$20240715$20240729$PER$$US-AMGEN-USASP2024138041$AMGEN$$74$YR$E$F$Y$$$20240729$$CN$US$US
240897461$24089746$1$I$20240710$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138483$AMGEN$$75$YR$E$M$Y$$$20240715$$CN$US$US
240897471$24089747$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48517$$FDA-CTU$$89$YR$$F$N$$$20240712$N$$US$
240897481$24089748$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48535$$FDA-CTU$$73$YR$$F$N$$$20240712$N$$US$
240897491$24089749$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48544$$FDA-CTU$$50$YR$$F$N$$$20240712$N$$US$
240897501$24089750$1$I$$20240704$20240715$20240715$EXP$$CN-STERISCIENCE B.V.-2024-ST-001026$Steriscience PTE$Wang D, Xu Z, Zeng L, Zhang J, Zhang G. A Case of Gangrenous Herpes Zoster Complicated with Candida albicans Infection. Clin-Cosmet-Invest-Dermatol. 2023;16:1737-1740$65$YR$$M$Y$$$20240715$$HP$CN$CN
240897511$24089751$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48609$$FDA-CTU$$$$$F$N$$$20240711$N$HP$US$
240897531$24089753$1$I$$20240702$20240715$20240715$EXP$$US-STERISCIENCE B.V.-2024-ST-001010$Steriscience PTE$Devine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series.. J-Pediatr-Pharmacol-Ther. 2023;28(2):161-166$60$DY$$$Y$$$20240715$$HP$US$US
240897541$24089754$1$I$$20240703$20240715$20240715$EXP$CA-MHPD-E2B_07079740$CA-Accord-434079$ACCORD$$64$YR$A$F$Y$$$20240715$$HP$CA$CA
240897551$24089755$1$I$20240412$20240703$20240715$20240715$EXP$ES-AEMPS-1543179$ES-Accord-433985$ACCORD$$48$YR$A$F$Y$$$20240715$$MD$ES$ES
240897561$24089756$1$I$$20240703$20240715$20240715$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008232$STRIDES$Oshima S, Takahashi S, Kitano T.. Cutaneous involvement in diffuse large B-cell lymphoma.. Oxf-Med-Case-Reports. 2024;2024 (6):266-267$85$YR$$M$Y$$$20240715$$HP$JP$JP
240897571$24089757$1$I$20240301$20240703$20240715$20240715$EXP$FR-AFSSAPS-LL2024001238$FR-Accord-434323$ACCORD$$57$YR$A$F$Y$$$20240715$$MD$FR$FR
240897581$24089758$1$I$$20240703$20240715$20240715$EXP$$CN-STERISCIENCE B.V.-2024-ST-001011$Steriscience PTE$Xuan W, Wang Z, Lin J, Zou L, Yang X, Xu Y, et al.. Case report: Aggressive progression of acute heart failure due to juvenile tuberculosis-associated Takayasu arteritis with aortic stenosis and thrombosis.. Front-Cardiovasc-Med. 2023;10$10$YR$$M$Y$$$20240715$$HP$CN$CN
240897591$24089759$1$I$20160521$20240709$20240715$20240715$EXP$$NVSC2024IN143806$NOVARTIS$$33$YR$$M$Y$$$20240715$$CN$IN$IN
240897601$24089760$1$I$$20240708$20240715$20240715$EXP$$NVSC2024US141593$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240897613$24089761$3$F$$20240712$20240715$20240718$PER$$NVSC2024US144316$NOVARTIS$$$$$M$Y$$$20240718$$HP$US$US
240897622$24089762$2$F$$20240916$20240715$20240917$EXP$$NVSC2024MW144878$NOVARTIS$$$$$F$Y$$$20240917$$MD$MW$MW
240897632$24089763$2$F$20240708$20240722$20240715$20240723$EXP$IT-MINISAL02-994493$NVSC2024IT144089$NOVARTIS$$37$YR$$F$Y$48$KG$20240723$$MD$IT$IT
240897641$24089764$1$I$$20240701$20240715$20240715$EXP$$CN-PHATHOM PHARMACEUTICALS INC.-2024PHT00547$Phathom Pharmaceuticals$Xin G, Xuan L, Yun W, Haisheng Q, Guoxin Z.. Comparison of the efficacy between Vonoprazan fumarate and Rabeprazole combined with mucosal protectors for artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled study. Chinese Journal of Digestive Endoscopy. 2024;41$$$$$Y$$$20240715$$HP$CN$CN
240897651$24089765$1$I$$20240402$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003454$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240897661$24089766$1$I$20240403$20240405$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003463$TG THERAPEUTICS$$27$YR$$F$Y$$$20240715$$MD$US$US
240897671$24089767$1$I$20240326$20240402$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003456$TG THERAPEUTICS$$71$YR$$$Y$$$20240715$$CN$US$US
240897681$24089768$1$I$$20240403$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003458$TG THERAPEUTICS$$$$$$Y$$$20240715$$HP$US$US
240897691$24089769$1$I$20240330$20240403$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003452$TG THERAPEUTICS$$38$YR$$F$Y$$$20240715$$CN$US$US
240897701$24089770$1$I$20240402$20240402$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003453$TG THERAPEUTICS$$30$YR$$F$Y$$$20240715$$CN$US$US
240897711$24089771$1$I$20240101$20240626$20240715$20240715$PER$$US-TEVA-VS-3215296$TEVA$$$$A$F$Y$$$20240715$$CN$US$US
240897721$24089772$1$I$$20240703$20240715$20240715$EXP$GB-MHRA-TPP17131720C6607580YC1719940868647$GB-Accord-434190$ACCORD$$71$YR$E$M$Y$96$KG$20240715$$MD$GB$GB
240897731$24089773$1$I$$20240710$20240715$20240715$EXP$$US-JNJFOC-20240731731$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$HP$US$US
240897741$24089774$1$I$$20240703$20240715$20240715$EXP$GB-MHRA-MIDB-adb1368b-9bcb-4b05-a4ab-570112a7771c$GB-Accord-434195$ACCORD$$79$YR$E$$Y$$$20240715$$PH$GB$GB
240897751$24089775$1$I$$20240703$20240715$20240715$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP008284$STRIDES$Jabiry-Zieniewicz Z, Stelmach DA, Jasak K, Knap-Wielgus W, Szumska A, Kalicinski P, et al.. Pregnancy in Liver and Kidney Female Recipient: A Case Report.. Transplant-Proc. 2024;56 (4)::998-999.$27$YR$$F$Y$$$20240715$$HP$PL$PL
240897761$24089776$1$I$20240101$20240710$20240715$20240715$EXP$$US-ABBVIE-5837852$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240897771$24089777$1$I$20240101$20240711$20240715$20240715$EXP$$US-ABBVIE-5838032$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240897781$24089778$1$I$$20240710$20240715$20240715$EXP$$US-SA-2024SA205923$SANOFI AVENTIS$$$$A$F$Y$65.77$KG$20240715$$MD$US$US
240897791$24089779$1$I$$20240703$20240715$20240715$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP008291$STRIDES$Jabiry-Zieniewicz Z, Stelmach DA, Jasak K, Knap-Wielgus W, Szumska A, Kalicinski P, et al.. Pregnancy in Liver and Kidney Female Recipient: A Case Report.. Transplant-Proc. 2024;56 (4):998-999.$$$$F$Y$$$20240715$$HP$PL$PL
240897801$24089780$1$I$$20240712$20240715$20240715$PER$$US-TAKEDA-2024TUS071292$TAKEDA$$27$YR$$F$Y$87.09$KG$20240715$$MD$US$US
240897812$24089781$2$F$$20240821$20240715$20240830$30DAY$$US-GSK-US2024084055$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
240897821$24089782$1$I$$20240705$20240715$20240715$30DAY$$US-GSK-US2024084054$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
240897831$24089783$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007707$ELI LILLY AND CO$$25$YR$A$M$Y$$$20240715$$CN$US$US
240897841$24089784$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007629$ELI LILLY AND CO$$41$YR$A$$Y$$$20240715$$CN$US$US
240897852$24089785$2$F$$20240829$20240715$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008477$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240910$$MD$US$US
240897862$24089786$2$F$20240401$20240904$20240715$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202407007933$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240910$$CN$US$US
240897871$24089787$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008012$ELI LILLY AND CO$$$$$$Y$$$20240715$$CN$US$US
240897881$24089788$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007827$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240715$$CN$US$US
240897891$24089789$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008225$ELI LILLY AND CO$$52$YR$A$F$Y$68.481$KG$20240715$$CN$US$US
240897901$24089790$1$I$$20240710$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110915$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$67.59$KG$20240715$$CN$US$US
240897911$24089791$1$I$20240401$20240405$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003459$TG THERAPEUTICS$$19$YR$$F$Y$$$20240715$$HP$US$US
240897921$24089792$1$I$$20240405$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003461$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240897931$24089793$1$I$$20240408$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003466$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240897941$24089794$1$I$20240401$20240408$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003464$TG THERAPEUTICS$$48$YR$$F$Y$$$20240715$$CN$US$US
240897951$24089795$1$I$20240601$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110820$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$74.84$KG$20240715$$HP$US$US
240897961$24089796$1$I$20240404$20240410$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003472$TG THERAPEUTICS$$42$YR$$M$Y$$$20240715$$HP$US$US
240897971$24089797$1$I$$20240410$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003470$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240897981$24089798$1$I$20240401$20240410$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003469$TG THERAPEUTICS$$32$YR$$M$Y$$$20240715$$CN$US$US
240897991$24089799$1$I$20240409$20240410$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003474$TG THERAPEUTICS$$22$YR$$M$Y$$$20240715$$CN$US$US
240898001$24089800$1$I$20240308$20240408$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003465$TG THERAPEUTICS$$31$YR$$M$Y$97.506$KG$20240715$$CN$US$US
240898011$24089801$1$I$20240301$20240408$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003468$TG THERAPEUTICS$$72$YR$$F$Y$$$20240715$$CN$US$US
240898021$24089802$1$I$20230801$20230817$20240715$20240715$PER$$US-PERRIGO-23US009477$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898031$24089803$1$I$20220801$20230823$20240715$20240715$PER$$US-PERRIGO-23US009436$PERRIGO$$31$YR$$M$Y$69.841$KG$20240715$$CN$US$US
240898041$24089804$1$I$20230801$20230823$20240715$20240715$PER$$US-PERRIGO-23US009487$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898051$24089805$1$I$$20240703$20240715$20240715$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP008254$STRIDES$Ali SB, Vembar P, Sukumaran S, Gunawardane D, Hughes T, Smith A.. Tocilizumab in grade 4 hepatitis secondary to immune checkpoint inhibitor: a case report and review of the literature.. Immunotherapy. 2023;15 (14):1125-1132$68$YR$$F$Y$52$KG$20240715$$HP$AU$AU
240898061$24089806$1$I$20230801$20230818$20240715$20240715$PER$$US-PERRIGO-23US009479$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898071$24089807$1$I$20230801$20230823$20240715$20240715$PER$$US-PERRIGO-23US009454$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240898081$24089808$1$I$20230801$20230821$20240715$20240715$PER$$US-PERRIGO-23US009448$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898091$24089809$1$I$20230801$20230827$20240715$20240715$PER$$US-PERRIGO-23US009481$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898101$24089810$1$I$20230801$20230827$20240715$20240715$PER$$US-PERRIGO-23US009480$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898111$24089811$1$I$20230801$20230821$20240715$20240715$PER$$US-PERRIGO-23US009444$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898121$24089812$1$I$20230801$20230822$20240715$20240715$PER$$US-PERRIGO-23US009475$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898132$24089813$2$F$$20240801$20240715$20240807$EXP$$CA-ABBVIE-5838524$ABBVIE$$$$A$M$Y$$$20240807$$CN$CA$CA
240898141$24089814$1$I$20240708$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48597$$FDA-CTU$$76$YR$$M$N$92.6$KG$20240715$N$CN$US$
240898151$24089815$1$I$$20240703$20240715$20240715$EXP$GB-MHRA-DEFECT-202406221311545970-BHSNJ$GB-Accord-434408$ACCORD$$$$$$Y$$$20240715$$CN$GB$GB
240898161$24089816$1$I$$20240703$20240715$20240715$EXP$CA-MHPD-E2B_07078949$CA-Accord-434076$ACCORD$$58$YR$A$M$Y$$$20240715$$MD$CA$CA
240898171$24089817$1$I$20240601$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48600$$FDA-CTU$$64$YR$$F$N$$$20240711$N$HP$US$
240898191$24089819$1$I$$20240704$20240715$20240715$EXP$$IT-Accord-434173$ACCORD$Scollo C, Rossi D, D^Andria R, Magnano R, Pezzi L, D^Alleva A, et al. Cardiovascular considerations in antidepressant therapy: sinus arrest due to sertraline. European Heart Journal Supplements. 2024;26(Supplement 2):ii78. DOI: 10.1093/eurheartjsupp/suae036.184.$39$YR$A$F$Y$$$20240715$$MD$IT$IT
240898201$24089820$1$I$$20240410$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003477$TG THERAPEUTICS$$$$$F$Y$$$20240715$$HP$US$US
240898211$24089821$1$I$20240410$20240412$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003482$TG THERAPEUTICS$$23$YR$$F$Y$$$20240715$$CN$US$US
240898221$24089822$1$I$$20240703$20240715$20240715$EXP$GB-MHRA-TPP17680614C969841YC1719835277354$GB-Accord-434374$ACCORD$$60$YR$A$M$Y$92$KG$20240715$$MD$GB$GB
240898231$24089823$1$I$$20240703$20240715$20240715$EXP$CA-MHPD-001085751$CA-Accord-434157$ACCORD$$44$YR$A$F$Y$$$20240715$$HP$CA$CA
240898241$24089824$1$I$20240405$20240412$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003480$TG THERAPEUTICS$$$$$F$Y$$$20240715$$HP$US$US
240898251$24089825$1$I$20240709$20240712$20240715$20240715$EXP$GB-MHRA-MED-202407111401486780-PGRCW$GB-ORGANON-O2407GBR001199$ORGANON$$$$$M$Y$145$KG$20240715$$CN$GB$GB
240898261$24089826$1$I$20240330$20240411$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003475$TG THERAPEUTICS$$44$YR$$F$Y$123.36$KG$20240715$$CN$US$US
240898271$24089827$1$I$20230101$20240704$20240715$20240715$EXP$$CA-ROCHE-3218097$ROCHE$$35$YR$A$F$Y$44$KG$20240715$$HP$CA$CA
240898281$24089828$1$I$20240301$20240411$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003478$TG THERAPEUTICS$$44$YR$$F$Y$123.36$KG$20240715$$CN$US$US
240898291$24089829$1$I$20230801$20230824$20240715$20240715$PER$$US-PERRIGO-23US009537$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898301$24089830$1$I$20230801$20230823$20240715$20240715$PER$$US-PERRIGO-23US009532$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898311$24089831$1$I$20230801$20230823$20240715$20240715$PER$$US-PERRIGO-23US009489$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898321$24089832$1$I$20230801$20230823$20240715$20240715$PER$$US-PERRIGO-23US009490$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898331$24089833$1$I$20230801$20230823$20240715$20240715$PER$$US-PERRIGO-23US009488$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898341$24089834$1$I$20230801$20230824$20240715$20240715$PER$$US-PERRIGO-23US009540$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898351$24089835$1$I$20230801$20230822$20240715$20240715$PER$$US-PERRIGO-23US009498$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898361$24089836$1$I$20230801$20230824$20240715$20240715$PER$$US-PERRIGO-23US009538$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898371$24089837$1$I$20230701$20230822$20240715$20240715$PER$$US-PERRIGO-23US009492$PERRIGO$$24$YR$$M$Y$$$20240715$$CN$US$US
240898381$24089838$1$I$20230801$20230825$20240715$20240715$PER$$US-PERRIGO-23US009604$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898391$24089839$1$I$20230801$20230825$20240715$20240715$PER$$US-PERRIGO-23US009576$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240898401$24089840$1$I$20230801$20230822$20240715$20240715$PER$$US-PERRIGO-23US009499$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898411$24089841$1$I$20230801$20230825$20240715$20240715$PER$$US-PERRIGO-23US009553$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240898421$24089842$1$I$20230801$20230825$20240715$20240715$PER$$US-PERRIGO-23US009569$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898431$24089843$1$I$20230801$20230817$20240715$20240715$PER$$US-PERRIGO-23US009503$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898441$24089844$1$I$20230801$20230824$20240715$20240715$PER$$US-PERRIGO-23US009536$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898451$24089845$1$I$20230801$20230821$20240715$20240715$PER$$US-PERRIGO-23US009501$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898461$24089846$1$I$20230801$20230821$20240715$20240715$PER$$US-PERRIGO-23US009502$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898471$24089847$1$I$20230801$20230821$20240715$20240715$PER$$US-PERRIGO-23US009500$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240898481$24089848$1$I$20230801$20230825$20240715$20240715$PER$$US-PERRIGO-23US009568$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898491$24089849$1$I$$20240712$20240715$20240715$EXP$$US-ABBVIE-5839253$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240898501$24089850$1$I$20240412$20240412$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003451$TG THERAPEUTICS$$40$YR$$F$Y$$$20240715$$HP$US$US
240898511$24089851$1$I$$20240415$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003498$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240898521$24089852$1$I$20240410$20240412$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003481$TG THERAPEUTICS$$50$YR$$M$Y$70.295$KG$20240715$$CN$US$US
240898531$24089853$1$I$$20240415$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003488$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240898541$24089854$1$I$$20240705$20240715$20240715$EXP$$IT-MYLANLABS-2024M1064940$MYLAN$Andreozzi V, Capuano R, Scannapieco S, Barra F, d^Arco B, Giordano C, et al. Bariatric surgery and dimethyl fumarate-induced lymphopenia in patients with multiple sclerosis. Neurol-Sci 2024; 45 2807-2810.$50$YR$$F$Y$$$20240715$$HP$IT$IT
240898551$24089855$1$I$$20240705$20240715$20240715$EXP$$IT-MYLANLABS-2024M1064867$MYLAN$Andreozzi V, Capuano R, Scannapieco S, Barra F, d^Arco B, Giordano C, et al. Bariatric surgery and dimethyl fumarate-induced lymphopenia in patients with multiple sclerosis. Neurol-Sci 2024; 45 2807-2810.$27$YR$$F$Y$$$20240715$$HP$IT$IT
240898561$24089856$1$I$20230801$20230829$20240715$20240715$PER$$US-PERRIGO-23US010522$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898571$24089857$1$I$20230801$20230829$20240715$20240715$PER$$US-PERRIGO-23US009682$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898581$24089858$1$I$20230801$20230827$20240715$20240715$PER$$US-PERRIGO-23US009607$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898591$24089859$1$I$$20240703$20240715$20240715$EXP$CN-MLMSERVICE-20240115-4773282-1$CN-STRIDES ARCOLAB LIMITED-2024SP008259$STRIDES$Han X, Liu X, Zhang C, Wen Q, Zhang X.. PD-1 blockade combined with decitabine to treat refractory peripheral T-cell lymphoma not otherwise specified: A case report and review of literature.. J-Cancer-Res-Ther. 2023;19:1680-16884$43$YR$$F$Y$$$20240715$$MD$CN$CN
240898601$24089860$1$I$20230801$20230826$20240715$20240715$PER$$US-PERRIGO-23US009606$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898611$24089861$1$I$20230801$20230825$20240715$20240715$PER$$US-PERRIGO-23US009605$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898621$24089862$1$I$20230831$20230831$20240715$20240715$PER$$US-PERRIGO-23US010527$PERRIGO$$68$YR$$F$Y$80.726$KG$20240715$$CN$US$US
240898631$24089863$1$I$20230801$20230829$20240715$20240715$PER$$US-PERRIGO-23US009669$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898641$24089864$1$I$20230801$20230827$20240715$20240715$PER$$US-PERRIGO-23US009684$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898651$24089865$1$I$20230801$20230830$20240715$20240715$PER$$US-PERRIGO-23US010537$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898661$24089866$1$I$20230801$20230828$20240715$20240715$PER$$US-PERRIGO-23US009687$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898671$24089867$1$I$$20240415$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003489$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240898681$24089868$1$I$20231031$20240415$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003497$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240898691$24089869$1$I$20240328$20240415$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003495$TG THERAPEUTICS$$56$YR$$F$Y$58.957$KG$20240715$$CN$US$US
240898701$24089870$1$I$20240314$20240415$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003494$TG THERAPEUTICS$$56$YR$$F$Y$58.957$KG$20240715$$CN$US$US
240898711$24089871$1$I$20240401$20240416$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003492$TG THERAPEUTICS$$56$YR$$F$Y$$$20240715$$CN$US$US
240898721$24089872$1$I$20240401$20240416$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003493$TG THERAPEUTICS$$56$YR$$F$Y$$$20240715$$CN$US$US
240898731$24089873$1$I$20240101$20240415$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003499$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240898741$24089874$1$I$$20240709$20240715$20240715$PER$$US-ABBVIE-5835130$ABBVIE$$$$$$Y$$$20240715$$CN$US$US
240898751$24089875$1$I$$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160549$ASTRAZENECA$$69$YR$$M$Y$100$KG$20240715$$HP$FR$
240898761$24089876$1$I$20160101$20240708$20240715$20240715$EXP$DE-CADRBFARM-2024328863$DE-CHEPLA-2024008553$CHEPLAPHARM$$57$YR$$M$Y$68$KG$20240715$$CN$COUNTRY NOT SPECIFIED$DE
240898771$24089877$1$I$20230801$20230902$20240715$20240715$PER$$US-PERRIGO-23US010635$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898781$24089878$1$I$20230801$20230901$20240715$20240715$PER$$US-PERRIGO-23US010682$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898791$24089879$1$I$20111022$20240708$20240715$20240715$EXP$$BE-CHEPLA-2024008566$CHEPLAPHARM$$60$YR$$M$Y$82$KG$20240715$$MD$COUNTRY NOT SPECIFIED$BE
240898801$24089880$1$I$$20240706$20240715$20240715$EXP$GB-MHRA-MED-202405101423535400-WTCJS$GB-CHEPLA-2024008606$CHEPLAPHARM$$$$$$Y$$$20240715$$HP$COUNTRY NOT SPECIFIED$GB
240898811$24089881$1$I$20230801$20230831$20240715$20240715$PER$$US-PERRIGO-23US010605$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898821$24089882$1$I$20230901$20230906$20240715$20240715$PER$$US-PERRIGO-23US010729$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898831$24089883$1$I$20230801$20230830$20240715$20240715$PER$$US-PERRIGO-23US010540$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898841$24089884$1$I$20230801$20230905$20240715$20240715$PER$$US-PERRIGO-23US010704$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898851$24089885$1$I$20230801$20230830$20240715$20240715$PER$$US-PERRIGO-23US010546$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898861$24089886$1$I$20230801$20230830$20240715$20240715$PER$$US-PERRIGO-23US010543$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898871$24089887$1$I$20230801$20230831$20240715$20240715$PER$$US-PERRIGO-23US010576$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898881$24089888$1$I$20230801$20230901$20240715$20240715$PER$$US-PERRIGO-23US010596$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898891$24089889$1$I$20230801$20230830$20240715$20240715$PER$$US-PERRIGO-23US010548$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898901$24089890$1$I$20230801$20230906$20240715$20240715$PER$$US-PERRIGO-23US010728$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898911$24089891$1$I$20230801$20230831$20240715$20240715$PER$$US-PERRIGO-23US010633$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898921$24089892$1$I$20230801$20230831$20240715$20240715$PER$$US-PERRIGO-23US010634$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898931$24089893$1$I$20230801$20230905$20240715$20240715$PER$$US-PERRIGO-23US010677$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898941$24089894$1$I$20230801$20230904$20240715$20240715$PER$$US-PERRIGO-23US010671$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898951$24089895$1$I$20050101$20230901$20240715$20240715$PER$$US-PERRIGO-23US010575$PERRIGO$$$$$F$Y$170$KG$20240715$$CN$US$US
240898961$24089896$1$I$20230801$20230903$20240715$20240715$PER$$US-PERRIGO-23US010672$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898971$24089897$1$I$20240416$20240416$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003503$TG THERAPEUTICS$$43$YR$$M$Y$$$20240715$$CN$US$US
240898981$24089898$1$I$20230801$20230831$20240715$20240715$PER$$US-PERRIGO-23US010606$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240898991$24089899$1$I$20230801$20230906$20240715$20240715$PER$$US-PERRIGO-23US010705$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899001$24089900$1$I$$20240703$20240715$20240715$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008260$STRIDES$Yang M, Cai Y, Wan L, Ji L, Song XM.. Case report: Autoimmune encephalomyelitis following cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.. Front-Med. 2024;11$53$YR$$F$Y$$$20240715$$HP$CN$CN
240899032$24089903$2$F$$20240730$20240715$20240807$EXP$$US-GSK-US2024084463$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
240899044$24089904$4$F$$20240809$20240715$20240816$EXP$$CO-GSK-CO2024AMR065962$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$CO$CO
240899051$24089905$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405021346225070-FQBPR$GB-TEVA-VS-3218727$TEVA$$80$YR$$F$Y$$$20240715$$HP$GB$GB
240899061$24089906$1$I$20240201$20240514$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003476$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240899071$24089907$1$I$20240426$20240506$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003561$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240899082$24089908$2$F$20240301$20240816$20240715$20240822$EXP$$US-JNJFOC-20240723441$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240823$$HP$US$US
240899091$24089909$1$I$20240523$20240524$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003640$TG THERAPEUTICS$$35$YR$$M$Y$$$20240715$$CN$US$US
240899101$24089910$1$I$20240624$20240624$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003606$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240899111$24089911$1$I$20240501$20240529$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003612$TG THERAPEUTICS$$68$YR$$F$Y$99.773$KG$20240715$$CN$US$US
240899121$24089912$1$I$20240428$20240625$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003582$TG THERAPEUTICS$$36$YR$$F$Y$$$20240715$$CN$US$US
240899131$24089913$1$I$20230301$20240708$20240715$20240715$EXP$FR-AFSSAPS-LY2024000797$FR-ROCHE-10000019649$ROCHE$$58$YR$A$M$Y$$$20240715$$PH$FR$FR
240899141$24089914$1$I$20230901$20230911$20240715$20240715$PER$$US-PERRIGO-23US010950$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240899151$24089915$1$I$20230901$20230908$20240715$20240715$PER$$US-PERRIGO-23US010858$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899161$24089916$1$I$20230901$20230913$20240715$20240715$PER$$US-PERRIGO-23US011038$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899171$24089917$1$I$20230801$20230906$20240715$20240715$PER$$US-PERRIGO-23US010772$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899181$24089918$1$I$20230901$20230911$20240715$20240715$PER$$US-PERRIGO-23US010928$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899191$24089919$1$I$20230901$20230908$20240715$20240715$PER$$US-PERRIGO-23US010893$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899201$24089920$1$I$20230801$20230906$20240715$20240715$PER$$US-PERRIGO-23US010942$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899211$24089921$1$I$20230901$20230906$20240715$20240715$PER$$US-PERRIGO-23US010732$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899221$24089922$1$I$20230901$20230908$20240715$20240715$PER$$US-PERRIGO-23US010853$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899231$24089923$1$I$20230901$20230912$20240715$20240715$PER$$US-PERRIGO-23US010944$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899241$24089924$1$I$20230901$20230909$20240715$20240715$PER$$US-PERRIGO-23US010887$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899251$24089925$1$I$20230901$20230913$20240715$20240715$PER$$US-PERRIGO-23US011083$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899261$24089926$1$I$20230901$20230914$20240715$20240715$PER$$US-PERRIGO-23US011100$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899281$24089928$1$I$20230901$20230911$20240715$20240715$PER$$US-PERRIGO-23US010939$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899291$24089929$1$I$20230801$20230907$20240715$20240715$PER$$US-PERRIGO-23US010923$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899301$24089930$1$I$20230901$20230910$20240715$20240715$PER$$US-PERRIGO-23US010925$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899311$24089931$1$I$20230901$20230912$20240715$20240715$PER$$US-PERRIGO-23US010943$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899321$24089932$1$I$20230901$20230908$20240715$20240715$PER$$US-PERRIGO-23US010849$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899331$24089933$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48599$$FDA-CTU$$$$$M$N$$$20240712$N$HP$US$
240899351$24089935$1$I$20230901$20230910$20240715$20240715$PER$$US-PERRIGO-23US010889$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899361$24089936$1$I$20230901$20230912$20240715$20240715$PER$$US-PERRIGO-23US011034$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899371$24089937$1$I$20240101$20240708$20240715$20240715$EXP$$US-SA-2024SA203200$SANOFI AVENTIS$$71$YR$E$M$Y$90.718$KG$20240715$$MD$US$US
240899381$24089938$1$I$20220101$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405071957286520-FKGWQ$GB-RDY-SPO/GBR/24/0010157$DR REDDYS$$72$YR$E$M$Y$64$KG$20240715$$CN$GB$GB
240899391$24089939$1$I$20230901$20230915$20240715$20240715$PER$$US-PERRIGO-23US011107$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899401$24089940$1$I$20230901$20230917$20240715$20240715$PER$$US-PERRIGO-23US011157$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899411$24089941$1$I$20230901$20230915$20240715$20240715$PER$$US-PERRIGO-23US011105$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899421$24089942$1$I$20230820$20230920$20240715$20240715$PER$$US-PERRIGO-23US011205$PERRIGO$$48$YR$$M$Y$$$20240715$$CN$US$US
240899431$24089943$1$I$20230901$20230919$20240715$20240715$PER$$US-PERRIGO-23US011154$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899441$24089944$1$I$20230901$20230915$20240715$20240715$PER$$US-PERRIGO-23US011128$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899451$24089945$1$I$$20240605$20240715$20240715$EXP$$US-BAYER-2024A085943$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240715$$MD$US$US
240899461$24089946$1$I$20230901$20230918$20240715$20240715$PER$$US-PERRIGO-23US011208$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899471$24089947$1$I$20230901$20230918$20240715$20240715$PER$$US-PERRIGO-23US011202$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899481$24089948$1$I$20230901$20230914$20240715$20240715$PER$$US-PERRIGO-23US011103$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899491$24089949$1$I$20230901$20230914$20240715$20240715$PER$$US-PERRIGO-23US011120$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899501$24089950$1$I$20240708$20240710$20240715$20240715$EXP$$US-AMGEN-USASP2024137456$AMGEN$$$$$$Y$$$20240715$$HP$US$US
240899511$24089951$1$I$20240226$20240416$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003496$TG THERAPEUTICS$$33$YR$$$Y$$$20240715$$CN$US$US
240899521$24089952$1$I$20231106$20240417$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003504$TG THERAPEUTICS$$51$YR$$F$Y$$$20240715$$HP$US$US
240899531$24089953$1$I$$20240417$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003501$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240899541$24089954$1$I$20240417$20240418$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003508$TG THERAPEUTICS$$38$YR$$F$Y$$$20240715$$CN$US$US
240899551$24089955$1$I$20240401$20240416$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003491$TG THERAPEUTICS$$55$YR$$F$Y$$$20240715$$CN$US$US
240899561$24089956$1$I$20240404$20240417$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003505$TG THERAPEUTICS$$45$YR$$M$Y$$$20240715$$CN$US$US
240899571$24089957$1$I$$20240417$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003500$TG THERAPEUTICS$$63$YR$$$Y$$$20240715$$CN$US$US
240899582$24089958$2$F$20240701$20240709$20240715$20240718$PER$$US-SA-2024SA203116$SANOFI AVENTIS$$16$YR$T$M$Y$108$KG$20240718$$MD$US$US
240899591$24089959$1$I$20240705$20240705$20240715$20240715$PER$$US-SA-2023SA076375$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240715$$MD$US$US
240899611$24089961$1$I$20240430$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405081653055240-HCSJK$GB-TEVA-VS-3218890$TEVA$$40$YR$$F$Y$$$20240715$$MD$GB$GB
240899621$24089962$1$I$20240702$20240703$20240715$20240715$EXP$$PK-ROCHE-10000020459$ROCHE$$59$YR$A$M$Y$$$20240715$$CN$PK$PK
240899641$24089964$1$I$$20240703$20240715$20240715$EXP$$IN-Accord-433931$ACCORD$Tamil Selvi E, Rahangan A. Methotrexate Induced Muco-Cutaneous Ulcer: A Case Report. International Journal of Pharmaceutical Sciences Review and Research. 2024;84(5):75-6. DOI: 10.47583/ijpsrr.2024.v84i05.012.$59$YR$A$F$Y$$$20240715$$MD$IN$IN
240899651$24089965$1$I$20230901$20230918$20240715$20240715$PER$$US-PERRIGO-23US011209$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899662$24089966$2$F$$20240711$20240715$20240722$EXP$$IR-Accord-434170$ACCORD$Shahbazi F, Shojaei L. Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases. Current drug safety. 2024. DOI: 10.2174/0115748863299100240507052341.$49$YR$A$M$Y$85$KG$20240719$$PH$IR$IR
240899671$24089967$1$I$20230901$20230919$20240715$20240715$PER$$US-PERRIGO-23US011253$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899681$24089968$1$I$20230901$20230920$20240715$20240715$PER$$US-PERRIGO-23US011294$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899691$24089969$1$I$20230901$20230922$20240715$20240715$PER$$US-PERRIGO-23US011300$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899701$24089970$1$I$20230901$20230921$20240715$20240715$PER$$US-PERRIGO-23US011321$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899711$24089971$1$I$20230901$20230919$20240715$20240715$PER$$US-PERRIGO-23US011237$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899721$24089972$1$I$20230901$20230921$20240715$20240715$PER$$US-PERRIGO-23US011322$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899731$24089973$1$I$20230901$20230919$20240715$20240715$PER$$US-PERRIGO-23US011238$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899751$24089975$1$I$20230901$20230921$20240715$20240715$PER$$US-PERRIGO-23US011254$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899761$24089976$1$I$20230901$20230922$20240715$20240715$PER$$US-PERRIGO-23US011301$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899772$24089977$2$F$20240709$20240815$20240715$20240817$PER$$US-JNJFOC-20240729558$JOHNSON AND JOHNSON$$$$$M$Y$$$20240817$$CN$US$US
240899781$24089978$1$I$$20240701$20240715$20240715$EXP$$MX-IPCA LABORATORIES LIMITED-IPC-2024-MX-001735$IPCA$Cesar D. Bautista-Sanchez , Luis E. Mart?nez-Bravo and Diego A. Hidalgo-Diaz. Pancytopenia in neuromyelitis optica spectrum disorder induced by azathioprine-allopurinol interaction. Neuroimmunology Reports. 2024;6(100219):1-3$$$$$Y$$$20240715$$HP$MX$MX
240899803$24089980$3$F$20240710$20240820$20240715$20240826$30DAY$$US-JNJFOC-20240727031$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240826$$PH$US$US
240899811$24089981$1$I$$20240709$20240715$20240715$EXP$$CA-JNJFOC-20240725389$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$HP$CA$CA
240899821$24089982$1$I$$20240709$20240715$20240715$EXP$$US-EMD Serono-2024037662$EMD SERONO INC$$$$A$F$Y$81$KG$20240715$$CN$US$US
240899831$24089983$1$I$20230901$20230922$20240715$20240715$PER$$US-PERRIGO-23US011360$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899841$24089984$1$I$20230901$20230926$20240715$20240715$PER$$US-PERRIGO-23US011461$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899851$24089985$1$I$20230526$20230926$20240715$20240715$PER$$US-PERRIGO-23US011411$PERRIGO$$39$YR$$M$Y$85.261$KG$20240715$$CN$US$US
240899871$24089987$1$I$20230901$20231001$20240715$20240715$PER$$US-PERRIGO-23US011597$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899881$24089988$1$I$20230901$20230930$20240715$20240715$PER$$US-PERRIGO-23US011572$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899891$24089989$1$I$20230901$20230927$20240715$20240715$PER$$US-PERRIGO-23US011508$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899901$24089990$1$I$20230927$20230928$20240715$20240715$PER$$US-PERRIGO-23US011483$PERRIGO$$78$YR$$F$Y$$$20240715$$CN$US$US
240899911$24089991$1$I$20230901$20230923$20240715$20240715$PER$$US-PERRIGO-23US011358$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899921$24089992$1$I$20230901$20230928$20240715$20240715$PER$$US-PERRIGO-23US011563$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899931$24089993$1$I$20230901$20230928$20240715$20240715$PER$$US-PERRIGO-23US011535$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899941$24089994$1$I$20230901$20230927$20240715$20240715$PER$$US-PERRIGO-23US011507$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899951$24089995$1$I$20230901$20230913$20240715$20240715$PER$$US-PERRIGO-23US011599$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899961$24089996$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48543$$FDA-CTU$$$$$F$N$$$20240711$N$HP$US$
240899971$24089997$1$I$20230901$20230925$20240715$20240715$PER$$US-PERRIGO-23US011400$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240899981$24089998$1$I$$20231002$20240715$20240715$PER$$US-PERRIGO-23US011586$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240899991$24089999$1$I$20230901$20230928$20240715$20240715$PER$$US-PERRIGO-23US011534$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900001$24090000$1$I$20230901$20231001$20240715$20240715$PER$$US-PERRIGO-23US011598$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900011$24090001$1$I$20230901$20230925$20240715$20240715$PER$$US-PERRIGO-23US011509$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900021$24090002$1$I$$20240712$20240712$20240712$DIR$710036$$FDA-CTU$$$$$UNK$N$$$20240712$$CN$US$
240900031$24090003$1$I$$20240712$20240712$20240712$DIR$710034$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240900041$24090004$1$I$20230901$20230924$20240715$20240715$PER$$US-PERRIGO-23US011361$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900051$24090005$1$I$20230901$20230930$20240715$20240715$PER$$US-PERRIGO-23US011571$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900061$24090006$1$I$20230326$20230926$20240715$20240715$PER$$US-PERRIGO-23US011421$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240900071$24090007$1$I$$20240710$20240715$20240715$EXP$$JP-PFIZER INC-202400212185$PFIZER$Matsui, H.. Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). Pancreas. 2024;53(6):e501-e512$71$YR$$$Y$$$20240715$$MD$JP$JP
240900081$24090008$1$I$$20240710$20240715$20240715$EXP$$JP-PFIZER INC-202400212183$PFIZER$Matsui, H.. Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). Pancreas. 2024;53(6):e501-e512$78$YR$$M$Y$$$20240715$$MD$JP$JP
240900091$24090009$1$I$20240712$20240712$20240712$20240712$DIR$710042$$FDA-CTU$$60$YR$$M$N$$$20240712$Y$$US$
240900101$24090010$1$I$$20240710$20240715$20240715$EXP$$FR-PFIZER INC-PV202400091803$PFIZER$Strizzolo, R.. Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab. World Allergy Organization Journal. 2024;17(7):10.1016/j.waojou.2024.100923$$$A$$Y$$$20240715$$MD$FR$FR
240900111$24090011$1$I$20231001$20231002$20240715$20240715$PER$$US-PERRIGO-23US011639$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240900121$24090012$1$I$20231001$20231003$20240715$20240715$PER$$US-PERRIGO-23US011714$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900131$24090013$1$I$20230901$20231002$20240715$20240715$PER$$US-PERRIGO-23US011675$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900141$24090014$1$I$20230901$20231003$20240715$20240715$PER$$US-PERRIGO-23US011712$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900151$24090015$1$I$20230901$20231003$20240715$20240715$PER$$US-PERRIGO-23US011708$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900161$24090016$1$I$20230101$20231002$20240715$20240715$PER$$US-PERRIGO-23US011676$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900171$24090017$1$I$20230901$20231003$20240715$20240715$PER$$US-PERRIGO-23US011673$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900181$24090018$1$I$20230901$20231003$20240715$20240715$PER$$US-PERRIGO-23US011678$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900191$24090019$1$I$20231001$20231003$20240715$20240715$PER$$US-PERRIGO-23US011713$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900201$24090020$1$I$20230901$20231004$20240715$20240715$PER$$US-PERRIGO-23US011734$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900212$24090021$2$F$20230803$20240729$20240715$20240807$EXP$$AT-TEVA-VS-3218251$TEVA$$60$YR$$M$Y$$$20240807$$CN$AT$AT
240900231$24090023$1$I$20240601$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111644$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240715$$HP$US$US
240900241$24090024$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111058$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240715$$HP$US$US
240900252$24090025$2$F$$20240807$20240715$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111609$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$83.46$KG$20240826$$CN$US$US
240900261$24090026$1$I$20240401$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110641$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$58.97$KG$20240715$$CN$US$US
240900271$24090027$1$I$20240412$20240418$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003507$TG THERAPEUTICS$$38$YR$$F$Y$$$20240715$$MD$US$US
240900281$24090028$1$I$20240328$20240419$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003512$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240900291$24090029$1$I$20240417$20240419$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003517$TG THERAPEUTICS$$63$YR$$F$Y$$$20240715$$CN$US$US
240900301$24090030$1$I$20240418$20240419$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003514$TG THERAPEUTICS$$37$YR$$$Y$$$20240715$$HP$US$US
240900311$24090031$1$I$$20240419$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003515$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240900321$24090032$1$I$20240402$20240419$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003516$TG THERAPEUTICS$$58$YR$$F$Y$$$20240715$$CN$US$US
240900341$24090034$1$I$20231101$20240419$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003513$TG THERAPEUTICS$$48$YR$$F$Y$$$20240715$$CN$US$US
240900351$24090035$1$I$20240415$20240419$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003510$TG THERAPEUTICS$$42$YR$$F$Y$$$20240715$$HP$US$US
240900361$24090036$1$I$$20240709$20240715$20240715$30DAY$$US-GSK-US2024085118$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
240900371$24090037$1$I$20240321$20240422$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003460$TG THERAPEUTICS$$53$YR$$F$Y$$$20240715$$CN$US$US
240900381$24090038$1$I$$20240709$20240715$20240715$EXP$$US-SPECGX-T202401515$SPECGX$$$$$$Y$$$20240715$$PH$US$US
240900391$24090039$1$I$20240312$20240708$20240715$20240715$EXP$FR-AFSSAPS-LY2024000792$FR-ROCHE-10000020669$ROCHE$$70$YR$E$F$Y$84$KG$20240715$$PH$FR$FR
240900401$24090040$1$I$20240524$20240709$20240715$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038852$BOEHRINGER INGELHEIM$$50$YR$A$F$Y$$$20240715$$HP$US$US
240900411$24090041$1$I$20231001$20231008$20240715$20240715$PER$$US-PERRIGO-23US011899$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240900421$24090042$1$I$20231001$20231009$20240715$20240715$PER$$US-PERRIGO-23US011919$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900431$24090043$1$I$20231001$20231009$20240715$20240715$PER$$US-PERRIGO-23US011921$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900441$24090044$1$I$$20240710$20240715$20240715$EXP$$CA-APOTEX-2024AP008228$APOTEX$$80$YR$$M$Y$58$KG$20240715$$HP$CA$CA
240900451$24090045$1$I$20230901$20231005$20240715$20240715$PER$$US-PERRIGO-23US011839$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900461$24090046$1$I$20230901$20231004$20240715$20240715$PER$$US-PERRIGO-23US011787$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900471$24090047$1$I$20230901$20231005$20240715$20240715$PER$$US-PERRIGO-23US011798$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900481$24090048$1$I$20231001$20231011$20240715$20240715$PER$$US-PERRIGO-23US012010$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900491$24090049$1$I$20230901$20231004$20240715$20240715$PER$$US-PERRIGO-23US011776$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900501$24090050$1$I$20230901$20231005$20240715$20240715$PER$$US-PERRIGO-23US011781$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900511$24090051$1$I$20231001$20231010$20240715$20240715$PER$$US-PERRIGO-23US011970$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900521$24090052$1$I$$20231006$20240715$20240715$PER$$US-PERRIGO-23US011792$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900531$24090053$1$I$20231001$20231011$20240715$20240715$PER$$US-PERRIGO-23US012009$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900541$24090054$1$I$20231004$20231009$20240715$20240715$PER$$US-PERRIGO-23US011862$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900551$24090055$1$I$20231001$20231010$20240715$20240715$PER$$US-PERRIGO-23US011977$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900561$24090056$1$I$20220801$20231005$20240715$20240715$PER$$US-PERRIGO-23US011736$PERRIGO$$71$YR$$F$Y$60.771$KG$20240715$$CN$US$US
240900571$24090057$1$I$20220201$20231006$20240715$20240715$PER$$US-PERRIGO-23US011763$PERRIGO$$78$YR$$M$Y$77.098$KG$20240715$$CN$US$US
240900581$24090058$1$I$20230922$20231009$20240715$20240715$PER$$US-PERRIGO-23US011849$PERRIGO$$45$YR$$M$Y$70.295$KG$20240715$$CN$US$US
240900591$24090059$1$I$20231001$20231009$20240715$20240715$PER$$US-PERRIGO-23US011920$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900601$24090060$1$I$20230401$20231005$20240715$20240715$PER$$US-PERRIGO-23US011739$PERRIGO$$47$YR$$M$Y$67.12$KG$20240715$$CN$US$US
240900611$24090061$1$I$20231001$20231010$20240715$20240715$PER$$US-PERRIGO-23US011922$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900621$24090062$1$I$20240703$20240703$20240715$20240715$EXP$GB-MHRA-MED-202407030833047240-QRVZH$GB-Accord-434188$ACCORD$$55$YR$A$M$Y$80$KG$20240715$$MD$GB$GB
240900631$24090063$1$I$20240701$20240703$20240715$20240715$EXP$$US-Accord-434142$ACCORD$$22$YR$A$M$Y$$$20240715$$HP$US$US
240900641$24090064$1$I$20240624$20240701$20240715$20240715$EXP$$US-Accord-433783$ACCORD$$61$YR$A$M$Y$$$20240715$$HP$US$US
240900651$24090065$1$I$$20240704$20240715$20240715$EXP$$US-Accord-434456$ACCORD$Perez M, Barrionuevo V, Arias C, Baehring JM. Favorable Radiographic Response in a Patient With an Oligodendroglioma Treated With Azacitidine and Venetoclax for Acute Myeloid Leukemia. Cureus. 2024 Jun 2;16(6):e61540.$48$YR$A$M$Y$$$20240715$$HP$US$US
240900661$24090066$1$I$$20240703$20240715$20240715$EXP$CA-MHPD-001084244$CA-Accord-434159$ACCORD$$50$YR$A$F$Y$$$20240715$$HP$CA$CA
240900671$24090067$1$I$$20240703$20240715$20240715$EXP$$US-Accord-433944$ACCORD$Javadi T, Morales B, Olson JJ, Kothari S, Zhang L, Abedalthagafi M. Extracavitary primary effusion aJavadi T, Morales B, Olson JJ, Kothari S, Zhang L, Abedalthagafi M. Extracavitary primary effusion lymphoma presenting as a solitary brain mass. CNS Oncology. 2024;13(1):2357535. DOI: 10.1080/20450907.2024.2357535.$62$YR$A$M$Y$$$20240715$$MD$US$US
240900681$24090068$1$I$$20240703$20240715$20240715$EXP$$US-Accord-433947$ACCORD$Khan MS, Ahmed O, Nwaedozie S. Anaconda Right Coronary Artery. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(Suppl 1). DOI:10.1161/atvb.43.suppl_1.442.$61$YR$A$M$Y$$$20240715$$MD$US$US
240900691$24090069$1$I$20240613$20240703$20240715$20240715$EXP$CN-HENLIUS-24CN015743$CN-Accord-435403$ACCORD$$53$YR$A$F$Y$58$KG$20240715$$MD$CN$CN
240900701$24090070$1$I$$20240704$20240715$20240715$EXP$$ES-Accord-434166$ACCORD$Sanchez-Guixe M, Muinos F, Pinheiro-Santin M, Gonzalez-Huici V, Rodriguez-Hernandez CJ, Avgustinova A, et al. Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer Discovery. 2024;14(6):953-64.$2$DEC$A$F$Y$$$20240715$$MD$ES$ES
240900711$24090071$1$I$$20240703$20240715$20240715$EXP$CA-MHPD-E2B_07073001$CA-Accord-434071$ACCORD$$56$YR$A$F$Y$$$20240715$$HP$CA$CA
240900721$24090072$1$I$20240712$20240712$20240712$20240712$DIR$710041$$FDA-CTU$$76$YR$$UNK$N$$$20240712$N$HP$US$
240900731$24090073$1$I$$20240703$20240715$20240715$EXP$CA-MHPD-E2B_07075222$CA-Accord-434082$ACCORD$$68$YR$E$M$Y$$$20240715$$HP$CA$CA
240900742$24090074$2$F$$20240719$20240715$20240729$EXP$$JP-UCBSA-2024034028$UCB$Asai A. Treatment at home in cooperation with local healthcare institutions] Elderly Onset Epilepsy as a Common Disease for the Sake of Stable Old Age. The Journal of the Saitama Medical Society. 2024;58(1):360-2$86$YR$$F$Y$$$20240729$$MD$JP$JP
240900751$24090075$1$I$20231001$20231015$20240715$20240715$PER$$US-PERRIGO-23US012096$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900761$24090076$1$I$20231001$20231013$20240715$20240715$PER$$US-PERRIGO-23US012062$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900771$24090077$1$I$20231001$20231017$20240715$20240715$PER$$US-PERRIGO-23US012087$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900781$24090078$1$I$20231001$20231017$20240715$20240715$PER$$US-PERRIGO-23US012125$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900791$24090079$1$I$$20231017$20240715$20240715$PER$$US-PERRIGO-23US012083$PERRIGO$$$$$F$Y$74.83$KG$20240715$$CN$US$US
240900801$24090080$1$I$20231001$20231016$20240715$20240715$PER$$US-PERRIGO-23US012103$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900811$24090081$1$I$20230801$20231017$20240715$20240715$PER$$US-PERRIGO-23US012092$PERRIGO$$59$YR$$M$Y$77.098$KG$20240715$$CN$US$US
240900821$24090082$1$I$20231003$20231017$20240715$20240715$PER$$US-PERRIGO-23US012152$PERRIGO$$72$YR$$F$Y$66.213$KG$20240715$$CN$US$US
240900831$24090083$1$I$20231001$20231012$20240715$20240715$PER$$US-PERRIGO-23US012016$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900841$24090084$1$I$20231001$20231016$20240715$20240715$PER$$US-PERRIGO-23US012102$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240900851$24090085$1$I$$20240605$20240715$20240715$EXP$$US-BAYER-2024A085944$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240715$$MD$US$US
240900861$24090086$1$I$$20240625$20240715$20240715$PER$$US-APOTEX-2024AP007870$APOTEX$$$$$M$Y$$$20240715$$CN$US$US
240900871$24090087$1$I$20240419$20240423$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003524$TG THERAPEUTICS$$20$YR$$F$Y$$$20240715$$CN$US$US
240900881$24090088$1$I$20240404$20240424$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003462$TG THERAPEUTICS$$30$YR$$F$Y$$$20240715$$PH$US$US
240900891$24090089$1$I$20240401$20240424$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003525$TG THERAPEUTICS$$42$YR$$F$Y$$$20240715$$CN$US$US
240900901$24090090$1$I$20240416$20240424$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003530$TG THERAPEUTICS$$68$YR$$F$Y$96.599$KG$20240715$$CN$US$US
240900911$24090091$1$I$20240418$20240423$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003526$TG THERAPEUTICS$$37$YR$$F$Y$$$20240715$$HP$US$US
240900921$24090092$1$I$20240401$20240423$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003521$TG THERAPEUTICS$$39$YR$$F$Y$$$20240715$$CN$US$US
240900931$24090093$1$I$20240411$20240424$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003527$TG THERAPEUTICS$$46$YR$$F$Y$$$20240715$$CN$US$US
240900941$24090094$1$I$$20240422$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003528$TG THERAPEUTICS$$$$$F$Y$$$20240715$$MD$US$US
240900951$24090095$1$I$20240416$20240423$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003523$TG THERAPEUTICS$$36$YR$$M$Y$120.18$KG$20240715$$CN$US$US
240900961$24090096$1$I$20240423$20240423$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003522$TG THERAPEUTICS$$58$YR$$M$Y$113.83$KG$20240715$$CN$US$US
240900972$24090097$2$F$20240702$20240806$20240715$20240810$EXP$$CN-SA-2024SA201792$SANOFI AVENTIS$$1$YR$I$M$Y$10$KG$20240810$$CN$CN$CN
240900991$24090099$1$I$$20240708$20240715$20240715$EXP$$US-ROCHE-10000020743$ROCHE$$82$YR$E$F$Y$$$20240715$$CN$US$US
240901001$24090100$1$I$20181101$20240708$20240715$20240715$EXP$$NVSC2024CN143539$NOVARTIS$Liu Y, Xiao Z, Zhang J, Dong C, Wu H. Low-dose prednisone plus entecavir in the treatment of hepatitis b virus associated glomerulonephritis with massive proteinuria: a report of 3 cases. JOURNAL OF CLINICAL NEPHROLOGY. 2024;24(6):524-8$56$YR$$F$Y$$$20240715$$HP$CN$CN
240901011$24090101$1$I$20231001$20231023$20240715$20240715$PER$$US-PERRIGO-23US012404$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901021$24090102$1$I$20231001$20231018$20240715$20240715$PER$$US-PERRIGO-23US012207$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901031$24090103$1$I$20231016$20231026$20240715$20240715$PER$$US-PERRIGO-23US012494$PERRIGO$$74$YR$$F$Y$54.422$KG$20240715$$CN$US$US
240901041$24090104$1$I$20210101$20231023$20240715$20240715$PER$$US-PERRIGO-23US012316$PERRIGO$$$$$F$Y$81.633$KG$20240715$$CN$US$US
240901051$24090105$1$I$20231001$20231019$20240715$20240715$PER$$US-PERRIGO-23US012300$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901061$24090106$1$I$20231001$20231019$20240715$20240715$PER$$US-PERRIGO-23US012297$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901071$24090107$1$I$20231001$20231009$20240715$20240715$PER$$US-PERRIGO-23US012184$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240901081$24090108$1$I$20231001$20231018$20240715$20240715$PER$$US-PERRIGO-23US012204$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240901091$24090109$1$I$20231001$20231024$20240715$20240715$PER$$US-PERRIGO-23US012461$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901101$24090110$1$I$20231001$20231021$20240715$20240715$PER$$US-PERRIGO-23US012301$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901111$24090111$1$I$20231001$20231020$20240715$20240715$PER$$US-PERRIGO-23US012311$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901121$24090112$1$I$20231001$20231024$20240715$20240715$PER$$US-PERRIGO-23US012467$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901131$24090113$1$I$20231001$20231020$20240715$20240715$PER$$US-PERRIGO-23US012308$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901141$24090114$1$I$20230901$20231023$20240715$20240715$PER$$US-PERRIGO-23US012314$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901151$24090115$1$I$20231001$20231024$20240715$20240715$PER$$US-PERRIGO-23US012468$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901161$24090116$1$I$20231001$20231018$20240715$20240715$PER$$US-PERRIGO-23US012208$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901171$24090117$1$I$20231001$20231024$20240715$20240715$PER$$US-PERRIGO-23US012406$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240901181$24090118$1$I$20231001$20231024$20240715$20240715$PER$$US-PERRIGO-23US012466$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901191$24090119$1$I$20231001$20231021$20240715$20240715$PER$$US-PERRIGO-23US012302$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901201$24090120$1$I$20240101$20240610$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003683$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240901221$24090122$1$I$20240501$20240612$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003691$TG THERAPEUTICS$$32$YR$$F$Y$$$20240715$$CN$US$US
240901231$24090123$1$I$$20240630$20240715$20240715$EXP$$US-Indoco-000576$INDOCO$Pathan S. Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage. Hosp Pharm. 2024 Aug;59(4):394-406.$82$YR$E$M$Y$$$20240715$$HP$US$US
240901241$24090124$1$I$$20231022$20240715$20240715$PER$$US-PERRIGO-23US012572$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901251$24090125$1$I$$20231025$20240715$20240715$PER$$US-PERRIGO-23US012574$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901261$24090126$1$I$$20231016$20240715$20240715$PER$$US-PERRIGO-23US012569$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901271$24090127$1$I$$20231020$20240715$20240715$PER$$US-PERRIGO-23US012571$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901281$24090128$1$I$20231001$20231028$20240715$20240715$PER$$US-PERRIGO-23US012537$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901291$24090129$1$I$20231001$20231027$20240715$20240715$PER$$US-PERRIGO-23US012539$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901301$24090130$1$I$$20231018$20240715$20240715$PER$$US-PERRIGO-23US012570$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901311$24090131$1$I$$20231022$20240715$20240715$PER$$US-PERRIGO-23US012573$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901321$24090132$1$I$20231001$20231027$20240715$20240715$PER$$US-PERRIGO-23US012538$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901331$24090133$1$I$20231001$20231025$20240715$20240715$PER$$US-PERRIGO-23US012509$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901342$24090134$2$F$20140101$20240809$20240715$20240813$EXP$$US-CHEPLA-2024008630$CHEPLAPHARM$$53$YR$$F$Y$71.209$KG$20240813$$MD$COUNTRY NOT SPECIFIED$US
240901351$24090135$1$I$20240207$20240708$20240715$20240715$EXP$FR-AFSSAPS-RE2024000648$FR-CHEPLA-2024008544$CHEPLAPHARM$$61$YR$$F$Y$70$KG$20240715$$MD$COUNTRY NOT SPECIFIED$FR
240901361$24090136$1$I$20220401$20240708$20240715$20240715$EXP$$US-CHEPLA-2024008612$CHEPLAPHARM$$74$YR$E$M$Y$108.9$KG$20240715$$MD$COUNTRY NOT SPECIFIED$US
240901371$24090137$1$I$$20240613$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003708$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240901381$24090138$1$I$20240531$20240618$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003709$TG THERAPEUTICS$$53$YR$$F$Y$$$20240715$$CN$US$US
240901391$24090139$1$I$20240601$20240619$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003715$TG THERAPEUTICS$$32$YR$$F$Y$$$20240715$$CN$US$US
240901401$24090140$1$I$20240516$20240619$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003713$TG THERAPEUTICS$$46$YR$$M$Y$$$20240715$$CN$US$US
240901411$24090141$1$I$20240617$20240619$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003716$TG THERAPEUTICS$$39$YR$$F$Y$$$20240715$$CN$US$US
240901421$24090142$1$I$20240501$20240614$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003704$TG THERAPEUTICS$$$$$F$Y$102.04$KG$20240715$$CN$US$US
240901432$24090143$2$F$$20240711$20240715$20240722$EXP$$GB-BEH-2024175453$CSL BEHRING$$$$E$$Y$70$KG$20240722$$MD$GB$GB
240901441$24090144$1$I$20240701$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111633$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$103.87$KG$20240715$$CN$US$US
240901461$24090146$1$I$$20231031$20240715$20240715$PER$$US-PERRIGO-23US012696$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901471$24090147$1$I$$20231101$20240715$20240715$PER$$US-PERRIGO-23US012753$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901481$24090148$1$I$$20231030$20240715$20240715$PER$$US-PERRIGO-23US012642$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901491$24090149$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48534$$FDA-CTU$$59$YR$$M$N$86.18$KG$20240712$N$$US$
240901501$24090150$1$I$$20231027$20240715$20240715$PER$$US-PERRIGO-23US012697$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901511$24090151$1$I$$20231102$20240715$20240715$PER$$US-PERRIGO-23US012747$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901521$24090152$1$I$$20231029$20240715$20240715$PER$$US-PERRIGO-23US012604$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901531$24090153$1$I$$20231031$20240715$20240715$PER$$US-PERRIGO-23US012710$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901541$24090154$1$I$$20231102$20240715$20240715$PER$$US-PERRIGO-23US012745$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901551$24090155$1$I$$20231030$20240715$20240715$PER$$US-PERRIGO-23US012644$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901561$24090156$1$I$$20231104$20240715$20240715$PER$$US-PERRIGO-23US012749$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901571$24090157$1$I$$20231104$20240715$20240715$PER$$US-PERRIGO-23US012748$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901581$24090158$1$I$$20231029$20240715$20240715$PER$$US-PERRIGO-23US012603$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901591$24090159$1$I$$20231031$20240715$20240715$PER$$US-PERRIGO-23US012693$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901601$24090160$1$I$$20231031$20240715$20240715$PER$$US-PERRIGO-23US012691$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901631$24090163$1$I$$20240708$20240715$20240715$EXP$$CA-CHEPLA-2024008559$CHEPLAPHARM$$57$YR$$F$Y$$$20240715$$HP$COUNTRY NOT SPECIFIED$CA
240901641$24090164$1$I$$20231102$20240715$20240715$PER$$US-PERRIGO-23US012744$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901651$24090165$1$I$20231028$20231102$20240715$20240715$PER$$US-PERRIGO-23US012711$PERRIGO$$64$YR$$F$Y$74.83$KG$20240715$$CN$US$US
240901661$24090166$1$I$$20231102$20240715$20240715$PER$$US-PERRIGO-23US012746$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901671$24090167$1$I$$20231031$20240715$20240715$PER$$US-PERRIGO-23US012709$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901681$24090168$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48547$$FDA-CTU$$50$YR$$F$N$90.72$KG$20240712$N$$US$
240901691$24090169$1$I$$20231103$20240715$20240715$PER$$US-PERRIGO-23US012790$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901701$24090170$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48617$$FDA-CTU$$$$$F$N$$$20240712$N$HP$US$
240901711$24090171$1$I$$20231031$20240715$20240715$PER$$US-PERRIGO-23US012792$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901721$24090172$1$I$$20231106$20240715$20240715$PER$$US-PERRIGO-23US012830$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240901731$24090173$1$I$$20231103$20240715$20240715$PER$$US-PERRIGO-23US012814$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901741$24090174$1$I$$20231105$20240715$20240715$PER$$US-PERRIGO-23US012819$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901751$24090175$1$I$$20231107$20240715$20240715$PER$$US-PERRIGO-23US012880$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240901761$24090176$1$I$$20231105$20240715$20240715$PER$$US-PERRIGO-23US012818$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901771$24090177$1$I$$20231105$20240715$20240715$PER$$US-PERRIGO-23US012816$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901781$24090178$1$I$$20231105$20240715$20240715$PER$$US-PERRIGO-23US012817$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901791$24090179$1$I$20231001$20240430$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003542$TG THERAPEUTICS$$67$YR$$F$Y$$$20240715$$HP$US$US
240901801$24090180$1$I$20210210$20231108$20240715$20240715$PER$$US-PERRIGO-23US012907$PERRIGO$$62$YR$$M$Y$83.22$KG$20240715$$CN$US$US
240901811$24090181$1$I$20240328$20240424$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003537$TG THERAPEUTICS$$46$YR$$F$Y$$$20240715$$CN$US$US
240901821$24090182$1$I$20240422$20240429$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003539$TG THERAPEUTICS$$43$YR$$F$Y$$$20240715$$CN$US$US
240901831$24090183$1$I$20240424$20240425$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003529$TG THERAPEUTICS$$51$YR$$F$Y$$$20240715$$CN$US$US
240901841$24090184$1$I$20240425$20240426$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003535$TG THERAPEUTICS$$35$YR$$F$Y$$$20240715$$CN$US$US
240901851$24090185$1$I$20240423$20240426$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003533$TG THERAPEUTICS$$36$YR$$F$Y$$$20240715$$HP$US$US
240901861$24090186$1$I$20231127$20240426$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003532$TG THERAPEUTICS$$70$YR$$F$Y$$$20240715$$CN$US$US
240901871$24090187$1$I$20240418$20240426$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003534$TG THERAPEUTICS$$41$YR$$F$Y$$$20240715$$HP$US$US
240901881$24090188$1$I$20240101$20240425$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003531$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240901892$24090189$2$F$20240701$20240802$20240715$20240813$PER$$US-SA-2024SA204260$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240814$$CN$US$US
240901901$24090190$1$I$20210325$20240710$20240715$20240715$EXP$$US-SA-2024SA204875$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240715$$HP$US$US
240901911$24090191$1$I$20231204$20240710$20240715$20240715$EXP$$ES-AUROBINDO-AUR-APL-2024-034425$AUROBINDO$$30$YR$$F$Y$$$20240715$$MD$ES$ES
240901921$24090192$1$I$$20240605$20240715$20240715$EXP$$US-BAYER-2024A085945$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240715$$MD$US$US
240901933$24090193$3$F$20240710$20240820$20240715$20240823$PER$$US-AMGEN-USASP2024138864$AMGEN$$71$YR$E$F$Y$$$20240822$$CN$US$US
240901941$24090194$1$I$$20231106$20240715$20240715$PER$$US-PERRIGO-23US012909$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901951$24090195$1$I$$20231108$20240715$20240715$PER$$US-PERRIGO-23US013030$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901961$24090196$1$I$$20231106$20240715$20240715$PER$$US-PERRIGO-23US012911$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901971$24090197$1$I$$20231109$20240715$20240715$PER$$US-PERRIGO-23US013005$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901981$24090198$1$I$$20231108$20240715$20240715$PER$$US-PERRIGO-23US013003$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240901991$24090199$1$I$$20231103$20240715$20240715$PER$$US-PERRIGO-23US013025$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240902001$24090200$1$I$20231001$20231108$20240715$20240715$PER$$US-PERRIGO-23US012989$PERRIGO$$38$YR$$M$Y$78.458$KG$20240715$$CN$US$US
240902011$24090201$1$I$$20231108$20240715$20240715$PER$$US-PERRIGO-23US013004$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902021$24090202$1$I$20220101$20231109$20240715$20240715$PER$$US-PERRIGO-23US012993$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902031$24090203$1$I$$20210727$20240715$20240715$PER$$CA-PFM-2021-08019$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240715$$MD$CA$CA
240902041$24090204$1$I$$20210727$20240715$20240715$PER$$CA-PFM-2021-08031$PIERRE FABRE MEDICAMENT$$49$YR$$M$Y$$$20240715$$MD$CA$CA
240902051$24090205$1$I$$20210727$20240715$20240715$PER$$CA-PFM-2021-08036$PIERRE FABRE MEDICAMENT$$51$YR$$F$Y$$$20240715$$MD$CA$CA
240902061$24090206$1$I$$20210727$20240715$20240715$PER$$CA-PFM-2021-08032$PIERRE FABRE MEDICAMENT$$37$YR$$M$Y$$$20240715$$MD$CA$CA
240902071$24090207$1$I$$20210727$20240715$20240715$PER$$CA-PFM-2021-08030$PIERRE FABRE MEDICAMENT$$34$YR$$F$Y$$$20240715$$MD$CA$CA
240902081$24090208$1$I$$20210727$20240715$20240715$PER$$CA-PFM-2021-08021$PIERRE FABRE MEDICAMENT$$58$YR$$F$Y$$$20240715$$MD$CA$CA
240902091$24090209$1$I$$20210727$20240715$20240715$PER$$CA-PFM-2021-08020$PIERRE FABRE MEDICAMENT$$20$YR$$F$Y$$$20240715$$MD$CA$CA
240902101$24090210$1$I$$20210727$20240715$20240715$PER$$CA-PFM-2021-08033$PIERRE FABRE MEDICAMENT$$66$YR$$F$Y$$$20240715$$MD$CA$CA
240902111$24090211$1$I$$20210727$20240715$20240715$PER$$CA-PFM-2021-08034$PIERRE FABRE MEDICAMENT$$40$YR$$F$Y$$$20240715$$MD$CA$CA
240902121$24090212$1$I$$20210727$20240715$20240715$PER$$CA-PFM-2021-08022$PIERRE FABRE MEDICAMENT$$32$YR$$F$Y$$$20240715$$MD$CA$CA
240902131$24090213$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08037$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240715$$MD$CA$CA
240902141$24090214$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08040$PIERRE FABRE MEDICAMENT$$28$YR$$F$Y$$$20240715$$MD$CA$CA
240902151$24090215$1$I$$20210727$20240715$20240715$PER$$CA-PFM-2021-08023$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240715$$MD$CA$CA
240902161$24090216$1$I$$20210727$20240715$20240715$PER$$CA-PFM-2021-08029$PIERRE FABRE MEDICAMENT$$27$YR$$F$Y$$$20240715$$MD$CA$CA
240902172$24090217$2$F$20240709$20240715$20240715$20240716$PER$$US-AMGEN-USASP2024139517$AMGEN$$90$YR$E$F$Y$$$20240716$$CN$US$US
240902181$24090218$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08039$PIERRE FABRE MEDICAMENT$$26$YR$$F$Y$$$20240715$$MD$CA$CA
240902191$24090219$1$I$$20220316$20240715$20240715$PER$$CA-PFM-2021-08009$PIERRE FABRE MEDICAMENT$$$$$F$Y$$$20240715$$MD$CA$CA
240902201$24090220$1$I$$20240624$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003731$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240902211$24090221$1$I$20240620$20240621$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003729$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240902221$24090222$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08038$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$$$20240715$$MD$CA$CA
240902231$24090223$1$I$20240601$20240621$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003733$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240902241$24090224$1$I$20240603$20240621$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003732$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240902251$24090225$1$I$20240617$20240621$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003723$TG THERAPEUTICS$$44$YR$$F$Y$$$20240715$$CN$US$US
240902261$24090226$1$I$20240614$20240619$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003727$TG THERAPEUTICS$$36$YR$$F$Y$76.644$KG$20240715$$CN$US$US
240902271$24090227$1$I$20240604$20240619$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003719$TG THERAPEUTICS$$39$YR$$F$Y$$$20240715$$CN$US$US
240902281$24090228$1$I$20240520$20240620$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003717$TG THERAPEUTICS$$70$YR$$F$Y$$$20240715$$CN$US$US
240902291$24090229$1$I$20240621$20240621$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003728$TG THERAPEUTICS$$$$$$Y$$$20240715$$HP$US$US
240902301$24090230$1$I$$20220316$20240715$20240715$PER$$CA-PFM-2021-08011$PIERRE FABRE MEDICAMENT$$59$YR$$F$Y$$$20240715$$MD$CA$CA
240902311$24090231$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08041$PIERRE FABRE MEDICAMENT$$28$YR$$F$Y$$$20240715$$MD$CA$CA
240902321$24090232$1$I$20240530$20240627$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003734$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240902331$24090233$1$I$$20231110$20240715$20240715$PER$$US-PERRIGO-23US013064$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902341$24090234$1$I$$20231112$20240715$20240715$PER$$US-PERRIGO-23US013130$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902351$24090235$1$I$$20231113$20240715$20240715$PER$$US-PERRIGO-23US013177$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902361$24090236$1$I$$20231113$20240715$20240715$PER$$US-PERRIGO-23US013193$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902371$24090237$1$I$$20220316$20240715$20240715$PER$$CA-PFM-2021-08010$PIERRE FABRE MEDICAMENT$$60$YR$$F$Y$$$20240715$$MD$CA$CA
240902381$24090238$1$I$20230901$20231109$20240715$20240715$PER$$US-PERRIGO-23US013031$PERRIGO$$61$YR$$M$Y$65.76$KG$20240715$$CN$US$US
240902391$24090239$1$I$$20231108$20240715$20240715$PER$$US-PERRIGO-23US013045$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902401$24090240$1$I$$20231112$20240715$20240715$PER$$US-PERRIGO-23US013128$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902411$24090241$1$I$$20231113$20240715$20240715$PER$$US-PERRIGO-23US013191$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902421$24090242$1$I$$20231114$20240715$20240715$PER$$US-PERRIGO-23US013250$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902431$24090243$1$I$20231101$20231114$20240715$20240715$PER$$US-PERRIGO-23US013153$PERRIGO$$70$YR$$M$Y$95.238$KG$20240715$$CN$US$US
240902441$24090244$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48525$$FDA-CTU$$$$$M$N$$$20240711$N$HP$US$
240902451$24090245$1$I$20240710$20240712$20240712$20240712$DIR$710046$$FDA-CTU$$29$YR$$F$N$60.75$KG$20240712$Y$CN$US$
240902461$24090246$1$I$$20231117$20240715$20240715$PER$$US-PERRIGO-23US013310$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902471$24090247$1$I$$20231116$20240715$20240715$PER$$US-PERRIGO-23US013311$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902481$24090248$1$I$20230401$20231110$20240715$20240715$PER$$US-PERRIGO-23US013061$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240902491$24090249$1$I$$20231110$20240715$20240715$PER$$US-PERRIGO-23US013063$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902501$24090250$1$I$$20231117$20240715$20240715$PER$$US-PERRIGO-23US013309$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902521$24090252$1$I$$20231109$20240715$20240715$PER$$US-PERRIGO-23US013032$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902531$24090253$1$I$$20231113$20240715$20240715$PER$$US-PERRIGO-23US013133$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902541$24090254$1$I$$20231110$20240715$20240715$PER$$US-PERRIGO-23US013093$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240902551$24090255$1$I$20231013$20231113$20240715$20240715$PER$$US-PERRIGO-23US013122$PERRIGO$$$$$F$Y$68.027$KG$20240715$$CN$US$US
240902561$24090256$1$I$$20231110$20240715$20240715$PER$$US-PERRIGO-23US013035$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240902571$24090257$1$I$$20240612$20240715$20240715$PER$$US-ROCHE-10000002590$ROCHE$$$$E$M$Y$$$20240715$$CN$US$US
240902591$24090259$1$I$20230301$20240712$20240715$20240715$EXP$IT-MINISAL02-994454$IT-JNJFOC-20240732735$JOHNSON AND JOHNSON$$62$YR$A$F$Y$55$KG$20240715$$MD$IT$IT
240902621$24090262$1$I$20240711$20240712$20240712$20240712$DIR$710052$$FDA-CTU$$43$YR$$F$N$$$20240712$N$HP$US$
240902631$24090263$1$I$$20240712$20240712$20240712$DIR$710035$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240902651$24090265$1$I$20230901$20240703$20240715$20240715$EXP$GB-MHRA-MED-202407021235502260-VRZQL$GB-Accord-434329$ACCORD$$$$$M$Y$$$20240715$$MD$GB$GB
240902661$24090266$1$I$20240501$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091841178130-FVBTL$GB-TEVA-VS-3218895$TEVA$$47$YR$$F$Y$$$20240715$$CN$GB$GB
240902671$24090267$1$I$20240601$20240707$20240712$20240712$DIR$FDA-CDER-CTU-2024-48613$$FDA-CTU$$37$YR$$F$N$75.3$KG$20240707$N$HP$US$
240902691$24090269$1$I$20240627$20240703$20240715$20240715$EXP$$US-Accord-434010$ACCORD$$67$YR$E$M$Y$$$20240715$$HP$US$US
240902711$24090271$1$I$$20240703$20240715$20240715$EXP$$HU-Accord-434725$ACCORD$A. Jona, E. Kiss, A. Kenyeres, L. Gergely, Z. Simon, A. Illes. Our experience with Mosunetuzumab. Hematology-Transfusiology. 2024;76.$64$YR$A$M$Y$$$20240715$$MD$HU$HU
240902741$24090274$1$I$$20240703$20240715$20240715$EXP$CA-MHPD-001090818$CA-Accord-434165$ACCORD$$68$YR$E$F$Y$$$20240715$$PH$CA$CA
240902751$24090275$1$I$$20240704$20240715$20240715$EXP$$ES-Accord-434167$ACCORD$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection? Transplant Infectious Disease. 2024;26(3):e14276$6$MON$I$M$Y$$$20240715$$MD$ES$ES
240902761$24090276$1$I$20240527$20240703$20240715$20240715$EXP$CN-HENLIUS-24CN015745$CN-Accord-434797$ACCORD$$60$YR$A$F$Y$65$KG$20240715$$MD$CN$CN
240902771$24090277$1$I$$20240703$20240715$20240715$EXP$CA-MHPD-E2B_07075430$CA-Accord-434065$ACCORD$$46$YR$A$F$Y$$$20240715$$HP$CA$CA
240902781$24090278$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48607$$FDA-CTU$$$$$M$N$$$20240711$N$HP$US$
240902801$24090280$1$I$$20240703$20240715$20240715$EXP$$ES-Accord-434232$ACCORD$Roman SG, Nikolaeva EM, Mosquera JG, Ibanez MG, Roman R, Rodriguez S. Molecular characterization and drug sensitivity of a gastric FGFR2-TACC2 and a pancreatic KRASp.G12C primary culture. Cancer-Research. 2024 Mar 22;84(6).$$$$$Y$$$20240715$$MD$ES$ES
240902811$24090281$1$I$$20231120$20240715$20240715$PER$$US-PERRIGO-23US013312$PERRIGO$$$$$F$Y$65.76$KG$20240715$$CN$US$US
240902821$24090282$1$I$$20240712$20240712$20240712$DIR$710059$$FDA-CTU$$$$$M$N$$$20240712$Y$HP$US$
240902831$24090283$1$I$$20231117$20240715$20240715$PER$$US-PERRIGO-23US013313$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240902841$24090284$1$I$$20240708$20240715$20240715$30DAY$$US-GSK-US2024084443$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
240902851$24090285$1$I$20240527$20240711$20240715$20240715$EXP$$ES-AUROBINDO-AUR-APL-2024-034507$AUROBINDO$$38$YR$$F$Y$$$20240715$$MD$ES$ES
240902871$24090287$1$I$$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008858$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240715$$CN$US$US
240902891$24090289$1$I$$20210630$20240715$20240715$PER$$JP-PFM-2021-07183$PIERRE FABRE MEDICAMENT$$1$YR$$M$Y$$$20240715$$MD$JP$JP
240902901$24090290$1$I$$20210727$20240715$20240715$PER$$JP-PFM-2021-07234$PIERRE FABRE MEDICAMENT$$10$MON$$$Y$$$20240715$$PH$JP$JP
240902911$24090291$1$I$20240601$20240625$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003738$TG THERAPEUTICS$$39$YR$$F$Y$136.05$KG$20240715$$CN$US$US
240902921$24090292$1$I$$20210708$20240715$20240715$PER$$ES-PFM-2021-07268$PIERRE FABRE MEDICAMENT$$$$A$F$Y$4$KG$20240715$$CN$ES$ES
240902931$24090293$1$I$$20240625$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003745$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240902951$24090295$1$I$20240519$20240627$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003754$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240902961$24090296$1$I$20240617$20240627$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003752$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240902971$24090297$1$I$20240607$20240624$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003735$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240902981$24090298$1$I$$20240627$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003749$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240903001$24090300$1$I$20240618$20240627$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003751$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240903011$24090301$1$I$$20231116$20240715$20240715$PER$$US-PERRIGO-23US013372$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240903021$24090302$1$I$$20231117$20240715$20240715$PER$$US-PERRIGO-23US013316$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240903031$24090303$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08148$PIERRE FABRE MEDICAMENT$$48$YR$$F$Y$$$20240715$$MD$CA$CA
240903041$24090304$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08149$PIERRE FABRE MEDICAMENT$$40$YR$$M$Y$$$20240715$$MD$CA$CA
240903051$24090305$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08153$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240715$$MD$CA$CA
240903061$24090306$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08154$PIERRE FABRE MEDICAMENT$$41$YR$$F$Y$$$20240715$$MD$CA$CA
240903071$24090307$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08155$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240715$$MD$CA$CA
240903081$24090308$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08151$PIERRE FABRE MEDICAMENT$$51$YR$$M$Y$$$20240715$$MD$CA$CA
240903091$24090309$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08157$PIERRE FABRE MEDICAMENT$$28$YR$$F$Y$$$20240715$$MD$CA$CA
240903111$24090311$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08156$PIERRE FABRE MEDICAMENT$$28$YR$$F$Y$$$20240715$$MD$CA$CA
240903121$24090312$1$I$$20210802$20240715$20240715$PER$$CA-PFM-2021-08158$PIERRE FABRE MEDICAMENT$$36$YR$$F$Y$$$20240715$$MD$CA$CA
240903131$24090313$1$I$$20210817$20240715$20240715$PER$$CA-PFM-2021-08353$PIERRE FABRE MEDICAMENT$$33$YR$$F$Y$$$20240715$$MD$CA$CA
240903141$24090314$1$I$$20210817$20240715$20240715$PER$$CA-PFM-2021-08354$PIERRE FABRE MEDICAMENT$$29$YR$$F$Y$$$20240715$$MD$CA$CA
240903151$24090315$1$I$$20210817$20240715$20240715$PER$$CA-PFM-2021-08355$PIERRE FABRE MEDICAMENT$$39$YR$$F$Y$$$20240715$$MD$CA$CA
240903162$24090316$2$F$$20240830$20240715$20240830$EXP$$GB-MYLANLABS-2024M1065711$MYLAN$$$$$F$Y$$$20240830$$HP$GB$GB
240903171$24090317$1$I$20240711$20240711$20240715$20240715$EXP$$GB-MYLANLABS-2024M1065212$MYLAN$$54$YR$$F$Y$$$20240715$$MD$GB$GB
240903181$24090318$1$I$$20240711$20240715$20240715$EXP$$AU-MYLANLABS-2024M1065300$MYLAN$$$$$M$Y$$$20240715$$PH$AU$AU
240903191$24090319$1$I$20240611$20240712$20240715$20240715$EXP$$GB-MYLANLABS-2024M1065710$MYLAN$$$$$M$Y$$$20240715$$MD$GB$GB
240903201$24090320$1$I$20240709$20240712$20240715$20240715$EXP$GB-MHRA-MED-202407111100441400-DSWBG$GB-MYLANLABS-2024M1065465$MYLAN$$55$YR$$M$Y$$$20240715$$MD$GB$GB
240903211$24090321$1$I$$20240705$20240715$20240715$EXP$$IT-MYLANLABS-2024M1064082$MYLAN$Grimaudo MS, Laffi A, Gennaro N, Fazio R, D^Orazio F, Sama L, et al. Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule. Front-Oncol 2023; 13.$50$YR$$M$Y$$$20240715$$HP$IT$IT
240903221$24090322$1$I$$20240705$20240715$20240715$EXP$$JP-MYLANLABS-2024M1064824$MYLAN$Matsuyama T, Tomioka Y, Matsuyama H, Kamenohara Y, Tanigawa K, Dotake Y, et al. Severe asthma remaining well-controlled after mepolizumab discontinuation: A case report and literature review. Respirol-Case-Rep 2023; 11 (6):.. 2023;11 (6)$62$YR$$M$Y$$$20240715$$HP$JP$JP
240903231$24090323$1$I$20210901$20240712$20240715$20240715$EXP$GB-MHRA-MED-202407121200052970-HPVRW$GB-MYLANLABS-2024M1065509$MYLAN$$73$YR$$F$Y$$$20240715$$PH$GB$GB
240903241$24090324$1$I$$20240705$20240715$20240715$EXP$$UA-MYLANLABS-2024M1064991$MYLAN$Chernyshova L, Lysytsia O, Stryha N, Beglaryan S, Shadrin O. Bone Marrow Transplantation as a Method of Choice in Treatment of Gain-of-Function Mutations in STAT1. Case Report. Paediatr-East-Eur 2021; 9 (3): 414-423.$22$MON$$M$Y$$$20240715$$HP$UA$UA
240903251$24090325$1$I$$20240702$20240715$20240715$PER$$US-ROCHE-10000018623$ROCHE$$$$$$Y$$$20240715$$CN$US$US
240903261$24090326$1$I$$20220316$20240715$20240715$PER$$CA-PFM-2021-08352$PIERRE FABRE MEDICAMENT$$43$YR$$F$Y$$$20240715$$MD$CA$CA
240903271$24090327$1$I$$20240703$20240715$20240715$EXP$$US-Accord-434400$ACCORD$$60$YR$A$M$Y$$$20240715$$HP$US$US
240903281$24090328$1$I$20231223$20240703$20240715$20240715$EXP$FR-AFSSAPS-NY2024000761$FR-Accord-434392$ACCORD$$30$YR$A$F$Y$50$KG$20240715$$MD$FR$FR
240903295$24090329$5$F$20240703$20240809$20240715$20240918$EXP$$US-Accord-434403$ACCORD$$22$YR$A$F$Y$$$20240918$$MD$US$US
240903311$24090331$1$I$$20240703$20240715$20240715$EXP$CA-MHPD-E2B_07075270$CA-Accord-434069$ACCORD$$53$YR$A$F$Y$$$20240715$$MD$CA$CA
240903321$24090332$1$I$20231201$20240703$20240715$20240715$EXP$ES-AEMPS-1539101$ES-Accord-434214$ACCORD$$2$YR$C$F$Y$12$KG$20240715$$MD$ES$ES
240903331$24090333$1$I$$20240703$20240715$20240715$EXP$CA-MHPD-E2B_07078987$CA-Accord-434085$ACCORD$$70$YR$E$F$Y$$$20240715$$CN$CA$CA
240903341$24090334$1$I$$20240703$20240715$20240715$EXP$CA-MHPD-E2B_07075300$CA-Accord-434064$ACCORD$$41$YR$A$F$Y$$$20240715$$MD$CA$CA
240903351$24090335$1$I$$20240709$20240715$20240715$EXP$$US-BAUSCH-BL-2024-010644$BAUSCH AND LOMB$$58$YR$$F$Y$$$20240715$$CN$US$US
240903361$24090336$1$I$20230101$20240507$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003502$TG THERAPEUTICS$$$$$M$Y$85.261$KG$20240715$$CN$US$US
240903371$24090337$1$I$20240404$20240515$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003486$TG THERAPEUTICS$$34$YR$$F$Y$$$20240715$$CN$US$US
240903381$24090338$1$I$$20240520$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003484$TG THERAPEUTICS$$$$$F$Y$64.399$KG$20240715$$CN$US$US
240903391$24090339$1$I$$20240522$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003479$TG THERAPEUTICS$$$$$F$Y$$$20240715$$HP$US$US
240903401$24090340$1$I$20240228$20240508$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003490$TG THERAPEUTICS$$37$YR$$F$Y$38.095$KG$20240715$$CN$US$US
240903411$24090341$1$I$$20240709$20240715$20240715$PER$$US-ABBVIE-5835253$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240903431$24090343$1$I$$20240702$20240715$20240715$EXP$$CN-ADMA BIOLOGICS INC.-CN-2024ADM000098$ADMA BIOLOGICS$Yan C, Liu TT, Lao, Gao LT. Chronic inflammatory demyelinating polyneuropathy with pulmonary nocardiosis: A case report. Medicine. 2024;103(24):e38544$65$YR$$M$Y$$$20240715$$MD$CN$CN
240903441$24090344$1$I$$20240130$20240715$20240715$EXP$$BR-ULTRAGENYX PHARMACEUTICAL INC.-BR-UGX-24-00225$ULTRAGENYX PHARMACEUTICAL$$14$YR$$F$Y$$$20240715$$MD$BR$BR
240903451$24090345$1$I$$20210712$20240715$20240715$PER$$JP-PFM-2021-07510$PIERRE FABRE MEDICAMENT$$1$YR$$F$Y$$$20240715$$PH$JP$JP
240903461$24090346$1$I$$20240702$20240715$20240715$EXP$$CN-ADMA BIOLOGICS INC.-CN-2024ADM000099$ADMA BIOLOGICS$Yan C, Liu TT, Lao, Gao LT. Chronic inflammatory demyelinating polyneuropathy with pulmonary nocardiosis: A case report. Medicine. 2024;103(24):e38544$65$YR$$M$Y$$$20240715$$MD$CN$CN
240903471$24090347$1$I$$20240704$20240715$20240715$EXP$$HU-ADIENNEP-2024AD000583$ADIENNE PHARMA + BIOTECH$Lakatos V, Gopcsa L, Balogh A, Fabian J, Remenyi P. T-sejtes prolimfocitas leukemia kezelese es transzplantacioja ket eset bemutatasaval [T-cell prolymphocytic leukaemia treatment and transplantation presented through two case reports]. Haematology - Transfusiology. 2024;65-6. Available from: https://doi.org/10.1556/2068.2024.10003 [Article in Hungarian]$$$A$F$Y$$$20240711$$MD$HU$
240903481$24090348$1$I$20240527$20240712$20240712$20240712$DIR$710057$$FDA-CTU$$55$YR$$M$N$130.4$KG$20240712$N$HP$US$
240903491$24090349$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48523$$FDA-CTU$$56$YR$$F$N$88.45$KG$20240712$N$HP$US$
240903501$24090350$1$I$20240708$20240712$20240712$20240712$DIR$710061$$FDA-CTU$$36$YR$$F$N$56.25$KG$20240712$N$CN$US$
240903512$24090351$2$F$20240704$20240717$20240715$20240724$EXP$$CO-ROCHE-10000021717$ROCHE$$$$$F$Y$$$20240724$$CN$CO$CO
240903531$24090353$1$I$20210618$20210902$20240715$20240715$PER$$JP-PFM-2021-07449$PIERRE FABRE MEDICAMENT$$18$MON$$M$Y$$$20240715$$MD$JP$JP
240903561$24090356$1$I$20240622$20240712$20240712$20240712$DIR$710066$$FDA-CTU$$68$YR$$F$N$72$KG$20240712$N$HP$PR$
240903571$24090357$1$I$20210625$20210924$20240715$20240715$PER$$JP-PFM-2021-07589$PIERRE FABRE MEDICAMENT$$2$MON$$F$Y$$$20240715$$PH$JP$JP
240903591$24090359$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144909$NOVARTIS$$$$$$Y$$$20240715$$MD$US$US
240903602$24090360$2$F$$20240605$20240715$20240716$EXP$$US-BAYER-2024A085946$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17.5:e250664$$$$F$Y$$$20240716$$MD$US$US
240903625$24090362$5$F$20240327$20240828$20240715$20240905$EXP$$KR-BLUEPRINT MEDICINES CORPORATION-2024BUS000025$Unknown Manufacturer$$$$$$Y$$$20240903$$MD$KR$KR
240903631$24090363$1$I$20240101$20240708$20240715$20240715$PER$$US-SA-2024SA205183$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240715$$MD$US$US
240903642$24090364$2$F$$20240829$20240715$20240913$PER$$US-SA-2024SA202912$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240913$$MD$US$US
240903651$24090365$1$I$20240712$20240712$20240712$20240712$DIR$710067$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240903661$24090366$1$I$20240712$20240712$20240712$20240712$DIR$710071$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240903671$24090367$1$I$$20240701$20240715$20240715$PER$$US-ROCHE-10000025355$ROCHE$$$$$$Y$$$20240715$$CN$US$US
240903682$24090368$2$F$$20240709$20240715$20240717$PER$$US-ROCHE-10000023281$ROCHE$$$$A$F$Y$48$KG$20240717$$CN$US$US
240903691$24090369$1$I$20240627$20240705$20240715$20240715$PER$$US-SA-2024SA202984$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240715$$MD$US$US
240903702$24090370$2$F$20240101$20240726$20240715$20240807$PER$$US-SA-2024SA202953$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240807$$MD$US$US
240903711$24090371$1$I$20240701$20240711$20240715$20240715$PER$$US-ROCHE-10000025124$ROCHE$$17$YR$T$M$Y$$$20240715$$CN$US$US
240903721$24090372$1$I$$20240712$20240712$20240712$DIR$710069$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240903731$24090373$1$I$20240623$20240712$20240715$20240715$PER$$US-ROCHE-10000026095$ROCHE$$25$YR$A$M$Y$$$20240715$$CN$US$US
240903741$24090374$1$I$$20240712$20240715$20240715$PER$$US-ROCHE-10000026208$ROCHE$$$$I$M$Y$$$20240715$$CN$US$US
240903751$24090375$1$I$$20240712$20240715$20240715$PER$$US-ROCHE-10000025879$ROCHE$$17$YR$T$M$Y$$$20240715$$CN$US$US
240903774$24090377$4$F$20240101$20240715$20240715$20240725$PER$$US-SA-2024SA204447$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240725$$MD$US$US
240903781$24090378$1$I$$20210705$20240715$20240715$PER$$IL-PFM-2021-07252$PIERRE FABRE MEDICAMENT$Pam N, Kridin K, Khamaysi Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatologic Therapy. 2021;34(3)$$$I$$Y$$$20240715$$MD$IL$IL
240903791$24090379$1$I$$20210705$20240715$20240715$PER$$IL-PFM-2021-07253$PIERRE FABRE MEDICAMENT$Pam N, Kridin K, Khamaysi Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatologic Therapy. 2021;34(3)$$$I$$Y$$$20240715$$MD$IL$IL
240903801$24090380$1$I$20210105$20210805$20240715$20240715$PER$FR-AFSSAPS-LY20216398$FR-PFM-2021-07859$PIERRE FABRE MEDICAMENT$$38$YR$$F$Y$55$KG$20240715$$MD$FR$FR
240903811$24090381$1$I$20210623$20210803$20240715$20240715$PER$$JP-PFM-2021-07995$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$$$20240715$$MD$JP$JP
240903821$24090382$1$I$20210815$20210816$20240715$20240715$PER$$FR-PFM-2021-08138$PIERRE FABRE MEDICAMENT$$4$MON$$F$Y$$$20240715$$CN$FR$FR
240903831$24090383$1$I$$20240711$20240715$20240715$EXP$$HU-ADIENNEP-2024AD000584$ADIENNE PHARMA + BIOTECH$Lakatos V, Gopcsa L, Balogh A, Fabian J, Remenyi P. T-sejtes prolimfocitas leukemia kezelese es transzplantacioja ket eset bemutatasaval [T-cell prolymphocytic leukaemia treatment and transplantation presented through two case reports]. Haematology - Transfusiology. 2024;65-6. Available from: https://doi.org/10.1556/2068.2024.10003 [Article in Hungarian]$$$A$M$Y$$$20240711$$MD$HU$
240903841$24090384$1$I$$20210816$20240715$20240715$PER$NL-LRB-00661029$NL-PFM-2021-08172$PIERRE FABRE MEDICAMENT$$$$A$F$Y$110$KG$20240715$$CN$NL$NL
240903851$24090385$1$I$20240101$20240705$20240715$20240715$EXP$$US-PTA-005707$BANNER$$81$YR$E$F$Y$$$20240715$$CN$US$
240903862$24090386$2$F$$20240712$20240715$20240717$EXP$$JP-PFIZER INC-202400212747$PFIZER$Kanno, N.. Epstein-Barr Virus-Positive Mucocutaneous Ulcer With Medication-Related Osteonecrosis of the Jaw Arising in the Mandible of a Rheumatoid Arthritis Patient: A Case Report. Cureus. 2024;16(5):e61280$54$YR$$M$Y$$$20240717$$MD$JP$JP
240903871$24090387$1$I$$20240711$20240715$20240715$EXP$$US-PFIZER INC-202400213450$PFIZER$Mabry, R.. Visual Loss After Intranasal Corticosteroid Injection Incidence, Causes, and Prevention. Arch Otolaryngol. 1981;107:484-486$$$$$Y$$$20240715$$MD$US$US
240903892$24090389$2$F$$20240718$20240715$20240725$EXP$$US-PFIZER INC-202400211166$PFIZER$Gault, K.. THE ROLE OF PHYSICAL THERAPY WITHIN A MULTIDISCIPLINARY PANCREATIC CANCER CLINIC TO OPTIMIZE CARE. Rehabilitation Oncology. 2024;42(2):119$78$YR$$F$Y$$$20240725$$HP$US$US
240903911$24090391$1$I$20220101$20240709$20240715$20240715$EXP$$US-PFIZER INC-202400210373$PFIZER$Scott, N.. Cytomegalovirus Retinitis in an Eye with Unilateral Retinoblastoma: A Case Report. Case Reports in Ophthalmology. 2024;15(1):476-82$2$YR$$M$Y$$$20240715$$MD$US$US
240903922$24090392$2$F$$20240712$20240715$20240718$EXP$$US-PFIZER INC-202400209514$PFIZER$Kuraitis, D.. Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis. JAAD Case Reports. 2024;50:33-36$68$YR$$M$Y$$$20240718$$MD$US$US
240903932$24090393$2$F$20240710$20240724$20240715$20240727$PER$$US-AMGEN-USASP2024137549$AMGEN$$80$YR$E$F$Y$$$20240727$$CN$US$US
240903941$24090394$1$I$$20240709$20240715$20240715$EXP$$CA-PFIZER INC-202400209834$PFIZER$Gourmel, A.. Multimodal therapeutic approach for a severe case of kaposiform lymphangiomatosis from procedural interventions to targeted therapies. Pediatric Blood and Cancer. 2024;71(8):10.1002/pbc.31079$10$YR$$F$Y$$$20240715$$HP$CA$CA
240903951$24090395$1$I$$20240712$20240715$20240715$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039700$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240715$$CN$CA$CA
240903961$24090396$1$I$$20240501$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003552$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240903971$24090397$1$I$20231229$20240502$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003554$TG THERAPEUTICS$$57$YR$$F$Y$61.678$KG$20240715$$CN$US$US
240903991$24090399$1$I$20240328$20240501$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003543$TG THERAPEUTICS$$48$YR$$F$Y$$$20240715$$CN$US$US
240904001$24090400$1$I$20230515$20240610$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003555$TG THERAPEUTICS$$50$YR$$F$Y$74.83$KG$20240715$$CN$US$US
240904011$24090401$1$I$20240502$20240502$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003550$TG THERAPEUTICS$$38$YR$$F$Y$$$20240715$$CN$US$US
240904021$24090402$1$I$20240430$20240502$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003548$TG THERAPEUTICS$$48$YR$$F$Y$$$20240715$$CN$US$US
240904031$24090403$1$I$20240419$20240430$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003540$TG THERAPEUTICS$$40$YR$$M$Y$$$20240715$$CN$US$US
240904041$24090404$1$I$20240101$20240501$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003551$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240904051$24090405$1$I$20240401$20240502$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003549$TG THERAPEUTICS$$50$YR$$F$Y$$$20240715$$CN$US$US
240904061$24090406$1$I$$20240710$20240715$20240715$PER$$US-ROCHE-10000023151$ROCHE$$$$A$M$Y$$$20240715$$CN$US$US
240904071$24090407$1$I$$20240710$20240715$20240715$PER$$US-ROCHE-10000023671$ROCHE$$$$A$M$Y$$$20240715$$CN$US$US
240904081$24090408$1$I$20240622$20240710$20240715$20240715$PER$$US-ROCHE-10000024737$ROCHE$$35$YR$A$F$Y$$$20240715$$CN$US$US
240904092$24090409$2$F$20240430$20240716$20240715$20240722$EXP$FR-AFSSAPS-TO2024001230$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039687$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240722$$PH$FR$FR
240904101$24090410$1$I$$20210705$20240715$20240715$PER$$PT-PFM-2021-07246$PIERRE FABRE MEDICAMENT$Constanca Soares dos Santos, Patricia Vaz Silva, Rui Castelo, Joaquim Tiago. Premature closure of ductus arteriosus after a single dose of diclofenac during pregnancy. BMJ Case Report. 2021;14:1-7$$$N$M$Y$3$KG$20240715$$HP$PT$PT
240904111$24090411$1$I$$20210712$20240715$20240715$PER$$ES-PFM-2021-07455$PIERRE FABRE MEDICAMENT$Guasp M., Esteller D., Ruiz-Garcia R., Naranjo L., Sepulveda Gazquez M., Alejaldre A., at.el.. A case of Morvan^s syndrome with non-characterized neuronal surface antibodies. European Journal of Neurology. 2021;28:871-2$68$YR$$M$Y$$$20240715$$HP$ES$ES
240904121$24090412$1$I$$20210705$20240715$20240715$PER$$IL-PFM-2021-07254$PIERRE FABRE MEDICAMENT$Pam N, Kridin K, Khamaysi Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatologic Therapy. 2021;34(3)$$$I$$Y$$$20240715$$MD$IL$IL
240904131$24090413$1$I$$20210705$20240715$20240715$PER$$IL-PFM-2021-07255$PIERRE FABRE MEDICAMENT$Pam N, Kridin K, Khamaysi Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatologic Therapy. 2021;34(3)$$$I$$Y$$$20240715$$MD$IL$IL
240904141$24090414$1$I$$20210705$20240715$20240715$PER$$IL-PFM-2021-07256$PIERRE FABRE MEDICAMENT$Pam N, Kridin K, Khamaysi Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatologic Therapy. 2021;34(3)$$$I$$Y$$$20240715$$MD$IL$IL
240904151$24090415$1$I$$20210719$20240715$20240715$PER$$IT-PFM-2021-07551$PIERRE FABRE MEDICAMENT$Caruso E, Silvia F, Davide C, Corrado Mambro D, Angel Ortiz Ruizet D. Arrhythmias in Common Arterial Trunk (CAT): Uncommon Atrial Tachycardia in CAT with Anomalous Pulmonary Venous Connection and Re-entry Atrial Tachycardia in CAT with HIV Seropositive Mother. congenital hear disease. 2021;16(4):417-25$$$$F$Y$3$KG$20240715$$HP$IT$IT
240904161$24090416$1$I$$20210726$20240715$20240715$PER$$CH-PFM-2021-07723$PIERRE FABRE MEDICAMENT$Mazzara C, Leoni-Foglia C, Balmer C, Stefani-Gluecksberg A. A neonatal case of Wolff-Parkinson-White syndrome. Swiss Medical Weekly. 2021;115$24$DY$$F$Y$$$20240715$$HP$CH$CH
240904171$24090417$1$I$$20210719$20240715$20240715$PER$$BE-PFM-2021-07552$PIERRE FABRE MEDICAMENT$Francois Dermesropian, Marie-Cecile Nassogne, Jean-Marc Biard, Dana Dumitriu. Prenatal and postnatal diagnosis and management of congenital intracranial hemangioma. Pediatrics and Neonatology. 2021;62:453-55$3$DY$$M$Y$$$20240715$$HP$BE$BE
240904181$24090418$1$I$$20210726$20240715$20240715$PER$$HR-PFM-2021-07724$PIERRE FABRE MEDICAMENT$Dilber D, Habek D, Hrgovic Z, Habek JC. Variceal bleeding due to idiopathic portal vein thrombosis in a 15-year-old boy. Clinical Case Reports. 2019;7:1612-14$15$YR$$M$Y$$$20240715$$HP$HR$HR
240904191$24090419$1$I$$20210719$20240715$20240715$PER$$JP-PFM-2021-07554$PIERRE FABRE MEDICAMENT$Ito H, Shizuku T, Aoki S, Fukutake S, Odo T, Yamamoto K et al. Magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor patient with a clipped cerebral aneurysm and Alzheimers disease : A case report. neurology clinical neuroscience. 2021;9:333-5$60$YR$$F$Y$$$20240715$$HP$JP$JP
240904201$24090420$1$I$$20210804$20240715$20240715$PER$$RO-PFM-2021-07886$PIERRE FABRE MEDICAMENT$Popescu M, Dragan G, Oprescu A. The importance of accurate imaging diagnosis of a vascular anomaly prior to the surgical procedure. Romanian Medical Journal. 2021;LXVIII:301-305$3$YR$$F$Y$$$20240715$$HP$RO$RO
240904211$24090421$1$I$$20210726$20240715$20240715$PER$$ES-PFM-2021-07725$PIERRE FABRE MEDICAMENT$Ching Lopez A, Martinez-Gonzalez LJ, Arrabal L, Saiz J, Gavilan A, Barbas C, et al. Combined Genome, Transcriptome and Metabolome Analysis in the Diagnosis of Childhood Cerebellar Ataxia. International Journal of Molecular Sciences. 2021;22:2990$$$T$F$Y$$$20240715$$HP$ES$ES
240904221$24090422$1$I$$20210809$20240715$20240715$PER$$CA-PFM-2021-07992$PIERRE FABRE MEDICAMENT$Maxwell Ng, Ali S, Sue J, Cullen N, McCulladh S, Perera G et al. Beneficial cognitive effect of lamotrigine in severe acquired brain injury: A case report. Interdisciplinary Neurosurgery: Advanced Techniques and Case Management. 2021;1-5$29$YR$$M$Y$$$20240715$$HP$CA$CA
240904231$24090423$1$I$$20210816$20240715$20240715$PER$$RO-PFM-2021-08309$PIERRE FABRE MEDICAMENT$C Cirstoveanu, A Mihaela Bizubac, C Mustea, S Manolache, A Istrate Barzan, D Sfrijan, et al. Antiproliferative therapy with sirolimus and propranolol for congenital vascular anomalies in newborns Case reports. EXPERIMENTAL AND THERAPEUTIC MEDICINE. 2021;22:1097$$$N$F$Y$$$20240715$$HP$RO$RO
240904241$24090424$1$I$$20210816$20240715$20240715$PER$$RO-PFM-2021-08318$PIERRE FABRE MEDICAMENT$Cirstoveanu C, Bizubac AM, Mustea C, Manolache S, Barzan AI, Sfrijan D, et al. Antiproliferative therapy with sirolimus and propranolol for congenital vascular anomalies in newborns Case reports. EXPERIMENTAL AND THERAPEUTIC MEDICINE. 2021;22:1097$$$I$F$Y$$$20240715$$HP$RO$RO
240904251$24090425$1$I$$20210816$20240715$20240715$PER$$RO-PFM-2021-08319$PIERRE FABRE MEDICAMENT$Cirstoveanu C, Bizubac AM, Mustea C, Manolache S, Barzan AI, Sfrijan D, et al. Antiproliferative therapy with sirolimus and propranolol for congenital vascular anomalies in newborns Case reports. EXPERIMENTAL AND THERAPEUTIC MEDICINE. 2021;22:1097$10$DY$$F$Y$$$20240715$$HP$RO$RO
240904261$24090426$1$I$$20210728$20240715$20240715$PER$$JP-PFM-2021-07801$PIERRE FABRE MEDICAMENT$Nakata T, Tachi M, Yasuda K, Nakashima S, Minamoto T, Oda T. Damus-Kay-Stansel procedure with ventricular septal defect enlargement. Asian Cardiovascular + Thoracic Annals. 2021;29(5):405-407$$$I$M$Y$3$KG$20240715$$HP$JP$JP
240904271$24090427$1$I$$20210802$20240715$20240715$PER$$ES-PFM-2021-07849$PIERRE FABRE MEDICAMENT$Naharro-Fernandez C, deQuintana-Sancho A, Lopez-Sundh A, Reguero-del Cura L, Gonzalez-Lopez M. Successful treatment of idiopathic Harlequin Syndrome with oxybutynin and propranolol. Australasian Journal of Dermatology. 2021$47$YR$$F$Y$$$20240715$$HP$ES$ES
240904281$24090428$1$I$$20210816$20240715$20240715$PER$$RO-PFM-2021-08317$PIERRE FABRE MEDICAMENT$Cirstoveanu C, Bizubac AM, Mustea C, Manolache S, Barzan AI, Sfrijan D, et al. Antiproliferative therapy with sirolimus and propranolol for congenital vascular anomalies in newborns Case reports. EXPERIMENTAL AND THERAPEUTIC MEDICINE. 2021;22:1097$$$I$F$Y$$$20240715$$HP$RO$RO
240904291$24090429$1$I$20240503$20240503$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003557$TG THERAPEUTICS$$54$YR$$F$Y$$$20240715$$HP$US$US
240904301$24090430$1$I$$20240506$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003558$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240904311$24090431$1$I$$20210817$20240715$20240715$PER$$TR-PFM-2021-08262$PIERRE FABRE MEDICAMENT$Sak M, Gokce I, Cicek N, Yildiz N, Baltacioglu F, Harika A. Renal Artery Stenosis Presenting with Resistant Hypertension in Children and Adolescents: A Report of Five Cases. Turkish Journal of Nephrology. 2020;29(3):242-6$8$YR$$M$Y$$$20240715$$HP$TR$TR
240904321$24090432$1$I$20240415$20240506$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003566$TG THERAPEUTICS$$59$YR$$F$Y$$$20240715$$CN$US$US
240904331$24090433$1$I$20240501$20240507$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003568$TG THERAPEUTICS$$40$YR$$F$Y$$$20240715$$CN$US$US
240904341$24090434$1$I$20240508$20240509$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003575$TG THERAPEUTICS$$62$YR$$F$Y$$$20240715$$CN$US$US
240904351$24090435$1$I$20240430$20240506$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003562$TG THERAPEUTICS$$72$YR$$F$Y$$$20240715$$CN$US$US
240904361$24090436$1$I$20240401$20240506$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003563$TG THERAPEUTICS$$73$YR$$F$Y$$$20240715$$CN$US$US
240904371$24090437$1$I$20240501$20240506$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003565$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240904381$24090438$1$I$20240507$20240509$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003574$TG THERAPEUTICS$$52$YR$$F$Y$$$20240715$$CN$US$US
240904391$24090439$1$I$20240415$20240506$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003560$TG THERAPEUTICS$$70$YR$$F$Y$$$20240715$$CN$US$US
240904401$24090440$1$I$$20240430$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003545$TG THERAPEUTICS$$$$$$Y$$$20240715$$HP$US$US
240904411$24090441$1$I$$20240508$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003583$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240904421$24090442$1$I$$20240508$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003572$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240904431$24090443$1$I$20240215$20240508$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003573$TG THERAPEUTICS$$56$YR$$F$Y$$$20240715$$HP$US$US
240904441$24090444$1$I$20240420$20240501$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003547$TG THERAPEUTICS$$53$YR$$F$Y$$$20240715$$CN$US$US
240904451$24090445$1$I$20240503$20240509$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003576$TG THERAPEUTICS$$30$YR$$F$Y$46.259$KG$20240715$$CN$US$US
240904461$24090446$1$I$$20240430$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003546$TG THERAPEUTICS$$$$$$Y$$$20240715$$HP$US$US
240904481$24090448$1$I$20240426$20240509$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003553$TG THERAPEUTICS$$54$YR$$F$Y$$$20240715$$HP$US$US
240904491$24090449$1$I$$20240502$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003567$TG THERAPEUTICS$$$$$$Y$$$20240715$$HP$US$US
240904502$24090450$2$F$20240110$20240916$20240715$20240926$EXP$$IT-AUROBINDO-AUR-APL-2024-033913$AUROBINDO$$$$E$F$Y$$$20240926$$MD$IT$IT
240904511$24090451$1$I$$20240712$20240712$20240712$DIR$710074$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240904521$24090452$1$I$20240712$20240712$20240712$20240712$DIR$710073$$FDA-CTU$$$$$UNK$N$$$20240712$N$CN$US$
240904531$24090453$1$I$20240703$20240712$20240712$20240712$DIR$710072$$FDA-CTU$$81$YR$$M$N$81$KG$20240712$N$MD$US$
240904541$24090454$1$I$$20240705$20240715$20240715$EXP$$US-MYLANLABS-2024M1064870$MYLAN$Sanchez A, Elliott EI, Wang P, Spichler-Moffarah A. Legionella pneumophila and Staphylococcus aureus co-infections in a patient with SARS-CoV-2. BMJ-Case-Rep 2022; 15 (3):.$6$DEC$$M$Y$$$20240715$$HP$US$US
240904551$24090455$1$I$$20240705$20240715$20240715$EXP$$US-MYLANLABS-2024M1064918$MYLAN$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep 2023; 40 14-18.$35$YR$$F$Y$$$20240715$$MD$US$US
240904561$24090456$1$I$$20240705$20240715$20240715$EXP$$US-MYLANLABS-2024M1064911$MYLAN$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep 2023; 40 14-18.$$$$F$Y$$$20240715$$MD$US$US
240904571$24090457$1$I$$20240705$20240715$20240715$EXP$$US-MYLANLABS-2024M1064914$MYLAN$Herzberg SD, Bosso AM, Sangal NR, Bosso JV. Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease. Ann-Allergy-Asthma-Immunol 2023; 131 (4): 528-530.$$$$F$Y$$$20240715$$MD$US$US
240904583$24090458$3$F$20240418$20240729$20240715$20240808$EXP$$JP-ROCHE-3573201$ROCHE$$74$YR$E$F$Y$48$KG$20240808$$MD$JP$JP
240904591$24090459$1$I$20240409$20240708$20240715$20240715$EXP$$IE-TAKEDA-2024TUS039414$TAKEDA$$34$YR$$M$Y$$$20240715$$CN$IE$IE
240904601$24090460$1$I$20240503$20240510$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003580$TG THERAPEUTICS$$43$YR$$F$Y$$$20240715$$HP$US$US
240904611$24090461$1$I$$20240712$20240715$20240715$EXP$GB-MHRA-MED-202407121609474360-QJFYN$GB-SANDOZ INC.-SDZ2024GB064973$SANDOZ$$45$YR$$F$Y$$$20240715$$CN$GB$GB
240904621$24090462$1$I$$20240701$20240715$20240715$PER$$US-APOTEX-2024AP007909$APOTEX$$$$$$Y$$$20240715$$CN$US$US
240904633$24090463$3$F$20191012$20240809$20240715$20240902$EXP$$CA-CELLTRION INC.-2019CA025197$CELLTRION$$$$$$Y$$$20240902$$MD$CA$CA
240904641$24090464$1$I$20240510$20240510$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003581$TG THERAPEUTICS$$48$YR$$F$Y$$$20240715$$HP$US$US
240904651$24090465$1$I$20240108$20240514$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003592$TG THERAPEUTICS$$54$YR$$M$Y$$$20240715$$CN$US$US
240904661$24090466$1$I$20231216$20240510$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003585$TG THERAPEUTICS$$59$YR$$F$Y$62.132$KG$20240715$$MD$US$US
240904671$24090467$1$I$20231206$20240513$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003587$TG THERAPEUTICS$$68$YR$$F$Y$$$20240715$$CN$US$US
240904681$24090468$1$I$$20240514$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003593$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240904691$24090469$1$I$$20240510$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003584$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240904701$24090470$1$I$20240510$20240513$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003588$TG THERAPEUTICS$$53$YR$$F$Y$$$20240715$$CN$US$US
240904711$24090471$1$I$20240424$20240510$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003579$TG THERAPEUTICS$$58$YR$$M$Y$$$20240715$$CN$US$US
240904721$24090472$1$I$20240509$20240513$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003586$TG THERAPEUTICS$$47$YR$$M$Y$$$20240715$$CN$US$US
240904731$24090473$1$I$20230901$20240709$20240715$20240715$EXP$$GB-JNJFOC-20240723908$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240715$$CN$GB$GB
240904741$24090474$1$I$$20240708$20240715$20240715$30DAY$$US-GSK-US2024084979$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
240904751$24090475$1$I$$20240708$20240715$20240715$EXP$$AR-009507513-2407ARG008478$MERCK$$72$YR$$F$Y$$$20240715$$CN$AR$AR
240904761$24090476$1$I$20240520$20240710$20240715$20240715$EXP$$US-GILEAD-2024-0680505$GILEAD$$83$YR$E$M$Y$$$20240715$$CN$US$US
240904771$24090477$1$I$20240101$20240709$20240715$20240715$PER$$US-SA-2024SA204501$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240715$$MD$US$US
240904781$24090478$1$I$20240101$20240708$20240715$20240715$PER$$US-SA-2024SA204530$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240715$$MD$US$US
240904791$24090479$1$I$20240101$20240708$20240715$20240715$EXP$$US-ORGANON-O2407USA000906$ORGANON$$$$$M$Y$$$20240715$$CN$US$US
240904801$24090480$1$I$$20240711$20240715$20240715$EXP$$FR-TAKEDA-2024TUS061260$TAKEDA$$$$A$M$Y$$$20240715$$CN$GB$FR
240904811$24090481$1$I$$20240712$20240715$20240715$30DAY$$DE-ABBVIE-5589968$ABBVIE$$$$$$Y$$$20240715$$HP$DE$US
240904821$24090482$1$I$20240623$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138485$AMGEN$$42$YR$A$M$Y$$$20240715$$CN$US$US
240904831$24090483$1$I$$20240515$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003595$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240904841$24090484$1$I$20240426$20240528$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003577$TG THERAPEUTICS$$40$YR$$$Y$$$20240715$$CN$US$US
240904851$24090485$1$I$20240513$20240514$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003594$TG THERAPEUTICS$$68$YR$$M$Y$$$20240715$$CN$US$US
240904861$24090486$1$I$20240503$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405130822311460-KYBWF$GB-MYLANLABS-2024M1065254$MYLAN$$38$YR$$M$Y$80$KG$20240715$$CN$GB$GB
240904871$24090487$1$I$20240626$20240705$20240715$20240715$EXP$$GB-MYLANLABS-2024M1065572$MYLAN$$83$YR$$F$Y$65$KG$20240715$$HP$GB$GB
240904881$24090488$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144408$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240904891$24090489$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144638$NOVARTIS$$$$$$Y$$$20240715$$CN$US$US
240904901$24090490$1$I$$20240712$20240715$20240715$PER$$US-TAKEDA-2024TUS071194$TAKEDA$$10$YR$$M$Y$30$KG$20240715$$PH$US$US
240904911$24090491$1$I$20240501$20240516$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003604$TG THERAPEUTICS$$29$YR$$F$Y$$$20240715$$CN$US$US
240904921$24090492$1$I$20240511$20240515$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003600$TG THERAPEUTICS$$41$YR$$F$Y$106.58$KG$20240715$$CN$US$US
240904931$24090493$1$I$20240409$20240516$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003598$TG THERAPEUTICS$$56$YR$$F$Y$$$20240715$$PH$US$US
240904941$24090494$1$I$20240501$20240516$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003599$TG THERAPEUTICS$$49$YR$$F$Y$$$20240715$$CN$US$US
240904951$24090495$1$I$20240101$20240515$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003597$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240904961$24090496$1$I$$20240712$20240712$20240712$DIR$710049$$FDA-CTU$$$$$UNK$N$$$20240712$$CN$US$
240904981$24090498$1$I$20240411$20240516$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003601$TG THERAPEUTICS$$56$YR$$F$Y$$$20240715$$CN$US$US
240904991$24090499$1$I$20240706$20240712$20240712$20240712$DIR$710088$$FDA-CTU$$61$YR$$F$N$$$20240712$Y$HP$US$
240905001$24090500$1$I$20240710$20240712$20240712$20240712$DIR$710084$$FDA-CTU$$74$YR$$F$N$56.25$KG$20240712$N$CN$US$
240905011$24090501$1$I$20240426$20240516$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003602$TG THERAPEUTICS$$47$YR$$F$Y$$$20240715$$CN$US$US
240905021$24090502$1$I$$20240712$20240712$20240712$DIR$710082$$FDA-CTU$$$$$UNK$N$$$20240712$$CN$US$
240905041$24090504$1$I$20240614$20240705$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-033947$AUROBINDO$$93$YR$$M$Y$64.4$KG$20240715$$PH$FR$FR
240905051$24090505$1$I$$20240605$20240715$20240715$EXP$$US-BAYER-2024A085951$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240715$$MD$US$US
240905061$24090506$1$I$20240408$20240705$20240715$20240715$EXP$PT-INFARMED-J202406-426$PT-TEVA-VS-3218253$TEVA$$53$YR$$F$Y$55$KG$20240715$$MD$PT$PT
240905071$24090507$1$I$20240621$20240712$20240712$20240712$DIR$710050$$FDA-CTU$$50$YR$$M$N$$$20240712$Y$$US$
240905081$24090508$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111272$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240715$$HP$US$US
240905092$24090509$2$F$$20240722$20240715$20240726$PER$$US-ABBVIE-5839988$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
240905101$24090510$1$I$$20240523$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003620$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240905111$24090511$1$I$20240101$20240517$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003611$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240905121$24090512$1$I$20240517$20240520$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003613$TG THERAPEUTICS$$47$YR$$M$Y$$$20240715$$CN$US$US
240905131$24090513$1$I$20240401$20240517$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003610$TG THERAPEUTICS$$25$YR$$F$Y$$$20240715$$CN$US$US
240905141$24090514$1$I$20240515$20240521$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003619$TG THERAPEUTICS$$46$YR$$M$Y$$$20240715$$CN$US$US
240905151$24090515$1$I$$20240520$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003621$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240905161$24090516$1$I$20240501$20240522$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003605$TG THERAPEUTICS$$30$YR$$F$Y$$$20240715$$CN$US$US
240905171$24090517$1$I$20240501$20240617$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003618$TG THERAPEUTICS$$30$YR$$F$Y$$$20240715$$CN$US$US
240905181$24090518$1$I$20240520$20240520$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003615$TG THERAPEUTICS$$54$YR$$F$Y$$$20240715$$CN$US$US
240905191$24090519$1$I$20240424$20240520$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003614$TG THERAPEUTICS$$60$YR$$F$Y$$$20240715$$CN$US$US
240905203$24090520$3$F$20240628$20240806$20240715$20240812$30DAY$$US-MYLANLABS-2024M1065118$MYLAN$$$$$$Y$$$20240812$$HP$US$US
240905211$24090521$1$I$$20240711$20240715$20240715$EXP$$US-TAKEDA-2024TUS070840$TAKEDA$$$$$F$Y$$$20240715$$CN$US$US
240905221$24090522$1$I$20240708$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138442$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240905231$24090523$1$I$20240101$20240708$20240715$20240715$EXP$$IL-AMGEN-ISRSP2024136751$AMGEN$$69$YR$E$F$Y$$$20240715$$MD$IL$IL
240905242$24090524$2$F$20240712$20240715$20240715$20240716$PER$$US-AMGEN-USASP2024139578$AMGEN$$72$YR$E$M$Y$$$20240716$$CN$US$US
240905251$24090525$1$I$$20240708$20240715$20240715$PER$$US-ROCHE-10000019576$ROCHE$Hartjes K, Koo D, Al-Ibraheemi A, Sweeny K, Wehrman A, Elisofon S, et al. Early Graft Loss With Suspected Seventh-Day Syndrome Following Pediatric Liver Transplantation. Pediatric Transplantation. 2024-Aug;28 (5):1-12. doi:10.1111/petr.14818.$14$YR$T$F$Y$$$20240715$$HP$US$US
240905261$24090526$1$I$20240401$20240520$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003633$TG THERAPEUTICS$$64$YR$$F$Y$$$20240715$$CN$US$US
240905271$24090527$1$I$20240101$20240516$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003609$TG THERAPEUTICS$$39$YR$$F$Y$$$20240715$$HP$US$US
240905281$24090528$1$I$20240509$20240514$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003590$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240905291$24090529$1$I$20240422$20240520$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003544$TG THERAPEUTICS$$37$YR$$F$Y$79.09$KG$20240715$$HP$US$US
240905301$24090530$1$I$20240506$20240520$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003635$TG THERAPEUTICS$$38$YR$$F$Y$79.09$KG$20240715$$HP$US$US
240905311$24090531$1$I$20230915$20240520$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003616$TG THERAPEUTICS$$64$YR$$F$Y$$$20240715$$CN$US$US
240905321$24090532$1$I$20240513$20240516$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003603$TG THERAPEUTICS$$$$$F$Y$$$20240715$$HP$US$US
240905331$24090533$1$I$20230901$20240520$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003632$TG THERAPEUTICS$$64$YR$$F$Y$$$20240715$$CN$US$US
240905341$24090534$1$I$20240430$20240520$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003569$TG THERAPEUTICS$$39$YR$$M$Y$102.6$KG$20240715$$HP$US$US
240905362$24090536$2$F$$20240904$20240715$20240906$EXP$$CA-TAKEDA-2024TUS070897$TAKEDA$$$$$F$Y$$$20240906$$MD$CA$CA
240905371$24090537$1$I$$20240522$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003625$TG THERAPEUTICS$$$$$F$Y$$$20240715$$HP$US$US
240905381$24090538$1$I$20240510$20240528$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003636$TG THERAPEUTICS$$40$YR$$$Y$$$20240715$$CN$US$US
240905391$24090539$1$I$$20240524$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003637$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240905401$24090540$1$I$20240517$20240522$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003624$TG THERAPEUTICS$$52$YR$$F$Y$61.224$KG$20240715$$CN$US$US
240905411$24090541$1$I$20240101$20240524$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003634$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240905421$24090542$1$I$20240506$20240521$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003623$TG THERAPEUTICS$$30$YR$$F$Y$$$20240715$$CN$US$US
240905431$24090543$1$I$$20240524$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003638$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240905441$24090544$1$I$20240522$20240604$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003626$TG THERAPEUTICS$$52$YR$$F$Y$$$20240715$$CN$US$US
240905451$24090545$1$I$$20240703$20240715$20240715$EXP$$JP-UCBSA-2024034936$UCB$$80$YR$$F$Y$$$20240715$$MD$JP$JP
240905461$24090546$1$I$$20240708$20240715$20240715$PER$$US-ALXN-202407USA000502US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
240905471$24090547$1$I$20240511$20240705$20240715$20240715$EXP$$CN-009507513-2407CHN004026$MERCK$$92$YR$$F$Y$40$KG$20240715$$HP$CN$CN
240905481$24090548$1$I$20240501$20240524$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003641$TG THERAPEUTICS$$33$YR$$F$Y$129.71$KG$20240715$$CN$US$US
240905491$24090549$1$I$20240622$20240705$20240715$20240715$EXP$$CN-009507513-2407CHN004125$MERCK$$70$YR$$M$Y$66.5$KG$20240715$$HP$CN$CN
240905502$24090550$2$F$$20240711$20240715$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008653$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240717$$CN$US$US
240905511$24090551$1$I$$20240702$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008445$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240715$$CN$US$US
240905522$24090552$2$F$$20240711$20240715$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407008418$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240723$$CN$US$US
240905531$24090553$1$I$20240601$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008325$ELI LILLY AND CO$$$$A$F$Y$$$20240715$$CN$US$US
240905541$24090554$1$I$$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007172$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240715$$CN$US$US
240905551$24090555$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007993$ELI LILLY AND CO$$$$A$M$Y$$$20240715$$CN$US$US
240905561$24090556$1$I$20230422$20240705$20240715$20240715$EXP$IT-MINISAL02-923814$IT-TEVA-VS-3217845$TEVA$$1$YR$$F$Y$9$KG$20240715$$PH$IT$IT
240905571$24090557$1$I$20240515$20240529$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003649$TG THERAPEUTICS$$50$YR$$M$Y$$$20240715$$HP$US$US
240905581$24090558$1$I$20240529$20240529$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003648$TG THERAPEUTICS$$46$YR$$F$Y$$$20240715$$CN$US$US
240905591$24090559$1$I$20240503$20240529$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003650$TG THERAPEUTICS$$51$YR$$F$Y$$$20240715$$CN$US$US
240905611$24090561$1$I$20240530$20240530$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003655$TG THERAPEUTICS$$31$YR$$F$Y$$$20240715$$CN$US$US
240905621$24090562$1$I$20240708$20240712$20240712$20240712$DIR$710043$$FDA-CTU$$68$YR$$F$N$87.3$KG$20240712$N$CN$US$
240905631$24090563$1$I$20240510$20240620$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003643$TG THERAPEUTICS$$69$YR$$F$Y$69$KG$20240715$$CN$US$US
240905642$24090564$2$F$20221223$20240918$20240715$20240927$EXP$HU-EMA-DD-20240704-7482827-094920$HU-BIOCON BIOLOGICS LIMITED-BBL2024005037$BIOCON$Cegledi A., Batai A., Dolgos J., Fekete M., Gopcsa L., Kiraly V. et al.. Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol.. Pathology and Oncology Research. 2024;30:01-09$$$$$Y$$$20240927$$HP$HU$HU
240905651$24090565$1$I$20240430$20240530$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003660$TG THERAPEUTICS$$49$YR$$F$Y$$$20240715$$CN$US$US
240905661$24090566$1$I$20240712$20240712$20240712$20240712$DIR$710078$$FDA-CTU$$75$YR$$F$N$$$20240712$N$$US$
240905671$24090567$1$I$20240301$20240712$20240712$20240712$DIR$710056$$FDA-CTU$$66$YR$$F$N$74.25$KG$20240712$N$CN$US$
240905681$24090568$1$I$20240517$20240531$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003656$TG THERAPEUTICS$$57$YR$$F$Y$$$20240715$$CN$US$US
240905691$24090569$1$I$20230101$20240531$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003659$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240905701$24090570$1$I$$20240705$20240715$20240715$EXP$$CA-TAKEDA-2024TUS069515$TAKEDA$$$$$F$Y$$$20240715$$MD$CA$CA
240905711$24090571$1$I$20240601$20240703$20240715$20240715$PER$$US-SA-2024SA200828$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240715$$MD$US$US
240905721$24090572$1$I$$20240709$20240715$20240715$EXP$$JP-SA-2024SA203391$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240715$$CN$JP$JP
240905731$24090573$1$I$$20240709$20240715$20240715$PER$$US-ABBVIE-5840310$ABBVIE$$$$$$Y$$$20240715$$CN$US$US
240905742$24090574$2$F$$20240723$20240715$20240802$EXP$$CH-TEVA-VS-3217033$TEVA$Herken J, Uerlings V, Zundel S, Aichner J, Hodel M. Fetal bladder rupture after high-dose maternal opioid treatment: a case report. Case-Rep-Perinat-Med 2024; 13 (1):.; Herken J, Uerlings V, Zundel S, Aichner J, Hodel M. Fetal bladder rupture after high-dose maternal opioid treatment: a case report. Case-Rep-Perinat-Med 2024; 13 (1):.$$$$M$Y$$$20240802$$MD$CH$CH
240905761$24090576$1$I$$20240605$20240715$20240715$EXP$$US-BAYER-2024A085952$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240715$$MD$US$US
240905781$24090578$1$I$20230101$20240603$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003666$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240905791$24090579$1$I$20240605$20240611$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003674$TG THERAPEUTICS$$45$YR$$F$Y$$$20240715$$CN$US$US
240905801$24090580$1$I$20240517$20240604$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003671$TG THERAPEUTICS$$53$YR$$F$Y$$$20240715$$CN$US$US
240905811$24090581$1$I$20240101$20240604$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003672$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240905821$24090582$1$I$20240401$20240529$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003664$TG THERAPEUTICS$$68$YR$$F$Y$99.773$KG$20240715$$CN$US$US
240905831$24090583$1$I$20240409$20240531$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003667$TG THERAPEUTICS$$72$YR$$F$Y$$$20240715$$CN$US$US
240905841$24090584$1$I$20240515$20240605$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003675$TG THERAPEUTICS$$38$YR$$F$Y$72.562$KG$20240715$$CN$US$US
240905861$24090586$1$I$20231116$20240530$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003661$TG THERAPEUTICS$$30$YR$$F$Y$$$20240715$$CN$US$US
240905871$24090587$1$I$$20240530$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003662$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240905881$24090588$1$I$20240603$20240603$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003665$TG THERAPEUTICS$$61$YR$$F$Y$$$20240715$$CN$US$US
240905891$24090589$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA203748$SANOFI AVENTIS$$$$$M$Y$$$20240715$$CN$US$US
240905901$24090590$1$I$20240601$20240710$20240715$20240715$PER$$US-SA-2024SA205596$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240715$$MD$US$US
240905911$24090591$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA202885$SANOFI AVENTIS$$$$$$Y$$$20240715$$PH$US$US
240905922$24090592$2$F$$20240716$20240715$20240724$PER$$US-SA-2024SA204901$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240725$$CN$US$US
240905932$24090593$2$F$20230601$20240809$20240715$20240815$PER$$US-SA-2024SA202589$SANOFI AVENTIS$$76$YR$E$F$Y$69.388$KG$20240815$$MD$US$US
240905941$24090594$1$I$$20240708$20240715$20240715$EXP$$CN-SANDOZ INC.-SDZ2024CN064026$SANDOZ$Zhang Hongxia Zou Fang Wang Bu Li Maochen  Peng Xiaocui Liu Jianhua Zhang Zhihua. Reports Severe pneumonia caused by Trichosporon asahii a report of 3 cases and a review of the literature. Chinese Journal of Mycology. 2024;19:161-172$50$YR$$M$Y$$$20240715$$MD$CN$CN
240905951$24090595$1$I$$20240709$20240715$20240715$PER$$US-AMGEN-USASP2024137409$AMGEN$$60$YR$A$F$Y$$$20240715$$MD$US$US
240905963$24090596$3$F$20240706$20240718$20240715$20240726$30DAY$$US-AMGEN-USASP2024134959$AMGEN$$69$YR$E$F$Y$87$KG$20240726$$PH$US$US
240905971$24090597$1$I$20240131$20240712$20240712$20240712$DIR$710100$$FDA-CTU$$81$YR$$UNK$N$63.9$KG$20240712$N$CN$US$
240905992$24090599$2$F$20230320$20240722$20240715$20240726$EXP$$ES-JNJFOC-20240724063$JOHNSON AND JOHNSON$$34$YR$A$F$Y$66.9$KG$20240726$$MD$ES$ES
240906001$24090600$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000026340$ROCHE$Hussain S, Faisal H, Dy G. Prolonged disease control despite ALK inhibitor discontinuation in advanced ALK-positive NSCLC. European Journal of Case Reports in Internal Medicine. 2024-Apr-24;11 (6): doi:10.12890/2024_004527.$65$YR$E$M$Y$$$20240715$$MD$US$US
240906011$24090601$1$I$$20240713$20240715$20240715$PER$$US-ROCHE-10000026449$ROCHE$$$$A$F$Y$$$20240715$$CN$US$US
240906021$24090602$1$I$$20240712$20240715$20240715$PER$$US-ROCHE-10000026328$ROCHE$$21$YR$A$F$Y$$$20240715$$HP$US$US
240906032$24090603$2$F$$20240805$20240715$20240807$30DAY$$US-GSK-US2024084981$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
240906041$24090604$1$I$$20240705$20240715$20240715$EXP$$PL-AUROBINDO-AUR-APL-2024-033708$AUROBINDO$Wcis?o S, Bojkowska-Otr?bska K, Salamon A, Skowronek A, Kandziora K, Labuz-Roszak B.. Zespo? cytotoksycznego uszkodzenia cia?a modzelowatego - opis trzech przypadkow.. Polski Przegl?d Neurologiczny.. 2024;20(1):37-42.$48$YR$$M$Y$$$20240715$$HP$PL$PL
240906051$24090605$1$I$20240101$20240710$20240715$20240715$EXP$$CA-UCBSA-2024035576$UCB$$$$$F$Y$$$20240715$$CN$CA$CA
240906061$24090606$1$I$20240101$20240705$20240715$20240715$EXP$$CN-009507513-2407CHN004122$MERCK$$$$$M$Y$$$20240715$$MD$CN$CN
240906072$24090607$2$F$$20240725$20240715$20240803$EXP$$CH-TEVA-VS-3217270$TEVA$Gambini L, Meienberg F, Koeberle R, Potlukova E, Angelini A, Gut L. Hypercalcemia due to severe Amiodarone-induced Thyrotoxicosis - A case report. Swiss-Med-Wkly 2024; 154 (Suppl.) 113S abstr. P144.; Gambini L, Meienberg F, Koeberle R, Potlukova E, Angelini A, Gut L. Hypercalcemia due to severe Amiodarone-induced Thyrotoxicosis - A case report. Swiss-Med-Wkly 2024; 154 (Suppl.) 113S abstr. P144.$60$YR$$M$Y$$$20240803$$HP$CH$CH
240906081$24090608$1$I$20230101$20240522$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003628$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240906091$24090609$1$I$20240101$20240522$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003630$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240906101$24090610$1$I$$20240522$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003629$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240906111$24090611$1$I$$20240529$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003652$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240906121$24090612$1$I$20230718$20240522$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003627$TG THERAPEUTICS$$30$YR$$M$Y$$$20240715$$CN$US$US
240906131$24090613$1$I$20240525$20240605$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003673$TG THERAPEUTICS$$61$YR$$F$Y$$$20240715$$HP$US$US
240906141$24090614$1$I$20240501$20240531$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003663$TG THERAPEUTICS$$25$YR$$F$Y$$$20240715$$CN$US$US
240906151$24090615$1$I$20240501$20240529$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003651$TG THERAPEUTICS$$56$YR$$M$Y$$$20240715$$MD$US$US
240906161$24090616$1$I$$20240528$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003647$TG THERAPEUTICS$$$$$$Y$$$20240715$$MD$US$US
240906171$24090617$1$I$20240101$20240522$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003631$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240906181$24090618$1$I$20240307$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405081048274840-ZSQNM$GB-TEVA-VS-3218878$TEVA$$69$YR$$M$Y$85$KG$20240715$$CN$GB$GB
240906192$24090619$2$F$20240101$20240805$20240715$20240812$EXP$$JP-ROCHE-10000020725$ROCHE$$8$DEC$E$F$Y$$$20240812$$MD$JP$JP
240906202$24090620$2$F$$20240912$20240715$20240918$EXP$$US-ABBVIE-5836560$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
240906211$24090621$1$I$20240531$20240610$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003682$TG THERAPEUTICS$$40$YR$$M$Y$$$20240715$$CN$US$US
240906221$24090622$1$I$20240519$20240610$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003681$TG THERAPEUTICS$$42$YR$$M$Y$$$20240715$$CN$US$US
240906232$24090623$2$F$$20240715$20240715$20240728$PER$$US-APOTEX-2024AP007910$APOTEX$$$$E$F$Y$$$20240728$$CN$US$US
240906241$24090624$1$I$20240527$20240607$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003679$TG THERAPEUTICS$$44$YR$$F$Y$$$20240715$$CN$US$US
240906251$24090625$1$I$$20240607$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003676$TG THERAPEUTICS$$$$$F$Y$77.098$KG$20240715$$CN$US$US
240906261$24090626$1$I$20240531$20240607$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003677$TG THERAPEUTICS$$49$YR$$F$Y$$$20240715$$CN$US$US
240906271$24090627$1$I$$20240703$20240715$20240715$PER$$US-RDY-LIT/USA/24/0010129$DR REDDYS$Halawi H, Harris JE, Goodarzi A, Yau S, Youssef JG, Botros M, et al. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy. 2024 Mar;44(3): 283-289. doi:10.1002/phar.2910.$46$YR$A$M$Y$$$20240715$$HP$US$US
240906291$24090629$1$I$20210201$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407051337161390-LVTDW$GB-TEVA-VS-3218923$TEVA$$84$YR$$F$Y$66$KG$20240715$$PH$GB$GB
240906301$24090630$1$I$$20240710$20240715$20240715$EXP$GB-MHRA-MED-202407101040248900-LGHCQ$GB-MYLANLABS-2024M1064860$MYLAN$$56$YR$$M$Y$78$KG$20240715$$PH$GB$GB
240906312$24090631$2$F$20240622$20240807$20240715$20240807$EXP$$AU-MYLANLABS-2024M1064951$MYLAN$$61$YR$$M$Y$$$20240807$$HP$AU$AU
240906331$24090633$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405161749045790-KCRYP$GB-TEVA-VS-3218855$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240906341$24090634$1$I$20240608$20240612$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003689$TG THERAPEUTICS$$48$YR$$F$Y$83.9$KG$20240715$$CN$US$US
240906351$24090635$1$I$20240606$20240610$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003687$TG THERAPEUTICS$$53$YR$$F$Y$151.02$KG$20240715$$CN$US$US
240906361$24090636$1$I$$20240605$20240715$20240715$EXP$$US-BAYER-2024A085954$BAYER$Zimmer Z.; Hill R.; Fratto V.; Lutgendorf M.A.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Reports. 2024;17:5:e250664$$$$F$Y$$$20240715$$MD$US$US
240906371$24090637$1$I$20240607$20240612$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003693$TG THERAPEUTICS$$43$YR$$M$Y$$$20240715$$CN$US$US
240906381$24090638$1$I$20240220$20240610$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003684$TG THERAPEUTICS$$63$YR$$F$Y$$$20240715$$CN$US$US
240906391$24090639$1$I$20240429$20240611$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003690$TG THERAPEUTICS$$61$YR$$F$Y$$$20240715$$CN$US$US
240906401$24090640$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405121939169600-YKPBD$GB-TEVA-VS-3219113$TEVA$$$$$F$Y$$$20240715$$MD$GB$GB
240906411$24090641$1$I$20240701$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407051155033770-TMNSG$GB-TEVA-VS-3218964$TEVA$$54$YR$$F$Y$66$KG$20240715$$CN$GB$GB
240906421$24090642$1$I$20240626$20240705$20240715$20240715$EXP$$GB-TEVA-VS-3218921$TEVA$$83$YR$$F$Y$65$KG$20240715$$HP$GB$GB
240906431$24090643$1$I$20240101$20240710$20240715$20240715$EXP$$US-ABBVIE-5837095$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240906441$24090644$1$I$20240201$20240613$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003700$TG THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240906451$24090645$1$I$20240101$20240613$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003696$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240906461$24090646$1$I$20240601$20240613$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003699$TG THERAPEUTICS$$40$YR$$F$Y$$$20240715$$CN$US$US
240906471$24090647$1$I$20240610$20240611$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003688$TG THERAPEUTICS$$43$YR$$M$Y$$$20240715$$CN$US$US
240906491$24090649$1$I$20240608$20240612$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003695$TG THERAPEUTICS$$44$YR$$F$Y$$$20240715$$HP$US$US
240906501$24090650$1$I$20240601$20240610$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003680$TG THERAPEUTICS$$61$YR$$M$Y$$$20240715$$CN$US$US
240906511$24090651$1$I$20240702$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407051348598510-SBJGQ$GB-TEVA-VS-3219441$TEVA$$85$YR$$F$Y$$$20240715$$PH$GB$GB
240906521$24090652$1$I$20240401$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407051359595510-KNSMJ$GB-TEVA-VS-3219132$TEVA$$$$$F$Y$$$20240715$$PH$GB$GB
240906532$24090653$2$F$20180706$20240718$20240715$20240723$EXP$$FR-SANDOZ INC.-PHHY2019FR009182$SANDOZ$$76$YR$$F$Y$70$KG$20240723$$MD$FR$FR
240906541$24090654$1$I$$20240703$20240715$20240715$EXP$$TR-UCBSA-2024033775$UCB$Deniz R, Guzelbey T, Mutlu IN, Erdim C, Akkuzu G, Karaalioglu B et al. Successful treatment of a rheumatoid arthritis patient with severe synovial hypertrophy and impaired shoulder function with microwave ablation technique. Skeletal Radiology. 2024;53(8):1639-43$$$A$F$Y$$$20240715$$MD$TR$TR
240906552$24090655$2$F$$20240802$20240715$20240805$PER$$US-ALXN-202407USA000525US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
240906562$24090656$2$F$$20240805$20240715$20240807$PER$$US-AstraZeneca-2024A156657$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
240906571$24090657$1$I$20240610$20240613$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003697$TG THERAPEUTICS$$48$YR$$M$Y$$$20240715$$CN$US$US
240906581$24090658$1$I$20240628$20240710$20240715$20240715$EXP$$AU-MYLANLABS-2024M1065084$MYLAN$$59$YR$$M$Y$$$20240715$$HP$AU$AU
240906591$24090659$1$I$$20240703$20240715$20240715$EXP$$JP-ROCHE-10000022967$ROCHE$Higashide T,  Mastering anti-VEGF therapy: Point commentaries on explanation to the patient and detailed treatment methods. Neovascular glaucoma, Graphic Journal of Ophthalmology.. 2021;10 (4):433-42.$65$YR$E$M$Y$$$20240715$$MD$JP$JP
240906611$24090661$1$I$$20240707$20240715$20240715$PER$$US-JNJFOC-20240721265$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240906621$24090662$1$I$20230701$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033707$AUROBINDO$$35$YR$$$Y$$$20240715$$CN$GB$GB
240906631$24090663$1$I$$20240703$20240715$20240715$EXP$$JP-UCBSA-2024034356$UCB$$$$$M$Y$$$20240715$$MD$JP$JP
240906641$24090664$1$I$20240603$20240617$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003707$TG THERAPEUTICS$$61$YR$$M$Y$$$20240715$$CN$US$US
240906651$24090665$1$I$20240101$20240614$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003703$TG THERAPEUTICS$$$$$F$Y$$$20240715$$CN$US$US
240906681$24090668$1$I$20240707$20240712$20240712$20240712$DIR$710095$$FDA-CTU$$67$YR$$M$N$$$20240712$N$HP$US$
240906691$24090669$1$I$20240427$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405071233161550-ZVCMT$GB-TEVA-VS-3218839$TEVA$$84$YR$$F$Y$51$KG$20240715$$PH$GB$GB
240906701$24090670$1$I$20240101$20240618$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003710$TG THERAPEUTICS$$$$$F$Y$$$20240715$$HP$US$US
240906711$24090671$1$I$20240508$20240614$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003711$TG THERAPEUTICS$$72$YR$$F$Y$$$20240715$$CN$US$US
240906721$24090672$1$I$20240624$20240625$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003736$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240906731$24090673$1$I$20240308$20240618$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003720$TG THERAPEUTICS$$36$YR$$F$Y$$$20240715$$CN$US$US
240906741$24090674$1$I$20240616$20240625$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003740$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240906751$24090675$1$I$20240404$20240620$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003726$TG THERAPEUTICS$$31$YR$$$Y$$$20240715$$CN$US$US
240906771$24090677$1$I$20211201$20240706$20240715$20240715$PER$$US-SA-2024SA203294$SANOFI AVENTIS$$$$C$F$Y$$$20240715$$MD$US$US
240906781$24090678$1$I$$20240702$20240715$20240715$PER$$US-BAYER-2024A095610$BAYER$$55$YR$A$F$Y$$$20240715$$MD$US$US
240906791$24090679$1$I$20240101$20240710$20240715$20240715$PER$$US-ABBVIE-5837161$ABBVIE$$$$$F$Y$$$20240715$$HP$US$US
240906803$24090680$3$F$$20240730$20240715$20240808$EXP$$SE-TAKEDA-2024TUS070859$TAKEDA$$40$YR$$F$Y$$$20240808$$CN$SE$SE
240906811$24090681$1$I$20230505$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405101240033280-FJZBW$GB-TEVA-VS-3218484$TEVA$$44$YR$$M$Y$$$20240715$$CN$GB$GB
240906821$24090682$1$I$20240529$20240614$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003706$TG THERAPEUTICS$$54$YR$$F$Y$$$20240715$$CN$US$US
240906831$24090683$1$I$20240101$20240710$20240715$20240715$EXP$$CA-Orion Corporation ORION PHARMA-24_00029847$ORION$$56$YR$A$M$Y$$$20240715$$MD$CA$
240906841$24090684$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405071205522550-YWQRT$GB-TEVA-VS-3218570$TEVA$$$$$$Y$$$20240715$$PH$GB$GB
240906851$24090685$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405171039194060-GFPCV$GB-TEVA-VS-3218877$TEVA$$$$$$Y$$$20240715$$CN$GB$GB
240906861$24090686$1$I$20240101$20240705$20240715$20240715$EXP$$FR-AUROBINDO-AUR-APL-2024-033759$AUROBINDO$$67$YR$$F$Y$54$KG$20240715$$MD$FR$FR
240906871$24090687$1$I$20240318$20240618$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003721$TG THERAPEUTICS$$36$YR$$F$Y$$$20240715$$CN$US$US
240906881$24090688$1$I$20240611$20240619$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003714$TG THERAPEUTICS$$32$YR$$F$Y$$$20240715$$MD$US$US
240906891$24090689$1$I$20230101$20240703$20240715$20240715$PER$$US-SERVIER-S24008586$SERVIER$$$$$$Y$$$20240715$$MD$US$US
240906901$24090690$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405082151173820-KWLMP$GB-TEVA-VS-3218892$TEVA$$$$$M$Y$89$KG$20240715$$CN$GB$GB
240906911$24090691$1$I$20240625$20240625$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003744$TG THERAPEUTICS$$$$$$Y$$$20240715$$HP$US$US
240906921$24090692$1$I$20240625$20240626$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003747$TG THERAPEUTICS$$$$$$Y$$$20240715$$HP$US$US
240906931$24090693$1$I$20240625$20240625$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003739$TG THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240906941$24090694$1$I$20230101$20240620$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003724$TG THERAPEUTICS$$30$YR$$F$Y$$$20240715$$CN$US$US
240906951$24090695$1$I$$20240620$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003725$TG THERAPEUTICS$$30$YR$$F$Y$$$20240715$$CN$US$US
240906961$24090696$1$I$20240625$20240626$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003746$TG THERAPEUTICS$$$$$$Y$$$20240715$$MD$US$US
240906971$24090697$1$I$$20240705$20240715$20240715$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000076$Unknown Manufacturer$$$$$$Y$$$20240715$$CN$US$US
240906981$24090698$1$I$$20240614$20240715$20240715$PER$$US-TG THERAPEUTICS INC.-TGT003541$TG THERAPEUTICS$$$$$F$Y$$$20240715$$HP$US$US
240906991$24090699$1$I$20240101$20240711$20240715$20240715$EXP$$CA-UCBSA-2024035562$UCB$$$$$F$Y$$$20240715$$MD$CA$CA
240907001$24090700$1$I$20240308$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405051658493230-QSLNK$GB-TEVA-VS-3218902$TEVA$$51$YR$$M$Y$113$KG$20240715$$CN$GB$GB
240907011$24090701$1$I$20240612$20240711$20240715$20240715$EXP$$US-ABBVIE-5837150$ABBVIE$$76$YR$$F$Y$$$20240715$$CN$US$US
240907022$24090702$2$F$$20240819$20240715$20240822$PER$$US-AMGEN-USASP2024138143$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
240907031$24090703$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138527$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240907042$24090704$2$F$$20240715$20240715$20240717$PER$$US-AMGEN-USASP2024139672$AMGEN$$$$$$Y$$$20240717$$CN$US$US
240907051$24090705$1$I$$20240709$20240715$20240715$EXP$$AU-ASTELLAS-2024EU006793$ASTELLAS$$65$YR$$F$Y$$$20240715$$HP$GB$AU
240907061$24090706$1$I$20080821$20240709$20240715$20240715$EXP$$NL-ASTELLAS-2024EU006792$ASTELLAS$$57$YR$$F$Y$$$20240715$$HP$GB$NL
240907071$24090707$1$I$20090301$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-033744$AUROBINDO$$18$YR$$M$Y$$$20240715$$CN$GB$GB
240907081$24090708$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110309$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240715$$HP$US$US
240907091$24090709$1$I$$20240709$20240715$20240715$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-110779$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240715$$MD$IL$IL
240907101$24090710$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202406141859256240-VGQKJ$GB-TEVA-VS-3210655$TEVA$$$$$M$Y$$$20240715$$CN$GB$GB
240907112$24090711$2$F$20240701$20240716$20240715$20240716$EXP$$CA-BAYER-2024A097099$BAYER$$35$YR$A$F$Y$$$20240716$$HP$CA$CA
240907121$24090712$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202406251221265000-PMZRF$GB-TEVA-VS-3219007$TEVA$$6$YR$$M$Y$$$20240715$$PH$GB$GB
240907131$24090713$1$I$$20240711$20240715$20240715$PER$$US-BIOVITRUM-2024-US-009793$BIOVITRUM$$$$N$F$Y$$$20240715$$CN$US$US
240907141$24090714$1$I$20240503$20240709$20240715$20240715$EXP$$CA-Orion Corporation ORION PHARMA-24_00030790$ORION$$77$YR$E$F$Y$90.703$KG$20240715$$HP$CA$
240907151$24090715$1$I$20240412$20240705$20240715$20240715$EXP$$GB-CELLTRION INC.-2024GB016625$CELLTRION$$$$$$Y$$$20240715$$MD$GB$GB
240907161$24090716$1$I$20220101$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405071957286520-FKGWQ$GB-TEVA-VS-3218904$TEVA$$72$YR$$M$Y$64$KG$20240715$$CN$GB$GB
240907171$24090717$1$I$20091101$20240709$20240715$20240715$EXP$$CN-ASTELLAS-2024EU006804$ASTELLAS$$48$YR$$M$Y$52$KG$20240715$$HP$GB$CN
240907181$24090718$1$I$20220906$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405111227472190-RWVFM$GB-TEVA-VS-3218982$TEVA$$71$YR$$M$Y$70$KG$20240715$$CN$GB$GB
240907191$24090719$1$I$$20240703$20240715$20240715$PER$$US-RDY-LIT/USA/24/0010131$DR REDDYS$Halawi H, Harris JE, Goodarzi A, Yau S, Youssef JG, Botros M, et al. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy. 2024 Mar;44(3): 283-289. doi:10.1002/phar.2910.$43$YR$A$M$Y$$$20240715$$HP$US$US
240907201$24090720$1$I$$20240705$20240715$20240715$EXP$IT-MLMSERVICE-20240628-PI115611-00275-1$IT-JUBILANT CADISTA PHARMACEUTICALS-2024IT000956$JUBILANT$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et al. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars.. Toxicology Reports. 2024;13:101683$15$YR$$F$Y$48$KG$20240715$$MD$IT$IT
240907211$24090721$1$I$20230113$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405101026316640-YKWSH$GB-TEVA-VS-3218349$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240907222$24090722$2$F$$20240918$20240715$20240926$EXP$GB-MHRA-MED-202406260950346500-CPFHT$GB-TEVA-VS-3219344$TEVA$$$$$M$Y$$$20240926$$CN$GB$GB
240907231$24090723$1$I$$20240223$20240715$20240715$EXP$GB-MHRA-MED-202402221709435970-DWTBS$GB-TEVA-VS-3163915$TEVA$$68$YR$$M$Y$$$20240715$$HP$GB$GB
240907241$24090724$1$I$20080315$20240709$20240715$20240715$EXP$$NL-ASTELLAS-2024EU006796$ASTELLAS$$61$YR$$F$Y$$$20240715$$HP$GB$NL
240907251$24090725$1$I$20240621$20240705$20240715$20240715$EXP$$IT-AUROBINDO-AUR-APL-2024-033726$AUROBINDO$$71$YR$$F$Y$$$20240715$$MD$IT$IT
240907261$24090726$1$I$20240709$20240710$20240715$20240715$EXP$$US-AMGEN-USASP2024137824$AMGEN$$71$YR$E$F$Y$$$20240715$$CN$US$US
240907271$24090727$1$I$$20240630$20240715$20240715$PER$$US-APOTEX-2024AP007929$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240715$$HP$US$US
240907281$24090728$1$I$$20240711$20240715$20240715$EXP$$US-ABBVIE-5837124$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240907291$24090729$1$I$20240619$20240705$20240715$20240715$EXP$GB-MHRA-MED-202406251708203540-SHNBQ$GB-TEVA-VS-3219156$TEVA$$20$YR$$F$Y$$$20240715$$PH$GB$GB
240907301$24090730$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202406241158499430-PQWVD$GB-TEVA-VS-3219340$TEVA$$$$$$Y$$$20240715$$HP$GB$GB
240907311$24090731$1$I$$20240708$20240715$20240715$EXP$$US-GILEAD-2024-0680392$GILEAD$Bishop MD, Korutaro V., Boyce CL, Beck IA, Styrchak SM, Knowles K, et al.. Characterizing HIV drug resistance in cases of vertical transmission in the VesTed randomized antiretroviral treatment trial. Journal of Acquired Immune Deficiency Syndromes. 2024;96(4):385-392$$$N$F$Y$3.14$KG$20240715$$HP$US$US
240907321$24090732$1$I$20230101$20240711$20240715$20240715$EXP$$US-ABBVIE-5837823$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240907331$24090733$1$I$$20240709$20240715$20240715$PER$$US-009507513-2407USA004805$MERCK$$$$$F$Y$$$20240715$$CN$US$US
240907341$24090734$1$I$$20240705$20240715$20240715$EXP$$IT-AUROBINDO-AUR-APL-2019-065707$AUROBINDO$Pietrafusa N, Ferretti A, Trivisano M, De Palma L, Calabrese C, Carfi Pavia G, et al.. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy. Pediatric Drugs.. 2019;21(4):283-290$15$YR$$F$Y$$$20240715$$HP$IT$IT
240907351$24090735$1$I$20240703$20240712$20240715$20240715$EXP$$CN-ROCHE-10000024850$ROCHE$$54$YR$A$F$Y$$$20240715$$HP$CN$CN
240907361$24090736$1$I$20240712$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008537$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240715$$CN$US$US
240907371$24090737$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008471$ELI LILLY AND CO$$$$$$Y$$$20240715$$CN$US$US
240907381$24090738$1$I$20240709$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111044$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240715$$HP$US$US
240907391$24090739$1$I$20240404$20240705$20240715$20240715$EXP$$GB-AUROBINDO-AUR-APL-2024-034230$AUROBINDO$$24$YR$$F$Y$65$KG$20240715$$CN$GB$GB
240907401$24090740$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111344$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240715$$CN$US$US
240907411$24090741$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111780$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240715$$CN$US$US
240907421$24090742$1$I$$20240710$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109939$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240715$$CN$US$US
240907431$24090743$1$I$20240709$20240711$20240715$20240715$EXP$$US-ABBVIE-5837978$ABBVIE$$67$YR$$M$Y$$$20240715$$CN$US$US
240907451$24090745$1$I$20240701$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111447$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240715$$PH$US$US
240907461$24090746$1$I$20240508$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405131452203780-CTBQR$GB-TEVA-VS-3218303$TEVA$$16$YR$$M$Y$$$20240715$$HP$GB$GB
240907471$24090747$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111593$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$55.34$KG$20240715$$CN$US$US
240907481$24090748$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111515$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240715$$CN$US$US
240907491$24090749$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111389$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240715$$HP$US$US
240907501$24090750$1$I$20240501$20240705$20240715$20240715$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-111202$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$53.3$KG$20240715$$MD$JP$JP
240907511$24090751$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111198$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240715$$MD$US$US
240907521$24090752$1$I$$20240704$20240715$20240715$EXP$$AU-ROCHE-10000023137$ROCHE$$$$$F$Y$$$20240715$$CN$AU$AU
240907531$24090753$1$I$$20240711$20240715$20240715$PER$$US-JNJFOC-20240730670$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240907541$24090754$1$I$$20240710$20240715$20240715$EXP$$US-SANDOZ INC.-SDZ2024US064922$SANDOZ$$$$$$Y$$$20240715$$CN$US$US
240907551$24090755$1$I$20240417$20240712$20240715$20240715$EXP$FR-AFSSAPS-PO2024000737$FR-DSJP-DSE-2024-135527$DAIICHI$$51$YR$$F$Y$84$KG$20240715$$MD$FR$FR
240907561$24090756$1$I$$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024137609$AMGEN$$68$YR$E$F$Y$$$20240715$$MD$US$US
240907572$24090757$2$F$20240718$20240731$20240715$20240803$PER$$US-AMGEN-USASP2024138634$AMGEN$$78$YR$E$F$Y$$$20240803$$PH$US$US
240907581$24090758$1$I$20240630$20240704$20240715$20240715$EXP$$CA-ROCHE-10000024961$ROCHE$$58$YR$A$F$Y$78$KG$20240715$$HP$CA$CA
240907591$24090759$1$I$$20240703$20240715$20240715$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-00897$SAMSUNG BIOEPIS$$$$$F$Y$$$20240715$$CN$CA$CA
240907613$24090761$3$F$20231129$20240801$20240715$20240805$EXP$$DE-SANDOZ INC.-SDZ2024DE065014$SANDOZ$$$$E$F$Y$89$KG$20240805$$MD$DE$DE
240907621$24090762$1$I$20240607$20240710$20240715$20240715$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-13834$IPSEN$$71$YR$E$F$Y$$$20240715$$HP$CA$CA
240907631$24090763$1$I$20240709$20240710$20240715$20240715$EXP$$US-ABBVIE-5837919$ABBVIE$$67$YR$$F$Y$$$20240715$$CN$US$US
240907661$24090766$1$I$20240701$20240712$20240712$20240712$DIR$710099$$FDA-CTU$$62$YR$$F$N$83.7$KG$20240712$N$HP$US$
240907672$24090767$2$F$$20240723$20240715$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111572$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240801$$PH$US$US
240907684$24090768$4$F$20240801$20240926$20240715$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111616$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$70.31$KG$20240930$$CN$US$US
240907702$24090770$2$F$20201201$20240806$20240715$20240814$EXP$$TR-UPSHER-SMITH LABORATORIES, LLC-20240700012$UPSHER SMITH LABORATORIES$Kaya Akca U.; Sener S.; Batu E.D.; Balik Z.; Basaran O.; Bilginer Y. et al.. Drug-induced lupus erythematosus in childhood: Case-based review. Lupus. 2024;33:7:737-748$11$YR$$F$Y$$$20240814$$$TR$TR
240907711$24090771$1$I$$20240708$20240715$20240715$30DAY$$US-GSK-US2024084966$GLAXOSMITHKLINE$$$$$M$Y$$$20240715$$PH$US$US
240907722$24090772$2$F$20240612$20240729$20240715$20240801$EXP$$DE-DSJP-DSE-2024-135571$DAIICHI$$59$YR$$M$Y$105$KG$20240801$$MD$DE$DE
240907732$24090773$2$F$20240601$20240727$20240715$20240809$PER$$US-APOTEX-2024AP007913$APOTEX$$$$$M$Y$$$20240809$$CN$US$US
240907742$24090774$2$F$20240429$20240709$20240715$20240718$EXP$FR-AFSSAPS-RS2024000652$FR-009507513-2407FRA004119$MERCK$$75$YR$$M$Y$87$KG$20240718$$MD$FR$FR
240907751$24090775$1$I$20240101$20240709$20240715$20240715$EXP$$US-SA-2024SA204948$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240715$$MD$US$US
240907771$24090777$1$I$20240707$20240712$20240712$20240712$DIR$710097$$FDA-CTU$$63$YR$$M$N$81$KG$20240712$N$CN$US$
240907781$24090778$1$I$20240712$20240712$20240712$20240712$DIR$710108$$FDA-CTU$$37$YR$$F$N$63$KG$20240712$N$CN$US$
240907791$24090779$1$I$20240625$20240712$20240712$20240712$DIR$710106$$FDA-CTU$$43$YR$$F$N$74.25$KG$20240712$N$CN$US$
240907821$24090782$1$I$20240703$20240712$20240712$20240712$DIR$710098$$FDA-CTU$$54$YR$$F$N$64.8$KG$20240712$N$CN$US$
240907833$24090783$3$F$$20240716$20240715$20240729$EXP$$US-TAKEDA-2024TUS070282$TAKEDA$$$$$M$Y$$$20240729$$CN$US$US
240907841$24090784$1$I$20240710$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48537$$FDA-CTU$$80$YR$$M$N$$$20240712$N$HP$US$
240907851$24090785$1$I$20240711$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139678$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240907861$24090786$1$I$$20240708$20240715$20240715$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500466$MYOVANT SCIENCES$$$$$M$Y$$$20240715$$CN$US$US
240907871$24090787$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA201499$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240715$$CN$US$US
240907882$24090788$2$F$20230101$20240708$20240715$20240717$PER$$US-SA-2024SA204664$SANOFI AVENTIS$$41$YR$A$F$Y$60.7$KG$20240717$$MD$US$US
240907891$24090789$1$I$20240417$20240708$20240715$20240715$PER$$US-SA-2024SA204077$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240715$$CN$US$US
240907901$24090790$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA204604$SANOFI AVENTIS$$$$$F$Y$$$20240715$$PH$US$US
240907911$24090791$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA204695$SANOFI AVENTIS$$9$YR$C$F$Y$31.4$KG$20240715$$MD$US$US
240907921$24090792$1$I$$20240708$20240715$20240715$EXP$$CN-SANDOZ INC.-SDZ2024CN064025$SANDOZ$Hongxia Z., Fang Z., Bu W.  Maochen L., Xiaocui P.,Jianhua L., Zhihua Z. et al. Reports Severe pneumonia caused by Trichosporon asahii a report of 3 cases and a review of the literature. Chinese Journal of Mycology. 2024;19:161-172$74$YR$$M$Y$$$20240715$$MD$CN$CN
240907931$24090793$1$I$20240707$20240709$20240715$20240715$EXP$$CN-ROCHE-10000022384$ROCHE$$69$YR$E$M$Y$75$KG$20240715$$CN$CN$CN
240907945$24090794$5$F$20240101$20240724$20240715$20240729$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-13899$IPSEN$$85$YR$E$F$Y$$$20240729$$HP$CA$CA
240907951$24090795$1$I$20230512$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405151946588760-LDGBP$GB-TEVA-VS-3218571$TEVA$$$$$$Y$$$20240715$$CN$GB$GB
240907961$24090796$1$I$20240106$20240707$20240715$20240715$EXP$FR-AFSSAPS-NY2024000337$EU-BAUSCHBL-2024BNL029708$BAUSCH AND LOMB$$77$YR$$F$Y$59$KG$20240715$$CN$EU$EU
240907971$24090797$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138339$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240907982$24090798$2$F$$20240719$20240715$20240722$EXP$$PL-SA-2024SA204889$SANOFI AVENTIS$Latacz P, Piekorz P, Simka M.. Retrograde Endovascular Recanalization of the Superior Mesenteric Artery for the Treatment of Acute Bowel Ischemia: Case Report.. Surg Tech Dee.. 2024;13(2):205-13$82$YR$E$F$Y$$$20240722$$MD$PL$PL
240907991$24090799$1$I$$20240709$20240715$20240715$PER$$US-MYLANLABS-2024M1064679$MYLAN$$$$$F$Y$63.5$KG$20240715$$CN$US$US
240908011$24090801$1$I$20240503$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405111059449250-DBJQY$GB-TEVA-VS-3218321$TEVA$$$$$M$Y$$$20240715$$CN$GB$GB
240908021$24090802$1$I$20240303$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091750579480-GMBDS$GB-TEVA-VS-3218327$TEVA$$$$$M$Y$$$20240715$$CN$GB$GB
240908031$24090803$1$I$20240521$20240701$20240715$20240715$PER$$US-ROCHE-3570251$ROCHE$$71$YR$E$F$Y$$$20240715$$CN$US$US
240908042$24090804$2$F$$20240920$20240715$20240927$EXP$$NVSC2024US144731$NOVARTIS$Binod KC, Jabbour A, Poudel P, Banki K, Perl A. IL-17A inhibitor-induced leucocytoclastic  vasculitis is responsive to IL-23 blockade in a psoriatic arthritis patient. ANN RHEUM DIS. 2024;83(2):265-7$59$YR$$M$Y$$$20240927$$HP$US$US
240908052$24090805$2$F$20240601$20240711$20240715$20240718$EXP$$NVSC2024US144791$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
240908061$24090806$1$I$$20240712$20240715$20240715$EXP$$NVSC2024GR144851$NOVARTIS$$$$$M$Y$$$20240715$$MD$GR$GR
240908071$24090807$1$I$20230228$20240710$20240715$20240715$EXP$$CN-UCBSA-2024035140$UCB$$$$N$M$Y$5.4$KG$20240715$$CN$CN$CN
240908081$24090808$1$I$$20240701$20240715$20240715$PER$$US-ROCHE-10000023643$ROCHE$Zakowski M, Ladanyi M, Kris M. EGFR Mutations in Small-Cell Lung Cancers in Patients Who Have Never Smoked. n engl j med. 2006-Jul-13;255 (2):213-215.$45$YR$A$F$Y$$$20240715$$MD$US$US
240908102$24090810$2$F$20240101$20240812$20240715$20240814$EXP$$US-UCBSA-2024035571$UCB$$$$$M$Y$$$20240814$$HP$US$US
240908113$24090811$3$F$20240726$20240917$20240715$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111591$BRISTOL MYERS SQUIBB$$59$YR$A$$Y$$$20240924$$MD$US$US
240908131$24090813$1$I$$20240708$20240715$20240715$EXP$$TH-ASTELLAS-2024US019759$ASTELLAS$$$$$F$Y$$$20240715$$MD$TH$TH
240908142$24090814$2$F$20240707$20240802$20240715$20240806$PER$$US-AMGEN-USASP2024139773$AMGEN$$65$YR$E$F$Y$$$20240805$$HP$US$US
240908151$24090815$1$I$20220901$20240701$20240715$20240715$EXP$$US-MEDEXUS PHARMA, INC.-2024MED00299$MEDEXUS PHARMA$Xu E, Thomas S, Habibi B. Intrathecal Methotrexate-Induced Lumbosacral Polyradiculopathy: A Case Report. Pain. Med. Case. Rep. 2024;8(1):31-35$71$YR$$F$Y$$$20240715$$HP$US$US
240908171$24090817$1$I$$20240710$20240715$20240715$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700373$MYOVANT SCIENCES$$$$$M$Y$$$20240715$$MD$US$US
240908181$24090818$1$I$20240121$20240715$20240715$20240715$EXP$PT-INFARMED-T202407-129$NVSC2024PT145123$NOVARTIS$$56$YR$$F$Y$58$KG$20240715$$MD$PT$PT
240908192$24090819$2$F$20240301$20240718$20240715$20240724$EXP$$CO-UCBSA-2024035523$UCB$$9$YR$$M$Y$$$20240724$$CN$CO$CO
240908202$24090820$2$F$20240702$20240716$20240715$20240722$PER$$BR-BRACCO-2024BR04173$BRACCO$$45$YR$$F$Y$$$20240722$$PH$BR$BR
240908211$24090821$1$I$$20240709$20240715$20240715$EXP$$GB-MYLANLABS-2024M1064944$MYLAN$$$$$M$Y$$$20240715$$PH$GB$GB
240908221$24090822$1$I$$20240709$20240715$20240715$EXP$$GB-MYLANLABS-2024M1065018$MYLAN$$$$$F$Y$$$20240715$$MD$GB$GB
240908231$24090823$1$I$20240508$20240709$20240715$20240715$EXP$CH-SM-2024-13569$CH-MYLANLABS-2024M1065196$MYLAN$$72$YR$$F$Y$$$20240715$$HP$CH$CH
240908241$24090824$1$I$20240612$20240705$20240715$20240715$EXP$$FR-ASTELLAS-2024EU006790$ASTELLAS$$19$YR$$F$Y$56$KG$20240715$$MD$FR$FR
240908251$24090825$1$I$20201112$20240708$20240715$20240715$EXP$PL-URPL-1-3290-2020$PL-ROCHE-10000019799$ROCHE$$35$YR$A$F$Y$51$KG$20240715$$MD$PL$PL
240908261$24090826$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138363$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240908272$24090827$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3218348$TEVA$Kuzmishin GB, Turka J, Rudick A. Acute Onset of Multiorgan Toxicity With Bilateral Pleural Effusions Within 6 Weeks of Initiation of Amiodarone Therapy. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.; Kuzmishin GB, Turka J, Rudick A. Acute Onset of Multiorgan Toxicity With Bilateral Pleural Effusions Within 6 Weeks of Initiation of Amiodarone Therapy. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.$72$YR$$M$Y$$$20240802$$HP$US$US
240908282$24090828$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3218392$TEVA$Wong C, Ang G, Malik M, Iqbal S. The Clash of Two Treatments: Antidote Hydroxocobalamin Hinders Hemodialysis. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A5658.; Wong C, Ang G, Malik M, Iqbal S. The Clash of Two Treatments: Antidote Hydroxocobalamin Hinders Hemodialysis. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A5658.$69$YR$$M$Y$$$20240802$$HP$US$US
240908291$24090829$1$I$$20240702$20240715$20240715$EXP$$ZA-ELI_LILLY_AND_COMPANY-ZA202407005767$ELI LILLY AND CO$$2$MON$I$$Y$$$20240715$$CN$ZA$ZA
240908301$24090830$1$I$$20240703$20240715$20240715$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407003462$ELI LILLY AND CO$$63$YR$A$F$Y$66$KG$20240715$$CN$GB$GB
240908312$24090831$2$F$20240630$20240824$20240715$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002558$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240905$$CN$US$US
240908321$24090832$1$I$20240301$20240703$20240715$20240715$EXP$FR-AFSSAPS-LL2024001238$FR-ELI_LILLY_AND_COMPANY-FR202407003316$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240715$$CN$FR$FR
240908331$24090833$1$I$$20240703$20240715$20240715$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407001837$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240715$$CN$AU$AU
240908341$24090834$1$I$$20240708$20240715$20240715$EXP$$GB-PFIZER INC-2017SGN03180$PFIZER$Howell, M et al. Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin. British Journal of Haematology. 2017;179:841-843. BRITISH JOURNAL OF HAEMATOLOGY. 2017;179:841-843$19$YR$$M$Y$$$20240715$$HP$GB$GB
240908351$24090835$1$I$20240601$20240701$20240715$20240715$EXP$FR-AFSSAPS-GR2024000799$FR-ELI_LILLY_AND_COMPANY-FR202407002301$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240715$$CN$FR$FR
240908361$24090836$1$I$20240627$20240704$20240715$20240715$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407007846$ELI LILLY AND CO$$46$YR$A$M$Y$48$KG$20240715$$CN$DE$CN
240908371$24090837$1$I$20170106$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405142045567050-ZYRQP$GB-TEVA-VS-3218497$TEVA$$18$YR$$F$Y$55$KG$20240715$$CN$GB$GB
240908381$24090838$1$I$20240509$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405090820398950-MQBSY$GB-TEVA-VS-3218544$TEVA$$62$YR$$M$Y$78$KG$20240715$$MD$GB$GB
240908391$24090839$1$I$20240704$20240705$20240715$20240715$EXP$$CN-JNJFOC-20240728031$JOHNSON AND JOHNSON$$3$YR$C$M$Y$15$KG$20240715$$HP$CN$CN
240908401$24090840$1$I$20240710$20240711$20240715$20240715$PER$$US-JNJFOC-20240730827$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240715$$CN$US$US
240908411$24090841$1$I$$20240710$20240715$20240715$EXP$$US-GILEAD-2024-0680475$GILEAD$$5$YR$C$M$Y$$$20240715$$CN$US$US
240908421$24090842$1$I$20240607$20240703$20240715$20240715$PER$$US-AstraZeneca-2024A160848$ASTRAZENECA$$$$$$Y$$$20240715$$CN$US$
240908431$24090843$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA202992$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240715$$MD$US$US
240908441$24090844$1$I$20240701$20240710$20240715$20240715$PER$$US-SA-2024SA205609$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240715$$MD$US$US
240908453$24090845$3$F$$20240801$20240715$20240812$EXP$$KR-SAMSUNG BIOEPIS-SB-2024-20545$SAMSUNG BIOEPIS$$$$$$Y$$$20240812$$HP$KR$KR
240908462$24090846$2$F$20240312$20240717$20240715$20240728$EXP$$JP-AMGEN-JPNSP2024116811$AMGEN$$80$YR$E$M$Y$$$20240728$$PH$JP$JP
240908471$24090847$1$I$20240101$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405161522236280-PTZSM$GB-TEVA-VS-3218584$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240908484$24090848$4$F$$20240725$20240715$20240731$EXP$$SK-MYLANLABS-2024M1064888$MYLAN$Horna S, Lecky P, Krivus J, Michalova R, Galajda P, Mokan M.. Anorexia nervosa - a review of complications and nutritional support (case report).. LEKARSKY OBZOR. 2024;73(6):218-25$20$YR$$F$Y$$$20240731$$HP$SK$SK
240908491$24090849$1$I$$20240708$20240715$20240715$EXP$$US-PFIZER INC-PV202400090190$PFIZER$$22$YR$$M$Y$$$20240715$$MD$US$US
240908501$24090850$1$I$20240626$20240709$20240715$20240715$EXP$IT-MINISAL02-993575$IT-PFIZER INC-202400213335$PFIZER$$74$YR$$F$Y$$$20240715$$PH$IT$IT
240908511$24090851$1$I$20240615$20240709$20240715$20240715$EXP$RO-NMA-2024-SP0455$RO-PFIZER INC-202400209428$PFIZER$$75$YR$$F$Y$71$KG$20240715$$MD$RO$RO
240908521$24090852$1$I$$20240709$20240715$20240715$EXP$$AU-PFIZER INC-PV202400074352$PFIZER$$34$YR$$M$Y$110$KG$20240715$$MD$AU$AU
240908532$24090853$2$F$20240606$20240710$20240715$20240717$EXP$$US-PFIZER INC-202400213536$PFIZER$$$$$F$Y$$$20240717$$MD$US$US
240908542$24090854$2$F$$20240717$20240715$20240724$EXP$$PL-MYLANLABS-2024M1065822$MYLAN$Kuc A, Stachura A, Jazdzyk P, Grzelinska J, Swiecicki L. Adjunctive electroconvulsive therapy in the treatment of a patient with comorbid major depressive disorder, posttraumatic stress disorder, and anorexia nervosa - a case report. Postepy-Psychiatrii-i-Neurologii 2024; 33 (1): 43-48.$28$YR$$F$Y$$$20240724$$HP$PL$PL
240908551$24090855$1$I$$20240709$20240715$20240715$EXP$$CA-PFIZER INC-202400211184$PFIZER$$57$YR$$F$Y$$$20240715$$HP$CA$CA
240908561$24090856$1$I$$20240708$20240715$20240715$EXP$$CA-MYOVANT SCIENCES GMBH-2024MYSCI0700272$MYOVANT SCIENCES$$$$$$Y$$$20240715$$MD$CA$CA
240908572$24090857$2$F$20240703$20240715$20240715$20240801$PER$$US-AMGEN-USASP2024139520$AMGEN$$69$YR$E$F$Y$$$20240801$$CN$US$US
240908591$24090859$1$I$20240301$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091936429690-CVRSY$GB-TORRENT-00037088$TORRENT$$29$YR$A$F$Y$$$20240715$$CN$GB$GB
240908601$24090860$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405060340208450-NZPQH$GB-TORRENT-00037060$TORRENT$$$$$F$Y$$$20240715$$CN$GB$GB
240908612$24090861$2$F$20240617$20240716$20240715$20240723$PER$$US-BRACCO-2024US04218$BRACCO$$32$YR$$M$Y$$$20240723$$CN$US$US
240908621$24090862$1$I$$20240711$20240715$20240715$EXP$$US-GILEAD-2024-0680571$GILEAD$$$$T$F$Y$$$20240715$$CN$US$US
240908631$24090863$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091618218170-JRLNH$GB-TORRENT-00037120$TORRENT$$$$$M$Y$$$20240715$$CN$GB$GB
240908651$24090865$1$I$20240511$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405130952401190-ZKJHG$GB-TORRENT-00037119$TORRENT$$31$YR$A$F$Y$$$20240715$$MD$GB$GB
240908661$24090866$1$I$20170106$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405142045567050-ZYRQP$GB-TORRENT-00037124$TORRENT$$18$YR$A$F$Y$55$KG$20240715$$CN$GB$GB
240908671$24090867$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405031749081940-KZGTV$GB-TEVA-VS-3218445$TEVA$$$$$F$Y$71$KG$20240715$$CN$GB$GB
240908681$24090868$1$I$20240319$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405151243130040-JBWGD$GB-TEVA-VS-3218721$TEVA$$$$$M$Y$$$20240715$$PH$GB$GB
240908751$24090875$1$I$20240624$20240712$20240715$20240715$EXP$ES-AEMPS-1546789$NVSC2024ES144533$NOVARTIS$$76$YR$$F$Y$$$20240715$$MD$ES$ES
240908771$24090877$1$I$$20240709$20240715$20240715$EXP$GB-MHRA-MED-202407081941398620-JHQTD$GB-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2407GB05495$INSUD PHARMA$$$$$F$Y$$$20240715$$CN$GB$GB
240908791$24090879$1$I$20240401$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405040826594520-WRQDF$GB-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2407GB05482$INSUD PHARMA$$$$$F$Y$$$20240715$$CN$GB$GB
240908801$24090880$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202406222302414570-RMZLV$GB-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2407GB05492$INSUD PHARMA$$54$YR$$F$Y$68$KG$20240715$$CN$GB$GB
240908811$24090881$1$I$20240101$20240709$20240715$20240715$EXP$$US-ABBVIE-5834637$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240908821$24090882$1$I$$20240704$20240715$20240715$EXP$$US-TORRENT-00013672$TORRENT$$65$YR$E$F$Y$$$20240715$$MD$US$US
240908831$24090883$1$I$20100801$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405122225348480-DJMVQ$GB-TEVA-VS-3218363$TEVA$$$$$F$Y$72$KG$20240715$$CN$GB$GB
240908842$24090884$2$F$$20240708$20240715$20240717$EXP$$IN-TORRENT-00003591$TORRENT$$18$YR$A$M$Y$$$20240717$$MD$IN$IN
240908851$24090885$1$I$20231122$20240701$20240715$20240715$EXP$$IT-SEBELA IRELAND LIMITED-2024SEB00050$SEBELA$Malavasi M, Notarianni G, Pontillo D. et.al. THE CONUNDRUM OF DRUG INTERACTIONS AND HOLTER MONITORING: LAMIN GENE MUTATION DISCOVERED BY A TORSADE DE POINTES EPISODE FOLLOWED BY OUT-OF-THE-HOSPITAL RESUSCITATION. Eur. Heart J. Suppl.. 2024;26:ii55-ii56$57$YR$$$Y$$$20240715$$HP$IT$IT
240908861$24090886$1$I$20240517$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405171048158400-VRWNL$GB-TEVA-VS-3218741$TEVA$$19$YR$$$Y$$$20240715$$CN$GB$GB
240908871$24090887$1$I$20230301$20240708$20240715$20240715$EXP$$CL-AMGEN-CHLSP2024136247$AMGEN$$12$YR$T$F$Y$$$20240715$$MD$CL$CL
240908881$24090888$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA204204$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240715$$MD$US$US
240908891$24090889$1$I$20240101$20240711$20240715$20240715$EXP$$CA-UCBSA-2024023956$UCB$$$$$F$Y$$$20240715$$CN$CA$CA
240908901$24090890$1$I$20231013$20240709$20240715$20240715$EXP$IT-MINISAL02-993568$IT-SA-2024SA203407$SANOFI AVENTIS$$$$$F$Y$$$20240715$$MD$IT$IT
240908911$24090891$1$I$20240601$20240709$20240715$20240715$EXP$$IN-PFIZER INC-PV202400090763$PFIZER$$63$YR$$F$Y$$$20240715$$CN$IN$IN
240908922$24090892$2$F$20240501$20240903$20240715$20240920$EXP$$US-SA-2024SA204891$SANOFI AVENTIS$$46$YR$A$F$Y$72$KG$20240920$$MD$US$US
240908931$24090893$1$I$$20240710$20240715$20240715$EXP$$DE-PFIZER INC-202400210268$PFIZER$$$$$F$Y$$$20240715$$MD$DE$DE
240908942$24090894$2$F$$20240722$20240715$20240725$EXP$$ES-PFIZER INC-202101383628$PFIZER$$54$YR$$F$Y$$$20240725$$MD$ES$ES
240908951$24090895$1$I$$20240709$20240715$20240715$EXP$$AU-PFIZER INC-PV202400090029$PFIZER$$59$YR$$M$Y$95$KG$20240715$$MD$AU$AU
240908961$24090896$1$I$$20240710$20240715$20240715$EXP$$US-PFIZER INC-PV202400090724$PFIZER$$$$$$Y$$$20240715$$CN$US$US
240908974$24090897$4$F$$20240812$20240715$20240814$EXP$$US-PFIZER INC-PV202400090857$PFIZER$$64$YR$$F$Y$$$20240814$$CN$US$US
240908981$24090898$1$I$$20240709$20240715$20240715$EXP$$DO-PFIZER INC-PV202400090537$PFIZER$$73$YR$$F$Y$$$20240715$$CN$DO$DO
240908991$24090899$1$I$$20240710$20240715$20240715$EXP$$JP-PFIZER INC-202400212069$PFIZER$$$$$F$Y$$$20240715$$MD$JP$JP
240909002$24090900$2$F$$20240715$20240715$20240719$PER$$US-AMGEN-USASP2024137964$AMGEN$$66$YR$E$F$Y$$$20240719$$CN$CA$CA
240909011$24090901$1$I$$20240702$20240715$20240715$PER$$GB-AMGEN-GBRSP2024134248$AMGEN$$$$$F$Y$$$20240715$$MD$GB$GB
240909021$24090902$1$I$20240701$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139510$AMGEN$$$$E$M$Y$$$20240715$$MD$US$US
240909031$24090903$1$I$20240101$20240711$20240715$20240715$EXP$$US-ABBVIE-5839136$ABBVIE$$$$$$Y$$$20240715$$CN$US$US
240909041$24090904$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110983$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$89.81$KG$20240715$$CN$US$US
240909051$24090905$1$I$20210730$20240712$20240715$20240715$EXP$$US-TAKEDA-2021TUS027951$TAKEDA$$37$YR$$M$Y$77$KG$20240715$$CN$US$US
240909061$24090906$1$I$$20240709$20240715$20240715$EXP$$US-MYLANLABS-2024M1065414$MYLAN$$$$$$Y$$$20240715$$CN$US$US
240909071$24090907$1$I$20240708$20240709$20240715$20240715$EXP$$US-MYLANLABS-2024M1064526$MYLAN$$53$YR$$F$Y$$$20240715$$PH$US$US
240909081$24090908$1$I$20220712$20240709$20240715$20240715$EXP$$US-MYLANLABS-2024M1065514$MYLAN$$23$YR$$F$Y$$$20240715$$MD$US$US
240909091$24090909$1$I$20240711$20240711$20240715$20240715$PER$$US-JNJFOC-20240730223$JOHNSON AND JOHNSON$$59$YR$A$$Y$$$20240715$$CN$US$US
240909101$24090910$1$I$20240601$20240709$20240715$20240715$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024085014$VIIV$$25$YR$$M$Y$$$20240715$$HP$US$US
240909111$24090911$1$I$$20240704$20240715$20240715$EXP$GB-MHRA-MED-202407041215189050-SRPKJ$GB-Atnahs Limited-ATNAHS20240701958$Atnahs Healthcare$$$$$M$Y$$$20240715$$CN$GB$GB
240909121$24090912$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405161739416590-TDVGQ$GB-TEVA-VS-3218748$TEVA$$$$$F$Y$$$20240715$$PH$GB$GB
240909131$24090913$1$I$20220804$20240708$20240715$20240715$EXP$$CA-TAKEDA-2022TUS089706$TAKEDA$$46$YR$$M$Y$$$20240715$$CN$CA$CA
240909141$24090914$1$I$20240715$20240715$20240715$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039760$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240715$$CN$US$US
240909151$24090915$1$I$$20240711$20240715$20240715$EXP$$US-UCBSA-2024035638$UCB$$$$$$Y$$$20240715$$CN$US$US
240909161$24090916$1$I$$20240630$20240715$20240715$PER$$US-APOTEX-2024AP008008$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240715$$HP$US$US
240909171$24090917$1$I$$20240708$20240715$20240715$EXP$FR-AFSSAPS-AVMA2024000286$FR-MYLANLABS-2024M1064358$MYLAN$$43$YR$$F$Y$$$20240715$$PH$FR$FR
240909181$24090918$1$I$$20240708$20240715$20240715$EXP$$GR-MYLANLABS-2024M1065269$MYLAN$Savvidou OD, Kaspiris A, Goumenos S, Trikoupis I, Melissaridou D, Kalogeropoulos A, et al. Knee Arthrodesis with a Modular Silver-Coated Endoprosthesis for Infected Total Knee Arthroplasty with Extensive Bone Loss: A Retrospective Case-Series Study. J-Clin-Med 2023; 12 (10):.$62$YR$$F$Y$$$20240715$$HP$GR$GR
240909191$24090919$1$I$20240619$20240708$20240715$20240715$EXP$SE-SEMPA-2024-005278$SE-MYLANLABS-2024M1064417$MYLAN$$85$YR$$F$Y$$$20240715$$MD$SE$SE
240909201$24090920$1$I$20240401$20240708$20240715$20240715$EXP$$US-MYLANLABS-2024M1064364$MYLAN$$59$YR$$M$Y$$$20240715$$CN$US$US
240909211$24090921$1$I$$20240708$20240715$20240715$EXP$$FR-MYLANLABS-2024M1065058$MYLAN$Gendarme S, Pastre J, Billaud EM, Gibault L, Guillemain R, Oudard S, et al. Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patients. Therapie 2023; 78 (3): 267-278.$$$$M$Y$$$20240715$$HP$FR$FR
240909221$24090922$1$I$$20240708$20240715$20240715$EXP$$US-MYLANLABS-2024M1065391$MYLAN$$$$$F$Y$68.03$KG$20240715$$CN$US$US
240909231$24090923$1$I$20240606$20240708$20240715$20240715$EXP$FR-AFSSAPS-CN2024000600$FR-MYLANLABS-2024M1064343$MYLAN$$59$YR$$F$Y$114$KG$20240715$$MD$FR$FR
240909241$24090924$1$I$$20240708$20240715$20240715$EXP$$ES-MYLANLABS-2024M1064288$MYLAN$$56$YR$$F$Y$$$20240715$$CN$ES$ES
240909251$24090925$1$I$20240205$20240701$20240715$20240715$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240700052$RIGEL PHARMACEUTICALS$$75$YR$$F$Y$$$20240715$$MD$JP$JP
240909261$24090926$1$I$20240309$20240708$20240715$20240715$EXP$FR-AFSSAPS-CN2024000585$FR-MYLANLABS-2024M1064945$MYLAN$$14$YR$$F$Y$60$KG$20240715$$PH$FR$FR
240909271$24090927$1$I$$20240708$20240715$20240715$EXP$$DE-MYLANLABS-2024M1064305$MYLAN$$$$$F$Y$$$20240715$$MD$DE$DE
240909282$24090928$2$F$$20240712$20240715$20240718$EXP$$FR-MYLANLABS-2024M1064363$MYLAN$Chappuy M, de Ternay J, Merah I, Rolland B, Ragonnet D.. Le Centre ressource lyonnais des addictions m?dicamenteuses (CERLAM) Lyon resource center for prescription drug use disorder.. Le Courrier des Addictions. 2024;XXVI (2):24-27$33$YR$$F$Y$$$20240718$$PH$FR$FR
240909291$24090929$1$I$$20240710$20240715$20240715$EXP$$US-PFIZER INC-PV202400091572$PFIZER$$$$$$Y$$$20240715$$HP$US$US
240909301$24090930$1$I$20240430$20240708$20240715$20240715$EXP$$US-MYLANLABS-2024M1064323$MYLAN$$70$YR$$M$Y$$$20240715$$HP$US$US
240909311$24090931$1$I$20240501$20240710$20240715$20240715$EXP$$US-PFIZER INC-PV202400091671$PFIZER$$62$YR$$F$Y$$$20240715$$HP$US$US
240909321$24090932$1$I$20230901$20240710$20240715$20240715$EXP$$US-PFIZER INC-202400211283$PFIZER$$65$YR$$M$Y$$$20240715$$MD$US$US
240909334$24090933$4$F$20240101$20240907$20240715$20240909$EXP$$CA-PFIZER INC-202400211075$PFIZER$$48$YR$$M$Y$$$20240909$$MD$CA$CA
240909351$24090935$1$I$20240630$20240710$20240715$20240715$EXP$$CN-PFIZER INC-PV202400090644$PFIZER$$19$YR$$F$Y$44$KG$20240715$$HP$CN$CN
240909361$24090936$1$I$$20240710$20240715$20240715$EXP$$US-PFIZER INC-202400211176$PFIZER$$56$YR$$F$Y$48.53$KG$20240715$$CN$US$US
240909371$24090937$1$I$$20240710$20240715$20240715$EXP$$US-PFIZER INC-202400211221$PFIZER$$$$$F$Y$$$20240715$$CN$US$US
240909381$24090938$1$I$20160501$20240710$20240715$20240715$EXP$$US-PFIZER INC-202400212695$PFIZER$$67$YR$$F$Y$$$20240715$$HP$US$US
240909391$24090939$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007272$ELI LILLY AND CO$$$$$M$Y$$$20240715$$CN$US$US
240909402$24090940$2$F$$20240712$20240715$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009013$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240717$$CN$US$US
240909411$24090941$1$I$20240711$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008035$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240715$$CN$US$US
240909421$24090942$1$I$$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008614$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240715$$PH$US$US
240909431$24090943$1$I$$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008702$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240715$$CN$US$US
240909441$24090944$1$I$20240710$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007239$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240715$$CN$US$US
240909451$24090945$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007280$ELI LILLY AND CO$$74$YR$E$$Y$$$20240715$$CN$US$US
240909461$24090946$1$I$20240710$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407006873$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240715$$CN$US$US
240909471$24090947$1$I$$20240708$20240715$20240715$EXP$$US-BBU-2024000161$BIOGEN$Fenton GA, Dean EA. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/ Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case Rep Oncol. 2024 Jan 09;17:75-81. doi:10.1159/000535426$64$YR$$F$Y$$$20240715$$HP$US$US
240909484$24090948$4$F$20240628$20240920$20240715$20240926$EXP$$US-Vifor (International) Inc.-VIT-2024-06113$VIFOR$$63$YR$$F$Y$45.5$KG$20240926$$HP$US$US
240909491$24090949$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111049$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240715$$CN$US$US
240909501$24090950$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024139316$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240909521$24090952$1$I$20240710$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024139400$AMGEN$$78$YR$E$F$Y$$$20240715$$CN$US$US
240909532$24090953$2$F$20240101$20240719$20240715$20240724$EXP$$US-AMGEN-USASP2024136505$AMGEN$$55$YR$A$F$Y$$$20240724$$CN$US$US
240909541$24090954$1$I$$20240711$20240715$20240715$PER$$NVSC2024US145520$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240909571$24090957$1$I$20240703$20240710$20240715$20240715$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024085684$VIIV$$25$YR$$M$Y$$$20240715$$HP$US$US
240909581$24090958$1$I$20240401$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405171316143680-BKDRM$GB-TEVA-VS-3218900$TEVA$$$$$M$Y$$$20240715$$HP$GB$GB
240909591$24090959$1$I$$20240708$20240715$20240715$PER$$US-JNJFOC-20240724397$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240909601$24090960$1$I$20230918$20240701$20240715$20240715$EXP$$KR-VISIOX-2024VSX00057$Visiox$$37$YR$$M$Y$$$20240715$$MD$KR$KR
240909611$24090961$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48532$$FDA-CTU$$70$YR$$F$N$$$20240712$N$$US$
240909621$24090962$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48616$$FDA-CTU$$77$YR$$F$N$$$20240712$N$$US$
240909631$24090963$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48520$$FDA-CTU$$82$YR$$F$N$$$20240712$N$$US$
240909641$24090964$1$I$20240712$20240713$20240713$20240713$DIR$710112$$FDA-CTU$$67$YR$$M$N$$$20240713$N$CN$EG$
240909651$24090965$1$I$20240710$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48618$$FDA-CTU$$56$YR$$F$N$$$20240712$N$HP$US$
240909672$24090967$2$F$$20240906$20240715$20240906$EXP$$US-PFIZER INC-202400210200$PFIZER$$14$YR$$M$Y$49.9$KG$20240906$$CN$US$US
240909681$24090968$1$I$20240706$20240710$20240715$20240715$EXP$$KR-PFIZER INC-PV202400090700$PFIZER$$16$YR$$M$Y$$$20240715$$HP$KR$KR
240909691$24090969$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASL2024138678$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240909711$24090971$1$I$20240614$20240617$20240712$20240712$DIR$FDA-CDER-CTU-2024-48519$$FDA-CTU$$66$YR$$M$N$65.3$KG$20240617$N$CN$US$
240909722$24090972$2$F$20170101$20240815$20240715$20240821$EXP$CN-MLMSERVICE-20240620-PI104046-00306-4$CN-ROCHE-10000017737$ROCHE$Fan T, Yan Y, Lu Q, Li J, Chen H. Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report.. Transplantation proceedings. 2024-Jun;56 (5):1169-72. doi:10.1016/j.transproceed.2024.05.015..$57$YR$A$F$Y$$$20240821$$HP$CN$CN
240909732$24090973$2$F$$20240711$20240715$20240719$PER$$US-AMGEN-USASP2024139369$AMGEN$$$$A$F$Y$$$20240718$$HP$US$US
240909741$24090974$1$I$20240709$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138491$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240909751$24090975$1$I$20240619$20240702$20240715$20240715$EXP$$CN-BEH-2024175216$CSL BEHRING$$71$YR$E$M$Y$51$KG$20240715$$HP$CN$CN
240909762$24090976$2$F$20190101$20240719$20240715$20240726$EXP$$US-TAKEDA-2024TUS071111$TAKEDA$$$$$M$Y$$$20240726$$HP$US$US
240909772$24090977$2$F$20240624$20240904$20240715$20240923$30DAY$$AU-BECTON DICKINSON-AU-BD-24-000420$BECTON DICKINSON$$$$$$Y$$$20240923$$HP$AU$AU
240909782$24090978$2$F$20100101$20240709$20240715$20240722$EXP$$US-ABBVIE-5834616$ABBVIE$$$$$M$Y$108$KG$20240722$$CN$US$US
240909791$24090979$1$I$$20240708$20240715$20240715$EXP$$AR-009507513-2407ARG008544$MERCK$$59$YR$$M$Y$$$20240715$$HP$AR$AR
240909801$24090980$1$I$$20240712$20240715$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039632$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240715$$CN$US$US
240909811$24090981$1$I$$20240705$20240715$20240715$PER$$US-JNJFOC-20240715704$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240909821$24090982$1$I$$20240707$20240715$20240715$PER$$US-JNJFOC-20240721744$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240909831$24090983$1$I$20240705$20240705$20240715$20240715$EXP$$US-VIIV HEALTHCARE LIMITED-US2024084003$VIIV$$56$YR$$M$Y$$$20240715$$CN$US$US
240909841$24090984$1$I$$20240708$20240715$20240715$EXP$$AU-GSK-AU2024APC084845$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$HP$AU$AU
240909851$24090985$1$I$$20240530$20240715$20240715$30DAY$$JP-UCBSA-2024029949$UCB$$$$$$Y$$$20240715$$HP$JP$JP
240909861$24090986$1$I$$20210608$20240715$20240715$PER$$CA-PFM-2021-06417$PIERRE FABRE MEDICAMENT$$38$YR$$M$Y$$$20240715$$MD$CA$CA
240909871$24090987$1$I$$20210608$20240715$20240715$PER$$CA-PFM-2021-06416$PIERRE FABRE MEDICAMENT$$35$YR$$F$Y$$$20240715$$MD$CA$CA
240909881$24090988$1$I$$20210608$20240715$20240715$PER$$CA-PFM-2021-06414$PIERRE FABRE MEDICAMENT$$47$YR$$F$Y$$$20240715$$MD$CA$CA
240909891$24090989$1$I$$20210608$20240715$20240715$PER$$CA-PFM-2021-06408$PIERRE FABRE MEDICAMENT$$65$YR$$M$Y$$$20240715$$MD$CA$CA
240909901$24090990$1$I$$20210608$20240715$20240715$PER$$CA-PFM-2021-06404$PIERRE FABRE MEDICAMENT$$29$YR$$M$Y$$$20240715$$MD$CA$CA
240909911$24090991$1$I$20240410$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405092049109730-NJRVD$GB-TEVA-VS-3218359$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240909921$24090992$1$I$$20210608$20240715$20240715$PER$$CA-PFM-2021-06410$PIERRE FABRE MEDICAMENT$$51$YR$$F$Y$$$20240715$$MD$CA$CA
240909931$24090993$1$I$20240601$20240627$20240715$20240715$PER$$US-TEVA-VS-3214685$TEVA$$73$YR$$F$Y$$$20240715$$CN$US$US
240909941$24090994$1$I$$20210608$20240715$20240715$PER$$CA-PFM-2021-06413$PIERRE FABRE MEDICAMENT$$45$YR$$F$Y$$$20240715$$MD$CA$CA
240909951$24090995$1$I$$20220201$20240715$20240715$PER$$CA-PFM-2021-06400$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240715$$MD$CA$CA
240909961$24090996$1$I$$20210608$20240715$20240715$PER$$CA-PFM-2021-06415$PIERRE FABRE MEDICAMENT$$51$YR$$F$Y$$$20240715$$MD$CA$CA
240909972$24090997$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3218429$TEVA$Simpson M, Awuah KB, Patel D, Ogline O, Pratapneni S, Disilvio BE. Early Extra Corporeal Membrane Oxygenation (ECMO) and Esophagogastroduodenoscopy (EGD) Implementation: A Timely Intervention in a Patient With Extended-Release Bupropion Overdose. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Simpson M, Awuah KB, Patel D, Ogline O, Pratapneni S, Disilvio BE. Early Extra Corporeal Membrane Oxygenation (ECMO) and Esophagogastroduodenoscopy (EGD) Implementation: A Timely Intervention in a Patient Wi...$41$YR$$M$Y$$$20240802$$HP$US$US
240909991$24090999$1$I$20240710$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139749$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240910001$24091000$1$I$$20210608$20240715$20240715$PER$$CA-PFM-2021-06406$PIERRE FABRE MEDICAMENT$$73$YR$$F$Y$$$20240715$$MD$CA$CA
240910011$24091001$1$I$20210525$20210602$20240715$20240715$PER$FR-AFSSAPS-PO20212404$FR-PFM-2021-05742$PIERRE FABRE MEDICAMENT$$20$YR$$F$Y$56$KG$20240715$$MD$FR$FR
240910021$24091002$1$I$20210520$20210526$20240715$20240715$PER$$JP-PFM-2021-05610$PIERRE FABRE MEDICAMENT$$3$MON$$M$Y$7.1$KG$20240715$$PH$JP$JP
240910031$24091003$1$I$$20210603$20240715$20240715$PER$$IL-PFM-2021-05786$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240715$$MD$IL$IL
240910041$24091004$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407041638114080-CWTRH$GB-TEVA-VS-3218482$TEVA$$$$$M$Y$$$20240715$$MD$GB$GB
240910051$24091005$1$I$20200101$20220201$20240715$20240715$PER$$CA-PFM-2021-06574$PIERRE FABRE MEDICAMENT$$56$YR$$F$Y$$$20240715$$MD$CA$CA
240910061$24091006$1$I$$20220201$20240715$20240715$PER$$CA-PFM-2021-06576$PIERRE FABRE MEDICAMENT$$45$YR$$F$Y$$$20240715$$MD$CA$CA
240910071$24091007$1$I$20240605$20240711$20240715$20240715$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-13937$IPSEN$$47$YR$A$M$Y$$$20240715$$CN$CA$CA
240910081$24091008$1$I$20240711$20240713$20240713$20240713$DIR$710133$$FDA-CTU$$69$YR$$M$N$69.3$KG$20240713$N$CN$US$
240910091$24091009$1$I$20240707$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48605$$FDA-CTU$$82$YR$$M$N$$$20240712$Y$HP$US$
240910101$24091010$1$I$$20240712$20240715$20240715$PER$$US-DSJP-DSU-2024-135630$DAIICHI$$$$$F$Y$$$20240715$$CN$US$US
240910111$24091011$1$I$20230601$20240713$20240713$20240713$DIR$710135$$FDA-CTU$$56$YR$$F$N$72.9$KG$20240713$N$CN$US$
240910122$24091012$2$F$20211101$20240814$20240715$20240826$EXP$$JP-PFIZER INC-PV202400092226$PFIZER$$4$YR$$M$Y$$$20240826$$MD$JP$JP
240910141$24091014$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48576$$FDA-CTU$$58$YR$$M$N$77.11$KG$20240712$N$$US$
240910151$24091015$1$I$$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48526$$FDA-CTU$$$$$M$N$$$20240711$N$HP$US$
240910163$24091016$3$F$20240414$20240705$20240715$20240912$EXP$GB-MHRA-MED-202405131552461280-YCJTB$GB-BAYER-2024A100837$BAYER$$47$YR$A$M$Y$137$KG$20240912$$HP$GB$GB
240910171$24091017$1$I$$20210609$20240715$20240715$PER$$JP-PFM-2021-06212$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240715$$CN$JP$JP
240910181$24091018$1$I$20240712$20240713$20240713$20240713$DIR$710124$$FDA-CTU$$40$YR$$F$N$60$KG$20240713$Y$CN$US$
240910191$24091019$1$I$20210522$20210604$20240715$20240715$PER$$JP-PFM-2021-06025$PIERRE FABRE MEDICAMENT$$1$YR$$M$Y$$$20240715$$PH$JP$JP
240910201$24091020$1$I$$20210609$20240715$20240715$PER$$JP-PFM-2021-06213$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240715$$CN$JP$JP
240910211$24091021$1$I$20231116$20240705$20240715$20240715$PER$$US-SA-2024SA205308$SANOFI AVENTIS$$63$YR$A$F$Y$73$KG$20240715$$MD$US$US
240910221$24091022$1$I$20240601$20240705$20240715$20240715$PER$$US-SA-2024SA202998$SANOFI AVENTIS$$63$YR$A$M$Y$113$KG$20240715$$MD$US$US
240910232$24091023$2$F$20240101$20240919$20240715$20240930$PER$$US-SA-2024SA118248$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240930$$MD$US$US
240910241$24091024$1$I$20230201$20240710$20240715$20240715$EXP$$US-SA-2024SA205159$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240715$$CN$US$US
240910253$24091025$3$F$$20240724$20240715$20240729$PER$$US-ROCHE-10000026181$ROCHE$$$$$$Y$$$20240729$$HP$US$US
240910261$24091026$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111217$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240715$$HP$US$US
240910271$24091027$1$I$$20240705$20240715$20240715$EXP$$AU-MYLANLABS-2024M1064855$MYLAN$Huynh A, Siggs OM, Wainstein BK, Gray PE. Infliximab Reverses Symptoms and May Protect from Developing Chronic Restrictive Ophthalmopathy in Children with Familial Orbital Myositis: A Case Report. Ocular-Immunol-Inflamm 2023; 31 (5): 1097-1100.$16$YR$$F$Y$$$20240715$$MD$AU$AU
240910281$24091028$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA204690$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240715$$MD$US$US
240910293$24091029$3$F$20240617$20240819$20240715$20240820$EXP$$NVSC2024DE144510$NOVARTIS$$37$YR$$M$Y$145$KG$20240820$$MD$DE$DE
240910301$24091030$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA205575$SANOFI AVENTIS$$$$C$F$Y$$$20240715$$MD$US$US
240910311$24091031$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA100884$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240715$$MD$US$US
240910321$24091032$1$I$$20240708$20240715$20240715$PER$$US-TAKEDA-2024TUS069783$TAKEDA$$$$$$Y$$$20240715$$CN$US$US
240910331$24091033$1$I$$20240705$20240715$20240715$EXP$$FR-DECIPHERA PHARMACEUTICALS LLC-2024FR000376$DECIPHERA PHARMACEUTICALS$$$$E$F$Y$$$20240715$$PH$FR$FR
240910341$24091034$1$I$20210607$20210607$20240715$20240715$PER$$DE-PFM-2021-06601$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$10$KG$20240715$$HP$DE$DE
240910352$24091035$2$F$20240624$20240711$20240715$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024083924$VIIV$$54$YR$$F$Y$$$20240719$$HP$US$US
240910371$24091037$1$I$$20210612$20240715$20240715$PER$$JP-PFM-2021-06357$PIERRE FABRE MEDICAMENT$$9$MON$$F$Y$$$20240715$$MD$JP$JP
240910381$24091038$1$I$$20210615$20240715$20240715$PER$$FR-PFM-2021-06361$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240715$$MD$FR$FR
240910391$24091039$1$I$$20210615$20240715$20240715$PER$$FR-PFM-2021-06363$PIERRE FABRE MEDICAMENT$$$$I$$Y$$$20240715$$MD$FR$FR
240910401$24091040$1$I$$20210623$20240715$20240715$PER$$JP-PFM-2021-06968$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240715$$PH$JP$JP
240910411$24091041$1$I$20210521$20210621$20240715$20240715$PER$$FR-PFM-2021-06427$PIERRE FABRE MEDICAMENT$$1$MON$$F$Y$$$20240715$$MD$FR$FR
240910421$24091042$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138435$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240910431$24091043$1$I$20210301$20211108$20240715$20240715$PER$$JP-PFM-2021-06537$PIERRE FABRE MEDICAMENT$$0$YR$$M$Y$10$KG$20240715$$MD$JP$JP
240910441$24091044$1$I$20240703$20240709$20240715$20240715$PER$$US-ABBVIE-5839097$ABBVIE$$45$YR$$$Y$$$20240715$$CN$US$US
240910451$24091045$1$I$20240626$20240712$20240715$20240715$EXP$IT-MINISAL02-994500$IT-JNJFOC-20240732717$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240715$$MD$IT$IT
240910461$24091046$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091129453300-NFQDJ$GB-TEVA-VS-3218935$TEVA$$$$$$Y$$$20240715$$HP$GB$GB
240910471$24091047$1$I$20240101$20240709$20240715$20240715$PER$$US-ROCHE-10000024163$ROCHE$$61$YR$A$M$Y$$$20240715$$HP$US$US
240910481$24091048$1$I$$20240712$20240715$20240715$PER$$US-TAKEDA-2024TUS071304$TAKEDA$$$$$F$Y$65$KG$20240715$$CN$US$US
240910492$24091049$2$F$20240202$20240719$20240715$20240724$EXP$$NVSC2024US000812$NOVARTIS$$52$YR$$F$Y$$$20240724$$CN$US$US
240910511$24091051$1$I$$20210531$20240715$20240715$PER$$FR-PFM-2021-05533$PIERRE FABRE MEDICAMENT$Blanc F, Bessis D, Bigorre M. Infraumbilical raphe: a new congenital anomaly in PELVIS syndrome. International Journal of Dermatology. 2021;60:e227-e252$1$YR$$F$Y$$$20240715$$HP$FR$FR
240910521$24091052$1$I$$20240708$20240715$20240715$EXP$$US-SA-2024SA202757$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240715$$MD$US$US
240910531$24091053$1$I$$20210531$20240715$20240715$PER$$DE-PFM-2021-05666$PIERRE FABRE MEDICAMENT$Hanser A, Hofbeck M, Sturm E, Warmann S, Roder S, Michel J, et al. selective embolization combined with propranolol in five infants with acute symptomatic hepatic hemangioma. Thoracic and Cardiovascular Surgeon. 2021;69:s93-s117$$$I$$Y$$$20240715$$HP$DE$DE
240910541$24091054$1$I$$20240705$20240715$20240715$EXP$$FR-DECIPHERA PHARMACEUTICALS LLC-2024FR000598$DECIPHERA PHARMACEUTICALS$$$$A$F$Y$43$KG$20240715$$PH$FR$FR
240910551$24091055$1$I$$20210525$20240715$20240715$PER$$IT-PFM-2021-05526$PIERRE FABRE MEDICAMENT$Paparella R, Mallardo S, Lubrano R. Projectile vomiting and Valsalva-like abdominal contractions as an uncommon presentation of supraventricular tachycardia in an infant. Journal of Electrocardiology. 2021;66:136-8$1$MON$$M$Y$$$20240715$$HP$IT$IT
240910561$24091056$1$I$$20210531$20240715$20240715$PER$$CA-PFM-2021-05560$PIERRE FABRE MEDICAMENT$Fralick M, Sarma S. Thyrotoxic Periodic Paralysis. The new england journal of medicine. 2021;384(19):e71$25$YR$$M$Y$$$20240715$$HP$CA$CA
240910571$24091057$1$I$$20210601$20240715$20240715$PER$$JP-PFM-2021-05616$PIERRE FABRE MEDICAMENT$Ito H, Yamamoto K, Fukutake S, Taira T, Yamaguchi T. Diffusion tensor imaging-based magnetic resonance imaging-guided focused ultrasound thalamotomy for tremor recurrence after radiofrequency thalamotomy: A case report.. Neurology and Clinical Neuroscience. 2021;9(3):242-244$42$YR$$F$Y$$$20240715$$MD$JP$JP
240910604$24091060$4$F$$20240912$20240715$20240918$30DAY$$US-PFIZER INC-PV202400089623$PFIZER$$$$$F$Y$$$20240918$$CN$US$US
240910611$24091061$1$I$20240530$20240709$20240715$20240715$EXP$GB-MHRA-MED-202407091241097290-KYSVT$GB-PFIZER INC-202400209642$PFIZER$$$$$F$Y$$$20240715$$CN$GB$GB
240910621$24091062$1$I$20240101$20240710$20240715$20240715$EXP$$US-ABBVIE-5836958$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240910631$24091063$1$I$20210429$20210625$20240715$20240715$PER$IT-MINISAL02-746097$IT-PFM-2021-07021$PIERRE FABRE MEDICAMENT$$2$MON$$M$Y$$$20240715$$HP$IT$IT
240910661$24091066$1$I$20170628$20211006$20240715$20240715$PER$$JP-PFM-2021-05695$PIERRE FABRE MEDICAMENT$Yuki Matsushita et al. Evaluation of therapeutic effect of oral Hemangiol therapy for infantile haemangioma in our hospital in our hospital. The 64th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery. 2021$0$YR$$M$Y$$$20240715$$HP$JP$JP
240910671$24091067$1$I$$20240709$20240715$20240715$EXP$$US-ABBVIE-5833777$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240910681$24091068$1$I$20240617$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48598$$FDA-CTU$$23$YR$$M$N$$$20240712$N$$US$
240910691$24091069$1$I$$20240709$20240715$20240715$EXP$$CA-TAKEDA-2024TUS070712$TAKEDA$$$$$F$Y$94$KG$20240715$$HP$CA$CA
240910721$24091072$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48518$$FDA-CTU$$64$YR$$F$N$$$20240712$N$$US$
240910731$24091073$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111675$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240715$$CN$US$US
240910741$24091074$1$I$20240613$20240702$20240715$20240715$EXP$ES-AEMPS-1538666$ES-GUERBET / LLC-ES-20240027$GUERBET$$89$YR$E$F$Y$80$KG$20240715$$MD$ES$ES
240910752$24091075$2$F$$20240814$20240715$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039762$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240814$$CN$US$US
240910761$24091076$1$I$20240601$20240712$20240715$20240715$PER$$US-JNJFOC-20240734076$JOHNSON AND JOHNSON$$44$YR$A$$Y$$$20240715$$CN$US$US
240910771$24091077$1$I$20240701$20240709$20240715$20240715$EXP$$AT-ABBVIE-5836604$ABBVIE$$74$YR$$M$Y$$$20240715$$CN$AT$AT
240910791$24091079$1$I$$20240708$20240715$20240715$EXP$$US-JNJFOC-20240720624$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240910801$24091080$1$I$20240701$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48548$$FDA-CTU$$71$YR$$M$N$$$20240711$N$HP$US$
240910811$24091081$1$I$20230509$20240713$20240713$20240713$DIR$710115$$FDA-CTU$$73$YR$$UNK$N$67.5$KG$20240713$Y$CN$US$
240910821$24091082$1$I$20240703$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48542$$FDA-CTU$$51$YR$$M$N$$$20240712$N$HP$US$
240910831$24091083$1$I$$20240710$20240715$20240715$EXP$$US-TAKEDA-US202023621$TAKEDA$$$$$F$Y$59$KG$20240715$$CN$US$US
240910851$24091085$1$I$20240707$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48527$$FDA-CTU$$86$YR$$F$N$$$20240712$N$HP$US$
240910871$24091087$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48522$$FDA-CTU$$57$YR$$F$N$$$20240712$N$$US$
240910881$24091088$1$I$20240708$20240713$20240713$20240713$DIR$710143$$FDA-CTU$$82$YR$$F$N$51.3$KG$20240713$N$CN$US$
240910901$24091090$1$I$$20210607$20240715$20240715$PER$$CH-PFM-2021-05937$PIERRE FABRE MEDICAMENT$Luchsinger I, Knopfel N, Theiler M, Schwieger-Briel A, Weibel L. Ipsilateral clubbing of the fingers in an infant with a large segmental infantile hemangioma. Pediatric Dermatology. 2021;38:5-6$5$WK$$F$Y$$$20240715$$HP$CH$CH
240910911$24091091$1$I$$20210609$20240715$20240715$PER$$RO-PFM-2021-05994$PIERRE FABRE MEDICAMENT$Popescu M, Dragan G. Vascular tumors: when to observe, treat or send to the surgeon. Pediatru.ro. 2021;61:8-12$$$$$Y$$$20240715$$HP$RO$RO
240910921$24091092$1$I$$20210621$20240715$20240715$PER$$JP-PFM-2021-06758$PIERRE FABRE MEDICAMENT$Mayu Bando et al.. Study of infantile haemangioma treated with oral propranolol in our department. The 64th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery. 2021;274$$$I$$Y$$$20240715$$HP$JP$JP
240910931$24091093$1$I$$20210625$20240715$20240715$PER$$IT-PFM-2021-06705$PIERRE FABRE MEDICAMENT$Eleonora M, Umberto P, Valentina F,  Giulia G, Giulia P, Sabina C. Do anti-CGRP drugs have a role in migraine aura therapy?. Journal of Neurology. 2021;268:2273-4$42$YR$$M$Y$$$20240715$$HP$IT$IT
240910941$24091094$1$I$$20210621$20240715$20240715$PER$$JP-PFM-2021-06760$PIERRE FABRE MEDICAMENT$Suzuki T et al.. Effectiveness of introducing propranolol therapy by one-day hospitalization for infantile haemangioma. The Japanese Society of Pediatric Surgeons. 2021;57:509$$$I$$Y$$$20240715$$HP$JP$JP
240910951$24091095$1$I$$20210621$20240715$20240715$PER$$JP-PFM-2021-06761$PIERRE FABRE MEDICAMENT$Takaaki Suzuki et al. Effectiveness of introducing propranolol therapy by one-day hospitalization for infantile haemangioma. The Japanese Society of Pediatric Surgeons. 2021;57:509$$$I$$Y$$$20240715$$HP$JP$JP
240910961$24091096$1$I$$20210611$20240715$20240715$PER$$IT-PFM-2021-06029$PIERRE FABRE MEDICAMENT$Macchiaiolo M, Markowich H. A, Diociaiuti A, Gonfiantini V. M, Paola S. B, Ippolita R et al. Diffuse infantile hepatic hemangiomas in a patient with Beckwith-Wiedemann syndrome: A new association?. American Journal of medical genetics. 2020;182SA:1972-6$2$MON$$$Y$$$20240715$$HP$IT$IT
240910971$24091097$1$I$$20210531$20240715$20240715$PER$$KR-PFM-2021-06112$PIERRE FABRE MEDICAMENT$Kim J.. Use of Propranolol for Infantile Hepatic Hemangioma. Perinatology. 2021;31:36-41$15$DY$$M$Y$$$20240715$$MD$KR$KR
240910981$24091098$1$I$$20210628$20240715$20240715$PER$$CH-PFM-2021-06976$PIERRE FABRE MEDICAMENT$Giannantoni N, Rigamonti E, Rampolli F, Grazioli-Gauthier L, Allali G, Vanini G. Myoclonus and Cerebellar Ataxia Associated with SARS-CoV-2 Infection: Case Report and Review of the Literature. European Journal of Case Reports in Internal Medicine. 2021$67$YR$$M$Y$$$20240715$$HP$CH$CH
240910991$24091099$1$I$$20210709$20240715$20240715$PER$$JP-PFM-2021-05713$PIERRE FABRE MEDICAMENT$Takashi Shimizu et al. Therapeutic experience in our hospital for infantile haemangioma. The compendium of the 64th Annual Meeting of Japan Society of Plastic and Recons$$$I$$Y$$$20240715$$HP$JP$JP
240911001$24091100$1$I$$20210628$20240715$20240715$PER$$JP-PFM-2021-07151$PIERRE FABRE MEDICAMENT$Naoko Baba. New therapy of Infantile Hemangioma. Practical Dermatology$2$MON$$F$Y$$$20240715$$HP$JP$JP
240911011$24091101$1$I$$20210701$20240715$20240715$PER$$TR-PFM-2021-07072$PIERRE FABRE MEDICAMENT$Emekli SA, Samanci B, SimsirG, Hanagasi AH, Gurvit H, Bilgic B et al. A novel PNPLA6 mutation in a Turkish family with intractable Holmes tremor and spastic ataxia. Neurological Sciences. 2021;42:1535-1539$32$YR$$F$Y$$$20240715$$HP$TR$TR
240911021$24091102$1$I$20180901$20210819$20240715$20240715$PER$$JP-PFM-2021-05774$PIERRE FABRE MEDICAMENT$Akiko Izumozaki et al. Evaluation of therapeutic effect of oral Hemangiol therapy for infantile haemangioma using MRI. The 64th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery. 2021$9$MON$$F$Y$$$20240715$$HP$JP$JP
240911031$24091103$1$I$20180124$20211027$20240715$20240715$PER$$JP-PFM-2021-06755$PIERRE FABRE MEDICAMENT$Mayu Bando et al. Study of infantile haemangioma treated with oral propranolol in our department. The 64th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery. 2021;274$1$MON$$M$Y$$$20240715$$HP$JP$JP
240911041$24091104$1$I$20170831$20211027$20240715$20240715$PER$$JP-PFM-2021-06757$PIERRE FABRE MEDICAMENT$Mayu Bando et al. Study of infantile haemangioma treated with oral propranolol in our department. The 64th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery. 2021;274$2$MON$$F$Y$$$20240715$$HP$JP$JP
240911051$24091105$1$I$20170107$20211027$20240715$20240715$PER$$JP-PFM-2021-06756$PIERRE FABRE MEDICAMENT$Mayu Bando et al. Study of infantile haemangioma treated with oral propranolol in our department. The 64th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery. 2021;274$1$MON$$F$Y$$$20240715$$HP$JP$JP
240911061$24091106$1$I$$20211027$20240715$20240715$PER$$JP-PFM-2021-06759$PIERRE FABRE MEDICAMENT$Bando M et al.. Study of infantile haemangioma treated with oral propranolol in our department. The 64th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery. 2021;274$$$I$$Y$$$20240715$$MD$JP$JP
240911081$24091108$1$I$$20220214$20240715$20240715$PER$$JP-PFM-2021-06762$PIERRE FABRE MEDICAMENT$Nakatani T. Management of infantile laryngeal haemangioma. Japanese Society of Pediatric Surgeons$$$I$$Y$$$20240715$$HP$JP$JP
240911091$24091109$1$I$$20220214$20240715$20240715$PER$$JP-PFM-2021-06763$PIERRE FABRE MEDICAMENT$Nakatani T. Management of infantile laryngeal haemangioma. Japanese Society of Pediatric Surgeons$$$I$$Y$$$20240715$$HP$JP$JP
240911102$24091110$2$F$$20240903$20240715$20240926$EXP$$US-SA-2024SA205597$SANOFI AVENTIS$$$$$M$Y$$$20240926$$MD$US$US
240911111$24091111$1$I$20240519$20240630$20240715$20240715$EXP$$DZ-ROCHE-3578568$ROCHE$$46$YR$A$F$Y$$$20240715$$MD$DZ$DZ
240911121$24091112$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48606$$FDA-CTU$$85$YR$$M$N$$$20240712$N$$US$
240911131$24091113$1$I$20240101$20240708$20240715$20240715$PER$$US-SA-2024SA203209$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240715$$MD$US$US
240911141$24091114$1$I$20240705$20240713$20240713$20240713$DIR$710144$$FDA-CTU$$37$YR$$F$N$69.75$KG$20240713$N$CN$US$
240911151$24091115$1$I$20240618$20240713$20240713$20240713$DIR$710119$$FDA-CTU$$46$YR$$M$N$$$20240713$Y$PH$US$
240911161$24091116$1$I$20240708$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48604$$FDA-CTU$$81$YR$$M$N$$$20240712$N$PH$US$
240911171$24091117$1$I$$20240701$20240715$20240715$EXP$$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-05580$HIKMA$Favi E, Cresseri D, Perego M, Ikehata M, Iesari S, Campise MR, et al.. Favi E, Cresseri D, Perego M, Ikehata M, Iesari S, Campise MR, et al. Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept. Clinical Immunology. 2024;264:110240:1-18 pgs$50$YR$$M$Y$$$20240715$$MD$IT$IT
240911181$24091118$1$I$$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024138244$AMGEN$$$$$$Y$$$20240715$$HP$US$US
240911191$24091119$1$I$$20240704$20240715$20240715$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003540$TERSERA THERAPEUTICS$$$$$$Y$$$20240715$$CN$AU$AU
240911201$24091120$1$I$$20240704$20240715$20240715$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003537$TERSERA THERAPEUTICS$$$$$$Y$$$20240715$$CN$AU$AU
240911211$24091121$1$I$$20240709$20240715$20240715$EXP$$US-GILEAD-2024-0680120$GILEAD$$67$YR$E$F$Y$$$20240715$$MD$US$US
240911241$24091124$1$I$20240710$20240711$20240712$20240712$DIR$FDA-CDER-CTU-2024-48612$$FDA-CTU$$85$YR$$F$N$$$20240711$N$HP$US$
240911251$24091125$1$I$20240707$20240708$20240715$20240715$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700281$MYOVANT SCIENCES$$76$YR$$M$Y$$$20240715$$CN$US$US
240911261$24091126$1$I$20240712$20240713$20240713$20240713$DIR$710142$$FDA-CTU$$62$YR$$M$N$87.75$KG$20240713$N$CN$US$
240911271$24091127$1$I$19940101$20240710$20240715$20240715$EXP$$US-ABBVIE-5836914$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240911281$24091128$1$I$20240701$20240708$20240715$20240715$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000599$DECIPHERA PHARMACEUTICALS$$75$YR$E$F$Y$$$20240715$$CN$US$US
240911291$24091129$1$I$20240711$20240713$20240713$20240713$DIR$710151$$FDA-CTU$$24$YR$$F$N$71.1$KG$20240713$N$CN$US$
240911301$24091130$1$I$20240607$20240713$20240713$20240713$DIR$710149$$FDA-CTU$$66$YR$$F$N$81$KG$20240713$N$CN$US$
240911311$24091131$1$I$$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48540$$FDA-CTU$$61$YR$$F$N$$$20240712$N$$US$
240911321$24091132$1$I$$20240712$20240715$20240715$PER$$US-HALEON-2186943$Haleon PLC$$$$$$Y$$$20240715$$CN$US$US
240911331$24091133$1$I$20240710$20240713$20240713$20240713$DIR$710145$$FDA-CTU$$31$YR$$F$N$88.65$KG$20240713$N$CN$US$
240911341$24091134$1$I$$20240711$20240715$20240715$PER$$US-HALEON-2186768$Haleon PLC$$$$$$Y$$$20240715$$CN$US$US
240911351$24091135$1$I$20120101$20240709$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110490$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$79.38$KG$20240715$$CN$US$US
240911361$24091136$1$I$20220101$20240708$20240715$20240715$EXP$$AT-EXELIXIS-CABO-22056537$EXELIXIS$HCP A. RCC: rapid response to multiple therapies. Jatros Haematology and Oncology. 2023$46$YR$$F$Y$$$20240715$$MD$AT$AT
240911372$24091137$2$F$$20240809$20240715$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06037$LUPIN$$$$$$Y$$$20240830$$CN$US$US
240911382$24091138$2$F$20240115$20240814$20240715$20240822$EXP$$US-009507513-2406USA008956$MERCK$$77$YR$$F$Y$104.5$KG$20240822$$HP$US$US
240911401$24091140$1$I$20240711$20240711$20240715$20240715$EXP$$US-ABBVIE-5837482$ABBVIE$$66$YR$$F$Y$$$20240715$$CN$US$US
240911411$24091141$1$I$20240614$20240709$20240715$20240715$EXP$FR-AFSSAPS-AN2024000848$FR-MYLANLABS-2024M1064338$MYLAN$$32$YR$$F$Y$55.7$KG$20240715$$PH$FR$FR
240911421$24091142$1$I$20240516$20240709$20240715$20240715$EXP$CH-SM-2024-13579$CH-MYLANLABS-2024M1065112$MYLAN$$71$YR$$F$Y$$$20240715$$HP$CH$CH
240911431$24091143$1$I$20240319$20240709$20240715$20240715$EXP$FR-AFSSAPS-AVPA2024000621$FR-MYLANLABS-2024M1064245$MYLAN$$47$YR$$M$Y$$$20240715$$MD$FR$FR
240911441$24091144$1$I$20240612$20240709$20240715$20240715$EXP$$FR-MYLANLABS-2024M1064266$MYLAN$$$$A$F$Y$72$KG$20240715$$MD$FR$FR
240911451$24091145$1$I$20230701$20240709$20240715$20240715$EXP$FR-AFSSAPS-DJ2024000821$FR-MYLANLABS-2024M1064548$MYLAN$$66$YR$$M$Y$$$20240715$$MD$FR$FR
240911461$24091146$1$I$20230301$20240709$20240715$20240715$EXP$FR-AFSSAPS-GR2024000833$FR-MYLANLABS-2024M1064320$MYLAN$$46$YR$$F$Y$$$20240715$$PH$FR$FR
240911471$24091147$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA203427$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240715$$MD$US$US
240911482$24091148$2$F$20240101$20240730$20240715$20240807$PER$$US-SA-2024SA201134$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240807$$MD$US$US
240911492$24091149$2$F$$20240717$20240715$20240722$EXP$$US-ABBVIE-5838003$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
240911501$24091150$1$I$20240630$20240630$20240715$20240715$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-454857$RANBAXY$$32$YR$$F$Y$$$20240715$$CN$GB$GB
240911511$24091151$1$I$$20240630$20240715$20240715$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455832$RANBAXY$$28$YR$$M$Y$$$20240715$$PH$CA$CA
240911531$24091153$1$I$$20240630$20240715$20240715$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456190$RANBAXY$Makhmudova U, Schulze PC, Lorkowski S, Marz W, Geiling JA, Weingartner O.. Monogenic hypertriglyceridemia and recurrent pancreatitis in a homozygous carrier of a rare APOA5 mutation: a case report.. J Med Case Rep. 2024;18 (1):278$25$YR$$M$Y$$$20240715$$HP$DE$DE
240911541$24091154$1$I$$20240630$20240715$20240715$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455838$RANBAXY$$90$YR$$F$Y$$$20240715$$PH$CA$CA
240911551$24091155$1$I$20240101$20240709$20240715$20240715$PER$$US-BIOGEN-2024BI01273045$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240911561$24091156$1$I$20240302$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405072058043420-FPMZN$GB-TEVA-VS-3218619$TEVA$$70$YR$$M$Y$122$KG$20240715$$CN$GB$GB
240911573$24091157$3$F$20240628$20240730$20240715$20240801$PER$$JP-Eisai-EC-2024-169961$EISAI$$74$YR$E$M$Y$64.2$KG$20240801$$MD$JP$JP
240911581$24091158$1$I$20240612$20240709$20240715$20240715$PER$$JP-Eisai-EC-2024-169966$EISAI$$$$$$Y$51$KG$20240715$$MD$JP$JP
240911592$24091159$2$F$20240710$20240715$20240715$20240723$PER$$US-AMGEN-USASP2024138056$AMGEN$$83$YR$E$F$Y$$$20240723$$CN$US$US
240911603$24091160$3$F$20240101$20240726$20240715$20240801$PER$$US-AMGEN-USASP2024139062$AMGEN$$45$YR$A$M$Y$$$20240801$$CN$US$US
240911611$24091161$1$I$$20240701$20240715$20240715$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-06501$HIKMA$Pic?o de Carvalho C, Carmo F, Martins R, Matos E, Torres E, Rebelo M. Pic?o de Carvalho C, Carmo F, Martins R, Matos E, Torres E, Rebelo M. When vitamin supplementation would make all the difference. Birth and Growth Medical Journal. 2024;33(2):127-132$6$MON$$F$Y$$$20240715$$MD$PT$PT
240911621$24091162$1$I$20231201$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405060341067210-TCMHK$GB-RDY-SPO/GBR/24/0010092$DR REDDYS$$$$$F$Y$$$20240715$$CN$GB$GB
240911631$24091163$1$I$20240529$20240709$20240715$20240715$30DAY$$US-GSK-US2024084996$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
240911641$24091164$1$I$20240515$20240713$20240713$20240713$DIR$710116$$FDA-CTU$$70$YR$$M$N$77.4$KG$20240713$N$CN$US$
240911651$24091165$1$I$20240701$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48562$$FDA-CTU$$76$YR$$M$N$$$20240712$N$HP$US$
240911661$24091166$1$I$20100310$20240713$20240713$20240713$DIR$710121$$FDA-CTU$$65$YR$$M$N$112.5$KG$20240713$N$CN$US$
240911671$24091167$1$I$20240620$20240704$20240715$20240715$EXP$IT-MINISAL02-992706$IT-SA-2024SA200023$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240715$$PH$IT$IT
240911681$24091168$1$I$20230915$20240709$20240715$20240715$EXP$FR-AFSSAPS-GR2024000812$FR-MYLANLABS-2024M1064685$MYLAN$$44$YR$$M$Y$$$20240715$$MD$FR$FR
240911691$24091169$1$I$20230601$20240709$20240715$20240715$EXP$FR-AFSSAPS-DJ2024000816$FR-MYLANLABS-2024M1064604$MYLAN$$68$YR$$F$Y$$$20240715$$MD$FR$FR
240911701$24091170$1$I$20240101$20240709$20240715$20240715$EXP$$US-SA-2024SA204955$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240715$$MD$US$US
240911712$24091171$2$F$20230101$20240828$20240715$20240829$EXP$$US-UCBSA-2024030476$UCB$$$$$M$Y$79.37$KG$20240829$$CN$US$US
240911721$24091172$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111293$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240715$$CN$US$US
240911731$24091173$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110910$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240715$$CN$US$US
240911741$24091174$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407051958175750-YVZGF$GB-TEVA-VS-3219213$TEVA$$$$$$Y$$$20240715$$PH$GB$GB
240911772$24091177$2$F$20240610$20240801$20240715$20240806$EXP$$FR-MYLANLABS-2024M1064905$MYLAN$$59$YR$$M$Y$60$KG$20240806$$PH$FR$FR
240911781$24091178$1$I$$20240710$20240715$20240715$PER$$US-ABBVIE-5838093$ABBVIE$$$$$$Y$$$20240715$$HP$US$US
240911801$24091180$1$I$20240704$20240710$20240715$20240715$EXP$$CN-PFIZER INC-PV202400090673$PFIZER$$90$YR$$M$Y$60$KG$20240715$$HP$CN$CN
240911813$24091181$3$F$20240606$20240815$20240715$20240816$EXP$$JP-PFIZER INC-202400189603$PFIZER$$85$YR$$F$Y$30.1$KG$20240816$$PH$JP$JP
240911821$24091182$1$I$20240701$20240710$20240715$20240715$EXP$$KR-PFIZER INC-PV202400090832$PFIZER$$$$$M$Y$$$20240715$$CN$KR$KR
240911832$24091183$2$F$20210220$20240822$20240715$20240829$EXP$IE-HPRA-2024-113917$IE-BAYER-2024A099279$BAYER$$$$A$F$Y$$$20240829$$CN$IE$IE
240911841$24091184$1$I$20240601$20240711$20240715$20240715$EXP$SE-SEMPA-2024-005381$SE-PFIZER INC-202400212282$PFIZER$$53$YR$$M$Y$$$20240715$$MD$SE$SE
240911851$24091185$1$I$$20240711$20240715$20240715$EXP$$CA-PFIZER INC-202400213384$PFIZER$$87$YR$$M$Y$$$20240715$$CN$CA$CA
240911861$24091186$1$I$20240101$20240711$20240715$20240715$EXP$$US-PFIZER INC-PV202400091453$PFIZER$$74$YR$$M$Y$$$20240715$$CN$US$US
240911873$24091187$3$F$20240223$20240802$20240715$20240806$EXP$$CA-PFIZER INC-202400051260$PFIZER$$52$YR$$F$Y$$$20240806$$HP$CA$CA
240911881$24091188$1$I$$20240711$20240715$20240715$EXP$$AR-PFIZER INC-202400213577$PFIZER$$76$YR$$F$Y$$$20240715$$CN$AR$AR
240911892$24091189$2$F$20240518$20240716$20240715$20240719$EXP$$DE-PFIZER INC-202400210285$PFIZER$$69$YR$$F$Y$42$KG$20240719$$MD$DE$DE
240911901$24091190$1$I$20220701$20240709$20240715$20240715$EXP$FR-AFSSAPS-GR2024000817$FR-MYLANLABS-2024M1064666$MYLAN$$75$YR$$F$Y$$$20240715$$PH$FR$FR
240911912$24091191$2$F$$20240809$20240715$20240823$EXP$$JP-VERICEL-JP-VCEL-24-000263$VERICEL$$65$YR$$F$Y$$$20240823$$MD$JP$JP
240911931$24091193$1$I$20240519$20240703$20240715$20240715$EXP$$CN-ASTELLAS-2024US019706$ASTELLAS$$76$YR$$M$Y$$$20240715$$CN$CN$CN
240911941$24091194$1$I$20220228$20240713$20240713$20240713$DIR$710146$$FDA-CTU$$74$YR$$F$N$$$20240713$Y$CN$US$
240911961$24091196$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111931$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$89.81$KG$20240715$$CN$US$US
240911971$24091197$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110989$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$92.08$KG$20240715$$CN$US$US
240912011$24091201$1$I$20240111$20240713$20240713$20240713$DIR$710134$$FDA-CTU$$56$YR$$F$N$72.9$KG$20240713$N$CN$US$
240912021$24091202$1$I$20240509$20240701$20240715$20240715$EXP$ES-AEMPS-1538970$ES-HIKMA PHARMACEUTICALS USA INC.-ES-H14001-24-06207$HIKMA$$$$E$F$Y$$$20240715$$MD$ES$ES
240912032$24091203$2$F$20240531$20240717$20240715$20240723$PER$$US-BAYER-2024A099646$BAYER$$27$YR$A$F$Y$75.737$KG$20240723$$CN$US$US
240912041$24091204$1$I$$20240620$20240715$20240715$PER$$US-JNJFOC-20240665514$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240912051$24091205$1$I$$20240711$20240715$20240715$PER$$US-JNJFOC-20240729829$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240715$$CN$US$US
240912062$24091206$2$F$$20240717$20240715$20240726$PER$$US-JNJFOC-20240711716$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$US$US
240912071$24091207$1$I$$20240709$20240715$20240715$EXP$$NVSC2024CA142878$NOVARTIS$$$$$F$Y$$$20240715$$MD$CA$CA
240912081$24091208$1$I$20240520$20240708$20240715$20240715$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024084436$VIIV$$47$YR$$M$Y$$$20240715$$MD$US$US
240912091$24091209$1$I$20240621$20240704$20240715$20240715$PER$$US-SA-2019SA283626$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240715$$MD$US$US
240912102$24091210$2$F$20240401$20240726$20240715$20240805$PER$$US-SA-2024SA204291$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240804$$MD$US$US
240912111$24091211$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA083576$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240715$$MD$US$US
240912121$24091212$1$I$20240601$20240709$20240715$20240715$PER$$US-SA-2024SA204430$SANOFI AVENTIS$$$$A$M$Y$$$20240715$$MD$US$US
240912131$24091213$1$I$20171101$20240708$20240715$20240715$PER$$US-SA-2024SA204451$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240715$$MD$US$US
240912141$24091214$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA204670$SANOFI AVENTIS$$$$T$F$Y$$$20240715$$MD$US$US
240912151$24091215$1$I$20240621$20240704$20240715$20240715$PER$$US-SA-2023SA402298$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240715$$MD$US$US
240912161$24091216$1$I$$20230512$20240715$20240715$PER$$US-AMGEN-USASP2024139916$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240912172$24091217$2$F$20240419$20240710$20240715$20240717$EXP$SE-SEMPA-2024-005287$SE-009507513-2407SWE004833$MERCK$$59$YR$$M$Y$86$KG$20240717$$MD$SE$SE
240912191$24091219$1$I$$20240709$20240715$20240715$30DAY$$FR-PFIZER INC-PV202400090474$PFIZER$$7$YR$$M$Y$$$20240715$$MD$FR$FR
240912223$24091222$3$F$20240708$20240830$20240715$20240903$30DAY$$US-PFIZER INC-202400210026$PFIZER$$12$YR$$M$Y$34.47$KG$20240903$$HP$US$US
240912241$24091224$1$I$20231208$20240711$20240715$20240715$EXP$FR-AFSSAPS-DJ2024000818$FR-PFIZER INC-202400212271$PFIZER$$75$YR$$F$Y$50$KG$20240715$$PH$FR$FR
240912252$24091225$2$F$20240101$20240907$20240715$20240909$EXP$$CA-PFIZER INC-202400213460$PFIZER$$55$YR$$M$Y$$$20240909$$HP$CA$CA
240912263$24091226$3$F$$20240814$20240715$20240814$30DAY$$US-PFIZER INC-202400209969$PFIZER$$9$YR$$F$Y$$$20240814$$CN$US$US
240912277$24091227$7$F$$20240916$20240715$20240920$30DAY$$US-PFIZER INC-202400205091$PFIZER$$52$YR$$F$Y$$$20240920$$CN$US$US
240912286$24091228$6$F$$20240916$20240715$20240920$30DAY$$US-PFIZER INC-202400210049$PFIZER$$11$YR$$F$Y$$$20240920$$CN$US$US
240912291$24091229$1$I$$20240712$20240715$20240715$EXP$$IN-PFIZER INC-PV202400092411$PFIZER$$59$YR$$F$Y$$$20240715$$CN$IN$IN
240912303$24091230$3$F$20240704$20240912$20240715$20240917$30DAY$$US-PFIZER INC-202400210046$PFIZER$$12$YR$$M$Y$$$20240917$$HP$US$US
240912311$24091231$1$I$$20240711$20240715$20240715$EXP$$BE-PFIZER INC-202400213405$PFIZER$$$$$M$Y$$$20240715$$MD$BE$BE
240912323$24091232$3$F$$20240913$20240715$20240918$30DAY$$US-PFIZER INC-202400209274$PFIZER$$80$YR$$M$Y$$$20240918$$CN$US$US
240912341$24091234$1$I$$20240709$20240715$20240715$EXP$$JP-OTSUKA-2024_019458$OTSUKA$$$$$$Y$$$20240715$$PH$JP$JP
240912351$24091235$1$I$$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008598$ELI LILLY AND CO$$$$$F$Y$$$20240715$$CN$US$US
240912361$24091236$1$I$20240509$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405161321288170-VSLJQ$GB-TEVA-VS-3218648$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240912371$24091237$1$I$$20240710$20240715$20240715$PER$$US-AstraZeneca-2024A158191$ASTRAZENECA$$$$$F$Y$$$20240715$$MD$US$
240912381$24091238$1$I$$20240701$20240715$20240715$PER$$US-QUAGEN-2024QUASPO00213$QUAGEN PHARMACEUTICALS$$4$YR$C$M$Y$$$20240715$$CN$US$US
240912391$24091239$1$I$$20240710$20240715$20240715$EXP$$DE-BAYER-2024A100177$BAYER$$$$$F$Y$$$20240715$$MD$DE$DE
240912405$24091240$5$F$20240621$20240723$20240715$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-101518$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240726$$PH$JP$JP
240912411$24091241$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111946$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240715$$CN$US$US
240912422$24091242$2$F$$20240826$20240715$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111400$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240829$$CN$US$US
240912431$24091243$1$I$$20240710$20240715$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110153$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$80$KG$20240715$$HP$CA$CA
240912444$24091244$4$F$20240621$20240723$20240715$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-105337$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240726$$PH$JP$JP
240912452$24091245$2$F$$20240811$20240715$20240813$PER$$US-AMGEN-USASP2024139124$AMGEN$$65$YR$E$M$Y$$$20240813$$MD$US$US
240912461$24091246$1$I$20240101$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138432$AMGEN$$82$YR$E$F$Y$$$20240715$$MD$US$US
240912471$24091247$1$I$20230101$20240618$20240715$20240715$PER$$US-JNJFOC-20240721320$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240715$$CN$US$US
240912481$24091248$1$I$$20240708$20240715$20240715$PER$$US-JNJFOC-20240731766$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$LW$US$US
240912511$24091251$1$I$$20240702$20240715$20240715$EXP$$US-Merck Healthcare KGaA-2024036192$MERCK KGAA$Khan MS, Ahmed O, Nwaedozie S. Anaconda Right Coronary Artery. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023 May 01;43(Supple 1): Abstract Number: 442$61$YR$A$M$Y$$$20240710$$HP$US$US
240912521$24091252$1$I$$20240627$20240715$20240715$PER$$US-TEVA-VS-3215012$TEVA$$$$$M$Y$$$20240715$$CN$US$US
240912532$24091253$2$F$20240627$20240710$20240715$20240722$EXP$$US-BAYER-2024A100493$BAYER$$83$YR$E$F$Y$$$20240722$$CN$US$US
240912541$24091254$1$I$$20240708$20240715$20240715$EXP$$US-GSK-US2024084391$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$US$US
240912551$24091255$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA204465$SANOFI AVENTIS$$$$$$Y$$$20240715$$CN$US$US
240912561$24091256$1$I$20200508$20240712$20240715$20240715$EXP$PL-URPL-1-3694-2020$PL-SA-2024SA205797$SANOFI AVENTIS$$63$YR$A$F$Y$70$KG$20240715$$MD$PL$PL
240912571$24091257$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5653163$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240912581$24091258$1$I$20231219$20240710$20240715$20240715$EXP$$GB-MYLANLABS-2024M1034891$MYLAN$$$$$M$Y$$$20240715$$CN$GB$GB
240912591$24091259$1$I$20110320$20180607$20240715$20240715$EXP$$PL-Ipsen Biopharmaceuticals, Inc.-2011-3939$IPSEN$$12$YR$T$M$Y$44$KG$20240715$$MD$PL$PL
240912602$24091260$2$F$$20240820$20240715$20240820$EXP$$NZ-MYLANLABS-2024M1064514$MYLAN$$$$$M$Y$$$20240820$$HP$NZ$NZ
240912611$24091261$1$I$20180101$20240707$20240715$20240715$EXP$$GB-MYLANLABS-2024M1065840$MYLAN$Obeng L, Patel A, Villa G, Mourad A, Whibley M, Gilleece Y, et al. Autoimmune Hepatitis in People Living with HIV: A Case Series and Review of Literature. Open-AIDS-J 2023; 17 1-7.$53$YR$$F$Y$$$20240715$$HP$GB$GB
240912621$24091262$1$I$20240629$20240703$20240715$20240715$EXP$$US-Covis Pharma GmbH-2024COV00838$COVIS PHARMA$$34$YR$A$F$Y$$$20240715$$CN$US$US
240912631$24091263$1$I$$20240703$20240715$20240715$PER$$US-Covis Pharma GmbH-2024COV00835$COVIS PHARMA$$27$YR$A$$Y$$$20240715$$$US$US
240912641$24091264$1$I$$20240701$20240715$20240715$PER$$US-ALKERMES INC.-ALK-2024-001805$ALKERMES$$$$$M$Y$$$20240715$$HP$US$US
240912651$24091265$1$I$20240305$20240705$20240715$20240715$EXP$GB-MHRA-MED-202406260926267920-QLDBR$GB-TEVA-VS-3219442$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240912662$24091266$2$F$$20240716$20240715$20240717$30DAY$$US-PFIZER INC-202400210208$PFIZER$$14$YR$$M$Y$$$20240717$$CN$US$US
240912675$24091267$5$F$$20240913$20240715$20240918$30DAY$$US-PFIZER INC-202400209957$PFIZER$$12$YR$$F$Y$$$20240918$$CN$US$US
240912681$24091268$1$I$20240101$20240711$20240715$20240715$EXP$$CN-PFIZER INC-PV202400091308$PFIZER$$35$YR$$F$Y$74$KG$20240715$$HP$CN$CN
240912693$24091269$3$F$$20240912$20240715$20240916$30DAY$$US-PFIZER INC-202400211276$PFIZER$$10$YR$$M$Y$$$20240916$$CN$US$US
240912701$24091270$1$I$20220101$20240711$20240715$20240715$EXP$$US-PFIZER INC-PV202400091829$PFIZER$$$$$F$Y$$$20240715$$CN$US$US
240912715$24091271$5$F$20240708$20240911$20240715$20240913$30DAY$$US-PFIZER INC-202400210041$PFIZER$$13$YR$$M$Y$43.084$KG$20240913$$CN$US$US
240912733$24091273$3$F$20240709$20240814$20240715$20240814$30DAY$$US-PFIZER INC-PV202400066278$PFIZER$$11$YR$$F$Y$$$20240814$$CN$US$US
240912744$24091274$4$F$$20240912$20240715$20240917$30DAY$$US-PFIZER INC-202400210043$PFIZER$$9$YR$$M$Y$28.8$KG$20240917$$CN$US$US
240912751$24091275$1$I$$20240711$20240715$20240715$EXP$$CA-PFIZER INC-PV202400091194$PFIZER$$46$YR$$F$Y$$$20240715$$CN$CA$CA
240912762$24091276$2$F$$20240924$20240715$20240927$30DAY$$CA-PFIZER INC-PV202400090478$PFIZER$$14$YR$$M$Y$$$20240927$$CN$CA$CA
240912772$24091277$2$F$20240703$20240712$20240715$20240717$EXP$$US-Eisai-EC-2024-169965$EISAI$$74$YR$E$F$Y$$$20240717$$HP$US$US
240912781$24091278$1$I$20240601$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111746$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240715$$HP$US$US
240912791$24091279$1$I$$20240703$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010149$DR REDDYS$Berry M, Wang AM, Lahham RF, Zhang X, Pacheco LD. Ischemic Hepatitis and Septic Shock Secondary to Murine Typhus Infection in Pregnancy. AJP Reports. 2024 Jun 10;14(2): E185-E187. doi:10.1055/a-2330-4249.$37$YR$A$F$Y$$$20240715$$MD$US$US
240912802$24091280$2$F$20240623$20240710$20240715$20240718$EXP$GB-MHRA-MED-202407101218237110-KJPCV$GB-BAYER-2024A100826$BAYER$$36$YR$A$M$Y$83$KG$20240718$$CN$GB$GB
240912812$24091281$2$F$20240710$20240820$20240715$20240822$PER$$US-JNJFOC-20240726662$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240822$$PH$US$US
240912822$24091282$2$F$20240521$20240729$20240715$20240730$EXP$IE-HPRA-2024-114039$IE-JNJFOC-20240732756$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240730$$HP$IE$IE
240912831$24091283$1$I$20240101$20240709$20240715$20240715$EXP$$US-AMGEN-USASP2024135997$AMGEN$$81$YR$E$M$Y$$$20240715$$CN$US$US
240912851$24091285$1$I$20240427$20240714$20240714$20240714$DIR$710164$$FDA-CTU$$34$MON$$F$N$15.75$KG$20240714$$CN$US$
240912861$24091286$1$I$20240620$20240712$20240715$20240715$EXP$$US-INCYTE CORPORATION-2024IN007374$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240912871$24091287$1$I$$20240708$20240715$20240715$PER$$US-ROCHE-10000020685$ROCHE$$$$A$F$Y$$$20240715$$CN$US$US
240912881$24091288$1$I$20240101$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024137984$AMGEN$$74$YR$E$M$Y$$$20240715$$PH$US$US
240912891$24091289$1$I$20230901$20240712$20240715$20240715$EXP$$US-INCYTE CORPORATION-2024IN007368$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240912901$24091290$1$I$20230610$20240705$20240715$20240715$EXP$IT-MINISAL02-931277$IT-TEVA-VS-3217869$TEVA$$1$YR$$F$Y$9$KG$20240715$$PH$IT$IT
240912911$24091291$1$I$$20240710$20240715$20240715$PER$$US-ROCHE-10000023364$ROCHE$$$$A$M$Y$$$20240715$$CN$US$US
240912921$24091292$1$I$$20240712$20240715$20240715$PER$$US-ROCHE-10000026378$ROCHE$$$$E$F$Y$$$20240715$$CN$US$US
240912931$24091293$1$I$20220101$20240702$20240715$20240715$EXP$$US-CIPLA LTD.-2024US07266$CIPLA$Meller L, Scott NL, Jagadeesh V, Oca M, Wilson K, Zuraski C, et al.. Cytomegalovirus Retinitis in an Eye with Unilateral Retinoblastoma: A Case Report.. Case Reports in Opthalmology.. 2024;15 (1):476 to 482$$$$$Y$$$20240715$$HP$US$US
240912942$24091294$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3219209$TEVA$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant 2023; 23 (7): 1048-1057.; Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventr...$$$A$F$Y$$$20240802$$HP$US$US
240912962$24091296$2$F$$20240904$20240715$20240909$30DAY$$KR-PFIZER INC-PV202400090725$PFIZER$$14$YR$$$Y$$$20240909$$CN$KR$KR
240912972$24091297$2$F$20240501$20240718$20240715$20240723$PER$$US-KARYOPHARM-2024KPT001305$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240723$$CN$US$US
240912981$24091298$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111185$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240715$$CN$US$US
240912991$24091299$1$I$20240601$20240712$20240715$20240715$EXP$$US-UCBSA-2024035555$UCB$$78$YR$$M$Y$$$20240715$$CN$US$US
240913001$24091300$1$I$$20240710$20240715$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110590$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240715$$MD$CA$CA
240913011$24091301$1$I$20240530$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111724$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$106.14$KG$20240715$$PH$US$US
240913021$24091302$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110751$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240715$$HP$US$US
240913031$24091303$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111107$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240715$$HP$US$US
240913041$24091304$1$I$20221101$20240712$20240715$20240715$EXP$$US-INCYTE CORPORATION-2024IN007365$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240913063$24091306$3$F$20240101$20240719$20240715$20240903$EXP$$US-AMGEN-USASP2024136601$AMGEN$$70$YR$E$F$Y$$$20240903$$MD$US$US
240913074$24091307$4$F$20220801$20240910$20240715$20240918$EXP$$JP-OTSUKA-2024_013772$OTSUKA$$34$YR$$F$Y$$$20240918$$MD$JP$JP
240913081$24091308$1$I$$20240705$20240715$20240715$PER$$US-TEVA-VS-3219033$TEVA$$$$A$F$Y$$$20240715$$CN$US$US
240913091$24091309$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407052204504620-HSCGN$GB-TEVA-VS-3219296$TEVA$$61$YR$$F$Y$$$20240715$$CN$GB$GB
240913101$24091310$1$I$$20240702$20240715$20240715$EXP$$GB-CIPLA LTD.-2024GB07199$CIPLA$$$$$$Y$$$20240715$$CN$GB$GB
240913111$24091311$1$I$$20240711$20240715$20240715$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135636$DAIICHI$$$$$F$Y$$$20240715$$MD$US$US
240913121$24091312$1$I$$20240710$20240715$20240715$EXP$$BR-DSJP-DSE-2024-135596$DAIICHI$$60$YR$$M$Y$$$20240715$$MD$BR$BR
240913132$24091313$2$F$20240708$20240724$20240715$20240729$EXP$$US-MYLANLABS-2024M1065443$MYLAN$$33$YR$$F$Y$140.59$KG$20240729$$CN$US$US
240913141$24091314$1$I$20240101$20240710$20240715$20240715$EXP$$US-MYLANLABS-2024M1064815$MYLAN$$$$$F$Y$$$20240715$$CN$US$US
240913151$24091315$1$I$$20240710$20240715$20240715$EXP$$ES-PFIZER INC-2018SGN02111$PFIZER$$25$YR$$M$Y$$$20240715$$MD$ES$ES
240913172$24091317$2$F$$20240821$20240715$20240821$30DAY$$GB-PFIZER INC-PV202400090498$PFIZER$$54$YR$$M$Y$$$20240821$$MD$GB$GB
240913182$24091318$2$F$20240627$20240821$20240715$20240821$30DAY$$AR-PFIZER INC-202400206854$PFIZER$$14$YR$$M$Y$$$20240821$$CN$AR$AR
240913192$24091319$2$F$20240628$20240801$20240715$20240807$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US002232$PAREXEL$$$$$$Y$$$20240807$$HP$US$US
240913203$24091320$3$F$20231101$20240730$20240715$20240801$EXP$$US-UCBSA-2024035561$UCB$$79$YR$$F$Y$$$20240801$$CN$US$US
240913211$24091321$1$I$20240601$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110347$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240715$$HP$US$US
240913221$24091322$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111583$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240715$$CN$US$US
240913231$24091323$1$I$20240517$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405171537305410-FGCJN$GB-GUERBET / LLC-GB-20240088$GUERBET$$45$YR$A$F$Y$$$20240715$$HP$GB$GB
240913241$24091324$1$I$20240713$20240714$20240714$20240714$DIR$710157$$FDA-CTU$$49$YR$$M$N$91.35$KG$20240714$N$CN$US$
240913251$24091325$1$I$20240713$20240714$20240714$20240714$DIR$710155$$FDA-CTU$$51$YR$$M$N$112.5$KG$20240714$N$CN$US$
240913261$24091326$1$I$$20240707$20240715$20240715$EXP$$JP-009507513-2407JPN001551J$MERCK$Iimura Y, Sato N. EP-1319 A Case of Contrast-induced Nephropathy during Preoperative Chemotherapy. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 507$60$YR$$F$Y$$$20240715$$MD$JP$JP
240913272$24091327$2$F$$20240813$20240715$20240816$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003832$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240816$$CN$US$US
240913281$24091328$1$I$20240628$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407051751398890-PQYDJ$GB-TEVA-VS-3219443$TEVA$$22$YR$$M$Y$129$KG$20240715$$CN$GB$GB
240913291$24091329$1$I$$20240710$20240715$20240715$EXP$$TW-TAKEDA-2024TUS070684$TAKEDA$$$$$F$Y$$$20240715$$CN$TW$TW
240913301$24091330$1$I$$20240703$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010135$DR REDDYS$Li S, Halloran P, Siref A. Concurrent Neutrophilic Eccrine Hidradenitis and Leukocytoclastic Vasculitis. American Journal of Dermatopathology. 2024 Jul;46: S20. doi:10.1097/DAD.0000000000002757.$58$YR$A$F$Y$$$20240715$$MD$US$US
240913321$24091332$1$I$$20240714$20240714$20240714$DIR$710166$$FDA-CTU$$31$YR$$F$N$$$20240714$N$CN$US$
240913331$24091333$1$I$20240714$20240714$20240714$20240714$DIR$710161$$FDA-CTU$$26$YR$$F$N$51.75$KG$20240714$N$CN$US$
240913341$24091334$1$I$20200101$20240708$20240715$20240715$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003328$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$CA$CA
240913351$24091335$1$I$20240101$20240712$20240715$20240715$EXP$$US-009507513-2407USA008893$MERCK$$$$$F$Y$$$20240715$$PH$US$US
240913361$24091336$1$I$20240405$20240628$20240715$20240715$PER$$US-JNJFOC-20240700781$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240715$$CN$US$US
240913371$24091337$1$I$20180601$20240711$20240715$20240715$EXP$$US-TAKEDA-US201900829$TAKEDA$$65$YR$$M$Y$77$KG$20240715$$MD$US$US
240913381$24091338$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024139348$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240913391$24091339$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007760$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240715$$CN$US$US
240913401$24091340$1$I$20240711$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008561$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240715$$CN$US$US
240913411$24091341$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007895$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240715$$CN$US$US
240913421$24091342$1$I$20240706$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007009$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240715$$CN$US$US
240913431$24091343$1$I$20240705$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008599$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240715$$CN$US$US
240913441$24091344$1$I$$20240712$20240715$20240715$PER$$US-HALEON-2187009$Haleon PLC$$$$$M$Y$$$20240715$$CN$US$US
240913451$24091345$1$I$$20240628$20240715$20240715$PER$$US-009507513-2407USA000342$MERCK$$$$$M$Y$$$20240715$$CN$US$US
240913471$24091347$1$I$$20240701$20240715$20240715$EXP$$AT-EPICPHARMA-AT-2024EPCLIT00813$EPIC PHARM$Muser NR.Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer-case report.Memo-Magazine of European Medical Oncology.MAY-2024;17:107-109$61$YR$A$F$Y$$$20240715$$HP$AT$AT
240913492$24091349$2$F$20240601$20240717$20240715$20240718$PER$$US-JNJFOC-20240726018$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240718$$CN$US$US
240913511$24091351$1$I$20210101$20240710$20240715$20240715$EXP$$CZ-AstraZeneca-2024A160429$ASTRAZENECA$$$$E$F$Y$$$20240715$$MD$CZ$
240913532$24091353$2$F$$20240717$20240715$20240722$EXP$$CA-BAYER-2024A100969$BAYER$$$$$F$Y$$$20240722$$HP$CA$CA
240913541$24091354$1$I$20240601$20240705$20240715$20240715$PER$$US-SA-2024SA184894$SANOFI AVENTIS$$54$YR$A$F$Y$71.21$KG$20240715$$MD$US$US
240913551$24091355$1$I$20240714$20240714$20240714$20240714$DIR$710163$$FDA-CTU$$56$YR$$F$N$57.15$KG$20240714$N$CN$US$
240913561$24091356$1$I$20240428$20240714$20240714$20240714$DIR$710173$$FDA-CTU$$44$YR$$F$N$83.25$KG$20240714$N$CN$US$
240913571$24091357$1$I$20240705$20240706$20240715$20240715$EXP$$IN-INCYTE CORPORATION-2024IN007371$INCYTE$$$$$$Y$$$20240715$$CN$IN$IN
240913581$24091358$1$I$$20240701$20240715$20240715$EXP$$MA-EPICPHARMA-MA-2024EPCLIT00812$EPIC PHARM$Karima Ouchane.Reversible posterior leukoencephalopathy syndrome following carboplatin and paclitaxel in cervical cancer: Case report. .SAGE Open Medical Case Reports.09-MAY-2024;12:1-6$38$YR$A$F$Y$$$20240715$$HP$MA$MA
240913591$24091359$1$I$20240601$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109425$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240715$$CN$US$US
240913603$24091360$3$F$$20240801$20240715$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111134$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240805$$CN$US$US
240913612$24091361$2$F$$20240807$20240715$20240809$EXP$$CA-TAKEDA-2024TUS071211$TAKEDA$$$$$F$Y$$$20240809$$MD$CA$CA
240913621$24091362$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144873$NOVARTIS$$$$$$Y$$$20240715$$CN$US$US
240913631$24091363$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138574$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240913641$24091364$1$I$20240101$20240710$20240715$20240715$EXP$$CA-JNJFOC-20240727931$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240715$$HP$CA$CA
240913651$24091365$1$I$20240101$20240707$20240715$20240715$PER$$US-SA-2024SA203058$SANOFI AVENTIS$$12$YR$T$M$Y$73.93$KG$20240715$$MD$US$US
240913662$24091366$2$F$20230113$20240705$20240715$20240717$EXP$$FR-CELLTRION INC.-2024FR016652$CELLTRION$$$$$$Y$$$20240717$$MD$FR$FR
240913671$24091367$1$I$$20240712$20240715$20240715$EXP$$GB-UCBSA-2024035664$UCB$$$$$F$Y$$$20240715$$CN$GB$GB
240913681$24091368$1$I$$20240701$20240715$20240715$EXP$$GB-EPICPHARMA-GB-2024EPCLIT00814$EPIC PHARM$Chant K.Cumulative risk factors contributing to hearing loss in preterm infants.Fetal and Neonatal Edition.SEP-2023;108:464-470$3$YR$C$M$Y$$$20240715$$HP$US$GB
240913692$24091369$2$F$20240101$20240815$20240715$20240824$EXP$$CA-ABBVIE-5838005$ABBVIE$$37$YR$$F$Y$$$20240824$$CN$CA$CA
240913701$24091370$1$I$$20240708$20240715$20240715$EXP$$AU-ALXN-202407OCE000444AU$ALEXION PHARMACEUTICALS$$40$YR$$M$Y$$$20240715$$CN$AU$AU
240913711$24091371$1$I$$20240708$20240715$20240715$PER$$US-AstraZeneca-2024A156208$ASTRAZENECA$$$$$F$Y$$$20240715$$CN$US$
240913722$24091372$2$F$20240701$20240903$20240715$20240906$EXP$$JP-AstraZeneca-2024A159290$ASTRAZENECA$$80$YR$$M$Y$$$20240906$$MD$JP$
240913731$24091373$1$I$$20240705$20240715$20240715$PER$$US-BAYER-2024A097482$BAYER$$$$$F$Y$$$20240715$$HP$US$US
240913741$24091374$1$I$20230904$20240709$20240715$20240715$PER$$US-BIOGEN-2023BI01227271$BIOGEN$$64$YR$$F$Y$$$20240715$$CN$US$US
240913761$24091376$1$I$20240626$20240710$20240715$20240715$EXP$$CN-SANDOZ INC.-SDZ2024CN065015$SANDOZ$$62$YR$$F$Y$50$KG$20240715$$HP$CN$CN
240913771$24091377$1$I$20240629$20240710$20240715$20240715$EXP$$CN-Merck Healthcare KGaA-2024037750$MERCK KGAA$$47$YR$A$F$Y$65$KG$20240715$$HP$CN$CN
240913781$24091378$1$I$$20240708$20240715$20240715$EXP$$CA-BAUSCH-BL-2024-010478$BAUSCH AND LOMB$$$$$F$Y$$$20240715$$HP$CA$CA
240913792$24091379$2$F$$20240905$20240715$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110996$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240906$$CN$US$US
240913802$24091380$2$F$$20240723$20240715$20240802$EXP$$CA-TEVA-VS-3217685$TEVA$Marwaha AS, Cockcroft DW, Philipenko B. Psyllium Husk (Metamucil) Induced Non-atopic Perennial Asthma: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209.; Marwaha AS, Cockcroft DW, Philipenko B. Psyllium Husk (Metamucil) Induced Non-atopic Perennial Asthma: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209.$44$YR$$F$Y$$$20240802$$HP$CA$CA
240913811$24091381$1$I$$20240709$20240715$20240715$EXP$$BR-DAIICHI SANKYO, INC.-DSE-2024-135402$DAIICHI$$53$YR$$F$Y$$$20240715$$MD$BR$BR
240913821$24091382$1$I$$20240708$20240715$20240715$EXP$$US-GILEAD-2024-0680394$GILEAD$Bishop MD, Korutaro V., Boyce CL, Beck IA, Styrchak SM, Knowles K, et al.. Characterizing HIV drug resistance in cases of vertical transmission in the VesTed randomized antiretroviral treatment trial. Journal of Acquired Immune Deficiency Syndromes. 2024;96(4):385-392. doi:UNK$$$N$M$Y$3.2$KG$20240715$$HP$US$US
240913831$24091383$1$I$$20240711$20240715$20240715$EXP$$US-UCBSA-2024035680$UCB$$$$$M$Y$$$20240715$$MD$US$US
240913841$24091384$1$I$20211227$20240712$20240715$20240715$EXP$$US-UCBSA-2024011601$UCB$$52$YR$$F$Y$$$20240715$$HP$US$US
240913851$24091385$1$I$20240601$20240708$20240715$20240715$PER$$US-BAYER-2024A098228$BAYER$$90$YR$E$M$Y$$$20240715$$CN$US$US
240913862$24091386$2$F$20070616$20240708$20240715$20240724$EXP$FR-SA-A02200801858$FR-UCBSA-2024034455$UCB$$$$$F$Y$3.76$KG$20240724$$MD$FR$FR
240913872$24091387$2$F$$20240814$20240715$20240819$EXP$$CA-BAUSCH-BL-2024-010542$BAUSCH AND LOMB$$44$YR$$F$Y$70$KG$20240819$$HP$CA$CA
240913881$24091388$1$I$20240510$20240705$20240715$20240715$EXP$$CN-SA-2024SA203697$SANOFI AVENTIS$$77$YR$E$F$Y$65$KG$20240715$$HP$CN$CN
240913891$24091389$1$I$20240419$20240422$20240715$20240715$PER$$US-AMGEN-USASP2024139941$AMGEN$$76$YR$E$F$Y$$$20240715$$CN$US$US
240913902$24091390$2$F$$20240919$20240715$20240924$PER$$US-ROCHE-10000021793$ROCHE$$24$YR$A$M$Y$$$20240924$$CN$US$US
240913911$24091391$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA204564$SANOFI AVENTIS$$$$A$M$Y$$$20240715$$MD$US$US
240913921$24091392$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405101423535400-WTCJS$GB-TEVA-VS-3218710$TEVA$$$$$$Y$$$20240715$$HP$GB$GB
240913931$24091393$1$I$20240101$20240709$20240715$20240715$PER$$US-SA-2024SA204525$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240715$$MD$US$US
240913941$24091394$1$I$$20240705$20240715$20240715$PER$$US-BAYER-2024A097618$BAYER$$$$$M$Y$$$20240715$$CN$US$US
240913951$24091395$1$I$20210417$20240711$20240715$20240715$EXP$$US-PURDUE-USA-2024-0310731$PURDUE$$19$YR$$M$Y$$$20240715$$CN$US$US
240913961$24091396$1$I$20240704$20240709$20240715$20240715$PER$$US-BIOGEN-2024BI01273031$BIOGEN$$75$YR$$F$Y$$$20240715$$CN$US$US
240913971$24091397$1$I$20240708$20240712$20240713$20240713$DIR$FDA-CDER-CTU-2024-48551$$FDA-CTU$$70$YR$$F$N$70.9$KG$20240712$N$$US$
240913981$24091398$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110431$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240715$$CN$US$US
240913991$24091399$1$I$20240629$20240629$20240715$20240715$EXP$$VN-FreseniusKabi-FK202410327$FRESENIUS KABI$$$$$M$Y$$$20240715$$MD$VN$VN
240914001$24091400$1$I$20240629$20240629$20240715$20240715$EXP$$VN-FreseniusKabi-FK202410328$FRESENIUS KABI$$$$A$M$Y$$$20240715$$MD$VN$VN
240914011$24091401$1$I$20240101$20240702$20240715$20240715$PER$$US-FreseniusKabi-FK202410536$FRESENIUS KABI$$$$$F$Y$$$20240715$$PH$US$US
240914022$24091402$2$F$$20240725$20240715$20240730$PER$$US-ROCHE-10000025796$ROCHE$$$$$F$Y$$$20240730$$HP$US$US
240914031$24091403$1$I$$20240712$20240715$20240715$PER$$US-ROCHE-10000025765$ROCHE$$$$$F$Y$$$20240715$$MD$US$US
240914041$24091404$1$I$20240709$20240709$20240715$20240715$PER$$US-AMGEN-USASP2024136223$AMGEN$$77$YR$E$F$Y$$$20240715$$CN$US$US
240914051$24091405$1$I$$20240709$20240715$20240715$PER$$US-ROCHE-10000023044$ROCHE$$$$$$Y$$$20240715$$CN$US$US
240914072$24091407$2$F$$20240716$20240715$20240722$PER$$US-ROCHE-10000023220$ROCHE$$$$$$Y$$$20240719$$HP$US$US
240914082$24091408$2$F$20240710$20240715$20240715$20240716$PER$$IT-KARYOPHARM-2024KPT001311$KARYOPHARM THERAPEUTICS$$52$YR$$F$Y$62$KG$20240716$$MD$IT$IT
240914102$24091410$2$F$$20240805$20240715$20240806$PER$$US-ALXN-202407USA000468US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240914112$24091411$2$F$$20240716$20240715$20240716$EXP$$US-Mission Pharmacal Company-2159116$MISSION$$49$YR$$F$Y$$$20240716$$$US$US
240914121$24091412$1$I$$20240711$20240715$20240715$PER$$US-AMX-008115$AMYLYX PHARMACEUTICALS$$$$A$$Y$$$20240715$$CN$US$US
240914131$24091413$1$I$20240711$20240712$20240715$20240715$PER$$US-JNJFOC-20240734268$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240715$$CN$US$US
240914143$24091414$3$F$$20240925$20240715$20240927$PER$$NVSC2024US145336$NOVARTIS$$$$$F$Y$$$20240927$$MD$US$US
240914151$24091415$1$I$$20240711$20240715$20240715$EXP$$CA-SANDOZ INC.-NVSC2020CA193186$SANDOZ$$69$YR$$F$Y$$$20240715$$CN$CA$CA
240914162$24091416$2$F$$20240711$20240715$20240717$PER$$US-PURDUE PHARMA-USA-2024-0310729$PURDUE$$$$$M$Y$86.18$KG$20240717$$CN$US$US
240914172$24091417$2$F$20240708$20240710$20240715$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407006394$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240716$$CN$US$US
240914183$24091418$3$F$20240301$20240904$20240715$20240916$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202401007676$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240916$$CN$BR$BR
240914191$24091419$1$I$20240710$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007147$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240715$$CN$US$US
240914201$24091420$1$I$$20240712$20240715$20240715$PER$$US-BIOVITRUM-2024-US-008860$BIOVITRUM$$74$YR$$F$Y$$$20240715$$CN$US$US
240914211$24091421$1$I$$20240708$20240715$20240715$EXP$$US-PFIZER INC-PV202400090231$PFIZER$Abuazzam, F.. A Rare Case of Membranous Nephropathy in a Patient With Immune-Mediated Necrotizing Myositis: Rituximab Escape. Journal of the American Society of Nephrology. 2022;33:176$42$YR$$M$Y$$$20240715$$HP$US$US
240914221$24091422$1$I$$20240712$20240715$20240715$EXP$$DE-PFIZER INC-202400213121$PFIZER$$83$YR$$F$Y$60$KG$20240715$$MD$DE$DE
240914231$24091423$1$I$$20240711$20240715$20240715$EXP$$US-PFIZER INC-PV202400091431$PFIZER$$$$$$Y$$$20240715$$CN$US$US
240914241$24091424$1$I$$20240709$20240715$20240715$PER$$US-BIOGEN-2024BI01272963$BIOGEN$$$$$M$Y$$$20240715$$CN$US$US
240914251$24091425$1$I$20240127$20240711$20240715$20240715$EXP$FR-AFSSAPS-ST2024001138$FR-PFIZER INC-202400212120$PFIZER$$56$YR$$M$Y$77.2$KG$20240715$$HP$FR$FR
240914261$24091426$1$I$20240501$20240709$20240715$20240715$EXP$$US-PFIZER INC-PV202400074098$PFIZER$$77$YR$$F$Y$$$20240715$$HP$US$US
240914271$24091427$1$I$$20240713$20240715$20240715$EXP$$IN-PFIZER INC-PV202400092183$PFIZER$$43$YR$$M$Y$$$20240715$$CN$IN$IN
240914292$24091429$2$F$$20240916$20240715$20240918$EXP$$US-PFIZER INC-202400213301$PFIZER$$65$YR$$F$Y$$$20240918$$HP$US$US
240914301$24091430$1$I$20240701$20240709$20240715$20240715$PER$$US-BIOGEN-2024BI01273040$BIOGEN$$29$YR$$M$Y$$$20240715$$CN$US$US
240914311$24091431$1$I$$20240709$20240715$20240715$PER$$US-BIOGEN-2024BI01273069$BIOGEN$$$$$M$Y$$$20240715$$CN$US$US
240914321$24091432$1$I$$20240710$20240715$20240715$PER$$US-BIOGEN-2024BI01269811$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240914331$24091433$1$I$$20240709$20240715$20240715$PER$$US-BAYER-2024A099193$BAYER$$19$YR$A$F$Y$$$20240715$$HP$US$US
240914341$24091434$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111638$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$74.84$KG$20240715$$CN$US$US
240914351$24091435$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111977$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240715$$CN$US$US
240914363$24091436$3$F$20221101$20240719$20240715$20240726$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-111585$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$90$KG$20240726$$MD$DE$DE
240914371$24091437$1$I$20230630$20240702$20240715$20240715$EXP$$KR-TEVA-VS-3217413$TEVA$$$$A$F$Y$$$20240715$$HP$KR$KR
240914381$24091438$1$I$20240710$20240710$20240715$20240715$PER$$US-BAYER-2024A099602$BAYER$$40$YR$A$F$Y$$$20240715$$MD$US$US
240914391$24091439$1$I$$20240701$20240715$20240715$EXP$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000404$Day One Biopharmaceuticals$$41$YR$$M$Y$$$20240715$$CN$US$US
240914401$24091440$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5693768$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240914411$24091441$1$I$20230904$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405141317487200-VGRFY$GB-TEVA-VS-3218475$TEVA$$67$YR$$F$Y$$$20240715$$CN$GB$GB
240914421$24091442$1$I$$20240709$20240715$20240715$EXP$$BR-DSJP-DSE-2024-135400$DAIICHI$$75$YR$$M$Y$$$20240715$$MD$BR$BR
240914431$24091443$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000023555$ROCHE$$$$E$F$Y$$$20240715$$HP$US$US
240914441$24091444$1$I$$20240711$20240715$20240715$PER$$NVSC2024US145389$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240914451$24091445$1$I$$20240712$20240715$20240715$PER$$US-JNJFOC-20240734297$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$HP$US$US
240914462$24091446$2$F$20231101$20240805$20240715$20240808$EXP$$NVSC2024IT144749$NOVARTIS$$$$$M$Y$$$20240808$$CN$IT$IT
240914471$24091447$1$I$20240601$20240701$20240715$20240715$PER$$US-009507513-2407USA000810$MERCK$$67$YR$$M$Y$$$20240715$$CN$US$US
240914481$24091448$1$I$$20240708$20240715$20240715$PER$$US-BAYER-2024A098649$BAYER$$84$YR$E$$Y$$$20240715$$CN$US$US
240914491$24091449$1$I$$20240701$20240715$20240715$PER$$US-ROCHE-10000020006$ROCHE$$$$$F$Y$$$20240715$$MD$US$US
240914501$24091450$1$I$20220101$20240708$20240715$20240715$EXP$$US-INDIVIOR US-INDV-145912-2024$RECKITT BENCKISER$$$$$$Y$$$20240715$$CN$US$US
240914511$24091451$1$I$20230712$20240705$20240715$20240715$EXP$IT-MINISAL02-936590$IT-TEVA-VS-3217916$TEVA$$1$YR$$F$Y$9$KG$20240715$$PH$IT$IT
240914521$24091452$1$I$$20240705$20240715$20240715$EXP$$GB-TEVA-VS-3219347$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240914532$24091453$2$F$20231120$20240807$20240715$20240808$EXP$GB-MHRA-MED-202407121029463380-WHDGY$GB-PFIZER INC-202400213351$PFIZER$$51$YR$$F$Y$60$KG$20240808$$CN$GB$GB
240914541$24091454$1$I$$20240708$20240715$20240715$EXP$$US-PFIZER INC-PV202400090343$PFIZER$Meeder, R.. Dyadic Work in Conjunction With Electroconvulsive Therapy in a 12-Year-Old Female With Autism Spectrum Disorder and Catatonia. Ochsner Journal. 2024;24(2):141-146$12$YR$$F$Y$$$20240715$$MD$US$US
240914552$24091455$2$F$20240715$20240719$20240715$20240725$EXP$$CA-PFIZER INC-202400099188$PFIZER$$66$YR$$M$Y$$$20240725$$MD$CA$CA
240914563$24091456$3$F$20240625$20240724$20240715$20240726$EXP$$CA-PFIZER INC-202400213396$PFIZER$$81$YR$$F$Y$103$KG$20240726$$HP$CA$CA
240914581$24091458$1$I$$20240711$20240715$20240715$EXP$$US-PFIZER INC-202400212927$PFIZER$$60$YR$$F$Y$$$20240715$$HP$US$US
240914591$24091459$1$I$20240601$20240712$20240715$20240715$EXP$GB-MHRA-MED-202407121558575780-FMSJC$GB-PFIZER INC-202400213559$PFIZER$$$$$F$Y$$$20240715$$HP$GB$GB
240914601$24091460$1$I$$20240712$20240715$20240715$EXP$$CN-PFIZER INC-202400213363$PFIZER$$$$A$M$Y$$$20240715$$MD$CN$CN
240914611$24091461$1$I$20240606$20240712$20240715$20240715$EXP$$US-PFIZER INC-202400213529$PFIZER$$$$$F$Y$$$20240715$$MD$US$US
240914624$24091462$4$F$20240701$20240914$20240715$20240918$EXP$$US-PFIZER INC-202400213463$PFIZER$$61$YR$$F$Y$71.21$KG$20240918$$CN$US$US
240914641$24091464$1$I$$20240711$20240715$20240715$EXP$$CA-PFIZER INC-202400213362$PFIZER$$62$YR$$F$Y$$$20240715$$HP$CA$CA
240914651$24091465$1$I$$20240711$20240715$20240715$EXP$$US-PFIZER INC-202400213428$PFIZER$$$$$$Y$$$20240715$$PH$US$US
240914661$24091466$1$I$20240101$20240711$20240715$20240715$EXP$$GB-PFIZER INC-202400212380$PFIZER$$56$YR$$F$Y$94$KG$20240715$$MD$GB$GB
240914671$24091467$1$I$20231128$20240711$20240715$20240715$EXP$FR-AFSSAPS-ST2024001137$FR-PFIZER INC-202400212121$PFIZER$$65$YR$$F$Y$56.5$KG$20240715$$HP$FR$FR
240914681$24091468$1$I$20240101$20240711$20240715$20240715$EXP$$CA-PFIZER INC-202400213965$PFIZER$$69$YR$$M$Y$$$20240715$$HP$CA$CA
240914691$24091469$1$I$$20240709$20240715$20240715$EXP$$US-PFIZER INC-PV202400090304$PFIZER$Chamseddine, S.. Severe febrile neutropenia and pancytopenia in a patient with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: a case report. Journal of Gastrointestinal Oncology. 2024;15(3):1324-1330$6$DEC$$M$Y$$$20240715$$HP$US$US
240914702$24091470$2$F$$20240920$20240715$20240923$EXP$$NVSC2024CH143727$NOVARTIS$$$$$M$Y$$$20240923$$CN$CH$CH
240914711$24091471$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144935$NOVARTIS$$57$YR$$M$Y$96.68$KG$20240715$$HP$US$US
240914721$24091472$1$I$$20240708$20240715$20240715$EXP$$CA-FreseniusKabi-FK202410777$FRESENIUS KABI$$40$YR$A$F$Y$$$20240715$$CN$CA$CA
240914731$24091473$1$I$$20240705$20240715$20240715$EXP$$US-FreseniusKabi-FK202411016$FRESENIUS KABI$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatric Blood + Cancer. 2024;71: 1-5. doi:10.1002/pbc.31004.$41$YR$A$M$Y$$$20240715$$HP$US$US
240914741$24091474$1$I$$20240708$20240715$20240715$EXP$$CA-FreseniusKabi-FK202410773$FRESENIUS KABI$$68$YR$E$F$Y$73$KG$20240715$$CN$CA$CA
240914751$24091475$1$I$$20240708$20240715$20240715$EXP$$CA-FreseniusKabi-FK202410802$FRESENIUS KABI$$12$YR$T$F$Y$32$KG$20240715$$HP$CA$CA
240914761$24091476$1$I$20240607$20240710$20240715$20240715$EXP$GB-MHRA-MED-202407101106503030-SRTDG$GB-MYLANLABS-2024M1064735$MYLAN$$56$YR$$F$Y$71$KG$20240715$$CN$GB$GB
240914771$24091477$1$I$20240513$20240710$20240715$20240715$EXP$$FR-MYLANLABS-2024M1064661$MYLAN$$21$YR$$M$Y$$$20240715$$HP$FR$FR
240914781$24091478$1$I$$20240709$20240715$20240715$PER$$US-Mission Pharmacal Company-2159117$MISSION$$54$YR$$F$Y$$$20240715$$$US$US
240914801$24091480$1$I$20240131$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48654$$FDA-CTU$$81$YR$$$N$64.41$KG$20240715$N$CN$US$
240914811$24091481$1$I$20240516$20240710$20240715$20240715$EXP$GB-MHRA-MED-202407102102341960-WSBCG$GB-MYLANLABS-2024M1064997$MYLAN$$$$$F$Y$58$KG$20240715$$CN$GB$GB
240914821$24091482$1$I$$20240710$20240715$20240715$EXP$GB-MHRA-TPP13563131C10015503YC1720516046805$GB-MYLANLABS-2024M1064732$MYLAN$$86$YR$$F$Y$57$KG$20240715$$MD$GB$GB
240914833$24091483$3$F$20240101$20240814$20240715$20240903$PER$$US-KARYOPHARM-2024KPT001233$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
240914841$24091484$1$I$$20240715$20240715$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039771$BOEHRINGER INGELHEIM$$$$$$Y$$$20240715$$HP$US$US
240914852$24091485$2$F$20240401$20240718$20240715$20240723$PER$$US-BAYER-2024A100001$BAYER$$32$YR$A$F$Y$$$20240723$$MD$US$US
240914861$24091486$1$I$$20240711$20240715$20240715$EXP$$BE-ABBVIE-5839495$ABBVIE$$$$$M$Y$$$20240715$$MD$BE$BE
240914872$24091487$2$F$$20240717$20240715$20240723$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-096551$REGENERON$$$$$M$Y$$$20240723$$CN$CA$CA
240914881$24091488$1$I$20190101$20240701$20240715$20240715$EXP$$US-FreseniusKabi-FK202410414$FRESENIUS KABI$$34$YR$A$M$Y$$$20240715$$CN$US$US
240914891$24091489$1$I$$20240705$20240715$20240715$PER$$US-GILEAD-2024-0679799$GILEAD$$$$E$M$Y$$$20240715$$CN$US$US
240914901$24091490$1$I$20240708$20240712$20240713$20240713$DIR$FDA-CDER-CTU-2024-48550$$FDA-CTU$$$$$F$N$62.5$KG$20240712$N$$US$
240914932$24091493$2$F$20240711$20240715$20240715$20240717$PER$$US-AMGEN-USASP2024139591$AMGEN$$75$YR$E$F$Y$$$20240717$$CN$US$US
240914941$24091494$1$I$$20240711$20240715$20240715$PER$$US-BAYER-2024A100255$BAYER$$$$$$Y$$$20240715$$CN$US$US
240914952$24091495$2$F$20240101$20240828$20240715$20240912$PER$$US-SA-2024SA203327$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240912$$MD$US$US
240914961$24091496$1$I$$20240712$20240715$20240715$PER$$US-BAYER-2024A100970$BAYER$$$$$F$Y$$$20240715$$CN$US$US
240914972$24091497$2$F$20240101$20240903$20240715$20240913$PER$$US-SA-2024SA204600$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240913$$MD$US$US
240914991$24091499$1$I$$20240711$20240715$20240715$PER$$US-BAYER-2024A101182$BAYER$$$$$F$Y$$$20240715$$CN$US$US
240915001$24091500$1$I$20240712$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111904$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240715$$MD$US$US
240915011$24091501$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111429$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240715$$CN$US$US
240915022$24091502$2$F$20240101$20240905$20240715$20240909$PER$$US-BIOGEN-2024BI01259306$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
240915041$24091504$1$I$20230804$20240705$20240715$20240715$EXP$IT-MINISAL02-943339$IT-TEVA-VS-3217870$TEVA$$18$YR$$M$Y$48$KG$20240715$$PH$IT$IT
240915052$24091505$2$F$20240711$20240712$20240715$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110796$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240722$$PH$US$US
240915061$24091506$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111982$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240715$$CN$US$US
240915072$24091507$2$F$$20240811$20240715$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111619$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$58.51$KG$20240813$$CN$US$US
240915081$24091508$1$I$20240628$20240705$20240715$20240715$EXP$$CN-SA-2024SA202754$SANOFI AVENTIS$$54$YR$A$F$Y$57$KG$20240715$$HP$CN$CN
240915091$24091509$1$I$$20240712$20240715$20240715$PER$$US-BAYER-2024A101207$BAYER$$$$$F$Y$$$20240715$$HP$US$US
240915101$24091510$1$I$20240503$20240711$20240715$20240715$EXP$$DE-JNJFOC-20240737286$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240715$$CN$DE$DE
240915113$24091511$3$F$$20240717$20240715$20240717$PER$$US-JNJFOC-20240730606$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$US$US
240915122$24091512$2$F$20231018$20240806$20240715$20240813$EXP$CA-MMM-6P9XHIKQ$CA-GSK-CA2023110203$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CA$CA
240915131$24091513$1$I$$20240708$20240715$20240715$EXP$$CA-SANDOZ INC.-NVSC2023CA033941$SANDOZ$$$$A$M$Y$$$20240715$$CN$CA$CA
240915151$24091515$1$I$$20240709$20240715$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-011429$VERTEX$$10$YR$$M$Y$$$20240715$$CN$US$US
240915161$24091516$1$I$20220601$20240714$20240714$20240714$DIR$710193$$FDA-CTU$$45$YR$$F$N$80.1$KG$20240714$N$CN$US$
240915171$24091517$1$I$$20240709$20240715$20240715$EXP$$US-VERTEX PHARMACEUTICALS-2024-011411$VERTEX$$$$$M$Y$$$20240715$$CN$US$US
240915181$24091518$1$I$20240703$20240714$20240714$20240714$DIR$710169$$FDA-CTU$$$$$M$N$117$KG$20240714$N$CN$US$
240915201$24091520$1$I$20240101$20240709$20240715$20240715$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011436$VERTEX$$$$A$M$Y$$$20240715$$CN$GB$GB
240915211$24091521$1$I$$20240709$20240715$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-011422$VERTEX$$$$$F$Y$$$20240715$$CN$US$US
240915221$24091522$1$I$$20240710$20240715$20240715$PER$$US-ABBVIE-5836636$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240915231$24091523$1$I$$20240708$20240715$20240715$EXP$$JP-ROCHE-10000022814$ROCHE$Kimura A, Nakagomi H, Inoue M, Oka T, Hirotsu Y, Amemiya K, et al. Dynamic change of cancer genome profiling in metachronous bilateral breast cancer with BRCA pathogenic variant. International Cancer Conference Journal. 2024-Jul;13 (3):193-198. doi:10.1007/s13691-024-00685-3.$61$YR$A$F$Y$$$20240715$$HP$JP$JP
240915242$24091524$2$F$$20240717$20240715$20240724$EXP$$US-LUNDBECK-DKLU4001637$LUNDBECK$$$$$$Y$$$20240724$$CN$US$US
240915251$24091525$1$I$$20240705$20240715$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-011263$VERTEX$$$$$M$Y$$$20240715$$CN$US$US
240915261$24091526$1$I$$20240709$20240715$20240715$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011380$VERTEX$$$$A$F$Y$$$20240715$$CN$GB$GB
240915273$24091527$3$F$$20240822$20240715$20240827$EXP$$US-VERTEX PHARMACEUTICALS-2024-011346$VERTEX$$$$A$$Y$$$20240827$$CN$US$US
240915281$24091528$1$I$$20240709$20240715$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-011405$VERTEX$$$$$F$Y$$$20240715$$CN$US$US
240915292$24091529$2$F$$20240729$20240715$20240802$EXP$$US-VERTEX PHARMACEUTICALS-2024-011514$VERTEX$$$$$$Y$$$20240802$$CN$US$US
240915301$24091530$1$I$20240705$20240710$20240715$20240715$EXP$GB-MHRA-MED-202407101057161840-DBVTL$GB-VERTEX PHARMACEUTICALS-2024-011467$VERTEX$$39$YR$$F$Y$$$20240715$$PH$GB$GB
240915312$24091531$2$F$$20240709$20240715$20240717$PER$$US-VERTEX PHARMACEUTICALS-2024-011410$VERTEX$$$$$$Y$$$20240717$$CN$US$US
240915321$24091532$1$I$$20240709$20240715$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-011376$VERTEX$$$$$F$Y$$$20240715$$HP$US$US
240915331$24091533$1$I$$20240708$20240715$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-011361$VERTEX$$$$$$Y$$$20240715$$CN$US$US
240915341$24091534$1$I$$20240709$20240715$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-011453$VERTEX$$5$YR$$M$Y$$$20240715$$CN$US$US
240915351$24091535$1$I$$20240709$20240715$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-011441$VERTEX$$$$$$Y$$$20240715$$CN$US$US
240915361$24091536$1$I$20240702$20240710$20240715$20240715$EXP$GB-MHRA-MED-202407101130489460-TCHLQ$GB-VERTEX PHARMACEUTICALS-2024-011468$VERTEX$$20$YR$$F$Y$$$20240715$$PH$GB$GB
240915371$24091537$1$I$20240627$20240710$20240715$20240715$EXP$GB-MHRA-MED-202407100853300340-FKQSM$GB-VERTEX PHARMACEUTICALS-2024-011465$VERTEX$$36$YR$$M$Y$$$20240715$$PH$GB$GB
240915381$24091538$1$I$$20240709$20240715$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-011442$VERTEX$$$$$F$Y$$$20240715$$CN$US$US
240915391$24091539$1$I$$20240709$20240715$20240715$EXP$$FR-DSJP-DSE-2024-135388$DAIICHI$$$$$F$Y$$$20240715$$MD$FR$FR
240915401$24091540$1$I$20240601$20240710$20240715$20240715$EXP$$GB-MYLANLABS-2024M1065088$MYLAN$$$$$M$Y$$$20240715$$MD$GB$GB
240915411$24091541$1$I$$20240710$20240715$20240715$EXP$$PL-MYLANLABS-2024M1064772$MYLAN$Jerzak M, Bindas J, Szczukocka M.. Diffuse alveolar haemorrhage ? case report and literature review.. Journal of Pre-Clinical and Clinical Research. 2024;18 (2):147-150$36$YR$$F$Y$$$20240715$$HP$PL$PL
240915421$24091542$1$I$$20240709$20240715$20240715$EXP$$US-PFIZER INC-202400205389$PFIZER$$59$YR$$F$Y$$$20240715$$HP$US$US
240915433$24091543$3$F$$20240901$20240715$20240902$EXP$$US-PFIZER INC-2021SGN01916$PFIZER$$6$DEC$$F$Y$$$20240902$$HP$US$US
240915441$24091544$1$I$$20240711$20240715$20240715$EXP$$US-PFIZER INC-202400213452$PFIZER$Mabry, R.. Visual Loss After Intranasal Corticosteroid Injection Incidence, Causes, and Prevention. Arch Otolaryngol. 1981;107:484-486$$$$$Y$$$20240715$$MD$US$US
240915451$24091545$1$I$$20240710$20240715$20240715$EXP$$US-PFIZER INC-PV202400090576$PFIZER$Voelz, K.. 6-Mercaptopurine-associated Sinusoidal Obstructive Syndrome During Interim Maintenance I: A Case Report.. Journal of Pediatric Hematology/Oncology. 2024;46(5):e317-e321$14$YR$$M$Y$$$20240715$$MD$US$US
240915461$24091546$1$I$20230123$20240709$20240715$20240715$EXP$$AT-PFIZER INC-2023SGN01940$PFIZER$$49$YR$$F$Y$58$KG$20240715$$MD$AT$AT
240915472$24091547$2$F$20231010$20240730$20240715$20240805$EXP$$GR-PFIZER INC-202400208500$PFIZER$$69$YR$$F$Y$44$KG$20240805$$MD$GR$GR
240915481$24091548$1$I$$20240708$20240715$20240715$EXP$$AT-PFIZER INC-2022SGN11045$PFIZER$$68$YR$$F$Y$$$20240715$$MD$AT$AT
240915491$24091549$1$I$20231116$20240708$20240715$20240715$EXP$$AT-PFIZER INC-2023SGN13704$PFIZER$$26$YR$$F$Y$$$20240715$$MD$AT$AT
240915501$24091550$1$I$20240204$20240710$20240715$20240715$EXP$$DE-PFIZER INC-PV202400090431$PFIZER$$70$YR$$F$Y$$$20240715$$MD$DE$DE
240915511$24091551$1$I$$20240711$20240715$20240715$EXP$$US-PFIZER INC-202400213451$PFIZER$Mabry, R.. Visual Loss After Intranasal Corticosteroid Injection Incidence, Causes, and Prevention. Arch Otolaryngol. 1981;107:484-486$$$$$Y$$$20240715$$MD$US$US
240915522$24091552$2$F$20240601$20240809$20240715$20240820$EXP$$JP-ARDELYX-2024ARDX005105$ARDELYX$$6$DEC$$M$Y$$$20240820$$HP$JP$JP
240915531$24091553$1$I$20240101$20240710$20240715$20240715$EXP$$US-PFIZER INC-PV202400090609$PFIZER$$69$YR$$F$Y$45.4$KG$20240715$$CN$US$US
240915544$24091554$4$F$$20240823$20240715$20240827$PER$$NVSC2024US144899$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
240915551$24091555$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144846$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240915561$24091556$1$I$$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110550$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240715$$CN$US$US
240915571$24091557$1$I$$20240704$20240715$20240715$EXP$GB-MHRA-MED-202407041350123850-LJDQC$GB-TORRENT-00037092$TORRENT$$$$$F$Y$66$KG$20240715$$CN$GB$GB
240915581$24091558$1$I$20240616$20240628$20240715$20240715$EXP$$CN-Eisai-EC-2024-169262$EISAI$$41$YR$A$F$Y$49$KG$20240715$$HP$CN$CN
240915591$24091559$1$I$20220601$20240708$20240715$20240715$EXP$$IT-MINISAL02-874164$Haleon PLC$$60$YR$$F$Y$$$20240712$$MD$IT$IT
240915601$24091560$1$I$20240412$20240708$20240715$20240715$EXP$FR-AFSSAPS-NT2024000810$FR-FreseniusKabi-FK202410924$FRESENIUS KABI$$61$YR$A$M$Y$65.2$KG$20240715$$MD$FR$FR
240915611$24091561$1$I$$20240708$20240715$20240715$EXP$FR-AFSSAPS-NT2024000788$FR-FreseniusKabi-FK202410947$FRESENIUS KABI$$62$YR$A$F$Y$$$20240715$$MD$FR$FR
240915621$24091562$1$I$$20240708$20240715$20240715$EXP$$US-ALXN-202407USA000458US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
240915631$24091563$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138610$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240915641$24091564$1$I$$20240705$20240715$20240715$EXP$$CA-CELLTRION INC.-2024CA016430$CELLTRION$$$$$$Y$$$20240715$$CN$CA$CA
240915651$24091565$1$I$20240501$20240528$20240715$20240715$PER$$US-KARYOPHARM-2024KPT001126$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240715$$CN$US$US
240915661$24091566$1$I$20240101$20240708$20240715$20240715$PER$$US-SA-2024SA204172$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240715$$MD$US$US
240915671$24091567$1$I$20240101$20240710$20240715$20240715$EXP$$US-SA-2024SA205936$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240715$$MD$US$US
240915681$24091568$1$I$$20240707$20240715$20240715$EXP$$JP-009507513-2407JPN001614J$MERCK$Kubo A, Tori M, Shimo T, Ano K, Ishimura Y, Yoshidome K. EP-0524 Experience with Pembrolizumab as Preoperative and Postoperative Therapy in Our Hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 308$$$$F$Y$$$20240715$$MD$JP$JP
240915691$24091569$1$I$$20240714$20240715$20240715$EXP$$NVSC2024ID145423$NOVARTIS$$$$$F$Y$$$20240715$$MD$ID$ID
240915701$24091570$1$I$$20240709$20240715$20240715$EXP$$PT-TAKEDA-2024TUS069754$TAKEDA$Lafuente S, Faria N, Matos AR. Eosinophilic pneumonia -when the cause is in the medication. Medicina Interna. 2024;30(1):121$48$YR$$M$Y$$$20240715$$HP$PT$PT
240915711$24091571$1$I$20200427$20240710$20240715$20240715$EXP$PL-URPL-1-1309-2020$PL-MYLANLABS-2024M1064657$MYLAN$$33$YR$$F$Y$72$KG$20240715$$MD$PL$PL
240915722$24091572$2$F$$20240711$20240715$20240718$EXP$$CA-GSK-CA2023170260$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$HP$CA$CA
240915731$24091573$1$I$20240701$20240710$20240715$20240715$EXP$$GB-SANDOZ INC.-SDZ2024GB064677$SANDOZ$$48$YR$$F$Y$$$20240715$$CN$GB$GB
240915741$24091574$1$I$$20240708$20240715$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST004168$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240712$$CN$US$US
240915752$24091575$2$F$$20240708$20240715$20240726$PER$$US-TEVA-VS-3213926$TEVA$$53$YR$$F$Y$$$20240726$$CN$US$US
240915761$24091576$1$I$20240501$20240712$20240715$20240715$EXP$FR-AFSSAPS-AM2024000551$FR-SANDOZ INC.-SDZ2024FR064857$SANDOZ$$66$YR$$M$Y$79$KG$20240715$$MD$FR$FR
240915771$24091577$1$I$$20240711$20240715$20240715$30DAY$$US-SANDOZ INC.-SDZ2024US064877$SANDOZ$$$$$$Y$$$20240715$$CN$US$US
240915781$24091578$1$I$20240401$20240709$20240715$20240715$EXP$$GB-BLUEPRINT MEDICINES CORPORATION-2024BUS000141$Unknown Manufacturer$$$$$$Y$$$20240712$$CN$GB$GB
240915792$24091579$2$F$$20240805$20240715$20240809$EXP$$ES-AstraZeneca-2024A156791$ASTRAZENECA$Marti-Pastor, M; Bou-Monterde, R; Ciancotti-Oliver, L et al.. Effectiveness of tixagevimab/cilgavimab in reducing infection, hospital admissions and SARS-CoV-2 mortality in immunocompromised patients. Medicina Cl?nica 2024;$$$$$Y$$$20240809$$HP$ES$
240915802$24091580$2$F$$20240706$20240715$20240819$EXP$$US-AstraZeneca-2024A157933$ASTRAZENECA$Wolf, DS; Patil, P. Congenital Head and Neck Plexiform Neurofibromas in Neurofibromatosis Type 1: Complications and Response to Treatment with MEK Inhibitors. 2024 Neurofibromatosis (NF) Conference of the Children^s Tumor Foundation (CTF) 2024;$$$I$M$Y$$$20240819$$MD$US$
240915812$24091581$2$F$$20240715$20240715$20240724$EXP$$RU-INCYTE CORPORATION-2024IN007369$INCYTE$Pristanskova EA, Machneva EB, Olkhova  LV, Kuritsyna MS, Shestopalov  GI, Nikolaeva YA et al.. Insufficient Cellular Characteristics Of An Allogeneic Hematopoietic Transplant - A Non-Standard Approach To Solving The Problem. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY. 2024;69 N2:303-4$$$$$Y$$$20240724$$HP$RU$RU
240915821$24091582$1$I$20230724$20240714$20240714$20240714$DIR$710160$$FDA-CTU$$75$YR$$F$N$130.5$KG$20240714$N$CN$US$
240915841$24091584$1$I$20240301$20240710$20240715$20240715$EXP$$CA-LUNDBECK-DKLU3076721$LUNDBECK$$$$$$Y$$$20240715$$CN$CA$CA
240915851$24091585$1$I$$20240712$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111719$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240715$$CN$US$US
240915871$24091587$1$I$20240101$20240710$20240715$20240715$EXP$$US-AMGEN-USASP2024137776$AMGEN$$82$YR$E$F$Y$$$20240715$$HP$US$US
240915882$24091588$2$F$20240706$20240710$20240715$20240718$EXP$$CL-AKCEA THERAPEUTICS, INC.-2024IS005946$AKCEA THERAPEUTICS$$$$$$Y$$$20240716$$HP$CL$CL
240915891$24091589$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138674$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240915901$24091590$1$I$20230911$20240702$20240715$20240715$EXP$$KR-TEVA-VS-3216202$TEVA$$$$A$F$Y$$$20240715$$HP$KR$KR
240915912$24091591$2$F$20230101$20240827$20240715$20240904$EXP$$JP-009507513-2407JPN001824J$MERCK$Kobayashi J, Kikuchi M, Miyabe R, Sofue A, Atsuta K. EP-1111 A Case of Severe hepatic function disorder and Hypopituitarism after Pembrolizumab Treatment for Stage III A Breast Cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 455$57$YR$$F$Y$$$20240904$$MD$JP$JP
240915921$24091592$1$I$20240701$20240709$20240715$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST004218$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240712$$CN$US$US
240915931$24091593$1$I$$20240708$20240715$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST004160$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240712$$CN$US$US
240915941$24091594$1$I$$20240711$20240715$20240715$PER$$US-AMX-008116$AMYLYX PHARMACEUTICALS$$$$A$$Y$$$20240715$$CN$US$US
240915951$24091595$1$I$$20240419$20240715$20240715$PER$$US-GE HEALTHCARE-2024CSU004082$GE HEALTHCARE$$$$$$Y$$$20240715$$HP$US$US
240915961$24091596$1$I$20240706$20240708$20240715$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST004176$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240712$$CN$US$US
240915981$24091598$1$I$$20240710$20240715$20240715$PER$$US-JNJFOC-20240726862$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$HP$US$US
240915991$24091599$1$I$$20240712$20240715$20240715$EXP$$US-GILEAD-2024-0680680$GILEAD$$78$YR$E$M$Y$$$20240715$$MD$US$US
240916001$24091600$1$I$$20240712$20240715$20240715$EXP$$US-GILEAD-2024-0680700$GILEAD$$78$YR$E$M$Y$$$20240715$$MD$US$US
240916011$24091601$1$I$$20240711$20240715$20240715$EXP$$US-GILEAD-2024-0680580$GILEAD$$$$A$M$Y$$$20240715$$CN$US$US
240916022$24091602$2$F$$20240710$20240715$20240718$EXP$$BE-BLUEPRINT MEDICINES CORPORATION-2024BUS000147$PPD DEVELOPMENT LP$$$$$$Y$$$20240717$$PH$BE$BE
240916031$24091603$1$I$20240513$20240524$20240715$20240715$EXP$$NVSC2024IN145052$NOVARTIS$$87$YR$$F$Y$$$20240715$$CN$IN$IN
240916041$24091604$1$I$20240601$20240708$20240715$20240715$EXP$$US-Stemline Therapeutics, Inc.-2024ST004164$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240712$$CN$US$US
240916051$24091605$1$I$20240608$20240710$20240715$20240715$EXP$$CA-LUNDBECK-DKLU4001616$LUNDBECK$$$$$$Y$$$20240715$$CN$CA$CA
240916061$24091606$1$I$20230912$20240702$20240715$20240715$EXP$$KR-TEVA-VS-3216336$TEVA$$$$E$M$Y$$$20240715$$HP$KR$KR
240916071$24091607$1$I$$20240712$20240715$20240715$EXP$$US-GILEAD-2024-0680702$GILEAD$$78$YR$E$M$Y$$$20240715$$MD$US$US
240916081$24091608$1$I$20240601$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407052107125620-QTCVP$GB-TEVA-VS-3219375$TEVA$$53$YR$$F$Y$$$20240715$$MD$GB$GB
240916091$24091609$1$I$20230816$20240702$20240715$20240715$EXP$$KR-TEVA-VS-3216378$TEVA$$$$A$M$Y$$$20240715$$HP$KR$KR
240916101$24091610$1$I$20240627$20240708$20240715$20240715$EXP$BE-FAMHP-DHH-N2024-122337$BE-FreseniusKabi-FK202410799$FRESENIUS KABI$$63$YR$A$M$Y$106$KG$20240715$$PH$BE$BE
240916111$24091611$1$I$20240618$20240705$20240715$20240715$EXP$$US-Eisai-EC-2024-169683$EISAI$$72$YR$E$M$Y$79.4$KG$20240715$$CN$US$US
240916121$24091612$1$I$20231228$20240706$20240715$20240715$EXP$$IN-INCYTE CORPORATION-2024IN007361$INCYTE$$$$$$Y$$$20240715$$CN$IN$IN
240916131$24091613$1$I$$20240709$20240715$20240715$PER$$US-ABBVIE-5836773$ABBVIE$$$$$$Y$$$20240715$$CN$US$US
240916142$24091614$2$F$$20240807$20240715$20240816$EXP$$US-TEVA-VS-3219907$TEVA$$58$YR$$M$Y$$$20240816$$CN$US$US
240916151$24091615$1$I$$20240712$20240715$20240715$EXP$$US-GILEAD-2024-0680703$GILEAD$$78$YR$E$M$Y$$$20240715$$MD$US$US
240916161$24091616$1$I$$20240705$20240715$20240715$EXP$$US-OTSUKA-2024_018156$OTSUKA$$$$$F$Y$$$20240715$$HP$US$US
240916171$24091617$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3219320$TEVA$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant 2023; 23 (7): 1048-1057.$$$A$M$Y$$$20240715$$HP$US$US
240916181$24091618$1$I$$20240708$20240715$20240715$EXP$$GB-TEVA-VS-3219387$TEVA$$57$YR$$M$Y$137$KG$20240715$$MD$GB$GB
240916221$24091622$1$I$20130101$20240714$20240714$20240714$DIR$710167$$FDA-CTU$$56$YR$$F$N$$$20240714$N$CN$US$
240916231$24091623$1$I$20240709$20240709$20240713$20240713$DIR$FDA-CDER-CTU-2024-48549$$FDA-CTU$$$$$F$N$78.5$KG$20240709$N$$US$
240916241$24091624$1$I$$20240714$20240714$20240714$DIR$710176$$FDA-CTU$$69$YR$$F$N$63$KG$20240714$N$CN$US$
240916251$24091625$1$I$20240708$20240713$20240713$20240713$DIR$FDA-CDER-CTU-2024-48630$$FDA-CTU$$65$YR$$F$N$$$20240713$Y$HP$US$
240916261$24091626$1$I$20240706$20240712$20240713$20240713$DIR$FDA-CDER-CTU-2024-48552$$FDA-CTU$$16$YR$$M$N$56.4$KG$20240712$N$$US$
240916271$24091627$1$I$20240628$20240714$20240714$20240714$DIR$710191$$FDA-CTU$$65$YR$$F$N$67.5$KG$20240714$N$CN$US$
240916281$24091628$1$I$20240712$20240712$20240713$20240713$DIR$FDA-CDER-CTU-2024-48657$$FDA-CTU$$67$YR$$F$N$121$KG$20240712$N$$US$
240916292$24091629$2$F$20240601$20240820$20240715$20240828$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036404$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$$$20240828$$CN$CA$CA
240916301$24091630$1$I$20240705$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138240$AMGEN$$79$YR$E$F$Y$$$20240715$$CN$US$US
240916312$24091631$2$F$20240701$20240719$20240715$20240725$EXP$$FR-LUNDBECK-DKLU4001631$LUNDBECK$$$$$$Y$$$20240725$$MD$FR$FR
240916321$24091632$1$I$20240101$20240516$20240715$20240715$PER$$US-TEVA-VS-3216936$TEVA$$81$YR$$M$Y$$$20240715$$PH$US$US
240916331$24091633$1$I$$20240711$20240715$20240715$EXP$$US-INCYTE CORPORATION-2024IN007329$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240916342$24091634$2$F$$20240701$20240715$20240716$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092156$GLENMARK$Abdelrahim M, Esmail A, Divatia MK, Xu J, Kodali S, Victor DW, et al. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. Journal of Clinical Medicine. 2024;13:3068$$$$$Y$$$20240716$$HP$US$US
240916351$24091635$1$I$$20240705$20240715$20240715$PER$$US-ABBVIE-5835573$ABBVIE$$$$E$F$Y$$$20240715$$HP$US$US
240916361$24091636$1$I$$20240712$20240715$20240715$EXP$$US-GILEAD-2024-0680706$GILEAD$$78$YR$E$M$Y$$$20240715$$MD$US$US
240916371$24091637$1$I$$20240709$20240715$20240715$EXP$$GB-TAKEDA-2024TUS070978$TAKEDA$$$$$M$Y$$$20240715$$CN$GB$GB
240916381$24091638$1$I$20240708$20240708$20240715$20240715$EXP$$IE-MYLANLABS-2024M1064277$MYLAN$$$$$M$Y$$$20240715$$CN$IE$IE
240916391$24091639$1$I$20231201$20240708$20240715$20240715$EXP$$DE-MYLANLABS-2024M1063938$MYLAN$$79$YR$$M$Y$$$20240715$$CN$DE$DE
240916401$24091640$1$I$20231223$20240708$20240715$20240715$EXP$FR-AFSSAPS-NY2024000761$FR-MYLANLABS-2024M1064117$MYLAN$$30$YR$$F$Y$50$KG$20240715$$MD$FR$FR
240916412$24091641$2$F$$20240801$20240715$20240807$EXP$$DE-MYLANLABS-2024M1064216$MYLAN$$17$YR$$F$Y$$$20240807$$MD$DE$DE
240916421$24091642$1$I$$20240708$20240715$20240715$EXP$$SK-MYLANLABS-2024M1063968$MYLAN$$68$YR$$F$Y$$$20240715$$MD$SK$SK
240916431$24091643$1$I$$20240708$20240715$20240715$EXP$$AT-MYLANLABS-2024M1064143$MYLAN$$$$$F$Y$$$20240715$$MD$AT$AT
240916441$24091644$1$I$$20240708$20240715$20240715$EXP$$DE-MYLANLABS-2024M1064153$MYLAN$$$$$F$Y$$$20240715$$MD$DE$DE
240916451$24091645$1$I$20240621$20240708$20240715$20240715$EXP$FR-AFSSAPS-NT2024000803$FR-MYLANLABS-2024M1063927$MYLAN$$93$YR$$F$Y$44.7$KG$20240715$$MD$FR$FR
240916462$24091646$2$F$$20240726$20240715$20240731$EXP$BE-FAMHP-DHH-N2024-122326$BE-MYLANLABS-2024M1063917$MYLAN$$$$$M$Y$$$20240731$$PH$BE$BE
240916471$24091647$1$I$$20240708$20240715$20240715$EXP$$CZ-MYLANLABS-2024M1065023$MYLAN$Charvatova M, Krejci V. CLINICAL BENEFIT OF TDM ANTIPSYCHOTICS FOR PERSONALIZED MEDICINE. Ceska Slov. Psychiatr.. 2024;120(3):143-150$62$YR$$M$Y$$$20240715$$MD$CZ$CZ
240916481$24091648$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111705$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240715$$CN$US$US
240916491$24091649$1$I$20220101$20240708$20240715$20240715$EXP$$DE-MYLANLABS-2024M1064104$MYLAN$Juri-Alexander Witt, Susanna Moskau-Hartmann, Karmele Olaciregui Dague, Rainer Surges + Christoph Helmstaedter.. Severe memory decline along with unaffected executive functions under 400 mg/day of cenobamate leading to a collapse in school performance. Neurocase: Behavior, Cognition and Neuroscience- Taylor and Francis. 2024;Volume 30:1-6$18$YR$$M$Y$$$20240715$$HP$DE$DE
240916501$24091650$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3219366$TEVA$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant 2023; 23 (7): 1048-1057.$$$$M$Y$$$20240715$$HP$US$US
240916511$24091651$1$I$$20240711$20240715$20240715$EXP$$CN-TAKEDA-2024TUS071012$TAKEDA$$$$$M$Y$$$20240715$$CN$CN$CN
240916521$24091652$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA204081$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240715$$MD$US$US
240916531$24091653$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA203751$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240715$$HP$US$US
240916541$24091654$1$I$20240601$20240709$20240715$20240715$PER$$US-SA-2024SA204514$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240715$$MD$US$US
240916551$24091655$1$I$20231201$20240708$20240715$20240715$EXP$$US-GSK-US2024084977$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$US$US
240916561$24091656$1$I$$20240704$20240715$20240715$EXP$$CY-GILEAD-2024-0679787$GILEAD$$$$$$Y$$$20240715$$CN$CY$CY
240916571$24091657$1$I$$20240625$20240715$20240715$PER$$US-TEVA-VS-3214283$TEVA$$79$YR$$F$Y$72.57$KG$20240715$$CN$US$US
240916582$24091658$2$F$20240710$20240712$20240715$20240717$EXP$$FR-LUNDBECK-DKLU4001629$LUNDBECK$$$$$$Y$$$20240717$$MD$FR$FR
240916591$24091659$1$I$20200422$20240712$20240715$20240715$EXP$$US-TAKEDA-US202014319$TAKEDA$$58$YR$$F$Y$$$20240715$$MD$US$US
240916601$24091660$1$I$$20240710$20240715$20240715$EXP$$US-LUNDBECK-DKLU4001623$LUNDBECK$$$$$$Y$$$20240715$$HP$US$US
240916611$24091661$1$I$20240501$20240711$20240715$20240715$PER$$US-ORGANON-O2405USA002158$ORGANON$$36$YR$$F$Y$$$20240715$$HP$US$US
240916621$24091662$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111033$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240715$$HP$US$US
240916631$24091663$1$I$20240307$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405161110176040-VBSDZ$GB-TEVA-VS-3218607$TEVA$$68$YR$$F$Y$$$20240715$$CN$GB$GB
240916642$24091664$2$F$20240101$20240801$20240715$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110551$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240814$$CN$US$US
240916651$24091665$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111497$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240715$$CN$US$US
240916661$24091666$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110473$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240715$$HP$US$US
240916671$24091667$1$I$$20231125$20240715$20240715$PER$$US-PERRIGO-23US013523$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240916681$24091668$1$I$$20231120$20240715$20240715$PER$$US-PERRIGO-23US013507$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916691$24091669$1$I$$20231127$20240715$20240715$PER$$US-PERRIGO-23US013688$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916701$24091670$1$I$20240531$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111018$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240715$$CN$US$US
240916711$24091671$1$I$20230101$20231128$20240715$20240715$PER$$US-PERRIGO-23US013621$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240916721$24091672$1$I$$20231119$20240715$20240715$PER$$US-PERRIGO-23US013511$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916731$24091673$1$I$$20231127$20240715$20240715$PER$$US-PERRIGO-23US013687$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916741$24091674$1$I$$20231121$20240715$20240715$PER$$US-PERRIGO-23US013544$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916751$24091675$1$I$$20231122$20240715$20240715$PER$$US-PERRIGO-23US013546$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916761$24091676$1$I$20240705$20240712$20240713$20240713$DIR$FDA-CDER-CTU-2024-48553$$FDA-CTU$$79$YR$$F$N$83$KG$20240712$N$$US$
240916771$24091677$1$I$$20231120$20240715$20240715$PER$$US-PERRIGO-23US013504$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916781$24091678$1$I$$20231120$20240715$20240715$PER$$US-PERRIGO-23US013517$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916791$24091679$1$I$20240701$20240712$20240713$20240713$DIR$FDA-CDER-CTU-2024-48663$$FDA-CTU$$67$YR$$F$N$63$KG$20240712$N$$US$
240916801$24091680$1$I$$20231119$20240715$20240715$PER$$US-PERRIGO-23US013449$PERRIGO$$$$$M$Y$$$20240715$$$US$US
240916811$24091681$1$I$$20231121$20240715$20240715$PER$$US-PERRIGO-23US013545$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916821$24091682$1$I$$20231120$20240715$20240715$PER$$US-PERRIGO-23US013524$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916831$24091683$1$I$20231113$20231127$20240715$20240715$PER$$US-PERRIGO-23US013550$PERRIGO$$68$YR$$F$Y$83.9$KG$20240715$$CN$US$US
240916841$24091684$1$I$$20231120$20240715$20240715$PER$$US-PERRIGO-23US013506$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916851$24091685$1$I$$20240703$20240715$20240715$EXP$$GB-PERRIGO-24GB006298$PERRIGO$$20$YR$$M$Y$59$KG$20240715$$HP$GB$GB
240916861$24091686$1$I$20230101$20231130$20240715$20240715$PER$$US-PERRIGO-23US013705$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240916871$24091687$1$I$$20231120$20240715$20240715$PER$$US-PERRIGO-23US013525$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916881$24091688$1$I$20230801$20231129$20240715$20240715$PER$$US-PERRIGO-23US013674$PERRIGO$$58$YR$$F$Y$81.633$KG$20240715$$CN$US$US
240916891$24091689$1$I$$20240702$20240715$20240715$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06369$LUPIN$$$$$$Y$$$20240715$$CN$US$US
240916903$24091690$3$F$20210101$20240828$20240715$20240830$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039739$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$$$20240830$$HP$DE$DE
240916912$24091691$2$F$$20240910$20240715$20240925$EXP$$DE-BRAEBURN-DE-BRA-24-000642$BRAEBURN PHARMACEUTICALS$$50$YR$$F$Y$$$20240925$$MD$DE$DE
240916931$24091693$1$I$$20231129$20240715$20240715$PER$$US-PERRIGO-23US013778$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916941$24091694$1$I$$20231130$20240715$20240715$PER$$US-PERRIGO-23US013845$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916951$24091695$1$I$$20231204$20240715$20240715$PER$$US-PERRIGO-23US013905$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240916961$24091696$1$I$20231128$20231130$20240715$20240715$PER$$US-PERRIGO-23US013743$PERRIGO$$73$YR$$F$Y$52.154$KG$20240715$$CN$US$US
240916971$24091697$1$I$20230101$20231206$20240715$20240715$PER$$US-PERRIGO-23US013935$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240916981$24091698$1$I$20240403$20240709$20240715$20240715$EXP$$US-MYLANLABS-2024M1065172$MYLAN$$$$$F$Y$$$20240715$$CN$US$US
240916991$24091699$1$I$$20231202$20240715$20240715$PER$$US-PERRIGO-23US013871$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917001$24091700$1$I$$20231205$20240715$20240715$PER$$US-PERRIGO-23US013904$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240917011$24091701$1$I$$20231128$20240715$20240715$PER$$US-PERRIGO-23US013745$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917021$24091702$1$I$$20231130$20240715$20240715$PER$$US-PERRIGO-23US013848$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917031$24091703$1$I$$20231129$20240715$20240715$PER$$US-PERRIGO-23US013900$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240917041$24091704$1$I$$20231128$20240715$20240715$PER$$US-PERRIGO-23US013746$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917051$24091705$1$I$$20231129$20240715$20240715$PER$$US-PERRIGO-23US013803$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917061$24091706$1$I$$20231128$20240715$20240715$PER$$US-PERRIGO-23US013742$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917071$24091707$1$I$$20231130$20240715$20240715$PER$$US-PERRIGO-23US013847$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917081$24091708$1$I$$20231129$20240715$20240715$PER$$US-PERRIGO-23US013777$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917091$24091709$1$I$$20231204$20240715$20240715$PER$$US-PERRIGO-23US013937$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917101$24091710$1$I$$20231128$20240715$20240715$PER$$US-PERRIGO-23US013756$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917111$24091711$1$I$20230401$20240704$20240715$20240715$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2023-077740$REGENERON$$78$YR$$F$Y$$$20240715$$HP$CO$CO
240917121$24091712$1$I$$20231206$20240715$20240715$PER$$US-PERRIGO-23US013965$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240917131$24091713$1$I$$20231206$20240715$20240715$PER$$US-PERRIGO-23US014007$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917141$24091714$1$I$$20231208$20240715$20240715$PER$$US-PERRIGO-23US014064$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917151$24091715$1$I$$20231204$20240715$20240715$PER$$US-PERRIGO-23US013952$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917161$24091716$1$I$$20231204$20240715$20240715$PER$$US-PERRIGO-23US013964$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917171$24091717$1$I$$20231207$20240715$20240715$PER$$US-PERRIGO-23US014063$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917181$24091718$1$I$$20231205$20240715$20240715$PER$$US-PERRIGO-23US014074$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240917191$24091719$1$I$$20231204$20240715$20240715$PER$$US-PERRIGO-23US013955$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917201$24091720$1$I$$20231208$20240715$20240715$PER$$US-PERRIGO-23US014066$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917211$24091721$1$I$$20231204$20240715$20240715$PER$$US-PERRIGO-23US013941$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917221$24091722$1$I$$20231208$20240715$20240715$PER$$US-PERRIGO-23US014067$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917231$24091723$1$I$$20231206$20240715$20240715$PER$$US-PERRIGO-23US014031$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917241$24091724$1$I$$20231205$20240715$20240715$PER$$US-PERRIGO-23US014009$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917252$24091725$2$F$$20240904$20240715$20240912$EXP$$CA-TAKEDA-2018TUS010230$TAKEDA$$$$$M$Y$$$20240912$$CN$CA$CA
240917261$24091726$1$I$$20231206$20240715$20240715$PER$$US-PERRIGO-23US014011$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917271$24091727$1$I$$20240712$20240715$20240715$PER$$US-HALEON-2186968$Haleon PLC$$$$$$Y$$$20240715$$CN$US$US
240917281$24091728$1$I$$20231204$20240715$20240715$PER$$US-PERRIGO-23US013938$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917292$24091729$2$F$20191222$20240806$20240715$20240808$EXP$$US-TAKEDA-US201945402$TAKEDA$$76$YR$$F$Y$$$20240808$$HP$US$US
240917301$24091730$1$I$20240401$20240709$20240715$20240715$EXP$$US-ABBVIE-5834560$ABBVIE$$29$YR$$F$Y$$$20240715$$CN$US$US
240917311$24091731$1$I$$20231211$20240715$20240715$PER$$US-PERRIGO-23US014181$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917321$24091732$1$I$$20231213$20240715$20240715$PER$$US-PERRIGO-23US014658$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917331$24091733$1$I$$20231212$20240715$20240715$PER$$US-PERRIGO-23US014610$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917341$24091734$1$I$$20231210$20240715$20240715$PER$$US-PERRIGO-23US014192$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917351$24091735$1$I$$20231207$20240715$20240715$PER$$US-PERRIGO-23US014092$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917361$24091736$1$I$$20231207$20240715$20240715$PER$$US-PERRIGO-23US014093$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917371$24091737$1$I$$20231211$20240715$20240715$PER$$US-PERRIGO-23US014186$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917381$24091738$1$I$$20231209$20240715$20240715$PER$$US-PERRIGO-23US014096$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917391$24091739$1$I$20231201$20231212$20240715$20240715$PER$$US-PERRIGO-23US014253$PERRIGO$$43$YR$$M$Y$86.168$KG$20240715$$CN$US$US
240917401$24091740$1$I$$20231213$20240715$20240715$PER$$US-PERRIGO-23US014657$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917411$24091741$1$I$$20231209$20240715$20240715$PER$$US-PERRIGO-23US014094$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240917421$24091742$1$I$$20231213$20240715$20240715$PER$$US-PERRIGO-23US014655$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917431$24091743$1$I$$20231212$20240715$20240715$PER$$US-PERRIGO-23US014612$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917441$24091744$1$I$$20231211$20240715$20240715$PER$$US-PERRIGO-23US014191$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917451$24091745$1$I$$20231211$20240715$20240715$PER$$US-PERRIGO-23US014187$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917461$24091746$1$I$$20231209$20240715$20240715$PER$$US-PERRIGO-23US014095$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917471$24091747$1$I$20240627$20240709$20240715$20240715$EXP$FR-AFSSAPS-BR2024000543$FR-MYLANLABS-2024M1064614$MYLAN$$50$YR$$M$Y$82$KG$20240715$$HP$FR$FR
240917481$24091748$1$I$20240101$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138750$AMGEN$$$$$$Y$$$20240715$$MD$US$US
240917491$24091749$1$I$$20240708$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008206$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240715$$CN$US$US
240917501$24091750$1$I$$20240709$20240715$20240715$EXP$$DE-MYLANLABS-2024M1064510$MYLAN$$29$YR$$F$Y$$$20240715$$MD$DE$DE
240917511$24091751$1$I$$20240708$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407005210$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240715$$CN$US$US
240917521$24091752$1$I$20240601$20240709$20240715$20240715$EXP$SE-SEMPA-2024-005075$SE-MYLANLABS-2024M1064598$MYLAN$$43$YR$$M$Y$$$20240715$$HP$SE$SE
240917531$24091753$1$I$$20240707$20240715$20240715$EXP$$JP-009507513-2407JPN001825J$MERCK$Yariyama K, Mizutani M, Ohara A, Abe G, Yoneda H. EP-1104 A case of hepatic function disorder due to immune-related adverse event (irAE) of pembrolizumab which diagnosed on liver biopsy.. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 453$55$YR$$F$Y$$$20240715$$MD$JP$JP
240917542$24091754$2$F$$20240909$20240715$20240916$EXP$$CO-GSK-CO2023AMR141064$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$PH$CO$CO
240917551$24091755$1$I$$20231215$20240715$20240715$PER$$US-PERRIGO-23US014683$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917561$24091756$1$I$$20231217$20240715$20240715$PER$$US-PERRIGO-23US014690$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917571$24091757$1$I$$20231216$20240715$20240715$PER$$US-PERRIGO-23US014689$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917581$24091758$1$I$$20231219$20240715$20240715$PER$$US-PERRIGO-23US014799$PERRIGO$$$$$$Y$$$20240715$$CN$US$US
240917591$24091759$1$I$$20231215$20240715$20240715$PER$$US-PERRIGO-23US014687$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917601$24091760$1$I$$20231218$20240715$20240715$PER$$US-PERRIGO-23US014788$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917611$24091761$1$I$20240601$20240711$20240715$20240715$EXP$$US-INCYTE CORPORATION-2024IN007315$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240917621$24091762$1$I$$20231218$20240715$20240715$PER$$US-PERRIGO-23US014787$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917631$24091763$1$I$$20231216$20240715$20240715$PER$$US-PERRIGO-23US014688$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917641$24091764$1$I$$20231218$20240715$20240715$PER$$US-PERRIGO-23US014797$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917651$24091765$1$I$$20231218$20240715$20240715$PER$$US-PERRIGO-23US014789$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917661$24091766$1$I$$20240702$20240715$20240715$EXP$$JP-ADVANZ PHARMA-202407005865$ADVANZ PHARMA$$$$$$Y$$$20240715$$MD$JP$JP
240917671$24091767$1$I$$20240711$20240715$20240715$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-08335$IPSEN$$$$$$Y$$$20240715$$HP$US$US
240917682$24091768$2$F$$20240808$20240715$20240814$EXP$$US-INCYTE CORPORATION-2024IN007313$INCYTE$$$$$$Y$$$20240814$$CN$US$US
240917691$24091769$1$I$$20231229$20240715$20240715$PER$$US-PERRIGO-23US015009$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917701$24091770$1$I$$20231229$20240715$20240715$PER$$US-PERRIGO-23US015008$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917711$24091771$1$I$20240503$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405041836341630-WGSTP$GB-TEVA-VS-3218552$TEVA$$53$YR$$F$Y$$$20240715$$CN$GB$GB
240917721$24091772$1$I$$20231220$20240715$20240715$PER$$US-PERRIGO-23US014881$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917731$24091773$1$I$$20231220$20240715$20240715$PER$$US-PERRIGO-23US014872$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917741$24091774$1$I$20231110$20231221$20240715$20240715$PER$$US-PERRIGO-23US014877$PERRIGO$$77$YR$$M$Y$78.005$KG$20240715$$CN$US$US
240917751$24091775$1$I$$20231227$20240715$20240715$PER$$US-PERRIGO-23US014952$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917761$24091776$1$I$20231213$20231227$20240715$20240715$PER$$US-PERRIGO-23US014943$PERRIGO$$81$YR$$M$Y$88.435$KG$20240715$$CN$US$US
240917771$24091777$1$I$$20231225$20240715$20240715$PER$$US-PERRIGO-23US014924$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917781$24091778$1$I$$20231225$20240715$20240715$PER$$US-PERRIGO-23US014916$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917791$24091779$1$I$$20231219$20240715$20240715$PER$$US-PERRIGO-23US014853$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917801$24091780$1$I$$20231227$20240715$20240715$PER$$US-PERRIGO-23US014951$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917811$24091781$1$I$$20231220$20240715$20240715$PER$$US-PERRIGO-23US014900$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917821$24091782$1$I$$20231222$20240715$20240715$PER$$US-PERRIGO-23US014922$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917831$24091783$1$I$$20231227$20240715$20240715$PER$$US-PERRIGO-23US014953$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917841$24091784$1$I$$20231225$20240715$20240715$PER$$US-PERRIGO-23US014917$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917851$24091785$1$I$$20231220$20240715$20240715$PER$$US-PERRIGO-23US014901$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917861$24091786$1$I$20240701$20240712$20240715$20240715$PER$$US-BAYER-2024A101294$BAYER$$28$YR$A$F$Y$$$20240715$$MD$US$US
240917871$24091787$1$I$20230101$20231221$20240715$20240715$PER$$US-PERRIGO-23US014879$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917881$24091788$1$I$$20231220$20240715$20240715$PER$$US-PERRIGO-23US014882$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917891$24091789$1$I$$20240711$20240715$20240715$EXP$$ES-BIOVITRUM-2024-ES-009768$BIOVITRUM$$$$A$F$Y$$$20240715$$MD$ES$ES
240917901$24091790$1$I$$20231228$20240715$20240715$PER$$US-PERRIGO-23US015012$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917911$24091791$1$I$$20231228$20240715$20240715$PER$$US-PERRIGO-23US015014$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917921$24091792$1$I$$20231229$20240715$20240715$PER$$US-PERRIGO-23US015010$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917931$24091793$1$I$$20231227$20240715$20240715$PER$$US-PERRIGO-23US015088$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240917941$24091794$1$I$$20240712$20240713$20240713$DIR$FDA-CDER-CTU-2024-48623$$FDA-CTU$$$$$M$N$$$20240712$N$HP$US$
240917951$24091795$1$I$20240711$20240712$20240713$20240713$DIR$FDA-CDER-CTU-2024-48661$$FDA-CTU$$65$YR$$F$N$119.8$KG$20240712$N$$US$
240917961$24091796$1$I$$20240102$20240715$20240715$PER$$US-PERRIGO-24US000091$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240917971$24091797$1$I$$20231231$20240715$20240715$PER$$US-PERRIGO-23US015086$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240917981$24091798$1$I$$20240102$20240715$20240715$PER$$US-PERRIGO-24US000084$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918001$24091800$1$I$$20240702$20240715$20240715$EXP$$FR-TAKEDA-2024TUS070119$TAKEDA$$65$YR$$M$Y$$$20240715$$CN$FR$FR
240918011$24091801$1$I$$20240101$20240715$20240715$PER$$US-PERRIGO-24US000049$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918021$24091802$1$I$$20240713$20240713$20240713$DIR$FDA-CDER-CTU-2024-48627$$FDA-CTU$$71$YR$$F$N$$$20240713$N$$US$
240918031$24091803$1$I$$20240102$20240715$20240715$PER$$US-PERRIGO-24US000092$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918041$24091804$1$I$20230901$20240711$20240715$20240715$EXP$$US-INCYTE CORPORATION-2024IN007273$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240918051$24091805$1$I$$20231229$20240715$20240715$PER$$US-PERRIGO-23US015011$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918062$24091806$2$F$20240509$20240705$20240715$20240717$EXP$$AU-BRAEBURN-AU-BRA-24-000647$BRAEBURN PHARMACEUTICALS$$71$YR$$F$Y$$$20240717$$HP$AU$AU
240918071$24091807$1$I$20240104$20240108$20240715$20240715$PER$$US-PERRIGO-24US000199$PERRIGO$$54$YR$$M$Y$63.492$KG$20240715$$CN$US$US
240918081$24091808$1$I$$20240105$20240715$20240715$PER$$US-PERRIGO-24US000167$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918091$24091809$1$I$$20240104$20240715$20240715$PER$$US-PERRIGO-24US000179$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918101$24091810$1$I$$20240105$20240715$20240715$PER$$US-PERRIGO-24US000135$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918111$24091811$1$I$$20240105$20240715$20240715$PER$$US-PERRIGO-24US000172$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918121$24091812$1$I$$20240102$20240715$20240715$PER$$US-PERRIGO-24US000093$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918131$24091813$1$I$$20240105$20240715$20240715$PER$$US-PERRIGO-24US000186$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240918143$24091814$3$F$20221018$20240830$20240715$20240903$EXP$$NVSC2023RU168343$NOVARTIS$$55$YR$$F$Y$$$20240903$$MD$RU$RU
240918154$24091815$4$F$20240708$20240719$20240715$20240723$PER$$NVSC2024US145181$NOVARTIS$$38$YR$$M$Y$$$20240723$$CN$US$US
240918162$24091816$2$F$20240229$20240723$20240715$20240731$EXP$$US-VIIV HEALTHCARE LIMITED-US2024083834$VIIV$$$$$$Y$$$20240731$$MD$US$US
240918171$24091817$1$I$$20240703$20240715$20240715$PER$$US-ROCHE-10000020427$ROCHE$$$$E$M$Y$$$20240715$$MD$US$US
240918181$24091818$1$I$$20240109$20240715$20240715$PER$$US-PERRIGO-24US000328$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240918191$24091819$1$I$$20240109$20240715$20240715$PER$$US-PERRIGO-24US000391$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918201$24091820$1$I$$20240109$20240715$20240715$PER$$US-PERRIGO-24US000392$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918211$24091821$1$I$$20240107$20240715$20240715$PER$$US-PERRIGO-24US000213$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918221$24091822$1$I$$20240108$20240715$20240715$PER$$US-PERRIGO-24US000320$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918231$24091823$1$I$$20240109$20240715$20240715$PER$$US-PERRIGO-24US000292$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918241$24091824$1$I$$20240109$20240715$20240715$PER$$US-PERRIGO-24US000393$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918251$24091825$1$I$$20240109$20240715$20240715$PER$$US-PERRIGO-24US000382$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918261$24091826$1$I$20240102$20240110$20240715$20240715$PER$$US-PERRIGO-24US000333$PERRIGO$$74$YR$$M$Y$99.773$KG$20240715$$CN$US$US
240918271$24091827$1$I$$20240108$20240715$20240715$PER$$US-PERRIGO-24US000257$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240918281$24091828$1$I$20231201$20240109$20240715$20240715$PER$$US-PERRIGO-24US000263$PERRIGO$$72$YR$$M$Y$65.76$KG$20240715$$CN$US$US
240918291$24091829$1$I$$20240714$20240714$20240714$DIR$FDA-CDER-CTU-2024-48554$$FDA-CTU$$60$YR$$F$N$$$20240714$N$$US$
240918301$24091830$1$I$20240109$20240110$20240715$20240715$PER$$US-PERRIGO-24US000401$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918311$24091831$1$I$$20240110$20240715$20240715$PER$$US-PERRIGO-24US000390$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240918321$24091832$1$I$$20240715$20240715$20240715$EXP$$GB-JNJFOC-20240737642$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$GB$GB
240918331$24091833$1$I$$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48786$$FDA-CTU$$$$$M$N$$$20240712$N$HP$US$
240918341$24091834$1$I$$20240710$20240715$20240715$EXP$$US-JNJFOC-20240725896$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240918351$24091835$1$I$$20240711$20240715$20240715$PER$$US-JNJFOC-20240729949$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$MD$US$US
240918361$24091836$1$I$$20240708$20240715$20240715$EXP$$US-AMGEN-USASL2024135059$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240918371$24091837$1$I$$20240710$20240715$20240715$EXP$$US-AMGEN-USASP2024138228$AMGEN$$$$$F$Y$$$20240715$$HP$US$US
240918381$24091838$1$I$$20240710$20240715$20240715$EXP$$CH-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00376$VELOXIS PHARMACEUTICALS$Cancela Costa A, Kritikos A, Glampedakis E, Da Silva Pereira Clara J, Schaller F, Mercier T, et al.. Antifungal drug penetration in soft tissue abscesses: a comparative analysis. The journal of antimicrobial chemotherapy. 2024;79(7):1668-72$61$YR$$M$Y$$$20240715$$MD$CH$CH
240918391$24091839$1$I$$20240110$20240715$20240715$PER$$US-PERRIGO-24US000454$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918401$24091840$1$I$20231027$20240115$20240715$20240715$PER$$US-PERRIGO-24US000494$PERRIGO$$51$YR$$F$Y$47.619$KG$20240715$$CN$US$US
240918421$24091842$1$I$$20240111$20240715$20240715$PER$$US-PERRIGO-24US000425$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918431$24091843$1$I$$20240110$20240715$20240715$PER$$US-PERRIGO-24US000455$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918441$24091844$1$I$20230101$20240112$20240715$20240715$PER$$US-PERRIGO-24US000451$PERRIGO$$$$$M$Y$83.9$KG$20240715$$CN$US$US
240918451$24091845$1$I$$20240110$20240715$20240715$PER$$US-PERRIGO-24US000423$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918461$24091846$1$I$20230901$20240110$20240715$20240715$PER$$US-PERRIGO-24US000471$PERRIGO$$60$YR$$M$Y$61.224$KG$20240715$$CN$US$US
240918471$24091847$1$I$$20240110$20240715$20240715$PER$$US-PERRIGO-24US000424$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918481$24091848$1$I$$20240603$20240715$20240715$EXP$$GB-GILEAD-2024-0675441$GILEAD$$$$A$$Y$$$20240715$$MD$GB$GB
240918492$24091849$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3217677$TEVA$Bachert HD, Thavarajah K, Abu Sayf A, Calo SMS, Abdul Hameed AM. Interstitial Lung Disease in a Patient With Hydroxyurea-associated Dermatomyositis-like Eruption With Abnormal P53 Expression. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.; Bachert HD, Thavarajah K, Abu Sayf A, Calo SMS, Abdul Hameed AM. Interstitial Lung Disease in a Patient With Hydroxyurea-associated Dermatomyositis-like Eruption With Abnormal P53 Expression. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.$73$YR$$M$Y$$$20240802$$HP$US$US
240918512$24091851$2$F$$20240713$20240715$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111557$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240718$$CN$US$US
240918521$24091852$1$I$20231101$20240703$20240715$20240715$EXP$$FR-ACRAF SpA-2024-035041$SK LIFE SCIENCE$$$$$$Y$$$20240715$$MD$FR$FR
240918531$24091853$1$I$$20240704$20240715$20240715$EXP$$BE-ACRAF SpA-2024-035078$SK LIFE SCIENCE$$$$$$Y$$$20240715$$MD$BE$BE
240918541$24091854$1$I$20231001$20240117$20240715$20240715$PER$$US-PERRIGO-24US000691$PERRIGO$$57$YR$$M$Y$83.9$KG$20240715$$CN$US$US
240918551$24091855$1$I$$20240117$20240715$20240715$PER$$US-PERRIGO-24US000665$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918561$24091856$1$I$$20240112$20240715$20240715$PER$$US-PERRIGO-24US000682$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240918571$24091857$1$I$$20240118$20240715$20240715$PER$$US-PERRIGO-24US000696$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918581$24091858$1$I$20240106$20240113$20240715$20240715$PER$$US-PERRIGO-24US000712$PERRIGO$$79$YR$$M$Y$86.168$KG$20240715$$CN$US$US
240918591$24091859$1$I$$20240119$20240715$20240715$PER$$US-PERRIGO-24US000698$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918601$24091860$1$I$$20240118$20240715$20240715$PER$$US-PERRIGO-24US000695$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918611$24091861$1$I$$20240116$20240715$20240715$PER$$US-PERRIGO-24US000553$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918621$24091862$1$I$$20240115$20240715$20240715$PER$$US-PERRIGO-24US000586$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918631$24091863$1$I$$20240118$20240715$20240715$PER$$US-PERRIGO-24US000713$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918641$24091864$1$I$$20240117$20240715$20240715$PER$$US-PERRIGO-24US000686$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918651$24091865$1$I$$20240119$20240715$20240715$PER$$US-PERRIGO-24US000672$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918661$24091866$1$I$$20240114$20240715$20240715$PER$$US-PERRIGO-24US000525$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918671$24091867$1$I$$20240119$20240715$20240715$PER$$US-PERRIGO-24US000697$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918681$24091868$1$I$$20240116$20240715$20240715$PER$$US-PERRIGO-24US000611$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918691$24091869$1$I$20231001$20240118$20240715$20240715$PER$$US-PERRIGO-24US000622$PERRIGO$$70$YR$$M$Y$88.889$KG$20240715$$CN$US$US
240918701$24091870$1$I$20240108$20240119$20240715$20240715$PER$$US-PERRIGO-24US000714$PERRIGO$$66$YR$$M$Y$72.562$KG$20240715$$CN$US$US
240918711$24091871$1$I$$20240114$20240715$20240715$PER$$US-PERRIGO-24US000551$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918721$24091872$1$I$$20240119$20240715$20240715$PER$$US-PERRIGO-24US000670$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918731$24091873$1$I$$20240707$20240715$20240715$EXP$$US-BAYER-2024A098157$BAYER$$$$$M$Y$$$20240715$$CN$US$US
240918741$24091874$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405101423535400-WTCJS$GB-RDY-SPO/GBR/24/0010150$DR REDDYS$$$$$$Y$$$20240715$$HP$GB$GB
240918761$24091876$1$I$$20240119$20240715$20240715$PER$$US-PERRIGO-24US000762$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240918771$24091877$1$I$$20240122$20240715$20240715$PER$$US-PERRIGO-24US000857$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918781$24091878$1$I$$20240123$20240715$20240715$PER$$US-PERRIGO-24US000910$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918791$24091879$1$I$20221005$20240711$20240715$20240715$EXP$$CA-TAKEDA-2024TUS071289$TAKEDA$$84$YR$$M$Y$$$20240715$$CN$CA$CA
240918801$24091880$1$I$$20240122$20240715$20240715$PER$$US-PERRIGO-24US000865$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918811$24091881$1$I$$20240122$20240715$20240715$PER$$US-PERRIGO-24US000867$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918821$24091882$1$I$$20240123$20240715$20240715$PER$$US-PERRIGO-24US000869$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240918831$24091883$1$I$$20240121$20240715$20240715$PER$$US-PERRIGO-24US000757$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918841$24091884$1$I$$20240122$20240715$20240715$PER$$US-PERRIGO-24US000866$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918853$24091885$3$F$20240731$20240814$20240715$20240816$EXP$$CA-TAKEDA-2024TUS071286$TAKEDA$$40$YR$$M$Y$$$20240816$$CN$CA$CA
240918861$24091886$1$I$20230201$20240124$20240715$20240715$PER$$US-PERRIGO-24US000859$PERRIGO$$68$YR$$F$Y$55.329$KG$20240715$$CN$US$US
240918871$24091887$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144910$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240918882$24091888$2$F$$20240809$20240715$20240812$PER$$NVSC2024US145578$NOVARTIS$$$$$$Y$$$20240812$$HP$US$US
240918892$24091889$2$F$20200101$20240902$20240715$20240908$EXP$$JP-009507513-2407JPN001782J$MERCK$$$$$F$Y$$$20240908$$MD$JP$JP
240918901$24091890$1$I$20240709$20240711$20240715$20240715$PER$$US-JNJFOC-20240731815$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240715$$HP$US$US
240918911$24091891$1$I$$20240708$20240715$20240715$PER$$US-JNJFOC-20240719193$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240918921$24091892$1$I$$20240127$20240715$20240715$PER$$US-PERRIGO-24US000987$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918931$24091893$1$I$$20240130$20240715$20240715$PER$$US-PERRIGO-24US001213$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918941$24091894$1$I$$20240130$20240715$20240715$PER$$US-PERRIGO-24US001212$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918951$24091895$1$I$$20240130$20240715$20240715$PER$$US-PERRIGO-24US001109$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240918961$24091896$1$I$20230101$20240129$20240715$20240715$PER$$US-PERRIGO-24US001007$PERRIGO$$63$YR$$M$Y$82.54$KG$20240715$$CN$US$US
240918971$24091897$1$I$$20240129$20240715$20240715$PER$$US-PERRIGO-24US001149$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918981$24091898$1$I$$20240127$20240715$20240715$PER$$US-PERRIGO-24US000963$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240918991$24091899$1$I$$20240126$20240715$20240715$PER$$US-PERRIGO-24US000985$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919001$24091900$1$I$$20240128$20240715$20240715$PER$$US-PERRIGO-24US001021$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919011$24091901$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48787$$FDA-CTU$$60$YR$$M$N$$$20240715$N$$US$
240919021$24091902$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48794$$FDA-CTU$$21$YR$$F$N$95.25$KG$20240715$N$$US$
240919031$24091903$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48774$$FDA-CTU$$74$YR$$F$N$163$LBS$20240715$N$$US$
240919041$24091904$1$I$$20240130$20240715$20240715$PER$$US-PERRIGO-24US001216$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919051$24091905$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3219212$TEVA$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant 2023; 23 (7): 1048-1057.$$$$M$Y$$$20240715$$HP$US$US
240919061$24091906$1$I$20240524$20240617$20240715$20240715$PER$$US-ROCHE-3570905$ROCHE$$$$$$Y$$$20240715$$CN$US$US
240919071$24091907$1$I$$20240201$20240715$20240715$PER$$US-PERRIGO-24US001235$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919081$24091908$1$I$$20240201$20240715$20240715$PER$$US-PERRIGO-24US001237$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919091$24091909$1$I$$20240202$20240715$20240715$PER$$US-PERRIGO-24US001246$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919101$24091910$1$I$$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48739$$FDA-CTU$$$$$F$N$$$20240712$N$HP$US$
240919121$24091912$1$I$$20240131$20240715$20240715$PER$$US-PERRIGO-24US001239$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919131$24091913$1$I$$20240202$20240715$20240715$PER$$US-PERRIGO-24US001245$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919141$24091914$1$I$$20240131$20240715$20240715$PER$$US-PERRIGO-24US001250$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919151$24091915$1$I$$20240203$20240715$20240715$PER$$US-PERRIGO-24US001247$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919161$24091916$1$I$$20240131$20240715$20240715$PER$$US-PERRIGO-24US001256$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919171$24091917$1$I$$20240203$20240715$20240715$PER$$US-PERRIGO-24US001248$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919181$24091918$1$I$$20240201$20240715$20240715$PER$$US-PERRIGO-24US001236$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919191$24091919$1$I$$20240201$20240715$20240715$PER$$US-PERRIGO-24US001262$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919201$24091920$1$I$$20240129$20240715$20240715$PER$$US-PERRIGO-24US001281$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240919211$24091921$1$I$$20240201$20240715$20240715$PER$$US-PERRIGO-24US001283$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240919221$24091922$1$I$$20240129$20240715$20240715$PER$$US-PERRIGO-24US001294$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240919231$24091923$1$I$20240110$20240201$20240715$20240715$PER$$US-PERRIGO-24US001257$PERRIGO$$42$YR$$M$Y$117.91$KG$20240715$$CN$US$US
240919241$24091924$1$I$$20240204$20240715$20240715$PER$$US-PERRIGO-24US001344$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919251$24091925$1$I$$20240204$20240715$20240715$PER$$US-PERRIGO-24US001327$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919261$24091926$1$I$$20240205$20240715$20240715$PER$$US-PERRIGO-24US001328$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240919271$24091927$1$I$$20240129$20240715$20240715$PER$$US-PERRIGO-24US001276$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240919281$24091928$1$I$$20240204$20240715$20240715$PER$$US-PERRIGO-24US001347$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919291$24091929$1$I$$20240131$20240715$20240715$PER$$US-PERRIGO-24US001260$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919301$24091930$1$I$$20240709$20240715$20240715$EXP$$US-BAYER-2024A099134$BAYER$$63$YR$A$M$Y$$$20240715$$CN$US$US
240919311$24091931$1$I$20240207$20240711$20240715$20240715$EXP$GB-MHRA-MED-202407110744127450-CSZHF$GB-ABBVIE-5838469$ABBVIE$$37$YR$$M$Y$$$20240715$$CN$GB$GB
240919331$24091933$1$I$$20240205$20240715$20240715$PER$$US-PERRIGO-24US001439$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919341$24091934$1$I$$20240209$20240715$20240715$PER$$US-PERRIGO-24US001517$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919351$24091935$1$I$$20240210$20240715$20240715$PER$$US-PERRIGO-24US001520$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919361$24091936$1$I$$20240205$20240715$20240715$PER$$US-PERRIGO-24US001436$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919371$24091937$1$I$$20240204$20240715$20240715$PER$$US-PERRIGO-24US001348$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919381$24091938$1$I$20240120$20240205$20240715$20240715$PER$$US-PERRIGO-24US001384$PERRIGO$$68$YR$$F$Y$61.224$KG$20240715$$CN$US$US
240919391$24091939$1$I$$20240205$20240715$20240715$PER$$US-PERRIGO-24US001438$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919401$24091940$1$I$$20240205$20240715$20240715$PER$$US-PERRIGO-24US001440$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919411$24091941$1$I$$20240209$20240715$20240715$PER$$US-PERRIGO-24US001519$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919421$24091942$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3219370$TEVA$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant 2023; 23 (7): 1048-1057.$$$A$M$Y$$$20240715$$HP$US$US
240919431$24091943$1$I$$20240121$20240715$20240715$PER$$US-PERRIGO-24US000764$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919441$24091944$1$I$$20240712$20240715$20240715$PER$$US-HALEON-2186919$Haleon PLC$$$$$$Y$$$20240715$$CN$US$US
240919451$24091945$1$I$20240707$20240715$20240715$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039774$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240715$$CN$US$US
240919461$24091946$1$I$$20240708$20240715$20240715$EXP$$US-JAZZ-2022-US-004679$JAZZ$$$$$M$Y$$$20240715$$MD$US$US
240919471$24091947$1$I$$20240207$20240715$20240715$PER$$US-PERRIGO-24US001546$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919481$24091948$1$I$20240101$20240211$20240715$20240715$PER$$US-PERRIGO-24US001583$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919491$24091949$1$I$$20240212$20240715$20240715$PER$$US-PERRIGO-24US001629$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919501$24091950$1$I$$20240208$20240715$20240715$PER$$US-PERRIGO-24US001550$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919511$24091951$1$I$$20240212$20240715$20240715$PER$$US-PERRIGO-24US001628$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919521$24091952$1$I$$20240208$20240715$20240715$PER$$US-PERRIGO-24US001560$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919531$24091953$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405101432592510-CTPFY$GB-TEVA-VS-3218354$TEVA$$$$$M$Y$$$20240715$$MD$GB$GB
240919542$24091954$2$F$$20240901$20240715$20240903$PER$$US-AMGEN-USASP2024139874$AMGEN$$17$YR$T$F$Y$$$20240903$$HP$US$US
240919551$24091955$1$I$20200429$20240711$20240715$20240715$EXP$PL-URPL-1-3704-2020$PL-MYLANLABS-2024M1065053$MYLAN$$19$YR$$F$Y$70$KG$20240715$$MD$PL$PL
240919561$24091956$1$I$20211026$20240711$20240715$20240715$EXP$GB-GE HEALTHCARE-2024CSU007489$GB-MYLANLABS-2024M1065490$MYLAN$$75$YR$$M$Y$92$KG$20240715$$PH$GB$GB
240919571$24091957$1$I$$20240708$20240715$20240715$EXP$$SK-MYLANLABS-2024M1057080$MYLAN$Kukucka T, Ondrejka I, Kovacova V, Mlyncekova Z, Macejova A, Hrtanek I. et.al.. Selected abstracts from the 5th year of the case study conference Conundrums in child psychiatry. PSYCHIATRIA PRE PRAX. 2024;25(2):84$13$YR$$F$Y$$$20240715$$MD$SK$SK
240919581$24091958$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145588$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240919592$24091959$2$F$20240101$20240905$20240715$20240911$EXP$$NVSC2024DE144621$NOVARTIS$$$$A$M$Y$$$20240911$$MD$DE$DE
240919601$24091960$1$I$$20240712$20240715$20240715$EXP$$NVSC2024DE145312$NOVARTIS$$99$YR$$M$Y$$$20240715$$MD$DE$DE
240919611$24091961$1$I$$20240710$20240715$20240715$EXP$$ES-PFIZER INC-2019SGN01312$PFIZER$$56$YR$$M$Y$$$20240715$$HP$ES$ES
240919621$24091962$1$I$20230401$20240709$20240715$20240715$EXP$$GR-PFIZER INC-2023SGN04870$PFIZER$$49$YR$$F$Y$$$20240715$$MD$GR$GR
240919632$24091963$2$F$20240701$20240902$20240715$20240906$EXP$$JP-PFIZER INC-202400210027$PFIZER$$75$YR$$F$Y$$$20240906$$MD$JP$JP
240919641$24091964$1$I$$20240709$20240715$20240715$EXP$$GR-PFIZER INC-2023SGN04873$PFIZER$$$$$F$Y$$$20240715$$MD$GR$GR
240919651$24091965$1$I$$20240701$20240715$20240715$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06134$LUPIN$Kobayashi T, Ford B, Diekema DJ, Sekar P. Disseminated Mycobacterium chimaera infection successfully treated with a clofazimine-containing regimen and long-term follow-up after discontinuing treatment. IDCases. 2024;36:e01991:1-4$67$YR$$M$Y$$$20240715$$HP$US$US
240919661$24091966$1$I$$20240213$20240715$20240715$PER$$US-PERRIGO-24US001716$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919671$24091967$1$I$$20240215$20240715$20240715$PER$$US-PERRIGO-24US001758$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919681$24091968$1$I$20230701$20240216$20240715$20240715$PER$$US-PERRIGO-24US001781$PERRIGO$$60$YR$$M$Y$92.971$KG$20240715$$CN$US$US
240919691$24091969$1$I$$20240213$20240715$20240715$PER$$US-PERRIGO-24US001702$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919701$24091970$1$I$$20240212$20240715$20240715$PER$$US-PERRIGO-24US001647$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919711$24091971$1$I$$20240216$20240715$20240715$PER$$US-PERRIGO-24US001770$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919721$24091972$1$I$$20240215$20240715$20240715$PER$$US-PERRIGO-24US001760$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919731$24091973$1$I$$20240213$20240715$20240715$PER$$US-PERRIGO-24US001703$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919741$24091974$1$I$$20240216$20240715$20240715$PER$$US-PERRIGO-24US001779$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919751$24091975$1$I$$20240213$20240715$20240715$PER$$US-PERRIGO-24US001715$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919761$24091976$1$I$$20240216$20240715$20240715$PER$$US-PERRIGO-24US001768$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919771$24091977$1$I$$20240214$20240715$20240715$PER$$US-PERRIGO-24US001712$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919781$24091978$1$I$$20240212$20240715$20240715$PER$$US-PERRIGO-24US001630$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919791$24091979$1$I$$20240216$20240715$20240715$PER$$US-PERRIGO-24US001767$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919801$24091980$1$I$$20240213$20240715$20240715$PER$$US-PERRIGO-24US001711$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919811$24091981$1$I$$20240213$20240715$20240715$PER$$US-PERRIGO-24US001701$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919821$24091982$1$I$$20240213$20240715$20240715$PER$$US-PERRIGO-24US001717$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919831$24091983$1$I$20240701$20240709$20240715$20240715$PER$$US-Eisai-EC-2024-169918$EISAI$$50$YR$A$M$Y$$$20240715$$CN$US$US
240919841$24091984$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405081535377470-TPYSN$GB-TEVA-VS-3218779$TEVA$$$$$F$Y$87$KG$20240715$$PH$GB$GB
240919851$24091985$1$I$$20240713$20240715$20240715$DIR$FDA-CDER-CTU-2024-48790$$FDA-CTU$$$$$F$N$$$20240713$N$HP$US$
240919861$24091986$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48756$$FDA-CTU$$47$YR$$F$N$$$20240715$N$$US$
240919871$24091987$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48783$$FDA-CTU$$73$YR$$M$N$104.33$KG$20240715$N$$US$
240919881$24091988$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111266$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240715$$HP$US$US
240919891$24091989$1$I$$20240701$20240715$20240715$EXP$$JP-GUERBET / LLC-JP-20240091$GUERBET$Foreign Body Granuloma After Embolization ofInternal Iliac Artery Aneurysm Using N-Butyl-2-Cyanoacrylate: A Case Report. Cureus. 2024 May 13;16(5): 1-5. doi:DOI: 10.7759/cureus.60187.$77$YR$E$M$Y$$$20240715$$MD$JP$JP
240919901$24091990$1$I$$20240110$20240715$20240715$PER$$US-PERRIGO-24US001894$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240919911$24091991$1$I$$20240220$20240715$20240715$PER$$US-PERRIGO-24US001959$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919921$24091992$1$I$$20240222$20240715$20240715$PER$$US-PERRIGO-24US001973$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919931$24091993$1$I$$20240219$20240715$20240715$PER$$US-PERRIGO-24US001878$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919941$24091994$1$I$$20240219$20240715$20240715$PER$$US-PERRIGO-24US001884$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919951$24091995$1$I$20210716$20240710$20240715$20240715$EXP$$CA-TAKEDA-2021TUS043204$TAKEDA$$33$YR$$F$Y$$$20240715$$HP$CA$CA
240919961$24091996$1$I$$20240218$20240715$20240715$PER$$US-PERRIGO-24US001850$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240919971$24091997$1$I$20240101$20240213$20240715$20240715$PER$$US-PERRIGO-24US001805$PERRIGO$$39$YR$$M$Y$53.515$KG$20240715$$CN$US$US
240919981$24091998$1$I$$20240219$20240715$20240715$PER$$US-PERRIGO-24US001825$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240919991$24091999$1$I$$20240220$20240715$20240715$PER$$US-PERRIGO-24US001957$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240920001$24092000$1$I$$20240221$20240715$20240715$PER$$US-PERRIGO-24US001974$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240920011$24092001$1$I$$20240710$20240715$20240715$PER$$US-BAYER-2024A100116$BAYER$$$$$M$Y$$$20240715$$HP$US$US
240920022$24092002$2$F$$20240712$20240715$20240717$PER$$US-AMGEN-USASP2024139283$AMGEN$$$$A$F$Y$$$20240717$$CN$US$US
240920031$24092003$1$I$$20240708$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010096$DR REDDYS$Hogan KO. Preventative plasmapheresis in a diabetic pregnant patient with hypertriglyceridemia and distal pancreatectomy. Transfusion Medicine. 2023 Oct;33(5): 413-415. doi:10.1111/tme.12985.$$$N$$Y$$$20240715$$HP$US$US
240920041$24092004$1$I$$20240703$20240715$20240715$EXP$$US-BAYER-2024A100738$BAYER$Kwon D, Seu M, Barnes S.. Mind the Anion Gap: 5-Oxoproline-Induced High Anion Gap Metabolic Acidosis in End-Stage Renal Disease.. Cureus. 2024;16(5):e61328$74$YR$E$F$Y$$$20240715$$MD$US$US
240920051$24092005$1$I$$20240223$20240715$20240715$PER$$US-PERRIGO-24US002015$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240920061$24092006$1$I$$20240226$20240715$20240715$PER$$US-PERRIGO-24US002158$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240920071$24092007$1$I$$20240226$20240715$20240715$PER$$US-PERRIGO-24US002162$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240920081$24092008$1$I$$20240223$20240715$20240715$PER$$US-PERRIGO-24US002016$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240920091$24092009$1$I$$20240221$20240715$20240715$PER$$US-PERRIGO-24US002027$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240920101$24092010$1$I$$20240223$20240715$20240715$PER$$US-PERRIGO-24US002014$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240920111$24092011$1$I$20240110$20240210$20240715$20240715$PER$$US-PERRIGO-24US002035$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240920121$24092012$1$I$$20240223$20240715$20240715$PER$$US-PERRIGO-24US002011$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240920131$24092013$1$I$20240126$20240226$20240715$20240715$PER$$US-PERRIGO-24US002098$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240920141$24092014$1$I$$20240226$20240715$20240715$PER$$US-PERRIGO-24US002157$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240920151$24092015$1$I$$20240226$20240715$20240715$PER$$US-PERRIGO-24US002167$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240920161$24092016$1$I$$20240223$20240715$20240715$PER$$US-PERRIGO-24US002021$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240920171$24092017$1$I$$20240225$20240715$20240715$PER$$US-PERRIGO-24US002049$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240920181$24092018$1$I$20240201$20240228$20240715$20240715$PER$$US-PERRIGO-24US002168$PERRIGO$$25$YR$$M$Y$69$KG$20240715$$CN$US$US
240920192$24092019$2$F$$20240716$20240715$20240718$PER$$US-JNJFOC-20240730215$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$US$US
240920202$24092020$2$F$20240601$20240805$20240715$20240805$EXP$$MA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039596$BOEHRINGER INGELHEIM$$79$YR$E$$Y$$$20240805$$MD$MA$MA
240920211$24092021$1$I$20240705$20240711$20240715$20240715$EXP$$US-BAYER-2024A100924$BAYER$$52$YR$A$M$Y$69.841$KG$20240715$$CN$US$US
240920222$24092022$2$F$$20240710$20240715$20240924$PER$$US-ABBVIE-5835167$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
240920232$24092023$2$F$20240705$20240729$20240715$20240802$EXP$$CA-ABBVIE-5839636$ABBVIE$$80$YR$$M$Y$$$20240802$$HP$CA$CA
240920241$24092024$1$I$$20240709$20240715$20240715$EXP$$GB-PFIZER INC-202400210293$PFIZER$Teoh, P.. Invasive Trichoderma longibrachiatum infection in a neutropaenic patient.. Medical Mycology Case Reports. 2024;45:10.1016/j.mmcr.2024.100656$51$YR$$F$Y$$$20240715$$MD$GB$GB
240920251$24092025$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48779$$FDA-CTU$$60$YR$$F$N$232$LBS$20240715$N$$US$
240920261$24092026$1$I$$20240708$20240715$20240715$PER$$US-009507513-2407USA003851$MERCK$$$$$$Y$$$20240715$$MD$US$US
240920271$24092027$1$I$$20240709$20240715$20240715$EXP$$JP-PFIZER INC-PV202400090032$PFIZER$Ichimata, S.. Sudden unexpected death after initial infusion of rituximab for Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma: an autopsy case. Diagnostic pathology. 2024;19(1):89$84$YR$$M$Y$55$KG$20240715$$HP$JP$JP
240920281$24092028$1$I$20220401$20240715$20240715$20240715$EXP$IT-MINISAL02-995042$NVSC2024IT145182$NOVARTIS$$75$YR$$F$Y$72$KG$20240715$$PH$IT$IT
240920301$24092030$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48744$$FDA-CTU$$66$YR$$F$N$$$20240715$N$$US$
240920311$24092031$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48785$$FDA-CTU$$64$YR$$F$N$$$20240715$N$$US$
240920331$24092033$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48781$$FDA-CTU$$60$YR$$F$N$$$20240715$N$$US$
240920341$24092034$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110872$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240715$$HP$US$US
240920351$24092035$1$I$20240101$20240711$20240715$20240715$EXP$$US-ABBVIE-5837110$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240920361$24092036$1$I$20190201$20240703$20240715$20240715$PER$$US-SA-2024SA204017$SANOFI AVENTIS$$23$YR$A$F$Y$86.36$KG$20240715$$MD$US$US
240920372$24092037$2$F$20240629$20240816$20240715$20240829$PER$$US-SA-2024SA204594$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240829$$MD$US$US
240920381$24092038$1$I$20240630$20240705$20240715$20240715$PER$$US-SA-2024SA201407$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240715$$MD$US$US
240920391$24092039$1$I$20230401$20240703$20240715$20240715$PER$$US-SA-2024SA201578$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240715$$MD$US$US
240920401$24092040$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA204147$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240715$$MD$US$US
240920411$24092041$1$I$$20240710$20240715$20240715$EXP$$JP-AstraZeneca-2024A159625$ASTRAZENECA$$$$A$$Y$$$20240715$$MD$JP$
240920432$24092043$2$F$20240624$20240806$20240715$20240828$PER$$US-TOLMAR, INC.-24US050459$TOLMAR$$68$YR$$M$Y$$$20240827$$HP$US$US
240920441$24092044$1$I$20240601$20240624$20240715$20240715$PER$$US-TOLMAR, INC.-24US050529$TOLMAR$$47$YR$$F$Y$$$20240715$$PH$US$US
240920451$24092045$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA201867$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240715$$PH$US$US
240920461$24092046$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA204553$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240715$$MD$US$US
240920471$24092047$1$I$$20240711$20240715$20240715$PER$$US-HALEON-2186709$Haleon PLC$$$$$$Y$$$20240715$$CN$US$US
240920481$24092048$1$I$20240701$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138469$AMGEN$$$$$M$Y$$$20240715$$PH$US$US
240920494$24092049$4$F$$20240925$20240715$20240930$30DAY$$US-PFIZER INC-PV202400087236$PFIZER$$$$$$Y$$$20240930$$CN$US$US
240920503$24092050$3$F$20240707$20240825$20240715$20240826$30DAY$$US-PFIZER INC-202400208866$PFIZER$$23$MON$$F$Y$$$20240826$$HP$US$US
240920532$24092053$2$F$$20240912$20240715$20240917$30DAY$$US-PFIZER INC-PV202400087244$PFIZER$$$$$$Y$$$20240917$$HP$US$US
240920542$24092054$2$F$$20240716$20240715$20240717$EXP$$US-PFIZER INC-202400210202$PFIZER$$14$YR$$M$Y$49.9$KG$20240717$$CN$US$US
240920553$24092055$3$F$$20240908$20240715$20240909$30DAY$$CO-PFIZER INC-202400202560$PFIZER$$13$YR$$M$Y$$$20240909$$CN$CO$CO
240920562$24092056$2$F$$20240715$20240715$20240717$EXP$$NVSC2024CA143687$NOVARTIS$$$$$F$Y$$$20240717$$HP$CA$CA
240920572$24092057$2$F$20240707$20240812$20240715$20240819$EXP$$US-APELLIS-2024-APL-0000428$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
240920583$24092058$3$F$20240708$20240903$20240715$20240909$EXP$$JP-Eisai-EC-2024-169968$EISAI$$90$YR$E$F$Y$54$KG$20240909$$MD$JP$JP
240920591$24092059$1$I$$20240703$20240715$20240715$EXP$$JP-GUERBET / LLC-JP-20240092$GUERBET$$$$$F$Y$$$20240715$$MD$JP$JP
240920601$24092060$1$I$$20240702$20240715$20240715$EXP$$US-MEITHEAL-2024MPLIT00200$MEITHEAL PHARMACEUTICALS$Braat J, et al..Atypical Presentation of Central Serous Chorioretinopathy (CSCR) After Lung Transplantation.American Journal of Respiratory and Critical Care Medicine.may-2024;209:1$59$YR$A$F$Y$$$20240715$$HP$US$US
240920613$24092061$3$F$$20240816$20240715$20240823$EXP$$US-ALXN-202407USA000658US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$HP$US$US
240920621$24092062$1$I$$20240711$20240715$20240715$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-135615$DAIICHI$$$$$F$Y$$$20240715$$PH$US$US
240920632$24092063$2$F$20240501$20240916$20240715$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111153$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240918$$HP$US$US
240920641$24092064$1$I$20240711$20240711$20240715$20240715$EXP$GB-MHRA-MED-202407112204104930-KSJYC$GB-MYLANLABS-2024M1065450$MYLAN$$47$YR$$F$Y$$$20240715$$CN$GB$GB
240920651$24092065$1$I$$20240711$20240715$20240715$EXP$GB-MHRA-MED-202407111638543220-JVWFM$GB-MYLANLABS-2024M1065336$MYLAN$$$$$F$Y$$$20240715$$PH$GB$GB
240920661$24092066$1$I$20240101$20240710$20240715$20240715$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003844$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240715$$CN$US$US
240920671$24092067$1$I$$20240711$20240715$20240715$EXP$$US-BAYER-2024A100320$BAYER$$66$YR$E$M$Y$$$20240715$$CN$US$US
240920681$24092068$1$I$$20240702$20240715$20240715$EXP$$US-MEITHEAL-2024MPLIT00202$MEITHEAL PHARMACEUTICALS$Tajfiroozeh D, et al.A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis..American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$15$YR$T$M$Y$$$20240715$$HP$US$US
240920711$24092071$1$I$20240702$20240709$20240715$20240715$EXP$$US-JNJFOC-20240729385$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240715$$HP$US$US
240920731$24092073$1$I$$20240702$20240715$20240715$EXP$$US-MEITHEAL-2024MPLIT00203$MEITHEAL PHARMACEUTICALS$Hossain S, et al..Daptomycin-induced Lung Injury.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$55$YR$A$M$Y$$$20240715$$HP$US$US
240920741$24092074$1$I$20240501$20240711$20240715$20240715$EXP$GB-MHRA-MED-202407111952215770-NZYMJ$GB-MYLANLABS-2024M1065494$MYLAN$$73$YR$$M$Y$94$KG$20240715$$CN$GB$GB
240920751$24092075$1$I$$20240702$20240715$20240715$EXP$$US-MEITHEAL-2024MPLIT00204$MEITHEAL PHARMACEUTICALS$Dhaliwal K, et al.Toxic Megacolon: A Rare Adverse Effect of Etoposide Chemotherapy.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209 (1):A5663$59$YR$A$M$Y$$$20240715$$HP$US$US
240920761$24092076$1$I$$20240709$20240715$20240715$EXP$$IE-BAYER-2024A099278$BAYER$$75$YR$E$M$Y$$$20240715$$HP$IE$IE
240920771$24092077$1$I$$20240702$20240715$20240715$EXP$$US-MEITHEAL-2024MPLIT00205$MEITHEAL PHARMACEUTICALS$Holbert K..Multiorgan Failure From Heat Stroke in a Person Taking Glycopyrrolate. American Journal of Respiratory and Critical Care Medicine.JAN-2024;209 (1):A7329$24$YR$A$M$Y$$$20240715$$HP$US$US
240920781$24092078$1$I$$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111856$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240715$$CN$US$US
240920791$24092079$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110838$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$48.53$KG$20240715$$CN$US$US
240920801$24092080$1$I$$20240702$20240715$20240715$EXP$$US-MEITHEAL-2024MPLIT00201$MEITHEAL PHARMACEUTICALS$Manjunath S, et al.Atrial Fibrillation With Rapid Ventricular Response in Pediatric Lupus Carditis Following Pulse Steroid Therapy.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209 (1):A1729$16$YR$T$M$Y$$$20240715$$HP$US$US
240920811$24092081$1$I$20240706$20240707$20240715$20240715$EXP$$NVSC2024CN143380$NOVARTIS$$$$$M$Y$$$20240715$$CN$CN$CN
240920821$24092082$1$I$20240201$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091711040630-QMNWC$GB-TEVA-VS-3218376$TEVA$$36$YR$$M$Y$$$20240715$$CN$GB$GB
240920842$24092084$2$F$$20240726$20240715$20240806$EXP$$TR-ROCHE-10000026184$ROCHE$$76$YR$E$F$Y$$$20240806$$CN$TR$TR
240920851$24092085$1$I$$20240712$20240715$20240715$EXP$$US-UCBSA-2024035457$UCB$$$$$M$Y$$$20240715$$PH$US$US
240920861$24092086$1$I$$20240705$20240715$20240715$EXP$$AU-JNJFOC-20240729405$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$AU$AU
240920871$24092087$1$I$$20240713$20240715$20240715$EXP$GB-MHRA-MED-202407131625572030-BPNRG$GB-MYLANLABS-2024M1065712$MYLAN$$$$$$Y$$$20240715$$CN$GB$GB
240920881$24092088$1$I$$20240708$20240715$20240715$EXP$$US-GSK-US2024AMR085754$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$US$US
240920901$24092090$1$I$$20240709$20240715$20240715$EXP$$NVSC2024DE144734$NOVARTIS$Cremer A, Enssle JC, Pfaff S, Kouidri K, Lang F, Brandts C et al. Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell  transplantation with FLT3?mutated AML. ANNALS OF HEMATOLOGY. 2023;102:2903?8$$$A$$Y$$$20240715$$HP$DE$DE
240920911$24092091$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145579$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240920921$24092092$1$I$20240702$20240710$20240715$20240715$EXP$IT-MINISAL02-993866$IT-AMGEN-ITASP2024137031$AMGEN$$63$YR$A$M$Y$$$20240715$$MD$IT$IT
240920931$24092093$1$I$20240101$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111996$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240715$$CN$US$US
240920941$24092094$1$I$20240508$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405092126187340-KVGCN$GB-RDY-SPO/GBR/24/0010124$DR REDDYS$$35$YR$A$F$Y$$$20240715$$CN$GB$GB
240920951$24092095$1$I$$20240703$20240715$20240715$PER$$US-SA-2024SA203073$SANOFI AVENTIS$$$$A$F$Y$104$KG$20240715$$MD$US$US
240920962$24092096$2$F$20240712$20240730$20240715$20240802$PER$$US-AMGEN-USASP2024139553$AMGEN$$66$YR$E$F$Y$$$20240801$$CN$US$US
240920971$24092097$1$I$$20240703$20240715$20240715$PER$$US-SA-2024SA202712$SANOFI AVENTIS$$$$A$F$Y$79$KG$20240715$$MD$US$US
240920991$24092099$1$I$$20240711$20240715$20240715$PER$$US-JNJFOC-20240729941$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$US$US
240921012$24092101$2$F$$20240828$20240715$20240828$PER$$NVSC2024US144853$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
240921021$24092102$1$I$$20240702$20240715$20240715$EXP$$US-SLATERUN-2024SRLIT00108$SLATE RUN$Simpson M, et al.Early Extra Corporeal Membrane Oxygenation (ECMO) and Esophagogastroduodenoscopy (EGD) Implementation: A Timely Intervention in a Patient With Extended-Release Bupropion Overdose.American Journal of Respiratory and Critical Care Medicine.may-2024;209:A5672$41$YR$A$M$Y$$$20240715$$HP$US$US
240921031$24092103$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008628$ELI LILLY AND CO$$$$$F$Y$$$20240715$$HP$US$US
240921041$24092104$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00111$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.04-JUN-2024;18 (1):1-10$17$YR$T$M$Y$$$20240715$$HP$CN$CN
240921061$24092106$1$I$$20240710$20240715$20240715$EXP$$CO-BAYER-2024A101083$BAYER$$$$$M$Y$$$20240715$$HP$CO$CO
240921072$24092107$2$F$$20240813$20240715$20240823$EXP$$CH-SLATERUN-2024SRLIT00109$SLATE RUN$Jeltsch S, et al.How to differentiate erythema multiforme major from Stevens-Johnson syndrome?.Swiss Medical Weekly.MAY-2024;154 (1):112 S$41$YR$A$M$Y$$$20240823$$HP$CH$CH
240921081$24092108$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00113$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.jun-2024;18:1-10$51$YR$A$F$Y$$$20240715$$HP$CN$CN
240921091$24092109$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00112$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.04-JUN-2024;18 (1):1-10$40$YR$A$M$Y$$$20240715$$HP$CN$CN
240921101$24092110$1$I$$20240709$20240715$20240715$EXP$$US-LUNDBECK-DKLU4001632$LUNDBECK$$$$$$Y$$$20240715$$PH$US$US
240921111$24092111$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00114$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.jun-2024;18:1-10$37$YR$A$F$Y$$$20240715$$HP$CN$CN
240921121$24092112$1$I$$20240706$20240715$20240715$EXP$$IN-ROCHE-10000022202$ROCHE$$56$YR$A$M$Y$$$20240715$$CN$IN$IN
240921131$24092113$1$I$$20240708$20240715$20240715$EXP$FR-AFSSAPS-AVMA2024000286$FR-SA-2024SA200317$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240715$$PH$FR$FR
240921141$24092114$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00115$SLATE RUN$Wu J, et al..Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.04-JUN-2024;18 (1):1-10$38$YR$A$M$Y$$$20240715$$HP$CN$CN
240921161$24092116$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091232574480-CBJKQ$GB-TEVA-VS-3218436$TEVA$$$$$M$Y$$$20240715$$HP$GB$GB
240921171$24092117$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00116$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.jun-2024;18:1-10$19$YR$A$M$Y$$$20240715$$HP$CN$CN
240921181$24092118$1$I$$20240709$20240715$20240715$EXP$$JP-009507513-2404JPN002306J$MERCK$$6$DEC$$M$Y$$$20240715$$MD$JP$JP
240921192$24092119$2$F$$20240726$20240715$20240730$EXP$$FR-DSJP-DSE-2024-135592$DAIICHI$$$$A$F$Y$85$KG$20240730$$MD$FR$FR
240921202$24092120$2$F$$20240819$20240715$20240829$EXP$$JP-ROCHE-10000023843$ROCHE$$77$YR$E$M$Y$$$20240829$$MD$JP$JP
240921212$24092121$2$F$20231009$20240718$20240715$20240723$EXP$$FI-REGENERON PHARMACEUTICALS, INC.-2024-097019$REGENERON$$55$YR$$F$Y$$$20240723$$CN$FI$FI
240921222$24092122$2$F$20240613$20240806$20240715$20240813$EXP$$CA-OTSUKA-2023_008143$OTSUKA$$24$YR$$F$Y$$$20240813$$HP$CA$CA
240921241$24092124$1$I$20240622$20240703$20240715$20240715$PER$$US-TEVA-VS-3218665$TEVA$$19$YR$$F$Y$81.65$KG$20240715$$CN$US$US
240921251$24092125$1$I$20240101$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138677$AMGEN$$72$YR$E$F$Y$$$20240715$$CN$US$US
240921261$24092126$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405140926193210-RWLZF$GB-RDY-SPO/GBR/24/0010121$DR REDDYS$$$$$F$Y$$$20240715$$HP$GB$GB
240921271$24092127$1$I$$20240711$20240715$20240715$EXP$$CA-MYLANLABS-2024M1065500$MYLAN$$73$YR$$M$Y$$$20240715$$MD$CA$CA
240921281$24092128$1$I$20240510$20240711$20240715$20240715$EXP$FR-AFSSAPS-TO2024000937$FR-SA-2024SA168467$SANOFI AVENTIS$$77$YR$E$F$Y$68$KG$20240715$$PH$FR$FR
240921292$24092129$2$F$$20240710$20240715$20240722$EXP$$CA-MYLANLABS-2024M1065497$MYLAN$$$$$F$Y$86$KG$20240722$$CN$CA$CA
240921303$24092130$3$F$20240420$20240802$20240715$20240815$EXP$$US-UCBSA-2024034504$UCB$$49$YR$$F$Y$$$20240815$$CN$US$US
240921312$24092131$2$F$20240101$20240716$20240715$20240720$EXP$$US-ABBVIE-5833293$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
240921321$24092132$1$I$$20240709$20240715$20240715$EXP$$JP-ABBVIE-5833826$ABBVIE$$$$$F$Y$$$20240715$$CN$JP$JP
240921331$24092133$1$I$$20240711$20240715$20240715$EXP$$US-ABBVIE-5837479$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240921351$24092135$1$I$20200506$20240711$20240715$20240715$EXP$PL-URPL-1-3691-2020$PL-MYLANLABS-2024M1065022$MYLAN$$40$YR$$M$Y$80$KG$20240715$$MD$PL$PL
240921361$24092136$1$I$$20240701$20240715$20240715$PER$$US-ALKERMES INC.-ALK-2024-001807$ALKERMES$$$$$F$Y$$$20240715$$HP$US$US
240921371$24092137$1$I$20240219$20240709$20240715$20240715$EXP$FR-AFSSAPS-AN2024000874$FR-MYLANLABS-2024M1064303$MYLAN$$15$YR$$M$Y$38.1$KG$20240715$$MD$FR$FR
240921381$24092138$1$I$$20240711$20240715$20240715$EXP$$US-OTSUKA-2024_019628$OTSUKA$$$$$M$Y$$$20240715$$CN$US$US
240921391$24092139$1$I$20240418$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405071703163580-SFGKJ$GB-TEVA-VS-3218477$TEVA$$$$$M$Y$$$20240715$$HP$GB$GB
240921411$24092141$1$I$20240614$20240711$20240715$20240715$EXP$$US-ROCHE-10000025281$ROCHE$$67$YR$E$F$Y$$$20240715$$CN$US$US
240921422$24092142$2$F$20231101$20240805$20240715$20240812$EXP$FR-AFSSAPS-TS2024000765$FR-MYLANLABS-2024M1065000$MYLAN$$78$YR$$F$Y$$$20240812$$MD$FR$FR
240921431$24092143$1$I$20240506$20240711$20240715$20240715$EXP$ES-AEMPS-1545204$ES-MYLANLABS-2024M1065129$MYLAN$$73$YR$$M$Y$$$20240715$$HP$ES$ES
240921441$24092144$1$I$20240627$20240711$20240715$20240715$EXP$$US-OTSUKA-2024_019642$OTSUKA$$70$YR$$F$Y$65.77$KG$20240715$$CN$US$US
240921451$24092145$1$I$$20240709$20240715$20240715$EXP$$EG-009507513-2407EGY005085$MERCK$$$$E$F$Y$$$20240715$$CN$EG$EG
240921461$24092146$1$I$$20240703$20240715$20240715$PER$$US-TEVA-VS-3217378$TEVA$$$$A$F$Y$$$20240715$$CN$US$US
240921472$24092147$2$F$20240608$20240814$20240715$20240819$EXP$$NVSC2024RU144888$NOVARTIS$$53$YR$$M$Y$53$KG$20240819$$CN$RU$RU
240921483$24092148$3$F$20240415$20240904$20240715$20240911$EXP$$NVSC2024RU143818$NOVARTIS$$$$A$$Y$$$20240911$$MD$RU$RU
240921491$24092149$1$I$$20240711$20240715$20240715$PER$$NVSC2024US145337$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240921501$24092150$1$I$$20240708$20240715$20240715$EXP$$NVSC2024FR143581$NOVARTIS$Gendarme S, Pastre J, Billaud EM, Gibault L, Guillemain R, Oudard S, et al.. Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patients. THERAPIE. 2023;78(3):267-78$$$$$Y$$$20240715$$HP$FR$FR
240921511$24092151$1$I$20220315$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003798$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240921521$24092152$1$I$$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003799$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240921531$24092153$1$I$$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003801$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240921541$24092154$1$I$20200325$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003802$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240921551$24092155$1$I$20190516$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003804$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240921561$24092156$1$I$20190301$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003805$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240921571$24092157$1$I$$20240208$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000905$BIOCON$$$$$$Y$$$20240715$$CN$US$US
240921581$24092158$1$I$$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003792$BIOCON$$$$$$Y$$$20240715$$CN$US$US
240921591$24092159$1$I$20240601$20240711$20240715$20240715$EXP$FR-AFSSAPS-NT2024000773$FR-GSK-FR2024085996$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$FR$FR
240921604$24092160$4$F$$20240903$20240715$20240912$EXP$$ES-JNJFOC-20240535320$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240912$$CN$ES$ES
240921611$24092161$1$I$$20240213$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001009$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240921621$24092162$1$I$$20240213$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000999$BIOCON$$$$$$Y$$$20240715$$CN$US$US
240921631$24092163$1$I$$20240301$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001461$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240921641$24092164$1$I$20240311$20240404$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001637$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240921651$24092165$1$I$20240311$20240429$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002342$BIOCON$$$$$$Y$$$20240715$$CN$US$US
240921661$24092166$1$I$$20240426$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003065$BIOCON$$$$$$Y$$$20240715$$CN$US$US
240921671$24092167$1$I$$20240520$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003642$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240921681$24092168$1$I$$20240531$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004096$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240921691$24092169$1$I$$20240506$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002538$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240921701$24092170$1$I$$20240711$20240715$20240715$EXP$$IL-OTSUKA-2024_019703$OTSUKA$Yeshareem L, Yacobovich J, Lebel A, Noy-Lotan S, Dgany O, Steinberg-Shemer O et.al.. Genetic backgrounds and clinical characteristics of congenital neutropenias in Israel. Eur J Haematol. 2024;113(2):146-62$$$$M$Y$$$20240715$$HP$IL$IL
240921711$24092171$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138410$AMGEN$$$$$M$Y$$$20240715$$CN$US$US
240921722$24092172$2$F$$20240814$20240715$20240819$PER$$US-AMGEN-USASP2024139914$AMGEN$$52$YR$A$F$Y$$$20240819$$MD$US$US
240921731$24092173$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407050414230250-RQSFP$GB-TEVA-VS-3218533$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240921741$24092174$1$I$20240528$20240709$20240715$20240715$PER$$US-SA-2024SA184286$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240715$$MD$US$US
240921761$24092176$1$I$$20240514$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003001$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240921771$24092177$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00117$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.jun-2024;18:1-10$22$YR$A$M$Y$$$20240715$$HP$CN$CN
240921781$24092178$1$I$20240711$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138580$AMGEN$$75$YR$E$M$Y$$$20240715$$CN$US$US
240921792$24092179$2$F$$20240717$20240715$20240722$EXP$$CA-UCBSA-2024035592$UCB$$97$YR$$F$Y$$$20240719$$HP$CA$CA
240921801$24092180$1$I$$20240712$20240715$20240715$EXP$$US-ABBVIE-5839721$ABBVIE$$$$$F$Y$$$20240715$$HP$US$US
240921811$24092181$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00119$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.jun-2024;18:1-10$39$YR$A$M$Y$$$20240715$$HP$CN$CN
240921821$24092182$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00118$SLATE RUN$Wu J, et al..Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.4-JUN-2024;18 (1):1-10$62$YR$A$M$Y$$$20240715$$HP$CN$CN
240921831$24092183$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00120$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.jun-2024;18:1-10$71$YR$E$F$Y$$$20240715$$HP$CN$CN
240921841$24092184$1$I$20240101$20240705$20240715$20240715$EXP$$JP-TEVA-VS-3220710$TEVA$$$$$F$Y$$$20240715$$CN$JP$JP
240921851$24092185$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00121$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.4-JUN-2024;18 (1):1-10$48$YR$A$M$Y$$$20240715$$HP$CN$CN
240921861$24092186$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007572$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240715$$CN$US$US
240921871$24092187$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008483$ELI LILLY AND CO$$$$$$Y$$$20240715$$CN$US$US
240921891$24092189$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00122$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.jun-2024;18:1-10$34$YR$A$F$Y$$$20240715$$HP$CN$CN
240921902$24092190$2$F$$20240716$20240715$20240722$EXP$$TW-PFIZER INC-PV202400091404$PFIZER$Hsieh, C.. Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosed in a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Association?. Indian Journal of Dermatology. 2024;69(3):264-267$66$YR$$M$Y$$$20240722$$HP$TW$TW
240921911$24092191$1$I$20240627$20240715$20240715$20240715$EXP$$DE-GILEAD-2024-0680359$GILEAD$$69$YR$E$M$Y$$$20240715$$MD$DE$DE
240921931$24092193$1$I$$20240709$20240715$20240715$PER$$US-ROCHE-10000022894$ROCHE$$$$A$M$Y$$$20240715$$CN$US$US
240921941$24092194$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00123$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.jun-2024;18:1-10$56$YR$A$F$Y$$$20240715$$HP$CN$CN
240921951$24092195$1$I$20230901$20240112$20240715$20240715$EXP$$US-ARGENX-2024-ARGX-US000321$ARGENX BVBA$$$$$$Y$$$20240715$$HP$US$US
240921961$24092196$1$I$20230101$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111804$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240715$$CN$US$US
240921981$24092198$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138601$AMGEN$$$$A$F$Y$$$20240715$$MD$US$US
240921991$24092199$1$I$$20240702$20240715$20240715$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR00947$TARO$$$$$$Y$$$20240715$$PH$CA$CA
240922011$24092201$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48758$$FDA-CTU$$91$YR$$F$N$$$20240715$N$$US$
240922031$24092203$1$I$$20240705$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107779$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$86.18$KG$20240715$$CN$US$US
240922041$24092204$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00124$SLATE RUN$Wu J, et al..Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.4-JUN-2024;18 (1):1-10$84$YR$E$M$Y$$$20240715$$HP$CN$CN
240922051$24092205$1$I$$20240708$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108300$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240715$$HP$US$US
240922061$24092206$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00125$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.jun-2024;18:1-10$63$YR$A$M$Y$$$20240715$$HP$CN$CN
240922071$24092207$1$I$$20240713$20240715$20240715$DIR$FDA-CDER-CTU-2024-48802$$FDA-CTU$$$$$F$N$$$20240713$N$HP$US$
240922081$24092208$1$I$$20240703$20240715$20240715$EXP$$ES-TAKEDA-2024TUS071408$TAKEDA$$28$YR$$F$Y$$$20240715$$MD$ES$ES
240922091$24092209$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48789$$FDA-CTU$$51$YR$$F$N$$$20240715$N$$US$
240922101$24092210$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48784$$FDA-CTU$$52$YR$$F$N$$$20240715$N$$US$
240922121$24092212$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00126$SLATE RUN$Wu J, et al.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.jun-2024;18:1-10$72$YR$E$M$Y$$$20240715$$HP$CN$CN
240922131$24092213$1$I$$20240702$20240715$20240715$EXP$$CN-SLATERUN-2024SRLIT00127$SLATE RUN$Wu J, et al..Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.04-JUN-2024;18 (1):1-10$19$YR$A$M$Y$$$20240715$$HP$CN$CN
240922141$24092214$1$I$$20240702$20240715$20240715$EXP$$TN-SLATERUN-2024SRLIT00128$SLATE RUN$Ben Hammamia S, et al.Neurotoxicity Related to Multidrug Association: A Case Report.Journal of Clinical Psychopharmacology.jun-2024;44 (3):317-319$57$YR$A$F$Y$$$20240715$$MD$TN$TN
240922153$24092215$3$F$20240621$20240830$20240715$20240924$PER$$FR-TOLMAR, INC.-24FR050477$TOLMAR$$93$YR$$M$Y$$$20240923$$HP$FR$FR
240922162$24092216$2$F$20240621$20240719$20240715$20240812$PER$$FR-TOLMAR, INC.-24FR050406$TOLMAR$$64$YR$$M$Y$$$20240812$$PH$FR$FR
240922171$24092217$1$I$20230622$20240704$20240715$20240715$EXP$IT-MINISAL02-989085$IT-ROCHE-10000016751$ROCHE$$49$YR$A$F$Y$$$20240715$$MD$IT$IT
240922181$24092218$1$I$20240601$20240702$20240715$20240715$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-IBA-000244$Unknown Manufacturer$$$$$$Y$$$20240715$$CN$US$US
240922192$24092219$2$F$$20240719$20240715$20240812$PER$$FR-TOLMAR, INC.-24FR050366$TOLMAR$$75$YR$$M$Y$$$20240812$$PH$FR$FR
240922201$24092220$1$I$20240417$20240710$20240715$20240715$EXP$$US-OTSUKA-2024_013602$OTSUKA$$34$YR$$F$Y$71.2$KG$20240715$$MD$US$US
240922211$24092221$1$I$20231201$20240621$20240715$20240715$PER$$GT-TOLMAR, INC.-24GT050482$TOLMAR$$61$YR$$M$Y$$$20240715$$CN$GT$GT
240922222$24092222$2$F$$20240717$20240715$20240812$PER$$IT-TOLMAR, INC.-24IT050326$TOLMAR$$$$$M$Y$$$20240812$$HP$IT$IT
240922231$24092223$1$I$20240619$20240619$20240715$20240715$PER$$NI-TOLMAR, INC.-24NI050415$TOLMAR$$8$YR$$F$Y$$$20240715$$CN$NI$NI
240922241$24092224$1$I$20240604$20240619$20240715$20240715$PER$$NL-TOLMAR, INC.-24NL050297$TOLMAR$$80$YR$$M$Y$$$20240715$$CN$NL$NL
240922251$24092225$1$I$20240618$20240621$20240715$20240715$PER$$HN-TOLMAR, INC.-24HN050471$TOLMAR$$80$YR$$M$Y$$$20240715$$CN$HN$HN
240922262$24092226$2$F$20240621$20240723$20240715$20240821$PER$$NL-TOLMAR, INC.-24NL050436$TOLMAR$$69$YR$$M$Y$$$20240821$$HP$NL$NL
240922272$24092227$2$F$20240614$20240829$20240715$20240923$PER$$PA-TOLMAR, INC.-24PA050402$TOLMAR$$87$YR$$M$Y$$$20240923$$CN$PA$PA
240922281$24092228$1$I$20240614$20240619$20240715$20240715$PER$$PA-TOLMAR, INC.-24PA050355$TOLMAR$$90$YR$$M$Y$$$20240715$$CN$PA$PA
240922291$24092229$1$I$$20240621$20240715$20240715$PER$$PH-TOLMAR, INC.-24PH050452$TOLMAR$$$$$M$Y$$$20240715$$MD$PH$PH
240922302$24092230$2$F$$20240705$20240715$20240717$EXP$GB-MHRA-MED-202405132346085840-QZKWM$GB-BAYER-2024A100755$BAYER$$$$$M$Y$69$KG$20240717$$CN$GB$GB
240922311$24092231$1$I$20240430$20240708$20240715$20240715$EXP$$FR-DSJP-DSE-2024-135201$DAIICHI$$$$E$F$Y$55$KG$20240715$$MD$FR$FR
240922321$24092232$1$I$$20240710$20240715$20240715$EXP$$CA-BAUSCH-BL-2024-010531$BAUSCH AND LOMB$$48$YR$$F$Y$68$KG$20240715$$HP$CA$CA
240922331$24092233$1$I$20240713$20240714$20240714$20240714$DIR$710194$$FDA-CTU$$23$YR$$M$N$108$KG$20240714$N$CN$US$
240922341$24092234$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48762$$FDA-CTU$$60$YR$$F$N$125$LBS$20240715$N$$US$
240922351$24092235$1$I$20240701$20240714$20240714$20240714$DIR$710196$$FDA-CTU$$29$YR$$F$N$67.5$KG$20240714$N$CN$US$
240922371$24092237$1$I$$20240714$20240714$20240714$DIR$710199$$FDA-CTU$$40$YR$$F$N$76.5$KG$20240714$N$CN$US$
240922381$24092238$1$I$20240202$20240714$20240714$20240714$DIR$710198$$FDA-CTU$$45$YR$$F$N$117$KG$20240714$N$CN$US$
240922401$24092240$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48818$$FDA-CTU$$73$YR$$F$N$$$20240715$N$$US$
240922411$24092241$1$I$20231014$20240712$20240715$20240715$EXP$FR-AFSSAPS-PA2024000835$FR-SANDOZ INC.-SDZ2024FR064858$SANDOZ$$50$YR$$F$Y$93$KG$20240715$$MD$FR$FR
240922422$24092242$2$F$20240202$20240729$20240715$20240730$EXP$$DE-SANDOZ INC.-SDZ2024DE026954$SANDOZ$$43$YR$$F$Y$61$KG$20240730$$MD$DE$DE
240922431$24092243$1$I$$20240626$20240715$20240715$PER$$US-ABBVIE-5838023$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240922441$24092244$1$I$20240626$20240705$20240715$20240715$EXP$GB-MHRA-MED-202406260823074440-ZTJLM$GB-TEVA-VS-3219257$TEVA$$58$YR$$M$Y$72$KG$20240715$$CN$GB$GB
240922451$24092245$1$I$$20240711$20240715$20240715$EXP$GB-MHRA-MED-202407110823316370-YMRDP$GB-PFIZER INC-202400212212$PFIZER$$47$YR$$F$Y$70$KG$20240715$$CN$GB$GB
240922461$24092246$1$I$20180101$20240710$20240715$20240715$EXP$$ES-PFIZER INC-2019420237$PFIZER$Gorgulu, B.. Successful desensitization to brentuximab after anaphylactic shock. Journal of Investigational Allergology + Clinical Immunology. 2018;28 (5):352-54$34$YR$$M$Y$$$20240715$$MD$TR$ES
240922481$24092248$1$I$20240103$20240714$20240714$20240714$DIR$710181$$FDA-CTU$$56$YR$$F$N$83.25$KG$20240714$N$CN$US$
240922491$24092249$1$I$20240708$20240714$20240714$20240714$DIR$710177$$FDA-CTU$$56$YR$$M$N$57.6$KG$20240714$N$CN$US$
240922531$24092253$1$I$20230110$20240711$20240715$20240715$EXP$$FR-PFIZER INC-2023SGN05080$PFIZER$$40$YR$$F$Y$$$20240715$$MD$FR$FR
240922541$24092254$1$I$20240710$20240713$20240715$20240715$DIR$FDA-CDER-CTU-2024-48821$$FDA-CTU$$69$YR$$F$N$$$20240713$N$HP$US$
240922551$24092255$1$I$20240630$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48814$$FDA-CTU$$58$YR$$M$N$$$20240715$Y$PH$US$
240922571$24092257$1$I$20200808$20240711$20240715$20240715$EXP$$CN-PFIZER INC-PV202400091560$PFIZER$$28$YR$$M$Y$54$KG$20240715$$HP$CN$CN
240922592$24092259$2$F$20221111$20240722$20240715$20240726$EXP$$ES-PFIZER INC-2023SGN05505$PFIZER$$65$YR$$M$Y$$$20240726$$MD$ES$ES
240922603$24092260$3$F$$20240815$20240715$20240819$EXP$$US-PFIZER INC-PV202400091795$PFIZER$$77$YR$$F$Y$$$20240819$$CN$US$US
240922612$24092261$2$F$20240705$20240717$20240715$20240722$EXP$$US-BIOMARINAP-US-2024-159026$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
240922621$24092262$1$I$20240520$20240705$20240715$20240715$EXP$$CN-ROCHE-10000019351$ROCHE$$44$YR$A$F$Y$50$KG$20240715$$HP$CN$CN
240922631$24092263$1$I$$20240710$20240715$20240715$PER$$US-ABBVIE-5837650$ABBVIE$$$$A$F$Y$$$20240715$$HP$US$US
240922641$24092264$1$I$$20240701$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106172$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240715$$CN$US$US
240922651$24092265$1$I$20240401$20240710$20240715$20240715$EXP$$US-OTSUKA-2024_014650$OTSUKA$$47$YR$$M$Y$$$20240715$$MD$US$US
240922671$24092267$1$I$20240307$20240714$20240715$20240715$PER$$US-AMGEN-USASP2024139936$AMGEN$$75$YR$E$F$Y$$$20240715$$CN$US$US
240922681$24092268$1$I$20240418$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405071703163580-SFGKJ$GB-RDY-SPO/GBR/24/0010120$DR REDDYS$$$$$M$Y$$$20240715$$HP$GB$GB
240922691$24092269$1$I$$20240708$20240715$20240715$EXP$$US-AMGEN-USASP2024135290$AMGEN$Chiu G. B.; Tseng A. M.; Heur M.. Sustained descemetocele management with Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) treatment. American Journal of Ophthalmology Case Reports. 2024;36:1-5$56$YR$A$M$Y$$$20240715$$HP$US$US
240922701$24092270$1$I$$20240307$20240715$20240715$PER$$US-PERRIGO-24US002517$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922711$24092271$1$I$$20240309$20240715$20240715$PER$$US-PERRIGO-24US002498$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922721$24092272$1$I$$20240226$20240715$20240715$PER$$US-PERRIGO-24US002171$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922731$24092273$1$I$$20240304$20240715$20240715$PER$$US-PERRIGO-24US002398$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922741$24092274$1$I$$20240306$20240715$20240715$PER$$US-PERRIGO-24US002512$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922751$24092275$1$I$$20240306$20240715$20240715$PER$$US-PERRIGO-24US002502$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922761$24092276$1$I$20240101$20240307$20240715$20240715$PER$$US-PERRIGO-24US002441$PERRIGO$$52$YR$$M$Y$95.238$KG$20240715$$CN$US$US
240922771$24092277$1$I$$20240310$20240715$20240715$PER$$US-PERRIGO-24US002602$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922781$24092278$1$I$$20240305$20240715$20240715$PER$$US-PERRIGO-24US002456$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922791$24092279$1$I$$20240226$20240715$20240715$PER$$US-PERRIGO-24US002170$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922801$24092280$1$I$$20240306$20240715$20240715$PER$$US-PERRIGO-24US002501$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922811$24092281$1$I$20240207$20240228$20240715$20240715$PER$$US-PERRIGO-24US002172$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240922821$24092282$1$I$$20240305$20240715$20240715$PER$$US-PERRIGO-24US002449$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922831$24092283$1$I$$20240229$20240715$20240715$PER$$US-PERRIGO-24US002295$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922841$24092284$1$I$$20240308$20240715$20240715$PER$$US-PERRIGO-24US002613$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240922851$24092285$1$I$$20240227$20240715$20240715$PER$$US-PERRIGO-24US002215$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922861$24092286$1$I$$20240302$20240715$20240715$PER$$US-PERRIGO-24US002245$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922871$24092287$1$I$$20240309$20240715$20240715$PER$$US-PERRIGO-24US002497$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922881$24092288$1$I$$20240307$20240715$20240715$PER$$US-PERRIGO-24US002514$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922891$24092289$1$I$$20240301$20240715$20240715$PER$$US-PERRIGO-24US002272$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922901$24092290$1$I$$20240307$20240715$20240715$PER$$US-PERRIGO-24US002515$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922911$24092291$1$I$$20240302$20240715$20240715$PER$$US-PERRIGO-24US002244$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922921$24092292$1$I$$20240228$20240715$20240715$PER$$US-PERRIGO-24US002262$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922931$24092293$1$I$$20240226$20240715$20240715$PER$$US-PERRIGO-24US002176$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922941$24092294$1$I$$20240228$20240715$20240715$PER$$US-PERRIGO-24US002269$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922951$24092295$1$I$20240303$20240313$20240715$20240715$PER$$US-PERRIGO-24US002619$PERRIGO$$73$YR$$M$Y$$$20240715$$CN$US$US
240922961$24092296$1$I$$20240307$20240715$20240715$PER$$US-PERRIGO-24US002516$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922971$24092297$1$I$$20240228$20240715$20240715$PER$$US-PERRIGO-24US002263$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922981$24092298$1$I$$20240301$20240715$20240715$PER$$US-PERRIGO-24US002264$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240922991$24092299$1$I$$20240311$20240715$20240715$PER$$US-PERRIGO-24US002622$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923001$24092300$1$I$$20240711$20240715$20240715$EXP$$GB-BAYER-2024A100646$BAYER$$$$$M$Y$$$20240715$$MD$GB$GB
240923013$24092301$3$F$20240704$20240805$20240715$20240808$EXP$$US-OTSUKA-2024_019549$OTSUKA$$52$YR$$F$Y$$$20240808$$HP$US$US
240923021$24092302$1$I$$20240707$20240715$20240715$EXP$$CN-TAKEDA-2024TUS071040$TAKEDA$$$$$$Y$$$20240715$$CN$CN$CN
240923031$24092303$1$I$20240116$20240710$20240715$20240715$EXP$$US-AstraZeneca-2024A158250$ASTRAZENECA$$25246$DY$$F$Y$$$20240715$$CN$US$
240923041$24092304$1$I$$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160533$ASTRAZENECA$$81$YR$$F$Y$44$KG$20240715$$HP$FR$
240923051$24092305$1$I$20240618$20240710$20240715$20240715$EXP$$VN-AstraZeneca-2024A160216$ASTRAZENECA$$25171$DY$$M$Y$$$20240715$$CN$VN$
240923071$24092307$1$I$$20240709$20240715$20240715$PER$$NVSC2024US145603$NOVARTIS$$$$$$Y$$$20240715$$HP$US$US
240923082$24092308$2$F$20230101$20240829$20240715$20240903$EXP$$ES-BIOCON BIOLOGICS LIMITED-BBL2024005035$BIOCON$$$$$$Y$$$20240903$$CN$ES$ES
240923091$24092309$1$I$20200101$20240709$20240715$20240715$EXP$$FR-AstraZeneca-2024A135800$ASTRAZENECA$$58$YR$$F$Y$$$20240715$$CN$FR$
240923101$24092310$1$I$$20240312$20240715$20240715$PER$$US-PERRIGO-24US002626$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923111$24092311$1$I$20240126$20240315$20240715$20240715$PER$$US-PERRIGO-24US002748$PERRIGO$$56$YR$$M$Y$92.971$KG$20240715$$CN$US$US
240923121$24092312$1$I$$20240313$20240715$20240715$PER$$US-PERRIGO-24US002717$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923131$24092313$1$I$$20240702$20240715$20240715$EXP$$US-AIPING-2024AILIT00025$AIPING PHARMACEUTICAL$$55$YR$A$F$Y$$$20240715$$MD$US$US
240923141$24092314$1$I$$20240314$20240715$20240715$PER$$US-PERRIGO-24US002773$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923151$24092315$1$I$$20240316$20240715$20240715$PER$$US-PERRIGO-24US002772$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923161$24092316$1$I$$20240315$20240715$20240715$PER$$US-PERRIGO-24US002770$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923171$24092317$1$I$$20240312$20240715$20240715$PER$$US-PERRIGO-24US002623$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923181$24092318$1$I$$20240315$20240715$20240715$PER$$US-PERRIGO-24US002768$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923191$24092319$1$I$$20240314$20240715$20240715$PER$$US-PERRIGO-24US002752$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923201$24092320$1$I$$20240707$20240715$20240715$EXP$$US-AstraZeneca-2024A156716$ASTRAZENECA$$$$$$Y$$$20240715$$CN$US$
240923211$24092321$1$I$$20240314$20240715$20240715$PER$$US-PERRIGO-24US002771$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923221$24092322$1$I$$20240314$20240715$20240715$PER$$US-PERRIGO-24US002774$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923231$24092323$1$I$$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160600$ASTRAZENECA$$76$YR$$M$Y$$$20240715$$HP$FR$
240923242$24092324$2$F$$20240821$20240715$20240827$EXP$$CA-JNJFOC-20240724132$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240828$$CN$CA$CA
240923252$24092325$2$F$20231201$20240723$20240715$20240726$EXP$$JP-AstraZeneca-2024A096257$ASTRAZENECA$$65$YR$$M$Y$39$KG$20240726$$MD$JP$
240923261$24092326$1$I$$20240702$20240715$20240715$PER$$US-TEVA-VS-3217267$TEVA$$$$A$M$Y$$$20240715$$HP$US$US
240923271$24092327$1$I$$20240710$20240715$20240715$EXP$$DE-OTSUKA-2024_019604$OTSUKA$$87$YR$$M$Y$$$20240715$$MD$DE$DE
240923281$24092328$1$I$$20240702$20240715$20240715$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR00946$TARO$$$$$$Y$$$20240715$$CN$CA$CA
240923301$24092330$1$I$$20240702$20240715$20240715$EXP$$US-AIPING-2024AILIT00026$AIPING PHARMACEUTICAL$Simone C, et al..Levetiracetam-associated Rhabdomyolysis.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209 (1):A5704$20$YR$A$M$Y$$$20240715$$HP$US$US
240923311$24092331$1$I$$20240318$20240715$20240715$PER$$US-PERRIGO-24US002846$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923321$24092332$1$I$$20240319$20240715$20240715$PER$$US-PERRIGO-24US002942$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923332$24092333$2$F$$20240715$20240715$20240722$EXP$$US-PCCINC-2024-PPL-000518$PIRAMAL$Kraus M.J.; Nguyen J.. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report. Case Reports in Neurology. 2024;16:142-147$$$$$Y$$$20240723$$MD$US$US
240923341$24092334$1$I$$20240320$20240715$20240715$PER$$US-PERRIGO-24US002841$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240923351$24092335$1$I$$20240319$20240715$20240715$PER$$US-PERRIGO-24US002937$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923361$24092336$1$I$$20240319$20240715$20240715$PER$$US-PERRIGO-24US002883$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240923372$24092337$2$F$20180718$20240708$20240715$20240718$EXP$$CN-GSK-AU2024APC085263$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$AU$AU
240923381$24092338$1$I$$20240709$20240715$20240715$EXP$GB-MHRA-MED-202407090046268750-HCSGP$GB-ABBVIE-5838295$ABBVIE$$18$YR$$M$Y$$$20240715$$CN$GB$GB
240923391$24092339$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48830$$FDA-CTU$$74$YR$$M$N$$$20240715$N$$US$
240923421$24092342$1$I$$20240318$20240715$20240715$PER$$US-PERRIGO-24US002848$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923431$24092343$1$I$$20240320$20240715$20240715$PER$$US-PERRIGO-24US002934$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923441$24092344$1$I$$20240320$20240715$20240715$PER$$US-PERRIGO-24US002950$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923451$24092345$1$I$$20240325$20240715$20240715$PER$$US-PERRIGO-24US003027$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923461$24092346$1$I$$20240322$20240715$20240715$PER$$US-PERRIGO-24US002974$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923471$24092347$1$I$20240201$20240319$20240715$20240715$PER$$US-PERRIGO-24US002935$PERRIGO$$59$YR$$M$Y$88.435$KG$20240715$$CN$US$US
240923481$24092348$1$I$20230101$20240321$20240715$20240715$PER$$US-PERRIGO-24US002994$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240923491$24092349$1$I$20240620$20240714$20240714$20240714$DIR$710192$$FDA-CTU$$46$YR$$F$N$65.25$KG$20240714$N$CN$US$
240923501$24092350$1$I$$20240319$20240715$20240715$PER$$US-PERRIGO-24US002825$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240923511$24092351$1$I$$20240320$20240715$20240715$PER$$US-PERRIGO-24US002966$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923521$24092352$1$I$$20240318$20240715$20240715$PER$$US-PERRIGO-24US002854$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923531$24092353$1$I$$20240322$20240715$20240715$PER$$US-PERRIGO-24US003004$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923541$24092354$1$I$$20240322$20240715$20240715$PER$$US-PERRIGO-24US002982$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923551$24092355$1$I$$20240320$20240715$20240715$PER$$US-PERRIGO-24US002951$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923561$24092356$1$I$20240705$20240708$20240715$20240715$EXP$$CN-GSK-CN2024APC084723$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$HP$CN$CN
240923571$24092357$1$I$20240601$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111645$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$91$KG$20240715$$PH$US$US
240923581$24092358$1$I$$20240708$20240715$20240715$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024084908$VIIV$$$$$M$Y$$$20240715$$HP$US$US
240923593$24092359$3$F$$20240829$20240715$20240903$EXP$$US-SANDOZ INC.-SDZ2023US003728$SANDOZ$$$$$M$Y$$$20240903$$MD$US$US
240923601$24092360$1$I$$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111788$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240715$$CN$US$US
240923611$24092361$1$I$$20240703$20240715$20240715$EXP$$JP-ROCHE-10000022078$ROCHE$$67$YR$E$F$Y$$$20240715$$PH$JP$JP
240923621$24092362$1$I$20240620$20240709$20240715$20240715$PER$$US-ROCHE-10000022169$ROCHE$$$$$F$Y$$$20240715$$CN$US$US
240923631$24092363$1$I$$20240326$20240715$20240715$PER$$US-PERRIGO-24US003181$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923641$24092364$1$I$20240305$20240326$20240715$20240715$PER$$US-PERRIGO-24US003120$PERRIGO$$75$YR$$F$Y$72.562$KG$20240715$$CN$US$US
240923651$24092365$1$I$$20240324$20240715$20240715$PER$$US-PERRIGO-24US003114$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923661$24092366$1$I$$20240709$20240715$20240715$EXP$$US-AMGEN-USASP2024136479$AMGEN$Nawras A.; Khan M. A.; Kamal S. et al.. Renal cell carcinoma mimicking IgG4-related pseudotumor in autoimmune pancreatitis. JOP -JOURNAL OF THE PANCREAS. 2014;15 (5):520-522$73$YR$E$M$Y$$$20240715$$HP$US$US
240923671$24092367$1$I$20220101$20240326$20240715$20240715$PER$$US-PERRIGO-24US003091$PERRIGO$$$$E$F$Y$$$20240715$$CN$US$US
240923681$24092368$1$I$$20240709$20240715$20240715$EXP$$US-AMGEN-USASP2024135668$AMGEN$George D.; Halabi S.; Heath E.I. et al.. A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. Cancer. 2021;127 (16):2954-2965$$$$$Y$$$20240715$$MD$US$US
240923691$24092369$1$I$$20240325$20240715$20240715$PER$$US-PERRIGO-24US003153$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923701$24092370$1$I$$20240325$20240715$20240715$PER$$US-PERRIGO-24US003028$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923711$24092371$1$I$$20240326$20240715$20240715$PER$$US-PERRIGO-24US003170$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923721$24092372$1$I$$20240325$20240715$20240715$PER$$US-PERRIGO-24US003138$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923731$24092373$1$I$$20240324$20240715$20240715$PER$$US-PERRIGO-24US003112$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923741$24092374$1$I$$20240325$20240715$20240715$PER$$US-PERRIGO-24US003125$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923751$24092375$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024139447$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240923762$24092376$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3218398$TEVA$Shapoo N, Poor A, Trenard N. Lost in the Mix: A Challenging Diagnosis of Myxedema Coma in an Elderly Patient. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A3392.; Shapoo N, Poor A, Trenard N. Lost in the Mix: A Challenging Diagnosis of Myxedema Coma in an Elderly Patient. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A3392.$86$YR$$M$Y$$$20240802$$HP$US$US
240923772$24092377$2$F$20240701$20240715$20240715$20240717$PER$$US-AMGEN-USASP2024139804$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
240923781$24092378$1$I$$20240404$20240715$20240715$PER$$US-PERRIGO-24US003448$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923791$24092379$1$I$$20240401$20240715$20240715$PER$$US-PERRIGO-24US003384$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923801$24092380$1$I$$20240329$20240715$20240715$PER$$US-PERRIGO-24US003209$PERRIGO$$$$$$Y$$$20240715$$CN$US$US
240923811$24092381$1$I$20240207$20240402$20240715$20240715$PER$$US-PERRIGO-24US003372$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923821$24092382$1$I$$20240405$20240715$20240715$PER$$US-PERRIGO-24US003457$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923831$24092383$1$I$20240201$20240404$20240715$20240715$PER$$US-PERRIGO-24US003410$PERRIGO$$65$YR$$F$Y$72.562$KG$20240715$$CN$US$US
240923841$24092384$1$I$$20240329$20240715$20240715$PER$$US-PERRIGO-24US003221$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923851$24092385$1$I$$20240403$20240715$20240715$PER$$US-PERRIGO-24US003452$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923861$24092386$1$I$20240101$20240403$20240715$20240715$PER$$US-PERRIGO-24US003387$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240923871$24092387$1$I$$20240329$20240715$20240715$PER$$US-PERRIGO-24US003190$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923881$24092388$1$I$$20240327$20240715$20240715$PER$$US-PERRIGO-24US003262$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923891$24092389$1$I$$20240402$20240715$20240715$PER$$US-PERRIGO-24US003393$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923901$24092390$1$I$$20240403$20240715$20240715$PER$$US-PERRIGO-24US003373$PERRIGO$$$$$$Y$$$20240715$$CN$US$US
240923911$24092391$1$I$20231001$20240401$20240715$20240715$PER$$US-PERRIGO-24US003270$PERRIGO$$66$YR$$M$Y$73.469$KG$20240715$$CN$US$US
240923921$24092392$1$I$20230401$20240404$20240715$20240715$PER$$US-PERRIGO-24US003411$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240923931$24092393$1$I$$20240402$20240715$20240715$PER$$US-PERRIGO-24US003402$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923941$24092394$1$I$$20240403$20240715$20240715$PER$$US-PERRIGO-24US003366$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240923951$24092395$1$I$$20240329$20240715$20240715$PER$$US-PERRIGO-24US003182$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240923961$24092396$1$I$20231129$20240329$20240715$20240715$PER$$US-PERRIGO-24US003199$PERRIGO$$70$YR$$F$Y$63.492$KG$20240715$$CN$US$US
240923971$24092397$1$I$20231201$20240327$20240715$20240715$PER$$US-PERRIGO-24US003276$PERRIGO$$30$YR$$M$Y$92.063$KG$20240715$$CN$US$US
240923982$24092398$2$F$20231130$20240823$20240715$20240827$EXP$$US-OTSUKA-2024_000213$OTSUKA$$74$YR$$M$Y$78.91$KG$20240827$$HP$US$US
240923991$24092399$1$I$$20240406$20240715$20240715$PER$$US-PERRIGO-24US003471$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924001$24092400$1$I$$20240406$20240715$20240715$PER$$US-PERRIGO-24US003470$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924011$24092401$1$I$$20240128$20240715$20240715$PER$$US-PERRIGO-24US003556$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924021$24092402$1$I$$20240408$20240715$20240715$PER$$US-PERRIGO-24US003545$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924031$24092403$1$I$$20240407$20240715$20240715$PER$$US-PERRIGO-24US003557$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924041$24092404$1$I$20240401$20240401$20240715$20240715$PER$$US-PERRIGO-24US003547$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924051$24092405$1$I$$20240403$20240715$20240715$PER$$US-PERRIGO-24US003461$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924061$24092406$1$I$$20240403$20240715$20240715$PER$$US-PERRIGO-24US003460$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924071$24092407$1$I$$20240406$20240715$20240715$PER$$US-PERRIGO-24US003468$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924081$24092408$1$I$20240201$20240425$20240715$20240715$PER$$US-KARYOPHARM-2024KPT000962$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240715$$MD$US$US
240924101$24092410$1$I$$20240712$20240715$20240715$EXP$GB-MHRA-MED-202405161141079560-GSLYT$GB-ASTELLAS-2024US019859$ASTELLAS$$$$$M$Y$$$20240715$$CN$GB$GB
240924111$24092411$1$I$$20240403$20240715$20240715$PER$$US-PERRIGO-24US003462$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924121$24092412$1$I$$20240411$20240715$20240715$PER$$US-PERRIGO-24US003644$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924131$24092413$1$I$$20240413$20240715$20240715$PER$$US-PERRIGO-24US003709$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924141$24092414$1$I$$20240408$20240715$20240715$PER$$US-PERRIGO-24US003564$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924151$24092415$1$I$$20240414$20240715$20240715$PER$$US-PERRIGO-24US003751$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924161$24092416$1$I$$20240410$20240715$20240715$PER$$US-PERRIGO-24US003647$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924171$24092417$1$I$$20240410$20240715$20240715$PER$$US-PERRIGO-24US003660$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924181$24092418$1$I$$20240412$20240715$20240715$PER$$US-PERRIGO-24US003706$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924191$24092419$1$I$$20240409$20240715$20240715$PER$$US-PERRIGO-24US003605$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924201$24092420$1$I$$20240409$20240715$20240715$PER$$US-PERRIGO-24US003610$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924211$24092421$1$I$20240101$20240412$20240715$20240715$PER$$US-PERRIGO-24US003665$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240924221$24092422$1$I$20240331$20240414$20240715$20240715$PER$$US-PERRIGO-24US003716$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240924231$24092423$1$I$$20240409$20240715$20240715$PER$$US-PERRIGO-24US003615$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924241$24092424$1$I$$20240407$20240715$20240715$PER$$US-PERRIGO-24US003558$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924251$24092425$1$I$20240411$20240411$20240715$20240715$PER$$US-PERRIGO-24US003621$PERRIGO$$67$YR$$F$Y$66.213$KG$20240715$$CN$US$US
240924261$24092426$1$I$$20240413$20240715$20240715$PER$$US-PERRIGO-24US003710$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924271$24092427$1$I$$20240411$20240715$20240715$PER$$US-PERRIGO-24US003666$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924281$24092428$1$I$$20240414$20240715$20240715$PER$$US-PERRIGO-24US003752$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924291$24092429$1$I$$20240407$20240715$20240715$PER$$US-PERRIGO-24US003560$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924301$24092430$1$I$$20240409$20240715$20240715$PER$$US-PERRIGO-24US003609$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924311$24092431$1$I$$20240413$20240715$20240715$PER$$US-PERRIGO-24US003705$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924321$24092432$1$I$20170101$20240711$20240715$20240715$EXP$$FR-PFIZER INC-2018SGN00037$PFIZER$$48$YR$$F$Y$101$KG$20240715$$MD$FR$FR
240924331$24092433$1$I$20180511$20240711$20240715$20240715$EXP$FR-AFSSAPS-MP20182017$FR-PFIZER INC-2018SGN02252$PFIZER$$36$YR$$F$Y$54$KG$20240715$$HP$FR$FR
240924342$24092434$2$F$20240630$20240905$20240715$20240909$EXP$$US-PFIZER INC-PV202400091852$PFIZER$$88$YR$$M$Y$$$20240909$$HP$US$US
240924351$24092435$1$I$20170701$20240711$20240715$20240715$EXP$$FR-PFIZER INC-2018SGN01220$PFIZER$$63$YR$$M$Y$91$KG$20240715$$MD$FR$FR
240924361$24092436$1$I$$20240415$20240715$20240715$PER$$US-PERRIGO-24US003840$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924371$24092437$1$I$$20240603$20240715$20240715$PER$$US-TRAVERE-2024TVT00564$TRAVERE THERAPEUTICS$$47$YR$A$M$Y$$$20240715$$CN$US$US
240924382$24092438$2$F$20240101$20240711$20240715$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111493$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240717$$MD$US$US
240924391$24092439$1$I$$20240710$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110394$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240715$$HP$US$US
240924401$24092440$1$I$$20240703$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107756$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240715$$HP$US$US
240924412$24092441$2$F$$20240724$20240715$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111631$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$81.65$KG$20240726$$CN$US$US
240924421$24092442$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111446$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240715$$CN$US$US
240924431$24092443$1$I$20240701$20240708$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109811$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240715$$CN$US$US
240924441$24092444$1$I$$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109217$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240715$$PH$US$US
240924451$24092445$1$I$20240712$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48845$$FDA-CTU$$$$$$N$$$20240712$N$$US$
240924491$24092449$1$I$20240710$20240711$20240715$20240715$EXP$$US-ORGANON-O2407USA001234$ORGANON$$$$$$Y$$$20240715$$CN$US$US
240924502$24092450$2$F$20240117$20240710$20240715$20240717$EXP$$NVSC2024CA013641$NOVARTIS$$$$A$F$Y$$$20240717$$PH$CA$CA
240924521$24092452$1$I$$20240705$20240715$20240715$30DAY$$US-GSK-US2024083948$GLAXOSMITHKLINE$$$$$M$Y$$$20240715$$CN$US$US
240924531$24092453$1$I$$20240415$20240715$20240715$PER$$US-PERRIGO-24US003845$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924541$24092454$1$I$$20240415$20240715$20240715$PER$$US-PERRIGO-24US003852$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924551$24092455$1$I$$20240415$20240715$20240715$PER$$US-PERRIGO-24US003763$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240924561$24092456$1$I$$20240415$20240715$20240715$PER$$US-PERRIGO-24US003854$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924571$24092457$1$I$$20240415$20240715$20240715$PER$$US-PERRIGO-24US003837$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924581$24092458$1$I$$20240416$20240715$20240715$PER$$US-PERRIGO-24US003767$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240924591$24092459$1$I$$20240415$20240715$20240715$PER$$US-PERRIGO-24US003851$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924601$24092460$1$I$$20240415$20240715$20240715$PER$$US-PERRIGO-24US003836$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924611$24092461$1$I$$20240415$20240715$20240715$PER$$US-PERRIGO-24US003853$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924622$24092462$2$F$$20240726$20240715$20240729$EXP$$US-UCBSA-2024035287$UCB$$$$$M$Y$$$20240729$$CN$US$US
240924631$24092463$1$I$$20240702$20240715$20240715$EXP$$US-ASCENT-2024ASLIT00011$ASCENT$$55$YR$A$F$Y$$$20240715$$MD$US$US
240924641$24092464$1$I$$20240710$20240715$20240715$EXP$$CA-UCBSA-2024035319$UCB$$74$YR$$M$Y$$$20240715$$CN$CA$CA
240924651$24092465$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405060340208450-NZPQH$GB-RDY-SPO/GBR/24/0010103$DR REDDYS$$$$$F$Y$$$20240715$$CN$GB$GB
240924661$24092466$1$I$$20240416$20240715$20240715$PER$$US-PERRIGO-24US003879$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924671$24092467$1$I$$20240419$20240715$20240715$PER$$US-PERRIGO-24US003920$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924681$24092468$1$I$$20240702$20240715$20240715$EXP$$CH-ASCENT-2024ASLIT00010$ASCENT$Jeltsch S, et al.How to differentiate erythema multiforme major from Stevens-Johnson syndrome?.Swiss Medical Weekly.MAY-2024;154 (1):112 S$41$YR$A$M$Y$$$20240715$$HP$CH$CH
240924691$24092469$1$I$$20240423$20240715$20240715$PER$$US-PERRIGO-24US004129$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924701$24092470$1$I$$20240422$20240715$20240715$PER$$US-PERRIGO-24US004099$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924711$24092471$1$I$$20240417$20240715$20240715$PER$$US-PERRIGO-24US003919$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924721$24092472$1$I$$20240417$20240715$20240715$PER$$US-PERRIGO-24US003858$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924731$24092473$1$I$$20240417$20240715$20240715$PER$$US-PERRIGO-24US003885$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240924741$24092474$1$I$$20240419$20240715$20240715$PER$$US-PERRIGO-24US003960$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240924751$24092475$1$I$$20240423$20240715$20240715$PER$$US-PERRIGO-24US004130$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924761$24092476$1$I$$20240421$20240715$20240715$PER$$US-PERRIGO-24US003953$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240924771$24092477$1$I$$20240421$20240715$20240715$PER$$US-PERRIGO-24US004047$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924781$24092478$1$I$$20240418$20240715$20240715$PER$$US-PERRIGO-24US003942$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924791$24092479$1$I$20230601$20240425$20240715$20240715$PER$$US-PERRIGO-24US004139$PERRIGO$$44$YR$$M$Y$86.168$KG$20240715$$CN$US$US
240924801$24092480$1$I$$20240423$20240715$20240715$PER$$US-PERRIGO-24US004131$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924811$24092481$1$I$$20240422$20240715$20240715$PER$$US-PERRIGO-24US004096$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924821$24092482$1$I$$20240416$20240715$20240715$PER$$US-PERRIGO-24US003881$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924831$24092483$1$I$20240401$20240418$20240715$20240715$PER$$US-PERRIGO-24US003891$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240924841$24092484$1$I$$20240422$20240715$20240715$PER$$US-PERRIGO-24US004094$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924851$24092485$1$I$$20240620$20240715$20240715$PER$$US-INCYTE CORPORATION-2024IN006649$INCYTE$$$$$$Y$$$20240715$$HP$US$US
240924863$24092486$3$F$20240701$20240920$20240715$20240926$PER$$US-SA-2024SA204704$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240926$$MD$US$US
240924871$24092487$1$I$20240419$20240424$20240715$20240715$PER$$US-PERRIGO-24US004170$PERRIGO$$31$YR$$M$Y$68.027$KG$20240715$$CN$US$US
240924881$24092488$1$I$$20240704$20240715$20240715$EXP$GB-MHRA-MED-202405060334504350-VGMLK$GB-TEVA-VS-3218272$TEVA$$$$$M$Y$$$20240715$$CN$GB$GB
240924894$24092489$4$F$$20240710$20240715$20240716$PER$$US-SA-2024SA205921$SANOFI AVENTIS$$$$I$M$Y$$$20240716$$MD$US$US
240924901$24092490$1$I$$20240425$20240715$20240715$PER$$US-PERRIGO-24US004182$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924911$24092491$1$I$$20240709$20240715$20240715$EXP$$GB-OTSUKA-2024_019428$OTSUKA$$$$$M$Y$$$20240715$$MD$GB$GB
240924921$24092492$1$I$20230201$20240501$20240715$20240715$PER$$US-PERRIGO-24US004300$PERRIGO$$61$YR$$F$Y$72.562$KG$20240715$$CN$US$US
240924931$24092493$1$I$$20240429$20240715$20240715$PER$$US-PERRIGO-24US004307$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924941$24092494$1$I$$20240502$20240715$20240715$PER$$US-PERRIGO-24US004378$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924951$24092495$1$I$$20240429$20240715$20240715$PER$$US-PERRIGO-24US004314$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924961$24092496$1$I$$20240501$20240715$20240715$PER$$US-PERRIGO-24US004377$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240924971$24092497$1$I$$20240502$20240715$20240715$PER$$US-PERRIGO-24US004402$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240924981$24092498$1$I$$20240426$20240715$20240715$PER$$US-PERRIGO-24US004193$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240924991$24092499$1$I$$20240427$20240715$20240715$PER$$US-PERRIGO-24US004184$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925001$24092500$1$I$$20240424$20240715$20240715$PER$$US-PERRIGO-24US004180$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925011$24092501$1$I$$20240423$20240715$20240715$PER$$US-PERRIGO-24US004172$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925021$24092502$1$I$20240401$20240430$20240715$20240715$PER$$US-PERRIGO-24US004274$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240925031$24092503$1$I$$20240501$20240715$20240715$PER$$US-PERRIGO-24US004375$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925041$24092504$1$I$$20240430$20240715$20240715$PER$$US-PERRIGO-24US004335$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925051$24092505$1$I$20240403$20240503$20240715$20240715$PER$$US-PERRIGO-24US004408$PERRIGO$$32$YR$$M$Y$63.492$KG$20240715$$CN$US$US
240925061$24092506$1$I$$20240424$20240715$20240715$PER$$US-PERRIGO-24US004181$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925071$24092507$1$I$$20240429$20240715$20240715$PER$$US-PERRIGO-24US004315$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925081$24092508$1$I$$20240428$20240715$20240715$PER$$US-PERRIGO-24US004257$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925092$24092509$2$F$$20240821$20240715$20240827$EXP$$JP-ARGENX-2024-ARGX-JP005230$ARGENX BVBA$$$$$$Y$$$20240827$$MD$JP$JP
240925102$24092510$2$F$$20240827$20240715$20240901$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001383$BLUEPRINT MEDICINES$$$$$M$Y$$$20240902$$CN$US$US
240925112$24092511$2$F$20240701$20240729$20240715$20240805$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001393$BLUEPRINT MEDICINES$$69$YR$E$F$Y$$$20240805$$CN$US$US
240925121$24092512$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091225221480-CZWPG$GB-TEVA-VS-3217878$TEVA$$$$$M$Y$$$20240715$$PH$GB$GB
240925141$24092514$1$I$20240326$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48822$$FDA-CTU$$67$YR$$F$N$64.86$KG$20240712$N$HP$US$
240925151$24092515$1$I$$20240709$20240715$20240715$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001387$BLUEPRINT MEDICINES$$$$$M$Y$$$20240715$$CN$US$US
240925161$24092516$1$I$$20240507$20240715$20240715$PER$$US-PERRIGO-24US004549$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925171$24092517$1$I$20240401$20240514$20240715$20240715$PER$$US-PERRIGO-24US004726$PERRIGO$$37$YR$$M$Y$82.54$KG$20240715$$CN$US$US
240925181$24092518$1$I$$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48745$$FDA-CTU$$$$$F$N$$$20240712$N$HP$US$
240925191$24092519$1$I$$20240507$20240715$20240715$PER$$US-PERRIGO-24US004529$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925201$24092520$1$I$$20240507$20240715$20240715$PER$$US-PERRIGO-24US004544$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925211$24092521$1$I$$20240510$20240715$20240715$PER$$US-PERRIGO-24US004644$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240925221$24092522$1$I$20240101$20240508$20240715$20240715$PER$$US-PERRIGO-24US004507$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240925231$24092523$1$I$$20240507$20240715$20240715$PER$$US-PERRIGO-24US004550$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925241$24092524$1$I$$20240510$20240715$20240715$PER$$US-PERRIGO-24US004735$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925251$24092525$1$I$$20240507$20240715$20240715$PER$$US-PERRIGO-24US004551$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925271$24092527$1$I$20240624$20240712$20240712$20240712$DIR$FDA-CDER-CTU-2024-48839$$FDA-CTU$$83$YR$$M$N$117.93$KG$20240712$N$CN$US$
240925291$24092529$1$I$$20240506$20240715$20240715$PER$$US-PERRIGO-24US004490$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925301$24092530$1$I$$20240509$20240715$20240715$PER$$US-PERRIGO-24US004604$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925311$24092531$1$I$$20240508$20240715$20240715$PER$$US-PERRIGO-24US004601$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925321$24092532$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007573$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240715$$CN$US$US
240925331$24092533$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008004$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240715$$CN$US$US
240925341$24092534$1$I$20240503$20240711$20240715$20240715$EXP$$FR-ANIPHARMA-2024-FR-000108$ANI$$61$YR$$F$Y$$$20240715$$MD$FR$FR
240925351$24092535$1$I$20230313$20240711$20240715$20240715$EXP$FR-AFSSAPS-RN2023000337$FR-PFIZER INC-2023SGN03867$PFIZER$$17$YR$$M$Y$$$20240715$$MD$FR$FR
240925371$24092537$1$I$$20240515$20240715$20240715$PER$$US-PERRIGO-24US004794$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240925381$24092538$1$I$$20240514$20240715$20240715$PER$$US-PERRIGO-24US004827$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925391$24092539$1$I$$20240515$20240715$20240715$PER$$US-PERRIGO-24US004860$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925401$24092540$1$I$$20240513$20240715$20240715$PER$$US-PERRIGO-24US004795$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925421$24092542$1$I$$20240515$20240715$20240715$PER$$US-PERRIGO-24US004853$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925431$24092543$1$I$$20240513$20240715$20240715$PER$$US-PERRIGO-24US004785$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925441$24092544$1$I$$20240513$20240715$20240715$PER$$US-PERRIGO-24US004797$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925451$24092545$1$I$$20240515$20240715$20240715$PER$$US-PERRIGO-24US004850$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925461$24092546$1$I$20230101$20240516$20240715$20240715$PER$$US-PERRIGO-24US004820$PERRIGO$$$$$F$Y$72.562$KG$20240715$$CN$US$US
240925471$24092547$1$I$20240710$20240711$20240715$20240715$PER$$US-ROCHE-10000025797$ROCHE$$11$YR$C$M$Y$$$20240715$$CN$US$US
240925481$24092548$1$I$$20240512$20240715$20240715$PER$$US-PERRIGO-24US004740$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925491$24092549$1$I$20240201$20240708$20240715$20240715$PER$$US-MYLANLABS-2024M1064276$MYLAN$$44$YR$$F$Y$$$20240715$$CN$US$US
240925501$24092550$1$I$20240701$20240712$20240715$20240715$PER$$US-ROCHE-10000026250$ROCHE$$42$YR$A$M$Y$$$20240715$$CN$US$US
240925515$24092551$5$F$20240707$20240719$20240715$20240724$EXP$$CA-ROCHE-10000025128$ROCHE$$54$YR$A$F$Y$$$20240724$$HP$CA$CA
240925521$24092552$1$I$$20240709$20240715$20240715$PER$$US-ABBVIE-5834798$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240925532$24092553$2$F$$20240909$20240715$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111094$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240916$$CN$US$US
240925541$24092554$1$I$20240425$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091255457530-RQMFK$GB-TEVA-VS-3218314$TEVA$$20$YR$$F$Y$$$20240715$$HP$GB$GB
240925551$24092555$1$I$20240101$20240703$20240715$20240715$EXP$$PY-BIOMARINAP-PY-2024-159168$BIOMARIN$$$$$$Y$$$20240715$$MD$PY$PY
240925561$24092556$1$I$$20240521$20240715$20240715$PER$$US-PERRIGO-24US005088$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925571$24092557$1$I$$20240521$20240715$20240715$PER$$US-PERRIGO-24US005078$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925581$24092558$1$I$$20240517$20240715$20240715$PER$$US-PERRIGO-24US004923$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925591$24092559$1$I$$20240518$20240715$20240715$PER$$US-PERRIGO-24US004929$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925601$24092560$1$I$$20240522$20240715$20240715$PER$$US-PERRIGO-24US005080$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925611$24092561$1$I$$20240524$20240715$20240715$PER$$US-PERRIGO-24US005116$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925621$24092562$1$I$$20240521$20240715$20240715$PER$$US-PERRIGO-24US005025$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925631$24092563$1$I$$20240528$20240715$20240715$PER$$US-PERRIGO-24US005191$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240925641$24092564$1$I$$20240521$20240715$20240715$PER$$US-PERRIGO-24US005085$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925651$24092565$1$I$$20240515$20240715$20240715$PER$$US-PERRIGO-24US004888$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925661$24092566$1$I$20221101$20240523$20240715$20240715$PER$$US-PERRIGO-24US005090$PERRIGO$$24$YR$$F$Y$61.224$KG$20240715$$CN$US$US
240925671$24092567$1$I$20240419$20240524$20240715$20240715$PER$$US-PERRIGO-24US005153$PERRIGO$$42$YR$$M$Y$85.261$KG$20240715$$CN$US$US
240925681$24092568$1$I$$20240521$20240715$20240715$PER$$US-PERRIGO-24US005082$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925691$24092569$1$I$$20240521$20240715$20240715$PER$$US-PERRIGO-24US005087$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925701$24092570$1$I$$20240521$20240715$20240715$PER$$US-PERRIGO-24US005062$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925711$24092571$1$I$$20240517$20240715$20240715$PER$$US-PERRIGO-24US005029$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925721$24092572$1$I$$20240524$20240715$20240715$PER$$US-PERRIGO-24US005140$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925731$24092573$1$I$$20240522$20240715$20240715$PER$$US-PERRIGO-24US005079$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925741$24092574$1$I$$20240523$20240715$20240715$PER$$US-PERRIGO-24US005148$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925751$24092575$1$I$$20240527$20240715$20240715$PER$$US-PERRIGO-24US005210$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925761$24092576$1$I$$20240530$20240715$20240715$PER$$US-PERRIGO-24US005321$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925771$24092577$1$I$$20240702$20240715$20240715$EXP$$US-PRAXGEN-2024PPLIT00039$PRAXGEN PHARMACEUTICALS$Braat J, et al..Atypical Presentation of Central Serous Chorioretinopathy (CSCR) After Lung Transplantation.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$7$DEC$$F$Y$$$20240715$$HP$US$US
240925781$24092578$1$I$$20240702$20240715$20240715$EXP$$PK-GENEYORK-2024PPLIT00040$GENEYORK PHARMA$Ahmed R, et al..Lung Hernia: An Uncommon Presentation After Chronic Obstructive Pulmonary Disease.American Journal of Respiratory and Critical Care Medicine.may-2024;209 (9):A5820$61$YR$E$F$Y$$$20240715$$HP$PK$PK
240925791$24092579$1$I$$20240529$20240715$20240715$PER$$US-PERRIGO-24US005309$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925801$24092580$1$I$$20240528$20240715$20240715$PER$$US-PERRIGO-24US005272$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925811$24092581$1$I$$20240603$20240715$20240715$PER$$US-PERRIGO-24US005491$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925821$24092582$1$I$$20240529$20240715$20240715$PER$$US-PERRIGO-24US005317$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925831$24092583$1$I$20240501$20240531$20240715$20240715$PER$$US-PERRIGO-24US005342$PERRIGO$$$$A$$Y$$$20240715$$CN$US$US
240925841$24092584$1$I$$20240528$20240715$20240715$PER$$US-PERRIGO-24US005277$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925851$24092585$1$I$$20240528$20240715$20240715$PER$$US-PERRIGO-24US005289$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925861$24092586$1$I$20220101$20240606$20240715$20240715$PER$$US-PERRIGO-24US005480$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240925873$24092587$3$F$20240707$20240902$20240715$20240910$EXP$$NVSC2024CZ143684$NOVARTIS$$$$N$M$Y$$$20240910$$MD$CZ$CZ
240925881$24092588$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145147$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240925892$24092589$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3218402$TEVA$Jones AC, Tillman F3rd, Kahlon C, Seys R, Pepin M. Characterizing acute and postsurgical pain management in patients receiving buprenorphine or buprenorphine/naloxone. J-Am-Pharm-Assoc 2024; 64 (3):.; Jones AC, Tillman F3rd, Kahlon C, Seys R, Pepin M. Characterizing acute and postsurgical pain management in patients receiving buprenorphine or buprenorphine/naloxone. J-Am-Pharm-Assoc 2024; 64 (3):.$$$A$$Y$$$20240802$$PH$US$US
240925901$24092590$1$I$20240302$20240709$20240715$20240715$EXP$$CA-ROCHE-10000026008$ROCHE$$45$YR$A$M$Y$$$20240715$$HP$CA$CA
240925911$24092591$1$I$$20240712$20240715$20240715$PER$$US-ROCHE-10000025909$ROCHE$$$$A$F$Y$$$20240715$$HP$US$US
240925925$24092592$5$F$$20240815$20240715$20240819$PER$$US-ROCHE-10000026265$ROCHE$$$$C$F$Y$$$20240819$$HP$US$US
240925931$24092593$1$I$$20240610$20240715$20240715$PER$$US-PERRIGO-24US005699$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925941$24092594$1$I$$20240610$20240715$20240715$PER$$US-PERRIGO-24US005695$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925951$24092595$1$I$$20240604$20240715$20240715$PER$$US-PERRIGO-24US005511$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925961$24092596$1$I$20230401$20240611$20240715$20240715$PER$$US-PERRIGO-24US005708$PERRIGO$$53$YR$$M$Y$77.098$KG$20240715$$CN$US$US
240925971$24092597$1$I$$20240611$20240715$20240715$PER$$US-PERRIGO-24US005722$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925981$24092598$1$I$$20240610$20240715$20240715$PER$$US-PERRIGO-24US005693$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240925991$24092599$1$I$$20240605$20240715$20240715$PER$$US-PERRIGO-24US005590$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926001$24092600$1$I$$20240603$20240715$20240715$PER$$US-PERRIGO-24US005492$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926011$24092601$1$I$$20240605$20240715$20240715$PER$$US-PERRIGO-24US005591$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926021$24092602$1$I$$20240610$20240715$20240715$PER$$US-PERRIGO-24US005697$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926031$24092603$1$I$$20240606$20240715$20240715$PER$$US-PERRIGO-24US005592$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926041$24092604$1$I$$20240605$20240715$20240715$PER$$US-PERRIGO-24US005568$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926051$24092605$1$I$$20240604$20240715$20240715$PER$$US-PERRIGO-24US005520$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926061$24092606$1$I$$20240603$20240715$20240715$PER$$US-PERRIGO-24US005493$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926071$24092607$1$I$$20240608$20240715$20240715$PER$$US-PERRIGO-24US005573$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926081$24092608$1$I$$20240607$20240715$20240715$PER$$US-PERRIGO-24US005572$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926091$24092609$1$I$$20240604$20240715$20240715$PER$$US-PERRIGO-24US005550$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926101$24092610$1$I$$20240610$20240715$20240715$PER$$US-PERRIGO-24US005691$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926111$24092611$1$I$$20240610$20240715$20240715$PER$$US-PERRIGO-24US005696$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926121$24092612$1$I$20240101$20240603$20240715$20240715$PER$$US-PERRIGO-24US005787$PERRIGO$$$$$F$Y$$$20240715$$CN$US$US
240926131$24092613$1$I$$20240612$20240715$20240715$PER$$US-PERRIGO-24US005781$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926141$24092614$1$I$$20240611$20240715$20240715$PER$$US-PERRIGO-24US005739$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926151$24092615$1$I$$20240611$20240715$20240715$PER$$US-PERRIGO-24US005738$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926161$24092616$1$I$$20240611$20240715$20240715$PER$$US-PERRIGO-24US005735$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926171$24092617$1$I$20240610$20240612$20240715$20240715$PER$$US-PERRIGO-24US005723$PERRIGO$$60$YR$$M$Y$170$KG$20240715$$CN$US$US
240926181$24092618$1$I$$20240710$20240715$20240715$EXP$$US-SA-2024SA205615$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240715$$MD$US$US
240926191$24092619$1$I$$20240611$20240715$20240715$PER$$US-PERRIGO-24US005737$PERRIGO$$$$$M$Y$$$20240715$$CN$US$US
240926202$24092620$2$F$20240802$20240808$20240715$20240815$EXP$$US-SA-2024SA205944$SANOFI AVENTIS$$71$YR$E$F$Y$47.619$KG$20240815$$MD$US$US
240926211$24092621$1$I$$20240712$20240715$20240715$EXP$$CA-PFIZER INC-PV202400092463$PFIZER$$31$YR$$$Y$$$20240715$$HP$CA$CA
240926221$24092622$1$I$$20240715$20240715$20240715$EXP$$CA-ORGANON-O2407CAN001238$ORGANON$$68$YR$$F$Y$$$20240715$$PH$CA$CA
240926231$24092623$1$I$20200131$20240711$20240715$20240715$EXP$FR-AFSSAPS-LL20200416$FR-PFIZER INC-2020SGN01642$PFIZER$$64$YR$$M$Y$$$20240715$$PH$FR$FR
240926241$24092624$1$I$$20240620$20240715$20240715$PER$$US-INCYTE CORPORATION-2024IN006647$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240926251$24092625$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48748$$FDA-CTU$$69$YR$$F$N$$$20240715$N$$US$
240926261$24092626$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48750$$FDA-CTU$$75$YR$$F$N$201$LBS$20240715$N$$US$
240926281$24092628$1$I$$20240713$20240715$20240715$DIR$FDA-CDER-CTU-2024-48747$$FDA-CTU$$$$$M$N$$$20240713$N$HP$US$
240926312$24092631$2$F$$20240828$20240715$20240829$PER$$NVSC2024US145453$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
240926322$24092632$2$F$20240630$20240718$20240715$20240724$EXP$$NVSC2024RU143757$NOVARTIS$$70$YR$$M$Y$$$20240724$$MD$RU$RU
240926332$24092633$2$F$20240528$20240705$20240715$20240717$EXP$$CN-009507513-2407CHN004061$MERCK$$67$YR$$M$Y$65$KG$20240717$$HP$CN$CN
240926341$24092634$1$I$$20240705$20240715$20240715$PER$$US-TEVA-VS-3219544$TEVA$$$$$F$Y$$$20240715$$CN$US$US
240926351$24092635$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202406261659083070-WNLCP$GB-TEVA-VS-3218622$TEVA$$$$$M$Y$$$20240715$$PH$GB$GB
240926361$24092636$1$I$$20240620$20240715$20240715$PER$$US-INCYTE CORPORATION-2024IN006645$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240926371$24092637$1$I$$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160539$ASTRAZENECA$$61$YR$$M$Y$$$20240715$$HP$FR$
240926381$24092638$1$I$$20240620$20240715$20240715$PER$$US-INCYTE CORPORATION-2024IN006643$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240926391$24092639$1$I$$20240705$20240715$20240715$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02441$AMNEAL$$$$$F$Y$$$20240715$$HP$US$US
240926402$24092640$2$F$20240701$20240711$20240715$20240724$EXP$$US-TEVA-VS-3219689$TEVA$$75$YR$$M$Y$$$20240724$$CN$US$US
240926411$24092641$1$I$$20240614$20240715$20240715$PER$$US-ROCHE-10000003644$ROCHE$$$$A$F$Y$$$20240715$$CN$US$US
240926421$24092642$1$I$20220220$20240712$20240715$20240715$EXP$$US-TAKEDA-2022TUS013945$TAKEDA$$53$YR$$M$Y$$$20240715$$CN$US$US
240926431$24092643$1$I$20240101$20240710$20240715$20240715$EXP$$US-SA-2024SA204449$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240715$$MD$US$US
240926441$24092644$1$I$$20240710$20240715$20240715$EXP$$JP-ABBVIE-5839712$ABBVIE$$57$YR$$M$Y$$$20240715$$MD$JP$JP
240926451$24092645$1$I$20190605$20240709$20240715$20240715$PER$$US-009507513-2407USA005756$MERCK$Charles AJ, Smith VL, Goodwin CR, Johnson MO. An adult with recurrent atypical teratoid rhabdoid tumor of the spine. CNS Oncology. 2024;13 (1)$50$YR$$M$Y$$$20240715$$HP$US$US
240926461$24092646$1$I$$20240703$20240715$20240715$PER$$US-IMP-2024000462$Harrow Health$$$$E$F$Y$$$20240715$$CN$US$US
240926471$24092647$1$I$$20240711$20240715$20240715$EXP$$CA-AstraZeneca-2024A160145$ASTRAZENECA$$50$YR$$F$Y$68$KG$20240715$$MD$CA$
240926483$24092648$3$F$$20240903$20240715$20240916$PER$$US-INCYTE CORPORATION-2024IN006641$INCYTE$$$$$$Y$$$20240916$$CN$US$US
240926492$24092649$2$F$20240101$20240818$20240715$20240827$PER$$US-SA-2024SA203635$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240827$$MD$US$US
240926501$24092650$1$I$$20240620$20240715$20240715$PER$$US-INCYTE CORPORATION-2024IN006637$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240926511$24092651$1$I$$20240711$20240715$20240715$EXP$$US-MYLANLABS-2024M1065640$MYLAN$$$$$F$Y$$$20240715$$CN$US$US
240926521$24092652$1$I$$20240712$20240715$20240715$PER$$US-JNJFOC-20240734695$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$HP$US$US
240926531$24092653$1$I$20240710$20240711$20240715$20240715$PER$$US-JNJFOC-20240730822$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240715$$CN$US$US
240926541$24092654$1$I$$20240711$20240715$20240715$EXP$$BR-JNJFOC-20240734389$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$MD$BR$BR
240926551$24092655$1$I$20240630$20240710$20240715$20240715$EXP$$US-BAYER-2024A100186$BAYER$$59$YR$A$F$Y$$$20240715$$CN$US$US
240926561$24092656$1$I$20240404$20240712$20240715$20240715$EXP$GB-MHRA-MED-202405031412135180-KYPGB$GB-ASTELLAS-2024US019892$ASTELLAS$$63$YR$$F$Y$$$20240715$$CN$GB$GB
240926571$24092657$1$I$20180730$20240711$20240715$20240715$EXP$FR-AFSSAPS-AM20181484$FR-PFIZER INC-2018SGN02865$PFIZER$$67$YR$$M$Y$104$KG$20240715$$MD$FR$FR
240926581$24092658$1$I$20180821$20240711$20240715$20240715$EXP$FR-AFSSAPS-AM20181485$FR-PFIZER INC-2018SGN02834$PFIZER$$68$YR$$M$Y$98$KG$20240715$$MD$FR$FR
240926601$24092660$1$I$$20240619$20240715$20240715$PER$$US-INCYTE CORPORATION-2024IN006581$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240926611$24092661$1$I$20210828$20240711$20240715$20240715$EXP$$CN-PFIZER INC-PV202400091452$PFIZER$$69$YR$$M$Y$50$KG$20240715$$HP$CN$CN
240926622$24092662$2$F$20240101$20240712$20240715$20240719$EXP$FR-AFSSAPS-GR2024000849$FR-OTSUKA-2024_019223$OTSUKA$$18$YR$$F$Y$$$20240719$$MD$FR$FR
240926631$24092663$1$I$$20240711$20240715$20240715$EXP$$NVSC2024CN006165$NOVARTIS$$50$YR$$M$Y$$$20240715$$CN$CN$CN
240926642$24092664$2$F$$20240712$20240715$20240718$EXP$$NVSC2024MW145138$NOVARTIS$$$$$M$Y$$$20240718$$MD$MW$MW
240926651$24092665$1$I$20240628$20240703$20240715$20240715$PER$$US-IMP-2024000463$Harrow Health$$77$YR$E$F$Y$$$20240715$$CN$US$US
240926661$24092666$1$I$20240101$20240708$20240715$20240715$PER$$US-SA-2024SA204216$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240715$$MD$US$US
240926671$24092667$1$I$20240101$20240706$20240715$20240715$PER$$US-SA-2024SA174376$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240715$$MD$US$US
240926681$24092668$1$I$$20240708$20240715$20240715$PER$$US-MYLANLABS-2024M1064397$MYLAN$$$$$F$Y$$$20240715$$CN$US$US
240926691$24092669$1$I$$20240618$20240715$20240715$30DAY$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00312$XERIS PHARMACEUTICALS$$$$$F$Y$70.307$KG$20240712$$CN$US$US
240926701$24092670$1$I$20240702$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139802$AMGEN$$79$YR$E$F$Y$$$20240715$$CN$US$US
240926711$24092671$1$I$$20240710$20240715$20240715$PER$$PR-JNJFOC-20240726385$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$MD$PR$PR
240926721$24092672$1$I$$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003761$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240926731$24092673$1$I$20180804$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003786$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240926741$24092674$1$I$20180831$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003787$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240926751$24092675$1$I$$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003797$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240926761$24092676$1$I$20220722$20220729$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2022M1083186$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240926771$24092677$1$I$20220928$20220928$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2022M1110764$BIOCON$$27$YR$$M$Y$54.43$KG$20240715$$$US$US
240926781$24092678$1$I$$20230725$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1079931$BIOCON$$$$$F$Y$$$20240715$$HP$US$US
240926791$24092679$1$I$$20240711$20240715$20240715$PER$$US-ABBVIE-5837920$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240926801$24092680$1$I$$20240715$20240715$20240715$EXP$$CA-ORGANON-O2407CAN001259$ORGANON$$36$YR$$F$Y$99.79$KG$20240715$$MD$CA$CA
240926811$24092681$1$I$$20240607$20240715$20240715$PER$$US-INCYTE CORPORATION-2024IN006151$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240926831$24092683$1$I$20200820$20240521$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003751$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240926841$24092684$1$I$20240513$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405140254114100-JSHRC$GB-TEVA-VS-3218319$TEVA$$41$YR$$F$Y$103$KG$20240715$$CN$GB$GB
240926851$24092685$1$I$$20240503$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000953$BIOCON$$$$$$Y$$$20240715$$HP$US$US
240926861$24092686$1$I$$20240219$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001131$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240926871$24092687$1$I$20231030$20231030$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1116135$BIOCON$$$$$$Y$$$20240715$$PH$US$US
240926881$24092688$1$I$$20231207$20240715$20240715$PER$$US-ANVISA-BBL2023001158$BIOCON$$$$$$Y$$$20240715$$MD$US$US
240926891$24092689$1$I$20240131$20240201$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000741$BIOCON$$$$$$Y$$$20240715$$CN$US$US
240926901$24092690$1$I$$20240320$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001893$BIOCON$$$$$$Y$$$20240715$$CN$US$US
240926911$24092691$1$I$$20240412$20240715$20240715$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002569$BIOCON$$$$$$Y$$$20240715$$CN$US$US
240926921$24092692$1$I$$20240708$20240715$20240715$PER$$US-BIOGEN-2019BI00808976$BIOGEN$$$$$M$Y$$$20240715$$CN$US$US
240926931$24092693$1$I$$20240527$20240715$20240715$PER$$US-PERRIGO-24US005235$PERRIGO$$$$A$$Y$$$20240715$$$US$US
240926941$24092694$1$I$$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024137500$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240926951$24092695$1$I$$20240714$20240715$20240715$DIR$FDA-CDER-CTU-2024-48769$$FDA-CTU$$$$$F$N$$$20240714$N$HP$US$
240926961$24092696$1$I$20240101$20240715$20240715$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039807$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240715$$CN$US$US
240926971$24092697$1$I$$20240708$20240715$20240715$EXP$$EG-SANDOZ INC.-SDZ2024EG060863$SANDOZ$$$$$F$Y$$$20240715$$CN$EG$EG
240926981$24092698$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48761$$FDA-CTU$$$$$M$N$$$20240715$N$HP$US$
240926991$24092699$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48757$$FDA-CTU$$96$YR$$M$N$$$20240715$N$$US$
240927001$24092700$1$I$20240710$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48760$$FDA-CTU$$56$YR$$F$N$$$20240712$N$PH$US$
240927011$24092701$1$I$20240705$20240708$20240715$20240715$EXP$$AR-TAKEDA-2024TUS070713$TAKEDA$$15$YR$$M$Y$$$20240715$$CN$AR$AR
240927021$24092702$1$I$20240706$20240708$20240715$20240715$PER$$US-BAYER-2024A098724$BAYER$$68$YR$E$M$Y$$$20240715$$CN$US$US
240927032$24092703$2$F$20240404$20240723$20240715$20240729$EXP$$US-ABBVIE-5831965$ABBVIE$$66$YR$$M$Y$117.9$KG$20240729$$CN$US$US
240927041$24092704$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007838$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240715$$CN$US$US
240927052$24092705$2$F$$20240712$20240715$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008320$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$US$US
240927061$24092706$1$I$$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008632$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240715$$CN$US$US
240927071$24092707$1$I$$20240710$20240715$20240715$PER$$US-JNJFOC-20240729102$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$MD$US$US
240927091$24092709$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48766$$FDA-CTU$$42$YR$$F$N$263$LBS$20240715$N$$US$
240927151$24092715$1$I$$20240709$20240715$20240715$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR086359$VIIV$$$$$M$Y$$$20240715$$PH$US$US
240927161$24092716$1$I$20231113$20240705$20240715$20240715$EXP$IT-MINISAL02-957233$IT-TEVA-VS-3154797$TEVA$$12$YR$$M$Y$57$KG$20240715$$PH$IT$IT
240927171$24092717$1$I$$20240709$20240715$20240715$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038916$BOEHRINGER INGELHEIM$Makihara Kan, Minamoto Toshiko, Nakagawa Kyoko, Haraga Hikaru, Nonomura Yuki, Okada Hiroe, Ishikawa Masako, Oride Aki, Kanasaki Haruhiko, Kyo Satoru ; A case of pregnancy complicated by scleroderma with marked renal failure after childbirth;Journal of Japan Society of Perinatal and Neonatal Medicine; 2024.6.22;60;S1;303$0$YR$N$M$Y$2.34$KG$20240715$$MD$JP$JP
240927181$24092718$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48778$$FDA-CTU$$77$YR$$F$N$250$LBS$20240715$N$$US$
240927191$24092719$1$I$$20240710$20240715$20240715$EXP$$US-BAUSCH-BL-2024-005562$BAUSCH AND LOMB$$90$YR$$M$Y$$$20240715$$MD$US$US
240927201$24092720$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145482$NOVARTIS$$$$$$Y$$$20240715$$CN$US$US
240927211$24092721$1$I$$20240703$20240715$20240715$EXP$$TN-SCIEGENP-2024SCLIT00327$SCIEGEN$Ben Hammamia S, et al..Neurotoxicity Related to Multidrug Association: A Case Report.Journal of Clinical Psychopharmacology.JUN-2024;44 (3):317-19$57$YR$A$F$Y$$$20240715$$MD$TN$TN
240927221$24092722$1$I$20240704$20240708$20240715$20240715$EXP$$US-SA-2024SA204290$SANOFI AVENTIS$$80$YR$E$M$Y$90.265$KG$20240715$$MD$US$US
240927231$24092723$1$I$20240704$20240713$20240715$20240715$EXP$$NVSC2024CN145304$NOVARTIS$$54$YR$$M$Y$77$KG$20240715$$HP$CN$CN
240927241$24092724$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48780$$FDA-CTU$$60$YR$$F$N$219$LBS$20240715$N$HP$US$
240927251$24092725$1$I$$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48782$$FDA-CTU$$$$$F$N$$$20240712$N$HP$US$
240927261$24092726$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48838$$FDA-CTU$$74$YR$$M$N$$$20240715$N$$US$
240927271$24092727$1$I$$20240703$20240715$20240715$EXP$$US-SCIEGENP-2024SCLIT00328$SCIEGEN$Wang Q, et al.Atypical Presentation of Pulmonary-Renal Syndrome (PRS) Caused by Hydralazine-induced Antineutrophil Cytoplasmic Antibody Vasculitis/Lupus Overlap: A Case Report.American Journal of Respiratory and Critical Care Medicine.may-2024;209$74$YR$E$F$Y$$$20240715$$HP$US$US
240927281$24092728$1$I$20230220$20240710$20240715$20240715$EXP$FR-AFSSAPS-PC2024000519$FR-009507513-2407FRA004690$MERCK$$59$YR$$M$Y$64$KG$20240715$$MD$FR$FR
240927291$24092729$1$I$$20240703$20240715$20240715$EXP$$US-SCIEGENP-2024SCLIT00329$SCIEGEN$Peters JD, et al.A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209 (1):A2021$85$YR$E$F$Y$$$20240715$$HP$US$US
240927301$24092730$1$I$$20240712$20240715$20240715$EXP$GB-MHRA-MED-202407121609474360-QJFYN$GB-ORGANON-O2407GBR001227$ORGANON$$45$YR$$F$Y$$$20240715$$CN$GB$GB
240927311$24092731$1$I$$20240702$20240715$20240715$EXP$$US-LGM Pharma Solutions, LLC-2159123$LGM PHARMA$$57$YR$$M$Y$$$20240715$$$US$US
240927322$24092732$2$F$20240201$20240715$20240715$20240723$PER$$US-MYLANLABS-2024M1064676$MYLAN$$19$YR$$F$Y$$$20240723$$CN$US$US
240927331$24092733$1$I$20240625$20240709$20240715$20240715$PER$$US-MYLANLABS-2024M1064787$MYLAN$$21$YR$$F$Y$54.43$KG$20240715$$CN$US$US
240927342$24092734$2$F$$20240716$20240715$20240718$PER$$US-PFIZER INC-202400212667$PFIZER$$79$YR$$F$Y$$$20240718$$HP$US$US
240927351$24092735$1$I$$20240708$20240715$20240715$EXP$$CA-FERRINGPH-2024FE03760$FERRING$$$$$$Y$$$20240715$$HP$CA$CA
240927361$24092736$1$I$$20240710$20240715$20240715$PER$$US-PFIZER INC-PV202400091641$PFIZER$$$$$$Y$$$20240715$$HP$US$US
240927371$24092737$1$I$$20240710$20240715$20240715$PER$$US-PFIZER INC-202400211821$PFIZER$$$$$M$Y$$$20240715$$CN$US$US
240927381$24092738$1$I$$20240712$20240715$20240715$PER$$US-PFIZER INC-202400213941$PFIZER$$$$$F$Y$$$20240715$$CN$US$US
240927391$24092739$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-202400213306$PFIZER$$22$YR$$M$Y$$$20240715$$CN$US$US
240927401$24092740$1$I$20240101$20240710$20240715$20240715$PER$$US-PFIZER INC-202400211335$PFIZER$$$$A$F$Y$$$20240715$$HP$US$US
240927412$24092741$2$F$$20240717$20240715$20240717$PER$$US-PFIZER INC-202400212209$PFIZER$$31$YR$$F$Y$$$20240717$$HP$US$US
240927421$24092742$1$I$$20240710$20240715$20240715$PER$$US-PFIZER INC-202400212208$PFIZER$$74$YR$$F$Y$$$20240715$$MD$US$US
240927431$24092743$1$I$$20240712$20240715$20240715$PER$$US-PFIZER INC-202400214413$PFIZER$$14$YR$$F$Y$$$20240715$$CN$US$US
240927441$24092744$1$I$20240201$20240704$20240715$20240715$EXP$FR-AFSSAPS-DJ2024000813$FR-FERRINGPH-2024FE03666$FERRING$$$$$$Y$$$20240715$$MD$FR$FR
240927451$24092745$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-202400212505$PFIZER$$62$YR$$F$Y$58.97$KG$20240715$$CN$US$US
240927461$24092746$1$I$20240710$20240713$20240715$20240715$PER$$US-PFIZER INC-202400214021$PFIZER$$45$YR$$F$Y$$$20240715$$CN$US$US
240927471$24092747$1$I$$20240709$20240715$20240715$PER$$US-PFIZER INC-202400211274$PFIZER$$51$YR$$M$Y$$$20240715$$HP$US$US
240927481$24092748$1$I$$20240712$20240715$20240715$PER$$US-PFIZER INC-202400213917$PFIZER$$53$YR$$F$Y$$$20240715$$PH$US$US
240927491$24092749$1$I$$20240712$20240715$20240715$PER$$US-PFIZER INC-PV202300143364$PFIZER$$65$YR$$F$Y$$$20240715$$HP$US$US
240927501$24092750$1$I$20240501$20240711$20240715$20240715$PER$$US-PFIZER INC-202400213556$PFIZER$$90$YR$$F$Y$$$20240715$$HP$US$US
240927511$24092751$1$I$20240531$20240712$20240715$20240715$PER$$US-PFIZER INC-202400192286$PFIZER$$72$YR$$F$Y$$$20240715$$CN$US$US
240927521$24092752$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-202400213296$PFIZER$$14$YR$$F$Y$$$20240715$$HP$US$US
240927531$24092753$1$I$$20240709$20240715$20240715$EXP$$CN-FERRINGPH-2024FE03812$FERRING$$$$$$Y$$$20240715$$CN$CN$CN
240927542$24092754$2$F$20240701$20240715$20240715$20240717$PER$$US-PFIZER INC-202400212404$PFIZER$$$$$F$Y$$$20240717$$MD$US$US
240927552$24092755$2$F$$20240712$20240715$20240717$PER$$US-PFIZER INC-202400211215$PFIZER$$28$YR$$M$Y$$$20240717$$HP$US$US
240927562$24092756$2$F$$20240815$20240715$20240819$PER$$US-PFIZER INC-PV202400091574$PFIZER$$74$YR$$F$Y$$$20240819$$HP$US$US
240927573$24092757$3$F$$20240816$20240715$20240816$PER$$US-PFIZER INC-PV202400090870$PFIZER$$$$$$Y$$$20240816$$MD$US$US
240927581$24092758$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-202400213860$PFIZER$$$$$F$Y$$$20240715$$MD$US$US
240927595$24092759$5$F$20240101$20240906$20240715$20240910$PER$$US-PFIZER INC-PV202400092115$PFIZER$$59$YR$$F$Y$$$20240910$$HP$US$US
240927603$24092760$3$F$20240714$20240814$20240715$20240816$PER$$US-PFIZER INC-202400214007$PFIZER$$69$YR$$F$Y$68.934$KG$20240816$$CN$US$US
240927611$24092761$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-202400213535$PFIZER$$63$YR$$M$Y$$$20240715$$MD$US$US
240927621$24092762$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400088629$PFIZER$$69$YR$$F$Y$$$20240715$$CN$US$US
240927633$24092763$3$F$$20240816$20240715$20240816$PER$$US-PFIZER INC-PV202400089814$PFIZER$$57$YR$$$Y$$$20240816$$CN$US$US
240927642$24092764$2$F$$20240716$20240715$20240718$PER$$US-PFIZER INC-202400213842$PFIZER$$47$YR$$F$Y$$$20240718$$HP$US$US
240927651$24092765$1$I$$20240712$20240715$20240715$PER$$US-PFIZER INC-202400213633$PFIZER$$$$$M$Y$$$20240715$$MD$US$US
240927661$24092766$1$I$20240423$20240708$20240715$20240715$EXP$FR-AFSSAPS-CF2024000244$FR-FERRINGPH-2024FE03730$FERRING$$$$$$Y$$$20240715$$MD$FR$FR
240927673$24092767$3$F$$20240722$20240715$20240723$PER$$US-PFIZER INC-PV202400092068$PFIZER$$64$YR$$F$Y$$$20240723$$HP$US$US
240927681$24092768$1$I$$20240710$20240715$20240715$PER$$US-PFIZER INC-PV202400091552$PFIZER$$$$$$Y$$$20240715$$HP$US$US
240927691$24092769$1$I$$20240708$20240715$20240715$PER$$US-PFIZER INC-PV202400090307$PFIZER$$6$YR$$M$Y$$$20240715$$MD$US$US
240927701$24092770$1$I$20240701$20240713$20240715$20240715$PER$$US-PFIZER INC-202400213988$PFIZER$$$$$$Y$$$20240715$$CN$US$US
240927712$24092771$2$F$20240705$20240710$20240715$20240718$PER$$US-PFIZER INC-202400211286$PFIZER$$34$YR$$F$Y$49.9$KG$20240718$$CN$US$US
240927721$24092772$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400091280$PFIZER$$$$$$Y$$$20240715$$CN$US$US
240927731$24092773$1$I$$20240708$20240715$20240715$PER$$US-PFIZER INC-PV202400090187$PFIZER$$9$YR$$M$Y$$$20240715$$MD$US$US
240927742$24092774$2$F$$20240726$20240715$20240731$PER$$US-PFIZER INC-PV202400092036$PFIZER$$62$YR$$F$Y$$$20240731$$CN$US$US
240927752$24092775$2$F$20240707$20240731$20240715$20240805$PER$$US-PFIZER INC-202400212882$PFIZER$$80$YR$$F$Y$44.444$KG$20240805$$CN$US$US
240927761$24092776$1$I$$20240709$20240715$20240715$EXP$$CN-FERRINGPH-2024FE03811$FERRING$$$$$$Y$$$20240715$$CN$CN$CN
240927772$24092777$2$F$$20240723$20240715$20240725$PER$$US-PFIZER INC-PV202400091581$PFIZER$$$$$F$Y$$$20240725$$CN$US$US
240927781$24092778$1$I$$20240710$20240715$20240715$PER$$US-PFIZER INC-202400212399$PFIZER$$35$YR$$M$Y$$$20240715$$CN$US$US
240927791$24092779$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400091656$PFIZER$$70$YR$$M$Y$$$20240715$$HP$US$US
240927801$24092780$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-202400213885$PFIZER$$63$YR$$F$Y$$$20240715$$HP$US$US
240927811$24092781$1$I$$20240712$20240715$20240715$PER$$US-PFIZER INC-202400213849$PFIZER$$57$YR$$F$Y$$$20240715$$HP$US$US
240927821$24092782$1$I$20240709$20240712$20240715$20240715$PER$$US-PFIZER INC-202400213326$PFIZER$$68$YR$$F$Y$$$20240715$$CN$US$US
240927832$24092783$2$F$$20240904$20240715$20240909$PER$$US-PFIZER INC-PV202400053204$PFIZER$$72$YR$$F$Y$$$20240909$$HP$US$US
240927843$24092784$3$F$20240701$20240812$20240715$20240815$PER$$US-PFIZER INC-202400211090$PFIZER$$65$YR$$F$Y$52.154$KG$20240815$$CN$US$US
240927853$24092785$3$F$20240401$20240829$20240715$20240903$EXP$$US-PFIZER INC-PV202400091917$PFIZER$$93$YR$$M$Y$76.19$KG$20240903$$MD$US$US
240927862$24092786$2$F$$20240909$20240715$20240911$EXP$$JP-FERRINGPH-2024FE03698$FERRING$Matsumoto M, Kaiho N, Kawarai Y, Hasegawa K, Obayashi S, Mitsuhashi A. A case of bilateral tubal pregnancy diagnosed after laparoscopic surgery. j obstr gyn. 2024;61 (2):176$$$$$Y$$$20240911$$HP$JP$JP
240927874$24092787$4$F$$20240813$20240715$20240819$PER$$US-PFIZER INC-PV202400081517$PFIZER$$22$YR$$F$Y$65.76$KG$20240819$$HP$US$US
240927881$24092788$1$I$$20240711$20240715$20240715$PER$$JP-PFIZER INC-PV202400091235$PFIZER$$$$$$Y$$$20240715$$MD$JP$JP
240927891$24092789$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400091540$PFIZER$$81$YR$$F$Y$$$20240715$$CN$US$US
240927901$24092790$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400091550$PFIZER$$$$$$Y$$$20240715$$CN$US$US
240927911$24092791$1$I$$20240712$20240715$20240715$PER$$US-PFIZER INC-202400213915$PFIZER$$62$YR$$F$Y$$$20240715$$CN$US$US
240927921$24092792$1$I$$20240708$20240715$20240715$PER$$US-PFIZER INC-PV202400090269$PFIZER$$30$YR$$M$Y$$$20240715$$MD$US$US
240927931$24092793$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400091595$PFIZER$$69$YR$$F$Y$$$20240715$$HP$US$US
240927941$24092794$1$I$$20240709$20240715$20240715$PER$$US-PFIZER INC-PV202400090739$PFIZER$$61$YR$$M$Y$$$20240715$$HP$US$US
240927952$24092795$2$F$20240701$20240729$20240715$20240801$PER$$US-PFIZER INC-202400213558$PFIZER$$47$YR$$F$Y$82.54$KG$20240801$$HP$US$US
240927972$24092797$2$F$20240713$20240716$20240715$20240718$PER$$US-PFIZER INC-PV202400092033$PFIZER$$$$$$Y$$$20240718$$CN$US$US
240927981$24092798$1$I$20240708$20240711$20240715$20240715$PER$$US-PFIZER INC-202400212923$PFIZER$$47$YR$$F$Y$$$20240715$$CN$US$US
240927991$24092799$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-202400213855$PFIZER$$66$YR$$F$Y$$$20240715$$HP$US$US
240928001$24092800$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400091848$PFIZER$$46$YR$$$Y$$$20240715$$HP$US$US
240928012$24092801$2$F$20240706$20240729$20240715$20240801$PER$$US-PFIZER INC-202400211099$PFIZER$$62$YR$$M$Y$$$20240801$$CN$US$US
240928021$24092802$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-202400213551$PFIZER$$58$YR$$F$Y$$$20240715$$HP$US$US
240928033$24092803$3$F$20240101$20240829$20240715$20240904$PER$$US-PFIZER INC-PV202400091690$PFIZER$$51$YR$$F$Y$$$20240904$$HP$US$US
240928042$24092804$2$F$20240101$20240805$20240715$20240807$PER$$US-PFIZER INC-PV202400092101$PFIZER$$39$YR$$F$Y$$$20240807$$HP$US$US
240928051$24092805$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48832$$FDA-CTU$$56$YR$$M$N$$$20240715$N$$US$
240928061$24092806$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400091822$PFIZER$$63$YR$$F$Y$$$20240715$$HP$US$US
240928071$24092807$1$I$20240710$20240712$20240715$20240715$PER$$US-PFIZER INC-202400213918$PFIZER$$40$YR$$M$Y$$$20240715$$CN$US$US
240928081$24092808$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-202400213572$PFIZER$$47$YR$$F$Y$$$20240715$$CN$US$US
240928091$24092809$1$I$20240601$20240710$20240715$20240715$PER$$US-PFIZER INC-PV202400090861$PFIZER$$66$YR$$M$Y$$$20240715$$HP$US$US
240928101$24092810$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-202400213159$PFIZER$$66$YR$$F$Y$$$20240715$$MD$US$US
240928111$24092811$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48862$$FDA-CTU$$80$YR$$F$N$$$20240715$N$$US$
240928121$24092812$1$I$20240611$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48854$$FDA-CTU$$13$YR$$F$N$$$20240715$Y$PH$US$
240928131$24092813$1$I$20240601$20240711$20240715$20240715$PER$$US-PFIZER INC-202400213456$PFIZER$$85$YR$$F$Y$$$20240715$$CN$US$US
240928141$24092814$1$I$$20240703$20240715$20240715$EXP$$US-SCIEGENP-2024SCLIT00330$SCIEGEN$Goldberg E, et al.Diffuse Alveolar Hemorrhage Secondary to Hydralazine-induced Vasculitis Causing Pulmonary-renal Syndrome.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209 (1):A2007$80$YR$E$F$Y$$$20240715$$HP$US$US
240928162$24092816$2$F$20240101$20240801$20240715$20240805$PER$$US-PFIZER INC-PV202400091527$PFIZER$$80$YR$$F$Y$$$20240805$$HP$US$US
240928171$24092817$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-202400212886$PFIZER$$$$$$Y$$$20240715$$CN$US$US
240928181$24092818$1$I$20240714$20240714$20240715$20240715$PER$$US-PFIZER INC-202400213992$PFIZER$$47$YR$$F$Y$$$20240715$$CN$US$US
240928191$24092819$1$I$20240601$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400092075$PFIZER$$30$YR$$M$Y$$$20240715$$HP$US$US
240928201$24092820$1$I$20240711$20240711$20240715$20240715$PER$$US-PFIZER INC-202400212841$PFIZER$$64$YR$$F$Y$52$KG$20240715$$PH$US$US
240928211$24092821$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400091529$PFIZER$$46$YR$$F$Y$$$20240715$$HP$US$US
240928223$24092822$3$F$20240101$20240822$20240715$20240827$PER$$US-PFIZER INC-202400077824$PFIZER$$14$YR$$F$Y$49.9$KG$20240827$$CN$US$US
240928231$24092823$1$I$20240711$20240714$20240715$20240715$PER$$US-PFIZER INC-202400213940$PFIZER$$57$YR$$F$Y$$$20240715$$CN$US$US
240928241$24092824$1$I$$20240712$20240715$20240715$PER$$US-PFIZER INC-202400214449$PFIZER$$23$YR$$F$Y$$$20240715$$MD$US$US
240928252$24092825$2$F$20240703$20240724$20240715$20240730$30DAY$$US-AMGEN-USASP2024137504$AMGEN$$57$YR$A$M$Y$134.7$KG$20240729$$PH$US$US
240928261$24092826$1$I$$20240712$20240715$20240715$EXP$FR-AFSSAPS-AVNT2024000511$FR-SANDOZ INC.-SDZ2024FR064995$SANDOZ$$24$YR$$F$Y$$$20240715$$HP$FR$FR
240928271$24092827$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405101722428740-NRBYG$GB-TEVA-VS-3218371$TEVA$$$$$M$Y$$$20240715$$PH$GB$GB
240928281$24092828$1$I$$20240703$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010138$DR REDDYS$Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. Journal of Pediatric Orthopaedics. 2024 Jul;33(4): 407-410. doi:10.1097/BPB.0000000000001136.$$$C$$Y$$$20240715$$HP$US$US
240928291$24092829$1$I$$20240703$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010139$DR REDDYS$Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. Journal of Pediatric Orthopaedics. 2024 Jul;33(4): 407-410. doi:10.1097/BPB.0000000000001136.$$$C$$Y$$$20240715$$HP$US$US
240928301$24092830$1$I$$20240703$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010141$DR REDDYS$Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. Journal of Pediatric Orthopaedics. 2024 Jul;33(4): 407-410. doi:10.1097/BPB.0000000000001136.$$$$$Y$$$20240715$$HP$US$US
240928311$24092831$1$I$$20240703$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010142$DR REDDYS$Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. Journal of Pediatric Orthopaedics. 2024 Jul;33(4): 407-410. doi:10.1097/BPB.0000000000001136.$$$C$$Y$$$20240715$$HP$US$US
240928321$24092832$1$I$$20240703$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010143$DR REDDYS$Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. Journal of Pediatric Orthopaedics. 2024 Jul;33(4): 407-410. doi:10.1097/BPB.0000000000001136.$$$C$$Y$$$20240715$$HP$US$US
240928331$24092833$1$I$20230419$20240711$20240715$20240715$EXP$FR-AFSSAPS-TS2024000773$FR-MYLANLABS-2024M1065175$MYLAN$$42$YR$$F$Y$77$KG$20240715$$MD$FR$FR
240928341$24092834$1$I$20210304$20240711$20240715$20240715$EXP$FR-AFSSAPS-LY2024001010$FR-MYLANLABS-2024M1065117$MYLAN$$23$YR$$F$Y$60$KG$20240715$$MD$FR$FR
240928353$24092835$3$F$20240626$20240913$20240715$20240916$EXP$$NVSC2024US144077$NOVARTIS$$57$YR$$F$Y$$$20240916$$CN$US$US
240928361$24092836$1$I$$20240711$20240715$20240715$EXP$$PT-MYLANLABS-2024M1065120$MYLAN$Rocha DI, Novo A, Azevedo SM, Barroso D. Sezary syndrome: a crucial cause of uncontrollable itching. PUBLICACAO ESPECIAL. 2024;2:58-61$74$YR$$F$Y$$$20240715$$HP$PT$PT
240928371$24092837$1$I$20240316$20240710$20240715$20240715$EXP$$US-APELLIS-2024-APL-0000445$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240715$$CN$US$US
240928381$24092838$1$I$$20240701$20240715$20240715$PER$$US-TEVA-VS-3216564$TEVA$$$$$M$Y$$$20240715$$CN$US$US
240928394$24092839$4$F$20240515$20240925$20240715$20240927$EXP$$ES-PFIZER INC-202400214694$PFIZER$$66$YR$$F$Y$66$KG$20240927$$HP$ES$ES
240928401$24092840$1$I$20240617$20240709$20240715$20240715$EXP$SE-SEMPA-2024-005289$SE-MYLANLABS-2024M1064571$MYLAN$$1$YR$$M$Y$$$20240715$$MD$SE$SE
240928411$24092841$1$I$$20240709$20240715$20240715$EXP$$ES-MYLANLABS-2024M1064934$MYLAN$$62$YR$$F$Y$$$20240715$$CN$ES$ES
240928421$24092842$1$I$20240512$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405120905293360-ZRKFW$GB-TEVA-VS-3218427$TEVA$$62$YR$$M$Y$78$KG$20240715$$CN$GB$GB
240928431$24092843$1$I$$20240709$20240715$20240715$EXP$$US-JNJFOC-20240727798$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240715$$CN$US$US
240928441$24092844$1$I$20240701$20240711$20240715$20240715$PER$$US-JNJFOC-20240730284$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240715$$PH$US$US
240928452$24092845$2$F$$20240723$20240715$20240729$EXP$$CZ-MYLANLABS-2024M1065036$MYLAN$Charvatova M.. CLINICAL BENEFIT OF TDM ANTIPSYCHOTICS FOR PERSONALIZED MEDICINE.. CESKA A SLOVENSKA PSYCHIATRIE.. 2024;120(3):143-150$30$YR$$M$Y$$$20240729$$MD$CZ$CZ
240928461$24092846$1$I$20240626$20240710$20240715$20240715$EXP$FR-AFSSAPS-TS2024000768$FR-009507513-2407FRA004838$MERCK$$72$YR$$F$Y$52$KG$20240715$$MD$FR$FR
240928471$24092847$1$I$20240630$20240705$20240715$20240715$EXP$CN-NMPACDR-3601301025637202400588$CN-BAXTER-2024BAX021369$BAXTER$$48$YR$$M$Y$50$KG$20240715$$MD$CN$CN
240928481$24092848$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405081329426520-VLQDT$GB-TEVA-VS-3218758$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240928491$24092849$1$I$20240502$20240708$20240715$20240715$EXP$FR-AFSSAPS-NT2024000808$FR-BAXTER-2024BAX021314$BAXTER$$72$YR$$F$Y$92$KG$20240715$$MD$FR$FR
240928501$24092850$1$I$20240625$20240705$20240715$20240715$EXP$CN-NMPACDR-3706011015556202400354$CN-BAXTER-2024BAX021372$BAXTER$$56$YR$$F$Y$60$KG$20240715$$MD$CN$CN
240928511$24092851$1$I$$20240708$20240715$20240715$EXP$$CA-BAXTER-2024BAX021331$BAXTER$$67$YR$$F$Y$$$20240715$$CN$CA$CA
240928521$24092852$1$I$$20240710$20240715$20240715$PER$$US-SA-2024SA205373$SANOFI AVENTIS$$92$YR$E$F$Y$$$20240715$$MD$US$US
240928533$24092853$3$F$20240704$20240906$20240715$20240917$EXP$$JP-SA-2024SA204004$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240917$$MD$JP$JP
240928542$24092854$2$F$20240216$20240909$20240715$20240923$EXP$ES-AEMPS-1540288$ES-BAXTER-2024BAX021286$BAXTER$$20$YR$$F$Y$44$KG$20240923$$MD$ES$ES
240928551$24092855$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA203814$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240715$$HP$US$US
240928563$24092856$3$F$20240623$20240815$20240715$20240828$PER$$US-SA-2024SA199588$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240828$$MD$US$US
240928572$24092857$2$F$20240101$20240813$20240715$20240819$EXP$$JP-009507513-2407JPN001011J$MERCK$$8$DEC$$F$Y$$$20240819$$MD$JP$JP
240928581$24092858$1$I$$20240703$20240715$20240715$PER$$US-GILEAD-2024-0679581$GILEAD$$$$A$M$Y$$$20240715$$HP$US$US
240928601$24092860$1$I$20240708$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139917$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240928611$24092861$1$I$$20240709$20240715$20240715$EXP$$CA-ABBVIE-5836840$ABBVIE$$$$A$F$Y$$$20240715$$CN$CA$CA
240928621$24092862$1$I$20240301$20240710$20240715$20240715$EXP$$AT-ABBVIE-5836622$ABBVIE$$40$YR$$F$Y$$$20240715$$CN$AT$AT
240928632$24092863$2$F$20240622$20240904$20240715$20240910$EXP$$US-ABBVIE-5837284$ABBVIE$$33$YR$$F$Y$$$20240910$$CN$US$US
240928641$24092864$1$I$20240627$20240713$20240715$20240715$EXP$GB-MHRA-EMIS-659-7d8a1354-519f-4ff9-8b5e-0c23ea2cebb8$GB-ORGANON-O2407GBR001231$ORGANON$$76$YR$$M$Y$113$KG$20240715$$PH$GB$GB
240928652$24092865$2$F$20240501$20240724$20240715$20240730$EXP$$US-BIOGEN-2024BI01273291$BIOGEN$$65$YR$$M$Y$$$20240730$$CN$US$US
240928672$24092867$2$F$$20240911$20240715$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111973$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$73.03$KG$20240912$$CN$US$US
240928681$24092868$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111893$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240715$$CN$US$US
240928692$24092869$2$F$20240705$20240710$20240715$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110357$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240717$$HP$US$US
240928701$24092870$1$I$$20240710$20240715$20240715$EXP$$US-BIOGEN-2024BI01273347$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240928711$24092871$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111629$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$115.67$KG$20240715$$CN$US$US
240928731$24092873$1$I$$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108662$BRISTOL MYERS SQUIBB$Lochrin SE, Buonocore DJ, Young RJ, Kaley TJ, Postow MA, Wolchok JD, et al. Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab. Pigment Cell + Melanoma Research. 2024 Jul 03;1-7. doi:10.1111/pcmr.13179.$31$YR$A$M$Y$$$20240715$$HP$US$US
240928751$24092875$1$I$20240528$20240710$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111526$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240715$$HP$US$US
240928762$24092876$2$F$$20240802$20240715$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111300$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240805$$CN$US$US
240928771$24092877$1$I$$20240708$20240715$20240715$PER$$US-MYLANLABS-2024M1064693$MYLAN$$$$$M$Y$$$20240715$$CN$US$US
240928783$24092878$3$F$20240617$20240729$20240715$20240806$PER$$US-ABBVIE-5834958$ABBVIE$$25$YR$$F$Y$61$KG$20240806$$CN$US$US
240928791$24092879$1$I$20240709$20240712$20240715$20240715$EXP$GB-MHRA-MED-202407111100441400-DSWBG$GB-TEVA-VS-3220745$TEVA$$55$YR$$M$Y$$$20240715$$MD$GB$GB
240928802$24092880$2$F$20240101$20240712$20240715$20240722$PER$$US-SA-2024SA201258$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240720$$MD$US$US
240928811$24092881$1$I$20240705$20240708$20240715$20240715$EXP$$VN-VANTIVE-2024VAN018271$Vantive US Healthcare$$$$E$F$Y$$$20240715$$MD$VN$VN
240928821$24092882$1$I$$20240603$20240715$20240715$PER$$US-PFIZER INC-PV202400091768$PFIZER$$73$YR$$F$Y$$$20240715$$CN$US$US
240928831$24092883$1$I$$20240703$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0009990$DR REDDYS$Hammond TC, Emeruwa I, Swain SR, Larson SM, Castells MC. Life-threatening Mast Cell Activation and Anaphylaxis in Mast Cell Leukemia and the Role of Omalizumab. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: A5294. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5294.$31$YR$A$M$Y$$$20240715$$HP$US$US
240928842$24092884$2$F$$20240802$20240715$20240805$PER$$NVSC2024US145628$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
240928851$24092885$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145419$NOVARTIS$$$$$$Y$$$20240715$$CN$US$US
240928861$24092886$1$I$$20240710$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407006916$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240715$$CN$US$US
240928871$24092887$1$I$20190801$20240709$20240715$20240715$EXP$$DE-MYLANLABS-2024M1064457$MYLAN$$33$YR$$F$Y$$$20240715$$MD$DE$DE
240928881$24092888$1$I$20240607$20240611$20240715$20240715$EXP$$FR-APELLIS-2024-APL-0000440$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240715$$PH$FR$FR
240928892$24092889$2$F$20240530$20240715$20240715$20240717$EXP$$US-ROCHE-10000023054$ROCHE$$44$YR$A$F$Y$$$20240717$$CN$US$US
240928901$24092890$1$I$20240701$20240708$20240715$20240715$EXP$$CO-VANTIVE-2024VAN018153$Vantive US Healthcare$$80$YR$$M$Y$56$KG$20240715$$HP$CO$CO
240928911$24092891$1$I$$20240709$20240715$20240715$EXP$$US-JNJFOC-20240724415$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$CN$US$US
240928921$24092892$1$I$$20240708$20240715$20240715$EXP$$KR-VANTIVE-2024VAN016977$Vantive US Healthcare$$$$$M$Y$$$20240715$$CN$KR$KR
240928931$24092893$1$I$$20240707$20240715$20240715$PER$$US-BIOGEN-2024BI01272896$BIOGEN$$$$$M$Y$$$20240715$$HP$US$US
240928941$24092894$1$I$20231209$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111024$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$61.51$KG$20240715$$CN$US$US
240928951$24092895$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110518$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240715$$CN$US$US
240928961$24092896$1$I$20071001$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405041636055350-WYDFT$GB-TEVA-VS-3218432$TEVA$$53$YR$$M$Y$74$KG$20240715$$CN$GB$GB
240928971$24092897$1$I$20230104$20240708$20240715$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110174$BRISTOL MYERS SQUIBB$$8$DEC$E$$Y$$$20240715$$MD$CA$CA
240928981$24092898$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111651$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$75.3$KG$20240715$$CN$US$US
240928991$24092899$1$I$20200801$20240704$20240715$20240715$PER$$US-SA-2024SA201062$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240715$$MD$US$US
240929001$24092900$1$I$20240301$20240710$20240715$20240715$PER$$US-ROCHE-10000023181$ROCHE$$76$YR$E$F$Y$71.21$KG$20240715$$CN$US$US
240929021$24092902$1$I$$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48808$$FDA-CTU$$$$$F$N$$$20240712$N$HP$US$
240929031$24092903$1$I$$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48804$$FDA-CTU$$$$$F$N$$$20240712$N$HP$US$
240929041$24092904$1$I$20240523$20240709$20240715$20240715$EXP$FR-AFSSAPS-NT2024000766$FR-MYLANLABS-2024M1065111$MYLAN$$63$YR$$F$Y$32$KG$20240715$$HP$FR$FR
240929052$24092905$2$F$$20240716$20240715$20240717$PER$$US-ROCHE-10000024380$ROCHE$$53$YR$A$F$Y$$$20240717$$CN$US$US
240929063$24092906$3$F$$20240805$20240715$20240813$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003839$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240813$$CN$US$US
240929071$24092907$1$I$$20240710$20240715$20240715$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003874$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240715$$CN$US$US
240929081$24092908$1$I$$20240708$20240715$20240715$PER$$US-SA-2024SA204247$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240715$$MD$US$US
240929091$24092909$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48791$$FDA-CTU$$52$YR$$F$N$166$LBS$20240715$N$$US$
240929101$24092910$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48788$$FDA-CTU$$67$YR$$F$N$298$LBS$20240715$N$$US$
240929111$24092911$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48813$$FDA-CTU$$93$YR$$F$N$$$20240715$N$$US$
240929131$24092913$1$I$20220101$20240710$20240715$20240715$EXP$$BR-TAKEDA-2024TUS071088$TAKEDA$$$$$F$Y$$$20240715$$CN$BR$BR
240929141$24092914$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48852$$FDA-CTU$$74$YR$$M$N$$$20240715$N$$US$
240929151$24092915$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48820$$FDA-CTU$$78$YR$$F$N$116$LBS$20240715$N$$US$
240929165$24092916$5$F$20240101$20240912$20240715$20240918$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003816$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$US$US
240929171$24092917$1$I$20240519$20240709$20240715$20240715$EXP$FR-AFSSAPS-AVTO2024000101$FR-MYLANLABS-2024M1064625$MYLAN$$29$YR$$M$Y$$$20240715$$MD$FR$FR
240929184$24092918$4$F$20240501$20240715$20240715$20240815$PER$$US-TRAVERE-2024TVT00565$TRAVERE THERAPEUTICS$$77$YR$$M$Y$$$20240815$$CN$US$US
240929192$24092919$2$F$20240703$20240809$20240715$20240814$PER$$US-Eisai-EC-2024-169866$EISAI$$83$YR$E$F$Y$$$20240814$$CN$US$US
240929211$24092921$1$I$$20240713$20240715$20240715$EXP$$DE-BAUSCH-BL-2024-010729$BAUSCH AND LOMB$$$$$M$Y$$$20240715$$MD$DE$DE
240929221$24092922$1$I$20240710$20240711$20240715$20240715$PER$$US-JNJFOC-20240731728$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240715$$HP$US$US
240929231$24092923$1$I$$20240703$20240715$20240715$PER$$US-TEVA-VS-3217826$TEVA$$68$YR$$M$Y$$$20240715$$CN$US$US
240929241$24092924$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091057376870-TPDWZ$GB-TEVA-VS-3218414$TEVA$$$$$F$Y$$$20240715$$PH$GB$GB
240929251$24092925$1$I$20230605$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160520$ASTRAZENECA$$90$YR$$F$Y$$$20240715$$HP$FR$
240929262$24092926$2$F$$20240819$20240715$20240824$PER$$US-AstraZeneca-2024A160802$ASTRAZENECA$$58$YR$$F$Y$$$20240824$$MD$US$
240929281$24092928$1$I$20090301$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405121551375800-CVNQW$GB-TEVA-VS-3218385$TEVA$$18$YR$$M$Y$$$20240715$$CN$GB$GB
240929301$24092930$1$I$20240101$20240708$20240715$20240715$EXP$$US-009507513-2407USA003871$MERCK$$$$$F$Y$$$20240715$$CN$US$US
240929311$24092931$1$I$$20240708$20240715$20240715$EXP$$AT-BAXTER-2024BAX021285$BAXTER$$$$A$M$Y$$$20240715$$MD$AT$AT
240929321$24092932$1$I$20240520$20240705$20240715$20240715$EXP$FR-AFSSAPS-NC2024000792$FR-BAXTER-2024BAX021195$BAXTER$$11$YR$$F$Y$38$KG$20240715$$MD$FR$FR
240929331$24092933$1$I$20240616$20240705$20240715$20240715$EXP$CN-NMPACDR-42010311045289202400312$CN-BAXTER-2024BAX021379$BAXTER$$2$YR$$M$Y$13$KG$20240715$$MD$CN$CN
240929341$24092934$1$I$20240101$20240711$20240715$20240715$EXP$$US-ABBVIE-5837765$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240929351$24092935$1$I$$20240710$20240715$20240715$PER$$US-TAKEDA-2024TUS070681$TAKEDA$$$$$M$Y$91$KG$20240715$$MD$US$US
240929361$24092936$1$I$20240507$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405081533546600-FJRHP$GB-BAXTER-2024BAX021247$BAXTER$$64$YR$$F$Y$85$KG$20240715$$PH$GB$GB
240929371$24092937$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112039$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240715$$CN$US$US
240929381$24092938$1$I$$20240705$20240715$20240715$30DAY$$US-GSK-US2024AMR084114$GLAXOSMITHKLINE$$$$$F$Y$$$20240715$$CN$US$US
240929391$24092939$1$I$20240707$20240711$20240715$20240715$EXP$GB-MHRA-MED-202407112158541270-CKJVM$GB-SANDOZ INC.-SDZ2024GB064974$SANDOZ$$38$YR$$F$Y$98$KG$20240715$$CN$GB$GB
240929401$24092940$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5838266$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240929411$24092941$1$I$$20240709$20240715$20240715$EXP$$FR-JNJFOC-20240723990$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$MD$FR$FR
240929421$24092942$1$I$$20240710$20240715$20240715$EXP$$CA-BAUSCH-BL-2024-010545$BAUSCH AND LOMB$$$$$F$Y$$$20240715$$HP$CA$CA
240929441$24092944$1$I$20240715$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48836$$FDA-CTU$$65$YR$$M$N$118.3$KG$20240715$N$PH$US$
240929461$24092946$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48805$$FDA-CTU$$65$YR$$F$N$$$20240715$N$HP$US$
240929472$24092947$2$F$$20240809$20240715$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111997$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$84.82$KG$20240814$$CN$US$US
240929481$24092948$1$I$$20240708$20240715$20240715$EXP$$US-GSK-US2024AMR085613$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$CN$US$US
240929491$24092949$1$I$20240708$20240710$20240715$20240715$EXP$$US-GILEAD-2024-0680331$GILEAD$$50$YR$A$M$Y$$$20240715$$HP$US$US
240929501$24092950$1$I$$20240709$20240715$20240715$PER$$US-GILEAD-2024-0680492$GILEAD$$$$$$Y$$$20240715$$HP$US$US
240929512$24092951$2$F$$20240709$20240715$20240718$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700289$MYOVANT SCIENCES$$$$$M$Y$$$20240718$$CN$US$US
240929521$24092952$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405091618218170-JRLNH$GB-TEVA-VS-3218813$TEVA$$$$$M$Y$$$20240715$$CN$GB$GB
240929531$24092953$1$I$$20240709$20240715$20240715$PER$$US-GILEAD-2024-0680495$GILEAD$$$$$$Y$$$20240715$$HP$US$US
240929541$24092954$1$I$20240701$20240715$20240715$20240715$EXP$IT-MINISAL02-994324$IT-SANDOZ INC.-SDZ2024IT065092$SANDOZ$$56$YR$$F$Y$$$20240715$$MD$IT$IT
240929551$24092955$1$I$20240701$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024137344$AMGEN$$35$YR$A$M$Y$$$20240715$$CN$US$US
240929562$24092956$2$F$20240101$20240730$20240715$20240802$PER$$US-ABBVIE-5835303$ABBVIE$$$$$F$Y$$$20240802$$MD$US$US
240929571$24092957$1$I$$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008636$ELI LILLY AND CO$$69$YR$E$$Y$$$20240715$$CN$US$US
240929581$24092958$1$I$20240701$20240712$20240715$20240715$EXP$$US-GILEAD-2024-0680666$GILEAD$$75$YR$E$F$Y$$$20240715$$CN$US$US
240929591$24092959$1$I$$20240705$20240715$20240715$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06479$HIKMA$$67$YR$$$Y$$$20240715$$HP$CA$CA
240929601$24092960$1$I$$20240705$20240715$20240715$PER$$US-APELLIS-2024-APL-0000417$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240715$$MD$US$US
240929632$24092963$2$F$20240627$20240715$20240715$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111838$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$52.16$KG$20240718$$HP$US$US
240929641$24092964$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111485$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240715$$CN$US$US
240929653$24092965$3$F$20240529$20240805$20240715$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-088817$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$PH$JP$JP
240929661$24092966$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111298$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240715$$CN$US$US
240929671$24092967$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111245$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240715$$CN$US$US
240929681$24092968$1$I$$20240708$20240715$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-109920$BRISTOL MYERS SQUIBB$$6$DEC$E$F$Y$$$20240715$$CN$CA$CA
240929691$24092969$1$I$$20240712$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111783$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240715$$CN$US$US
240929701$24092970$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5836913$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240929711$24092971$1$I$$20240712$20240715$20240715$EXP$$US-GILEAD-2024-0680711$GILEAD$$78$YR$E$M$Y$$$20240715$$MD$US$US
240929721$24092972$1$I$$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48815$$FDA-CTU$$54$YR$$M$N$$$20240712$N$HP$US$
240929731$24092973$1$I$$20240711$20240715$20240715$EXP$$US-ABBVIE-5838653$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240929741$24092974$1$I$$20240711$20240715$20240715$EXP$$NVSC2024CN145322$NOVARTIS$$75$YR$$M$Y$$$20240715$$CN$CN$CN
240929751$24092975$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405081109202620-QLSHP$GB-TEVA-VS-3218782$TEVA$$$$$F$Y$$$20240715$$HP$GB$GB
240929761$24092976$1$I$$20240707$20240715$20240715$EXP$$ID-AstraZeneca-2024A158998$ASTRAZENECA$$71$YR$$M$Y$$$20240715$$MD$ID$
240929771$24092977$1$I$20240101$20240703$20240715$20240715$PER$$US-AstraZeneca-2024A160729$ASTRAZENECA$$$$$$Y$$$20240715$$CN$US$
240929781$24092978$1$I$20240629$20240703$20240715$20240715$PER$$US-009507513-2407USA002005$MERCK$$32$YR$$F$Y$$$20240715$$HP$US$US
240929811$24092981$1$I$$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48797$$FDA-CTU$$$$$F$N$$$20240712$N$HP$US$
240929821$24092982$1$I$$20240705$20240715$20240715$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06504$HIKMA$$59$YR$$M$Y$$$20240715$$HP$CA$CA
240929831$24092983$1$I$$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160510$ASTRAZENECA$$72$YR$$F$Y$$$20240715$$HP$FR$
240929851$24092985$1$I$20240603$20240709$20240715$20240715$PER$$US-GILEAD-2024-0680155$GILEAD$$62$YR$A$F$Y$$$20240715$$HP$US$US
240929861$24092986$1$I$20240708$20240712$20240715$20240715$EXP$$US-ABBVIE-5839410$ABBVIE$$55$YR$$F$Y$$$20240715$$CN$US$US
240929871$24092987$1$I$$20240604$20240715$20240715$PER$$US-TRAVERE-2024TVT00566$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240715$$CN$US$US
240929881$24092988$1$I$$20240708$20240715$20240715$EXP$$BR-JNJFOC-20240725841$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$MD$BR$BR
240929892$24092989$2$F$20240918$20240919$20240715$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111040$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240920$$CN$US$US
240929901$24092990$1$I$20240127$20240628$20240715$20240715$EXP$FR-AFSSAPS-AVMA2024000247$FR-MYLANLABS-2024M1061097$MYLAN$$54$YR$$M$Y$$$20240715$$PH$FR$FR
240929912$24092991$2$F$20240625$20240826$20240715$20240916$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000422$BECTON DICKINSON$$$$$$Y$$$20240916$$CN$GB$GB
240929932$24092993$2$F$20240625$20240826$20240715$20240916$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000423$BECTON DICKINSON$$$$$$Y$$$20240916$$CN$GB$GB
240929941$24092994$1$I$$20240711$20240715$20240715$EXP$$CA-AstraZeneca-2024A160537$ASTRAZENECA$$$$$F$Y$$$20240715$$MD$CA$
240929951$24092995$1$I$20180205$20240712$20240715$20240715$EXP$$DE-SANDOZ INC.-PHHY2018DE040569$SANDOZ$$62$YR$$M$Y$91$KG$20240715$$MD$DE$DE
240929971$24092997$1$I$20240531$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48812$$FDA-CTU$$58$YR$$F$N$229$LBS$20240715$N$CN$US$
240929993$24092999$3$F$20240707$20240808$20240715$20240816$EXP$$JP-OTSUKA-2024_019307$OTSUKA$$71$YR$$F$Y$$$20240816$$PH$JP$JP
240930001$24093000$1$I$20240101$20240702$20240715$20240715$PER$$US-ALKERMES INC.-ALK-2024-001831$ALKERMES$$$$$F$Y$$$20240715$$HP$US$US
240930012$24093001$2$F$$20240723$20240715$20240730$30DAY$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02512$AMNEAL$$$$$F$Y$$$20240730$$CN$US$US
240930021$24093002$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405170858595570-QCHVJ$GB-TEVA-VS-3218615$TEVA$$$$$F$Y$$$20240715$$PH$GB$GB
240930051$24093005$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144917$NOVARTIS$$$$$F$Y$$$20240715$$HP$US$US
240930061$24093006$1$I$$20240711$20240715$20240715$PER$$US-HALEON-2186702$Haleon PLC$$$$$$Y$$$20240715$$CN$US$US
240930071$24093007$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405141236543910-PFYNT$GB-TEVA-VS-3218491$TEVA$$$$$F$Y$69$KG$20240715$$HP$GB$GB
240930091$24093009$1$I$20240702$20240711$20240715$20240715$EXP$FR-AFSSAPS-NT2024000827$FR-PFIZER INC-202400212104$PFIZER$$86$YR$$M$Y$75$KG$20240715$$MD$FR$FR
240930102$24093010$2$F$$20240730$20240715$20240805$EXP$$JP-PFIZER INC-202400212228$PFIZER$Asano, H.. Neurolymphomatosis secondary to primary central nervous system lymphoma: illustrative case. Journal of neurosurgery. Case lessons. 2024;8(1):10.3171/CASE24107$5$DEC$$F$Y$$$20240805$$MD$JP$JP
240930113$24093011$3$F$$20240909$20240715$20240911$EXP$$US-PFIZER INC-PV202400081096$PFIZER$$64$YR$$F$Y$$$20240911$$CN$US$US
240930121$24093012$1$I$20240607$20240710$20240715$20240715$EXP$$GB-ANIPHARMA-2024-UK-000132$ANI$$56$YR$$F$Y$71$KG$20240715$$CN$GB$GB
240930132$24093013$2$F$$20240712$20240715$20240718$EXP$$CN-PFIZER INC-202400212728$PFIZER$Liu, S.. Telitacicept Treatment Refractory Lupus Nephritis: A Case Report.. Case Reports in Nephrology and Dialysis. 2024;14(1):42-47$25$YR$$F$Y$$$20240718$$MD$CN$CN
240930141$24093014$1$I$$20240712$20240715$20240715$EXP$$NVSC2024US145432$NOVARTIS$$$$$M$Y$$$20240715$$CN$US$US
240930151$24093015$1$I$20240501$20240710$20240715$20240715$PER$$US-Eisai-EC-2024-170032$EISAI$$67$YR$E$M$Y$$$20240715$$CN$US$US
240930161$24093016$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112008$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240715$$CN$US$US
240930171$24093017$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111189$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240715$$HP$US$US
240930181$24093018$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3219263$TEVA$Luskin MR, Murakami MA, Keating J, Winer ES, Garcia JS, Stahl M, et al. A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL and Blast Phase CML in Adults. Blood 2023; 142 (Suppl. 1) 965 (plus Oral Presentation).$57$YR$$F$Y$$$20240715$$MD$US$US
240930192$24093019$2$F$20240101$20240916$20240715$20240927$EXP$$US-UCBSA-2024023113$UCB$$$$$M$Y$$$20240927$$CN$US$US
240930201$24093020$1$I$$20240705$20240715$20240715$EXP$$GB-TEVA-VS-3218736$TEVA$$$$$M$Y$$$20240715$$CN$GB$GB
240930221$24093022$1$I$$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A139713$ASTRAZENECA$$65$YR$$F$Y$$$20240715$$HP$FR$
240930231$24093023$1$I$20231101$20240711$20240715$20240715$EXP$$AU-AstraZeneca-2024A069708$ASTRAZENECA$$58$YR$$F$Y$44$KG$20240715$$PH$AU$
240930241$24093024$1$I$$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160463$ASTRAZENECA$$75$YR$$M$Y$75$KG$20240715$$HP$FR$
240930252$24093025$2$F$20230627$20240805$20240715$20240808$EXP$$JP-AstraZeneca-2023A156832$ASTRAZENECA$$74$YR$$M$Y$41$KG$20240808$$MD$JP$
240930261$24093026$1$I$20240621$20240708$20240715$20240715$EXP$$IT-AstraZeneca-2024A155698$ASTRAZENECA$$63$YR$$F$Y$$$20240715$$MD$IT$
240930271$24093027$1$I$$20240709$20240715$20240715$EXP$$BE-MYLANLABS-2018M1095976$MYLAN$Vandenbriele C.,. Price S..QTc in the elderly.. European Heart Journal.. 2018;39(16):1445$76$YR$$F$Y$$$20240715$$MD$BE$BE
240930282$24093028$2$F$20240415$20240711$20240715$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407007575$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240717$$CN$US$US
240930291$24093029$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008319$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240715$$CN$US$US
240930311$24093031$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405161205305210-RPVGW$GB-TEVA-VS-3218463$TEVA$$$$$F$Y$$$20240715$$PH$GB$GB
240930321$24093032$1$I$$20240710$20240715$20240715$EXP$$US-SANDOZ INC.-SDZ2024US064592$SANDOZ$$$$$$Y$$$20240715$$CN$US$US
240930331$24093033$1$I$20240623$20240705$20240715$20240715$EXP$GB-MHRA-MED-202407041516136050-KGNPZ$GB-TEVA-VS-3218447$TEVA$$88$YR$$F$Y$$$20240715$$MD$GB$GB
240930351$24093035$1$I$20230807$20240708$20240715$20240715$EXP$$US-PERRIGO-24US006572$PERRIGO$$43$YR$$$Y$$$20240715$$CN$US$US
240930362$24093036$2$F$20240515$20240708$20240715$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108531$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240719$$CN$US$US
240930371$24093037$1$I$$20240713$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112041$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$55.79$KG$20240715$$CN$US$US
240930381$24093038$1$I$20240629$20240705$20240715$20240715$PER$$US-SA-2024SA202600$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240715$$MD$US$US
240930392$24093039$2$F$$20240829$20240715$20240904$EXP$$US-SANDOZ INC.-SDZ2023US011256$SANDOZ$$$$$F$Y$68.027$KG$20240904$$HP$US$US
240930401$24093040$1$I$$20240715$20240715$20240715$EXP$NL-LRB-00981622$NL-PFIZER INC-202400214730$PFIZER$$44$YR$$F$Y$$$20240715$$MD$NL$NL
240930411$24093041$1$I$20240711$20240712$20240715$20240715$EXP$$CN-PFIZER INC-PV202400091952$PFIZER$$35$YR$$F$Y$56$KG$20240715$$HP$CN$CN
240930421$24093042$1$I$20161201$20240711$20240715$20240715$EXP$$FR-PFIZER INC-2017SGN00404$PFIZER$$51$YR$$F$Y$94$KG$20240715$$MD$FR$FR
240930431$24093043$1$I$20230404$20240714$20240715$20240715$EXP$GB-MHRA-MED-202407140343532710-MLPFB$GB-PFIZER INC-202400213766$PFIZER$$19$YR$$F$Y$$$20240715$$CN$GB$GB
240930441$24093044$1$I$$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139791$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240930451$24093045$1$I$20231113$20240705$20240715$20240715$EXP$IT-MINISAL02-958014$IT-TEVA-VS-3159083$TEVA$$7$YR$$M$Y$33$KG$20240715$$PH$IT$IT
240930462$24093046$2$F$$20240729$20240715$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108298$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240806$$CN$US$US
240930481$24093048$1$I$$20230602$20240715$20240715$EXP$$US-NOVOPROD-1246229$NOVO NORDISK$$$$$$Y$$$20240715$$CN$US$US
240930491$24093049$1$I$20240613$20240619$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-099528$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240715$$CN$US$US
240930501$24093050$1$I$20230915$20240705$20240715$20240715$EXP$GB-MHRA-WEBCOVID-202405031001175710-NGDRS$GB-RDY-SPO/GBR/24/0010045$DR REDDYS$$70$YR$E$$Y$83$KG$20240715$$CN$GB$GB
240930511$24093051$1$I$20240325$20240709$20240715$20240715$EXP$FR-AFSSAPS-GR2024000811$FR-MYLANLABS-2024M1064561$MYLAN$$64$YR$$F$Y$$$20240715$$MD$FR$FR
240930521$24093052$1$I$$20240709$20240715$20240715$EXP$FR-AFSSAPS-GR2024000823$FR-MYLANLABS-2024M1064624$MYLAN$$44$YR$$F$Y$$$20240715$$PH$FR$FR
240930532$24093053$2$F$20240613$20240726$20240715$20240726$EXP$IT-MINISAL02-994690$NVSC2024IT145132$NOVARTIS$$35$YR$$F$Y$$$20240726$$MD$IT$IT
240930541$24093054$1$I$20240701$20240715$20240715$20240715$EXP$IT-MINISAL02-994224$IT-SANDOZ INC.-SDZ2024IT065049$SANDOZ$$$$$F$Y$$$20240715$$MD$IT$IT
240930551$24093055$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405101852475700-BKTGS$GB-TEVA-VS-3218390$TEVA$$$$$$Y$$$20240715$$CN$GB$GB
240930561$24093056$1$I$20240710$20240711$20240715$20240715$EXP$$GB-SANDOZ INC.-SDZ2024GB064835$SANDOZ$$68$YR$$M$Y$57$KG$20240715$$MD$GB$GB
240930572$24093057$2$F$$20230822$20240715$20240814$EXP$$US-NOVOPROD-1245704$NOVO NORDISK$$$$$$Y$$$20240814$$CN$US$US
240930581$24093058$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405041847147620-RJSCK$GB-TEVA-VS-3218472$TEVA$$$$$F$Y$$$20240715$$PH$GB$GB
240930591$24093059$1$I$$20230703$20240715$20240715$EXP$$US-NOVOPROD-1245689$NOVO NORDISK$$$$$$Y$$$20240715$$CN$US$US
240930601$24093060$1$I$$20230825$20240715$20240715$EXP$$US-NOVOPROD-1113159$NOVO NORDISK$$$$A$M$Y$$$20240715$$CN$US$US
240930621$24093062$1$I$$20231012$20240715$20240715$EXP$$US-NOVOPROD-1246893$NOVO NORDISK$$$$$M$Y$$$20240715$$CN$US$US
240930631$24093063$1$I$$20230714$20240715$20240715$EXP$$US-NOVOPROD-1247860$NOVO NORDISK$$70$YR$$$Y$$$20240715$$CN$US$US
240930644$24093064$4$F$20240712$20240809$20240715$20240813$PER$$US-AMGEN-USASP2024139894$AMGEN$$69$YR$E$F$Y$$$20240813$$CN$US$US
240930651$24093065$1$I$$20240709$20240715$20240715$EXP$$AU-TAKEDA-2024TUS070161$TAKEDA$$$$$M$Y$$$20240715$$HP$AU$AU
240930661$24093066$1$I$$20240712$20240715$20240715$EXP$ES-EMA-DD-20240705-7482647-093839$ES-SANDOZ INC.-SDZ2024ES064851$SANDOZ$$10$YR$$M$Y$$$20240715$$MD$ES$ES
240930671$24093067$1$I$20240709$20240709$20240715$20240715$EXP$$US-OTSUKA-2024_019544$OTSUKA$$$$$F$Y$$$20240715$$CN$US$US
240930681$24093068$1$I$$20240711$20240715$20240715$PER$$US-HALEON-2186666$Haleon PLC$$$$$$Y$$$20240715$$CN$US$US
240930693$24093069$3$F$$20240802$20240715$20240805$EXP$$FR-ANIPHARMA-2024-FR-000109$ANI$$49$YR$$F$Y$$$20240805$$CN$FR$FR
240930701$24093070$1$I$20240710$20240713$20240715$20240715$EXP$GB-MHRA-MED-202407131808148350-KDJRZ$GB-SANDOZ INC.-SDZ2024GB065038$SANDOZ$$47$YR$$F$Y$$$20240715$$HP$GB$GB
240930712$24093071$2$F$20240710$20240715$20240715$20240717$30DAY$$IT-SANDOZ INC.-SDZ2024IT064890$SANDOZ$$40$YR$$M$Y$80$KG$20240717$$CN$IT$IT
240930721$24093072$1$I$$20240713$20240715$20240715$EXP$GB-MHRA-MED-202407131026080490-MKHLY$GB-SANDOZ INC.-SDZ2024GB064994$SANDOZ$$$$$F$Y$$$20240715$$CN$GB$GB
240930731$24093073$1$I$$20240710$20240715$20240715$EXP$GB-MHRA-MED-202407101321247590-LKHQS$GB-OTSUKA-2024_019565$OTSUKA$$$$$$Y$$$20240715$$CN$GB$GB
240930745$24093074$5$F$20240710$20240815$20240715$20240821$EXP$$CA-BEH-2024174330$CSL BEHRING$$81$YR$E$F$Y$72.72$KG$20240821$$HP$CA$CA
240930751$24093075$1$I$20240707$20240711$20240715$20240715$PER$$US-JNJFOC-20240729541$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240715$$CN$US$US
240930761$24093076$1$I$$20240711$20240715$20240715$30DAY$$US-SANDOZ INC.-SDZ2024US064743$SANDOZ$$$$$F$Y$$$20240715$$CN$US$US
240930801$24093080$1$I$$20240710$20240715$20240715$EXP$$GB-MYLANLABS-2024M1065709$MYLAN$$$$$F$Y$$$20240715$$CN$GB$GB
240930811$24093081$1$I$$20240709$20240715$20240715$EXP$$PL-MYLANLABS-2024M1064563$MYLAN$BoroWczyk ZM, Pyszczorska M. Nursing management and care on an adolescent patient with pulmonary embolism - A case study. Pielegniarstwo polskie NR. 2024;2 (92):54-88$15$YR$$F$Y$$$20240715$$HP$PL$PL
240930821$24093082$1$I$20240629$20240712$20240715$20240715$EXP$GB-MHRA-MED-202407121951508790-FZTMR$GB-SANDOZ INC.-SDZ2024GB064993$SANDOZ$$69$YR$$M$Y$58$KG$20240715$$CN$GB$GB
240930831$24093083$1$I$20240708$20240708$20240715$20240715$PER$$US-SA-2024SA204283$SANOFI AVENTIS$$18$YR$A$F$Y$50.8$KG$20240715$$MD$US$US
240930841$24093084$1$I$$20240705$20240715$20240715$PER$$US-SA-2024SA202630$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240715$$MD$US$US
240930851$24093085$1$I$$20240709$20240715$20240715$EXP$$ES-MYLANLABS-2024M1064618$MYLAN$$69$YR$$M$Y$$$20240715$$MD$ES$ES
240930861$24093086$1$I$$20240710$20240715$20240715$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135441$DAIICHI$$38$YR$$F$Y$$$20240715$$CN$US$US
240930871$24093087$1$I$20240514$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405171141332930-KLCBG$GB-TEVA-VS-3218848$TEVA$$89$YR$$F$Y$$$20240715$$PH$GB$GB
240930881$24093088$1$I$20230414$20240705$20240715$20240715$EXP$$BY-BAYER-2024A099855$BAYER$$35$YR$A$F$Y$$$20240715$$HP$BY$BY
240930891$24093089$1$I$$20240710$20240715$20240715$EXP$$US-UCBSA-2024035494$UCB$$$$$$Y$$$20240715$$MD$US$US
240930903$24093090$3$F$$20240814$20240715$20240917$PER$$US-TRAVERE-2024TVT00567$TRAVERE THERAPEUTICS$$22$YR$A$M$Y$92.99$KG$20240917$$CN$US$US
240930911$24093091$1$I$$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024137732$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240930921$24093092$1$I$20240101$20240710$20240715$20240715$EXP$$GB-AMGEN-GBRSP2024138258$AMGEN$$81$YR$E$M$Y$$$20240715$$CN$GB$GB
240930931$24093093$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405121027032300-HPZVD$GB-TEVA-VS-3218515$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240930941$24093094$1$I$$20240619$20240715$20240715$PER$$US-FMCRTG-FMC-2406-000745$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240715$$HP$US$US
240930951$24093095$1$I$$20240622$20240715$20240715$PER$$US-FMCRTG-FMC-2407-000785$FRESENIUS MEDICAL CARE$$65$YR$E$M$Y$$$20240715$$HP$US$US
240930961$24093096$1$I$$20240624$20240715$20240715$PER$$US-FMCRTG-FMC-2406-000755$FRESENIUS MEDICAL CARE$$76$YR$E$F$Y$106$KG$20240715$$HP$US$US
240930971$24093097$1$I$$20240625$20240715$20240715$PER$$US-FMCRTG-FMC-2407-000773$FRESENIUS MEDICAL CARE$$38$YR$A$M$Y$113.1$KG$20240715$$HP$US$US
240930981$24093098$1$I$$20240710$20240715$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20200905200$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240715$$HP$CA$CA
240930991$24093099$1$I$$20240703$20240715$20240715$EXP$$US-FMCRTG-FMC-2407-000801$FRESENIUS MEDICAL CARE$$46$YR$A$F$Y$$$20240715$$HP$US$US
240931001$24093100$1$I$20240601$20240705$20240715$20240715$EXP$GB-MHRA-MED-202406241440310490-TWLVN$GB-RDY-SPO/GBR/24/0010041$DR REDDYS$$49$YR$A$M$Y$120$KG$20240715$$CN$GB$GB
240931011$24093101$1$I$$20240705$20240715$20240715$EXP$$GB-TEVA-VS-3218579$TEVA$$$$A$F$Y$$$20240715$$MD$GB$GB
240931024$24093102$4$F$20240507$20240906$20240715$20240909$EXP$$DE-SANDOZ INC.-SDZ2024DE065070$SANDOZ$$67$YR$$F$Y$$$20240909$$MD$DE$DE
240931031$24093103$1$I$$20240705$20240715$20240715$EXP$US-MLMSERVICE-20240628-PI115400-00099-1$US-RDY-SPO/USA/24/0010172$DR REDDYS$Landers ZD, Mazhar A. Fluoroquinolone-Induced Multisystem Toxicity: A Case Report. Cureus. 2024;16(5):e61174. DOI: 10.7759/cureus.61174.$41$YR$A$M$Y$$$20240715$$MD$US$US
240931041$24093104$1$I$$20240710$20240715$20240715$EXP$$US-SANDOZ INC.-SDZ2023US003609$SANDOZ$$$$$M$Y$72.57$KG$20240715$$MD$US$US
240931061$24093106$1$I$$20240702$20240715$20240715$PER$$US-BIOMARINAP-US-2024-158942$BIOMARIN$$$$$$Y$$$20240715$$CN$US$US
240931071$24093107$1$I$20240516$20240703$20240715$20240715$PER$$US-BIOMARINAP-US-2024-158980$BIOMARIN$$$$$$Y$$$20240715$$CN$US$US
240931081$24093108$1$I$$20240708$20240715$20240715$PER$$US-MYLANLABS-2024M1064747$MYLAN$$$$$F$Y$$$20240715$$CN$US$US
240931091$24093109$1$I$20240304$20240705$20240715$20240715$EXP$GB-MHRA-MED-202406250632099320-KRPZL$GB-TEVA-VS-3218723$TEVA$$73$YR$$M$Y$73$KG$20240715$$CN$GB$GB
240931101$24093110$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405071347078800-MHQSN$GB-TEVA-VS-3218829$TEVA$$$$$F$Y$56$KG$20240715$$HP$GB$GB
240931111$24093111$1$I$$20240703$20240715$20240715$PER$$US-BIOMARINAP-US-2024-159046$BIOMARIN$$$$$$Y$$$20240715$$CN$US$US
240931121$24093112$1$I$$20240705$20240715$20240715$EXP$$GB-TEVA-VS-3218698$TEVA$$85$YR$$M$Y$93$KG$20240715$$MD$GB$GB
240931131$24093113$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405072127436610-YVGCZ$GB-TEVA-VS-3218769$TEVA$$$$$F$Y$$$20240715$$CN$GB$GB
240931141$24093114$1$I$$20240711$20240715$20240715$EXP$GB-MHRA-MED-202407111600294780-SVPHF$GB-SANDOZ INC.-SDZ2024GB064992$SANDOZ$$58$YR$$F$Y$$$20240715$$PH$GB$GB
240931151$24093115$1$I$$20240702$20240715$20240715$PER$$US-PFIZER INC-202400208837$PFIZER$$$$$M$Y$$$20240715$$HP$US$US
240931161$24093116$1$I$$20240711$20240715$20240715$PER$$US-JNJFOC-20240731778$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$MD$US$US
240931171$24093117$1$I$$20240711$20240715$20240715$EXP$$CA-JNJFOC-20240733949$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$HP$CA$CA
240931181$24093118$1$I$20240705$20240711$20240715$20240715$EXP$$CN-PFIZER INC-PV202400091340$PFIZER$$58$YR$$F$Y$$$20240715$$HP$CN$CN
240931191$24093119$1$I$$20240715$20240715$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039828$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$$$20240715$$CN$US$US
240931201$24093120$1$I$20190416$20240708$20240715$20240715$EXP$FR-AFSSAPS-PC2024000517$FR-REGENERON PHARMACEUTICALS, INC.-2024-094889$REGENERON$$82$YR$$M$Y$$$20240715$$MD$FR$FR
240931211$24093121$1$I$$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405151902076100-FZBVM$GB-TEVA-VS-3218832$TEVA$$$$$F$Y$54$KG$20240715$$CN$GB$GB
240931221$24093122$1$I$20230726$20240705$20240715$20240715$EXP$$IN-INCYTE CORPORATION-2024IN000232$INCYTE$$$$$$Y$$$20240715$$CN$IN$IN
240931231$24093123$1$I$20240531$20240704$20240715$20240715$EXP$$CN-TAKEDA-2024TUS070756$TAKEDA$$58$YR$$F$Y$55$KG$20240715$$HP$CN$CN
240931241$24093124$1$I$$20240710$20240715$20240715$PER$$US-MYLANLABS-2024M1065402$MYLAN$$$$$F$Y$$$20240715$$CN$US$US
240931251$24093125$1$I$$20240710$20240715$20240715$EXP$$US-OTSUKA-2024_019552$OTSUKA$$$$$M$Y$68.04$KG$20240715$$CN$US$US
240931261$24093126$1$I$$20240711$20240715$20240715$EXP$$US-KYOWAKIRIN-2024KK016879$KYOWA$$$$$$Y$$$20240715$$MD$US$US
240931281$24093128$1$I$20240621$20240704$20240715$20240715$EXP$$FR-AstraZeneca-2024A153667$ASTRAZENECA$$66$YR$$F$Y$65$KG$20240715$$MD$FR$
240931291$24093129$1$I$20240620$20240705$20240715$20240715$EXP$$GB-TEVA-VS-3218766$TEVA$$61$YR$$F$Y$60$KG$20240715$$MD$GB$GB
240931301$24093130$1$I$$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160699$ASTRAZENECA$$$$$M$Y$$$20240715$$HP$FR$
240931311$24093131$1$I$$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160213$ASTRAZENECA$$60$YR$$F$Y$$$20240715$$HP$FR$
240931351$24093135$1$I$20231001$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160161$ASTRAZENECA$$69$YR$$F$Y$$$20240715$$HP$FR$
240931361$24093136$1$I$$20240712$20240715$20240715$EXP$$CN-AstraZeneca-2024A160237$ASTRAZENECA$$68$YR$$F$Y$51$KG$20240715$$MD$CN$
240931371$24093137$1$I$$20240711$20240715$20240715$EXP$$IT-MYLANLABS-2024M1065154$MYLAN$Di Trana A, Di Giorgi A, Carlier J, Serra F, Busard? FP, Pichini S.. ^Tranq-dope^: The first fatal intoxication due to xylazine-adulterated heroin in Italy. Clin Chim Acta. 2024;561:119826$33$YR$$M$Y$$$20240715$$HP$IT$IT
240931381$24093138$1$I$$20240703$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010130$DR REDDYS$Halawi H, Harris JE, Goodarzi A, Yau S, Youssef JG, Botros M, et al. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy. 2024 Mar;44(3): 283-289. doi:10.1002/phar.2910.$58$YR$A$M$Y$$$20240715$$HP$US$US
240931391$24093139$1$I$$20240703$20240715$20240715$PER$$US-RDY-LIT/USA/24/0010132$DR REDDYS$Halawi H, Harris JE, Goodarzi A, Yau S, Youssef JG, Botros M, et al. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy. 2024 Mar;44(3): 283-289. doi:10.1002/phar.2910.$24$YR$A$M$Y$$$20240715$$HP$US$US
240931401$24093140$1$I$$20240703$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010128$DR REDDYS$Halawi H, Harris JE, Goodarzi A, Yau S, Youssef JG, Botros M, et al. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy. 2024 Mar;44(3): 283-289. doi:10.1002/phar.2910.$29$YR$A$M$Y$$$20240715$$HP$US$US
240931413$24093141$3$F$20240101$20240904$20240715$20240913$EXP$$HR-TEVA-VS-3220731$TEVA$$55$YR$$F$Y$$$20240913$$MD$HR$HR
240931431$24093143$1$I$$20240705$20240715$20240715$EXP$$GB-TEVA-VS-3219880$TEVA$$$$A$F$Y$$$20240715$$CN$GB$GB
240931442$24093144$2$F$20200502$20240711$20240715$20240718$EXP$PL-URPL-1-3706-2020$PL-MYLANLABS-2024M1065048$MYLAN$$63$YR$$M$Y$90$KG$20240718$$MD$PL$PL
240931452$24093145$2$F$20221229$20240524$20240715$20240717$PER$$US-APELLIS-APL-2022-001865$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
240931462$24093146$2$F$20240706$20240815$20240715$20240830$PER$$US-MYLANLABS-2024M1064720$MYLAN$$66$YR$$F$Y$53.07$KG$20240830$$CN$US$US
240931471$24093147$1$I$$20240711$20240715$20240715$EXP$$CA-MYLANLABS-2024M1065661$MYLAN$$37$YR$$M$Y$122$KG$20240715$$HP$CA$CA
240931481$24093148$1$I$$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160087$ASTRAZENECA$$57$YR$$M$Y$$$20240715$$HP$FR$
240931491$24093149$1$I$$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160311$ASTRAZENECA$$73$YR$$F$Y$46$KG$20240715$$HP$FR$
240931512$24093151$2$F$20100427$20240730$20240715$20240802$EXP$$TW-ASTELLAS-2010002140$ASTELLAS$$56$YR$$M$Y$$$20240802$$HP$GB$TW
240931521$24093152$1$I$$20240709$20240715$20240715$EXP$$AU-PFIZER INC-PV202400091153$PFIZER$Li, E.. A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies. European Journal of Haematology. 2024;10.1111/ejh.14266$$$E$$Y$$$20240715$$HP$AU$AU
240931531$24093153$1$I$$20240701$20240715$20240715$EXP$$US-TEVA-VS-3219262$TEVA$Luskin MR, Murakami MA, Keating J, Winer ES, Garcia JS, Stahl M, et al. A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL and Blast Phase CML in Adults. Blood 2023; 142 (Suppl. 1) 965 (plus Oral Presentation).$85$YR$$M$Y$$$20240715$$MD$US$US
240931541$24093154$1$I$$20240709$20240715$20240715$EXP$$CA-SANDOZ INC.-SDZ2024CA064147$SANDOZ$$43$YR$$F$Y$$$20240715$$HP$CA$CA
240931561$24093156$1$I$$20240709$20240715$20240715$PER$$US-MYLANLABS-2024M1064687$MYLAN$$$$$M$Y$113.85$KG$20240715$$CN$US$US
240931571$24093157$1$I$20240519$20240709$20240715$20240715$EXP$FR-AFSSAPS-AVTO2024000105$FR-MYLANLABS-2024M1064542$MYLAN$$50$YR$$M$Y$$$20240715$$MD$FR$FR
240931581$24093158$1$I$20240112$20240709$20240715$20240715$EXP$FR-AFSSAPS-GR2024000808$FR-MYLANLABS-2024M1064689$MYLAN$$78$YR$$F$Y$$$20240715$$PH$FR$FR
240931592$24093159$2$F$20230301$20240924$20240715$20240928$EXP$$JP-009507513-2407JPN001079J$MERCK$$28$YR$$F$Y$$$20240928$$MD$JP$JP
240931603$24093160$3$F$20220127$20240715$20240715$20240919$EXP$$NVSC2022CH156897$NOVARTIS$$63$YR$$F$Y$70.2$KG$20240919$$MD$CH$CH
240931611$24093161$1$I$20240401$20240709$20240715$20240715$EXP$$US-AMGEN-USASP2024137648$AMGEN$$22$YR$A$M$Y$$$20240715$$CN$US$US
240931621$24093162$1$I$20240626$20240711$20240715$20240715$EXP$$NVSC2024CN145313$NOVARTIS$$89$YR$$M$Y$50$KG$20240715$$HP$CN$CN
240931631$24093163$1$I$20240618$20240709$20240715$20240715$EXP$$DE-MYLANLABS-2024M1064680$MYLAN$$85$YR$$F$Y$52$KG$20240715$$MD$DE$DE
240931641$24093164$1$I$20240623$20240710$20240715$20240715$EXP$$CN-WOODWARD-2024-CN-000261$WOODWARD PHARMA SERVICES$$35$YR$$F$Y$$$20240712$$HP$CN$CN
240931652$24093165$2$F$$20240917$20240715$20240919$EXP$$US-KYOWAKIRIN-2024KK016623$KYOWA$$$$$$Y$$$20240919$$HP$US$US
240931661$24093166$1$I$$20240703$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010126$DR REDDYS$Henry PJ, Wen JH, Feldman EB, Vargas J. Minocycline Induced Parenchymal Lung Disease with Peripheral Eosinophilia. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: A1999. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1999.$70$YR$E$M$Y$$$20240715$$HP$US$US
240931671$24093167$1$I$20240101$20240712$20240715$20240715$PER$$US-JNJFOC-20240734887$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240715$$HP$US$US
240931691$24093169$1$I$$20240712$20240715$20240715$EXP$$CN-TAKEDA-2024TUS071378$TAKEDA$$$$$M$Y$$$20240715$$CN$CN$CN
240931702$24093170$2$F$20240706$20240718$20240715$20240723$EXP$$JP-TAKEDA-2024TUS071283$TAKEDA$$16$YR$$F$Y$60.4$KG$20240723$$MD$JP$JP
240931711$24093171$1$I$$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407009169$ELI LILLY AND CO$$$$$F$Y$$$20240715$$CN$US$US
240931721$24093172$1$I$20210127$20240711$20240715$20240715$EXP$$KR-WOODWARD-2024-KR-000038$WOODWARD PHARMA SERVICES$$83$YR$$F$Y$$$20240715$$PH$KR$KR
240931731$24093173$1$I$$20240705$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407005000$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240715$$CN$US$US
240931741$24093174$1$I$$20240712$20240715$20240715$PER$$US-PFIZER INC-202400213605$PFIZER$$$$$F$Y$$$20240715$$MD$US$US
240931751$24093175$1$I$$20240713$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112057$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$48.53$KG$20240715$$CN$US$US
240931761$24093176$1$I$$20240711$20240715$20240715$EXP$$ZA-BRISTOL-MYERS SQUIBB COMPANY-2024-111716$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240715$$HP$ZA$ZA
240931771$24093177$1$I$$20240711$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111722$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240715$$CN$US$US
240931781$24093178$1$I$$20240712$20240715$20240715$PER$$US-JNJFOC-20240736830$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$CN$US$US
240931792$24093179$2$F$$20240722$20240715$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112090$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240723$$CN$US$US
240931801$24093180$1$I$20240624$20240702$20240715$20240715$PER$$US-JNJFOC-20240710852$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240715$$CN$US$US
240931811$24093181$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111527$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240715$$MD$US$US
240931821$24093182$1$I$20240711$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112179$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240715$$CN$US$US
240931831$24093183$1$I$$20240619$20240715$20240715$PER$$US-IMP-2024000423$Harrow Health$$$$E$F$Y$$$20240715$$CN$US$US
240931851$24093185$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145140$NOVARTIS$$$$$$Y$$$20240715$$MD$US$US
240931862$24093186$2$F$$20240807$20240715$20240807$PER$$US-ALXN-202407USA000728US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240931871$24093187$1$I$$20240709$20240715$20240715$EXP$$AU-PFIZER INC-202400212496$PFIZER$Li, E.. A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies. European Journal of Haematology. 2024;10.1111/ejh.14266$$$E$$Y$$$20240715$$HP$AU$AU
240931881$24093188$1$I$$20240704$20240715$20240715$EXP$$US-RDY-LIT/USA/24/0010100$DR REDDYS$Rashid AM, Cheung TP, Paracha R, Vitale GC, Vyce SD. Minocycline-Induced Black Bone Disease in Foot and Ankle Surgery: A Case Report. Journal of the American Podiatric Medical Association. 2024 Mar;114(2): doi:10.7547/23-091.$51$YR$A$M$Y$$$20240715$$HP$US$US
240931891$24093189$1$I$$20240703$20240715$20240715$PER$$US-RDY-LIT/USA/24/0010134$DR REDDYS$Grand D, Davis M, Dagrosa A, Carter J, Cloutier J. Lymphomatoid Drug-Induced Hypersensitivity Syndrome to Minocycline. American Journal of Dermatopathology. 2024 Jul;46(7): S16. doi:10.1097/DAD.0000000000002757.$18$YR$A$M$Y$$$20240715$$HP$US$US
240931901$24093190$1$I$$20240705$20240715$20240715$PER$$US-SA-2023SA325543$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240715$$CN$US$US
240931921$24093192$1$I$$20240704$20240715$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-112027$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240715$$HP$CA$CA
240931941$24093194$1$I$$20240710$20240715$20240715$EXP$$JP-ABBVIE-5824325$ABBVIE$$$$$$Y$$$20240715$$PH$JP$JP
240931953$24093195$3$F$$20240828$20240715$20240904$PER$$US-PFIZER INC-PV202400081757$PFIZER$$43$YR$$F$Y$$$20240904$$CN$US$US
240931961$24093196$1$I$20240705$20240705$20240715$20240715$PER$$US-EMD Serono-2024037251$EMD SERONO INC$$62$YR$A$M$Y$$$20240715$$CN$US$US
240931971$24093197$1$I$$20240715$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112093$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240715$$CN$US$US
240931983$24093198$3$F$20240711$20240725$20240715$20240729$PER$$US-JNJFOC-20240736651$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240729$$CN$US$US
240931991$24093199$1$I$20240201$20240709$20240715$20240715$EXP$FR-AFSSAPS-LM2024000374$FR-MYLANLABS-2024M1064537$MYLAN$$68$YR$$F$Y$63$KG$20240715$$MD$FR$FR
240932002$24093200$2$F$20240101$20240710$20240715$20240718$PER$$US-SA-2024SA203277$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240718$$MD$US$US
240932011$24093201$1$I$20240710$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139309$AMGEN$$79$YR$E$F$Y$$$20240715$$PH$US$US
240932021$24093202$1$I$$20240709$20240715$20240715$EXP$$NVSC2024TH144481$NOVARTIS$Tiwattanon K, John S, Koomdee N, Jinda P, Rachanakul J, Jantararoungtong T et al.. Implementation of HLA-B*15:02 genotyping as standard-of-care for reducing carbamazepine/oxcarbazepine induced cutaneous adverse drug reactions in thailand. FRONTIERS IN PHARMACOLOGY. 2022;13:1-10$93$YR$$M$Y$$$20240715$$HP$TH$TH
240932031$24093203$1$I$20240701$20240710$20240715$20240715$PER$$US-PFIZER INC-PV202400091469$PFIZER$$61$YR$$F$Y$$$20240715$$HP$US$US
240932042$24093204$2$F$$20240720$20240715$20240724$PER$$US-JNJFOC-20240737431$JOHNSON AND JOHNSON$$78$YR$E$F$Y$81.6$KG$20240724$$CN$US$US
240932051$24093205$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400091805$PFIZER$$46$YR$$F$Y$$$20240715$$CN$US$US
240932062$24093206$2$F$$20240814$20240715$20240814$PER$$US-PFIZER INC-PV202400092032$PFIZER$$8$YR$$F$Y$26.5$KG$20240814$$MD$US$US
240932071$24093207$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400091824$PFIZER$$$$$$Y$$$20240715$$CN$US$US
240932081$24093208$1$I$20240601$20240711$20240715$20240715$PER$$US-PFIZER INC-PV202400091923$PFIZER$$46$YR$$F$Y$$$20240715$$HP$US$US
240932092$24093209$2$F$20240708$20240716$20240715$20240718$PER$$IE-PFIZER INC-202400212450$PFIZER$$$$$$Y$$$20240718$$PH$IE$IE
240932101$24093210$1$I$$20240711$20240715$20240715$PER$$US-PFIZER INC-202400213887$PFIZER$$60$YR$$$Y$$$20240715$$MD$US$US
240932111$24093211$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110442$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240715$$CN$US$US
240932121$24093212$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111917$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240715$$CN$US$US
240932131$24093213$1$I$20240601$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111906$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$114.76$KG$20240715$$PH$US$US
240932141$24093214$1$I$20240110$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405161316449030-BKDSY$GB-RDY-SPO/GBR/24/0010061$DR REDDYS$$13$YR$T$M$Y$$$20240715$$CN$GB$GB
240932152$24093215$2$F$$20240802$20240715$20240813$EXP$GB-MHRA-MED-202405162318157690-FNGQT$GB-RDY-SPO/GBR/24/0010112$DR REDDYS$$$$$M$Y$$$20240813$$CN$GB$GB
240932161$24093216$1$I$20240612$20240614$20240715$20240715$PER$$US-IMP-2024000400$Harrow Health$$75$YR$E$F$Y$$$20240715$$CN$US$US
240932171$24093217$1$I$$20240708$20240715$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039159$BOEHRINGER INGELHEIM$$$$$M$Y$81.647$KG$20240715$$CN$US$US
240932183$24093218$3$F$20240101$20240828$20240715$20240923$PER$$US-SA-2024SA089066$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240923$$MD$US$US
240932191$24093219$1$I$$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407006535$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240715$$CN$US$US
240932201$24093220$1$I$20240709$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407008793$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240715$$CN$US$US
240932211$24093221$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110402$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240715$$HP$US$US
240932222$24093222$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3217892$TEVA$Hodson EL, Kranyak A, Salem I, Buckey JC. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases. J-Tissue-Viability 2024;.; Hodson EL, Kranyak A, Salem I, Buckey JC. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases. J-Tissue-Viability 2024;.; Hodson EL, Kranyak A, Salem I, Buckey JC. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases. J-Tissue-Viability 2024;.$54$YR$$F$Y$$$20240802$$HP$US$US
240932231$24093223$1$I$20240101$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138672$AMGEN$$71$YR$E$F$Y$$$20240715$$HP$US$US
240932241$24093224$1$I$20240601$20240704$20240715$20240715$EXP$$CN-KYOWAKIRIN-2024KK016795$KYOWA$$$$$$Y$$$20240715$$HP$FI$CN
240932251$24093225$1$I$20240701$20240710$20240715$20240715$PER$$US-ABBVIE-5838438$ABBVIE$$21$YR$$F$Y$$$20240715$$CN$US$US
240932261$24093226$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144867$NOVARTIS$$$$$F$Y$$$20240715$$HP$US$US
240932271$24093227$1$I$20240514$20240712$20240715$20240715$EXP$FR-AFSSAPS-PP2024000775$NVSC2024FR144857$NOVARTIS$$62$YR$$F$Y$75$KG$20240715$$MD$FR$FR
240932281$24093228$1$I$20240612$20240712$20240715$20240715$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039794$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$52$KG$20240715$$HP$CO$CO
240932292$24093229$2$F$20240710$20240718$20240715$20240802$EXP$$US-ALXN-202407USA000707US$ALEXION PHARMACEUTICALS$$57$YR$$F$Y$113.38$KG$20240802$$MD$US$US
240932301$24093230$1$I$20240619$20240709$20240715$20240715$EXP$FR-AFSSAPS-LM2024000377$FR-MYLANLABS-2024M1064459$MYLAN$$14$YR$$M$Y$55.3$KG$20240715$$MD$FR$FR
240932311$24093231$1$I$$20240614$20240715$20240715$PER$$US-IMP-2024000401$Harrow Health$$$$E$F$Y$$$20240715$$CN$US$US
240932321$24093232$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145192$NOVARTIS$$$$$F$Y$$$20240715$$CN$US$US
240932331$24093233$1$I$$20240705$20240715$20240715$EXP$$IT-TEVA-VS-3177492$TEVA$$31$YR$$M$Y$$$20240715$$CN$IT$IT
240932341$24093234$1$I$$20240701$20240715$20240715$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-06295$HIKMA$$15$YR$$F$Y$$$20240715$$HP$GB$GB
240932351$24093235$1$I$20240626$20240709$20240715$20240715$EXP$IT-MINISAL02-993575$IT-MYLANLABS-2024M1064594$MYLAN$$74$YR$$F$Y$$$20240715$$PH$IT$IT
240932362$24093236$2$F$20231123$20240826$20240715$20240830$EXP$FR-AFSSAPS-RS2023000963$FR-MYLANLABS-2024M1064451$MYLAN$$43$YR$$F$Y$92$KG$20240830$$MD$FR$FR
240932372$24093237$2$F$20230701$20240723$20240715$20240729$EXP$$US-BIOGEN-2023BI01218910$BIOGEN$$57$YR$$F$Y$$$20240729$$CN$US$US
240932381$24093238$1$I$20240630$20240702$20240715$20240715$PER$$US-ROCHE-10000019088$ROCHE$$76$YR$E$M$Y$81.5$KG$20240715$$PH$US$US
240932391$24093239$1$I$20240607$20240709$20240715$20240715$EXP$FR-AFSSAPS-GR2024000832$FR-MYLANLABS-2024M1064518$MYLAN$$10$YR$$M$Y$35$KG$20240715$$PH$FR$FR
240932401$24093240$1$I$20231101$20240712$20240715$20240715$EXP$IT-MINISAL02-991448$IT-ROCHE-10000025571$ROCHE$$41$YR$A$F$Y$$$20240715$$MD$IT$IT
240932411$24093241$1$I$20240301$20240628$20240715$20240715$PER$$US-009507513-2407USA000307$MERCK$$84$YR$$M$Y$$$20240715$$CN$US$US
240932421$24093242$1$I$$20240712$20240715$20240715$PER$$US-JNJFOC-20240734503$JOHNSON AND JOHNSON$$$$$F$Y$$$20240715$$CN$US$US
240932431$24093243$1$I$$20240705$20240715$20240715$PER$$US-VERTEX PHARMACEUTICALS-2024-011258$VERTEX$$$$C$F$Y$$$20240715$$CN$US$US
240932441$24093244$1$I$20231001$20240712$20240715$20240715$EXP$$US-OTSUKA-2024_019751$OTSUKA$$89$YR$$M$Y$$$20240715$$HP$US$US
240932453$24093245$3$F$20240101$20240805$20240715$20240806$EXP$$US-KYOWAKIRIN-2024KK016928$KYOWA$$$$$$Y$$$20240806$$HP$US$US
240932462$24093246$2$F$$20240723$20240715$20240801$EXP$$DK-TEVA-VS-3219092$TEVA$$$$E$F$Y$$$20240801$$CN$DK$DK
240932471$24093247$1$I$20240412$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405161342509090-YDSMH$GB-RDY-SPO/GBR/24/0010077$DR REDDYS$$55$YR$A$F$Y$$$20240715$$HP$GB$GB
240932481$24093248$1$I$$20240710$20240715$20240715$EXP$$US-AstraZeneca-2024A159306$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$US$
240932491$24093249$1$I$$20240710$20240715$20240715$PER$$US-ALXN-202407USA000706US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
240932502$24093250$2$F$20240601$20240806$20240715$20240807$PER$$US-ALXN-202407USA000679US$ALEXION PHARMACEUTICALS$$60$YR$$$Y$$$20240807$$CN$US$US
240932522$24093252$2$F$$20240913$20240715$20240916$PER$$US-PFIZER INC-202400135737$PFIZER$$84$YR$$F$Y$$$20240916$$CN$US$US
240932531$24093253$1$I$20240601$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111732$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240715$$HP$US$US
240932542$24093254$2$F$$20240919$20240715$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111921$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240920$$CN$US$US
240932552$24093255$2$F$20240601$20240819$20240715$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110855$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240827$$HP$US$US
240932561$24093256$1$I$20240703$20240710$20240715$20240715$EXP$$US-BIOGEN-2024BI01273392$BIOGEN$$66$YR$$F$Y$$$20240715$$CN$US$US
240932603$24093260$3$F$20240629$20240905$20240715$20240909$PER$$US-PFIZER INC-202400212644$PFIZER$$23$YR$$M$Y$65.77$KG$20240909$$HP$US$US
240932612$24093261$2$F$$20240815$20240715$20240815$PER$$US-PFIZER INC-PV202400090036$PFIZER$$15$YR$$M$Y$$$20240815$$MD$US$US
240932623$24093262$3$F$20180522$20240911$20240715$20240917$EXP$$AT-PFIZER INC-2022SGN07486$PFIZER$$41$YR$$F$Y$$$20240917$$MD$AT$AT
240932641$24093264$1$I$20240507$20240705$20240715$20240715$EXP$GB-MHRA-MED-202405152018230800-ZLDHK$GB-RDY-SPO/GBR/24/0010119$DR REDDYS$$27$YR$A$F$Y$70$KG$20240715$$CN$GB$GB
240932651$24093265$1$I$$20240710$20240715$20240715$PER$$US-ALXN-202407USA000683US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
240932662$24093266$2$F$$20240807$20240715$20240807$PER$$US-ALXN-202407USA000673US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240932672$24093267$2$F$$20240711$20240715$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111741$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240716$$MD$US$US
240932681$24093268$1$I$20210101$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111505$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240715$$CN$US$US
240932691$24093269$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111434$BRISTOL MYERS SQUIBB$$33$YR$A$M$Y$$$20240715$$HP$US$US
240932701$24093270$1$I$$20240625$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102458$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$82.55$KG$20240715$$MD$US$US
240932711$24093271$1$I$$20240702$20240715$20240715$EXP$$US-GENEYORK-2024PPLIT00041$GENEYORK PHARMA$Valido K, et al..Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach..JAAD Case Reports.apr-2024;48:49-53$52$YR$A$F$Y$$$20240715$$MD$US$US
240932721$24093272$1$I$$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024138822$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240932731$24093273$1$I$20240626$20240709$20240715$20240715$EXP$IT-MINISAL02-993571$IT-MYLANLABS-2024M1064565$MYLAN$$74$YR$$F$Y$$$20240715$$PH$IT$IT
240932741$24093274$1$I$20240101$20240617$20240715$20240715$PER$$US-IMP-2024000406$Harrow Health$$$$E$M$Y$$$20240715$$CN$US$US
240932751$24093275$1$I$$20240705$20240715$20240715$EXP$$DE-AstraZeneca-2024A160183$ASTRAZENECA$$$$$M$Y$$$20240715$$CN$DE$
240932771$24093277$1$I$$20240707$20240715$20240715$EXP$$JP-009507513-2407JPN001606J$MERCK$Sakai H, Takamatsu Y, Saito K, Yoshikawa T, Hasegawa K, Kitano A, et al.. EP-0505 Experience with perioperative drug therapy using pembrolizumab in our department. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 304$$$$F$Y$$$20240715$$MD$JP$JP
240932792$24093279$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3219006$TEVA$Rao M, Casias M, Abidi MZ. Disseminated Scedosporium infection in the early post-kidney transplant period. Transpl-Infect-Dis 2024; 26 (2):.; Rao M, Casias M, Abidi MZ. Disseminated Scedosporium infection in the early post-kidney transplant period. Transpl-Infect-Dis 2024; 26 (2):.$63$YR$$F$Y$$$20240802$$HP$US$US
240932802$24093280$2$F$20240118$20240815$20240715$20240819$EXP$$US-Taiho Oncology Inc-2023-010066$TAIHO ONCOLOGY INC$$72$YR$E$F$Y$83.55$KG$20240819$$CN$US$US
240932811$24093281$1$I$20230828$20240703$20240715$20240715$EXP$$US-ELI_LILLY_AND_COMPANY-US202407003881$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240715$$CN$US$US
240932821$24093282$1$I$$20240709$20240715$20240715$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407006521$ELI LILLY AND CO$$76$YR$E$M$Y$70$KG$20240715$$CN$CN$CN
240932831$24093283$1$I$$20240703$20240715$20240715$EXP$GB-MHRA-MED-202407031058459900-QWPFS$GB-ELI_LILLY_AND_COMPANY-GB202407003237$ELI LILLY AND CO$$$$$F$Y$$$20240715$$CN$GB$GB
240932841$24093284$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007950$ELI LILLY AND CO$$$$$M$Y$$$20240715$$CN$US$US
240932851$24093285$1$I$$20240703$20240715$20240715$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002887$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240715$$CN$US$US
240932861$24093286$1$I$20240710$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007712$ELI LILLY AND CO$$$$$F$Y$$$20240715$$CN$US$US
240932872$24093287$2$F$$20240806$20240715$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202406007603$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240816$$HP$US$US
240932881$24093288$1$I$20230610$20240702$20240715$20240715$EXP$$US-ELI_LILLY_AND_COMPANY-US202407003161$ELI LILLY AND CO$$49$YR$A$$Y$$$20240715$$LW$US$US
240932891$24093289$1$I$$20240703$20240715$20240715$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002705$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240715$$CN$US$US
240932901$24093290$1$I$$20240703$20240715$20240715$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202407004387$ELI LILLY AND CO$$$$$M$Y$$$20240715$$MD$SA$SA
240932911$24093291$1$I$20231201$20240703$20240715$20240715$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407003311$ELI LILLY AND CO$$$$$M$Y$62.5$KG$20240715$$CN$DE$DE
240932921$24093292$1$I$$20240703$20240715$20240715$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407003064$ELI LILLY AND CO$$$$$F$Y$$$20240715$$CN$DE$DE
240932932$24093293$2$F$20220301$20240814$20240715$20240827$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202407003400$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240827$$CN$ES$ES
240932941$24093294$1$I$20230101$20240703$20240715$20240715$EXP$$US-ELI_LILLY_AND_COMPANY-US202407003525$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240715$$CN$US$US
240932951$24093295$1$I$$20240710$20240715$20240715$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007135$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240715$$HP$US$US
240932961$24093296$1$I$$20240701$20240715$20240715$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407002185$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240715$$CN$FR$FR
240932971$24093297$1$I$$20240703$20240715$20240715$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202407004487$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240715$$MD$AE$AE
240932982$24093298$2$F$20240601$20240822$20240715$20240903$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004131$ELI LILLY AND CO$$65$YR$E$M$Y$138.3$KG$20240903$$MD$US$US
240932992$24093299$2$F$$20240712$20240715$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111425$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$$$20240717$$PH$US$US
240933001$24093300$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111625$BRISTOL MYERS SQUIBB$$79$YR$E$$Y$75.75$KG$20240715$$CN$US$US
240933011$24093301$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110464$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240715$$CN$US$US
240933021$24093302$1$I$20230601$20240704$20240715$20240715$EXP$$JP-EAGLE PHARMACEUTICALS, INC.-JP-2024EAG000176$EAGLE$$62$YR$$M$Y$$$20240715$$MD$JP$JP
240933031$24093303$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111292$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240715$$CN$US$US
240933042$24093304$2$F$$20240814$20240715$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112026$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$76.2$KG$20240820$$CN$US$US
240933052$24093305$2$F$$20240807$20240715$20240807$PER$$US-ALXN-202407USA000668US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240933061$24093306$1$I$$20240710$20240715$20240715$PER$$US-ALXN-202407USA000632US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240715$$CN$US$US
240933071$24093307$1$I$20240715$20240715$20240715$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039854$BOEHRINGER INGELHEIM$$76$YR$E$$Y$$$20240715$$CN$US$US
240933081$24093308$1$I$$20240712$20240715$20240715$EXP$$US-OTSUKA-2024_019742$OTSUKA$$$$$$Y$$$20240715$$CN$US$US
240933091$24093309$1$I$$20240712$20240715$20240715$EXP$$US-PURDUE PHARMA-USA-2024-0310732$PURDUE$$$$$F$Y$$$20240715$$CN$US$US
240933102$24093310$2$F$20230301$20240716$20240715$20240725$EXP$$AT-PURDUE-USA-2024-0310549$PURDUE$$52$YR$$F$Y$$$20240725$$CN$AT$AT
240933111$24093311$1$I$$20240711$20240715$20240715$EXP$$US-PURDUE PHARMA-USA-2024-0310761$PURDUE$$18$YR$$F$Y$$$20240715$$CN$US$US
240933121$24093312$1$I$$20240712$20240715$20240715$EXP$CA-HEALTHCANVIG-E2B_07096705$CA-PURDUE-USA-2024-0310738$PURDUE$$33$YR$$F$Y$$$20240715$$MD$CA$CA
240933131$24093313$1$I$20240517$20240709$20240715$20240715$EXP$$CH-PURDUE-USA-2024-0310751$PURDUE$$76$YR$$F$Y$$$20240715$$MD$CH$CH
240933141$24093314$1$I$$20240711$20240715$20240715$EXP$CA-HEALTHCANVIG-E2B_07121986$CA-PURDUE-USA-2024-0310735$PURDUE$Waldner RC, Doulla M, Atallah J, Rathwell S, Grimbly C.. Leuprolide Acetate and QTc Interval in Gender-Diverse Youth. Transgender Health. 2023;8(1):84-88$17$YR$$M$Y$$$20240715$$HP$CA$CA
240933151$24093315$1$I$$20240704$20240715$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107796$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240715$$HP$CA$CA
240933161$24093316$1$I$$20240711$20240715$20240715$PER$$US-PURDUE PHARMA-USA-2024-0310760$PURDUE$$$$$M$Y$$$20240715$$CN$US$US
240933171$24093317$1$I$$20240711$20240715$20240715$PER$$US-PURDUE PHARMA-USA-2024-0310733$PURDUE$$$$$$Y$$$20240715$$CN$US$US
240933193$24093319$3$F$$20240909$20240715$20240918$PER$$US-BIOMARINAP-US-2024-159149$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
240933201$24093320$1$I$20240523$20240523$20240715$20240715$PER$$US-MEITHEAL-2024MPSPO00151$MEITHEAL PHARMACEUTICALS$$$$$M$Y$$$20240711$$HP$US$US
240933212$24093321$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3219129$TEVA$Hirt PA, Gonzalez AM, Acosta AS, Price A, Elgart GW, Nousari CH, et al. Cutaneous Mycobacterium avium-intracellulare infection masquerading as sarcoidosis. Pediatr-Dermatol 2024; 41 (3): 497-500.; Hirt PA, Gonzalez AM, Acosta AS, Price A, Elgart GW, Nousari CH, et al. Cutaneous Mycobacterium avium-intracellulare infection masquerading as sarcoidosis. Pediatr-Dermatol 2024; 41 (3): 497-500.; Hirt PA, Gonzalez AM, Acosta AS, Price A, Elgart GW, Nousari CH, et al. Cutaneous Mycobacterium avium-i...$14$YR$$M$Y$$$20240802$$MD$US$US
240933222$24093322$2$F$20240628$20240716$20240715$20240722$PER$$US-BRACCO-2024US04216$BRACCO$$65$YR$$M$Y$$$20240722$$CN$US$US
240933241$24093324$1$I$20240704$20240712$20240715$20240715$EXP$$US-BAUSCHBL-2024BNL030084$BAUSCH AND LOMB$$92$YR$$M$Y$$$20240715$$CN$US$US
240933251$24093325$1$I$$20240709$20240715$20240715$EXP$$DE-JNJFOC-20240733043$JOHNSON AND JOHNSON$$$$$$Y$$$20240715$$MD$DE$DE
240933261$24093326$1$I$20240301$20240710$20240715$20240715$EXP$FR-AFSSAPS-NT2024000806$FR-009507513-2407FRA005013$MERCK$$66$YR$$F$Y$55$KG$20240715$$MD$FR$FR
240933271$24093327$1$I$$20240715$20240715$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039843$BOEHRINGER INGELHEIM$$$$$$Y$$$20240715$$CN$US$US
240933281$24093328$1$I$20240712$20240715$20240715$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039813$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240715$$CN$US$US
240933302$24093330$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3219133$TEVA$Kumari R, Singla T, Perswani P, Ghosh S. A Curious Case of Pleural Effusion. Am-J-Respir-Crit-Care-Med 2024; 209 A1952.; Kumari R, Singla T, Perswani P, Ghosh S. A Curious Case of Pleural Effusion. Am-J-Respir-Crit-Care-Med 2024; 209 A1952.$79$YR$$F$Y$$$20240802$$HP$US$US
240933311$24093331$1$I$$20240705$20240715$20240715$EXP$LK-MLMSERVICE-20240628-PI116128-00031-1$LK-RDY-SPO/LKA/24/0010091$DR REDDYS$Abeyagunawardena I, Madurapperuma C, Thuvarakan P, Thowfeek Z, Sujeewa N, Katulanda G, et al. Uncommon triggers of insulin autoimmune syndrome: a case report. Journal of medical case reports. 2024;18(1):292. DOI: 10.1186/s13256-024-04616-x.$67$YR$E$M$Y$$$20240715$$MD$LK$LK
240933321$24093332$1$I$$20240701$20240715$20240715$EXP$$FR-AstraZeneca-2024A160089$ASTRAZENECA$$69$YR$$M$Y$$$20240715$$HP$FR$
240933331$24093333$1$I$20240626$20240705$20240715$20240715$EXP$GB-MHRA-TPP19993736C1459647YC1719391196560$GB-RDY-SPO/GBR/24/0010004$DR REDDYS$$80$YR$E$F$Y$108$KG$20240715$$MD$GB$GB
240933341$24093334$1$I$20240604$20240707$20240715$20240715$EXP$$CN-AstraZeneca-2024A158985$ASTRAZENECA$$18883$DY$$F$Y$60$KG$20240715$$MD$CN$
240933351$24093335$1$I$20240702$20240715$20240715$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039847$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240715$$CN$US$US
240933361$24093336$1$I$$20240703$20240715$20240715$EXP$$US-BAYER-2024A074058$BAYER$$57$YR$A$F$Y$99.32$KG$20240715$$CN$US$US
240933381$24093338$1$I$$20240715$20240715$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039790$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240715$$CN$US$US
240933391$24093339$1$I$20240706$20240708$20240715$20240715$EXP$$CN-009507513-2407CHN008415$MERCK$$74$YR$$F$Y$48$KG$20240715$$HP$CN$CN
240933402$24093340$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3219276$TEVA$Luskin MR, Stevenson KE, Mendez LM, Wang ES, Wadleigh M, Garcia JS, et al. A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL in Adults. Blood 2021; 138 (Suppl.) 2305.; Luskin MR, Stevenson KE, Mendez LM, Wang ES, Wadleigh M, Garcia JS, et al. A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL in Adults. Blood 2021; 138 (Suppl.) 2305.$65$YR$$M$Y$$$20240802$$HP$US$US
240933412$24093341$2$F$$20240712$20240715$20240716$EXP$$US-ROCHE-10000023347$ROCHE$$80$YR$E$M$Y$$$20240716$$CN$US$US
240933421$24093342$1$I$$20240708$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109077$BRISTOL MYERS SQUIBB$O^Meara KT, Fansiwala K, Kathuria-Prakash N, El-Masry M, Oh S. Acute hypoxic respiratory failure due to Lenalidomide-induced interstitial pneumonitis in a patient with multiple myeloma. BMC Pulmonary Medicine.2024 Jul 04;24(1):1-5.doi:10.1186/s12890-024-03129-z.$80$YR$E$M$Y$$$20240715$$HP$US$US
240933431$24093343$1$I$$20240709$20240715$20240715$PER$$US-GILEAD-2024-0680506$GILEAD$$$$$$Y$$$20240715$$HP$US$US
240933441$24093344$1$I$$20240709$20240715$20240715$PER$$US-GILEAD-2024-0680501$GILEAD$$$$$$Y$$$20240715$$HP$US$US
240933451$24093345$1$I$20240317$20240402$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-019425$FOUNDATION CONSUMER HEALTHCARE$$25$YR$$F$Y$61.24$KG$20240715$$CN$US$US
240933461$24093346$1$I$20190101$20240402$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-019611$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933471$24093347$1$I$20240401$20240402$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-019643$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933481$24093348$1$I$$20240403$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-019881$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933491$24093349$1$I$20240404$20240404$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-020030$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933501$24093350$1$I$20240404$20240404$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-020147$FOUNDATION CONSUMER HEALTHCARE$$22$YR$$F$Y$61.24$KG$20240715$$CN$US$US
240933511$24093351$1$I$$20240402$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-019760$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$HP$US$US
240933521$24093352$1$I$20240327$20240403$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-019766$FOUNDATION CONSUMER HEALTHCARE$$32$YR$$F$Y$77.11$KG$20240715$$CN$US$US
240933531$24093353$1$I$20240405$20240408$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-020840$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933541$24093354$1$I$20240301$20240408$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-020898$FOUNDATION CONSUMER HEALTHCARE$$33$YR$$F$Y$72.58$KG$20240715$$CN$US$US
240933551$24093355$1$I$20240403$20240409$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-021121$FOUNDATION CONSUMER HEALTHCARE$$24$YR$$F$Y$67.59$KG$20240715$$CN$US$US
240933561$24093356$1$I$20240325$20240410$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-021245$FOUNDATION CONSUMER HEALTHCARE$$23$YR$$F$Y$58.97$KG$20240715$$CN$US$US
240933571$24093357$1$I$$20240412$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-021942$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933581$24093358$1$I$20240411$20240415$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-022292$FOUNDATION CONSUMER HEALTHCARE$$28$YR$$F$Y$63.5$KG$20240715$$CN$US$US
240933591$24093359$1$I$20231001$20240416$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-022484$FOUNDATION CONSUMER HEALTHCARE$$23$YR$$F$Y$74.84$KG$20240715$$CN$US$US
240933601$24093360$1$I$20240411$20240417$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-022733$FOUNDATION CONSUMER HEALTHCARE$$35$YR$$F$Y$58.97$KG$20240715$$CN$US$US
240933611$24093361$1$I$20240330$20240403$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-019903$FOUNDATION CONSUMER HEALTHCARE$$39$YR$$F$Y$74.84$KG$20240715$$CN$US$US
240933621$24093362$1$I$$20240415$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2023-US-045117$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933631$24093363$1$I$20230416$20240416$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-022486$FOUNDATION CONSUMER HEALTHCARE$$28$YR$$F$Y$54.43$KG$20240715$$CN$US$US
240933641$24093364$1$I$20240302$20240416$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-022611$FOUNDATION CONSUMER HEALTHCARE$$20$YR$$F$Y$81.65$KG$20240715$$CN$US$US
240933651$24093365$1$I$20240418$20240419$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-023269$FOUNDATION CONSUMER HEALTHCARE$$22$YR$$F$Y$50.35$KG$20240715$$CN$US$US
240933661$24093366$1$I$20240403$20240419$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-023329$FOUNDATION CONSUMER HEALTHCARE$$32$YR$$F$Y$77.11$KG$20240715$$CN$US$US
240933671$24093367$1$I$20240418$20240423$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-023892$FOUNDATION CONSUMER HEALTHCARE$$32$YR$$F$Y$56.7$KG$20240715$$CN$US$US
240933681$24093368$1$I$20220101$20240423$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-023917$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933691$24093369$1$I$20240422$20240424$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-024146$FOUNDATION CONSUMER HEALTHCARE$$21$YR$$F$Y$133.81$KG$20240715$$CN$US$US
240933701$24093370$1$I$20240421$20240424$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-024161$FOUNDATION CONSUMER HEALTHCARE$$20$YR$$F$Y$49.9$KG$20240715$$CN$US$US
240933711$24093371$1$I$20240415$20240424$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-024181$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933721$24093372$1$I$20240425$20240426$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-024653$FOUNDATION CONSUMER HEALTHCARE$$17$YR$$F$Y$45.36$KG$20240715$$CN$US$US
240933731$24093373$1$I$$20240427$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-024946$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933741$24093374$1$I$20240415$20240429$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-024953$FOUNDATION CONSUMER HEALTHCARE$$29$YR$$F$Y$55$KG$20240715$$CN$US$US
240933751$24093375$1$I$20240428$20240429$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-025010$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933761$24093376$1$I$20240415$20240429$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-025014$FOUNDATION CONSUMER HEALTHCARE$$22$YR$$F$Y$83.01$KG$20240715$$CN$US$US
240933771$24093377$1$I$20240422$20240429$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-025043$FOUNDATION CONSUMER HEALTHCARE$$36$YR$$F$Y$79.38$KG$20240715$$CN$US$US
240933781$24093378$1$I$20240427$20240430$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-025217$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933791$24093379$1$I$20240430$20240501$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-025419$FOUNDATION CONSUMER HEALTHCARE$$19$YR$$F$Y$43.09$KG$20240715$$CN$US$US
240933801$24093380$1$I$20240501$20240501$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-025488$FOUNDATION CONSUMER HEALTHCARE$$19$YR$$F$Y$88.45$KG$20240715$$CN$US$US
240933811$24093381$1$I$20240406$20240408$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-020748$FOUNDATION CONSUMER HEALTHCARE$$35$YR$$F$Y$50.8$KG$20240715$$CN$US$US
240933821$24093382$1$I$20240415$20240501$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-025621$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933831$24093383$1$I$20240430$20240503$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-025923$FOUNDATION CONSUMER HEALTHCARE$$31$YR$$F$Y$70.31$KG$20240715$$CN$US$US
240933841$24093384$1$I$20240503$20240503$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-025930$FOUNDATION CONSUMER HEALTHCARE$$38$YR$$F$Y$113.4$KG$20240715$$CN$US$US
240933851$24093385$1$I$20240502$20240503$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-025931$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933861$24093386$1$I$20240417$20240503$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-026021$FOUNDATION CONSUMER HEALTHCARE$$28$YR$$F$Y$61.24$KG$20240715$$CN$US$US
240933871$24093387$1$I$20240426$20240503$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-026038$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933881$24093388$1$I$20240504$20240506$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-026242$FOUNDATION CONSUMER HEALTHCARE$$20$YR$$F$Y$$$20240715$$CN$US$US
240933891$24093389$1$I$20240401$20240508$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-026881$FOUNDATION CONSUMER HEALTHCARE$$47$YR$$F$Y$56.7$KG$20240715$$CN$US$US
240933901$24093390$1$I$20240507$20240509$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-027187$FOUNDATION CONSUMER HEALTHCARE$$24$YR$$F$Y$57.15$KG$20240715$$CN$US$US
240933911$24093391$1$I$20240501$20240509$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-027299$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933921$24093392$1$I$20240510$20240510$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-027437$FOUNDATION CONSUMER HEALTHCARE$$19$YR$$F$Y$52.16$KG$20240715$$CN$US$US
240933931$24093393$1$I$20240401$20240510$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-027439$FOUNDATION CONSUMER HEALTHCARE$$15$YR$$F$Y$54.43$KG$20240715$$CN$US$US
240933941$24093394$1$I$20240413$20240510$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-027442$FOUNDATION CONSUMER HEALTHCARE$$20$YR$$F$Y$55.34$KG$20240715$$CN$US$US
240933951$24093395$1$I$20240420$20240510$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-027454$FOUNDATION CONSUMER HEALTHCARE$$19$YR$$F$Y$68.04$KG$20240715$$CN$US$US
240933961$24093396$1$I$20240509$20240510$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-027534$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240933971$24093397$1$I$20240513$20240513$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-027856$FOUNDATION CONSUMER HEALTHCARE$$21$YR$$F$Y$40.82$KG$20240715$$CN$US$US
240933981$24093398$1$I$20240512$20240514$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-027976$FOUNDATION CONSUMER HEALTHCARE$$27$YR$$F$Y$47.17$KG$20240715$$CN$US$US
240933991$24093399$1$I$20230901$20240514$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-028000$FOUNDATION CONSUMER HEALTHCARE$$23$YR$$F$Y$$$20240715$$CN$US$US
240934001$24093400$1$I$20240510$20240514$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-028208$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240934011$24093401$1$I$20240426$20240426$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-024695$FOUNDATION CONSUMER HEALTHCARE$$19$YR$$F$Y$61.24$KG$20240715$$CN$US$US
240934021$24093402$1$I$20240514$20240515$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-028290$FOUNDATION CONSUMER HEALTHCARE$$50$YR$$F$Y$$$20240715$$CN$US$US
240934031$24093403$1$I$20240426$20240516$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-028477$FOUNDATION CONSUMER HEALTHCARE$$27$YR$$F$Y$$$20240715$$CN$US$US
240934041$24093404$1$I$20240512$20240516$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-028497$FOUNDATION CONSUMER HEALTHCARE$$19$YR$$F$Y$83.92$KG$20240715$$CN$US$US
240934051$24093405$1$I$20240515$20240516$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-028540$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240934061$24093406$1$I$20240516$20240517$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-028683$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240934071$24093407$1$I$20240514$20240517$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-028755$FOUNDATION CONSUMER HEALTHCARE$$37$YR$$F$Y$99.79$KG$20240715$$CN$US$US
240934081$24093408$1$I$20240515$20240517$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-028761$FOUNDATION CONSUMER HEALTHCARE$$17$YR$$F$Y$65.77$KG$20240715$$CN$US$US
240934091$24093409$1$I$20240517$20240517$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-028833$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240934101$24093410$1$I$20240518$20240521$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-029363$FOUNDATION CONSUMER HEALTHCARE$$45$YR$$F$Y$99.79$KG$20240715$$CN$US$US
240934111$24093411$1$I$20240524$20240524$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-030037$FOUNDATION CONSUMER HEALTHCARE$$25$YR$$F$Y$61.24$KG$20240715$$CN$US$US
240934121$24093412$1$I$$20240524$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-030131$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$PH$US$US
240934131$24093413$1$I$20240518$20240528$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-030329$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240934141$24093414$1$I$20240527$20240528$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-030397$FOUNDATION CONSUMER HEALTHCARE$$17$YR$$F$Y$56.7$KG$20240715$$CN$US$US
240934151$24093415$1$I$20240415$20240529$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-030602$FOUNDATION CONSUMER HEALTHCARE$$25$YR$$F$Y$95.26$KG$20240715$$CN$US$US
240934161$24093416$1$I$20240501$20240529$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-030604$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240934171$24093417$1$I$20240526$20240529$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-030620$FOUNDATION CONSUMER HEALTHCARE$$18$YR$$F$Y$52.16$KG$20240715$$CN$US$US
240934181$24093418$1$I$20240524$20240529$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-030647$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$77.11$KG$20240715$$CN$US$US
240934191$24093419$1$I$20240529$20240529$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-030716$FOUNDATION CONSUMER HEALTHCARE$$23$YR$$F$Y$99.79$KG$20240715$$CN$US$US
240934201$24093420$1$I$20240528$20240529$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-030758$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240934211$24093421$1$I$20231101$20240531$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-031146$FOUNDATION CONSUMER HEALTHCARE$$32$YR$$F$Y$56.7$KG$20240715$$CN$US$US
240934221$24093422$1$I$20240521$20240531$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-031151$FOUNDATION CONSUMER HEALTHCARE$$31$YR$$F$Y$54.43$KG$20240715$$CN$US$US
240934231$24093423$1$I$20231201$20240531$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-031242$FOUNDATION CONSUMER HEALTHCARE$$35$YR$$F$Y$83.46$KG$20240715$$CN$US$US
240934241$24093424$1$I$20240530$20240531$20240715$20240715$PER$$US-FOUNDATIONCONSUMERHC-2024-US-031260$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240715$$CN$US$US
240934251$24093425$1$I$20240425$20240704$20240715$20240715$EXP$GB-MHRA-MED-202405031135328880-TRPLK$GB-ALCON LABORATORIES-ALC2024GB003255$ALCON$$41$YR$$M$Y$$$20240715$$HP$GB$GB
240934262$24093426$2$F$$20240711$20240715$20240823$PER$$US-LUNDBECK-DKLU4000108$LUNDBECK$$$$$$Y$$$20240823$$CN$US$US
240934291$24093429$1$I$$20240701$20240715$20240715$EXP$$US-HQ SPECIALTY-US-2024INT000067$INTERCHEM$Jameson GS, Hosein PJ, Pierce E, Kamgar M, Gordon MS, Snyder C, et al. Phase II clinical trial of nab- paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer. Cancer medicine. 2024;13(12):e7412$67$YR$$M$Y$$$20240715$$HP$US$US
240934301$24093430$1$I$$20240709$20240715$20240715$PER$$US-ALXN-202407USA000663US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
240934311$24093431$1$I$$20240701$20240715$20240715$EXP$$US-HQ SPECIALTY-US-2024INT000068$INTERCHEM$Jameson GS, Hosein PJ, Pierce E, Kamgar M, Gordon MS, Snyder C, et al. Phase II clinical trial of nab- paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer. Cancer medicine. 2024;13(12):e7412$60$YR$$M$Y$$$20240715$$HP$US$US
240934321$24093432$1$I$$20240710$20240715$20240715$PER$$US-ABBVIE-5837901$ABBVIE$$$$$$Y$$$20240715$$HP$US$US
240934331$24093433$1$I$$20240711$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112084$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240715$$CN$US$US
240934341$24093434$1$I$$20240714$20240715$20240715$EXP$$EG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039692$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240715$$MD$EG$EG
240934351$24093435$1$I$$20230529$20240715$20240715$PER$$US-NOVOPROD-1235757$NOVO NORDISK$$$$$$Y$$$20240715$$PH$US$US
240934362$24093436$2$F$20240602$20240712$20240715$20240718$EXP$$CR-BIOGEN-2024BI01269625$BIOGEN$$36$YR$$F$Y$63$KG$20240718$$CN$CR$CR
240934371$24093437$1$I$20240126$20240227$20240715$20240715$PER$$US-NOVOPROD-1187109$NOVO NORDISK$$52$YR$$F$Y$$$20240715$$CN$US$US
240934381$24093438$1$I$$20240131$20240715$20240715$PER$$US-NOVOPROD-1175288$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
240934391$24093439$1$I$$20240212$20240715$20240715$PER$$US-NOVOPROD-1175983$NOVO NORDISK$$$$$F$Y$$$20240715$$MD$US$US
240934401$24093440$1$I$20240325$20240506$20240715$20240715$PER$$US-NOVOPROD-1208843$NOVO NORDISK$$61$YR$$F$Y$$$20240715$$CN$US$US
240934411$24093441$1$I$$20231227$20240715$20240715$PER$$US-NOVOPROD-1157703$NOVO NORDISK$$$$A$F$Y$$$20240715$$CN$US$US
240934421$24093442$1$I$20240313$20240522$20240715$20240715$PER$$US-NOVOPROD-1232341$NOVO NORDISK$$47$YR$$F$Y$$$20240715$$CN$US$US
240934431$24093443$1$I$20230101$20240307$20240715$20240715$PER$$US-NOVOPROD-1184959$NOVO NORDISK$$$$$M$Y$$$20240715$$CN$US$US
240934441$24093444$1$I$$20240413$20240715$20240715$PER$$US-NOVOPROD-1207044$NOVO NORDISK$$$$A$F$Y$$$20240715$$CN$US$US
240934451$24093445$1$I$$20240119$20240715$20240715$PER$$US-NOVOPROD-1186811$NOVO NORDISK$$$$$M$Y$$$20240715$$CN$US$US
240934461$24093446$1$I$20240131$20240702$20240715$20240715$PER$$US-NOVOPROD-1195773$NOVO NORDISK$$63$YR$$F$Y$$$20240715$$CN$US$US
240934471$24093447$1$I$20240409$20240518$20240715$20240715$PER$$US-NOVOPROD-1228908$NOVO NORDISK$$56$YR$$M$Y$$$20240715$$CN$US$US
240934481$24093448$1$I$20240208$20240209$20240715$20240715$PER$$US-NOVOPROD-1175394$NOVO NORDISK$$38$YR$$F$Y$$$20240715$$CN$US$US
240934491$24093449$1$I$20240501$20240523$20240715$20240715$PER$$US-NOVOPROD-1235372$NOVO NORDISK$$69$YR$$M$Y$$$20240715$$CN$US$US
240934501$24093450$1$I$20240419$20240426$20240715$20240715$PER$$US-NOVOPROD-1215813$NOVO NORDISK$$56$YR$$F$Y$$$20240715$$CN$US$US
240934511$24093451$1$I$20240101$20240110$20240715$20240715$PER$$US-NOVOPROD-1161210$NOVO NORDISK$$63$YR$$F$Y$$$20240715$$CN$US$US
240934521$24093452$1$I$$20240314$20240715$20240715$PER$$US-NOVOPROD-1192780$NOVO NORDISK$$$$A$F$Y$$$20240715$$CN$US$US
240934531$24093453$1$I$$20240102$20240715$20240715$PER$$US-NOVOPROD-1159690$NOVO NORDISK$$$$$M$Y$$$20240715$$CN$US$US
240934541$24093454$1$I$$20240531$20240715$20240715$PER$$US-NOVOPROD-1236895$NOVO NORDISK$$$$A$F$Y$$$20240715$$CN$US$US
240934551$24093455$1$I$$20231212$20240715$20240715$PER$$US-NOVOPROD-1152384$NOVO NORDISK$$51$YR$$F$Y$$$20240715$$CN$US$US
240934561$24093456$1$I$20240101$20240411$20240715$20240715$PER$$US-NOVOPROD-1205773$NOVO NORDISK$$21$YR$$M$Y$95.238$KG$20240715$$MD$US$US
240934571$24093457$1$I$20231130$20240219$20240715$20240715$PER$$US-NOVOPROD-1167675$NOVO NORDISK$$54$YR$$F$Y$$$20240715$$CN$US$US
240934581$24093458$1$I$$20240711$20240715$20240715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-111007$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$80$KG$20240715$$HP$CA$CA
240934591$24093459$1$I$$20240520$20240715$20240715$PER$$US-NOVOPROD-1228671$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
240934601$24093460$1$I$20240201$20240203$20240715$20240715$PER$$US-NOVOPROD-1172616$NOVO NORDISK$$27$YR$$F$Y$$$20240715$$HP$US$US
240934611$24093461$1$I$$20240418$20240715$20240715$PER$$US-NOVOPROD-1198367$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
240934621$24093462$1$I$$20240108$20240715$20240715$PER$$DE-NOVOPROD-1167370$NOVO NORDISK$$32$YR$$F$Y$$$20240715$$CN$DE$US
240934631$24093463$1$I$$20240426$20240715$20240715$PER$$US-NOVOPROD-1213359$NOVO NORDISK$$23$YR$$M$Y$$$20240715$$CN$US$US
240934641$24093464$1$I$$20240223$20240715$20240715$PER$$US-NOVOPROD-1182602$NOVO NORDISK$$$$$M$Y$$$20240715$$CN$US$US
240934651$24093465$1$I$20240120$20240130$20240715$20240715$PER$$US-NOVOPROD-1172979$NOVO NORDISK$$28$YR$$F$Y$$$20240715$$CN$US$US
240934661$24093466$1$I$20240406$20240413$20240715$20240715$PER$$US-NOVOPROD-1210871$NOVO NORDISK$$47$YR$$F$Y$$$20240715$$CN$US$US
240934671$24093467$1$I$$20240222$20240715$20240715$PER$$US-NOVOPROD-1182119$NOVO NORDISK$$$$$F$Y$$$20240715$$PH$US$US
240934681$24093468$1$I$$20240314$20240715$20240715$PER$$US-NOVOPROD-1192044$NOVO NORDISK$$$$A$F$Y$$$20240715$$MD$US$US
240934691$24093469$1$I$$20240318$20240715$20240715$PER$$US-NOVOPROD-1176512$NOVO NORDISK$$$$$M$Y$$$20240715$$HP$US$US
240934701$24093470$1$I$$20240322$20240715$20240715$PER$$US-NOVOPROD-1196881$NOVO NORDISK$$$$$F$Y$$$20240715$$HP$US$US
240934711$24093471$1$I$20231012$20240306$20240715$20240715$PER$$US-NOVOPROD-1189385$NOVO NORDISK$$49$YR$$F$Y$$$20240715$$CN$US$US
240934721$24093472$1$I$$20240513$20240715$20240715$PER$$US-NOVOPROD-1223230$NOVO NORDISK$$$$A$$Y$$$20240715$$CN$US$US
240934731$24093473$1$I$$20240221$20240715$20240715$PER$$US-NOVOPROD-1180670$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
240934741$24093474$1$I$$20240513$20240715$20240715$PER$$US-NOVOPROD-1225774$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
240934751$24093475$1$I$$20231205$20240715$20240715$PER$$US-NOVOPROD-1149727$NOVO NORDISK$$14$YR$$F$Y$$$20240715$$MD$US$US
240934761$24093476$1$I$$20240212$20240715$20240715$PER$$US-NOVOPROD-1175984$NOVO NORDISK$$$$$F$Y$$$20240715$$MD$US$US
240934771$24093477$1$I$20240321$20240322$20240715$20240715$PER$$US-NOVOPROD-1197012$NOVO NORDISK$$74$YR$$F$Y$$$20240715$$CN$US$US
240934781$24093478$1$I$20231128$20240528$20240715$20240715$PER$$US-NOVOPROD-1148487$NOVO NORDISK$$35$YR$$F$Y$$$20240715$$CN$US$US
240934791$24093479$1$I$$20240123$20240715$20240715$PER$$US-NOVOPROD-1166806$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
240934801$24093480$1$I$$20240320$20240715$20240715$PER$$US-NOVOPROD-1195166$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
240934811$24093481$1$I$$20240213$20240715$20240715$PER$$US-NOVOPROD-1176846$NOVO NORDISK$$$$$F$Y$$$20240715$$PH$US$US
240934821$24093482$1$I$$20240124$20240715$20240715$PER$$US-NOVOPROD-1168807$NOVO NORDISK$$52$YR$$F$Y$$$20240715$$CN$US$US
240934831$24093483$1$I$20231001$20231213$20240715$20240715$PER$$US-NOVOPROD-1152357$NOVO NORDISK$$$$$F$Y$$$20240715$$CN$US$US
240934841$24093484$1$I$$20240418$20240715$20240715$PER$$US-NOVOPROD-1209447$NOVO NORDISK$$$$$M$Y$$$20240715$$MD$US$US
240934851$24093485$1$I$20230101$20240219$20240715$20240715$PER$$US-NOVOPROD-1180673$NOVO NORDISK$$73$YR$$F$Y$$$20240715$$CN$US$US
240934862$24093486$2$F$$20240712$20240715$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407007463$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240718$$CN$US$US
240934882$24093488$2$F$20240623$20240705$20240715$20240718$EXP$$CN-009507513-2407CHN004322$MERCK$$67$YR$$F$Y$67$KG$20240718$$HP$CN$CN
240934891$24093489$1$I$20240309$20240705$20240715$20240715$EXP$FR-AFSSAPS-AVMA2024000274$FR-TEVA-VS-3218252$TEVA$$39$YR$$F$Y$$$20240715$$PH$FR$FR
240934901$24093490$1$I$$20240711$20240715$20240715$EXP$$CA-AstraZeneca-2024A160309$ASTRAZENECA$$43$YR$$F$Y$$$20240715$$MD$CA$
240934911$24093491$1$I$20240419$20240419$20240715$20240715$PER$$US-GE HEALTHCARE-2024CSU008013$GE HEALTHCARE$$$$$F$Y$$$20240715$$HP$US$US
240934921$24093492$1$I$$20240419$20240715$20240715$PER$$US-GE HEALTHCARE-2024CSU008010$GE HEALTHCARE$$$$$$Y$$$20240715$$HP$US$US
240934931$24093493$1$I$$20240419$20240715$20240715$PER$$US-GE HEALTHCARE-2024CSU008011$GE HEALTHCARE$$$$$$Y$$$20240715$$HP$US$US
240934941$24093494$1$I$20240326$20240419$20240715$20240715$PER$$US-GE HEALTHCARE-2024CSU004349$GE HEALTHCARE$$$$$F$Y$$$20240715$$HP$US$US
240934951$24093495$1$I$$20240419$20240715$20240715$PER$$US-GE HEALTHCARE-2024CSU008009$GE HEALTHCARE$$$$$$Y$$$20240715$$HP$US$US
240934961$24093496$1$I$$20240709$20240715$20240715$PER$$US-ALXN-202407USA000662US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240715$$CN$US$US
240934971$24093497$1$I$20240101$20240715$20240715$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039770$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$$$20240715$$CN$US$US
240934981$24093498$1$I$$20240709$20240715$20240715$PER$$US-GILEAD-2024-0680508$GILEAD$$$$$$Y$$$20240715$$HP$US$US
240934991$24093499$1$I$$20240710$20240715$20240715$PER$$US-INCYTE CORPORATION-2024IN007300$INCYTE$$$$$$Y$$$20240715$$HP$US$US
240935001$24093500$1$I$20240707$20240708$20240715$20240715$PER$$US-BAUSCHBL-2024BNL029851$BAUSCH AND LOMB$$86$YR$$F$Y$$$20240715$$CN$US$US
240935021$24093502$1$I$20240616$20240708$20240715$20240715$EXP$GB-MHRA-MED-202407041336324260-QPFZC$GB-009507513-2407GBR003726$MERCK$$$$$F$Y$$$20240715$$MD$GB$GB
240935032$24093503$2$F$$20240710$20240715$20240731$PER$$US-INCYTE CORPORATION-2024IN007298$INCYTE$$$$$$Y$$$20240801$$CN$US$US
240935044$24093504$4$F$$20240823$20240715$20240903$PER$$US-AstraZeneca-2024A149446$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
240935051$24093505$1$I$$20240710$20240715$20240715$PER$$US-INCYTE CORPORATION-2024IN007275$INCYTE$$$$$$Y$$$20240715$$CN$US$US
240935061$24093506$1$I$$20240712$20240715$20240715$EXP$$US-GILEAD-2024-0680691$GILEAD$$82$YR$E$M$Y$$$20240715$$HP$US$US
240935071$24093507$1$I$$20240702$20240715$20240715$PER$$US-JNJFOC-20240737223$JOHNSON AND JOHNSON$$$$A$$Y$$$20240715$$CN$US$US
240935081$24093508$1$I$$20240624$20240715$20240715$PER$$US-LUNDBECK-DKLU4001013$LUNDBECK$$$$$$Y$$$20240715$$HP$US$US
240935092$24093509$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3218957$TEVA$Maldarelli ME, Grier WR. A Noxious Mimic - Pulmonary Nocardiosis Presenting as a Lung Mass in an Orthotopic Liver Transplant Patient. Am-J-Respir-Crit-Care-Med 2024; 209 A2434.; Maldarelli ME, Grier WR. A Noxious Mimic - Pulmonary Nocardiosis Presenting as a Lung Mass in an Orthotopic Liver Transplant Patient. Am-J-Respir-Crit-Care-Med 2024; 209 A2434.$72$YR$$M$Y$$$20240802$$HP$US$US
240935101$24093510$1$I$$20240712$20240715$20240715$EXP$$US-GILEAD-2024-0680701$GILEAD$$82$YR$E$M$Y$$$20240715$$MD$US$US
240935111$24093511$1$I$20240705$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109537$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240715$$PH$US$US
240935122$24093512$2$F$20240711$20240717$20240715$20240723$PER$$US-ABBVIE-5839052$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
240935131$24093513$1$I$20240705$20240708$20240715$20240715$PER$$US-009507513-2407USA003943$MERCK$$1$YR$$M$Y$$$20240715$$MD$US$US
240935152$24093515$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3218984$TEVA$Novoa FJ, Cheema S, Conner S. A Case of Symptomatic Hypercalcemia Secondary to Histoplasmosis. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A6332.; Novoa FJ, Cheema S, Conner S. A Case of Symptomatic Hypercalcemia Secondary to Histoplasmosis. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A6332.$57$YR$$F$Y$$$20240802$$HP$US$US
240935163$24093516$3$F$20240625$20240815$20240715$20240823$EXP$$CN-G1 THERAPEUTICS-2024G1CN0000090$G1 THERAPEUTICS$$$$$$Y$$$20240823$$MD$CN$CN
240935171$24093517$1$I$$20240711$20240715$20240715$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135611$DAIICHI$$5$DEC$$F$Y$$$20240715$$MD$US$US
240935181$24093518$1$I$$20240711$20240715$20240715$EXP$$IT-AMGEN-ITASP2024138665$AMGEN$Alma A.; Fiorito F.; Casari A. et al.. A case of Hodgkin lymphoma with cutaneous involvement assessed with dermoscopy and reflectance confocal microscopy. Skin Research and Technology. 2024;30 (7):1-2$81$YR$E$F$Y$$$20240715$$HP$IT$IT
240935191$24093519$1$I$$20240620$20240715$20240715$PER$$US-FMCRTG-FMC-2406-000751$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240715$$CN$US$US
240935202$24093520$2$F$$20240805$20240715$20240806$PER$$US-ALXN-202407USA000608US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
240935211$24093521$1$I$$20240710$20240715$20240715$PER$$US-ABBVIE-5837740$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240935221$24093522$1$I$$20240709$20240715$20240715$EXP$$FR-009507513-2407FRA008826$MERCK$$66$YR$$M$Y$$$20240715$$CN$FR$FR
240935231$24093523$1$I$20240706$20240707$20240715$20240715$PER$$US-BIOMARINAP-US-2024-159055$BIOMARIN$$$$$$Y$$$20240715$$CN$US$US
240935251$24093525$1$I$$20240709$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109608$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$72.57$KG$20240715$$CN$US$US
240935261$24093526$1$I$20240401$20240708$20240715$20240715$EXP$$JP-009507513-2405JPN000866J$MERCK$$8$DEC$$M$Y$$$20240715$$MD$JP$JP
240935272$24093527$2$F$20230511$20240716$20240715$20240724$EXP$$NVSC2023AT179956$NOVARTIS$$35$YR$$F$Y$62$KG$20240724$$MD$AT$AT
240935282$24093528$2$F$$20240722$20240715$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111713$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240726$$CN$US$US
240935292$24093529$2$F$$20240721$20240715$20240729$PER$$US-ALXN-202407USA000610US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
240935301$24093530$1$I$20240403$20240708$20240715$20240715$PER$IT-MINISAL02-993882$IT-Eisai-EC-2024-169721$EISAI$$80$YR$E$M$Y$64$KG$20240715$$PH$IT$IT
240935311$24093531$1$I$20240601$20240626$20240715$20240715$EXP$$US-AstraZeneca-2024A148654$ASTRAZENECA$$20143$DY$$F$Y$$$20240715$$CN$US$
240935321$24093532$1$I$$20240703$20240715$20240715$EXP$$GB-GSK-GB2024083204$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$HP$GB$GB
240935331$24093533$1$I$$20240709$20240715$20240715$EXP$PT-ORESUND-24OPAJY0212P$PT-GSK-PT2024085354$GLAXOSMITHKLINE$$$$$$Y$$$20240715$$MD$PT$PT
240935341$24093534$1$I$$20240712$20240715$20240715$PER$$US-JNJFOC-20240734777$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240715$$PH$US$US
240935352$24093535$2$F$20210924$20240831$20240715$20240903$EXP$$TW-009507513-2407TWN008648$MERCK$$37$YR$$M$Y$$$20240903$$MD$TW$TW
240935361$24093536$1$I$$20240708$20240715$20240715$PER$$US-ALXN-202407USA000593US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240715$$CN$US$US
240935383$24093538$3$F$$20240828$20240715$20240904$EXP$DE-INDIVIOR EUROPE LIMITED-INDV-145806-2024$DE-GSK-DE2024086158$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$HP$DE$DE
240935392$24093539$2$F$20240717$20240730$20240715$20240731$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039791$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240731$$HP$CO$CO
240935411$24093541$1$I$$20240712$20240715$20240715$PER$$US-JNJFOC-20240734528$JOHNSON AND JOHNSON$$$$$M$Y$$$20240715$$HP$US$US
240935421$24093542$1$I$20230804$20240709$20240715$20240715$EXP$$GB-APELLIS-APL-2023-002845$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240715$$CN$GB$GB
240935432$24093543$2$F$20240101$20240904$20240715$20240910$EXP$$JP-009507513-2407JPN001016J$MERCK$$68$YR$$F$Y$$$20240910$$MD$JP$JP
240935443$24093544$3$F$$20240912$20240715$20240919$EXP$$JP-009507513-2407JPN001541J$MERCK$Yoshioka A, Sudo T, Yamaguchi T. EP-1101 Experienced with Pembrolizumab in our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 453$52$YR$$F$Y$$$20240919$$MD$JP$JP
240935452$24093545$2$F$20240625$20240726$20240715$20240806$EXP$$CN-G1 THERAPEUTICS-2024G1CN0000089$G1 THERAPEUTICS$$$$$$Y$$$20240806$$MD$CN$CN
240935472$24093547$2$F$20240624$20240711$20240715$20240723$PER$$US-JNJFOC-20240738095$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240722$$HP$US$US
240935482$24093548$2$F$$20240905$20240715$20240909$EXP$$US-GILEAD-2024-0680705$GILEAD$$54$YR$A$M$Y$$$20240909$$HP$US$US
240935491$24093549$1$I$$20240709$20240715$20240715$PER$$US-GILEAD-2024-0680494$GILEAD$$$$$$Y$$$20240715$$HP$US$US
240935501$24093550$1$I$$20240705$20240715$20240715$PER$$US-APELLIS-2024-APL-0000423$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240715$$CN$US$US
240935511$24093551$1$I$$20240711$20240715$20240715$EXP$$BR-ROCHE-10000026182$ROCHE$$60$YR$A$M$Y$$$20240715$$HP$BR$BR
240935522$24093552$2$F$20240515$20240715$20240715$20240720$PER$$US-JNJFOC-20240737176$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240720$$CN$US$US
240935531$24093553$1$I$$20240701$20240715$20240715$EXP$$US-HLS-202400192$HLS THERAPEUTICS$$46$YR$A$F$Y$$$20240715$$PH$US$US
240935551$24093555$1$I$$20240708$20240715$20240715$PER$$US-BIOMARINAP-US-2024-159033$BIOMARIN$$$$$$Y$$$20240715$$CN$US$US
240935561$24093556$1$I$$20240708$20240715$20240715$PER$$US-BIOMARINAP-US-2024-158972$BIOMARIN$$$$$$Y$$$20240715$$CN$US$US
240935571$24093557$1$I$20240701$20240708$20240715$20240715$PER$$US-BIOMARINAP-US-2024-159035$BIOMARIN$$$$$$Y$$$20240715$$CN$US$US
240935581$24093558$1$I$$20240708$20240715$20240715$PER$$US-BIOMARINAP-US-2024-159048$BIOMARIN$$$$$$Y$$$20240715$$CN$US$US
240935591$24093559$1$I$20240324$20240624$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-101836$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240715$$PH$US$US
240935603$24093560$3$F$$20240821$20240715$20240903$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06556$NEUROCRINE BIOSCIENCES$$33$YR$$F$Y$$$20240904$$CN$US$US
240935611$24093561$1$I$20221101$20240709$20240715$20240715$PER$$US-AMGEN-USASP2024136357$AMGEN$$36$YR$A$F$Y$$$20240715$$CN$US$US
240935621$24093562$1$I$$20240702$20240715$20240715$PER$$US-ALKERMES INC.-ALK-2024-001806$ALKERMES$$$$$F$Y$$$20240716$$HP$US$US
240935631$24093563$1$I$20240601$20240702$20240715$20240715$PER$$US-ALKERMES INC.-ALK-2024-001811$ALKERMES$$55$YR$$F$Y$$$20240716$$HP$US$US
240935641$24093564$1$I$$20240702$20240715$20240715$PER$$US-ALKERMES INC.-ALK-2024-001810$ALKERMES$$$$$M$Y$$$20240716$$HP$US$US
240935652$24093565$2$F$20240707$20240730$20240715$20240806$PER$$US-BIOMARINAP-US-2024-159059$BIOMARIN$$$$$$Y$$$20240806$$CN$US$US
240935662$24093566$2$F$20240701$20240912$20240715$20240924$PER$$US-ALKERMES INC.-ALK-2024-001814$ALKERMES$$23$YR$$M$Y$74.83$KG$20240924$$HP$US$US
240935671$24093567$1$I$20240620$20240702$20240715$20240715$PER$$US-ALKERMES INC.-ALK-2024-001815$ALKERMES$$39$YR$$M$Y$$$20240716$$HP$US$US
240935681$24093568$1$I$$20240711$20240715$20240715$PER$$NVSC2024US144618$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240935691$24093569$1$I$20240601$20240702$20240715$20240715$PER$$US-ALKERMES INC.-ALK-2024-001816$ALKERMES$$$$$M$Y$$$20240716$$MD$US$US
240935702$24093570$2$F$20240621$20240719$20240715$20240726$PER$$US-ALKERMES INC.-ALK-2024-001733$ALKERMES$$36$YR$$F$Y$103.4$KG$20240726$$HP$US$US
240935712$24093571$2$F$20240101$20240712$20240715$20240723$PER$$US-ALKERMES INC.-ALK-2024-001214$ALKERMES$$$$$F$Y$114.29$KG$20240723$$CN$US$US
240935721$24093572$1$I$20240101$20240702$20240715$20240715$PER$$US-ALKERMES INC.-ALK-2024-001817$ALKERMES$$$$$F$Y$$$20240716$$CN$US$US
240935731$24093573$1$I$$20240703$20240715$20240715$PER$US-DRL-USA-SPO/USA/24/0010081$US-RDY-SPO/USA/24/0010081$DR REDDYS$Golparvar A, Nafeh O, Alzamani M, Singh V, Jennings M. The Development of Disinhibited Social Engagement Disorder: A Case Report on the Psychiatric Implications of Prenatal Fentanyl Use. Cureus. 2024;16(5):e61078. DOI:10.7759/cureus.61078.$$$$F$Y$$$20240716$$MD$US$US
240935741$24093574$1$I$$20240708$20240715$20240715$PER$$US-BIOMARINAP-US-2024-159086$BIOMARIN$$$$$$Y$$$20240715$$CN$US$US
240935751$24093575$1$I$$20240712$20240715$20240715$PER$$US-AMGEN-USASP2024139417$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240935762$24093576$2$F$$20240716$20240715$20240717$EXP$$GR-SANDOZ INC.-SDZ2024GR065056$SANDOZ$$55$YR$$M$Y$$$20240717$$HP$GR$GR
240935771$24093577$1$I$$20240711$20240715$20240715$EXP$$CA-AstraZeneca-2024A160281$ASTRAZENECA$$50$YR$$F$Y$$$20240716$$MD$CA$
240935781$24093578$1$I$$20240617$20240715$20240715$PER$$US-009507513-2406USA006001$MERCK$$$$$M$Y$$$20240715$$CN$US$US
240935792$24093579$2$F$$20240814$20240715$20240823$PER$$US-APELLIS-APL-2023-003133$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240823$$CN$US$US
240935801$24093580$1$I$$20240710$20240715$20240715$EXP$$NVSJ2024JP008417$NOVARTIS$Miyajima N, Kimura K, Tsuboi T, Matsushita H, Kawase Y.. A case of bone metastases of breast cancer in which the response was judged as stable disease during drug therapy, but the disease led to bone marrow carcinomatosis and the condition acutely worsened. (Abstract Book for) the 32nd Annual Meeting of the Japanese Breast Cancer Societ. 2024;EP-1193$75$YR$$M$Y$$$20240716$$HP$JP$JP
240935811$24093581$1$I$20240710$20240710$20240715$20240715$PER$$US-JNJFOC-20240727173$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$CN$US$US
240935821$24093582$1$I$$20240709$20240715$20240715$PER$$US-ALXN-A202306196$ALEXION PHARMACEUTICALS$$$$A$M$Y$$$20240716$$CN$US$US
240935831$24093583$1$I$$20240712$20240715$20240715$PER$$US-JNJFOC-20240735453$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$HP$US$US
240935841$24093584$1$I$$20240709$20240715$20240715$PER$$US-SA-2024SA203738$SANOFI AVENTIS$$$$$F$Y$$$20240716$$CN$US$US
240935851$24093585$1$I$$20240708$20240715$20240715$EXP$$IN-JNJFOC-20240722579$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240716$$HP$IN$IN
240935861$24093586$1$I$20210605$20240709$20240715$20240715$EXP$$GB-SANDOZ INC.-NVSC2021GB128784$SANDOZ$$57$YR$$F$Y$$$20240715$$CN$GB$GB
240935871$24093587$1$I$20240715$20240715$20240715$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039870$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240716$$MD$US$US
240935881$24093588$1$I$20240408$20240710$20240715$20240715$30DAY$$AT-SANDOZ INC.-SDZ2024AT039808$SANDOZ$$$$C$M$Y$$$20240715$$CN$AT$AT
240935891$24093589$1$I$20240701$20240715$20240715$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039837$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240716$$CN$US$US
240935901$24093590$1$I$$20240715$20240715$20240715$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039833$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240716$$CN$US$US
240935911$24093591$1$I$20240615$20240711$20240715$20240715$EXP$$AR-SANDOZ INC.-SDZ2024AR064955$SANDOZ$$11$YR$$F$Y$37$KG$20240715$$CN$AR$AR
240935921$24093592$1$I$$20240710$20240715$20240715$EXP$$JP-TAKEDA-2024TJP010466$TAKEDA$$$$A$$Y$$$20240715$$MD$JP$JP
240935931$24093593$1$I$$20240628$20240715$20240715$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06599$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240716$$HP$US$US
240935944$24093594$4$F$20240701$20240714$20240715$20240722$EXP$$IL-009507513-2407ISR008232$MERCK$$$$$F$Y$$$20240722$$HP$IL$IL
240935951$24093595$1$I$$20240629$20240715$20240715$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06584$NEUROCRINE BIOSCIENCES$$19$YR$$M$Y$$$20240716$$CN$US$US
240935962$24093596$2$F$$20240820$20240715$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039866$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240826$$CN$US$US
240935972$24093597$2$F$$20240726$20240715$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110106$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$69.85$KG$20240729$$MD$US$US
240935981$24093598$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110709$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240716$$CN$US$US
240935991$24093599$1$I$20240630$20240712$20240715$20240715$EXP$FI-FIMEA-202402409$FI-SANDOZ INC.-SDZ2024FI065034$SANDOZ$$37$YR$$F$Y$$$20240715$$CN$FI$FI
240936001$24093600$1$I$$20240709$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007631$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240715$$CN$US$US
240936011$24093601$1$I$$20240708$20240715$20240715$EXP$$US-SHIONOGI, INC-2024001416$SHIONOGI$S. R. Levan, A. Perez et al. Burkholderia Cepacia Mediastinitis in a Patient With Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5854$$$$$Y$$$20240715$$HP$US$US
240936021$24093602$1$I$$20240711$20240715$20240715$EXP$GB-MHRA-MED-202407111638543220-JVWFM$GB-SANDOZ INC.-SDZ2024GB064990$SANDOZ$$$$$F$Y$$$20240715$$PH$GB$GB
240936031$24093603$1$I$$20240712$20240715$20240715$EXP$$EU-BAUSCHBL-2024BNL028723$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240716$$MD$EU$EU
240936042$24093604$2$F$20240418$20240722$20240715$20240724$EXP$$EU-BAUSCHBL-2024BNL026891$BAUSCH AND LOMB$$68$YR$$M$Y$74.3$KG$20240724$$MD$EU$EU
240936051$24093605$1$I$20240623$20240710$20240715$20240715$EXP$$CN-SANDOZ INC.-SDZ2024CN064901$SANDOZ$$18$YR$$F$Y$53$KG$20240715$$HP$CN$CN
240936061$24093606$1$I$$20240711$20240715$20240715$PER$$US-JNJFOC-20240729468$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$HP$US$US
240936071$24093607$1$I$20240701$20240713$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112005$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$75.75$KG$20240716$$HP$US$US
240936082$24093608$2$F$$20240911$20240715$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111834$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$55.34$KG$20240912$$CN$US$US
240936091$24093609$1$I$$20240711$20240715$20240715$EXP$$NVSJ2024JP008448$NOVARTIS$$$$$$Y$$$20240716$$CN$JP$JP
240936102$24093610$2$F$20240501$20240712$20240715$20240722$PER$$US-AMGEN-USASP2024138649$AMGEN$$$$$$Y$$$20240722$$CN$US$US
240936111$24093611$1$I$20240622$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024137970$AMGEN$$70$YR$E$M$Y$$$20240715$$CN$US$US
240936121$24093612$1$I$$20240708$20240715$20240715$EXP$$CA-JNJFOC-20240729668$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240716$$HP$CA$CA
240936131$24093613$1$I$$20240710$20240715$20240715$EXP$$JP-TAKEDA-2024TJP010467$TAKEDA$$$$A$$Y$$$20240715$$MD$JP$JP
240936141$24093614$1$I$20240701$20240709$20240715$20240715$EXP$$CN-BEIGENE-BGN-2024-010707$BEIGENE$$$$$$Y$$$20240715$$HP$CN$CN
240936151$24093615$1$I$20220617$20240708$20240715$20240715$EXP$$EU-BAUSCHBL-2024BNL029758$BAUSCH AND LOMB$$29$YR$$M$Y$88.2$KG$20240716$$HP$EU$EU
240936161$24093616$1$I$20240701$20240708$20240715$20240715$EXP$$CN-JNJFOC-20240721732$JOHNSON AND JOHNSON$$16$YR$T$M$Y$55$KG$20240716$$HP$CN$CN
240936171$24093617$1$I$$20240701$20240715$20240715$30DAY$$US-JNJFOC-20240723219$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240936181$24093618$1$I$20230601$20231229$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00651$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240715$$CN$US$US
240936191$24093619$1$I$20230101$20231031$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00562$PRINSTON PHARMACEUTICAL$$$$$F$Y$90.703$KG$20240711$$CN$US$US
240936201$24093620$1$I$20240101$20240201$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00054$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240624$$CN$US$US
240936211$24093621$1$I$$20240206$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00059$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240624$$CN$US$US
240936221$24093622$1$I$20230101$20231001$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00491$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240624$$CN$US$US
240936231$24093623$1$I$20230101$20231003$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00495$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240624$$CN$US$US
240936241$24093624$1$I$20230101$20231016$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00543$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240624$$CN$US$US
240936251$24093625$1$I$20231202$20240205$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00058$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240624$$CN$US$US
240936261$24093626$1$I$$20230925$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00486$PRINSTON PHARMACEUTICAL$$$$$$Y$88.435$KG$20240624$$CN$US$US
240936271$24093627$1$I$20230901$20230928$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00487$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240624$$CN$US$US
240936281$24093628$1$I$$20231003$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00498$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240624$$CN$US$US
240936291$24093629$1$I$$20240128$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00049$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240624$$CN$US$US
240936301$24093630$1$I$20240404$20240423$20240715$20240715$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00194$PRINSTON PHARMACEUTICAL$$80$YR$$F$Y$59.41$KG$20240703$$CN$US$US
240936311$24093631$1$I$20220101$20240118$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00020$PRINSTON PHARMACEUTICAL$$$$$F$Y$90.718$KG$20240624$$CN$US$US
240936321$24093632$1$I$20230808$20231030$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00561$PRINSTON PHARMACEUTICAL$$49$YR$$F$Y$86.168$KG$20240624$$CN$US$US
240936331$24093633$1$I$20240103$20240104$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00002$PRINSTON PHARMACEUTICAL$$64$YR$$F$Y$$$20240624$$CN$US$US
240936341$24093634$1$I$$20230830$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00428$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240624$$PH$US$US
240936351$24093635$1$I$20230101$20230917$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00465$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240624$$CN$US$US
240936361$24093636$1$I$20230601$20230628$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00326$PRINSTON PHARMACEUTICAL$$47$YR$$F$Y$$$20240624$$PH$US$US
240936371$24093637$1$I$20230601$20230718$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00348$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240624$$CN$US$US
240936381$24093638$1$I$$20230816$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00403$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240624$$CN$US$US
240936392$24093639$2$F$$20240805$20240715$20240813$PER$$US-BAUSCHBL-2024BNL029818$BAUSCH AND LOMB$$$$$F$Y$$$20240814$$CN$US$US
240936402$24093640$2$F$20240101$20240805$20240715$20240813$PER$$US-BAUSCHBL-2024BNL029804$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240814$$CN$US$US
240936411$24093641$1$I$20240705$20240709$20240715$20240715$EXP$$CN-BEIGENE-BGN-2024-010705$BEIGENE$$$$$$Y$$$20240715$$HP$CN$CN
240936421$24093642$1$I$20230101$20230906$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00439$PRINSTON PHARMACEUTICAL$$$$$F$Y$81.179$KG$20240624$$CN$US$US
240936431$24093643$1$I$20230101$20230628$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00325$PRINSTON PHARMACEUTICAL$$$$$M$Y$104.31$KG$20240624$$CN$US$US
240936441$24093644$1$I$20230101$20230805$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00380$PRINSTON PHARMACEUTICAL$$69$YR$$F$Y$83.9$KG$20240624$$CN$US$US
240936451$24093645$1$I$20230101$20230908$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00444$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240624$$HP$US$US
240936461$24093646$1$I$$20230814$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00397$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240624$$CN$US$US
240936471$24093647$1$I$20230801$20230828$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00421$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240624$$CN$US$US
240936481$24093648$1$I$20180101$20230609$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00298$PRINSTON PHARMACEUTICAL$$$$$F$Y$113.38$KG$20240624$$CN$US$US
240936491$24093649$1$I$20220101$20230730$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00368$PRINSTON PHARMACEUTICAL$$$$$F$Y$81.633$KG$20240624$$CN$US$US
240936501$24093650$1$I$20230601$20230802$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00373$PRINSTON PHARMACEUTICAL$$35$YR$$M$Y$73.923$KG$20240624$$CN$US$US
240936511$24093651$1$I$20230801$20230828$20240715$20240715$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00420$PRINSTON PHARMACEUTICAL$$43$YR$$F$Y$63.492$KG$20240624$$CN$US$US
240936521$24093652$1$I$20240711$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007732$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240715$$CN$US$US
240936534$24093653$4$F$20240703$20240904$20240715$20240912$PER$$US-ROCHE-10000022388$ROCHE$$64$YR$A$F$Y$$$20240912$$HP$US$US
240936541$24093654$1$I$20240101$20240709$20240715$20240715$PER$$US-ABBVIE-5836035$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240936551$24093655$1$I$$20231120$20240715$20240715$PER$$US-NOVOPROD-1143456$NOVO NORDISK$$$$$$Y$$$20240716$$PH$US$US
240936561$24093656$1$I$20240301$20240709$20240715$20240715$EXP$$US-ABBVIE-5836393$ABBVIE$$56$YR$$F$Y$$$20240715$$CN$US$US
240936571$24093657$1$I$$20240705$20240715$20240715$PER$$US-ROCHE-10000021498$ROCHE$$31$YR$A$F$Y$$$20240716$$CN$US$US
240936582$24093658$2$F$$20240729$20240715$20240730$PER$$US-ROCHE-10000021450$ROCHE$$$$$M$Y$$$20240730$$CN$US$US
240936591$24093659$1$I$$20240709$20240715$20240715$PER$$US-ROCHE-10000022953$ROCHE$$22$YR$A$M$Y$$$20240716$$CN$US$US
240936601$24093660$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110508$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240716$$CN$US$US
240936612$24093661$2$F$$20240812$20240715$20240813$PER$$US-ROCHE-10000025718$ROCHE$$19$YR$A$F$Y$$$20240813$$CN$US$US
240936623$24093662$3$F$20240401$20240712$20240715$20240823$EXP$$US-ABBVIE-5838267$ABBVIE$$71$YR$$F$Y$102$KG$20240823$$MD$US$US
240936631$24093663$1$I$20240715$20240715$20240715$20240715$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039902$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240716$$CN$US$US
240936641$24093664$1$I$20240711$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138340$AMGEN$$78$YR$E$F$Y$$$20240715$$CN$US$US
240936651$24093665$1$I$$20240712$20240715$20240715$EXP$$GB-AMGEN-GBRSP2024139663$AMGEN$$$$$M$Y$$$20240715$$CN$GB$GB
240936661$24093666$1$I$20240618$20240701$20240715$20240715$EXP$$CN-Techdow-J2024HPR000433$SHENZHEN TECHDOW PHARMACEUTICAL$$78$YR$E$M$Y$$$20240716$$MD$CN$CN
240936681$24093668$1$I$20190101$20240709$20240715$20240715$EXP$$US-ABBVIE-5834180$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240936691$24093669$1$I$$20240709$20240715$20240715$EXP$$US-BIOGEN-2024BI01252370$BIOGEN$$$$$F$Y$$$20240715$$MD$US$US
240936701$24093670$1$I$20240626$20240709$20240715$20240715$EXP$$CN-BEIGENE-BGN-2024-010684$BEIGENE$$$$$$Y$$$20240715$$HP$CN$CN
240936711$24093671$1$I$$20240708$20240715$20240715$EXP$$US-BIOGEN-2024BI01272973$BIOGEN$$$$$F$Y$$$20240715$$CN$US$US
240936721$24093672$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5837133$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240936731$24093673$1$I$$20240712$20240715$20240715$PER$$US-ROCHE-10000025888$ROCHE$$$$A$F$Y$$$20240716$$CN$US$US
240936743$24093674$3$F$20240711$20240829$20240715$20240905$PER$$US-ROCHE-10000025959$ROCHE$$9$YR$C$M$Y$24.95$KG$20240905$$HP$US$US
240936751$24093675$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000025402$ROCHE$$$$E$F$Y$$$20240716$$CN$US$US
240936762$24093676$2$F$$20240826$20240715$20240829$PER$$US-ROCHE-10000026097$ROCHE$$$$A$F$Y$90.26$KG$20240829$$CN$US$US
240936771$24093677$1$I$$20240711$20240715$20240715$PER$$US-ROCHE-10000024989$ROCHE$$$$E$M$Y$$$20240716$$CN$US$US
240936792$24093679$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3218381$TEVA$Leiser A, Virdee R, Kinniry P. Severe Epinephrine-Induced Lactic Acidosis. Am-J-Respir-Crit-Care-Med 2024; 209.; Leiser A, Virdee R, Kinniry P. Severe Epinephrine-Induced Lactic Acidosis. Am-J-Respir-Crit-Care-Med 2024; 209.$69$YR$$M$Y$$$20240802$$HP$US$US
240936801$24093680$1$I$20240702$20240711$20240715$20240715$EXP$$JP-TAKEDA-2024TJP010462$TAKEDA$$90$YR$$M$Y$$$20240715$$MD$JP$JP
240936812$24093681$2$F$20240101$20240820$20240715$20240828$EXP$$US-BIOGEN-2024BI01272858$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
240936822$24093682$2$F$$20240731$20240715$20240802$EXP$$GB-ABBVIE-5833101$ABBVIE$$$$A$F$Y$$$20240802$$CN$GB$GB
240936832$24093683$2$F$20240101$20240905$20240715$20240910$EXP$$CA-JNJFOC-20240724052$JOHNSON AND JOHNSON$$58$YR$A$M$Y$143$KG$20240911$$HP$CA$CA
240936841$24093684$1$I$20240708$20240711$20240715$20240715$EXP$$JP-TAKEDA-2024TJP010491$TAKEDA$$7$DEC$$M$Y$$$20240715$$MD$JP$JP
240936851$24093685$1$I$$20240709$20240715$20240715$PER$$US-ROCHE-10000022137$ROCHE$$43$YR$A$F$Y$$$20240716$$CN$US$US
240936861$24093686$1$I$20220101$20240708$20240715$20240715$PER$$US-ROCHE-10000021476$ROCHE$$63$YR$A$F$Y$$$20240716$$CN$US$US
240936871$24093687$1$I$$20240705$20240715$20240715$PER$$US-ROCHE-3570985$ROCHE$$60$YR$A$F$Y$$$20240716$$CN$US$US
240936882$24093688$2$F$$20240705$20240715$20240809$PER$$US-ROCHE-10000019206$ROCHE$$16$YR$T$M$Y$$$20240809$$MD$US$US
240936891$24093689$1$I$20240705$20240705$20240715$20240715$PER$$US-ROCHE-10000025121$ROCHE$$49$YR$A$F$Y$78.47$KG$20240716$$CN$US$US
240936901$24093690$1$I$$20240705$20240715$20240715$PER$$US-ROCHE-10000021392$ROCHE$$$$A$F$Y$$$20240716$$CN$US$US
240936912$24093691$2$F$$20240822$20240715$20240826$PER$$US-ROCHE-10000023702$ROCHE$$19$YR$A$F$Y$$$20240826$$CN$US$US
240936922$24093692$2$F$20240701$20240718$20240715$20240725$30DAY$$US-AMGEN-USASP2024136649$AMGEN$$67$YR$E$M$Y$98.9$KG$20240725$$HP$US$US
240936931$24093693$1$I$20230101$20240709$20240715$20240715$EXP$$US-JNJFOC-20240504154$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240716$$HP$US$US
240936961$24093696$1$I$$20240709$20240715$20240715$EXP$$US-JNJFOC-20240723422$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240716$$HP$US$US
240936972$24093697$2$F$$20240807$20240715$20240813$30DAY$$AT-JNJFOC-20240726967$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$CN$AT$AT
240936981$24093698$1$I$20240701$20240715$20240715$20240715$EXP$SE-SEMPA-2024-005451$SE-JNJFOC-20240737929$JOHNSON AND JOHNSON$$67$YR$E$M$Y$110$KG$20240716$$MD$SE$SE
240936991$24093699$1$I$$20240710$20240715$20240715$PER$$US-AMGEN-USASP2024138306$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240937001$24093700$1$I$$20240712$20240715$20240715$PER$$US-JNJFOC-20240734707$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$PH$US$US
240937011$24093701$1$I$20240101$20240710$20240715$20240715$EXP$$US-JNJFOC-20240728130$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240716$$HP$US$US
240937021$24093702$1$I$$20240712$20240715$20240715$EXP$$US-ABBVIE-5840363$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240937031$24093703$1$I$20230711$20240711$20240715$20240715$EXP$$CA-ABBVIE-5839944$ABBVIE$$84$YR$$F$Y$$$20240715$$CN$CA$CA
240937042$24093704$2$F$$20240729$20240715$20240731$EXP$$CA-ABBVIE-5834740$ABBVIE$$$$E$F$Y$$$20240731$$CN$CA$CA
240937051$24093705$1$I$$20240709$20240715$20240715$EXP$$IN-JNJFOC-20240724136$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$HP$IN$IN
240937061$24093706$1$I$20240101$20240711$20240715$20240715$EXP$$US-ABBVIE-5838025$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240937072$24093707$2$F$20240101$20240712$20240715$20240717$EXP$$US-ABBVIE-5837501$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
240937081$24093708$1$I$20240701$20240711$20240715$20240715$EXP$$CA-ABBVIE-5839855$ABBVIE$$67$YR$$F$Y$$$20240715$$CN$CA$CA
240937093$24093709$3$F$20230101$20240807$20240715$20240813$EXP$$US-ABBVIE-5671398$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
240937101$24093710$1$I$20171127$20240709$20240715$20240715$EXP$$BE-ABBVIE-18K-013-3096292-00$ABBVIE$$70$YR$$F$Y$$$20240715$$MD$BE$BE
240937111$24093711$1$I$20240701$20240712$20240715$20240715$EXP$$US-ABBVIE-5840351$ABBVIE$$55$YR$$F$Y$$$20240715$$CN$US$US
240937121$24093712$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5836212$ABBVIE$$$$$M$Y$$$20240715$$HP$US$US
240937131$24093713$1$I$20240709$20240710$20240715$20240715$EXP$$CA-ABBVIE-5836739$ABBVIE$$$$E$F$Y$$$20240715$$CN$CA$CA
240937141$24093714$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5836852$ABBVIE$$$$$$Y$$$20240715$$HP$US$US
240937152$24093715$2$F$20240705$20240719$20240715$20240726$30DAY$$US-AMGEN-USASP2024135702$AMGEN$$63$YR$A$F$Y$92$KG$20240726$$PH$US$US
240937171$24093717$1$I$20240708$20240711$20240715$20240715$PER$$NVSC2024US145722$NOVARTIS$$$$$M$Y$$$20240716$$HP$US$US
240937181$24093718$1$I$20240101$20240711$20240715$20240715$EXP$$DE-ABBVIE-5839026$ABBVIE$$$$A$F$Y$$$20240715$$PH$DE$DE
240937192$24093719$2$F$$20240723$20240715$20240802$EXP$$US-TEVA-VS-3218403$TEVA$Singh M, Kuo JK, Raza A. Lamotrigine Induced Drug Reaction With Eosinophilia With Systemic Symptoms (DRESS)With HHV-6 Reactivation Causing Severe Encephalitis and Status Epilepticus. Am-J-Respir-Crit-Care-Med 2024; 209 A1358.; Singh M, Kuo JK, Raza A. Lamotrigine Induced Drug Reaction With Eosinophilia With Systemic Symptoms (DRESS)With HHV-6 Reactivation Causing Severe Encephalitis and Status Epilepticus. Am-J-Respir-Crit-Care-Med 2024; 209 A1358.$18$YR$$F$Y$$$20240802$$HP$US$US
240937201$24093720$1$I$$20240701$20240715$20240715$EXP$$IL-TEVA-VS-3217208$TEVA$Rahamimov R, Telem S, Davidovichi B, Bielopolski D, Steinmetz T, Nesher E, et al. The association between hydrochlorothiazide use and non-melanoma skin cancer in kidney transplant recipients. Clin-Kidney-J 2024; 17 (5):.$$$A$$Y$$$20240715$$HP$IL$IL
240937212$24093721$2$F$$20240805$20240715$20240806$PER$$US-ALXN-202407USA000651US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
240937232$24093723$2$F$$20240712$20240715$20240721$PER$$US-AMGEN-USASP2024139891$AMGEN$$$$$F$Y$$$20240721$$HP$US$US
240937241$24093724$1$I$20240101$20240712$20240715$20240715$EXP$$US-ABBVIE-5839073$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240937251$24093725$1$I$$20240709$20240715$20240715$EXP$$US-ABBVIE-5836757$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240937261$24093726$1$I$$20240708$20240715$20240715$EXP$$US-BIOGEN-2024BI01272939$BIOGEN$$$$$F$Y$$$20240715$$HP$US$US
240937271$24093727$1$I$20240521$20240710$20240715$20240715$EXP$IT-MINISAL02-994002$IT-BIOGEN-2024BI01273259$BIOGEN$$33$YR$$M$Y$81$KG$20240715$$MD$IT$IT
240937283$24093728$3$F$$20240827$20240715$20240829$EXP$$US-ABBVIE-5836974$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
240937291$24093729$1$I$$20240710$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112079$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240716$$CN$US$US
240937301$24093730$1$I$$20240713$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112020$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240716$$HP$US$US
240937312$24093731$2$F$$20240712$20240715$20240731$PER$$US-ABBVIE-5838918$ABBVIE$$$$E$F$Y$$$20240731$$MD$US$US
240937321$24093732$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-5835474$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240937341$24093734$1$I$$20240709$20240715$20240715$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110101$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$61.23$KG$20240716$$CN$US$US
240937351$24093735$1$I$$20240705$20240715$20240715$PER$$US-ABBVIE-5833728$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240937362$24093736$2$F$$20240904$20240715$20240906$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039861$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240906$$CN$US$US
240937371$24093737$1$I$$20240710$20240715$20240715$EXP$$US-ABBVIE-4771061$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240937381$24093738$1$I$20230515$20240710$20240715$20240715$EXP$$CA-ABBVIE-5837067$ABBVIE$$65$YR$$F$Y$$$20240715$$CN$CA$CA
240937391$24093739$1$I$$20240712$20240715$20240715$EXP$$US-ABBVIE-5839790$ABBVIE$$$$$M$Y$$$20240715$$HP$US$US
240937402$24093740$2$F$$20240722$20240715$20240729$PER$$US-ABBVIE-5835146$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
240937411$24093741$1$I$$20240708$20240715$20240715$EXP$$JP-009507513-2407JPN001849J$MERCK$$56$YR$$$Y$$$20240715$$MD$JP$JP
240937421$24093742$1$I$20230201$20240710$20240715$20240715$EXP$$US-BIOGEN-2024BI01273297$BIOGEN$$68$YR$$F$Y$$$20240715$$CN$US$US
240937431$24093743$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111975$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$61.23$KG$20240716$$PH$US$US
240937441$24093744$1$I$$20240714$20240715$20240715$PER$$US-AMGEN-USASP2024139970$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240937451$24093745$1$I$$20240711$20240715$20240715$EXP$$US-ABBVIE-5838044$ABBVIE$$$$$M$Y$$$20240715$$HP$US$US
240937461$24093746$1$I$$20240712$20240715$20240715$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111847$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240716$$CN$US$US
240937471$24093747$1$I$$20240711$20240715$20240715$EXP$$US-ABBVIE-5838587$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240937511$24093751$1$I$20231009$20240710$20240715$20240715$EXP$$ES-ABBVIE-5839403$ABBVIE$$63$YR$$M$Y$$$20240715$$MD$ES$ES
240937522$24093752$2$F$$20240808$20240715$20240812$PER$$US-JNJFOC-20240725617$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$HP$US$US
240937531$24093753$1$I$20230722$20240712$20240715$20240715$EXP$$US-JNJFOC-20240733159$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240716$$HP$US$US
240937542$24093754$2$F$20240701$20240717$20240715$20240719$EXP$$US-ABBVIE-5837934$ABBVIE$$89$YR$$F$Y$$$20240719$$CN$US$US
240937551$24093755$1$I$20240409$20240709$20240715$20240715$EXP$$CN-JNJFOC-20240725162$JOHNSON AND JOHNSON$$69$YR$E$F$Y$53.3$KG$20240716$$HP$CN$CN
240937571$24093757$1$I$20240101$20240711$20240715$20240715$EXP$$US-ABBVIE-5838698$ABBVIE$$$$$M$Y$$$20240715$$CN$US$US
240937581$24093758$1$I$$20240628$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407000597$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240715$$CN$US$US
240937591$24093759$1$I$20240707$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007823$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240715$$CN$US$US
240937601$24093760$1$I$$20240712$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407009266$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240715$$CN$US$US
240937611$24093761$1$I$$20240711$20240715$20240715$PER$$US-ELI_LILLY_AND_COMPANY-US202407007828$ELI LILLY AND CO$$$$A$F$Y$$$20240715$$CN$US$US
240937622$24093762$2$F$20240411$20240801$20240715$20240805$EXP$$FR-PFIZER INC-202400212406$PFIZER$$52$YR$$F$Y$76$KG$20240805$$MD$FR$FR
240937631$24093763$1$I$20231101$20240711$20240715$20240715$EXP$$CA-PFIZER INC-202400213595$PFIZER$$73$YR$$F$Y$$$20240715$$MD$CA$CA
240937641$24093764$1$I$20220620$20240709$20240715$20240715$EXP$$ZA-PFIZER INC-PV202400090419$PFIZER$$45$YR$$F$Y$$$20240715$$MD$ZA$ZA
240937652$24093765$2$F$20240216$20240717$20240715$20240718$EXP$$FR-PFIZER INC-202400212857$PFIZER$$70$YR$$M$Y$100$KG$20240718$$MD$FR$FR
240937662$24093766$2$F$20240710$20240724$20240715$20240729$EXP$$CA-PFIZER INC-202400212920$PFIZER$$58$YR$$F$Y$$$20240729$$HP$CA$CA
240937672$24093767$2$F$20230901$20240924$20240715$20240926$EXP$$US-PFIZER INC-PV202300107949$PFIZER$$66$YR$$F$Y$70.31$KG$20240926$$HP$US$US
240937683$24093768$3$F$20240706$20240814$20240715$20240827$EXP$$CA-ABBVIE-5838555$ABBVIE$$75$YR$$M$Y$$$20240827$$HP$CA$CA
240937691$24093769$1$I$$20240710$20240715$20240715$EXP$$PL-JNJFOC-20240732946$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240716$$CN$PL$PL
240937701$24093770$1$I$$20240711$20240715$20240715$PER$$US-AMGEN-USASP2024138660$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240937711$24093771$1$I$$20240714$20240715$20240715$PER$$US-AMGEN-USASP2024139967$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240937723$24093772$3$F$20240701$20240809$20240715$20240815$EXP$$US-BIOGEN-2024BI01273472$BIOGEN$$58$YR$$F$Y$$$20240815$$CN$US$US
240937731$24093773$1$I$$20240711$20240715$20240715$EXP$$US-ABBVIE-5839732$ABBVIE$$$$$F$Y$$$20240715$$CN$US$US
240937741$24093774$1$I$$20240712$20240715$20240715$PER$$NVSC2024US145644$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240937751$24093775$1$I$20240629$20240709$20240715$20240715$EXP$$CN-JNJFOC-20240725531$JOHNSON AND JOHNSON$$73$YR$E$F$Y$50$KG$20240716$$HP$CN$CN
240937761$24093776$1$I$$20240710$20240715$20240715$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01283$NOVITIUM PHARMA$Han Xiao.PD-1 blockade combined with decitabine to treat refractory peripheral T-cell lymphoma not otherwise specified: A case report and review of literature.Journal of Cancer Research and Therapeutics.28-DEC-2023;19(6):1680-1684$43$YR$A$F$Y$$$20240716$$HP$CN$CN
240937771$24093777$1$I$20240709$20240711$20240716$20240716$EXP$$ID-AstraZeneca-2024A160472$ASTRAZENECA$$28680$DY$$F$Y$$$20240716$$CN$ID$
240937782$24093778$2$F$$20240905$20240716$20240911$EXP$$GB-BIOGEN-2024BI01273444$BIOGEN$$$$A$M$Y$$$20240911$$CN$GB$GB
240937792$24093779$2$F$20240711$20240822$20240716$20240823$PER$$US-TAKEDA-2024TUS071004$TAKEDA$$38$YR$$F$Y$$$20240823$$CN$US$US
240937801$24093780$1$I$$20240708$20240716$20240716$EXP$$CN-JNJFOC-20240728056$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$HP$CN$CN
240937821$24093782$1$I$$20240711$20240716$20240716$EXP$$US-ABBVIE-5838350$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240937831$24093783$1$I$20240319$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109861$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$71.21$KG$20240716$$HP$US$US
240937842$24093784$2$F$$20240718$20240716$20240720$EXP$$NVSC2024US145684$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
240937852$24093785$2$F$$20240809$20240716$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202407008794$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240813$$CN$US$US
240937861$24093786$1$I$20240701$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008613$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240715$$CN$US$US
240937871$24093787$1$I$20240116$20240708$20240716$20240716$EXP$$FR-CELLTRION INC.-2024FR016840$CELLTRION$$$$$$Y$$$20240716$$MD$FR$FR
240937881$24093788$1$I$20240101$20240711$20240716$20240716$EXP$$CA-ABBVIE-5838547$ABBVIE$$38$YR$$F$Y$$$20240716$$CN$CA$CA
240937891$24093789$1$I$$20240621$20240716$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002952$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
240937902$24093790$2$F$20240101$20240724$20240716$20240801$EXP$$US-JNJFOC-20240720316$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$MD$US$US
240937911$24093791$1$I$$20240709$20240716$20240716$EXP$$CA-JNJFOC-20240636615$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240716$$HP$CA$CA
240937923$24093792$3$F$20240706$20240910$20240716$20240917$EXP$JP-MMM-C3FBE5G1$JP-GSK-JP2024084504$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$JP$JP
240937931$24093793$1$I$$20240711$20240716$20240716$EXP$$JP-ASTELLAS-2024JP004938$ASTELLAS$$$$$M$Y$$$20240716$$PH$JP$JP
240937941$24093794$1$I$$20240703$20240716$20240716$EXP$$US-CIPLA LTD.-2024US07423$CIPLA$Nagi T, Barnes S, Weiss A.. Rare case of endoscopically diagnosed ischemic colitis secondary to chronic Phentermine use. ACG Case Reports Journal. 2024;11:e01363:1 to 3$$$$$Y$$$20240716$$MD$US$US
240937951$24093795$1$I$$20240703$20240716$20240716$EXP$$US-CIPLA LTD.-2024US07435$CIPLA$Taylor SR, Venkataraman V, Connors JM.. Hyperfibrinolysis during the treatment of rhabdomyosarcoma. Research and Practice in thrombosis and Haemostasis. 2024;8:e102467:1 to 5$$$$$Y$$$20240716$$HP$US$US
240937961$24093796$1$I$20240514$20240705$20240716$20240716$EXP$$GB-CELLTRION INC.-2024GB016643$CELLTRION$$$$$$Y$$$20240716$$CN$GB$GB
240937971$24093797$1$I$$20240710$20240716$20240716$EXP$$US-ABBVIE-5835363$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240937981$24093798$1$I$$20240711$20240716$20240716$EXP$$PL-ASTELLAS-2024US019881$ASTELLAS$$47$YR$$F$Y$$$20240716$$CN$PL$PL
240937991$24093799$1$I$20240601$20240703$20240716$20240716$PER$$US-JNJFOC-20240718193$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240716$$CN$US$US
240938002$24093800$2$F$$20240712$20240716$20240717$PER$$NVSC2024US145494$NOVARTIS$$$$$$Y$$$20240717$$CN$US$US
240938011$24093801$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139965$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240938021$24093802$1$I$$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111867$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240716$$CN$US$US
240938041$24093804$1$I$$20240711$20240716$20240716$EXP$$US-ABBVIE-5838336$ABBVIE$$$$$M$Y$$$20240716$$HP$US$US
240938051$24093805$1$I$$20240711$20240716$20240716$EXP$$US-ABBVIE-5838490$ABBVIE$$$$$$Y$$$20240716$$HP$US$US
240938063$24093806$3$F$20240501$20240913$20240716$20240920$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-021679$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240920$$CN$US$US
240938071$24093807$1$I$20240701$20240711$20240716$20240716$EXP$$IE-ABBVIE-5839463$ABBVIE$$85$YR$$M$Y$$$20240716$$CN$IE$IE
240938081$24093808$1$I$$20240708$20240716$20240716$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000236$EMCURE$$$$$$Y$$$20240716$$CN$US$US
240938091$24093809$1$I$20240627$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024138723$AMGEN$$45$YR$A$F$Y$$$20240715$$HP$US$US
240938101$24093810$1$I$20240525$20240711$20240716$20240716$EXP$$US-ABBVIE-5838314$ABBVIE$$76$YR$$M$Y$$$20240716$$CN$US$US
240938111$24093811$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145664$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
240938121$24093812$1$I$$20240707$20240716$20240716$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000242$EMCURE$Mess SA, Stephanos KN.. Temperance With Tranexamic Acid: Increased  Risk of Venous Thromboembolism in  Abdominoplasty. Aesthet Surg J Open Forum.. 2024;6:ojae044$53$YR$$F$Y$$$20240716$$MD$US$US
240938131$24093813$1$I$$20240621$20240716$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002955$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
240938142$24093814$2$F$20240101$20240809$20240716$20240812$PER$$US-AMGEN-USASP2024138007$AMGEN$$66$YR$E$F$Y$$$20240812$$CN$US$US
240938151$24093815$1$I$$20240709$20240716$20240716$EXP$$US-PIRAMAL CRITICAL CARE LIMITED-2024-PPL-000520$PIRAMAL$$$$$$Y$$$20240716$$HP$US$US
240938171$24093817$1$I$20231001$20240708$20240716$20240716$EXP$FR-AFSSAPS-PB2024000748$FR-Eisai-EC-2024-169699$EISAI$$48$YR$A$M$Y$60$KG$20240716$$MD$FR$FR
240938181$24093818$1$I$20240320$20240708$20240716$20240716$EXP$IT-MINISAL02-993584$IT-Eisai-EC-2024-169701$EISAI$$32$YR$A$F$Y$$$20240716$$PH$IT$IT
240938193$24093819$3$F$$20240816$20240716$20240820$30DAY$$CA-JNJFOC-20240705314$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240820$$PH$CA$CA
240938201$24093820$1$I$20240711$20240712$20240716$20240716$EXP$$US-TAKEDA-2024TUS071300$TAKEDA$$51$YR$$M$Y$$$20240716$$CN$US$US
240938211$24093821$1$I$20240712$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008587$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240716$$CN$US$US
240938221$24093822$1$I$20240710$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008856$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240716$$CN$US$US
240938232$24093823$2$F$$20240924$20240716$20240927$PER$$US-PCCINC-2024-PPL-000521$PIRAMAL$$$$$$Y$$$20240927$$CN$US$US
240938241$24093824$1$I$20240701$20240711$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039654$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240716$$CN$US$US
240938251$24093825$1$I$20240615$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202406017904$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240716$$HP$US$US
240938261$24093826$1$I$$20240711$20240716$20240716$EXP$$US-UCBSA-2024035438$UCB$$$$$F$Y$$$20240716$$HP$US$US
240938271$24093827$1$I$20240624$20240711$20240716$20240716$EXP$$US-ABBVIE-5839722$ABBVIE$$79$YR$$M$Y$$$20240716$$CN$US$US
240938281$24093828$1$I$$20240713$20240716$20240716$PER$$NVSC2024US145584$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240938292$24093829$2$F$20240318$20240801$20240716$20240806$EXP$$US-ABBVIE-5836939$ABBVIE$$61$YR$$M$Y$82$KG$20240806$$CN$US$US
240938301$24093830$1$I$$20240708$20240716$20240716$EXP$$US-ABBVIE-5835316$ABBVIE$$$$$$Y$$$20240716$$CN$US$US
240938311$24093831$1$I$$20240624$20240716$20240716$PER$$US-SAGENT PHARMACEUTICALS-2024SAG000137$SAGENT$$$$$$Y$$$20240705$$HP$US$US
240938321$24093832$1$I$$20240624$20240716$20240716$PER$$US-SAGENT PHARMACEUTICALS-2024SAG000138$SAGENT$$$$$$Y$$$20240705$$HP$US$US
240938331$24093833$1$I$$20240624$20240716$20240716$PER$$US-SAGENT PHARMACEUTICALS-2024SAG000139$SAGENT$$$$$$Y$$$20240705$$HP$US$US
240938341$24093834$1$I$$20240425$20240716$20240716$PER$$US-SAGENT PHARMACEUTICALS-2024SAG000109$SAGENT$$$$$$Y$$$20240705$$HP$US$US
240938351$24093835$1$I$$20230905$20240716$20240716$PER$$US-SAGENT PHARMACEUTICALS-2023SAG000126$SAGENT$$$$$$Y$$$20240705$$PH$US$US
240938361$24093836$1$I$$20240117$20240716$20240716$PER$$US-SAGENT PHARMACEUTICALS-2023SAG000175$SAGENT$$$$$$Y$$$20240705$$PH$US$US
240938371$24093837$1$I$$20240711$20240716$20240716$EXP$$DE-JAZZ PHARMACEUTICALS-2024-DE-010709$JAZZ$$$$$$Y$$$20240715$$MD$DE$DE
240938382$24093838$2$F$$20240715$20240716$20240718$PER$$US-ABBVIE-5835153$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
240938392$24093839$2$F$20240101$20240815$20240716$20240824$EXP$$IT-GENMAB-2024-02528$GENMAB$$66$YR$$F$Y$65$KG$20240824$$MD$IT$IT
240938401$24093840$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5839142$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240938411$24093841$1$I$$20240703$20240716$20240716$EXP$$AU-STERISCIENCE B.V.-2024-ST-001017$Steriscience PTE$Ali SB, Vembar P, Sukumaran S, Gunawardane D, Hughes T, Smith A.. Tocilizumab in grade 4 hepatitis secondary to immune checkpoint inhibitor: a case report and review of the literature.. Immunotherapy. 2023;15 (14):1125-1132$68$YR$$F$Y$52$KG$20240716$$HP$AU$AU
240938421$24093842$1$I$$20231107$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017046$STRIDES$Fountain Hb, Fountain Cade, Fountain Mark, Fountain Nell, Fountain N.. Dopaminergic Overdrive: Restless Leg Syndrome Treatment Causing Impulse Control Disorder.. Chest. 2023;164 (Suppl) (4):A6361-A6362.$40$YR$$M$Y$$$20240716$$HP$US$US
240938431$24093843$1$I$$20231004$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015242$STRIDES$$$$$F$Y$$$20240716$$CN$US$US
240938441$24093844$1$I$$20230830$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2023SP014042$STRIDES$Fisher K, Clifford E, Piniella N, Gallagher R, Leder A. Alopecia in females with young onset Parkinson+apos;s disease: An exploratory survey. J-Parkinsons-Dis. 2023;13(1):378$$$$F$Y$$$20240716$$HP$US$US
240938451$24093845$1$I$20240101$20240710$20240716$20240716$EXP$$US-ABBVIE-5836982$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240938461$24093846$1$I$$20240709$20240716$20240716$EXP$$NVSC2024CO144812$NOVARTIS$$$$$$Y$$$20240716$$MD$CO$CO
240938481$24093848$1$I$20231001$20231229$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2023SP018975$STRIDES$$56$YR$$F$Y$90.703$KG$20240716$$CN$US$US
240938491$24093849$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-10000026911$ROCHE$$$$$$Y$$$20240716$$HP$US$US
240938501$24093850$1$I$$20240710$20240716$20240716$PER$$US-ABBVIE-5838684$ABBVIE$$$$$F$Y$$$20240716$$HP$US$US
240938512$24093851$2$F$20240709$20240726$20240716$20240801$PER$$US-ABBVIE-5837657$ABBVIE$$61$YR$$F$Y$$$20240801$$CN$US$US
240938521$24093852$1$I$20231201$20240709$20240716$20240716$EXP$$US-ABBVIE-5691443$ABBVIE$$45$YR$$F$Y$$$20240716$$CN$US$US
240938531$24093853$1$I$$20240711$20240716$20240716$EXP$$US-ABBVIE-5837880$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240938541$24093854$1$I$20230701$20240711$20240716$20240716$EXP$$US-ABBVIE-5837743$ABBVIE$$72$YR$$M$Y$$$20240716$$CN$US$US
240938551$24093855$1$I$$20240711$20240716$20240716$PER$$US-AstraZeneca-2024A161008$ASTRAZENECA$$$$$F$Y$$$20240716$$MD$US$
240938561$24093856$1$I$$20240711$20240716$20240716$EXP$$US-ABBVIE-5838589$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240938571$24093857$1$I$20240624$20240710$20240716$20240716$EXP$$US-ABBVIE-5836899$ABBVIE$$29$YR$$F$Y$$$20240716$$CN$US$US
240938582$24093858$2$F$20230831$20240710$20240716$20240717$EXP$$ES-ABBVIE-5839472$ABBVIE$$49$YR$$F$Y$$$20240717$$MD$ES$ES
240938591$24093859$1$I$20230101$20240710$20240716$20240716$EXP$$US-ABBVIE-5837368$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240938601$24093860$1$I$20230101$20240703$20240716$20240716$EXP$$QA-ELI_LILLY_AND_COMPANY-QA202407004379$ELI LILLY AND CO$$$$A$F$Y$$$20240716$$MD$QA$QA
240938611$24093861$1$I$20240601$20240703$20240716$20240716$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002763$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240716$$CN$US$US
240938621$24093862$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008552$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240716$$CN$US$US
240938631$24093863$1$I$20240707$20240709$20240716$20240716$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407006545$ELI LILLY AND CO$$74$YR$E$F$Y$56$KG$20240716$$CN$CN$CN
240938641$24093864$1$I$20240429$20240703$20240716$20240716$EXP$FR-AFSSAPS-RS2024000652$FR-ELI_LILLY_AND_COMPANY-FR202407003300$ELI LILLY AND CO$$75$YR$E$M$Y$87$KG$20240716$$CN$FR$FR
240938651$24093865$1$I$20240624$20240708$20240716$20240716$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407008313$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240716$$CN$DE$CN
240938661$24093866$1$I$20240604$20240703$20240716$20240716$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407003734$ELI LILLY AND CO$$33$YR$A$F$Y$52$KG$20240716$$CN$CN$CN
240938671$24093867$1$I$20240629$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008419$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240716$$CN$US$US
240938681$24093868$1$I$20231223$20240703$20240716$20240716$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407003770$ELI LILLY AND CO$$30$YR$A$F$Y$50$KG$20240716$$CN$FR$FR
240938691$24093869$1$I$$20240703$20240716$20240716$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202407003183$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240716$$HP$BE$BE
240938701$24093870$1$I$$20240703$20240716$20240716$EXP$$US-ELI_LILLY_AND_COMPANY-US202407002789$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240716$$HP$US$US
240938711$24093871$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008553$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240716$$CN$US$US
240938721$24093872$1$I$$20240708$20240716$20240716$EXP$$IT-CELLTRION INC.-2024IT016836$CELLTRION$$$$$$Y$$$20240716$$MD$IT$IT
240938731$24093873$1$I$20240609$20240610$20240716$20240716$PER$$US-AJANTA-2024AJA00114$AJANTA PHARMA$$78$YR$E$M$Y$158$KG$20240716$$CN$US$US
240938741$24093874$1$I$$20240712$20240716$20240716$EXP$$US-UCBSA-2024035541$UCB$$$$$F$Y$$$20240716$$CN$US$US
240938751$24093875$1$I$20240627$20240711$20240716$20240716$EXP$$US-ABBVIE-5838545$ABBVIE$$87$YR$$M$Y$$$20240716$$CN$US$US
240938761$24093876$1$I$20240101$20240709$20240716$20240716$EXP$$US-ABBVIE-5834764$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240938771$24093877$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139985$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240938781$24093878$1$I$20240709$20240709$20240716$20240716$EXP$$US-JNJFOC-20240728352$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240716$$HP$US$US
240938792$24093879$2$F$$20240717$20240716$20240723$EXP$$JP-JNJFOC-20240729322$JOHNSON AND JOHNSON$HOSOKAWA K. PAH complicated with cardiac disease: based on the 7th World Symposium on Pulmonary Hypertension (WSPH). 2024;.$8$DEC$E$F$Y$$$20240723$$MD$JP$JP
240938801$24093880$1$I$20240514$20240710$20240716$20240716$EXP$$US-ABBVIE-5836716$ABBVIE$$62$YR$$M$Y$$$20240716$$CN$US$US
240938811$24093881$1$I$$20240709$20240716$20240716$PER$$US-ABBVIE-5839046$ABBVIE$$$$$$Y$$$20240716$$CN$US$US
240938821$24093882$1$I$20240712$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139182$AMGEN$$65$YR$E$F$Y$$$20240715$$CN$US$US
240938832$24093883$2$F$$20240717$20240716$20240724$EXP$$CA-ABBVIE-5839876$ABBVIE$$$$$M$Y$$$20240724$$CN$CA$CA
240938841$24093884$1$I$$20240715$20240716$20240716$EXP$NL-LRB-00985592$NL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039734$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$77$KG$20240716$$MD$NL$NL
240938852$24093885$2$F$20240101$20240711$20240716$20240723$EXP$$US-ABBVIE-5791473$ABBVIE$$$$$M$Y$70$KG$20240723$$CN$US$US
240938862$24093886$2$F$20240403$20240918$20240716$20240923$EXP$DE-BFARM-24002570$DE-JNJFOC-20240728176$JOHNSON AND JOHNSON$$42$YR$A$M$Y$64$KG$20240923$$MD$DE$DE
240938871$24093887$1$I$20240629$20240711$20240716$20240716$EXP$$ES-ABBVIE-5831316$ABBVIE$$77$YR$$M$Y$$$20240716$$CN$ES$ES
240938881$24093888$1$I$20240701$20240712$20240716$20240716$EXP$$US-ABBVIE-5840345$ABBVIE$$76$YR$$F$Y$$$20240716$$CN$US$US
240938891$24093889$1$I$$20240527$20240716$20240716$PER$$US-AUROBINDO-AUR-APL-2024-027156$AUROBINDO$$$$$$Y$$$20240716$$PH$US$US
240938901$24093890$1$I$$20240713$20240716$20240716$PER$$US-ROCHE-10000026325$ROCHE$$51$YR$A$F$Y$$$20240716$$CN$US$US
240938912$24093891$2$F$$20240711$20240716$20240718$EXP$$US-SA-2024SA203669$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240718$$CN$US$US
240938921$24093892$1$I$20240611$20240708$20240716$20240716$EXP$$CA-JNJFOC-20240731994$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240716$$HP$CA$CA
240938933$24093893$3$F$20240601$20240812$20240716$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-020497$UNITED THERAPEUTICS$$58$YR$$F$Y$77.551$KG$20240820$$$US$US
240938941$24093894$1$I$20240711$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024138981$AMGEN$$$$$M$Y$$$20240715$$CN$US$US
240938951$24093895$1$I$20240301$20240710$20240716$20240716$EXP$$US-ABBVIE-5837000$ABBVIE$$48$YR$$F$Y$$$20240716$$CN$US$US
240938961$24093896$1$I$20240703$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139324$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240938971$24093897$1$I$20240401$20240704$20240716$20240716$EXP$$GB-AUROBINDO-AUR-APL-2024-033569$AUROBINDO$$25$YR$$M$Y$$$20240716$$MD$GB$GB
240938982$24093898$2$F$20231009$20240708$20240716$20240717$EXP$$US-CHATTEMPRD-2024OHG023640$CHATTEM$$59$YR$A$F$Y$$$20240717$$LW$US$US
240938992$24093899$2$F$$20240710$20240716$20240717$EXP$$US-CHATTEMPRD-2024OHG023852$CHATTEM$$$$$M$Y$$$20240717$$LW$US$US
240939002$24093900$2$F$20240101$20240920$20240716$20240926$EXP$$US-ABBVIE-5838889$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
240939011$24093901$1$I$$20230802$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2023SP012853$STRIDES$Arayangkool C, Lee J, Lian K-C.. PROFOUND HYPOMAGNESEMIA IN A PATIENT TREATED WITH LONG-TERM PROTON PUMP INHIBITOR.. J-Gen-Intern-Med.. 2023;38(2):S622-S623$83$YR$$M$Y$$$20240716$$HP$US$US
240939021$24093902$1$I$$20240205$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2024SP001465$STRIDES$Perkins DR, Kandah O, Check L, Sherertz R.. Syncope and the Inability to Move: Was It the Magnesium?.. Cureus. 2023;15(6)$68$YR$$M$Y$$$20240716$$HP$US$US
240939031$24093903$1$I$$20230529$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2023SP008914$STRIDES$Chanaa F, Barsten K, Clayton S.. Complete Esophageal Obstruction: A Rare Complication of Zollinger-Ellison Syndrome (ZES).. Am-J-Gastroenterol. 2022;117 (2)(10):S1543 abstr. S2290.$73$YR$$M$Y$$$20240716$$MD$US$US
240939042$24093904$2$F$$20240710$20240716$20240717$EXP$$US-CHATTEMPRD-2024OHG023872$CHATTEM$$$$$F$Y$$$20240717$$LW$US$US
240939051$24093905$1$I$20230419$20240708$20240716$20240716$EXP$$AU-GSK-AU2024APC085427$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$MD$AU$AU
240939061$24093906$1$I$$20240229$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002719$STRIDES$Iskandir C, Khan A, Damani T, Addrizzo-Harris DJ.. Clinical and Radiological Improvement in Adult Non-Cystic Fibrosis Bronchiectasis Following Robotic Toupet Fundoplication.. Am-J-Respir-Crit-Care-Med. 2023;207$62$YR$$F$Y$$$20240716$$HP$US$US
240939071$24093907$1$I$$20230531$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2023SP008991$STRIDES$Prakash S, Saavedra R, Lehmann R, Mokadem M.. Candy cane syndrome presenting with refractory heartburn 15 years after Roux-en-Y bypass.. J-Surg-Case-Rep. 2023;2023(3).$57$YR$$F$Y$$$20240716$$HP$US$US
240939081$24093908$1$I$$20240711$20240716$20240716$PER$$US-UNITED THERAPEUTICS-UNT-2024-021491$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240716$$$US$US
240939091$24093909$1$I$$20230928$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015324$STRIDES$Steinbrink JM, Narayanasamy S, Wolfe CR, Maziarz E, Byrns J, Kiser JJ, et al.. Antiviral Treatment Failures After Transplantation of Organs From Donors With Hepatitis C Infection: A Report of 4 Cases.. Am-J-Kidney-Dis. 2023;82(3):368-372$67$YR$$M$Y$$$20240716$$MD$US$US
240939101$24093910$1$I$$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024138855$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240939122$24093912$2$F$20240707$20240729$20240716$20240805$EXP$$DE-BAXTER-2024BAX021389$BAXTER$$79$YR$$F$Y$$$20240805$$HP$DE$DE
240939132$24093913$2$F$20240601$20240814$20240716$20240819$PER$$US-AMGEN-USASP2024139618$AMGEN$$69$YR$E$M$Y$$$20240819$$CN$US$US
240939141$24093914$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139977$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240939151$24093915$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008569$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240716$$CN$US$US
240939161$24093916$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008556$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240716$$CN$US$US
240939171$24093917$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024139561$AMGEN$$$$A$F$Y$$$20240715$$HP$US$US
240939191$24093919$1$I$$20240708$20240716$20240716$EXP$$US-AMGEN-USASP2024135315$AMGEN$Kaffenberger B.; Yan A.; Gallardo M. et al.. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management. Archives of Dermatological Research. 2024;316 (7):1-10$37$YR$A$F$Y$$$20240715$$HP$US$US
240939202$24093920$2$F$$20240710$20240716$20240722$EXP$$US-SANDOZ INC.-SDZ2023US004454$SANDOZ$$$$$F$Y$$$20240722$$MD$US$US
240939211$24093921$1$I$20240707$20240710$20240716$20240716$EXP$$GB-JNJFOC-20240728795$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240716$$HP$GB$GB
240939222$24093922$2$F$20240611$20240716$20240716$20240721$PER$$US-AMGEN-USASP2024139522$AMGEN$$67$YR$E$F$Y$$$20240721$$MD$US$US
240939235$24093923$5$F$$20240919$20240716$20240924$EXP$$BR-GENMAB-2024-02095$GENMAB$$$$$$Y$$$20240924$$MD$BR$BR
240939241$24093924$1$I$$20240705$20240716$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107749$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$70$KG$20240716$$HP$CA$CA
240939256$24093925$6$F$20240101$20240912$20240716$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-020672$UNITED THERAPEUTICS$$$$$F$Y$94.331$KG$20240920$$$US$US
240939261$24093926$1$I$20240706$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139327$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240939271$24093927$1$I$20240602$20240705$20240716$20240716$EXP$NO-NOMAADVRE-PASRAPP-2024-V9za4g$NO-NOVOPROD-1250821$NOVO NORDISK$$65$YR$$M$Y$$$20240716$$CN$NO$NO
240939281$24093928$1$I$20240501$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405021430123560-SJKQY$GB-NOVOPROD-1252426$NOVO NORDISK$$$$$F$Y$$$20240716$$PH$GB$GB
240939291$24093929$1$I$$20240705$20240716$20240716$EXP$$US-NOVOPROD-1248320$NOVO NORDISK$$$$A$F$Y$$$20240716$$HP$US$US
240939301$24093930$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405021510271170-RHLPK$GB-NOVOPROD-1252389$NOVO NORDISK$$$$$F$Y$$$20240716$$HP$GB$GB
240939311$24093931$1$I$20240112$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405031137053290-SYQDZ$GB-NOVOPROD-1252457$NOVO NORDISK$$58$YR$$M$Y$70$KG$20240716$$PH$GB$GB
240939321$24093932$1$I$20240630$20240703$20240716$20240716$EXP$$US-NOVOPROD-1251446$NOVO NORDISK$$88$YR$$F$Y$$$20240716$$CN$US$US
240939331$24093933$1$I$20240626$20240704$20240716$20240716$EXP$GB-MHRA-MED-202407041447185430-TVHGQ$GB-NOVOPROD-1252509$NOVO NORDISK$$$$$F$Y$$$20240716$$CN$GB$GB
240939341$24093934$1$I$$20240704$20240716$20240716$EXP$$CA-NOVOPROD-1251889$NOVO NORDISK$$$$$F$Y$$$20240716$$MD$CA$CA
240939351$24093935$1$I$$20240625$20240716$20240716$PER$$CA-TOLMAR, INC.-24CA050013$TOLMAR$$$$$M$Y$$$20240716$$CN$CA$CA
240939361$24093936$1$I$$20240625$20240716$20240716$PER$$CA-TOLMAR, INC.-24CA050087$TOLMAR$$$$$M$Y$$$20240716$$CN$CA$CA
240939371$24093937$1$I$$20240625$20240716$20240716$PER$$CA-TOLMAR, INC.-24CA050354$TOLMAR$$$$$M$Y$$$20240716$$CN$CA$CA
240939382$24093938$2$F$20240619$20240808$20240716$20240902$PER$$CA-TOLMAR, INC.-24CA050487$TOLMAR$$86$YR$$M$Y$$$20240902$$HP$CA$CA
240939392$24093939$2$F$20240501$20240910$20240716$20240925$PER$$CA-TOLMAR, INC.-24CA050496$TOLMAR$$74$YR$$M$Y$$$20240925$$CN$CA$CA
240939402$24093940$2$F$20240101$20240715$20240716$20240805$PER$$CA-TOLMAR, INC.-24CA050498$TOLMAR$$$$$M$Y$$$20240805$$CN$CA$CA
240939411$24093941$1$I$$20240625$20240716$20240716$PER$$CA-TOLMAR, INC.-24CA050501$TOLMAR$$$$$M$Y$$$20240716$$CN$CA$CA
240939422$24093942$2$F$20240702$20240730$20240716$20240805$30DAY$$US-AMGEN-USASP2024135587$AMGEN$$77$YR$E$M$Y$78.7$KG$20240805$$PH$US$US
240939431$24093943$1$I$$20240625$20240716$20240716$PER$$CA-TOLMAR, INC.-24CA050505$TOLMAR$$$$$M$Y$$$20240716$$CN$CA$CA
240939441$24093944$1$I$20240625$20240625$20240716$20240716$PER$$CA-TOLMAR, INC.-24CA050530$TOLMAR$$80$YR$$M$Y$$$20240716$$CN$CA$CA
240939451$24093945$1$I$20240109$20240625$20240716$20240716$PER$$CA-TOLMAR, INC.-24CA050500$TOLMAR$$71$YR$$M$Y$$$20240716$$CN$CA$CA
240939461$24093946$1$I$20230122$20240708$20240716$20240716$EXP$$FR-CELLTRION INC.-2024FR016760$CELLTRION$$$$$$Y$$$20240716$$PH$FR$FR
240939471$24093947$1$I$$20240625$20240716$20240716$PER$$CA-TOLMAR, INC.-24CA050572$TOLMAR$$$$$M$Y$$$20240716$$CN$CA$CA
240939481$24093948$1$I$20240625$20240711$20240716$20240716$EXP$$US-GSK-US2024086320$GLAXOSMITHKLINE$$23$YR$$F$Y$$$20240716$$CN$US$US
240939491$24093949$1$I$20240620$20240705$20240716$20240716$EXP$$RO-NOVOPROD-1251150$NOVO NORDISK$$53$YR$$F$Y$$$20240716$$MD$RO$RO
240939501$24093950$1$I$20240427$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405061940292840-YNQHM$GB-NOVOPROD-1252081$NOVO NORDISK$$37$YR$$F$Y$92$KG$20240716$$CN$GB$GB
240939511$24093951$1$I$20240605$20240705$20240716$20240716$EXP$FR-AFSSAPS-PA2024001237$FR-NOVOPROD-1250856$NOVO NORDISK$$23$YR$$F$Y$49$KG$20240716$$CN$FR$FR
240939522$24093952$2$F$$20240716$20240716$20240725$EXP$$EG-NOVOPROD-1251263$NOVO NORDISK$$$$N$M$Y$3$KG$20240725$$CN$EG$EG
240939531$24093953$1$I$20231001$20240705$20240716$20240716$EXP$$US-NOVOPROD-1252160$NOVO NORDISK$$74$YR$$M$Y$$$20240716$$CN$US$US
240939541$24093954$1$I$20240619$20240705$20240716$20240716$EXP$$US-NOVOPROD-1251494$NOVO NORDISK$$64$YR$$F$Y$$$20240716$$CN$US$US
240939551$24093955$1$I$20240511$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405141034114320-YLRTP$GB-NOVOPROD-1252061$NOVO NORDISK$$60$YR$$F$Y$70$KG$20240716$$HP$GB$GB
240939561$24093956$1$I$20230101$20240705$20240716$20240716$EXP$$ES-NOVOPROD-1250894$NOVO NORDISK$$72$YR$$F$Y$94$KG$20240716$$CN$ES$ES
240939571$24093957$1$I$$20240709$20240716$20240716$PER$$US-AMGEN-USASP2024135906$AMGEN$$$$$F$Y$$$20240715$$CN$US$US
240939581$24093958$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139962$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240939591$24093959$1$I$20230801$20240712$20240716$20240716$EXP$$GB-AMGEN-GBRSP2024138891$AMGEN$$69$YR$E$F$Y$72$KG$20240715$$CN$GB$GB
240939601$24093960$1$I$$20230911$20240716$20240716$PER$$US-AUROBINDO-AUR-APL-2023-055140$AUROBINDO$$$$$F$Y$$$20240716$$PH$US$US
240939611$24093961$1$I$20240619$20240712$20240716$20240716$EXP$FR-AFSSAPS-GR2024000871$FR-JNJFOC-20240734699$JOHNSON AND JOHNSON$$60$YR$A$F$Y$71$KG$20240716$$PH$FR$FR
240939621$24093962$1$I$$20240711$20240716$20240716$EXP$$NVSC2024US144158$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
240939631$24093963$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145615$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240939641$24093964$1$I$20240707$20240709$20240716$20240716$PER$$US-ABBVIE-5837420$ABBVIE$$43$YR$$M$Y$$$20240716$$CN$US$US
240939651$24093965$1$I$20240703$20240709$20240716$20240716$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000601$PAREXEL$$$$$$Y$$$20240716$$HP$CN$CN
240939661$24093966$1$I$20240101$20240710$20240716$20240716$PER$$US-UNITED THERAPEUTICS-UNT-2024-021292$UNITED THERAPEUTICS$$$$$M$Y$82.993$KG$20240716$$$US$US
240939671$24093967$1$I$$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024138362$AMGEN$$62$YR$A$F$Y$$$20240715$$HP$US$US
240939681$24093968$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139974$AMGEN$$$$$$Y$$$20240715$$HP$US$US
240939691$24093969$1$I$20240330$20240712$20240716$20240716$EXP$$GB-AMGEN-GBRSP2024138900$AMGEN$$59$YR$A$M$Y$$$20240715$$HP$GB$GB
240939701$24093970$1$I$20240131$20240712$20240716$20240716$EXP$$CA-TAKEDA-2024TUS004816$TAKEDA$$67$YR$$F$Y$$$20240716$$CN$CA$CA
240939712$24093971$2$F$$20240725$20240716$20240802$PER$$US-JNJFOC-20240721339$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$CN$US$US
240939722$24093972$2$F$20240710$20240730$20240716$20240806$EXP$$AR-TAKEDA-2024TUS071430$TAKEDA$$5$YR$$M$Y$$$20240806$$HP$AR$AR
240939731$24093973$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405071249126050-CYFKR$GB-MSNLABS-2024MSNSPO01556$MSN LABORATORIES$$$$$$Y$$$20240716$$HP$GB$GB
240939742$24093974$2$F$20190101$20240711$20240716$20240724$EXP$$UG-MACLEODS PHARMA-MAC2024048131$MACLEODS$Nambuya M, Mayanja-Kizza H.case report: recurrent anemia related to long term acyclovir use in a pregnant HIV infected Ugandan.African Health Sciences.2024;24(1):91-3$$$$$Y$$$20240724$$MD$UG$UG
240939751$24093975$1$I$$20240708$20240716$20240716$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008471$STRIDES$Indhumathi E, Karthikeyan B, Nair SV.. RENAL CORTICAL NECROSIS IN TRANSPLANT PATIENT WITH COVID INFECTION.. Indian-J-Nephrol. 2021;31 (Suppl.):S60$47$YR$$M$Y$$$20240716$$MD$IN$IN
240939761$24093976$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009112$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240716$$CN$US$US
240939771$24093977$1$I$20240501$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008723$ELI LILLY AND CO$$$$$$Y$$$20240716$$CN$US$US
240939781$24093978$1$I$$20240705$20240716$20240716$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06428$HIKMA$$74$YR$$F$Y$$$20240716$$HP$CA$CA
240939791$24093979$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007754$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240716$$CN$US$US
240939801$24093980$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008783$ELI LILLY AND CO$$$$$M$Y$$$20240716$$CN$US$US
240939811$24093981$1$I$20240705$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008575$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240716$$CN$US$US
240939824$24093982$4$F$20240820$20240820$20240716$20240828$EXP$$CA-TAKEDA-2024TUS066130$TAKEDA$$73$YR$$F$Y$$$20240828$$CN$CA$CA
240939831$24093983$1$I$$20240711$20240716$20240716$EXP$$US-ABBVIE-5839129$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240939841$24093984$1$I$$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112211$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240716$$CN$US$US
240939851$24093985$1$I$20040101$20240529$20240716$20240716$PER$$US-CIPLA LTD.-2024US05811$CIPLA$$$$$$Y$$$20240716$$CN$US$US
240939861$24093986$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024140053$AMGEN$$$$$$Y$$$20240715$$HP$US$US
240939873$24093987$3$F$20240711$20240809$20240716$20240813$PER$$US-HALEON-2187023$Haleon PLC$$$$$F$Y$$$20240813$$CN$US$US
240939881$24093988$1$I$$20240709$20240716$20240716$EXP$$US-TAKEDA-2024TUS071160$TAKEDA$$$$$M$Y$$$20240716$$CN$US$US
240939891$24093989$1$I$$20240708$20240716$20240716$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP008485$STRIDES$Ozek G, Aksoylar S, Ucar SK, Canda E, Akcan M, Carti O, et al.. Hematopoietic stem cell transplantation with reduced toxicity conditioning regimen in mitochondrial neurogastrointestinal encephalopathy syndrome.. Pediatr-Blood-Cancer. 2023;70 (7)$20$YR$$M$Y$$$20240716$$HP$TR$TR
240939903$24093990$3$F$20240701$20240809$20240716$20240816$30DAY$$IL-JNJFOC-20240701577$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240816$$HP$IL$IL
240939912$24093991$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218282$TEVA$Yegudkin I, Feng L, Manzouri S, Funnamark R, Ciurczak N, McKenzie ME, et al. Neurogenic Pulmonary Edema in the Setting of Intracerebral Hemorrhage: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A1157.; Yegudkin I, Feng L, Manzouri S, Funnamark R, Ciurczak N, McKenzie ME, et al. Neurogenic Pulmonary Edema in the Setting of Intracerebral Hemorrhage: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A1157.$40$YR$$M$Y$$$20240805$$HP$US$US
240939921$24093992$1$I$20240101$20240710$20240716$20240716$EXP$$US-JNJFOC-20240728329$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240716$$CN$US$US
240939932$24093993$2$F$20240708$20240715$20240716$20240722$EXP$$CA-JNJFOC-20240724283$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240722$$HP$CA$CA
240939941$24093994$1$I$20240524$20240705$20240716$20240716$EXP$FR-AFSSAPS-ST2024001119$FR-STRIDES ARCOLAB LIMITED-2024SP008035$STRIDES$$37$YR$$M$Y$79.9$KG$20240716$$MD$FR$FR
240939951$24093995$1$I$20240101$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405071530405740-VRZDY$GB-NOVOPROD-1252180$NOVO NORDISK$$$$$F$Y$120$KG$20240716$$PH$GB$GB
240939961$24093996$1$I$20240406$20240705$20240716$20240716$EXP$GB-MHRA-MED-202406261434065550-TPZFV$GB-NOVOPROD-1252496$NOVO NORDISK$$56$YR$$F$Y$142$KG$20240716$$PH$GB$GB
240939971$24093997$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405101815270140-HRZQN$GB-NOVOPROD-1252534$NOVO NORDISK$$$$$F$Y$$$20240716$$CN$GB$GB
240939981$24093998$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405131225268730-FVKQJ$GB-NOVOPROD-1252368$NOVO NORDISK$$$$$F$Y$$$20240716$$HP$GB$GB
240939991$24093999$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202407041616482970-DKRHN$GB-NOVOPROD-1252522$NOVO NORDISK$$$$$F$Y$143$KG$20240716$$HP$GB$GB
240940001$24094000$1$I$$20240705$20240716$20240716$EXP$$US-NOVOPROD-1252500$NOVO NORDISK$$$$$M$Y$$$20240716$$CN$US$US
240940011$24094001$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405090816429460-HNCSF$GB-NOVOPROD-1252477$NOVO NORDISK$$$$$F$Y$$$20240716$$PH$GB$GB
240940021$24094002$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405071428202560-YMRND$GB-NOVOPROD-1252283$NOVO NORDISK$$$$$F$Y$$$20240716$$CN$GB$GB
240940031$24094003$1$I$20240212$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405111016566690-HBRGS$GB-NOVOPROD-1252492$NOVO NORDISK$$44$YR$$F$Y$77$KG$20240716$$CN$GB$GB
240940041$24094004$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405131136404120-CJTKW$GB-NOVOPROD-1252531$NOVO NORDISK$$$$$F$Y$$$20240716$$CN$GB$GB
240940051$24094005$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405090813595280-VFHBY$GB-NOVOPROD-1252516$NOVO NORDISK$$$$$F$Y$$$20240716$$PH$GB$GB
240940061$24094006$1$I$20240306$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405101559392990-LDCFJ$GB-NOVOPROD-1252257$NOVO NORDISK$$52$YR$$F$Y$86$KG$20240716$$MD$GB$GB
240940072$24094007$2$F$$20240805$20240716$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-021324$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240807$$$US$US
240940081$24094008$1$I$20240429$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405081309181010-YSTKH$GB-NOVOPROD-1252513$NOVO NORDISK$$35$YR$$F$Y$132$KG$20240716$$CN$GB$GB
240940091$24094009$1$I$20240508$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405171132117740-DHRCP$GB-NOVOPROD-1252497$NOVO NORDISK$$$$$F$Y$$$20240716$$MD$GB$GB
240940101$24094010$1$I$20240327$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405080809041130-BWRZQ$GB-NOVOPROD-1252336$NOVO NORDISK$$64$YR$$M$Y$$$20240716$$HP$GB$GB
240940111$24094011$1$I$20240314$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405080709261820-NSZDW$GB-NOVOPROD-1252318$NOVO NORDISK$$41$YR$$F$Y$$$20240716$$CN$GB$GB
240940121$24094012$1$I$20240412$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405081028452160-GZWQM$GB-NOVOPROD-1252476$NOVO NORDISK$$$$$F$Y$146$KG$20240716$$PH$GB$GB
240940131$24094013$1$I$$20240709$20240716$20240716$PER$$US-ABBVIE-5839098$ABBVIE$$$$$$Y$$$20240716$$CN$US$US
240940141$24094014$1$I$$20240708$20240716$20240716$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP008486$STRIDES$Ozek G, Aksoylar S, Ucar SK, Canda E, Akcan M, Carti O, et al.. Hematopoietic stem cell transplantation with reduced toxicity conditioning regimen in mitochondrial neurogastrointestinal encephalopathy syndrome.. Pediatr-Blood-Cancer. 2023;70 (7)$14$YR$$M$Y$$$20240716$$HP$TR$TR
240940151$24094015$1$I$20240703$20240706$20240716$20240716$30DAY$$US-GSK-US2024084088$GLAXOSMITHKLINE$$70$YR$$M$Y$$$20240716$$CN$US$US
240940161$24094016$1$I$$20240705$20240716$20240716$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06431$HIKMA$$78$YR$$M$Y$$$20240716$$HP$CA$CA
240940172$24094017$2$F$20240603$20240902$20240716$20240904$EXP$$JP-ROCHE-10000024326$ROCHE$$5$DEC$A$F$Y$$$20240904$$MD$JP$JP
240940181$24094018$1$I$$20240709$20240716$20240716$EXP$$JP-SANDOZ INC.-SDZ2024JP064017$SANDOZ$Kanno N, Ito T, Takaoka S, Yamagata K, Bukawa H. Epstein-Barr Virus-Positive Mucocutaneous Ulcer With Medication-Related Osteonecrosis of the Jaw Arising in the Mandible of a Rheumatoid Arthritis Patient: A Case Report. Cureus. 2024;16(5):e61280$54$YR$$M$Y$$$20240716$$MD$JP$JP
240940191$24094019$1$I$20240601$20240708$20240716$20240716$EXP$$BR-JNJFOC-20240728895$JOHNSON AND JOHNSON$$70$YR$E$F$Y$84$KG$20240716$$CN$BR$BR
240940202$24094020$2$F$20240701$20240829$20240716$20240903$EXP$$CA-JNJFOC-20240728486$JOHNSON AND JOHNSON$$15$YR$T$M$Y$65$KG$20240903$$HP$CA$CA
240940211$24094021$1$I$20240701$20240708$20240716$20240716$30DAY$$US-GSK-US2024084343$GLAXOSMITHKLINE$$56$YR$$M$Y$$$20240716$$CN$US$US
240940231$24094023$1$I$$20240708$20240716$20240716$EXP$TR-MLMSERVICE-20231030-4623606-1$TR-STRIDES ARCOLAB LIMITED-2023SP016721$STRIDES$Gul EE, Bektasoglu G, Dogan Z.. Brugada phenocopy associated with multiple psychotic drugs. Journal of Electrocardiology. 2023;81:156-158$17$YR$$F$Y$$$20240716$$MD$TR$TR
240940241$24094024$1$I$20240101$20240711$20240716$20240716$EXP$$US-ABBVIE-5837862$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240940252$24094025$2$F$20240101$20240717$20240716$20240722$EXP$$US-ABBVIE-5838320$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
240940261$24094026$1$I$20240123$20240711$20240716$20240716$EXP$$US-ABBVIE-5837953$ABBVIE$$54$YR$$F$Y$$$20240716$$CN$US$US
240940271$24094027$1$I$$20191205$20240716$20240716$EXP$$US-AstraZeneca-2019SF60867$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240940281$24094028$1$I$20190701$20190827$20240716$20240716$EXP$$US-AstraZeneca-2019SF23367$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240940292$24094029$2$F$20240402$20240731$20240716$20240807$EXP$FR-AFSSAPS-PC2024000513$FR-CHEPLA-2024008706$CHEPLAPHARM$$89$YR$$M$Y$85$KG$20240807$$PH$COUNTRY NOT SPECIFIED$FR
240940301$24094030$1$I$$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007878$ELI LILLY AND CO$$$$$$Y$$$20240716$$CN$US$US
240940311$24094031$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008657$ELI LILLY AND CO$$$$$M$Y$$$20240716$$PH$US$US
240940321$24094032$1$I$20240712$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008900$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240716$$CN$US$US
240940332$24094033$2$F$20240101$20240722$20240716$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-021448$UNITED THERAPEUTICS$$$$$M$Y$75.737$KG$20240731$$$US$US
240940341$24094034$1$I$$20240711$20240716$20240716$EXP$GB-MHRA-MED-202407092212033490-KTPGJ$GB-STRIDES ARCOLAB LIMITED-2024SP008469$STRIDES$$$$$F$Y$$$20240716$$CN$GB$GB
240940353$24094035$3$F$$20240828$20240716$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA064799$SANDOZ$$17$YR$$F$Y$$$20240830$$CN$CA$CA
240940364$24094036$4$F$20240322$20240920$20240716$20240924$EXP$$US-SANDOZ INC.-SDZ2024US065249$SANDOZ$$81$YR$$F$Y$32.2$KG$20240924$$MD$US$US
240940371$24094037$1$I$$20240621$20240716$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002770$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
240940381$24094038$1$I$$20240713$20240716$20240716$PER$$US-AMGEN-USASP2024139728$AMGEN$$$$$$Y$$$20240715$$MD$US$US
240940391$24094039$1$I$$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024138281$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240940401$24094040$1$I$20240701$20240712$20240716$20240716$EXP$$CA-JNJFOC-20240735347$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240716$$PH$CA$CA
240940411$24094041$1$I$$20240708$20240716$20240716$PER$$US-ROCHE-10000020404$ROCHE$$$$E$M$Y$$$20240716$$CN$US$US
240940421$24094042$1$I$$20240710$20240716$20240716$PER$$US-ROCHE-10000024011$ROCHE$$$$$$Y$$$20240716$$MD$US$US
240940432$24094043$2$F$$20240715$20240716$20240717$PER$$US-HALEON-2187123$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
240940442$24094044$2$F$$20240711$20240716$20240717$EXP$$CA-ABBVIE-5838550$ABBVIE$$$$E$F$Y$$$20240717$$CN$CA$CA
240940451$24094045$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405091236482430-LDHQZ$GB-NOVOPROD-1252545$NOVO NORDISK$$$$$F$Y$$$20240716$$CN$GB$GB
240940462$24094046$2$F$$20240813$20240716$20240823$EXP$$AT-NOVOPROD-1252791$NOVO NORDISK$$$$$F$Y$$$20240823$$CN$AT$AT
240940471$24094047$1$I$20240320$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405141612169930-CMZPV$GB-NOVOPROD-1252537$NOVO NORDISK$$40$YR$$F$Y$102$KG$20240716$$HP$GB$GB
240940481$24094048$1$I$$20240705$20240716$20240716$EXP$$US-NOVOPROD-1253662$NOVO NORDISK$$$$E$M$Y$$$20240716$$CN$US$US
240940491$24094049$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405091151424640-HCNZV$GB-NOVOPROD-1253450$NOVO NORDISK$$$$$F$Y$$$20240716$$CN$GB$GB
240940501$24094050$1$I$$20240705$20240716$20240716$EXP$RU-RZN-2446184$RU-NOVOPROD-1252754$NOVO NORDISK$$$$$M$Y$$$20240716$$HP$RU$RU
240940511$24094051$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405081548510120-CNQWT$GB-NOVOPROD-1253356$NOVO NORDISK$$$$$F$Y$$$20240716$$CN$GB$GB
240940521$24094052$1$I$$20240705$20240716$20240716$EXP$$US-NOVOPROD-1255015$NOVO NORDISK$$$$$F$Y$$$20240716$$CN$US$US
240940531$24094053$1$I$20240501$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405131345571570-CDGFR$GB-NOVOPROD-1253342$NOVO NORDISK$$71$YR$$M$Y$$$20240716$$HP$GB$GB
240940541$24094054$1$I$$20240705$20240716$20240716$EXP$$TR-NOVOPROD-1252798$NOVO NORDISK$$779$MON$$M$Y$64$KG$20240716$$CN$TR$TR
240940551$24094055$1$I$20231007$20240705$20240716$20240716$EXP$$TR-NOVOPROD-1252752$NOVO NORDISK$$$$$M$Y$$$20240716$$CN$TR$TR
240940561$24094056$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405152044196960-BSHZF$GB-NOVOPROD-1252924$NOVO NORDISK$$$$$F$Y$$$20240716$$CN$GB$GB
240940571$24094057$1$I$$20240705$20240716$20240716$EXP$$US-NOVOPROD-1253429$NOVO NORDISK$$$$$M$Y$$$20240716$$CN$US$US
240940581$24094058$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405101701310890-FKTVJ$GB-NOVOPROD-1253041$NOVO NORDISK$$$$$F$Y$$$20240716$$CN$GB$GB
240940591$24094059$1$I$20180101$20240706$20240716$20240716$EXP$$EG-NOVOPROD-1253921$NOVO NORDISK$$541$MON$$F$Y$85$KG$20240716$$CN$EG$EG
240940601$24094060$1$I$20240601$20240711$20240716$20240716$EXP$$US-UCBSA-2024035481$UCB$$47$YR$$F$Y$$$20240716$$HP$US$US
240940611$24094061$1$I$20231103$20240705$20240716$20240716$EXP$$ES-AUROBINDO-AUR-APL-2024-033638$AUROBINDO$$$$A$F$Y$$$20240716$$MD$ES$ES
240940622$24094062$2$F$$20240801$20240716$20240806$EXP$$CN-AMGEN-CHNSP2024135436$AMGEN$$8$YR$C$F$Y$$$20240806$$MD$CN$CN
240940631$24094063$1$I$$20240713$20240716$20240716$PER$$US-BIOVITRUM-2024-US-009844$BIOVITRUM$$83$YR$$M$Y$$$20240716$$CN$US$US
240940641$24094064$1$I$$20240701$20240716$20240716$EXP$$US-TEVA-VS-3219331$TEVA$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am-J-Transplant 2023; 23 (7): 1048-1057.$$$$M$Y$$$20240716$$HP$US$US
240940661$24094066$1$I$$20240708$20240716$20240716$EXP$$CA-CELLTRION INC.-2024CA016717$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
240940671$24094067$1$I$$20240701$20240716$20240716$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06017$LUPIN$Wong C, Ang G, Malik M, Iqbal S. From tongue swelling to skin sloughing: Azithromycin-induced SJS/TEN. American Journal of Respiratory and Critical Care Medicine. 2024;209$71$YR$$F$Y$$$20240716$$HP$US$US
240940681$24094068$1$I$20240404$20240705$20240716$20240716$EXP$$GB-AUROBINDO-AUR-APL-2024-033758$AUROBINDO$$22$YR$$F$Y$73$KG$20240716$$CN$GB$GB
240940691$24094069$1$I$20191030$20191204$20240716$20240716$EXP$$CO-AstraZeneca-2019SF76284$ASTRAZENECA$$25182$DY$$M$Y$$$20240716$$CN$CO$
240940701$24094070$1$I$20240624$20240705$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-033370$AUROBINDO$$61$YR$$F$Y$54$KG$20240716$$MD$FR$FR
240940712$24094071$2$F$20240611$20240715$20240716$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111630$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240719$$PH$US$US
240940721$24094072$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139984$AMGEN$$$$$$Y$$$20240715$$CN$US$US
240940731$24094073$1$I$20240709$20240712$20240716$20240716$EXP$$US-ROCHE-10000027267$ROCHE$$62$YR$A$M$Y$$$20240716$$CN$US$US
240940741$24094074$1$I$$20240705$20240716$20240716$EXP$$PL-AUROBINDO-AUR-APL-2024-031932$AUROBINDO$Gazo?yszyn N. Diagnostyka wsp??chorobowo?ci u osoby niebinarnej-studium przypadku? (Diagnosis of co-morbidity in a non-binary person - a case study). Psychiatria Po Dyplomie (Psychiatry After Diploma). 2024;ISSN: 2449-934X$23$YR$$M$Y$$$20240716$$MD$PL$PL
240940752$24094075$2$F$$20240808$20240716$20240812$30DAY$$BR-AMGEN-BRASP2024136481$AMGEN$$$$$$Y$$$20240812$$PH$BR$BR
240940761$24094076$1$I$20240711$20240711$20240716$20240716$PER$$US-JNJFOC-20240730436$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240716$$CN$US$US
240940772$24094077$2$F$20240712$20240716$20240716$20240723$PER$$US-JNJFOC-20240733935$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240724$$CN$US$US
240940781$24094078$1$I$20240712$20240715$20240716$20240716$EXP$GB-MHRA-MED-202407151651530000-WJBNF$GB-JNJFOC-20240738454$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240716$$PH$GB$GB
240940794$24094079$4$F$20240101$20240908$20240716$20240920$PER$$US-ALKERMES INC.-ALK-2024-001840$ALKERMES$$$$$M$Y$86.168$KG$20240920$$HP$US$US
240940801$24094080$1$I$20240202$20240710$20240716$20240716$EXP$$DE-JNJFOC-20240731809$JOHNSON AND JOHNSON$$3$YR$C$F$Y$14$KG$20240716$$MD$DE$DE
240940811$24094081$1$I$$20240712$20240716$20240716$EXP$$DE-ABBVIE-5839877$ABBVIE$$$$$F$Y$$$20240716$$CN$DE$DE
240940831$24094083$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202405004460$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240716$$CN$US$US
240940841$24094084$1$I$$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007910$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240716$$CN$US$US
240940851$24094085$1$I$20240711$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008933$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240716$$CN$US$US
240940861$24094086$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008937$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240716$$CN$US$US
240940871$24094087$1$I$20240707$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008944$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240716$$CN$US$US
240940882$24094088$2$F$$20240711$20240716$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407007842$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240718$$CN$US$US
240940891$24094089$1$I$20240702$20240702$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008528$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240716$$CN$US$US
240940901$24094090$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009151$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240716$$CN$US$US
240940911$24094091$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008511$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240716$$CN$US$US
240940921$24094092$1$I$20240516$20240705$20240716$20240716$EXP$$ES-AUROBINDO-AUR-APL-2024-033727$AUROBINDO$$61$YR$$M$Y$85$KG$20240716$$MD$ES$ES
240940931$24094093$1$I$20240101$20240711$20240716$20240716$EXP$$US-ABBVIE-5838552$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240940942$24094094$2$F$$20240729$20240716$20240808$EXP$$US-TEVA-VS-3219218$TEVA$Kanack AJ, Schaefer JK, Sridharan M, Splinter NP, Kohlhagen MC, Singh B, et al. Monoclonal gammopathy of thrombotic/thrombocytopenic significance. Blood 2023; 141 (14): 1772-1776.; Kanack AJ, Schaefer JK, Sridharan M, Splinter NP, Kohlhagen MC, Singh B, et al. Monoclonal gammopathy of thrombotic/thrombocytopenic significance. Blood 2023; 141 (14): 1772-1776.; Kanack AJ, Schaefer JK, Sridharan M, Splinter NP, Kohlhagen MC, Singh B, et al. Monoclonal gammopathy of thrombotic/thrombocytopenic si...$$$$M$Y$$$20240808$$HP$US$US
240940951$24094095$1$I$$20240703$20240716$20240716$PER$$US-TEVA-VS-3218771$TEVA$$$$$M$Y$$$20240716$$CN$US$US
240940961$24094096$1$I$$20240704$20240716$20240716$PER$$US-TEVA-VS-3219557$TEVA$$$$A$F$Y$$$20240716$$HP$US$US
240940973$24094097$3$F$20240712$20240717$20240716$20240723$PER$$US-AMGEN-USASP2024140091$AMGEN$$74$YR$E$F$Y$$$20240722$$CN$US$US
240940981$24094098$1$I$20240711$20240713$20240716$20240716$PER$$US-AMGEN-USASP2024139808$AMGEN$$61$YR$A$F$Y$$$20240715$$HP$US$US
240941004$24094100$4$F$20230626$20240829$20240716$20240911$EXP$$JP-AMGEN-JPNSP2024138087$AMGEN$Shirai K, Ichikawa D, Yoshitome A, Takayama S, Han W, Kiyomi O. A study of avacopan combination therapy in ANCA-associated vasculitis. The 67th Annual Meeting of the Japanese Society of Nephrology. 2024;66(4):606.$61$YR$A$M$Y$$$20240911$$MD$JP$JP
240941012$24094101$2$F$$20240904$20240716$20240905$EXP$$JP-TAKEDA-2024TJP010125$TAKEDA$$69$YR$$F$Y$$$20240905$$MD$JP$JP
240941022$24094102$2$F$20240101$20240712$20240716$20240717$PER$$US-AMGEN-USASP2024139544$AMGEN$$70$YR$E$F$Y$$$20240717$$MD$US$US
240941031$24094103$1$I$$20240701$20240716$20240716$EXP$$US-SAMSUNG BIOEPIS-SB-2024-20795$SAMSUNG BIOEPIS$Sri Meghana K, Jaffe G. PRIMARY VITREORETINAL LYMPHOMA MASQUERADING AS POSTOPERATIVE ENDOPHTHALMITIS IN A PREGNANT PATIENT WITH LONG STANDING IDIOPATHIC PANUVEITIS. Retinal cases and brief reports. 18(4). doi:https://dx.doi.org/10.1097/ICB.0000000000001430$37$YR$A$F$Y$$$20240716$$MD$US$US
240941041$24094104$1$I$$20240705$20240716$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-033441$AUROBINDO$Kraus MJ, Nguyen J. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report. Case Reports in Neurology. 2024;16(1):142-7$38$YR$$F$Y$63.5$KG$20240716$$MD$US$US
240941051$24094105$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145658$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240941071$24094107$1$I$20240615$20240709$20240716$20240716$EXP$$CN-BEIGENE-BGN-2024-010709$BEIGENE$$$$$$Y$$$20240716$$HP$CN$CN
240941092$24094109$2$F$20240101$20240816$20240716$20240822$EXP$$CL-JNJFOC-20240733930$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240822$$CN$CL$CL
240941102$24094110$2$F$$20240801$20240716$20240806$30DAY$$CH-JNJFOC-20240733575$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$PH$CH$CH
240941112$24094111$2$F$$20240710$20240716$20240718$PER$$US-SA-2024SA202756$SANOFI AVENTIS$$$$A$M$Y$88.4$KG$20240718$$MD$US$US
240941121$24094112$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA150685$SANOFI AVENTIS$$$$A$F$Y$87.9$KG$20240716$$MD$US$US
240941131$24094113$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA203125$SANOFI AVENTIS$$$$E$M$Y$$$20240716$$MD$US$US
240941141$24094114$1$I$20240101$20240705$20240716$20240716$PER$$US-SA-2024SA202932$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240716$$MD$US$US
240941152$24094115$2$F$20240101$20240724$20240716$20240801$PER$$US-SA-2024SA200040$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240801$$CN$US$US
240941161$24094116$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA202570$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240716$$CN$US$US
240941171$24094117$1$I$$20240702$20240716$20240716$PER$$US-SA-2024SA201201$SANOFI AVENTIS$$$$A$F$Y$78$KG$20240716$$MD$US$US
240941182$24094118$2$F$20240101$20240709$20240716$20240718$PER$$US-SA-2024SA202871$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240718$$MD$US$US
240941191$24094119$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA202946$SANOFI AVENTIS$$$$A$F$Y$73.4$KG$20240716$$MD$US$US
240941201$24094120$1$I$20240201$20240705$20240716$20240716$PER$$US-SA-2024SA203063$SANOFI AVENTIS$$61$YR$A$M$Y$84.8$KG$20240716$$MD$US$US
240941211$24094121$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA203075$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240716$$CN$US$US
240941221$24094122$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA203318$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240716$$MD$US$US
240941231$24094123$1$I$20240601$20240709$20240716$20240716$PER$$US-SA-2024SA204780$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240716$$MD$US$US
240941243$24094124$3$F$20240601$20240903$20240716$20240916$PER$$US-SA-2024SA202499$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240916$$MD$US$US
240941251$24094125$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA202665$SANOFI AVENTIS$$$$$M$Y$$$20240716$$CN$US$US
240941261$24094126$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA201690$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240716$$MD$US$US
240941271$24094127$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA204825$SANOFI AVENTIS$$$$E$$Y$$$20240716$$MD$US$US
240941281$24094128$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203616$SANOFI AVENTIS$$$$T$F$Y$$$20240716$$CN$US$US
240941291$24094129$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA202685$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240716$$MD$US$US
240941301$24094130$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA203212$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240716$$MD$US$US
240941311$24094131$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA203778$SANOFI AVENTIS$$$$$$Y$$$20240716$$CN$US$US
240941322$24094132$2$F$$20240725$20240716$20240803$PER$$US-SA-2024SA203364$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240803$$MD$US$US
240941331$24094133$1$I$$20240710$20240716$20240716$PER$$US-AstraZeneca-2024A158481$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240941341$24094134$1$I$20190627$20191119$20240716$20240716$EXP$$US-AstraZeneca-2019SE94488$ASTRAZENECA$$21710$DY$$$Y$$$20240716$$CN$US$
240941352$24094135$2$F$$20240719$20240716$20240723$EXP$$JP-TAKEDA-2023TJP017540$TAKEDA$$31$YR$$F$Y$$$20240723$$PH$JP$JP
240941361$24094136$1$I$$20200107$20240716$20240716$EXP$$CA-AstraZeneca-2020SE03080$ASTRAZENECA$$55$YR$$M$Y$$$20240716$$MD$CA$
240941371$24094137$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024139181$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240941381$24094138$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139004$AMGEN$$$$$M$Y$$$20240715$$CN$US$US
240941391$24094139$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139665$AMGEN$$$$$F$Y$$$20240715$$HP$US$US
240941403$24094140$3$F$20240711$20240730$20240716$20240801$PER$$US-AMGEN-USASP2024138468$AMGEN$$51$YR$A$F$Y$51$KG$20240801$$HP$US$US
240941411$24094141$1$I$20240522$20240710$20240716$20240716$EXP$$ES-AUROBINDO-AUR-APL-2024-034426$AUROBINDO$$80$YR$$M$Y$$$20240716$$HP$ES$ES
240941422$24094142$2$F$20230301$20240918$20240716$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-033754$AUROBINDO$$73$YR$$M$Y$105.9$KG$20240928$$PH$FR$FR
240941431$24094143$1$I$20091002$20240621$20240716$20240716$EXP$$SG-ROCHE-10000025803$ROCHE$$80$YR$E$M$Y$58$KG$20240716$$MD$SG$SG
240941441$24094144$1$I$$20240504$20240716$20240716$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003081$BIOCON$$$$$$Y$$$20240716$$PH$US$US
240941451$24094145$1$I$$20240228$20240716$20240716$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001418$BIOCON$$$$$$Y$$$20240716$$CN$US$US
240941461$24094146$1$I$$20240709$20240716$20240716$30DAY$$US-GSK-US2024085010$GLAXOSMITHKLINE$$$$$F$Y$$$20240716$$HP$US$US
240941471$24094147$1$I$20240709$20240709$20240716$20240716$EXP$$FR-Orion Corporation ORION PHARMA-ENTC2024-0083$ORION$$73$YR$E$F$Y$$$20240716$$CN$FR$
240941481$24094148$1$I$$20240701$20240716$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06607$LUPIN$$$$$$Y$$$20240716$$CN$US$US
240941491$24094149$1$I$20240710$20240710$20240716$20240716$EXP$$JP-VANTIVE-2024VAN018270$Vantive US Healthcare$$49$YR$$M$Y$$$20240716$$MD$JP$JP
240941501$24094150$1$I$20240607$20240712$20240716$20240716$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039817$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240716$$HP$CO$CO
240941511$24094151$1$I$$20240708$20240716$20240716$EXP$$CA-APOTEX-2024AP008101$APOTEX$$74$YR$$M$Y$$$20240716$$HP$CA$CA
240941521$24094152$1$I$$20240708$20240716$20240716$EXP$$ES-AMGEN-ESPSP2024139599$AMGEN$$$$$F$Y$$$20240715$$MD$ES$ES
240941531$24094153$1$I$20240619$20240708$20240716$20240716$EXP$$GB-CELLTRION INC.-2024GB016958$CELLTRION$$$$$$Y$$$20240716$$HP$GB$GB
240941551$24094155$1$I$$20240708$20240716$20240716$PER$$US-JNJFOC-20240738334$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240941561$24094156$1$I$20240711$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008518$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240716$$CN$US$US
240941571$24094157$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008574$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240716$$CN$US$US
240941581$24094158$1$I$$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008257$ELI LILLY AND CO$$$$$M$Y$$$20240716$$CN$US$US
240941591$24094159$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008030$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240716$$CN$US$US
240941602$24094160$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218278$TEVA$Elkhapery A, Vallabhajosyula S, Niu C, Taifour H, O^Connor K. An Unintentional Second Chance: Co-poisoning With Insulin Glargine and Carvidolol. Am-J-Respir-Crit-Care-Med 2024; 209.; Elkhapery A, Vallabhajosyula S, Niu C, Taifour H, O^Connor K. An Unintentional Second Chance: Co-poisoning With Insulin Glargine and Carvidolol. Am-J-Respir-Crit-Care-Med 2024; 209.$54$YR$$M$Y$$$20240805$$HP$US$US
240941611$24094161$1$I$$20240710$20240716$20240716$PER$$US-CHATTEMPRD-2024OHG023853$CHATTEM$$$$$F$Y$$$20240716$$CN$US$US
240941622$24094162$2$F$$20240815$20240716$20240817$PER$$US-HALEON-2186940$Haleon PLC$$88$YR$$$Y$$$20240817$$CN$US$US
240941631$24094163$1$I$$20240708$20240716$20240716$EXP$$DE-AMGEN-DEUSP2024139226$AMGEN$Gottsauner M.; Meier J.; Eichberger J. et al.. Antiresorptive agents enhance ossification of free flap reconstructions of the mandible: a radiological retrospective cohort study. Frontiers in Oncology. 2024;14:1-9$$$$$Y$$$20240715$$HP$DE$DE
240941641$24094164$1$I$20240709$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024138617$AMGEN$$$$$$Y$$$20240715$$PH$US$US
240941652$24094165$2$F$20240101$20240726$20240716$20240801$PER$$US-ABBVIE-5840072$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
240941661$24094166$1$I$20240201$20240704$20240716$20240716$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109539$ZYDUS PHARM$$$$$$Y$$$20240716$$CN$US$US
240941671$24094167$1$I$20240629$20240709$20240716$20240716$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109537$ZYDUS PHARM$$$$$$Y$$$20240716$$CN$US$US
240941681$24094168$1$I$$20240701$20240716$20240716$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109597$ZYDUS PHARM$Fahel AT, Okar L, Sokhn J.. A Case of PRES in the Context of HIT: A Diagnostic Dilemma. Am-J-Respir-Crit-Care-Med. 2024;209:A5648$$$$$Y$$$20240716$$HP$US$US
240941691$24094169$1$I$$20240701$20240716$20240716$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109388$ZYDUS PHARM$Elkhapery A, Vallabhajosyula S, Niu C, Taifour H, O^Connor K.. An Unintentional Second Chance: Copoisoning With Insulin Glargine and Carvidolol.. Am-J-Respir-Crit-Care-Med. 2024;209:A5660$$$$$Y$$$20240716$$HP$US$US
240941701$24094170$1$I$20240620$20240701$20240716$20240716$EXP$FR-AFSSAPS-RE2024000660$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109495$ZYDUS PHARM$$$$$$Y$$$20240716$$MD$FR$FR
240941712$24094171$2$F$20240101$20240712$20240716$20240722$EXP$$FI-ORGANON-O2407FIN001250$ORGANON$$22$YR$$F$Y$$$20240722$$HP$FI$FI
240941721$24094172$1$I$20240529$20240701$20240716$20240716$EXP$FR-AFSSAPS-AM2024000534$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109308$ZYDUS PHARM$$$$$$Y$$$20240716$$PH$FR$FR
240941731$24094173$1$I$20240501$20240701$20240716$20240716$EXP$FR-AFSSAPS-GR2024000801$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109350$ZYDUS PHARM$$$$$$Y$$$20240716$$PH$FR$FR
240941741$24094174$1$I$20240412$20240701$20240716$20240716$EXP$FR-AFSSAPS-GR2024000778$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109351$ZYDUS PHARM$$$$$$Y$$$20240716$$PH$FR$FR
240941752$24094175$2$F$20240610$20240715$20240716$20240730$EXP$FR-AFSSAPS-RN2024000699$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109276$ZYDUS PHARM$$$$$$Y$$$20240730$$MD$FR$FR
240941761$24094176$1$I$20240429$20240701$20240716$20240716$EXP$ES-AEMPS-1540865$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109374$ZYDUS PHARM$$$$$$Y$$$20240716$$HP$ES$ES
240941771$24094177$1$I$$20240711$20240716$20240716$EXP$$FR-JNJFOC-20240739995$JOHNSON AND JOHNSON$$89$YR$E$M$Y$$$20240716$$PH$FR$FR
240941781$24094178$1$I$$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024137315$AMGEN$Hyman L.; Haller J. A.; Tomaiuolo M. et al.. Disparities in Retinal Vein Occlusion Presentation and Initiation of Anti-VEGF Therapy- An Academy IRIS Registry Analysis. Ophthalmology Retina. 2024;8 (7):657-665$$$$$Y$$$20240715$$HP$US$US
240941791$24094179$1$I$20121009$20240709$20240716$20240716$EXP$$CH-CHEPLA-2024008637$CHEPLAPHARM$$62$YR$$M$Y$$$20240716$$MD$COUNTRY NOT SPECIFIED$CH
240941801$24094180$1$I$$20240710$20240716$20240716$PER$$US-CHATTEMPRD-2024OHG023913$CHATTEM$$35$YR$A$$Y$$$20240716$$CN$US$US
240941811$24094181$1$I$20240101$20240708$20240716$20240716$EXP$$US-INTERCEPT-PM2024001343$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
240941821$24094182$1$I$20190806$20190806$20240716$20240716$EXP$$US-AstraZeneca-2019SF14283$ASTRAZENECA$$4695$WK$$F$Y$$$20240716$$CN$US$
240941831$24094183$1$I$20240701$20240705$20240716$20240716$EXP$$CN-QILU TIANHE PHARMACEUTICAL CO. LTD-QLT-000023-2024$QILU TIANHE PHARMACEUTICAL$$75$YR$E$M$Y$47.5$KG$20240710$$HP$CN$CN
240941844$24094184$4$F$20240101$20240809$20240716$20240819$EXP$$US-INTERCEPT-PM2024001384$INTERCEPT PHARMACEUTICALS$$$$$F$Y$61.678$KG$20240819$$CN$US$US
240941851$24094185$1$I$$20240711$20240716$20240716$PER$$US-GILEAD-2024-0680513$GILEAD$$31$YR$A$M$Y$$$20240715$$PH$US$US
240941861$24094186$1$I$20240711$20240711$20240716$20240716$PER$$US-CHATTEMPRD-2024OHG024068$CHATTEM$$$$$F$Y$$$20240716$$CN$US$US
240941871$24094187$1$I$$20240708$20240716$20240716$EXP$$JP-009507513-2407JPN001855J$MERCK$$72$YR$$$Y$$$20240716$$MD$JP$JP
240941881$24094188$1$I$$20240709$20240716$20240716$EXP$$GR-UCBSA-2024035447$UCB$$17$YR$$F$Y$$$20240716$$MD$GR$GR
240941892$24094189$2$F$20240709$20240812$20240716$20240812$EXP$IT-MINISAL02-994967$NVSC2024IT145149$NOVARTIS$$37$YR$$M$Y$90$KG$20240812$$CN$IT$IT
240941903$24094190$3$F$$20240711$20240716$20240722$PER$$NVSC2024US143690$NOVARTIS$$$$$M$Y$$$20240722$$CN$US$US
240941913$24094191$3$F$20240101$20240718$20240716$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-021370$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240724$$$US$US
240941921$24094192$1$I$$20240709$20240716$20240716$PER$$US-AMGEN-USASP2024137752$AMGEN$Yiu G.; Gulati S.; Higgins V. et al.. Factors Involved in Anti-VEGF Treatment Decisions for Neovascular Age-Related Macular Degeneration: Insights from Real-World Clinical Practice. Clinical Ophthalmology. 2024;18:1679-1690$$$$$Y$$$20240715$$HP$US$US
240941932$24094193$2$F$$20240806$20240716$20240809$EXP$$JP-JNJFOC-20240727914$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$HP$JP$JP
240941941$24094194$1$I$20240712$20240715$20240716$20240716$EXP$GB-MHRA-MED-202407151638180890-TGQBM$GB-JNJFOC-20240738448$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240716$$PH$GB$GB
240941951$24094195$1$I$20240402$20240703$20240716$20240716$EXP$ES-AEMPS-1511478$ES-SAMSUNG BIOEPIS-SB-2024-20664$SAMSUNG BIOEPIS$$51$YR$A$F$Y$$$20240716$$MD$ES$ES
240941961$24094196$1$I$$20240703$20240716$20240716$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-20760$SAMSUNG BIOEPIS$$70$YR$E$F$Y$$$20240716$$CN$GB$GB
240941971$24094197$1$I$$20240708$20240716$20240716$30DAY$$US-GSK-US2024084970$GLAXOSMITHKLINE$$$$$F$Y$$$20240716$$CN$US$US
240941981$24094198$1$I$20230831$20240708$20240716$20240716$EXP$$US-GSK-US2024084332$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240716$$CN$US$US
240941991$24094199$1$I$20240325$20240703$20240716$20240716$EXP$FR-AFSSAPS-PA2024000999$FR-SAMSUNG BIOEPIS-SB-2024-20638$SAMSUNG BIOEPIS$$17$YR$A$M$Y$70$KG$20240716$$MD$FR$FR
240942002$24094200$2$F$$20240718$20240716$20240725$EXP$$JP-AMGEN-JPNSP2024137809$AMGEN$$9$DEC$E$F$Y$$$20240725$$PH$JP$JP
240942012$24094201$2$F$20240506$20240729$20240716$20240801$EXP$$JP-TAKEDA-2024TJP010476$TAKEDA$$7$DEC$$M$Y$$$20240801$$MD$JP$JP
240942021$24094202$1$I$20240629$20240710$20240716$20240716$EXP$$CN-JNJFOC-20240729348$JOHNSON AND JOHNSON$$70$YR$E$F$Y$51$KG$20240716$$HP$CN$CN
240942031$24094203$1$I$20240601$20240712$20240716$20240716$EXP$FR-AFSSAPS-PB2024000677$FR-ROCHE-10000026054$ROCHE$$62$YR$A$F$Y$$$20240716$$MD$FR$FR
240942041$24094204$1$I$$20240703$20240716$20240716$EXP$$GB-CIPLA LTD.-2024GB07238$CIPLA$$$$$$Y$$$20240716$$CN$GB$GB
240942053$24094205$3$F$20240612$20240822$20240716$20240903$EXP$$JP-ADVANZ PHARMA-202406005151$ADVANZ PHARMA$$$$$$Y$$$20240903$$PH$JP$JP
240942061$24094206$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-10000026251$ROCHE$$83$YR$E$F$Y$$$20240716$$HP$US$US
240942071$24094207$1$I$20240605$20240709$20240716$20240716$EXP$$CN-BEIGENE-BGN-2024-010708$BEIGENE$$$$$$Y$$$20240716$$HP$CN$CN
240942081$24094208$1$I$$20240704$20240716$20240716$PER$$US-AstraZeneca-2024A159231$ASTRAZENECA$$$$$$Y$$$20240716$$CN$US$
240942091$24094209$1$I$20240710$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008428$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240716$$CN$US$US
240942101$24094210$1$I$20240623$20240709$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407006617$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240716$$CN$US$US
240942112$24094211$2$F$20240705$20240729$20240716$20240731$EXP$$CO-ROCHE-10000022899$ROCHE$$4$MON$I$M$Y$6.1$KG$20240731$$CN$CO$CO
240942121$24094212$1$I$20240401$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008670$ELI LILLY AND CO$$16$YR$T$F$Y$$$20240716$$CN$US$US
240942131$24094213$1$I$20240401$20240705$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407004799$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240716$$CN$US$US
240942141$24094214$1$I$20240712$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008588$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240716$$CN$US$US
240942153$24094215$3$F$20240601$20240730$20240716$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407007791$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240801$$CN$US$US
240942161$24094216$1$I$20240709$20240709$20240716$20240716$EXP$$US-JNJFOC-20240728152$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240716$$HP$US$US
240942171$24094217$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008420$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240716$$CN$US$US
240942181$24094218$1$I$$20240709$20240716$20240716$30DAY$$US-GSK-US2024085116$GLAXOSMITHKLINE$$$$$F$Y$$$20240716$$CN$US$US
240942192$24094219$2$F$20231001$20240917$20240716$20240925$EXP$$US-ROCHE-10000022434$ROCHE$$27$YR$A$F$Y$124.28$KG$20240925$$CN$US$US
240942201$24094220$1$I$20240605$20240712$20240716$20240716$EXP$$CN-ROCHE-10000024862$ROCHE$$42$YR$A$F$Y$60$KG$20240716$$HP$CN$CN
240942211$24094221$1$I$$20240702$20240716$20240716$PER$$US-TAKEDA-2024TUS067121$TAKEDA$$$$$$Y$$$20240716$$MD$US$US
240942221$24094222$1$I$$20240317$20240716$20240716$EXP$$US-ChurchDwight-2024-CDW-01116$CHURCH + DWIGHT$$$$$$Y$$$20240715$$CN$US$US
240942233$24094223$3$F$20240626$20240722$20240716$20240805$EXP$$JP-AMGEN-JPNSP2024138122$AMGEN$$73$YR$E$F$Y$$$20240805$$MD$JP$JP
240942261$24094226$1$I$$20240710$20240716$20240716$EXP$$CN-BEIGENE-BGN-2024-010801$BEIGENE$Wang J, Lan H, Mao X, Chen Y. Pituitary-adrenal axis dysfunction induced by tislelizumab immunotherapy for non-small cell lung cancer: a case series and literature review. BMC Pulmonary Medicine. 2024;24:327:1-8$$$$$Y$$$20240716$$MD$CN$CN
240942271$24094227$1$I$$20240416$20240716$20240716$EXP$$SA-ALKEM LABORATORIES LIMITED-SA-ALKEM-2024-08814$ALKEM$Muthaffar OY, Alqarni A, Shafei JA, Bahowarth SY, Alyazidi AS, Naseer MI.. Childhood-related neural genotype-phenotype in ATP1A3 mutations: comprehensive analysis. Genes + Genomics. 2024;46:475-487$9$MON$$$Y$$$20240716$$HP$SA$SA
240942281$24094228$1$I$$20240517$20240716$20240716$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-11201$ALKEM$Conroy C, Radulescu A, Attia SL, Shelman N, Lee JT, Monticelli RG, Hall S, Kohli R, Softic S. The combined pioglitazone and topiramate therapy for management of pediatric patients with severe MASLD. Saudi Journal of Gastroenterology. 2024;0:0:1-9$14$YR$$$Y$$$20240716$$HP$US$US
240942291$24094229$1$I$$20240517$20240716$20240716$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-11208$ALKEM$Conroy C, Radulescu A, Attia SL, Shelman N, Lee JT, Monticelli RG, Hall S, Kohli R, Softic S. The combined pioglitazone and topiramate therapy for management of pediatric patients with severe MASLD. Saudi Journal of Gastroenterology. Saud;0:0:1-9$12$YR$$$Y$$$20240716$$HP$US$US
240942301$24094230$1$I$$20240517$20240716$20240716$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-11206$ALKEM$Conroy C, Radulescu A, Attia SL, Shelman N, Lee JT, Monticelli RG, Hall S, Kohli R, Softic S. The combined pioglitazone and topiramate therapy for management of pediatric patients with severe MASLD. Saudi Journal of Gastroenterology. 2024;0:0:1-9$15$YR$$$Y$$$20240716$$HP$US$US
240942311$24094231$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145656$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
240942321$24094232$1$I$$20240416$20240716$20240716$EXP$$SA-ALKEM LABORATORIES LIMITED-SA-ALKEM-2024-08806$ALKEM$Muthaffar OY, Alqarni A, Shafei JA, Bahowarth SY, Alyazidi AS, Naseer MI. Childhood-related neural genotype-phenotype in ATP1A3 mutations: comprehensive analysis. Genes and Genomics. 2024;46:475-487$10$YR$$F$Y$$$20240716$$HP$SA$SA
240942331$24094233$1$I$$20240617$20240716$20240716$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-14002$ALKEM$Bhaskaran D, Thomas S, Scaria LM. Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications. Indian Journal of Pediatrics. 2024;unk:unk$$$$F$Y$$$20240716$$HP$IN$IN
240942341$24094234$1$I$$20240416$20240716$20240716$EXP$$SA-ALKEM LABORATORIES LIMITED-SA-ALKEM-2024-08807$ALKEM$Muthaffar OY, Alqarni A, Shafei JA, Bahowarth SY, Alyazidi AS, Naseer MI.. Childhood-related neural genotype-phenotype in ATP1A3 mutations: comprehensive analysis. Genes + Genomics. 2024;46:475-487$6$MON$$$Y$$$20240716$$HP$SA$SA
240942351$24094235$1$I$$20240424$20240716$20240716$EXP$$CH-ALKEM LABORATORIES LIMITED-CH-ALKEM-2024-09315$ALKEM$Damsa C, Warczyk S, Cailhol L, et al. Panic attacks associated with topiramate. J Clin Psychiatry. 2006;67:326-327$27$YR$$F$Y$$$20240716$$HP$CH$CH
240942361$24094236$1$I$$20240424$20240716$20240716$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-09313$ALKEM$Goldberg JF. Panic attacks associated with the use of topiramate. J Clin Psychopharmacol. 2001;21:461-462$24$YR$$F$Y$$$20240716$$HP$US$US
240942372$24094237$2$F$$20240701$20240716$20240716$PER$$US-ROCHE-10000019168$ROCHE$$$$A$F$Y$$$20240716$$CN$US$US
240942381$24094238$1$I$$20240408$20240716$20240716$EXP$DE-GERMAN-LIT/DEU/24/0004909$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-06762$ALKEM$Lee A, Chadde M, Altenm?ller E, Schoonderwaldt E.. Characteristics of Task-specific Tremor in String Instrument Players. Tremor and Other Hyperkinetic Movements. 2014;unk:unk$62$YR$$M$Y$$$20240716$$HP$DE$DE
240942391$24094239$1$I$$20240530$20240716$20240716$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12262$ALKEM$Friederich LW, Cox ME, Hyson BE, Bishop-Freeman SC. Suspected North Carolina counterfeit pill-involved deaths, 2020-2022. Journal of Analytical Toxicology. 2024;48 (4):242-251$67$YR$$F$Y$$$20240716$$HP$US$US
240942403$24094240$3$F$$20240722$20240716$20240730$PER$$US-ROCHE-10000024491$ROCHE$$$$$$Y$$$20240730$$PH$US$US
240942411$24094241$1$I$20230321$20240703$20240716$20240716$EXP$SE-SEMPA-2024-003294$SE-SAMSUNG BIOEPIS-SB-2024-20690$SAMSUNG BIOEPIS$$75$YR$E$M$Y$$$20240716$$MD$SE$SE
240942421$24094242$1$I$$20240430$20240716$20240716$EXP$IT-MLMSERVICE-20240410-PI000180-00320-2$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-08502$ALKEM$Di Rauso G, Orlandi N, Jacopetti M, Bigliardi G, Antonelli F, Meletti S, et al.. Botulinum neurotoxin as early treatment in acute-onset lesional hemiballism. Neurological sciences. 2024;unk:unk$78$YR$$M$Y$$$20240716$$MD$IT$IT
240942431$24094243$1$I$$20240627$20240716$20240716$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-13694$ALKEM$Guerrini R, Specchio N, Aledo-Serrano ?, Pringsheim M, Darra F, Mayer T, Gil-Nagel A, Polster T, Zuberi SM, Lothe A, Gammaitoni A, Strzelczyk A.. An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a realworld practice setting: A report from the Fenfluramine European Early Access Program. Epilepsia Open. 2022;7:578-87$29$YR$$M$Y$$$20240716$$MD$IT$DE
240942443$24094244$3$F$20220113$20240906$20240716$20240911$EXP$$US-PAREXEL-2021-KAM-US003542$TAKEDA$$34$YR$$F$Y$86.16$KG$20240911$$HP$US$US
240942461$24094246$1$I$$20240710$20240716$20240716$PER$$US-ABBVIE-5839158$ABBVIE$$$$$F$Y$$$20240716$$MD$US$US
240942471$24094247$1$I$20240412$20240703$20240716$20240716$EXP$FR-AFSSAPS-NC2024000467$FR-SAMSUNG BIOEPIS-SB-2024-20682$SAMSUNG BIOEPIS$$22$YR$A$F$Y$$$20240716$$MD$FR$FR
240942481$24094248$1$I$20240611$20240708$20240716$20240716$EXP$$CN-JNJFOC-20240721719$JOHNSON AND JOHNSON$$71$YR$E$F$Y$50$KG$20240716$$HP$CN$CN
240942492$24094249$2$F$20240713$20240716$20240716$20240719$PER$$US-AMGEN-USASP2024140153$AMGEN$$$$$F$Y$$$20240719$$CN$US$US
240942501$24094250$1$I$$20240514$20240716$20240716$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00609$TARO$$$$$$Y$$$20240716$$PH$US$US
240942511$24094251$1$I$$20240715$20240716$20240716$EXP$NL-LRB-00990104$NL-JNJFOC-20240738609$JOHNSON AND JOHNSON$$67$YR$E$F$Y$75$KG$20240716$$MD$NL$NL
240942522$24094252$2$F$$20240709$20240716$20240717$EXP$$IT-SA-2024SA203282$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240717$$MD$IT$IT
240942531$24094253$1$I$20180101$20240709$20240716$20240716$EXP$$EG-SA-2024SA203262$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240716$$HP$EG$EG
240942542$24094254$2$F$$20240809$20240716$20240813$PER$$US-AMGEN-USASP2024139054$AMGEN$$60$YR$A$F$Y$$$20240813$$CN$US$US
240942552$24094255$2$F$$20240723$20240716$20240726$PER$$US-AMGEN-USASP2024139052$AMGEN$$$$$$Y$$$20240726$$CN$US$US
240942561$24094256$1$I$20240705$20240713$20240716$20240716$PER$$US-AMGEN-USASP2024139814$AMGEN$$41$YR$A$F$Y$$$20240716$$CN$US$US
240942571$24094257$1$I$$20240705$20240716$20240716$EXP$$US-ALVOGEN-2024095094$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$45$YR$$M$Y$$$20240716$$HP$US$US
240942581$24094258$1$I$$20240705$20240716$20240716$EXP$$US-ALVOGEN-2024095093$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$49$YR$$M$Y$$$20240716$$HP$US$US
240942591$24094259$1$I$$20240711$20240716$20240716$EXP$$US-SA-2024SA205601$SANOFI AVENTIS$$$$$M$Y$$$20240716$$CN$US$US
240942601$24094260$1$I$20240626$20240711$20240716$20240716$EXP$$US-SA-2024SA205707$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240716$$MD$US$US
240942612$24094261$2$F$20240601$20240819$20240716$20240822$EXP$$US-SA-2024SA206121$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240822$$MD$US$US
240942621$24094262$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111773$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240716$$HP$US$US
240942631$24094263$1$I$$20240705$20240716$20240716$EXP$$US-ALVOGEN-2024095092$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and  prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$35$YR$$F$Y$$$20240716$$HP$US$US
240942641$24094264$1$I$$20230614$20240716$20240716$EXP$$US-UniquePharma-2023UNI000030$UNIQUE PHARMACEUTICALS$$$$$F$Y$$$20240716$$PH$US$US
240942651$24094265$1$I$20240623$20240708$20240716$20240716$EXP$$IN-ROCHE-3536305$ROCHE$$72$YR$E$M$Y$$$20240716$$CN$IN$IN
240942671$24094267$1$I$20240701$20240711$20240716$20240716$EXP$$CN-ROCHE-10000024516$ROCHE$$68$YR$E$M$Y$86$KG$20240716$$HP$CN$CN
240942681$24094268$1$I$$20240705$20240716$20240716$EXP$$US-ALVOGEN-2024095091$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$36$YR$$M$Y$$$20240716$$HP$US$US
240942691$24094269$1$I$$20240705$20240716$20240716$EXP$$US-ALVOGEN-2024095089$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$36$YR$$M$Y$$$20240716$$HP$US$US
240942701$24094270$1$I$$20240705$20240716$20240716$EXP$$US-ALVOGEN-2024095086$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$22$YR$$F$Y$$$20240716$$HP$US$US
240942711$24094271$1$I$$20240705$20240716$20240716$EXP$$US-ALVOGEN-2024095090$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$21$YR$$M$Y$$$20240716$$HP$US$US
240942721$24094272$1$I$20240711$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139176$AMGEN$$$$$F$Y$$$20240716$$CN$US$US
240942731$24094273$1$I$$20240701$20240716$20240716$EXP$$RO-TEVA-VS-3216446$TEVA$Literature Reference: Artur D M, Ioana   M, Mihai A R. STREPTOCOCCAL TOXIC SHOCK SYNDROME: A PLOT TWIST IN DIAGNOSIS AND TREATMENT. Medical Journal of Mariensis. Vol. 70, Suppl. 3, 2024. 335$23$YR$$F$Y$$$20240716$$HP$RO$RO
240942741$24094274$1$I$$20240708$20240716$20240716$EXP$$US-HALEON-2186303$Haleon PLC$$27$YR$$F$Y$$$20240715$$HP$US$US
240942751$24094275$1$I$$20240705$20240716$20240716$EXP$$US-ALVOGEN-2024095084$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and  prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$32$YR$$M$Y$$$20240716$$HP$US$US
240942761$24094276$1$I$$20240708$20240716$20240716$EXP$$CA-APOTEX-2024AP008173$APOTEX$$$$E$F$Y$$$20240716$$PH$CA$CA
240942771$24094277$1$I$$20240705$20240716$20240716$EXP$$US-ALVOGEN-2024095083$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and  prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$22$YR$$F$Y$$$20240716$$HP$US$US
240942781$24094278$1$I$$20240705$20240716$20240716$EXP$$US-ALVOGEN-2024095081$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$37$YR$$M$Y$$$20240716$$HP$US$US
240942791$24094279$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008584$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240716$$HP$US$US
240942801$24094280$1$I$20240101$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008734$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240716$$CN$US$US
240942811$24094281$1$I$$20240710$20240716$20240716$EXP$$US-JNJFOC-20240726400$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240942821$24094282$1$I$$20240710$20240716$20240716$PER$$US-JNJFOC-20240728812$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240942831$24094283$1$I$20240101$20240715$20240716$20240716$EXP$NL-LRB-00981677$NL-JNJFOC-20240737743$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240716$$PH$NL$NL
240942841$24094284$1$I$$20240705$20240716$20240716$PER$$US-JNJFOC-20240714768$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$MD$US$US
240942852$24094285$2$F$$20240809$20240716$20240815$EXP$$NVSJ2024JP008455$NOVARTIS$$$$$$Y$$$20240816$$MD$JP$JP
240942861$24094286$1$I$$20240709$20240716$20240716$30DAY$$US-GSK-US2024085146$GLAXOSMITHKLINE$$$$A$M$Y$$$20240716$$CN$US$US
240942873$24094287$3$F$20230101$20240916$20240716$20240923$EXP$$CH-ROCHE-10000026281$ROCHE$$$$A$F$Y$$$20240923$$MD$CH$CH
240942881$24094288$1$I$$20240711$20240716$20240716$EXP$$JP-TAKEDA-2024TJP010484$TAKEDA$$6$DEC$$M$Y$$$20240716$$MD$JP$JP
240942892$24094289$2$F$20240711$20240722$20240716$20240729$PER$$US-AMGEN-USASP2024139154$AMGEN$$88$YR$E$F$Y$$$20240729$$CN$US$US
240942901$24094290$1$I$20240101$20240712$20240716$20240716$EXP$$BG-ABBVIE-5790898$ABBVIE$$55$YR$$F$Y$$$20240716$$CN$BG$BG
240942911$24094291$1$I$$20240709$20240716$20240716$EXP$$CA-APOTEX-2024AP008171$APOTEX$$51$YR$$F$Y$$$20240716$$CN$CA$CA
240942921$24094292$1$I$$20240710$20240716$20240716$EXP$$US-SANDOZ INC.-SDZ2023US019645$SANDOZ$$$$$F$Y$79.365$KG$20240716$$HP$US$US
240942931$24094293$1$I$$20200817$20240716$20240716$EXP$$US-AstraZeneca-2020SF03099$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240942941$24094294$1$I$$20190711$20240716$20240716$EXP$$US-AstraZeneca-2019SF00667$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240942961$24094296$1$I$20190925$20191022$20240716$20240716$EXP$$CO-AstraZeneca-2019SF51604$ASTRAZENECA$$21907$DY$$F$Y$$$20240716$$CN$CO$
240942971$24094297$1$I$20240301$20240711$20240716$20240716$EXP$$US-ABBVIE-5838690$ABBVIE$$70$YR$$F$Y$$$20240716$$CN$US$US
240942981$24094298$1$I$$20240702$20240716$20240716$EXP$$PH-ROCHE-10000014369$ROCHE$$77$YR$E$M$Y$$$20240716$$MD$PH$PH
240942993$24094299$3$F$$20240628$20240716$20240725$EXP$$DE-ROCHE-10000022329$ROCHE$$$$$F$Y$$$20240725$$MD$DE$DE
240943001$24094300$1$I$20240709$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024136963$AMGEN$$84$YR$E$F$Y$$$20240716$$CN$US$US
240943011$24094301$1$I$$20240708$20240716$20240716$EXP$$IT-CELLTRION INC.-2024IT009038$CELLTRION$Tursi, A.. Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study. Expert Opinion on Biological Therapy. 2024;24(1-2):101-109$$$$$Y$$$20240716$$HP$IT$IT
240943021$24094302$1$I$20240703$20240711$20240716$20240716$EXP$$CA-ABBVIE-5839864$ABBVIE$$81$YR$$F$Y$$$20240716$$HP$CA$CA
240943031$24094303$1$I$20240531$20240711$20240716$20240716$EXP$$JP-TAKEDA-2024TJP010480$TAKEDA$$17$YR$$M$Y$$$20240716$$MD$JP$JP
240943041$24094304$1$I$$20240709$20240716$20240716$EXP$$US-GSK-US2024085066$GLAXOSMITHKLINE$$$$$M$Y$$$20240716$$MD$US$US
240943051$24094305$1$I$$20240708$20240716$20240716$EXP$$US-ARGENX-2024-ARGX-US005289$ARGENX BVBA$$$$$$Y$$$20240716$$CN$US$US
240943062$24094306$2$F$$20240716$20240716$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112070$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240717$$CN$US$US
240943072$24094307$2$F$$20240719$20240716$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111739$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240723$$CN$US$US
240943081$24094308$1$I$$20240710$20240716$20240716$EXP$$ZA-JNJFOC-20240731187$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240716$$HP$ZA$ZA
240943092$24094309$2$F$20240623$20240807$20240716$20240808$EXP$$NVSJ2024JP008443$NOVARTIS$$82$YR$$F$Y$$$20240809$$MD$JP$JP
240943102$24094310$2$F$$20240813$20240716$20240820$30DAY$$TR-JNJFOC-20240723240$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$TR$TR
240943111$24094311$1$I$20240324$20240628$20240716$20240716$PER$$JP-PFM-2024-02045$PIERRE FABRE MEDICAMENT$$3$MON$$F$Y$5.82$KG$20240716$$PH$JP$JP
240943121$24094312$1$I$20230927$20240701$20240716$20240716$PER$$US-PFM-2023-05940$PIERRE FABRE MEDICAMENT$$0$YR$$F$Y$6.43$KG$20240716$$HP$US$US
240943131$24094313$1$I$$20240708$20240716$20240716$PER$$US-PFM-2024-01393$PIERRE FABRE MEDICAMENT$$$$$F$Y$6.517$KG$20240716$$HP$US$US
240943142$24094314$2$F$$20240702$20240716$20240913$EXP$$US-Axsome Therapeutics, Inc.-AXS202407-000950$AXSOME THERAPEUTICS$$$$$F$Y$$$20240913$$$US$
240943151$24094315$1$I$20220902$20240705$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-033980$AUROBINDO$$57$YR$$F$Y$$$20240716$$MD$FR$FR
240943162$24094316$2$F$20170101$20240807$20240716$20240819$EXP$$NO-ROCHE-10000024568$ROCHE$$47$YR$A$F$Y$$$20240819$$CN$NO$NO
240943171$24094317$1$I$$20191021$20240716$20240716$EXP$$RU-AstraZeneca-2019SF50315$ASTRAZENECA$$65$YR$$M$Y$71$KG$20240716$$CN$RU$
240943181$24094318$1$I$$20191114$20240716$20240716$EXP$$US-AstraZeneca-2019SF64711$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240943191$24094319$1$I$$20240710$20240716$20240716$EXP$$KR-JNJFOC-20240728379$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$HP$KR$KR
240943202$24094320$2$F$20240306$20240801$20240716$20240809$EXP$$JP-009507513-2407JPN001803J$MERCK$$7$DEC$$F$Y$$$20240809$$MD$JP$JP
240943211$24094321$1$I$$20240703$20240716$20240716$EXP$$GB-ROCHE-10000019021$ROCHE$$$$E$F$Y$$$20240716$$CN$GB$GB
240943221$24094322$1$I$20240710$20240711$20240716$20240716$30DAY$$US-GSK-US2024086344$GLAXOSMITHKLINE$$80$YR$$M$Y$$$20240716$$CN$US$US
240943231$24094323$1$I$$20240709$20240716$20240716$30DAY$$US-GSK-US2024085135$GLAXOSMITHKLINE$$$$$F$Y$$$20240716$$CN$US$US
240943241$24094324$1$I$20240705$20240705$20240716$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-034485$AUROBINDO$$50$YR$$F$Y$$$20240716$$PH$US$US
240943251$24094325$1$I$$20240616$20240716$20240716$PER$$US-ROCHE-10000004255$ROCHE$$$$$$Y$$$20240716$$CN$US$US
240943261$24094326$1$I$20240703$20240710$20240716$20240716$PER$$US-ABBVIE-5839788$ABBVIE$$66$YR$$F$Y$$$20240716$$CN$US$US
240943272$24094327$2$F$$20240723$20240716$20240802$EXP$$US-TEVA-VS-3217670$TEVA$Deka A, Joseph E, Sharma N, Berhanu T, Kaplan J. Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature. J-Psychiatr-Pract 2024; 30 (3): 234-241.; Deka A, Joseph E, Sharma N, Berhanu T, Kaplan J. Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature. J-Psychiatr-Pract 2024; 30 (3): 234-241.$78$YR$$F$Y$$$20240802$$MD$US$US
240943281$24094328$1$I$$20240705$20240716$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-112309$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$70$KG$20240716$$HP$CA$CA
240943291$24094329$1$I$20240708$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024138439$AMGEN$$67$YR$E$M$Y$$$20240716$$CN$US$US
240943302$24094330$2$F$20240629$20240808$20240716$20240820$PER$$US-ROCHE-10000021810$ROCHE$$15$YR$T$M$Y$$$20240820$$CN$US$US
240943311$24094331$1$I$20230301$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024139554$AMGEN$$70$YR$E$F$Y$$$20240716$$CN$US$US
240943322$24094332$2$F$20240708$20240718$20240716$20240724$PER$$US-AMGEN-USASP2024138752$AMGEN$$60$YR$A$M$Y$$$20240724$$CN$US$US
240943332$24094333$2$F$20240705$20240716$20240716$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407008694$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240722$$CN$US$US
240943341$24094334$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008579$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240716$$CN$US$US
240943353$24094335$3$F$20240601$20240729$20240716$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-021228$UNITED THERAPEUTICS$$29$YR$$F$Y$70.748$KG$20240807$$$US$US
240943361$24094336$1$I$$20240708$20240716$20240716$EXP$$FR-CELLTRION INC.-2024FR016757$CELLTRION$$$$$$Y$$$20240716$$MD$FR$FR
240943371$24094337$1$I$20240710$20240710$20240716$20240716$EXP$$GT-JNJFOC-20240730478$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$MD$GT$GT
240943381$24094338$1$I$$20240705$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-033790$AUROBINDO$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al.. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxic-Analyt-Clinique. 2023;35 (3):175-197$44$YR$$M$Y$$$20240716$$HP$FR$FR
240943393$24094339$3$F$$20240808$20240716$20240819$30DAY$$AR-JNJFOC-20240705940$JOHNSON AND JOHNSON$$86$YR$E$F$Y$62$KG$20240819$$CN$AR$AR
240943401$24094340$1$I$$20240712$20240716$20240716$PER$$US-ABBVIE-5840320$ABBVIE$$$$$$Y$$$20240716$$CN$US$US
240943412$24094341$2$F$20240101$20240904$20240716$20240911$EXP$$CA-CELLTRION INC.-2024CA001541$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
240943421$24094342$1$I$20220112$20240708$20240716$20240716$30DAY$$US-GSK-US2022011285$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240716$$CN$US$US
240943431$24094343$1$I$$20240626$20240716$20240716$PER$$US-ABBVIE-5840838$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240943441$24094344$1$I$20240620$20240708$20240716$20240716$EXP$$CO-VANTIVE-2024VAN018183$Vantive US Healthcare$$40$YR$$M$Y$58.4$KG$20240716$$HP$CO$CO
240943451$24094345$1$I$$20240709$20240716$20240716$EXP$$CL-VANTIVE-2024VAN017123$Vantive US Healthcare$$$$$F$Y$$$20240716$$HP$CL$CL
240943461$24094346$1$I$$20240709$20240716$20240716$EXP$$CL-VANTIVE-2024VAN016920$Vantive US Healthcare$$$$$M$Y$$$20240716$$HP$CL$CL
240943471$24094347$1$I$20170101$20240711$20240716$20240716$PER$$US-AstraZeneca-2024A160502$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240943481$24094348$1$I$$20191212$20240716$20240716$EXP$$US-AstraZeneca-2019SF81793$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240943491$24094349$1$I$20240601$20240617$20240716$20240716$PER$$US-009507513-2406USA005696$MERCK$$68$YR$$$Y$$$20240716$$CN$US$US
240943502$24094350$2$F$20240707$20240724$20240716$20240731$EXP$$CA-ROCHE-10000027011$ROCHE$$36$YR$A$F$Y$$$20240731$$MD$CA$CA
240943521$24094352$1$I$$20240708$20240716$20240716$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR086125$VIIV$$$$$M$Y$$$20240716$$CN$US$US
240943531$24094353$1$I$20240515$20240708$20240716$20240716$PER$$US-ABBVIE-5838182$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240943541$24094354$1$I$20240101$20240708$20240716$20240716$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00683$CATALYST PHARMA$$$$$M$Y$54.422$KG$20240716$$CN$US$US
240943551$24094355$1$I$20240703$20240708$20240716$20240716$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00646$CATALYST PHARMA$$67$YR$$F$Y$$$20240716$$CN$US$US
240943561$24094356$1$I$$20240705$20240716$20240716$EXP$$US-RDY-LIT/USA/24/0010268$DR REDDYS$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD Case Reports. 2023;40: 14-18. doi:10.1016/j.jdcr.2023.08.001.$70$YR$E$F$Y$$$20240716$$HP$US$US
240943572$24094357$2$F$$20240918$20240716$20240925$EXP$$JP-ROCHE-10000026133$ROCHE$Saeki A, Tezuka S, Hashimoto A, Hosobe Y, Fukae K, Kuroda R et al.. A case of advanced ovarian or tubal cancer with the BRCA1 gene mutation. Modern Trends in Obstetrics + Gynecology. 2024;72(2):289-294$69$YR$E$F$Y$$$20240925$$MD$JP$JP
240943581$24094358$1$I$$20240711$20240716$20240716$PER$$US-ROCHE-10000026048$ROCHE$$$$$$Y$$$20240716$$CN$US$US
240943591$24094359$1$I$20240701$20240711$20240716$20240716$EXP$$GB-JNJFOC-20240312843$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240716$$CN$GB$GB
240943603$24094360$3$F$20230615$20240829$20240716$20240906$EXP$$CA-CELLTRION INC.-2023CA022198$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
240943611$24094361$1$I$$20240711$20240716$20240716$PER$$US-ROCHE-10000025663$ROCHE$$$$$$Y$$$20240716$$MD$US$US
240943621$24094362$1$I$$20240711$20240716$20240716$PER$$US-ROCHE-10000025675$ROCHE$$$$$$Y$$$20240716$$MD$US$US
240943631$24094363$1$I$$20240710$20240716$20240716$PER$$US-ROCHE-10000023036$ROCHE$$$$$$Y$$$20240716$$PH$US$US
240943641$24094364$1$I$$20240714$20240716$20240716$PER$$US-ROCHE-10000027035$ROCHE$$$$$$Y$$$20240716$$CN$US$US
240943651$24094365$1$I$20240701$20240712$20240716$20240716$EXP$$US-UCBSA-2024035509$UCB$$62$YR$$F$Y$$$20240716$$CN$US$US
240943661$24094366$1$I$$20240711$20240716$20240716$EXP$$US-UCBSA-2024035689$UCB$$$$$$Y$$$20240716$$MD$US$US
240943671$24094367$1$I$$20240712$20240716$20240716$PER$$US-GILEAD-2024-0680714$GILEAD$$51$YR$A$F$Y$$$20240716$$CN$US$US
240943682$24094368$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218600$TEVA$Hayes LM, Ward BC, Kulkarni D, Mathew M, Babu A, Schwartz A. Rapidly Progressive Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction With Multi-Organ Dysfunction as a Complication of Nontransplant Associated Chemotherapy. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A5686.; Hayes LM, Ward BC, Kulkarni D, Mathew M, Babu A, Schwartz A. Rapidly Progressive Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction With Multi-Organ Dysfunction as a Complication of Nontransplant Associated Chemoth...$22$YR$$M$Y$$$20240805$$HP$US$US
240943691$24094369$1$I$$20240703$20240716$20240716$PER$$US-TEVA-VS-3218696$TEVA$$73$YR$$F$Y$$$20240716$$CN$US$US
240943701$24094370$1$I$$20240705$20240716$20240716$EXP$$EG-ROCHE-10000020178$ROCHE$Salah N, Mekkawy M, Abou-Taleb H, Alaa-Eldin M, Nabih O. Neo-adjuvant versus adjuvant use of bevacizumab in the management of advanced ovarian cancer. Doi: 10.21608/BFSA.2023.245511.1957. Bulletin of Pharmaceutical Sciences. 2024-Jun;47 (1):273-87. doi:10.21608/BFSA.2023.245511.1957.$$$$$Y$$$20240716$$HP$EG$EG
240943721$24094372$1$I$$20240520$20240716$20240716$EXP$$ID-ROCHE-10000012599$ROCHE$$$$$$Y$$$20240716$$CN$ID$ID
240943751$24094375$1$I$$20240708$20240716$20240716$30DAY$$US-GSK-US2024084969$GLAXOSMITHKLINE$$$$$M$Y$$$20240716$$CN$US$US
240943761$24094376$1$I$20240613$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024138273$AMGEN$$$$$$Y$$$20240716$$CN$US$US
240943771$24094377$1$I$20240613$20240709$20240716$20240716$EXP$$IN-ROCHE-10000023325$ROCHE$$58$YR$A$M$Y$$$20240716$$CN$IN$IN
240943781$24094378$1$I$$20240712$20240716$20240716$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR087290$VIIV$$$$A$$Y$$$20240716$$CN$US$US
240943791$24094379$1$I$$20240705$20240716$20240716$EXP$$CN-ROCHE-10000017494$ROCHE$Wanming H, Tong, Yang W, Yuan Y, Li Y and Tang W. Case report: Sustained remission after combined sintilimab, anti-VEGF therapy, and chemotherapy in a patient with non-small cell lung cancer harboring acquired EGFR 19Del/T790M/cis-C797S mutation resistance. Frontiers in Oncology. 2024;14: doi:10.3389/fonc.2024.1298389.$61$YR$A$M$Y$$$20240716$$HP$CN$CN
240943801$24094380$1$I$$20240702$20240716$20240716$PER$$US-TEVA-VS-3217282$TEVA$$$$$M$Y$$$20240716$$CN$US$US
240943812$24094381$2$F$$20240726$20240716$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039922$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240729$$CN$US$US
240943821$24094382$1$I$$20200114$20240716$20240716$EXP$$US-AstraZeneca-2020SE08198$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240943831$24094383$1$I$$20190812$20240716$20240716$EXP$$US-AstraZeneca-2019SF17111$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240943841$24094384$1$I$20240601$20240702$20240716$20240716$PER$$US-RDY-CLI/USA/24/0010181$DR REDDYS$$68$YR$E$F$Y$73.48$KG$20240716$$CN$US$US
240943851$24094385$1$I$20240709$20240709$20240716$20240716$PER$$US-ABBVIE-5837719$ABBVIE$$$$$$Y$$$20240716$$HP$US$US
240943861$24094386$1$I$$20240712$20240716$20240716$EXP$$US-BAUSCH-BL-2024-010705$BAUSCH AND LOMB$$78$YR$$F$Y$$$20240716$$CN$US$US
240943871$24094387$1$I$20240620$20240711$20240716$20240716$EXP$$US-BAUSCH-BL-2024-010690$BAUSCH AND LOMB$$56$YR$$M$Y$$$20240716$$HP$US$US
240943881$24094388$1$I$$20240709$20240716$20240716$EXP$$BR-JNJFOC-20240726165$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$MD$BR$BR
240943891$24094389$1$I$$20240711$20240716$20240716$EXP$$CL-JNJFOC-20240734202$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240716$$CN$CL$CL
240943901$24094390$1$I$$20240711$20240716$20240716$EXP$GB-MHRA-MED-202407111600294780-SVPHF$GB-BIOGEN-2024BI01273470$BIOGEN$$58$YR$$F$Y$$$20240716$$PH$GB$GB
240943911$24094391$1$I$20240509$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405161417555930-YSQJT$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-06417$HIKMA$$82$YR$$F$Y$77$KG$20240716$$MD$GB$GB
240943921$24094392$1$I$20240626$20240708$20240716$20240716$EXP$$CN-ROCHE-10000020811$ROCHE$$3$YR$C$F$Y$18$KG$20240716$$HP$CN$CN
240943932$24094393$2$F$20240320$20240716$20240716$20240731$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000589$PAREXEL$$$$$$Y$$$20240731$$MD$CN$CN
240943942$24094394$2$F$$20240808$20240716$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111932$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240810$$HP$US$US
240943951$24094395$1$I$$20240713$20240716$20240716$PER$$US-AMGEN-USASP2024139783$AMGEN$$$$A$F$Y$$$20240716$$CN$US$US
240943961$24094396$1$I$20240601$20240705$20240716$20240716$EXP$$JP-AMGEN-JPNSP2024139014$AMGEN$$8$DEC$E$M$Y$$$20240716$$MD$JP$JP
240943971$24094397$1$I$$20240702$20240716$20240716$EXP$$US-ENDO USA, INC.-2024-002872$ENDO$$$$$F$Y$$$20240716$$HP$US$US
240943981$24094398$1$I$20240701$20240710$20240716$20240716$PER$$US-ABBVIE-5839077$ABBVIE$$$$$$Y$$$20240716$$MD$US$US
240943991$24094399$1$I$20240629$20240709$20240716$20240716$EXP$$US-TAKEDA-2024TUS005191$TAKEDA$$65$YR$$M$Y$$$20240716$$CN$US$US
240944002$24094400$2$F$20240512$20240724$20240716$20240726$EXP$$FR-HALEON-2186845$Haleon PLC$$50$YR$$M$Y$89$KG$20240726$$MD$FR$FR
240944011$24094401$1$I$$20240714$20240716$20240716$PER$$US-AMGEN-USASP2024140039$AMGEN$$$$$$Y$$$20240716$$CN$US$US
240944022$24094402$2$F$$20240828$20240716$20240828$PER$$NVSC2024US145580$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
240944031$24094403$1$I$$20240621$20240716$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002961$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
240944041$24094404$1$I$$20240705$20240716$20240716$EXP$$IN-ROCHE-10000022939$ROCHE$$52$YR$A$M$Y$$$20240716$$CN$IN$IN
240944052$24094405$2$F$20240606$20240802$20240716$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-033724$AUROBINDO$$54$YR$$M$Y$$$20240814$$MD$IT$IT
240944062$24094406$2$F$$20240815$20240716$20240816$PER$$US-JNJFOC-20240732537$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$LW$US$US
240944072$24094407$2$F$$20240716$20240716$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-033439$AUROBINDO$Kraus MJ, Nguyen J. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report. Case Reports in Neurology. 2024;16(1):142-7$38$YR$$F$Y$63.5$KG$20240725$$MD$US$US
240944081$24094408$1$I$$20240709$20240716$20240716$EXP$$CA-UCBSA-2024035338$UCB$$1$DY$$M$Y$2$KG$20240716$$HP$CA$CA
240944091$24094409$1$I$$20240703$20240716$20240716$PER$$US-RDY-LIT/USA/24/0010145$DR REDDYS$Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. Journal of Pediatric Orthopaedics. 2024 Jul;33(4): 407-410. doi:10.1097/BPB.0000000000001136.$$$C$$Y$$$20240716$$HP$US$US
240944101$24094410$1$I$$20240708$20240716$20240716$EXP$$NVSC2024GB104337$NOVARTIS$$$$$F$Y$$$20240716$$CN$GB$GB
240944111$24094411$1$I$$20240704$20240716$20240716$EXP$$IN-ROCHE-10000021401$ROCHE$$49$YR$A$F$Y$$$20240716$$CN$IN$IN
240944133$24094413$3$F$$20240723$20240716$20240801$EXP$$CA-HALEON-2186652$Haleon PLC$$44$YR$$F$Y$$$20240801$$HP$CA$CA
240944151$24094415$1$I$20240601$20240709$20240716$20240716$EXP$$JP-009507513-2407JPN001834J$MERCK$$8$DEC$$M$Y$$$20240716$$MD$JP$JP
240944161$24094416$1$I$20240412$20240705$20240716$20240716$EXP$$JP-ROCHE-10000007897$ROCHE$$9$DEC$E$M$Y$$$20240716$$MD$JP$JP
240944171$24094417$1$I$20240712$20240712$20240716$20240716$EXP$$KR-JNJFOC-20240732573$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$CN$KR$KR
240944181$24094418$1$I$$20240708$20240716$20240716$EXP$$US-APOTEX-2024AP008240$APOTEX$Siler C, Fuller W, Whaley D, Keating J. Polypharmacy in Older Adults: A Case Study. South Dakota Medicine. 2023;76 (3):124-127$64$YR$$F$Y$$$20240716$$MD$US$US
240944191$24094419$1$I$20240621$20240711$20240716$20240716$EXP$$CN-HALEON-2186686$Haleon PLC$$14$YR$$M$Y$69$KG$20240715$$HP$CN$CN
240944201$24094420$1$I$20240117$20240712$20240716$20240716$EXP$FR-AFSSAPS-PC2024000572$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-111740$BRISTOL MYERS SQUIBB$$75$YR$A$F$Y$$$20240716$$HP$FR$FR
240944211$24094421$1$I$20240703$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139828$AMGEN$$80$YR$E$F$Y$$$20240716$$HP$US$US
240944222$24094422$2$F$$20240726$20240716$20240819$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002718$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
240944232$24094423$2$F$$20240807$20240716$20240815$EXP$$US-SA-2024SA204818$SANOFI AVENTIS$$$$A$F$Y$$$20240815$$MD$US$US
240944241$24094424$1$I$20240429$20240708$20240716$20240716$EXP$$US-CELLTRION INC.-2024US016721$CELLTRION$$$$$$Y$$$20240716$$CN$US$US
240944251$24094425$1$I$20240101$20240708$20240716$20240716$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018435$UNITED THERAPEUTICS$$$$$M$Y$92.971$KG$20240716$$$US$US
240944261$24094426$1$I$$20240710$20240716$20240716$PER$$US-ALXN-202407USA000657US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
240944271$24094427$1$I$20240707$20240709$20240716$20240716$EXP$$US-SA-2024SA204906$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240716$$MD$US$US
240944281$24094428$1$I$$20240709$20240716$20240716$EXP$$US-SA-2024SA205594$SANOFI AVENTIS$$45$YR$A$F$Y$81.1$KG$20240716$$MD$US$US
240944291$24094429$1$I$$20231222$20240716$20240716$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2023001784$BIOCON$$$$$$Y$$$20240716$$CN$US$US
240944301$24094430$1$I$20240525$20240709$20240716$20240716$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS003565$TERSERA THERAPEUTICS$$$$$$Y$$$20240716$$CN$NL$NL
240944312$24094431$2$F$$20240722$20240716$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002964$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
240944322$24094432$2$F$20240601$20240715$20240716$20240717$EXP$$PK-ROCHE-10000024312$ROCHE$$66$YR$E$F$Y$$$20240717$$CN$PK$PK
240944333$24094433$3$F$20240101$20240829$20240716$20240906$EXP$$US-SA-2024SA204751$SANOFI AVENTIS$$32$YR$A$F$Y$61.678$KG$20240906$$CN$US$US
240944341$24094434$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111512$BRISTOL MYERS SQUIBB$$23$YR$A$F$Y$$$20240716$$HP$US$US
240944351$24094435$1$I$20240703$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110813$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$63.5$KG$20240716$$CN$US$US
240944362$24094436$2$F$20240701$20240809$20240716$20240823$EXP$$FR-UCBSA-2024035220$UCB$$33$YR$$F$Y$72$KG$20240823$$CN$FR$FR
240944381$24094438$1$I$$20240709$20240716$20240716$PER$$US-ABBVIE-5836325$ABBVIE$$25$YR$$M$Y$$$20240716$$HP$US$US
240944392$24094439$2$F$20240301$20240715$20240716$20240718$EXP$$US-ABBVIE-5837011$ABBVIE$$51$YR$$F$Y$91$KG$20240718$$CN$US$US
240944401$24094440$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405101401069270-STKMW$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-06388$HIKMA$$$$T$F$Y$$$20240716$$MD$GB$GB
240944411$24094441$1$I$20240501$20240712$20240716$20240716$PER$$US-ABBVIE-5839743$ABBVIE$$55$YR$$F$Y$$$20240716$$MD$US$US
240944421$24094442$1$I$20220108$20240703$20240716$20240716$EXP$$JP-ROCHE-10000022526$ROCHE$$3$YR$C$F$Y$17.6$KG$20240716$$MD$JP$JP
240944431$24094443$1$I$$20240705$20240716$20240716$EXP$$US-RDY-LIT/USA/24/0010270$DR REDDYS$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD Case Reports. 2023;40: 14-18. doi:10.1016/j.jdcr.2023.08.001.$71$YR$E$F$Y$$$20240716$$HP$US$US
240944441$24094444$1$I$$20240705$20240716$20240716$EXP$$US-RDY-LIT/USA/24/0010269$DR REDDYS$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD Case Reports. 2023;40: 14-18. doi:10.1016/j.jdcr.2023.08.001.$58$YR$A$F$Y$$$20240716$$HP$US$US
240944451$24094445$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008695$ELI LILLY AND CO$$$$A$F$Y$$$20240716$$CN$US$US
240944461$24094446$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007926$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240716$$CN$US$US
240944471$24094447$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008968$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240716$$CN$US$US
240944481$24094448$1$I$$20240704$20240716$20240716$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002020$Alvotech$$66$YR$$F$Y$$$20240716$$MD$CA$CA
240944502$24094450$2$F$$20240718$20240716$20240720$EXP$$DE-SANDOZ INC.-NVSC2021DE217434$SANDOZ$$14$YR$$M$Y$$$20240720$$MD$DE$DE
240944511$24094451$1$I$20240601$20240705$20240716$20240716$PER$$US-ROCHE-10000019411$ROCHE$$78$YR$E$F$Y$92.08$KG$20240716$$CN$US$US
240944521$24094452$1$I$$20240708$20240716$20240716$PER$$US-AMGEN-USASP2024135688$AMGEN$$$$$M$Y$$$20240716$$CN$US$US
240944531$24094453$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024139179$AMGEN$$$$$$Y$$$20240716$$PH$US$US
240944541$24094454$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139927$AMGEN$$$$$M$Y$$$20240716$$CN$US$US
240944561$24094456$1$I$$20240709$20240716$20240716$EXP$$CA-HALEON-2186790$Haleon PLC$$48$YR$$F$Y$68$KG$20240715$$HP$CA$CA
240944571$24094457$1$I$20240601$20240710$20240716$20240716$PER$$US-ALXN-202407USA000665US$ALEXION PHARMACEUTICALS$$72$YR$$F$Y$$$20240716$$CN$US$US
240944581$24094458$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111894$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$81.19$KG$20240716$$HP$US$US
240944591$24094459$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139069$AMGEN$$$$$F$Y$$$20240716$$CN$US$US
240944601$24094460$1$I$$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112056$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$111.58$KG$20240716$$CN$US$US
240944611$24094461$1$I$$20240708$20240716$20240716$30DAY$$US-GSK-US2024084455$GLAXOSMITHKLINE$$$$$M$Y$$$20240716$$HP$US$US
240944621$24094462$1$I$$20240708$20240716$20240716$PER$$US-RDY-SPO/USA/24/0010221$DR REDDYS$$22$YR$A$F$Y$$$20240716$$MD$US$US
240944631$24094463$1$I$20240516$20240701$20240716$20240716$PER$$US-ROCHE-3566999$ROCHE$$67$YR$E$F$Y$58.06$KG$20240716$$CN$US$US
240944641$24094464$1$I$20240429$20240708$20240716$20240716$PER$FR-AFSSAPS-CN2024000621$FR-IDORSIA-008215-2024-FR$IDORSIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240716$$MD$FR$FR
240944651$24094465$1$I$20240515$20240708$20240716$20240716$PER$FR-AFSSAPS-NC2024000798$FR-IDORSIA-008216-2024-FR$IDORSIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240716$$MD$FR$FR
240944661$24094466$1$I$20221001$20240701$20240716$20240716$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06018$LUPIN$Ouyang J, Sasidharan S, Jatoi T, Salifu M. How high can anion gaps be in patients with metabolic acidosis? A case report. American Journal of Respiratory and Critical Care Medicine. 2024;209$61$YR$$F$Y$$$20240716$$HP$US$US
240944671$24094467$1$I$$20200217$20240716$20240716$EXP$$US-AstraZeneca-2020SE25247$ASTRAZENECA$$$$$F$Y$77.1$KG$20240716$$CN$US$
240944681$24094468$1$I$20240620$20240708$20240716$20240716$EXP$IT-MINISAL02-992706$IT-TEVA-VS-3219062$TEVA$$59$YR$$M$Y$$$20240716$$PH$IT$IT
240944693$24094469$3$F$$20240820$20240716$20240823$PER$$US-ROCHE-10000021871$ROCHE$$22$YR$A$F$Y$$$20240823$$CN$US$US
240944701$24094470$1$I$$20240711$20240716$20240716$EXP$$US-GSK-US2024086485$GLAXOSMITHKLINE$$$$$F$Y$$$20240716$$CN$US$US
240944711$24094471$1$I$20230503$20240711$20240716$20240716$EXP$$CN-JNJFOC-20240732568$JOHNSON AND JOHNSON$$57$YR$A$F$Y$60$KG$20240716$$HP$CN$CN
240944721$24094472$1$I$20231120$20240711$20240716$20240716$EXP$$KR-JNJFOC-20240731937$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$HP$KR$KR
240944732$24094473$2$F$20240101$20240830$20240716$20240904$EXP$$CA-JNJFOC-20240554228$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240904$$CN$CA$CA
240944741$24094474$1$I$20240712$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139127$AMGEN$$44$YR$A$M$Y$$$20240716$$CN$US$US
240944752$24094475$2$F$20230101$20240708$20240716$20240722$EXP$CN-MLMSERVICE-20240626-PI111243-00306-1$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-14869$ALKEM$Peng M, Lin T, Song Z, Huang T, Pan X.. High dose tacrolimus-induced acute pancreatitis after kidney transplantation: a case report. Pancreas. 2024;unk:unk$31$YR$$M$Y$$$20240722$$MD$CN$CN
240944761$24094476$1$I$$20240701$20240716$20240716$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15004$ALKEM$Moser M. Acute psychosis as a complication of hydralazine therapy in essential hypertension. J Am Med Assoc. 1953;152:1329$$$$$Y$$$20240716$$HP$US$US
240944771$24094477$1$I$20240401$20240703$20240716$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06143$HIKMA$$74$YR$$M$Y$$$20240716$$MD$US$US
240944782$24094478$2$F$$20240712$20240716$20240718$EXP$$GB-BIOGEN-2024BI01262445$BIOGEN$$$$$F$Y$$$20240718$$CN$GB$GB
240944791$24094479$1$I$20230529$20240708$20240716$20240716$EXP$$BR-BIOGEN-2024BI01273352$BIOGEN$$33$YR$$F$Y$48$KG$20240716$$CN$BR$BR
240944801$24094480$1$I$$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111699$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240716$$MD$US$US
240944811$24094481$1$I$$20240701$20240716$20240716$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-14942$ALKEM$Di Trana A, Di Giorgi A, Carlier J, Serra F, Busard? FP, Pichini S. ^Tranq-dope^: The first fatal intoxication due to xylazine-adulterated heroin in Italy. Clin Chim Acta. 2024;561:119826$33$YR$$M$Y$$$20240716$$HP$IT$IT
240944821$24094482$1$I$$20240702$20240716$20240716$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-06264$LUPIN$$$$$$Y$$$20240716$$CN$AU$AU
240944831$24094483$1$I$20240102$20240711$20240716$20240716$EXP$$CN-JNJFOC-20240733423$JOHNSON AND JOHNSON$$66$YR$E$F$Y$59$KG$20240716$$HP$CN$CN
240944841$24094484$1$I$20240601$20240712$20240716$20240716$EXP$FR-AFSSAPS-AVNT2024000506$FR-GSK-FR2024087042$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$PH$FR$FR
240944852$24094485$2$F$20240711$20240819$20240716$20240821$EXP$$JP-TAKEDA-2024TJP010552$TAKEDA$$8$DEC$$M$Y$$$20240821$$MD$JP$JP
240944861$24094486$1$I$20240201$20240708$20240716$20240716$EXP$$US-UCBSA-2024015568$UCB$$45$YR$$F$Y$$$20240716$$HP$US$US
240944873$24094487$3$F$20240201$20240820$20240716$20240828$EXP$$NVSC2024AR047863$NOVARTIS$$60$YR$$F$Y$$$20240828$$CN$AR$AR
240944881$24094488$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008666$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240716$$CN$US$US
240944891$24094489$1$I$20240709$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008698$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240716$$CN$US$US
240944901$24094490$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007776$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240716$$CN$US$US
240944911$24094491$1$I$20240709$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008424$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240716$$CN$US$US
240944921$24094492$1$I$20240626$20240705$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407004374$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240716$$CN$US$US
240944931$24094493$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008543$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240716$$CN$US$US
240944941$24094494$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008974$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240716$$CN$US$US
240944951$24094495$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009543$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240716$$CN$US$US
240944962$24094496$2$F$$20240814$20240716$20240816$30DAY$$US-ELI_LILLY_AND_COMPANY-US202407007682$ELI LILLY AND CO$$$$A$$Y$$$20240816$$CN$US$US
240944971$24094497$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009448$ELI LILLY AND CO$$34$YR$A$$Y$$$20240716$$CN$US$US
240944981$24094498$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008953$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$US$US
240944991$24094499$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008525$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240716$$CN$US$US
240945001$24094500$1$I$20240712$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008733$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240716$$CN$US$US
240945011$24094501$1$I$20240712$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008748$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240716$$HP$US$US
240945021$24094502$1$I$$20240705$20240716$20240716$EXP$$IN-ROCHE-3556306$ROCHE$$72$YR$E$M$Y$$$20240716$$CN$IN$IN
240945031$24094503$1$I$20240707$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007359$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240716$$HP$US$US
240945041$24094504$1$I$$20240711$20240716$20240716$EXP$$CO-JNJFOC-20240733827$JOHNSON AND JOHNSON$$65$YR$E$F$Y$54$KG$20240716$$HP$CO$CO
240945051$24094505$1$I$$20240711$20240716$20240716$EXP$$US-TAKEDA-2024TUS033475$TAKEDA$$$$$F$Y$51$KG$20240716$$CN$US$US
240945063$24094506$3$F$20240712$20240715$20240716$20240818$PER$$US-JNJFOC-20240737876$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240819$$HP$US$US
240945072$24094507$2$F$$20240909$20240716$20240911$EXP$$JP-TAKEDA-2024TJP010446$TAKEDA$$7$DEC$$$Y$$$20240911$$MD$JP$JP
240945081$24094508$1$I$$20200318$20240716$20240716$EXP$$US-AstraZeneca-2020SE40829$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240945094$24094509$4$F$20240712$20240805$20240716$20240808$EXP$$US-JNJFOC-20240734729$JOHNSON AND JOHNSON$$35$YR$A$M$Y$127.12$KG$20240808$$HP$US$US
240945101$24094510$1$I$20230711$20240711$20240716$20240716$EXP$$CN-JNJFOC-20240733641$JOHNSON AND JOHNSON$$73$YR$E$M$Y$52$KG$20240716$$HP$CN$CN
240945111$24094511$1$I$20231023$20240711$20240716$20240716$EXP$$CN-JNJFOC-20240733078$JOHNSON AND JOHNSON$$72$YR$E$M$Y$72$KG$20240716$$HP$CN$CN
240945121$24094512$1$I$20190901$20191004$20240716$20240716$EXP$$ZA-AstraZeneca-2019SF38688$ASTRAZENECA$$3131$WK$$F$Y$$$20240716$$CN$ZA$
240945131$24094513$1$I$20230101$20240711$20240716$20240716$EXP$$CL-ABBVIE-5837414$ABBVIE$$$$$F$Y$$$20240716$$CN$CL$CL
240945141$24094514$1$I$20091228$20240621$20240716$20240716$EXP$$HK-ROCHE-10000025000$ROCHE$$74$YR$E$M$Y$87$KG$20240716$$HP$HK$HK
240945152$24094515$2$F$$20240725$20240716$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111769$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240729$$HP$US$US
240945161$24094516$1$I$20240501$20240710$20240716$20240716$EXP$$US-JNJFOC-20240728136$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240716$$HP$US$US
240945172$24094517$2$F$20240701$20240709$20240716$20240723$EXP$$CN-ROCHE-10000021593$ROCHE$$57$YR$A$F$Y$64$KG$20240723$$HP$CN$CN
240945181$24094518$1$I$$20240710$20240716$20240716$PER$$US-ALXN-202407USA000671US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240716$$HP$US$US
240945192$24094519$2$F$20240101$20240712$20240716$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039666$BOEHRINGER INGELHEIM$$61$YR$A$F$Y$$$20240814$$CN$US$US
240945201$24094520$1$I$20240604$20240708$20240716$20240716$EXP$AT-BASGAGES-2024-004915$AT-BEH-2024175160$CSL BEHRING$$59$YR$A$M$Y$$$20240716$$PH$AT$AT
240945211$24094521$1$I$$20240705$20240716$20240716$EXP$$US-RDY-LIT/USA/24/0010271$DR REDDYS$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD Case Reports. 2023;40: 14-18. doi:10.1016/j.jdcr.2023.08.001.$76$YR$E$F$Y$$$20240716$$HP$US$US
240945221$24094522$1$I$20220330$20240711$20240716$20240716$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-13135$IPSEN$$74$YR$E$M$Y$$$20240716$$MD$CA$CA
240945232$24094523$2$F$$20240713$20240716$20240717$PER$$US-ABBVIE-5840337$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
240945241$24094524$1$I$$20240710$20240716$20240716$PER$$NVSC2024US144538$NOVARTIS$$$$$M$Y$$$20240716$$CN$US$US
240945252$24094525$2$F$20240626$20240722$20240716$20240730$PER$$US-AMGEN-USASP2024135732$AMGEN$$74$YR$E$F$Y$78$KG$20240729$$HP$US$US
240945261$24094526$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145660$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240945271$24094527$1$I$$20240714$20240716$20240716$PER$$US-JNJFOC-20240740494$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240945282$24094528$2$F$$20240729$20240716$20240808$EXP$$US-TEVA-VS-3219225$TEVA$Chaudhary AJ, Khan MZ, Sohail A, Zaidi SMH, Denha E, Venkat D. Acute onset nitrofurantoin-induced autoimmune hepatitis after urinary tract infection treatment. Clin-Case-Rep 2024; 12 (6):.; Chaudhary AJ, Khan MZ, Sohail A, Zaidi SMH, Denha E, Venkat D. Acute onset nitrofurantoin-induced autoimmune hepatitis after urinary tract infection treatment. Clin-Case-Rep 2024; 12 (6):.; Chaudhary AJ, Khan MZ, Sohail A, Zaidi SMH, Denha E, Venkat D. Acute onset nitrofurantoin-induced autoimmune hepatiti...$84$YR$$F$Y$$$20240808$$HP$US$US
240945291$24094529$1$I$$20240708$20240716$20240716$EXP$$US-AMAROX PHARMA-ASP2024US02291$ASPIRO PHARMA$Mignone D, Shah K, Alawneh B, Papadakos SP, Michelakis N.. A rude awakening: A case of sugammadex causing transient cardiomyopathy mimicking stemi. Journal of the American College of Cardiology.. 2024;83 (13):3618$43$YR$$M$Y$$$20240716$$HP$US$US
240945301$24094530$1$I$$20240708$20240716$20240716$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001382$BLUEPRINT MEDICINES$$$$$F$Y$$$20240716$$CN$US$US
240945311$24094531$1$I$$20240708$20240716$20240716$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001390$BLUEPRINT MEDICINES$$$$$M$Y$$$20240716$$CN$US$US
240945321$24094532$1$I$$20240710$20240716$20240716$EXP$$US-BEH-2024175603$CSL BEHRING$$$$A$M$Y$$$20240716$$HP$US$US
240945331$24094533$1$I$20240610$20240709$20240716$20240716$EXP$IT-MINISAL02-993021$IT-TEVA-VS-3219398$TEVA$$60$YR$$F$Y$$$20240716$$MD$IT$IT
240945344$24094534$4$F$$20240718$20240716$20240725$PER$$US-ROCHE-10000021171$ROCHE$$$$$$Y$$$20240725$$HP$US$US
240945351$24094535$1$I$$20240712$20240716$20240716$PER$$US-JNJFOC-20240737159$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240945361$24094536$1$I$$20240703$20240716$20240716$PER$$US-RDY-CLI/USA/24/0009950$DR REDDYS$$$$$M$Y$28.3$KG$20240716$$CN$US$US
240945371$24094537$1$I$$20231031$20240716$20240716$PER$$US-APOTEX-2023AP016344$APOTEX$Currens L, Harrison N, Schmidt M, Amjad H, Mu W, Scholz SW, et al.. A case of familial frontotemporal dementia caused by a progranulin gene mutation. Clinical Parkinsonism + Related Disorders. 2023;89:1-4$73$YR$$F$Y$$$20240716$$HP$US$US
240945381$24094538$1$I$$20230918$20240716$20240716$PER$$US-APOTEX-2023AP014100$APOTEX$Remz MA, Wong JK, Hilliard JD, Tholanikunnel T, Rawls AE, Okun MS.. Identification and Management of Persistent Stimulation-Induced Dyskinesia Associated with STN DBS: The See-Saw Dilemma. Tremor and Other Hyperkinetic Movements. 2023;13(1):1-7$73$YR$$F$Y$$$20240716$$MD$US$US
240945391$24094539$1$I$$20240708$20240716$20240716$PER$$US-RDY-SPO/USA/24/0010226$DR REDDYS$$24$YR$A$F$Y$$$20240716$$MD$US$US
240945401$24094540$1$I$$20240708$20240716$20240716$PER$$US-RDY-SPO/USA/24/0010228$DR REDDYS$$21$YR$A$$Y$$$20240716$$MD$US$US
240945411$24094541$1$I$20160101$20231025$20240716$20240716$PER$$US-APOTEX-2023AP016188$APOTEX$Rich AM, Karakoleva EV, McInerney J, Farace E, De Jesus S. Cerebrotendinous xanthomatosis tremor successfully controlled post-ventral intermediate nucleus-deep brain stimulation: a case report. Frontiers in Neurology. 2023;14:1243379:1-5$42$YR$$M$Y$$$20240716$$HP$US$US
240945421$24094542$1$I$$20240712$20240716$20240716$EXP$$US-UCBSA-2024035725$UCB$$$$$$Y$$$20240716$$CN$US$US
240945431$24094543$1$I$20240621$20240710$20240716$20240716$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024085844$VIIV$$2$YR$$F$Y$$$20240716$$CN$US$US
240945441$24094544$1$I$20240621$20240710$20240716$20240716$30DAY$$US-GSK-US2024085844$GLAXOSMITHKLINE$$2$YR$$F$Y$$$20240716$$CN$US$US
240945452$24094545$2$F$20240701$20240812$20240716$20240822$EXP$$US-GSK-US2024AMR088562$GLAXOSMITHKLINE$$59$YR$$F$Y$69$KG$20240822$$CN$US$US
240945461$24094546$1$I$20240711$20240712$20240716$20240716$EXP$$CY-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039735$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$70$KG$20240716$$MD$CY$CY
240945471$24094547$1$I$20240101$20240710$20240716$20240716$PER$$US-ALXN-202407USA000677US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
240945481$24094548$1$I$$20240710$20240716$20240716$EXP$$US-ABBVIE-5837214$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240945493$24094549$3$F$20230426$20240705$20240716$20240821$EXP$$ES-AUROBINDO-AUR-APL-2024-033730$AUROBINDO$$67$YR$$M$Y$$$20240821$$MD$ES$ES
240945502$24094550$2$F$20230101$20240920$20240716$20240926$EXP$$US-ABBVIE-5837244$ABBVIE$$$$$F$Y$40$KG$20240926$$CN$US$US
240945511$24094551$1$I$$20240702$20240716$20240716$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-06231$LUPIN$$$$$$Y$$$20240716$$CN$AU$AU
240945522$24094552$2$F$20240712$20240712$20240716$20240719$PER$$US-AMGEN-USASP2024139842$AMGEN$$64$YR$A$M$Y$$$20240718$$CN$US$US
240945531$24094553$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A156702$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240945541$24094554$1$I$$20200212$20240716$20240716$EXP$$US-AstraZeneca-2020SE24177$ASTRAZENECA$$67$YR$$M$Y$$$20240716$$CN$US$
240945551$24094555$1$I$$20200313$20240716$20240716$EXP$$ID-AstraZeneca-2020SE39461$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$ID$
240945561$24094556$1$I$$20240621$20240716$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002966$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
240945571$24094557$1$I$$20240710$20240716$20240716$EXP$$US-ABBVIE-5838239$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240945581$24094558$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009318$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$US$US
240945591$24094559$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008801$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240716$$CN$US$US
240945601$24094560$1$I$$20240708$20240716$20240716$EXP$$CA-APOTEX-2024AP008053$APOTEX$$66$YR$$F$Y$$$20240716$$HP$CA$CA
240945612$24094561$2$F$20240701$20240903$20240716$20240905$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-268963$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$$$20240905$$CN$US$US
240945622$24094562$2$F$$20240720$20240716$20240801$EXP$$IT-AUROBINDO-AUR-APL-2024-033535$AUROBINDO$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et al.. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars.. Toxicology Reports.. 2024;13:101683$15$YR$$F$Y$48$KG$20240801$$MD$IT$IT
240945631$24094563$1$I$$20240709$20240716$20240716$EXP$$US-ABBVIE-5836842$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240945651$24094565$1$I$$20240621$20240716$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002963$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
240945661$24094566$1$I$$20240621$20240716$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002945$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$PH$US$US
240945671$24094567$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-10000026419$ROCHE$$78$YR$E$F$Y$$$20240716$$MD$US$US
240945681$24094568$1$I$20240710$20240710$20240716$20240716$EXP$$CA-JNJFOC-20240728665$JOHNSON AND JOHNSON$$17$YR$T$M$Y$80.5$KG$20240716$$HP$CA$CA
240945691$24094569$1$I$$20240709$20240716$20240716$EXP$GB-MHRA-MED-202407091714434570-BCLMS$GB-ESPERIONTHERAPEUTICS-2024GBR01089$ESPERION THERAPEUTICS$$$$$F$Y$$$20240716$$PH$GB$GB
240945701$24094570$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139958$AMGEN$$$$$$Y$$$20240716$$CN$US$US
240945711$24094571$1$I$$20240713$20240716$20240716$PER$$US-ROCHE-10000025921$ROCHE$$75$YR$E$M$Y$$$20240716$$MD$US$US
240945721$24094572$1$I$$20240708$20240716$20240716$EXP$GB-MHRA-MED-202406281144360370-LSKWG$GB-HETERO-AMR2024GB02223$HETERO$$$$$$Y$$$20240716$$CN$GB$GB
240945732$24094573$2$F$20240603$20240718$20240716$20240727$EXP$$TW-ROCHE-10000024752$ROCHE$$62$YR$A$M$Y$51.5$KG$20240727$$MD$TW$TW
240945742$24094574$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218685$TEVA$Goldberg E, Syed A, Desai S, Franco R, Ali Z. Diffuse Alveolar Hemorrhage Secondary to Hydralazine-induced Vasculitis Causing Pulmonary-renal Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209.; Goldberg E, Syed A, Desai S, Franco R, Ali Z. Diffuse Alveolar Hemorrhage Secondary to Hydralazine-induced Vasculitis Causing Pulmonary-renal Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209.$80$YR$$F$Y$$$20240805$$HP$US$US
240945751$24094575$1$I$$20240708$20240716$20240716$EXP$$DE-Encube-000815$ENCUBE ETHICALS$Suwalski P, Wilke F, Fairweather D, Landmesser U, Heidecker B. Application of magnetocardiography for myocarditis assessment in a testosterone-substituted female-to-male individual. Am Heart J Plus. 2024 May 31;43:100412. doi: 10.1016/j.ahjo.2024.100412. PMID: 38882591; PMCID: PMC11179062.$38$YR$A$F$Y$$$20240715$$MD$DE$
240945761$24094576$1$I$20240301$20240711$20240716$20240716$EXP$$US-ABBVIE-5837143$ABBVIE$$64$YR$$F$Y$$$20240716$$CN$US$US
240945781$24094578$1$I$$20240623$20240716$20240716$PER$$US-JNJFOC-20240666281$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240945791$24094579$1$I$20240101$20240709$20240716$20240716$EXP$$US-ABBVIE-5827549$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240945802$24094580$2$F$20240618$20240806$20240716$20240814$EXP$$CA-ROCHE-10000016573$ROCHE$$53$YR$A$M$Y$93$KG$20240814$$HP$CA$CA
240945811$24094581$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111830$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240716$$HP$US$US
240945821$24094582$1$I$20240601$20240712$20240716$20240716$EXP$$US-UCBSA-2024035703$UCB$$62$YR$$F$Y$$$20240716$$HP$US$US
240945831$24094583$1$I$20240101$20240710$20240716$20240716$PER$$US-ABBVIE-5837485$ABBVIE$$$$$F$Y$102$KG$20240716$$CN$US$US
240945841$24094584$1$I$$20240705$20240716$20240716$EXP$$US-RDY-LIT/USA/24/0010272$DR REDDYS$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD Case Reports. 2023;40: 14-18. doi:10.1016/j.jdcr.2023.08.001.$55$YR$A$F$Y$$$20240716$$HP$US$US
240945851$24094585$1$I$20240703$20240708$20240716$20240716$PER$$US-ABBVIE-5837526$ABBVIE$$16$YR$$F$Y$$$20240716$$HP$US$US
240945861$24094586$1$I$$20230825$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2023SP013861$STRIDES$Ha ET, Attallah M, Parikh MA, Kobayashi Y.. Positive Nuclear Stress Test After STEMI: Importance of Invasive Physiologic Assessment and Acetylcholine Testing.. JACC-Cardiovasc-Interv. 2023;16(9):1116-1117$54$YR$$M$Y$$$20240716$$MD$US$US
240945871$24094587$1$I$$20240712$20240716$20240716$PER$$US-ABBVIE-5838743$ABBVIE$$$$$F$Y$$$20240716$$HP$US$US
240945883$24094588$3$F$20240616$20240801$20240716$20240805$PER$$US-HETERO-HET2024US02234$HETERO$$39$YR$$M$Y$138.32$KG$20240805$$CN$US$US
240945891$24094589$1$I$$20240706$20240716$20240716$EXP$$IN-ROCHE-10000022271$ROCHE$$58$YR$A$F$Y$$$20240716$$CN$IN$IN
240945902$24094590$2$F$$20240801$20240716$20240806$EXP$$DE-ABBVIE-5838867$ABBVIE$$$$A$$Y$$$20240806$$MD$DE$DE
240945911$24094591$1$I$$20240703$20240716$20240716$PER$$US-ROCHE-10000020734$ROCHE$$$$$$Y$$$20240716$$CN$US$US
240945922$24094592$2$F$$20240723$20240716$20240802$EXP$$US-TEVA-VS-3217673$TEVA$Zafar P, Nasrullah A, Patel D, Holden K, Balaan MR. Community Acquired Pneumonia or Hydralazine-Induced Vasculitis - A Clinical Dilemma. Am-J-Respir-Crit-Care-Med 2024; 209.; Zafar P, Nasrullah A, Patel D, Holden K, Balaan MR. Community Acquired Pneumonia or Hydralazine-Induced Vasculitis - A Clinical Dilemma. Am-J-Respir-Crit-Care-Med 2024; 209.$82$YR$$F$Y$$$20240802$$HP$US$US
240945931$24094593$1$I$20240601$20240705$20240716$20240716$EXP$$US-SA-2024SA080374$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240716$$MD$US$US
240945941$24094594$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202406251044280450-NLVQB$GB-SA-2024SA200218$SANOFI AVENTIS$$$$$$Y$$$20240716$$MD$GB$GB
240945951$24094595$1$I$$20240710$20240716$20240716$PER$$US-ABBVIE-5838757$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240945961$24094596$1$I$20240708$20240710$20240716$20240716$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000600$PAREXEL$$74$YR$$M$Y$$$20240716$$HP$CN$CN
240945971$24094597$1$I$$20240710$20240716$20240716$PER$$US-ABBVIE-5836333$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240945982$24094598$2$F$20240101$20240802$20240716$20240806$EXP$$US-UCBSA-2024035500$UCB$$$$$M$Y$$$20240806$$CN$US$US
240945991$24094599$1$I$$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112098$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240716$$CN$US$US
240946001$24094600$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145464$NOVARTIS$$$$$M$Y$$$20240716$$CN$US$US
240946011$24094601$1$I$$20240704$20240716$20240716$EXP$$SE-Orion Corporation ORION PHARMA-24_00030715$ORION$$82$YR$E$M$Y$$$20240716$$HP$SE$
240946021$24094602$1$I$$20231019$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016169$STRIDES$Hossain Eshan S, Bedross A, Alkhidir Ayah, Wazir Hina, Ayaz Ahmed M, Hussein Sami, et al.. Minoxidil-associated pericardial effusion with impending tamponade: A case report.. Chest. 2023;164 (Suppl) (4):A3510-A3511.$72$YR$$M$Y$$$20240716$$HP$US$US
240946031$24094603$1$I$20240101$20240711$20240716$20240716$EXP$$US-ABBVIE-5837739$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240946041$24094604$1$I$20240625$20240711$20240716$20240716$EXP$$CN-BEIGENE-BGN-2024-010843$BEIGENE$$$$$$Y$$$20240716$$HP$CN$CN
240946052$24094605$2$F$$20240724$20240716$20240725$EXP$$PT-JNJFOC-20240717609$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240725$$HP$PT$PT
240946061$24094606$1$I$$20240709$20240716$20240716$EXP$$US-SANDOZ INC.-SDZ2024US064876$SANDOZ$$$$$M$Y$$$20240716$$MD$US$US
240946071$24094607$1$I$$20240711$20240716$20240716$PER$$US-HALEON-2186711$Haleon PLC$$$$$$Y$$$20240716$$CN$US$US
240946081$24094608$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139997$AMGEN$$$$$$Y$$$20240716$$CN$US$US
240946091$24094609$1$I$$20240112$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000580$STRIDES$Wakefield C, Ngo B, Naydin S, Rahme R, Binning M.. Intrathecal Nicardipine for Severe Intractable Reversible Cerebral Vasoconstriction Syndrome: A Novel Case Report.. Cureus. 2023;15(7):e42269$58$YR$$F$Y$$$20240716$$HP$US$US
240946102$24094610$2$F$20240619$20240709$20240716$20240722$PER$$US-ABBVIE-5835828$ABBVIE$$$$$F$Y$$$20240719$$HP$US$US
240946113$24094611$3$F$20240620$20240813$20240716$20240827$EXP$$US-FARMAPROD-202407-2463$DOMPE FARMACEUTICI$$42$YR$A$F$Y$59.1$KG$20240827$$CN$US$US
240946121$24094612$1$I$20240606$20240621$20240716$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002036$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240716$$CN$US$US
240946131$24094613$1$I$20240327$20240708$20240716$20240716$EXP$IT-MINISAL02-993335$IT-SA-2024SA201814$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240716$$PH$IT$IT
240946141$24094614$1$I$20240614$20240711$20240716$20240716$EXP$$CN-BEIGENE-BGN-2024-010861$BEIGENE$$$$$$Y$$$20240716$$HP$CN$CN
240946151$24094615$1$I$20240704$20240708$20240716$20240716$EXP$$US-APOTEX-2024AP008119$APOTEX$$65$YR$E$F$Y$$$20240716$$HP$US$US
240946161$24094616$1$I$$20240621$20240716$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002968$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
240946181$24094618$1$I$$20240709$20240716$20240716$PER$$PR-JNJFOC-20240724555$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240716$$CN$PR$PR
240946191$24094619$1$I$$20240515$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005818$STRIDES$Laws J, Bridges B, Bruccoleri R, Vandevoorde R, King J.. THERAPEUTIC PLASMA EXCHANGE FOR REFRACTORY VERAPAMIL POISONING. Crit-Care-Med. 2024;52 (Suppl.) (1):S68$14$YR$$F$Y$$$20240716$$HP$US$US
240946201$24094620$1$I$$20240703$20240716$20240716$EXP$$US-SCIEGENP-2024SCLIT00331$SCIEGEN$Simone C, et al..Levetiracetam-associated Rhabdomyolysis.American Journal of Respiratory and Critical Care Medicine.may-2024;209 (1)$20$YR$A$M$Y$$$20240716$$HP$US$US
240946211$24094621$1$I$$20240701$20240716$20240716$PER$$US-RDY-SPO/USA/24/0009706$DR REDDYS$$$$$$Y$$$20240716$$CN$US$US
240946222$24094622$2$F$$20240908$20240716$20240920$EXP$$US-SCIEGENP-2024SCLIT00333$SCIEGEN$Simmer P et al..HOT AND BOTHERED: A RARE CASE OF DYSKINESIA HYPERPYREXIA SYNDROME. Critical Care Medicine.JAN-2024;52 (1):S289$53$YR$A$F$Y$$$20240920$$HP$US$US
240946231$24094623$1$I$$20240703$20240716$20240716$EXP$$US-SCIEGENP-2024SCLIT00332$SCIEGEN$Koubaa I, et al.Severe Urinary Retention Associated With Combined Treatment With Escitalopram and Quetiapine: A Case Report.Journal of Clinical Psychopharmacology.MAY-2024;44 (3):328-30$18$YR$A$M$Y$$$20240716$$MD$MA$US
240946241$24094624$1$I$$20240708$20240716$20240716$EXP$$US-JNJFOC-20240733672$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$MD$US$US
240946251$24094625$1$I$$20240703$20240716$20240716$EXP$$US-SCIEGENP-2024SCLIT00335$SCIEGEN$Kim AH, et al.A Critical Case of Hydralazine-induced Vasculitis Presenting With Pulmonary Renal Syndrome. American Journal of Respiratory and Critical Care Medicine.JAN-2024;209 (1):A7071$72$YR$E$M$Y$$$20240716$$HP$US$US
240946261$24094626$1$I$$20240703$20240716$20240716$EXP$$US-SCIEGENP-2024SCLIT00334$SCIEGEN$Wong C, et al.Hydralazine to Pulmonary Hemorrhage: A Case of Drug Induced Vasculitis.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:1$85$YR$E$M$Y$$$20240716$$HP$US$US
240946271$24094627$1$I$$20240710$20240716$20240716$PER$$US-ABBVIE-5836850$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240946281$24094628$1$I$$20240703$20240716$20240716$EXP$$US-SCIEGENP-2024SCLIT00336$SCIEGEN$$82$YR$E$F$Y$$$20240716$$HP$US$US
240946291$24094629$1$I$$20240703$20240716$20240716$EXP$$US-SCIEGENP-2024SCLIT00337$SCIEGEN$Devault KF, et al.Hydralazine Induced Pleuropericarditis With Bilateral Eosinophilic Pleural Effusions.American Journal of Respiratory and Critical Care Medicine.May-2024;209:A2029$81$YR$E$M$Y$$$20240716$$HP$US$US
240946302$24094630$2$F$20220928$20240823$20240716$20240905$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001099$AKEBIA THERAPEUTICS$$63$YR$$M$Y$56.4$KG$20240905$$MD$JP$JP
240946311$24094631$1$I$$20231115$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017483$STRIDES$Chandrashekar N, Asp AA.. Glucocorticoids and Pheochromocytoma- a Recipe for Disaster?.. J-Endocr-Soc. 2021;5 (Suppl.):A133$60$YR$$M$Y$$$20240716$$MD$US$US
240946321$24094632$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008043$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240716$$CN$US$US
240946332$24094633$2$F$20230101$20240711$20240716$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407005910$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240718$$CN$US$US
240946341$24094634$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008802$ELI LILLY AND CO$$$$$F$Y$$$20240716$$HP$US$US
240946351$24094635$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009657$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240716$$CN$US$US
240946361$24094636$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008488$ELI LILLY AND CO$$$$$$Y$$$20240716$$CN$US$US
240946371$24094637$1$I$20240701$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008546$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240716$$CN$US$US
240946381$24094638$1$I$20240712$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008715$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240716$$CN$US$US
240946401$24094640$1$I$$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007651$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240716$$CN$US$US
240946411$24094641$1$I$$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008648$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240716$$CN$US$US
240946421$24094642$1$I$$20240703$20240716$20240716$EXP$$US-SCIEGENP-2024SCLIT00338$SCIEGEN$Gupta UD, et al.Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209 (1):A3415$43$YR$A$F$Y$$$20240716$$HP$US$US
240946431$24094643$1$I$$20240708$20240716$20240716$EXP$$BR-AstraZeneca-2024A157181$ASTRAZENECA$$$$$$Y$$$20240716$$MD$BR$
240946441$24094644$1$I$20200201$20200427$20240716$20240716$EXP$$US-AstraZeneca-2020SE57680$ASTRAZENECA$$23590$DY$$F$Y$$$20240716$$CN$US$
240946451$24094645$1$I$$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159504$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240946461$24094646$1$I$$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159078$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240946471$24094647$1$I$$20240103$20240716$20240716$PER$$US-APOTEX-2023AP017696$APOTEX$$$$E$$Y$$$20240716$$CN$US$US
240946481$24094648$1$I$$20230811$20240716$20240716$PER$$US-APOTEX-2023AP012324$APOTEX$$$$$F$Y$$$20240716$$CN$US$US
240946491$24094649$1$I$20230901$20231020$20240716$20240716$PER$$US-APOTEX-2023AP014085$APOTEX$$$$$M$Y$$$20240716$$CN$US$US
240946501$24094650$1$I$20230101$20231025$20240716$20240716$PER$$US-APOTEX-2023AP014670$APOTEX$$$$$F$Y$$$20240716$$CN$US$US
240946511$24094651$1$I$20240517$20240709$20240716$20240716$EXP$FR-AFSSAPS-PV2024000508$FR-ROCHE-10000021765$ROCHE$$74$YR$E$F$Y$58$KG$20240716$$MD$FR$FR
240946523$24094652$3$F$20240101$20240917$20240716$20240920$EXP$$US-ROCHE-10000025722$ROCHE$$62$YR$A$F$Y$$$20240921$$CN$US$US
240946532$24094653$2$F$$20240719$20240716$20240724$PER$$US-HETERO-HET2024US02147$HETERO$$$$$F$Y$$$20240724$$PH$US$US
240946541$24094654$1$I$$20240516$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005843$STRIDES$Harris T, Rhee EK, Papez AL.. MP-470552-006 BELHASSEN^S VENTRICULAR TACHYCARDIA: A CASE OF AN INFANT REQUIRING MORE THAN JUST VERAPAMIL.. Heart-Rhythm. 2024;21 (Suppl.) (5):S110 abstr. MP-470552-006$6$MON$$M$Y$7.5$KG$20240716$$HP$US$US
240946551$24094655$1$I$20240520$20240709$20240716$20240716$EXP$FR-AFSSAPS-NC2024000792$FR-TEVA-VS-3219440$TEVA$$11$YR$$F$Y$38$KG$20240716$$MD$FR$FR
240946561$24094656$1$I$$20240715$20240716$20240716$PER$$US-GILEAD-2024-0680781$GILEAD$$$$A$F$Y$$$20240716$$PH$US$US
240946571$24094657$1$I$20240206$20240708$20240716$20240716$EXP$FR-AFSSAPS-MP2024001012$FR-TEVA-VS-3219126$TEVA$$54$YR$$F$Y$$$20240716$$MD$FR$FR
240946581$24094658$1$I$$20240709$20240716$20240716$EXP$$US-SA-2024SA023273$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240716$$CN$US$US
240946591$24094659$1$I$$20240713$20240716$20240716$EXP$GB-MHRA-MED-202407131625572030-BPNRG$GB-ORGANON-O2407GBR001319$ORGANON$$$$$$Y$$$20240716$$CN$GB$GB
240946602$24094660$2$F$$20240627$20240716$20240722$EXP$$DE-ROCHE-10000021971$ROCHE$$$$E$F$Y$$$20240719$$MD$DE$DE
240946612$24094661$2$F$$20240719$20240716$20240725$EXP$$CA-ABBVIE-5839878$ABBVIE$$$$A$M$Y$$$20240725$$CN$CA$CA
240946621$24094662$1$I$$20231113$20240716$20240716$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017572$STRIDES$Gao H, Kransdorf E, Ebinger J, Kittleson MM.. Hypertrophic Cardiomyopathy After Heart Transplantation: A Single-Center Case Series.. JACC-Case-Rep. 2023;14:1-6$34$YR$$M$Y$$$20240716$$MD$US$US
240946631$24094663$1$I$20240712$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139116$AMGEN$$71$YR$E$M$Y$$$20240716$$CN$US$US
240946641$24094664$1$I$$20240705$20240716$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-028481$AUROBINDO$Salupo N, Baker M, Dhingra J, Herlitz L, Mehdi A.. MINIMAL CHANGE DISEASE AS A PARANEOPLASTIC MANIFESTATION OF SMALL CELL LUNG CANCER. Am-J-Kidney-Dis. 2024;83 (Suppl.)(4):S50$91$YR$$F$Y$$$20240716$$HP$US$US
240946651$24094665$1$I$$20240715$20240716$20240716$PER$$US-ROCHE-10000027298$ROCHE$$26$YR$A$F$Y$$$20240716$$HP$US$US
240946661$24094666$1$I$$20240711$20240716$20240716$PER$$US-ABBVIE-5838564$ABBVIE$$$$$$Y$$$20240716$$CN$US$US
240946671$24094667$1$I$$20240712$20240716$20240716$EXP$$US-SANDOZ INC.-NVSC2023US102678$SANDOZ$$$$$F$Y$$$20240716$$CN$US$US
240946681$24094668$1$I$20190315$20240708$20240716$20240716$EXP$$ZA-AMGEN-ZAFSP2019045797$AMGEN$$47$YR$A$F$Y$68$KG$20240716$$MD$ZA$ZA
240946691$24094669$1$I$$20240710$20240716$20240716$EXP$$CA-APOTEX-2024AP008202$APOTEX$$$$$$Y$$$20240716$$CN$CA$CA
240946701$24094670$1$I$20240629$20240704$20240716$20240716$EXP$$IN-ROCHE-10000021355$ROCHE$$76$YR$E$M$Y$$$20240716$$CN$IN$IN
240946711$24094671$1$I$$20240711$20240716$20240716$EXP$$US-ABBVIE-5839923$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240946721$24094672$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024138951$AMGEN$$$$$F$Y$$$20240716$$CN$US$US
240946731$24094673$1$I$20240601$20240711$20240716$20240716$EXP$$CA-ABBVIE-5839947$ABBVIE$$$$E$M$Y$$$20240716$$CN$CA$CA
240946751$24094675$1$I$20240418$20240709$20240716$20240716$EXP$FR-AFSSAPS-RN2024000661$FR-ROCHE-10000021164$ROCHE$$38$YR$A$M$Y$74$KG$20240716$$MD$FR$FR
240946761$24094676$1$I$$20240704$20240716$20240716$EXP$$TR-ROCHE-10000016673$ROCHE$Kinikoglu O, Odabas H, Alt?ntas Y, Yildiz A, Cakan B, Akdag G, et al. Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer. Medicina (Kaunas, Lithuania). 2024-Jun-07;60 (6):1-14. doi:10.3390/medicina60060951.$$$$$Y$$$20240716$$HP$TR$TR
240946771$24094677$1$I$20240101$20240711$20240716$20240716$EXP$$US-ABBVIE-5840820$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240946781$24094678$1$I$20240708$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159491$ASTRAZENECA$$28960$DY$$F$Y$$$20240716$$CN$US$
240946791$24094679$1$I$$20240711$20240716$20240716$PER$$US-HALEON-2187045$Haleon PLC$$$$$F$Y$$$20240716$$CN$US$US
240946801$24094680$1$I$20191101$20191127$20240716$20240716$EXP$$CO-AstraZeneca-2019SF72819$ASTRAZENECA$$25182$DY$$F$Y$$$20240716$$CN$CO$
240946811$24094681$1$I$$20240709$20240716$20240716$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005126$BIOCON$$$$$$Y$$$20240716$$HP$CA$CA
240946822$24094682$2$F$$20240723$20240716$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001396$BLUEPRINT MEDICINES$$$$$M$Y$$$20240731$$CN$US$US
240946831$24094683$1$I$20240626$20240709$20240716$20240716$PER$$US-BIOGEN-2024BI01273278$BIOGEN$$52$YR$$F$Y$$$20240716$$CN$US$US
240946841$24094684$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145476$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240946853$24094685$3$F$20240714$20240719$20240716$20240725$PER$$US-AMGEN-USASP2024140125$AMGEN$$51$YR$A$F$Y$$$20240725$$CN$US$US
240946863$24094686$3$F$$20240724$20240716$20240801$EXP$$JP-009507513-2407JPN001848J$MERCK$Takeshika R, Hosono H, Mori R, Takao C, Kusakabe M. EP-1181 A Case Clinically Diagnosed with Pulmonary Tumour Thrombotic Microangiopathy in which Rapid Respiratory Failure Developed during Treatment for Recurrent Breast Cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 473$60$YR$$F$Y$$$20240801$$MD$JP$JP
240946871$24094687$1$I$$20240708$20240716$20240716$EXP$$US-AMGEN-USASP2024136423$AMGEN$Wang Y.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):1-8$$$$$Y$$$20240716$$HP$US$US
240946881$24094688$1$I$$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111738$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$66.68$KG$20240716$$CN$US$US
240946893$24094689$3$F$20221016$20240822$20240716$20240828$EXP$$US-TAKEDA-2022TUS066531$TAKEDA$$24$YR$$M$Y$$$20240828$$CN$US$US
240946901$24094690$1$I$20240629$20240705$20240716$20240716$EXP$$ES-AUROBINDO-AUR-APL-2024-033345$AUROBINDO$$56$YR$$F$Y$81$KG$20240716$$MD$ES$ES
240946911$24094691$1$I$20240501$20240621$20240716$20240716$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108944$ZYDUS PHARM$$$$$$Y$$$20240716$$CN$US$US
240946921$24094692$1$I$20240316$20240412$20240716$20240716$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-105900$ZYDUS PHARM$$$$$$Y$$$20240716$$CN$US$US
240946931$24094693$1$I$20240602$20240610$20240716$20240716$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108569$ZYDUS PHARM$$$$$$Y$$$20240716$$CN$US$US
240946941$24094694$1$I$$20240708$20240716$20240716$30DAY$$US-GSK-US2024084975$GLAXOSMITHKLINE$$$$$F$Y$$$20240716$$CN$US$US
240946951$24094695$1$I$20240302$20240705$20240716$20240716$EXP$$GB-AUROBINDO-AUR-APL-2024-034067$AUROBINDO$$70$YR$$M$Y$122$KG$20240716$$CN$GB$GB
240946961$24094696$1$I$20230101$20240710$20240716$20240716$EXP$$JP-TAKEDA-2024TUS071409$TAKEDA$$12$YR$$M$Y$23$KG$20240716$$MD$JP$JP
240946981$24094698$1$I$$20240710$20240716$20240716$PER$$NVSC2024US145654$NOVARTIS$$$$A$F$Y$$$20240716$$CN$US$US
240946991$24094699$1$I$$20240705$20240716$20240716$EXP$$US-ROCHE-10000001515$ROCHE$Crooker K, Stedman E, Hitt J, Tompkins B, Repp A. Causes and outcomes of non-chemotherapy induced neutropenic fever in hospitalized adults: An observational study. Medicine (Baltimore). 2024;103 (18):1-5. doi:10.1097/MD.0000000000038060.$$$$$Y$$$20240716$$MD$US$US
240947001$24094700$1$I$$20240703$20240716$20240716$EXP$$IN-ROCHE-RCA5146196$ROCHE$$42$YR$A$M$Y$$$20240716$$MD$IN$IN
240947011$24094701$1$I$20240620$20240705$20240716$20240716$EXP$$GB-AUROBINDO-AUR-APL-2024-033470$AUROBINDO$$61$YR$$F$Y$60$KG$20240716$$MD$GB$GB
240947021$24094702$1$I$$20240709$20240716$20240716$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024085043$VIIV$$$$$$Y$$$20240716$$HP$US$US
240947032$24094703$2$F$$20240827$20240716$20240903$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001384$BLUEPRINT MEDICINES$$$$$F$Y$$$20240903$$CN$US$US
240947041$24094704$1$I$$20240711$20240716$20240716$EXP$$GB-AMGEN-GBRSL2024139404$AMGEN$$64$YR$A$F$Y$$$20240716$$CN$GB$GB
240947051$24094705$1$I$$20240715$20240716$20240716$PER$$US-AMGEN-USASP2024140128$AMGEN$$$$$M$Y$$$20240716$$CN$US$US
240947062$24094706$2$F$$20240710$20240716$20240925$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007528$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
240947073$24094707$3$F$20240101$20240819$20240716$20240828$EXP$$JP-TAKEDA-2024TUS065427$TAKEDA$$72$YR$$M$Y$$$20240828$$MD$JP$JP
240947081$24094708$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405162318157690-FNGQT$GB-AMAROX PHARMA-AMR2024GB02160$HETERO$$$$$M$Y$$$20240716$$CN$GB$GB
240947091$24094709$1$I$20240711$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009267$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240716$$CN$US$US
240947101$24094710$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009439$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240716$$CN$US$US
240947111$24094711$1$I$$20240711$20240716$20240716$PER$$US-ABBVIE-5838019$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240947121$24094712$1$I$20240401$20240704$20240716$20240716$EXP$$CN-UCBSA-2024024817$UCB$$29$YR$$F$Y$52$KG$20240716$$MD$CN$CN
240947131$24094713$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008619$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240716$$CN$US$US
240947142$24094714$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218943$TEVA$Patel S, Prajapati V, Patel P. Culture Negative Infective Endocarditis Secondary to Septic Emboli of Lung. Am-J-Respir-Crit-Care-Med 2024; 209 A2414.; Patel S, Prajapati V, Patel P. Culture Negative Infective Endocarditis Secondary to Septic Emboli of Lung. Am-J-Respir-Crit-Care-Med 2024; 209 A2414.$32$YR$$F$Y$$$20240805$$HP$US$US
240947161$24094716$1$I$$20240714$20240716$20240716$PER$$US-HALEON-2187209$Haleon PLC$$$$$$Y$$$20240716$$CN$US$US
240947171$24094717$1$I$20240601$20240705$20240716$20240716$EXP$$JP-ROCHE-10000024733$ROCHE$$$$$F$Y$$$20240716$$CN$JP$JP
240947181$24094718$1$I$20231207$20240715$20240716$20240716$EXP$$PL-SANDOZ INC.-SDZ2024PL056791$SANDOZ$$69$YR$$F$Y$71$KG$20240716$$MD$PL$PL
240947192$24094719$2$F$$20240806$20240716$20240814$EXP$$CA-ROCHE-10000022985$ROCHE$$$$$M$Y$$$20240814$$CN$CA$CA
240947201$24094720$1$I$20240626$20240705$20240716$20240716$EXP$$CN-ROCHE-10000019793$ROCHE$$56$YR$A$F$Y$64$KG$20240716$$HP$CN$CN
240947212$24094721$2$F$$20240806$20240716$20240809$PER$$US-ROCHE-10000000375$ROCHE$$$$A$F$Y$58.51$KG$20240809$$CN$US$US
240947221$24094722$1$I$20240510$20240711$20240716$20240716$EXP$$ID-AstraZeneca-2024A160166$ASTRAZENECA$$24691$DY$$F$Y$$$20240716$$CN$ID$
240947231$24094723$1$I$$20240708$20240716$20240716$EXP$$PL-AstraZeneca-2024A160428$ASTRAZENECA$$$$$$Y$$$20240716$$MD$PL$
240947241$24094724$1$I$$20240703$20240716$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06238$HIKMA$Lyon BA, Wynne D.. Lyon BA, Wynne D. Amiodarone-Induced Epididymitis: A Case Report and Review of the Literature.. Cureus.. 2024;16(6):e62861:1-6$78$YR$$M$Y$196$KG$20240716$$MD$US$US
240947251$24094725$1$I$$20240708$20240716$20240716$PER$$US-AstraZeneca-2024A157235$ASTRAZENECA$$24$YR$$F$Y$$$20240716$$CN$US$
240947261$24094726$1$I$20240517$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159562$ASTRAZENECA$$26136$DY$$M$Y$$$20240716$$CN$US$
240947272$24094727$2$F$20231109$20240711$20240716$20240720$EXP$$JP-TAKEDA-2024TUS015554$TAKEDA$$60$YR$$F$Y$$$20240720$$MD$JP$JP
240947284$24094728$4$F$$20240827$20240716$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003152$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
240947291$24094729$1$I$$20191223$20240716$20240716$EXP$$US-AstraZeneca-2019SF88124$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240947301$24094730$1$I$20240712$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139587$AMGEN$$54$YR$A$F$Y$$$20240716$$CN$US$US
240947312$24094731$2$F$$20240906$20240716$20240911$EXP$$NO-AMGEN-NORSP2024139575$AMGEN$$$$$F$Y$$$20240910$$CN$NO$NO
240947321$24094732$1$I$20240705$20240711$20240716$20240716$EXP$$CN-AMGEN-CHNSP2024138224$AMGEN$$66$YR$E$F$Y$45$KG$20240716$$HP$CN$CN
240947332$24094733$2$F$$20240821$20240716$20240827$EXP$$GB-AMGEN-GBRSP2024139869$AMGEN$$69$YR$E$F$Y$$$20240826$$CN$GB$GB
240947341$24094734$1$I$20240520$20240626$20240716$20240716$EXP$$BR-CELLTRION INC.-2024BR015180$CELLTRION$$$$$$Y$$$20240716$$CN$BR$BR
240947351$24094735$1$I$$20240711$20240716$20240716$EXP$$CA-BIOGEN-2024BI01273590$BIOGEN$$$$$F$Y$$$20240716$$CN$CA$CA
240947363$24094736$3$F$20240606$20240722$20240716$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-094655$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240729$$PH$JP$JP
240947371$24094737$1$I$$20240709$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039366$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240716$$CN$US$US
240947381$24094738$1$I$20240613$20240710$20240716$20240716$EXP$$US-GSK-US2024085845$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$HP$US$US
240947391$24094739$1$I$20240113$20240702$20240716$20240716$EXP$GB-MHRA-MED-202406301130511070-FLYHN$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14767$ALKEM$$24$YR$$M$Y$$$20240716$$CN$GB$GB
240947401$24094740$1$I$$20240711$20240716$20240716$EXP$$US-UCBSA-2024035179$UCB$$$$$F$Y$$$20240716$$HP$US$US
240947411$24094741$1$I$20240615$20240702$20240716$20240716$EXP$GB-MHRA-MED-202406290731408350-JDBNM$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14765$ALKEM$$77$YR$$M$Y$90$KG$20240716$$CN$GB$GB
240947422$24094742$2$F$20170101$20240717$20240716$20240731$EXP$PL-MLMSERVICE-20240625-PI109039-00306-1$PL-ALKEM LABORATORIES LIMITED-PL-ALKEM-2024-14795$ALKEM$Storoniak H, Debska-Slizien A.. Miliary Tuberculosis as Postmortem Diagnosis in Solid Organ Transplant Recipient: Case Report and Review of the Literature. Transplantation Proceedings. 2024;56(4):968-971$70$YR$$M$Y$$$20240731$$MD$PL$PL
240947431$24094743$1$I$$20240702$20240716$20240716$EXP$$PL-ALKEM LABORATORIES LIMITED-PL-ALKEM-2024-15060$ALKEM$Nowicka M, Gorska M, Nowicka Z, Edyko K, Edyko P, Wislicki S, Zawiasa-Bryszewska A, Strzelczyk J, Matych J, Kurnatowska I. Tacrolimus: Influence of the Posttransplant Concentration/Dose Ratio on Kidney Graft Function in a Two-Year Follow-Up. Kidney Blood Press Res. 2019;44:1075-1088$$$$$Y$$$20240716$$HP$PL$PL
240947441$24094744$1$I$20240624$20240702$20240716$20240716$EXP$GB-MHRA-MED-202406302112329280-PBJSY$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14771$ALKEM$$37$YR$$F$Y$64$KG$20240716$$CN$GB$GB
240947451$24094745$1$I$$20240709$20240716$20240716$EXP$$CA-GSK-CA2024058981$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$CA$CA
240947461$24094746$1$I$20240624$20240702$20240716$20240716$EXP$GB-MHRA-TPP20250639C9122355YC1719302864556$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14772$ALKEM$$63$YR$$F$Y$57$KG$20240716$$PH$GB$GB
240947471$24094747$1$I$20230612$20230623$20240716$20240716$EXP$$US-UniquePharma-2023UNI000031$UNIQUE PHARMACEUTICALS$$74$YR$$M$Y$108.86$KG$20240716$$CN$US$US
240947481$24094748$1$I$$20240705$20240716$20240716$EXP$$GB-AUROBINDO-AUR-APL-2024-033671$AUROBINDO$$$$A$F$Y$$$20240716$$CN$GB$GB
240947491$24094749$1$I$$20240711$20240716$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010673$JAZZ$$$$$F$Y$$$20240716$$CN$US$US
240947501$24094750$1$I$20240419$20240703$20240716$20240716$EXP$$US-ACORDA-ACO_177506_2024$ACORDA$$83$YR$$M$Y$$$20240716$$CN$US$US
240947511$24094751$1$I$$20240712$20240716$20240716$PER$$US-ABBVIE-5838876$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240947522$24094752$2$F$20240612$20240712$20240716$20240731$30DAY$$US-JNJFOC-20240711864$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240801$$HP$US$US
240947531$24094753$1$I$$20240715$20240716$20240716$PER$$US-ROCHE-10000027718$ROCHE$$28$YR$A$F$Y$$$20240716$$MD$US$US
240947541$24094754$1$I$$20240702$20240716$20240716$PER$$US-BEIGENE-BGN-2024-010951$BEIGENE$$$$$$Y$$$20240716$$CN$US$US
240947552$24094755$2$F$20240708$20240717$20240716$20240722$EXP$$NVSJ2024JP008155$NOVARTIS$$98$YR$$F$Y$$$20240722$$PH$JP$JP
240947561$24094756$1$I$$20240715$20240716$20240716$PER$$NVSC2024US146098$NOVARTIS$$$$$M$Y$$$20240716$$MD$US$US
240947571$24094757$1$I$$20240709$20240716$20240716$EXP$$CA-APOTEX-2024AP008143$APOTEX$$72$YR$$F$Y$$$20240716$$HP$CA$CA
240947581$24094758$1$I$20240510$20240702$20240716$20240716$EXP$IT-MINISAL02-992206$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-06274$HIKMA$$62$YR$$F$Y$55$KG$20240716$$MD$IT$IT
240947591$24094759$1$I$$20240710$20240716$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110204$BRISTOL MYERS SQUIBB$$7$YR$C$M$Y$$$20240716$$HP$CA$CA
240947601$24094760$1$I$$20240702$20240716$20240716$EXP$GB-MHRA-MIDB- 5c5977f1-7f26-4321-b456-1036d1661ac9$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001688$IPCA$$$$$$Y$$$20240716$$HP$GB$GB
240947611$24094761$1$I$$20240705$20240716$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-034429$AUROBINDO$Franco GR, Sharma D, Hsu C, Ghany MG.. DEFYING DANGER: ASSESSING OLOROFIM^S IMPACT ON THE LIVER - A CASE REPORT OF SEVERE DILI AND SUCCESSFUL RECHALLENGE. Gastroenterology. 2024;166 (Suppl.)(5):S-1697 abstr. Mo1570.$67$YR$$M$Y$$$20240716$$HP$US$US
240947624$24094762$4$F$$20240913$20240716$20240919$EXP$$US-TAKEDA-2021TUS052535$TAKEDA$$$$$M$Y$82$KG$20240919$$HP$US$US
240947631$24094763$1$I$$20240527$20240716$20240716$PER$$US-AUROBINDO-AUR-APL-2024-027159$AUROBINDO$$$$$$Y$$$20240716$$PH$US$US
240947641$24094764$1$I$20240130$20240705$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-033366$AUROBINDO$$42$YR$$F$Y$$$20240716$$PH$FR$FR
240947651$24094765$1$I$20240425$20240712$20240716$20240716$EXP$$US-UCBSA-2024021403$UCB$$3$YR$$M$Y$$$20240716$$CN$US$US
240947661$24094766$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145784$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240947671$24094767$1$I$20240710$20240710$20240716$20240716$EXP$$US-VIIV HEALTHCARE LIMITED-US2024085693$VIIV$$54$YR$$M$Y$$$20240716$$CN$US$US
240947681$24094768$1$I$20240423$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159361$ASTRAZENECA$$$$$$Y$$$20240716$$CN$US$
240947691$24094769$1$I$$20201022$20240716$20240716$EXP$$US-AstraZeneca-2020SE92847$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240947702$24094770$2$F$20240712$20240828$20240716$20240828$PER$$NVSC2024US146038$NOVARTIS$$71$YR$$F$Y$$$20240828$$CN$US$US
240947711$24094771$1$I$20240101$20240712$20240716$20240716$EXP$$US-JNJFOC-20240734859$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240716$$HP$US$US
240947721$24094772$1$I$$20240711$20240716$20240716$EXP$$US-GSK-US2024086322$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$US$US
240947731$24094773$1$I$$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159225$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240947741$24094774$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008601$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$US$US
240947751$24094775$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008605$ELI LILLY AND CO$$53$YR$A$$Y$$$20240716$$CN$US$US
240947761$24094776$1$I$20240605$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008706$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240716$$CN$US$US
240947771$24094777$1$I$20240701$20240708$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407005640$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240716$$HP$US$US
240947781$24094778$1$I$$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159063$ASTRAZENECA$$$$$$Y$$$20240716$$MD$US$
240947792$24094779$2$F$$20240719$20240716$20240724$EXP$$KW-ROCHE-10000023253$ROCHE$$$$$$Y$$$20240724$$MD$KW$KW
240947802$24094780$2$F$$20240903$20240716$20240911$EXP$$CA-AstraZeneca-2024A157834$ASTRAZENECA$$$$$F$Y$$$20240911$$HP$CA$
240947811$24094781$1$I$$20200818$20240716$20240716$EXP$$US-AstraZeneca-2020SF05778$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240947821$24094782$1$I$20231101$20240712$20240716$20240716$EXP$FR-AFSSAPS-AN2024000899$NVSC2024FR144191$NOVARTIS$$44$YR$$F$Y$49$KG$20240716$$MD$FR$FR
240947831$24094783$1$I$$20240715$20240716$20240716$PER$$US-ROCHE-10000027716$ROCHE$$11$YR$C$M$Y$$$20240716$$CN$US$US
240947841$24094784$1$I$$20240709$20240716$20240716$PER$$US-JNJFOC-20240722630$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$HP$US$US
240947851$24094785$1$I$$20240701$20240716$20240716$EXP$$US-TEVA-VS-3219139$TEVA$Folkerth R, Jayakumar J, Manesh A, Pandurangan K, Perl D, Priemer D, et al. Comparison of neuropathologies among rabies patients treated with standard, Milwaukee, and/or experimental AAV-RAB strategies. J-Neuropathol-Exp-Neurol 2024; 83 (6): 453.$57$YR$$M$Y$$$20240716$$HP$US$US
240947861$24094786$1$I$$20240707$20240716$20240716$PER$$US-APOTEX-2024AP008190$APOTEX$Jaspersen SL, Bruns DA, Candee MS, Battaglia A, Carey JC, Fishler KP.. Seizures in trisomy 18: Prevalence, description, and treatment. American Journal of Medical Genetics Part A. 2023;191A (4):1026-1037$$$$$Y$$$20240716$$MD$US$US
240947881$24094788$1$I$$20240708$20240716$20240716$EXP$$IN-Encube-000820$ENCUBE ETHICALS$Singh A, Goyal MK, Midha V, Mahajan R, Kaur K, Gupta YK, Singh D, Bansal N, Kaur R, Kalra S, Goyal O, Mehta V, Sood A. Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial. Am J Gastroenterol. 2024 Jul 1;119(7):1365-1372. doi: 10.14309/ajg.0000000000002635. Epub 2023 Dec 22. PMID: 38131615.$$$$$Y$$$20240715$$MD$IN$
240947891$24094789$1$I$20240101$20240706$20240716$20240716$EXP$$CA-CELLTRION INC.-2024CA000260$CELLTRION$$$$$$Y$$$20240716$$CN$CA$CA
240947902$24094790$2$F$$20240729$20240716$20240807$EXP$$US-TEVA-VS-3217813$TEVA$Singh N, Ramonell RP, Cody B, Dunlap DG. A Growing Concern: Solitary Pulmonary Nodule Caused by Pneumocystis Jirovecci in an Immunocompromised Patient. Am-J-Respir-Crit-Care-Med 2024; 209 A2381.; Singh N, Ramonell RP, Cody B, Dunlap DG. A Growing Concern: Solitary Pulmonary Nodule Caused by Pneumocystis Jirovecci in an Immunocompromised Patient. Am-J-Respir-Crit-Care-Med 2024; 209 A2381.$71$YR$$M$Y$$$20240807$$HP$US$US
240947911$24094791$1$I$$20240708$20240716$20240716$PER$$US-HETERO-HET2024US02231$HETERO$$$$$M$Y$71.655$KG$20240716$$CN$US$US
240947921$24094792$1$I$20210101$20240709$20240716$20240716$EXP$CZ-EMA-DD-20240319-7482705-141837$CZ-Orion Corporation ORION PHARMA-24_00030745$ORION$Koristek Z. Lecba relabovane B-akutni lymfoblasticke leukemie pomoci inotuzumab ozogamicinu (Treatment of relapsed B-acute lymphoblastic leukemia with inotuzumab ozogamicin). ACTA MEDICINAE. 2023;13(4):46-7.$27$YR$A$M$Y$$$20240716$$MD$CZ$
240947933$24094793$3$F$20240708$20240716$20240716$20240729$PER$$US-AMGEN-USASP2024140481$AMGEN$$58$YR$A$F$Y$$$20240729$$CN$US$US
240947942$24094794$2$F$$20240615$20240716$20240716$PER$$US-ROCHE-10000003548$ROCHE$$$$$F$Y$45.36$KG$20240716$$CN$US$US
240947951$24094795$1$I$$20240710$20240716$20240716$EXP$$US-ABBVIE-5840257$ABBVIE$$$$A$$Y$$$20240716$$CN$US$US
240947961$24094796$1$I$$20240712$20240716$20240716$PER$$US-ABBVIE-5839508$ABBVIE$$$$A$F$Y$$$20240716$$MD$US$US
240947973$24094797$3$F$20240520$20240717$20240716$20240722$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2024-097963$REGENERON$$49$YR$$F$Y$$$20240722$$CN$CO$CO
240947982$24094798$2$F$20240709$20240819$20240716$20240823$EXP$$US-AMGEN-USASP2024137864$AMGEN$$73$YR$E$F$Y$$$20240823$$CN$US$US
240947993$24094799$3$F$20240628$20240731$20240716$20240809$PER$$US-APOTEX-2024AP007914$APOTEX$$$$$F$Y$$$20240809$$CN$US$US
240948001$24094800$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111964$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240716$$PH$US$US
240948011$24094801$1$I$$20240711$20240716$20240716$EXP$$US-JNJFOC-20240730006$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240716$$MD$US$US
240948021$24094802$1$I$20240315$20240710$20240716$20240716$PER$$US-JNJFOC-20240727812$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$HP$US$US
240948031$24094803$1$I$20240513$20240704$20240716$20240716$EXP$FR-AFSSAPS-PC2024000498$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-06356$HIKMA$$49$YR$$F$Y$$$20240716$$PH$FR$FR
240948041$24094804$1$I$$20240711$20240716$20240716$EXP$$CA-TAKEDA-2024TUS071347$TAKEDA$$$$$M$Y$$$20240716$$MD$CA$CA
240948051$24094805$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A156112$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240948061$24094806$1$I$20240705$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A157002$ASTRAZENECA$$13049$DY$$M$Y$$$20240716$$CN$US$
240948071$24094807$1$I$20240710$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159633$ASTRAZENECA$$$$$F$Y$$$20240716$$MD$US$
240948084$24094808$4$F$20240701$20240813$20240716$20240814$PER$$US-AMGEN-USASP2024140040$AMGEN$$75$YR$E$F$Y$$$20240814$$CN$US$US
240948091$24094809$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A157028$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240948101$24094810$1$I$$20191018$20240716$20240716$EXP$$IT-AstraZeneca-2019SF50292$ASTRAZENECA$$$$$F$Y$$$20240716$$MD$IT$
240948111$24094811$1$I$$20240711$20240716$20240716$EXP$$ZA-AstraZeneca-2024A160407$ASTRAZENECA$$23010$DY$$M$Y$$$20240716$$CN$ZA$
240948121$24094812$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A156002$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240948131$24094813$1$I$20190910$20191021$20240716$20240716$EXP$$IT-AstraZeneca-2019SF50090$ASTRAZENECA$$26103$DY$$F$Y$67$KG$20240716$$MD$IT$
240948143$24094814$3$F$$20240822$20240716$20240828$PER$$NVSC2024US145620$NOVARTIS$$$$$$Y$$$20240828$$CN$US$US
240948151$24094815$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145574$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240948161$24094816$1$I$$20240702$20240716$20240716$PER$$US-APOTEX-2024AP007928$APOTEX$$$$$F$Y$$$20240716$$CN$US$US
240948181$24094818$1$I$20240525$20240708$20240716$20240716$EXP$FR-AFSSAPS-PP2024000717$FR-TEVA-VS-3218788$TEVA$$30$YR$$M$Y$75$KG$20240716$$CN$FR$FR
240948192$24094819$2$F$$20240729$20240716$20240807$EXP$$US-TEVA-VS-3217902$TEVA$Almazan EP, Ellaicy O, Carter DJ, Kaleka K, Faruqi M. Another Case of the Blues, Methylene Blue as Adjunctive Therapy in Calcium-channel Blocker Induced Vasoplegia. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Almazan EP, Ellaicy O, Carter DJ, Kaleka K, Faruqi M. Another Case of the Blues, Methylene Blue as Adjunctive Therapy in Calcium-channel Blocker Induced Vasoplegia. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$65$YR$$F$Y$$$20240807$$HP$US$US
240948201$24094820$1$I$20221128$20240709$20240716$20240716$EXP$PL-URPL-DML-MLP.4401.1.776.2022$PL-TEVA-VS-3219546$TEVA$$82$YR$$F$Y$61$KG$20240716$$MD$PL$PL
240948211$24094821$1$I$20090301$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405121551375800-CVNQW$GB-RDY-SPO/GBR/24/0010052$DR REDDYS$$18$YR$A$M$Y$$$20240716$$CN$GB$GB
240948221$24094822$1$I$$20240715$20240716$20240716$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039964$BOEHRINGER INGELHEIM$$$$$$Y$$$20240716$$HP$CA$CA
240948231$24094823$1$I$20240621$20240705$20240716$20240716$EXP$$CN-TAKEDA-2024TUS070757$TAKEDA$$66$YR$$M$Y$58$KG$20240716$$HP$CN$CN
240948242$24094824$2$F$20240802$20240907$20240716$20240912$EXP$$IN-ROCHE-10000022641$ROCHE$$69$YR$E$M$Y$$$20240912$$CN$IN$IN
240948251$24094825$1$I$20240710$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007879$ELI LILLY AND CO$$24$YR$A$M$Y$$$20240716$$CN$US$US
240948261$24094826$1$I$$20240709$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007444$ELI LILLY AND CO$$$$A$M$Y$$$20240716$$CN$US$US
240948271$24094827$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008497$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240716$$CN$US$US
240948281$24094828$1$I$$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008442$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240716$$CN$US$US
240948291$24094829$1$I$20240604$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008716$ELI LILLY AND CO$$$$$$Y$$$20240716$$CN$US$US
240948301$24094830$1$I$$20240703$20240716$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06318$HIKMA$Lyon BA, Wynne D.. Lyon BA, Wynne D. Amiodarone-Induced Epididymitis: A Case Report and Review of the Literature.. Cureus. 2024;16(6):e62861$78$YR$$M$Y$88.904$KG$20240716$$MD$US$US
240948321$24094832$1$I$20240708$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112012$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$103.87$KG$20240716$$CN$US$US
240948331$24094833$1$I$20240601$20240709$20240716$20240716$EXP$$CN-SA-2024SA206218$SANOFI AVENTIS$$72$YR$E$F$Y$47$KG$20240716$$HP$CN$CN
240948342$24094834$2$F$$20240711$20240716$20240718$EXP$$US-SA-2024SA204871$SANOFI AVENTIS$$$$E$F$Y$72.5$KG$20240718$$MD$US$US
240948351$24094835$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024139513$AMGEN$$$$$$Y$$$20240716$$PH$US$US
240948361$24094836$1$I$20240708$20240709$20240716$20240716$EXP$$CA-GSK-CA2024085659$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$CA$CA
240948372$24094837$2$F$20230201$20240801$20240716$20240807$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-06588$LUPIN$$$$$$Y$$$20240807$$CN$IN$IN
240948381$24094838$1$I$20161107$20240705$20240716$20240716$EXP$ES-EMA-DD-20171213-faizanevprod-093338$ES-NOVOPROD-1250889$NOVO NORDISK$$32$YR$$F$Y$57$KG$20240716$$MD$ES$ES
240948395$24094839$5$F$20240101$20240806$20240716$20240813$EXP$$GB-ABBVIE-5838567$ABBVIE$$$$E$F$Y$$$20240813$$HP$GB$GB
240948401$24094840$1$I$$20240710$20240716$20240716$PER$$US-TAKEDA-2024TUS070676$TAKEDA$$$$$F$Y$$$20240716$$HP$US$US
240948413$24094841$3$F$$20240829$20240716$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002960$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
240948421$24094842$1$I$20240701$20240703$20240716$20240716$PER$$US-APOTEX-2024AP007946$APOTEX$$$$$M$Y$$$20240716$$CN$US$US
240948431$24094843$1$I$20240101$20240710$20240716$20240716$PER$$US-BIOGEN-2024BI01273230$BIOGEN$$$$$F$Y$$$20240716$$CN$US$US
240948441$24094844$1$I$$20240710$20240716$20240716$PER$$US-BIOGEN-2024BI01273175$BIOGEN$$$$$F$Y$$$20240716$$CN$US$US
240948451$24094845$1$I$$20240715$20240716$20240716$EXP$$NVSC2024DE145193$NOVARTIS$$38$YR$$F$Y$$$20240716$$CN$DE$DE
240948461$24094846$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112315$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240716$$HP$US$US
240948472$24094847$2$F$20240630$20240731$20240716$20240805$PER$$US-ROCHE-10000024584$ROCHE$$60$YR$A$F$Y$$$20240805$$CN$US$US
240948491$24094849$1$I$$20240712$20240716$20240716$EXP$$US-ROCHE-10000026204$ROCHE$$$$A$F$Y$$$20240716$$CN$US$US
240948501$24094850$1$I$20230801$20240711$20240716$20240716$EXP$$US-ABBVIE-5833638$ABBVIE$$70$YR$$F$Y$$$20240716$$CN$US$US
240948511$24094851$1$I$$20240711$20240716$20240716$EXP$$DE-ABBVIE-5838538$ABBVIE$$$$$F$Y$$$20240716$$CN$DE$DE
240948523$24094852$3$F$20231012$20240801$20240716$20240822$EXP$$US-ABBVIE-5838593$ABBVIE$$23$YR$$F$Y$$$20240822$$CN$US$US
240948531$24094853$1$I$$20240708$20240716$20240716$EXP$$AU-ALXN-202407OCE000412AU$ALEXION PHARMACEUTICALS$$$$N$F$Y$$$20240716$$MD$AU$AU
240948542$24094854$2$F$20201217$20240729$20240716$20240729$EXP$IT-MINISAL02-991732$IT-ROCHE-10000026633$ROCHE$$54$YR$A$M$Y$$$20240729$$MD$IT$IT
240948553$24094855$3$F$20240301$20240812$20240716$20240819$EXP$$CA-CELLTRION INC.-2024CA008779$CELLTRION$$$$$$Y$$$20240819$$MD$CA$CA
240948561$24094856$1$I$20240618$20240710$20240716$20240716$PER$$US-TAKEDA-2024TUS070273$TAKEDA$$25$YR$$F$Y$$$20240716$$MD$US$US
240948571$24094857$1$I$$20240711$20240716$20240716$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14041$IPSEN$$$$$$Y$$$20240716$$HP$US$US
240948581$24094858$1$I$$20240517$20240716$20240716$PER$$US-ABBVIE-5839742$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240948591$24094859$1$I$20220316$20220423$20240716$20240716$EXP$$IT-AstraZeneca-2022A145077$ASTRAZENECA$$3577$WK$$F$Y$$$20240716$$MD$IT$
240948611$24094861$1$I$20200101$20240703$20240716$20240716$EXP$$CA-CHATTEMPRD-2023SA178180$CHATTEM$Feschuk AM, Pratt ME.. Topical steroid withdrawal syndrome in a mother and son: A case report.. SAGE Open Medical Case Reports. 2023;11:1-4. doi:10.1177/20503I3X231164268$42$YR$A$F$Y$$$20240716$$HP$CA$CA
240948621$24094862$1$I$$20221108$20240716$20240716$EXP$$JP-AstraZeneca-2022A341326$ASTRAZENECA$$65$YR$$M$Y$49$KG$20240716$$MD$JP$
240948631$24094863$1$I$$20240708$20240716$20240716$EXP$$ZA-AstraZeneca-2024A157010$ASTRAZENECA$$59$YR$$F$Y$$$20240716$$CN$ZA$
240948641$24094864$1$I$20190509$20200127$20240716$20240716$EXP$$FR-AstraZeneca-2019SE74966$ASTRAZENECA$$21373$DY$$F$Y$86$KG$20240716$$MD$FR$
240948651$24094865$1$I$$20200728$20240716$20240716$EXP$$US-AstraZeneca-2020SE95962$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240948661$24094866$1$I$$20240704$20240716$20240716$EXP$$JP-AstraZeneca-2024A154896$ASTRAZENECA$$$$$M$Y$$$20240716$$MD$JP$
240948672$24094867$2$F$$20190815$20240716$20240815$EXP$$CH-AstraZeneca-2019SF20899$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$CH$
240948681$24094868$1$I$$20230613$20240716$20240716$EXP$$IT-AstraZeneca-2023A140416$ASTRAZENECA$$$$$$Y$$$20240716$$MD$IT$
240948692$24094869$2$F$20240410$20240715$20240716$20240720$EXP$FR-AFSSAPS-NY2024000650$FR-ROCHE-10000021331$ROCHE$$78$YR$E$M$Y$77$KG$20240719$$MD$FR$FR
240948701$24094870$1$I$$20240713$20240716$20240716$PER$$US-HALEON-2187195$Haleon PLC$$$$$$Y$$$20240716$$CN$US$US
240948714$24094871$4$F$20240703$20240720$20240716$20240729$EXP$$BR-TOLMAR, INC.-24BR050938$TOLMAR$$10$YR$$F$Y$$$20240729$$MD$BR$BR
240948721$24094872$1$I$$20240708$20240716$20240716$EXP$$CA-TOLMAR, INC.-24CA050850$TOLMAR$$$$$M$Y$$$20240716$$CN$CA$CA
240948731$24094873$1$I$$20240708$20240716$20240716$EXP$$CA-TOLMAR, INC.-24CA050881$TOLMAR$$$$$M$Y$$$20240716$$CN$CA$CA
240948741$24094874$1$I$20240610$20240710$20240716$20240716$EXP$GB-MHRA-MED-202407102314443940-ZKVHD$GB-SA-2024SA203612$SANOFI AVENTIS$$33$YR$A$F$Y$96$KG$20240716$$CN$GB$GB
240948751$24094875$1$I$20240601$20240708$20240716$20240716$EXP$$FR-TOLMAR, INC.-24FR050826$TOLMAR$$80$YR$$M$Y$$$20240716$$MD$FR$FR
240948761$24094876$1$I$$20240708$20240716$20240716$EXP$$NL-TOLMAR, INC.-24NL050832$TOLMAR$$$$$M$Y$$$20240716$$HP$NL$NL
240948772$24094877$2$F$$20240711$20240716$20240722$EXP$$NL-TOLMAR, INC.-24NL050897$TOLMAR$$$$$M$Y$$$20240719$$HP$NL$NL
240948781$24094878$1$I$20240101$20240709$20240716$20240716$PER$$US-BIOGEN-2024BI01268373$BIOGEN$$$$$M$Y$$$20240716$$CN$US$US
240948791$24094879$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145613$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240948801$24094880$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111775$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240716$$HP$US$US
240948821$24094882$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024139361$AMGEN$$$$$$Y$$$20240716$$PH$US$US
240948831$24094883$1$I$20240709$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024137083$AMGEN$$66$YR$E$F$Y$$$20240716$$CN$US$US
240948841$24094884$1$I$$20240705$20240716$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-033437$AUROBINDO$Landers ZD, Mazhar A.. Fluoroquinolone-Induced Multisystem Toxicity: A Case Report.. Cureus.. 2024;16(5):e61174$41$YR$$M$Y$$$20240716$$MD$US$US
240948852$24094885$2$F$$20240711$20240716$20240722$EXP$$GB-JNJFOC-20240735373$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$GB$GB
240948861$24094886$1$I$$20240711$20240716$20240716$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003579$TERSERA THERAPEUTICS$$$$$$Y$$$20240716$$CN$AU$AU
240948872$24094887$2$F$$20240729$20240716$20240806$EXP$$US-TEVA-VS-3217825$TEVA$Stone EG. Unintended adverse consequences of a clinical decision support system: two cases. J-Am-Med-Inf-Assoc 2018; 25 (5): 564-567.; Stone EG. Unintended adverse consequences of a clinical decision support system: two cases. J-Am-Med-Inf-Assoc 2018; 25 (5): 564-567.$63$YR$$M$Y$$$20240806$$HP$US$US
240948881$24094888$1$I$$20240710$20240716$20240716$EXP$$PT-TERSERA THERAPEUTICS LLC-2024TRS003578$TERSERA THERAPEUTICS$$$$$$Y$$$20240716$$MD$PT$PT
240948891$24094889$1$I$$20240710$20240716$20240716$PER$$US-ABBVIE-5838778$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240948901$24094890$1$I$20231219$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405080717533430-KGMJC$GB-TERSERA THERAPEUTICS LLC-2024TRS003539$TERSERA THERAPEUTICS$$$$$$Y$$$20240716$$MD$GB$GB
240948911$24094891$1$I$20240604$20240715$20240716$20240716$EXP$FR-AFSSAPS-PO2024000767$FR-SANDOZ INC.-SDZ2024FR065144$SANDOZ$$76$YR$$M$Y$76$KG$20240716$$MD$FR$FR
240948921$24094892$1$I$$20240709$20240716$20240716$EXP$$US-ABBVIE-5835286$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240948931$24094893$1$I$$20240703$20240716$20240716$EXP$$MY-ROCHE-10000022993$ROCHE$$$$E$M$Y$$$20240716$$MD$MY$MY
240948942$24094894$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218394$TEVA$Chowdhury T, Mainali A, Uprety N, Bisural R, Adhikari S, Gousy N, et al. The Deadly Duel: Legionnaires Disease and Multiple Myeloma: A Case of Fatal Pulmonary Renal Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209 A3608 (plus Poster).; Chowdhury T, Mainali A, Uprety N, Bisural R, Adhikari S, Gousy N, et al. The Deadly Duel: Legionnaires Disease and Multiple Myeloma: A Case of Fatal Pulmonary Renal Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209 A3608 (plus Poster).$57$YR$$M$Y$$$20240805$$HP$US$US
240948951$24094895$1$I$$20240703$20240716$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06246$HIKMA$Roma N, Padala V, Pattoli M, Desai S, Krinock M, Durkin M, et al.. Roma N, Padala V, Pattoli M, Desai S, Krinock M, Durkin M, et al. BRASH Syndrome: A Rare Clinical Phenomenon. CJC Open. 2024;6(6):840-2$66$YR$$F$Y$$$20240716$$MD$US$US
240948961$24094896$1$I$$20240703$20240716$20240716$PER$$US-TAKEDA-2024TUS067721$TAKEDA$$$$$$Y$$$20240716$$MD$US$US
240948971$24094897$1$I$$20240712$20240716$20240716$PER$$US-JNJFOC-20240735550$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$CN$US$US
240948981$24094898$1$I$20230124$20240708$20240716$20240716$EXP$$FR-CELLTRION INC.-2024FR016781$CELLTRION$$$$$$Y$$$20240716$$MD$FR$FR
240948992$24094899$2$F$20220101$20240702$20240716$20240717$PER$$US-JNJFOC-20240710784$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240717$$CN$US$US
240949001$24094900$1$I$$20240711$20240716$20240716$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14014$IPSEN$$$$A$F$Y$$$20240716$$HP$US$US
240949011$24094901$1$I$20240601$20240705$20240716$20240716$EXP$$SE-AUROBINDO-AUR-APL-2024-033696$AUROBINDO$$71$YR$$M$Y$$$20240716$$MD$SE$SE
240949021$24094902$1$I$$20240711$20240716$20240716$PER$$US-ABBVIE-5839575$ABBVIE$$58$YR$$F$Y$$$20240716$$MD$US$US
240949031$24094903$1$I$$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111075$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240716$$CN$US$US
240949042$24094904$2$F$$20240710$20240716$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA064931$SANDOZ$$$$A$F$Y$$$20240722$$MD$CA$CA
240949052$24094905$2$F$$20240717$20240716$20240723$PER$$US-LEO Pharma-371986$LEO PHARM$$33$YR$$F$Y$$$20240722$$CN$US$US
240949061$24094906$1$I$20240612$20240702$20240716$20240716$PER$$US-APOTEX-2024AP007932$APOTEX$$$$$F$Y$$$20240716$$CN$US$US
240949071$24094907$1$I$$20240711$20240716$20240716$PER$$US-ROCHE-10000023554$ROCHE$$$$$F$Y$$$20240716$$CN$US$US
240949081$24094908$1$I$$20240711$20240716$20240716$PER$$US-ROCHE-10000025941$ROCHE$$$$$$Y$$$20240716$$CN$US$US
240949091$24094909$1$I$$20240709$20240716$20240716$PER$$US-ROCHE-10000027247$ROCHE$$$$$$Y$$$20240716$$CN$US$US
240949101$24094910$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-10000025757$ROCHE$$$$$$Y$$$20240716$$CN$US$US
240949111$24094911$1$I$$20240702$20240716$20240716$PER$$US-ROCHE-10000024249$ROCHE$$70$YR$E$F$Y$$$20240716$$CN$US$US
240949121$24094912$1$I$20240710$20240710$20240716$20240716$30DAY$$US-GSK-US2024085746$GLAXOSMITHKLINE$$59$YR$$M$Y$$$20240716$$CN$US$US
240949131$24094913$1$I$20240101$20240712$20240716$20240716$EXP$$US-JNJFOC-20240734802$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240716$$HP$US$US
240949141$24094914$1$I$$20190815$20240716$20240716$EXP$$CH-AstraZeneca-2019SF20977$ASTRAZENECA$$$$$F$Y$$$20240716$$MD$CH$
240949151$24094915$1$I$20190812$20190822$20240716$20240716$EXP$$CO-AstraZeneca-2019SF21153$ASTRAZENECA$$24544$DY$$F$Y$$$20240716$$CN$CO$
240949161$24094916$1$I$$20240702$20240716$20240716$EXP$$US-CIPLA LTD.-2023US04110$CIPLA$Acharya I, Weisman DS, Smith LW, Arend LJ. Diagnostic dilemma: Drug-induced vasculitis versus systemic vasculitis. BMJ. 2023;16 (7)$$$$$Y$$$20240716$$HP$US$US
240949171$24094917$1$I$20240227$20240708$20240716$20240716$EXP$$FR-AstraZeneca-2024A155236$ASTRAZENECA$$80$YR$$F$Y$46.7$KG$20240716$$MD$FR$
240949181$24094918$1$I$$20240708$20240716$20240716$EXP$$ZA-AstraZeneca-2024A157130$ASTRAZENECA$$57$YR$$M$Y$$$20240716$$CN$ZA$
240949191$24094919$1$I$$20201123$20240716$20240716$EXP$$US-AstraZeneca-2020SF57882$ASTRAZENECA$$64$YR$$F$Y$$$20240716$$CN$US$
240949201$24094920$1$I$$20200604$20240716$20240716$EXP$$US-AstraZeneca-2020SE74267$ASTRAZENECA$$73$YR$$M$Y$$$20240716$$CN$US$
240949211$24094921$1$I$20240626$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159235$ASTRAZENECA$$27345$DY$$M$Y$$$20240716$$CN$US$
240949221$24094922$1$I$$20210921$20240716$20240716$EXP$$US-AstraZeneca-2021A735976$ASTRAZENECA$$59$YR$$F$Y$64$KG$20240716$$CN$US$
240949231$24094923$1$I$$20240712$20240716$20240716$EXP$$GB-MSD-2003GBR002707AA$ORGANON$$$$$M$Y$$$20240716$$CN$GB$GB
240949241$24094924$1$I$$20240707$20240716$20240716$EXP$$ES-AMAROX PHARMA-AMR2024ES02271$HETERO$Lppez TL, Barcelo AFI, Gutierrez CG, Blasco M, Grafia I, Bastida C, et.al.. Clopidogrel- induced thrombotic microangiopathy: A case report. European Journal of Hospital Pharmacy. 2024;0:1-4$75$YR$$M$Y$$$20240716$$HP$ES$ES
240949251$24094925$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111809$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240716$$HP$US$US
240949261$24094926$1$I$20240713$20240713$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112101$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$51.71$KG$20240716$$PH$US$US
240949271$24094927$1$I$$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111435$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$107.2$KG$20240716$$HP$US$US
240949281$24094928$1$I$20240501$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111079$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240716$$HP$US$US
240949291$24094929$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111882$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240716$$CN$US$US
240949301$24094930$1$I$20240101$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112011$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240716$$CN$US$US
240949311$24094931$1$I$20240601$20240708$20240716$20240716$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-110833$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240716$$MD$JP$JP
240949321$24094932$1$I$20240711$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024138759$AMGEN$$76$YR$E$F$Y$$$20240716$$CN$US$US
240949331$24094933$1$I$$20240621$20240716$20240716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002948$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
240949343$24094934$3$F$$20240919$20240716$20240926$EXP$$US-AMGEN-USASP2024137715$AMGEN$$$$$F$Y$$$20240926$$MD$US$US
240949351$24094935$1$I$$20240622$20240716$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002950$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
240949361$24094936$1$I$20221110$20240708$20240716$20240716$EXP$$CA-CELLTRION INC.-2024CA006246$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
240949371$24094937$1$I$$20240627$20240716$20240716$PER$$US-JNJFOC-20240700623$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240949391$24094939$1$I$$20240628$20240716$20240716$PER$$US-ABBVIE-5840669$ABBVIE$$$$$$Y$$$20240716$$CN$US$US
240949401$24094940$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-10000026938$ROCHE$$34$YR$A$F$Y$$$20240716$$CN$US$US
240949412$24094941$2$F$$20240729$20240716$20240807$EXP$$US-TEVA-VS-3219117$TEVA$Folkerth R, Jayakumar J, Manesh A, Pandurangan K, Perl D, Priemer D, et al. Comparison of neuropathologies among rabies patients treated with standard, Milwaukee, and/or experimental AAV-RAB strategies. J-Neuropathol-Exp-Neurol 2024; 83 (6): 453.; Folkerth R, Jayakumar J, Manesh A, Pandurangan K, Perl D, Priemer D, et al. Comparison of neuropathologies among rabies patients treated with standard, Milwaukee, and/or experimental AAV-RAB strategies. J-Neuropathol-Exp-Neurol 2024; 83 (6): 453.$17$YR$$M$Y$$$20240807$$HP$US$US
240949421$24094942$1$I$$20240708$20240716$20240716$EXP$$DE-UCBSA-2024034660$UCB$Baysal L, Ludolph AC, Wagner J.. Clinical and paraclinical features of first unprovoked seizures in the elderly. Epilepsy + behavior E+B.. 2024;158:1-7$$$$$Y$$$20240716$$HP$DE$DE
240949431$24094943$1$I$$20240708$20240716$20240716$EXP$$US-ROCHE-10000022119$ROCHE$Eyada M, Michael V, Fellman B, Patel S, Soliman P, How J, et al. Oral cyclophosphamide plus bevacizumab in recurrent ovarian, fallopian tube and primary peritoneal cancer(Abstract no. 5517). Journal of Clinical Oncology. 2024;42 (Suppl 16):$$$$$Y$$$20240716$$HP$US$US
240949441$24094944$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-10000026628$ROCHE$$$$A$F$Y$$$20240716$$CN$US$US
240949451$24094945$1$I$$20240711$20240716$20240716$PER$$US-LEO Pharma-371955$LEO PHARM$$48$YR$$F$Y$$$20240716$$PH$US$US
240949461$24094946$1$I$$20240708$20240716$20240716$EXP$$JP-AMGEN-JPNSP2024137746$AMGEN$Okada Y;. Risk of neutropenia in psoriasis patients prescribed anti-IL-23 antibody in comparison with anti-IL-17 antibody or adalimumab based on real-world data from the MID-NET in Japan. Journal of Dermatological Treatment. 2024;35 (1)$$$$$Y$$$20240716$$HP$JP$JP
240949481$24094948$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-10000027251$ROCHE$$20$YR$A$F$Y$$$20240716$$CN$US$US
240949491$24094949$1$I$$20240711$20240716$20240716$EXP$$CN-ROCHE-10000024366$ROCHE$$57$YR$A$M$Y$$$20240716$$CN$CN$CN
240949501$24094950$1$I$$20240703$20240716$20240716$PER$$US-ROCHE-10000025943$ROCHE$$$$$$Y$$$20240716$$CN$US$US
240949512$24094951$2$F$$20240715$20240716$20240802$PER$$US-ROCHE-10000027518$ROCHE$$$$$$Y$$$20240802$$HP$US$US
240949521$24094952$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111770$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240716$$CN$US$US
240949532$24094953$2$F$20240101$20240812$20240716$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111774$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240813$$CN$US$US
240949542$24094954$2$F$20240711$20240724$20240716$20240730$PER$$US-ABBVIE-5839781$ABBVIE$$25$YR$$F$Y$86.1$KG$20240730$$CN$US$US
240949564$24094956$4$F$20240712$20240807$20240716$20240822$30DAY$$US-JNJFOC-20240733333$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240823$$CN$US$US
240949571$24094957$1$I$$20240708$20240716$20240716$EXP$$GB-AUROBINDO-AUR-APL-2019-079612$AUROBINDO$$$$$M$Y$85$KG$20240716$$HP$GB$GB
240949582$24094958$2$F$$20240724$20240716$20240730$EXP$$JP-GSK-JP2024071117$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$PH$JP$JP
240949591$24094959$1$I$20240601$20240702$20240716$20240716$EXP$$AT-TEVA-VS-3217344$TEVA$$$$A$F$Y$$$20240716$$PH$AT$AT
240949602$24094960$2$F$$20240712$20240716$20240718$EXP$$US-BIOGEN-2024BI01273468$BIOGEN$$$$$F$Y$$$20240718$$CN$US$US
240949612$24094961$2$F$$20240712$20240716$20240723$PER$$US-ROCHE-10000010644$ROCHE$Biswas Roy S, Ross M, Patil P, Trepeta R, Bremner R, Panchabhai T. Primary Nocardia infection causing a fluorodeoxyglucose-avid right renal Mass in a redo lung transplant recipient. Case Reports in Transplantation.2018:1-5. doi:10.1155/2018/9752860.$63$YR$A$F$Y$$$20240723$$HP$US$US
240949621$24094962$1$I$20240610$20240708$20240716$20240716$EXP$$NVSC2024FR144795$NOVARTIS$$73$YR$$M$Y$104$KG$20240716$$PH$FR$FR
240949641$24094964$1$I$20240308$20240709$20240716$20240716$EXP$$GB-CHEPLA-2024008633$CHEPLAPHARM$$47$YR$$F$Y$$$20240716$$CN$COUNTRY NOT SPECIFIED$GB
240949651$24094965$1$I$$20240705$20240716$20240716$EXP$$CN-ROCHE-10000002010$ROCHE$Wang Y, Xu Y, Liu X, Li C, Wang J, Zhang X, et al. The efficacy andsafetyoftrastuzumaband albumin-bound paclitaxel with or without pyrotinib as neoadjuvant therapy for HER2-positive breast cancer: aprospective observational cohort study. Gland surgery. 2024-May-30;13 (5):654-62. doi:10.21037/gs-24-81.$$$$$Y$$$20240716$$HP$CN$CN
240949661$24094966$1$I$20240701$20240712$20240716$20240716$PER$$US-JNJFOC-20240734504$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240716$$CN$US$US
240949671$24094967$1$I$$20240710$20240716$20240716$PER$$US-LEO Pharma-371946$LEO PHARM$$62$YR$$F$Y$$$20240716$$HP$US$US
240949681$24094968$1$I$$20240705$20240716$20240716$EXP$$CA-CHATTEMPRD-2019SA354949$CHATTEM$$27$YR$A$F$Y$$$20240716$$HP$CA$CA
240949692$24094969$2$F$$20240723$20240716$20240802$EXP$$GB-TEVA-VS-3216974$TEVA$Fenech M, Ajanaku A, McCormick A, Coupland SE, Krishna Y, Sultan Z, et al. Orbital Kimura disease: maintenance therapy using mycophenolate mofetil. Orbit 2024; 1-8.; Fenech M, Ajanaku A, McCormick A, Coupland SE, Krishna Y, Sultan Z, et al. Orbital Kimura disease: maintenance therapy using mycophenolate mofetil. Orbit 2024; 1-8.$55$YR$$M$Y$$$20240802$$HP$GB$GB
240949701$24094970$1$I$$20240714$20240716$20240716$PER$$US-TAKEDA-2024TUS071656$TAKEDA$$$$$$Y$$$20240716$$CN$US$US
240949711$24094971$1$I$$20211130$20240716$20240716$EXP$$US-AstraZeneca-2021A850155$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240949721$24094972$1$I$$20201030$20240716$20240716$EXP$$US-AstraZeneca-2020SF44275$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240949731$24094973$1$I$20191201$20191205$20240716$20240716$EXP$$CO-AstraZeneca-2019SF77829$ASTRAZENECA$$19843$DY$$F$Y$$$20240716$$CN$CO$
240949741$24094974$1$I$20240428$20240711$20240716$20240716$EXP$$US-ABBVIE-5838067$ABBVIE$$60$YR$$F$Y$$$20240716$$CN$US$US
240949751$24094975$1$I$$20201009$20240716$20240716$EXP$$US-AstraZeneca-2020SF31384$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240949761$24094976$1$I$$20200304$20240716$20240716$EXP$$US-AstraZeneca-2020SE33669$ASTRAZENECA$$$$$F$Y$$$20240716$$MD$US$
240949771$24094977$1$I$$20191015$20240716$20240716$EXP$$US-AstraZeneca-2019SF47684$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240949781$24094978$1$I$20190515$20191218$20240716$20240716$EXP$$CA-AstraZeneca-2019SF00540$ASTRAZENECA$$18016$DY$$M$Y$$$20240716$$CN$CA$
240949792$24094979$2$F$20200801$20200813$20240716$20240730$EXP$$US-AstraZeneca-2020SF03085$ASTRAZENECA$$763$MON$$F$Y$$$20240730$$CN$US$
240949801$24094980$1$I$$20220107$20240716$20240716$EXP$$US-AstraZeneca-2022A015131$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240949811$24094981$1$I$$20231020$20240716$20240716$EXP$$IT-AstraZeneca-2023A243879$ASTRAZENECA$$$$$$Y$$$20240716$$MD$IT$
240949821$24094982$1$I$20240626$20240708$20240716$20240716$PER$$US-HALEON-2186053$Haleon PLC$$68$YR$$F$Y$$$20240709$$CN$US$US
240949831$24094983$1$I$20160101$20190808$20240716$20240716$EXP$$US-AstraZeneca-2019SF15136$ASTRAZENECA$$$$$F$Y$84.8$KG$20240716$$CN$US$
240949841$24094984$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A156987$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240949852$24094985$2$F$$20240711$20240716$20240717$PER$$NVSC2024US144902$NOVARTIS$$$$$F$Y$$$20240717$$MD$US$US
240949863$24094986$3$F$$20240831$20240716$20240910$EXP$$CA-CELLTRION INC.-2024CA005667$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
240949871$24094987$1$I$$20240712$20240716$20240716$PER$$US-TAKEDA-2024TUS071316$TAKEDA$$$$$F$Y$$$20240716$$CN$US$US
240949881$24094988$1$I$20240601$20240712$20240716$20240716$EXP$$GB-AMGEN-GBRSP2024138853$AMGEN$$$$$F$Y$$$20240716$$PH$GB$GB
240949892$24094989$2$F$$20240830$20240716$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112299$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240903$$HP$US$US
240949901$24094990$1$I$20240715$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112367$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240716$$HP$US$US
240949911$24094991$1$I$20240628$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110880$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$62.6$KG$20240716$$CN$US$US
240949922$24094992$2$F$$20240708$20240716$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108663$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240718$$CN$US$US
240949932$24094993$2$F$$20240717$20240716$20240725$PER$$US-ABBVIE-5837037$ABBVIE$$$$$$Y$$$20240725$$HP$US$US
240949941$24094994$1$I$$20240705$20240716$20240716$EXP$$CA-CHATTEMPRD-2019SA354975$CHATTEM$$52$YR$A$F$Y$$$20240716$$HP$CA$CA
240949952$24094995$2$F$$20240730$20240716$20240731$EXP$$FR-ROCHE-10000008183$ROCHE$Solignac J, Boschi C, Pernin V, Fouilloux V, Motte A, Aherfi S, et al. The question of screening organ donors for hepatitis e virus: a case report of transmission by kidney transplantation in France and a review of the literature. Virology Journal. 2024;21 (1): doi:10.1186/s12985-024-02401-2.$6$DEC$A$F$Y$64$KG$20240731$$HP$FR$FR
240949962$24094996$2$F$20240623$20240726$20240716$20240802$EXP$IT-MINISAL02-992909$IT-TEVA-VS-3219009$TEVA$$78$YR$$F$Y$76$KG$20240802$$MD$IT$IT
240949971$24094997$1$I$$20240703$20240716$20240716$PER$$US-APOTEX-2024AP007989$APOTEX$Halawi H, Harris JE, Goodarzi A, Yau S, Youssef JG, Botros M, et al. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy. 2024;44 (3):283-289$46$YR$$M$Y$$$20240716$$HP$US$US
240949981$24094998$1$I$$20240705$20240716$20240716$EXP$$CA-CHATTEMPRD-2019SA354866$CHATTEM$$$$$M$Y$$$20240716$$HP$CA$CA
240950001$24095000$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145874$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240950012$24095001$2$F$$20240708$20240716$20240722$EXP$$US-BEH-2024175702$CSL BEHRING$$28$YR$A$F$Y$59.3$KG$20240722$$CN$US$US
240950021$24095002$1$I$20240601$20240711$20240716$20240716$PER$$US-JNJFOC-20240730037$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240716$$CN$US$US
240950031$24095003$1$I$$20240705$20240716$20240716$EXP$$CA-CHATTEMPRD-2019SA355038$CHATTEM$$33$YR$A$F$Y$$$20240716$$MD$CA$CA
240950041$24095004$1$I$$20240710$20240716$20240716$EXP$$US-TAKEDA-2024TUS071011$TAKEDA$$$$$M$Y$$$20240716$$MD$US$US
240950052$24095005$2$F$20240301$20240723$20240716$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111612$BRISTOL MYERS SQUIBB$$12$YR$T$M$Y$$$20240725$$HP$US$US
240950061$24095006$1$I$20240101$20240701$20240716$20240716$EXP$$US-AMICUS THERAPEUTICS, INC.-AMI_3227$AMICUS THERAPEUTICS$$$$$F$Y$87.075$KG$20240716$$CN$US$US
240950072$24095007$2$F$20240613$20240723$20240716$20240819$PER$$US-TOLMAR, INC.-24US050218$TOLMAR$$72$YR$$M$Y$$$20240819$$HP$US$US
240950082$24095008$2$F$20240613$20240724$20240716$20240814$PER$$US-TOLMAR, INC.-24US050220$TOLMAR$$$$$M$Y$$$20240813$$HP$US$US
240950091$24095009$1$I$20240617$20240620$20240716$20240716$PER$$US-TOLMAR, INC.-24US050281$TOLMAR$$73$YR$$M$Y$$$20240716$$HP$US$US
240950102$24095010$2$F$20240614$20240730$20240716$20240826$PER$$US-TOLMAR, INC.-24US050250$TOLMAR$$87$YR$$M$Y$$$20240826$$PH$US$US
240950111$24095011$1$I$$20240619$20240716$20240716$PER$$US-TOLMAR, INC.-24US050310$TOLMAR$$$$$M$Y$$$20240716$$HP$US$US
240950121$24095012$1$I$$20240619$20240716$20240716$PER$$US-TOLMAR, INC.-24US050319$TOLMAR$$$$$M$Y$82.54$KG$20240716$$HP$US$US
240950132$24095013$2$F$20240619$20240731$20240716$20240827$PER$$US-TOLMAR, INC.-24US050357$TOLMAR$$$$$M$Y$$$20240827$$HP$US$US
240950141$24095014$1$I$$20240620$20240716$20240716$PER$$US-TOLMAR, INC.-24US050370$TOLMAR$$$$A$F$Y$$$20240716$$HP$US$US
240950152$24095015$2$F$20240614$20240801$20240716$20240827$PER$$US-TOLMAR, INC.-24US050372$TOLMAR$$73$YR$$M$Y$$$20240827$$HP$US$US
240950161$24095016$1$I$$20240620$20240716$20240716$PER$$US-TOLMAR, INC.-24US050373$TOLMAR$$$$A$F$Y$$$20240716$$HP$US$US
240950171$24095017$1$I$$20240620$20240716$20240716$PER$$US-TOLMAR, INC.-24US050375$TOLMAR$$$$A$F$Y$$$20240716$$HP$US$US
240950181$24095018$1$I$$20240620$20240716$20240716$PER$$US-TOLMAR, INC.-24US050374$TOLMAR$$$$A$F$Y$$$20240716$$HP$US$US
240950191$24095019$1$I$$20240620$20240716$20240716$PER$$US-TOLMAR, INC.-24US050376$TOLMAR$$$$$F$Y$$$20240716$$HP$US$US
240950201$24095020$1$I$20240629$20240703$20240716$20240716$EXP$$IT-CIPLA LTD.-2024IT07219$CIPLA$$$$$$Y$$$20240716$$MD$IT$IT
240950211$24095021$1$I$$20240620$20240716$20240716$PER$$US-TOLMAR, INC.-24US050377$TOLMAR$$$$A$F$Y$$$20240716$$HP$US$US
240950221$24095022$1$I$$20240702$20240716$20240716$EXP$$US-ABBVIE-5834269$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240950231$24095023$1$I$20240607$20240708$20240716$20240716$EXP$FR-AFSSAPS-BX2024001275$FR-TEVA-VS-3218708$TEVA$$75$YR$$F$Y$74.5$KG$20240716$$PH$FR$FR
240950241$24095024$1$I$$20240708$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108751$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240716$$HP$US$US
240950251$24095025$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111959$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240716$$CN$US$US
240950261$24095026$1$I$$20240708$20240716$20240716$EXP$$FR-CELLTRION INC.-2024FR016552$CELLTRION$Farkh C, Debus J, Andrieu V, Gay J. Massive circulating metastatic cells: A case of carcinocythemia. Clinical Case Reports. 2024;12(2):1-2$$$$$Y$$$20240716$$HP$FR$FR
240950271$24095027$1$I$$20240712$20240716$20240716$PER$$US-HALEON-2187048$Haleon PLC$$$$$$Y$$$20240716$$CN$US$US
240950281$24095028$1$I$$20240708$20240716$20240716$EXP$$CN-AMGEN-CHNSP2024137832$AMGEN$Wenrong H.; Yi M.; Xiubin X. et al.. Analysis of the efficacy and safety of bone disease treatment in patients with newly diagnosed multiple myeloma treated with denosumab or zoledronic acid. Zhonghua xueyexue zazhi. 2024;45 (4):345-350$$$$$Y$$$20240716$$HP$CN$CN
240950291$24095029$1$I$20240101$20240711$20240716$20240716$EXP$$CA-JNJFOC-20240728516$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240716$$HP$CA$CA
240950301$24095030$1$I$$20240710$20240716$20240716$EXP$$CA-APOTEX-2024AP008230$APOTEX$$85$YR$$M$Y$105$KG$20240716$$HP$CA$CA
240950312$24095031$2$F$20240620$20240731$20240716$20240808$30DAY$$US-JNJFOC-20240664367$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240808$$CN$US$US
240950322$24095032$2$F$20240713$20240716$20240716$20240718$PER$$US-AMGEN-USASP2024140434$AMGEN$$75$YR$E$F$Y$$$20240718$$CN$US$US
240950331$24095033$1$I$$20240715$20240716$20240716$PER$$US-AMGEN-USASP2024140476$AMGEN$$$$$F$Y$$$20240716$$CN$US$US
240950341$24095034$1$I$$20240708$20240716$20240716$EXP$$US-AMGEN-USASP2024135650$AMGEN$$$$$$Y$$$20240716$$CN$US$US
240950353$24095035$3$F$$20240903$20240716$20240911$PER$$US-APOTEX-2024AP008041$APOTEX$$$$$M$Y$$$20240911$$CN$US$US
240950361$24095036$1$I$$20240708$20240716$20240716$EXP$$CA-CELLTRION INC.-2023CA010767$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
240950381$24095038$1$I$20240702$20240710$20240716$20240716$EXP$GB-MHRA-MED-202407101114394590-WQBHF$GB-ROCHE-10000023352$ROCHE$$79$YR$E$M$Y$$$20240716$$HP$GB$GB
240950392$24095039$2$F$20220906$20240822$20240716$20240825$EXP$JP-intagehealthcare-A3270S021701$JP-TAKEDA-2022TUS051077$TAKEDA$$6$YR$$M$Y$19$KG$20240825$$MD$JP$JP
240950401$24095040$1$I$20240101$20240711$20240716$20240716$EXP$$US-ABBVIE-5837752$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240950412$24095041$2$F$20240628$20240726$20240716$20240802$EXP$$JP-SA-2024SA198592$SANOFI AVENTIS$$4$MON$I$M$Y$$$20240802$$MD$JP$JP
240950421$24095042$1$I$20240710$20240711$20240716$20240716$PER$$US-UNITED THERAPEUTICS-UNT-2024-021530$UNITED THERAPEUTICS$$68$YR$$M$Y$74.83$KG$20240716$$$US$US
240950431$24095043$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405011114534980-QJWKT$GB-TEVA-VS-3217772$TEVA$$$$$F$Y$89$KG$20240716$$CN$GB$GB
240950441$24095044$1$I$20240626$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111414$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240716$$CN$US$US
240950451$24095045$1$I$$20240712$20240716$20240716$EXP$$US-BAUSCH-BL-2024-005577$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240716$$CN$US$US
240950461$24095046$1$I$20240507$20240708$20240716$20240716$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02537$AMNEAL$$55$YR$$M$Y$$$20240716$$MD$US$US
240950471$24095047$1$I$$20240715$20240715$20240715$DIR$710313$$FDA-CTU$$$$$M$N$$$20240715$N$PH$US$
240950481$24095048$1$I$20240302$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405072058043420-FPMZN$GB-SA-2024SA200045$SANOFI AVENTIS$$70$YR$E$M$Y$122$KG$20240716$$CN$GB$GB
240950492$24095049$2$F$20240619$20240716$20240716$20240722$EXP$$CA-ROCHE-10000017950$ROCHE$$67$YR$E$F$Y$$$20240722$$CN$CA$CA
240950501$24095050$1$I$$20240708$20240716$20240716$PER$$US-ROCHE-10000020677$ROCHE$$$$$F$Y$$$20240716$$CN$US$US
240950514$24095051$4$F$$20240919$20240716$20240927$EXP$$JP-UCBSA-2024034620$UCB$$56$YR$$F$Y$$$20240927$$CN$JP$JP
240950521$24095052$1$I$20240621$20240705$20240716$20240716$EXP$$US-SA-2024SA202254$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240716$$MD$US$US
240950531$24095053$1$I$$20240711$20240716$20240716$EXP$$CA-TAKEDA-2024TUS071410$TAKEDA$$$$$F$Y$$$20240716$$CN$CA$CA
240950545$24095054$5$F$$20240926$20240716$20240930$EXP$$CA-ROCHE-RCA4963853$ROCHE$$$$A$F$Y$$$20240930$$CN$CA$CA
240950551$24095055$1$I$$20240713$20240716$20240716$PER$$NVSC2024US145621$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
240950562$24095056$2$F$$20240918$20240716$20240919$EXP$$NVSC2024RU145732$NOVARTIS$$$$$F$Y$$$20240919$$MD$RU$RU
240950571$24095057$1$I$20240511$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405111859298430-VKGCT$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-06415$HIKMA$$3$YR$$F$Y$17$KG$20240716$$MD$GB$GB
240950581$24095058$1$I$$20240715$20240716$20240716$EXP$$US-BAUSCH-BL-2024-010806$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240716$$CN$US$US
240950591$24095059$1$I$20230401$20240709$20240716$20240716$EXP$$US-CHIESI-2024CHF04155$CHIESI$$80$YR$$M$Y$64.86$KG$20240716$$CN$US$US
240950601$24095060$1$I$$20240711$20240716$20240716$PER$$US-ROCHE-10000025693$ROCHE$$$$$$Y$$$20240716$$MD$US$US
240950611$24095061$1$I$$20240711$20240716$20240716$PER$$US-ROCHE-10000025691$ROCHE$$$$$$Y$$$20240716$$MD$US$US
240950621$24095062$1$I$$20240711$20240716$20240716$PER$$US-ROCHE-10000025688$ROCHE$$$$$$Y$$$20240716$$MD$US$US
240950631$24095063$1$I$20190801$20240711$20240716$20240716$PER$$US-ROCHE-10000024788$ROCHE$$37$YR$A$F$Y$90.72$KG$20240716$$CN$US$US
240950641$24095064$1$I$20240710$20240710$20240716$20240716$PER$$US-ABBVIE-5839094$ABBVIE$$61$YR$$F$Y$$$20240716$$CN$US$US
240950651$24095065$1$I$$20240711$20240716$20240716$PER$$US-ROCHE-10000025496$ROCHE$$$$$$Y$$$20240716$$MD$US$US
240950661$24095066$1$I$$20240711$20240716$20240716$PER$$US-ROCHE-10000025700$ROCHE$$$$$$Y$$$20240716$$MD$US$US
240950671$24095067$1$I$$20240711$20240716$20240716$PER$$US-ROCHE-10000025498$ROCHE$$$$$$Y$$$20240716$$MD$US$US
240950681$24095068$1$I$$20240710$20240716$20240716$EXP$$JP-TAKEDA-2024TJP010468$TAKEDA$$$$A$$Y$$$20240716$$MD$JP$JP
240950691$24095069$1$I$$20240707$20240716$20240716$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008669$STRIDES$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E.. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM.. Int-J-Molecular-Sci. 2023;24 (17)$10$YR$$F$Y$$$20240716$$HP$ES$ES
240950701$24095070$1$I$$20240708$20240716$20240716$EXP$$US-SA-2024SA204755$SANOFI AVENTIS$$70$YR$E$M$Y$74.84$KG$20240716$$MD$US$US
240950711$24095071$1$I$$20240708$20240716$20240716$EXP$$CA-BAXTER-2024BAX021328$BAXTER$$$$$$Y$$$20240716$$CN$CA$CA
240950721$24095072$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5839525$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240950731$24095073$1$I$$20240708$20240716$20240716$EXP$FR-AFSSAPS-PB2024000734$FR-BAXTER-2024BAX021320$BAXTER$$41$YR$$F$Y$$$20240716$$MD$FR$FR
240950742$24095074$2$F$20240101$20240730$20240716$20240806$EXP$$US-SA-2024SA205600$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240806$$CN$US$US
240950752$24095075$2$F$20240518$20240716$20240716$20240720$EXP$$DE-SANDOZ INC.-SDZ2024DE065073$SANDOZ$$69$YR$$F$Y$42$KG$20240720$$MD$DE$DE
240950761$24095076$1$I$$20240708$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2017-08036$AUROBINDO$DE DEYNE S,  DE LA GASTINE B,  GRAS G,  DARGERE S,  VERDON R.  COQUEREL A.. [ACUTE RENAL FAILURE WITH ACYCLOVIR IN A 42-YEAR-OLD PATIENT WITHOUT PREVIOUS RENAL DYSFUNCTION].. [FRENCH] LA REVUE DE MEDECINE INTERNE.. 2006;27(11):892-4$42$YR$$M$Y$70$KG$20240716$$HP$FR$FR
240950773$24095077$3$F$20240101$20240823$20240716$20240831$EXP$$CA-CELLTRION INC.-2024CA011716$CELLTRION$$$$$$Y$$$20240831$$HP$CA$CA
240950781$24095078$1$I$20240601$20240711$20240716$20240716$EXP$$CA-ABBVIE-5838562$ABBVIE$$61$YR$$F$Y$$$20240716$$CN$CA$CA
240950791$24095079$1$I$$20240708$20240716$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009929$JAZZ$$$$$F$Y$$$20240716$$HP$US$US
240950802$24095080$2$F$20240713$20240716$20240716$20240717$PER$$US-AMGEN-USASP2024140433$AMGEN$$78$YR$E$F$Y$$$20240717$$CN$US$US
240950811$24095081$1$I$$20240711$20240716$20240716$PER$$US-ROCHE-10000025674$ROCHE$$$$$$Y$$$20240716$$MD$US$US
240950831$24095083$1$I$$20240711$20240716$20240716$PER$$NVSC2024US145635$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
240950842$24095084$2$F$20240610$20240808$20240716$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024085068$VIIV$$46$YR$$M$Y$$$20240816$$HP$US$US
240950851$24095085$1$I$20240617$20240709$20240716$20240716$EXP$$US-GSK-US2024085134$GLAXOSMITHKLINE$$90$YR$$F$Y$$$20240716$$CN$US$US
240950862$24095086$2$F$$20240730$20240716$20240802$PER$$US-AMGEN-USASP2024137846$AMGEN$$$$$$Y$$$20240802$$CN$US$US
240950871$24095087$1$I$20240511$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405130952401190-ZKJHG$GB-AMAROX PHARMA-AMR2024GB02174$HETERO$$31$YR$$F$Y$$$20240716$$MD$GB$GB
240950882$24095088$2$F$20240630$20240718$20240716$20240801$PER$$US-AMGEN-USASP2024139063$AMGEN$$41$YR$A$F$Y$$$20240801$$CN$US$US
240950891$24095089$1$I$20240710$20240715$20240716$20240716$PER$$US-AMGEN-USASP2024140181$AMGEN$$62$YR$A$F$Y$$$20240716$$HP$US$US
240950902$24095090$2$F$20240710$20240711$20240716$20240806$PER$$US-AMGEN-USASP2024138262$AMGEN$$69$YR$E$F$Y$$$20240806$$CN$US$US
240950911$24095091$1$I$$20240702$20240716$20240716$EXP$$SA-DEXPHARM-2024-2363$DEXCEL$Kashif, S.; Al-Mani, S. Y.; Almani, N. Y.  A Rare Psoriasis Drug Eruption Induced by Levetiracetam: A Case Study from Saudi Arabia. International Journal of Pharmacology 2024, V20, P704-708$40$YR$A$F$Y$$$20240716$$HP$SA$SA
240950922$24095092$2$F$20240628$20240731$20240716$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105024$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240801$$PH$US$US
240950931$24095093$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111947$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240716$$CN$US$US
240950941$24095094$1$I$20240418$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405071703163580-SFGKJ$GB-JUBILANT PHARMA LTD-2024GB000937$JUBILANT$$$$A$M$Y$$$20240716$$HP$GB$GB
240950951$24095095$1$I$$20240708$20240716$20240716$EXP$$JP-TEYRO-2024-TY-000314$Teyro Labs$Onishi M, Furuta M, Yoshioka E, Yamada T, Hama T, Furusawa K, et al..Complete response induced by nivolumab monotherapy in gastric neuroendocrine carcinoma: a case report..Int Cancer Conf J.2024;13(3):319-324$8$DEC$E$F$Y$$$20240716$$HP$JP$JP
240950961$24095096$1$I$20240627$20240711$20240716$20240716$EXP$$US-ABBVIE-5838253$ABBVIE$$79$YR$$F$Y$$$20240716$$CN$US$US
240950971$24095097$1$I$$20240605$20240716$20240716$EXP$$IT-AUROBINDO-AUR-APL-2022-026944$AUROBINDO$Salvati A, Biagioni T, Ferrari AR, Lopergolo D, Brovedani P, Bartolini E.. Different epilepsy course of a novel AHDC1 mutation in a female monozygotic twin pair. Seizure-European journal of epilepsy. 2022;99:127-130$7$YR$$F$Y$$$20240716$$HP$IT$IT
240950981$24095098$1$I$20240528$20240708$20240716$20240716$EXP$$CN-ROCHE-10000020353$ROCHE$$64$YR$A$F$Y$$$20240716$$HP$CN$CN
240950991$24095099$1$I$20240707$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159043$ASTRAZENECA$$28959$DY$$F$Y$$$20240716$$CN$US$
240951001$24095100$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A157514$ASTRAZENECA$$39$YR$$M$Y$$$20240716$$CN$US$
240951011$24095101$1$I$20191101$20200217$20240716$20240716$EXP$$US-AstraZeneca-2020SE25882$ASTRAZENECA$$637$MON$$F$Y$$$20240716$$CN$US$
240951022$24095102$2$F$20240601$20240723$20240716$20240729$EXP$$AT-SA-2024SA205694$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240729$$MD$AT$AT
240951031$24095103$1$I$$20191113$20240716$20240716$EXP$$US-AstraZeneca-2019SF63460$ASTRAZENECA$$$$$M$Y$$$20240716$$MD$US$
240951041$24095104$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A156442$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240951051$24095105$1$I$$20200811$20240716$20240716$EXP$$GB-AstraZeneca-2020SF03219$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$GB$
240951061$24095106$1$I$20240705$20240711$20240716$20240716$EXP$$CA-ABBVIE-5838840$ABBVIE$$51$YR$$$Y$$$20240716$$CN$CA$CA
240951071$24095107$1$I$20190824$20190903$20240716$20240716$EXP$$US-AstraZeneca-2019SF26462$ASTRAZENECA$$$$$F$Y$$$20240716$$HP$US$
240951081$24095108$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024138417$AMGEN$$$$$F$Y$$$20240716$$MD$US$US
240951091$24095109$1$I$$20200303$20240716$20240716$EXP$$US-AstraZeneca-2020SE33380$ASTRAZENECA$$$$$M$Y$$$20240716$$MD$US$
240951101$24095110$1$I$$20210322$20240716$20240716$EXP$$US-AstraZeneca-2021A205403$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240951111$24095111$1$I$20200829$20231124$20240716$20240716$EXP$$JP-AstraZeneca-2021A294548$ASTRAZENECA$$44$YR$$M$Y$62$KG$20240716$$MD$JP$
240951121$24095112$1$I$20240101$20240711$20240716$20240716$EXP$$CA-ABBVIE-5838491$ABBVIE$$52$YR$$M$Y$$$20240716$$MD$CA$CA
240951131$24095113$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A156397$ASTRAZENECA$$$$$$Y$$$20240716$$MD$US$
240951141$24095114$1$I$$20240709$20240716$20240716$EXP$$CA-TAKEDA-2024TUS070664$TAKEDA$$48$YR$$F$Y$$$20240716$$HP$CA$CA
240951151$24095115$1$I$$20230512$20240716$20240716$EXP$$IT-AstraZeneca-2023A143687$ASTRAZENECA$$$$$$Y$$$20240716$$MD$IT$
240951181$24095118$1$I$20240701$20240711$20240716$20240716$EXP$$US-SA-2024SA205603$SANOFI AVENTIS$$$$$M$Y$$$20240716$$MD$US$US
240951191$24095119$1$I$20240101$20240711$20240716$20240716$EXP$$US-SA-2024SA166309$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240716$$CN$US$US
240951201$24095120$1$I$20240401$20240711$20240716$20240716$EXP$FR-AFSSAPS-RN2024000748$FR-LEO Pharma-371899$LEO PHARM$$37$YR$$F$Y$$$20240716$$MD$FR$FR
240951212$24095121$2$F$20240606$20240704$20240716$20240718$EXP$$AU-BEH-2024175352$CSL BEHRING$$57$YR$A$$Y$$$20240718$$MD$AU$AU
240951221$24095122$1$I$$20240712$20240716$20240716$EXP$$US-ROCHE-10000027264$ROCHE$$59$YR$A$M$Y$125.19$KG$20240716$$MD$US$US
240951231$24095123$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-10000025963$ROCHE$$$$A$M$Y$$$20240716$$CN$US$US
240951241$24095124$1$I$20230615$20240708$20240716$20240716$EXP$FR-AFSSAPS-PP2024000715$FR-TEVA-VS-3219074$TEVA$$96$YR$$M$Y$62$KG$20240716$$PH$FR$FR
240951251$24095125$1$I$$20240715$20240716$20240716$PER$$US-ROCHE-10000027424$ROCHE$$$$$$Y$$$20240716$$HP$US$US
240951261$24095126$1$I$20240624$20240701$20240716$20240716$PER$$US-RDY-SPO/USA/24/0009708$DR REDDYS$$28$YR$A$F$Y$$$20240716$$MD$US$US
240951271$24095127$1$I$$20240625$20240716$20240716$PER$$US-RDY-SPO/USA/24/0009411$DR REDDYS$$17$YR$T$$Y$$$20240716$$MD$US$US
240951282$24095128$2$F$20240710$20240731$20240716$20240805$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-13998$IPSEN$$79$YR$E$M$Y$$$20240805$$HP$GB$GB
240951291$24095129$1$I$$20240705$20240716$20240716$EXP$DE-MLMSERVICE-20190917-1957477-1$DE-RDY-GER/GER/19/0114618$DR REDDYS$Mizera L, Klingel K, Gawaz M, Greulich S. Fatigue, breathlessness and chest pain in a 31-year-old man with schizoaffective disorder. Der Internist. 2019. DOI:10.1007/s00108-019-00674-2.$31$YR$A$M$Y$110$KG$20240716$$MD$DE$DE
240951301$24095130$1$I$$20240711$20240716$20240716$EXP$$CA-ABBVIE-5838502$ABBVIE$$87$YR$$M$Y$$$20240716$$MD$CA$CA
240951311$24095131$1$I$$20240715$20240716$20240716$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039979$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$77.11$KG$20240716$$CN$CA$CA
240951321$24095132$1$I$$20240703$20240716$20240716$EXP$$BE-SPC-000457$SOLARIS PHARMA$Feenstra E, Van Roest A, Boes J, Spiritus T, Kenis S, Duval ELIM, et al. A Pediatric Case of Fusobacterium necrophorum Mastoiditis and Meningitis Case Report in a Healthy Child and Review of the Literature. Case Rep Pediatr. 2024 Jun 12;2024:6365796. doi: 10.1155/2024/6365796.$3$YR$C$F$Y$$$20240716$$HP$BE$BE
240951331$24095133$1$I$$20240708$20240716$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-039113$JAZZ$$$$$M$Y$$$20240716$$CN$US$US
240951342$24095134$2$F$20240703$20240815$20240716$20240820$EXP$$PK-ROCHE-10000022598$ROCHE$$79$YR$E$M$Y$$$20240820$$MD$PK$PK
240951353$24095135$3$F$20240701$20240829$20240716$20240909$EXP$$US-INSMED, INC.-2024-01893-US$INSMED$$75$YR$$F$Y$$$20240909$$CN$US$US
240951371$24095137$1$I$20200107$20200427$20240716$20240716$EXP$$IT-AstraZeneca-2020SE56119$ASTRAZENECA$$72$YR$$F$Y$$$20240716$$MD$IT$
240951381$24095138$1$I$$20190905$20240716$20240716$EXP$$US-AstraZeneca-2019SF28309$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240951391$24095139$1$I$20240214$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A156251$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240951401$24095140$1$I$$20200506$20240716$20240716$EXP$$US-AstraZeneca-2020SE62050$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240951411$24095141$1$I$$20240708$20240716$20240716$EXP$$ZA-AstraZeneca-2024A157020$ASTRAZENECA$$75$YR$$F$Y$$$20240716$$CN$ZA$
240951421$24095142$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A156259$ASTRAZENECA$$$$$$Y$$$20240716$$CN$US$
240951431$24095143$1$I$$20190905$20240716$20240716$EXP$$US-AstraZeneca-2019SF28432$ASTRAZENECA$$67$YR$$F$Y$$$20240716$$CN$US$
240951441$24095144$1$I$$20191216$20240716$20240716$EXP$$US-AstraZeneca-2019SF85348$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240951451$24095145$1$I$$20190710$20240716$20240716$EXP$$US-AstraZeneca-2019SF01086$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240951461$24095146$1$I$$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112141$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240716$$CN$US$US
240951472$24095147$2$F$20240628$20240910$20240716$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111802$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240916$$HP$US$US
240951482$24095148$2$F$$20240729$20240716$20240805$EXP$$GB-TEVA-VS-3220178$TEVA$Abada M. Conversion disorder after general anaesthesia for cystoscopy: A case report. Saudi-J-Anaesth 2024; 18 (3): 445-446.; Abada M. Conversion disorder after general anaesthesia for cystoscopy: A case report. Saudi-J-Anaesth 2024; 18 (3): 445-446.$62$YR$$F$Y$$$20240805$$HP$GB$GB
240951491$24095149$1$I$$20240712$20240716$20240716$PER$$US-TAKEDA-2024TUS071353$TAKEDA$$$$$F$Y$$$20240716$$MD$US$US
240951511$24095151$1$I$$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111756$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$68.04$KG$20240716$$CN$US$US
240951521$24095152$1$I$$20240711$20240716$20240716$EXP$$US-ABBVIE-5838558$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240951531$24095153$1$I$$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111456$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240716$$CN$US$US
240951541$24095154$1$I$$20240711$20240716$20240716$EXP$$US-ABBVIE-5840398$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240951551$24095155$1$I$20240603$20240705$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-033362$AUROBINDO$$66$YR$$M$Y$81$KG$20240716$$MD$FR$FR
240951571$24095157$1$I$$20240711$20240716$20240716$PER$$US-ABBVIE-5836962$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240951581$24095158$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405030841217640-RCGSB$GB-TEVA-VS-3217775$TEVA$$$$$F$Y$$$20240716$$HP$GB$GB
240951591$24095159$1$I$20240628$20240711$20240716$20240716$EXP$$TW-JNJFOC-20240733208$JOHNSON AND JOHNSON$$57$YR$A$F$Y$70$KG$20240716$$CN$TW$TW
240951601$24095160$1$I$$20240710$20240716$20240716$PER$$US-JNJFOC-20240731580$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$HP$US$US
240951612$24095161$2$F$$20240725$20240716$20240731$EXP$$JP-JNJFOC-20240740702$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240731$$PH$JP$JP
240951621$24095162$1$I$$20240708$20240716$20240716$EXP$$US-APOTEX-2024AP008177$APOTEX$Young KZ, Guan LL, Friedman BJ, Rambhatla PV.. Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil. International Journal of Women^s Dermatology. 2022;8 (3):e061 (1-2)$47$YR$$F$Y$$$20240716$$HP$US$US
240951641$24095164$1$I$$20240708$20240716$20240716$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR085415$VIIV$$$$$M$Y$$$20240716$$CN$US$US
240951652$24095165$2$F$$20240723$20240716$20240802$EXP$$DE-TEVA-2023-DE-2889791$TEVA$Knorr F, Schellekens KPJ, Schoot RA,Landman-Parker J, Teltschik H-M,Forster J, Riquelme A, Huitema ADR,van Eijkelenburg NKA, Beishuizen A, Zwaan CM,Woessmann W, van der Lugt J. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica 108: 1442-1446, No. 5, May 2023; Knorr F, Schellekens K, Schoot R, Landman-Parker J, Teltschik H, Forster J, et al. COMBINATION TREATMENT WITH VINBLASTINE AND CRIZOTINIB IN...$17$YR$$M$Y$$$20240802$$HP$DE$DE
240951661$24095166$1$I$20240710$20240710$20240716$20240716$EXP$$CA-Orion Corporation ORION PHARMA-24_00030777$ORION$$62$YR$A$M$Y$$$20240716$$HP$CA$
240951701$24095170$1$I$$20240702$20240716$20240716$EXP$$US-MYLANLABS-2024M1063750$MYLAN$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am-J-Transplant 2011; 11 (3): 500-510.$63$YR$$M$Y$$$20240716$$HP$US$US
240951711$24095171$1$I$$20240704$20240716$20240716$EXP$$US-MYLANLABS-2024M1064499$MYLAN$Zardoost P, Buckman Z, Weaver J, Elston S, Prouty A, Stuart R, et al. Continuous renal replacement therapy for lithium toxicity: A worthy treatment to avoid intradialytic hypotension and vasopressors. Clin-Case-Rep 2024; 12 (4).$54$YR$$F$Y$$$20240716$$HP$US$US
240951731$24095173$1$I$20240607$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112201$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240716$$CN$US$US
240951741$24095174$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112210$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240716$$HP$US$US
240951751$24095175$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111955$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240716$$CN$US$US
240951762$24095176$2$F$20240630$20240819$20240716$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110889$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240828$$HP$US$US
240951772$24095177$2$F$20240201$20240806$20240716$20240806$EXP$$TW-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039946$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$44.4$KG$20240806$$MD$TW$TW
240951781$24095178$1$I$20240519$20240701$20240716$20240716$PER$$US-ROCHE-3573468$ROCHE$$24$YR$A$M$Y$95.34$KG$20240716$$CN$US$US
240951801$24095180$1$I$$20240715$20240716$20240716$PER$$US-AMGEN-USASP2024140432$AMGEN$$70$YR$E$M$Y$$$20240716$$PH$US$US
240951822$24095182$2$F$$20240725$20240716$20240726$PER$$US-ABBVIE-5840653$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
240951831$24095183$1$I$20240704$20240710$20240716$20240716$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13945$IPSEN$$82$YR$E$M$Y$100.24$KG$20240716$$CN$US$US
240951842$24095184$2$F$20240313$20240803$20240716$20240809$EXP$$US-AMAROX PHARMA-HET2024US02236$HETERO$$71$YR$$M$Y$$$20240809$$HP$US$US
240951851$24095185$1$I$$20240701$20240716$20240716$EXP$$GB-LUPIN HEALTHCARE (UK) LIMITED-2024-06040$LUPIN$Umakanthan T,. The impact of stigma on forensic psychiatric patients - A case report. British Journal of Psychiatry Open. 2022;8:S125-S126$60$YR$$M$Y$$$20240716$$MD$GB$GB
240951862$24095186$2$F$20240711$20240717$20240716$20240720$PER$$US-JNJFOC-20240730807$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240719$$CN$US$US
240951872$24095187$2$F$$20240716$20240716$20240722$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-097944$REGENERON$$$$$M$Y$$$20240722$$CN$CA$CA
240951881$24095188$1$I$$20240715$20240716$20240716$EXP$$TR-UCBSA-2024035775$UCB$Erturk Cetin O, Algedik P, Akyuz G, Surmeli R, Zanapal?oglu U, Alev Saltak G et al. Minor/Major Congenital Malformations and Neurodevelopmental Outcomes in Children Prenatally Exposed to Levetiracetam, Lamotrigine, and Carbamazepine Monotherapy. Clinical neuropharmacology. 2024;1-6$$$A$F$Y$$$20240716$$MD$TR$TR
240951902$24095190$2$F$$20240802$20240716$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010572$JAZZ$$38$YR$$M$Y$$$20240808$$CN$US$US
240951911$24095191$1$I$$20240711$20240716$20240716$EXP$$US-TAKEDA-2024TUS071143$TAKEDA$$$$$M$Y$$$20240716$$CN$US$US
240951921$24095192$1$I$20240501$20240710$20240716$20240716$EXP$$IE-ROCHE-10000025930$ROCHE$$$$$F$Y$$$20240716$$CN$IE$IE
240951933$24095193$3$F$$20240903$20240716$20240909$EXP$$CA-TAKEDA-2024TUS038055$TAKEDA$$$$$F$Y$$$20240909$$MD$CA$CA
240951941$24095194$1$I$20240426$20240709$20240716$20240716$EXP$$EG-Ipsen Biopharmaceuticals, Inc.-2024-14025$IPSEN$$47$YR$A$F$Y$48$KG$20240716$$MD$EG$EG
240951951$24095195$1$I$20240601$20240703$20240716$20240716$EXP$$FR-CIPLA LTD.-2024FR07241$CIPLA$$$$$$Y$$$20240716$$PH$FR$FR
240951962$24095196$2$F$20240712$20240717$20240716$20240723$PER$$US-AMGEN-USASP2024140495$AMGEN$$76$YR$E$F$Y$$$20240723$$CN$US$US
240951971$24095197$1$I$20230201$20240705$20240716$20240716$EXP$$DE-EXELIXIS-CABO-24079413$EXELIXIS$$72$YR$$F$Y$$$20240716$$MD$DE$DE
240951981$24095198$1$I$$20240608$20240716$20240716$30DAY$$IT-SANDOZ INC.-SDZ2024IT065231$SANDOZ$$$$$$Y$$$20240716$$CN$IT$IT
240951993$24095199$3$F$20240101$20240719$20240716$20240727$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020375$UNITED THERAPEUTICS$$$$$F$Y$63.039$KG$20240727$$$US$US
240952012$24095201$2$F$20231013$20240710$20240716$20240719$EXP$$CO-EXELIXIS-CABO-23069735$EXELIXIS$$66$YR$$M$Y$62$KG$20240719$$CN$CO$CO
240952022$24095202$2$F$20240601$20240802$20240716$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010578$JAZZ$$$$A$F$Y$$$20240813$$CN$US$US
240952031$24095203$1$I$$20190716$20240716$20240716$EXP$$US-AstraZeneca-2019SE27401$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240952041$24095204$1$I$$20190918$20240716$20240716$EXP$$US-AstraZeneca-2019SF34595$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240952051$24095205$1$I$$20240709$20240716$20240716$PER$$US-ROCHE-10000023931$ROCHE$$38$YR$A$F$Y$$$20240716$$HP$US$US
240952061$24095206$1$I$$20200511$20240716$20240716$EXP$$US-AstraZeneca-2020SE63455$ASTRAZENECA$$60$YR$$F$Y$$$20240716$$CN$US$
240952072$24095207$2$F$$20240813$20240716$20240821$EXP$$CA-APOTEX-2024AP008117$APOTEX$$85$YR$$F$Y$$$20240821$$HP$CA$CA
240952081$24095208$1$I$$20240710$20240716$20240716$EXP$AT-009507513-2406AUT002724$AT-ROCHE-10000022858$ROCHE$$30$YR$A$F$Y$$$20240716$$CN$AT$AT
240952091$24095209$1$I$20230101$20240708$20240716$20240716$30DAY$$US-GSK-US2024084968$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240716$$CN$US$US
240952101$24095210$1$I$$20190816$20240716$20240716$EXP$$US-AstraZeneca-2019SE83636$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240952111$24095211$1$I$20240629$20240703$20240716$20240716$EXP$$IT-CIPLA LTD.-2024IT07233$CIPLA$$$$$$Y$$$20240716$$MD$IT$IT
240952121$24095212$1$I$$20210121$20240716$20240716$EXP$$US-AstraZeneca-2021A012114$ASTRAZENECA$$46$YR$$M$Y$$$20240716$$CN$US$
240952132$24095213$2$F$$20240708$20240716$20240816$EXP$$IT-AstraZeneca-2024A159145$ASTRAZENECA$$45$YR$$F$Y$53$KG$20240816$$MD$IT$
240952141$24095214$1$I$20240101$20240711$20240716$20240716$EXP$$SE-AstraZeneca-2024A158718$ASTRAZENECA$$53$YR$$M$Y$70$KG$20240716$$MD$SE$
240952152$24095215$2$F$$20240729$20240716$20240806$EXP$$CA-AstraZeneca-2019SE94509$ASTRAZENECA$$$$$F$Y$$$20240806$$HP$CA$
240952161$24095216$1$I$20240707$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159490$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240952171$24095217$1$I$$20200703$20240716$20240716$EXP$$IT-AstraZeneca-2020SE86251$ASTRAZENECA$$$$$F$Y$$$20240716$$MD$IT$
240952181$24095218$1$I$$20220518$20240716$20240716$EXP$$US-AstraZeneca-2021A303469$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240952191$24095219$1$I$20240624$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159243$ASTRAZENECA$$74$YR$$M$Y$$$20240716$$CN$US$
240952201$24095220$1$I$20191001$20191211$20240716$20240716$EXP$$US-AstraZeneca-2019SF64625$ASTRAZENECA$$74$YR$$F$Y$84.8$KG$20240716$$CN$US$
240952211$24095221$1$I$$20240708$20240716$20240716$EXP$$IT-AstraZeneca-2024A159139$ASTRAZENECA$$73$YR$$F$Y$72$KG$20240716$$MD$IT$
240952221$24095222$1$I$$20190718$20240716$20240716$EXP$$US-AstraZeneca-2019SF04238$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240952231$24095223$1$I$$20200703$20240716$20240716$EXP$$IT-AstraZeneca-2020SE86358$ASTRAZENECA$$$$$F$Y$$$20240716$$MD$IT$
240952241$24095224$1$I$20240615$20240708$20240716$20240716$EXP$$GB-AstraZeneca-2024A155767$ASTRAZENECA$$71$YR$$M$Y$117$KG$20240716$$MD$GB$
240952251$24095225$1$I$$20200324$20240716$20240716$EXP$$US-AstraZeneca-2020SE41671$ASTRAZENECA$$54$YR$$F$Y$$$20240716$$CN$US$
240952261$24095226$1$I$$20240703$20240716$20240716$EXP$$US-CIPLA LTD.-2024US07279$CIPLA$Al-Moussally F, Thompson BM, Masarweh OM, Shah N, Gaudi S, Restrepo J. Atorvastatin-associated eosinophilic spongiosis: A case report and a relevant literature review of dermatological manifestations. Cureus. 2024;16 (5) e61071:Na$$$$$Y$$$20240716$$MD$US$US
240952272$24095227$2$F$20240709$20240821$20240716$20240829$EXP$$US-AstraZeneca-2024A159387$ASTRAZENECA$$30344$DY$$M$Y$$$20240829$$CN$US$
240952282$24095228$2$F$20240627$20240802$20240716$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010580$JAZZ$$46$YR$$F$Y$57$KG$20240813$$CN$US$US
240952291$24095229$1$I$$20191001$20240716$20240716$EXP$$US-AstraZeneca-2019SF41122$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240952301$24095230$1$I$$20190731$20240716$20240716$EXP$$US-AstraZeneca-2019SF11238$ASTRAZENECA$$65$YR$$F$Y$$$20240716$$CN$US$
240952352$24095235$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218980$TEVA$Gualano FM, Hassoun P, Carter CL, Hanson D. Embryonal tumor with multilayered rosettes: Post-treatment maturation and implications for future therapy. Cancer-Rep 2023; 6 (5): 1-7.; Gualano FM, Hassoun P, Carter CL, Hanson D. Embryonal tumor with multilayered rosettes: Post-treatment maturation and implications for future therapy. Cancer-Rep 2023; 6 (5): 1-7.$5$MON$$F$Y$$$20240805$$HP$US$US
240952361$24095236$1$I$20240707$20240711$20240716$20240716$30DAY$$US-GSK-US2024086333$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240716$$CN$US$US
240952371$24095237$1$I$$20240708$20240716$20240716$EXP$$JP-EMD Serono-2024037914$EMD SERONO INC$$66$YR$E$F$Y$54$KG$20240716$$MD$JP$JP
240952391$24095239$1$I$$20240711$20240716$20240716$PER$$US-JNJFOC-20240730445$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240952402$24095240$2$F$$20240702$20240716$20240717$PER$$US-TEVA-VS-3218106$TEVA$$67$YR$$F$Y$72.57$KG$20240717$$CN$US$US
240952411$24095241$1$I$20240618$20240708$20240716$20240716$EXP$IT-MINISAL02-992811$IT-TEVA-VS-3218553$TEVA$$35$YR$$M$Y$$$20240716$$MD$IT$IT
240952421$24095242$1$I$$20240709$20240716$20240716$PER$$US-ABBVIE-5840483$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240952431$24095243$1$I$$20240702$20240716$20240716$EXP$$ES-DEXPHARM-2024-2358$DEXCEL$Rubio, I.; de la Puente, E. M.; Boveda, O.; Jimenez, I.; Pena, I. Green neutrophilic inclusions in patient with drug intoxication: a case report. Journal of Laboratory and Precision Medicine 2024, V9, PJan 2024. Available from$54$YR$A$F$Y$$$20240716$$HP$ES$ES
240952441$24095244$1$I$$20240708$20240716$20240716$EXP$$IT-CELLTRION INC.-2024IT016832$CELLTRION$De Tursi M, Carella C. Lapatinib in second-line treatment for metastatic breast cancer: Rapid clinical benefit and long-term response. Tumori. 2013;99 (6):E261-E263$$$$$Y$$$20240716$$HP$IT$IT
240952461$24095246$1$I$$20240704$20240716$20240716$PER$$US-JNJFOC-20240721710$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240952471$24095247$1$I$$20240709$20240716$20240716$EXP$$IN-ROCHE-10000026799$ROCHE$Vajifdar F, Badki P. Low-dose tenecteplase during cardiopulmonary resuscitation in massive pulmonary embolism. International Journal of Emergency Medicine. 2024;17:1: 82. doi:10.1186/s12245-024-00659-5.$18$YR$A$M$Y$$$20240716$$HP$IN$IN
240952482$24095248$2$F$20240715$20240816$20240716$20240823$PER$$US-AMGEN-USASP2024140496$AMGEN$$77$YR$E$F$Y$$$20240823$$CN$US$US
240952491$24095249$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139105$AMGEN$$$$$M$Y$$$20240716$$CN$US$US
240952514$24095251$4$F$20240713$20240812$20240716$20240814$PER$$US-AMGEN-USASP2024140435$AMGEN$$67$YR$E$F$Y$$$20240814$$CN$US$US
240952521$24095252$1$I$20240101$20240715$20240716$20240716$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021608$UNITED THERAPEUTICS$$$$$F$Y$$$20240716$$$US$US
240952531$24095253$1$I$$20240710$20240716$20240716$EXP$$US-ORGANON-O2407USA001102$ORGANON$$$$$F$Y$148$KG$20240716$$CN$US$US
240952541$24095254$1$I$20240709$20240709$20240716$20240716$EXP$$US-VIIV HEALTHCARE LIMITED-US2024085097$VIIV$$61$YR$$F$Y$$$20240716$$CN$US$US
240952551$24095255$1$I$$20240709$20240716$20240716$EXP$$US-SERVIER-S24008751$SERVIER$$$$$$Y$$$20240716$$CN$US$US
240952561$24095256$1$I$20240710$20240710$20240716$20240716$PER$$US-ALXN-202407USA000708US$ALEXION PHARMACEUTICALS$$34$YR$$$Y$$$20240716$$CN$US$US
240952571$24095257$1$I$$20240709$20240716$20240716$EXP$$GB-VANTIVE-2024VAN018242$Vantive US Healthcare$$$$$M$Y$$$20240716$$CN$GB$GB
240952582$24095258$2$F$$20240812$20240716$20240820$EXP$$IN-VANTIVE-2024VAN018279$Vantive US Healthcare$$60$YR$$F$Y$$$20240820$$CN$IN$IN
240952591$24095259$1$I$$20240710$20240716$20240716$EXP$$JP-TAKEDA-2024TJP010469$TAKEDA$$$$A$$Y$$$20240716$$MD$JP$JP
240952603$24095260$3$F$20240620$20240729$20240716$20240806$EXP$$BR-CELLTRION INC.-2024BR017022$CELLTRION$$$$$$Y$$$20240806$$CN$BR$BR
240952611$24095261$1$I$20240701$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139688$AMGEN$$45$YR$A$M$Y$$$20240716$$CN$US$US
240952621$24095262$1$I$$20240619$20240716$20240716$EXP$$US-UCBSA-2024021106$UCB$$$$$F$Y$$$20240716$$CN$US$US
240952631$24095263$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5838677$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240952641$24095264$1$I$20240708$20240710$20240716$20240716$EXP$$CO-VANTIVE-2024VAN018263$Vantive US Healthcare$$55$YR$$M$Y$77$KG$20240716$$HP$CO$CO
240952651$24095265$1$I$$20240703$20240716$20240716$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109516$ZYDUS PHARM$Habib A, Butt K, Ibrahim R, Shaaban A, Lee HS.. BRASH syndrome: A rare but reversible cause of sinus node dysfunction.. HeartRhythm-Case-Rep. 2024;10(6):398-401$$$$$Y$$$20240716$$MD$US$US
240952662$24095266$2$F$20240623$20240716$20240716$20240726$30DAY$$US-GSK-US2024086983$GLAXOSMITHKLINE$$32$YR$$F$Y$$$20240726$$CN$US$US
240952671$24095267$1$I$$20240701$20240716$20240716$EXP$$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109390$ZYDUS PHARM$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A et al.. B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature. Leukemia + Lymphoma. 2023;64:. Leukemia + Lymphoma. 2023;64:1701-05.$$$$$Y$$$20240716$$HP$ES$ES
240952681$24095268$1$I$20240506$20240701$20240716$20240716$EXP$ES-EMA-DD-20240628-7483181-074332$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109401$ZYDUS PHARM$$$$$$Y$$$20240716$$MD$ES$ES
240952711$24095271$1$I$20160101$20190802$20240716$20240716$EXP$$US-AstraZeneca-2019SE83758$ASTRAZENECA$$64$YR$$F$Y$56.7$KG$20240716$$MD$US$
240952721$24095272$1$I$20201029$20201030$20240716$20240716$EXP$$AU-AstraZeneca-2020SF43661$ASTRAZENECA$$10849$DY$$M$Y$$$20240716$$CN$AU$
240952731$24095273$1$I$$20240624$20240716$20240716$PER$$US-JNJFOC-20240665828$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$CN$US$US
240952741$24095274$1$I$20240501$20240705$20240716$20240716$EXP$$US-IBSA PHARMA INC.-2024IBS000307$IBSA INSTITUT BIOCHIMIQUE$$$$$$Y$$$20240716$$CN$US$US
240952751$24095275$1$I$$20191211$20240716$20240716$EXP$$US-AstraZeneca-2019SF81717$ASTRAZENECA$$$$$M$Y$$$20240716$$MD$US$
240952771$24095277$1$I$$20240708$20240716$20240716$EXP$$CA-AstraZeneca-2024A159295$ASTRAZENECA$$38$YR$$M$Y$$$20240716$$MD$CA$
240952781$24095278$1$I$20190401$20190725$20240716$20240716$EXP$$RU-AstraZeneca-2019SF08423$ASTRAZENECA$$51$YR$$M$Y$82$KG$20240716$$CN$RU$
240952791$24095279$1$I$$20200527$20240716$20240716$EXP$$US-AstraZeneca-2020SE70512$ASTRAZENECA$$37$YR$$F$Y$$$20240716$$CN$US$
240952803$24095280$3$F$20240301$20240910$20240716$20240916$EXP$$DE-AstraZeneca-2024A156013$ASTRAZENECA$$24707$DY$$F$Y$56$KG$20240916$$CN$DE$
240952811$24095281$1$I$$20200601$20240716$20240716$EXP$$US-AstraZeneca-2020SE72163$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240952821$24095282$1$I$20190723$20190807$20240716$20240716$EXP$$US-AstraZeneca-2019SF14339$ASTRAZENECA$$21007$DY$$M$Y$170.1$KG$20240716$$CN$US$
240952831$24095283$1$I$$20240709$20240716$20240716$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021132$UNITED THERAPEUTICS$$$$$F$Y$63.039$KG$20240716$$$US$US
240952842$24095284$2$F$$20240820$20240716$20240828$EXP$$US-AstraZeneca-2024A156124$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
240952851$24095285$1$I$20200427$20200603$20240716$20240716$EXP$$CO-AstraZeneca-2020SE73464$ASTRAZENECA$$20450$DY$$F$Y$$$20240716$$CN$CO$
240952871$24095287$1$I$$20200722$20240716$20240716$EXP$$GB-AstraZeneca-2020SE55580$ASTRAZENECA$$$$$M$Y$$$20240716$$HP$GB$
240952881$24095288$1$I$$20191015$20240716$20240716$EXP$$RU-AstraZeneca-2019SF47509$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$RU$
240952891$24095289$1$I$$20240712$20240716$20240716$EXP$$GB-ABBVIE-5838866$ABBVIE$$$$E$M$Y$$$20240716$$CN$GB$GB
240952901$24095290$1$I$20221229$20240708$20240716$20240716$EXP$$DE-BIOCON BIOLOGICS LIMITED-BBL2024005116$BIOCON$$$$$$Y$$$20240716$$HP$DE$DE
240952911$24095291$1$I$$20240703$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064061$MYLAN$Catucci S, Lombardi M, Massari E, Maiorano A, Meliota G, Pirolo T. Multifocal atrial tachycardia and hypertrophic cardiomyopathy in three patients with costello syndrome. Eur-Heart-J-Suppl 2024; 26 (Suppl. 2) ii48.$10$DY$$$Y$$$20240716$$HP$IT$IT
240952921$24095292$1$I$$20240707$20240716$20240716$EXP$$PL-MYLANLABS-2024M1065382$MYLAN$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain-Sci 2023; 13 (3).$27$YR$$M$Y$$$20240716$$HP$PL$PL
240952931$24095293$1$I$$20240707$20240716$20240716$EXP$$PL-MYLANLABS-2024M1065397$MYLAN$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain-Sci 2023; 13 (3).$23$YR$$M$Y$$$20240716$$HP$PL$PL
240952941$24095294$1$I$$20240705$20240716$20240716$EXP$$IN-MYLANLABS-2024M1064859$MYLAN$Vallabhaneni S, Mendonca TM, Nayak RR, Kamath G, Kamath A. Linezolid induced toxic optic neuropathy in drug resistant tuberculosis-A case series. Indian-J-Tuberc 2023; 1-5.$32$YR$$M$Y$$$20240716$$HP$IN$IN
240952951$24095295$1$I$$20240708$20240716$20240716$EXP$$-STRIDES ARCOLAB LIMITED-2024SP008508$STRIDES$Cortes M, Cho K W, Chowdhury N M, et al. Amoxicillin-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome With Acute Onset of Diffuse Rash and Acute Kidney Injury (AKI). Cureus. 2024;16(1):e51707$60$YR$$F$Y$$$20240716$$HP$COUNTRY NOT SPECIFIED$
240952971$24095297$1$I$$20240705$20240716$20240716$EXP$$US-MYLANLABS-2024M1064908$MYLAN$Moga T, Robillard K, Prabhu A, Jamot S, Bain A. HSV Esophagitis With Hematemesis and Recalcitrant Food Bolus. Am-J-Gastroenterol 2022; 117 (10): S1570 abstr. S2332.$58$YR$$F$Y$$$20240716$$MD$US$US
240952981$24095298$1$I$$20240703$20240716$20240716$EXP$$US-MYLANLABS-2024M1064083$MYLAN$Halawi H, Harris JE, Goodarzi A, Yau S, Youssef JG, Botros M, et al. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy 2024; 44 (3): 283-289.$58$YR$$M$Y$$$20240716$$HP$US$US
240952991$24095299$1$I$$20240705$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064626$MYLAN$De Marchi A, Raccis M, Sanna G, Decandia F, Navarese E, Casu G. Between scylla and charybdis: multiple left atrial thrombi despite oral anticoagulation and antiplatelet therapy in a patient candidate for left atrial appendage occlusion. Eur-Heart-J-Suppl 2024; 26 (Suppl. 2) ii150-ii151.$76$YR$$F$Y$$$20240716$$HP$IT$IT
240953001$24095300$1$I$$20240707$20240716$20240716$EXP$$PL-MYLANLABS-2024M1065380$MYLAN$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain-Sci 2023; 13 (3):.$27$YR$$M$Y$$$20240716$$HP$PL$PL
240953011$24095301$1$I$$20240705$20240716$20240716$EXP$$US-MYLANLABS-2024M1064617$MYLAN$Salar T, Al-Hosainat N, Subedi R, Hameed M, Brodsky S, Dahhan A. A case of hydralazine induced severe renal- limited ANCA vasculitis leading to ESRD in a 63-Year-Old man. Am-J-Kidney-Dis 2023; 81 (Suppl. 1) (4): S42 abstr. 142.$63$YR$$M$Y$$$20240716$$HP$US$US
240953031$24095303$1$I$$20240707$20240716$20240716$EXP$$PL-MYLANLABS-2024M1065383$MYLAN$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain-Sci 2023; 13 (3):.$38$YR$$F$Y$$$20240716$$HP$PL$PL
240953043$24095304$3$F$$20240927$20240716$20240930$PER$$NVSC2024US146195$NOVARTIS$$$$$$Y$$$20240930$$MD$US$US
240953051$24095305$1$I$$20240707$20240716$20240716$EXP$$PL-MYLANLABS-2024M1065390$MYLAN$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain-Sci 2023; 13 (3):.$38$YR$$F$Y$$$20240716$$HP$PL$PL
240953061$24095306$1$I$$20240708$20240716$20240716$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008489$STRIDES$Gondek S, Ogledzinski M, Lin W, Milejczyk K, Juengel B, Potter L, et al.. Persistence of long-term insulin independence after islet transplantation and two subsequent pregnancies.. Eur-J-Transl-Clin-Med. 2023;6 (1):9-13$$$A$F$Y$66$KG$20240716$$HP$US$US
240953071$24095307$1$I$20200502$20240706$20240716$20240716$EXP$$PL-AUROBINDO-AUR-APL-2024-034200$AUROBINDO$$63$YR$$M$Y$90$KG$20240716$$MD$PL$PL
240953081$24095308$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139623$AMGEN$$$$$$Y$$$20240716$$MD$US$US
240953091$24095309$1$I$$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024138353$AMGEN$$$$$$Y$$$20240716$$CN$US$US
240953111$24095311$1$I$$20240708$20240716$20240716$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008490$STRIDES$Gondek S, Ogledzinski M, Lin W, Milejczyk K, Juengel B, Potter L, et al.. Persistence of long-term insulin independence after islet transplantation and two subsequent pregnancies.. Eur-J-Transl-Clin-Med. 2023;6 (1):9-13$$$$$Y$$$20240716$$HP$US$US
240953121$24095312$1$I$$20240708$20240716$20240716$EXP$$HU-STRIDES ARCOLAB LIMITED-2024SP008491$STRIDES$Irsai G, Tampu-Kiss T, Dezso B, Miltenyi Z, Illes A, Mehes G.. Complications of systemic cytomegalovirus infection in therapy refracter Hodgkin^s lymphoma. [Hungarian].. Orv-Hetil. 2012;153 (19):751-755$$$$F$Y$$$20240716$$HP$HU$HU
240953141$24095314$1$I$$20240621$20240716$20240716$PER$$US-TOLMAR, INC.-24US049989$TOLMAR$$$$$$Y$$$20240716$$HP$US$US
240953151$24095315$1$I$$20240703$20240716$20240716$EXP$$ES-MSNLABS-2024MSNLIT01501$MSN LABORATORIES$Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A et al.B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation.Report of three cases and review of the literature.Leukemia and Lymphoma.2023;64(10):1701-1705$$$$$Y$$$20240716$$MD$ES$ES
240953161$24095316$1$I$20220301$20240704$20240716$20240716$EXP$$US-AMGEN-USASP2024133686$AMGEN$Bendari: A.; Abdelhafez: A.; Sham: S.. Intravascular large B-cell lymphoma (IVLBCL): subtle presentation and challenging diagnosis; a case report. Surgical and Experimental Pathology. 2024;7 (9):1-6$63$YR$A$M$Y$$$20240716$$HP$US$US
240953171$24095317$1$I$$20240619$20240716$20240716$PER$$US-TOLMAR, INC.-24US050017$TOLMAR$$$$$$Y$$$20240716$$HP$US$US
240953192$24095319$2$F$20240527$20240715$20240716$20240807$PER$$US-TOLMAR, INC.-24US049996$TOLMAR$$85$YR$$M$Y$$$20240807$$HP$US$US
240953201$24095320$1$I$$20240620$20240716$20240716$PER$$US-TOLMAR, INC.-24US050008$TOLMAR$$$$$M$Y$$$20240716$$HP$US$US
240953212$24095321$2$F$20240611$20240722$20240716$20240819$PER$$US-TOLMAR, INC.-24US050130$TOLMAR$$89$YR$$M$Y$$$20240814$$PH$US$US
240953221$24095322$1$I$$20240619$20240716$20240716$PER$$US-TOLMAR, INC.-24US050073$TOLMAR$$$$$$Y$$$20240716$$CN$US$US
240953231$24095323$1$I$$20240619$20240716$20240716$PER$$US-TOLMAR, INC.-24US050074$TOLMAR$$$$$$Y$$$20240716$$CN$US$US
240953251$24095325$1$I$20240315$20240322$20240716$20240716$PER$$US-AJANTA-2024AJA00057$AJANTA PHARMA$$73$YR$E$F$Y$155$KG$20240716$$CN$US$US
240953261$24095326$1$I$20240709$20240710$20240716$20240716$PER$$US-ALXN-202407USA000682US$ALEXION PHARMACEUTICALS$$48$YR$$F$Y$$$20240716$$CN$US$US
240953271$24095327$1$I$$20240531$20240716$20240716$PER$$US-AJANTA-2024AJA00105$AJANTA PHARMA$$$$$F$Y$$$20240716$$CN$US$US
240953284$24095328$4$F$$20240801$20240716$20240809$PER$$US-AMGEN-USASP2024140422$AMGEN$$$$$F$Y$$$20240809$$HP$US$US
240953291$24095329$1$I$20240614$20240715$20240716$20240716$PER$$US-AMGEN-USASP2024140475$AMGEN$$77$YR$E$M$Y$$$20240716$$MD$US$US
240953301$24095330$1$I$$20240705$20240716$20240716$EXP$$US-MYLANLABS-2024M1064900$MYLAN$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep 2023; 40 14-18.$$$A$F$Y$$$20240716$$MD$US$US
240953312$24095331$2$F$20240601$20240819$20240716$20240823$EXP$$NVSC2024BR145021$NOVARTIS$$34$YR$$F$Y$60$KG$20240824$$CN$BR$BR
240953321$24095332$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112415$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240716$$MD$US$US
240953332$24095333$2$F$20230427$20240730$20240716$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-033995$AUROBINDO$$88$YR$$F$Y$78$KG$20240808$$PH$FR$FR
240953341$24095334$1$I$$20240708$20240716$20240716$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008495$STRIDES$Gondek S, Ogledzinski M, Lin W, Milejczyk K, Juengel B, Potter L, et al.. Persistence of long-term insulin independence after islet transplantation and two subsequent pregnancies.. Eur-J-Transl-Clin-Med. 2023;6 (1):9-13$36$YR$$F$Y$$$20240716$$HP$US$US
240953371$24095337$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112336$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240716$$CN$US$US
240953381$24095338$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111648$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$79.38$KG$20240716$$CN$US$US
240953391$24095339$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111766$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240716$$CN$US$US
240953401$24095340$1$I$$20240713$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112123$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$108.86$KG$20240716$$CN$US$US
240953411$24095341$1$I$$20240703$20240716$20240716$PER$$US-ROCHE-10000021558$ROCHE$$$$A$F$Y$$$20240716$$CN$US$US
240953421$24095342$1$I$$20240714$20240716$20240716$PER$$US-HALEON-2187125$Haleon PLC$$$$$$Y$$$20240716$$CN$US$US
240953431$24095343$1$I$$20240627$20240716$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06474$LUPIN$$$$$$Y$$$20240716$$CN$US$US
240953442$24095344$2$F$20240710$20240814$20240716$20240819$EXP$$TW-TAKEDA-2024TUS071303$TAKEDA$$34$YR$$M$Y$$$20240819$$CN$TW$TW
240953451$24095345$1$I$$20240702$20240716$20240716$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-06223$LUPIN$$$$$F$Y$$$20240716$$CN$AU$AU
240953471$24095347$1$I$20240626$20240706$20240716$20240716$EXP$$IT-AUROBINDO-AUR-APL-2024-033823$AUROBINDO$$50$YR$$F$Y$$$20240716$$MD$IT$IT
240953481$24095348$1$I$$20240715$20240716$20240716$EXP$$NL-SANDOZ INC.-SDZ2024NL065112$SANDOZ$$49$YR$$M$Y$$$20240716$$HP$NL$NL
240953491$24095349$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48991$$FDA-CTU$$74$YR$$F$N$$$20240715$N$$US$
240953501$24095350$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48917$$FDA-CTU$$72$YR$$F$N$$$20240715$N$$US$
240953511$24095351$1$I$20240705$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48911$$FDA-CTU$$42$YR$$F$N$$$20240712$N$HP$US$
240953561$24095356$1$I$20240612$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49013$$FDA-CTU$$67$YR$$M$N$$$20240715$Y$PH$US$
240953601$24095360$1$I$$20240708$20240716$20240716$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008462$STRIDES$Escalada-Pellitero S, Garcia-Salido A, Clemente-Garulo D, Azorin-Cuadrillero D, De Lama Caro-Paton G, Lopez-Robledillo JC.. Fatal Pulmonary Veno-Occlusive Disease and Systemic Juvenile Idiopathic Arthritis: Case Report and Literature Review.. Reumatol-Clin. 2023;19 (1):53-56$6$YR$$F$Y$$$20240716$$HP$ES$ES
240953611$24095361$1$I$20231201$20240711$20240716$20240716$EXP$$US-TAKEDA-2023TUS082183$TAKEDA$$64$YR$$F$Y$167.8$KG$20240716$$HP$US$US
240953621$24095362$1$I$$20240715$20240716$20240716$PER$$US-BAYER-2024A101510$BAYER$$20$YR$A$F$Y$$$20240716$$CN$US$US
240953641$24095364$1$I$20240520$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48919$$FDA-CTU$$20$YR$$M$N$$$20240712$N$HP$US$
240953661$24095366$1$I$$20240708$20240716$20240716$EXP$CA-LEO Pharma-367138$CA-LEO Pharma-367138$LEO PHARM$$$$$M$Y$$$20240712$$PH$CA$CA
240953671$24095367$1$I$$20240612$20240716$20240716$PER$$US-JNJFOC-20240717999$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240953681$24095368$1$I$$20200605$20240716$20240716$EXP$$US-AstraZeneca-2020SE74225$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240953691$24095369$1$I$20190705$20190708$20240716$20240716$EXP$$CO-AstraZeneca-2019SF01292$ASTRAZENECA$$15808$DY$$F$Y$$$20240716$$CN$CO$
240953701$24095370$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A161028$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240953711$24095371$1$I$$20200919$20240716$20240716$EXP$$US-AstraZeneca-2020SF21122$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240953722$24095372$2$F$20230301$20240715$20240716$20240724$EXP$$IT-AUROBINDO-AUR-APL-2024-033444$AUROBINDO$Carta A, Cavassa V, Puci MV, Averna R, Sotgiu G, Valeri G, et al.. Treatment of Aggressive Behavior and Agitation in an 11-Year-Old Boy with Co-Occurring Autism and ADHD: A Case Report and Literature Review on the Use of Intravenous Valproate in Emergency Psychiatry.. Journal of clinical medicine. 2024;13(12):3573$11$YR$$M$Y$$$20240724$$MD$IT$IT
240953731$24095373$1$I$$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159268$ASTRAZENECA$$$$$M$Y$$$20240716$$HP$US$
240953741$24095374$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A156194$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240953751$24095375$1$I$$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159403$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240953761$24095376$1$I$20240512$20240706$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-034026$AUROBINDO$$18$YR$$F$Y$59.5$KG$20240716$$MD$FR$FR
240953771$24095377$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A156403$ASTRAZENECA$$$$$$Y$$$20240716$$MD$US$
240953781$24095378$1$I$20200612$20200617$20240716$20240716$EXP$$US-AstraZeneca-2020SE78921$ASTRAZENECA$$17585$DY$$F$Y$$$20240716$$CN$US$
240953792$24095379$2$F$$20240812$20240716$20240820$EXP$$US-AstraZeneca-2024A156212$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
240953812$24095381$2$F$20190128$20240810$20240716$20240813$EXP$$CA-TAKEDA-2024TUS067255$TAKEDA$$33$YR$$F$Y$$$20240813$$MD$CA$CA
240953821$24095382$1$I$20240608$20240710$20240716$20240716$EXP$$CA-TAKEDA-2024TUS070925$TAKEDA$$46$YR$$F$Y$$$20240716$$MD$CA$CA
240953831$24095383$1$I$$20240604$20240716$20240716$PER$$US-TRAVERE-2024TVT00568$TRAVERE THERAPEUTICS$$61$YR$A$M$Y$$$20240716$$CN$US$US
240953841$24095384$1$I$20240624$20240710$20240716$20240716$PER$$US-ABBVIE-5838391$ABBVIE$$60$YR$$M$Y$$$20240716$$CN$US$US
240953851$24095385$1$I$20240702$20240705$20240716$20240716$EXP$$US-SA-2024SA200059$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240716$$MD$US$US
240953862$24095386$2$F$$20240715$20240716$20240718$PER$$NVSC2024US146246$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
240953871$24095387$1$I$19990101$20200504$20240716$20240716$EXP$$US-AstraZeneca-2020SE60275$ASTRAZENECA$$62$YR$$M$Y$79.4$KG$20240716$$CN$US$
240953881$24095388$1$I$20210325$20240708$20240716$20240716$EXP$$CA-TAKEDA-2021TUS018267$TAKEDA$$37$YR$$F$Y$$$20240716$$HP$CA$CA
240953891$24095389$1$I$$20240709$20240716$20240716$EXP$$-STRIDES ARCOLAB LIMITED-2024SP008507$STRIDES$Welsh LH, Bose JT, Sahhar HS.. Calcium Channel Blocker Overdose Causes Acute Respiratory Distress Syndrome and Acute Kidney Injury in a 15-Year-Old Female.. Cureus. 2023;15(8):e43806$15$YR$$F$Y$63.7$KG$20240716$$HP$COUNTRY NOT SPECIFIED$
240953901$24095390$1$I$$20240715$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039814$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240716$$CN$US$US
240953913$24095391$3$F$$20240715$20240716$20240722$PER$$US-AMGEN-USASP2024140449$AMGEN$$$$$$Y$$$20240722$$CN$US$US
240953922$24095392$2$F$20240101$20240716$20240716$20240718$PER$$US-AMGEN-USASP2024140486$AMGEN$$84$YR$E$F$Y$$$20240718$$CN$US$US
240953931$24095393$1$I$$20240715$20240716$20240716$EXP$$US-TAKEDA-2023TUS107622$TAKEDA$$$$$F$Y$94$KG$20240716$$CN$US$US
240953941$24095394$1$I$$20240708$20240716$20240716$EXP$GB-MHRA-MED-202407070010010870-LRKHD$GB-862174955-ML2024-03941$Unknown Manufacturer$$44$YR$A$F$Y$$$20240716$$CN$GB$GB
240953951$24095395$1$I$$20240703$20240716$20240716$PER$$JP-BIOCODEX2-2024000996$BIOCODEX$$$$$$Y$$$20240708$$PH$JP$JP
240953961$24095396$1$I$20240624$20240708$20240716$20240716$EXP$$GB-862174955-ML2024-03946$Unknown Manufacturer$$76$YR$E$F$Y$67$KG$20240716$$MD$GB$GB
240953971$24095397$1$I$$20240702$20240716$20240716$EXP$$US-862174955-ML2024-03874$Unknown Manufacturer$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024 May 25;316(279): 1-5. Doi: 10.1007/s00403-024-03083-0$49$YR$A$F$Y$$$20240716$$HP$US$US
240953982$24095398$2$F$$20240712$20240716$20240716$EXP$$US-GILEAD-2024-0680553$GILEAD$$40$YR$A$M$Y$$$20240716$$HP$US$US
240953991$24095399$1$I$$20240709$20240716$20240716$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008482$STRIDES$Rasheed A A, Vellanki K, Woo F, Jeehey D J.. Hyponatremia in a Patient With Vasodilatory Shock Due to Overdose of Antihypertensive Medications: A Case Report. Cureus. 2023;15(9):e45053$75$YR$$F$Y$$$20240716$$HP$US$US
240954001$24095400$1$I$$20240715$20240716$20240716$PER$$US-BAYER-2024A101629$BAYER$$$$$F$Y$$$20240716$$CN$US$US
240954012$24095401$2$F$$20240723$20240716$20240726$PER$$US-LEO Pharma-371850$LEO PHARM$$47$YR$$F$Y$$$20240726$$PH$US$US
240954022$24095402$2$F$$20240718$20240716$20240725$PER$$US-HALEON-2187066$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
240954031$24095403$1$I$$20240710$20240716$20240716$EXP$$CA-TAKEDA-2024TUS071195$TAKEDA$$$$$M$Y$$$20240716$$CN$CA$CA
240954042$24095404$2$F$$20240717$20240716$20240726$EXP$GB-MHRA-MED-202405092230026680-HLRYS$GB-TEVA-VS-3218410$TEVA$$$$$$Y$$$20240726$$MD$GB$GB
240954051$24095405$1$I$$20240711$20240716$20240716$EXP$GB-MHRA-MED-202407091039521900-GMQNV$GB-STRIDES ARCOLAB LIMITED-2024SP008500$STRIDES$$34$YR$$F$Y$$$20240716$$CN$GB$GB
240954062$24095406$2$F$$20240707$20240716$20240726$EXP$$JP-009507513-2407JPN001779J$MERCK$Koki A, Abe N, Unesoko M, Zaha H. EP-0535 A Case of Hemophagocytic Syndrome Suspected during Preoperative Pembrolizumab Treatment after Influenza Infection, Presenting Difficulty in Diagnosis. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 311$62$YR$$F$Y$$$20240726$$MD$JP$JP
240954071$24095407$1$I$$20240708$20240716$20240716$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109983$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240716$$MD$JP$JP
240954081$24095408$1$I$$20240713$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111995$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$92.08$KG$20240716$$CN$US$US
240954091$24095409$1$I$20240101$20240710$20240716$20240716$EXP$$US-ABBVIE-5836191$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240954101$24095410$1$I$$20240706$20240716$20240716$EXP$$ES-AUROBINDO-AUR-APL-2024-034242$AUROBINDO$$79$YR$$M$Y$$$20240716$$HP$ES$ES
240954112$24095411$2$F$20240614$20240802$20240716$20240807$EXP$GB-MHRA-MED-202407100125064420-GCWKP$GB-STRIDES ARCOLAB LIMITED-2024SP008470$STRIDES$$37$YR$$M$Y$72$KG$20240807$$CN$GB$GB
240954122$24095412$2$F$$20240903$20240716$20240906$EXP$$US-ABBVIE-5836900$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
240954131$24095413$1$I$20240711$20240710$20240716$20240716$PER$$US-BAYER-2024A099830$BAYER$$73$YR$E$F$Y$$$20240716$$CN$US$US
240954142$24095414$2$F$20230901$20240726$20240716$20240805$EXP$$RU-SA-2024SA203628$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240805$$CN$RU$RU
240954152$24095415$2$F$$20240717$20240716$20240724$EXP$$US-ZENPEP LLC-2024AIMT01075$AIMMUNE$$$$$$Y$$$20240724$$CN$US$US
240954161$24095416$1$I$$20240705$20240716$20240716$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-06307$HIKMA$$$$$$Y$$$20240716$$PH$CA$CA
240954171$24095417$1$I$$20240709$20240716$20240716$EXP$$FR-GSK-FR2024085148$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$PH$FR$FR
240954181$24095418$1$I$$20240709$20240716$20240716$EXP$$CA-CELLTRION INC.-2023CA009006$CELLTRION$$$$$$Y$$$20240716$$HP$CA$CA
240954191$24095419$1$I$20231001$20240701$20240716$20240716$EXP$$PK-ROCHE-10000015317$ROCHE$$31$YR$A$M$Y$$$20240716$$CN$PK$PK
240954201$24095420$1$I$$20240712$20240716$20240716$EXP$$US-TAKEDA-2016BLT003692$TAKEDA$$$$$F$Y$$$20240716$$CN$US$US
240954211$24095421$1$I$20240615$20240708$20240716$20240716$EXP$$CN-SA-2024SA204892$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240716$$HP$CN$CN
240954221$24095422$1$I$20240321$20240710$20240716$20240716$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-111383$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$116$KG$20240716$$HP$DE$DE
240954231$24095423$1$I$$20240712$20240716$20240716$PER$$NVSC2024US146204$NOVARTIS$$$$$F$Y$63$KG$20240716$$CN$US$US
240954241$24095424$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5839561$ABBVIE$$$$$$Y$$$20240716$$MD$US$US
240954251$24095425$1$I$$20240419$20240716$20240716$PER$$US-AUROBINDO-AUR-APL-2024-017631$AUROBINDO$$$$$$Y$$$20240716$$CN$US$US
240954261$24095426$1$I$$20240508$20240716$20240716$PER$$US-AUROBINDO-AUR-APL-2024-023901$AUROBINDO$$81$YR$$F$Y$62.595$KG$20240716$$CN$US$US
240954271$24095427$1$I$$20240606$20240716$20240716$PER$$US-AUROBINDO-AUR-APL-2024-021289$AUROBINDO$$68$YR$$F$Y$62.595$KG$20240716$$CN$US$US
240954281$24095428$1$I$$20240710$20240716$20240716$PER$$US-BAYER-2024A099836$BAYER$$70$YR$E$M$Y$$$20240716$$HP$US$US
240954291$24095429$1$I$$20240710$20240716$20240716$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-021314$UNITED THERAPEUTICS$$$$$$Y$$$20240716$$$CA$CA
240954301$24095430$1$I$$20240711$20240716$20240716$PER$$US-BAYER-2024A100266$BAYER$$87$YR$E$F$Y$$$20240716$$CN$US$US
240954311$24095431$1$I$$20240711$20240716$20240716$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13943$IPSEN$$$$$F$Y$$$20240716$$HP$US$US
240954321$24095432$1$I$$20240706$20240716$20240716$EXP$$PT-AUROBINDO-AUR-APL-2024-034288$AUROBINDO$Rocha DI, Novo A, Azevedo SM, Barroso D.. Sezary syndrome: a crucial cause of uncontrollable itching. PUBLICACAO ESPECIAL.. 2024;2:58-61$74$YR$$F$Y$$$20240716$$HP$PT$PT
240954331$24095433$1$I$20240710$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48902$$FDA-CTU$$90$YR$$F$N$$$20240715$N$$US$
240954341$24095434$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48924$$FDA-CTU$$70$YR$$F$N$$$20240715$N$$US$
240954351$24095435$1$I$20240622$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-49009$$FDA-CTU$$68$YR$$F$N$$$20240712$N$HP$US$
240954361$24095436$1$I$20240616$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49035$$FDA-CTU$$79$YR$$M$N$$$20240715$N$PH$US$
240954431$24095443$1$I$$20240715$20240716$20240716$PER$$US-HALEON-2187201$Haleon PLC$$$$$F$Y$$$20240716$$CN$US$US
240954441$24095444$1$I$$20240628$20240716$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05002$LUPIN$$$$$$Y$$$20240716$$CN$US$US
240954451$24095445$1$I$20240610$20240706$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-034013$AUROBINDO$$42$YR$$F$Y$62$KG$20240716$$PH$FR$FR
240954461$24095446$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112428$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240716$$CN$US$US
240954472$24095447$2$F$20240710$20240717$20240716$20240723$PER$$US-BAYER-2024A100285$BAYER$$8$YR$C$F$Y$$$20240723$$CN$US$US
240954482$24095448$2$F$20200901$20240726$20240716$20240802$EXP$$PT-009507513-2407PRT004718$MERCK$$72$YR$$M$Y$$$20240802$$MD$PT$PT
240954501$24095450$1$I$$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112245$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240716$$CN$US$US
240954511$24095451$1$I$$20240704$20240716$20240716$EXP$CA-MHPD-E2B_07081776$CA-Accord-434347$ACCORD$$55$YR$A$F$Y$$$20240716$$MD$CA$CA
240954521$24095452$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202407041136045490-HKLQD$GB-Accord-434345$ACCORD$$$$$M$Y$70$KG$20240716$$CN$GB$GB
240954531$24095453$1$I$20240614$20240704$20240716$20240716$EXP$FR-AFSSAPS-AN2024000876$FR-Accord-434133$ACCORD$$53$YR$A$M$Y$$$20240716$$PH$FR$FR
240954541$24095454$1$I$20200401$20240704$20240716$20240716$EXP$$AU-Accord-434163$ACCORD$Thorburn S, Majumdar A, Smibert O. Chronic hepatitis E masquerading as allograft rejection in a liver transplant recipient. Transplant Infectious Disease. 2024;26(3):e14303. DOI: 10.1111/tid.14303.$41$YR$A$M$Y$$$20240716$$MD$AU$AU
240954551$24095455$1$I$$20240704$20240716$20240716$EXP$$JP-Accord-434177$ACCORD$Tokuchi M, Yonishi H, Namba-Hamano T. Successful treatment of a renal allograft abscess with antimicrobial agents alone and appropriate follow-up imaging. Transplant Infectious Disease. 2024;26(3):e14278.$22$YR$A$F$Y$$$20240716$$MD$JP$JP
240954561$24095456$1$I$20240112$20240704$20240716$20240716$EXP$FR-AFSSAPS-2024057192$FR-Accord-434135$ACCORD$$78$YR$$F$Y$$$20240716$$PH$FR$FR
240954571$24095457$1$I$$20240704$20240716$20240716$EXP$CA-MHPD-E2B_07081169$CA-Accord-434364$ACCORD$$78$YR$E$M$Y$$$20240716$$MD$CA$CA
240954581$24095458$1$I$$20240706$20240716$20240716$EXP$$DE-AUROBINDO-AUR-APL-2024-033946$AUROBINDO$$$$$M$Y$$$20240716$$PH$DE$DE
240954593$24095459$3$F$20240529$20240722$20240716$20240802$EXP$$DE-Accord-434493$ACCORD$$17$YR$T$F$Y$63.9$KG$20240802$$HP$DE$DE
240954602$24095460$2$F$20240712$20240717$20240716$20240723$PER$$US-AMGEN-USASP2024139024$AMGEN$$80$YR$E$M$Y$$$20240723$$CN$US$US
240954611$24095461$1$I$$20240703$20240716$20240716$PER$$US-TEVA-VS-3217304$TEVA$$42$YR$$F$Y$$$20240716$$CN$US$US
240954621$24095462$1$I$$20240703$20240716$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06321$HIKMA$Yuen CA, Pekmezci M, Bao S, Kong X.. Yuen CA, Pekmezci M, Bao S, Kong X. Metastatic glioblastoma to the lungs: a case report and literature review.. CNS Oncology.. 2024;13(1):2351789.$$$$$Y$$$20240716$$MD$US$US
240954631$24095463$1$I$20240627$20240713$20240716$20240716$EXP$$NVSC2024US145694$NOVARTIS$$70$YR$$$Y$$$20240716$$CN$US$US
240954641$24095464$1$I$$20240715$20240716$20240716$PER$$US-TAKEDA-2024TUS071685$TAKEDA$$$$$$Y$$$20240716$$CN$US$US
240954652$24095465$2$F$$20240729$20240716$20240808$EXP$$CA-TEVA-VS-3219081$TEVA$Fabri L, Tobia A, Ludemann J, Rathgeber S, Kieran E, Nguyen T, et al. Trametinib and Lymphangiectasia in Noonan Syndrome: A Success Story. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Fabri L, Tobia A, Ludemann J, Rathgeber S, Kieran E, Nguyen T, et al. Trametinib and Lymphangiectasia in Noonan Syndrome: A Success Story. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$7$WK$$M$Y$$$20240808$$HP$CA$CA
240954662$24095466$2$F$$20240722$20240716$20240726$EXP$$JP-ASTELLAS-2024JP004940$ASTELLAS$$95$YR$$F$Y$$$20240726$$PH$JP$JP
240954674$24095467$4$F$20240713$20240904$20240716$20240905$PER$$US-AMGEN-USASP2024140421$AMGEN$$74$YR$E$M$Y$$$20240904$$CN$US$US
240954681$24095468$1$I$$20240712$20240716$20240716$PER$$US-BAYER-2024A100921$BAYER$$$$$$Y$$$20240716$$CN$US$US
240954691$24095469$1$I$20231130$20240708$20240716$20240716$EXP$IT-MINISAL02-992901$IT-TEVA-VS-3218636$TEVA$$56$YR$$F$Y$61$KG$20240716$$MD$IT$IT
240954721$24095472$1$I$20240501$20240712$20240716$20240716$PER$$US-BAYER-2024A100928$BAYER$$42$YR$A$F$Y$$$20240716$$MD$US$US
240954731$24095473$1$I$$20240712$20240716$20240716$EXP$$CA-ABBVIE-5839945$ABBVIE$$$$A$M$Y$$$20240716$$CN$CA$CA
240954741$24095474$1$I$20240101$20240711$20240716$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-012429$JAZZ$$$$$F$Y$$$20240716$$CN$US$US
240954764$24095476$4$F$20240708$20240903$20240716$20240909$EXP$$IN-ASTELLAS-2024US020147$ASTELLAS$$68$YR$E$F$Y$$$20240909$$CN$IN$IN
240954771$24095477$1$I$$20240709$20240716$20240716$PER$$US-LEO Pharma-371923$LEO PHARM$$54$YR$$M$Y$$$20240715$$PH$US$US
240954791$24095479$1$I$$20240711$20240716$20240716$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-112144$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240716$$MD$DE$DE
240954801$24095480$1$I$20240620$20240708$20240716$20240716$EXP$$AR-AstraZeneca-2024A156911$ASTRAZENECA$$15640$DY$$F$Y$$$20240716$$CN$AR$
240954811$24095481$1$I$$20200430$20240716$20240716$EXP$$US-AstraZeneca-2020SE59124$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240954821$24095482$1$I$$20190930$20240716$20240716$EXP$$US-AstraZeneca-2019SF40706$ASTRAZENECA$$26720$DY$$M$Y$$$20240716$$HP$US$
240954831$24095483$1$I$20200807$20200811$20240716$20240716$EXP$$US-AstraZeneca-2020SF02132$ASTRAZENECA$$23653$DY$$M$Y$$$20240716$$CN$US$
240954841$24095484$1$I$$20240714$20240716$20240716$PER$$US-AMGEN-USASP2024140065$AMGEN$$$$$F$Y$$$20240716$$CN$US$US
240954851$24095485$1$I$$20190822$20240716$20240716$EXP$$US-AstraZeneca-2019SF21480$ASTRAZENECA$$$$$F$Y$$$20240716$$HP$US$
240954861$24095486$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139483$AMGEN$$$$$F$Y$$$20240716$$HP$US$US
240954871$24095487$1$I$$20240703$20240716$20240716$EXP$$US-Appco Pharma LLC-2159161$APPCO PHARMA$Initial$58$YR$$F$Y$$$20240716$$$US$US
240954881$24095488$1$I$$20200619$20240716$20240716$EXP$$US-AstraZeneca-2020SE80287$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240954891$24095489$1$I$$20191129$20240716$20240716$EXP$$US-AstraZeneca-2019SF74062$ASTRAZENECA$$56$YR$$F$Y$$$20240716$$CN$US$
240954911$24095491$1$I$$20240710$20240716$20240716$EXP$$CA-TEVA-VS-3220355$TEVA$$42$YR$$M$Y$$$20240716$$HP$CA$CA
240954921$24095492$1$I$$20190820$20240716$20240716$EXP$$CO-AstraZeneca-2019SF21273$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$CO$
240954932$24095493$2$F$$20240815$20240716$20240821$30DAY$$AR-JNJFOC-20240736930$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$MD$AR$AR
240954941$24095494$1$I$$20190820$20240716$20240716$EXP$$US-AstraZeneca-2019SF21382$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240954951$24095495$1$I$20240603$20240709$20240716$20240716$EXP$$NVSC2024EG118614$NOVARTIS$$30$YR$$F$Y$83$KG$20240716$$CN$EG$EG
240954961$24095496$1$I$$20240703$20240716$20240716$EXP$$OM-Appco Pharma LLC-2159159$APPCO PHARMA$Initial$$$$M$Y$1.9$KG$20240716$$$OM$OM
240954971$24095497$1$I$$20240703$20240716$20240716$EXP$$OM-Appco Pharma LLC-2159158$APPCO PHARMA$Initial$30$YR$$F$Y$$$20240716$$$OM$OM
240954981$24095498$1$I$$20240702$20240716$20240716$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109470$ZYDUS PHARM$Salman A, Rathinam A, Muhmmad S.. Hemorrhagic Pericardial Effusion Associated With Ibrutinib: A Case Report.. Am-J-Respir-Crit-Care-Med. 2024;209:A5654$$$$$Y$$$20240716$$HP$US$US
240954991$24095499$1$I$$20240715$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039928$BOEHRINGER INGELHEIM$$$$$$Y$$$20240716$$CN$US$US
240955001$24095500$1$I$20230401$20240712$20240716$20240716$PER$$US-BAYER-2024A100966$BAYER$$45$YR$A$F$Y$$$20240716$$MD$US$US
240955011$24095501$1$I$20240629$20240709$20240716$20240716$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159148$JIANGSU HANSOH PHARMACEUTICAL$$80$YR$$M$Y$54$KG$20240716$$MD$CN$CN
240955031$24095503$1$I$$20240708$20240716$20240716$EXP$$TH-ASTELLAS-2024US019951$ASTELLAS$$17$YR$$M$Y$$$20240716$$MD$TH$TH
240955041$24095504$1$I$$20240710$20240716$20240716$EXP$$CA-TEVA-VS-3220312$TEVA$$64$YR$$M$Y$$$20240716$$HP$CA$CA
240955051$24095505$1$I$$20240705$20240716$20240716$EXP$$GB-ASTELLAS-2024EU006849$ASTELLAS$$53$YR$$M$Y$$$20240716$$HP$GB$GB
240955061$24095506$1$I$20240628$20240712$20240716$20240716$PER$$US-BAYER-2024A101205$BAYER$$32$YR$A$F$Y$$$20240716$$MD$US$US
240955081$24095508$1$I$20240627$20240708$20240716$20240716$EXP$CN-NMPACDR-1410241563502202400240$CN-BAXTER-2024BAX021433$BAXTER$$46$YR$$F$Y$59$KG$20240716$$MD$CN$CN
240955092$24095509$2$F$$20240729$20240716$20240806$EXP$$US-TEVA-VS-3218986$TEVA$Patel P, Turbin RE, Husain S, Wang S. Neurosyphilis Mimicking Connective Tissue Disease. BMJ-Case-Rep 2023; 16 (9):.; Patel P, Turbin RE, Husain S, Wang S. Neurosyphilis Mimicking Connective Tissue Disease. BMJ-Case-Rep 2023; 16 (9):.$7$DEC$$M$Y$$$20240806$$HP$US$US
240955101$24095510$1$I$20240101$20240709$20240716$20240716$EXP$$CA-ABBVIE-5837097$ABBVIE$$$$A$F$Y$$$20240716$$CN$CA$CA
240955113$24095511$3$F$20240711$20240823$20240716$20240826$PER$$US-AMGEN-USASP2024138083$AMGEN$$53$YR$A$M$Y$$$20240826$$CN$US$US
240955121$24095512$1$I$$20240703$20240716$20240716$EXP$$US-Appco Pharma LLC-2159154$APPCO PHARMA$Initial$72$YR$$F$Y$$$20240716$$$US$US
240955131$24095513$1$I$$20240701$20240716$20240716$EXP$$US-Marksans Pharma Limited-2159144$MARKSANS$Kwon D, Seu M, Barnes S. Mind the Anion Gap: 5-Oxoproline-Induced High Anion Gap Metabolic Acidosis in End-Stage Renal Disease. Cureus. 2024 May 29;16(5):e61328. doi: 10.7759/cureus.61328. PMID: 38947688.$74$YR$$F$Y$$$20240716$$$US$US
240955142$24095514$2$F$$20240809$20240716$20240816$30DAY$$FR-JNJFOC-20240736907$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$FR$FR
240955151$24095515$1$I$20240513$20240712$20240716$20240716$PER$$US-BAYER-2024A101277$BAYER$$32$YR$A$F$Y$$$20240716$$HP$US$US
240955161$24095516$1$I$$20240701$20240716$20240716$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2159138$BRECKENRIDGE$$$$$M$Y$$$20240716$$$ES$A1
240955171$24095517$1$I$$20240701$20240716$20240716$EXP$$US-Marksans Pharma Limited-2159146$MARKSANS$Radecki DT, Robieson WZ, Gopalkrishnan M, Greenberg E, Aziz M. Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7-17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies. Journal of child and adolescent psychopharmacology. 2024 Jun;34(5):241-250. doi: 10.1089/cap.2023.0080. PMID: 38700708. (LVM-MD-14 group)$$$$$Y$$$20240716$$$US$US
240955181$24095518$1$I$$20240701$20240716$20240716$EXP$$US-Marksans Pharma Limited-2159145$MARKSANS$Radecki DT, Robieson WZ, Gopalkrishnan M, Greenberg E, Aziz M. Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7-17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies. Journal of child and adolescent psychopharmacology. 2024 Jun;34(5):241-250. doi: 10.1089/cap.2023.0080. PMID: 38700708. (LVM-MD-11 group)$$$$$Y$$$20240716$$$US$US
240955191$24095519$1$I$$20240710$20240716$20240716$EXP$$NVSC2024RU144843$NOVARTIS$$$$A$F$Y$$$20240716$$MD$RU$RU
240955211$24095521$1$I$$20240701$20240716$20240716$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2159135$BRECKENRIDGE$$$$$F$Y$$$20240716$$$ES$A1
240955221$24095522$1$I$$20240703$20240716$20240716$EXP$$IT-Appco Pharma LLC-2159157$APPCO PHARMA$Initial$15$YR$$F$Y$$$20240716$$$IT$IT
240955232$24095523$2$F$20240618$20240717$20240716$20240723$EXP$$NVSC2024AU137925$NOVARTIS$$69$YR$$F$Y$$$20240723$$PH$AU$AU
240955241$24095524$1$I$20240501$20240715$20240716$20240716$EXP$FR-AFSSAPS-TO2024000863$NVSC2024FR145538$NOVARTIS$$28$YR$$F$Y$$$20240716$$PH$FR$FR
240955251$24095525$1$I$$20240708$20240716$20240716$EXP$$NVSJ2024JP008290$NOVARTIS$$84$YR$$M$Y$$$20240716$$MD$JP$JP
240955271$24095527$1$I$20240512$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48943$$FDA-CTU$$$$$$N$$$20240715$N$CN$US$
240955281$24095528$1$I$20240713$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49005$$FDA-CTU$$39$YR$$F$N$$$20240715$N$PH$US$
240955291$24095529$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48899$$FDA-CTU$$82$YR$$F$N$$$20240715$N$$US$
240955331$24095533$1$I$20240624$20240705$20240716$20240716$EXP$$NVSC2024ZA138888$NOVARTIS$$50$YR$$F$Y$$$20240716$$CN$ZA$ZA
240955342$24095534$2$F$20240101$20240809$20240716$20240816$EXP$$NL-ABBVIE-5833889$ABBVIE$$$$E$F$Y$$$20240816$$CN$NL$NL
240955351$24095535$1$I$20240619$20240715$20240716$20240716$EXP$$NVSC2024US145693$NOVARTIS$$58$YR$$F$Y$$$20240716$$CN$US$US
240955361$24095536$1$I$$20240714$20240716$20240716$EXP$$GB-MYLANLABS-2024M1066105$MYLAN$$$$$M$Y$$$20240716$$CN$GB$GB
240955371$24095537$1$I$20240605$20240704$20240716$20240716$EXP$$FR-ALSI-2024000199$AIRGAS$$19$YR$$M$Y$$$20240716$$MD$FR$FR
240955381$24095538$1$I$$20240709$20240716$20240716$EXP$$NVSC2024CA145487$NOVARTIS$$49$YR$$F$Y$96$KG$20240716$$CN$CA$CA
240955391$24095539$1$I$$20240703$20240716$20240716$EXP$$US-Appco Pharma LLC-2159162$APPCO PHARMA$Initial$24$YR$$M$Y$$$20240716$$$US$US
240955401$24095540$1$I$$20240705$20240716$20240716$PER$$US-Appco Pharma LLC-2159163$APPCO PHARMA$$$$$M$Y$$$20240716$$$US$US
240955412$24095541$2$F$20240401$20240813$20240716$20240828$EXP$$JP-ASTELLAS-2024JP002919$ASTELLAS$$8$DEC$E$M$Y$$$20240818$$MD$JP$JP
240955421$24095542$1$I$20240419$20240711$20240716$20240716$EXP$$JP-ASTELLAS-2024JP002669$ASTELLAS$$7$DEC$$M$Y$$$20240716$$MD$JP$JP
240955431$24095543$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-10000027383$ROCHE$$$$C$M$Y$$$20240716$$CN$US$US
240955441$24095544$1$I$$20240714$20240716$20240716$PER$$US-ROCHE-10000027492$ROCHE$$$$T$M$Y$$$20240716$$CN$US$US
240955451$24095545$1$I$20240201$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48900$$FDA-CTU$$21$YR$$F$N$101.6$KG$20240715$N$PH$US$
240955461$24095546$1$I$$20240624$20240716$20240716$PER$$US-Nuvo Pharmaceuticals Inc-2159164$NUVO PHARMACEUTICALS$$$$$$Y$$$20240716$$$US$US
240955471$24095547$1$I$$20240702$20240716$20240716$EXP$$US-Daito Pharmaceutical Co., Ltd.-2159140$DAITO PHARMACEUTICALS$Literature article$15$YR$$M$Y$$$20240716$$$US$US
240955482$24095548$2$F$$20240722$20240716$20240805$EXP$$IR-Appco Pharma LLC-2159160$APPCO PHARMA$FU 1$52$YR$$F$Y$$$20240805$$$IR$IR
240955491$24095549$1$I$$20240708$20240716$20240716$EXP$$CA-APOTEX-2024AP008062$APOTEX$$$$$M$Y$$$20240716$$HP$CA$CA
240955511$24095551$1$I$20240501$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48972$$FDA-CTU$$57$YR$$F$N$$$20240715$N$PH$US$
240955531$24095553$1$I$20240401$20240429$20240716$20240716$PER$$US-AJANTA-2024AJA00086$AJANTA PHARMA$$$$$$Y$$$20240716$$CN$US$US
240955551$24095555$1$I$20240629$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111768$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240716$$CN$US$US
240955561$24095556$1$I$$20240711$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111222$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$44.45$KG$20240716$$CN$US$US
240955571$24095557$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112264$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240716$$HP$US$US
240955581$24095558$1$I$$20240709$20240716$20240716$PER$$US-JNJFOC-20240724199$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$CN$US$US
240955592$24095559$2$F$20240623$20240722$20240716$20240723$EXP$IT-MINISAL02-993868$IT-GSK-IT2024086100$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$IT$IT
240955601$24095560$1$I$$20240711$20240716$20240716$30DAY$$US-GSK-US2024086601$GLAXOSMITHKLINE$$$$A$F$Y$$$20240716$$CN$US$US
240955612$24095561$2$F$$20240710$20240716$20240721$EXP$$US-GSK-US2024085873$GLAXOSMITHKLINE$$$$$F$Y$$$20240721$$MD$US$US
240955621$24095562$1$I$$20240709$20240716$20240716$EXP$$US-VIIV HEALTHCARE LIMITED-US2024085703$VIIV$$$$$F$Y$$$20240716$$CN$US$US
240955632$24095563$2$F$20240629$20240715$20240716$20240801$PER$$US-AMGEN-USASP2024139030$AMGEN$$71$YR$E$$Y$$$20240801$$CN$US$US
240955642$24095564$2$F$20240715$20240716$20240716$20240719$PER$$US-AMGEN-USASP2024140441$AMGEN$$80$YR$E$M$Y$$$20240719$$CN$US$US
240955651$24095565$1$I$20240419$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405160833067880-ZLMSD$GB-Accord-434723$ACCORD$$$$$F$Y$100$KG$20240716$$CN$GB$GB
240955661$24095566$1$I$20240607$20240704$20240716$20240716$EXP$FR-AFSSAPS-GR2024000832$FR-Accord-434696$ACCORD$$10$YR$C$M$Y$35$KG$20240716$$PH$FR$FR
240955671$24095567$1$I$20240520$20240704$20240716$20240716$EXP$CN-HENLIUS-24CN015773$CN-Accord-435914$ACCORD$$44$YR$A$F$Y$50$KG$20240716$$MD$CN$CN
240955681$24095568$1$I$$20240709$20240716$20240716$PER$$US-BAYER-2024A098811$BAYER$$20$YR$A$F$Y$$$20240716$$HP$US$US
240955691$24095569$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405071205522550-YWQRT$GB-Accord-434926$ACCORD$$$$$$Y$$$20240716$$PH$GB$GB
240955701$24095570$1$I$20230915$20240705$20240716$20240716$EXP$GB-MHRA-WEBCOVID-202405031001175710-NGDRS$GB-Accord-434691$ACCORD$$70$YR$E$$Y$83$KG$20240716$$CN$GB$GB
240955711$24095571$1$I$20240612$20240705$20240716$20240716$EXP$$US-Accord-434410$ACCORD$$37$YR$A$M$Y$$$20240716$$HP$US$US
240955721$24095572$1$I$20240101$20240710$20240716$20240716$EXP$$US-ASTELLAS-2024US019690$ASTELLAS$$49$YR$$F$Y$$$20240716$$CN$US$US
240955731$24095573$1$I$20080928$20240710$20240716$20240716$EXP$$NL-ASTELLAS-2024EU006840$ASTELLAS$$70$YR$$F$Y$$$20240716$$HP$GB$NL
240955741$24095574$1$I$20220101$20240704$20240716$20240716$EXP$FR-AFSSAPS-2024057907$FR-Accord-434698$ACCORD$$44$YR$A$F$Y$$$20240716$$PH$FR$FR
240955752$24095575$2$F$20240625$20240807$20240716$20240817$EXP$PT-INFARMED-R202406-732$PT-Accord-434874$ACCORD$$37$YR$A$M$Y$$$20240817$$PH$PT$PT
240955761$24095576$1$I$$20240617$20240716$20240716$30DAY$$US-VEROBIOTECH-2024USVEROSPO00141$VERO BIOTECH$$$$$$Y$$$20240716$$HP$US$US
240955771$24095577$1$I$$20240713$20240716$20240716$PER$$NVSC2024US145770$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240955782$24095578$2$F$$20240716$20240716$20240717$PER$$NVSC2024US146252$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
240955793$24095579$3$F$20240628$20240801$20240716$20240812$EXP$$KR-Accord-434039$ACCORD$$64$YR$A$M$Y$64.7$KG$20240812$$HP$KR$KR
240955805$24095580$5$F$20240101$20240916$20240716$20240924$EXP$$CA-CELLTRION INC.-2024CA017217$CELLTRION$$$$$$Y$$$20240924$$CN$CA$CA
240955811$24095581$1$I$$20240709$20240716$20240716$PER$$US-AstraZeneca-2024A112830$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240955821$24095582$1$I$$20240702$20240716$20240716$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-06218$LUPIN$$$$$$Y$$$20240716$$CN$AU$AU
240955831$24095583$1$I$20190101$20190816$20240716$20240716$EXP$$US-AstraZeneca-2019SF16041$ASTRAZENECA$$77$YR$$F$Y$$$20240716$$CN$US$
240955841$24095584$1$I$$20190815$20240716$20240716$EXP$$US-AstraZeneca-2019SF19249$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240955853$24095585$3$F$$20240616$20240716$20240811$EXP$$US-AstraZeneca-2020SE03073$ASTRAZENECA$$$$$F$Y$87.1$KG$20240812$$CN$US$
240955861$24095586$1$I$$20240708$20240716$20240716$EXP$$BR-AstraZeneca-2024A160031$ASTRAZENECA$$71$YR$$M$Y$$$20240716$$CN$BR$
240955871$24095587$1$I$20080202$20240710$20240716$20240716$EXP$$NL-ASTELLAS-2024EU006839$ASTELLAS$$61$YR$$F$Y$$$20240716$$HP$GB$NL
240955881$24095588$1$I$20240706$20240711$20240716$20240716$EXP$$JP-PFIZER INC-PV202400091409$PFIZER$$$$$$Y$$$20240716$$MD$JP$JP
240955892$24095589$2$F$20240501$20240811$20240716$20240817$PER$$US-JNJFOC-20240717955$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240817$$CN$US$US
240955901$24095590$1$I$20240711$20240711$20240716$20240716$EXP$$US-JNJFOC-20240735042$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240716$$HP$US$US
240955911$24095591$1$I$20240512$20240715$20240716$20240716$EXP$FR-AFSSAPS-TS2024000776$FR-SANDOZ INC.-SDZ2024FR065125$SANDOZ$$50$YR$$M$Y$89$KG$20240716$$MD$FR$FR
240955922$24095592$2$F$$20240816$20240716$20240822$30DAY$$NL-JNJFOC-20240736870$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$PH$NL$NL
240955931$24095593$1$I$20240626$20240711$20240716$20240716$EXP$$US-JNJFOC-20240731727$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240716$$HP$US$US
240955941$24095594$1$I$20100520$20240710$20240716$20240716$EXP$$TW-ASTELLAS-2024EU006846$ASTELLAS$$57$YR$$M$Y$54$KG$20240716$$HP$GB$TW
240955952$24095595$2$F$20240626$20240713$20240716$20240725$EXP$$US-Accord-434455$ACCORD$$17$YR$T$F$Y$$$20240725$$HP$US$US
240955961$24095596$1$I$20240620$20240705$20240716$20240716$EXP$CN-HENLIUS-24CN015792$CN-Accord-435917$ACCORD$$58$YR$A$F$Y$60$KG$20240716$$MD$CN$CN
240955971$24095597$1$I$20210101$20240702$20240716$20240716$EXP$$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-06298$HIKMA$$$$A$M$Y$55$KG$20240716$$MD$GB$GB
240955991$24095599$1$I$20240627$20240704$20240716$20240716$EXP$FR-AFSSAPS-BR2024000543$FR-Accord-434646$ACCORD$$50$YR$A$M$Y$82$KG$20240716$$HP$FR$FR
240956001$24095600$1$I$$20240704$20240716$20240716$EXP$AU-TGA-805818$AU-Accord-433791$ACCORD$$$$$$Y$$$20240716$$HP$AU$AU
240956011$24095601$1$I$$20240704$20240716$20240716$EXP$CA-MHPD-E2B_07084303$CA-Accord-434245$ACCORD$$52$YR$A$F$Y$70$KG$20240716$$HP$CA$CA
240956021$24095602$1$I$20240201$20240704$20240716$20240716$EXP$FR-AFSSAPS-LM2024000374$FR-Accord-434139$ACCORD$$68$YR$E$F$Y$63$KG$20240716$$MD$FR$FR
240956031$24095603$1$I$20240703$20240705$20240716$20240716$EXP$SE-SEMPA-2024-005355$SE-Accord-434953$ACCORD$$76$YR$E$F$Y$82$KG$20240716$$MD$SE$SE
240956041$24095604$1$I$20231101$20240704$20240716$20240716$EXP$GB-MHRA-MED-202407041053066220-FWYTH$GB-Accord-434343$ACCORD$$41$YR$A$M$Y$65$KG$20240716$$CN$GB$GB
240956051$24095605$1$I$20240219$20240704$20240716$20240716$EXP$FR-AFSSAPS-AN2024000874$FR-Accord-434572$ACCORD$$15$YR$T$M$Y$38.1$KG$20240716$$MD$FR$FR
240956061$24095606$1$I$20231101$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405160929377240-YBTNR$GB-Accord-434688$ACCORD$$70$YR$E$M$Y$96$KG$20240716$$MD$GB$GB
240956071$24095607$1$I$20240601$20240704$20240716$20240716$EXP$SE-SEMPA-2024-005075$SE-Accord-434132$ACCORD$$43$YR$A$M$Y$$$20240716$$HP$SE$SE
240956081$24095608$1$I$$20240704$20240716$20240716$EXP$$BR-Accord-431968$ACCORD$$$$A$M$Y$86.6$KG$20240716$$PH$BR$BR
240956091$24095609$1$I$20090827$20240710$20240716$20240716$EXP$$GB-ASTELLAS-2024EU006845$ASTELLAS$$69$YR$$F$Y$46$KG$20240716$$HP$GB$GB
240956101$24095610$1$I$20240709$20240709$20240716$20240716$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024085007$VIIV$$46$YR$$M$Y$$$20240716$$MD$US$US
240956121$24095612$1$I$$20240709$20240716$20240716$EXP$SK-Zentiva-2024-ZT-011068$SK-ROCHE-10000021247$ROCHE$Bellova B, Michalko D, Lubica A, Figurova J, Deptova J, Felsoci M, et al. Difuzny velkobunkovy B-lymfom (DLBCL) u stareho mladenca. Interna medicina. 2024;24 (4):169-171.$$$E$M$Y$$$20240716$$MD$SK$SK
240956131$24095613$1$I$20240101$20240712$20240716$20240716$EXP$$US-ABBVIE-5840555$ABBVIE$$72$YR$$F$Y$$$20240716$$CN$US$US
240956151$24095615$1$I$20240606$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49010$$FDA-CTU$$61$YR$$F$N$$$20240715$N$$US$
240956171$24095617$1$I$20240704$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48999$$FDA-CTU$$51$YR$$F$N$$$20240715$N$$US$
240956181$24095618$1$I$20191115$20240714$20240714$20240714$DIR$FDA-CDER-CTU-2024-48875$$FDA-CTU$$26$YR$$F$N$86.18$KG$20240714$N$CN$US$
240956211$24095621$1$I$$20240702$20240716$20240716$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-06211$LUPIN$$$$$$Y$$$20240716$$CN$AU$AU
240956241$24095624$1$I$20230601$20231122$20240716$20240716$EXP$IT-MINISAL02-953612$IT-TEVA-VS-3136004$TEVA$$40$YR$$F$Y$49$KG$20240716$$MD$IT$IT
240956251$24095625$1$I$$20240711$20240716$20240716$EXP$$GB-MYLANLABS-2024M1065472$MYLAN$$$$$$Y$$$20240716$$CN$GB$GB
240956282$24095628$2$F$$20240716$20240716$20240718$PER$$US-AMGEN-USASP2024140137$AMGEN$$$$$$Y$$$20240718$$CN$US$US
240956291$24095629$1$I$$20240712$20240716$20240716$EXP$$GB-AMGEN-GBRSP2024138993$AMGEN$$$$$F$Y$$$20240716$$CN$GB$GB
240956301$24095630$1$I$20230828$20240715$20240716$20240716$EXP$FR-AFSSAPS-AVCN2024000524$FR-SANDOZ INC.-SDZ2024FR065130$SANDOZ$$37$YR$$M$Y$$$20240716$$MD$FR$FR
240956311$24095631$1$I$$20240706$20240716$20240716$EXP$$MA-HIKMA PHARMACEUTICALS-MA-H14001-24-06423$HIKMA$Ouchane K, Bellefkih FZ, Benchakroun N, Bourhafour M, Chekrine T, Bouchbika Z, et al.. Ouchane K, Bellefkih FZ, Benchakroun N, Bourhafour M, Chekrine T, Bouchbika Z, et al. Reversible posterior leukoencephalopathy syndrome following carboplatin and paclitaxel in cervical cancer: Case report. SAGE Open Medical Case Reports. 2024;12:1-6$38$YR$$F$Y$$$20240716$$MD$MA$MA
240956321$24095632$1$I$20240627$20240712$20240716$20240716$EXP$$US-AMGEN-USASP2024139438$AMGEN$$51$YR$A$M$Y$$$20240716$$HP$US$US
240956331$24095633$1$I$20240201$20240709$20240716$20240716$PER$$US-ABBVIE-5835994$ABBVIE$$69$YR$$M$Y$70.306$KG$20240716$$CN$US$US
240956341$24095634$1$I$$20240708$20240716$20240716$PER$$US-ROCHE-10000026496$ROCHE$Chung J, Bundy J, Khan S, Hunt A, Carroll S, Ali A, et al. Intraosseous Administration of Tenecteplase for Thrombolysis of an Acute Ischemic Stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2024-Jul-04;107850.$51$YR$A$F$Y$$$20240716$$HP$US$US
240956351$24095635$1$I$$20240708$20240716$20240716$EXP$$BE-MYLANLABS-2024M1065257$MYLAN$London F, Stanciu-Pop C, Mulquin N. Chronic cavitary pulmonary aspergillosis in a teriflunomide-treated multiple sclerosis patient. Clin-Neurol-Neurosurg 2024; 236.$55$YR$$M$Y$$$20240716$$HP$BE$BE
240956361$24095636$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064281$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F.. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study.. Int. J. Mol. Sci.. 2024$46$YR$$M$Y$$$20240716$$HP$IT$IT
240956371$24095637$1$I$20231106$20240709$20240716$20240716$EXP$$GB-MYLANLABS-2023M1119021$MYLAN$$35$YR$$F$Y$$$20240716$$MD$GB$GB
240956381$24095638$1$I$$20240709$20240716$20240716$EXP$$ES-MYLANLABS-2024M1064289$MYLAN$$$$$F$Y$$$20240716$$MD$ES$ES
240956391$24095639$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064282$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F.. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study.. Int. J. Mol. Sci.. 2024;25, 5573:1-13.$70$YR$$M$Y$$$20240716$$HP$IT$IT
240956401$24095640$1$I$$20240708$20240716$20240716$EXP$$AU-MYLANLABS-2024M1065047$MYLAN$Kam I, Prentice D, Kho LK, Dharsono F. Inflammatory epilepsy (FIRES) and haemophagocytic lymphohistiocytosis (HLH): an adult case. BMJ-Case-Rep 2023; 16 (1): 1-4.$4$DEC$$M$Y$$$20240716$$HP$AU$AU
240956411$24095641$1$I$$20240708$20240716$20240716$EXP$$IN-MYLANLABS-2024M1065259$MYLAN$Bansal R, Zhamutashvili M, Gognadze T, Dolmazishvili E, Jojua N. A severe case of non typhoidal salmonella associated with multiple organ damage- case study and literature review. [Review]. Georgian-Med-News 2024; 4 (349): 98-102.$25$YR$$F$Y$$$20240716$$HP$IN$IN
240956421$24095642$1$I$20240603$20240715$20240716$20240716$EXP$FR-AFSSAPS-PB2024000773$FR-UCBSA-2024035708$UCB$$52$YR$$F$Y$65$KG$20240716$$PH$FR$FR
240956434$24095643$4$F$20230620$20240730$20240716$20240815$EXP$$CN-009507513-2407CHN008877$MERCK$$64$YR$$M$Y$70$KG$20240815$$MD$CN$CN
240956441$24095644$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145725$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
240956462$24095646$2$F$20240611$20240805$20240716$20240812$EXP$$BE-PFIZER INC-PV202400091124$PFIZER$$85$YR$$M$Y$$$20240812$$MD$BE$BE
240956472$24095647$2$F$$20240815$20240716$20240819$EXP$$CN-PFIZER INC-PV202400091754$PFIZER$Qin, J.. Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial. Nature Medicine. 2024;10.1038/s41591-024-03064-w$$$A$$Y$$$20240819$$HP$CN$CN
240956491$24095649$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405091236306270-HZRSG$GB-PERRIGO-24GB006355$PERRIGO$$$$$M$Y$$$20240716$$PH$GB$GB
240956501$24095650$1$I$20240509$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405101906024010-LHQRG$GB-PERRIGO-24GB006356$PERRIGO$$68$YR$$F$Y$78$KG$20240716$$CN$GB$GB
240956511$24095651$1$I$20240705$20240705$20240716$20240716$EXP$GB-MHRA-TPP1646280C10487728YC1720184674848$GB-PERRIGO-24GB006351$PERRIGO$$35$YR$$F$Y$76$KG$20240716$$HP$GB$GB
240956523$24095652$3$F$20240603$20240705$20240716$20240815$PER$$US-TRAVERE-2024TVT00569$TRAVERE THERAPEUTICS$$53$YR$A$M$Y$$$20240815$$CN$US$US
240956531$24095653$1$I$$20240712$20240716$20240716$EXP$$IT-CELLTRION INC.-2024IT017301$CELLTRION$$$$$$Y$$$20240716$$MD$IT$IT
240956541$24095654$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024139563$AMGEN$$$$$$Y$$$20240716$$PH$US$US
240956551$24095655$1$I$$20240712$20240716$20240716$EXP$$GB-AMGEN-GBRSP2024138986$AMGEN$$$$$M$Y$$$20240716$$CN$GB$GB
240956562$24095656$2$F$$20240708$20240716$20240717$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008492$STRIDES$Agarwal A, Amit M, Chaffin J, Strobel A. Blastic plasmacytoid dendritic cell neoplasm in an adolescent female: A rare entity with challenging diagnosis and management.. BMJ-Case-Rep. 2023;16 (5)$$$$$Y$$$20240717$$HP$US$US
240956571$24095657$1$I$$20240706$20240716$20240716$EXP$$CN-ROCHE-10000007658$ROCHE$Zheng Y, Xiang Y, Shi H, Lin Z, Cheng S, Zhu J. Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate-stage Hepatocellular Carcinoma: A Multicenter Retrospective Study. Journal of hepatocellular carcinoma. 2024-Jun-12;11:1079-93. doi:10.2147/JHC.S461630.$$$$$Y$$$20240716$$HP$CN$CN
240956581$24095658$1$I$$20240710$20240716$20240716$PER$$US-ROCHE-10000023646$ROCHE$$26$YR$A$F$Y$173.7$KG$20240716$$HP$US$US
240956591$24095659$1$I$$20210325$20240716$20240716$EXP$$US-AstraZeneca-2021A229372$ASTRAZENECA$$29$YR$$M$Y$$$20240716$$CN$US$
240956601$24095660$1$I$20200526$20200618$20240716$20240716$EXP$$NL-AstraZeneca-2020SE78352$ASTRAZENECA$$20769$DY$$F$Y$$$20240716$$CN$NL$
240956611$24095661$1$I$20240708$20240709$20240716$20240716$PER$$US-AstraZeneca-2024A157779$ASTRAZENECA$$31657$DY$$F$Y$$$20240716$$CN$US$
240956621$24095662$1$I$$20190910$20240716$20240716$EXP$$ZA-AstraZeneca-2019SF29687$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$ZA$
240956632$24095663$2$F$20240711$20240923$20240716$20240927$PER$$US-AMGEN-USASP2024139617$AMGEN$$64$YR$A$F$Y$$$20240926$$CN$US$US
240956651$24095665$1$I$20231010$20240715$20240716$20240716$EXP$AT-EMA-DD-20240709-7482661-082429$AT-SANDOZ INC.-SDZ2024AT065051$SANDOZ$$60$YR$$F$Y$80$KG$20240716$$MD$AT$AT
240956661$24095666$1$I$$20190919$20240716$20240716$EXP$$ZA-AstraZeneca-2019SF34908$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$ZA$
240956671$24095667$1$I$20240525$20240711$20240716$20240716$EXP$$ID-AstraZeneca-2024A160247$ASTRAZENECA$$29708$DY$$M$Y$$$20240716$$CN$ID$
240956681$24095668$1$I$$20240711$20240716$20240716$PER$$US-UNITED THERAPEUTICS-UNT-2024-021456$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240716$$$US$US
240956731$24095673$1$I$$20191011$20240716$20240716$EXP$$CA-AstraZeneca-2019SF39054$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$CA$
240956741$24095674$1$I$20240712$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008671$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240716$$CN$US$US
240956751$24095675$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008757$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240716$$CN$US$US
240956761$24095676$1$I$20240701$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008981$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240716$$CN$US$US
240956771$24095677$1$I$20240510$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008724$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240716$$CN$US$US
240956781$24095678$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009481$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240716$$CN$US$US
240956791$24095679$1$I$20240601$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009437$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240716$$CN$US$US
240956802$24095680$2$F$20240604$20240726$20240716$20240731$PER$$US-LEO Pharma-371949$LEO PHARM$$63$YR$$F$Y$$$20240731$$CN$US$US
240956812$24095681$2$F$$20240816$20240716$20240827$EXP$$AU-BEH-2024175454$CSL BEHRING$$85$YR$E$M$Y$$$20240827$$HP$AU$AU
240956821$24095682$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024140017$AMGEN$$$$$$Y$$$20240716$$MD$US$US
240956831$24095683$1$I$$20240712$20240716$20240716$30DAY$$US-GSK-US2024087708$GLAXOSMITHKLINE$$$$$F$Y$$$20240716$$CN$US$US
240956843$24095684$3$F$$20240906$20240716$20240916$30DAY$$US-GSK-US2024085155$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
240956851$24095685$1$I$$20240704$20240716$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06468$HIKMA$$$$$$Y$$$20240716$$CN$US$US
240956862$24095686$2$F$$20240806$20240716$20240811$30DAY$$AU-JNJFOC-20240736840$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$PH$AU$AU
240956883$24095688$3$F$$20240830$20240716$20240902$PER$$US-HALEON-2187197$Haleon PLC$$75$YR$$M$Y$$$20240902$$CN$US$US
240956891$24095689$1$I$20240405$20240715$20240716$20240716$EXP$CZ-CZSUKL-24001991$CZ-SANDOZ INC.-SDZ2024CZ065074$SANDOZ$$52$YR$$F$Y$79$KG$20240716$$MD$CZ$CZ
240956901$24095690$1$I$$20240710$20240716$20240716$EXP$$US-TAKEDA-2024TUS046878$TAKEDA$$$$$F$Y$51$KG$20240716$$MD$US$US
240956921$24095692$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48981$$FDA-CTU$$69$YR$$F$N$$$20240715$N$$US$
240956931$24095693$1$I$20230601$20240227$20240716$20240716$EXP$FR-AFSSAPS-PP2024000067$FR-TEVA-VS-3164888$TEVA$$71$YR$$M$Y$75$KG$20240716$$MD$FR$FR
240956941$24095694$1$I$$20240702$20240716$20240716$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-06083$LUPIN$$$$$$Y$$$20240716$$CN$AU$AU
240956951$24095695$1$I$20240708$20240708$20240716$20240716$EXP$$CN-ROCHE-10000020607$ROCHE$$47$YR$A$M$Y$72$KG$20240716$$CN$CN$CN
240956961$24095696$1$I$20240702$20240706$20240716$20240716$EXP$$ES-AUROBINDO-AUR-APL-2024-034020$AUROBINDO$$67$YR$$F$Y$$$20240716$$HP$ES$ES
240956971$24095697$1$I$$20240711$20240716$20240716$PER$$US-LEO Pharma-371985$LEO PHARM$$35$YR$$M$Y$$$20240716$$PH$US$US
240956981$24095698$1$I$20240325$20240617$20240716$20240716$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002675$ACADIA PHARMACEUTICALS$$11$YR$$M$Y$$$20240716$$CN$US$US
240956991$24095699$1$I$$20240704$20240716$20240716$EXP$$AU-TEVA-VS-3217831$TEVA$$59$YR$$F$Y$$$20240716$$MD$AU$AU
240957002$24095700$2$F$20240706$20240807$20240716$20240807$PER$$US-ALXN-202407USA000726US$ALEXION PHARMACEUTICALS$$45$YR$$F$Y$$$20240807$$CN$US$US
240957011$24095701$1$I$20240622$20240708$20240716$20240716$EXP$IT-MINISAL02-993621$IT-BAXTER-2024BAX021317$BAXTER$$47$YR$$M$Y$73$KG$20240716$$MD$IT$IT
240957032$24095703$2$F$$20240711$20240716$20240718$EXP$$NL-AUROBINDO-AUR-APL-2024-034331$AUROBINDO$Van Schaik, A. Gezien Hevige vulvaire pijn. Medisch contact. 2024;79 (26):26-27$24$YR$$F$Y$$$20240718$$MD$NL$NL
240957041$24095704$1$I$20240101$20240709$20240716$20240716$PER$$US-BAYER-2024A098900$BAYER$$58$YR$A$F$Y$72.562$KG$20240716$$CN$US$US
240957051$24095705$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112474$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240716$$CN$US$US
240957061$24095706$1$I$$20240709$20240716$20240716$EXP$$GB-DEXPHARM-2024-2262$DEXCEL$Bhatti, A.; Kalearasu, A.; Jayapalen, V. Tachyphylaxis-induced myocardial infarction in a patient with vasospastic angina. Heart 2024, V110 (Suppl. 3), PA80-A81 abstr. 75.$70$YR$E$F$Y$$$20240716$$HP$GB$
240957071$24095707$1$I$20200429$20240706$20240716$20240716$EXP$$PL-AUROBINDO-AUR-APL-2024-033811$AUROBINDO$$19$YR$$F$Y$70$KG$20240716$$MD$PL$PL
240957091$24095709$1$I$20231109$20240712$20240716$20240716$EXP$$CA-UCBSA-2023054270$UCB$$65$YR$$F$Y$$$20240716$$CN$CA$CA
240957101$24095710$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024139469$AMGEN$$$$$$Y$$$20240716$$PH$US$US
240957111$24095711$1$I$20240605$20240706$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-033997$AUROBINDO$$89$YR$$F$Y$50$KG$20240716$$MD$FR$FR
240957121$24095712$1$I$$20240704$20240716$20240716$EXP$$TR-ROCHE-10000015708$ROCHE$Khanmammadov N, Dogan I, Okay N, Yildiz A, Khishigsuren B, Azizy A. Evaluation of the Efficacy of Bevacizumab-based Therapies in Patients with Platinum- Resistant or-Allergic Metastatic Ovarian Cancer. Turk Onkoloji Dergisi. 2024;39 (2):176-82. doi:10.5505/tjo.2024.4229.$$$$$Y$$$20240716$$MD$TR$TR
240957141$24095714$1$I$$20240715$20240716$20240716$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039956$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240716$$HP$US$US
240957151$24095715$1$I$$20240709$20240716$20240716$PER$$US-BAYER-2024A098915$BAYER$$87$YR$E$M$Y$$$20240716$$CN$US$US
240957161$24095716$1$I$20220701$20240706$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-034024$AUROBINDO$$53$YR$$F$Y$$$20240716$$PH$FR$FR
240957171$24095717$1$I$20240501$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405171114400390-TPNYF$GB-RDY-SPO/GBR/24/0010068$DR REDDYS$$$$$F$Y$$$20240716$$CN$GB$GB
240957181$24095718$1$I$20240509$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405171415438930-CKYNW$GB-RDY-SPO/GBR/24/0010158$DR REDDYS$$$$N$M$Y$2$KG$20240716$$MD$GB$GB
240957191$24095719$1$I$20240709$20240709$20240716$20240716$PER$$US-BIOGEN-2024BI01273493$BIOGEN$$48$YR$$F$Y$$$20240716$$HP$US$US
240957201$24095720$1$I$$20240711$20240716$20240716$EXP$$US-BIOGEN-2024BI01273748$BIOGEN$$$$$M$Y$$$20240716$$HP$US$US
240957211$24095721$1$I$20221129$20240710$20240716$20240716$EXP$FR-AFSSAPS-PP2024000693$FR-CHEPLA-2024008760$CHEPLAPHARM$$0$YR$N$M$Y$2.375$KG$20240716$$MD$COUNTRY NOT SPECIFIED$FR
240957221$24095722$1$I$$20240715$20240716$20240716$PER$$NVSC2024US146274$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
240957231$24095723$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48959$$FDA-CTU$$88$YR$$F$N$96.16$KG$20240715$N$$US$
240957241$24095724$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48989$$FDA-CTU$$61$YR$$M$N$$$20240715$N$$US$
240957251$24095725$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48975$$FDA-CTU$$48$YR$$F$N$$$20240715$N$$US$
240957261$24095726$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48995$$FDA-CTU$$45$YR$$F$N$$$20240715$N$$US$
240957271$24095727$1$I$20240618$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48898$$FDA-CTU$$77$YR$$F$N$71.9$KG$20240715$N$PH$US$
240957281$24095728$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48982$$FDA-CTU$$67$YR$$F$N$$$20240715$N$$US$
240957311$24095731$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48993$$FDA-CTU$$60$YR$$F$N$$$20240715$N$$US$
240957331$24095733$1$I$20240518$20240702$20240716$20240716$EXP$FR-AFSSAPS-RN2024000697$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-06269$HIKMA$$$$$$Y$$$20240716$$MD$FR$FR
240957352$24095735$2$F$20240101$20240722$20240716$20240729$EXP$$JP-GENMAB-2024-02441$GENMAB$$$$$$Y$$$20240729$$PH$JP$JP
240957361$24095736$1$I$$20240708$20240716$20240716$PER$$US-BAYER-2024A098191$BAYER$$$$$$Y$$$20240716$$CN$US$US
240957371$24095737$1$I$$20240706$20240716$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-034788$AUROBINDO$Hwang E, Jimenez Restrepo A.. Incessant right ventricular outflow tract tachycardia with an unexpected substrate. Heart Rhythm. 2024;21 (Suppl.)(5):S590-S591$58$YR$$F$Y$$$20240716$$HP$US$US
240957381$24095738$1$I$20240415$20240706$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-034002$AUROBINDO$$85$YR$$F$Y$$$20240716$$MD$FR$FR
240957391$24095739$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48913$$FDA-CTU$$$$$F$N$$$20240715$N$HP$US$
240957401$24095740$1$I$$20240712$20240716$20240716$EXP$$CA-SANDOZ INC.-SDZ2024CA065372$SANDOZ$$$$$M$Y$17$KG$20240716$$CN$CA$CA
240957413$24095741$3$F$20240625$20240719$20240716$20240723$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039808$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$50$KG$20240723$$HP$CO$CO
240957431$24095743$1$I$$20240710$20240716$20240716$EXP$$US-PFIZER INC-PV202400091184$PFIZER$$76$YR$$F$Y$67.483$KG$20240716$$MD$US$US
240957441$24095744$1$I$20201121$20240711$20240716$20240716$EXP$$CN-PFIZER INC-PV202400091549$PFIZER$$85$YR$$M$Y$67$KG$20240716$$HP$CN$CN
240957461$24095746$1$I$20240709$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49006$$FDA-CTU$$76$YR$$M$N$$$20240715$Y$PH$US$
240957471$24095747$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49027$$FDA-CTU$$66$YR$$M$N$$$20240715$N$$US$
240957481$24095748$1$I$20240409$20240708$20240716$20240716$EXP$PT-INFARMED-E202407-41$PT-PFIZER INC-202400214202$PFIZER$$54$YR$$M$Y$$$20240716$$PH$PT$PT
240957493$24095749$3$F$$20240902$20240716$20240905$EXP$$US-PFIZER INC-202400210369$PFIZER$Weigle, D.. Uncommon and Unfavorable: Heparin-Induced Hyperkalemia. Journal of cardiothoracic and vascular anesthesia. 2024;38(9):2024-2027$56$YR$$M$Y$$$20240905$$MD$US$US
240957503$24095750$3$F$20220101$20240717$20240716$20240722$EXP$$IN-PFIZER INC-PV202300018019$PFIZER$$59$YR$$F$Y$$$20240722$$CN$IN$IN
240957511$24095751$1$I$20190526$20240711$20240716$20240716$EXP$$CN-PFIZER INC-PV202400091515$PFIZER$$73$YR$$F$Y$60$KG$20240716$$HP$CN$CN
240957521$24095752$1$I$$20240711$20240716$20240716$EXP$$CA-PFIZER INC-202400213509$PFIZER$$84$YR$$M$Y$$$20240716$$HP$CA$CA
240957531$24095753$1$I$$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48918$$FDA-CTU$$$$$M$N$$$20240712$N$HP$US$
240957541$24095754$1$I$$20240711$20240716$20240716$EXP$$FR-PFIZER INC-2022SGN11879$PFIZER$$$$A$M$Y$79$KG$20240716$$MD$FR$FR
240957551$24095755$1$I$$20240706$20240716$20240716$PER$$US-BAYER-2024A098692$BAYER$$$$$F$Y$$$20240716$$CN$US$US
240957561$24095756$1$I$$20240704$20240716$20240716$EXP$$CH-MACLEODS PHARMA-MAC2024048157$MACLEODS$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al..Unhappy Hearts With The Antidepressant Venlafaxine.Swiss Medical Weekly.2024;154 (Supplement 278):63S-64S$$$$$Y$$$20240716$$MD$CH$CH
240957571$24095757$1$I$20240430$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405031440330930-PMBTF$GB-MACLEODS PHARMA-MAC2024048145$MACLEODS$$$$$$Y$$$20240716$$PH$GB$GB
240957581$24095758$1$I$$20240704$20240716$20240716$EXP$$CH-MACLEODS PHARMA-MAC2024048156$MACLEODS$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al..UNHAPPY HEARTS WITH THE ANTIDEPRESSANT VENLAFAXINE.Swiss Medical Weekly.2024;154 (278):63S-64S$$$$$Y$$$20240716$$MD$CH$CH
240957591$24095759$1$I$$20240704$20240716$20240716$EXP$$CH-MACLEODS PHARMA-MAC2024048158$MACLEODS$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al..Unhappy hearts with the antidepressant venlafaxine.Swiss Medical Weekly.2024;154(Supplement 278):63S-64S$52$YR$A$F$Y$$$20240716$$MD$CH$CH
240957601$24095760$1$I$$20240708$20240716$20240716$EXP$$RU-AMGEN-RUSSP2024136478$AMGEN$Karachunskiy A. I.; Rumyantseva Y. V.; Zharikova L. I. et al.. Bispecific monoclonal antibody blinatumomab in the first-line therapy of B-lineage acute lymphoblastic leukemia in children and adolescents: interim results of the Russian Ministry of Health approbation protocol. Pediatric Hematology/Oncology and Immunopathology. 2024;23 (1):14-24$$$$$Y$$$20240716$$HP$RU$RU
240957611$24095761$1$I$$20240704$20240716$20240716$EXP$$CH-MACLEODS PHARMA-MAC2024048159$MACLEODS$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al..Unhappy Hearts With The Antidepressant Venlafaxine..Swiss Medical Weekly.2024;154 (Supplement 278):63S-64S$51$YR$A$F$Y$$$20240716$$MD$CH$CH
240957621$24095762$1$I$20240429$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405021613108220-GFLBS$GB-MACLEODS PHARMA-MAC2024048143$MACLEODS$$$$$$Y$$$20240716$$HP$GB$GB
240957631$24095763$1$I$$20240704$20240716$20240716$EXP$$TR-MACLEODS PHARMA-MAC2024048226$MACLEODS$Yegin EG, Eryuksel E, Giral A, Ceyhan B, Ozdogan OC..Decision-making dilemma in drug-induced acute pancreatitis..Journal of Digestive Diseases.01-DEC-2014;15(12):694-697$$$$$Y$$$20240716$$HP$TR$TR
240957641$24095764$1$I$20240424$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405022233422160-QCRDZ$GB-MACLEODS PHARMA-MAC2024048163$MACLEODS$$$$$$Y$$$20240716$$CN$GB$GB
240957651$24095765$1$I$$20240704$20240716$20240716$EXP$$KR-MACLEODS PHARMA-MAC2024048187$MACLEODS$Lee JE, Jeon CH, Chang DK, Lee MS, Oh HY..Henoch-schonlein purpura associated with propylthiouracil overdose.Nephrology Dialysis Transplantation.01-AUG-2006;21(8):2338-9$$$$$Y$$$20240716$$HP$KR$KR
240957661$24095766$1$I$$20240704$20240716$20240716$EXP$$US-MACLEODS PHARMA-MAC2024048173$MACLEODS$Custer MK, Kidd T, Ducker K, Lall R..An Unusual Presentation of Propylthiouracil-Induced Immunoglobulin A Vasculitis With Positive Anti-proteinase-3 and Anti-myeloperoxidase Antibodies.Cureus.2024;16(4):e58535.$$$$$Y$$$20240716$$HP$US$US
240957672$24095767$2$F$$20240820$20240716$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112251$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$113.4$KG$20240822$$CN$US$US
240957681$24095768$1$I$20240201$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405040555034480-WJKLS$GB-MACLEODS PHARMA-MAC2024048165$MACLEODS$$$$$$Y$$$20240716$$CN$GB$GB
240957691$24095769$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405032025487950-WVPBQ$GB-MACLEODS PHARMA-MAC2024048164$MACLEODS$$$$$M$Y$90$KG$20240716$$CN$GB$GB
240957701$24095770$1$I$20240703$20240703$20240716$20240716$EXP$GB-MHRA-MED-202407030833047240-QRVZH$GB-LUPIN PHARMACEUTICALS INC.-2024-06051$LUPIN$$$$$$Y$$$20240716$$MD$GB$GB
240957711$24095771$1$I$20150601$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405021518569640-TZGLF$GB-MACLEODS PHARMA-MAC2024048162$MACLEODS$$$$$$Y$$$20240716$$CN$GB$GB
240957721$24095772$1$I$$20240704$20240716$20240716$EXP$$IN-MACLEODS PHARMA-MAC2024048221$MACLEODS$Baral T, Sekhar S, Thomas L, Acharya R, Krishnan K, Shetty S, et.al.Isoniazid induced pancreatitis: A systematic review.Tuberculosis.15 JUN 2024;148:102535$$$$$Y$$$20240716$$HP$IN$IN
240957731$24095773$1$I$$20240704$20240716$20240716$EXP$$AU-TEVA-VS-3218747$TEVA$$$$E$F$Y$$$20240716$$MD$AU$AU
240957742$24095774$2$F$20230630$20240719$20240716$20240726$EXP$$NVSC2024GR127514$NOVARTIS$$56$YR$$F$Y$$$20240726$$CN$GR$GR
240957752$24095775$2$F$20240710$20240717$20240716$20240722$PER$$US-AMGEN-USASP2024139053$AMGEN$$74$YR$E$M$Y$$$20240722$$PH$US$US
240957761$24095776$1$I$20240101$20240618$20240716$20240716$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000134$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
240957771$24095777$1$I$$20240710$20240716$20240716$PER$$US-BIOGEN-2024BI01273197$BIOGEN$$$$$F$Y$$$20240716$$CN$US$US
240957781$24095778$1$I$20231201$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405060341067210-TCMHK$GB-TORRENT-00037071$TORRENT$$$$$F$Y$$$20240716$$CN$GB$GB
240957791$24095779$1$I$20240430$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405081653055240-HCSJK$GB-TORRENT-00037081$TORRENT$$40$YR$A$F$Y$$$20240716$$MD$GB$GB
240957802$24095780$2$F$$20240718$20240716$20240725$PER$$US-BIOGEN-2024BI01265275$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
240957811$24095781$1$I$20240101$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405051757411590-CGWLN$GB-TORRENT-00037051$TORRENT$$42$YR$A$F$Y$$$20240716$$CN$GB$GB
240957822$24095782$2$F$20240110$20240802$20240716$20240808$EXP$GB-MHRA-MED-202405161316449030-BKDSY$GB-TORRENT-00037150$TORRENT$$13$YR$T$M$Y$$$20240808$$CN$GB$GB
240957831$24095783$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405170858595570-QCHVJ$GB-TORRENT-00037152$TORRENT$$$$$F$Y$$$20240716$$PH$GB$GB
240957841$24095784$1$I$20240509$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405090820398950-MQBSY$GB-TORRENT-00037083$TORRENT$$62$YR$A$M$Y$78$KG$20240716$$MD$GB$GB
240957851$24095785$1$I$20240501$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405130012593890-VJCNG$GB-TORRENT-00037091$TORRENT$$$$$F$Y$76$KG$20240716$$CN$GB$GB
240957861$24095786$1$I$20240322$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405161416520420-JKQYG$GB-TORRENT-00037139$TORRENT$$44$YR$A$M$Y$$$20240716$$CN$GB$GB
240957871$24095787$1$I$20240101$20240709$20240716$20240716$EXP$$US-SA-2024SA204843$SANOFI AVENTIS$$73$YR$E$M$Y$73.93$KG$20240716$$MD$US$US
240957881$24095788$1$I$$20240708$20240716$20240716$EXP$$BE-TEVA-VS-3220760$TEVA$Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A, et al. PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer. Cold-Spring-Harb-Mol-Case-Stud 2023; 9 (2): 1-16.; Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A, et al. PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer. Cold-Spring-Harb-Mol-Case-Stud 2023; 9 (2): 1-16.$30$YR$$F$Y$$$20240716$$HP$BE$BE
240957891$24095789$1$I$20240626$20240705$20240716$20240716$EXP$GB-MHRA-MED-202406260823074440-ZTJLM$GB-TORRENT-00037165$TORRENT$$58$YR$A$M$Y$72$KG$20240716$$CN$GB$GB
240957901$24095790$1$I$20240703$20240705$20240716$20240716$EXP$$US-Accord-434449$ACCORD$$63$YR$A$F$Y$$$20240716$$PH$US$US
240957911$24095791$1$I$20220701$20240704$20240716$20240716$EXP$FR-AFSSAPS-2024057460$FR-Accord-434426$ACCORD$$75$YR$E$F$Y$$$20240716$$PH$FR$FR
240957921$24095792$1$I$$20240704$20240716$20240716$EXP$CA-MHPD-E2B_07081778$CA-Accord-434361$ACCORD$$75$YR$E$F$Y$72$KG$20240716$$HP$CA$CA
240957931$24095793$1$I$20240704$20240706$20240716$20240716$EXP$$GB-AUROBINDO-AUR-APL-2024-034045$AUROBINDO$$$$A$F$Y$$$20240716$$CN$GB$GB
240957942$24095794$2$F$20190918$20240821$20240716$20240902$EXP$$PL-MACLEODS PHARMA-MAC2024048306$MACLEODS$$$$$$Y$$$20240902$$MD$PL$PL
240957952$24095795$2$F$$20240712$20240716$20240723$EXP$$MX-Accord-434478$ACCORD$Bautista-Sanchez CD, Martinez-Bravo LE, Hidalgo-Diaz DA. Pancytopenia in neuromyelitis optica spectrum disorder induced by azathioprine-allopurinol interaction. Neuroimmunology Reports. 2024;6:100219$63$YR$A$F$Y$50$KG$20240723$$MD$MX$MX
240957961$24095796$1$I$20230915$20240704$20240716$20240716$EXP$FR-AFSSAPS-2024057414$FR-Accord-434438$ACCORD$$44$YR$A$M$Y$$$20240716$$MD$FR$FR
240957972$24095797$2$F$$20240714$20240716$20240724$EXP$$TW-Accord-434178$ACCORD$Zhang K, Chu S, Ding D. High-grade serous carcinoma of the fallopian tube in a young woman with chromosomal 4q abnormality: A case report. World Journal of Clinical Cases. 2024;12(18):3539-47.$35$YR$A$F$Y$37$KG$20240724$$MD$TW$TW
240957981$24095798$1$I$20240612$20240711$20240716$20240716$EXP$$US-UCBSA-2024035577$UCB$$64$YR$$F$Y$$$20240716$$CN$US$US
240957991$24095799$1$I$$20240704$20240716$20240716$EXP$$IT-Accord-434171$ACCORD$Samperi S, Laura C, Trambaiolo P, D^Ambrosi A, Mustilli M, Romano S, et al. A STRANGE CASE OF CARDIOTOXICITY FROM ANTIBLASTIC TREATMENT: A HIGH PRICE TO PAY. European Heart Journal, Supplement. 2024;26(Supplement 2):ii178-9. DOI:10.1093/eurheartjsupp/suae036.431.$58$YR$A$F$Y$$$20240716$$MD$IT$IT
240958001$24095800$1$I$$20240704$20240716$20240716$EXP$$US-Accord-433351$ACCORD$Fink NS, Abubshait L, Deshisky A. Anti-HMGCR (Hydroxy-3-Methylglutaryl-CoA Reductase) Myopathy: A Rare Cause of Proximal Muscle Weakness. Cureus. 2024 May 26;16(5):e61094.$65$YR$E$F$Y$$$20240716$$HP$US$US
240958012$24095801$2$F$20240702$20240729$20240716$20240808$EXP$$US-Accord-434471$ACCORD$$44$YR$A$M$Y$$$20240808$$HP$US$US
240958021$24095802$1$I$20240627$20240711$20240716$20240716$EXP$$CO-UCBSA-2024035815$UCB$$54$YR$$F$Y$$$20240716$$CN$CO$CO
240958031$24095803$1$I$20231030$20240704$20240716$20240716$EXP$IT-MINISAL02-993559$IT-Accord-434684$ACCORD$$67$YR$E$F$Y$$$20240716$$MD$IT$IT
240958041$24095804$1$I$20240703$20240705$20240716$20240716$EXP$$US-Accord-434419$ACCORD$$68$YR$E$F$Y$$$20240716$$PH$US$US
240958051$24095805$1$I$$20240711$20240716$20240716$EXP$$GB-SANDOZ INC.-SDZ2023GB035569$SANDOZ$$$$$F$Y$$$20240716$$CN$GB$GB
240958061$24095806$1$I$$20240702$20240716$20240716$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-06111$LUPIN$$$$$$Y$$$20240716$$CN$AU$AU
240958071$24095807$1$I$$20240715$20240716$20240716$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039914$BOEHRINGER INGELHEIM$$59$YR$A$F$Y$69$KG$20240716$$HP$CA$CA
240958081$24095808$1$I$$20240709$20240716$20240716$EXP$$US-SA-2024SA204895$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240958091$24095809$1$I$20210620$20240704$20240716$20240716$EXP$IT-EMA-DD-20240703-7482665-055852$IT-Accord-434522$ACCORD$$71$YR$E$F$Y$$$20240716$$HP$IT$IT
240958101$24095810$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139347$AMGEN$$22$YR$A$F$Y$$$20240716$$PH$US$US
240958111$24095811$1$I$$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024137300$AMGEN$$$$C$$Y$$$20240716$$HP$US$US
240958121$24095812$1$I$20240401$20240715$20240716$20240716$EXP$DK-DKMA-30730738$DK-SANDOZ INC.-SDZ2024DK065080$SANDOZ$$78$YR$$M$Y$$$20240716$$HP$DK$DK
240958131$24095813$1$I$20200301$20240228$20240716$20240716$EXP$FR-AFSSAPS-ST2024000263$FR-TEVA-VS-3165449$TEVA$$42$YR$$F$Y$$$20240716$$MD$FR$FR
240958141$24095814$1$I$20240101$20240712$20240716$20240716$EXP$$US-SA-2024SA206748$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240716$$CN$US$US
240958151$24095815$1$I$20240601$20240712$20240716$20240716$EXP$FR-AFSSAPS-RN2024000740$FR-SA-2024SA205344$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240716$$PH$FR$FR
240958161$24095816$1$I$20240321$20240706$20240716$20240716$EXP$$RU-AMAROX PHARMA-HET2024RU02219$HETERO$$$$$F$Y$52$KG$20240716$$MD$RU$RU
240958171$24095817$1$I$20230919$20240702$20240716$20240716$EXP$$KR-TEVA-VS-3216385$TEVA$$$$E$M$Y$$$20240716$$HP$KR$KR
240958191$24095819$1$I$20240302$20240702$20240716$20240716$EXP$$PK-ROCHE-10000020551$ROCHE$$66$YR$E$F$Y$$$20240716$$CN$PK$PK
240958212$24095821$2$F$$20240717$20240716$20240725$EXP$US-MLMSERVICE-20240703-PI117503-00120-1$US-JUBILANT CADISTA PHARMACEUTICALS-2024US000990$JUBILANT$Nguyen C, Stanek JL. Sternomanubrial joint pain secondary to ulcerative colitis treated with ultrasound-guided injection. PM and R. 2024;16(6):650-2$31$YR$$M$Y$$$20240725$$MD$US$US
240958221$24095822$1$I$$20240708$20240716$20240716$EXP$$BE-TAKEDA-2023TUS124525$TAKEDA$$$$$$Y$$$20240716$$HP$BE$BE
240958231$24095823$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405131113575700-DCBJZ$GB-TORRENT-00037148$TORRENT$$32$YR$A$F$Y$$$20240716$$MD$GB$GB
240958241$24095824$1$I$20240512$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405120905293360-ZRKFW$GB-TORRENT-00037093$TORRENT$$62$YR$A$M$Y$78$KG$20240716$$CN$GB$GB
240958251$24095825$1$I$20240107$20240705$20240716$20240716$EXP$GB-MHRA-MED-202406251219224260-VPSWC$GB-TORRENT-00037144$TORRENT$$21$YR$A$F$Y$$$20240716$$MD$GB$GB
240958261$24095826$1$I$$20240710$20240716$20240716$PER$$US-BIOGEN-2024BI01273146$BIOGEN$$$$$$Y$$$20240716$$CN$US$US
240958282$24095828$2$F$$20240730$20240716$20240802$PER$$NVSC2024US146224$NOVARTIS$$$$$$Y$$$20240802$$PH$US$US
240958291$24095829$1$I$20230816$20240702$20240716$20240716$EXP$$KR-TEVA-VS-3216397$TEVA$$$$E$F$Y$$$20240716$$HP$KR$KR
240958301$24095830$1$I$$20240715$20240716$20240716$EXP$$DE-TAKEDA-2024TUS071637$TAKEDA$$$$$F$Y$$$20240716$$HP$DE$DE
240958311$24095831$1$I$$20240702$20240716$20240716$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-06112$LUPIN$$25$YR$$F$Y$$$20240716$$CN$AU$AU
240958321$24095832$1$I$20240401$20240706$20240716$20240716$EXP$$ES-AUROBINDO-AUR-APL-2024-033879$AUROBINDO$$76$YR$$F$Y$$$20240716$$MD$ES$ES
240958331$24095833$1$I$$20240626$20240716$20240716$EXP$$DE-ROCHE-10000024327$ROCHE$Al-Sawaf O, Robrecht S, Zhang C, Olivieri S, Chang N, Fink A, et al. Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized CLL14 study. Leuk Lymphoma. 2023;64 (SUPP: 1):S113.$$$$$Y$$$20240716$$HP$DE$DE
240958341$24095834$1$I$$20240703$20240716$20240716$EXP$$US-TEVA-VS-3219485$TEVA$$$$A$M$Y$$$20240716$$HP$US$US
240958351$24095835$1$I$20230721$20240702$20240716$20240716$EXP$$KR-TEVA-VS-3216405$TEVA$$$$A$F$Y$$$20240716$$HP$KR$KR
240958361$24095836$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405101415057720-NPTCZ$GB-TORRENT-00037107$TORRENT$$$$$F$Y$70$KG$20240716$$HP$GB$GB
240958371$24095837$1$I$20240705$20240709$20240716$20240716$EXP$$CN-ROCHE-10000022103$ROCHE$$69$YR$E$M$Y$$$20240716$$MD$CN$CN
240958383$24095838$3$F$20240311$20240812$20240716$20240820$EXP$GB-MHRA-MED-202405090912582800-FMHRG$GB-TORRENT-00037096$TORRENT$$73$YR$E$M$Y$101$KG$20240820$$PH$GB$GB
240958391$24095839$1$I$20240515$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405151322554580-JFDSQ$GB-TORRENT-00037128$TORRENT$$30$YR$A$F$Y$110$KG$20240716$$CN$GB$GB
240958401$24095840$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48885$$FDA-CTU$$$$$$N$$$20240715$N$$US$
240958411$24095841$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49014$$FDA-CTU$$$$$M$N$$$20240715$N$HP$US$
240958421$24095842$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405082345420790-DRFMC$GB-TORRENT-00037115$TORRENT$$$$$F$Y$62$KG$20240716$$CN$GB$GB
240958431$24095843$1$I$$20240712$20240716$20240716$EXP$$GB-AMGEN-GBRSP2024138985$AMGEN$$$$$M$Y$72$KG$20240716$$MD$GB$GB
240958441$24095844$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405162318157690-FNGQT$GB-TORRENT-00037142$TORRENT$$$$$M$Y$$$20240716$$CN$GB$GB
240958451$24095845$1$I$20240715$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48891$$FDA-CTU$$81$YR$$M$N$$$20240715$N$$US$
240958461$24095846$1$I$20240714$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48896$$FDA-CTU$$88$YR$$M$N$$$20240715$Y$PH$US$
240958471$24095847$1$I$$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48979$$FDA-CTU$$$$$M$N$$$20240712$N$HP$US$
240958481$24095848$1$I$$20240704$20240716$20240716$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-23-02141$HIKMA$$58$YR$$F$Y$74$KG$20240716$$HP$CA$CA
240958494$24095849$4$F$20240705$20240912$20240716$20240927$30DAY$$BR-AMGEN-BRASP2024136702$AMGEN$$$$$M$Y$$$20240926$$PH$BR$BR
240958502$24095850$2$F$20240401$20240912$20240716$20240920$EXP$$DE-AMGEN-DEUSP2024135158$AMGEN$$50$YR$A$F$Y$80$KG$20240919$$MD$DE$DE
240958511$24095851$1$I$$20240710$20240716$20240716$EXP$$US-NORDICGR-056690$NORDIC PHARMA$Higuita NIA, Yuen C. Hemophagocytic lymphohistiocytosis secondary to Ehrlichia chaffeensis in adults: A case series from Oklahoma. Am J Med Sci. 2021 Feb;361(2):269-273. https://doi.org/10.1016/j.amjms.2020.08.029; Higuita NIA, Yuen, C. Hemophagocytic lymphohistiocytosis secondary to Ehrlichia chaffeensis in adults: A case series from Oklahoma. Am J Med Sci. 2021 Feb;361(2):269-273. https://doi.org/10.1016/j.amjms.2020.08.029$49$YR$$M$Y$$$20240716$$MD$US$US
240958521$24095852$1$I$$20240708$20240716$20240716$EXP$$JP-ROCHE-10000025219$ROCHE$Fujii N, Nishimoto Y, Miwa I, Ito M, Asada H, Sanai H et al.. Two cases of peritoneal cancer in which half-dose bevacizumab therapy was effective in controlling ascites accumulation at the terminal phase. Modern Trends in Obstetrics + Gynecology. 2023;72(2):267-271$67$YR$E$F$Y$$$20240716$$MD$JP$JP
240958531$24095853$1$I$$20240711$20240716$20240716$EXP$CA-SA-SAC20240712000973$CA-SA-2024SA205759$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240716$$HP$CA$CA
240958541$24095854$1$I$20240626$20240711$20240715$20240715$DIR$FDA-CDER-CTU-2024-48927$$FDA-CTU$$39$YR$$F$N$$$20240711$N$HP$US$
240958551$24095855$1$I$20240401$20240712$20240716$20240716$EXP$$US-UCBSA-2024035551$UCB$$65$YR$$F$Y$$$20240716$$CN$US$US
240958561$24095856$1$I$$20240712$20240716$20240716$PER$$US-BIOGEN-2024BI01270345$BIOGEN$$$$$F$Y$$$20240716$$CN$US$US
240958571$24095857$1$I$20240620$20240708$20240716$20240716$EXP$FR-AFSSAPS-RE2024000660$FR-TEVA-VS-3218796$TEVA$$87$YR$$F$Y$72$KG$20240716$$MD$FR$FR
240958601$24095860$1$I$20240315$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49017$$FDA-CTU$$77$YR$$F$N$$$20240715$N$HP$US$
240958621$24095862$1$I$20191121$20191205$20240716$20240716$EXP$$CO-AstraZeneca-2019SF77912$ASTRAZENECA$$3196$WK$$F$Y$$$20240716$$CN$CO$
240958631$24095863$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A157519$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240958641$24095864$1$I$$20240705$20240716$20240716$EXP$$US-AUROBINDO-AUR-APL-2024-034389$AUROBINDO$Samuel Shabtaie; Nicholas Y. Tan; Ciorsti MacIntyre; Ammar M. Killu; Abhishek J, Freddy Del Carpio Munoz, et,al.. THE PERFECT STORM: ARRHYTHMIC MITRAL VALVE PROLAPSE AND CONCEALED LONG QT SYNDROME TYPE 1 RESULTING IN RECURRENT PVC-INDUCED VENTRICULAR FIBRILLATION. Heart Rhythm. 2024;21:5S$36$YR$$F$Y$$$20240716$$HP$US$US
240958651$24095865$1$I$$20200311$20240716$20240716$EXP$$US-AstraZeneca-2020SE37248$ASTRAZENECA$$$$$F$Y$$$20240716$$HP$US$
240958661$24095866$1$I$20200601$20200805$20240716$20240716$EXP$$AU-AstraZeneca-2020SE99830$ASTRAZENECA$$535$MON$$F$Y$$$20240716$$CN$AU$
240958673$24095867$3$F$$20240730$20240716$20240805$PER$$US-AstraZeneca-2024A145144$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
240958681$24095868$1$I$$20200805$20240716$20240716$EXP$$US-AstraZeneca-2020SE99496$ASTRAZENECA$$$$$F$Y$52.2$KG$20240716$$CN$US$
240958691$24095869$1$I$20201110$20240711$20240716$20240716$EXP$$CN-PFIZER INC-PV202400091487$PFIZER$$84$YR$$M$Y$$$20240716$$HP$CN$CN
240958701$24095870$1$I$20221202$20240711$20240716$20240716$EXP$FR-AFSSAPS-PO20222069$FR-PFIZER INC-202201389701$PFIZER$$66$YR$$F$Y$63$KG$20240716$$MD$FR$FR
240958711$24095871$1$I$20230313$20240711$20240716$20240716$EXP$FR-AFSSAPS-RN2023000337$FR-PFIZER INC-202300151202$PFIZER$$17$YR$$M$Y$$$20240716$$MD$FR$FR
240958721$24095872$1$I$$20240706$20240716$20240716$EXP$$PH-PFIZER INC-202400204711$PFIZER$$33$YR$$M$Y$$$20240716$$CN$PH$PH
240958731$24095873$1$I$$20191016$20240716$20240716$EXP$$CA-AstraZeneca-2019SF41424$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$CA$
240958741$24095874$1$I$$20191010$20240716$20240716$EXP$$US-AstraZeneca-2019SF46113$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240958751$24095875$1$I$$20191008$20240716$20240716$EXP$$RU-AstraZeneca-2019SF43894$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$RU$
240958761$24095876$1$I$20240407$20240710$20240716$20240716$EXP$$US-SERVIER-S24005096$SERVIER$$$$$$Y$$$20240716$$CN$US$US
240958771$24095877$1$I$$20200416$20240716$20240716$EXP$$US-AstraZeneca-2020SE52617$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240958791$24095879$1$I$20240712$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112795$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240716$$CN$US$US
240958801$24095880$1$I$20240701$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111813$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$70.26$KG$20240716$$PH$US$US
240958811$24095881$1$I$$20240715$20240716$20240716$PER$$US-ABBVIE-5841187$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240958821$24095882$1$I$$20240708$20240716$20240716$EXP$$CN-ROCHE-10000009456$ROCHE$Zhang J, Wang X, Du H, Xue Y. Therapeutic Efficacy, Safety and Predictive Indicators of Eribulin Plus Anti-Angiogenic Medicine for Metastatic Breast Cancer. Journal of the College of Physicians and Surgeons Pakistan. 2024-Jun;34 (6):682-7. doi:10.29271/jcpsp.2024.06.682.$$$$$Y$$$20240716$$HP$CN$CN
240958842$24095884$2$F$20240622$20240807$20240716$20240807$PER$$US-ALXN-202407USA000681US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
240958852$24095885$2$F$$20240717$20240716$20240717$EXP$$CA-BAYER-2024A101533$BAYER$$$$$F$Y$$$20240717$$HP$CA$CA
240958861$24095886$1$I$20240423$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405101435442930-CTHRF$GB-RDY-SPO/GBR/24/0009999$DR REDDYS$$36$YR$A$M$Y$$$20240716$$PH$GB$GB
240958872$24095887$2$F$20230101$20240731$20240716$20240827$PER$$US-JNJFOC-20240717894$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240827$$CN$US$US
240958881$24095888$1$I$20240101$20240711$20240716$20240716$PER$$US-ABBVIE-5839183$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240958892$24095889$2$F$$20240807$20240716$20240818$30DAY$$AU-JNJFOC-20240735734$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$AU$AU
240958901$24095890$1$I$20240714$20240714$20240716$20240716$EXP$GB-MHRA-MED-202407141136241030-SLPZT$GB-ABBVIE-5840692$ABBVIE$$$$$$Y$$$20240716$$CN$GB$GB
240958911$24095891$1$I$20240611$20240712$20240716$20240716$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-14065$IPSEN$$83$YR$E$F$Y$$$20240716$$CN$GB$GB
240958921$24095892$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48895$$FDA-CTU$$61$YR$$F$N$$$20240715$N$$US$
240958931$24095893$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48914$$FDA-CTU$$33$YR$$M$N$$$20240715$N$$US$
240958942$24095894$2$F$$20240729$20240716$20240808$EXP$$CN-TEVA-VS-3219481$TEVA$Zhang J, Zhang R. Megalosplenia as an initial manifestation of multiple myeloma with a novel CYLD gene mutation: A case report and literature review. Medicine 2024; 103 (14):.; Zhang J, Zhang R. Megalosplenia as an initial manifestation of multiple myeloma with a novel CYLD gene mutation: A case report and literature review. Medicine 2024; 103 (14):.; Zhang J, Zhang R. Megalosplenia as an initial manifestation of multiple myeloma with a novel CYLD gene mutation: A case report and literature r...$65$YR$$F$Y$$$20240808$$HP$CN$CN
240958951$24095895$1$I$20240401$20240702$20240716$20240716$PER$$US-SA-2024SA199229$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240716$$MD$US$US
240958961$24095896$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48933$$FDA-CTU$$72$YR$$F$N$$$20240715$N$$US$
240958971$24095897$1$I$20240710$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49021$$FDA-CTU$$48$YR$$M$N$$$20240715$Y$HP$US$
240958991$24095899$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA202940$SANOFI AVENTIS$$$$C$M$Y$14.24$KG$20240716$$MD$US$US
240959001$24095900$1$I$20240703$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48905$$FDA-CTU$$58$YR$$M$N$$$20240712$N$HP$US$
240959011$24095901$1$I$$20240703$20240716$20240716$PER$$US-SA-2024SA202707$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240716$$MD$US$US
240959021$24095902$1$I$20240101$20240705$20240716$20240716$PER$$US-SA-2024SA204049$SANOFI AVENTIS$$21$YR$A$F$Y$61$KG$20240716$$MD$US$US
240959032$24095903$2$F$20240101$20240730$20240716$20240807$PER$$US-SA-2024SA202936$SANOFI AVENTIS$$35$YR$A$F$Y$56.69$KG$20240807$$MD$US$US
240959041$24095904$1$I$20200101$20240705$20240716$20240716$PER$$US-SA-2024SA055509$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240716$$MD$US$US
240959061$24095906$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA202979$SANOFI AVENTIS$$$$T$F$Y$$$20240716$$MD$US$US
240959071$24095907$1$I$20240601$20240705$20240716$20240716$PER$$US-SA-2024SA201426$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240716$$MD$US$US
240959081$24095908$1$I$$20240628$20240716$20240716$PER$$US-SA-2024SA207030$SANOFI AVENTIS$$$$I$F$Y$$$20240716$$MD$US$US
240959091$24095909$1$I$$20240708$20240716$20240716$EXP$$TN-MYLANLABS-2024M1065767$MYLAN$Ayadi S, Monastiri S, Safta AB, Hammami M, Samaali I, Kammoun M, et al. Gastric metastasis and peritoneal carcinosis revealing primary breast cancer: an unusual presentation. Future-Sci-OA 2024; 10 (1): 1-7.$53$YR$$F$Y$$$20240716$$HP$TN$TN
240959101$24095910$1$I$$20240708$20240716$20240716$EXP$$TW-ROCHE-10000020062$ROCHE$Hung Y, Hung C and Chou W. Evaluating the cancer aging and research group model in predicting immunochemotherapy toxicity among elderly patients with diffuse large B-cell lymphoma. International Immunopharmacology. 2024;138:1-8. doi:10.1016/j.intimp.2024.112544.$$$$$Y$$$20240716$$MD$TW$TW
240959111$24095911$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064523$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F.. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study. Int. J. Mol. Sci. 2024;25 (5573):1-13$64$YR$$M$Y$$$20240716$$HP$IT$IT
240959121$24095912$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064553$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study. Int. J. Mol. Sci.. 25:5573$75$YR$$M$Y$$$20240716$$HP$IT$IT
240959141$24095914$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064555$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study. Int. J. Mol. Sci.. 2024;5573:1-13$78$YR$$M$Y$$$20240716$$HP$IT$IT
240959151$24095915$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064554$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F.. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study.. Int. J. Mol. Sci.. 2024;25:1-13.$68$YR$$M$Y$$$20240716$$HP$IT$IT
240959161$24095916$1$I$$20240708$20240716$20240716$EXP$$IT-MYLANLABS-2024M1065842$MYLAN$Raveglia F, Libretti L, Cioffi U, Guttadauro A, Petrella F. Minimally Invasive Surgical Management of Chronic Cough-Induced Rib Fracture Non-Union: A Case Report. Am-J-Case-Rep 2024; 25 (0): e943222.$54$YR$$M$Y$$$20240716$$HP$IT$IT
240959171$24095917$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA206330$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240716$$MD$US$US
240959181$24095918$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA202306$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240716$$MD$US$US
240959191$24095919$1$I$20240618$20240708$20240716$20240716$EXP$IT-MINISAL02-992421$IT-TEVA-VS-3218667$TEVA$$65$YR$$F$Y$75$KG$20240716$$MD$IT$IT
240959201$24095920$1$I$20240601$20240710$20240716$20240716$PER$$US-SA-2024SA205617$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240716$$MD$US$US
240959211$24095921$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205134$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240716$$CN$US$US
240959221$24095922$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA205128$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240959231$24095923$1$I$20240601$20240709$20240716$20240716$PER$$US-SA-2024SA204513$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240716$$MD$US$US
240959241$24095924$1$I$20240703$20240705$20240716$20240716$PER$$US-SA-2024SA203114$SANOFI AVENTIS$$61$YR$A$F$Y$58$KG$20240716$$MD$US$US
240959251$24095925$1$I$20240101$20240707$20240716$20240716$PER$$US-SA-2024SA141919$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240716$$MD$US$US
240959261$24095926$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA202987$SANOFI AVENTIS$$$$A$F$Y$99.79$KG$20240716$$MD$US$US
240959271$24095927$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204898$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240716$$MD$US$US
240959281$24095928$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA203744$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240716$$CN$US$US
240959291$24095929$1$I$20240701$20240709$20240716$20240716$PER$$US-SA-2024SA205838$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240716$$MD$US$US
240959301$24095930$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA203648$SANOFI AVENTIS$$$$A$F$Y$99.79$KG$20240716$$MD$US$US
240959311$24095931$1$I$20240101$20240705$20240716$20240716$PER$$US-SA-2024SA203071$SANOFI AVENTIS$$19$YR$A$F$Y$95.25$KG$20240716$$MD$US$US
240959321$24095932$1$I$20240601$20240707$20240716$20240716$PER$$US-SA-2024SA202821$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240716$$MD$US$US
240959331$24095933$1$I$$20240708$20240716$20240716$EXP$$US-MYLANLABS-2024M1065289$MYLAN$Siler C, Fuller W, Whaley D, Keating J. Polypharmacy in Older Adults: A Case Study. S-D-Med 2023; 76 (3): 124-127.$64$YR$$F$Y$$$20240716$$MD$US$US
240959341$24095934$1$I$20240101$20240710$20240716$20240716$PER$$US-SA-2024SA206502$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240716$$MD$US$US
240959351$24095935$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205261$SANOFI AVENTIS$$$$A$M$Y$$$20240716$$MD$US$US
240959362$24095936$2$F$20240401$20240717$20240716$20240726$PER$$US-SA-2024SA206107$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240726$$MD$US$US
240959371$24095937$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205953$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240716$$MD$US$US
240959381$24095938$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205145$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240716$$MD$US$US
240959392$24095939$2$F$20231201$20240724$20240716$20240805$PER$$US-SA-2024SA202773$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240805$$MD$US$US
240959401$24095940$1$I$$20240710$20240716$20240716$EXP$$NVSC2024MX144933$NOVARTIS$$$$$F$Y$$$20240716$$MD$MX$MX
240959412$24095941$2$F$20240807$20240826$20240716$20240828$PER$$NVSC2024US146297$NOVARTIS$$78$YR$$M$Y$100.4$KG$20240828$$HP$US$US
240959421$24095942$1$I$$20240711$20240716$20240716$PER$$NVSC2024US145143$NOVARTIS$$$$$M$Y$$$20240716$$CN$US$US
240959434$24095943$4$F$20240912$20240912$20240716$20240920$EXP$$CA-TAKEDA-2024TUS068415$TAKEDA$$24$YR$$F$Y$$$20240920$$CN$CA$CA
240959441$24095944$1$I$20240101$20240715$20240716$20240716$EXP$FR-AFSSAPS-PA2024001336$NVSC2024FR145458$NOVARTIS$$50$YR$$M$Y$87.7$KG$20240716$$PH$FR$FR
240959451$24095945$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA202889$SANOFI AVENTIS$$$$E$F$Y$$$20240716$$MD$US$US
240959461$24095946$1$I$$20240711$20240716$20240716$PER$$US-ABBVIE-5839269$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240959471$24095947$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204458$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240716$$CN$US$US
240959481$24095948$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA204545$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240716$$MD$US$US
240959491$24095949$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA204251$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240716$$MD$US$US
240959501$24095950$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203600$SANOFI AVENTIS$$$$A$M$Y$$$20240716$$MD$US$US
240959512$24095951$2$F$20240101$20240801$20240716$20240810$PER$$US-SA-2024SA204932$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240810$$MD$US$US
240959521$24095952$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA206615$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240716$$MD$US$US
240959531$24095953$1$I$20240708$20240709$20240716$20240716$PER$$US-SA-2024SA203174$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240716$$MD$US$US
240959541$24095954$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204763$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240716$$MD$US$US
240959551$24095955$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205005$SANOFI AVENTIS$$66$YR$E$M$Y$64.5$KG$20240716$$CN$US$US
240959572$24095957$2$F$$20240715$20240716$20240724$PER$$US-SA-2024SA205322$SANOFI AVENTIS$$$$$M$Y$$$20240724$$CN$US$US
240959581$24095958$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204297$SANOFI AVENTIS$$$$A$M$Y$83$KG$20240716$$MD$US$US
240959591$24095959$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205086$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240716$$MD$US$US
240959601$24095960$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA207002$SANOFI AVENTIS$$$$E$F$Y$113$KG$20240716$$MD$US$US
240959611$24095961$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA206918$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240716$$MD$US$US
240959621$24095962$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204710$SANOFI AVENTIS$$$$T$F$Y$63$KG$20240716$$MD$US$US
240959632$24095963$2$F$20240709$20240712$20240716$20240810$PER$$US-SA-2024SA203691$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240810$$CN$US$US
240959641$24095964$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA204078$SANOFI AVENTIS$$$$C$F$Y$16.3$KG$20240716$$MD$US$US
240959651$24095965$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA206610$SANOFI AVENTIS$$$$E$F$Y$$$20240716$$MD$US$US
240959661$24095966$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA206854$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240716$$MD$US$US
240959673$24095967$3$F$$20240822$20240716$20240913$PER$$US-SA-2024SA204192$SANOFI AVENTIS$$$$A$M$Y$107.04$KG$20240913$$MD$US$US
240959681$24095968$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA205093$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240716$$MD$US$US
240959691$24095969$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204005$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240716$$CN$US$US
240959701$24095970$1$I$$20240708$20240716$20240716$EXP$$CN-JNJFOC-20240724991$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$PH$CN$CN
240959711$24095971$1$I$20221016$20240702$20240716$20240716$PER$$US-JNJFOC-20240707236$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240716$$CN$US$US
240959721$24095972$1$I$20240601$20240709$20240716$20240716$PER$$US-SA-2024SA205479$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240716$$MD$US$US
240959731$24095973$1$I$20231201$20240708$20240716$20240716$PER$$US-SA-2024SA204082$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240716$$MD$US$US
240959741$24095974$1$I$20240501$20240708$20240716$20240716$PER$$US-SA-2024SA204214$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240716$$MD$US$US
240959751$24095975$1$I$20240701$20240709$20240716$20240716$PER$$US-SA-2024SA205860$SANOFI AVENTIS$$56$YR$A$F$Y$99.7$KG$20240716$$MD$US$US
240959761$24095976$1$I$$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48952$$FDA-CTU$$$$$M$N$$$20240712$N$HP$US$
240959771$24095977$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA202796$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240716$$MD$US$US
240959781$24095978$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA206642$SANOFI AVENTIS$$$$T$F$Y$$$20240716$$MD$US$US
240959792$24095979$2$F$$20240820$20240716$20240829$PER$$US-SA-2024SA204846$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240829$$MD$US$US
240959801$24095980$1$I$20240707$20240708$20240716$20240716$PER$$US-SA-2024SA202522$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240716$$CN$US$US
240959811$24095981$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA205752$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240716$$MD$US$US
240959822$24095982$2$F$20240101$20240723$20240716$20240801$PER$$US-SA-2024SA204268$SANOFI AVENTIS$$55$YR$A$M$Y$104.31$KG$20240801$$MD$US$US
240959831$24095983$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49019$$FDA-CTU$$72$YR$$M$N$$$20240715$N$$US$
240959841$24095984$1$I$20240712$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49031$$FDA-CTU$$54$YR$$F$N$$$20240715$N$$US$
240959852$24095985$2$F$$20240911$20240716$20240917$PER$$US-SA-2024SA205272$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240918$$MD$US$US
240959861$24095986$1$I$20240709$20240710$20240716$20240716$PER$$US-SA-2024SA203396$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240716$$MD$US$US
240959871$24095987$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA204974$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240716$$CN$US$US
240959881$24095988$1$I$20240701$20240708$20240716$20240716$PER$$US-SA-2024SA202507$SANOFI AVENTIS$$$$$M$Y$$$20240716$$CN$US$US
240959891$24095989$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203463$SANOFI AVENTIS$$$$$M$Y$$$20240716$$CN$US$US
240959902$24095990$2$F$20240101$20240710$20240716$20240722$PER$$US-SA-2024SA204593$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240722$$MD$US$US
240959913$24095991$3$F$$20240729$20240716$20240807$PER$$US-SA-2024SA203101$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240807$$CN$US$US
240959921$24095992$1$I$20240708$20240708$20240716$20240716$PER$$US-SA-2024SA204054$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240716$$MD$US$US
240959931$24095993$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205347$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240959941$24095994$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205564$SANOFI AVENTIS$$$$A$F$Y$49$KG$20240716$$MD$US$US
240959951$24095995$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205055$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$CN$US$US
240959961$24095996$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA206373$SANOFI AVENTIS$$$$$F$Y$$$20240716$$LW$US$US
240959971$24095997$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA205745$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240716$$MD$US$US
240959981$24095998$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204345$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240716$$MD$US$US
240959991$24095999$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA206404$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240716$$MD$US$US
240960001$24096000$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204326$SANOFI AVENTIS$$$$C$M$Y$48$KG$20240716$$MD$US$US
240960011$24096001$1$I$20240701$20240710$20240716$20240716$PER$$US-SA-2024SA204784$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240716$$HP$US$US
240960021$24096002$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA205037$SANOFI AVENTIS$$$$A$M$Y$83.46$KG$20240716$$MD$US$US
240960031$24096003$1$I$$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024139644$AMGEN$$$$$F$Y$$$20240716$$MD$US$US
240960041$24096004$1$I$20240601$20240709$20240716$20240716$PER$$US-SA-2024SA204666$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240716$$MD$US$US
240960051$24096005$1$I$$20240708$20240716$20240716$EXP$$IN-AMGEN-INDSP2024138049$AMGEN$Tripathy S.K.; Majumdar S.D.; Pradhan S.S. et al.. A Short Course of Preoperative Denosumab Injection Followed by Surgery in High-Risk Giant Cell Tumors of the Extremities: A Retrospective Study. Indian Journal of Surgical Oncology. 2024;1- 12$38$YR$A$M$Y$$$20240716$$HP$IN$IN
240960061$24096006$1$I$20240701$20240708$20240716$20240716$PER$$US-SA-2024SA203245$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240716$$CN$US$US
240960071$24096007$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203572$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$CN$US$US
240960081$24096008$1$I$20240101$20240710$20240716$20240716$PER$$US-SA-2024SA204629$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240716$$MD$US$US
240960091$24096009$1$I$20240709$20240709$20240716$20240716$PER$$US-SA-2024SA202905$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240716$$CN$US$US
240960102$24096010$2$F$$20240731$20240716$20240805$PER$$US-SA-2024SA184213$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240805$$MD$US$US
240960111$24096011$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA205709$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240716$$MD$US$US
240960121$24096012$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204500$SANOFI AVENTIS$$$$A$M$Y$$$20240716$$MD$US$US
240960131$24096013$1$I$$20200617$20240716$20240716$EXP$$AU-AstraZeneca-2020SE78958$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$AU$
240960141$24096014$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203432$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240716$$CN$US$US
240960151$24096015$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA204305$SANOFI AVENTIS$$44$YR$A$F$Y$87$KG$20240716$$MD$US$US
240960161$24096016$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA204584$SANOFI AVENTIS$$$$T$F$Y$$$20240716$$MD$US$US
240960171$24096017$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA204274$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240716$$MD$US$US
240960181$24096018$1$I$20240401$20240708$20240716$20240716$PER$$US-SA-2024SA204742$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240716$$MD$US$US
240960191$24096019$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA201507$SANOFI AVENTIS$$$$A$M$Y$$$20240716$$CN$US$US
240960201$24096020$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA204835$SANOFI AVENTIS$$26$YR$A$F$Y$65$KG$20240716$$MD$US$US
240960211$24096021$1$I$20240415$20240709$20240716$20240716$PER$$US-SA-2024SA203994$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240716$$PH$US$US
240960221$24096022$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA204272$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240716$$MD$US$US
240960231$24096023$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA204903$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240716$$CN$US$US
240960241$24096024$1$I$20190601$20190717$20240716$20240716$EXP$$US-AstraZeneca-2019SF04495$ASTRAZENECA$$1017$MON$$M$Y$79$KG$20240716$$CN$US$
240960251$24096025$1$I$$20240711$20240716$20240716$PER$$US-ABBVIE-5837832$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240960261$24096026$1$I$20200511$20200527$20240716$20240716$EXP$$US-AstraZeneca-2020SE69845$ASTRAZENECA$$77$YR$$F$Y$$$20240716$$CN$US$
240960271$24096027$1$I$$20190808$20240716$20240716$EXP$$US-AstraZeneca-2019SF14668$ASTRAZENECA$$$$$F$Y$90.7$KG$20240716$$CN$US$
240960281$24096028$1$I$20240501$20240712$20240716$20240716$EXP$$AR-BIOGEN-2024BI01273687$BIOGEN$$7$YR$$F$Y$$$20240716$$CN$AR$AR
240960291$24096029$1$I$$20191016$20240716$20240716$EXP$$US-AstraZeneca-2019SF48011$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240960301$24096030$1$I$$20190811$20240716$20240716$EXP$$RU-AstraZeneca-2019SF16181$ASTRAZENECA$$72$YR$$F$Y$$$20240716$$CN$RU$
240960311$24096031$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA203005$SANOFI AVENTIS$$$$A$M$Y$$$20240716$$HP$US$US
240960321$24096032$1$I$20240101$20240711$20240716$20240716$EXP$$US-AMGEN-USASP2024139270$AMGEN$$74$YR$E$F$Y$$$20240716$$HP$US$US
240960331$24096033$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA205026$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240716$$MD$US$US
240960341$24096034$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205214$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240716$$CN$US$US
240960351$24096035$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA204992$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240716$$MD$US$US
240960361$24096036$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204324$SANOFI AVENTIS$$45$YR$A$F$Y$96.1$KG$20240716$$MD$US$US
240960371$24096037$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203189$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240716$$CN$US$US
240960381$24096038$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204333$SANOFI AVENTIS$$$$E$F$Y$$$20240716$$MD$US$US
240960391$24096039$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205856$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240716$$MD$US$US
240960414$24096041$4$F$20240708$20240827$20240716$20240911$EXP$$US-SA-2024SA204153$SANOFI AVENTIS$$72$YR$E$M$Y$95.7$KG$20240911$$MD$US$US
240960421$24096042$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA202639$SANOFI AVENTIS$$$$C$M$Y$$$20240716$$MD$US$US
240960431$24096043$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA206438$SANOFI AVENTIS$$$$C$F$Y$$$20240716$$MD$US$US
240960441$24096044$1$I$20230101$20240710$20240716$20240716$PER$$US-SA-2024SA204946$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240716$$CN$US$US
240960451$24096045$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA143586$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240716$$MD$US$US
240960462$24096046$2$F$20240810$20240811$20240716$20240820$PER$$US-SA-2024SA159456$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240820$$MD$US$US
240960471$24096047$1$I$20240101$20240710$20240716$20240716$PER$$US-SA-2024SA206399$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240716$$MD$US$US
240960481$24096048$1$I$20240601$20240708$20240716$20240716$PER$$US-SA-2024SA205462$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240716$$MD$US$US
240960491$24096049$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA203876$SANOFI AVENTIS$$$$A$M$Y$$$20240716$$MD$US$US
240960502$24096050$2$F$20240101$20240803$20240716$20240811$PER$$US-SA-2024SA202945$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240811$$MD$US$US
240960511$24096051$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA206216$SANOFI AVENTIS$$$$E$M$Y$79.37$KG$20240716$$MD$US$US
240960521$24096052$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA205127$SANOFI AVENTIS$$32$YR$A$F$Y$78.92$KG$20240716$$MD$US$US
240960531$24096053$1$I$20240101$20240710$20240716$20240716$PER$$US-SA-2024SA205365$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240716$$MD$US$US
240960542$24096054$2$F$20240101$20240828$20240716$20240919$PER$$US-SA-2024SA204311$SANOFI AVENTIS$$7$YR$C$F$Y$24.9$KG$20240919$$MD$US$US
240960551$24096055$1$I$20240401$20240710$20240716$20240716$PER$$US-SA-2024SA204676$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240716$$MD$US$US
240960561$24096056$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA202937$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240716$$MD$US$US
240960571$24096057$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA203087$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240716$$MD$US$US
240960581$24096058$1$I$20240707$20240710$20240716$20240716$PER$$US-SA-2024SA203604$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240716$$CN$US$US
240960591$24096059$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204516$SANOFI AVENTIS$$$$C$M$Y$$$20240716$$MD$US$US
240960601$24096060$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203276$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240716$$MD$US$US
240960611$24096061$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA204173$SANOFI AVENTIS$$56$YR$A$F$Y$118$KG$20240716$$MD$US$US
240960622$24096062$2$F$20240101$20240912$20240716$20240922$PER$$US-SA-2024SA204362$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240922$$MD$US$US
240960632$24096063$2$F$20240701$20240826$20240716$20240913$PER$$US-SA-2024SA206258$SANOFI AVENTIS$$60$YR$A$F$Y$88.904$KG$20240913$$MD$US$US
240960651$24096065$1$I$20240601$20240710$20240716$20240716$PER$$US-SA-2024SA206030$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240716$$MD$US$US
240960662$24096066$2$F$20240101$20240812$20240716$20240819$PER$$US-SA-2024SA205738$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240819$$MD$US$US
240960671$24096067$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205158$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240960681$24096068$1$I$20081206$20240711$20240716$20240716$EXP$$NL-ASTELLAS-2024EU006907$ASTELLAS$$53$YR$$F$Y$$$20240716$$HP$GB$NL
240960691$24096069$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203575$SANOFI AVENTIS$$$$A$M$Y$$$20240716$$CN$US$US
240960701$24096070$1$I$20230701$20240709$20240716$20240716$PER$$US-SA-2024SA205884$SANOFI AVENTIS$$$$A$M$Y$88$KG$20240716$$MD$US$US
240960711$24096071$1$I$20240715$20240715$20240715$20240715$DIR$710218$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240960721$24096072$1$I$20200101$20240703$20240716$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06247$HIKMA$Yan A, Gallardo M, Savu A, Kaffenberger B. Yan A, Gallardo M, Savu A, Kaffenberger B. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management.. Archives of Dermatological Research. 2024;316(7):397$59$YR$$M$Y$$$20240716$$MD$US$US
240960731$24096073$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203809$SANOFI AVENTIS$$$$$$Y$$$20240716$$MD$US$US
240960741$24096074$1$I$20230419$20240706$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-034008$AUROBINDO$$42$YR$$F$Y$77$KG$20240716$$MD$FR$FR
240960751$24096075$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA202923$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240716$$MD$US$US
240960761$24096076$1$I$20240627$20240710$20240716$20240716$PER$$US-SA-2023SA134552$SANOFI AVENTIS$$45$YR$A$M$Y$62.59$KG$20240716$$MD$US$US
240960771$24096077$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204511$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240960782$24096078$2$F$$20240722$20240716$20240731$PER$$US-SA-2024SA204347$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240731$$MD$US$US
240960791$24096079$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204469$SANOFI AVENTIS$$$$A$F$Y$65$KG$20240716$$MD$US$US
240960801$24096080$1$I$20240704$20240708$20240716$20240716$PER$$US-SA-2024SA204609$SANOFI AVENTIS$$58$YR$A$M$Y$72.121$KG$20240716$$MD$US$US
240960811$24096081$1$I$20240525$20240710$20240716$20240716$PER$$US-SA-2024SA206310$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240716$$MD$US$US
240960831$24096083$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204199$SANOFI AVENTIS$$$$A$M$Y$94$KG$20240716$$MD$US$US
240960841$24096084$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA205972$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240716$$MD$US$US
240960851$24096085$1$I$20240601$20240709$20240716$20240716$PER$$US-SA-2024SA204837$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240716$$MD$US$US
240960862$24096086$2$F$20240101$20240805$20240716$20240813$PER$$US-SA-2024SA204560$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240814$$MD$US$US
240960871$24096087$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA205823$SANOFI AVENTIS$$54$YR$A$F$Y$120$KG$20240716$$MD$US$US
240960881$24096088$1$I$20240601$20240710$20240716$20240716$PER$$US-SA-2024SA205025$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$HP$US$US
240960891$24096089$1$I$20220101$20240708$20240716$20240716$PER$$US-SA-2024SA204320$SANOFI AVENTIS$$63$YR$A$M$Y$113$KG$20240716$$MD$US$US
240960901$24096090$1$I$20240601$20240708$20240716$20240716$PER$$US-SA-2024SA206167$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240716$$MD$US$US
240960911$24096091$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA203683$SANOFI AVENTIS$$$$A$M$Y$$$20240716$$MD$US$US
240960921$24096092$1$I$20240214$20240708$20240716$20240716$PER$$US-SA-2024SA204263$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240716$$MD$US$US
240960931$24096093$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA206279$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240716$$MD$US$US
240960941$24096094$1$I$20240706$20240708$20240716$20240716$PER$$US-SA-2024SA202637$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240716$$CN$US$US
240960952$24096095$2$F$$20240912$20240716$20240926$PER$$US-SA-2024SA206638$SANOFI AVENTIS$$$$T$F$Y$81.646$KG$20240926$$MD$US$US
240960961$24096096$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203566$SANOFI AVENTIS$$$$$M$Y$$$20240716$$HP$US$US
240960972$24096097$2$F$20240101$20240904$20240716$20240927$PER$$US-SA-2024SA204350$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240927$$MD$US$US
240960981$24096098$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA203958$SANOFI AVENTIS$$$$E$F$Y$$$20240716$$MD$US$US
240961001$24096100$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA198206$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240716$$MD$US$US
240961011$24096101$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205472$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240961021$24096102$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205176$SANOFI AVENTIS$$$$$F$Y$$$20240716$$CN$US$US
240961031$24096103$1$I$20240401$20240709$20240716$20240716$PER$$US-SA-2024SA204752$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240716$$MD$US$US
240961041$24096104$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA159202$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240716$$MD$US$US
240961051$24096105$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA206080$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240716$$CN$US$US
240961062$24096106$2$F$20240501$20240911$20240716$20240927$PER$$US-SA-2024SA206919$SANOFI AVENTIS$$38$YR$A$F$Y$83.91$KG$20240927$$MD$US$US
240961071$24096107$1$I$$20240711$20240716$20240716$PER$$US-SA-2024SA206306$SANOFI AVENTIS$$$$E$M$Y$$$20240716$$MD$US$US
240961081$24096108$1$I$$20240711$20240716$20240716$PER$$US-SA-2024SA206276$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240716$$MD$US$US
240961092$24096109$2$F$20240709$20240715$20240716$20240724$PER$$US-SA-2024SA207147$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240724$$MD$US$US
240961101$24096110$1$I$$20240711$20240716$20240716$PER$$US-SA-2024SA206539$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240716$$MD$US$US
240961111$24096111$1$I$$20240711$20240716$20240716$PER$$US-SA-2024SA100898$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240716$$CN$US$US
240961121$24096112$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204574$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240716$$MD$US$US
240961141$24096114$1$I$$20240711$20240716$20240716$PER$$US-SA-2024SA206455$SANOFI AVENTIS$$10$YR$C$M$Y$27.7$KG$20240716$$MD$US$US
240961151$24096115$1$I$20240710$20240711$20240716$20240716$PER$$US-SA-2024SA205928$SANOFI AVENTIS$$$$$F$Y$$$20240716$$HP$US$US
240961161$24096116$1$I$20240710$20240710$20240716$20240716$PER$$US-SA-2024SA206869$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240716$$MD$US$US
240961171$24096117$1$I$$20240712$20240716$20240716$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14043$IPSEN$$$$$F$Y$$$20240716$$CN$US$US
240961181$24096118$1$I$20240630$20240715$20240716$20240716$PER$$US-BAYER-2024A101499$BAYER$$25$YR$A$F$Y$$$20240716$$HP$US$US
240961191$24096119$1$I$20240713$20240713$20240716$20240716$EXP$$NVSC2024US145939$NOVARTIS$$90$YR$$M$Y$$$20240716$$CN$US$US
240961201$24096120$1$I$20240201$20240708$20240716$20240716$EXP$$FR-ASTELLAS-2024EU006837$ASTELLAS$$40$YR$$F$Y$$$20240716$$MD$FR$FR
240961211$24096121$1$I$20240618$20240710$20240716$20240716$EXP$IT-MINISAL02-994407$IT-BIOCON BIOLOGICS LIMITED-BBL2024005139$BIOCON$$$$$$Y$$$20240716$$MD$IT$IT
240961221$24096122$1$I$20240709$20240715$20240715$20240715$DIR$710217$$FDA-CTU$$29$YR$$F$N$69.75$KG$20240715$N$CN$US$
240961241$24096124$1$I$20240523$20240711$20240716$20240716$EXP$FR-AFSSAPS-NT2024000766$FR-CHEPLA-2024008808$CHEPLAPHARM$$63$YR$$F$Y$32$KG$20240716$$HP$COUNTRY NOT SPECIFIED$FR
240961253$24096125$3$F$20181120$20240815$20240716$20240819$EXP$$CO-SANDOZ INC.-PHHY2018CO200874$SANDOZ$$63$YR$$M$Y$85$KG$20240819$$CN$CO$CO
240961271$24096127$1$I$20161001$20240711$20240716$20240716$EXP$$FR-PFIZER INC-2016SGN01970$PFIZER$$26$YR$$M$Y$68$KG$20240716$$MD$FR$FR
240961283$24096128$3$F$20230505$20240826$20240716$20240830$EXP$$AT-PFIZER INC-2023SGN11028$PFIZER$$32$YR$$F$Y$62$KG$20240830$$MD$AT$AT
240961293$24096129$3$F$20150101$20240730$20240716$20240801$EXP$$FR-PFIZER INC-2016SGN00061$PFIZER$$55$YR$$M$Y$68$KG$20240801$$HP$FR$FR
240961301$24096130$1$I$20230901$20240712$20240716$20240716$PER$$US-BAYER-2024A101356$BAYER$$$$$F$Y$$$20240716$$CN$US$US
240961312$24096131$2$F$$20240723$20240716$20240802$EXP$$FR-TEVA-VS-3217200$TEVA$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. J-Clin-Immunol 2023; 43 (3): 647-652.; Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. J-Clin-Immunol 2023; 43 (3): 647-652.; Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al. Primary Inv...$33$YR$$M$Y$$$20240802$$HP$FR$FR
240961321$24096132$1$I$20230901$20240709$20240716$20240716$EXP$$PT-009507513-2407PRT005796$MERCK$$39$YR$$F$Y$$$20240716$$MD$PT$PT
240961331$24096133$1$I$20240601$20240712$20240716$20240716$PER$$US-ORGANON-O2407USA001312$ORGANON$$$$$$Y$$$20240716$$CN$US$US
240961381$24096138$1$I$20240629$20240715$20240715$20240715$DIR$710248$$FDA-CTU$$33$YR$$M$N$103.5$KG$20240715$N$CN$US$
240961391$24096139$1$I$$20240715$20240715$20240715$DIR$710264$$FDA-CTU$$$$$UNK$N$$$20240715$$CN$US$
240961402$24096140$2$F$$20240806$20240716$20240816$30DAY$$US-GSK-US2024086591$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
240961411$24096141$1$I$$20240708$20240716$20240716$EXP$$ES-JNJFOC-20240723782$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$CN$ES$ES
240961431$24096143$1$I$20240102$20240715$20240715$20240715$DIR$710250$$FDA-CTU$$52$YR$$F$N$99$KG$20240715$N$CN$US$
240961441$24096144$1$I$20240629$20240715$20240715$20240715$DIR$710306$$FDA-CTU$$32$YR$$F$N$54$KG$20240715$N$CN$GU$
240961451$24096145$1$I$$20240709$20240716$20240716$EXP$$US-JNJFOC-20240722809$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$HP$US$US
240961461$24096146$1$I$$20240708$20240716$20240716$PER$$US-BAYER-2024A098255$BAYER$$$$$M$Y$$$20240716$$CN$US$US
240961474$24096147$4$F$20221201$20240912$20240716$20240916$EXP$$NVSC2023GB047922$NOVARTIS$$$$$F$Y$$$20240916$$CN$GB$GB
240961481$24096148$1$I$$20240715$20240716$20240716$PER$$US-AMGEN-USASP2024140360$AMGEN$$40$YR$A$F$Y$$$20240716$$CN$US$US
240961491$24096149$1$I$$20240715$20240716$20240716$EXP$$CA-SANDOZ INC.-SDZ2024CA065405$SANDOZ$$14$YR$$M$Y$41$KG$20240716$$PH$CA$CA
240961501$24096150$1$I$$20240711$20240716$20240716$EXP$$US-AMGEN-USASP2024138290$AMGEN$Patel B.; Hathaway Q.A.; Abdeen Y. et al.. Prediction of heart failure and all-cause mortality using cardiac ultrasomics in patients with breast cancer. The International Journal of Cardiovascular Imaging. 2024;40 (6):1305-1317$$$$$Y$$$20240716$$HP$US$US
240961511$24096151$1$I$20240501$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008721$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$US$US
240961521$24096152$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008183$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240716$$HP$US$US
240961531$24096153$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008538$ELI LILLY AND CO$$$$$M$Y$$$20240716$$CN$US$US
240961541$24096154$1$I$$20240708$20240716$20240716$EXP$$US-AMGEN-USASP2024136310$AMGEN$Shostak E.; Amin R.; Braverman G. et al.. Progressive Dyspnea in a Woman With Tracheal Stenosis and Rheumatoid Arthritis. chest. 2024;166 (1):e15-e20$82$YR$E$F$Y$$$20240716$$MD$US$US
240961551$24096155$1$I$$20240712$20240716$20240716$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-14055$IPSEN$$$$$F$Y$$$20240716$$CN$GB$GB
240961561$24096156$1$I$$20240613$20240716$20240716$EXP$$PK-ROCHE-3562361$ROCHE$$68$YR$E$F$Y$$$20240716$$CN$PK$PK
240961571$24096157$1$I$$20240708$20240716$20240716$PER$$US-JNJFOC-20240738509$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$HP$US$US
240961581$24096158$1$I$$20240709$20240716$20240716$PER$$US-JNJFOC-20240738391$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$PH$US$US
240961591$24096159$1$I$20231114$20240711$20240716$20240716$EXP$$CN-JNJFOC-20240733143$JOHNSON AND JOHNSON$$55$YR$A$M$Y$74$KG$20240716$$HP$CN$CN
240961602$24096160$2$F$$20240807$20240716$20240819$30DAY$$BE-JNJFOC-20240733359$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$PH$BE$BE
240961611$24096161$1$I$$20240701$20240716$20240716$EXP$$FR-TEVA-VS-3217202$TEVA$Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. J-Clin-Immunol 2023; 43 (3): 647-652.; Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. J-Clin-Immunol 2023; 43 (3): 647-652.$4$YR$$F$Y$$$20240716$$HP$FR$FR
240961631$24096163$1$I$20240612$20240705$20240716$20240716$EXP$$IN-ROCHE-10000022941$ROCHE$$56$YR$A$M$Y$$$20240716$$CN$IN$IN
240961641$24096164$1$I$20240701$20240712$20240716$20240716$EXP$GB-MHRA-MED-202407110949461770-RVFNY$GB-JNJFOC-20240732824$JOHNSON AND JOHNSON$$75$YR$E$F$Y$61$KG$20240716$$PH$GB$GB
240961651$24096165$1$I$$20240715$20240716$20240716$EXP$$US-INCYTE CORPORATION-2024IN007424$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240961661$24096166$1$I$20230911$20240701$20240716$20240716$EXP$$US-COOPERSURGICAL, INC.-2024CPS002073$COOPERSURGICAL$$$$$F$Y$$$20240716$$LW$US$US
240961671$24096167$1$I$20220620$20240701$20240716$20240716$EXP$$US-COOPERSURGICAL, INC.-2024CPS002078$COOPERSURGICAL$$$$$F$Y$$$20240716$$LW$US$US
240961681$24096168$1$I$20240715$20240715$20240716$20240716$PER$$US-AMGEN-USASP2024140393$AMGEN$$70$YR$E$M$Y$$$20240716$$CN$US$US
240961693$24096169$3$F$20240714$20240815$20240716$20240820$PER$$US-AMGEN-USASP2024140396$AMGEN$$68$YR$E$F$Y$$$20240820$$CN$US$US
240961701$24096170$1$I$$20240616$20240716$20240716$PER$$US-009507513-2406USA005553$MERCK$$$$$M$Y$$$20240716$$MD$US$US
240961712$24096171$2$F$20240714$20240716$20240716$20240717$PER$$US-AMGEN-USASP2024140485$AMGEN$$65$YR$E$M$Y$$$20240716$$CN$US$US
240961721$24096172$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024139299$AMGEN$$$$$$Y$$$20240716$$PH$US$US
240961732$24096173$2$F$20230711$20240822$20240716$20240830$EXP$FR-AFSSAPS-PP2024000692$FR-CHEPLA-2024008717$CHEPLAPHARM$$0$YR$N$F$Y$2.5$KG$20240830$$MD$COUNTRY NOT SPECIFIED$FR
240961742$24096174$2$F$$20240711$20240716$20240725$30DAY$$US-JNJFOC-20240729942$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
240961751$24096175$1$I$20240628$20240711$20240716$20240716$EXP$$JP-JNJFOC-20240740665$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$MD$JP$JP
240961762$24096176$2$F$$20240812$20240716$20240815$30DAY$$TR-JNJFOC-20240730989$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$TR$TR
240961771$24096177$1$I$$20190730$20240716$20240716$EXP$$US-AstraZeneca-2018SF35650$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240961781$24096178$1$I$20190530$20190823$20240716$20240716$EXP$$CA-AstraZeneca-2019SE94357$ASTRAZENECA$$29773$DY$$F$Y$$$20240716$$CN$CA$
240961791$24096179$1$I$20210901$20240618$20240716$20240716$PER$$US-009507513-2406USA006326$MERCK$$83$YR$$F$Y$$$20240716$$CN$US$US
240961802$24096180$2$F$20240531$20240730$20240716$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-033999$AUROBINDO$$88$YR$$F$Y$78$KG$20240809$$PH$FR$FR
240961811$24096181$1$I$20240423$20240706$20240716$20240716$EXP$$FR-AUROBINDO-AUR-APL-2024-033996$AUROBINDO$$76$YR$$F$Y$$$20240716$$PH$FR$FR
240961821$24096182$1$I$20240529$20240708$20240716$20240716$EXP$AT-BASGAGES-2024-004809$AT-TEVA-VS-3218699$TEVA$$57$YR$$F$Y$$$20240716$$PH$AT$AT
240961831$24096183$1$I$20240702$20240703$20240716$20240716$EXP$$US-BRAEBURN-US-BRA-24-000626$BRAEBURN PHARMACEUTICALS$$32$YR$$M$Y$$$20240716$$HP$US$US
240961841$24096184$1$I$20200506$20240706$20240716$20240716$EXP$$PL-AUROBINDO-AUR-APL-2024-034215$AUROBINDO$$40$YR$$M$Y$80$KG$20240716$$MD$PL$PL
240961862$24096186$2$F$20240709$20240731$20240716$20240809$EXP$$CO-UCBSA-2024035803$UCB$$59$YR$$F$Y$$$20240809$$CN$CO$CO
240961901$24096190$1$I$$20240715$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112700$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240716$$CN$US$US
240961911$24096191$1$I$$20240705$20240716$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06400$HIKMA$Landers ZD, Mazhar A.. Landers ZD, Mazhar A. Fluoroquinolone-Induced Multisystem Toxicity: A Case Report.. Cureus. 2024;16(5):e61174.$$$$$Y$$$20240716$$MD$US$US
240961931$24096193$1$I$20240412$20240708$20240716$20240716$EXP$$JP-009507513-2405JPN003350J$MERCK$$45$YR$$F$Y$$$20240716$$MD$JP$JP
240961941$24096194$1$I$20240620$20240710$20240716$20240716$EXP$$UA-ABBVIE-5831195$ABBVIE$$62$YR$$F$Y$$$20240715$$HP$DE$DE
240961952$24096195$2$F$$20240723$20240716$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-112033$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240910$$MD$JP$JP
240961971$24096197$1$I$20211128$20240715$20240716$20240716$EXP$$US-INCYTE CORPORATION-2024IN007433$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240961981$24096198$1$I$20240702$20240715$20240715$20240715$DIR$710226$$FDA-CTU$$68$YR$$F$N$79.65$KG$20240715$N$CN$US$
240961991$24096199$1$I$20240604$20240715$20240716$20240716$EXP$FR-AFSSAPS-PO2024000767$FR-SA-2024SA206432$SANOFI AVENTIS$$76$YR$E$M$Y$76$KG$20240716$$MD$FR$FR
240962011$24096201$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48923$$FDA-CTU$$4$YR$$F$N$$$20240715$N$$US$
240962021$24096202$1$I$$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48929$$FDA-CTU$$$$$M$N$$$20240712$N$HP$US$
240962031$24096203$1$I$20240101$20240710$20240716$20240716$PER$$US-SA-2024SA206504$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240716$$MD$US$US
240962041$24096204$1$I$20240101$20240705$20240716$20240716$PER$$US-SA-2024SA207035$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240716$$MD$US$US
240962051$24096205$1$I$20231017$20240706$20240716$20240716$PER$$US-SA-2024SA206341$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240716$$MD$US$US
240962074$24096207$4$F$20240101$20240815$20240716$20240822$PER$$US-AMGEN-USASP2024139246$AMGEN$$63$YR$A$M$Y$$$20240822$$CN$US$US
240962081$24096208$1$I$20240713$20240715$20240716$20240716$PER$$US-AMGEN-USASP2024140438$AMGEN$$66$YR$E$M$Y$$$20240716$$CN$US$US
240962092$24096209$2$F$$20240830$20240716$20240913$PER$$US-SA-2024SA204959$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240913$$MD$US$US
240962101$24096210$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA203310$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240716$$MD$US$US
240962113$24096211$3$F$20240101$20240807$20240716$20240820$PER$$US-SA-2024SA205878$SANOFI AVENTIS$$53$YR$A$F$Y$92.5$KG$20240820$$MD$US$US
240962121$24096212$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA205443$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240716$$MD$US$US
240962131$24096213$1$I$20240401$20240709$20240716$20240716$PER$$US-SA-2024SA206081$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240716$$CN$US$US
240962141$24096214$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA206207$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240716$$MD$US$US
240962151$24096215$1$I$20240705$20240709$20240716$20240716$PER$$US-SA-2024SA204697$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240716$$MD$US$US
240962161$24096216$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA207292$SANOFI AVENTIS$$$$A$$Y$$$20240716$$CN$US$US
240962171$24096217$1$I$20220801$20240708$20240716$20240716$PER$$US-SA-2022SA467508$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240716$$MD$US$US
240962181$24096218$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203207$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240962191$24096219$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205454$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240716$$MD$US$US
240962201$24096220$1$I$20240527$20240710$20240716$20240716$PER$$US-SA-2024SA205893$SANOFI AVENTIS$$77$YR$E$F$Y$55.7$KG$20240716$$MD$US$US
240962211$24096221$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA207064$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240962221$24096222$1$I$20240101$20240710$20240716$20240716$PER$$US-SA-2024SA204727$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240716$$CN$US$US
240962231$24096223$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205286$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240716$$CN$US$US
240962241$24096224$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA196650$SANOFI AVENTIS$$$$A$F$Y$71$KG$20240716$$MD$US$US
240962251$24096225$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA206582$SANOFI AVENTIS$$$$E$M$Y$95.2$KG$20240716$$MD$US$US
240962261$24096226$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205113$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240716$$MD$US$US
240962271$24096227$1$I$20221008$20240711$20240716$20240716$EXP$$DE-MYLANLABS-2024M1064771$MYLAN$$17$YR$$F$Y$$$20240716$$CN$DE$DE
240962281$24096228$1$I$$20240619$20240716$20240716$PER$$US-009507513-2406USA006703$MERCK$Raymond-Forde S., Raymond-Forde S., Godfrey A.M., Alexander K.R. The Gift of a Heart, With Strings Attached: A Case of Strongyloides Stercoralis Hyperinfection Syndrome With Fulminant Respiratory Failure. American Journal of Respiratory and Critical Care Medicine. 2024;209$43$YR$$F$Y$$$20240716$$HP$US$US
240962292$24096229$2$F$$20240705$20240716$20240913$EXP$$BE-BAYER-2024A100706$BAYER$Ruythooren F.; Ghijselings S.; Depypere M.; Metsemakers W.-J.; Henckaerts L.; Noppe N.; Vles G.. Ureaplasma urealyticum osteomyelitis of the greater trochanter in a patient with multiple sclerosis using ocrelizumab - A case report. Journal of Bone and Joint Infection. 2024;9:3:167-171$26$YR$A$M$Y$$$20240913$$HP$BE$BE
240962301$24096230$1$I$20240409$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456591$RANBAXY$$94$YR$$F$Y$$$20240716$$MD$IT$IT
240962311$24096231$1$I$20231108$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456763$RANBAXY$$60$YR$$F$Y$70$KG$20240716$$MD$FR$FR
240962321$24096232$1$I$20240404$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456756$RANBAXY$$65$YR$$F$Y$80$KG$20240716$$MD$IT$IT
240962331$24096233$1$I$20240328$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456755$RANBAXY$$87$YR$$M$Y$$$20240716$$MD$FR$FR
240962341$24096234$1$I$20240528$20240701$20240716$20240716$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456981$RANBAXY$$66$YR$$M$Y$73$KG$20240716$$CN$GB$GB
240962351$24096235$1$I$$20240701$20240716$20240716$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456813$RANBAXY$$15$YR$$F$Y$$$20240716$$HP$GB$GB
240962361$24096236$1$I$20240319$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456735$RANBAXY$$89$YR$$F$Y$56$KG$20240716$$PH$FR$FR
240962371$24096237$1$I$20240311$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456716$RANBAXY$$67$YR$$F$Y$112$KG$20240716$$MD$FR$FR
240962381$24096238$1$I$20240327$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456689$RANBAXY$$62$YR$$F$Y$$$20240716$$MD$IT$IT
240962391$24096239$1$I$$20240701$20240716$20240716$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455826$RANBAXY$$53$YR$$M$Y$135$KG$20240716$$CN$NL$NL
240962401$24096240$1$I$20231004$20240701$20240716$20240716$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456403$RANBAXY$$76$YR$$F$Y$$$20240716$$PH$ES$ES
240962411$24096241$1$I$20240606$20240701$20240716$20240716$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456732$RANBAXY$$83$YR$$$Y$$$20240716$$PH$GB$GB
240962421$24096242$1$I$20240425$20240701$20240716$20240716$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455903$RANBAXY$$74$YR$$F$Y$$$20240716$$PH$GB$GB
240962431$24096243$1$I$20230101$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456653$RANBAXY$$47$YR$$F$Y$$$20240716$$MD$IT$IT
240962441$24096244$1$I$$20240701$20240716$20240716$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456433$RANBAXY$Ninkov T, Chan J, Von Nida J. A Case of Terbinafine-Induced Subacute Cutaneous Lupus Erythematosus rapidly resolving with Upadacitinib.. Clin Exp Dermatol. 2024;0 (0):1-3$71$YR$$F$Y$$$20240716$$HP$AU$AU
240962451$24096245$1$I$20230609$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455902$RANBAXY$$38$YR$$M$Y$$$20240716$$MD$IT$IT
240962461$24096246$1$I$20240203$20240701$20240716$20240716$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456681$RANBAXY$$31$YR$$M$Y$70$KG$20240716$$MD$DE$DE
240962471$24096247$1$I$20231128$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456405$RANBAXY$$59$YR$$M$Y$128$KG$20240716$$PH$FR$FR
240962481$24096248$1$I$20240301$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455686$RANBAXY$$34$YR$$M$Y$$$20240716$$PH$FR$FR
240962491$24096249$1$I$20240313$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456819$RANBAXY$$17$YR$$M$Y$$$20240716$$MD$FR$FR
240962501$24096250$1$I$20220501$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456791$RANBAXY$$58$YR$$F$Y$70$KG$20240716$$MD$IT$IT
240962521$24096252$1$I$$20240701$20240716$20240716$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456280$RANBAXY$Najera-Chavez BC, Seeber L, Goldhahn K, Panzer A. Use of Sodium Channel Blockers in the Thr226Met Pathologic Variant of SCN1A: A Case Report. Neuropediatrics. 2022;54:417-421$12$WK$$$Y$$$20240716$$HP$DE$DE
240962531$24096253$1$I$$20240701$20240716$20240716$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456814$RANBAXY$$78$YR$$M$Y$$$20240716$$PH$GB$GB
240962541$24096254$1$I$$20240701$20240716$20240716$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456327$RANBAXY$Sato T, Fukui S, Nakano T, Hasegawa K, Kikuta H, Kameyama T, et al.. Balloon pulmonary angioplasty under awake veno-arterial extracorporeal membrane oxygenation in a patient with class III obesity with chronic thromboembolic pulmonary hypertension complicated with multiple serious comorbidities.. Pulm Circ. 2024;14 (2):1-4$43$YR$$F$Y$168$KG$20240716$$HP$JP$JP
240962551$24096255$1$I$20240410$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456344$RANBAXY$$22$YR$$F$Y$$$20240716$$MD$IT$IT
240962561$24096256$1$I$20240307$20240701$20240716$20240716$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456389$RANBAXY$Desiderio G, Maria FD, Alkojok A, Galizia V, Arena G, Macarie I et al.. PROGRESSES AND CHALLENGES IN THE MANAGEMENT OF MULTIPLE MYELOMA: NAVIGATING THROUGH A RELAPSING-REMITTING COURSE. Acta Medica Marisiensis. 2024;Vol.70, Suppl.3:194$58$YR$$M$Y$$$20240716$$HP$RO$RO
240962571$24096257$1$I$20240322$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456455$RANBAXY$$30$YR$$M$Y$50$KG$20240716$$MD$FR$FR
240962581$24096258$1$I$$20240701$20240716$20240716$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456919$RANBAXY$Tanioka N, Kuwahara M, Sakai T, Nokubo Y, Shimizu S, Hiroi M, et al. Minimally invasive conversion surgery for unresectable gastric cancer with splenic metastasis and splenic vein tumor thrombus: a case report. Curr Oncol. 2024;31(5):2662-2669$67$YR$$M$Y$$$20240716$$HP$JP$JP
240962591$24096259$1$I$20231104$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455820$RANBAXY$$59$YR$$F$Y$78$KG$20240716$$MD$FR$FR
240962601$24096260$1$I$20240308$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456712$RANBAXY$$68$YR$$M$Y$69.5$KG$20240716$$MD$FR$FR
240962611$24096261$1$I$20240101$20240701$20240716$20240716$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456418$RANBAXY$$59$YR$$M$Y$$$20240716$$MD$SE$SE
240962621$24096262$1$I$20230901$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456812$RANBAXY$$99$YR$$M$Y$67.3$KG$20240716$$PH$FR$FR
240962631$24096263$1$I$$20240701$20240716$20240716$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456745$RANBAXY$Latorre S, Moreno I, Gordillo MJ. Case report: Three years of refractory atypical depression successfully treated with old school moclobemide. Eur Psychiatry. 2017;41(1):239$54$YR$$F$Y$$$20240716$$HP$ES$ES
240962641$24096264$1$I$20230615$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456594$RANBAXY$$87$YR$$M$Y$$$20240716$$MD$FR$FR
240962651$24096265$1$I$$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456765$RANBAXY$$34$YR$$M$Y$$$20240716$$CN$FR$FR
240962661$24096266$1$I$$20240709$20240716$20240716$EXP$$US-SA-2024SA203583$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240716$$MD$US$US
240962671$24096267$1$I$20240709$20240715$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112616$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240716$$CN$US$US
240962682$24096268$2$F$20240101$20240726$20240716$20240802$EXP$$MX-SA-2024SA204693$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240802$$MD$MX$MX
240962691$24096269$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA207181$SANOFI AVENTIS$$$$A$M$Y$65.77$KG$20240716$$MD$US$US
240962711$24096271$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205084$SANOFI AVENTIS$$$$$$Y$$$20240716$$MD$US$US
240962721$24096272$1$I$$20240710$20240716$20240716$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039561$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240716$$CN$US$US
240962731$24096273$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA205043$SANOFI AVENTIS$$$$T$F$Y$47$KG$20240716$$MD$US$US
240962741$24096274$1$I$20240624$20240708$20240716$20240716$PER$$US-SA-2024SA205169$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240716$$MD$US$US
240962751$24096275$1$I$$20240715$20240715$20240715$DIR$710243$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240962761$24096276$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48997$$FDA-CTU$$$$$M$N$$$20240715$N$HP$US$
240962771$24096277$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205895$SANOFI AVENTIS$$$$A$F$Y$79.83$KG$20240716$$MD$US$US
240962781$24096278$1$I$$20240708$20240716$20240716$PER$$US-SA-2023SA367709$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240716$$CN$US$US
240962791$24096279$1$I$20240602$20240715$20240715$20240715$DIR$710206$$FDA-CTU$$44$YR$$F$N$88.2$KG$20240715$N$CN$US$
240962801$24096280$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48939$$FDA-CTU$$66$YR$$F$N$$$20240715$N$$US$
240962812$24096281$2$F$20240601$20240802$20240716$20240809$EXP$$FR-SA-2024SA204724$SANOFI AVENTIS$$88$YR$E$F$Y$78$KG$20240809$$PH$FR$FR
240962821$24096282$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48894$$FDA-CTU$$51$YR$$M$N$$$20240715$N$$US$
240962831$24096283$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204026$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240716$$CN$US$US
240962841$24096284$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205486$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240716$$MD$US$US
240962853$24096285$3$F$20240607$20240826$20240716$20240830$EXP$$US-INCYTE CORPORATION-2024IN006363$INCYTE$$$$$$Y$$$20240830$$CN$US$US
240962861$24096286$1$I$20240506$20240715$20240715$20240715$DIR$710287$$FDA-CTU$$47$YR$$F$N$67.5$KG$20240715$N$CN$US$
240962871$24096287$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48901$$FDA-CTU$$31$YR$$F$N$$$20240715$N$$US$
240962882$24096288$2$F$20240706$20240801$20240716$20240805$30DAY$$US-AMGEN-USASP2024136018$AMGEN$$67$YR$E$M$Y$68.49$KG$20240805$$PH$US$US
240962892$24096289$2$F$$20240809$20240716$20240820$PER$$US-SA-2024SA203057$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240820$$CN$US$US
240962901$24096290$1$I$20240301$20240709$20240716$20240716$PER$$US-SA-2024SA204337$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240716$$MD$US$US
240962911$24096291$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA204025$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240716$$MD$US$US
240962921$24096292$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205487$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240962931$24096293$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA207113$SANOFI AVENTIS$$$$T$F$Y$46$KG$20240716$$MD$US$US
240962941$24096294$1$I$$20240710$20240716$20240716$EXP$$US-JNJFOC-20240727435$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240716$$HP$US$US
240962952$24096295$2$F$20240621$20240710$20240716$20240718$EXP$$CN-JNJFOC-20240737855$JOHNSON AND JOHNSON$$$$N$M$Y$1$KG$20240718$$HP$CN$CN
240962961$24096296$1$I$20230323$20240711$20240716$20240716$EXP$$CN-JNJFOC-20240733377$JOHNSON AND JOHNSON$$59$YR$A$M$Y$72$KG$20240716$$HP$CN$CN
240962971$24096297$1$I$20240613$20240715$20240716$20240716$EXP$FR-AFSSAPS-NC2024000830$FR-GILEAD-2024-0680783$GILEAD$$27$YR$A$M$Y$$$20240716$$MD$FR$FR
240962981$24096298$1$I$20240605$20240705$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007131$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240962991$24096299$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008679$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240716$$CN$US$US
240963001$24096300$1$I$20240713$20240713$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009287$ELI LILLY AND CO$$$$A$F$Y$$$20240716$$CN$US$US
240963011$24096301$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008498$ELI LILLY AND CO$$$$$M$Y$$$20240716$$CN$US$US
240963022$24096302$2$F$$20240902$20240716$20240921$PER$$US-TEVA-VS-3220064$TEVA$$46$YR$$F$Y$$$20240921$$MD$US$US
240963031$24096303$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456548$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963042$24096304$2$F$$20240723$20240716$20240807$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456436$RANBAXY$Merrill K, Davis A, Jackson E, Riker M, Kirk C, Yung D. Direct prostacyclin transition in pediatric patients with pulmonary hypertension. Pulm Circ. 2024;14 (2):e12373;1-5$15$YR$$M$Y$55$KG$20240807$$HP$US$US
240963051$24096305$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008774$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240716$$CN$US$US
240963061$24096306$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456532$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963071$24096307$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456400$RANBAXY$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch Dermatol Res. 2024;May;316 (6):279(1-5)$26$YR$$F$Y$$$20240716$$HP$US$US
240963081$24096308$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456607$RANBAXY$Wong C, Ang G, Malik M, Iqbal S. From Tongue Swelling to Skin Sloughing: Azithromycin-induced SJS/TEN From Tongue Swelling to Skin Sloughing: Azithromycin-induced SJS/TEN. Am J Respir Crit Care Med. 2024;209 (0):A5659$71$YR$$F$Y$$$20240716$$HP$US$US
240963091$24096309$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456502$RANBAXY$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch Dermatol Res. 2024;316 (6):279(1-5)$49$YR$$F$Y$$$20240716$$HP$US$US
240963101$24096310$1$I$20221001$20240701$20240716$20240716$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456289$RANBAXY$Kayabasi M, Gorken IB, Durak I, Karaoglu A, Saatci AO. ERDAFITINIB-INDUCED BILATERAL MULTIFOCAL SEROUS RETINAL DETACHMENTS AND SEVERE DRY EYE RELATED UNILATERAL PERIPHERAL ULCERATIVE KERATITIS IN A PATIENT WITH METASTATIC UROTHELIAL CARCINOMA. Eur J Case Rep Intern Med. 2024;11(6):No pagination$76$YR$$M$Y$$$20240716$$HP$TR$TR
240963111$24096311$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456558$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963121$24096312$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456545$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963131$24096313$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456554$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963141$24096314$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456552$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963151$24096315$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456511$RANBAXY$Khattar G, Sanayeh EB, Makram M, Rabah H, Baker SA, Khan S, et al. The Concomitant Occurrence Of Hidradenitis Suppurativa And Fournier^s Gangrene. Eur J Case Rep Intern Med. 2024;11 (6):1-2$42$YR$$F$Y$$$20240716$$HP$US$US
240963161$24096316$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456534$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963171$24096317$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456540$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963181$24096318$1$I$$20240701$20240716$20240716$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456527$RANBAXY$Buhari GK, Erkekol FO, Pekel A, Yilmaz U, Keren M, Musabak U. Evaluation of the basophil activation in immediate type hypersensitivity reactions to chemotherapeutic agents. Alergo Polska. 2024;Jan-Mar;11 (1):48-55$$$$M$Y$$$20240716$$HP$TR$TR
240963191$24096319$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456438$RANBAXY$Hanif IH, Abdelrahim S, Al Shaarani M, Lu H, Ahmad R, Goswami S, et al. Immune Checkpoint Therapy-Induced Lupus Nephritis. Kidney Int Rep. 2024;9 (5):1534-1537$9$DEC$$M$Y$$$20240716$$HP$US$US
240963201$24096320$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456351$RANBAXY$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am J Transplant. 2023;23 (7):1048-1057$$$$M$Y$$$20240716$$HP$US$US
240963211$24096321$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456432$RANBAXY$Merrill K, Davis A, Jackson E, Riker M, Kirk C, Yung D. Direct prostacyclin transition in pediatric patients with pulmonary hypertension. Pulm Circ. 2024;14 (2):e12373;1-5$12$YR$$M$Y$38$KG$20240716$$HP$US$US
240963221$24096322$1$I$20240328$20240701$20240716$20240716$EXP$$HU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455641$RANBAXY$$30$YR$$M$Y$76$KG$20240716$$CN$HU$HU
240963231$24096323$1$I$$20240701$20240716$20240716$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456333$RANBAXY$Fernandez-Gordon Sanchez FM, Gomez Labrador C, Wong Becerra L, Paz Fernandez BA, Martinez Aguilar AP, Castano-Milla C. Active microscopic colitis precipitated by fluoxetine. Rev Esp Enferm Dig. 2024;0 (0):CC 10336$41$YR$$F$Y$$$20240716$$HP$ES$ES
240963241$24096324$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456474$RANBAXY$Laughter MR, Tegla CA, Pawar S, Moshiri AS, Orlow SJ. Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C. JAAD Case Rep. 2024;Jul; 49 (0):28-31$37$YR$$M$Y$$$20240716$$MD$US$US
240963251$24096325$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456349$RANBAXY$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am J Transplant. 2023;23 (7):1048-1057$$$$M$Y$$$20240716$$HP$US$US
240963261$24096326$1$I$$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456368$RANBAXY$La Spina M, Caruso M, Gulizia C, Comella M, Soma R, Meli M, et al. Diencephalic Syndrome: Misleading Clinical Onset of Low-Grade Glioma. Curr Oncol. 2023;30(9):8401-8410$$$C$F$Y$$$20240716$$HP$IT$IT
240963271$24096327$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456341$RANBAXY$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P,Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am J Transplant. 2023;23 (7):1048-1057$$$$F$Y$$$20240716$$HP$US$US
240963281$24096328$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456392$RANBAXY$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch Dermatol Res. 2024;May; 316 (6):279$75$YR$$M$Y$$$20240716$$HP$US$US
240963291$24096329$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456298$RANBAXY$Grodsky JD, Doshi R, Riaz KM. Medical management and visual rehabilitation of limbal niche dysfunction. J Cataract Refract Surg. 2020;Feb;46(2):312-316$61$YR$$F$Y$$$20240716$$MD$US$US
240963301$24096330$1$I$$20240705$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107691$BRISTOL MYERS SQUIBB$$16$YR$T$F$Y$$$20240716$$PH$US$US
240963311$24096331$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49000$$FDA-CTU$$61$YR$$F$N$$$20240715$N$$US$
240963331$24096333$1$I$20240520$20240712$20240715$20240715$DIR$FDA-CDER-CTU-2024-48963$$FDA-CTU$$20$YR$$M$N$$$20240712$N$HP$US$
240963341$24096334$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49003$$FDA-CTU$$57$YR$$F$N$167$LBS$20240715$N$$US$
240963351$24096335$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48920$$FDA-CTU$$67$YR$$M$N$$$20240715$N$$US$
240963361$24096336$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48926$$FDA-CTU$$62$YR$$F$N$79$LBS$20240715$N$$US$
240963381$24096338$1$I$$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-48908$$FDA-CTU$$$$$F$N$$$20240715$N$HP$US$
240963391$24096339$1$I$20240712$20240715$20240715$20240715$DIR$710216$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240963401$24096340$1$I$20240701$20240715$20240715$20240715$DIR$710214$$FDA-CTU$$60$YR$$F$N$103.05$KG$20240715$N$CN$US$
240963411$24096341$1$I$20240713$20240715$20240715$20240715$DIR$710222$$FDA-CTU$$91$YR$$F$N$$$20240715$N$HP$US$
240963431$24096343$1$I$20230511$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455390$RANBAXY$$44$YR$$F$Y$$$20240716$$MD$IT$IT
240963441$24096344$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456565$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963452$24096345$2$F$$20240724$20240716$20240808$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456577$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240808$$HP$US$US
240963461$24096346$1$I$20240402$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455471$RANBAXY$$71$YR$$F$Y$69$KG$20240716$$MD$FR$FR
240963471$24096347$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456556$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963481$24096348$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456574$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963501$24096350$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456539$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963511$24096351$1$I$20240120$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-452116$RANBAXY$$89$YR$$F$Y$76$KG$20240716$$PH$FR$FR
240963521$24096352$1$I$20230204$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455373$RANBAXY$$73$YR$$F$Y$80$KG$20240716$$MD$IT$IT
240963531$24096353$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456555$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963541$24096354$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456542$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963551$24096355$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456500$RANBAXY$Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Arch Dermatol Res. 2024;316 (6):279(1-5)$85$YR$$M$Y$$$20240716$$HP$US$US
240963561$24096356$1$I$20240702$20240715$20240715$20240715$DIR$710220$$FDA-CTU$$61$YR$$F$N$85.5$KG$20240715$N$CN$US$
240963571$24096357$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456475$RANBAXY$Lu Y, Neyra JA. How I Treat Rhabdomyolysis-Induced AKI?. CJASN. 2024;Mar; 19:385-387$40$YR$$M$Y$$$20240716$$HP$US$US
240963581$24096358$1$I$$20240701$20240716$20240716$EXP$$SY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456329$RANBAXY$Alsultan M, Kliea M, Hassan Q, Basha K. Delayed acyclovir therapy for disseminated varicella zoster in an adult kidney transplant recipient: a case report and literature review. Ann Med Surgery. 2023;85(3):519-523$31$YR$$M$Y$$$20240716$$MD$SY$SY
240963591$24096359$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456559$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963601$24096360$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456346$RANBAXY$Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, et al. Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. Am J Transplant. 2023;23 (7):1048-1057$$$A$M$Y$$$20240716$$HP$US$US
240963611$24096361$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456557$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963621$24096362$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456430$RANBAXY$Merrill K, Davis A, Jackson E, Riker M, Kirk C, Yung D. Direct prostacyclin transition in pediatric patients with pulmonary hypertension. Pulm Circ. 2024;14 (2):e12373;1-5$12$YR$$F$Y$41$KG$20240716$$HP$US$US
240963631$24096363$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456572$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963641$24096364$1$I$20240413$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405061021294440-DNLRH$GB-MYOVANT SCIENCES GMBH-2024MYSCI0700427$MYOVANT SCIENCES$$52$YR$$F$Y$60$KG$20240716$$CN$GB$GB
240963651$24096365$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456575$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963661$24096366$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456535$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963671$24096367$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456543$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240963681$24096368$1$I$$20240709$20240716$20240716$EXP$$US-KOANAAP-SML-US-2024-00729$Unknown Manufacturer$Hammond TC, Emeruwa I, Swain SR, Larson SM, Castells MC. Life-threatening Mast Cell Activation and Anaphylaxis in Mast Cell Leukemia and the Role of Omalizumab. Am-J-Respir-Crit-Care-Med. 2024;209: A5294.$31$YR$A$M$Y$$$20240716$$MD$US$US
240963691$24096369$1$I$$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456268$RANBAXY$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol Drug Saf. 2024;33 (6):e5814$14$YR$$F$Y$$$20240716$$HP$FR$FR
240963701$24096370$1$I$$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456270$RANBAXY$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol Drug Saf. 2024;33(6):e5814$$$A$$Y$$$20240716$$HP$FR$FR
240963711$24096371$1$I$$20240701$20240716$20240716$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456168$RANBAXY$Fu J, Chen L, Su T, Xu S, Liu Y. Mild phenotypes of phosphoglycerate dehydrogenase deficiency by a novel mutation of PHGDH gene: Case report and literature review. Int J Dev Neurosci. 2023;83:44-52$14$YR$$M$Y$32$KG$20240716$$HP$CN$CN
240963721$24096372$1$I$$20240701$20240716$20240716$EXP$$OM-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456271$RANBAXY$Madhani SAMA. PERITONEAL DIALYSIS FOR TREATING REFRACTORY ACIDOSIS IN A CHILD WITH DIABETIC KETOACIDOSIS A CASE REPORT. BMJ Paediatr Open. 2024;8(Suppl.):A21/57$24$MON$$M$Y$$$20240716$$HP$OM$OM
240963731$24096373$1$I$$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456269$RANBAXY$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol Drug Saf. 2024;33 (6):e5814$$$C$$Y$$$20240716$$HP$FR$FR
240963741$24096374$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456228$RANBAXY$$$$E$M$Y$$$20240716$$CN$US$US
240963751$24096375$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455131$RANBAXY$$$$$$Y$$$20240716$$HP$US$US
240963761$24096376$1$I$$20240701$20240716$20240716$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456263$RANBAXY$Chen M, Yao K, Cao M, Liu H, Xue C, Qin T, et al. HER2?targeting antibody-drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real?world study. Cancer Immunol Immunother. 2023;72:2309-2318$$$$$Y$$$20240716$$HP$CN$CN
240963772$24096377$2$F$$20240912$20240716$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455597$RANBAXY$Tardy C, Puszkiel A, Boudou-Rouquette P, De Percin S, Alexandre J, Berge M, et al. Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection.. Cancer Chemother Pharmacol. 2024;93:169-175$49$YR$$M$Y$64$KG$20240927$$HP$FR$FR
240963781$24096378$1$I$20240608$20240701$20240716$20240716$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455674$RANBAXY$$48$YR$A$M$Y$77$KG$20240716$$HP$CN$CN
240963791$24096379$1$I$$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456262$RANBAXY$Chiloiro S, Appetecchia M, Bianchi A, Costa D, De Acetis C, Gargiulo P, et al. Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences. Drugs Cont. 2024;13(0):1-9$65$YR$$F$Y$$$20240716$$HP$IT$IT
240963801$24096380$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454929$RANBAXY$$32$YR$$F$Y$$$20240716$$CN$US$US
240963811$24096381$1$I$$20240701$20240716$20240716$EXP$$SK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456206$RANBAXY$Niznanska Z, Hengerics Szabo A, Masar M, Szucs R, Sikuta J, Niznansky L. A Tissue Distribution Study of Propafenone in an Intentional Fatal Poisoning Case. Int J Mol Sci. 2024;25 (10):1-15$53$YR$$M$Y$99$KG$20240716$$HP$SK$SK
240963821$24096382$1$I$$20240701$20240716$20240716$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456257$RANBAXY$Vokurka S. The case of a patient with mRCC - how many lines of treatment make sense and are appropriate?. kazuistiky. 2024;-:S6-S7(1-4)$62$YR$$$Y$$$20240716$$MD$CZ$CZ
240963831$24096383$1$I$$20240701$20240716$20240716$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456179$RANBAXY$Lu X, Huiping W, Yan L. Dupilumab facial redness caused by the treatment with dupilumab in a case of atopic dermatitis. Chin J Dermatol. 2022;Apr; 55(4):337-338$65$YR$$F$Y$$$20240716$$HP$CN$CN
240963841$24096384$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455153$RANBAXY$Rao M, Casias M, Abidi MZ. Disseminated Scedosporium infection in the early post-kidney transplant period. Transpl Infect Dis. 2024;26 (2):-$63$YR$$F$Y$$$20240716$$HP$US$US
240963851$24096385$1$I$$20240701$20240716$20240716$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456279$RANBAXY$Nagata Y, Akiba S, Horiuchi H, Okumoto K, Hachinohe S, Ohe R. A case of methotrexate-related lymphoproliferative disease showing multiple liver lesions in a patient with rheumatoid arthritis. Clin J Gastroenterol. 2024;0 (0):no pagination$66$YR$$F$Y$$$20240716$$HP$JP$JP
240963861$24096386$1$I$$20240617$20240716$20240716$EXP$$HK-ROCHE-10000000596$ROCHE$$$$$$Y$$$20240716$$MD$HK$HK
240963872$24096387$2$F$$20240912$20240716$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455594$RANBAXY$Tardy C, Puszkiel A, Boudou-Rouquette P, De Percin S, Alexandre J, Berge M, et al. Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection.. Cancer Chemother Pharmacol. 2024;93:169-175$55$YR$$M$Y$86$KG$20240927$$HP$FR$FR
240963882$24096388$2$F$$20240912$20240716$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455596$RANBAXY$Tardy C, Puszkiel A, Boudou-Rouquette P, De Percin S, Alexandre J, Berge M, et al. Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection. Cancer Chemother Pharmacol. 2024;93:169-175$50$YR$$F$Y$135$KG$20240927$$HP$FR$FR
240963891$24096389$1$I$20240627$20240708$20240716$20240716$EXP$$CN-AstraZeneca-2024A158717$ASTRAZENECA$$50$YR$$M$Y$$$20240716$$MD$CN$
240963902$24096390$2$F$20240228$20240715$20240716$20240723$EXP$$CA-AstraZeneca-2024A160541$ASTRAZENECA$$18867$DY$$F$Y$$$20240723$$CN$CA$
240963911$24096391$1$I$$20191225$20240716$20240716$EXP$$RU-AstraZeneca-2019SF89846$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$RU$
240963921$24096392$1$I$$20211203$20240716$20240716$EXP$$US-AstraZeneca-2021A860953$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240963931$24096393$1$I$20210303$20210317$20240716$20240716$EXP$$US-AstraZeneca-2021A166724$ASTRAZENECA$$24013$DY$$M$Y$$$20240716$$CN$US$
240963941$24096394$1$I$20240613$20240709$20240716$20240716$EXP$$US-BAYER-2024A099044$BAYER$$28$YR$A$$Y$$$20240716$$CN$US$US
240963952$24096395$2$F$$20240906$20240716$20240911$PER$$NVSC2024US145811$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
240963961$24096396$1$I$20240101$20240709$20240716$20240716$EXP$$US-SA-2024SA205561$SANOFI AVENTIS$$64$YR$A$M$Y$110.13$KG$20240716$$MD$US$US
240963971$24096397$1$I$$20240712$20240716$20240716$EXP$$US-GILEAD-2024-0680673$GILEAD$$35$YR$A$M$Y$$$20240716$$MD$US$US
240963981$24096398$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204522$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240716$$MD$US$US
240963991$24096399$1$I$20230921$20240701$20240716$20240716$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-455623$RANBAXY$$60$YR$$M$Y$$$20240716$$MD$FR$FR
240964001$24096400$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456541$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240964011$24096401$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456435$RANBAXY$Smith C, Silveira L, Crotteau M, Garth K, Canniff J, Fetters KB, et al. Modern antiretroviral regimens in pregnant women: virologic outcomes and durability. AIDS. 2024;38:21-29$$$A$F$Y$$$20240716$$HP$US$US
240964021$24096402$1$I$$20240701$20240716$20240716$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456477$RANBAXY$Mustea TI, Morar MM, Muntean AM, Nistor S, Pop AV. CHALLENGES IN MANAGING EARLY-ONSET CROHN^S DISEASE. Acta Med Marisiensis. 2024;70(3):188-189$41$YR$$M$Y$$$20240716$$HP$RO$RO
240964031$24096403$1$I$$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456360$RANBAXY$La Spina M, Caruso M, Gulizia C, Comella M, Soma R, Meli M, et al. Diencephalic Syndrome: Misleading Clinical Onset of Low-Grade Glioma. Curr Oncol. 2023;30(9):8401-8410$$$C$M$Y$$$20240716$$HP$IT$IT
240964041$24096404$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456561$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240964051$24096405$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456509$RANBAXY$Ouyang J, Sasidharan S, Jatoi T, Salifu M. How High Can Anion Gaps Be in Patients With Metabolic Acidosis? A Case Report. Am J Respir Crit Care Med. 2024;209 (0):A3409$61$YR$$F$Y$$$20240716$$HP$US$US
240964061$24096406$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456536$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240964071$24096407$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456549$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240964081$24096408$1$I$$20240701$20240716$20240716$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456307$RANBAXY$Slawek-Szmyt S, Araszkiewicz A, Jankiewicz S, Grygier M, Mularek- Kubzdela T, Lesiak M. Intracranial hemorrhage in a patient with pulmonary embolism: how to overcome 2 problems?. Pol Arch Med Wewn. 2023;133 (3):16422; 1-3$69$YR$$M$Y$$$20240716$$MD$PL$PL
240964091$24096409$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456560$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240964101$24096410$1$I$$20240701$20240716$20240716$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456526$RANBAXY$Buhari GK, Erkekol FO, Pekel A, Yilmaz U, Keren M, Musabak U. Evaluation of the basophil activation in immediate type hypersensitivity reactions to chemotherapeutic agents. Alergo Polska. 2024;Jan-Mar;11 (1):48-55$60$YR$$M$Y$$$20240716$$HP$TR$TR
240964111$24096411$1$I$20240501$20240702$20240716$20240716$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00344$Unknown Manufacturer$$9$YR$$M$Y$25.8$KG$20240716$$CN$US$US
240964121$24096412$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456569$RANBAXY$May CC, Holden D, Robbins BT, Cook AM, Jung S, Smetana KS, et al. Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents. Neurocrit Care. 2024;40:262-271$$$$$Y$$$20240716$$HP$US$US
240964132$24096413$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218284$TEVA$Salman A, Jabra E, Paul V. From Epi Rush to Multi-Organ Crush: A Case of Epinephrine Overdose and Organ Dysfunction. Am-J-Respir-Crit-Care-Med 2024; 209 A3659.; Salman A, Jabra E, Paul V. From Epi Rush to Multi-Organ Crush: A Case of Epinephrine Overdose and Organ Dysfunction. Am-J-Respir-Crit-Care-Med 2024; 209 A3659.$62$YR$$M$Y$$$20240805$$HP$US$US
240964141$24096414$1$I$$20240701$20240716$20240716$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456487$RANBAXY$Schumaier NP, Heidemann DG, Gupta C. Durvalumab-associated limbal stem cell deficiency and secondary corneal perforation. Am J Ophthalmol Case Rep. 2024;35 (0):102074$65$YR$$M$Y$$$20240716$$HP$US$US
240964151$24096415$1$I$$20240708$20240716$20240716$EXP$$NVSC2024TH144205$NOVARTIS$Penthinapong T, Saelue P, Sripakdee W, Doungngern T, Tanvejsilp P. Realistic efficacy of oxymetholone compared with rabbit-antithymocyte globulin for severe acquired aplastic anemia. PHARMACEUTICAL SCIENCES ASIA. 2024;51(2):155-63$$$$$Y$$$20240716$$HP$TH$TH
240964162$24096416$2$F$20240101$20240722$20240716$20240801$EXP$$US-INSMED, INC.-2024-02413-US$INSMED$$$$$M$Y$$$20240801$$CN$US$US
240964171$24096417$1$I$$20240701$20240716$20240716$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456335$RANBAXY$Bartoletti A, Delvino P, Minetto M, Milanesi A, Bozzalla CassioneE, Quadrelli VS, et al. Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis. AIDS Res Ther. 2023;20 (1):50; 1-4$65$YR$$M$Y$$$20240716$$HP$IT$IT
240964181$24096418$1$I$20240101$20240702$20240716$20240716$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000140$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
240964191$24096419$1$I$20230926$20240715$20240715$20240715$DIR$710203$$FDA-CTU$$49$YR$$M$N$92.25$KG$20240715$Y$CN$US$
240964201$24096420$1$I$20240710$20240715$20240715$20240715$DIR$710224$$FDA-CTU$$70$YR$$F$N$64$KG$20240715$N$PH$US$
240964211$24096421$1$I$$20240708$20240716$20240716$EXP$$CA-APOTEX-2024AP008113$APOTEX$$72$YR$$F$Y$$$20240716$$CN$CA$CA
240964221$24096422$1$I$20240522$20240709$20240716$20240716$PER$FR-AFSSAPS-CN2024000658$FR-PFM-2024-03963$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240716$$PH$FR$FR
240964231$24096423$1$I$20240612$20240710$20240716$20240716$EXP$$AT-MYLANLABS-2024M1065161$MYLAN$$$$$M$Y$$$20240716$$MD$AT$AT
240964251$24096425$1$I$20240101$20240711$20240716$20240716$EXP$$CA-ABBVIE-5838031$ABBVIE$$$$E$M$Y$$$20240716$$HP$CA$CA
240964261$24096426$1$I$20240101$20240708$20240716$20240716$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700048$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240716$$HP$US$US
240964272$24096427$2$F$20240501$20240722$20240716$20240731$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240700055$RIGEL PHARMACEUTICALS$$79$YR$$M$Y$$$20240731$$MD$JP$JP
240964281$24096428$1$I$20240101$20240610$20240716$20240716$EXP$529825$US-RIGEL-20240600012$RIGEL PHARMACEUTICALS$$$$$F$Y$109.68$KG$20240716$$CN$US$US
240964291$24096429$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205327$SANOFI AVENTIS$$$$A$M$Y$$$20240716$$MD$US$US
240964301$24096430$1$I$$20240708$20240716$20240716$EXP$$NVSC2024AU112289$NOVARTIS$$$$A$F$Y$$$20240716$$HP$AU$AU
240964312$24096431$2$F$$20240726$20240716$20240801$PER$$NVSC2024US145772$NOVARTIS$$36$YR$$$Y$$$20240801$$CN$US$US
240964321$24096432$1$I$$20240701$20240716$20240716$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456525$RANBAXY$Buhari GK, Erkekol FO, Pekel A, Yilmaz U, Keren M, Musabak U. Evaluation of the basophil activation in immediate type hypersensitivity reactions to chemotherapeutic agents. Alergo Polska. 2024;Jan-Mar;11 (1):48-55$60$YR$$M$Y$$$20240716$$HP$TR$TR
240964331$24096433$1$I$$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112050$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240716$$CN$US$US
240964351$24096435$1$I$20240601$20240715$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112191$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240716$$CN$US$US
240964361$24096436$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112507$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240716$$HP$US$US
240964371$24096437$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112368$BRISTOL MYERS SQUIBB$$83$YR$A$M$Y$$$20240716$$HP$US$US
240964381$24096438$1$I$$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111976$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240716$$CN$US$US
240964391$24096439$1$I$$20240710$20240716$20240716$PER$$US-ABBVIE-5837342$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240964401$24096440$1$I$$20240711$20240716$20240716$EXP$$US-ABBVIE-5838281$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240964412$24096441$2$F$20240701$20240723$20240716$20240815$EXP$$FR-GILEAD-2024-0680531$GILEAD$$74$YR$E$F$Y$58$KG$20240815$$MD$FR$FR
240964421$24096442$1$I$$20240712$20240716$20240716$EXP$$ES-GILEAD-2024-0680655$GILEAD$$$$$$Y$$$20240716$$CN$ES$ES
240964431$24096443$1$I$$20240708$20240716$20240716$PER$$IT-PFM-2024-03980$PIERRE FABRE MEDICAMENT$Nosetti L, Zaffanello M, Lombardi C, Gerosa A, Piacentini G, Abramo M et al. Early Screening for Long QT Syndrome and Cardiac Anomalies in Infants: A Comprehensive Study. Clinics and Practice. 2024;14:1038-53$$$$$Y$$$20240716$$HP$IT$IT
240964442$24096444$2$F$$20240726$20240716$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06555$LUPIN$$$$$$Y$$$20240818$$CN$US$US
240964451$24096445$1$I$20240408$20240708$20240716$20240716$EXP$$KR-TAKEDA-2024TUS069934$TAKEDA$$$$E$M$Y$$$20240716$$MD$KR$KR
240964461$24096446$1$I$20200810$20240709$20240716$20240716$EXP$$KR-009507513-2407KOR004065$MERCK$$$$$M$Y$$$20240716$$HP$KR$KR
240964472$24096447$2$F$20240126$20240717$20240716$20240722$PER$$US-AMGEN-USASP2024140451$AMGEN$$69$YR$E$M$Y$$$20240722$$MD$US$US
240964481$24096448$1$I$20240101$20240710$20240716$20240716$EXP$$US-ABBVIE-5837977$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240964491$24096449$1$I$$20240709$20240716$20240716$EXP$$US-MYLANLABS-2024M1065381$MYLAN$Rezayev A, Coggins WS, Amole A, Kamran M, Tanaka T. Placement of Endovascular Stent for Reperfusion of Cerebral Infarct After Pediatric Traumatic Internal Carotid Artery Dissection. J-Radiol-Case-Rep 2024; 18 (1): 26-34.$10$YR$$F$Y$$$20240716$$HP$US$US
240964501$24096450$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064950$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F.. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study. Int. J. Mol. Sci.. 1-13$78$YR$$M$Y$$$20240716$$HP$IT$IT
240964512$24096451$2$F$20240624$20240808$20240716$20240813$EXP$$US-ABBVIE-5837395$ABBVIE$$61$YR$$F$Y$$$20240813$$CN$US$US
240964521$24096452$1$I$$20240709$20240716$20240716$EXP$$US-MYLANLABS-2024M1065361$MYLAN$Kuraitis D, Bogner P, Gopalakrishnan D, Pei S. Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis. JAAD-Case-Rep 2024; 50 33-36.$68$YR$$M$Y$$$20240716$$HP$US$US
240964531$24096453$1$I$20240612$20240709$20240716$20240716$EXP$FR-AFSSAPS-AN2024000875$FR-MYLANLABS-2024M1064998$MYLAN$$65$YR$$M$Y$$$20240716$$PH$FR$FR
240964541$24096454$1$I$$20240712$20240716$20240716$PER$$US-TAKEDA-2024TUS071340$TAKEDA$$8$YR$$$Y$$$20240716$$HP$US$US
240964551$24096455$1$I$$20240712$20240716$20240716$EXP$$US-INCYTE CORPORATION-2024IN007404$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240964561$24096456$1$I$$20240710$20240716$20240716$PER$$US-ROCHE-10000023256$ROCHE$$$$$F$Y$$$20240716$$HP$US$US
240964571$24096457$1$I$20230503$20240712$20240716$20240716$EXP$$US-INCYTE CORPORATION-2024IN007407$INCYTE$$$$$$Y$$$20240716$$HP$US$US
240964581$24096458$1$I$20240125$20240710$20240716$20240716$EXP$$US-ABBVIE-5838131$ABBVIE$$76$YR$$M$Y$88.904$KG$20240716$$HP$US$US
240964592$24096459$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218401$TEVA$Yasir M, Gelaye AE. Rare Case of Resistant Aspergillus Niger Invasive Pulmonary Aspergillosis. Am-J-Respir-Crit-Care-Med 2024; 209 A3586.; Yasir M, Gelaye AE. Rare Case of Resistant Aspergillus Niger Invasive Pulmonary Aspergillosis. Am-J-Respir-Crit-Care-Med 2024; 209 A3586.$70$YR$$F$Y$$$20240805$$HP$US$US
240964601$24096460$1$I$$20240626$20240716$20240716$PER$$US-ABBVIE-5838431$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240964611$24096461$1$I$$20230724$20240716$20240716$PER$$US-NORIDC PHARMA, INC-2023US002948$PAREXEL$$$$$$Y$$$20240715$$PH$US$US
240964621$24096462$1$I$20240105$20240710$20240716$20240716$EXP$$US-ABBVIE-5837610$ABBVIE$$69$YR$$M$Y$$$20240716$$CN$US$US
240964631$24096463$1$I$$20240709$20240716$20240716$EXP$$PT-AMGEN-PRTSP2024137172$AMGEN$$$$$M$Y$$$20240716$$MD$PT$PT
240964642$24096464$2$F$$20240909$20240716$20240910$PER$$US-ALXN-202407USA000667US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
240964653$24096465$3$F$20240607$20240913$20240716$20240917$EXP$$NVSC2024US146172$NOVARTIS$$79$YR$$M$Y$66$KG$20240917$$HP$US$US
240964661$24096466$1$I$$20240708$20240716$20240716$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001392$BLUEPRINT MEDICINES$$$$$M$Y$$$20240716$$CN$US$US
240964671$24096467$1$I$$20240713$20240716$20240716$EXP$$US-INCYTE CORPORATION-2024IN007400$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240964682$24096468$2$F$20240622$20240726$20240716$20240801$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006224$AURINIA PHARMACEUTICALS$$39$YR$$F$Y$61.224$KG$20240801$$CN$US$US
240964691$24096469$1$I$20240629$20240710$20240716$20240716$EXP$$CN-BAYER-2024A099973$BAYER$$23$YR$A$F$Y$50$KG$20240716$$HP$CN$CN
240964701$24096470$1$I$20240101$20240709$20240716$20240716$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005987$AURINIA PHARMACEUTICALS$$$$$M$Y$75$KG$20240716$$CN$US$US
240964711$24096471$1$I$$20200129$20240716$20240716$EXP$$US-AstraZeneca-2020SE16823$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240964724$24096472$4$F$20240101$20240805$20240716$20240810$EXP$$US-SA-2024SA201043$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240810$$MD$US$US
240964731$24096473$1$I$$20240710$20240716$20240716$EXP$$CA-TAKEDA-2024TUS071153$TAKEDA$$$$$F$Y$$$20240716$$CN$CA$CA
240964741$24096474$1$I$$20240712$20240716$20240716$EXP$$US-INCYTE CORPORATION-2024IN007389$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240964751$24096475$1$I$$20210619$20240716$20240716$EXP$$US-AstraZeneca-2019SE24413$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240964761$24096476$1$I$20210401$20210401$20240716$20240716$EXP$$US-AstraZeneca-2021A263076$ASTRAZENECA$$25846$DY$$M$Y$$$20240716$$CN$US$
240964771$24096477$1$I$$20200221$20240716$20240716$EXP$$US-AstraZeneca-2020SE28406$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240964782$24096478$2$F$$20240809$20240716$20240813$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407007697$ELI LILLY AND CO$$90$YR$E$M$Y$$$20240813$$CN$JP$JP
240964792$24096479$2$F$$20240725$20240716$20240802$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407006835$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240802$$CN$JP$JP
240964801$24096480$1$I$20240701$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007008$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240716$$CN$US$US
240964811$24096481$1$I$$20240710$20240716$20240716$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007279$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240716$$HP$US$US
240964821$24096482$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007984$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240716$$CN$US$US
240964831$24096483$1$I$20240711$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008485$ELI LILLY AND CO$$$$$$Y$$$20240716$$CN$US$US
240964841$24096484$1$I$$20240703$20240716$20240716$EXP$$US-ELI_LILLY_AND_COMPANY-US202407003918$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240716$$CN$US$US
240964851$24096485$1$I$20240712$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009154$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240716$$CN$US$US
240964861$24096486$1$I$20240712$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008592$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240716$$CN$US$US
240964871$24096487$1$I$20210821$20240704$20240716$20240716$EXP$DE-AMK-255272$DE-ELI_LILLY_AND_COMPANY-DE202407003530$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240716$$CN$DE$DE
240964881$24096488$1$I$20240628$20240705$20240716$20240716$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407004914$ELI LILLY AND CO$$$$$$Y$$$20240716$$CN$JP$JP
240964891$24096489$1$I$20240430$20240703$20240716$20240716$EXP$$US-ELI_LILLY_AND_COMPANY-US202407003524$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240716$$CN$US$US
240964901$24096490$1$I$20240707$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009438$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240716$$CN$US$US
240964911$24096491$1$I$$20240703$20240716$20240716$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407003458$ELI LILLY AND CO$$75$YR$E$F$Y$70$KG$20240716$$CN$GB$GB
240964931$24096493$1$I$20240702$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008542$ELI LILLY AND CO$$$$$F$Y$$$20240716$$HP$US$US
240964941$24096494$1$I$20240701$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008775$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240716$$CN$US$US
240964951$24096495$1$I$20230921$20230922$20240716$20240716$PER$$US-NORIDC PHARMA, INC-2023US003529$PAREXEL$$$$$$Y$$$20240715$$CN$US$US
240964971$24096497$1$I$20240101$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110947$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240716$$HP$US$US
240964984$24096498$4$F$20221021$20240720$20240716$20240905$EXP$$AR-MYLANLABS-2024M1065620$MYLAN$$15$YR$$F$Y$$$20240905$$CN$AR$AR
240964991$24096499$1$I$20240630$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110378$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$95.25$KG$20240716$$HP$US$US
240965001$24096500$1$I$20240602$20240712$20240716$20240716$EXP$$AU-MYLANLABS-2024M1050791$MYLAN$$23$YR$$M$Y$$$20240716$$PH$AU$AU
240965012$24096501$2$F$$20240806$20240716$20240809$EXP$$US-JNJFOC-20240729667$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$CN$US$US
240965026$24096502$6$F$20220622$20240912$20240716$20240924$EXP$$CA-TAKEDA-2024TUS071422$TAKEDA$$72$YR$$M$Y$$$20240924$$CN$CA$CA
240965031$24096503$1$I$$20240712$20240716$20240716$EXP$$ZA-MYLANLABS-2024M1066256$MYLAN$Liebenberg J, John TJ, Khalfey H, D^Andrea I, Kyriakakis C. Subacute dual stent thromboses in a COVID-19-positive patient. Cardiovasc-J-S-Afr 2022; 33 (6): 329-332.$71$YR$$M$Y$$$20240716$$HP$ZA$ZA
240965041$24096504$1$I$20230906$20230906$20240716$20240716$PER$$US-NORIDC PHARMA, INC-2023US003907$PAREXEL$$$$$$Y$$$20240715$$CN$US$US
240965051$24096505$1$I$$20240710$20240716$20240716$EXP$$JP-BAYER-2024A100506$BAYER$$55$YR$A$F$Y$$$20240716$$HP$JP$JP
240965061$24096506$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145625$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240965071$24096507$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA203843$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240716$$MD$US$US
240965081$24096508$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA204722$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240716$$MD$US$US
240965092$24096509$2$F$20210501$20240805$20240716$20240813$PER$$US-SA-2023SA307024$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240814$$MD$US$US
240965101$24096510$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA206520$SANOFI AVENTIS$$$$A$M$Y$74.8$KG$20240716$$MD$US$US
240965112$24096511$2$F$20240101$20240801$20240716$20240810$PER$$US-SA-2024SA206311$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240810$$CN$US$US
240965121$24096512$1$I$20240601$20240708$20240716$20240716$PER$$US-SA-2024SA205459$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240716$$MD$US$US
240965131$24096513$1$I$$20240709$20240716$20240716$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003417$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
240965142$24096514$2$F$20240201$20240730$20240716$20240805$30DAY$$AR-SANDOZ INC.-NVSC2022AR163889$SANDOZ$$54$YR$$M$Y$$$20240805$$CN$AR$AR
240965153$24096515$3$F$20240620$20240730$20240716$20240802$PER$$US-AMGEN-USASP2024138982$AMGEN$$71$YR$E$F$Y$$$20240802$$HP$US$US
240965162$24096516$2$F$20240601$20240709$20240716$20240719$EXP$$US-AMGEN-USASL2024135958$AMGEN$$72$YR$E$F$Y$$$20240719$$CN$US$US
240965171$24096517$1$I$20240706$20240711$20240716$20240716$EXP$$US-BAYER-2024A100351$BAYER$$20$YR$A$M$Y$$$20240716$$CN$US$US
240965181$24096518$1$I$20240201$20240712$20240716$20240716$EXP$$CA-GSK-CA2024014953$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$HP$CA$CA
240965193$24096519$3$F$20240710$20240722$20240716$20240730$EXP$$US-ALXN-202407USA000824US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
240965201$24096520$1$I$$20240711$20240716$20240716$PER$$US-009507513-2407USA008591$MERCK$$$$$M$Y$$$20240716$$CN$US$US
240965211$24096521$1$I$$20240710$20240716$20240716$EXP$$NVSC2024US143760$NOVARTIS$$$$$M$Y$$$20240716$$CN$US$US
240965221$24096522$1$I$20240712$20240715$20240716$20240716$PER$$NVSC2024US146320$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240965232$24096523$2$F$20240706$20240711$20240716$20240722$EXP$$US-Accord-435315$ACCORD$$72$YR$E$F$Y$$$20240722$$HP$US$US
240965241$24096524$1$I$20240704$20240704$20240716$20240716$EXP$GB-MHRA-MED-202407040842268510-NPTFG$GB-Accord-434322$ACCORD$$54$YR$A$M$Y$73$KG$20240716$$CN$GB$GB
240965252$24096525$2$F$20231101$20240808$20240716$20240820$EXP$FR-AFSSAPS-TS2024000765$FR-Accord-434524$ACCORD$$78$YR$E$F$Y$$$20240820$$MD$FR$FR
240965261$24096526$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202406261231367260-ZLNPR$GB-Accord-434582$ACCORD$$30$YR$A$$Y$69$KG$20240716$$CN$GB$GB
240965271$24096527$1$I$$20240704$20240716$20240716$EXP$$CN-Accord-434226$ACCORD$Lan Y, Zhao J, Zhao F, Li J, Li X. Partial response to trastuzumab deruxtecan (DS8201) following progression in HER2-amplified breast cancer with pulmonary metastases managed with disitamab vedotin (RC48): a comprehensive case report and literature review. Front Oncol. 2024 Jun 17;14:1338661.$$$$F$Y$$$20240716$$HP$CN$CN
240965281$24096528$1$I$20240624$20240703$20240716$20240716$EXP$$US-Accord-433997$ACCORD$$60$YR$A$M$Y$$$20240716$$PH$US$US
240965291$24096529$1$I$$20240704$20240716$20240716$EXP$CA-MHPD-E2B_07085406$CA-Accord-434230$ACCORD$$30$YR$A$M$Y$$$20240716$$HP$CA$CA
240965301$24096530$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202407041350123850-LJDQC$GB-Accord-434360$ACCORD$$$$$F$Y$66$KG$20240716$$CN$GB$GB
240965311$24096531$1$I$$20240704$20240716$20240716$EXP$CA-MHPD-E2B_07087683$CA-Accord-434243$ACCORD$$45$YR$A$F$Y$$$20240716$$MD$CA$CA
240965321$24096532$1$I$20240619$20240704$20240716$20240716$EXP$FR-AFSSAPS-2024058082$FR-Accord-434153$ACCORD$$14$YR$T$M$Y$55.3$KG$20240716$$MD$FR$FR
240965331$24096533$1$I$$20240711$20240716$20240716$EXP$$AR-PFIZER INC-202400212423$PFIZER$$66$YR$$F$Y$$$20240716$$CN$AR$AR
240965341$24096534$1$I$20240501$20240715$20240716$20240716$EXP$FR-AFSSAPS-BX2024001432$FR-PFIZER INC-202400214663$PFIZER$$78$YR$$F$Y$50$KG$20240716$$PH$FR$FR
240965351$24096535$1$I$20240617$20240713$20240716$20240716$EXP$$CN-PFIZER INC-PV202400091941$PFIZER$$32$YR$$F$Y$81$KG$20240716$$HP$CN$CN
240965361$24096536$1$I$20240301$20240715$20240716$20240716$EXP$$US-PFIZER INC-202400215794$PFIZER$$67$YR$$F$Y$$$20240716$$CN$US$US
240965371$24096537$1$I$$20240710$20240716$20240716$EXP$$US-PFIZER INC-202400211188$PFIZER$Voelz, K.. 6-Mercaptopurine-associated Sinusoidal Obstructive Syndrome During Interim Maintenance I: A Case Report.. Journal of Pediatric Hematology/Oncology. 2024;46(5):e317-e321$14$YR$$M$Y$$$20240716$$MD$US$US
240965382$24096538$2$F$20240714$20240718$20240716$20240724$PER$$US-AMGEN-USASP2024140407$AMGEN$$69$YR$E$M$Y$$$20240724$$CN$US$US
240965391$24096539$1$I$$20240715$20240716$20240716$EXP$$GB-PFIZER INC-202400214849$PFIZER$$53$YR$$M$Y$$$20240716$$HP$GB$GB
240965401$24096540$1$I$20240101$20240711$20240716$20240716$EXP$$CA-PFIZER INC-PV202400091790$PFIZER$$11$YR$$M$Y$$$20240716$$HP$CA$CA
240965411$24096541$1$I$20240101$20240711$20240716$20240716$EXP$$CA-PFIZER INC-PV202400091791$PFIZER$$11$YR$$M$Y$$$20240716$$HP$CA$CA
240965421$24096542$1$I$20240708$20240711$20240716$20240716$EXP$$US-BAYER-2024A100359$BAYER$$22$YR$A$M$Y$$$20240716$$CN$US$US
240965431$24096543$1$I$20240101$20240710$20240716$20240716$PER$$US-SA-2024SA204623$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240716$$MD$US$US
240965442$24096544$2$F$20240101$20240806$20240716$20240814$PER$$US-SA-2024SA203681$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240814$$CN$US$US
240965452$24096545$2$F$20240101$20240719$20240716$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108991$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240722$$CN$US$US
240965463$24096546$3$F$20240101$20240919$20240716$20240926$PER$$US-SA-2024SA201786$SANOFI AVENTIS$$65$YR$E$F$Y$118.38$KG$20240926$$MD$US$US
240965471$24096547$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112517$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240716$$CN$US$US
240965481$24096548$1$I$20240701$20240708$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109774$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240716$$HP$US$US
240965494$24096549$4$F$20240709$20240903$20240716$20240910$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700384$SUNOVION$$$$$$Y$$$20240910$$HP$US$US
240965501$24096550$1$I$$20240704$20240716$20240716$EXP$$DE-RICHTER-2024-GR-006127$MYOVANT SCIENCES$$$$$F$Y$$$20240716$$MD$DE$DE
240965511$24096551$1$I$20240601$20240710$20240716$20240716$PER$$US-SA-2024SA207131$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240716$$MD$US$US
240965522$24096552$2$F$20240101$20240711$20240716$20240722$PER$$US-SA-2024SA205795$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240720$$MD$US$US
240965532$24096553$2$F$$20240807$20240716$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05967$LUPIN$$$$$$Y$$$20240817$$CN$US$US
240965552$24096555$2$F$20240101$20240717$20240716$20240722$EXP$$US-UCBSA-2024030989$UCB$$$$$F$Y$$$20240722$$CN$US$US
240965561$24096556$1$I$20240501$20240709$20240716$20240716$EXP$$US-UCBSA-2024028013$UCB$$81$YR$$F$Y$195$KG$20240716$$CN$US$US
240965572$24096557$2$F$$20240723$20240716$20240802$EXP$$IT-TEVA-VS-3216984$TEVA$Gardin A, Cavallaro M, Labate A. The importance of MRI in the acute phase of herpes encephalitis mimicking an acute ischemic stroke. Neurol-Sci 2023; 44 4563-4567.; Gardin A, Cavallaro M, Labate A. The importance of MRI in the acute phase of herpes encephalitis mimicking an acute ischemic stroke. Neurol-Sci 2023; 44 4563-4567.; Gardin A, Cavallaro M, Labate A. The importance of MRI in the acute phase of herpes encephalitis mimicking an acute ischemic stroke. Neurol-Sci 2023; 44 4563-4567.$80$YR$$M$Y$$$20240802$$HP$IT$IT
240965582$24096558$2$F$20240711$20240712$20240716$20240717$EXP$$US-MYLANLABS-2024M1065987$MYLAN$$26$YR$$F$Y$$$20240717$$MD$US$US
240965591$24096559$1$I$20230112$20240711$20240716$20240716$EXP$$SE-MYLANLABS-2024M1065245$MYLAN$$53$YR$$F$Y$$$20240716$$CN$SE$SE
240965605$24096560$5$F$20240101$20240808$20240716$20240814$EXP$$US-ABBVIE-5835945$ABBVIE$$$$$F$Y$58.966$KG$20240814$$CN$US$US
240965612$24096561$2$F$20230601$20240729$20240716$20240802$EXP$$JP-AMGEN-JPNSP2024013664$AMGEN$$83$YR$E$F$Y$$$20240802$$MD$JP$JP
240965621$24096562$1$I$20240715$20240715$20240716$20240716$PER$$US-AMGEN-USASP2024140123$AMGEN$$67$YR$E$M$Y$$$20240716$$CN$US$US
240965631$24096563$1$I$20240601$20240708$20240716$20240716$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-090382$REGENERON$$$$$M$Y$$$20240716$$MD$DE$DE
240965641$24096564$1$I$$20240715$20240716$20240716$30DAY$$US-SANDOZ INC.-SDZ2024US065457$SANDOZ$$$$$F$Y$$$20240716$$HP$US$US
240965651$24096565$1$I$$20240709$20240716$20240716$EXP$$CA-GSK-CA2024AMR085256$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$CA$CA
240965662$24096566$2$F$20240701$20240723$20240716$20240729$PER$$US-BAYER-2024A100965$BAYER$$48$YR$A$F$Y$$$20240729$$HP$US$US
240965681$24096568$1$I$$20240712$20240716$20240716$EXP$$RO-TAKEDA-2024TUS071072$TAKEDA$$43$YR$$$Y$$$20240716$$HP$RO$RO
240965693$24096569$3$F$20230101$20240912$20240716$20240918$EXP$$NL-ABBVIE-5542568$ABBVIE$$69$YR$$M$Y$$$20240918$$CN$NL$NL
240965701$24096570$1$I$$20240711$20240716$20240716$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR088677$VIIV$$$$$M$Y$$$20240716$$CN$US$US
240965711$24096571$1$I$$20240708$20240716$20240716$EXP$$ZA-AstraZeneca-2024A156337$ASTRAZENECA$$79$YR$$F$Y$$$20240716$$CN$ZA$
240965721$24096572$1$I$20240710$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49041$$FDA-CTU$$$$$F$N$69.9$KG$20240715$N$$US$
240965731$24096573$1$I$$20240715$20240715$20240715$DIR$710208$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240965741$24096574$1$I$20211108$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49037$$FDA-CTU$$78$YR$$F$N$42$KG$20240715$N$$US$
240965751$24096575$1$I$20240712$20240715$20240715$20240715$DIR$710233$$FDA-CTU$$20$YR$$F$N$143.6$KG$20240715$N$PH$US$
240965762$24096576$2$F$20240629$20240725$20240716$20240730$EXP$$NVSC2024US146137$NOVARTIS$$88$YR$$F$Y$62.6$KG$20240730$$MD$US$US
240965771$24096577$1$I$$20240709$20240716$20240716$EXP$$IL-009507513-2407ISR004688$MERCK$$63$YR$$M$Y$$$20240716$$PH$IL$IL
240965784$24096578$4$F$20200101$20240904$20240716$20240909$EXP$$BR-009507513-2407BRA008968$MERCK$$87$YR$$F$Y$60$KG$20240909$$CN$BR$BR
240965791$24096579$1$I$20230901$20240710$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007288$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240965801$24096580$1$I$$20240709$20240716$20240716$EXP$$US-ALXN-202407USA000527US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$MD$US$US
240965811$24096581$1$I$$20240711$20240716$20240716$PER$$US-GILEAD-2024-0680466$GILEAD$$$$$F$Y$$$20240716$$HP$US$US
240965824$24096582$4$F$20240501$20240902$20240716$20240905$EXP$$MX-009507513-2405MEX009160$MERCK$$21$YR$$F$Y$65$KG$20240905$$MD$MX$MX
240965831$24096583$1$I$$20240711$20240716$20240716$EXP$$US-ABBVIE-5838048$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240965841$24096584$1$I$$20240711$20240716$20240716$EXP$$CA-MYLANLABS-2024M1065452$MYLAN$$38$YR$$F$Y$48$KG$20240716$$CN$CA$CA
240965851$24096585$1$I$$20240711$20240716$20240716$EXP$$CA-MYLANLABS-2024M1065367$MYLAN$$16$YR$$F$Y$60$KG$20240716$$PH$CA$CA
240965861$24096586$1$I$$20240711$20240716$20240716$PER$$US-UNITED THERAPEUTICS-UNT-2024-021526$UNITED THERAPEUTICS$$$$$F$Y$76.644$KG$20240716$$$US$US
240965881$24096588$1$I$$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49058$$FDA-CTU$$$$$M$N$$$20240715$N$HP$US$
240965891$24096589$1$I$20240621$20240711$20240716$20240716$EXP$$US-BAYER-2024A101373$BAYER$$75$YR$E$M$Y$$$20240716$$CN$US$US
240965901$24096590$1$I$20240708$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49024$$FDA-CTU$$45$YR$$M$N$55.5$KG$20240715$N$$US$
240965911$24096591$1$I$20240101$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405131139068190-CBKRJ$GB-ELI_LILLY_AND_COMPANY-GB202407003840$ELI LILLY AND CO$$$$$F$Y$53$KG$20240716$$CN$GB$GB
240965951$24096595$1$I$$20240710$20240716$20240716$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407009248$ELI LILLY AND CO$$$$$$Y$$$20240716$$CN$JP$JP
240965962$24096596$2$F$20240101$20240711$20240716$20240719$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407007177$ELI LILLY AND CO$$$$$M$Y$$$20240719$$CN$KR$KR
240965971$24096597$1$I$20240701$20240705$20240716$20240716$EXP$$AT-ELI_LILLY_AND_COMPANY-AT202407008950$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240716$$CN$DE$AT
240965991$24096599$1$I$20240710$20240715$20240715$20240715$DIR$710219$$FDA-CTU$$66$YR$$F$N$76.5$KG$20240715$N$CN$US$
240966001$24096600$1$I$20240618$20240715$20240715$20240715$DIR$710236$$FDA-CTU$$50$YR$$F$N$$$20240715$N$HP$US$
240966013$24096601$3$F$$20240822$20240716$20240829$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407007635$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240829$$CN$JP$JP
240966021$24096602$1$I$20240625$20240704$20240716$20240716$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407006498$ELI LILLY AND CO$$61$YR$A$F$Y$44$KG$20240716$$CN$DE$CN
240966032$24096603$2$F$20231115$20240726$20240716$20240807$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202407004634$ELI LILLY AND CO$$83$YR$E$M$Y$96$KG$20240807$$MD$IT$IT
240966051$24096605$1$I$20240127$20240715$20240715$20240715$DIR$710212$$FDA-CTU$$23$YR$$F$N$63$KG$20240715$N$CN$US$
240966061$24096606$1$I$$20240715$20240715$20240715$DIR$710242$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240966071$24096607$1$I$20240626$20240715$20240715$20240715$DIR$710241$$FDA-CTU$$55$YR$$F$N$84$KG$20240715$N$PH$US$
240966082$24096608$2$F$20240606$20240718$20240716$20240724$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407003652$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240724$$CN$JP$JP
240966091$24096609$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202407040814309700-BPQKN$GB-ELI_LILLY_AND_COMPANY-GB202407003517$ELI LILLY AND CO$$$$$F$Y$72$KG$20240716$$CN$GB$GB
240966101$24096610$1$I$20220322$20240704$20240716$20240716$EXP$IT-MINISAL02-992819$IT-ELI_LILLY_AND_COMPANY-IT202407008115$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240716$$CN$DE$IT
240966111$24096611$1$I$$20240705$20240716$20240716$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406011581$ELI LILLY AND CO$$9$YR$C$F$Y$$$20240716$$CN$JP$JP
240966121$24096612$1$I$20240629$20240704$20240716$20240716$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407006433$ELI LILLY AND CO$$59$YR$A$M$Y$70$KG$20240716$$CN$DE$CN
240966132$24096613$2$F$20240701$20240905$20240716$20240912$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-097582$REGENERON$$$$$$Y$$$20240912$$MD$JP$JP
240966141$24096614$1$I$20240429$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405041514300140-SMDGL$GB-ELI_LILLY_AND_COMPANY-GB202407003925$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$GB$GB
240966151$24096615$1$I$$20240709$20240716$20240716$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001397$BLUEPRINT MEDICINES$$$$$F$Y$$$20240716$$CN$US$US
240966161$24096616$1$I$$20240710$20240716$20240716$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003848$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
240966171$24096617$1$I$$20240618$20240716$20240716$PER$$US-009507513-2406USA006558$MERCK$$25$YR$$M$Y$$$20240716$$MD$US$US
240966181$24096618$1$I$$20240709$20240716$20240716$EXP$$NVSC2024CO083906$NOVARTIS$$$$$F$Y$68$KG$20240716$$CN$CO$CO
240966191$24096619$1$I$20240506$20240715$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112590$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240716$$HP$US$US
240966201$24096620$1$I$$20240709$20240716$20240716$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001398$BLUEPRINT MEDICINES$$$$$M$Y$$$20240716$$CN$US$US
240966211$24096621$1$I$20160413$20240705$20240716$20240716$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-ESP-2016046542$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240716$$MD$ES$ES
240966221$24096622$1$I$$20240704$20240716$20240716$EXP$$IN-ROCHE-10000021200$ROCHE$$57$YR$A$M$Y$$$20240716$$CN$IN$IN
240966231$24096623$1$I$20220101$20240709$20240716$20240716$EXP$$US-OTSUKA-2024_019419$OTSUKA$$$$$M$Y$$$20240716$$CN$US$US
240966241$24096624$1$I$$20240711$20240716$20240716$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003889$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
240966251$24096625$1$I$20240101$20240712$20240716$20240716$EXP$$TW-PFIZER INC-PV202400091450$PFIZER$$$$$$Y$$$20240716$$MD$TW$TW
240966261$24096626$1$I$20240101$20240715$20240716$20240716$EXP$FR-AFSSAPS-TO2024001282$NVSC2024FR145387$NOVARTIS$$73$YR$$M$Y$$$20240716$$PH$FR$FR
240966272$24096627$2$F$20240601$20240719$20240716$20240722$EXP$$US-PFIZER INC-202400213900$PFIZER$$38$YR$$F$Y$$$20240722$$CN$US$US
240966281$24096628$1$I$20240712$20240712$20240716$20240716$EXP$$US-PFIZER INC-202400213624$PFIZER$$53$YR$$M$Y$$$20240716$$CN$US$US
240966291$24096629$1$I$$20240712$20240716$20240716$EXP$$CA-PFIZER INC-202400213492$PFIZER$$80$YR$$M$Y$$$20240716$$MD$CA$CA
240966301$24096630$1$I$20220201$20240712$20240716$20240716$EXP$ES-AEMPS-1546245$ES-PFIZER INC-202400213140$PFIZER$$45$YR$$F$Y$$$20240716$$MD$ES$ES
240966311$24096631$1$I$$20240711$20240716$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110747$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240716$$HP$CA$CA
240966321$24096632$1$I$$20240709$20240716$20240716$EXP$$AU-PFIZER INC-202400212500$PFIZER$Li, E.. A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies. European Journal of Haematology. 2024;10.1111/ejh.14266$$$E$$Y$$$20240716$$HP$AU$AU
240966334$24096633$4$F$20240101$20240920$20240716$20240925$EXP$$CA-PFIZER INC-202400204114$PFIZER$$73$YR$$F$Y$$$20240925$$PH$CA$CA
240966341$24096634$1$I$20240614$20240712$20240716$20240716$EXP$GB-MHRA-MED-202407111115052540-YNHCD$GB-PFIZER INC-202400213352$PFIZER$$72$YR$$M$Y$$$20240716$$CN$GB$GB
240966352$24096635$2$F$$20240716$20240716$20240718$EXP$$JP-PFIZER INC-202400213395$PFIZER$$9$DEC$$F$Y$$$20240718$$MD$JP$JP
240966361$24096636$1$I$20240406$20240712$20240716$20240716$EXP$FR-AFSSAPS-NY2024000750$FR-PFIZER INC-202400213036$PFIZER$$17$YR$$F$Y$$$20240716$$PH$FR$FR
240966371$24096637$1$I$20240522$20240712$20240716$20240716$EXP$FR-AFSSAPS-NC2024000828$FR-PFIZER INC-202400213066$PFIZER$$62$YR$$F$Y$$$20240716$$MD$FR$FR
240966381$24096638$1$I$20240711$20240712$20240716$20240716$EXP$$CN-PFIZER INC-PV202400092007$PFIZER$$33$YR$$F$Y$$$20240716$$HP$CN$CN
240966403$24096640$3$F$20240101$20240716$20240716$20240722$EXP$$CA-PFIZER INC-202400189434$PFIZER$$66$YR$$F$Y$$$20240722$$HP$CA$CA
240966412$24096641$2$F$20230101$20240712$20240716$20240717$EXP$$JP-PFIZER INC-PV202400091587$PFIZER$$6$DEC$$M$Y$$$20240717$$MD$JP$JP
240966422$24096642$2$F$$20240718$20240716$20240723$EXP$$IN-PFIZER INC-2020051529$PFIZER$$69$YR$$M$Y$$$20240723$$CN$IN$IN
240966431$24096643$1$I$$20240710$20240716$20240716$EXP$$US-PFIZER INC-PV202400071093$PFIZER$Guajardo, A.. Safety of taxane chemotherapy for the treatment of breast cancer during pregnancy: an international cohort study. Cancer Research. 2024;84(9 Suppl):10.1158/1538-7445.SABCS23-PS13$39$YR$$F$Y$$$20240716$$HP$US$US
240966441$24096644$1$I$20240703$20240712$20240716$20240716$EXP$GB-MHRA-MED-202407120834373590-RMKVP$GB-PFIZER INC-202400213265$PFIZER$$50$YR$$M$Y$$$20240716$$PH$GB$GB
240966451$24096645$1$I$$20240712$20240716$20240716$EXP$GB-MHRA-TPP4829565C1835637YC1720769641527$GB-PFIZER INC-202400213540$PFIZER$$71$YR$$M$Y$72$KG$20240716$$MD$GB$GB
240966461$24096646$1$I$$20240709$20240716$20240716$EXP$$AU-PFIZER INC-202400212497$PFIZER$Li, E.. A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies. European Journal of Haematology. 2024;10.1111/ejh.14266$$$E$$Y$$$20240716$$HP$AU$AU
240966471$24096647$1$I$$20240703$20240716$20240716$EXP$$US-MPL-000047$MLV PHARMA$$64$YR$A$F$Y$$$20240706$$MD$US$US
240966481$24096648$1$I$$20240703$20240716$20240716$EXP$$US-MEDLEY-000012$MEDLEY PHARMACEUTICALS$$60$YR$A$F$Y$$$20240704$$MD$US$US
240966491$24096649$1$I$$20240703$20240716$20240716$EXP$$ES-MPL-000046$MLV PHARMA$$83$YR$E$F$Y$$$20240705$$MD$ES$ES
240966501$24096650$1$I$$20240703$20240716$20240716$EXP$$US-MEDLEY-000011$MEDLEY PHARMACEUTICALS$$32$YR$A$F$Y$$$20240704$$MD$US$US
240966511$24096651$1$I$$20240709$20240716$20240716$EXP$$AU-PFIZER INC-202400212499$PFIZER$Li, E.. A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies. European Journal of Haematology. 2024;10.1111/ejh.14266$$$E$$Y$$$20240716$$HP$AU$AU
240966521$24096652$1$I$20240624$20240715$20240715$20240715$DIR$710237$$FDA-CTU$$$$$UNK$N$$$20240715$N$$US$
240966531$24096653$1$I$20080601$20240715$20240715$20240715$DIR$710247$$FDA-CTU$$62$YR$$F$N$55.35$KG$20240715$N$CN$US$
240966553$24096655$3$F$20240629$20240715$20240716$20240813$PER$$US-ROCHE-10000025654$ROCHE$$$$$M$Y$$$20240813$$CN$US$US
240966571$24096657$1$I$$20240709$20240716$20240716$EXP$$AU-PFIZER INC-202400212498$PFIZER$Li, E.. A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies. European Journal of Haematology. 2024;10.1111/ejh.14266$$$E$$Y$$$20240716$$HP$AU$AU
240966581$24096658$1$I$20240405$20240702$20240716$20240716$EXP$$ES-GLENMARK PHARMACEUTICALS-2024GMK092115$GLENMARK$$$$$$Y$$$20240716$$PH$ES$ES
240966591$24096659$1$I$20240607$20240709$20240716$20240716$PER$$US-SA-2024SA207267$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240716$$MD$US$US
240966601$24096660$1$I$20240701$20240709$20240716$20240716$PER$$US-SA-2024SA206012$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240716$$MD$US$US
240966621$24096662$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA207112$SANOFI AVENTIS$$$$A$F$Y$70.307$KG$20240716$$MD$US$US
240966631$24096663$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA203113$SANOFI AVENTIS$$$$T$F$Y$39.37$KG$20240716$$MD$US$US
240966642$24096664$2$F$20240101$20240817$20240716$20240829$PER$$US-SA-2024SA205599$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240829$$MD$US$US
240966651$24096665$1$I$20240611$20240712$20240716$20240716$EXP$FR-AFSSAPS-PP2024000756$FR-SA-2024SA206094$SANOFI AVENTIS$$89$YR$E$M$Y$70$KG$20240716$$MD$FR$FR
240966661$24096666$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410935$FRESENIUS KABI$$68$YR$E$F$Y$$$20240716$$HP$CA$CA
240966671$24096667$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410881$FRESENIUS KABI$$$$$F$Y$$$20240716$$HP$CA$CA
240966681$24096668$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410910$FRESENIUS KABI$$$$$F$Y$$$20240716$$HP$CA$CA
240966691$24096669$1$I$$20240705$20240716$20240716$EXP$$US-FreseniusKabi-FK202411017$FRESENIUS KABI$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatric Blood + Cancer. 2024;71: 1-5. doi:10.1002/pbc.31004.$23$YR$A$F$Y$$$20240716$$HP$US$US
240966701$24096670$1$I$20240703$20240712$20240716$20240716$EXP$$CN-SANDOZ INC.-SDZ2024CN065060$SANDOZ$$81$YR$$M$Y$57$KG$20240716$$HP$CN$CN
240966721$24096672$1$I$$20240711$20240716$20240716$EXP$$BR-DSJP-DSE-2024-135420$DAIICHI$$$$$F$Y$$$20240716$$MD$BR$BR
240966734$24096673$4$F$20230801$20240801$20240716$20240815$PER$$US-ROCHE-10000024826$ROCHE$$41$YR$A$F$Y$67.13$KG$20240815$$HP$US$US
240966741$24096674$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5839385$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240966751$24096675$1$I$$20200415$20240716$20240716$EXP$$US-AstraZeneca-2020SE52756$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240966761$24096676$1$I$$20240715$20240715$20240715$DIR$710255$$FDA-CTU$$$$$UNK$N$$$20240715$$CN$US$
240966771$24096677$1$I$20240626$20240711$20240716$20240716$DIR$FDA-CDER-CTU-2024-49060$$FDA-CTU$$62$YR$$F$N$$$20240711$N$HP$US$
240966781$24096678$1$I$$20240715$20240715$20240715$DIR$710254$$FDA-CTU$$$$$UNK$N$$$20240715$$CN$US$
240966791$24096679$1$I$20240601$20240709$20240716$20240716$30DAY$$US-GSK-US2024085151$GLAXOSMITHKLINE$$83$YR$$M$Y$$$20240716$$CN$US$US
240966801$24096680$1$I$20231212$20240715$20240716$20240716$EXP$ES-AEMPS-1545458$NVSC2024ES145546$NOVARTIS$$52$YR$$M$Y$110$KG$20240716$$MD$ES$ES
240966811$24096681$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49071$$FDA-CTU$$90$YR$$M$N$$$20240716$N$$US$
240966821$24096682$1$I$20240601$20240712$20240716$20240716$DIR$FDA-CDER-CTU-2024-49057$$FDA-CTU$$25$YR$$F$N$$$20240712$N$HP$US$
240966831$24096683$1$I$20240715$20240715$20240715$20240715$DIR$710249$$FDA-CTU$$72$YR$$M$N$95.4$KG$20240715$N$CN$US$
240966841$24096684$1$I$$20240703$20240716$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06496$HIKMA$Khan MS, Ahmed O, Nwaedozie S.. Khan MS, Ahmed O, Nwaedozie S. Anaconda Right Coronary Artery.. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(Suppl 1)$$$$$Y$$$20240716$$MD$US$US
240966861$24096686$1$I$20240519$20240715$20240715$20240715$DIR$710256$$FDA-CTU$$57$YR$$F$N$41.1$KG$20240715$N$HP$US$
240966872$24096687$2$F$$20240729$20240716$20240807$EXP$$US-TEVA-VS-3219223$TEVA$Grodsky JD, Doshi R, Riaz KM. Medical management and visual rehabilitation of limbal niche dysfunction. J-Cataract-Refract-Surg 2020; 46 (2): 312-316.; Grodsky JD, Doshi R, Riaz KM. Medical management and visual rehabilitation of limbal niche dysfunction. J-Cataract-Refract-Surg 2020; 46 (2): 312-316.; Grodsky JD, Doshi R, Riaz KM. Medical management and visual rehabilitation of limbal niche dysfunction. J-Cataract-Refract-Surg 2020; 46 (2): 312-316.$61$YR$$F$Y$$$20240807$$HP$US$US
240966895$24096689$5$F$$20240911$20240716$20240913$30DAY$$US-PFIZER INC-202400211238$PFIZER$$18$YR$$F$Y$$$20240913$$CN$US$US
240966903$24096690$3$F$$20240709$20240716$20240722$30DAY$$GB-PFIZER INC-PV202400090496$PFIZER$$18$YR$$M$Y$$$20240722$$CN$GB$GB
240966912$24096691$2$F$20240513$20240726$20240716$20240730$30DAY$$JP-PFIZER INC-202400106054$PFIZER$$$$$$Y$$$20240730$$PH$JP$JP
240966924$24096692$4$F$$20240807$20240716$20240813$30DAY$$US-PFIZER INC-202400211294$PFIZER$$14$YR$$M$Y$$$20240813$$HP$US$US
240966946$24096694$6$F$20240709$20240924$20240716$20240927$30DAY$$US-PFIZER INC-202400211317$PFIZER$$7$YR$$F$Y$$$20240927$$MD$US$US
240966951$24096695$1$I$$20240711$20240716$20240716$30DAY$$CA-PFIZER INC-202400212561$PFIZER$$$$$F$Y$$$20240716$$PH$CA$CA
240966962$24096696$2$F$20240101$20240911$20240716$20240911$EXP$$CA-PFIZER INC-202400103099$PFIZER$$66$YR$$F$Y$$$20240911$$HP$CA$CA
240966972$24096697$2$F$20240709$20240815$20240716$20240819$30DAY$$JP-PFIZER INC-PV202400090016$PFIZER$$$$$M$Y$$$20240819$$CN$JP$JP
240966992$24096699$2$F$$20240913$20240716$20240913$30DAY$$DE-PFIZER INC-PV202400090429$PFIZER$$$$$$Y$$$20240913$$HP$DE$DE
240967007$24096700$7$F$$20240922$20240716$20240925$EXP$$US-PFIZER INC-202400211703$PFIZER$$16$YR$$M$Y$$$20240925$$HP$US$US
240967011$24096701$1$I$$20240711$20240716$20240716$EXP$$CN-PFIZER INC-PV202400090996$PFIZER$$53$YR$$M$Y$$$20240716$$CN$CN$CN
240967021$24096702$1$I$$20240703$20240716$20240716$EXP$$PK-ROCHE-10000022533$ROCHE$$66$YR$E$F$Y$$$20240716$$CN$PK$PK
240967031$24096703$1$I$20240714$20240715$20240716$20240716$PER$$US-AMGEN-USASP2024140436$AMGEN$$57$YR$A$F$Y$$$20240716$$CN$US$US
240967041$24096704$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112572$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240716$$PH$US$US
240967061$24096706$1$I$$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110737$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240716$$CN$US$US
240967071$24096707$1$I$$20240708$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109638$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240716$$CN$US$US
240967081$24096708$1$I$20240407$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111941$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240716$$CN$US$US
240967091$24096709$1$I$$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111829$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240716$$CN$US$US
240967101$24096710$1$I$20200101$20240710$20240716$20240716$EXP$FR-AFSSAPS-AVCN2024000525$FR-Waylis Therapeutics LLC-ATNAHS20240701986$Waylis$$21$YR$A$M$Y$$$20240716$$MD$FR$FR
240967111$24096711$1$I$$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111274$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$91.63$KG$20240716$$CN$US$US
240967121$24096712$1$I$$20240710$20240716$20240716$EXP$$IT-MYLANLABS-2024M1066127$MYLAN$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et al. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicol-Rep 2024; 13 101683.$15$YR$$F$Y$48$KG$20240716$$HP$IT$IT
240967131$24096713$1$I$$20240710$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007204$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240967141$24096714$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA206599$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240716$$MD$US$US
240967151$24096715$1$I$$20240711$20240716$20240716$PER$$US-SA-2024SA207163$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240716$$MD$US$US
240967172$24096717$2$F$20240101$20240821$20240716$20240917$PER$$US-SA-2024SA207261$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240918$$MD$US$US
240967181$24096718$1$I$20240701$20240708$20240716$20240716$PER$$US-SA-2024SA205307$SANOFI AVENTIS$$39$YR$A$F$Y$62.132$KG$20240716$$MD$US$US
240967191$24096719$1$I$$20240711$20240716$20240716$PER$$US-JNJFOC-20240731865$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240716$$CN$US$US
240967201$24096720$1$I$$20240712$20240716$20240716$PER$$NVSC2024US146353$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240967211$24096721$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5839886$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240967222$24096722$2$F$$20240729$20240716$20240806$EXP$$US-TEVA-VS-3219087$TEVA$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. Rheumatology 2024; 63 (5): 1291-1296.; Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. Rheumatology 2024; 63 (5): 1291-1296.; Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al. Susceptibility of ...$35$YR$$M$Y$$$20240806$$HP$US$US
240967231$24096723$1$I$$20240711$20240716$20240716$EXP$$US-ABBVIE-5840476$ABBVIE$$$$$$Y$$$20240716$$CN$US$US
240967241$24096724$1$I$$20240705$20240716$20240716$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06407$HIKMA$Ghalayni R, Al Kalaji B, Malik K.. Ghalayni R, Al Kalaji B, Malik K. From Friend to Foe: A Case of Naloxone-Induced Pulmonary Edema.. Hospital Pharmacy. 2024;59(4):407-410$$$$$Y$$$20240716$$MD$US$US
240967253$24096725$3$F$20240101$20240828$20240716$20240911$EXP$$CA-UCBSA-2024035898$UCB$$$$$F$Y$$$20240911$$CN$CA$CA
240967261$24096726$1$I$20240710$20240715$20240716$20240716$EXP$GB-MHRA-MED-202407151147209780-NGTWM$GB-MYLANLABS-2024M1066000$MYLAN$$62$YR$$M$Y$$$20240716$$MD$GB$GB
240967271$24096727$1$I$$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49062$$FDA-CTU$$$$$M$N$$$20240715$N$HP$US$
240967281$24096728$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA200973$SANOFI AVENTIS$$$$E$F$Y$$$20240716$$MD$US$US
240967292$24096729$2$F$20240701$20240808$20240716$20240810$PER$$US-AMGEN-USASP2024140419$AMGEN$$$$$$Y$$$20240809$$PH$US$US
240967302$24096730$2$F$20240101$20240807$20240716$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-020696$UNITED THERAPEUTICS$$$$$F$Y$53.515$KG$20240813$$$US$US
240967325$24096732$5$F$$20240919$20240716$20240924$30DAY$$US-PFIZER INC-202400210015$PFIZER$$80$YR$$F$Y$$$20240924$$CN$US$US
240967332$24096733$2$F$$20240723$20240716$20240725$EXP$$CA-PFIZER INC-202400214533$PFIZER$$66$YR$$F$Y$$$20240725$$HP$CA$CA
240967351$24096735$1$I$20240715$20240715$20240715$20240715$DIR$710257$$FDA-CTU$$63$YR$$M$N$81$KG$20240715$Y$HP$US$
240967363$24096736$3$F$20240630$20240822$20240716$20240823$30DAY$$AR-PFIZER INC-202400207787$PFIZER$$6$YR$$F$Y$$$20240823$$CN$AR$AR
240967373$24096737$3$F$$20240916$20240716$20240920$30DAY$$US-PFIZER INC-202400209546$PFIZER$$12$YR$$M$Y$$$20240920$$CN$US$US
240967386$24096738$6$F$20240708$20240923$20240716$20240925$30DAY$$CL-PFIZER INC-PV202400091199$PFIZER$$10$YR$$M$Y$$$20240925$$CN$CL$CL
240967403$24096740$3$F$20240101$20240917$20240716$20240923$30DAY$$US-PFIZER INC-PV202400089551$PFIZER$$11$YR$$M$Y$40.816$KG$20240923$$CN$US$US
240967413$24096741$3$F$$20240924$20240716$20240927$EXP$$US-PFIZER INC-202400211219$PFIZER$$9$YR$$M$Y$$$20240927$$CN$US$US
240967421$24096742$1$I$20240715$20240715$20240715$20240715$DIR$710258$$FDA-CTU$$74$YR$$F$N$$$20240715$N$HP$US$
240967431$24096743$1$I$$20240703$20240716$20240716$DIR$FDA-CDER-CTU-2024-49064$$FDA-CTU$$$$$UNK$N$$$20240703$N$HP$US$
240967441$24096744$1$I$$20240712$20240716$20240716$DIR$FDA-CDER-CTU-2024-49043$$FDA-CTU$$$$$M$N$$$20240712$N$HP$US$
240967451$24096745$1$I$20240301$20240429$20240716$20240716$PER$$US-SPECGX-T202401029$SPECGX$$$$$M$Y$$$20240716$$CN$US$US
240967461$24096746$1$I$20240212$20240318$20240716$20240716$PER$$US-SPECGX-T202400691$SPECGX$$66$YR$$F$Y$48$KG$20240716$$CN$US$US
240967471$24096747$1$I$20240101$20240711$20240716$20240716$PER$$US-ABBVIE-5837599$ABBVIE$$$$$F$Y$$$20240716$$MD$US$US
240967482$24096748$2$F$$20240717$20240716$20240724$EXP$$US-PERRIGO-24US006636$PERRIGO$Nguyen C, Stanek JL. Sternomanubrial joint pain secondary to ulcerative colitis treated with ultrasound-guided injection. PM and R. 2024;16(6):650-2. DOI: 10.1002/pmrj.13031.$31$YR$$M$Y$$$20240724$$MD$US$US
240967491$24096749$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410806$FRESENIUS KABI$$71$YR$E$M$Y$103$KG$20240716$$HP$CA$CA
240967501$24096750$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410810$FRESENIUS KABI$$68$YR$E$M$Y$64$KG$20240716$$HP$CA$CA
240967511$24096751$1$I$$20240610$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN006214$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240967522$24096752$2$F$$20240712$20240716$20240726$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06548$HIKMA$Kraus MJ, Nguyen J.. Kraus MJ, Nguyen J. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report.. Case Reports in Neurology.. 2024;16(1):142-147$38$YR$$F$Y$63.5$KG$20240726$$MD$US$US
240967531$24096753$1$I$20060101$20240708$20240716$20240716$PER$$US-JNJFOC-20240722094$JOHNSON AND JOHNSON$$3$YR$C$M$Y$$$20240716$$HP$US$US
240967541$24096754$1$I$$20240710$20240716$20240716$EXP$$NL-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003838$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240716$$HP$NL$NL
240967552$24096755$2$F$$20240715$20240716$20240718$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003896$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240718$$MD$US$US
240967561$24096756$1$I$$20240708$20240716$20240716$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003782$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
240967571$24096757$1$I$20210101$20240708$20240716$20240716$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003864$ALNYLAM PHARMACEUTICALS$Bois T., Lee K.C., L^Official G., Donal E.. Recurrent ventricular tachycardia in a patient with A19D mutation-associated hereditary transthyretin amyloidosis: a case report. European Heart Journal - Case Reports. 2024;8:6$$$$$Y$$$20240716$$HP$FR$FR
240967581$24096758$1$I$$20240628$20240716$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06437$LUPIN$$$$$$Y$$$20240716$$CN$US$US
240967592$24096759$2$F$$20240802$20240716$20240812$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010588$JAZZ$$14$YR$$M$Y$$$20240812$$CN$US$US
240967601$24096760$1$I$$20240708$20240716$20240716$EXP$$CA-AMGEN-CANSP2024136990$AMGEN$Abualrob H.; Loannidis G.; Jaglal S. et.al.. Hip fracture rate and osteoporosis treatment in Ontario: A population-based retrospective cohort study. Archives of Osteoporosis. 2024;19 (53):1-17$$$$$Y$$$20240716$$HP$CA$CA
240967611$24096761$1$I$$20240708$20240716$20240716$EXP$$TR-AMGEN-TURSP2024136736$AMGEN$Deniz R.; Guzelbey T.; Mutlu I.N. et.al.. Successful treatment of a rheumatoid arthritis patient with severe synovial hypertrophy and impaired shoulder function with microwave ablation technique. Skeletal Radiology. 2024;53 (8):1639-1643$33$YR$A$F$Y$$$20240716$$HP$TR$TR
240967621$24096762$1$I$$20240709$20240716$20240716$EXP$$IT-TAKEDA-2024TUS070853$TAKEDA$$14$YR$$M$Y$$$20240716$$MD$IT$IT
240967631$24096763$1$I$$20200722$20240716$20240716$EXP$$US-AstraZeneca-2020SE91763$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240967641$24096764$1$I$$20240701$20240716$20240716$EXP$$US-EMERGENT BIOSOLUTIONS,-24000100$EMERGENT BIOSOLUTIONS$Ghalayni R, Al Kalaji B, Malik K. From Friend to Foe: A Case of Naloxone-Induced Pulmonary Edema. Hosp Pharm. 2024;59(4):407-10$66$YR$$F$Y$$$20240716$$HP$US$US
240967651$24096765$1$I$20240601$20240705$20240716$20240716$PER$$US-SA-2024SA204864$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240716$$MD$US$US
240967661$24096766$1$I$$20201009$20240716$20240716$EXP$$US-AstraZeneca-2020SF31726$ASTRAZENECA$$41$YR$$F$Y$$$20240716$$CN$US$
240967671$24096767$1$I$20230807$20240715$20240716$20240716$EXP$$DE-SANDOZ INC.-SDZ2024DE027464$SANDOZ$$68$YR$$M$Y$$$20240716$$MD$DE$DE
240967681$24096768$1$I$20240213$20240715$20240715$20240715$DIR$710251$$FDA-CTU$$25$YR$$F$N$130.5$KG$20240715$N$CN$US$
240967691$24096769$1$I$20230711$20240708$20240716$20240716$PER$$US-SA-2024SA204611$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240716$$MD$US$US
240967701$24096770$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205004$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240716$$CN$US$US
240967721$24096772$1$I$$20240711$20240716$20240716$PER$$US-ABBVIE-5837741$ABBVIE$$$$$$Y$$$20240716$$CN$US$US
240967731$24096773$1$I$$20191102$20240716$20240716$EXP$$RU-AstraZeneca-2019SF57776$ASTRAZENECA$$59$YR$$M$Y$$$20240716$$CN$RU$
240967742$24096774$2$F$20240601$20240812$20240716$20240819$EXP$$US-AMGEN-USASL2024128002$AMGEN$$70$YR$E$F$Y$$$20240819$$CN$US$US
240967751$24096775$1$I$$20240708$20240716$20240716$EXP$$US-AMGEN-USASP2024135362$AMGEN$Kaffenberger B.; Yan A.; Gallardo M. et. al.. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management. Archives of Dermatological Research. 2024;316 (7):1-10$47$YR$A$M$Y$$$20240716$$HP$US$US
240967761$24096776$1$I$$20210104$20240716$20240716$EXP$$US-AstraZeneca-2020SF28974$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240967771$24096777$1$I$$20240708$20240716$20240716$EXP$$US-AMGEN-USASP2024135554$AMGEN$Kaffenberger B.; Yan A.; Gallardo M. et. al.. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management. Archives of Dermatological Research. 2024;316 (7):1-10$31$YR$A$F$Y$$$20240716$$HP$US$US
240967781$24096778$1$I$20230101$20240705$20240716$20240716$EXP$$US-VIVUS, Inc.-2024V1000849$VIVUS$$62$YR$A$F$Y$$$20240711$$CN$US$US
240967792$24096779$2$F$20231201$20240202$20240716$20240927$PER$$US-VIVUS LLC-2024V1000113$VIVUS$$34$YR$A$F$Y$131.66$KG$20240913$$CN$US$US
240967801$24096780$1$I$20240613$20240708$20240716$20240716$EXP$ES-AEMPS-1541844$ES-TEVA-VS-3219003$TEVA$$61$YR$$F$Y$$$20240716$$MD$ES$ES
240967811$24096781$1$I$$20240708$20240716$20240716$EXP$$ES-AMGEN-ESPSP2024135755$AMGEN$Ros-sanchez E.; Oliver-gutierrez D.; Buck P. et.al.. Purpureocillium lilacinum-related endophthalmitis: case report. Journal of Ophthalmic Inflammation and Infection. 2024;14 (1):1-5$64$YR$A$M$Y$$$20240716$$HP$ES$ES
240967822$24096782$2$F$20240703$20240709$20240716$20240716$EXP$$US-AMGEN-USASP2024138498$AMGEN$$$$$F$Y$$$20240716$$MD$US$US
240967831$24096783$1$I$$20240709$20240716$20240716$PER$$US-VERTEX PHARMACEUTICALS-2024-011447$VERTEX$$$$$$Y$$$20240716$$CN$US$US
240967842$24096784$2$F$$20240722$20240716$20240726$PER$$US-VERTEX PHARMACEUTICALS-2024-011268$VERTEX$$2$YR$$M$Y$$$20240726$$CN$US$US
240967852$24096785$2$F$20240101$20240903$20240716$20240909$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011522$VERTEX$$$$$F$Y$$$20240909$$CN$GB$GB
240967861$24096786$1$I$$20240709$20240716$20240716$PER$$US-VERTEX PHARMACEUTICALS-2024-011439$VERTEX$$$$$$Y$$$20240716$$CN$US$US
240967871$24096787$1$I$$20240709$20240716$20240716$PER$$US-VERTEX PHARMACEUTICALS-2024-011455$VERTEX$$$$$F$Y$$$20240716$$CN$US$US
240967881$24096788$1$I$$20191203$20240716$20240716$EXP$$US-AstraZeneca-2019SF75317$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240967891$24096789$1$I$$20240708$20240716$20240716$EXP$$JP-TEVA-VS-3220547$TEVA$$$$E$F$Y$$$20240716$$MD$JP$JP
240967901$24096790$1$I$20240629$20240629$20240716$20240716$EXP$$VN-FreseniusKabi-FK202410301$FRESENIUS KABI$$77$YR$E$M$Y$$$20240716$$MD$VN$VN
240967911$24096791$1$I$20240605$20240708$20240716$20240716$EXP$ES-AEMPS-1543196$ES-FreseniusKabi-FK202410816$FRESENIUS KABI$$52$YR$A$F$Y$$$20240716$$MD$ES$ES
240967921$24096792$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410821$FRESENIUS KABI$$76$YR$E$M$Y$80$KG$20240716$$HP$CA$CA
240967931$24096793$1$I$$20240708$20240716$20240716$EXP$US-MLMSERVICE-20240701-PI118504-00123-1$US-RDY-SPO/USA/24/0010192$DR REDDYS$Kuraitis D, Bogner P, Gopalakrishnan D, Pei S. Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis. JAAD Case Reports. 2024;50:33-6. DOI: 10.1016/j.jdcr.2024.05.012.$68$YR$E$M$Y$$$20240716$$MD$US$US
240967941$24096794$1$I$$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405101132538610-LZDKT$GB-RDY-SPO/GBR/24/0010003$DR REDDYS$$$$$F$Y$62$KG$20240716$$CN$GB$GB
240967952$24096795$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218546$TEVA$Barrows C, Horton M, Allaham A, Israel HP. A Case of Acute Hypoxic Respiratory Failure After Administration of Rituximab. Am-J-Respir-Crit-Care-Med 2024; 209 A6326.; Barrows C, Horton M, Allaham A, Israel HP. A Case of Acute Hypoxic Respiratory Failure After Administration of Rituximab. Am-J-Respir-Crit-Care-Med 2024; 209 A6326.$61$YR$$M$Y$$$20240805$$HP$US$US
240967961$24096796$1$I$$20240701$20240716$20240716$EXP$$US-TEVA-VS-3219085$TEVA$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. Rheumatology 2024; 63 (5): 1291-1296.; Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. Rheumatology 2024; 63 (5): 1291-1296.$42$YR$$M$Y$$$20240716$$HP$US$US
240967971$24096797$1$I$20240507$20240715$20240715$20240715$DIR$710239$$FDA-CTU$$78$YR$$M$N$69.75$KG$20240715$N$CN$US$
240967982$24096798$2$F$$20240816$20240716$20240822$30DAY$$AU-JNJFOC-20240724255$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$PH$AU$AU
240967992$24096799$2$F$$20240807$20240716$20240809$30DAY$$AR-JNJFOC-20240725557$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$HP$AR$AR
240968002$24096800$2$F$$20240719$20240716$20240731$EXP$$US-JNJFOC-20240737948$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240731$$HP$US$US
240968011$24096801$1$I$$20240715$20240716$20240716$EXP$$GB-MYLANLABS-2024M1066147$MYLAN$$$$$F$Y$$$20240716$$CN$GB$GB
240968022$24096802$2$F$20240110$20240923$20240716$20240926$EXP$$IT-MYLANLABS-2024M1064699$MYLAN$$$$E$F$Y$$$20240926$$MD$IT$IT
240968031$24096803$1$I$20240414$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405131552461280-YCJTB$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-06419$HIKMA$$47$YR$$M$Y$137$KG$20240716$$HP$GB$GB
240968041$24096804$1$I$20240624$20240624$20240716$20240716$PER$$US-BEH-2024174784$CSL BEHRING$$86$YR$E$F$Y$$$20240716$$PH$US$US
240968051$24096805$1$I$$20240712$20240716$20240716$EXP$$US-PFIZER INC-202400213884$PFIZER$$$$$$Y$$$20240716$$MD$US$US
240968061$24096806$1$I$20240702$20240715$20240716$20240716$EXP$$CN-BAYER-2024A101698$BAYER$$42$YR$A$M$Y$95$KG$20240716$$HP$CN$CN
240968073$24096807$3$F$$20240711$20240716$20240809$EXP$$BR-PFIZER INC-PV202400092441$PFIZER$$61$YR$$M$Y$$$20240809$$MD$BR$BR
240968081$24096808$1$I$$20240712$20240716$20240716$EXP$$FR-PFIZER INC-202400213401$PFIZER$$15$YR$$M$Y$54$KG$20240716$$PH$FR$FR
240968091$24096809$1$I$20240619$20240712$20240716$20240716$EXP$$CN-PFIZER INC-PV202400091950$PFIZER$$14$YR$$M$Y$33$KG$20240716$$HP$CN$CN
240968101$24096810$1$I$$20240710$20240716$20240716$EXP$$JP-PFIZER INC-202400212184$PFIZER$Matsui, H.. Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). Pancreas. 2024;53(6):e501-e512$67$YR$$M$Y$$$20240716$$MD$JP$JP
240968111$24096811$1$I$20240101$20240712$20240716$20240716$EXP$$US-PFIZER INC-202400213854$PFIZER$$29$YR$$F$Y$58.97$KG$20240716$$CN$US$US
240968121$24096812$1$I$20170101$20240712$20240716$20240716$EXP$$BR-PFIZER INC-2017049169$PFIZER$$71$YR$$F$Y$$$20240716$$CN$BR$BR
240968132$24096813$2$F$$20240717$20240716$20240718$EXP$$US-PFIZER INC-PV202400092899$PFIZER$$$$$$Y$$$20240718$$CN$US$US
240968141$24096814$1$I$$20240710$20240716$20240716$PER$$US-Karo Pharma-2159168$Karo Pharma$$45$YR$$M$Y$$$20240716$$$US$US
240968151$24096815$1$I$$20240712$20240716$20240716$EXP$$US-PFIZER INC-202400213618$PFIZER$$$$$F$Y$$$20240716$$MD$US$US
240968161$24096816$1$I$$20240702$20240716$20240716$EXP$$PR-Stemline Therapeutics, Inc.-2024ST004287$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240715$$MD$PR$PR
240968171$24096817$1$I$20240301$20240711$20240716$20240716$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-111683$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240716$$MD$JP$JP
240968181$24096818$1$I$20240321$20240708$20240716$20240716$EXP$PT-INFARMED-J202406-503$PT-TEVA-VS-3219014$TEVA$$27$YR$$M$Y$78$KG$20240716$$MD$PT$PT
240968191$24096819$1$I$$20240301$20240716$20240716$EXP$GB-MHRA-MED-202402291608458500-CPSYL$GB-TEVA-VS-3166603$TEVA$$$$$$Y$$$20240716$$MD$GB$GB
240968201$24096820$1$I$20230101$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112215$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$90.7$KG$20240716$$PH$US$US
240968211$24096821$1$I$$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111992$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$43$KG$20240716$$PH$US$US
240968221$24096822$1$I$$20230612$20240716$20240716$PER$$US-IGSA-BIG0023954$GRIFOLS$$48$YR$$F$Y$$$20240716$$HP$US$US
240968231$24096823$1$I$20230501$20230601$20240716$20240716$PER$$US-IGSA-BIG0023704$GRIFOLS$$61$YR$$F$Y$$$20240716$$CN$US$US
240968241$24096824$1$I$20230310$20230712$20240716$20240716$PER$$US-IGSA-BIG0024604$GRIFOLS$$59$YR$$M$Y$$$20240716$$PH$US$US
240968251$24096825$1$I$20230724$20230724$20240716$20240716$PER$$US-IGSA-BIG0024864$GRIFOLS$$53$YR$$M$Y$$$20240716$$HP$US$US
240968261$24096826$1$I$20230703$20230719$20240716$20240716$PER$$US-IGSA-BIG0024759$GRIFOLS$$11$YR$$F$Y$$$20240716$$PH$US$US
240968271$24096827$1$I$$20230621$20240716$20240716$PER$$US-IGSA-BIG0024196$GRIFOLS$$$$$F$Y$$$20240716$$HP$US$US
240968281$24096828$1$I$20230608$20230627$20240716$20240716$PER$$US-IGSA-BIG0024233$GRIFOLS$$55$YR$$F$Y$$$20240716$$PH$US$US
240968291$24096829$1$I$20230427$20230622$20240716$20240716$PER$$US-IGSA-BIG0024162$GRIFOLS$$56$YR$$F$Y$$$20240716$$PH$US$US
240968301$24096830$1$I$$20230704$20240716$20240716$PER$$US-IGSA-BIG0024342$GRIFOLS$Dibs, Mohammad. Orbital Myositis Presenting as a Late Immune-Related Adverse Event Four Months After Stopping Immune Checkpoint Inhibitor. Neurology AAN Publications. 2023;17 Supplement 2$50$YR$$F$Y$$$20240716$$MD$US$US
240968311$24096831$1$I$$20230608$20240716$20240716$PER$$US-IGSA-BIG0023872$GRIFOLS$Bello, C., Xie, Y., Tahboub, R., Lewandrowski, N., Zantek, N.D., Garrity, D., Sargent, K., Vauthrin, M., Chhibber, V., Zhao, Y.D., Li, Y.. MANAGEMENT OF AN APHERESIS PATIENT WITH PULMONARY EMBOLI ON SYSTEMIC UNFRACTIONATED HEPARIN. Journal of Clinical Apheresis. 2023;38:329-330$76$YR$$M$Y$$$20240716$$HP$US$US
240968321$24096832$1$I$20221001$20230720$20240716$20240716$PER$$US-IGSA-BIG0024868$GRIFOLS$$48$YR$$F$Y$$$20240716$$MD$US$US
240968331$24096833$1$I$$20230601$20240716$20240716$PER$$US-IGSA-BIG0023675$GRIFOLS$$$$$F$Y$86.168$KG$20240716$$CN$US$US
240968341$24096834$1$I$$20230622$20240716$20240716$PER$$US-IGSA-BIG0024129$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240968351$24096835$1$I$$20230707$20240716$20240716$PER$$US-IGSA-BIG0024539$GRIFOLS$$$$$M$Y$113.83$KG$20240716$$CN$US$US
240968361$24096836$1$I$$20230713$20240716$20240716$PER$$US-IGSA-BIG0024606$GRIFOLS$$55$YR$$F$Y$$$20240716$$HP$US$US
240968371$24096837$1$I$20230717$20230721$20240716$20240716$PER$$US-IGSA-BIG0024814$GRIFOLS$$68$YR$$M$Y$92.971$KG$20240716$$HP$US$US
240968381$24096838$1$I$20230101$20230609$20240716$20240716$PER$$US-IGSA-BIG0023915$GRIFOLS$$$$$M$Y$108.84$KG$20240716$$CN$US$US
240968391$24096839$1$I$$20230703$20240716$20240716$PER$$US-IGSA-BIG0024329$GRIFOLS$Desai, Urvi. How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast. Neurology and Therapy. 2023$68$YR$$F$Y$$$20240716$$MD$US$US
240968401$24096840$1$I$20230601$20230623$20240716$20240716$PER$$US-IGSA-BIG0024197$GRIFOLS$$51$YR$$F$Y$92.971$KG$20240716$$HP$US$US
240968411$24096841$1$I$$20230714$20240716$20240716$PER$$US-GRIFOLS-BIG0024791$GRIFOLS$Marquez D, Romero R, Klavansky D, Reynolds AS.. HSV Encephalomyelitis in an Immunocompetent Patient With Prior Splenectomy. Neurohospitalist. 2023;13(3):312-316$44$YR$$M$Y$$$20240716$$MD$US$US
240968421$24096842$1$I$20230501$20230607$20240716$20240716$PER$$US-IGSA-BIG0023906$GRIFOLS$$54$YR$$F$Y$104.31$KG$20240716$$CN$US$US
240968431$24096843$1$I$$20230601$20240716$20240716$PER$$US-IGSA-BIG0023710$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240968441$24096844$1$I$20230419$20230622$20240716$20240716$PER$$US-IGSA-BIG0024055$GRIFOLS$$38$YR$$M$Y$95$KG$20240716$$PH$US$US
240968451$24096845$1$I$$20230623$20240716$20240716$PER$$US-IGSA-BIG0024208$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240968461$24096846$1$I$$20230621$20240716$20240716$PER$$US-IGSA-BIG0024186$GRIFOLS$$$$$F$Y$72$KG$20240716$$PH$US$US
240968471$24096847$1$I$20230614$20230616$20240716$20240716$PER$$US-IGSA-BIG0024189$GRIFOLS$$15$YR$$M$Y$60.1$KG$20240716$$HP$US$US
240968481$24096848$1$I$$20230602$20240716$20240716$PER$$US-IGSA-BIG0023705$GRIFOLS$$$$$M$Y$$$20240716$$CN$US$US
240968491$24096849$1$I$20230717$20230718$20240716$20240716$PER$$US-IGSA-BIG0024684$GRIFOLS$$73$YR$$M$Y$68.027$KG$20240716$$HP$US$US
240968501$24096850$1$I$$20230726$20240716$20240716$PER$$US-IGSA-BIG0024964$GRIFOLS$$18$YR$$F$Y$$$20240716$$MD$US$US
240968511$24096851$1$I$20230601$20230630$20240716$20240716$PER$$US-IGSA-BIG0024305$GRIFOLS$$$$$F$Y$$$20240716$$MD$US$US
240968524$24096852$4$F$$20240826$20240716$20240828$PER$$NVSC2024US145639$NOVARTIS$$$$$$Y$$$20240829$$CN$US$US
240968531$24096853$1$I$$20230721$20240716$20240716$PER$$US-GRIFOLS-BIG0025003$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240968541$24096854$1$I$$20230710$20240716$20240716$PER$$US-IGSA-BIG0024486$GRIFOLS$$$$$M$Y$$$20240716$$CN$US$US
240968551$24096855$1$I$20230616$20230623$20240716$20240716$PER$$US-IGSA-BIG0024161$GRIFOLS$$76$YR$$M$Y$129$KG$20240716$$HP$US$US
240968561$24096856$1$I$$20230724$20240716$20240716$PER$$US-IGSA-BIG0024939$GRIFOLS$$$$$M$Y$$$20240716$$CN$US$US
240968571$24096857$1$I$20230530$20230725$20240716$20240716$PER$$US-IGSA-BIG0024823$GRIFOLS$$53$YR$$M$Y$94.331$KG$20240716$$HP$US$US
240968581$24096858$1$I$20230801$20230907$20240716$20240716$PER$$US-IGSA-BIG0025703$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240968591$24096859$1$I$20230918$20230919$20240716$20240716$PER$$US-IGSA-BIG0025850$GRIFOLS$$58$YR$$M$Y$$$20240716$$PH$US$US
240968601$24096860$1$I$$20230920$20240716$20240716$PER$$US-IGSA-BIG0025925$GRIFOLS$Mueller A., Kwa M., Kerr H.. 40528 Administration of bortezomib in patients with refractory scleromyxedema: A case report. Journal of the American Academy of Dermatology. 2023;89:3:1-4$58$YR$$F$Y$$$20240716$$HP$US$US
240968611$24096861$1$I$$20230823$20240716$20240716$PER$$US-IGSA-BIG0025579$GRIFOLS$$69$YR$$M$Y$$$20240716$$HP$US$US
240968621$24096862$1$I$20230617$20230802$20240716$20240716$PER$$US-IGSA-BIG0025214$GRIFOLS$$60$YR$$F$Y$$$20240716$$HP$US$US
240968631$24096863$1$I$20230728$20230809$20240716$20240716$PER$$US-IGSA-BIG0025398$GRIFOLS$$35$YR$$F$Y$63$KG$20240716$$PH$US$US
240968641$24096864$1$I$$20230913$20240716$20240716$PER$$US-IGSA-BIG0025802$GRIFOLS$$$$$F$Y$$$20240716$$MD$US$US
240968651$24096865$1$I$20230917$20230926$20240716$20240716$PER$$US-IGSA-BIG0025983$GRIFOLS$$46$YR$$F$Y$57$KG$20240716$$PH$US$US
240968661$24096866$1$I$20230928$20230929$20240716$20240716$PER$$US-IGSA-BIG0025995$GRIFOLS$$77$YR$$F$Y$61.224$KG$20240716$$HP$US$US
240968671$24096867$1$I$$20230811$20240716$20240716$PER$$US-IGSA-BIG0025433$GRIFOLS$Ojbindra KCa, c , Ananta Subedib, Rakshya Sharmab. Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia. J Med Cases. 2023;14(7):227-231$66$YR$$M$Y$91$KG$20240716$$HP$US$US
240968681$24096868$1$I$20230824$20230824$20240716$20240716$PER$$US-IGSA-BIG0025582$GRIFOLS$$58$YR$$M$Y$$$20240716$$CN$US$US
240968691$24096869$1$I$20230907$20230907$20240716$20240716$PER$$US-IGSA-BIG0025715$GRIFOLS$$67$YR$$F$Y$99.773$KG$20240716$$HP$US$US
240968701$24096870$1$I$$20230915$20240716$20240716$PER$$US-IGSA-BIG0025817$GRIFOLS$$$$$M$Y$$$20240716$$CN$US$US
240968711$24096871$1$I$20230912$20230919$20240716$20240716$PER$$US-IGSA-BIG0025852$GRIFOLS$$54$YR$$M$Y$$$20240716$$PH$US$US
240968721$24096872$1$I$20230915$20230925$20240716$20240716$PER$$US-IGSA-BIG0025940$GRIFOLS$$52$YR$$M$Y$103.4$KG$20240716$$HP$US$US
240968731$24096873$1$I$$20230818$20240716$20240716$PER$$US-IGSA-BIG0025500$GRIFOLS$$$$$F$Y$136.05$KG$20240716$$CN$US$US
240968741$24096874$1$I$$20230926$20240716$20240716$PER$$US-IGSA-BIG0025965$GRIFOLS$$$$$F$Y$56.7$KG$20240716$$PH$US$US
240968751$24096875$1$I$20180101$20230731$20240716$20240716$PER$$US-IGSA-BIG0025217$GRIFOLS$My Choice: To Get a Port or Transition to SubQ. IG Me. 2023;June-July 2023:49$$$$F$Y$$$20240716$$CN$US$US
240968761$24096876$1$I$$20230824$20240716$20240716$PER$$US-IGSA-BIG0025584$GRIFOLS$$$$$M$Y$$$20240716$$CN$US$US
240968771$24096877$1$I$20230701$20230802$20240716$20240716$PER$$US-IGSA-BIG0025203$GRIFOLS$$62$YR$$F$Y$$$20240716$$CN$US$US
240968781$24096878$1$I$$20230731$20240716$20240716$PER$$US-IGSA-BIG0025070$GRIFOLS$DeBois, Dawn. The Double-Edged Sword of Social Media for IG. IG Living magazine. 2023;47$$$$F$Y$$$20240716$$CN$US$US
240968791$24096879$1$I$$20230728$20240716$20240716$PER$$US-IGSA-BIG0025012$GRIFOLS$$$$$M$Y$88.435$KG$20240716$$HP$US$US
240968801$24096880$1$I$20200101$20230904$20240716$20240716$PER$$US-IGSA-BIG0025673$GRIFOLS$Xie Z, et al.. Markers of endothelial glycocalyx dysfunction in Clarkson disease. Journal of Translational Medicine. 2022;20:2-10$49$YR$$F$Y$$$20240716$$HP$US$US
240968811$24096881$1$I$20230912$20230912$20240716$20240716$PER$$US-IGSA-BIG0025798$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240968821$24096882$1$I$20230901$20230901$20240716$20240716$PER$$US-IGSA-BIG0025692$GRIFOLS$$42$YR$$M$Y$147.85$KG$20240716$$HP$US$US
240968831$24096883$1$I$$20230809$20240716$20240716$PER$$US-IGSA-BIG0025386$GRIFOLS$$$$$F$Y$$$20240716$$HP$US$US
240968841$24096884$1$I$20230808$20230810$20240716$20240716$PER$$US-IGSA-BIG0025421$GRIFOLS$$42$YR$$F$Y$$$20240716$$PH$US$US
240968851$24096885$1$I$20230926$20230926$20240716$20240716$PER$$US-IGSA-BIG0025959$GRIFOLS$$56$YR$$M$Y$$$20240716$$HP$US$US
240968861$24096886$1$I$$20230905$20240716$20240716$PER$$US-IGSA-BIG0025706$GRIFOLS$$$$$F$Y$$$20240716$$PH$US$US
240968871$24096887$1$I$20230925$20230925$20240716$20240716$PER$$US-IGSA-BIG0025933$GRIFOLS$$70$YR$$F$Y$67$KG$20240716$$HP$US$US
240968881$24096888$1$I$$20230822$20240716$20240716$PER$$US-IGSA-BIG0025558$GRIFOLS$$63$YR$$F$Y$72.562$KG$20240716$$CN$US$US
240968891$24096889$1$I$20230826$20230901$20240716$20240716$PER$$US-IGSA-BIG0025669$GRIFOLS$$64$YR$$M$Y$90.703$KG$20240716$$CN$US$US
240968901$24096890$1$I$20230828$20230913$20240716$20240716$PER$$US-IGSA-BIG0025789$GRIFOLS$$31$YR$$F$Y$68.027$KG$20240716$$CN$US$US
240968911$24096891$1$I$20230908$20230919$20240716$20240716$PER$$US-IGSA-BIG0025849$GRIFOLS$$53$YR$$F$Y$$$20240716$$PH$US$US
240968921$24096892$1$I$20230806$20230814$20240716$20240716$PER$$US-IGSA-BIG0025448$GRIFOLS$$65$YR$$F$Y$56.689$KG$20240716$$CN$US$US
240968931$24096893$1$I$20230801$20230830$20240716$20240716$PER$$US-IGSA-BIG0025637$GRIFOLS$$9$YR$$M$Y$$$20240716$$CN$US$US
240968941$24096894$1$I$20230726$20230728$20240716$20240716$PER$$US-IGSA-BIG0025040$GRIFOLS$$40$YR$$F$Y$$$20240716$$PH$US$US
240968951$24096895$1$I$20230910$20230929$20240716$20240716$PER$$US-IGSA-BIG0026006$GRIFOLS$$17$YR$$F$Y$82.54$KG$20240716$$PH$US$US
240968961$24096896$1$I$20230921$20230925$20240716$20240716$PER$$US-IGSA-BIG0025942$GRIFOLS$$68$YR$$M$Y$109.75$KG$20240716$$HP$US$US
240968971$24096897$1$I$20230929$20230929$20240716$20240716$PER$$US-IGSA-BIG0026003$GRIFOLS$$59$YR$$F$Y$57.7$KG$20240716$$PH$US$US
240968981$24096898$1$I$$20230803$20240716$20240716$PER$$US-IGSA-BIG0025243$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240968991$24096899$1$I$20230926$20230926$20240716$20240716$PER$$US-IGSA-BIG0025958$GRIFOLS$$76$YR$$M$Y$$$20240716$$HP$US$US
240969001$24096900$1$I$$20240709$20240716$20240716$EXP$$NVSC2024MX145054$NOVARTIS$$$$$F$Y$$$20240716$$CN$MX$MX
240969011$24096901$1$I$20230101$20230905$20240716$20240716$PER$$US-IGSA-BIG0025700$GRIFOLS$$$$$M$Y$108.8$KG$20240716$$CN$US$US
240969021$24096902$1$I$20230911$20230918$20240716$20240716$PER$$US-IGSA-BIG0025853$GRIFOLS$$53$YR$$F$Y$75.283$KG$20240716$$HP$US$US
240969031$24096903$1$I$$20230822$20240716$20240716$PER$$US-IGSA-BIG0024961$GRIFOLS$$$$$F$Y$48.526$KG$20240716$$PH$US$US
240969041$24096904$1$I$20230907$20230915$20240716$20240716$PER$$US-IGSA-BIG0025808$GRIFOLS$$43$YR$$F$Y$63.492$KG$20240716$$HP$US$US
240969051$24096905$1$I$$20230925$20240716$20240716$PER$$US-IGSA-BIG0025922$GRIFOLS$Jessica Bian, George P. Bayliss. A Rare Case of Guillian-Barr? Syndrome Associated with Cytomegalovirus. J Am Soc Nephrol. 2015;26:1042A$62$YR$$F$Y$$$20240716$$HP$US$US
240969061$24096906$1$I$20240614$20240709$20240716$20240716$EXP$$IT-SA-2024SA183326$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240716$$HP$IT$IT
240969071$24096907$1$I$$20231120$20240716$20240716$PER$$US-IGSA-BIG0026594$GRIFOLS$Wirtshafter, S., Hanna, G., Blum, M., Geara, A.S. Mixed Cryoglobulinemic Glomerulonephritis Triggered by Influenza Vaccination. Journal of the American Society of Nephrology. 2023;34:600$68$YR$$M$Y$$$20240716$$HP$US$US
240969081$24096908$1$I$$20231010$20240716$20240716$PER$$US-IGSA-BIG0026100$GRIFOLS$$76$YR$$F$Y$$$20240716$$HP$US$US
240969091$24096909$1$I$20231012$20231027$20240716$20240716$PER$$US-IGSA-BIG0026315$GRIFOLS$$$$$F$Y$$$20240716$$HP$US$US
240969101$24096910$1$I$20231001$20231127$20240716$20240716$PER$$US-IGSA-BIG0026691$GRIFOLS$$54$YR$$F$Y$$$20240716$$PH$US$US
240969111$24096911$1$I$$20230928$20240716$20240716$PER$$US-IGSA-BIG0025997$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240969121$24096912$1$I$$20230802$20240716$20240716$PER$$US-IGSA-BIG0025219$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240969131$24096913$1$I$20231201$20231229$20240716$20240716$PER$$US-IGSA-BIG0027110$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240969141$24096914$1$I$$20231102$20240716$20240716$PER$$US-IGSA-BIG0026444$GRIFOLS$Jelena Eremija, Sanjay Patel, Sydney Rice and Michael Daines. Intravenous immunoglobulin treatment improves multiple neuropsychiatric outcomes in patients with pediatric acute-onset neuropsychiatric syndrome. Frontiers in pediatrics. 2023;1-6$$$C$$Y$$$20240716$$HP$US$US
240969151$24096915$1$I$$20231108$20240716$20240716$PER$$US-IGSA-BIG0026478$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240969161$24096916$1$I$20231101$20231127$20240716$20240716$PER$$US-IGSA-BIG0026690$GRIFOLS$$71$YR$$M$Y$93.878$KG$20240716$$PH$US$US
240969171$24096917$1$I$$20231017$20240716$20240716$PER$$US-IGSA-BIG0026245$GRIFOLS$$$$$M$Y$$$20240716$$PH$US$US
240969181$24096918$1$I$20231111$20231117$20240716$20240716$PER$$US-IGSA-BIG0026578$GRIFOLS$$84$YR$$M$Y$77.098$KG$20240716$$PH$US$US
240969191$24096919$1$I$20231230$20240105$20240716$20240716$PER$$US-IGSA-BIG0027206$GRIFOLS$$52$YR$$F$Y$$$20240716$$CN$US$US
240969201$24096920$1$I$20230501$20231130$20240716$20240716$PER$$US-IGSA-BIG0026741$GRIFOLS$$83$YR$$F$Y$74.83$KG$20240716$$CN$US$US
240969211$24096921$1$I$20231210$20231227$20240716$20240716$PER$$US-IGSA-BIG0027059$GRIFOLS$$42$YR$$F$Y$83.9$KG$20240716$$HP$US$US
240969221$24096922$1$I$20231227$20231229$20240716$20240716$PER$$US-IGSA-BIG0027086$GRIFOLS$$73$YR$$M$Y$80.726$KG$20240716$$HP$US$US
240969231$24096923$1$I$20231020$20231122$20240716$20240716$PER$$US-IGSA-BIG0026646$GRIFOLS$$42$YR$$M$Y$$$20240716$$PH$US$US
240969241$24096924$1$I$$20231102$20240716$20240716$PER$$US-IGSA-BIG0026445$GRIFOLS$Jelena Eremija, Sanjay Patel, Sydney Rice and Michael Daines. Intravenous immunoglobulin treatment improves multiple neuropsychiatric outcomes in patients with pediatric acute-onset neuropsychiatric syndrome. Frontiers in pediatrics. 2023;1-6$$$C$$Y$$$20240716$$HP$US$US
240969251$24096925$1$I$20231101$20231106$20240716$20240716$PER$$US-IGSA-BIG0026433$GRIFOLS$$37$YR$$F$Y$$$20240716$$PH$US$US
240969261$24096926$1$I$$20231114$20240716$20240716$PER$$US-IGSA-BIG0026565$GRIFOLS$$$$$F$Y$62.585$KG$20240716$$CN$US$US
240969271$24096927$1$I$$20231116$20240716$20240716$PER$$US-IGSA-BIG0026563$GRIFOLS$$60$YR$$M$Y$$$20240716$$PH$US$US
240969281$24096928$1$I$20231205$20231206$20240716$20240716$PER$$US-IGSA-BIG0026837$GRIFOLS$$69$YR$$F$Y$68.481$KG$20240716$$HP$US$US
240969291$24096929$1$I$20231101$20231215$20240716$20240716$PER$$US-IGSA-BIG0026943$GRIFOLS$$60$YR$$M$Y$$$20240716$$PH$US$US
240969301$24096930$1$I$20231020$20231023$20240716$20240716$PER$$US-IGSA-BIG0026307$GRIFOLS$$53$YR$$F$Y$61.224$KG$20240716$$CN$US$US
240969311$24096931$1$I$$20231102$20240716$20240716$PER$$US-IGSA-BIG0026441$GRIFOLS$Jelena Eremija, Sanjay Patel, Sydney Rice and Michael Daines. Intravenous immunoglobulin treatment improves multiple neuropsychiatric outcomes in patients with pediatric acute-onset neuropsychiatric syndrome. Frontiers in pediatrics. 2023;1-6$$$C$M$Y$$$20240716$$HP$US$US
240969321$24096932$1$I$$20231201$20240716$20240716$PER$$US-IGSA-BIG0026758$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240969331$24096933$1$I$$20231012$20240716$20240716$PER$$US-IGSA-BIG0026142$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240969341$24096934$1$I$20230119$20231002$20240716$20240716$PER$$US-IGSA-BIG0026017$GRIFOLS$$46$YR$$F$Y$$$20240716$$CN$US$US
240969351$24096935$1$I$$20231115$20240716$20240716$PER$$US-IGSA-BIG0026536$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240969361$24096936$1$I$$20231207$20240716$20240716$PER$$US-IGSA-BIG0026830$GRIFOLS$Dawson A Foster, Endurance O Evbayekha, Joseph Sokhn.. A Paradoxal Reaction from Intravenous Immunoglobulin. Blood. 2023;142:5572$73$YR$$F$Y$$$20240716$$MD$US$US
240969371$24096937$1$I$$20231228$20240716$20240716$PER$$US-IGSA-BIG0027075$GRIFOLS$PAULA CASTELLANOS, Ejigayehu Abate, Ana Chindris, Sarika Rao, Jonathan Hoyne, Victor Bernet. ASSOCIATION OF ABNORMAL THYROID FUNCTION WITH IVIG TREATMENT: A CASE REPORT AND LITERATURE REVIEW. THYROID. 2023;33:44-45$69$YR$$M$Y$$$20240716$$HP$US$US
240969381$24096938$1$I$$20231003$20240716$20240716$PER$$US-IGSA-BIG0026004$GRIFOLS$$33$YR$$F$Y$67.6$KG$20240716$$PH$US$US
240969391$24096939$1$I$20231013$20231019$20240716$20240716$PER$$US-IGSA-BIG0026241$GRIFOLS$$93$YR$$M$Y$$$20240716$$CN$US$US
240969401$24096940$1$I$20230720$20230811$20240716$20240716$PER$$US-IGSA-BIG0024883$GRIFOLS$$71$YR$$F$Y$$$20240716$$CN$US$US
240969411$24096941$1$I$$20231229$20240716$20240716$PER$$US-IGSA-BIG0027111$GRIFOLS$$$$$F$Y$$$20240716$$MD$US$US
240969421$24096942$1$I$20231122$20231130$20240716$20240716$PER$$US-IGSA-BIG0026733$GRIFOLS$$32$YR$$F$Y$61.224$KG$20240716$$HP$US$US
240969431$24096943$1$I$20231227$20231229$20240716$20240716$PER$$US-IGSA-BIG0027087$GRIFOLS$$48$YR$$F$Y$88.435$KG$20240716$$HP$US$US
240969441$24096944$1$I$$20231004$20240716$20240716$PER$$US-IGSA-BIG0026063$GRIFOLS$Xiaoyang Li and Anahit Mehrabyan. Managing Myasthenia Gravis with Eculizumab Monotherapy Through Pregnancy. The Canadian Journal of Neurological Sciences. 2023;50:803?805$33$YR$$F$Y$$$20240716$$MD$US$US
240969451$24096945$1$I$$20231227$20240716$20240716$PER$$US-IGSA-BIG0027085$GRIFOLS$$$$$M$Y$$$20240716$$CN$US$US
240969461$24096946$1$I$20231010$20231020$20240716$20240716$PER$$US-IGSA-BIG0026255$GRIFOLS$$50$YR$$F$Y$$$20240716$$PH$US$US
240969471$24096947$1$I$20231215$20231219$20240716$20240716$PER$$US-IGSA-BIG0026977$GRIFOLS$$54$YR$$F$Y$44.898$KG$20240716$$CN$US$US
240969481$24096948$1$I$$20231102$20240716$20240716$PER$$US-IGSA-BIG0026443$GRIFOLS$Jelena Eremija, Sanjay Patel, Sydney Rice and Michael Daines. Intravenous immunoglobulin treatment improves multiple neuropsychiatric outcomes in patients with pediatric acute-onset neuropsychiatric syndrome. Frontiers in pediatrics. 2023;1-6$$$C$$Y$$$20240716$$HP$US$US
240969491$24096949$1$I$$20231025$20240716$20240716$PER$$US-IGSA-BIG0026319$GRIFOLS$$$$$F$Y$72.562$KG$20240716$$PH$US$US
240969501$24096950$1$I$$20231201$20240716$20240716$PER$$US-IGSA-BIG0026798$GRIFOLS$$$$$F$Y$$$20240716$$HP$US$US
240969511$24096951$1$I$20231217$20231218$20240716$20240716$PER$$US-IGSA-BIG0026969$GRIFOLS$$73$YR$$F$Y$$$20240716$$CN$US$US
240969521$24096952$1$I$$20231127$20240716$20240716$PER$$US-IGSA-BIG0026687$GRIFOLS$Kodali, Reddy S.. Osmotic Nephropathy from a Non-Sucrose Based Ivig. Am J Transplant. 2020;20:839$67$YR$$M$Y$$$20240716$$MD$US$US
240969531$24096953$1$I$20240101$20240711$20240716$20240716$EXP$$CA-ABBVIE-5838559$ABBVIE$$63$YR$$F$Y$$$20240716$$CN$CA$CA
240969541$24096954$1$I$$20231016$20240716$20240716$PER$$US-IGSA-BIG0026212$GRIFOLS$$$$$M$Y$$$20240716$$CN$US$US
240969551$24096955$1$I$20231129$20231208$20240716$20240716$PER$$US-IGSA-BIG0026829$GRIFOLS$$27$YR$$M$Y$76.19$KG$20240716$$HP$US$US
240969561$24096956$1$I$20220907$20240711$20240716$20240716$EXP$$CN-JNJFOC-20240733857$JOHNSON AND JOHNSON$$54$YR$A$F$Y$61$KG$20240716$$HP$CN$CN
240969571$24096957$1$I$20240629$20240711$20240716$20240716$EXP$$US-TAKEDA-2024TUS071087$TAKEDA$$32$YR$$$Y$$$20240716$$MD$US$US
240969581$24096958$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205964$SANOFI AVENTIS$$1$YR$I$$Y$$$20240716$$CN$US$US
240969591$24096959$1$I$20240108$20240108$20240716$20240716$PER$$US-IGSA-BIG0027248$GRIFOLS$$$$$F$Y$$$20240716$$HP$US$US
240969601$24096960$1$I$20240124$20240124$20240716$20240716$PER$$US-IGSA-BIG0027431$GRIFOLS$$$$$F$Y$$$20240716$$PH$US$US
240969611$24096961$1$I$20230911$20231013$20240716$20240716$PER$$US-IGSA-BIG0026162$GRIFOLS$$68$YR$$F$Y$59.864$KG$20240716$$HP$US$US
240969621$24096962$1$I$$20240228$20240716$20240716$PER$$US-IGSA-BIG0027950$GRIFOLS$$$$$M$Y$$$20240716$$PH$US$US
240969631$24096963$1$I$20240313$20240313$20240716$20240716$PER$$US-IGSA-BIG0028140$GRIFOLS$$$$$F$Y$68.027$KG$20240716$$CN$US$US
240969641$24096964$1$I$$20240320$20240716$20240716$PER$$US-IGSA-BIG0028302$GRIFOLS$$$$$F$Y$$$20240716$$MD$US$US
240969651$24096965$1$I$$20240328$20240716$20240716$PER$$US-IGSA-BIG0028322$GRIFOLS$$$$$M$Y$$$20240716$$HP$US$US
240969661$24096966$1$I$$20240329$20240716$20240716$PER$$US-IGSA-BIG0028347$GRIFOLS$$$$$F$Y$$$20240716$$HP$US$US
240969671$24096967$1$I$20240208$20240228$20240716$20240716$PER$$US-IGSA-BIG0027908$GRIFOLS$$59$YR$$F$Y$56.689$KG$20240716$$CN$US$US
240969681$24096968$1$I$20240201$20240402$20240716$20240716$PER$$US-IGSA-BIG0028415$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240969691$24096969$1$I$20231116$20231116$20240716$20240716$PER$$US-IGSA-BIG0026595$GRIFOLS$$$$$F$Y$$$20240716$$HP$US$US
240969701$24096970$1$I$$20240411$20240716$20240716$PER$$US-IGSA-BIG0028539$GRIFOLS$Sahar, A., Brewer, M.. A case of atypical Kawasaki Disease with elevated serum IL-18 and ferritin levels + potential IVIG resistance. The American Journal of the Medical Sciences. 2024;367:275$15$MON$$F$Y$$$20240716$$MD$US$US
240969711$24096971$1$I$20240224$20240226$20240716$20240716$PER$$US-IGSA-BIG0027870$GRIFOLS$$77$YR$$M$Y$69$KG$20240716$$PH$US$US
240969721$24096972$1$I$20240101$20240306$20240716$20240716$PER$$US-IGSA-BIG0028026$GRIFOLS$$$$$M$Y$$$20240716$$PH$US$US
240969731$24096973$1$I$$20240305$20240716$20240716$PER$$US-IGSA-BIG0027984$GRIFOLS$$$$$F$Y$78.9$KG$20240716$$CN$US$US
240969741$24096974$1$I$$20240318$20240716$20240716$PER$$US-IGSA-BIG0028171$GRIFOLS$$$$$M$Y$$$20240716$$CN$US$US
240969751$24096975$1$I$20240127$20240127$20240716$20240716$PER$$US-IGSA-BIG0027469$GRIFOLS$$59$YR$$F$Y$$$20240716$$HP$US$US
240969761$24096976$1$I$$20240201$20240716$20240716$PER$$US-IGSA-BIG0027550$GRIFOLS$$55$YR$$F$Y$$$20240716$$HP$US$US
240969771$24096977$1$I$20240215$20240321$20240716$20240716$PER$$US-IGSA-BIG0028067$GRIFOLS$$13$YR$$M$Y$48.526$KG$20240716$$HP$US$US
240969781$24096978$1$I$20240110$20240227$20240716$20240716$PER$$US-IGSA-BIG0027727$GRIFOLS$$66$YR$$F$Y$98.8$KG$20240716$$PH$US$US
240969791$24096979$1$I$20231201$20231228$20240716$20240716$PER$$US-IGSA-BIG0027076$GRIFOLS$$73$YR$$M$Y$87.075$KG$20240716$$PH$US$US
240969801$24096980$1$I$20240329$20240403$20240716$20240716$PER$$US-IGSA-BIG0028398$GRIFOLS$$47$YR$$F$Y$138.32$KG$20240716$$CN$US$US
240969811$24096981$1$I$$20240219$20240716$20240716$PER$$US-IGSA-BIG0027756$GRIFOLS$Alkhatib EH, et al.. Case Report: Insulin hypersensitivity in youth with type 1 diabetes. Frontiers in Endocrinology. 2023;14:1-9$15$YR$$M$Y$$$20240716$$MD$US$US
240969821$24096982$1$I$$20240320$20240716$20240716$PER$$US-IGSA-BIG0028233$GRIFOLS$$$$$F$Y$$$20240716$$HP$US$US
240969831$24096983$1$I$$20240103$20240716$20240716$PER$$US-IGSA-BIG0027177$GRIFOLS$Ahmed Zaka, Ozra Dehkordi, Roger Weir, Mosunmola Oyawusi, Richard M. Millis. A Case of Guillain-Barr? Syndrome With Multiple Causative Factors in a Young Male. Cureus. 2023;15(11):1-4$28$YR$$M$Y$$$20240716$$HP$US$US
240969841$24096984$1$I$20240319$20240129$20240716$20240716$PER$$US-IGSA-BIG0027494$GRIFOLS$$34$YR$$F$Y$$$20240716$$CN$US$US
240969851$24096985$1$I$$20240403$20240716$20240716$PER$$US-IGSA-BIG0028420$GRIFOLS$Obiakor, Bianca. Functional and Cutaneous Treatment Outcomes With Intravenous Immunoglobulin for Eosinophilic Fasciitis A Retrospective Study. JOURNAL OF DRUGS IN DERMATOLOGY. 2024;23:e107 - e109$64$YR$$F$Y$$$20240716$$MD$US$US
240969861$24096986$1$I$$20240311$20240716$20240716$PER$$US-IGSA-BIG0028085$GRIFOLS$$$$A$F$Y$$$20240716$$HP$US$US
240969871$24096987$1$I$$20231215$20240716$20240716$PER$$US-IGSA-BIG0026947$GRIFOLS$$$$$F$Y$$$20240716$$HP$US$US
240969881$24096988$1$I$20240221$20240305$20240716$20240716$PER$$US-IGSA-BIG0027956$GRIFOLS$$24$YR$$F$Y$70.295$KG$20240716$$CN$US$US
240969901$24096990$1$I$$20240131$20240716$20240716$PER$$US-IGSA-BIG0027521$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240969911$24096991$1$I$$20240418$20240716$20240716$PER$$US-IGSA-BIG0028731$GRIFOLS$Leah Rosoph, Luisa Ladel, Ronak Patel, Patrick Webster. Intravenous Immunoglobulin-Induced Aseptic Meningitis in a Dermatomyositis Patient. Cureus. 2024;1-8$47$YR$$F$Y$$$20240716$$MD$US$US
240969921$24096992$1$I$$20240329$20240716$20240716$PER$$US-IGSA-BIG0028327$GRIFOLS$$$$$$Y$$$20240716$$HP$US$US
240969931$24096993$1$I$$20240304$20240716$20240716$PER$$US-IGSA-BIG0027977$GRIFOLS$$$$$M$Y$23.583$KG$20240716$$CN$US$US
240969941$24096994$1$I$$20240327$20240716$20240716$PER$$US-IGSA-BIG0028319$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240969951$24096995$1$I$20240301$20240411$20240716$20240716$PER$$US-IGSA-BIG0028522$GRIFOLS$$$$$M$Y$$$20240716$$CN$US$US
240969961$24096996$1$I$20240502$20240502$20240716$20240716$PER$$US-IGSA-BIG0028898$GRIFOLS$$$$$F$Y$$$20240716$$HP$US$US
240969971$24096997$1$I$$20240412$20240716$20240716$PER$$US-IGSA-BIG0028622$GRIFOLS$$$$$M$Y$90.7$KG$20240716$$CN$US$US
240969981$24096998$1$I$20240208$20240214$20240716$20240716$PER$$US-IGSA-BIG0027687$GRIFOLS$$69$YR$$F$Y$72$KG$20240716$$MD$US$US
240969991$24096999$1$I$$20240130$20240716$20240716$PER$$US-IGSA-BIG0027509$GRIFOLS$Jacqueline N. Poston and Rebecca Kruse-Jarres. How I treat von Willebrand disorders in older adults. Blood. 2024;143:197-204$72$YR$$M$Y$$$20240716$$HP$US$US
240970001$24097000$1$I$$20240403$20240716$20240716$PER$$US-IGSA-BIG0028418$GRIFOLS$Obiakor B. Functional and Cutaneous Treatment Outcomes With Intravenous Immunoglobulin for Eosinophilic Fasciitis A Retrospective Study. JOURNAL OF DRUGS IN DERMATOLOGY. 204;23:e107 - e109$61$YR$$F$Y$$$20240716$$MD$US$US
240970011$24097001$1$I$$20240418$20240716$20240716$PER$$US-IGSA-BIG0028711$GRIFOLS$$$$$M$Y$$$20240716$$CN$US$US
240970021$24097002$1$I$20240320$20240325$20240716$20240716$PER$$US-IGSA-BIG0028266$GRIFOLS$$46$YR$$F$Y$68.027$KG$20240716$$CN$US$US
240970031$24097003$1$I$$20240116$20240716$20240716$PER$$US-IGSA-BIG0027244$GRIFOLS$$$$$M$Y$$$20240716$$CN$US$US
240970041$24097004$1$I$$20240402$20240716$20240716$PER$$US-IGSA-BIG0028364$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240970051$24097005$1$I$$20240716$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040044$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240716$$CN$US$US
240970061$24097006$1$I$20240216$20240301$20240716$20240716$PER$$US-IGSA-BIG0027953$GRIFOLS$$78$YR$$M$Y$92.971$KG$20240716$$CN$US$US
240970071$24097007$1$I$20240101$20240115$20240716$20240716$PER$$US-IGSA-BIG0027307$GRIFOLS$$71$YR$$F$Y$86.168$KG$20240716$$HP$US$US
240970091$24097009$1$I$20240101$20240516$20240716$20240716$PER$$US-IGSA-BIG0029123$GRIFOLS$$$$$M$Y$$$20240716$$CN$US$US
240970101$24097010$1$I$$20240423$20240716$20240716$PER$$US-IGSA-BIG0028752$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240970111$24097011$1$I$$20240506$20240716$20240716$PER$$US-IGSA-BIG0028995$GRIFOLS$Rafal Alhatemi,MD, Hussein Alsudani,MD. Elevated Thyroglobulin Antibodies Following Intravenous Immunoglobulin Therapy in Thyroid Cancer. Endocrine Practice. 2024;30(5):S152-S153$77$YR$$F$Y$$$20240716$$MD$US$US
240970121$24097012$1$I$20240514$20240522$20240716$20240716$PER$$US-IGSA-BIG0029195$GRIFOLS$$74$YR$$F$Y$81.633$KG$20240716$$CN$US$US
240970131$24097013$1$I$20240425$20240506$20240716$20240716$PER$$US-IGSA-BIG0028967$GRIFOLS$$73$YR$$M$Y$77.551$KG$20240716$$HP$US$US
240970141$24097014$1$I$20231101$20240530$20240716$20240716$PER$$US-IGSA-BIG0029296$GRIFOLS$$25$YR$$F$Y$86.168$KG$20240716$$CN$US$US
240970151$24097015$1$I$$20240515$20240716$20240716$PER$$US-IGSA-BIG0029124$GRIFOLS$Rangan, A., Monsour, M.. AN UNCOMMON CASE OF HYPERTONIC HYPONATREMIA WITH IVIG. American Journal of Kidney Diseases. 2024;83:47$61$YR$$F$Y$$$20240716$$MD$US$US
240970161$24097016$1$I$20240314$20240408$20240716$20240716$PER$$US-IGSA-BIG0028405$GRIFOLS$$49$YR$$F$Y$78.7$KG$20240716$$PH$US$US
240970171$24097017$1$I$20240101$20240423$20240716$20240716$PER$$US-IGSA-BIG0028832$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240970181$24097018$1$I$$20240419$20240716$20240716$PER$$US-IGSA-BIG0028707$GRIFOLS$$$$$F$Y$$$20240716$$HP$US$US
240970191$24097019$1$I$20240426$20240516$20240716$20240716$PER$$US-IGSA-BIG0029080$GRIFOLS$$68$YR$$M$Y$89.4$KG$20240716$$HP$US$US
240970201$24097020$1$I$$20240710$20240716$20240716$EXP$$ES-BAYER-2024A100478$BAYER$$$$$M$Y$$$20240716$$MD$ES$ES
240970211$24097021$1$I$$20240513$20240716$20240716$PER$$US-IGSA-BIG0029064$GRIFOLS$$$$$M$Y$99.32$KG$20240716$$CN$US$US
240970221$24097022$1$I$20240520$20240520$20240716$20240716$PER$$US-IGSA-BIG0029207$GRIFOLS$$69$YR$$M$Y$$$20240716$$CN$US$US
240970231$24097023$1$I$$20240521$20240716$20240716$PER$$US-IGSA-BIG0029202$GRIFOLS$$$$$F$Y$$$20240716$$HP$US$US
240970241$24097024$1$I$$20240205$20240716$20240716$PER$$US-IGSA-BIG0027604$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240970251$24097025$1$I$$20240502$20240716$20240716$PER$$US-IGSA-BIG0028895$GRIFOLS$$$$$F$Y$72$KG$20240716$$PH$US$US
240970261$24097026$1$I$20240505$20240509$20240716$20240716$PER$$US-IGSA-BIG0029027$GRIFOLS$$69$YR$$M$Y$104.3$KG$20240716$$HP$US$US
240970271$24097027$1$I$$20240604$20240716$20240716$PER$$US-IGSA-BIG0027131$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240970281$24097028$1$I$$20240701$20240716$20240716$EXP$$US-EMERGENT BIOSOLUTIONS,-24000101$EMERGENT BIOSOLUTIONS$Alyacoub R, Elkattawy S, Ejikeme C, Noori MAM, Remolina C. Naloxone induced pulmonary edema. J Community Hosp Intern Med Perspect. 2021;11(1):139-42$62$YR$$F$Y$$$20240716$$HP$US$US
240970291$24097029$1$I$$20240711$20240716$20240716$EXP$$HN-MYLANLABS-2024M1065695$MYLAN$$$$$F$Y$90.71$KG$20240716$$CN$HN$HN
240970301$24097030$1$I$$20240517$20240716$20240716$PER$$US-IGSA-BIG0029167$GRIFOLS$Sullivan, M.I., Gupta, M.J., Taylor, K.A., Van Mater, H.A., Pizoli, C.E.. Disease Course and Response to Immunotherapy in Children With Childhood Disintegrative Disorder: A Retrospective Case Series. Journal of Child Neurology. 2024;39:11-21$8$YR$$M$Y$$$20240716$$MD$US$US
240970313$24097031$3$F$$20240916$20240716$20240925$30DAY$$CO-JNJFOC-20240713444$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240925$$HP$CO$CO
240970321$24097032$1$I$$20240711$20240716$20240716$EXP$$AT-JNJFOC-20240735457$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$MD$AT$AT
240970331$24097033$1$I$20240710$20240710$20240716$20240716$EXP$$US-JNJFOC-20240726609$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240716$$CN$US$US
240970341$24097034$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009050$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240716$$CN$US$US
240970351$24097035$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008831$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240716$$CN$US$US
240970361$24097036$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008548$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240716$$CN$US$US
240970371$24097037$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008560$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240716$$CN$US$US
240970381$24097038$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009420$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240716$$CN$US$US
240970391$24097039$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008727$ELI LILLY AND CO$$33$YR$A$$Y$$$20240716$$CN$US$US
240970402$24097040$2$F$20240707$20240715$20240716$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407008903$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240718$$CN$US$US
240970411$24097041$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008649$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240716$$CN$US$US
240970421$24097042$1$I$20240714$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009505$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240716$$CN$US$US
240970431$24097043$1$I$20240101$20240321$20240716$20240716$PER$$US-IGSA-BIG0028267$GRIFOLS$$52$YR$$F$Y$$$20240716$$CN$US$US
240970441$24097044$1$I$20240501$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008522$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240716$$CN$US$US
240970451$24097045$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008772$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240716$$CN$US$US
240970461$24097046$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008839$ELI LILLY AND CO$$$$$M$Y$$$20240716$$CN$US$US
240970471$24097047$1$I$20231214$20240122$20240716$20240716$PER$$US-IGSA-BIG0027426$GRIFOLS$$35$YR$$F$Y$$$20240716$$CN$US$US
240970481$24097048$1$I$$20240426$20240716$20240716$PER$$US-IGSA-BIG0028901$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240970491$24097049$1$I$20230730$20230731$20240716$20240716$PER$$US-EVOFEM BIOSCIENCES, INC.-2023-EVO-US000057$PAREXEL$$$$$$Y$$$20240617$$CN$US$US
240970501$24097050$1$I$20240712$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008659$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240716$$CN$US$US
240970511$24097051$1$I$$20240708$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407006781$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240716$$CN$US$US
240970521$24097052$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008920$ELI LILLY AND CO$$$$$$Y$$$20240716$$CN$US$US
240970531$24097053$1$I$20230926$20231117$20240716$20240716$PER$$US-EVOFEM BIOSCIENCES, INC.-2023-EVO-US000064$PAREXEL$$$$$$Y$$$20240617$$CN$US$US
240970541$24097054$1$I$$20240124$20240716$20240716$PER$$US-EVOFEM BIOSCIENCES, INC.-2024-EVO-US000008$PAREXEL$$$$$$Y$$$20240617$$MD$US$US
240970552$24097055$2$F$20240701$20240731$20240716$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018389$UNITED THERAPEUTICS$$62$YR$$F$Y$65.76$KG$20240810$$$US$US
240970561$24097056$1$I$$20231023$20240716$20240716$PER$$US-EVOFEM BIOSCIENCES, INC.-2023-EVO-US000073$PAREXEL$$$$$$Y$$$20240617$$CN$US$US
240970571$24097057$1$I$20231007$20231226$20240716$20240716$PER$$US-EVOFEM BIOSCIENCES, INC.-2023-EVO-US000072$PAREXEL$$$$$$Y$$$20240617$$CN$US$US
240970581$24097058$1$I$$20231130$20240716$20240716$PER$$US-EVOFEM BIOSCIENCES, INC.-2023-EVO-US000078$PAREXEL$$$$$$Y$$$20240617$$HP$US$US
240970591$24097059$1$I$$20231030$20240716$20240716$PER$$US-EVOFEM BIOSCIENCES, INC.-2023-EVO-US000075$PAREXEL$$$$$$Y$$$20240617$$CN$US$US
240970601$24097060$1$I$$20240212$20240716$20240716$PER$$US-EVOFEM BIOSCIENCES, INC.-2024-EVO-US000013$PAREXEL$$$$$$Y$$$20240617$$CN$US$US
240970611$24097061$1$I$20240225$20240227$20240716$20240716$PER$$US-EVOFEM BIOSCIENCES, INC.-2024-EVO-US000016$PAREXEL$$$$$$Y$$$20240620$$CN$US$US
240970621$24097062$1$I$$20240423$20240716$20240716$PER$$US-EVOFEM BIOSCIENCES, INC.-2024-EVO-US000021$PAREXEL$$$$$$Y$$$20240617$$MD$US$US
240970631$24097063$1$I$$20240419$20240716$20240716$PER$$US-IGSA-BIG0028720$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240970641$24097064$1$I$$20240108$20240716$20240716$PER$$US-IGSA-BIG0027208$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240970652$24097065$2$F$$20240722$20240716$20240729$EXP$$GB-TAKEDA-2024TUS053178$TAKEDA$$$$$F$Y$$$20240729$$CN$GB$GB
240970661$24097066$1$I$$20240530$20240716$20240716$PER$$US-IGSA-BIG0029310$GRIFOLS$$$$$F$Y$$$20240716$$CN$US$US
240970671$24097067$1$I$$20240710$20240716$20240716$EXP$$US-AMGEN-USASP2024137665$AMGEN$$69$YR$E$F$Y$$$20240716$$HP$US$US
240970682$24097068$2$F$$20240802$20240716$20240812$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010586$JAZZ$$55$YR$$F$Y$$$20240812$$CN$US$US
240970691$24097069$1$I$$20240708$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109511$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240716$$CN$US$US
240970701$24097070$1$I$20240701$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112609$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240716$$CN$US$US
240970711$24097071$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-10000027265$ROCHE$$$$E$M$Y$$$20240716$$CN$US$US
240970721$24097072$1$I$20240101$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111008$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$54.43$KG$20240716$$CN$US$US
240970731$24097073$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112036$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240716$$CN$US$US
240970741$24097074$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111898$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240716$$HP$US$US
240970752$24097075$2$F$$20240719$20240716$20240730$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06316$LUPIN$$$$$$Y$$$20240730$$PH$US$US
240970761$24097076$1$I$$20240710$20240716$20240716$PER$$US-BIOGEN-2024BI01273268$BIOGEN$$$$$F$Y$$$20240716$$CN$US$US
240970771$24097077$1$I$20240709$20240711$20240716$20240716$PER$$US-ABBVIE-5837670$ABBVIE$$25$YR$$F$Y$$$20240716$$MD$US$US
240970781$24097078$1$I$20020101$20240708$20240716$20240716$PER$$US-BIOGEN-2024BI01273671$BIOGEN$$$$$F$Y$$$20240716$$MD$US$US
240970821$24097082$1$I$$20240709$20240716$20240716$EXP$$CA-GSK-CA2024AMR086024$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$HP$CA$CA
240970831$24097083$1$I$20230301$20240710$20240716$20240716$EXP$$TW-DSJP-DSJ-2024-135390$DAIICHI$$74$YR$$M$Y$86$KG$20240716$$MD$TW$TW
240970841$24097084$1$I$20240705$20240713$20240716$20240716$EXP$$CN-PFIZER INC-PV202400091936$PFIZER$$70$YR$$M$Y$60$KG$20240716$$HP$CN$CN
240970851$24097085$1$I$$20240714$20240716$20240716$EXP$GB-MHRA-MED-202407140916588560-HNKRV$GB-PFIZER INC-202400213771$PFIZER$$53$YR$$F$Y$$$20240716$$CN$GB$GB
240970861$24097086$1$I$$20240628$20240716$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06332$LUPIN$$$$$$Y$$$20240716$$CN$US$US
240970872$24097087$2$F$20240711$20240717$20240716$20240722$EXP$$PE-PFIZER INC-202400213759$PFIZER$$82$YR$$F$Y$$$20240722$$MD$PE$PE
240970891$24097089$1$I$20170405$20240711$20240716$20240716$EXP$$FR-PFIZER INC-2017SGN02241$PFIZER$$32$YR$$M$Y$82$KG$20240716$$MD$FR$FR
240970901$24097090$1$I$$20240715$20240716$20240716$EXP$$BE-PFIZER INC-202400214988$PFIZER$$20$YR$$M$Y$$$20240716$$PH$BE$BE
240970911$24097091$1$I$20240713$20240715$20240716$20240716$EXP$$US-PFIZER INC-202400215310$PFIZER$$66$YR$$F$Y$$$20240716$$HP$US$US
240970922$24097092$2$F$$20240805$20240716$20240812$EXP$$DE-PFIZER INC-202400212355$PFIZER$Knorr, F.. COMBINATION TREATMENT WITH VINBLASTINE AND CRIZOTINIB IN PEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA. Leukemia Research. 2022;121 (Suppl.):66$17$YR$$M$Y$$$20240812$$HP$DE$DE
240970932$24097093$2$F$$20240808$20240716$20240813$30DAY$$CA-JNJFOC-20240711896$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$HP$CA$CA
240970944$24097094$4$F$20240129$20240910$20240716$20240917$EXP$$CA-GSK-CA2024000644$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
240970961$24097096$1$I$$20240711$20240716$20240716$EXP$$US-SA-2024SA205990$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240970972$24097097$2$F$$20240802$20240716$20240812$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010589$JAZZ$$34$YR$$F$Y$$$20240812$$CN$US$US
240970981$24097098$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5840765$ABBVIE$$$$$$Y$$$20240716$$CN$US$US
240970991$24097099$1$I$20240408$20240708$20240716$20240716$EXP$IT-MINISAL02-992888$IT-TEVA-VS-3219018$TEVA$$78$YR$$M$Y$$$20240716$$MD$IT$IT
240971001$24097100$1$I$$20240708$20240716$20240716$EXP$$GR-BIOCON BIOLOGICS LIMITED-BBL2024005080$BIOCON$Kourti A., Drosakis I., Athanasopouloul E. et.al.. PULMONARY INVOLVEMENT IN PEDIATRIC PATIENTS WITH IDIOPATHIC INFLAMMATORY BOWEL DISEASE.. 22nd PANHELLENIC CONGRESS OF IDIOPATHIC INFLAMMATORY BOWEL DISEASES. 2024$$$$$Y$$$20240716$$HP$GR$GR
240971021$24097102$1$I$$20240711$20240716$20240716$EXP$$CA-MYLANLABS-2024M1065669$MYLAN$$$$$M$Y$$$20240716$$MD$CA$CA
240971031$24097103$1$I$20230601$20240712$20240716$20240716$EXP$$TW-DAIICHI SANKYO, INC.-DSJ-2024-135374$DAIICHI$$91$YR$$M$Y$63$KG$20240716$$MD$TW$TW
240971041$24097104$1$I$$20240712$20240716$20240716$EXP$$US-AMGEN-USASP2024138804$AMGEN$Andre N.; Donze C.; Revon-riviere G. et al.. Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide. Pediatric Blood +Cancer. 2024;71:1 to 6$21$YR$A$F$Y$$$20240716$$HP$US$US
240971051$24097105$1$I$$20240715$20240716$20240716$EXP$GB-MHRA-MED-202407151354095780-MGYVC$GB-ORGANON-O2407GBR001346$ORGANON$$74$YR$$F$Y$$$20240716$$MD$GB$GB
240971061$24097106$1$I$$20240708$20240716$20240716$EXP$US-MLMSERVICE-20240701-PI117496-00082-2$US-RDY-SPO/USA/24/0010197$DR REDDYS$Fenton GA, Dean EA. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case Reports in Oncology. 2024;17(1):75-81. DOI: 10.1159/000535426.$64$YR$A$F$Y$$$20240716$$MD$US$US
240971072$24097107$2$F$$20240801$20240716$20240813$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06303$LUPIN$$$$$$Y$$$20240813$$HP$US$US
240971083$24097108$3$F$20240627$20240829$20240716$20240912$PER$$US-RISINGPHARMA-US-2024RISSPO00245$RISING PHARMACEUTICALS$$43$YR$A$F$Y$180$KG$20240912$$PH$US$US
240971091$24097109$1$I$$20240715$20240716$20240716$EXP$$CA-ORGANON-O2407CAN001326$ORGANON$$$$$M$Y$$$20240716$$CN$CA$CA
240971102$24097110$2$F$$20240711$20240716$20240716$PER$$US-JNJFOC-20240724581$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$CN$US$US
240971111$24097111$1$I$20240703$20240704$20240716$20240716$EXP$GB-MHRA-MED-202407041459345310-HBWCZ$GB-GLENMARK PHARMACEUTICALS-2024GMK092188$GLENMARK$$$$$$Y$$$20240716$$HP$GB$GB
240971124$24097112$4$F$$20240722$20240716$20240726$EXP$$US-AMGEN-USASP2024138500$AMGEN$$$$$$Y$$$20240726$$MD$US$US
240971131$24097113$1$I$20240709$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024137427$AMGEN$$50$YR$A$M$Y$$$20240716$$CN$US$US
240971141$24097114$1$I$$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49083$$FDA-CTU$$$$$F$N$$$20240715$N$HP$US$
240971151$24097115$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49085$$FDA-CTU$$71$YR$$F$N$$$20240716$N$$US$
240971161$24097116$1$I$20240122$20240711$20240716$20240716$30DAY$$US-PFIZER INC-PV202400044150$PFIZER$$$$$$Y$$$20240716$$HP$US$US
240971172$24097117$2$F$$20240828$20240716$20240904$PER$$US-PFIZER INC-PV202400091639$PFIZER$$65$YR$$M$Y$$$20240904$$HP$US$US
240971191$24097119$1$I$$20240515$20240716$20240716$DIR$FDA-CDER-CTU-2024-49087$$FDA-CTU$$$$$M$N$$$20240515$N$HP$US$
240971201$24097120$1$I$20240708$20240709$20240716$20240716$PER$$US-PFIZER INC-202400211224$PFIZER$$66$YR$$F$Y$$$20240716$$HP$US$US
240971213$24097121$3$F$20231229$20240722$20240716$20240725$30DAY$$US-PFIZER INC-PV202400044220$PFIZER$$$$$F$Y$$$20240725$$HP$US$US
240971221$24097122$1$I$20220905$20240711$20240716$20240716$EXP$FR-AFSSAPS-CN20221799$FR-PFIZER INC-2022SGN09190$PFIZER$$78$YR$$F$Y$56.961$KG$20240716$$MD$FR$FR
240971232$24097123$2$F$$20240919$20240716$20240923$PER$$US-PFIZER INC-PV202400031362$PFIZER$$61$YR$$F$Y$$$20240923$$HP$US$US
240971241$24097124$1$I$20180917$20240711$20240716$20240716$EXP$FR-AFSSAPS-PV20190166$FR-PFIZER INC-2019SGN01120$PFIZER$$61$YR$$M$Y$78$KG$20240716$$MD$FR$FR
240971251$24097125$1$I$$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49082$$FDA-CTU$$$$$M$N$$$20240715$N$HP$US$
240971261$24097126$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49088$$FDA-CTU$$67$YR$$F$N$$$20240716$N$$US$
240971271$24097127$1$I$20240201$20240711$20240716$20240716$EXP$FR-AFSSAPS-RS2024000170$FR-PFIZER INC-2024SGN01793$PFIZER$$53$YR$$M$Y$79$KG$20240716$$MD$FR$FR
240971281$24097128$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-PV202400092084$PFIZER$$$$$$Y$$$20240716$$HP$US$US
240971291$24097129$1$I$$20240715$20240716$20240716$EXP$$MA-PFIZER INC-PV202400093171$PFIZER$$$$$F$Y$$$20240716$$CN$MA$MA
240971303$24097130$3$F$$20240916$20240716$20240920$30DAY$$US-PFIZER INC-202400205926$PFIZER$$13$YR$$M$Y$$$20240920$$CN$US$US
240971321$24097132$1$I$20201207$20240711$20240716$20240716$EXP$FR-AFSSAPS-PV20200792$FR-PFIZER INC-2021SGN00127$PFIZER$$61$YR$$M$Y$41$KG$20240716$$MD$FR$FR
240971332$24097133$2$F$$20240816$20240716$20240820$PER$$US-PFIZER INC-202400213264$PFIZER$$48$YR$$M$Y$$$20240820$$MD$US$US
240971341$24097134$1$I$20240701$20240710$20240716$20240716$PER$$US-PFIZER INC-202400212085$PFIZER$$66$YR$$F$Y$$$20240716$$HP$US$US
240971352$24097135$2$F$20240701$20240711$20240716$20240717$PER$$US-PFIZER INC-202400213077$PFIZER$$55$YR$$F$Y$$$20240717$$PH$US$US
240971361$24097136$1$I$$20240709$20240716$20240716$PER$$US-PFIZER INC-202400209827$PFIZER$$$$$F$Y$$$20240716$$PH$US$US
240971371$24097137$1$I$20221202$20240711$20240716$20240716$EXP$FR-AFSSAPS-PO20222069$FR-PFIZER INC-2022SGN12749$PFIZER$$66$YR$$F$Y$63$KG$20240716$$MD$FR$FR
240971381$24097138$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-202400213602$PFIZER$$$$$M$Y$$$20240716$$MD$US$US
240971391$24097139$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-202400213813$PFIZER$$52$YR$$F$Y$$$20240716$$MD$US$US
240971401$24097140$1$I$20240709$20240710$20240716$20240716$PER$$US-PFIZER INC-202400212012$PFIZER$$68$YR$$F$Y$$$20240716$$CN$US$US
240971414$24097141$4$F$$20240910$20240716$20240913$EXP$$US-PFIZER INC-PV202400092048$PFIZER$$77$YR$$F$Y$$$20240913$$CN$US$US
240971422$24097142$2$F$$20240820$20240716$20240821$PER$$US-PFIZER INC-202400213890$PFIZER$$74$YR$$F$Y$$$20240821$$HP$US$US
240971431$24097143$1$I$$20240711$20240716$20240716$EXP$$US-PFIZER INC-PV202400091704$PFIZER$Mabry, R.. Visual Loss After Intranasal Corticosteroid Injection Incidence, Causes, and Prevention. Arch Otolaryngol. 1981;107:484-486$$$$$Y$$$20240716$$MD$US$US
240971442$24097144$2$F$$20240716$20240716$20240717$PER$$US-PFIZER INC-202400213962$PFIZER$$58$YR$$F$Y$$$20240717$$HP$US$US
240971451$24097145$1$I$$20240710$20240716$20240716$PER$$US-PFIZER INC-PV202400091501$PFIZER$$51$YR$$F$Y$$$20240716$$HP$US$US
240971461$24097146$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-202400212909$PFIZER$$34$YR$$M$Y$$$20240716$$MD$US$US
240971473$24097147$3$F$20230516$20240716$20240716$20240723$EXP$$US-PFIZER INC-US-GBT-021312$PFIZER$$33$YR$$F$Y$$$20240723$$CN$US$US
240971481$24097148$1$I$20191021$20240711$20240716$20240716$EXP$FR-AFSSAPS-AN20191388$FR-PFIZER INC-2019SGN04592$PFIZER$$55$YR$$M$Y$66$KG$20240716$$HP$FR$FR
240971491$24097149$1$I$20210826$20240711$20240716$20240716$EXP$FR-AFSSAPS-LY20222033$FR-PFIZER INC-2022SGN03237$PFIZER$$29$YR$$M$Y$78$KG$20240716$$PH$FR$FR
240971502$24097150$2$F$$20240716$20240716$20240718$PER$$US-PFIZER INC-202400213959$PFIZER$$61$YR$$F$Y$$$20240718$$HP$US$US
240971511$24097151$1$I$$20240715$20240716$20240716$EXP$$MA-PFIZER INC-PV202400093164$PFIZER$$$$$$Y$$$20240716$$CN$MA$MA
240971521$24097152$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-202400212547$PFIZER$$$$$M$Y$$$20240716$$PH$US$US
240971531$24097153$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-PV202400092457$PFIZER$$66$YR$$F$Y$$$20240716$$CN$US$US
240971541$24097154$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-202400213814$PFIZER$$$$$$Y$$$20240716$$PH$US$US
240971552$24097155$2$F$20240704$20240710$20240716$20240911$EXP$RU-RZN-2444656$RU-BAYER-2024A100072$BAYER$$18$YR$A$F$Y$45$KG$20240911$$HP$RU$RU
240971561$24097156$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-202400213905$PFIZER$$63$YR$$F$Y$$$20240716$$HP$US$US
240971572$24097157$2$F$$20240814$20240716$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112283$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$85.28$KG$20240821$$CN$US$US
240971582$24097158$2$F$$20240805$20240716$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112662$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$118.84$KG$20240807$$CN$US$US
240971601$24097160$1$I$20240111$20240710$20240716$20240716$EXP$$FI-PFIZER INC-202400031931$PFIZER$$70$YR$$F$Y$96$KG$20240716$$HP$FI$FI
240971611$24097161$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111983$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240716$$CN$US$US
240971621$24097162$1$I$$20240711$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112032$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240716$$CN$US$US
240971631$24097163$1$I$$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110629$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$75.3$KG$20240716$$PH$US$US
240971641$24097164$1$I$$20240710$20240716$20240716$PER$$US-BIOGEN-2024BI01273207$BIOGEN$$$$$F$Y$$$20240716$$CN$US$US
240971651$24097165$1$I$20230522$20240708$20240716$20240716$EXP$IT-MINISAL02-992833$IT-TEVA-VS-3219069$TEVA$$58$YR$$M$Y$$$20240716$$MD$IT$IT
240971661$24097166$1$I$$20240702$20240716$20240716$EXP$$JP-RISINGPHARMA-JP-2024RISLIT00237$RISING PHARMACEUTICALS$Naohito Ide.Central Nervous System Adverse Reactions to Amantadine Intoxication: A Case Report and Analysis of JADER.In vivo.2024;38:2090-2096$63$YR$A$F$Y$36.7$KG$20240716$$HP$JP$JP
240971672$24097167$2$F$$20240806$20240716$20240813$EXP$$US-BAYER-2024A100178$BAYER$$81$YR$E$F$Y$$$20240813$$CN$US$US
240971681$24097168$1$I$20240604$20240715$20240716$20240716$PER$$US-JNJFOC-20240738965$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240716$$HP$US$US
240971691$24097169$1$I$20240701$20240710$20240716$20240716$PER$$HN-REGENERON PHARMACEUTICALS, INC.-2024-097943$REGENERON$$$$$$Y$$$20240716$$CN$HN$HN
240971703$24097170$3$F$20240430$20240917$20240716$20240926$EXP$$JP-DSJP-DSJ-2024-134881$DAIICHI$$44$YR$$F$Y$56.4$KG$20240926$$MD$JP$JP
240971721$24097172$1$I$20240709$20240709$20240716$20240716$EXP$$US-GSK-US2024085104$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$US$US
240971731$24097173$1$I$$20240710$20240716$20240716$EXP$$US-SA-2024SA205639$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240716$$MD$US$US
240971741$24097174$1$I$20230801$20240710$20240716$20240716$PER$$US-ABBVIE-5839123$ABBVIE$$39$YR$$F$Y$$$20240716$$CN$US$US
240971751$24097175$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5840552$ABBVIE$$$$$$Y$$$20240716$$HP$US$US
240971763$24097176$3$F$20220104$20240723$20240716$20240730$EXP$$JP-DSJP-DSJ-2024-127253$DAIICHI$$86$YR$$M$Y$$$20240730$$MD$JP$JP
240971772$24097177$2$F$$20240716$20240716$20240718$EXP$$US-PFIZER INC-PV202400091881$PFIZER$Price, N.. Chronic paronychia associated with fluconazole use in two pediatric patients with coccidioidomycosis. IDCases. 2024;37:10.1016/j.idcr.2024.e02026$13$YR$$M$Y$$$20240718$$MD$US$US
240971781$24097178$1$I$$20240715$20240716$20240716$EXP$NL-LRB-00981518$NL-PFIZER INC-202400214878$PFIZER$$64$YR$$M$Y$87$KG$20240716$$PH$NL$NL
240971791$24097179$1$I$20230701$20240711$20240716$20240716$PER$$US-SA-2024SA206357$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240716$$MD$US$US
240971801$24097180$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205248$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240716$$MD$US$US
240971811$24097181$1$I$20240601$20240712$20240716$20240716$PER$$JP-Eisai-EC-2024-170226$EISAI$$$$$F$Y$$$20240716$$MD$JP$JP
240971821$24097182$1$I$$20190717$20240716$20240716$EXP$$US-AstraZeneca-2019SF04228$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240971832$24097183$2$F$$20240816$20240716$20240818$PER$$US-AstraZeneca-2024A161728$ASTRAZENECA$$$$$F$Y$$$20240818$$MD$US$
240971841$24097184$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112344$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240716$$HP$US$US
240971851$24097185$1$I$$20191230$20240716$20240716$EXP$$US-AstraZeneca-2020SE00942$ASTRAZENECA$$56$YR$$M$Y$$$20240716$$CN$US$
240971861$24097186$1$I$$20191202$20240716$20240716$EXP$$US-AstraZeneca-2019SF74295$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240971871$24097187$1$I$$20211201$20240716$20240716$EXP$$US-AstraZeneca-2021A852122$ASTRAZENECA$$$$$F$Y$98.9$KG$20240716$$CN$US$
240971881$24097188$1$I$$20240708$20240716$20240716$EXP$$US-MYLANLABS-2024M1065150$MYLAN$$$$$M$Y$$$20240716$$CN$US$US
240971891$24097189$1$I$20230726$20240708$20240716$20240716$EXP$$PL-FreseniusKabi-FK202410898$FRESENIUS KABI$$70$YR$E$F$Y$108$KG$20240716$$MD$PL$PL
240971901$24097190$1$I$20240710$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49079$$FDA-CTU$$61$YR$$F$N$$$20240716$N$HP$US$
240971911$24097191$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410929$FRESENIUS KABI$$69$YR$E$F$Y$75$KG$20240716$$HP$CA$CA
240971921$24097192$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49084$$FDA-CTU$$52$YR$$F$N$$$20240716$N$$US$
240971931$24097193$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49092$$FDA-CTU$$69$YR$$F$N$$$20240716$N$$US$
240971941$24097194$1$I$$20240708$20240716$20240716$EXP$$US-RDY-SPO/USA/24/0010231$DR REDDYS$$$$$$Y$$$20240716$$CN$US$US
240971952$24097195$2$F$20170510$20240822$20240716$20240827$EXP$$PHHY2018CO136089$NOVARTIS$$54$YR$$M$Y$76$KG$20240827$$CN$CO$CO
240971961$24097196$1$I$$20240715$20240716$20240716$EXP$$CA-ORGANON-O2407CAN001329$ORGANON$$34$YR$$F$Y$$$20240716$$MD$CA$CA
240971971$24097197$1$I$$20240715$20240716$20240716$EXP$$CA-ORGANON-O2407CAN001325$ORGANON$Unknown. Unknown. Unknown. Unk$35$YR$$F$Y$$$20240716$$HP$CA$CA
240971981$24097198$1$I$20240703$20240708$20240716$20240716$PER$$US-ABBVIE-5834600$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240971993$24097199$3$F$20231028$20240719$20240716$20240802$EXP$$ES-HIKMA PHARMACEUTICALS USA INC.-ES-H14001-24-06182$HIKMA$$68$YR$$F$Y$50.1$KG$20240802$$MD$ES$ES
240972001$24097200$1$I$$20240711$20240716$20240716$EXP$$US-BAYER-2024A100278$BAYER$$$$$$Y$$$20240716$$CN$US$US
240972011$24097201$1$I$$20240702$20240716$20240716$EXP$$JP-RISINGPHARMA-JP-2024RISLIT00246$RISING PHARMACEUTICALS$Kazunari Yoshida.Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine: A Case Report.Journal of Clinical Psychopharmacology.2024;44(4):424-425$4$DEC$A$M$Y$$$20240716$$MD$JP$JP
240972021$24097202$1$I$$20240710$20240716$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010592$JAZZ$$34$YR$$F$Y$77.27$KG$20240716$$CN$US$US
240972031$24097203$1$I$$20240710$20240716$20240716$EXP$$TW-DSJP-DSJ-2024-135362$DAIICHI$$9$DEC$$M$Y$58$KG$20240716$$MD$TW$TW
240972041$24097204$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202404302151369050-KRZFG$GB-TEVA-VS-3217718$TEVA$$$$$M$Y$$$20240716$$CN$GB$GB
240972051$24097205$1$I$20240201$20240628$20240716$20240716$PER$$CR-TOLMAR, INC.-21CR030142$TOLMAR$$91$YR$$M$Y$$$20240715$$HP$CR$CR
240972061$24097206$1$I$$20240709$20240716$20240716$EXP$$US-ABBVIE-5837008$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240972071$24097207$1$I$20240101$20240710$20240716$20240716$EXP$$US-ABBVIE-5836891$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240972082$24097208$2$F$$20240807$20240716$20240903$PER$$US-TOLMAR, INC.-24US050439$TOLMAR$$$$$M$Y$$$20240903$$HP$US$US
240972093$24097209$3$F$20230609$20240904$20240716$20240912$PER$$US-SA-2024SA205497$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240912$$MD$US$US
240972101$24097210$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA204210$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240716$$MD$US$US
240972114$24097211$4$F$20240815$20240820$20240716$20240823$PER$$US-AMGEN-USASP2024140445$AMGEN$$77$YR$E$F$Y$$$20240823$$PH$US$US
240972121$24097212$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205129$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240716$$MD$US$US
240972135$24097213$5$F$20240530$20240918$20240716$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008443$JAZZ$$26$YR$$M$Y$$$20240924$$HP$US$US
240972141$24097214$1$I$20240702$20240709$20240716$20240716$EXP$$CN-DSJP-DSJ-2024-135107$DAIICHI$$66$YR$$M$Y$62.4$KG$20240716$$HP$CN$CN
240972161$24097216$1$I$$20240702$20240716$20240716$EXP$$US-RISINGPHARMA-US-2024RISLIT00244$RISING PHARMACEUTICALS$S Vallabhajosyula.Fighting the Recovering Heart While Drowning in Volume: Role of  VA-V ECMO Configuration in Migrating Mixing Cloud Effect.Am-J-Respir-Crit-Care-Med.2024;209:A5582$43$YR$A$F$Y$$$20240716$$HP$US$US
240972171$24097217$1$I$$20240711$20240716$20240716$EXP$$CA-JNJFOC-20240736644$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240716$$HP$CA$CA
240972191$24097219$1$I$20220101$20240711$20240716$20240716$DIR$FDA-CDER-CTU-2024-49093$$FDA-CTU$$57$YR$$F$N$77.11$KG$20240711$N$MD$US$
240972201$24097220$1$I$20240425$20240712$20240716$20240716$PER$$NVSC2024US146393$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240972211$24097221$1$I$$20200507$20240716$20240716$EXP$$US-AstraZeneca-2020SE61502$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240972221$24097222$1$I$$20240704$20240716$20240716$30DAY$$CA-SA-2024SA188518$SANOFI AVENTIS$$$$E$M$Y$$$20240716$$CN$CA$CA
240972231$24097223$1$I$$20200303$20240716$20240716$EXP$$US-AstraZeneca-2020SE33526$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240972241$24097224$1$I$$20230116$20240716$20240716$EXP$$IN-AstraZeneca-2023A016092$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$IN$
240972251$24097225$1$I$$20201218$20240716$20240716$EXP$$US-AstraZeneca-2020SF70684$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240972262$24097226$2$F$$20240707$20240716$20240729$EXP$$JP-009507513-2407JPN001811J$MERCK$Katagata N, Minami H, Ookouchi C, Nagatsuka M, Matsuzaki M, Nomizu T, et al.. EP-0686 A case of suspected hemophagocytic syndrome after pembrolizumab administration for triple-negative recurrent breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 349$33$YR$$F$Y$$$20240729$$MD$JP$JP
240972271$24097227$1$I$$20240712$20240716$20240716$EXP$$CA-SANDOZ INC.-SDZ2024CA065336$SANDOZ$$85$YR$$M$Y$$$20240716$$HP$CA$CA
240972281$24097228$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA203584$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240972291$24097229$1$I$$20240708$20240716$20240716$EXP$$US-TEVA-VS-3220304$TEVA$$$$A$M$Y$$$20240716$$HP$US$US
240972301$24097230$1$I$20240201$20240708$20240716$20240716$EXP$FR-AFSSAPS-LM2024000374$FR-FreseniusKabi-FK202410925$FRESENIUS KABI$$68$YR$E$F$Y$63$KG$20240716$$MD$FR$FR
240972311$24097231$1$I$20240501$20240708$20240716$20240716$EXP$FR-AFSSAPS-AM2024000551$FR-FreseniusKabi-FK202410951$FRESENIUS KABI$$66$YR$A$M$Y$79$KG$20240716$$MD$FR$FR
240972321$24097232$1$I$20240605$20240710$20240716$20240716$EXP$SE-SEMPA-2024-005380$SE-TAKEDA-2024TUS071166$TAKEDA$$69$YR$$M$Y$$$20240716$$HP$SE$SE
240972331$24097233$1$I$20220701$20240705$20240716$20240716$EXP$$US-RDY-LIT/USA/24/0010274$DR REDDYS$Sancillo R, Wickham J, DeMasters D. A CASE OF RITUXIMAB RESCUE THERAPY IN CLASS V LUPUS NEPHRITIS WITH SEVERE HEMATOLOGICAL MANIFESTATIONS. American Journal of Kidney Diseases. 2023;81(4):$20$YR$A$F$Y$$$20240716$$HP$US$US
240972342$24097234$2$F$$20240730$20240716$20240814$PER$$US-Calliditas-2024CAL01242$CALLIDITAS THERAPEUTICS$$65$YR$E$F$Y$85.3$KG$20240813$$CN$US$US
240972351$24097235$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410877$FRESENIUS KABI$$72$YR$E$F$Y$$$20240716$$HP$CA$CA
240972361$24097236$1$I$20240601$20240716$20240716$20240716$EXP$$NZ-MYLANLABS-2024M1066281$MYLAN$$25$YR$$M$Y$$$20240716$$HP$NZ$NZ
240972372$24097237$2$F$20240708$20240902$20240716$20240903$PER$$US-BIOVITRUM-2024-US-009887$BIOVITRUM$$50$YR$$F$Y$$$20240903$$CN$US$US
240972381$24097238$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49091$$FDA-CTU$$79$YR$$F$N$$$20240716$N$$US$
240972391$24097239$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49089$$FDA-CTU$$50$YR$$F$N$$$20240716$N$$US$
240972441$24097244$1$I$20240704$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49045$$FDA-CTU$$54$YR$$F$N$$$20240715$N$HP$US$
240972461$24097246$1$I$20240706$20240713$20240716$20240716$EXP$$NVSC2024CN146176$NOVARTIS$$49$YR$$F$Y$$$20240716$$HP$CN$CN
240972471$24097247$1$I$$20240303$20240716$20240716$EXP$GB-MHRA-MED-202403011453372780-LTDJQ$GB-TEVA-VS-3166535$TEVA$$$$$$Y$$$20240716$$MD$GB$GB
240972482$24097248$2$F$$20240715$20240716$20240717$EXP$$US-PFIZER INC-202400214666$PFIZER$$53$YR$$M$Y$$$20240717$$MD$US$US
240972491$24097249$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400214406$PFIZER$$$$$$Y$$$20240716$$MD$US$US
240972503$24097250$3$F$20240709$20240821$20240716$20240827$EXP$$US-PFIZER INC-202400215301$PFIZER$$77$YR$$F$Y$$$20240827$$HP$US$US
240972512$24097251$2$F$$20240912$20240716$20240916$PER$$US-PFIZER INC-PV202400092163$PFIZER$$62$YR$$F$Y$$$20240916$$HP$US$US
240972521$24097252$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400213910$PFIZER$$$$$$Y$$$20240716$$CN$US$US
240972532$24097253$2$F$$20240802$20240716$20240812$PER$$US-SA-2024SA204265$SANOFI AVENTIS$$$$E$F$Y$$$20240812$$MD$US$US
240972541$24097254$1$I$20240712$20240712$20240716$20240716$PER$$US-PFIZER INC-202400214300$PFIZER$$72$YR$$F$Y$$$20240716$$CN$US$US
240972561$24097256$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400213488$PFIZER$$45$YR$$F$Y$$$20240716$$CN$US$US
240972572$24097257$2$F$$20240813$20240716$20240820$PER$$US-PFIZER INC-202400213844$PFIZER$$79$YR$$F$Y$$$20240820$$HP$US$US
240972581$24097258$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA206125$SANOFI AVENTIS$$70$YR$E$M$Y$95.25$KG$20240716$$MD$US$US
240972591$24097259$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-PV202400092196$PFIZER$$11$YR$$$Y$$$20240716$$CN$US$US
240972601$24097260$1$I$$20240327$20240716$20240716$PER$$US-FENNEC PHARMACEUTICALS, INC.-2023FEN00015$FENNEC PHARMACEUTICALS$$3$DEC$$M$Y$$$20240716$$CN$US$US
240972611$24097261$1$I$$20240702$20240716$20240716$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06248$LUPIN$Contag CA, Studemeister L, Bogler Y, Cooper JD. Q fever presenting as splenic infarct without endocarditis. IDCases. 2024;37:1-3$44$YR$$M$Y$$$20240716$$HP$US$US
240972621$24097262$1$I$20240101$20240708$20240716$20240716$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-111089$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$72$KG$20240716$$MD$DE$DE
240972641$24097264$1$I$20240314$20240715$20240716$20240716$EXP$SE-SEMPA-2024-005481$NVSC2024SE145165$NOVARTIS$$55$YR$$F$Y$88$KG$20240716$$CN$SE$SE
240972651$24097265$1$I$20240101$20240711$20240716$20240716$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-002967$AMGEN$$74$YR$E$F$Y$$$20240716$$HP$US$US
240972661$24097266$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49098$$FDA-CTU$$19$YR$$F$N$78.93$KG$20240716$N$$US$
240972671$24097267$1$I$20240501$20240712$20240716$20240716$EXP$$US-ABBVIE-5839080$ABBVIE$$62$YR$$F$Y$$$20240716$$CN$US$US
240972681$24097268$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203595$SANOFI AVENTIS$$$$$F$Y$$$20240716$$CN$US$US
240972691$24097269$1$I$20240614$20240709$20240716$20240716$PER$$US-SA-2024SA205787$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240716$$MD$US$US
240972701$24097270$1$I$$20240712$20240716$20240716$PER$$US-BAYER-2024A101080$BAYER$$$$$F$Y$$$20240716$$CN$US$US
240972712$24097271$2$F$20240712$20240712$20240716$20240820$EXP$$CN-BAYER-2024A101059$BAYER$$68$YR$E$F$Y$51$KG$20240820$$HP$CN$CN
240972721$24097272$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400213604$PFIZER$$$$E$M$Y$$$20240716$$MD$US$US
240972731$24097273$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400215349$PFIZER$$52$YR$$F$Y$$$20240716$$HP$US$US
240972741$24097274$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400213867$PFIZER$$40$YR$$F$Y$$$20240716$$CN$US$US
240972751$24097275$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-PV202400092335$PFIZER$$76$YR$$F$Y$$$20240716$$MD$US$US
240972761$24097276$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400215326$PFIZER$$40$YR$$F$Y$$$20240716$$HP$US$US
240972772$24097277$2$F$$20240716$20240716$20240718$PER$$US-PFIZER INC-PV202400092542$PFIZER$$69$YR$$M$Y$$$20240718$$CN$US$US
240972781$24097278$1$I$20240301$20240711$20240716$20240716$PER$$US-PFIZER INC-202400213902$PFIZER$$86$YR$$F$Y$$$20240716$$HP$US$US
240972792$24097279$2$F$$20240722$20240716$20240723$PER$$US-PFIZER INC-PV202400092955$PFIZER$$53$YR$$F$Y$$$20240723$$CN$US$US
240972801$24097280$1$I$20210101$20240712$20240716$20240716$PER$$US-PFIZER INC-PV202400092793$PFIZER$$60$YR$$M$Y$$$20240716$$HP$US$US
240972811$24097281$1$I$20240710$20240712$20240716$20240716$PER$$US-PFIZER INC-202400214354$PFIZER$$68$YR$$F$Y$$$20240716$$CN$US$US
240972822$24097282$2$F$20240711$20240821$20240716$20240827$PER$$US-PFIZER INC-202400214336$PFIZER$$71$YR$$F$Y$113.38$KG$20240827$$CN$US$US
240972831$24097283$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400215290$PFIZER$$76$YR$$F$Y$$$20240716$$HP$US$US
240972841$24097284$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-202400213926$PFIZER$$62$YR$$F$Y$$$20240716$$HP$US$US
240972851$24097285$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-PV202300142022$PFIZER$$30$YR$$F$Y$$$20240716$$HP$US$US
240972861$24097286$1$I$20210101$20240711$20240716$20240716$PER$$US-PFIZER INC-2022SGN08666$PFIZER$$64$YR$$F$Y$$$20240716$$CN$US$US
240972872$24097287$2$F$20240101$20240807$20240716$20240812$PER$$US-PFIZER INC-202400214313$PFIZER$$60$YR$$F$Y$$$20240812$$HP$US$US
240972881$24097288$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-202400214785$PFIZER$$27$YR$$F$Y$$$20240716$$CN$US$US
240972892$24097289$2$F$20240101$20240906$20240716$20240910$PER$$US-PFIZER INC-PV202400092076$PFIZER$$68$YR$$F$Y$$$20240910$$HP$US$US
240972901$24097290$1$I$20240501$20240712$20240716$20240716$PER$$US-PFIZER INC-PV202400092508$PFIZER$$41$YR$$F$Y$$$20240716$$CN$US$US
240972915$24097291$5$F$20240101$20240909$20240716$20240910$PER$$US-PFIZER INC-202400213620$PFIZER$$20$YR$$M$Y$82.086$KG$20240910$$CN$US$US
240972921$24097292$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400214416$PFIZER$$$$A$F$Y$$$20240716$$CN$US$US
240972931$24097293$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-202400214417$PFIZER$$57$YR$$F$Y$$$20240716$$HP$US$US
240972941$24097294$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-202400205521$PFIZER$$54$YR$$M$Y$$$20240716$$MD$US$US
240972951$24097295$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-PV202400092756$PFIZER$$51$YR$$F$Y$$$20240716$$CN$US$US
240972961$24097296$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-PV202400059777$PFIZER$$62$YR$$F$Y$$$20240716$$HP$US$US
240972971$24097297$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-PV202400092645$PFIZER$$$$$M$Y$$$20240716$$CN$US$US
240972981$24097298$1$I$20240711$20240712$20240716$20240716$PER$$US-PFIZER INC-202400214360$PFIZER$$65$YR$$F$Y$$$20240716$$CN$US$US
240972991$24097299$1$I$20240710$20240712$20240716$20240716$PER$$US-PFIZER INC-202400214540$PFIZER$$65$YR$$F$Y$$$20240716$$HP$US$US
240973001$24097300$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-PV202400092809$PFIZER$$38$YR$$F$Y$$$20240716$$HP$US$US
240973011$24097301$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-202400213574$PFIZER$$65$YR$$F$Y$$$20240716$$HP$US$US
240973023$24097302$3$F$20240701$20240821$20240716$20240823$PER$$US-PFIZER INC-202400214217$PFIZER$$75$YR$$F$Y$$$20240823$$HP$US$US
240973031$24097303$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400214414$PFIZER$$75$YR$$F$Y$$$20240716$$MD$US$US
240973041$24097304$1$I$20240601$20240711$20240716$20240716$PER$$US-PFIZER INC-202400213895$PFIZER$$49$YR$$F$Y$$$20240716$$HP$US$US
240973052$24097305$2$F$$20240718$20240716$20240724$PER$$US-PFIZER INC-202400212852$PFIZER$$54$YR$$M$Y$$$20240724$$MD$US$US
240973061$24097306$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400206006$PFIZER$$19$YR$$F$Y$$$20240716$$CN$US$US
240973071$24097307$1$I$$20240712$20240716$20240716$EXP$$JP-ABBVIE-5782831$ABBVIE$$70$YR$$M$Y$$$20240716$$MD$JP$JP
240973081$24097308$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400213582$PFIZER$$$$$M$Y$$$20240716$$CN$US$US
240973091$24097309$1$I$20240429$20240712$20240716$20240716$EXP$$US-UCBSA-2024025745$UCB$$80$YR$$M$Y$$$20240716$$CN$US$US
240973101$24097310$1$I$$20240715$20240716$20240716$PER$$US-BAYER-2024A101496$BAYER$$$$$F$Y$$$20240716$$CN$US$US
240973111$24097311$1$I$20240615$20240711$20240716$20240716$EXP$FR-AFSSAPS-PA2024001275$FR-GSK-FR2024086703$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$FR$FR
240973123$24097312$3$F$20240705$20240815$20240716$20240821$30DAY$$US-AMGEN-USASP2024137499$AMGEN$$73$YR$E$M$Y$83.447$KG$20240821$$PH$US$US
240973131$24097313$1$I$20240101$20240710$20240716$20240716$EXP$$CA-KARYOPHARM-2024KPT001113$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240716$$PH$CA$CA
240973143$24097314$3$F$20240710$20240802$20240716$20240808$30DAY$$US-AMGEN-USASL2024137184$AMGEN$$52$YR$A$F$Y$$$20240808$$MD$US$US
240973151$24097315$1$I$$20240710$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110686$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$99.79$KG$20240716$$CN$US$US
240973161$24097316$1$I$$20240604$20240716$20240716$PER$$US-TRAVERE-2024TVT00571$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240716$$CN$US$US
240973171$24097317$1$I$20240702$20240705$20240716$20240716$EXP$$CN-FreseniusKabi-FK202410699$FRESENIUS KABI$$68$YR$E$M$Y$47$KG$20240716$$HP$CN$CN
240973181$24097318$1$I$20200831$20240709$20240716$20240716$EXP$$KR-009507513-2407KOR004001$MERCK$$$$E$M$Y$$$20240716$$HP$KR$KR
240973191$24097319$1$I$$20240703$20240716$20240716$PER$$US-RDY-SPO/USA/24/0009956$DR REDDYS$$30$YR$A$F$Y$$$20240716$$MD$US$US
240973201$24097320$1$I$$20240715$20240716$20240716$EXP$$US-INCYTE CORPORATION-2024IN007432$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240973211$24097321$1$I$20240702$20240705$20240716$20240716$EXP$GB-MHRA-MED-202407051348598510-SBJGQ$GB-RDY-SPO/GBR/24/0010046$DR REDDYS$$85$YR$E$F$Y$$$20240716$$PH$GB$GB
240973223$24097322$3$F$20240101$20240715$20240716$20240729$PER$$US-BIOMARINAP-US-2024-159110$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
240973231$24097323$1$I$$20200930$20240716$20240716$EXP$$US-AstraZeneca-2020SF27019$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240973241$24097324$1$I$20200903$20240708$20240716$20240716$EXP$PL-URPL-1-2925-2020$PL-TEVA-VS-3219119$TEVA$$70$YR$$F$Y$$$20240716$$MD$PL$PL
240973251$24097325$1$I$20230628$20240712$20240716$20240716$EXP$$JP-AstraZeneca-2023A163568$ASTRAZENECA$$83$YR$$M$Y$61$KG$20240716$$MD$JP$
240973261$24097326$1$I$$20190717$20240716$20240716$EXP$$US-AstraZeneca-2019SF04149$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240973271$24097327$1$I$20240706$20240711$20240716$20240716$EXP$$CO-AstraZeneca-2024A160092$ASTRAZENECA$$63$YR$$F$Y$75$KG$20240716$$CN$CO$
240973281$24097328$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008503$ELI LILLY AND CO$$$$$$Y$$$20240716$$CN$US$US
240973291$24097329$1$I$20240713$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009658$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240716$$CN$US$US
240973301$24097330$1$I$20240701$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009576$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240716$$CN$US$US
240973311$24097331$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009574$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240716$$CN$US$US
240973321$24097332$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008894$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240716$$CN$US$US
240973331$24097333$1$I$20240715$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009411$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240716$$CN$US$US
240973341$24097334$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009373$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240716$$MD$US$US
240973351$24097335$1$I$20240715$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49100$$FDA-CTU$$92$YR$$M$N$$$20240715$N$HP$US$
240973361$24097336$1$I$$20240708$20240716$20240716$EXP$$US-ASTELLAS-2024US019671$ASTELLAS$$$$$M$Y$$$20240716$$MD$US$US
240973373$24097337$3$F$20240625$20240805$20240716$20240812$EXP$PT-INFARMED-R202406-732$PT-MYLANLABS-2024M1064708$MYLAN$$37$YR$$M$Y$$$20240812$$PH$PT$PT
240973381$24097338$1$I$$20240702$20240716$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06622$LUPIN$$$$$$Y$$$20240716$$CN$US$US
240973391$24097339$1$I$$20240709$20240716$20240716$EXP$$CA-GSK-CA2024AMR085905$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$HP$CA$CA
240973401$24097340$1$I$$20240716$20240716$20240716$PER$$US-BAYER-2024A103128$BAYER$$$$$$Y$$$20240716$$CN$US$US
240973421$24097342$1$I$20230901$20240709$20240716$20240716$EXP$$PT-009507513-2407PRT006242$MERCK$$45$YR$$F$Y$$$20240716$$MD$PT$PT
240973431$24097343$1$I$20240712$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112882$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240716$$CN$US$US
240973451$24097345$1$I$$20240612$20240716$20240716$PER$$US-ACER THERAPEUTICS INC.-2024-SPO-OLP-0003$ACER THERAPEUTICS$$$$$$Y$$$20240716$$HP$US$US
240973461$24097346$1$I$$20240711$20240716$20240716$PER$$US-ABBVIE-5839283$ABBVIE$$76$YR$$F$Y$$$20240716$$CN$US$US
240973471$24097347$1$I$$20240423$20240716$20240716$PER$$US-ACER THERAPEUTICS INC.-2024-SPO-OLP-0002$ACER THERAPEUTICS$$$$$$Y$$$20240716$$HP$US$US
240973481$24097348$1$I$$20240709$20240716$20240716$EXP$$US-ROCHE-10000008544$ROCHE$$74$YR$E$F$Y$$$20240716$$CN$US$US
240973492$24097349$2$F$20240709$20240802$20240716$20240805$PER$$US-ALXN-202407USA000528US$ALEXION PHARMACEUTICALS$$23$YR$$F$Y$$$20240805$$CN$US$US
240973501$24097350$1$I$$20240710$20240716$20240716$PER$$US-ALXN-202407USA000650US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
240973512$24097351$2$F$20240711$20240821$20240716$20240823$PER$$US-AMGEN-USASP2024139564$AMGEN$$65$YR$E$F$Y$$$20240823$$CN$US$US
240973523$24097352$3$F$$20240730$20240716$20240805$PER$$US-AMGEN-USASP2024140468$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
240973531$24097353$1$I$20231016$20240709$20240716$20240716$EXP$$KR-TAKEDA-2024TUS070407$TAKEDA$$65$YR$$M$Y$70.3$KG$20240716$$MD$KR$KR
240973544$24097354$4$F$20240604$20240812$20240716$20240816$EXP$$US-AMGEN-USASP2024136998$AMGEN$$51$YR$A$M$Y$$$20240816$$MD$US$US
240973551$24097355$1$I$$20240712$20240716$20240716$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135629$DAIICHI$$$$$F$Y$$$20240716$$CN$US$US
240973561$24097356$1$I$$20240711$20240716$20240716$PER$$US-DSJP-DSU-2024-135673$DAIICHI$$$$$F$Y$$$20240716$$CN$US$US
240973571$24097357$1$I$20240512$20240712$20240716$20240716$EXP$FR-AFSSAPS-TS2024000776$FR-MYLANLABS-2024M1065428$MYLAN$$50$YR$$M$Y$89$KG$20240716$$MD$FR$FR
240973583$24097358$3$F$$20240904$20240716$20240904$EXP$$CO-PFIZER INC-202400213938$PFIZER$Tabares, B.. Fatal co-infection by multiple pathogens in an indigenous woman with autoimmune hemolytic anemia and tuberculosis: a case report. BMC Infectious Diseases. 2024;24(1):645$28$YR$$F$Y$$$20240904$$HP$CO$CO
240973591$24097359$1$I$20240619$20240715$20240716$20240716$EXP$$DE-PFIZER INC-202400214661$PFIZER$$17$YR$$F$Y$62.993$KG$20240716$$MD$DE$DE
240973601$24097360$1$I$20230401$20240709$20240716$20240716$EXP$$RS-PFIZER INC-202400210350$PFIZER$Pesic, A.. UNIQUE PRESENTATION OF T-CELL/HISTIOCYTE-RICH LARGE B CELL LYMPHOMA COMPLICATED WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: CASE REPORT AND REVIEW OF THE LITERATURE. Journal of Medical Biochemistry. 2024;43(4):631-637$32$YR$$M$Y$$$20240716$$HP$RS$RS
240973613$24097361$3$F$$20240917$20240716$20240923$30DAY$$US-PFIZER INC-202400204571$PFIZER$$4$MON$$F$Y$$$20240923$$CN$US$US
240973621$24097362$1$I$$20240715$20240716$20240716$EXP$NL-LRB-00981755$NL-PFIZER INC-202400214743$PFIZER$$64$YR$$F$Y$54$KG$20240716$$MD$NL$NL
240973631$24097363$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145760$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
240973642$24097364$2$F$$20240717$20240716$20240718$EXP$$PL-PFIZER INC-202400212224$PFIZER$Chadzynski, P.. Tolosa-Hunt syndrome: a review of diagnostic criteria based on a case series. ADVANCES IN PSYCHIATRY + NEUROLOGY. 2024;33(1):26-34$$$E$F$Y$$$20240718$$MD$PL$PL
240973651$24097365$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203796$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240716$$MD$US$US
240973661$24097366$1$I$20240601$20240705$20240716$20240716$PER$$US-SA-2024SA203658$SANOFI AVENTIS$$47$YR$A$F$Y$52.1$KG$20240716$$MD$US$US
240973671$24097367$1$I$20240708$20240708$20240716$20240716$PER$$US-SA-2024SA202925$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240716$$MD$US$US
240973681$24097368$1$I$20240101$20240703$20240716$20240716$PER$$US-SA-2024SA199595$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240716$$MD$US$US
240973693$24097369$3$F$20240621$20240802$20240716$20240813$PER$$US-INCYTE CORPORATION-2024IN007351$INCYTE$$$$$$Y$$$20240813$$CN$US$US
240973702$24097370$2$F$20231210$20240716$20240716$20240717$EXP$$US-ROCHE-10000027110$ROCHE$$1$YR$I$F$Y$$$20240717$$CN$US$US
240973711$24097371$1$I$$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111736$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240716$$HP$US$US
240973721$24097372$1$I$20240708$20240711$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110895$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$61.23$KG$20240716$$CN$US$US
240973732$24097373$2$F$20240703$20240731$20240716$20240812$PER$$US-ALKERMES INC.-ALK-2024-001827$ALKERMES$$28$YR$$M$Y$104.76$KG$20240812$$HP$US$US
240973751$24097375$1$I$$20240711$20240716$20240716$PER$$US-SA-2024SA206259$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240716$$MD$US$US
240973761$24097376$1$I$20230526$20240708$20240716$20240716$EXP$FR-AFSSAPS-TO2024000120$FR-FreseniusKabi-FK202410934$FRESENIUS KABI$$75$YR$E$M$Y$$$20240716$$MD$FR$FR
240973771$24097377$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410822$FRESENIUS KABI$$55$YR$A$M$Y$76$KG$20240716$$HP$CA$CA
240973811$24097381$1$I$20240712$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49073$$FDA-CTU$$65$YR$$F$N$$$20240716$N$PH$US$
240973821$24097382$1$I$20240708$20240711$20240716$20240716$DIR$FDA-CDER-CTU-2024-49052$$FDA-CTU$$42$YR$$M$N$$$20240711$N$HP$US$
240973841$24097384$1$I$20240715$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49068$$FDA-CTU$$89$YR$$F$N$$$20240715$N$HP$US$
240973861$24097386$1$I$$20240711$20240716$20240716$EXP$$NVSC2024US145587$NOVARTIS$$$$$M$Y$$$20240716$$CN$US$US
240973872$24097387$2$F$$20240816$20240716$20240819$PER$$US-PFIZER INC-202400215121$PFIZER$$13$YR$$M$Y$$$20240819$$CN$US$US
240973901$24097390$1$I$$20240711$20240716$20240716$EXP$$US-SA-2024SA206407$SANOFI AVENTIS$$$$A$M$Y$$$20240716$$MD$US$US
240973911$24097391$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400214363$PFIZER$$$$$M$Y$$$20240716$$MD$US$US
240973922$24097392$2$F$$20240715$20240716$20240722$EXP$$TH-PFIZER INC-202400213226$PFIZER$Iampreechakul, P.. Holocord myelopathy misdiagnosed as neuromyelitis optica spectrum disorder (NMOSD): A unique case of dural arteriovenous fistula at the craniocervical junction along first spinal nerve. Surgical Neurology International. 2024;15(209):1-8$70$YR$$F$Y$$$20240722$$MD$TH$TH
240973933$24097393$3$F$20240709$20240916$20240716$20240919$PER$$US-PFIZER INC-202400212283$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
240973942$24097394$2$F$$20240719$20240716$20240723$30DAY$$GB-PFIZER INC-PV202400086120$PFIZER$$10$YR$$F$Y$$$20240723$$CN$GB$GB
240973953$24097395$3$F$20201029$20240716$20240716$20240725$EXP$$IT-PFIZER INC-202400214486$PFIZER$Maso, V.. COVID-19 and lupus nephritis exacerbation in unvaccinated patients: a clinical case and literature review. Italian Journal of Nephrology. 2024;41 (3):10.69097/41-03-2024-07$28$YR$$F$Y$$$20240725$$MD$IT$IT
240973962$24097396$2$F$$20240715$20240716$20240722$EXP$$CN-PFIZER INC-202400213872$PFIZER$Shao, Y.. Liver autotransplantation and atrial reconstruction on a patient with multiorgan alveolar echinococcosis: a case report.. BMC infectious diseases. 2024;24(1):659$59$YR$$F$Y$$$20240722$$MD$CN$CN
240973981$24097398$1$I$$20240715$20240715$20240715$DIR$710268$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240973991$24097399$1$I$20230802$20240702$20240716$20240716$EXP$$US-ACORDA-ACO_177556_2024$ACORDA$$66$YR$$M$Y$$$20240716$$CN$US$US
240974001$24097400$1$I$20240101$20240702$20240716$20240716$30DAY$$CA-JNJFOC-20240709519$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240716$$HP$CA$CA
240974012$24097401$2$F$$20240716$20240716$20240717$PER$$US-JNJFOC-20240730863$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$CN$US$US
240974023$24097402$3$F$20231221$20240828$20240716$20240904$EXP$$US-009507513-2407USA005217$MERCK$Piemonti L,Vettor L, Contro E.. A case report of metastatic gastric cancer treated with pembrolizumab during pregnancy. Fetal diagnosis and therapy. 2024;1-7$$$$F$Y$1.685$KG$20240904$$HP$IT$IT
240974031$24097403$1$I$$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111387$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240716$$CN$US$US
240974041$24097404$1$I$20240414$20240710$20240716$20240716$EXP$ES-AEMPS-1542796$ES-JNJFOC-20240728150$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240716$$MD$ES$ES
240974051$24097405$1$I$$20240710$20240716$20240716$EXP$$CO-BAYER-2024A102407$BAYER$$$$$M$Y$$$20240716$$HP$CO$CO
240974072$24097407$2$F$$20240920$20240716$20240924$EXP$$NVSC2024CO145661$NOVARTIS$$$$$$Y$$$20240924$$MD$CO$CO
240974081$24097408$1$I$$20240702$20240716$20240716$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06805$LUPIN$$$$$$Y$$$20240716$$CN$US$US
240974092$24097409$2$F$$20240712$20240716$20240718$EXP$$NVSC2024US144370$NOVARTIS$Wang JS, Wong T, Wu KA, Mullikin TC, Armstrong A. Diffuse Pneumonitis after Lutetium-177-PSMA-617 Treatment in a Patient with Metastatic Castration Resistant Prostate Cancer. BMJ CASE REPORTS. 2024;17:e257772 (1-6)$6$DEC$$M$Y$$$20240718$$HP$US$US
240974102$24097410$2$F$$20240715$20240716$20240722$EXP$$NVSC2024FR145263$NOVARTIS$Archer E, Bosdure L, Lejeune J, Faucheux L, Guery EA, Sillamy N et al.. Hypofibrinogenemie induite par les corticoides seuls au cours du traitement d^une leucemie aigue lymphoblastique: a propos d^un cas clinique au CHU de Tours (Hypofibrinogenemia induced by corticosteroids alone during treatment of acute  lymphoblastic leukemia: a case report from Tours University Hospital). REVUE FRANCOPHONE O^HEMOSTASE ET THROMBOSE. 2024;6(2):67-70$14$YR$$M$Y$$$20240722$$HP$FR$FR
240974121$24097412$1$I$20240701$20240703$20240716$20240716$PER$$US-ALKERMES INC.-ALK-2024-001833$ALKERMES$$16$YR$$F$Y$$$20240716$$PH$US$US
240974132$24097413$2$F$$20240729$20240716$20240802$EXP$$JP-DSJP-DSJ-2024-134883$DAIICHI$$77$YR$$M$Y$$$20240802$$MD$JP$JP
240974142$24097414$2$F$$20240711$20240716$20240718$PER$$US-BIOGEN-2024BI01273496$BIOGEN$$$$$M$Y$$$20240718$$CN$US$US
240974151$24097415$1$I$20240712$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49067$$FDA-CTU$$98$YR$$M$N$$$20240715$N$HP$US$
240974161$24097416$1$I$20240611$20240708$20240716$20240716$EXP$FR-AFSSAPS-AN2024000845$FR-TEVA-VS-3219128$TEVA$$73$YR$$M$Y$$$20240716$$MD$FR$FR
240974171$24097417$1$I$$20240702$20240716$20240716$30DAY$$US-JNJFOC-20240706530$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240974181$24097418$1$I$$20240714$20240716$20240716$PER$$NVSC2024US145805$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240974191$24097419$1$I$$20240710$20240716$20240716$EXP$$NVSC2024US144625$NOVARTIS$$57$YR$$F$Y$$$20240716$$MD$US$US
240974201$24097420$1$I$$20240715$20240716$20240716$EXP$$US-PFIZER INC-PV202400092947$PFIZER$$79$YR$$F$Y$$$20240716$$CN$US$US
240974213$24097421$3$F$$20240820$20240716$20240826$EXP$$JP-PFIZER INC-PV202400091866$PFIZER$Nakai, T.. Development of neuro-Behcet^s disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy: A case report. Breast disease. 2024;43(1):223-229$40$YR$$F$Y$$$20240826$$HP$JP$JP
240974221$24097422$1$I$20240714$20240715$20240715$20240715$DIR$710259$$FDA-CTU$$73$YR$$F$N$72.9$KG$20240715$N$CN$US$
240974231$24097423$1$I$$20240715$20240715$20240715$DIR$710267$$FDA-CTU$$$$$F$N$$$20240715$N$PH$US$
240974241$24097424$1$I$$20240711$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007348$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240974251$24097425$1$I$$20240708$20240716$20240716$EXP$$IN-AstraZeneca-2024A156443$ASTRAZENECA$Agarwal, K; Bishnoi, K; Mishra, S; Purkait, S.. Uncommon Site of Metastasis: A Case Report of Breast Carcinoma Spreading to the Pancreas. Indian Journal of Nuclear Medicine 2024;39(2):120-122.$50$YR$$F$Y$$$20240716$$MD$IN$
240974261$24097426$1$I$20230209$20240708$20240716$20240716$EXP$$AU-TAKEDA-2024TUS070565$TAKEDA$$82$YR$$M$Y$$$20240716$$MD$AU$AU
240974271$24097427$1$I$20231011$20240711$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007343$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240974291$24097429$1$I$20240601$20240710$20240716$20240716$EXP$$CN-DSJP-DSJ-2024-135267$DAIICHI$$39$YR$$F$Y$48$KG$20240716$$HP$CN$CN
240974301$24097430$1$I$$20201218$20240716$20240716$EXP$$US-AstraZeneca-2020SF53991$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240974311$24097431$1$I$20230303$20240707$20240716$20240716$EXP$GB-MHRA-MED-202407072305556260-SKFLV$GB-RDY-SPO/GBR/24/0010065$DR REDDYS$$26$YR$A$M$Y$$$20240716$$CN$GB$GB
240974321$24097432$1$I$20190805$20240711$20240716$20240716$EXP$$CO-UCBSA-2024035939$UCB$$68$YR$$F$Y$$$20240716$$CN$CO$CO
240974331$24097433$1$I$$20240711$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007340$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240974341$24097434$1$I$$20240711$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007338$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240974351$24097435$1$I$20170101$20240711$20240716$20240716$EXP$$US-ABBVIE-5805068$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240974363$24097436$3$F$20240101$20240723$20240716$20240805$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-001543$SK LIFE SCIENCE$$$$$$Y$$$20240805$$HP$CA$CA
240974371$24097437$1$I$$20240711$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007328$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240974391$24097439$1$I$20181219$20240709$20240716$20240716$EXP$FR-AFSSAPS-ST2024001115$FR-TEVA-VS-3219426$TEVA$$39$YR$$F$Y$$$20240716$$MD$FR$FR
240974411$24097441$1$I$20240510$20240712$20240716$20240716$EXP$$US-PURDUE PHARMA-USA-2024-0310740$PURDUE$$65$YR$$M$Y$127$KG$20240716$$CN$US$US
240974421$24097442$1$I$20240512$20240703$20240716$20240716$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-000993$SK LIFE SCIENCE$$$$$$Y$$$20240716$$CN$US$US
240974431$24097443$1$I$$20240715$20240716$20240716$EXP$CA-HEALTHCANVIG-001087625$CA-PURDUE-USA-2024-0310771$PURDUE$$66$YR$$F$Y$$$20240716$$HP$CA$CA
240974441$24097444$1$I$$20240715$20240716$20240716$EXP$CA-HEALTHCANVIG-001088790$CA-PURDUE-USA-2024-0310780$PURDUE$$93$YR$$F$Y$55$KG$20240716$$HP$CA$CA
240974451$24097445$1$I$$20240715$20240715$20240715$DIR$710269$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240974461$24097446$1$I$$20240715$20240715$20240715$DIR$710266$$FDA-CTU$$$$$F$N$$$20240715$N$HP$US$
240974471$24097447$1$I$$20240715$20240716$20240716$EXP$$CA-PURDUE-USA-2024-0310792$PURDUE$$53$YR$$M$Y$$$20240716$$HP$CA$CA
240974481$24097448$1$I$$20240701$20240716$20240716$EXP$$US-EMERGENT BIOSOLUTIONS,-24000102$EMERGENT BIOSOLUTIONS$Marsalisi C, Guo HJ, Reddy P. The Double-Edged Sword: Naloxone-Induced Noncardiogenic Pulmonary Edema. Cureus. 2023;15(7):e41642$46$YR$$M$Y$$$20240716$$HP$US$US
240974491$24097449$1$I$20240101$20240712$20240716$20240716$EXP$$US-ABBVIE-5839139$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240974501$24097450$1$I$$20240715$20240715$20240715$DIR$710272$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240974511$24097451$1$I$$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49081$$FDA-CTU$$$$$F$N$$$20240715$N$HP$US$
240974521$24097452$1$I$20240525$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49053$$FDA-CTU$$82$YR$$F$N$$$20240715$N$HP$US$
240974531$24097453$1$I$20220801$20240709$20240716$20240716$EXP$$NVSC2024CZ144823$NOVARTIS$$51$YR$$F$Y$$$20240716$$MD$CZ$CZ
240974541$24097454$1$I$20230701$20240710$20240716$20240716$EXP$$BE-DSJP-DSE-2024-135577$DAIICHI$$61$YR$$F$Y$$$20240716$$MD$BE$BE
240974553$24097455$3$F$20240710$20240918$20240716$20240921$EXP$$CA-TAKEDA-2024TUS070890$TAKEDA$$57$YR$$F$Y$$$20240921$$HP$CA$CA
240974565$24097456$5$F$$20240808$20240716$20240822$EXP$$US-ALXN-202407USA000666US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$MD$US$US
240974571$24097457$1$I$20170101$20240714$20240716$20240716$EXP$$IL-SHIRE-IL201734690AA$TAKEDA$$$$A$F$Y$$$20240716$$MD$IL$IL
240974581$24097458$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49132$$FDA-CTU$$72$YR$$F$N$$$20240716$N$$US$
240974591$24097459$1$I$$20240715$20240715$20240715$DIR$710271$$FDA-CTU$$$$$UNK$N$$$20240715$$CN$US$
240974601$24097460$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49075$$FDA-CTU$$88$YR$$F$N$$$20240716$N$$US$
240974611$24097461$1$I$$20240715$20240715$20240715$DIR$710270$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240974621$24097462$1$I$20240601$20240712$20240716$20240716$PER$$US-DSJP-DSU-2024-135634$DAIICHI$$48$YR$$F$Y$$$20240716$$CN$US$US
240974631$24097463$1$I$$20240715$20240716$20240716$PER$$US-HALEON-2187292$Haleon PLC$$$$$$Y$$$20240716$$CN$US$US
240974641$24097464$1$I$$20240704$20240716$20240716$EXP$$GB-ACRAF SpA-2024-035091$SK LIFE SCIENCE$$$$$$Y$$$20240716$$HP$GB$GB
240974651$24097465$1$I$$20240711$20240716$20240716$EXP$$JP-BAYER-2024A100308$BAYER$$$$$M$Y$$$20240716$$MD$JP$JP
240974661$24097466$1$I$$20240715$20240715$20240715$DIR$710275$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240974671$24097467$1$I$20240703$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49117$$FDA-CTU$$44$YR$$F$N$$$20240716$N$$US$
240974681$24097468$1$I$$20240715$20240715$20240715$DIR$710276$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240974691$24097469$1$I$20240101$20240704$20240716$20240716$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-001010$SK LIFE SCIENCE$$$$$$Y$$$20240716$$MD$CA$CA
240974701$24097470$1$I$$20240710$20240716$20240716$EXP$$RU-PERRIGO-24RU006626$PERRIGO$Sayfullin RF, Abdieva KE, Razumeykina AV, Zolotareva AP, Ivanova OA. A case of infectious mononucleosis caused by Epstein-Barr virus complicated by autoimmune hemolytic anemia. Children Infections. 2024;23(2):55-60. DOI:10.22627/2072-8107-2024-23-2-55-60.$$$$F$Y$$$20240716$$MD$RU$RU
240974711$24097471$1$I$$20240710$20240716$20240716$EXP$$US-SA-2024SA204426$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240716$$CN$US$US
240974721$24097472$1$I$20240715$20240715$20240715$20240715$DIR$710282$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240974731$24097473$1$I$$20240624$20240716$20240716$DIR$FDA-CDER-CTU-2024-49044$$FDA-CTU$$$$$M$N$$$20240624$N$HP$US$
240974751$24097475$1$I$20240701$20240715$20240715$20240715$DIR$710281$$FDA-CTU$$67$YR$$M$N$$$20240715$N$CN$US$
240974761$24097476$1$I$20240715$20240715$20240715$20240715$DIR$710286$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240974771$24097477$1$I$$20240715$20240715$20240715$DIR$710288$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240974781$24097478$1$I$20240624$20240712$20240716$20240716$EXP$$US-GSK-US2024AMR088939$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$US$US
240974791$24097479$1$I$20240407$20240704$20240716$20240716$EXP$FR-AFSSAPS-NC2024000778$FR-SK LIFE SCIENCE, INC-SKPVG-2024-001574$SK LIFE SCIENCE$$$$$$Y$$$20240716$$MD$FR$FR
240974801$24097480$1$I$20240601$20240712$20240716$20240716$EXP$$US-ABBVIE-5839527$ABBVIE$$56$YR$$F$Y$$$20240716$$CN$US$US
240974811$24097481$1$I$20240101$20240701$20240716$20240716$PER$$US-Eisai-EC-2024-169322$EISAI$$$$E$M$Y$$$20240716$$MD$US$US
240974821$24097482$1$I$20240611$20240628$20240716$20240716$PER$$US-Eisai-EC-2024-169377$EISAI$$77$YR$E$M$Y$$$20240716$$MD$US$US
240974842$24097484$2$F$20240601$20240716$20240716$20240823$PER$$US-Eisai-EC-2024-169351$EISAI$$80$YR$E$F$Y$$$20240823$$CN$US$US
240974861$24097486$1$I$20240629$20240629$20240716$20240716$EXP$$VN-FreseniusKabi-FK202410326$FRESENIUS KABI$$$$$F$Y$$$20240716$$MD$VN$VN
240974872$24097487$2$F$$20240731$20240716$20240806$EXP$$BR-TAKEDA-2024TUS071706$TAKEDA$$8$YR$$$Y$$$20240806$$CN$BR$BR
240974881$24097488$1$I$$20240701$20240716$20240716$EXP$$US-EMERGENT BIOSOLUTIONS,-24000104$EMERGENT BIOSOLUTIONS$Kummer RL, Kempainen RR, Olives TD, Leatherman JW, Prekker ME.. Naloxone-associated pulmonary edema following recreational opioid overdose: A case series. Am J Emerg Med. 2024;53:41-3$23$YR$$$Y$$$20240716$$MD$US$US
240974891$24097489$1$I$20240707$20240710$20240716$20240716$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13922$IPSEN$$68$YR$E$F$Y$56.6$KG$20240716$$CN$US$US
240974911$24097491$1$I$$20240713$20240716$20240716$DIR$FDA-CDER-CTU-2024-49086$$FDA-CTU$$$$$F$N$$$20240713$N$HP$US$
240974922$24097492$2$F$20240711$20240712$20240716$20240718$PER$$US-AMGEN-USASP2024139782$AMGEN$$$$$M$Y$$$20240718$$CN$US$US
240974931$24097493$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49078$$FDA-CTU$$90$YR$$M$N$$$20240716$N$$US$
240974941$24097494$1$I$20240316$20240715$20240715$20240715$DIR$710246$$FDA-CTU$$38$YR$$F$N$67.5$KG$20240715$N$CN$US$
240974951$24097495$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49143$$FDA-CTU$$36$YR$$F$N$$$20240716$N$$US$
240974961$24097496$1$I$20240705$20240705$20240716$20240716$PER$$US-BIOGEN-2024BI01272921$BIOGEN$$23$YR$$$Y$$$20240716$$PH$US$US
240974971$24097497$1$I$20240627$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49069$$FDA-CTU$$62$YR$$M$N$$$20240715$N$HP$US$
240974981$24097498$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49145$$FDA-CTU$$50$YR$$F$N$$$20240716$N$$US$
240974991$24097499$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202407041350123850-LJDQC$GB-TEVA-VS-3217472$TEVA$$$$$F$Y$66$KG$20240716$$CN$GB$GB
240975002$24097500$2$F$$20240729$20240716$20240807$EXP$$US-TEVA-VS-3219041$TEVA$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series. Pediatr-Nephrol 2024; 0 (0): no pagination.; Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series. Pediatr-Nephrol 2024; 0 (0): no pagination.; Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol...$6$YR$$F$Y$$$20240807$$HP$US$US
240975011$24097501$1$I$20240715$20240715$20240715$20240715$DIR$710300$$FDA-CTU$$85$YR$$UNK$N$$$20240715$Y$$US$
240975021$24097502$1$I$$20240701$20240716$20240716$EXP$$US-EMERGENT BIOSOLUTIONS,-24000105$EMERGENT BIOSOLUTIONS$Chau T, Joseph M, Amin K, Siddens C, Jaime G, Seeger CM, et al.. Pulmonary edema after naloxone administration for opioid reversal: A systematic review of case reports and causality assessment using the Naranjo scale. Clin Toxicol. 2024;62(5):334-42$27$YR$$M$Y$$$20240716$$HP$US$US
240975031$24097503$1$I$$20240701$20240716$20240716$EXP$$US-EMERGENT BIOSOLUTIONS,-24000103$EMERGENT BIOSOLUTIONS$Kummer RL, Kempainen RR, Olives TD, Leatherman JW, Prekker ME. Naloxone-associated pulmonary edema following recreational opioid overdose: A case series. Am J Emerg Med. 2022;53:41-3$24$YR$$$Y$$$20240716$$MD$US$US
240975041$24097504$1$I$$20240701$20240716$20240716$EXP$$BR-SANDOZ INC.-SDZ2024BR065305$SANDOZ$$$$$M$Y$$$20240716$$CN$BR$BR
240975051$24097505$1$I$$20240709$20240716$20240716$EXP$$NVSC2024IL143797$NOVARTIS$$34$YR$$F$Y$$$20240716$$HP$IL$IL
240975062$24097506$2$F$$20240905$20240716$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040059$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240906$$CN$US$US
240975071$24097507$1$I$$20240711$20240716$20240716$EXP$$US-SA-2024SA207088$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240716$$CN$US$US
240975081$24097508$1$I$20240528$20240711$20240716$20240716$EXP$$CN-SA-2024SA207281$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240716$$HP$CN$CN
240975091$24097509$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA202959$SANOFI AVENTIS$$$$A$F$Y$109.31$KG$20240716$$MD$US$US
240975101$24097510$1$I$20240524$20240711$20240716$20240716$EXP$SI-JAZMP-NCPHV-2024SI0651_0651$SI-SA-2024SA206776$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240716$$PH$SI$SI
240975121$24097512$1$I$$20240709$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110088$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240716$$HP$US$US
240975131$24097513$1$I$$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111876$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240716$$CN$US$US
240975144$24097514$4$F$20240601$20240909$20240716$20240913$EXP$$JP-ALXN-202407JPN000493JP$ALEXION PHARMACEUTICALS$$8$DEC$$M$Y$$$20240913$$MD$JP$JP
240975151$24097515$1$I$$20240708$20240716$20240716$EXP$$BE-AstraZeneca-2024A160169$ASTRAZENECA$$$$$F$Y$$$20240716$$MD$BE$
240975162$24097516$2$F$20240706$20240725$20240716$20240729$EXP$$VN-BAYER-2024A100685$BAYER$$50$YR$A$F$Y$51$KG$20240729$$PH$VN$VN
240975171$24097517$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203231$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240716$$MD$US$US
240975181$24097518$1$I$20240101$20240711$20240716$20240716$PER$$US-SA-2024SA206275$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240975191$24097519$1$I$20240501$20240705$20240716$20240716$PER$$US-SA-2024SA204098$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240716$$MD$US$US
240975201$24097520$1$I$20240101$20240705$20240716$20240716$PER$$US-SA-2024SA202628$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240716$$MD$US$US
240975211$24097521$1$I$20240601$20240705$20240716$20240716$PER$$US-SA-2024SA203079$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240716$$MD$US$US
240975221$24097522$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA202792$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240716$$MD$US$US
240975232$24097523$2$F$20240713$20240822$20240716$20240826$PER$$US-AMGEN-USASP2024140064$AMGEN$$69$YR$E$M$Y$$$20240825$$CN$US$US
240975241$24097524$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203882$SANOFI AVENTIS$$$$$F$Y$$$20240716$$PH$US$US
240975253$24097525$3$F$$20240925$20240716$20240930$PER$$US-BIOVITRUM-2024-US-009882$BIOVITRUM$$26$YR$$M$Y$$$20240930$$CN$US$US
240975261$24097526$1$I$$20240701$20240716$20240716$EXP$$US-EMERGENT BIOSOLUTIONS,-24000106$EMERGENT BIOSOLUTIONS$Sallam T, Talish M, Ghazzal A. Ali L, Alabdul Razzaq A. Naloxone-Induced Pulmonary Edema. Am J Respir Crit Care Med. 2020;201:A4948$35$YR$$M$Y$$$20240716$$HP$US$US
240975271$24097527$1$I$$20240712$20240716$20240716$EXP$$US-PERRIGO-24US006642$PERRIGO$Tallmadge M, MacBeth M, Palatnik A. New Onset of Symptomatic Peptic Ulcer Disease Postpartum Secondary to Nonsteroidal Anti-Inflammatory Drug Use. Case reports in obstetrics and gynecology. 2024;2024:6422824. DOI: 10.1155/2024/6422824.$27$YR$$F$Y$$$20240716$$MD$US$US
240975281$24097528$1$I$20190418$20240710$20240716$20240716$EXP$$US-BAXTER-2024BAX021542$BAXTER$$13$YR$$M$Y$47.4$KG$20240716$$MD$US$US
240975291$24097529$1$I$20240522$20240710$20240716$20240716$EXP$$US-ABBVIE-5837967$ABBVIE$$82$YR$$F$Y$$$20240716$$CN$US$US
240975301$24097530$1$I$$20240707$20240716$20240716$EXP$$PL-MYLANLABS-2024M1065373$MYLAN$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain-Sci 2023; 13 (3).$28$YR$$M$Y$$$20240716$$HP$PL$PL
240975311$24097531$1$I$$20240709$20240716$20240716$EXP$$PL-MYLANLABS-2024M1065857$MYLAN$Krzystanek M, Martyniak E, Palasz A, Skalacka K, Chwalba A, Wierzbinski P. Amantadine in Treatment of Dysthymia-The Pilot Case Series Study. Pharmaceuticals 2023; 16 (6):.$37$YR$$F$Y$$$20240716$$HP$PL$PL
240975321$24097532$1$I$$20240709$20240716$20240716$EXP$$US-MYLANLABS-2024M1065804$MYLAN$Xu E, Downing M, De La Pena M. A Series of Stellate Ganglion Blocks for the Management of Post-Traumatic Stress Disorder: A Case Report. Pain-Med-Case-Rep 2023; 7 (7): 341-344.$40$YR$$M$Y$$$20240716$$HP$US$US
240975331$24097533$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064623$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F.. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study. Int J Mol Sci.. 2024$73$YR$$M$Y$$$20240716$$HP$IT$IT
240975341$24097534$1$I$20240711$20240711$20240716$20240716$PER$$US-ABBVIE-5839060$ABBVIE$$31$YR$$F$Y$$$20240716$$CN$US$US
240975352$24097535$2$F$20240704$20240708$20240716$20240901$EXP$$US-BAXTER-2024BAX021406$BAXTER$$41$YR$$F$Y$$$20240901$$CN$US$US
240975361$24097536$1$I$20240619$20240709$20240716$20240716$EXP$$UA-TAKEDA-2024TUS060395$TAKEDA$$25$YR$$F$Y$51$KG$20240716$$MD$UA$UA
240975371$24097537$1$I$$20240628$20240716$20240716$PER$$US-Eisai-EC-2024-169378$EISAI$$70$YR$E$M$Y$$$20240716$$MD$US$US
240975381$24097538$1$I$20240701$20240708$20240716$20240716$PER$$US-SA-2024SA203548$SANOFI AVENTIS$$42$YR$A$M$Y$90.7$KG$20240716$$MD$US$US
240975391$24097539$1$I$20240711$20240711$20240716$20240716$EXP$$US-SA-2024SA205975$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240716$$MD$US$US
240975401$24097540$1$I$$20240703$20240716$20240716$PER$$US-Eisai-EC-2024-169483$EISAI$$$$$$Y$$$20240716$$MD$US$US
240975421$24097542$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49101$$FDA-CTU$$62$YR$$M$N$$$20240716$N$$US$
240975431$24097543$1$I$20240715$20240715$20240715$20240715$DIR$710303$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240975451$24097545$1$I$20240403$20240715$20240715$20240715$DIR$710301$$FDA-CTU$$45$YR$$F$N$42.8$KG$20240715$N$PH$US$
240975461$24097546$1$I$20240607$20240715$20240715$20240715$DIR$710304$$FDA-CTU$$22$YR$$M$N$95.2$KG$20240715$N$PH$US$
240975471$24097547$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49149$$FDA-CTU$$60$YR$$F$N$63.5$KG$20240716$N$$US$
240975481$24097548$1$I$$20240715$20240715$20240715$DIR$710273$$FDA-CTU$$$$$UNK$N$$$20240715$$CN$US$
240975491$24097549$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49090$$FDA-CTU$$66$YR$$M$N$111.13$KG$20240716$N$$US$
240975501$24097550$1$I$$20240715$20240715$20240715$DIR$710263$$FDA-CTU$$64$YR$$F$N$80.2$KG$20240715$N$$US$
240975521$24097552$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49077$$FDA-CTU$$72$YR$$M$N$$$20240716$N$$US$
240975531$24097553$1$I$20240715$20240715$20240715$20240715$DIR$710297$$FDA-CTU$$49$YR$$M$N$103.5$KG$20240715$N$CN$US$
240975541$24097554$1$I$20240706$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49061$$FDA-CTU$$40$YR$$F$N$$$20240715$N$HP$US$
240975571$24097557$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49156$$FDA-CTU$$76$YR$$F$N$$$20240716$N$$US$
240975581$24097558$1$I$20240601$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49055$$FDA-CTU$$85$YR$$F$N$$$20240715$N$HP$US$
240975592$24097559$2$F$20240529$20240812$20240716$20240814$EXP$PT-INFARMED-B202406-577$PT-FreseniusKabi-FK202410848$FRESENIUS KABI$$65$YR$E$F$Y$$$20240814$$PH$PT$PT
240975601$24097560$1$I$20240501$20240708$20240716$20240716$EXP$FR-AFSSAPS-TS2024000774$FR-FreseniusKabi-FK202410949$FRESENIUS KABI$$69$YR$E$M$Y$63$KG$20240716$$MD$FR$FR
240975611$24097561$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410761$FRESENIUS KABI$$43$YR$A$F$Y$44$KG$20240716$$HP$CA$CA
240975621$24097562$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410942$FRESENIUS KABI$$73$YR$E$F$Y$57$KG$20240716$$HP$CA$CA
240975631$24097563$1$I$$20240712$20240716$20240716$PER$$US-HALEON-2186927$Haleon PLC$$$$$$Y$$$20240716$$CN$US$US
240975642$24097564$2$F$$20240712$20240716$20240724$EXP$$US-RDY-SPO/USA/24/0010166$DR REDDYS$Ghalayni R, Al Kalaji B, Malik K. From Friend to Foe: A Case of Naloxone-Induced Pulmonary Edema. Hospital Pharmacy. 2024;59(4):407-10. DOI:10.1177/00185787241230074.$66$YR$E$F$Y$$$20240724$$MD$US$US
240975651$24097565$1$I$20240328$20240708$20240716$20240716$EXP$$FR-FreseniusKabi-FK202410891$FRESENIUS KABI$$70$YR$E$F$Y$59$KG$20240716$$MD$FR$FR
240975662$24097566$2$F$$20240716$20240716$20240724$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003876$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240724$$MD$IT$IT
240975682$24097568$2$F$20240703$20240712$20240716$20240723$EXP$$US-ABBVIE-5838599$ABBVIE$$76$YR$$M$Y$81.646$KG$20240723$$CN$US$US
240975692$24097569$2$F$$20240716$20240716$20240720$PER$$US-AMGEN-USASP2024140106$AMGEN$$$$$F$Y$$$20240720$$CN$US$US
240975701$24097570$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008611$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$US$US
240975711$24097571$1$I$20240301$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008909$ELI LILLY AND CO$$$$$$Y$$$20240716$$CN$US$US
240975721$24097572$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008673$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240716$$CN$US$US
240975731$24097573$1$I$20240712$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008654$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240716$$CN$US$US
240975741$24097574$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009030$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240716$$CN$US$US
240975761$24097576$1$I$$20240714$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009465$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240716$$CN$US$US
240975771$24097577$1$I$20240711$20240712$20240716$20240716$EXP$$US-ABBVIE-5838996$ABBVIE$$57$YR$$F$Y$$$20240716$$CN$US$US
240975781$24097578$1$I$$20240715$20240716$20240716$PER$$US-JNJFOC-20240737428$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$CN$US$US
240975791$24097579$1$I$$20240711$20240716$20240716$PER$$US-JNJFOC-20240730484$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240975801$24097580$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA205063$SANOFI AVENTIS$$$$E$F$Y$$$20240716$$MD$US$US
240975811$24097581$1$I$$20240711$20240716$20240716$EXP$$US-SA-2024SA206849$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240716$$MD$US$US
240975821$24097582$1$I$20240101$20240705$20240716$20240716$PER$$US-SA-2024SA202911$SANOFI AVENTIS$$71$YR$E$F$Y$65.7$KG$20240716$$MD$US$US
240975831$24097583$1$I$$20240709$20240716$20240716$PER$$US-ALXN-202407USA000711US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
240975841$24097584$1$I$20230101$20240710$20240716$20240716$EXP$$US-ABBVIE-5830949$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240975851$24097585$1$I$$20240710$20240716$20240716$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-110237$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240716$$MD$ES$ES
240975871$24097587$1$I$$20240715$20240716$20240716$PER$$US-BAYER-2024A101939$BAYER$$$$$$Y$$$20240716$$CN$US$US
240975881$24097588$1$I$20230203$20240711$20240716$20240716$EXP$$JP-DSJP-DSJ-2024-116023$DAIICHI$Yuasa T, Akagi Y, Kagawa C, Shibayama C, Okuyama A, Kamada M, et al.. A case of a patient with hepatic cirrhosis requiring emergency intratracheal intubation due to difficulty in haemostasis after tooth extraction. The 33rd Annual Meeting of JMCP. 2024;96$75$YR$$M$Y$57$KG$20240716$$MD$JP$JP
240975893$24097589$3$F$20220701$20240719$20240716$20240722$EXP$$US-ROCHE-10000019609$ROCHE$$36$YR$A$F$Y$90.71$KG$20240722$$CN$US$US
240975902$24097590$2$F$20240601$20240805$20240716$20240808$EXP$$US-ABBVIE-5838004$ABBVIE$$50$YR$$M$Y$$$20240808$$CN$US$US
240975931$24097593$1$I$20240101$20240711$20240716$20240716$EXP$$US-ABBVIE-5838129$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240975953$24097595$3$F$20240713$20240807$20240716$20240810$PER$$US-AMGEN-USASP2024140129$AMGEN$$75$YR$E$F$Y$$$20240809$$CN$US$US
240975983$24097598$3$F$20240706$20240823$20240716$20240830$PER$$US-AstraZeneca-2024A157700$ASTRAZENECA$$26830$DY$$F$Y$$$20240830$$CN$US$
240975991$24097599$1$I$20230414$20240705$20240716$20240716$EXP$$BY-BAYER-2024A099856$BAYER$$39$YR$A$F$Y$$$20240716$$HP$BY$BY
240976001$24097600$1$I$20240520$20240709$20240716$20240716$EXP$$NVSC2024CO144854$NOVARTIS$$56$YR$$M$Y$$$20240716$$CN$CO$CO
240976022$24097602$2$F$$20240716$20240716$20240718$EXP$$CA-AstraZeneca-2020SE58715$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$CA$
240976041$24097604$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49157$$FDA-CTU$$68$YR$$F$N$53.98$KG$20240716$N$$US$
240976051$24097605$1$I$20240607$20240715$20240715$20240715$DIR$710314$$FDA-CTU$$41$YR$$F$N$83.25$KG$20240715$N$CN$US$
240976061$24097606$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064558$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study. Int J Mol Sci.. 2024$74$YR$$M$Y$$$20240716$$HP$IT$IT
240976071$24097607$1$I$20240701$20240712$20240716$20240716$EXP$$US-ABBVIE-5839704$ABBVIE$$64$YR$$F$Y$$$20240716$$CN$US$US
240976081$24097608$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5839806$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240976092$24097609$2$F$20240705$20240717$20240716$20240724$EXP$$JP-Eisai-EC-2024-169857$EISAI$$77$YR$E$M$Y$$$20240724$$MD$JP$JP
240976102$24097610$2$F$20240101$20240716$20240716$20240722$EXP$$CA-ABBVIE-5839974$ABBVIE$$54$YR$$F$Y$$$20240722$$CN$CA$CA
240976111$24097611$1$I$$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49080$$FDA-CTU$$$$$F$N$$$20240715$N$HP$US$
240976131$24097613$1$I$$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49144$$FDA-CTU$$$$$M$N$$$20240715$N$HP$US$
240976141$24097614$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064560$MYLAN$Detassis S, Precazzini F, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study. International Journal of Molecular Sciences. 2024;5573:1-13$82$YR$$M$Y$$$20240716$$HP$IT$IT
240976151$24097615$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064569$MYLAN$Detassis S, Grasso M, Del Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F.. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-ResistantProstate Cancer: A Pilot Study.. Int. J. Mol. Sci. 2024;25:1-13$75$YR$$M$Y$$$20240716$$HP$IT$IT
240976161$24097616$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064636$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F.. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study.. Int. J. Mol. Sci.$78$YR$$M$Y$$$20240716$$HP$IT$IT
240976171$24097617$1$I$20240710$20240712$20240716$20240716$EXP$$DO-ABBVIE-5840705$ABBVIE$$82$YR$$M$Y$67$KG$20240716$$HP$DO$DO
240976182$24097618$2$F$20240707$20240708$20240716$20240723$EXP$$UY-FreseniusKabi-FK202410959$FRESENIUS KABI$$$$$F$Y$$$20240723$$MD$UY$UY
240976191$24097619$1$I$20240701$20240708$20240716$20240716$EXP$$UY-FreseniusKabi-FK202410961$FRESENIUS KABI$$25$YR$A$F$Y$$$20240716$$MD$UY$UY
240976202$24097620$2$F$$20240715$20240716$20240723$EXP$$IN-VANTIVE-2024VAN018318$Vantive US Healthcare$$61$YR$$F$Y$$$20240723$$CN$IN$IN
240976211$24097621$1$I$20240710$20240715$20240715$20240715$DIR$710321$$FDA-CTU$$74$YR$$F$N$117$KG$20240715$N$CN$US$
240976221$24097622$1$I$$20240709$20240716$20240716$EXP$$CA-GSK-CA2024AMR085268$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$CA$CA
240976231$24097623$1$I$20240602$20240710$20240716$20240716$EXP$$EC-VANTIVE-2024VAN017749$Vantive US Healthcare$$70$YR$$F$Y$52.2$KG$20240716$$HP$EC$EC
240976241$24097624$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410880$FRESENIUS KABI$$78$YR$E$M$Y$$$20240716$$HP$CA$CA
240976251$24097625$1$I$20240710$20240710$20240716$20240716$EXP$$CA-JNJFOC-20240732444$JOHNSON AND JOHNSON$$16$YR$T$M$Y$57$KG$20240716$$HP$CA$CA
240976261$24097626$1$I$20240715$20240715$20240715$20240715$DIR$710260$$FDA-CTU$$81$YR$$M$N$$$20240715$N$CN$US$
240976291$24097629$1$I$20240620$20240715$20240715$20240715$DIR$710262$$FDA-CTU$$66$YR$$M$N$$$20240715$Y$HP$US$
240976301$24097630$1$I$20240715$20240715$20240715$20240715$DIR$710315$$FDA-CTU$$44$YR$$M$N$76.5$KG$20240715$N$CN$US$
240976322$24097632$2$F$$20240729$20240716$20240806$EXP$$US-TEVA-VS-3219101$TEVA$Prabhu S, Malempati S, Markowitz D. Amlodipine: Not an Ace in the Hole. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Prabhu S, Malempati S, Markowitz D. Amlodipine: Not an Ace in the Hole. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$56$YR$$M$Y$$$20240806$$HP$US$US
240976331$24097633$1$I$20220511$20240711$20240716$20240716$EXP$$US-CHIESI-2024CHF04227$CHIESI$$16$YR$$M$Y$$$20240716$$PH$US$US
240976341$24097634$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204314$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240716$$MD$US$US
240976351$24097635$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA205473$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240716$$MD$US$US
240976361$24097636$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204339$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240716$$MD$US$US
240976371$24097637$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA204286$SANOFI AVENTIS$$$$E$F$Y$$$20240716$$MD$US$US
240976381$24097638$1$I$20240710$20240711$20240716$20240716$EXP$$GB-AMGEN-GBRSL2024139025$AMGEN$$55$YR$A$F$Y$$$20240716$$CN$GB$GB
240976391$24097639$1$I$$20240708$20240716$20240716$EXP$$CA-AMGEN-CANSP2024139331$AMGEN$$28$YR$A$M$Y$62$KG$20240716$$HP$CA$CA
240976401$24097640$1$I$$20240626$20240716$20240716$PER$$US-009507513-2406USA009496$MERCK$$$$$M$Y$$$20240716$$HP$US$US
240976411$24097641$1$I$$20240715$20240716$20240716$PER$$US-HALEON-2187334$Haleon PLC$$$$$$Y$$$20240716$$CN$US$US
240976421$24097642$1$I$20240627$20240711$20240716$20240716$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-111159$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$68.95$KG$20240716$$CN$PR$PR
240976431$24097643$1$I$20240430$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111725$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240716$$CN$US$US
240976441$24097644$1$I$$20240708$20240716$20240716$EXP$$US-MYLANLABS-2024M1065283$MYLAN$Li A, Manak CK. (029) Management of Agitation Secondary to Immune Cell-Effector Associated Neurotoxicity Syndrome (ICANS) in a Pediatric Patient. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S14-S15.$18$YR$$F$Y$$$20240716$$HP$US$US
240976451$24097645$1$I$$20240301$20240716$20240716$EXP$GB-MHRA-MED-202402291610522130-BDNYZ$GB-TEVA-VS-3166850$TEVA$$$$$$Y$$$20240716$$MD$GB$GB
240976462$24097646$2$F$20240612$20240718$20240716$20240722$EXP$$CA-BIOVITRUM-2024-CA-008757$BIOVITRUM$$26$YR$$F$Y$$$20240722$$MD$CA$CA
240976472$24097647$2$F$20240709$20240918$20240716$20240919$EXP$$NVSC2024US145954$NOVARTIS$$44$YR$$M$Y$$$20240919$$CN$US$US
240976481$24097648$1$I$$20240705$20240716$20240716$PER$$NVSC2024US143582$NOVARTIS$$32$YR$$F$Y$$$20240716$$CN$US$US
240976491$24097649$1$I$$20240628$20240716$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06410$LUPIN$$$$$$Y$$$20240716$$CN$US$US
240976501$24097650$1$I$20231001$20240704$20240716$20240716$EXP$$CH-OPKO PHARMACEUTICALS, LLC.-2024OPK00159$OPKO HEALTH$$46$YR$$F$Y$$$20240715$$CN$CH$DE
240976511$24097651$1$I$20240529$20240708$20240716$20240716$EXP$$CO-BIOVITRUM-2024-CO-009864$BIOVITRUM$$69$DY$$M$Y$$$20240716$$CN$CO$CO
240976521$24097652$1$I$$20240711$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007325$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240976531$24097653$1$I$$20240628$20240716$20240716$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05879$LUPIN$$$$$$Y$$$20240716$$CN$US$US
240976541$24097654$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49159$$FDA-CTU$$19$YR$$M$N$$$20240716$N$$US$
240976551$24097655$1$I$$20240715$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039906$BOEHRINGER INGELHEIM$$$$$$Y$$$20240716$$MD$US$US
240976561$24097656$1$I$$20240712$20240716$20240716$PER$$NVSC2024US146414$NOVARTIS$$$$$$Y$$$20240716$$MD$US$US
240976571$24097657$1$I$$20240709$20240716$20240716$EXP$$US-FreseniusKabi-FK202411151$FRESENIUS KABI$Xu E, Thomas S, Habibi B. Intrathecal Methotrexate-Induced Lumbosacral Polyradiculopathy: A Case Report. Pain Medicine Case Reports. 2024 Jan;8(1): 31-35. doi:https://www.painmedicine-casereports.com/current/pdf?article=NzEx+journal=50.$69$YR$E$F$Y$$$20240716$$MD$US$US
240976582$24097658$2$F$$20240719$20240716$20240812$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06835$LUPIN$$$$$$Y$$$20240812$$CN$US$US
240976591$24097659$1$I$20240201$20240711$20240716$20240716$EXP$$JP-AstraZeneca-2024A159735$ASTRAZENECA$$70$YR$$F$Y$$$20240716$$HP$JP$
240976601$24097660$1$I$$20240705$20240716$20240716$EXP$$IT-ROCHE-3388374$ROCHE$Canino F, Barbolini M, De Giorgi U, Dominici M, Gianni L, Moscetti L, Omarini C, Zamagn C, Molinaro A, Antonelli G, Baglio F, Martinelli G, Natalizio S, Ponzoni O and Piacentini F. Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial [Abstract number: P120]. Doi:10.1016/S0960-9776(23)00237-0. Breast 2023 Apr;68:S60-.$$$$$Y$$$20240716$$HP$IT$IT
240976611$24097661$1$I$20231101$20240708$20240716$20240716$EXP$$RO-AstraZeneca-2024A160286$ASTRAZENECA$$52$YR$$F$Y$95$KG$20240716$$MD$RO$
240976621$24097662$1$I$$20240708$20240716$20240716$EXP$$CA-AstraZeneca-2024A156404$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$CA$
240976631$24097663$1$I$$20240712$20240716$20240716$EXP$$BR-AstraZeneca-2024A161218$ASTRAZENECA$$$$A$M$Y$$$20240716$$CN$BR$
240976641$24097664$1$I$20240628$20240715$20240715$20240715$DIR$710290$$FDA-CTU$$44$YR$$M$N$$$20240715$N$HP$US$
240976651$24097665$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49158$$FDA-CTU$$65$YR$$F$N$185$LBS$20240716$N$$US$
240976661$24097666$1$I$20240708$20240715$20240715$20240715$DIR$710325$$FDA-CTU$$$$$UNK$N$$$20240715$N$CN$US$
240976671$24097667$1$I$20240715$20240715$20240715$20240715$DIR$710294$$FDA-CTU$$65$YR$$M$N$75.6$KG$20240715$N$CN$US$
240976681$24097668$1$I$$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49160$$FDA-CTU$$$$$F$N$$$20240715$N$HP$US$
240976691$24097669$1$I$20240501$20240711$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007323$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240976701$24097670$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008818$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240716$$CN$US$US
240976711$24097671$1$I$20231001$20231027$20240716$20240716$PER$$US-PERRIGO-23US012564$PERRIGO$$$$A$$Y$$$20240716$$CN$US$US
240976721$24097672$1$I$20231001$20231009$20240716$20240716$PER$$US-PERRIGO-23US011937$PERRIGO$$$$$M$Y$$$20240716$$CN$US$US
240976731$24097673$1$I$$20231125$20240716$20240716$PER$$US-PERRIGO-23US013641$PERRIGO$$$$A$$Y$$$20240716$$CN$US$US
240976741$24097674$1$I$20230701$20230727$20240716$20240716$PER$$US-PERRIGO-23US008642$PERRIGO$$$$A$$Y$$$20240716$$CN$US$US
240976751$24097675$1$I$$20240312$20240716$20240716$PER$$US-PERRIGO-24US002672$PERRIGO$$$$A$$Y$$$20240716$$CN$US$US
240976761$24097676$1$I$20240215$20240318$20240716$20240716$PER$$US-PERRIGO-24US002821$PERRIGO$$46$YR$$F$Y$$$20240716$$CN$US$US
240976771$24097677$1$I$20200401$20230915$20240716$20240716$PER$$US-PERRIGO-23US011101$PERRIGO$$$$$F$Y$$$20240716$$CN$US$US
240976781$24097678$1$I$20230901$20230915$20240716$20240716$PER$$US-PERRIGO-23US011255$PERRIGO$$36$YR$$F$Y$$$20240716$$CN$US$US
240976791$24097679$1$I$20230301$20231117$20240716$20240716$PER$$US-PERRIGO-23US013335$PERRIGO$$56$YR$$M$Y$$$20240716$$CN$US$US
240976801$24097680$1$I$20240424$20240709$20240716$20240716$EXP$GB-MHRA-MED-202407091558048270-FPTQW$GB-ROCHE-10000022178$ROCHE$$$$$M$Y$$$20240716$$MD$GB$GB
240976812$24097681$2$F$20240627$20240807$20240716$20240809$EXP$$US-BIOMARINAP-US-2024-159193$BIOMARIN$$$$$$Y$$$20240809$$CN$US$US
240976821$24097682$1$I$20230701$20240711$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007321$INCYTE$$$$$$Y$$$20240716$$HP$US$US
240976831$24097683$1$I$20240101$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024140142$AMGEN$$63$YR$A$F$Y$$$20240716$$CN$US$US
240976841$24097684$1$I$20240401$20240401$20240716$20240716$PER$$US-PERRIGO-24US003328$PERRIGO$$64$YR$$M$Y$$$20240716$$CN$US$US
240976851$24097685$1$I$$20240419$20240716$20240716$PER$$US-PERRIGO-24US004084$PERRIGO$$$$$M$Y$$$20240716$$CN$US$US
240976861$24097686$1$I$20240712$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112216$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240716$$PH$US$US
240976871$24097687$1$I$20240523$20240711$20240716$20240716$EXP$$US-JNJFOC-20240730724$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240716$$HP$US$US
240976882$24097688$2$F$20240309$20240725$20240716$20240801$EXP$$US-GSK-US2024085021$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$HP$US$US
240976892$24097689$2$F$$20240729$20240716$20240808$EXP$$US-TEVA-VS-3219198$TEVA$Poondru S, Joseph A, Harding JC, Sundaramoorthi H, Mehta-Shah N, Green P, et al. Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy. Case-Rep-Oncol 2022; 15 (3): 918-926.; Poondru S, Joseph A, Harding JC, Sundaramoorthi H, Mehta-Shah N, Green P, et al. Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy. Case-Rep-Oncol 2022; 15 (3): 918-926.; Poondru S, Joseph A, Harding JC, Sundaramoorthi H, Mehta-Shah N, Green P, et al. Adult T-Cell Leukemia-Lymphoma P...$51$YR$$F$Y$$$20240808$$HP$US$US
240976912$24097691$2$F$20240522$20240828$20240716$20240905$EXP$$JP-INCYTE CORPORATION-2024IN007269$INCYTE$$$$$$Y$$$20240905$$MD$JP$JP
240976921$24097692$1$I$$20240703$20240716$20240716$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-20802$SAMSUNG BIOEPIS$$58$YR$A$F$Y$$$20240716$$CN$GB$GB
240976931$24097693$1$I$$20240712$20240716$20240716$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135631$DAIICHI$$$$$F$Y$$$20240716$$CN$US$US
240976942$24097694$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218959$TEVA$Zemel MC, Hughes A, Wong WW. A Tale of Two Chest Tubes, Marijuana Versus Sarcoid. Am-J-Respir-Crit-Care-Med 2024; 209.; Zemel MC, Hughes A, Wong WW. A Tale of Two Chest Tubes, Marijuana Versus Sarcoid. Am-J-Respir-Crit-Care-Med 2024; 209.$27$YR$$M$Y$$$20240805$$HP$US$US
240976951$24097695$1$I$20240101$20240708$20240716$20240716$EXP$$SK-INCYTE CORPORATION-2024IN007254$INCYTE$$$$$$Y$$$20240716$$MD$SK$SK
240976963$24097696$3$F$$20240913$20240716$20240925$EXP$$US-SA-2024SA205574$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240925$$CN$US$US
240976971$24097697$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA206013$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240716$$MD$US$US
240976981$24097698$1$I$20230621$20240715$20240715$20240715$DIR$710265$$FDA-CTU$$36$YR$$M$N$76.5$KG$20240715$Y$CN$US$
240976991$24097699$1$I$20240507$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49094$$FDA-CTU$$22$YR$$F$N$79.9$KG$20240715$N$PH$US$
240977001$24097700$1$I$20240406$20240708$20240716$20240716$EXP$GB-MHRA-MED-202405052145084960-QSPLG$GB-NALPROPION PHARMACEUTICALS INC.-GB-2024CUR003244$CURRAX PHARMACEUTICALS$$45$YR$$M$Y$87$KG$20240716$$CN$GB$GB
240977011$24097701$1$I$$20240708$20240716$20240716$EXP$GB-MHRA-MED-202405141236562230-GKJPN$GB-NALPROPION PHARMACEUTICALS INC.-GB-2024CUR003247$CURRAX PHARMACEUTICALS$$$$$$Y$$$20240716$$PH$GB$GB
240977021$24097702$1$I$20240715$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49111$$FDA-CTU$$91$YR$$M$N$$$20240715$N$$US$
240977031$24097703$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49166$$FDA-CTU$$29$YR$$F$N$220$LBS$20240716$N$$US$
240977041$24097704$1$I$20240510$20240708$20240716$20240716$EXP$GB-MHRA-MED-202405151036542320-KBYGS$GB-NALPROPION PHARMACEUTICALS INC.-GB-2024CUR003245$CURRAX PHARMACEUTICALS$$39$YR$$F$Y$82$KG$20240716$$CN$GB$GB
240977051$24097705$1$I$20240417$20240712$20240716$20240716$EXP$FR-AFSSAPS-PO2024000737$FR-MYLANLABS-2024M1065355$MYLAN$$51$YR$$F$Y$84$KG$20240716$$MD$FR$FR
240977061$24097706$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49162$$FDA-CTU$$72$YR$$M$N$232$LBS$20240716$N$$US$
240977071$24097707$1$I$$20240715$20240716$20240716$EXP$$AU-SANDOZ INC.-SDZ2024AU065327$SANDOZ$$$$$$Y$$$20240716$$HP$AU$AU
240977081$24097708$1$I$20170301$20240710$20240716$20240716$EXP$DE-EMA-DD-20181218-kumarvn_p-140148$DE-MYLANLABS-2024M1065028$MYLAN$$78$YR$$M$Y$84$KG$20240716$$HP$DE$DE
240977092$24097709$2$F$20240706$20240719$20240716$20240725$EXP$$CN-GSK-CN2024APC084149$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$CN$CN
240977101$24097710$1$I$20240201$20240708$20240716$20240716$EXP$FR-AFSSAPS-GR2024000838$FR-INCYTE CORPORATION-2024IN007218$INCYTE$$$$$$Y$$$20240716$$MD$FR$FR
240977112$24097711$2$F$$20240731$20240716$20240810$PER$$US-SA-2024SA204257$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240810$$MD$US$US
240977121$24097712$1$I$20240101$20240712$20240716$20240716$EXP$FR-AFSSAPS-PB2024000773$FR-ABBVIE-5840662$ABBVIE$$52$YR$$F$Y$65$KG$20240716$$PH$FR$FR
240977131$24097713$1$I$20200508$20240712$20240716$20240716$EXP$PL-URPL-1-3694-2020$PL-MYLANLABS-2024M1065488$MYLAN$$63$YR$$F$Y$70$KG$20240716$$MD$PL$PL
240977142$24097714$2$F$$20240705$20240716$20240719$EXP$$BR-ALXN-202407SAM000040BR$ALEXION PHARMACEUTICALS$$34$YR$$M$Y$98$KG$20240719$$CN$BR$BR
240977151$24097715$1$I$$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110904$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240716$$CN$US$US
240977162$24097716$2$F$20240701$20240729$20240716$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109470$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240802$$CN$US$US
240977171$24097717$1$I$20230701$20230727$20240716$20240716$PER$$US-PERRIGO-23US008660$PERRIGO$$$$A$$Y$$$20240716$$CN$US$US
240977181$24097718$1$I$20240627$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49165$$FDA-CTU$$63$YR$$M$N$$$20240715$N$HP$US$
240977201$24097720$1$I$$20240711$20240716$20240716$EXP$$US-AMGEN-USASP2024138658$AMGEN$$$$$F$Y$$$20240716$$CN$US$US
240977211$24097721$1$I$$20240707$20240716$20240716$EXP$$JP-009507513-2407JPN001778J$MERCK$Fujimoto K, Norimura S, Kubo T, Nakagawa Y, Kenzaki K. EP-1435 A Case of Eosinophilic pneumonia in a Triple-negative Breast Cancer after Treatment with Pembrolizumab. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 536$8$DEC$$F$Y$$$20240716$$MD$JP$JP
240977221$24097722$1$I$$20240611$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN006267$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240977231$24097723$1$I$20240606$20240709$20240716$20240716$EXP$$IT-009507513-2407ITA005580$MERCK$$54$YR$$F$Y$52$KG$20240716$$MD$IT$IT
240977241$24097724$1$I$20240701$20240716$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040062$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$$$20240716$$CN$US$US
240977253$24097725$3$F$20240710$20240716$20240716$20240805$PER$$US-AMGEN-USASP2024140811$AMGEN$$87$YR$E$F$Y$$$20240803$$CN$US$US
240977261$24097726$1$I$20240610$20240708$20240716$20240716$EXP$IT-MINISAL02-992921$IT-TEVA-VS-3218599$TEVA$$84$YR$$F$Y$90$KG$20240716$$MD$IT$IT
240977271$24097727$1$I$20240201$20240708$20240716$20240716$EXP$IT-MINISAL02-992875$IT-TEVA-VS-3218714$TEVA$$76$YR$$F$Y$$$20240716$$MD$IT$IT
240977281$24097728$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024138968$AMGEN$$$$$$Y$$$20240716$$HP$US$US
240977292$24097729$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218946$TEVA$Hassan S, Khawam S, Hartfield R, Patel P, Cole R, Goudie MP. Unmasking the Peril of Minoxidil: A Case of Pericardial Effusion Leading to Tamponade in Resistant Hypertension. Am-J-Respir-Crit-Care-Med 2024; 209.; Hassan S, Khawam S, Hartfield R, Patel P, Cole R, Goudie MP. Unmasking the Peril of Minoxidil: A Case of Pericardial Effusion Leading to Tamponade in Resistant Hypertension. Am-J-Respir-Crit-Care-Med 2024; 209.$26$YR$$F$Y$$$20240805$$HP$US$US
240977301$24097730$1$I$20240601$20240712$20240716$20240716$EXP$$JP-PFIZER INC-202400213252$PFIZER$$65$YR$$F$Y$$$20240716$$PH$JP$JP
240977312$24097731$2$F$20240707$20240718$20240716$20240722$EXP$$CN-PFIZER INC-PV202400092716$PFIZER$$90$YR$$M$Y$70$KG$20240722$$HP$CN$CN
240977321$24097732$1$I$20240601$20240712$20240716$20240716$EXP$$BR-ABBVIE-5801511$ABBVIE$$67$YR$$F$Y$$$20240716$$MD$BR$BR
240977342$24097734$2$F$$20240821$20240716$20240827$30DAY$$DK-MYLANLABS-2024M1065437$MYLAN$$$$$$Y$$$20240827$$CN$DK$DK
240977351$24097735$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49169$$FDA-CTU$$54$YR$$F$N$190$LBS$20240716$N$$US$
240977361$24097736$1$I$20240429$20240709$20240716$20240716$EXP$GR-GREOF-202400724$NL-KOWA-24EU001866$KOWA PHARM$$$$$$Y$$$20240716$$HP$NL$GR
240977371$24097737$1$I$20240516$20240715$20240716$20240716$EXP$FR-AFSSAPS-LL2024001295$NVSC2024FR145159$NOVARTIS$$52$YR$$M$Y$84$KG$20240716$$MD$FR$FR
240977382$24097738$2$F$20240101$20240917$20240716$20240926$PER$$US-SA-2024SA205489$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240926$$MD$US$US
240977391$24097739$1$I$20240701$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009559$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240716$$CN$US$US
240977401$24097740$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009471$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240716$$CN$US$US
240977411$24097741$1$I$$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007742$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240716$$CN$US$US
240977421$24097742$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008742$ELI LILLY AND CO$$$$$$Y$$$20240716$$HP$US$US
240977431$24097743$1$I$$20240709$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007436$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240716$$PH$US$US
240977441$24097744$1$I$20240611$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008687$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240716$$MD$US$US
240977451$24097745$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008978$ELI LILLY AND CO$$$$A$F$Y$$$20240716$$CN$US$US
240977461$24097746$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009532$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240716$$CN$US$US
240977471$24097747$1$I$20240709$20240709$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407006465$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240716$$CN$US$US
240977481$24097748$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008663$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240716$$CN$US$US
240977492$24097749$2$F$$20240723$20240716$20240802$EXP$$US-TEVA-VS-3217757$TEVA$Grabie Y, Acharya S, Sadiq W, Rotblat D, Chalhoub MN. Iatrogenic Bilothorax Following Dislodgment of Cholecystostomy Tube. Am-J-Respir-Crit-Care-Med 2024; 209.; Grabie Y, Acharya S, Sadiq W, Rotblat D, Chalhoub MN. Iatrogenic Bilothorax Following Dislodgment of Cholecystostomy Tube. Am-J-Respir-Crit-Care-Med 2024; 209.$83$YR$$M$Y$$$20240802$$HP$US$US
240977501$24097750$1$I$$20240708$20240716$20240716$PER$$US-ROCHE-10000019600$ROCHE$Leblanc F, Francis R, Grier D, Myers K, Shimamura A, Pommert L. A case of co-occurring acutemyeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adultwith Shwachman-Diamond syndrome (Letter to the Editor). Pediatric Blood + Cancer. 2024;71 (8):1-4. doi:10.1002/pbc.31137.$27$YR$A$M$Y$$$20240716$$HP$US$US
240977511$24097751$1$I$20240101$20240711$20240716$20240716$EXP$$US-ABBVIE-5838656$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240977521$24097752$1$I$20240101$20240712$20240716$20240716$EXP$$CA-ABBVIE-5839971$ABBVIE$$44$YR$$F$Y$$$20240716$$CN$CA$CA
240977531$24097753$1$I$$20240705$20240716$20240716$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-107501$BRISTOL MYERS SQUIBB$Zaccheddu E, Zappu A, Barella S, Clemente MG, Orecchia V, Pilia MP, et al. Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept. British Journal of Haematology 2024;204(6):2505-7. doi:10.1111/bjh.19480.$28$YR$A$F$Y$$$20240716$$HP$IT$IT
240977561$24097756$1$I$20240619$20240710$20240716$20240716$EXP$IT-MINISAL02-994362$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-110998$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240716$$PH$IT$IT
240977571$24097757$1$I$20240711$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112080$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240716$$CN$US$US
240977582$24097758$2$F$$20240717$20240716$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112806$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240718$$CN$US$US
240977591$24097759$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204122$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240716$$MD$US$US
240977601$24097760$1$I$$20200211$20240716$20240716$EXP$$US-AstraZeneca-2020SE22855$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240977611$24097761$1$I$$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159152$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240977623$24097762$3$F$$20240912$20240716$20240918$EXP$$US-AstraZeneca-2024A155275$ASTRAZENECA$$71$YR$$F$Y$78.9$KG$20240918$$MD$US$
240977631$24097763$1$I$$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49168$$FDA-CTU$$$$$M$N$$$20240715$N$HP$US$
240977641$24097764$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49172$$FDA-CTU$$49$YR$$M$N$$$20240716$N$$US$
240977651$24097765$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49171$$FDA-CTU$$59$YR$$F$N$200$LBS$20240716$N$$US$
240977681$24097768$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49174$$FDA-CTU$$52$YR$$F$N$$$20240716$N$$US$
240977691$24097769$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A156951$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240977701$24097770$1$I$$20200508$20240716$20240716$EXP$$US-AstraZeneca-2020SE63152$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240977711$24097771$1$I$20240706$20240710$20240716$20240716$EXP$$UY-009507513-2407URY009094$MERCK$$30$YR$$F$Y$$$20240716$$MD$UY$UY
240977721$24097772$1$I$20240501$20240705$20240716$20240716$EXP$GB-MHRA-MED-202405161222545590-CYPST$GB-BAUSCH-BL-2024-010774$BAUSCH AND LOMB$$88$YR$$$Y$$$20240716$$CN$GB$GB
240977731$24097773$1$I$$20240709$20240716$20240716$EXP$$NVSC2024TN144816$NOVARTIS$$70$YR$$F$Y$$$20240716$$MD$TN$TN
240977741$24097774$1$I$$20240709$20240716$20240716$EXP$$CN-TAKEDA-2024TUS070631$TAKEDA$$$$$M$Y$$$20240716$$CN$CN$CN
240977751$24097775$1$I$$20240708$20240716$20240716$EXP$$US-JNJFOC-20240720096$JOHNSON AND JOHNSON$$60$YR$A$F$Y$63.56$KG$20240716$$CN$US$US
240977761$24097776$1$I$20240613$20240709$20240716$20240716$PER$$US-JNJFOC-20240727079$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$HP$US$US
240977772$24097777$2$F$20240712$20240716$20240716$20240718$PER$$US-PFIZER INC-202400213937$PFIZER$$72$YR$$F$Y$81.65$KG$20240718$$CN$US$US
240977781$24097778$1$I$20240517$20240715$20240716$20240716$PER$$US-PFIZER INC-PV202400065288$PFIZER$$47$YR$$F$Y$$$20240716$$HP$US$US
240977792$24097779$2$F$$20240729$20240716$20240801$PER$$US-PFIZER INC-202400214534$PFIZER$$86$YR$$M$Y$86.18$KG$20240801$$HP$US$US
240977801$24097780$1$I$20240710$20240713$20240716$20240716$PER$$US-PFIZER INC-202400214399$PFIZER$$61$YR$$F$Y$$$20240716$$HP$US$US
240977811$24097781$1$I$20240712$20240713$20240716$20240716$PER$$US-PFIZER INC-202400213762$PFIZER$$$$E$M$Y$$$20240716$$CN$US$US
240977821$24097782$1$I$20240711$20240713$20240716$20240716$PER$$US-PFIZER INC-202400213761$PFIZER$$32$YR$$M$Y$$$20240716$$CN$US$US
240977831$24097783$1$I$$20240715$20240716$20240716$PER$$US-PFIZER INC-PV202400092916$PFIZER$$$$$$Y$$$20240716$$HP$US$US
240977851$24097785$1$I$$20240712$20240716$20240716$PER$$PR-PFIZER INC-202400214485$PFIZER$$43$YR$$F$Y$$$20240716$$HP$PR$PR
240977861$24097786$1$I$20240711$20240715$20240716$20240716$PER$$US-PFIZER INC-202400215067$PFIZER$$69$YR$$F$Y$56.7$KG$20240716$$CN$US$US
240977871$24097787$1$I$20240712$20240715$20240716$20240716$PER$$US-PFIZER INC-202400215792$PFIZER$$78$YR$$F$Y$$$20240716$$CN$US$US
240977881$24097788$1$I$20240711$20240713$20240716$20240716$PER$$US-PFIZER INC-202400214409$PFIZER$$38$YR$$F$Y$$$20240716$$CN$US$US
240977891$24097789$1$I$$20240715$20240716$20240716$PER$$US-PFIZER INC-PV202400053283$PFIZER$$68$YR$$F$Y$$$20240716$$HP$US$US
240977901$24097790$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400215327$PFIZER$$$$$M$Y$$$20240716$$CN$US$US
240977911$24097791$1$I$20140101$20240714$20240716$20240716$PER$$US-PFIZER INC-PV202400092346$PFIZER$$60$YR$$F$Y$$$20240716$$CN$US$US
240977921$24097792$1$I$20240715$20240715$20240716$20240716$PER$$US-PFIZER INC-202400215126$PFIZER$$70$YR$$F$Y$$$20240716$$CN$US$US
240977931$24097793$1$I$$20240715$20240716$20240716$PER$$US-PFIZER INC-202400216134$PFIZER$$$$E$F$Y$$$20240716$$CN$US$US
240977941$24097794$1$I$$20240715$20240716$20240716$PER$$US-PFIZER INC-202400215618$PFIZER$$35$YR$$F$Y$$$20240716$$HP$US$US
240977951$24097795$1$I$20240711$20240713$20240716$20240716$PER$$US-PFIZER INC-202400214351$PFIZER$$62$YR$$F$Y$$$20240716$$CN$US$US
240977963$24097796$3$F$$20240819$20240716$20240821$PER$$US-PFIZER INC-PV202400092614$PFIZER$$58$YR$$F$Y$$$20240821$$HP$US$US
240977971$24097797$1$I$$20240715$20240716$20240716$PER$$US-PFIZER INC-PV202400092835$PFIZER$$45$YR$$F$Y$$$20240716$$CN$US$US
240977981$24097798$1$I$20240712$20240714$20240716$20240716$PER$$US-PFIZER INC-202400214038$PFIZER$$51$YR$$M$Y$$$20240716$$CN$US$US
240977991$24097799$1$I$$20240715$20240716$20240716$PER$$US-PFIZER INC-PV202400092938$PFIZER$$85$YR$$F$Y$$$20240716$$HP$US$US
240978001$24097800$1$I$20240713$20240713$20240716$20240716$PER$$US-PFIZER INC-202400214367$PFIZER$$$$E$F$Y$$$20240716$$CN$US$US
240978011$24097801$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400214549$PFIZER$$19$YR$$F$Y$$$20240716$$HP$US$US
240978022$24097802$2$F$20240711$20240718$20240716$20240722$PER$$US-PFIZER INC-202400214111$PFIZER$$63$YR$$F$Y$$$20240722$$CN$US$US
240978031$24097803$1$I$20240712$20240713$20240716$20240716$PER$$US-PFIZER INC-202400214319$PFIZER$$76$YR$$F$Y$$$20240716$$CN$US$US
240978041$24097804$1$I$20240710$20240713$20240716$20240716$PER$$US-PFIZER INC-202400214004$PFIZER$$75$YR$$F$Y$$$20240716$$CN$US$US
240978051$24097805$1$I$$20240715$20240716$20240716$PER$$US-PFIZER INC-PV202400092656$PFIZER$$46$YR$$F$Y$$$20240716$$MD$US$US
240978062$24097806$2$F$20240712$20240731$20240716$20240805$PER$$US-PFIZER INC-202400214434$PFIZER$$75$YR$$F$Y$63.946$KG$20240805$$CN$US$US
240978072$24097807$2$F$20240712$20240809$20240716$20240813$PER$$US-PFIZER INC-202400215620$PFIZER$$70$YR$$F$Y$$$20240813$$CN$US$US
240978083$24097808$3$F$20240715$20240725$20240716$20240730$PER$$US-PFIZER INC-PV202400092870$PFIZER$$84$YR$$F$Y$$$20240730$$HP$US$US
240978093$24097809$3$F$$20240801$20240716$20240805$PER$$US-PFIZER INC-PV202400092618$PFIZER$$65$YR$$F$Y$$$20240805$$HP$US$US
240978101$24097810$1$I$20240301$20240711$20240716$20240716$PER$$US-PFIZER INC-202400213575$PFIZER$$66$YR$$F$Y$$$20240716$$HP$US$US
240978111$24097811$1$I$$20240715$20240716$20240716$PER$$US-PFIZER INC-202400215517$PFIZER$$64$YR$$M$Y$$$20240716$$CN$US$US
240978124$24097812$4$F$$20240912$20240716$20240918$PER$$US-PFIZER INC-PV202400092814$PFIZER$$52$YR$$F$Y$$$20240918$$HP$US$US
240978141$24097814$1$I$$20240715$20240716$20240716$PER$$US-PFIZER INC-PV202400092797$PFIZER$$76$YR$$F$Y$$$20240716$$HP$US$US
240978151$24097815$1$I$$20240714$20240716$20240716$PER$$US-PFIZER INC-202400214431$PFIZER$$$$A$$Y$$$20240716$$CN$US$US
240978161$24097816$1$I$20240101$20240630$20240716$20240716$EXP$$US-ABBVIE-5840941$ABBVIE$$$$$$Y$$$20240716$$CN$US$US
240978172$24097817$2$F$$20240715$20240716$20240717$PER$$US-PFIZER INC-202400215392$PFIZER$$53$YR$$F$Y$$$20240717$$PH$US$US
240978182$24097818$2$F$$20240812$20240716$20240814$PER$$US-PFIZER INC-PV202400021593$PFIZER$$61$YR$$F$Y$$$20240814$$HP$US$US
240978194$24097819$4$F$$20240719$20240716$20240723$PER$$US-PFIZER INC-202400215185$PFIZER$$68$YR$$F$Y$65.77$KG$20240723$$CN$US$US
240978211$24097821$1$I$20240710$20240711$20240716$20240716$PER$$US-BAUSCH-BL-2024-010622$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240716$$CN$US$US
240978221$24097822$1$I$20240122$20240708$20240716$20240716$EXP$FR-AFSSAPS-TO2024000936$FR-Eisai-EC-2024-169724$EISAI$$70$YR$E$F$Y$55$KG$20240716$$PH$FR$FR
240978231$24097823$1$I$20240629$20240701$20240716$20240716$EXP$$VN-FreseniusKabi-FK202410329$FRESENIUS KABI$$$$$F$Y$$$20240716$$MD$VN$VN
240978241$24097824$1$I$20231004$20240701$20240716$20240716$EXP$$US-COOPERSURGICAL, INC.-2024CPS002086$COOPERSURGICAL$$$$$F$Y$$$20240716$$LW$US$US
240978251$24097825$1$I$20230926$20240701$20240716$20240716$EXP$$US-COOPERSURGICAL, INC.-2024CPS002082$COOPERSURGICAL$$$$$F$Y$$$20240716$$LW$US$US
240978261$24097826$1$I$$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024138138$AMGEN$$$$$$Y$$$20240716$$PH$US$US
240978271$24097827$1$I$$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024138094$AMGEN$$$$$$Y$$$20240716$$PH$US$US
240978281$24097828$1$I$$20240701$20240716$20240716$EXP$$JP-MEDEXUS PHARMA, INC.-2024MED00302$MEDEXUS PHARMA$Iimori M., Sonomura K., Ueyama Y., Oobayashi Y., Adachi H., Nakayama M. Minimal Change Nephrotic Syndrome Secondary to Methotrexate-associated Hodgkin Lymphoma.. Intern. Med. 2024;63(12):1771-1776$64$YR$$M$Y$80$KG$20240716$$HP$JP$JP
240978291$24097829$1$I$20240101$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139162$AMGEN$$$$$M$Y$$$20240716$$MD$US$US
240978301$24097830$1$I$$20240709$20240716$20240716$EXP$$US-ABBVIE-5840442$ABBVIE$$$$$F$Y$$$20240716$$MD$US$US
240978311$24097831$1$I$$20240715$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010804$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240716$$CN$CA$CA
240978321$24097832$1$I$20240701$20240710$20240716$20240716$EXP$$CN-AMGEN-CHNSP2024136636$AMGEN$$61$YR$A$M$Y$41$KG$20240716$$HP$CN$CN
240978341$24097834$1$I$$20240712$20240716$20240716$EXP$$US-GSK-US2024087668$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$HP$US$US
240978351$24097835$1$I$$20240703$20240716$20240716$PER$$US-Eisai-EC-2024-169502$EISAI$$$$$$Y$$$20240716$$MD$US$US
240978361$24097836$1$I$$20240715$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010805$BAUSCH AND LOMB$$61$YR$$F$Y$$$20240716$$CN$CA$CA
240978371$24097837$1$I$$20240715$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010813$BAUSCH AND LOMB$$54$YR$$F$Y$$$20240716$$CN$CA$CA
240978381$24097838$1$I$$20240715$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010787$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240716$$HP$CA$CA
240978391$24097839$1$I$$20240712$20240716$20240716$EXP$$US-SANDOZ INC.-SDZ2024US065088$SANDOZ$$$$$F$Y$$$20240716$$CN$US$US
240978401$24097840$1$I$20240613$20240716$20240716$20240716$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040053$BOEHRINGER INGELHEIM$$92$YR$E$M$Y$$$20240716$$CN$US$US
240978411$24097841$1$I$$20240706$20240716$20240716$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-02561$AMNEAL$Jingami N, Cho K, Nitta T, Takatani M, Kobayashi K, et al.. Case report: Consecutive hyperbaric oxygen therapy for delayed post-hypoxic leukoencephalopathy resulting from CHANTER syndrome caused by opioid intoxication. Front Med. 2024;11$$$$$Y$$$20240716$$HP$JP$JP
240978421$24097842$1$I$20240101$20240712$20240716$20240716$EXP$$US-ABBVIE-5838979$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240978431$24097843$1$I$$20240715$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010816$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240716$$CN$CA$CA
240978441$24097844$1$I$$20240715$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010814$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240716$$CN$CA$CA
240978451$24097845$1$I$$20240715$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010817$BAUSCH AND LOMB$$59$YR$$F$Y$$$20240716$$CN$CA$CA
240978461$24097846$1$I$$20240715$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010825$BAUSCH AND LOMB$$79$YR$$F$Y$$$20240716$$CN$CA$CA
240978471$24097847$1$I$$20240715$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010826$BAUSCH AND LOMB$$85$YR$$M$Y$$$20240716$$CN$CA$CA
240978481$24097848$1$I$$20240715$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010823$BAUSCH AND LOMB$$83$YR$$$Y$$$20240716$$CN$CA$CA
240978491$24097849$1$I$$20240715$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010827$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240716$$CN$CA$CA
240978501$24097850$1$I$$20240702$20240716$20240716$PER$$US-ROCHE-10000018761$ROCHE$$$$C$$Y$$$20240716$$PH$US$US
240978521$24097852$1$I$20231122$20240229$20240716$20240716$EXP$IT-MINISAL02-970415$IT-TEVA-VS-3167028$TEVA$$58$YR$$F$Y$$$20240716$$MD$IT$IT
240978531$24097853$1$I$$20240715$20240716$20240716$EXP$$CA-ORGANON-O2407CAN001303$ORGANON$$15$YR$$F$Y$54$KG$20240716$$HP$CA$CA
240978551$24097855$1$I$20210201$20240708$20240716$20240716$EXP$$DE-OTSUKA-2024_014197$OTSUKA$$$$$F$Y$$$20240716$$HP$DE$DE
240978561$24097856$1$I$$20240617$20240716$20240716$PER$$US-AstraZeneca-2024A141127$ASTRAZENECA$$$$$M$Y$$$20240716$$MD$US$
240978571$24097857$1$I$20200427$20200602$20240716$20240716$EXP$$AU-AstraZeneca-2020SE73625$ASTRAZENECA$$2697$WK$$F$Y$$$20240716$$CN$AU$
240978581$24097858$1$I$20231214$20240709$20240716$20240716$EXP$$FR-AstraZeneca-2024A160020$ASTRAZENECA$$1$WK$$F$Y$$$20240716$$MD$FR$
240978592$24097859$2$F$20240610$20240826$20240716$20240830$EXP$$US-AstraZeneca-2024A159424$ASTRAZENECA$$33161$DY$$F$Y$$$20240830$$MD$US$
240978601$24097860$1$I$20230329$20240710$20240716$20240716$EXP$FR-AFSSAPS-AN2024000853$FR-MYLANLABS-2024M1064788$MYLAN$$73$YR$$M$Y$105.9$KG$20240716$$PH$FR$FR
240978611$24097861$1$I$$20200630$20240716$20240716$EXP$$US-AstraZeneca-2020SE83546$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240978621$24097862$1$I$20231211$20240709$20240716$20240716$EXP$$FR-AstraZeneca-2024A160177$ASTRAZENECA$$2$MON$$M$Y$6.2$KG$20240716$$MD$FR$
240978631$24097863$1$I$$20240708$20240716$20240716$EXP$$CA-AstraZeneca-2024A159395$ASTRAZENECA$$81$YR$$M$Y$$$20240716$$MD$CA$
240978642$24097864$2$F$$20240730$20240716$20240806$EXP$$BR-TAKEDA-2024TUS071714$TAKEDA$$29$YR$$$Y$$$20240806$$CN$BR$BR
240978651$24097865$1$I$$20240709$20240716$20240716$EXP$$US-OTSUKA-2024_019573$OTSUKA$$$$$M$Y$$$20240716$$HP$US$US
240978662$24097866$2$F$20240601$20240822$20240716$20240826$PER$$US-ROCHE-10000026241$ROCHE$$23$YR$A$M$Y$83.91$KG$20240826$$CN$US$US
240978671$24097867$1$I$20240628$20240712$20240716$20240716$PER$$US-ROCHE-10000027270$ROCHE$$35$YR$A$M$Y$$$20240716$$CN$US$US
240978691$24097869$1$I$$20240708$20240716$20240716$EXP$$AU-JNJFOC-20240721392$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240716$$CN$AU$AU
240978702$24097870$2$F$$20240723$20240716$20240723$PER$$US-JNJFOC-20240735393$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
240978711$24097871$1$I$$20240715$20240716$20240716$PER$$US-ROCHE-10000027129$ROCHE$$$$E$M$Y$$$20240716$$CN$US$US
240978721$24097872$1$I$20240630$20240715$20240716$20240716$PER$$US-ROCHE-10000027357$ROCHE$$1$YR$I$M$Y$$$20240716$$CN$US$US
240978731$24097873$1$I$$20240706$20240716$20240716$EXP$$DE-AMNEAL PHARMACEUTICALS-2024-AMRX-02562$AMNEAL$Solarino B, RieBelmann B, Buschmann C.T, Tsokos M.. Multidrug poisoning involving nicotine and tramadol. Forensic Sci Int.. 2010;194:1-3:e17-e19$46$YR$$M$Y$$$20240716$$HP$DE$DE
240978741$24097874$1$I$$20240715$20240716$20240716$PER$$US-ROCHE-10000026945$ROCHE$$$$T$M$Y$$$20240716$$CN$US$US
240978751$24097875$1$I$$20240701$20240716$20240716$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06639$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240716$$MD$US$US
240978762$24097876$2$F$20220526$20240827$20240716$20240903$EXP$$US-OTSUKA-2024_019649$OTSUKA$$33$YR$$F$Y$86.2$KG$20240903$$MD$US$US
240978771$24097877$1$I$$20240701$20240716$20240716$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06638$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240716$$MD$US$US
240978793$24097879$3$F$$20240814$20240716$20240819$30DAY$$CA-PFIZER INC-202400207752$PFIZER$$$$$$Y$$$20240819$$HP$CA$CA
240978801$24097880$1$I$$20240710$20240716$20240716$PER$$US-PFIZER INC-202400211049$PFIZER$$81$YR$$M$Y$$$20240716$$CN$US$US
240978811$24097881$1$I$$20240711$20240716$20240716$EXP$$US-PFIZER INC-202400213811$PFIZER$$52$YR$$F$Y$$$20240716$$MD$US$US
240978842$24097884$2$F$20220911$20240730$20240716$20240801$EXP$FR-AFSSAPS-CN20221837$FR-PFIZER INC-2023SGN09908$PFIZER$$78$YR$$F$Y$55$KG$20240801$$MD$FR$FR
240978852$24097885$2$F$$20240708$20240716$20240718$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06655$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240718$$HP$US$US
240978861$24097886$1$I$$20240712$20240716$20240716$PER$$NVSC2024US146423$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240978871$24097887$1$I$20240501$20240705$20240716$20240716$EXP$$US-ABBVIE-5840152$ABBVIE$$86$YR$$F$Y$$$20240716$$MD$US$US
240978881$24097888$1$I$$20240711$20240716$20240716$EXP$$US-OTSUKA-2024_019644$OTSUKA$$$$$M$Y$$$20240716$$HP$US$US
240978892$24097889$2$F$20240706$20240722$20240716$20240723$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010729$JAZZ$$30$YR$$M$Y$$$20240723$$HP$US$US
240978901$24097890$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49170$$FDA-CTU$$56$YR$$M$N$$$20240716$N$$US$
240978911$24097891$1$I$20240429$20240710$20240716$20240716$EXP$GR-GREOF-202400724$GR-MYLANLABS-2024M1064979$MYLAN$$70$YR$$F$Y$85$KG$20240716$$MD$GR$GR
240978923$24097892$3$F$$20240822$20240716$20240828$EXP$$JP-009507513-2407JPN004590$MERCK$Fujimoto T, Sugino Y, Soya K, Kohashiguchi K, Higashino S, Uwamori F, et al.. Resumption of Enfortumab Vedotin Supported by Diagnosis of a Late- Onset Immune-Related Adverse Event in Metastatic Urothelial Carcinoma : A Case Report.. Hinyokika kiyo. Acta urologica Japonica.. 2024;70(6):161-6$71$YR$$M$Y$$$20240828$$HP$JP$JP
240978931$24097893$1$I$$20240711$20240716$20240716$EXP$$CN-MYLANLABS-2024M1065510$MYLAN$$$$$$Y$$$20240716$$HP$CN$CN
240978943$24097894$3$F$20240714$20240717$20240716$20240723$PER$$US-AMGEN-USASP2024140138$AMGEN$$80$YR$E$M$Y$$$20240723$$PH$US$US
240978951$24097895$1$I$$20240701$20240716$20240716$EXP$$US-TEVA-VS-3219086$TEVA$Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. Rheumatology 2024; 63 (5): 1291-1296.; Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, et al. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease. Rheumatology 2024; 63 (5): 1291-1296.$68$YR$$M$Y$$$20240716$$HP$US$US
240978961$24097896$1$I$20240104$20240708$20240716$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-112676$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240716$$MD$CA$CA
240978971$24097897$1$I$20240417$20240708$20240716$20240716$EXP$ES-AEMPS-1538599$ES-TEVA-VS-3218534$TEVA$$65$YR$$M$Y$$$20240716$$MD$ES$ES
240978981$24097898$1$I$$20240711$20240716$20240716$EXP$$US-JNJFOC-20240732076$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$HP$US$US
240978991$24097899$1$I$$20240711$20240716$20240716$EXP$$US-JNJFOC-20240729283$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240716$$CN$US$US
240979001$24097900$1$I$20240119$20240703$20240716$20240716$EXP$$PH-TEVA-VS-3218738$TEVA$$85$YR$$F$Y$$$20240716$$CN$PH$PH
240979011$24097901$1$I$$20240710$20240716$20240716$EXP$$CA-TAKEDA-2024TUS071151$TAKEDA$$$$$M$Y$$$20240716$$CN$CA$CA
240979031$24097903$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA204754$SANOFI AVENTIS$$$$A$$Y$$$20240716$$CN$US$US
240979041$24097904$1$I$20240706$20240708$20240716$20240716$PER$$US-SA-2024SA204325$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240716$$MD$US$US
240979051$24097905$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA205829$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240716$$MD$US$US
240979061$24097906$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA205854$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240716$$MD$US$US
240979071$24097907$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA195358$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240716$$MD$US$US
240979081$24097908$1$I$$20240708$20240716$20240716$PER$$US-SA-2024SA200372$SANOFI AVENTIS$$$$A$M$Y$68.946$KG$20240716$$MD$US$US
240979091$24097909$1$I$$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49161$$FDA-CTU$$$$$F$N$$$20240715$N$HP$US$
240979102$24097910$2$F$20240601$20240725$20240716$20240803$PER$$US-SA-2024SA204277$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240803$$MD$US$US
240979112$24097911$2$F$$20240816$20240716$20240816$30DAY$$US-PFIZER INC-202400206297$PFIZER$$12$YR$$M$Y$$$20240816$$CN$US$US
240979131$24097913$1$I$20240709$20240709$20240716$20240716$EXP$$US-APELLIS-2024-APL-0000446$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
240979141$24097914$1$I$20240101$20240711$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040071$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240716$$CN$US$US
240979151$24097915$1$I$20240101$20240703$20240716$20240716$PER$$US-Eisai-EC-2024-169503$EISAI$$77$YR$E$F$Y$$$20240716$$MD$US$US
240979161$24097916$1$I$20240501$20240708$20240716$20240716$EXP$FR-AFSSAPS-GR2024000801$FR-TEVA-VS-3219059$TEVA$$79$YR$$M$Y$$$20240716$$PH$FR$FR
240979171$24097917$1$I$$20240709$20240716$20240716$EXP$$US-PERRIGO-24US006628$PERRIGO$Kwon D, Seu M, Barnes S. Mind the Anion Gap: 5-Oxoproline-Induced High Anion Gap Metabolic Acidosis in End-Stage Renal Disease. Cureus. 2024;16(5):e61328. DOI: 10.7759/cureus.61328.$74$YR$$F$Y$$$20240716$$MD$US$US
240979181$24097918$1$I$20240615$20240708$20240716$20240716$EXP$PT-INFARMED-R202406-547$PT-TEVA-VS-3218762$TEVA$$42$YR$$F$Y$$$20240716$$PH$PT$PT
240979191$24097919$1$I$20240101$20240709$20240716$20240716$PER$$US-ABBVIE-5836358$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240979201$24097920$1$I$$20240711$20240716$20240716$PER$$US-JNJFOC-20240729810$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$HP$US$US
240979212$24097921$2$F$$20240923$20240716$20240930$EXP$$US-JNJFOC-20240731708$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240930$$HP$US$US
240979222$24097922$2$F$20240607$20240716$20240716$20240724$PER$$US-ALXN-202407USA000464US$ALEXION PHARMACEUTICALS$$54$YR$$F$Y$$$20240724$$CN$US$US
240979233$24097923$3$F$$20240729$20240716$20240806$EXP$$CA-AstraZeneca-2024A150400$ASTRAZENECA$$56$YR$$M$Y$$$20240806$$CN$CA$
240979241$24097924$1$I$$20201005$20240716$20240716$EXP$$US-AstraZeneca-2020SF30605$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240979251$24097925$1$I$$20240711$20240716$20240716$EXP$$CA-AstraZeneca-2024A094719$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$CA$
240979262$24097926$2$F$$20240710$20240716$20240718$EXP$$CA-AstraZeneca-2023A234170$ASTRAZENECA$$$$$M$Y$$$20240718$$MD$CA$
240979271$24097927$1$I$20240131$20240709$20240716$20240716$EXP$$FR-AstraZeneca-2024A160143$ASTRAZENECA$$1$MON$$M$Y$3.9$KG$20240716$$MD$FR$
240979281$24097928$1$I$20200826$20200908$20240716$20240716$EXP$$US-AstraZeneca-2020SF04305$ASTRAZENECA$$61$YR$$M$Y$81.6$KG$20240716$$MD$US$
240979291$24097929$1$I$$20210414$20240716$20240716$EXP$$US-AstraZeneca-2021A324658$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240979303$24097930$3$F$20240714$20240911$20240716$20240918$EXP$$US-GSK-US2024084995$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$US$US
240979312$24097931$2$F$$20240813$20240716$20240821$EXP$$US-AstraZeneca-2024A156373$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
240979321$24097932$1$I$$20240711$20240716$20240716$EXP$$CA-AstraZeneca-2024A108181$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$CA$
240979331$24097933$1$I$$20240710$20240716$20240716$EXP$GR-GREOF-202400715$GR-MYLANLABS-2024M1065163$MYLAN$$64$YR$$F$Y$$$20240716$$MD$GR$GR
240979341$24097934$1$I$20201008$20201102$20240716$20240716$EXP$$US-AstraZeneca-2020SF44665$ASTRAZENECA$$3047$WK$$F$Y$$$20240716$$CN$US$
240979371$24097937$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49173$$FDA-CTU$$47$YR$$F$N$$$20240716$N$$US$
240979381$24097938$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49175$$FDA-CTU$$39$YR$$F$N$$$20240716$N$$US$
240979392$24097939$2$F$$20240729$20240716$20240808$EXP$$US-TEVA-VS-3219221$TEVA$Manjunath S, Khandhar PB. Atrial Fibrillation With Rapid Ventricular Response in Pediatric Lupus Carditis Following Pulse Steroid Therapy. Am-J-Respir-Crit-Care-Med 2024; 209.; Manjunath S, Khandhar PB. Atrial Fibrillation With Rapid Ventricular Response in Pediatric Lupus Carditis Following Pulse Steroid Therapy. Am-J-Respir-Crit-Care-Med 2024; 209.$16$YR$$M$Y$$$20240808$$HP$US$US
240979403$24097940$3$F$20230701$20240801$20240716$20240807$EXP$$NVSC2024CA144637$NOVARTIS$$28$YR$$F$Y$78.9$KG$20240807$$MD$CA$CA
240979411$24097941$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49188$$FDA-CTU$$54$YR$$M$N$$$20240716$N$$US$
240979423$24097942$3$F$20240701$20240731$20240716$20240802$30DAY$$US-PFIZER INC-202400210032$PFIZER$$15$YR$$M$Y$50.794$KG$20240802$$CN$US$US
240979431$24097943$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49187$$FDA-CTU$$74$YR$$F$N$190$LBS$20240716$N$$US$
240979441$24097944$1$I$20240701$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49181$$FDA-CTU$$70$YR$$F$N$54.5$KG$20240716$N$PH$US$
240979454$24097945$4$F$20240712$20240822$20240716$20240822$30DAY$$PT-PFIZER INC-PV202400092307$PFIZER$$$$A$F$Y$$$20240822$$MD$PT$PT
240979461$24097946$1$I$20240501$20240711$20240716$20240716$30DAY$$AR-PFIZER INC-202400213562$PFIZER$$8$YR$$F$Y$$$20240716$$CN$AR$AR
240979471$24097947$1$I$20240601$20240708$20240716$20240716$PER$$US-SA-2024SA203980$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240716$$MD$US$US
240979481$24097948$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA201518$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240716$$MD$US$US
240979491$24097949$1$I$20240621$20240709$20240716$20240716$EXP$$US-AMGEN-USASP2024136676$AMGEN$$54$YR$A$F$Y$$$20240716$$CN$US$US
240979501$24097950$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024138416$AMGEN$$$$$F$Y$$$20240716$$MD$US$US
240979511$24097951$1$I$20240601$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112236$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240716$$CN$US$US
240979521$24097952$1$I$20240601$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111905$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240716$$CN$US$US
240979531$24097953$1$I$20240701$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112604$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240716$$CN$US$US
240979542$24097954$2$F$$20240722$20240716$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112649$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240723$$PH$US$US
240979562$24097956$2$F$20240101$20240906$20240716$20240913$EXP$$US-SECURA BIO, INC.-2024-SECUR-US000069$PAREXEL$$$$$$Y$$$20240913$$CN$US$US
240979571$24097957$1$I$$20240711$20240716$20240716$PER$$US-ABBVIE-5839884$ABBVIE$$$$$$Y$$$20240716$$MD$US$US
240979581$24097958$1$I$20230101$20240709$20240716$20240716$EXP$$NVSC2024CZ144848$NOVARTIS$$78$YR$$F$Y$$$20240716$$MD$CZ$CZ
240979591$24097959$1$I$20240101$20240712$20240716$20240716$EXP$$CA-JNJFOC-20240708953$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240716$$HP$CA$CA
240979602$24097960$2$F$20201207$20240816$20240716$20240827$EXP$$US-BIOGEN-2024BI01272694$BIOGEN$$72$YR$$F$Y$$$20240827$$CN$US$US
240979611$24097961$1$I$$20240426$20240716$20240716$EXP$$IT-ROCHE-3555140$ROCHE$$$$$$Y$$$20240716$$MD$IT$IT
240979631$24097963$1$I$$20240705$20240716$20240716$EXP$$PL-TAKEDA-2024TUS070568$TAKEDA$$72$YR$$M$Y$$$20240716$$HP$PL$PL
240979642$24097964$2$F$20240627$20240731$20240716$20240826$PER$$US-Eisai-EC-2024-169802$EISAI$$73$YR$E$F$Y$46.72$KG$20240826$$HP$US$US
240979651$24097965$1$I$20240601$20240703$20240716$20240716$PER$$US-Eisai-EC-2024-169505$EISAI$$76$YR$E$F$Y$$$20240716$$CN$US$US
240979661$24097966$1$I$20240101$20240711$20240716$20240716$EXP$$US-JNJFOC-20240731729$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240716$$CN$US$US
240979671$24097967$1$I$20230627$20240705$20240716$20240716$EXP$$JP-AMGEN-JPNSP2024114457$AMGEN$$$$$F$Y$$$20240716$$MD$JP$JP
240979682$24097968$2$F$$20240708$20240716$20240722$EXP$$RU-AMGEN-RUSSP2024136429$AMGEN$Zhukova O.V. Therapy of moderate to severe plaque psoriasis. Meditsinskiy Sovet. 2024;18 (2):34-42$47$YR$A$M$Y$$$20240722$$HP$RU$RU
240979692$24097969$2$F$$20240729$20240716$20240806$EXP$$US-TEVA-VS-3219222$TEVA$Ravi S, Ravi SN, Ballam Nagaraj N, Upadhyay H. Acute Respiratory Compromise in the Context of COVID-19 and Gemcitabine. Am-J-Respir-Crit-Care-Med 2024; 209 A5539.; Ravi S, Ravi SN, Ballam Nagaraj N, Upadhyay H. Acute Respiratory Compromise in the Context of COVID-19 and Gemcitabine. Am-J-Respir-Crit-Care-Med 2024; 209 A5539.$48$YR$$F$Y$$$20240806$$HP$US$US
240979701$24097970$1$I$20240601$20240709$20240716$20240716$EXP$$US-GSK-US2024085098$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$US$US
240979711$24097971$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024139681$AMGEN$$$$$$Y$$$20240716$$CN$US$US
240979721$24097972$1$I$$20240711$20240716$20240716$EXP$$US-OTSUKA-2024_019706$OTSUKA$Bartlett AL, Wagner JE, Jones B, Wells S, Sabulski A, Fuller C et.al.. Fanconi anemia neuroinflammatory syndrome: brain lesions and neurologic injury in Fanconi anemia. Blood Advances. 2024;8(12):3027-37$17$YR$$M$Y$$$20240716$$HP$US$US
240979732$24097973$2$F$20240301$20240911$20240716$20240914$EXP$$US-ABBVIE-5750997$ABBVIE$$69$YR$$F$Y$130$KG$20240914$$CN$US$US
240979742$24097974$2$F$20220424$20240717$20240716$20240724$EXP$$CA-GSK-CA2022069338$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$CA$CA
240979752$24097975$2$F$$20240805$20240716$20240812$EXP$$US-GSK-US2024085136$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
240979761$24097976$1$I$$20240712$20240716$20240716$EXP$$CA-PFIZER INC-PV202400092496$PFIZER$$72$YR$$M$Y$$$20240716$$CN$CA$CA
240979781$24097978$1$I$20240501$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008638$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240716$$CN$US$US
240979791$24097979$1$I$20100101$20240712$20240716$20240716$EXP$$RO-TAKEDA-2024TUS071078$TAKEDA$$41$YR$$M$Y$$$20240716$$HP$RO$RO
240979801$24097980$1$I$20240711$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009572$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240716$$CN$US$US
240979811$24097981$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008595$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240716$$CN$US$US
240979821$24097982$1$I$$20240705$20240716$20240716$PER$$US-ALKERMES INC.-ALK-2024-001837$ALKERMES$$46$YR$$M$Y$$$20240716$$HP$US$US
240979831$24097983$1$I$20240714$20240716$20240716$20240716$DIR$710333$$FDA-CTU$$9$YR$$M$N$$$20240716$N$CN$US$
240979841$24097984$1$I$20240618$20240716$20240716$20240716$DIR$710337$$FDA-CTU$$63$YR$$F$N$75.6$KG$20240716$N$CN$US$
240979851$24097985$1$I$$20240716$20240716$20240716$DIR$710349$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
240979861$24097986$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49190$$FDA-CTU$$$$$F$N$$$20240716$N$HP$US$
240979871$24097987$1$I$20240712$20240716$20240716$20240716$DIR$710350$$FDA-CTU$$59$YR$$F$N$$$20240716$N$PH$US$
240979881$24097988$1$I$$20240712$20240716$20240716$PER$$US-BAUSCH-BL-2024-010702$BAUSCH AND LOMB$$$$$F$Y$$$20240716$$CN$US$US
240979891$24097989$1$I$$20240715$20240716$20240716$PER$$US-TAKEDA-2024TUS071650$TAKEDA$$$$$$Y$$$20240716$$CN$US$US
240979902$24097990$2$F$$20240722$20240716$20240726$PER$$US-BAUSCH-BL-2024-010783$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240726$$CN$US$US
240979911$24097991$1$I$20240712$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139121$AMGEN$$$$$M$Y$$$20240716$$PH$US$US
240979921$24097992$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112989$BRISTOL MYERS SQUIBB$$27$YR$A$F$Y$$$20240716$$CN$US$US
240979931$24097993$1$I$$20240711$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112091$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240716$$CN$US$US
240979942$24097994$2$F$$20240705$20240716$20240802$EXP$$TW-BEH-2024175041$CSL BEHRING$$$$N$$Y$$$20240802$$HP$TW$TW
240979951$24097995$1$I$$20240710$20240716$20240716$EXP$$FR-AMGEN-FRASP2024137339$AMGEN$$$$$$Y$$$20240716$$PH$FR$FR
240979961$24097996$1$I$20231203$20240712$20240716$20240716$EXP$FR-AFSSAPS-BS2024000373$FR-ROCHE-10000025261$ROCHE$$29$YR$A$M$Y$77$KG$20240716$$MD$FR$FR
240979971$24097997$1$I$20240711$20240712$20240716$20240716$EXP$$US-GSK-US2024086650$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$CN$US$US
240979981$24097998$1$I$$20210118$20240716$20240716$EXP$$US-AstraZeneca-2021A010144$ASTRAZENECA$$60$YR$$F$Y$$$20240716$$CN$US$
240979991$24097999$1$I$$20240710$20240716$20240716$EXP$$US-009507513-2407USA009041$MERCK$$$$E$$Y$$$20240716$$MD$US$US
240980001$24098000$1$I$$20240709$20240716$20240716$EXP$$JP-AstraZeneca-2024A031976$ASTRAZENECA$Nakamura K, et al.. O79-5 A case in which a patient took olaparib during early pregnancy continued her pregnancy and gave birth. Journal of Japan Society of Perinatal and Neonatal Medicine 2024;60(S1):305.$$$I$M$Y$$$20240716$$MD$JP$
240980011$24098001$1$I$20200905$20200925$20240716$20240716$EXP$$CO-AstraZeneca-2020SF24549$ASTRAZENECA$$27247$DY$$F$Y$$$20240716$$CN$CO$
240980023$24098002$3$F$20240701$20240724$20240716$20240729$EXP$$CA-AstraZeneca-2024A160384$ASTRAZENECA$$25043$DY$$M$Y$$$20240729$$MD$CA$
240980033$24098003$3$F$20230220$20240809$20240716$20240814$EXP$$JP-AstraZeneca-2024A159738$ASTRAZENECA$$89$YR$$F$Y$$$20240814$$MD$JP$
240980041$24098004$1$I$20240711$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159313$ASTRAZENECA$$23552$DY$$M$Y$$$20240716$$CN$US$
240980051$24098005$1$I$$20210928$20240716$20240716$EXP$$US-AstraZeneca-2021A752081$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240980063$24098006$3$F$$20240813$20240716$20240819$EXP$$GB-MYLANLABS-2024M1065713$MYLAN$$$$$M$Y$$$20240819$$CN$GB$GB
240980071$24098007$1$I$20210401$20240705$20240716$20240716$PER$$US-SA-2024SA201446$SANOFI AVENTIS$$13$YR$T$F$Y$34.92$KG$20240716$$MD$US$US
240980081$24098008$1$I$20240705$20240711$20240716$20240716$EXP$$US-ROCHE-10000025036$ROCHE$$65$YR$E$F$Y$75.1$KG$20240716$$CN$US$US
240980091$24098009$1$I$20240704$20240710$20240716$20240716$EXP$$US-ROCHE-10000024145$ROCHE$$70$YR$E$M$Y$$$20240716$$HP$US$US
240980101$24098010$1$I$$20240716$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040064$BOEHRINGER INGELHEIM$$$$$$Y$$$20240716$$CN$US$US
240980111$24098011$1$I$20240521$20240715$20240716$20240716$EXP$GB-MHRA-MED-202407151307249730-KJDNP$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039933$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240716$$HP$GB$GB
240980121$24098012$1$I$$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111110$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240716$$HP$US$US
240980131$24098013$1$I$20220601$20240711$20240716$20240716$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-111597$BRISTOL MYERS SQUIBB$Shi M, Zhang Y. Efficacy of nimotuzumab in combination with immunotherapy for a young recurrent cervical cancer patient: a case report and literature review. Anti-cancer Drugs. 2024;35(7):p644-52. doi:10.1097/CAD.0000000000001611.$45$YR$A$F$Y$$$20240716$$HP$CN$CN
240980141$24098014$1$I$20220101$20240705$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108011$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$63.5$KG$20240716$$CN$US$US
240980151$24098015$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49167$$FDA-CTU$$66$YR$$F$N$145$LBS$20240716$N$$US$
240980162$24098016$2$F$$20240913$20240716$20240918$EXP$$JP-009507513-2407JPN002290J$MERCK$$75$YR$$F$Y$$$20240918$$PH$JP$JP
240980171$24098017$1$I$20240426$20240716$20240716$20240716$DIR$710332$$FDA-CTU$$34$YR$$F$N$75.7$KG$20240716$N$CN$AU$
240980181$24098018$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49189$$FDA-CTU$$30$YR$$M$N$$$20240716$N$$US$
240980191$24098019$1$I$20240505$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024137814$AMGEN$$74$YR$E$M$Y$$$20240716$$CN$US$US
240980201$24098020$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA206573$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240716$$MD$US$US
240980211$24098021$1$I$20240622$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49176$$FDA-CTU$$55$YR$$F$N$58$KG$20240716$N$PH$US$
240980221$24098022$1$I$20240601$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112642$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240716$$CN$US$US
240980231$24098023$1$I$$20240709$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111126$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240716$$HP$US$US
240980241$24098024$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112476$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$117.03$KG$20240716$$CN$US$US
240980271$24098027$1$I$20230101$20240710$20240716$20240716$EXP$$US-AMGEN-USASP2024137290$AMGEN$$53$YR$A$F$Y$$$20240716$$CN$US$US
240980281$24098028$1$I$$20240715$20240716$20240716$PER$$US-ROCHE-10000027409$ROCHE$$$$A$F$Y$$$20240716$$CN$US$US
240980291$24098029$1$I$20240201$20240708$20240716$20240716$EXP$FR-AFSSAPS-TS2024000749$FR-TEVA-VS-3218786$TEVA$$79$YR$$M$Y$107$KG$20240716$$MD$FR$FR
240980312$24098031$2$F$20240707$20240716$20240716$20240718$PER$$US-AMGEN-USASP2024140641$AMGEN$$81$YR$E$M$Y$$$20240718$$CN$US$US
240980321$24098032$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49184$$FDA-CTU$$74$YR$$F$N$134$LBS$20240716$N$$US$
240980331$24098033$1$I$20240712$20240716$20240716$20240716$DIR$710347$$FDA-CTU$$49$YR$$M$N$$$20240716$N$PH$US$
240980341$24098034$1$I$20240614$20240716$20240716$20240716$DIR$710345$$FDA-CTU$$48$YR$$F$N$$$20240716$N$PH$US$
240980351$24098035$1$I$20240627$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49194$$FDA-CTU$$54$YR$$M$N$$$20240716$Y$PH$US$
240980361$24098036$1$I$20240715$20240716$20240716$20240716$DIR$710346$$FDA-CTU$$79$YR$$F$N$$$20240716$N$PH$US$
240980371$24098037$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49191$$FDA-CTU$$6$YR$$F$N$$$20240716$N$$US$
240980381$24098038$1$I$20240702$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49197$$FDA-CTU$$69$YR$$F$N$$$20240716$N$HP$US$
240980401$24098040$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49192$$FDA-CTU$$70$YR$$F$N$$$20240716$N$$US$
240980411$24098041$1$I$20240301$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49186$$FDA-CTU$$58$YR$$F$N$$$20240716$N$HP$US$
240980421$24098042$1$I$20240627$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49193$$FDA-CTU$$50$YR$$F$N$$$20240716$N$HP$US$
240980431$24098043$1$I$20240629$20240716$20240716$20240716$DIR$710327$$FDA-CTU$$7$YR$$M$N$22.5$KG$20240716$Y$CN$US$
240980461$24098046$1$I$$20240709$20240716$20240716$PER$$US-BIOGEN-2024BI01273033$BIOGEN$$$$$$Y$$$20240716$$CN$US$US
240980471$24098047$1$I$20240301$20240708$20240716$20240716$PER$$US-SA-2024SA203724$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240716$$MD$US$US
240980481$24098048$1$I$20230801$20240709$20240716$20240716$PER$$US-SA-2024SA205490$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240716$$MD$US$US
240980491$24098049$1$I$20240601$20240710$20240716$20240716$EXP$$EG-SA-2024SA205321$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240716$$HP$EG$EG
240980501$24098050$1$I$20221101$20240711$20240716$20240716$EXP$$PT-PFIZER INC-2023SGN10733$PFIZER$$65$YR$$M$Y$87$KG$20240716$$MD$PT$PT
240980511$24098051$1$I$$20200323$20240716$20240716$EXP$$US-BIOVITRUM-2020SE42640$BIOVITRUM$$0$YR$$F$Y$$$20240716$$CN$US$US
240980524$24098052$4$F$20240618$20240820$20240716$20240826$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-127887$DAIICHI$$49$YR$$F$Y$71.8$KG$20240826$$MD$US$US
240980531$24098053$1$I$20240614$20240702$20240716$20240716$PER$$US-Eisai-EC-2024-169544$EISAI$$69$YR$E$F$Y$$$20240716$$MD$US$US
240980541$24098054$1$I$20240625$20240703$20240716$20240716$PER$$US-Eisai-EC-2024-169524$EISAI$$84$YR$E$M$Y$$$20240716$$CN$US$US
240980554$24098055$4$F$$20240906$20240716$20240910$EXP$$AU-ROCHE-10000024321$ROCHE$$72$YR$E$F$Y$$$20240910$$MD$AU$AU
240980561$24098056$1$I$$20240710$20240716$20240716$EXP$$FR-AMGEN-FRASP2024137331$AMGEN$$$$$$Y$$$20240716$$PH$FR$FR
240980571$24098057$1$I$20230402$20240710$20240716$20240716$EXP$$ES-ABBVIE-5838834$ABBVIE$$63$YR$$M$Y$$$20240716$$MD$ES$ES
240980582$24098058$2$F$20240617$20240716$20240716$20240720$PER$$US-ROCHE-10000021408$ROCHE$$54$YR$A$F$Y$$$20240719$$CN$US$US
240980591$24098059$1$I$$20240703$20240716$20240716$PER$$US-ROCHE-10000021456$ROCHE$$$$E$F$Y$$$20240716$$CN$US$US
240980603$24098060$3$F$20240628$20240822$20240716$20240826$PER$$US-ROCHE-10000016556$ROCHE$$81$YR$E$F$Y$$$20240826$$CN$US$US
240980611$24098061$1$I$20240615$20240705$20240716$20240716$PER$$US-ROCHE-10000026316$ROCHE$$66$YR$E$F$Y$102.96$KG$20240716$$CN$US$US
240980622$24098062$2$F$$20240827$20240716$20240902$EXP$$PL-AstraZeneca-2024A160123$ASTRAZENECA$$$$$F$Y$$$20240902$$MD$PL$
240980633$24098063$3$F$$20240805$20240716$20240829$PER$$US-AstraZeneca-2024A153861$ASTRAZENECA$$68$YR$$F$Y$125$KG$20240829$$CN$US$
240980641$24098064$1$I$$20211004$20240716$20240716$EXP$$US-AstraZeneca-2021A760089$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240980651$24098065$1$I$20240328$20240712$20240716$20240716$EXP$DK-DKMA-30734524$DK-MYLANLABS-2024M1065441$MYLAN$$52$YR$$F$Y$104$KG$20240716$$MD$DK$DK
240980664$24098066$4$F$$20240806$20240716$20240814$EXP$$CA-AstraZeneca-2024A150503$ASTRAZENECA$$44$YR$$F$Y$71.2$KG$20240814$$HP$CA$
240980671$24098067$1$I$$20240715$20240716$20240716$EXP$$NVSC2024CA146112$NOVARTIS$$18$YR$$F$Y$53$KG$20240716$$PH$CA$CA
240980681$24098068$1$I$20240614$20240708$20240716$20240716$EXP$$IT-AstraZeneca-2024A155551$ASTRAZENECA$$83$YR$$F$Y$$$20240716$$MD$IT$
240980691$24098069$1$I$$20201028$20240716$20240716$EXP$$US-AstraZeneca-2020SF43678$ASTRAZENECA$$$$$$Y$$$20240716$$CN$US$
240980701$24098070$1$I$$20240716$20240716$20240716$DIR$710356$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
240980721$24098072$1$I$$20240703$20240716$20240716$EXP$$US-B.Braun Medical Inc.-2159176$B BRAUN$Literature Article$76$YR$$M$Y$$$20240716$$$US$US
240980731$24098073$1$I$$20240711$20240716$20240716$EXP$$NVSC2024CA145630$NOVARTIS$$44$YR$$M$Y$$$20240716$$CN$CA$CA
240980741$24098074$1$I$$20240709$20240716$20240716$PER$$US-ABBVIE-5833461$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240980751$24098075$1$I$20240619$20240702$20240716$20240716$PER$$US-TAKEDA-2024TUS067017$TAKEDA$$$$$F$Y$$$20240716$$HP$US$US
240980761$24098076$1$I$$20240711$20240716$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-111130$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240716$$CN$CA$CA
240980771$24098077$1$I$20240401$20240715$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112724$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240716$$CN$US$US
240980783$24098078$3$F$20240625$20240820$20240716$20240826$EXP$$NVSC2024MX144882$NOVARTIS$$34$YR$$F$Y$70$KG$20240826$$CN$MX$MX
240980792$24098079$2$F$20240101$20240913$20240716$20240919$EXP$$UY-ABBVIE-5836922$ABBVIE$$$$$F$Y$$$20240919$$CN$UY$UY
240980801$24098080$1$I$20240101$20240710$20240716$20240716$EXP$$US-AMERICAN REGENT INC-2024002690$AMERICAN REGENT$$$$$F$Y$$$20240716$$CN$US$US
240980811$24098081$1$I$20240308$20240703$20240716$20240716$EXP$$CA-TAKEDA-2024TUS025738$TAKEDA$$62$YR$$F$Y$$$20240716$$CN$CA$CA
240980822$24098082$2$F$$20240729$20240716$20240807$EXP$$US-TEVA-VS-3219224$TEVA$Thompson TZ, Rearick WA, Pizzuto MF, Quinsey C, Enyart CE, Trau SP. Increasing Seizures, Encephalopathy, and Hypothermia in an 18-Year-Old Woman. Pediatrics 2023; 151 (3):.; Thompson TZ, Rearick WA, Pizzuto MF, Quinsey C, Enyart CE, Trau SP. Increasing Seizures, Encephalopathy, and Hypothermia in an 18-Year-Old Woman. Pediatrics 2023; 151 (3):.; Thompson TZ, Rearick WA, Pizzuto MF, Quinsey C, Enyart CE, Trau SP. Increasing Seizures, Encephalopathy, and Hypothermia in an 18-Year-Old Woman. Ped...$18$YR$$F$Y$$$20240807$$HP$US$US
240980832$24098083$2$F$20240601$20240723$20240716$20240730$EXP$$US-ABBVIE-5837007$ABBVIE$$41$YR$$F$Y$$$20240730$$CN$US$US
240980841$24098084$1$I$$20240705$20240716$20240716$EXP$$JP-BAYER-2024A099297$BAYER$Goto M.; Anzai T.; Yamane R.; Yakuwa N.; Takahashi K.; Murashima A.. Pregnancy outcomes after first-trimester exposure to fluoroquinolones: Findings based on an integrated database from two Japanese institutions. Congenital Anomalies. 2024$$$N$$Y$$$20240716$$HP$JP$JP
240980852$24098085$2$F$$20240910$20240716$20240916$PER$$US-BAUSCH-BL-2024-010610$BAUSCH AND LOMB$$$$$F$Y$$$20240916$$MD$US$US
240980881$24098088$1$I$20240715$20240716$20240716$20240716$DIR$710358$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
240980911$24098091$1$I$20240715$20240716$20240716$20240716$DIR$710359$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
240980923$24098092$3$F$20240601$20240802$20240716$20240807$EXP$$DE-BAUSCH-BL-2024-010778$BAUSCH AND LOMB$$32$YR$$M$Y$$$20240807$$MD$DE$DE
240980931$24098093$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5838732$ABBVIE$$82$YR$$M$Y$$$20240716$$MD$US$US
240980954$24098095$4$F$$20240722$20240716$20240815$PER$$US-TRAVERE-2024TVT00572$TRAVERE THERAPEUTICS$$44$YR$A$M$Y$$$20240815$$CN$US$US
240980961$24098096$1$I$20240602$20240703$20240716$20240716$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000592$PAREXEL$$$$$$Y$$$20240716$$HP$CN$CN
240980972$24098097$2$F$$20240729$20240716$20240808$EXP$$US-TEVA-VS-3219199$TEVA$Rallabhandi S, Keelapandal Ganesh M, Kaufmann B. Cardiac Arrest: A Rare Complication of Chest Tube Placement. Am-J-Respir-Crit-Care-Med 2024; 209 A3644.; Rallabhandi S, Keelapandal Ganesh M, Kaufmann B. Cardiac Arrest: A Rare Complication of Chest Tube Placement. Am-J-Respir-Crit-Care-Med 2024; 209 A3644.$74$YR$$F$Y$$$20240808$$HP$US$US
240980981$24098098$1$I$20220701$20240710$20240716$20240716$EXP$FR-AFSSAPS-GR2024000839$FR-MYLANLABS-2024M1065171$MYLAN$$53$YR$$F$Y$$$20240716$$PH$FR$FR
240980991$24098099$1$I$20240226$20240710$20240716$20240716$EXP$FR-AFSSAPS-NT2024000759$FR-MYLANLABS-2024M1065057$MYLAN$$15$YR$$F$Y$$$20240716$$MD$FR$FR
240981001$24098100$1$I$$20240710$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010530$BAUSCH AND LOMB$$$$$F$Y$$$20240716$$HP$CA$CA
240981012$24098101$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218433$TEVA$Huang J, Shehzad D, Ahmed I, Yu JC. Recognizing Veno-occlusive Disease After Inotuzumab Treatment: An Urgent Call to Physicians in Non-Transplant Centers. Am-J-Respir-Crit-Care-Med 2024; 209.; Huang J, Shehzad D, Ahmed I, Yu JC. Recognizing Veno-occlusive Disease After Inotuzumab Treatment: An Urgent Call to Physicians in Non-Transplant Centers. Am-J-Respir-Crit-Care-Med 2024; 209.$47$YR$$F$Y$$$20240805$$HP$US$US
240981021$24098102$1$I$20240417$20240708$20240716$20240716$EXP$$GB-INCYTE CORPORATION-2024IN005485$INCYTE$$$$$$Y$$$20240716$$CN$GB$GB
240981031$24098103$1$I$$20240715$20240716$20240716$PER$$US-HALEON-2187220$Haleon PLC$$$$$$Y$$$20240716$$CN$US$US
240981041$24098104$1$I$$20240713$20240716$20240716$EXP$$GB-ABBVIE-5841015$ABBVIE$$$$A$M$Y$$$20240716$$CN$GB$GB
240981051$24098105$1$I$$20240711$20240716$20240716$EXP$$BR-TAKEDA-2024TUS071828$TAKEDA$$$$$F$Y$$$20240716$$CN$BR$BR
240981061$24098106$1$I$$20240702$20240716$20240716$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2159177$BRECKENRIDGE$$$$$M$Y$$$20240716$$$ES$A1
240981081$24098108$1$I$$20240705$20240716$20240716$PER$$US-SA-2024SA202690$SANOFI AVENTIS$$$$C$M$Y$$$20240716$$MD$US$US
240981091$24098109$1$I$20240101$20240709$20240716$20240716$PER$$US-SA-2024SA204072$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240716$$MD$US$US
240981101$24098110$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204534$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240716$$MD$US$US
240981111$24098111$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204409$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240716$$MD$US$US
240981121$24098112$1$I$20240401$20240708$20240716$20240716$PER$$US-SA-2024SA204267$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240716$$MD$US$US
240981131$24098113$1$I$20240613$20240711$20240716$20240716$EXP$$FR-AMERICAN REGENT INC-2024002684$AMERICAN REGENT$$57$YR$$M$Y$220$KG$20240716$$MD$FR$FR
240981141$24098114$1$I$$20240712$20240716$20240716$PER$$NVSC2024US146163$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240981151$24098115$1$I$20230105$20240709$20240716$20240716$EXP$ES-AEMPS-1399087$ES-TEVA-VS-3219294$TEVA$$48$YR$$F$Y$$$20240716$$MD$ES$ES
240981161$24098116$1$I$$20240703$20240716$20240716$EXP$$US-B.Braun Medical Inc.-2159178$B BRAUN$Literature Article$19$YR$$F$Y$$$20240716$$$US$US
240981171$24098117$1$I$20230413$20240705$20240716$20240716$EXP$$JP-UCBSA-2023021678$UCB$$13$YR$$F$Y$43.6$KG$20240716$$MD$JP$JP
240981182$24098118$2$F$20240601$20240718$20240716$20240807$PER$$CN-Blueprint Medicines Corporation-SP-CN-2024-001423$BLUEPRINT MEDICINES$$2$YR$C$M$Y$$$20240807$$CN$CN$CN
240981191$24098119$1$I$20240224$20240711$20240716$20240716$EXP$IT-MINISAL02-994013$IT-MYLANLABS-2024M1065204$MYLAN$$64$YR$$F$Y$$$20240716$$MD$IT$IT
240981204$24098120$4$F$20240213$20240806$20240716$20240813$EXP$$CA-GSK-CA2024014448$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CA$CA
240981211$24098121$1$I$20240101$20240710$20240716$20240716$PER$$US-SA-2024SA205488$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240716$$MD$US$US
240981222$24098122$2$F$20240101$20240724$20240716$20240730$EXP$$US-AMGEN-USASP2024137420$AMGEN$$46$YR$A$F$Y$$$20240730$$MD$US$US
240981232$24098123$2$F$$20240815$20240716$20240822$EXP$$US-AMGEN-USASP2024136549$AMGEN$Yuen C.A.; Pekmezci M.; Bao S. et.al.. Metastatic glioblastoma to the lungs: a case report and literature review. CNS Oncology. 2024;13 (1):1-15$63$YR$A$F$Y$$$20240822$$HP$US$US
240981242$24098124$2$F$$20240716$20240716$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-111265$BRISTOL MYERS SQUIBB$Literature citation unavailable$65$YR$E$F$Y$$$20240719$$HP$CA$CA
240981251$24098125$1$I$20240101$20240705$20240716$20240716$PER$$US-SA-2024SA203299$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240716$$MD$US$US
240981262$24098126$2$F$$20240725$20240716$20240731$EXP$$GB-AMGEN-GBRSP2024139009$AMGEN$$37$YR$A$F$Y$$$20240731$$PH$GB$GB
240981271$24098127$1$I$$20210201$20240716$20240716$EXP$$US-AstraZeneca-2021A026579$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240981281$24098128$1$I$20240421$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A127816$ASTRAZENECA$$27774$DY$$F$Y$$$20240716$$CN$US$
240981291$24098129$1$I$$20240708$20240716$20240716$EXP$$US-AMGEN-USASP2024137774$AMGEN$Hui R. L.; Wong H. W.; Nguyen V. H. et al.. Outcomes of Rituximab-abbs versus Rituximab in Patients with Diffuse Large B-Cell Lymphoma in a Noninferiority Study. BioDrugs. 2024;1-10$$$$$Y$$$20240716$$HP$US$US
240981301$24098130$1$I$$20240701$20240716$20240716$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01125$AVADEL CNS PHARMA$$34$YR$$F$Y$$$20240716$$CN$US$US
240981311$24098131$1$I$20240322$20240708$20240716$20240716$EXP$ES-AEMPS-1541914$ES-TEVA-VS-3219005$TEVA$$73$YR$$M$Y$$$20240716$$PH$ES$ES
240981321$24098132$1$I$$20240708$20240716$20240716$EXP$$CA-FreseniusKabi-FK202410781$FRESENIUS KABI$$68$YR$E$F$Y$92$KG$20240716$$HP$CA$CA
240981331$24098133$1$I$20240401$20240715$20240716$20240716$EXP$$US-MYLANLABS-2024M1053495$MYLAN$$61$YR$$F$Y$$$20240716$$HP$US$US
240981341$24098134$1$I$20240621$20240708$20240716$20240716$EXP$IT-MINISAL02-993592$IT-FreseniusKabi-FK202410794$FRESENIUS KABI$$58$YR$A$M$Y$$$20240716$$MD$IT$IT
240981351$24098135$1$I$20230403$20240702$20240716$20240716$EXP$$US-MYLANLABS-2024M1063608$MYLAN$$$$$F$Y$143.7$KG$20240716$$HP$US$US
240981367$24098136$7$F$20240501$20240919$20240716$20240930$EXP$$US-TRAVERE-2024TVT00573$TRAVERE THERAPEUTICS$$21$YR$A$F$Y$$$20240930$$CN$US$US
240981372$24098137$2$F$$20240812$20240716$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112846$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240819$$CN$US$US
240981381$24098138$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113004$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240716$$CN$US$US
240981401$24098140$1$I$$20240712$20240716$20240716$PER$$US-JNJFOC-20240740552$JOHNSON AND JOHNSON$$$$A$$Y$$$20240716$$CN$US$US
240981411$24098141$1$I$$20240708$20240716$20240716$PER$$US-JNJFOC-20240740553$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$CN$US$US
240981421$24098142$1$I$20240630$20240708$20240716$20240716$EXP$$JP-TEVA-VS-3220065$TEVA$$70$YR$$M$Y$$$20240716$$PH$JP$JP
240981431$24098143$1$I$$20240709$20240716$20240716$EXP$GB-MHRA-MED-202407091327046950-KHLJW$GB-TEVA-VS-3219823$TEVA$$10$YR$$M$Y$$$20240716$$CN$GB$GB
240981441$24098144$1$I$20240422$20240709$20240716$20240716$EXP$GB-MHRA-MED-202407081841575090-QFZBS$GB-TEVA-VS-3219865$TEVA$$64$YR$$M$Y$72$KG$20240716$$CN$GB$GB
240981451$24098145$1$I$20240606$20240711$20240716$20240716$EXP$$PT-AMERICAN REGENT INC-2024002692$AMERICAN REGENT$$27$YR$$F$Y$$$20240716$$MD$PT$PT
240981461$24098146$1$I$20240423$20240710$20240716$20240716$EXP$FR-AFSSAPS-GR2024000845$FR-MYLANLABS-2024M1065097$MYLAN$$76$YR$$F$Y$$$20240716$$PH$FR$FR
240981471$24098147$1$I$20240609$20240710$20240716$20240716$EXP$FR-AFSSAPS-TS2024000767$FR-MYLANLABS-2024M1064722$MYLAN$$80$YR$$M$Y$58$KG$20240716$$MD$FR$FR
240981481$24098148$1$I$20220201$20240710$20240716$20240716$EXP$FR-SA-SAC20220214000599$FR-MYLANLABS-2022M1026376$MYLAN$$72$YR$$M$Y$82$KG$20240716$$HP$FR$FR
240981491$24098149$1$I$$20240715$20240716$20240716$PER$$US-HALEON-2187295$Haleon PLC$$$$$$Y$$$20240716$$CN$US$US
240981501$24098150$1$I$$20240715$20240716$20240716$PER$$US-HALEON-2187264$Haleon PLC$$$$$M$Y$$$20240716$$CN$US$US
240981511$24098151$1$I$20240701$20240702$20240716$20240716$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000142$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
240981521$24098152$1$I$20231125$20240712$20240716$20240716$EXP$FR-AFSSAPS-AVMA2024000303$FR-MYLANLABS-2024M1065521$MYLAN$$49$YR$$M$Y$$$20240716$$PH$FR$FR
240981531$24098153$1$I$$20240715$20240716$20240716$EXP$PL-POLFAT-1671$PL-UCBSA-2024035715$UCB$$$$$M$Y$$$20240716$$CN$PL$PL
240981541$24098154$1$I$20240702$20240703$20240716$20240716$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000143$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
240981552$24098155$2$F$20240101$20240716$20240716$20240724$PER$$US-SA-2024SA204211$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240724$$MD$US$US
240981561$24098156$1$I$20240503$20240716$20240716$20240716$DIR$710353$$FDA-CTU$$44$YR$$M$N$157.5$KG$20240716$N$CN$US$
240981571$24098157$1$I$$20240708$20240716$20240716$EXP$$IT-AstraZeneca-2024A159146$ASTRAZENECA$$72$YR$$F$Y$58$KG$20240716$$MD$IT$
240981581$24098158$1$I$$20240711$20240716$20240716$PER$$US-JNJFOC-20240741655$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240716$$CN$US$US
240981591$24098159$1$I$$20201211$20240716$20240716$EXP$$JP-AstraZeneca-2020SF70001$ASTRAZENECA$$50$YR$$F$Y$$$20240716$$MD$JP$
240981601$24098160$1$I$$20240708$20240716$20240716$EXP$$US-AstraZeneca-2024A156336$ASTRAZENECA$$$$$M$Y$85.7$KG$20240716$$CN$US$
240981611$24098161$1$I$20240604$20240708$20240716$20240716$EXP$$CN-AstraZeneca-2024A158221$ASTRAZENECA$$27047$DY$$F$Y$52$KG$20240716$$MD$CN$
240981621$24098162$1$I$$20231121$20240716$20240716$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2023-26343$IPSEN$$$$$$Y$$$20240716$$MD$CA$CA
240981631$24098163$1$I$20240613$20240708$20240716$20240716$EXP$FR-AFSSAPS-TS2024000750$FR-TEVA-VS-3219067$TEVA$$79$YR$$M$Y$107$KG$20240716$$MD$FR$FR
240981651$24098165$1$I$$20240708$20240716$20240716$EXP$$US-AMGEN-USASP2024136860$AMGEN$Goswami R.; Sharma S.; Desai S. et al.. Case report: eosinophilic myocarditis in hypereosinophilic syndrome-a journey to heart transplantation. Frontiers in Immunology. 2024;15:1-7$51$YR$A$F$Y$$$20240716$$HP$US$US
240981661$24098166$1$I$$20240712$20240716$20240716$PER$$NVSC2024US146455$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240981671$24098167$1$I$20240101$20240703$20240716$20240716$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000144$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240716$$CN$US$US
240981683$24098168$3$F$20240701$20240813$20240716$20240820$EXP$$US-JNJFOC-20240732071$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240821$$MD$US$US
240981691$24098169$1$I$20240702$20240709$20240716$20240716$PER$$US-BAYER-2024A099346$BAYER$$97$YR$E$F$Y$$$20240716$$CN$US$US
240981701$24098170$1$I$$20240708$20240716$20240716$EXP$$PL-BAYER-2024A100664$BAYER$Woro? J, Siwek M.. Bolesny wytrysk jako konsekwencja niekorzystnych interakcji escitalopramu, mianseryny i fluorochinolon?w u pacjenta cierpi?cego na depresj?.Medycyna Praktyczna Psychiatria(Painful ejaculation as consequence unfavorable interactions escitalopram, mianserins i fluoroquinolones u patient suffering from depression) (Painful ejaculation as a consequence of unfavorable interactions of escitalopram, mianserins and fluoroquinolones in a patient suffering from depression).. Medycyna Pr$24$YR$A$M$Y$$$20240716$$MD$PL$PL
240981711$24098171$1$I$$20240712$20240716$20240716$EXP$$RO-MYLANLABS-2024M1065421$MYLAN$Voina E-A, Stoiu A-M, Mosteanu O, Pop T. A.. The role of infections in paving the way for liver failure in cirrhosis: case report. Acta Medica Marisiensis - Seria Medica. 2024;70 (S3)$70$YR$$M$Y$$$20240716$$MD$RO$RO
240981721$24098172$1$I$$20240709$20240716$20240716$EXP$$US-VIIV HEALTHCARE LIMITED-US2024085074$VIIV$$$$$$Y$$$20240716$$HP$US$US
240981731$24098173$1$I$$20240711$20240716$20240716$EXP$$CA-AstraZeneca-2024A160157$ASTRAZENECA$$44$YR$$F$Y$97$KG$20240716$$MD$CA$
240981742$24098174$2$F$20220101$20240902$20240716$20240906$EXP$$SI-MYLANLABS-2024M1041830$MYLAN$Korosec HL, Blagus T, Redensek TS, Dolzan V, Bon J, Pjevac M.. Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics. Frontiers in Psychiatry. 2024;15:1-9$60$YR$$F$Y$$$20240906$$HP$SI$SI
240981771$24098177$1$I$20240712$20240716$20240716$20240716$DIR$710348$$FDA-CTU$$27$YR$$F$N$$$20240716$N$PH$US$
240981781$24098178$1$I$20240604$20240716$20240716$20240716$DIR$710360$$FDA-CTU$$67$YR$$F$N$68.4$KG$20240716$N$HP$US$
240981801$24098180$1$I$$20240702$20240716$20240716$PER$$US-EMERGENT BIOSOLUTIONS,-24000107$EMERGENT BIOSOLUTIONS$Garcia EA, Foote MMK, McPherson TD, Lash MK, Bosompem AN, Bouscaren A, et al.. Severe Mpox among people with advanced human immunodeficiency virus receiving prolonged tecovirimat in New York City. Open Forum Infect Dis. 2024$$$A$M$Y$$$20240716$$HP$US$US
240981811$24098181$1$I$20240710$20240710$20240716$20240716$EXP$$GB-TEVA-VS-3220018$TEVA$$30$YR$$M$Y$88$KG$20240716$$MD$GB$GB
240981822$24098182$2$F$$20240710$20240716$20240723$EXP$$HN-MYLANLABS-2024M1065694$MYLAN$$$$$F$Y$63.5$KG$20240723$$CN$HN$HN
240981831$24098183$1$I$$20240709$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109136$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240716$$HP$US$US
240981841$24098184$1$I$20220322$20240708$20240716$20240716$EXP$IT-MINISAL02-992819$IT-TEVA-VS-3218726$TEVA$$57$YR$$M$Y$$$20240716$$MD$IT$IT
240981862$24098186$2$F$20240101$20240820$20240716$20240902$PER$$US-JNJFOC-20240719291$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240902$$CN$US$US
240981871$24098187$1$I$20240626$20240708$20240716$20240716$EXP$$CN-TAKEDA-2024TUS071281$TAKEDA$$69$YR$$M$Y$70$KG$20240716$$HP$CN$CN
240981881$24098188$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024138578$AMGEN$$$$$M$Y$$$20240716$$CN$US$US
240981891$24098189$1$I$20230101$20240708$20240716$20240716$EXP$$US-ZENPEP LLC-2024AIMT01077$AIMMUNE$$$$$F$Y$56.009$KG$20240716$$CN$US$US
240981901$24098190$1$I$$20240702$20240716$20240716$PER$$US-EMERGENT BIOSOLUTIONS,-24000108$EMERGENT BIOSOLUTIONS$Garcia EA, Foote MMK, McPherson TD, Lash MK, Bosompem AN, Bouscaren A, et al.. Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City. Open Forum Infect Dis. 2024$$$A$M$Y$$$20240716$$HP$US$US
240981911$24098191$1$I$20240101$20240710$20240716$20240716$EXP$$US-ABBVIE-5835921$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240981921$24098192$1$I$20240101$20240711$20240716$20240716$EXP$$GB-ABBVIE-5838748$ABBVIE$$58$YR$$F$Y$$$20240716$$CN$GB$GB
240981931$24098193$1$I$$20240708$20240716$20240716$EXP$$AU-ALXN-202407OCE000417AU$ALEXION PHARMACEUTICALS$$32$YR$$F$Y$$$20240716$$MD$AU$AU
240981941$24098194$1$I$$20240710$20240716$20240716$EXP$$US-ABBVIE-5837727$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240981951$24098195$1$I$$20240712$20240716$20240716$EXP$$US-SA-2024SA207100$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240716$$MD$US$US
240981963$24098196$3$F$$20240909$20240716$20240911$30DAY$$US-PFIZER INC-202400210148$PFIZER$$15$YR$$M$Y$$$20240911$$CN$US$US
240981974$24098197$4$F$20240703$20240916$20240716$20240923$30DAY$$US-PFIZER INC-202400208001$PFIZER$$14$YR$$M$Y$40.363$KG$20240923$$CN$US$US
240981984$24098198$4$F$$20240717$20240716$20240723$EXP$$AU-PFIZER INC-202400213871$PFIZER$Goradia, S.. Anti-melanoma differentiation-associated gene 5 (anti-MDA5) positive dermatomyositis: early detection is crucial. BMJ Case Reports. 2024;17(6):e259338$7$DEC$$F$Y$50$KG$20240723$$MD$AU$AU
240981993$24098199$3$F$$20240909$20240716$20240910$30DAY$$HK-PFIZER INC-202400213503$PFIZER$$$$$$Y$$$20240910$$PH$HK$HK
240982011$24098201$1$I$$20240713$20240716$20240716$EXP$$US-PFIZER INC-PV202400092131$PFIZER$Ballotari, M.. A Postmortem Case Report involving Fentanyl, Desalkylgidazepam and Bromazolam. Journal of analytical toxicology. 2024;10.1093/jat/bkae059$24$YR$$M$Y$$$20240716$$HP$US$US
240982021$24098202$1$I$$20240711$20240716$20240716$EXP$$FR-PFIZER INC-202400213281$PFIZER$Ferraz, F.. Post-steroid panniculitis: Rare complication in the treatment of acute leukaemia. European Paediatric Haematology and Oncology. 1985;2(1):171-172$42$MON$$M$Y$$$20240716$$HP$FR$FR
240982031$24098203$1$I$20230913$20240715$20240716$20240716$EXP$$BE-PFIZER INC-202400048261$PFIZER$$70$YR$$F$Y$52$KG$20240716$$MD$BE$BE
240982041$24098204$1$I$20240101$20240708$20240716$20240716$30DAY$$IL-PFIZER INC-PV202400089823$PFIZER$$8$YR$$F$Y$$$20240716$$CN$IL$IL
240982052$24098205$2$F$$20240716$20240716$20240718$EXP$$US-PFIZER INC-202400215354$PFIZER$Pommert, L.. A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome. Pediatric Blood and Cancer. 2024;71(8):e31137$27$YR$$M$Y$$$20240718$$MD$US$US
240982061$24098206$1$I$20150719$20240711$20240716$20240716$EXP$$FR-PFIZER INC-2015SGN02227$PFIZER$$32$YR$$M$Y$95$KG$20240716$$MD$FR$FR
240982072$24098207$2$F$20240420$20240717$20240716$20240718$EXP$GB-MHRA-MED-202407121140152270-WKVTR$GB-PFIZER INC-202400213426$PFIZER$$15$YR$$M$Y$56$KG$20240718$$CN$GB$GB
240982091$24098209$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204739$SANOFI AVENTIS$$$$A$F$Y$90$KG$20240716$$MD$US$US
240982101$24098210$1$I$20240708$20240710$20240716$20240716$PER$$US-SA-2024SA206098$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240716$$MD$US$US
240982111$24098211$1$I$20240704$20240708$20240716$20240716$PER$$US-SA-2024SA204874$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240716$$MD$US$US
240982121$24098212$1$I$20240201$20240708$20240716$20240716$PER$$US-SA-2024SA204956$SANOFI AVENTIS$$73$YR$E$F$Y$91.172$KG$20240716$$MD$US$US
240982131$24098213$1$I$20240601$20240710$20240716$20240716$PER$$US-SA-2024SA204702$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240716$$MD$US$US
240982142$24098214$2$F$20240708$20240908$20240716$20240909$30DAY$$CO-PFIZER INC-202400209739$PFIZER$$10$YR$$F$Y$$$20240909$$CN$CO$CO
240982162$24098216$2$F$$20240715$20240716$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112708$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240717$$CN$US$US
240982172$24098217$2$F$$20240717$20240716$20240724$EXP$$GB-TEVA-VS-3220022$TEVA$$89$YR$$F$Y$57$KG$20240724$$PH$GB$GB
240982181$24098218$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064633$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F.. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study.. Int. J. Mol. Sci.$75$YR$$M$Y$$$20240716$$HP$IT$IT
240982191$24098219$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064525$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study. Int. J. Mol. Sci.. 1-13$76$YR$$M$Y$$$20240716$$HP$IT$IT
240982201$24098220$1$I$$20240709$20240716$20240716$EXP$$IT-MYLANLABS-2024M1064599$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F.. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study.. Int J Mol Sci.. 2024;25:1-13$63$YR$$M$Y$$$20240716$$HP$IT$IT
240982211$24098221$1$I$$20240704$20240716$20240716$EXP$$CZ-TEVA-VS-3219061$TEVA$$$$A$M$Y$$$20240716$$CN$CZ$CZ
240982231$24098223$1$I$20240101$20240715$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040088$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240716$$CN$US$US
240982251$24098225$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008795$ELI LILLY AND CO$$$$$M$Y$$$20240716$$CN$US$US
240982261$24098226$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008999$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240716$$CN$US$US
240982271$24098227$1$I$$20240703$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407004017$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$US$US
240982281$24098228$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009563$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240716$$CN$US$US
240982291$24098229$1$I$$20240711$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008114$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240716$$CN$US$US
240982301$24098230$1$I$20240715$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009673$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240716$$CN$US$US
240982312$24098231$2$F$$20240815$20240716$20240820$EXP$$RO-ORGANON-O2407ROM001369$ORGANON$Gaido? ID, Man A, Ilie? R, Man SC.. BIOLOGICAL THERAPY FOR ATOPIC ASTHMA? UNUSUAL TREATMENT FOR A COMMON ILLNESS.. Acta Medica Marisiensis.. 2024;70 (3):268$7$YR$$M$Y$$$20240820$$HP$RO$RO
240982322$24098232$2$F$20210831$20240715$20240716$20240723$EXP$$CN-PFIZER INC-202400213914$PFIZER$Yang, J.. Case report: A rare case of anti-PD-1 sintilimab-induced agranulocytosis/severe neutropenia in non-small cell lung cancer and literature review. Frontiers in oncology. 2024;14:10.3389/fonc.2024.1415748$68$YR$$M$Y$$$20240723$$MD$CN$CN
240982342$24098234$2$F$20231106$20240715$20240716$20240724$EXP$$DE-PFIZER INC-202400215437$PFIZER$$79$YR$$M$Y$74$KG$20240724$$HP$DE$DE
240982361$24098236$1$I$$20240712$20240716$20240716$PER$$US-TAKEDA-2024TUS071467$TAKEDA$$$$$M$Y$127$KG$20240716$$MD$US$US
240982371$24098237$1$I$$20240709$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109058$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240716$$HP$US$US
240982382$24098238$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218399$TEVA$Guzman A. Should Severe Hypertriglyceridemia Also Be Considered as a Contraindication for Use of Glucagon like Peptide 1 (GLP-1) Agonists?. J-Endocr-Soc 2020; 4 (Suppl.) A122.; Guzman A. Should Severe Hypertriglyceridemia Also Be Considered as a Contraindication for Use of Glucagon like Peptide 1 (GLP-1) Agonists?. J-Endocr-Soc 2020; 4 (Suppl.) A122.$46$YR$$M$Y$$$20240805$$MD$US$US
240982391$24098239$1$I$$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024137306$AMGEN$Moshirfar M.; Kelkar N.; Ronquillo Y. C. et al.. Implication of Corneal Refractive Surgery in Duchenne Muscular Dystrophy. Case Reports in Ophthalmology. 2024;15 (1):374-382$21$YR$A$M$Y$$$20240716$$HP$US$US
240982401$24098240$1$I$20240630$20240709$20240716$20240716$EXP$$EG-EMD Serono-2024037532$EMD SERONO INC$$35$YR$A$F$Y$$$20240716$$HP$EG$EG
240982411$24098241$1$I$20240101$20240705$20240716$20240716$PER$$US-SA-2024SA203266$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240716$$MD$US$US
240982421$24098242$1$I$20240619$20240708$20240716$20240716$PER$$US-SA-2024SA205100$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240716$$MD$US$US
240982432$24098243$2$F$20240710$20240710$20240716$20240722$PER$$US-SA-2024SA205041$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240722$$MD$US$US
240982441$24098244$1$I$$20240710$20240716$20240716$EXP$$IL-Ipsen Biopharmaceuticals, Inc.-2024-14035$IPSEN$$$$A$F$Y$$$20240716$$MD$IL$IL
240982452$24098245$2$F$$20240723$20240716$20240802$EXP$$US-TEVA-VS-3217679$TEVA$Renzetti M, Potnis K, Vemmou E, Hansen B, Lin D, Yaggi HK. Salty, Sweet, and Severe: A Case of Linagliptin-induced Severe Hyponatremia. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.; Renzetti M, Potnis K, Vemmou E, Hansen B, Lin D, Yaggi HK. Salty, Sweet, and Severe: A Case of Linagliptin-induced Severe Hyponatremia. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.$76$YR$$F$Y$$$20240802$$HP$US$US
240982461$24098246$1$I$$20240716$20240716$20240716$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040038$BOEHRINGER INGELHEIM$$$$$$Y$$$20240716$$CN$US$US
240982471$24098247$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112885$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$60.78$KG$20240716$$CN$US$US
240982481$24098248$1$I$20240101$20240715$20240716$20240716$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-112665$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240716$$CN$PR$PR
240982492$24098249$2$F$$20240710$20240716$20240717$PER$$NVSC2024US143777$NOVARTIS$$$$$$Y$$$20240717$$CN$US$US
240982501$24098250$1$I$20240605$20240716$20240716$20240716$DIR$710362$$FDA-CTU$$87$YR$$M$N$85$KG$20240716$N$HP$US$
240982511$24098251$1$I$20240609$20240716$20240716$20240716$DIR$710364$$FDA-CTU$$87$YR$$M$N$85$KG$20240716$N$HP$US$
240982531$24098253$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA205480$SANOFI AVENTIS$$$$A$M$Y$116.57$KG$20240716$$MD$US$US
240982541$24098254$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA205451$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240716$$MD$US$US
240982551$24098255$1$I$20240101$20240709$20240716$20240716$EXP$$CH-GILEAD-2024-0680198$GILEAD$$69$YR$E$M$Y$$$20240716$$MD$CH$CH
240982602$24098260$2$F$20240601$20240724$20240716$20240801$PER$$US-UNITED THERAPEUTICS-UNT-2024-019735$UNITED THERAPEUTICS$$73$YR$$F$Y$$$20240801$$$US$US
240982611$24098261$1$I$20240616$20240715$20240716$20240716$PER$$US-ROCHE-10000027698$ROCHE$$20$YR$A$M$Y$$$20240716$$CN$US$US
240982621$24098262$1$I$$20240709$20240716$20240716$EXP$$JP-TEVA-VS-3220995$TEVA$$78$YR$$M$Y$$$20240716$$PH$JP$JP
240982631$24098263$1$I$20240213$20240710$20240716$20240716$EXP$FR-AFSSAPS-AVLY2024000078$FR-MYLANLABS-2024M1064738$MYLAN$$20$YR$$F$Y$$$20240716$$MD$FR$FR
240982642$24098264$2$F$20220101$20240809$20240716$20240814$EXP$$DE-INCYTE CORPORATION-2023IN003211$INCYTE$$$$$$Y$$$20240814$$HP$DE$DE
240982661$24098266$1$I$20240509$20240711$20240716$20240716$PER$$JP-Eisai-EC-2024-170074$EISAI$$88$YR$E$F$Y$47$KG$20240716$$HP$JP$JP
240982671$24098267$1$I$20240405$20240708$20240716$20240716$EXP$ES-AEMPS-1541918$ES-TEVA-VS-3218660$TEVA$$50$YR$$M$Y$$$20240716$$PH$ES$ES
240982681$24098268$1$I$20240709$20240710$20240716$20240716$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13986$IPSEN$$33$YR$A$F$Y$$$20240716$$HP$US$US
240982691$24098269$1$I$$20240708$20240716$20240716$EXP$$DK-MYLANLABS-2023M1090556$MYLAN$Knudsen GHo, Kermanian N, Kock-Jensen CH, Antulov R. Opioid-Induced Leukoencephalopathies: A Report of Two Cases. Case-Rep-Neurol. 2022;14 (1):25-30$30$YR$$M$Y$$$20240716$$HP$DK$DK
240982702$24098270$2$F$$20240718$20240716$20240722$PER$$US-JNJFOC-20240734306$JOHNSON AND JOHNSON$$$$$$Y$$$20240721$$HP$US$US
240982713$24098271$3$F$20240101$20240829$20240716$20240911$PER$$US-SA-2024SA196683$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240911$$MD$US$US
240982721$24098272$1$I$$20240701$20240716$20240716$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407006770$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240716$$CN$DE$JP
240982731$24098273$1$I$$20240712$20240716$20240716$EXP$$US-AMGEN-USASP2024138825$AMGEN$Andre N.; Donze C.; Revon-riviere G. et al.. Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide. Pediatric Blood +Cancer. 2024;71:1 to 6$12$YR$T$F$Y$$$20240716$$HP$US$US
240982742$24098274$2$F$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112655$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240716$$CN$US$US
240982751$24098275$1$I$$20240712$20240716$20240716$EXP$$US-AMGEN-USASP2024138810$AMGEN$Andre N.; Donze C.; Revon-riviere G. et al.. Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide. Pediatric Blood +Cancer. 2024;71:1 to 6$14$YR$T$F$Y$$$20240716$$HP$US$US
240982761$24098276$1$I$$20210427$20240716$20240716$EXP$$US-AstraZeneca-2021A369987$ASTRAZENECA$$$$$F$Y$67.1$KG$20240716$$CN$US$
240982772$24098277$2$F$$20240711$20240716$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-111139$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$88$KG$20240719$$HP$CA$CA
240982791$24098279$1$I$$20240715$20240716$20240716$EXP$$CA-BAUSCH-BL-2024-010797$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240716$$CN$CA$CA
240982802$24098280$2$F$$20240715$20240716$20240726$EXP$$US-MYLANLABS-2024M1064262$MYLAN$$57$YR$$M$Y$158.76$KG$20240726$$CN$US$US
240982811$24098281$1$I$20231129$20240708$20240716$20240716$EXP$$FR-BAUSCH-BL-2024-010854$BAUSCH AND LOMB$$88$YR$$M$Y$$$20240716$$HP$FR$FR
240982821$24098282$1$I$$20240710$20240716$20240716$EXP$$GB-EMD Serono-2024038028$EMD SERONO INC$$$$A$F$Y$$$20240716$$CN$GB$GB
240982831$24098283$1$I$$20240711$20240716$20240716$EXP$$US-JAZZ-2021-US-009579$JAZZ$$$$$F$Y$$$20240716$$CN$US$US
240982841$24098284$1$I$$20240715$20240716$20240716$PER$$US-HALEON-2187290$Haleon PLC$$$$$$Y$$$20240716$$CN$US$US
240982851$24098285$1$I$20240603$20240710$20240716$20240716$EXP$FR-AFSSAPS-AN2024000837$FR-MYLANLABS-2024M1064668$MYLAN$$66$YR$$M$Y$81$KG$20240716$$MD$FR$FR
240982861$24098286$1$I$$20240715$20240716$20240716$PER$$US-JNJFOC-20240739072$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240716$$HP$US$US
240982871$24098287$1$I$$20240715$20240716$20240716$PER$$US-JNJFOC-20240738741$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$HP$US$US
240982882$24098288$2$F$$20240729$20240716$20240806$EXP$$US-TEVA-VS-3219053$TEVA$Chang J-H, Kudose S, Droubi S, Verduzco HA, Awori J, Ratner LE, et al. Four Cases of Kidney Transplants With Donor HCV-Derived Immune Complex Glomerulonephritis. Kidney-Int-Rep 2024; 9 (6): 1903-1907.; Chang J-H, Kudose S, Droubi S, Verduzco HA, Awori J, Ratner LE, et al. Four Cases of Kidney Transplants With Donor HCV-Derived Immune Complex Glomerulonephritis. Kidney-Int-Rep 2024; 9 (6): 1903-1907.$60$YR$$M$Y$73$KG$20240806$$HP$US$US
240982891$24098289$1$I$$20240712$20240716$20240716$PER$$NVSC2024US145577$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240982901$24098290$1$I$$20240710$20240716$20240716$EXP$$FR-MYLANLABS-2024M1065419$MYLAN$$$$$F$Y$$$20240716$$CN$FR$FR
240982911$24098291$1$I$20240629$20240711$20240716$20240716$EXP$$CN-MYLANLABS-2024M1065554$MYLAN$$17$YR$$F$Y$56$KG$20240716$$HP$CN$CN
240982921$24098292$1$I$$20240709$20240716$20240716$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-025323$JAZZ$$$$$M$Y$$$20240716$$CN$US$US
240982931$24098293$1$I$$20240711$20240716$20240716$PER$$US-ALXN-202407USA000781US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
240982942$24098294$2$F$20240701$20240906$20240716$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111504$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240910$$CN$US$US
240982951$24098295$1$I$$20240715$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112636$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240716$$CN$US$US
240982964$24098296$4$F$20240101$20240911$20240716$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112547$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240913$$CN$US$US
240982972$24098297$2$F$$20240717$20240716$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112564$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240722$$CN$US$US
240982981$24098298$1$I$$20240704$20240716$20240716$PER$$US-IMP-2024000464$Harrow Health$$$$A$F$Y$$$20240716$$CN$US$US
240982992$24098299$2$F$$20240826$20240716$20240903$EXP$$US-AstraZeneca-2024A157559$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
240983001$24098300$1$I$$20240715$20240716$20240716$PER$$US-AstraZeneca-2024A161364$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240983011$24098301$1$I$$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110608$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240716$$HP$US$US
240983031$24098303$1$I$20240101$20240709$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159078$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240983041$24098304$1$I$$20240708$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159032$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240983053$24098305$3$F$$20240910$20240716$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111777$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240911$$HP$US$US
240983061$24098306$1$I$20240619$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113055$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240716$$MD$US$US
240983071$24098307$1$I$$20240710$20240716$20240716$EXP$$NVSC2024US143717$NOVARTIS$$$$A$F$Y$$$20240716$$CN$US$US
240983081$24098308$1$I$$20240713$20240716$20240716$PER$$NVSC2024US145622$NOVARTIS$$$$$F$Y$$$20240716$$CN$US$US
240983091$24098309$1$I$$20240716$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040095$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240716$$CN$US$US
240983101$24098310$1$I$$20240715$20240716$20240716$EXP$$NVSC2024RO145142$NOVARTIS$$54$YR$$F$Y$$$20240716$$MD$RO$RO
240983111$24098311$1$I$20240101$20240716$20240716$20240716$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040082$BOEHRINGER INGELHEIM$$90$YR$E$F$Y$$$20240716$$CN$US$US
240983122$24098312$2$F$$20240717$20240716$20240724$EXP$$TN-INCYTE CORPORATION-2024IN007422$INCYTE$$$$$$Y$$$20240724$$MD$TN$TN
240983131$24098313$1$I$$20240712$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007412$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240983141$24098314$1$I$20240401$20240710$20240716$20240716$PER$$US-SA-2024SA205598$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240716$$MD$US$US
240983151$24098315$1$I$$20240709$20240716$20240716$EXP$$TW-AMGEN-TWNSP2024136968$AMGEN$Tsai C.; Lin C.; Chou Y. et al.. Clinical Applications of Comprehensive Genomic Profiling in Advanced Non-Small-Cell Lung Cancer-A Case Series. Current oncology. 2024;31 (6):3161-3176$56$YR$A$F$Y$$$20240716$$HP$TW$TW
240983171$24098317$1$I$$20240709$20240716$20240716$PER$$US-AMGEN-USASP2024138279$AMGEN$$$$$$Y$$$20240716$$CN$US$US
240983184$24098318$4$F$20230101$20240822$20240716$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-020606$JAZZ$$$$$F$Y$56.236$KG$20240825$$MD$US$US
240983191$24098319$1$I$$20240715$20240716$20240716$PER$$US-JNJFOC-20240738714$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$HP$US$US
240983201$24098320$1$I$$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407007523$ELI LILLY AND CO$$39$YR$A$$Y$$$20240716$$CN$US$US
240983211$24098321$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009458$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240716$$CN$US$US
240983221$24098322$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009520$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240716$$CN$US$US
240983231$24098323$1$I$20240710$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008549$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240716$$CN$US$US
240983241$24098324$1$I$$20240710$20240716$20240716$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202407008898$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$CO$CO
240983252$24098325$2$F$$20240715$20240716$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407008289$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240719$$CN$US$US
240983261$24098326$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405050907585500-RVTNZ$GB-ELI_LILLY_AND_COMPANY-GB202407003928$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$GB$GB
240983271$24098327$1$I$20210901$20240704$20240716$20240716$EXP$$RO-ELI_LILLY_AND_COMPANY-RO202407005621$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240716$$MD$RO$RO
240983281$24098328$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009603$ELI LILLY AND CO$$2$YR$I$F$Y$$$20240716$$CN$US$US
240983291$24098329$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009396$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240716$$CN$US$US
240983301$24098330$1$I$20240501$20240712$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007411$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240983311$24098331$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112858$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240716$$CN$US$US
240983321$24098332$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112887$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240716$$CN$US$US
240983331$24098333$1$I$$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112775$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240716$$CN$US$US
240983341$24098334$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112878$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240716$$CN$US$US
240983351$24098335$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112850$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240716$$CN$US$US
240983361$24098336$1$I$$20240708$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109405$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240716$$CN$US$US
240983371$24098337$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112694$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$68.49$KG$20240716$$CN$US$US
240983381$24098338$1$I$$20240710$20240716$20240716$PER$$US-BAYER-2024A099611$BAYER$$18$YR$A$F$Y$$$20240716$$HP$US$US
240983391$24098339$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA206113$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240983401$24098340$1$I$20240704$20240710$20240716$20240716$EXP$$CN-009507513-2407CHN008920$MERCK$$54$YR$$M$Y$$$20240716$$HP$CN$CN
240983411$24098341$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA207545$SANOFI AVENTIS$$31$YR$A$M$Y$100.6$KG$20240716$$MD$US$US
240983421$24098342$1$I$$20240712$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007410$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240983431$24098343$1$I$20240611$20240710$20240716$20240716$EXP$FR-AFSSAPS-BX2024001382$FR-MYLANLABS-2024M1064742$MYLAN$$58$YR$$F$Y$60$KG$20240716$$MD$FR$FR
240983441$24098344$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112446$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240716$$CN$US$US
240983451$24098345$1$I$20240101$20240709$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109155$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240716$$HP$US$US
240983461$24098346$1$I$$20240712$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007408$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240983471$24098347$1$I$20240705$20240715$20240716$20240716$EXP$$DE-GILEAD-2024-0680796$GILEAD$$56$YR$A$M$Y$$$20240716$$MD$DE$DE
240983481$24098348$1$I$$20210817$20240716$20240716$EXP$$US-AstraZeneca-2021A687418$ASTRAZENECA$$$$$M$Y$$$20240716$$CN$US$
240983491$24098349$1$I$20240412$20240708$20240716$20240716$EXP$FR-AFSSAPS-GR2024000778$FR-TEVA-VS-3219141$TEVA$$85$YR$$F$Y$$$20240716$$PH$FR$FR
240983501$24098350$1$I$20240616$20240708$20240716$20240716$EXP$GB-MHRA-MED-202406300231145930-SKJZD$GB-TEVA-VS-3219094$TEVA$$73$YR$$F$Y$120$KG$20240716$$CN$GB$GB
240983512$24098351$2$F$20240620$20240902$20240716$20240903$EXP$$DE-GILEAD-2024-0680859$GILEAD$$69$YR$E$M$Y$$$20240903$$HP$DE$DE
240983521$24098352$1$I$20191101$20240711$20240716$20240716$EXP$$CN-BAYER-2024A100507$BAYER$$71$YR$E$F$Y$$$20240716$$HP$CN$CN
240983582$24098358$2$F$20240711$20240807$20240716$20240809$EXP$$GB-MYLANLABS-2024M1065676$MYLAN$$$$$M$Y$$$20240809$$PH$GB$GB
240983591$24098359$1$I$$20240710$20240716$20240716$PER$$US-AMGEN-USASP2024138815$AMGEN$$$$$$Y$$$20240716$$CN$US$US
240983601$24098360$1$I$$20240708$20240716$20240716$EXP$GB-MHRA-MED-202407070025010300-VNFWD$GB-TEVA-VS-3219015$TEVA$$20$YR$$F$Y$$$20240716$$CN$GB$GB
240983621$24098362$1$I$20240408$20240715$20240716$20240716$EXP$PT-INFARMED-J202407-92$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-112830$BRISTOL MYERS SQUIBB$$32$YR$A$M$Y$$$20240716$$PH$PT$PT
240983641$24098364$1$I$$20240715$20240716$20240716$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039930$BOEHRINGER INGELHEIM$$82$YR$E$M$Y$$$20240716$$PH$CA$CA
240983651$24098365$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112431$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$78.02$KG$20240716$$MD$US$US
240983662$24098366$2$F$$20240809$20240716$20240819$PER$$US-INCYTE CORPORATION-2024IN007406$INCYTE$$$$$$Y$$$20240819$$CN$US$US
240983671$24098367$1$I$$20240716$20240716$20240716$EXP$$ES-GILEAD-2024-0680867$GILEAD$$$$$$Y$$$20240716$$HP$ES$ES
240983691$24098369$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111797$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240716$$HP$US$US
240983701$24098370$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113056$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240716$$CN$US$US
240983741$24098374$1$I$$20240709$20240716$20240716$EXP$$US-SMPA-2024SPA000129$SUNOVION$$$$$$Y$$$20240716$$MD$US$US
240983751$24098375$1$I$20240604$20240708$20240716$20240716$EXP$FR-AFSSAPS-LY2024000949$FR-Taiho Oncology Inc-2024-006964$TAIHO ONCOLOGY INC$$44$YR$A$F$Y$82.1$KG$20240716$$PH$FR$FR
240983761$24098376$1$I$$20240708$20240716$20240716$EXP$$US-SMPA-2024SPA000130$SUNOVION$$$$$$Y$$$20240716$$CN$US$US
240983771$24098377$1$I$$20240710$20240716$20240716$PER$$US-SMPA-2024SPA000131$SUNOVION$$$$$$Y$$$20240716$$CN$US$US
240983781$24098378$1$I$$20240715$20240716$20240716$PER$$NVSC2024US146271$NOVARTIS$$$$$$Y$$$20240716$$CN$US$US
240983791$24098379$1$I$$20240708$20240716$20240716$EXP$FR-AFSSAPS-AVCN2024000462$FR-TEVA-VS-3219217$TEVA$$28$YR$$M$Y$$$20240716$$HP$FR$FR
240983802$24098380$2$F$$20240801$20240716$20240806$PER$$NVSC2024US146210$NOVARTIS$$$$$$Y$$$20240806$$CN$US$US
240983811$24098381$1$I$20240501$20240712$20240716$20240716$EXP$$IL-AMERICAN REGENT INC-2024002698$AMERICAN REGENT$$44$YR$$F$Y$$$20240716$$PH$IL$IL
240983821$24098382$1$I$$20240713$20240716$20240716$EXP$$GB-SANDOZ INC.-SDZ2024GB065270$SANDOZ$$$$$F$Y$$$20240716$$CN$GB$GB
240983833$24098383$3$F$$20240802$20240716$20240809$EXP$$US-AstraZeneca-2024A156167$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
240983841$24098384$1$I$20220201$20240712$20240716$20240716$PER$$US-INCYTE CORPORATION-2024IN007414$INCYTE$$$$$$Y$$$20240716$$CN$US$US
240983851$24098385$1$I$20240630$20240712$20240716$20240716$EXP$$US-BAYER-2024A102949$BAYER$$92$YR$E$F$Y$$$20240716$$CN$US$US
240983861$24098386$1$I$20240628$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111796$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240716$$PH$US$US
240983871$24098387$1$I$$20240709$20240716$20240716$PER$$US-MYLANLABS-2024M1065170$MYLAN$$$$$F$Y$$$20240716$$CN$US$US
240983881$24098388$1$I$20240430$20240715$20240716$20240716$EXP$FR-AFSSAPS-TO2024001230$NVSC2024FR145151$NOVARTIS$$75$YR$$M$Y$$$20240716$$PH$FR$FR
240983902$24098390$2$F$$20240715$20240716$20240718$EXP$$NVSC2024CA145000$NOVARTIS$$44$YR$$F$Y$$$20240719$$HP$CA$CA
240983921$24098392$1$I$20240624$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112506$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$69.85$KG$20240716$$CN$US$US
240983932$24098393$2$F$20240515$20240829$20240716$20240904$EXP$FR-AFSSAPS-LY2024000884$FR-009507513-2407FRA004705$MERCK$$64$YR$$F$Y$$$20240904$$PH$FR$FR
240983941$24098394$1$I$$20211029$20240716$20240716$EXP$$US-AstraZeneca-2021A792773$ASTRAZENECA$$63$YR$$M$Y$$$20240716$$CN$US$
240983951$24098395$1$I$$20240712$20240716$20240716$PER$$US-PFIZER INC-202400213964$PFIZER$$36$YR$$M$Y$72.57$KG$20240716$$CN$US$US
240983961$24098396$1$I$$20240710$20240716$20240716$PER$$US-PFIZER INC-202400211819$PFIZER$$8$YR$$M$Y$$$20240716$$HP$US$US
240983971$24098397$1$I$$20240711$20240716$20240716$PER$$US-PFIZER INC-2024SGN05526$PFIZER$$70$YR$$F$Y$$$20240716$$CN$US$US
240983981$24098398$1$I$20240301$20240710$20240716$20240716$PER$$US-PFIZER INC-202400216199$PFIZER$$60$YR$$F$Y$$$20240716$$CN$US$US
240983991$24098399$1$I$$20240715$20240716$20240716$PER$$NVSC2024US146491$NOVARTIS$$$$$F$Y$$$20240716$$MD$US$US
240984001$24098400$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113080$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240716$$CN$US$US
240984012$24098401$2$F$20240629$20240807$20240716$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112558$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240809$$CN$US$US
240984022$24098402$2$F$$20240913$20240716$20240918$EXP$$PT-MYLANLABS-2024M1058619$MYLAN$Coimbra M, De Sousa AS, Semedo E.. Horner^s Syndrome and Sympathectomy of the Ipsilateral Upper Limb after Lumbar Epidural Block. Revista da sociedade portuguesa de anestesiologia. 2024;33 (Supp 1):43$29$YR$$F$Y$$$20240918$$HP$PT$PT
240984031$24098403$1$I$$20240715$20240716$20240716$EXP$$US-BAUSCH-BL-2024-010818$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240716$$CN$US$US
240984042$24098404$2$F$$20240705$20240716$20240909$EXP$$US-CBFLEET-202407-US-002184$CB FLEET$$$$$F$Y$$$20240909$$CN$US$US
240984051$24098405$1$I$20240101$20240709$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159087$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240984062$24098406$2$F$$20240712$20240716$20240716$EXP$$BR-BIOMARINAP-BR-2024-159209$BIOMARIN$$$$$$Y$$$20240716$$CN$BR$BR
240984071$24098407$1$I$$20240710$20240716$20240716$PER$$US-EMD Serono-2024037871$EMD SERONO INC$$54$YR$A$M$Y$$$20240716$$CN$US$US
240984081$24098408$1$I$$20240709$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159091$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240984091$24098409$1$I$20240101$20240710$20240716$20240716$EXP$$DE-BAUSCH-BL-2024-010686$BAUSCH AND LOMB$$75$YR$$M$Y$$$20240716$$CN$DE$DE
240984101$24098410$1$I$$20240711$20240716$20240716$EXP$$JP-PURDUE-USA-2024-0310786$PURDUE$$$$$F$Y$$$20240716$$PH$JP$JP
240984111$24098411$1$I$20240428$20240715$20240716$20240716$EXP$ES-AEMPS-1541872$ES-PURDUE-USA-2024-0310772$PURDUE$$$$E$M$Y$$$20240716$$HP$ES$ES
240984122$24098412$2$F$20230301$20240716$20240716$20240723$EXP$$AT-PURDUE-USA-2024-0310528$PURDUE$$41$YR$$M$Y$$$20240723$$CN$AT$AT
240984153$24098415$3$F$20240702$20240903$20240716$20240904$30DAY$$AR-PFIZER INC-202400205280$PFIZER$$6$YR$$F$Y$$$20240904$$CN$AR$AR
240984162$24098416$2$F$20240531$20240805$20240716$20240812$EXP$$CA-PURDUE-USA-2024-0310777$PURDUE$$56$YR$$M$Y$74$KG$20240812$$HP$CA$CA
240984171$24098417$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008291$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240716$$CN$US$US
240984181$24098418$1$I$20220101$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008581$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240716$$CN$US$US
240984201$24098420$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008823$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240716$$CN$US$US
240984211$24098421$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009482$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240716$$CN$US$US
240984222$24098422$2$F$20240628$20240719$20240716$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106191$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$58.06$KG$20240724$$CN$US$US
240984232$24098423$2$F$$20240729$20240716$20240808$EXP$$US-TEVA-VS-3219118$TEVA$Woods L, Tomasco O, Ghamande SA. Influenza Induced MIS-A With Refractory Shock in a Patient With Preexisting Pituitary Hypophysitis. Am-J-Respir-Crit-Care-Med 2024; 209.; Woods L, Tomasco O, Ghamande SA. Influenza Induced MIS-A With Refractory Shock in a Patient With Preexisting Pituitary Hypophysitis. Am-J-Respir-Crit-Care-Med 2024; 209.$39$YR$$F$Y$$$20240808$$HP$US$US
240984241$24098424$1$I$$20240709$20240716$20240716$EXP$$US-AMERICAN REGENT INC-2024002666$AMERICAN REGENT$Mignone D, Shah K, Alawneh B, Papadakos SP, Michelakis N. A rude awakening: A case of sugammadex causing transient cardiomyopathy mimicking STEMI. The Journal of the American College of Cardiology. 2024;83(Suppl. 13 A):3618[abstract]$43$YR$$M$Y$$$20240716$$HP$US$US
240984251$24098425$1$I$20190412$20240712$20240716$20240716$EXP$GB-MHRA-MED-202407121113045010-HLCWN$GB-MYLANLABS-2024M1065574$MYLAN$$66$YR$$F$Y$$$20240716$$PH$GB$GB
240984261$24098426$1$I$20240614$20240712$20240716$20240716$EXP$FR-AFSSAPS-NT2024000812$FR-MYLANLABS-2024M1065519$MYLAN$$44$YR$$F$Y$$$20240716$$PH$FR$FR
240984272$24098427$2$F$$20240729$20240716$20240807$EXP$$US-TEVA-VS-3218987$TEVA$Lord ML, Rana D, Hossain S, Chang C, Palli V. A Fatal Case of Lyme Myocarditis With Babesia Co-infection. Am-J-Respir-Crit-Care-Med 2024; 209.; Lord ML, Rana D, Hossain S, Chang C, Palli V. A Fatal Case of Lyme Myocarditis With Babesia Co-infection. Am-J-Respir-Crit-Care-Med 2024; 209.$79$YR$$F$Y$$$20240807$$HP$US$US
240984281$24098428$1$I$$20240715$20240716$20240716$PER$$NVSC2024US146490$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240984301$24098430$1$I$20240501$20240712$20240716$20240716$EXP$$US-PFIZER INC-202400215000$PFIZER$$52$YR$$F$Y$$$20240716$$HP$US$US
240984312$24098431$2$F$20240530$20240802$20240716$20240807$EXP$$IT-PFIZER INC-PV202400092359$PFIZER$$57$YR$$F$Y$70$KG$20240807$$HP$IT$IT
240984321$24098432$1$I$$20240709$20240716$20240716$EXP$$CA-PFIZER INC-202400208997$PFIZER$$47$YR$$M$Y$$$20240716$$MD$CA$CA
240984331$24098433$1$I$$20240713$20240716$20240716$EXP$$IN-PFIZER INC-2019313543$PFIZER$$67$YR$$F$Y$$$20240716$$CN$IN$IN
240984341$24098434$1$I$$20240712$20240716$20240716$EXP$$US-PFIZER INC-202400214430$PFIZER$$71$YR$$F$Y$$$20240716$$CN$US$US
240984351$24098435$1$I$20240708$20240715$20240716$20240716$PER$$US-009507513-2407USA009851$MERCK$$$$$$Y$$$20240716$$HP$US$US
240984361$24098436$1$I$$20240715$20240716$20240716$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039997$BOEHRINGER INGELHEIM$$41$YR$A$M$Y$$$20240716$$CN$CA$CA
240984392$24098439$2$F$$20240729$20240716$20240807$EXP$$US-TEVA-VS-3219052$TEVA$Huang H, Greven MA. TRAUMATIC LENS SUBLUXATION FROM PICKLEBALL INJURY: A CASE SERIES. Retin-Cases-Brief-Rep 2024; 18 (1): 15-17.; Huang H, Greven MA. TRAUMATIC LENS SUBLUXATION FROM PICKLEBALL INJURY: A CASE SERIES. Retin-Cases-Brief-Rep 2024; 18 (1): 15-17.; Huang H, Greven MA. TRAUMATIC LENS SUBLUXATION FROM PICKLEBALL INJURY: A CASE SERIES. Retin-Cases-Brief-Rep 2024; 18 (1): 15-17.$76$YR$$F$Y$$$20240807$$HP$US$US
240984401$24098440$1$I$$20240711$20240716$20240716$EXP$$US-AstraZeneca-2024A159749$ASTRAZENECA$$$$$F$Y$$$20240716$$HP$US$
240984411$24098441$1$I$$20240708$20240716$20240716$EXP$$JP-AstraZeneca-2024A154166$ASTRAZENECA$$75$YR$$M$Y$$$20240716$$MD$JP$
240984421$24098442$1$I$$20240624$20240716$20240716$PER$$US-AstraZeneca-2024A150622$ASTRAZENECA$$$$$F$Y$$$20240716$$MD$US$
240984431$24098443$1$I$20240401$20240708$20240716$20240716$EXP$$ZA-AstraZeneca-2024A155774$ASTRAZENECA$$50$YR$$M$Y$$$20240716$$CN$ZA$
240984441$24098444$1$I$$20240617$20240716$20240716$PER$$US-IMP-2024000412$Harrow Health$$$$A$M$Y$$$20240716$$CN$US$US
240984451$24098445$1$I$20240702$20240709$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159108$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240984462$24098446$2$F$$20240729$20240716$20240806$EXP$$US-TEVA-VS-3218950$TEVA$Tajfiroozeh D, Silva R, Otsuka KN, Wai A. A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis. Am-J-Respir-Crit-Care-Med 2024; 209.; Tajfiroozeh D, Silva R, Otsuka KN, Wai A. A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis. Am-J-Respir-Crit-Care-Med 2024; 209.$$$$M$Y$$$20240806$$HP$US$US
240984472$24098447$2$F$20240504$20240712$20240716$20240723$EXP$CH-SM-2024-13557$CH-PFIZER INC-202400213404$PFIZER$$78$YR$$F$Y$52$KG$20240723$$MD$CH$CH
240984481$24098448$1$I$$20240710$20240716$20240716$EXP$$PT-MYLANLABS-2024M1065606$MYLAN$Albuquerque F, Neto M, Cad?rio MJ, Oliveira J, Saraiva A, Maduro AI, Duarte C.. Granulomatosis with polyangiitis and concomitant superinfection: a defying diagnosis and management approach. Cureus. 2024;16 (5):e60606$45$YR$$F$Y$$$20240716$$MD$PT$PT
240984502$24098450$2$F$$20240916$20240716$20240925$EXP$$AE-LUNDBECK-DKLU4001679$LUNDBECK$$$$$$Y$$$20240925$$CN$AE$AE
240984511$24098451$1$I$$20240716$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040101$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240716$$HP$US$US
240984531$24098453$1$I$$20240617$20240716$20240716$PER$$US-IMP-2024000413$Harrow Health$$$$A$F$Y$$$20240716$$CN$US$US
240984541$24098454$1$I$$20240712$20240716$20240716$EXP$GB-MHRA-MED-202407121609474360-QJFYN$GB-MYLANLABS-2024M1065591$MYLAN$$45$YR$$F$Y$$$20240716$$CN$GB$GB
240984551$24098455$1$I$$20240709$20240716$20240716$EXP$$TR-009507513-2407TUR004568$MERCK$Atahan C, Ugurluer G, Kumbasar B, Ozyar E, Atalar B.. Myonecrosis as a rare side effect of stereotactic body radiotherapy for bone metastases: Report of two cases and a comprehensive literature review. Cancer/Radiotherapie. 2024;28(3):275-79$63$YR$$M$Y$$$20240716$$HP$TR$TR
240984562$24098456$2$F$20211221$20220203$20240716$20240716$PER$$US-HLS-202200176$HLS THERAPEUTICS$$56$YR$A$$Y$$$20240716$$MD$US$US
240984572$24098457$2$F$20240703$20240708$20240716$20240716$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-13816$IPSEN$$40$YR$A$M$Y$47$KG$20240716$$HP$US$US
240984581$24098458$1$I$$20240715$20240716$20240716$PER$$NVSC2024US146497$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240984591$24098459$1$I$$20240415$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006162$JAZZ$$$$$$Y$$$20240716$$HP$US$US
240984601$24098460$1$I$20240401$20240424$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006570$JAZZ$$26$YR$$F$Y$$$20240716$$PH$US$US
240984611$24098461$1$I$$20240409$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005908$JAZZ$$3$YR$$M$Y$$$20240716$$PH$US$US
240984621$24098462$1$I$$20240501$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006951$JAZZ$$$$$M$Y$$$20240716$$HP$US$US
240984631$24098463$1$I$$20240416$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006218$JAZZ$$$$$M$Y$$$20240716$$PH$US$US
240984641$24098464$1$I$$20240710$20240716$20240716$EXP$$DE-AstraZeneca-2024A159310$ASTRAZENECA$$72$YR$$M$Y$65$KG$20240716$$MD$DE$
240984651$24098465$1$I$$20240404$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005953$JAZZ$$3$YR$$M$Y$$$20240716$$MD$US$US
240984671$24098467$1$I$$20240418$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006332$JAZZ$$$$$$Y$$$20240716$$PH$US$US
240984681$24098468$1$I$20240422$20240422$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006506$JAZZ$$18$YR$$M$Y$$$20240716$$HP$US$US
240984691$24098469$1$I$$20240417$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006269$JAZZ$$13$YR$$$Y$$$20240716$$HP$US$US
240984701$24098470$1$I$$20240708$20240716$20240716$EXP$$PL-AstraZeneca-2024A160308$ASTRAZENECA$$$$$F$Y$62$KG$20240716$$MD$PL$
240984712$24098471$2$F$$20240802$20240716$20240811$PER$$US-AstraZeneca-2024A147412$ASTRAZENECA$$$$$$Y$$$20240811$$CN$US$
240984721$24098472$1$I$$20190712$20240716$20240716$EXP$$US-AstraZeneca-2019SE76714$ASTRAZENECA$$$$$F$Y$$$20240716$$CN$US$
240984731$24098473$1$I$20240301$20240711$20240716$20240716$PER$$US-JNJFOC-20240730489$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240716$$CN$US$US
240984742$24098474$2$F$$20240715$20240716$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113087$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240719$$CN$US$US
240984761$24098476$1$I$$20240701$20240716$20240716$EXP$$US-TEVA-VS-3219044$TEVA$Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series. Pediatr-Nephrol 2024; 0 (0): no pagination.; Goswami S, Hanson AE, Rajadhyaksha E, Dangle PP, Schwaderer AL. Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series. Pediatr-Nephrol 2024; 0 (0): no pagination.$15$YR$$M$Y$$$20240716$$HP$US$US
240984771$24098477$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111861$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$117.48$KG$20240716$$CN$US$US
240984781$24098478$1$I$20240103$20240709$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008812$JAZZ$$16$YR$$M$Y$78.7$KG$20240716$$HP$US$US
240984791$24098479$1$I$$20240502$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006970$JAZZ$$$$$M$Y$$$20240716$$HP$US$US
240984801$24098480$1$I$$20240617$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009437$JAZZ$$3$YR$$M$Y$$$20240716$$PH$US$US
240984812$24098481$2$F$$20240715$20240716$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112690$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240718$$MD$US$US
240984821$24098482$1$I$20240214$20240709$20240716$20240716$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008809$JAZZ$$3$YR$$M$Y$12.6$KG$20240716$$HP$US$US
240984831$24098483$1$I$20240701$20240710$20240716$20240716$EXP$$US-ALXN-202407USA000676US$ALEXION PHARMACEUTICALS$$71$YR$$F$Y$66.667$KG$20240716$$HP$US$US
240984841$24098484$1$I$20120126$20240702$20240716$20240716$EXP$$US-BIOGEN-2012BI004598$BIOGEN$$45$YR$$F$Y$$$20240716$$MD$US$US
240984851$24098485$1$I$$20240708$20240716$20240716$EXP$$ZA-AstraZeneca-2024A155876$ASTRAZENECA$$72$YR$$F$Y$$$20240716$$CN$ZA$
240984872$24098487$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218945$TEVA$Epler KE, Crouch DR, Van Nostrand K. Serotonin- Like- Syndrome Resulting From Tranexamic Acid Applied to Airways During Flexible Bronchoscopy. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Epler KE, Crouch DR, Van Nostrand K. Serotonin- Like- Syndrome Resulting From Tranexamic Acid Applied to Airways During Flexible Bronchoscopy. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$44$YR$$M$Y$$$20240805$$HP$US$US
240984881$24098488$1$I$$20240716$20240716$20240716$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040043$BOEHRINGER INGELHEIM$$$$$$Y$$$20240716$$CN$US$US
240984901$24098490$1$I$20240529$20240715$20240716$20240716$EXP$$ES-SANDOZ INC.-SDZ2024ES065135$SANDOZ$$47$YR$$F$Y$$$20240716$$MD$ES$ES
240984912$24098491$2$F$$20240729$20240716$20240805$EXP$$US-TEVA-VS-3218956$TEVA$Braat J, Shacker M, Arjuna A. Atypical Presentation of Central Serous Chorioretinopathy (CSCR) After Lung Transplantation. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Braat J, Shacker M, Arjuna A. Atypical Presentation of Central Serous Chorioretinopathy (CSCR) After Lung Transplantation. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$$$A$F$Y$$$20240805$$HP$US$US
240984921$24098492$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112485$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240716$$HP$US$US
240984941$24098494$1$I$$20240618$20240716$20240716$PER$$US-IMP-2024000424$Harrow Health$$$$E$M$Y$$$20240716$$CN$US$US
240984953$24098495$3$F$20240101$20240722$20240716$20240801$EXP$FR-AFSSAPS-NT2024000836$FR-ABBVIE-5840165$ABBVIE$$64$YR$$F$Y$60$KG$20240801$$MD$FR$FR
240984962$24098496$2$F$20231014$20240826$20240716$20240902$EXP$FR-AFSSAPS-PA2024000835$FR-009507513-2407FRA005792$MERCK$$50$YR$$F$Y$93$KG$20240902$$MD$FR$FR
240984971$24098497$1$I$20230608$20240709$20240716$20240716$EXP$$KR-009507513-2407KOR003538$MERCK$$79$YR$$M$Y$$$20240716$$PH$KR$KR
240984981$24098498$1$I$20240627$20240710$20240716$20240716$EXP$GB-MHRA-MED-202407101100347400-BRGYQ$GB-009507513-2407GBR005192$MERCK$$67$YR$$M$Y$92$KG$20240716$$HP$GB$GB
240984991$24098499$1$I$$20240628$20240716$20240716$PER$$US-IMP-2024000449$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985001$24098500$1$I$20240618$20240629$20240716$20240716$PER$$US-IMP-2024000444$Harrow Health$$44$YR$A$M$Y$$$20240716$$CN$US$US
240985011$24098501$1$I$$20240703$20240716$20240716$EXP$$JP-B.Braun Medical Inc.-2159183$B BRAUN$Literature Article$59$YR$$M$Y$$$20240716$$$JP$JP
240985022$24098502$2$F$$20240729$20240716$20240806$EXP$$US-TEVA-VS-3219057$TEVA$Islam I, Makaryus M, Khanijo S. Breathing Blue: Sulfasalazine-Induced Methemoglobinemia and Hypoxemia. Am-J-Respir-Crit-Care-Med 2024; 209 A1998.; Islam I, Makaryus M, Khanijo S. Breathing Blue: Sulfasalazine-Induced Methemoglobinemia and Hypoxemia. Am-J-Respir-Crit-Care-Med 2024; 209 A1998.$80$YR$$M$Y$$$20240806$$HP$US$US
240985031$24098503$1$I$$20240703$20240716$20240716$EXP$$CA-B.Braun Medical Inc.-2159187$B BRAUN$Literature Article$6$MON$$F$Y$$$20240716$$$CA$CA
240985041$24098504$1$I$$20240703$20240716$20240716$EXP$$IT-B.Braun Medical Inc.-2159182$B BRAUN$Literature Article$13$YR$$F$Y$$$20240716$$$IT$IT
240985051$24098505$1$I$$20240624$20240716$20240716$PER$$US-i-Health, Inc.-2159188$I-HEALTH$$$$$F$Y$$$20240716$$$US$US
240985061$24098506$1$I$$20240703$20240716$20240716$EXP$$IN-B.Braun Medical Inc.-2159185$B BRAUN$Literature Article$24$YR$$F$Y$$$20240716$$$IN$IN
240985072$24098507$2$F$$20240716$20240716$20240723$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040000$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$84.8$KG$20240723$$MD$CA$CA
240985081$24098508$1$I$$20240715$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112504$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240716$$HP$US$US
240985092$24098509$2$F$20240624$20240730$20240716$20240807$EXP$$US-ORPHANEU-2024005235$RECORDATI$$$$$$Y$$$20240807$$CN$US$US
240985101$24098510$1$I$$20240705$20240716$20240716$PER$$US-009507513-2407USA003334$MERCK$$$$$M$Y$$$20240716$$CN$US$US
240985111$24098511$1$I$20240101$20240627$20240716$20240716$PER$$US-IMP-2024000443$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985121$24098512$1$I$$20240703$20240716$20240716$EXP$$JP-B.Braun Medical Inc.-2159190$B BRAUN$Literarure Article$65$YR$$M$Y$$$20240716$$$JP$JP
240985131$24098513$1$I$$20240626$20240716$20240716$PER$$US-JNJFOC-20240700599$JOHNSON AND JOHNSON$$$$$$Y$$$20240716$$CN$US$US
240985141$24098514$1$I$20240628$20240705$20240716$20240716$EXP$$CN-GE HEALTHCARE-2024CSU007757$GE HEALTHCARE$$73$YR$$M$Y$77$KG$20240716$$HP$CN$CN
240985151$24098515$1$I$20240531$20240531$20240716$20240716$PER$$US-GE HEALTHCARE-2024CSU006020$GE HEALTHCARE$$66$YR$$M$Y$121.2$KG$20240716$$HP$US$US
240985161$24098516$1$I$20240501$20240716$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040108$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240716$$CN$US$US
240985172$24098517$2$F$$20240723$20240716$20240802$EXP$$US-TEVA-VS-3217682$TEVA$Kiley KD, Melnychuk E. A Controversial Topic: PJP Prophylaxis in Patients With Long-Term Immunologic Agents +/- Steroids. Am-J-Respir-Crit-Care-Med 2024; 209 A3572 (plus Poster).; Kiley KD, Melnychuk E. A Controversial Topic: PJP Prophylaxis in Patients With Long-Term Immunologic Agents +/- Steroids. Am-J-Respir-Crit-Care-Med 2024; 209 A3572 (plus Poster).$30$YR$$F$Y$42$KG$20240802$$HP$US$US
240985182$24098518$2$F$20240101$20240815$20240716$20240912$PER$$US-IMP-2024000461$Harrow Health$$81$YR$E$F$Y$$$20240912$$CN$US$US
240985192$24098519$2$F$$20240723$20240716$20240802$EXP$$US-TEVA-VS-3217683$TEVA$Tatapudi S, Sarva ST, Jayaraman G, Krupa MS, Bhimaraj A, Kesavan RB. Silicone Heart: Unraveling Cardiac Sarcoidosis in a 42-Year-Old Female. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Tatapudi S, Sarva ST, Jayaraman G, Krupa MS, Bhimaraj A, Kesavan RB. Silicone Heart: Unraveling Cardiac Sarcoidosis in a 42-Year-Old Female. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$42$YR$$F$Y$$$20240802$$HP$US$US
240985201$24098520$1$I$$20240710$20240716$20240716$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135625$DAIICHI$$$$$F$Y$$$20240716$$CN$US$US
240985211$24098521$1$I$$20240701$20240716$20240716$PER$$US-IMP-2024000465$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985231$24098523$1$I$20240601$20240617$20240716$20240716$PER$$US-IMP-2024000404$Harrow Health$$73$YR$E$F$Y$$$20240716$$CN$US$US
240985241$24098524$1$I$20240101$20240710$20240716$20240716$EXP$$US-ABBVIE-5838088$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240985251$24098525$1$I$$20240715$20240716$20240716$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040005$BOEHRINGER INGELHEIM$$85$YR$E$F$Y$$$20240716$$PH$CA$CA
240985261$24098526$1$I$$20240618$20240716$20240716$PER$$US-IMP-2024000410$Harrow Health$$$$E$M$Y$$$20240716$$CN$US$US
240985271$24098527$1$I$20240127$20240701$20240716$20240716$EXP$EU-AFSSAPS-AVMA2024000247$EU-ETHYPHARM-2024001730$ETHYPHARM$$$$$$Y$$$20240716$$PH$EU$
240985281$24098528$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009398$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240716$$CN$US$US
240985291$24098529$1$I$20220316$20240701$20240716$20240716$EXP$EU-AFSSAPS-AVPO2024000119$EU-ETHYPHARM-2024001731$ETHYPHARM$$$$$$Y$$$20240716$$PH$EU$EU
240985301$24098530$1$I$$20240618$20240716$20240716$PER$$US-IMP-2024000409$Harrow Health$$$$E$M$Y$$$20240716$$CN$US$US
240985311$24098531$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009429$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240716$$CN$US$US
240985322$24098532$2$F$$20240730$20240716$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407008851$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240731$$CN$US$US
240985331$24098533$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009529$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240716$$CN$US$US
240985341$24098534$1$I$$20240712$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407008859$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240716$$CN$US$US
240985351$24098535$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009431$ELI LILLY AND CO$$62$YR$A$$Y$$$20240716$$CN$US$US
240985361$24098536$1$I$20240410$20240619$20240716$20240716$PER$$US-IMP-2024000414$Harrow Health$$73$YR$E$F$Y$$$20240716$$CN$US$US
240985371$24098537$1$I$$20240618$20240716$20240716$PER$$US-IMP-2024000408$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985381$24098538$1$I$20240601$20240618$20240716$20240716$PER$$US-IMP-2024000415$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985391$24098539$1$I$$20240619$20240716$20240716$PER$$US-IMP-2024000417$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985401$24098540$1$I$20240601$20240619$20240716$20240716$PER$$US-IMP-2024000418$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985411$24098541$1$I$20240624$20240710$20240716$20240716$PER$$US-SA-2024SA204572$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240716$$CN$US$US
240985421$24098542$1$I$20240101$20240708$20240716$20240716$PER$$US-SA-2024SA204718$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240716$$MD$US$US
240985431$24098543$1$I$20240401$20240709$20240716$20240716$PER$$US-SA-2024SA204647$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240716$$MD$US$US
240985441$24098544$1$I$$20240619$20240716$20240716$PER$$US-IMP-2024000416$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985451$24098545$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204504$SANOFI AVENTIS$$$$A$F$Y$$$20240716$$MD$US$US
240985461$24098546$1$I$20240307$20240620$20240716$20240716$PER$$US-IMP-2024000419$Harrow Health$$77$YR$E$F$Y$$$20240716$$CN$US$US
240985471$24098547$1$I$$20240715$20240716$20240716$PER$$NVSC2024US146507$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240985481$24098548$1$I$20240628$20240703$20240716$20240716$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI06806$NEUROCRINE BIOSCIENCES$$4$DEC$$F$Y$$$20240716$$MD$JP$JP
240985491$24098549$1$I$20240701$20240710$20240716$20240716$EXP$$CN-009507513-2407CHN008538$MERCK$$68$YR$$M$Y$65$KG$20240716$$HP$CN$CN
240985501$24098550$1$I$$20240620$20240716$20240716$PER$$US-IMP-2024000422$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985511$24098551$1$I$20210101$20240710$20240716$20240716$EXP$$NVSC2023MX129822$NOVARTIS$$$$$F$Y$82$KG$20240716$$CN$MX$MX
240985521$24098552$1$I$$20240620$20240716$20240716$PER$$US-IMP-2024000421$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985531$24098553$1$I$$20240621$20240716$20240716$PER$$US-IMP-2024000433$Harrow Health$$$$E$M$Y$$$20240716$$CN$US$US
240985551$24098555$1$I$20240101$20240708$20240716$20240716$PER$$US-VERTEX PHARMACEUTICALS-2024-011374$VERTEX$$17$MON$$M$Y$$$20240716$$HP$US$US
240985561$24098556$1$I$$20240622$20240716$20240716$PER$$US-IMP-2024000428$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985571$24098557$1$I$$20240623$20240716$20240716$PER$$US-IMP-2024000429$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985581$24098558$1$I$20220101$20240408$20240716$20240716$EXP$$RU-VERTEX PHARMACEUTICALS-2024-011378$VERTEX$Maksimycheva TY, Kondratieva EI, Voronkova AY, Budzinsky RM. The fulminant form of pseudomembranous colitis in a child with cystic fibrosis [????????????? ????? ???????????????????  ?????? ? ??????? ? ??????????????]. Archives of Pediatrics and Pediatric Surgery. 2023;1:40-52$$$T$F$Y$$$20240716$$HP$RU$RU
240985591$24098559$1$I$$20240621$20240716$20240716$PER$$US-IMP-2024000431$Harrow Health$$70$YR$E$F$Y$$$20240716$$CN$US$US
240985601$24098560$1$I$$20240709$20240716$20240716$EXP$$CH-GILEAD-2024-0680175$GILEAD$$72$YR$E$M$Y$$$20240716$$MD$CH$CH
240985611$24098561$1$I$20240526$20240624$20240716$20240716$PER$$US-IMP-2024000432$Harrow Health$$86$YR$E$F$Y$$$20240716$$CN$US$US
240985621$24098562$1$I$$20240625$20240716$20240716$PER$$US-IMP-2024000435$Harrow Health$$$$A$F$Y$$$20240716$$CN$US$US
240985631$24098563$1$I$20240101$20240621$20240716$20240716$PER$$US-IMP-2024000436$Harrow Health$$62$YR$A$M$Y$$$20240716$$CN$US$US
240985642$24098564$2$F$$20240722$20240716$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110524$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240730$$CN$US$US
240985651$24098565$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112722$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240716$$HP$US$US
240985661$24098566$1$I$$20240703$20240716$20240716$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-20839$SAMSUNG BIOEPIS$$42$YR$A$F$Y$$$20240716$$HP$GB$GB
240985671$24098567$1$I$$20240627$20240716$20240716$PER$$US-IMP-2024000438$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985682$24098568$2$F$$20240628$20240716$20240716$PER$$US-IMP-2024000445$Harrow Health$$$$A$M$Y$$$20240716$$CN$US$US
240985691$24098569$1$I$$20240715$20240716$20240716$PER$$NVSC2024US146501$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240985701$24098570$1$I$$20240628$20240716$20240716$PER$$US-IMP-2024000446$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985711$24098571$1$I$$20240628$20240716$20240716$PER$$US-IMP-2024000447$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985721$24098572$1$I$$20240709$20240716$20240716$EXP$$GB-AstraZeneca-2024A160150$ASTRAZENECA$$$$$$Y$$$20240716$$HP$GB$
240985731$24098573$1$I$20240601$20240701$20240716$20240716$PER$$US-IMP-2024000451$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985741$24098574$1$I$20240409$20240715$20240716$20240716$EXP$GB-MHRA-MED-202407091501372040-BJCML$GB-GILEAD-2024-0680742$GILEAD$$62$YR$A$F$Y$$$20240716$$HP$GB$GB
240985761$24098576$1$I$20240621$20240701$20240716$20240716$PER$$US-IMP-2024000454$Harrow Health$$88$YR$E$F$Y$$$20240716$$CN$US$US
240985771$24098577$1$I$20240608$20240701$20240716$20240716$PER$$US-IMP-2024000455$Harrow Health$$80$YR$E$F$Y$$$20240716$$CN$US$US
240985781$24098578$1$I$$20240701$20240716$20240716$PER$$US-IMP-2024000456$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985791$24098579$1$I$$20240701$20240716$20240716$PER$$US-IMP-2024000460$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985801$24098580$1$I$$20240701$20240716$20240716$EXP$$US-HLS-202400197$HLS THERAPEUTICS$$26$YR$A$M$Y$$$20240716$$HP$US$US
240985811$24098581$1$I$20240630$20240702$20240716$20240716$PER$$US-IMP-2024000459$Harrow Health$$79$YR$E$F$Y$$$20240716$$CN$US$US
240985821$24098582$1$I$20240101$20240702$20240716$20240716$PER$$US-IMP-2024000458$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985831$24098583$1$I$$20240702$20240716$20240716$PER$$US-IMP-2024000457$Harrow Health$$$$E$F$Y$$$20240716$$CN$US$US
240985841$24098584$1$I$$20240710$20240716$20240716$PER$$US-SA-2024SA205868$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240716$$CN$US$US
240985851$24098585$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA204908$SANOFI AVENTIS$$$$A$F$Y$108.8$KG$20240716$$MD$US$US
240985861$24098586$1$I$20240709$20240709$20240716$20240716$PER$$US-SA-2024SA205006$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240716$$MD$US$US
240985871$24098587$1$I$$20240716$20240716$20240716$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040054$BOEHRINGER INGELHEIM$$$$$$Y$$$20240716$$CN$US$US
240985881$24098588$1$I$20240607$20240708$20240716$20240716$PER$$US-SA-2024SA203235$SANOFI AVENTIS$$30$YR$A$F$Y$95.25$KG$20240716$$MD$US$US
240985891$24098589$1$I$20230818$20240708$20240716$20240716$EXP$DE-CADRBFARM-2024329058$DE-TEVA-VS-3218582$TEVA$$34$YR$$F$Y$68$KG$20240716$$CN$DE$DE
240985901$24098590$1$I$$20240715$20240716$20240716$PER$$NVSC2024US146500$NOVARTIS$$$$$$Y$$$20240716$$HP$US$US
240985911$24098591$1$I$20240101$20240705$20240716$20240716$PER$$US-SA-2024SA203168$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240717$$MD$US$US
240985922$24098592$2$F$20240701$20240811$20240716$20240820$PER$$US-SA-2024SA203569$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240820$$MD$US$US
240985931$24098593$1$I$20240601$20240708$20240716$20240716$PER$$US-SA-2024SA205082$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240717$$MD$US$US
240985941$24098594$1$I$20240201$20240705$20240716$20240716$PER$$US-SA-2024SA202891$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240717$$MD$US$US
240985951$24098595$1$I$20240601$20240708$20240716$20240716$PER$$US-SA-2024SA205131$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240717$$MD$US$US
240985962$24098596$2$F$20240101$20240815$20240716$20240828$PER$$US-SA-2024SA201350$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240828$$MD$US$US
240985971$24098597$1$I$$20240709$20240716$20240716$PER$$US-SA-2024SA203444$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240717$$MD$US$US
240985981$24098598$1$I$20230101$20240708$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407010145$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240716$$CN$US$US
240985991$24098599$1$I$20240701$20240705$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407004006$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240716$$CN$US$US
240986001$24098600$1$I$20230417$20240708$20240716$20240716$EXP$FR-AFSSAPS-LM2024000369$FR-TEVA-VS-3218804$TEVA$$39$YR$$F$Y$$$20240716$$MD$FR$FR
240986011$24098601$1$I$$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110530$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240716$$CN$US$US
240986022$24098602$2$F$20240101$20240808$20240716$20240810$PER$$US-JNJFOC-20240708080$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240810$$CN$US$US
240986031$24098603$1$I$$20240715$20240716$20240716$PER$$NVSC2024US146448$NOVARTIS$$$$$F$Y$78$KG$20240717$$CN$US$US
240986041$24098604$1$I$$20240710$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110382$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240716$$MD$US$US
240986063$24098606$3$F$20240123$20240808$20240716$20240814$EXP$$CO-TAKEDA-2024TUS010733$TAKEDA$$5$YR$$M$Y$20$KG$20240814$$CN$CO$CO
240986071$24098607$1$I$$20240702$20240716$20240716$EXP$$US-HLS-202400209$HLS THERAPEUTICS$$18$YR$A$M$Y$$$20240716$$HP$US$US
240986081$24098608$1$I$20240627$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024138496$AMGEN$$77$YR$E$F$Y$$$20240716$$CN$US$US
240986092$24098609$2$F$$20240801$20240716$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111727$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240804$$HP$US$US
240986111$24098611$1$I$$20240708$20240716$20240716$PER$$US-GILEAD-2024-0680402$GILEAD$$$$$$Y$$$20240716$$HP$US$US
240986121$24098612$1$I$$20240710$20240716$20240716$PER$$US-ALXN-202407USA000763US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
240986131$24098613$1$I$$20240702$20240716$20240716$EXP$$US-HLS-202400211$HLS THERAPEUTICS$$55$YR$A$M$Y$$$20240716$$PH$US$US
240986141$24098614$1$I$20240706$20240708$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159076$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240986152$24098615$2$F$20240101$20240718$20240716$20240806$PER$$US-JNJFOC-20240669877$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$CN$US$US
240986161$24098616$1$I$$20240712$20240716$20240716$EXP$$RO-TAKEDA-2024TUS071081$TAKEDA$$70$YR$$M$Y$$$20240716$$HP$RO$RO
240986171$24098617$1$I$20240708$20240709$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159115$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240986181$24098618$1$I$$20240710$20240716$20240716$PER$$US-ALXN-202407USA000750US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
240986191$24098619$1$I$$20240708$20240716$20240716$PER$$US-JNJFOC-20240741171$JOHNSON AND JOHNSON$$$$$M$Y$$$20240716$$CN$US$US
240986202$24098620$2$F$20240601$20240904$20240716$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111800$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240905$$HP$US$US
240986211$24098621$1$I$20220215$20240711$20240716$20240716$EXP$$US-TAKEDA-2021TUS023288$TAKEDA$$72$YR$$F$Y$73$KG$20240716$$HP$US$US
240986221$24098622$1$I$$20240702$20240716$20240716$EXP$$US-HLS-202400214$HLS THERAPEUTICS$$$$E$$Y$$$20240716$$HP$US$US
240986231$24098623$1$I$$20240710$20240716$20240716$PER$$US-ALXN-202407USA000710US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240716$$CN$US$US
240986241$24098624$1$I$$20240715$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407009870$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240716$$CN$US$US
240986251$24098625$1$I$$20240707$20240716$20240716$PER$$US-JNJFOC-20240718651$JOHNSON AND JOHNSON$$$$$F$Y$$$20240716$$CN$US$US
240986262$24098626$2$F$$20240807$20240716$20240807$PER$$US-ALXN-202407USA000709US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
240986271$24098627$1$I$20220501$20240708$20240716$20240716$EXP$$RO-AstraZeneca-2024A158832$ASTRAZENECA$$52$YR$$F$Y$95$KG$20240717$$MD$RO$
240986282$24098628$2$F$$20240821$20240716$20240827$EXP$$US-ALXN-202407USA000672US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
240986291$24098629$1$I$$20240702$20240716$20240716$EXP$$US-HLS-202400239$HLS THERAPEUTICS$$39$YR$A$M$Y$$$20240716$$HP$IN$US
240986301$24098630$1$I$$20240716$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407010113$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240716$$CN$US$US
240986312$24098631$2$F$20240716$20240716$20240716$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407008160$ELI LILLY AND CO$$87$YR$E$F$Y$$$20240722$$CN$US$US
240986321$24098632$1$I$$20240710$20240716$20240716$PER$$US-ALXN-202407USA000624US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240716$$CN$US$US
240986331$24098633$1$I$$20240702$20240716$20240716$EXP$$US-HLS-202400237$HLS THERAPEUTICS$$42$YR$A$F$Y$$$20240716$$HP$AE$US
240986341$24098634$1$I$$20240710$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159118$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240986352$24098635$2$F$20240201$20240918$20240716$20240920$EXP$$NVSC2024US145731$NOVARTIS$$60$YR$$F$Y$$$20240920$$MD$US$US
240986362$24098636$2$F$20240201$20240919$20240716$20240923$EXP$$NVSC2024US026463$NOVARTIS$$35$YR$$F$Y$$$20240923$$CN$US$US
240986371$24098637$1$I$$20240711$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159142$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240986381$24098638$1$I$20240606$20240709$20240716$20240716$EXP$IT-MINISAL02-993025$IT-TEVA-VS-3219299$TEVA$$60$YR$$M$Y$$$20240716$$MD$IT$IT
240986391$24098639$1$I$20240426$20240709$20240716$20240716$EXP$SE-SEMPA-2024-003666$SE-TEVA-VS-3219388$TEVA$$45$YR$$F$Y$78$KG$20240716$$CN$SE$SE
240986401$24098640$1$I$$20240710$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159163$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240986411$24098641$1$I$$20240710$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159122$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240986421$24098642$1$I$$20240710$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159162$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240986431$24098643$1$I$20240101$20240712$20240716$20240716$EXP$$CA-BIOGEN-2024BI01273791$BIOGEN$$$$$F$Y$$$20240716$$CN$CA$CA
240986441$24098644$1$I$20240621$20240709$20240716$20240716$EXP$IT-MINISAL02-993228$IT-TEVA-VS-3219402$TEVA$$$$$M$Y$$$20240716$$MD$IT$IT
240986451$24098645$1$I$$20240711$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159164$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240986461$24098646$1$I$$20240711$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159170$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240986471$24098647$1$I$$20240711$20240716$20240716$PER$$US-BIOMARINAP-US-2024-159144$BIOMARIN$$$$$$Y$$$20240716$$CN$US$US
240986481$24098648$1$I$$20230720$20240716$20240716$PER$$US-NOVOPROD-1096757$NOVO NORDISK$$73$YR$$M$Y$$$20240717$$CN$US$US
240986491$24098649$1$I$$20230802$20240716$20240716$PER$$US-NOVOPROD-1104883$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240986501$24098650$1$I$$20240207$20240716$20240716$PER$$US-NOVOPROD-1175423$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240986511$24098651$1$I$$20230811$20240716$20240716$PER$$US-NOVOPROD-1104942$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$HP$US$US
240986521$24098652$1$I$20240129$20240207$20240716$20240716$PER$$US-NOVOPROD-1175312$NOVO NORDISK$$50$YR$$M$Y$$$20240717$$CN$US$US
240986531$24098653$1$I$$20240212$20240716$20240716$PER$$US-NOVOPROD-1175523$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240986542$24098654$2$F$20231210$20240312$20240716$20240716$PER$$US-NOVOPROD-1175411$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
240986551$24098655$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1175507$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240986561$24098656$1$I$$20240207$20240716$20240716$PER$$US-NOVOPROD-1175322$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240986571$24098657$1$I$20240122$20240308$20240716$20240716$PER$$US-NOVOPROD-1175383$NOVO NORDISK$$54$YR$$F$Y$$$20240717$$CN$US$US
240986581$24098658$1$I$20240206$20240207$20240716$20240716$PER$$US-NOVOPROD-1175487$NOVO NORDISK$$29$YR$$F$Y$$$20240717$$CN$US$US
240986591$24098659$1$I$$20240207$20240716$20240716$PER$$US-NOVOPROD-1175361$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240986601$24098660$1$I$$20240205$20240716$20240716$PER$$US-NOVOPROD-1175466$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240986611$24098661$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1175897$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240986621$24098662$1$I$20230501$20240315$20240716$20240716$PER$$US-NOVOPROD-1175712$NOVO NORDISK$$33$YR$$M$Y$$$20240717$$CN$US$US
240986631$24098663$1$I$$20240206$20240716$20240716$PER$$US-NOVOPROD-1175675$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240986641$24098664$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1175850$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240986651$24098665$1$I$$20240207$20240716$20240716$PER$$US-NOVOPROD-1175908$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
240986661$24098666$1$I$$20240202$20240716$20240716$PER$$US-NOVOPROD-1175703$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240986671$24098667$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1175585$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$MD$US$US
240986681$24098668$1$I$$20240207$20240716$20240716$PER$$US-NOVOPROD-1175915$NOVO NORDISK$$65$YR$$$Y$$$20240717$$CN$US$US
240986691$24098669$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1175733$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240986701$24098670$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1175903$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240986711$24098671$1$I$20230101$20240304$20240716$20240716$PER$$US-NOVOPROD-1175990$NOVO NORDISK$$60$YR$$M$Y$124.72$KG$20240717$$MD$US$US
240986721$24098672$1$I$20230601$20240211$20240716$20240716$PER$$US-NOVOPROD-1175912$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
240986731$24098673$1$I$20230901$20240208$20240716$20240716$PER$$US-NOVOPROD-1175817$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
240986741$24098674$1$I$$20240206$20240716$20240716$PER$$US-NOVOPROD-1175655$NOVO NORDISK$$$$$M$Y$$$20240717$$PH$US$US
240986751$24098675$1$I$$20240127$20240716$20240716$PER$$US-NOVOPROD-1175676$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240986761$24098676$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1175843$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240986771$24098677$1$I$20230615$20240202$20240716$20240716$PER$$US-NOVOPROD-1175572$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240986781$24098678$1$I$20230601$20240208$20240716$20240716$PER$$US-NOVOPROD-1175638$NOVO NORDISK$$81$YR$$M$Y$$$20240717$$MD$US$US
240986791$24098679$1$I$20240208$20240208$20240716$20240716$PER$$US-NOVOPROD-1175609$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
240986801$24098680$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1175804$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240986811$24098681$1$I$20240131$20240208$20240716$20240716$PER$$US-NOVOPROD-1175871$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240986821$24098682$1$I$20230701$20240207$20240716$20240716$PER$$US-NOVOPROD-1175921$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240986831$24098683$1$I$20231130$20240311$20240716$20240716$PER$$US-NOVOPROD-1175891$NOVO NORDISK$$29$YR$$F$Y$$$20240717$$CN$US$US
240986841$24098684$1$I$20240201$20240207$20240716$20240716$PER$$US-NOVOPROD-1175715$NOVO NORDISK$$$$$F$Y$$$20240717$$PH$US$US
240986851$24098685$1$I$$20240209$20240716$20240716$PER$$US-NOVOPROD-1176554$NOVO NORDISK$$$$A$$Y$$$20240717$$MD$US$US
240986861$24098686$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1176007$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240986871$24098687$1$I$$20240304$20240716$20240716$PER$$US-NOVOPROD-1176807$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
240986881$24098688$1$I$$20240307$20240716$20240716$PER$$US-NOVOPROD-1176180$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
240986891$24098689$1$I$$20240213$20240716$20240716$PER$$US-NOVOPROD-1176501$NOVO NORDISK$$$$A$M$Y$$$20240717$$HP$US$US
240986901$24098690$1$I$$20240207$20240716$20240716$PER$$US-NOVOPROD-1176277$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240986911$24098691$1$I$$20240209$20240716$20240716$PER$$US-NOVOPROD-1176658$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240986921$24098692$1$I$20210701$20240208$20240716$20240716$PER$$US-NOVOPROD-1176821$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240986931$24098693$1$I$$20240418$20240716$20240716$PER$$US-NOVOPROD-1175997$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
240986941$24098694$1$I$20240207$20240208$20240716$20240716$PER$$US-NOVOPROD-1176123$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
240986951$24098695$1$I$$20240210$20240716$20240716$PER$$US-NOVOPROD-1176387$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$PH$US$US
240986961$24098696$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1176280$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240986971$24098697$1$I$20240130$20240322$20240716$20240716$PER$$US-NOVOPROD-1176292$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$MD$US$US
240986981$24098698$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1176145$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$MD$US$US
240986991$24098699$1$I$$20230525$20240716$20240716$PER$$US-NOVOPROD-1176508$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240987001$24098700$1$I$20240120$20240212$20240716$20240716$PER$$US-NOVOPROD-1176549$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
240987011$24098701$1$I$$20240213$20240716$20240716$PER$$US-NOVOPROD-1176774$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240987021$24098702$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1176149$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$HP$US$US
240987031$24098703$1$I$20231222$20240220$20240716$20240716$PER$$US-NOVOPROD-1176321$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
240987041$24098704$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1176291$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240987051$24098705$1$I$20240108$20240416$20240716$20240716$PER$$US-NOVOPROD-1176588$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
240987061$24098706$1$I$$20240209$20240716$20240716$PER$$US-NOVOPROD-1176432$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987071$24098707$1$I$$20240210$20240716$20240716$PER$$US-NOVOPROD-1176093$NOVO NORDISK$$54$YR$$F$Y$$$20240717$$PH$US$US
240987081$24098708$1$I$$20240209$20240716$20240716$PER$$US-NOVOPROD-1176429$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987091$24098709$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1176449$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240987101$24098710$1$I$20240101$20240212$20240716$20240716$PER$$US-NOVOPROD-1177109$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240987111$24098711$1$I$$20240213$20240716$20240716$PER$$US-NOVOPROD-1177226$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987121$24098712$1$I$$20240213$20240716$20240716$PER$$US-NOVOPROD-1177646$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240987131$24098713$1$I$$20240209$20240716$20240716$PER$$US-NOVOPROD-1177249$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240987141$24098714$1$I$$20240212$20240716$20240716$PER$$US-NOVOPROD-1177647$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240987151$24098715$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1177221$NOVO NORDISK$$80$YR$$F$Y$$$20240717$$MD$US$US
240987161$24098716$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1176938$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240987171$24098717$1$I$$20240213$20240716$20240716$PER$$US-NOVOPROD-1177788$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240987182$24098718$2$F$$20240207$20240716$20240716$PER$$US-NOVOPROD-1177737$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987191$24098719$1$I$$20240212$20240716$20240716$PER$$US-NOVOPROD-1176999$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987201$24098720$1$I$$20240213$20240716$20240716$PER$$US-NOVOPROD-1177119$NOVO NORDISK$$85$YR$$F$Y$$$20240717$$MD$US$US
240987211$24098721$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1177222$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987221$24098722$1$I$$20240212$20240716$20240716$PER$$US-NOVOPROD-1177201$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987231$24098723$1$I$$20230628$20240716$20240716$PER$$US-NOVOPROD-1097080$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240987241$24098724$1$I$$20240306$20240716$20240716$PER$$US-NOVOPROD-1177224$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987251$24098725$1$I$$20240213$20240716$20240716$PER$$US-NOVOPROD-1177634$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240987261$24098726$1$I$$20240212$20240716$20240716$PER$$US-NOVOPROD-1176958$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240987271$24098727$1$I$20240212$20240213$20240716$20240716$PER$$US-NOVOPROD-1177601$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987281$24098728$1$I$20240206$20240211$20240716$20240716$PER$$US-NOVOPROD-1177097$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987291$24098729$1$I$$20240213$20240716$20240716$PER$$US-NOVOPROD-1177537$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987301$24098730$1$I$20240212$20240610$20240716$20240716$PER$$US-NOVOPROD-1177667$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
240987311$24098731$1$I$$20230726$20240716$20240716$PER$$US-NOVOPROD-1098257$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240987321$24098732$1$I$20230704$20230823$20240716$20240716$PER$$US-NOVOPROD-1099259$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240987332$24098733$2$F$$20230703$20240716$20240716$PER$$US-NOVOPROD-1097885$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240987341$24098734$1$I$20230717$20230717$20240716$20240716$PER$$US-NOVOPROD-1097978$NOVO NORDISK$$47$YR$$M$Y$$$20240717$$CN$US$US
240987351$24098735$1$I$$20240214$20240716$20240716$PER$$US-NOVOPROD-1098614$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987361$24098736$1$I$$20230810$20240716$20240716$PER$$US-NOVOPROD-1103238$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240987371$24098737$1$I$20230724$20230726$20240716$20240716$PER$$US-NOVOPROD-1102933$NOVO NORDISK$$42$YR$$F$Y$$$20240717$$CN$US$US
240987381$24098738$1$I$20230515$20230724$20240716$20240716$PER$$US-NOVOPROD-1103149$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987391$24098739$1$I$$20230727$20240716$20240716$PER$$US-NOVOPROD-1101008$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240987402$24098740$2$F$20230501$20240214$20240716$20240716$PER$$US-NOVOPROD-1178092$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
240987411$24098741$1$I$20240131$20240401$20240716$20240716$PER$$US-NOVOPROD-1178417$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
240987421$24098742$1$I$20240206$20240213$20240716$20240716$PER$$US-NOVOPROD-1178085$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
240987431$24098743$1$I$20240104$20240215$20240716$20240716$PER$$US-NOVOPROD-1178424$NOVO NORDISK$$50$YR$$M$Y$$$20240717$$CN$US$US
240987441$24098744$1$I$$20240403$20240716$20240716$PER$$US-NOVOPROD-1178114$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987451$24098745$1$I$20240214$20240214$20240716$20240716$PER$$US-NOVOPROD-1178400$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240987461$24098746$1$I$$20240214$20240716$20240716$PER$$US-NOVOPROD-1178393$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240987471$24098747$1$I$20240207$20240214$20240716$20240716$PER$$US-NOVOPROD-1178399$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240987481$24098748$1$I$20240112$20240213$20240716$20240716$PER$$US-NOVOPROD-1178080$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
240987491$24098749$1$I$20240125$20240215$20240716$20240716$PER$$US-NOVOPROD-1178335$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
240987501$24098750$1$I$$20240306$20240716$20240716$PER$$US-NOVOPROD-1178238$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240987511$24098751$1$I$20240131$20240320$20240716$20240716$PER$$US-NOVOPROD-1178385$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240987521$24098752$1$I$$20240214$20240716$20240716$PER$$US-NOVOPROD-1178211$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987531$24098753$1$I$20240101$20240322$20240716$20240716$PER$$US-NOVOPROD-1178224$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
240987541$24098754$1$I$20240101$20240214$20240716$20240716$PER$$US-NOVOPROD-1178125$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
240987551$24098755$1$I$20230701$20240212$20240716$20240716$PER$$US-NOVOPROD-1178242$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987561$24098756$1$I$$20240209$20240716$20240716$PER$$US-NOVOPROD-1178095$NOVO NORDISK$$64$YR$$M$Y$$$20240717$$CN$US$US
240987571$24098757$1$I$20240201$20240214$20240716$20240716$PER$$US-NOVOPROD-1178549$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
240987581$24098758$1$I$20240615$20240709$20240716$20240716$EXP$FR-AFSSAPS-PO2024000732$FR-TEVA-VS-3219501$TEVA$$66$YR$$F$Y$54.5$KG$20240716$$MD$FR$FR
240987591$24098759$1$I$20231211$20240709$20240716$20240716$EXP$SE-SEMPA-2023-016715$SE-TEVA-VS-3219422$TEVA$$79$YR$$M$Y$$$20240716$$MD$SE$SE
240987601$24098760$1$I$$20240213$20240716$20240716$PER$$US-NOVOPROD-1178630$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
240987611$24098761$1$I$20230601$20240308$20240716$20240716$PER$$US-NOVOPROD-1178810$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
240987621$24098762$1$I$20231101$20240212$20240716$20240716$PER$$US-NOVOPROD-1178673$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240987632$24098763$2$F$20240213$20240419$20240716$20240716$PER$$US-NOVOPROD-1178662$NOVO NORDISK$$44$YR$$F$Y$$$20240717$$HP$US$US
240987641$24098764$1$I$20230901$20240322$20240716$20240716$PER$$US-NOVOPROD-1178815$NOVO NORDISK$$78$YR$$M$Y$$$20240717$$CN$US$US
240987651$24098765$1$I$$20240214$20240716$20240716$PER$$US-NOVOPROD-1178776$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987661$24098766$1$I$20230930$20240214$20240716$20240716$PER$$US-NOVOPROD-1178723$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240987671$24098767$1$I$20240124$20240213$20240716$20240716$PER$$US-NOVOPROD-1178663$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
240987681$24098768$1$I$20240213$20240214$20240716$20240716$PER$$US-NOVOPROD-1178546$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987691$24098769$1$I$20231001$20240213$20240716$20240716$PER$$US-NOVOPROD-1178603$NOVO NORDISK$$76$YR$$$Y$$$20240717$$CN$US$US
240987702$24098770$2$F$$20240215$20240716$20240716$PER$$US-NOVOPROD-1178767$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987711$24098771$1$I$$20240214$20240716$20240716$PER$$US-NOVOPROD-1178635$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
240987721$24098772$1$I$$20240214$20240716$20240716$PER$$US-NOVOPROD-1178732$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240987731$24098773$1$I$20230911$20240206$20240716$20240716$PER$$US-NOVOPROD-1178817$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240987741$24098774$1$I$$20240213$20240716$20240716$PER$$US-NOVOPROD-1178578$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240987751$24098775$1$I$20230512$20240213$20240716$20240716$PER$$US-NOVOPROD-1178489$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240987761$24098776$1$I$$20240214$20240716$20240716$PER$$US-NOVOPROD-1178819$NOVO NORDISK$$$$$F$Y$110.2$KG$20240717$$CN$US$US
240987771$24098777$1$I$20231201$20240213$20240716$20240716$PER$$US-NOVOPROD-1179130$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
240987781$24098778$1$I$20240418$20240712$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039707$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240717$$CN$US$US
240987791$24098779$1$I$$20240215$20240716$20240716$PER$$US-NOVOPROD-1179125$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240987801$24098780$1$I$20240219$20240528$20240716$20240716$PER$$US-NOVOPROD-1179272$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
240987811$24098781$1$I$$20240221$20240716$20240716$PER$$US-NOVOPROD-1179199$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987821$24098782$1$I$20240310$20240415$20240716$20240716$PER$$US-NOVOPROD-1178848$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240987831$24098783$1$I$20240212$20240215$20240716$20240716$PER$$US-NOVOPROD-1179221$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
240987842$24098784$2$F$20230215$20240215$20240716$20240717$PER$$US-NOVOPROD-1179031$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
240987851$24098785$1$I$20230201$20240326$20240716$20240716$PER$$US-NOVOPROD-1178852$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
240987861$24098786$1$I$20231019$20240319$20240716$20240716$PER$$US-NOVOPROD-1179239$NOVO NORDISK$$60$YR$$M$Y$$$20240717$$CN$US$US
240987871$24098787$1$I$20220101$20240214$20240716$20240716$PER$$US-NOVOPROD-1178899$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
240987882$24098788$2$F$20240301$20240624$20240716$20240716$PER$$US-NOVOPROD-1179257$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
240987891$24098789$1$I$$20240215$20240716$20240716$PER$$US-NOVOPROD-1179224$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240987901$24098790$1$I$$20240215$20240716$20240716$PER$$US-NOVOPROD-1179215$NOVO NORDISK$$$$A$M$Y$$$20240717$$MD$US$US
240987911$24098791$1$I$$20240215$20240716$20240716$PER$$US-NOVOPROD-1179024$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
240987921$24098792$1$I$$20240215$20240716$20240716$PER$$US-NOVOPROD-1179301$NOVO NORDISK$$77$YR$$M$Y$$$20240717$$MD$US$US
240987931$24098793$1$I$$20240214$20240716$20240716$PER$$US-NOVOPROD-1179299$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987941$24098794$1$I$$20240214$20240716$20240716$PER$$US-NOVOPROD-1179196$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987951$24098795$1$I$20231115$20240214$20240716$20240716$PER$$US-NOVOPROD-1179277$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240987961$24098796$1$I$20230301$20240308$20240716$20240716$PER$$US-NOVOPROD-1179353$NOVO NORDISK$$67$YR$$$Y$$$20240717$$MD$US$US
240987971$24098797$1$I$20230701$20230809$20240716$20240716$PER$$US-NOVOPROD-1106887$NOVO NORDISK$$41$YR$$F$Y$$$20240717$$CN$US$US
240987981$24098798$1$I$$20230810$20240716$20240716$PER$$US-NOVOPROD-1106714$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240987991$24098799$1$I$$20230816$20240716$20240716$PER$$US-NOVOPROD-1109005$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988001$24098800$1$I$$20230806$20240716$20240716$PER$$US-NOVOPROD-1108947$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240988011$24098801$1$I$$20230806$20240716$20240716$PER$$US-NOVOPROD-1108951$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988021$24098802$1$I$$20240513$20240716$20240716$PER$$US-NOVOPROD-1107560$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988031$24098803$1$I$20230809$20230817$20240716$20240716$PER$$US-NOVOPROD-1108167$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240988041$24098804$1$I$$20230804$20240716$20240716$PER$$US-NOVOPROD-1108879$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988051$24098805$1$I$20230101$20240419$20240716$20240716$PER$$US-NOVOPROD-1107576$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988061$24098806$1$I$20230627$20230816$20240716$20240716$PER$$US-NOVOPROD-1108246$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
240988071$24098807$1$I$20240207$20240213$20240716$20240716$PER$$US-NOVOPROD-1179695$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
240988081$24098808$1$I$$20240209$20240716$20240716$PER$$US-NOVOPROD-1178003$NOVO NORDISK$$64$YR$$M$Y$$$20240717$$CN$US$US
240988091$24098809$1$I$20230601$20240216$20240716$20240716$PER$$US-NOVOPROD-1179488$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
240988101$24098810$1$I$$20240213$20240716$20240716$PER$$US-NOVOPROD-1179692$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988111$24098811$1$I$20230731$20230807$20240716$20240716$PER$$US-NOVOPROD-1109802$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$CN$US$US
240988121$24098812$1$I$20240101$20240214$20240716$20240716$PER$$US-NOVOPROD-1179420$NOVO NORDISK$$83$YR$$M$Y$$$20240717$$CN$US$US
240988131$24098813$1$I$20231215$20240216$20240716$20240716$PER$$US-NOVOPROD-1179644$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
240988141$24098814$1$I$20230601$20240520$20240716$20240716$PER$$US-NOVOPROD-1179639$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
240988151$24098815$1$I$$20240212$20240716$20240716$PER$$US-NOVOPROD-1177848$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240988161$24098816$1$I$20240209$20240212$20240716$20240716$PER$$US-NOVOPROD-1177882$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
240988171$24098817$1$I$$20240215$20240716$20240716$PER$$US-NOVOPROD-1179393$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
240988181$24098818$1$I$$20240216$20240716$20240716$PER$$US-NOVOPROD-1179507$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988191$24098819$1$I$$20230814$20240716$20240716$PER$$US-NOVOPROD-1110031$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240988201$24098820$1$I$20240212$20240216$20240716$20240716$PER$$US-NOVOPROD-1179530$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240988211$24098821$1$I$20231101$20240212$20240716$20240716$PER$$US-NOVOPROD-1177831$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
240988221$24098822$1$I$$20230821$20240716$20240716$PER$$US-NOVOPROD-1109103$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240988231$24098823$1$I$$20240216$20240716$20240716$PER$$US-NOVOPROD-1179665$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988241$24098824$1$I$20240122$20240209$20240716$20240716$PER$$US-NOVOPROD-1177897$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988252$24098825$2$F$20230401$20240509$20240716$20240716$PER$$US-NOVOPROD-1179782$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
240988261$24098826$1$I$$20240219$20240716$20240716$PER$$US-NOVOPROD-1180035$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$HP$US$US
240988271$24098827$1$I$$20240219$20240716$20240716$PER$$US-NOVOPROD-1179884$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988281$24098828$1$I$$20240216$20240716$20240716$PER$$US-NOVOPROD-1179697$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
240988291$24098829$1$I$20240201$20240216$20240716$20240716$PER$$US-NOVOPROD-1179781$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
240988301$24098830$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1179795$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988311$24098831$1$I$$20230817$20240716$20240716$PER$$US-NOVOPROD-1110609$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988321$24098832$1$I$$20230816$20240716$20240716$PER$$US-NOVOPROD-1112076$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988331$24098833$1$I$$20240715$20240716$20240716$EXP$$BR-BEIGENE-BGN-2024-011054$BEIGENE$$$$$$Y$$$20240716$$MD$BR$BR
240988341$24098834$1$I$$20240710$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407006697$ELI LILLY AND CO$$$$$$Y$$$20240716$$CN$US$US
240988351$24098835$1$I$$20230907$20240716$20240716$PER$$US-NOVOPROD-1118168$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240988361$24098836$1$I$$20230907$20240716$20240716$PER$$US-NOVOPROD-1115716$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240988371$24098837$1$I$20230901$20230905$20240716$20240716$PER$$US-NOVOPROD-1117309$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
240988381$24098838$1$I$20230301$20230919$20240716$20240716$PER$$US-NOVOPROD-1119334$NOVO NORDISK$$49$YR$$F$Y$$$20240717$$CN$US$US
240988391$24098839$1$I$$20230919$20240716$20240716$PER$$US-NOVOPROD-1119715$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988401$24098840$1$I$20230909$20230914$20240716$20240716$PER$$US-NOVOPROD-1119760$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240988411$24098841$1$I$20231006$20240715$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113010$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240717$$MD$US$US
240988421$24098842$1$I$20240716$20240716$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040146$BOEHRINGER INGELHEIM$$91$YR$E$F$Y$$$20240717$$CN$US$US
240988431$24098843$1$I$$20240103$20240716$20240716$PER$$US-NOVOPROD-1160869$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988441$24098844$1$I$20240103$20240123$20240716$20240716$PER$$US-NOVOPROD-1160960$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$CN$US$US
240988451$24098845$1$I$20231228$20240104$20240716$20240716$PER$$US-NOVOPROD-1160852$NOVO NORDISK$$72$YR$$M$Y$$$20240717$$CN$US$US
240988461$24098846$1$I$20240102$20240103$20240716$20240716$PER$$US-NOVOPROD-1160830$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988471$24098847$1$I$20231201$20240103$20240716$20240716$PER$$US-NOVOPROD-1160656$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
240988481$24098848$1$I$20230903$20231010$20240716$20240716$PER$$US-NOVOPROD-1119880$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
240988491$24098849$1$I$$20240104$20240716$20240716$PER$$US-NOVOPROD-1160517$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988501$24098850$1$I$$20240311$20240716$20240716$PER$$US-NOVOPROD-1160413$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240988511$24098851$1$I$20231130$20240103$20240716$20240716$PER$$US-NOVOPROD-1160532$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
240988521$24098852$1$I$20231226$20240118$20240716$20240716$PER$$US-NOVOPROD-1160495$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$MD$US$US
240988531$24098853$1$I$$20240103$20240716$20240716$PER$$US-NOVOPROD-1160591$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988541$24098854$1$I$20231001$20240103$20240716$20240716$PER$$US-NOVOPROD-1160846$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$HP$US$US
240988551$24098855$1$I$$20240101$20240716$20240716$PER$$US-NOVOPROD-1160790$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240988561$24098856$1$I$$20240711$20240716$20240716$EXP$$JP-SAKK-2024SA203519AA$SANOFI AVENTIS$$$$$$Y$$$20240717$$PH$JP$JP
240988571$24098857$1$I$20231205$20240206$20240716$20240716$PER$$US-NOVOPROD-1161567$NOVO NORDISK$$49$YR$$M$Y$97.959$KG$20240717$$MD$US$US
240988581$24098858$1$I$$20240103$20240716$20240716$PER$$US-NOVOPROD-1160996$NOVO NORDISK$$50$YR$$F$Y$$$20240717$$HP$US$US
240988591$24098859$1$I$$20240104$20240716$20240716$PER$$US-NOVOPROD-1160982$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240988601$24098860$1$I$20231229$20240105$20240716$20240716$PER$$US-NOVOPROD-1161415$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$MD$US$US
240988611$24098861$1$I$20230104$20240103$20240716$20240716$PER$$US-NOVOPROD-1160993$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
240988621$24098862$1$I$20231229$20240104$20240716$20240716$PER$$US-NOVOPROD-1161071$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988631$24098863$1$I$$20240108$20240716$20240716$PER$$US-NOVOPROD-1161191$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240988641$24098864$1$I$$20240207$20240716$20240716$PER$$US-NOVOPROD-1161194$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988651$24098865$1$I$$20240105$20240716$20240716$PER$$US-NOVOPROD-1161545$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988661$24098866$1$I$20240105$20240106$20240716$20240716$PER$$US-NOVOPROD-1161215$NOVO NORDISK$$25$YR$$M$Y$$$20240717$$MD$US$US
240988671$24098867$1$I$$20240104$20240716$20240716$PER$$US-NOVOPROD-1161060$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240988681$24098868$1$I$$20240105$20240716$20240716$PER$$US-NOVOPROD-1161395$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240988691$24098869$1$I$20231225$20240324$20240716$20240716$PER$$US-NOVOPROD-1161204$NOVO NORDISK$$54$YR$$$Y$$$20240717$$CN$US$US
240988701$24098870$1$I$$20240104$20240716$20240716$PER$$US-NOVOPROD-1161160$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988711$24098871$1$I$$20240104$20240716$20240716$PER$$US-NOVOPROD-1161068$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240988721$24098872$1$I$20231223$20240104$20240716$20240716$PER$$US-NOVOPROD-1160971$NOVO NORDISK$$73$YR$$M$Y$$$20240717$$CN$US$US
240988731$24098873$1$I$20231014$20240105$20240716$20240716$PER$$US-NOVOPROD-1161133$NOVO NORDISK$$35$YR$$F$Y$$$20240717$$CN$US$US
240988742$24098874$2$F$$20240125$20240716$20240716$PER$$US-NOVOPROD-1160969$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240988751$24098875$1$I$$20240312$20240716$20240716$PER$$US-NOVOPROD-1161594$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988761$24098876$1$I$20230901$20240311$20240716$20240716$PER$$US-NOVOPROD-1161554$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$HP$US$US
240988771$24098877$1$I$20231128$20240104$20240716$20240716$PER$$US-NOVOPROD-1161021$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
240988781$24098878$1$I$$20240102$20240716$20240716$PER$$US-NOVOPROD-1161034$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240988791$24098879$1$I$$20240110$20240716$20240716$PER$$US-NOVOPROD-1163353$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240988801$24098880$1$I$$20240110$20240716$20240716$PER$$US-NOVOPROD-1163120$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240988811$24098881$1$I$20231010$20240206$20240716$20240716$PER$$US-NOVOPROD-1163304$NOVO NORDISK$$54$YR$$F$Y$$$20240717$$CN$US$US
240988821$24098882$1$I$20231229$20240105$20240716$20240716$PER$$US-NOVOPROD-1163360$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988831$24098883$1$I$20231101$20240324$20240716$20240716$PER$$US-NOVOPROD-1163068$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
240988841$24098884$1$I$$20240104$20240716$20240716$PER$$US-NOVOPROD-1161603$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988851$24098885$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1162769$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240988861$24098886$1$I$$20240110$20240716$20240716$PER$$US-NOVOPROD-1163184$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$MD$US$US
240988871$24098887$1$I$$20240111$20240716$20240716$PER$$US-NOVOPROD-1163043$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988881$24098888$1$I$20231231$20240108$20240716$20240716$PER$$US-NOVOPROD-1163129$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240988891$24098889$1$I$20230901$20240108$20240716$20240716$PER$$US-NOVOPROD-1163384$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
240988901$24098890$1$I$20240106$20240112$20240716$20240716$PER$$US-NOVOPROD-1163014$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
240988911$24098891$1$I$$20240110$20240716$20240716$PER$$US-NOVOPROD-1163389$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988921$24098892$1$I$$20240108$20240716$20240716$PER$$US-NOVOPROD-1163109$NOVO NORDISK$$$$A$F$Y$$$20240717$$HP$US$US
240988931$24098893$1$I$$20240108$20240716$20240716$PER$$US-NOVOPROD-1162920$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988941$24098894$1$I$$20240108$20240716$20240716$PER$$US-NOVOPROD-1163102$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240988951$24098895$1$I$20230602$20240105$20240716$20240716$PER$$US-NOVOPROD-1161599$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240988961$24098896$1$I$$20240109$20240716$20240716$PER$$US-NOVOPROD-1163257$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240988971$24098897$1$I$20240703$20240709$20240716$20240716$EXP$$CO-JNJFOC-20240725939$JOHNSON AND JOHNSON$$31$YR$A$F$Y$59$KG$20240717$$HP$CO$CO
240988991$24098899$1$I$$20240709$20240716$20240716$EXP$$CA-BIOGEN-2024BI01273872$BIOGEN$$$$$F$Y$$$20240716$$CN$CA$CA
240989002$24098900$2$F$20240101$20240325$20240716$20240716$PER$$US-NOVOPROD-1163565$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$MD$US$US
240989011$24098901$1$I$$20240110$20240716$20240716$PER$$US-NOVOPROD-1163436$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989021$24098902$1$I$20240110$20240111$20240716$20240716$PER$$US-NOVOPROD-1164102$NOVO NORDISK$$39$YR$$M$Y$$$20240717$$CN$US$US
240989031$24098903$1$I$$20240110$20240716$20240716$PER$$US-NOVOPROD-1163878$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989041$24098904$1$I$$20240111$20240716$20240716$PER$$US-NOVOPROD-1163621$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
240989051$24098905$1$I$$20240112$20240716$20240716$PER$$US-NOVOPROD-1163993$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989061$24098906$1$I$20231201$20240110$20240716$20240716$PER$$US-NOVOPROD-1163893$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
240989071$24098907$1$I$$20240109$20240716$20240716$PER$$US-NOVOPROD-1163589$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240989081$24098908$1$I$20240111$20240111$20240716$20240716$PER$$US-NOVOPROD-1163532$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
240989091$24098909$1$I$20230401$20240112$20240716$20240716$PER$$US-NOVOPROD-1164055$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$PH$US$US
240989101$24098910$1$I$$20240110$20240716$20240716$PER$$US-NOVOPROD-1163427$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240989112$24098911$2$F$20230101$20240110$20240716$20240716$PER$$US-NOVOPROD-1163420$NOVO NORDISK$$79$YR$$M$Y$$$20240717$$CN$US$US
240989121$24098912$1$I$$20240112$20240716$20240716$PER$$US-NOVOPROD-1164076$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240989131$24098913$1$I$20231225$20240108$20240716$20240716$PER$$US-NOVOPROD-1164057$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
240989141$24098914$1$I$20230110$20240117$20240716$20240716$PER$$US-NOVOPROD-1163888$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
240989151$24098915$1$I$20231101$20240125$20240716$20240716$PER$$US-NOVOPROD-1163901$NOVO NORDISK$$75$YR$$M$Y$$$20240717$$CN$US$US
240989161$24098916$1$I$$20240111$20240716$20240716$PER$$US-NOVOPROD-1163922$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989171$24098917$1$I$$20240322$20240716$20240716$PER$$US-NOVOPROD-1164082$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989181$24098918$1$I$20231201$20240112$20240716$20240716$PER$$US-NOVOPROD-1164036$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
240989191$24098919$1$I$$20240112$20240716$20240716$PER$$US-NOVOPROD-1164018$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989201$24098920$1$I$20240109$20240112$20240716$20240716$PER$$US-NOVOPROD-1164084$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240989221$24098922$1$I$20110101$20240711$20240716$20240716$EXP$$US-ABBVIE-5838191$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240989231$24098923$1$I$20240301$20240712$20240716$20240716$EXP$$US-ABBVIE-5839800$ABBVIE$$80$YR$$F$Y$$$20240716$$CN$US$US
240989241$24098924$1$I$20240710$20240711$20240716$20240716$EXP$$CA-ABBVIE-5838884$ABBVIE$$$$E$M$Y$$$20240716$$CN$CA$CA
240989251$24098925$1$I$$20240110$20240716$20240716$PER$$US-NOVOPROD-1164330$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989261$24098926$1$I$20180101$20240112$20240716$20240716$PER$$US-NOVOPROD-1164430$NOVO NORDISK$$38$YR$$F$Y$$$20240717$$CN$US$US
240989272$24098927$2$F$$20240202$20240716$20240716$PER$$US-NOVOPROD-1164120$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240989281$24098928$1$I$$20240108$20240716$20240716$PER$$US-NOVOPROD-1164257$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989291$24098929$1$I$$20240105$20240716$20240716$PER$$US-NOVOPROD-1161607$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240989301$24098930$1$I$20240105$20240112$20240716$20240716$PER$$US-NOVOPROD-1164305$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989311$24098931$1$I$$20240112$20240716$20240716$PER$$US-NOVOPROD-1164130$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989321$24098932$1$I$$20240111$20240716$20240716$PER$$US-NOVOPROD-1164249$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989331$24098933$1$I$20240101$20240112$20240716$20240716$PER$$US-NOVOPROD-1164108$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240989341$24098934$1$I$20240112$20240116$20240716$20240716$PER$$US-NOVOPROD-1164175$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
240989351$24098935$1$I$20230101$20240108$20240716$20240716$PER$$US-NOVOPROD-1161654$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
240989361$24098936$1$I$$20240112$20240716$20240716$PER$$US-NOVOPROD-1164118$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989371$24098937$1$I$20240102$20240125$20240716$20240716$PER$$US-NOVOPROD-1161728$NOVO NORDISK$$76$YR$$M$Y$104.22$KG$20240717$$HP$US$US
240989381$24098938$1$I$20231101$20240109$20240716$20240716$PER$$US-NOVOPROD-1162009$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
240989391$24098939$1$I$20231201$20240105$20240716$20240716$PER$$US-NOVOPROD-1161990$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
240989401$24098940$1$I$20231208$20240208$20240716$20240716$PER$$US-NOVOPROD-1161763$NOVO NORDISK$$78$YR$$M$Y$$$20240717$$CN$US$US
240989411$24098941$1$I$$20240202$20240716$20240716$PER$$US-NOVOPROD-1161793$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989421$24098942$1$I$$20240108$20240716$20240716$PER$$US-NOVOPROD-1162082$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240989431$24098943$1$I$20231225$20240105$20240716$20240716$PER$$US-NOVOPROD-1161993$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
240989441$24098944$1$I$$20240110$20240716$20240716$PER$$US-NOVOPROD-1161819$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989451$24098945$1$I$20230101$20240108$20240716$20240716$PER$$US-NOVOPROD-1162145$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240989461$24098946$1$I$$20240104$20240716$20240716$PER$$US-NOVOPROD-1161810$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989471$24098947$1$I$$20240109$20240716$20240716$PER$$US-NOVOPROD-1162168$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240989481$24098948$1$I$$20240108$20240716$20240716$PER$$US-NOVOPROD-1161759$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989491$24098949$1$I$20240108$20240109$20240716$20240716$PER$$US-NOVOPROD-1161861$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
240989501$24098950$1$I$20231224$20240108$20240716$20240716$PER$$US-NOVOPROD-1162015$NOVO NORDISK$$54$YR$$F$Y$$$20240717$$CN$US$US
240989511$24098951$1$I$$20240108$20240716$20240716$PER$$US-NOVOPROD-1162034$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
240989521$24098952$1$I$20230902$20240105$20240716$20240716$PER$$US-NOVOPROD-1161878$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240989531$24098953$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1162130$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240989541$24098954$1$I$20231201$20240109$20240716$20240716$PER$$US-NOVOPROD-1162004$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
240989551$24098955$1$I$$20240109$20240716$20240716$PER$$US-NOVOPROD-1162171$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240989561$24098956$1$I$20240620$20240711$20240716$20240716$EXP$$US-ABBVIE-5837236$ABBVIE$$88$YR$$M$Y$$$20240716$$CN$US$US
240989571$24098957$1$I$20221025$20240708$20240716$20240716$EXP$$ES-JNJFOC-20240723978$JOHNSON AND JOHNSON$$34$YR$A$F$Y$66.9$KG$20240717$$MD$ES$ES
240989581$24098958$1$I$20240107$20240108$20240716$20240716$PER$$US-NOVOPROD-1162239$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
240989591$24098959$1$I$20230901$20240109$20240716$20240716$PER$$US-NOVOPROD-1162577$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240989601$24098960$1$I$20231217$20240109$20240716$20240716$PER$$US-NOVOPROD-1162544$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989611$24098961$1$I$20231219$20240109$20240716$20240716$PER$$US-NOVOPROD-1162609$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989621$24098962$1$I$20231115$20240220$20240716$20240716$PER$$US-NOVOPROD-1162319$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
240989631$24098963$1$I$$20240110$20240716$20240716$PER$$US-NOVOPROD-1162409$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240989641$24098964$1$I$$20240109$20240716$20240716$PER$$US-NOVOPROD-1162613$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989651$24098965$1$I$$20240109$20240716$20240716$PER$$US-NOVOPROD-1162314$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240989661$24098966$1$I$20240109$20240109$20240716$20240716$PER$$US-NOVOPROD-1162583$NOVO NORDISK$$46$YR$$F$Y$$$20240717$$CN$US$US
240989671$24098967$1$I$20231230$20240108$20240716$20240716$PER$$US-NOVOPROD-1162533$NOVO NORDISK$$33$YR$$F$Y$$$20240717$$CN$US$US
240989681$24098968$1$I$20240101$20240109$20240716$20240716$PER$$US-NOVOPROD-1162684$NOVO NORDISK$$62$YR$$M$Y$$$20240717$$MD$US$US
240989691$24098969$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1162568$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989702$24098970$2$F$20240101$20240109$20240716$20240716$PER$$US-NOVOPROD-1162633$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
240989711$24098971$1$I$20231220$20240109$20240716$20240716$PER$$US-NOVOPROD-1162351$NOVO NORDISK$$76$YR$$$Y$$$20240717$$CN$US$US
240989721$24098972$1$I$20230601$20240112$20240716$20240716$PER$$US-NOVOPROD-1164903$NOVO NORDISK$$52$YR$$F$Y$$$20240717$$CN$US$US
240989731$24098973$1$I$20231201$20240112$20240716$20240716$PER$$US-NOVOPROD-1164822$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989741$24098974$1$I$$20240710$20240716$20240716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110215$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240717$$HP$CA$CA
240989751$24098975$1$I$20231231$20240115$20240716$20240716$PER$$US-NOVOPROD-1164771$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
240989761$24098976$1$I$20240101$20240304$20240716$20240716$PER$$US-NOVOPROD-1164910$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240989771$24098977$1$I$$20240117$20240716$20240716$PER$$US-NOVOPROD-1164999$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240989781$24098978$1$I$20240109$20240116$20240716$20240716$PER$$US-NOVOPROD-1164851$NOVO NORDISK$$46$YR$$F$Y$$$20240717$$CN$US$US
240989791$24098979$1$I$$20240116$20240716$20240716$PER$$US-NOVOPROD-1164819$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989801$24098980$1$I$20230101$20240116$20240716$20240716$PER$$US-NOVOPROD-1164835$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240989811$24098981$1$I$$20240112$20240716$20240716$PER$$US-NOVOPROD-1164886$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240989821$24098982$1$I$20231208$20240308$20240716$20240716$PER$$US-NOVOPROD-1164544$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240989831$24098983$1$I$20230131$20240111$20240716$20240716$PER$$US-NOVOPROD-1165039$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240989841$24098984$1$I$20230101$20240513$20240716$20240716$PER$$US-NOVOPROD-1164733$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240989851$24098985$1$I$$20240116$20240716$20240716$PER$$US-NOVOPROD-1165001$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240989861$24098986$1$I$20230701$20240114$20240716$20240716$PER$$US-NOVOPROD-1164929$NOVO NORDISK$$77$YR$$M$Y$$$20240717$$CN$US$US
240989871$24098987$1$I$$20240116$20240716$20240716$PER$$US-NOVOPROD-1165045$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989881$24098988$1$I$$20240116$20240716$20240716$PER$$US-NOVOPROD-1164948$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
240989891$24098989$1$I$20231201$20240116$20240716$20240716$PER$$US-NOVOPROD-1164829$NOVO NORDISK$$75$YR$$M$Y$$$20240717$$CN$US$US
240989901$24098990$1$I$$20240112$20240716$20240716$PER$$US-NOVOPROD-1164531$NOVO NORDISK$$31$YR$$F$Y$$$20240717$$HP$US$US
240989911$24098991$1$I$20240111$20240115$20240716$20240716$PER$$US-NOVOPROD-1164927$NOVO NORDISK$$46$YR$$F$Y$$$20240717$$HP$US$US
240989921$24098992$1$I$$20230809$20240716$20240716$PER$$US-NOVOPROD-1162760$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240989931$24098993$1$I$$20240708$20240716$20240716$EXP$$JP-009507513-2407JPN001858J$MERCK$$53$YR$$$Y$$$20240716$$MD$JP$JP
240989941$24098994$1$I$$20240708$20240716$20240716$EXP$$JP-009507513-2407JPN001854J$MERCK$$73$YR$$$Y$$$20240716$$MD$JP$JP
240989951$24098995$1$I$$20240113$20240716$20240716$PER$$US-NOVOPROD-1165412$NOVO NORDISK$$$$$F$Y$198.19$KG$20240717$$CN$US$US
240989961$24098996$1$I$20240110$20240116$20240716$20240716$PER$$US-NOVOPROD-1165436$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989971$24098997$1$I$$20240126$20240716$20240716$PER$$US-NOVOPROD-1165736$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989981$24098998$1$I$$20240116$20240716$20240716$PER$$US-NOVOPROD-1165466$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240989991$24098999$1$I$$20240117$20240716$20240716$PER$$US-NOVOPROD-1165867$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240990001$24099000$1$I$20230615$20240305$20240716$20240716$PER$$US-NOVOPROD-1165794$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
240990011$24099001$1$I$$20240112$20240716$20240716$PER$$US-NOVOPROD-1165204$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240990021$24099002$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1165574$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240990031$24099003$1$I$20220101$20240119$20240716$20240716$PER$$US-NOVOPROD-1165830$NOVO NORDISK$$71$YR$$M$Y$99.773$KG$20240717$$CN$US$US
240990041$24099004$1$I$$20240117$20240716$20240716$PER$$US-NOVOPROD-1165290$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240990051$24099005$1$I$20231028$20240118$20240716$20240716$PER$$US-NOVOPROD-1165845$NOVO NORDISK$$78$YR$$M$Y$$$20240717$$CN$US$US
240990061$24099006$1$I$20240118$20240118$20240716$20240716$PER$$US-NOVOPROD-1165057$NOVO NORDISK$$40$YR$$F$Y$$$20240717$$HP$US$US
240990071$24099007$1$I$20230801$20240110$20240716$20240716$PER$$US-NOVOPROD-1165372$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990081$24099008$1$I$$20240117$20240716$20240716$PER$$US-NOVOPROD-1165381$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240990091$24099009$1$I$$20240116$20240716$20240716$PER$$US-NOVOPROD-1165839$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240990101$24099010$1$I$20240127$20240202$20240716$20240716$PER$$US-NOVOPROD-1165789$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
240990111$24099011$1$I$$20240116$20240716$20240716$PER$$US-NOVOPROD-1165468$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
240990121$24099012$1$I$20240104$20240206$20240716$20240716$PER$$US-NOVOPROD-1165327$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$PH$US$US
240990131$24099013$1$I$20231120$20240117$20240716$20240716$PER$$US-NOVOPROD-1165556$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240990141$24099014$1$I$20231211$20240108$20240716$20240716$PER$$US-NOVOPROD-1165277$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
240990151$24099015$1$I$$20240108$20240716$20240716$PER$$US-NOVOPROD-1165590$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990161$24099016$1$I$$20240114$20240716$20240716$PER$$US-NOVOPROD-1165464$NOVO NORDISK$$$$A$F$Y$$$20240717$$MD$US$US
240990171$24099017$1$I$20191119$20240116$20240716$20240716$PER$$US-NOVOPROD-1165507$NOVO NORDISK$$39$YR$$F$Y$$$20240717$$CN$US$US
240990181$24099018$1$I$20230904$20240710$20240716$20240716$EXP$$US-ABBVIE-5839821$ABBVIE$$68$YR$$M$Y$$$20240716$$CN$US$US
240990191$24099019$1$I$20231201$20240117$20240716$20240716$PER$$US-NOVOPROD-1166245$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240990201$24099020$1$I$20231105$20240117$20240716$20240716$PER$$US-NOVOPROD-1165935$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240990211$24099021$1$I$20240111$20240117$20240716$20240716$PER$$US-NOVOPROD-1166175$NOVO NORDISK$$47$YR$$M$Y$$$20240717$$MD$US$US
240990221$24099022$1$I$$20240306$20240716$20240716$PER$$US-NOVOPROD-1166082$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240990231$24099023$1$I$20231101$20240117$20240716$20240716$PER$$US-NOVOPROD-1166336$NOVO NORDISK$$84$YR$$F$Y$$$20240717$$CN$US$US
240990242$24099024$2$F$$20240130$20240716$20240716$PER$$US-NOVOPROD-1166438$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990251$24099025$1$I$20231201$20240118$20240716$20240716$PER$$US-NOVOPROD-1165893$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990261$24099026$1$I$$20240118$20240716$20240716$PER$$US-NOVOPROD-1165980$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990271$24099027$1$I$20230701$20240117$20240716$20240716$PER$$US-NOVOPROD-1165995$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240990281$24099028$1$I$20240112$20240118$20240716$20240716$PER$$US-NOVOPROD-1166224$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
240990291$24099029$1$I$$20240116$20240716$20240716$PER$$US-NOVOPROD-1166103$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240990301$24099030$1$I$$20240116$20240716$20240716$PER$$US-NOVOPROD-1166117$NOVO NORDISK$$80$YR$$M$Y$$$20240717$$MD$US$US
240990311$24099031$1$I$$20240118$20240716$20240716$PER$$US-NOVOPROD-1166111$NOVO NORDISK$$48$YR$$F$Y$$$20240717$$CN$US$US
240990321$24099032$1$I$$20240118$20240716$20240716$PER$$US-NOVOPROD-1166076$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240990331$24099033$1$I$20240118$20240118$20240716$20240716$PER$$US-NOVOPROD-1165910$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
240990341$24099034$1$I$$20240117$20240716$20240716$PER$$US-NOVOPROD-1166347$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990351$24099035$1$I$$20231229$20240716$20240716$PER$$US-NOVOPROD-1165988$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990361$24099036$1$I$20230601$20240117$20240716$20240716$PER$$US-NOVOPROD-1166408$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
240990371$24099037$1$I$$20240114$20240716$20240716$PER$$US-NOVOPROD-1165917$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990381$24099038$1$I$20231101$20240205$20240716$20240716$PER$$US-NOVOPROD-1166375$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
240990391$24099039$1$I$$20240118$20240716$20240716$PER$$US-NOVOPROD-1166540$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240990401$24099040$1$I$$20240119$20240716$20240716$PER$$US-NOVOPROD-1166166$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990411$24099041$1$I$20240606$20240715$20240716$20240716$EXP$FR-AFSSAPS-CF2024000332$FR-GILEAD-2024-0680788$GILEAD$$63$YR$A$F$Y$74$KG$20240716$$PH$FR$FR
240990422$24099042$2$F$20240513$20240716$20240716$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113029$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240718$$HP$US$US
240990431$24099043$1$I$20240104$20240320$20240716$20240716$PER$$US-NOVOPROD-1166548$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
240990441$24099044$1$I$20240104$20240119$20240716$20240716$PER$$US-NOVOPROD-1166731$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990451$24099045$1$I$$20230731$20240716$20240716$PER$$US-NOVOPROD-1166834$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240990461$24099046$1$I$$20240119$20240716$20240716$PER$$US-NOVOPROD-1166824$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240990471$24099047$1$I$20221001$20240305$20240716$20240716$PER$$US-NOVOPROD-1166821$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
240990481$24099048$1$I$20230813$20240118$20240716$20240716$PER$$US-NOVOPROD-1166900$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990491$24099049$1$I$20240104$20240117$20240716$20240716$PER$$US-NOVOPROD-1166638$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
240990501$24099050$1$I$20231201$20240119$20240716$20240716$PER$$US-NOVOPROD-1166637$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990511$24099051$1$I$$20240119$20240716$20240716$PER$$US-NOVOPROD-1166635$NOVO NORDISK$$83$YR$$M$Y$$$20240717$$CN$US$US
240990521$24099052$1$I$$20240119$20240716$20240716$PER$$US-NOVOPROD-1166829$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990531$24099053$1$I$20240118$20240122$20240716$20240716$PER$$US-NOVOPROD-1166643$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
240990541$24099054$1$I$20230101$20240119$20240716$20240716$PER$$US-NOVOPROD-1166676$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
240990551$24099055$1$I$$20230802$20240716$20240716$PER$$US-NOVOPROD-1166795$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240990561$24099056$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1167379$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240990571$24099057$1$I$20240112$20240118$20240716$20240716$PER$$US-NOVOPROD-1166576$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
240990581$24099058$1$I$$20240118$20240716$20240716$PER$$US-NOVOPROD-1166687$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240990591$24099059$1$I$$20240119$20240716$20240716$PER$$US-NOVOPROD-1166955$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990601$24099060$1$I$$20240117$20240716$20240716$PER$$US-NOVOPROD-1166741$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
240990611$24099061$1$I$$20240119$20240716$20240716$PER$$US-NOVOPROD-1166820$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240990621$24099062$1$I$$20230711$20240716$20240716$PER$$US-NOVOPROD-1166931$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990631$24099063$1$I$$20240118$20240716$20240716$PER$$US-NOVOPROD-1166552$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240990641$24099064$1$I$20231113$20240119$20240716$20240716$PER$$US-NOVOPROD-1166663$NOVO NORDISK$$81$YR$$M$Y$$$20240717$$CN$US$US
240990651$24099065$1$I$$20240118$20240716$20240716$PER$$US-NOVOPROD-1166897$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240990661$24099066$1$I$$20240118$20240716$20240716$PER$$US-NOVOPROD-1166739$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990672$24099067$2$F$$20240801$20240716$20240806$EXP$$JP-SA-2024SA178249$SANOFI AVENTIS$$$$$$Y$$$20240807$$MD$JP$JP
240990681$24099068$1$I$20240301$20240708$20240716$20240716$EXP$$US-ABBVIE-5836050$ABBVIE$$45$YR$$F$Y$$$20240716$$CN$US$US
240990692$24099069$2$F$$20240724$20240716$20240813$PER$$US-AstraZeneca-2024A146221$ASTRAZENECA$$63$YR$$F$Y$74.8$KG$20240813$$CN$US$
240990701$24099070$1$I$$20230613$20240716$20240716$PER$$US-NOVOPROD-1167310$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240990711$24099071$1$I$20240113$20240118$20240716$20240716$PER$$US-NOVOPROD-1167131$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
240990722$24099072$2$F$20240114$20240122$20240716$20240716$PER$$US-NOVOPROD-1167584$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
240990731$24099073$1$I$20231101$20240117$20240716$20240716$PER$$US-NOVOPROD-1167175$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
240990741$24099074$1$I$20230101$20230726$20240716$20240716$PER$$US-NOVOPROD-1168266$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240990751$24099075$1$I$$20240122$20240716$20240716$PER$$US-NOVOPROD-1167388$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240990761$24099076$1$I$$20231204$20240716$20240716$PER$$DE-NOVOPROD-1167368$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$DE$US
240990771$24099077$1$I$$20240119$20240716$20240716$PER$$US-NOVOPROD-1167036$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240990781$24099078$1$I$$20230714$20240716$20240716$PER$$US-NOVOPROD-1167413$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240990791$24099079$1$I$20230401$20240312$20240716$20240716$PER$$US-NOVOPROD-1167472$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
240990801$24099080$1$I$$20240108$20240716$20240716$PER$$US-NOVOPROD-1167554$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990811$24099081$1$I$20230323$20240124$20240716$20240716$PER$$US-NOVOPROD-1168146$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990821$24099082$1$I$20231201$20240118$20240716$20240716$PER$$US-NOVOPROD-1167356$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240990831$24099083$1$I$20231201$20240124$20240716$20240716$PER$$US-NOVOPROD-1168142$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
240990841$24099084$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1167588$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240990851$24099085$1$I$20230630$20240117$20240716$20240716$PER$$US-NOVOPROD-1167171$NOVO NORDISK$$58$YR$$M$Y$$$20240717$$CN$US$US
240990861$24099086$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1167384$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240990871$24099087$1$I$20231226$20240401$20240716$20240716$PER$$US-NOVOPROD-1168254$NOVO NORDISK$$82$YR$$F$Y$$$20240717$$CN$US$US
240990881$24099088$1$I$$20240121$20240716$20240716$PER$$US-NOVOPROD-1168255$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240990891$24099089$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1167233$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240990901$24099090$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1167387$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240990911$24099091$1$I$$20240116$20240716$20240716$PER$$US-NOVOPROD-1167180$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240990921$24099092$1$I$$20240122$20240716$20240716$PER$$US-NOVOPROD-1167601$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240990931$24099093$1$I$$20240702$20240716$20240716$PER$$US-ELI_LILLY_AND_COMPANY-US202407002192$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240716$$CN$US$US
240990941$24099094$1$I$$20230726$20240716$20240716$PER$$US-NOVOPROD-1168393$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
240990951$24099095$1$I$20221101$20240125$20240716$20240716$PER$$US-NOVOPROD-1168441$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
240990962$24099096$2$F$20240125$20240125$20240716$20240716$PER$$US-NOVOPROD-1168442$NOVO NORDISK$$44$YR$$F$Y$$$20240717$$CN$US$US
240990971$24099097$1$I$$20230606$20240716$20240716$PER$$US-NOVOPROD-1168665$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240990981$24099098$1$I$20221115$20240206$20240716$20240716$PER$$US-NOVOPROD-1168497$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
240990991$24099099$1$I$20230531$20230605$20240716$20240716$PER$$US-NOVOPROD-1168670$NOVO NORDISK$$44$YR$$F$Y$$$20240717$$CN$US$US
240991001$24099100$1$I$$20240123$20240716$20240716$PER$$US-NOVOPROD-1168626$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991011$24099101$1$I$20230601$20230706$20240716$20240716$PER$$US-NOVOPROD-1168389$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240991021$24099102$1$I$$20240131$20240716$20240716$PER$$US-NOVOPROD-1168500$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240991031$24099103$1$I$20240101$20240122$20240716$20240716$PER$$US-NOVOPROD-1168564$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
240991041$24099104$1$I$$20230605$20240716$20240716$PER$$US-NOVOPROD-1168668$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991051$24099105$1$I$$20240122$20240716$20240716$PER$$US-NOVOPROD-1168275$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991061$24099106$1$I$20240111$20240125$20240716$20240716$PER$$US-NOVOPROD-1168593$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
240991071$24099107$1$I$20231101$20240301$20240716$20240716$PER$$US-NOVOPROD-1168644$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240991081$24099108$1$I$20230101$20240123$20240716$20240716$PER$$US-NOVOPROD-1168632$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991091$24099109$1$I$$20230705$20240716$20240716$PER$$US-NOVOPROD-1168525$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240991101$24099110$1$I$$20230620$20240716$20240716$PER$$US-NOVOPROD-1168551$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240991111$24099111$1$I$20230101$20240125$20240716$20240716$PER$$US-NOVOPROD-1168618$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
240991121$24099112$1$I$20230629$20230706$20240716$20240716$PER$$US-NOVOPROD-1168396$NOVO NORDISK$$54$YR$$M$Y$$$20240717$$CN$US$US
240991131$24099113$1$I$$20230614$20240716$20240716$PER$$US-NOVOPROD-1168661$NOVO NORDISK$$66$YR$$M$Y$127$KG$20240717$$CN$US$US
240991141$24099114$1$I$$20240122$20240716$20240716$PER$$US-NOVOPROD-1168491$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991151$24099115$1$I$$20240122$20240716$20240716$PER$$US-NOVOPROD-1168654$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
240991161$24099116$1$I$$20230727$20240716$20240716$PER$$US-NOVOPROD-1168667$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240991171$24099117$1$I$20230901$20240125$20240716$20240716$PER$$US-NOVOPROD-1168454$NOVO NORDISK$$77$YR$$M$Y$$$20240717$$CN$US$US
240991181$24099118$1$I$20240209$20240715$20240716$20240716$EXP$FR-AFSSAPS-CN2024000684$FR-SANDOZ INC.-SDZ2024FR065115$SANDOZ$$13$YR$$F$Y$57$KG$20240716$$PH$FR$FR
240991191$24099119$1$I$20190601$20240715$20240716$20240716$EXP$$HU-SANDOZ INC.-SDZ2024HU065193$SANDOZ$$39$YR$$F$Y$$$20240716$$MD$HU$HU
240991201$24099120$1$I$$20240305$20240716$20240716$PER$$US-NOVOPROD-1169089$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
240991211$24099121$1$I$20240124$20240124$20240716$20240716$PER$$US-NOVOPROD-1168908$NOVO NORDISK$$49$YR$$M$Y$$$20240717$$CN$US$US
240991221$24099122$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1168985$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991231$24099123$1$I$20240618$20240709$20240716$20240716$EXP$$US-JNJFOC-20240650129$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240717$$HP$US$US
240991241$24099124$1$I$20240124$20240125$20240716$20240716$PER$$US-NOVOPROD-1168686$NOVO NORDISK$$47$YR$$F$Y$$$20240717$$CN$US$US
240991251$24099125$1$I$$20240121$20240716$20240716$PER$$US-NOVOPROD-1168720$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991261$24099126$1$I$$20240123$20240716$20240716$PER$$US-NOVOPROD-1169094$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991271$24099127$1$I$$20240123$20240716$20240716$PER$$US-NOVOPROD-1168725$NOVO NORDISK$$53$YR$$M$Y$$$20240717$$PH$US$US
240991281$24099128$1$I$20240125$20240318$20240716$20240716$PER$$US-NOVOPROD-1168947$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
240991291$24099129$1$I$20240117$20240124$20240716$20240716$PER$$US-NOVOPROD-1168768$NOVO NORDISK$$54$YR$$M$Y$$$20240717$$CN$US$US
240991301$24099130$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1169157$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991311$24099131$1$I$$20230714$20240716$20240716$PER$$US-NOVOPROD-1168792$NOVO NORDISK$$34$YR$$F$Y$$$20240717$$CN$US$US
240991321$24099132$1$I$$20240205$20240716$20240716$PER$$US-NOVOPROD-1168728$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
240991331$24099133$1$I$20231001$20240318$20240716$20240716$PER$$US-NOVOPROD-1168752$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
240991341$24099134$1$I$$20240219$20240716$20240716$PER$$US-NOVOPROD-1169030$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240991351$24099135$1$I$20240116$20240123$20240716$20240716$PER$$US-NOVOPROD-1169072$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240991361$24099136$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1168764$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991371$24099137$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1168995$NOVO NORDISK$$$$E$M$Y$$$20240717$$CN$US$US
240991381$24099138$1$I$20240122$20240124$20240716$20240716$PER$$US-NOVOPROD-1168928$NOVO NORDISK$$52$YR$$F$Y$$$20240717$$CN$US$US
240991391$24099139$1$I$20231117$20240122$20240716$20240716$PER$$US-NOVOPROD-1168789$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240991401$24099140$1$I$$20240123$20240716$20240716$PER$$US-NOVOPROD-1169137$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240991411$24099141$1$I$20240124$20240315$20240716$20240716$PER$$US-NOVOPROD-1168803$NOVO NORDISK$$36$YR$$M$Y$$$20240717$$CN$US$US
240991422$24099142$2$F$$20240710$20240716$20240720$EXP$$US-SANDOZ INC.-SDZ2023US010633$SANDOZ$$$$$F$Y$79.365$KG$20240720$$MD$US$US
240991432$24099143$2$F$20240714$20240716$20240716$20240719$EXP$$US-ABBVIE-5839757$ABBVIE$$58$YR$$F$Y$$$20240719$$CN$US$US
240991441$24099144$1$I$$20230630$20240716$20240716$PER$$US-NOVOPROD-1169461$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991451$24099145$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1169353$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991461$24099146$1$I$$20231004$20240716$20240716$PER$$US-NOVOPROD-1169453$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991471$24099147$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1169193$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991482$24099148$2$F$20240124$20240418$20240716$20240716$PER$$US-NOVOPROD-1169511$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
240991491$24099149$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1169388$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991501$24099150$1$I$$20230623$20240716$20240716$PER$$US-NOVOPROD-1169278$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240991511$24099151$1$I$20231213$20240124$20240716$20240716$PER$$US-NOVOPROD-1169473$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
240991521$24099152$1$I$20240123$20240125$20240716$20240716$PER$$US-NOVOPROD-1169481$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
240991531$24099153$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1169315$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240991542$24099154$2$F$20230601$20230727$20240716$20240716$PER$$US-NOVOPROD-1169218$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991551$24099155$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1169456$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240991561$24099156$1$I$20230201$20240122$20240716$20240716$PER$$US-NOVOPROD-1169436$NOVO NORDISK$$45$YR$$F$Y$$$20240717$$CN$US$US
240991571$24099157$1$I$20240116$20240123$20240716$20240716$PER$$US-NOVOPROD-1169161$NOVO NORDISK$$57$YR$$M$Y$$$20240717$$CN$US$US
240991581$24099158$1$I$20231004$20231004$20240716$20240716$PER$$US-NOVOPROD-1169455$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
240991591$24099159$1$I$$20230710$20240716$20240716$PER$$US-NOVOPROD-1169366$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
240991601$24099160$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1169340$NOVO NORDISK$$36$YR$$F$Y$$$20240717$$CN$US$US
240991611$24099161$1$I$20240101$20240711$20240716$20240716$EXP$$JP-SAKK-2024SA204383AA$SANOFI AVENTIS$$$$$M$Y$$$20240717$$CN$JP$JP
240991621$24099162$1$I$$20240709$20240716$20240716$EXP$$JP-SA-2024SA200951$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240717$$HP$JP$JP
240991631$24099163$1$I$$20240709$20240716$20240716$PER$$US-JNJFOC-20240725613$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$HP$US$US
240991641$24099164$1$I$20240603$20240711$20240716$20240716$EXP$$AT-ABBVIE-5838548$ABBVIE$$74$YR$$M$Y$$$20240716$$HP$AT$AT
240991651$24099165$1$I$20220101$20220509$20240716$20240716$EXP$$NL-ABBVIE-5839397$ABBVIE$$74$YR$$M$Y$$$20240716$$MD$NL$NL
240991661$24099166$1$I$$20240123$20240716$20240716$PER$$US-NOVOPROD-1167924$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991671$24099167$1$I$$20240201$20240716$20240716$PER$$US-NOVOPROD-1167777$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240991681$24099168$1$I$$20230615$20240716$20240716$PER$$US-NOVOPROD-1167790$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240991691$24099169$1$I$20230101$20240119$20240716$20240716$PER$$US-NOVOPROD-1167765$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
240991701$24099170$1$I$20230706$20230714$20240716$20240716$PER$$US-NOVOPROD-1169551$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240991711$24099171$1$I$20240124$20240123$20240716$20240716$PER$$US-NOVOPROD-1169528$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
240991721$24099172$1$I$$20230626$20240716$20240716$PER$$US-NOVOPROD-1169541$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
240991731$24099173$1$I$$20240123$20240716$20240716$PER$$US-NOVOPROD-1169530$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991741$24099174$1$I$$20230619$20240716$20240716$PER$$US-NOVOPROD-1167792$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240991751$24099175$1$I$20230510$20240530$20240716$20240716$PER$$US-NOVOPROD-1167616$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240991761$24099176$1$I$20240130$20240209$20240716$20240716$PER$$US-NOVOPROD-1169531$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
240991771$24099177$1$I$$20230619$20240716$20240716$PER$$US-NOVOPROD-1169576$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991781$24099178$1$I$20240123$20240123$20240716$20240716$PER$$US-NOVOPROD-1167922$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240991791$24099179$1$I$$20240122$20240716$20240716$PER$$US-NOVOPROD-1167727$NOVO NORDISK$$50$YR$$F$Y$$$20240717$$MD$US$US
240991801$24099180$1$I$20220101$20240123$20240716$20240716$PER$$US-NOVOPROD-1167830$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
240991811$24099181$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1168073$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991821$24099182$1$I$$20240119$20240716$20240716$PER$$US-NOVOPROD-1168019$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991831$24099183$1$I$$20230628$20240716$20240716$PER$$US-NOVOPROD-1168106$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$COUNTRY NOT SPECIFIED$US
240991841$24099184$1$I$$20240122$20240716$20240716$PER$$US-NOVOPROD-1168060$NOVO NORDISK$$50$YR$$M$Y$$$20240717$$CN$US$US
240991851$24099185$1$I$20230101$20230612$20240716$20240716$PER$$US-NOVOPROD-1168013$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991861$24099186$1$I$20230101$20240112$20240716$20240716$PER$$US-NOVOPROD-1168118$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
240991871$24099187$1$I$$20240119$20240716$20240716$PER$$US-NOVOPROD-1167948$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991881$24099188$1$I$$20240117$20240716$20240716$PER$$US-NOVOPROD-1168113$NOVO NORDISK$$$$A$F$Y$$$20240717$$HP$US$US
240991891$24099189$1$I$$20240111$20240716$20240716$PER$$US-NOVOPROD-1168121$NOVO NORDISK$$50$YR$$M$Y$$$20240717$$PH$US$US
240991902$24099190$2$F$20240101$20240123$20240716$20240716$PER$$US-NOVOPROD-1167945$NOVO NORDISK$$86$YR$$F$Y$$$20240717$$CN$US$US
240991911$24099191$1$I$$20230706$20240716$20240716$PER$$US-NOVOPROD-1169589$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240991921$24099192$1$I$$20230706$20240716$20240716$PER$$US-NOVOPROD-1169622$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991931$24099193$1$I$20240126$20240205$20240716$20240716$PER$$US-NOVOPROD-1169657$NOVO NORDISK$$80$YR$$M$Y$$$20240717$$CN$US$US
240991941$24099194$1$I$$20240123$20240716$20240716$PER$$US-NOVOPROD-1168029$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240991951$24099195$1$I$20230530$20240530$20240716$20240716$PER$$US-NOVOPROD-1168108$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240991962$24099196$2$F$$20230628$20240716$20240723$PER$$US-NOVOPROD-1168105$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
240991971$24099197$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1169651$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240991985$24099198$5$F$$20240723$20240716$20240731$EXP$$PL-JNJFOC-20240722033$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240731$$HP$PL$PL
240991992$24099199$2$F$20220101$20240131$20240716$20240717$PER$$US-NOVOPROD-1169655$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
240992011$24099201$1$I$$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112787$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240717$$CN$US$US
240992022$24099202$2$F$$20240719$20240716$20240724$EXP$$CA-SANDOZ INC.-SDZ2023CA008721$SANDOZ$$$$$F$Y$$$20240724$$CN$CA$CA
240992031$24099203$1$I$$20240126$20240716$20240716$PER$$US-NOVOPROD-1169718$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992041$24099204$1$I$$20240126$20240716$20240716$PER$$US-NOVOPROD-1169871$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240992051$24099205$1$I$20220101$20240305$20240716$20240716$PER$$US-NOVOPROD-1169883$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
240992061$24099206$1$I$20231205$20240220$20240716$20240716$PER$$US-NOVOPROD-1169806$NOVO NORDISK$$72$YR$$M$Y$$$20240717$$CN$US$US
240992071$24099207$1$I$$20240125$20240716$20240716$PER$$US-NOVOPROD-1169679$NOVO NORDISK$$56$YR$$M$Y$$$20240717$$HP$US$US
240992081$24099208$1$I$20240125$20240126$20240716$20240716$PER$$US-NOVOPROD-1169662$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
240992091$24099209$1$I$20240101$20240123$20240716$20240716$PER$$US-NOVOPROD-1169711$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240992101$24099210$1$I$$20240126$20240716$20240716$PER$$US-NOVOPROD-1169793$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992111$24099211$1$I$$20230629$20240716$20240716$PER$$US-NOVOPROD-1169819$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240992122$24099212$2$F$$20240123$20240716$20240716$PER$$US-NOVOPROD-1169741$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992132$24099213$2$F$$20240123$20240716$20240716$PER$$US-NOVOPROD-1169921$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240992141$24099214$1$I$$20240122$20240716$20240716$PER$$US-NOVOPROD-1169740$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992151$24099215$1$I$$20240123$20240716$20240716$PER$$US-NOVOPROD-1169770$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992161$24099216$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1169987$NOVO NORDISK$$39$YR$$M$Y$$$20240717$$HP$US$US
240992171$24099217$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405071526055020-NHCPK$GB-ELI_LILLY_AND_COMPANY-GB202407003968$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$GB$GB
240992181$24099218$1$I$20240422$20240704$20240716$20240716$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407003884$ELI LILLY AND CO$$42$YR$A$$Y$108$KG$20240716$$CN$GB$GB
240992191$24099219$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405061241196020-SCQHL$GB-ELI_LILLY_AND_COMPANY-GB202407003932$ELI LILLY AND CO$$$$$F$Y$131$KG$20240716$$CN$GB$GB
240992201$24099220$1$I$20240704$20240704$20240716$20240716$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202407004400$ELI LILLY AND CO$$$$$F$Y$$$20240716$$MD$AE$AE
240992211$24099221$1$I$$20240709$20240716$20240716$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006523$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240716$$CN$US$US
240992221$24099222$1$I$$20240705$20240716$20240716$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407004789$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$BR$BR
240992231$24099223$1$I$20240101$20240704$20240716$20240716$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407003143$ELI LILLY AND CO$$$$$M$Y$$$20240716$$CN$KR$KR
240992241$24099224$1$I$$20240704$20240716$20240716$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407003643$ELI LILLY AND CO$$$$$M$Y$$$20240716$$CN$DE$DE
240992251$24099225$1$I$$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405071125540520-GVQLK$GB-ELI_LILLY_AND_COMPANY-GB202407003948$ELI LILLY AND CO$$$$$F$Y$$$20240716$$CN$GB$GB
240992261$24099226$1$I$20240630$20240704$20240716$20240716$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407003829$ELI LILLY AND CO$$$$$M$Y$$$20240716$$CN$GB$GB
240992271$24099227$1$I$20240429$20240704$20240716$20240716$EXP$GB-MHRA-MED-202405011348253990-ZRFWJ$GB-ELI_LILLY_AND_COMPANY-GB202407003874$ELI LILLY AND CO$$75$YR$E$M$Y$72$KG$20240716$$CN$GB$GB
240992282$24099228$2$F$20240624$20240904$20240716$20240916$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407003345$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240916$$PH$GB$GB
240992291$24099229$1$I$$20240715$20240716$20240716$EXP$$US-ABBVIE-5841692$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240992301$24099230$1$I$20240108$20240123$20240716$20240716$PER$$US-NOVOPROD-1169995$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240992311$24099231$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1170106$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992321$24099232$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1170689$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240992331$24099233$1$I$20231210$20240212$20240716$20240716$PER$$US-NOVOPROD-1170152$NOVO NORDISK$$67$YR$$$Y$$$20240717$$CN$US$US
240992341$24099234$1$I$$20230908$20240716$20240716$PER$$US-NOVOPROD-1170586$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992351$24099235$1$I$$20240122$20240716$20240716$PER$$US-NOVOPROD-1170151$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240992361$24099236$1$I$$20230718$20240716$20240716$PER$$US-NOVOPROD-1170287$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992371$24099237$1$I$20180101$20240125$20240716$20240716$PER$$US-NOVOPROD-1170316$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240992381$24099238$1$I$20220101$20240125$20240716$20240716$PER$$US-NOVOPROD-1170235$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$CN$US$US
240992391$24099239$1$I$$20240125$20240716$20240716$PER$$US-NOVOPROD-1170319$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240992401$24099240$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1170675$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992411$24099241$1$I$$20240123$20240716$20240716$PER$$US-NOVOPROD-1170190$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240992422$24099242$2$F$$20230718$20240716$20240716$PER$$US-NOVOPROD-1170136$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
240992431$24099243$1$I$20230101$20240125$20240716$20240716$PER$$US-NOVOPROD-1170163$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
240992441$24099244$1$I$$20240125$20240716$20240716$PER$$US-NOVOPROD-1170162$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240992451$24099245$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1170114$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992461$24099246$1$I$$20240130$20240716$20240716$PER$$US-NOVOPROD-1170468$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992471$24099247$1$I$20231001$20240628$20240716$20240716$PER$$US-NOVOPROD-1171240$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240992481$24099248$1$I$$20230721$20240716$20240716$PER$$US-NOVOPROD-1170895$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992492$24099249$2$F$$20240126$20240716$20240716$PER$$US-NOVOPROD-1171238$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992501$24099250$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1170964$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992511$24099251$1$I$20240101$20240131$20240716$20240716$PER$$US-NOVOPROD-1171208$NOVO NORDISK$$69$YR$$F$Y$156$KG$20240717$$CN$US$US
240992521$24099252$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1170795$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992531$24099253$1$I$20231226$20240129$20240716$20240716$PER$$US-NOVOPROD-1170857$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240992541$24099254$1$I$$20240122$20240716$20240716$PER$$US-NOVOPROD-1171177$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240992551$24099255$1$I$20240129$20240129$20240716$20240716$PER$$US-NOVOPROD-1170757$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240992561$24099256$1$I$20230101$20240312$20240716$20240716$PER$$US-NOVOPROD-1171044$NOVO NORDISK$$$$E$M$Y$$$20240717$$CN$US$US
240992571$24099257$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1171251$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
240992581$24099258$1$I$20231207$20240325$20240716$20240716$PER$$US-NOVOPROD-1170777$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$HP$US$US
240992591$24099259$1$I$20231004$20231013$20240716$20240716$PER$$US-NOVOPROD-1170933$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240992601$24099260$1$I$$20230616$20240716$20240716$PER$$US-NOVOPROD-1170979$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992611$24099261$1$I$$20240130$20240716$20240716$PER$$US-NOVOPROD-1171265$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992621$24099262$1$I$20240123$20240129$20240716$20240716$PER$$US-NOVOPROD-1170808$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240992631$24099263$1$I$20230301$20240212$20240716$20240716$PER$$US-NOVOPROD-1170938$NOVO NORDISK$$32$YR$$F$Y$$$20240717$$CN$US$US
240992641$24099264$1$I$20230101$20240129$20240716$20240716$PER$$US-NOVOPROD-1171147$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
240992651$24099265$1$I$$20240229$20240716$20240716$PER$$US-NOVOPROD-1171270$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
240992661$24099266$1$I$$20240424$20240716$20240716$PER$$US-NOVOPROD-1171014$NOVO NORDISK$$54$YR$$M$Y$$$20240717$$HP$US$US
240992671$24099267$1$I$20240708$20240715$20240716$20240716$PER$$US-AMGEN-USASP2024140374$AMGEN$$80$YR$E$F$Y$$$20240716$$CN$US$US
240992682$24099268$2$F$20240101$20240718$20240716$20240727$EXP$$US-AMGEN-USASP2024135278$AMGEN$$79$YR$E$F$Y$62.5$KG$20240727$$MD$US$US
240992691$24099269$1$I$$20240131$20240716$20240716$PER$$US-NOVOPROD-1171962$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992701$24099270$1$I$20230101$20240129$20240716$20240716$PER$$US-NOVOPROD-1171368$NOVO NORDISK$$50$YR$$F$Y$$$20240717$$CN$US$US
240992711$24099271$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1171738$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992721$24099272$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1171511$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992731$24099273$1$I$$20240131$20240716$20240716$PER$$US-NOVOPROD-1172034$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240992741$24099274$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1171464$NOVO NORDISK$$54$YR$$F$Y$$$20240717$$CN$US$US
240992751$24099275$1$I$20240101$20240130$20240716$20240716$PER$$US-NOVOPROD-1171541$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992761$24099276$1$I$20240101$20240129$20240716$20240716$PER$$US-NOVOPROD-1171296$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240992771$24099277$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1171690$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992781$24099278$1$I$$20240401$20240716$20240716$PER$$US-NOVOPROD-1171916$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240992791$24099279$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1171583$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240992801$24099280$1$I$$20230914$20240716$20240716$PER$$US-NOVOPROD-1171660$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
240992811$24099281$1$I$$20240130$20240716$20240716$PER$$US-NOVOPROD-1171750$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240992821$24099282$1$I$20240101$20240127$20240716$20240716$PER$$US-NOVOPROD-1171393$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
240992831$24099283$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1171523$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992841$24099284$1$I$$20240209$20240716$20240716$PER$$US-NOVOPROD-1171373$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992851$24099285$1$I$20240123$20240129$20240716$20240716$PER$$US-NOVOPROD-1171698$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
240992861$24099286$1$I$$20240125$20240716$20240716$PER$$US-NOVOPROD-1171570$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992871$24099287$1$I$$20240715$20240716$20240716$PER$$US-AMGEN-USASP2024140446$AMGEN$$$$$M$Y$$$20240716$$MD$US$US
240992881$24099288$1$I$$20240708$20240716$20240716$EXP$$HU-SANDOZ INC.-SDZ2024HU064814$SANDOZ$$$$$M$Y$60$KG$20240716$$CN$HU$HU
240992891$24099289$1$I$20240706$20240710$20240716$20240716$EXP$$NVSC2024IN144862$NOVARTIS$$23$YR$$F$Y$$$20240717$$CN$IN$IN
240992901$24099290$1$I$20231223$20240201$20240716$20240716$PER$$US-NOVOPROD-1172207$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
240992911$24099291$1$I$$20230629$20240716$20240716$PER$$US-NOVOPROD-1172368$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
240992921$24099292$1$I$$20240201$20240716$20240716$PER$$US-NOVOPROD-1172397$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992931$24099293$1$I$$20240131$20240716$20240716$PER$$US-NOVOPROD-1172246$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240992941$24099294$1$I$$20240123$20240716$20240716$PER$$US-NOVOPROD-1172316$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240992951$24099295$1$I$20240101$20240201$20240716$20240716$PER$$US-NOVOPROD-1172455$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240992961$24099296$1$I$20230501$20240201$20240716$20240716$PER$$US-NOVOPROD-1172396$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240992971$24099297$1$I$$20240130$20240716$20240716$PER$$US-NOVOPROD-1172302$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240992981$24099298$1$I$$20240131$20240716$20240716$PER$$US-NOVOPROD-1172419$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240992991$24099299$1$I$20240101$20240201$20240716$20240716$PER$$US-NOVOPROD-1172389$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993001$24099300$1$I$$20240129$20240716$20240716$PER$$US-NOVOPROD-1172332$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993011$24099301$1$I$$20240201$20240716$20240716$PER$$US-NOVOPROD-1172407$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240993021$24099302$1$I$20240126$20240201$20240716$20240716$PER$$US-NOVOPROD-1172253$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
240993031$24099303$1$I$20240101$20240201$20240716$20240716$PER$$US-NOVOPROD-1172453$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
240993041$24099304$1$I$20230701$20231004$20240716$20240716$PER$$US-NOVOPROD-1172381$NOVO NORDISK$$50$YR$$M$Y$$$20240717$$CN$US$US
240993051$24099305$1$I$$20230919$20240716$20240716$PER$$US-NOVOPROD-1172251$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993061$24099306$1$I$$20230615$20240716$20240716$PER$$US-NOVOPROD-1172224$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240993071$24099307$1$I$$20240201$20240716$20240716$PER$$US-NOVOPROD-1172394$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993081$24099308$1$I$20240110$20240409$20240716$20240716$PER$$US-NOVOPROD-1172294$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
240993091$24099309$1$I$$20240201$20240716$20240716$PER$$US-NOVOPROD-1172408$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993101$24099310$1$I$20230801$20240123$20240716$20240716$PER$$US-NOVOPROD-1172073$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
240993111$24099311$1$I$$20240130$20240716$20240716$PER$$US-NOVOPROD-1172110$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240993121$24099312$1$I$$20240201$20240716$20240716$PER$$US-NOVOPROD-1172081$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993131$24099313$1$I$$20240201$20240716$20240716$PER$$US-NOVOPROD-1172213$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240993141$24099314$1$I$20180101$20240311$20240716$20240716$PER$$US-NOVOPROD-1172122$NOVO NORDISK$$31$YR$$F$Y$$$20240717$$HP$US$US
240993151$24099315$1$I$20240625$20240711$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110901$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240717$$HP$US$US
240993161$24099316$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1172507$NOVO NORDISK$$34$YR$$F$Y$$$20240717$$CN$US$US
240993171$24099317$1$I$$20240131$20240716$20240716$PER$$US-NOVOPROD-1172555$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
240993182$24099318$2$F$20220101$20240202$20240716$20240716$PER$$US-NOVOPROD-1172818$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
240993191$24099319$1$I$$20240202$20240716$20240716$PER$$US-NOVOPROD-1172807$NOVO NORDISK$$$$A$M$Y$136.05$KG$20240717$$CN$US$US
240993201$24099320$1$I$20230101$20240219$20240716$20240716$PER$$US-NOVOPROD-1172541$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
240993211$24099321$1$I$$20240201$20240716$20240716$PER$$US-NOVOPROD-1172845$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993221$24099322$1$I$$20240201$20240716$20240716$PER$$US-NOVOPROD-1172609$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993231$24099323$1$I$20240202$20240202$20240716$20240716$PER$$US-NOVOPROD-1172636$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
240993241$24099324$1$I$20230801$20240131$20240716$20240716$PER$$US-NOVOPROD-1172467$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
240993251$24099325$1$I$$20240202$20240716$20240716$PER$$US-NOVOPROD-1172771$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
240993261$24099326$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1172462$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240993271$24099327$1$I$20230401$20230518$20240716$20240716$PER$$US-NOVOPROD-1067480$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
240993281$24099328$1$I$20230512$20230519$20240716$20240716$PER$$US-NOVOPROD-1067423$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
240993291$24099329$1$I$20230325$20230531$20240716$20240716$PER$$US-NOVOPROD-1063397$NOVO NORDISK$$74$YR$$M$Y$$$20240717$$MD$US$US
240993301$24099330$1$I$20230101$20240102$20240716$20240716$PER$$US-NOVOPROD-1062160$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993311$24099331$1$I$$20240716$20240716$20240716$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040128$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240717$$CN$US$US
240993321$24099332$1$I$20240630$20240711$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111062$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240717$$HP$US$US
240993331$24099333$1$I$20230511$20230518$20240716$20240716$PER$$US-NOVOPROD-1071750$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993341$24099334$1$I$$20240713$20240716$20240716$EXP$$US-SANDOZ INC.-SDZ2024US065460$SANDOZ$$$$$F$Y$$$20240716$$HP$US$US
240993352$24099335$2$F$$20240415$20240716$20240716$PER$$US-NOVOPROD-1069074$NOVO NORDISK$$82$YR$$F$Y$$$20240717$$CN$US$US
240993361$24099336$1$I$$20230526$20240716$20240716$PER$$US-NOVOPROD-1073370$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240993371$24099337$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1072624$NOVO NORDISK$$76$YR$$$Y$$$20240717$$CN$US$US
240993381$24099338$1$I$20230102$20240530$20240716$20240716$PER$$US-NOVOPROD-1072613$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240993391$24099339$1$I$$20240710$20240716$20240716$PER$$US-AstraZeneca-2024A161905$ASTRAZENECA$$80$YR$$M$Y$$$20240717$$CN$US$
240993402$24099340$2$F$$20230619$20240716$20240716$PER$$US-NOVOPROD-1077678$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240993411$24099341$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1074686$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240993421$24099342$1$I$$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024139832$AMGEN$$$$$$Y$$$20240716$$PH$US$US
240993432$24099343$2$F$20240615$20240808$20240716$20240812$PER$$US-JNJFOC-20240725523$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$HP$US$US
240993442$24099344$2$F$20240101$20240729$20240716$20240802$EXP$FR-AFSSAPS-AVBX2024000355$FR-JNJFOC-20240737602$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240802$$MD$FR$FR
240993451$24099345$1$I$$20240715$20240716$20240716$PER$$US-JNJFOC-20240738148$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$CN$US$US
240993461$24099346$1$I$$20240716$20240716$20240716$PER$$US-JNJFOC-20240741689$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$HP$US$US
240993471$24099347$1$I$$20240712$20240716$20240716$PER$$US-JNJFOC-20240734218$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
240993492$24099349$2$F$$20240829$20240716$20240829$PER$$NVSC2024US146436$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
240993501$24099350$1$I$$20230711$20240716$20240716$PER$$US-NOVOPROD-1078272$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993511$24099351$1$I$$20240117$20240716$20240716$PER$$US-NOVOPROD-1172997$NOVO NORDISK$$$$A$F$Y$$$20240717$$HP$US$US
240993521$24099352$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1172867$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240993531$24099353$1$I$$20240205$20240716$20240716$PER$$US-NOVOPROD-1173101$NOVO NORDISK$$$$A$F$Y$$$20240717$$HP$US$US
240993542$24099354$2$F$20240202$20240506$20240716$20240716$PER$$US-NOVOPROD-1172902$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
240993551$24099355$1$I$$20230606$20240716$20240716$PER$$US-NOVOPROD-1079369$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240993562$24099356$2$F$20231129$20240417$20240716$20240716$PER$$US-NOVOPROD-1172945$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
240993571$24099357$1$I$$20240201$20240716$20240716$PER$$US-NOVOPROD-1172960$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240993581$24099358$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1173156$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240993591$24099359$1$I$$20240201$20240716$20240716$PER$$US-NOVOPROD-1172873$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240993601$24099360$1$I$$20240710$20240716$20240716$EXP$$AU-BEIGENE-BGN-2024-010799$BEIGENE$$$$$$Y$$$20240716$$HP$AU$AU
240993611$24099361$1$I$20240512$20240712$20240716$20240716$EXP$FR-AFSSAPS-PB2024000758$FR-SANDOZ INC.-SDZ2024FR065162$SANDOZ$$18$YR$$F$Y$59.5$KG$20240716$$MD$FR$FR
240993621$24099362$1$I$$20240517$20240716$20240716$PER$$US-NOVOPROD-1173509$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993631$24099363$1$I$20240108$20240401$20240716$20240716$PER$$US-NOVOPROD-1173689$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
240993641$24099364$1$I$20231201$20240220$20240716$20240716$PER$$US-NOVOPROD-1173593$NOVO NORDISK$$52$YR$$F$Y$$$20240717$$HP$US$US
240993651$24099365$1$I$$20240205$20240716$20240716$PER$$US-NOVOPROD-1173640$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240993661$24099366$1$I$$20240126$20240716$20240716$PER$$US-NOVOPROD-1173210$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240993671$24099367$1$I$$20240205$20240716$20240716$PER$$US-NOVOPROD-1173581$NOVO NORDISK$$$$A$F$Y$$$20240717$$HP$US$US
240993681$24099368$1$I$$20240124$20240716$20240716$PER$$US-NOVOPROD-1173200$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993691$24099369$1$I$20240202$20240227$20240716$20240716$PER$$US-NOVOPROD-1173309$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993701$24099370$1$I$$20240202$20240716$20240716$PER$$US-NOVOPROD-1173531$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
240993711$24099371$1$I$$20240205$20240716$20240716$PER$$US-NOVOPROD-1173525$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993721$24099372$1$I$$20240130$20240716$20240716$PER$$US-NOVOPROD-1173706$NOVO NORDISK$$49$YR$$M$Y$$$20240717$$CN$US$US
240993731$24099373$1$I$$20240202$20240716$20240716$PER$$US-NOVOPROD-1173369$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240993741$24099374$1$I$20240129$20240130$20240716$20240716$PER$$US-NOVOPROD-1173503$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
240993751$24099375$1$I$20240115$20240229$20240716$20240716$PER$$US-NOVOPROD-1173722$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
240993761$24099376$1$I$20240117$20240131$20240716$20240716$PER$$US-NOVOPROD-1173462$NOVO NORDISK$$62$YR$$M$Y$$$20240717$$CN$US$US
240993771$24099377$1$I$$20240205$20240716$20240716$PER$$US-NOVOPROD-1173645$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
240993781$24099378$1$I$$20240205$20240716$20240716$PER$$US-NOVOPROD-1173746$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993791$24099379$1$I$$20240125$20240716$20240716$PER$$US-NOVOPROD-1173193$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993801$24099380$1$I$20240201$20240202$20240716$20240716$PER$$US-NOVOPROD-1173434$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
240993812$24099381$2$F$20240707$20240730$20240716$20240805$PER$$US-AMGEN-USASP2024137971$AMGEN$$75$YR$E$F$Y$$$20240804$$CN$US$US
240993821$24099382$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1174372$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240993831$24099383$1$I$$20240206$20240716$20240716$PER$$US-NOVOPROD-1173960$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993841$24099384$1$I$$20230918$20240716$20240716$PER$$US-NOVOPROD-1174053$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993851$24099385$1$I$$20240207$20240716$20240716$PER$$US-NOVOPROD-1174363$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993861$24099386$1$I$$20240206$20240716$20240716$PER$$US-NOVOPROD-1174175$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
240993871$24099387$1$I$$20240205$20240716$20240716$PER$$US-NOVOPROD-1174159$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240993881$24099388$1$I$20240101$20240524$20240716$20240716$PER$$US-NOVOPROD-1174307$NOVO NORDISK$$83$YR$$M$Y$$$20240717$$CN$US$US
240993891$24099389$1$I$$20240206$20240716$20240716$PER$$US-NOVOPROD-1174396$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240993901$24099390$1$I$$20240204$20240716$20240716$PER$$US-NOVOPROD-1174060$NOVO NORDISK$$$$$M$Y$190$KG$20240717$$CN$US$US
240993911$24099391$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1174388$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240993921$24099392$1$I$$20240204$20240716$20240716$PER$$US-NOVOPROD-1174047$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240993931$24099393$1$I$$20240206$20240716$20240716$PER$$US-NOVOPROD-1174294$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993941$24099394$1$I$$20240205$20240716$20240716$PER$$US-NOVOPROD-1174184$NOVO NORDISK$$55$YR$$M$Y$$$20240717$$MD$US$US
240993951$24099395$1$I$$20240131$20240716$20240716$PER$$US-NOVOPROD-1173892$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240993961$24099396$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1174385$NOVO NORDISK$$23$YR$$F$Y$$$20240717$$CN$US$US
240993971$24099397$1$I$20231215$20240425$20240716$20240716$PER$$US-NOVOPROD-1174315$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
240993981$24099398$1$I$20230904$20240318$20240716$20240716$PER$$US-NOVOPROD-1173845$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$HP$US$US
240993991$24099399$1$I$$20230609$20240716$20240716$PER$$US-NOVOPROD-1174232$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240994001$24099400$1$I$20230509$20240205$20240716$20240716$PER$$US-NOVOPROD-1174223$NOVO NORDISK$$48$YR$$F$Y$$$20240717$$CN$US$US
240994011$24099401$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1174370$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240994021$24099402$1$I$$20240206$20240716$20240716$PER$$US-NOVOPROD-1173886$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240994031$24099403$1$I$20240210$20240305$20240716$20240716$PER$$US-NOVOPROD-1174220$NOVO NORDISK$$84$YR$$F$Y$$$20240717$$MD$US$US
240994041$24099404$1$I$$20240206$20240716$20240716$PER$$US-NOVOPROD-1174390$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994051$24099405$1$I$$20240207$20240716$20240716$PER$$US-NOVOPROD-1174851$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240994062$24099406$2$F$20220101$20240205$20240716$20240716$PER$$US-NOVOPROD-1174724$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994071$24099407$1$I$20231029$20240712$20240716$20240716$EXP$FR-AFSSAPS-TO2024001221$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-112730$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240717$$PH$FR$FR
240994081$24099408$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1174650$NOVO NORDISK$$26$YR$$F$Y$$$20240717$$CN$US$US
240994091$24099409$1$I$$20240130$20240716$20240716$PER$$US-NOVOPROD-1174540$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994101$24099410$1$I$20230801$20240207$20240716$20240716$PER$$US-NOVOPROD-1174771$NOVO NORDISK$$86$YR$$M$Y$$$20240717$$CN$US$US
240994111$24099411$1$I$20231228$20240130$20240716$20240716$PER$$US-NOVOPROD-1174523$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
240994121$24099412$1$I$$20240207$20240716$20240716$PER$$US-NOVOPROD-1174671$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
240994131$24099413$1$I$$20240205$20240716$20240716$PER$$US-NOVOPROD-1174682$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994141$24099414$1$I$$20240131$20240716$20240716$PER$$US-NOVOPROD-1174567$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994151$24099415$1$I$$20240315$20240716$20240716$PER$$US-NOVOPROD-1174708$NOVO NORDISK$$78$YR$$M$Y$92.8$KG$20240717$$HP$US$US
240994161$24099416$1$I$$20240321$20240716$20240716$PER$$US-NOVOPROD-1174797$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240994171$24099417$1$I$20230901$20240207$20240716$20240716$PER$$US-NOVOPROD-1174676$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994181$24099418$1$I$$20240205$20240716$20240716$PER$$US-NOVOPROD-1174720$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240994191$24099419$1$I$$20240206$20240716$20240716$PER$$US-NOVOPROD-1174692$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994201$24099420$1$I$$20240202$20240716$20240716$PER$$US-NOVOPROD-1174823$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240994211$24099421$1$I$$20240221$20240716$20240716$PER$$US-NOVOPROD-1174661$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994221$24099422$1$I$$20240131$20240716$20240716$PER$$US-NOVOPROD-1174642$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994231$24099423$1$I$20220101$20230926$20240716$20240716$PER$$US-NOVOPROD-1174548$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240994241$24099424$1$I$$20240206$20240716$20240716$PER$$US-NOVOPROD-1174807$NOVO NORDISK$$$$E$M$Y$$$20240717$$CN$US$US
240994251$24099425$1$I$$20240208$20240716$20240716$PER$$US-NOVOPROD-1174652$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240994261$24099426$1$I$$20240709$20240716$20240716$EXP$$US-ABBVIE-5836861$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240994271$24099427$1$I$$20230615$20240716$20240716$PER$$US-NOVOPROD-1080100$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994281$24099428$1$I$20231013$20240206$20240716$20240716$PER$$US-NOVOPROD-1175184$NOVO NORDISK$$31$YR$$F$Y$$$20240717$$CN$US$US
240994291$24099429$1$I$20240206$20240219$20240716$20240716$PER$$US-NOVOPROD-1174956$NOVO NORDISK$$47$YR$$M$Y$$$20240717$$PH$US$US
240994302$24099430$2$F$$20240208$20240716$20240716$PER$$US-NOVOPROD-1175008$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994311$24099431$1$I$$20240326$20240716$20240716$PER$$US-NOVOPROD-1175290$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994321$24099432$1$I$20230519$20230607$20240716$20240716$PER$$US-NOVOPROD-1080388$NOVO NORDISK$$55$YR$$M$Y$$$20240717$$CN$US$US
240994331$24099433$1$I$20240107$20240207$20240716$20240716$PER$$US-NOVOPROD-1175307$NOVO NORDISK$$78$YR$$M$Y$$$20240717$$CN$US$US
240994341$24099434$1$I$20240120$20240206$20240716$20240716$PER$$US-NOVOPROD-1174918$NOVO NORDISK$$74$YR$$M$Y$$$20240717$$CN$US$US
240994351$24099435$1$I$$20240219$20240716$20240716$PER$$US-NOVOPROD-1174969$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240994371$24099437$1$I$$20240711$20240716$20240716$PER$$US-AMGEN-USASP2024138429$AMGEN$$$$$$Y$$$20240716$$CN$US$US
240994381$24099438$1$I$$20230615$20240716$20240716$PER$$US-NOVOPROD-1083213$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240994394$24099439$4$F$20240101$20240725$20240716$20240731$EXP$$ES-ABBVIE-5835120$ABBVIE$$$$$F$Y$$$20240731$$CN$ES$ES
240994402$24099440$2$F$20240101$20240722$20240716$20240730$PER$$US-ABBVIE-5835148$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
240994411$24099441$1$I$$20230627$20240716$20240716$PER$$US-NOVOPROD-1087169$NOVO NORDISK$$$$E$M$Y$$$20240717$$CN$US$US
240994421$24099442$1$I$$20230621$20240716$20240716$PER$$US-NOVOPROD-1085870$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240994431$24099443$1$I$$20230619$20240716$20240716$PER$$US-NOVOPROD-1085026$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994441$24099444$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5839498$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240994451$24099445$1$I$$20240716$20240716$20240716$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040109$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240717$$CN$CA$CA
240994462$24099446$2$F$20240101$20240725$20240716$20240731$EXP$$US-ABBVIE-5839010$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
240994471$24099447$1$I$$20230623$20240716$20240716$PER$$US-NOVOPROD-1089815$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994481$24099448$1$I$$20230628$20240716$20240716$PER$$US-NOVOPROD-1090653$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994491$24099449$1$I$$20240711$20240716$20240716$EXP$$US-BEIGENE-BGN-2024-010970$BEIGENE$$$$$$Y$$$20240716$$MD$US$US
240994501$24099450$1$I$20240627$20240712$20240716$20240716$EXP$$US-SANDOZ INC.-SDZ2024US065215$SANDOZ$$10$YR$$F$Y$31$KG$20240716$$CN$US$US
240994512$24099451$2$F$20240101$20240710$20240716$20240924$EXP$$US-ABBVIE-5836427$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
240994522$24099452$2$F$$20240809$20240716$20240812$30DAY$$AU-JNJFOC-20240727334$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$AU$AU
240994533$24099453$3$F$20240710$20240909$20240716$20240913$EXP$$US-JNJFOC-20240729773$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240913$$MD$US$US
240994541$24099454$1$I$$20230703$20240716$20240716$PER$$US-NOVOPROD-1091362$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240994552$24099455$2$F$20230614$20230831$20240716$20240716$PER$$US-NOVOPROD-1091209$NOVO NORDISK$$80$YR$$M$Y$$$20240717$$CN$US$US
240994561$24099456$1$I$20231120$20240415$20240716$20240716$PER$$US-NOVOPROD-1211354$NOVO NORDISK$$61$YR$$M$Y$220$KG$20240717$$CN$US$US
240994571$24099457$1$I$$20240415$20240716$20240716$PER$$US-NOVOPROD-1211020$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
240994581$24099458$1$I$$20240414$20240716$20240716$PER$$US-NOVOPROD-1211290$NOVO NORDISK$$77$YR$$$Y$$$20240717$$CN$US$US
240994591$24099459$1$I$20240411$20240418$20240716$20240716$PER$$US-NOVOPROD-1211010$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
240994601$24099460$1$I$$20240416$20240716$20240716$PER$$US-NOVOPROD-1211274$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240994611$24099461$1$I$20230901$20240415$20240716$20240716$PER$$US-NOVOPROD-1211333$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
240994621$24099462$1$I$20210101$20240421$20240716$20240716$PER$$US-NOVOPROD-1210888$NOVO NORDISK$$45$YR$$F$Y$$$20240717$$CN$US$US
240994631$24099463$1$I$$20231010$20240716$20240716$PER$$US-NOVOPROD-1211115$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240994641$24099464$1$I$$20240415$20240716$20240716$PER$$US-NOVOPROD-1211111$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240994651$24099465$1$I$$20240416$20240716$20240716$PER$$US-NOVOPROD-1211255$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240994662$24099466$2$F$20240311$20240415$20240716$20240716$PER$$US-NOVOPROD-1211324$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240994671$24099467$1$I$20240101$20240531$20240716$20240716$PER$$US-NOVOPROD-1210887$NOVO NORDISK$$82$YR$$F$Y$$$20240717$$CN$US$US
240994681$24099468$1$I$$20240415$20240716$20240716$PER$$US-NOVOPROD-1211328$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240994691$24099469$1$I$$20230703$20240716$20240716$PER$$US-NOVOPROD-1091146$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240994701$24099470$1$I$20240408$20240416$20240716$20240716$PER$$US-NOVOPROD-1211268$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
240994711$24099471$1$I$20231101$20240416$20240716$20240716$PER$$US-NOVOPROD-1210910$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240994722$24099472$2$F$$20240513$20240716$20240716$PER$$US-NOVOPROD-1211518$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240994731$24099473$1$I$$20240422$20240716$20240716$PER$$US-NOVOPROD-1212079$NOVO NORDISK$$$$E$M$Y$$$20240717$$CN$US$US
240994741$24099474$1$I$$20240528$20240716$20240716$PER$$US-NOVOPROD-1211355$NOVO NORDISK$$$$A$F$Y$$$20240717$$HP$US$US
240994751$24099475$1$I$$20240417$20240716$20240716$PER$$US-NOVOPROD-1211586$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240994761$24099476$1$I$20240412$20240417$20240716$20240716$PER$$US-NOVOPROD-1212178$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
240994771$24099477$1$I$20240410$20240415$20240716$20240716$PER$$US-NOVOPROD-1212066$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240994781$24099478$1$I$$20240415$20240716$20240716$PER$$US-NOVOPROD-1211375$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994791$24099479$1$I$20231101$20240417$20240716$20240716$PER$$US-NOVOPROD-1211516$NOVO NORDISK$$54$YR$$F$Y$$$20240717$$CN$US$US
240994801$24099480$1$I$$20240422$20240716$20240716$PER$$US-NOVOPROD-1211577$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240994811$24099481$1$I$20240410$20240411$20240716$20240716$PER$$US-NOVOPROD-1211529$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
240994821$24099482$1$I$$20240418$20240716$20240716$PER$$US-NOVOPROD-1212094$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
240994831$24099483$1$I$$20240416$20240716$20240716$PER$$US-NOVOPROD-1211866$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240994841$24099484$1$I$20240404$20240418$20240716$20240716$PER$$US-NOVOPROD-1212169$NOVO NORDISK$$29$YR$$F$Y$$$20240717$$CN$US$US
240994851$24099485$1$I$20240106$20240415$20240716$20240716$PER$$US-NOVOPROD-1211500$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240994861$24099486$1$I$20220802$20240414$20240716$20240716$PER$$US-NOVOPROD-1212132$NOVO NORDISK$$52$YR$$$Y$$$20240717$$CN$US$US
240994871$24099487$1$I$20240409$20240426$20240716$20240716$PER$$US-NOVOPROD-1211461$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240994881$24099488$1$I$20240406$20240411$20240716$20240716$PER$$US-NOVOPROD-1211542$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
240994891$24099489$1$I$$20240417$20240716$20240716$PER$$US-NOVOPROD-1212246$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240994901$24099490$1$I$$20240417$20240716$20240716$PER$$US-NOVOPROD-1212156$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994911$24099491$1$I$$20240415$20240716$20240716$PER$$US-NOVOPROD-1212075$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240994921$24099492$1$I$20240308$20240506$20240716$20240716$PER$$US-NOVOPROD-1211818$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240994931$24099493$1$I$$20240416$20240716$20240716$PER$$US-NOVOPROD-1211880$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994941$24099494$1$I$$20240417$20240716$20240716$PER$$US-NOVOPROD-1212509$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240994951$24099495$1$I$20240408$20240417$20240716$20240716$PER$$US-NOVOPROD-1212345$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240994961$24099496$1$I$$20230706$20240716$20240716$PER$$US-NOVOPROD-1093053$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240994971$24099497$1$I$20240415$20240416$20240716$20240716$PER$$US-NOVOPROD-1212439$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
240994981$24099498$1$I$$20240417$20240716$20240716$PER$$US-NOVOPROD-1212367$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240994991$24099499$1$I$$20240417$20240716$20240716$PER$$US-NOVOPROD-1212340$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240995001$24099500$1$I$20240301$20240417$20240716$20240716$PER$$US-NOVOPROD-1212266$NOVO NORDISK$$80$YR$$F$Y$$$20240717$$CN$US$US
240995011$24099501$1$I$20230601$20230714$20240716$20240716$PER$$US-NOVOPROD-1095257$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
240995021$24099502$1$I$$20230712$20240716$20240716$PER$$US-NOVOPROD-1095022$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995031$24099503$1$I$$20230705$20240716$20240716$PER$$US-NOVOPROD-1091747$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995041$24099504$1$I$20240407$20240417$20240716$20240716$PER$$US-NOVOPROD-1212325$NOVO NORDISK$$50$YR$$F$Y$$$20240717$$CN$US$US
240995051$24099505$1$I$20240101$20240701$20240716$20240716$PER$$US-NOVOPROD-1212407$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240995061$24099506$1$I$20240415$20240417$20240716$20240716$PER$$US-NOVOPROD-1212303$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
240995071$24099507$1$I$$20240404$20240716$20240716$PER$$US-NOVOPROD-1206757$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995081$24099508$1$I$20240405$20240405$20240716$20240716$PER$$US-NOVOPROD-1206722$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
240995091$24099509$1$I$20231205$20240715$20240716$20240716$EXP$$DE-SANDOZ INC.-SDZ2024DE065300$SANDOZ$$$$C$M$Y$24$KG$20240716$$HP$DE$DE
240995101$24099510$1$I$$20240404$20240716$20240716$PER$$US-NOVOPROD-1206801$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995112$24099511$2$F$$20240530$20240716$20240716$PER$$US-NOVOPROD-1206855$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995121$24099512$1$I$20190101$20240412$20240716$20240716$PER$$US-NOVOPROD-1206601$NOVO NORDISK$$$$A$M$Y$$$20240717$$MD$US$US
240995131$24099513$1$I$20240222$20240403$20240716$20240716$PER$$US-NOVOPROD-1206606$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
240995141$24099514$1$I$$20240528$20240716$20240716$PER$$US-NOVOPROD-1206785$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$HP$US$US
240995151$24099515$1$I$$20230713$20240716$20240716$PER$$US-NOVOPROD-1206811$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240995161$24099516$1$I$$20240502$20240716$20240716$PER$$US-NOVOPROD-1206964$NOVO NORDISK$$$$$M$Y$$$20240717$$PH$US$US
240995171$24099517$1$I$$20240403$20240716$20240716$PER$$US-NOVOPROD-1206960$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240995181$24099518$1$I$$20240403$20240716$20240716$PER$$US-NOVOPROD-1207043$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240995191$24099519$1$I$20231201$20240408$20240716$20240716$PER$$US-NOVOPROD-1207262$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240995201$24099520$1$I$$20240404$20240716$20240716$PER$$US-NOVOPROD-1206953$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240995211$24099521$1$I$$20240405$20240716$20240716$PER$$US-NOVOPROD-1206957$NOVO NORDISK$$49$YR$$F$Y$$$20240717$$CN$US$US
240995221$24099522$1$I$$20240408$20240716$20240716$PER$$US-NOVOPROD-1207210$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240995231$24099523$1$I$$20240517$20240716$20240716$PER$$US-NOVOPROD-1207166$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240995241$24099524$1$I$$20240523$20240716$20240716$PER$$US-NOVOPROD-1207254$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240995251$24099525$1$I$20230101$20240429$20240716$20240716$PER$$US-NOVOPROD-1207188$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
240995261$24099526$1$I$20240111$20240406$20240716$20240716$PER$$US-NOVOPROD-1207224$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
240995271$24099527$1$I$20240529$20240712$20240716$20240716$EXP$$CO-ABBVIE-5841815$ABBVIE$$54$YR$$F$Y$$$20240716$$MD$CO$CO
240995281$24099528$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-10000026824$ROCHE$$$$E$M$Y$$$20240717$$CN$US$US
240995293$24099529$3$F$$20240729$20240716$20240731$EXP$$CH-ABBVIE-5731240$ABBVIE$$$$$M$Y$$$20240731$$CN$CH$CH
240995301$24099530$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-3517794$ROCHE$$74$YR$E$F$Y$$$20240717$$CN$US$US
240995311$24099531$1$I$$20240712$20240716$20240716$PER$$US-ROCHE-10000026301$ROCHE$$81$YR$E$M$Y$$$20240717$$CN$US$US
240995322$24099532$2$F$20230101$20240716$20240716$20240722$EXP$$US-ABBVIE-5838650$ABBVIE$$$$$F$Y$79.378$KG$20240719$$CN$US$US
240995331$24099533$1$I$$20240406$20240716$20240716$PER$$US-NOVOPROD-1207405$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240995341$24099534$1$I$$20240521$20240716$20240716$PER$$US-NOVOPROD-1210570$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240995351$24099535$1$I$$20230926$20240716$20240716$PER$$US-NOVOPROD-1210612$NOVO NORDISK$$60$YR$$M$Y$$$20240717$$CN$US$US
240995361$24099536$1$I$20240325$20240506$20240716$20240716$PER$$US-NOVOPROD-1207401$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
240995371$24099537$1$I$20240327$20240412$20240716$20240716$PER$$US-NOVOPROD-1210592$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
240995381$24099538$1$I$$20240407$20240716$20240716$PER$$US-NOVOPROD-1207403$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240995391$24099539$1$I$$20231006$20240716$20240716$PER$$US-NOVOPROD-1210575$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240995401$24099540$1$I$$20240712$20240716$20240716$EXP$$CA-ABBVIE-5841847$ABBVIE$$$$$M$Y$$$20240716$$HP$CA$CA
240995411$24099541$1$I$$20230713$20240716$20240716$PER$$US-NOVOPROD-1210718$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240995421$24099542$1$I$20240409$20240411$20240716$20240716$PER$$US-NOVOPROD-1210711$NOVO NORDISK$$24$YR$$F$Y$$$20240717$$CN$US$US
240995431$24099543$1$I$20240419$20240419$20240716$20240716$PER$$US-NOVOPROD-1210840$NOVO NORDISK$$79$YR$$M$Y$223$KG$20240717$$CN$US$US
240995441$24099544$1$I$20240524$20240605$20240716$20240716$PER$$US-NOVOPROD-1210629$NOVO NORDISK$$82$YR$$F$Y$$$20240717$$CN$US$US
240995452$24099545$2$F$20231101$20240417$20240716$20240716$PER$$US-NOVOPROD-1212526$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
240995461$24099546$1$I$20231201$20240416$20240716$20240716$PER$$US-NOVOPROD-1210725$NOVO NORDISK$$63$YR$$M$Y$$$20240717$$CN$US$US
240995471$24099547$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1210730$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240995481$24099548$1$I$$20240417$20240716$20240716$PER$$US-NOVOPROD-1210628$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995491$24099549$1$I$$20240410$20240716$20240716$PER$$US-NOVOPROD-1210652$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
240995501$24099550$1$I$$20230717$20240716$20240716$PER$$US-NOVOPROD-1210685$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995511$24099551$1$I$$20240411$20240716$20240716$PER$$US-NOVOPROD-1210626$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240995521$24099552$1$I$$20240411$20240716$20240716$PER$$US-NOVOPROD-1210780$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240995531$24099553$1$I$20240404$20240411$20240716$20240716$PER$$US-NOVOPROD-1210645$NOVO NORDISK$$80$YR$$F$Y$$$20240717$$CN$US$US
240995541$24099554$1$I$$20240416$20240716$20240716$PER$$US-NOVOPROD-1210733$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240995551$24099555$1$I$20240403$20240410$20240716$20240716$PER$$US-NOVOPROD-1210658$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
240995561$24099556$1$I$$20240715$20240716$20240716$EXP$$GB-SANDOZ INC.-SDZ2024GB065247$SANDOZ$$$$A$M$Y$$$20240716$$CN$GB$GB
240995572$24099557$2$F$$20240808$20240716$20240812$EXP$$NVSJ2024JP008362$NOVARTIS$$79$YR$$F$Y$$$20240813$$PH$JP$JP
240995592$24099559$2$F$20240101$20240808$20240716$20240813$EXP$$GB-SANDOZ INC.-SDZ2024GB065244$SANDOZ$$$$$F$Y$$$20240813$$CN$GB$GB
240995601$24099560$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1212785$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995611$24099561$1$I$20240404$20240521$20240716$20240716$PER$$US-NOVOPROD-1212634$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
240995621$24099562$1$I$20240329$20240416$20240716$20240716$PER$$US-NOVOPROD-1212802$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
240995631$24099563$1$I$$20240415$20240716$20240716$PER$$US-NOVOPROD-1212747$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240995641$24099564$1$I$20240228$20240415$20240716$20240716$PER$$US-NOVOPROD-1212664$NOVO NORDISK$$50$YR$$F$Y$$$20240717$$CN$US$US
240995651$24099565$1$I$$20240410$20240716$20240716$PER$$US-NOVOPROD-1212914$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
240995661$24099566$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1212801$NOVO NORDISK$$$$A$F$Y$$$20240717$$MD$US$US
240995671$24099567$1$I$20240418$20240424$20240716$20240716$PER$$US-NOVOPROD-1212585$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$MD$US$US
240995681$24099568$1$I$$20240411$20240716$20240716$PER$$US-NOVOPROD-1213000$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995691$24099569$1$I$$20240417$20240716$20240716$PER$$US-NOVOPROD-1212685$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240995701$24099570$1$I$20240312$20240417$20240716$20240716$PER$$US-NOVOPROD-1212598$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995711$24099571$1$I$$20240410$20240716$20240716$PER$$US-NOVOPROD-1212883$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240995721$24099572$1$I$$20240411$20240716$20240716$PER$$US-NOVOPROD-1212999$NOVO NORDISK$$$$A$F$Y$183$KG$20240717$$CN$US$US
240995731$24099573$1$I$20240410$20240506$20240716$20240716$PER$$US-NOVOPROD-1212790$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240995741$24099574$1$I$$20240417$20240716$20240716$PER$$US-NOVOPROD-1212594$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240995751$24099575$1$I$20240301$20240417$20240716$20240716$PER$$US-NOVOPROD-1212600$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
240995761$24099576$1$I$$20240417$20240716$20240716$PER$$US-NOVOPROD-1212658$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
240995771$24099577$1$I$20240711$20240712$20240716$20240716$EXP$$US-ABBVIE-5839095$ABBVIE$$35$YR$$F$Y$$$20240716$$CN$US$US
240995781$24099578$1$I$$20240715$20240716$20240716$PER$$US-ABBVIE-5841346$ABBVIE$$$$$F$Y$$$20240716$$HP$US$US
240995791$24099579$1$I$20240510$20240711$20240716$20240716$EXP$$US-ABBVIE-5838355$ABBVIE$$32$YR$$M$Y$$$20240716$$CN$US$US
240995802$24099580$2$F$$20240717$20240716$20240720$PER$$US-ABBVIE-5840766$ABBVIE$$$$$$Y$$$20240720$$HP$US$US
240995811$24099581$1$I$$20240418$20240716$20240716$PER$$US-NOVOPROD-1213075$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$HP$US$US
240995821$24099582$1$I$20220401$20240418$20240716$20240716$PER$$US-NOVOPROD-1213535$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995831$24099583$1$I$20240301$20240419$20240716$20240716$PER$$US-NOVOPROD-1213258$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
240995841$24099584$1$I$$20240426$20240716$20240716$PER$$US-NOVOPROD-1213352$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995851$24099585$1$I$$20240610$20240716$20240716$PER$$US-NOVOPROD-1213361$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
240995861$24099586$1$I$20240418$20240523$20240716$20240716$PER$$US-NOVOPROD-1213487$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
240995871$24099587$1$I$20240101$20240419$20240716$20240716$PER$$US-NOVOPROD-1213404$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240995881$24099588$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1213454$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
240995891$24099589$1$I$20240315$20240419$20240716$20240716$PER$$US-NOVOPROD-1213439$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240995901$24099590$1$I$20240301$20240418$20240716$20240716$PER$$US-NOVOPROD-1213081$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240995911$24099591$1$I$$20240426$20240716$20240716$PER$$US-NOVOPROD-1213366$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240995921$24099592$1$I$20240330$20240418$20240716$20240716$PER$$US-NOVOPROD-1213387$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
240995931$24099593$1$I$20240101$20240517$20240716$20240716$PER$$US-NOVOPROD-1213101$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
240995941$24099594$1$I$20240410$20240410$20240716$20240716$PER$$US-NOVOPROD-1213037$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
240995951$24099595$1$I$20240404$20240418$20240716$20240716$PER$$US-NOVOPROD-1213418$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
240995961$24099596$1$I$20240201$20240419$20240716$20240716$PER$$US-NOVOPROD-1213270$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
240995971$24099597$1$I$20240101$20240513$20240716$20240716$PER$$US-NOVOPROD-1213444$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240995981$24099598$1$I$20240229$20240411$20240716$20240716$PER$$US-NOVOPROD-1213051$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
240995991$24099599$1$I$20240710$20240711$20240716$20240716$EXP$$US-TAKEDA-2024TUS071049$TAKEDA$$23$YR$$M$Y$$$20240716$$MD$US$US
240996001$24099600$1$I$$20240709$20240716$20240716$EXP$$US-ABBVIE-5840801$ABBVIE$$$$$M$Y$$$20240716$$MD$US$US
240996011$24099601$1$I$20240406$20240419$20240716$20240716$PER$$US-NOVOPROD-1213606$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
240996021$24099602$1$I$20220501$20240501$20240716$20240716$PER$$US-NOVOPROD-1213847$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
240996031$24099603$1$I$20240419$20240419$20240716$20240716$PER$$US-NOVOPROD-1215110$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996041$24099604$1$I$20240201$20240419$20240716$20240716$PER$$US-NOVOPROD-1213657$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240996051$24099605$1$I$20240409$20240416$20240716$20240716$PER$$US-NOVOPROD-1213882$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996061$24099606$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1213645$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240996071$24099607$1$I$$20240603$20240716$20240716$PER$$US-NOVOPROD-1213611$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996082$24099608$2$F$20240112$20240418$20240716$20240716$PER$$US-NOVOPROD-1213571$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240996091$24099609$1$I$$20240605$20240716$20240716$PER$$US-NOVOPROD-1213734$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996101$24099610$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1213676$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240996111$24099611$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1213628$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240996121$24099612$1$I$20240421$20240422$20240716$20240716$PER$$US-NOVOPROD-1213679$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240996131$24099613$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1213692$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996141$24099614$1$I$$20240420$20240716$20240716$PER$$US-NOVOPROD-1213914$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240996151$24099615$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1213818$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996161$24099616$1$I$$20240423$20240716$20240716$PER$$US-NOVOPROD-1215111$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240996171$24099617$1$I$20240415$20240419$20240716$20240716$PER$$US-NOVOPROD-1215131$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
240996181$24099618$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1213660$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
240996191$24099619$1$I$20240430$20240527$20240716$20240716$PER$$US-NOVOPROD-1215143$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
240996201$24099620$1$I$$20240416$20240716$20240716$PER$$US-NOVOPROD-1215132$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996211$24099621$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5841144$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240996221$24099622$1$I$20240412$20240607$20240716$20240716$PER$$US-NOVOPROD-1215329$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240996231$24099623$1$I$$20240430$20240716$20240716$PER$$US-NOVOPROD-1215305$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
240996241$24099624$1$I$$20240423$20240716$20240716$PER$$US-NOVOPROD-1215349$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240996253$24099625$3$F$$20240423$20240716$20240716$PER$$US-NOVOPROD-1215202$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240996261$24099626$1$I$$20240423$20240716$20240716$PER$$US-NOVOPROD-1215260$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240996271$24099627$1$I$$20240424$20240716$20240716$PER$$US-NOVOPROD-1215413$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240996281$24099628$1$I$$20240424$20240716$20240716$PER$$US-NOVOPROD-1215272$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240996291$24099629$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1215167$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
240996301$24099630$1$I$20240424$20240424$20240716$20240716$PER$$US-NOVOPROD-1215404$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996311$24099631$1$I$$20240424$20240716$20240716$PER$$US-NOVOPROD-1215246$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996321$24099632$1$I$$20230614$20240716$20240716$PER$$US-NOVOPROD-1215398$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240996331$24099633$1$I$20240412$20240419$20240716$20240716$PER$$US-NOVOPROD-1215223$NOVO NORDISK$$31$YR$$F$Y$$$20240717$$CN$US$US
240996341$24099634$1$I$20240404$20240513$20240716$20240716$PER$$US-NOVOPROD-1215298$NOVO NORDISK$$77$YR$$M$Y$$$20240717$$CN$US$US
240996351$24099635$1$I$20240208$20240423$20240716$20240716$PER$$US-NOVOPROD-1215336$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$CN$US$US
240996361$24099636$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1215354$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996371$24099637$1$I$20240515$20240715$20240716$20240716$EXP$FR-AFSSAPS-LL2024001273$FR-JNJFOC-20240737590$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240717$$MD$FR$FR
240996381$24099638$1$I$20240229$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111801$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240717$$CN$US$US
240996391$24099639$1$I$20240201$20240415$20240716$20240716$PER$$US-NOVOPROD-1215624$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240996401$24099640$1$I$$20240424$20240716$20240716$PER$$US-NOVOPROD-1215429$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240996411$24099641$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1214178$NOVO NORDISK$$60$YR$$M$Y$$$20240717$$HP$US$US
240996421$24099642$1$I$$20240422$20240716$20240716$PER$$US-NOVOPROD-1214131$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996431$24099643$1$I$$20240423$20240716$20240716$PER$$US-NOVOPROD-1215632$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996441$24099644$1$I$20240416$20240423$20240716$20240716$PER$$US-NOVOPROD-1215591$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
240996451$24099645$1$I$$20240422$20240716$20240716$PER$$US-NOVOPROD-1215697$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240996461$24099646$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1215547$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996471$24099647$1$I$$20240422$20240716$20240716$PER$$US-NOVOPROD-1215600$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240996481$24099648$1$I$20240101$20240424$20240716$20240716$PER$$US-NOVOPROD-1215550$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
240996491$24099649$1$I$20240323$20240423$20240716$20240716$PER$$US-NOVOPROD-1215464$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
240996501$24099650$1$I$$20240423$20240716$20240716$PER$$US-NOVOPROD-1215592$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240996511$24099651$1$I$$20240412$20240716$20240716$PER$$US-NOVOPROD-1215527$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
240996521$24099652$1$I$20240417$20240424$20240716$20240716$PER$$US-NOVOPROD-1215563$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
240996531$24099653$1$I$$20240423$20240716$20240716$PER$$US-NOVOPROD-1213988$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240996541$24099654$1$I$$20240424$20240716$20240716$PER$$US-NOVOPROD-1215433$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240996551$24099655$1$I$$20240424$20240716$20240716$PER$$US-NOVOPROD-1215452$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996561$24099656$1$I$20240430$20240430$20240716$20240716$PER$$US-NOVOPROD-1215492$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
240996571$24099657$1$I$20231201$20240424$20240716$20240716$PER$$US-NOVOPROD-1215485$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240996581$24099658$1$I$$20240402$20240716$20240716$PER$$US-NOVOPROD-1215558$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996591$24099659$1$I$$20240422$20240716$20240716$PER$$US-NOVOPROD-1215564$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996601$24099660$1$I$$20240422$20240716$20240716$PER$$US-NOVOPROD-1214106$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240996611$24099661$1$I$20231125$20240424$20240716$20240716$PER$$US-NOVOPROD-1215430$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240996621$24099662$1$I$20230101$20240429$20240716$20240716$PER$$US-NOVOPROD-1215615$NOVO NORDISK$$19$YR$$F$Y$$$20240717$$CN$US$US
240996632$24099663$2$F$20240703$20240717$20240716$20240725$30DAY$$US-AMGEN-USASP2024134169$AMGEN$$58$YR$A$F$Y$91.9$KG$20240724$$PH$US$US
240996641$24099664$1$I$20240501$20240712$20240716$20240716$PER$$US-AMGEN-USASP2024138889$AMGEN$$$$$$Y$$$20240716$$CN$US$US
240996651$24099665$1$I$$20240715$20240716$20240716$EXP$$US-TAKEDA-2024TUS071833$TAKEDA$$$$$M$Y$$$20240716$$MD$US$US
240996661$24099666$1$I$$20240423$20240716$20240716$PER$$US-NOVOPROD-1214931$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996671$24099667$1$I$$20240424$20240716$20240716$PER$$US-NOVOPROD-1214959$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240996681$24099668$1$I$20230916$20240623$20240716$20240716$PER$$US-NOVOPROD-1214685$NOVO NORDISK$$63$YR$$M$Y$$$20240717$$CN$US$US
240996691$24099669$1$I$$20240422$20240716$20240716$PER$$US-NOVOPROD-1214347$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996701$24099670$1$I$$20240426$20240716$20240716$PER$$US-NOVOPROD-1215064$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
240996712$24099671$2$F$20231206$20240520$20240716$20240716$PER$$US-NOVOPROD-1214479$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
240996721$24099672$1$I$20240418$20240422$20240716$20240716$PER$$US-NOVOPROD-1214324$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
240996731$24099673$1$I$$20240509$20240716$20240716$PER$$US-NOVOPROD-1214907$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996741$24099674$1$I$$20240422$20240716$20240716$PER$$US-NOVOPROD-1214319$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240996751$24099675$1$I$20240405$20240419$20240716$20240716$PER$$US-NOVOPROD-1214887$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240996761$24099676$1$I$$20240423$20240716$20240716$PER$$US-NOVOPROD-1215077$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996771$24099677$1$I$$20240517$20240716$20240716$PER$$US-NOVOPROD-1214955$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996781$24099678$1$I$20240201$20240423$20240716$20240716$PER$$US-NOVOPROD-1214714$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
240996791$24099679$1$I$$20240424$20240716$20240716$PER$$US-NOVOPROD-1214215$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
240996801$24099680$1$I$$20240418$20240716$20240716$PER$$US-NOVOPROD-1215051$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240996812$24099681$2$F$$20240801$20240716$20240812$EXP$$US-NOVOPROD-1214409$NOVO NORDISK$$74$YR$$M$Y$$$20240812$$CN$US$US
240996821$24099682$1$I$$20240423$20240716$20240716$PER$$US-NOVOPROD-1214722$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240996831$24099683$1$I$20240419$20240422$20240716$20240716$PER$$US-NOVOPROD-1214529$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
240996841$24099684$1$I$$20240707$20240716$20240716$EXP$$TR-JNJFOC-20240724790$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240717$$HP$TR$TR
240996851$24099685$1$I$20240201$20240422$20240716$20240716$PER$$US-NOVOPROD-1214523$NOVO NORDISK$$84$YR$$F$Y$$$20240717$$CN$US$US
240996861$24099686$1$I$$20240714$20240716$20240716$PER$$NVSC2024US146587$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
240996871$24099687$1$I$$20240715$20240716$20240716$PER$$NVSC2024US146596$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
240996881$24099688$1$I$$20240424$20240716$20240716$PER$$US-NOVOPROD-1215915$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996891$24099689$1$I$$20240430$20240716$20240716$PER$$US-NOVOPROD-1216086$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
240996901$24099690$1$I$$20240423$20240716$20240716$PER$$US-NOVOPROD-1215897$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240996911$24099691$1$I$20240410$20240424$20240716$20240716$PER$$US-NOVOPROD-1215820$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
240996921$24099692$1$I$$20240502$20240716$20240716$PER$$US-NOVOPROD-1216492$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240996931$24099693$1$I$20240326$20240429$20240716$20240716$PER$$US-NOVOPROD-1216009$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
240996941$24099694$1$I$20231101$20240424$20240716$20240716$PER$$US-NOVOPROD-1215926$NOVO NORDISK$$75$YR$$$Y$$$20240717$$CN$US$US
240996951$24099695$1$I$$20240424$20240716$20240716$PER$$US-NOVOPROD-1215944$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240996961$24099696$1$I$$20240501$20240716$20240716$PER$$US-NOVOPROD-1216464$NOVO NORDISK$$$$$M$Y$$$20240717$$PH$US$US
240996971$24099697$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1216366$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240996982$24099698$2$F$20220801$20240321$20240716$20240716$PER$$US-NOVOPROD-1195778$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240996991$24099699$1$I$20230601$20240416$20240716$20240716$PER$$US-NOVOPROD-1216055$NOVO NORDISK$$50$YR$$M$Y$$$20240717$$CN$US$US
240997001$24099700$1$I$20240301$20240613$20240716$20240716$PER$$US-NOVOPROD-1216504$NOVO NORDISK$$44$YR$$F$Y$$$20240717$$CN$US$US
240997012$24099701$2$F$$20240412$20240716$20240716$PER$$US-NOVOPROD-1215934$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240997021$24099702$1$I$20240301$20240419$20240716$20240716$PER$$US-NOVOPROD-1215749$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240997031$24099703$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1216478$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240997041$24099704$1$I$$20240430$20240716$20240716$PER$$US-NOVOPROD-1215081$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$MD$US$US
240997051$24099705$1$I$$20240423$20240716$20240716$PER$$US-NOVOPROD-1215877$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240997061$24099706$1$I$20210101$20240424$20240716$20240716$PER$$US-NOVOPROD-1216398$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240997071$24099707$1$I$20240408$20240610$20240716$20240716$PER$$US-NOVOPROD-1216039$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
240997081$24099708$1$I$$20240712$20240716$20240716$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112907$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240717$$CN$US$US
240997091$24099709$1$I$20240416$20240423$20240716$20240716$PER$$US-NOVOPROD-1215723$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240997101$24099710$1$I$20240101$20240712$20240716$20240716$EXP$$US-BIOGEN-2024BI01273672$BIOGEN$$$$$F$Y$$$20240716$$CN$US$US
240997111$24099711$1$I$20240618$20240715$20240716$20240716$EXP$IT-MINISAL02-994407$IT-SANDOZ INC.-SDZ2024IT065064$SANDOZ$$67$YR$$M$Y$$$20240716$$MD$IT$IT
240997122$24099712$2$F$20180201$20240809$20240716$20240815$EXP$$DE-BIOGEN-2024BI01273476$BIOGEN$$49$YR$$F$Y$$$20240815$$CN$DE$DE
240997131$24099713$1$I$20240327$20240429$20240716$20240716$PER$$US-NOVOPROD-1216741$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
240997141$24099714$1$I$20240415$20240425$20240716$20240716$PER$$US-NOVOPROD-1216614$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
240997151$24099715$1$I$$20240510$20240716$20240716$PER$$US-NOVOPROD-1216645$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997161$24099716$1$I$20240318$20240425$20240716$20240716$PER$$US-NOVOPROD-1216753$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240997171$24099717$1$I$20240131$20240425$20240716$20240716$PER$$US-NOVOPROD-1216676$NOVO NORDISK$$18$YR$$$Y$$$20240717$$CN$US$US
240997181$24099718$1$I$$20240603$20240716$20240716$PER$$US-NOVOPROD-1216675$NOVO NORDISK$$$$A$M$Y$$$20240717$$MD$US$US
240997191$24099719$1$I$$20240426$20240716$20240716$PER$$US-NOVOPROD-1216655$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
240997201$24099720$1$I$$20240424$20240716$20240716$PER$$US-NOVOPROD-1216635$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240997211$24099721$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1216752$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240997221$24099722$1$I$$20240529$20240716$20240716$PER$$US-NOVOPROD-1216720$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240997231$24099723$1$I$20240421$20240422$20240716$20240716$PER$$US-NOVOPROD-1216569$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
240997241$24099724$1$I$20230601$20240425$20240716$20240716$PER$$US-NOVOPROD-1216534$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997251$24099725$1$I$20240322$20240426$20240716$20240716$PER$$US-NOVOPROD-1216680$NOVO NORDISK$$58$YR$$M$Y$$$20240717$$CN$US$US
240997261$24099726$1$I$20231101$20240529$20240716$20240716$PER$$US-NOVOPROD-1216750$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$MD$US$US
240997271$24099727$1$I$$20231013$20240716$20240716$PER$$US-NOVOPROD-1216716$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240997281$24099728$1$I$20230101$20240429$20240716$20240716$PER$$US-NOVOPROD-1216737$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
240997291$24099729$1$I$$20240429$20240716$20240716$PER$$US-NOVOPROD-1216719$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240997301$24099730$1$I$20231130$20240429$20240716$20240716$PER$$US-NOVOPROD-1216740$NOVO NORDISK$$82$YR$$M$Y$137$KG$20240717$$CN$US$US
240997311$24099731$1$I$$20240429$20240716$20240716$PER$$US-NOVOPROD-1217019$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997321$24099732$1$I$$20231004$20240716$20240716$PER$$US-NOVOPROD-1216779$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240997331$24099733$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1217252$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997341$24099734$1$I$$20231012$20240716$20240716$PER$$US-NOVOPROD-1217093$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997351$24099735$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1217271$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240997361$24099736$1$I$$20231013$20240716$20240716$PER$$US-NOVOPROD-1217039$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997371$24099737$1$I$$20231004$20240716$20240716$PER$$US-NOVOPROD-1216804$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997381$24099738$1$I$$20240426$20240716$20240716$PER$$US-NOVOPROD-1217043$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997391$24099739$1$I$20240421$20240425$20240716$20240716$PER$$US-NOVOPROD-1217222$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
240997401$24099740$1$I$$20240426$20240716$20240716$PER$$US-NOVOPROD-1217070$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$PH$US$US
240997411$24099741$1$I$$20240427$20240716$20240716$PER$$US-NOVOPROD-1217153$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240997421$24099742$1$I$20240411$20240427$20240716$20240716$PER$$US-NOVOPROD-1217207$NOVO NORDISK$$25$YR$$F$Y$$$20240717$$CN$US$US
240997431$24099743$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1217005$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240997441$24099744$1$I$$20240429$20240716$20240716$PER$$US-NOVOPROD-1217017$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
240997451$24099745$1$I$20240417$20240610$20240716$20240716$PER$$US-NOVOPROD-1217328$NOVO NORDISK$$59$YR$$M$Y$123.81$KG$20240717$$MD$US$US
240997461$24099746$1$I$20230101$20240701$20240716$20240716$PER$$US-NOVOPROD-1217144$NOVO NORDISK$$80$YR$$$Y$$$20240717$$CN$US$US
240997471$24099747$1$I$$20240502$20240716$20240716$PER$$US-NOVOPROD-1216899$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
240997481$24099748$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1217163$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997491$24099749$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1217348$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240997501$24099750$1$I$20240401$20240426$20240716$20240716$PER$$US-NOVOPROD-1217209$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997511$24099751$1$I$$20231003$20240716$20240716$PER$$US-NOVOPROD-1217160$NOVO NORDISK$$80$YR$$$Y$$$20240717$$CN$US$US
240997521$24099752$1$I$$20240426$20240716$20240716$PER$$US-NOVOPROD-1217170$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240997531$24099753$1$I$20240115$20240517$20240716$20240716$PER$$US-NOVOPROD-1217002$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
240997541$24099754$1$I$$20240426$20240716$20240716$PER$$US-NOVOPROD-1217065$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240997551$24099755$1$I$$20240426$20240716$20240716$PER$$US-NOVOPROD-1217360$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997561$24099756$1$I$20240701$20240712$20240716$20240716$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111880$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240717$$HP$US$US
240997571$24099757$1$I$20240619$20240621$20240716$20240716$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000529$PAREXEL$$$$$$Y$$$20240717$$HP$US$US
240997582$24099758$2$F$20240710$20240809$20240716$20240816$PER$$US-JNJFOC-20240726521$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240816$$CN$US$US
240997591$24099759$1$I$20240628$20240711$20240716$20240716$EXP$FR-AFSSAPS-MP2024001121$FR-GSK-FR2024086232$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$PH$FR$FR
240997601$24099760$1$I$$20240503$20240716$20240716$PER$$US-NOVOPROD-1217555$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
240997611$24099761$1$I$20240428$20240429$20240716$20240716$PER$$US-NOVOPROD-1217914$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
240997621$24099762$1$I$20240202$20240319$20240716$20240716$PER$$US-NOVOPROD-1195793$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997631$24099763$1$I$$20240429$20240716$20240716$PER$$US-NOVOPROD-1217684$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997641$24099764$1$I$$20240502$20240716$20240716$PER$$US-NOVOPROD-1217713$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
240997651$24099765$1$I$$20230929$20240716$20240716$PER$$US-NOVOPROD-1217536$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
240997661$24099766$1$I$$20240428$20240716$20240716$PER$$US-NOVOPROD-1217488$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240997671$24099767$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1217608$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997681$24099768$1$I$20240327$20240425$20240716$20240716$PER$$US-NOVOPROD-1217361$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997691$24099769$1$I$$20240319$20240716$20240716$PER$$US-NOVOPROD-1195890$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240997701$24099770$1$I$20240301$20240506$20240716$20240716$PER$$US-NOVOPROD-1217888$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240997711$24099771$1$I$$20231011$20240716$20240716$PER$$US-NOVOPROD-1217511$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240997721$24099772$1$I$20230101$20240321$20240716$20240716$PER$$US-NOVOPROD-1195992$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
240997731$24099773$1$I$20240317$20240320$20240716$20240716$PER$$US-NOVOPROD-1195878$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240997741$24099774$1$I$$20240318$20240716$20240716$PER$$US-NOVOPROD-1195852$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240997751$24099775$1$I$$20230929$20240716$20240716$PER$$US-NOVOPROD-1217617$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240997761$24099776$1$I$$20230929$20240716$20240716$PER$$US-NOVOPROD-1217548$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240997771$24099777$1$I$$20240429$20240716$20240716$PER$$US-NOVOPROD-1217846$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240997781$24099778$1$I$$20240429$20240716$20240716$PER$$US-NOVOPROD-1217880$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240997791$24099779$1$I$$20240425$20240716$20240716$PER$$US-NOVOPROD-1217392$NOVO NORDISK$$39$YR$$F$Y$$$20240717$$CN$US$US
240997801$24099780$1$I$$20240502$20240716$20240716$PER$$US-NOVOPROD-1217736$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
240997811$24099781$1$I$20240227$20240320$20240716$20240716$PER$$US-NOVOPROD-1195874$NOVO NORDISK$$54$YR$$F$Y$$$20240717$$CN$US$US
240997821$24099782$1$I$$20240322$20240716$20240716$PER$$US-NOVOPROD-1195936$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240997831$24099783$1$I$20231101$20240425$20240716$20240716$PER$$US-NOVOPROD-1195917$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
240997841$24099784$1$I$$20231010$20240716$20240716$PER$$US-NOVOPROD-1217719$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997851$24099785$1$I$$20240429$20240716$20240716$PER$$US-NOVOPROD-1217761$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997861$24099786$1$I$$20240429$20240716$20240716$PER$$US-NOVOPROD-1217772$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997871$24099787$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5839477$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240997881$24099788$1$I$20240712$20240712$20240716$20240716$EXP$$US-ABBVIE-5839726$ABBVIE$$67$YR$$F$Y$$$20240716$$CN$US$US
240997891$24099789$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5840461$ABBVIE$$$$$M$Y$$$20240716$$CN$US$US
240997901$24099790$1$I$$20240705$20240716$20240716$EXP$$TW-BEH-2024175037$CSL BEHRING$$41$YR$A$F$Y$$$20240716$$HP$TW$TW
240997911$24099791$1$I$$20240321$20240716$20240716$PER$$US-NOVOPROD-1196471$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240997921$24099792$1$I$$20240319$20240716$20240716$PER$$US-NOVOPROD-1196173$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240997931$24099793$1$I$$20240320$20240716$20240716$PER$$US-NOVOPROD-1196409$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
240997951$24099795$1$I$20230301$20240321$20240716$20240716$PER$$US-NOVOPROD-1196117$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240997961$24099796$1$I$$20240318$20240716$20240716$PER$$US-NOVOPROD-1196132$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240997971$24099797$1$I$20200101$20240318$20240716$20240716$PER$$US-NOVOPROD-1196487$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
240997981$24099798$1$I$20240319$20240321$20240716$20240716$PER$$US-NOVOPROD-1196468$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
240997991$24099799$1$I$$20240313$20240716$20240716$PER$$US-NOVOPROD-1196519$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240998001$24099800$1$I$20190701$20240321$20240716$20240716$PER$$US-NOVOPROD-1196098$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
240998011$24099801$1$I$$20240321$20240716$20240716$PER$$US-NOVOPROD-1196094$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240998021$24099802$1$I$20240306$20240319$20240716$20240716$PER$$US-NOVOPROD-1196233$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998031$24099803$1$I$$20240319$20240716$20240716$PER$$US-NOVOPROD-1196343$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
240998041$24099804$1$I$$20240401$20240716$20240716$PER$$US-NOVOPROD-1196102$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240998051$24099805$1$I$$20240321$20240716$20240716$PER$$US-NOVOPROD-1196186$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240998061$24099806$1$I$$20240514$20240716$20240716$PER$$US-NOVOPROD-1196051$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240998072$24099807$2$F$$20240328$20240716$20240716$PER$$US-NOVOPROD-1196581$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
240998081$24099808$1$I$20220901$20240521$20240716$20240716$PER$$US-NOVOPROD-1196171$NOVO NORDISK$$64$YR$$M$Y$$$20240717$$CN$US$US
240998091$24099809$1$I$$20240321$20240716$20240716$PER$$US-NOVOPROD-1196052$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240998104$24099810$4$F$$20240823$20240716$20240830$EXP$$CA-ABBVIE-5841890$ABBVIE$$$$$F$Y$$$20240830$$PH$CA$CA
240998111$24099811$1$I$20240711$20240711$20240716$20240716$EXP$GB-MHRA-MED-202407111713473970-BLKFR$GB-GSK-GB2024086416$GLAXOSMITHKLINE$$$$$$Y$$$20240716$$PH$GB$GB
240998121$24099812$1$I$$20240712$20240716$20240716$EXP$$US-ABBVIE-5840818$ABBVIE$$$$$F$Y$$$20240716$$CN$US$US
240998131$24099813$1$I$20240208$20240318$20240716$20240716$PER$$US-NOVOPROD-1197138$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
240998141$24099814$1$I$$20240320$20240716$20240716$PER$$US-NOVOPROD-1196798$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998151$24099815$1$I$$20240321$20240716$20240716$PER$$US-NOVOPROD-1196953$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998161$24099816$1$I$20240105$20240712$20240716$20240716$EXP$$IT-SANDOZ INC.-SDZ2024IT064893$SANDOZ$$70$YR$$M$Y$$$20240716$$HP$IT$IT
240998171$24099817$1$I$$20240321$20240716$20240716$PER$$US-NOVOPROD-1196968$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240998181$24099818$1$I$20240206$20240426$20240716$20240716$PER$$US-NOVOPROD-1196652$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
240998191$24099819$1$I$$20240422$20240716$20240716$PER$$US-NOVOPROD-1196640$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998201$24099820$1$I$20240319$20240410$20240716$20240716$PER$$US-NOVOPROD-1196762$NOVO NORDISK$$61$YR$$M$Y$$$20240717$$MD$US$US
240998211$24099821$1$I$$20240322$20240716$20240716$PER$$US-NOVOPROD-1196647$NOVO NORDISK$$$$$M$Y$$$20240717$$PH$US$US
240998221$24099822$1$I$$20240322$20240716$20240716$PER$$US-NOVOPROD-1197036$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240998231$24099823$1$I$20220101$20240321$20240716$20240716$PER$$US-NOVOPROD-1197103$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
240998241$24099824$1$I$$20240325$20240716$20240716$PER$$US-NOVOPROD-1196879$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998251$24099825$1$I$20231101$20240320$20240716$20240716$PER$$US-NOVOPROD-1196838$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240998261$24099826$1$I$$20240320$20240716$20240716$PER$$US-NOVOPROD-1196589$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
240998271$24099827$1$I$$20240325$20240716$20240716$PER$$US-NOVOPROD-1196717$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998281$24099828$1$I$$20240322$20240716$20240716$PER$$US-NOVOPROD-1197059$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998291$24099829$1$I$$20240320$20240716$20240716$PER$$US-NOVOPROD-1196654$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998301$24099830$1$I$$20240321$20240716$20240716$PER$$US-NOVOPROD-1196767$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
240998311$24099831$1$I$$20240321$20240716$20240716$PER$$US-NOVOPROD-1196817$NOVO NORDISK$$$$A$F$Y$$$20240717$$MD$US$US
240998321$24099832$1$I$20240630$20240712$20240716$20240716$EXP$$US-ABBVIE-5840562$ABBVIE$$55$YR$$F$Y$$$20240716$$CN$US$US
240998331$24099833$1$I$20240308$20240520$20240716$20240716$PER$$US-NOVOPROD-1196867$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
240998341$24099834$1$I$20240223$20240322$20240716$20240716$PER$$US-NOVOPROD-1196778$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998351$24099835$1$I$20240625$20240712$20240716$20240716$EXP$FR-AFSSAPS-RS2024000685$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-112003$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$58$KG$20240717$$PH$FR$FR
240998361$24099836$1$I$20240710$20240711$20240716$20240716$EXP$$CA-ABBVIE-5838546$ABBVIE$$$$A$M$Y$$$20240716$$CN$CA$CA
240998372$24099837$2$F$20240322$20240322$20240716$20240716$PER$$US-NOVOPROD-1197720$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998381$24099838$1$I$20240201$20240322$20240716$20240716$PER$$US-NOVOPROD-1197472$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
240998391$24099839$1$I$20230701$20240326$20240716$20240716$PER$$US-NOVOPROD-1197798$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
240998401$24099840$1$I$$20240419$20240716$20240716$PER$$US-NOVOPROD-1197471$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240998411$24099841$1$I$$20240322$20240716$20240716$PER$$US-NOVOPROD-1197282$NOVO NORDISK$$$$$M$Y$$$20240717$$PH$US$US
240998421$24099842$1$I$20240301$20240321$20240716$20240716$PER$$US-NOVOPROD-1197493$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
240998431$24099843$1$I$$20240326$20240716$20240716$PER$$US-NOVOPROD-1197840$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240998441$24099844$1$I$$20240322$20240716$20240716$PER$$US-NOVOPROD-1197174$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240998451$24099845$1$I$$20240325$20240716$20240716$PER$$US-NOVOPROD-1197225$NOVO NORDISK$$$$$F$Y$$$20240717$$PH$US$US
240998461$24099846$1$I$20240201$20240325$20240716$20240716$PER$$US-NOVOPROD-1197889$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
240998471$24099847$1$I$$20240325$20240716$20240716$PER$$US-NOVOPROD-1197322$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240998481$24099848$1$I$20230601$20240326$20240716$20240716$PER$$US-NOVOPROD-1197239$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998491$24099849$1$I$$20240603$20240716$20240716$PER$$US-NOVOPROD-1197915$NOVO NORDISK$$$$E$F$Y$$$20240717$$MD$US$US
240998501$24099850$1$I$20240101$20240325$20240716$20240716$PER$$US-NOVOPROD-1197401$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998511$24099851$1$I$$20240321$20240716$20240716$PER$$US-NOVOPROD-1197336$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998521$24099852$1$I$20230201$20240321$20240716$20240716$PER$$US-NOVOPROD-1197492$NOVO NORDISK$$52$YR$$F$Y$$$20240717$$CN$US$US
240998531$24099853$1$I$20230901$20240322$20240716$20240716$PER$$US-NOVOPROD-1197885$NOVO NORDISK$$53$YR$$M$Y$$$20240717$$CN$US$US
240998541$24099854$1$I$$20240322$20240716$20240716$PER$$US-NOVOPROD-1197161$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240998551$24099855$1$I$$20240322$20240716$20240716$PER$$US-NOVOPROD-1197463$NOVO NORDISK$$$$$M$Y$$$20240717$$PH$US$US
240998561$24099856$1$I$$20240326$20240716$20240716$PER$$US-NOVOPROD-1197853$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240998571$24099857$1$I$20240301$20240326$20240716$20240716$PER$$US-NOVOPROD-1197784$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
240998581$24099858$1$I$$20240708$20240716$20240716$EXP$$US-ROCHE-10000021551$ROCHE$$76$YR$E$F$Y$$$20240717$$CN$US$US
240998591$24099859$1$I$$20240324$20240716$20240716$PER$$US-NOVOPROD-1197961$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998601$24099860$1$I$$20240325$20240716$20240716$PER$$US-NOVOPROD-1198178$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240998611$24099861$1$I$$20240529$20240716$20240716$PER$$US-NOVOPROD-1235569$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998621$24099862$1$I$$20240321$20240716$20240716$PER$$US-NOVOPROD-1197964$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
240998631$24099863$1$I$20231205$20240322$20240716$20240716$PER$$US-NOVOPROD-1197944$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
240998641$24099864$1$I$20231101$20240530$20240716$20240716$PER$$US-NOVOPROD-1235818$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
240998651$24099865$1$I$$20230824$20240716$20240716$PER$$US-NOVOPROD-1235741$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998661$24099866$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1236219$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998671$24099867$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1236195$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240998681$24099868$1$I$20240530$20240530$20240716$20240716$PER$$US-NOVOPROD-1236236$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
240998691$24099869$1$I$$20230821$20240716$20240716$PER$$US-NOVOPROD-1235828$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240998701$24099870$1$I$20240528$20240530$20240716$20240716$PER$$US-NOVOPROD-1236068$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240998711$24099871$1$I$20240501$20240530$20240716$20240716$PER$$US-NOVOPROD-1236277$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240998721$24099872$1$I$$20231005$20240716$20240716$PER$$US-NOVOPROD-1235576$NOVO NORDISK$$97$YR$$F$Y$$$20240717$$CN$US$US
240998731$24099873$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1235545$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240998741$24099874$1$I$20231122$20240322$20240716$20240716$PER$$US-NOVOPROD-1197966$NOVO NORDISK$$47$YR$$F$Y$$$20240717$$CN$US$US
240998751$24099875$1$I$$20240322$20240716$20240716$PER$$US-NOVOPROD-1197920$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240998761$24099876$1$I$$20240326$20240716$20240716$PER$$US-NOVOPROD-1197999$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998771$24099877$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1235610$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240998781$24099878$1$I$$20240325$20240716$20240716$PER$$US-NOVOPROD-1198026$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240998791$24099879$1$I$20220101$20240530$20240716$20240716$PER$$US-NOVOPROD-1235556$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
240998801$24099880$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1236279$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240998811$24099881$1$I$$20230804$20240716$20240716$PER$$US-NOVOPROD-1235758$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240998821$24099882$1$I$20240516$20240701$20240716$20240716$PER$$US-NOVOPROD-1236231$NOVO NORDISK$$38$YR$$M$Y$$$20240717$$CN$US$US
240998831$24099883$1$I$$20240325$20240716$20240716$PER$$US-NOVOPROD-1198149$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240998841$24099884$1$I$20240518$20240530$20240716$20240716$PER$$US-NOVOPROD-1235606$NOVO NORDISK$$58$YR$$M$Y$$$20240717$$CN$US$US
240998851$24099885$1$I$$20240715$20240716$20240716$PER$$US-HALEON-2187347$Haleon PLC$$$$$F$Y$$$20240716$$CN$US$US
240998861$24099886$1$I$$20240523$20240716$20240716$PER$$US-NOVOPROD-1199138$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240998872$24099887$2$F$$20240325$20240716$20240721$PER$$US-NOVOPROD-1199436$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
240998881$24099888$1$I$20240312$20240326$20240716$20240716$PER$$US-NOVOPROD-1199708$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
240998891$24099889$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1236403$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
240998901$24099890$1$I$20240304$20240325$20240716$20240716$PER$$US-NOVOPROD-1199309$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240998911$24099891$1$I$$20240329$20240716$20240716$PER$$US-NOVOPROD-1199303$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
240998921$24099892$1$I$$20240325$20240716$20240716$PER$$US-NOVOPROD-1199485$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998931$24099893$1$I$20240205$20240328$20240716$20240716$PER$$US-NOVOPROD-1199466$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240998941$24099894$1$I$20240101$20240327$20240716$20240716$PER$$US-NOVOPROD-1199716$NOVO NORDISK$$73$YR$$M$Y$$$20240717$$CN$US$US
240998951$24099895$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1236420$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240998961$24099896$1$I$$20240327$20240716$20240716$PER$$US-NOVOPROD-1199623$NOVO NORDISK$$83$YR$$F$Y$$$20240717$$CN$US$US
240998971$24099897$1$I$20231001$20240326$20240716$20240716$PER$$US-NOVOPROD-1199131$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240998981$24099898$1$I$$20240329$20240716$20240716$PER$$US-NOVOPROD-1199786$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240998991$24099899$1$I$$20240327$20240716$20240716$PER$$US-NOVOPROD-1199746$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999001$24099900$1$I$20240101$20240530$20240716$20240716$PER$$US-NOVOPROD-1236417$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
240999011$24099901$1$I$$20240327$20240716$20240716$PER$$US-NOVOPROD-1199638$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240999021$24099902$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1236333$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999031$24099903$1$I$20231101$20240328$20240716$20240716$PER$$US-NOVOPROD-1199761$NOVO NORDISK$$62$YR$$M$Y$$$20240717$$CN$US$US
240999041$24099904$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1236410$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999051$24099905$1$I$20231001$20240328$20240716$20240716$PER$$US-NOVOPROD-1199684$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
240999061$24099906$1$I$20240101$20240326$20240716$20240716$PER$$US-NOVOPROD-1199347$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999071$24099907$1$I$$20240401$20240716$20240716$PER$$US-NOVOPROD-1199770$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
240999081$24099908$1$I$20231201$20240329$20240716$20240716$PER$$US-NOVOPROD-1199264$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
240999091$24099909$1$I$20240329$20240329$20240716$20240716$PER$$US-NOVOPROD-1199593$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
240999102$24099910$2$F$$20240730$20240716$20240805$EXP$$AU-AMGEN-AUSSP2024140585$AMGEN$$$$$M$Y$$$20240805$$CN$AU$AU
240999112$24099911$2$F$20240602$20240830$20240716$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113065$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240905$$CN$US$US
240999121$24099912$1$I$20240201$20240531$20240716$20240716$PER$$US-NOVOPROD-1236666$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240999131$24099913$1$I$$20240531$20240716$20240716$PER$$US-NOVOPROD-1236763$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240999141$24099914$1$I$20240216$20240328$20240716$20240716$PER$$US-NOVOPROD-1199873$NOVO NORDISK$$58$YR$$M$Y$$$20240717$$CN$US$US
240999151$24099915$1$I$$20240401$20240716$20240716$PER$$US-NOVOPROD-1199850$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240999161$24099916$1$I$$20240530$20240716$20240716$PER$$US-NOVOPROD-1236436$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240999171$24099917$1$I$20240515$20240531$20240716$20240716$PER$$US-NOVOPROD-1236521$NOVO NORDISK$$75$YR$$M$Y$$$20240717$$CN$US$US
240999181$24099918$1$I$$20230830$20240716$20240716$PER$$US-NOVOPROD-1236633$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999191$24099919$1$I$20240311$20240701$20240716$20240716$PER$$US-NOVOPROD-1236705$NOVO NORDISK$$63$YR$$M$Y$$$20240717$$CN$US$US
240999201$24099920$1$I$20240311$20240327$20240716$20240716$PER$$US-NOVOPROD-1199936$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
240999211$24099921$1$I$20240306$20240415$20240716$20240716$PER$$US-NOVOPROD-1199862$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
240999221$24099922$1$I$$20240612$20240716$20240716$PER$$US-NOVOPROD-1200046$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240999231$24099923$1$I$$20240328$20240716$20240716$PER$$US-NOVOPROD-1199983$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240999241$24099924$1$I$$20240531$20240716$20240716$PER$$US-NOVOPROD-1236706$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999251$24099925$1$I$$20240329$20240716$20240716$PER$$US-NOVOPROD-1199804$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999261$24099926$1$I$20231230$20240328$20240716$20240716$PER$$US-NOVOPROD-1199788$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240999271$24099927$1$I$$20240531$20240716$20240716$PER$$US-NOVOPROD-1236527$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
240999281$24099928$1$I$$20230802$20240716$20240716$PER$$US-NOVOPROD-1236603$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999291$24099929$1$I$$20230807$20240716$20240716$PER$$US-NOVOPROD-1236596$NOVO NORDISK$$70$YR$$$Y$$$20240717$$CN$US$US
240999301$24099930$1$I$20240301$20240418$20240716$20240716$PER$$US-NOVOPROD-1199799$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
240999311$24099931$1$I$20210201$20240411$20240716$20240716$PER$$US-NOVOPROD-1199919$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$HP$US$US
240999321$24099932$1$I$20231101$20240531$20240717$20240717$PER$$US-NOVOPROD-1237073$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
240999331$24099933$1$I$$20230726$20240717$20240717$PER$$US-NOVOPROD-1239576$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999341$24099934$1$I$$20240531$20240717$20240717$PER$$US-NOVOPROD-1237045$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999351$24099935$1$I$$20230726$20240717$20240717$PER$$US-NOVOPROD-1238367$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240999361$24099936$1$I$$20230721$20240717$20240717$PER$$US-NOVOPROD-1239202$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999371$24099937$1$I$$20240604$20240717$20240717$PER$$US-NOVOPROD-1239346$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240999381$24099938$1$I$$20230811$20240717$20240717$PER$$US-NOVOPROD-1239181$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240999391$24099939$1$I$$20230728$20240717$20240717$PER$$US-NOVOPROD-1237173$NOVO NORDISK$$75$YR$$$Y$$$20240717$$CN$US$US
240999401$24099940$1$I$$20240531$20240717$20240717$PER$$US-NOVOPROD-1236906$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240999411$24099941$1$I$$20230731$20240717$20240717$PER$$US-NOVOPROD-1237440$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999421$24099942$1$I$$20240531$20240717$20240717$PER$$US-NOVOPROD-1236917$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999431$24099943$1$I$$20240710$20240717$20240717$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01280$NOVITIUM PHARMA$Chaoyue Zhang.Case report: A highly active refractory myasthenia gravis with treatment of telitacicept combined with efgartigimod.Frontiers in Immunology.10-MAY-2024;15:1-9$37$YR$A$F$Y$$$20240717$$HP$CN$CN
240999441$24099944$1$I$20240201$20240531$20240717$20240717$PER$$US-NOVOPROD-1236889$NOVO NORDISK$$41$YR$$F$Y$$$20240717$$CN$US$US
240999451$24099945$1$I$20230724$20230727$20240717$20240717$PER$$US-NOVOPROD-1238368$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999461$24099946$1$I$$20230801$20240717$20240717$PER$$US-NOVOPROD-1237379$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999471$24099947$1$I$$20230721$20240717$20240717$PER$$US-NOVOPROD-1239083$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999481$24099948$1$I$$20230731$20240717$20240717$PER$$US-NOVOPROD-1237110$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999491$24099949$1$I$$20240531$20240717$20240717$PER$$US-NOVOPROD-1236844$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999501$24099950$1$I$$20230726$20240717$20240717$PER$$US-NOVOPROD-1238273$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999511$24099951$1$I$20230728$20230728$20240717$20240717$PER$$US-NOVOPROD-1237251$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999521$24099952$1$I$20230729$20230731$20240717$20240717$PER$$US-NOVOPROD-1237272$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999531$24099953$1$I$$20240531$20240717$20240717$PER$$US-NOVOPROD-1237207$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999541$24099954$1$I$20240529$20240531$20240717$20240717$PER$$US-NOVOPROD-1237738$NOVO NORDISK$$79$YR$$M$Y$$$20240717$$CN$US$US
240999551$24099955$1$I$$20230814$20240717$20240717$PER$$US-NOVOPROD-1237968$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999561$24099956$1$I$$20230803$20240717$20240717$PER$$US-NOVOPROD-1238035$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999571$24099957$1$I$$20230731$20240717$20240717$PER$$US-NOVOPROD-1237262$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240999581$24099958$1$I$$20230727$20240717$20240717$PER$$US-NOVOPROD-1238366$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999591$24099959$1$I$$20240531$20240717$20240717$PER$$US-NOVOPROD-1236878$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
240999601$24099960$1$I$$20230814$20240717$20240717$PER$$US-NOVOPROD-1237907$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999613$24099961$3$F$$20240909$20240717$20240918$EXP$$US-ROCHE-10000022297$ROCHE$$76$YR$E$M$Y$$$20240918$$CN$US$US
240999621$24099962$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112596$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240717$$CN$US$US
240999631$24099963$1$I$$20240711$20240717$20240717$EXP$$US-ABBVIE-5838595$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
240999642$24099964$2$F$20240628$20240917$20240717$20240926$30DAY$$FR-JNJFOC-20240701633$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240926$$PH$FR$FR
240999651$24099965$1$I$$20240424$20240717$20240717$PER$$US-NOVOPROD-1241555$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999661$24099966$1$I$$20230719$20240717$20240717$PER$$US-NOVOPROD-1241125$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999672$24099967$2$F$20240301$20240424$20240717$20240717$PER$$US-NOVOPROD-1241652$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999681$24099968$1$I$20240212$20240607$20240717$20240717$PER$$US-NOVOPROD-1241631$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
240999691$24099969$1$I$$20240424$20240717$20240717$PER$$US-NOVOPROD-1241565$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999701$24099970$1$I$$20240325$20240717$20240717$PER$$US-NOVOPROD-1198211$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240999711$24099971$1$I$$20230727$20240717$20240717$PER$$US-NOVOPROD-1239602$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999721$24099972$1$I$20230717$20230718$20240717$20240717$PER$$US-NOVOPROD-1240118$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999731$24099973$1$I$$20230710$20240717$20240717$PER$$US-NOVOPROD-1240883$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999741$24099974$1$I$20240418$20240419$20240717$20240717$PER$$US-NOVOPROD-1241102$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240999751$24099975$1$I$$20240325$20240717$20240717$PER$$US-NOVOPROD-1241467$NOVO NORDISK$$68$YR$$F$Y$183$KG$20240717$$CN$US$US
240999761$24099976$1$I$$20230810$20240717$20240717$PER$$US-NOVOPROD-1241656$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999771$24099977$1$I$$20240326$20240717$20240717$PER$$US-NOVOPROD-1241241$NOVO NORDISK$$74$YR$$M$Y$$$20240717$$CN$US$US
240999781$24099978$1$I$$20230801$20240717$20240717$PER$$US-NOVOPROD-1240833$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240999791$24099979$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1240837$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240999801$24099980$1$I$$20230725$20240717$20240717$PER$$US-NOVOPROD-1239624$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999812$24099981$2$F$$20230604$20240717$20240717$PER$$US-NOVOPROD-1241549$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999821$24099982$1$I$$20230725$20240717$20240717$PER$$US-NOVOPROD-1239633$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999831$24099983$1$I$20240416$20240603$20240717$20240717$PER$$US-NOVOPROD-1241139$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
240999841$24099984$1$I$$20230725$20240717$20240717$PER$$US-NOVOPROD-1239625$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
240999851$24099985$1$I$20240626$20240705$20240717$20240717$EXP$GB-MHRA-MED-202407041514305460-JRCHB$GB-ESPERIONTHERAPEUTICS-2024GBR01060$ESPERION THERAPEUTICS$$$$$$Y$$$20240717$$CN$GB$GB
240999861$24099986$1$I$20171005$20240709$20240717$20240717$EXP$$BE-ABBVIE-17K-013-3085500-00$ABBVIE$$67$YR$$M$Y$61.2$KG$20240717$$MD$BE$BE
240999871$24099987$1$I$$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008468$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240716$$HP$US$US
240999881$24099988$1$I$$20240327$20240717$20240717$PER$$US-NOVOPROD-1199060$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999891$24099989$1$I$20240320$20240328$20240717$20240717$PER$$US-NOVOPROD-1198679$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
240999901$24099990$1$I$$20240326$20240717$20240717$PER$$US-NOVOPROD-1198700$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999911$24099991$1$I$$20240328$20240717$20240717$PER$$US-NOVOPROD-1198648$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
240999921$24099992$1$I$$20240624$20240717$20240717$PER$$US-NOVOPROD-1198534$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
240999931$24099993$1$I$20240319$20240513$20240717$20240717$PER$$US-NOVOPROD-1198365$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
240999941$24099994$1$I$20240324$20240324$20240717$20240717$PER$$US-NOVOPROD-1198536$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
240999951$24099995$1$I$$20240325$20240717$20240717$PER$$US-NOVOPROD-1198543$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
240999961$24099996$1$I$$20240328$20240717$20240717$PER$$US-NOVOPROD-1199045$NOVO NORDISK$$$$A$F$Y$$$20240717$$HP$US$US
240999971$24099997$1$I$20240311$20240325$20240717$20240717$PER$$US-NOVOPROD-1198498$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
240999981$24099998$1$I$$20240329$20240717$20240717$PER$$US-NOVOPROD-1198684$NOVO NORDISK$$38$YR$$F$Y$$$20240717$$CN$US$US
240999991$24099999$1$I$$20240326$20240717$20240717$PER$$US-NOVOPROD-1198686$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241000001$24100000$1$I$$20240328$20240717$20240717$PER$$US-NOVOPROD-1198355$NOVO NORDISK$$$$$F$Y$$$20240717$$PH$US$US
241000011$24100001$1$I$20231201$20240325$20240717$20240717$PER$$US-NOVOPROD-1198489$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000021$24100002$1$I$$20240325$20240717$20240717$PER$$US-NOVOPROD-1198556$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241000031$24100003$1$I$$20240325$20240717$20240717$PER$$US-NOVOPROD-1198640$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000041$24100004$1$I$$20240327$20240717$20240717$PER$$US-NOVOPROD-1198994$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000051$24100005$1$I$$20240327$20240717$20240717$PER$$US-NOVOPROD-1198655$NOVO NORDISK$$42$YR$$F$Y$$$20240717$$CN$US$US
241000061$24100006$1$I$20240323$20240327$20240717$20240717$PER$$US-NOVOPROD-1199117$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000071$24100007$1$I$$20240324$20240717$20240717$PER$$US-NOVOPROD-1198542$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000081$24100008$1$I$$20240325$20240717$20240717$PER$$US-NOVOPROD-1198239$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241000091$24100009$1$I$$20240326$20240717$20240717$PER$$US-NOVOPROD-1198596$NOVO NORDISK$$$$E$M$Y$$$20240717$$MD$US$US
241000101$24100010$1$I$$20230626$20240717$20240717$PER$$US-NOVOPROD-1198847$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000111$24100011$1$I$20240325$20240325$20240717$20240717$PER$$US-NOVOPROD-1198275$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000121$24100012$1$I$$20240325$20240717$20240717$PER$$US-NOVOPROD-1198294$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000131$24100013$1$I$20240126$20240506$20240717$20240717$PER$$US-NOVOPROD-1199017$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
241000141$24100014$1$I$20230301$20240325$20240717$20240717$PER$$US-NOVOPROD-1198225$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241000151$24100015$1$I$20240323$20240326$20240717$20240717$PER$$US-NOVOPROD-1198571$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241000161$24100016$1$I$$20240715$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112719$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240717$$HP$US$US
241000171$24100017$1$I$$20230703$20240717$20240717$PER$$US-NOVOPROD-1200211$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000181$24100018$1$I$$20230621$20240717$20240717$PER$$US-NOVOPROD-1200440$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000191$24100019$1$I$$20240329$20240717$20240717$PER$$US-NOVOPROD-1200359$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000201$24100020$1$I$$20240402$20240717$20240717$PER$$US-NOVOPROD-1200383$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241000211$24100021$1$I$20240319$20240424$20240717$20240717$PER$$US-NOVOPROD-1195714$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
241000221$24100022$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1200416$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241000231$24100023$1$I$20240310$20240327$20240717$20240717$PER$$US-NOVOPROD-1200329$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
241000241$24100024$1$I$$20240327$20240717$20240717$PER$$US-NOVOPROD-1200463$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241000251$24100025$1$I$20200801$20240329$20240717$20240717$PER$$US-NOVOPROD-1200502$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
241000261$24100026$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1200415$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241000271$24100027$1$I$$20240321$20240717$20240717$PER$$US-NOVOPROD-1200100$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000281$24100028$1$I$$20240328$20240717$20240717$PER$$US-NOVOPROD-1200254$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000291$24100029$1$I$$20230608$20240717$20240717$PER$$US-NOVOPROD-1200462$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241000301$24100030$1$I$$20240328$20240717$20240717$PER$$US-NOVOPROD-1200096$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241000311$24100031$1$I$$20230608$20240717$20240717$PER$$US-NOVOPROD-1200168$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241000321$24100032$1$I$$20240327$20240717$20240717$PER$$US-NOVOPROD-1199126$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000331$24100033$1$I$20240215$20240328$20240717$20240717$PER$$US-NOVOPROD-1200435$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
241000341$24100034$1$I$$20240328$20240717$20240717$PER$$US-NOVOPROD-1200326$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241000351$24100035$1$I$$20240328$20240717$20240717$PER$$US-NOVOPROD-1200126$NOVO NORDISK$$60$YR$$$Y$$$20240717$$HP$US$US
241000361$24100036$1$I$20240327$20240425$20240717$20240717$PER$$US-NOVOPROD-1200338$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$MD$US$US
241000371$24100037$1$I$$20230712$20240717$20240717$PER$$US-NOVOPROD-1200063$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000382$24100038$2$F$$20240327$20240717$20240723$PER$$US-NOVOPROD-1200135$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241000391$24100039$1$I$20240321$20240327$20240717$20240717$PER$$US-NOVOPROD-1200349$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241000401$24100040$1$I$$20240329$20240717$20240717$PER$$US-NOVOPROD-1200350$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000411$24100041$1$I$20231201$20240710$20240717$20240717$EXP$$CA-ABBVIE-5840944$ABBVIE$$87$YR$$M$Y$$$20240717$$HP$CA$CA
241000421$24100042$1$I$20240709$20240713$20240717$20240717$EXP$$CN-HALEON-2186995$Haleon PLC$$16$YR$$M$Y$$$20240716$$HP$CN$CN
241000431$24100043$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5840870$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241000441$24100044$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5839905$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241000451$24100045$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5840110$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241000462$24100046$2$F$20240101$20240805$20240717$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109409$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240809$$CN$US$US
241000471$24100047$1$I$$20240715$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113082$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240717$$CN$US$US
241000481$24100048$1$I$$20230717$20240717$20240717$PER$$US-NOVOPROD-1241711$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000491$24100049$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1242981$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000501$24100050$1$I$20230712$20230719$20240717$20240717$PER$$US-NOVOPROD-1242063$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000511$24100051$1$I$$20230720$20240717$20240717$PER$$US-NOVOPROD-1243963$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
241000521$24100052$1$I$$20230804$20240717$20240717$PER$$US-NOVOPROD-1242353$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000531$24100053$1$I$$20230621$20240717$20240717$PER$$US-NOVOPROD-1242923$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000541$24100054$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1242959$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000551$24100055$1$I$$20231106$20240717$20240717$PER$$US-NOVOPROD-1242844$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000561$24100056$1$I$$20230913$20240717$20240717$PER$$US-NOVOPROD-1242290$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000571$24100057$1$I$$20230718$20240717$20240717$PER$$US-NOVOPROD-1242310$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241000581$24100058$1$I$$20230801$20240717$20240717$PER$$US-NOVOPROD-1242961$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241000591$24100059$1$I$$20240423$20240717$20240717$PER$$US-NOVOPROD-1241693$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241000601$24100060$1$I$$20231106$20240717$20240717$PER$$US-NOVOPROD-1242124$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000612$24100061$2$F$$20230705$20240717$20240717$PER$$US-NOVOPROD-1242949$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000621$24100062$1$I$$20230720$20240717$20240717$PER$$US-NOVOPROD-1241951$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000631$24100063$1$I$$20230727$20240717$20240717$PER$$US-NOVOPROD-1242749$NOVO NORDISK$$73$YR$$M$Y$$$20240717$$CN$US$US
241000641$24100064$1$I$$20240216$20240717$20240717$PER$$US-NOVOPROD-1242466$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000651$24100065$1$I$$20230720$20240717$20240717$PER$$US-NOVOPROD-1242211$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000661$24100066$1$I$$20240624$20240717$20240717$PER$$US-NOVOPROD-1242081$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000671$24100067$1$I$$20230607$20240717$20240717$PER$$US-NOVOPROD-1242957$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000681$24100068$1$I$$20230703$20240717$20240717$PER$$US-NOVOPROD-1241715$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000691$24100069$1$I$$20230606$20240717$20240717$PER$$US-NOVOPROD-1242969$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000701$24100070$1$I$$20230621$20240717$20240717$PER$$US-NOVOPROD-1241925$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000711$24100071$1$I$$20230817$20240717$20240717$PER$$US-NOVOPROD-1242455$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000721$24100072$1$I$$20230712$20240717$20240717$PER$$US-NOVOPROD-1242437$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
241000731$24100073$1$I$20240624$20240711$20240717$20240717$EXP$DE-BFARM-24004784$DE-EMD Serono-2024037943$EMD SERONO INC$$27$YR$A$F$Y$$$20240717$$MD$DE$DE
241000741$24100074$1$I$$20240715$20240717$20240717$PER$$US-JNJFOC-20240741595$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$MD$US$US
241000752$24100075$2$F$$20240726$20240717$20240805$PER$$US-ABBVIE-5838801$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241000771$24100077$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1246912$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000781$24100078$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1247025$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000791$24100079$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1246794$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000801$24100080$1$I$$20230804$20240717$20240717$PER$$US-NOVOPROD-1246370$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000811$24100081$1$I$20231201$20240507$20240717$20240717$PER$$US-NOVOPROD-1247030$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000821$24100082$1$I$20240301$20240513$20240717$20240717$PER$$US-NOVOPROD-1246834$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241000831$24100083$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1246519$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000841$24100084$1$I$$20230626$20240717$20240717$PER$$US-NOVOPROD-1243969$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000851$24100085$1$I$20211130$20240701$20240717$20240717$PER$$US-NOVOPROD-1247032$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
241000861$24100086$1$I$20230807$20230807$20240717$20240717$PER$$US-NOVOPROD-1246419$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000871$24100087$1$I$$20231103$20240717$20240717$PER$$US-NOVOPROD-1245803$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000881$24100088$1$I$$20240531$20240717$20240717$PER$$US-NOVOPROD-1246740$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241000891$24100089$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1246763$NOVO NORDISK$$80$YR$$F$Y$$$20240717$$CN$US$US
241000901$24100090$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1245707$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000911$24100091$1$I$$20240328$20240717$20240717$PER$$US-NOVOPROD-1246828$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241000921$24100092$1$I$$20230605$20240717$20240717$PER$$US-NOVOPROD-1245781$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000931$24100093$1$I$$20240529$20240717$20240717$PER$$US-NOVOPROD-1246825$NOVO NORDISK$$58$YR$$M$Y$$$20240717$$MD$US$US
241000941$24100094$1$I$20240301$20240401$20240717$20240717$PER$$US-NOVOPROD-1246816$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241000951$24100095$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1246521$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241000961$24100096$1$I$$20240429$20240717$20240717$PER$$US-NOVOPROD-1247022$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241000971$24100097$1$I$20240401$20240411$20240717$20240717$PER$$US-NOVOPROD-1246772$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
241000981$24100098$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1246785$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241000991$24100099$1$I$20240201$20240229$20240717$20240717$PER$$US-NOVOPROD-1246704$NOVO NORDISK$$82$YR$$M$Y$$$20240717$$CN$US$US
241001001$24100100$1$I$$20240426$20240717$20240717$PER$$US-NOVOPROD-1247090$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001011$24100101$1$I$$20240531$20240717$20240717$PER$$US-NOVOPROD-1246744$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001021$24100102$1$I$$20240503$20240717$20240717$PER$$US-NOVOPROD-1246666$NOVO NORDISK$$$$$$Y$$$20240717$$HP$US$US
241001032$24100103$2$F$$20240730$20240717$20240806$EXP$$US-ABBVIE-5840585$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241001041$24100104$1$I$$20240711$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US064769$SANDOZ$$$$$$Y$$$20240717$$HP$US$US
241001051$24100105$1$I$$20240425$20240717$20240717$PER$$US-NOVOPROD-1247480$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241001062$24100106$2$F$20240503$20240906$20240717$20240912$EXP$$US-ABBVIE-5767455$ABBVIE$$70$YR$$F$Y$$$20240912$$CN$US$US
241001071$24100107$1$I$20240429$20240506$20240717$20240717$PER$$US-NOVOPROD-1247805$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241001081$24100108$1$I$$20240319$20240717$20240717$PER$$US-NOVOPROD-1247836$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
241001091$24100109$1$I$$20240422$20240717$20240717$PER$$US-NOVOPROD-1247471$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001101$24100110$1$I$$20231031$20240717$20240717$PER$$US-NOVOPROD-1247663$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001111$24100111$1$I$20231201$20240220$20240717$20240717$PER$$US-NOVOPROD-1247551$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001121$24100112$1$I$$20240322$20240717$20240717$PER$$US-NOVOPROD-1247714$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001132$24100113$2$F$20240401$20240510$20240717$20240717$PER$$US-NOVOPROD-1247210$NOVO NORDISK$$77$YR$$M$Y$$$20240717$$CN$US$US
241001141$24100114$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1247400$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001151$24100115$1$I$20240304$20240306$20240717$20240717$PER$$US-NOVOPROD-1247747$NOVO NORDISK$$35$YR$$F$Y$$$20240717$$CN$US$US
241001161$24100116$1$I$$20240318$20240717$20240717$PER$$US-NOVOPROD-1247871$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001171$24100117$1$I$$20230222$20240717$20240717$PER$$US-NOVOPROD-1247220$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001181$24100118$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1247150$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001191$24100119$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1247153$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001201$24100120$1$I$20240201$20240304$20240717$20240717$PER$$US-NOVOPROD-1247796$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241001211$24100121$1$I$20240201$20240308$20240717$20240717$PER$$US-NOVOPROD-1247739$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001221$24100122$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1247401$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001231$24100123$1$I$$20240313$20240717$20240717$PER$$US-NOVOPROD-1247719$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001241$24100124$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1247875$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001251$24100125$1$I$$20231017$20240717$20240717$PER$$US-NOVOPROD-1247494$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001261$24100126$1$I$$20240424$20240717$20240717$PER$$US-NOVOPROD-1247487$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241001271$24100127$1$I$$20240325$20240717$20240717$PER$$US-NOVOPROD-1247563$NOVO NORDISK$$$$$F$Y$$$20240717$$PH$US$US
241001281$24100128$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1247869$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001291$24100129$1$I$$20230721$20240717$20240717$PER$$US-NOVOPROD-1247161$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001301$24100130$1$I$$20230609$20240717$20240717$PER$$US-NOVOPROD-1247752$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001311$24100131$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1247516$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001321$24100132$1$I$20231201$20240711$20240717$20240717$EXP$FR-AFSSAPS-PP2024000770$FR-GSK-FR2024086225$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$FR$FR
241001331$24100133$1$I$20240601$20240712$20240717$20240717$EXP$$US-ABBVIE-5839260$ABBVIE$$82$YR$$M$Y$$$20240717$$CN$US$US
241001341$24100134$1$I$$20240709$20240717$20240717$EXP$$CA-HALEON-2186466$Haleon PLC$$80$YR$$M$Y$69$KG$20240716$$HP$CA$CA
241001351$24100135$1$I$20230210$20240530$20240717$20240717$PER$$US-NOVOPROD-1248117$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001361$24100136$1$I$$20240403$20240717$20240717$PER$$US-NOVOPROD-1200609$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001371$24100137$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1248034$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001381$24100138$1$I$20240315$20240329$20240717$20240717$PER$$US-NOVOPROD-1200774$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
241001391$24100139$1$I$$20240327$20240717$20240717$PER$$US-NOVOPROD-1200552$NOVO NORDISK$$$$A$F$Y$$$20240717$$PH$US$US
241001401$24100140$1$I$$20230613$20240717$20240717$PER$$US-NOVOPROD-1200649$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001411$24100141$1$I$$20240403$20240717$20240717$PER$$US-NOVOPROD-1200711$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$HP$US$US
241001421$24100142$1$I$20230101$20240612$20240717$20240717$PER$$US-NOVOPROD-1200651$NOVO NORDISK$$53$YR$$F$Y$133.33$KG$20240717$$HP$US$US
241001431$24100143$1$I$$20240328$20240717$20240717$PER$$US-NOVOPROD-1200509$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001441$24100144$1$I$20231201$20240328$20240717$20240717$PER$$US-NOVOPROD-1200520$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241001451$24100145$1$I$20240327$20240328$20240717$20240717$PER$$US-NOVOPROD-1200546$NOVO NORDISK$$86$YR$$F$Y$$$20240717$$CN$US$US
241001461$24100146$1$I$20240301$20240402$20240717$20240717$PER$$US-NOVOPROD-1200722$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
241001471$24100147$1$I$$20230707$20240717$20240717$PER$$US-NOVOPROD-1200535$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001481$24100148$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-10000026392$ROCHE$$$$E$F$Y$$$20240717$$CN$US$US
241001492$24100149$2$F$$20240815$20240717$20240819$PER$$US-ROCHE-10000026664$ROCHE$$$$A$F$Y$$$20240819$$CN$US$US
241001501$24100150$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-10000025950$ROCHE$$$$$$Y$$$20240717$$HP$US$US
241001511$24100151$1$I$20230101$20240708$20240717$20240717$PER$$US-BIOGEN-2023BI01242224$BIOGEN$$$$$F$Y$$$20240717$$CN$US$US
241001521$24100152$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5839847$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241001531$24100153$1$I$20240401$20240709$20240717$20240717$EXP$$US-ABBVIE-5824261$ABBVIE$$76$YR$$F$Y$48$KG$20240717$$CN$US$US
241001541$24100154$1$I$20231001$20240709$20240717$20240717$EXP$$US-AMGEN-USASP2024138802$AMGEN$$70$YR$E$F$Y$$$20240716$$CN$US$US
241001551$24100155$1$I$$20240711$20240717$20240717$PER$$US-JNJFOC-20240733161$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241001561$24100156$1$I$20240701$20240711$20240717$20240717$EXP$$US-ABBVIE-5840328$ABBVIE$$74$YR$$M$Y$$$20240717$$CN$US$US
241001571$24100157$1$I$20240708$20240708$20240717$20240717$EXP$$JP-ROCHE-10000025161$ROCHE$$$$A$F$Y$$$20240717$$MD$JP$JP
241001581$24100158$1$I$$20240715$20240717$20240717$EXP$$DE-SANDOZ INC.-NVSC2021DE061088$SANDOZ$$44$YR$$M$Y$$$20240717$$MD$DE$DE
241001591$24100159$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009885$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240717$$CN$US$US
241001601$24100160$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112807$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$89.36$KG$20240717$$HP$US$US
241001611$24100161$1$I$20240601$20240712$20240717$20240717$EXP$$US-ABBVIE-5841392$ABBVIE$$47$YR$$F$Y$$$20240717$$CN$US$US
241001621$24100162$1$I$$20230613$20240717$20240717$PER$$US-NOVOPROD-1201003$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001631$24100163$1$I$$20240329$20240717$20240717$PER$$US-NOVOPROD-1201075$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001641$24100164$1$I$$20230621$20240717$20240717$PER$$US-NOVOPROD-1201123$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001651$24100165$1$I$20240201$20240329$20240717$20240717$PER$$US-NOVOPROD-1201018$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241001661$24100166$1$I$$20240329$20240717$20240717$PER$$US-NOVOPROD-1201149$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001671$24100167$1$I$20231101$20240402$20240717$20240717$PER$$US-NOVOPROD-1201232$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
241001681$24100168$1$I$20230806$20240329$20240717$20240717$PER$$US-NOVOPROD-1201225$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
241001691$24100169$1$I$$20240327$20240717$20240717$PER$$US-NOVOPROD-1201050$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001701$24100170$1$I$$20230613$20240717$20240717$PER$$US-NOVOPROD-1201253$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001711$24100171$1$I$$20230710$20240717$20240717$PER$$US-NOVOPROD-1200823$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001721$24100172$1$I$$20240329$20240717$20240717$PER$$US-NOVOPROD-1200950$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001731$24100173$1$I$$20230608$20240717$20240717$PER$$US-NOVOPROD-1201008$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001741$24100174$1$I$$20230620$20240717$20240717$PER$$US-NOVOPROD-1201086$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001751$24100175$1$I$$20230628$20240717$20240717$PER$$US-NOVOPROD-1201125$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001761$24100176$1$I$$20230613$20240717$20240717$PER$$US-NOVOPROD-1200952$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001771$24100177$1$I$$20240329$20240717$20240717$PER$$US-NOVOPROD-1201022$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241001781$24100178$1$I$$20240329$20240717$20240717$PER$$US-NOVOPROD-1200897$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241001791$24100179$1$I$$20230607$20240717$20240717$PER$$US-NOVOPROD-1201236$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001801$24100180$1$I$$20240329$20240717$20240717$PER$$US-NOVOPROD-1201186$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001811$24100181$1$I$$20240711$20240717$20240717$EXP$$US-STERISCIENCE B.V.-2024-ST-001032$Steriscience PTE$Rodriguez C, Yosry N, Qaiser S, Luzuriaga A, Adelizzi A.. BRASH: A Deadly Acronym.. Am-J-Respir-Crit-Care-Med. 2024;209$84$YR$$F$Y$$$20240717$$HP$US$US
241001821$24100182$1$I$$20240715$20240717$20240717$PER$$NVSC2024US146629$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241001831$24100183$1$I$20180405$20240710$20240717$20240717$EXP$$CA-SANDOZ INC.-PHHY2018CA072667$SANDOZ$$61$YR$$F$Y$$$20240717$$CN$CA$CA
241001841$24100184$1$I$$20240709$20240717$20240717$PER$$US-JNJFOC-20240723109$JOHNSON AND JOHNSON$$90$YR$E$M$Y$$$20240717$$MD$US$US
241001851$24100185$1$I$20190801$20190820$20240717$20240717$EXP$$CO-AstraZeneca-2019SF21723$ASTRAZENECA$$13767$DY$$F$Y$$$20240717$$CN$CO$
241001861$24100186$1$I$$20240704$20240717$20240717$EXP$AU-TGA-805817$AU-Accord-433792$ACCORD$$$$$$Y$$$20240716$$HP$AU$AU
241001871$24100187$1$I$20240309$20240329$20240717$20240717$PER$$US-NOVOPROD-1201811$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
241001881$24100188$1$I$$20240402$20240717$20240717$PER$$US-NOVOPROD-1201665$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001891$24100189$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1201724$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241001901$24100190$1$I$$20230616$20240717$20240717$PER$$US-NOVOPROD-1202063$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001911$24100191$1$I$$20240425$20240717$20240717$PER$$US-NOVOPROD-1201846$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001921$24100192$1$I$$20230615$20240717$20240717$PER$$US-NOVOPROD-1201258$NOVO NORDISK$$80$YR$$F$Y$$$20240717$$CN$US$US
241001931$24100193$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1201841$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001941$24100194$1$I$$20230628$20240717$20240717$PER$$US-NOVOPROD-1202020$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001951$24100195$1$I$$20240329$20240717$20240717$PER$$US-NOVOPROD-1202009$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241001961$24100196$1$I$$20230626$20240717$20240717$PER$$US-NOVOPROD-1201939$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241001971$24100197$1$I$20230608$20230612$20240717$20240717$PER$$US-NOVOPROD-1201321$NOVO NORDISK$$77$YR$$M$Y$$$20240717$$CN$US$US
241001981$24100198$1$I$$20230609$20240717$20240717$PER$$US-NOVOPROD-1201303$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241001991$24100199$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1201862$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241002001$24100200$1$I$$20240331$20240717$20240717$PER$$US-NOVOPROD-1201548$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002011$24100201$1$I$20220101$20240403$20240717$20240717$PER$$US-NOVOPROD-1201494$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
241002021$24100202$1$I$20231101$20240328$20240717$20240717$PER$$US-NOVOPROD-1201661$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
241002031$24100203$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1201554$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
241002041$24100204$1$I$$20230614$20240717$20240717$PER$$US-NOVOPROD-1201690$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002051$24100205$1$I$$20230607$20240717$20240717$PER$$US-NOVOPROD-1201621$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002061$24100206$1$I$$20230627$20240717$20240717$PER$$US-NOVOPROD-1201757$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002071$24100207$1$I$20221201$20230612$20240717$20240717$PER$$US-NOVOPROD-1201319$NOVO NORDISK$$63$YR$$$Y$$$20240717$$CN$US$US
241002081$24100208$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1201689$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241002091$24100209$1$I$$20230619$20240717$20240717$PER$$US-NOVOPROD-1202030$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002101$24100210$1$I$20240301$20240329$20240717$20240717$PER$$US-NOVOPROD-1201787$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
241002111$24100211$1$I$$20230628$20240717$20240717$PER$$US-NOVOPROD-1201756$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
241002121$24100212$1$I$20240328$20240330$20240717$20240717$PER$$US-NOVOPROD-1201529$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
241002131$24100213$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1202059$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002142$24100214$2$F$20240612$20240730$20240717$20240808$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039501$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$80$KG$20240808$$MD$FR$FR
241002151$24100215$1$I$$20240708$20240717$20240717$EXP$$US-ABBVIE-5840612$ABBVIE$$$$$F$Y$$$20240717$$MD$US$US
241002161$24100216$1$I$20231009$20240710$20240717$20240717$EXP$$US-ABBVIE-5840025$ABBVIE$$89$YR$$F$Y$41$KG$20240717$$MD$US$US
241002171$24100217$1$I$$20240716$20240717$20240717$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040142$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240717$$CN$CA$CA
241002181$24100218$1$I$$20230608$20240717$20240717$PER$$US-NOVOPROD-1202157$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002191$24100219$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5841736$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241002201$24100220$1$I$$20230628$20240717$20240717$PER$$US-NOVOPROD-1202279$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002211$24100221$1$I$$20230727$20240717$20240717$PER$$US-NOVOPROD-1202451$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002221$24100222$1$I$20240327$20240328$20240717$20240717$PER$$US-NOVOPROD-1202505$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241002231$24100223$1$I$$20230714$20240717$20240717$PER$$US-NOVOPROD-1207443$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002241$24100224$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1202508$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241002251$24100225$1$I$$20230707$20240717$20240717$PER$$US-NOVOPROD-1202160$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002261$24100226$1$I$$20230606$20240717$20240717$PER$$US-NOVOPROD-1202256$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241002271$24100227$1$I$20230626$20230626$20240717$20240717$PER$$US-NOVOPROD-1202208$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002281$24100228$1$I$$20240506$20240717$20240717$PER$$US-NOVOPROD-1202077$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002291$24100229$1$I$$20240404$20240717$20240717$PER$$US-NOVOPROD-1202499$NOVO NORDISK$$28$YR$$F$Y$$$20240717$$HP$US$US
241002301$24100230$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1202463$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002311$24100231$1$I$$20230613$20240717$20240717$PER$$US-NOVOPROD-1202119$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002321$24100232$1$I$20240201$20240402$20240717$20240717$PER$$US-NOVOPROD-1202474$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241002331$24100233$1$I$20220823$20240402$20240717$20240717$PER$$US-NOVOPROD-1202125$NOVO NORDISK$$38$YR$$F$Y$$$20240717$$CN$US$US
241002341$24100234$1$I$$20230606$20240717$20240717$PER$$US-NOVOPROD-1202106$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002351$24100235$1$I$$20230712$20240717$20240717$PER$$US-NOVOPROD-1202154$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002361$24100236$1$I$$20230620$20240717$20240717$PER$$US-NOVOPROD-1202519$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002371$24100237$1$I$20230705$20230705$20240717$20240717$PER$$US-NOVOPROD-1202373$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
241002381$24100238$1$I$20240312$20240402$20240717$20240717$PER$$US-NOVOPROD-1202123$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
241002391$24100239$1$I$$20230626$20240717$20240717$PER$$US-NOVOPROD-1202294$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241002401$24100240$1$I$20230702$20230705$20240717$20240717$PER$$US-NOVOPROD-1202380$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002411$24100241$1$I$$20240327$20240717$20240717$PER$$US-NOVOPROD-1202488$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002421$24100242$1$I$20240101$20240402$20240717$20240717$PER$$US-NOVOPROD-1202437$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241002431$24100243$1$I$$20230612$20240717$20240717$PER$$US-NOVOPROD-1202104$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002441$24100244$1$I$$20240604$20240717$20240717$EXP$$AR-ROCHE-10000025461$ROCHE$$$$$F$Y$$$20240717$$CN$AR$AR
241002451$24100245$1$I$20240701$20240702$20240717$20240717$PER$$US-ROCHE-10000017547$ROCHE$$9$YR$C$F$Y$19.5$KG$20240717$$CN$US$US
241002462$24100246$2$F$$20240712$20240717$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003051$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
241002471$24100247$1$I$$20240415$20240717$20240717$PER$$US-NOVOPROD-1207931$NOVO NORDISK$$$$E$M$Y$$$20240717$$MD$US$US
241002481$24100248$1$I$20240316$20240710$20240717$20240717$EXP$IT-MINISAL02-994014$IT-GSK-IT2024085565$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$HP$IT$IT
241002491$24100249$1$I$$20240405$20240717$20240717$PER$$US-NOVOPROD-1207614$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002501$24100250$1$I$$20240408$20240717$20240717$PER$$US-NOVOPROD-1207579$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002511$24100251$1$I$20240123$20240408$20240717$20240717$PER$$US-NOVOPROD-1207776$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241002521$24100252$1$I$$20240404$20240717$20240717$PER$$US-NOVOPROD-1207637$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002531$24100253$1$I$20240204$20240408$20240717$20240717$PER$$US-NOVOPROD-1207783$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241002541$24100254$1$I$20240201$20240408$20240717$20240717$PER$$US-NOVOPROD-1208036$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241002551$24100255$1$I$$20240408$20240717$20240717$PER$$US-NOVOPROD-1207483$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002561$24100256$1$I$20230401$20230622$20240717$20240717$PER$$US-NOVOPROD-1207961$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241002571$24100257$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1248609$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002581$24100258$1$I$$20230714$20240717$20240717$PER$$US-NOVOPROD-1207810$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002591$24100259$1$I$$20240416$20240717$20240717$PER$$US-NOVOPROD-1207917$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241002601$24100260$1$I$$20240415$20240717$20240717$PER$$US-NOVOPROD-1207764$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$HP$US$US
241002611$24100261$1$I$$20231012$20240717$20240717$PER$$US-NOVOPROD-1249056$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002621$24100262$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1248820$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241002631$24100263$1$I$$20231011$20240717$20240717$PER$$US-NOVOPROD-1249248$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002641$24100264$1$I$20220101$20240415$20240717$20240717$PER$$US-NOVOPROD-1207894$NOVO NORDISK$$77$YR$$M$Y$$$20240717$$CN$US$US
241002651$24100265$1$I$$20240416$20240717$20240717$PER$$US-NOVOPROD-1207897$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241002661$24100266$1$I$$20230824$20240717$20240717$PER$$US-NOVOPROD-1248596$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002671$24100267$1$I$$20240408$20240717$20240717$PER$$US-NOVOPROD-1208009$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002681$24100268$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1207660$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241002691$24100269$1$I$20231201$20240306$20240717$20240717$PER$$US-NOVOPROD-1251760$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241002701$24100270$1$I$$20230829$20240717$20240717$PER$$US-NOVOPROD-1248577$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002711$24100271$1$I$$20240408$20240717$20240717$PER$$US-NOVOPROD-1207679$NOVO NORDISK$$44$YR$$F$Y$$$20240717$$MD$US$US
241002722$24100272$2$F$$20240806$20240717$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112758$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240812$$CN$US$US
241002731$24100273$1$I$$20240710$20240717$20240717$EXP$$US-NOVITIUMPHARMA-2024USNVP01274$NOVITIUM PHARMA$E. W. Adams.Nocardiosis With Rapid Radiographic Progression.American Journal of Respiratory and Critical Care Medicine.19-MAY-2024;209:A2416$85$YR$E$M$Y$$$20240717$$HP$US$US
241002743$24100274$3$F$$20240712$20240717$20240725$PER$$US-ROCHE-10000026394$ROCHE$$$$C$F$Y$21.77$KG$20240726$$CN$US$US
241002751$24100275$1$I$$20240621$20240717$20240717$PER$$US-JNJFOC-20240666214$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$HP$US$US
241002761$24100276$1$I$20240401$20240405$20240717$20240717$PER$$US-NOVOPROD-1204834$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241002771$24100277$1$I$$20230707$20240717$20240717$PER$$US-NOVOPROD-1204659$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241002781$24100278$1$I$$20240405$20240717$20240717$PER$$US-NOVOPROD-1204780$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002791$24100279$1$I$$20240405$20240717$20240717$PER$$US-NOVOPROD-1204833$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241002801$24100280$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1204708$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241002811$24100281$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1204772$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$MD$US$US
241002821$24100282$1$I$$20240713$20240717$20240717$PER$$US-ROCHE-10000026682$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241002831$24100283$1$I$$20240404$20240717$20240717$PER$$US-NOVOPROD-1204856$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241002841$24100284$1$I$20240308$20240408$20240717$20240717$PER$$US-NOVOPROD-1208104$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241002851$24100285$1$I$$20240610$20240717$20240717$PER$$US-NOVOPROD-1208093$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241002861$24100286$1$I$20240101$20240418$20240717$20240717$PER$$US-NOVOPROD-1204919$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002871$24100287$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1208060$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002881$24100288$1$I$$20230613$20240717$20240717$PER$$US-NOVOPROD-1204878$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002891$24100289$1$I$$20240404$20240717$20240717$PER$$US-NOVOPROD-1204930$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241002901$24100290$1$I$$20240408$20240717$20240717$PER$$US-NOVOPROD-1208090$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241002911$24100291$1$I$$20240404$20240717$20240717$PER$$US-NOVOPROD-1204854$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241002922$24100292$2$F$$20240506$20240717$20240717$PER$$US-NOVOPROD-939163$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241002931$24100293$1$I$20240301$20240405$20240717$20240717$PER$$US-NOVOPROD-1204884$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241002941$24100294$1$I$20240309$20240412$20240717$20240717$PER$$US-NOVOPROD-1204840$NOVO NORDISK$$63$YR$$M$Y$$$20240717$$CN$US$US
241002951$24100295$1$I$20240101$20240415$20240717$20240717$PER$$US-NOVOPROD-1204876$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241002961$24100296$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5840529$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241002971$24100297$1$I$$20240709$20240717$20240717$EXP$$US-ABBVIE-5836424$ABBVIE$$$$$$Y$$$20240717$$MD$US$US
241002981$24100298$1$I$20240625$20240710$20240717$20240717$EXP$BE-FAMHP-DHH-N2024-122346$BE-GSK-BE2024086093$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$BE$BE
241002991$24100299$1$I$20240403$20240409$20240717$20240717$PER$$US-NOVOPROD-1208711$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
241003001$24100300$1$I$20240101$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140848$AMGEN$$48$YR$A$F$Y$$$20240716$$HP$US$US
241003011$24100301$1$I$20240202$20240710$20240717$20240717$EXP$$CA-ABBVIE-5673994$ABBVIE$$76$YR$$F$Y$$$20240717$$PH$CA$CA
241003021$24100302$1$I$$20190815$20240717$20240717$EXP$$CH-AstraZeneca-2019SF26497$ASTRAZENECA$$$$$F$Y$$$20240717$$MD$CH$
241003031$24100303$1$I$20240601$20240701$20240717$20240717$EXP$$US-ABBVIE-5821791$ABBVIE$$77$YR$$M$Y$$$20240717$$CN$US$US
241003041$24100304$1$I$20240706$20240712$20240717$20240717$EXP$GB-MHRA-MED-202407121031073480-GNJLP$GB-009507513-2407GBR009301$MERCK$$$$$F$Y$$$20240717$$HP$GB$GB
241003051$24100305$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1208238$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003061$24100306$1$I$$20240408$20240717$20240717$PER$$US-NOVOPROD-1208154$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241003071$24100307$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1208342$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003081$24100308$1$I$20240408$20240506$20240717$20240717$PER$$US-NOVOPROD-1208119$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
241003091$24100309$1$I$$20240416$20240717$20240717$PER$$US-NOVOPROD-1208525$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
241003101$24100310$1$I$20240101$20240410$20240717$20240717$PER$$US-NOVOPROD-1208692$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
241003111$24100311$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1208249$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003121$24100312$1$I$20240101$20240506$20240717$20240717$PER$$US-NOVOPROD-1208759$NOVO NORDISK$$48$YR$$F$Y$$$20240717$$CN$US$US
241003131$24100313$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1208694$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241003141$24100314$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1208333$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241003151$24100315$1$I$20240408$20240408$20240717$20240717$PER$$US-NOVOPROD-1208137$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003161$24100316$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1208765$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241003171$24100317$1$I$$20230807$20240717$20240717$PER$$US-NOVOPROD-1208378$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003181$24100318$1$I$20231001$20240409$20240717$20240717$PER$$US-NOVOPROD-1208707$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003191$24100319$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1208752$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003201$24100320$1$I$20240201$20240409$20240717$20240717$PER$$US-NOVOPROD-1208753$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241003211$24100321$1$I$20231217$20240416$20240717$20240717$PER$$US-NOVOPROD-1208345$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
241003221$24100322$1$I$$20240624$20240717$20240717$PER$$US-JNJFOC-20240669347$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241003232$24100323$2$F$$20240716$20240717$20240720$EXP$$DE-SANDOZ INC.-SDZ2024DE065122$SANDOZ$$32$YR$$M$Y$78$KG$20240720$$CN$DE$DE
241003241$24100324$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1208823$NOVO NORDISK$$$$A$F$Y$$$20240717$$HP$US$US
241003251$24100325$1$I$20240101$20240711$20240717$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-021518$UNITED THERAPEUTICS$$$$$M$Y$79.365$KG$20240717$$$US$US
241003261$24100326$1$I$$20230718$20240717$20240717$PER$$US-NOVOPROD-1208841$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241003271$24100327$1$I$20240101$20240710$20240717$20240717$EXP$$US-BEIGENE-BGN-2024-010821$BEIGENE$$$$$$Y$$$20240717$$CN$US$US
241003281$24100328$1$I$20240101$20240715$20240717$20240717$EXP$$US-ABBVIE-5840997$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241003291$24100329$1$I$20240225$20240328$20240717$20240717$PER$$US-NOVOPROD-1202589$NOVO NORDISK$$70$YR$$$Y$$$20240717$$CN$US$US
241003301$24100330$1$I$$20230807$20240717$20240717$PER$$US-NOVOPROD-1202630$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241003311$24100331$1$I$20240301$20240402$20240717$20240717$PER$$US-NOVOPROD-1202617$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241003321$24100332$1$I$$20240408$20240717$20240717$PER$$US-NOVOPROD-1202730$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
241003331$24100333$1$I$$20240329$20240717$20240717$PER$$US-NOVOPROD-1202739$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003341$24100334$1$I$$20230621$20240717$20240717$PER$$US-NOVOPROD-1202976$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241003351$24100335$1$I$20240301$20240403$20240717$20240717$PER$$US-NOVOPROD-1202862$NOVO NORDISK$$56$YR$$M$Y$$$20240717$$CN$US$US
241003361$24100336$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1202695$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241003371$24100337$1$I$20190601$20240710$20240717$20240717$EXP$$US-ROCHE-2347760$ROCHE$$56$YR$A$M$Y$77.11$KG$20240717$$CN$US$US
241003381$24100338$1$I$$20230629$20240717$20240717$PER$$US-NOVOPROD-1202549$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241003391$24100339$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1202897$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241003401$24100340$1$I$20230411$20240530$20240717$20240717$PER$$US-NOVOPROD-1202717$NOVO NORDISK$$63$YR$$$Y$$$20240717$$CN$US$US
241003411$24100341$1$I$$20240223$20240717$20240717$PER$$US-NOVOPROD-1202635$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003421$24100342$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1202870$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241003431$24100343$1$I$20230614$20230705$20240717$20240717$PER$$US-NOVOPROD-1202995$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241003441$24100344$1$I$$20230605$20240717$20240717$PER$$US-NOVOPROD-1202993$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003451$24100345$1$I$20230604$20230606$20240717$20240717$PER$$US-NOVOPROD-1202916$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241003461$24100346$1$I$$20230613$20240717$20240717$PER$$US-NOVOPROD-1202596$NOVO NORDISK$$52$YR$$F$Y$$$20240717$$HP$US$US
241003472$24100347$2$F$$20240807$20240717$20240813$EXP$$US-ABBVIE-5838177$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
241003481$24100348$1$I$20240101$20240712$20240717$20240717$PER$$US-ABBVIE-5839058$ABBVIE$$$$$$Y$$$20240717$$HP$US$US
241003491$24100349$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1203112$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241003501$24100350$1$I$$20230627$20240717$20240717$PER$$US-NOVOPROD-1203039$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003511$24100351$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1203204$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241003521$24100352$1$I$20240101$20240403$20240717$20240717$PER$$US-NOVOPROD-1203162$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241003531$24100353$1$I$20240103$20240503$20240717$20240717$PER$$US-NOVOPROD-1203375$NOVO NORDISK$$43$YR$$F$Y$$$20240717$$CN$US$US
241003541$24100354$1$I$$20230630$20240717$20240717$PER$$US-NOVOPROD-1203369$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241003551$24100355$1$I$20240315$20240402$20240717$20240717$PER$$US-NOVOPROD-1203496$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$HP$US$US
241003561$24100356$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1203733$NOVO NORDISK$$$$A$$Y$$$20240717$$HP$US$US
241003571$24100357$1$I$$20240711$20240717$20240717$EXP$$US-ABBVIE-5838754$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241003581$24100358$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1203423$NOVO NORDISK$$$$A$M$Y$$$20240717$$HP$US$US
241003591$24100359$1$I$$20230626$20240717$20240717$PER$$US-NOVOPROD-1203611$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003601$24100360$1$I$20240331$20240401$20240717$20240717$PER$$US-NOVOPROD-1203119$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241003611$24100361$1$I$$20240403$20240717$20240717$PER$$US-NOVOPROD-1203155$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241003622$24100362$2$F$$20240404$20240717$20240717$PER$$US-NOVOPROD-1203199$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003631$24100363$1$I$20220101$20240405$20240717$20240717$PER$$US-NOVOPROD-1203716$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
241003641$24100364$1$I$20240312$20240402$20240717$20240717$PER$$US-NOVOPROD-1203378$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
241003651$24100365$1$I$$20240403$20240717$20240717$PER$$US-NOVOPROD-1203692$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003661$24100366$1$I$$20240402$20240717$20240717$PER$$US-NOVOPROD-1203567$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241003671$24100367$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1203581$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241003681$24100368$1$I$$20240402$20240717$20240717$PER$$US-NOVOPROD-1203044$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241003691$24100369$1$I$$20230606$20240717$20240717$PER$$US-NOVOPROD-1203063$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241003701$24100370$1$I$20230101$20240403$20240717$20240717$PER$$US-NOVOPROD-1203490$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241003711$24100371$1$I$$20240711$20240717$20240717$EXP$$CA-ABBVIE-5838839$ABBVIE$$57$YR$$F$Y$$$20240717$$CN$CA$CA
241003722$24100372$2$F$20240624$20240718$20240717$20240722$EXP$$US-ABBVIE-5839382$ABBVIE$$54$YR$$M$Y$$$20240722$$CN$US$US
241003731$24100373$1$I$20240101$20240711$20240717$20240717$EXP$$US-ABBVIE-5838233$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241003741$24100374$1$I$$20240711$20240717$20240717$EXP$$GB-SANDOZ INC.-SDZ2024GB014576$SANDOZ$$$$$F$Y$$$20240717$$CN$GB$GB
241003752$24100375$2$F$20230301$20240715$20240717$20240722$EXP$$IN-AMGEN-INDSP2024138599$AMGEN$$57$YR$A$M$Y$63$KG$20240722$$MD$IN$IN
241003761$24100376$1$I$$20240711$20240717$20240717$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01290$NOVITIUM PHARMA$Chihiro Sakurazawa.A case of multiorgan failure due to carbamazepine intoxication successfully treated with multimodal blood purification therapy.CEN Case Reports.18-JUN-2024;NA:1-3$47$YR$A$F$Y$$$20240717$$HP$JP$JP
241003771$24100377$1$I$$20231004$20240717$20240717$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015436$STRIDES$Ramsey B, Yazdi L, Laiwala R, Srinivasan S.. Neuroleptic Malignant-Like Syndrome as a Potential Etiology for Donepezil Related Rhabdomyolysis.. Curr-Geriatr-Rep. 2023;12(3):112-116.$6$DEC$$$Y$$$20240717$$HP$US$US
241003781$24100378$1$I$$20240710$20240717$20240717$EXP$$US-SA-2024SA206209$SANOFI AVENTIS$$$$A$F$Y$63.9$KG$20240717$$MD$US$US
241003791$24100379$1$I$$20240408$20240717$20240717$PER$$US-NOVOPROD-1203742$NOVO NORDISK$$30$YR$$F$Y$$$20240717$$HP$US$US
241003801$24100380$1$I$20240321$20240401$20240717$20240717$PER$$US-NOVOPROD-1204149$NOVO NORDISK$$49$YR$$F$Y$$$20240717$$CN$US$US
241003811$24100381$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1204244$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241003821$24100382$1$I$$20240404$20240717$20240717$PER$$US-NOVOPROD-1204251$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$MD$US$US
241003831$24100383$1$I$20240315$20240418$20240717$20240717$PER$$US-NOVOPROD-1204363$NOVO NORDISK$$48$YR$$M$Y$$$20240717$$MD$US$US
241003841$24100384$1$I$$20240404$20240717$20240717$PER$$US-NOVOPROD-1204207$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003851$24100385$1$I$$20240411$20240717$20240717$PER$$US-NOVOPROD-1204288$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241003861$24100386$1$I$20240701$20240711$20240717$20240717$EXP$$US-AMGEN-USASP2024138615$AMGEN$$64$YR$A$F$Y$$$20240716$$HP$US$US
241003871$24100387$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1203907$NOVO NORDISK$$63$YR$$$Y$$$20240717$$CN$US$US
241003881$24100388$1$I$20240401$20240405$20240717$20240717$PER$$US-NOVOPROD-1204294$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241003891$24100389$1$I$20240315$20240401$20240717$20240717$PER$$US-NOVOPROD-1204069$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
241003901$24100390$1$I$$20240402$20240717$20240717$PER$$US-NOVOPROD-1204185$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003911$24100391$1$I$$20240401$20240717$20240717$PER$$US-NOVOPROD-1204333$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241003921$24100392$1$I$$20240402$20240717$20240717$PER$$US-NOVOPROD-1203929$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241003931$24100393$1$I$20230901$20240402$20240717$20240717$PER$$US-NOVOPROD-1203940$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
241003941$24100394$1$I$$20230622$20240717$20240717$PER$$US-NOVOPROD-1203879$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241003951$24100395$1$I$$20230913$20240717$20240717$PER$$US-NOVOPROD-1204228$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241003961$24100396$1$I$$20240405$20240717$20240717$PER$$US-NOVOPROD-1204378$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241003971$24100397$1$I$20240327$20240403$20240717$20240717$PER$$US-NOVOPROD-1204126$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
241003981$24100398$1$I$$20240608$20240717$20240717$PER$$US-NOVOPROD-1203927$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241003991$24100399$1$I$20240403$20240405$20240717$20240717$PER$$US-NOVOPROD-1203785$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241004001$24100400$1$I$$20240402$20240717$20240717$PER$$US-NOVOPROD-1204141$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241004012$24100401$2$F$20240713$20240716$20240717$20240718$PER$$US-AMGEN-USASP2024140391$AMGEN$$73$YR$E$F$Y$$$20240718$$CN$US$US
241004022$24100402$2$F$$20240710$20240717$20240721$EXP$$US-ABBVIE-5842170$ABBVIE$$$$$M$Y$$$20240721$$CN$US$US
241004033$24100403$3$F$20240101$20240719$20240717$20240726$EXP$$US-ABBVIE-5838475$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241004041$24100404$1$I$20220531$20240710$20240717$20240717$EXP$$ES-GSK-ES2022EME106318$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$ES$ES
241004051$24100405$1$I$$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024140016$AMGEN$$$$$$Y$$$20240716$$CN$US$US
241004061$24100406$1$I$20240713$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140527$AMGEN$$35$YR$A$F$Y$$$20240716$$CN$US$US
241004071$24100407$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1181977$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241004081$24100408$1$I$20231018$20240711$20240717$20240717$EXP$$DE-ABBVIE-5839014$ABBVIE$$61$YR$$F$Y$$$20240717$$MD$DE$DE
241004092$24100409$2$F$20220701$20240829$20240717$20240903$EXP$$US-SANDOZ INC.-SDZ2023US006914$SANDOZ$$23$YR$$M$Y$$$20240903$$HP$US$US
241004102$24100410$2$F$$20240716$20240717$20240723$EXP$$US-JNJFOC-20240721534$JOHNSON AND JOHNSON$$12$YR$T$F$Y$$$20240723$$HP$US$US
241004111$24100411$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1181868$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241004121$24100412$1$I$$20230703$20240717$20240717$PER$$US-NOVOPROD-1204443$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241004131$24100413$1$I$20231225$20240221$20240717$20240717$PER$$US-NOVOPROD-1181960$NOVO NORDISK$$80$YR$$F$Y$$$20240717$$CN$US$US
241004141$24100414$1$I$$20240222$20240717$20240717$PER$$US-NOVOPROD-1181876$NOVO NORDISK$$41$YR$$F$Y$$$20240717$$MD$US$US
241004151$24100415$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1182000$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241004161$24100416$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1181859$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241004171$24100417$1$I$20240304$20240313$20240717$20240717$PER$$DK-NOVOPROD-1204454$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$DK$US
241004181$24100418$1$I$$20230703$20240717$20240717$PER$$US-NOVOPROD-1204594$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241004191$24100419$1$I$$20240222$20240717$20240717$PER$$US-NOVOPROD-1181681$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241004201$24100420$1$I$$20240222$20240717$20240717$PER$$US-NOVOPROD-1182033$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241004211$24100421$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1181873$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241004221$24100422$1$I$20231217$20240222$20240717$20240717$PER$$US-NOVOPROD-1181637$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
241004231$24100423$1$I$$20230608$20240717$20240717$PER$$US-NOVOPROD-1204427$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241004241$24100424$1$I$20231101$20240311$20240717$20240717$PER$$US-NOVOPROD-1181670$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
241004251$24100425$1$I$$20240219$20240717$20240717$PER$$US-NOVOPROD-1181628$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241004261$24100426$1$I$20231001$20240221$20240717$20240717$PER$$US-NOVOPROD-1181946$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241004271$24100427$1$I$$20230614$20240717$20240717$PER$$US-NOVOPROD-1204421$NOVO NORDISK$$$$$$Y$$$20240717$$HP$US$US
241004281$24100428$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1208866$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241004291$24100429$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1204457$NOVO NORDISK$$$$A$F$Y$$$20240717$$HP$US$US
241004301$24100430$1$I$20230901$20240221$20240717$20240717$PER$$US-NOVOPROD-1181633$NOVO NORDISK$$52$YR$$F$Y$$$20240717$$CN$US$US
241004311$24100431$1$I$$20240322$20240717$20240717$PER$$US-NOVOPROD-1181568$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241004321$24100432$1$I$20240201$20240222$20240717$20240717$PER$$US-NOVOPROD-1181825$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241004331$24100433$1$I$$20240405$20240717$20240717$PER$$US-NOVOPROD-1204642$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241004341$24100434$1$I$20240409$20240410$20240717$20240717$PER$$US-NOVOPROD-1208853$NOVO NORDISK$$44$YR$$M$Y$$$20240717$$CN$US$US
241004354$24100435$4$F$20220901$20240912$20240717$20240920$EXP$$US-ABBVIE-5690396$ABBVIE$$31$YR$$M$Y$$$20240920$$CN$US$US
241004361$24100436$1$I$$20240712$20240717$20240717$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-112328$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240717$$MD$DE$DE
241004371$24100437$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000027696$ROCHE$$60$YR$A$F$Y$$$20240717$$CN$US$US
241004383$24100438$3$F$$20240909$20240717$20240911$EXP$$ES-SANDOZ INC.-SDZ2024ES065148$SANDOZ$$6$MON$$M$Y$$$20240911$$HP$ES$ES
241004391$24100439$1$I$20240130$20240409$20240717$20240717$PER$$US-NOVOPROD-1209162$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
241004401$24100440$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1209221$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241004411$24100441$1$I$20240303$20240409$20240717$20240717$PER$$US-NOVOPROD-1209241$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241004421$24100442$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1209301$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
241004432$24100443$2$F$20240201$20240417$20240717$20240717$PER$$US-NOVOPROD-1208997$NOVO NORDISK$$61$YR$$M$Y$$$20240717$$CN$US$US
241004441$24100444$1$I$20240409$20240409$20240717$20240717$PER$$US-NOVOPROD-1209021$NOVO NORDISK$$48$YR$$F$Y$$$20240717$$CN$US$US
241004451$24100445$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1209207$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241004462$24100446$2$F$$20240506$20240717$20240717$PER$$US-NOVOPROD-1209191$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241004471$24100447$1$I$20240405$20240515$20240717$20240717$PER$$US-NOVOPROD-1208916$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241004481$24100448$1$I$20240405$20240409$20240717$20240717$PER$$US-NOVOPROD-1209190$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241004491$24100449$1$I$20240101$20240409$20240717$20240717$PER$$US-NOVOPROD-1209295$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
241004501$24100450$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1209007$NOVO NORDISK$$41$YR$$F$Y$$$20240717$$CN$US$US
241004511$24100451$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1209212$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241004521$24100452$1$I$$20230824$20240717$20240717$PER$$US-NOVOPROD-1209068$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241004531$24100453$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1209187$NOVO NORDISK$$45$YR$$F$Y$$$20240717$$CN$US$US
241004541$24100454$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1208990$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
241004551$24100455$1$I$$20240409$20240717$20240717$PER$$US-NOVOPROD-1209128$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241004561$24100456$1$I$$20240603$20240717$20240717$PER$$US-NOVOPROD-1209415$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241004571$24100457$1$I$$20240715$20240717$20240717$PER$$NVSC2024US146488$NOVARTIS$$$$$$Y$$$20240717$$CN$US$US
241004581$24100458$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5841531$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241004591$24100459$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1209720$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241004601$24100460$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1209875$NOVO NORDISK$$35$YR$$F$Y$$$20240717$$MD$US$US
241004611$24100461$1$I$$20230714$20240717$20240717$PER$$US-NOVOPROD-1209878$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241004621$24100462$1$I$$20230615$20240717$20240717$PER$$US-NOVOPROD-1209969$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241004631$24100463$1$I$$20190905$20240717$20240717$EXP$$US-AstraZeneca-2019SF28554$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241004651$24100465$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1209837$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
241004661$24100466$1$I$$20240413$20240717$20240717$PER$$US-NOVOPROD-1210272$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241004671$24100467$1$I$20240418$20240418$20240717$20240717$PER$$US-NOVOPROD-1209578$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241004681$24100468$1$I$20240322$20240410$20240717$20240717$PER$$US-NOVOPROD-1209716$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
241004691$24100469$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1209574$NOVO NORDISK$$$$E$F$Y$$$20240717$$MD$US$US
241004701$24100470$1$I$20240408$20240410$20240717$20240717$PER$$US-NOVOPROD-1210037$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$CN$US$US
241004711$24100471$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1210086$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241004721$24100472$1$I$20240101$20240410$20240717$20240717$PER$$US-NOVOPROD-1209507$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241004731$24100473$1$I$20240318$20240429$20240717$20240717$PER$$US-NOVOPROD-1210286$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241004741$24100474$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1210114$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241004751$24100475$1$I$$20231013$20240717$20240717$PER$$US-NOVOPROD-1209919$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
241004761$24100476$1$I$20240331$20240410$20240717$20240717$PER$$US-NOVOPROD-1209617$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
241004771$24100477$1$I$20240127$20240411$20240717$20240717$PER$$US-NOVOPROD-1210201$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241004781$24100478$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1209874$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
241004791$24100479$1$I$20240411$20240412$20240717$20240717$PER$$US-NOVOPROD-1210028$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241004801$24100480$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1209516$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241004811$24100481$1$I$$20231013$20240717$20240717$PER$$US-NOVOPROD-1209917$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241004821$24100482$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1209729$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
241004831$24100483$1$I$$20240417$20240717$20240717$PER$$US-NOVOPROD-1210135$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241004841$24100484$1$I$$20240412$20240717$20240717$PER$$US-NOVOPROD-1210139$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241004851$24100485$1$I$$20230706$20240717$20240717$PER$$US-NOVOPROD-1210082$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241004861$24100486$1$I$$20230717$20240717$20240717$PER$$US-NOVOPROD-1210033$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241004871$24100487$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1209704$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
241004891$24100489$1$I$20230101$20231006$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00512$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240705$$CN$US$US
241004901$24100490$1$I$20230801$20231115$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00585$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240705$$CN$US$US
241004911$24100491$1$I$$20231214$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00631$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240705$$CN$US$US
241004921$24100492$1$I$$20231218$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00635$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240705$$CN$US$US
241004931$24100493$1$I$$20240113$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00027$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240705$$CN$US$US
241004941$24100494$1$I$$20240205$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00056$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240705$$CN$US$US
241004951$24100495$1$I$$20240214$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00075$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240705$$CN$US$US
241004961$24100496$1$I$$20240303$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00107$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240705$$CN$US$US
241004971$24100497$1$I$$20231109$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00574$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240705$$CN$US$US
241004981$24100498$1$I$20231101$20240319$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00131$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240705$$CN$US$US
241004991$24100499$1$I$20240401$20240517$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00227$PRINSTON PHARMACEUTICAL$$83$YR$$M$Y$70.748$KG$20240705$$CN$US$US
241005001$24100500$1$I$20231010$20231011$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00532$PRINSTON PHARMACEUTICAL$$$$A$F$Y$$$20240705$$CN$US$US
241005011$24100501$1$I$$20240221$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00088$PRINSTON PHARMACEUTICAL$$$$$F$Y$84.822$KG$20240705$$CN$US$US
241005021$24100502$1$I$$20240306$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00109$PRINSTON PHARMACEUTICAL$$$$$F$Y$46.266$KG$20240705$$CN$US$US
241005031$24100503$1$I$20230101$20230706$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00337$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240705$$CN$US$US
241005041$24100504$1$I$20240601$20240713$20240717$20240717$EXP$$GB-SANDOZ INC.-NVSC2020GB082027$SANDOZ$$49$YR$$F$Y$$$20240717$$CN$GB$GB
241005051$24100505$1$I$20240101$20240306$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00108$PRINSTON PHARMACEUTICAL$$$$$F$Y$59.864$KG$20240705$$CN$US$US
241005061$24100506$1$I$20240101$20240510$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00213$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240705$$CN$US$US
241005071$24100507$1$I$20240708$20240709$20240717$20240717$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02088$AMNEAL$$68$YR$$F$Y$$$20240717$$MD$US$US
241005081$24100508$1$I$20230701$20230724$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00356$PRINSTON PHARMACEUTICAL$$62$YR$$F$Y$90.703$KG$20240705$$CN$US$US
241005091$24100509$1$I$$20230907$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00442$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240705$$CN$US$US
241005101$24100510$1$I$20230101$20231110$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00578$PRINSTON PHARMACEUTICAL$$46$YR$$F$Y$$$20240705$$CN$US$US
241005111$24100511$1$I$20240428$20240508$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00211$PRINSTON PHARMACEUTICAL$$34$YR$$F$Y$63.049$KG$20240705$$CN$US$US
241005121$24100512$1$I$20230101$20230718$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00351$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240705$$PH$US$US
241005131$24100513$1$I$20230101$20230705$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00320$PRINSTON PHARMACEUTICAL$$$$$F$Y$70.295$KG$20240705$$CN$US$US
241005141$24100514$1$I$20220101$20230807$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00378$PRINSTON PHARMACEUTICAL$$$$$F$Y$73.923$KG$20240705$$PH$US$US
241005151$24100515$1$I$20230401$20230705$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00319$PRINSTON PHARMACEUTICAL$$50$YR$$F$Y$83.9$KG$20240705$$CN$US$US
241005161$24100516$1$I$20230101$20230817$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00404$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240705$$CN$US$US
241005171$24100517$1$I$$20230828$20240717$20240717$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00422$PRINSTON PHARMACEUTICAL$$68$YR$$F$Y$$$20240705$$CN$US$US
241005181$24100518$1$I$$20240711$20240717$20240717$PER$$US-JNJFOC-20240729928$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
241005191$24100519$1$I$$20240621$20240717$20240717$PER$$US-NOVOPROD-1205083$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005201$24100520$1$I$$20240412$20240717$20240717$PER$$US-NOVOPROD-1210336$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005211$24100521$1$I$$20240705$20240717$20240717$EXP$$CA-CHATTEMPRD-2019SA354908$CHATTEM$$$$$F$Y$$$20240717$$MD$CA$CA
241005221$24100522$1$I$$20240402$20240717$20240717$PER$$US-NOVOPROD-1205155$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005231$24100523$1$I$20240415$20240415$20240717$20240717$PER$$US-NOVOPROD-1210325$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005241$24100524$1$I$$20240419$20240717$20240717$PER$$US-NOVOPROD-1210474$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$HP$US$US
241005251$24100525$1$I$$20240414$20240717$20240717$PER$$US-NOVOPROD-1210394$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005261$24100526$1$I$$20230621$20240717$20240717$PER$$US-NOVOPROD-1205162$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005271$24100527$1$I$20240201$20240423$20240717$20240717$PER$$US-NOVOPROD-1204939$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
241005281$24100528$1$I$20240408$20240412$20240717$20240717$PER$$US-NOVOPROD-1210375$NOVO NORDISK$$80$YR$$F$Y$$$20240717$$CN$US$US
241005291$24100529$1$I$20240404$20240404$20240717$20240717$PER$$US-NOVOPROD-1205005$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$MD$US$US
241005301$24100530$1$I$$20230612$20240717$20240717$PER$$US-NOVOPROD-1204947$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005311$24100531$1$I$20240301$20240402$20240717$20240717$PER$$US-NOVOPROD-1204937$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241005321$24100532$1$I$$20240412$20240717$20240717$PER$$US-NOVOPROD-1210307$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241005332$24100533$2$F$$20230616$20240717$20240717$PER$$US-NOVOPROD-1205192$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005341$24100534$1$I$$20240415$20240717$20240717$PER$$US-NOVOPROD-1210294$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005351$24100535$1$I$20240412$20240412$20240717$20240717$PER$$US-NOVOPROD-1210393$NOVO NORDISK$$74$YR$$M$Y$$$20240717$$CN$US$US
241005362$24100536$2$F$$20240806$20240717$20240812$30DAY$$US-GSK-US2024086607$GLAXOSMITHKLINE$$$$$M$Y$$$20240812$$CN$US$US
241005371$24100537$1$I$20240601$20240706$20240717$20240717$EXP$$FR-AUROBINDO-AUR-APL-2024-034025$AUROBINDO$$69$YR$$M$Y$78$KG$20240717$$PH$FR$FR
241005382$24100538$2$F$$20240801$20240717$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003208$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241005391$24100539$1$I$$20230707$20240717$20240717$PER$$US-NOVOPROD-1205316$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005401$24100540$1$I$20240307$20240404$20240717$20240717$PER$$US-NOVOPROD-1205762$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
241005411$24100541$1$I$20180322$20240705$20240717$20240717$EXP$$CA-CHATTEMPRD-2019SA354845$CHATTEM$$50$YR$A$F$Y$$$20240717$$PH$CA$CA
241005422$24100542$2$F$$20240719$20240717$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-034252$AUROBINDO$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al.. A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology(SFTA). Toxic-Analyt-Clinique. 2023;35 (3) Supple:175-197$35$YR$$M$Y$$$20240730$$MD$FR$FR
241005431$24100543$1$I$20231101$20240704$20240717$20240717$EXP$$GB-CIPLA LTD.-2024GB07285$CIPLA$$$$$$Y$$$20240717$$CN$GB$GB
241005441$24100544$1$I$$20240705$20240717$20240717$EXP$$CA-CHATTEMPRD-2019SA354995$CHATTEM$$$$$F$Y$$$20240717$$HP$CA$CA
241005451$24100545$1$I$20230101$20240409$20240717$20240717$PER$$US-NOVOPROD-1205667$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$MD$US$US
241005461$24100546$1$I$$20230621$20240717$20240717$PER$$US-NOVOPROD-1205344$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005471$24100547$1$I$$20230705$20240717$20240717$PER$$US-NOVOPROD-1205585$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241005481$24100548$1$I$$20240402$20240717$20240717$PER$$US-NOVOPROD-1205736$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241005491$24100549$1$I$$20230606$20240717$20240717$PER$$US-NOVOPROD-1205591$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005501$24100550$1$I$$20240411$20240717$20240717$PER$$US-NOVOPROD-1205716$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241005511$24100551$1$I$$20230608$20240717$20240717$PER$$US-NOVOPROD-1205425$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005522$24100552$2$F$$20240506$20240717$20240717$PER$$US-NOVOPROD-1205763$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241005531$24100553$1$I$$20230712$20240717$20240717$PER$$US-NOVOPROD-1205422$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005541$24100554$1$I$$20230911$20240717$20240717$PER$$US-NOVOPROD-1205494$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005551$24100555$1$I$$20230620$20240717$20240717$PER$$US-NOVOPROD-1205497$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005561$24100556$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1205626$NOVO NORDISK$$50$YR$$F$Y$$$20240717$$HP$US$US
241005571$24100557$1$I$$20230612$20240717$20240717$PER$$US-NOVOPROD-1205510$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241005581$24100558$1$I$$20230616$20240717$20240717$PER$$US-NOVOPROD-1205299$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005591$24100559$1$I$$20230623$20240717$20240717$PER$$US-NOVOPROD-1205588$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005601$24100560$1$I$20230601$20230620$20240717$20240717$PER$$US-NOVOPROD-1205382$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005611$24100561$1$I$$20230706$20240717$20240717$PER$$US-NOVOPROD-1205477$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241005621$24100562$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1205248$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241005631$24100563$1$I$$20230705$20240717$20240717$PER$$US-NOVOPROD-1205535$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005641$24100564$1$I$20240201$20240402$20240717$20240717$PER$$US-NOVOPROD-1205198$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241005651$24100565$1$I$$20230710$20240717$20240717$PER$$US-NOVOPROD-1205581$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005662$24100566$2$F$$20240720$20240717$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-033939$AUROBINDO$Chappuy M, de Ternay J, Merah I, Rolland B, Ragonnet  D.. Le Centre ressource lyonnais des addictions m?dicamenteuses (CERLAM) Lyon resource center for prescription drug use disorder.. Le Courrier des Addictions.. 2024;XXVI(2):24-27.$30$YR$$M$Y$$$20240731$$MD$FR$FR
241005672$24100567$2$F$20180101$20240720$20240717$20240802$EXP$$SE-CIPLA LTD.-2024SE07284$CIPLA$$$$$$Y$$$20240802$$CN$SE$ZA
241005681$24100568$1$I$20190819$20190820$20240717$20240717$EXP$$US-AstraZeneca-2019SF21816$ASTRAZENECA$$20941$DY$$M$Y$$$20240717$$CN$US$
241005691$24100569$1$I$$20190927$20240717$20240717$EXP$$US-AstraZeneca-2019SF38187$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241005701$24100570$1$I$$20191223$20240717$20240717$EXP$$US-AstraZeneca-2019SF45863$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241005711$24100571$1$I$$20190918$20240717$20240717$EXP$$RU-AstraZeneca-2019SF34607$ASTRAZENECA$$$$$M$Y$94$KG$20240717$$CN$RU$
241005721$24100572$1$I$20190405$20190822$20240717$20240717$EXP$$CO-AstraZeneca-2019SF21953$ASTRAZENECA$$23237$DY$$F$Y$$$20240717$$CN$CO$
241005731$24100573$1$I$20240101$20240711$20240717$20240717$EXP$$DE-JNJFOC-20240736141$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240717$$MD$DE$DE
241005741$24100574$1$I$20220701$20240706$20240717$20240717$EXP$$FR-AUROBINDO-AUR-APL-2024-030845$AUROBINDO$$57$YR$$M$Y$$$20240717$$PH$FR$FR
241005751$24100575$1$I$20240330$20240403$20240717$20240717$PER$$US-NOVOPROD-1205906$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005761$24100576$1$I$$20240412$20240717$20240717$PER$$US-NOVOPROD-1206394$NOVO NORDISK$$$$$F$Y$$$20240717$$PH$US$US
241005771$24100577$1$I$20240320$20240506$20240717$20240717$PER$$US-NOVOPROD-1206217$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$MD$US$US
241005781$24100578$1$I$$20240403$20240717$20240717$PER$$US-NOVOPROD-1205976$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005791$24100579$1$I$20240403$20240404$20240717$20240717$PER$$US-NOVOPROD-1205986$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
241005801$24100580$1$I$20231101$20240624$20240717$20240717$PER$$US-NOVOPROD-1206122$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$MD$US$US
241005811$24100581$1$I$20240301$20240403$20240717$20240717$PER$$US-NOVOPROD-1206050$NOVO NORDISK$$45$YR$$M$Y$$$20240717$$CN$US$US
241005821$24100582$1$I$$20240411$20240717$20240717$PER$$US-NOVOPROD-1205827$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005831$24100583$1$I$$20240404$20240717$20240717$PER$$US-NOVOPROD-1206486$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241005841$24100584$1$I$$20240405$20240717$20240717$PER$$US-NOVOPROD-1206495$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005851$24100585$1$I$$20240410$20240717$20240717$PER$$US-NOVOPROD-1205867$NOVO NORDISK$$45$YR$$F$Y$$$20240717$$MD$US$US
241005861$24100586$1$I$$20230626$20240717$20240717$PER$$US-NOVOPROD-1206064$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241005871$24100587$1$I$20240430$20240502$20240717$20240717$PER$$US-NOVOPROD-1205983$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005881$24100588$1$I$$20240404$20240717$20240717$PER$$US-NOVOPROD-1205979$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241005891$24100589$1$I$20240401$20240403$20240717$20240717$PER$$US-NOVOPROD-1205779$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
241005901$24100590$1$I$20220901$20240402$20240717$20240717$PER$$US-NOVOPROD-1206583$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241005911$24100591$1$I$$20240411$20240717$20240717$PER$$US-NOVOPROD-1206522$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241005921$24100592$1$I$$20240403$20240717$20240717$PER$$US-NOVOPROD-1206566$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241005931$24100593$1$I$$20240405$20240717$20240717$PER$$US-NOVOPROD-1206452$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241005941$24100594$1$I$$20240403$20240717$20240717$PER$$US-NOVOPROD-1205767$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005951$24100595$1$I$$20240403$20240717$20240717$PER$$US-NOVOPROD-1205915$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241005961$24100596$1$I$$20240606$20240717$20240717$PER$$US-NOVOPROD-1206534$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241005971$24100597$1$I$$20240403$20240717$20240717$PER$$US-NOVOPROD-1206068$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241005981$24100598$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-10000025932$ROCHE$$41$YR$A$F$Y$$$20240717$$CN$US$US
241005991$24100599$1$I$20240501$20240715$20240717$20240717$EXP$FR-AFSSAPS-RN2024000770$FR-SANDOZ INC.-SDZ2024FR065358$SANDOZ$$80$YR$$M$Y$$$20240717$$MD$FR$FR
241006001$24100600$1$I$20210901$20240711$20240717$20240717$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-111642$BRISTOL MYERS SQUIBB$Qin Y, Lu S, Chen J, Peng J, Yang J. Case report: a rare case of anti-PD-1 sintilimab-induced agranulocytosis/severe neutropenia in non-small cell lung cancer and literature review. Frontiers in Oncology. 2024 Jun 18;14:1-7. doi:10.3389/fonc.2024.1415748.$68$YR$E$M$Y$$$20240717$$HP$CN$CN
241006011$24100601$1$I$$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024139929$AMGEN$$$$$$Y$$$20240716$$HP$US$US
241006022$24100602$2$F$$20240903$20240717$20240905$EXP$$GB-SANDOZ INC.-SDZ2024GB028535$SANDOZ$$$$$F$Y$$$20240905$$CN$GB$GB
241006031$24100603$1$I$$20240711$20240717$20240717$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01301$NOVITIUM PHARMA$Shunsuke Nakamura.Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine.Internal Medicine.13-NOV-2023;63(12):1829-1835$72$YR$E$F$Y$$$20240717$$HP$JP$JP
241006041$24100604$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1221788$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241006051$24100605$1$I$20240330$20240403$20240717$20240717$PER$$US-NOVOPROD-1206590$NOVO NORDISK$$48$YR$$F$Y$$$20240717$$CN$US$US
241006061$24100606$1$I$20240423$20240506$20240717$20240717$PER$$US-NOVOPROD-1221803$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006071$24100607$1$I$20240505$20240506$20240717$20240717$PER$$US-NOVOPROD-1221888$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241006081$24100608$1$I$20240427$20240503$20240717$20240717$PER$$US-NOVOPROD-1221939$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241006091$24100609$1$I$20240618$20240706$20240717$20240717$EXP$$FR-AUROBINDO-AUR-APL-2024-033909$AUROBINDO$$64$YR$$F$Y$77$KG$20240717$$PH$FR$FR
241006101$24100610$1$I$20240403$20240503$20240717$20240717$PER$$US-NOVOPROD-1221878$NOVO NORDISK$$51$YR$$M$Y$$$20240717$$CN$US$US
241006111$24100611$1$I$20240408$20240503$20240717$20240717$PER$$US-NOVOPROD-1221865$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241006121$24100612$1$I$$20240506$20240717$20240717$PER$$US-NOVOPROD-1221846$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006132$24100613$2$F$20240211$20240311$20240717$20240717$PER$$US-NOVOPROD-1182041$NOVO NORDISK$$43$YR$$F$Y$$$20240717$$CN$US$US
241006141$24100614$1$I$$20240505$20240717$20240717$PER$$US-NOVOPROD-1221875$NOVO NORDISK$$69$YR$$$Y$$$20240717$$CN$US$US
241006151$24100615$1$I$$20240222$20240717$20240717$PER$$US-NOVOPROD-1182159$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006161$24100616$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1221828$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241006171$24100617$1$I$$20240508$20240717$20240717$PER$$US-NOVOPROD-1222079$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006181$24100618$1$I$20240215$20240510$20240717$20240717$PER$$US-NOVOPROD-1182179$NOVO NORDISK$$73$YR$$M$Y$$$20240717$$CN$US$US
241006191$24100619$1$I$$20240220$20240717$20240717$PER$$US-NOVOPROD-1182051$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006201$24100620$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1182098$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241006211$24100621$1$I$20240401$20240506$20240717$20240717$PER$$US-NOVOPROD-1221823$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
241006221$24100622$1$I$20240306$20240506$20240717$20240717$PER$$US-NOVOPROD-1222097$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
241006231$24100623$1$I$$20230929$20240717$20240717$PER$$US-NOVOPROD-1222084$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006241$24100624$1$I$20240704$20240711$20240717$20240717$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02566$AMNEAL$$2$YR$$F$Y$10.884$KG$20240717$$CN$US$US
241006252$24100625$2$F$20240701$20240712$20240717$20240722$PER$$CA-TOLMAR, INC.-24CA050957$TOLMAR$$74$YR$$M$Y$$$20240722$$CN$CA$CA
241006261$24100626$1$I$20240701$20240712$20240717$20240717$EXP$$CN-ASTELLAS-2024US020007$ASTELLAS$$76$YR$$M$Y$$$20240717$$CN$CN$CN
241006272$24100627$2$F$20230101$20240718$20240717$20240726$EXP$$TR-TOLMAR, INC.-24TR050958$TOLMAR$$56$YR$$M$Y$$$20240726$$MD$TR$TR
241006281$24100628$1$I$20230501$20240706$20240717$20240717$EXP$$DE-AUROBINDO-AUR-APL-2024-034092$AUROBINDO$$65$YR$$F$Y$$$20240717$$CN$DE$DE
241006301$24100630$1$I$$20240710$20240717$20240717$EXP$$US-GSK-US2024AMR086140$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$HP$US$US
241006311$24100631$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA204662$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240717$$MD$US$US
241006321$24100632$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206463$SANOFI AVENTIS$$$$T$M$Y$52$KG$20240717$$MD$US$US
241006331$24100633$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA205762$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240717$$MD$US$US
241006342$24100634$2$F$$20240812$20240717$20240821$PER$$US-SA-2024SA206040$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240821$$CN$US$US
241006351$24100635$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206380$SANOFI AVENTIS$$$$$$Y$$$20240717$$LW$US$US
241006361$24100636$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206226$SANOFI AVENTIS$$$$E$F$Y$$$20240717$$MD$US$US
241006371$24100637$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA205867$SANOFI AVENTIS$$$$A$$Y$$$20240717$$HP$US$US
241006382$24100638$2$F$20240101$20240916$20240717$20240923$PER$$US-SA-2024SA204309$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240923$$MD$US$US
241006391$24100639$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206635$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240717$$MD$US$US
241006401$24100640$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA206902$SANOFI AVENTIS$$80$YR$E$F$Y$52$KG$20240717$$MD$US$US
241006411$24100641$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206639$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240717$$MD$US$US
241006421$24100642$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206644$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240717$$MD$US$US
241006432$24100643$2$F$20240101$20240801$20240717$20240809$PER$$US-SA-2024SA206630$SANOFI AVENTIS$$12$YR$T$M$Y$42$KG$20240809$$MD$US$US
241006442$24100644$2$F$20240101$20240712$20240717$20240722$PER$$US-SA-2024SA207335$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240722$$MD$US$US
241006451$24100645$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA204455$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240717$$CN$US$US
241006461$24100646$1$I$20220113$20240706$20240717$20240717$EXP$$IT-AUROBINDO-AUR-APL-2024-033917$AUROBINDO$$60$YR$$M$Y$$$20240717$$MD$IT$IT
241006471$24100647$1$I$$20230823$20240717$20240717$PER$$US-NOVOPROD-1222223$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241006481$24100648$1$I$20220629$20240710$20240717$20240717$PER$$US-SA-2024SA204577$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240717$$CN$US$US
241006491$24100649$1$I$20240217$20240328$20240717$20240717$PER$$US-NOVOPROD-1222249$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
241006501$24100650$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1222678$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006511$24100651$1$I$20230606$20240507$20240717$20240717$PER$$US-NOVOPROD-1222658$NOVO NORDISK$$48$YR$$F$Y$$$20240717$$CN$US$US
241006521$24100652$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1222342$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006531$24100653$1$I$20240227$20240521$20240717$20240717$PER$$US-NOVOPROD-1222492$NOVO NORDISK$$74$YR$$M$Y$$$20240717$$CN$US$US
241006541$24100654$1$I$$20240508$20240717$20240717$PER$$US-NOVOPROD-1222464$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006551$24100655$1$I$$20230913$20240717$20240717$PER$$US-NOVOPROD-1222235$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241006561$24100656$1$I$$20230912$20240717$20240717$PER$$US-NOVOPROD-1222332$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006571$24100657$1$I$20220101$20240506$20240717$20240717$PER$$US-NOVOPROD-1222259$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
241006581$24100658$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1222666$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006591$24100659$1$I$20240507$20240515$20240717$20240717$PER$$US-NOVOPROD-1222706$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
241006601$24100660$1$I$$20240506$20240717$20240717$PER$$US-NOVOPROD-1222270$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241006611$24100661$1$I$20240401$20240506$20240717$20240717$PER$$US-NOVOPROD-1222370$NOVO NORDISK$$72$YR$$M$Y$$$20240717$$CN$US$US
241006621$24100662$1$I$$20240715$20240717$20240717$PER$$US-HALEON-2187211$Haleon PLC$$$$$F$Y$$$20240717$$CN$US$US
241006632$24100663$2$F$$20240826$20240717$20240909$EXP$$US-ASTELLAS-2024EU006896$ASTELLAS$$$$E$M$Y$$$20240909$$CN$US$US
241006641$24100664$1$I$20240429$20240506$20240717$20240717$PER$$US-NOVOPROD-1222150$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
241006651$24100665$1$I$20240506$20240514$20240717$20240717$PER$$US-NOVOPROD-1222381$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
241006661$24100666$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1222708$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006672$24100667$2$F$$20230913$20240717$20240717$PER$$US-NOVOPROD-1222104$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241006691$24100669$1$I$$20240508$20240717$20240717$PER$$US-NOVOPROD-1222529$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006702$24100670$2$F$$20240822$20240717$20240823$PER$$US-ALXN-202407USA000791US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241006711$24100671$1$I$$20240705$20240717$20240717$PER$$US-TEVA-VS-3219010$TEVA$$$$E$F$Y$$$20240717$$CN$US$US
241006721$24100672$1$I$20200502$20240706$20240717$20240717$EXP$$PL-AUROBINDO-AUR-APL-2024-034212$AUROBINDO$$19$YR$$F$Y$40$KG$20240717$$MD$PL$PL
241006731$24100673$1$I$20240628$20240711$20240717$20240717$EXP$$CN-BEIGENE-BGN-2024-010839$BEIGENE$$$$$$Y$$$20240717$$HP$CN$CN
241006741$24100674$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1222917$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241006751$24100675$1$I$$20240506$20240717$20240717$PER$$US-NOVOPROD-1223349$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241006761$24100676$1$I$20240416$20240503$20240717$20240717$PER$$US-NOVOPROD-1222786$NOVO NORDISK$$50$YR$$F$Y$$$20240717$$CN$US$US
241006771$24100677$1$I$20240309$20240507$20240717$20240717$PER$$US-NOVOPROD-1223210$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
241006781$24100678$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1223364$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006791$24100679$1$I$20240201$20240507$20240717$20240717$PER$$US-NOVOPROD-1223383$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241006801$24100680$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1223081$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006811$24100681$1$I$20240506$20240506$20240717$20240717$PER$$US-NOVOPROD-1222909$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
241006821$24100682$1$I$$20240506$20240717$20240717$PER$$US-NOVOPROD-1222914$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241006831$24100683$1$I$20240423$20240507$20240717$20240717$PER$$US-NOVOPROD-1222764$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
241006841$24100684$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1222726$NOVO NORDISK$$62$YR$$M$Y$$$20240717$$HP$US$US
241006852$24100685$2$F$$20230725$20240717$20240723$PER$$US-NOVOPROD-1222842$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241006861$24100686$1$I$$20240506$20240717$20240717$PER$$US-NOVOPROD-1222907$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241006871$24100687$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1223356$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006881$24100688$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1222928$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241006891$24100689$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1222755$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241006901$24100690$1$I$20240101$20240507$20240717$20240717$PER$$US-NOVOPROD-1222753$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241006911$24100691$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1223040$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241006921$24100692$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1223362$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241006931$24100693$1$I$$20240607$20240717$20240717$PER$$US-NOVOPROD-1223273$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241006941$24100694$1$I$20240504$20240506$20240717$20240717$PER$$US-NOVOPROD-1222912$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241006951$24100695$1$I$20240507$20240507$20240717$20240717$PER$$US-NOVOPROD-1222724$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
241006961$24100696$1$I$20240101$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009813$ELI LILLY AND CO$$$$$$Y$$$20240717$$CN$US$US
241006971$24100697$1$I$20240503$20240507$20240717$20240717$PER$$US-NOVOPROD-1223183$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
241006981$24100698$1$I$$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009907$ELI LILLY AND CO$$$$$F$Y$$$20240717$$HP$US$US
241006991$24100699$1$I$$20240708$20240717$20240717$EXP$$US-Encube-000816$ENCUBE ETHICALS$Heng YJ, Baker GM, Fein-Zachary VJ, Guzman-Arocho YD, Bret-Mounet VC, Massicott ES, Torous VF, Schnitt SJ, Gitin S, Russo P, Tobias AM, Bartlett RA, Varma G, Kontos D, Yaghjyan L, Irwig MS, Potter JE, Wulf GM. Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individuals. Breast Cancer Res. 2024 Jul 2;26(1):109. doi: 10.1186/s13058-024-01867-w. PMID: 38956693; PMCID: PMC11221014.$$$$F$Y$$$20240716$$MD$US$
241007002$24100700$2$F$20240101$20240829$20240717$20240920$EXP$$US-SA-2024SA207233$SANOFI AVENTIS$$68$YR$E$F$Y$65$KG$20240920$$MD$US$US
241007011$24100701$1$I$$20240710$20240717$20240717$EXP$$US-SA-2024SA206990$SANOFI AVENTIS$$$$E$F$Y$78.9$KG$20240717$$MD$US$US
241007031$24100703$1$I$20240422$20240712$20240717$20240717$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013504$UNITED THERAPEUTICS$$69$YR$$F$Y$90.249$KG$20240717$$$US$US
241007041$24100704$1$I$$20240715$20240717$20240717$PER$$US-ABBVIE-5841115$ABBVIE$$21$YR$$F$Y$$$20240717$$CN$US$US
241007051$24100705$1$I$20240711$20240712$20240717$20240717$EXP$$CA-ABBVIE-5839989$ABBVIE$$$$E$F$Y$$$20240717$$CN$CA$CA
241007061$24100706$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5840707$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241007071$24100707$1$I$20240101$20240705$20240717$20240717$PER$$US-SA-2024SA201922$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240717$$CN$US$US
241007082$24100708$2$F$20240601$20240730$20240717$20240807$PER$$US-SA-2024SA204329$SANOFI AVENTIS$$12$YR$T$M$Y$57.1$KG$20240807$$MD$US$US
241007091$24100709$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA204356$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240717$$MD$US$US
241007101$24100710$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA205494$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
241007111$24100711$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA204262$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240717$$CN$US$US
241007123$24100712$3$F$$20240711$20240717$20240718$PER$$US-SA-2024SA205464$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240718$$HP$US$US
241007131$24100713$1$I$20190701$20240710$20240717$20240717$PER$$US-SA-2024SA207185$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240717$$MD$US$US
241007141$24100714$1$I$20240601$20240708$20240717$20240717$PER$$US-SA-2024SA205137$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240717$$MD$US$US
241007151$24100715$1$I$20220103$20240710$20240717$20240717$PER$$US-SA-2024SA205865$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240717$$MD$US$US
241007161$24100716$1$I$20240601$20240708$20240717$20240717$PER$$US-SA-2024SA205265$SANOFI AVENTIS$$81$YR$E$F$Y$61.6$KG$20240717$$MD$US$US
241007172$24100717$2$F$20211116$20240708$20240717$20240717$EXP$$US-CHATTEMPRD-2022SA239467$CHATTEM$$29$YR$A$M$Y$90$KG$20240717$$LW$US$US
241007181$24100718$1$I$20240427$20240508$20240717$20240717$PER$$US-NOVOPROD-1223768$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
241007191$24100719$1$I$20240710$20240711$20240717$20240717$PER$$US-SA-2024SA205083$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240717$$MD$US$US
241007201$24100720$1$I$20240501$20240508$20240717$20240717$PER$$US-NOVOPROD-1223661$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241007211$24100721$1$I$20240422$20240508$20240717$20240717$PER$$US-NOVOPROD-1223800$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
241007221$24100722$1$I$20240301$20240508$20240717$20240717$PER$$US-NOVOPROD-1223617$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241007231$24100723$1$I$20240301$20240506$20240717$20240717$PER$$US-NOVOPROD-1223398$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241007241$24100724$1$I$20240501$20240506$20240717$20240717$PER$$US-NOVOPROD-1223465$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241007251$24100725$1$I$$20240508$20240717$20240717$PER$$US-NOVOPROD-1223642$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241007261$24100726$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1223677$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241007271$24100727$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1223589$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241007281$24100728$1$I$20240507$20240603$20240717$20240717$PER$$US-NOVOPROD-1223755$NOVO NORDISK$$50$YR$$M$Y$$$20240717$$HP$US$US
241007291$24100729$1$I$20230101$20240508$20240717$20240717$PER$$US-NOVOPROD-1223748$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241007301$24100730$1$I$$20240508$20240717$20240717$PER$$US-NOVOPROD-1223762$NOVO NORDISK$$60$YR$$M$Y$$$20240717$$MD$US$US
241007311$24100731$1$I$$20240508$20240717$20240717$PER$$US-NOVOPROD-1223749$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241007321$24100732$1$I$$20240506$20240717$20240717$PER$$US-NOVOPROD-1223486$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241007331$24100733$1$I$20240317$20240529$20240717$20240717$PER$$US-NOVOPROD-1223435$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$MD$US$US
241007341$24100734$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1223628$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241007351$24100735$1$I$20240507$20240507$20240717$20240717$PER$$US-NOVOPROD-1223634$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241007361$24100736$1$I$20240624$20240715$20240717$20240717$EXP$$US-ABBVIE-5841072$ABBVIE$$63$YR$$M$Y$$$20240717$$CN$US$US
241007371$24100737$1$I$20240508$20240508$20240717$20240717$PER$$US-NOVOPROD-1223738$NOVO NORDISK$$64$YR$$M$Y$$$20240717$$CN$US$US
241007383$24100738$3$F$20240101$20240910$20240717$20240917$EXP$$US-ABBVIE-5840486$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
241007392$24100739$2$F$20240701$20240719$20240717$20240805$PER$$US-AMGEN-USASP2024140035$AMGEN$$84$YR$E$F$Y$$$20240805$$CN$US$US
241007402$24100740$2$F$20140319$20240808$20240717$20240812$EXP$$GB-SANDOZ INC.-SDZ2024GB065355$SANDOZ$$64$YR$$M$Y$89$KG$20240812$$PH$GB$GB
241007411$24100741$1$I$20240524$20240716$20240717$20240717$EXP$FR-AFSSAPS-LY2024000828$FR-JNJFOC-20240741927$JOHNSON AND JOHNSON$$70$YR$E$F$Y$79.35$KG$20240717$$PH$FR$FR
241007421$24100742$1$I$20240615$20240715$20240717$20240717$EXP$$US-ABBVIE-5841135$ABBVIE$$89$YR$$F$Y$$$20240717$$CN$US$US
241007431$24100743$1$I$20230101$20240710$20240717$20240717$PER$$US-SA-2024SA204921$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240717$$MD$US$US
241007442$24100744$2$F$20240401$20240801$20240717$20240810$PER$$US-SA-2024SA204731$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240810$$MD$US$US
241007454$24100745$4$F$20240101$20240830$20240717$20240918$EXP$$US-SA-2024SA207505$SANOFI AVENTIS$$11$YR$C$M$Y$57.007$KG$20240918$$MD$US$US
241007462$24100746$2$F$20240705$20240729$20240717$20240806$PER$$US-SA-2023SA405497$SANOFI AVENTIS$$18$YR$A$F$Y$58.967$KG$20240806$$MD$US$US
241007472$24100747$2$F$20240606$20240821$20240717$20240917$PER$$US-SA-2024SA207513$SANOFI AVENTIS$$52$YR$A$F$Y$71.66$KG$20240918$$MD$US$US
241007481$24100748$1$I$$20240708$20240717$20240717$EXP$$US-TEVA-VS-3219730$TEVA$$$$A$F$Y$$$20240717$$HP$US$US
241007491$24100749$1$I$$20240715$20240717$20240717$EXP$$US-ABBVIE-5841339$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241007501$24100750$1$I$20240501$20240709$20240717$20240717$30DAY$$US-GSK-US2024084917$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240717$$CN$US$US
241007511$24100751$1$I$$20240508$20240717$20240717$PER$$US-NOVOPROD-1223924$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241007521$24100752$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1223892$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241007531$24100753$1$I$20240507$20240524$20240717$20240717$PER$$US-NOVOPROD-1224163$NOVO NORDISK$$51$YR$$M$Y$$$20240717$$CN$US$US
241007541$24100754$1$I$$20240711$20240717$20240717$EXP$$US-GSK-US2024086608$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$US$US
241007551$24100755$1$I$20240509$20240510$20240717$20240717$PER$$US-NOVOPROD-1223826$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
241007561$24100756$1$I$20240408$20240508$20240717$20240717$PER$$US-NOVOPROD-1223811$NOVO NORDISK$$72$YR$$M$Y$$$20240717$$CN$US$US
241007571$24100757$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1223949$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241007581$24100758$1$I$20240508$20240508$20240717$20240717$PER$$US-NOVOPROD-1224011$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241007591$24100759$1$I$$20240715$20240717$20240717$EXP$$US-ABBVIE-5841723$ABBVIE$$$$$M$Y$$$20240717$$HP$US$US
241007601$24100760$1$I$20240701$20240712$20240717$20240717$EXP$$CN-ABBVIE-5840744$ABBVIE$$79$YR$$F$Y$45$KG$20240717$$HP$CN$CN
241007613$24100761$3$F$$20240809$20240717$20240812$EXP$$NVSC2024US146711$NOVARTIS$$$$$$Y$$$20240812$$HP$US$US
241007622$24100762$2$F$20220527$20240806$20240717$20240811$EXP$$JP-ABBVIE-5841047$ABBVIE$$59$YR$$M$Y$66.8$KG$20240811$$MD$JP$JP
241007631$24100763$1$I$20191017$20240708$20240717$20240717$EXP$PT-INFARMED-B202406-409$PT-TEVA-VS-3219147$TEVA$$63$YR$$F$Y$$$20240717$$MD$PT$PT
241007642$24100764$2$F$20240101$20240805$20240717$20240806$PER$$US-ALXN-202407USA000537US$ALEXION PHARMACEUTICALS$$72$YR$$M$Y$$$20240806$$CN$US$US
241007651$24100765$1$I$20230801$20240209$20240717$20240717$PER$$US-NOVOPROD-1130746$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241007661$24100766$1$I$$20231003$20240717$20240717$PER$$US-NOVOPROD-1130743$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241007671$24100767$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024138621$AMGEN$$$$$$Y$$$20240716$$CN$US$US
241007682$24100768$2$F$20240711$20240916$20240717$20240922$EXP$$US-JNJFOC-20240735387$JOHNSON AND JOHNSON$$56$YR$A$M$Y$73.1$KG$20240922$$MD$US$US
241007691$24100769$1$I$20240708$20240710$20240717$20240717$EXP$JP-MMM-HECUKW6L$JP-GSK-JP2024085513$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$JP$JP
241007701$24100770$1$I$$20240711$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065479$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
241007711$24100771$1$I$$20231005$20240717$20240717$PER$$US-NOVOPROD-1136271$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241007721$24100772$1$I$$20231013$20240717$20240717$PER$$US-NOVOPROD-1132146$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241007731$24100773$1$I$$20240712$20240717$20240717$EXP$$US-JNJFOC-20240734453$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$HP$US$US
241007741$24100774$1$I$$20240715$20240717$20240717$EXP$NL-LRB-00981688$NL-JNJFOC-20240738045$JOHNSON AND JOHNSON$$19$MON$I$M$Y$12$KG$20240717$$CN$NL$NL
241007761$24100776$1$I$20240701$20240712$20240717$20240717$EXP$$CN-BEIGENE-BGN-2024-010919$BEIGENE$$$$$$Y$$$20240717$$HP$CN$CN
241007771$24100777$1$I$20240207$20240221$20240717$20240717$PER$$US-NOVOPROD-1182383$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241007781$24100778$1$I$20240201$20240312$20240717$20240717$PER$$US-NOVOPROD-1182225$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241007791$24100779$1$I$20231201$20240222$20240717$20240717$PER$$US-NOVOPROD-1182323$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241007801$24100780$1$I$$20240222$20240717$20240717$PER$$US-NOVOPROD-1182274$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241007811$24100781$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1182377$NOVO NORDISK$$73$YR$$M$Y$$$20240717$$MD$US$US
241007821$24100782$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1182379$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241007831$24100783$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA203573$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240717$$MD$US$US
241007841$24100784$1$I$20240701$20240711$20240717$20240717$EXP$$CN-BEIGENE-BGN-2024-010845$BEIGENE$$$$$$Y$$$20240717$$HP$CN$CN
241007851$24100785$1$I$20240704$20240711$20240717$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-110814$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240717$$CN$JP$JP
241007863$24100786$3$F$20240713$20240731$20240717$20240806$PER$$US-AMGEN-USASP2024140795$AMGEN$$79$YR$E$F$Y$$$20240806$$CN$US$US
241007872$24100787$2$F$20240707$20240718$20240717$20240722$PER$$US-AMGEN-USASP2024140440$AMGEN$$67$YR$E$F$Y$$$20240722$$CN$US$US
241007881$24100788$1$I$$20240709$20240717$20240717$EXP$$US-ROCHE-10000011429$ROCHE$$53$YR$A$M$Y$$$20240717$$MD$US$US
241007891$24100789$1$I$$20240223$20240717$20240717$PER$$US-NOVOPROD-1182826$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241007901$24100790$1$I$20240620$20240710$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110723$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$52.16$KG$20240717$$CN$US$US
241007912$24100791$2$F$20230803$20240223$20240717$20240717$PER$$US-NOVOPROD-1182829$NOVO NORDISK$$78$YR$$M$Y$$$20240717$$CN$US$US
241007921$24100792$1$I$20240123$20240223$20240717$20240717$PER$$US-NOVOPROD-1182946$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241007931$24100793$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1183034$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241007941$24100794$1$I$20230215$20240222$20240717$20240717$PER$$US-NOVOPROD-1183043$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
241007951$24100795$1$I$20240131$20240222$20240717$20240717$PER$$US-NOVOPROD-1182628$NOVO NORDISK$$$$$F$Y$132.6$KG$20240717$$CN$US$US
241007961$24100796$1$I$20240107$20240329$20240717$20240717$PER$$US-NOVOPROD-1182936$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
241007971$24100797$1$I$$20240220$20240717$20240717$PER$$US-NOVOPROD-1182652$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241007981$24100798$1$I$20231201$20240223$20240717$20240717$PER$$US-NOVOPROD-1183009$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
241007991$24100799$1$I$20240208$20240401$20240717$20240717$PER$$US-NOVOPROD-1182780$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
241008001$24100800$1$I$20240223$20240223$20240717$20240717$PER$$US-NOVOPROD-1182851$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008011$24100801$1$I$20230101$20240222$20240717$20240717$PER$$US-NOVOPROD-1182686$NOVO NORDISK$$71$YR$$$Y$$$20240717$$CN$US$US
241008021$24100802$1$I$$20240223$20240717$20240717$PER$$US-NOVOPROD-1182945$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241008031$24100803$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1183020$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241008041$24100804$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1182972$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008051$24100805$1$I$$20231013$20240717$20240717$PER$$US-NOVOPROD-1182795$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241008061$24100806$1$I$20240216$20240307$20240717$20240717$PER$$US-NOVOPROD-1182947$NOVO NORDISK$$71$YR$$$Y$$$20240717$$CN$US$US
241008072$24100807$2$F$20240701$20240712$20240717$20240725$EXP$$US-ENDO USA, INC.-2024-002904$ENDO$$$$$M$Y$$$20240725$$HP$US$US
241008081$24100808$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1182387$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241008091$24100809$1$I$20240619$20240715$20240717$20240717$EXP$$NVSC2024ZW146400$NOVARTIS$$50$YR$$M$Y$$$20240717$$MD$ZW$ZW
241008101$24100810$1$I$20240527$20240712$20240717$20240717$EXP$$CN-BEIGENE-BGN-2024-010923$BEIGENE$$$$$$Y$$$20240717$$HP$CN$CN
241008111$24100811$1$I$$20191030$20240717$20240717$EXP$$CA-AstraZeneca-2019SF64182$ASTRAZENECA$$$$$F$Y$$$20240717$$HP$CA$
241008121$24100812$1$I$$20240708$20240717$20240717$PER$$US-AMGEN-USASP2024137987$AMGEN$Hajizadeh S.; O^donnell C.; Dore A.. Case of isolated scleromalacia perforans with seropositivity for rheumatoid arthritis. BMJ Case Reports. 2024;17 (6):1-3$$$$M$Y$$$20240716$$MD$US$US
241008131$24100813$1$I$$20191120$20240717$20240717$EXP$$US-AstraZeneca-2019SF68107$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241008141$24100814$1$I$20190101$20191001$20240717$20240717$EXP$$BR-AstraZeneca-2019SF40729$ASTRAZENECA$$63$YR$$F$Y$$$20240717$$CN$BR$
241008151$24100815$1$I$$20191120$20240717$20240717$EXP$$CR-AstraZeneca-2019SF68219$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CR$
241008161$24100816$1$I$20240705$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A159594$ASTRAZENECA$$21496$DY$$M$Y$$$20240717$$CN$US$
241008171$24100817$1$I$20230726$20240715$20240717$20240717$EXP$FR-EMA-DD-20240708-7482715-134933$FR-SANDOZ INC.-SDZ2024FR065141$SANDOZ$$64$YR$$F$Y$57.2$KG$20240717$$PH$FR$FR
241008181$24100818$1$I$$20240710$20240717$20240717$PER$$US-ABBVIE-5839664$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241008192$24100819$2$F$20240224$20240226$20240717$20240717$PER$$US-NOVOPROD-1183085$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241008201$24100820$1$I$$20240223$20240717$20240717$PER$$US-NOVOPROD-1183182$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241008211$24100821$1$I$$20240226$20240717$20240717$PER$$US-NOVOPROD-1183206$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008231$24100823$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1183864$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241008241$24100824$1$I$$20240322$20240717$20240717$PER$$US-NOVOPROD-1183561$NOVO NORDISK$$$$$F$Y$$$20240717$$PH$US$US
241008251$24100825$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1183177$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
241008261$24100826$1$I$20240222$20240224$20240717$20240717$PER$$US-NOVOPROD-1183410$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
241008272$24100827$2$F$20240414$20240722$20240717$20240728$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02550$AMNEAL$$86$YR$$M$Y$52.608$KG$20240728$$CN$US$US
241008281$24100828$1$I$20221001$20240226$20240717$20240717$PER$$US-NOVOPROD-1183973$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241008291$24100829$1$I$20240111$20240222$20240717$20240717$PER$$US-NOVOPROD-1183795$NOVO NORDISK$$49$YR$$$Y$$$20240717$$CN$US$US
241008301$24100830$1$I$$20240223$20240717$20240717$PER$$US-NOVOPROD-1183190$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241008311$24100831$1$I$20240214$20240221$20240717$20240717$PER$$US-NOVOPROD-1183924$NOVO NORDISK$$54$YR$$F$Y$$$20240717$$CN$US$US
241008321$24100832$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1183205$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008331$24100833$1$I$20240201$20240227$20240717$20240717$PER$$US-NOVOPROD-1183562$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241008341$24100834$1$I$$20230713$20240717$20240717$PER$$US-NOVOPROD-1183594$NOVO NORDISK$$61$YR$$$Y$$$20240717$$CN$US$US
241008351$24100835$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1183792$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241008361$24100836$1$I$20231001$20240311$20240717$20240717$PER$$US-NOVOPROD-1183599$NOVO NORDISK$$75$YR$$M$Y$$$20240717$$CN$US$US
241008371$24100837$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1183392$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008381$24100838$1$I$$20240223$20240717$20240717$PER$$US-NOVOPROD-1183050$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008391$24100839$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1183951$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241008401$24100840$1$I$$20240226$20240717$20240717$PER$$US-NOVOPROD-1183383$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008411$24100841$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009490$ELI LILLY AND CO$$$$A$F$Y$$$20240717$$CN$US$US
241008421$24100842$1$I$20240101$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009857$ELI LILLY AND CO$$$$$$Y$$$20240717$$CN$US$US
241008431$24100843$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009351$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240717$$CN$US$US
241008441$24100844$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009321$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240717$$CN$US$US
241008451$24100845$1$I$20240101$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009844$ELI LILLY AND CO$$$$$$Y$$$20240717$$CN$US$US
241008461$24100846$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010067$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240717$$CN$US$US
241008471$24100847$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009340$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240717$$CN$US$US
241008481$24100848$1$I$20240712$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009497$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240717$$CN$US$US
241008491$24100849$1$I$20240601$20240709$20240717$20240717$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-018748$UNITED THERAPEUTICS$$49$YR$$F$Y$$$20240717$$$JP$JP
241008501$24100850$1$I$$20240710$20240717$20240717$EXP$$CA-TAKEDA-CA202032484$TAKEDA$$34$YR$$F$Y$$$20240717$$CN$CA$CA
241008511$24100851$1$I$$20240712$20240717$20240717$PER$$US-JNJFOC-20240734023$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
241008521$24100852$1$I$$20240712$20240717$20240717$EXP$$US-JNJFOC-20240734045$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240717$$CN$US$US
241008531$24100853$1$I$20240611$20240716$20240717$20240717$EXP$CZ-CZSUKL-24001795$CZ-ROCHE-10000027742$ROCHE$$45$YR$A$F$Y$55$KG$20240717$$MD$CZ$CZ
241008541$24100854$1$I$20240111$20240715$20240717$20240717$EXP$$FI-SANDOZ INC.-SDZ2024FI022504$SANDOZ$$70$YR$$F$Y$96$KG$20240717$$HP$FI$FI
241008551$24100855$1$I$20231207$20240709$20240717$20240717$EXP$FR-AFSSAPS-AVMA2024000285$FR-TEVA-VS-3219431$TEVA$$50$YR$$F$Y$$$20240717$$PH$FR$FR
241008561$24100856$1$I$20240220$20240226$20240717$20240717$PER$$US-NOVOPROD-1184399$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
241008571$24100857$1$I$$20240129$20240717$20240717$PER$$US-NOVOPROD-1184052$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008581$24100858$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1184651$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008591$24100859$1$I$20240219$20240226$20240717$20240717$PER$$US-NOVOPROD-1184330$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
241008601$24100860$1$I$20240225$20240227$20240717$20240717$PER$$US-NOVOPROD-1184599$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
241008611$24100861$1$I$20230601$20240228$20240717$20240717$PER$$US-NOVOPROD-1184189$NOVO NORDISK$$49$YR$$M$Y$$$20240717$$CN$US$US
241008621$24100862$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1184455$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241008631$24100863$1$I$$20240226$20240717$20240717$PER$$US-NOVOPROD-1184215$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008641$24100864$1$I$$20240226$20240717$20240717$PER$$US-NOVOPROD-1184220$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241008651$24100865$1$I$20240216$20240226$20240717$20240717$PER$$US-NOVOPROD-1184328$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241008661$24100866$1$I$20240201$20240318$20240717$20240717$PER$$US-NOVOPROD-1184076$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
241008671$24100867$1$I$20230904$20240226$20240717$20240717$PER$$US-NOVOPROD-1183979$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241008681$24100868$1$I$20240212$20240408$20240717$20240717$PER$$US-NOVOPROD-1184321$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$HP$US$US
241008691$24100869$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1184616$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008701$24100870$1$I$20240214$20240226$20240717$20240717$PER$$US-NOVOPROD-1184370$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241008711$24100871$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1184193$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
241008721$24100872$1$I$$20240226$20240717$20240717$PER$$US-NOVOPROD-1184314$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008731$24100873$1$I$20230601$20240228$20240717$20240717$PER$$US-NOVOPROD-1184529$NOVO NORDISK$$54$YR$$F$Y$$$20240717$$CN$US$US
241008741$24100874$1$I$20231208$20240223$20240717$20240717$PER$$US-NOVOPROD-1184072$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241008751$24100875$1$I$20230101$20240226$20240717$20240717$PER$$US-NOVOPROD-1184422$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241008761$24100876$1$I$$20240226$20240717$20240717$PER$$US-NOVOPROD-1184724$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241008771$24100877$1$I$20210501$20240228$20240717$20240717$PER$$US-NOVOPROD-1184184$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008781$24100878$1$I$20240108$20240322$20240717$20240717$PER$$US-NOVOPROD-1184121$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
241008791$24100879$1$I$20231201$20240228$20240717$20240717$PER$$US-NOVOPROD-1184461$NOVO NORDISK$$73$YR$$M$Y$$$20240717$$CN$US$US
241008801$24100880$1$I$20240212$20240225$20240717$20240717$PER$$US-NOVOPROD-1184030$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
241008811$24100881$1$I$$20240709$20240717$20240717$EXP$GB-MHRA-MED-202406281431213880-YGRFD$GB-AMAROX PHARMA-AMR2024GB02220$HETERO$$$$$$Y$$$20240717$$CN$GB$GB
241008821$24100882$1$I$20240611$20240715$20240717$20240717$EXP$GB-MHRA-MED-202407151404190870-HZQBY$GB-GSK-GB2024088620$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$GB$GB
241008833$24100883$3$F$20240101$20240816$20240717$20240828$EXP$$US-INSMED, INC.-2024-02744-US$INSMED$$$$$F$Y$$$20240828$$CN$US$US
241008841$24100884$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1224237$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241008851$24100885$1$I$20240508$20240508$20240717$20240717$PER$$US-NOVOPROD-1224169$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241008861$24100886$1$I$20240507$20240508$20240717$20240717$PER$$US-NOVOPROD-1224269$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
241008871$24100887$1$I$20240218$20240228$20240717$20240717$PER$$US-NOVOPROD-1184740$NOVO NORDISK$$83$YR$$M$Y$$$20240717$$CN$US$US
241008881$24100888$1$I$20240418$20240509$20240717$20240717$PER$$US-NOVOPROD-1224188$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241008891$24100889$1$I$20240403$20240508$20240717$20240717$PER$$US-NOVOPROD-1224274$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008901$24100890$1$I$20230801$20240226$20240717$20240717$PER$$US-NOVOPROD-1184739$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241008911$24100891$1$I$20240506$20240509$20240717$20240717$PER$$US-NOVOPROD-1224260$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241008921$24100892$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1224301$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241008931$24100893$1$I$20240301$20240603$20240717$20240717$PER$$US-NOVOPROD-1184726$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$MD$US$US
241008941$24100894$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1184792$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241008951$24100895$1$I$20240202$20240410$20240717$20240717$PER$$US-NOVOPROD-1184760$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241008961$24100896$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1224284$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
241008971$24100897$1$I$20240401$20240507$20240717$20240717$PER$$US-NOVOPROD-1224203$NOVO NORDISK$$49$YR$$F$Y$$$20240717$$CN$US$US
241008981$24100898$1$I$$20240226$20240717$20240717$PER$$US-NOVOPROD-1184814$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$PH$US$US
241008991$24100899$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1184787$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009001$24100900$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1224227$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009011$24100901$1$I$$20240515$20240717$20240717$PER$$US-NOVOPROD-1224171$NOVO NORDISK$$43$YR$$M$Y$$$20240717$$MD$US$US
241009021$24100902$1$I$20230901$20240228$20240717$20240717$PER$$US-NOVOPROD-1184788$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
241009031$24100903$1$I$20240301$20240716$20240717$20240717$EXP$CZ-CZSUKL-24001740$CZ-ROCHE-10000027660$ROCHE$$48$YR$A$M$Y$88$KG$20240717$$MD$CZ$CZ
241009041$24100904$1$I$$20240711$20240717$20240717$PER$$US-ABBVIE-5841791$ABBVIE$$$$$$Y$$$20240717$$CN$US$US
241009051$24100905$1$I$$20240711$20240717$20240717$EXP$$US-AMGEN-USASP2024138612$AMGEN$$$$$$Y$$$20240716$$PH$US$US
241009071$24100907$1$I$20230803$20230802$20240717$20240717$PER$$US-NOVOPROD-1224493$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241009081$24100908$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1224732$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
241009091$24100909$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1224835$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241009101$24100910$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1224394$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241009111$24100911$1$I$20240504$20240510$20240717$20240717$PER$$US-NOVOPROD-1224723$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241009121$24100912$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1224675$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009131$24100913$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1224725$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009141$24100914$1$I$20240502$20240522$20240717$20240717$PER$$US-NOVOPROD-1224973$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
241009151$24100915$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1224356$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241009161$24100916$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1224449$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241009171$24100917$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1224650$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
241009181$24100918$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1224893$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241009191$24100919$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1224465$NOVO NORDISK$$45$YR$$F$Y$$$20240717$$MD$US$US
241009202$24100920$2$F$20240401$20240510$20240717$20240717$PER$$US-NOVOPROD-1224790$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009211$24100921$1$I$20240417$20240508$20240717$20240717$PER$$US-NOVOPROD-1224303$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
241009221$24100922$1$I$$20240605$20240717$20240717$PER$$US-NOVOPROD-1224305$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241009231$24100923$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1224540$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241009241$24100924$1$I$20230901$20240510$20240717$20240717$PER$$US-NOVOPROD-1224979$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241009251$24100925$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1224755$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241009261$24100926$1$I$$20240509$20240717$20240717$PER$$US-NOVOPROD-1224514$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009271$24100927$1$I$20240501$20240522$20240717$20240717$PER$$US-NOVOPROD-1224490$NOVO NORDISK$$41$YR$$M$Y$$$20240717$$CN$US$US
241009281$24100928$1$I$20230717$20240509$20240717$20240717$PER$$US-NOVOPROD-1224578$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241009291$24100929$1$I$$20240416$20240717$20240717$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-08393$ALKEM$Kadaba P, Beitia L, Rosen A, Weinberg A, Lewis S, Simpson WL.. Utility of nifedipine use for Doppler ultrasound early after liver transplantation to predict short-term complications and long-term outcomes. Abdominal Radiology. 2024;49:1103-1112$52$YR$$M$Y$$$20240717$$HP$US$US
241009301$24100930$1$I$$20240530$20240717$20240717$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12159$ALKEM$Hancock RH, Swan RH.. Nifedipine-induced gingival overgrowth. Report of a case treated by controlling plaque. J Clin Periodontol. 1992;19:12-14$$$$$Y$$$20240717$$HP$US$US
241009311$24100931$1$I$$20240606$20240717$20240717$EXP$$ZA-ALKEM LABORATORIES LIMITED-ZA-ALKEM-2024-12851$ALKEM$Naidoo LC, Stephen LX.. Nifedipine-induced gingival hyperplasia: non-surgical management of a patient. Spec Care Dentist. 1999;19:29-34$$$$$Y$$$20240717$$HP$ZA$ZA
241009321$24100932$1$I$$20240606$20240717$20240717$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-12810$ALKEM$Shibukawa Y, Fujinami K, Yamashita S. Clinical case report of long-term follow-up in type-2 diabetes patient with severe chronic periodontitis and nifedipine-induced gingival overgrowth. Bull Tokyo Dent Coll. 2012;53:91-9$$$$$Y$$$20240717$$HP$JP$JP
241009331$24100933$1$I$$20240606$20240717$20240717$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-12824$ALKEM$Ramsdale DR, Morris JL, Hardy P.. Gingival hyperplasia with nifedipine. Br Heart J. 1995;73:115$$$$$Y$$$20240717$$HP$GB$GB
241009341$24100934$1$I$$20240530$20240717$20240717$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-12156$ALKEM$De Carvalho Farias B, Cabral PA, Gusmao ES, Jamelli SR, Cimoes R. Non-surgical treatment of gingival overgrowth induced by nifedipine: a case report on an elderly patient. Gerodontology. 2009;27:76-80$$$E$$Y$$$20240717$$HP$BR$BR
241009351$24100935$1$I$$20240530$20240717$20240717$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12516$ALKEM$Zimmer Z, Hill R, Fratto V, Lutgendorf MA.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Rep. 2024;17(5):e250664$$$C$M$Y$$$20240717$$MD$US$US
241009362$24100936$2$F$20240524$20240717$20240717$20240717$EXP$IT-MINISAL02-992368$IT-ROCHE-10000027901$ROCHE$$41$YR$A$M$Y$$$20240717$$MD$IT$IT
241009371$24100937$1$I$20231120$20240710$20240717$20240717$EXP$$CN-BEIGENE-BGN-2024-010773$BEIGENE$Zhang Nan, Yan Bin, Lou hui Hua, Di Wen. Tislelizumab in the treatment of immune nephritis, ureteritis and cystitis caused by endometrioid carcinoma: a case report. Chin J Obstet Gynecol. 2024;Vol. 59 (No. 6):476-479$$$$$Y$$$20240717$$MD$CN$CN
241009381$24100938$1$I$$20240530$20240717$20240717$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12073$ALKEM$Zimmer Z, Hill R, Fratto V, Lutgendorf MA.. Acute peripartum pancreatitis complicating seronegative antiphospholipid antibody syndrome in pregnancy. BMJ Case Rep. 2024;17:e250664$$$$F$Y$$$20240717$$HP$US$US
241009391$24100939$1$I$20240404$20240404$20240717$20240717$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-08288$ALKEM$$78$YR$$M$Y$$$20240717$$CN$US$US
241009401$24100940$1$I$20240625$20240713$20240717$20240717$EXP$$CN-AMGEN-CHNSP2024139937$AMGEN$$72$YR$E$F$Y$80$KG$20240716$$HP$CN$CN
241009412$24100941$2$F$$20240802$20240717$20240807$EXP$$JP-ABBVIE-5842315$ABBVIE$$$$$M$Y$$$20240807$$PH$JP$JP
241009421$24100942$1$I$20210201$20240716$20240717$20240717$EXP$$IL-TAKEDA-2024TUS071922$TAKEDA$$$$A$F$Y$$$20240717$$MD$IL$IL
241009431$24100943$1$I$$20240711$20240717$20240717$EXP$$BR-TAKEDA-2024TUS071645$TAKEDA$$34$YR$$$Y$$$20240717$$CN$BR$BR
241009441$24100944$1$I$$20191215$20240717$20240717$EXP$$RU-AstraZeneca-2019SF84620$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$RU$
241009451$24100945$1$I$$20200610$20240717$20240717$EXP$$US-AstraZeneca-2019SF74025$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241009461$24100946$1$I$$20191129$20240717$20240717$EXP$$FR-AstraZeneca-2019SF74885$ASTRAZENECA$$$$$M$Y$$$20240717$$MD$FR$
241009471$24100947$1$I$$20191203$20240717$20240717$EXP$$CR-AstraZeneca-2019SF76235$ASTRAZENECA$$60$YR$$M$Y$$$20240717$$CN$CR$
241009481$24100948$1$I$$20191205$20240717$20240717$EXP$$US-AstraZeneca-2019SF77331$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241009491$24100949$1$I$$20191127$20240717$20240717$EXP$$US-AstraZeneca-2019SF71091$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241009501$24100950$1$I$$20191009$20240717$20240717$EXP$$US-AstraZeneca-2019SF45890$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241009511$24100951$1$I$$20240709$20240717$20240717$EXP$$US-TAKEDA-2024TUS017748$TAKEDA$$$$$M$Y$$$20240717$$CN$US$US
241009521$24100952$1$I$$20240711$20240717$20240717$PER$$US-ROCHE-10000025670$ROCHE$$$$$$Y$$$20240717$$MD$US$US
241009531$24100953$1$I$$20240711$20240717$20240717$PER$$US-ROCHE-10000025683$ROCHE$$$$$$Y$$$20240717$$MD$US$US
241009541$24100954$1$I$$20240711$20240717$20240717$PER$$US-ROCHE-10000025685$ROCHE$$$$$$Y$$$20240717$$MD$US$US
241009551$24100955$1$I$$20240711$20240717$20240717$PER$$US-ROCHE-10000025231$ROCHE$$$$$$Y$$$20240717$$MD$US$US
241009561$24100956$1$I$$20240711$20240717$20240717$PER$$US-ROCHE-10000025671$ROCHE$$$$$$Y$$$20240717$$MD$US$US
241009571$24100957$1$I$$20240705$20240717$20240717$EXP$$ES-AUROBINDO-AUR-APL-2024-033952$AUROBINDO$Pomares H, Arribas I, Quinones T, Hernandez JV, Amoros JR, Artigal CM, et al.. Long-term outcomes after venetoclax-hypomethylating agent combination therapy discontinuation, in patients with acute myeloid leukemia.Experience of a single center.. Blood. 2023;142(Suppl 1):4225-4226$$$A$$Y$$$20240717$$MD$ES$ES
241009581$24100958$1$I$$20240711$20240717$20240717$PER$$US-ROCHE-10000025652$ROCHE$$$$$$Y$$$20240717$$MD$US$US
241009591$24100959$1$I$$20240711$20240717$20240717$PER$$US-ROCHE-10000025668$ROCHE$$$$$$Y$$$20240717$$MD$US$US
241009601$24100960$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1225095$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241009613$24100961$3$F$20240618$20240903$20240717$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002935$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240926$$CN$US$US
241009621$24100962$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1225009$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241009632$24100963$2$F$$20240510$20240717$20240717$PER$$US-NOVOPROD-1225054$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241009641$24100964$1$I$20240310$20240510$20240717$20240717$PER$$US-NOVOPROD-1225109$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009652$24100965$2$F$$20240513$20240717$20240717$PER$$US-NOVOPROD-1225166$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241009661$24100966$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1225041$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009671$24100967$1$I$$20240705$20240717$20240717$EXP$$US-AUROBINDO-AUR-APL-2014-01760$AUROBINDO$Moseley Brian D. Refractory status epilepticus treated with trigeminal nerve stimulation. Epilepsy Research. 2014;108:600-603$32$YR$$M$Y$$$20240717$$HP$US$US
241009681$24100968$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1225046$NOVO NORDISK$$60$YR$$$Y$$$20240717$$HP$US$US
241009691$24100969$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1225104$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009702$24100970$2$F$20240201$20240513$20240717$20240717$PER$$US-NOVOPROD-1225153$NOVO NORDISK$$75$YR$$M$Y$$$20240717$$CN$US$US
241009711$24100971$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1224982$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241009721$24100972$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1225058$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009731$24100973$1$I$20240422$20240510$20240717$20240717$PER$$US-NOVOPROD-1224986$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
241009742$24100974$2$F$20240710$20240711$20240717$20240717$EXP$$US-ROCHE-10000024719$ROCHE$$55$YR$A$F$Y$70.31$KG$20240717$$CN$US$US
241009751$24100975$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1225019$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241009761$24100976$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009550$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240717$$CN$US$US
241009771$24100977$1$I$$20240708$20240717$20240717$EXP$$CA-TEVA-VS-3220205$TEVA$$53$YR$$F$Y$$$20240717$$HP$CA$CA
241009781$24100978$1$I$$20240708$20240717$20240717$EXP$$GB-TEVA-VS-3220632$TEVA$$$$A$M$Y$$$20240717$$CN$GB$GB
241009791$24100979$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1225510$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241009801$24100980$1$I$$20240514$20240717$20240717$PER$$US-NOVOPROD-1225783$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241009811$24100981$1$I$20240409$20240513$20240717$20240717$PER$$US-NOVOPROD-1225358$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241009821$24100982$1$I$$20240514$20240717$20240717$PER$$US-NOVOPROD-1225796$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241009831$24100983$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1225305$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009841$24100984$1$I$20140101$20240708$20240717$20240717$EXP$$BR-TEVA-VS-3189864$TEVA$$61$YR$$F$Y$$$20240717$$CN$BR$BR
241009852$24100985$2$F$20240401$20240513$20240717$20240717$PER$$US-NOVOPROD-1225546$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241009861$24100986$1$I$20220101$20240422$20240717$20240717$PER$$US-NOVOPROD-1225205$NOVO NORDISK$$88$YR$$F$Y$$$20240717$$CN$US$US
241009871$24100987$1$I$20240115$20240514$20240717$20240717$PER$$US-NOVOPROD-1225353$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009881$24100988$1$I$$20240514$20240717$20240717$PER$$US-NOVOPROD-1225757$NOVO NORDISK$$39$YR$$F$Y$$$20240717$$CN$US$US
241009891$24100989$1$I$$20240515$20240717$20240717$PER$$US-NOVOPROD-1225194$NOVO NORDISK$$$$A$M$Y$$$20240717$$HP$US$US
241009901$24100990$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1225682$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009911$24100991$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1225263$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241009921$24100992$1$I$20240508$20240514$20240717$20240717$PER$$US-NOVOPROD-1225168$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009931$24100993$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1225845$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009941$24100994$1$I$20240506$20240510$20240717$20240717$PER$$US-NOVOPROD-1225174$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241009961$24100996$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1225800$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241009971$24100997$1$I$20240427$20240513$20240717$20240717$PER$$US-NOVOPROD-1225550$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241009981$24100998$1$I$20240304$20240510$20240717$20240717$PER$$US-NOVOPROD-1225337$NOVO NORDISK$$86$YR$$F$Y$$$20240717$$CN$US$US
241009991$24100999$1$I$$20240512$20240717$20240717$PER$$US-NOVOPROD-1225278$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241010001$24101000$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1225294$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241010011$24101001$1$I$20240426$20240510$20240717$20240717$PER$$US-NOVOPROD-1225240$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
241010021$24101002$1$I$$20240709$20240717$20240717$EXP$$TR-009507513-2407TUR009782$MERCK$Atahan C, Ugurluer G, Kumbasar B, Ozyar E, Atalar B.. Myonecrosis as a rare side effect of stereotactic body radiotherapy for bone metastases: Report of two cases and a comprehensive literature review. Cancer/Radiotherapie. 2024;28(3):275-79$58$YR$$F$Y$$$20240716$$HP$TR$TR
241010032$24101003$2$F$$20240708$20240717$20240729$EXP$$JP-009507513-2407JPN001919J$MERCK$Takada N, Fukui T, Irie H, Funatsu Y, Koh H. CASE REPORT Immune Checkpoint Inhibitor-induced Sclerosing Cholangitis:Three Cases Reported from Our Hospital. Japanese Journal of Lung Cancer. 2024;64(3):193-9$68$YR$$M$Y$$$20240729$$MD$JP$JP
241010041$24101004$1$I$20240101$20240712$20240717$20240717$PER$$US-ABBVIE-5840505$ABBVIE$$$$$$Y$$$20240717$$CN$US$US
241010051$24101005$1$I$20231104$20240712$20240717$20240717$EXP$$GB-AMGEN-GBRSP2024138894$AMGEN$$71$YR$E$M$Y$83$KG$20240716$$CN$GB$GB
241010061$24101006$1$I$$20240715$20240717$20240717$EXP$$BR-ROCHE-10000028425$ROCHE$$$$$$Y$$$20240717$$MD$BR$BR
241010071$24101007$1$I$$20240710$20240717$20240717$PER$$US-BIOGEN-2024BI01268732$BIOGEN$$$$$F$Y$$$20240717$$HP$US$US
241010081$24101008$1$I$$20240710$20240717$20240717$PER$$US-BIOGEN-2024BI01260321$BIOGEN$$$$$M$Y$$$20240717$$CN$US$US
241010091$24101009$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140759$AMGEN$$54$YR$A$M$Y$$$20240716$$CN$US$US
241010102$24101010$2$F$20240419$20240731$20240717$20240805$EXP$$FR-TAKEDA-2024TUS071362$TAKEDA$$64$YR$$F$Y$$$20240805$$HP$FR$FR
241010111$24101011$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1225853$NOVO NORDISK$$55$YR$$M$Y$$$20240717$$MD$US$US
241010122$24101012$2$F$$20240513$20240717$20240717$PER$$US-NOVOPROD-1226013$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241010131$24101013$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1225987$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241010141$24101014$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1225889$NOVO NORDISK$$83$YR$$M$Y$$$20240717$$MD$US$US
241010152$24101015$2$F$$20240510$20240717$20240723$PER$$US-NOVOPROD-1225927$NOVO NORDISK$$$$$$Y$$$20240723$$LW$US$US
241010161$24101016$1$I$$20240514$20240717$20240717$PER$$US-NOVOPROD-1226197$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241010171$24101017$1$I$$20240515$20240717$20240717$PER$$US-NOVOPROD-1225913$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241010181$24101018$1$I$$20240514$20240717$20240717$PER$$US-NOVOPROD-1225968$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241010201$24101020$1$I$20060101$20240712$20240717$20240717$PER$$US-ROCHE-10000026001$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241010212$24101021$2$F$$20240715$20240717$20240717$EXP$$US-ROCHE-10000027496$ROCHE$$53$YR$A$M$Y$$$20240717$$CN$US$US
241010221$24101022$1$I$$20240702$20240717$20240717$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109457$ZYDUS PHARM$Hayes LM, Hayes LM, Ward BC, Ward BC, Kulkarni D, Kulkarni D, et al.. Rapidly Progressive Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction With Multi-Organ Dysfunction as a Complication of Nontransplant Associated Chemotherapy.. Am-J-Respir-Crit-Care-Med. 2024;209:A5686.$$$$$Y$$$20240717$$HP$US$US
241010231$24101023$1$I$$20240620$20240717$20240717$PER$$US-ROCHE-10000009130$ROCHE$$59$YR$A$F$Y$$$20240717$$CN$US$US
241010241$24101024$1$I$20240520$20240620$20240717$20240717$PER$$US-ROCHE-10000008307$ROCHE$$$$$F$Y$86.18$KG$20240717$$CN$US$US
241010252$24101025$2$F$$20240718$20240717$20240722$EXP$$CA-ROCHE-10000027461$ROCHE$$$$A$F$Y$$$20240722$$HP$CA$CA
241010261$24101026$1$I$$20240715$20240717$20240717$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039991$BOEHRINGER INGELHEIM$$$$$$Y$$$20240717$$HP$US$US
241010274$24101027$4$F$20240101$20240814$20240717$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-020142$UNITED THERAPEUTICS$$$$$F$Y$38.549$KG$20240822$$$US$US
241010281$24101028$1$I$$20240210$20240717$20240717$PER$$US-NOVOPROD-1146644$NOVO NORDISK$$78$YR$$M$Y$$$20240717$$CN$US$US
241010293$24101029$3$F$20240101$20240710$20240717$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-020781$UNITED THERAPEUTICS$$$$$M$Y$109.3$KG$20240719$$$US$US
241010311$24101031$1$I$$20240711$20240717$20240717$EXP$$CA-009507513-2407CAN009116$MERCK$$74$YR$$M$Y$70$KG$20240717$$HP$CA$CA
241010323$24101032$3$F$20240714$20240828$20240717$20240830$PER$$US-AMGEN-USASP2024140474$AMGEN$$81$YR$E$M$Y$$$20240830$$CN$US$US
241010331$24101033$1$I$$20200708$20240717$20240717$EXP$$AU-AstraZeneca-2020SE87660$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$AU$
241010341$24101034$1$I$$20191129$20240717$20240717$EXP$$RU-AstraZeneca-2019SF73610$ASTRAZENECA$$78$YR$$M$Y$70$KG$20240717$$CN$RU$
241010352$24101035$2$F$20240101$20240712$20240717$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-021354$UNITED THERAPEUTICS$$$$$F$Y$69.977$KG$20240720$$$US$US
241010362$24101036$2$F$20181201$20190927$20240717$20240805$EXP$$CA-AstraZeneca-2019SE21555$ASTRAZENECA$$799$MON$$F$Y$$$20240805$$CN$CA$
241010371$24101037$1$I$$20191204$20240717$20240717$EXP$$US-AstraZeneca-2019SF76108$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241010383$24101038$3$F$20240701$20240718$20240717$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021391$UNITED THERAPEUTICS$$50$YR$$M$Y$$$20240726$$$US$US
241010391$24101039$1$I$20191001$20191212$20240717$20240717$EXP$$US-AstraZeneca-2019SF81625$ASTRAZENECA$$593$MON$$F$Y$$$20240717$$CN$US$
241010401$24101040$1$I$20240515$20240709$20240717$20240717$EXP$$DE-AstraZeneca-2024A157681$ASTRAZENECA$$74$YR$$M$Y$$$20240717$$CN$DE$
241010411$24101041$1$I$$20200109$20240717$20240717$EXP$$CA-AstraZeneca-2019SF86979$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CA$
241010421$24101042$1$I$$20231206$20240717$20240717$PER$$US-NOVOPROD-1151397$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241010431$24101043$1$I$20210101$20231205$20240717$20240717$PER$$US-NOVOPROD-1151679$NOVO NORDISK$$63$YR$$M$Y$$$20240717$$CN$US$US
241010451$24101045$1$I$$20240223$20240717$20240717$PER$$US-NOVOPROD-1151363$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241010461$24101046$1$I$20230903$20231207$20240717$20240717$PER$$US-NOVOPROD-1148172$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
241010471$24101047$1$I$$20231208$20240717$20240717$PER$$US-NOVOPROD-1151712$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241010481$24101048$1$I$$20231211$20240717$20240717$PER$$US-NOVOPROD-1151719$NOVO NORDISK$$$$$M$Y$$$20240717$$PH$US$US
241010491$24101049$1$I$20231111$20231208$20240717$20240717$PER$$US-NOVOPROD-1151691$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241010501$24101050$1$I$20231209$20240211$20240717$20240717$PER$$US-NOVOPROD-1151283$NOVO NORDISK$$61$YR$$M$Y$$$20240717$$CN$US$US
241010511$24101051$1$I$$20231207$20240717$20240717$PER$$US-NOVOPROD-1151219$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241010521$24101052$1$I$20231130$20240408$20240717$20240717$PER$$US-NOVOPROD-1151291$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
241010531$24101053$1$I$$20231208$20240717$20240717$PER$$US-NOVOPROD-1151269$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241010541$24101054$1$I$$20231206$20240717$20240717$PER$$US-NOVOPROD-1151500$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241010551$24101055$1$I$$20231201$20240717$20240717$PER$$US-NOVOPROD-1148213$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241010561$24101056$1$I$$20231208$20240717$20240717$PER$$US-NOVOPROD-1151238$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241010571$24101057$1$I$20210101$20231208$20240717$20240717$PER$$US-NOVOPROD-1151230$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241010581$24101058$1$I$$20231206$20240717$20240717$PER$$US-NOVOPROD-1151358$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241010591$24101059$1$I$$20240712$20240717$20240717$EXP$$IT-WT-2024-38599763$Waylis$Camagni S, et al. Living Donor Lung Transplantation After Hematopoietic Stem Cell Transplantation From the Same Donor. A Risk Worth Taking. Protein Cell. Chest journal. 2024, 165(4):e91-e93.$5$YR$C$M$Y$$$20240717$$MD$IT$IT
241010601$24101060$1$I$$20240713$20240717$20240717$PER$$US-HALEON-2187074$Haleon PLC$$$$$F$Y$$$20240717$$CN$US$US
241010611$24101061$1$I$$20240712$20240717$20240717$PER$$US-BIOGEN-2024BI01270098$BIOGEN$$$$$F$Y$$$20240717$$CN$US$US
241010622$24101062$2$F$$20240909$20240717$20240911$PER$$US-BIOGEN-2024BI01273233$BIOGEN$$$$$M$Y$$$20240911$$CN$US$US
241010631$24101063$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1151941$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241010641$24101064$1$I$20240627$20240709$20240717$20240717$EXP$$IQ-ROCHE-10000026358$ROCHE$$16$YR$T$$Y$$$20240717$$HP$IQ$IQ
241010653$24101065$3$F$$20240213$20240717$20240717$PER$$US-NOVOPROD-1151954$NOVO NORDISK$$88$YR$$F$Y$$$20240717$$CN$US$US
241010662$24101066$2$F$20230601$20231211$20240717$20240717$PER$$US-NOVOPROD-1152169$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
241010671$24101067$1$I$$20231212$20240717$20240717$PER$$US-NOVOPROD-1152226$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241010681$24101068$1$I$20231208$20231211$20240717$20240717$PER$$US-NOVOPROD-1151845$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241010691$24101069$1$I$20231031$20240117$20240717$20240717$PER$$US-NOVOPROD-1152025$NOVO NORDISK$$53$YR$$M$Y$$$20240717$$CN$US$US
241010701$24101070$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1151890$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241010711$24101071$1$I$20231210$20231211$20240717$20240717$PER$$US-NOVOPROD-1151912$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$CN$US$US
241010721$24101072$1$I$20230801$20240220$20240717$20240717$PER$$US-NOVOPROD-1152203$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$MD$US$US
241010731$24101073$1$I$20231210$20240314$20240717$20240717$PER$$US-NOVOPROD-1151958$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241010741$24101074$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1152191$NOVO NORDISK$$34$YR$$F$Y$$$20240717$$MD$US$US
241010751$24101075$1$I$20231210$20231211$20240717$20240717$PER$$US-NOVOPROD-1152222$NOVO NORDISK$$39$YR$$F$Y$$$20240717$$CN$US$US
241010761$24101076$1$I$$20231206$20240717$20240717$PER$$US-NOVOPROD-1152170$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241010771$24101077$1$I$20240401$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405021346199740-TWCQK$GB-MSNLABS-2024MSNSPO01542$MSN LABORATORIES$$$$$$Y$$$20240717$$CN$GB$GB
241010781$24101078$1$I$$20240708$20240717$20240717$EXP$$US-JNJFOC-20240722044$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241010791$24101079$1$I$20240522$20240710$20240717$20240717$PER$$US-ALXN-202407USA000738US$ALEXION PHARMACEUTICALS$$61$YR$$F$Y$$$20240717$$CN$US$US
241010801$24101080$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024139449$AMGEN$$$$$$Y$$$20240716$$PH$US$US
241010811$24101081$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1152661$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241010821$24101082$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1152590$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241010831$24101083$1$I$$20231212$20240717$20240717$PER$$US-NOVOPROD-1152439$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241010841$24101084$1$I$20240227$20240513$20240717$20240717$PER$$US-NOVOPROD-1187327$NOVO NORDISK$$59$YR$$M$Y$122.5$KG$20240717$$MD$US$US
241010851$24101085$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1152654$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241010861$24101086$1$I$20231203$20231222$20240717$20240717$PER$$US-NOVOPROD-1152337$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
241010871$24101087$1$I$$20231212$20240717$20240717$PER$$US-NOVOPROD-1152416$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241010881$24101088$1$I$20231210$20231213$20240717$20240717$PER$$US-NOVOPROD-1152300$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241010891$24101089$1$I$$20231211$20240717$20240717$PER$$US-NOVOPROD-1152452$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241010901$24101090$1$I$$20240206$20240717$20240717$PER$$US-NOVOPROD-1152327$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241010911$24101091$1$I$$20231212$20240717$20240717$PER$$US-NOVOPROD-1152417$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241010921$24101092$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1152842$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241010931$24101093$1$I$20231101$20231212$20240717$20240717$PER$$US-NOVOPROD-1152880$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
241010941$24101094$1$I$20240221$20240229$20240717$20240717$PER$$US-NOVOPROD-1187368$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$MD$US$US
241010951$24101095$1$I$$20231212$20240717$20240717$PER$$US-NOVOPROD-1152230$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241010961$24101096$1$I$$20231214$20240717$20240717$PER$$US-NOVOPROD-1152704$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241010972$24101097$2$F$20231211$20240708$20240717$20240717$PER$$US-NOVOPROD-1152253$NOVO NORDISK$$42$YR$$F$Y$105.22$KG$20240717$$MD$US$US
241010981$24101098$1$I$$20231211$20240717$20240717$PER$$US-NOVOPROD-1152795$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241010991$24101099$1$I$20230801$20240109$20240717$20240717$PER$$US-NOVOPROD-1152874$NOVO NORDISK$$58$YR$$M$Y$$$20240717$$MD$US$US
241011001$24101100$1$I$20230401$20231213$20240717$20240717$PER$$US-NOVOPROD-1152303$NOVO NORDISK$$82$YR$$M$Y$$$20240717$$CN$US$US
241011011$24101101$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112904$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240717$$CN$US$US
241011022$24101102$2$F$20240508$20240806$20240717$20240814$EXP$IT-MINISAL02-993159$IT-TEVA-VS-3219404$TEVA$$62$YR$$F$Y$$$20240814$$MD$IT$IT
241011031$24101103$1$I$$20240709$20240717$20240717$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000609$DECIPHERA PHARMACEUTICALS$$68$YR$A$F$Y$$$20240717$$CN$US$US
241011041$24101104$1$I$20240101$20240710$20240717$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-021534$UNITED THERAPEUTICS$$$$$F$Y$47.392$KG$20240717$$$US$US
241011051$24101105$1$I$$20240716$20240717$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040205$BOEHRINGER INGELHEIM$$$$$$Y$$$20240717$$CN$US$US
241011062$24101106$2$F$20240712$20240715$20240717$20240722$PER$$US-ABBVIE-5840650$ABBVIE$$$$$$Y$$$20240722$$HP$US$US
241011071$24101107$1$I$20240601$20240711$20240717$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-019022$UNITED THERAPEUTICS$$65$YR$$M$Y$64.853$KG$20240717$$$US$US
241011081$24101108$1$I$20240711$20240712$20240717$20240717$EXP$$CN-AMGEN-CHNSP2024139909$AMGEN$$$$$$Y$$$20240716$$MD$CN$CN
241011091$24101109$1$I$20240610$20240712$20240717$20240717$EXP$FR-AFSSAPS-NC2024000828$FR-AMGEN-FRASP2024139079$AMGEN$$62$YR$A$F$Y$$$20240716$$MD$FR$FR
241011103$24101110$3$F$20240620$20240730$20240717$20240815$30DAY$$US-AMGEN-USASL2024138402$AMGEN$$64$YR$A$M$Y$$$20240814$$CN$US$US
241011111$24101111$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1187513$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241011121$24101112$1$I$20220617$20240708$20240717$20240717$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02529$AMNEAL$$76$YR$$M$Y$$$20240717$$CN$US$US
241011132$24101113$2$F$20240124$20240516$20240717$20240717$PER$$US-NOVOPROD-1187505$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$MD$US$US
241011141$24101114$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1187592$NOVO NORDISK$$$$E$F$Y$$$20240717$$HP$US$US
241011151$24101115$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1187601$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241011161$24101116$1$I$$20240402$20240717$20240717$PER$$US-NOVOPROD-1187646$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
241011171$24101117$1$I$20230901$20240304$20240717$20240717$PER$$US-NOVOPROD-1187972$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241011181$24101118$1$I$20240304$20240509$20240717$20240717$PER$$US-NOVOPROD-1187949$NOVO NORDISK$$53$YR$$M$Y$$$20240717$$CN$US$US
241011191$24101119$1$I$20240124$20240304$20240717$20240717$PER$$US-NOVOPROD-1187975$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241011201$24101120$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1187661$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241011211$24101121$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1187644$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241011221$24101122$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1187946$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241011231$24101123$1$I$20231101$20240304$20240717$20240717$PER$$US-NOVOPROD-1187515$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241011241$24101124$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1187558$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241011251$24101125$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1187760$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241011261$24101126$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1187935$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241011271$24101127$1$I$$20240326$20240717$20240717$PER$$US-NOVOPROD-1187869$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241011281$24101128$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1187612$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241011291$24101129$1$I$$20240303$20240717$20240717$PER$$US-NOVOPROD-1188002$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241011301$24101130$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1187593$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241011314$24101131$4$F$20240626$20240809$20240717$20240813$30DAY$$CA-JNJFOC-20240713010$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240813$$HP$CA$CA
241011323$24101132$3$F$20240714$20240718$20240717$20240724$PER$$US-AMGEN-USASP2024140417$AMGEN$$63$YR$A$F$Y$$$20240724$$CN$US$US
241011331$24101133$1$I$$20240702$20240717$20240717$PER$$US-ROCHE-10000020645$ROCHE$$$$A$F$Y$$$20240717$$CN$US$US
241011341$24101134$1$I$$20240702$20240717$20240717$PER$$US-ROCHE-10000018932$ROCHE$$62$YR$A$F$Y$$$20240717$$CN$US$US
241011351$24101135$1$I$20220426$20240710$20240717$20240717$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039144$BOEHRINGER INGELHEIM$Ma Z, Xu S, Liu T, Chen X. Conservative treatment of a case of spontaneous cervical subdural haematoma. Journal of Capital Medical University. 2024 Jun;537-542.$82$YR$E$F$Y$$$20240717$$MD$CN$CN
241011362$24101136$2$F$20240709$20240905$20240717$20240912$EXP$$JP-GSK-JP2024089058$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$JP$JP
241011371$24101137$1$I$$20240702$20240717$20240717$PER$$US-ROCHE-10000022812$ROCHE$$49$YR$A$F$Y$$$20240717$$CN$US$US
241011391$24101139$1$I$$20240709$20240717$20240717$EXP$$NL-AUROBINDO-AUR-APL-2024-034048$AUROBINDO$Gilles F. H. Diercks , Joost M. Meijer, Maria C. Bolling, Sonja M. H. J. Scholtens-Jaegers, Jeroen Bremer, Barbara Horvath.. Absence of Epidermal Antibodies in Stevens?Johnson Syndrome/ Toxic Epidermal Necrolysis Patients but Beware of Single Positive Results. Dermatology Research and Practice. 2024;5$55$YR$$F$Y$$$20240717$$HP$NL$NL
241011401$24101140$1$I$20240101$20240710$20240717$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-010418$UNITED THERAPEUTICS$$$$$F$Y$55.329$KG$20240717$$$US$US
241011411$24101141$1$I$$20240713$20240717$20240717$EXP$$JP-TAKEDA-2024TJP010581$TAKEDA$$58$YR$$F$Y$$$20240717$$MD$JP$JP
241011421$24101142$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1188831$NOVO NORDISK$$$$A$$Y$$$20240717$$PH$US$US
241011432$24101143$2$F$20231201$20240301$20240717$20240717$PER$$US-NOVOPROD-1188065$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
241011441$24101144$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1188009$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241011451$24101145$1$I$20240218$20240301$20240717$20240717$PER$$US-NOVOPROD-1188854$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241011461$24101146$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1188808$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241011471$24101147$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1188806$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241011481$24101148$1$I$$20240517$20240717$20240717$PER$$US-NOVOPROD-1228915$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241011491$24101149$1$I$$20230720$20240717$20240717$PER$$US-NOVOPROD-1228960$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241011501$24101150$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1188840$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241011511$24101151$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1188030$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
241011521$24101152$1$I$$20230619$20240717$20240717$PER$$US-NOVOPROD-1188871$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241011531$24101153$1$I$$20230919$20240717$20240717$PER$$US-NOVOPROD-1228919$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241011541$24101154$1$I$20240220$20240307$20240717$20240717$PER$$US-NOVOPROD-1188838$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241011551$24101155$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1188007$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241011561$24101156$1$I$$20240308$20240717$20240717$PER$$US-NOVOPROD-1188751$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241011571$24101157$1$I$20240224$20240306$20240717$20240717$PER$$US-NOVOPROD-1188052$NOVO NORDISK$$58$YR$$M$Y$$$20240717$$CN$US$US
241011581$24101158$1$I$20230701$20240307$20240717$20240717$PER$$US-NOVOPROD-1188835$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241011591$24101159$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1188814$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241011601$24101160$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1188618$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241011611$24101161$1$I$20240301$20240305$20240717$20240717$PER$$US-NOVOPROD-1188737$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
241011621$24101162$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1188633$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241011631$24101163$1$I$$20240517$20240717$20240717$PER$$US-NOVOPROD-1228920$NOVO NORDISK$$60$YR$$M$Y$$$20240717$$HP$US$US
241011641$24101164$1$I$$20240708$20240717$20240717$EXP$GB-MHRA-MED-202406281141054980-NZHDV$GB-AMAROX PHARMA-AMR2024GB02225$HETERO$$$$$$Y$$$20240717$$CN$GB$GB
241011651$24101165$1$I$$20240711$20240717$20240717$EXP$$US-ABBVIE-5840244$ABBVIE$Wiese J, Derian NA, Ghimire S, Bambhroliya Z, Joshi T. Glecaprevir-pibrentasvir and ethinyl es-tradiol-induced liver injury in a patient without cirrhosis. Cureus. 2024;16(6):e61980.$33$YR$$F$Y$$$20240717$$HP$US$US
241011661$24101166$1$I$20230103$20240708$20240717$20240717$EXP$$FR-CELLTRION INC.-2024FR016755$CELLTRION$$$$$$Y$$$20240717$$MD$FR$FR
241011671$24101167$1$I$20231101$20240705$20240717$20240717$PER$$US-SA-2024SA202699$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240717$$MD$US$US
241011681$24101168$1$I$$20240705$20240717$20240717$PER$$US-SA-2024SA201070$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240717$$CN$US$US
241011691$24101169$1$I$20240702$20240709$20240717$20240717$EXP$$US-TAKEDA-2024TUS070821$TAKEDA$$60$YR$$F$Y$108$KG$20240717$$CN$US$US
241011703$24101170$3$F$20240101$20240817$20240717$20240823$EXP$$ES-AUROBINDO-AUR-APL-2024-035051$AUROBINDO$$75$YR$$M$Y$$$20240823$$MD$ES$ES
241011711$24101171$1$I$$20240708$20240717$20240717$PER$$US-SA-2024SA203674$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240717$$MD$US$US
241011721$24101172$1$I$20240601$20240710$20240717$20240717$PER$$US-SA-2024SA206487$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240717$$CN$US$US
241011731$24101173$1$I$$20240709$20240717$20240717$PER$$US-APOTEX-2024AP008247$APOTEX$Wilkinson AJ, Yang A, Chen GH.. Stellate ganglion block to mitigate thalamic pain syndrome of an oncological origin. Pain Practice. 2024;24:231-234$44$YR$$F$Y$81$KG$20240717$$HP$US$US
241011741$24101174$1$I$20240101$20240709$20240717$20240717$PER$$US-ABBVIE-5841130$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241011751$24101175$1$I$$20191210$20240717$20240717$EXP$$US-AstraZeneca-2019SF80760$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241011761$24101176$1$I$$20191227$20240717$20240717$EXP$$RU-AstraZeneca-2019SF89632$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$RU$
241011771$24101177$1$I$20240101$20240708$20240717$20240717$PER$$US-SA-2024SA203389$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240717$$MD$US$US
241011781$24101178$1$I$20191017$20191023$20240717$20240717$EXP$$US-AstraZeneca-2019SF51579$ASTRAZENECA$$19628$DY$$F$Y$$$20240717$$CN$US$
241011792$24101179$2$F$20240614$20240829$20240717$20240906$EXP$IT-MINISAL02-992911$IT-TEVA-VS-3218707$TEVA$$86$YR$$M$Y$75$KG$20240906$$MD$IT$IT
241011801$24101180$1$I$$20200812$20240717$20240717$EXP$$US-AstraZeneca-2020SF03346$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241011811$24101181$1$I$20191206$20191220$20240717$20240717$EXP$$RU-AstraZeneca-2019SF86892$ASTRAZENECA$$59$YR$$M$Y$100$KG$20240717$$CN$RU$
241011821$24101182$1$I$$20200114$20240717$20240717$EXP$$RU-AstraZeneca-2020SE06936$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$RU$
241011831$24101183$1$I$20240516$20240517$20240717$20240717$PER$$US-NOVOPROD-1229061$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241011841$24101184$1$I$$20200108$20240717$20240717$EXP$$US-AstraZeneca-2020SE04814$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241011851$24101185$1$I$$20230911$20240717$20240717$PER$$US-NOVOPROD-1229060$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241011862$24101186$2$F$$20240517$20240717$20240721$PER$$US-NOVOPROD-1229179$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241011871$24101187$1$I$$20230911$20240717$20240717$PER$$US-NOVOPROD-1229014$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241011881$24101188$1$I$20220101$20240520$20240717$20240717$PER$$US-NOVOPROD-1229209$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241011891$24101189$1$I$20240110$20240523$20240717$20240717$PER$$US-NOVOPROD-1229028$NOVO NORDISK$$54$YR$$$Y$$$20240717$$CN$US$US
241011901$24101190$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1229266$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241011913$24101191$3$F$$20240517$20240717$20240717$PER$$US-NOVOPROD-1228984$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241011921$24101192$1$I$20240428$20240520$20240717$20240717$PER$$US-NOVOPROD-1229210$NOVO NORDISK$$72$YR$$M$Y$$$20240717$$CN$US$US
241011931$24101193$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1229130$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241011941$24101194$1$I$20240510$20240708$20240717$20240717$PER$$US-NOVOPROD-1229110$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241011952$24101195$2$F$$20240711$20240717$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-017481$UNITED THERAPEUTICS$$$$$M$Y$102.95$KG$20240720$$$US$US
241011961$24101196$1$I$20240422$20240520$20240717$20240717$PER$$US-NOVOPROD-1229249$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241011971$24101197$1$I$20240513$20240520$20240717$20240717$PER$$US-NOVOPROD-1229248$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241011981$24101198$1$I$20211201$20240711$20240717$20240717$EXP$$DE-JNJFOC-20240735596$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240717$$MD$DE$DE
241011992$24101199$2$F$20240710$20240716$20240717$20240723$EXP$$CA-JNJFOC-20240736643$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20240722$$HP$CA$CA
241012001$24101200$1$I$$20191028$20240717$20240717$EXP$$US-AstraZeneca-2019SF53725$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241012011$24101201$1$I$$20200813$20240717$20240717$EXP$$US-AstraZeneca-2020SF05092$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241012021$24101202$1$I$$20240710$20240717$20240717$EXP$$JP-AMGEN-JPNSP2024139142$AMGEN$Okada A, Mukai S, Saito Y, Nishida T, Fukuda T, Ohdan H. Bowel pseudo-obstruction caused by goblet cell adenocarcinoma of the appendix: A case report. International Journal of Surgery Case Reports. 2024;121$$$A$M$Y$$$20240716$$MD$JP$JP
241012034$24101203$4$F$20240703$20240718$20240717$20240731$PER$$US-ROCHE-10000024956$ROCHE$$62$YR$A$F$Y$90.71$KG$20240731$$CN$US$US
241012045$24101204$5$F$20240626$20240913$20240717$20240918$PER$$US-ROCHE-10000013289$ROCHE$$63$YR$A$F$Y$107.95$KG$20240918$$CN$US$US
241012051$24101205$1$I$20240531$20240709$20240717$20240717$PER$$US-ROCHE-3577524$ROCHE$$38$YR$A$F$Y$68.04$KG$20240717$$CN$US$US
241012063$24101206$3$F$20240101$20240909$20240717$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-021567$UNITED THERAPEUTICS$$$$$M$Y$81.633$KG$20240919$$$US$US
241012072$24101207$2$F$$20240716$20240717$20240718$EXP$GB-MHRA-MED-202405101401069270-STKMW$GB-UCBSA-2024034151$UCB$$$$T$F$Y$$$20240718$$MD$GB$GB
241012082$24101208$2$F$20240320$20240730$20240717$20240801$PER$$US-AMGEN-USASP2024138338$AMGEN$$80$YR$E$F$Y$53.57$KG$20240801$$HP$US$US
241012091$24101209$1$I$20230501$20240206$20240717$20240717$PER$$US-NOVOPROD-1148220$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
241012101$24101210$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1229387$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241012111$24101211$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1229396$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241012121$24101212$1$I$20231128$20240111$20240717$20240717$PER$$US-NOVOPROD-1148216$NOVO NORDISK$$44$YR$$F$Y$77.098$KG$20240717$$MD$US$US
241012131$24101213$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1229303$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241012142$24101214$2$F$$20240506$20240717$20240717$PER$$US-NOVOPROD-1229382$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241012151$24101215$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1229323$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012161$24101216$1$I$$20231218$20240717$20240717$PER$$US-NOVOPROD-1148393$NOVO NORDISK$$$$$M$Y$$$20240717$$PH$US$US
241012171$24101217$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1229391$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012181$24101218$1$I$$20231201$20240717$20240717$PER$$US-NOVOPROD-1148595$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241012192$24101219$2$F$$20240520$20240717$20240717$PER$$US-NOVOPROD-1229411$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241012201$24101220$1$I$20231201$20231201$20240717$20240717$PER$$US-NOVOPROD-1148369$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
241012211$24101221$1$I$20230101$20231201$20240717$20240717$PER$$US-NOVOPROD-1148449$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012221$24101222$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1229268$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012231$24101223$1$I$$20231202$20240717$20240717$PER$$US-NOVOPROD-1148560$NOVO NORDISK$$26$YR$$$Y$$$20240717$$CN$US$US
241012241$24101224$1$I$20240510$20240520$20240717$20240717$PER$$US-NOVOPROD-1229432$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241012251$24101225$1$I$20230114$20240108$20240717$20240717$PER$$US-NOVOPROD-1148386$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241012261$24101226$1$I$20240422$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405031303370180-SCPBV$GB-MSNLABS-2024MSNSPO01545$MSN LABORATORIES$$$$$$Y$$$20240717$$PH$GB$GB
241012272$24101227$2$F$$20240802$20240717$20240806$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010808$JAZZ$$$$$M$Y$$$20240805$$HP$US$US
241012283$24101228$3$F$20240710$20240823$20240717$20240829$PER$$US-JNJFOC-20240734723$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240829$$CN$US$US
241012312$24101231$2$F$20240624$20240717$20240717$20240720$EXP$$US-ABBVIE-5840551$ABBVIE$$85$YR$$F$Y$$$20240720$$CN$US$US
241012321$24101232$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-10000027521$ROCHE$$$$A$F$Y$$$20240717$$CN$US$US
241012331$24101233$1$I$$20240712$20240717$20240717$EXP$$CA-ABBVIE-5839970$ABBVIE$$$$E$M$Y$$$20240717$$CN$CA$CA
241012343$24101234$3$F$$20240807$20240717$20240813$EXP$JP-MMM-PFVW4CI7$JP-GSK-JP2024085669$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$MD$JP$JP
241012351$24101235$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008009$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241012361$24101236$1$I$20230911$20240709$20240717$20240717$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02522$AMNEAL$$91$YR$$M$Y$$$20240717$$CN$US$US
241012371$24101237$1$I$20240705$20240709$20240717$20240717$EXP$$US-GSK-US2024085096$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240717$$MD$US$US
241012381$24101238$1$I$$20240710$20240717$20240717$EXP$GB-MHRA-MED-202407101553020330-GFMBZ$GB-ESPERIONTHERAPEUTICS-2024GBR01093$ESPERION THERAPEUTICS$$78$YR$$M$Y$79$KG$20240717$$PH$GB$GB
241012391$24101239$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1148637$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012401$24101240$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1148763$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012411$24101241$1$I$$20231218$20240717$20240717$PER$$US-NOVOPROD-1149068$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012421$24101242$1$I$20231124$20231205$20240717$20240717$PER$$US-NOVOPROD-1148760$NOVO NORDISK$$37$YR$$F$Y$$$20240717$$CN$US$US
241012431$24101243$1$I$20210619$20240223$20240717$20240717$PER$$US-NOVOPROD-1149203$NOVO NORDISK$$80$$$M$Y$$$20240717$$CN$US$US
241012441$24101244$1$I$$20231205$20240717$20240717$PER$$US-NOVOPROD-1149270$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241012451$24101245$1$I$20231127$20231201$20240717$20240717$PER$$US-NOVOPROD-1149067$NOVO NORDISK$$73$YR$$M$Y$$$20240717$$CN$US$US
241012461$24101246$1$I$20231124$20231227$20240717$20240717$PER$$US-NOVOPROD-1148948$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241012471$24101247$1$I$$20231201$20240717$20240717$PER$$US-NOVOPROD-1148952$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012481$24101248$1$I$$20231201$20240717$20240717$PER$$US-NOVOPROD-1149208$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241012491$24101249$1$I$$20231201$20240717$20240717$PER$$US-NOVOPROD-1148861$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241012501$24101250$1$I$20230501$20231204$20240717$20240717$PER$$US-NOVOPROD-1149264$NOVO NORDISK$$42$YR$$F$Y$$$20240717$$CN$US$US
241012511$24101251$1$I$$20231201$20240717$20240717$PER$$US-NOVOPROD-1148860$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241012521$24101252$1$I$20230501$20231226$20240717$20240717$PER$$US-NOVOPROD-1148759$NOVO NORDISK$$78$YR$$M$Y$$$20240717$$CN$US$US
241012531$24101253$1$I$$20231201$20240717$20240717$PER$$US-NOVOPROD-1149052$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241012541$24101254$1$I$20231124$20231201$20240717$20240717$PER$$US-NOVOPROD-1148624$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012551$24101255$1$I$$20231205$20240717$20240717$PER$$US-NOVOPROD-1149189$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
241012561$24101256$1$I$$20231201$20240717$20240717$PER$$US-NOVOPROD-1148619$NOVO NORDISK$$35$YR$$$Y$$$20240717$$CN$US$US
241012571$24101257$1$I$20230112$20231218$20240717$20240717$PER$$US-NOVOPROD-1148798$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$PH$US$US
241012582$24101258$2$F$20240705$20240905$20240717$20240911$PER$$US-ROCHE-10000026129$ROCHE$$18$YR$A$$Y$58.97$KG$20240911$$CN$US$US
241012591$24101259$1$I$20240510$20240708$20240717$20240717$EXP$FI-FIMEA-202402316$FI-TEVA-VS-3219107$TEVA$$66$YR$$M$Y$$$20240717$$MD$FI$FI
241012601$24101260$1$I$20240709$20240710$20240717$20240717$PER$$US-ALXN-202407USA000703US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
241012611$24101261$1$I$$20240706$20240717$20240717$EXP$$FR-AUROBINDO-AUR-APL-2024-034203$AUROBINDO$$24$YR$$F$Y$$$20240717$$HP$FR$FR
241012621$24101262$1$I$$20240702$20240717$20240717$EXP$$AU-LUPIN EUROPE GMBH-2024-06209$LUPIN$$$$$$Y$$$20240717$$CN$AU$AU
241012631$24101263$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008010$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241012641$24101264$1$I$20240715$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140547$AMGEN$$73$YR$E$F$Y$$$20240716$$CN$US$US
241012651$24101265$1$I$20230518$20240530$20240717$20240717$PER$$US-NOVOPROD-1188120$NOVO NORDISK$$56$YR$$$Y$$$20240717$$CN$US$US
241012661$24101266$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1149340$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012671$24101267$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1149754$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241012681$24101268$1$I$20231031$20231204$20240717$20240717$PER$$US-NOVOPROD-1149345$NOVO NORDISK$$47$YR$$F$Y$$$20240717$$CN$US$US
241012691$24101269$1$I$20230101$20231201$20240717$20240717$PER$$US-NOVOPROD-1149634$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241012701$24101270$1$I$20231113$20231204$20240717$20240717$PER$$US-NOVOPROD-1149280$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241012711$24101271$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1149594$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012721$24101272$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1149325$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241012731$24101273$1$I$$20240712$20240717$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-021670$UNITED THERAPEUTICS$$$$$F$Y$132.88$KG$20240717$$$US$US
241012741$24101274$1$I$$20231205$20240717$20240717$PER$$US-NOVOPROD-1149347$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241012751$24101275$1$I$$20231201$20240717$20240717$PER$$US-NOVOPROD-1149639$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012761$24101276$1$I$20231201$20240301$20240717$20240717$PER$$US-NOVOPROD-1188094$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241012771$24101277$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1149355$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012781$24101278$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1149328$NOVO NORDISK$$$$E$M$Y$$$20240717$$CN$US$US
241012791$24101279$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000027573$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241012801$24101280$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1149591$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241012812$24101281$2$F$$20240906$20240717$20240911$PER$$US-ROCHE-10000023755$ROCHE$$20$YR$A$F$Y$$$20240911$$MD$US$US
241012821$24101282$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-10000025795$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241012831$24101283$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1188090$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241012841$24101284$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1188117$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012851$24101285$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1149598$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241012861$24101286$1$I$$20240709$20240717$20240717$EXP$$US-JNJFOC-20240725230$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241012871$24101287$1$I$$20240711$20240717$20240717$EXP$$IL-JNJFOC-20240733169$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$MD$IL$IL
241012891$24101289$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008011$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241012901$24101290$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111897$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240717$$HP$US$US
241012911$24101291$1$I$20240301$20240318$20240717$20240717$PER$$US-NOVOPROD-1188423$NOVO NORDISK$$50$YR$$F$Y$$$20240717$$CN$US$US
241012922$24101292$2$F$$20240711$20240717$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-111140$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$65$KG$20240717$$PH$CA$CA
241012931$24101293$1$I$$20240229$20240717$20240717$PER$$US-NOVOPROD-1188365$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012941$24101294$1$I$20230830$20240306$20240717$20240717$PER$$US-NOVOPROD-1188335$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012951$24101295$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1188388$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241012961$24101296$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1188330$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012971$24101297$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1188286$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241012981$24101298$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1188257$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241012991$24101299$1$I$20231217$20240304$20240717$20240717$PER$$US-NOVOPROD-1188305$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013001$24101300$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1188252$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013011$24101301$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1188358$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013021$24101302$1$I$20240105$20240607$20240717$20240717$PER$$US-NOVOPROD-1188215$NOVO NORDISK$$51$YR$$M$Y$$$20240717$$CN$US$US
241013031$24101303$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1188290$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241013041$24101304$1$I$20240227$20240305$20240717$20240717$PER$$US-NOVOPROD-1188391$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
241013051$24101305$1$I$20231201$20240223$20240717$20240717$PER$$US-NOVOPROD-1188433$NOVO NORDISK$$45$YR$$F$Y$$$20240717$$CN$US$US
241013061$24101306$1$I$20240301$20240308$20240717$20240717$PER$$US-NOVOPROD-1188380$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241013071$24101307$1$I$$20231029$20240717$20240717$PER$$US-NOVOPROD-1188402$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241013081$24101308$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1188361$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241013091$24101309$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1188438$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013101$24101310$1$I$$20240711$20240717$20240717$PER$$US-CHATTEMPRD-2024OHG024067$CHATTEM$$$$$F$Y$$$20240717$$HP$US$US
241013121$24101312$1$I$20240520$20240709$20240717$20240717$EXP$FR-AFSSAPS-AN2024000826$FR-TEVA-VS-3219427$TEVA$$58$YR$$F$Y$90$KG$20240717$$PH$FR$FR
241013131$24101313$1$I$$20240713$20240717$20240717$PER$$US-ABBVIE-5840755$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241013141$24101314$1$I$$20191226$20240717$20240717$EXP$$US-AstraZeneca-2019SF89524$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241013151$24101315$1$I$20190625$20191030$20240717$20240717$EXP$$ZA-AstraZeneca-2019SF56079$ASTRAZENECA$$20916$DY$$M$Y$$$20240717$$CN$ZA$
241013161$24101316$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008012$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241013171$24101317$1$I$20240715$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009489$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240717$$CN$US$US
241013181$24101318$1$I$$20200123$20240717$20240717$EXP$$RU-AstraZeneca-2020SE13270$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$RU$
241013191$24101319$1$I$$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008493$ELI LILLY AND CO$$$$$M$Y$$$20240717$$CN$US$US
241013201$24101320$1$I$$20200928$20240717$20240717$EXP$$ZA-AstraZeneca-2020SF26745$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$ZA$
241013212$24101321$2$F$$20240803$20240717$20240813$EXP$$KZ-HETERO-HET2024KZ02251$HETERO$$$$$M$Y$$$20240813$$HP$KZ$KZ
241013221$24101322$1$I$$20240711$20240717$20240717$PER$$US-CHATTEMPRD-2024OHG023930$CHATTEM$$$$$M$Y$$$20240717$$CN$US$US
241013231$24101323$1$I$$20200106$20240717$20240717$EXP$$CA-AstraZeneca-2020SE02603$ASTRAZENECA$$51$YR$$F$Y$$$20240717$$MD$CA$
241013241$24101324$1$I$$20200131$20240717$20240717$EXP$$US-AstraZeneca-2020SE17469$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241013251$24101325$1$I$$20200106$20240717$20240717$EXP$$US-AstraZeneca-2020SE04719$ASTRAZENECA$$71$YR$$F$Y$$$20240717$$CN$US$
241013262$24101326$2$F$20240609$20240716$20240717$20240718$EXP$PT-INFARMED-R202407-59$PT-SANDOZ INC.-SDZ2024PT065116$SANDOZ$$50$YR$$F$Y$100$KG$20240718$$MD$PT$PT
241013271$24101327$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1188479$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241013281$24101328$1$I$$20231205$20240717$20240717$PER$$US-NOVOPROD-1149842$NOVO NORDISK$$$$$F$Y$$$20240717$$PH$US$US
241013291$24101329$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1188598$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013301$24101330$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1188540$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241013312$24101331$2$F$$20231205$20240717$20240717$PER$$US-NOVOPROD-1149818$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013321$24101332$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1188504$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013331$24101333$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1188599$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241013341$24101334$1$I$20240228$20240306$20240717$20240717$PER$$US-NOVOPROD-1188525$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
241013351$24101335$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1188590$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013362$24101336$2$F$$20240306$20240717$20240717$PER$$US-NOVOPROD-1188550$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013371$24101337$1$I$20240707$20240708$20240717$20240717$EXP$$EG-ROCHE-3003973$ROCHE$$31$YR$A$F$Y$$$20240717$$CN$EG$EG
241013381$24101338$1$I$20231206$20240405$20240717$20240717$PER$$US-NOVOPROD-1149804$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241013391$24101339$1$I$20240303$20240306$20240717$20240717$PER$$US-NOVOPROD-1188512$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241013401$24101340$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1184853$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
241013411$24101341$1$I$20240228$20240305$20240717$20240717$PER$$US-NOVOPROD-1188485$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
241013421$24101342$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1188490$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013431$24101343$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1188608$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241013441$24101344$1$I$20240302$20240308$20240717$20240717$PER$$US-NOVOPROD-1188455$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241013451$24101345$1$I$$20240202$20240717$20240717$PER$$US-NOVOPROD-1149783$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013461$24101346$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1188596$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013471$24101347$1$I$$20230619$20240717$20240717$PER$$US-NOVOPROD-1188484$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241013481$24101348$1$I$20230901$20231204$20240717$20240717$PER$$US-NOVOPROD-1149825$NOVO NORDISK$$52$YR$$M$Y$$$20240717$$CN$US$US
241013491$24101349$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1188612$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241013501$24101350$1$I$20240701$20240709$20240717$20240717$30DAY$$US-GSK-US2024084903$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240717$$CN$US$US
241013511$24101351$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1188615$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241013522$24101352$2$F$20240704$20240717$20240717$20240726$EXP$$US-GSK-US2024AMR085589$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241013531$24101353$1$I$$20200206$20240717$20240717$EXP$$US-AstraZeneca-2020SE19837$ASTRAZENECA$$$$$$Y$$$20240717$$PH$US$
241013541$24101354$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-RCA5207309$ROCHE$Purohit R, Khal R, McCabe K, Bhanusali N, Farooq M, Beg S. Neurosarcoidosis-induced winging scapula: Efficacy of infliximab treatment in addressing multifaceted challenges. Modern rheumatology case reports. 2024-May-23;1-4. doi:10.1093/mrcr/rxae030/7680337.$45$YR$A$M$Y$$$20240717$$MD$US$US
241013551$24101355$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009781$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240717$$CN$US$US
241013563$24101356$3$F$20240401$20240718$20240717$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407010314$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240722$$CN$US$US
241013571$24101357$1$I$20230928$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009740$ELI LILLY AND CO$$47$YR$A$$Y$$$20240717$$CN$US$US
241013581$24101358$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009605$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240717$$CN$US$US
241013591$24101359$1$I$20240714$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009602$ELI LILLY AND CO$$54$YR$A$$Y$$$20240717$$CN$US$US
241013601$24101360$1$I$20240715$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009798$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240717$$CN$US$US
241013611$24101361$1$I$20221230$20240709$20240717$20240717$EXP$$ES-CELLTRION INC.-2024ES016932$CELLTRION$$$$$$Y$$$20240717$$MD$ES$ES
241013621$24101362$1$I$$20240708$20240717$20240717$EXP$$CA-BEH-2024175578$CSL BEHRING$$$$E$F$Y$59.4$KG$20240717$$CN$CA$CA
241013631$24101363$1$I$20240711$20240715$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112242$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$$$20240717$$CN$US$US
241013641$24101364$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008013$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241013651$24101365$1$I$20240501$20240710$20240717$20240717$PER$$US-ALXN-202405USA000045US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$HP$US$US
241013663$24101366$3$F$20240110$20240226$20240717$20240717$PER$$US-NOVOPROD-1185167$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
241013672$24101367$2$F$20220228$20240229$20240717$20240723$PER$$US-NOVOPROD-1185109$NOVO NORDISK$$50$YR$$F$Y$$$20240723$$CN$US$US
241013681$24101368$1$I$20230301$20240411$20240717$20240717$PER$$US-NOVOPROD-1185113$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
241013691$24101369$1$I$20240222$20240325$20240717$20240717$PER$$US-NOVOPROD-1184973$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
241013701$24101370$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1185251$NOVO NORDISK$$45$YR$$F$Y$$$20240717$$CN$US$US
241013711$24101371$1$I$20240109$20240228$20240717$20240717$PER$$US-NOVOPROD-1185297$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241013721$24101372$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1184974$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241013731$24101373$1$I$$20240312$20240717$20240717$PER$$US-NOVOPROD-1185049$NOVO NORDISK$$62$YR$$M$Y$$$20240717$$PH$US$US
241013741$24101374$1$I$20240224$20240329$20240717$20240717$PER$$US-NOVOPROD-1185079$NOVO NORDISK$$82$YR$$M$Y$$$20240717$$CN$US$US
241013751$24101375$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1184906$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241013761$24101376$1$I$20230901$20240301$20240717$20240717$PER$$US-NOVOPROD-1185130$NOVO NORDISK$$50$YR$$F$Y$$$20240717$$CN$US$US
241013771$24101377$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1185035$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241013781$24101378$1$I$20240227$20240226$20240717$20240717$PER$$US-NOVOPROD-1185085$NOVO NORDISK$$57$YR$$M$Y$97.506$KG$20240717$$CN$US$US
241013791$24101379$1$I$20240225$20240228$20240717$20240717$PER$$US-NOVOPROD-1184980$NOVO NORDISK$$83$YR$$F$Y$$$20240717$$CN$US$US
241013801$24101380$1$I$20240101$20240307$20240717$20240717$PER$$US-NOVOPROD-1184895$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$MD$US$US
241013811$24101381$1$I$$20240226$20240717$20240717$PER$$US-NOVOPROD-1185092$NOVO NORDISK$$$$A$M$Y$$$20240717$$MD$US$US
241013822$24101382$2$F$20240703$20240718$20240717$20240729$PER$$US-CHATTEMPRD-2024OHG023638$CHATTEM$$$$$F$Y$$$20240729$$CN$US$US
241013831$24101383$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008014$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241013841$24101384$1$I$$20240715$20240717$20240717$PER$$NVSC2024US146794$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241013851$24101385$1$I$$20240709$20240717$20240717$30DAY$$US-GSK-US2024AMR088670$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$US$US
241013861$24101386$1$I$20240501$20240710$20240717$20240717$EXP$$US-GSK-US2024085827$GLAXOSMITHKLINE$$56$YR$$M$Y$$$20240717$$CN$US$US
241013871$24101387$1$I$$20240710$20240717$20240717$PER$$US-CHATTEMPRD-2024OHG023971$CHATTEM$$$$A$M$Y$$$20240717$$CN$US$US
241013881$24101388$1$I$20240323$20240708$20240717$20240717$EXP$GB-MHRA-MED-202406281038502460-PFVRS$GB-AMAROX PHARMA-AMR2024GB02227$HETERO$$$$$$Y$$$20240717$$CN$GB$GB
241013891$24101389$1$I$$20240710$20240717$20240717$EXP$$CN-BEIGENE-BGN-2024-010803$BEIGENE$Wang J, Lan H, Mao X, Chen Y. Pituitary-adrenal axis dysfunction induced by tislelizumab immunotherapy for non-small cell lung cancer: a case series and literature review. BMC Pulmonary Medicine. 2024;24:327:1-8$$$$$Y$$$20240717$$MD$CN$CN
241013901$24101390$1$I$$20240701$20240717$20240717$EXP$ALK-US-2024-0148$US-IHL-000589$INVENTIA HEALTHCARE$$$$$F$Y$$$20240701$$CN$US$US
241013911$24101391$1$I$$20240702$20240717$20240717$EXP$$AU-LUPIN EUROPE GMBH-2024-06230$LUPIN$$$$$$Y$$$20240717$$CN$AU$AU
241013921$24101392$1$I$20240711$20240711$20240717$20240717$EXP$$US-JNJFOC-20240735396$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240717$$MD$US$US
241013932$24101393$2$F$$20240228$20240717$20240717$PER$$US-NOVOPROD-1185619$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241013941$24101394$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1185388$NOVO NORDISK$$$$$$Y$$$20240717$$MD$US$US
241013951$24101395$1$I$20230101$20240223$20240717$20240717$PER$$US-NOVOPROD-1185588$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241013961$24101396$1$I$20240216$20240318$20240717$20240717$PER$$US-NOVOPROD-1185396$NOVO NORDISK$$80$YR$$F$Y$$$20240717$$CN$US$US
241013971$24101397$1$I$$20240229$20240717$20240717$PER$$US-NOVOPROD-1185612$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241013981$24101398$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1185629$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241013991$24101399$1$I$$20240325$20240717$20240717$PER$$US-NOVOPROD-1185493$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241014001$24101400$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1185571$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241014011$24101401$1$I$20240101$20240710$20240717$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-019549$UNITED THERAPEUTICS$$$$$F$Y$113.83$KG$20240717$$$US$US
241014021$24101402$1$I$20240130$20240227$20240717$20240717$PER$$US-NOVOPROD-1185481$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241014031$24101403$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1185543$NOVO NORDISK$$$$A$M$Y$$$20240717$$MD$US$US
241014041$24101404$1$I$20240101$20240624$20240717$20240717$PER$$US-NOVOPROD-1185422$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
241014051$24101405$1$I$20231001$20240228$20240717$20240717$PER$$US-NOVOPROD-1185480$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241014061$24101406$1$I$$20240229$20240717$20240717$PER$$US-NOVOPROD-1185416$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$MD$US$US
241014071$24101407$1$I$20240225$20240227$20240717$20240717$PER$$US-NOVOPROD-1185572$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241014081$24101408$1$I$$20240226$20240717$20240717$PER$$US-NOVOPROD-1185436$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014091$24101409$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1185538$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$MD$US$US
241014101$24101410$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1185539$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014111$24101411$1$I$20240709$20240715$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112969$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$30.39$KG$20240717$$CN$US$US
241014121$24101412$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008015$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241014131$24101413$1$I$$20240707$20240717$20240717$EXP$$DE-TEVA-VS-3220005$TEVA$$$$$M$Y$$$20240717$$CN$DE$DE
241014141$24101414$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000028329$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241014151$24101415$1$I$20240513$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-PHHY2018CA021502$SANDOZ$$85$YR$$F$Y$$$20240717$$CN$CA$CA
241014161$24101416$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008018$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241014171$24101417$1$I$$20240711$20240717$20240717$EXP$GB-MHRA-MED-202407101209001950-WRHFP$GB-DEXPHARM-2024-2333$DEXCEL$$25$YR$A$F$Y$60$KG$20240717$$CN$GB$GB
241014181$24101418$1$I$$20240712$20240717$20240717$EXP$$GB-AMGEN-GBRSP2024139385$AMGEN$$$$$M$Y$$$20240716$$HP$GB$GB
241014191$24101419$1$I$20240714$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140444$AMGEN$$$$$$Y$$$20240716$$PH$US$US
241014201$24101420$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1186909$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241014211$24101421$1$I$20240123$20240229$20240717$20240717$PER$$US-NOVOPROD-1186280$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241014221$24101422$1$I$20240228$20240229$20240717$20240717$PER$$US-NOVOPROD-1185671$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014231$24101423$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1185739$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241014241$24101424$1$I$$20240214$20240717$20240717$PER$$US-NOVOPROD-1185650$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241014251$24101425$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1186703$NOVO NORDISK$$$$A$M$Y$$$20240717$$MD$US$US
241014261$24101426$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1186166$NOVO NORDISK$$41$YR$$F$Y$$$20240717$$HP$US$US
241014271$24101427$1$I$$20240229$20240717$20240717$PER$$US-NOVOPROD-1186118$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241014282$24101428$2$F$20231124$20240329$20240717$20240717$PER$$US-NOVOPROD-1186026$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
241014291$24101429$1$I$$20240302$20240717$20240717$PER$$US-NOVOPROD-1186836$NOVO NORDISK$$50$YR$$F$Y$$$20240717$$CN$US$US
241014301$24101430$1$I$20230101$20240301$20240717$20240717$PER$$US-NOVOPROD-1186132$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
241014311$24101431$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1186434$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241014321$24101432$1$I$20240221$20240422$20240717$20240717$PER$$US-NOVOPROD-1186848$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$MD$US$US
241014331$24101433$1$I$20230701$20240227$20240717$20240717$PER$$US-NOVOPROD-1185794$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014341$24101434$1$I$$20240229$20240717$20240717$PER$$US-NOVOPROD-1185926$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014351$24101435$1$I$20230301$20240229$20240717$20240717$PER$$US-NOVOPROD-1186256$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
241014361$24101436$1$I$20240101$20240227$20240717$20240717$PER$$US-NOVOPROD-1185804$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
241014371$24101437$1$I$$20240310$20240717$20240717$PER$$US-NOVOPROD-1186539$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014381$24101438$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1186359$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241014391$24101439$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1185741$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014401$24101440$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1186903$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241014411$24101441$1$I$$20240229$20240717$20240717$PER$$US-NOVOPROD-1185931$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241014421$24101442$1$I$20240129$20240227$20240717$20240717$PER$$US-NOVOPROD-1185730$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241014431$24101443$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1186088$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241014441$24101444$1$I$20240214$20240315$20240717$20240717$PER$$US-NOVOPROD-1186423$NOVO NORDISK$$46$YR$$F$Y$$$20240717$$HP$US$US
241014451$24101445$1$I$$20240711$20240717$20240717$EXP$$US-JNJFOC-20240730793$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
241014461$24101446$1$I$$20240715$20240717$20240717$PER$$NVSC2024US146728$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241014471$24101447$1$I$$20240712$20240717$20240717$PER$$US-ABBVIE-5840618$ABBVIE$$$$$$Y$$$20240717$$HP$US$US
241014491$24101449$1$I$$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024139676$AMGEN$$$$$$Y$$$20240716$$PH$US$US
241014501$24101450$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1187185$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241014511$24101451$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1187281$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241014521$24101452$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1187017$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241014531$24101453$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1187232$NOVO NORDISK$$$$$$Y$117$KG$20240717$$CN$US$US
241014541$24101454$1$I$20240124$20240228$20240717$20240717$PER$$US-NOVOPROD-1186944$NOVO NORDISK$$47$YR$$F$Y$$$20240717$$CN$US$US
241014552$24101455$2$F$20240711$20240722$20240717$20240729$PER$$US-AMGEN-USASP2024138473$AMGEN$$31$YR$A$M$Y$$$20240729$$HP$US$US
241014561$24101456$1$I$$20240513$20240717$20240717$PER$$US-NOVOPROD-1226282$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
241014571$24101457$1$I$20240223$20240301$20240717$20240717$PER$$US-NOVOPROD-1187049$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241014581$24101458$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1187306$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241014591$24101459$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1187323$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241014601$24101460$1$I$20240226$20240227$20240717$20240717$PER$$US-NOVOPROD-1187117$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241014611$24101461$1$I$20240501$20240529$20240717$20240717$PER$$US-NOVOPROD-1226317$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241014621$24101462$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1226620$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241014631$24101463$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1187166$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241014641$24101464$1$I$20240211$20240227$20240717$20240717$PER$$US-NOVOPROD-1187111$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241014651$24101465$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1187278$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241014661$24101466$1$I$20240220$20240529$20240717$20240717$PER$$US-NOVOPROD-1187113$NOVO NORDISK$$52$YR$$F$Y$$$20240717$$CN$US$US
241014671$24101467$1$I$$20240514$20240717$20240717$PER$$US-NOVOPROD-1226544$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241014681$24101468$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1187206$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241014691$24101469$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1187063$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241014701$24101470$1$I$$20240514$20240717$20240717$PER$$US-NOVOPROD-1226244$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014711$24101471$1$I$20240309$20240408$20240717$20240717$PER$$US-NOVOPROD-1186950$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
241014721$24101472$1$I$$20240229$20240717$20240717$PER$$US-NOVOPROD-1186989$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241014731$24101473$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1187107$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241014741$24101474$1$I$20240629$20240701$20240717$20240717$PER$$US-ABBVIE-5832345$ABBVIE$$28$YR$$M$Y$$$20240717$$CN$US$US
241014752$24101475$2$F$20101102$20240711$20240717$20240725$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14901$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14901$ALKEM$$12$YR$$F$Y$35.5$KG$20240725$$MD$DE$DE
241014761$24101476$1$I$$20240703$20240717$20240717$EXP$GB-MHRA-MED-202406291157398850-KGTCR$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14915$ALKEM$$30$YR$$M$Y$$$20240717$$CN$GB$GB
241014771$24101477$1$I$20110103$20240703$20240717$20240717$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14927$ALKEM$$12$YR$$F$Y$39.8$KG$20240717$$HP$DE$DE
241014781$24101478$1$I$$20240708$20240717$20240717$EXP$$CA-CELLTRION INC.-2024CA016716$CELLTRION$$$$$$Y$$$20240717$$HP$CA$CA
241014791$24101479$1$I$$20240703$20240717$20240717$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14903$ALKEM$$$$$M$Y$$$20240717$$CN$DE$DE
241014801$24101480$1$I$$20240703$20240717$20240717$EXP$GB-MHRA-MED-202407020643199960-VMKHF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14913$ALKEM$$$$$F$Y$95$KG$20240717$$CN$GB$GB
241014811$24101481$1$I$$20240703$20240717$20240717$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14292$ALKEM$$62$YR$$M$Y$$$20240717$$HP$AU$AU
241014822$24101482$2$F$$20240903$20240717$20240918$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-21283$SAMSUNG BIOEPIS$Kouranos V. The role of infliximab in treating refractory cardiac sarcoidosis. Case series and systematic review of literature. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 2024 Jun 28;41(2):E2024013: doi:10.36141/svdld.v41i2.14484.$54$YR$A$M$Y$$$20240918$$HP$GB$GB
241014831$24101483$1$I$$20240702$20240717$20240717$EXP$$AU-LUPIN HEALTHCARE (UK) LIMITED-2024-06203$LUPIN$$$$$F$Y$$$20240717$$CN$AU$AU
241014841$24101484$1$I$$20240514$20240717$20240717$PER$$US-NOVOPROD-1226950$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014851$24101485$1$I$$20240514$20240717$20240717$PER$$US-NOVOPROD-1226927$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014862$24101486$2$F$20211222$20240712$20240717$20240725$EXP$CN-MLMSERVICE-20240625-PI111404-00089-2$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-14899$ALKEM$Zhang L, Wang L, Umar Z, Huang Y, Gu B.. Weathering the storm: diagnosis and treatment of a life-threatening disseminated Nocardia otitidiscaviarum infection. Frontiers in Cellular and Infection Microbiology. 2024;14:1397847$66$YR$$M$Y$$$20240725$$MD$CN$CN
241014872$24101487$2$F$$20240712$20240717$20240725$EXP$CN-MLMSERVICE-20240625-PI111522-00097-1$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-14941$ALKEM$Wu J, Hu Y.. A late-onset hyperammonemia syndrome caused by Ureaplasma parvum infection after kidney transplantation. Heliyon. 2024;10(11):e32134$64$YR$$M$Y$$$20240725$$MD$CN$CN
241014881$24101488$1$I$20240514$20240701$20240717$20240717$PER$$US-NOVOPROD-1227158$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014891$24101489$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1226891$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241014901$24101490$1$I$20240516$20240516$20240717$20240717$PER$$US-NOVOPROD-1226965$NOVO NORDISK$$51$YR$$M$Y$$$20240717$$CN$US$US
241014911$24101491$1$I$$20240514$20240717$20240717$PER$$US-NOVOPROD-1226728$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241014921$24101492$1$I$$20240515$20240717$20240717$PER$$US-NOVOPROD-1227193$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241014931$24101493$1$I$$20240515$20240717$20240717$PER$$US-NOVOPROD-1227355$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241014941$24101494$1$I$20240424$20240515$20240717$20240717$PER$$US-NOVOPROD-1227188$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
241014951$24101495$1$I$$20240610$20240717$20240717$PER$$US-NOVOPROD-1226679$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014961$24101496$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1226959$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241014971$24101497$1$I$$20240705$20240717$20240717$PER$$US-NOVOPROD-1228669$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241014981$24101498$1$I$20240510$20240515$20240717$20240717$PER$$US-NOVOPROD-1227337$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241014991$24101499$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1227674$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015001$24101500$1$I$20240516$20240516$20240717$20240717$PER$$US-NOVOPROD-1227221$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015011$24101501$1$I$20240416$20240514$20240717$20240717$PER$$US-NOVOPROD-1226939$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241015021$24101502$1$I$$20240515$20240717$20240717$PER$$US-NOVOPROD-1227217$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241015031$24101503$1$I$$20240515$20240717$20240717$PER$$US-NOVOPROD-1227350$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241015041$24101504$1$I$20240515$20240515$20240717$20240717$PER$$US-NOVOPROD-1227562$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241015051$24101505$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1227057$NOVO NORDISK$$70$YR$$$Y$$$20240717$$MD$US$US
241015061$24101506$1$I$20220101$20240517$20240717$20240717$PER$$US-NOVOPROD-1227105$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
241015071$24101507$1$I$$20240515$20240717$20240717$PER$$US-NOVOPROD-1227359$NOVO NORDISK$$62$YR$$M$Y$$$20240717$$MD$US$US
241015082$24101508$2$F$$20240918$20240717$20240919$EXP$$RU-JNJFOC-20240728138$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240919$$HP$RU$RU
241015093$24101509$3$F$$20240905$20240717$20240916$30DAY$$US-JNJFOC-20240733311$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$US$US
241015101$24101510$1$I$20220617$20240715$20240717$20240717$EXP$$AT-SANDOZ INC.-SDZ2024AT065237$SANDOZ$$29$YR$$M$Y$88.2$KG$20240717$$HP$AT$AT
241015111$24101511$1$I$20230101$20240715$20240717$20240717$EXP$NL-LRB-00981505$NL-JNJFOC-20240740213$JOHNSON AND JOHNSON$$72$YR$E$M$Y$98$KG$20240717$$MD$NL$NL
241015121$24101512$1$I$$20240708$20240717$20240717$EXP$$US-UCBSA-2024034842$UCB$$$$$F$Y$$$20240717$$HP$US$US
241015132$24101513$2$F$20211201$20240903$20240717$20240917$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-21282$SAMSUNG BIOEPIS$Kouranos V. The role of infliximab in treating refractory cardiac sarcoidosis. Case series and systematic review of literature. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 2024 Jun 28;41(2):E2024013: doi:https://doi.org/10.36141/svdld.v41i2.14484.$43$YR$A$M$Y$$$20240917$$MD$GB$GB
241015151$24101515$1$I$$20240514$20240717$20240717$PER$$US-NOVOPROD-1228864$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015161$24101516$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1228683$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015171$24101517$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1149844$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015181$24101518$1$I$20240418$20240517$20240717$20240717$PER$$US-NOVOPROD-1228673$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015191$24101519$1$I$20240520$20240520$20240717$20240717$PER$$US-NOVOPROD-1228674$NOVO NORDISK$$61$YR$$M$Y$$$20240717$$CN$US$US
241015201$24101520$1$I$$20231205$20240717$20240717$PER$$US-NOVOPROD-1149901$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015211$24101521$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1228693$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241015221$24101522$1$I$20240501$20240517$20240717$20240717$PER$$US-NOVOPROD-1228800$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
241015232$24101523$2$F$20230403$20231205$20240717$20240717$PER$$US-NOVOPROD-1149946$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$CN$US$US
241015241$24101524$1$I$$20231205$20240717$20240717$PER$$US-NOVOPROD-1149963$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015251$24101525$1$I$20231205$20231226$20240717$20240717$PER$$US-NOVOPROD-1149999$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241015261$24101526$1$I$$20231205$20240717$20240717$PER$$US-NOVOPROD-1149935$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241015271$24101527$1$I$$20240519$20240717$20240717$PER$$US-NOVOPROD-1228709$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241015281$24101528$1$I$$20231205$20240717$20240717$PER$$US-NOVOPROD-1149904$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241015291$24101529$1$I$20240501$20240610$20240717$20240717$PER$$US-NOVOPROD-1228690$NOVO NORDISK$$56$YR$$M$Y$$$20240717$$CN$US$US
241015301$24101530$1$I$$20240517$20240717$20240717$PER$$US-NOVOPROD-1228910$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$CN$US$US
241015311$24101531$1$I$$20240517$20240717$20240717$PER$$US-NOVOPROD-1228894$NOVO NORDISK$$$$$M$Y$$$20240717$$PH$US$US
241015321$24101532$1$I$$20240517$20240717$20240717$PER$$US-NOVOPROD-1228913$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241015331$24101533$1$I$$20231205$20240717$20240717$PER$$US-NOVOPROD-1149888$NOVO NORDISK$$30$YR$$F$Y$$$20240717$$MD$US$US
241015342$24101534$2$F$20230101$20240807$20240717$20240818$EXP$$DK-AUROBINDO-AUR-APL-2024-034028$AUROBINDO$$31$DY$$M$Y$5$KG$20240818$$MD$DK$DK
241015351$24101535$1$I$$20240712$20240717$20240717$EXP$$SG-BEIGENE-BGN-2024-010870$BEIGENE$$$$$$Y$$$20240717$$HP$SG$SG
241015361$24101536$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009606$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240717$$HP$US$US
241015371$24101537$1$I$$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010245$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240717$$CN$US$US
241015381$24101538$1$I$20240711$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008616$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240717$$CN$US$US
241015392$24101539$2$F$$20240716$20240717$20240723$PER$$US-JNJFOC-20240741089$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
241015401$24101540$1$I$20240101$20240710$20240717$20240717$PER$$US-JNJFOC-20240727086$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240717$$CN$US$US
241015411$24101541$1$I$20230829$20240706$20240717$20240717$EXP$$ES-AUROBINDO-AUR-APL-2024-033966$AUROBINDO$$63$YR$$F$Y$$$20240717$$MD$ES$ES
241015422$24101542$2$F$20240401$20240805$20240717$20240807$EXP$$AU-ABBVIE-5838121$ABBVIE$$64$YR$$M$Y$80$KG$20240807$$MD$AU$AU
241015431$24101543$1$I$$20191107$20240717$20240717$EXP$$US-AstraZeneca-2019SF60744$ASTRAZENECA$$53$YR$$F$Y$$$20240717$$CN$US$
241015441$24101544$1$I$$20200103$20240717$20240717$EXP$$US-AstraZeneca-2019SF46075$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241015451$24101545$1$I$$20240702$20240717$20240717$EXP$$AU-LUPIN HEALTHCARE (UK) LIMITED-2024-06228$LUPIN$$49$YR$$F$Y$$$20240717$$CN$AU$AU
241015461$24101546$1$I$$20200824$20240717$20240717$EXP$$US-AstraZeneca-2020SF09270$ASTRAZENECA$$59$YR$$F$Y$123.4$KG$20240717$$CN$US$
241015471$24101547$1$I$20231126$20240704$20240717$20240717$EXP$ES-AEMPS-1539108$ES-TEVA-VS-3217489$TEVA$$69$YR$$F$Y$$$20240717$$MD$ES$ES
241015481$24101548$1$I$$20200210$20240717$20240717$EXP$$US-AstraZeneca-2020SE22059$ASTRAZENECA$$$$$$Y$$$20240717$$HP$US$
241015491$24101549$1$I$$20200326$20240717$20240717$EXP$$US-AstraZeneca-2019SE17919$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241015501$24101550$1$I$20200108$20200124$20240717$20240717$EXP$$RU-AstraZeneca-2020SE13555$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$RU$
241015511$24101551$1$I$$20191114$20240717$20240717$EXP$$US-AstraZeneca-2019SF63458$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241015521$24101552$1$I$20230701$20231204$20240717$20240717$PER$$US-NOVOPROD-1150213$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015531$24101553$1$I$20231203$20231227$20240717$20240717$PER$$US-NOVOPROD-1150672$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241015541$24101554$1$I$$20231208$20240717$20240717$PER$$US-NOVOPROD-1150898$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241015551$24101555$1$I$20231101$20231207$20240717$20240717$PER$$US-NOVOPROD-1150651$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
241015562$24101556$2$F$20230814$20231227$20240717$20240717$PER$$US-NOVOPROD-1150001$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
241015571$24101557$1$I$$20240216$20240717$20240717$PER$$US-NOVOPROD-1150072$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015581$24101558$1$I$$20231201$20240717$20240717$PER$$US-NOVOPROD-1150294$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$CN$US$US
241015591$24101559$1$I$$20231207$20240717$20240717$PER$$US-NOVOPROD-1150552$NOVO NORDISK$$$$A$$Y$$$20240717$$PH$US$US
241015601$24101560$1$I$20231128$20231207$20240717$20240717$PER$$US-NOVOPROD-1151034$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015611$24101561$1$I$$20231204$20240717$20240717$PER$$US-NOVOPROD-1150764$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015621$24101562$1$I$$20231205$20240717$20240717$PER$$US-NOVOPROD-1151010$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015631$24101563$1$I$$20231226$20240717$20240717$PER$$US-NOVOPROD-1150432$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015641$24101564$1$I$$20240227$20240717$20240717$PER$$US-NOVOPROD-1150839$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241015651$24101565$1$I$$20231207$20240717$20240717$PER$$US-NOVOPROD-1150818$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015661$24101566$1$I$$20231208$20240717$20240717$PER$$US-NOVOPROD-1150915$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241015671$24101567$1$I$$20231206$20240717$20240717$PER$$US-NOVOPROD-1150661$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241015681$24101568$1$I$$20231206$20240717$20240717$PER$$US-NOVOPROD-1150940$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241015691$24101569$1$I$$20231208$20240717$20240717$PER$$US-NOVOPROD-1151029$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015701$24101570$1$I$$20231206$20240717$20240717$PER$$US-NOVOPROD-1150243$NOVO NORDISK$$53$YR$$$Y$$$20240717$$CN$US$US
241015711$24101571$1$I$$20200212$20240717$20240717$EXP$$US-AstraZeneca-2020SE23925$ASTRAZENECA$$$$$F$Y$$$20240717$$HP$US$
241015721$24101572$1$I$$20200130$20240717$20240717$EXP$$US-AstraZeneca-2020SE16154$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241015731$24101573$1$I$20240708$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160468$ASTRAZENECA$$27416$DY$$F$Y$$$20240717$$CN$US$
241015741$24101574$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157773$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241015751$24101575$1$I$$20191216$20240717$20240717$EXP$$CA-AstraZeneca-2019SE88430$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CA$
241015763$24101576$3$F$20240705$20240715$20240717$20240905$PER$$US-ROCHE-10000025965$ROCHE$$67$YR$E$M$Y$145.15$KG$20240905$$CN$US$US
241015772$24101577$2$F$20240701$20240819$20240717$20240822$PER$$US-AMGEN-USASP2024138849$AMGEN$$63$YR$A$F$Y$$$20240821$$PH$US$US
241015782$24101578$2$F$$20240710$20240717$20240724$PER$$US-AstraZeneca-2024A161572$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241015791$24101579$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-10000022461$ROCHE$Gerstner E, Choi B, Curry W. Infusion of CARv3-TEAM-E T Cells in Glioblastoma. Reply. The New England journal of medicine. 2024-Jun-27;390 (24):2330-2331. doi:10.1056/NEJMc2405721.$$$$M$Y$$$20240717$$MD$US$US
241015801$24101580$1$I$$20240702$20240717$20240717$EXP$$AU-LUPIN EUROPE GMBH-2024-06109$LUPIN$$$$$$Y$$$20240717$$CN$AU$AU
241015811$24101581$1$I$$20231207$20240717$20240717$PER$$US-NOVOPROD-1151196$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015821$24101582$1$I$$20240426$20240717$20240717$PER$$US-NOVOPROD-1218145$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241015831$24101583$1$I$$20240429$20240717$20240717$PER$$US-NOVOPROD-1218289$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015841$24101584$1$I$$20230925$20240717$20240717$PER$$US-NOVOPROD-1218347$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015851$24101585$1$I$$20240429$20240717$20240717$PER$$US-NOVOPROD-1218107$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241015861$24101586$1$I$20240427$20240509$20240717$20240717$PER$$US-NOVOPROD-1218204$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015871$24101587$1$I$20240328$20240429$20240717$20240717$PER$$US-NOVOPROD-1218083$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241015881$24101588$1$I$$20230927$20240717$20240717$PER$$US-NOVOPROD-1218328$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015891$24101589$1$I$$20240503$20240717$20240717$PER$$US-NOVOPROD-1217981$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241015901$24101590$1$I$$20240426$20240717$20240717$PER$$US-NOVOPROD-1217995$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241015911$24101591$1$I$$20231205$20240717$20240717$PER$$US-NOVOPROD-1151208$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241015921$24101592$1$I$$20240426$20240717$20240717$PER$$US-NOVOPROD-1218136$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015931$24101593$1$I$$20240429$20240717$20240717$PER$$US-NOVOPROD-1218200$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241015941$24101594$1$I$$20231002$20240717$20240717$PER$$US-NOVOPROD-1218321$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241015951$24101595$1$I$$20240426$20240717$20240717$PER$$US-NOVOPROD-1218142$NOVO NORDISK$$$$$$Y$$$20240717$$HP$US$US
241015961$24101596$1$I$20240420$20240523$20240717$20240717$PER$$US-NOVOPROD-1217973$NOVO NORDISK$$62$YR$$F$Y$78.005$KG$20240717$$HP$US$US
241015971$24101597$1$I$20240430$20240610$20240717$20240717$PER$$US-NOVOPROD-1218412$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
241015981$24101598$1$I$$20230929$20240717$20240717$PER$$US-NOVOPROD-1218362$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241015991$24101599$1$I$$20230928$20240717$20240717$PER$$US-NOVOPROD-1218004$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241016001$24101600$1$I$20240420$20240429$20240717$20240717$PER$$US-NOVOPROD-1218178$NOVO NORDISK$$72$YR$$M$Y$$$20240717$$MD$US$US
241016011$24101601$1$I$$20240429$20240717$20240717$PER$$US-NOVOPROD-1218211$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016021$24101602$1$I$20240429$20240429$20240717$20240717$PER$$US-NOVOPROD-1218177$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$MD$US$US
241016031$24101603$1$I$20240429$20240429$20240717$20240717$PER$$US-NOVOPROD-1218291$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
241016041$24101604$1$I$$20240429$20240717$20240717$PER$$US-NOVOPROD-1218297$NOVO NORDISK$$32$YR$$F$Y$$$20240717$$MD$US$US
241016051$24101605$1$I$$20231211$20240717$20240717$PER$$US-NOVOPROD-1151156$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016061$24101606$1$I$20240201$20240426$20240717$20240717$PER$$US-NOVOPROD-1218059$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241016072$24101607$2$F$20240710$20240821$20240717$20240826$PER$$US-JNJFOC-20240726987$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20240826$$CN$US$US
241016082$24101608$2$F$20240523$20240917$20240717$20240919$EXP$$US-JNJFOC-20240739011$JOHNSON AND JOHNSON$$67$YR$E$$Y$$$20240919$$MD$US$US
241016092$24101609$2$F$20240709$20240924$20240717$20240927$EXP$$US-JNJFOC-20240723417$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240927$$CN$US$US
241016101$24101610$1$I$$20240708$20240717$20240717$EXP$$TR-Encube-000817$ENCUBE ETHICALS$Sen EK, Berberoglu M, Senyazar G, Kizilcan Cetin S, Ceran A, Erisen Karaca S, Ozsu E, Aycan Z, Siklar Z. Assessment of the Admission and Follow-up Characteristics of Children Diagnosed with Secondary Osteoporosis. J Clin Res Pediatr Endocrinol. 2024 Jul 2. doi: 10.4274/jcrpe.galenos.2024.2024-4-4. Epub ahead of print. PMID: 38953735.$$$$$Y$$$20240716$$MD$TR$
241016121$24101612$1$I$$20240709$20240717$20240717$EXP$$US-GSK-US2024084983$GLAXOSMITHKLINE$$$$$F$Y$$$20240717$$HP$US$US
241016132$24101613$2$F$$20240731$20240717$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113097$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240805$$CN$US$US
241016141$24101614$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112502$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$72.12$KG$20240717$$CN$US$US
241016151$24101615$1$I$$20240702$20240717$20240717$EXP$$GB-LUPIN EUROPE GMBH-2024-05977$LUPIN$$$$$$Y$$$20240717$$HP$GB$GB
241016161$24101616$1$I$20240617$20240712$20240717$20240717$EXP$$CN-BEIGENE-BGN-2024-010909$BEIGENE$$$$$$Y$$$20240717$$HP$CN$CN
241016171$24101617$1$I$20240321$20240430$20240717$20240717$PER$$US-NOVOPROD-1218576$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241016181$24101618$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1227744$NOVO NORDISK$$$$E$M$Y$$$20240717$$HP$US$US
241016191$24101619$1$I$$20240515$20240717$20240717$PER$$US-NOVOPROD-1228004$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241016201$24101620$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1227815$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016211$24101621$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1227780$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241016221$24101622$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1227869$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016231$24101623$1$I$$20230927$20240717$20240717$PER$$US-NOVOPROD-1218420$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016241$24101624$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1218599$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241016251$24101625$1$I$$20240508$20240717$20240717$PER$$US-NOVOPROD-1218620$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241016261$24101626$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1227739$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016271$24101627$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1227685$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016281$24101628$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1218541$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241016291$24101629$1$I$$20240515$20240717$20240717$PER$$US-NOVOPROD-1227984$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016301$24101630$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1218611$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241016311$24101631$1$I$20221014$20240430$20240717$20240717$PER$$US-NOVOPROD-1218671$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
241016321$24101632$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1218415$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241016331$24101633$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1218708$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241016341$24101634$1$I$20240515$20240516$20240717$20240717$PER$$US-NOVOPROD-1228019$NOVO NORDISK$$77$YR$$M$Y$$$20240717$$CN$US$US
241016351$24101635$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1218696$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241016361$24101636$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1227852$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016371$24101637$1$I$20240401$20240516$20240717$20240717$PER$$US-NOVOPROD-1227926$NOVO NORDISK$$82$YR$$M$Y$$$20240717$$CN$US$US
241016381$24101638$1$I$$20230707$20240717$20240717$PER$$US-NOVOPROD-1218714$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241016391$24101639$1$I$$20230918$20240717$20240717$PER$$US-NOVOPROD-1218702$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241016402$24101640$2$F$$20240708$20240717$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457078$RANBAXY$Li S, Halloran P, Siref A. Concurrent Neutrophilic Eccrine Hidradenitis and Leukocytoclastic Vasculitis. Am J Dermatopathol. 2024;46(7):S20$58$YR$$F$Y$$$20240723$$MD$US$US
241016411$24101641$1$I$20240626$20240706$20240717$20240717$EXP$$DE-AUROBINDO-AUR-APL-2024-034018$AUROBINDO$$71$YR$$F$Y$53$KG$20240717$$MD$DE$DE
241016421$24101642$1$I$$20200223$20240717$20240717$EXP$$US-AstraZeneca-2020SE25628$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241016432$24101643$2$F$$20240716$20240717$20240731$PER$$US-AstraZeneca-2024A160067$ASTRAZENECA$$$$$M$Y$$$20240731$$PH$US$
241016441$24101644$1$I$$20200203$20240717$20240717$EXP$$US-AstraZeneca-2020SE17961$ASTRAZENECA$$$$$M$Y$79.4$KG$20240717$$CN$US$
241016451$24101645$1$I$$20200206$20240717$20240717$EXP$$US-AstraZeneca-2020SE19870$ASTRAZENECA$$$$$F$Y$$$20240717$$HP$US$
241016461$24101646$1$I$20240428$20240516$20240717$20240717$PER$$US-NOVOPROD-1228026$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241016471$24101647$1$I$$20240530$20240717$20240717$PER$$US-AJANTA-2024AJA00106$AJANTA PHARMA$$$$$M$Y$$$20240716$$CN$US$US
241016481$24101648$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1228458$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241016491$24101649$1$I$$20231012$20240717$20240717$PER$$US-NOVOPROD-1228302$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016501$24101650$1$I$20240401$20240517$20240717$20240717$PER$$US-NOVOPROD-1228183$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
241016511$24101651$1$I$$20240517$20240717$20240717$PER$$US-NOVOPROD-1228124$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016521$24101652$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1228221$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241016531$24101653$1$I$20240301$20240517$20240717$20240717$PER$$US-NOVOPROD-1228110$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241016541$24101654$1$I$20240401$20240517$20240717$20240717$PER$$US-NOVOPROD-1228163$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241016551$24101655$1$I$$20240517$20240717$20240717$PER$$US-NOVOPROD-1228535$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241016561$24101656$1$I$20240325$20240527$20240717$20240717$PER$$US-NOVOPROD-1228107$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
241016571$24101657$1$I$20240514$20240517$20240717$20240717$PER$$US-NOVOPROD-1228602$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241016581$24101658$1$I$$20240517$20240717$20240717$PER$$US-NOVOPROD-1228512$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016591$24101659$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1228139$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016601$24101660$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1228600$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241016611$24101661$1$I$$20240517$20240717$20240717$PER$$US-NOVOPROD-1228102$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241016621$24101662$1$I$$20240517$20240717$20240717$PER$$US-NOVOPROD-1228140$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241016631$24101663$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1228213$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016641$24101664$1$I$20240506$20240517$20240717$20240717$PER$$US-NOVOPROD-1228438$NOVO NORDISK$$82$YR$$M$Y$$$20240717$$CN$US$US
241016651$24101665$1$I$20240401$20240701$20240717$20240717$PER$$US-NOVOPROD-1228150$NOVO NORDISK$$78$YR$$M$Y$$$20240717$$CN$US$US
241016661$24101666$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1228363$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241016671$24101667$1$I$$20240516$20240717$20240717$PER$$US-NOVOPROD-1228208$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241016681$24101668$1$I$$20240712$20240717$20240717$EXP$$JP-ABBVIE-5842322$ABBVIE$$60$YR$$M$Y$$$20240717$$MD$JP$JP
241016692$24101669$2$F$$20240715$20240717$20240717$EXP$$US-ROCHE-10000027574$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241016701$24101670$1$I$20171101$20240712$20240717$20240717$EXP$$US-ROCHE-3578456$ROCHE$$43$YR$A$F$Y$80$KG$20240717$$PH$US$UM
241016711$24101671$1$I$20240501$20240706$20240717$20240717$EXP$$FR-AUROBINDO-AUR-APL-2024-034009$AUROBINDO$$66$YR$$M$Y$79$KG$20240717$$MD$FR$FR
241016721$24101672$1$I$$20240710$20240717$20240717$EXP$$US-JNJFOC-20240728403$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241016731$24101673$1$I$20240601$20240710$20240717$20240717$EXP$$CA-JNJFOC-20240736393$JOHNSON AND JOHNSON$$89$YR$$F$Y$$$20240717$$CN$CA$CA
241016742$24101674$2$F$$20240807$20240717$20240816$30DAY$$FR-JNJFOC-20240733654$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$PH$FR$FR
241016753$24101675$3$F$20230101$20240805$20240717$20240806$EXP$$DE-JNJFOC-20240737007$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240806$$MD$DE$DE
241016761$24101676$1$I$20240515$20240517$20240717$20240717$PER$$US-NOVOPROD-1228605$NOVO NORDISK$$54$YR$$F$Y$$$20240717$$CN$US$US
241016771$24101677$1$I$$20240709$20240717$20240717$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005160$BIOCON$$$$$$Y$$$20240717$$CN$CA$CA
241016781$24101678$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1218877$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241016791$24101679$1$I$20240613$20240706$20240717$20240717$EXP$$FR-AUROBINDO-AUR-APL-2024-033889$AUROBINDO$$32$YR$$M$Y$76$KG$20240717$$PH$FR$FR
241016801$24101680$1$I$$20240501$20240717$20240717$PER$$US-NOVOPROD-1218868$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241016811$24101681$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1218771$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241016821$24101682$1$I$20240401$20240507$20240717$20240717$PER$$US-NOVOPROD-1218796$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
241016831$24101683$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1218718$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016841$24101684$1$I$20240516$20240517$20240717$20240717$PER$$US-NOVOPROD-1228655$NOVO NORDISK$$82$YR$$F$Y$$$20240717$$CN$US$US
241016851$24101685$1$I$$20230920$20240717$20240717$PER$$US-NOVOPROD-1219019$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
241016861$24101686$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1218715$NOVO NORDISK$$$$A$M$Y$$$20240717$$MD$US$US
241016871$24101687$1$I$$20230925$20240717$20240717$PER$$US-NOVOPROD-1218783$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016881$24101688$1$I$20230504$20240506$20240717$20240717$PER$$US-NOVOPROD-1219155$NOVO NORDISK$$48$YR$$F$Y$$$20240717$$CN$US$US
241016891$24101689$1$I$$20230918$20240717$20240717$PER$$US-NOVOPROD-1218830$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241016901$24101690$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1218977$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241016911$24101691$1$I$$20240429$20240717$20240717$PER$$US-NOVOPROD-1218790$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241016921$24101692$1$I$20240201$20240430$20240717$20240717$PER$$US-NOVOPROD-1218860$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241016931$24101693$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1218931$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241016941$24101694$1$I$20240401$20240430$20240717$20240717$PER$$US-NOVOPROD-1218743$NOVO NORDISK$$78$YR$$M$Y$$$20240717$$CN$US$US
241016951$24101695$1$I$20231013$20231013$20240717$20240717$PER$$US-NOVOPROD-1218767$NOVO NORDISK$$75$YR$$$Y$$$20240717$$CN$US$US
241016961$24101696$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1218724$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241016971$24101697$1$I$20231202$20240516$20240717$20240717$PER$$US-NOVOPROD-1218849$NOVO NORDISK$$56$YR$$M$Y$$$20240717$$CN$US$US
241016981$24101698$1$I$20240429$20240607$20240717$20240717$PER$$US-NOVOPROD-1219109$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241016991$24101699$1$I$20240424$20240430$20240717$20240717$PER$$US-NOVOPROD-1218752$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017001$24101700$1$I$$20240628$20240717$20240717$PER$$US-NOVOPROD-1219133$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241017011$24101701$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1219157$NOVO NORDISK$$59$YR$$$Y$$$20240717$$CN$US$US
241017021$24101702$1$I$$20240708$20240717$20240717$EXP$$JP-ROCHE-10000025204$ROCHE$Takada N, Fukui T, Irie H, Funatsu Y, Koh H. Immune Checkpoint Inhibitor-induced Sclerosing Cholangitis: Three Cases Reported from Our Hospital. Japanese Journal of Lung Cancer. 2024;63 (3):193-9.$69$YR$E$M$Y$$$20240717$$MD$JP$JP
241017032$24101703$2$F$$20240710$20240717$20240717$EXP$$US-ROCHE-10000024996$ROCHE$$$$A$M$Y$$$20240717$$CN$US$US
241017041$24101704$1$I$$20240709$20240717$20240717$PER$$US-AMGEN-USASP2024136581$AMGEN$Saleh Z.F.; Saleh Z.. Anti-NXP2 antibody positive dermatomyositis presenting as unilateral heliotrope rash. JAAD Case Reports. 2024;50:25-29$58$YR$A$F$Y$$$20240717$$MD$US$US
241017051$24101705$1$I$20240601$20240709$20240717$20240717$EXP$FR-AFSSAPS-NT2024000781$FR-TEVA-VS-3219525$TEVA$$90$YR$$F$Y$74$KG$20240717$$PH$FR$FR
241017061$24101706$1$I$20240219$20240708$20240717$20240717$EXP$FR-AFSSAPS-CN2024000584$FR-TEVA-VS-3218743$TEVA$$21$YR$$F$Y$$$20240717$$PH$FR$FR
241017074$24101707$4$F$$20240814$20240717$20240816$PER$$US-ROCHE-10000026885$ROCHE$$$$A$F$Y$48.6$KG$20240816$$CN$US$US
241017081$24101708$1$I$$20240626$20240717$20240717$EXP$$LB-ROCHE-10000024585$ROCHE$$81$YR$E$M$Y$70$KG$20240717$$MD$LB$LB
241017091$24101709$1$I$$20240501$20240717$20240717$PER$$US-NOVOPROD-1219351$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017101$24101710$1$I$20240430$20240506$20240717$20240717$PER$$US-NOVOPROD-1219275$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
241017111$24101711$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1219662$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017121$24101712$1$I$20220101$20240501$20240717$20240717$PER$$US-NOVOPROD-1219202$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017131$24101713$1$I$20240424$20240514$20240717$20240717$PER$$US-NOVOPROD-1219555$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241017141$24101714$1$I$20240101$20240501$20240717$20240717$PER$$US-NOVOPROD-1219584$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
241017151$24101715$1$I$$20231003$20240717$20240717$PER$$US-NOVOPROD-1219205$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241017161$24101716$1$I$20240424$20240508$20240717$20240717$PER$$US-NOVOPROD-1219670$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
241017171$24101717$1$I$20240201$20240501$20240717$20240717$PER$$US-NOVOPROD-1219585$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017181$24101718$1$I$20240423$20240501$20240717$20240717$PER$$US-NOVOPROD-1219342$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241017191$24101719$1$I$20240101$20240501$20240717$20240717$PER$$US-NOVOPROD-1219664$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
241017201$24101720$1$I$$20230920$20240717$20240717$PER$$US-NOVOPROD-1219209$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241017212$24101721$2$F$$20240724$20240717$20240806$EXP$$DE-AUROBINDO-AUR-APL-2024-034089$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299?313$35$YR$$M$Y$$$20240806$$HP$DE$DE
241017221$24101722$1$I$$20240501$20240717$20240717$PER$$US-NOVOPROD-1219277$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017231$24101723$1$I$$20240501$20240717$20240717$PER$$US-NOVOPROD-1219736$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017241$24101724$1$I$$20240501$20240717$20240717$PER$$US-NOVOPROD-1219359$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017252$24101725$2$F$20231201$20240501$20240717$20240717$PER$$US-NOVOPROD-1219667$NOVO NORDISK$$86$YR$$M$Y$$$20240717$$CN$US$US
241017261$24101726$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1219715$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241017271$24101727$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1219638$NOVO NORDISK$$$$E$$Y$$$20240717$$CN$US$US
241017281$24101728$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1219629$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
241017291$24101729$1$I$$20240712$20240717$20240717$EXP$$US-UCBSA-2024035727$UCB$$$$$F$Y$99.32$KG$20240717$$HP$US$US
241017301$24101730$1$I$$20240715$20240717$20240717$EXP$$AU-SANDOZ INC.-SDZ2024AU065408$SANDOZ$$$$$$Y$$$20240717$$HP$AU$AU
241017312$24101731$2$F$$20240803$20240717$20240809$EXP$$KZ-HETERO-HET2024KZ02252$HETERO$$$$$F$Y$$$20240809$$HP$KZ$KZ
241017321$24101732$1$I$20240711$20240712$20240717$20240717$PER$$US-ORGANON-O2407USA001362$ORGANON$$37$YR$$F$Y$$$20240717$$HP$US$US
241017332$24101733$2$F$20240117$20240731$20240717$20240815$EXP$$GB-CELLTRION INC.-2024GB016946$CELLTRION$$$$$$Y$$$20240815$$MD$GB$GB
241017341$24101734$1$I$$20240715$20240717$20240717$EXP$$US-ABBVIE-5841782$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241017351$24101735$1$I$20230810$20240706$20240717$20240717$EXP$$IT-AUROBINDO-AUR-APL-2024-034190$AUROBINDO$$68$YR$$M$Y$$$20240717$$MD$IT$IT
241017361$24101736$1$I$$20240711$20240717$20240717$EXP$$CA-ABBVIE-5838854$ABBVIE$$$$A$M$Y$$$20240717$$HP$CA$CA
241017371$24101737$1$I$$20240502$20240717$20240717$PER$$US-NOVOPROD-1219926$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017381$24101738$1$I$20240401$20240501$20240717$20240717$PER$$US-NOVOPROD-1220028$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
241017391$24101739$1$I$$20230919$20240717$20240717$PER$$US-NOVOPROD-1220300$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241017401$24101740$1$I$$20240501$20240717$20240717$PER$$US-NOVOPROD-1219759$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241017411$24101741$1$I$$20240501$20240717$20240717$PER$$US-NOVOPROD-1219813$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241017421$24101742$1$I$20240417$20240501$20240717$20240717$PER$$US-NOVOPROD-1220124$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
241017431$24101743$1$I$$20230811$20240717$20240717$PER$$US-NOVOPROD-1219945$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241017441$24101744$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1219769$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017451$24101745$1$I$$20240502$20240717$20240717$PER$$US-NOVOPROD-1220211$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241017461$24101746$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1219793$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241017471$24101747$1$I$$20240501$20240717$20240717$PER$$US-NOVOPROD-1220048$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241017481$24101748$1$I$20240401$20240501$20240717$20240717$PER$$US-NOVOPROD-1219832$NOVO NORDISK$$43$YR$$F$Y$$$20240717$$CN$US$US
241017491$24101749$1$I$$20240501$20240717$20240717$PER$$US-NOVOPROD-1219775$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017501$24101750$1$I$20240201$20240501$20240717$20240717$PER$$US-NOVOPROD-1220288$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
241017511$24101751$1$I$20240105$20240507$20240717$20240717$PER$$US-NOVOPROD-1219970$NOVO NORDISK$$49$YR$$F$Y$$$20240717$$CN$US$US
241017521$24101752$1$I$$20240502$20240717$20240717$PER$$US-NOVOPROD-1220248$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241017531$24101753$1$I$20240326$20240501$20240717$20240717$PER$$US-NOVOPROD-1220416$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241017541$24101754$1$I$$20230927$20240717$20240717$PER$$US-NOVOPROD-1220096$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017551$24101755$1$I$20230901$20240506$20240717$20240717$PER$$US-NOVOPROD-1220400$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
241017561$24101756$1$I$$20240430$20240717$20240717$PER$$US-NOVOPROD-1219737$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241017571$24101757$1$I$20240101$20240711$20240717$20240717$EXP$$US-ABBVIE-5838705$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241017581$24101758$1$I$20220427$20240704$20240717$20240717$EXP$$FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2024-019315$VALIDUS$$$$$$Y$$$20240717$$MD$FR$FR
241017592$24101759$2$F$20220101$20240801$20240717$20240808$EXP$$US-ABBVIE-5839661$ABBVIE$$58$YR$$M$Y$$$20240808$$CN$US$US
241017601$24101760$1$I$20240530$20240712$20240717$20240717$EXP$$JP-009507513-2407JPN002421J$MERCK$$22$YR$$F$Y$46$KG$20240717$$PH$JP$JP
241017611$24101761$1$I$20240101$20240712$20240717$20240717$EXP$$CA-ABBVIE-5841695$ABBVIE$$69$YR$$F$Y$$$20240717$$CN$CA$CA
241017621$24101762$1$I$$20240702$20240717$20240717$EXP$$AU-LUPIN EUROPE GMBH-2024-06107$LUPIN$$$$$$Y$$$20240717$$CN$AU$AU
241017631$24101763$1$I$$20240702$20240717$20240717$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-06221$LUPIN$$$$$$Y$$$20240717$$CN$AU$AU
241017642$24101764$2$F$20240420$20240801$20240717$20240806$PER$$NVSC2024US146800$NOVARTIS$$66$YR$$M$Y$$$20240806$$HP$US$US
241017651$24101765$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024138690$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
241017661$24101766$1$I$$20240503$20240717$20240717$PER$$US-NOVOPROD-1220937$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241017671$24101767$1$I$$20230809$20240717$20240717$PER$$US-NOVOPROD-1220838$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241017681$24101768$1$I$20240503$20240503$20240717$20240717$PER$$US-NOVOPROD-1221297$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241017691$24101769$1$I$20240411$20240528$20240717$20240717$PER$$US-NOVOPROD-1220953$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241017701$24101770$1$I$$20240503$20240717$20240717$PER$$US-NOVOPROD-1220889$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017711$24101771$1$I$20220801$20240503$20240717$20240717$PER$$US-NOVOPROD-1221038$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241017721$24101772$1$I$$20240501$20240717$20240717$PER$$US-NOVOPROD-1220642$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241017731$24101773$1$I$$20230913$20240717$20240717$PER$$US-NOVOPROD-1220824$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017741$24101774$1$I$20240501$20240501$20240717$20240717$PER$$US-NOVOPROD-1220545$NOVO NORDISK$$83$YR$$M$Y$$$20240717$$CN$US$US
241017751$24101775$1$I$$20240503$20240717$20240717$PER$$US-NOVOPROD-1221243$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241017761$24101776$1$I$$20240502$20240717$20240717$PER$$US-NOVOPROD-1220429$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017771$24101777$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1221160$NOVO NORDISK$$$$$$Y$$$20240717$$LW$US$US
241017781$24101778$1$I$$20240503$20240717$20240717$PER$$US-NOVOPROD-1221135$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241017791$24101779$1$I$20230101$20240502$20240717$20240717$PER$$US-NOVOPROD-1220534$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241017801$24101780$1$I$$20240501$20240717$20240717$PER$$US-NOVOPROD-1220450$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241017811$24101781$1$I$20240101$20240507$20240717$20240717$PER$$US-NOVOPROD-1220626$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$MD$US$US
241017821$24101782$1$I$20230911$20230914$20240717$20240717$PER$$US-NOVOPROD-1220871$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241017831$24101783$1$I$20240425$20240523$20240717$20240717$PER$$US-NOVOPROD-1221053$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017841$24101784$1$I$20240505$20240506$20240717$20240717$PER$$US-NOVOPROD-1220751$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241017851$24101785$1$I$$20240503$20240717$20240717$PER$$US-NOVOPROD-1220932$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241017861$24101786$1$I$20230401$20240514$20240717$20240717$PER$$US-NOVOPROD-1220977$NOVO NORDISK$$52$YR$$F$Y$$$20240717$$CN$US$US
241017871$24101787$1$I$20240417$20240502$20240717$20240717$PER$$US-NOVOPROD-1220686$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241017881$24101788$1$I$20240101$20240503$20240717$20240717$PER$$US-NOVOPROD-1221342$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241017891$24101789$1$I$$20240715$20240717$20240717$EXP$$KZ-ROCHE-10000028358$ROCHE$$58$YR$A$$Y$$$20240717$$MD$KZ$KZ
241017901$24101790$1$I$$20190702$20240717$20240717$EXP$$US-AstraZeneca-2019SE96265$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241017911$24101791$1$I$$20240709$20240717$20240717$EXP$$JP-ROCHE-3472149$ROCHE$$9$DEC$E$$Y$$$20240717$$MD$JP$JP
241017921$24101792$1$I$$20191206$20240717$20240717$EXP$$US-AstraZeneca-2019SF71639$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241017931$24101793$1$I$$20190701$20240717$20240717$EXP$$US-AstraZeneca-2019SE96982$ASTRAZENECA$$$$$$Y$$$20240717$$CN$US$
241017941$24101794$1$I$$20230710$20240717$20240717$PER$$US-NOVOPROD-1221580$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017952$24101795$2$F$$20230926$20240717$20240717$PER$$US-NOVOPROD-1221486$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241017961$24101796$1$I$$20240503$20240717$20240717$PER$$US-NOVOPROD-1221593$NOVO NORDISK$$52$YR$$F$Y$$$20240717$$CN$US$US
241017971$24101797$1$I$20240301$20240524$20240717$20240717$PER$$US-NOVOPROD-1221406$NOVO NORDISK$$83$YR$$F$Y$$$20240717$$CN$US$US
241017981$24101798$1$I$$20230914$20240717$20240717$PER$$US-NOVOPROD-1221628$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241017991$24101799$1$I$$20200303$20240717$20240717$EXP$$CA-AstraZeneca-2020SE28255$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CA$
241018001$24101800$1$I$$20240503$20240717$20240717$PER$$US-NOVOPROD-1221488$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241018011$24101801$1$I$$20240507$20240717$20240717$PER$$US-NOVOPROD-1221463$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241018021$24101802$1$I$20240503$20240503$20240717$20240717$PER$$US-NOVOPROD-1221503$NOVO NORDISK$$76$YR$$M$Y$$$20240717$$CN$US$US
241018031$24101803$1$I$20240426$20240503$20240717$20240717$PER$$US-NOVOPROD-1221345$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241018041$24101804$1$I$20210324$20240508$20240717$20240717$PER$$US-NOVOPROD-1221520$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
241018051$24101805$1$I$20240301$20240606$20240717$20240717$PER$$US-NOVOPROD-1221784$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
241018061$24101806$1$I$20240502$20240503$20240717$20240717$PER$$US-NOVOPROD-1221707$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241018071$24101807$1$I$$20240504$20240717$20240717$PER$$US-NOVOPROD-1221738$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018081$24101808$1$I$$20230926$20240717$20240717$PER$$US-NOVOPROD-1221455$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018091$24101809$1$I$20190310$20191011$20240717$20240717$EXP$$US-AstraZeneca-2019SE26683$ASTRAZENECA$$24597$DY$$F$Y$$$20240717$$CN$US$
241018101$24101810$1$I$20230501$20240505$20240717$20240717$PER$$US-NOVOPROD-1221732$NOVO NORDISK$$33$YR$$F$Y$$$20240717$$CN$US$US
241018111$24101811$1$I$$20240109$20240717$20240717$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000315$STRIDES$$$$$F$Y$49.887$KG$20240717$$CN$US$US
241018121$24101812$1$I$$20200304$20240717$20240717$EXP$$US-AstraZeneca-2020SE34804$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241018131$24101813$1$I$20211022$20240706$20240717$20240717$EXP$FR-AFSSAPS-AM2024000546$FR-AUROBINDO-AUR-APL-2024-033914$AUROBINDO$$91$YR$$F$Y$45.4$KG$20240717$$MD$FR$FR
241018141$24101814$1$I$$20240710$20240717$20240717$EXP$NL-LRB-00976743$NL-AMAROX PHARMA-AMR2024NL02238$HETERO$$55$YR$$M$Y$108$KG$20240717$$CN$NL$NL
241018151$24101815$1$I$$20240712$20240717$20240717$PER$$US-JNJFOC-20161214742$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$LW$US$US
241018161$24101816$1$I$$20240711$20240717$20240717$EXP$$GB-JNJFOC-20240736064$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240717$$CN$GB$GB
241018171$24101817$1$I$20240208$20240712$20240717$20240717$EXP$$AU-TAKEDA-2024TUS013061$TAKEDA$$46$YR$$F$Y$$$20240717$$CN$AU$AU
241018181$24101818$1$I$$20240706$20240717$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-034692$AUROBINDO$Ainab I, Sandhu A, D. Varosy P; Cerbin L; A. Rosenberg M; Z. Tumolo A, et al.. Be Still My New Beating Heart: A Case Of Atrial Standstill Following Orthotopic Heart Transplantation.. Heart Rhythm. 2024;Vol 21, No 5S:S598-S599$50$YR$$F$Y$$$20240717$$HP$US$US
241018192$24101819$2$F$20240212$20240212$20240717$20240717$PER$$US-NOVOPROD-1180418$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
241018201$24101820$1$I$$20230926$20240717$20240717$PER$$US-NOVOPROD-1125121$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241018211$24101821$1$I$$20240215$20240717$20240717$PER$$US-NOVOPROD-1180441$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241018221$24101822$1$I$$20230927$20240717$20240717$PER$$US-NOVOPROD-1126093$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241018231$24101823$1$I$$20240702$20240717$20240717$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202407-000026$AZURITY PHARMACEUTICALS$Xu E, Thomas S, Habibi B.. Intrathecal Methotrexate-Induced Lumbosacral Polyradiculopathy: A Case Report. Pain Medicine Case Reports. 2024;8 (1):31-5$69$YR$$F$Y$$$20240717$$MD$US$US
241018241$24101824$1$I$20230101$20240213$20240717$20240717$PER$$US-NOVOPROD-1180442$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241018251$24101825$1$I$$20240220$20240717$20240717$PER$$US-NOVOPROD-1180520$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018261$24101826$1$I$20231108$20240220$20240717$20240717$PER$$US-NOVOPROD-1180538$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
241018273$24101827$3$F$20240115$20240911$20240717$20240925$EXP$$US-NOVOPROD-1180409$NOVO NORDISK$$82$YR$$F$Y$$$20240925$$CN$US$US
241018281$24101828$1$I$$20240709$20240717$20240717$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005114$BIOCON$$$$$$Y$$$20240717$$HP$CA$CA
241018291$24101829$1$I$$20240215$20240717$20240717$PER$$US-NOVOPROD-1180422$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018301$24101830$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008019$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241018312$24101831$2$F$20230301$20240408$20240717$20240721$PER$$US-NOVOPROD-1181457$NOVO NORDISK$$43$YR$$F$Y$$$20240721$$CN$US$US
241018321$24101832$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1181398$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241018331$24101833$1$I$$20240219$20240717$20240717$PER$$US-NOVOPROD-1180904$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018341$24101834$1$I$$20240219$20240717$20240717$PER$$US-NOVOPROD-1180838$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241018351$24101835$1$I$$20240219$20240717$20240717$PER$$US-NOVOPROD-1180583$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241018361$24101836$1$I$20240203$20240219$20240717$20240717$PER$$US-NOVOPROD-1180937$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018372$24101837$2$F$20231001$20240219$20240717$20240717$PER$$US-NOVOPROD-1180566$NOVO NORDISK$$74$YR$$$Y$$$20240717$$CN$US$US
241018381$24101838$1$I$$20240220$20240717$20240717$PER$$US-NOVOPROD-1180635$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018391$24101839$1$I$$20240220$20240717$20240717$PER$$US-NOVOPROD-1180642$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$HP$US$US
241018401$24101840$1$I$20240212$20240305$20240717$20240717$PER$$US-NOVOPROD-1180835$NOVO NORDISK$$54$YR$$M$Y$$$20240717$$CN$US$US
241018411$24101841$1$I$$20240220$20240717$20240717$PER$$US-NOVOPROD-1180639$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018421$24101842$1$I$20240219$20240220$20240717$20240717$PER$$US-NOVOPROD-1180622$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241018431$24101843$1$I$20240101$20240221$20240717$20240717$PER$$US-NOVOPROD-1181549$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241018441$24101844$1$I$$20240219$20240717$20240717$PER$$US-NOVOPROD-1180841$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241018451$24101845$1$I$20230201$20240219$20240717$20240717$PER$$US-NOVOPROD-1180796$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018461$24101846$1$I$20230119$20240220$20240717$20240717$PER$$US-NOVOPROD-1180613$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241018471$24101847$1$I$$20240517$20240717$20240717$PER$$US-NOVOPROD-1180608$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241018481$24101848$1$I$20231201$20240504$20240717$20240717$PER$$US-NOVOPROD-1217961$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
241018491$24101849$1$I$$20240219$20240717$20240717$PER$$US-NOVOPROD-1180828$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241018501$24101850$1$I$20240123$20240221$20240717$20240717$PER$$US-NOVOPROD-1180663$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241018522$24101852$2$F$20240425$20240904$20240717$20240907$EXP$$ES-JNJFOC-20240642387$JOHNSON AND JOHNSON$$78$YR$E$M$Y$50$KG$20240907$$MD$ES$ES
241018531$24101853$1$I$$20240702$20240717$20240717$EXP$$AU-LUPIN EUROPE GMBH-2024-06210$LUPIN$$$$$$Y$$$20240717$$CN$AU$AU
241018541$24101854$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008020$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241018551$24101855$1$I$20220101$20230908$20240717$20240717$PER$$US-NOVOPROD-1127324$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
241018561$24101856$1$I$$20230627$20240717$20240717$PER$$US-NOVOPROD-1181014$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241018571$24101857$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1181388$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241018581$24101858$1$I$20231123$20240221$20240717$20240717$PER$$US-NOVOPROD-1181257$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
241018591$24101859$1$I$20240101$20240219$20240717$20240717$PER$$US-NOVOPROD-1181016$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
241018601$24101860$1$I$20240201$20240216$20240717$20240717$PER$$US-NOVOPROD-1180986$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018611$24101861$1$I$$20230608$20240717$20240717$PER$$US-NOVOPROD-1181361$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241018621$24101862$1$I$20240216$20240220$20240717$20240717$PER$$US-NOVOPROD-1181328$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241018631$24101863$1$I$20231201$20240209$20240717$20240717$PER$$US-NOVOPROD-1181152$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018641$24101864$1$I$$20240220$20240717$20240717$PER$$US-NOVOPROD-1181302$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241018651$24101865$1$I$$20240221$20240717$20240717$PER$$US-NOVOPROD-1181070$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241018661$24101866$1$I$20240101$20240221$20240717$20240717$PER$$US-NOVOPROD-1181113$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241018671$24101867$1$I$20231001$20240221$20240717$20240717$PER$$US-NOVOPROD-1181009$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018681$24101868$1$I$$20240220$20240717$20240717$PER$$US-NOVOPROD-1181150$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018691$24101869$1$I$$20240219$20240717$20240717$PER$$US-NOVOPROD-1181097$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241018701$24101870$1$I$$20240715$20240717$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039950$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240717$$CN$US$US
241018711$24101871$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008021$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241018721$24101872$1$I$20240101$20240711$20240717$20240717$EXP$$US-JNJFOC-20240735841$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240717$$HP$US$US
241018733$24101873$3$F$20240702$20240826$20240717$20240906$EXP$$US-JNJFOC-20240740666$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20240906$$CN$US$US
241018741$24101874$1$I$20220906$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405111227472190-RWVFM$GB-MSNLABS-2024MSNSPO01558$MSN LABORATORIES$$$$$$Y$$$20240717$$CN$GB$GB
241018761$24101876$1$I$$20240712$20240717$20240717$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-098026$REGENERON$$77$YR$$F$Y$$$20240717$$CN$CH$CH
241018771$24101877$1$I$$20240709$20240717$20240717$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005090$BIOCON$$$$$$Y$$$20240717$$MD$CA$CA
241018781$24101878$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008022$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241018791$24101879$1$I$20240601$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024137968$AMGEN$$82$YR$E$F$Y$$$20240717$$CN$US$US
241018801$24101880$1$I$20240710$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140550$AMGEN$$$$$$Y$$$20240717$$HP$US$US
241018811$24101881$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024138418$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241018821$24101882$1$I$$20240712$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065433$SANDOZ$$77$YR$$F$Y$$$20240717$$HP$CA$CA
241018831$24101883$1$I$20191201$20200312$20240717$20240717$EXP$$CO-AstraZeneca-2020SE38828$ASTRAZENECA$$25470$DY$$F$Y$$$20240717$$CN$CO$
241018841$24101884$1$I$20240217$20240223$20240717$20240717$PER$$US-NOVOPROD-1180395$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241018851$24101885$1$I$20230801$20240219$20240717$20240717$PER$$US-NOVOPROD-1180171$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241018861$24101886$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1181396$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241018871$24101887$1$I$20231205$20240219$20240717$20240717$PER$$US-NOVOPROD-1180372$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018881$24101888$1$I$20240205$20240212$20240717$20240717$PER$$US-NOVOPROD-1180290$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018891$24101889$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1229486$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018901$24101890$1$I$20230616$20230616$20240717$20240717$PER$$US-NOVOPROD-1180061$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
241018911$24101891$1$I$$20240220$20240717$20240717$PER$$US-NOVOPROD-1180402$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241018922$24101892$2$F$$20240807$20240717$20240807$PER$$US-ALXN-202407USA000736US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241018931$24101893$1$I$$20191217$20240717$20240717$EXP$$US-AstraZeneca-2019SF84965$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241018942$24101894$2$F$$20240905$20240717$20240906$PER$$US-AstraZeneca-2024A161272$ASTRAZENECA$$$$$F$Y$$$20240906$$PH$US$
241018951$24101895$1$I$$20200214$20240717$20240717$EXP$$US-AstraZeneca-2020SE24902$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241018961$24101896$1$I$$20200525$20240717$20240717$EXP$$AU-AstraZeneca-2020SE70506$ASTRAZENECA$$$$$$Y$$$20240717$$MD$AU$
241018971$24101897$1$I$20191201$20191220$20240717$20240717$EXP$$US-AstraZeneca-2019SF87090$ASTRAZENECA$$23863$DY$$F$Y$$$20240717$$CN$US$
241018981$24101898$1$I$20191101$20191224$20240717$20240717$EXP$$CO-AstraZeneca-2019SF89680$ASTRAZENECA$$26288$DY$$F$Y$$$20240717$$CN$CO$
241018991$24101899$1$I$20200201$20200312$20240717$20240717$EXP$$US-AstraZeneca-2020SE40156$ASTRAZENECA$$60$YR$$F$Y$$$20240717$$CN$US$
241019001$24101900$1$I$$20200227$20240717$20240717$EXP$$CA-AstraZeneca-2020SE25685$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CA$
241019021$24101902$1$I$20190701$20191203$20240717$20240717$EXP$$CA-AstraZeneca-2019SF76248$ASTRAZENECA$$926$MON$$F$Y$$$20240717$$CN$CA$
241019031$24101903$1$I$$20200306$20240717$20240717$EXP$$US-AstraZeneca-2020SE36381$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241019041$24101904$1$I$$20200212$20240717$20240717$EXP$$US-AstraZeneca-2020SE22587$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241019051$24101905$1$I$$20200924$20240717$20240717$EXP$$US-AstraZeneca-2020SE24018$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241019061$24101906$1$I$20240520$20240531$20240717$20240717$PER$$US-NOVOPROD-1229467$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241019071$24101907$1$I$20240101$20240216$20240717$20240717$PER$$US-NOVOPROD-1180367$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
241019081$24101908$1$I$20240201$20240216$20240717$20240717$PER$$US-NOVOPROD-1180338$NOVO NORDISK$$62$YR$$M$Y$$$20240717$$CN$US$US
241019091$24101909$1$I$$20240218$20240717$20240717$PER$$US-NOVOPROD-1180262$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241019101$24101910$1$I$20240210$20240219$20240717$20240717$PER$$US-NOVOPROD-1180353$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
241019111$24101911$1$I$$20230907$20240717$20240717$PER$$US-NOVOPROD-1229503$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019121$24101912$1$I$20240101$20240325$20240717$20240717$PER$$US-NOVOPROD-1180319$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
241019131$24101913$1$I$$20240216$20240717$20240717$PER$$US-NOVOPROD-1180394$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019141$24101914$1$I$20240215$20240216$20240717$20240717$PER$$US-NOVOPROD-1180047$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241019151$24101915$1$I$$20240219$20240717$20240717$PER$$US-NOVOPROD-1180256$NOVO NORDISK$$$$E$M$Y$$$20240717$$MD$US$US
241019161$24101916$1$I$20240210$20240218$20240717$20240717$PER$$US-NOVOPROD-1180270$NOVO NORDISK$$42$YR$$$Y$$$20240717$$CN$US$US
241019171$24101917$1$I$$20240218$20240717$20240717$PER$$US-NOVOPROD-1180269$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019181$24101918$1$I$$20240712$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065419$SANDOZ$$78$YR$$M$Y$80$KG$20240717$$HP$CA$CA
241019191$24101919$1$I$20240401$20240709$20240717$20240717$EXP$$CN-009507513-2407CHN009385$MERCK$$79$YR$$M$Y$$$20240717$$HP$CN$CN
241019201$24101920$1$I$$20240702$20240717$20240717$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-06101$LUPIN$$$$$$Y$$$20240717$$CN$AU$AU
241019211$24101921$1$I$$20240702$20240717$20240717$EXP$$AU-LUPIN EUROPE GMBH-2024-06233$LUPIN$$$$$$Y$$$20240717$$CN$AU$AU
241019221$24101922$1$I$$20240630$20240717$20240717$PER$$US-APOTEX-2024AP008028$APOTEX$Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al.. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American Journal of Hematology. 2024;99 (7):1423-1426$$$A$$Y$$$20240717$$HP$US$US
241019231$24101923$1$I$$20240710$20240717$20240717$EXP$$JP-SANDOZ INC.-SDZ2024JP064746$SANDOZ$Shinkura N, Inamoto S, Okino T, Emoto N. A Case of Triple-Negative Breast Cancer Complicated by Venous Thrombosis During Neoadjuvant Chemotherapy Including Pembrolizumab. The 32nd Annual Meeting of the Japanese Breast Cancer Society (Abstracts). 2024;EP-1084$47$YR$$F$Y$$$20240717$$MD$JP$JP
241019241$24101924$1$I$20240615$20240715$20240717$20240717$PER$$US-JNJFOC-20240738573$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
241019251$24101925$1$I$$20240705$20240717$20240717$30DAY$$US-JNJFOC-20240733573$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$PH$US$US
241019261$24101926$1$I$20240710$20240711$20240717$20240717$PER$$US-JNJFOC-20240729535$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240717$$CN$US$US
241019273$24101927$3$F$$20240919$20240717$20240924$EXP$$CA-JNJFOC-20240731872$JOHNSON AND JOHNSON$$7$YR$C$F$Y$27$KG$20240924$$HP$CA$CA
241019281$24101928$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1230139$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241019291$24101929$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1230204$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019301$24101930$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1229567$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241019311$24101931$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1230019$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241019321$24101932$1$I$$20240624$20240717$20240717$PER$$US-NOVOPROD-1230118$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
241019331$24101933$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1230217$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241019341$24101934$1$I$20231201$20240521$20240717$20240717$PER$$US-NOVOPROD-1230015$NOVO NORDISK$$80$YR$$F$Y$$$20240717$$CN$US$US
241019351$24101935$1$I$20240213$20240220$20240717$20240717$PER$$US-NOVOPROD-1230246$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
241019361$24101936$1$I$$20230906$20240717$20240717$PER$$US-NOVOPROD-1229790$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241019372$24101937$2$F$20240401$20240520$20240717$20240717$PER$$US-NOVOPROD-1229748$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
241019381$24101938$1$I$20240406$20240520$20240717$20240717$PER$$US-NOVOPROD-1229690$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
241019391$24101939$1$I$20240201$20240521$20240717$20240717$PER$$US-NOVOPROD-1230094$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
241019401$24101940$1$I$20240201$20240521$20240717$20240717$PER$$US-NOVOPROD-1229938$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241019411$24101941$1$I$$20230905$20240717$20240717$PER$$US-NOVOPROD-1230040$NOVO NORDISK$$$$E$M$Y$$$20240717$$CN$US$US
241019421$24101942$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1230230$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241019431$24101943$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1229923$NOVO NORDISK$$$$$F$Y$124.72$KG$20240717$$CN$US$US
241019441$24101944$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1230111$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$MD$US$US
241019451$24101945$1$I$$20240520$20240717$20240717$PER$$US-NOVOPROD-1229552$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241019461$24101946$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1230129$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019471$24101947$1$I$$20230908$20240717$20240717$PER$$US-NOVOPROD-1230236$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019481$24101948$1$I$$20240712$20240717$20240717$EXP$$AU-TAKEDA-2024TUS071548$TAKEDA$$$$$F$Y$$$20240717$$CN$AU$AU
241019492$24101949$2$F$$20240709$20240717$20240722$EXP$$DE-ROCHE-10000023811$ROCHE$$$$A$M$Y$$$20240722$$MD$DE$DE
241019512$24101951$2$F$20231212$20231215$20240717$20240717$PER$$US-NOVOPROD-1154682$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241019521$24101952$1$I$20230301$20231219$20240717$20240717$PER$$US-NOVOPROD-1155276$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241019531$24101953$1$I$$20240103$20240717$20240717$PER$$US-NOVOPROD-1155112$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019541$24101954$1$I$20230401$20231219$20240717$20240717$PER$$US-NOVOPROD-1154969$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241019551$24101955$1$I$$20240706$20240717$20240717$EXP$$NL-AUROBINDO-AUR-APL-2024-033808$AUROBINDO$Van der Veen S, Eggink H, Elting JW, Sival D, Verschuuren-Bemelmans CC, de Koning TJ et al. The natural history of progressive myoclonus ataxia. Neurobiology of Disease. 2024;199:1-12$$$T$F$Y$$$20240717$$HP$NL$NL
241019561$24101956$1$I$20230701$20240321$20240717$20240717$PER$$US-NOVOPROD-1154471$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
241019571$24101957$1$I$20230901$20240315$20240717$20240717$PER$$US-NOVOPROD-1154915$NOVO NORDISK$$47$YR$$F$Y$$$20240717$$CN$US$US
241019581$24101958$1$I$$20231219$20240717$20240717$PER$$US-NOVOPROD-1154625$NOVO NORDISK$$$$$$Y$$$20240717$$HP$US$US
241019591$24101959$1$I$$20231215$20240717$20240717$PER$$US-NOVOPROD-1154822$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241019601$24101960$1$I$20230101$20231219$20240717$20240717$PER$$US-NOVOPROD-1155235$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241019611$24101961$1$I$$20240304$20240717$20240717$PER$$US-NOVOPROD-1154442$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241019621$24101962$1$I$20231218$20240102$20240717$20240717$PER$$US-NOVOPROD-1154768$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
241019631$24101963$1$I$$20231218$20240717$20240717$PER$$US-NOVOPROD-1154588$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241019641$24101964$1$I$$20231218$20240717$20240717$PER$$US-NOVOPROD-1154523$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241019651$24101965$1$I$$20231218$20240717$20240717$PER$$US-NOVOPROD-1154910$NOVO NORDISK$$48$YR$$$Y$$$20240717$$CN$US$US
241019661$24101966$1$I$$20231218$20240717$20240717$PER$$US-NOVOPROD-1154827$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241019671$24101967$1$I$$20231221$20240717$20240717$PER$$US-NOVOPROD-1155131$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019681$24101968$1$I$$20231215$20240717$20240717$PER$$US-NOVOPROD-1154676$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019691$24101969$1$I$20231204$20240102$20240717$20240717$PER$$US-NOVOPROD-1154575$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$MD$US$US
241019701$24101970$1$I$$20231215$20240717$20240717$PER$$US-NOVOPROD-1154671$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241019711$24101971$1$I$$20240102$20240717$20240717$PER$$US-NOVOPROD-1154700$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241019721$24101972$1$I$$20231219$20240717$20240717$PER$$US-NOVOPROD-1154833$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019731$24101973$1$I$20231214$20231215$20240717$20240717$EXP$GB-MHRA-TPP17385573C8622510YC1702559540104$GB-TEVA-VS-3144862$TEVA$$57$YR$$M$Y$87$KG$20240717$$MD$GB$GB
241019741$24101974$1$I$$20240711$20240717$20240717$PER$$US-JNJFOC-20240733384$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$MD$US$US
241019752$24101975$2$F$20240305$20240730$20240717$20240802$EXP$$JP-JNJFOC-20240743444$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240802$$HP$JP$JP
241019771$24101977$1$I$$20240712$20240717$20240717$PER$$US-JNJFOC-20240734786$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$HP$US$US
241019781$24101978$1$I$$20240711$20240717$20240717$PER$$US-JNJFOC-20240729995$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241019791$24101979$1$I$$20240711$20240717$20240717$PER$$US-HALEON-2186761$Haleon PLC$$$$$F$Y$$$20240717$$CN$US$US
241019801$24101980$1$I$20240706$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140910$AMGEN$$65$YR$E$M$Y$$$20240717$$CN$US$US
241019811$24101981$1$I$20240525$20240705$20240717$20240717$EXP$FR-AFSSAPS-ST2024001059$FR-ROCHE-10000018911$ROCHE$$32$YR$A$F$Y$66$KG$20240717$$MD$FR$FR
241019821$24101982$1$I$$20240704$20240717$20240717$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-19936$SAMSUNG BIOEPIS$$72$YR$E$F$Y$$$20240717$$CN$GB$GB
241019832$24101983$2$F$$20240715$20240717$20240725$30DAY$$US-UCBSA-2024033436$UCB$$$$$F$Y$$$20240725$$CN$US$US
241019841$24101984$1$I$$20240708$20240717$20240717$EXP$$CA-APOTEX-2024AP008046$APOTEX$$29$YR$$F$Y$57$KG$20240717$$HP$CA$CA
241019851$24101985$1$I$$20240708$20240717$20240717$EXP$$US-Bion-013437$BIONPHARMA$$$$$F$Y$$$20240715$$CN$US$US
241019863$24101986$3$F$20240306$20240729$20240717$20240808$EXP$FR-AFSSAPS-AVMA2024000272$FR-SA-2024SA198664$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240808$$PH$FR$FR
241019871$24101987$1$I$20240305$20240306$20240717$20240717$PER$$US-NOVOPROD-1188885$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241019882$24101988$2$F$$20240730$20240717$20240801$PER$$US-HETERO-HET2024US02265$HETERO$$$$$M$Y$$$20240801$$CN$US$US
241019891$24101989$1$I$20240307$20240401$20240717$20240717$PER$$US-NOVOPROD-1189004$NOVO NORDISK$$59$YR$$F$Y$106.58$KG$20240717$$MD$US$US
241019901$24101990$1$I$20240115$20240513$20240717$20240717$PER$$US-NOVOPROD-1189071$NOVO NORDISK$$49$YR$$F$Y$70.295$KG$20240717$$MD$US$US
241019911$24101991$1$I$20240101$20240306$20240717$20240717$PER$$US-NOVOPROD-1189106$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241019921$24101992$1$I$20231220$20231220$20240717$20240717$PER$$US-NOVOPROD-1155400$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241019931$24101993$1$I$20240501$20240520$20240717$20240717$PER$$US-NOVOPROD-1229439$NOVO NORDISK$$49$YR$$F$Y$$$20240717$$CN$US$US
241019941$24101994$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1189112$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019951$24101995$1$I$20221101$20240306$20240717$20240717$PER$$US-NOVOPROD-1188878$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
241019961$24101996$1$I$20231201$20231220$20240717$20240717$PER$$US-NOVOPROD-1155384$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019971$24101997$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1189036$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241019982$24101998$2$F$$20231219$20240717$20240717$PER$$US-NOVOPROD-1155388$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241019991$24101999$1$I$20230301$20231214$20240717$20240717$PER$$US-NOVOPROD-1155407$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241020001$24102000$1$I$20240516$20240521$20240717$20240717$PER$$US-NOVOPROD-1230325$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241020011$24102001$1$I$20231116$20240129$20240717$20240717$PER$$US-NOVOPROD-1155299$NOVO NORDISK$$84$YR$$F$Y$$$20240717$$CN$US$US
241020021$24102002$1$I$$20240308$20240717$20240717$PER$$US-NOVOPROD-1188959$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241020031$24102003$1$I$20231205$20231219$20240717$20240717$PER$$US-NOVOPROD-1155465$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241020041$24102004$1$I$20231218$20231219$20240717$20240717$PER$$US-NOVOPROD-1155478$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241020051$24102005$1$I$20230701$20231221$20240717$20240717$PER$$US-NOVOPROD-1155405$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
241020061$24102006$1$I$20231217$20240123$20240717$20240717$PER$$US-NOVOPROD-1155399$NOVO NORDISK$$26$YR$$F$Y$$$20240717$$CN$US$US
241020071$24102007$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1188905$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$MD$US$US
241020081$24102008$1$I$20231220$20240102$20240717$20240717$PER$$US-NOVOPROD-1155516$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241020091$24102009$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1189101$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241020101$24102010$1$I$$20240707$20240717$20240717$EXP$GB-MHRA-MED-202407071941537630-RTWMN$GB-TEVA-VS-3219334$TEVA$$33$YR$$M$Y$77$KG$20240717$$CN$GB$GB
241020111$24102011$1$I$$20240715$20240717$20240717$EXP$NL-LRB-00981413$NL-UCBSA-2024035732$UCB$$52$YR$$M$Y$89$KG$20240717$$MD$NL$NL
241020121$24102012$1$I$20221007$20240712$20240717$20240717$EXP$$US-TAKEDA-2022TUS072577$TAKEDA$$61$YR$$M$Y$$$20240717$$CN$US$US
241020131$24102013$1$I$$20240707$20240717$20240717$EXP$GB-MHRA-MED-202407072242561420-ZLKTH$GB-TEVA-VS-3219448$TEVA$$$$$$Y$$$20240717$$CN$GB$GB
241020141$24102014$1$I$$20240711$20240717$20240717$EXP$$US-TAKEDA-2024TUS071459$TAKEDA$$$$$F$Y$$$20240717$$CN$US$US
241020152$24102015$2$F$$20240917$20240717$20240923$EXP$$JP-009507513-2407JPN001579J$MERCK$Furukawa J, Tsukahara D. EP-0516 A study of eight cases of triple-negative breast cancer preoperatively treated with pembrolizumab. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 306$67$YR$$$Y$$$20240923$$MD$JP$JP
241020161$24102016$1$I$20240708$20240708$20240717$20240717$EXP$$JP-ROCHE-10000023448$ROCHE$$$$E$M$Y$$$20240717$$MD$JP$JP
241020171$24102017$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1230798$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241020181$24102018$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1230826$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241020191$24102019$1$I$20240514$20240521$20240717$20240717$PER$$US-NOVOPROD-1230456$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
241020201$24102020$1$I$20240326$20240521$20240717$20240717$PER$$US-NOVOPROD-1230368$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
241020211$24102021$1$I$20240101$20240521$20240717$20240717$PER$$US-NOVOPROD-1230588$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241020221$24102022$1$I$20240519$20240522$20240717$20240717$PER$$US-NOVOPROD-1230691$NOVO NORDISK$$57$YR$$F$Y$$$20240717$$CN$US$US
241020231$24102023$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1230718$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241020241$24102024$1$I$20240504$20240522$20240717$20240717$PER$$US-NOVOPROD-1230788$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
241020251$24102025$1$I$20231101$20240215$20240717$20240717$PER$$US-NOVOPROD-1230803$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
241020261$24102026$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1230862$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241020271$24102027$1$I$20240521$20240524$20240717$20240717$PER$$US-NOVOPROD-1230553$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241020281$24102028$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1230386$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241020291$24102029$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1230397$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$HP$US$US
241020301$24102030$1$I$20240507$20240521$20240717$20240717$PER$$US-NOVOPROD-1230682$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241020311$24102031$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1230429$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241020321$24102032$1$I$20240201$20240521$20240717$20240717$PER$$US-NOVOPROD-1230465$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
241020331$24102033$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1230928$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241020341$24102034$1$I$20231201$20240521$20240717$20240717$PER$$US-NOVOPROD-1230374$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241020351$24102035$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1230348$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241020361$24102036$1$I$$20240510$20240717$20240717$PER$$US-NOVOPROD-1230464$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241020371$24102037$1$I$20230701$20230911$20240717$20240717$PER$$US-NOVOPROD-1230381$NOVO NORDISK$$42$YR$$F$Y$$$20240717$$CN$US$US
241020381$24102038$1$I$20230901$20230901$20240717$20240717$PER$$US-NOVOPROD-1230509$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241020391$24102039$1$I$$20240521$20240717$20240717$PER$$US-NOVOPROD-1230401$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241020401$24102040$1$I$$20240617$20240717$20240717$PER$$US-NOVOPROD-1230499$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241020412$24102041$2$F$$20240712$20240717$20240722$EXP$$JP-SA-2024SA194989$SANOFI AVENTIS$$60$YR$A$$Y$$$20240722$$MD$JP$JP
241020422$24102042$2$F$$20240715$20240717$20240722$EXP$$US-Bion-013444$BIONPHARMA$$39$YR$A$F$Y$$$20240719$$CN$US$US
241020431$24102043$1$I$20150201$20240715$20240717$20240717$EXP$$US-TAKEDA-US201501730$TAKEDA$$61$YR$$F$Y$$$20240717$$MD$US$US
241020441$24102044$1$I$20200529$20200612$20240717$20240717$EXP$$CO-AstraZeneca-2020SE73546$ASTRAZENECA$$15371$DY$$F$Y$$$20240717$$CN$CO$
241020451$24102045$1$I$20240709$20240710$20240717$20240717$EXP$$DE-ABBVIE-5835748$ABBVIE$$62$YR$$F$Y$$$20240717$$CN$DE$DE
241020461$24102046$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456480$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$43$YR$$M$Y$$$20240717$$HP$US$US
241020471$24102047$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456426$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$59$YR$$F$Y$$$20240717$$HP$US$US
241020481$24102048$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456445$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$51$YR$$M$Y$$$20240717$$HP$US$US
241020491$24102049$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456757$RANBAXY$Rezaei S, Steen D, Amin S. Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears. Am J Ophthalmol Case Rep. 2023;32:101909$81$YR$$M$Y$$$20240717$$HP$US$US
241020501$24102050$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456754$RANBAXY$Gullapalli D, Raza A, Khan A, Ganti SS, Pervaiz A. Battling the breath-stealers: Blastomyces and Pseudomonas triggering acute respiratory distress syndrome. Med Mycol Case Reports. 2024;45:100655$46$YR$$M$Y$$$20240717$$HP$US$US
241020511$24102051$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456408$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$71$YR$$M$Y$$$20240717$$HP$US$US
241020521$24102052$1$I$20231001$20231211$20240717$20240717$PER$$US-NOVOPROD-1153203$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
241020531$24102053$1$I$$20240702$20240717$20240717$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456818$RANBAXY$Arai M. Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson?s disease patients. Neuro Endocrinol Lett. 2011;32(1):39-43$$$$$Y$$$20240717$$MD$JP$JP
241020541$24102054$1$I$$20240702$20240717$20240717$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456573$RANBAXY$Boontaveeyuwat E, Willis F, Fassihi H, Sarkany RPE. Successful serial plasmapheresis for solar urticaria, a case report and literature. J Dermatolog Treat. 2024;35 (1):2350229 (1-6)$56$YR$$F$Y$$$20240717$$HP$GB$GB
241020551$24102055$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456478$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$43$YR$$M$Y$$$20240717$$HP$US$US
241020561$24102056$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456494$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$67$YR$$F$Y$$$20240717$$HP$US$US
241020571$24102057$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456780$RANBAXY$Sharma S, Desai S, Leoni J, Paghdar S, Ruiz J, Goswami R. Case report: eosinophilic myocarditis in hypereosinophilic syndrome: a journey to heart transplantation. Front Immunol. 2024;15 (0):1418665$51$YR$$F$Y$$$20240717$$HP$US$US
241020581$24102058$1$I$$20231208$20240717$20240717$PER$$US-NOVOPROD-1153178$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241020591$24102059$1$I$20231201$20231212$20240717$20240717$PER$$US-NOVOPROD-1153492$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241020601$24102060$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1153269$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241020611$24102061$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1153424$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241020621$24102062$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1153419$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241020632$24102063$2$F$$20231213$20240717$20240717$PER$$US-NOVOPROD-1153187$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241020641$24102064$1$I$$20231212$20240717$20240717$PER$$US-NOVOPROD-1153377$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241020651$24102065$1$I$20231217$20240102$20240717$20240717$PER$$US-NOVOPROD-1153240$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$HP$US$US
241020661$24102066$1$I$$20231212$20240717$20240717$PER$$US-NOVOPROD-1153493$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241020671$24102067$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456481$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$$$$$Y$$$20240717$$HP$US$US
241020681$24102068$1$I$20231206$20231212$20240717$20240717$PER$$US-NOVOPROD-1153272$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241020691$24102069$1$I$20231210$20231227$20240717$20240717$PER$$US-NOVOPROD-1153379$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241020701$24102070$1$I$20231001$20231212$20240717$20240717$PER$$US-NOVOPROD-1153467$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241020711$24102071$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1153431$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241020721$24102072$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1152941$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241020731$24102073$1$I$20240424$20240522$20240717$20240717$PER$$US-NOVOPROD-1230945$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241020741$24102074$1$I$20231104$20240122$20240717$20240717$PER$$US-NOVOPROD-1153142$NOVO NORDISK$$74$YR$$M$Y$$$20240717$$CN$US$US
241020751$24102075$1$I$20230901$20231213$20240717$20240717$PER$$US-NOVOPROD-1153430$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
241020761$24102076$1$I$$20240702$20240717$20240717$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456795$RANBAXY$Solak SS, Ilyas HY. Tofacitinib: a successful treatment option for SAPHO syndrome. Intern J Dermatol. 2024;63:671-674$42$YR$$F$Y$$$20240717$$HP$TR$TR
241020771$24102077$1$I$$20240702$20240717$20240717$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456450$RANBAXY$Yin J, Wang N, Guo H, Zhang Y. Liver transplantation following late-onset hepatic sinusoidal obstruction syndrome occurred beyond 1-year postallogeneic hematopoietic stem cell transplantation. Clin Case Rep. 2023;11(1):1-6$48$YR$$F$Y$$$20240717$$HP$CN$CN
241020781$24102078$1$I$20231208$20231214$20240717$20240717$PER$$US-NOVOPROD-1153418$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241020791$24102079$1$I$$20240702$20240717$20240717$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456380$RANBAXY$Zhan M, Liu T, ZhangZ, Wang G, Cao Z, Li X, et al. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia. Front Pediatr. 2023;Jun;11:1153767(1-12)$$$C$$Y$$$20240717$$HP$CN$CN
241020801$24102080$1$I$$20240702$20240717$20240717$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456696$RANBAXY$Qiu Y, Qin A, Zhao R, Ding J, Jia WW-G, Singh M, et al. Oncolytic virotherapy stimulates anti-tumor immune response and demonstrates activity in advanced sarcoma: Report of two cases. Oncol Lett. 2024;27 (6):244(1-7)$52$YR$$F$Y$$$20240717$$HP$CN$CN
241020811$24102081$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456760$RANBAXY$Suresh S, Chaitanya G, Kachhvah AD, Vashin V, Saranathan M, Pati S.. Case report: Nocturnal low-frequency stimulation of the centromedian thalamic nucleus improves sleep quality and seizure control. Front Hum Neurosci. 2024;18 (0):1392100$39$YR$$M$Y$$$20240717$$HP$US$US
241020821$24102082$1$I$$20240702$20240717$20240717$EXP$$AT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456600$RANBAXY$Muller A, Franzoi M, Enokl-Tomantschger U, Pollheimer M, Steidl K, Hatzenbichler P, et al.. Case report: a man with a pancreatic adenocarcinoma and negative CA 19-9, but positive CA 125. Z Gastroenterol. 2024;62 (5):e493$46$YR$$M$Y$$$20240717$$HP$AT$AT
241020831$24102083$1$I$$20240702$20240717$20240717$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456566$RANBAXY$Zhai W, Liu H, Li J, Xin H. Pregabalin-induced rhabdomyolysis: a case series and literature analysis. J Int Med Res. 2024;52 (6):1-7$$$E$F$Y$$$20240717$$HP$CN$CN
241020841$24102084$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456321$RANBAXY$Wu LW, Qasim Hussaini SM, Lee JW, Shu DH, Hruban RH, Laheru DA. Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma-two case reports. Ann Pancreat Cancer. 2022;5:1-8$69$YR$$M$Y$$$20240717$$HP$US$US
241020851$24102085$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456495$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$45$YR$$F$Y$$$20240717$$HP$US$US
241020861$24102086$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456766$RANBAXY$Langford B, D^Souza RS, Pingree M, Mauck WD. Treatment of Ulnar Neuropathic Pain with Peripheral Nerve Stimulation: Two Case Reports. Pain Med. 2023;24 (5):566-569$58$YR$$M$Y$$$20240717$$MD$US$US
241020871$24102087$1$I$$20240702$20240717$20240717$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456784$RANBAXY$Li T, Li X, Hong S, Jiang L, Ma J. Clinical characteristics of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy in children: A case series of 16 patients. J Neuroimmunol. 2023;382:578176; 1-8$179$MON$$F$Y$$$20240717$$HP$CN$CN
241020881$24102088$1$I$$20240702$20240717$20240717$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456713$RANBAXY$Furukawa S, Hiraki M, Sakurai R, Kohya N, Murayama K, Kamachi K, et al. A Case of Consciousness Disorder Due to Hyperammonemia Induced by Modified FOLFOX6 for Multiple Liver Metastasis from Rectal Cancer. Gan To Kagaku Ryoho. 2024;51 (5):567-570$74$YR$$M$Y$61$KG$20240717$$HP$JP$JP
241020891$24102089$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456799$RANBAXY$Beck OG, Hardesty MM.. Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion. Gynecol-Oncol-Rep. 2023;47:101187$51$YR$$F$Y$$$20240717$$HP$US$US
241020901$24102090$1$I$$20240702$20240717$20240717$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456972$RANBAXY$Ishikawa K,Nakamura T, Kawai F, Uehara Y, Mori N. Stenotrophomonas maltophilia Infection Associated with COVID-19: A Case Series and Literature Review. Am J Case Rep. 2022;23:e936889 (1-17)$80$YR$$M$Y$$$20240717$$HP$JP$JP
241020911$24102091$1$I$$20240702$20240717$20240717$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456675$RANBAXY$Bascuas Arribas M, Camino Serrano M, Sanz Santiago V, Lopez-Neyra A. Severe asthma resistant to biological treatment?.. An-Pediatr. 2024;100 (5):e9$13$YR$$F$Y$$$20240717$$HP$ES$ES
241020922$24102092$2$F$$20240911$20240717$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456694$RANBAXY$Qiu Y, Qin A, Zhao R, Ding J, Jia WW-G, Singh M, et al. Oncolytic virotherapy stimulates anti-tumor immune response and demonstrates activity in advanced sarcoma: Report of two cases. Oncol Lett. 2024;27 (6):244 (1-7)$68$YR$$M$Y$$$20240926$$HP$CN$CN
241020931$24102093$1$I$$20240702$20240717$20240717$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456976$RANBAXY$Ishikawa K,Nakamura T, Kawai F, Uehara Y, Mori N. Stenotrophomonas maltophilia Infection Associated with COVID-19: A Case Series and Literature Review. Am J Case Rep. 2022;23:e936889 (1-17)$48$YR$$M$Y$$$20240717$$HP$JP$JP
241020941$24102094$1$I$20240601$20240702$20240717$20240717$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456935$RANBAXY$$$$$F$Y$$$20240717$$HP$GB$GB
241020951$24102095$1$I$$20240702$20240717$20240717$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456974$RANBAXY$Ishikawa K,Nakamura T, Kawai F, Uehara Y, Mori N. Stenotrophomonas maltophilia Infection Associated with COVID-19: A Case Series and Literature Review. Am J Case Rep. 2022;23:e936889 (1-17)$80$YR$$M$Y$$$20240717$$HP$JP$JP
241020961$24102096$1$I$$20240702$20240717$20240717$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456789$RANBAXY$Chang Y-H, Hung K-S, Hsu C-K. The tunneling technique of intralesional 5-fluorouracil in combination with triamcinolone injection for intractable keloids. Intern J Dermatol. 2023;62:1551-1552$20$YR$$M$Y$$$20240717$$MD$TW$TW
241020971$24102097$1$I$$20240702$20240717$20240717$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456817$RANBAXY$Arai M. Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson^s disease patients. Neuro Endocrinol Lett. 2011;32(1):39-43$$$$$Y$$$20240717$$MD$JP$JP
241020981$24102098$1$I$$20240702$20240717$20240717$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456375$RANBAXY$Shen Y-C, Wu J-C, Lin T-T, Chang K-C, Su J-J, Juang J-M. Case Report:: Lacosamide unmasking SCN5A-associated Brugada syndrome in a young female  with epilepsy. Front CardioVasc Med. 2024;May; 11:1406614(1-6)$33$YR$$F$Y$$$20240717$$HP$TW$TW
241020991$24102099$1$I$$20240702$20240717$20240717$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456332$RANBAXY$Yeh L-C, Meng SW.. ASixty- Five-Year-Old Man With Coronary Artery Aneurysm Experiences Acute Myocardial Infarction. J Am Coll Cardiol. 2024;83 (Suppl 16):Abs TCTAP C-012; S59-S61$65$YR$$M$Y$$$20240717$$HP$TW$TW
241021001$24102100$1$I$$20240702$20240717$20240717$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456629$RANBAXY$$49$YR$$F$Y$53$KG$20240717$$MD$GB$GB
241021011$24102101$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456798$RANBAXY$Cunningham CA, Grys TE, Downey FX, Saling CF, Orenstein R, Blair JE. Deep Sternal Wound Infection Caused by Rhizopus Species After Coronary Artery Bypass Graft. Open Forum Infect Dis. 2024;11(6):1-4$76$YR$$M$Y$$$20240717$$MD$US$US
241021021$24102102$1$I$$20240702$20240717$20240717$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456790$RANBAXY$Li T, Li X, Hong S, Jiang L, Ma J. Clinical characteristics of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy in children: A case series of 16 patients. J Neuroimmunol. 2023;382:578176; 1-8$150$MON$$M$Y$$$20240717$$HP$CN$CN
241021032$24102103$2$F$$20240801$20240717$20240812$EXP$$JP-SA-2024SA203137$SANOFI AVENTIS$$$$$M$Y$$$20240813$$MD$JP$JP
241021041$24102104$1$I$$20240702$20240717$20240717$EXP$$EG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456948$RANBAXY$Elshony HS, Al-Ghamdi A. Acute motor conduction block neuropathy after initiation of omalizumab:case report and literature review for possible causality. eNeurologicalSci. 2024;36 (0):1-5$45$YR$$M$Y$$$20240717$$HP$EG$EG
241021051$24102105$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456314$RANBAXY$Wu LW, Qasim Hussaini SM, Lee JW, Shu DH, Hruban RH, Laheru DA. Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma-two case reports. Ann Pancreat Cancer. 2022;5:1-8$67$YR$$M$Y$$$20240717$$HP$US$US
241021061$24102106$1$I$$20240702$20240717$20240717$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456655$RANBAXY$Neacsu ED, Montalban EM, de Miguel BM. Resolution of a rare case of hypercalcemia in a PTHrpproducing pancreatic neuroendocrine tumor using selective internal radiation therapy with 90Y microspheres. Ann Pancreat Cancer. 2024;7 (0):1-7$7$DEC$$F$Y$$$20240717$$HP$ES$ES
241021071$24102107$1$I$$20240702$20240717$20240717$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456821$RANBAXY$Urai S, Tomofuji S, Bando H, Kanzawa M, Yamamoto M, Fukuoka H et al. The early-stage clinical course of anti-pituitary-specific transcription factor-1 hypophysitis diagnosed post-immune checkpoint inhibitor treatment: A case with review of literature. J Neuroendocrinol. 2024;36:e13395$69$YR$$M$Y$45.6$KG$20240717$$HP$JP$JP
241021081$24102108$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456773$RANBAXY$Radaelli M, Husain M, Makepeace J, Hadadi C, Kenigsberg BB. Chylothorax: A Rare Complication After Single Chamber Implantable Cardioverter Defibrillator Extraction. Am J Respir Crit Care Med. 2024;209:A3655$63$YR$$M$Y$$$20240717$$HP$US$US
241021091$24102109$1$I$$20240702$20240717$20240717$EXP$$PS-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456961$RANBAXY$Maqboul I, Daraghmeh L, Eleiwi MR, Qasrawi H, Akkawi M, AwadGhanem A. Atraumatic splenic rupture after administering aspirin, clopidogrel, and heparin to a patient with unstable angina: A case report. SAGE Open Med Case Rep. 2024;12:1-5$49$YR$$M$Y$$$20240717$$HP$PS$PS
241021101$24102110$1$I$$20240702$20240717$20240717$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456822$RANBAXY$Liew KC, O^Keeffe J, Rajandas H, Lee YP, Harris O, Parimannan S, et al. Insights into the Evolution of P. aeruginosa Antimicrobial Resistance in a Patient Undergoing Intensive Therapy. Antibiotics (Basel). 2023;12 (3):483$51$YR$$M$Y$$$20240717$$HP$AU$AU
241021111$24102111$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456382$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$40$YR$$F$Y$$$20240717$$HP$US$US
241021121$24102112$1$I$$20240702$20240717$20240717$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456710$RANBAXY$Mulkerrin G, Hennessy MJ. Nonsense mutation in DEPDC5 gene in a patient with carbamazepineresponsive focal epilepsy. Epilepsy Behav Rep. 2024;27 (0):no pagination$41$YR$$M$Y$$$20240717$$HP$IE$IE
241021131$24102113$1$I$$20240711$20240717$20240717$EXP$$IL-ABBVIE-5841640$ABBVIE$$82$YR$$$Y$$$20240717$$MD$IL$IL
241021141$24102114$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456376$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$64$YR$$M$Y$$$20240717$$HP$US$US
241021152$24102115$2$F$$20240725$20240717$20240731$EXP$$GB-SANDOZ INC.-NVSC2022GB152279$SANDOZ$$$$A$M$Y$$$20240731$$CN$GB$GB
241021161$24102116$1$I$20240623$20240711$20240717$20240717$EXP$$CN-SA-2024SA206928$SANOFI AVENTIS$$55$YR$A$M$Y$59$KG$20240717$$HP$CN$CN
241021171$24102117$1$I$20240702$20240705$20240717$20240717$EXP$$RU-ROCHE-10000019477$ROCHE$$42$YR$A$M$Y$$$20240717$$MD$RU$RU
241021183$24102118$3$F$20240715$20240731$20240717$20240805$PER$$US-AMGEN-USASP2024140970$AMGEN$$71$YR$E$F$Y$$$20240805$$CN$US$US
241021191$24102119$1$I$$20240716$20240717$20240717$PER$$US-AMGEN-USASP2024141385$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241021201$24102120$1$I$$20240715$20240717$20240717$EXP$$US-GSK-US2024088673$GLAXOSMITHKLINE$$$$$M$Y$$$20240717$$MD$US$US
241021211$24102121$1$I$20231214$20231215$20240717$20240717$PER$$US-NOVOPROD-1153964$NOVO NORDISK$$42$YR$$F$Y$$$20240717$$CN$US$US
241021221$24102122$1$I$20231209$20240102$20240717$20240717$PER$$US-NOVOPROD-1153925$NOVO NORDISK$$37$YR$$F$Y$$$20240717$$CN$US$US
241021231$24102123$1$I$$20240108$20240717$20240717$PER$$US-NOVOPROD-1153928$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241021242$24102124$2$F$20220101$20240102$20240717$20240717$PER$$US-NOVOPROD-1154279$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241021251$24102125$1$I$$20231216$20240717$20240717$PER$$US-NOVOPROD-1154094$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241021261$24102126$1$I$$20231214$20240717$20240717$PER$$US-NOVOPROD-1153903$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241021271$24102127$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1153601$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241021281$24102128$1$I$$20231212$20240717$20240717$PER$$US-NOVOPROD-1153957$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241021291$24102129$1$I$$20231214$20240717$20240717$PER$$US-NOVOPROD-1153681$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241021301$24102130$1$I$20231201$20231215$20240717$20240717$PER$$US-NOVOPROD-1154000$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
241021311$24102131$1$I$$20240125$20240717$20240717$PER$$US-NOVOPROD-1153833$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241021321$24102132$1$I$20231124$20240110$20240717$20240717$PER$$US-NOVOPROD-1153891$NOVO NORDISK$$73$YR$$M$Y$$$20240717$$CN$US$US
241021331$24102133$1$I$$20231212$20240717$20240717$PER$$US-NOVOPROD-1153535$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241021341$24102134$1$I$20230301$20231214$20240717$20240717$PER$$US-NOVOPROD-1153735$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241021351$24102135$1$I$$20240503$20240717$20240717$PER$$US-NOVOPROD-1153658$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241021361$24102136$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1154097$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241021371$24102137$1$I$$20231216$20240717$20240717$PER$$US-NOVOPROD-1154092$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241021381$24102138$1$I$$20231211$20240717$20240717$PER$$US-NOVOPROD-1154011$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241021391$24102139$1$I$20231207$20231211$20240717$20240717$PER$$US-NOVOPROD-1153510$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241021401$24102140$1$I$$20231214$20240717$20240717$PER$$US-NOVOPROD-1153880$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241021411$24102141$1$I$20231214$20231215$20240717$20240717$PER$$US-NOVOPROD-1153576$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241021421$24102142$1$I$20231118$20240201$20240717$20240717$PER$$US-NOVOPROD-1153895$NOVO NORDISK$$80$YR$$F$Y$$$20240717$$CN$US$US
241021431$24102143$1$I$20240101$20240708$20240717$20240717$EXP$$AU-ABBVIE-5841399$ABBVIE$$31$YR$$M$Y$$$20240717$$CN$AU$AU
241021443$24102144$3$F$20240623$20240725$20240717$20240806$PER$$US-ALXN-202407USA000737US$ALEXION PHARMACEUTICALS$$29$YR$$F$Y$56.2$KG$20240806$$CN$US$US
241021451$24102145$1$I$$20240709$20240717$20240717$PER$$US-APOTEX-2024AP008248$APOTEX$Mittal S, Eftekharzadeh S, Weinstein C, Fombona A, Hyacinthe N, Shah YB, et al.. Does ketorolac administration at the time of hypospadias surgery increase unplanned encounters in the immediate postoperative period?. Journal of Pediatric Urology. 2023;19(3):289.e1-289.e6$$$C$$Y$$$20240717$$HP$US$US
241021462$24102146$2$F$$20240731$20240717$20240814$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456823$RANBAXY$Stoppa A, Roda E, Garcia-Esteve L, Roca-Lecumberri A. A case of pregnancy with severe polyhydramnios related to long-term use of lithium. Bipolar Disord. 2024;26:405-408$$$N$$Y$2.26$KG$20240814$$HP$ES$ES
241021471$24102147$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456786$RANBAXY$Fan J, Thanedar S, Ovechko V, Jana B. Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers. Case Rep Oncol. 2024;17:517-523$56$YR$$M$Y$$$20240717$$HP$US$US
241021481$24102148$1$I$$20240702$20240717$20240717$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454722$RANBAXY$$$$$$Y$$$20240717$$CN$BR$BR
241021491$24102149$1$I$$20240702$20240717$20240717$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456520$RANBAXY$Zhang C, Lin Y, Kuang Q, Li H, Jiang Q, Yang X. Case report: A highly active refractory myasthenia gravis with treatment of telitacicept combined with efgartigimod. Front Immunol. 2024;May 10; 15 (0):1400459; 1-6$37$YR$$F$Y$$$20240717$$HP$CN$CN
241021501$24102150$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456493$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$56$YR$$F$Y$$$20240717$$HP$US$US
241021511$24102151$1$I$$20240702$20240717$20240717$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456942$RANBAXY$$65$YR$$F$Y$88$KG$20240717$$PH$GB$GB
241021521$24102152$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456665$RANBAXY$DeVine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. J Pediatr Pharmacol Ther. 2023;28(2):161-166$60$DY$$$Y$$$20240717$$PH$US$US
241021531$24102153$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456482$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$$$$$Y$$$20240717$$HP$US$US
241021541$24102154$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456463$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$56$YR$$M$Y$$$20240717$$HP$US$US
241021551$24102155$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456412$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$64$YR$$M$Y$$$20240717$$HP$US$US
241021561$24102156$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456483$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$57$YR$$F$Y$$$20240717$$HP$US$US
241021571$24102157$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456410$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$63$YR$$M$Y$$$20240717$$HP$US$US
241021581$24102158$1$I$$20240702$20240717$20240717$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456690$RANBAXY$Shibutani M, Tanda H, Fukuoka T, Kasashima H, Kashiwagi S, Maeda K. An Improvement of Exertional Dyspnea by the Reintroduction of Anti-EGFR Antibody in Patients with Metastatic Rectal Cancer Who Developed Cancerous Lymphangiopathy: A Case Report.. Case Rep Oncol. 2024;17:511-516$68$YR$$M$Y$$$20240717$$HP$JP$JP
241021591$24102159$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456718$RANBAXY$Faircloth JM, Bhatt ND, Chartan CA, Coleman RD, Villafranco N, Ruiz FE, et al. Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration. Front Pediatr. 2023;11:1050508(1-8)$5$YR$$F$Y$15.1$KG$20240717$$HP$US$US
241021601$24102160$1$I$$20240702$20240717$20240717$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456916$RANBAXY$Alruwaili M, Alruwaili R, Alshaalan ZM, Aljumah TK, Alsaidan AA, Alorayyidh MM, et al. Levetiracetam Induced Acute Hypersensitivity Reaction in a Previously Undiagnosed Epilepsy Elderly Woman: A Case Report. Int J Pharmacol. 2024;20 (5):912-915$71$YR$$F$Y$$$20240717$$HP$SA$SA
241021611$24102161$1$I$$20240702$20240717$20240717$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456750$RANBAXY$Cohen DL, Nakash S, Bermont A, Richter V, Shirin H. Predictors of Underlying Esophageal Motility Disorders in Patients Presenting with Esophageal Candidiasis. South Med J. 2023;Aug;116(8):701-706$34$YR$$F$Y$$$20240717$$MD$IL$IL
241021621$24102162$1$I$$20240702$20240717$20240717$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456589$RANBAXY$Pastore MR, Milan S, Cirigliano G, Tognetto D. Capecitabine-Related Fourth Nerve Palsy: A Case Report. Case Rep Oncol. 2024;17 (1):532-536$72$YR$$F$Y$$$20240717$$HP$IT$IT
241021631$24102163$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456720$RANBAXY$Faircloth JM, Bhatt ND, Chartan CA, Coleman RD, Villafranco N, Ruiz FE, et al. Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration. Front Pediatr. 2023;Mar;11:1-8(1050508)$5$YR$$F$Y$14$KG$20240717$$HP$US$US
241021641$24102164$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456717$RANBAXY$Faircloth JM, Bhatt ND, Chartan CA, Coleman RD, Villafranco N, Ruiz FE, et a. Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration. Front Pediatr. 2023;11:10505089(1-8)$3$YR$$M$Y$$$20240717$$HP$US$US
241021651$24102165$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456496$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$20$YR$$F$Y$$$20240717$$HP$US$US
241021661$24102166$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456469$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$50$YR$$M$Y$$$20240717$$HP$US$US
241021671$24102167$1$I$$20240702$20240717$20240717$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456811$RANBAXY$Arai M. Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson^s disease patients. Neuro Endocrinol Lett. 2011;32(1):39-43$$$$$Y$$$20240717$$MD$JP$JP
241021681$24102168$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456252$RANBAXY$$$$$F$Y$$$20240717$$LW$US$US
241021691$24102169$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456670$RANBAXY$Rehman A, Olayiwola A, Vu CA, Bhatt P, Joseph J-A, Ayoade F. Nocardia brasiliensis Pyomyositis in an Immunocompetent Patient Following Gardening Activity. J Investig Med High Impact Case Rep. 2024;12:1-4$48$YR$$M$Y$$$20240717$$MD$US$US
241021701$24102170$1$I$$20240702$20240717$20240717$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452814$RANBAXY$Iimori M, Sonomura K, Ueyama Y, Oobayashi Y, Adachi H, Nakayama M. Minimal Change Nephrotic Syndrome Secondary to Methotrexate-associated Hodgkin Lymphoma. Intern Med. 2024;63 (12):1771-1776$64$YR$$M$Y$80$KG$20240717$$HP$JP$JP
241021711$24102171$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456671$RANBAXY$Contag CA, Studemeister L, Bogler Y, Cooper JD. Q fever presenting as splenic infarct without endocarditis. ID Cases. 2024;37:e02012$44$YR$$M$Y$$$20240717$$HP$US$US
241021721$24102172$1$I$20240601$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140747$AMGEN$$39$YR$A$M$Y$$$20240717$$HP$US$US
241021731$24102173$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456442$RANBAXY$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$38$YR$$F$Y$$$20240717$$HP$US$US
241021741$24102174$1$I$$20240702$20240717$20240717$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456661$RANBAXY$Devine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. J Pediatr Pharmacol Ther. 2023;28(2):161-166$52$DY$$$Y$$$20240717$$PH$US$US
241021752$24102175$2$F$20240715$20240821$20240717$20240823$PER$$US-AMGEN-USASP2024141303$AMGEN$$78$YR$E$M$Y$$$20240823$$CN$US$US
241021761$24102176$1$I$20230615$20240313$20240717$20240717$PER$$US-NOVOPROD-1190979$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241021771$24102177$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1190693$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241021781$24102178$1$I$20240129$20240311$20240717$20240717$PER$$US-NOVOPROD-1190733$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241021791$24102179$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1190990$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241021802$24102180$2$F$20240311$20240311$20240717$20240717$PER$$US-NOVOPROD-1191047$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$PH$US$US
241021811$24102181$1$I$$20230803$20240717$20240717$PER$$US-NOVOPROD-1190973$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241021821$24102182$1$I$20230901$20240312$20240717$20240717$PER$$US-NOVOPROD-1191009$NOVO NORDISK$$61$YR$$$Y$$$20240717$$CN$US$US
241021831$24102183$1$I$$20240314$20240717$20240717$PER$$US-NOVOPROD-1190798$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241021841$24102184$1$I$20240214$20240308$20240717$20240717$PER$$US-NOVOPROD-1190690$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
241021851$24102185$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1190934$NOVO NORDISK$$$$$F$Y$$$20240717$$PH$US$US
241021861$24102186$1$I$20240309$20240311$20240717$20240717$PER$$US-NOVOPROD-1190638$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241021871$24102187$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1190694$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241021881$24102188$1$I$$20240312$20240717$20240717$PER$$US-NOVOPROD-1190573$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241021891$24102189$1$I$$20231217$20240717$20240717$PER$$US-NOVOPROD-1154336$NOVO NORDISK$$31$YR$$F$Y$$$20240717$$CN$US$US
241021901$24102190$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1190599$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241021911$24102191$1$I$$20240312$20240717$20240717$PER$$US-NOVOPROD-1190577$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$HP$US$US
241021921$24102192$1$I$$20231218$20240717$20240717$PER$$US-NOVOPROD-1154363$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241021931$24102193$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1154375$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241021941$24102194$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1154382$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241021951$24102195$1$I$$20231213$20240717$20240717$PER$$US-NOVOPROD-1154400$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241021961$24102196$1$I$20230901$20240311$20240717$20240717$PER$$US-NOVOPROD-1191011$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241021971$24102197$1$I$$20240308$20240717$20240717$PER$$US-NOVOPROD-1190813$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241021981$24102198$1$I$20231120$20231214$20240717$20240717$PER$$US-NOVOPROD-1154343$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241021991$24102199$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112865$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240717$$CN$US$US
241022002$24102200$2$F$$20240829$20240717$20240903$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005130$BIOCON$$$$$$Y$$$20240903$$HP$CA$CA
241022011$24102201$1$I$20240401$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112895$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240717$$CN$US$US
241022021$24102202$1$I$$20240712$20240717$20240717$EXP$$JP-JNJFOC-20240744147$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$PH$JP$JP
241022033$24102203$3$F$20240622$20240819$20240717$20240822$30DAY$$FR-JNJFOC-20240717004$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240822$$PH$FR$FR
241022041$24102204$1$I$$20240712$20240717$20240717$EXP$$US-JNJFOC-20240734607$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241022051$24102205$1$I$$20240314$20240717$20240717$PER$$US-NOVOPROD-1191124$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241022061$24102206$1$I$20230430$20240314$20240717$20240717$PER$$US-NOVOPROD-1191161$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241022071$24102207$1$I$20240101$20240312$20240717$20240717$PER$$US-NOVOPROD-1191563$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241022081$24102208$1$I$$20240312$20240717$20240717$PER$$US-NOVOPROD-1191922$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241022091$24102209$1$I$20240311$20240312$20240717$20240717$PER$$US-NOVOPROD-1191865$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241022101$24102210$1$I$$20240308$20240717$20240717$PER$$US-NOVOPROD-1191166$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241022111$24102211$1$I$20240201$20240308$20240717$20240717$PER$$US-NOVOPROD-1191169$NOVO NORDISK$$80$YR$$M$Y$$$20240717$$CN$US$US
241022121$24102212$1$I$$20240308$20240717$20240717$PER$$US-NOVOPROD-1191070$NOVO NORDISK$$85$YR$$$Y$$$20240717$$CN$US$US
241022131$24102213$1$I$$20240312$20240717$20240717$PER$$US-NOVOPROD-1191853$NOVO NORDISK$$60$YR$$M$Y$$$20240717$$CN$US$US
241022141$24102214$1$I$20230602$20240415$20240717$20240717$PER$$US-NOVOPROD-1191862$NOVO NORDISK$$63$YR$$M$Y$$$20240717$$CN$US$US
241022151$24102215$1$I$$20240312$20240717$20240717$PER$$US-NOVOPROD-1191339$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241022161$24102216$1$I$$20240313$20240717$20240717$PER$$US-NOVOPROD-1191823$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241022171$24102217$1$I$$20240312$20240717$20240717$PER$$US-NOVOPROD-1191435$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241022181$24102218$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1191259$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241022191$24102219$1$I$20230101$20240308$20240717$20240717$PER$$US-NOVOPROD-1191273$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
241022201$24102220$1$I$20240105$20240307$20240717$20240717$PER$$US-NOVOPROD-1191245$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
241022211$24102221$1$I$$20240313$20240717$20240717$PER$$US-NOVOPROD-1191879$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241022221$24102222$1$I$20230301$20240307$20240717$20240717$PER$$US-NOVOPROD-1191263$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
241022231$24102223$1$I$$20230622$20240717$20240717$PER$$US-NOVOPROD-1191613$NOVO NORDISK$$29$YR$$F$Y$$$20240717$$HP$US$US
241022241$24102224$1$I$20240307$20240314$20240717$20240717$PER$$US-NOVOPROD-1191784$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241022251$24102225$1$I$$20240715$20240717$20240717$EXP$$US-TAKEDA-2016BLT003493$TAKEDA$$$$$M$Y$$$20240717$$HP$US$US
241022261$24102226$1$I$20240201$20240618$20240717$20240717$EXP$GB-MHRA-MED-202406171445220680-JFYRK$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13426$ALKEM$$$$$M$Y$$$20240717$$HP$GB$GB
241022271$24102227$1$I$20231101$20240514$20240717$20240717$EXP$GB-MHRA-ADR 28717528$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10363$ALKEM$$43$YR$$F$Y$68$KG$20240717$$PH$GB$GB
241022281$24102228$1$I$20240411$20240515$20240717$20240717$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-10423$ALKEM$$26$YR$$M$Y$73$KG$20240717$$PH$DE$DE
241022291$24102229$1$I$$20240613$20240717$20240717$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-13188$ALKEM$Kolesnik M, Chaudhry N, Libbon R, Spitz M. Perampanel and Postictal Agitation. Epileptic Disorders. 2024;00:1-3$34$YR$$M$Y$$$20240717$$HP$US$US
241022301$24102230$1$I$$20240507$20240717$20240717$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-09870$ALKEM$$18$YR$$$Y$$$20240717$$MD$DE$DE
241022311$24102231$1$I$$20240531$20240717$20240717$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12431$ALKEM$$$$$$Y$$$20240717$$CN$US$US
241022321$24102232$1$I$$20240424$20240717$20240717$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-09420$ALKEM$$17$YR$$F$Y$$$20240717$$CN$US$US
241022331$24102233$1$I$$20240314$20240717$20240717$PER$$US-NOVOPROD-1192629$NOVO NORDISK$$$$$M$Y$$$20240717$$PH$US$US
241022341$24102234$1$I$20240225$20240415$20240717$20240717$PER$$US-NOVOPROD-1192156$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241022351$24102235$1$I$$20240610$20240717$20240717$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-13064$ALKEM$Biassoni E, Bellucci M, Micalizzi E, Miggino M, Andorno E, Porcile E, Resaz M, Roccatagliata L, Castellan L, Villani F, Ferrari A.. The role of EEG and neuroimaging in the diagnosis of non-convulsive status epilepticus in Subacute Encephalopathy with Seizures in Alcoholics (SESA syndrome): a case report and overview of the literature. Neurological Sciences. 2024;unk:unk$58$YR$$M$Y$$$20240717$$HP$IT$IT
241022361$24102236$1$I$$20240613$20240717$20240717$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-11599$ALKEM$$$$A$F$Y$$$20240717$$CN$DE$DE
241022371$24102237$1$I$$20240624$20240717$20240717$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14042$ALKEM$$16$YR$$M$Y$$$20240717$$MD$DE$DE
241022381$24102238$1$I$$20240626$20240717$20240717$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14206$ALKEM$Winter Y. No more seizures under fenfluramine therapy-49-year-old patient with Lennox-Gastaut syndrome. Thieme. 2024;Unk:Unk$49$YR$$M$Y$120$KG$20240717$$MD$DE$DE
241022391$24102239$1$I$$20240529$20240717$20240717$EXP$IN-MLMSERVICE-20240510-PI057796-00306-1$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-10847$ALKEM$Mazumder MA, Gulati S.. Tacrolimus-Induced Focal Myoclonus of Unilateral Hand in a Kidney Transplant Recipient. Indian Journal of Nephrology. 2024;34(1):93$33$YR$$F$Y$$$20240717$$MD$IN$IN
241022401$24102240$1$I$20240501$20240626$20240717$20240717$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-13160$ALKEM$$16$YR$$F$Y$54$KG$20240717$$CN$DE$DE
241022411$24102241$1$I$$20240228$20240717$20240717$PER$$US-NOVOPROD-1192266$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241022421$24102242$1$I$$20240313$20240717$20240717$PER$$US-NOVOPROD-1192064$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241022431$24102243$1$I$20230101$20240311$20240717$20240717$PER$$US-NOVOPROD-1191959$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241022441$24102244$1$I$$20240312$20240717$20240717$PER$$US-NOVOPROD-1192507$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241022451$24102245$1$I$$20240313$20240717$20240717$PER$$US-NOVOPROD-1192158$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241022461$24102246$1$I$20240313$20240313$20240717$20240717$PER$$US-NOVOPROD-1192328$NOVO NORDISK$$79$YR$$M$Y$$$20240717$$CN$US$US
241022471$24102247$1$I$$20240312$20240717$20240717$PER$$US-NOVOPROD-1192426$NOVO NORDISK$$$$E$F$Y$$$20240717$$CN$US$US
241022481$24102248$1$I$20240313$20240327$20240717$20240717$PER$$US-NOVOPROD-1192073$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
241022491$24102249$1$I$$20240314$20240717$20240717$PER$$US-NOVOPROD-1192614$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241022501$24102250$1$I$20231101$20240415$20240717$20240717$PER$$US-NOVOPROD-1192082$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
241022511$24102251$1$I$20240215$20240508$20240717$20240717$PER$$US-NOVOPROD-1192556$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241022521$24102252$1$I$20240301$20240423$20240717$20240717$PER$$US-NOVOPROD-1191979$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$PH$US$US
241022531$24102253$1$I$20240311$20240312$20240717$20240717$PER$$US-NOVOPROD-1192027$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
241022541$24102254$1$I$$20240314$20240717$20240717$PER$$US-NOVOPROD-1192551$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241022551$24102255$1$I$20240310$20240312$20240717$20240717$PER$$US-NOVOPROD-1192210$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
241022561$24102256$1$I$20231201$20240313$20240717$20240717$PER$$US-NOVOPROD-1192079$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241022571$24102257$1$I$$20240314$20240717$20240717$PER$$US-NOVOPROD-1192637$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241022581$24102258$1$I$20240304$20240311$20240717$20240717$PER$$US-NOVOPROD-1192380$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
241022591$24102259$1$I$$20240308$20240717$20240717$PER$$US-NOVOPROD-1192038$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241022601$24102260$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1192389$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241022611$24102261$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1192308$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241022622$24102262$2$F$20240519$20240722$20240717$20240726$EXP$$CO-UCBSA-2024035884$UCB$$69$YR$$F$Y$60$KG$20240726$$CN$CO$CO
241022631$24102263$1$I$$20240710$20240717$20240717$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024086590$VIIV$$$$$M$Y$$$20240717$$HP$US$US
241022641$24102264$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5840814$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241022651$24102265$1$I$20240505$20240715$20240717$20240717$EXP$GB-MHRA-MED-202407150925440130-WTZRN$GB-ORGANON-O2407GBR001317$ORGANON$$$$$F$Y$$$20240717$$PH$GB$GB
241022661$24102266$1$I$$20240709$20240717$20240717$EXP$$GR-BIOCON BIOLOGICS LIMITED-BBL2024005099$BIOCON$Nakou E. Dimopoulou K. Zorbas P. et al.. ENDOSCOPIC SALVAGE RESECTION OF EARLY RECTAL CANCER IN A PATIENT WITH COMPLICATED CROHNS FISTULE UNDER TREATMENT WITH ANTI-TNF AGENTS.,. 22nd PANHELLENIC CONGRESS OF IDIOPATHIC INFLAMMATORY BOWEL DISEASE.. 2024$$$$$Y$$$20240717$$HP$GR$GR
241022671$24102267$1$I$20230503$20240711$20240717$20240717$EXP$$CN-JNJFOC-20240733349$JOHNSON AND JOHNSON$$67$YR$E$F$Y$68$KG$20240717$$HP$CN$CN
241022701$24102270$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157088$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241022711$24102271$1$I$$20200608$20240717$20240717$EXP$$US-AstraZeneca-2020SE75193$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241022721$24102272$1$I$$20200107$20240717$20240717$EXP$$CA-AstraZeneca-2020SE03075$ASTRAZENECA$$59$YR$$F$Y$$$20240717$$MD$CA$
241022733$24102273$3$F$$20240829$20240717$20240916$PER$$US-AstraZeneca-2024A159330$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
241022741$24102274$1$I$$20240709$20240717$20240717$EXP$$SG-AstraZeneca-2024A158301$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$SG$
241022752$24102275$2$F$20240210$20240318$20240717$20240717$PER$$US-NOVOPROD-1193593$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
241022761$24102276$1$I$20240309$20240314$20240717$20240717$PER$$US-NOVOPROD-1192697$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241022771$24102277$1$I$20240308$20240313$20240717$20240717$PER$$US-NOVOPROD-1193104$NOVO NORDISK$$63$YR$$M$Y$$$20240717$$CN$US$US
241022781$24102278$1$I$20240313$20240401$20240717$20240717$PER$$US-NOVOPROD-1192750$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241022791$24102279$1$I$$20240312$20240717$20240717$PER$$US-NOVOPROD-1193140$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241022801$24102280$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1233231$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241022811$24102281$1$I$20221201$20240318$20240717$20240717$PER$$US-NOVOPROD-1193432$NOVO NORDISK$$72$YR$$M$Y$$$20240717$$CN$US$US
241022821$24102282$1$I$$20240314$20240717$20240717$PER$$US-NOVOPROD-1193066$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241022831$24102283$1$I$20240523$20240524$20240717$20240717$PER$$US-NOVOPROD-1233116$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$CN$US$US
241022841$24102284$1$I$20240301$20240315$20240717$20240717$PER$$US-NOVOPROD-1192876$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
241022851$24102285$1$I$20230101$20240315$20240717$20240717$PER$$US-NOVOPROD-1192843$NOVO NORDISK$$60$YR$$$Y$$$20240717$$CN$US$US
241022862$24102286$2$F$20231201$20240312$20240717$20240717$PER$$US-NOVOPROD-1193076$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241022871$24102287$1$I$$20240315$20240717$20240717$PER$$US-NOVOPROD-1193187$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241022881$24102288$1$I$20221201$20230623$20240717$20240717$PER$$US-NOVOPROD-1193064$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241022891$24102289$1$I$20230501$20230621$20240717$20240717$PER$$US-NOVOPROD-1193361$NOVO NORDISK$$37$YR$$F$Y$$$20240717$$MD$US$US
241022901$24102290$1$I$$20240314$20240717$20240717$PER$$US-NOVOPROD-1193199$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241022911$24102291$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1233205$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241022921$24102292$1$I$$20240313$20240717$20240717$PER$$US-NOVOPROD-1193109$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241022931$24102293$1$I$20230808$20240424$20240717$20240717$PER$$US-NOVOPROD-1192851$NOVO NORDISK$$82$YR$$M$Y$$$20240717$$CN$US$US
241022941$24102294$1$I$$20240709$20240717$20240717$PER$$US-APOTEX-2024AP008250$APOTEX$Mittal S, Eftekharzadeh S, Weinstein C, Fombona A, Hyacinthe N, Shah YB, et al.. Does ketorolac administration at the time of hypospadias surgery increase unplanned encounters in the immediate postoperative period?. Journal of Pediatric Urology Company. 2023;19(3):289.e1-289.e6$$$C$$Y$$$20240717$$HP$US$US
241022951$24102295$1$I$20240315$20240528$20240717$20240717$PER$$US-NOVOPROD-1193095$NOVO NORDISK$$62$YR$$M$Y$$$20240717$$CN$US$US
241022971$24102297$1$I$20240301$20240704$20240717$20240717$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-07332$SAMSUNG BIOEPIS$$75$YR$E$F$Y$$$20240717$$CN$GB$GB
241022981$24102298$1$I$$20240710$20240717$20240717$EXP$$JP-SANDOZ INC.-SDZ2024JP064750$SANDOZ$Kida M, Imada T, Sugiura K. A Case of Post-Breast Cancer Surgery Patient Who Developed Agranulocytosis Due to Tamoxifen After Recovery from Interstitial Pneumonia Caused by Anastrozole. The 32nd General Meeting of the Japanese Society for Breast Cancer (Proceedings). 2024;EP-1263$70$YR$$F$Y$$$20240717$$MD$JP$JP
241023002$24102300$2$F$$20240909$20240717$20240916$EXP$$FR-ROCHE-10000022470$ROCHE$$81$YR$E$$Y$$$20240916$$MD$FR$FR
241023011$24102301$1$I$20240704$20240712$20240717$20240717$30DAY$$US-GSK-US2024087757$GLAXOSMITHKLINE$$72$YR$$M$Y$$$20240717$$CN$US$US
241023021$24102302$1$I$$20240712$20240717$20240717$EXP$$JP-JNJFOC-20240743977$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240717$$PH$JP$JP
241023031$24102303$1$I$$20240710$20240717$20240717$EXP$$CA-GSK-CA2024085787$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$CA$CA
241023041$24102304$1$I$$20230822$20240717$20240717$PER$$US-NOVOPROD-1233381$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023051$24102305$1$I$$20240702$20240717$20240717$EXP$$PT-AZURITY PHARMACEUTICALS, INC.-AZR202407-000019$AZURITY PHARMACEUTICALS$Freitas GJ, Rodrigues A, Lisboa S, Mariz MJ.. Composite mantle cell and Burkitt lymphoma: a rare case report. Porto Biomedical Journal. 2024;9(3):e257$68$YR$$M$Y$$$20240717$$HP$PT$PT
241023062$24102306$2$F$20231201$20240528$20240717$20240717$PER$$US-NOVOPROD-1233490$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241023071$24102307$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1233706$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023081$24102308$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1233664$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241023091$24102309$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1233758$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241023101$24102310$1$I$20230101$20240531$20240717$20240717$PER$$US-NOVOPROD-1233497$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241023111$24102311$1$I$20240528$20240528$20240717$20240717$PER$$US-NOVOPROD-1233741$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
241023121$24102312$1$I$$20230724$20240717$20240717$PER$$US-NOVOPROD-1233537$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241023131$24102313$1$I$$20240531$20240717$20240717$PER$$US-NOVOPROD-1233418$NOVO NORDISK$$60$YR$$M$Y$$$20240717$$MD$US$US
241023141$24102314$1$I$20240514$20240528$20240717$20240717$PER$$US-NOVOPROD-1233938$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241023151$24102315$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1233675$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023161$24102316$1$I$$20240525$20240717$20240717$PER$$US-NOVOPROD-1233236$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023171$24102317$1$I$$20230822$20240717$20240717$PER$$US-NOVOPROD-1233385$NOVO NORDISK$$82$YR$$F$Y$$$20240717$$CN$US$US
241023181$24102318$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1234050$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241023191$24102319$1$I$20240401$20240531$20240717$20240717$PER$$US-NOVOPROD-1233299$NOVO NORDISK$$29$YR$$F$Y$$$20240717$$CN$US$US
241023201$24102320$1$I$$20230816$20240717$20240717$PER$$US-NOVOPROD-1233982$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023211$24102321$1$I$$20230816$20240717$20240717$PER$$US-NOVOPROD-1233956$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241023221$24102322$1$I$$20230823$20240717$20240717$PER$$US-NOVOPROD-1233390$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023231$24102323$1$I$20231101$20240528$20240717$20240717$PER$$US-NOVOPROD-1233685$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
241023241$24102324$1$I$$20230821$20240717$20240717$PER$$US-NOVOPROD-1233371$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023251$24102325$1$I$20240410$20240528$20240717$20240717$PER$$US-NOVOPROD-1233592$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
241023261$24102326$1$I$20240521$20240528$20240717$20240717$PER$$US-NOVOPROD-1233656$NOVO NORDISK$$84$YR$$F$Y$$$20240717$$CN$US$US
241023271$24102327$1$I$$20230824$20240717$20240717$PER$$US-NOVOPROD-1233416$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023281$24102328$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1233882$NOVO NORDISK$$37$YR$$M$Y$77.098$KG$20240717$$CN$US$US
241023291$24102329$1$I$$20240712$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065340$SANDOZ$$$$$$Y$$$20240717$$HP$CA$CA
241023301$24102330$1$I$$20240710$20240717$20240717$PER$$US-ROCHE-10000023093$ROCHE$$$$$$Y$$$20240717$$HP$US$US
241023311$24102331$1$I$20240207$20240710$20240717$20240717$EXP$$US-VANTIVE-2024BAX015785$Vantive US Healthcare$$71$YR$$M$Y$$$20240717$$MD$US$US
241023321$24102332$1$I$20240711$20240712$20240717$20240717$EXP$$VN-VANTIVE-2024VAN018310$Vantive US Healthcare$$$$C$F$Y$$$20240717$$HP$VN$VN
241023331$24102333$1$I$$20240529$20240717$20240717$PER$$US-NOVOPROD-1234299$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$HP$US$US
241023341$24102334$1$I$$20230809$20240717$20240717$PER$$US-NOVOPROD-1234188$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241023351$24102335$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1234166$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023361$24102336$1$I$$20230809$20240717$20240717$PER$$US-NOVOPROD-1234062$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241023371$24102337$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1234197$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241023381$24102338$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1234224$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241023391$24102339$1$I$20240528$20240528$20240717$20240717$PER$$US-NOVOPROD-1234336$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241023401$24102340$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1234194$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023411$24102341$1$I$$20240529$20240717$20240717$PER$$US-NOVOPROD-1234311$NOVO NORDISK$$$$A$$Y$$$20240717$$CN$US$US
241023421$24102342$1$I$$20240529$20240717$20240717$PER$$US-NOVOPROD-1234288$NOVO NORDISK$$49$YR$$F$Y$$$20240717$$PH$US$US
241023431$24102343$1$I$20240101$20240624$20240717$20240717$PER$$US-NOVOPROD-1234371$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241023441$24102344$1$I$$20230818$20240717$20240717$PER$$US-NOVOPROD-1234298$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023451$24102345$1$I$$20230818$20240717$20240717$PER$$US-NOVOPROD-1234153$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023461$24102346$1$I$$20230816$20240717$20240717$PER$$US-NOVOPROD-1234217$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241023471$24102347$1$I$20230901$20240528$20240717$20240717$PER$$US-NOVOPROD-1234353$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
241023481$24102348$1$I$20240327$20240529$20240717$20240717$PER$$US-NOVOPROD-1234312$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241023491$24102349$1$I$$20230809$20240717$20240717$PER$$US-NOVOPROD-1234253$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241023501$24102350$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1234252$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023511$24102351$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1234136$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023521$24102352$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1234404$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023531$24102353$1$I$20240409$20240528$20240717$20240717$PER$$US-NOVOPROD-1234323$NOVO NORDISK$$61$YR$$F$Y$$$20240717$$CN$US$US
241023541$24102354$1$I$20240528$20240528$20240717$20240717$PER$$US-NOVOPROD-1234151$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241023551$24102355$1$I$20231029$20240528$20240717$20240717$PER$$US-NOVOPROD-1234345$NOVO NORDISK$$64$YR$$M$Y$$$20240717$$CN$US$US
241023561$24102356$1$I$20240101$20240710$20240717$20240717$EXP$$US-INTERCEPT-PM2024001389$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
241023571$24102357$1$I$$20240709$20240717$20240717$PER$$US-APOTEX-2024AP008251$APOTEX$Mittal S, Eftekharzadeh S, Weinstein C, Fombona A, Hyacinthe N, Shah YB, et al.. Does ketorolac administration at the time of hypospadias surgery increase unplanned encounters in the immediate postoperative period?. Journal of Pediatric Urology Company. 2023;19(3):289.e1-289.e6$$$C$$Y$$$20240717$$HP$US$US
241023582$24102358$2$F$$20240729$20240717$20240731$EXP$$JP-ABBVIE-5842363$ABBVIE$$$$$M$Y$$$20240731$$MD$JP$JP
241023594$24102359$4$F$20240307$20240911$20240717$20240917$EXP$$US-ABBVIE-5840580$ABBVIE$$73$YR$$F$Y$56$KG$20240917$$CN$US$US
241023602$24102360$2$F$20240711$20240812$20240717$20240812$PER$$US-ALXN-202407USA000814US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241023611$24102361$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5840595$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241023624$24102362$4$F$$20240806$20240717$20240816$EXP$$US-GSK-US2024AMR088465$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
241023631$24102363$1$I$$20230817$20240717$20240717$PER$$US-NOVOPROD-1235229$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241023641$24102364$1$I$$20240529$20240717$20240717$PER$$US-NOVOPROD-1235398$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241023651$24102365$1$I$$20240713$20240717$20240717$EXP$$US-ABBVIE-5840723$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241023661$24102366$1$I$$20240715$20240717$20240717$PER$$US-JNJFOC-20240741245$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241023671$24102367$1$I$20240522$20240529$20240717$20240717$PER$$US-NOVOPROD-1234502$NOVO NORDISK$$72$YR$$F$Y$$$20240717$$CN$US$US
241023681$24102368$1$I$20240510$20240529$20240717$20240717$PER$$US-NOVOPROD-1234719$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241023691$24102369$1$I$20240401$20240529$20240717$20240717$PER$$US-NOVOPROD-1235272$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
241023701$24102370$1$I$$20230818$20240717$20240717$PER$$US-NOVOPROD-1234971$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023711$24102371$1$I$$20240529$20240717$20240717$PER$$US-NOVOPROD-1235175$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023723$24102372$3$F$$20240724$20240717$20240725$EXP$$CA-SANDOZ INC.-SDZ2024CA064806$SANDOZ$$$$$F$Y$$$20240725$$HP$CA$CA
241023731$24102373$1$I$20240524$20240529$20240717$20240717$PER$$US-NOVOPROD-1235123$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
241023741$24102374$1$I$20240522$20240529$20240717$20240717$PER$$US-NOVOPROD-1235201$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
241023751$24102375$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1234488$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241023761$24102376$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1235193$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241023771$24102377$1$I$$20240529$20240717$20240717$PER$$US-NOVOPROD-1234758$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241023781$24102378$1$I$20240523$20240529$20240717$20240717$PER$$US-NOVOPROD-1234850$NOVO NORDISK$$62$YR$$M$Y$$$20240717$$CN$US$US
241023791$24102379$1$I$20240517$20240617$20240717$20240717$PER$$US-NOVOPROD-1234508$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
241023801$24102380$1$I$20240201$20240528$20240717$20240717$PER$$US-NOVOPROD-1234418$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241023811$24102381$1$I$$20230818$20240717$20240717$PER$$US-NOVOPROD-1234978$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023821$24102382$1$I$$20240529$20240717$20240717$PER$$US-NOVOPROD-1235178$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023831$24102383$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1234513$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023841$24102384$1$I$$20230822$20240717$20240717$PER$$US-NOVOPROD-1235012$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241023851$24102385$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1234481$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023861$24102386$1$I$20240417$20240529$20240717$20240717$PER$$US-NOVOPROD-1234717$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$CN$US$US
241023871$24102387$1$I$$20230807$20240717$20240717$PER$$US-NOVOPROD-1235245$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241023881$24102388$1$I$20240521$20240528$20240717$20240717$PER$$US-NOVOPROD-1234553$NOVO NORDISK$$43$YR$$M$Y$$$20240717$$CN$US$US
241023891$24102389$1$I$20240401$20240617$20240717$20240717$PER$$US-NOVOPROD-1234954$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241023901$24102390$1$I$$20240606$20240717$20240717$PER$$US-NOVOPROD-1234925$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241023911$24102391$1$I$$20240704$20240717$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107517$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240717$$HP$CA$CA
241023921$24102392$1$I$20240619$20240715$20240717$20240717$PER$$US-HALEON-2187362$Haleon PLC$$$$$M$Y$$$20240717$$CN$US$US
241023931$24102393$1$I$20231220$20240710$20240717$20240717$EXP$GB-MHRA-31130421$GB-GE HEALTHCARE-2024CSU007836$GE HEALTHCARE$$57$YR$$$Y$$$20240717$$HP$GB$GB
241023941$24102394$1$I$$20240708$20240717$20240717$EXP$$US-ROCHE-10000020949$ROCHE$$67$YR$E$F$Y$$$20240717$$CN$US$US
241023952$24102395$2$F$$20240802$20240717$20240807$EXP$$NVSJ2024JP008413$NOVARTIS$Sugimura N, Okamoto A, Uryu E, Miyashita M, Takao S. A case of HER2-positive breast cancer after systemic therapy for luminal type  breast cancer with distant metastasis at the time of initial diagnosis. Journal of the Japanese Breast Cancer Society, The 32nd Annual Meeting of the  J. 2024;EP-1007$$$$$Y$$$20240807$$HP$JP$JP
241023961$24102396$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000027903$ROCHE$$$$A$F$Y$$$20240717$$HP$US$US
241023971$24102397$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000027442$ROCHE$$$$A$F$Y$$$20240717$$CN$US$US
241023981$24102398$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000027452$ROCHE$$$$E$F$Y$56.7$KG$20240717$$CN$US$US
241023991$24102399$1$I$20240529$20240529$20240717$20240717$PER$$US-NOVOPROD-1235401$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024001$24102400$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1235515$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241024011$24102401$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1158651$NOVO NORDISK$$48$YR$$$Y$$$20240717$$CN$US$US
241024021$24102402$1$I$$20231229$20240717$20240717$PER$$US-NOVOPROD-1158584$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241024031$24102403$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1158606$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241024042$24102404$2$F$$20231229$20240717$20240723$PER$$US-NOVOPROD-1158691$NOVO NORDISK$$58$YR$$M$Y$$$20240723$$CN$US$US
241024051$24102405$1$I$20230301$20231218$20240717$20240717$PER$$US-NOVOPROD-1158639$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024062$24102406$2$F$$20231229$20240717$20240723$PER$$US-NOVOPROD-1158707$NOVO NORDISK$$71$YR$$F$Y$$$20240723$$CN$US$US
241024071$24102407$1$I$$20240102$20240717$20240717$PER$$US-NOVOPROD-1158784$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241024081$24102408$1$I$$20240712$20240717$20240717$PER$$US-NOVOPROD-1235471$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024091$24102409$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1158649$NOVO NORDISK$$64$YR$$$Y$$$20240717$$CN$US$US
241024101$24102410$1$I$$20240529$20240717$20240717$PER$$US-NOVOPROD-1235543$NOVO NORDISK$$$$$F$Y$$$20240717$$PH$US$US
241024111$24102411$1$I$20231201$20231229$20240717$20240717$PER$$US-NOVOPROD-1158791$NOVO NORDISK$$33$YR$$F$Y$$$20240717$$CN$US$US
241024121$24102412$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1158573$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241024131$24102413$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1158817$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241024141$24102414$1$I$20231221$20231229$20240717$20240717$PER$$US-NOVOPROD-1158570$NOVO NORDISK$$80$YR$$M$Y$$$20240717$$CN$US$US
241024151$24102415$1$I$20231124$20231229$20240717$20240717$PER$$US-NOVOPROD-1158796$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
241024161$24102416$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1158831$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024171$24102417$1$I$20231101$20240220$20240717$20240717$PER$$US-NOVOPROD-1158644$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$CN$US$US
241024181$24102418$1$I$20240505$20240612$20240717$20240717$PER$$US-NOVOPROD-1235466$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
241024191$24102419$1$I$20221201$20231226$20240717$20240717$PER$$US-NOVOPROD-1158572$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241024201$24102420$1$I$$20240710$20240717$20240717$EXP$$JP-SANDOZ INC.-SDZ2024JP064751$SANDOZ$Sato E, Osanai T, Sakoma T. Two Cases of Rhomboid Skin Flap Reconstruction for Local Recurrence after Breast Cancer Surgery. The 32nd Annual Meeting of the Japanese Breast Cancer Association (Abstracts). 2024;EP-0344$67$YR$$F$Y$$$20240717$$MD$JP$JP
241024211$24102421$1$I$20240101$20240715$20240717$20240717$EXP$$US-ABBVIE-5842009$ABBVIE$$$$$M$Y$$$20240717$$HP$US$US
241024221$24102422$1$I$20240710$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024138680$AMGEN$$60$YR$A$F$Y$$$20240717$$CN$US$US
241024231$24102423$1$I$$20240715$20240717$20240717$EXP$NL-LRB-00985903$NL-JNJFOC-20240737426$JOHNSON AND JOHNSON$$76$YR$E$M$Y$85$KG$20240717$$CN$NL$NL
241024241$24102424$1$I$$20240715$20240717$20240717$PER$$US-JNJFOC-20240738751$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$HP$US$US
241024251$24102425$1$I$20231116$20240716$20240717$20240717$EXP$FR-AFSSAPS-AM2024000572$FR-JNJFOC-20240743877$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240717$$MD$FR$FR
241024261$24102426$1$I$$20240711$20240717$20240717$EXP$$US-GSK-US2024AMR086813$GLAXOSMITHKLINE$$$$$F$Y$$$20240717$$CN$US$US
241024273$24102427$3$F$$20240717$20240717$20240724$EXP$$US-GSK-US2024AMR085910$GLAXOSMITHKLINE$$$$$M$Y$$$20240724$$MD$US$US
241024281$24102428$1$I$20230101$20240708$20240717$20240717$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00723$BIOCRYST PHARMACEUTICALS$$30$YR$$F$Y$$$20240717$$MD$US$US
241024291$24102429$1$I$20221201$20240709$20240717$20240717$EXP$$NL-CELLTRION INC.-2024NL016925$CELLTRION$$$$$$Y$$$20240717$$MD$NL$NL
241024301$24102430$1$I$$20201006$20240717$20240717$EXP$$BR-AstraZeneca-2020SE98171$ASTRAZENECA$$57$YR$$F$Y$$$20240717$$CN$BR$
241024311$24102431$1$I$$20240102$20240717$20240717$PER$$US-NOVOPROD-1159153$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241024321$24102432$1$I$$20240102$20240717$20240717$PER$$US-NOVOPROD-1158977$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241024331$24102433$1$I$$20231229$20240717$20240717$PER$$US-NOVOPROD-1159057$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241024341$24102434$1$I$$20240120$20240717$20240717$PER$$US-NOVOPROD-1159081$NOVO NORDISK$$35$YR$$F$Y$$$20240717$$CN$US$US
241024352$24102435$2$F$20230101$20240126$20240717$20240717$PER$$US-NOVOPROD-1158980$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$MD$US$US
241024361$24102436$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1158853$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024371$24102437$1$I$$20231224$20240717$20240717$PER$$US-NOVOPROD-1158931$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241024381$24102438$1$I$$20231229$20240717$20240717$PER$$US-NOVOPROD-1159014$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024391$24102439$1$I$$20240101$20240717$20240717$PER$$US-NOVOPROD-1158774$NOVO NORDISK$$$$$F$Y$205$KG$20240717$$CN$US$US
241024401$24102440$1$I$20190703$20190717$20240717$20240717$EXP$$US-AstraZeneca-2019SF03635$ASTRAZENECA$$76$YR$$F$Y$85.7$KG$20240717$$CN$US$
241024411$24102441$1$I$$20231229$20240717$20240717$PER$$US-NOVOPROD-1159024$NOVO NORDISK$$39$YR$$F$Y$$$20240717$$CN$US$US
241024421$24102442$1$I$20231226$20240323$20240717$20240717$PER$$US-NOVOPROD-1158933$NOVO NORDISK$$49$YR$$F$Y$$$20240717$$CN$US$US
241024431$24102443$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1158835$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024441$24102444$1$I$20231113$20231229$20240717$20240717$PER$$US-NOVOPROD-1159182$NOVO NORDISK$$72$YR$$M$Y$$$20240717$$CN$US$US
241024451$24102445$1$I$$20231229$20240717$20240717$PER$$US-NOVOPROD-1158855$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241024461$24102446$1$I$20231220$20240212$20240717$20240717$PER$$US-NOVOPROD-1158833$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241024471$24102447$1$I$20231209$20231226$20240717$20240717$PER$$US-NOVOPROD-1159046$NOVO NORDISK$$55$YR$$M$Y$$$20240717$$CN$US$US
241024481$24102448$1$I$20231201$20231226$20240717$20240717$PER$$US-NOVOPROD-1158912$NOVO NORDISK$$38$YR$$F$Y$$$20240717$$CN$US$US
241024491$24102449$1$I$20231225$20231229$20240717$20240717$PER$$US-NOVOPROD-1158976$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241024501$24102450$1$I$$20231229$20240717$20240717$PER$$US-NOVOPROD-1159016$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241024513$24102451$3$F$20200310$20240812$20240717$20240814$EXP$$DE-ABBVIE-5840245$ABBVIE$$71$YR$$F$Y$$$20240814$$MD$DE$DE
241024521$24102452$1$I$$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024139975$AMGEN$$$$$$Y$$$20240717$$HP$US$US
241024532$24102453$2$F$$20240715$20240717$20240723$PER$$US-AMGEN-USASP2024140940$AMGEN$$$$$F$Y$$$20240723$$HP$US$US
241024542$24102454$2$F$$20240810$20240717$20240814$EXP$$US-ABBVIE-5840701$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
241024551$24102455$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-10000026094$ROCHE$$$$E$M$Y$$$20240717$$CN$US$US
241024561$24102456$1$I$$20240709$20240717$20240717$PER$$US-ABBVIE-5838376$ABBVIE$$$$$$Y$$$20240717$$MD$US$US
241024571$24102457$1$I$20240204$20240708$20240717$20240717$EXP$FR-AFSSAPS-RE2024000656$FR-TEVA-VS-3218883$TEVA$$78$YR$$F$Y$74$KG$20240717$$MD$FR$FR
241024581$24102458$1$I$20231228$20240102$20240717$20240717$PER$$US-NOVOPROD-1159206$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
241024591$24102459$1$I$$20231229$20240717$20240717$PER$$US-NOVOPROD-1159435$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024601$24102460$1$I$$20240102$20240717$20240717$PER$$US-NOVOPROD-1159434$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241024611$24102461$1$I$$20240327$20240717$20240717$PER$$US-NOVOPROD-1159316$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024622$24102462$2$F$$20240726$20240717$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA065624$SANDOZ$$34$YR$$M$Y$$$20240731$$MD$CA$CA
241024631$24102463$1$I$20231201$20240104$20240717$20240717$PER$$US-NOVOPROD-1159836$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241024641$24102464$1$I$20230901$20240103$20240717$20240717$PER$$US-NOVOPROD-1159417$NOVO NORDISK$$62$YR$$M$Y$$$20240717$$CN$US$US
241024651$24102465$1$I$$20231229$20240717$20240717$PER$$US-NOVOPROD-1159345$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024661$24102466$1$I$$20231229$20240717$20240717$PER$$US-NOVOPROD-1159382$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024671$24102467$1$I$$20231229$20240717$20240717$PER$$US-NOVOPROD-1159336$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024681$24102468$1$I$20231201$20240102$20240717$20240717$PER$$US-NOVOPROD-1159614$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241024691$24102469$1$I$20220601$20240319$20240717$20240717$PER$$US-NOVOPROD-1159815$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$MD$US$US
241024701$24102470$1$I$$20240102$20240717$20240717$PER$$US-NOVOPROD-1159284$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241024711$24102471$1$I$20231201$20240103$20240717$20240717$PER$$US-NOVOPROD-1159763$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$MD$US$US
241024721$24102472$1$I$$20231227$20240717$20240717$PER$$US-NOVOPROD-1159429$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024731$24102473$1$I$$20240103$20240717$20240717$PER$$US-NOVOPROD-1159596$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
241024741$24102474$1$I$$20231229$20240717$20240717$PER$$US-NOVOPROD-1159642$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241024751$24102475$1$I$$20231230$20240717$20240717$PER$$US-NOVOPROD-1159208$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241024761$24102476$1$I$20231206$20240102$20240717$20240717$PER$$US-NOVOPROD-1159715$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
241024771$24102477$1$I$20231214$20231229$20240717$20240717$PER$$US-NOVOPROD-1159730$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241024781$24102478$1$I$$20240711$20240717$20240717$PER$$US-BAUSCHBL-2024BNL030024$BAUSCH AND LOMB$$$$$M$Y$$$20240717$$CN$US$US
241024793$24102479$3$F$20230927$20240914$20240717$20240920$EXP$$CN-ABBVIE-5840888$ABBVIE$$2$YR$$F$Y$12$KG$20240920$$MD$CN$CN
241024811$24102481$1$I$20240627$20240708$20240717$20240717$EXP$$US-BEH-2024175442$CSL BEHRING$$75$YR$E$M$Y$75.283$KG$20240717$$CN$US$US
241024822$24102482$2$F$20240309$20240318$20240717$20240717$PER$$US-NOVOPROD-1193610$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241024831$24102483$1$I$20230501$20240422$20240717$20240717$PER$$US-NOVOPROD-1193688$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241024841$24102484$1$I$$20240315$20240717$20240717$PER$$US-NOVOPROD-1193655$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241024851$24102485$1$I$20231229$20240131$20240717$20240717$PER$$US-NOVOPROD-1159931$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
241024862$24102486$2$F$20230101$20240102$20240717$20240717$PER$$US-NOVOPROD-1159940$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241024871$24102487$1$I$20240301$20240412$20240717$20240717$PER$$US-NOVOPROD-1193684$NOVO NORDISK$$79$YR$$M$Y$$$20240717$$CN$US$US
241024882$24102488$2$F$$20240416$20240717$20240717$PER$$US-NOVOPROD-1193701$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$CN$US$US
241024892$24102489$2$F$$20240315$20240717$20240717$PER$$US-NOVOPROD-1193719$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241024901$24102490$1$I$20231219$20240102$20240717$20240717$PER$$US-NOVOPROD-1159939$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241024911$24102491$1$I$$20240318$20240717$20240717$PER$$US-NOVOPROD-1193609$NOVO NORDISK$$50$YR$$M$Y$$$20240717$$MD$US$US
241024921$24102492$1$I$20230503$20240221$20240717$20240717$PER$$US-NOVOPROD-1159879$NOVO NORDISK$$73$YR$$$Y$$$20240717$$HP$US$US
241024931$24102493$1$I$$20240711$20240717$20240717$EXP$$IE-Bion-013441$BIONPHARMA$$$$A$M$Y$$$20240717$$HP$IE$IE
241024941$24102494$1$I$20240626$20240626$20240717$20240717$EXP$$BR-AMGEN-BRASP2024140183$AMGEN$$61$YR$A$M$Y$100$KG$20240717$$MD$BR$BR
241024951$24102495$1$I$20240318$20240712$20240717$20240717$EXP$$DE-AMGEN-DEUNI2024139044$AMGEN$$31$YR$A$F$Y$51$KG$20240717$$MD$DE$DE
241024961$24102496$1$I$$20240712$20240717$20240717$PER$$US-JNJFOC-20240735394$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$HP$US$US
241024971$24102497$1$I$$20240711$20240717$20240717$PER$$US-JNJFOC-20240730298$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$MD$US$US
241024981$24102498$1$I$$20240715$20240717$20240717$EXP$$TR-Bion-013458$BIONPHARMA$$17$YR$T$F$Y$$$20240717$$HP$TR$TR
241024991$24102499$1$I$$20240710$20240717$20240717$PER$$US-JNJFOC-20240731125$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241025001$24102500$1$I$$20240701$20240717$20240717$PER$$US-ROCHE-10000020556$ROCHE$$62$YR$A$F$Y$$$20240717$$CN$US$US
241025011$24102501$1$I$20090823$20240710$20240717$20240717$EXP$$CH-CHEPLA-2024008707$CHEPLAPHARM$$66$YR$$M$Y$$$20240717$$CN$COUNTRY NOT SPECIFIED$CH
241025022$24102502$2$F$20240708$20240712$20240717$20240717$EXP$$BE-CHEPLA-2024008751$CHEPLAPHARM$$38$YR$$F$Y$$$20240717$$MD$COUNTRY NOT SPECIFIED$BE
241025031$24102503$1$I$20240529$20240710$20240717$20240717$EXP$ES-AEMPS-1541374$ES-CHEPLA-2024008682$CHEPLAPHARM$$26$YR$$F$Y$52$KG$20240716$$PH$COUNTRY NOT SPECIFIED$ES
241025041$24102504$1$I$20240625$20240711$20240717$20240717$EXP$PT-INFARMED-R202406-732$PT-CHEPLA-2024008750$CHEPLAPHARM$$37$YR$$M$Y$$$20240716$$PH$COUNTRY NOT SPECIFIED$PT
241025051$24102505$1$I$$20240708$20240717$20240717$30DAY$$US-GSK-US2024084959$GLAXOSMITHKLINE$$$$$F$Y$$$20240717$$CN$US$US
241025062$24102506$2$F$$20240912$20240717$20240924$PER$$US-GSK-US2024085138$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
241025071$24102507$1$I$$20240313$20240717$20240717$PER$$US-NOVOPROD-1193806$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025081$24102508$1$I$20240229$20240401$20240717$20240717$PER$$US-NOVOPROD-1193828$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241025092$24102509$2$F$$20240318$20240717$20240717$PER$$US-NOVOPROD-1193866$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241025101$24102510$1$I$$20240313$20240717$20240717$PER$$US-NOVOPROD-1193812$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025111$24102511$1$I$$20240313$20240717$20240717$PER$$US-NOVOPROD-1193799$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025121$24102512$1$I$$20240315$20240717$20240717$PER$$US-NOVOPROD-1193798$NOVO NORDISK$$51$YR$$F$Y$$$20240717$$CN$US$US
241025132$24102513$2$F$20221101$20240313$20240717$20240717$PER$$US-NOVOPROD-1193862$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025141$24102514$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1193789$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241025151$24102515$1$I$$20230614$20240717$20240717$PER$$US-NOVOPROD-1193935$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241025161$24102516$1$I$$20240412$20240717$20240717$PER$$US-NOVOPROD-1193800$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241025171$24102517$1$I$$20240715$20240717$20240717$PER$$US-ABBVIE-5841908$ABBVIE$$$$$$Y$$$20240717$$CN$US$US
241025181$24102518$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112522$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240717$$CN$US$US
241025202$24102520$2$F$20240315$20240404$20240717$20240717$PER$$US-NOVOPROD-1194366$NOVO NORDISK$$75$YR$$M$Y$$$20240717$$CN$US$US
241025211$24102521$1$I$20240206$20240320$20240717$20240717$PER$$US-NOVOPROD-1194281$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241025221$24102522$1$I$$20240318$20240717$20240717$PER$$US-NOVOPROD-1194140$NOVO NORDISK$$$$E$M$Y$$$20240717$$CN$US$US
241025231$24102523$1$I$20240213$20240313$20240717$20240717$PER$$US-NOVOPROD-1193746$NOVO NORDISK$$64$YR$$F$Y$71.6$KG$20240717$$HP$US$US
241025241$24102524$1$I$$20240319$20240717$20240717$PER$$US-NOVOPROD-1194083$NOVO NORDISK$$34$YR$$F$Y$$$20240717$$CN$US$US
241025251$24102525$1$I$20240202$20240315$20240717$20240717$PER$$US-NOVOPROD-1194020$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241025261$24102526$1$I$$20240318$20240717$20240717$PER$$US-NOVOPROD-1194345$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025271$24102527$1$I$$20240315$20240717$20240717$PER$$US-NOVOPROD-1194407$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241025281$24102528$1$I$$20240126$20240717$20240717$PER$$US-NOVOPROD-1194353$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241025291$24102529$1$I$20240210$20240318$20240717$20240717$PER$$US-NOVOPROD-1194160$NOVO NORDISK$$74$YR$$M$Y$$$20240717$$CN$US$US
241025301$24102530$1$I$$20240315$20240717$20240717$PER$$US-NOVOPROD-1194264$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
241025311$24102531$1$I$$20240318$20240717$20240717$PER$$US-NOVOPROD-1194404$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241025321$24102532$1$I$20240108$20240319$20240717$20240717$PER$$US-NOVOPROD-1194320$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241025331$24102533$1$I$$20230808$20240717$20240717$PER$$US-NOVOPROD-1194262$NOVO NORDISK$$82$YR$$$Y$$$20240717$$CN$US$US
241025341$24102534$1$I$$20240319$20240717$20240717$PER$$US-NOVOPROD-1194156$NOVO NORDISK$$74$YR$$M$Y$$$20240717$$HP$US$US
241025351$24102535$1$I$20240101$20240320$20240717$20240717$PER$$US-NOVOPROD-1194409$NOVO NORDISK$$74$YR$$M$Y$$$20240717$$CN$US$US
241025361$24102536$1$I$$20240318$20240717$20240717$PER$$US-NOVOPROD-1194136$NOVO NORDISK$$$$$M$Y$$$20240717$$PH$US$US
241025371$24102537$1$I$20230801$20240112$20240717$20240717$PER$$US-NOVOPROD-1194508$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025381$24102538$1$I$$20240314$20240717$20240717$PER$$US-NOVOPROD-1194284$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025391$24102539$1$I$20240320$20240320$20240717$20240717$PER$$US-NOVOPROD-1194293$NOVO NORDISK$$43$YR$$F$Y$$$20240717$$HP$US$US
241025401$24102540$1$I$$20240702$20240717$20240717$EXP$$AU-LUPIN EUROPE GMBH-2024-06127$LUPIN$$$$$$Y$$$20240717$$CN$AU$AU
241025422$24102542$2$F$20240405$20240711$20240717$20240724$EXP$$CN-JNJFOC-20240733383$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240724$$HP$CN$CN
241025431$24102543$1$I$$20240702$20240717$20240717$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109443$ZYDUS PHARM$Singh M, Kuo JK, Raza A.. Lamotrigine Induced Drug Reaction With Eosinophilia With Systemic Symptoms (DRESS)With HHV-6 Reactivation Causing Severe Encephalitis and Status Epilepticus.. Am-J-Respir-Crit-Care-Med. 2024;209:A1358$$$$$Y$$$20240717$$HP$US$US
241025441$24102544$1$I$20240612$20240708$20240717$20240717$EXP$FR-AFSSAPS-AN2024000875$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109640$ZYDUS PHARM$$$$$$Y$$$20240717$$PH$FR$FR
241025451$24102545$1$I$$20240702$20240717$20240717$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109459$ZYDUS PHARM$Mahmoud A, Le C, Kurt O, Zoarob D, Ayaz S.. An Unsettling Twist: Unveiling Acute Hyponatremia Induced by Linezolid: A Case Report.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240717$$HP$US$US
241025461$24102546$1$I$$20240703$20240717$20240717$EXP$$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-109405$ZYDUS PHARM$$$$$$Y$$$20240717$$PH$GB$GB
241025471$24102547$1$I$$20240710$20240717$20240717$EXP$$JP-AstraZeneca-2024A159607$ASTRAZENECA$$$$$$Y$$$20240717$$MD$JP$
241025481$24102548$1$I$20200101$20200811$20240717$20240717$EXP$$TH-AstraZeneca-2020SF01783$ASTRAZENECA$$65$YR$$F$Y$$$20240717$$CN$TH$
241025491$24102549$1$I$20240313$20240320$20240717$20240717$PER$$US-NOVOPROD-1194802$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
241025501$24102550$1$I$20240101$20240318$20240717$20240717$PER$$US-NOVOPROD-1194629$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241025511$24102551$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065452$SANDOZ$$$$$M$Y$$$20240717$$HP$CA$CA
241025521$24102552$1$I$$20240318$20240717$20240717$PER$$US-NOVOPROD-1194633$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025531$24102553$1$I$$20240318$20240717$20240717$PER$$US-NOVOPROD-1194585$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241025541$24102554$1$I$$20240319$20240717$20240717$PER$$US-NOVOPROD-1195021$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025551$24102555$1$I$20231002$20240709$20240717$20240717$EXP$$FR-BIOCON BIOLOGICS LIMITED-BBL2024000986$BIOCON$$$$$$Y$$$20240717$$MD$FR$FR
241025561$24102556$1$I$20240130$20240422$20240717$20240717$PER$$US-NOVOPROD-1194533$NOVO NORDISK$$53$YR$$M$Y$90.249$KG$20240717$$HP$US$US
241025571$24102557$1$I$$20240315$20240717$20240717$PER$$US-NOVOPROD-1194908$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025581$24102558$1$I$$20240315$20240717$20240717$PER$$US-NOVOPROD-1194935$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241025591$24102559$1$I$20240317$20240317$20240717$20240717$PER$$US-NOVOPROD-1194857$NOVO NORDISK$$81$YR$$M$Y$$$20240717$$CN$US$US
241025601$24102560$1$I$$20240317$20240717$20240717$PER$$US-NOVOPROD-1194799$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241025611$24102561$1$I$20240227$20240320$20240717$20240717$PER$$US-NOVOPROD-1194567$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
241025621$24102562$1$I$$20240319$20240717$20240717$PER$$US-NOVOPROD-1194913$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241025631$24102563$1$I$20240315$20240319$20240717$20240717$PER$$US-NOVOPROD-1194740$NOVO NORDISK$$38$YR$$F$Y$$$20240717$$CN$US$US
241025641$24102564$1$I$$20240319$20240717$20240717$PER$$US-NOVOPROD-1194653$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
241025651$24102565$1$I$$20240318$20240717$20240717$PER$$US-NOVOPROD-1194695$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025661$24102566$1$I$20240209$20240321$20240717$20240717$PER$$US-NOVOPROD-1195047$NOVO NORDISK$$77$YR$$M$Y$$$20240717$$CN$US$US
241025671$24102567$1$I$20240311$20240319$20240717$20240717$PER$$US-NOVOPROD-1194917$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025681$24102568$1$I$$20240318$20240717$20240717$PER$$US-NOVOPROD-1194634$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241025691$24102569$1$I$$20240320$20240717$20240717$PER$$US-NOVOPROD-1195054$NOVO NORDISK$$56$YR$$M$Y$$$20240717$$CN$US$US
241025701$24102570$1$I$20210301$20240320$20240717$20240717$PER$$US-NOVOPROD-1194961$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025711$24102571$1$I$20230301$20240318$20240717$20240717$PER$$US-NOVOPROD-1194645$NOVO NORDISK$$60$YR$$M$Y$$$20240717$$CN$US$US
241025721$24102572$1$I$20240318$20240318$20240717$20240717$PER$$US-NOVOPROD-1194670$NOVO NORDISK$$60$YR$$F$Y$$$20240717$$CN$US$US
241025731$24102573$1$I$$20240319$20240717$20240717$PER$$US-NOVOPROD-1194854$NOVO NORDISK$$50$YR$$M$Y$$$20240717$$HP$US$US
241025741$24102574$1$I$$20240317$20240717$20240717$PER$$US-NOVOPROD-1194849$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241025751$24102575$1$I$$20240708$20240717$20240717$EXP$$IN-ROCHE-3446189$ROCHE$$70$YR$E$M$Y$$$20240717$$MD$IN$IN
241025761$24102576$1$I$$20240715$20240717$20240717$EXP$$SK-ROCHE-10000028001$ROCHE$$$$$M$Y$$$20240717$$PH$SK$SK
241025771$24102577$1$I$20240625$20240704$20240717$20240717$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000603$PAREXEL$$$$$$Y$$$20240717$$HP$CN$CN
241025781$24102578$1$I$$20240709$20240717$20240717$EXP$$US-JNJFOC-20240723103$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$HP$US$US
241025794$24102579$4$F$20240710$20240823$20240717$20240830$30DAY$$US-JNJFOC-20240730463$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240830$$PH$US$US
241025801$24102580$1$I$20240711$20240712$20240717$20240717$EXP$$CA-JNJFOC-20240735072$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240717$$CN$CA$CA
241025811$24102581$1$I$$20240320$20240717$20240717$PER$$US-NOVOPROD-1195709$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241025821$24102582$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1189212$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025831$24102583$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1189190$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241025841$24102584$1$I$20240229$20240507$20240717$20240717$PER$$US-NOVOPROD-1189147$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$MD$US$US
241025851$24102585$1$I$20240321$20240327$20240717$20240717$PER$$US-NOVOPROD-1195588$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025861$24102586$1$I$$20240319$20240717$20240717$PER$$US-NOVOPROD-1195659$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025871$24102587$1$I$$20240313$20240717$20240717$PER$$US-NOVOPROD-1195149$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241025881$24102588$1$I$20240311$20240411$20240717$20240717$PER$$US-NOVOPROD-1195451$NOVO NORDISK$$63$YR$$M$Y$$$20240717$$CN$US$US
241025891$24102589$1$I$20180101$20240320$20240717$20240717$PER$$US-NOVOPROD-1195267$NOVO NORDISK$$44$YR$$F$Y$$$20240717$$CN$US$US
241025901$24102590$1$I$20240202$20240501$20240717$20240717$PER$$US-NOVOPROD-1195120$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241025911$24102591$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1189218$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241025921$24102592$1$I$20240316$20240320$20240717$20240717$PER$$US-NOVOPROD-1195141$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
241025931$24102593$1$I$$20240318$20240717$20240717$PER$$US-NOVOPROD-1195428$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025941$24102594$1$I$$20240319$20240717$20240717$PER$$US-NOVOPROD-1195603$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241025951$24102595$1$I$20231001$20240307$20240717$20240717$PER$$US-NOVOPROD-1189171$NOVO NORDISK$$87$YR$$F$Y$$$20240717$$CN$US$US
241025961$24102596$1$I$20240308$20240307$20240717$20240717$PER$$US-NOVOPROD-1189281$NOVO NORDISK$$77$YR$$M$Y$$$20240717$$CN$US$US
241025971$24102597$1$I$20240211$20240307$20240717$20240717$PER$$US-NOVOPROD-1189159$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241025981$24102598$1$I$$20240319$20240717$20240717$PER$$US-NOVOPROD-1195710$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241025991$24102599$1$I$$20240319$20240717$20240717$PER$$US-NOVOPROD-1195316$NOVO NORDISK$$$$A$F$Y$$$20240717$$MD$US$US
241026001$24102600$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1189193$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026011$24102601$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1189173$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026021$24102602$1$I$20221116$20240703$20240717$20240717$EXP$$KR-BLUEPRINT MEDICINES CORPORATION-2024BUS000149$Unknown Manufacturer$$$$$$Y$$$20240716$$MD$KR$KR
241026032$24102603$2$F$$20240725$20240717$20240729$EXP$$JP-SANDOZ INC.-SDZ2024JP064748$SANDOZ$Sasaki E, Ohashi M, Nishimoto Y, Komai M, Itoi N, Ri T. Two Cases of Local Recurrence 22 Years after Bilateral Breast-Conserving Surgery. The 32nd Annual Meeting of the Japanese Breast Cancer Society (Abstracts). 2024;EP-1184$74$YR$$F$Y$$$20240729$$MD$JP$JP
241026042$24102604$2$F$20240626$20240905$20240717$20240912$EXP$PT-INFARMED-B202406-690$PT-AMGEN-PRTSP2024137997$AMGEN$$44$YR$A$F$Y$80$KG$20240912$$PH$PT$PT
241026051$24102605$1$I$$20240710$20240717$20240717$EXP$$US-GSK-US2024085728$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$US$US
241026061$24102606$1$I$20240625$20240709$20240717$20240717$EXP$$US-Stemline Therapeutics, Inc.-2024ST004207$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240716$$CN$US$US
241026071$24102607$1$I$$20240705$20240717$20240717$EXP$$IN-ROCHE-10000022634$ROCHE$$62$YR$A$M$Y$$$20240717$$CN$IN$IN
241026081$24102608$1$I$$20240715$20240717$20240717$PER$$US-ABBVIE-5841732$ABBVIE$$$$$$Y$$$20240717$$CN$US$US
241026091$24102609$1$I$$20240712$20240717$20240717$EXP$$NVSC2024US145754$NOVARTIS$$38$YR$$F$Y$$$20240717$$HP$US$US
241026101$24102610$1$I$20240601$20240710$20240717$20240717$EXP$$US-Stemline Therapeutics, Inc.-2024ST004239$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240716$$CN$US$US
241026111$24102611$1$I$$20240708$20240717$20240717$EXP$GB-MHRA-MED-202405031148239530-WSKJZ$GB-AMAROX PHARMA-AMR2024GB02228$HETERO$$$$$F$Y$$$20240717$$HP$GB$GB
241026122$24102612$2$F$$20240521$20240717$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003252$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240718$$CN$US$US
241026131$24102613$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-10000025662$ROCHE$$$$$F$Y$$$20240717$$MD$US$US
241026141$24102614$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1189448$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026151$24102615$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1160047$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241026161$24102616$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1189288$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026172$24102617$2$F$$20240305$20240717$20240721$PER$$US-NOVOPROD-1189381$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241026181$24102618$1$I$20221101$20240102$20240717$20240717$PER$$US-NOVOPROD-1160171$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241026191$24102619$1$I$$20240102$20240717$20240717$PER$$US-NOVOPROD-1160340$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026202$24102620$2$F$$20240807$20240717$20240808$PER$$US-ALXN-202407USA000792US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240808$$CN$US$US
241026211$24102621$1$I$20230301$20240102$20240717$20240717$PER$$US-NOVOPROD-1160343$NOVO NORDISK$$69$YR$$F$Y$$$20240717$$CN$US$US
241026221$24102622$1$I$$20240103$20240717$20240717$PER$$US-NOVOPROD-1160118$NOVO NORDISK$$70$YR$$F$Y$$$20240717$$HP$US$US
241026231$24102623$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1189450$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241026241$24102624$1$I$20231127$20240104$20240717$20240717$PER$$US-NOVOPROD-1160372$NOVO NORDISK$$54$YR$$F$Y$$$20240717$$CN$US$US
241026251$24102625$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1189297$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241026261$24102626$1$I$20240201$20240307$20240717$20240717$PER$$US-NOVOPROD-1189349$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241026271$24102627$1$I$20230909$20240104$20240717$20240717$PER$$US-NOVOPROD-1160303$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241026281$24102628$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1189393$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026291$24102629$1$I$20240522$20240523$20240717$20240717$PER$$US-NOVOPROD-1232510$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$CN$US$US
241026301$24102630$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1189282$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026311$24102631$1$I$20240101$20240408$20240717$20240717$PER$$US-NOVOPROD-1189362$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
241026321$24102632$1$I$$20230607$20240717$20240717$PER$$US-NOVOPROD-1189429$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026331$24102633$1$I$20240301$20240523$20240717$20240717$PER$$US-NOVOPROD-1232417$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026341$24102634$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1189352$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241026351$24102635$1$I$20240523$20240523$20240717$20240717$PER$$US-NOVOPROD-1232407$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241026361$24102636$1$I$20240303$20240307$20240717$20240717$PER$$US-NOVOPROD-1189397$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241026371$24102637$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1189398$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241026381$24102638$1$I$20230901$20240102$20240717$20240717$PER$$US-NOVOPROD-1160086$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241026391$24102639$1$I$20231005$20240523$20240717$20240717$PER$$US-NOVOPROD-1232484$NOVO NORDISK$$22$YR$$F$Y$$$20240717$$HP$US$US
241026401$24102640$1$I$20240601$20240715$20240717$20240717$EXP$$US-UCBSA-2024035917$UCB$$33$YR$$F$Y$$$20240717$$HP$US$US
241026412$24102641$2$F$20240701$20240729$20240717$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040177$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240730$$CN$US$US
241026421$24102642$1$I$20230116$20240709$20240717$20240717$EXP$$FR-CELLTRION INC.-2024FR017004$CELLTRION$$$$$$Y$$$20240717$$MD$FR$FR
241026431$24102643$1$I$20240707$20240712$20240717$20240717$EXP$$CN-BEIGENE-BGN-2024-010904$BEIGENE$$$$$$Y$$$20240717$$HP$CN$CN
241026441$24102644$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140192$AMGEN$$$$C$F$Y$$$20240717$$HP$US$US
241026451$24102645$1$I$$20240708$20240717$20240717$PER$$US-JNJFOC-20240742137$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240717$$CN$US$US
241026461$24102646$1$I$$20240712$20240717$20240717$PER$$US-JNJFOC-20240736191$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240717$$MD$US$US
241026471$24102647$1$I$$20240715$20240717$20240717$PER$$NVSC2024US146899$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241026481$24102648$1$I$20220801$20240709$20240717$20240717$EXP$$ES-ROCHE-10000006893$ROCHE$$66$YR$E$M$Y$$$20240717$$MD$ES$ES
241026491$24102649$1$I$20240307$20240620$20240717$20240717$PER$$US-NOVOPROD-1189522$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
241026501$24102650$1$I$20230601$20240523$20240717$20240717$PER$$US-NOVOPROD-1232526$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
241026511$24102651$1$I$20240115$20240306$20240717$20240717$PER$$US-NOVOPROD-1189961$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241026521$24102652$1$I$$20240308$20240717$20240717$PER$$US-NOVOPROD-1189660$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026531$24102653$1$I$20240101$20240308$20240717$20240717$PER$$US-NOVOPROD-1189648$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241026541$24102654$1$I$$20240308$20240717$20240717$PER$$US-NOVOPROD-1189713$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241026552$24102655$2$F$20220701$20240327$20240717$20240717$PER$$US-NOVOPROD-1189707$NOVO NORDISK$$59$YR$$F$Y$$$20240717$$CN$US$US
241026561$24102656$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1189815$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241026571$24102657$1$I$20240228$20240307$20240717$20240717$PER$$US-NOVOPROD-1189662$NOVO NORDISK$$69$YR$$M$Y$$$20240717$$CN$US$US
241026581$24102658$1$I$$20240306$20240717$20240717$PER$$US-NOVOPROD-1189453$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241026591$24102659$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1189650$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$HP$US$US
241026601$24102660$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1189949$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241026611$24102661$1$I$20221101$20240308$20240717$20240717$PER$$US-NOVOPROD-1189686$NOVO NORDISK$$55$YR$$M$Y$$$20240717$$CN$US$US
241026621$24102662$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1189717$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241026631$24102663$1$I$$20240305$20240717$20240717$PER$$US-NOVOPROD-1190009$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241026641$24102664$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1189950$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026651$24102665$1$I$$20240307$20240717$20240717$PER$$US-NOVOPROD-1189976$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026661$24102666$1$I$$20240429$20240717$20240717$PER$$US-NOVOPROD-1189746$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
241026671$24102667$1$I$$20240301$20240717$20240717$PER$$US-NOVOPROD-1189952$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026682$24102668$2$F$$20240306$20240717$20240717$PER$$US-NOVOPROD-1190020$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241026692$24102669$2$F$20211129$20240918$20240717$20240924$EXP$$CO-UCBSA-2024035937$UCB$$87$YR$$M$Y$$$20240924$$CN$CO$CO
241026701$24102670$1$I$20240623$20240712$20240717$20240717$EXP$$CN-BEIGENE-BGN-2024-010907$BEIGENE$$$$$$Y$$$20240717$$HP$CN$CN
241026712$24102671$2$F$$20240405$20240717$20240717$PER$$US-NOVOPROD-1190220$NOVO NORDISK$$$$E$F$Y$92.063$KG$20240717$$CN$US$US
241026721$24102672$1$I$20210101$20240311$20240717$20240717$PER$$US-NOVOPROD-1190133$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026731$24102673$1$I$20240303$20240308$20240717$20240717$PER$$US-NOVOPROD-1190125$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026741$24102674$1$I$20230301$20240308$20240717$20240717$PER$$US-NOVOPROD-1190152$NOVO NORDISK$$48$YR$$F$Y$$$20240717$$CN$US$US
241026751$24102675$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1190259$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241026761$24102676$1$I$20240301$20240307$20240717$20240717$PER$$US-NOVOPROD-1190128$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026771$24102677$1$I$20240301$20240311$20240717$20240717$PER$$US-NOVOPROD-1190263$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026781$24102678$1$I$20240308$20240311$20240717$20240717$PER$$US-NOVOPROD-1190278$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026791$24102679$1$I$20231101$20240708$20240717$20240717$PER$$US-NOVOPROD-1190096$NOVO NORDISK$$$$A$M$Y$$$20240717$$MD$US$US
241026801$24102680$1$I$20230101$20240306$20240717$20240717$PER$$US-NOVOPROD-1190037$NOVO NORDISK$$81$YR$$F$Y$$$20240717$$CN$US$US
241026811$24102681$1$I$20240308$20240308$20240717$20240717$PER$$US-NOVOPROD-1190103$NOVO NORDISK$$86$YR$$F$Y$$$20240717$$CN$US$US
241026821$24102682$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1190255$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026831$24102683$1$I$20240307$20240308$20240717$20240717$PER$$US-NOVOPROD-1190091$NOVO NORDISK$$54$YR$$F$Y$$$20240717$$CN$US$US
241026841$24102684$1$I$20240101$20240307$20240717$20240717$PER$$US-NOVOPROD-1190067$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241026852$24102685$2$F$20210101$20240311$20240717$20240717$PER$$US-NOVOPROD-1190228$NOVO NORDISK$$81$YR$$M$Y$$$20240717$$CN$US$US
241026861$24102686$1$I$$20240308$20240717$20240717$PER$$US-NOVOPROD-1190146$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241026871$24102687$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1190230$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241026881$24102688$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-10000026213$ROCHE$$$$E$F$Y$$$20240717$$CN$US$US
241026891$24102689$1$I$$20240710$20240717$20240717$PER$$US-JNJFOC-20240733688$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$115.8$KG$20240717$$MD$US$US
241026901$24102690$1$I$20240605$20240710$20240717$20240717$EXP$AT-BASGAGES-2024-004520$AT-TEVA-VS-3219804$TEVA$$56$YR$$F$Y$$$20240717$$CN$AT$AT
241026911$24102691$1$I$$20240716$20240717$20240717$EXP$$CZ-SANDOZ INC.-SDZ2024CZ065464$SANDOZ$$2$YR$$M$Y$$$20240717$$HP$CZ$CZ
241026921$24102692$1$I$20240227$20240229$20240717$20240717$PER$$US-NOVOPROD-1190288$NOVO NORDISK$$79$YR$$M$Y$$$20240717$$CN$US$US
241026931$24102693$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1231012$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026941$24102694$1$I$20230810$20230828$20240717$20240717$PER$$US-NOVOPROD-1231197$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241026951$24102695$1$I$20230901$20231005$20240717$20240717$PER$$US-NOVOPROD-1190513$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241026961$24102696$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1231370$NOVO NORDISK$$$$$F$Y$$$20240717$$MD$US$US
241026971$24102697$1$I$$20230829$20240717$20240717$PER$$US-NOVOPROD-1231323$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241026981$24102698$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1190337$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241026991$24102699$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1190498$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241027001$24102700$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1231049$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241027011$24102701$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1231247$NOVO NORDISK$$$$A$$Y$$$20240717$$PH$US$US
241027021$24102702$1$I$$20230907$20240717$20240717$PER$$US-NOVOPROD-1231422$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027031$24102703$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1230957$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241027041$24102704$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1231044$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241027051$24102705$1$I$20240501$20240528$20240717$20240717$PER$$US-NOVOPROD-1231371$NOVO NORDISK$$49$YR$$M$Y$$$20240717$$MD$US$US
241027061$24102706$1$I$20240501$20240531$20240717$20240717$PER$$US-NOVOPROD-1231497$NOVO NORDISK$$74$YR$$F$Y$$$20240717$$CN$US$US
241027071$24102707$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1190430$NOVO NORDISK$$$$$F$Y$$$20240717$$HP$US$US
241027081$24102708$1$I$20240514$20240522$20240717$20240717$PER$$US-NOVOPROD-1231116$NOVO NORDISK$$28$YR$$M$Y$$$20240717$$MD$US$US
241027091$24102709$1$I$20240506$20240530$20240717$20240717$PER$$US-NOVOPROD-1231178$NOVO NORDISK$$$$$F$Y$62.58$KG$20240717$$HP$US$US
241027101$24102710$1$I$$20240528$20240717$20240717$PER$$US-NOVOPROD-1231375$NOVO NORDISK$$56$YR$$M$Y$$$20240717$$CN$US$US
241027111$24102711$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1231033$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241027121$24102712$1$I$20220501$20240307$20240717$20240717$PER$$US-NOVOPROD-1190544$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027131$24102713$1$I$$20230828$20240717$20240717$PER$$US-NOVOPROD-1231386$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241027141$24102714$1$I$20240219$20240327$20240717$20240717$PER$$US-NOVOPROD-1190455$NOVO NORDISK$$63$YR$$F$Y$90.703$KG$20240717$$MD$US$US
241027151$24102715$1$I$$20231012$20240717$20240717$PER$$US-NOVOPROD-1190425$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027161$24102716$1$I$$20240311$20240717$20240717$PER$$US-NOVOPROD-1190341$NOVO NORDISK$$84$YR$$$Y$$$20240717$$CN$US$US
241027171$24102717$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1231303$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241027181$24102718$1$I$20240201$20240520$20240717$20240717$PER$$US-NOVOPROD-1231000$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241027191$24102719$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1231498$NOVO NORDISK$$25$YR$$F$Y$$$20240717$$CN$US$US
241027202$24102720$2$F$$20240718$20240717$20240802$EXP$$FR-VER-202400010$VERITY PHARMACEUTICALS$$51$YR$A$F$Y$54$KG$20240802$$CN$FR$FR
241027211$24102721$1$I$20240715$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140220$AMGEN$$73$YR$E$F$Y$$$20240717$$CN$US$US
241027221$24102722$1$I$20240101$20240711$20240717$20240717$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-013047$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240717$$CN$JP$JP
241027231$24102723$1$I$$20240702$20240717$20240717$EXP$$US-HLS-202400215$HLS THERAPEUTICS$$$$A$$Y$$$20240717$$MD$US$US
241027243$24102724$3$F$$20240823$20240717$20240830$EXP$$CA-ABBVIE-5839960$ABBVIE$$$$A$F$Y$$$20240830$$CN$CA$CA
241027251$24102725$1$I$$20240710$20240717$20240717$EXP$$CA-APOTEX-2024AP008192$APOTEX$$18$YR$$F$Y$53$KG$20240717$$PH$CA$CA
241027261$24102726$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1232154$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027271$24102727$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1231518$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241027281$24102728$1$I$$20230901$20240717$20240717$PER$$US-NOVOPROD-1232088$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027291$24102729$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1231540$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241027301$24102730$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1231713$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241027311$24102731$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1231884$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241027321$24102732$1$I$20240516$20240523$20240717$20240717$PER$$US-NOVOPROD-1231875$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
241027331$24102733$1$I$20240301$20240523$20240717$20240717$PER$$US-NOVOPROD-1231978$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
241027341$24102734$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1231563$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027351$24102735$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1231715$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027361$24102736$1$I$20240514$20240523$20240717$20240717$PER$$US-NOVOPROD-1231956$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241027371$24102737$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1231933$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241027381$24102738$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1232094$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241027391$24102739$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1231995$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241027401$24102740$1$I$$20240501$20240717$20240717$PER$$US-NOVOPROD-1231565$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027411$24102741$1$I$20240401$20240522$20240717$20240717$PER$$US-NOVOPROD-1231751$NOVO NORDISK$$73$YR$$M$Y$$$20240717$$CN$US$US
241027421$24102742$1$I$$20240529$20240717$20240717$PER$$US-NOVOPROD-1232026$NOVO NORDISK$$55$YR$$M$Y$$$20240717$$MD$US$US
241027431$24102743$1$I$20240515$20240530$20240717$20240717$PER$$US-NOVOPROD-1231571$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027441$24102744$1$I$20240201$20240523$20240717$20240717$PER$$US-NOVOPROD-1231566$NOVO NORDISK$$71$YR$$$Y$$$20240717$$CN$US$US
241027451$24102745$1$I$$20230831$20240717$20240717$PER$$US-NOVOPROD-1231993$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027461$24102746$1$I$$20240529$20240717$20240717$PER$$US-NOVOPROD-1231977$NOVO NORDISK$$49$YR$$F$Y$$$20240717$$HP$US$US
241027471$24102747$1$I$20240501$20240523$20240717$20240717$PER$$US-NOVOPROD-1232169$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
241027481$24102748$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1231812$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027491$24102749$1$I$$20240522$20240717$20240717$PER$$US-NOVOPROD-1231504$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027501$24102750$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009413$ELI LILLY AND CO$$$$$F$Y$$$20240717$$PH$US$US
241027511$24102751$1$I$$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010460$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240717$$CN$US$US
241027541$24102754$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008709$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
241027551$24102755$1$I$20240711$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009405$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240717$$CN$US$US
241027561$24102756$1$I$20231201$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009500$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240717$$CN$US$US
241027571$24102757$1$I$$20240710$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407007067$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
241027582$24102758$2$F$20240709$20240723$20240717$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407008423$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240724$$CN$US$US
241027591$24102759$1$I$20240701$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009774$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240717$$CN$US$US
241027601$24102760$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010056$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240717$$CN$US$US
241027611$24102761$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009867$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240717$$CN$US$US
241027621$24102762$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009838$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240717$$CN$US$US
241027631$24102763$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009415$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240717$$CN$US$US
241027641$24102764$1$I$20240714$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009544$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240717$$CN$US$US
241027651$24102765$1$I$20240715$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009404$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240717$$PH$US$US
241027661$24102766$1$I$20240711$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008034$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240717$$CN$US$US
241027671$24102767$1$I$20240703$20240708$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407005324$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240717$$CN$US$US
241027681$24102768$1$I$20240710$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009801$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240717$$CN$US$US
241027691$24102769$1$I$20240714$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010025$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240717$$CN$US$US
241027701$24102770$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009620$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
241027711$24102771$1$I$$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008430$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240717$$CN$US$US
241027721$24102772$1$I$20240101$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009865$ELI LILLY AND CO$$$$$$Y$$$20240717$$CN$US$US
241027731$24102773$1$I$20240701$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009920$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240717$$CN$US$US
241027741$24102774$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009834$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240717$$CN$US$US
241027751$24102775$1$I$20240401$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202404013522$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240717$$MD$US$US
241027762$24102776$2$F$20240712$20240905$20240717$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202407009779$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240909$$CN$US$US
241027771$24102777$1$I$20240601$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009839$ELI LILLY AND CO$$62$YR$A$$Y$$$20240717$$PH$US$US
241027781$24102778$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009913$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
241027791$24102779$1$I$20240611$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009956$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240717$$CN$US$US
241027801$24102780$1$I$20240710$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202405000283$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240717$$CN$US$US
241027811$24102781$1$I$$20240710$20240717$20240717$EXP$$US-ROCHE-10000022992$ROCHE$$77$YR$E$M$Y$$$20240717$$CN$US$US
241027821$24102782$1$I$20231121$20240709$20240717$20240717$EXP$$DE-CELLTRION INC.-2024DE016926$CELLTRION$$$$$$Y$$$20240717$$MD$DE$DE
241027831$24102783$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160358$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241027841$24102784$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1232224$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241027851$24102785$1$I$20240709$20240709$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112554$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240717$$CN$US$US
241027861$24102786$1$I$20240401$20240524$20240717$20240717$PER$$US-NOVOPROD-1232352$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241027871$24102787$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1232223$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027881$24102788$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1232176$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241027891$24102789$1$I$$20240529$20240717$20240717$PER$$US-NOVOPROD-1232215$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241027902$24102790$2$F$20231108$20240715$20240717$20240725$EXP$$US-NOVOPROD-1232205$NOVO NORDISK$$74$YR$$F$Y$$$20240725$$CN$US$US
241027911$24102791$1$I$20240520$20240523$20240717$20240717$PER$$US-NOVOPROD-1232241$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241027921$24102792$1$I$20230818$20230818$20240717$20240717$PER$$US-NOVOPROD-1232378$NOVO NORDISK$$$$$M$Y$$$20240717$$PH$US$US
241027931$24102793$1$I$20240515$20240523$20240717$20240717$PER$$US-NOVOPROD-1232202$NOVO NORDISK$$71$YR$$F$Y$$$20240717$$CN$US$US
241027941$24102794$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1232207$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241027951$24102795$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1232256$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241027961$24102796$1$I$$20230724$20240717$20240717$PER$$US-NOVOPROD-1232218$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241027971$24102797$1$I$$20230818$20240717$20240717$PER$$US-NOVOPROD-1232372$NOVO NORDISK$$$$E$$Y$$$20240717$$CN$US$US
241027981$24102798$1$I$20240306$20240523$20240717$20240717$PER$$US-NOVOPROD-1232253$NOVO NORDISK$$44$YR$$F$Y$$$20240717$$PH$US$US
241027991$24102799$1$I$20240511$20240524$20240717$20240717$PER$$US-NOVOPROD-1232396$NOVO NORDISK$$74$YR$$M$Y$$$20240717$$CN$US$US
241028001$24102800$1$I$20240428$20240524$20240717$20240717$PER$$US-NOVOPROD-1232212$NOVO NORDISK$$65$YR$$F$Y$$$20240717$$CN$US$US
241028011$24102801$1$I$$20230720$20240717$20240717$PER$$US-NOVOPROD-1232225$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241028021$24102802$1$I$$20240523$20240717$20240717$PER$$US-NOVOPROD-1232220$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241028031$24102803$1$I$20240708$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140467$AMGEN$$64$YR$A$F$Y$$$20240717$$CN$US$US
241028042$24102804$2$F$20240714$20240716$20240717$20240720$PER$$US-AMGEN-USASP2024140358$AMGEN$$82$YR$E$F$Y$$$20240719$$CN$US$US
241028051$24102805$1$I$20240424$20240711$20240717$20240717$PER$$NVSC2024US144842$NOVARTIS$$$$$M$Y$$$20240717$$HP$US$US
241028061$24102806$1$I$$20240703$20240717$20240717$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06746$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241028071$24102807$1$I$$20240715$20240717$20240717$PER$$US-JNJFOC-20240739896$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$PH$US$US
241028082$24102808$2$F$$20240806$20240717$20240811$30DAY$$IT-JNJFOC-20240736859$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$PH$IT$IT
241028091$24102809$1$I$20171004$20240702$20240717$20240717$EXP$$US-COOPERSURGICAL, INC.-2024CPS002103$COOPERSURGICAL$$$$$F$Y$$$20240717$$LW$US$US
241028101$24102810$1$I$20141101$20240702$20240717$20240717$EXP$$US-COOPERSURGICAL, INC.-2024CPS002084$COOPERSURGICAL$$$$$F$Y$$$20240717$$LW$US$US
241028111$24102811$1$I$20210319$20240702$20240717$20240717$EXP$$US-COOPERSURGICAL, INC.-2024CPS002092$COOPERSURGICAL$$$$$F$Y$$$20240717$$LW$US$US
241028121$24102812$1$I$20210212$20240702$20240717$20240717$EXP$$US-COOPERSURGICAL, INC.-2024CPS002091$COOPERSURGICAL$$$$$F$Y$$$20240717$$LW$US$US
241028131$24102813$1$I$20210604$20240702$20240717$20240717$EXP$$US-COOPERSURGICAL, INC.-2024CPS002093$COOPERSURGICAL$$$$$F$Y$$$20240717$$LW$US$US
241028141$24102814$1$I$20150319$20240702$20240717$20240717$EXP$$US-COOPERSURGICAL, INC.-2024CPS002102$COOPERSURGICAL$$$$$F$Y$$$20240717$$LW$US$US
241028151$24102815$1$I$20210322$20240702$20240717$20240717$EXP$$US-COOPERSURGICAL, INC.-2024CPS002083$COOPERSURGICAL$$$$$F$Y$$$20240717$$LW$US$US
241028161$24102816$1$I$20210617$20240702$20240717$20240717$EXP$$US-COOPERSURGICAL, INC.-2024CPS002085$COOPERSURGICAL$$$$$F$Y$$$20240717$$LW$US$US
241028171$24102817$1$I$20240531$20240704$20240717$20240717$EXP$$FR-ROCHE-10000026450$ROCHE$$72$YR$E$F$Y$$$20240717$$MD$FR$FR
241028181$24102818$1$I$20240518$20240524$20240717$20240717$PER$$US-NOVOPROD-1232847$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
241028191$24102819$1$I$20231106$20231220$20240717$20240717$PER$$US-NOVOPROD-1155556$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241028201$24102820$1$I$20240523$20240524$20240717$20240717$PER$$US-NOVOPROD-1232766$NOVO NORDISK$$41$YR$$M$Y$$$20240717$$CN$US$US
241028212$24102821$2$F$20240201$20240524$20240717$20240717$PER$$US-NOVOPROD-1232850$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
241028221$24102822$1$I$20231201$20240524$20240717$20240717$PER$$US-NOVOPROD-1233004$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$CN$US$US
241028231$24102823$1$I$20230301$20231221$20240717$20240717$PER$$US-NOVOPROD-1155883$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
241028241$24102824$1$I$$20231218$20240717$20240717$PER$$US-NOVOPROD-1155528$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241028251$24102825$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1232894$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241028261$24102826$1$I$$20240530$20240717$20240717$PER$$US-NOVOPROD-1232528$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$MD$US$US
241028271$24102827$1$I$20220101$20231220$20240717$20240717$PER$$US-NOVOPROD-1155542$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
241028281$24102828$1$I$20240301$20240524$20240717$20240717$PER$$US-NOVOPROD-1233077$NOVO NORDISK$$76$YR$$$Y$$$20240717$$CN$US$US
241028291$24102829$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1233006$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241028301$24102830$1$I$$20231002$20240717$20240717$PER$$US-NOVOPROD-1232650$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241028311$24102831$1$I$20230701$20240124$20240717$20240717$PER$$US-NOVOPROD-1155550$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241028321$24102832$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1232853$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241028331$24102833$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1232398$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241028341$24102834$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1232869$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241028351$24102835$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1232917$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241028361$24102836$1$I$20240522$20240524$20240717$20240717$PER$$US-NOVOPROD-1232795$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241028371$24102837$1$I$20240702$20240710$20240717$20240717$PER$$US-BAUSCHBL-2024BNL029968$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240717$$CN$US$US
241028381$24102838$1$I$$20231218$20240717$20240717$PER$$US-NOVOPROD-1156070$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241028391$24102839$1$I$$20231220$20240717$20240717$PER$$US-NOVOPROD-1156168$NOVO NORDISK$$72$YR$$M$Y$$$20240717$$CN$US$US
241028401$24102840$1$I$20231101$20240227$20240717$20240717$PER$$US-NOVOPROD-1156610$NOVO NORDISK$$53$YR$$F$Y$$$20240717$$CN$US$US
241028411$24102841$1$I$$20231222$20240717$20240717$PER$$US-NOVOPROD-1156596$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241028421$24102842$1$I$$20231219$20240717$20240717$PER$$US-NOVOPROD-1156009$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241028431$24102843$1$I$$20231218$20240717$20240717$PER$$US-NOVOPROD-1156060$NOVO NORDISK$$$$E$$Y$$$20240717$$CN$US$US
241028441$24102844$1$I$20231221$20240301$20240717$20240717$PER$$US-NOVOPROD-1156622$NOVO NORDISK$$64$YR$$M$Y$$$20240717$$CN$US$US
241028452$24102845$2$F$20231211$20231219$20240717$20240717$PER$$US-NOVOPROD-1156453$NOVO NORDISK$$58$YR$$F$Y$$$20240717$$CN$US$US
241028462$24102846$2$F$20230901$20231220$20240717$20240717$PER$$US-NOVOPROD-1156554$NOVO NORDISK$$70$YR$$M$Y$$$20240717$$CN$US$US
241028471$24102847$1$I$$20231220$20240717$20240717$PER$$US-NOVOPROD-1156224$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241028481$24102848$1$I$20230801$20231214$20240717$20240717$PER$$US-NOVOPROD-1155981$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241028491$24102849$1$I$20231101$20231220$20240717$20240717$PER$$US-NOVOPROD-1155935$NOVO NORDISK$$66$YR$$M$Y$$$20240717$$CN$US$US
241028501$24102850$1$I$$20231221$20240717$20240717$PER$$US-NOVOPROD-1155987$NOVO NORDISK$$56$YR$$F$Y$$$20240717$$LW$US$US
241028511$24102851$1$I$$20231218$20240717$20240717$PER$$US-NOVOPROD-1156057$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241028521$24102852$1$I$$20231219$20240717$20240717$PER$$US-NOVOPROD-1156185$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241028531$24102853$1$I$$20231219$20240717$20240717$PER$$US-NOVOPROD-1155989$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241028541$24102854$1$I$$20240125$20240717$20240717$PER$$US-NOVOPROD-1156598$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241028551$24102855$1$I$$20231222$20240717$20240717$PER$$US-NOVOPROD-1156606$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241028561$24102856$1$I$20231214$20231221$20240717$20240717$PER$$US-NOVOPROD-1155914$NOVO NORDISK$$73$YR$$F$Y$$$20240717$$CN$US$US
241028571$24102857$1$I$20231208$20231220$20240717$20240717$PER$$US-NOVOPROD-1156542$NOVO NORDISK$$36$YR$$F$Y$$$20240717$$HP$US$US
241028581$24102858$1$I$20231101$20231215$20240717$20240717$PER$$US-NOVOPROD-1156016$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241028591$24102859$1$I$$20240715$20240717$20240717$EXP$$US-UCBSA-2024036006$UCB$$$$$F$Y$$$20240717$$HP$US$US
241028602$24102860$2$F$$20240903$20240717$20240909$EXP$$US-ASTELLAS-2024US020133$ASTELLAS$$73$YR$E$M$Y$$$20240909$$CN$US$US
241028611$24102861$1$I$20231201$20240708$20240717$20240717$EXP$$JP-EMD Serono-2024038173$EMD SERONO INC$$79$YR$E$F$Y$56$KG$20240717$$MD$JP$JP
241028621$24102862$1$I$20240624$20240704$20240717$20240717$EXP$$PK-ROCHE-10000023004$ROCHE$$53$YR$A$F$Y$$$20240717$$CN$PK$PK
241028631$24102863$1$I$20220328$20240712$20240717$20240717$EXP$$FR-BIOCON BIOLOGICS LIMITED-BBL2023002114$BIOCON$$$$$$Y$$$20240717$$HP$FR$FR
241028641$24102864$1$I$$20231226$20240717$20240717$PER$$US-NOVOPROD-1157194$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241028651$24102865$1$I$20231025$20240124$20240717$20240717$PER$$US-NOVOPROD-1157203$NOVO NORDISK$$59$YR$$M$Y$$$20240717$$CN$US$US
241028661$24102866$1$I$$20231222$20240717$20240717$PER$$US-NOVOPROD-1156869$NOVO NORDISK$$42$YR$$M$Y$$$20240717$$MD$US$US
241028671$24102867$1$I$$20231220$20240717$20240717$PER$$US-NOVOPROD-1156791$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241028681$24102868$1$I$20230301$20240212$20240717$20240717$PER$$US-NOVOPROD-1156802$NOVO NORDISK$$77$YR$$F$Y$$$20240717$$CN$US$US
241028691$24102869$1$I$20230927$20240404$20240717$20240717$PER$$US-NOVOPROD-1157132$NOVO NORDISK$$74$YR$$M$Y$$$20240717$$CN$US$US
241028701$24102870$1$I$20231001$20231227$20240717$20240717$PER$$US-NOVOPROD-1157423$NOVO NORDISK$$68$YR$$M$Y$$$20240717$$CN$US$US
241028711$24102871$1$I$$20231226$20240717$20240717$PER$$US-NOVOPROD-1157333$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241028721$24102872$1$I$$20231226$20240717$20240717$PER$$US-NOVOPROD-1157338$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241028731$24102873$1$I$$20231220$20240717$20240717$PER$$US-NOVOPROD-1156785$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241028741$24102874$1$I$20230701$20231218$20240717$20240717$PER$$US-NOVOPROD-1156832$NOVO NORDISK$$64$YR$$F$Y$$$20240717$$CN$US$US
241028751$24102875$1$I$20230904$20240209$20240717$20240717$PER$$US-NOVOPROD-1157183$NOVO NORDISK$$68$YR$$F$Y$$$20240717$$MD$US$US
241028761$24102876$1$I$$20231222$20240717$20240717$PER$$US-NOVOPROD-1157239$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241028771$24102877$1$I$$20231226$20240717$20240717$PER$$US-NOVOPROD-1157468$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241028781$24102878$1$I$$20231221$20240717$20240717$PER$$US-NOVOPROD-1156712$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241028791$24102879$1$I$20230101$20231221$20240717$20240717$PER$$US-NOVOPROD-1157447$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
241028801$24102880$1$I$$20231221$20240717$20240717$PER$$US-NOVOPROD-1156749$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241028811$24102881$1$I$20231212$20240219$20240717$20240717$PER$$US-NOVOPROD-1157330$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241028821$24102882$1$I$20230101$20231227$20240717$20240717$PER$$US-NOVOPROD-1157289$NOVO NORDISK$$22$YR$$M$Y$$$20240717$$HP$US$US
241028831$24102883$1$I$$20231226$20240717$20240717$PER$$US-NOVOPROD-1157465$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241028841$24102884$1$I$$20200408$20240717$20240717$EXP$$US-AstraZeneca-2020SE49357$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241028851$24102885$1$I$$20210113$20240717$20240717$EXP$$US-AstraZeneca-2020SF11043$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241028861$24102886$1$I$$20190715$20240717$20240717$EXP$$NL-AstraZeneca-2019SF03429$ASTRAZENECA$$$$$$Y$$$20240717$$MD$NL$
241028871$24102887$1$I$$20200323$20240717$20240717$EXP$$US-AstraZeneca-2020SE42001$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241028881$24102888$1$I$$20200303$20240717$20240717$EXP$$US-AstraZeneca-2020SE33443$ASTRAZENECA$$$$$M$Y$63$KG$20240717$$CN$US$
241028891$24102889$1$I$$20200821$20240717$20240717$EXP$$GB-AstraZeneca-2020SF07719$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$GB$
241028903$24102890$3$F$20240101$20240805$20240717$20240903$PER$$US-AstraZeneca-2024A159072$ASTRAZENECA$$90$YR$$F$Y$$$20240903$$CN$US$
241028911$24102891$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A158314$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241028921$24102892$1$I$$20240709$20240717$20240717$EXP$$JP-AstraZeneca-2024A158102$ASTRAZENECA$$$$$$Y$$$20240717$$PH$JP$
241028931$24102893$1$I$$20240709$20240717$20240717$PER$$US-ROCHE-10000023201$ROCHE$$68$YR$E$M$Y$$$20240717$$CN$US$US
241028942$24102894$2$F$$20240829$20240717$20240906$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-111192$BRISTOL MYERS SQUIBB$$$$A$M$Y$$$20240906$$MD$IT$IT
241028951$24102895$1$I$20240617$20240715$20240717$20240717$EXP$PT-INFARMED-J202407-265$PT-GILEAD-2024-0680810$GILEAD$$32$YR$A$M$Y$67$KG$20240717$$CN$PT$PT
241028961$24102896$1$I$$20240711$20240717$20240717$PER$$US-MTPC-MTDA2024-0014619$Unknown Manufacturer$$$$A$$Y$$$20240717$$PH$US$US
241028972$24102897$2$F$20240612$20240724$20240717$20240731$EXP$$JP-MTPC-MTPC2024-0014506$Unknown Manufacturer$$72$YR$$M$Y$$$20240731$$PH$JP$JP
241028981$24102898$1$I$20240105$20240715$20240717$20240717$EXP$$ZA-SANDOZ INC.-SDZ2024ZA001569$SANDOZ$$51$YR$$F$Y$$$20240717$$CN$ZA$ZA
241028992$24102899$2$F$$20240829$20240717$20240830$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040218$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240830$$CN$US$US
241029001$24102900$1$I$20240101$20240710$20240717$20240717$EXP$$US-CHIESI-2024CHF04182$CHIESI$$$$$F$Y$71$KG$20240717$$CN$US$US
241029011$24102901$1$I$20231117$20240116$20240717$20240717$PER$$US-NOVOPROD-1157873$NOVO NORDISK$$67$YR$$F$Y$$$20240717$$CN$US$US
241029021$24102902$1$I$20231215$20240305$20240717$20240717$PER$$US-NOVOPROD-1157872$NOVO NORDISK$$53$YR$$M$Y$$$20240717$$CN$US$US
241029031$24102903$1$I$20231201$20240229$20240717$20240717$PER$$US-NOVOPROD-1157666$NOVO NORDISK$$85$YR$$M$Y$$$20240717$$MD$US$US
241029041$24102904$1$I$20231227$20231228$20240717$20240717$PER$$US-NOVOPROD-1157596$NOVO NORDISK$$71$YR$$M$Y$$$20240717$$CN$US$US
241029051$24102905$1$I$20231117$20231226$20240717$20240717$PER$$US-NOVOPROD-1157475$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241029061$24102906$1$I$$20231226$20240717$20240717$PER$$US-NOVOPROD-1157805$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241029071$24102907$1$I$20231209$20240222$20240717$20240717$PER$$US-NOVOPROD-1157725$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
241029081$24102908$1$I$20231227$20231227$20240717$20240717$PER$$US-NOVOPROD-1157493$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241029091$24102909$1$I$20231017$20231226$20240717$20240717$PER$$US-NOVOPROD-1157474$NOVO NORDISK$$45$YR$$F$Y$$$20240717$$CN$US$US
241029101$24102910$1$I$20231201$20240212$20240717$20240717$PER$$US-NOVOPROD-1157699$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241029111$24102911$1$I$$20231215$20240717$20240717$PER$$US-NOVOPROD-1157867$NOVO NORDISK$$$$$M$Y$$$20240717$$MD$US$US
241029121$24102912$1$I$20231121$20231227$20240717$20240717$PER$$US-NOVOPROD-1157957$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241029131$24102913$1$I$$20231225$20240717$20240717$PER$$US-NOVOPROD-1157886$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241029141$24102914$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1157983$NOVO NORDISK$$59$YR$$$Y$$$20240717$$CN$US$US
241029151$24102915$1$I$20221101$20240710$20240717$20240717$EXP$$US-CHIESI-2024CHF04183$CHIESI$$11$YR$$M$Y$$$20240717$$MD$US$US
241029161$24102916$1$I$20230101$20231226$20240717$20240717$PER$$US-NOVOPROD-1157516$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241029171$24102917$1$I$20230201$20240116$20240717$20240717$PER$$US-NOVOPROD-1157866$NOVO NORDISK$$48$YR$$F$Y$$$20240717$$CN$US$US
241029181$24102918$1$I$$20231227$20240717$20240717$PER$$US-NOVOPROD-1157710$NOVO NORDISK$$79$YR$$F$Y$$$20240717$$CN$US$US
241029191$24102919$1$I$$20231227$20240717$20240717$PER$$US-NOVOPROD-1157702$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241029201$24102920$1$I$20231201$20231227$20240717$20240717$PER$$US-NOVOPROD-1157660$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241029211$24102921$1$I$$20240704$20240717$20240717$EXP$GB-MHRA-MED-202405020930463390-BMKSH$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001710$IPCA$$$$$$Y$$$20240717$$PH$GB$GB
241029231$24102923$1$I$20231001$20240702$20240717$20240717$EXP$$FR-PHARMAAND GMBH-2024PHR00414$pharmaAND$$62$YR$$F$Y$$$20240717$$MD$FR$FR
241029241$24102924$1$I$20240101$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112425$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240717$$HP$US$US
241029251$24102925$1$I$20240531$20240716$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113094$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240717$$CN$US$US
241029262$24102926$2$F$$20240918$20240717$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112532$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240920$$CN$US$US
241029271$24102927$1$I$$20240524$20240717$20240717$PER$$US-NOVOPROD-1158192$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241029281$24102928$1$I$20240420$20240707$20240717$20240717$EXP$GB-MHRA-MED-202407071345118960-SRWCL$GB-NOVOPROD-1252400$NOVO NORDISK$$24$YR$$F$Y$73$KG$20240717$$CN$GB$GB
241029291$24102929$1$I$20231227$20240105$20240717$20240717$PER$$US-NOVOPROD-1158185$NOVO NORDISK$$81$YR$$M$Y$$$20240717$$CN$US$US
241029301$24102930$1$I$20240101$20240705$20240717$20240717$EXP$$US-NOVOPROD-1253253$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241029311$24102931$1$I$$20231226$20240717$20240717$PER$$US-NOVOPROD-1158352$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241029321$24102932$1$I$20231201$20231228$20240717$20240717$PER$$US-NOVOPROD-1158535$NOVO NORDISK$$78$YR$$F$Y$$$20240717$$CN$US$US
241029331$24102933$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1158369$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241029341$24102934$1$I$$20231226$20240717$20240717$PER$$US-NOVOPROD-1158276$NOVO NORDISK$$65$YR$$M$Y$$$20240717$$CN$US$US
241029351$24102935$1$I$$20231227$20240717$20240717$PER$$US-NOVOPROD-1158256$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241029361$24102936$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1158543$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241029372$24102937$2$F$$20240806$20240717$20240816$EXP$$CN-NOVOPROD-1254579$NOVO NORDISK$$66$YR$$F$Y$75$KG$20240816$$CN$CN$CN
241029381$24102938$1$I$$20240111$20240717$20240717$PER$$US-NOVOPROD-1158419$NOVO NORDISK$$67$YR$$M$Y$$$20240717$$CN$US$US
241029391$24102939$1$I$20231206$20231226$20240717$20240717$PER$$US-NOVOPROD-1158416$NOVO NORDISK$$41$YR$$F$Y$$$20240717$$CN$US$US
241029401$24102940$1$I$20240630$20240707$20240717$20240717$EXP$GB-MHRA-MED-202407071355390310-QKFDH$GB-NOVOPROD-1252395$NOVO NORDISK$$40$YR$$F$Y$98$KG$20240717$$MD$GB$GB
241029411$24102941$1$I$$20231227$20240717$20240717$PER$$US-NOVOPROD-1158246$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241029421$24102942$1$I$$20240312$20240717$20240717$PER$$US-NOVOPROD-1190571$NOVO NORDISK$$$$$M$Y$$$20240717$$HP$US$US
241029431$24102943$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1158035$NOVO NORDISK$$55$YR$$F$Y$$$20240717$$CN$US$US
241029441$24102944$1$I$$20231228$20240717$20240717$PER$$US-NOVOPROD-1158540$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241029451$24102945$1$I$$20240711$20240717$20240717$EXP$$JP-EMD Serono-2024038022$EMD SERONO INC$$77$YR$E$M$Y$$$20240717$$PH$JP$JP
241029461$24102946$1$I$20240101$20240702$20240717$20240717$EXP$$DE-ROCHE-10000026307$ROCHE$$$$$F$Y$$$20240717$$MD$DE$DE
241029471$24102947$1$I$$20240626$20240717$20240717$PER$$US-JNJFOC-20240669375$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241029481$24102948$1$I$$20240706$20240717$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-034686$AUROBINDO$Ahmad E, Tawney A, Mehta N, Kutinsky IB.. SUCCESSFUL SUPPRESSION OF SHORT- COUPLED PURKINJE VF TRIGGERS WITH FLECAINIDE.. Heart-Rhythm. 2024;21 (Suppl.)(5):S306-S307$28$YR$$F$Y$$$20240717$$HP$US$US
241029491$24102949$1$I$20240615$20240709$20240717$20240717$EXP$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-01353$ULTRAGENYX PHARMACEUTICAL$$1$YR$$M$Y$$$20240717$$CN$US$US
241029501$24102950$1$I$$20240710$20240717$20240717$EXP$$JP-ROCHE-10000027332$ROCHE$$49$YR$A$F$Y$$$20240717$$MD$JP$JP
241029511$24102951$1$I$20240610$20240708$20240717$20240717$EXP$GB-MHRA-MED-202407081026314480-QHGRB$GB-NOVOPROD-1252525$NOVO NORDISK$$40$YR$$F$Y$$$20240717$$CN$GB$GB
241029521$24102952$1$I$$20240708$20240717$20240717$EXP$$US-NOVOPROD-1253529$NOVO NORDISK$$$$$$Y$$$20240717$$CN$US$US
241029531$24102953$1$I$20240301$20240708$20240717$20240717$EXP$$US-NOVOPROD-1247861$NOVO NORDISK$$$$A$F$Y$$$20240717$$CN$US$US
241029541$24102954$1$I$$20240708$20240717$20240717$EXP$$US-NOVOPROD-1254511$NOVO NORDISK$$$$A$M$Y$$$20240717$$CN$US$US
241029551$24102955$1$I$20240506$20240708$20240717$20240717$EXP$GB-MHRA-MED-202405101434168630-JLRHF$GB-NOVOPROD-1252544$NOVO NORDISK$$63$YR$$M$Y$$$20240717$$PH$GB$GB
241029561$24102956$1$I$20240426$20240708$20240717$20240717$EXP$DK-DKMA-30733809$DK-NOVOPROD-1252591$NOVO NORDISK$$67$YR$$F$Y$60$KG$20240717$$MD$DK$DK
241029571$24102957$1$I$$20240707$20240717$20240717$EXP$$US-NOVOPROD-1255365$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241029581$24102958$1$I$$20240708$20240717$20240717$EXP$$JP-NOVOPROD-1252821$NOVO NORDISK$$85$YR$$F$Y$$$20240717$$PH$JP$JP
241029591$24102959$1$I$$20240708$20240717$20240717$EXP$$US-NOVOPROD-1253556$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241029611$24102961$1$I$20240603$20240708$20240717$20240717$EXP$$US-NOVOPROD-1254449$NOVO NORDISK$$62$YR$$F$Y$$$20240717$$CN$US$US
241029621$24102962$1$I$$20240708$20240717$20240717$EXP$CA-HEALTHCANVIG-001090648$CA-NOVOPROD-1255332$NOVO NORDISK$$55$YR$$M$Y$86.1$KG$20240717$$PH$CA$CA
241029631$24102963$1$I$20240112$20240707$20240717$20240717$EXP$$US-NOVOPROD-1253563$NOVO NORDISK$$63$YR$$F$Y$$$20240717$$CN$US$US
241029642$24102964$2$F$$20240712$20240717$20240723$EXP$$US-NOVOPROD-1253566$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241029651$24102965$1$I$20240301$20240708$20240717$20240717$EXP$DK-DKMA-30729653$DK-NOVOPROD-1252588$NOVO NORDISK$$76$YR$$F$Y$$$20240717$$MD$DK$DK
241029661$24102966$1$I$$20240708$20240717$20240717$EXP$$US-NOVOPROD-1252256$NOVO NORDISK$$$$$M$Y$$$20240717$$CN$US$US
241029671$24102967$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202407051239129710-SHRWC$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-109449$ZYDUS PHARM$$$$$$Y$$$20240717$$CN$GB$GB
241029681$24102968$1$I$20240510$20240708$20240717$20240717$EXP$FR-AFSSAPS-SE2024000541$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109647$ZYDUS PHARM$$$$$$Y$$$20240717$$MD$FR$FR
241029691$24102969$1$I$20240611$20240708$20240717$20240717$EXP$FR-AFSSAPS-BX2024001382$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109650$ZYDUS PHARM$$$$$$Y$$$20240717$$MD$FR$FR
241029701$24102970$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009822$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240717$$CN$US$US
241029711$24102971$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009750$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240717$$CN$US$US
241029721$24102972$1$I$$20240714$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010044$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240717$$CN$US$US
241029731$24102973$1$I$20240713$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010064$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240717$$CN$US$US
241029741$24102974$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009736$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240717$$CN$US$US
241029751$24102975$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009522$ELI LILLY AND CO$$$$$$Y$$$20240717$$CN$US$US
241029761$24102976$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009436$ELI LILLY AND CO$$$$$M$Y$$$20240717$$CN$US$US
241029771$24102977$1$I$20240710$20240710$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008660$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240717$$HP$US$US
241029781$24102978$1$I$20240619$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010508$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240717$$CN$US$US
241029791$24102979$1$I$20240715$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009421$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240717$$CN$US$US
241029801$24102980$1$I$20240619$20240710$20240717$20240717$EXP$$LB-ROCHE-10000013095$ROCHE$$74$YR$E$M$Y$$$20240717$$CN$LB$LB
241029811$24102981$1$I$$20240708$20240717$20240717$PER$$US-HALEON-2186080$Haleon PLC$$$$$$Y$$$20240709$$CN$US$US
241029821$24102982$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024141063$AMGEN$$$$$M$Y$$$20240717$$CN$US$US
241029831$24102983$1$I$20240101$20240715$20240717$20240717$EXP$$CA-ABBVIE-5842351$ABBVIE$$75$YR$$M$Y$$$20240717$$HP$CA$CA
241029841$24102984$1$I$20240511$20240514$20240717$20240717$PER$$US-NOVOPROD-1226658$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241029851$24102985$1$I$$20240708$20240717$20240717$EXP$$CA-APOTEX-2024AP008069$APOTEX$$50$YR$$M$Y$$$20240717$$HP$CA$CA
241029861$24102986$1$I$$20240314$20240717$20240717$PER$$US-NOVOPROD-1193787$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241029871$24102987$1$I$20231113$20240522$20240717$20240717$PER$$US-NOVOPROD-1147207$NOVO NORDISK$$66$YR$$F$Y$$$20240717$$CN$US$US
241029881$24102988$1$I$20231001$20240522$20240717$20240717$PER$$US-NOVOPROD-1207194$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241029891$24102989$1$I$20240307$20240318$20240717$20240717$PER$$US-NOVOPROD-1194124$NOVO NORDISK$$75$YR$$F$Y$$$20240717$$CN$US$US
241029901$24102990$1$I$20240625$20240708$20240717$20240717$EXP$GB-MHRA-MED-202407011148496560-HCBTQ$GB-TEVA-VS-3219140$TEVA$$72$YR$$F$Y$65$KG$20240717$$CN$GB$GB
241029911$24102991$1$I$20240601$20240708$20240717$20240717$EXP$GB-MHRA-MED-202407081013031350-FPMLC$GB-TEVA-VS-3219450$TEVA$$64$YR$$M$Y$$$20240717$$PH$GB$GB
241029922$24102992$2$F$$20240726$20240717$20240805$EXP$$IR-ROCHE-10000024767$ROCHE$Rahbar M, Latifi M P, Mahmoudi E, Seyhoun I, Dehghani S. Long-term graft survival in a kidney transplant recipient with glioblastoma: Case report. Transplantation Reports. 2024;9 (3):1-3. doi:10.1016/j.tpr.2024.100158.$61$YR$A$F$Y$$$20240804$$HP$IR$IR
241029931$24102993$1$I$$20240710$20240717$20240717$EXP$$CA-ROCHE-10000026377$ROCHE$$$$$$Y$$$20240717$$CN$CA$CA
241029941$24102994$1$I$20240501$20240702$20240717$20240717$EXP$$US-COOPERSURGICAL, INC.-2024CPS001913$COOPERSURGICAL$$26$YR$$F$Y$81.633$KG$20240717$$HP$US$US
241029951$24102995$1$I$20210601$20240710$20240717$20240717$PER$$US-BIOGEN-2021BI01028531$BIOGEN$$40$YR$$M$Y$$$20240717$$CN$US$US
241029961$24102996$1$I$20240621$20240711$20240717$20240717$PER$$PR-BIOGEN-2024BI01273364$BIOGEN$$43$YR$$M$Y$63.56$KG$20240717$$CN$PR$PR
241029973$24102997$3$F$20220821$20240715$20240717$20240722$PER$$US-BIOGEN-2022BI01162848$BIOGEN$$66$YR$$F$Y$$$20240722$$CN$US$US
241029982$24102998$2$F$$20240821$20240717$20240830$30DAY$$US-GSK-US2024AMR086066$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$CN$US$US
241029991$24102999$1$I$20221230$20240711$20240717$20240717$EXP$$CN-JNJFOC-20240733160$JOHNSON AND JOHNSON$$64$YR$A$M$Y$72.5$KG$20240717$$HP$CN$CN
241030001$24103000$1$I$20240506$20240712$20240717$20240717$EXP$$CN-BEIGENE-BGN-2024-010902$BEIGENE$$$$$$Y$$$20240717$$HP$CN$CN
241030011$24103001$1$I$$20240711$20240717$20240717$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14042$IPSEN$$$$$$Y$$$20240717$$HP$US$US
241030021$24103002$1$I$20191201$20200121$20240717$20240717$EXP$$TH-AstraZeneca-2020SE11650$ASTRAZENECA$$66$YR$$F$Y$$$20240717$$CN$TH$
241030031$24103003$1$I$20240617$20240708$20240717$20240717$EXP$FR-AFSSAPS-LY2024000927$FR-TEVA-VS-3219048$TEVA$$52$YR$$F$Y$$$20240717$$PH$FR$FR
241030041$24103004$1$I$20200513$20200603$20240717$20240717$EXP$$CN-AstraZeneca-2020SE70698$ASTRAZENECA$$23896$DY$$F$Y$35$KG$20240717$$CN$CN$
241030051$24103005$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157797$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241030061$24103006$1$I$$20190806$20240717$20240717$EXP$$TW-AstraZeneca-2019SF13205$ASTRAZENECA$$80$YR$$F$Y$$$20240717$$CN$TW$
241030071$24103007$1$I$$20200804$20240717$20240717$EXP$$US-AstraZeneca-2020SE98806$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241030081$24103008$1$I$$20200121$20240717$20240717$EXP$$US-AstraZeneca-2020SE11430$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241030091$24103009$1$I$$20190731$20240717$20240717$EXP$$AU-AstraZeneca-2019SF09869$ASTRAZENECA$$$$$F$Y$$$20240717$$MD$AU$
241030101$24103010$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A156905$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241030111$24103011$1$I$$20240709$20240717$20240717$EXP$$GB-AstraZeneca-2024A156402$ASTRAZENECA$$60$YR$$M$Y$123$KG$20240717$$MD$GB$
241030121$24103012$1$I$$20200403$20240717$20240717$EXP$$US-AstraZeneca-2020SE48171$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241030131$24103013$1$I$$20200413$20240717$20240717$EXP$$US-AstraZeneca-2020SE50978$ASTRAZENECA$$54$YR$$F$Y$$$20240717$$CN$US$
241030141$24103014$1$I$20180101$20190923$20240717$20240717$EXP$$CO-AstraZeneca-2019SF36782$ASTRAZENECA$$20460$DY$$F$Y$$$20240717$$CN$CO$
241030151$24103015$1$I$$20200324$20240717$20240717$EXP$$US-AstraZeneca-2020SE42422$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241030161$24103016$1$I$20240708$20240713$20240717$20240717$PER$$US-LEO Pharma-371998$LEO PHARM$$47$YR$$F$Y$$$20240717$$CN$US$US
241030174$24103017$4$F$20240701$20240820$20240717$20240831$EXP$$CA-UCBSA-2024035975$UCB$$70$YR$$F$Y$$$20240831$$CN$CA$CA
241030181$24103018$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06435$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241030201$24103020$1$I$$20240706$20240717$20240717$EXP$$US-ROCHE-10000023776$ROCHE$Barnaba Durairaj M, Caraway H, Buresh R, Sampath R, And Waghchoure S. Rapidly Progressing Secondary Organizing Pneumonia Due to Underlying Immunosuppression With Rituximab in SARS-CoV-2 Patients. Cureus. 2024-May-15;16 (5):1-7. doi:10.7759/cureus.60328.$54$YR$A$M$Y$$$20240717$$HP$US$US
241030211$24103021$1$I$20240527$20240711$20240717$20240717$EXP$$CN-BEIGENE-BGN-2024-010855$BEIGENE$$$$$$Y$$$20240717$$HP$CN$CN
241030232$24103023$2$F$$20240727$20240717$20240731$EXP$$JP-GSK-JP2024089168$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$MD$JP$JP
241030241$24103024$1$I$20240220$20240709$20240717$20240717$EXP$$CA-CELLTRION INC.-2024CA007549$CELLTRION$$$$$$Y$$$20240717$$CN$CA$CA
241030253$24103025$3$F$$20240814$20240717$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002983$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
241030261$24103026$1$I$$20240716$20240717$20240717$PER$$US-HALEON-2187467$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
241030271$24103027$1$I$20230924$20230925$20240717$20240717$PER$$US-APOTEX-2023AP014268$APOTEX$$67$YR$E$F$Y$$$20240717$$CN$US$US
241030281$24103028$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113315$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240717$$HP$US$US
241030291$24103029$1$I$$20240711$20240717$20240717$EXP$$CA-ABBVIE-5838462$ABBVIE$$$$E$F$Y$$$20240717$$CN$CA$CA
241030302$24103030$2$F$$20240807$20240717$20240808$PER$$US-ALXN-202407USA000779US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241030311$24103031$1$I$$20240704$20240717$20240717$EXP$GB-MHRA-MED-202405011633482420-QSCHD$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001712$IPCA$$$$$$Y$$$20240717$$PH$GB$GB
241030321$24103032$1$I$20240411$20240708$20240717$20240717$EXP$$FR-Orion Corporation ORION PHARMA-TREX2024-0183$ORION$$78$YR$E$M$Y$65$KG$20240717$$CN$FR$
241030332$24103033$2$F$20110101$20240802$20240717$20240808$EXP$$US-ABBVIE-5837126$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241030341$24103034$1$I$20231023$20240711$20240717$20240717$EXP$$CN-JNJFOC-20240733760$JOHNSON AND JOHNSON$$78$YR$E$F$Y$50$KG$20240717$$HP$CN$CN
241030351$24103035$1$I$$20240708$20240717$20240717$EXP$$CA-APOTEX-2024AP008052$APOTEX$$65$YR$$F$Y$$$20240717$$MD$CA$CA
241030361$24103036$1$I$$20240626$20240717$20240717$PER$$US-JNJFOC-20240675377$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241030371$24103037$1$I$20240708$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024140544$AMGEN$$72$YR$E$F$Y$$$20240717$$CN$US$US
241030382$24103038$2$F$20240715$20240715$20240717$20240723$PER$$US-AMGEN-USASP2024140877$AMGEN$$34$YR$A$M$Y$$$20240723$$HP$US$US
241030393$24103039$3$F$20240701$20240802$20240717$20240808$30DAY$$US-AMGEN-USASP2024138388$AMGEN$$58$YR$A$F$Y$64.41$KG$20240808$$HP$US$US
241030401$24103040$1$I$20240522$20240709$20240717$20240717$EXP$FR-AFSSAPS-BS2024000398$FR-TEVA-VS-3219524$TEVA$$87$YR$$F$Y$$$20240717$$MD$FR$FR
241030412$24103041$2$F$$20240802$20240717$20240805$EXP$$CA-ROCHE-10000028188$ROCHE$$$$A$F$Y$$$20240805$$HP$CA$CA
241030421$24103042$1$I$$20240712$20240717$20240717$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-14066$IPSEN$$$$$M$Y$$$20240717$$CN$GB$GB
241030432$24103043$2$F$$20240731$20240717$20240806$EXP$$CA-ABBVIE-5838440$ABBVIE$$$$A$F$Y$77$KG$20240806$$CN$CA$CA
241030441$24103044$1$I$20230921$20240708$20240717$20240717$EXP$$FR-Orion Corporation ORION PHARMA-TREX2024-0184$ORION$$69$YR$E$M$Y$90$KG$20240717$$HP$FR$
241030452$24103045$2$F$$20240709$20240717$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06030$LUPIN$$$$$$Y$$$20240808$$CN$US$US
241030462$24103046$2$F$20240101$20240709$20240717$20240726$PER$$US-TEVA-VS-3221142$TEVA$$84$YR$$M$Y$$$20240726$$CN$US$US
241030471$24103047$1$I$$20240709$20240717$20240717$EXP$$CA-CELLTRION INC.-2024CA017001$CELLTRION$$$$$$Y$$$20240717$$CN$CA$CA
241030491$24103049$1$I$$20240715$20240717$20240717$EXP$$US-JNJFOC-20240737809$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
241030501$24103050$1$I$$20240712$20240717$20240717$PER$$US-LEO Pharma-371990$LEO PHARM$$46$YR$$F$Y$$$20240717$$CN$US$US
241030511$24103051$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06465$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241030521$24103052$1$I$$20200309$20240717$20240717$EXP$$US-AstraZeneca-2020SE36788$ASTRAZENECA$$59$YR$$F$Y$$$20240717$$CN$US$
241030531$24103053$1$I$$20190913$20240717$20240717$EXP$$ZA-AstraZeneca-2019SF31096$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$ZA$
241030541$24103054$1$I$$20190805$20240717$20240717$EXP$$US-AstraZeneca-2019SF13168$ASTRAZENECA$$$$$F$Y$52.2$KG$20240717$$CN$US$
241030551$24103055$1$I$$20190905$20240717$20240717$EXP$$US-AstraZeneca-2019SF27750$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241030561$24103056$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009765$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240717$$CN$US$US
241030571$24103057$1$I$$20240710$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407006198$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240717$$HP$US$US
241030581$24103058$1$I$20240713$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009914$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240717$$CN$US$US
241030591$24103059$1$I$20240707$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009631$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240717$$CN$US$US
241030601$24103060$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009428$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240717$$CN$US$US
241030611$24103061$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160026$ASTRAZENECA$$$$$M$Y$$$20240717$$HP$US$
241030621$24103062$1$I$20240714$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009640$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240717$$CN$US$US
241030631$24103063$1$I$20190528$20191001$20240717$20240717$EXP$$CO-AstraZeneca-2019SF40446$ASTRAZENECA$$28706$DY$$F$Y$$$20240717$$CN$CO$
241030641$24103064$1$I$$20200131$20240717$20240717$EXP$$US-AstraZeneca-2020SE18154$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241030651$24103065$1$I$20200711$20200714$20240717$20240717$EXP$$US-AstraZeneca-2020SE89411$ASTRAZENECA$$16484$DY$$M$Y$95.3$KG$20240717$$CN$US$
241030661$24103066$1$I$20180801$20190927$20240717$20240717$EXP$$US-AstraZeneca-2019SF42332$ASTRAZENECA$$827$MON$$F$Y$68$KG$20240717$$CN$US$
241030671$24103067$1$I$$20200407$20240717$20240717$EXP$$US-AstraZeneca-2020SE48850$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241030681$24103068$1$I$20170427$20190808$20240717$20240717$EXP$$CO-AstraZeneca-2019SF15630$ASTRAZENECA$$1709$WK$$F$Y$$$20240717$$CN$CO$
241030691$24103069$1$I$$20240709$20240717$20240717$EXP$$CH-AstraZeneca-2024A160278$ASTRAZENECA$$$$$M$Y$$$20240717$$MD$CH$
241030701$24103070$1$I$$20190809$20240717$20240717$EXP$$US-AstraZeneca-2019SF15212$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241030711$24103071$1$I$$20191101$20240717$20240717$EXP$$US-AstraZeneca-2019SF46767$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241030721$24103072$1$I$20240313$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160201$ASTRAZENECA$$25375$DY$$F$Y$$$20240717$$HP$US$
241030731$24103073$1$I$$20201007$20240717$20240717$EXP$$US-AstraZeneca-2020SF31521$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241030741$24103074$1$I$20190711$20190715$20240717$20240717$EXP$$US-AstraZeneca-2019SF03074$ASTRAZENECA$$27468$DY$$F$Y$$$20240717$$CN$US$
241030751$24103075$1$I$$20200415$20240717$20240717$EXP$$TH-AstraZeneca-2020SE53166$ASTRAZENECA$$42$YR$$F$Y$$$20240717$$CN$TH$
241030761$24103076$1$I$$20191022$20240717$20240717$EXP$$US-AstraZeneca-2019SF51724$ASTRAZENECA$$$$$$Y$$$20240717$$CN$US$
241030771$24103077$1$I$$20201126$20240717$20240717$EXP$$GB-AstraZeneca-2020SF01419$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$GB$
241030781$24103078$1$I$20200928$20201021$20240717$20240717$EXP$$US-AstraZeneca-2020SF38222$ASTRAZENECA$$22641$DY$$F$Y$$$20240717$$CN$US$
241030791$24103079$1$I$$20200625$20240717$20240717$EXP$$US-AstraZeneca-2020SE82686$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241030801$24103080$1$I$$20240715$20240717$20240717$PER$$NVSC2024US146427$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241030812$24103081$2$F$$20240924$20240717$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113061$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$64.41$KG$20240926$$CN$US$US
241030821$24103082$1$I$$20240702$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107348$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240717$$PH$US$US
241030833$24103083$3$F$$20240916$20240717$20240923$EXP$$AU-009507513-2407AUS004625$MERCK$$68$YR$$M$Y$$$20240923$$CN$AU$AU
241030841$24103084$1$I$$20240711$20240717$20240717$EXP$$US-ROCHE-10000024273$ROCHE$$$$A$F$Y$$$20240717$$CN$US$US
241030862$24103086$2$F$$20240726$20240717$20240730$EXP$$CA-TAKEDA-2024TUS068037$TAKEDA$$$$$F$Y$$$20240730$$CN$CA$CA
241030874$24103087$4$F$20220401$20240814$20240717$20240820$EXP$$US-ROCHE-3086676$ROCHE$$91$YR$E$F$Y$$$20240820$$CN$US$US
241030881$24103088$1$I$20240601$20240705$20240717$20240717$EXP$$US-INSMED, INC.-2024-02775-US$INSMED$$20$YR$$M$Y$$$20240717$$CN$US$US
241030891$24103089$1$I$$20240617$20240717$20240717$EXP$$AU-TEVA-VS-3213047$TEVA$Dhaliwal N, Roberts DM. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clin-Toxicol-(Phila) 2024; 0 (0): 1-6.; Dhaliwal N, Roberts DM. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clin-Toxicol-(Phila) 2024; 0 (0): 1-6.$$$$$Y$$$20240717$$HP$AU$AU
241030901$24103090$1$I$$20240708$20240717$20240717$EXP$$GB-TEVA-VS-3219146$TEVA$$$$$$Y$$$20240717$$CN$GB$GB
241030911$24103091$1$I$$20240712$20240717$20240717$EXP$$US-JNJFOC-20240734388$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$CN$US$US
241030921$24103092$1$I$20230314$20240530$20240717$20240717$PER$$US-CHIESI-2024CHF03208$CHIESI$$29$YR$$F$Y$70$KG$20240717$$CN$US$US
241030931$24103093$1$I$20240501$20240530$20240717$20240717$PER$$US-CHIESI-2024CHF03224$CHIESI$$51$YR$$F$Y$80$KG$20240717$$CN$US$US
241030941$24103094$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000027351$ROCHE$$$$$F$Y$$$20240717$$PH$US$US
241030951$24103095$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000360$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$38$WK$I$F$Y$$$20240717$$MD$US$US
241030961$24103096$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024138619$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241030971$24103097$1$I$$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024139428$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
241030981$24103098$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000359$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$33$WK$I$M$Y$$$20240717$$MD$US$US
241030991$24103099$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000358$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$38$WK$I$F$Y$$$20240717$$MD$US$US
241031001$24103100$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000362$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$39$WK$I$F$Y$$$20240717$$MD$US$US
241031011$24103101$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000361$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$28$WK$I$M$Y$$$20240717$$MD$US$US
241031021$24103102$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000365$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$37$WK$I$M$Y$$$20240717$$MD$US$US
241031031$24103103$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000366$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$35$WK$I$F$Y$$$20240717$$MD$US$US
241031041$24103104$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000363$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$39$WK$I$F$Y$$$20240717$$MD$US$US
241031051$24103105$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000364$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$36$WK$I$F$Y$$$20240717$$MD$US$US
241031071$24103107$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000367$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$40$WK$I$M$Y$$$20240717$$MD$US$US
241031081$24103108$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000369$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$31$WK$I$M$Y$$$20240717$$MD$US$US
241031091$24103109$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000368$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$40$WK$I$F$Y$$$20240717$$MD$US$US
241031101$24103110$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000372$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$25$WK$I$M$Y$$$20240717$$MD$US$US
241031111$24103111$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000371$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$33$WK$I$F$Y$$$20240717$$MD$US$US
241031121$24103112$1$I$$20240712$20240717$20240717$EXP$$CA-TAKEDA-2024TUS071761$TAKEDA$$$$$M$Y$$$20240717$$MD$CA$CA
241031131$24103113$1$I$$20240705$20240717$20240717$EXP$$US-PDX-000370$PHARMADAX$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$39$WK$I$F$Y$$$20240717$$MD$US$US
241031143$24103114$3$F$20240715$20240808$20240717$20240809$PER$$US-AMGEN-USASP2024140597$AMGEN$$75$YR$E$F$Y$$$20240809$$CN$US$US
241031151$24103115$1$I$20240715$20240715$20240717$20240717$PER$$US-JNJFOC-20240739803$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241031161$24103116$1$I$20210329$20240708$20240717$20240717$EXP$$CN-RDY-LIT/CHN/24/0010278$DR REDDYS$Tianya L, Zhang Y, Han Y. Medication Analysis of Rare Platelet Reactivity Variability in a Patient with Recurrent Brain Infarction. Herald of Medicine. 2024 Jun;43(1):$65$YR$E$M$Y$60$KG$20240717$$HP$CN$CN
241031171$24103117$1$I$20230927$20240711$20240717$20240717$EXP$$US-ORGANON-O2407USA001281$ORGANON$$$$$F$Y$$$20240717$$CN$US$US
241031182$24103118$2$F$$20240716$20240717$20240718$EXP$$US-ROCHE-10000028707$ROCHE$$64$YR$A$F$Y$$$20240718$$CN$US$US
241031193$24103119$3$F$20240101$20240816$20240717$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-018209$UNITED THERAPEUTICS$$$$$F$Y$67.12$KG$20240823$$$US$US
241031201$24103120$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06461$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241031212$24103121$2$F$20240201$20240716$20240717$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003327$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240809$$CN$US$US
241031222$24103122$2$F$$20240809$20240717$20240813$EXP$$CA-TAKEDA-2023TUS117703$TAKEDA$$$$$M$Y$$$20240813$$CN$CA$CA
241031232$24103123$2$F$20240717$20240717$20240717$20240725$EXP$$CA-TAKEDA-2024TUS071662$TAKEDA$$80$YR$$F$Y$$$20240725$$CN$CA$CA
241031244$24103124$4$F$20240706$20240909$20240717$20240918$30DAY$$US-GSK-US2024088557$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240918$$CN$US$US
241031251$24103125$1$I$$20240711$20240717$20240717$30DAY$$US-GSK-US2024086597$GLAXOSMITHKLINE$$76$YR$$M$Y$$$20240717$$CN$US$US
241031261$24103126$1$I$$20240711$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112136$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240717$$CN$US$US
241031281$24103128$1$I$$20240711$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110749$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$77$KG$20240717$$PH$US$US
241031292$24103129$2$F$$20240919$20240717$20240930$EXP$$GB-TAKEDA-2024TUS071442$TAKEDA$$$$$F$Y$$$20240930$$CN$GB$GB
241031301$24103130$1$I$20230804$20240715$20240717$20240717$EXP$FR-AFSSAPS-AM2024000566$FR-TAKEDA-2024TUS071512$TAKEDA$$37$YR$$F$Y$90$KG$20240717$$HP$FR$FR
241031312$24103131$2$F$20240401$20240729$20240717$20240801$EXP$$US-ABBVIE-5719233$ABBVIE$$81$YR$$M$Y$79$KG$20240801$$CN$US$US
241031321$24103132$1$I$$20240716$20240717$20240717$PER$$NVSC2024US146786$NOVARTIS$$$$$$Y$$$20240717$$MD$US$US
241031331$24103133$1$I$$20240715$20240717$20240717$PER$$US-BAUSCH-BL-2024-010841$BAUSCH AND LOMB$$$$$F$Y$$$20240717$$CN$US$US
241031341$24103134$1$I$$20240715$20240717$20240717$PER$$US-BAUSCH-BL-2024-010846$BAUSCH AND LOMB$$$$$F$Y$$$20240717$$CN$US$US
241031351$24103135$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06543$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241031361$24103136$1$I$20200128$20240708$20240717$20240717$EXP$$ES-SA-2024SA200924$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240717$$MD$ES$ES
241031371$24103137$1$I$$20240704$20240717$20240717$EXP$GB-MHRA-MED-202405011654184450-TSCFD$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001713$IPCA$$$$$$Y$$$20240717$$PH$GB$GB
241031381$24103138$1$I$20240601$20240712$20240717$20240717$EXP$FR-AFSSAPS-AVNT2024000506$FR-BAUSCH-BL-2024-010709$BAUSCH AND LOMB$$44$YR$$F$Y$$$20240717$$PH$FR$FR
241031391$24103139$1$I$20240701$20240710$20240717$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-021184$UNITED THERAPEUTICS$$80$YR$$F$Y$$$20240717$$$US$US
241031401$24103140$1$I$20240101$20240710$20240717$20240717$EXP$$US-JNJFOC-20240730460$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240717$$CN$US$US
241031411$24103141$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010793$BAUSCH AND LOMB$$50$YR$$M$Y$$$20240717$$CN$CA$CA
241031421$24103142$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010794$BAUSCH AND LOMB$$49$YR$$F$Y$$$20240717$$CN$CA$CA
241031441$24103144$1$I$$20240710$20240717$20240717$EXP$$GB-CELLTRION INC.-2024GB017091$CELLTRION$$$$$$Y$$$20240717$$CN$GB$GB
241031451$24103145$1$I$$20240712$20240717$20240717$EXP$$NVSC2024FR146429$NOVARTIS$$40$YR$$F$Y$$$20240717$$MD$FR$FR
241031461$24103146$1$I$$20240714$20240717$20240717$EXP$$NVSC2024US146420$NOVARTIS$$$$$$Y$$$20240717$$MD$US$US
241031472$24103147$2$F$$20240906$20240717$20240914$EXP$$CA-TAKEDA-2024TUS071369$TAKEDA$$$$$F$Y$$$20240914$$CN$CA$CA
241031481$24103148$1$I$$20190812$20240717$20240717$EXP$$US-AstraZeneca-2019SF16700$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241031491$24103149$1$I$$20191108$20240717$20240717$EXP$$US-AstraZeneca-2019SF61197$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241031501$24103150$1$I$20191021$20191023$20240717$20240717$EXP$$US-AstraZeneca-2019SF52559$ASTRAZENECA$$29833$DY$$M$Y$$$20240717$$CN$US$
241031511$24103151$1$I$20200426$20200427$20240717$20240717$EXP$$US-AstraZeneca-2020SE57606$ASTRAZENECA$$31958$DY$$M$Y$71.7$KG$20240717$$CN$US$
241031521$24103152$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06538$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241031531$24103153$1$I$$20201106$20240717$20240717$EXP$$CA-AstraZeneca-2020SF45718$ASTRAZENECA$$$$$F$Y$$$20240717$$PH$CA$
241031541$24103154$1$I$$20191113$20240717$20240717$EXP$$US-AstraZeneca-2019SF63922$ASTRAZENECA$$$$$$Y$$$20240717$$CN$US$
241031551$24103155$1$I$20210613$20240709$20240717$20240717$EXP$$NO-SA-2024SA206247$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240717$$CN$NO$NO
241031561$24103156$1$I$20240708$20240709$20240717$20240717$EXP$$ZA-AstraZeneca-2024A157379$ASTRAZENECA$$44$YR$$F$Y$$$20240717$$CN$ZA$
241031571$24103157$1$I$20240101$20240710$20240717$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-021293$UNITED THERAPEUTICS$$$$$M$Y$82.54$KG$20240717$$$US$US
241031581$24103158$1$I$$20201027$20240717$20240717$EXP$$US-AstraZeneca-2020SF42708$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241031591$24103159$1$I$20200307$20200507$20240717$20240717$EXP$$CN-AstraZeneca-2020SE61115$ASTRAZENECA$$19839$DY$$M$Y$$$20240717$$CN$CN$
241031601$24103160$1$I$$20200430$20240717$20240717$EXP$$US-AstraZeneca-2020SE59080$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241031612$24103161$2$F$$20240820$20240717$20240828$EXP$$US-AstraZeneca-2024A160538$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
241031621$24103162$1$I$20200216$20200216$20240717$20240717$EXP$$US-AstraZeneca-2020SE26296$ASTRAZENECA$$74$YR$$F$Y$$$20240717$$CN$US$
241031631$24103163$1$I$$20191018$20240717$20240717$EXP$$US-AstraZeneca-2019SF50230$ASTRAZENECA$$$$$M$Y$$$20240717$$HP$US$
241031641$24103164$1$I$$20191115$20240717$20240717$EXP$$US-AstraZeneca-2019SF65425$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241031653$24103165$3$F$$20240819$20240717$20240823$PER$$US-ROCHE-10000021128$ROCHE$$$$$$Y$$$20240823$$CN$US$US
241031661$24103166$1$I$20190717$20190910$20240717$20240717$EXP$$US-AstraZeneca-2019SF08397$ASTRAZENECA$$17027$DY$$F$Y$$$20240717$$CN$US$
241031671$24103167$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010803$BAUSCH AND LOMB$$54$YR$$F$Y$$$20240717$$CN$CA$CA
241031681$24103168$1$I$20240625$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A161254$ASTRAZENECA$$25942$DY$$F$Y$$$20240717$$CN$US$
241031691$24103169$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010815$BAUSCH AND LOMB$$58$YR$$M$Y$$$20240717$$CN$CA$CA
241031701$24103170$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010870$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240717$$CN$CA$CA
241031711$24103171$1$I$$20240715$20240717$20240717$EXP$$US-TAKEDA-US201604467$TAKEDA$$$$$M$Y$$$20240717$$HP$US$US
241031721$24103172$1$I$$20240711$20240717$20240717$EXP$$US-TAKEDA-2024TUS048301$TAKEDA$$$$$M$Y$91$KG$20240717$$CN$US$US
241031731$24103173$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010801$BAUSCH AND LOMB$$68$YR$$F$Y$$$20240717$$CN$CA$CA
241031741$24103174$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A158150$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241031751$24103175$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010796$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240717$$CN$CA$CA
241031761$24103176$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010824$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240717$$CN$CA$CA
241031771$24103177$1$I$$20200225$20240717$20240717$EXP$$AU-AstraZeneca-2020SE30118$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$AU$
241031781$24103178$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024139363$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241031791$24103179$1$I$$20201202$20240717$20240717$EXP$$US-AstraZeneca-2020SF62492$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241031801$24103180$1$I$20180629$20190820$20240717$20240717$EXP$$CO-AstraZeneca-2019SF19986$ASTRAZENECA$$2646$WK$$F$Y$$$20240717$$CN$CO$
241031811$24103181$1$I$$20190801$20240717$20240717$EXP$$BG-AstraZeneca-2019SF11572$ASTRAZENECA$$44$YR$$M$Y$$$20240717$$MD$BG$
241031821$24103182$1$I$20200809$20200814$20240717$20240717$EXP$$US-AstraZeneca-2020SF05028$ASTRAZENECA$$23702$DY$$M$Y$$$20240717$$CN$US$
241031831$24103183$1$I$$20200512$20240717$20240717$EXP$$US-AstraZeneca-2020SE63681$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241031841$24103184$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010871$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240717$$CN$CA$CA
241031851$24103185$1$I$$20240617$20240717$20240717$EXP$$AU-TEVA-VS-3213038$TEVA$Dhaliwal N, Roberts DM. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clin-Toxicol-(Phila) 2024; 0 (0): 1-6.; Dhaliwal N, Roberts DM. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clin-Toxicol-(Phila) 2024; 0 (0): 1-6.$$$$$Y$$$20240717$$HP$AU$AU
241031861$24103186$1$I$20180906$20240713$20240717$20240717$EXP$$CA-TAKEDA-2024TUS071693$TAKEDA$$46$YR$$F$Y$$$20240717$$MD$CA$CA
241031871$24103187$1$I$$20240710$20240717$20240717$EXP$$JP-SA-2024SA201744$SANOFI AVENTIS$$$$$F$Y$$$20240717$$PH$JP$JP
241031881$24103188$1$I$$20240711$20240717$20240717$EXP$$US-ABBVIE-5838958$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241031891$24103189$1$I$$20240701$20240717$20240717$PER$$US-TEVA-VS-3217483$TEVA$$57$YR$$M$Y$$$20240717$$CN$US$US
241031901$24103190$1$I$$20240708$20240717$20240717$PER$$US-ROCHE-10000020531$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241031911$24103191$1$I$$20240709$20240717$20240717$PER$$US-ROCHE-10000022259$ROCHE$$$$$F$Y$$$20240717$$CN$US$US
241031922$24103192$2$F$$20240814$20240717$20240819$EXP$$US-JNJFOC-20240738970$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240819$$CN$US$US
241031931$24103193$1$I$$20240715$20240717$20240717$EXP$$US-JNJFOC-20240738955$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$CN$US$US
241031951$24103195$1$I$$20240715$20240717$20240717$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039968$BOEHRINGER INGELHEIM$$45$YR$A$F$Y$70$KG$20240717$$PH$CA$CA
241031961$24103196$1$I$20240702$20240712$20240717$20240717$EXP$$US-ABBVIE-5840142$ABBVIE$$33$YR$$F$Y$$$20240717$$CN$US$US
241031971$24103197$1$I$20240305$20240712$20240717$20240717$EXP$FR-AFSSAPS-TO2024001157$FR-SA-2024SA206072$SANOFI AVENTIS$$84$YR$E$M$Y$57.1$KG$20240717$$PH$FR$FR
241031981$24103198$1$I$$20240708$20240717$20240717$EXP$GB-MHRA-MED-202407071922360750-SGWTP$GB-TEVA-VS-3219083$TEVA$$36$YR$$F$Y$89$KG$20240717$$CN$GB$GB
241031991$24103199$1$I$$20240710$20240717$20240717$EXP$$CA-APOTEX-2024AP008237$APOTEX$$9$YR$$M$Y$$$20240717$$HP$CA$CA
241032001$24103200$1$I$20240714$20240716$20240717$20240717$EXP$$SG-VANTIVE-2024VAN018347$Vantive US Healthcare$$81$YR$$M$Y$$$20240717$$CN$SG$SG
241032011$24103201$1$I$$20240711$20240717$20240717$EXP$$IN-VANTIVE-2024VAN018327$Vantive US Healthcare$$48$YR$$M$Y$$$20240717$$CN$IN$IN
241032024$24103202$4$F$$20240712$20240717$20240719$EXP$$US-AMGEN-USASP2024139443$AMGEN$$$$$$Y$$$20240719$$MD$US$US
241032031$24103203$1$I$$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407007909$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240717$$CN$US$US
241032041$24103204$1$I$$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010514$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
241032051$24103205$1$I$20240101$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009869$ELI LILLY AND CO$$$$$$Y$$$20240717$$CN$US$US
241032061$24103206$1$I$$20240708$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407005323$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240717$$CN$US$US
241032071$24103207$1$I$$20240704$20240717$20240717$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-21049$SAMSUNG BIOEPIS$$24$YR$A$M$Y$76$KG$20240717$$PH$AU$AU
241032081$24103208$1$I$20200810$20240709$20240717$20240717$EXP$$CA-ROCHE-2659554$ROCHE$$45$YR$A$F$Y$$$20240717$$CN$CA$CA
241032091$24103209$1$I$20230101$20240712$20240717$20240717$EXP$FR-AFSSAPS-RS2024000680$FR-SA-2024SA205807$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240717$$MD$FR$FR
241032101$24103210$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06130$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241032111$24103211$1$I$20240703$20240711$20240717$20240717$EXP$IT-MINISAL02-993921$IT-SA-2024SA205358$SANOFI AVENTIS$$65$YR$E$F$Y$55$KG$20240717$$MD$IT$IT
241032121$24103212$1$I$$20240716$20240717$20240717$PER$$NVSC2024US146941$NOVARTIS$$$$$$Y$$$20240717$$MD$US$US
241032131$24103213$1$I$$20240715$20240717$20240717$EXP$$NVSC2024US146286$NOVARTIS$$62$YR$$M$Y$$$20240717$$CN$US$US
241032142$24103214$2$F$20240702$20240905$20240717$20240919$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-21107$SAMSUNG BIOEPIS$$61$YR$A$F$Y$59$KG$20240919$$MD$DE$DE
241032151$24103215$1$I$20240711$20240711$20240717$20240717$PER$$US-ALXN-202407USA000754US$ALEXION PHARMACEUTICALS$$61$YR$$F$Y$$$20240717$$CN$US$US
241032161$24103216$1$I$$20240710$20240717$20240717$EXP$$IN-ROCHE-3573681$ROCHE$$34$YR$A$M$Y$65$KG$20240717$$MD$IN$IN
241032171$24103217$1$I$$20240716$20240717$20240717$PER$$US-ROCHE-10000028612$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241032182$24103218$2$F$20240603$20240716$20240717$20240718$EXP$$IE-ROCHE-10000028255$ROCHE$$$$$F$Y$$$20240718$$CN$IE$IE
241032191$24103219$1$I$$20240712$20240717$20240717$EXP$$CA-TAKEDA-2024TUS071585$TAKEDA$$$$$M$Y$$$20240717$$MD$CA$CA
241032211$24103221$1$I$20240101$20240716$20240717$20240717$EXP$$ZA-ABBVIE-5842355$ABBVIE$$88$YR$$M$Y$$$20240717$$CN$ZA$ZA
241032224$24103222$4$F$20230101$20240910$20240717$20240914$EXP$$US-ABBVIE-5806468$ABBVIE$$$$$F$Y$64.863$KG$20240914$$CN$US$US
241032231$24103223$1$I$$20240714$20240717$20240717$EXP$$JP-ABBVIE-5842346$ABBVIE$$$$$M$Y$$$20240717$$CN$JP$JP
241032242$24103224$2$F$20240101$20240719$20240717$20240724$EXP$$US-SA-2024SA193484$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240724$$HP$US$US
241032251$24103225$1$I$20240515$20240715$20240717$20240717$EXP$FR-AFSSAPS-NC2024000643$FR-TAKEDA-2024TUS071995$TAKEDA$$58$YR$$F$Y$$$20240717$$HP$FR$FR
241032261$24103226$1$I$$20240709$20240717$20240717$EXP$$CA-TAKEDA-2024TUS070702$TAKEDA$$11$YR$$F$Y$$$20240717$$HP$CA$CA
241032271$24103227$1$I$20240101$20240712$20240717$20240717$EXP$$CA-ABBVIE-5839931$ABBVIE$$61$YR$$M$Y$$$20240717$$CN$CA$CA
241032282$24103228$2$F$20240708$20240715$20240717$20240719$EXP$$CA-ABBVIE-5842344$ABBVIE$$74$YR$$M$Y$$$20240719$$MD$CA$CA
241032292$24103229$2$F$20240710$20240726$20240717$20240801$30DAY$$US-AMGEN-USASP2024138331$AMGEN$$66$YR$E$F$Y$117.5$KG$20240801$$PH$US$US
241032302$24103230$2$F$20240101$20240717$20240717$20240718$EXP$$US-ABBVIE-5841998$ABBVIE$$$$$M$Y$47$KG$20240718$$CN$US$US
241032311$24103231$1$I$$20240715$20240717$20240717$EXP$$GB-ABBVIE-5842356$ABBVIE$$$$A$F$Y$$$20240717$$CN$GB$GB
241032321$24103232$1$I$$20240712$20240717$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039656$BOEHRINGER INGELHEIM$$$$$$Y$$$20240717$$CN$US$US
241032331$24103233$1$I$20240601$20240715$20240717$20240717$EXP$$ES-ABBVIE-5842370$ABBVIE$$74$YR$$M$Y$$$20240717$$CN$ES$ES
241032341$24103234$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06510$LUPIN$$$$$$Y$$$20240717$$HP$US$US
241032352$24103235$2$F$20240711$20240716$20240717$20240722$EXP$$CA-ROCHE-10000027468$ROCHE$$31$YR$A$F$Y$$$20240722$$CN$CA$CA
241032361$24103236$1$I$20240707$20240716$20240717$20240717$EXP$FR-AFSSAPS-MP2024001141$FR-ORGANON-O2407FRA001433$ORGANON$$79$YR$$F$Y$$$20240717$$PH$FR$FR
241032371$24103237$1$I$$20240715$20240717$20240717$EXP$$US-ROCHE-10000028076$ROCHE$$34$YR$A$F$Y$$$20240717$$MD$US$US
241032382$24103238$2$F$$20240706$20240717$20240717$PER$$US-ROCHE-10000023688$ROCHE$Barnaba Durairaj M, Caraway H, Buresh R, Sampath R, And Waghchoure S. Rapidly Progressing Secondary Organizing Pneumonia Due to Underlying Immunosuppression With Rituximab in SARS-CoV-2 Patients. Cureus. 2024-May-15;16 (5):1-7. doi:10.7759/cureus.60328.$67$YR$E$F$Y$$$20240717$$HP$US$US
241032391$24103239$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024141536$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241032402$24103240$2$F$$20240716$20240717$20240718$PER$$US-AMGEN-USASP2024140944$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
241032412$24103241$2$F$20240705$20240724$20240717$20240730$PER$$US-AMGEN-USASP2024138486$AMGEN$$57$YR$A$F$Y$73.48$KG$20240729$$HP$US$US
241032421$24103242$1$I$20240715$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140371$AMGEN$$$$$$Y$$$20240717$$HP$US$US
241032431$24103243$1$I$$20240710$20240717$20240717$EXP$$CA-APOTEX-2024AP008200$APOTEX$$63$YR$$F$Y$$$20240717$$PH$CA$CA
241032441$24103244$1$I$20240506$20240708$20240717$20240717$EXP$ES-EMA-DD-20240628-7483181-074332$ES-TEVA-VS-3218775$TEVA$$67$YR$$F$Y$69.1$KG$20240717$$MD$ES$ES
241032451$24103245$1$I$20190329$20190814$20240717$20240717$EXP$$US-AstraZeneca-2019SF17847$ASTRAZENECA$$25507$DY$$F$Y$$$20240717$$CN$US$
241032461$24103246$1$I$$20201126$20240717$20240717$EXP$$PH-AstraZeneca-2020SF57748$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$PH$
241032471$24103247$1$I$$20200601$20240717$20240717$EXP$$US-AstraZeneca-2020SE71592$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241032481$24103248$1$I$$20191129$20240717$20240717$EXP$$US-AstraZeneca-2019SF73077$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241032491$24103249$1$I$$20191202$20240717$20240717$EXP$$US-AstraZeneca-2019SF74450$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241032501$24103250$1$I$$20200817$20240717$20240717$EXP$$US-AstraZeneca-2020SF07341$ASTRAZENECA$$50$YR$$F$Y$$$20240717$$CN$US$
241032511$24103251$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157186$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241032521$24103252$1$I$$20190812$20240717$20240717$EXP$$US-AstraZeneca-2019SF17226$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241032531$24103253$1$I$$20200902$20240717$20240717$EXP$$US-AstraZeneca-2020SE72822$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241032541$24103254$1$I$20240714$20240714$20240717$20240717$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000077$Unknown Manufacturer$$$$$$Y$$$20240717$$CN$US$US
241032551$24103255$1$I$$20191205$20240717$20240717$EXP$$FR-AstraZeneca-2019SF78329$ASTRAZENECA$$$$$M$Y$$$20240717$$MD$FR$
241032561$24103256$1$I$$20201020$20240717$20240717$EXP$$CA-AstraZeneca-2020SF37869$ASTRAZENECA$$$$$F$Y$$$20240717$$MD$CA$
241032571$24103257$1$I$$20191212$20240717$20240717$EXP$$CA-AstraZeneca-2019SF82111$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CA$
241032581$24103258$1$I$$20210120$20240717$20240717$EXP$$AU-AstraZeneca-2020SF11023$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$AU$
241032591$24103259$1$I$$20191220$20240717$20240717$EXP$$RU-AstraZeneca-2019SF86219$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$RU$
241032601$24103260$1$I$$20200127$20240717$20240717$EXP$$US-AstraZeneca-2019SF90188$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241032611$24103261$1$I$20191101$20210310$20240717$20240717$EXP$$CA-AstraZeneca-2020SE91213$ASTRAZENECA$$603$MON$$F$Y$$$20240717$$CN$CA$
241032621$24103262$1$I$$20190824$20240717$20240717$EXP$$US-AstraZeneca-2019SF23088$ASTRAZENECA$$82$YR$$F$Y$$$20240717$$CN$US$
241032631$24103263$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160374$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241032641$24103264$1$I$$20201104$20240717$20240717$EXP$$US-AstraZeneca-2020SF46165$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241032651$24103265$1$I$20240713$20240715$20240717$20240717$EXP$$FR-ABBVIE-5842371$ABBVIE$$84$YR$$F$Y$$$20240717$$CN$FR$FR
241032663$24103266$3$F$$20240731$20240717$20240813$EXP$$IT-AUROBINDO-AUR-APL-2024-033992$AUROBINDO$Di Trana A, Di Giorgi A, Carlier J, Serra F, Busard? FP, Pichini S.. ^Tranq-dope^: The first fatal intoxication due to xylazine-adulterated heroin in Italy.. Clin Chim Acta.. 2024;561:119826$33$YR$$M$Y$$$20240813$$PH$IT$IT
241032671$24103267$1$I$$20240706$20240717$20240717$EXP$$DE-AUROBINDO-AUR-APL-2024-034019$AUROBINDO$$4$MON$$F$Y$$$20240717$$MD$DE$DE
241032682$24103268$2$F$20240712$20240816$20240717$20240819$EXP$$BG-JNJFOC-20240736177$JOHNSON AND JOHNSON$$67$YR$E$M$Y$100$KG$20240819$$CN$BG$BG
241032691$24103269$1$I$$20240714$20240717$20240717$EXP$$US-JNJFOC-20240737209$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
241032701$24103270$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06541$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241032711$24103271$1$I$$20240712$20240717$20240717$EXP$$JP-GSK-JP2024089201$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$JP$JP
241032721$24103272$1$I$$20240715$20240717$20240717$PER$$US-BIOVITRUM-2024-US-005101$BIOVITRUM$$80$YR$$F$Y$$$20240717$$CN$US$US
241032731$24103273$1$I$$20240711$20240717$20240717$PER$$US-ROCHE-10000023477$ROCHE$Sun F, Batra A, Dickson D, Li Y, Wu E. Efgartigimod infusion in the treatment regimen for myasthenic crisis: A case report. Muscle and Nerve. 2024;70 (2):290-2. doi:10.1002/mus.28178.$48$YR$A$F$Y$$$20240717$$MD$US$US
241032751$24103275$1$I$$20240707$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034100$AUROBINDO$$$$$F$Y$73$KG$20240717$$CN$GB$GB
241032761$24103276$1$I$$20240709$20240717$20240717$EXP$$US-ROCHE-10000020299$ROCHE$Shah N, Pia A, Wu T, Williams A, Weber M, Sinclaire B, et al. Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials. Doi: 10.3390/cancers16122223. Cancers. 2024-Jun;16 (12):1-16. doi:10.3390/cancers16122223.$$$$$Y$$$20240717$$HP$US$US
241032781$24103278$1$I$$20240712$20240717$20240717$EXP$$CA-HALEON-2187265$Haleon PLC$$47$YR$$F$Y$$$20240717$$HP$CA$CA
241032811$24103281$1$I$$20240703$20240717$20240717$PER$$US-TAKEDA-2024TUS067612$TAKEDA$$$$$M$Y$$$20240717$$CN$US$US
241032821$24103282$1$I$$20240712$20240717$20240717$PER$$US-TAKEDA-2024TUS071749$TAKEDA$$$$$$Y$$$20240717$$CN$US$US
241032841$24103284$1$I$$20240706$20240717$20240717$EXP$$FR-AUROBINDO-AUR-APL-2024-034155$AUROBINDO$Bohren Y, Timbolschi ID.. Perineural Botulinum Toxin Injection for Cancer-related Pain: Case Report of Two Patient.. Pain Medicine Case Reports.. 2023;7(5):261-4$56$YR$$M$Y$$$20240717$$MD$FR$FR
241032851$24103285$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140176$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
241032861$24103286$1$I$20230303$20240707$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034083$AUROBINDO$$26$YR$$M$Y$$$20240717$$CN$GB$GB
241032871$24103287$1$I$20240101$20240711$20240717$20240717$EXP$$US-ABBVIE-5838758$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241032881$24103288$1$I$20240101$20240411$20240717$20240717$EXP$$CA-CELLTRION INC.-2024CA009099$CELLTRION$$$$$$Y$$$20240717$$HP$CA$CA
241032891$24103289$1$I$20240709$20240715$20240717$20240717$EXP$GB-MHRA-MED-202407151125228640-RKLZF$GB-ORGANON-O2407GBR001383$ORGANON$$77$YR$$F$Y$$$20240717$$PH$GB$GB
241032901$24103290$1$I$$20240715$20240717$20240717$PER$$US-ABBVIE-5842293$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241032911$24103291$1$I$20230529$20240708$20240717$20240717$EXP$$ES-AUROBINDO-AUR-APL-2024-034325$AUROBINDO$$76$YR$$F$Y$$$20240717$$MD$ES$ES
241032921$24103292$1$I$$20240711$20240717$20240717$EXP$$US-ABBVIE-5837955$ABBVIE$$$$$F$Y$$$20240717$$HP$US$US
241032931$24103293$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008759$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240717$$CN$US$US
241032941$24103294$1$I$$20240713$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009292$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240717$$CN$US$US
241032951$24103295$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009915$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240717$$CN$US$US
241032961$24103296$1$I$20240712$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009377$ELI LILLY AND CO$$$$A$F$Y$$$20240717$$CN$US$US
241032971$24103297$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009624$ELI LILLY AND CO$$$$$M$Y$$$20240717$$CN$US$US
241032981$24103298$1$I$20240714$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009432$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240717$$CN$US$US
241032991$24103299$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008906$ELI LILLY AND CO$$$$$$Y$$$20240717$$CN$US$US
241033001$24103300$1$I$20240714$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009495$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240717$$CN$US$US
241033011$24103301$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5841997$ABBVIE$$$$A$$Y$$$20240717$$CN$US$US
241033021$24103302$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06554$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241033031$24103303$1$I$20240626$20240712$20240717$20240717$EXP$FR-AFSSAPS-BX2024001418$FR-KYOWAKIRIN-2024KK016985$KYOWA$$$$$$Y$$$20240717$$PH$FR$FR
241033052$24103305$2$F$$20240814$20240717$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113041$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240819$$HP$US$US
241033061$24103306$1$I$20240710$20240712$20240717$20240717$EXP$$US-KYOWAKIRIN-2024KK017000$KYOWA$$$$$$Y$$$20240717$$PH$US$US
241033071$24103307$1$I$20230101$20240711$20240717$20240717$EXP$$US-KYOWAKIRIN-2023KK015804$KYOWA$$$$$$Y$$$20240717$$HP$US$US
241033082$24103308$2$F$20240601$20240717$20240717$20240719$EXP$$US-ABBVIE-5838135$ABBVIE$$60$YR$$M$Y$$$20240719$$CN$US$US
241033091$24103309$1$I$20240706$20240710$20240717$20240717$EXP$$PK-ROCHE-10000025489$ROCHE$$44$YR$A$F$Y$$$20240717$$CN$PK$PK
241033101$24103310$1$I$20240530$20240708$20240717$20240717$EXP$$FR-AUROBINDO-AUR-APL-2024-034308$AUROBINDO$$67$YR$$F$Y$52$KG$20240717$$PH$FR$FR
241033111$24103311$1$I$20240104$20240711$20240717$20240717$EXP$$US-ABBVIE-5838614$ABBVIE$$58$YR$$F$Y$$$20240717$$CN$US$US
241033121$24103312$1$I$$20240711$20240717$20240717$EXP$$US-ABBVIE-5838473$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241033141$24103314$1$I$20240416$20240531$20240717$20240717$EXP$FR-AFSSAPS-RN2024000554$FR-HALEON-2179473$Haleon PLC$$49$YR$$M$Y$$$20240717$$CN$FR$FR
241033151$24103315$1$I$$20240708$20240717$20240717$EXP$$SE-ROCHE-10000022741$ROCHE$Grundberg O, Skribek M, Swerkersson S, Skorpil M, K?lbeck K, Grozman V, et al. Diffusion weighted MRI and apparent diffusion coefficient as a prognostic biomarker in evaluating chemotherapy-antiangiogenic treated stage IV non-small cell lung cancer: A prospective, single-arm, open-label, clinical trial (BevMar). European Journal of Radiology. 2024-Aug;177: doi:10.1016/j.ejrad.2024.111557.$67$YR$E$F$Y$$$20240717$$HP$SE$SE
241033161$24103316$1$I$20240617$20240716$20240717$20240717$EXP$$CN-AMGEN-CHNSP2024140744$AMGEN$$61$YR$A$F$Y$60$KG$20240717$$HP$CN$CN
241033171$24103317$1$I$$20200310$20240717$20240717$EXP$$US-AstraZeneca-2020SE37787$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241033181$24103318$1$I$20240610$20240715$20240717$20240717$EXP$$US-AstraZeneca-2024A161511$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241033191$24103319$1$I$$20240715$20240717$20240717$PER$$US-AstraZeneca-2024A161874$ASTRAZENECA$$$$$$Y$$$20240717$$MD$US$
241033201$24103320$1$I$20200108$20200128$20240717$20240717$EXP$$CA-AstraZeneca-2020SE08682$ASTRAZENECA$$26775$DY$$M$Y$$$20240717$$CN$CA$
241033211$24103321$1$I$$20201007$20240717$20240717$EXP$$DE-AstraZeneca-2020SF31631$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$DE$
241033221$24103322$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A158687$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241033231$24103323$1$I$$20190822$20240717$20240717$EXP$$US-AstraZeneca-2019SF22221$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241033241$24103324$1$I$20200309$20200330$20240717$20240717$EXP$$TH-AstraZeneca-2020SE47020$ASTRAZENECA$$82$YR$$F$Y$$$20240717$$CN$TH$
241033251$24103325$1$I$$20200124$20240717$20240717$EXP$$RU-AstraZeneca-2020SE13721$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$RU$
241033261$24103326$1$I$20191016$20191022$20240717$20240717$EXP$$US-AstraZeneca-2019SF51565$ASTRAZENECA$$76$YR$$M$Y$$$20240717$$CN$US$
241033271$24103327$1$I$$20200130$20240717$20240717$EXP$$RU-AstraZeneca-2020SE16856$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$RU$
241033282$24103328$2$F$20240101$20240729$20240717$20240731$EXP$$US-UCBSA-2024035928$UCB$$$$$M$Y$$$20240731$$CN$US$US
241033291$24103329$1$I$20190816$20191125$20240717$20240717$EXP$$BR-AstraZeneca-2019SF24103$ASTRAZENECA$$13926$DY$$F$Y$$$20240717$$CN$BR$
241033301$24103330$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06131$LUPIN$$$$$$Y$$$20240717$$PH$US$US
241033321$24103332$1$I$20240201$20240712$20240717$20240717$EXP$$BG-BIOCON BIOLOGICS LIMITED-BBL2024005211$BIOCON$$$$$$Y$$$20240717$$MD$BG$BG
241033331$24103333$1$I$$20240715$20240717$20240717$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-023764$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240717$$CN$US$US
241033341$24103334$1$I$$20240708$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-032513$AUROBINDO$$$$$$Y$$$20240717$$CN$GB$GB
241033351$24103335$1$I$$20240708$20240717$20240717$PER$$US-RDY-SPO/USA/24/0010223$DR REDDYS$$17$YR$T$$Y$$$20240717$$MD$US$US
241033361$24103336$1$I$$20240708$20240717$20240717$PER$$US-RDY-SPO/USA/24/0010225$DR REDDYS$$63$YR$E$$Y$$$20240717$$MD$US$US
241033371$24103337$1$I$$20240708$20240717$20240717$PER$$US-RDY-SPO/USA/24/0010212$DR REDDYS$$17$YR$T$F$Y$$$20240717$$MD$US$US
241033382$24103338$2$F$20240714$20240715$20240717$20240724$PER$$US-AMGEN-USASL2024141059$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241033391$24103339$1$I$20240619$20240709$20240717$20240717$EXP$IT-MINISAL02-993224$IT-TEVA-VS-3219411$TEVA$$$$$F$Y$$$20240717$$MD$IT$IT
241033401$24103340$1$I$$20240711$20240717$20240717$PER$$US-BIOGEN-2024BI01273443$BIOGEN$$$$$F$Y$$$20240717$$CN$US$US
241033421$24103342$1$I$$20240712$20240717$20240717$EXP$$NVSC2024IN145377$NOVARTIS$$$$$F$Y$$$20240717$$MD$IN$IN
241033431$24103343$1$I$$20240715$20240717$20240717$EXP$$CA-ABBVIE-5842369$ABBVIE$$81$YR$$F$Y$86$KG$20240717$$HP$CA$CA
241033441$24103344$1$I$20110101$20240708$20240717$20240717$EXP$$NL-AUROBINDO-AUR-APL-2017-12337$AUROBINDO$Breur JMPJ, De Graaf M, Breugem CC, Pasmans SGMA.. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: A case report.. Pediatric Dermatology. 2011;28:169-171$18$MON$$F$Y$$$20240717$$MD$NL$NL
241033452$24103345$2$F$$20240708$20240717$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457307$RANBAXY$Zheng J, Ibrahim F, Hachem A. Severe covid-19 infection complicated by hemophagocytic lymphohistiocytosis (HLH). J Invest Med. 2023;71 (6):NP79 (P22)$55$YR$$M$Y$$$20240723$$HP$US$US
241033461$24103346$1$I$20231201$20240716$20240717$20240717$EXP$FR-AFSSAPS-LY2024000922$FR-ROCHE-10000028400$ROCHE$$73$YR$E$F$Y$76$KG$20240717$$PH$FR$FR
241033471$24103347$1$I$20240415$20240716$20240717$20240717$EXP$FR-AFSSAPS-PC2024000499$FR-ROCHE-10000028391$ROCHE$$63$YR$A$M$Y$86$KG$20240717$$MD$FR$FR
241033481$24103348$1$I$$20240716$20240717$20240717$EXP$$GB-ROCHE-10000028264$ROCHE$$$$E$F$Y$$$20240717$$CN$GB$GB
241033492$24103349$2$F$$20240807$20240717$20240807$PER$$US-ALXN-202407USA000822US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$MD$US$US
241033502$24103350$2$F$$20240808$20240717$20240812$30DAY$$TR-JNJFOC-20240736833$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$TR$TR
241033511$24103351$1$I$20240101$20240712$20240717$20240717$EXP$$CA-JNJFOC-20240734697$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$HP$CA$CA
241033525$24103352$5$F$20220708$20240912$20240717$20240917$EXP$$JP-JNJFOC-20220836641$JOHNSON AND JOHNSON$$89$YR$E$F$Y$45.2$KG$20240917$$MD$JP$JP
241033531$24103353$1$I$$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024139567$AMGEN$$79$YR$E$F$Y$$$20240717$$CN$US$US
241033541$24103354$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024138668$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241033551$24103355$1$I$$20240711$20240717$20240717$EXP$$US-AMGEN-USASP2024138511$AMGEN$Caza T.N.; Walker P.D.. Clinicopathologic Features of Kidney Disease in Patients With Cystic Fibrosis. Kidney International Reports. 2024;9:2286-2289$39$YR$A$M$Y$$$20240717$$HP$US$US
241033561$24103356$1$I$$20240713$20240717$20240717$PER$$US-ABBVIE-5841677$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241033571$24103357$1$I$$20240711$20240717$20240717$PER$$US-TAKEDA-2024TUS071563$TAKEDA$$$$$M$Y$$$20240717$$HP$US$US
241033581$24103358$1$I$$20240706$20240717$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-027096$AUROBINDO$Baskaran B, Lipford M.. AN UNSHAKEABLE CASE OF REFRACTORY RLSANDROGEN RECEPTOR INHIBITOR THERAPYAS A CAUSE OF RLS EXACERBATION. Sleep. 2024;47 (Suppl. 1):A504-A505$58$YR$$M$Y$$$20240717$$MD$US$US
241033593$24103359$3$F$$20240812$20240717$20240813$PER$$US-TAKEDA-2024TUS071750$TAKEDA$$$$$F$Y$$$20240813$$PH$US$US
241033601$24103360$1$I$20240421$20240712$20240717$20240717$EXP$$US-BIOGEN-2024BI01273666$BIOGEN$$59$YR$$F$Y$$$20240717$$CN$US$US
241033612$24103361$2$F$20240701$20240913$20240717$20240920$EXP$$US-BIOGEN-2024BI01273524$BIOGEN$$36$YR$$F$Y$$$20240920$$PH$US$US
241033621$24103362$1$I$$20191028$20240717$20240717$EXP$$NL-TERSERA THERAPEUTICS LLC-2019TRS002517$TERSERA THERAPEUTICS$$$$$$Y$$$20240717$$CN$NL$NL
241033631$24103363$1$I$20200117$20200213$20240717$20240717$EXP$$CO-TERSERA THERAPEUTICS LLC-2020TRS000429$TERSERA THERAPEUTICS$$$$$$Y$$$20240717$$CN$CO$CO
241033641$24103364$1$I$20200315$20200416$20240717$20240717$EXP$$CO-TERSERA THERAPEUTICS LLC-2020TRS000981$TERSERA THERAPEUTICS$$$$$$Y$$$20240717$$CN$CO$CO
241033651$24103365$1$I$20240601$20240710$20240717$20240717$EXP$FR-AFSSAPS-PB2024000734$FR-TEVA-VS-3219834$TEVA$$41$YR$$F$Y$$$20240717$$MD$FR$FR
241033661$24103366$1$I$$20240713$20240717$20240717$PER$$US-AMGEN-USASP2024140011$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
241033671$24103367$1$I$$20240710$20240717$20240717$EXP$$AU-AMGEN-AUSSP2024138002$AMGEN$Fantoni A.; Warburton L.; Solomon B. et al.. Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT). Clinical Lung Cancer. 2024;25 (5):449-459$$$$$Y$$$20240717$$HP$AU$AU
241033681$24103368$1$I$$20240708$20240717$20240717$EXP$$US-AMGEN-USASP2024137519$AMGEN$Yu E. Y.; Ferrario C.; Linch M. D. et al.. Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D. EUROPEAN UROLOGY ONCOLOGY. 2024;1-11$$$$$Y$$$20240717$$HP$US$US
241033691$24103369$1$I$20240617$20240708$20240717$20240717$EXP$$IT-AUROBINDO-AUR-APL-2024-034291$AUROBINDO$$83$YR$$F$Y$$$20240717$$MD$IT$IT
241033701$24103370$1$I$$20240705$20240717$20240717$PER$$US-TAKEDA-2024TUS071433$TAKEDA$$32$YR$$F$Y$$$20240717$$CN$US$US
241033712$24103371$2$F$20240517$20240717$20240717$20240725$PER$$US-ABBVIE-5841040$ABBVIE$$33$YR$$F$Y$$$20240725$$MD$US$US
241033721$24103372$1$I$20220101$20240715$20240717$20240717$EXP$$US-UCBSA-2024035947$UCB$$40$YR$$F$Y$$$20240717$$HP$US$US
241033731$24103373$1$I$$20240708$20240717$20240717$EXP$$US-RDY-LIT/USA/24/0010202$DR REDDYS$Yeung SJ, Qdaisat A, Bischof JJ, Caterino JM, Demetrios DN, Coyne C. A case series of adrenal insufficiency (likely due to hypophysitis) in cancer patients treated with immune checkpoint inhibitors. American Journal of Emergency Medicine. 2024 Jun;80(0): 227.e1-227.e5. doi:10.1016/j.ajem.2024.04.046.$54$YR$A$F$Y$$$20240717$$MD$US$US
241033741$24103374$1$I$$20240708$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-032530$AUROBINDO$$$$$$Y$$$20240717$$CN$GB$GB
241033751$24103375$1$I$$20240716$20240717$20240717$EXP$$US-GILEAD-2024-0680995$GILEAD$$$$$$Y$$$20240717$$LW$US$US
241033761$24103376$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5839750$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241033771$24103377$1$I$$20200323$20240717$20240717$EXP$$US-AstraZeneca-2020SE42790$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241033781$24103378$1$I$$20200203$20240717$20240717$EXP$$US-AstraZeneca-2020SE18100$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241033791$24103379$1$I$$20240712$20240717$20240717$PER$$US-ABBVIE-5840346$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241033803$24103380$3$F$20240601$20240902$20240717$20240902$PER$$US-ALXN-202407USA000733US$ALEXION PHARMACEUTICALS$$76$YR$$F$Y$$$20240902$$CN$US$US
241033811$24103381$1$I$20200206$20200217$20240717$20240717$EXP$$US-AstraZeneca-2020SE25409$ASTRAZENECA$$23799$DY$$M$Y$$$20240717$$CN$US$
241033821$24103382$1$I$$20190814$20240717$20240717$EXP$$US-AstraZeneca-2019SE88320$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241033831$24103383$1$I$$20240705$20240717$20240717$EXP$$US-ALVOGEN-2024095080$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$53$YR$$M$Y$$$20240717$$HP$US$US
241033841$24103384$1$I$$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010717$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240717$$CN$US$US
241033852$24103385$2$F$$20240715$20240717$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407007104$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240719$$CN$US$US
241033861$24103386$1$I$$20191030$20240717$20240717$EXP$$US-AstraZeneca-2019SF56118$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241033871$24103387$1$I$$20200526$20240717$20240717$EXP$$US-AstraZeneca-2020SE70294$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241033881$24103388$1$I$$20240704$20240717$20240717$EXP$$BG-ROCHE-10000000840$ROCHE$Nikolova D, Nikolova D, Yordanov A, Maslarova A, Sokolova L, Radinov A. Good clinical response following Ibrutinib treatment of a rare case of lymphoplasmacytic lymphoma secreting IgA kappa paraprotein: A case report. Oncology Letters. 2024;28 (2): doi:10.3892/ol.2024.14471.$62$YR$A$F$Y$$$20240717$$MD$BG$BG
241033891$24103389$1$I$$20210115$20240717$20240717$EXP$$US-AstraZeneca-2021A010452$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241033901$24103390$1$I$20190323$20190907$20240717$20240717$EXP$$CO-AstraZeneca-2019SF29964$ASTRAZENECA$$2759$WK$$F$Y$$$20240717$$CN$CO$
241033911$24103391$1$I$$20210222$20240717$20240717$EXP$$US-AstraZeneca-2021A083931$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241033921$24103392$1$I$$20210128$20240717$20240717$EXP$$US-AstraZeneca-2021A022801$ASTRAZENECA$$75$YR$$F$Y$$$20240717$$CN$US$
241033931$24103393$1$I$$20200520$20240717$20240717$EXP$$CN-AstraZeneca-2020SE68231$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CN$
241033941$24103394$1$I$20200312$20200313$20240717$20240717$EXP$$US-AstraZeneca-2020SE39892$ASTRAZENECA$$24537$DY$$F$Y$$$20240717$$CN$US$
241033951$24103395$1$I$$20200512$20240717$20240717$EXP$$US-AstraZeneca-2020SE63357$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241033971$24103397$1$I$20200101$20201218$20240717$20240717$EXP$$TW-AstraZeneca-2020SF70137$ASTRAZENECA$$66$YR$$M$Y$$$20240717$$CN$TW$
241033981$24103398$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008911$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240717$$CN$US$US
241033991$24103399$1$I$20240101$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113355$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240717$$HP$US$US
241034001$24103400$1$I$20240601$20240711$20240717$20240717$EXP$$US-VIIV HEALTHCARE LIMITED-US2024086521$VIIV$$59$YR$$F$Y$$$20240717$$CN$US$US
241034011$24103401$1$I$$20240712$20240717$20240717$30DAY$$US-GSK-US2024AMR088578$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$US$US
241034021$24103402$1$I$20240701$20240710$20240717$20240717$EXP$$KW-TAKEDA-2024TUS071562$TAKEDA$$56$YR$$F$Y$$$20240717$$CN$KW$KW
241034032$24103403$2$F$$20240806$20240717$20240809$EXP$$SG-ROCHE-10000016218$ROCHE$$74$YR$E$F$Y$$$20240810$$CN$SG$SG
241034041$24103404$1$I$20240715$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140794$AMGEN$$65$YR$E$F$Y$$$20240717$$CN$US$US
241034051$24103405$1$I$20210301$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024139675$AMGEN$$68$YR$E$F$Y$$$20240717$$HP$US$US
241034081$24103408$1$I$20240414$20240708$20240717$20240717$EXP$$ES-AUROBINDO-AUR-APL-2024-034320$AUROBINDO$$14$YR$$M$Y$$$20240717$$MD$ES$ES
241034091$24103409$1$I$20240605$20240711$20240717$20240717$EXP$$IN-ROCHE-10000018598$ROCHE$$49$YR$A$F$Y$74$KG$20240717$$MD$IN$IN
241034101$24103410$1$I$$20240710$20240717$20240717$EXP$$CA-VANTIVE-2024VAN018282$Vantive US Healthcare$$$$$F$Y$$$20240717$$CN$CA$CA
241034111$24103411$1$I$$20240710$20240717$20240717$EXP$$IT-DECIPHERA PHARMACEUTICALS LLC-2024IT000605$DECIPHERA PHARMACEUTICALS$$$$$M$Y$$$20240717$$MD$IT$IT
241034121$24103412$1$I$20240508$20240710$20240717$20240717$EXP$FR-AFSSAPS-PB2024000724$FR-TEVA-VS-3220341$TEVA$$77$YR$$F$Y$48$KG$20240717$$MD$FR$FR
241034131$24103413$1$I$$20240711$20240717$20240717$EXP$$BR-TAKEDA-2024TUS071660$TAKEDA$$42$YR$$$Y$$$20240717$$CN$BR$BR
241034141$24103414$1$I$$20240712$20240717$20240717$EXP$$US-TAKEDA-2024TUS039273$TAKEDA$$$$$M$Y$$$20240717$$CN$US$US
241034151$24103415$1$I$20240713$20240715$20240717$20240717$EXP$$US-ABBVIE-5842205$ABBVIE$$77$YR$$M$Y$$$20240717$$CN$US$US
241034171$24103417$1$I$20231109$20240709$20240717$20240717$EXP$FR-AFSSAPS-AN2024000830$FR-TEVA-VS-3219439$TEVA$$73$YR$$F$Y$$$20240717$$MD$FR$FR
241034181$24103418$1$I$20240601$20240705$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108126$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240717$$HP$US$US
241034192$24103419$2$F$$20240814$20240717$20240816$PER$$US-AMGEN-USASP2024139087$AMGEN$$$$$F$Y$$$20240816$$CN$US$US
241034201$24103420$1$I$20231109$20240709$20240717$20240717$EXP$FR-AFSSAPS-NY2024000741$FR-TEVA-VS-3219497$TEVA$$38$YR$$F$Y$69.5$KG$20240717$$MD$FR$FR
241034211$24103421$1$I$20230715$20240712$20240717$20240717$EXP$$DE-ABBVIE-5839967$ABBVIE$$48$YR$$M$Y$$$20240717$$MD$DE$DE
241034221$24103422$1$I$$20240711$20240717$20240717$EXP$$CA-TAKEDA-2024TUS071579$TAKEDA$$$$$M$Y$$$20240717$$MD$CA$CA
241034231$24103423$1$I$$20240709$20240717$20240717$EXP$$US-CELLTRION INC.-2024US016979$CELLTRION$$$$$$Y$$$20240717$$CN$US$US
241034241$24103424$1$I$20240701$20240715$20240717$20240717$EXP$$US-ABBVIE-5842154$ABBVIE$$57$YR$$M$Y$$$20240717$$CN$US$US
241034251$24103425$1$I$$20240712$20240717$20240717$EXP$$US-ROCHE-10000026218$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241034261$24103426$1$I$$20240716$20240717$20240717$EXP$$US-GILEAD-2024-0680996$GILEAD$$$$$$Y$$$20240717$$LW$US$US
241034282$24103428$2$F$20240703$20240712$20240717$20240722$PER$$US-ABBVIE-5838128$ABBVIE$$29$YR$$F$Y$68$KG$20240722$$CN$US$US
241034291$24103429$1$I$$20240715$20240717$20240717$PER$$US-JNJFOC-20240741398$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241034302$24103430$2$F$$20240801$20240717$20240810$EXP$$US-TEVA-VS-3212093$TEVA$Botero L, McNeill K, Makower D. Axial Neuropathy in Two Breast Cancer Patients receiving Fam-trastuzumab deruxtecan: A Case Report. Cancer-Res 2024; 84 (Suppl.) (9): (plus Poster) abstr. PO3-12-12.; Botero L, McNeill K, Makower D. Axial Neuropathy in Two Breast Cancer Patients receiving Fam-trastuzumab deruxtecan: A Case Report. Cancer-Res 2024; 84 (Suppl.) (9): (plus Poster) abstr. PO3-12-12.$56$YR$$F$Y$$$20240810$$HP$US$US
241034311$24103431$1$I$$20240709$20240717$20240717$EXP$$CA-APOTEX-2024AP008151$APOTEX$$92$YR$$F$Y$$$20240717$$PH$CA$CA
241034321$24103432$1$I$20240607$20240621$20240717$20240717$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001673$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240717$$CN$US$US
241034331$24103433$1$I$20191001$20240716$20240717$20240717$EXP$$FR-TAKEDA-2021TUS044442$TAKEDA$$25$YR$$M$Y$$$20240717$$HP$FR$FR
241034341$24103434$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113043$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240717$$CN$US$US
241034354$24103435$4$F$$20240816$20240717$20240821$EXP$$US-GSK-US2024AMR087078$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
241034401$24103440$1$I$$20240703$20240717$20240717$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001089$AKEBIA THERAPEUTICS$$$$$$Y$$$20240717$$MD$JP$JP
241034413$24103441$3$F$$20240819$20240717$20240822$EXP$$NVSC2024US145735$NOVARTIS$$$$$F$Y$95$KG$20240822$$CN$US$US
241034423$24103442$3$F$20240714$20240826$20240717$20240829$PER$$US-AMGEN-USASP2024140880$AMGEN$$76$YR$E$F$Y$$$20240829$$CN$US$US
241034431$24103443$1$I$$20240709$20240717$20240717$EXP$$DE-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003825$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240717$$MD$DE$DE
241034441$24103444$1$I$20240703$20240715$20240717$20240717$EXP$$US-ABBVIE-5842070$ABBVIE$$67$YR$$M$Y$$$20240717$$CN$US$US
241034451$24103445$1$I$$20240705$20240717$20240717$EXP$$US-ALVOGEN-2024095079$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$56$YR$$M$Y$$$20240717$$HP$US$US
241034461$24103446$1$I$$20240708$20240717$20240717$EXP$$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-06601$HIKMA$Hans FP, Benning L, Pooth J, Busch H. Hans FP, Benning L, Pooth J, Busch H. A potentially lifesaving error: unintentional high-dose adrenaline administration in anaphylaxis-induced cardiac arrest; a case report.. International journal of emergency medicine.. 2024;17(1):78$66$YR$$F$Y$$$20240717$$MD$DE$DE
241034471$24103447$1$I$20240503$20240710$20240717$20240717$EXP$$BR-TAKEDA-2023TUS054499$TAKEDA$$50$YR$$M$Y$$$20240717$$CN$BR$BR
241034486$24103448$6$F$20240709$20240830$20240717$20240912$PER$$US-JNJFOC-20240733623$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240912$$PH$US$US
241034491$24103449$1$I$$20240704$20240717$20240717$EXP$GB-MHRA-MED-202405021617124220-NDSPQ$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001717$IPCA$$$$$$Y$$$20240717$$PH$GB$GB
241034502$24103450$2$F$$20240924$20240717$20240930$EXP$$US-JNJFOC-20240725874$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
241034511$24103451$1$I$20220219$20240708$20240717$20240717$EXP$$CA-MYLANLABS-2022M1121742$BIOCON$$$$$$Y$$$20240717$$MD$CA$CA
241034521$24103452$1$I$$20240715$20240717$20240717$EXP$$KZ-TAKEDA-2024TUS071945$TAKEDA$$$$$$Y$$$20240717$$CN$KZ$KZ
241034531$24103453$1$I$20240710$20240710$20240717$20240717$EXP$$US-ABBVIE-5836173$ABBVIE$$67$YR$$M$Y$$$20240717$$CN$US$US
241034542$24103454$2$F$20240101$20240718$20240717$20240726$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000591$DECIPHERA PHARMACEUTICALS$$69$YR$E$M$Y$$$20240726$$CN$US$US
241034551$24103455$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140788$AMGEN$$$$$F$Y$$$20240717$$PH$US$US
241034561$24103456$1$I$20240615$20240709$20240717$20240717$EXP$PT-INFARMED-R202406-546$PT-TEVA-VS-3219541$TEVA$$77$YR$$F$Y$$$20240717$$PH$PT$PT
241034573$24103457$3$F$20240101$20240809$20240717$20240814$EXP$$US-ABBVIE-5839524$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
241034581$24103458$1$I$20240605$20240703$20240717$20240717$EXP$$CN-ROCHE-10000015998$ROCHE$$82$YR$E$F$Y$$$20240717$$HP$CN$CN
241034591$24103459$1$I$$20240709$20240717$20240717$EXP$$CZ-CELLTRION INC.-2024CZ016924$CELLTRION$Zitko T.. Upadacitinib u pacientky se sarkoid?zou indukovanou inhibitorem TNF (Upadacitinib in a patient with TNF Inhibitor-Induced Sarcoidosis). Farmakoterapie. 2023;6:779-780$$$$$Y$$$20240717$$HP$CZ$CZ
241034601$24103460$1$I$$20240705$20240717$20240717$EXP$$US-ALVOGEN-2024095078$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$55$YR$$F$Y$$$20240717$$HP$US$US
241034621$24103462$1$I$20240301$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009571$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240717$$CN$US$US
241034631$24103463$1$I$20240601$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009498$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240717$$CN$US$US
241034641$24103464$1$I$20211201$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009630$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240717$$CN$US$US
241034651$24103465$1$I$20240712$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008713$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240717$$CN$US$US
241034661$24103466$1$I$20240708$20240709$20240717$20240717$EXP$GB-MHRA-MED-202407091456425100-NKPBH$GB-NEBO-663736$PHARMACOSMOS$$49$YR$$F$Y$72$KG$20240717$$MD$GB$GB
241034671$24103467$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008829$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240717$$CN$US$US
241034701$24103470$1$I$20231201$20240708$20240717$20240717$EXP$$AU-ASTELLAS-2024US019512$ASTELLAS$$80$YR$$M$Y$$$20240717$$CN$AU$AU
241034711$24103471$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009090$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240717$$CN$US$US
241034721$24103472$1$I$20240301$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008789$ELI LILLY AND CO$$$$A$F$Y$$$20240717$$CN$US$US
241034731$24103473$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009456$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240717$$CN$US$US
241034742$24103474$2$F$$20240820$20240717$20240827$30DAY$$US-GSK-US2024085858$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$PH$US$US
241034751$24103475$1$I$$20240710$20240717$20240717$EXP$$CO-ROCHE-10000024082$ROCHE$$56$YR$A$F$Y$$$20240717$$CN$CO$CO
241034761$24103476$1$I$20240402$20240622$20240717$20240717$PER$$US-AUROBINDO-AUR-APL-2024-018438$AUROBINDO$$84$YR$$M$Y$79.37$KG$20240717$$CN$US$US
241034771$24103477$1$I$$20240303$20240717$20240717$EXP$GB-MHRA-MED-202403021303525300-QNYFD$GB-TEVA-VS-3167022$TEVA$$$$$M$Y$$$20240717$$HP$GB$GB
241034781$24103478$1$I$$20240705$20240717$20240717$EXP$$US-ALVOGEN-2024095077$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$38$YR$$F$Y$$$20240717$$HP$US$US
241034791$24103479$1$I$$20240709$20240717$20240717$PER$$US-APOTEX-2024AP008335$APOTEX$Idowu D, Ezema K, Corcoran J, Farkas A.. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clinical Toxicology. 2024;62 (5):296-302$$$$$Y$$$20240717$$HP$US$US
241034801$24103480$1$I$20230730$20230730$20240717$20240717$PER$$US-AUROBINDO-AUR-APL-2023-051952$AUROBINDO$$$$$F$Y$$$20240717$$CN$US$US
241034811$24103481$1$I$20230627$20230808$20240717$20240717$PER$$US-AUROBINDO-AUR-APL-2023-051404$AUROBINDO$$21$YR$$M$Y$104.3$KG$20240717$$CN$US$US
241034821$24103482$1$I$20190719$20190815$20240717$20240717$EXP$$CO-AstraZeneca-2019SF18045$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CO$
241034831$24103483$1$I$20221119$20230104$20240717$20240717$EXP$$US-AstraZeneca-2023A002647$ASTRAZENECA$$22412$DY$$F$Y$$$20240717$$CN$US$
241034841$24103484$1$I$20240627$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140996$AMGEN$$76$YR$E$F$Y$$$20240717$$HP$US$US
241034851$24103485$1$I$$20200107$20240717$20240717$EXP$$CA-AstraZeneca-2020SE03118$ASTRAZENECA$$$$$F$Y$106$KG$20240717$$MD$CA$
241034861$24103486$1$I$$20200210$20240717$20240717$EXP$$FR-AstraZeneca-2020SE23224$ASTRAZENECA$$$$$M$Y$$$20240717$$MD$FR$
241034871$24103487$1$I$20190905$20190919$20240717$20240717$EXP$$CO-AstraZeneca-2019SF35496$ASTRAZENECA$$26812$DY$$F$Y$$$20240717$$CN$CO$
241034881$24103488$1$I$$20200214$20240717$20240717$EXP$$US-AstraZeneca-2020SE23841$ASTRAZENECA$$64$YR$$M$Y$$$20240717$$MD$US$
241034892$24103489$2$F$$20240912$20240717$20240917$EXP$$TR-ROCHE-10000026232$ROCHE$$30$YR$A$F$Y$$$20240917$$PH$TR$TR
241034901$24103490$1$I$$20240709$20240717$20240717$PER$$US-ROCHE-10000022279$ROCHE$$$$A$F$Y$$$20240717$$CN$US$US
241034911$24103491$1$I$$20201007$20240717$20240717$EXP$$US-AstraZeneca-2020SF31584$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241034921$24103492$1$I$20231027$20231027$20240717$20240717$PER$$US-AUROBINDO-AUR-APL-2023-066914$AUROBINDO$$$$$F$Y$$$20240717$$CN$US$US
241034931$24103493$1$I$20231212$20240124$20240717$20240717$PER$$US-AUROBINDO-AUR-APL-2023-079591$AUROBINDO$$$$$F$Y$$$20240717$$CN$US$US
241034941$24103494$1$I$$20200131$20240717$20240717$EXP$$US-AstraZeneca-2020SE18230$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241034951$24103495$1$I$20240319$20240709$20240717$20240717$EXP$FR-AFSSAPS-RE2024000646$FR-TEVA-VS-3219514$TEVA$$84$YR$$M$Y$92$KG$20240717$$MD$FR$FR
241034961$24103496$1$I$20230101$20240711$20240717$20240717$EXP$$US-ABBVIE-5840437$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241034971$24103497$1$I$20200506$20200508$20240717$20240717$EXP$$TH-AstraZeneca-2020SE61815$ASTRAZENECA$$67$YR$$F$Y$$$20240717$$PH$TH$
241034981$24103498$1$I$$20190927$20240717$20240717$EXP$$US-AstraZeneca-2019SF39728$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241034991$24103499$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A158404$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241035061$24103506$1$I$$20240627$20240717$20240717$PER$$US-JNJFOC-20240700304$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$HP$US$US
241035081$24103508$1$I$$20220915$20240717$20240717$EXP$$US-AstraZeneca-2022A319431$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241035091$24103509$1$I$$20190712$20240717$20240717$EXP$$US-AstraZeneca-2019SF02284$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241035101$24103510$1$I$$20240712$20240717$20240717$PER$$US-AstraZeneca-2024A160276$ASTRAZENECA$$$$$M$Y$$$20240717$$PH$US$
241035111$24103511$1$I$$20200427$20240717$20240717$EXP$$CR-AstraZeneca-2020SE57777$ASTRAZENECA$$62$YR$$F$Y$$$20240717$$CN$CR$
241035121$24103512$1$I$$20191001$20240717$20240717$EXP$$US-AstraZeneca-2019SF41745$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241035131$24103513$1$I$$20240709$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034378$AUROBINDO$$26$YR$$F$Y$$$20240717$$CN$GB$GB
241035151$24103515$1$I$$20201009$20240717$20240717$EXP$$US-AstraZeneca-2020SF32927$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241035161$24103516$1$I$$20240706$20240717$20240717$EXP$$CA-MPL-000048$MLV PHARMA$$70$YR$E$F$Y$$$20240708$$MD$CA$CA
241035171$24103517$1$I$$20240707$20240717$20240717$EXP$$DE-VKT-000568$VKT PHARMA PRIVATE LIMITED$$74$YR$E$F$Y$$$20240711$$MD$DE$DE
241035181$24103518$1$I$20200909$20200918$20240717$20240717$EXP$$US-AstraZeneca-2020SF22278$ASTRAZENECA$$34225$DY$$M$Y$$$20240717$$CN$US$
241035191$24103519$1$I$$20240707$20240717$20240717$EXP$$DE-VKT-000569$VKT PHARMA PRIVATE LIMITED$$78$YR$E$F$Y$$$20240711$$MD$DE$DE
241035201$24103520$1$I$$20200107$20240717$20240717$EXP$$CA-AstraZeneca-2020SE03713$ASTRAZENECA$$65$YR$$M$Y$$$20240717$$MD$CA$
241035211$24103521$1$I$$20240707$20240717$20240717$EXP$$DE-VKT-000570$VKT PHARMA PRIVATE LIMITED$$61$YR$A$M$Y$$$20240711$$MD$DE$DE
241035221$24103522$1$I$$20191009$20240717$20240717$EXP$$US-AstraZeneca-2019SF44508$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241035231$24103523$1$I$20190426$20200124$20240717$20240717$EXP$$CO-AstraZeneca-2020SE12661$ASTRAZENECA$$23258$DY$$F$Y$$$20240717$$CN$CO$
241035241$24103524$1$I$20240621$20240709$20240717$20240717$EXP$$CZ-CELLTRION INC.-2024CZ016015$CELLTRION$$$$$$Y$$$20240717$$MD$CZ$CZ
241035251$24103525$1$I$$20240707$20240717$20240717$EXP$$IR-CARNEGIE-000014$Carnegie Pharmaceuticals$$25$YR$A$F$Y$$$20240710$$MD$IR$IR
241035261$24103526$1$I$$20240705$20240717$20240717$EXP$$US-MPL-000049$MLV PHARMA$$83$YR$E$F$Y$$$20240708$$MD$US$US
241035271$24103527$1$I$$20240709$20240717$20240717$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005128$BIOCON$$$$$$Y$$$20240717$$MD$CA$CA
241035281$24103528$1$I$$20240716$20240717$20240717$EXP$$US-GILEAD-2024-0680992$GILEAD$$$$$$Y$$$20240717$$LW$US$US
241035291$24103529$1$I$$20240710$20240717$20240717$EXP$RO-MLMSERVICE-20240703-PI120268-00136-1$RO-ABBVIE-5841986$ABBVIE$Cana Ruiu D, Maria DT, Popa R, Moraru S, Micu EG, Vaduva C, et al. A 68-year-old man with depression and acute renal failure due to rhabdomyolysis associated with alcohol intoxication while taking low-dose escitalopram: a case report. Am J Case Rep. 2024;25:e943422-1-10.$$$$$Y$$$20240717$$MD$RO$RO
241035301$24103530$1$I$$20240709$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034474$AUROBINDO$$$$$M$Y$$$20240717$$MD$GB$GB
241035311$24103531$1$I$20240701$20240711$20240717$20240717$EXP$$JP-GSK-JP2024089169$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$JP$JP
241035321$24103532$1$I$$20240705$20240717$20240717$EXP$$US-ALVOGEN-2024095076$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$39$YR$$F$Y$$$20240717$$HP$US$US
241035331$24103533$1$I$$20240708$20240717$20240717$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089716$VIIV$$$$$$Y$$$20240717$$HP$US$US
241035344$24103534$4$F$20240601$20240916$20240717$20240923$EXP$$CA-GSK-CA2024077686$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$HP$CA$CA
241035351$24103535$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024139178$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241035362$24103536$2$F$$20240730$20240717$20240809$EXP$$GB-TEVA-VS-3212908$TEVA$Rehman U, Hever P, Eiben I, Geh J. Guidance on the treatment of rare deep subcutaneous mycobacterium abscess following cosmetic procedures: a case series and systematic review of the literature. Eur-J-Plast-Surg 2023; 46 (4): 625-635.; Rehman U, Hever P, Eiben I, Geh J. Guidance on the treatment of rare deep subcutaneous mycobacterium abscess following cosmetic procedures: a case series and systematic review of the literature. Eur-J-Plast-Surg 2023; 46 (4): 625-635.$36$YR$$F$Y$$$20240809$$HP$GB$GB
241035371$24103537$1$I$$20240708$20240717$20240717$EXP$$US-RDY-LIT/USA/24/0010393$DR REDDYS$Young KZ, Guan LL, Friedman BJ, Rambhatla PV. Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil. International Journal of Womenandapos;s Dermatology. 2022 Oct 01;8(3): doi:10.1097/JW9.0000000000000061.$47$YR$A$F$Y$$$20240717$$HP$US$US
241035382$24103538$2$F$$20240708$20240717$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06039$LUPIN$$$$$$Y$$$20240806$$CN$US$US
241035391$24103539$1$I$20240125$20240709$20240717$20240717$EXP$GB-MHRA-MED-202407081950377100-MCSQK$GB-RDY-SPO/GBR/24/0010230$DR REDDYS$$4$YR$C$M$Y$16$KG$20240717$$CN$GB$GB
241035401$24103540$1$I$$20240709$20240717$20240717$EXP$GB-MHRA-MED-202407091039521900-GMQNV$GB-RDY-SPO/GBR/24/0010220$DR REDDYS$$34$YR$A$F$Y$$$20240717$$CN$GB$GB
241035411$24103541$1$I$$20240710$20240717$20240717$PER$$US-ALXN-202407USA000648US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
241035421$24103542$1$I$$20240702$20240717$20240717$PER$$US-ROCHE-10000018995$ROCHE$$89$YR$E$M$Y$$$20240717$$MD$US$US
241035432$24103543$2$F$20240108$20240712$20240717$20240723$EXP$$TW-ROCHE-10000024798$ROCHE$$10$DY$N$$Y$$$20240723$$MD$TW$TW
241035441$24103544$1$I$$20240708$20240717$20240717$EXP$$TR-ROCHE-10000023438$ROCHE$$27$YR$A$F$Y$$$20240717$$CN$TR$TR
241035451$24103545$1$I$$20240708$20240717$20240717$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06602$HIKMA$Kuraitis D, Bogner P, Gopalakrishnan D, Pei S.. Kuraitis D, Bogner P, Gopalakrishnan D, Pei S. Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis.. JAAD Case Reports.. 2024;50:33-6$68$YR$$M$Y$$$20240717$$MD$US$US
241035461$24103546$1$I$20240601$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06170$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241035471$24103547$1$I$20200821$20201001$20240717$20240717$EXP$$AU-TERSERA THERAPEUTICS LLC-2020TRS003127$TERSERA THERAPEUTICS$$$$$$Y$$$20240717$$CN$AU$AU
241035492$24103549$2$F$20240713$20240719$20240717$20240724$PER$$US-AMGEN-USASP2024140186$AMGEN$$68$YR$E$M$Y$$$20240724$$CN$US$US
241035501$24103550$1$I$$20200916$20240717$20240717$EXP$$US-AstraZeneca-2020SF20397$ASTRAZENECA$$72$YR$$M$Y$$$20240717$$CN$US$
241035511$24103551$1$I$20240321$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160324$ASTRAZENECA$$27432$DY$$F$Y$$$20240717$$HP$US$
241035521$24103552$1$I$$20200924$20240717$20240717$EXP$$US-AstraZeneca-2020SF24083$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241035531$24103553$1$I$20240409$20240708$20240717$20240717$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024084453$VIIV$$29$YR$$M$Y$$$20240717$$CN$US$US
241035541$24103554$1$I$$20190829$20240717$20240717$EXP$$CA-AstraZeneca-2019SF26281$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CA$
241035551$24103555$1$I$$20191011$20240717$20240717$EXP$$RU-AstraZeneca-2019SF46334$ASTRAZENECA$$83$YR$$F$Y$52$KG$20240717$$CN$RU$
241035561$24103556$1$I$$20200305$20240717$20240717$EXP$$US-AstraZeneca-2020SE35597$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241035571$24103557$1$I$$20191015$20240717$20240717$EXP$$US-AstraZeneca-2019SF48208$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241035581$24103558$1$I$20190101$20190717$20240717$20240717$EXP$$US-AstraZeneca-2019SF03620$ASTRAZENECA$$14702$DY$$M$Y$129.3$KG$20240717$$CN$US$
241035591$24103559$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160523$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241035602$24103560$2$F$$20240819$20240717$20240827$EXP$$AU-ROCHE-10000028039$ROCHE$$2$YR$C$M$Y$$$20240827$$CN$AU$AU
241035611$24103561$1$I$20240505$20240704$20240717$20240717$EXP$$IT-ROCHE-10000023741$ROCHE$$64$YR$A$F$Y$$$20240717$$MD$IT$IT
241035621$24103562$1$I$20240628$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160218$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241035631$24103563$1$I$$20200903$20240717$20240717$EXP$$TW-AstraZeneca-2020SF14953$ASTRAZENECA$$59$YR$$M$Y$57.2$KG$20240717$$CN$TW$
241035641$24103564$1$I$$20191022$20240717$20240717$EXP$$US-AstraZeneca-2019SF50663$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241035651$24103565$1$I$$20190722$20240717$20240717$EXP$$US-AstraZeneca-2019SF05813$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241035662$24103566$2$F$20240101$20240717$20240717$20240723$EXP$$US-ABBVIE-5841999$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241035672$24103567$2$F$$20240918$20240717$20240926$EXP$$KR-ROCHE-10000026631$ROCHE$Kwon HJ, Kim KH, Yoon JH. Refractory bullous pemphigoid successfully treated with reslizumab: a possible novel therapeutic modality. ANNALS OF DERMATOLOGY. 2023;35(1):S103-6. doi:10.5021/ad.21.177$69$YR$E$M$Y$$$20240926$$HP$KR$KR
241035682$24103568$2$F$20240712$20240716$20240717$20240719$PER$$US-AMGEN-USASP2024140418$AMGEN$$79$YR$E$F$Y$$$20240719$$CN$US$US
241035692$24103569$2$F$20240711$20240812$20240717$20240814$PER$$US-AMGEN-USASP2024140912$AMGEN$$73$YR$E$F$Y$$$20240814$$CN$US$US
241035701$24103570$1$I$20240101$20240712$20240717$20240717$EXP$$US-AMGEN-USASP2024140029$AMGEN$$$$A$F$Y$$$20240717$$CN$US$US
241035711$24103571$1$I$20240624$20240715$20240717$20240717$EXP$$US-ABBVIE-5842206$ABBVIE$$83$YR$$F$Y$$$20240717$$CN$US$US
241035721$24103572$1$I$20240301$20240606$20240717$20240717$PER$$US-IMP-2024000367$Harrow Health$$$$$M$Y$$$20240717$$CN$US$US
241035731$24103573$1$I$$20240710$20240717$20240717$EXP$$BR-TAKEDA-2024TUS071478$TAKEDA$$$$$M$Y$$$20240717$$CN$BR$BR
241035771$24103577$1$I$20230101$20240712$20240717$20240717$EXP$$US-ABBVIE-5840500$ABBVIE$$70$YR$$M$Y$$$20240717$$CN$US$US
241035783$24103578$3$F$20240703$20240917$20240717$20240925$EXP$$US-JNJFOC-20240726433$JOHNSON AND JOHNSON$$76$YR$E$M$Y$97$KG$20240925$$CN$US$US
241035791$24103579$1$I$20211126$20240709$20240717$20240717$EXP$$FR-CELLTRION INC.-2024FR016945$CELLTRION$$$$$$Y$$$20240717$$MD$FR$FR
241035801$24103580$1$I$20220101$20240712$20240717$20240717$EXP$$US-ABBVIE-5840805$ABBVIE$$56$YR$$M$Y$$$20240717$$CN$US$US
241035811$24103581$1$I$20240501$20240710$20240717$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-014820$JAZZ$$38$YR$$F$Y$$$20240717$$HP$US$US
241035821$24103582$1$I$$20240613$20240717$20240717$PER$$US-IMP-2024000392$Harrow Health$$$$E$F$Y$$$20240717$$CN$US$US
241035832$24103583$2$F$$20240801$20240717$20240809$EXP$$US-TEVA-VS-3212091$TEVA$Haddad S, Graff S, Hadfield M, Wang Y, Taneja C, Leonard K, et al. Safety and efficacy of KEYNOTE-522 in combination with anti-retroviral therapy in a patient with HIV and triple-negative breast cancer. Cancer-Res 2024; 84 (Suppl.) (9): (plus Poster) abstr. PO2-20-11.; Haddad S, Graff S, Hadfield M, Wang Y, Taneja C, Leonard K, et al. Safety and efficacy of KEYNOTE-522 in combination with anti-retroviral therapy in a patient with HIV and triple-negative breast cancer. Cancer-Res 2024; 84 (Sup...$55$YR$$F$Y$$$20240809$$HP$US$US
241035842$24103584$2$F$20240707$20240724$20240717$20240801$EXP$$IT-ALXN-202407EEA000475IT$ALEXION PHARMACEUTICALS$$36$YR$$F$Y$80$KG$20240801$$MD$IT$IT
241035851$24103585$1$I$$20240709$20240717$20240717$EXP$$GB-CELLTRION INC.-2024GB017018$CELLTRION$$$$$$Y$$$20240717$$CN$GB$GB
241035861$24103586$1$I$$20240710$20240717$20240717$EXP$$MY-ASTELLAS-2024EU006855$ASTELLAS$$46$YR$$M$Y$$$20240717$$HP$MY$MY
241035871$24103587$1$I$$20240711$20240717$20240717$EXP$$US-AMGEN-USASP2024138297$AMGEN$$$$A$F$Y$$$20240717$$HP$US$US
241035881$24103588$1$I$20230101$20240710$20240717$20240717$EXP$$TH-009507513-2407THA008864$MERCK$$67$YR$$M$Y$$$20240717$$CN$TH$TH
241035891$24103589$1$I$20240701$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008778$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240717$$CN$US$US
241035902$24103590$2$F$$20240806$20240717$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407008053$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240809$$MD$JP$JP
241035911$24103591$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009692$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240717$$CN$US$US
241035931$24103593$1$I$20240617$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008214$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240717$$HP$US$US
241035941$24103594$1$I$20240715$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009871$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240717$$CN$US$US
241035951$24103595$1$I$20240714$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009332$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240717$$CN$US$US
241035962$24103596$2$F$$20240715$20240717$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407009317$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240723$$CN$US$US
241035971$24103597$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009514$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240717$$PH$US$US
241035981$24103598$1$I$$20240711$20240717$20240717$PER$$US-ROCHE-10000024647$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241035991$24103599$1$I$$20240602$20240717$20240717$PER$$US-ASCENT-2024ASSPO00002$ASCENT$$$$$F$Y$$$20240717$$CN$US$US
241036001$24103600$1$I$20240601$20240618$20240717$20240717$PER$$US-IMP-2024000420$Harrow Health$$$$E$F$Y$$$20240717$$CN$US$US
241036011$24103601$1$I$$20240506$20240717$20240717$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06603$HIKMA$Mederos Liriano M, Hageboeck K, Colantonio M, Alawad S, Thayer J. Mederos Liriano M, Hageboeck K, Colantonio M, Alawad S, Thayer J. Tipped Over the Edge: A Case of Diabetes Ketoacidosis Precipitated by High-Dose Steroids in the Setting of a Large Peritonsillar Abscess. Cureus. 2024;16(3):e56917$50$YR$$M$Y$$$20240717$$MD$US$US
241036021$24103602$1$I$$20240622$20240717$20240717$PER$$US-JNJFOC-20240662456$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241036032$24103603$2$F$$20240906$20240717$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113408$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240909$$HP$US$US
241036042$24103604$2$F$$20240805$20240717$20240808$30DAY$$BR-JNJFOC-20240733290$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$PH$BR$BR
241036051$24103605$1$I$20240601$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113095$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240717$$PH$US$US
241036071$24103607$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000028249$ROCHE$$8$YR$C$M$Y$$$20240717$$CN$US$US
241036081$24103608$1$I$20240601$20240711$20240717$20240717$PER$$US-ROCHE-3576394$ROCHE$$70$YR$E$F$Y$63.5$KG$20240717$$CN$US$US
241036091$24103609$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-10000026645$ROCHE$$$$A$F$Y$$$20240717$$MD$US$US
241036101$24103610$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-10000025677$ROCHE$$$$A$F$Y$$$20240717$$CN$US$US
241036111$24103611$1$I$20200301$20240709$20240717$20240717$EXP$$PL-ROCHE-2700601$ROCHE$Ochrem B, Ochrem B. 69 letnia kobieta z aglanulocytoza w przebiegu tocznia rumieniowatego ukladowego.. MEDYCYNA PRAKTYCZNA. 2020;6:104-107.$69$YR$E$F$Y$$$20240717$$HP$PL$PL
241036121$24103612$1$I$$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024139798$AMGEN$$$$$M$Y$$$20240717$$MD$US$US
241036132$24103613$2$F$$20240801$20240717$20240809$EXP$$JP-GSK-JP2024GSK085626$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$MD$JP$JP
241036141$24103614$1$I$$20240710$20240717$20240717$EXP$$CA-CELLTRION INC.-2024CA016879$CELLTRION$$$$$$Y$$$20240717$$HP$CA$CA
241036152$24103615$2$F$20240701$20240809$20240717$20240812$PER$$US-AMGEN-USASP2024141035$AMGEN$$72$YR$E$F$Y$$$20240812$$CN$US$US
241036171$24103617$1$I$$20240716$20240717$20240717$PER$$US-ROCHE-10000028842$ROCHE$$$$A$M$Y$$$20240717$$CN$US$US
241036181$24103618$1$I$$20240716$20240717$20240717$PER$$US-ROCHE-10000029002$ROCHE$$$$A$F$Y$$$20240717$$CN$US$US
241036191$24103619$1$I$$20240703$20240717$20240717$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202407-000875$UNICHEM$$44$YR$A$F$Y$$$20240717$$HP$US$
241036211$24103621$1$I$$20240702$20240717$20240717$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00548$Phathom Pharmaceuticals$$$$$M$Y$$$20240717$$MD$JP$JP
241036221$24103622$1$I$20231007$20240702$20240717$20240717$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00549$Phathom Pharmaceuticals$$94$YR$$F$Y$$$20240717$$MD$JP$JP
241036232$24103623$2$F$20240601$20240715$20240717$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06434$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241036241$24103624$1$I$$20240705$20240717$20240717$EXP$$US-ALVOGEN-2024095075$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$54$YR$$M$Y$$$20240717$$HP$US$US
241036261$24103626$1$I$$20240618$20240717$20240717$PER$$US-IMP-2024000425$Harrow Health$$$$A$F$Y$$$20240717$$CN$US$US
241036271$24103627$1$I$20080428$20240711$20240717$20240717$EXP$$NL-ASTELLAS-2024US019829$ASTELLAS$$57$YR$$F$Y$$$20240717$$HP$GB$NL
241036281$24103628$1$I$20240101$20240711$20240717$20240717$EXP$$US-UCBSA-2024035620$UCB$$$$$F$Y$55.283$KG$20240717$$HP$US$US
241036291$24103629$1$I$20240213$20240715$20240717$20240717$EXP$AU-GLAXOSMITHKLINE-AU2024069494$AU-SANDOZ INC.-SDZ2024AU065526$SANDOZ$$$$E$F$Y$$$20240717$$MD$AU$AU
241036301$24103630$1$I$20230317$20230531$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392897$RANBAXY$$74$YR$E$M$Y$$$20240717$$HP$US$US
241036311$24103631$1$I$$20230526$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392877$RANBAXY$$$$$M$Y$$$20240717$$CN$US$US
241036321$24103632$1$I$$20230926$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411459$RANBAXY$$$$E$M$Y$$$20240717$$CN$US$US
241036331$24103633$1$I$$20230706$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399814$RANBAXY$$$$$M$Y$$$20240717$$PH$US$US
241036341$24103634$1$I$$20240116$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429335$RANBAXY$$$$$$Y$$$20240717$$HP$US$US
241036351$24103635$1$I$$20230524$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392782$RANBAXY$$$$$M$Y$$$20240717$$CN$US$US
241036361$24103636$1$I$$20230822$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407018$RANBAXY$$$$$$Y$$$20240717$$HP$US$US
241036371$24103637$1$I$20230619$20230710$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400875$RANBAXY$$70$YR$E$M$Y$$$20240717$$CN$US$US
241036381$24103638$1$I$$20230807$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404875$RANBAXY$$$$E$M$Y$$$20240717$$CN$US$US
241036391$24103639$1$I$20230718$20230801$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404257$RANBAXY$$72$YR$E$M$Y$$$20240717$$CN$US$US
241036401$24103640$1$I$20230620$20230714$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401655$RANBAXY$$77$YR$E$F$Y$$$20240717$$CN$US$US
241036411$24103641$1$I$20230522$20230526$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392875$RANBAXY$$83$YR$E$M$Y$$$20240717$$CN$US$US
241036421$24103642$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000027933$ROCHE$$$$A$F$Y$$$20240717$$CN$US$US
241036431$24103643$1$I$$20230911$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392876$RANBAXY$$$$E$M$Y$$$20240717$$HP$US$US
241036441$24103644$1$I$$20230605$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394546$RANBAXY$$$$$M$Y$$$20240717$$CN$US$US
241036451$24103645$1$I$20230731$20230801$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404260$RANBAXY$$69$YR$E$M$Y$$$20240717$$CN$US$US
241036461$24103646$1$I$$20231013$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413814$RANBAXY$$$$$M$Y$$$20240717$$CN$US$US
241036471$24103647$1$I$20231201$20231205$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421725$RANBAXY$$81$YR$E$M$Y$$$20240717$$CN$US$US
241036481$24103648$1$I$$20231128$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-423289$RANBAXY$$$$$$Y$$$20240717$$PH$US$US
241036491$24103649$1$I$$20231229$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-426806$RANBAXY$$$$$M$Y$$$20240717$$CN$US$US
241036501$24103650$1$I$$20231129$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-423707$RANBAXY$$$$$$Y$$$20240717$$PH$US$US
241036511$24103651$1$I$$20231128$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-423291$RANBAXY$$$$$M$Y$$$20240717$$PH$US$US
241036521$24103652$1$I$20230508$20230801$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392879$RANBAXY$$71$YR$E$M$Y$$$20240717$$CN$US$US
241036531$24103653$1$I$$20231005$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-412534$RANBAXY$$$$E$M$Y$$$20240717$$CN$US$US
241036541$24103654$1$I$$20240315$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438302$RANBAXY$$$$$$Y$$$20240717$$HP$US$US
241036551$24103655$1$I$$20240619$20240717$20240717$PER$$US-IMP-2024000426$Harrow Health$$$$E$F$Y$$$20240717$$CN$US$US
241036561$24103656$1$I$$20240308$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-437578$RANBAXY$$$$E$M$Y$$$20240717$$CN$US$US
241036571$24103657$1$I$20240418$20240716$20240717$20240717$EXP$FR-AFSSAPS-MP2024001149$FR-SANDOZ INC.-SDZ2024FR065565$SANDOZ$$1$YR$$M$Y$11.5$KG$20240717$$MD$FR$FR
241036582$24103658$2$F$20240710$20240712$20240717$20240717$30DAY$$US-SANDOZ INC.-SDZ2024US065471$SANDOZ$$$$A$F$Y$$$20240717$$CN$US$US
241036591$24103659$1$I$$20240712$20240717$20240717$PER$$NVSC2024US145777$NOVARTIS$$47$YR$$F$Y$$$20240717$$CN$US$US
241036601$24103660$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112379$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240717$$MD$US$US
241036611$24103661$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111791$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240717$$HP$US$US
241036621$24103662$1$I$$20240711$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112015$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240717$$HP$US$US
241036631$24103663$1$I$$20190904$20240717$20240717$EXP$$US-AstraZeneca-2019SF27955$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241036641$24103664$1$I$$20200818$20240717$20240717$EXP$$US-AstraZeneca-2020SF06010$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241036651$24103665$1$I$$20200514$20240717$20240717$EXP$$CA-AstraZeneca-2020SE25408$ASTRAZENECA$$$$$F$Y$$$20240717$$MD$CA$
241036661$24103666$1$I$20240706$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112551$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$102.51$KG$20240717$$CN$US$US
241036671$24103667$1$I$$20201019$20240717$20240717$EXP$$US-AstraZeneca-2020SF37551$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241036681$24103668$1$I$$20201023$20240717$20240717$EXP$$US-AstraZeneca-2020SF39881$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241036691$24103669$1$I$20240710$20240710$20240717$20240717$EXP$$US-JNJFOC-20240727201$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240717$$HP$US$US
241036701$24103670$1$I$$20240712$20240717$20240717$EXP$$JP-GSK-JP2024089209$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$JP$JP
241036711$24103671$1$I$20240301$20240710$20240717$20240717$EXP$$US-GSK-US2024085822$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240717$$HP$US$US
241036721$24103672$1$I$20200630$20200920$20240717$20240717$EXP$$US-AstraZeneca-2020SE86619$ASTRAZENECA$$11412$DY$$F$Y$$$20240717$$CN$US$
241036731$24103673$1$I$$20200813$20240717$20240717$EXP$$US-AstraZeneca-2020SF03139$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241036741$24103674$1$I$20190915$20190917$20240717$20240717$EXP$$US-AstraZeneca-2019SF33669$ASTRAZENECA$$22756$DY$$F$Y$$$20240717$$CN$US$
241036751$24103675$1$I$$20191028$20240717$20240717$EXP$$PL-AstraZeneca-2019SF55458$ASTRAZENECA$$$$$F$Y$$$20240717$$MD$PL$
241036771$24103677$1$I$20240619$20240715$20240717$20240717$EXP$$CN-ROCHE-10000027278$ROCHE$$6$YR$C$F$Y$20.5$KG$20240717$$HP$CN$CN
241036781$24103678$1$I$20180322$20191022$20240717$20240717$EXP$$CO-AstraZeneca-2019SF09993$ASTRAZENECA$$21171$DY$$M$Y$$$20240717$$CN$CO$
241036791$24103679$1$I$$20201027$20240717$20240717$EXP$$AU-AstraZeneca-2020SF41217$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$AU$
241036801$24103680$1$I$$20240709$20240717$20240717$EXP$$GT-AstraZeneca-2024A085364$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$GT$
241036812$24103681$2$F$20240621$20240904$20240717$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE065476$SANDOZ$$85$YR$$F$Y$$$20240905$$MD$DE$DE
241036821$24103682$1$I$20191021$20191101$20240717$20240717$EXP$$US-AstraZeneca-2019SF57025$ASTRAZENECA$$29834$DY$$M$Y$$$20240717$$CN$US$
241036831$24103683$1$I$$20200713$20240717$20240717$EXP$$US-AstraZeneca-2020SE89386$ASTRAZENECA$$51$YR$$F$Y$$$20240717$$CN$US$
241036841$24103684$1$I$$20240620$20240717$20240717$PER$$US-IMP-2024000427$Harrow Health$$$$A$F$Y$$$20240717$$CN$US$US
241036871$24103687$1$I$20240628$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06440$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241036881$24103688$1$I$$20240705$20240717$20240717$PER$$US-TEVA-VS-3219550$TEVA$$$$A$F$Y$$$20240717$$CN$US$US
241036901$24103690$1$I$$20240711$20240717$20240717$PER$$US-TAKEDA-2024TUS070746$TAKEDA$$$$$$Y$$$20240717$$CN$US$US
241036911$24103691$1$I$$20240711$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112175$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240717$$CN$US$US
241036921$24103692$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112848$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240717$$CN$US$US
241036931$24103693$1$I$20240715$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113525$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240717$$HP$US$US
241036941$24103694$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113258$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240717$$HP$US$US
241036963$24103696$3$F$$20240814$20240717$20240820$PER$$US-AMGEN-USASP2024140791$AMGEN$$$$$F$Y$$$20240819$$CN$US$US
241036971$24103697$1$I$$20240709$20240717$20240717$EXP$$US-GSK-US2024AMR086069$GLAXOSMITHKLINE$$87$YR$$F$Y$$$20240717$$MD$US$US
241036981$24103698$1$I$20240714$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140318$AMGEN$$72$YR$E$M$Y$$$20240717$$CN$US$US
241036991$24103699$1$I$$20240712$20240717$20240717$EXP$$NVSC2024GB145592$NOVARTIS$$63$YR$$M$Y$$$20240717$$HP$GB$GB
241037001$24103700$1$I$20240703$20240704$20240717$20240717$EXP$$PK-ROCHE-10000022988$ROCHE$$60$YR$A$F$Y$$$20240717$$MD$PK$PK
241037011$24103701$1$I$$20240705$20240717$20240717$EXP$$JP-TAKEDA-2024TUS035019$TAKEDA$$79$YR$$M$Y$62$KG$20240717$$MD$JP$JP
241037021$24103702$1$I$$20240705$20240717$20240717$EXP$$US-ALVOGEN-2024095074$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$18$YR$$F$Y$$$20240717$$HP$US$US
241037031$24103703$1$I$20240704$20240708$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110341$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$84.82$KG$20240717$$CN$US$US
241037041$24103704$1$I$$20240703$20240717$20240717$EXP$$EG-ROCHE-10000020097$ROCHE$$25$YR$A$F$Y$$$20240717$$CN$EG$EG
241037051$24103705$1$I$$20240711$20240717$20240717$EXP$GB-MHRA-30708036$GB-ROCHE-10000025176$ROCHE$$8$MON$I$$Y$$$20240717$$PH$GB$GB
241037062$24103706$2$F$$20240715$20240717$20240722$EXP$$CO-GSK-CO2024AMR022402$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$CO$CO
241037071$24103707$1$I$$20240712$20240717$20240717$EXP$$US-JNJFOC-20240734592$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$MD$US$US
241037081$24103708$1$I$20230210$20240711$20240717$20240717$EXP$$CN-JNJFOC-20240732147$JOHNSON AND JOHNSON$$73$YR$E$M$Y$65$KG$20240717$$HP$CN$CN
241037092$24103709$2$F$$20240730$20240717$20240808$30DAY$$US-JNJFOC-20240730945$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$PH$US$US
241037103$24103710$3$F$$20240807$20240717$20240809$30DAY$$CA-JNJFOC-20240732070$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$CN$CA$CA
241037111$24103711$1$I$$20240708$20240717$20240717$EXP$SG-UCBSA-2024035474$SG-JNJFOC-20240741222$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$HP$SG$SG
241037121$24103712$1$I$20240622$20240624$20240717$20240717$PER$$US-IMP-2024000434$Harrow Health$$68$YR$E$F$Y$$$20240717$$CN$US$US
241037131$24103713$1$I$$20240706$20240717$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-026761$AUROBINDO$Adamkiewicz D, Magazin M, Thomas D.. A Case of Pharmacologic Anisocoria in Systemic Glycopyrrolate Use from Presumed Local Ocular Inoculation.. Neuroophthalmol. 2023;4841-45$22$YR$$F$Y$$$20240717$$HP$US$US
241037141$24103714$1$I$$20240715$20240717$20240717$PER$$US-TAKEDA-2024TUS071906$TAKEDA$$55$YR$$M$Y$68$KG$20240717$$MD$US$US
241037151$24103715$1$I$$20240707$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034090$AUROBINDO$$$$$$Y$$$20240717$$CN$GB$GB
241037161$24103716$1$I$$20240712$20240717$20240717$EXP$$AR-EMD Serono-2024038351$EMD SERONO INC$$$$A$F$Y$$$20240717$$CN$AR$AR
241037171$24103717$1$I$$20240711$20240717$20240717$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14008$IPSEN$$$$$$Y$$$20240717$$HP$US$US
241037191$24103719$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009446$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240717$$CN$US$US
241037201$24103720$1$I$$20240705$20240717$20240717$EXP$$US-ALVOGEN-2024095073$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$66$YR$$M$Y$$$20240717$$HP$US$US
241037213$24103721$3$F$$20240723$20240717$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407009800$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240725$$CN$US$US
241037221$24103722$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009817$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240717$$HP$US$US
241037231$24103723$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010274$ELI LILLY AND CO$$69$YR$E$$Y$$$20240717$$CN$US$US
241037241$24103724$1$I$20240713$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009876$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240717$$CN$US$US
241037251$24103725$1$I$20240513$20240710$20240717$20240717$EXP$$DE-TEVA-VS-3219630$TEVA$$75$YR$$M$Y$65$KG$20240717$$MD$DE$DE
241037261$24103726$1$I$$20240708$20240717$20240717$EXP$$JP-TEYRO-2024-TY-000313$Teyro Labs$Sekimata M, Kinjo Y, Tohyama A, Murakami M, Hashiwaki S, Saito Y, et al..Cytokine release syndrome induced by immune checkpoint inhibitor treatment for uterine cervical cancer recurrence: A case report..ONCOLOGY LETTERS.2024;28:331$49$YR$A$F$Y$$$20240717$$HP$JP$JP
241037271$24103727$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024141088$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241037283$24103728$3$F$$20240815$20240717$20240819$PER$$US-AMGEN-USASP2024141313$AMGEN$$56$YR$A$F$Y$$$20240819$$HP$US$US
241037291$24103729$1$I$20240101$20240703$20240717$20240717$PER$$US-JNJFOC-20240713690$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240717$$CN$US$US
241037312$24103731$2$F$20240711$20240715$20240717$20240827$PER$$US-IMP-2024000440$Harrow Health$$$$A$F$Y$$$20240827$$CN$US$US
241037322$24103732$2$F$$20240715$20240717$20240724$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-112644$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$74$KG$20240725$$HP$CA$CA
241037332$24103733$2$F$20240823$20240823$20240717$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112657$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240827$$CN$US$US
241037341$24103734$1$I$$20240708$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108633$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240717$$HP$US$US
241037351$24103735$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112910$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240717$$HP$US$US
241037371$24103737$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112473$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240717$$HP$US$US
241037381$24103738$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112231$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240717$$PH$US$US
241037391$24103739$1$I$20240705$20240707$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034068$AUROBINDO$$37$YR$$F$Y$79$KG$20240717$$CN$GB$GB
241037401$24103740$1$I$$20190806$20240717$20240717$EXP$$ZA-AstraZeneca-2019SF13193$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$ZA$
241037411$24103741$1$I$$20201123$20240717$20240717$EXP$$US-AstraZeneca-2020SF57864$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241037431$24103743$1$I$$20190925$20240717$20240717$EXP$$US-AstraZeneca-2019SF37264$ASTRAZENECA$$$$$F$Y$37.6$KG$20240717$$CN$US$
241037441$24103744$1$I$$20201109$20240717$20240717$EXP$$US-AstraZeneca-2020SF48914$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241037451$24103745$1$I$$20201104$20240717$20240717$EXP$$US-AstraZeneca-2020SF46137$ASTRAZENECA$$$$$F$Y$$$20240717$$HP$US$
241037461$24103746$1$I$$20240717$20240717$20240717$PER$$US-HALEON-2187522$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
241037471$24103747$1$I$$20201021$20240717$20240717$EXP$$US-AstraZeneca-2020SF39422$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241037481$24103748$1$I$$20191106$20240717$20240717$EXP$$US-AstraZeneca-2019SF59162$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241037491$24103749$1$I$20190101$20191001$20240717$20240717$EXP$$TW-AstraZeneca-2019SF40469$ASTRAZENECA$$53$YR$$F$Y$$$20240717$$CN$TW$
241037501$24103750$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A160732$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241037513$24103751$3$F$20190101$20240717$20240717$20240903$EXP$$US-AstraZeneca-2019SF15465$ASTRAZENECA$$69$YR$$M$Y$79.4$KG$20240903$$CN$US$
241037521$24103752$1$I$$20201215$20240717$20240717$EXP$$AU-AstraZeneca-2020SF69637$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$AU$
241037531$24103753$1$I$20240701$20240715$20240717$20240717$PER$$US-ABBVIE-5842066$ABBVIE$$$$$$Y$$$20240717$$CN$US$US
241037541$24103754$1$I$$20240626$20240717$20240717$EXP$$PH-ROCHE-10000021053$ROCHE$$$$$$Y$$$20240717$$MD$PH$PH
241037551$24103755$1$I$$20240705$20240717$20240717$PER$$US-ROCHE-10000021264$ROCHE$$$$E$M$Y$$$20240717$$CN$US$US
241037561$24103756$1$I$20240101$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140876$AMGEN$$$$$$Y$$$20240717$$MD$US$US
241037571$24103757$1$I$20240704$20240715$20240717$20240717$EXP$$CO-ABBVIE-5842448$ABBVIE$$81$YR$$M$Y$$$20240717$$CN$CO$CO
241037581$24103758$1$I$$20240715$20240717$20240717$PER$$US-ABBVIE-5842598$ABBVIE$$$$$M$Y$$$20240717$$HP$US$US
241037591$24103759$1$I$20240712$20240712$20240717$20240717$EXP$$CA-ABBVIE-5839900$ABBVIE$$55$YR$$F$Y$$$20240717$$CN$CA$CA
241037601$24103760$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5840738$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241037611$24103761$1$I$$20240705$20240717$20240717$EXP$$US-ALVOGEN-2024095068$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$24$YR$$F$Y$$$20240717$$HP$US$US
241037622$24103762$2$F$$20240731$20240717$20240802$EXP$$US-TAKEDA-2022TUS034793$TAKEDA$$$$$F$Y$75$KG$20240802$$HP$US$US
241037632$24103763$2$F$20240311$20240812$20240717$20240823$EXP$GB-MHRA-MED-202405090912582800-FMHRG$GB-MACLEODS PHARMA-MAC2024048184$MACLEODS$$$$$$Y$$$20240823$$PH$GB$GB
241037641$24103764$1$I$20240509$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405090820398950-MQBSY$GB-MACLEODS PHARMA-MAC2024048180$MACLEODS$$$$$$Y$$$20240717$$MD$GB$GB
241037651$24103765$1$I$20240101$20240705$20240717$20240717$EXP$$ZA-MACLEODS PHARMA-MAC2024048151$MACLEODS$$$$$$Y$$$20240717$$CN$ZA$ZA
241037661$24103766$1$I$20240712$20240715$20240717$20240717$EXP$$CA-ABBVIE-5842320$ABBVIE$$40$YR$$$Y$$$20240717$$CN$CA$CA
241037671$24103767$1$I$20240625$20240711$20240717$20240717$EXP$$US-ABBVIE-5838702$ABBVIE$$53$YR$$F$Y$$$20240717$$CN$US$US
241037682$24103768$2$F$$20240719$20240717$20240730$EXP$$ZA-MACLEODS PHARMA-MAC2024048152$MACLEODS$$$$$$Y$$$20240730$$CN$ZA$ZA
241037701$24103770$1$I$$20240711$20240717$20240717$PER$$US-ABBVIE-5840297$ABBVIE$$$$A$M$Y$$$20240717$$HP$US$US
241037711$24103771$1$I$20240711$20240715$20240717$20240717$EXP$$ES-ABBVIE-5842348$ABBVIE$$76$YR$$F$Y$$$20240717$$CN$ES$ES
241037721$24103772$1$I$$20240626$20240717$20240717$PER$$US-IMP-2024000441$Harrow Health$$$$A$F$Y$$$20240717$$CN$US$US
241037731$24103773$1$I$$20240708$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034342$AUROBINDO$$20$YR$$F$Y$$$20240717$$CN$GB$GB
241037745$24103774$5$F$20240626$20240909$20240717$20240918$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003272$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240918$$CN$US$US
241037763$24103776$3$F$20221101$20240724$20240717$20240729$EXP$$ES-ABBVIE-5455001$ABBVIE$$70$YR$$F$Y$$$20240729$$MD$ES$ES
241037781$24103778$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112756$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240717$$CN$US$US
241037791$24103779$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112976$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240717$$CN$US$US
241037801$24103780$1$I$$20240716$20240717$20240717$EXP$$US-GILEAD-2024-0680993$GILEAD$$$$$$Y$$$20240717$$LW$US$US
241037811$24103781$1$I$20240101$20240628$20240717$20240717$PER$$US-IMP-2024000448$Harrow Health$$$$A$F$Y$$$20240717$$CN$US$US
241037821$24103782$1$I$20240702$20240708$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034335$AUROBINDO$$77$YR$$F$Y$$$20240717$$PH$GB$GB
241037832$24103783$2$F$20240713$20240805$20240717$20240806$EXP$$CA-ABBVIE-5842360$ABBVIE$$$$E$M$Y$$$20240806$$CN$CA$CA
241037842$24103784$2$F$20240101$20240823$20240717$20240827$EXP$$NVSC2024ES143796$NOVARTIS$$$$A$F$Y$$$20240827$$MD$ES$ES
241037851$24103785$1$I$20240701$20240712$20240717$20240717$EXP$$US-ABBVIE-5840829$ABBVIE$$56$YR$$F$Y$$$20240717$$CN$US$US
241037871$24103787$1$I$$20240708$20240717$20240717$EXP$$CA-APOTEX-2024AP008067$APOTEX$$50$YR$$F$Y$68$KG$20240717$$HP$CA$CA
241037901$24103790$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49287$$FDA-CTU$$$$$M$N$$$20240716$N$HP$US$
241037961$24103796$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5840685$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241037971$24103797$1$I$$20240712$20240717$20240717$EXP$$BG-ABBVIE-5812012$ABBVIE$$69$YR$$F$Y$$$20240717$$CN$BG$BG
241037982$24103798$2$F$20240708$20240911$20240717$20240915$EXP$$US-ABBVIE-5841967$ABBVIE$$65$YR$$M$Y$79$KG$20240915$$CN$US$US
241037991$24103799$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024141317$AMGEN$$$$$F$Y$$$20240717$$HP$US$US
241038001$24103800$1$I$20240715$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140752$AMGEN$$72$YR$E$F$Y$$$20240717$$CN$US$US
241038012$24103801$2$F$20240707$20240726$20240717$20240729$PER$$US-AMGEN-USASP2024140431$AMGEN$$67$YR$E$F$Y$$$20240729$$CN$US$US
241038021$24103802$1$I$$20240705$20240717$20240717$EXP$$US-ALVOGEN-2024095067$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$31$YR$$M$Y$$$20240717$$HP$US$US
241038031$24103803$1$I$$20240708$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109615$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240717$$HP$US$US
241038041$24103804$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112617$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240717$$CN$US$US
241038051$24103805$1$I$$20240705$20240717$20240717$EXP$$US-ROCHE-10000022196$ROCHE$$59$YR$A$F$Y$$$20240717$$HP$US$US
241038063$24103806$3$F$20231207$20240809$20240717$20240814$EXP$$CA-TAKEDA-2023TUS121884$TAKEDA$$87$YR$$M$Y$$$20240814$$CN$CA$CA
241038071$24103807$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405082252288840-WVCSN$GB-Accord-434604$ACCORD$$40$YR$A$M$Y$86$KG$20240717$$CN$GB$GB
241038081$24103808$1$I$$20240705$20240717$20240717$EXP$CA-MHPD-E2B_07061666$CA-Accord-434761$ACCORD$$50$YR$A$F$Y$$$20240717$$HP$CA$CA
241038091$24103809$1$I$20240617$20240705$20240717$20240717$EXP$$US-Accord-434416$ACCORD$$28$YR$A$M$Y$$$20240717$$HP$US$US
241038101$24103810$1$I$20160101$20240705$20240717$20240717$EXP$$JP-Accord-434477$ACCORD$Urabe Y, Ishikawa H, Ishikawa A, Ishiguro S, Ishibashi K, Arihiro K et al. Two Cases of Increased Gastrointestinal Polyps in Familial Adenomatous Polyposis following Antiacid Agent Intake. Case Reports in Gastroenterology. 2024;18(1):293-8.$6$DEC$A$F$Y$$$20240717$$MD$JP$JP
241038111$24103811$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202406261659083070-WNLCP$GB-Accord-434946$ACCORD$$$$$M$Y$$$20240717$$PH$GB$GB
241038121$24103812$1$I$20240418$20240705$20240717$20240717$EXP$GB-MHRA-WEBRADR-202406231224413510-MYWZD$GB-Accord-434587$ACCORD$$33$YR$A$F$Y$83$KG$20240717$$CN$GB$GB
241038131$24103813$1$I$20240626$20240705$20240717$20240717$EXP$GB-MHRA-MED-202406260823074440-ZTJLM$GB-Accord-434556$ACCORD$$58$YR$A$M$Y$72$KG$20240717$$CN$GB$GB
241038141$24103814$1$I$20220701$20240706$20240717$20240717$EXP$FR-AFSSAPS-2024058377$FR-Accord-435174$ACCORD$$53$YR$A$F$Y$$$20240717$$PH$FR$FR
241038151$24103815$1$I$20240628$20240705$20240717$20240717$EXP$GB-MHRA-MED-202407051751398890-PQYDJ$GB-Accord-434557$ACCORD$$22$YR$A$M$Y$129$KG$20240717$$CN$GB$GB
241038161$24103816$1$I$20240702$20240705$20240717$20240717$EXP$GB-MHRA-MED-202407051348598510-SBJGQ$GB-Accord-434626$ACCORD$$85$YR$E$F$Y$$$20240717$$PH$GB$GB
241038171$24103817$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405171305488340-NRGVL$GB-MSNLABS-2024MSNSPO01560$MSN LABORATORIES$$$$$$Y$$$20240717$$CN$GB$GB
241038181$24103818$1$I$$20240703$20240717$20240717$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109529$ZYDUS PHARM$Holt J, Salas M, Lee SW.. Aromatase inhibitor-associated distal radioulnar joint instability and tear of the extensor digiti minimi: A Case report.. Am-J-Phys-Med-Rehabil. 2024;103(7):e86-e89$$$$$Y$$$20240717$$MD$US$US
241038191$24103819$1$I$$20240715$20240717$20240717$PER$$US-ABBVIE-5842256$ABBVIE$$$$$$Y$$$20240717$$MD$US$US
241038201$24103820$1$I$$20240708$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034363$AUROBINDO$$$$$M$Y$76$KG$20240717$$CN$GB$GB
241038211$24103821$1$I$20240522$20240701$20240717$20240717$PER$$US-IMP-2024000452$Harrow Health$$76$YR$E$F$Y$$$20240717$$CN$US$US
241038221$24103822$1$I$20240429$20240710$20240717$20240717$EXP$FR-AFSSAPS-RS2024000652$FR-TEVA-VS-3220286$TEVA$$75$YR$$M$Y$87$KG$20240717$$MD$FR$FR
241038232$24103823$2$F$$20240718$20240717$20240724$EXP$$JP-GSK-JP2024089225$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$JP$JP
241038242$24103824$2$F$$20240718$20240717$20240724$EXP$$JP-GSK-JP2024089212$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$JP$JP
241038251$24103825$1$I$$20240707$20240717$20240717$EXP$$ES-MYLANLABS-2024M1065764$MYLAN$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17).$14$YR$$F$Y$$$20240717$$HP$ES$ES
241038261$24103826$1$I$$20240707$20240717$20240717$EXP$$PL-MYLANLABS-2024M1065392$MYLAN$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain-Sci 2023; 13 (3):.$36$YR$$F$Y$$$20240717$$HP$PL$PL
241038271$24103827$1$I$$20240708$20240717$20240717$EXP$$US-MYLANLABS-2024M1065043$MYLAN$Gondek S, Ogledzinski M, Lin W, Milejczyk K, Juengel B, Potter L, et al. Persistence of long-term insulin independence after islet transplantation and two subsequent pregnancies. Eur-J-Transl-Clin-Med 2023; 6 (1): 9-13.$36$YR$$F$Y$$$20240717$$HP$US$US
241038291$24103829$1$I$$20240705$20240717$20240717$EXP$$US-MYLANLABS-2024M1064922$MYLAN$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep 2023; 40 14-18.$$$A$F$Y$$$20240717$$MD$US$US
241038301$24103830$1$I$20240713$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140478$AMGEN$$75$YR$E$M$Y$$$20240717$$CN$US$US
241038312$24103831$2$F$20240701$20240731$20240717$20240802$PER$$US-AMGEN-USASP2024140472$AMGEN$$30$YR$A$F$Y$$$20240802$$CN$US$US
241038321$24103832$1$I$$20240705$20240717$20240717$EXP$$US-MYLANLABS-2024M1064916$MYLAN$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep 2023; 40 14-18.$$$$F$Y$$$20240717$$MD$US$US
241038331$24103833$1$I$$20240707$20240717$20240717$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008670$STRIDES$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E.. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM.. Int-J-Molecular-Sci. 2023;24 (17)$14$YR$$F$Y$$$20240717$$HP$ES$ES
241038341$24103834$1$I$$20240705$20240717$20240717$EXP$$US-MYLANLABS-2024M1064890$MYLAN$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatr-Blood-Cancer 2024; 71 (7): e31004.$22$YR$$F$Y$$$20240717$$HP$US$US
241038351$24103835$1$I$20240101$20240701$20240717$20240717$PER$$US-IMP-2024000453$Harrow Health$$$$A$F$Y$$$20240717$$CN$US$US
241038361$24103836$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05984$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241038371$24103837$1$I$20240601$20240709$20240717$20240717$EXP$FR-AFSSAPS-BR2024000537$FR-TEVA-VS-3219520$TEVA$$54$YR$$F$Y$98$KG$20240717$$PH$FR$FR
241038381$24103838$1$I$$20240706$20240717$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-034678$AUROBINDO$Wegner Wippel C, J. Gleva M, Moore K, Rentschler S, Robinson C, Cuculich P.. Low Dose Radiation To Entire Systemic Ventricle In A Patient With Intractable Ventricular Fibrillation And Left Ventricular Assist Device. Heart Rhythm. 2024;Vol 21, No 5S:S719-S720$40$YR$$M$Y$$$20240717$$HP$US$US
241038391$24103839$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49286$$FDA-CTU$$68$YR$$F$N$$$20240716$N$$US$
241038413$24103841$3$F$20190826$20240731$20240717$20240801$EXP$$CO-UCBSA-2024036045$UCB$$67$YR$$F$Y$$$20240801$$CN$CO$CO
241038421$24103842$1$I$$20191111$20240717$20240717$EXP$$ZA-AstraZeneca-2019SF61697$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$ZA$
241038431$24103843$1$I$$20201104$20240717$20240717$EXP$$US-AstraZeneca-2020SF47716$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241038441$24103844$1$I$$20240709$20240717$20240717$EXP$$US-ALXN-202407USA000642US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$MD$US$US
241038451$24103845$1$I$$20240710$20240717$20240717$PER$$US-AstraZeneca-2024A159710$ASTRAZENECA$$$$A$F$Y$$$20240717$$MD$US$
241038461$24103846$1$I$$20190813$20240717$20240717$EXP$$US-AstraZeneca-2019SF16739$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241038471$24103847$1$I$$20200227$20240717$20240717$EXP$$US-AstraZeneca-2019SF42796$ASTRAZENECA$$63$YR$$F$Y$$$20240717$$CN$US$
241038481$24103848$1$I$$20240704$20240717$20240717$EXP$$ES-ALVOGEN-2024095088$ALVOGEN$S?nchez-Sellero I, Cabarcos-Fern?ndez P, Jauregu?zar-Rodr?guez ME, Alvarez-Freire I, Tabernero-Duque MJ and Bermejo-Barrera AM. Development and Validation of a Sonication-Assisted Dispersive Liquid?Liquid Microextraction Procedure and an HPLC-PDA Method for Quantitative Determination of Zolpidem in Human Plasma and Its Application to Forensic Samples. Molecules. 2024 May 24;29:2490. doi:https://doi.org/10.3390/molecules29112490$47$YR$$M$Y$$$20240717$$HP$ES$ES
241038491$24103849$1$I$20190620$20191008$20240717$20240717$EXP$$CO-AstraZeneca-2019SF45692$ASTRAZENECA$$17323$DY$$F$Y$$$20240717$$CN$CO$
241038501$24103850$1$I$$20191125$20240717$20240717$EXP$$IL-AstraZeneca-2019SF70303$ASTRAZENECA$$$$$$Y$$$20240717$$MD$IL$
241038512$24103851$2$F$20240705$20240806$20240717$20240809$EXP$$RU-AstraZeneca-2024A160354$ASTRAZENECA$$15$YR$$F$Y$54$KG$20240809$$MD$RU$
241038521$24103852$1$I$20191108$20191128$20240717$20240717$EXP$$CO-AstraZeneca-2019SF73411$ASTRAZENECA$$24850$DY$$M$Y$$$20240717$$CN$CO$
241038531$24103853$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49267$$FDA-CTU$$$$$M$N$$$20240716$N$HP$US$
241038541$24103854$1$I$$20240716$20240717$20240717$PER$$US-HALEON-2187500$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
241038551$24103855$1$I$$20240708$20240717$20240717$EXP$$US-JNJFOC-20240723491$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241038561$24103856$1$I$$20240707$20240717$20240717$EXP$$IL-ROCHE-10000027161$ROCHE$$$$A$F$Y$$$20240717$$HP$IL$IL
241038572$24103857$2$F$20240304$20240903$20240717$20240912$EXP$$JP-009507513-2407JPN002076J$MERCK$$$$$F$Y$$$20240912$$MD$JP$JP
241038581$24103858$1$I$$20190814$20240717$20240717$EXP$$US-AstraZeneca-2019SF18001$ASTRAZENECA$$59$YR$$F$Y$$$20240717$$CN$US$
241038591$24103859$1$I$$20240707$20240717$20240717$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008671$STRIDES$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E.. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM.. Int-J-Molecular-Sci. 2023;24 (17)$3$YR$$F$Y$$$20240717$$HP$ES$ES
241038603$24103860$3$F$20230306$20240812$20240717$20240814$EXP$$NVSC2023KR079776$NOVARTIS$$73$YR$$F$Y$50.3$KG$20240814$$MD$KR$KR
241038612$24103861$2$F$$20240725$20240717$20240730$EXP$$GB-MYLANLABS-2024M1065305$MYLAN$$38$YR$$F$Y$$$20240730$$PH$GB$GB
241038621$24103862$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49289$$FDA-CTU$$72$YR$$F$N$$$20240716$N$$US$
241038631$24103863$1$I$20240702$20240703$20240717$20240717$PER$$US-RDY-CLI/USA/24/0009941$DR REDDYS$$21$YR$A$M$Y$65$KG$20240717$$CN$US$US
241038642$24103864$2$F$$20240822$20240717$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06507$LUPIN$$$$$$Y$$$20240909$$PH$US$US
241038652$24103865$2$F$$20240806$20240717$20240821$30DAY$$US-GSK-US2024AMR089096$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
241038661$24103866$1$I$$20240703$20240717$20240717$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109532$ZYDUS PHARM$Geller A, Martinez Manzano J, Benzaquen S.. An Exudative Enigma: Recurrent Pleural Effusions Following Drug-Eluting Bead Transarterial Chemoembolization With Percutaneous Ethanol Injection for Palliative Treatment of Hepatocellular Carcinoma.. Am-J-Respir-Crit-Care-Med. 2024;209:A5812$$$$$Y$$$20240717$$HP$US$US
241038671$24103867$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49263$$FDA-CTU$$$$$M$N$$$20240716$N$HP$US$
241038691$24103869$1$I$$20240707$20240717$20240717$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008672$STRIDES$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E.. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM.. Int-J-Molecular-Sci. 2023;24 (17)$3$YR$$F$Y$$$20240717$$HP$ES$ES
241038702$24103870$2$F$20230101$20240723$20240717$20240729$PER$$US-AMGEN-USASP2024139514$AMGEN$$73$YR$E$F$Y$$$20240729$$CN$US$US
241038711$24103871$1$I$20240101$20240702$20240717$20240717$PER$$US-IMP-2024000470$Harrow Health$$$$E$M$Y$$$20240717$$CN$US$US
241038721$24103872$1$I$$20240704$20240717$20240717$EXP$$ES-ALVOGEN-2024095087$ALVOGEN$Sanchez-Sellero I, Cabarcos-Fernandez P, Jaureguizar-Rodriguez ME, Alvarez-Freire I, Tabernero-Duque MJ and Bermejo-Barrera AM. Development and Validation of a Sonication-Assisted Dispersive Liquid?Liquid Microextraction Procedure and an HPLC-PDA Method for Quantitative Determination of Zolpidem in Human Plasma and Its Application to Forensic Samples. Molecules. 2024 May 24;29:2490. doi:https://doi.org/10.3390/molecules29112490$76$YR$$F$Y$$$20240717$$HP$ES$ES
241038731$24103873$1$I$$20240124$20240717$20240717$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429409$RANBAXY$$$$$$Y$$$20240717$$HP$US$US
241038741$24103874$1$I$20240201$20240705$20240717$20240717$EXP$$GB-CIPLA LTD.-2024GB07368$CIPLA$$$$$$Y$$$20240717$$CN$GB$GB
241038751$24103875$1$I$20240715$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009533$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240717$$CN$US$US
241038761$24103876$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009955$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240717$$CN$US$US
241038771$24103877$1$I$$20240707$20240717$20240717$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008576$STRIDES$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E.. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM.. Int-J-Molecular-Sci. 2023;24 (17)$5$YR$$M$Y$$$20240717$$HP$ES$ES
241038781$24103878$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009884$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240717$$CN$US$US
241038791$24103879$1$I$20240601$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010007$ELI LILLY AND CO$$$$$M$Y$$$20240717$$CN$US$US
241038801$24103880$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009003$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240717$$HP$US$US
241038812$24103881$2$F$$20240716$20240717$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010710$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240718$$CN$US$US
241038821$24103882$1$I$$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008615$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240717$$CN$US$US
241038831$24103883$1$I$20240715$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010122$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240717$$CN$US$US
241038841$24103884$1$I$$20240710$20240717$20240717$EXP$$GB-SA-2024SA204415$SANOFI AVENTIS$$$$$$Y$$$20240717$$PH$GB$GB
241038851$24103885$1$I$20240307$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405162030425190-YNHGW$GB-Accord-434586$ACCORD$$33$YR$A$F$Y$73$KG$20240717$$CN$GB$GB
241038861$24103886$1$I$20240630$20240706$20240717$20240717$EXP$FI-FIMEA-202402409$FI-Accord-435288$ACCORD$$37$YR$A$F$Y$$$20240717$$CN$FI$FI
241038871$24103887$1$I$$20240705$20240717$20240717$EXP$SE-SEMPA-2024-005345$SE-Accord-434924$ACCORD$$55$YR$A$F$Y$$$20240717$$CN$SE$SE
241038881$24103888$1$I$20240528$20240705$20240717$20240717$EXP$GB-MHRA-MED-202406251912063080-PNHML$GB-Accord-434990$ACCORD$$$$$M$Y$90$KG$20240717$$CN$GB$GB
241038901$24103890$1$I$$20220614$20240717$20240717$EXP$PL-EMA-2022425-AUTODUP-1650915827180$PL-Accord-427630$ACCORD$$$$A$M$Y$$$20240717$$MD$PL$PL
241038911$24103891$1$I$$20240705$20240717$20240717$EXP$$US-Accord-434444$ACCORD$$$$$F$Y$$$20240717$$CN$US$US
241038921$24103892$1$I$20170106$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405142045567050-ZYRQP$GB-Accord-434545$ACCORD$$18$YR$A$F$Y$55$KG$20240717$$CN$GB$GB
241038931$24103893$1$I$20240601$20240705$20240717$20240717$EXP$FR-AFSSAPS-PO2024000747$FR-Accord-434868$ACCORD$$48$YR$A$F$Y$55$KG$20240717$$PH$FR$FR
241038941$24103894$1$I$20210811$20220507$20240717$20240717$EXP$PL-EMA-2022325-AUTODUP-1648244453571$PL-Accord-426897$ACCORD$$70$YR$E$F$Y$$$20240717$$MD$PL$PL
241038953$24103895$3$F$$20240828$20240717$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113398$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240904$$CN$US$US
241038961$24103896$1$I$20231022$20240709$20240717$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-113389$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240717$$CN$CA$CA
241038971$24103897$1$I$$20240705$20240717$20240717$EXP$CA-MHPD-001083759$CA-Accord-434816$ACCORD$$54$YR$A$M$Y$112$KG$20240717$$HP$CA$CA
241038981$24103898$1$I$$20240714$20240717$20240717$PER$$US-AMGEN-USASP2024139957$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241038992$24103899$2$F$$20240711$20240717$20240722$EXP$JP-MLMSERVICE-20240701-PI119195-00059-1$JP-STRIDES ARCOLAB LIMITED-2024SP008705$STRIDES$Yamada H, Toko M, Nakamori M, Ueno H, Aoki S, Sugimoto T, et al.. Progressive multifocal leukoencephalopathy associated with systemic lupus erythematosus: longitudinal observation of lymphocytes, JC virus in cerebrospinal fluid, and brain magnetic resonance imaging.. Journal of NeuroVirology. 2024$60$YR$$F$Y$$$20240722$$MD$JP$JP
241039001$24103900$1$I$$20240712$20240717$20240717$EXP$$US-SA-2024SA207031$SANOFI AVENTIS$$$$E$M$Y$80.73$KG$20240717$$MD$US$US
241039011$24103901$1$I$20240701$20240702$20240717$20240717$PER$$US-IMP-2024000471$Harrow Health$$81$YR$E$F$Y$$$20240717$$CN$US$US
241039021$24103902$1$I$$20240708$20240717$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-034086$AUROBINDO$Fenton GA, Dean EA.. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report.. Case Reports in Oncology.. 2024;17(1):75-81$64$YR$$F$Y$$$20240717$$MD$US$US
241039041$24103904$1$I$$20240709$20240717$20240717$EXP$$CA-STRIDES ARCOLAB LIMITED-2024SP008560$STRIDES$Wilken BF, Moran-Mendoza O, Pourafkari M, Asai Y.. Drug-induced interstitial lung disease associated with dupilumab for the treatment of atopic dermatitis.  ;:. JAAD-Case-Rep. 2024;50 (0):12-15.$8$DEC$$F$Y$$$20240717$$HP$CA$CA
241039051$24103905$1$I$$20240708$20240717$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-029530$AUROBINDO$$70$YR$$F$Y$$$20240717$$MD$US$US
241039061$24103906$1$I$$20240708$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-032655$AUROBINDO$$$$$$Y$$$20240717$$CN$GB$GB
241039071$24103907$1$I$20240702$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49276$$FDA-CTU$$88$YR$$M$N$$$20240716$N$PH$US$
241039081$24103908$1$I$$20240704$20240717$20240717$EXP$$ES-ALVOGEN-2024095085$ALVOGEN$Sanchez-Sellero I, Cabarcos-Fernandez P, Jaureguizar-Rodriguez ME, Alvarez-Freire I, Tabernero-Duque MJ and Bermejo-Barrera AM. Development and Validation of a Sonication-Assisted Dispersive Liquid?Liquid Microextraction Procedure and an HPLC-PDA Method for Quantitative Determination of Zolpidem in Human Plasma and Its Application to Forensic Samples. Molecules. 2024 May 24;29:2490. doi:https://doi.org/10.3390/molecules29112490$60$YR$$F$Y$$$20240717$$HP$ES$ES
241039101$24103910$1$I$$20240709$20240717$20240717$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008562$STRIDES$Zhao Y, Yang W, Zhao X, Hu X, Hu J, Liu X, et al.. Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia. ;. Front-Pediatr. 2023;10:1095143.$11$YR$$M$Y$$$20240717$$HP$CN$CN
241039111$24103911$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49281$$FDA-CTU$$75$YR$$F$N$162$LBS$20240716$N$$US$
241039123$24103912$3$F$20210820$20240724$20240717$20240801$EXP$$CA-TAKEDA-2021TUS054462$TAKEDA$$80$YR$$F$Y$$$20240801$$CN$CA$CA
241039132$24103913$2$F$$20240717$20240717$20240724$EXP$JP-MLMSERVICE-20240701-PI118292-00059-1$JP-STRIDES ARCOLAB LIMITED-2024SP008703$STRIDES$Tsukui D, Haga T, Abe K.. Discordance Between Mucosal Appearances and Pathologic Findings in Intestinal Mycobacterial Infection in an Immunocompromised Patient.. Mayo Clinic Proceedings. 2024;99(7):1112-1113$6$DEC$$M$Y$$$20240724$$MD$JP$JP
241039141$24103914$1$I$$20240716$20240717$20240717$EXP$$CA-TAKEDA-2024TUS072064$TAKEDA$$$$$M$Y$$$20240717$$CN$CA$CA
241039161$24103916$1$I$$20240708$20240717$20240717$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008598$STRIDES$Li X, Jin Y.. Zolpidem-triggered atrial fibrillation in a patient with cardiomyopathy: a case report.. BMC-Cardiovasc-Disord. 2024;24 (1):339$40$YR$$M$Y$$$20240717$$HP$CN$CN
241039172$24103917$2$F$20240715$20240717$20240717$20240723$PER$$US-AMGEN-USASP2024141209$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241039182$24103918$2$F$$20240722$20240717$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-034126$AUROBINDO$Chen F, Boominathan P.. Aortoesophageal Fistula Following a Cervical Epidural Steroid Injection: Case Report.. Pain Medicine Case Reports. 2023;7(8):345-7$7$DEC$$M$Y$$$20240802$$MD$US$US
241039192$24103919$2$F$$20240719$20240717$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-034301$AUROBINDO$Larabi IA, Ghish A, Kintz P, Marillier M, Fabresse N, Pelletier R, et al.. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).. Toxic-Analyt-Clinique.. 2023;35 (3):175-197.$44$YR$$M$Y$$$20240730$$MD$FR$FR
241039201$24103920$1$I$$20240709$20240717$20240717$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008566$STRIDES$Castex MP, Stefanowicz J, Clement L, Weclawek-Tompol J, Hameury F, Fresneau B, et al.. Choriocarcinoma in neonates and infants: A severe but curable disease.. Pediatr-Blood-Cancer. 2024;71 (8):1-5.$$$$M$Y$$$20240717$$HP$FR$FR
241039211$24103921$1$I$20240701$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49290$$FDA-CTU$$75$YR$$F$N$59$KG$20240716$N$HP$US$
241039221$24103922$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49285$$FDA-CTU$$$$$F$N$$$20240716$N$HP$US$
241039251$24103925$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49265$$FDA-CTU$$86$YR$$M$N$$$20240716$N$$US$
241039262$24103926$2$F$20240101$20240712$20240717$20240721$PER$$US-ROCHE-10000025334$ROCHE$$13$YR$T$M$Y$43.5$KG$20240721$$CN$US$US
241039271$24103927$1$I$$20240709$20240717$20240717$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008475$STRIDES$Bojja S, Javed N, Bojja S, Itare V, Nasr R. Amlodipine Overdose in a Transgender Woman: A Case Study. Cureus. 2023;15 (7):e42511$43$YR$$$Y$$$20240717$$HP$US$US
241039281$24103928$1$I$$20240708$20240717$20240717$EXP$JP-MLMSERVICE-20240701-PI118343-00214-1$JP-STRIDES ARCOLAB LIMITED-2024SP008704$STRIDES$Sakai Y, Karakawa S, Koutaki T, Higuchi K, Hashimoto A, Watanabe H.. Concomitant Administration of Vancomycin with a High Dose of Meropenem May Cause Acute Kidney Injury.. Case reports in infectious diseases. 2024;2024:7956014$65$YR$$F$Y$58.3$KG$20240717$$PH$JP$JP
241039291$24103929$1$I$$20240709$20240717$20240717$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008653$STRIDES$Zhao Y, Yang W, Zhao X, Hu X, Hu J, Liu X, et al.. Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia.. Front-Pediatr. 2023;10:1095143$17$YR$$M$Y$$$20240717$$HP$CN$CN
241039301$24103930$1$I$$20240710$20240717$20240717$EXP$$GB-009507513-2407GBR005811$MERCK$$$$$M$Y$$$20240717$$HP$GB$GB
241039311$24103931$1$I$$20240704$20240717$20240717$EXP$$ES-ALVOGEN-2024095082$ALVOGEN$Sanchez-Sellero I, Cabarcos-Fernandez P, Jaureguizar-Rodriguez ME, Alvarez-Freire I, Tabernero-Duque MJ and Bermejo-Barrera AM. Development and Validation of a Sonication-Assisted Dispersive Liquid?Liquid Microextraction Procedure and an HPLC-PDA Method for Quantitative Determination of Zolpidem in Human Plasma and Its Application to Forensic Samples. Molecules. 2024 May 24;29:2490. doi:https://doi.org/10.3390/molecules29112490$23$YR$$F$Y$$$20240717$$HP$ES$ES
241039321$24103932$1$I$20240627$20240708$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034368$AUROBINDO$$47$YR$$M$Y$72$KG$20240717$$CN$GB$GB
241039331$24103933$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112054$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240717$$CN$US$US
241039351$24103935$1$I$20221017$20240710$20240717$20240717$EXP$PL-URPL-DML-MLP.4401.1.774.2022$PL-TEVA-VS-3220311$TEVA$$82$YR$$F$Y$61$KG$20240717$$MD$PL$PL
241039361$24103936$1$I$$20240705$20240717$20240717$PER$$US-TEVA-VS-3219578$TEVA$$$$A$F$Y$$$20240717$$CN$US$US
241039371$24103937$1$I$20240404$20240708$20240717$20240717$EXP$$ES-AUROBINDO-AUR-APL-2024-034334$AUROBINDO$$26$YR$$M$Y$$$20240717$$MD$ES$ES
241039381$24103938$1$I$$20240710$20240717$20240717$EXP$$US-JNJFOC-20240726272$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
241039391$24103939$1$I$$20240709$20240717$20240717$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008652$STRIDES$Zhao Y, Yang W, Zhao X, Hu X, Hu J, Liu X, et al.. Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia.. Front-Pediatr.. 2023;10:1095143$10$YR$$M$Y$$$20240717$$HP$CN$CN
241039401$24103940$1$I$$20240710$20240717$20240717$PER$$US-EMD Serono-2024037854$EMD SERONO INC$$36$YR$A$F$Y$$$20240717$$CN$US$US
241039411$24103941$1$I$$20240709$20240717$20240717$EXP$$BE-STRIDES ARCOLAB LIMITED-2024SP008658$STRIDES$Georgery M, Ram A, Van Meerhaeghe T, Drowart A, Clause A-L, Lago LD, et al.. Occurrence of Fatal Tubulopathy in an Old, Fit Patient Receiving Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report.. Case-Rep-Oncol. 2024;17 (1):239-246.$82$YR$$F$Y$$$20240717$$HP$BE$BE
241039421$24103942$1$I$$20240705$20240717$20240717$EXP$$VN-SANDOZ INC.-SDZ2024VN065708$SANDOZ$Minh PD, Thai NX, Thuan CQ, Sam TM. Supportive treatment results after radical prostatectomy. VIETNAM MEDICAL JOURNAL. 2024;539:204-9$$$$M$Y$$$20240717$$HP$VN$VN
241039431$24103943$1$I$20231014$20240708$20240717$20240717$EXP$FR-AFSSAPS-PA2024000835$FR-RDY-SPO/FRA/24/0010085$DR REDDYS$$50$YR$A$F$Y$93$KG$20240717$$MD$FR$FR
241039441$24103944$1$I$$20240711$20240717$20240717$EXP$$GB-TAKEDA-2024TUS071775$TAKEDA$$$$$F$Y$$$20240717$$CN$GB$GB
241039452$24103945$2$F$$20240715$20240717$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-034079$AUROBINDO$Kuraitis D, Bogner P, Gopalakrishnan D, Pei S.. Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis.. JAAD Case Reports.. 2024;50:33-6$68$YR$$M$Y$$$20240724$$MD$US$US
241039461$24103946$1$I$20240704$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140941$AMGEN$$78$YR$E$F$Y$$$20240717$$CN$US$US
241039471$24103947$1$I$$20240710$20240717$20240717$PER$$US-AMGEN-USASP2024138608$AMGEN$$$$$F$Y$$$20240717$$PH$US$US
241039481$24103948$1$I$20240706$20240711$20240717$20240717$EXP$$CO-UCBSA-2024035752$UCB$$20$YR$$M$Y$$$20240717$$CN$CO$CO
241039495$24103949$5$F$20240708$20240828$20240717$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021369$UNITED THERAPEUTICS$$69$YR$$M$Y$78.912$KG$20240906$$$US$US
241039502$24103950$2$F$$20240712$20240717$20240721$EXP$CA-STRIDES ARCOLAB LIMITED-2024SP008684$CA-STRIDES ARCOLAB LIMITED-2024SP008684$STRIDES$Herrington J, Batthish M, Takrouri H, Yarascavitch B, Gross A.. Asymptomatic intraspinal epidermoid cyst in a 7-year-old male with juvenile idiopathic arthritis identified by an advanced physiotherapist practitioner: a case report.. Journal of Manual and Manipulative Therapy. 2024;32 (3):343-351$7$YR$$M$Y$$$20240719$$MD$CA$CA
241039511$24103951$1$I$$20240710$20240717$20240717$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008633$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$43$YR$$F$Y$$$20240717$$HP$FR$FR
241039521$24103952$1$I$20231116$20240708$20240717$20240717$EXP$$IT-AUROBINDO-AUR-APL-2024-034257$AUROBINDO$$54$YR$$F$Y$$$20240717$$MD$IT$IT
241039531$24103953$1$I$$20240708$20240717$20240717$EXP$$US-HETERO-HET2024US02304$HETERO$Marino-Nunez D, Chadha A, Onajin O.. A Fatal Case of Cryptococcoid Vasculopathy. Am-J-Dermatopathol. 2024;46(7):S7$$$$M$Y$$$20240717$$HP$US$US
241039541$24103954$1$I$20240416$20240708$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034516$AUROBINDO$$54$YR$$M$Y$$$20240717$$MD$GB$GB
241039551$24103955$1$I$20240702$20240708$20240717$20240717$EXP$$IT-AUROBINDO-AUR-APL-2024-034340$AUROBINDO$$80$YR$$M$Y$$$20240717$$PH$IT$IT
241039561$24103956$1$I$20240205$20240707$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034072$AUROBINDO$$41$YR$$M$Y$56$KG$20240717$$CN$GB$GB
241039572$24103957$2$F$$20240708$20240717$20240717$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP008687$STRIDES$Kim J, Lee J, Lee S, Kim K.. Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report.. Medicina-Kaunas. 2024;60 (6)$79$YR$$M$Y$$$20240717$$HP$KR$KR
241039581$24103958$1$I$$20240709$20240717$20240717$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008659$STRIDES$Yokota H, Asahi R, Akamine Y, Kobayashi M, Wakabayashi H, Sakamoto S, et al.. Case report of QT interval prolongation induced by anamorelin in an obese patient with non-small cell lung cancer.. J-Pharm-Health-Care-Sci. 2024;10$6$DEC$$F$Y$$$20240717$$HP$JP$JP
241039591$24103959$1$I$$20240710$20240717$20240717$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008635$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$43$YR$$F$Y$$$20240717$$HP$FR$FR
241039601$24103960$1$I$20240624$20240708$20240717$20240717$EXP$$GB-TEVA-VS-3219472$TEVA$$76$YR$$F$Y$67$KG$20240717$$MD$GB$GB
241039611$24103961$1$I$$20201228$20240717$20240717$EXP$$US-AstraZeneca-2020SF75496$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241039622$24103962$2$F$20240201$20240722$20240717$20240726$EXP$$CO-UCBSA-2024036096$UCB$$50$YR$$M$Y$74$KG$20240726$$CN$CO$CO
241039631$24103963$1$I$$20240710$20240717$20240717$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008679$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$14$YR$$$Y$$$20240717$$HP$FR$FR
241039641$24103964$1$I$$20200924$20240717$20240717$EXP$$US-AstraZeneca-2020SF24034$ASTRAZENECA$$69$YR$$F$Y$$$20240717$$CN$US$
241039651$24103965$1$I$$20191014$20240717$20240717$EXP$$RU-AstraZeneca-2019SF47023$ASTRAZENECA$$62$YR$$M$Y$78$KG$20240717$$CN$RU$
241039661$24103966$1$I$20180101$20190819$20240717$20240717$EXP$$RU-AstraZeneca-2019SF20002$ASTRAZENECA$$60$YR$$F$Y$92$KG$20240717$$CN$RU$
241039671$24103967$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160391$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241039691$24103969$1$I$20190630$20191018$20240717$20240717$EXP$$CO-AstraZeneca-2019SF49655$ASTRAZENECA$$22788$DY$$F$Y$$$20240717$$CN$CO$
241039701$24103970$1$I$$20191204$20240717$20240717$EXP$$RU-AstraZeneca-2019SF75710$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$RU$
241039711$24103971$1$I$$20240708$20240717$20240717$EXP$$US-AUROBINDO-AUR-APL-2024-035336$AUROBINDO$Wong RW, Seasely AR, Gongora E, Hoopes CW, Bellot S, McElwee SK, et al.. Strategies and outcomes of extracorporeal membrane oxygenation use in peripartum patients: a single institution experience. J-Matern-Fetal-Neonat-Med. 2024;37:1, 2355293$$$$F$Y$$$20240717$$HP$US$US
241039721$24103972$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157266$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241039731$24103973$1$I$$20191204$20240717$20240717$EXP$$US-AstraZeneca-2019SF76637$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241039741$24103974$1$I$$20210113$20240717$20240717$EXP$$US-AstraZeneca-2021A009053$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241039751$24103975$1$I$$20240710$20240717$20240717$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008680$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$14$YR$$M$Y$$$20240717$$HP$FR$FR
241039761$24103976$1$I$$20240711$20240717$20240717$EXP$$US-GSK-US2024086546$GLAXOSMITHKLINE$$$$$F$Y$$$20240717$$CN$US$US
241039771$24103977$1$I$20240210$20240710$20240717$20240717$EXP$$US-GSK-US2024086568$GLAXOSMITHKLINE$$5$DEC$$F$Y$$$20240717$$PH$US$US
241039781$24103978$1$I$$20191120$20240717$20240717$EXP$$US-AstraZeneca-2019SF68105$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241039791$24103979$1$I$$20240705$20240717$20240717$EXP$$US-MYLANLABS-2024M1064880$MYLAN$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatr-Blood-Cancer 2024; 71 (7): e31004.$28$YR$$M$Y$$$20240717$$HP$US$US
241039801$24103980$1$I$$20240709$20240717$20240717$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP008674$STRIDES$Tan XN, Yew CY, Ragg SJ, Harrup RA, Johnston AM.. Outpatient autologous stem cell transplantation in Royal Hobart Hospital, Tasmania: a single-centre, retrospective review in the Australian setting.. Intern-Med-J. 2022;52 (7):1242-1250$$$$$Y$$$20240717$$HP$AU$AU
241039811$24103981$1$I$$20240715$20240717$20240717$PER$$US-ABBVIE-5841530$ABBVIE$$$$$$Y$$$20240717$$PH$US$US
241039821$24103982$1$I$$20240712$20240717$20240717$EXP$$AR-TAKEDA-2024TUS071582$TAKEDA$$$$$M$Y$$$20240717$$CN$AR$AR
241039832$24103983$2$F$$20240806$20240717$20240809$EXP$$US-TAKEDA-2024TUS071539$TAKEDA$$$$$F$Y$$$20240809$$CN$US$US
241039841$24103984$1$I$$20240709$20240717$20240717$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008686$STRIDES$Gonzalez-Gomez A, Caro-Teller JM, Gonzalez-Barrios I, Castro-Frontinan A, Rodriguez-Quesada PP, Ferrari-Piquero JM.. Safety profile of nirmatrelvir-ritonavir: Evidence of adverse events due to drug-drug interactions. Farm-Hosp. 2024;48 (2):70-74$$$$$Y$$$20240717$$HP$ES$ES
241039851$24103985$1$I$20240101$20240703$20240717$20240717$PER$$US-IMP-2024000472$Harrow Health$$$$E$F$Y$$$20240717$$CN$US$US
241039861$24103986$1$I$$20240708$20240717$20240717$EXP$$DK-STRIDES ARCOLAB LIMITED-2024SP008702$STRIDES$Knudsen GHo, Kermanian N, Kock-Jensen CH, Antulov R.. Opioid-Induced Leukoencephalopathies: A Report of Two Cases. Case-Rep-Neurol. 2022;14 (1):25-30$2$DEC$$M$Y$$$20240717$$HP$DK$DK
241039871$24103987$1$I$$20240710$20240717$20240717$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008682$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$21$YR$$F$Y$$$20240717$$HP$FR$FR
241039881$24103988$1$I$$20240709$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034318$AUROBINDO$$$$$F$Y$$$20240717$$CN$GB$GB
241039891$24103989$1$I$20230101$20240709$20240717$20240717$EXP$$BE-STRIDES ARCOLAB LIMITED-2024SP008699$STRIDES$Rossignon P, Nguyen LDK, Boegner P, Ku J, Herpain A.. Refractory insulin resistance and hemophagocytic lymphohistiocytosis following enfortumab vedotin treatment: A case report.. Mol-Clin-Oncol. 2024;20 (6):1-7$58$YR$$M$Y$$$20240717$$HP$BE$BE
241039901$24103990$1$I$$20240710$20240717$20240717$PER$$US-ALXN-202407USA000739US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
241039913$24103991$3$F$$20240913$20240717$20240919$EXP$$US-TAKEDA-2024TUS066251$TAKEDA$$$$$M$Y$$$20240919$$CN$US$US
241039921$24103992$1$I$$20240709$20240717$20240717$EXP$$PL-AUROBINDO-AUR-APL-2024-034542$AUROBINDO$$34$YR$$F$Y$53$KG$20240717$$MD$PL$PL
241039932$24103993$2$F$$20240920$20240717$20240923$EXP$$NVSC2024US146089$NOVARTIS$$26$YR$$M$Y$$$20240923$$CN$US$US
241039951$24103995$1$I$20240328$20240712$20240717$20240717$EXP$FR-AFSSAPS-TO2024001080$FR-ROCHE-10000025240$ROCHE$$58$YR$A$M$Y$97$KG$20240717$$MD$FR$FR
241039961$24103996$1$I$20240101$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113371$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240717$$HP$US$US
241039973$24103997$3$F$20240701$20240826$20240717$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111336$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240828$$CN$US$US
241039983$24103998$3$F$$20240830$20240717$20240902$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-112122$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$67$KG$20240902$$CN$DE$DE
241040013$24104001$3$F$20240701$20240808$20240717$20240814$PER$$CN-Eisai-EC-2024-169886$EISAI$$55$YR$A$F$Y$54$KG$20240814$$MD$CN$CN
241040021$24104002$1$I$20240101$20240704$20240717$20240717$PER$$US-IMP-2024000473$Harrow Health$$$$E$F$Y$$$20240717$$CN$US$US
241040031$24104003$1$I$$20240717$20240717$20240717$EXP$$IL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040240$BOEHRINGER INGELHEIM$$6$DEC$A$M$Y$$$20240717$$MD$IL$IL
241040041$24104004$1$I$20240709$20240712$20240717$20240717$PER$$US-HALEON-2187035$Haleon PLC$$54$YR$$F$Y$$$20240717$$CN$US$US
241040051$24104005$1$I$$20240709$20240717$20240717$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP008589$STRIDES$Tan XN, Yew CY, Ragg SJ, Harrup RA, Johnston AM.. Outpatient autologous stem cell transplantation in Royal Hobart Hospital, Tasmania: a single-centre, retrospective review in the Australian setting.. Intern-Med-J ; :. 2022;52 (7):1242-1250$$$$$Y$$$20240717$$HP$AU$AU
241040061$24104006$1$I$$20240627$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05968$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241040072$24104007$2$F$$20240722$20240717$20240725$PER$$US-JNJFOC-20240733697$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$CN$US$US
241040081$24104008$1$I$$20240711$20240717$20240717$30DAY$$US-GSK-US2024086588$GLAXOSMITHKLINE$$$$$F$Y$$$20240717$$CN$US$US
241040101$24104010$1$I$20180718$20240708$20240717$20240717$EXP$$AU-GSK-AU2024APC085219$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$AU$AU
241040111$24104011$1$I$20231014$20240709$20240717$20240717$EXP$FR-AFSSAPS-PA2024000835$FR-BAXTER-2024BAX021357$BAXTER$$50$YR$$F$Y$93$KG$20240717$$MD$FR$FR
241040121$24104012$1$I$20240530$20240708$20240717$20240717$EXP$PT-INFARMED-T202405-1013$PT-BAXTER-2024BAX021318$BAXTER$$42$YR$$F$Y$70$KG$20240717$$MD$PT$PT
241040131$24104013$1$I$20230920$20240708$20240717$20240717$EXP$$NZ-BAXTER-2023BAX032142$BAXTER$$65$YR$$F$Y$55.6$KG$20240717$$MD$NZ$NZ
241040141$24104014$1$I$20240623$20240708$20240717$20240717$EXP$CN-NMPACDR-4501031911191202400015$CN-BAXTER-2024BAX021440$BAXTER$$45$YR$$M$Y$73$KG$20240717$$MD$CN$CN
241040152$24104015$2$F$20240420$20240719$20240717$20240726$EXP$$IL-BAXTER-2024BAX017635$BAXTER$$70$YR$$M$Y$94$KG$20240726$$MD$IL$IL
241040161$24104016$1$I$20240619$20240705$20240717$20240717$EXP$FR-AFSSAPS-2024058749$FR-Accord-434936$ACCORD$$56$YR$A$F$Y$53$KG$20240717$$PH$FR$FR
241040171$24104017$1$I$20240501$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405130012593890-VJCNG$GB-Accord-434649$ACCORD$$$$$F$Y$76$KG$20240717$$CN$GB$GB
241040181$24104018$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405091230085770-TBQVG$GB-Accord-434660$ACCORD$$$$$M$Y$$$20240717$$PH$GB$GB
241040192$24104019$2$F$20240531$20240807$20240717$20240819$EXP$FR-AFSSAPS-AN2024000897$FR-Accord-435290$ACCORD$$88$YR$E$F$Y$78$KG$20240819$$PH$FR$FR
241040202$24104020$2$F$20220601$20240815$20240717$20240827$EXP$$AT-Accord-434985$ACCORD$Sommer L, Weber S, Listabarth S, Trojer A, Groemer M, Konig D. Clozapine therapy for loss of efficacy of antipsychotic treatment after liver transplantation. Immunosuppression with tacrolimus as a complicating factor. Psychopraxis. Neuropraxis. 2024;27:159-62. doi:10.1007/s00739-024-01000-?8.$50$YR$A$M$Y$$$20240827$$HP$AT$AT
241040211$24104021$1$I$$20240705$20240717$20240717$EXP$CA-MHPD-E2B_07106800$CA-Accord-434695$ACCORD$$62$YR$A$M$Y$$$20240717$$MD$CA$CA
241040221$24104022$1$I$20240429$20240712$20240717$20240717$EXP$$GB-AMGEN-GBRSP2024138885$AMGEN$$$$$F$Y$$$20240717$$HP$GB$GB
241040231$24104023$1$I$20240701$20240714$20240716$20240716$DIR$FDA-CDER-CTU-2024-49253$$FDA-CTU$$$$$M$N$$$20240714$N$HP$US$
241040241$24104024$1$I$20240709$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140470$AMGEN$$47$YR$A$M$Y$$$20240717$$CN$US$US
241040251$24104025$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06526$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241040261$24104026$1$I$$20240703$20240717$20240717$EXP$$ES-AZURITY PHARMACEUTICALS, INC.-AZR202407-000031$AZURITY PHARMACEUTICALS$Ayen-Rodriguez A, Gil-Villalba A, Ruiz-Villaverde R, Navarro-Trivino FJ.. Methotrexate Toxicity in Dermatological Patients. Actas Dermo-Sifiliograficas. 2024;115:T741-3$69$YR$$M$Y$$$20240717$$HP$ES$ES
241040271$24104027$1$I$$20240710$20240717$20240717$EXP$$NVSJ2024JP008423$NOVARTIS$Matsuoka M, Saimura M, Wakamatsu S, Kurata K, Nakamoto M, Koga K, et al.. A case of locally advanced mucinous carcinoma which recurred early after surgery and presented as superior vena cava syndrome. (Abstract Book for) the 32nd Annual Meeting of the Japanese Breast Cancer Societ. 2024;358$$$A$F$Y$$$20240717$$HP$JP$JP
241040303$24104030$3$F$20240618$20240814$20240717$20240820$EXP$DE-BFARM-24004962$NVSC2024DE145562$NOVARTIS$$9$WK$$M$Y$3$KG$20240820$$MD$DE$DE
241040311$24104031$1$I$$20240715$20240717$20240717$PER$$NVSC2024US146233$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
241040321$24104032$1$I$$20240715$20240717$20240717$EXP$$NVSC2024CA146190$NOVARTIS$$$$$M$Y$$$20240717$$CN$CA$CA
241040331$24104033$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405131113575700-DCBJZ$GB-Accord-434671$ACCORD$$32$YR$A$F$Y$$$20240717$$MD$GB$GB
241040341$24104034$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405091618218170-JRLNH$GB-Accord-434851$ACCORD$$$$$M$Y$$$20240717$$CN$GB$GB
241040351$24104035$1$I$20240627$20240706$20240717$20240717$EXP$$US-Accord-434481$ACCORD$$54$YR$A$M$Y$$$20240717$$PH$US$US
241040361$24104036$1$I$20240617$20240703$20240717$20240717$EXP$$US-Accord-434140$ACCORD$$64$YR$A$M$Y$$$20240717$$HP$US$US
241040371$24104037$1$I$20240606$20240705$20240717$20240717$EXP$IT-MINISAL02-993711$IT-Accord-434931$ACCORD$$54$YR$A$M$Y$$$20240717$$MD$IT$IT
241040381$24104038$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405091232574480-CBJKQ$GB-Accord-434832$ACCORD$$$$$M$Y$$$20240717$$HP$GB$GB
241040391$24104039$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009616$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
241040401$24104040$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009578$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240717$$CN$US$US
241040411$24104041$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009890$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240717$$CN$US$US
241040423$24104042$3$F$$20240807$20240717$20240820$EXP$$IT-Accord-434475$ACCORD$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et al. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicol Rep. 2024 Jun 21;13:101683.$15$YR$T$F$Y$48$KG$20240820$$MD$IT$IT
241040432$24104043$2$F$$20240708$20240717$20240717$EXP$IN-MLMSERVICE-20240701-PI117712-00153-1$IN-STRIDES ARCOLAB LIMITED-2024SP008575$STRIDES$Dhobale M, Sarangi S, Yadav A, Khanande R.. Hyperkinetic conduct disorder as a risk factor for switch from unipolar to bipolar disorder.. Indian Journal of Psychiatry. 2024;66(Suppl.1):S180$18$YR$$M$Y$$$20240717$$MD$IN$IN
241040441$24104044$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010133$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240717$$CN$US$US
241040451$24104045$1$I$20240701$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009469$ELI LILLY AND CO$$73$YR$E$$Y$$$20240717$$CN$US$US
241040463$24104046$3$F$20240405$20240905$20240717$20240913$EXP$$JP-MRZWEB-24-01805$MERZ$$79$YR$$F$Y$$$20240913$$MD$JP$JP
241040471$24104047$1$I$$20240712$20240717$20240717$PER$$US-JNJFOC-20240735483$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240717$$CN$US$US
241040481$24104048$1$I$$20240702$20240717$20240717$30DAY$$US-JNJFOC-20240730923$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241040501$24104050$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065536$SANDOZ$$63$YR$$M$Y$$$20240717$$HP$CA$CA
241040511$24104051$1$I$20240526$20240709$20240717$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-020281$UNITED THERAPEUTICS$$55$YR$$F$Y$$$20240717$$$US$US
241040521$24104052$1$I$20240501$20240709$20240717$20240717$EXP$IT-MINISAL02-993150$IT-TEVA-VS-3219330$TEVA$$70$YR$$F$Y$$$20240717$$MD$IT$IT
241040531$24104053$1$I$20240629$20240709$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034302$AUROBINDO$$52$YR$$F$Y$105$KG$20240717$$CN$GB$GB
241040551$24104055$1$I$$20240708$20240717$20240717$PER$$US-BAYER-2024A098501$BAYER$$$$$F$Y$$$20240717$$CN$US$US
241040561$24104056$1$I$$20240709$20240717$20240717$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008558$STRIDES$Zhao Y, Yang W, Zhao X, Hu X, Hu J, Liu X, et al.. Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia.. Front-Pediatr. 2023;10:1095143.$9$YR$$F$Y$$$20240717$$HP$CN$CN
241040571$24104057$1$I$$20240710$20240717$20240717$EXP$$US-GSK-US2024085809$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$US$US
241040581$24104058$1$I$20200508$20240709$20240717$20240717$EXP$$PL-AUROBINDO-AUR-APL-2024-034501$AUROBINDO$$63$YR$$F$Y$70$KG$20240717$$MD$PL$PL
241040603$24104060$3$F$20240101$20240917$20240717$20240925$EXP$$GB-ROCHE-3536606$ROCHE$$57$YR$A$F$Y$$$20240925$$CN$GB$GB
241040611$24104061$1$I$20240316$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405081234168730-VGBQC$GB-Accord-435018$ACCORD$$8$YR$C$M$Y$22$KG$20240717$$CN$GB$GB
241040621$24104062$1$I$20220906$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405111227472190-RWVFM$GB-Accord-434692$ACCORD$$71$YR$E$M$Y$70$KG$20240717$$CN$GB$GB
241040631$24104063$1$I$20230505$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405101240033280-FJZBW$GB-Accord-434608$ACCORD$$44$YR$A$M$Y$$$20240717$$CN$GB$GB
241040642$24104064$2$F$20100101$20240718$20240717$20240729$EXP$GB-MHRA-MED-202407051416214150-ZJLQR$GB-Accord-434535$ACCORD$$0$DY$$F$Y$$$20240729$$CN$GB$GB
241040651$24104065$1$I$20210301$20220124$20240717$20240717$EXP$PL-EMA-20211221-AUTODUP-1640042308070$PL-Accord-426664$ACCORD$$71$YR$E$M$Y$$$20240717$$MD$PL$PL
241040661$24104066$1$I$20230601$20240705$20240717$20240717$EXP$GB-MHRA-WEBRADR-202406252245272640-TJYLR$GB-Accord-434610$ACCORD$$44$YR$A$M$Y$108$KG$20240717$$CN$GB$GB
241040671$24104067$1$I$20240301$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405091936429690-CVRSY$GB-Accord-434578$ACCORD$$29$YR$A$F$Y$$$20240717$$CN$GB$GB
241040681$24104068$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405171415438930-CKYNW$GB-Accord-434534$ACCORD$$0$DY$$M$Y$2$KG$20240717$$MD$GB$GB
241040692$24104069$2$F$$20240715$20240717$20240727$EXP$$GB-Accord-434474$ACCORD$Darnborough S. Managing menopause in an irradiated pelvis uncharted territory. Post Reproductive Health. 2024;30(2):127-34.$5$DEC$A$F$Y$$$20240727$$MD$GB$GB
241040701$24104070$1$I$20240710$20240710$20240717$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-021378$UNITED THERAPEUTICS$$81$YR$$F$Y$63.039$KG$20240717$$$US$US
241040714$24104071$4$F$20240401$20240919$20240717$20240923$EXP$$NVSC2024US144437$NOVARTIS$$10$YR$$M$Y$$$20240923$$CN$US$US
241040721$24104072$1$I$$20191023$20240717$20240717$EXP$$US-AstraZeneca-2019SF52739$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241040731$24104073$1$I$$20201008$20240717$20240717$EXP$$US-AstraZeneca-2020SF31449$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241040741$24104074$1$I$$20240709$20240717$20240717$PER$$US-ABBVIE-5839043$ABBVIE$$$$$$Y$$$20240717$$CN$US$US
241040752$24104075$2$F$20240516$20240917$20240717$20240930$EXP$FR-AFSSAPS-TO2024001184$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06486$HIKMA$$33$YR$$F$Y$51$KG$20240930$$MD$FR$FR
241040761$24104076$1$I$20191203$20191203$20240717$20240717$EXP$$US-AstraZeneca-2019SF74536$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241040771$24104077$1$I$$20191223$20240717$20240717$EXP$$US-AstraZeneca-2019SF88692$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241040781$24104078$1$I$$20190903$20240717$20240717$EXP$$US-AstraZeneca-2019SF26444$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241040791$24104079$1$I$20191125$20191220$20240717$20240717$EXP$$RU-AstraZeneca-2019SF86623$ASTRAZENECA$$74$YR$$F$Y$73$KG$20240717$$CN$RU$
241040801$24104080$1$I$$20240702$20240717$20240717$EXP$$US-TORRENT-00013678$TORRENT$$18$YR$A$M$Y$$$20240717$$HP$US$US
241040811$24104081$1$I$$20240709$20240717$20240717$PER$$US-TAKEDA-2024TUS069946$TAKEDA$$$$$F$Y$71$KG$20240717$$MD$US$US
241040821$24104082$1$I$20180101$20240707$20240717$20240717$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP008608$STRIDES$Obeng L, Patel A, Villa G, Mourad A, Whibley M, Gilleece Y, et al.. Autoimmune Hepatitis in People Living with HIV: A Case Series and Review of Literature.. Open-AIDS-J. 2023;17:1-7$$$$$Y$$$20240717$$HP$GB$GB
241040831$24104083$1$I$$20240708$20240717$20240717$EXP$$JP-ROCHE-10000025125$ROCHE$Takada N, Fukui T, Irie H, Funatsu Y, Koh H. Immune Checkpoint Inhibitor-induced Sclerosing Cholangitis: Three Cases Reported from Our Hospital. Japanese Journal of Lung Cancer. 2024;64 (3):193-9.$73$YR$E$F$Y$$$20240717$$MD$JP$JP
241040851$24104085$1$I$$20240709$20240717$20240717$30DAY$$US-GSK-US2024085121$GLAXOSMITHKLINE$$$$$F$Y$$$20240717$$CN$US$US
241040861$24104086$1$I$$20240712$20240717$20240717$EXP$$US-GSK-US2024087742$GLAXOSMITHKLINE$$$$$F$Y$$$20240717$$CN$US$US
241040871$24104087$1$I$$20240712$20240717$20240717$EXP$$NVSC2024PH145238$NOVARTIS$$49$YR$$M$Y$$$20240717$$CN$PH$PH
241040881$24104088$1$I$20200210$20200602$20240717$20240717$EXP$$US-AstraZeneca-2020SE25282$ASTRAZENECA$$15953$DY$$F$Y$$$20240717$$CN$US$
241040921$24104092$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49243$$FDA-CTU$$60$YR$$F$N$196$LBS$20240716$N$$US$
241040941$24104094$1$I$$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49242$$FDA-CTU$$$$$F$N$$$20240715$N$HP$US$
241040971$24104097$1$I$20230901$20240703$20240717$20240717$EXP$GB-MHRA-MED-202407021235502260-VRZQL$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-06304$HIKMA$$$$$M$Y$$$20240717$$MD$GB$GB
241040981$24104098$1$I$20100609$20240711$20240717$20240717$EXP$$CH-CHEPLA-2024008768$CHEPLAPHARM$$51$YR$$F$Y$$$20240717$$MD$COUNTRY NOT SPECIFIED$CH
241040991$24104099$1$I$20111230$20240711$20240717$20240717$EXP$$CH-CHEPLA-2024008769$CHEPLAPHARM$$$$$M$Y$$$20240717$$MD$COUNTRY NOT SPECIFIED$CH
241041001$24104100$1$I$$20240711$20240717$20240717$EXP$$CA-CHEPLA-2024008796$CHEPLAPHARM$$$$$F$Y$$$20240717$$CN$COUNTRY NOT SPECIFIED$CA
241041011$24104101$1$I$20240716$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49288$$FDA-CTU$$82$YR$$F$N$$$20240716$Y$PH$US$
241041022$24104102$2$F$20240614$20240905$20240717$20240910$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-028102$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$$$20240910$$CN$CA$CA
241041031$24104103$1$I$$20240711$20240717$20240717$PER$$US-PFIZER INC-PV202400092188$PFIZER$$69$YR$$$Y$$$20240717$$CN$US$US
241041041$24104104$1$I$20240522$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49279$$FDA-CTU$$87$YR$$M$N$$$20240716$Y$PH$US$
241041051$24104105$1$I$20240712$20240712$20240717$20240717$PER$$US-PFIZER INC-202400215050$PFIZER$$41$YR$$F$Y$$$20240717$$CN$US$US
241041061$24104106$1$I$$20240711$20240717$20240717$PER$$US-PFIZER INC-202400082149$PFIZER$$64$YR$$F$Y$$$20240717$$HP$US$US
241041071$24104107$1$I$$20240712$20240717$20240717$PER$$US-PFIZER INC-PV202400093152$PFIZER$$81$YR$$F$Y$$$20240717$$CN$US$US
241041081$24104108$1$I$$20240712$20240717$20240717$PER$$US-PFIZER INC-PV202400093162$PFIZER$$65$YR$$M$Y$$$20240717$$CN$US$US
241041091$24104109$1$I$$20240711$20240717$20240717$PER$$US-PFIZER INC-202400213996$PFIZER$$53$YR$$F$Y$$$20240717$$HP$US$US
241041101$24104110$1$I$$20240711$20240717$20240717$PER$$US-PFIZER INC-PV202400092179$PFIZER$$84$YR$$$Y$$$20240717$$CN$US$US
241041111$24104111$1$I$$20240710$20240717$20240717$PER$$US-PFIZER INC-202400212732$PFIZER$$75$YR$$M$Y$$$20240717$$HP$US$US
241041121$24104112$1$I$$20240712$20240717$20240717$PER$$US-PFIZER INC-PV202400092539$PFIZER$$74$YR$$F$Y$$$20240717$$CN$US$US
241041131$24104113$1$I$20240709$20240712$20240717$20240717$PER$$US-PFIZER INC-202400214359$PFIZER$$55$YR$$F$Y$$$20240717$$CN$US$US
241041141$24104114$1$I$$20240712$20240717$20240717$PER$$US-PFIZER INC-PV202400093157$PFIZER$$45$YR$$M$Y$$$20240717$$CN$US$US
241041153$24104115$3$F$20240801$20240829$20240717$20240904$PER$$US-PFIZER INC-PV202300206928$PFIZER$$76$YR$$F$Y$63.9$KG$20240904$$MD$US$US
241041162$24104116$2$F$20231201$20240910$20240717$20240913$PER$$US-PFIZER INC-PV202400092095$PFIZER$$53$YR$$F$Y$$$20240913$$HP$US$US
241041171$24104117$1$I$20240101$20240712$20240717$20240717$PER$$US-PFIZER INC-202400215360$PFIZER$$54$YR$$M$Y$$$20240717$$CN$US$US
241041181$24104118$1$I$$20240712$20240717$20240717$PER$$US-PFIZER INC-PV202400093175$PFIZER$$$$$M$Y$$$20240717$$CN$US$US
241041192$24104119$2$F$$20240716$20240717$20240718$PER$$US-PFIZER INC-202400212752$PFIZER$$21$YR$$F$Y$$$20240718$$HP$US$US
241041201$24104120$1$I$20240708$20240711$20240717$20240717$PER$$US-PFIZER INC-202400212508$PFIZER$$40$YR$$F$Y$$$20240717$$CN$US$US
241041211$24104121$1$I$20240710$20240711$20240717$20240717$PER$$US-PFIZER INC-202400212643$PFIZER$$64$YR$$F$Y$$$20240717$$MD$US$US
241041222$24104122$2$F$$20240723$20240717$20240724$PER$$US-PFIZER INC-202400215328$PFIZER$$$$$M$Y$$$20240724$$CN$US$US
241041231$24104123$1$I$$20240712$20240717$20240717$PER$$US-PFIZER INC-202400215066$PFIZER$$50$YR$$F$Y$$$20240717$$HP$US$US
241041241$24104124$1$I$$20240712$20240717$20240717$PER$$US-PFIZER INC-PV202400092527$PFIZER$$74$YR$$F$Y$$$20240717$$CN$US$US
241041251$24104125$1$I$$20240711$20240717$20240717$PER$$US-PFIZER INC-202400214400$PFIZER$$65$YR$$F$Y$$$20240717$$HP$US$US
241041261$24104126$1$I$$20240709$20240717$20240717$PER$$US-AMGEN-USASP2024137149$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241041271$24104127$1$I$20240501$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405050947484060-KPTFW$GB-AMGEN-GBRSP2024140045$AMGEN$$77$YR$E$F$Y$74$KG$20240717$$CN$GB$GB
241041281$24104128$1$I$20230801$20240712$20240717$20240717$EXP$$GB-AMGEN-GBRSP2024138865$AMGEN$$32$YR$A$M$Y$$$20240717$$CN$GB$GB
241041292$24104129$2$F$$20240827$20240717$20240906$EXP$$CZ-AUROBINDO-AUR-APL-2024-034579$AUROBINDO$$52$YR$$F$Y$$$20240906$$CN$CZ$CZ
241041301$24104130$1$I$$20240711$20240717$20240717$EXP$$US-JNJFOC-20240731833$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241041312$24104131$2$F$$20240725$20240717$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110858$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$105.23$KG$20240729$$CN$US$US
241041321$24104132$1$I$$20240710$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111030$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$58.06$KG$20240717$$MD$US$US
241041341$24104134$1$I$20240703$20240706$20240717$20240717$EXP$$US-Accord-434480$ACCORD$$17$YR$T$M$Y$$$20240717$$HP$US$US
241041351$24104135$1$I$$20240705$20240717$20240717$EXP$$US-Accord-434443$ACCORD$$$$$$Y$$$20240717$$CN$US$US
241041361$24104136$1$I$20240601$20240705$20240717$20240717$EXP$DE-BFARM-24004754$DE-Accord-434938$ACCORD$$35$YR$A$F$Y$47$KG$20240717$$MD$DE$DE
241041371$24104137$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405082345420790-DRFMC$GB-Accord-434849$ACCORD$$$$$F$Y$62$KG$20240717$$CN$GB$GB
241041381$24104138$1$I$20231201$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405060341067210-TCMHK$GB-Accord-434853$ACCORD$$$$$F$Y$$$20240717$$CN$GB$GB
241041391$24104139$1$I$20240626$20240705$20240717$20240717$EXP$FR-AFSSAPS-TS2024000768$FR-Accord-434909$ACCORD$$72$YR$E$F$Y$52$KG$20240717$$MD$FR$FR
241041401$24104140$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202407051239129710-SHRWC$GB-Accord-434930$ACCORD$$$$$F$Y$$$20240717$$CN$GB$GB
241041411$24104141$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405141236543910-PFYNT$GB-Accord-434880$ACCORD$$$$$F$Y$69$KG$20240717$$HP$GB$GB
241041422$24104142$2$F$$20240802$20240717$20240813$EXP$GB-MHRA-MED-202405162318157690-FNGQT$GB-Accord-434906$ACCORD$$$$$M$Y$$$20240813$$CN$GB$GB
241041431$24104143$1$I$$20220301$20240717$20240717$EXP$$PT-ASTELLAS-2024EU007017$ASTELLAS$Luis T, Candeias C, Domingues S, Oliva-Teles N, Mota C, Reis CF. Partial tetrasomy 18 mosaicism: Pre and postnatal diagnosis of a unique pattern. Taiwanese Journal of Obstetrics and Gynecology. 2022;61(1):150-2$$$$F$Y$0.975$KG$20240717$$HP$PT$PT
241041441$24104144$1$I$$20240716$20240717$20240717$PER$$US-ROCHE-10000028799$ROCHE$$$$A$M$Y$$$20240717$$CN$US$US
241041451$24104145$1$I$20240609$20240715$20240717$20240717$PER$$US-ROCHE-10000027421$ROCHE$$11$YR$C$M$Y$$$20240717$$CN$US$US
241041461$24104146$1$I$$20240708$20240717$20240717$30DAY$$US-GSK-US2024AMR084697$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$US$US
241041471$24104147$1$I$$20240710$20240717$20240717$EXP$$AU-MYLANLABS-2024M1065912$MYLAN$Vaselli NM, Du Preez S, Jasenthu Kankanamage N. Clozapine-induced pneumonitis mimicking an atypical pneumonia. BMJ-Case-Rep 2024; 17 (3): 01-04 abstr. e259154.$4$DEC$$F$Y$$$20240717$$MD$AU$AU
241041491$24104149$1$I$$20240710$20240717$20240717$EXP$$US-MYLANLABS-2024M1066152$MYLAN$Naumann J, Naumann T. Acute Precipitated Opioid Withdrawal With Akathisia, Delirium, and Lactic Acidosis from Low-Dose Naltrexone for Chronic Pain: Case Report. Pain-Med-Case-Rep 2023; 7 (8): 353-356.$66$YR$$M$Y$$$20240717$$HP$US$US
241041501$24104150$1$I$20240603$20240711$20240717$20240717$PER$$US-ROCHE-3576633$ROCHE$$$$$F$Y$$$20240717$$CN$US$US
241041514$24104151$4$F$20240704$20240806$20240717$20240812$PER$$US-ROCHE-10000026446$ROCHE$$62$YR$A$F$Y$$$20240812$$CN$US$US
241041521$24104152$1$I$$20240716$20240717$20240717$PER$$US-ROCHE-10000028756$ROCHE$$$$C$M$Y$$$20240717$$CN$US$US
241041531$24104153$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113255$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240717$$HP$US$US
241041542$24104154$2$F$$20240722$20240717$20240731$EXP$GB-MHRA-MED-202405151353006080-KDBHY$GB-TEVA-VS-3219328$TEVA$$93$YR$$M$Y$$$20240731$$MD$GB$GB
241041561$24104156$1$I$20240626$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49283$$FDA-CTU$$69$YR$$F$N$$$20240716$Y$PH$US$
241041571$24104157$1$I$$20240708$20240717$20240717$EXP$$SE-ROCHE-10000026907$ROCHE$Grundberg O, Skribek M, Swerkersson S, Skorpil M, K?lbeck K, Grozman V, et al. Diffusion weighted MRI and apparent diffusion coefficient as a prognostic biomarker in evaluating chemotherapy-antiangiogenic treated stage IV non-small cell lung cancer: A prospective, single-arm, open-label, clinical trial (BevMar). European Journal of Radiology. 2024-Aug;177: doi:10.1016/j.ejrad.2024.111557.$77$YR$E$M$Y$$$20240717$$HP$SE$SE
241041581$24104158$1$I$20240701$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140619$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241041591$24104159$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49240$$FDA-CTU$$67$YR$$F$N$$$20240716$N$$US$
241041602$24104160$2$F$20240101$20240715$20240717$20240722$EXP$$CA-JNJFOC-20240445421$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240721$$CN$CA$CA
241041621$24104162$1$I$$20240716$20240717$20240717$PER$$US-ROCHE-10000028620$ROCHE$$$$E$F$Y$$$20240717$$CN$US$US
241041631$24104163$1$I$$20240715$20240717$20240717$EXP$$NVSC2024GB146482$NOVARTIS$$$$$M$Y$$$20240717$$HP$GB$GB
241041642$24104164$2$F$$20240912$20240717$20240920$EXP$$NVSJ2024JP008409$NOVARTIS$Ono Y, Kimizuka K, Sugiyama J, Fukatsu Y, Miyake H, Ogura M. A case of subcutaneous emphysema and mediastinitis of the neck caused by antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in a patient with bone metastasis after surgery for right breast cancer. Journal of the Japanese Breast Cancer Society, The 32nd Annual Meeting of the Ja. 2024;EP-1295$66$YR$$F$Y$$$20240920$$HP$JP$JP
241041651$24104165$1$I$20240701$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49291$$FDA-CTU$$70$YR$$F$N$54.5$KG$20240716$N$PH$US$
241041661$24104166$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49246$$FDA-CTU$$$$$F$N$$$20240716$N$HP$US$
241041671$24104167$1$I$$20240710$20240717$20240717$EXP$$US-MYLANLABS-2024M1066223$MYLAN$Patel K, McQuaid S, Ketterl T, Benedetti DJ, Sokol E. Two cases of hepatoblastoma in Bohring-Opitz syndrome: An emerging association. Pediatr-Blood-Cancer 2024; 71 (7).$2$YR$$M$Y$$$20240717$$HP$US$US
241041681$24104168$1$I$$20200214$20240717$20240717$EXP$$US-AstraZeneca-2020SE24187$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241041691$24104169$1$I$$20200218$20240717$20240717$EXP$$US-AstraZeneca-2020SE26140$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241041701$24104170$1$I$$20240710$20240717$20240717$PER$$US-AstraZeneca-2024A161877$ASTRAZENECA$$$$$F$Y$81.6$KG$20240717$$CN$US$
241041711$24104171$1$I$$20200422$20240717$20240717$EXP$$US-AstraZeneca-2020SE33545$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241041721$24104172$1$I$20240710$20240710$20240717$20240717$EXP$$US-BAYER-2024A100803$BAYER$$61$YR$A$M$Y$97.506$KG$20240717$$HP$US$US
241041731$24104173$1$I$$20240710$20240717$20240717$EXP$$US-MYLANLABS-2024M1065951$MYLAN$Fenton GA, Dean EA. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case-Rep-Oncol 2024; 17 (1): 75-81.$64$YR$$F$Y$$$20240717$$HP$US$US
241041741$24104174$1$I$$20240710$20240717$20240717$EXP$$US-MYLANLABS-2024M1065954$MYLAN$Garman JC, Mahgoub Y, Pathare A. Psychogenic Hyperphagia: Excessive Eating as Stereotypy in a Patient with Catatonia. J-Psychiatr-Pract 2024; 30 (3): 242-244.$30$YR$$M$Y$$$20240717$$MD$US$US
241041751$24104175$1$I$$20240710$20240717$20240717$EXP$$US-MYLANLABS-2024M1066161$MYLAN$Gravenmier C, Shah B, Hussaini M, Zhang L. Chimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment. Leuk-Lymphoma 2024; 65 (5): 674-678.$58$YR$$M$Y$$$20240717$$HP$US$US
241041761$24104176$1$I$20191227$20191230$20240717$20240717$EXP$$CO-AstraZeneca-2019SF91830$ASTRAZENECA$$23907$DY$$M$Y$$$20240717$$CN$CO$
241041771$24104177$1$I$$20200609$20240717$20240717$EXP$$US-AstraZeneca-2020SE75225$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241041781$24104178$1$I$20240516$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A160613$ASTRAZENECA$$55$YR$$F$Y$$$20240717$$CN$US$
241041791$24104179$1$I$$20200311$20240717$20240717$EXP$$US-AstraZeneca-2020SE37260$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241041801$24104180$1$I$$20200224$20240717$20240717$EXP$$US-AstraZeneca-2020SE29613$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241041821$24104182$1$I$$20240715$20240717$20240717$EXP$GB-MHRA-MED-202407141118344140-MBDYZ$GB-CHATTEMPRD-2024OHG024239$CHATTEM$$55$YR$A$F$Y$66$KG$20240717$$CN$GB$GB
241041831$24104183$1$I$$20201030$20240717$20240717$EXP$$US-AstraZeneca-2020SF44369$ASTRAZENECA$$70$YR$$M$Y$$$20240717$$CN$US$
241041841$24104184$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5840672$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241041851$24104185$1$I$20200701$20210205$20240717$20240717$EXP$$US-AstraZeneca-2020SE41059$ASTRAZENECA$$58$YR$$F$Y$$$20240717$$HP$US$
241041861$24104186$1$I$20201103$20201103$20240717$20240717$EXP$$CO-AstraZeneca-2020SF46596$ASTRAZENECA$$26329$DY$$M$Y$$$20240717$$CN$CO$
241041871$24104187$1$I$20240501$20240711$20240717$20240717$EXP$$CO-ABBVIE-5805321$ABBVIE$$81$YR$$M$Y$59$KG$20240717$$CN$CO$CO
241041881$24104188$1$I$$20200402$20240717$20240717$EXP$$US-AstraZeneca-2020SE06045$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241041891$24104189$1$I$$20201119$20240717$20240717$EXP$$US-AstraZeneca-2020SF55011$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241041901$24104190$1$I$20220701$20240709$20240717$20240717$EXP$$CN-AstraZeneca-2024A156836$ASTRAZENECA$Ding J., Gu H., Yang Z., Lu Y., Guo G.. Breast metastasis from lung adenocarcinoma: a case report and review of the literature. Frontiers in Oncology 2024;14:$52$YR$$F$Y$$$20240717$$HP$CN$
241041911$24104191$1$I$20240715$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010148$ELI LILLY AND CO$$$$$M$Y$$$20240717$$CN$US$US
241041921$24104192$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009851$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240717$$HP$US$US
241041931$24104193$1$I$$20201125$20240717$20240717$EXP$$ZA-AstraZeneca-2020SF58857$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$ZA$
241041941$24104194$1$I$$20240702$20240717$20240717$EXP$$JP-AMGEN-JPNSP2024141119$AMGEN$$$$$$Y$$$20240717$$MD$JP$JP
241041961$24104196$1$I$$20240716$20240717$20240717$PER$$US-ROCHE-10000028790$ROCHE$$$$E$M$Y$$$20240717$$CN$US$US
241041971$24104197$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113227$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240717$$HP$US$US
241041981$24104198$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06354$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241041991$24104199$1$I$$20240702$20240717$20240717$EXP$$US-ELITEPHARMA-2024ELLIT00170$ELITE$Liu J, et al..Branch retinal artery occlusion in a 49-year-Old woman taking phentermine.American Journal of Ophthalmology Case Reports.15-FEB-2024;35 (1):102013$49$YR$A$F$Y$$$20240715$$HP$US$US
241042001$24104200$1$I$20240618$20240712$20240717$20240717$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02585$AMNEAL$$60$YR$$M$Y$$$20240717$$CN$US$US
241042011$24104201$1$I$$20240702$20240717$20240717$EXP$$US-ELITEPHARMA-2024ELLIT00171$ELITE$Tajfiroozeh D, et al..A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209 (1):A2289$15$YR$T$M$Y$$$20240715$$HP$US$US
241042021$24104202$1$I$$20240704$20240717$20240717$EXP$$US-MSNLABS-2024MSNSPO01508$MSN LABORATORIES$$$$$$Y$$$20240717$$CN$US$US
241042031$24104203$1$I$20240709$20240712$20240717$20240717$PER$$US-JNJFOC-20240737015$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
241042041$24104204$1$I$20240701$20240712$20240717$20240717$EXP$$CA-JNJFOC-20240736100$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240717$$HP$CA$CA
241042051$24104205$1$I$20240419$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405071334285430-VTKJN$GB-Accord-434593$ACCORD$$37$YR$A$F$Y$58$KG$20240717$$PH$GB$GB
241042062$24104206$2$F$20200816$20240822$20240717$20240828$EXP$DE-BFARM-22002616$DE-Accord-426714$ACCORD$$28$YR$A$M$Y$83$KG$20240828$$CN$DE$DE
241042071$24104207$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49269$$FDA-CTU$$64$YR$$F$N$$$20240716$N$$US$
241042081$24104208$1$I$20090301$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405121551375800-CVNQW$GB-Accord-434543$ACCORD$$18$YR$A$M$Y$$$20240717$$CN$GB$GB
241042091$24104209$1$I$$20240705$20240717$20240717$EXP$CA-MHPD-E2B_07093306$CA-Accord-434758$ACCORD$$40$YR$A$F$Y$$$20240717$$HP$CA$CA
241042111$24104211$1$I$20240201$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405091711040630-QMNWC$GB-Accord-434592$ACCORD$$36$YR$A$M$Y$$$20240717$$CN$GB$GB
241042121$24104212$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49277$$FDA-CTU$$62$YR$$F$N$$$20240716$N$$US$
241042141$24104214$1$I$20240514$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405140824070430-GTNLS$GB-Accord-434615$ACCORD$$61$YR$A$M$Y$82$KG$20240717$$MD$GB$GB
241042151$24104215$1$I$20230426$20240705$20240717$20240717$EXP$ES-AEMPS-1541314$ES-Accord-434921$ACCORD$$67$YR$E$M$Y$$$20240717$$MD$ES$ES
241042161$24104216$1$I$20240415$20240706$20240717$20240717$EXP$FR-AFSSAPS-AN2024000847$FR-Accord-435013$ACCORD$$85$YR$E$F$Y$$$20240717$$MD$FR$FR
241042181$24104218$1$I$20231107$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405160812016360-QLCBY$GB-Accord-434571$ACCORD$$26$YR$A$F$Y$54$KG$20240717$$CN$GB$GB
241042192$24104219$2$F$20230427$20240807$20240717$20240819$EXP$FR-AFSSAPS-AN2024000896$FR-Accord-435048$ACCORD$$88$YR$E$F$Y$78$KG$20240819$$PH$FR$FR
241042222$24104222$2$F$20240709$20240909$20240717$20240910$EXP$$NVSC2024FR146387$NOVARTIS$$35$YR$$F$Y$$$20240910$$MD$FR$FR
241042232$24104223$2$F$$20240724$20240717$20240806$EXP$$CN-BEIGENE-BGN-2024-004513$BEIGENE$$$$$$Y$$$20240806$$MD$CN$CN
241042241$24104224$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405060340208450-NZPQH$GB-Accord-434836$ACCORD$$$$$F$Y$$$20240717$$CN$GB$GB
241042251$24104225$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405081659194210-LKFVD$GB-Accord-434869$ACCORD$$$$$F$Y$$$20240717$$PH$GB$GB
241042261$24104226$1$I$20230201$20240706$20240717$20240717$EXP$SE-SEMPA-2024-004211$SE-Accord-435230$ACCORD$$47$YR$A$F$Y$75$KG$20240717$$MD$SE$SE
241042271$24104227$1$I$20240509$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405090820398950-MQBSY$GB-Accord-434641$ACCORD$$62$YR$A$M$Y$78$KG$20240717$$MD$GB$GB
241042281$24104228$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405121027032300-HPZVD$GB-Accord-434914$ACCORD$$$$$F$Y$$$20240717$$CN$GB$GB
241042291$24104229$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405081533546600-FJRHP$GB-Accord-434661$ACCORD$$64$YR$A$F$Y$85$KG$20240717$$PH$GB$GB
241042301$24104230$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405101722428740-NRBYG$GB-Accord-434634$ACCORD$$$$$M$Y$$$20240717$$PH$GB$GB
241042311$24104231$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405161323275360-MHCRZ$GB-Accord-434860$ACCORD$$$$$M$Y$99$KG$20240717$$CN$GB$GB
241042321$24104232$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405161648088610-SHLVP$GB-Accord-434820$ACCORD$$$$$M$Y$97$KG$20240717$$PH$GB$GB
241042331$24104233$1$I$20240517$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405171053306570-DYQVC$GB-Accord-434708$ACCORD$$78$YR$E$M$Y$$$20240717$$PH$GB$GB
241042341$24104234$1$I$20240702$20240709$20240717$20240717$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159204$JIANGSU HANSOH PHARMACEUTICAL$$69$YR$$M$Y$60$KG$20240717$$MD$CN$CN
241042351$24104235$1$I$20240617$20240617$20240717$20240717$PER$$US-Amphastar Pharmaceuticals, Inc.-2159200$AMPHASTAR$$65$YR$$M$Y$61.364$KG$20240717$$$US$US
241042362$24104236$2$F$20230101$20240808$20240717$20240816$EXP$$US-ABBVIE-5841750$ABBVIE$$$$$M$Y$75.296$KG$20240816$$CN$US$US
241042371$24104237$1$I$20240708$20240708$20240717$20240717$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2159207$JIANGSU HENGRUI MEDICINE$$74$YR$$M$Y$49$KG$20240717$$MD$CN$CN
241042381$24104238$1$I$$20240704$20240717$20240717$EXP$$US-Caplin Steriles Limited-2159206$CAPLIN POINT LABORATORIES$Bulsara K G, Patel H, Goldstein A, et al. (May 26, 2024) A Rare Case of Argatroban-Induced Anaphylaxis in a Patient With Intermediate-High Risk Pulmonary Embolism. Cureus 16(5): e61129. DOI 10.7759/cureus.61129$32$YR$$F$Y$$$20240717$$$US$US
241042391$24104239$1$I$$20240716$20240717$20240717$PER$$US-HALEON-2187493$Haleon PLC$$$$$F$Y$$$20240717$$CN$US$US
241042401$24104240$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05952$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241042415$24104241$5$F$20240713$20240923$20240717$20240930$30DAY$$US-PFIZER INC-202400214292$PFIZER$$12$YR$$M$Y$$$20240930$$HP$US$US
241042421$24104242$1$I$$20240711$20240717$20240717$PER$$US-BIOGEN-2020BI00903994$BIOGEN$$$$$M$Y$$$20240717$$CN$US$US
241042431$24104243$1$I$20240629$20240712$20240717$20240717$EXP$$US-AMGEN-USASP2024139260$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241042452$24104245$2$F$20240707$20240724$20240717$20240729$PER$$US-AMGEN-USASP2024140274$AMGEN$$56$YR$A$M$Y$$$20240729$$CN$US$US
241042462$24104246$2$F$$20240807$20240717$20240821$EXP$$JP-AMGEN-JPNSP2024141125$AMGEN$Morishita H, Asukai M, Hagiwara K, Nakamura H, Takeuchi Y, Abe M. Experience with Romosozumab for multiple vertebral fractures after Denosumab interruption. Journal of Chubu Japan Society of Orthopedic and Disaster Surgery. 2024;67:307-8$79$YR$E$F$Y$$$20240821$$MD$JP$JP
241042471$24104247$1$I$$20240708$20240717$20240717$EXP$$CA-APOTEX-2024AP008059$APOTEX$$72$YR$$M$Y$$$20240717$$HP$CA$CA
241042482$24104248$2$F$20230817$20240723$20240717$20240805$EXP$$JP-ROCHE-10000027899$ROCHE$$9$DEC$E$M$Y$56.4$KG$20240805$$MD$JP$JP
241042501$24104250$1$I$$20240703$20240717$20240717$EXP$$LK-Breckenridge Pharmaceutical, Inc.-2159198$BRECKENRIDGE$Literature Article$67$YR$$M$Y$$$20240717$$$IN$LK
241042511$24104251$1$I$$20240715$20240717$20240717$PER$$NVSC2024US146449$NOVARTIS$$$$$F$Y$$$20240717$$HP$US$US
241042522$24104252$2$F$$20240717$20240717$20240722$PER$$US-ROCHE-10000028713$ROCHE$$$$I$F$Y$$$20240719$$CN$US$US
241042532$24104253$2$F$20240315$20240730$20240717$20240806$EXP$FR-AFSSAPS-AN2024000806$FR-ROCHE-10000025199$ROCHE$$50$YR$A$F$Y$69$KG$20240806$$PH$FR$FR
241042541$24104254$1$I$20240601$20240716$20240717$20240717$PER$$US-ROCHE-10000028689$ROCHE$$16$YR$T$F$Y$$$20240717$$CN$US$US
241042551$24104255$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000028661$ROCHE$$$$A$M$Y$$$20240717$$CN$US$US
241042561$24104256$1$I$$20240703$20240717$20240717$EXP$$US-Appco Pharma LLC-2159212$APPCO PHARMA$Initial$4$YR$$F$Y$$$20240717$$MD$US$US
241042571$24104257$1$I$$20240703$20240717$20240717$EXP$$US-Appco Pharma LLC-2159210$APPCO PHARMA$Initial$56$YR$$F$Y$$$20240717$$$US$US
241042582$24104258$2$F$$20240730$20240717$20240809$EXP$$US-TEVA-VS-3214377$TEVA$Nwodim O, Karsalia R, Heslin ME, Lieberman AE, Wang SZ, Kalanuria AA, et al. Opioid-related xylazine toxicity manifesting as myonecrosis, rhabdomyolysis, multifocal ischemic cerebral infarcts, and cerebral edema. J-Am-Coll-Emerg-Physicians-Open 2024; 5.; Nwodim O, Karsalia R, Heslin ME, Lieberman AE, Wang SZ, Kalanuria AA, et al. Opioid-related xylazine toxicity manifesting as myonecrosis, rhabdomyolysis, multifocal ischemic cerebral infarcts, and cerebral edema. J-Am-Coll-Emerg-Physicians-Op...$27$YR$$F$Y$$$20240809$$MD$US$US
241042591$24104259$1$I$$20240703$20240717$20240717$EXP$$US-Appco Pharma LLC-2159213$APPCO PHARMA$Initial$61$YR$$M$Y$$$20240717$$PH$US$US
241042612$24104261$2$F$20150701$20240718$20240717$20240723$PER$$US-JNJFOC-20170419277$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240722$$LW$US$US
241042621$24104262$1$I$$20240711$20240717$20240717$EXP$$US-GSK-US2024AMR088636$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$US$US
241042631$24104263$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000028734$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241042641$24104264$1$I$$20240703$20240717$20240717$EXP$$FR-Appco Pharma LLC-2159217$APPCO PHARMA$Initial$26$YR$$M$Y$$$20240717$$$FR$FR
241042651$24104265$1$I$$20240703$20240717$20240717$EXP$$US-Appco Pharma LLC-2159209$APPCO PHARMA$Initial$43$YR$$M$Y$$$20240717$$$US$US
241042661$24104266$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49280$$FDA-CTU$$61$YR$$M$N$$$20240716$N$$US$
241042671$24104267$1$I$20240714$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49282$$FDA-CTU$$64$YR$$F$N$$$20240716$Y$PH$US$
241042681$24104268$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49254$$FDA-CTU$$$$$F$N$$$20240716$N$HP$US$
241042691$24104269$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49261$$FDA-CTU$$93$YR$$F$N$$$20240716$N$$US$
241042711$24104271$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49274$$FDA-CTU$$85$YR$$F$N$159$LBS$20240716$N$$US$
241042721$24104272$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49270$$FDA-CTU$$59$YR$$F$N$250$LBS$20240716$N$$US$
241042731$24104273$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49272$$FDA-CTU$$70$YR$$M$N$$$20240716$N$$US$
241042741$24104274$1$I$$20240703$20240717$20240717$EXP$$US-Appco Pharma LLC-2159211$APPCO PHARMA$Initial$66$YR$$M$Y$$$20240717$$$US$US
241042751$24104275$1$I$$20240705$20240717$20240717$EXP$$US-RDY-LIT/USA/24/0010503$DR REDDYS$Lien M, Sanders I, Chen KC, Galavis YS, illarroya-Marquina I, Makkoukdji N, et al. Nonsexual Genital Ulcers Secondary to Epstein-Barr Virus in a Pediatric Patient. J Pediatr Health Care. 2024;doi:10.1016/j.pedhc.2024.05.002.$14$YR$T$F$Y$$$20240717$$HP$US$US
241042761$24104276$1$I$$20240703$20240717$20240717$EXP$$FR-Appco Pharma LLC-2159219$APPCO PHARMA$Initial$43$YR$$M$Y$$$20240717$$$FR$FR
241042771$24104277$1$I$20240501$20240712$20240717$20240717$EXP$$GB-AMGEN-GBRSP2024138881$AMGEN$$$$$F$Y$$$20240717$$HP$GB$GB
241042781$24104278$1$I$$20240703$20240717$20240717$EXP$$CH-Appco Pharma LLC-2159208$APPCO PHARMA$Initial$68$YR$$M$Y$$$20240717$$$CH$CH
241042792$24104279$2$F$20240714$20240722$20240717$20240724$PER$$US-AMGEN-USASP2024140892$AMGEN$$68$YR$E$F$Y$71.655$KG$20240724$$MD$US$US
241042801$24104280$1$I$20240601$20240711$20240717$20240717$EXP$SE-SEMPA-2024-005381$SE-BAUSCH-BL-2024-010607$BAUSCH AND LOMB$$53$YR$$M$Y$$$20240717$$MD$SE$SE
241042811$24104281$1$I$20240410$20240708$20240717$20240717$PER$FR-AFSSAPS-AVPA2024000619$FR-PFM-2024-03964$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240717$$MD$FR$FR
241042821$24104282$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000027615$ROCHE$$$$$$Y$$$20240717$$MD$US$US
241042831$24104283$1$I$20240509$20240715$20240717$20240717$PER$$US-ROCHE-10000028693$ROCHE$$68$YR$E$M$Y$$$20240717$$MD$US$US
241042841$24104284$1$I$20240715$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024141410$AMGEN$$$$$M$Y$$$20240717$$CN$US$US
241042851$24104285$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010866$BAUSCH AND LOMB$$85$YR$$F$Y$$$20240717$$CN$CA$CA
241042861$24104286$1$I$$20240710$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065777$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$33$YR$$F$Y$$$20240717$$HP$FR$FR
241042871$24104287$1$I$$20240710$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065786$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$11$YR$$M$Y$$$20240717$$HP$FR$FR
241042881$24104288$1$I$$20240710$20240717$20240717$EXP$$IN-MYLANLABS-2024M1065925$MYLAN$Sushma D, Behera R, Jena J, Ali SM. Comparative effectiveness of tramadol and dexmedetomidine for the control of shivering in patients undergoing spinal anaesthesia. Int-J-Acad-Med-Pharm 2023; 5 (6): 1137-1141.$$$A$$Y$$$20240717$$MD$IN$IN
241042891$24104289$1$I$$20240708$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102604$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240717$$CN$US$US
241042901$24104290$1$I$$20240710$20240717$20240717$EXP$$US-MYLANLABS-2024M1066169$MYLAN$Meeder R, Peterson A, Reynard H, Andersen L. Dyadic Work in Conjunction With Electroconvulsive Therapy in a 12-Year-Old Female With Autism Spectrum Disorder and Catatonia. Ochsner-J 2024; 24 (2): 141-146.$12$YR$$F$Y$$$20240717$$HP$US$US
241042911$24104291$1$I$$20240709$20240717$20240717$EXP$$US-APOTEX-2024AP008244$APOTEX$Liss DB, Phillips TM, Pizon AF, Schwarz ES. Delayed seizures in bupropion overdose with concomitant ingestion of alpha-2 agonist: a case report. Toxicology Communications. 2017;1 (1):15-17$17$YR$$F$Y$$$20240717$$HP$US$US
241042921$24104292$1$I$$20240710$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010556$BAUSCH AND LOMB$$40$YR$$F$Y$$$20240717$$HP$CA$CA
241042932$24104293$2$F$$20240718$20240717$20240718$PER$$US-JNJFOC-20240743705$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$US$US
241042942$24104294$2$F$20240710$20240725$20240717$20240729$EXP$$US-JNJFOC-20240731816$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$CN$US$US
241042951$24104295$1$I$20240513$20240708$20240717$20240717$EXP$DE-DCGMA-24203551$DE-TORRENT-00026988$TORRENT$$75$YR$E$M$Y$65$KG$20240717$$MD$DE$DE
241042961$24104296$1$I$$20240707$20240717$20240717$EXP$GB-MHRA-MED-202407072242561420-ZLKTH$GB-TORRENT-00037162$TORRENT$$$$$$Y$$$20240717$$CN$GB$GB
241042972$24104297$2$F$20240601$20240722$20240717$20240725$EXP$DE-BFARM-24004754$DE-TORRENT-00026992$TORRENT$$35$YR$A$F$Y$47$KG$20240725$$MD$DE$DE
241042981$24104298$1$I$$20240703$20240717$20240717$EXP$$ES-AZURITY PHARMACEUTICALS, INC.-AZR202407-000032$AZURITY PHARMACEUTICALS$Ayen-Rodriguez A, Gil-Villalba A, Ruiz-Villaverde R, Navarro-Trivino FJ.. Methotrexate Toxicity in Dermatological Patients. Actas Dermo-Sifiliograficas. 2024;115:T741-3$86$YR$$M$Y$$$20240717$$HP$ES$ES
241042991$24104299$1$I$$20240710$20240717$20240717$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089853$VIIV$$$$$$Y$$$20240717$$HP$US$US
241043001$24104300$1$I$$20240710$20240717$20240717$EXP$$CN-ROCHE-10000022926$ROCHE$$70$YR$E$F$Y$$$20240717$$CN$CN$CN
241043011$24104301$1$I$$20240711$20240717$20240717$EXP$$RU-SANDOZ INC.-SDZ2024RU065299$SANDOZ$$$$$M$Y$83$KG$20240717$$MD$RU$RU
241043021$24104302$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06560$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241043031$24104303$1$I$20240704$20240704$20240717$20240717$EXP$GB-MHRA-MED-202407040842268510-NPTFG$GB-LUPIN PHARMACEUTICALS INC.-2024-06143$LUPIN$$$$$$Y$$$20240717$$CN$GB$GB
241043051$24104305$1$I$$20240709$20240717$20240717$EXP$GB-MHRA-MED-202407091327046950-KHLJW$GB-TORRENT-00037196$TORRENT$$10$YR$C$M$Y$$$20240717$$CN$GB$GB
241043061$24104306$1$I$$20240716$20240717$20240717$PER$$NVSC2024US146848$NOVARTIS$$$$$F$Y$$$20240717$$HP$US$US
241043071$24104307$1$I$20240713$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140646$AMGEN$$65$YR$E$M$Y$$$20240717$$CN$US$US
241043081$24104308$1$I$20240712$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140907$AMGEN$$68$YR$E$F$Y$$$20240717$$CN$US$US
241043091$24104309$1$I$$20240709$20240717$20240717$EXP$GB-MYLANLABS-2024M1063102$GB-TORRENT-00037206$TORRENT$$$$$M$Y$$$20240717$$MD$GB$GB
241043101$24104310$1$I$$20240702$20240717$20240717$EXP$$PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456734$RANBAXY$Akhter S, Jamil I, Shahab D, Rehman A, Kundi I, Khan J, et al. Life Threatening, Cytokine Release Storm (CRS) With Antithymocyte Globulin (ATG) And Its Management.. Transplantation. 2022;106 (Suppl) (9):S363$27$YR$$M$Y$$$20240717$$HP$PK$PK
241043111$24104311$1$I$$20240702$20240717$20240717$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456904$RANBAXY$Alimi H, Moud AI, Yadollahi A. Right pulmonary artery compression following acute type A aortic dissection resulting in acute right ventricular heart failure: A case report. J Cardiovas Thorac Res. 2024;16(1):60-63$82$YR$$M$Y$$$20240717$$HP$IR$IR
241043121$24104312$1$I$$20240702$20240717$20240717$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457400$RANBAXY$Ruzickova O. Complicated osteoporosis - a case report. Farmakoterapeuti cka revue. 2024;9(3):233-7$51$YR$$F$Y$$$20240717$$HP$CZ$CZ
241043131$24104313$1$I$20220607$20240703$20240717$20240717$EXP$FR-AFSSAPS-BR2024000519$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-06480$HIKMA$$$$$$Y$$$20240717$$PH$FR$FR
241043141$24104314$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113163$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240717$$PH$US$US
241043151$24104315$1$I$$20240708$20240717$20240717$EXP$$CA-APOTEX-2024AP008116$APOTEX$$47$YR$$F$Y$$$20240717$$HP$CA$CA
241043162$24104316$2$F$$20240725$20240717$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010737$JAZZ$$$$$F$Y$$$20240729$$CN$US$US
241043171$24104317$1$I$20240702$20240709$20240717$20240717$EXP$GB-MHRA-TPP32770833C2677317YC1720440010522$GB-TORRENT-00037201$TORRENT$$10$YR$C$M$Y$28$KG$20240717$$HP$GB$GB
241043183$24104318$3$F$20231210$20240722$20240717$20240726$EXP$DE-CADRBFARM-2024329105$DE-TORRENT-00026989$TORRENT$$76$YR$E$F$Y$54$KG$20240726$$MD$DE$DE
241043191$24104319$1$I$$20240705$20240717$20240717$EXP$$US-FreseniusKabi-FK202411019$FRESENIUS KABI$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatric Blood + Cancer. 2024;71: 1-5. doi:10.1002/pbc.31004.$13$YR$T$F$Y$$$20240717$$HP$US$US
241043201$24104320$1$I$20210401$20240709$20240717$20240717$PER$$US-EMD Serono-2024038804$EMD SERONO INC$$52$YR$A$F$Y$$$20240717$$MD$US$US
241043211$24104321$1$I$$20240708$20240717$20240717$EXP$$CA-FreseniusKabi-FK202410954$FRESENIUS KABI$$74$YR$E$F$Y$64$KG$20240717$$PH$CA$CA
241043221$24104322$1$I$20190106$20240703$20240717$20240717$EXP$GB-MHRA-MED-202407022222049650-KTBQJ$GB-LUPIN PHARMACEUTICALS INC.-2024-06009$LUPIN$$$$$$Y$$$20240717$$CN$GB$GB
241043231$24104323$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06537$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241043241$24104324$1$I$20240701$20240708$20240717$20240717$EXP$$IN-ROCHE-10000010635$ROCHE$$77$YR$E$M$Y$$$20240717$$CN$IN$IN
241043251$24104325$1$I$$20240712$20240717$20240717$EXP$$US-SA-2024SA208122$SANOFI AVENTIS$$$$E$M$Y$$$20240717$$MD$US$US
241043261$24104326$1$I$20240101$20240712$20240717$20240717$EXP$$US-SA-2024SA207563$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240717$$MD$US$US
241043271$24104327$1$I$20240101$20240712$20240717$20240717$EXP$$US-SA-2024SA208090$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240717$$MD$US$US
241043281$24104328$1$I$20240101$20240711$20240717$20240717$EXP$$CA-Orion Corporation ORION PHARMA-24_00030865$ORION$$11$YR$C$M$Y$$$20240717$$HP$CA$
241043292$24104329$2$F$20220930$20240809$20240717$20240816$EXP$$PT-SA-2024SA206203$SANOFI AVENTIS$Veloso M F, Genesio M, Canelas S.. port vein thrombosis and protein s deficiency: a case of non-compliance with the anticoagulant therapy.. Rev Port Med Geral Fam.. 2024;40 (supp.12):S67$24$YR$A$M$Y$$$20240816$$HP$PT$PT
241043301$24104330$1$I$20240601$20240712$20240717$20240717$EXP$$US-SA-2024SA206740$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240717$$MD$US$US
241043311$24104331$1$I$$20240712$20240717$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010710$JAZZ$$$$$F$Y$$$20240717$$CN$US$US
241043321$24104332$1$I$20240614$20240614$20240717$20240717$30DAY$$AT-SANDOZ INC.-SDZ2024AT065275$SANDOZ$$$$$M$Y$$$20240717$$CN$AT$AT
241043331$24104333$1$I$20240623$20240711$20240717$20240717$EXP$GB-MHRA-MED-202406270852281540-HWGRJ$GB-ASTELLAS-2024US019877$ASTELLAS$$78$YR$$M$Y$$$20240717$$CN$GB$GB
241043343$24104334$3$F$20150901$20240917$20240717$20240924$EXP$$CA-TAKEDA-2015TUS015195$TAKEDA$$67$YR$$M$Y$$$20240924$$CN$CA$CA
241043351$24104335$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009226$ELI LILLY AND CO$$29$YR$A$M$Y$$$20240717$$CN$US$US
241043361$24104336$1$I$$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010409$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240717$$CN$US$US
241043371$24104337$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009581$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240717$$HP$US$US
241043381$24104338$1$I$$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009443$ELI LILLY AND CO$$$$A$F$Y$$$20240717$$CN$US$US
241043391$24104339$1$I$$20230717$20240717$20240717$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-63689$HIKMA$$$$$$Y$$$20240716$$MD$US$US
241043401$24104340$1$I$20240626$20240705$20240717$20240717$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000272$NOVAST$$$$$$Y$$$20240717$$HP$CN$CN
241043431$24104343$1$I$$20240710$20240717$20240717$PER$$US-ALXN-202407USA000759US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
241043441$24104344$1$I$$20240703$20240717$20240717$EXP$$FR-Appco Pharma LLC-2159220$APPCO PHARMA$Initial$47$YR$$M$Y$$$20240717$$$FR$FR
241043451$24104345$1$I$$20240712$20240717$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009323$JAZZ$$$$$M$Y$$$20240717$$CN$US$US
241043461$24104346$1$I$$20240704$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06725$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241043471$24104347$1$I$$20240712$20240717$20240717$EXP$$TR-GILEAD-2024-0679973$GILEAD$$$$$F$Y$$$20240717$$MD$TR$TR
241043481$24104348$1$I$20230601$20240711$20240717$20240717$EXP$$DE-JNJFOC-20240737351$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240717$$MD$DE$DE
241043491$24104349$1$I$20240101$20240712$20240717$20240717$PER$$US-JNJFOC-20240734805$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240717$$CN$US$US
241043501$24104350$1$I$20240706$20240716$20240716$20240716$DIR$710408$$FDA-CTU$$21$YR$$M$N$$$20240716$N$CN$US$
241043513$24104351$3$F$$20240722$20240717$20240726$EXP$$CA-HALEON-2187041$Haleon PLC$$50$YR$$F$Y$68$KG$20240726$$HP$CA$CA
241043541$24104354$1$I$$20240715$20240716$20240716$DIR$FDA-CDER-CTU-2024-49284$$FDA-CTU$$$$$F$N$$$20240715$N$HP$US$
241043551$24104355$1$I$$20200107$20240717$20240717$EXP$$CA-AstraZeneca-2020SE03716$ASTRAZENECA$$67$YR$$M$Y$$$20240717$$MD$CA$
241043561$24104356$1$I$$20200413$20240717$20240717$EXP$$MX-AstraZeneca-2020SE51151$ASTRAZENECA$$$$$F$Y$84$KG$20240717$$CN$MX$
241043571$24104357$1$I$20191101$20200120$20240717$20240717$EXP$$MX-AstraZeneca-2020SE10441$ASTRAZENECA$$27$MON$$F$Y$12.5$KG$20240717$$CN$MX$
241043581$24104358$1$I$$20200629$20240717$20240717$EXP$$IE-AstraZeneca-2020SE81875$ASTRAZENECA$$$$$M$Y$$$20240717$$HP$IE$
241043591$24104359$1$I$$20200122$20240717$20240717$EXP$$US-AstraZeneca-2020SE12334$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241043601$24104360$1$I$$20190904$20240717$20240717$EXP$$US-AstraZeneca-2019SF28217$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241043611$24104361$1$I$$20201209$20240717$20240717$EXP$$US-AstraZeneca-2020SF66286$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241043622$24104362$2$F$20240601$20240725$20240717$20240816$PER$$US-AstraZeneca-2024A140424$ASTRAZENECA$$23904$DY$$M$Y$$$20240816$$CN$US$
241043631$24104363$1$I$$20240715$20240717$20240717$EXP$$CA-ABBVIE-5841094$ABBVIE$$13$YR$$F$Y$$$20240717$$CN$CA$CA
241043651$24104365$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49278$$FDA-CTU$$73$YR$$F$N$230$LBS$20240716$N$$US$
241043661$24104366$1$I$$20201222$20240717$20240717$EXP$$US-AstraZeneca-2020SF72770$ASTRAZENECA$$$$$M$Y$89.4$KG$20240717$$CN$US$
241043671$24104367$1$I$$20200615$20240717$20240717$EXP$$US-AstraZeneca-2020SE63296$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241043681$24104368$1$I$20240705$20240712$20240717$20240717$EXP$$US-BAYER-2024A101424$BAYER$$96$YR$E$F$Y$$$20240717$$CN$US$US
241043691$24104369$1$I$$20240703$20240717$20240717$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-06492$HIKMA$Lobato CT, Castelo Branco S, Camoes J, Molinos E.. Lobato CT, Castelo Branco S, Camoes J, Molinos E. Rhabdomyolysis secondary to a weight-loss prescription.. BMJ Case Reports.. 2024;e258208.:17 (6)$$$$$Y$$$20240717$$MD$PT$PT
241043701$24104370$1$I$$20200528$20240717$20240717$EXP$$US-AstraZeneca-2020SE71691$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241043711$24104371$1$I$$20240709$20240717$20240717$EXP$GB-MHRA-MED-202407091042262220-KWDTG$GB-TEVA-VS-3219968$TEVA$$31$YR$$F$Y$34$KG$20240717$$CN$GB$GB
241043722$24104372$2$F$$20240912$20240717$20240916$EXP$$NVSC2024IR146230$NOVARTIS$Hoorshad N, Tarafdari A, Zamani N, Hasani SS, Pasikhani MD.. Bilateral tubal ectopic pregnancy following induction ovulation can be  missed in emergent ultrasonography: Case report. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS. 2024;121:1-4$25$YR$$F$Y$$$20240916$$HP$IR$IR
241043731$24104373$1$I$20230101$20240710$20240717$20240717$EXP$$BR-MYLANLABS-2024M1065525$MYLAN$$$$$$Y$$$20240717$$CN$BR$BR
241043741$24104374$1$I$$20200605$20240717$20240717$EXP$$US-AstraZeneca-2020SE74088$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241043761$24104376$1$I$$20200616$20240717$20240717$EXP$$CA-AstraZeneca-2020SE78507$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CA$
241043771$24104377$1$I$$20200630$20240717$20240717$EXP$$US-AstraZeneca-2020SE83554$ASTRAZENECA$$$$$F$Y$$$20240717$$HP$US$
241043791$24104379$1$I$$20240708$20240717$20240717$EXP$$CA-FreseniusKabi-FK202410795$FRESENIUS KABI$$62$YR$A$M$Y$122$KG$20240717$$HP$CA$CA
241043801$24104380$1$I$$20200205$20240717$20240717$EXP$$US-AstraZeneca-2020SE19118$ASTRAZENECA$$$$$F$Y$$$20240717$$HP$US$
241043811$24104381$1$I$20240629$20240629$20240717$20240717$EXP$$VN-FreseniusKabi-FK202410330$FRESENIUS KABI$$$$$M$Y$$$20240717$$MD$VN$VN
241043821$24104382$1$I$20240201$20240708$20240717$20240717$EXP$FR-AFSSAPS-MA2024000810$FR-FreseniusKabi-FK202410853$FRESENIUS KABI$$10$YR$C$F$Y$$$20240717$$MD$FR$FR
241043831$24104383$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06511$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241043841$24104384$1$I$20190426$20240712$20240717$20240717$EXP$$CA-TAKEDA-2024TUS071917$TAKEDA$$59$YR$$M$Y$$$20240717$$MD$CA$CA
241043852$24104385$2$F$20181130$20240722$20240717$20240730$EXP$$CO-SANDOZ INC.-NVSC2021CO027320$SANDOZ$$71$YR$$F$Y$85$KG$20240730$$CN$CO$CO
241043861$24104386$1$I$20240624$20240709$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-034280$AUROBINDO$$66$YR$$M$Y$73$KG$20240717$$MD$GB$GB
241043871$24104387$1$I$$20240711$20240717$20240717$PER$$US-BAYER-2024A101128$BAYER$$$$$$Y$$$20240717$$HP$US$US
241043882$24104388$2$F$$20240719$20240717$20240729$30DAY$$US-GSK-US2024087020$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$MD$US$US
241043892$24104389$2$F$20240601$20240917$20240717$20240924$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-098395$REGENERON$$85$YR$$M$Y$$$20240924$$HP$CO$CO
241043901$24104390$1$I$20240601$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49251$$FDA-CTU$$53$YR$$F$N$$$20240716$N$$US$
241043911$24104391$1$I$$20240715$20240717$20240717$EXP$$NVSC2024GB146546$NOVARTIS$$20$YR$$F$Y$$$20240717$$CN$GB$GB
241043922$24104392$2$F$$20240828$20240717$20240830$EXP$$US-ASTELLAS-2024US019997$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
241043931$24104393$1$I$$20220315$20240717$20240717$EXP$$FR-ASTELLAS-2024EU007021$ASTELLAS$Michel C, Simon E. Angiotensin-converting enzyme inhibitor and fetal nephromegaly. Gynecologie, obstetrique, fertilite + senologie. 2022;No information:1-2$$$$M$Y$1.26$KG$20240717$$HP$FR$FR
241043963$24104396$3$F$20240707$20240808$20240717$20240816$EXP$$NVSC2024IL143402$NOVARTIS$$23$YR$$M$Y$71.2$KG$20240816$$MD$IL$IL
241043981$24104398$1$I$$20240709$20240717$20240717$EXP$$IL-SANDOZ INC.-SDZ2024IL064818$SANDOZ$$80$YR$$M$Y$$$20240717$$PH$IL$IL
241043991$24104399$1$I$20240527$20240712$20240717$20240717$EXP$$US-BAYER-2024A101693$BAYER$$68$YR$E$F$Y$62.585$KG$20240717$$CN$US$US
241044011$24104401$1$I$20240601$20240712$20240717$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008728$JAZZ$$53$YR$$M$Y$$$20240717$$CN$US$US
241044021$24104402$1$I$20231127$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49219$$FDA-CTU$$83$YR$$F$N$125$LBS$20240715$N$CN$US$
241044041$24104404$1$I$$20231129$20240717$20240717$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67903$HIKMA$$$$$F$Y$$$20240716$$CN$US$US
241044051$24104405$1$I$$20231108$20240717$20240717$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-62864$HIKMA$$3$YR$$F$Y$$$20240716$$CN$US$US
241044061$24104406$1$I$$20230907$20240717$20240717$PER$$US-HIKMA PHARMACEUTICALS-US-H14001-23-62861$HIKMA$$$$$F$Y$$$20240716$$CN$US$US
241044072$24104407$2$F$20240412$20240702$20240717$20240812$PER$$US-COSETTE-CP2024US000154$COSETTE PHARMACEUTICALS$$36$YR$A$F$Y$$$20240812$$HP$US$US
241044081$24104408$1$I$$20240329$20240717$20240717$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-02277$HIKMA$$$$$F$Y$$$20240716$$HP$US$US
241044092$24104409$2$F$20240717$20240730$20240717$20240802$EXP$$CA-UCBSA-2024036033$UCB$$46$YR$$F$Y$$$20240802$$MD$CA$CA
241044101$24104410$1$I$$20240711$20240717$20240717$PER$$US-BAYER-2024A101065$BAYER$$70$YR$E$F$Y$$$20240717$$CN$US$US
241044111$24104411$1$I$$20210112$20240717$20240717$EXP$$US-AstraZeneca-2021A007402$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241044121$24104412$1$I$$20190917$20240717$20240717$EXP$$CO-AstraZeneca-2019SF33882$ASTRAZENECA$$25320$DY$$F$Y$$$20240717$$CN$CO$
241044131$24104413$1$I$$20191129$20240717$20240717$EXP$$FR-AstraZeneca-2019SF74717$ASTRAZENECA$$$$$M$Y$$$20240717$$MD$FR$
241044141$24104414$1$I$$20191111$20240717$20240717$EXP$$US-AstraZeneca-2019SF61457$ASTRAZENECA$$$$$F$Y$38.6$KG$20240717$$CN$US$
241044152$24104415$2$F$$20240712$20240717$20240719$EXP$$JP-AstraZeneca-2024A159061$ASTRAZENECA$$$$$$Y$$$20240719$$MD$JP$
241044161$24104416$1$I$$20191105$20240717$20240717$EXP$$US-AstraZeneca-2019SF58946$ASTRAZENECA$$$$$$Y$$$20240717$$CN$US$
241044171$24104417$1$I$20230601$20230822$20240717$20240717$EXP$$US-AstraZeneca-2023A156821$ASTRAZENECA$$68$YR$$$Y$151.5$KG$20240717$$CN$US$
241044181$24104418$1$I$$20191031$20240717$20240717$EXP$$CA-AstraZeneca-2019SF56619$ASTRAZENECA$$42$YR$$F$Y$$$20240717$$MD$CA$
241044191$24104419$1$I$$20200731$20240717$20240717$EXP$$ZA-AstraZeneca-2020SE96893$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$ZA$
241044201$24104420$1$I$$20240712$20240717$20240717$PER$$US-PFIZER INC-PV202400092506$PFIZER$$6$YR$$M$Y$$$20240717$$CN$US$US
241044211$24104421$1$I$$20240712$20240717$20240717$PER$$US-PFIZER INC-202400214498$PFIZER$$65$YR$$M$Y$$$20240717$$CN$US$US
241044222$24104422$2$F$$20240717$20240717$20240719$PER$$US-PFIZER INC-202400215488$PFIZER$$58$YR$$F$Y$$$20240719$$MD$US$US
241044231$24104423$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-PV202400092767$PFIZER$$57$YR$$M$Y$$$20240717$$MD$US$US
241044243$24104424$3$F$20240101$20240802$20240717$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021159$UNITED THERAPEUTICS$$$$$F$Y$58.957$KG$20240810$$$US$US
241044252$24104425$2$F$20240101$20240715$20240717$20240722$PER$$US-PFIZER INC-202400213592$PFIZER$$$$C$M$Y$$$20240722$$HP$US$US
241044261$24104426$1$I$$20240712$20240717$20240717$PER$$US-PFIZER INC-PV202400092592$PFIZER$$62$YR$$F$Y$$$20240717$$HP$US$US
241044271$24104427$1$I$$20240713$20240717$20240717$PER$$US-PFIZER INC-PV202400092217$PFIZER$$47$YR$$$Y$$$20240717$$CN$US$US
241044281$24104428$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215047$PFIZER$$$$$F$Y$$$20240717$$MD$US$US
241044291$24104429$1$I$20240401$20240714$20240717$20240717$PER$$US-PFIZER INC-202400215297$PFIZER$$20$YR$$F$Y$$$20240717$$CN$US$US
241044301$24104430$1$I$$20230329$20240717$20240717$EXP$$US-AstraZeneca-2023A075352$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241044311$24104431$1$I$$20240712$20240717$20240717$PER$$US-PFIZER INC-PV202400093223$PFIZER$$59$YR$$F$Y$$$20240717$$HP$US$US
241044322$24104432$2$F$20240101$20240801$20240717$20240805$PER$$US-PFIZER INC-202400215394$PFIZER$$81$YR$$F$Y$74.39$KG$20240805$$CN$US$US
241044332$24104433$2$F$20240714$20240903$20240717$20240904$PER$$US-PFIZER INC-202400214437$PFIZER$$54$YR$$F$Y$$$20240904$$CN$US$US
241044341$24104434$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215150$PFIZER$$65$YR$$F$Y$$$20240717$$MD$US$US
241044352$24104435$2$F$$20240726$20240717$20240726$PER$$US-PFIZER INC-PV202400084124$PFIZER$$59$YR$$F$Y$$$20240726$$CN$US$US
241044361$24104436$1$I$$20240714$20240717$20240717$PER$$US-PFIZER INC-202400215117$PFIZER$$$$$F$Y$$$20240717$$CN$US$US
241044371$24104437$1$I$20240703$20240712$20240717$20240717$PER$$US-PFIZER INC-202400213993$PFIZER$$39$YR$$F$Y$$$20240717$$CN$US$US
241044382$24104438$2$F$$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215147$PFIZER$$$$$F$Y$$$20240717$$MD$US$US
241044391$24104439$1$I$20240713$20240714$20240717$20240717$PER$$US-PFIZER INC-202400214457$PFIZER$$44$YR$$F$Y$$$20240717$$CN$US$US
241044401$24104440$1$I$$20240714$20240717$20240717$PER$$US-PFIZER INC-PV202400092576$PFIZER$$$$$$Y$$$20240717$$CN$US$US
241044421$24104442$1$I$20191101$20191120$20240717$20240717$EXP$$US-AstraZeneca-2019SF66735$ASTRAZENECA$$1057$MON$$M$Y$$$20240717$$CN$US$
241044431$24104443$1$I$$20230724$20240717$20240717$EXP$$US-AstraZeneca-2023A169704$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241044441$24104444$1$I$20231228$20240709$20240717$20240717$EXP$GB-MHRA-MED-202406241300397730-GKZMW$GB-ROCHE-10000021835$ROCHE$$69$YR$E$F$Y$$$20240717$$MD$GB$GB
241044451$24104445$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160560$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241044461$24104446$1$I$20191101$20191120$20240717$20240717$EXP$$CO-AstraZeneca-2019SF69256$ASTRAZENECA$$25341$DY$$M$Y$$$20240717$$CN$CO$
241044471$24104447$1$I$20191121$20191128$20240717$20240717$EXP$$CO-AstraZeneca-2019SF73172$ASTRAZENECA$$22471$DY$$M$Y$$$20240717$$CN$CO$
241044482$24104448$2$F$20240712$20240823$20240717$20240828$EXP$$JP-BAYER-2024A103434$BAYER$$81$YR$E$F$Y$$$20240828$$PH$JP$JP
241044491$24104449$1$I$$20240703$20240717$20240717$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-20822$SAMSUNG BIOEPIS$$74$YR$E$F$Y$$$20240717$$CN$GB$GB
241044501$24104450$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113412$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240717$$CN$US$US
241044511$24104451$1$I$20240601$20240712$20240717$20240717$EXP$GB-MHRA-MED-202407021411177980-WQGZY$GB-ASTELLAS-2024US019890$ASTELLAS$$73$YR$$F$Y$$$20240717$$CN$GB$GB
241044531$24104453$1$I$20220601$20240706$20240716$20240716$DIR$FDA-CDER-CTU-2024-49245$$FDA-CTU$$37$YR$$M$N$216$LBS$20240706$N$$US$
241044541$24104454$1$I$$20240712$20240716$20240716$DIR$FDA-CDER-CTU-2024-49255$$FDA-CTU$$$$$M$N$$$20240712$N$HP$US$
241044551$24104455$1$I$20240320$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49231$$FDA-CTU$$45$YR$$F$N$128$LBS$20240716$N$CN$US$
241044571$24104457$1$I$$20240704$20240717$20240717$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06583$HIKMA$Bulsara KG, Patel H, Goldstein A, Mathew M. Bulsara KG, Patel H, Goldstein A, Mathew M. A Rare Case of Argatroban-Induced Anaphylaxis in a Patient With Intermediate-High Risk Pulmonary Embolism. Cureus. 2024;16(5):e61129$32$YR$$F$Y$$$20240717$$MD$US$US
241044582$24104458$2$F$$20240719$20240717$20240721$EXP$$AR-BAYER-2024A103525$BAYER$$$$$F$Y$$$20240719$$CN$AR$AR
241044591$24104459$1$I$20240610$20240710$20240717$20240717$EXP$FR-AFSSAPS-BR2024000538$FR-009507513-2407FRA004655$MERCK$$71$YR$$M$Y$$$20240717$$MD$FR$FR
241044601$24104460$1$I$$20240710$20240717$20240717$EXP$$CN-009507513-2407CHN007931$MERCK$Jin S, Shen Z, Li J, Liu X, Zhu Q, Li F, et al.. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. Journal of Clinical Pathology. 2024;77(7):471-7$$$$M$Y$$$20240717$$HP$CN$CN
241044611$24104461$1$I$20240101$20240710$20240717$20240717$EXP$$IQ-009507513-2407IRQ008837$MERCK$$58$YR$$M$Y$$$20240717$$MD$IQ$IQ
241044621$24104462$1$I$$20240715$20240717$20240717$EXP$$DE-SANDOZ INC.-SDZ2024DE065156$SANDOZ$$18$YR$$M$Y$$$20240717$$HP$DE$DE
241044631$24104463$1$I$$20240709$20240717$20240717$EXP$$US-AMGEN-USASP2024137577$AMGEN$$$$A$M$Y$$$20240717$$CN$US$US
241044641$24104464$1$I$20240629$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024141429$AMGEN$$70$YR$E$M$Y$$$20240717$$PH$US$US
241044662$24104466$2$F$20230101$20240815$20240717$20240823$EXP$$DE-ALKABELLO A/S-2024AA002740$ALK-ABELLO$$$$$$Y$$$20240823$$CN$DE$DE
241044671$24104467$1$I$$20240715$20240717$20240717$PER$$US-JNJFOC-20240739107$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
241044681$24104468$1$I$20070618$20240711$20240717$20240717$EXP$$DE-AMGEN-DEUSP2024137929$AMGEN$$58$YR$A$F$Y$60$KG$20240717$$MD$DE$DE
241044693$24104469$3$F$$20240902$20240717$20240904$EXP$$CA-TAKEDA-2024TUS072062$TAKEDA$$$$$F$Y$$$20240904$$CN$CA$CA
241044702$24104470$2$F$$20240710$20240717$20240722$EXP$$KR-SANDOZ INC.-SDZ2024KR065025$SANDOZ$$86$YR$$F$Y$$$20240722$$MD$KR$KR
241044711$24104471$1$I$$20240710$20240717$20240717$30DAY$$US-GSK-US2024073670$GLAXOSMITHKLINE$$$$$F$Y$$$20240717$$CN$US$US
241044731$24104473$1$I$20240101$20240620$20240717$20240717$PER$$US-009507513-2406USA007198$MERCK$$$$E$M$Y$$$20240717$$CN$US$US
241044742$24104474$2$F$$20240707$20240717$20240723$EXP$$JP-009507513-2407JPN001612J$MERCK$Yoneta M, Yamaga I, Yata Y, Kato H, Moriyoshi K. EP-0500 Study on A Case of Triple-Negative Breast Cancer Treated with Preoperative Chemotherapy Containing Pembrolizumab.. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 302$53$YR$$F$Y$$$20240723$$MD$JP$JP
241044751$24104475$1$I$$20240710$20240717$20240717$30DAY$$US-SANDOZ INC.-SDZ2024US064487$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
241044761$24104476$1$I$20240528$20240715$20240717$20240717$EXP$$US-BAYER-2024A103287$BAYER$$71$YR$E$F$Y$$$20240717$$HP$US$US
241044771$24104477$1$I$$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49259$$FDA-CTU$$$$$F$N$133$LBS$20240716$Y$HP$US$
241044781$24104478$1$I$20240711$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49238$$FDA-CTU$$$$$F$N$$$20240716$N$$US$
241044791$24104479$1$I$$20230626$20240717$20240717$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-62954$HIKMA$$4$YR$$M$Y$$$20240716$$PH$US$US
241044801$24104480$1$I$$20230628$20240717$20240717$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-63061$HIKMA$$$$$$Y$$$20240716$$PH$US$US
241044811$24104481$1$I$$20240308$20240717$20240717$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00901$HIKMA$$$$$$Y$$$20240716$$HP$US$US
241044821$24104482$1$I$$20240710$20240717$20240717$EXP$$US-BAUSCH-BL-2024-010887$BAUSCH AND LOMB$Mushtaq M, Colletier K, Moghe A. Hepatitis B Reactivation and Liver Failure Because of COVID-19 Infection. ACG Case Rep J. 2024 JUN 27;11(7):E01397:. doi:10.14309/crj.0000000000001397$72$YR$$F$Y$$$20240717$$HP$US$US
241044831$24104483$1$I$$20240712$20240717$20240717$PER$$US-BAUSCH-BL-2024-010780$BAUSCH AND LOMB$$$$$M$Y$$$20240717$$CN$US$US
241044841$24104484$1$I$20240612$20240708$20240717$20240717$EXP$HR-HALMED-300085924$HR-BAUSCH-BL-2024-010882$BAUSCH AND LOMB$$52$YR$$F$Y$63$KG$20240717$$CN$HR$HR
241044851$24104485$1$I$$20240710$20240717$20240717$PER$$US-BAUSCH-BL-2024-010560$BAUSCH AND LOMB$$$$$F$Y$$$20240717$$CN$US$US
241044861$24104486$1$I$$20240516$20240717$20240717$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-04401$HIKMA$$$$$M$Y$$$20240716$$CN$US$US
241044871$24104487$1$I$$20240711$20240717$20240717$30DAY$$FR-SANDOZ INC.-SDZ2024FR065274$SANDOZ$$12$YR$$M$Y$$$20240717$$CN$FR$FR
241044901$24104490$1$I$20180323$20240715$20240717$20240717$EXP$$DE-SANDOZ INC.-SDZ2024DE065137$SANDOZ$$79$YR$$M$Y$$$20240717$$HP$DE$DE
241044912$24104491$2$F$$20240710$20240717$20240724$EXP$$US-SANDOZ INC.-SDZ2023US013618$SANDOZ$$$$$M$Y$$$20240724$$MD$US$US
241044921$24104492$1$I$20240301$20240715$20240717$20240717$PER$$US-ABBVIE-5842018$ABBVIE$$37$YR$$F$Y$$$20240717$$CN$US$US
241044931$24104493$1$I$20240606$20240716$20240717$20240717$EXP$IT-MINISAL02-992216$IT-ROCHE-10000028243$ROCHE$$36$YR$A$F$Y$$$20240717$$MD$IT$IT
241044941$24104494$1$I$$20240709$20240717$20240717$EXP$$IN-MYLANLABS-2024M1065728$MYLAN$Shakya E ,  Das G ,  Yadav A ,  Sukhupayo R ,  Sangroula R. Transforaminal Epidural Neuroplasty for Chronic Low Back Pain due to Spinal Canal Stenosis. Nepal-Med-J 2024; 7 (1): 64-67.$57$YR$$F$Y$$$20240717$$HP$IN$IN
241044951$24104495$1$I$$20240709$20240717$20240717$EXP$$IT-MYLANLABS-2024M1064756$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F.. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study.. Int. J. Mol. Sci.. 2024;25:1-13.$76$YR$$M$Y$$$20240717$$HP$IT$IT
241044961$24104496$1$I$$20240709$20240717$20240717$EXP$$IT-MYLANLABS-2024M1064957$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F.. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study. Int. J. Mol. Sci.$70$YR$$M$Y$$$20240717$$HP$IT$IT
241044971$24104497$1$I$20200101$20240709$20240717$20240717$EXP$$PL-MYLANLABS-2024M1065801$MYLAN$Krzystanek M, Martyniak E, Palasz A, Skalacka K, Chwalba A, Wierzbinski P. Amantadine in Treatment of Dysthymia-The Pilot Case Series Study. Pharmaceuticals 2023; 16 (6):.$34$YR$$M$Y$$$20240717$$HP$PL$PL
241044981$24104498$1$I$$20240709$20240717$20240717$EXP$$IT-MYLANLABS-2024M1064462$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study.. International Journal of Molecular Sciences. 2024;5573:1-13$85$YR$$M$Y$$$20240717$$HP$IT$IT
241044991$24104499$1$I$$20240709$20240717$20240717$EXP$$US-MYLANLABS-2024M1065748$MYLAN$Music S, Suvar T, Tan M, Amin S. Severe Bilateral Glossopharyngeal Neuralgia Managed With Nerve Blocks Following Plasmodium falciparum Malaria Infection Treated With Mefloquine. Pain-Med-Case-Rep 2024; 8 (3): 119-126.$38$YR$$F$Y$$$20240717$$HP$US$US
241045002$24104500$2$F$$20240718$20240717$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06129$LUPIN$$$$$$Y$$$20240808$$CN$US$US
241045012$24104501$2$F$$20240724$20240717$20240801$EXP$$PT-MYLANLABS-2024M1065888$MYLAN$Ferreira DG, Brito A, Costa J, Jorge R. Drug-induced liver injury with bromocriptine. Gazz-Med-Ital-Arch-Sci-Med 2024; 183 (4): 367-369.$40$YR$$F$Y$$$20240801$$HP$PT$PT
241045021$24104502$1$I$$20240705$20240717$20240717$EXP$$RU-ASTELLAS-2024EU006933$ASTELLAS$Prokopenko EI. How not to miss atypical hemolytic uremic syndrome in patients on kidney transplant waiting list. Nephrolog? and Dial?sis. 2024;26(2):204-15$33$YR$$M$Y$$$20240717$$MD$RU$RU
241045031$24104503$1$I$$20240709$20240717$20240717$EXP$$PL-MYLANLABS-2024M1065886$MYLAN$Rzepczyk S, Swiderski P, Sommerfeld-Klatta K, Tezyk A, Lukasik-Glebocka M, Zielinska-Psuja B, et al. Causes of Death during the Intravenous Infusion of Dimethylsulphoxide and Hydrogen Peroxide in the Course of Alternative Medicine Therapy. Toxics 2023; 11 (8): 1-8.$37$YR$$F$Y$$$20240717$$HP$PL$PL
241045041$24104504$1$I$20240126$20240711$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2023US022524$SANDOZ$$44$YR$$F$Y$53.061$KG$20240717$$CN$US$US
241045051$24104505$1$I$$20240709$20240717$20240717$EXP$$US-MYLANLABS-2024M1065780$MYLAN$Miller MJ, Lee P, Lee BG, Flegel WA, West-Mitchell K, Conry-Cantilena K, et al. Consideration for alpha-gal syndrome in two critically ill persons with group O blood who received group B plasma. Transfusion 2024; 64 (5): 949-951.$64$YR$$M$Y$$$20240717$$MD$US$US
241045063$24104506$3$F$$20240916$20240717$20240919$EXP$$GB-MYLANLABS-2024M1065292$MYLAN$$$$$M$Y$57.4$KG$20240919$$HP$GB$GB
241045071$24104507$1$I$20190101$20240709$20240717$20240717$EXP$$PL-MYLANLABS-2024M1065836$MYLAN$Krzystanek M, Martyniak E, Palasz A, Skalacka K, Chwalba A, Wierzbinski P. Amantadine in Treatment of Dysthymia-The Pilot Case Series Study. Pharmaceuticals 2023; 16 (6):.$38$YR$$F$Y$$$20240717$$HP$PL$PL
241045081$24104508$1$I$$20240709$20240717$20240717$EXP$$US-MYLANLABS-2024M1065740$MYLAN$Wilkinson AJ, Yang A, Chen GH. Stellate ganglion block to mitigate thalamic pain syndrome of an oncological origin. Pain-Pract 2024; 24 (1): 231-234.$44$YR$$F$Y$$$20240717$$MD$US$US
241045091$24104509$1$I$$20240709$20240717$20240717$EXP$$PS-MYLANLABS-2024M1066063$MYLAN$Abdoh Q, Rabi R, Musmar B, Abuhassan A, Barqawi A. Posterior Reversible Encephalopathy Syndrome After Infliximab Infusion for Fistulizing Crohn^s Disease. ACG-Case-Rep-J 2024; 11 (6): 1-5.$19$YR$$F$Y$$$20240717$$MD$PS$PS
241045101$24104510$1$I$$20240709$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065785$MYLAN$Castex MP, Stefanowicz J, Clement L, Weclawek-Tompol J, Hameury F, Fresneau B, et al. Choriocarcinoma in neonates and infants: A severe but curable disease. Pediatr-Blood-Cancer 2024; 71 (8): 1-5.$10$MON$$M$Y$$$20240717$$HP$FR$FR
241045111$24104511$1$I$$20240709$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065805$MYLAN$Castex MP, Stefanowicz J, Clement L, Weclawek-Tompol J, Hameury F, Fresneau B, et al. Choriocarcinoma in neonates and infants: A severe but curable disease. Pediatr-Blood-Cancer 2024; 71 (8): 1-5.$1$MON$$M$Y$$$20240717$$HP$FR$FR
241045121$24104512$1$I$$20240709$20240717$20240717$EXP$$JO-MYLANLABS-2024M1065853$MYLAN$Aljarrah Q, Ba-Shammakh SA, Allouh MZ, Afaneh MW. Blue Toe Syndrome in Behcet^s Disease: A Case Report. Am-J-Case-Rep 2024; 25 (0).$51$YR$$M$Y$$$20240717$$HP$JO$JO
241045131$24104513$1$I$$20240712$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065489$SANDOZ$$68$YR$$F$Y$$$20240717$$CN$CA$CA
241045141$24104514$1$I$20231101$20240712$20240717$20240717$EXP$$CA-Orion Corporation ORION PHARMA-24_00030801$ORION$$73$YR$E$F$Y$$$20240717$$MD$CA$
241045151$24104515$1$I$20240712$20240712$20240717$20240717$EXP$$US-BAYER-2024A101614$BAYER$$61$YR$A$M$Y$88.435$KG$20240717$$CN$US$US
241045161$24104516$1$I$20240528$20240715$20240717$20240717$EXP$SE-SEMPA-2024-005088$SE-SANDOZ INC.-SDZ2024SE065053$SANDOZ$$64$YR$$M$Y$$$20240717$$MD$SE$SE
241045171$24104517$1$I$$20240711$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065560$SANDOZ$$$$$M$Y$$$20240717$$MD$US$US
241045181$24104518$1$I$20240601$20240709$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065368$SANDOZ$$76$YR$$F$Y$$$20240717$$CN$US$US
241045191$24104519$1$I$20240701$20240712$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065468$SANDOZ$$72$YR$$F$Y$$$20240717$$CN$US$US
241045202$24104520$2$F$$20240723$20240717$20240725$EXP$$US-SANDOZ INC.-SDZ2024US065477$SANDOZ$$$$$F$Y$$$20240725$$CN$US$US
241045211$24104521$1$I$20240712$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140946$AMGEN$$40$YR$A$M$Y$$$20240717$$CN$US$US
241045221$24104522$1$I$20240712$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140855$AMGEN$$56$YR$A$F$Y$$$20240717$$CN$US$US
241045231$24104523$1$I$$20240626$20240717$20240717$EXP$$DE-ROCHE-10000024350$ROCHE$$68$YR$E$$Y$$$20240717$$MD$DE$DE
241045243$24104524$3$F$20240101$20240812$20240717$20240816$30DAY$$AU-JNJFOC-20240703731$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$PH$AU$AU
241045252$24104525$2$F$20160401$20240705$20240717$20240717$EXP$$US-ROCHE-10000020328$ROCHE$$45$YR$A$F$Y$58.97$KG$20240717$$CN$US$US
241045262$24104526$2$F$20240701$20240717$20240717$20240722$EXP$$JP-JNJFOC-20240713460$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240722$$PH$JP$JP
241045281$24104528$1$I$20240715$20240715$20240717$20240717$EXP$GB-MHRA-MED-202407152131306760-DBSVC$GB-SANDOZ INC.-SDZ2024GB065413$SANDOZ$$$$$F$Y$$$20240717$$CN$GB$GB
241045291$24104529$1$I$20240101$20240711$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065538$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
241045301$24104530$1$I$$20240711$20240717$20240717$30DAY$$US-SANDOZ INC.-SDZ2024US065314$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
241045311$24104531$1$I$$20240715$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065494$SANDOZ$$$$$M$Y$$$20240717$$CN$US$US
241045321$24104532$1$I$20240615$20240716$20240717$20240717$EXP$IT-MINISAL02-992212$IT-ROCHE-10000028357$ROCHE$$41$YR$A$M$Y$$$20240717$$MD$IT$IT
241045331$24104533$1$I$20240626$20240713$20240717$20240717$EXP$GB-MHRA-MED-202407131000570760-VFCNS$GB-ABBVIE-5841624$ABBVIE$$25$YR$$F$Y$$$20240717$$CN$GB$GB
241045341$24104534$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065523$SANDOZ$$58$YR$$F$Y$$$20240717$$HP$CA$CA
241045351$24104535$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065519$SANDOZ$$63$YR$$F$Y$$$20240717$$CN$CA$CA
241045361$24104536$1$I$$20240712$20240717$20240717$PER$$US-GILEAD-2024-0680707$GILEAD$$$$A$F$Y$$$20240717$$CN$US$US
241045371$24104537$1$I$$20240715$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112916$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240717$$CN$US$US
241045381$24104538$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113330$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240717$$HP$US$US
241045391$24104539$1$I$$20240708$20240717$20240717$EXP$$CA-APOTEX-2024AP008091$APOTEX$$71$YR$$M$Y$$$20240717$$HP$CA$CA
241045401$24104540$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065508$SANDOZ$$23$YR$$F$Y$$$20240717$$HP$CA$CA
241045411$24104541$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113416$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240717$$CN$US$US
241045431$24104543$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065462$SANDOZ$$8$YR$$M$Y$30$KG$20240717$$HP$CA$CA
241045441$24104544$1$I$20240101$20240710$20240717$20240717$EXP$FR-AFSSAPS-NT2024000825$FR-MYLANLABS-2024M1064672$MYLAN$$67$YR$$F$Y$54$KG$20240717$$MD$FR$FR
241045451$24104545$1$I$20240614$20240710$20240717$20240717$EXP$FR-AFSSAPS-LL2024001248$FR-MYLANLABS-2024M1064751$MYLAN$$93$YR$$M$Y$64.4$KG$20240717$$PH$FR$FR
241045462$24104546$2$F$$20240716$20240717$20240718$EXP$$AU-SANDOZ INC.-SDZ2024AU065333$SANDOZ$$$$$$Y$$$20240718$$HP$AU$AU
241045471$24104547$1$I$20231103$20240710$20240717$20240717$EXP$ES-AEMPS-1445862$ES-MYLANLABS-2024M1064976$MYLAN$$$$A$F$Y$$$20240717$$MD$ES$ES
241045481$24104548$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065393$SANDOZ$$26$YR$$M$Y$90$KG$20240717$$CN$CA$CA
241045491$24104549$1$I$20231201$20240710$20240717$20240717$EXP$FR-AFSSAPS-AN2024000753$FR-MYLANLABS-2024M1064789$MYLAN$$60$YR$$F$Y$81$KG$20240717$$MD$FR$FR
241045501$24104550$1$I$$20240710$20240717$20240717$EXP$SE-SEMPA-2024-005345$SE-MYLANLABS-2024M1064781$MYLAN$$55$YR$$F$Y$$$20240717$$CN$SE$SE
241045512$24104551$2$F$$20240912$20240717$20240920$EXP$$NVSC2024FR144258$NOVARTIS$Cognard J, Desjonqueres M, Laurent A, Jouret M, Plassart S, Tusseau M, Belot A. Efficacy of bispecific Anti-IL-1? and Anti-IL-18 antibodies (MAS825) in childhood Still^s disease with recurrent macrophagic activation syndrome: a case report. 2023$$$C$M$Y$$$20240920$$HP$FR$FR
241045521$24104552$1$I$$20240716$20240717$20240717$EXP$$NVSC2024CA146946$NOVARTIS$$68$YR$$M$Y$$$20240717$$MD$CA$CA
241045531$24104553$1$I$20240710$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140603$AMGEN$$66$YR$E$F$Y$$$20240717$$CN$US$US
241045541$24104554$1$I$$20240711$20240717$20240717$30DAY$$US-GSK-US2024086611$GLAXOSMITHKLINE$$$$$M$Y$$$20240717$$CN$US$US
241045551$24104555$1$I$$20240715$20240717$20240717$30DAY$$US-GSK-US2024088745$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240717$$CN$US$US
241045571$24104557$1$I$$20240711$20240717$20240717$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR087306$VIIV$$$$A$M$Y$$$20240717$$CN$US$US
241045581$24104558$1$I$$20240716$20240716$20240716$DIR$710354$$FDA-CTU$$$$$F$N$65.7$KG$20240716$N$HP$US$
241045591$24104559$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49377$$FDA-CTU$$$$$M$N$$$20240716$N$HP$US$
241045622$24104562$2$F$$20240730$20240717$20240809$EXP$$SG-TEVA-VS-3212980$TEVA$Yuen YS, Holder GE, Lingam G, Shen TYT. Diffuse retinal dysfunction following immune reconstitution uveitis in patients with prior cytomegalovirus retinitis: a novel observation. Doc-Ophthalmol 2023; 147 (2): 139-145.; Yuen YS, Holder GE, Lingam G, Shen TYT. Diffuse retinal dysfunction following immune reconstitution uveitis in patients with prior cytomegalovirus retinitis: a novel observation. Doc-Ophthalmol 2023; 147 (2): 139-145.$39$YR$$M$Y$$$20240809$$HP$SG$SG
241045632$24104563$2$F$20240701$20240902$20240717$20240909$EXP$$JP-009507513-2407JPN001816J$MERCK$$67$YR$$M$Y$$$20240909$$MD$JP$JP
241045641$24104564$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065557$SANDOZ$$62$YR$$F$Y$$$20240717$$MD$CA$CA
241045651$24104565$1$I$$20240715$20240717$20240717$EXP$$TN-EMD Serono-2024038532$EMD SERONO INC$$40$YR$A$F$Y$$$20240717$$CN$TN$TN
241045661$24104566$1$I$$20240716$20240716$20240716$DIR$710357$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241045671$24104567$1$I$20240101$20240617$20240717$20240717$PER$$US-009507513-2406USA006245$MERCK$$$$$F$Y$$$20240717$$CN$US$US
241045681$24104568$1$I$$20240709$20240717$20240717$EXP$$CL-SERVIER-S24008909$SERVIER$$$$$$Y$$$20240717$$PH$CL$CL
241045691$24104569$1$I$$20191029$20240717$20240717$EXP$$CA-AstraZeneca-2019SF54557$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$CA$
241045701$24104570$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157711$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241045711$24104571$1$I$$20190925$20240717$20240717$EXP$$US-AstraZeneca-2019SF37274$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241045721$24104572$1$I$$20240709$20240717$20240717$EXP$$CH-PFIZER INC-202400210134$PFIZER$Fischer, N.. Carboplatin-induced bilateral papilledema: a case report. Case Reports in Oncology. 2009;2:67-71$70$YR$$F$Y$$$20240717$$HP$CH$CH
241045731$24104573$1$I$$20240715$20240717$20240717$EXP$$US-PFIZER INC-202400216063$PFIZER$$86$YR$$$Y$$$20240717$$CN$US$US
241045741$24104574$1$I$20240708$20240715$20240717$20240717$EXP$$GB-PFIZER INC-202400215053$PFIZER$$63$YR$$M$Y$79$KG$20240717$$CN$GB$GB
241045751$24104575$1$I$$20240712$20240717$20240717$EXP$$CA-PFIZER INC-202201402672$PFIZER$$71$YR$$M$Y$$$20240717$$PH$CA$CA
241045761$24104576$1$I$$20240715$20240717$20240717$EXP$$PR-PFIZER INC-PV202400093003$PFIZER$$$$$$Y$$$20240717$$CN$PR$PR
241045782$24104578$2$F$$20240716$20240717$20240717$EXP$$US-PFIZER INC-PV202300178027$PFIZER$$69$YR$$F$Y$$$20240717$$CN$US$US
241045791$24104579$1$I$$20240713$20240717$20240717$EXP$$CN-PFIZER INC-202400214847$PFIZER$Zheng, X.. Rothia dentocariosa endocarditis with brain abscess and splenic abscess: case report and brief review. Frontiers in Cardiovascular Medicine. 2024;11:10.3389/fcvm.2024.1370736$40$YR$$M$Y$$$20240717$$HP$CN$CN
241045801$24104580$1$I$$20240716$20240717$20240717$EXP$$US-PFIZER INC-202400216465$PFIZER$$59$YR$$F$Y$$$20240717$$CN$US$US
241045812$24104581$2$F$$20240711$20240717$20240722$EXP$$IT-PFIZER INC-PV202400091187$PFIZER$Sanmartin, F.. A 67-Year-Old Man with Chronic Lymphocytic Leukemia (CLL) on Maintenance Therapy with Ibrutinib with Persistent SARS-CoV-2 Infection Unresponsive to Antiviral Treatments. The American Journal of Case Reports. 2024;25:10.12659/AJCR.941165$67$YR$$M$Y$$$20240722$$HP$IT$IT
241045821$24104582$1$I$20240517$20240712$20240717$20240717$EXP$$CN-PFIZER INC-PV202400091991$PFIZER$$17$YR$$M$Y$48$KG$20240717$$HP$CN$CN
241045831$24104583$1$I$$20240711$20240717$20240717$EXP$$US-PFIZER INC-202400213220$PFIZER$Martin, C.. Exogenous steroid replacement in a pediatric patient with adrenocortical carcinoma receiving mitotane. Pediatric Blood and Cancer. 2024;71(8):10.1002/pbc.31072$16$YR$$F$Y$$$20240717$$PH$US$US
241045843$24104584$3$F$20020101$20240908$20240717$20240909$EXP$$US-PFIZER INC-202400216493$PFIZER$$60$YR$$F$Y$64$KG$20240909$$CN$US$US
241045852$24104585$2$F$20230101$20240719$20240717$20240723$EXP$$IN-PFIZER INC-202400212226$PFIZER$Mathew, G.. A rare presentation of isolated candidal hepatic abscess in a maintenance hemodialysis patient. Hemodialysis international. International Symposium on Home Hemodialysis.. 2024;10.1111/hdi.13172$61$YR$$F$Y$42$KG$20240723$$MD$IN$IN
241045861$24104586$1$I$20240702$20240715$20240717$20240717$EXP$$CN-PFIZER INC-PV202400092720$PFIZER$$61$YR$$M$Y$46$KG$20240717$$HP$CN$CN
241045872$24104587$2$F$20240606$20240813$20240717$20240816$EXP$$CA-PFIZER INC-PV202400093222$PFIZER$$63$YR$$M$Y$$$20240816$$CN$CA$CA
241045881$24104588$1$I$20240713$20240715$20240717$20240717$EXP$$CA-PFIZER INC-202400216291$PFIZER$$90$YR$$M$Y$$$20240717$$PH$CA$CA
241045891$24104589$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-NVSC2023CA054005$SANDOZ$$69$YR$$F$Y$60$KG$20240717$$HP$CA$CA
241045901$24104590$1$I$$20240716$20240717$20240717$EXP$$IN-PFIZER INC-PV202400093671$PFIZER$$59$YR$$F$Y$$$20240717$$CN$IN$IN
241045911$24104591$1$I$20240705$20240712$20240717$20240717$EXP$IT-MINISAL02-994398$IT-PFIZER INC-202400214903$PFIZER$$55$YR$$F$Y$$$20240717$$MD$IT$IT
241045922$24104592$2$F$20220601$20240715$20240717$20240722$EXP$$CN-PFIZER INC-202400213218$PFIZER$Yan, W.. A case of treatment for pulmonary infection caused by multidrug-resistant Acinetobacter baumannii. Respirology case reports. 2024;12 (7):10.1002/rcr2.1420$68$YR$$M$Y$$$20240722$$MD$CN$CN
241045932$24104593$2$F$20220101$20240716$20240717$20240722$EXP$$IN-PFIZER INC-202400215378$PFIZER$Viswanathan, R.. Mucormycosis-Associated Colon Perforation in the Early Postrenal Transplant Period. Indian Journal of Transplantation. 2024;18(2):189-93$32$YR$$M$Y$$$20240722$$MD$IN$IN
241045941$24104594$1$I$20240712$20240715$20240717$20240717$EXP$GB-MHRA-MED-202407151659469150-MKBWS$GB-PFIZER INC-202400215087$PFIZER$$36$YR$$F$Y$$$20240717$$PH$GB$GB
241045951$24104595$1$I$$20240714$20240717$20240717$EXP$$US-PFIZER INC-202400215106$PFIZER$$$$$$Y$$$20240717$$CN$US$US
241045962$24104596$2$F$$20240823$20240717$20240830$EXP$$US-AstraZeneca-2024A157105$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
241045981$24104598$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160481$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241045991$24104599$1$I$20190801$20191202$20240717$20240717$EXP$$RU-AstraZeneca-2019SF74474$ASTRAZENECA$$59$YR$$M$Y$94$KG$20240717$$CN$RU$
241046001$24104600$1$I$$20240708$20240717$20240717$PER$$US-AstraZeneca-2024A156644$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241046011$24104601$1$I$$20190813$20240717$20240717$EXP$$US-AstraZeneca-2019SF17405$ASTRAZENECA$$60$YR$$M$Y$$$20240717$$CN$US$
241046021$24104602$1$I$$20240702$20240717$20240717$PER$$US-COSETTE-CP2024US000155$COSETTE PHARMACEUTICALS$$39$YR$A$F$Y$$$20240717$$HP$US$US
241046031$24104603$1$I$$20240715$20240717$20240717$PER$$US-AstraZeneca-2024A161670$ASTRAZENECA$$$$A$F$Y$$$20240717$$MD$US$
241046041$24104604$1$I$$20191022$20240717$20240717$EXP$$US-AstraZeneca-2019SF52200$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241046051$24104605$1$I$20200101$20200317$20240717$20240717$EXP$$US-AstraZeneca-2020SE41144$ASTRAZENECA$$55$YR$$F$Y$$$20240717$$CN$US$
241046061$24104606$1$I$$20191022$20240717$20240717$EXP$$US-AstraZeneca-2019SF48627$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241046071$24104607$1$I$$20240703$20240717$20240717$EXP$$FR-Appco Pharma LLC-2159222$APPCO PHARMA$Initial$33$YR$$M$Y$$$20240717$$$FR$FR
241046081$24104608$1$I$20191014$20191029$20240717$20240717$EXP$$US-AstraZeneca-2019SF55330$ASTRAZENECA$$25392$DY$$F$Y$$$20240717$$CN$US$
241046091$24104609$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113303$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240717$$HP$US$US
241046101$24104610$1$I$20240616$20240710$20240717$20240717$EXP$$US-CHIESI-2024CHF04178$CHIESI$$$$A$M$Y$$$20240717$$MD$US$US
241046111$24104611$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113149$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240717$$CN$US$US
241046121$24104612$1$I$20181201$20190930$20240717$20240717$EXP$$RU-AstraZeneca-2019SF40512$ASTRAZENECA$$53$YR$$M$Y$88$KG$20240717$$CN$RU$
241046136$24104613$6$F$20240101$20240910$20240717$20240922$EXP$$CA-UCBSA-2024036057$UCB$$$$$F$Y$$$20240922$$CN$CA$CA
241046141$24104614$1$I$$20190816$20240717$20240717$EXP$$US-AstraZeneca-2019SF19403$ASTRAZENECA$$64$YR$$F$Y$$$20240717$$CN$US$
241046151$24104615$1$I$$20191029$20240717$20240717$EXP$$US-AstraZeneca-2019SF54510$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241046161$24104616$1$I$$20240711$20240717$20240717$PER$$TR-ROCHE-10000009869$ROCHE$Unal S, Kuukonmaz B, Balamtekin N, Baysoy G, Elmas S, Orhan D, et al. Autoimmune hemolytic anemia and giant cell hepatitis: Report of three infants.. Turk J Haematol. 2010;27:308-13. doi:10.5152/tjh.2010.55.$2$MON$I$F$Y$$$20240717$$HP$TR$US
241046174$24104617$4$F$$20240906$20240717$20240917$PER$$US-LEADINGPHARMA-US-2024LEASPO00285$LEADING PHARMA$$69$YR$E$M$Y$$$20240917$$CN$US$US
241046181$24104618$1$I$$20240710$20240717$20240717$EXP$$IN-MYLANLABS-2024M1065941$MYLAN$Tambe S, Jangid K, Shinde G, Jadhav S, Mahobia S, Lala M, et al. Drug-induced systemic lupus erythematosus in a child living with HIV. India-J-Sex-Transm-Dis 2024; 45 (1): 59-61.$12$YR$$M$Y$$$20240717$$MD$IN$IN
241046191$24104619$1$I$$20240710$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065724$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$30$YR$$M$Y$$$20240717$$HP$FR$FR
241046201$24104620$1$I$$20240703$20240717$20240717$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06222$HIKMA$Golparvar A, Nafeh O, Alzamani M, Singh V, Jennings M.. Golparvar A, Nafeh O, Alzamani M, Singh V, Jennings M. The Development of Disinhibited Social Engagement Disorder: A Case Report on the Psychiatric Implications of Prenatal Fentanyl Use.. Cureus. 2024;16(5):e61078:1-4$$$C$F$Y$$$20240717$$MD$US$US
241046221$24104622$1$I$20200301$20240709$20240717$20240717$EXP$$IN-ASTELLAS-2024US019988$ASTELLAS$$32$YR$$M$Y$$$20240717$$HP$IN$IN
241046231$24104623$1$I$$20240716$20240716$20240716$DIR$710379$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241046241$24104624$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065475$SANDOZ$$18$YR$$F$Y$49$KG$20240717$$HP$CA$CA
241046251$24104625$1$I$$20240716$20240717$20240717$EXP$AU-TGA-0000812175$AU-SANDOZ INC.-SDZ2024AU065654$SANDOZ$$1$YR$$$Y$$$20240717$$HP$AU$AU
241046261$24104626$1$I$20220501$20240709$20240717$20240717$EXP$$FR-CELLTRION INC.-2024FR016937$CELLTRION$$$$$$Y$$$20240717$$MD$FR$FR
241046271$24104627$1$I$$20240709$20240717$20240717$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700299$MYOVANT SCIENCES$$$$$M$Y$$$20240717$$CN$US$US
241046281$24104628$1$I$$20240708$20240717$20240717$EXP$$CA-APOTEX-2024AP008120$APOTEX$$54$YR$$M$Y$$$20240717$$MD$CA$CA
241046291$24104629$1$I$20240627$20240709$20240717$20240717$EXP$ES-AEMPS-1542479$ES-TEVA-VS-3219396$TEVA$$52$YR$$F$Y$$$20240717$$MD$ES$ES
241046301$24104630$1$I$$20240711$20240717$20240717$EXP$$RU-SANDOZ INC.-SDZ2024RU065506$SANDOZ$$$$$F$Y$$$20240717$$CN$RU$RU
241046311$24104631$1$I$20060413$20240715$20240717$20240717$EXP$$AU-SANDOZ INC.-SDZ2024AU065356$SANDOZ$$68$YR$$F$Y$$$20240717$$MD$AU$AU
241046321$24104632$1$I$20240101$20240712$20240717$20240717$PER$$US-BAUSCH-BL-2024-010789$BAUSCH AND LOMB$$$$$M$Y$$$20240717$$CN$US$US
241046331$24104633$1$I$$20240710$20240717$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110313$BRISTOL MYERS SQUIBB$Literature Citation unavailable$75$YR$E$F$Y$$$20240717$$HP$CA$CA
241046342$24104634$2$F$20240706$20240716$20240717$20240718$EXP$$US-ROCHE-10000028782$ROCHE$$47$YR$A$F$Y$46.72$KG$20240718$$CN$US$US
241046351$24104635$1$I$$20240705$20240717$20240717$EXP$$US-ROCHE-10000007074$ROCHE$Tripathi N, Gebrael G, Chigarira B, Sahu K, Balasubramanian I, Caparas C, et al. Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis. Cancers. 2024-Jun;16 (11):1-15. doi:10.3390/cancers16112143.$$$$$Y$$$20240717$$MD$US$US
241046361$24104636$1$I$$20240711$20240717$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010607$JAZZ$$$$$F$Y$$$20240717$$CN$US$US
241046371$24104637$1$I$$20240708$20240717$20240717$EXP$$JP-RDY-SPO/JPN/24/0010341$DR REDDYS$$81$YR$E$F$Y$$$20240717$$PH$JP$JP
241046381$24104638$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06591$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241046392$24104639$2$F$$20240729$20240717$20240731$PER$$US-AMGEN-USASP2024140998$AMGEN$$70$YR$E$M$Y$$$20240731$$CN$US$US
241046401$24104640$1$I$$20240715$20240717$20240717$EXP$$CA-BAYER-2024A101745$BAYER$$46$YR$A$M$Y$$$20240717$$MD$CA$CA
241046412$24104641$2$F$20240101$20240813$20240717$20240814$EXP$$JP-JNJFOC-20240713842$JOHNSON AND JOHNSON$$74$YR$E$M$Y$55$KG$20240814$$MD$JP$JP
241046422$24104642$2$F$$20240809$20240717$20240814$30DAY$$FR-JNJFOC-20240701086$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240814$$PH$FR$FR
241046452$24104645$2$F$20070618$20240715$20240717$20240718$EXP$$DE-SANDOZ INC.-GXKR2007DE06957$SANDOZ$$58$YR$$F$Y$60$KG$20240718$$MD$DE$DE
241046461$24104646$1$I$20220801$20240712$20240717$20240717$EXP$GB-GE HEALTHCARE-2024CSU007334$GB-MYLANLABS-2024M1065889$MYLAN$$61$YR$$F$Y$61$KG$20240717$$PH$GB$GB
241046481$24104648$1$I$20240701$20240710$20240717$20240717$30DAY$$US-GSK-US2024085817$GLAXOSMITHKLINE$$73$YR$$M$Y$$$20240717$$CN$US$US
241046504$24104650$4$F$20240101$20240812$20240717$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-021765$UNITED THERAPEUTICS$$$$$F$Y$85.261$KG$20240821$$$US$US
241046513$24104651$3$F$20240601$20240820$20240717$20240821$PER$$US-ALXN-202407USA000749US$ALEXION PHARMACEUTICALS$$61$YR$$F$Y$$$20240821$$CN$US$US
241046521$24104652$1$I$20240101$20240710$20240717$20240717$EXP$$EG-009507513-2407EGY008542$MERCK$$54$YR$$M$Y$$$20240717$$CN$EG$EG
241046531$24104653$1$I$$20240710$20240717$20240717$EXP$$CA-BAUSCH-BL-2021-019571$BAUSCH AND LOMB$$56$YR$$F$Y$$$20240717$$HP$CA$CA
241046541$24104654$1$I$20231201$20240716$20240717$20240717$EXP$$DE-SANDOZ INC.-SDZ2024DE065481$SANDOZ$$63$YR$$F$Y$$$20240717$$MD$DE$DE
241046551$24104655$1$I$20240714$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009597$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240717$$CN$US$US
241046561$24104656$1$I$$20240703$20240717$20240717$EXP$$US-GRANULES-US-2024GRALIT00271$GRANULES INDIA$C. Simone.Levetiracetam-associated Rhabdomyolysis.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A5704$20$YR$A$M$Y$$$20240717$$HP$US$US
241046571$24104657$1$I$20240401$20240710$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407006957$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240717$$CN$US$US
241046581$24104658$1$I$20240703$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010283$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
241046591$24104659$1$I$$20240712$20240717$20240717$PER$$US-UNITED THERAPEUTICS-UNT-2024-021756$UNITED THERAPEUTICS$$$$$F$Y$58.05$KG$20240717$$$US$US
241046601$24104660$1$I$$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008165$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240717$$CN$US$US
241046612$24104661$2$F$20190101$20240715$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065522$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
241046621$24104662$1$I$20230101$20240715$20240717$20240717$EXP$AU-TGA-0000813061$AU-SANDOZ INC.-SDZ2024AU065398$SANDOZ$$$$$M$Y$$$20240717$$CN$AU$AU
241046631$24104663$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065609$SANDOZ$$23$YR$$F$Y$$$20240717$$HP$CA$CA
241046641$24104664$1$I$20240709$20240715$20240717$20240717$EXP$$CN-BAYER-2024A102012$BAYER$$61$YR$A$M$Y$67$KG$20240717$$HP$CN$CN
241046651$24104665$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113006$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240717$$CN$US$US
241046661$24104666$1$I$20211004$20240709$20240717$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-113343$BRISTOL MYERS SQUIBB$$7$DEC$E$$Y$$$20240717$$MD$CA$CA
241046672$24104667$2$F$20240612$20240823$20240717$20240829$30DAY$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096347$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$136.08$KG$20240829$$CN$US$US
241046681$24104668$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113059$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240717$$HP$US$US
241046691$24104669$1$I$20240612$20240715$20240717$20240717$PER$$US-BIOVITRUM-2024-US-009881$BIOVITRUM$$38$YR$$F$Y$$$20240717$$CN$US$US
241046704$24104670$4$F$20240619$20240731$20240717$20240810$EXP$SE-SEMPA-2024-005278$SE-TEVA-VS-3220321$TEVA$$85$YR$$F$Y$$$20240810$$MD$SE$SE
241046711$24104671$1$I$$20240716$20240717$20240717$PER$$NVSC2024US147067$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241046721$24104672$1$I$$20240713$20240717$20240717$EXP$GB-MHRA-MED-202407131026080490-MKHLY$GB-MYLANLABS-2024M1065833$MYLAN$$$$$F$Y$$$20240717$$CN$GB$GB
241046731$24104673$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065655$SANDOZ$$22$YR$$F$Y$$$20240717$$HP$CA$CA
241046741$24104674$1$I$$20240715$20240717$20240717$EXP$$IT-AMGEN-ITASP2024140355$AMGEN$$$$$F$Y$$$20240717$$CN$IT$IT
241046754$24104675$4$F$20240630$20240823$20240717$20240828$PER$$US-AMGEN-USASP2024141026$AMGEN$$$$$M$Y$$$20240827$$CN$US$US
241046762$24104676$2$F$20231007$20240901$20240717$20240909$EXP$$PK-AMGEN-PAKSP2024024330$AMGEN$$36$YR$A$F$Y$$$20240908$$CN$PK$PK
241046772$24104677$2$F$$20240812$20240717$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06548$LUPIN$$$$$$Y$$$20240829$$CN$US$US
241046781$24104678$1$I$20240301$20240710$20240717$20240717$EXP$FI-FIMEA-202402042$FI-TAKEDA-2024TUS071659$TAKEDA$$69$YR$$M$Y$$$20240717$$HP$FI$FI
241046791$24104679$1$I$$20240715$20240717$20240717$30DAY$$US-GSK-US2024088666$GLAXOSMITHKLINE$$$$$M$Y$$$20240717$$CN$US$US
241046801$24104680$1$I$20240709$20240710$20240717$20240717$30DAY$$US-GSK-US2024085712$GLAXOSMITHKLINE$$48$YR$$F$Y$$$20240717$$CN$US$US
241046821$24104682$1$I$20240629$20240716$20240716$20240716$DIR$710383$$FDA-CTU$$31$YR$$M$N$58.4$KG$20240716$N$$US$
241046841$24104684$1$I$$20191204$20240717$20240717$EXP$$US-AstraZeneca-2019SF76602$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241046851$24104685$1$I$$20240714$20240717$20240717$EXP$$SG-AstraZeneca-2024A160932$ASTRAZENECA$$$$E$M$Y$$$20240717$$MD$SG$
241046861$24104686$1$I$$20200113$20240717$20240717$EXP$$US-AstraZeneca-2019SF74521$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241046871$24104687$1$I$$20240711$20240717$20240717$EXP$$CA-MYLANLABS-2024M1066009$MYLAN$$$$$F$Y$$$20240717$$CN$CA$CA
241046881$24104688$1$I$20190928$20191003$20240717$20240717$EXP$$CO-AstraZeneca-2019SF42803$ASTRAZENECA$$14753$DY$$M$Y$$$20240717$$CN$CO$
241046891$24104689$1$I$$20230306$20240717$20240717$EXP$$US-AstraZeneca-2023A055539$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241046901$24104690$1$I$20220712$20240712$20240717$20240717$EXP$$CO-UCBSA-2024036010$UCB$$66$YR$$F$Y$$$20240717$$CN$CO$CO
241046911$24104691$1$I$20240529$20240710$20240717$20240717$EXP$$ES-AstraZeneca-2024A151606$ASTRAZENECA$$26$YR$$F$Y$52$KG$20240717$$MD$ES$
241046921$24104692$1$I$$20240715$20240717$20240717$EXP$$IT-BIOVITRUM-2024-IT-009919$BIOVITRUM$$$$$$Y$$$20240717$$MD$IT$IT
241046931$24104693$1$I$$20191204$20240717$20240717$EXP$$ID-AstraZeneca-2019SF76788$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$ID$
241046941$24104694$1$I$$20191213$20240717$20240717$EXP$$RU-AstraZeneca-2019SF82693$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$RU$
241046951$24104695$1$I$20191121$20191206$20240717$20240717$EXP$$CO-AstraZeneca-2019SF79387$ASTRAZENECA$$24077$DY$$M$Y$$$20240717$$CN$CO$
241046971$24104697$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06549$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241046982$24104698$2$F$$20240919$20240717$20240919$PER$$NVSC2024US146189$NOVARTIS$$$$$F$Y$$$20240919$$MD$US$US
241046991$24104699$1$I$$20240703$20240717$20240717$EXP$$US-GRANULES-US-2024GRALIT00262$GRANULES INDIA$E. K. Hourigan.The Right Side of Cardiogenic Shock: A Case of Beta-Blocker Induced Cardiogenic Shock in a Female With Suspected Pulmonary Hypertension.American Journal of Respiratory and Critical Care Medicine.2024;209:A1595$41$YR$A$F$Y$$$20240717$$HP$US$US
241047011$24104701$1$I$$20240711$20240717$20240717$EXP$$GB-MYLANLABS-2024M1065701$MYLAN$$$$$M$Y$$$20240717$$MD$GB$GB
241047021$24104702$1$I$$20240711$20240717$20240717$EXP$$FR-MYLANLABS-2024M1066134$MYLAN$$$$$F$Y$$$20240717$$CN$FR$FR
241047031$24104703$1$I$$20240704$20240717$20240717$EXP$IT-MINISAL02-992676$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-06366$HIKMA$$47$YR$$M$Y$95$KG$20240717$$CN$IT$IT
241047041$24104704$1$I$20160701$20240708$20240717$20240717$EXP$$DE-TEVA-VS-3218574$TEVA$$64$YR$$M$Y$$$20240717$$MD$DE$DE
241047052$24104705$2$F$20231018$20240729$20240717$20240801$EXP$$GB-MYLANLABS-2023M1112029$MYLAN$$53$YR$$M$Y$$$20240801$$MD$GB$GB
241047061$24104706$1$I$20240605$20240711$20240717$20240717$EXP$FR-AFSSAPS-MP2024001084$FR-MYLANLABS-2024M1065316$MYLAN$$53$YR$$F$Y$$$20240717$$PH$FR$FR
241047071$24104707$1$I$20240522$20240716$20240716$20240716$DIR$710434$$FDA-CTU$$75$YR$$F$N$59.1$KG$20240716$N$HP$US$
241047081$24104708$1$I$$20240716$20240716$20240716$DIR$710472$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
241047091$24104709$1$I$20240716$20240716$20240716$20240716$DIR$710461$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
241047101$24104710$1$I$$20240716$20240716$20240716$DIR$710435$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241047121$24104712$1$I$$20240716$20240716$20240716$DIR$710394$$FDA-CTU$$74$YR$$F$N$$$20240716$N$$US$
241047131$24104713$1$I$20240712$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49399$$FDA-CTU$$46$YR$$M$N$$$20240717$Y$HP$US$
241047141$24104714$1$I$$20240716$20240716$20240716$DIR$710439$$FDA-CTU$$86$YR$$F$N$$$20240716$N$$US$
241047171$24104717$1$I$$20240617$20240717$20240717$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00684$BIOCRYST PHARMACEUTICALS$$$$$F$Y$$$20240717$$MD$US$US
241047182$24104718$2$F$20231216$20240717$20240717$20240724$EXP$$BR-CELLTRION INC.-2024BR016986$CELLTRION$$$$$$Y$$$20240724$$CN$BR$BR
241047191$24104719$1$I$20240710$20240715$20240717$20240717$EXP$GB-MHRA-MED-202407151006314950-QKRPC$GB-DSJP-DSE-2024-135727$DAIICHI$$87$YR$$M$Y$71$KG$20240717$$MD$GB$GB
241047201$24104720$1$I$20240710$20240711$20240717$20240717$PER$$US-ALXN-202407USA000744US$ALEXION PHARMACEUTICALS$$51$YR$$F$Y$$$20240717$$CN$US$US
241047212$24104721$2$F$$20240715$20240717$20240807$EXP$$PT-GILEAD-2024-0680894$GILEAD$$69$YR$E$F$Y$$$20240807$$MD$PT$PT
241047221$24104722$1$I$$20240715$20240717$20240717$PER$$US-ABBVIE-5842589$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241047231$24104723$1$I$$20240708$20240717$20240717$EXP$$US-CLINIGEN-US-CLI-2024-010420$CLINIGEN$Masoud Akbari, Avram Alter, Keith A. Kuenzler. Spindle cell sarcoma of the chest wall: a pediatric case report. Journal of Surgical Case Reports. 2024;6$10$YR$$F$Y$$$20240717$$MD$US$US
241047242$24104724$2$F$$20240724$20240717$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113669$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240812$$CN$US$US
241047252$24104725$2$F$20240701$20240806$20240717$20240808$PER$$US-AMGEN-USASP2024140780$AMGEN$$67$YR$E$M$Y$$$20240808$$CN$US$US
241047271$24104727$1$I$20240613$20240709$20240717$20240717$EXP$FR-AFSSAPS-LL2024001223$FR-TEVA-VS-3219512$TEVA$$78$YR$$F$Y$$$20240717$$MD$FR$FR
241047283$24104728$3$F$20240601$20240723$20240717$20240726$PER$$US-AMGEN-USASP2024141245$AMGEN$$42$YR$A$F$Y$169.15$KG$20240726$$MD$US$US
241047291$24104729$1$I$20240707$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140677$AMGEN$$74$YR$E$F$Y$$$20240717$$CN$US$US
241047301$24104730$1$I$$20240709$20240717$20240717$EXP$$AU-MYLANLABS-2024M1065715$MYLAN$Ali SB, Lee W-I, Horvath N, Le T-TA, Smith W, Hissaria P. Lenalidomide Desensitization for Delayed Cutaneous Reaction: A Case Series and Review of the Literature. J-Allergy-Clin-Immunol-Pract 2023; 11 (5): 1503-1508.$64$YR$$M$Y$$$20240717$$MD$AU$AU
241047311$24104731$1$I$20240522$20240709$20240717$20240717$EXP$GB-MHRA-MED-202407081456497820-CSGBM$GB-SA-2024SA203473$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240717$$CN$GB$GB
241047321$24104732$1$I$20240519$20240704$20240717$20240717$EXP$$NZ-MYLANLABS-2024M1066580$MYLAN$$56$YR$$F$Y$$$20240717$$HP$NZ$NZ
241047331$24104733$1$I$20240524$20240708$20240717$20240717$EXP$$AU-MYLANLABS-2024M1064183$MYLAN$$17$YR$$F$Y$$$20240717$$HP$AU$AU
241047342$24104734$2$F$$20240723$20240717$20240731$EXP$$US-MYLANLABS-2024M1065887$MYLAN$Bishop MD, Korutaro V, Boyce CL, Beck IA, Styrchak SM, Knowles K, et al. Characterizing HIV drug resistance in cases of vertical transmission in the VesTed randomized antiretroviral treatment trial. J-Acquir-Immune-Defic-Syndr 2024; 96 (4): 385-392.$$$I$$Y$$$20240731$$HP$US$US
241047351$24104735$1$I$$20240715$20240717$20240717$EXP$$US-JNJFOC-20240737878$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$CN$US$US
241047362$24104736$2$F$20240627$20240827$20240717$20240918$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000428$BECTON DICKINSON$$$$$$Y$$$20240918$$CN$GB$GB
241047371$24104737$1$I$$20240715$20240717$20240717$PER$$NVSC2024US146599$NOVARTIS$$$$$M$Y$$$20240717$$CN$US$US
241047382$24104738$2$F$20240627$20240827$20240717$20240918$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000429$BECTON DICKINSON$$$$$$Y$$$20240918$$CN$GB$GB
241047392$24104739$2$F$20240627$20240911$20240717$20240927$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000430$BECTON DICKINSON$$$$$$Y$$$20240927$$CN$GB$GB
241047402$24104740$2$F$20240101$20240808$20240717$20240815$EXP$$US-009507513-2406USA002013$MERCK$$$$$F$Y$71.202$KG$20240815$$CN$US$US
241047412$24104741$2$F$20240627$20240911$20240717$20240930$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000431$BECTON DICKINSON$$$$$$Y$$$20240930$$CN$GB$GB
241047421$24104742$1$I$$20240711$20240717$20240717$EXP$$US-AMERICAN REGENT INC-2024002695$AMERICAN REGENT$$$$$F$Y$$$20240717$$MD$US$US
241047432$24104743$2$F$20240627$20240816$20240717$20240910$30DAY$$US-BECTON DICKINSON-US-BD-24-000437$BECTON DICKINSON$$$$$$Y$$$20240910$$CN$US$US
241047452$24104745$2$F$$20240730$20240717$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004217$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240802$$CN$US$US
241047462$24104746$2$F$20220301$20240709$20240717$20240720$EXP$$ES-CELLTRION INC.-2024ES016942$CELLTRION$$$$$$Y$$$20240720$$PH$ES$ES
241047476$24104747$6$F$20240101$20240904$20240717$20240913$EXP$$CA-CELLTRION INC.-2024CA013393$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
241047501$24104750$1$I$20240710$20240716$20240716$20240716$DIR$710405$$FDA-CTU$$20$YR$$F$N$67.5$KG$20240716$N$HP$US$
241047514$24104751$4$F$20211208$20240813$20240717$20240820$EXP$$NL-009507513-2407NLD005293$MERCK$$74$YR$$M$Y$89.3$KG$20240820$$HP$NL$NL
241047522$24104752$2$F$$20240710$20240717$20240718$EXP$$US-Stemline Therapeutics, Inc.-2024ST004198$STEMLINE THERAPEUTICS$$61$YR$E$F$Y$$$20240716$$CN$US$US
241047542$24104754$2$F$20240623$20240625$20240717$20240722$EXP$$FR-Stemline Therapeutics, Inc.-2024ST004155$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$61$KG$20240719$$MD$FR$FR
241047551$24104755$1$I$$20240716$20240716$20240716$DIR$710377$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241047581$24104758$1$I$$20240703$20240717$20240717$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR00959$TARO$$$$$$Y$$$20240717$$PH$CA$CA
241047591$24104759$1$I$$20240712$20240717$20240717$EXP$$US-PFIZER INC-202400215308$PFIZER$$75$YR$$M$Y$$$20240717$$HP$US$US
241047601$24104760$1$I$20240612$20240715$20240717$20240717$EXP$BG-BDA-27738$BG-PFIZER INC-202400214630$PFIZER$$30$YR$$F$Y$76$KG$20240717$$CN$BG$BG
241047621$24104762$1$I$20240117$20240715$20240717$20240717$EXP$GB-MHRA-MED-202407131737561700-SKCFJ$GB-PFIZER INC-202400214932$PFIZER$$66$YR$$F$Y$79$KG$20240717$$CN$GB$GB
241047631$24104763$1$I$$20240703$20240717$20240717$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR00965$TARO$$$$$$Y$$$20240717$$PH$CA$CA
241047642$24104764$2$F$$20240911$20240717$20240911$30DAY$$CO-PFIZER INC-202400208781$PFIZER$$11$YR$$M$Y$$$20240911$$CN$CO$CO
241047651$24104765$1$I$20240706$20240715$20240717$20240717$EXP$$CN-PFIZER INC-PV202400092700$PFIZER$$37$YR$$M$Y$63$KG$20240717$$HP$CN$CN
241047661$24104766$1$I$20240225$20240714$20240717$20240717$EXP$$IL-PFIZER INC-PV202400070963$PFIZER$$11$YR$$M$Y$35$KG$20240717$$MD$IL$IL
241047671$24104767$1$I$$20240716$20240717$20240717$EXP$$MA-PFIZER INC-PV202400093686$PFIZER$$$$$F$Y$$$20240717$$CN$MA$MA
241047681$24104768$1$I$$20240715$20240717$20240717$EXP$$US-PFIZER INC-202400215015$PFIZER$$$$$F$Y$$$20240717$$CN$US$US
241047692$24104769$2$F$$20240906$20240717$20240909$30DAY$$CL-PFIZER INC-202400207801$PFIZER$$9$YR$$F$Y$$$20240909$$CN$CL$CL
241047701$24104770$1$I$20240621$20240715$20240717$20240717$EXP$FR-AFSSAPS-LL2024001281$FR-PFIZER INC-202400214746$PFIZER$$69$YR$$M$Y$$$20240717$$MD$FR$FR
241047711$24104771$1$I$$20240712$20240717$20240717$EXP$SE-SEMPA-2024-005417$SE-PFIZER INC-202400213040$PFIZER$$58$YR$$M$Y$$$20240717$$MD$SE$SE
241047721$24104772$1$I$$20240715$20240717$20240717$EXP$GB-MHRA-MED-202407131304366660-SBFGQ$GB-PFIZER INC-202400215033$PFIZER$$$$$F$Y$$$20240717$$CN$GB$GB
241047731$24104773$1$I$$20240712$20240717$20240717$EXP$$US-AMGEN-USASP2024139391$AMGEN$$$$$F$Y$$$20240717$$MD$US$US
241047741$24104774$1$I$$20240712$20240717$20240717$EXP$$US-SA-2024SA195515$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240717$$MD$US$US
241047751$24104775$1$I$$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010387$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240717$$CN$US$US
241047761$24104776$1$I$$20240709$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407006587$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
241047772$24104777$2$F$20240701$20240717$20240717$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407009601$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240719$$CN$US$US
241047781$24104778$1$I$$20240716$20240717$20240717$EXP$$NVSC2024US147065$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241047791$24104779$1$I$$20240712$20240717$20240717$EXP$$NVSC2024US145344$NOVARTIS$$$$$M$Y$$$20240717$$CN$US$US
241047801$24104780$1$I$20240622$20240711$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111275$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240717$$HP$US$US
241047811$24104781$1$I$$20221230$20240717$20240717$EXP$$US-AstraZeneca-2022A420948$ASTRAZENECA$$$$$$Y$$$20240717$$CN$US$
241047821$24104782$1$I$$20191011$20240717$20240717$EXP$$US-AstraZeneca-2019SF45703$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241047831$24104783$1$I$$20191211$20240717$20240717$EXP$$US-AstraZeneca-2019SF80674$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241047841$24104784$1$I$20240101$20240711$20240717$20240717$EXP$$US-SA-2024SA206968$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240717$$MD$US$US
241047851$24104785$1$I$$20190703$20240717$20240717$EXP$$US-AstraZeneca-2019SE96879$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241047861$24104786$1$I$$20200304$20240717$20240717$EXP$$US-AstraZeneca-2020SE34590$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241047872$24104787$2$F$20240222$20240730$20240717$20240801$EXP$$CA-AMERICAN REGENT INC-2024002729$AMERICAN REGENT$$41$YR$$F$Y$$$20240801$$HP$CA$CA
241047881$24104788$1$I$$20190729$20240717$20240717$EXP$$US-AstraZeneca-2019SE96016$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241047891$24104789$1$I$$20230406$20240717$20240717$EXP$$US-AstraZeneca-2023A082510$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241047901$24104790$1$I$$20190725$20240717$20240717$EXP$$US-AstraZeneca-2019SF08424$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241047911$24104791$1$I$$20200228$20240717$20240717$EXP$$US-AstraZeneca-2020SE31078$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241047921$24104792$1$I$$20191101$20240717$20240717$EXP$$US-AstraZeneca-2019SF58642$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241047932$24104793$2$F$20240501$20240909$20240717$20240920$EXP$$CH-SA-2024SA207081$SANOFI AVENTIS$$20$YR$A$F$Y$60$KG$20240920$$CN$CH$CH
241047941$24104794$1$I$$20240703$20240717$20240717$EXP$$US-GRANULES-US-2024GRALIT00268$GRANULES INDIA$E. Lam.A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose.American Journal of Respiratory and Critical Care Medicine .2024;209:A5651$32$YR$A$F$Y$$$20240717$$HP$US$US
241047952$24104795$2$F$20231130$20240904$20240717$20240911$EXP$FR-AFSSAPS-TO2024001037$FR-SA-2024SA205640$SANOFI AVENTIS$$86$YR$E$M$Y$93.8$KG$20240911$$PH$FR$FR
241047961$24104796$1$I$$20240711$20240717$20240717$30DAY$$US-GSK-US2024086617$GLAXOSMITHKLINE$$$$$M$Y$$$20240717$$CN$US$US
241047971$24104797$1$I$$20240717$20240717$20240717$PER$$US-HALEON-2187504$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
241047981$24104798$1$I$$20240711$20240717$20240717$EXP$$CA-SA-2024SA205231$SANOFI AVENTIS$$50$YR$A$F$Y$68$KG$20240717$$HP$CA$CA
241047991$24104799$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024141391$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241048002$24104800$2$F$$20240812$20240717$20240816$EXP$$CA-APOTEX-2024AP008194$APOTEX$$26$YR$$M$Y$$$20240816$$HP$CA$CA
241048021$24104802$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49401$$FDA-CTU$$$$$M$N$$$20240716$N$HP$US$
241048051$24104805$1$I$20240716$20240716$20240716$20240716$DIR$710486$$FDA-CTU$$59$YR$$F$N$79.4$KG$20240716$N$PH$US$
241048081$24104808$1$I$20240228$20240716$20240716$20240716$DIR$710376$$FDA-CTU$$35$YR$$M$N$133.2$KG$20240716$N$PH$US$
241048131$24104813$1$I$20240711$20240716$20240716$20240716$DIR$710492$$FDA-CTU$$89$YR$$M$N$78.75$KG$20240716$N$CN$US$
241048141$24104814$1$I$20180901$20240709$20240717$20240717$EXP$$AU-TAKEDA-2024TUS070956$TAKEDA$$62$YR$$M$Y$$$20240717$$MD$AU$AU
241048151$24104815$1$I$20240705$20240715$20240717$20240717$EXP$IT-MINISAL02-994398$IT-SA-2024SA208300$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240717$$MD$IT$IT
241048171$24104817$1$I$$20240711$20240717$20240717$EXP$$CA-CHEPLA-2024008901$CHEPLAPHARM$$$$$M$Y$17$KG$20240717$$CN$COUNTRY NOT SPECIFIED$CA
241048184$24104818$4$F$$20240906$20240717$20240910$30DAY$$US-PFIZER INC-202400206598$PFIZER$$6$YR$$F$Y$$$20240910$$HP$US$US
241048191$24104819$1$I$20240307$20240712$20240717$20240717$EXP$FR-AFSSAPS-AVMA2024000280$FR-CHEPLA-2024008919$CHEPLAPHARM$$28$YR$$M$Y$$$20240717$$PH$COUNTRY NOT SPECIFIED$FR
241048203$24104820$3$F$$20240925$20240717$20240930$30DAY$$US-PFIZER INC-202400204501$PFIZER$$10$YR$$F$Y$$$20240930$$CN$US$US
241048213$24104821$3$F$$20240916$20240717$20240920$30DAY$$US-PFIZER INC-PV202400087946$PFIZER$$4$YR$$M$Y$$$20240920$$MD$US$US
241048224$24104822$4$F$$20240829$20240717$20240903$30DAY$$US-PFIZER INC-202400207771$PFIZER$$12$YR$$F$Y$$$20240903$$CN$US$US
241048233$24104823$3$F$$20240911$20240717$20240913$30DAY$$US-PFIZER INC-202400208257$PFIZER$$16$YR$$M$Y$$$20240913$$CN$US$US
241048253$24104825$3$F$$20240912$20240717$20240917$30DAY$$US-PFIZER INC-202400209709$PFIZER$$14$YR$$M$Y$$$20240917$$CN$US$US
241048271$24104827$1$I$$20240703$20240717$20240717$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06224$HIKMA$Javadi T, Morales B, Olson JJ, Kothari S, Zhang L, Abedalthagafi M.. Javadi T, Morales B, Olson JJ, Kothari S, Zhang L, Abedalthagafi M. Extracavitary primary effusion lymphoma presenting as a solitary brain mass.. CNS Oncol.. 2024;13(1):2357535.:1-5$62$YR$$M$Y$$$20240717$$MD$US$US
241048281$24104828$1$I$20240701$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113280$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240717$$HP$US$US
241048291$24104829$1$I$20240704$20240711$20240717$20240717$EXP$$CA-OTSUKA-2021_025830$OTSUKA$$82$YR$$M$Y$$$20240717$$MD$CA$CA
241048301$24104830$1$I$$20240705$20240717$20240717$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06398$HIKMA$Boris J, Al-Sudani H, Brophy A.. Boris J, Al-Sudani H, Brophy A. Flecainide overdose-induced wide-complex tachyarrhythmia treated with sodium bicarbonate infusion. BMJ case reports.. 2024;17(6):e256391$5$DEC$$M$Y$$$20240717$$MD$US$US
241048311$24104831$1$I$20240625$20240626$20240717$20240717$PER$$US-JNJFOC-20240675305$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$CN$US$US
241048334$24104833$4$F$20240101$20240912$20240717$20240920$EXP$$CA-CELLTRION INC.-2024CA016700$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
241048341$24104834$1$I$$20240711$20240717$20240717$PER$$US-ABBVIE-5838089$ABBVIE$$$$$$Y$$$20240717$$CN$US$US
241048351$24104835$1$I$20211109$20240715$20240717$20240717$EXP$SK-SUKLSK-20219840$SK-ROCHE-10000027391$ROCHE$$62$YR$A$F$Y$68$KG$20240717$$MD$SK$SK
241048361$24104836$1$I$20240601$20240710$20240717$20240717$EXP$DE-CADRBFARM-2024329102$DE-TEVA-VS-3219782$TEVA$$59$YR$$M$Y$76$KG$20240717$$CN$DE$DE
241048371$24104837$1$I$20231216$20240710$20240717$20240717$EXP$$NVSC2024US001345$NOVARTIS$$66$YR$$F$Y$66.7$KG$20240717$$MD$US$US
241048381$24104838$1$I$$20240531$20240717$20240717$30DAY$$US-UCBSA-2024029054$UCB$$$$$M$Y$$$20240717$$HP$US$US
241048392$24104839$2$F$$20240724$20240717$20240724$PER$$US-PFIZER INC-PV202400093332$PFIZER$$$$$$Y$$$20240724$$CN$US$US
241048402$24104840$2$F$$20240722$20240717$20240724$PER$$US-PFIZER INC-202400215064$PFIZER$$75$YR$$M$Y$$$20240724$$CN$US$US
241048412$24104841$2$F$$20240716$20240717$20240718$PER$$US-PFIZER INC-202400216229$PFIZER$$74$YR$$F$Y$$$20240718$$CN$US$US
241048421$24104842$1$I$20240715$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215927$PFIZER$$54$YR$$F$Y$$$20240717$$CN$US$US
241048431$24104843$1$I$20240701$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215793$PFIZER$$$$$M$Y$$$20240717$$HP$US$US
241048441$24104844$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-202400216296$PFIZER$$77$YR$$F$Y$$$20240717$$HP$US$US
241048451$24104845$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-PV202400092959$PFIZER$$73$YR$$F$Y$$$20240717$$HP$US$US
241048461$24104846$1$I$20240706$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215991$PFIZER$$$$A$F$Y$$$20240717$$CN$US$US
241048471$24104847$1$I$20240706$20240715$20240717$20240717$DIR$FDA-CDER-CTU-2024-49394$$FDA-CTU$$80$YR$$M$N$$$20240715$N$HP$US$
241048481$24104848$1$I$20240101$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215104$PFIZER$$$$$M$Y$$$20240717$$CN$US$US
241048491$24104849$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215049$PFIZER$$82$YR$$M$Y$72.57$KG$20240717$$CN$US$US
241048501$24104850$1$I$20240714$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215788$PFIZER$$53$YR$$F$Y$$$20240717$$CN$US$US
241048512$24104851$2$F$$20240718$20240717$20240726$PER$$US-PFIZER INC-PV202400093190$PFIZER$$67$YR$$F$Y$$$20240726$$CN$US$US
241048522$24104852$2$F$$20240801$20240717$20240805$PER$$US-PFIZER INC-202400216477$PFIZER$$68$YR$$M$Y$$$20240805$$CN$US$US
241048531$24104853$1$I$$20240710$20240717$20240717$DIR$FDA-CDER-CTU-2024-49386$$FDA-CTU$$$$$M$N$$$20240710$N$HP$US$
241048542$24104854$2$F$$20240715$20240717$20240718$PER$$US-PFIZER INC-202400215531$PFIZER$$69$YR$$M$Y$89.36$KG$20240718$$CN$US$US
241048551$24104855$1$I$20240715$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215518$PFIZER$$42$YR$$M$Y$$$20240717$$CN$US$US
241048561$24104856$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215418$PFIZER$$$$$F$Y$$$20240717$$CN$US$US
241048571$24104857$1$I$$20240716$20240717$20240717$PER$$US-PFIZER INC-202400216777$PFIZER$$76$YR$$F$Y$$$20240717$$CN$US$US
241048592$24104859$2$F$$20240816$20240717$20240816$30DAY$$US-PFIZER INC-202400106800$PFIZER$$2$YR$$M$Y$$$20240816$$CN$US$US
241048602$24104860$2$F$$20240805$20240717$20240807$PER$$US-PFIZER INC-PV202400092925$PFIZER$$61$YR$$F$Y$$$20240807$$HP$US$US
241048611$24104861$1$I$$20240716$20240717$20240717$PER$$US-PFIZER INC-PV202400093662$PFIZER$$49$YR$$F$Y$$$20240717$$CN$US$US
241048621$24104862$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215472$PFIZER$$77$YR$$F$Y$$$20240717$$CN$US$US
241048632$24104863$2$F$$20240729$20240717$20240802$PER$$US-PFIZER INC-PV202400092931$PFIZER$$53$YR$$F$Y$$$20240802$$HP$US$US
241048642$24104864$2$F$$20240731$20240717$20240802$PER$$US-PFIZER INC-202400108138$PFIZER$$45$YR$$F$Y$$$20240802$$CN$US$US
241048652$24104865$2$F$20240713$20240801$20240717$20240807$PER$$US-PFIZER INC-202400215411$PFIZER$$70$YR$$M$Y$131.52$KG$20240807$$CN$US$US
241048661$24104866$1$I$$20240716$20240717$20240717$PER$$US-PFIZER INC-202400216848$PFIZER$$33$YR$$M$Y$$$20240717$$CN$US$US
241048671$24104867$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-PV202400093026$PFIZER$$$$$$Y$$$20240717$$HP$US$US
241048681$24104868$1$I$20240713$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215739$PFIZER$$55$YR$$F$Y$$$20240717$$CN$US$US
241048691$24104869$1$I$20220701$20240715$20240717$20240717$PER$$US-PFIZER INC-PV202400092866$PFIZER$$55$YR$$M$Y$$$20240717$$CN$US$US
241048704$24104870$4$F$20240704$20240919$20240717$20240924$30DAY$$ES-PFIZER INC-202400209626$PFIZER$$9$YR$$M$Y$$$20240924$$CN$ES$ES
241048711$24104871$1$I$20240715$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215489$PFIZER$$71$YR$$M$Y$$$20240717$$CN$US$US
241048721$24104872$1$I$20240715$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215743$PFIZER$$81$YR$$F$Y$$$20240717$$CN$US$US
241048731$24104873$1$I$20240709$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215502$PFIZER$$77$YR$$F$Y$$$20240717$$CN$US$US
241048741$24104874$1$I$$20240716$20240717$20240717$PER$$US-PFIZER INC-202400216353$PFIZER$$$$$$Y$$$20240717$$CN$US$US
241048751$24104875$1$I$$20240716$20240717$20240717$PER$$US-PFIZER INC-202400216354$PFIZER$$49$YR$$F$Y$$$20240717$$CN$US$US
241048761$24104876$1$I$20240714$20240715$20240717$20240717$PER$$US-PFIZER INC-202400216017$PFIZER$$66$YR$$M$Y$$$20240717$$CN$US$US
241048771$24104877$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-PV202400093004$PFIZER$$$$$$Y$$$20240717$$HP$US$US
241048781$24104878$1$I$$20240716$20240717$20240717$PER$$US-PFIZER INC-PV202400093697$PFIZER$$63$YR$$M$Y$$$20240717$$CN$US$US
241048791$24104879$1$I$20240101$20240716$20240717$20240717$PER$$US-PFIZER INC-202400216537$PFIZER$$58$YR$$F$Y$$$20240717$$HP$US$US
241048802$24104880$2$F$$20240919$20240717$20240924$PER$$US-PFIZER INC-PV202400070779$PFIZER$$37$YR$$F$Y$$$20240924$$HP$US$US
241048814$24104881$4$F$20240709$20240805$20240717$20240808$EXP$$US-PFIZER INC-202400216436$PFIZER$$59$YR$$F$Y$$$20240808$$HP$US$US
241048821$24104882$1$I$20240701$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215650$PFIZER$$75$YR$$F$Y$$$20240717$$HP$US$US
241048831$24104883$1$I$20240101$20240715$20240717$20240717$PER$$US-PFIZER INC-202400216366$PFIZER$$59$YR$$F$Y$$$20240717$$HP$US$US
241048841$24104884$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-PV202400093042$PFIZER$$$$$$Y$$$20240717$$HP$US$US
241048851$24104885$1$I$$20240716$20240717$20240717$PER$$US-PFIZER INC-PV202400093438$PFIZER$$47$YR$$F$Y$$$20240717$$CN$US$US
241048861$24104886$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215603$PFIZER$$82$YR$$F$Y$$$20240717$$CN$US$US
241048871$24104887$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-PV202400092997$PFIZER$$$$$$Y$$$20240717$$HP$US$US
241048881$24104888$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215060$PFIZER$$88$YR$$F$Y$$$20240717$$CN$US$US
241048891$24104889$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-PV202400092813$PFIZER$$23$YR$$F$Y$$$20240717$$CN$US$US
241048901$24104890$1$I$$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215923$PFIZER$$36$YR$$F$Y$$$20240717$$CN$US$US
241048911$24104891$1$I$$20240716$20240717$20240717$PER$$US-PFIZER INC-PV202400093457$PFIZER$$53$YR$$F$Y$$$20240717$$HP$US$US
241048921$24104892$1$I$$20240715$20240717$20240717$30DAY$$US-SANDOZ INC.-SDZ2024US065601$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
241048932$24104893$2$F$$20240729$20240717$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112424$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$77.11$KG$20240801$$CN$US$US
241048942$24104894$2$F$$20240718$20240717$20240725$EXP$$GB-MYLANLABS-2024M1065851$MYLAN$$$$$M$Y$$$20240725$$PH$GB$GB
241048961$24104896$1$I$$20240712$20240717$20240717$EXP$$US-MYLANLABS-2024M1066163$MYLAN$Chen F, Boominathan P. Aortoesophageal Fistula Following a Cervical Epidural Steroid Injection: Case Report. Pain-Med-Case-Rep 2023; 7 (8): 345-347.$7$DEC$$M$Y$$$20240717$$MD$US$US
241048974$24104897$4$F$20240610$20240923$20240717$20240930$EXP$$US-TAKEDA-2024TUS071464$TAKEDA$$77$YR$$F$Y$66$KG$20240930$$HP$US$US
241048981$24104898$1$I$20170101$20240708$20240717$20240717$EXP$$AT-TAKEDA-2024TUS071727$TAKEDA$Mair L.. Talquetamab (talvey) in multiple myeloma significant remission in heavily pretreated patient. Spectrum Oncology Issue. 2024;100-101$55$YR$$M$Y$$$20240717$$MD$AT$AT
241048991$24104899$1$I$20240624$20240708$20240717$20240717$EXP$GB-MHRA-MED-202407071011142080-CVHZM$GB-TEVA-VS-3219341$TEVA$$$$$$Y$$$20240717$$CN$GB$GB
241049001$24104900$1$I$$20240709$20240717$20240717$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700304$MYOVANT SCIENCES$$91$YR$$M$Y$$$20240717$$MD$US$US
241049012$24104901$2$F$$20240807$20240717$20240812$30DAY$$FR-JNJFOC-20240666981$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$PH$FR$FR
241049021$24104902$1$I$20221101$20240712$20240717$20240717$EXP$$US-JNJFOC-20240734840$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
241049031$24104903$1$I$$20240618$20240717$20240717$30DAY$$US-UCBSA-2024032535$UCB$$$$$$Y$$$20240717$$CN$US$US
241049042$24104904$2$F$20240501$20240719$20240717$20240723$EXP$$US-JNJFOC-20240620134$JOHNSON AND JOHNSON$$66$YR$E$F$Y$82.7$KG$20240723$$HP$US$US
241049051$24104905$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024141214$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
241049061$24104906$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140758$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241049082$24104908$2$F$20240628$20240923$20240717$20240925$30DAY$$US-PFIZER INC-202400206377$PFIZER$$14$YR$$M$Y$$$20240925$$CN$US$US
241049091$24104909$1$I$20231201$20240708$20240717$20240717$EXP$FR-AFSSAPS-LY2024000922$FR-NORDICGR-056760$NORDIC PHARMA$$73$YR$$F$Y$76$KG$20240717$$PH$FR$FR
241049101$24104910$1$I$20240712$20240711$20240717$20240717$EXP$$CA-TAKEDA-2024TUS071729$TAKEDA$$61$YR$$M$Y$$$20240717$$CN$CA$CA
241049111$24104911$1$I$$20240618$20240717$20240717$30DAY$$US-VEROBIOTECH-2024USVEROSPO00144$VERO BIOTECH$$40$YR$A$F$Y$$$20240717$$HP$US$US
241049122$24104912$2$F$$20240807$20240717$20240812$EXP$$JP-PFIZER INC-202400210339$PFIZER$$12$YR$$M$Y$32$KG$20240812$$MD$JP$JP
241049131$24104913$1$I$20240319$20240709$20240717$20240717$EXP$FR-AFSSAPS-RE2024000642$FR-TEVA-VS-3219518$TEVA$$84$YR$$M$Y$92$KG$20240717$$MD$FR$FR
241049141$24104914$1$I$20240627$20240716$20240717$20240717$EXP$$NVSC2024US146840$NOVARTIS$$63$YR$$M$Y$$$20240717$$HP$US$US
241049151$24104915$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49402$$FDA-CTU$$58$YR$$F$N$93.89$KG$20240717$N$HP$US$
241049161$24104916$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024141423$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241049171$24104917$1$I$$20240711$20240717$20240717$EXP$$US-ROCHE-10000012968$ROCHE$Hussain S, Faisal H, Dy G. Prolonged disease control despite ALK inhibitor discontinuation in advanced ALK-positive nsclc. European Journal of Case Reports in Internal Medicine. 2024-Apr-24;11 (6): doi:10.12890/2024_004527.$80$YR$E$F$Y$$$20240717$$MD$US$US
241049182$24104918$2$F$20230101$20240717$20240717$20240723$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-098027$REGENERON$$91$YR$$F$Y$$$20240723$$CN$CH$CH
241049191$24104919$1$I$$20200131$20240717$20240717$EXP$$US-AstraZeneca-2020SE17418$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241049201$24104920$1$I$$20191009$20240717$20240717$EXP$$RU-AstraZeneca-2019SF45329$ASTRAZENECA$$57$YR$$F$Y$125$KG$20240717$$CN$RU$
241049211$24104921$1$I$20221201$20240711$20240717$20240717$EXP$$CO-JNJFOC-20240734322$JOHNSON AND JOHNSON$$63$YR$A$F$Y$66$KG$20240717$$HP$CO$CO
241049221$24104922$1$I$$20191011$20240717$20240717$EXP$$US-AstraZeneca-2019SF47178$ASTRAZENECA$$889$MON$$M$Y$$$20240717$$CN$US$
241049231$24104923$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A156974$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241049241$24104924$1$I$$20240620$20240717$20240717$30DAY$$US-VEROBIOTECH-2024USVEROSPO00142$VERO BIOTECH$$44$YR$A$F$Y$$$20240717$$HP$US$US
241049251$24104925$1$I$$20191106$20240717$20240717$EXP$$US-AstraZeneca-2019SF59151$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241049261$24104926$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160283$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241049276$24104927$6$F$20240701$20240830$20240717$20240909$EXP$$CA-TAKEDA-2024TUS069895$TAKEDA$$49$YR$$F$Y$$$20240909$$CN$CA$CA
241049281$24104928$1$I$20240619$20240712$20240717$20240717$EXP$FR-AFSSAPS-AVCN2024000517$FR-INDIVIOR UK LIMITED-INDV-145964-2024$RECKITT BENCKISER$$$$$$Y$$$20240717$$MD$FR$FR
241049295$24104929$5$F$20240704$20240924$20240717$20240926$30DAY$$FR-PFIZER INC-202400215166$PFIZER$$10$YR$$M$Y$23$KG$20240926$$PH$FR$FR
241049301$24104930$1$I$$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010790$ELI LILLY AND CO$$3$YR$C$F$Y$$$20240717$$CN$US$US
241049311$24104931$1$I$$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010317$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240717$$CN$US$US
241049321$24104932$1$I$$20240703$20240717$20240717$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06242$LUPIN$Hammond TC, Emeruwa I, Swain SR, Larson SM, Castells MC. Life-threatening mast cell activation and anaphylaxis in mast cell leukemia and the role of omalizumab. American Journal of Respiratory and Critical Care Medicine. 2024;209$31$YR$$M$Y$$$20240717$$HP$US$US
241049331$24104933$1$I$$20211028$20240717$20240717$EXP$$RO-ASTELLAS-2021US038306$ASTELLAS$$$$$F$Y$2.6$KG$20240717$$HP$RO$RO
241049341$24104934$1$I$$20240619$20240717$20240717$30DAY$$US-VEROBIOTECH-2024USVEROSPO00143$VERO BIOTECH$$$$$$Y$$$20240717$$HP$US$US
241049351$24104935$1$I$20240701$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113665$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240717$$CN$US$US
241049361$24104936$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112260$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240717$$CN$US$US
241049371$24104937$1$I$$20240708$20240717$20240717$EXP$$HN-BRISTOL-MYERS SQUIBB COMPANY-2024-108689$BRISTOL MYERS SQUIBB$$29$YR$A$F$Y$$$20240717$$MD$HN$HN
241049381$24104938$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113309$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240717$$HP$US$US
241049391$24104939$1$I$$20240716$20240717$20240717$EXP$$NVSC2024GB146480$NOVARTIS$$$$$F$Y$$$20240717$$CN$GB$GB
241049401$24104940$1$I$$20240717$20240717$20240717$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038605$BOEHRINGER INGELHEIM$$57$YR$A$M$Y$$$20240717$$PH$JP$JP
241049411$24104941$1$I$20230227$20240711$20240717$20240717$EXP$$CA-TAKEDA-2023TUS091516$TAKEDA$$5$YR$$F$Y$$$20240717$$HP$CA$CA
241049421$24104942$1$I$$20240703$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06743$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241049431$24104943$1$I$20240617$20240711$20240717$20240717$EXP$$GB-MYLANLABS-2024M1065320$MYLAN$$$$$M$Y$$$20240717$$CN$GB$GB
241049441$24104944$1$I$20240522$20240711$20240717$20240717$EXP$FR-AFSSAPS-GR2024000856$FR-MYLANLABS-2024M1065360$MYLAN$$88$YR$$F$Y$$$20240717$$PH$FR$FR
241049452$24104945$2$F$20240507$20240711$20240717$20240725$EXP$FR-AFSSAPS-TS2024000771$FR-MYLANLABS-2024M1065334$MYLAN$$49$YR$$F$Y$51$KG$20240725$$CN$FR$FR
241049461$24104946$1$I$20240510$20240711$20240717$20240717$EXP$FR-AFSSAPS-TO2024000937$FR-MYLANLABS-2024M1065333$MYLAN$$77$YR$$F$Y$68$KG$20240717$$PH$FR$FR
241049471$24104947$1$I$20220113$20240711$20240717$20240717$EXP$IT-MINISAL02-993869$IT-MYLANLABS-2024M1065219$MYLAN$$60$YR$$M$Y$$$20240717$$MD$IT$IT
241049481$24104948$1$I$$20240712$20240717$20240717$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700504$MYOVANT SCIENCES$$$$E$M$Y$$$20240717$$MD$US$US
241049491$24104949$1$I$20240101$20240711$20240717$20240717$EXP$$IT-INDIVIOR US-INDV-145966-2024$RECKITT BENCKISER$$$$$$Y$$$20240717$$MD$IT$IT
241049501$24104950$1$I$20221001$20240712$20240717$20240717$EXP$FR-AFSSAPS-AVCN2024000519$FR-INDIVIOR UK LIMITED-INDV-145965-2024$RECKITT BENCKISER$$$$$$Y$$$20240717$$MD$FR$FR
241049511$24104951$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140571$AMGEN$$$$$$Y$$$20240717$$HP$US$US
241049521$24104952$1$I$$20240702$20240717$20240717$PER$$US-ROCHE-10000018997$ROCHE$$46$YR$A$F$Y$$$20240717$$CN$US$US
241049532$24104953$2$F$$20240719$20240717$20240726$EXP$$JP-Eisai-EC-2024-169862$EISAI$$77$YR$E$M$Y$$$20240726$$HP$JP$JP
241049541$24104954$1$I$20240615$20240702$20240717$20240717$PER$$US-GRANULES-US-2024GRASPO00263$GRANULES INDIA$$83$YR$E$M$Y$81.64$KG$20240717$$PH$US$US
241049551$24104955$1$I$$20240715$20240717$20240717$EXP$$GB-SANDOZ INC.-SDZ2024GB065371$SANDOZ$$60$YR$$M$Y$93$KG$20240717$$MD$GB$GB
241049561$24104956$1$I$$20240708$20240717$20240717$PER$$US-ROCHE-10000021718$ROCHE$$$$$F$Y$$$20240717$$HP$US$US
241049571$24104957$1$I$$20240611$20240717$20240717$PER$$US-ROCHE-10000005667$ROCHE$$$$E$M$Y$63.8$KG$20240717$$HP$US$US
241049581$24104958$1$I$$20240708$20240717$20240717$EXP$$IN-BAYER-2024A100773$BAYER$Sandhu JK, Singh S, Basu S.. Case Series: Severe meibomian gland loss in polycystic ovarian syndrome patients on estrogen-progesterone therapy.. F1000Research. 2023;12:1154$27$YR$A$F$Y$$$20240717$$MD$IN$IN
241049591$24104959$1$I$20240517$20240711$20240717$20240717$EXP$HR-HALMED-300085743$HR-CHEPLA-2024008765$CHEPLAPHARM$$65$YR$$M$Y$$$20240717$$MD$COUNTRY NOT SPECIFIED$HR
241049601$24104960$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49395$$FDA-CTU$$$$$F$N$$$20240716$N$HP$US$
241049631$24104963$1$I$20240516$20240709$20240717$20240717$EXP$IT-MINISAL02-993230$IT-TEVA-VS-3219410$TEVA$$30$YR$$F$Y$61$KG$20240717$$MD$IT$IT
241049641$24104964$1$I$20240714$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140782$AMGEN$$30$YR$A$F$Y$$$20240717$$CN$US$US
241049651$24104965$1$I$20240714$20240716$20240717$20240717$PER$$US-JNJFOC-20240742492$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$MD$US$US
241049661$24104966$1$I$20240712$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49397$$FDA-CTU$$59$YR$$F$N$$$20240716$N$HP$US$
241049671$24104967$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49375$$FDA-CTU$$$$$M$N$$$20240716$N$HP$US$
241049681$24104968$1$I$$20240709$20240717$20240717$EXP$$BE-ROCHE-10000025560$ROCHE$$$$$M$Y$$$20240717$$MD$BE$BE
241049701$24104970$1$I$$20200213$20240717$20240717$EXP$$US-AstraZeneca-2020SE23762$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241049711$24104971$1$I$$20191217$20240717$20240717$EXP$$US-AstraZeneca-2019SF84479$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241049721$24104972$1$I$$20230323$20240717$20240717$EXP$$US-AstraZeneca-2023A069770$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241049731$24104973$1$I$$20200117$20240717$20240717$EXP$$US-AstraZeneca-2020SE10346$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241049741$24104974$1$I$$20190628$20240717$20240717$EXP$$US-AstraZeneca-2019SE95467$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241049751$24104975$1$I$$20240715$20240717$20240717$EXP$$CA-PFIZER INC-202400215081$PFIZER$$5$YR$$F$Y$$$20240717$$HP$CA$CA
241049761$24104976$1$I$20240629$20240712$20240717$20240717$EXP$$US-PFIZER INC-202400213596$PFIZER$$$$T$M$Y$$$20240717$$HP$US$US
241049771$24104977$1$I$$20240715$20240717$20240717$EXP$$CA-PFIZER INC-202400216217$PFIZER$$70$YR$$M$Y$$$20240717$$MD$CA$CA
241049782$24104978$2$F$20240701$20240726$20240717$20240731$EXP$$CA-PFIZER INC-202400215051$PFIZER$$50$YR$$F$Y$$$20240731$$HP$CA$CA
241049792$24104979$2$F$20240101$20240729$20240717$20240801$EXP$$HU-PFIZER INC-PV202400092402$PFIZER$$51$YR$$M$Y$65$KG$20240801$$CN$HU$HU
241049801$24104980$1$I$20240605$20240715$20240717$20240717$EXP$$CN-PFIZER INC-PV202400092715$PFIZER$$40$YR$$F$Y$50$KG$20240717$$HP$CN$CN
241049811$24104981$1$I$20240101$20240713$20240717$20240717$EXP$$IN-PFIZER INC-PV202400092118$PFIZER$$62$YR$$F$Y$$$20240717$$CN$IN$IN
241049822$24104982$2$F$20240322$20240730$20240717$20240805$EXP$$CA-PFIZER INC-202400216346$PFIZER$$66$YR$$F$Y$$$20240805$$HP$CA$CA
241049851$24104985$1$I$20240516$20240711$20240717$20240717$EXP$$FR-DSJP-DSE-2024-135747$DAIICHI$$$$E$F$Y$$$20240717$$MD$FR$FR
241049861$24104986$1$I$$20240715$20240717$20240717$EXP$$CA-PFIZER INC-202400216200$PFIZER$$48$YR$$F$Y$$$20240717$$HP$CA$CA
241049871$24104987$1$I$$20240715$20240717$20240717$EXP$$GB-ABBVIE-5841445$ABBVIE$$$$$M$Y$$$20240717$$CN$GB$GB
241049881$24104988$1$I$$20240712$20240717$20240717$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-113178$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240717$$MD$AU$AU
241049891$24104989$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112276$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240717$$HP$US$US
241049901$24104990$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113295$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240717$$HP$US$US
241049911$24104991$1$I$$20240715$20240717$20240717$EXP$$US-GILEAD-2024-0680833$GILEAD$$$$E$M$Y$$$20240717$$CN$US$US
241049921$24104992$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06464$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241049931$24104993$1$I$$20240714$20240717$20240717$EXP$GB-MHRA-MED-202407141650513870-WRJLM$GB-MYLANLABS-2024M1065745$MYLAN$$$$$M$Y$$$20240717$$CN$GB$GB
241049941$24104994$1$I$$20240711$20240717$20240717$EXP$$CA-MYLANLABS-2024M1065434$MYLAN$$65$YR$$F$Y$$$20240717$$MD$CA$CA
241049962$24104996$2$F$$20240712$20240717$20240722$PER$$US-BIOGEN-2024BI01273925$BIOGEN$$$$$M$Y$$$20240722$$CN$US$US
241049971$24104997$1$I$$20240715$20240717$20240717$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135758$DAIICHI$$$$$F$Y$$$20240717$$CN$US$US
241049982$24104998$2$F$$20240919$20240717$20240924$PER$$US-GSK-US2024087051$GLAXOSMITHKLINE$$$$$M$Y$$$20240924$$MD$US$US
241049993$24104999$3$F$20240715$20240806$20240717$20240809$EXP$$US-AMGEN-USASP2024140849$AMGEN$$84$YR$E$F$Y$$$20240809$$CN$US$US
241050001$24105000$1$I$20240101$20240715$20240717$20240717$PER$$US-JNJFOC-20240738423$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240717$$CN$US$US
241050011$24105001$1$I$$20240708$20240717$20240717$EXP$$US-MYLANLABS-2024M1065738$MYLAN$Young KZ, Guan LL, Friedman BJ, Rambhatla PV. Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil. Int-J-Womens-Dermatol 2022; 8 (3):.$47$YR$$F$Y$$$20240717$$MD$US$US
241050021$24105002$1$I$$20240704$20240717$20240717$EXP$GB-MHRA-MED-202407041136045490-HKLQD$GB-GLENMARK PHARMACEUTICALS-2024GMK092164$GLENMARK$$$$$$Y$$$20240717$$CN$GB$GB
241050031$24105003$1$I$20240301$20240710$20240717$20240717$EXP$$NVSC2024MX137552$NOVARTIS$$51$YR$$F$Y$103$KG$20240717$$CN$MX$MX
241050041$24105004$1$I$$20240702$20240717$20240717$EXP$$DK-LEADINGPHARMA-DK-2024LEALIT00301$LEADING PHARMA$Carina Lundby.Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects..Br J Clin Pharmacol.01-APR-2024;90:1741-1744$76$YR$E$F$Y$$$20240717$$HP$DK$DK
241050051$24105005$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024139511$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241050061$24105006$1$I$20240713$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140055$AMGEN$$37$YR$A$F$Y$$$20240717$$CN$US$US
241050071$24105007$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06468$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241050081$24105008$1$I$$20240710$20240717$20240717$EXP$$DE-ALXN-202407EEA000777DE$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$MD$DE$DE
241050092$24105009$2$F$$20240712$20240717$20240722$PER$$US-ROCHE-10000024435$ROCHE$$$$$$Y$$$20240719$$PH$US$US
241050105$24105010$5$F$20240710$20240806$20240717$20240808$EXP$$US-AVEO PHARMACEUTICALS, INC.-2024-AVEO-US000538$PAREXEL$$$$$$Y$$$20240808$$CN$US$US
241050111$24105011$1$I$$20240715$20240717$20240717$PER$$US-JNJFOC-20240738360$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$CN$US$US
241050121$24105012$1$I$$20240712$20240717$20240717$EXP$$US-PFIZER INC-PV202400092241$PFIZER$$63$YR$$M$Y$$$20240717$$CN$US$US
241050141$24105014$1$I$20240630$20240712$20240717$20240717$EXP$$CN-PFIZER INC-PV202400091986$PFIZER$$85$YR$$F$Y$59$KG$20240717$$HP$CN$CN
241050151$24105015$1$I$20240601$20240712$20240717$20240717$30DAY$$CO-PFIZER INC-PV202400092453$PFIZER$$$$$$Y$$$20240717$$CN$CO$CO
241050161$24105016$1$I$$20240708$20240717$20240717$PER$$US-BAYER-2024A098894$BAYER$$77$YR$E$F$Y$$$20240717$$CN$US$US
241050171$24105017$1$I$20240710$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008170$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240717$$CN$US$US
241050182$24105018$2$F$$20240715$20240717$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407009894$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240719$$CN$US$US
241050191$24105019$1$I$$20240709$20240717$20240717$EXP$$CA-PFIZER INC-202400213294$PFIZER$$85$YR$$F$Y$$$20240717$$HP$CA$CA
241050201$24105020$1$I$$20240709$20240717$20240717$EXP$$CA-PFIZER INC-202400214886$PFIZER$$63$YR$$F$Y$$$20240717$$HP$CA$CA
241050212$24105021$2$F$20240713$20240718$20240717$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407009158$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241050221$24105022$1$I$$20240709$20240717$20240717$EXP$$CA-PFIZER INC-202400213381$PFIZER$$38$YR$$M$Y$$$20240717$$HP$CA$CA
241050231$24105023$1$I$20240712$20240712$20240717$20240717$DIR$FDA-CDER-CTU-2024-49388$$FDA-CTU$$47$YR$$F$N$$$20240712$N$HP$US$
241050241$24105024$1$I$20240716$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49416$$FDA-CTU$$82$YR$$F$N$$$20240716$N$HP$US$
241050251$24105025$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49417$$FDA-CTU$$83$YR$$F$N$$$20240717$N$$US$
241050261$24105026$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112712$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240717$$HP$US$US
241050271$24105027$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112677$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240717$$CN$US$US
241050281$24105028$1$I$20240301$20240711$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112183$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240717$$CN$US$US
241050291$24105029$1$I$$20240711$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111412$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$90.72$KG$20240717$$CN$US$US
241050303$24105030$3$F$20240321$20240911$20240717$20240916$EXP$$CN-ROCHE-3564129$ROCHE$$61$YR$A$M$Y$$$20240916$$MD$CN$CN
241050311$24105031$1$I$$20230209$20240717$20240717$EXP$$US-AstraZeneca-2023A034785$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241050321$24105032$1$I$$20240710$20240717$20240717$EXP$$US-ABBVIE-2228906US$ABBVIE$$$$$M$Y$135$KG$20240717$$CN$US$US
241050331$24105033$1$I$20240101$20240710$20240717$20240717$EXP$$US-BIOGEN-2024BI01274062$BIOGEN$$$$$F$Y$$$20240717$$CN$US$US
241050341$24105034$1$I$$20191023$20240717$20240717$EXP$$ZA-AstraZeneca-2019SF52775$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$ZA$
241050352$24105035$2$F$$20240711$20240717$20240718$EXP$$US-AstraZeneca-2024A159245$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241050373$24105037$3$F$20240101$20240830$20240717$20240904$EXP$$IN-PFIZER INC-PV202400093124$PFIZER$$26$YR$$F$Y$$$20240904$$CN$IN$IN
241050382$24105038$2$F$20240710$20240822$20240717$20240827$EXP$$US-PFIZER INC-202400215316$PFIZER$$45$YR$$F$Y$54.43$KG$20240827$$CN$US$US
241050392$24105039$2$F$$20240815$20240717$20240820$EXP$$IN-PFIZER INC-PV202400043256$PFIZER$$74$YR$$F$Y$$$20240820$$CN$IN$IN
241050403$24105040$3$F$20240701$20240823$20240717$20240823$30DAY$$US-PFIZER INC-202400212684$PFIZER$$9$YR$$M$Y$$$20240823$$CN$US$US
241050411$24105041$1$I$20220908$20240708$20240717$20240717$EXP$$BR-PFIZER INC-PV202400091765$PFIZER$$58$YR$$F$Y$$$20240717$$CN$BR$BR
241050423$24105042$3$F$20240501$20240908$20240717$20240909$EXP$$CA-PFIZER INC-202400214710$PFIZER$$69$YR$$M$Y$$$20240909$$HP$CA$CA
241050432$24105043$2$F$$20240817$20240717$20240819$30DAY$$US-PFIZER INC-202400212014$PFIZER$$12$YR$$M$Y$$$20240819$$CN$US$US
241050441$24105044$1$I$20240312$20240710$20240717$20240717$EXP$$FR-AstraZeneca-2024A161412$ASTRAZENECA$$26$YR$$M$Y$$$20240717$$MD$FR$
241050451$24105045$1$I$$20240711$20240717$20240717$30DAY$$IL-PFIZER INC-PV202400091891$PFIZER$$$$C$F$Y$$$20240717$$CN$IL$IL
241050472$24105047$2$F$20221221$20240820$20240717$20240822$EXP$$CA-PFIZER INC-202201191490$PFIZER$$23$YR$$F$Y$125$KG$20240822$$MD$CA$CA
241050482$24105048$2$F$$20240817$20240717$20240819$30DAY$$US-PFIZER INC-202400212636$PFIZER$$25$YR$$F$Y$$$20240819$$CN$US$US
241050492$24105049$2$F$$20240913$20240717$20240917$EXP$$US-PFIZER INC-202400216212$PFIZER$$58$YR$$M$Y$$$20240917$$CN$US$US
241050501$24105050$1$I$20240602$20240715$20240717$20240717$EXP$FR-AFSSAPS-NT2024000668$FR-PFIZER INC-202400214668$PFIZER$$10$YR$$F$Y$45$KG$20240717$$CN$FR$FR
241050511$24105051$1$I$$20240715$20240717$20240717$EXP$NL-LRB-00981360$NL-PFIZER INC-202400214877$PFIZER$$60$YR$$F$Y$85$KG$20240717$$MD$NL$NL
241050524$24105052$4$F$20240101$20240911$20240717$20240913$30DAY$$US-PFIZER INC-202400212774$PFIZER$$28$YR$$M$Y$57.596$KG$20240913$$CN$US$US
241050532$24105053$2$F$$20240816$20240717$20240816$30DAY$$US-PFIZER INC-202400213108$PFIZER$$16$YR$$M$Y$$$20240816$$HP$US$US
241050543$24105054$3$F$$20240912$20240717$20240916$30DAY$$US-PFIZER INC-202400212734$PFIZER$$$$$$Y$$$20240916$$CN$US$US
241050561$24105056$1$I$20240117$20240715$20240717$20240717$EXP$FR-AFSSAPS-PC2024000572$FR-PFIZER INC-202400214781$PFIZER$$75$YR$$F$Y$$$20240717$$HP$FR$FR
241050571$24105057$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49392$$FDA-CTU$$$$$F$N$$$20240716$N$HP$US$
241050581$24105058$1$I$20191201$20191219$20240717$20240717$EXP$$RU-AstraZeneca-2019SF86888$ASTRAZENECA$$59$YR$$F$Y$100$KG$20240717$$CN$RU$
241050591$24105059$1$I$$20240711$20240717$20240717$EXP$$BR-JNJFOC-20240734301$JOHNSON AND JOHNSON$$27$YR$A$M$Y$73$KG$20240717$$CN$BR$BR
241050601$24105060$1$I$$20240712$20240717$20240717$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700539$MYOVANT SCIENCES$$$$$M$Y$$$20240717$$CN$US$US
241050612$24105061$2$F$$20240709$20240717$20240720$EXP$$JP-JNJFOC-20240732277$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$78.2$KG$20240719$$MD$JP$JP
241050621$24105062$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A156950$ASTRAZENECA$$$$$M$Y$229.8$KG$20240717$$CN$US$
241050632$24105063$2$F$20230101$20240723$20240717$20240729$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-002856$JAZZ$$$$$M$Y$$$20240728$$HP$US$US
241050641$24105064$1$I$20230718$20240709$20240717$20240717$EXP$DE-CADRBFARM-2024329184$DE-RDY-SPO/DEU/24/0010191$DR REDDYS$$57$YR$A$M$Y$85$KG$20240717$$CN$DE$DE
241050651$24105065$1$I$$20240709$20240717$20240717$PER$US-MLMSERVICE-20240702-PI119910-00175-1$US-RDY-SPO/USA/24/0010248$DR REDDYS$Escano L, Desai P. Hyperosmolar Hyperglycemic State-Induced Hyperviscosity as a Catalyst for Multiple Embolic Strokes. Cureus. 2024;16(6):e63331. DOI:10.7759/cureus.63331.$86$YR$E$M$Y$$$20240717$$MD$US$US
241050662$24105066$2$F$$20240830$20240717$20240902$PER$$NVSC2024US147211$NOVARTIS$$$$$$Y$$$20240902$$HP$US$US
241050671$24105067$1$I$20240503$20240711$20240717$20240717$EXP$$NVSC2024CA144361$NOVARTIS$$68$YR$$F$Y$$$20240717$$CN$CA$CA
241050681$24105068$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49418$$FDA-CTU$$65$YR$$M$N$$$20240717$N$$US$
241050691$24105069$1$I$20240601$20240711$20240717$20240717$DIR$FDA-CDER-CTU-2024-49383$$FDA-CTU$$41$YR$$F$N$$$20240711$N$HP$US$
241050701$24105070$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06472$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241050711$24105071$1$I$$20240628$20240717$20240717$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06524$LUPIN$$$$$$Y$$$20240717$$CN$US$US
241050721$24105072$1$I$$20240121$20240717$20240717$EXP$$FR-SA-2024SA006856$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$CN$DZ$DZ
241050731$24105073$1$I$$20240710$20240717$20240717$EXP$$US-009507513-2407USA004706$MERCK$$$$$M$Y$$$20240717$$CN$US$US
241050751$24105075$1$I$20240610$20240716$20240717$20240717$EXP$$CN-PFIZER INC-PV202400093410$PFIZER$$23$YR$$F$Y$50$KG$20240717$$HP$CN$CN
241050761$24105076$1$I$20220510$20240711$20240717$20240717$EXP$FR-AFSSAPS-LL20221869$FR-PFIZER INC-2022SGN06048$PFIZER$$51$YR$$M$Y$$$20240717$$MD$FR$FR
241050774$24105077$4$F$20230101$20240830$20240717$20240903$30DAY$$US-PFIZER INC-202400205530$PFIZER$$15$YR$$M$Y$$$20240903$$CN$US$US
241050782$24105078$2$F$$20240711$20240717$20240722$EXP$$GR-PFIZER INC-202400214838$PFIZER$Nalmpanti, A.. MONITORING OF PREGNANCY WITH MYASTHENIA GRAVIS, HISTORY OF INTERSTITIAL PREGNANCY AND RECURRENT MISCARRIAGES. 16th PANHELLENIC CONGRESS ON OBSTETRICS AND  GYNECOLOGY. 2024;116$30$YR$$F$Y$$$20240722$$MD$GR$GR
241050791$24105079$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140397$AMGEN$$$$$$Y$$$20240717$$HP$US$US
241050801$24105080$1$I$20240427$20240708$20240717$20240717$PER$$US-BAYER-2024A098590$BAYER$$68$YR$E$M$Y$$$20240717$$CN$US$US
241050811$24105081$1$I$20240101$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112803$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240717$$CN$US$US
241050822$24105082$2$F$$20240716$20240717$20240721$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113414$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$61$KG$20240722$$CN$US$US
241050831$24105083$1$I$$20240709$20240717$20240717$PER$$US-BAYER-2024A099217$BAYER$$$$$F$Y$$$20240717$$HP$US$US
241050841$24105084$1$I$$20240708$20240717$20240717$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001386$BLUEPRINT MEDICINES$$$$$F$Y$$$20240717$$CN$US$US
241050851$24105085$1$I$$20240715$20240717$20240717$30DAY$$US-GSK-US2024088780$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$PH$US$US
241050861$24105086$1$I$20240707$20240711$20240717$20240717$PER$$US-BAYER-2024A100463$BAYER$$8$YR$C$F$Y$$$20240717$$CN$US$US
241050871$24105087$1$I$$20240711$20240717$20240717$PER$$US-ALXN-202407USA000741US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
241050882$24105088$2$F$$20240909$20240717$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111378$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$93.89$KG$20240913$$CN$US$US
241050892$24105089$2$F$$20240920$20240717$20240926$EXP$$CO-ROCHE-3550855$ROCHE$$$$E$F$Y$55$KG$20240926$$CN$CO$CO
241050911$24105091$1$I$20240601$20240706$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107833$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240717$$PH$US$US
241050921$24105092$1$I$$20240708$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112394$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240717$$CN$US$US
241050931$24105093$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113423$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240717$$CN$US$US
241050942$24105094$2$F$20240710$20240910$20240717$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113235$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240911$$HP$US$US
241050951$24105095$1$I$$20240709$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109440$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240717$$MD$US$US
241050961$24105096$1$I$$20240715$20240717$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040168$BOEHRINGER INGELHEIM$$$$$$Y$$$20240717$$MD$US$US
241050971$24105097$1$I$$20240710$20240717$20240717$PER$$US-ABBVIE-5837805$ABBVIE$$$$$$Y$$$20240717$$HP$US$US
241050993$24105099$3$F$20240708$20240829$20240717$20240829$PER$$NVSC2024US145642$NOVARTIS$$26$YR$$M$Y$$$20240829$$CN$US$US
241051002$24105100$2$F$$20240719$20240717$20240726$EXP$$IE-SA-2024SA206297$SANOFI AVENTIS$Howley F, Abukhodair S, De Barra E, O^Connell K, McNally C.. Misidentification of Brucella melitensis as Ochrobactrum species: Potential pitfalls in the diagnosis of brucellosis.. BMJ Case Rep.. 2024;17(6):1-4$30$YR$A$M$Y$$$20240726$$MD$IE$IE
241051011$24105101$1$I$$20240712$20240717$20240717$EXP$$US-SA-2024SA207714$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240717$$MD$US$US
241051021$24105102$1$I$$20240715$20240717$20240717$PER$$US-HALEON-2187227$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
241051031$24105103$1$I$$20240709$20240717$20240717$PER$$US-ABBVIE-5836316$ABBVIE$$$$$$Y$$$20240717$$MD$US$US
241051041$24105104$1$I$$20240712$20240717$20240717$EXP$$JP-JNJFOC-20240741490$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$PH$JP$JP
241051051$24105105$1$I$$20240712$20240717$20240717$PER$$US-JNJFOC-20240735463$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$HP$US$US
241051061$24105106$1$I$$20240705$20240717$20240717$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004727$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240717$$CN$US$US
241051071$24105107$1$I$$20240711$20240717$20240717$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202407008604$ELI LILLY AND CO$$92$YR$E$F$Y$$$20240717$$CN$TW$TW
241051081$24105108$1$I$$20240711$20240717$20240717$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407007848$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240717$$CN$DE$DE
241051102$24105110$2$F$20240101$20240801$20240717$20240815$EXP$$US-ELI_LILLY_AND_COMPANY-US202407005552$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240815$$PH$US$US
241051112$24105111$2$F$$20240802$20240717$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006474$ELI LILLY AND CO$$75$YR$E$M$Y$125.62$KG$20240814$$CN$US$US
241051121$24105112$1$I$$20240709$20240717$20240717$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006828$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240717$$CN$US$US
241051131$24105113$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405101714401070-MWLDQ$GB-ELI_LILLY_AND_COMPANY-GB202407004712$ELI LILLY AND CO$$$$$$Y$$$20240717$$CN$GB$GB
241051141$24105114$1$I$20240611$20240705$20240717$20240717$EXP$GB-MHRA-MED-202407051633541690-ZSKGH$GB-ELI_LILLY_AND_COMPANY-GB202407004860$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$GB$GB
241051151$24105115$1$I$$20240705$20240717$20240717$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407004633$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240717$$PH$FR$FR
241051161$24105116$1$I$20240713$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009159$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240717$$CN$US$US
241051171$24105117$1$I$$20240709$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008417$ELI LILLY AND CO$$$$$$Y$$$20240717$$CN$US$US
241051181$24105118$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405091327047190-JKZPL$GB-ELI_LILLY_AND_COMPANY-GB202407004696$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$GB$GB
241051192$24105119$2$F$20240523$20240820$20240717$20240826$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407007864$ELI LILLY AND CO$$60$YR$A$M$Y$138$KG$20240826$$CN$DE$DE
241051201$24105120$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405011033049530-KDQFM$GB-ELI_LILLY_AND_COMPANY-GB202407004611$ELI LILLY AND CO$$59$YR$A$F$Y$127$KG$20240717$$CN$GB$GB
241051211$24105121$1$I$$20240705$20240717$20240717$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407004341$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$DE$DE
241051221$24105122$1$I$20240514$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405151532488810-BNWSF$GB-ELI_LILLY_AND_COMPANY-GB202407004841$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$GB$GB
241051231$24105123$1$I$20240503$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405032237556020-MKRJQ$GB-ELI_LILLY_AND_COMPANY-GB202407004619$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240717$$CN$GB$GB
241051242$24105124$2$F$20240601$20240712$20240717$20240724$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407006007$ELI LILLY AND CO$$85$YR$E$F$Y$44$KG$20240724$$CN$JP$JP
241051251$24105125$1$I$20240713$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010534$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240717$$CN$US$US
241051261$24105126$1$I$20240601$20240712$20240717$20240717$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008495$ELI LILLY AND CO$$59$YR$A$$Y$$$20240717$$CN$US$US
241051272$24105127$2$F$$20240715$20240717$20240726$EXP$$US-FARMAPROD-202407-2538$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240726$$CN$US$US
241051281$24105128$1$I$20220601$20240714$20240717$20240717$EXP$$SA-SANDOZ INC.-SDZ2024SA061139$SANDOZ$$45$YR$$F$Y$$$20240717$$CN$SA$SA
241051291$24105129$1$I$20240708$20240708$20240717$20240717$EXP$GB-MHRA-MED-202407080851433390-DGCJK$GB-TEVA-VS-3219143$TEVA$$64$YR$$M$Y$69$KG$20240717$$MD$GB$GB
241051301$24105130$1$I$20240711$20240712$20240717$20240717$PER$$US-BAYER-2024A101193$BAYER$$20$YR$A$F$Y$$$20240717$$HP$US$US
241051321$24105132$1$I$20240627$20240708$20240717$20240717$EXP$GB-MHRA-MED-202407080000097570-ZLBHF$GB-TEVA-VS-3219185$TEVA$$47$YR$$M$Y$72$KG$20240717$$CN$GB$GB
241051331$24105133$1$I$$20240717$20240717$20240717$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040294$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240717$$CN$US$US
241051341$24105134$1$I$20240710$20240711$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US064765$SANDOZ$$$$$$Y$$$20240717$$HP$US$US
241051351$24105135$1$I$$20240708$20240717$20240717$EXP$GB-MHRA-MED-202407081259418950-GBKPD$GB-TEVA-VS-3219508$TEVA$$39$YR$$F$Y$$$20240717$$HP$GB$GB
241051361$24105136$1$I$20240501$20240716$20240716$20240716$DIR$710523$$FDA-CTU$$42$YR$$M$N$150.75$KG$20240716$N$CN$US$
241051371$24105137$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49396$$FDA-CTU$$$$$M$N$$$20240716$N$$US$
241051381$24105138$1$I$20240628$20240716$20240716$20240716$DIR$710371$$FDA-CTU$$22$YR$$M$N$$$20240716$Y$PH$US$
241051411$24105141$1$I$$20240707$20240717$20240717$EXP$GB-MHRA-MED-202407071127259410-DFVHR$GB-TEVA-VS-3219447$TEVA$$50$YR$$F$Y$51$KG$20240717$$CN$GB$GB
241051421$24105142$1$I$20230401$20240711$20240717$20240717$EXP$FR-AFSSAPS-LY2023000879$FR-PFIZER INC-2023SGN07949$PFIZER$$65$YR$$M$Y$70$KG$20240717$$PH$FR$FR
241051431$24105143$1$I$20220701$20240716$20240716$20240716$DIR$710506$$FDA-CTU$$34$YR$$F$N$60.75$KG$20240716$N$CN$US$
241051442$24105144$2$F$$20240830$20240717$20240902$EXP$$FR-PFIZER INC-202400215005$PFIZER$$$$$$Y$$$20240902$$MD$FR$FR
241051451$24105145$1$I$20240716$20240716$20240716$20240716$DIR$710480$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
241051462$24105146$2$F$$20240830$20240717$20240902$EXP$$FR-PFIZER INC-PV202400092459$PFIZER$$$$$$Y$$$20240902$$MD$FR$FR
241051471$24105147$1$I$20240702$20240716$20240716$20240716$DIR$710526$$FDA-CTU$$64$YR$$F$N$94.05$KG$20240716$N$CN$US$
241051481$24105148$1$I$20231204$20240712$20240717$20240717$EXP$ES-AEMPS-1543334$ES-PFIZER INC-202400213154$PFIZER$$30$YR$$F$Y$$$20240717$$MD$ES$ES
241051491$24105149$1$I$20240528$20240715$20240717$20240717$EXP$$US-PFIZER INC-PV202400069942$PFIZER$$57$YR$$M$Y$$$20240717$$HP$US$US
241051501$24105150$1$I$20240701$20240716$20240716$20240716$DIR$710396$$FDA-CTU$$63$YR$$F$N$68.85$KG$20240716$N$CN$US$
241051511$24105151$1$I$$20240715$20240717$20240717$EXP$$CA-PFIZER INC-202400216157$PFIZER$$62$YR$$F$Y$$$20240717$$HP$CA$CA
241051521$24105152$1$I$20240716$20240716$20240716$20240716$DIR$710458$$FDA-CTU$$56$YR$$F$N$142.2$KG$20240716$N$$US$
241051541$24105154$1$I$$20240715$20240717$20240717$EXP$$US-PFIZER INC-PV202400092610$PFIZER$$93$YR$$M$Y$$$20240717$$HP$US$US
241051551$24105155$1$I$$20240710$20240717$20240717$PER$$US-ALXN-202407USA000730US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
241051561$24105156$1$I$20240710$20240712$20240717$20240717$PER$$US-BAYER-2024A101290$BAYER$$30$YR$A$F$Y$$$20240717$$MD$US$US
241051571$24105157$1$I$$20240710$20240717$20240717$EXP$$PL-ABBVIE-5837104$ABBVIE$$$$$M$Y$$$20240717$$MD$PL$PL
241051581$24105158$1$I$$20240716$20240717$20240717$PER$$US-HALEON-2187495$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
241051591$24105159$1$I$$20240715$20240717$20240717$EXP$$AU-MYLANLABS-2024M1065778$MYLAN$$$$$F$Y$$$20240717$$HP$AU$AU
241051601$24105160$1$I$$20240708$20240717$20240717$EXP$$CA-FreseniusKabi-FK202410941$FRESENIUS KABI$$74$YR$E$F$Y$94$KG$20240717$$PH$CA$CA
241051611$24105161$1$I$20240625$20240710$20240717$20240717$EXP$IT-MINISAL02-993733$IT-FreseniusKabi-FK202410948$FRESENIUS KABI$$70$YR$E$M$Y$$$20240717$$MD$IT$IT
241051621$24105162$1$I$20240101$20240710$20240717$20240717$EXP$$US-ABBVIE-5836996$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241051631$24105163$1$I$$20240717$20240717$20240717$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040268$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$62$KG$20240717$$HP$GB$GB
241051641$24105164$1$I$$20240710$20240717$20240717$EXP$$GB-UCBSA-2024015220$UCB$$$$$F$Y$$$20240717$$PH$GB$GB
241051652$24105165$2$F$20100101$20240716$20240717$20240719$EXP$FI-FIMEA-202402462$FI-OTSUKA-2024_019578$OTSUKA$$17$YR$$M$Y$$$20240719$$CN$FI$FI
241051662$24105166$2$F$$20240828$20240717$20240829$PER$$US-HALEON-2187555$Haleon PLC$$$$$M$Y$86.18$KG$20240829$$CN$US$US
241051671$24105167$1$I$$20240711$20240717$20240717$EXP$$DE-MYLANLABS-2024M1065832$MYLAN$Hans FP, Benning L, Pooth J-S, Busch H-J. A potentially lifesaving error: unintentional high-dose adrenaline administration in anaphylaxis-induced cardiac arrest; a case report. Int-J-Emerg-Med 2024; 17 (1):.$66$YR$$F$Y$$$20240717$$HP$DE$DE
241051681$24105168$1$I$$20240711$20240717$20240717$EXP$$BE-MYLANLABS-2024M1065792$MYLAN$Mertens B, Elkayal O, Dreesen E, Wauters J, Meersseman P, Debaveye Y, et al. Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review. Antibiotics-(Basel) 2023; 12 (7).$52$YR$$F$Y$$$20240717$$HP$BE$BE
241051691$24105169$1$I$$20240711$20240717$20240717$EXP$$AU-MYLANLABS-2024M1066297$MYLAN$Quirk T, Yao Y, Sverdlov A, Murch S. Malignant pericardial effusions: A retrospective look at etiology and prognosis in a tertiary oncological center. Asia-Pac-J-Clin-Oncol 2023; 19 (4): 468-472.$$$A$$Y$$$20240717$$HP$AU$AU
241051701$24105170$1$I$20240705$20240711$20240717$20240717$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011576$VERTEX$$$$A$F$Y$$$20240717$$CN$GB$GB
241051711$24105171$1$I$$20240711$20240717$20240717$EXP$$US-MYLANLABS-2024M1066553$MYLAN$Rodriguez H, Tan J, Reddy S. A Missed Mass: An Exceedingly Rare Round Cell Sarcoma Leading to Respiratory Failure in a 19-year-old. Am-J-Respir-Crit-Care-Med 2024; 209 (0)$19$YR$$F$Y$$$20240717$$HP$US$US
241051721$24105172$1$I$$20240711$20240717$20240717$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011578$VERTEX$$$$A$F$Y$$$20240717$$CN$GB$GB
241051731$24105173$1$I$$20240711$20240717$20240717$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011587$VERTEX$$$$$F$Y$$$20240717$$CN$GB$GB
241051741$24105174$1$I$$20240711$20240717$20240717$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011560$VERTEX$$$$A$F$Y$$$20240717$$CN$GB$GB
241051751$24105175$1$I$$20240711$20240717$20240717$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011594$VERTEX$$$$$F$Y$$$20240717$$CN$GB$GB
241051761$24105176$1$I$$20240711$20240717$20240717$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011592$VERTEX$$$$$F$Y$$$20240717$$CN$GB$GB
241051771$24105177$1$I$$20240710$20240717$20240717$EXP$$US-VERTEX PHARMACEUTICALS-2024-011610$VERTEX$$$$$M$Y$$$20240717$$CN$US$US
241051782$24105178$2$F$20240601$20240708$20240717$20240722$EXP$$JP-009507513-2407JPN001330J$MERCK$$75$YR$$M$Y$$$20240719$$MD$JP$JP
241051791$24105179$1$I$20240625$20240716$20240716$20240716$DIR$710512$$FDA-CTU$$60$YR$$F$N$63$KG$20240716$Y$CN$US$
241051801$24105180$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49425$$FDA-CTU$$45$YR$$F$N$83.01$KG$20240717$N$$US$
241051811$24105181$1$I$$20240615$20240717$20240717$PER$$US-ROCHE-10000028909$ROCHE$$$$$$Y$$$20240717$$HP$US$US
241051821$24105182$1$I$20240704$20240711$20240717$20240717$EXP$$CN-ROCHE-10000025163$ROCHE$$77$YR$E$M$Y$50$KG$20240717$$HP$CN$CN
241051831$24105183$1$I$$20240709$20240717$20240717$PER$$US-VERTEX PHARMACEUTICALS-2024-011401$VERTEX$$$$$F$Y$$$20240717$$CN$US$US
241051841$24105184$1$I$$20240708$20240717$20240717$PER$$US-VERTEX PHARMACEUTICALS-2024-011341$VERTEX$$$$$F$Y$$$20240717$$MD$US$US
241051851$24105185$1$I$20240401$20240710$20240717$20240717$EXP$FR-AFSSAPS-AN2024000842$FR-VERTEX PHARMACEUTICALS-2024-011462$VERTEX$$2$YR$$M$Y$14$KG$20240717$$MD$FR$FR
241051861$24105186$1$I$$20240712$20240717$20240717$EXP$$US-VERTEX PHARMACEUTICALS-2024-011640$VERTEX$$4$YR$$F$Y$$$20240717$$CN$US$US
241051871$24105187$1$I$20240325$20240709$20240717$20240717$EXP$SE-SEMPA-2024-005104$SE-VERTEX PHARMACEUTICALS-2024-011354$VERTEX$$15$YR$$M$Y$$$20240717$$MD$SE$SE
241051882$24105188$2$F$$20240919$20240717$20240925$PER$$US-VERTEX PHARMACEUTICALS-2024-011503$VERTEX$$$$$M$Y$$$20240925$$CN$US$US
241051891$24105189$1$I$$20220413$20240717$20240717$EXP$$US-AstraZeneca-2022A153432$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241051901$24105190$1$I$$20191031$20240717$20240717$EXP$$CA-AstraZeneca-2019SF55694$ASTRAZENECA$$61$YR$$F$Y$$$20240717$$MD$CA$
241051911$24105191$1$I$$20191220$20240717$20240717$EXP$$RU-AstraZeneca-2019SF88368$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$RU$
241051921$24105192$1$I$20190916$20190923$20240717$20240717$EXP$$US-AstraZeneca-2019SF36717$ASTRAZENECA$$15307$DY$$F$Y$$$20240717$$CN$US$
241051931$24105193$1$I$$20191101$20240717$20240717$EXP$$PL-AstraZeneca-2019SF57269$ASTRAZENECA$$$$$F$Y$$$20240717$$MD$PL$
241051941$24105194$1$I$$20200117$20240717$20240717$EXP$$CA-AstraZeneca-2019SE86072$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$CA$
241051952$24105195$2$F$20240326$20240829$20240717$20240906$PER$$US-BIOGEN-2024BI01273750$BIOGEN$$45$YR$$F$Y$$$20240906$$MD$US$US
241051961$24105196$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157705$ASTRAZENECA$$$$$F$Y$79$KG$20240717$$CN$US$
241051971$24105197$1$I$20240708$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160294$ASTRAZENECA$$27173$DY$$$Y$$$20240717$$MD$US$
241051982$24105198$2$F$20230315$20240717$20240717$20240723$PER$$US-BAYER-2024A101451$BAYER$$31$YR$A$F$Y$$$20240723$$HP$US$US
241051991$24105199$1$I$$20220912$20240717$20240717$EXP$$GB-AstraZeneca-2022A308517$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$GB$
241052001$24105200$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113075$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$90.26$KG$20240717$$CN$US$US
241052011$24105201$1$I$20240326$20240710$20240717$20240717$EXP$$SG-ABBVIE-5836783$ABBVIE$$$$$F$Y$$$20240717$$HP$SG$SG
241052021$24105202$1$I$$20240716$20240717$20240717$PER$$US-HALEON-2187460$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
241052032$24105203$2$F$20240204$20240726$20240717$20240803$EXP$$US-ABBVIE-5768153$ABBVIE$$63$YR$$M$Y$$$20240803$$CN$US$US
241052043$24105204$3$F$$20240918$20240717$20240920$PER$$NVSC2024US146275$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
241052051$24105205$1$I$20240705$20240715$20240717$20240717$EXP$$CO-ABBVIE-5842445$ABBVIE$$51$YR$$F$Y$$$20240717$$CN$CO$CO
241052062$24105206$2$F$20060101$20240726$20240717$20240801$EXP$$FR-MYLANLABS-2024M1065346$MYLAN$$27$YR$$M$Y$$$20240801$$CN$FR$FR
241052071$24105207$1$I$$20240715$20240717$20240717$PER$$US-BAYER-2024A101511$BAYER$$25$YR$A$F$Y$$$20240717$$MD$US$US
241052082$24105208$2$F$20240604$20240823$20240717$20240829$EXP$$US-Vifor (International) Inc.-VIT-2024-06180$VIFOR$$51$YR$$M$Y$$$20240829$$MD$US$US
241052091$24105209$1$I$$20240712$20240717$20240717$EXP$$SI-MEN-2024-105268$MENARINI$Prebil K et al. Complex visual hallucinations associated with ranolazine treatment: a case report. Canadian Journal of Cardiology. 2024$$$E$M$Y$$$20240717$$MD$SI$SI
241052101$24105210$1$I$20240315$20240712$20240717$20240717$EXP$GB-MHRA-MED-202406250940423480-PKQLH$GB-AMGEN-GBRSP2024138893$AMGEN$$51$YR$A$F$Y$93$KG$20240717$$CN$GB$GB
241052111$24105211$1$I$$20240715$20240717$20240717$PER$$NVSC2024US147267$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241052122$24105212$2$F$$20240809$20240717$20240830$PER$$AU-TOLMAR, INC.-24AU050526$TOLMAR$$$$$M$Y$$$20240830$$HP$AU$AU
241052131$24105213$1$I$$20240628$20240717$20240717$PER$$AU-TOLMAR, INC.-24AU050574$TOLMAR$$$$$M$Y$$$20240717$$CN$AU$AU
241052142$24105214$2$F$20240628$20240809$20240717$20240830$PER$$AU-TOLMAR, INC.-24AU050614$TOLMAR$$$$$$Y$$$20240830$$PH$AU$AU
241052151$24105215$1$I$$20240628$20240717$20240717$PER$$AU-TOLMAR, INC.-24AU050613$TOLMAR$$$$$M$Y$$$20240717$$CN$AU$AU
241052162$24105216$2$F$$20240809$20240717$20240830$PER$$AU-TOLMAR, INC.-24AU050617$TOLMAR$$$$$$Y$$$20240830$$HP$AU$AU
241052171$24105217$1$I$20240715$20240715$20240717$20240717$30DAY$$US-GSK-US2024088685$GLAXOSMITHKLINE$$148$YR$$F$Y$$$20240717$$CN$US$US
241052181$24105218$1$I$$20240628$20240717$20240717$PER$$AU-TOLMAR, INC.-24AU050621$TOLMAR$$$$$M$Y$$$20240717$$CN$AU$AU
241052191$24105219$1$I$$20240627$20240717$20240717$PER$$BR-TOLMAR, INC.-24BR050560$TOLMAR$$$$$F$Y$$$20240717$$CN$BR$BR
241052201$24105220$1$I$20240601$20240627$20240717$20240717$PER$$BR-TOLMAR, INC.-24BR050579$TOLMAR$$10$YR$$F$Y$$$20240717$$CN$BR$BR
241052212$24105221$2$F$20240626$20240809$20240717$20240903$PER$$US-TOLMAR, INC.-24US050694$TOLMAR$$74$YR$$M$Y$$$20240903$$HP$US$US
241052221$24105222$1$I$20240617$20240628$20240717$20240717$PER$$US-TOLMAR, INC.-24US050700$TOLMAR$$72$YR$$M$Y$$$20240717$$HP$US$US
241052231$24105223$1$I$$20240710$20240717$20240717$EXP$$CN-009507513-2407CHN009630$MERCK$Jin S, Shen Z, Li J, Liu X, Zhu Q, Li F, et al.. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. Journal of Clinical Pathology. 2024;77(7):471-7$$$$M$Y$$$20240717$$HP$CN$CN
241052241$24105224$1$I$$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024140906$AMGEN$$$$$$Y$$$20240717$$HP$US$US
241052251$24105225$1$I$20240711$20240711$20240717$20240717$PER$$US-BIOGEN-2024BI01273389$BIOGEN$$45$YR$$F$Y$$$20240717$$CN$US$US
241052261$24105226$1$I$20240716$20240716$20240717$20240717$PER$$US-BAYER-2024A103440$BAYER$$$$$F$Y$$$20240717$$CN$US$US
241052271$24105227$1$I$$20240712$20240717$20240717$EXP$$US-AMGEN-USASP2024139658$AMGEN$$$$$F$Y$$$20240717$$PH$US$US
241052281$24105228$1$I$20240714$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140584$AMGEN$$67$YR$E$F$Y$$$20240717$$CN$US$US
241052291$24105229$1$I$$20240711$20240717$20240717$PER$$US-BIOGEN-2024BI01273384$BIOGEN$$$$$F$Y$$$20240717$$HP$US$US
241052301$24105230$1$I$$20240716$20240717$20240717$PER$$US-ABBVIE-5842848$ABBVIE$$$$$$Y$$$20240717$$HP$US$US
241052311$24105231$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49429$$FDA-CTU$$86$YR$$F$N$$$20240717$N$$US$
241052321$24105232$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49427$$FDA-CTU$$67$YR$$F$N$$$20240717$N$$US$
241052331$24105233$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49433$$FDA-CTU$$$$$M$N$$$20240716$N$HP$US$
241052341$24105234$1$I$$20240708$20240717$20240717$EXP$$CA-FreseniusKabi-FK202410939$FRESENIUS KABI$$65$YR$E$M$Y$132$KG$20240717$$HP$CA$CA
241052351$24105235$1$I$20240629$20240708$20240717$20240717$EXP$$UY-FreseniusKabi-FK202410962$FRESENIUS KABI$$29$YR$A$F$Y$$$20240717$$MD$UY$UY
241052361$24105236$1$I$$20240627$20240717$20240717$PER$$US-BEH-2024174969$CSL BEHRING$$70$YR$E$F$Y$$$20240717$$CN$US$US
241052371$24105237$1$I$20240625$20240626$20240717$20240717$PER$$US-BEH-2024174911$CSL BEHRING$$52$YR$A$F$Y$$$20240717$$HP$US$US
241052381$24105238$1$I$$20240710$20240717$20240717$EXP$$IQ-009507513-2407IRQ008945$MERCK$$$$$M$Y$$$20240717$$MD$IQ$IQ
241052391$24105239$1$I$$20240705$20240717$20240717$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00565$Phathom Pharmaceuticals$$67$YR$$M$Y$$$20240717$$MD$JP$JP
241052401$24105240$1$I$$20240704$20240717$20240717$EXP$$BR-PHATHOM PHARMACEUTICALS INC.-2024PHT00568$Phathom Pharmaceuticals$$78$YR$$F$Y$$$20240717$$MD$BR$BR
241052411$24105241$1$I$$20240704$20240717$20240717$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00557$Phathom Pharmaceuticals$$$$$$Y$$$20240717$$MD$JP$JP
241052422$24105242$2$F$20210323$20240724$20240717$20240808$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00558$Phathom Pharmaceuticals$$79$YR$$M$Y$$$20240808$$PH$JP$JP
241052431$24105243$1$I$20240702$20240716$20240717$20240717$PER$$US-BAYER-2024A103912$BAYER$$$$$F$Y$$$20240717$$MD$US$US
241052442$24105244$2$F$$20240919$20240717$20240920$EXP$$NVSC2024US145688$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
241052452$24105245$2$F$$20240830$20240717$20240902$PER$$NVSC2024US146168$NOVARTIS$$$$$$Y$$$20240902$$CN$US$US
241052461$24105246$1$I$$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010902$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240717$$CN$US$US
241052472$24105247$2$F$$20240718$20240717$20240725$PER$$US-JNJFOC-20240734421$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$CN$US$US
241052481$24105248$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49426$$FDA-CTU$$54$YR$$M$N$$$20240717$N$$US$
241052491$24105249$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49398$$FDA-CTU$$43$YR$$F$N$$$20240717$N$$US$
241052501$24105250$1$I$20240601$20240712$20240717$20240717$EXP$$CA-GSK-CA2024087771$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$HP$CA$CA
241052511$24105251$1$I$20240410$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49431$$FDA-CTU$$91$YR$$M$N$$$20240716$N$HP$US$
241052522$24105252$2$F$20171201$20240820$20240717$20240821$EXP$$IT-SANDOZ INC.-SDZ2024IT065495$SANDOZ$$28$YR$$F$Y$$$20240821$$HP$IT$IT
241052531$24105253$1$I$20231001$20240715$20240717$20240717$PER$$US-ORGANON-O2407USA001372$ORGANON$$$$$F$Y$$$20240717$$CN$US$US
241052541$24105254$1$I$20240101$20240711$20240717$20240717$EXP$$AT-ABBVIE-5838492$ABBVIE$$59$YR$$F$Y$80$KG$20240717$$CN$AT$AT
241052551$24105255$1$I$$20240710$20240717$20240717$PER$$US-BAYER-2024A099848$BAYER$$$$$F$Y$$$20240717$$CN$US$US
241052571$24105257$1$I$$20240715$20240717$20240717$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135784$DAIICHI$$$$$F$Y$$$20240717$$CN$US$US
241052581$24105258$1$I$$20240711$20240717$20240717$PER$$US-BAYER-2024A100437$BAYER$$$$$$Y$$$20240717$$CN$US$US
241052592$24105259$2$F$20240701$20240820$20240717$20240912$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000432$BECTON DICKINSON$$$$$$Y$$$20240912$$CN$GB$GB
241052601$24105260$1$I$$20240710$20240717$20240717$EXP$$US-TAKEDA-2024TUS071116$TAKEDA$$$$$F$Y$59.06$KG$20240717$$HP$US$US
241052611$24105261$1$I$$20240712$20240717$20240717$EXP$$US-TAKEDA-2024TUS071681$TAKEDA$$$$$M$Y$$$20240717$$CN$US$US
241052622$24105262$2$F$20240701$20240827$20240717$20240917$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000433$BECTON DICKINSON$$$$$$Y$$$20240917$$CN$GB$GB
241052631$24105263$1$I$$20240715$20240717$20240717$PER$$US-BAYER-2024A101346$BAYER$$$$$$Y$$$20240717$$CN$US$US
241052641$24105264$1$I$$20240711$20240717$20240717$PER$$US-MYLANLABS-2024M1065536$MYLAN$$$$$F$Y$$$20240717$$CN$US$US
241052662$24105266$2$F$20240701$20240820$20240717$20240913$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000434$BECTON DICKINSON$$$$$$Y$$$20240913$$CN$GB$GB
241052672$24105267$2$F$20240701$20240820$20240717$20240912$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000436$BECTON DICKINSON$$$$$$Y$$$20240912$$CN$GB$GB
241052681$24105268$1$I$$20240711$20240717$20240717$EXP$$US-LUNDBECK-DKLU4001675$LUNDBECK$$$$$$Y$$$20240717$$HP$US$US
241052692$24105269$2$F$20240701$20240820$20240717$20240913$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000435$BECTON DICKINSON$$$$$$Y$$$20240913$$CN$GB$GB
241052701$24105270$1$I$20240625$20240701$20240717$20240717$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000438$BECTON DICKINSON$$$$$$Y$$$20240717$$CN$GB$GB
241052716$24105271$6$F$20240709$20240823$20240717$20240902$PER$$US-ROCHE-10000026917$ROCHE$$61$YR$A$M$Y$$$20240902$$CN$US$US
241052721$24105272$1$I$20240714$20240716$20240717$20240717$PER$$US-BAYER-2024A103461$BAYER$$69$YR$E$F$Y$$$20240717$$CN$US$US
241052731$24105273$1$I$$20240709$20240717$20240717$EXP$$RU-RDY-LIT/RUS/24/0010392$DR REDDYS$Skoropad VY, Mironova DY, Kolobaev IV, Ivanov SA, Kaprin AD. Toxicity analysis during neoadjuvant induction chemotherapy and subsequent chemoradiotherapy in patients with locally advanced gastric cancer. P.A. Herzen Journal of Oncology. 2024;13(2): 15-20. doi:10.17116/onkolog20241302115.$$$$$Y$$$20240717$$HP$RU$RU
241052742$24105274$2$F$20220927$20240821$20240717$20240823$EXP$$US-ROCHE-3194678$ROCHE$$32$YR$A$M$Y$70.31$KG$20240823$$CN$US$US
241052761$24105276$1$I$20240617$20240709$20240717$20240717$EXP$FR-AFSSAPS-RN2024000728$FR-TEVA-VS-3219528$TEVA$$68$YR$$F$Y$$$20240717$$MD$FR$FR
241052771$24105277$1$I$$20240716$20240716$20240716$DIR$710441$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241052781$24105278$1$I$20240708$20240715$20240715$20240715$DIR$FDA-CDER-CTU-2024-49382$$FDA-CTU$$49$YR$$M$N$$$20240715$N$HP$US$
241052791$24105279$1$I$$20240712$20240717$20240717$PER$$US-ROCHE-10000027150$ROCHE$$40$YR$A$M$Y$$$20240717$$MD$US$US
241052801$24105280$1$I$$20240710$20240717$20240717$EXP$$PK-ROCHE-10000025009$ROCHE$$69$YR$E$M$Y$$$20240717$$CN$PK$PK
241052821$24105282$1$I$$20240716$20240717$20240717$PER$$US-ROCHE-10000028820$ROCHE$$$$A$F$Y$$$20240717$$CN$US$US
241052831$24105283$1$I$$20240716$20240716$20240716$DIR$710448$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241052841$24105284$1$I$$20240716$20240717$20240717$PER$$US-ROCHE-10000028982$ROCHE$$$$A$F$Y$$$20240717$$CN$US$US
241052851$24105285$1$I$$20240709$20240717$20240717$PER$$US-MYLANLABS-2024M1065436$MYLAN$$$$$F$Y$70.31$KG$20240717$$CN$US$US
241052864$24105286$4$F$$20240724$20240717$20240905$PER$$US-LUNDBECK-DKLU4000797$LUNDBECK$$$$$$Y$$$20240905$$CN$US$US
241052871$24105287$1$I$$20240710$20240717$20240717$EXP$$CA-OTSUKA-2024_019693$OTSUKA$$17$YR$$F$Y$$$20240717$$MD$CA$CA
241052881$24105288$1$I$20230107$20240708$20240717$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110503$BRISTOL MYERS SQUIBB$$6$DEC$A$F$Y$$$20240717$$MD$CA$CA
241052891$24105289$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113101$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240717$$CN$US$US
241052901$24105290$1$I$20220701$20240716$20240717$20240717$EXP$FR-AFSSAPS-MA2024001190$FR-ORGANON-O2407FRA001441$ORGANON$$71$YR$$M$Y$64$KG$20240717$$CN$FR$FR
241052911$24105291$1$I$20200128$20200210$20240717$20240717$EXP$$IN-AstraZeneca-2020SE21860$ASTRAZENECA$$19020$DY$$F$Y$$$20240717$$CN$IN$
241052921$24105292$1$I$20240712$20240716$20240717$20240717$EXP$$IE-MYLANLABS-2024M1066596$MYLAN$$$$$M$Y$$$20240717$$HP$IE$IE
241052934$24105293$4$F$$20240729$20240717$20240801$EXP$$NZ-MYLANLABS-2024M1066603$MYLAN$$$$$F$Y$$$20240801$$PH$NZ$NZ
241052941$24105294$1$I$20240706$20240712$20240717$20240717$EXP$$ZA-AstraZeneca-2024A160464$ASTRAZENECA$$70$YR$$M$Y$$$20240717$$CN$ZA$
241052951$24105295$1$I$$20191112$20240717$20240717$EXP$$US-AstraZeneca-2019SF62367$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241052961$24105296$1$I$$20240716$20240717$20240717$EXP$$CA-MYLANLABS-2024M1064889$MYLAN$$$$$F$Y$$$20240717$$CN$CA$CA
241052971$24105297$1$I$$20230221$20240717$20240717$EXP$$US-AstraZeneca-2023A044518$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241052981$24105298$1$I$$20191112$20240717$20240717$EXP$$US-AstraZeneca-2019SF62740$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241052991$24105299$1$I$20160712$20190718$20240717$20240717$EXP$$MX-AstraZeneca-2019SF05106$ASTRAZENECA$$17517$DY$$F$Y$80$KG$20240717$$CN$MX$
241053001$24105300$1$I$$20220921$20240717$20240717$EXP$$US-AstraZeneca-2022A327863$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241053011$24105301$1$I$$20240709$20240717$20240717$EXP$$ZA-AstraZeneca-2024A157210$ASTRAZENECA$$64$YR$$M$Y$$$20240717$$CN$ZA$
241053021$24105302$1$I$$20191129$20240717$20240717$EXP$$FR-AstraZeneca-2019SF74669$ASTRAZENECA$$$$$M$Y$$$20240717$$MD$FR$
241053031$24105303$1$I$$20240709$20240717$20240717$EXP$$JP-AstraZeneca-2024A159105$ASTRAZENECA$$84$YR$$M$Y$$$20240717$$PH$JP$
241053041$24105304$1$I$$20210121$20240717$20240717$EXP$$US-AstraZeneca-2021A014953$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241053051$24105305$1$I$$20220224$20240717$20240717$EXP$$US-AstraZeneca-2022A088904$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241053061$24105306$1$I$$20240710$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065733$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6).$18$YR$$F$Y$$$20240717$$HP$FR$FR
241053071$24105307$1$I$$20210209$20240717$20240717$EXP$$US-AstraZeneca-2021A045947$ASTRAZENECA$$$$$M$Y$69.9$KG$20240717$$CN$US$
241053081$24105308$1$I$20210101$20210225$20240717$20240717$EXP$$US-AstraZeneca-2021A092580$ASTRAZENECA$$706$MON$$F$Y$54.4$KG$20240717$$CN$US$
241053091$24105309$1$I$$20200908$20240717$20240717$EXP$$US-AstraZeneca-2020SF15926$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241053101$24105310$1$I$20231128$20240708$20240717$20240717$EXP$$DE-EMD Serono-2024034178$EMD SERONO INC$$55$YR$A$M$Y$79$KG$20240717$$HP$DE$DE
241053111$24105311$1$I$20240614$20240715$20240717$20240717$EXP$FR-AFSSAPS-NT2024000812$FR-FreseniusKabi-FK202411170$FRESENIUS KABI$$44$YR$A$F$Y$$$20240717$$PH$FR$FR
241053121$24105312$1$I$20240708$20240715$20240717$20240717$EXP$$SG-FreseniusKabi-FK202411086$FRESENIUS KABI$$37$YR$A$M$Y$$$20240717$$HP$SG$SG
241053131$24105313$1$I$20240202$20240715$20240717$20240717$EXP$FR-AFSSAPS-MP2024001060$FR-FreseniusKabi-FK202411167$FRESENIUS KABI$$77$YR$E$M$Y$$$20240717$$MD$FR$FR
241053141$24105314$1$I$$20240712$20240717$20240717$EXP$$GR-AMGEN-GRCSP2024138920$AMGEN$$71$YR$E$F$Y$$$20240717$$CN$GR$GR
241053153$24105315$3$F$20240711$20240723$20240717$20240727$PER$$US-AMGEN-USASP2024140937$AMGEN$$62$YR$A$F$Y$$$20240727$$PH$US$US
241053161$24105316$1$I$20240301$20240712$20240717$20240717$EXP$$PH-OTSUKA-2024_014005$OTSUKA$$71$YR$$M$Y$$$20240717$$CN$PH$PH
241053171$24105317$1$I$$20240715$20240717$20240717$EXP$$US-INCYTE CORPORATION-2024IN007440$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241053181$24105318$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009758$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240717$$CN$US$US
241053191$24105319$1$I$20240716$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010683$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240717$$CN$US$US
241053211$24105321$1$I$$20210730$20240717$20240717$EXP$$PL-ASTELLAS-2024EU007041$ASTELLAS$$$$$M$Y$0.62$KG$20240717$$HP$PL$PL
241053221$24105322$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49437$$FDA-CTU$$52$YR$$F$N$$$20240717$N$$US$
241053231$24105323$1$I$20240621$20240716$20240716$20240716$DIR$710485$$FDA-CTU$$19$YR$$M$N$150.3$KG$20240716$N$PH$US$
241053241$24105324$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49438$$FDA-CTU$$69$YR$$F$N$100.24$KG$20240717$N$$US$
241053251$24105325$1$I$20240715$20240716$20240716$20240716$DIR$710454$$FDA-CTU$$63$YR$$F$N$67.6$KG$20240716$N$PH$US$
241053261$24105326$1$I$20230901$20240710$20240717$20240717$EXP$$US-VIIV HEALTHCARE LIMITED-US2024085676$VIIV$$$$$$Y$$$20240717$$HP$US$US
241053271$24105327$1$I$$20240709$20240717$20240717$PER$$US-MYLANLABS-2024M1064804$MYLAN$$$$$$Y$$$20240717$$CN$US$US
241053282$24105328$2$F$$20240722$20240717$20240726$EXP$$US-OTSUKA-2024_017541$OTSUKA$$$$$M$Y$74.39$KG$20240726$$HP$US$US
241053291$24105329$1$I$20240101$20240708$20240717$20240717$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00561$PARATEK PHARMACEUTICALS$$66$YR$$M$Y$$$20240717$$CN$US$US
241053301$24105330$1$I$20240321$20240703$20240717$20240717$EXP$$ES-GILEAD-2024-0679677$GILEAD$$$$$M$Y$$$20240717$$MD$ES$ES
241053322$24105332$2$F$20240401$20240806$20240717$20240821$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00553$Phathom Pharmaceuticals$$9$DEC$$M$Y$$$20240821$$MD$JP$JP
241053332$24105333$2$F$$20240812$20240717$20240812$PER$$US-ALXN-202407USA000742US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241053341$24105334$1$I$$20240711$20240717$20240717$PER$$US-ABBVIE-5840754$ABBVIE$$50$YR$$F$Y$$$20240717$$MD$US$US
241053351$24105335$1$I$$20240703$20240717$20240717$EXP$$CH-VIRTUS PHARMACEUTICALS, LLC-2024VTS00017$VIRTUS PHARMACEUTICALS$Diabasana Amandine. Hypokalemic paralysis a side-effect of short action beta2-agonist. Swiss Med. Wkly. 2024;(154):35S$6$YR$$F$Y$$$20240717$$HP$CH$CH
241053363$24105336$3$F$20230807$20240826$20240717$20240830$EXP$$KR-ROCHE-10000026951$ROCHE$$71$YR$E$F$Y$52.9$KG$20240830$$MD$KR$KR
241053371$24105337$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157611$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241053382$24105338$2$F$$20240711$20240717$20240722$EXP$$NVSC2024US145013$NOVARTIS$$$$$F$Y$$$20240722$$CN$US$US
241053393$24105339$3$F$$20240805$20240717$20240805$PER$$NVSC2024US147238$NOVARTIS$$$$$$Y$$$20240806$$HP$US$US
241053401$24105340$1$I$$20240712$20240717$20240717$EXP$$CR-AstraZeneca-2024A161477$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CR$
241053411$24105341$1$I$$20240712$20240717$20240717$EXP$$NVSC2024US145787$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
241053422$24105342$2$F$20240315$20240911$20240717$20240913$EXP$$NVSC2024CA146608$NOVARTIS$$76$YR$$F$Y$65.8$KG$20240913$$CN$CA$CA
241053431$24105343$1$I$$20201007$20240717$20240717$EXP$$US-AstraZeneca-2020SF31578$ASTRAZENECA$$$$$M$Y$$$20240717$$HP$US$
241053441$24105344$1$I$$20200730$20240717$20240717$EXP$$TW-AstraZeneca-2020SE89208$ASTRAZENECA$$72$YR$$F$Y$$$20240717$$CN$TW$
241053451$24105345$1$I$$20240710$20240717$20240717$PER$$US-USAntibiotics-000325$USAntibiotics$$$$$F$Y$$$20240717$$CN$US$
241053461$24105346$1$I$20220712$20240716$20240716$20240716$DIR$710459$$FDA-CTU$$39$YR$$F$N$56.25$KG$20240716$Y$CN$US$
241053471$24105347$1$I$$20240715$20240717$20240717$PER$$US-HALEON-2187257$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
241053481$24105348$1$I$$20240716$20240716$20240716$DIR$710452$$FDA-CTU$$63$YR$$F$N$$$20240716$N$PH$US$
241053491$24105349$1$I$$20240705$20240717$20240717$PER$$US-USAntibiotics-000323$USAntibiotics$$$$$M$Y$$$20240717$$HP$US$
241053501$24105350$1$I$$20240715$20240717$20240717$EXP$$CA-MYLANLABS-2024M1066484$MYLAN$$$$$M$Y$$$20240717$$CN$CA$CA
241053511$24105351$1$I$20230915$20240715$20240717$20240717$EXP$FR-AFSSAPS-PO2024000656$FR-FreseniusKabi-FK202411197$FRESENIUS KABI$$81$YR$E$F$Y$61$KG$20240717$$MD$FR$FR
241053521$24105352$1$I$20240601$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111720$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240717$$HP$US$US
241053531$24105353$1$I$$20240711$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111431$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240717$$CN$US$US
241053541$24105354$1$I$20240229$20240709$20240717$20240717$EXP$IT-MINISAL02-993154$IT-TEVA-VS-3219306$TEVA$$48$YR$$F$Y$$$20240717$$MD$IT$IT
241053551$24105355$1$I$20240624$20240710$20240717$20240717$EXP$$US-ARGENX-2024-ARGX-US005399$ARGENX BVBA$$$$$$Y$$$20240717$$CN$US$US
241053592$24105359$2$F$20240101$20240817$20240717$20240819$30DAY$$US-PFIZER INC-202400209964$PFIZER$$11$YR$$M$Y$$$20240819$$CN$US$US
241053603$24105360$3$F$$20240916$20240717$20240919$30DAY$$US-PFIZER INC-202400209952$PFIZER$$12$YR$$M$Y$$$20240919$$CN$US$US
241053616$24105361$6$F$$20240922$20240717$20240925$30DAY$$US-PFIZER INC-PV202400090532$PFIZER$$11$YR$$M$Y$46.1$KG$20240925$$MD$US$US
241053623$24105362$3$F$$20240913$20240717$20240919$30DAY$$FR-PFIZER INC-202400211082$PFIZER$$$$$$Y$$$20240919$$PH$FR$FR
241053653$24105365$3$F$20240710$20240918$20240717$20240920$30DAY$$US-PFIZER INC-202400211482$PFIZER$$18$YR$$F$Y$72.57$KG$20240920$$CN$US$US
241053663$24105366$3$F$$20240916$20240717$20240920$30DAY$$US-PFIZER INC-202400210048$PFIZER$$17$YR$$M$Y$$$20240920$$CN$US$US
241053673$24105367$3$F$$20240912$20240717$20240917$30DAY$$US-PFIZER INC-202400208985$PFIZER$$12$YR$$M$Y$$$20240917$$CN$US$US
241053684$24105368$4$F$$20240904$20240717$20240906$30DAY$$US-PFIZER INC-202400211293$PFIZER$$12$YR$$M$Y$$$20240906$$CN$US$US
241053691$24105369$1$I$$20240710$20240717$20240717$30DAY$$GB-PFIZER INC-PV202400090476$PFIZER$$9$YR$$M$Y$$$20240717$$CN$GB$GB
241053701$24105370$1$I$20240712$20240713$20240717$20240717$PER$$US-JNJFOC-20240736070$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$CN$US$US
241053712$24105371$2$F$$20240717$20240717$20240722$PER$$US-JNJFOC-20240736729$JOHNSON AND JOHNSON$$$$$$Y$$$20240721$$MD$US$US
241053721$24105372$1$I$$20240709$20240717$20240717$EXP$$DE-SA-2024SA206151$SANOFI AVENTIS$$$$$$Y$$$20240717$$MD$DE$DE
241053731$24105373$1$I$20240712$20240712$20240717$20240717$EXP$$US-JNJFOC-20240739576$JOHNSON AND JOHNSON$$61$YR$A$M$Y$88.6$KG$20240717$$HP$US$US
241053741$24105374$1$I$20240519$20240710$20240717$20240717$EXP$$CN-SA-2024SA206220$SANOFI AVENTIS$$73$YR$E$F$Y$70$KG$20240717$$HP$CN$CN
241053751$24105375$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113454$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240717$$HP$US$US
241053762$24105376$2$F$20240712$20240716$20240717$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113298$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$PH$US$US
241053771$24105377$1$I$$20240716$20240716$20240716$DIR$710484$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241053781$24105378$1$I$$20240716$20240716$20240716$DIR$710433$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241053791$24105379$1$I$20240716$20240716$20240716$20240716$DIR$710477$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
241053801$24105380$1$I$20240716$20240716$20240716$20240716$DIR$710473$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
241053821$24105382$1$I$20230920$20240716$20240716$20240716$DIR$710520$$FDA-CTU$$36$YR$$F$N$72$KG$20240716$N$CN$US$
241053831$24105383$1$I$20240301$20240716$20240717$20240717$EXP$SE-SEMPA-2024-004771$SE-ORGANON-O2407SWE001432$ORGANON$$49$YR$$F$Y$57$KG$20240717$$CN$SE$SE
241053842$24105384$2$F$20240125$20240904$20240717$20240910$EXP$FR-AFSSAPS-DJ2024000812$FR-SA-2024SA203877$SANOFI AVENTIS$$77$YR$E$M$Y$74$KG$20240910$$MD$FR$FR
241053851$24105385$1$I$$20240710$20240717$20240717$EXP$$DE-ROCHE-10000024480$ROCHE$$$$$F$Y$$$20240717$$MD$DE$DE
241053861$24105386$1$I$20090101$20240709$20240717$20240717$EXP$$FR-LUNDBECK-DKLU4001751$LUNDBECK$$$$$$Y$$$20240717$$MD$FR$FR
241053871$24105387$1$I$$20240715$20240717$20240717$30DAY$$FR-SANDOZ INC.-SDZ2024FR065554$SANDOZ$$$$$F$Y$$$20240717$$PH$FR$FR
241053881$24105388$1$I$20240401$20240712$20240717$20240717$EXP$$US-SA-2024SA207549$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240717$$MD$US$US
241053891$24105389$1$I$20240101$20240712$20240717$20240717$EXP$$CA-SA-2024SA208072$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240717$$PH$CA$CA
241053901$24105390$1$I$$20240715$20240717$20240717$EXP$$US-TAKEDA-2024TUS054863$TAKEDA$$$$$M$Y$69.488$KG$20240717$$CN$US$US
241053911$24105391$1$I$$20240707$20240717$20240717$EXP$$US-INFO-20240197$INFORLIFE$Kwon D, Seu M, Barnes S. Mind the Anion Gap: 5-Oxoproline-Induced High Anion Gap Metabolic Acidosis in End-Stage Renal Disease. Cureus. 2024;16(5):e61328. DOI: 10.7759/cureus.61328.$74$YR$E$F$Y$$$20240710$$MD$US$
241053922$24105392$2$F$$20240722$20240717$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US034557$SANDOZ$$$$$M$Y$$$20240724$$CN$US$US
241053932$24105393$2$F$20240101$20240912$20240717$20240916$30DAY$$AR-PFIZER INC-202400205963$PFIZER$$15$YR$$M$Y$$$20240916$$CN$AR$AR
241053941$24105394$1$I$20240701$20240709$20240717$20240717$EXP$$JP-009507513-2407JPN002433J$MERCK$$84$YR$$F$Y$$$20240717$$PH$JP$JP
241053951$24105395$1$I$$20240711$20240717$20240717$EXP$$RO-009507513-2407ROU007625$MERCK$$83$YR$$M$Y$$$20240717$$MD$RO$RO
241053961$24105396$1$I$$20240711$20240717$20240717$EXP$$US-FreseniusKabi-FK202411009$FRESENIUS KABI$$$$$$Y$$$20240717$$HP$US$US
241053971$24105397$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113337$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240717$$HP$US$US
241053991$24105399$1$I$$20240708$20240717$20240717$EXP$$RU-EMD Serono-2024037230$EMD SERONO INC$$69$YR$E$M$Y$$$20240717$$MD$RU$RU
241054001$24105400$1$I$$20240709$20240717$20240717$EXP$$US-AMGEN-USASP2024136593$AMGEN$Zonder J.A.; Azmi A.S.; Seymour E.K. et al.. Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study. Clinical Cancer Research. 2021;27 (12):3307-3316$$$$$Y$$$20240717$$HP$US$US
241054011$24105401$1$I$$20240710$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010441$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240717$$CN$US$US
241054021$24105402$1$I$20240516$20240705$20240717$20240717$EXP$ES-AEMPS-1539241$ES-ELI_LILLY_AND_COMPANY-ES202407005785$ELI LILLY AND CO$$61$YR$A$M$Y$85$KG$20240717$$CN$ES$ES
241054031$24105403$1$I$20240714$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009761$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240717$$CN$US$US
241054041$24105404$1$I$20240715$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009762$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240717$$CN$US$US
241054052$24105405$2$F$20240501$20240726$20240717$20240802$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202407008908$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240802$$CN$CO$CO
241054061$24105406$1$I$$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009921$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240717$$CN$US$US
241054071$24105407$1$I$$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010329$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240717$$HP$US$US
241054081$24105408$1$I$$20240709$20240717$20240717$EXP$$ES-MYLANLABS-2024M1065761$MYLAN$Clemente Hernandez B, Muelas Rives I, Aldea Manrique B, Hernandez Aragues I, Lopez Gomez C, Gracia Cazana T. Comment on: Report of terbinafine-resistant Trichophyton indotineae in a pregnant patient-A diagnostic and therapeutic challenge. J-Eur-Acad-Dermatol-Venereol 2024; 38 (7): e634-e635.$33$YR$$F$Y$$$20240717$$HP$ES$ES
241054101$24105410$1$I$20240701$20240716$20240717$20240717$EXP$$US-INCYTE CORPORATION-2024IN007481$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241054111$24105411$1$I$20240101$20240712$20240717$20240717$EXP$DK-DKMA-30729540$DK-AMGEN-DNKSP2024139020$AMGEN$$67$YR$E$M$Y$$$20240717$$MD$DK$DK
241054131$24105413$1$I$20240207$20240709$20240717$20240717$EXP$FR-AFSSAPS-RE2024000648$FR-TEVA-VS-3219380$TEVA$$61$YR$$F$Y$70$KG$20240717$$MD$FR$FR
241054141$24105414$1$I$$20240716$20240717$20240717$EXP$$NVSC2024CA146911$NOVARTIS$$$$$F$Y$$$20240717$$CN$CA$CA
241054151$24105415$1$I$$20240716$20240717$20240717$PER$$NVSC2024US146740$NOVARTIS$$$$$$Y$$$20240717$$CN$US$US
241054161$24105416$1$I$20240501$20240711$20240717$20240717$EXP$FR-AFSSAPS-AN2024000850$FR-BAYER-2024A099895$BAYER$$19$YR$A$F$Y$53$KG$20240717$$PH$FR$FR
241054171$24105417$1$I$20240714$20240716$20240716$20240716$DIR$710463$$FDA-CTU$$66$YR$$F$N$65.25$KG$20240716$N$CN$US$
241054181$24105418$1$I$20240716$20240716$20240716$20240716$DIR$710525$$FDA-CTU$$26$YR$$M$N$83.25$KG$20240716$N$CN$US$
241054191$24105419$1$I$20240716$20240716$20240716$20240716$DIR$710445$$FDA-CTU$$80$YR$$M$N$$$20240716$N$CN$US$
241054201$24105420$1$I$$20240716$20240716$20240716$DIR$710493$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241054211$24105421$1$I$20240716$20240716$20240716$20240716$DIR$710498$$FDA-CTU$$72$YR$$F$N$$$20240716$N$PH$US$
241054221$24105422$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49460$$FDA-CTU$$77$YR$$F$N$70.31$KG$20240717$N$$US$
241054231$24105423$1$I$20240717$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49463$$FDA-CTU$$48$YR$$F$N$$$20240717$N$$US$
241054241$24105424$1$I$20240307$20240709$20240717$20240717$EXP$FR-AFSSAPS-AVMA2024000280$FR-TEVA-VS-3219529$TEVA$$28$YR$$M$Y$$$20240717$$PH$FR$FR
241054261$24105426$1$I$$20240710$20240717$20240717$PER$$PR-ABBVIE-5839706$ABBVIE$$$$A$F$Y$$$20240717$$MD$PR$PR
241054281$24105428$1$I$$20240711$20240717$20240717$PER$$US-ABBVIE-5839557$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241054292$24105429$2$F$20240228$20240820$20240717$20240824$EXP$$NVSC2024US145264$NOVARTIS$$59$YR$$F$Y$$$20240824$$CN$US$US
241054301$24105430$1$I$20240514$20240715$20240717$20240717$EXP$FR-AFSSAPS-BX2024001367$FR-BAYER-2024A101404$BAYER$$75$YR$E$M$Y$$$20240717$$PH$FR$FR
241054311$24105431$1$I$$20240712$20240717$20240717$PER$$US-INCYTE CORPORATION-2024IN007397$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241054322$24105432$2$F$20240503$20240731$20240717$20240812$EXP$$DE-TPU-TPU-2024-00391$TEIKOKU$$28$YR$A$F$Y$108$KG$20240812$$CN$DE$DE
241054331$24105433$1$I$20240627$20240708$20240717$20240717$EXP$BE-FAMHP-DHH-N2024-122337$BE-BAXTER-2024BAX021276$BAXTER$$63$YR$$M$Y$106$KG$20240717$$PH$BE$BE
241054341$24105434$1$I$20240412$20240708$20240717$20240717$EXP$FR-AFSSAPS-NT2024000810$FR-BAXTER-2024BAX021274$BAXTER$$61$YR$$M$Y$65.2$KG$20240717$$MD$FR$FR
241054351$24105435$1$I$$20240708$20240717$20240717$EXP$$PT-TPU-TPU-2024-00392$TEIKOKU$Maia S, Xavier B, Sa M, Antunes E, Morais D, Sampaio J.. Negative Pressure Pulmonary Oedema: An Unexpected Intercurrence.. JOURNAL OF THE PORTUGUESE SOCIETY OF ANAESTHESIOLOGY/REVISTA DA SOCIEDADE PORTU. 2024;33(S1):49. doi:10.25751/rspa.35116$19$YR$A$M$Y$$$20240717$$HP$PT$PT
241054361$24105436$1$I$$20240708$20240717$20240717$EXP$$CA-BAXTER-2024BAX021327$BAXTER$$$$$$Y$$$20240717$$CN$CA$CA
241054381$24105438$1$I$20240301$20240711$20240717$20240717$EXP$$US-BAYER-2024A101001$BAYER$$$$$M$Y$$$20240717$$HP$US$US
241054401$24105440$1$I$20240219$20240708$20240717$20240717$EXP$FR-AFSSAPS-AN2024000874$FR-BAXTER-2024BAX021311$BAXTER$$15$YR$$M$Y$38.1$KG$20240717$$MD$FR$FR
241054411$24105441$1$I$20240412$20240709$20240717$20240717$EXP$FR-AFSSAPS-NC2024000817$FR-BAXTER-2024BAX021359$BAXTER$$60$YR$$M$Y$$$20240717$$MD$FR$FR
241054421$24105442$1$I$20240710$20240713$20240717$20240717$EXP$$GB-AUROBINDO-AUR-APL-2024-035145$AUROBINDO$$47$YR$$F$Y$$$20240717$$HP$GB$GB
241054431$24105443$1$I$$20240711$20240717$20240717$PER$$US-ABBVIE-5841560$ABBVIE$$$$$$Y$$$20240717$$CN$US$US
241054442$24105444$2$F$$20240712$20240717$20240731$PER$$US-INCYTE CORPORATION-2024IN007381$INCYTE$$$$$$Y$$$20240801$$CN$US$US
241054453$24105445$3$F$$20240804$20240717$20240806$EXP$$DK-BAYER-2024A101121$BAYER$$$$$F$Y$$$20240806$$PH$DK$DK
241054461$24105446$1$I$20240101$20240710$20240717$20240717$EXP$$IN-SANDOZ INC.-SDZ2023IN073087$SANDOZ$$27$YR$$F$Y$$$20240717$$CN$IN$IN
241054471$24105447$1$I$$20200117$20240717$20240717$EXP$$US-BIOVITRUM-2020SE11072$BIOVITRUM$$$$I$F$Y$$$20240717$$MD$US$US
241054481$24105448$1$I$20191101$20191128$20240717$20240717$EXP$$NL-BIOVITRUM-2019SF74840$BIOVITRUM$$$$$F$Y$$$20240717$$CN$NL$NL
241054491$24105449$1$I$20240513$20240710$20240717$20240717$EXP$IT-MINISAL02-993744$IT-009507513-2407ITA005440$MERCK$$39$YR$$F$Y$$$20240717$$MD$IT$IT
241054501$24105450$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112360$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240717$$HP$US$US
241054513$24105451$3$F$20240501$20240905$20240717$20240910$EXP$$CO-LUNDBECK-DKLU4001750$LUNDBECK$$$$$$Y$$$20240910$$CN$CO$CO
241054521$24105452$1$I$$20240710$20240717$20240717$PER$$US-MYLANLABS-2024M1065155$MYLAN$$$$$F$Y$$$20240717$$CN$US$US
241054547$24105454$7$F$20240624$20240920$20240717$20240924$EXP$$BE-AUROBINDO-AUR-APL-2024-035346$AUROBINDO$$85$YR$$M$Y$$$20240924$$MD$BE$BE
241054554$24105455$4$F$20240630$20240813$20240717$20240821$30DAY$$CO-AMGEN-COLSP2024132868$AMGEN$$$$$$Y$$$20240821$$PH$CO$CO
241054562$24105456$2$F$20240605$20240717$20240717$20240726$EXP$$US-IOVANCE BIOTHERAPEUTICS, INC-2024IOV000040$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240726$$HP$US$US
241054571$24105457$1$I$$20240710$20240717$20240717$EXP$$CN-009507513-2407CHN009628$MERCK$Jin S, Shen Z, Li J, Liu X, Zhu Q, Li F, et al.. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. Journal of Clinical Pathology. 2024;77(7):471-7$$$$M$Y$$$20240717$$HP$CN$CN
241054582$24105458$2$F$$20240823$20240717$20240828$EXP$$US-009507513-2407USA009472$MERCK$$62$YR$$F$Y$$$20240828$$PH$US$US
241054591$24105459$1$I$20240608$20240710$20240717$20240717$PER$$US-BAYER-2024A100519$BAYER$$57$YR$A$M$Y$$$20240717$$PH$US$US
241054611$24105461$1$I$$20240712$20240717$20240717$PER$$US-ABBVIE-5842835$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241054631$24105463$1$I$20240630$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49462$$FDA-CTU$$42$YR$$F$N$$$20240717$N$$US$
241054641$24105464$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49464$$FDA-CTU$$64$YR$$F$N$117.93$KG$20240717$N$$US$
241054651$24105465$1$I$20240708$20240716$20240716$20240716$DIR$710399$$FDA-CTU$$55$YR$$F$N$105$KG$20240716$N$PH$US$
241054661$24105466$1$I$20240701$20240716$20240716$20240716$DIR$710515$$FDA-CTU$$43$YR$$F$N$69.75$KG$20240716$N$CN$US$
241054671$24105467$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49465$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241054691$24105469$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49466$$FDA-CTU$$90$YR$$M$N$$$20240717$N$$US$
241054701$24105470$1$I$20240713$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49444$$FDA-CTU$$67$YR$$M$N$$$20240716$N$HP$US$
241054721$24105472$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112482$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240717$$CN$US$US
241054731$24105473$1$I$$20240714$20240717$20240717$EXP$$US-ABBVIE-5840740$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241054741$24105474$1$I$20230101$20240716$20240717$20240717$PER$$US-BAYER-2024A104100$BAYER$$38$YR$A$F$Y$$$20240717$$MD$US$US
241054751$24105475$1$I$20240401$20240716$20240716$20240716$DIR$710400$$FDA-CTU$$71$YR$$F$N$69.3$KG$20240716$N$CN$US$
241054761$24105476$1$I$20190101$20240708$20240717$20240717$EXP$$US-TPU-TPU-2024-00381$TEIKOKU$$$$$F$Y$$$20240717$$CN$US$US
241054774$24105477$4$F$20220101$20240909$20240717$20240921$EXP$$US-ABBVIE-5839849$ABBVIE$$$$$M$Y$92$KG$20240921$$CN$US$US
241054781$24105478$1$I$$20240717$20240717$20240717$PER$$US-BAYER-2024A104082$BAYER$$$$$$Y$$$20240717$$CN$US$US
241054791$24105479$1$I$20240601$20240708$20240717$20240717$EXP$$GB-TEVA-VS-3219495$TEVA$$79$YR$$M$Y$96$KG$20240717$$MD$GB$GB
241054801$24105480$1$I$$20240712$20240717$20240717$EXP$$CA-LUNDBECK-DKLU4001735$LUNDBECK$$$$$$Y$$$20240717$$MD$CA$CA
241054811$24105481$1$I$20240405$20240715$20240717$20240717$EXP$$ES-AUROBINDO-AUR-APL-2024-035358$AUROBINDO$$48$YR$$M$Y$$$20240717$$MD$ES$ES
241054821$24105482$1$I$20240714$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009698$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240717$$CN$US$US
241054831$24105483$1$I$20240421$20240709$20240717$20240717$EXP$$CA-TAKEDA-2024TUS013189$TAKEDA$$68$YR$$F$Y$$$20240717$$CN$CA$CA
241054841$24105484$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009770$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240717$$CN$US$US
241054851$24105485$1$I$20240312$20240716$20240716$20240716$DIR$710436$$FDA-CTU$$63$YR$$M$N$85.68$KG$20240716$N$$US$
241054862$24105486$2$F$20240101$20240809$20240717$20240812$EXP$$CA-ABBVIE-5730911$ABBVIE$$63$YR$$M$Y$$$20240812$$HP$CA$CA
241054871$24105487$1$I$$20240716$20240717$20240717$EXP$NL-LRB-00981144$NL-ORGANON-O2407NLD001389$ORGANON$$48$YR$$F$Y$75$KG$20240717$$CN$NL$NL
241054881$24105488$1$I$$20240712$20240717$20240717$EXP$$US-LUNDBECK-DKLU4001736$LUNDBECK$$$$$$Y$$$20240717$$HP$US$US
241054891$24105489$1$I$$20240703$20240717$20240717$PER$$US-TEVA-VS-3218692$TEVA$$72$YR$$F$Y$$$20240717$$PH$US$US
241054902$24105490$2$F$20240101$20240805$20240717$20240808$EXP$$FI-ABBVIE-5842054$ABBVIE$$$$$M$Y$57$KG$20240808$$CN$FI$FI
241054911$24105491$1$I$$20240709$20240717$20240717$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06138$VIFOR$$$$A$M$Y$$$20240717$$HP$ZA$ZA
241054922$24105492$2$F$$20240717$20240717$20240726$30DAY$$CN-SA-2024SA204246$SANOFI AVENTIS$$$$$F$Y$$$20240726$$CN$CN$CN
241054942$24105494$2$F$20220104$20240724$20240717$20240730$EXP$$ES-ROCHE-3014461$ROCHE$$51$YR$A$M$Y$89$KG$20240730$$HP$ES$ES
241054951$24105495$1$I$$20240715$20240717$20240717$PER$$NVSC2024US147296$NOVARTIS$$$$$M$Y$$$20240717$$CN$US$US
241054961$24105496$1$I$20230214$20230215$20240717$20240717$EXP$$US-AstraZeneca-2023A039277$ASTRAZENECA$$28688$DY$$M$Y$99.8$KG$20240717$$CN$US$
241054971$24105497$1$I$20230101$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024138018$AMGEN$$70$YR$E$M$Y$$$20240717$$CN$US$US
241054981$24105498$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160321$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241054991$24105499$1$I$20240312$20240516$20240717$20240717$EXP$$CA-BAXTER-2024BAX018381$BAXTER$$$$$$Y$$$20240717$$CN$CA$CA
241055001$24105500$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113484$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240717$$CN$US$US
241055011$24105501$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157872$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241055021$24105502$1$I$$20210208$20240717$20240717$EXP$$US-AstraZeneca-2021A051873$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241055031$24105503$1$I$$20210208$20240717$20240717$EXP$$US-AstraZeneca-2021A049056$ASTRAZENECA$$$$$F$Y$56.7$KG$20240717$$HP$US$
241055042$24105504$2$F$$20240820$20240717$20240829$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000611$DECIPHERA PHARMACEUTICALS$$52$YR$A$M$Y$$$20240829$$CN$US$US
241055051$24105505$1$I$20231211$20240716$20240716$20240716$DIR$710491$$FDA-CTU$$86$YR$$F$N$$$20240716$Y$PH$US$
241055061$24105506$1$I$20240716$20240716$20240716$20240716$DIR$710421$$FDA-CTU$$78$YR$$M$N$79.2$KG$20240716$N$PH$US$
241055081$24105508$1$I$20240707$20240709$20240717$20240717$EXP$$US-BAYER-2024A099680$BAYER$$56$YR$A$F$Y$$$20240717$$CN$US$US
241055101$24105510$1$I$$20240711$20240717$20240717$PER$$US-ABBVIE-5840400$ABBVIE$$$$$$Y$$$20240717$$MD$US$US
241055111$24105511$1$I$$20240705$20240717$20240717$PER$$US-SA-2024SA203076$SANOFI AVENTIS$$$$E$M$Y$$$20240717$$MD$US$US
241055121$24105512$1$I$$20240523$20240717$20240717$PER$$US-SA-2024SA205625$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240717$$MD$US$US
241055132$24105513$2$F$20240101$20240821$20240717$20240905$PER$$US-SA-2024SA199541$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240905$$MD$US$US
241055141$24105514$1$I$$20240703$20240717$20240717$PER$$US-SA-2024SA120531$SANOFI AVENTIS$$$$A$F$Y$55$KG$20240717$$MD$US$US
241055151$24105515$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111987$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240717$$HP$US$US
241055161$24105516$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113447$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240717$$CN$US$US
241055171$24105517$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113084$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240717$$CN$US$US
241055181$24105518$1$I$$20240716$20240716$20240716$DIR$710438$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241055191$24105519$1$I$$20240716$20240716$20240716$DIR$710466$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
241055201$24105520$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111748$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240717$$HP$US$US
241055211$24105521$1$I$20240708$20240710$20240717$20240717$PER$$US-BAYER-2024A099625$BAYER$$11$YR$C$M$Y$$$20240717$$CN$US$US
241055221$24105522$1$I$20240708$20240715$20240717$20240717$PER$$US-ABBVIE-5842644$ABBVIE$$$$A$F$Y$$$20240717$$HP$US$US
241055231$24105523$1$I$20240101$20240705$20240717$20240717$PER$$US-SA-2024SA202947$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240717$$MD$US$US
241055241$24105524$1$I$20240501$20240705$20240717$20240717$PER$$US-SA-2024SA204028$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240717$$MD$US$US
241055251$24105525$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA206003$SANOFI AVENTIS$$$$T$M$Y$85$KG$20240717$$MD$US$US
241055261$24105526$1$I$20200101$20240705$20240717$20240717$PER$$US-SA-2024SA201072$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240717$$MD$US$US
241055271$24105527$1$I$20240601$20240705$20240717$20240717$PER$$US-SA-2024SA202785$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240717$$MD$US$US
241055281$24105528$1$I$20230713$20240705$20240717$20240717$PER$$US-SA-2024SA203651$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240717$$MD$US$US
241055291$24105529$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA206051$SANOFI AVENTIS$$$$C$F$Y$$$20240717$$MD$US$US
241055301$24105530$1$I$20240601$20240705$20240717$20240717$PER$$US-SA-2024SA201289$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240717$$MD$US$US
241055311$24105531$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA204301$SANOFI AVENTIS$$14$YR$T$F$Y$42.5$KG$20240717$$MD$US$US
241055321$24105532$1$I$20240613$20240709$20240717$20240717$PER$$US-SA-2024SA204348$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240717$$MD$US$US
241055331$24105533$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010792$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240717$$CN$CA$CA
241055341$24105534$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010863$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240717$$CN$CA$CA
241055351$24105535$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010864$BAUSCH AND LOMB$$33$YR$$F$Y$$$20240717$$CN$CA$CA
241055361$24105536$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA205991$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240717$$MD$US$US
241055371$24105537$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA208088$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240717$$CN$US$US
241055381$24105538$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA205078$SANOFI AVENTIS$$$$$$Y$$$20240717$$CN$US$US
241055392$24105539$2$F$$20240715$20240717$20240809$PER$$US-SA-2024SA206329$SANOFI AVENTIS$$$$$$Y$$$20240809$$CN$US$US
241055401$24105540$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA205815$SANOFI AVENTIS$$$$C$M$Y$$$20240717$$MD$US$US
241055411$24105541$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA204156$SANOFI AVENTIS$$$$$$Y$$$20240717$$PH$US$US
241055421$24105542$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA205151$SANOFI AVENTIS$$$$C$M$Y$$$20240717$$MD$US$US
241055432$24105543$2$F$$20240712$20240717$20240722$PER$$US-SA-2024SA201642$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240720$$MD$US$US
241055442$24105544$2$F$20240101$20240918$20240717$20240925$PER$$US-SA-2024SA206548$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240925$$MD$US$US
241055451$24105545$1$I$$20240708$20240717$20240717$PER$$US-SA-2024SA204239$SANOFI AVENTIS$$$$A$F$Y$85.2$KG$20240717$$MD$US$US
241055462$24105546$2$F$20240101$20240808$20240717$20240816$PER$$US-SA-2024SA206905$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240816$$MD$US$US
241055471$24105547$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA206076$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240717$$MD$US$US
241055481$24105548$1$I$20240709$20240710$20240717$20240717$PER$$US-SA-2024SA207612$SANOFI AVENTIS$$57$YR$A$M$Y$109.76$KG$20240717$$MD$US$US
241055491$24105549$1$I$20240101$20240710$20240717$20240717$PER$$US-SA-2024SA206482$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240717$$MD$US$US
241055502$24105550$2$F$$20240719$20240717$20240731$PER$$US-SA-2024SA206092$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240731$$MD$US$US
241055511$24105551$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA206541$SANOFI AVENTIS$$$$E$F$Y$78$KG$20240717$$MD$US$US
241055521$24105552$1$I$$20240708$20240717$20240717$PER$$US-SA-2024SA203462$SANOFI AVENTIS$$$$E$F$Y$$$20240717$$MD$US$US
241055531$24105553$1$I$20240101$20240710$20240717$20240717$PER$$US-SA-2024SA207303$SANOFI AVENTIS$$$$$M$Y$$$20240717$$CN$US$US
241055541$24105554$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207375$SANOFI AVENTIS$$64$YR$A$M$Y$104.32$KG$20240717$$MD$US$US
241055551$24105555$1$I$$20240710$20240717$20240717$PER$$US-SA-2023SA231064$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240717$$MD$US$US
241055561$24105556$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207519$SANOFI AVENTIS$$$$C$M$Y$$$20240717$$MD$US$US
241055575$24105557$5$F$$20240813$20240717$20240821$PER$$US-SA-2024SA203671$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240821$$CN$US$US
241055581$24105558$1$I$$20240710$20240717$20240717$EXP$$GR-009507513-2407GRC009036$MERCK$$$$$M$Y$$$20240717$$PH$GR$GR
241055592$24105559$2$F$20240801$20240826$20240717$20240909$PER$$US-SA-2024SA206049$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240909$$CN$US$US
241055602$24105560$2$F$$20240809$20240717$20240820$PER$$US-SA-2024SA204585$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240820$$MD$US$US
241055612$24105561$2$F$20240612$20240730$20240717$20240808$PER$$US-SA-2024SA206620$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240808$$MD$US$US
241055621$24105562$1$I$20240101$20240708$20240717$20240717$PER$$US-SA-2024SA205165$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240717$$MD$US$US
241055633$24105563$3$F$20240101$20240918$20240717$20240927$PER$$US-SA-2024SA207854$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240927$$MD$US$US
241055641$24105564$1$I$$20240711$20240717$20240717$EXP$$DE-MYLANLABS-2024M1065485$MYLAN$$$$$M$Y$$$20240717$$PH$DE$DE
241055651$24105565$1$I$$20240709$20240717$20240717$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-098548$REGENERON$$$$$F$Y$$$20240717$$MD$CH$CH
241055663$24105566$3$F$$20240801$20240717$20240809$PER$$NVSC2024US147096$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
241055671$24105567$1$I$$20240708$20240717$20240717$PER$$US-SA-2024SA130577$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240717$$MD$US$US
241055681$24105568$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206611$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240717$$MD$US$US
241055691$24105569$1$I$20240701$20240708$20240717$20240717$PER$$US-SA-2024SA202960$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240717$$CN$US$US
241055701$24105570$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206208$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
241055711$24105571$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA204660$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240717$$MD$US$US
241055722$24105572$2$F$20240101$20240916$20240717$20240922$PER$$US-SA-2024SA207255$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240922$$MD$US$US
241055731$24105573$1$I$20240601$20240709$20240717$20240717$PER$$US-SA-2024SA203704$SANOFI AVENTIS$$2$YR$C$F$Y$10.8$KG$20240717$$MD$US$US
241055741$24105574$1$I$20240716$20240716$20240716$20240716$DIR$710385$$FDA-CTU$$50$YR$$M$N$$$20240716$N$$US$
241055751$24105575$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207235$SANOFI AVENTIS$$$$A$M$Y$90.7$KG$20240717$$MD$US$US
241055761$24105576$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207341$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240717$$MD$US$US
241055771$24105577$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207726$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240717$$MD$US$US
241055781$24105578$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA203538$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240717$$MD$US$US
241055791$24105579$1$I$20240701$20240710$20240717$20240717$PER$$US-SA-2024SA205017$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240717$$MD$US$US
241055801$24105580$1$I$20230101$20240710$20240717$20240717$PER$$US-SA-2024SA206345$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240717$$MD$US$US
241055811$24105581$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206551$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240717$$MD$US$US
241055821$24105582$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207528$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
241055833$24105583$3$F$20230301$20240808$20240717$20240816$PER$$US-SA-2024SA204638$SANOFI AVENTIS$$4$YR$C$F$Y$16.3$KG$20240816$$MD$US$US
241055842$24105584$2$F$20240101$20240827$20240717$20240828$EXP$$US-UCBSA-2024035851$UCB$$$$$F$Y$$$20240828$$CN$US$US
241055851$24105585$1$I$$20240709$20240717$20240717$EXP$$ES-INCYTE CORPORATION-2024IN007362$INCYTE$$$$$$Y$$$20240717$$MD$ES$ES
241055861$24105586$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010917$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240717$$CN$CA$CA
241055872$24105587$2$F$20240101$20240805$20240717$20240813$PER$$US-SA-2024SA200550$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240814$$MD$US$US
241055881$24105588$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA205458$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240717$$MD$US$US
241055891$24105589$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010924$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240717$$CN$CA$CA
241055901$24105590$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010922$BAUSCH AND LOMB$$59$YR$$F$Y$$$20240717$$CN$CA$CA
241055911$24105591$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010914$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240717$$CN$CA$CA
241055921$24105592$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010916$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240717$$CN$CA$CA
241055931$24105593$1$I$20230915$20240713$20240717$20240717$EXP$$ES-BAUSCH-BL-2024-010738$BAUSCH AND LOMB$$57$YR$$M$Y$$$20240717$$HP$ES$ES
241055941$24105594$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA205013$SANOFI AVENTIS$$50$YR$A$F$Y$80.73$KG$20240717$$MD$US$US
241055952$24105595$2$F$20240101$20240809$20240717$20240817$PER$$US-SA-2024SA203182$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240817$$MD$US$US
241055961$24105596$1$I$20240101$20240708$20240717$20240717$PER$$US-SA-2024SA205700$SANOFI AVENTIS$$$$E$F$Y$$$20240717$$MD$US$US
241055971$24105597$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207400$SANOFI AVENTIS$$$$T$M$Y$$$20240717$$MD$US$US
241055981$24105598$1$I$20240101$20240708$20240717$20240717$PER$$US-SA-2024SA159039$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240717$$MD$US$US
241055991$24105599$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207326$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240717$$MD$US$US
241056001$24105600$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206637$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240717$$MD$US$US
241056011$24105601$1$I$20240401$20240710$20240717$20240717$PER$$US-SA-2024SA207710$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240717$$MD$US$US
241056021$24105602$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA206519$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240717$$MD$US$US
241056031$24105603$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA205779$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
241056041$24105604$1$I$20240101$20240710$20240717$20240717$PER$$US-SA-2024SA207265$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240717$$MD$US$US
241056051$24105605$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA205466$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240717$$MD$US$US
241056061$24105606$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA204699$SANOFI AVENTIS$$$$E$F$Y$$$20240717$$MD$US$US
241056071$24105607$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA207853$SANOFI AVENTIS$$77$YR$E$F$Y$82$KG$20240717$$MD$US$US
241056082$24105608$2$F$20240712$20240806$20240717$20240812$EXP$$HU-TAKEDA-2024TUS071723$TAKEDA$$$$$F$Y$$$20240812$$CN$HU$HU
241056091$24105609$1$I$20240313$20240713$20240717$20240717$EXP$FR-AFSSAPS-AN2024000668$FR-BAUSCH-BL-2024-010728$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240717$$PH$FR$FR
241056103$24105610$3$F$20200101$20240719$20240717$20240729$PER$$US-SA-2024SA203821$SANOFI AVENTIS$$5$YR$C$M$Y$43.999$KG$20240729$$HP$US$US
241056112$24105611$2$F$$20240822$20240717$20240906$PER$$US-SA-2024SA207806$SANOFI AVENTIS$$$$A$M$Y$106.5$KG$20240906$$MD$US$US
241056122$24105612$2$F$20240101$20240810$20240717$20240819$PER$$US-SA-2024SA121595$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240819$$MD$US$US
241056132$24105613$2$F$20240101$20240712$20240717$20240723$PER$$US-SA-2024SA206609$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240724$$MD$US$US
241056141$24105614$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA206571$SANOFI AVENTIS$$61$YR$A$F$Y$74.8$KG$20240717$$MD$US$US
241056152$24105615$2$F$20240101$20240904$20240717$20240913$PER$$US-SA-2024SA204022$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240913$$MD$US$US
241056162$24105616$2$F$$20240709$20240717$20240718$PER$$US-SA-2024SA204273$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240718$$MD$US$US
241056171$24105617$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207357$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240717$$MD$US$US
241056181$24105618$1$I$20240501$20240710$20240717$20240717$PER$$US-SA-2024SA207472$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240717$$MD$US$US
241056191$24105619$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA206042$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240717$$MD$US$US
241056201$24105620$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206505$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240717$$MD$US$US
241056211$24105621$1$I$20240101$20240708$20240717$20240717$PER$$US-SA-2024SA202560$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240717$$MD$US$US
241056221$24105622$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA203690$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240717$$MD$US$US
241056231$24105623$1$I$20240610$20240716$20240716$20240716$DIR$710368$$FDA-CTU$$37$YR$$F$N$90.9$KG$20240716$N$PH$US$
241056241$24105624$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA206034$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
241056251$24105625$1$I$$20240716$20240716$20240716$DIR$710446$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241056262$24105626$2$F$20240101$20240722$20240717$20240729$PER$$US-SA-2024SA205764$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240729$$MD$US$US
241056272$24105627$2$F$20240101$20240730$20240717$20240807$PER$$US-SA-2024SA205467$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240807$$MD$US$US
241056281$24105628$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206442$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$HP$US$US
241056291$24105629$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207290$SANOFI AVENTIS$$$$C$M$Y$$$20240717$$MD$US$US
241056302$24105630$2$F$20240701$20240731$20240717$20240809$PER$$US-SA-2024SA206908$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240809$$CN$US$US
241056311$24105631$1$I$20240704$20240709$20240717$20240717$PER$$US-SA-2024SA205826$SANOFI AVENTIS$$57$YR$A$F$Y$85.7$KG$20240717$$MD$US$US
241056321$24105632$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA206540$SANOFI AVENTIS$$$$A$F$Y$77$KG$20240717$$MD$US$US
241056331$24105633$1$I$20240220$20240708$20240717$20240717$PER$$US-SA-2024SA205731$SANOFI AVENTIS$$59$YR$A$F$Y$77.17$KG$20240717$$MD$US$US
241056341$24105634$1$I$20240101$20240710$20240717$20240717$PER$$US-SA-2024SA207152$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240717$$MD$US$US
241056351$24105635$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA204349$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240717$$MD$US$US
241056361$24105636$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA206136$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240717$$MD$US$US
241056374$24105637$4$F$20240802$20240911$20240717$20240918$PER$$US-SA-2024SA204995$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240918$$MD$US$US
241056382$24105638$2$F$$20240805$20240717$20240814$PER$$US-SA-2024SA204712$SANOFI AVENTIS$$$$A$M$Y$79$KG$20240814$$MD$US$US
241056391$24105639$1$I$20240201$20240709$20240717$20240717$PER$$US-SA-2024SA205863$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240717$$MD$US$US
241056401$24105640$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207825$SANOFI AVENTIS$$$$A$M$Y$83.46$KG$20240717$$MD$US$US
241056411$24105641$1$I$$20240711$20240717$20240717$EXP$$DE-MYLANLABS-2024M1065463$MYLAN$$4$MON$$F$Y$$$20240717$$MD$DE$DE
241056421$24105642$1$I$20240601$20240710$20240717$20240717$PER$$US-SA-2024SA206349$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240717$$MD$US$US
241056431$24105643$1$I$20240101$20240708$20240717$20240717$PER$$US-SA-2024SA202794$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240717$$MD$US$US
241056441$24105644$1$I$20240701$20240709$20240717$20240717$PER$$US-SA-2024SA205133$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240717$$MD$US$US
241056451$24105645$1$I$$20240708$20240717$20240717$PER$$US-SA-2024SA205845$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240717$$MD$US$US
241056461$24105646$1$I$20240601$20240708$20240717$20240717$PER$$US-SA-2024SA203228$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240717$$MD$US$US
241056473$24105647$3$F$20240101$20240801$20240717$20240813$PER$$US-SA-2024SA203560$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240814$$PH$US$US
241056481$24105648$1$I$20240101$20240710$20240717$20240717$PER$$US-SA-2024SA206281$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240717$$MD$US$US
241056491$24105649$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA205481$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240717$$MD$US$US
241056501$24105650$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206632$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240717$$MD$US$US
241056512$24105651$2$F$20240101$20240803$20240717$20240812$PER$$US-SA-2024SA204579$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240812$$CN$US$US
241056522$24105652$2$F$20240101$20240903$20240717$20240928$PER$$US-SA-2024SA204550$SANOFI AVENTIS$$42$YR$A$F$Y$84.55$KG$20240928$$MD$US$US
241056531$24105653$1$I$20240101$20240708$20240717$20240717$PER$$US-SA-2024SA205024$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240717$$MD$US$US
241056541$24105654$1$I$20240701$20240710$20240717$20240717$PER$$US-SA-2024SA205602$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240717$$MD$US$US
241056563$24105656$3$F$20240101$20240917$20240717$20240924$PER$$US-SA-2024SA206837$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240924$$MD$US$US
241056571$24105657$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207867$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240717$$MD$US$US
241056581$24105658$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA205768$SANOFI AVENTIS$$$$$M$Y$$$20240717$$HP$US$US
241056591$24105659$1$I$20240101$20240710$20240717$20240717$PER$$US-SA-2024SA188895$SANOFI AVENTIS$$62$YR$A$M$Y$107.9$KG$20240717$$MD$US$US
241056601$24105660$1$I$20240601$20240708$20240717$20240717$PER$$US-SA-2024SA203328$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240717$$MD$US$US
241056611$24105661$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA205997$SANOFI AVENTIS$$$$C$M$Y$22$KG$20240717$$MD$US$US
241056621$24105662$1$I$20240702$20240709$20240717$20240717$EXP$GB-MHRA-TPP32770833C2677317YC1720440010522$GB-RDY-SPO/GBR/24/0010222$DR REDDYS$$10$YR$C$M$Y$28$KG$20240717$$HP$GB$GB
241056631$24105663$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA207606$SANOFI AVENTIS$$$$A$M$Y$97.5$KG$20240717$$MD$US$US
241056641$24105664$1$I$$20240708$20240717$20240717$EXP$$JP-009507513-2407JPN001314J$MERCK$$57$YR$$M$Y$$$20240717$$MD$JP$JP
241056661$24105666$1$I$20240301$20240711$20240717$20240717$PER$$US-SA-2024SA205941$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240717$$HP$US$US
241056671$24105667$1$I$20240101$20240711$20240717$20240717$PER$$US-SA-2024SA206252$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240717$$MD$US$US
241056681$24105668$1$I$20230101$20240710$20240717$20240717$PER$$US-SA-2024SA206312$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
241056691$24105669$1$I$20240101$20240711$20240717$20240717$PER$$US-SA-2024SA206467$SANOFI AVENTIS$$$$A$M$Y$$$20240717$$MD$US$US
241056701$24105670$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA205930$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240717$$MD$US$US
241056711$24105671$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA207590$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240717$$HP$US$US
241056721$24105672$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA205803$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$HP$US$US
241056731$24105673$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA206287$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240717$$MD$US$US
241056741$24105674$1$I$20240716$20240716$20240716$20240716$DIR$710513$$FDA-CTU$$68$YR$$F$N$67.5$KG$20240716$N$PH$US$
241056751$24105675$1$I$20240101$20240711$20240717$20240717$PER$$US-SA-2024SA207385$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240717$$MD$US$US
241056761$24105676$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA205935$SANOFI AVENTIS$$$$$M$Y$$$20240717$$CN$US$US
241056771$24105677$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA084722$SANOFI AVENTIS$$$$A$M$Y$$$20240717$$MD$US$US
241056781$24105678$1$I$20240711$20240711$20240717$20240717$PER$$US-SA-2024SA205810$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240717$$MD$US$US
241056791$24105679$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA206133$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240717$$CN$US$US
241056802$24105680$2$F$20240101$20240904$20240717$20240916$PER$$US-SA-2024SA207789$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240916$$MD$US$US
241056811$24105681$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA206933$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
241056831$24105683$1$I$20240709$20240716$20240717$20240717$EXP$$CN-BAYER-2024A103710$BAYER$$61$YR$A$M$Y$$$20240717$$HP$CN$CN
241056843$24105684$3$F$20240101$20240828$20240717$20240923$PER$$US-SA-2024SA206372$SANOFI AVENTIS$$86$YR$E$M$Y$80.1$KG$20240923$$MD$US$US
241056851$24105685$1$I$20240601$20240711$20240717$20240717$PER$$US-SA-2024SA207398$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240717$$MD$US$US
241056861$24105686$1$I$20240101$20240711$20240717$20240717$PER$$US-SA-2024SA205915$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240717$$PH$US$US
241056871$24105687$1$I$$20240712$20240717$20240717$PER$$US-SA-2024SA207635$SANOFI AVENTIS$$$$C$M$Y$$$20240717$$MD$US$US
241056881$24105688$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA207313$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240717$$MD$US$US
241056891$24105689$1$I$$20240712$20240717$20240717$PER$$US-SA-2024SA206949$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240717$$MD$US$US
241056901$24105690$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA206870$SANOFI AVENTIS$$$$$$Y$$$20240717$$MD$US$US
241056911$24105691$1$I$20240101$20240711$20240717$20240717$PER$$US-SA-2024SA207555$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240717$$MD$US$US
241056921$24105692$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA205942$SANOFI AVENTIS$$$$A$M$Y$$$20240717$$PH$US$US
241056931$24105693$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA205556$SANOFI AVENTIS$$43$YR$A$M$Y$229$KG$20240717$$MD$US$US
241056942$24105694$2$F$20240711$20240726$20240717$20240805$PER$$US-SA-2024SA207883$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240805$$CN$US$US
241056952$24105695$2$F$20220101$20240712$20240717$20240723$PER$$US-SA-2024SA207418$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240723$$MD$US$US
241056961$24105696$1$I$20230901$20240711$20240717$20240717$PER$$US-SA-2024SA207568$SANOFI AVENTIS$$57$YR$A$F$Y$106.5$KG$20240717$$MD$US$US
241056971$24105697$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA207864$SANOFI AVENTIS$$$$C$M$Y$15.4$KG$20240717$$MD$US$US
241056981$24105698$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA205630$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240717$$MD$US$US
241057001$24105700$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA207395$SANOFI AVENTIS$$$$$M$Y$$$20240717$$CN$US$US
241057011$24105701$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA206037$SANOFI AVENTIS$$$$E$M$Y$$$20240717$$MD$US$US
241057021$24105702$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA206308$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240717$$MD$US$US
241057031$24105703$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA207372$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240717$$MD$US$US
241057042$24105704$2$F$$20240719$20240717$20240801$PER$$US-SA-2024SA207314$SANOFI AVENTIS$$9$YR$C$F$Y$22.67$KG$20240801$$MD$US$US
241057051$24105705$1$I$$20240712$20240717$20240717$PER$$US-SA-2024SA208842$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240717$$MD$US$US
241057065$24105706$5$F$20240101$20240723$20240717$20240806$PER$$US-SA-2024SA206334$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240806$$MD$US$US
241057071$24105707$1$I$20240703$20240711$20240717$20240717$PER$$US-SA-2024SA205794$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$HP$US$US
241057082$24105708$2$F$20240728$20240731$20240717$20240809$PER$$US-SA-2024SA207336$SANOFI AVENTIS$$10$YR$C$F$Y$34.473$KG$20240809$$MD$US$US
241057091$24105709$1$I$20190301$20240711$20240717$20240717$PER$$US-SA-2024SA207577$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240717$$MD$US$US
241057101$24105710$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA206294$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240717$$MD$US$US
241057111$24105711$1$I$20210401$20240712$20240717$20240717$PER$$US-SA-2024SA206943$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240717$$CN$US$US
241057121$24105712$1$I$20240310$20240712$20240717$20240717$PER$$US-SA-2024SA207102$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240717$$MD$US$US
241057131$24105713$1$I$$20240710$20240717$20240717$EXP$$IL-BAYER-2024A100542$BAYER$$$$$M$Y$$$20240717$$HP$IL$IL
241057141$24105714$1$I$$20240712$20240717$20240717$PER$$US-SA-2024SA206991$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240717$$CN$US$US
241057152$24105715$2$F$$20240715$20240717$20240723$PER$$US-SA-2024SA206942$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240723$$MD$US$US
241057161$24105716$1$I$$20240712$20240717$20240717$PER$$US-SA-2024SA207199$SANOFI AVENTIS$$$$A$M$Y$117$KG$20240717$$MD$US$US
241057172$24105717$2$F$20240712$20240712$20240717$20240723$PER$$US-SA-2024SA207532$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240723$$HP$US$US
241057181$24105718$1$I$20240101$20240712$20240717$20240717$PER$$US-SA-2024SA207110$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240717$$HP$US$US
241057192$24105719$2$F$20230801$20240807$20240717$20240812$PER$$US-SA-2024SA208378$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240812$$MD$US$US
241057202$24105720$2$F$20130301$20240715$20240717$20240722$EXP$$ES-PFIZER INC-PV202400092790$PFIZER$Canueto, J.. Aggressive primary cutaneous CD30+ lymphoproliferative disorder in an organ transplant recipient in sustained complete remission with brentuximab vedotin. International Journal of Dermatology. 2018;57 (12):e153-e155$80$YR$$F$Y$$$20240722$$MD$ES$ES
241057211$24105721$1$I$$20240712$20240717$20240717$PER$$US-SA-2024SA206955$SANOFI AVENTIS$$$$E$F$Y$$$20240717$$MD$US$US
241057222$24105722$2$F$20220601$20240722$20240717$20240725$EXP$$CN-PFIZER INC-PV202400092469$PFIZER$Huang, J.. Case report: dose-dependent interaction between dexamethasone and voriconazole in severely ill patients with non-Hodgkin^s lymphoma being treated for invasive pulmonary aspergillosis. Frontiers in Pharmacology. 2024;15:1403966:10.3389/fphar.2024.1403966$64$YR$$M$Y$70$KG$20240725$$HP$CN$CN
241057231$24105723$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009897$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240717$$CN$US$US
241057241$24105724$1$I$$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010363$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240717$$CN$US$US
241057251$24105725$1$I$$20240711$20240717$20240717$EXP$$US-ROCHE-10000025711$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241057261$24105726$1$I$20240101$20240716$20240717$20240717$EXP$$TW-BAYER-2024A103712$BAYER$$$$$M$Y$$$20240717$$CN$TW$TW
241057281$24105728$1$I$20240505$20240715$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113496$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240717$$CN$US$US
241057291$24105729$1$I$$20240710$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110329$BRISTOL MYERS SQUIBB$$21$YR$A$M$Y$$$20240717$$HP$US$US
241057301$24105730$1$I$$20240711$20240717$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110824$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240717$$HP$CA$CA
241057311$24105731$1$I$$20240716$20240717$20240717$PER$$US-BAYER-2024A103863$BAYER$$$$$$Y$$$20240717$$CN$US$US
241057322$24105732$2$F$$20240723$20240717$20240724$EXP$$US-SANDOZ INC.-SDZ2024US065643$SANDOZ$$$$$F$Y$$$20240724$$CN$US$US
241057331$24105733$1$I$20240101$20240715$20240717$20240717$EXP$$GB-ABBVIE-5826610$ABBVIE$$48$YR$$F$Y$$$20240717$$CN$GB$GB
241057341$24105734$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5841473$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241057352$24105735$2$F$$20240729$20240717$20240806$EXP$$US-ABBVIE-5842176$ABBVIE$$$$$F$Y$43.091$KG$20240806$$CN$US$US
241057361$24105736$1$I$20240101$20240702$20240717$20240717$PER$$US-Millicent Holdings Ltd.-MILL20241010$MILLICENT HOLDINGS$$56$YR$A$F$Y$$$20240717$$CN$US$US
241057371$24105737$1$I$20240713$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140428$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241057381$24105738$1$I$$20240715$20240717$20240717$EXP$$GB-ABBVIE-5841164$ABBVIE$$$$E$M$Y$$$20240717$$CN$GB$GB
241057391$24105739$1$I$$20240710$20240717$20240717$EXP$$US-AMGEN-USASP2024137792$AMGEN$$$$E$F$Y$$$20240717$$CN$US$US
241057401$24105740$1$I$$20240617$20240717$20240717$PER$$US-LEX-000347$LEXICON PHARMACEUTICALS$$68$YR$$F$Y$$$20240717$$CN$US$US
241057411$24105741$1$I$20240514$20240712$20240717$20240717$EXP$$GB-AMGEN-GBRSP2024139001$AMGEN$$54$YR$A$F$Y$93$KG$20240717$$HP$GB$GB
241057421$24105742$1$I$20240101$20240709$20240717$20240717$PER$$JP-Eisai-EC-2024-169934$EISAI$$$$E$M$Y$$$20240717$$HP$JP$JP
241057431$24105743$1$I$$20201118$20240717$20240717$EXP$$US-AstraZeneca-2020SF54472$ASTRAZENECA$$64$YR$$F$Y$$$20240717$$CN$US$
241057441$24105744$1$I$20240601$20240709$20240717$20240717$EXP$FR-AFSSAPS-NT2024000773$FR-Eisai-EC-2024-169764$EISAI$$72$YR$E$F$Y$$$20240717$$CN$FR$FR
241057451$24105745$1$I$20201223$20210107$20240717$20240717$EXP$$US-AstraZeneca-2021A004105$ASTRAZENECA$$62$YR$$M$Y$$$20240717$$CN$US$
241057461$24105746$1$I$20240614$20240617$20240717$20240717$PER$$US-AstraZeneca-2024A141142$ASTRAZENECA$$28618$DY$$M$Y$69.4$KG$20240717$$PH$US$
241057471$24105747$1$I$20240320$20240716$20240717$20240717$EXP$$IT-WOODWARD-2024-IT-000095$WOODWARD PHARMA SERVICES$$32$YR$$F$Y$$$20240717$$PH$IT$IT
241057481$24105748$1$I$$20210514$20240717$20240717$EXP$$US-AstraZeneca-2021A011863$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241057492$24105749$2$F$20240101$20240813$20240717$20240822$PER$$US-SA-2024SA206152$SANOFI AVENTIS$$23$YR$A$M$Y$63.5$KG$20240822$$MD$US$US
241057502$24105750$2$F$20240101$20240812$20240717$20240816$EXP$$US-ABBVIE-5841964$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
241057511$24105751$1$I$20240306$20240709$20240717$20240717$PER$$US-SA-2024SA203808$SANOFI AVENTIS$$54$YR$A$M$Y$174.4$KG$20240717$$MD$US$US
241057521$24105752$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA209293$SANOFI AVENTIS$$$$C$F$Y$$$20240717$$CN$US$US
241057531$24105753$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA206141$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240717$$MD$US$US
241057541$24105754$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA207585$SANOFI AVENTIS$$$$E$F$Y$$$20240717$$MD$US$US
241057551$24105755$1$I$20240711$20240712$20240717$20240717$PER$$US-SA-2024SA207766$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240717$$MD$US$US
241057561$24105756$1$I$20240301$20240711$20240717$20240717$PER$$US-SA-2024SA206262$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240717$$MD$US$US
241057571$24105757$1$I$$20191204$20240717$20240717$EXP$$US-AstraZeneca-2019SF75969$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241057581$24105758$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157090$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241057591$24105759$1$I$20191101$20191118$20240717$20240717$EXP$$US-AstraZeneca-2019SF42843$ASTRAZENECA$$729$MON$$F$Y$$$20240717$$CN$US$
241057601$24105760$1$I$20240713$20240715$20240717$20240717$PER$$US-AstraZeneca-2024A161389$ASTRAZENECA$$25990$DY$$M$Y$$$20240717$$CN$US$
241057611$24105761$1$I$20240101$20240711$20240717$20240717$EXP$$US-ABBVIE-5838750$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241057622$24105762$2$F$20240707$20240831$20240717$20240909$EXP$$JP-BAYER-2024A099392$BAYER$$19$YR$A$M$Y$55.5$KG$20240909$$MD$JP$JP
241057631$24105763$1$I$20240520$20240709$20240717$20240717$EXP$$CN-AstraZeneca-2024A159000$ASTRAZENECA$$60$YR$$F$Y$54$KG$20240717$$MD$CN$
241057641$24105764$1$I$20240507$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405071407188760-QWSPF$GB-TEVA-VS-3218325$TEVA$$57$YR$$F$Y$$$20240717$$CN$GB$GB
241057651$24105765$1$I$20240702$20240713$20240717$20240717$PER$$US-JNJFOC-20240743721$JOHNSON AND JOHNSON$$$$$F$Y$$$20240717$$PH$US$US
241057662$24105766$2$F$$20240829$20240717$20240904$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001389$BLUEPRINT MEDICINES$$$$$F$Y$$$20240905$$MD$US$US
241057671$24105767$1$I$$20211229$20240717$20240717$EXP$$US-AstraZeneca-2021A909803$ASTRAZENECA$$17169$DY$$M$Y$$$20240717$$CN$US$
241057681$24105768$1$I$$20230626$20240717$20240717$EXP$$US-AstraZeneca-2023A147222$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241057691$24105769$1$I$$20240709$20240717$20240717$EXP$$CN-AstraZeneca-2024A159017$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$CN$
241057701$24105770$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157629$ASTRAZENECA$$$$$$Y$$$20240717$$PH$US$
241057711$24105771$1$I$$20191126$20240717$20240717$EXP$$US-AstraZeneca-2019SF61688$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241057721$24105772$1$I$20231209$20240710$20240717$20240717$EXP$$FR-AstraZeneca-2024A161299$ASTRAZENECA$$2$MON$$F$Y$5.3$KG$20240717$$MD$FR$
241057731$24105773$1$I$20240401$20240710$20240717$20240717$EXP$$RU-GSK-RU2024EME088399$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$RU$RU
241057741$24105774$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160376$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241057751$24105775$1$I$$20211206$20240717$20240717$EXP$$US-AstraZeneca-2021A857138$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241057771$24105777$1$I$20190818$20191030$20240717$20240717$EXP$$US-AstraZeneca-2019SF19696$ASTRAZENECA$$21124$DY$$F$Y$$$20240717$$MD$US$
241057781$24105778$1$I$20220227$20220317$20240717$20240717$EXP$$US-AstraZeneca-2022A118646$ASTRAZENECA$$61$YR$$M$Y$83$KG$20240717$$CN$US$
241057791$24105779$1$I$$20240708$20240717$20240717$PER$$US-ABBVIE-5834177$ABBVIE$$$$$$Y$$$20240717$$CN$US$US
241057801$24105780$1$I$$20190809$20240717$20240717$EXP$$US-AstraZeneca-2019SF16205$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241057811$24105781$1$I$20240706$20240712$20240717$20240717$EXP$$ZA-AstraZeneca-2024A160152$ASTRAZENECA$$56$YR$$F$Y$$$20240717$$CN$ZA$
241057822$24105782$2$F$$20240730$20240717$20240803$EXP$$CA-ABBVIE-5842433$ABBVIE$$$$$F$Y$$$20240803$$HP$CA$CA
241057833$24105783$3$F$20240708$20240809$20240717$20240816$EXP$$DE-BAXTER-2024BAX021491$BAXTER$$51$YR$$M$Y$$$20240816$$HP$DE$DE
241057842$24105784$2$F$$20240913$20240717$20240920$EXP$$ES-SANDOZ INC.-NVSC2023ES083617$SANDOZ$$6$YR$$F$Y$$$20240920$$HP$ES$ES
241057851$24105785$1$I$$20240716$20240717$20240717$EXP$$AU-SANDOZ INC.-SDZ2024AU065884$SANDOZ$$$$$$Y$$$20240717$$HP$AU$AU
241057861$24105786$1$I$20240704$20240716$20240717$20240717$EXP$$SA-ABBVIE-5842361$ABBVIE$$75$YR$$M$Y$$$20240717$$CN$SA$SA
241057872$24105787$2$F$$20240712$20240717$20240823$PER$$US-LUNDBECK-DKLU4000280$LUNDBECK$$$$$$Y$$$20240823$$CN$US$US
241057881$24105788$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112685$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240717$$HP$US$US
241057891$24105789$1$I$$20240712$20240717$20240717$EXP$$CO-ABBVIE-5817432$ABBVIE$$$$$M$Y$80$KG$20240717$$HP$CO$CO
241057903$24105790$3$F$20230901$20240724$20240717$20240801$EXP$$FR-SA-2024SA207530$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240801$$PH$FR$FR
241057911$24105791$1$I$$20240716$20240717$20240717$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040311$BOEHRINGER INGELHEIM$$$$$$Y$$$20240717$$MD$PL$PL
241057923$24105792$3$F$20240620$20240812$20240717$20240814$PER$$US-JNJFOC-20240734788$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240814$$CN$US$US
241057942$24105794$2$F$20211225$20240822$20240717$20240823$EXP$$AU-WOODWARD-2024-AU-000307$WOODWARD PHARMA SERVICES$$$$$M$Y$$$20240823$$HP$AU$AU
241057952$24105795$2$F$20230728$20240722$20240717$20240726$EXP$$ES-SANDOZ INC.-SDZ2023ES011284$SANDOZ$$95$YR$$M$Y$79$KG$20240726$$MD$ES$ES
241057962$24105796$2$F$20240601$20240715$20240717$20240718$EXP$$US-JNJFOC-20240740573$JOHNSON AND JOHNSON$$75$YR$E$F$Y$60.5$KG$20240718$$HP$US$US
241057971$24105797$1$I$20240601$20240711$20240717$20240717$EXP$$US-ARGENX-2024-ARGX-US005440$ARGENX BVBA$$$$$$Y$$$20240717$$CN$US$US
241057981$24105798$1$I$20240715$20240715$20240717$20240717$PER$$US-JNJFOC-20240738934$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240717$$CN$US$US
241057992$24105799$2$F$$20240722$20240717$20240723$EXP$$IE-PFIZER INC-202400215294$PFIZER$Howley, F.. Misidentification of Brucella melitensis as Ochrobactrum species: Potential pitfalls in the diagnosis of brucellosis. BMJ Case Reports. 2024;17(6):10.1136/bcr-2024-260072$3$DEC$$M$Y$$$20240723$$MD$IE$IE
241058001$24105800$1$I$$20240711$20240717$20240717$EXP$$ES-MYLANLABS-2024M1065880$MYLAN$$74$YR$$F$Y$$$20240717$$MD$ES$ES
241058012$24105801$2$F$20240514$20240814$20240717$20240826$EXP$$GB-CURIUM-2024000314$CURIUM PHARMACEUTICALS$$48$YR$$F$Y$$$20240826$$PH$GB$GB
241058021$24105802$1$I$$20240712$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112625$BRISTOL MYERS SQUIBB$$100$YR$E$F$Y$$$20240717$$CN$US$US
241058031$24105803$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140579$AMGEN$$$$$$Y$$$20240717$$HP$US$US
241058041$24105804$1$I$20240601$20240709$20240717$20240717$PER$$US-SA-2024SA205995$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240717$$MD$US$US
241058052$24105805$2$F$$20240819$20240717$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111879$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240828$$CN$US$US
241058061$24105806$1$I$$20240711$20240717$20240717$EXP$$IN-SANDOZ INC.-SDZ2024IN028651$SANDOZ$$$$$F$Y$$$20240717$$CN$IN$IN
241058071$24105807$1$I$20240704$20240711$20240717$20240717$PER$$US-ABBVIE-5840760$ABBVIE$$49$YR$$F$Y$$$20240717$$CN$US$US
241058081$24105808$1$I$20240613$20240711$20240717$20240717$EXP$FR-AFSSAPS-GR2024000860$FR-MYLANLABS-2024M1065332$MYLAN$$32$YR$$M$Y$76$KG$20240717$$PH$FR$FR
241058091$24105809$1$I$20240319$20240624$20240717$20240717$PER$$US-ABBVIE-5841155$ABBVIE$$25$YR$$F$Y$$$20240717$$HP$US$US
241058101$24105810$1$I$$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010356$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240717$$CN$US$US
241058111$24105811$1$I$$20240715$20240717$20240717$EXP$$BR-WOODWARD-2024-BR-000076$WOODWARD PHARMA SERVICES$$$$$M$Y$$$20240716$$HP$BR$BR
241058121$24105812$1$I$20240710$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009712$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240717$$CN$US$US
241058131$24105813$1$I$$20240703$20240717$20240717$PER$$US-Calliditas-2024CAL01256$CALLIDITAS THERAPEUTICS$$45$YR$A$F$Y$102.9$KG$20240717$$CN$US$US
241058142$24105814$2$F$20240629$20240716$20240717$20240723$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010476$JAZZ$$63$YR$$F$Y$$$20240722$$CN$US$US
241058151$24105815$1$I$20240708$20240715$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113426$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240717$$HP$US$US
241058162$24105816$2$F$$20240829$20240717$20240829$PER$$NVSC2024US147058$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
241058171$24105817$1$I$$20240625$20240717$20240717$PER$$AU-TOLMAR, INC.-24AU050535$TOLMAR$$$$$M$Y$$$20240717$$CN$AU$AU
241058181$24105818$1$I$$20240625$20240717$20240717$PER$$AU-TOLMAR, INC.-24AU050481$TOLMAR$$$$$M$Y$$$20240717$$CN$AU$AU
241058191$24105819$1$I$$20240716$20240717$20240717$PER$$NVSC2024US147286$NOVARTIS$$$$$$Y$$$20240717$$CN$US$US
241058202$24105820$2$F$$20240726$20240717$20240815$PER$$BR-TOLMAR, INC.-24BR050262$TOLMAR$$$$$M$Y$$$20240814$$CN$BR$BR
241058211$24105821$1$I$20240525$20240711$20240717$20240717$PER$$BR-TOLMAR, INC.-24BR049728$TOLMAR$$8$YR$$F$Y$$$20240717$$HP$BR$BR
241058221$24105822$1$I$$20240715$20240717$20240717$PER$$NVSC2024US147297$NOVARTIS$$$$$M$Y$$$20240717$$CN$US$US
241058231$24105823$1$I$20220101$20240625$20240717$20240717$PER$$BR-TOLMAR, INC.-24BR050538$TOLMAR$$$$$F$Y$$$20240717$$CN$BR$BR
241058241$24105824$1$I$20240622$20240711$20240717$20240717$EXP$$US-BIOGEN-2024BI01273478$BIOGEN$$50$YR$$F$Y$$$20240717$$CN$US$US
241058251$24105825$1$I$$20240625$20240717$20240717$PER$$BR-TOLMAR, INC.-24BR050492$TOLMAR$$$$$F$Y$$$20240717$$CN$BR$BR
241058261$24105826$1$I$20240523$20240625$20240717$20240717$PER$$CA-TOLMAR, INC.-24CA049788$TOLMAR$$$$E$M$Y$$$20240717$$HP$CA$CA
241058271$24105827$1$I$$20240712$20240717$20240717$EXP$$US-WOODWARD-2024-US-038315$WOODWARD PHARMA SERVICES$Habib A, Butt K, Ibrahim R, Shaaban A, Lee HS. .BRASH syndrome: A rare but reversible cause of sinus node dysfunction.Heart Rhythm Society.2024;10(6):398-401.$57$YR$$F$Y$$$20240716$$HP$US$US
241058281$24105828$1$I$20220901$20240716$20240717$20240717$EXP$AU-TGA-0000813057$AU-SANDOZ INC.-SDZ2024AU065716$SANDOZ$$$$$F$Y$$$20240717$$CN$AU$AU
241058291$24105829$1$I$20230707$20230731$20240717$20240717$PER$$US-GRUNENTHAL-2023-270391$AVERITAS$$89$YR$$F$Y$$$20240710$$HP$US$US
241058301$24105830$1$I$$20230804$20240717$20240717$PER$$US-GRUNENTHAL-2023-270196$AVERITAS$$$$E$F$Y$$$20240710$$HP$US$US
241058311$24105831$1$I$$20230608$20240717$20240717$PER$$US-GRUNENTHAL-2023-112543$AVERITAS$$$$E$F$Y$$$20240710$$PH$US$US
241058323$24105832$3$F$20240613$20240912$20240717$20240921$EXP$$JP-TEVA-VS-3221492$TEVA$$57$YR$$M$Y$60$KG$20240921$$PH$JP$JP
241058333$24105833$3$F$$20240827$20240717$20240904$EXP$$ES-AMGEN-ESPSP2024136535$AMGEN$Quesada-gomez J.M.; Entrenas-castillo M.; Entrenas-costa L.M. et al.. Calcifediol or Corticosteroids in the Treatment of COVID-19: An Observational Study. Nutrients. 2024;16 (12):1-13$$$$$Y$$$20240904$$HP$ES$ES
241058341$24105834$1$I$$20240703$20240717$20240717$EXP$$US-HLS-202400225$HLS THERAPEUTICS$$$$E$$Y$$$20240717$$HP$US$US
241058351$24105835$1$I$20240702$20240716$20240716$20240716$DIR$710378$$FDA-CTU$$73$YR$$M$N$92.25$KG$20240716$N$CN$US$
241058371$24105837$1$I$20240127$20240716$20240716$20240716$DIR$710387$$FDA-CTU$$23$YR$$F$N$67$KG$20240716$N$MD$US$
241058391$24105839$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49478$$FDA-CTU$$70$YR$$M$N$$$20240717$N$$US$
241058401$24105840$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49485$$FDA-CTU$$78$YR$$M$N$$$20240717$N$$US$
241058411$24105841$1$I$20240709$20240716$20240716$20240716$DIR$710440$$FDA-CTU$$80$YR$$F$N$$$20240716$N$$US$
241058421$24105842$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49475$$FDA-CTU$$42$YR$$M$N$$$20240717$N$$US$
241058431$24105843$1$I$20240716$20240716$20240716$20240716$DIR$710465$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
241058441$24105844$1$I$$20240716$20240716$20240716$DIR$710442$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241058451$24105845$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49487$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241058461$24105846$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49488$$FDA-CTU$$43$YR$$F$N$$$20240717$N$$US$
241058471$24105847$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49484$$FDA-CTU$$55$YR$$F$N$134$LBS$20240717$N$$US$
241058492$24105849$2$F$$20240816$20240717$20240822$EXP$$DE-JNJFOC-20240740787$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$MD$DE$DE
241058501$24105850$1$I$20240711$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112466$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240717$$HP$US$US
241058511$24105851$1$I$$20240711$20240717$20240717$PER$$JP-Eisai-EC-2024-170060$EISAI$$$$$M$Y$$$20240717$$MD$JP$JP
241058521$24105852$1$I$20240325$20240715$20240717$20240717$EXP$$AU-JNJFOC-20240737587$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240717$$CN$AU$AU
241058531$24105853$1$I$20240701$20240710$20240717$20240717$PER$$CN-Eisai-EC-2024-170109$EISAI$$83$YR$E$F$Y$49$KG$20240717$$HP$CN$CN
241058541$24105854$1$I$$20240710$20240717$20240717$PER$$JP-Eisai-EC-2024-170059$EISAI$Nagata Masayoshi. Urology Cancer Seminar.$61$YR$A$M$Y$$$20240717$$MD$JP$JP
241058551$24105855$1$I$$20240710$20240717$20240717$EXP$$CA-OTSUKA-2024_019671$OTSUKA$$$$$M$Y$$$20240717$$CN$CA$CA
241058561$24105856$1$I$$20240708$20240717$20240717$EXP$$JP-009507513-2407JPN001835J$MERCK$$8$DEC$$F$Y$$$20240717$$MD$JP$JP
241058572$24105857$2$F$$20240725$20240717$20240731$PER$$US-ALXN-202407USA000828US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241058581$24105858$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA205796$SANOFI AVENTIS$$$$$M$Y$$$20240717$$HP$US$US
241058592$24105859$2$F$20240101$20240807$20240717$20240814$PER$$US-SA-2024SA205899$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240814$$CN$US$US
241058602$24105860$2$F$20240624$20240823$20240717$20240902$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-13372$IPSEN$$41$YR$A$F$Y$$$20240902$$PH$JP$JP
241058611$24105861$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA207865$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240717$$MD$US$US
241058622$24105862$2$F$20240513$20240820$20240717$20240828$EXP$$US-AstraZeneca-2024A140467$ASTRAZENECA$$29561$DY$$M$Y$95.3$KG$20240828$$HP$US$
241058631$24105863$1$I$20240624$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A161442$ASTRAZENECA$$20363$DY$$F$Y$$$20240717$$CN$US$
241058641$24105864$1$I$20240603$20240714$20240717$20240717$EXP$GB-MHRA-MED-202407140618307480-QWSTH$GB-GSK-GB2024087818$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$GB$GB
241058651$24105865$1$I$$20191011$20240717$20240717$EXP$$US-AstraZeneca-2019SF46441$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241058661$24105866$1$I$20240708$20240709$20240717$20240717$EXP$$MX-AstraZeneca-2024A157228$ASTRAZENECA$$21385$DY$$M$Y$77$KG$20240717$$CN$MX$
241058671$24105867$1$I$$20191031$20240717$20240717$EXP$$US-AstraZeneca-2019SF57003$ASTRAZENECA$$$$$$Y$$$20240717$$CN$US$
241058681$24105868$1$I$20230727$20240712$20240717$20240717$EXP$$JP-AstraZeneca-2024A158701$ASTRAZENECA$$93$YR$$F$Y$$$20240717$$MD$JP$
241058691$24105869$1$I$20240603$20240716$20240717$20240717$EXP$$CN-PFIZER INC-PV202400093411$PFIZER$$33$YR$$F$Y$55$KG$20240717$$HP$CN$CN
241058721$24105872$1$I$20240529$20240710$20240717$20240717$EXP$$VN-PFIZER INC-202400191121$PFIZER$$50$YR$$F$Y$$$20240717$$CN$VN$VN
241058731$24105873$1$I$$20191112$20240717$20240717$EXP$$US-AstraZeneca-2019SF62732$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241058761$24105876$1$I$$20240717$20240717$20240717$EXP$$BE-PFIZER INC-202400217215$PFIZER$$$$A$F$Y$$$20240717$$MD$BE$BE
241058771$24105877$1$I$$20230918$20240717$20240717$PER$$US-NOVOPROD-1205492$NOVO NORDISK$$$$$F$Y$$$20240717$$CN$US$US
241058781$24105878$1$I$$20240716$20240717$20240717$EXP$$NVSC2024CA146867$NOVARTIS$$74$YR$$F$Y$$$20240717$$CN$CA$CA
241058791$24105879$1$I$$20240709$20240717$20240717$EXP$$ES-AMGEN-ESPSP2024136554$AMGEN$Quesada-gomez J.M.; Entrenas-castillo M.; Entrenas-costa L.M. et al.. Calcifediol or Corticosteroids in the Treatment of COVID-19: An Observational Study. Nutrients. 2024;16 (12):1-13$$$$$Y$$$20240717$$HP$ES$ES
241058801$24105880$1$I$20240701$20240712$20240717$20240717$EXP$$US-ABBVIE-5839288$ABBVIE$$86$YR$$F$Y$$$20240717$$CN$US$US
241058811$24105881$1$I$$20240711$20240717$20240717$EXP$$US-AMGEN-USASP2024138024$AMGEN$Rimel B.; Boyle T.; Burns S. et al.. Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study. Oncology and Therapy. 2024;1-11$$$$$Y$$$20240717$$HP$US$US
241058822$24105882$2$F$$20240820$20240717$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113434$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240823$$CN$US$US
241058831$24105883$1$I$$20240712$20240717$20240717$EXP$$US-AMGEN-USASP2024139566$AMGEN$$$$$$Y$$$20240717$$HP$US$US
241058841$24105884$1$I$20240101$20240709$20240717$20240717$EXP$$US-AMGEN-USASL2024129053$AMGEN$$48$YR$A$M$Y$$$20240717$$MD$US$US
241058851$24105885$1$I$$20240710$20240717$20240717$EXP$$CA-TEVA-VS-3220119$TEVA$$55$YR$$F$Y$$$20240717$$HP$CA$CA
241058861$24105886$1$I$20240701$20240711$20240717$20240717$PER$$US-SA-2024SA207616$SANOFI AVENTIS$$64$YR$A$M$Y$90.703$KG$20240717$$MD$US$US
241058871$24105887$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA206044$SANOFI AVENTIS$$$$T$F$Y$53.523$KG$20240717$$MD$US$US
241058881$24105888$1$I$20240701$20240705$20240717$20240717$EXP$$ES-TEVA-VS-3219987$TEVA$$60$YR$$F$Y$$$20240717$$CN$ES$ES
241058891$24105889$1$I$$20240510$20240717$20240717$PER$$US-KARYOPHARM-2024KPT001061$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240717$$MD$US$US
241058902$24105890$2$F$20240101$20240718$20240717$20240918$PER$$US-KARYOPHARM-2024KPT001290$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240918$$HP$US$US
241058912$24105891$2$F$20240530$20240720$20240717$20240730$EXP$FR-AFSSAPS-PA2024001240$ALC2024FR003296$ALCON$$$$$$Y$$$20240730$$HP$FR$FR
241058921$24105892$1$I$$20240712$20240717$20240717$PER$$US-ABBVIE-5842754$ABBVIE$$$$$$Y$$$20240717$$CN$US$US
241058931$24105893$1$I$20240101$20240710$20240717$20240717$EXP$$US-ABBVIE-5837968$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241058941$24105894$1$I$$20240716$20240717$20240717$PER$$US-JNJFOC-20240742350$JOHNSON AND JOHNSON$$$$$$Y$$$20240717$$CN$US$US
241058954$24105895$4$F$$20240812$20240717$20240822$30DAY$$US-JNJFOC-20240733791$JOHNSON AND JOHNSON$$71$YR$E$M$Y$90.346$KG$20240822$$HP$US$US
241058961$24105896$1$I$20230501$20230531$20240717$20240717$PER$$US-GRUNENTHAL-2023-112167$AVERITAS$$71$YR$$F$Y$$$20240710$$HP$US$US
241058971$24105897$1$I$20230301$20230607$20240717$20240717$PER$$US-GRUNENTHAL-2023-112538$AVERITAS$$81$YR$$M$Y$90.703$KG$20240710$$CN$US$US
241058981$24105898$1$I$$20240707$20240717$20240717$EXP$$US-JNJFOC-20240732254$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240717$$HP$US$US
241058992$24105899$2$F$$20240717$20240717$20240726$PER$$NVSC2024US146551$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
241059013$24105901$3$F$$20240719$20240717$20240725$PER$$US-ROCHE-10000025332$ROCHE$$$$$$Y$$$20240725$$MD$US$US
241059021$24105902$1$I$20240303$20240712$20240717$20240717$EXP$FR-AFSSAPS-AM2024000488$FR-ROCHE-10000026000$ROCHE$$83$YR$E$F$Y$58$KG$20240717$$MD$FR$FR
241059031$24105903$1$I$$20240712$20240717$20240717$EXP$$US-ROCHE-10000025976$ROCHE$$$$A$F$Y$$$20240717$$CN$US$US
241059052$24105905$2$F$20240708$20240731$20240717$20240809$PER$$US-SA-2024SA202014$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240809$$MD$US$US
241059061$24105906$1$I$20240101$20240711$20240717$20240717$PER$$US-SA-2024SA207759$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240717$$MD$US$US
241059071$24105907$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA206139$SANOFI AVENTIS$$$$C$M$Y$22.6$KG$20240717$$MD$US$US
241059081$24105908$1$I$$20240716$20240716$20240716$DIR$710424$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241059091$24105909$1$I$$20240708$20240717$20240717$PER$$US-SA-2024SA202573$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
241059101$24105910$1$I$20240101$20240711$20240717$20240717$PER$$US-SA-2024SA208913$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240717$$MD$US$US
241059112$24105911$2$F$20240101$20240919$20240717$20240926$EXP$$US-ABBVIE-5841860$ABBVIE$$$$$F$Y$63$KG$20240926$$CN$US$US
241059121$24105912$1$I$$20230626$20240717$20240717$PER$$US-GRUNENTHAL-2023-112150$AVERITAS$$$$A$F$Y$$$20240710$$HP$US$US
241059131$24105913$1$I$20230531$20230601$20240717$20240717$PER$$US-GRUNENTHAL-2023-112261$AVERITAS$$76$YR$$F$Y$$$20240710$$CN$US$US
241059141$24105914$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000027642$ROCHE$Unknown ,  Case report of QT interval prolongation induced by anamorelin in an obese patient with non-small cell lung cancer. Journal of Pharmaceutical Health Care and Sciences. 2024-Jun-26;10 (1):33.$$$A$F$Y$$$20240717$$HP$US$US
241059151$24105915$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000027555$ROCHE$$62$YR$A$M$Y$$$20240717$$CN$US$US
241059162$24105916$2$F$20240601$20240829$20240717$20240903$EXP$$CA-JNJFOC-20240728570$JOHNSON AND JOHNSON$$57$YR$A$M$Y$68$KG$20240903$$HP$CA$CA
241059171$24105917$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49483$$FDA-CTU$$27$YR$$M$N$266$LBS$20240717$N$$US$
241059181$24105918$1$I$20211022$20240711$20240717$20240717$EXP$FR-AFSSAPS-AM2024000546$FR-MYLANLABS-2024M1065339$MYLAN$$91$YR$$F$Y$45.4$KG$20240717$$MD$FR$FR
241059193$24105919$3$F$$20240829$20240717$20240829$PER$$NVSC2024US147061$NOVARTIS$$$$$F$Y$$$20240829$$HP$US$US
241059202$24105920$2$F$20240108$20240716$20240717$20240719$EXP$$NVSC2024TH147132$NOVARTIS$$$$$F$Y$$$20240719$$MD$TH$TH
241059211$24105921$1$I$20240706$20240708$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407005092$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240717$$CN$US$US
241059221$24105922$1$I$20240713$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009916$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240717$$CN$US$US
241059231$24105923$1$I$20240713$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009165$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240717$$CN$US$US
241059241$24105924$1$I$20240601$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009899$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240717$$CN$US$US
241059254$24105925$4$F$$20240904$20240717$20240906$PER$$US-PFIZER INC-PV202400087233$PFIZER$$$$$$Y$$$20240906$$CN$US$US
241059261$24105926$1$I$20240716$20240716$20240716$20240716$DIR$710462$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
241059272$24105927$2$F$$20240820$20240717$20240828$EXP$$IN-PFIZER INC-2023SGN08821$PFIZER$$33$YR$$M$Y$$$20240828$$CN$IN$IN
241059282$24105928$2$F$20240710$20240812$20240717$20240822$PER$$US-APELLIS-2024-APL-0000457$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240822$$CN$US$US
241059291$24105929$1$I$$20240712$20240717$20240717$PER$$US-ABBVIE-5840507$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241059301$24105930$1$I$$20240715$20240717$20240717$EXP$$US-AMGEN-USASP2024140886$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241059311$24105931$1$I$$20240712$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA065480$SANDOZ$$28$YR$$M$Y$$$20240717$$CN$CA$CA
241059321$24105932$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140736$AMGEN$$$$$$Y$$$20240717$$HP$US$US
241059331$24105933$1$I$$20240711$20240717$20240717$EXP$$BR-BIOMARINAP-BR-2024-159223$BIOMARIN$$$$$$Y$$$20240717$$CN$BR$BR
241059342$24105934$2$F$$20240831$20240717$20240904$EXP$$TW-009507513-2407TWN008259$MERCK$$$$$F$Y$$$20240904$$MD$TW$TW
241059362$24105936$2$F$$20240819$20240717$20240825$30DAY$$US-AMGEN-USASP2024138316$AMGEN$$$$$$Y$$$20240825$$CN$US$US
241059371$24105937$1$I$$20240710$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065734$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$43$YR$$F$Y$$$20240717$$HP$FR$FR
241059381$24105938$1$I$$20240712$20240717$20240717$EXP$$JP-JNJFOC-20240724738$JOHNSON AND JOHNSON$$$$C$$Y$5.7$KG$20240717$$PH$JP$JP
241059391$24105939$1$I$20240409$20240709$20240717$20240717$EXP$$TW-GSK-TW2024APC086139$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$PH$TW$TW
241059401$24105940$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49482$$FDA-CTU$$68$YR$$F$N$$$20240717$N$$US$
241059411$24105941$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49480$$FDA-CTU$$65$YR$$M$N$$$20240717$N$$US$
241059421$24105942$1$I$$20240704$20240717$20240717$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092163$GLENMARK$Fink NS, Abubshait L, Deshisky A.. Anti-HMGCR (Hydroxy-3-Methylglutaryl-CoA Reductase) Myopathy: A Rare Cause of Proximal Muscle Weakness.. Cureus.. 2024;16(5):e61094$$$$$Y$$$20240717$$MD$US$US
241059451$24105945$1$I$$20240709$20240717$20240717$PER$$US-AMGEN-USASP2024135954$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241059462$24105946$2$F$20240531$20240731$20240717$20240806$30DAY$$US-AMGEN-USASP2024138568$AMGEN$$68$YR$E$F$Y$$$20240806$$HP$US$US
241059471$24105947$1$I$20240625$20240704$20240717$20240717$EXP$$CN-TAKEDA-2024TUS070755$TAKEDA$$54$YR$$F$Y$62$KG$20240717$$HP$CN$CN
241059481$24105948$1$I$$20240710$20240717$20240717$EXP$$CA-TEVA-VS-3220125$TEVA$$64$YR$$F$Y$$$20240717$$HP$CA$CA
241059491$24105949$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49481$$FDA-CTU$$48$YR$$M$N$$$20240717$N$$US$
241059501$24105950$1$I$$20240716$20240717$20240717$EXP$$AU-SANDOZ INC.-SDZ2024AU065632$SANDOZ$$67$YR$$F$Y$$$20240717$$MD$AU$AU
241059511$24105951$1$I$20240701$20240716$20240716$20240716$DIR$710455$$FDA-CTU$$76$YR$$M$N$$$20240716$Y$HP$US$
241059523$24105952$3$F$$20240821$20240717$20240821$30DAY$$US-PFIZER INC-202400214976$PFIZER$$14$YR$$M$Y$$$20240821$$CN$US$US
241059533$24105953$3$F$20240629$20240907$20240717$20240909$30DAY$$CO-PFIZER INC-202400207698$PFIZER$$12$YR$$F$Y$$$20240909$$CN$CO$CO
241059543$24105954$3$F$$20240911$20240717$20240913$30DAY$$US-PFIZER INC-202400212911$PFIZER$$11$YR$$M$Y$$$20240913$$CN$US$US
241059554$24105955$4$F$$20240911$20240717$20240913$30DAY$$US-PFIZER INC-202400211298$PFIZER$$36$YR$$F$Y$72.57$KG$20240913$$CN$US$US
241059561$24105956$1$I$$20240715$20240717$20240717$EXP$$AU-SANDOZ INC.-NVSC2022AU238604$SANDOZ$$68$YR$$M$Y$$$20240717$$MD$AU$AU
241059572$24105957$2$F$$20240822$20240717$20240822$30DAY$$FR-PFIZER INC-PV202400091861$PFIZER$$12$YR$$M$Y$$$20240822$$CN$FR$FR
241059593$24105959$3$F$$20240911$20240717$20240911$30DAY$$CO-PFIZER INC-202400206831$PFIZER$$9$YR$$M$Y$$$20240911$$CN$CO$CO
241059602$24105960$2$F$$20240716$20240717$20240718$30DAY$$US-PFIZER INC-PV202400044510$PFIZER$$$$$$Y$$$20240718$$HP$US$US
241059612$24105961$2$F$20240610$20240903$20240717$20240904$30DAY$$CL-PFIZER INC-202400203307$PFIZER$$8$YR$$$Y$$$20240904$$CN$CL$CL
241059621$24105962$1$I$$20240715$20240717$20240717$EXP$NL-LRB-00984350$NL-PFIZER INC-202400214738$PFIZER$$42$YR$$F$Y$149$KG$20240717$$MD$NL$NL
241059632$24105963$2$F$$20240908$20240717$20240909$30DAY$$CO-PFIZER INC-PV202400087944$PFIZER$$$$$$Y$$$20240909$$MD$CO$CO
241059644$24105964$4$F$$20240916$20240717$20240919$30DAY$$CL-PFIZER INC-202400215043$PFIZER$$55$YR$$$Y$$$20240919$$CN$CL$CL
241059652$24105965$2$F$$20240729$20240717$20240802$EXP$$HU-BIOGEN-2024BI01273522$BIOGEN$$79$YR$$F$Y$$$20240802$$MD$HU$HU
241059661$24105966$1$I$20170701$20240709$20240717$20240717$PER$$US-SA-2024SA206099$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240717$$MD$US$US
241059671$24105967$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA197467$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240717$$MD$US$US
241059681$24105968$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112862$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240717$$CN$US$US
241059701$24105970$1$I$20240606$20240703$20240717$20240717$PER$$US-ROCHE-10000019001$ROCHE$$68$YR$E$M$Y$$$20240717$$CN$US$US
241059711$24105971$1$I$20240624$20240708$20240717$20240717$PER$$CN-Eisai-EC-2024-169877$EISAI$$52$YR$A$M$Y$$$20240717$$HP$CN$CN
241059722$24105972$2$F$$20240802$20240717$20240808$EXP$$JP-Eisai-EC-2024-169930$EISAI$$$$$$Y$$$20240808$$PH$JP$JP
241059731$24105973$1$I$$20211214$20240717$20240717$EXP$$US-AstraZeneca-2021A879060$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241059742$24105974$2$F$$20240905$20240717$20240911$EXP$$US-AstraZeneca-2024A157124$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
241059751$24105975$1$I$$20240716$20240716$20240716$DIR$710390$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241059761$24105976$1$I$20240714$20240716$20240716$20240716$DIR$710374$$FDA-CTU$$70$YR$$F$N$60$KG$20240716$N$CN$US$
241059771$24105977$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160127$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241059781$24105978$1$I$$20240703$20240717$20240717$EXP$$US-HLS-202400229$HLS THERAPEUTICS$$72$YR$E$F$Y$$$20240717$$PH$US$US
241059791$24105979$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160098$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241059801$24105980$1$I$20240629$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49486$$FDA-CTU$$83$YR$$M$N$$$20240717$Y$PH$US$
241059811$24105981$1$I$$20240709$20240717$20240717$EXP$$GB-AstraZeneca-2024A155899$ASTRAZENECA$$$$$M$Y$$$20240717$$MD$GB$
241059821$24105982$1$I$20240701$20240716$20240716$20240716$DIR$710417$$FDA-CTU$$64$YR$$F$N$67.95$KG$20240716$N$CN$US$
241059841$24105984$1$I$20240622$20240709$20240717$20240717$EXP$$IT-AstraZeneca-2024A156358$ASTRAZENECA$$67$YR$$M$Y$$$20240717$$MD$IT$
241059851$24105985$1$I$$20240713$20240717$20240717$EXP$$JP-AstraZeneca-2024A162830$ASTRAZENECA$Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M. Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice.$$$$$Y$$$20240717$$HP$JP$
241059861$24105986$1$I$20240614$20240710$20240717$20240717$EXP$$IT-AstraZeneca-2024A161689$ASTRAZENECA$$50$YR$$F$Y$$$20240717$$MD$IT$
241059871$24105987$1$I$$20210609$20240717$20240717$EXP$$AU-AstraZeneca-2021A475758$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$AU$
241059881$24105988$1$I$$20190829$20240717$20240717$EXP$$US-AstraZeneca-2019SF25249$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241059891$24105989$1$I$$20240709$20240717$20240717$EXP$$SG-AstraZeneca-2024A157196$ASTRAZENECA$$$$$F$Y$$$20240717$$MD$SG$
241059901$24105990$1$I$20240630$20240709$20240717$20240717$EXP$$CO-AstraZeneca-2024A159379$ASTRAZENECA$$32661$DY$$F$Y$$$20240717$$CN$CO$
241059911$24105991$1$I$$20240712$20240717$20240717$EXP$$GB-AstraZeneca-2024A160731$ASTRAZENECA$$$$$F$Y$$$20240717$$HP$GB$
241059921$24105992$1$I$$20200923$20240717$20240717$EXP$$US-AstraZeneca-2020SF23086$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241059931$24105993$1$I$20240709$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157673$ASTRAZENECA$$34531$DY$$M$Y$$$20240717$$CN$US$
241059951$24105995$1$I$$20190731$20240717$20240717$EXP$$US-AstraZeneca-2019SF11640$ASTRAZENECA$$86$YR$$M$Y$$$20240717$$CN$US$
241059961$24105996$1$I$20150719$20240711$20240717$20240717$EXP$$FR-PFIZER INC-2015SGN01295$PFIZER$$32$YR$$M$Y$95$KG$20240717$$MD$FR$FR
241059972$24105997$2$F$20240214$20240912$20240717$20240916$EXP$$JP-PFIZER INC-PV202400093477$PFIZER$$56$YR$$F$Y$53$KG$20240916$$PH$JP$JP
241059981$24105998$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49489$$FDA-CTU$$81$YR$$F$N$$$20240717$N$$US$
241059991$24105999$1$I$$20240716$20240716$20240716$DIR$710443$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241060001$24106000$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49490$$FDA-CTU$$32$YR$$F$N$$$20240717$N$$US$
241060012$24106001$2$F$$20240908$20240717$20240909$EXP$$CA-PFIZER INC-PV202400085397$PFIZER$$65$YR$$M$Y$65$KG$20240909$$MD$CA$CA
241060023$24106002$3$F$$20240814$20240717$20240816$30DAY$$CA-PFIZER INC-202400216379$PFIZER$$$$$$Y$$$20240816$$HP$CA$CA
241060031$24106003$1$I$$20240712$20240717$20240717$PER$$US-SA-2024SA207822$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240717$$MD$US$US
241060041$24106004$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA206085$SANOFI AVENTIS$$$$A$F$Y$71$KG$20240717$$MD$US$US
241060051$24106005$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113718$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240717$$HP$US$US
241060061$24106006$1$I$20231113$20240709$20240717$20240717$EXP$GB-MHRA-MED-202405091424109540-SRJVM$GB-TEVA-VS-3219974$TEVA$$62$YR$$M$Y$$$20240717$$HP$GB$GB
241060071$24106007$1$I$20240101$20240711$20240717$20240717$EXP$$JP-009507513-2407JPN002283J$MERCK$$8$DEC$$M$Y$$$20240717$$MD$JP$JP
241060081$24106008$1$I$20230508$20230525$20240717$20240717$PER$$US-GRUNENTHAL-2023-111617$AVERITAS$$66$YR$$M$Y$$$20240710$$MD$US$US
241060092$24106009$2$F$$20240716$20240717$20240723$EXP$$CA-GSK-CA2024062379$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$HP$CA$CA
241060101$24106010$1$I$$20240709$20240717$20240717$PER$$US-APELLIS-APL-2022-001457$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
241060112$24106011$2$F$20240529$20240911$20240717$20240919$EXP$$US-BIOMARINAP-US-2024-159219$BIOMARIN$$$$$$Y$$$20240919$$MD$US$US
241060121$24106012$1$I$$20240709$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159143$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241060131$24106013$1$I$$20240716$20240717$20240717$EXP$$NVSC2024CA146861$NOVARTIS$$85$YR$$F$Y$$$20240717$$HP$CA$CA
241060141$24106014$1$I$20240624$20240710$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159166$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241060152$24106015$2$F$$20240716$20240717$20240813$EXP$$CA-ORGANON-O2407CAN001443$ORGANON$$65$YR$$M$Y$$$20240813$$HP$CA$CA
241060171$24106017$1$I$$20240713$20240717$20240717$EXP$$ES-ANIPHARMA-2024-ES-000070$ANI$Fernandez-Gordon Sanchez FM, Gomez Labrador C, Wong Becerra L, et al.Active microscopic colitis precipitated by fluoxetine..Revista Espanola De Enfermedades Digestivas.2024;.$41$YR$$F$Y$$$20240717$$HP$ES$ES
241060184$24106018$4$F$20240617$20240917$20240717$20240924$EXP$$CA-BEH-2024174545$CSL BEHRING$$80$YR$E$F$Y$72$KG$20240924$$CN$CA$CA
241060191$24106019$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113840$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240717$$CN$US$US
241060201$24106020$1$I$$20240709$20240717$20240717$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-109384$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240717$$MD$IT$IT
241060211$24106021$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112365$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240717$$CN$US$US
241060221$24106022$1$I$20240101$20240712$20240717$20240717$EXP$$JP-ABBVIE-5838523$ABBVIE$$$$$$Y$$$20240717$$CN$JP$JP
241060231$24106023$1$I$$20240717$20240717$20240717$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040301$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$$$20240717$$MD$RU$RU
241060241$24106024$1$I$$20240717$20240717$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040331$BOEHRINGER INGELHEIM$$$$$$Y$$$20240717$$HP$US$US
241060251$24106025$1$I$20240401$20240711$20240717$20240717$PER$$US-ALXN-202407USA000825US$ALEXION PHARMACEUTICALS$$67$YR$$M$Y$$$20240717$$CN$US$US
241060261$24106026$1$I$$20230710$20240717$20240717$PER$$US-GRUNENTHAL-2023-112317$AVERITAS$$$$E$F$Y$$$20240710$$CN$US$US
241060271$24106027$1$I$20230530$20230629$20240717$20240717$PER$$US-GRUNENTHAL-2023-112412$AVERITAS$$62$YR$$M$Y$$$20240710$$PH$US$US
241060281$24106028$1$I$20230601$20230712$20240717$20240717$PER$$US-GRUNENTHAL-2023-112961$AVERITAS$$20$YR$$F$Y$$$20240710$$HP$US$US
241060292$24106029$2$F$20240712$20240820$20240717$20240823$EXP$$US-GSK-US2024088650$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$PH$US$US
241060301$24106030$1$I$$20240709$20240717$20240717$EXP$$ZA-AstraZeneca-2024A157128$ASTRAZENECA$$80$YR$$M$Y$$$20240717$$CN$ZA$
241060311$24106031$1$I$20190411$20190916$20240717$20240717$EXP$$CO-AstraZeneca-2019SF08637$ASTRAZENECA$$17869$DY$$F$Y$$$20240717$$CN$CO$
241060322$24106032$2$F$20140101$20240909$20240717$20240911$EXP$$GB-TEVA-VS-3221611$TEVA$$$$A$M$Y$73$KG$20240911$$MD$GB$GB
241060331$24106033$1$I$$20240709$20240717$20240717$EXP$$FR-AstraZeneca-2024A160899$ASTRAZENECA$$$$$F$Y$74$KG$20240717$$CN$FR$
241060342$24106034$2$F$$20240710$20240717$20240717$EXP$$JP-AstraZeneca-2024A016878$ASTRAZENECA$Fujii Y, et al.. P5-4 Study on efficacy and safety of durvalumab + tremelimumab in patients with unresectable hepatocellular carcinoma.. The 29th Japan Association of Systemic Therapy for HCC 2024;104-. .$$$A$$Y$$$20240717$$MD$JP$
241060351$24106035$1$I$20180101$20210407$20240717$20240717$EXP$$US-AstraZeneca-2021A286442$ASTRAZENECA$$64$YR$$M$Y$88.5$KG$20240717$$CN$US$
241060361$24106036$1$I$$20240709$20240717$20240717$EXP$$JP-AstraZeneca-2024A158648$ASTRAZENECA$Tanaka S. et al.. Case report two cases of tako-tsubo cardiomyopathy during egfr-tki therapy for rare non-small cell lung cancer with egfr gene mutations.. Japanese Journal of Lung Cancer 2024;64(3):200-205.$82$YR$$F$Y$$$20240717$$MD$JP$
241060371$24106037$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157324$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241060381$24106038$1$I$20240708$20240716$20240716$20240716$DIR$710528$$FDA-CTU$$55$YR$$M$N$128.25$KG$20240716$Y$CN$US$
241060392$24106039$2$F$$20240808$20240717$20240820$PER$$US-AstraZeneca-2024A160061$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
241060401$24106040$1$I$$20240712$20240717$20240717$EXP$$GB-AstraZeneca-2024A159905$ASTRAZENECA$$$$$F$Y$$$20240717$$MD$GB$
241060411$24106041$1$I$20240713$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009162$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240717$$CN$US$US
241060421$24106042$1$I$20240423$20240716$20240716$20240716$DIR$710404$$FDA-CTU$$69$YR$$M$N$51.9$KG$20240716$N$HP$US$
241060431$24106043$1$I$20240716$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49508$$FDA-CTU$$71$YR$$M$N$74.84$KG$20240717$N$PH$US$
241060441$24106044$1$I$20191125$20210430$20240717$20240717$EXP$$CO-AstraZeneca-2021A391842$ASTRAZENECA$$24958$DY$$M$Y$$$20240717$$CN$CO$
241060451$24106045$1$I$20190910$20190930$20240717$20240717$EXP$$CO-AstraZeneca-2019SF39993$ASTRAZENECA$$19748$DY$$M$Y$$$20240717$$CN$CO$
241060461$24106046$1$I$20231207$20240710$20240717$20240717$EXP$$FR-AstraZeneca-2024A161289$ASTRAZENECA$$1$MON$$M$Y$5.4$KG$20240717$$MD$FR$
241060471$24106047$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A161431$ASTRAZENECA$$$$$$Y$$$20240717$$MD$US$
241060481$24106048$1$I$20240712$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215970$PFIZER$$82$YR$$F$Y$$$20240717$$CN$US$US
241060491$24106049$1$I$$20240716$20240717$20240717$PER$$US-PFIZER INC-202400216565$PFIZER$$81$YR$$F$Y$$$20240717$$CN$US$US
241060501$24106050$1$I$20240509$20240709$20240717$20240717$EXP$IT-MINISAL02-992680$IT-TEVA-VS-3219316$TEVA$$56$YR$$F$Y$$$20240717$$MD$IT$IT
241060511$24106051$1$I$$20240712$20240717$20240717$EXP$$US-PFIZER INC-202400213995$PFIZER$$61$YR$$F$Y$$$20240717$$HP$US$US
241060521$24106052$1$I$$20240716$20240717$20240717$PER$$US-PFIZER INC-PV202400093587$PFIZER$$56$YR$$F$Y$$$20240717$$CN$US$US
241060531$24106053$1$I$20240715$20240716$20240717$20240717$PER$$US-PFIZER INC-202400216532$PFIZER$$$$E$F$Y$$$20240717$$CN$US$US
241060541$24106054$1$I$20230105$20230107$20240717$20240717$EXP$$TW-AstraZeneca-2023A006588$ASTRAZENECA$$75$YR$$F$Y$$$20240717$$CN$TW$
241060551$24106055$1$I$$20240712$20240717$20240717$PER$$US-PFIZER INC-PV202400092174$PFIZER$$76$YR$$F$Y$$$20240717$$CN$US$US
241060571$24106057$1$I$20240712$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215072$PFIZER$$73$YR$$F$Y$75.3$KG$20240717$$CN$US$US
241060581$24106058$1$I$$20240716$20240717$20240717$PER$$US-PFIZER INC-202400216871$PFIZER$$81$YR$$F$Y$$$20240717$$CN$US$US
241060601$24106060$1$I$$20240716$20240717$20240717$PER$$US-PFIZER INC-PV202400093609$PFIZER$$73$YR$$F$Y$$$20240717$$CN$US$US
241060611$24106061$1$I$20240101$20240712$20240717$20240717$PER$$US-PFIZER INC-202400215358$PFIZER$$$$$M$Y$$$20240717$$CN$US$US
241060621$24106062$1$I$$20240716$20240716$20240716$DIR$710470$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
241060631$24106063$1$I$$20240708$20240717$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113383$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240717$$MD$JP$JP
241060641$24106064$1$I$20240508$20240716$20240716$20240716$DIR$710426$$FDA-CTU$$64$YR$$M$N$100.2$KG$20240716$N$HP$US$
241060651$24106065$1$I$20230327$20240716$20240717$20240717$EXP$FR-AFSSAPS-PO2024000789$FR-ORGANON-O2407FRA001398$ORGANON$$39$YR$$F$Y$110$KG$20240717$$MD$FR$FR
241060661$24106066$1$I$20240421$20240704$20240717$20240717$EXP$GB-MHRA-MED-202405062010158120-YBLMV$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-06387$HIKMA$$49$YR$$F$Y$75$KG$20240717$$CN$GB$GB
241060671$24106067$1$I$$20240711$20240717$20240717$PER$$US-BAYER-2024A101130$BAYER$$$$$F$Y$$$20240717$$HP$US$US
241060701$24106070$1$I$$20240715$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159198$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241060711$24106071$1$I$$20240712$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159189$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241060721$24106072$1$I$$20240712$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159188$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241060731$24106073$1$I$20240708$20240715$20240717$20240717$EXP$$US-BAYER-2024A104037$BAYER$$64$YR$A$F$Y$$$20240717$$CN$US$US
241060741$24106074$1$I$20240508$20240716$20240716$20240716$DIR$710414$$FDA-CTU$$64$YR$$F$N$68.7$KG$20240716$N$$US$
241060751$24106075$1$I$$20240620$20240717$20240717$PER$$US-009507513-2406USA007452$MERCK$Akingbemi W, Kurtz G, Yegya-Raman N, Plastaras JP, Schuster SJ, Chong EA. Stereotactic radiotherapy and CART for treatment of secondary CNS lymphoma. Leukemia and Lymphoma. 2024;65(6):860-3$71$YR$$M$Y$$$20240717$$HP$US$US
241060771$24106077$1$I$$20240716$20240716$20240716$DIR$710471$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
241060791$24106079$1$I$20240715$20240716$20240717$20240717$EXP$GB-MHRA-MED-202407151917259180-CSJYM$GB-TEVA-VS-3221608$TEVA$$45$YR$$M$Y$97$KG$20240717$$CN$GB$GB
241060801$24106080$1$I$$20240710$20240717$20240717$PER$$US-BAYER-2024A100131$BAYER$$29$YR$A$F$Y$$$20240717$$CN$US$US
241060811$24106081$1$I$$20240712$20240717$20240717$EXP$$NVSC2024US075896$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
241060821$24106082$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024139322$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241060831$24106083$1$I$20240601$20240715$20240717$20240717$EXP$$US-ABBVIE-5842240$ABBVIE$$83$YR$$F$Y$$$20240717$$CN$US$US
241060851$24106085$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49514$$FDA-CTU$$59$YR$$F$N$$$20240717$N$$US$
241060862$24106086$2$F$$20240719$20240717$20240724$EXP$$US-JNJFOC-20240742053$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240725$$HP$US$US
241060871$24106087$1$I$20230701$20230719$20240717$20240717$PER$$US-GRUNENTHAL-2023-271061$AVERITAS$$85$YR$$M$Y$$$20240710$$CN$US$US
241060884$24106088$4$F$$20240823$20240717$20240829$EXP$$US-TAKEDA-2024TUS071792$TAKEDA$$$$$F$Y$$$20240829$$CN$US$US
241060892$24106089$2$F$$20240911$20240717$20240913$PER$$US-BIOGEN-2024BI01273406$BIOGEN$$$$$F$Y$$$20240913$$MD$US$US
241060901$24106090$1$I$20220101$20240710$20240717$20240717$PER$$US-BIOGEN-2022BI01124420$BIOGEN$$$$$F$Y$$$20240717$$HP$US$US
241060911$24106091$1$I$$20240715$20240717$20240717$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-112447$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$87.09$KG$20240717$$CN$PR$PR
241060921$24106092$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113136$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240717$$HP$US$US
241060941$24106094$1$I$$20240703$20240717$20240717$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007250$AEGERION$$$$$F$Y$$$20240717$$CN$US$US
241060953$24106095$3$F$$20240805$20240717$20240807$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001388$BLUEPRINT MEDICINES$$$$$F$Y$$$20240807$$CN$US$US
241060961$24106096$1$I$20240713$20240716$20240717$20240717$EXP$GB-MHRA-MED-202407161628095260-NRGVW$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040206$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240717$$MD$GB$GB
241060971$24106097$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA207619$SANOFI AVENTIS$$$$C$M$Y$$$20240717$$MD$US$US
241060981$24106098$1$I$20240101$20240711$20240717$20240717$PER$$US-SA-2024SA207348$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240717$$HP$US$US
241060991$24106099$1$I$20240709$20240711$20240717$20240717$PER$$US-SA-2024SA207641$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240717$$MD$US$US
241061001$24106100$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA206542$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240717$$MD$US$US
241061021$24106102$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49521$$FDA-CTU$$$$$M$N$$$20240717$N$HP$US$
241061031$24106103$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49527$$FDA-CTU$$81$YR$$M$N$$$20240717$N$$US$
241061041$24106104$1$I$20240717$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49523$$FDA-CTU$$13$YR$$M$N$$$20240717$N$$US$
241061051$24106105$1$I$$20240710$20240717$20240717$EXP$$US-ABBVIE-5835055$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241061061$24106106$1$I$$20240711$20240717$20240717$EXP$$CA-VANTIVE-2024VAN018377$Vantive US Healthcare$$$$$M$Y$$$20240717$$CN$CA$CA
241061071$24106107$1$I$20240711$20240711$20240717$20240717$EXP$$KR-VANTIVE-2024VAN018295$Vantive US Healthcare$$62$YR$$M$Y$$$20240717$$CN$KR$KR
241061081$24106108$1$I$20240707$20240711$20240717$20240717$EXP$$IN-VANTIVE-2024VAN017637$Vantive US Healthcare$$30$YR$$M$Y$$$20240717$$CN$IN$IN
241061101$24106110$1$I$20240101$20240712$20240717$20240717$EXP$$CA-JNJFOC-20240736036$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240717$$HP$CA$CA
241061111$24106111$1$I$$20240710$20240717$20240717$EXP$$DE-GSK-DE2024EME086396$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$DE$DE
241061121$24106112$1$I$$20240710$20240717$20240717$EXP$$CO-GSK-CO2024AMR086791$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$CO$CO
241061131$24106113$1$I$20220101$20240710$20240717$20240717$EXP$$CA-GSK-CA2022063897$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$CA$CA
241061141$24106114$1$I$20231201$20240715$20240717$20240717$EXP$$ES-ABBVIE-5599366$ABBVIE$$57$YR$$M$Y$$$20240717$$CN$ES$ES
241061151$24106115$1$I$$20211217$20240717$20240717$EXP$$US-AstraZeneca-2021A886711$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241061162$24106116$2$F$20240711$20240712$20240717$20240818$EXP$$JP-AstraZeneca-2024A161528$ASTRAZENECA$$$$$F$Y$$$20240819$$MD$JP$
241061171$24106117$1$I$$20230605$20240717$20240717$PER$$US-GRUNENTHAL-2023-112385$AVERITAS$$$$$F$Y$$$20240710$$HP$US$US
241061181$24106118$1$I$20230620$20230622$20240717$20240717$PER$$US-GRUNENTHAL-2023-112976$AVERITAS$$60$YR$$M$Y$$$20240710$$CN$US$US
241061192$24106119$2$F$20240101$20240712$20240717$20240718$EXP$$DE-AstraZeneca-2024A160804$ASTRAZENECA$$79$YR$$F$Y$$$20240718$$CN$DE$
241061201$24106120$1$I$$20190910$20240717$20240717$EXP$$US-AstraZeneca-2019SF30748$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241061212$24106121$2$F$$20240905$20240717$20240913$EXP$$JP-AstraZeneca-2024A158082$ASTRAZENECA$Shinbu K, et al.. Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six-Case Series. OncoTargets and Therapy 2024;17:717-726.$62$YR$$F$Y$$$20240913$$MD$JP$
241061222$24106122$2$F$20240101$20240716$20240717$20240724$EXP$$CO-AstraZeneca-2024A160301$ASTRAZENECA$$60$YR$$M$Y$71$KG$20240724$$CN$CO$
241061231$24106123$1$I$20240610$20240709$20240717$20240717$EXP$$RO-AstraZeneca-2024A160602$ASTRAZENECA$$43$YR$$F$Y$57$KG$20240717$$MD$RO$
241061241$24106124$1$I$$20200630$20240717$20240717$EXP$$GB-AstraZeneca-2020SE84686$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$GB$
241061251$24106125$1$I$$20210519$20240717$20240717$EXP$$CA-AstraZeneca-2021A449441$ASTRAZENECA$$$$$F$Y$$$20240717$$HP$CA$
241061261$24106126$1$I$$20240712$20240717$20240717$EXP$$CA-AstraZeneca-2024A056779$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$CA$
241061271$24106127$1$I$$20200925$20240717$20240717$EXP$$US-AstraZeneca-2020SF25901$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241061281$24106128$1$I$20221201$20240711$20240717$20240717$EXP$$US-MYLANLABS-2024M1065475$MYLAN$$$$$M$Y$$$20240717$$CN$US$US
241061301$24106130$1$I$$20240710$20240717$20240717$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001406$BLUEPRINT MEDICINES$$$$$M$Y$$$20240717$$CN$US$US
241061311$24106131$1$I$20240101$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113164$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240717$$HP$US$US
241061331$24106133$1$I$20240522$20240711$20240717$20240717$EXP$FR-AFSSAPS-CN2024000658$FR-MYLANLABS-2024M1065318$MYLAN$$64$YR$$F$Y$77$KG$20240717$$PH$FR$FR
241061341$24106134$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113091$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$63.96$KG$20240717$$CN$US$US
241061354$24106135$4$F$20240712$20240724$20240717$20240808$EXP$$CA-HLS-202401751$HLS THERAPEUTICS$$73$YR$E$M$Y$$$20240808$$PH$CA$CA
241061361$24106136$1$I$$20240715$20240717$20240717$PER$$US-ROCHE-10000027694$ROCHE$$$$$$Y$$$20240717$$CN$US$US
241061371$24106137$1$I$$20240715$20240717$20240717$EXP$$US-ABBVIE-5841941$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241061381$24106138$1$I$$20240624$20240717$20240717$PER$$US-INCYTE CORPORATION-2024IN006748$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241061394$24106139$4$F$20240621$20240731$20240717$20240807$PER$$US-ROCHE-10000023157$ROCHE$$79$YR$E$F$Y$$$20240808$$CN$US$US
241061401$24106140$1$I$$20240710$20240717$20240717$EXP$$CN-009507513-2407CHN009624$MERCK$Jin S, Shen Z, Li J, Liu X, Zhu Q, Li F, et al.. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. Journal of Clinical Pathology. 2024;77(7):471-7$$$$M$Y$$$20240717$$HP$CN$CN
241061411$24106141$1$I$$20240709$20240717$20240717$EXP$$US-AMGEN-USASP2024137375$AMGEN$Lapite, A.. Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: Asingle-center case series. Pediatric Blood + Cancer. 2024;71 (8):1-5$9$YR$C$M$Y$$$20240717$$HP$US$US
241061422$24106142$2$F$$20240911$20240717$20240917$EXP$$ES-MYLANLABS-2024M1065508$MYLAN$Rubio-Mora E, Rodr?guez JG, Carrascoso GR.. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transpl Infect Dis.. 2024;26(3):1-3$6$MON$$M$Y$$$20240917$$HP$ES$ES
241061431$24106143$1$I$$20240709$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159145$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241061441$24106144$1$I$$20240710$20240717$20240717$PER$$US-ABBVIE-5838451$ABBVIE$$$$$$Y$$$20240717$$CN$US$US
241061451$24106145$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009752$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240717$$CN$US$US
241061461$24106146$1$I$20240716$20240716$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010446$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
241061471$24106147$1$I$$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407008938$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240717$$CN$US$US
241061482$24106148$2$F$20170209$20240724$20240717$20240805$EXP$$FR-PFIZER INC-2017SGN02193$PFIZER$$62$YR$$F$Y$84$KG$20240805$$HP$FR$FR
241061491$24106149$1$I$20190612$20240712$20240717$20240717$EXP$$FR-SHIRE-FR202005436$TAKEDA$$59$YR$$F$Y$$$20240717$$HP$FR$FR
241061501$24106150$1$I$20240101$20240710$20240717$20240717$PER$$US-SA-2024SA205977$SANOFI AVENTIS$$$$T$F$Y$$$20240717$$MD$US$US
241061511$24106151$1$I$20240101$20240712$20240717$20240717$PER$$US-SA-2024SA208044$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240717$$MD$US$US
241061521$24106152$1$I$$20240708$20240717$20240717$PER$$US-SA-2024SA205525$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
241061531$24106153$1$I$20240401$20240709$20240717$20240717$PER$$US-SA-2024SA206025$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240717$$MD$US$US
241061541$24106154$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA203941$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240717$$CN$US$US
241061561$24106156$1$I$$20230531$20240717$20240717$PER$$US-GRUNENTHAL-2023-112239$AVERITAS$$$$$F$Y$$$20240710$$CN$US$US
241061571$24106157$1$I$20230501$20230524$20240717$20240717$PER$$US-GRUNENTHAL-2023-111997$AVERITAS$$67$YR$$F$Y$$$20240710$$HP$US$US
241061581$24106158$1$I$$20230522$20240717$20240717$PER$$US-GRUNENTHAL-2023-110960$AVERITAS$$$$E$M$Y$93.424$KG$20240710$$MD$US$US
241061591$24106159$1$I$$20230808$20240717$20240717$PER$$US-GRUNENTHAL-2023-271072$AVERITAS$$$$$F$Y$$$20240710$$MD$US$US
241061601$24106160$1$I$20230101$20230717$20240717$20240717$PER$$US-GRUNENTHAL-2023-270604$AVERITAS$$$$E$M$Y$68.934$KG$20240710$$CN$US$US
241061611$24106161$1$I$$20240624$20240717$20240717$PER$$US-INCYTE CORPORATION-2024IN006740$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241061631$24106163$1$I$20240601$20240612$20240717$20240717$PER$$US-INCYTE CORPORATION-2024IN006323$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241061641$24106164$1$I$$20240715$20240717$20240717$EXP$GB-MHRA-MED-202407151547157910-PSZNR$GB-TEVA-VS-3221140$TEVA$$$$$$Y$73$KG$20240717$$PH$GB$GB
241061651$24106165$1$I$$20240702$20240717$20240717$EXP$$GB-ALXN-202407EEA000232IE$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$MD$GB$IE
241061661$24106166$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA207414$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240717$$MD$US$US
241061671$24106167$1$I$20240707$20240709$20240717$20240717$PER$$US-SA-2024SA207362$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240717$$MD$US$US
241061682$24106168$2$F$20240304$20240719$20240717$20240723$EXP$$ES-GILEAD-2024-0679498$GILEAD$$$$$$Y$$$20240723$$HP$ES$ES
241061691$24106169$1$I$20240627$20240710$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111241$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240717$$PH$US$US
241061702$24106170$2$F$20240426$20240722$20240717$20240729$PER$$US-AMGEN-USASP2024139492$AMGEN$$41$YR$A$F$Y$103.4$KG$20240729$$CN$US$US
241061711$24106171$1$I$20240712$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49510$$FDA-CTU$$71$YR$$F$N$65.77$KG$20240717$N$PH$US$
241061721$24106172$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024139358$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241061732$24106173$2$F$20240514$20240812$20240717$20240829$EXP$$US-SPRINGWORKS THERAPEUTICS-SW-001683$SPRINGWORKS THERAPEUTIC$$32$YR$$F$Y$$$20240829$$HP$US$US
241061741$24106174$1$I$$20240710$20240717$20240717$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089852$VIIV$$$$$$Y$$$20240717$$HP$US$US
241061751$24106175$1$I$20240601$20240708$20240717$20240717$EXP$FR-AFSSAPS-TO2024001242$FR-FERRINGPH-2024FE03726$FERRING$$$$$$Y$$$20240717$$CN$FR$FR
241061761$24106176$1$I$$20240708$20240717$20240717$EXP$$CA-FERRINGPH-2024FE03795$FERRING$$$$$$Y$$$20240717$$HP$CA$CA
241061771$24106177$1$I$20240101$20240708$20240717$20240717$EXP$$JP-FERRINGPH-2024FE03857$FERRING$$$$$$Y$$$20240717$$CN$JP$JP
241061781$24106178$1$I$$20210412$20240717$20240717$EXP$$US-AstraZeneca-2021A305840$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241061791$24106179$1$I$$20240709$20240717$20240717$EXP$$JP-AstraZeneca-2024A159206$ASTRAZENECA$Inoue T. et al.. A case of EGFR mutation-positive lung adenocarcinoma in which Clostridium difficile colitis developed during administration of osimertinib as postoperative adjuvant chemotherapy. Japanese Journal of Lung Cancer 2024;64(3):257-.$66$YR$$F$Y$$$20240717$$MD$JP$
241061801$24106180$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A159204$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241061811$24106181$1$I$$20240711$20240717$20240717$EXP$$DE-AstraZeneca-2024A159293$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$DE$
241061821$24106182$1$I$$20230720$20240717$20240717$PER$$US-GRUNENTHAL-2023-270760$AVERITAS$$$$E$M$Y$$$20240710$$MD$US$US
241061831$24106183$1$I$20230601$20230717$20240717$20240717$PER$$US-GRUNENTHAL-2023-112960$AVERITAS$$76$YR$$F$Y$$$20240710$$MD$US$US
241061841$24106184$1$I$$20240711$20240717$20240717$EXP$$GB-MYLANLABS-2024M1065311$MYLAN$$$$$M$Y$$$20240717$$CN$GB$GB
241061851$24106185$1$I$$20240709$20240717$20240717$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000608$DECIPHERA PHARMACEUTICALS$$76$YR$E$M$Y$$$20240717$$HP$US$US
241061861$24106186$1$I$$20240708$20240717$20240717$PER$$US-SA-2024SA202735$SANOFI AVENTIS$$$$A$M$Y$$$20240717$$MD$US$US
241061872$24106187$2$F$20240701$20240712$20240717$20240809$PER$$US-SA-2024SA203687$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240809$$CN$US$US
241061881$24106188$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA206413$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240717$$MD$US$US
241061892$24106189$2$F$20050101$20240730$20240717$20240801$PER$$US-PURDUE PHARMA-USA-2024-0310794$PURDUE$$$$$M$Y$$$20240801$$CN$US$US
241061901$24106190$1$I$$20240717$20240717$20240717$PER$$US-PURDUE-USA-2024-0310795$PURDUE$$$$$$Y$$$20240717$$CN$US$US
241061911$24106191$1$I$$20240715$20240717$20240717$EXP$$CA-PURDUE-USA-2024-0310805$PURDUE$$72$YR$$F$Y$$$20240717$$HP$CA$CA
241061923$24106192$3$F$$20240829$20240717$20240909$EXP$CA-PURDUE-USA-2024-0310790$CA-PURDUE-USA-2024-0310790$PURDUE$$40$YR$$F$Y$96$KG$20240909$$HP$CA$CA
241061931$24106193$1$I$$20240711$20240717$20240717$EXP$$KR-009507513-2407KOR008870$MERCK$$$$$F$Y$$$20240717$$HP$KR$KR
241061944$24106194$4$F$20240423$20240801$20240717$20240807$30DAY$$AR-JNJFOC-20240724806$JOHNSON AND JOHNSON$$59$YR$A$F$Y$72$KG$20240807$$CN$AR$AR
241061953$24106195$3$F$$20240828$20240717$20240902$EXP$$CA-PFIZER INC-202400216647$PFIZER$$15$YR$$F$Y$$$20240902$$HP$CA$CA
241061961$24106196$1$I$$20240716$20240717$20240717$EXP$$JP-PFIZER INC-PV202400092854$PFIZER$$70$YR$$M$Y$$$20240717$$MD$JP$JP
241061992$24106199$2$F$20240101$20240716$20240717$20240725$EXP$$JP-TEVA-VS-3221356$TEVA$$75$YR$$M$Y$$$20240725$$PH$JP$JP
241062001$24106200$1$I$$20240715$20240717$20240717$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040153$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240717$$CN$US$US
241062011$24106201$1$I$20240611$20240712$20240717$20240717$PER$$NVSC2024US146850$NOVARTIS$$54$YR$$F$Y$$$20240717$$CN$US$US
241062022$24106202$2$F$$20240712$20240717$20240720$EXP$$NVSC2024AR146547$NOVARTIS$$$$$M$Y$$$20240719$$CN$AR$AR
241062061$24106206$1$I$$20240711$20240717$20240717$EXP$$NVSC2024US144314$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
241062071$24106207$1$I$$20240708$20240717$20240717$EXP$$NVSC2024CN143615$NOVARTIS$Yang M, Cai Y, Wan L, Ji L, Song XM. Case report: Autoimmune encephalomyelitis following cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.. FRONTIERS IN MEDICINE. 2024;11:01-6$53$YR$$F$Y$$$20240717$$HP$CN$CN
241062081$24106208$1$I$$20240709$20240717$20240717$EXP$$JP-TEVA-VS-3221009$TEVA$$$$$M$Y$$$20240717$$CN$JP$JP
241062092$24106209$2$F$$20240730$20240717$20240809$EXP$$SE-TEVA-VS-3212909$TEVA$Ott M, Mannchen JK, Jamshidi F, Werneke U. Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques. Therap-Adv-Psychopharmacol 2019; 9.; Ott M, Mannchen JK, Jamshidi F, Werneke U. Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques. Therap-Adv-Psychopharmacol 2019; 9.$73$YR$$F$Y$$$20240809$$HP$SE$SE
241062101$24106210$1$I$$20240702$20240717$20240717$EXP$$TR-AZURITY PHARMACEUTICALS, INC.-AZR202407-000021$AZURITY PHARMACEUTICALS$Akca KU, Sener S, Batu DE, Balik Z, Basaran O, Bilginer Y et al.. Drug-induced lupus erythematosus in childhood: Case-based review. Pediatric Lupus. 2024;33(7):737-48$11$YR$$F$Y$$$20240717$$HP$TR$TR
241062112$24106211$2$F$20240901$20240911$20240717$20240917$PER$$US-SA-2024SA206878$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240918$$MD$US$US
241062121$24106212$1$I$20240621$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009614$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240717$$CN$US$US
241062131$24106213$1$I$20240715$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009878$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240717$$CN$US$US
241062141$24106214$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009976$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240717$$CN$US$US
241062151$24106215$1$I$$20240704$20240717$20240717$EXP$GB-MHRA-MED-202405081127236150-GTRHJ$GB-GLENMARK PHARMACEUTICALS-2024GMK092191$GLENMARK$$$$$$Y$$$20240717$$HP$GB$GB
241062161$24106216$1$I$20240101$20240711$20240717$20240717$PER$$US-BIOGEN-2024BI01273456$BIOGEN$$$$$M$Y$$$20240717$$HP$US$US
241062171$24106217$1$I$$20240715$20240717$20240717$PER$$US-BAYER-2024A101922$BAYER$$$$$M$Y$$$20240717$$CN$US$US
241062182$24106218$2$F$20240705$20240716$20240717$20240718$EXP$$US-BAYER-2024A103490$BAYER$$61$YR$A$F$Y$96.599$KG$20240718$$HP$US$US
241062192$24106219$2$F$20240101$20240717$20240717$20240723$EXP$SE-SEMPA-2024-005421$SE-OTSUKA-2024_019666$OTSUKA$$58$YR$$M$Y$$$20240723$$MD$SE$SE
241062201$24106220$1$I$$20240711$20240717$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-111150$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$80$KG$20240717$$HP$CA$CA
241062211$24106221$1$I$$20240614$20240717$20240717$EXP$$FR-AstraZeneca-2024A142925$ASTRAZENECA$$$$$$Y$$$20240717$$HP$FR$
241062221$24106222$1$I$$20240709$20240717$20240717$EXP$$CA-AstraZeneca-2024A158592$ASTRAZENECA$$$$$F$Y$$$20240717$$HP$CA$
241062231$24106223$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160554$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241062241$24106224$1$I$$20240709$20240717$20240717$EXP$$CN-AstraZeneca-2024A157983$ASTRAZENECA$$75$YR$$F$Y$$$20240717$$CN$CN$
241062251$24106225$1$I$$20191204$20240717$20240717$EXP$$FR-AstraZeneca-2019SF76278$ASTRAZENECA$$$$$F$Y$$$20240717$$MD$FR$
241062261$24106226$1$I$20231029$20240712$20240717$20240717$EXP$$JP-AstraZeneca-2024A158100$ASTRAZENECA$$74$YR$$M$Y$$$20240717$$MD$JP$
241062271$24106227$1$I$20240703$20240710$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159165$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241062281$24106228$1$I$$20240710$20240717$20240717$EXP$$JP-009507513-2407JPN002323J$MERCK$$76$YR$$M$Y$$$20240717$$MD$JP$JP
241062301$24106230$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113370$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240717$$CN$US$US
241062321$24106232$1$I$20230915$20240705$20240717$20240717$EXP$$GB-CIPLA LTD.-2024GB07370$CIPLA$$$$$$Y$$$20240717$$CN$GB$GB
241062331$24106233$1$I$$20240606$20240717$20240717$PER$$US-TRAVERE-2024TVT00576$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240717$$CN$US$US
241062341$24106234$1$I$$20240716$20240717$20240717$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040306$BOEHRINGER INGELHEIM$$$$$$Y$$$20240717$$MD$PL$PL
241062351$24106235$1$I$20240101$20240715$20240717$20240717$PER$$US-ABBVIE-5841466$ABBVIE$$$$A$$Y$$$20240717$$MD$US$US
241062361$24106236$1$I$20240716$20240716$20240716$20240716$DIR$FDA-CDER-CTU-2024-49430$$FDA-CTU$$44$YR$$F$N$$$20240716$N$MD$US$
241062371$24106237$1$I$20240404$20240711$20240717$20240717$EXP$ES-AEMPS-1541457$ES-MYLANLABS-2024M1065461$MYLAN$$76$YR$$F$Y$$$20240717$$MD$ES$ES
241062381$24106238$1$I$$20240712$20240717$20240717$EXP$$QA-PERRIGO-24QA006641$PERRIGO$Kannappilly N, Peediyakkal MZ, Khatib MY, Ananthegowda DC, Elshafei MS, El Zeer H, et al. Ibuprofen-Induced Toxic Epidermal Necrolysis: A Case Report. International Journal of Dermatology and Venereology. 2024;7(2):108-10. DOI:10.1097/JD9.0000000000000249.$41$YR$$M$Y$$$20240717$$MD$QA$QA
241062391$24106239$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49548$$FDA-CTU$$81$YR$$F$N$$$20240717$N$$US$
241062401$24106240$1$I$20240101$20240710$20240717$20240717$PER$$US-BAUSCH-BL-2024-010666$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240717$$CN$US$US
241062411$24106241$1$I$$20240710$20240717$20240717$EXP$$CA-TEVA-VS-3220196$TEVA$$17$DY$$M$Y$$$20240717$$HP$CA$CA
241062421$24106242$1$I$20240601$20240712$20240717$20240717$EXP$$US-KYOWAKIRIN-2024KK017094$KYOWA$$$$$$Y$$$20240717$$HP$US$US
241062433$24106243$3$F$20240710$20240807$20240717$20240808$PER$$US-JNJFOC-20240739741$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241062441$24106244$1$I$20240601$20240712$20240717$20240717$EXP$$US-SA-2024SA207253$SANOFI AVENTIS$$$$A$M$Y$$$20240717$$MD$US$US
241062451$24106245$1$I$20240101$20240710$20240717$20240717$EXP$$US-SA-2024SA206984$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240717$$MD$US$US
241062461$24106246$1$I$$20240703$20240717$20240717$EXP$$IT-MYLANLABS-2024M1064092$MYLAN$Catucci S, Lombardi M, Massari E, Maiorano A, Meliota G, Pirolo T. Multifocal atrial tachycardia and hypertrophic cardiomyopathy in three patients with costello syndrome. Eur-Heart-J-Suppl 2024; 26 (Suppl. 2) ii48.$$$$$Y$$$20240717$$HP$IT$IT
241062471$24106247$1$I$$20240717$20240717$20240717$PER$$US-BAYER-2024A104098$BAYER$$$$$$Y$$$20240717$$CN$US$US
241062481$24106248$1$I$20240501$20240709$20240717$20240717$EXP$$US-ZENPEP LLC-2024AIMT01074$AIMMUNE$$$$$$Y$$$20240717$$CN$US$US
241062491$24106249$1$I$$20240710$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159116$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241062501$24106250$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140688$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
241062511$24106251$1$I$20240619$20240716$20240716$20240716$DIR$710516$$FDA-CTU$$43$YR$$F$N$74.7$KG$20240716$N$CN$US$
241062521$24106252$1$I$$20240716$20240716$20240716$DIR$710386$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241062541$24106254$1$I$20240601$20240711$20240717$20240717$EXP$$DE-MYLANLABS-2024M1065505$MYLAN$$84$YR$$F$Y$$$20240717$$CN$DE$DE
241062552$24106255$2$F$$20240716$20240717$20240720$PER$$NVSC2024US146249$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
241062561$24106256$1$I$$20240710$20240717$20240717$EXP$$JP-009507513-2407JPN002398J$MERCK$$65$YR$$F$Y$$$20240717$$MD$JP$JP
241062571$24106257$1$I$$20240709$20240717$20240717$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-110594$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240717$$MD$KR$KR
241062582$24106258$2$F$20240101$20240716$20240717$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113662$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240719$$HP$US$US
241062591$24106259$1$I$20240625$20240708$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109661$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240717$$CN$US$US
241062601$24106260$1$I$$20240716$20240716$20240716$DIR$710474$$FDA-CTU$$$$$UNK$N$$$20240716$N$CN$US$
241062611$24106261$1$I$20240708$20240716$20240716$20240716$DIR$710469$$FDA-CTU$$82$YR$$M$N$71.2$KG$20240716$Y$HP$US$
241062621$24106262$1$I$$20240716$20240716$20240716$DIR$710483$$FDA-CTU$$$$$UNK$N$$$20240716$$CN$US$
241062631$24106263$1$I$$20240409$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00144$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$HP$US$US
241062641$24106264$1$I$$20240328$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00177$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$MD$US$US
241062651$24106265$1$I$20240301$20240402$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00186$Phathom Pharmaceuticals$$72$YR$$F$Y$$$20240717$$MD$US$US
241062661$24106266$1$I$20240311$20240403$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00199$Phathom Pharmaceuticals$$57$YR$$F$Y$54.422$KG$20240717$$CN$US$US
241062671$24106267$1$I$20240401$20240408$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00205$Phathom Pharmaceuticals$$72$YR$$F$Y$63.503$KG$20240717$$CN$US$US
241062681$24106268$1$I$$20240409$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00210$Phathom Pharmaceuticals$$$$$$Y$$$20240717$$MD$US$US
241062691$24106269$1$I$$20240411$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00212$Phathom Pharmaceuticals$$$$$F$Y$78.925$KG$20240717$$CN$US$US
241062701$24106270$1$I$$20240410$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00214$Phathom Pharmaceuticals$$$$$M$Y$$$20240717$$MD$US$US
241062711$24106271$1$I$20240323$20240416$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00221$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$CN$US$US
241062721$24106272$1$I$20240319$20240413$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00222$Phathom Pharmaceuticals$$55$YR$$M$Y$$$20240717$$CN$US$US
241062731$24106273$1$I$20240101$20240403$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00196$Phathom Pharmaceuticals$$$$$F$Y$77.551$KG$20240717$$CN$US$US
241062741$24106274$1$I$20240101$20240408$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00203$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$CN$US$US
241062751$24106275$1$I$20240101$20240416$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00224$Phathom Pharmaceuticals$$61$YR$$F$Y$$$20240717$$CN$US$US
241062761$24106276$1$I$20240416$20240417$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00225$Phathom Pharmaceuticals$$71$YR$$M$Y$$$20240717$$CN$US$US
241062781$24106278$1$I$20240422$20240423$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00241$Phathom Pharmaceuticals$$$$$$Y$$$20240717$$CN$US$US
241062791$24106279$1$I$$20240423$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00243$Phathom Pharmaceuticals$$59$YR$$F$Y$$$20240717$$MD$US$US
241062801$24106280$1$I$20240402$20240424$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00248$Phathom Pharmaceuticals$$57$YR$$F$Y$$$20240717$$CN$US$US
241062811$24106281$1$I$$20240426$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00253$Phathom Pharmaceuticals$$69$YR$$F$Y$$$20240717$$CN$US$US
241062821$24106282$1$I$20240424$20240426$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00257$Phathom Pharmaceuticals$$64$YR$$F$Y$58.957$KG$20240717$$CN$US$US
241062831$24106283$1$I$$20240429$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00260$Phathom Pharmaceuticals$$58$YR$$M$Y$90.718$KG$20240717$$CN$US$US
241062841$24106284$1$I$20240401$20240427$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00261$Phathom Pharmaceuticals$$63$YR$$F$Y$74.83$KG$20240717$$CN$US$US
241062851$24106285$1$I$20240425$20240429$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00262$Phathom Pharmaceuticals$$77$YR$$F$Y$48.988$KG$20240717$$CN$US$US
241062861$24106286$1$I$20240212$20240418$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00231$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$CN$US$US
241062871$24106287$1$I$20240101$20240418$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00232$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$MD$US$US
241062881$24106288$1$I$20240417$20240418$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00233$Phathom Pharmaceuticals$$69$YR$$F$Y$69.4$KG$20240717$$CN$US$US
241062891$24106289$1$I$20240420$20240422$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00236$Phathom Pharmaceuticals$$38$YR$$F$Y$95.692$KG$20240717$$CN$US$US
241062901$24106290$1$I$$20240422$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00238$Phathom Pharmaceuticals$$62$YR$$F$Y$$$20240717$$CN$US$US
241062911$24106291$1$I$$20240506$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00288$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$MD$US$US
241062921$24106292$1$I$$20240507$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00290$Phathom Pharmaceuticals$$55$YR$$F$Y$$$20240717$$HP$US$US
241062931$24106293$1$I$$20240507$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00295$Phathom Pharmaceuticals$$$$$$Y$$$20240717$$HP$US$US
241062941$24106294$1$I$20240501$20240509$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00300$Phathom Pharmaceuticals$$57$YR$$F$Y$111.13$KG$20240717$$CN$US$US
241062951$24106295$1$I$$20240510$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00301$Phathom Pharmaceuticals$$$$$$Y$$$20240717$$CN$US$US
241062961$24106296$1$I$$20240510$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00317$Phathom Pharmaceuticals$$54$YR$$F$Y$$$20240717$$CN$US$US
241062971$24106297$1$I$20240401$20240513$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00318$Phathom Pharmaceuticals$$61$YR$$M$Y$$$20240717$$CN$US$US
241062981$24106298$1$I$20240322$20240423$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00240$Phathom Pharmaceuticals$$65$YR$$F$Y$$$20240717$$CN$US$US
241062991$24106299$1$I$20240404$20240507$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00294$Phathom Pharmaceuticals$$45$YR$$M$Y$88.889$KG$20240717$$HP$US$US
241063001$24106300$1$I$20240510$20240513$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00319$Phathom Pharmaceuticals$$65$YR$$F$Y$$$20240717$$CN$US$US
241063011$24106301$1$I$20240501$20240516$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00330$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$CN$US$US
241063021$24106302$1$I$20240101$20240515$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00334$Phathom Pharmaceuticals$$59$YR$$M$Y$$$20240717$$CN$US$US
241063031$24106303$1$I$20240501$20240515$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00335$Phathom Pharmaceuticals$$49$YR$$F$Y$$$20240717$$CN$US$US
241063041$24106304$1$I$20240515$20240517$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00336$Phathom Pharmaceuticals$$$$$M$Y$96.145$KG$20240717$$CN$US$US
241063051$24106305$1$I$20240215$20240515$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00337$Phathom Pharmaceuticals$$59$YR$$F$Y$$$20240717$$CN$US$US
241063061$24106306$1$I$20240501$20240520$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00338$Phathom Pharmaceuticals$$$$$M$Y$$$20240717$$CN$US$US
241063071$24106307$1$I$20240430$20240516$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00340$Phathom Pharmaceuticals$$55$YR$$M$Y$$$20240717$$CN$US$US
241063081$24106308$1$I$$20240516$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00341$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$CN$US$US
241063091$24106309$1$I$20240101$20240516$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00344$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$CN$US$US
241063101$24106310$1$I$20240101$20240516$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00346$Phathom Pharmaceuticals$$$$$M$Y$$$20240717$$CN$US$US
241063111$24106311$1$I$20240429$20240520$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00355$Phathom Pharmaceuticals$$32$YR$$F$Y$$$20240717$$CN$US$US
241063121$24106312$1$I$20240401$20240521$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00357$Phathom Pharmaceuticals$$86$YR$$F$Y$$$20240717$$CN$US$US
241063131$24106313$1$I$$20240523$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00360$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$HP$US$US
241063141$24106314$1$I$$20240523$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00361$Phathom Pharmaceuticals$$$$$$Y$$$20240717$$HP$US$US
241063151$24106315$1$I$20240101$20240523$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00363$Phathom Pharmaceuticals$$$$$M$Y$90.249$KG$20240717$$CN$US$US
241063161$24106316$1$I$20240506$20240522$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00366$Phathom Pharmaceuticals$$61$YR$$F$Y$$$20240717$$CN$US$US
241063171$24106317$1$I$20240401$20240429$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00263$Phathom Pharmaceuticals$$77$YR$$F$Y$$$20240717$$CN$US$US
241063181$24106318$1$I$20240101$20240429$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00259$Phathom Pharmaceuticals$$$$$M$Y$74.376$KG$20240717$$CN$US$US
241063191$24106319$1$I$20240506$20240509$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00298$Phathom Pharmaceuticals$$74$YR$$F$Y$$$20240717$$CN$US$US
241063201$24106320$1$I$$20240523$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00364$Phathom Pharmaceuticals$$$$$M$Y$$$20240717$$MD$US$US
241063211$24106321$1$I$20240401$20240522$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00367$Phathom Pharmaceuticals$$34$YR$$F$Y$$$20240717$$CN$US$US
241063221$24106322$1$I$20240428$20240429$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00264$Phathom Pharmaceuticals$$74$YR$$F$Y$$$20240717$$CN$US$US
241063231$24106323$1$I$20240424$20240501$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00265$Phathom Pharmaceuticals$$64$YR$$F$Y$72.575$KG$20240717$$CN$US$US
241063241$24106324$1$I$20240424$20240501$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00267$Phathom Pharmaceuticals$$72$YR$$F$Y$$$20240717$$CN$US$US
241063251$24106325$1$I$$20240502$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00273$Phathom Pharmaceuticals$$45$YR$$F$Y$$$20240717$$HP$US$US
241063261$24106326$1$I$20240401$20240502$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00274$Phathom Pharmaceuticals$$75$YR$$F$Y$$$20240717$$CN$US$US
241063271$24106327$1$I$20240401$20240502$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00275$Phathom Pharmaceuticals$$28$YR$$F$Y$$$20240717$$CN$US$US
241063281$24106328$1$I$20240424$20240502$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00276$Phathom Pharmaceuticals$$60$YR$$F$Y$$$20240717$$CN$US$US
241063291$24106329$1$I$20240301$20240503$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00281$Phathom Pharmaceuticals$$63$YR$$F$Y$$$20240717$$CN$US$US
241063301$24106330$1$I$20240501$20240506$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00284$Phathom Pharmaceuticals$$53$YR$$F$Y$$$20240717$$CN$US$US
241063311$24106331$1$I$20240518$20240531$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00513$Phathom Pharmaceuticals$$74$YR$$F$Y$$$20240717$$CN$US$US
241063321$24106332$1$I$$20240611$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00449$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$MD$US$US
241063331$24106333$1$I$$20240612$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00452$Phathom Pharmaceuticals$$73$YR$$F$Y$$$20240717$$CN$US$US
241063341$24106334$1$I$20240608$20240611$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00453$Phathom Pharmaceuticals$$76$YR$$F$Y$$$20240717$$CN$US$US
241063351$24106335$1$I$$20240612$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00455$Phathom Pharmaceuticals$$61$YR$$F$Y$$$20240717$$CN$US$US
241063361$24106336$1$I$20240530$20240612$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00457$Phathom Pharmaceuticals$$70$YR$$F$Y$$$20240717$$CN$US$US
241063371$24106337$1$I$$20240613$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00461$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$HP$US$US
241063381$24106338$1$I$20240401$20240425$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00249$Phathom Pharmaceuticals$$49$YR$$F$Y$$$20240717$$CN$US$US
241063391$24106339$1$I$$20240516$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00342$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$CN$US$US
241063401$24106340$1$I$20240427$20240505$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00354$Phathom Pharmaceuticals$$60$YR$$F$Y$$$20240717$$CN$US$US
241063411$24106341$1$I$20240519$20240611$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00451$Phathom Pharmaceuticals$$55$YR$$M$Y$$$20240717$$CN$US$US
241063421$24106342$1$I$20240522$20240612$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00458$Phathom Pharmaceuticals$$42$YR$$M$Y$68.027$KG$20240717$$CN$US$US
241063431$24106343$1$I$20240601$20240613$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00464$Phathom Pharmaceuticals$$45$YR$$M$Y$$$20240717$$CN$US$US
241063441$24106344$1$I$$20240613$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00465$Phathom Pharmaceuticals$$56$YR$$M$Y$$$20240717$$CN$US$US
241063451$24106345$1$I$20240101$20240614$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00467$Phathom Pharmaceuticals$$58$YR$$F$Y$$$20240717$$CN$US$US
241063461$24106346$1$I$20240614$20240617$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00477$Phathom Pharmaceuticals$$62$YR$$$Y$$$20240717$$CN$US$US
241063471$24106347$1$I$20240613$20240617$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00478$Phathom Pharmaceuticals$$62$YR$$F$Y$$$20240717$$CN$US$US
241063481$24106348$1$I$20240602$20240617$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00479$Phathom Pharmaceuticals$$69$YR$$F$Y$$$20240717$$CN$US$US
241063491$24106349$1$I$20240501$20240617$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00480$Phathom Pharmaceuticals$$64$YR$$F$Y$$$20240717$$CN$US$US
241063501$24106350$1$I$20240501$20240525$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00372$Phathom Pharmaceuticals$$28$YR$$M$Y$$$20240717$$CN$US$US
241063511$24106351$1$I$20240507$20240528$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00377$Phathom Pharmaceuticals$$69$YR$$F$Y$$$20240717$$CN$US$US
241063521$24106352$1$I$20240514$20240528$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00378$Phathom Pharmaceuticals$$83$YR$$F$Y$$$20240717$$CN$US$US
241063531$24106353$1$I$20240515$20240528$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00381$Phathom Pharmaceuticals$$28$YR$$M$Y$$$20240717$$CN$US$US
241063541$24106354$1$I$$20240529$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00389$Phathom Pharmaceuticals$$$$$$Y$$$20240717$$HP$US$US
241063551$24106355$1$I$$20240528$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00394$Phathom Pharmaceuticals$$57$YR$$M$Y$$$20240717$$CN$US$US
241063561$24106356$1$I$20240101$20240530$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00395$Phathom Pharmaceuticals$$$$$M$Y$85.714$KG$20240717$$CN$US$US
241063571$24106357$1$I$$20240603$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00404$Phathom Pharmaceuticals$$$$$$Y$$$20240717$$MD$US$US
241063581$24106358$1$I$20240411$20240418$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00230$Phathom Pharmaceuticals$$53$YR$$F$Y$63.039$KG$20240717$$HP$US$US
241063591$24106359$1$I$20240401$20240528$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00379$Phathom Pharmaceuticals$$56$YR$$M$Y$$$20240717$$CN$US$US
241063601$24106360$1$I$$20240617$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00484$Phathom Pharmaceuticals$$68$YR$$F$Y$$$20240717$$CN$US$US
241063611$24106361$1$I$20240101$20240617$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00486$Phathom Pharmaceuticals$$$$A$M$Y$$$20240717$$HP$US$US
241063621$24106362$1$I$20240530$20240620$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00493$Phathom Pharmaceuticals$$43$YR$$M$Y$$$20240717$$CN$US$US
241063631$24106363$1$I$20240101$20240620$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00494$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$MD$US$US
241063641$24106364$1$I$$20240529$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00390$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$CN$US$US
241063651$24106365$1$I$20240513$20240530$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00396$Phathom Pharmaceuticals$$55$YR$$M$Y$$$20240717$$CN$US$US
241063661$24106366$1$I$20240406$20240531$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00400$Phathom Pharmaceuticals$$54$YR$$F$Y$$$20240717$$CN$US$US
241063671$24106367$1$I$20240510$20240531$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00405$Phathom Pharmaceuticals$$49$YR$$F$Y$$$20240717$$CN$US$US
241063681$24106368$1$I$20240513$20240528$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00385$Phathom Pharmaceuticals$$45$YR$$F$Y$$$20240717$$CN$US$US
241063691$24106369$1$I$20240413$20240604$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00415$Phathom Pharmaceuticals$$57$YR$$F$Y$$$20240717$$CN$US$US
241063701$24106370$1$I$$20240606$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00420$Phathom Pharmaceuticals$$$$$$Y$$$20240717$$CN$US$US
241063711$24106371$1$I$$20240606$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00421$Phathom Pharmaceuticals$$32$YR$$M$Y$$$20240717$$CN$US$US
241063721$24106372$1$I$20240521$20240606$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00428$Phathom Pharmaceuticals$$63$YR$$M$Y$89.8$KG$20240717$$CN$US$US
241063731$24106373$1$I$$20240606$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00429$Phathom Pharmaceuticals$$77$YR$$M$Y$$$20240717$$CN$US$US
241063741$24106374$1$I$20240427$20240606$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00430$Phathom Pharmaceuticals$$58$YR$$F$Y$$$20240717$$CN$US$US
241063751$24106375$1$I$20240501$20240606$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00432$Phathom Pharmaceuticals$$58$YR$$F$Y$$$20240717$$CN$US$US
241063761$24106376$1$I$$20240610$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00442$Phathom Pharmaceuticals$$$$$F$Y$$$20240717$$CN$US$US
241063771$24106377$1$I$20240402$20240610$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00446$Phathom Pharmaceuticals$$57$YR$$F$Y$$$20240717$$CN$US$US
241063781$24106378$1$I$20240612$20240614$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00468$Phathom Pharmaceuticals$$72$YR$$F$Y$$$20240717$$CN$US$US
241063791$24106379$1$I$20240101$20240528$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00384$Phathom Pharmaceuticals$$70$YR$$$Y$$$20240717$$CN$US$US
241063801$24106380$1$I$20240520$20240606$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00431$Phathom Pharmaceuticals$$31$YR$$M$Y$$$20240717$$CN$US$US
241063811$24106381$1$I$20240519$20240610$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00444$Phathom Pharmaceuticals$$64$YR$$F$Y$77.098$KG$20240717$$CN$US$US
241063821$24106382$1$I$20240517$20240610$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00447$Phathom Pharmaceuticals$$65$YR$$M$Y$$$20240717$$CN$US$US
241063831$24106383$1$I$$20240620$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00495$Phathom Pharmaceuticals$$51$YR$$F$Y$$$20240717$$CN$US$US
241063841$24106384$1$I$20240620$20240621$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00497$Phathom Pharmaceuticals$$72$YR$$F$Y$78.471$KG$20240717$$CN$US$US
241063851$24106385$1$I$20240101$20240622$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00498$Phathom Pharmaceuticals$$61$YR$$F$Y$72.9$KG$20240717$$CN$US$US
241063861$24106386$1$I$$20240625$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00506$Phathom Pharmaceuticals$$46$YR$$F$Y$$$20240717$$CN$US$US
241063871$24106387$1$I$20240531$20240625$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00508$Phathom Pharmaceuticals$$71$YR$$F$Y$$$20240717$$CN$US$US
241063881$24106388$1$I$20240101$20240610$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00438$Phathom Pharmaceuticals$$61$YR$$F$Y$$$20240717$$CN$US$US
241063891$24106389$1$I$20240508$20240610$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00443$Phathom Pharmaceuticals$$64$YR$$F$Y$$$20240717$$CN$US$US
241063901$24106390$1$I$$20240710$20240717$20240717$PER$$US-BIOGEN-2024BI01273369$BIOGEN$$$$$F$Y$$$20240717$$HP$US$US
241063911$24106391$1$I$$20240506$20240717$20240717$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003947$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
241063921$24106392$1$I$20240622$20240716$20240717$20240717$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003923$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
241063931$24106393$1$I$$20240712$20240717$20240717$EXP$$US-AstraZeneca-2024A160522$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241063941$24106394$1$I$20240506$20240625$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00512$Phathom Pharmaceuticals$$39$YR$$F$Y$$$20240717$$CN$US$US
241063951$24106395$1$I$$20200210$20240717$20240717$EXP$$US-AstraZeneca-2020SE21761$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241063961$24106396$1$I$20231208$20240710$20240717$20240717$EXP$$FR-AstraZeneca-2024A161267$ASTRAZENECA$$1$MON$$F$Y$3.6$KG$20240717$$MD$FR$
241063971$24106397$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009820$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240717$$HP$US$US
241063981$24106398$1$I$20240101$20240610$20240717$20240717$PER$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00445$Phathom Pharmaceuticals$$76$YR$$F$Y$$$20240717$$CN$US$US
241063991$24106399$1$I$20240610$20240716$20240716$20240716$DIR$710397$$FDA-CTU$$53$YR$$F$N$99$KG$20240716$N$CN$US$
241064011$24106401$1$I$20230401$20240716$20240716$20240716$DIR$710401$$FDA-CTU$$40$YR$$F$N$51.75$KG$20240716$N$CN$US$
241064021$24106402$1$I$20240628$20240716$20240716$20240716$DIR$710456$$FDA-CTU$$37$YR$$F$N$$$20240716$Y$PH$US$
241064031$24106403$1$I$20240628$20240716$20240716$20240716$DIR$710451$$FDA-CTU$$28$YR$$F$N$$$20240716$Y$PH$US$
241064041$24106404$1$I$20240709$20240716$20240716$20240716$DIR$710403$$FDA-CTU$$79$YR$$F$N$67.5$KG$20240716$N$CN$US$
241064051$24106405$1$I$20240601$20240702$20240717$20240717$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0588$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240717$$CN$US$US
241064061$24106406$1$I$$20240715$20240717$20240717$PER$$NVSC2024US147327$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241064071$24106407$1$I$$20240709$20240717$20240717$EXP$GB-MHRA-MED-202407082013362770-TYVSG$GB-TEVA-VS-3219594$TEVA$$26$YR$$F$Y$$$20240717$$CN$GB$GB
241064082$24106408$2$F$$20240705$20240717$20240723$EXP$$DE-BAYER-2024A098217$BAYER$$71$YR$E$M$Y$93$KG$20240723$$HP$DE$DE
241064091$24106409$1$I$$20240710$20240717$20240717$EXP$$JP-009507513-2407JPN002337J$MERCK$$74$YR$$M$Y$$$20240717$$MD$JP$JP
241064102$24106410$2$F$$20240829$20240717$20240925$PER$$US-LUNDBECK-DKLU4000998$LUNDBECK$$$$$$Y$$$20240925$$CN$US$US
241064111$24106411$1$I$$20240715$20240717$20240717$30DAY$$US-GSK-US2024088758$GLAXOSMITHKLINE$$$$A$M$Y$$$20240717$$CN$US$US
241064122$24106412$2$F$$20240721$20240717$20240725$PER$$US-PFIZER INC-PV202400093024$PFIZER$$$$$$Y$$$20240725$$HP$US$US
241064131$24106413$1$I$20240101$20240715$20240717$20240717$PER$$US-PFIZER INC-202400215386$PFIZER$$65$YR$$F$Y$$$20240717$$CN$US$US
241064142$24106414$2$F$$20240830$20240717$20240830$PER$$NVSC2024US147082$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
241064151$24106415$1$I$$20240715$20240717$20240717$PER$$NVSC2024US147299$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241064164$24106416$4$F$20240101$20240806$20240717$20240813$PER$$US-SA-2024SA206529$SANOFI AVENTIS$$50$YR$A$M$Y$74.3$KG$20240814$$MD$US$US
241064171$24106417$1$I$20240701$20240710$20240717$20240717$PER$$US-SA-2024SA207365$SANOFI AVENTIS$$16$YR$T$F$Y$49$KG$20240717$$MD$US$US
241064181$24106418$1$I$20240614$20240704$20240717$20240717$EXP$IT-GUERBET / GUERBET SpA-IT-20240057$IT-GUERBET / LLC-IT-20240057$GUERBET$$24$YR$A$F$Y$60$KG$20240717$$PH$IT$IT
241064191$24106419$1$I$$20240711$20240717$20240717$PER$$US-BIOGEN-2024BI01273482$BIOGEN$$$$$F$Y$$$20240717$$CN$US$US
241064203$24106420$3$F$20240802$20240823$20240717$20240826$EXP$$CA-TAKEDA-2024TUS072030$TAKEDA$$27$YR$$F$Y$$$20240826$$CN$CA$CA
241064213$24106421$3$F$$20240920$20240717$20240925$EXP$$US-TAKEDA-2024TUS011292$TAKEDA$$$$$F$Y$71.655$KG$20240925$$HP$US$US
241064231$24106423$1$I$20240703$20240704$20240717$20240717$30DAY$$IT-SANDOZ INC.-SDZ2024IT065686$SANDOZ$$12$YR$$M$Y$43$KG$20240717$$CN$IT$IT
241064241$24106424$1$I$$20240709$20240717$20240717$EXP$GB-MHRA-MED-202407092212033490-KTPGJ$GB-TEVA-VS-3220003$TEVA$$$$$F$Y$$$20240717$$CN$GB$GB
241064251$24106425$1$I$$20240715$20240717$20240717$30DAY$$US-SANDOZ INC.-SDZ2024US065627$SANDOZ$$$$$M$Y$$$20240717$$CN$US$US
241064261$24106426$1$I$$20240715$20240717$20240717$30DAY$$AE-SANDOZ INC.-NVSC2023AE128880$SANDOZ$$$$$F$Y$$$20240717$$MD$AE$AE
241064271$24106427$1$I$$20240711$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065548$SANDOZ$$$$$$Y$$$20240717$$HP$US$US
241064281$24106428$1$I$20240202$20240716$20240716$20240716$DIR$710450$$FDA-CTU$$75$YR$$F$N$47$KG$20240716$N$CN$ES$
241064291$24106429$1$I$$20240711$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065319$SANDOZ$$$$$$Y$$$20240717$$CN$US$US
241064301$24106430$1$I$20240322$20240716$20240716$20240716$DIR$710489$$FDA-CTU$$66$YR$$M$N$130$KG$20240716$Y$HP$US$
241064311$24106431$1$I$$20240712$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065574$SANDOZ$$16$YR$$F$Y$$$20240717$$CN$US$US
241064321$24106432$1$I$$20240712$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065450$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
241064341$24106434$1$I$$20240715$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065589$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
241064351$24106435$1$I$$20240711$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065545$SANDOZ$$$$$$Y$$$20240717$$PH$US$US
241064361$24106436$1$I$$20240713$20240717$20240717$30DAY$$US-SANDOZ INC.-SDZ2024US065558$SANDOZ$$77$YR$$$Y$$$20240717$$CN$US$US
241064371$24106437$1$I$$20230522$20240717$20240717$PER$$US-GRUNENTHAL-2023-111900$AVERITAS$$71$YR$$F$Y$$$20240710$$MD$US$US
241064381$24106438$1$I$$20240710$20240717$20240717$EXP$$CA-TEVA-VS-3220276$TEVA$$83$YR$$F$Y$$$20240717$$HP$CA$CA
241064391$24106439$1$I$$20240621$20240717$20240717$EXP$$IN-SANDOZ INC.-SDZ2024IN065569$SANDOZ$$$$$F$Y$$$20240717$$CN$IN$IN
241064411$24106441$1$I$20240131$20240708$20240717$20240717$EXP$$US-BAYER-2024A099170$BAYER$$85$YR$E$M$Y$$$20240717$$CN$US$US
241064421$24106442$1$I$20240714$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024141052$AMGEN$$64$YR$A$M$Y$$$20240717$$CN$US$US
241064431$24106443$1$I$$20240713$20240717$20240717$EXP$$IT-PFIZER INC-PV202400092802$PFIZER$Giacomelli, A.. Fostemsavir to overcome drug-drug interactions in heavily treatment-experienced people with HIV and cancer. Journal of Antimicrobial Chemotherapy. 2024;79(7):1708-1709$7$DEC$$F$Y$$$20240717$$HP$IT$IT
241064441$24106444$1$I$$20240709$20240717$20240717$PER$$US-AMGEN-USASP2024141305$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241064451$24106445$1$I$$20230531$20240717$20240717$PER$$US-GRUNENTHAL-2023-112174$AVERITAS$$72$YR$$M$Y$$$20240710$$HP$US$US
241064461$24106446$1$I$$20240711$20240717$20240717$PER$$US-BIOGEN-2024BI01273483$BIOGEN$$$$$F$Y$$$20240717$$CN$US$US
241064473$24106447$3$F$$20240801$20240717$20240806$PER$$NVSC2024US147292$NOVARTIS$$$$$M$Y$$$20240806$$HP$US$US
241064482$24106448$2$F$20240712$20240719$20240717$20240724$EXP$$MY-Ipsen Biopharmaceuticals, Inc.-2024-14060$IPSEN$$$$$M$Y$$$20240724$$MD$MY$MY
241064491$24106449$1$I$20230711$20240715$20240717$20240717$EXP$GB-MHRA-MED-202407121352076420-QKDHG$GB-MYLANLABS-2024M1066138$MYLAN$$45$YR$$F$Y$$$20240717$$HP$GB$GB
241064501$24106450$1$I$20240622$20240711$20240717$20240717$EXP$FR-AFSSAPS-NT2024000789$FR-MYLANLABS-2024M1065378$MYLAN$$51$YR$$M$Y$83$KG$20240717$$MD$FR$FR
241064511$24106451$1$I$$20240710$20240717$20240717$EXP$$US-UROVANT SCIENCES GMBH-202407-URV-001020$UROVANT SCIENCES$$83$YR$$F$Y$$$20240717$$HP$US$US
241064531$24106453$1$I$20240320$20240709$20240717$20240717$EXP$FR-AFSSAPS-NY2024000727$FR-TEVA-VS-3219509$TEVA$$59$YR$$F$Y$70$KG$20240717$$PH$FR$FR
241064541$24106454$1$I$$20240710$20240717$20240717$EXP$$IN-SANDOZ INC.-SDZ2023IN074131$SANDOZ$$$$$F$Y$$$20240717$$CN$IN$IN
241064551$24106455$1$I$$20240716$20240717$20240717$EXP$AU-TGA-0000812177$AU-SANDOZ INC.-SDZ2024AU065657$SANDOZ$$14$YR$$$Y$$$20240717$$HP$AU$AU
241064561$24106456$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A160559$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241064571$24106457$1$I$20200301$20200306$20240717$20240717$EXP$$CO-AstraZeneca-2020SE35585$ASTRAZENECA$$24931$DY$$M$Y$$$20240717$$CN$CO$
241064581$24106458$1$I$$20240709$20240717$20240717$EXP$$ZA-AstraZeneca-2024A157944$ASTRAZENECA$$50$YR$$F$Y$$$20240717$$CN$ZA$
241064601$24106460$1$I$20240501$20240709$20240717$20240717$PER$$US-SA-2024SA207288$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240717$$MD$US$US
241064611$24106461$1$I$20240712$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112115$BRISTOL MYERS SQUIBB$$$$$M$Y$104.33$KG$20240717$$CN$US$US
241064622$24106462$2$F$$20240719$20240717$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112841$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240723$$CN$US$US
241064631$24106463$1$I$$20240711$20240717$20240717$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-112121$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240717$$MD$AU$AU
241064641$24106464$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112996$BRISTOL MYERS SQUIBB$$75$YR$E$$Y$$$20240717$$CN$US$US
241064651$24106465$1$I$20240708$20240716$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113467$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240717$$CN$US$US
241064661$24106466$1$I$$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157839$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241064673$24106467$3$F$$20240829$20240717$20240903$30DAY$$DK-MYLANLABS-2024M1065267$MYLAN$$$$$$Y$$$20240903$$HP$DK$DK
241064682$24106468$2$F$20230427$20240805$20240717$20240812$EXP$FR-AFSSAPS-AN2024000896$FR-MYLANLABS-2024M1065319$MYLAN$$88$YR$$F$Y$78$KG$20240812$$PH$FR$FR
241064692$24106469$2$F$20240531$20240805$20240717$20240812$EXP$FR-AFSSAPS-AN2024000897$FR-MYLANLABS-2024M1065313$MYLAN$$88$YR$$F$Y$78$KG$20240812$$PH$FR$FR
241064701$24106470$1$I$$20240702$20240717$20240717$EXP$$TH-BLUEPRINT MEDICINES CORPORATION-2024BUS000107$PPD DEVELOPMENT LP$$$$$$Y$$$20240717$$CN$TH$TH
241064711$24106471$1$I$20240708$20240711$20240717$20240717$PER$$US-BIOGEN-2024BI01273302$BIOGEN$$27$YR$$M$Y$$$20240717$$MD$US$US
241064722$24106472$2$F$20211001$20240723$20240717$20240729$EXP$$AT-SANDOZ INC.-SDZ2024AT065099$SANDOZ$$26$YR$$M$Y$$$20240729$$MD$AT$AT
241064732$24106473$2$F$20240101$20240718$20240717$20240724$EXP$$US-ABBVIE-5831945$ABBVIE$$$$$M$Y$$$20240724$$HP$US$US
241064741$24106474$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5840586$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241064751$24106475$1$I$$20240716$20240717$20240717$EXP$$GB-SANDOZ INC.-SDZ2024GB065597$SANDOZ$$$$$M$Y$$$20240717$$CN$GB$GB
241064761$24106476$1$I$$20240709$20240717$20240717$EXP$GB-MHRA-MED-202407090838550530-VNBCD$GB-TEVA-VS-3219516$TEVA$$77$YR$$M$Y$$$20240717$$HP$GB$GB
241064772$24106477$2$F$$20240913$20240717$20240913$EXP$$NVSC2024US147310$NOVARTIS$$39$YR$$F$Y$141$KG$20240913$$PH$US$US
241064781$24106478$1$I$$20240626$20240717$20240717$EXP$$NVSC2024US134782$NOVARTIS$$$$$F$Y$$$20240717$$CN$US$US
241064791$24106479$1$I$$20230628$20240717$20240717$PER$$US-GRUNENTHAL-2023-113208$AVERITAS$North J., Gordon K.. Chronic Idiopathic Small Fiber Painful Peripheral Neuropathy Treated with Qutenza? (capsaicin) 8% Topical System (QTZ): A Case Report$30$YR$$M$Y$$$20240710$$MD$US$US
241064802$24106480$2$F$$20240903$20240717$20240910$PER$$US-JNJFOC-20240737478$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240910$$CN$US$US
241064811$24106481$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207256$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240717$$MD$US$US
241064821$24106482$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA207189$SANOFI AVENTIS$$$$A$M$Y$99.7$KG$20240717$$MD$US$US
241064831$24106483$1$I$20240421$20240710$20240717$20240717$PER$$US-SA-2024SA207188$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240717$$MD$US$US
241064842$24106484$2$F$20240801$20240820$20240717$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113714$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240822$$CN$US$US
241064851$24106485$1$I$$20240610$20240717$20240717$EXP$$NVSC2024RU112097$NOVARTIS$Speransky GN. Systemic-onset juvenile arthritis: epidemiology, clinical picture, differential diagnosis in physician?s practice: results of a two-center retrospective cohort study. PEDIATRIA N.A. G.N. SPERANSKY. 2024;103 (2):52-60$6$MON$$$Y$$$20240717$$HP$RU$RU
241064861$24106486$1$I$20240513$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405131605341800-CTFSL$GB-GUERBET / LLC-GB-20240079$GUERBET$$$$$$Y$$$20240717$$HP$GB$GB
241064873$24106487$3$F$20240601$20240724$20240717$20240805$EXP$$US-ZENPEP LLC-2024AIMT01076$AIMMUNE$$$$$$Y$$$20240803$$HP$US$US
241064881$24106488$1$I$$20240714$20240717$20240717$PER$$US-HALEON-2187267$Haleon PLC$$$$$M$Y$$$20240717$$CN$US$US
241064891$24106489$1$I$$20200415$20240717$20240717$EXP$$US-AstraZeneca-2020SE52138$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241064901$24106490$1$I$20240501$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A157666$ASTRAZENECA$$6$YR$$M$Y$$$20240717$$CN$US$
241064911$24106491$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207178$SANOFI AVENTIS$$$$A$M$Y$74.8$KG$20240717$$MD$US$US
241064921$24106492$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA206509$SANOFI AVENTIS$$56$YR$A$F$Y$66.67$KG$20240717$$MD$US$US
241064931$24106493$1$I$$20240715$20240717$20240717$PER$$US-SA-2024SA208283$SANOFI AVENTIS$$$$$F$Y$$$20240717$$HP$US$US
241064941$24106494$1$I$20240101$20240710$20240717$20240717$PER$$US-SA-2024SA207125$SANOFI AVENTIS$$$$A$F$Y$70$KG$20240717$$MD$US$US
241064951$24106495$1$I$20240617$20240710$20240717$20240717$EXP$$DE-TEVA-VS-3219759$TEVA$$79$YR$$F$Y$87$KG$20240717$$MD$DE$DE
241064961$24106496$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113430$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240717$$HP$US$US
241064983$24106498$3$F$20240607$20240819$20240717$20240821$EXP$$IT-TAKEDA-2024TUS071544$TAKEDA$$$$$M$Y$$$20240821$$MD$IT$IT
241064991$24106499$1$I$$20240709$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109329$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$86$KG$20240717$$PH$US$US
241065001$24106500$1$I$20240704$20240706$20240717$20240717$EXP$$US-BAYER-2024A097876$BAYER$$48$YR$A$M$Y$$$20240717$$CN$US$US
241065011$24106501$1$I$20240601$20240710$20240717$20240717$EXP$$CA-JNJFOC-20240728669$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240717$$HP$CA$CA
241065023$24106502$3$F$$20240718$20240717$20240722$EXP$$US-PFIZER INC-202400215309$PFIZER$$68$YR$$F$Y$$$20240722$$CN$US$US
241065031$24106503$1$I$$20240716$20240717$20240717$PER$$NVSC2024US147271$NOVARTIS$$$$$F$Y$$$20240717$$MD$US$US
241065042$24106504$2$F$$20240728$20240717$20240731$PER$$NVSC2024US146435$NOVARTIS$$$$$$Y$$$20240731$$CN$US$US
241065051$24106505$1$I$20240701$20240716$20240717$20240717$EXP$$US-KYOWAKIRIN-2024KK017166$KYOWA$$$$$$Y$$$20240717$$HP$US$US
241065063$24106506$3$F$20240101$20240814$20240717$20240823$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007251$AEGERION$$$$$M$Y$80.3$KG$20240823$$MD$US$US
241065071$24106507$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112856$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$50.35$KG$20240717$$CN$US$US
241065081$24106508$1$I$$20240711$20240717$20240717$PER$$US-BIOGEN-2024BI01273301$BIOGEN$$$$$$Y$$$20240717$$HP$US$US
241065091$24106509$1$I$$20240716$20240717$20240717$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040316$BOEHRINGER INGELHEIM$$$$$$Y$$$20240717$$MD$PL$PL
241065101$24106510$1$I$$20230707$20240717$20240717$PER$$US-GRUNENTHAL-2023-112900$AVERITAS$$66$YR$$M$Y$$$20240710$$CN$US$US
241065111$24106511$1$I$$20240715$20240717$20240717$EXP$$AT-ABBVIE-5842601$ABBVIE$$$$$M$Y$$$20240717$$MD$AT$AT
241065121$24106512$1$I$$20240711$20240717$20240717$EXP$$US-LUNDBECK-DKLU4001676$LUNDBECK$$$$$$Y$$$20240717$$HP$US$US
241065131$24106513$1$I$$20230606$20240717$20240717$PER$$US-GRUNENTHAL-2023-112491$AVERITAS$$72$YR$$M$Y$$$20240710$$HP$US$US
241065141$24106514$1$I$$20230602$20240717$20240717$PER$$US-GRUNENTHAL-2023-111885$AVERITAS$$71$YR$$F$Y$$$20240710$$PH$US$US
241065151$24106515$1$I$$20240712$20240717$20240717$EXP$$ES-GILEAD-2024-0680535$GILEAD$$$$A$M$Y$$$20240717$$HP$ES$ES
241065162$24106516$2$F$$20240722$20240717$20240724$EXP$$IT-GILEAD-2024-0681002$GILEAD$$$$A$M$Y$$$20240724$$CN$IT$IT
241065174$24106517$4$F$$20240723$20240717$20240731$EXP$$US-ABBVIE-5841790$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241065182$24106518$2$F$20240620$20240729$20240717$20240802$EXP$$US-OTSUKA-2024_013263$OTSUKA$$60$YR$$F$Y$$$20240802$$MD$US$US
241065192$24106519$2$F$$20240807$20240717$20240808$PER$$US-ALXN-202407USA000798US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241065201$24106520$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112624$BRISTOL MYERS SQUIBB$$22$YR$A$M$Y$$$20240717$$CN$US$US
241065211$24106521$1$I$20240630$20240712$20240717$20240717$EXP$$US-BAUSCH-BL-2024-010704$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240717$$CN$US$US
241065221$24106522$1$I$20240624$20240712$20240717$20240717$EXP$GB-MHRA-MED-202407071011142080-CVHZM$GB-ASTELLAS-2024US019855$ASTELLAS$$$$$$Y$$$20240717$$CN$GB$GB
241065231$24106523$1$I$20240622$20240709$20240717$20240717$EXP$GB-MHRA-MED-202406241327583340-DZSHT$GB-TEVA-VS-3219951$TEVA$$64$YR$$F$Y$97$KG$20240717$$CN$GB$GB
241065242$24106524$2$F$$20240802$20240717$20240807$EXP$$JP-BAUSCH-BL-2024-010910$BAUSCH AND LOMB$$6$DEC$$M$Y$$$20240807$$MD$JP$JP
241065251$24106525$1$I$$20230526$20240717$20240717$PER$$US-GRUNENTHAL-2023-112102$AVERITAS$$66$YR$$M$Y$$$20240710$$PH$US$US
241065262$24106526$2$F$20100101$20240722$20240717$20240729$EXP$$RO-BAUSCH-BL-2024-010599$BAUSCH AND LOMB$Mustea T, Morar M, Muntean A, Nistor S, Pop A. Challenges in managing early-onset Crohn^s disease. Acta Medica Marisiensis. 2024;70(SUPPL.3):188-189.$$$A$M$Y$$$20240729$$HP$RO$RO
241065273$24106527$3$F$20240712$20240827$20240717$20240830$EXP$$US-KYOWAKIRIN-2024KK017083$KYOWA$$$$$$Y$$$20240830$$HP$US$US
241065281$24106528$1$I$20240702$20240709$20240717$20240717$EXP$$CN-AstraZeneca-2024A158997$ASTRAZENECA$$30977$DY$$F$Y$48$KG$20240717$$MD$CN$
241065292$24106529$2$F$$20240805$20240717$20240813$EXP$$ES-AstraZeneca-2024A156809$ASTRAZENECA$Marti-Pastor, M; Bou-Monterde, R;  Ciancotti-Oliver, L et al. Effectiveness of tixagevimab/cilgavimab in reducing infection, hospital admissions and SARS-CoV-2 mortality in immunocompromised. Medicina Clinica 2024;$$$$$Y$$$20240813$$HP$ES$
241065302$24106530$2$F$$20240807$20240717$20240814$EXP$$FI-AstraZeneca-2024A157030$ASTRAZENECA$$83$YR$$F$Y$$$20240814$$PH$FI$
241065311$24106531$1$I$$20200717$20240717$20240717$EXP$$US-AstraZeneca-2020SE91715$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$US$
241065321$24106532$1$I$$20240713$20240717$20240717$PER$$US-AstraZeneca-2024A160825$ASTRAZENECA$$$$A$M$Y$$$20240717$$MD$US$
241065331$24106533$1$I$$20240710$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065773$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$17$YR$$M$Y$$$20240717$$HP$FR$FR
241065342$24106534$2$F$$20240924$20240717$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113616$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$73.48$KG$20240925$$CN$US$US
241065361$24106536$1$I$20240417$20240708$20240717$20240717$EXP$GB-MHRA-MED-202405101735297400-BRCGK$GB-TEVA-VS-3219197$TEVA$$66$YR$$M$Y$80$KG$20240717$$MD$GB$GB
241065371$24106537$1$I$20230526$20240708$20240717$20240717$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-06593$HIKMA$$$$$$Y$$$20240717$$HP$GB$GB
241065381$24106538$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113643$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$76.66$KG$20240717$$CN$US$US
241065392$24106539$2$F$$20240916$20240717$20240923$EXP$$CA-BAUSCH-BL-2024-010915$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240923$$CN$CA$CA
241065401$24106540$1$I$$20240715$20240717$20240717$EXP$$CA-BAUSCH-BL-2024-010923$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240717$$CN$CA$CA
241065411$24106541$1$I$20240712$20240716$20240717$20240717$EXP$$US-BAUSCH-BL-2024-010941$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240717$$CN$US$US
241065421$24106542$1$I$20240411$20240713$20240717$20240717$PER$$US-INCYTE CORPORATION-2024IN007379$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241065432$24106543$2$F$$20240717$20240717$20240725$EXP$$DE-INCYTE CORPORATION-2024IN007364$INCYTE$$$$$$Y$$$20240725$$CN$DE$DE
241065441$24106544$1$I$$20240702$20240717$20240717$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US002188$PAREXEL$$$$$$Y$$$20240711$$MD$US$US
241065453$24106545$3$F$20230901$20240829$20240717$20240904$EXP$$CA-BAUSCH-BL-2023-014953$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240904$$CN$CA$CA
241065461$24106546$1$I$20220919$20240710$20240717$20240717$EXP$PL-URPL-DML-MLP.4401.1.773.2022$PL-TEVA-VS-3220387$TEVA$$82$YR$$F$Y$61$KG$20240717$$MD$PL$PL
241065471$24106547$1$I$$20240705$20240717$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-113780$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$96$KG$20240717$$HP$CA$CA
241065481$24106548$1$I$$20240709$20240717$20240717$PER$$US-MYLANLABS-2024M1065087$MYLAN$$$$$$Y$$$20240717$$CN$US$US
241065492$24106549$2$F$$20240808$20240717$20240813$PER$$US-MYLANLABS-2024M1064671$MYLAN$$$$$F$Y$$$20240813$$CN$US$US
241065501$24106550$1$I$$20230517$20240717$20240717$PER$$US-GRUNENTHAL-2023-111774$AVERITAS$$45$YR$$F$Y$$$20240710$$HP$US$US
241065511$24106551$1$I$$20240711$20240717$20240717$PER$$US-ALXN-202407USA000836US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
241065521$24106552$1$I$$20240711$20240717$20240717$PER$$US-ALXN-202407USA000847US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
241065531$24106553$1$I$20240101$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112535$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$83.4$KG$20240717$$HP$US$US
241065542$24106554$2$F$20240701$20240719$20240717$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112486$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240724$$HP$US$US
241065551$24106555$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111859$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240717$$CN$US$US
241065561$24106556$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112739$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240717$$HP$US$US
241065571$24106557$1$I$20240101$20240704$20240717$20240717$PER$$US-MYLANLABS-2024M1061987$MYLAN$$$$$F$Y$83.91$KG$20240717$$CN$US$US
241065581$24106558$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112652$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240717$$CN$US$US
241065591$24106559$1$I$$20240716$20240717$20240717$EXP$$ES-GILEAD-2024-0680885$GILEAD$$$$$$Y$$$20240717$$HP$ES$ES
241065601$24106560$1$I$$20240710$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065879$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$45$YR$$F$Y$$$20240717$$HP$FR$FR
241065611$24106561$1$I$20240705$20240709$20240717$20240717$EXP$$US-ABBVIE-5603384$ABBVIE$$73$YR$$F$Y$$$20240717$$CN$US$US
241065622$24106562$2$F$20220101$20240718$20240717$20240722$EXP$$CA-PFIZER INC-202400190577$PFIZER$$68$YR$$F$Y$74.8$KG$20240722$$HP$CA$CA
241065631$24106563$1$I$20240601$20240710$20240717$20240717$PER$$US-SA-2024SA207036$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240717$$MD$US$US
241065641$24106564$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA207004$SANOFI AVENTIS$$$$A$F$Y$90.2$KG$20240717$$MD$US$US
241065651$24106565$1$I$20240701$20240711$20240717$20240717$PER$$US-SA-2024SA207306$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240717$$MD$US$US
241065661$24106566$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207116$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240717$$MD$US$US
241065672$24106567$2$F$$20240927$20240717$20240927$PER$$NVSC2024US146865$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
241065681$24106568$1$I$20240710$20240711$20240717$20240717$EXP$$CN-FreseniusKabi-FK202411050$FRESENIUS KABI$$82$YR$E$F$Y$50$KG$20240717$$HP$CN$CN
241065691$24106569$1$I$$20240708$20240717$20240717$EXP$$CA-FreseniusKabi-FK202410943$FRESENIUS KABI$$6$YR$C$M$Y$21$KG$20240717$$HP$CA$CA
241065701$24106570$1$I$$20240711$20240717$20240717$PER$$US-ABBVIE-5840914$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241065711$24106571$1$I$$20230525$20240717$20240717$PER$$US-GRUNENTHAL-2023-112076$AVERITAS$$65$YR$$F$Y$$$20240710$$CN$US$US
241065721$24106572$1$I$20240714$20240715$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159206$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241065731$24106573$1$I$20240715$20240717$20240717$20240717$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040334$BOEHRINGER INGELHEIM$$70$YR$E$$Y$$$20240717$$CN$US$US
241065741$24106574$1$I$$20240711$20240717$20240717$EXP$$US-ABBVIE-5842406$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241065751$24106575$1$I$$20240710$20240717$20240717$EXP$$CA-TEVA-VS-3220376$TEVA$$33$YR$$F$Y$$$20240717$$MD$CA$CA
241065761$24106576$1$I$$20240712$20240717$20240717$EXP$$CA-SANDOZ INC.-NVSC2020CA156456$SANDOZ$$61$YR$$F$Y$$$20240717$$HP$CA$CA
241065771$24106577$1$I$$20240716$20240717$20240717$EXP$$AU-SANDOZ INC.-SDZ2024AU065876$SANDOZ$$$$$$Y$$$20240717$$HP$AU$AU
241065791$24106579$1$I$20240713$20240716$20240717$20240717$EXP$$GB-SANDOZ INC.-SDZ2024GB065418$SANDOZ$$26$YR$$F$Y$$$20240717$$CN$GB$GB
241065802$24106580$2$F$20220617$20240916$20240717$20240917$EXP$AT-EMA-DD-20240712-7482661-082834$AT-SANDOZ INC.-SDZ2024AT065584$SANDOZ$$29$YR$$M$Y$88.2$KG$20240917$$HP$AT$AT
241065811$24106581$1$I$$20240710$20240717$20240717$EXP$$CA-TEVA-VS-3220502$TEVA$$$$$F$Y$$$20240717$$HP$CA$CA
241065822$24106582$2$F$$20240805$20240717$20240813$EXP$$ES-AstraZeneca-2024A156812$ASTRAZENECA$Marti-Pastor, M; Bou-Monterde, R;  Ciancotti-Oliver, L et all. Effectiveness of tixagevimab/cilgavimab in reducing infection, hospital admissions and SARS-CoV-2 mortality in immunocompromised patients. Clinical Medicine 2024;$$$$$Y$$$20240813$$HP$ES$
241065831$24106583$1$I$20240620$20240709$20240717$20240717$EXP$IT-MINISAL02-993015$IT-TEVA-VS-3219401$TEVA$$69$YR$$F$Y$$$20240717$$MD$IT$IT
241065841$24106584$1$I$$20240711$20240717$20240717$PER$$US-ALXN-202407USA000882US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$HP$US$US
241065861$24106586$1$I$20240501$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009917$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240717$$CN$US$US
241065871$24106587$1$I$20240711$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009109$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240717$$CN$US$US
241065881$24106588$1$I$$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407007594$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
241065891$24106589$1$I$$20240712$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009106$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240717$$CN$US$US
241065901$24106590$1$I$$20240709$20240717$20240717$EXP$GB-MHRA-MED-202407081626102540-JWCDR$GB-TEVA-VS-3219960$TEVA$$$$$$Y$$$20240717$$HP$GB$GB
241065911$24106591$1$I$$20240708$20240717$20240717$PER$$US-MYLANLABS-2024M1064698$MYLAN$$$$$F$Y$$$20240717$$CN$US$US
241065921$24106592$1$I$$20240710$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065893$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$43$YR$$M$Y$$$20240717$$HP$FR$FR
241065932$24106593$2$F$$20240904$20240717$20240909$EXP$$CA-SANDOZ INC.-SDZ2024CA064499$SANDOZ$$40$YR$$F$Y$$$20240909$$HP$CA$CA
241065941$24106594$1$I$$20240709$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109267$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240717$$CN$US$US
241065954$24106595$4$F$$20240924$20240717$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113377$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240926$$CN$US$US
241065961$24106596$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113546$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240717$$CN$US$US
241065971$24106597$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113244$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240717$$CN$US$US
241065981$24106598$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA206995$SANOFI AVENTIS$$$$A$M$Y$124.1$KG$20240717$$MD$US$US
241065992$24106599$2$F$20231101$20240715$20240717$20240722$EXP$$KR-ROCHE-10000026567$ROCHE$Park K, Yoo J, Kim S, Kim Y. Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report. World Journal of Clinical Cases. 2024;12 (22):5177-83. doi:10.12998/wjcc.v12.i22.5177.$63$YR$A$M$Y$$$20240722$$HP$KR$KR
241066001$24106600$1$I$$20240715$20240717$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-113048$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$45$KG$20240717$$HP$CA$CA
241066011$24106601$1$I$$20240708$20240717$20240717$PER$$US-MYLANLABS-2024M1065045$MYLAN$$$$$M$Y$95.25$KG$20240717$$CN$US$US
241066021$24106602$1$I$20240625$20240711$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US064801$SANDOZ$$71$YR$$F$Y$57.3$KG$20240717$$CN$US$US
241066031$24106603$1$I$$20240716$20240717$20240717$EXP$$AU-SANDOZ INC.-SDZ2024AU065880$SANDOZ$$$$$$Y$$$20240717$$HP$AU$AU
241066041$24106604$1$I$$20230602$20240717$20240717$PER$$US-GRUNENTHAL-2023-112327$AVERITAS$Graf G, Neil O.C., Khan O.. Treatment of a patient with intractable Painful DPN and Raynaud syndrome using high concentration capsaicin 8% topical system: case report. Online article$76$YR$$F$Y$$$20240710$$HP$US$US
241066052$24106605$2$F$$20240726$20240717$20240802$EXP$$US-Calliditas-2024CAL01293$CALLIDITAS THERAPEUTICS$$74$YR$E$M$Y$67.7$KG$20240802$$CN$US$US
241066071$24106607$1$I$20200126$20240709$20240717$20240717$EXP$PL-URPL-1-1188-2020$PL-TEVA-VS-3219433$TEVA$$30$YR$$M$Y$$$20240717$$MD$PL$PL
241066081$24106608$1$I$20230419$20240711$20240717$20240717$EXP$FR-AFSSAPS-TS2024000773$FR-009507513-2407FRA005569$MERCK$$42$YR$$F$Y$77$KG$20240717$$MD$FR$FR
241066091$24106609$1$I$20240619$20240709$20240717$20240717$EXP$FR-AFSSAPS-RN2024000735$FR-TEVA-VS-3219429$TEVA$$49$YR$$M$Y$$$20240717$$MD$FR$FR
241066101$24106610$1$I$$20240711$20240717$20240717$PER$$US-SA-2024SA206074$SANOFI AVENTIS$$$$E$F$Y$$$20240717$$CN$US$US
241066111$24106611$1$I$20240601$20240710$20240717$20240717$PER$$US-SA-2024SA207136$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240717$$MD$US$US
241066121$24106612$1$I$$20240710$20240717$20240717$PER$$US-SA-2024SA207117$SANOFI AVENTIS$$$$A$F$Y$$$20240717$$MD$US$US
241066132$24106613$2$F$$20240829$20240717$20240916$PER$$US-SA-2024SA207122$SANOFI AVENTIS$$$$A$F$Y$87$KG$20240916$$MD$US$US
241066142$24106614$2$F$$20240910$20240717$20240917$PER$$US-SA-2024SA207137$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
241066151$24106615$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113344$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240717$$HP$US$US
241066161$24106616$1$I$$20240716$20240717$20240717$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-113735$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$126.55$KG$20240717$$CN$PR$PR
241066171$24106617$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113378$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240717$$CN$US$US
241066182$24106618$2$F$$20240809$20240717$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113699$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240813$$HP$US$US
241066192$24106619$2$F$$20240813$20240717$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113573$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$85.28$KG$20240814$$HP$US$US
241066201$24106620$1$I$20240601$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113567$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240717$$PH$US$US
241066211$24106621$1$I$20240502$20240715$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113495$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240717$$CN$US$US
241066221$24106622$1$I$$20240708$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109546$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240717$$CN$US$US
241066231$24106623$1$I$$20240712$20240717$20240717$30DAY$$GR-SANDOZ INC.-SDZ2024GR065582$SANDOZ$$16$YR$$F$Y$$$20240717$$CN$GR$GR
241066251$24106625$1$I$20240201$20240708$20240717$20240717$EXP$GB-MHRA-MED-202407072335454710-LSBVK$GB-SMPA-2024SPA000146$SUNOVION$$$$$$Y$$$20240717$$CN$GB$GB
241066261$24106626$1$I$$20240711$20240717$20240717$EXP$$US-SMPA-2024SPA000136$SUNOVION$$$$$$Y$$$20240717$$CN$US$US
241066271$24106627$1$I$$20240711$20240717$20240717$PER$$US-LUNDBECK-DKLU4001687$LUNDBECK$$$$$$Y$$$20240717$$CN$US$US
241066291$24106629$1$I$20240611$20240716$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065812$SANDOZ$$$$$$Y$$$20240717$$HP$US$US
241066301$24106630$1$I$20230101$20240715$20240717$20240717$PER$$US-SMPA-2024SPA000093$SUNOVION$$$$$$Y$$$20240717$$CN$US$US
241066312$24106631$2$F$20240705$20240726$20240717$20240730$EXP$$CN-AMERICAN REGENT INC-2024002741$AMERICAN REGENT$$34$YR$$F$Y$43$KG$20240730$$MD$CN$CN
241066321$24106632$1$I$$20191227$20240717$20240717$EXP$$HN-AstraZeneca-2020SE00202$ASTRAZENECA$$77$YR$$F$Y$$$20240717$$CN$HN$
241066331$24106633$1$I$$20191223$20240717$20240717$EXP$$US-AstraZeneca-2019SF89004$ASTRAZENECA$$76$YR$$M$Y$$$20240717$$CN$US$
241066341$24106634$1$I$20230901$20240711$20240717$20240717$EXP$$ES-GSK-ES2024EME086731$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$CN$ES$ES
241066351$24106635$1$I$20240619$20240715$20240717$20240717$EXP$ES-AEMPS-1547415$ES-SANDOZ INC.-SDZ2024ES065492$SANDOZ$$83$YR$$F$Y$52.7$KG$20240717$$MD$ES$ES
241066361$24106636$1$I$$20240710$20240717$20240717$EXP$$CA-TEVA-VS-3220107$TEVA$$76$YR$$M$Y$$$20240717$$MD$CA$CA
241066371$24106637$1$I$$20240708$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109624$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240717$$CN$US$US
241066391$24106639$1$I$$20240712$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112200$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240717$$PH$US$US
241066401$24106640$1$I$$20240711$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111925$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240717$$MD$US$US
241066411$24106641$1$I$20230601$20230621$20240717$20240717$PER$$US-GRUNENTHAL-2023-112959$AVERITAS$$35$YR$$M$Y$$$20240710$$HP$US$US
241066421$24106642$1$I$20230427$20230605$20240717$20240717$PER$$US-GRUNENTHAL-2023-112384$AVERITAS$$67$YR$$M$Y$$$20240710$$HP$US$US
241066431$24106643$1$I$$20230606$20240717$20240717$PER$$US-GRUNENTHAL-2023-112490$AVERITAS$$53$YR$$M$Y$$$20240710$$HP$US$US
241066442$24106644$2$F$20231129$20240911$20240717$20240919$EXP$$BE-APELLIS-APL-2023-003520$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240919$$HP$BE$BE
241066452$24106645$2$F$20201219$20240820$20240717$20240826$EXP$$PT-009507513-2407PRT009879$MERCK$$65$YR$$F$Y$$$20240826$$MD$PT$PT
241066461$24106646$1$I$20210317$20240709$20240717$20240717$EXP$FR-AFSSAPS-MA2024001144$FR-TEVA-VS-3219517$TEVA$$70$YR$$F$Y$$$20240717$$PH$FR$FR
241066471$24106647$1$I$$20240710$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065875$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$6$YR$$M$Y$$$20240717$$HP$FR$FR
241066481$24106648$1$I$$20240710$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065878$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$27$YR$$M$Y$$$20240717$$HP$FR$FR
241066491$24106649$1$I$20240105$20240711$20240717$20240717$EXP$$IT-MYLANLABS-2024M1065566$MYLAN$$70$YR$$M$Y$$$20240717$$HP$IT$IT
241066511$24106651$1$I$$20240711$20240717$20240717$EXP$$US-ALXN-202407USA000817US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240717$$CN$US$US
241066521$24106652$1$I$$20240705$20240717$20240717$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004923$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240717$$CN$US$US
241066534$24106653$4$F$$20240812$20240717$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008810$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240823$$CN$US$US
241066541$24106654$1$I$$20240705$20240717$20240717$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202407004021$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240717$$CN$ES$ES
241066551$24106655$1$I$20240706$20240711$20240717$20240717$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202406018922$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$BR$BR
241066561$24106656$1$I$20240628$20240705$20240717$20240717$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407004570$ELI LILLY AND CO$$54$YR$A$F$Y$50$KG$20240717$$CN$CN$CN
241066572$24106657$2$F$20240606$20240712$20240717$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009150$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240724$$CN$US$US
241066581$24106658$1$I$20240620$20240705$20240717$20240717$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407008128$ELI LILLY AND CO$$56$YR$A$F$Y$53$KG$20240717$$CN$DE$CN
241066592$24106659$2$F$20230101$20240813$20240717$20240821$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006145$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240821$$CN$US$US
241066601$24106660$1$I$20240715$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009909$ELI LILLY AND CO$$41$YR$A$$Y$$$20240717$$CN$US$US
241066611$24106661$1$I$$20240705$20240717$20240717$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004885$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240717$$CN$US$US
241066622$24106662$2$F$$20240722$20240717$20240725$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407008295$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240725$$PH$FR$FR
241066631$24106663$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405101510545020-SPZMK$GB-ELI_LILLY_AND_COMPANY-GB202407004693$ELI LILLY AND CO$$$$$M$Y$$$20240717$$CN$GB$GB
241066641$24106664$1$I$20240522$20240711$20240717$20240717$EXP$FR-AFSSAPS-AN2024000781$FR-ELI_LILLY_AND_COMPANY-FR202407008244$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240717$$CN$FR$FR
241066651$24106665$1$I$20230501$20240710$20240717$20240717$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202407007227$ELI LILLY AND CO$$$$$F$Y$$$20240717$$MD$CO$CO
241066661$24106666$1$I$20240701$20240708$20240717$20240717$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407009829$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240717$$CN$DE$CN
241066672$24106667$2$F$20230101$20240827$20240717$20240830$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407004906$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240830$$CN$JP$JP
241066681$24106668$1$I$$20240704$20240717$20240717$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202407005779$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240717$$CN$MX$MX
241066691$24106669$1$I$20230202$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405152358098260-JGDRY$GB-ELI_LILLY_AND_COMPANY-GB202407005679$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$GB$GB
241066701$24106670$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405131507002720-STMDV$GB-ELI_LILLY_AND_COMPANY-GB202407004738$ELI LILLY AND CO$$$$$M$Y$$$20240717$$CN$GB$GB
241066711$24106671$1$I$$20240712$20240717$20240717$EXP$$CH-ELI_LILLY_AND_COMPANY-CH202407008809$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240717$$CN$CH$CH
241066721$24106672$1$I$$20240712$20240717$20240717$EXP$$JP-PFIZER INC-202400212714$PFIZER$$$$$$Y$$$20240717$$PH$JP$JP
241066732$24106673$2$F$20240630$20240715$20240717$20240719$EXP$$US-PFIZER INC-202400215741$PFIZER$$50$YR$$F$Y$$$20240719$$CN$US$US
241066744$24106674$4$F$$20240719$20240717$20240726$PER$$NVSC2024US147308$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241066751$24106675$1$I$20240326$20240709$20240717$20240717$EXP$FR-AFSSAPS-CN2024000635$FR-TEVA-VS-3219535$TEVA$$15$DY$$M$Y$4.4$KG$20240717$$MD$FR$FR
241066761$24106676$1$I$$20240715$20240717$20240717$EXP$$CA-PURDUE-USA-2024-0310804$PURDUE$$73$YR$$F$Y$$$20240717$$CN$CA$CA
241066781$24106678$1$I$$20210204$20240717$20240717$EXP$$FR-DSJP-DSJ-2021-104530$DAIICHI$$$$E$F$Y$$$20240717$$MD$FR$FR
241066791$24106679$1$I$20230101$20240715$20240717$20240717$EXP$$US-PFIZER INC-202400216247$PFIZER$$64$YR$$F$Y$$$20240717$$HP$US$US
241066802$24106680$2$F$20140101$20240826$20240717$20240902$EXP$$US-ABBVIE-5841017$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
241066811$24106681$1$I$$20240714$20240717$20240717$EXP$$IN-ANIPHARMA-2024-IN-000114$ANI$Ike IM, Jayaprakashan KP, Raju R.A case of risperidone monotherapy causing serotonin syndrome in one of the monozygotic twins..Indian Journal of Psychiatry.2024;66(Suppl1):S52-S53.$15$YR$$M$Y$$$20240717$$MD$IN$IN
241066821$24106682$1$I$$20240715$20240717$20240717$EXP$$CA-ABBVIE-5842555$ABBVIE$$$$A$F$Y$$$20240717$$CN$CA$CA
241066831$24106683$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112869$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240717$$CN$US$US
241066843$24106684$3$F$$20240820$20240717$20240825$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109297$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240826$$HP$JP$JP
241066851$24106685$1$I$$20240710$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110766$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240717$$HP$US$US
241066861$24106686$1$I$20240701$20240716$20240717$20240717$30DAY$$US-SANDOZ INC.-SDZ2024US065932$SANDOZ$$$$$F$Y$$$20240717$$HP$US$US
241066871$24106687$1$I$$20240717$20240717$20240717$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040359$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240717$$CN$US$US
241066882$24106688$2$F$20240706$20240829$20240717$20240905$EXP$$US-Taiho Oncology Inc-2024-006926$TAIHO ONCOLOGY INC$$50$YR$A$M$Y$$$20240905$$CN$US$US
241066891$24106689$1$I$20240101$20240711$20240717$20240717$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-127599$DAIICHI$$51$YR$$F$Y$$$20240717$$MD$JP$JP
241066901$24106690$1$I$$20240708$20240717$20240717$EXP$US-MLMSERVICE-20240701-PI118346-00175-1$US-RDY-SPO/USA/24/0010194$DR REDDYS$Pham S, Heigle B, Gibbs C, Gebrehiwot WG, Pannu P.  Complications of Infective Endocarditis: A Case Report of Intracerebral Hemorrhage Exacerbated by Enoxaparin. Cureus. 2024;16(5):e61235. DOI:10.7759/cureus.61235.$76$YR$E$F$Y$$$20240717$$MD$US$US
241066911$24106691$1$I$20230727$20240711$20240717$20240717$EXP$SE-SEMPA-2024-004297$SE-MYLANLABS-2024M1065147$MYLAN$$30$YR$$F$Y$70$KG$20240717$$HP$SE$SE
241066921$24106692$1$I$$20201014$20240717$20240717$EXP$$CA-AstraZeneca-2020SE02592$ASTRAZENECA$$66$YR$$F$Y$$$20240717$$MD$CA$
241066934$24106693$4$F$20240101$20240814$20240717$20240823$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01078$AIMMUNE$$$$$$Y$$$20240824$$CN$US$US
241066941$24106694$1$I$20240714$20240715$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159212$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241066951$24106695$1$I$$20240715$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159218$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241066962$24106696$2$F$$20240718$20240717$20240722$PER$$US-BIOMARINAP-US-2024-159213$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241066972$24106697$2$F$20240610$20240729$20240717$20240820$PER$$US-INCYTE CORPORATION-2024IN006823$INCYTE$$$$$$Y$$$20240820$$HP$US$US
241066982$24106698$2$F$20240101$20240716$20240717$20240723$EXP$$US-KYOWAKIRIN-2024KK017002$KYOWA$$$$$$Y$$$20240723$$HP$US$US
241066991$24106699$1$I$$20240716$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159220$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241067001$24106700$1$I$$20240625$20240717$20240717$PER$$US-INCYTE CORPORATION-2024IN006807$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241067012$24106701$2$F$$20240731$20240717$20240821$PER$$US-INCYTE CORPORATION-2024IN006804$INCYTE$$$$$$Y$$$20240821$$HP$US$US
241067021$24106702$1$I$$20240715$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2023CA037579$SANDOZ$$$$$F$Y$$$20240717$$CN$CA$CA
241067041$24106704$1$I$20240707$20240710$20240717$20240717$PER$$CN-Eisai-EC-2024-170108$EISAI$$34$YR$A$F$Y$50$KG$20240717$$HP$CN$CN
241067052$24106705$2$F$$20240807$20240717$20240808$PER$$US-ALXN-202407USA000810US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241067063$24106706$3$F$$20240819$20240717$20240909$PER$$US-INCYTE CORPORATION-2024IN006802$INCYTE$$$$$$Y$$$20240909$$CN$US$US
241067071$24106707$1$I$$20240712$20240717$20240717$EXP$$MA-MYLANLABS-2024M1066302$MYLAN$$$$$$Y$$$20240717$$CN$MA$MA
241067081$24106708$1$I$20240624$20240705$20240717$20240717$EXP$GB-MHRA-MED-202406260314407530-PJYVK$GB-ELI_LILLY_AND_COMPANY-GB202407005685$ELI LILLY AND CO$$31$YR$A$F$Y$98$KG$20240717$$CN$GB$GB
241067091$24106709$1$I$20240512$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405151044571370-WNTZS$GB-ELI_LILLY_AND_COMPANY-GB202407004840$ELI LILLY AND CO$$28$YR$A$M$Y$109$KG$20240717$$CN$GB$GB
241067101$24106710$1$I$20231022$20240705$20240717$20240717$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004516$ELI LILLY AND CO$$65$YR$E$$Y$$$20240717$$CN$US$US
241067111$24106711$1$I$20240511$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405140857232230-VQCJB$GB-ELI_LILLY_AND_COMPANY-GB202407004769$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240717$$CN$GB$GB
241067121$24106712$1$I$20240601$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405111543567210-CFDKY$GB-ELI_LILLY_AND_COMPANY-GB202407004733$ELI LILLY AND CO$$$$$M$Y$$$20240717$$CN$GB$GB
241067131$24106713$1$I$20240223$20240705$20240717$20240717$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004561$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240717$$CN$US$US
241067141$24106714$1$I$20240708$20240709$20240717$20240717$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006598$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240717$$CN$US$US
241067151$24106715$1$I$20240624$20240705$20240717$20240717$EXP$GB-MHRA-MED-202407042244575890-LYRKN$GB-ELI_LILLY_AND_COMPANY-GB202407005626$ELI LILLY AND CO$$32$YR$A$F$Y$95$KG$20240717$$CN$GB$GB
241067161$24106716$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405161240064840-MSKDW$GB-ELI_LILLY_AND_COMPANY-GB202407005694$ELI LILLY AND CO$$$$$M$Y$77$KG$20240717$$CN$GB$GB
241067171$24106717$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202406260048531820-CZTLB$GB-ELI_LILLY_AND_COMPANY-GB202407005683$ELI LILLY AND CO$$61$YR$A$F$Y$98$KG$20240717$$CN$GB$GB
241067181$24106718$1$I$20240618$20240705$20240717$20240717$EXP$GB-MHRA-MED-202406232313086720-LYSBW$GB-ELI_LILLY_AND_COMPANY-GB202407005643$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$GB$GB
241067191$24106719$1$I$20240512$20240705$20240717$20240717$EXP$GB-MHRA-MED-202405151823596660-YSLNG$GB-ELI_LILLY_AND_COMPANY-GB202407004843$ELI LILLY AND CO$$47$YR$A$F$Y$92$KG$20240717$$CN$GB$GB
241067201$24106720$1$I$$20240625$20240717$20240717$PER$$US-INCYTE CORPORATION-2024IN006800$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241067211$24106721$1$I$$20240709$20240717$20240717$EXP$$NVSC2024CN147303$NOVARTIS$Zhao Y, Yang W, Zhao X, Hu X, Hu J, Liu X et. al.. Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia.. FRONTIERS IN PEDIATRICS. 2024;10:1-10$9$YR$$M$Y$$$20240717$$HP$CN$CN
241067221$24106722$1$I$$20240625$20240717$20240717$PER$$US-INCYTE CORPORATION-2024IN006799$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241067231$24106723$1$I$$20240710$20240717$20240717$EXP$$FR-MYLANLABS-2024M1065720$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$7$YR$$F$Y$$$20240717$$HP$FR$FR
241067241$24106724$1$I$$20240613$20240717$20240717$PER$$US-INCYTE CORPORATION-2024IN006364$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241067251$24106725$1$I$$20200109$20240717$20240717$EXP$$US-AstraZeneca-2020SE04696$ASTRAZENECA$$$$$F$Y$$$20240717$$CN$US$
241067265$24106726$5$F$20240625$20240915$20240717$20240924$EXP$$IL-Taiho Oncology Inc-2024-006930$TAIHO ONCOLOGY INC$$41$YR$A$F$Y$$$20240924$$CN$IL$IL
241067271$24106727$1$I$20240621$20240716$20240717$20240717$EXP$$US-KYOWAKIRIN-2024KK017181$KYOWA$$$$$$Y$$$20240717$$HP$US$US
241067281$24106728$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112973$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240717$$HP$US$US
241067332$24106733$2$F$$20240814$20240717$20240820$30DAY$$EG-SANDOZ INC.-SDZ2024EG065872$SANDOZ$$$$$M$Y$$$20240820$$CN$EG$EG
241067342$24106734$2$F$20240711$20240723$20240717$20240726$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010617$JAZZ$$21$YR$$M$Y$$$20240726$$HP$US$US
241067351$24106735$1$I$20240301$20240714$20240717$20240717$EXP$$EG-ABBVIE-5841041$ABBVIE$$77$YR$$M$Y$$$20240717$$CN$EG$EG
241067361$24106736$1$I$20240607$20240618$20240717$20240717$PER$$US-LEX-000348$LEXICON PHARMACEUTICALS$$78$YR$$F$Y$$$20240717$$CN$US$US
241067371$24106737$1$I$20240101$20240712$20240717$20240717$EXP$$GB-AMERICAN REGENT INC-2024002712$AMERICAN REGENT$$$$$$Y$$$20240717$$CN$GB$GB
241067381$24106738$1$I$20240712$20240715$20240717$20240717$EXP$$US-ABBVIE-5842147$ABBVIE$$46$YR$$M$Y$$$20240717$$CN$US$US
241067391$24106739$1$I$20240529$20240617$20240717$20240717$PER$$US-009507513-2406USA006920$MERCK$$51$YR$$M$Y$$$20240717$$PH$US$US
241067401$24106740$1$I$$20240715$20240717$20240717$EXP$$GB-SANDOZ INC.-SDZ2024GB065693$SANDOZ$$$$$F$Y$$$20240717$$PH$GB$GB
241067412$24106741$2$F$20240101$20240729$20240717$20240807$PER$$US-ABBVIE-5838468$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241067422$24106742$2$F$$20240725$20240717$20240802$PER$$US-ABBVIE-5835932$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241067431$24106743$1$I$$20240709$20240717$20240717$PER$$US-SA-2024SA207239$SANOFI AVENTIS$$$$A$M$Y$96.61$KG$20240717$$MD$US$US
241067441$24106744$1$I$$20240715$20240717$20240717$PER$$US-009507513-2407USA009832$MERCK$$$$$M$Y$$$20240717$$CN$US$US
241067452$24106745$2$F$$20240715$20240717$20240722$EXP$$GB-ABBVIE-5842479$ABBVIE$$$$A$F$Y$$$20240722$$CN$GB$GB
241067461$24106746$1$I$20240301$20240711$20240717$20240717$EXP$$US-LUNDBECK-DKLU4001685$LUNDBECK$$$$$$Y$$$20240717$$CN$US$US
241067471$24106747$1$I$$20240704$20240717$20240717$EXP$$US-APELLIS-2024-APL-0000322$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240717$$MD$US$US
241067481$24106748$1$I$20240715$20240715$20240717$20240717$EXP$$CA-ABBVIE-5842323$ABBVIE$$$$A$F$Y$$$20240717$$CN$CA$CA
241067491$24106749$1$I$20240712$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140749$AMGEN$$$$$F$Y$$$20240717$$MD$US$US
241067501$24106750$1$I$$20240709$20240717$20240717$EXP$$JP-SMPA-2024SMP010542$SUNOVION$$$$$$Y$$$20240717$$CN$JP$JP
241067512$24106751$2$F$20240110$20240729$20240717$20240802$EXP$$US-009507513-2407USA005196$MERCK$$58$YR$$M$Y$65.23$KG$20240802$$MD$US$US
241067521$24106752$1$I$20240715$20240716$20240717$20240717$PER$$US-JNJFOC-20240742590$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240717$$CN$US$US
241067551$24106755$1$I$20240701$20240712$20240717$20240717$EXP$$CN-INCYTE CORPORATION-2024IN007475$INCYTE$$$$$$Y$$$20240717$$HP$CN$CN
241067561$24106756$1$I$20240630$20240711$20240717$20240717$EXP$$CA-LUNDBECK-DKLU4001678$LUNDBECK$$$$$$Y$$$20240717$$HP$CA$CA
241067571$24106757$1$I$$20240712$20240717$20240717$PER$$US-SA-2024SA206812$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240717$$CN$US$US
241067581$24106758$1$I$20231001$20240710$20240717$20240717$EXP$$EU-BAUSCHBL-2024BNL027948$BAUSCH AND LOMB$Sucik M, Rosolanka R, Nosakova L, Krkoska D, Simekova K. Izoniazidom navodene poskodenie pecene sprevadzane ikterom. Gastroenterologie a hepatologie. 2024;78(2):156-164. doi:10.48095/ccgh2024156$64$YR$$F$Y$$$20240717$$MD$EU$EU
241067591$24106759$1$I$$20240715$20240717$20240717$PER$$US-INCYTE CORPORATION-2024IN007436$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241067601$24106760$1$I$20240413$20240711$20240717$20240717$EXP$FR-AFSSAPS-PP2024000739$FR-INCYTE CORPORATION-2024IN007320$INCYTE$$$$$$Y$$$20240717$$MD$FR$FR
241067611$24106761$1$I$$20240712$20240717$20240717$EXP$$US-LUNDBECK-DKLU4001746$LUNDBECK$$$$$$Y$$$20240717$$HP$US$US
241067621$24106762$1$I$$20240711$20240717$20240717$EXP$$TH-INCYTE CORPORATION-2024IN007309$INCYTE$$$$$$Y$$$20240717$$MD$TH$TH
241067631$24106763$1$I$$20240716$20240717$20240717$PER$$NVSC2024US147387$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241067641$24106764$1$I$20180915$20240713$20240717$20240717$EXP$$EU-BAUSCHBL-2024BNL030059$BAUSCH AND LOMB$$$$$$Y$$$20240717$$MD$EU$EU
241067652$24106765$2$F$20230101$20240728$20240717$20240801$EXP$$EU-BAUSCHBL-2024BNL030055$BAUSCH AND LOMB$$46$YR$$F$Y$$$20240801$$HP$EU$EU
241067661$24106766$1$I$$20240715$20240717$20240717$EXP$$NVSC2024GB004812$NOVARTIS$$$$A$F$Y$$$20240717$$CN$GB$GB
241067671$24106767$1$I$20240601$20240628$20240717$20240717$PER$$US-INCYTE CORPORATION-2024IN006930$INCYTE$$$$$$Y$$$20240717$$PH$US$US
241067681$24106768$1$I$$20240717$20240717$20240717$EXP$$JP-PFIZER INC-PV202400093434$PFIZER$$42$YR$$F$Y$$$20240717$$CN$JP$JP
241067691$24106769$1$I$20240715$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113713$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240717$$PH$US$US
241067701$24106770$1$I$20240701$20240716$20240717$20240717$EXP$$MX-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040315$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240717$$CN$MX$MX
241067711$24106771$1$I$$20240716$20240717$20240717$PER$$NVSC2024US147394$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241067721$24106772$1$I$$20240709$20240717$20240717$EXP$$NVSC2024CN147302$NOVARTIS$Zhao Y, Yang W, Zhao X, Hu X, Hu J, Liu X, et al.. Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia. FRONTIERS IN PEDIATRICS. 2023;10:1-10$15$YR$$M$Y$$$20240717$$HP$CN$CN
241067731$24106773$1$I$$20240709$20240717$20240717$EXP$$NVSC2024CN147301$NOVARTIS$Zhao Y, Yang W, Zhao X, Hu X, Hu J, Liu X et. al.. Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia.. FRONTIERS IN PEDIATRICS. 2024;10:1-10$17$YR$$M$Y$$$20240717$$HP$CN$CN
241067741$24106774$1$I$$20240710$20240717$20240717$EXP$$IT-GILEAD-2024-0680868$GILEAD$$78$YR$E$F$Y$$$20240717$$MD$IT$IT
241067751$24106775$1$I$$20240709$20240717$20240717$EXP$$NVSC2024CN147300$NOVARTIS$Zhao Y, Yang W, Zhao X, Hu X, Hu J, Liu X, et al.. Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia. FRONTIERS IN PEDIATRICS. 2023;10:1-10$16$YR$$M$Y$$$20240717$$HP$CN$CN
241067761$24106776$1$I$$20240715$20240717$20240717$EXP$$US-INCYTE CORPORATION-2024IN007430$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241067771$24106777$1$I$$20240628$20240717$20240717$PER$$US-INCYTE CORPORATION-2024IN006935$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241067781$24106778$1$I$20240530$20240709$20240717$20240717$EXP$PL-URPL-DML-MLP.4401.1.148.2024$PL-TEVA-VS-3219415$TEVA$$36$YR$$M$Y$64$KG$20240717$$PH$PL$PL
241067791$24106779$1$I$20240706$20240715$20240717$20240717$EXP$$US-INCYTE CORPORATION-2024IN007427$INCYTE$$$$$$Y$$$20240717$$CN$US$US
241067805$24106780$5$F$$20240904$20240717$20240906$EXP$$EU-BAUSCHBL-2023BNL002657$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240906$$MD$EU$EU
241067811$24106781$1$I$20231221$20240709$20240717$20240717$EXP$$US-AstraZeneca-2024A071555$ASTRAZENECA$$54$YR$$M$Y$174.4$KG$20240717$$HP$US$
241067821$24106782$1$I$$20240716$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113396$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240717$$HP$US$US
241067831$24106783$1$I$$20240716$20240717$20240717$EXP$$US-INCYTE CORPORATION-2024IN007484$INCYTE$$$$$$Y$$$20240717$$HP$US$US
241067842$24106784$2$F$20240101$20240713$20240717$20240723$EXP$$IN-Eisai-EC-2024-170142$EISAI$$67$YR$E$M$Y$$$20240723$$CN$IN$IN
241067851$24106785$1$I$$20200121$20240717$20240717$EXP$$RU-AstraZeneca-2020SE10857$ASTRAZENECA$$$$$M$Y$$$20240717$$CN$RU$
241067861$24106786$1$I$$20240712$20240717$20240717$PER$$US-Taiho Oncology Inc-2024-006920$TAIHO ONCOLOGY INC$$74$YR$E$F$Y$48.4$KG$20240717$$CN$US$US
241067871$24106787$1$I$20240101$20240617$20240717$20240717$PER$$US-009507513-2406USA005817$MERCK$$$$$M$Y$$$20240717$$PH$US$US
241067881$24106788$1$I$20240101$20240716$20240717$20240717$EXP$FR-AFSSAPS-BX2024001419$FR-GILEAD-2024-0680928$GILEAD$$60$YR$A$F$Y$60$KG$20240717$$PH$FR$FR
241067891$24106789$1$I$20240713$20240715$20240717$20240717$PER$$US-009507513-2407USA009633$MERCK$$48$YR$$M$Y$$$20240717$$CN$US$US
241067902$24106790$2$F$20240426$20240731$20240717$20240809$EXP$IT-MINISAL02-993093$IT-TEVA-VS-3219329$TEVA$$5$YR$$F$Y$21$KG$20240809$$PH$IT$IT
241067911$24106791$1$I$20150901$20240710$20240717$20240717$EXP$$FR-SANDOZ INC.-PHHY2017FR094682$SANDOZ$$73$YR$$M$Y$$$20240717$$MD$FR$FR
241067922$24106792$2$F$20240422$20240712$20240717$20240719$EXP$IT-MINISAL02-993510$IT-Taiho Oncology Inc-2024-006965$TAIHO ONCOLOGY INC$$65$YR$E$F$Y$$$20240719$$MD$IT$IT
241067941$24106794$1$I$$20240716$20240717$20240717$EXP$$US-GILEAD-2024-0680977$GILEAD$$$$E$F$Y$$$20240717$$HP$US$US
241067951$24106795$1$I$$20240710$20240717$20240717$PER$$US-JNJFOC-20240744392$JOHNSON AND JOHNSON$$$$$M$Y$$$20240717$$HP$US$US
241067961$24106796$1$I$$20240713$20240717$20240717$PER$$NVSC2024US146159$NOVARTIS$$$$$$Y$$$20240717$$CN$US$US
241067971$24106797$1$I$$20240715$20240717$20240717$EXP$$CH-SANDOZ INC.-SDZ2024CH065588$SANDOZ$$$$C$M$Y$$$20240717$$CN$CH$CH
241067991$24106799$1$I$$20240618$20240717$20240717$PER$$US-LEX-000352$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
241068002$24106800$2$F$$20240920$20240717$20240926$EXP$$FR-APELLIS-2024-APL-0000454$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240926$$HP$FR$FR
241068011$24106801$1$I$20240522$20240716$20240717$20240717$EXP$FR-AFSSAPS-AN2024000781$FR-SANDOZ INC.-SDZ2024FR058627$SANDOZ$$59$YR$$M$Y$$$20240717$$PH$FR$FR
241068022$24106802$2$F$$20240715$20240717$20240730$EXP$$IT-VIIV HEALTHCARE LIMITED-IT2024089149$VIIV$Muccini C, Gianotti N, Diotallevi S, Lolatto R, Spagnuolo V, Canetti D et al. One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study. Open Forum Infectious Diseases. 2024;11 (7)$$$$$Y$$$20240730$$MD$IT$IT
241068042$24106804$2$F$$20240715$20240717$20240730$EXP$$IT-VIIV HEALTHCARE LIMITED-IT2024089142$VIIV$Muccini C, Gianotti N, Diotallevi S, Lolatto R, Spagnuolo V, Canetti D et al. One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study. Open Forum Infectious Diseases. 2024;11 (7):unk$$$$$Y$$$20240730$$MD$IT$IT
241068051$24106805$1$I$20240101$20240710$20240717$20240717$EXP$$US-009507513-2407USA005091$MERCK$$57$YR$$F$Y$$$20240717$$CN$US$US
241068062$24106806$2$F$$20240917$20240717$20240920$EXP$$GB-SANDOZ INC.-SDZ2024GB065619$SANDOZ$$$$$M$Y$$$20240920$$CN$GB$GB
241068071$24106807$1$I$$20240710$20240717$20240717$EXP$$US-009507513-2407USA004985$MERCK$$$$$M$Y$$$20240717$$CN$US$US
241068081$24106808$1$I$20240101$20240617$20240717$20240717$PER$$US-009507513-2406USA006916$MERCK$$$$$M$Y$$$20240717$$MD$US$US
241068091$24106809$1$I$$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112488$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240717$$HP$US$US
241068101$24106810$1$I$$20240618$20240717$20240717$PER$$US-LEX-000351$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240717$$HP$US$US
241068111$24106811$1$I$$20240716$20240717$20240717$PER$$NVSC2024US147401$NOVARTIS$$$$$$Y$$$20240717$$HP$US$US
241068123$24106812$3$F$20200604$20240808$20240717$20240816$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010832$JAZZ$$55$YR$$F$Y$$$20240816$$HP$US$US
241068131$24106813$1$I$$20240711$20240717$20240717$PER$$US-ALXN-202407USA000821US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240717$$CN$US$US
241068141$24106814$1$I$20240717$20240717$20240717$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040353$BOEHRINGER INGELHEIM$$58$YR$A$F$Y$$$20240717$$CN$US$US
241068152$24106815$2$F$20240701$20240823$20240717$20240828$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-097633$REGENERON$$$$$F$Y$$$20240828$$CN$US$US
241068161$24106816$1$I$$20240717$20240717$20240717$EXP$$JP-PFIZER INC-PV202400093461$PFIZER$$63$YR$$M$Y$$$20240717$$CN$JP$JP
241068172$24106817$2$F$20240614$20240818$20240717$20240819$EXP$$IL-GILEAD-2024-0667331$GILEAD$$74$YR$E$F$Y$72$KG$20240819$$HP$IL$IL
241068191$24106819$1$I$$20240711$20240717$20240717$EXP$$CA-SANDOZ INC.-SDZ2024CA064807$SANDOZ$$56$YR$$F$Y$$$20240717$$HP$CA$CA
241068211$24106821$1$I$$20240710$20240717$20240717$PER$$US-AMGEN-USASL2024137859$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
241068221$24106822$1$I$$20240716$20240717$20240717$EXP$$ES-GILEAD-2024-0680872$GILEAD$$$$$$Y$$$20240717$$HP$ES$ES
241068231$24106823$1$I$20240101$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024139680$AMGEN$$23$YR$A$F$Y$$$20240717$$CN$US$US
241068251$24106825$1$I$20230101$20240717$20240717$20240717$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040399$BOEHRINGER INGELHEIM$$$$$$Y$$$20240717$$MD$US$US
241068264$24106826$4$F$20190603$20240920$20240717$20240926$EXP$IT-MINISAL02-991529$IT-009507513-2407ITA008409$MERCK$$1$YR$$F$Y$10$KG$20240926$$CN$IT$IT
241068271$24106827$1$I$20230901$20240711$20240717$20240717$EXP$$CN-009507513-2407CHN008978$MERCK$$64$YR$$M$Y$$$20240717$$MD$CN$CN
241068282$24106828$2$F$20240501$20240801$20240717$20240809$EXP$$JP-TAKEDA-2024TUS058000$TAKEDA$$7$DEC$$M$Y$$$20240809$$MD$JP$JP
241068291$24106829$1$I$20240101$20240715$20240717$20240717$EXP$$US-ABBVIE-5841509$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241068301$24106830$1$I$20240703$20240715$20240717$20240717$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-007559$JAZZ$$3$YR$$M$Y$$$20240717$$HP$US$US
241068311$24106831$1$I$20240517$20240704$20240717$20240717$EXP$FR-AFSSAPS-AN2024000798$FR-TAKEDA-2024TUS063622$TAKEDA$$69$YR$$F$Y$68$KG$20240717$$HP$FR$FR
241068322$24106832$2$F$$20240821$20240717$20240902$PER$$US-AstraZeneca-2024A146905$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$US$
241068331$24106833$1$I$$20240710$20240717$20240717$EXP$$PH-AstraZeneca-2024A157960$ASTRAZENECA$$$$E$$Y$$$20240717$$MD$PH$
241068341$24106834$1$I$$20240621$20240717$20240717$PER$$US-009507513-2406USA009543$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$2$YR$$$Y$$$20240717$$HP$US$US
241068352$24106835$2$F$20240613$20240723$20240717$20240725$PER$$US-JAZZ PHARMACEUTICALS-2023-US-023171$JAZZ$$16$YR$$F$Y$30.9$KG$20240724$$MD$US$US
241068361$24106836$1$I$$20240716$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159240$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241068372$24106837$2$F$$20240801$20240717$20240805$PER$$US-BIOMARINAP-US-2024-159245$BIOMARIN$$$$$$Y$$$20240805$$CN$US$US
241068381$24106838$1$I$20240701$20240716$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159238$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241068391$24106839$1$I$$20240712$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159190$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241068404$24106840$4$F$20240709$20240731$20240717$20240806$EXP$$CO-BIOMARINAP-CO-2024-159232$BIOMARIN$$$$$$Y$$$20240806$$CN$CO$CO
241068411$24106841$1$I$20240712$20240715$20240717$20240717$EXP$$CO-BIOMARINAP-CO-2024-159248$BIOMARIN$$$$$$Y$$$20240717$$CN$CO$CO
241068421$24106842$1$I$$20240702$20240717$20240717$EXP$$US-HLS-202400206$HLS THERAPEUTICS$$$$$$Y$$$20240717$$PH$US$US
241068431$24106843$1$I$20240422$20240424$20240717$20240717$PER$$US-GE HEALTHCARE-2024CSU004348$GE HEALTHCARE$$90$YR$$$Y$$$20240718$$HP$US$US
241068441$24106844$1$I$$20240717$20240717$20240717$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040400$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240717$$CN$US$US
241068451$24106845$1$I$20240424$20240425$20240717$20240717$PER$$US-GE HEALTHCARE-2024CSU004397$GE HEALTHCARE$$75$YR$$F$Y$$$20240718$$HP$US$US
241068461$24106846$1$I$$20240712$20240717$20240717$EXP$$JP-009507513-2407JPN002424J$MERCK$$$$E$$Y$$$20240717$$PH$JP$JP
241068472$24106847$2$F$20240403$20240722$20240717$20240730$EXP$$CA-LUNDBECK-DKLU3077804$LUNDBECK$$$$$$Y$$$20240730$$CN$CA$CA
241068481$24106848$1$I$$20240702$20240717$20240717$EXP$$US-HLS-202400203$HLS THERAPEUTICS$$68$YR$E$F$Y$$$20240717$$PH$US$US
241068491$24106849$1$I$$20240717$20240717$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040383$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240717$$HP$US$US
241068501$24106850$1$I$$20240715$20240717$20240717$EXP$$US-LUNDBECK-DKLU4001814$LUNDBECK$$$$$$Y$$$20240717$$CN$US$US
241068511$24106851$1$I$$20240717$20240717$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040386$BOEHRINGER INGELHEIM$$89$YR$E$$Y$$$20240717$$HP$US$US
241068521$24106852$1$I$$20240715$20240717$20240717$PER$$US-BIOMARINAP-US-2024-159235$BIOMARIN$$$$$$Y$$$20240717$$CN$US$US
241068531$24106853$1$I$20240101$20240710$20240717$20240717$PER$$US-SA-2024SA206014$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240718$$CN$US$US
241068541$24106854$1$I$$20240712$20240717$20240717$EXP$$US-009507513-2407USA009178$MERCK$$$$E$$Y$$$20240717$$CN$US$US
241068551$24106855$1$I$$20240715$20240717$20240717$EXP$$CA-JNJFOC-20240746174$JOHNSON AND JOHNSON$$85$YR$E$M$Y$84$KG$20240717$$PH$CA$CA
241068562$24106856$2$F$20230831$20240710$20240717$20240722$EXP$$HK-009507513-2407HKG008673$MERCK$$64$YR$$M$Y$$$20240722$$MD$HK$HK
241068572$24106857$2$F$20231201$20240725$20240717$20240731$PER$$US-JNJFOC-20240672505$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241068581$24106858$1$I$$20240705$20240717$20240717$PER$$US-TEVA-VS-3219602$TEVA$$$$E$F$Y$$$20240717$$HP$US$US
241068591$24106859$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010047$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240717$$CN$US$US
241068601$24106860$1$I$$20240717$20240717$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040396$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$CN$US$US
241068612$24106861$2$F$20240101$20240715$20240717$20240724$PER$$US-AMGEN-USASP2024140193$AMGEN$$74$YR$E$F$Y$$$20240723$$CN$US$US
241068621$24106862$1$I$$20240717$20240717$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040419$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$CN$US$US
241068631$24106863$1$I$$20240708$20240717$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109975$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$MD$JP$JP
241068641$24106864$1$I$$20240705$20240717$20240717$PER$$US-TEVA-VS-3219647$TEVA$$$$A$F$Y$$$20240717$$MD$US$US
241068652$24106865$2$F$20240711$20240725$20240717$20240730$EXP$$JP-SA-2024SA205504$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240731$$MD$JP$JP
241068663$24106866$3$F$$20240801$20240717$20240808$EXP$$US-009507513-2407USA010368$MERCK$$$$$M$Y$$$20240808$$HP$US$US
241068671$24106867$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5799956$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241068681$24106868$1$I$$20240710$20240717$20240717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-102399$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$MD$JP$JP
241068691$24106869$1$I$$20240712$20240717$20240717$EXP$$US-PURDUE-USA-2024-0310807$PURDUE$Pardi J., Ford S., Cooper G... Validation of an analytical method for quantitation of metonitazene and isotonitazene in plasma, blood, urine, liver and brain and application to authentic postmortem casework in New York City.. Journal of Analytical Toxicology. 2023;47:8::648-655$36$YR$$M$Y$$$20240718$$HP$US$US
241068701$24106870$1$I$$20240705$20240717$20240717$EXP$GB-MHRA-MED-202407042251073470-SGFJQ$GB-UCBSA-2024034176$UCB$$$$$F$Y$50$KG$20240718$$CN$GB$GB
241068732$24106873$2$F$20240101$20240806$20240717$20240815$PER$$US-BAUSCHBL-2024BNL029852$BAUSCH AND LOMB$$72$YR$$F$Y$76$KG$20240815$$CN$US$US
241068741$24106874$1$I$$20240710$20240717$20240717$EXP$$US-SANDOZ INC.-NVSC2023US111153$SANDOZ$$$$$F$Y$96.62$KG$20240717$$MD$US$US
241068752$24106875$2$F$$20240717$20240717$20240725$EXP$$US-ABBVIE-5841832$ABBVIE$$$$$M$Y$$$20240725$$MD$US$US
241068761$24106876$1$I$$20240711$20240717$20240717$EXP$$US-ABBVIE-5842159$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241068771$24106877$1$I$20230501$20240715$20240717$20240717$EXP$$DE-JNJFOC-20240740747$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240718$$MD$DE$DE
241068781$24106878$1$I$$20240711$20240717$20240717$EXP$$NVSJ2024JP008456$NOVARTIS$$$$$M$Y$$$20240718$$CN$JP$JP
241068791$24106879$1$I$20220724$20240714$20240717$20240717$EXP$$NVSJ2022JP095034$NOVARTIS$$$$$M$Y$$$20240718$$CN$JP$JP
241068801$24106880$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5826596$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241068811$24106881$1$I$$20240717$20240717$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040344$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$CN$US$US
241068821$24106882$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5841946$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241068831$24106883$1$I$20240101$20240715$20240717$20240717$EXP$$US-ABBVIE-5841013$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241068841$24106884$1$I$20240101$20240716$20240717$20240717$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040428$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240718$$CN$US$US
241068851$24106885$1$I$20240301$20240716$20240717$20240717$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040278$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240718$$PH$BR$BR
241068861$24106886$1$I$20230501$20240710$20240717$20240717$EXP$AT-BASGAGES-2024-004519$AT-009507513-2407AUT004679$MERCK$$68$YR$$M$Y$82$KG$20240717$$CN$AT$AT
241068883$24106888$3$F$20240601$20240813$20240717$20240820$PER$$US-BAUSCHBL-2024BNL030146$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240820$$CN$US$US
241068891$24106889$1$I$$20240709$20240717$20240717$PER$$US-BAUSCHBL-2024BNL029901$BAUSCH AND LOMB$$67$YR$$F$Y$81.64$KG$20240718$$CN$US$US
241068901$24106890$1$I$$20240711$20240717$20240717$PER$$US-BAUSCHBL-2024BNL030025$BAUSCH AND LOMB$$$$$F$Y$$$20240718$$CN$US$US
241068912$24106891$2$F$20240711$20240719$20240717$20240723$EXP$$JP-SA-2024SA205513$SANOFI AVENTIS$$$$$$Y$$$20240724$$PH$JP$JP
241068922$24106892$2$F$20240517$20240814$20240717$20240819$EXP$$EU-BAUSCHBL-2024BNL030064$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240820$$HP$EU$EU
241068932$24106893$2$F$20220801$20240709$20240717$20240723$EXP$$US-ABBVIE-5841765$ABBVIE$$56$YR$$F$Y$$$20240723$$LW$US$US
241068944$24106894$4$F$20240701$20240820$20240717$20240829$30DAY$$US-AMGEN-USASP2024137304$AMGEN$$72$YR$E$M$Y$88.9$KG$20240829$$PH$US$US
241068952$24106895$2$F$$20240730$20240717$20240808$30DAY$$BR-JNJFOC-20240671316$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$PH$BR$BR
241068961$24106896$1$I$20130101$20240708$20240717$20240717$EXP$$RU-AMGEN-RUSSP2024136563$AMGEN$Soldatkina N V.. Individual approach to metastatic colorectal cancer treatment (clinical cases). Koloproktologia. 2023;22(4):104-112$41$YR$A$F$Y$$$20240717$$HP$RU$RU
241068971$24106897$1$I$20240712$20240712$20240717$20240717$PER$$US-LEO Pharma-371988$LEO PHARM$$22$YR$$F$Y$$$20240718$$CN$US$US
241068981$24106898$1$I$$20240712$20240717$20240717$EXP$$NVSC2024US145804$NOVARTIS$$$$$F$Y$$$20240718$$CN$US$US
241069021$24106902$1$I$20240101$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024139954$AMGEN$$$$$F$Y$$$20240717$$PH$US$US
241069031$24106903$1$I$$20240715$20240717$20240717$EXP$$RU-ABBVIE-5842362$ABBVIE$$$$$$Y$$$20240717$$MD$RU$RU
241069041$24106904$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5839155$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241069051$24106905$1$I$$20240715$20240717$20240717$PER$$US-ABBVIE-5841373$ABBVIE$$$$A$F$Y$$$20240717$$MD$US$US
241069072$24106907$2$F$20240716$20240801$20240717$20240805$EXP$$NVSJ2024JP008523$NOVARTIS$$$$$M$Y$$$20240805$$PH$JP$JP
241069081$24106908$1$I$$20240711$20240717$20240717$PER$$US-ABBVIE-5838970$ABBVIE$$$$$$Y$$$20240717$$HP$US$US
241069093$24106909$3$F$20240709$20240719$20240717$20240805$30DAY$$US-AMGEN-USASP2024136682$AMGEN$$76$YR$E$M$Y$90.2$KG$20240805$$PH$US$US
241069101$24106910$1$I$20240627$20240712$20240717$20240717$EXP$$NVSC2024US145826$NOVARTIS$$62$YR$$M$Y$$$20240718$$CN$US$US
241069111$24106911$1$I$$20240710$20240717$20240717$EXP$$GB-AMGEN-GBRSL2024137564$AMGEN$$54$YR$A$F$Y$$$20240717$$CN$GB$GB
241069121$24106912$1$I$$20240716$20240717$20240717$PER$$US-AMGEN-USASP2024141124$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
241069132$24106913$2$F$20240101$20240809$20240717$20240813$EXP$$US-JNJFOC-20240308712$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240813$$HP$US$US
241069141$24106914$1$I$20240704$20240715$20240717$20240717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112648$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240718$$CN$US$US
241069151$24106915$1$I$20240703$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024139083$AMGEN$$57$YR$A$F$Y$$$20240717$$HP$US$US
241069161$24106916$1$I$20240701$20240716$20240717$20240717$PER$$US-AMGEN-USASP2024141208$AMGEN$$53$YR$A$F$Y$$$20240717$$CN$US$US
241069172$24106917$2$F$20240715$20240716$20240717$20240718$PER$$US-AMGEN-USASP2024140460$AMGEN$$66$YR$E$F$Y$$$20240718$$CN$US$US
241069181$24106918$1$I$$20240711$20240717$20240717$EXP$$US-BIOGEN-2024BI01273396$BIOGEN$$$$$F$Y$$$20240717$$CN$US$US
241069193$24106919$3$F$$20240820$20240717$20240827$EXP$$US-BIOGEN-2024BI01273831$BIOGEN$$$$$$Y$$$20240827$$HP$US$US
241069201$24106920$1$I$$20240705$20240717$20240717$EXP$AU-TGA-803140$AU-Orient Pharma-000243$ORIENT PHARMA$$44$YR$A$F$Y$$$20240717$$HP$AU$AU
241069211$24106921$1$I$$20240523$20240717$20240717$30DAY$$JP-SA-2024SA156316$SANOFI AVENTIS$$$$$$Y$$$20240718$$CN$JP$JP
241069221$24106922$1$I$$20240710$20240717$20240717$EXP$$US-ABBVIE-5836552$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241069231$24106923$1$I$20240101$20240712$20240717$20240717$PER$$US-AMGEN-USASP2024139902$AMGEN$$$$$M$Y$$$20240717$$CN$US$US
241069242$24106924$2$F$20240715$20240729$20240717$20240730$PER$$US-AMGEN-USASP2024140469$AMGEN$$55$YR$A$F$Y$78.1$KG$20240730$$HP$US$US
241069251$24106925$1$I$20240601$20240713$20240717$20240717$PER$$US-AMGEN-USASP2024140939$AMGEN$$48$YR$A$F$Y$$$20240717$$HP$US$US
241069274$24106927$4$F$20240715$20240927$20240717$20240930$EXP$$TW-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040171$BOEHRINGER INGELHEIM$$27$YR$A$F$Y$$$20240930$$MD$TW$TW
241069282$24106928$2$F$20240101$20240726$20240717$20240801$EXP$$US-009507513-2407USA009420$MERCK$$$$$F$Y$54.422$KG$20240801$$CN$US$US
241069292$24106929$2$F$$20240815$20240717$20240820$PER$$US-AMGEN-USASP2024140572$AMGEN$$$$$$Y$$$20240819$$HP$US$US
241069301$24106930$1$I$20240715$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140221$AMGEN$$84$YR$E$F$Y$$$20240717$$CN$US$US
241069313$24106931$3$F$20161223$20240813$20240717$20240824$EXP$$BE-ABBVIE-17K-013-3064711-00$ABBVIE$$78$YR$$F$Y$66$KG$20240824$$MD$BE$BE
241069321$24106932$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5838997$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241069332$24106933$2$F$$20240717$20240717$20240718$PER$$NVSC2024US147343$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
241069341$24106934$1$I$20230801$20240712$20240717$20240717$EXP$$US-ABBVIE-5840087$ABBVIE$$49$YR$$F$Y$$$20240717$$CN$US$US
241069351$24106935$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5841866$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241069361$24106936$1$I$20240702$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140109$AMGEN$$65$YR$E$M$Y$$$20240717$$CN$US$US
241069374$24106937$4$F$20240711$20240819$20240717$20240911$PER$$US-AMGEN-USASP2024139047$AMGEN$$$$$M$Y$$$20240910$$CN$US$US
241069381$24106938$1$I$20240711$20240711$20240717$20240717$EXP$$FR-ABBVIE-5842267$ABBVIE$$80$YR$$M$Y$$$20240717$$HP$FR$FR
241069401$24106940$1$I$20210701$20240716$20240717$20240717$EXP$$CA-ABBVIE-5842592$ABBVIE$$77$YR$$M$Y$$$20240717$$CN$CA$CA
241069411$24106941$1$I$$20240715$20240717$20240717$PER$$US-ABBVIE-5842645$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241069421$24106942$1$I$20240716$20240716$20240717$20240717$EXP$$US-JNJFOC-20240742174$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240718$$HP$US$US
241069433$24106943$3$F$20220114$20240823$20240717$20240918$PER$$US-BEIGENE-BGN-2024-009695$BEIGENE$$$$$$Y$$$20240918$$PH$US$US
241069441$24106944$1$I$20240101$20240712$20240717$20240717$EXP$$CO-ABBVIE-5841819$ABBVIE$$62$YR$$M$Y$63$KG$20240717$$CN$CO$CO
241069453$24106945$3$F$20240101$20240813$20240717$20240821$EXP$$BE-ABBVIE-5842524$ABBVIE$$83$YR$$M$Y$$$20240821$$HP$BE$BE
241069462$24106946$2$F$20240101$20240722$20240717$20240726$EXP$$US-ABBVIE-5842526$ABBVIE$$$$$F$Y$61.234$KG$20240726$$CN$US$US
241069471$24106947$1$I$$20240715$20240717$20240717$EXP$$AU-SANDOZ INC.-SDZ2024AU065488$SANDOZ$$$$C$$Y$$$20240717$$HP$AU$AU
241069481$24106948$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5804790$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241069501$24106950$1$I$20240101$20240715$20240717$20240717$EXP$$US-JNJFOC-20240739980$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240718$$HP$US$US
241069512$24106951$2$F$20240206$20240715$20240717$20240722$EXP$ES-AEMPS-1543791$ES-009507513-2407ESP009947$MERCK$$67$YR$$M$Y$86$KG$20240722$$PH$ES$ES
241069522$24106952$2$F$$20240718$20240717$20240722$EXP$$US-ABBVIE-5718365$ABBVIE$$$$$M$Y$77$KG$20240722$$CN$US$US
241069531$24106953$1$I$20240408$20240711$20240717$20240717$EXP$$US-ABBVIE-5813165$ABBVIE$$64$YR$$F$Y$$$20240717$$CN$US$US
241069541$24106954$1$I$$20240715$20240717$20240717$PER$$NVSC2024US147458$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
241069551$24106955$1$I$$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140165$AMGEN$$$$$M$Y$$$20240717$$CN$US$US
241069561$24106956$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009944$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240717$$CN$US$US
241069571$24106957$1$I$20240410$20240715$20240717$20240717$EXP$$AU-SANDOZ INC.-SDZ2024AU065431$SANDOZ$$71$YR$$M$Y$$$20240717$$MD$AU$AU
241069581$24106958$1$I$$20240711$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010086$ELI LILLY AND CO$$$$$$Y$$$20240717$$CN$US$US
241069592$24106959$2$F$20240709$20240809$20240717$20240813$30DAY$$US-AMGEN-USASP2024139446$AMGEN$$64$YR$A$F$Y$97.1$KG$20240813$$PH$US$US
241069601$24106960$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407010737$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240717$$CN$US$US
241069611$24106961$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5840719$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241069621$24106962$1$I$$20240704$20240717$20240717$EXP$$US-ABBVIE-5841022$ABBVIE$$$$$$Y$$$20240717$$MD$US$US
241069631$24106963$1$I$20240301$20240715$20240717$20240717$EXP$$CO-ABBVIE-5842441$ABBVIE$$80$YR$$F$Y$47$KG$20240717$$CN$CO$CO
241069641$24106964$1$I$$20240715$20240717$20240717$EXP$$US-ABBVIE-5841093$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241069651$24106965$1$I$$20240716$20240717$20240717$EXP$$AU-SANDOZ INC.-SDZ2024AU065777$SANDOZ$$65$YR$$M$Y$$$20240717$$MD$AU$AU
241069661$24106966$1$I$$20240710$20240717$20240717$PER$$US-JNJFOC-20240731283$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240718$$HP$US$US
241069671$24106967$1$I$20240704$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140797$AMGEN$$59$YR$A$F$Y$$$20240717$$CN$US$US
241069681$24106968$1$I$20240701$20240716$20240717$20240717$EXP$$US-ABBVIE-5842424$ABBVIE$$93$YR$$F$Y$$$20240717$$CN$US$US
241069691$24106969$1$I$20240101$20240715$20240717$20240717$EXP$$US-JNJFOC-20240739819$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240718$$HP$US$US
241069701$24106970$1$I$$20240712$20240717$20240717$30DAY$$US-SANDOZ INC.-SDZ2024US065397$SANDOZ$$$$$$Y$$$20240717$$HP$US$US
241069711$24106971$1$I$$20240712$20240717$20240717$EXP$$US-SANDOZ INC.-SDZ2024US065844$SANDOZ$$$$$M$Y$$$20240717$$CN$US$US
241069722$24106972$2$F$20240620$20240823$20240717$20240827$PER$$US-AMGEN-USASP2024141254$AMGEN$$76$YR$E$F$Y$$$20240827$$HP$US$US
241069731$24106973$1$I$$20240711$20240717$20240717$EXP$$NVSJ2024JP008460$NOVARTIS$$61$YR$$F$Y$$$20240718$$CN$JP$JP
241069741$24106974$1$I$20240101$20240709$20240717$20240717$PER$$US-SA-2024SA206507$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240718$$MD$US$US
241069751$24106975$1$I$20240709$20240709$20240717$20240717$PER$$US-SA-2024SA012342$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240718$$MD$US$US
241069761$24106976$1$I$$20240712$20240717$20240717$PER$$US-SA-2024SA207596$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240718$$CN$US$US
241069772$24106977$2$F$$20240730$20240717$20240809$EXP$$JP-TEVA-VS-3219479$TEVA$Shibutani M, Tanda H, Fukuoka T, Kasashima H, Kashiwagi S, Maeda K. An Improvement of Exertional Dyspnea by the Reintroduction of Anti-EGFR Antibody in Patients with Metastatic Rectal Cancer Who Developed Cancerous Lymphangiopathy: A Case Report. Case-Rep-Oncol 2024; 17 (1): 511-516.; Shibutani M, Tanda H, Fukuoka T, Kasashima H, Kashiwagi S, Maeda K. An Improvement of Exertional Dyspnea by the Reintroduction of Anti-EGFR Antibody in Patients with Metastatic Rectal Cancer Who Developed Cancer...$68$YR$$M$Y$$$20240809$$HP$JP$JP
241069781$24106978$1$I$20230802$20230803$20240717$20240717$PER$$US-GRUNENTHAL-2023-271956$AVERITAS$$$$$F$Y$$$20240710$$MD$US$US
241069791$24106979$1$I$$20230905$20240717$20240717$PER$$US-GRUNENTHAL-2023-273914$AVERITAS$$$$$F$Y$$$20240710$$HP$US$US
241069802$24106980$2$F$$20240730$20240717$20240809$EXP$$JP-TEVA-VS-3219480$TEVA$Horibe R, Yokota M, Uemura K, Hashimoto M, Kawagishi N, Nishiyama K. De novo Hepatitis B Virus Reactivation during Treatment with an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Patient with Advanced Lung Cancer. Intern-Med 2024; 63 (12): 1797-1800.; Horibe R, Yokota M, Uemura K, Hashimoto M, Kawagishi N, Nishiyama K. De novo Hepatitis B Virus Reactivation during Treatment with an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Patient with Advanced Lung Can...$71$YR$$F$Y$$$20240809$$HP$JP$JP
241069811$24106981$1$I$20240621$20240712$20240717$20240717$EXP$$CA-JNJFOC-20240736765$JOHNSON AND JOHNSON$$16$YR$T$M$Y$62$KG$20240718$$HP$CA$CA
241069821$24106982$1$I$20231015$20231016$20240717$20240717$PER$$US-GRUNENTHAL-2023-282738$AVERITAS$$72$YR$$F$Y$$$20240710$$CN$US$US
241069831$24106983$1$I$$20230612$20240717$20240717$PER$$US-GRUNENTHAL-2023-112609$AVERITAS$$70$YR$$M$Y$$$20240710$$PH$US$US
241069841$24106984$1$I$$20230921$20240717$20240717$PER$$US-GRUNENTHAL-2023-274643$AVERITAS$$60$YR$$F$Y$$$20240710$$CN$US$US
241069851$24106985$1$I$$20230725$20240717$20240717$PER$$US-GRUNENTHAL-2023-112903$AVERITAS$$79$YR$$M$Y$$$20240710$$CN$US$US
241069861$24106986$1$I$$20240709$20240717$20240717$EXP$$GB-BIOVITRUM-2024-GB-009721$ADC THERAPEUTICS$$$$E$M$Y$$$20240717$$MD$GB$GB
241069881$24106988$1$I$$20240712$20240717$20240717$EXP$$IE-JNJFOC-20240737465$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240718$$HP$IE$IE
241069891$24106989$1$I$$20230612$20240717$20240717$PER$$US-GRUNENTHAL-2023-112633$AVERITAS$$$$$M$Y$$$20240710$$HP$US$US
241069903$24106990$3$F$$20240719$20240717$20240726$PER$$US-SA-2024SA207582$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240726$$MD$US$US
241069911$24106991$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024139008$AMGEN$Zhang C.; Ersan S.; Yousef Y. et al.. The effect of teprotumumab infusion on ocular alignment in patients with symptomatic thyroid eye disease. Journal of AAPOS. 2024;1-7$$$$$Y$$$20240717$$MD$US$US
241069921$24106992$1$I$20230614$20240715$20240717$20240717$EXP$$US-ABBVIE-5841357$ABBVIE$$66$YR$$F$Y$$$20240717$$CN$US$US
241069931$24106993$1$I$$20240715$20240717$20240717$EXP$$US-ABBVIE-5841506$ABBVIE$$$$$M$Y$$$20240717$$CN$US$US
241069942$24106994$2$F$$20240718$20240717$20240723$PER$$US-ABBVIE-5841221$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241069951$24106995$1$I$$20231002$20240717$20240717$PER$$US-GRUNENTHAL-2023-275296$AVERITAS$$$$$F$Y$$$20240710$$HP$US$US
241069961$24106996$1$I$20240101$20240712$20240717$20240717$EXP$$US-ABBVIE-5840528$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241069971$24106997$1$I$20240712$20240715$20240717$20240717$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113328$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$78.02$KG$20240718$$HP$US$US
241069981$24106998$1$I$$20230915$20240717$20240717$PER$$US-GRUNENTHAL-2023-274289$AVERITAS$$$$$M$Y$$$20240710$$HP$US$US
241069992$24106999$2$F$20240708$20240808$20240717$20240814$EXP$$US-ABBVIE-5840827$ABBVIE$$79$YR$$M$Y$$$20240814$$CN$US$US
241070001$24107000$1$I$$20240716$20240717$20240717$EXP$$CA-ABBVIE-5842947$ABBVIE$$$$E$M$Y$$$20240717$$CN$CA$CA
241070011$24107001$1$I$20240101$20240715$20240717$20240717$EXP$$US-ABBVIE-5842008$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241070021$24107002$1$I$20240501$20240715$20240717$20240717$EXP$$US-ABBVIE-5842208$ABBVIE$$80$YR$$M$Y$$$20240717$$CN$US$US
241070032$24107003$2$F$$20240802$20240717$20240805$PER$$US-AstraZeneca-2024A162290$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241070043$24107004$3$F$$20240718$20240717$20240827$PER$$US-HALEON-2187553$Haleon PLC$$33$YR$$F$Y$$$20240827$$CN$US$US
241070052$24107005$2$F$$20240716$20240717$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407010809$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240807$$CN$US$US
241070063$24107006$3$F$$20240812$20240717$20240819$30DAY$$US-JNJFOC-20240674322$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$PH$US$US
241070071$24107007$1$I$20240624$20240711$20240717$20240717$PER$$US-SA-2024SA207294$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240718$$CN$US$US
241070081$24107008$1$I$$20240715$20240717$20240717$PER$$US-ELI_LILLY_AND_COMPANY-US202407009744$ELI LILLY AND CO$$$$$F$Y$$$20240717$$CN$US$US
241070092$24107009$2$F$$20240715$20240717$20240717$PER$$US-ROCHE-10000028702$ROCHE$$$$$F$Y$$$20240718$$MD$US$US
241070101$24107010$1$I$$20240712$20240717$20240717$EXP$$ZA-ABBVIE-5842434$ABBVIE$$53$YR$$M$Y$$$20240717$$CN$ZA$ZA
241070111$24107011$1$I$$20240715$20240717$20240717$EXP$$NVSC2023GB009789$NOVARTIS$$$$A$M$Y$$$20240718$$CN$GB$GB
241070121$24107012$1$I$$20240711$20240717$20240717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-113216$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240718$$HP$CA$CA
241070131$24107013$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024140978$AMGEN$$67$YR$E$F$Y$$$20240717$$CN$US$US
241070141$24107014$1$I$$20240715$20240717$20240717$EXP$$US-ABBVIE-5843200$ABBVIE$$$$$M$Y$$$20240717$$HP$US$US
241070151$24107015$1$I$20240714$20240715$20240717$20240717$PER$$US-AMGEN-USASP2024140464$AMGEN$$64$YR$A$M$Y$$$20240717$$CN$US$US
241070161$24107016$1$I$20080101$20240710$20240717$20240717$EXP$$US-JNJFOC-20240729014$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240718$$HP$US$US
241070171$24107017$1$I$$20240712$20240717$20240717$PER$$US-ABBVIE-5838841$ABBVIE$$$$$$Y$$$20240717$$HP$US$US
241070181$24107018$1$I$20230923$20240711$20240717$20240717$EXP$$MX-EMD Serono-2024038145$EMD SERONO INC$$61$YR$A$F$Y$$$20240718$$CN$MX$MX
241070191$24107019$1$I$20240516$20240716$20240717$20240717$EXP$$JP-TAKEDA-2024TJP010579$TAKEDA$$8$DEC$$$Y$$$20240717$$MD$JP$JP
241070201$24107020$1$I$$20240711$20240717$20240717$EXP$$BR-GSK-BR2024AMR088360$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$BR$BR
241070211$24107021$1$I$20240101$20240709$20240717$20240717$EXP$$US-ABBVIE-5838361$ABBVIE$$$$$M$Y$$$20240717$$HP$US$US
241070222$24107022$2$F$20240712$20240712$20240717$20240719$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111579$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240719$$CN$US$US
241070231$24107023$1$I$$20240715$20240717$20240717$EXP$$NZ-BRISTOL-MYERS SQUIBB COMPANY-2024-113232$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240718$$PH$NZ$NZ
241070241$24107024$1$I$$20240702$20240717$20240717$PER$$US-RDY-SPO/USA/24/0009712$DR REDDYS$$$$$$Y$$$20240718$$CN$US$US
241070261$24107026$1$I$$20240712$20240717$20240717$EXP$$US-ABBVIE-5838951$ABBVIE$$$$$F$Y$$$20240717$$CN$US$US
241070271$24107027$1$I$$20240716$20240717$20240717$30DAY$$US-SANDOZ INC.-SDZ2024US065917$SANDOZ$$$$$F$Y$$$20240717$$CN$US$US
241070282$24107028$2$F$20240701$20240714$20240717$20240719$EXP$$IL-ABBVIE-5839985$ABBVIE$$88$YR$$M$Y$$$20240719$$CN$IL$IL
241070291$24107029$1$I$$20240711$20240717$20240717$EXP$$US-GSK-US2024086618$GLAXOSMITHKLINE$$$$$$Y$$$20240717$$MD$US$US
241070301$24107030$1$I$$20240715$20240717$20240717$PER$$US-JNJFOC-20240739745$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
241070311$24107031$1$I$$20240715$20240717$20240717$EXP$$US-JNJFOC-20240739163$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$US$US
241070321$24107032$1$I$20240101$20240711$20240717$20240717$PER$$US-SA-2024SA207321$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240718$$MD$US$US
241070331$24107033$1$I$$20240708$20240717$20240717$EXP$$PT-ROCHE-10000028067$ROCHE$Vasconcelos A,  Complications and Relapse in a Mantle Cell Lymphoma Patient: A Case Report. Medicina interna. 2024-Jun;31:66-72. doi:10.24950/rspmi.2488.$73$YR$E$M$Y$$$20240718$$MD$PT$PT
241070352$24107035$2$F$$20240917$20240717$20240918$EXP$$JP-TAKEDA-2024TJP010592AA$TAKEDA$$12$YR$$F$Y$28$KG$20240918$$MD$JP$JP
241070361$24107036$1$I$20160101$20240714$20240717$20240717$EXP$$IL-SHIRE-IL201734694AA$TAKEDA$$$$A$F$Y$$$20240717$$MD$IL$IL
241070371$24107037$1$I$$20240711$20240717$20240717$PER$$US-AMGEN-USASP2024139269$AMGEN$$65$YR$E$F$Y$$$20240717$$MD$US$US
241070381$24107038$1$I$$20240705$20240718$20240718$PER$$US-TEVA-VS-3219556$TEVA$$$$$F$Y$$$20240717$$CN$US$US
241070391$24107039$1$I$$20240715$20240718$20240718$EXP$$US-AstraZeneca-2024A161756$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241070402$24107040$2$F$$20240801$20240718$20240807$EXP$$JP-ASTELLAS-2024JP004711$ASTELLAS$$64$YR$$F$Y$$$20240807$$PH$JP$JP
241070411$24107041$1$I$$20240715$20240718$20240718$PER$$US-AstraZeneca-2024A161533$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241070422$24107042$2$F$20240701$20240909$20240718$20240913$EXP$$JP-GSK-JP2024JPN086050$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$PH$JP$JP
241070431$24107043$1$I$$20240715$20240718$20240718$PER$$US-ABBVIE-5841254$ABBVIE$$$$$$Y$$$20240718$$MD$US$US
241070441$24107044$1$I$20240101$20240715$20240718$20240718$EXP$$US-ABBVIE-5841177$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241070451$24107045$1$I$$20240715$20240718$20240718$PER$$NVSC2024US147391$NOVARTIS$$$$$M$Y$$$20240718$$CN$US$US
241070462$24107046$2$F$$20240731$20240718$20240805$EXP$$GR-ROCHE-10000020597$ROCHE$Michailides C, Paraskevas P, Lagadinou M, Papantoniou K, Kavvousanos M, Marangos M, et al. A case report and literature review of a triple-vaccinated, rituximab-treated systemic lupus erythematosus patient with COVID-19 pneumonia. ARP rheumatology. 2024;3 (2):145-50. doi:10.63032/MNQF7735.$50$YR$A$F$Y$$$20240805$$HP$GR$GR
241070471$24107047$1$I$20100501$20240712$20240718$20240718$EXP$$US-BIOGEN-2024BI01271801$BIOGEN$$62$YR$$F$Y$$$20240718$$CN$US$US
241070491$24107049$1$I$20240705$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140894$AMGEN$$84$YR$E$M$Y$$$20240717$$CN$US$US
241070503$24107050$3$F$20240616$20240729$20240718$20240802$PER$$US-AMGEN-USASP2024141852$AMGEN$$49$YR$A$F$Y$$$20240802$$MD$US$US
241070511$24107051$1$I$20240710$20240711$20240718$20240718$PER$$US-SA-2024SA207769$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240718$$MD$US$US
241070521$24107052$1$I$20240101$20240712$20240718$20240718$PER$$US-SA-2024SA207415$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240718$$MD$US$US
241070531$24107053$1$I$$20230804$20240718$20240718$PER$$US-GRUNENTHAL-2023-272065$AVERITAS$$$$$F$Y$$$20240710$$HP$US$US
241070541$24107054$1$I$$20231006$20240718$20240718$PER$$US-GRUNENTHAL-2023-276592$AVERITAS$$48$YR$$M$Y$$$20240710$$CN$US$US
241070552$24107055$2$F$20240704$20240723$20240718$20240726$EXP$IT-MINISAL02-994486$IT-GSK-IT2024086832$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$MD$IT$IT
241070561$24107056$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA190133$SANOFI AVENTIS$$$$E$M$Y$$$20240718$$MD$US$US
241070572$24107057$2$F$$20240823$20240718$20240824$EXP$$US-JNJFOC-20240731725$JOHNSON AND JOHNSON$$$$$F$Y$$$20240825$$CN$US$US
241070581$24107058$1$I$$20231009$20240718$20240718$PER$$US-GRUNENTHAL-2023-279181$AVERITAS$$$$$F$Y$$$20240710$$MD$US$US
241070591$24107059$1$I$20230914$20230915$20240718$20240718$PER$$US-GRUNENTHAL-2023-274290$AVERITAS$$$$$F$Y$$$20240710$$HP$US$US
241070601$24107060$1$I$20240615$20240712$20240718$20240718$EXP$ES-AEMPS-1539607$ES-GSK-ES2024087003$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$ES$ES
241070611$24107061$1$I$$20231027$20240718$20240718$PER$$US-GRUNENTHAL-2023-293577$AVERITAS$$60$YR$$F$Y$$$20240710$$CN$US$US
241070621$24107062$1$I$$20230823$20240718$20240718$PER$$US-GRUNENTHAL-2023-272554$AVERITAS$$78$YR$$F$Y$$$20240710$$MD$US$US
241070631$24107063$1$I$$20240716$20240718$20240718$EXP$$ZA-ABBVIE-5842930$ABBVIE$$$$E$M$Y$$$20240718$$HP$ZA$ZA
241070641$24107064$1$I$20230301$20240711$20240718$20240718$EXP$GB-MHRA-MED-202407101640133760-ZJFLB$GB-DEXPHARM-2024-2382$DEXCEL$$62$YR$A$M$Y$$$20240718$$HP$GB$GB
241070651$24107065$1$I$20240518$20240711$20240718$20240718$EXP$FR-AFSSAPS-GR2024000732$FR-ROCHE-10000024486$ROCHE$$53$YR$A$F$Y$$$20240718$$PH$FR$FR
241070662$24107066$2$F$$20240731$20240718$20240807$EXP$$BR-TAKEDA-2024TUS071718$TAKEDA$$16$YR$$$Y$$$20240807$$CN$BR$BR
241070671$24107067$1$I$20240619$20240710$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113173$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$52$KG$20240718$$PH$US$US
241070681$24107068$1$I$$20230919$20240718$20240718$PER$$US-GRUNENTHAL-2023-274382$AVERITAS$$43$YR$$F$Y$$$20240710$$CN$US$US
241070691$24107069$1$I$20240714$20240715$20240718$20240718$EXP$$US-AstraZeneca-2024A161704$ASTRAZENECA$$26013$DY$$F$Y$$$20240718$$CN$US$
241070701$24107070$1$I$20240712$20240715$20240718$20240718$EXP$$US-AstraZeneca-2024A161305$ASTRAZENECA$$24549$DY$$M$Y$$$20240718$$MD$US$
241070711$24107071$1$I$20230101$20231128$20240718$20240718$EXP$$CA-AstraZeneca-2023A236301$ASTRAZENECA$$58$YR$$F$Y$$$20240718$$MD$CA$
241070721$24107072$1$I$20240701$20240711$20240718$20240718$PER$$US-SA-2024SA207900$SANOFI AVENTIS$$16$YR$T$M$Y$59.1$KG$20240718$$MD$US$US
241070732$24107073$2$F$20240712$20240805$20240718$20240812$PER$$US-AMGEN-USASP2024140452$AMGEN$$71$YR$E$M$Y$$$20240812$$PH$US$US
241070741$24107074$1$I$$20240712$20240718$20240718$PER$$NVSC2024US145573$NOVARTIS$$$$A$F$Y$$$20240718$$PH$US$US
241070751$24107075$1$I$20230801$20230808$20240718$20240718$PER$$US-GRUNENTHAL-2023-272126$AVERITAS$$73$YR$$F$Y$$$20240710$$HP$US$US
241070761$24107076$1$I$$20240711$20240718$20240718$EXP$$SI-MEN-2024-096679$MENARINI$Prebil K, Palandacic AK, Rus Prelog P. Complex visual hallucinations associated with ranolazine treatment: a case report. The Canadian Journal of Cardiology. 2024.$90$YR$E$M$Y$$$20240717$$MD$SI$SI
241070771$24107077$1$I$20240601$20240709$20240718$20240718$EXP$$FR-ABBVIE-5841682$ABBVIE$$36$YR$$M$Y$$$20240718$$PH$FR$FR
241070781$24107078$1$I$20231012$20231116$20240718$20240718$PER$$US-GRUNENTHAL-2023-288429$AVERITAS$$76$YR$$M$Y$$$20240710$$HP$US$US
241070791$24107079$1$I$$20231205$20240718$20240718$PER$$US-GRUNENTHAL-2023-290552$AVERITAS$$7$DEC$$M$Y$$$20240710$$MD$US$US
241070801$24107080$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5841193$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241070811$24107081$1$I$20240101$20240711$20240718$20240718$EXP$$CN-ABBVIE-5842573$ABBVIE$$$$$$Y$$$20240718$$HP$CN$CN
241070821$24107082$1$I$20240630$20240709$20240718$20240718$PER$$US-ABBVIE-5833963$ABBVIE$$$$$F$Y$$$20240718$$MD$US$US
241070832$24107083$2$F$$20240719$20240718$20240724$PER$$US-ABBVIE-5841589$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241070842$24107084$2$F$$20240809$20240718$20240816$EXP$$JP-ABBVIE-5843496$ABBVIE$$93$YR$$M$Y$$$20240816$$PH$JP$JP
241070861$24107086$1$I$20240619$20240710$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111060$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240718$$PH$US$US
241070871$24107087$1$I$$20240712$20240718$20240718$30DAY$$US-SANDOZ INC.-SDZ2024US065095$SANDOZ$$$$$F$Y$$$20240718$$MD$US$US
241070882$24107088$2$F$$20240809$20240718$20240815$30DAY$$BR-AMGEN-BRASP2024138317$AMGEN$$$$$$Y$$$20240815$$PH$BR$BR
241070891$24107089$1$I$$20240711$20240718$20240718$EXP$$US-ABBVIE-5842486$ABBVIE$$$$$F$Y$$$20240718$$MD$US$US
241070901$24107090$1$I$$20240708$20240718$20240718$PER$$US-ROCHE-10000027480$ROCHE$$$$E$F$Y$68.03$KG$20240718$$CN$US$US
241070912$24107091$2$F$20240101$20240703$20240718$20240723$PER$$US-APOTEX-2024AP007944$APOTEX$$$$A$M$Y$$$20240723$$PH$US$US
241070921$24107092$1$I$$20200526$20240718$20240718$EXP$$US-AstraZeneca-2020SE69404$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241070931$24107093$1$I$20240601$20240717$20240718$20240718$EXP$$NVSJ2024JP008684$NOVARTIS$$95$YR$$F$Y$$$20240718$$MD$JP$JP
241070941$24107094$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207821$SANOFI AVENTIS$$$$A$M$Y$88.4$KG$20240718$$MD$US$US
241070951$24107095$1$I$$20200626$20240718$20240718$EXP$$US-AstraZeneca-2020SE82878$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241070961$24107096$1$I$20230810$20230824$20240718$20240718$PER$$US-GRUNENTHAL-2023-272281$AVERITAS$$54$YR$$M$Y$$$20240710$$MD$US$US
241070971$24107097$1$I$$20240709$20240718$20240718$PER$$US-BEH-2024175405$CSL BEHRING$$$$C$F$Y$$$20240718$$HP$US$US
241070981$24107098$1$I$$20240703$20240718$20240718$PER$$US-APOTEX-2024AP007981$APOTEX$Rorex J, Nelson S, DiCaudo D, Swanson L. Fulvestrant Associated Chromhidrosis. American Journal of Dermatopathology. 2024;46(7):S25$61$YR$$F$Y$$$20240718$$HP$US$US
241070991$24107099$1$I$20230601$20230912$20240718$20240718$PER$$US-Accord-381016$ACCORD$$53$YR$$F$Y$$$20240718$$CN$US$US
241071001$24107100$1$I$$20240404$20240718$20240718$PER$$US-Accord-418529$ACCORD$$$$$F$Y$$$20240718$$CN$US$US
241071011$24107101$1$I$$20240311$20240718$20240718$PER$$US-Accord-413462$ACCORD$$$$$F$Y$$$20240718$$CN$US$US
241071021$24107102$1$I$$20231213$20240718$20240718$EXP$$US-Accord-396565$ACCORD$$$$$F$Y$$$20240718$$CN$US$US
241071031$24107103$1$I$$20230712$20240718$20240718$PER$$US-Accord-368895$ACCORD$$$$$F$Y$$$20240718$$CN$US$US
241071041$24107104$1$I$$20240409$20240718$20240718$PER$$US-Accord-419196$ACCORD$$$$$F$Y$$$20240718$$CN$US$US
241071051$24107105$1$I$20240201$20240710$20240718$20240718$EXP$$CA-ABBVIE-5842491$ABBVIE$$48$YR$$M$Y$$$20240718$$CN$CA$CA
241071061$24107106$1$I$20240705$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140843$AMGEN$$73$YR$E$F$Y$$$20240717$$CN$US$US
241071081$24107108$1$I$20240425$20240710$20240718$20240718$EXP$$US-ABBVIE-5839211$ABBVIE$$51$YR$$M$Y$$$20240718$$CN$US$US
241071091$24107109$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA206116$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240718$$CN$US$US
241071111$24107111$1$I$20240712$20240715$20240718$20240718$EXP$$US-ABBVIE-5841146$ABBVIE$$67$YR$$M$Y$$$20240718$$CN$US$US
241071121$24107112$1$I$20240501$20240604$20240718$20240718$EXP$$US-UCBSA-2024014696$UCB$$28$YR$$F$Y$$$20240718$$HP$US$US
241071131$24107113$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5841528$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241071144$24107114$4$F$20240711$20240820$20240718$20240828$30DAY$$US-JNJFOC-20240734721$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240828$$CN$US$US
241071151$24107115$1$I$$20240709$20240718$20240718$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000243$EMCURE$Farouji A, Haddad AW, Kloub M, Paige A, Miller R.. A Case of Metformin-Associated Lactic Acidosis Complicated by Acute Liver Failure, Acute Renal Failure, and Shock. Cureus. 2024;16(6):e61911$63$YR$$F$Y$$$20240718$$HP$US$US
241071161$24107116$1$I$20240701$20240711$20240718$20240718$EXP$$CA-ABBVIE-5838509$ABBVIE$$54$YR$$F$Y$$$20240718$$CN$CA$CA
241071171$24107117$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207772$SANOFI AVENTIS$$$$A$F$Y$51$KG$20240718$$MD$US$US
241071181$24107118$1$I$$20240709$20240718$20240718$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000247$EMCURE$Santoli J, Aldakkour JL, Tohidi H, Lin Y. Metformin-Associated Lactic Acidosis: A Case Report. HCA Healthcare Journal of Medicine. 2023;4(2):215-218$62$YR$$M$Y$$$20240718$$MD$US$US
241071191$24107119$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5842332$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241071201$24107120$1$I$20240214$20240710$20240718$20240718$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000244$EMCURE$Zieneldien T, Kim J, Greene J. Breakthrough Pneumocystis jirovecii Pneumonia in an Allogeneic Hematopoietic Stem Cell Transplant Recipient. Cureus. 2024;16(6):e61890$50$YR$$F$Y$$$20240718$$HP$US$US
241071211$24107121$1$I$$20240709$20240718$20240718$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000245$EMCURE$Mikhail ES, Jankowski M, Alexander D, Pandya D, Kunadi A.. Survival and Vision Restoration Following Severe Metformin-associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature. Journal of Community Hospital Internal Medicine Perspectives. 2024;14(2):96-99$72$YR$$F$Y$$$20240718$$HP$US$US
241071221$24107122$1$I$20240601$20240715$20240718$20240718$EXP$$US-ABBVIE-5841278$ABBVIE$$47$YR$$F$Y$$$20240718$$CN$US$US
241071231$24107123$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008681$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$17$YR$$M$Y$$$20240718$$HP$FR$FR
241071241$24107124$1$I$20231001$20240712$20240718$20240718$EXP$$CA-ABBVIE-5842547$ABBVIE$$91$YR$$M$Y$$$20240718$$CN$CA$CA
241071251$24107125$1$I$$20240703$20240718$20240718$PER$$US-APOTEX-2024AP007990$APOTEX$Halawi H, Harris JE, Goodarzi A, Yau S, Youssef JG, Botros M, et al. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy. 2024;44 (3):283-289$43$YR$$M$Y$$$20240718$$HP$US$US
241071261$24107126$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5762493$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241071271$24107127$1$I$$20231114$20240718$20240718$PER$$US-GRUNENTHAL-2023-296025$AVERITAS$$58$YR$$F$Y$$$20240710$$HP$US$US
241071281$24107128$1$I$$20231103$20240718$20240718$PER$$US-GRUNENTHAL-2023-299033$AVERITAS$$69$YR$$M$Y$$$20240710$$HP$US$US
241071291$24107129$1$I$20231101$20231116$20240718$20240718$EXP$$US-GRUNENTHAL-2023-296011$AVERITAS$$82$YR$$M$Y$$$20240710$$HP$US$US
241071301$24107130$1$I$$20240704$20240718$20240718$EXP$$IN-CIPLA LTD.-2024IN07427$CIPLA$Pathania S, Suvirya S, Rai A, Kumar S, Tyagi V, Agrawal T.. Inadvertent intra-arterial injection: Cutaneous complications and management. Indian Journal of Dermatology, Venereology and Leprosy. 2024;90 (4):496 to 498$$$$$Y$$$20240718$$HP$IN$IN
241071311$24107131$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5842416$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241071321$24107132$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008683$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$23$YR$$M$Y$$$20240718$$HP$FR$FR
241071333$24107133$3$F$20240628$20240826$20240718$20240902$PER$$US-ROCHE-10000029024$ROCHE$$62$YR$A$$Y$$$20240902$$CN$US$US
241071341$24107134$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008587$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$6$YR$$M$Y$$$20240718$$HP$FR$FR
241071351$24107135$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008592$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$6$YR$$M$Y$$$20240718$$HP$FR$FR
241071361$24107136$1$I$$20201010$20240718$20240718$EXP$$US-AstraZeneca-2020SF32884$ASTRAZENECA$$53$YR$$F$Y$$$20240718$$CN$US$
241071381$24107138$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140808$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
241071391$24107139$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008593$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$7$YR$$F$Y$$$20240718$$HP$FR$FR
241071402$24107140$2$F$$20240717$20240718$20240726$PER$$US-SA-2024SA207775$SANOFI AVENTIS$$$$A$M$Y$86.1$KG$20240726$$MD$US$US
241071411$24107141$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA207780$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240718$$MD$US$US
241071422$24107142$2$F$20231001$20240715$20240718$20240723$PER$$US-SA-2024SA207377$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240723$$MD$US$US
241071431$24107143$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113808$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$70.76$KG$20240718$$HP$US$US
241071441$24107144$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008594$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$9$YR$$F$Y$$$20240718$$HP$FR$FR
241071451$24107145$1$I$$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002327J$MERCK$$79$YR$$M$Y$$$20240718$$MD$JP$JP
241071461$24107146$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207833$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240718$$MD$US$US
241071472$24107147$2$F$$20240822$20240718$20240829$EXP$$US-ALXN-202407USA000841US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240829$$HP$US$US
241071481$24107148$1$I$$20240710$20240718$20240718$EXP$$US-ABBVIE-5836959$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241071491$24107149$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207419$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241071511$24107151$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008595$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$9$YR$$M$Y$$$20240718$$HP$FR$FR
241071521$24107152$1$I$$20240717$20240718$20240718$PER$$US-AMGEN-USASP2024141869$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241071532$24107153$2$F$$20240715$20240718$20240722$PER$$US-AMGEN-USASP2024138944$AMGEN$$$$C$$Y$$$20240722$$CN$US$US
241071541$24107154$1$I$$20240715$20240718$20240718$EXP$$CA-ABBVIE-5841066$ABBVIE$$16$YR$$F$Y$$$20240718$$CN$CA$CA
241071551$24107155$1$I$$20240709$20240718$20240718$EXP$$US-VIIV HEALTHCARE LIMITED-US2024084915$VIIV$$$$$M$Y$$$20240718$$CN$US$US
241071561$24107156$1$I$$20240716$20240718$20240718$EXP$$AR-PFIZER INC-202400217555$PFIZER$$66$YR$$F$Y$$$20240718$$CN$AR$AR
241071582$24107158$2$F$$20240819$20240718$20240821$EXP$$CA-PFIZER INC-202400216249$PFIZER$$87$YR$$M$Y$$$20240821$$HP$CA$CA
241071591$24107159$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008596$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$10$YR$$M$Y$$$20240718$$HP$FR$FR
241071601$24107160$1$I$$20231020$20240718$20240718$PER$$US-GRUNENTHAL-2023-290192$AVERITAS$$47$YR$$M$Y$$$20240710$$CN$US$US
241071611$24107161$1$I$$20240716$20240718$20240718$EXP$$JP-TAKEDA-2024TJP010617$TAKEDA$$9$DEC$$M$Y$$$20240718$$MD$JP$JP
241071622$24107162$2$F$$20240710$20240718$20240718$PER$$US-ROCHE-10000023080$ROCHE$$$$$$Y$$$20240718$$CN$US$US
241071631$24107163$1$I$20070901$20240717$20240718$20240718$EXP$IT-MINISAL02-995194$IT-JNJFOC-20240745056$JOHNSON AND JOHNSON$$28$YR$A$F$Y$68$KG$20240718$$CN$IT$IT
241071641$24107164$1$I$$20240715$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112672$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240718$$HP$US$US
241071651$24107165$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008597$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$11$YR$$M$Y$$$20240718$$HP$FR$FR
241071661$24107166$1$I$$20240710$20240718$20240718$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008755$STRIDES$Meng Y, Zhou M-X, Wu C-B, Wang D-H, Zhao J-R, Shi D-Y.. Continuous venovenous hemodiafiltration versus standard medical therapy for the prevention of rhabdomyolysis-induced acute kidney injury: a retrospective cohort study.. BMC-Nephrol. 2023;24 (1):1-10$$$$$Y$$$20240718$$HP$CN$CN
241071671$24107167$1$I$20240101$20240711$20240718$20240718$EXP$$FR-ABBVIE-5843542$ABBVIE$$53$YR$$F$Y$$$20240718$$PH$FR$FR
241071682$24107168$2$F$20221029$20240806$20240718$20240816$EXP$$DE-EMD Serono-2024038570$EMD SERONO INC$$59$YR$A$M$Y$71$KG$20240816$$CN$DE$DE
241071691$24107169$1$I$20240710$20240715$20240718$20240718$EXP$$US-ABBVIE-5841191$ABBVIE$$73$YR$$M$Y$$$20240718$$CN$US$US
241071701$24107170$1$I$$20240716$20240718$20240718$EXP$$US-ROCHE-10000028757$ROCHE$$54$YR$A$F$Y$$$20240718$$CN$US$US
241071711$24107171$1$I$20240712$20240716$20240718$20240718$PER$$US-ROCHE-10000028676$ROCHE$$63$YR$A$M$Y$98$KG$20240718$$PH$US$US
241071721$24107172$1$I$$20240715$20240718$20240718$PER$$US-ROCHE-10000027787$ROCHE$$$$A$F$Y$$$20240718$$CN$US$US
241071731$24107173$1$I$$20240712$20240718$20240718$EXP$$AE-ABBVIE-5842516$ABBVIE$$$$A$M$Y$64$KG$20240718$$MD$AE$AE
241071741$24107174$1$I$$20240705$20240718$20240718$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-107798$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$96$KG$20240718$$HP$CA$CA
241071751$24107175$1$I$20240101$20240712$20240718$20240718$EXP$$US-ABBVIE-5840821$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241071761$24107176$1$I$20240716$20240717$20240718$20240718$EXP$GB-MHRA-MED-202407171340255940-JYVMN$GB-JNJFOC-20240745333$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240718$$PH$GB$GB
241071771$24107177$1$I$$20240710$20240718$20240718$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP008725$STRIDES$Kaya Akca U, Sener S, Batu ED, Balik Z, Basaran O, Bilginer Y, et al.. Drug-induced lupus erythematosus in childhood: Case-based review.. Lupus. 2024;33(7):737-748.$$$C$F$Y$$$20240718$$HP$TR$TR
241071781$24107178$1$I$20230915$20240712$20240718$20240718$EXP$$US-TAKEDA-2024TUS071508$TAKEDA$$25$YR$$F$Y$$$20240718$$MD$US$US
241071791$24107179$1$I$$20240716$20240718$20240718$PER$$US-HALEON-2187575$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241071801$24107180$1$I$$20240712$20240718$20240718$PER$$US-ROCHE-10000026084$ROCHE$$$$$F$Y$$$20240718$$HP$US$US
241071811$24107181$1$I$$20240708$20240718$20240718$EXP$$US-NOVOPROD-1254305$NOVO NORDISK$$$$$M$Y$$$20240718$$CN$US$US
241071821$24107182$1$I$$20240710$20240718$20240718$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP008726$STRIDES$Kaya Akca U, Sener S, Batu ED, Balik Z, Basaran O, Bilginer Y, et al.. Drug-induced lupus erythematosus in childhood: Case-based review.. Lupus. 2024;33(7):737-748.$$$C$F$Y$$$20240718$$HP$TR$TR
241071831$24107183$1$I$$20240708$20240718$20240718$EXP$$DE-NOVOPROD-1253871$NOVO NORDISK$Mirko Junge et al.. Suicide by insulin injection in combination with ?-blocker application. Forensic Science International. 2000;113:457 ?460$68$YR$$M$Y$$$20240718$$HP$DE$DE
241071841$24107184$1$I$20240501$20240708$20240718$20240718$EXP$$US-NOVOPROD-1253604$NOVO NORDISK$$67$YR$$M$Y$$$20240718$$CN$US$US
241071851$24107185$1$I$20240705$20240708$20240718$20240718$EXP$GB-MHRA-MED-202407080918427480-QJVWL$GB-NOVOPROD-1252494$NOVO NORDISK$$$$$F$Y$98$KG$20240718$$CN$GB$GB
241071861$24107186$1$I$20240702$20240708$20240718$20240718$EXP$CN-NMPA-1312001557691202400181$CN-NOVOPROD-1252746$NOVO NORDISK$$68$YR$$F$Y$$$20240718$$HP$CN$CN
241071871$24107187$1$I$20230101$20240708$20240718$20240718$EXP$$US-NOVOPROD-1253820$NOVO NORDISK$$68$YR$$F$Y$$$20240718$$CN$US$US
241071881$24107188$1$I$$20240708$20240718$20240718$EXP$$GB-NOVOPROD-1253246$NOVO NORDISK$$43$YR$$F$Y$$$20240718$$HP$GB$GB
241071891$24107189$1$I$$20240708$20240718$20240718$EXP$$US-NOVOPROD-1254479$NOVO NORDISK$Winston, David C.. Suicide Via Insulin Overdose in Nondiabetics The New Mexico Experience. The American Journal of Forensic Medicine and Pathology. 2000;21(3):237-240$44$YR$$M$Y$$$20240718$$HP$US$US
241071901$24107190$1$I$20220915$20240708$20240718$20240718$EXP$NO-NOMAADVRE-RELISV-2024-Vg8mgx$NO-NOVOPROD-1252583$NOVO NORDISK$$55$YR$$F$Y$$$20240718$$MD$NO$NO
241071911$24107191$1$I$$20240708$20240718$20240718$EXP$$JP-NOVOPROD-1253109$NOVO NORDISK$$85$YR$$F$Y$$$20240718$$PH$JP$JP
241071921$24107192$1$I$$20240708$20240718$20240718$EXP$$US-NOVOPROD-1253515$NOVO NORDISK$$71$YR$$F$Y$$$20240718$$MD$US$US
241071932$24107193$2$F$20240331$20240717$20240718$20240729$EXP$$GR-NOVOPROD-1253759$NOVO NORDISK$$49$YR$$M$Y$$$20240729$$MD$CY$CY
241071941$24107194$1$I$$20240708$20240718$20240718$EXP$$US-NOVOPROD-1254074$NOVO NORDISK$$$$$$Y$$$20240718$$CN$US$US
241071951$24107195$1$I$20231222$20240708$20240718$20240718$EXP$DK-DKMA-30729367$DK-NOVOPROD-1252585$NOVO NORDISK$$73$YR$$M$Y$90$KG$20240718$$CN$DK$DK
241071961$24107196$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207904$SANOFI AVENTIS$$9$YR$C$M$Y$43.99$KG$20240718$$MD$US$US
241071971$24107197$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA206385$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240718$$MD$US$US
241071981$24107198$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA207339$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241071992$24107199$2$F$$20240803$20240718$20240812$EXP$$KZ-HETERO-HET2024KZ02248$HETERO$$$$$M$Y$$$20240812$$HP$KZ$KZ
241072001$24107200$1$I$$20240712$20240718$20240718$PER$$US-ROCHE-10000028749$ROCHE$$64$YR$A$F$Y$$$20240718$$CN$US$US
241072011$24107201$1$I$$20240715$20240718$20240718$EXP$CZ-CZSUKL-24001991$CZ-SA-2024SA206476$SANOFI AVENTIS$$52$YR$A$F$Y$79$KG$20240718$$MD$CZ$CZ
241072021$24107202$1$I$$20240712$20240718$20240718$EXP$$BR-TAKEDA-2024TUS072022$TAKEDA$$$$$M$Y$$$20240718$$MD$BR$BR
241072033$24107203$3$F$$20240826$20240718$20240827$PER$$NVSC2024US147541$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
241072041$24107204$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140715$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
241072051$24107205$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-001088091$CA-NOVOPROD-1254556$NOVO NORDISK$$71$YR$$M$Y$$$20240718$$HP$CA$CA
241072061$24107206$1$I$$20240708$20240718$20240718$EXP$$PL-EXELIXIS-CABO-24079511$EXELIXIS$Darewicz, M.. Cabozantinib plus nivolumab as the first line treatment of metastatic renal cell carcinoma with rhabdoid differentiation-a case report$63$YR$$F$Y$$$20240717$$MD$PL$PL
241072071$24107207$1$I$$20200909$20240718$20240718$EXP$$US-AstraZeneca-2020SF16460$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241072081$24107208$1$I$20200908$20201006$20240718$20240718$EXP$$GB-AstraZeneca-2020SF13793$ASTRAZENECA$$27112$DY$$F$Y$$$20240718$$HP$GB$
241072091$24107209$1$I$$20200915$20240718$20240718$EXP$$US-AstraZeneca-2020SF19842$ASTRAZENECA$$42$YR$$F$Y$$$20240718$$CN$US$
241072101$24107210$1$I$20190502$20201006$20240718$20240718$EXP$$US-AstraZeneca-2020SF30494$ASTRAZENECA$$23363$DY$$F$Y$$$20240718$$CN$US$
241072111$24107211$1$I$$20240711$20240718$20240718$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024087741$VIIV$$$$$$Y$$$20240718$$PH$US$US
241072121$24107212$1$I$20240623$20240712$20240718$20240718$EXP$FR-AFSSAPS-PC2024000551$FR-EMD Serono-2024038154$EMD SERONO INC$$54$YR$A$M$Y$76$KG$20240718$$MD$FR$FR
241072131$24107213$1$I$20170927$20240716$20240718$20240718$EXP$$FR-TAKEDA-FR201738237$TAKEDA$$26$YR$$M$Y$$$20240718$$HP$FR$FR
241072141$24107214$1$I$$20240708$20240718$20240718$EXP$$LK-STRIDES ARCOLAB LIMITED-2024SP008693$STRIDES$Abeyagunawardena I, Madurapperuma C, Thuvarakan P, Thowfeek Z, Sujeewa N, Katulanda G, et al.. Uncommon triggers of insulin autoimmune syndrome: a case report. J-Med-Case-Rep. 2024;18:1-4$67$YR$$M$Y$$$20240718$$HP$LK$LK
241072151$24107215$1$I$$20240716$20240718$20240718$PER$$NVSC2024US147568$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
241072161$24107216$1$I$$20240709$20240718$20240718$PER$$US-APOTEX-2024AP008249$APOTEX$Wilkinson AJ, Yang A, Chen GH.. Stellate ganglion block to mitigate thalamic pain syndrome of an oncological origin. Pain Practice. 2024;24:231-234$73$YR$$F$Y$62$KG$20240718$$HP$US$US
241072171$24107217$1$I$$20240703$20240718$20240718$PER$$US-TEVA-VS-3218778$TEVA$$$$$M$Y$$$20240718$$CN$US$US
241072181$24107218$1$I$20240101$20240711$20240718$20240718$EXP$$US-BIOGEN-2024BI01273480$BIOGEN$$$$$F$Y$$$20240718$$MD$US$US
241072191$24107219$1$I$$20240712$20240718$20240718$EXP$$US-BIOGEN-2024BI01273901$BIOGEN$$$$$M$Y$$$20240718$$CN$US$US
241072211$24107221$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA206597$SANOFI AVENTIS$$$$A$F$Y$63.5$KG$20240718$$MD$US$US
241072221$24107222$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA206619$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240718$$MD$US$US
241072231$24107223$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207778$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240718$$MD$US$US
241072241$24107224$1$I$20240711$20240711$20240718$20240718$PER$$US-SA-2024SA205948$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240718$$MD$US$US
241072251$24107225$1$I$$20240714$20240718$20240718$EXP$$US-HALEON-2187273$Haleon PLC$$$$$$Y$$$20240717$$CN$US$US
241072261$24107226$1$I$20240706$20240709$20240718$20240718$PER$$US-SA-2024SA206601$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240718$$MD$US$US
241072272$24107227$2$F$$20240708$20240718$20240722$EXP$$GB-CELLTRION INC.-2024GB016911$CELLTRION$$$$$$Y$$$20240722$$CN$GB$GB
241072281$24107228$1$I$$20240709$20240718$20240718$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP008675$STRIDES$Kim G, Lee WH, Kang S, Moon JR, Lee YS, Son JH, et al.. Vomiting-induced pharyngeal perforation during bowel preparation for colonoscopy: A case report.. World-J-Clin-Cases. 2024;12(18):3615-3621$38$YR$$M$Y$$$20240718$$MD$KR$KR
241072291$24107229$1$I$20240601$20240712$20240718$20240718$EXP$$US-UCBSA-2024036235$UCB$$48$YR$$M$Y$$$20240718$$MD$US$US
241072301$24107230$1$I$$20240705$20240718$20240718$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK092029$GLENMARK$$$$$$Y$$$20240718$$CN$GB$GB
241072311$24107231$1$I$$20240709$20240718$20240718$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008607$STRIDES$Cardona Quinones RA, Salem Hernandez SA, Sekimitsu S, Antongiorgi Torres J, Yerstein O, Safar LT.. A neuropsychiatric case of delayed post-hypoxic leukoencephalopathy from opioid intoxication resulting in Anton-Babinski syndrome and quadriplegia.. Neurocase. 2023;29 (5):160-166$26$YR$$M$Y$$$20240718$$HP$US$US
241072321$24107232$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008540$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$45$YR$$F$Y$$$20240718$$HP$FR$FR
241072331$24107233$1$I$$20240709$20240718$20240718$PER$$US-APOTEX-2024AP008231$APOTEX$Kiskaddon AL, Wilsey M, Gonzalez-Gomez I, Laks J, Miles A, Carapellucci J, et al.. Basiliximab therapy for immune-mediated bowel disease in a pediatric heart transplant patient. Pediatric Transplantation. 2023;27 (2): e14443:1-4$10$YR$$F$Y$$$20240718$$HP$US$US
241072341$24107234$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141782$AMGEN$$$$$F$Y$$$20240717$$CN$US$US
241072351$24107235$1$I$$20240711$20240718$20240718$EXP$$GR-ABBVIE-5838727$ABBVIE$Koropouli E, Bozi M, Polymeros D, Loupo B, Akrivaki A, Dimitriadou E, el al. CONTINUOUS INTESTINAL INFUSION OF DUODOPA CAN AMELIORATE THE MOTOR AND NON-MOTOR COMPLICATIONS ASSOCIATED WITH ADVANCED?PARKINSON^S DISEASE. Archives of Clinical Neurology. 2024;33(3):37-45.$$$$$Y$$$20240718$$MD$GR$GR
241072361$24107236$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008541$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$50$YR$$M$Y$$$20240718$$HP$FR$FR
241072371$24107237$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140504$AMGEN$$$$$F$Y$$$20240717$$PH$US$US
241072381$24107238$1$I$$20201007$20240718$20240718$EXP$$US-AstraZeneca-2020SF32138$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241072391$24107239$1$I$20240710$20240715$20240718$20240718$EXP$$US-AstraZeneca-2024A161423$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241072401$24107240$1$I$$20200801$20240718$20240718$EXP$$US-AstraZeneca-2020SE98244$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241072411$24107241$1$I$20200725$20200729$20240718$20240718$EXP$$US-AstraZeneca-2020SE97606$ASTRAZENECA$$63$YR$$M$Y$$$20240718$$CN$US$
241072421$24107242$1$I$$20200709$20240718$20240718$EXP$$US-AstraZeneca-2020SE72731$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241072431$24107243$1$I$$20240710$20240718$20240718$PER$$US-JNJFOC-20240727145$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$CN$US$US
241072442$24107244$2$F$20200601$20240829$20240718$20240905$EXP$$JP-JNJFOC-20240744944$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$MD$JP$JP
241072451$24107245$1$I$$20200812$20240718$20240718$EXP$$US-AstraZeneca-2020SF03120$ASTRAZENECA$$$$$F$Y$53.1$KG$20240718$$CN$US$
241072461$24107246$1$I$$20240710$20240718$20240718$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089850$VIIV$$$$$$Y$$$20240718$$HP$US$US
241072471$24107247$1$I$$20240716$20240718$20240718$EXP$$US-ABBVIE-5842473$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241072482$24107248$2$F$20240712$20240814$20240718$20240819$EXP$$TR-ABBVIE-5842541$ABBVIE$$70$YR$$F$Y$$$20240819$$CN$TR$TR
241072491$24107249$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008542$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$55$YR$$M$Y$$$20240718$$HP$FR$FR
241072501$24107250$1$I$$20240710$20240718$20240718$PER$$US-ABBVIE-5840091$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241072511$24107251$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-E2B_07134521$CA-NOVOPROD-1254666$NOVO NORDISK$$$$$F$Y$$$20240718$$CN$CA$CA
241072521$24107252$1$I$$20240708$20240718$20240718$EXP$$US-NOVOPROD-1254627$NOVO NORDISK$$$$$F$Y$$$20240718$$CN$US$US
241072531$24107253$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008543$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$57$YR$$M$Y$$$20240718$$HP$FR$FR
241072541$24107254$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008630$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$27$YR$$M$Y$$$20240718$$HP$FR$FR
241072551$24107255$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008631$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$30$YR$$M$Y$$$20240718$$HP$FR$FR
241072561$24107256$1$I$$20240715$20240718$20240718$EXP$$CA-ABBVIE-5842584$ABBVIE$$$$E$M$Y$86$KG$20240718$$CN$CA$CA
241072572$24107257$2$F$20240715$20240716$20240718$20240723$EXP$$FR-ABBVIE-5842410$ABBVIE$$70$YR$$F$Y$$$20240723$$HP$FR$FR
241072581$24107258$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-07116788$CA-NOVOPROD-1254660$NOVO NORDISK$$51$YR$$F$Y$$$20240718$$HP$CA$CA
241072591$24107259$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-E2B_07144439$CA-NOVOPROD-1254557$NOVO NORDISK$$71$YR$$M$Y$$$20240718$$CN$CA$CA
241072601$24107260$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008632$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$33$YR$$F$Y$$$20240718$$HP$FR$FR
241072611$24107261$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207133$SANOFI AVENTIS$$65$YR$E$F$Y$74.38$KG$20240718$$MD$US$US
241072621$24107262$1$I$$20240715$20240718$20240718$PER$$US-SA-2024SA208484$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$CN$US$US
241072631$24107263$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA207305$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240718$$MD$US$US
241072641$24107264$1$I$20240101$20240710$20240718$20240718$PER$$US-SA-2024SA206640$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240718$$CN$US$US
241072651$24107265$1$I$20210801$20240709$20240718$20240718$PER$$US-SA-2024SA206522$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240718$$MD$US$US
241072661$24107266$1$I$$20240715$20240718$20240718$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-113528$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240718$$HP$DE$DE
241072671$24107267$1$I$20240601$20240712$20240718$20240718$EXP$$GB-JNJFOC-20240734022$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20240718$$CN$GB$GB
241072681$24107268$1$I$$20240710$20240718$20240718$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP008634$STRIDES$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf. 2024;33 (6)$43$YR$$M$Y$$$20240718$$HP$FR$FR
241072692$24107269$2$F$$20240807$20240718$20240808$EXP$$CA-ABBVIE-5842922$ABBVIE$$61$YR$$M$Y$$$20240808$$CN$CA$CA
241072701$24107270$1$I$$20240601$20240718$20240718$PER$$US-AUROBINDO-AUR-APL-2024-018771$AUROBINDO$$48$YR$$F$Y$$$20240718$$MD$US$US
241072711$24107271$1$I$20240626$20240715$20240718$20240718$EXP$$DE-ABBVIE-5842515$ABBVIE$$43$YR$$M$Y$$$20240718$$CN$DE$DE
241072721$24107272$1$I$$20240524$20240718$20240718$PER$$US-AUROBINDO-AUR-APL-2024-017527$AUROBINDO$$73$YR$$F$Y$$$20240718$$HP$US$US
241072731$24107273$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-10000028916$ROCHE$$43$YR$A$F$Y$$$20240718$$MD$US$US
241072741$24107274$1$I$20240624$20240715$20240718$20240718$EXP$$CA-ABBVIE-5842529$ABBVIE$$63$YR$$F$Y$$$20240718$$CN$CA$CA
241072752$24107275$2$F$20230101$20240726$20240718$20240729$EXP$$NL-KOANAAP-SML-NL-2024-00738$SHILPA MEDICARE$$46$YR$A$F$Y$$$20240729$$HP$NL$NL
241072761$24107276$1$I$$20240709$20240718$20240718$EXP$$IN-KOANAAP-SML-IN-2024-00724$Unknown Manufacturer$D SD, P S, P CP, S S. An unusual case of Blastic Plasmacytoid DendriticCell Neoplasm Masquerading as Primary Refractory Cutaneous T-Cell Lymphoma.. Indian-J-Hematol-Blood-Transf. 2023;39: S133-S133.$40$YR$A$F$Y$$$20240718$$MD$IN$IN
241072771$24107277$1$I$$20240711$20240718$20240718$EXP$$SG-ELI_LILLY_AND_COMPANY-SG202407008311$ELI LILLY AND CO$Saw S.P.L.,Low Y.F.,Lai G.G.Y.,Chan L.L et al.Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC..Lung Cancer 2024;193:.DOI:https://doi.org/10.1016/j.lungcan.2024.107856$$$A$$Y$$$20240718$$HP$SG$SG
241072781$24107278$1$I$$20240711$20240718$20240718$EXP$$SG-ELI_LILLY_AND_COMPANY-SG202407008294$ELI LILLY AND CO$Saw S.P.L.,Low Y.F.,Lai G.G.Y.,Chan L.L et al.Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC..Lung Cancer 2024;193:.DOI:https://doi.org/10.1016/j.lungcan.2024.107856$$$A$$Y$$$20240718$$HP$SG$SG
241072801$24107280$1$I$20240101$20240711$20240718$20240718$EXP$$US-SA-2024SA206353$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240718$$MD$US$US
241072811$24107281$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-10000029140$ROCHE$$58$YR$A$F$Y$$$20240718$$CN$US$US
241072821$24107282$1$I$20240716$20240716$20240718$20240718$EXP$$US-ABBVIE-5843440$ABBVIE$$53$YR$$F$Y$$$20240718$$CN$US$US
241072831$24107283$1$I$$20240709$20240718$20240718$EXP$$BR-JNJFOC-20240726031$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$MD$BR$BR
241072841$24107284$1$I$$20240710$20240718$20240718$EXP$$FR-UCBSA-2024036178$UCB$$47$YR$$F$Y$$$20240718$$MD$FR$FR
241072851$24107285$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187538$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241072862$24107286$2$F$20240626$20240711$20240718$20240730$PER$$US-AMGEN-USASL2024138904$AMGEN$$41$YR$A$F$Y$$$20240730$$CN$US$US
241072871$24107287$1$I$20240628$20240715$20240718$20240718$EXP$$US-AstraZeneca-2024A161455$ASTRAZENECA$$31570$DY$$$Y$$$20240718$$MD$US$
241072881$24107288$1$I$$20230623$20240718$20240718$EXP$$AR-SANDOZ INC.-NVSC2023AR145386$SANDOZ$Leonardi N, Gilligan G, Piemonte E, Panico R. Therapeutic alternatives of medication-related osteonecrosis of the jaw (MRONJ): reports of two clinical cases and review of the literature. JOURNAL OF THE FACULTY OF MEDICAL SCIENCES OF CORDOBA. 2022;79(4):379-82$68$YR$$F$Y$$$20240718$$MD$AR$AR
241072891$24107289$1$I$$20200921$20240718$20240718$EXP$$US-AstraZeneca-2020SF22839$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241072901$24107290$1$I$$20200622$20240718$20240718$EXP$$US-AstraZeneca-2020SE71151$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241072911$24107291$1$I$$20210216$20240718$20240718$EXP$$US-AstraZeneca-2021A068305$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241072921$24107292$1$I$$20200626$20240718$20240718$EXP$$US-AstraZeneca-2020SE82577$ASTRAZENECA$$75$YR$$$Y$$$20240718$$CN$US$
241072931$24107293$1$I$$20201021$20240718$20240718$EXP$$ZA-AstraZeneca-2020SF38499$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$ZA$
241072941$24107294$1$I$$20240715$20240718$20240718$30DAY$$CA-SANDOZ INC.-SDZ2024CA065710$SANDOZ$$$$$M$Y$$$20240718$$CN$CA$CA
241072951$24107295$1$I$$20240708$20240718$20240718$30DAY$$US-GSK-US2024084958$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241072961$24107296$1$I$20240101$20240716$20240718$20240718$EXP$$US-UCBSA-2024036185$UCB$$$$$F$Y$77.37$KG$20240718$$HP$US$US
241072981$24107298$1$I$$20240709$20240718$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-110865$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$MD$JP$JP
241072992$24107299$2$F$$20240715$20240718$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040135$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240718$$HP$US$US
241073001$24107300$1$I$$20240712$20240718$20240718$PER$$US-AMGEN-USASP2024139976$AMGEN$$$$$F$Y$$$20240717$$MD$US$US
241073011$24107301$1$I$20240626$20240711$20240718$20240718$EXP$$CN-BEIGENE-BGN-2024-010858$BEIGENE$$$$$$Y$$$20240718$$HP$CN$CN
241073023$24107302$3$F$$20240715$20240718$20240726$EXP$$CA-HALEON-2187303$Haleon PLC$$40$YR$$F$Y$$$20240726$$HP$CA$CA
241073031$24107303$1$I$$20230814$20240718$20240718$PER$$US-GRUNENTHAL-2023-272536$AVERITAS$$$$A$M$Y$$$20240710$$CN$US$US
241073041$24107304$1$I$20231013$20231019$20240718$20240718$PER$$US-GRUNENTHAL-2023-285444$AVERITAS$$52$YR$$M$Y$$$20240710$$CN$US$US
241073051$24107305$1$I$20230629$20230725$20240718$20240718$PER$$US-GRUNENTHAL-2023-271220$AVERITAS$$74$YR$$F$Y$$$20240710$$HP$US$US
241073061$24107306$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA206555$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240718$$MD$US$US
241073072$24107307$2$F$$20240805$20240718$20240813$PER$$US-SA-2024SA206940$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240814$$MD$US$US
241073082$24107308$2$F$20240101$20240912$20240718$20240920$PER$$US-SA-2024SA206570$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240920$$MD$US$US
241073091$24107309$1$I$20240101$20240710$20240718$20240718$PER$$US-SA-2024SA206921$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240718$$PH$US$US
241073101$24107310$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA206580$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240718$$MD$US$US
241073112$24107311$2$F$20240709$20240709$20240718$20240724$EXP$$US-BEH-2024175724$CSL BEHRING$$65$YR$E$F$Y$97.052$KG$20240724$$CN$US$US
241073121$24107312$1$I$$20240704$20240718$20240718$EXP$GB-MHRA-MED-202406291228213970-KGHYM$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15031$ALKEM$$30$YR$$M$Y$$$20240718$$CN$GB$GB
241073131$24107313$1$I$$20240704$20240718$20240718$EXP$GB-MHRA-DEFECT-202406221311545970-BHSNJ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15110$ALKEM$$$$$$Y$$$20240718$$CN$GB$GB
241073142$24107314$2$F$20220101$20240717$20240718$20240731$EXP$JP-MLMSERVICE-20240627-PI112237-00117-1$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-15019$ALKEM$Sawada K, Kawaji T, Yamana K, Matsuhashi K, Hara Y, Kuriyama N, et al.. Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory distress syndrome: a case report. Journal of cardiothoracic surgery. 2024;19(1):358$40$YR$$F$Y$43$KG$20240731$$MD$JP$JP
241073153$24107315$3$F$20240601$20240903$20240718$20240905$PER$$US-AMGEN-USASP2024142008$AMGEN$$58$YR$A$F$Y$$$20240905$$CN$US$US
241073161$24107316$1$I$$20240708$20240718$20240718$30DAY$$US-GSK-US2024084988$GLAXOSMITHKLINE$$$$$M$Y$$$20240718$$CN$US$US
241073172$24107317$2$F$$20240717$20240718$20240731$EXP$PT-MLMSERVICE-20240626-PI112609-00057-1$PT-ALKEM LABORATORIES LIMITED-PT-ALKEM-2024-15022$ALKEM$Lobato CT, Castelo Branco S, Cam?es J, Molinos E. Rhabdomyolysis secondary to a weight-loss prescription. BMJ Case Reports. 2024;17(6):e258208$8$DEC$$M$Y$$$20240731$$MD$PT$PT
241073181$24107318$1$I$$20240710$20240718$20240718$PER$$US-ABBVIE-5837144$ABBVIE$$$$$F$Y$$$20240718$$MD$US$US
241073192$24107319$2$F$20240426$20240823$20240718$20240828$EXP$$JP-GENMAB-2024-01734AA$GENMAB$$88$YR$$F$Y$$$20240828$$HP$JP$JP
241073202$24107320$2$F$$20240905$20240718$20240925$EXP$$DK-SA-2024SA199864$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$HP$DK$DK
241073211$24107321$1$I$$20240708$20240718$20240718$EXP$EU-AFSSAPS-PB2024000753$EU-AFSSAPS-PB2024000753$UNITED THERAPEUTICS$$71$YR$$$Y$75$KG$20240718$$PH$EU$EU
241073221$24107322$1$I$20230101$20230811$20240718$20240718$PER$$US-GRUNENTHAL-2023-271678$AVERITAS$$75$YR$$M$Y$$$20240710$$MD$US$US
241073231$24107323$1$I$20240101$20240711$20240718$20240718$EXP$$US-SA-2024SA207722$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240718$$MD$US$US
241073241$24107324$1$I$$20240712$20240718$20240718$PER$$US-ABBVIE-5840069$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241073251$24107325$1$I$20200704$20200708$20240718$20240718$EXP$$US-AstraZeneca-2020SE87225$ASTRAZENECA$$27961$DY$$F$Y$$$20240718$$CN$US$
241073261$24107326$1$I$20240401$20240711$20240718$20240718$EXP$$PE-ELI_LILLY_AND_COMPANY-PE202405017360$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240718$$CN$PE$PE
241073271$24107327$1$I$20240626$20240705$20240718$20240718$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407005368$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240718$$CN$CN$CN
241073281$24107328$1$I$$20210318$20240718$20240718$EXP$$US-AstraZeneca-2021A174219$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241073291$24107329$1$I$20230901$20230920$20240718$20240718$PER$$US-GRUNENTHAL-2023-274473$AVERITAS$$$$A$F$Y$$$20240710$$HP$US$US
241073301$24107330$1$I$$20201102$20240718$20240718$EXP$$US-AstraZeneca-2020SF46632$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241073311$24107331$1$I$$20200130$20240718$20240718$EXP$$US-AstraZeneca-2020SE15564$ASTRAZENECA$$$$$F$Y$$$20240718$$HP$US$
241073321$24107332$1$I$20210120$20210324$20240718$20240718$EXP$$US-AstraZeneca-2021A208910$ASTRAZENECA$$22900$DY$$F$Y$$$20240718$$CN$US$
241073331$24107333$1$I$$20210120$20240718$20240718$EXP$$US-AstraZeneca-2021A011285$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241073341$24107334$1$I$20240628$20240711$20240718$20240718$EXP$$CN-BEIGENE-BGN-2024-010844$BEIGENE$$$$$$Y$$$20240718$$HP$CN$CN
241073351$24107335$1$I$$20201015$20240718$20240718$EXP$$GB-AstraZeneca-2020SF35698$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$GB$
241073362$24107336$2$F$$20240912$20240718$20240917$PER$$NVSC2024US146693$NOVARTIS$$$$$F$Y$94$KG$20240918$$CN$US$US
241073371$24107337$1$I$$20201207$20240718$20240718$EXP$$US-AstraZeneca-2020SF64721$ASTRAZENECA$$$$$F$Y$63.5$KG$20240718$$CN$US$
241073381$24107338$1$I$$20210225$20240718$20240718$EXP$$US-AstraZeneca-2021A096407$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241073391$24107339$1$I$$20210310$20240718$20240718$EXP$$CA-AstraZeneca-2021A140872$ASTRAZENECA$$$$$M$Y$$$20240718$$MD$CA$
241073401$24107340$1$I$$20201231$20240718$20240718$EXP$$US-AstraZeneca-2021A000621$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241073411$24107341$1$I$20240601$20240711$20240718$20240718$EXP$$JP-GENMAB-2024-02543$GENMAB$$64$YR$$F$Y$$$20240718$$MD$JP$JP
241073421$24107342$1$I$$20200825$20240718$20240718$EXP$$US-AstraZeneca-2020SF10125$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241073432$24107343$2$F$20240521$20240904$20240718$20240919$EXP$IT-MINISAL02-993753$IT-ELI_LILLY_AND_COMPANY-IT202407004853$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240919$$CN$IT$IT
241073441$24107344$1$I$$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405161307512480-VSDWF$GB-ELI_LILLY_AND_COMPANY-GB202407005700$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$GB$GB
241073451$24107345$1$I$20240101$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140231$AMGEN$$55$YR$A$M$Y$$$20240717$$CN$US$US
241073461$24107346$1$I$$20240713$20240718$20240718$PER$$US-AMGEN-USASP2024139816$AMGEN$$$$$M$Y$$$20240717$$CN$US$US
241073471$24107347$1$I$20240627$20240708$20240718$20240718$EXP$$CN-GALDERMA-CN2024011215$GALDERMA$$$$$$Y$$$20240718$$HP$CN$CN
241073481$24107348$1$I$$20240712$20240718$20240718$PER$$US-AMGEN-USASP2024140018$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241073492$24107349$2$F$20240506$20240808$20240718$20240813$30DAY$$US-SANDOZ INC.-SDZ2024US044955$SANDOZ$$15$YR$$M$Y$$$20240813$$MD$US$US
241073501$24107350$1$I$20230101$20230809$20240718$20240718$PER$$US-GRUNENTHAL-2023-272044$AVERITAS$$8$DEC$$M$Y$$$20240710$$MD$US$US
241073511$24107351$1$I$$20230907$20240718$20240718$PER$$US-GRUNENTHAL-2023-273301$AVERITAS$$7$DEC$$M$Y$102.95$KG$20240710$$HP$US$US
241073521$24107352$1$I$20230101$20231108$20240718$20240718$PER$$US-GRUNENTHAL-2023-300794$AVERITAS$$$$E$F$Y$$$20240710$$CN$US$US
241073533$24107353$3$F$20240622$20240911$20240718$20240913$EXP$FR-AFSSAPS-BX2024001439$FR-GSK-FR2024089370$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$FR$FR
241073541$24107354$1$I$$20240711$20240718$20240718$EXP$$US-VIIV HEALTHCARE LIMITED-US2024087781$VIIV$$$$$$Y$$$20240718$$HP$US$US
241073551$24107355$1$I$20240624$20240708$20240718$20240718$EXP$$CN-GALDERMA-CN2024011129$GALDERMA$$$$$$Y$$$20240718$$HP$CN$CN
241073561$24107356$1$I$$20240713$20240718$20240718$EXP$$US-HALEON-2187222$Haleon PLC$Navari YB. Unveiling the Deadly Dance of Hypocalcemia and Lactic Acidosis in a 59-Year-Old Woman with B-Cell Lymphoma. European journal of case reports in internal medicine. 11(7):004643. https://dx.doi.org/10.12890/2024_004643; Navari, Yasaman, Bazuaye, et al. Unveiling the Deadly Dance of Hypocalcemia and Lactic Acidosis in a 59-Year-Old Woman with B-Cell Lymphoma .. European journal of case reports in internal medicine. #PY#;11(7):004643. https://dx.doi.org/10.12890/2024_004643 (https://dx...$59$YR$$F$Y$$$20240716$$HP$US$US
241073571$24107357$1$I$$20240715$20240718$20240718$EXP$$US-GSK-US2024AMR089223$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$US$US
241073581$24107358$1$I$$20231031$20240718$20240718$PER$$US-GRUNENTHAL-2023-295903$AVERITAS$$72$YR$$F$Y$$$20240710$$MD$US$US
241073592$24107359$2$F$20180117$20240731$20240718$20240809$EXP$$US-INTERCEPT-PM2024001235$INTERCEPT PHARMACEUTICALS$$65$YR$$F$Y$$$20240809$$CN$US$US
241073601$24107360$1$I$20240701$20240713$20240718$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-021708$UNITED THERAPEUTICS$$44$YR$$F$Y$68.027$KG$20240718$$$US$US
241073612$24107361$2$F$$20240829$20240718$20240903$EXP$$US-SANDOZ INC.-SDZ2023US013341$SANDOZ$$$$$$Y$92.99$KG$20240903$$HP$US$US
241073621$24107362$1$I$$20240710$20240718$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113945$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$MD$JP$JP
241073631$24107363$1$I$20240624$20240715$20240718$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040224$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240718$$CN$US$US
241073652$24107365$2$F$20240101$20240812$20240718$20240814$PER$$US-AMGEN-USASP2024140705$AMGEN$$64$YR$A$F$Y$$$20240813$$HP$US$US
241073661$24107366$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-10000029131$ROCHE$$$$A$M$Y$$$20240718$$MD$US$US
241073671$24107367$1$I$20240623$20240708$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-034339$AUROBINDO$$83$YR$$F$Y$62$KG$20240718$$MD$GB$GB
241073691$24107369$1$I$20240709$20240710$20240718$20240718$EXP$$CN-BEIGENE-BGN-2024-010786$BEIGENE$$$$$$Y$$$20240718$$HP$CN$CN
241073701$24107370$1$I$20200927$20201211$20240718$20240718$EXP$$US-AstraZeneca-2020SF27259$ASTRAZENECA$$42$YR$$F$Y$72.6$KG$20240718$$CN$US$
241073711$24107371$1$I$$20210406$20240718$20240718$EXP$$US-AstraZeneca-2021A280734$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241073721$24107372$1$I$$20200130$20240718$20240718$EXP$$US-AstraZeneca-2020SE17454$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241073731$24107373$1$I$$20210129$20240718$20240718$EXP$$US-AstraZeneca-2021A025782$ASTRAZENECA$$$$$$Y$$$20240718$$CN$US$
241073741$24107374$1$I$20200901$20201106$20240718$20240718$EXP$$AU-AstraZeneca-2020SF46288$ASTRAZENECA$$824$MON$$F$Y$$$20240718$$CN$AU$
241073751$24107375$1$I$20181230$20200427$20240718$20240718$EXP$$CL-AstraZeneca-2020SE58317$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$CL$
241073761$24107376$1$I$$20200204$20240718$20240718$EXP$$US-AstraZeneca-2020SE19774$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241073771$24107377$1$I$$20201214$20240718$20240718$EXP$$US-AstraZeneca-2020SF68978$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241073781$24107378$1$I$20190601$20190712$20240718$20240718$EXP$$MX-AstraZeneca-2019SF02262$ASTRAZENECA$$23821$DY$$F$Y$79$KG$20240718$$CN$MX$
241073791$24107379$1$I$$20210222$20240718$20240718$EXP$$US-AstraZeneca-2021A084053$ASTRAZENECA$$43$YR$$F$Y$$$20240718$$HP$US$
241073801$24107380$1$I$$20200429$20240718$20240718$EXP$$US-AstraZeneca-2020SE21898$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241073811$24107381$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-10000029031$ROCHE$$53$YR$A$F$Y$$$20240718$$MD$US$US
241073821$24107382$1$I$20240101$20240709$20240718$20240718$PER$$US-ABBVIE-5839346$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241073832$24107383$2$F$$20240917$20240718$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024086595$VIIV$$$$$$Y$$$20240927$$PH$US$US
241073841$24107384$1$I$$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113794$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240718$$CN$US$US
241073852$24107385$2$F$$20240715$20240718$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112875$BRISTOL MYERS SQUIBB$Floyd J, Porragas-Paseiro H, Nguyen C, Moroney MR, Mastroyannis S, Guntupalli SR. Validation of the safety and efficacy of apixaban as postoperative thromboembolism prophylaxis for patients with gynecologic malignancies. Annals of Surgical Oncology. 2024 May 23;31(8):5102-10. doi:10.1245/s10434-024-15369-8.$$$$F$Y$$$20240725$$MD$US$US
241073861$24107386$1$I$$20240710$20240718$20240718$EXP$$US-JNJFOC-20240725753$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
241073872$24107387$2$F$$20240723$20240718$20240731$EXP$$AT-JNJFOC-20240730831$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240731$$MD$AT$AT
241073881$24107388$1$I$$20240710$20240718$20240718$EXP$$US-JNJFOC-20240729516$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$US$US
241073891$24107389$1$I$20240628$20240708$20240718$20240718$EXP$$CN-JNJFOC-20240721492$JOHNSON AND JOHNSON$$46$YR$A$F$Y$45$KG$20240718$$HP$CN$CN
241073901$24107390$1$I$20240506$20240711$20240718$20240718$EXP$$US-JNJFOC-20240516415$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240718$$MD$US$US
241073911$24107391$1$I$$20240711$20240718$20240718$EXP$$US-JNJFOC-20240737527$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
241073921$24107392$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141580$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241073931$24107393$1$I$20240507$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405111000550060-MSRDP$GB-RDY-SPO/GBR/24/0010060$DR REDDYS$$40$YR$A$M$Y$$$20240718$$CN$GB$GB
241073942$24107394$2$F$$20240718$20240718$20240722$PER$$US-HALEON-2187541$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
241073951$24107395$1$I$$20240716$20240718$20240718$PER$$US-ABBVIE-5842641$ABBVIE$$$$$$Y$$$20240718$$CN$US$US
241073961$24107396$1$I$20171010$20240709$20240718$20240718$EXP$$CN-ROCHE-2596846$ROCHE$$47$YR$A$M$Y$40$KG$20240718$$CN$CN$CN
241073971$24107397$1$I$$20230920$20240718$20240718$PER$$US-GRUNENTHAL-2023-274472$AVERITAS$$55$YR$$M$Y$$$20240710$$MD$US$US
241073981$24107398$1$I$20240707$20240711$20240718$20240718$EXP$$CN-BEIGENE-BGN-2024-010840$BEIGENE$$$$$$Y$$$20240718$$HP$CN$CN
241073991$24107399$1$I$$20240712$20240718$20240718$30DAY$$US-SANDOZ INC.-SDZ2023US030852$SANDOZ$$$$$M$Y$$$20240718$$HP$US$US
241074002$24107400$2$F$$20240822$20240718$20240826$30DAY$$US-SANDOZ INC.-NVSC2022US132189$SANDOZ$$$$$$Y$$$20240826$$HP$US$US
241074011$24107401$1$I$$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113090$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$69.85$KG$20240718$$CN$US$US
241074021$24107402$1$I$20210101$20240604$20240718$20240718$EXP$$US-TAKEDA-2024TUS072031$TAKEDA$$$$$F$Y$$$20240718$$CN$US$US
241074032$24107403$2$F$$20240820$20240718$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-034479$AUROBINDO$$$$$F$Y$$$20240902$$MD$US$US
241074042$24107404$2$F$$20240726$20240718$20240807$EXP$$US-AUROBINDO-AUR-APL-2024-035353$AUROBINDO$Portuguese AJ, Gauthier J, Tykodi SS, Hall ET, Hirayama AV, Yeung CCS, et al. CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic review. Bone-MarrowTransplant. 2023;58:353-359$47$YR$$M$Y$$$20240807$$HP$US$US
241074052$24107405$2$F$20240601$20240821$20240718$20240823$EXP$$AU-ABBVIE-5842561$ABBVIE$$44$YR$$F$Y$80$KG$20240823$$MD$AU$AU
241074061$24107406$1$I$$20240628$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06546$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241074071$24107407$1$I$20240101$20240710$20240718$20240718$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021341$UNITED THERAPEUTICS$$$$$M$Y$70.295$KG$20240718$$$US$US
241074081$24107408$1$I$20240713$20240710$20240718$20240718$EXP$$EG-ROCHE-10000025491$ROCHE$$30$YR$A$F$Y$120$KG$20240718$$CN$EG$EG
241074091$24107409$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141094$AMGEN$$$$$F$Y$$$20240717$$MD$US$US
241074101$24107410$1$I$$20240628$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06583$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241074111$24107411$1$I$$20240710$20240718$20240718$PER$$US-AMGEN-USASP2024138261$AMGEN$Miller J.B.; Razavi P.; Baldwin G. et al.. Changes in wider field swept-source OCT angiography vascular metrics with anti-vascular endothelial growth factor therapy in central retinal vein occlusion. Graefe^s Archive for Clinical and Experimental Ophthalmology. 2024;262 (7):2111-2120$$$$$Y$$$20240717$$HP$US$US
241074121$24107412$1$I$20240618$20240712$20240718$20240718$EXP$$US-TAKEDA-2024TUS071581$TAKEDA$$$$$F$Y$$$20240718$$CN$US$US
241074132$24107413$2$F$20240501$20240903$20240718$20240905$EXP$$US-TAKEDA-2024TUS033528$TAKEDA$$48$YR$$F$Y$185$KG$20240905$$CN$US$US
241074141$24107414$1$I$$20240716$20240718$20240718$PER$$NVSC2024US147653$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
241074151$24107415$1$I$$20240717$20240718$20240718$PER$$NVSC2024US147553$NOVARTIS$$$$$$Y$$$20240718$$CN$US$US
241074171$24107417$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034094$AUROBINDO$Li S, Halloran P, Siref A.. Concurrent Neutrophilic Eccrine Hidradenitis and Leukocytoclastic Vasculitis.. American Journal of Dermatopathology.. 2024;46(7):S20$58$YR$$F$Y$$$20240718$$MD$US$US
241074181$24107418$1$I$$20210130$20240718$20240718$EXP$$XI-AstraZeneca-2021A029166$ASTRAZENECA$$$$$M$Y$$$20240718$$PH$XI$
241074191$24107419$1$I$$20200106$20240718$20240718$EXP$$CA-AstraZeneca-2020SE02573$ASTRAZENECA$$30$YR$$M$Y$$$20240718$$MD$CA$
241074201$24107420$1$I$$20201231$20240718$20240718$EXP$$US-AstraZeneca-2021A001275$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241074211$24107421$1$I$$20200903$20240718$20240718$EXP$$US-AstraZeneca-2020SF14182$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241074221$24107422$1$I$20210128$20210205$20240718$20240718$EXP$$CO-AstraZeneca-2021A044972$ASTRAZENECA$$15607$DY$$F$Y$48$KG$20240718$$CN$CO$
241074231$24107423$1$I$$20201005$20240718$20240718$EXP$$US-AstraZeneca-2020SF30086$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241074241$24107424$1$I$20190901$20191107$20240718$20240718$EXP$$RU-AstraZeneca-2019SF60619$ASTRAZENECA$$74$YR$$M$Y$92$KG$20240718$$CN$RU$
241074251$24107425$1$I$$20201023$20240718$20240718$EXP$$US-AstraZeneca-2020SF40622$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241074261$24107426$1$I$$20200831$20240718$20240718$EXP$$CA-AstraZeneca-2020SF11922$ASTRAZENECA$$62$YR$$F$Y$67$KG$20240718$$MD$CA$
241074271$24107427$1$I$20221209$20240709$20240718$20240718$EXP$$FR-CELLTRION INC.-2024FR016938$CELLTRION$$$$$$Y$$$20240718$$MD$FR$FR
241074281$24107428$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034131$AUROBINDO$Slaczka F, Slaczka M, Janjua E.. Refractory Crohn^s Disease Responsive to Dietary Therapy: A Case Report.. Cureus. 2024;16(5):e61262$58$YR$$M$Y$$$20240718$$MD$US$US
241074291$24107429$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113812$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240718$$CN$US$US
241074302$24107430$2$F$$20240802$20240718$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112952$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240806$$CN$US$US
241074311$24107431$1$I$$20240708$20240718$20240718$PER$$US-TEVA-VS-3220430$TEVA$$$$A$F$Y$$$20240718$$CN$US$US
241074321$24107432$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141690$AMGEN$$$$$$Y$$$20240717$$CN$US$US
241074331$24107433$1$I$$20240716$20240718$20240718$PER$$NVSC2024US147665$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
241074342$24107434$2$F$$20240726$20240718$20240806$EXP$$US-AUROBINDO-AUR-APL-2024-034712$AUROBINDO$Tuttle MC, Ciampa DJ, Godena E, Kim BK, Sakmar KA, Vanwort-Meng L, et al.. The Evaluation and Treatment of Somatic Symptom Disorder in Primary Care Practices. Prim-Care-Comp-CNSDisorders. 2024;26(1):23f03549$40$YR$$F$Y$$$20240806$$MD$US$US
241074352$24107435$2$F$$20240716$20240718$20240724$PER$$US-AMGEN-USASP2024141470$AMGEN$$$$$F$Y$$$20240724$$HP$US$US
241074361$24107436$1$I$20240604$20240711$20240718$20240718$EXP$$CN-ROCHE-10000024294$ROCHE$$71$YR$E$M$Y$54$KG$20240718$$HP$CN$CN
241074371$24107437$1$I$$20240708$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-034329$AUROBINDO$$$$$F$Y$$$20240718$$HP$GB$GB
241074381$24107438$1$I$$20240628$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06590$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241074391$24107439$1$I$$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002330J$MERCK$$72$YR$$M$Y$$$20240718$$MD$JP$JP
241074404$24107440$4$F$$20240808$20240718$20240814$EXP$$JP-009507513-2407JPN009815$MERCK$$77$YR$$F$Y$41.9$KG$20240814$$MD$JP$JP
241074411$24107441$1$I$20240601$20240715$20240718$20240718$PER$$US-ABBVIE-5841747$ABBVIE$$69$YR$$F$Y$$$20240718$$MD$US$US
241074422$24107442$2$F$20240701$20240829$20240718$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002959$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240923$$CN$US$US
241074432$24107443$2$F$$20240723$20240718$20240726$EXP$$US-JNJFOC-20240737780$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$CN$US$US
241074441$24107444$1$I$$20240709$20240718$20240718$EXP$$IE-ROCHE-3486088$ROCHE$$$$A$F$Y$$$20240718$$CN$IE$IE
241074452$24107445$2$F$$20240719$20240718$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002958$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241074462$24107446$2$F$$20240827$20240718$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002962$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
241074473$24107447$3$F$$20240828$20240718$20240905$PER$$US-JNJFOC-20240739755$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$HP$US$US
241074481$24107448$1$I$$20240701$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06514$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241074491$24107449$1$I$20190701$20240705$20240718$20240718$EXP$PL-URPL-2-977-2019$PL-THEA-2024001516$Thea Pharma$$$$$F$Y$$$20240718$$CN$PL$PL
241074501$24107450$1$I$$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002393J$MERCK$$40$YR$$M$Y$$$20240718$$MD$JP$JP
241074512$24107451$2$F$20240621$20240725$20240718$20240729$EXP$$CA-ROCHE-10000021320$ROCHE$$36$YR$A$M$Y$$$20240729$$CN$CA$CA
241074523$24107452$3$F$20240101$20240909$20240718$20240919$EXP$$US-AMGEN-USASL2024117350$AMGEN$$66$YR$E$F$Y$$$20240919$$CN$US$US
241074531$24107453$1$I$$20240708$20240718$20240718$30DAY$$US-GSK-US2024AMR085216$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$US$US
241074542$24107454$2$F$20240701$20240809$20240718$20240813$30DAY$$TR-JNJFOC-20240705004$JOHNSON AND JOHNSON$$25$YR$A$F$Y$83$KG$20240813$$PH$TR$TR
241074551$24107455$1$I$20240625$20240715$20240718$20240718$PER$$US-BIOVITRUM-2024-US-009918$BIOVITRUM$$77$YR$$F$Y$$$20240718$$CN$US$US
241074561$24107456$1$I$20190101$20200409$20240718$20240718$EXP$$US-AstraZeneca-2020SE24752$ASTRAZENECA$$61$YR$$F$Y$$$20240718$$CN$US$
241074571$24107457$1$I$$20200914$20240718$20240718$EXP$$US-AstraZeneca-2020SF19147$ASTRAZENECA$$80$YR$$F$Y$$$20240718$$CN$US$
241074581$24107458$1$I$$20240712$20240718$20240718$EXP$$PL-ROCHE-10000012765$ROCHE$Banaszkiewicz M, Okon K, Popiela T, Buziak-Bereza M, Krzanowski M, Krzanowska K. Post-transplant lymphoproliferative disorder after kidney transplantation with organ-specific disease.. Polish Archives of Internal Medicine. 2024-May-28;134 (5):1-3. doi:10.20452/pamw.16698.$64$YR$A$M$Y$$$20240718$$HP$PL$PL
241074591$24107459$1$I$$20201030$20240718$20240718$EXP$$US-AstraZeneca-2020SF43659$ASTRAZENECA$$$$$F$Y$90.7$KG$20240718$$CN$US$
241074601$24107460$1$I$20191101$20200125$20240718$20240718$EXP$$RU-AstraZeneca-2020SE13548$ASTRAZENECA$$71$YR$$F$Y$65$KG$20240718$$CN$RU$
241074611$24107461$1$I$$20201125$20240718$20240718$EXP$$US-AstraZeneca-2020SF58865$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241074621$24107462$1$I$$20201228$20240718$20240718$EXP$$TW-AstraZeneca-2020SF75300$ASTRAZENECA$$$$$$Y$$$20240718$$CN$TW$
241074631$24107463$1$I$20240609$20240716$20240718$20240718$EXP$$US-AstraZeneca-2024A162363$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241074641$24107464$1$I$$20201028$20240718$20240718$EXP$$US-AstraZeneca-2020SF42655$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241074651$24107465$1$I$$20200127$20240718$20240718$EXP$$US-AstraZeneca-2020SE15877$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241074661$24107466$1$I$$20210406$20240718$20240718$EXP$$US-AstraZeneca-2021A289272$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241074671$24107467$1$I$$20240320$20240718$20240718$PER$$US-GRUNENTHAL-2024-115821$AVERITAS$$71$YR$$M$Y$$$20240710$$HP$US$US
241074681$24107468$1$I$$20231212$20240718$20240718$PER$$US-GRUNENTHAL-2023-317717$AVERITAS$$$$A$M$Y$$$20240710$$CN$US$US
241074691$24107469$1$I$$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112335$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240718$$HP$US$US
241074701$24107470$1$I$20240610$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113910$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240718$$CN$US$US
241074711$24107471$1$I$$20240623$20240718$20240718$PER$$CA-TOLMAR, INC.-24CA050508$TOLMAR$$$$$M$Y$$$20240718$$CN$CA$CA
241074722$24107472$2$F$20240611$20240912$20240718$20240927$PER$$CA-TOLMAR, INC.-24CA050346$TOLMAR$$87$YR$$M$Y$$$20240927$$CN$CA$CA
241074732$24107473$2$F$20240517$20240722$20240718$20240819$PER$$TR-TOLMAR, INC.-24TR051002$TOLMAR$$75$YR$$M$Y$$$20240819$$HP$TR$TR
241074742$24107474$2$F$$20240727$20240718$20240805$PER$$US-ABBVIE-5840118$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241074751$24107475$1$I$$20231207$20240718$20240718$PER$$US-GRUNENTHAL-2023-317668$AVERITAS$$$$A$F$Y$$$20240710$$MD$US$US
241074761$24107476$1$I$20240601$20240717$20240718$20240718$EXP$FR-AFSSAPS-RN2024000723$FR-ROCHE-10000029535$ROCHE$$62$YR$A$M$Y$$$20240718$$PH$FR$FR
241074772$24107477$2$F$20240514$20240910$20240718$20240916$EXP$GB-MHRA-MED-202405141717428410-HSDBW$GB-ROCHE-10000029197$ROCHE$$6$YR$C$F$Y$23$KG$20240916$$MD$GB$GB
241074781$24107478$1$I$20240623$20240715$20240718$20240718$EXP$$CN-ROCHE-10000027605$ROCHE$$52$YR$A$F$Y$47.5$KG$20240718$$HP$CN$CN
241074792$24107479$2$F$$20240713$20240718$20240722$EXP$$JP-009507513-2407JPN002118J$MERCK$$$$$M$Y$$$20240722$$MD$JP$JP
241074801$24107480$1$I$20240219$20240708$20240718$20240718$EXP$FR-AFSSAPS-AN2024000874$FR-STERISCIENCE B.V.-2024-ST-001024$Steriscience PTE$$15$YR$$M$Y$38.1$KG$20240718$$MD$FR$FR
241074811$24107481$1$I$20220101$20240710$20240718$20240718$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00702$CATALYST PHARMA$$$$$M$Y$$$20240718$$CN$US$US
241074821$24107482$1$I$20240625$20240709$20240718$20240718$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00686$CATALYST PHARMA$$80$YR$$M$Y$64.853$KG$20240718$$CN$US$US
241074831$24107483$1$I$20240704$20240708$20240718$20240718$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00654$CATALYST PHARMA$$49$YR$$F$Y$58.957$KG$20240718$$CN$US$US
241074841$24107484$1$I$20240712$20240715$20240718$20240718$EXP$$CN-ROCHE-10000027297$ROCHE$$75$YR$E$F$Y$$$20240718$$HP$CN$CN
241074851$24107485$1$I$20231201$20231207$20240718$20240718$PER$$US-GRUNENTHAL-2023-317719$AVERITAS$$$$$F$Y$$$20240710$$MD$US$US
241074861$24107486$1$I$$20240226$20240718$20240718$PER$$US-GRUNENTHAL-2024-115681$AVERITAS$$$$A$F$Y$$$20240710$$HP$US$US
241074872$24107487$2$F$20240620$20240715$20240718$20240724$PER$$US-AMGEN-USASP2024140725$AMGEN$$43$YR$A$M$Y$$$20240724$$HP$US$US
241074881$24107488$1$I$20240601$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113791$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240718$$MD$US$US
241074891$24107489$1$I$$20240712$20240718$20240718$30DAY$$US-GSK-US2024087785$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241074901$24107490$1$I$20240201$20240711$20240718$20240718$EXP$$AR-GSK-AR2024AMR088362$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$AR$AR
241074911$24107491$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-10000029672$ROCHE$$59$YR$A$F$Y$$$20240718$$MD$US$US
241074921$24107492$1$I$$20240712$20240718$20240718$EXP$$GB-AMGEN-GBRSP2024138903$AMGEN$$$$$F$Y$$$20240717$$PH$GB$GB
241074932$24107493$2$F$20210901$20240828$20240718$20240906$EXP$$NL-TEVA-VS-3220873$TEVA$van der HeideDH, Bogers JPAM, Schulte PRFJ. Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma. Schizophr-Res 2024; 267 72-74.; van der HeideDH, Bogers JPAM, Schulte PRFJ. Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma. Schizophr-Res 2024; 267 72-74.$54$YR$$M$Y$$$20240906$$HP$NL$NL
241074942$24107494$2$F$20230101$20240821$20240718$20240826$EXP$$RO-ROCHE-3580232$ROCHE$$31$YR$A$F$Y$68.67$KG$20240826$$CN$RO$RO
241074951$24107495$1$I$20240702$20240716$20240718$20240718$EXP$$CN-ROCHE-10000028806$ROCHE$$63$YR$A$F$Y$50$KG$20240718$$HP$CN$CN
241074961$24107496$1$I$20240601$20240624$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002967$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240718$$CN$US$US
241074971$24107497$1$I$20240705$20240715$20240718$20240718$EXP$$CN-ROCHE-10000027361$ROCHE$$33$YR$A$F$Y$63$KG$20240718$$HP$CN$CN
241074981$24107498$1$I$20240221$20240222$20240718$20240718$PER$$US-GRUNENTHAL-2024-116392$AVERITAS$$68$YR$$F$Y$$$20240710$$MD$US$US
241074991$24107499$1$I$$20240711$20240718$20240718$EXP$$US-ABBVIE-5841192$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241075001$24107500$1$I$20240614$20240709$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-034377$AUROBINDO$$79$YR$$F$Y$$$20240718$$MD$FR$FR
241075011$24107501$1$I$$20210707$20240718$20240718$EXP$$GB-AstraZeneca-2021A608411$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$GB$
241075021$24107502$1$I$$20201130$20240718$20240718$EXP$$US-AstraZeneca-2020SF61132$ASTRAZENECA$$60$YR$$F$Y$$$20240718$$CN$US$
241075035$24107503$5$F$20240101$20240903$20240718$20240906$PER$$US-BIOGEN-2024BI01273414$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
241075041$24107504$1$I$20200901$20200923$20240718$20240718$EXP$$US-AstraZeneca-2020SF23854$ASTRAZENECA$$30144$DY$$F$Y$$$20240718$$MD$US$
241075051$24107505$1$I$20200210$20200219$20240718$20240718$EXP$$CA-AstraZeneca-2020SE27726$ASTRAZENECA$$11185$DY$$F$Y$$$20240718$$CN$CA$
241075061$24107506$1$I$20231001$20240715$20240718$20240718$EXP$DE-PEI-202400014851$DE-UCBSA-2024035723$UCB$$50$YR$$M$Y$107$KG$20240718$$CN$DE$DE
241075071$24107507$1$I$$20191125$20240718$20240718$EXP$$CA-AstraZeneca-2019SF70726$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$CA$
241075081$24107508$1$I$20201111$20201120$20240718$20240718$EXP$$US-AstraZeneca-2020SF56241$ASTRAZENECA$$3536$WK$$F$Y$$$20240718$$CN$US$
241075091$24107509$1$I$20210301$20210427$20240718$20240718$EXP$$US-AstraZeneca-2021A375658$ASTRAZENECA$$67$YR$$F$Y$$$20240718$$CN$US$
241075102$24107510$2$F$$20240715$20240718$20240725$PER$$US-AstraZeneca-2024A161538$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241075111$24107511$1$I$$20200504$20240718$20240718$EXP$$US-AstraZeneca-2020SE17960$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241075121$24107512$1$I$$20210426$20240718$20240718$EXP$$AU-AstraZeneca-2021A365121$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$AU$
241075131$24107513$1$I$20200119$20200227$20240718$20240718$EXP$$CO-AstraZeneca-2020SE31242$ASTRAZENECA$$14310$DY$$F$Y$$$20240718$$CN$CO$
241075141$24107514$1$I$$20231205$20240718$20240718$PER$$US-GRUNENTHAL-2023-317715$AVERITAS$$$$$M$Y$$$20240710$$MD$US$US
241075151$24107515$1$I$$20191202$20240718$20240718$EXP$$CA-AstraZeneca-2019SF73454$ASTRAZENECA$$58$YR$$M$Y$$$20240718$$MD$CA$
241075161$24107516$1$I$20240201$20240222$20240718$20240718$PER$$US-GRUNENTHAL-2024-116388$AVERITAS$$67$YR$$F$Y$$$20240710$$HP$US$US
241075171$24107517$1$I$20231108$20231213$20240718$20240718$PER$$US-GRUNENTHAL-2023-300593$AVERITAS$$81$YR$$M$Y$$$20240710$$HP$US$US
241075191$24107519$1$I$$20240708$20240718$20240718$EXP$$CN-NOVOPROD-1254826$NOVO NORDISK$$$$$M$Y$$$20240718$$CN$CN$CN
241075205$24107520$5$F$20221126$20240813$20240718$20240823$EXP$$BR-NOVOPROD-1254679$NOVO NORDISK$$43$YR$$F$Y$70$KG$20240823$$CN$BR$BR
241075211$24107521$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-001088525$CA-NOVOPROD-1255514$NOVO NORDISK$$75$YR$$M$Y$81$KG$20240718$$HP$CA$CA
241075221$24107522$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-E2B_07134273$CA-NOVOPROD-1254749$NOVO NORDISK$$9$YR$$M$Y$$$20240718$$HP$CA$CA
241075231$24107523$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-001093176$CA-NOVOPROD-1255341$NOVO NORDISK$$22$YR$$F$Y$83.4$KG$20240718$$PH$CA$CA
241075241$24107524$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-E2B_07127621$CA-NOVOPROD-1254727$NOVO NORDISK$$8$YR$$M$Y$$$20240718$$HP$CA$CA
241075251$24107525$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-001090344$CA-NOVOPROD-1255260$NOVO NORDISK$$49$YR$$M$Y$$$20240718$$HP$CA$CA
241075261$24107526$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-E2B_03916109$CA-NOVOPROD-1255448$NOVO NORDISK$$$$$F$Y$$$20240718$$CN$CA$CA
241075271$24107527$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-E2B_07160758$CA-NOVOPROD-1254682$NOVO NORDISK$$17$YR$$F$Y$$$20240718$$MD$CA$CA
241075281$24107528$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-001088360$CA-NOVOPROD-1255327$NOVO NORDISK$$51$YR$$F$Y$76$KG$20240718$$HP$CA$CA
241075291$24107529$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIGCA-HEALTHCANVIG-E2B_07138906$CA-NOVOPROD-1254678$NOVO NORDISK$$33$YR$$M$Y$$$20240718$$CN$CA$CA
241075301$24107530$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-001089465$CA-NOVOPROD-1255380$NOVO NORDISK$$59$YR$$M$Y$82.1$KG$20240718$$CN$CA$CA
241075311$24107531$1$I$$20240628$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06602$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241075321$24107532$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-E2B_07170281$CA-NOVOPROD-1254725$NOVO NORDISK$$14$YR$$M$Y$$$20240718$$MD$CA$CA
241075331$24107533$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-E2B_07150995$CA-NOVOPROD-1254728$NOVO NORDISK$$12$YR$$F$Y$$$20240718$$CN$CA$CA
241075342$24107534$2$F$$20240805$20240718$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113907$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240809$$HP$US$US
241075351$24107535$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-001086163$CA-NOVOPROD-1254650$NOVO NORDISK$$40$YR$$F$Y$90$KG$20240718$$CN$CA$CA
241075362$24107536$2$F$20240323$20240729$20240718$20240809$EXP$$US-NOVOPROD-1231903$NOVO NORDISK$$38$YR$$F$Y$81.7$KG$20240809$$MD$US$US
241075372$24107537$2$F$$20240830$20240718$20240910$30DAY$$DE-NOVOPROD-1255067$NOVO NORDISK$$792$MON$$F$Y$$$20240910$$PH$DE$DE
241075381$24107538$1$I$20231101$20240709$20240718$20240718$EXP$$US-NOVOPROD-1164422$NOVO NORDISK$$$$A$M$Y$$$20240718$$CN$US$US
241075391$24107539$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-001088137$CA-NOVOPROD-1255531$NOVO NORDISK$$37$YR$$M$Y$$$20240718$$CN$CA$CA
241075401$24107540$1$I$$20240716$20240718$20240718$EXP$$GB-ROCHE-10000028322$ROCHE$$$$$M$Y$$$20240718$$PH$GB$GB
241075411$24107541$1$I$$20240628$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06552$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241075421$24107542$1$I$$20240228$20240718$20240718$PER$$US-GRUNENTHAL-2024-116700$AVERITAS$$$$$F$Y$$$20240710$$MD$US$US
241075432$24107543$2$F$$20240715$20240718$20240722$PER$$US-AMGEN-USASP2024141450$AMGEN$$46$YR$A$F$Y$$$20240722$$HP$US$US
241075441$24107544$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113890$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240718$$HP$US$US
241075452$24107545$2$F$20240704$20240729$20240718$20240802$PER$$US-AMGEN-USASP2024139727$AMGEN$$59$YR$A$M$Y$$$20240802$$HP$US$US
241075472$24107547$2$F$$20240830$20240718$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06551$LUPIN$$$$$$Y$$$20240919$$CN$US$US
241075482$24107548$2$F$20230826$20240716$20240718$20240724$EXP$FR-AFSSAPS-TO2024001046$FR-EMD Serono-2024038061$EMD SERONO INC$$91$YR$E$F$Y$$$20240724$$PH$FR$FR
241075491$24107549$1$I$$20240711$20240718$20240718$EXP$$NVSC2024IL134383$NOVARTIS$$65$YR$$F$Y$$$20240718$$HP$IL$IL
241075501$24107550$1$I$$20240710$20240718$20240718$EXP$$CA-CELLTRION INC.-2024CA016875$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
241075511$24107551$1$I$20240601$20240712$20240718$20240718$EXP$$US-JNJFOC-20240736563$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240718$$CN$US$US
241075521$24107552$1$I$20240701$20240702$20240718$20240718$30DAY$$GB-JNJFOC-20240704683$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$CN$GB$GB
241075531$24107553$1$I$$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405121027032300-HPZVD$GB-MSNLABS-2024MSNSPO01561$MSN LABORATORIES$$$$$$Y$$$20240718$$CN$GB$GB
241075542$24107554$2$F$$20240708$20240718$20240723$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456907$RANBAXY$Aggarwal A, Kumari N, Garg S, Dhyani M. Valproate induced psoriasis: An anomalous relationship.. Indian J Psychiatry. 2024;66 (Suppl.):S222$53$YR$$M$Y$$$20240723$$MD$IN$IN
241075554$24107555$4$F$20240710$20240820$20240718$20240823$PER$$US-AMGEN-USASP2024141873$AMGEN$$81$YR$E$M$Y$$$20240823$$CN$US$US
241075561$24107556$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141574$AMGEN$$$$$$Y$$$20240717$$PH$US$US
241075571$24107557$1$I$20240401$20240709$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-034523$AUROBINDO$$75$YR$$F$Y$50$KG$20240718$$PH$FR$FR
241075582$24107558$2$F$20220301$20240717$20240718$20240722$EXP$SE-SEMPA-2024-005445$SE-ABBVIE-5843089$ABBVIE$$25$YR$$M$Y$77$KG$20240722$$CN$SE$SE
241075591$24107559$1$I$$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113916$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240718$$CN$US$US
241075601$24107560$1$I$$20240710$20240718$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113946$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$MD$JP$JP
241075611$24107561$1$I$20240125$20240709$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-034273$AUROBINDO$$4$YR$$M$Y$16$KG$20240718$$CN$GB$GB
241075622$24107562$2$F$$20240808$20240718$20240812$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113394$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$41.9$KG$20240812$$MD$JP$JP
241075631$24107563$1$I$20240712$20240715$20240718$20240718$EXP$$CN-ROCHE-10000027466$ROCHE$$69$YR$E$F$Y$60$KG$20240718$$HP$CN$CN
241075641$24107564$1$I$20240711$20240711$20240718$20240718$EXP$$US-JNJFOC-20240729897$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240718$$HP$US$US
241075651$24107565$1$I$$20240228$20240718$20240718$PER$$US-GRUNENTHAL-2024-116702$AVERITAS$$$$A$F$Y$$$20240710$$CN$US$US
241075662$24107566$2$F$$20240727$20240718$20240806$EXP$$US-GSK-US2024AMR085688$GLAXOSMITHKLINE$$$$$M$Y$$$20240806$$HP$US$US
241075671$24107567$1$I$$20240708$20240718$20240718$30DAY$$US-GSK-US2024084951$GLAXOSMITHKLINE$$$$$M$Y$$$20240718$$CN$US$US
241075681$24107568$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141490$AMGEN$$$$$$Y$$$20240717$$HP$US$US
241075692$24107569$2$F$$20240802$20240718$20240807$EXP$$JP-AMGEN-JPNSP2024136896$AMGEN$$$$$$Y$$$20240807$$CN$JP$JP
241075703$24107570$3$F$$20240925$20240718$20240930$EXP$$CZ-AMGEN-CZESP2024136449$AMGEN$Jat.; Demel.. First Thunder36 conference: Thrombocytopenia across disciplines. Medicine after graduation. 2024;2:132-5$34$YR$A$F$Y$$$20240930$$HP$CZ$CZ
241075711$24107571$1$I$$20240701$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06609$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241075721$24107572$1$I$$20240129$20240718$20240718$PER$$US-GRUNENTHAL-2024-114451$AVERITAS$$$$E$M$Y$$$20240710$$HP$US$US
241075731$24107573$1$I$20240206$20240202$20240718$20240718$PER$$US-GRUNENTHAL-2024-115206$AVERITAS$$71$YR$$M$Y$$$20240710$$CN$US$US
241075741$24107574$1$I$20231125$20240709$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-034436$AUROBINDO$$49$YR$$M$Y$$$20240718$$PH$FR$FR
241075751$24107575$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140881$AMGEN$$$$$M$Y$$$20240718$$CN$US$US
241075761$24107576$1$I$$20240208$20240718$20240718$PER$$US-GRUNENTHAL-2024-114886$AVERITAS$$$$A$F$Y$$$20240710$$HP$US$US
241075771$24107577$1$I$$20240703$20240718$20240718$EXP$$US-HETERO-HET2024US02335$HETERO$Akel MB, Condren ME, Passmore SJ.. Brexpiprazole toxicity in a paediatric patient. BMJ Case Reports. 2024;17:e258561$$$C$M$Y$24.5$KG$20240718$$HP$US$US
241075781$24107578$1$I$$20240712$20240718$20240718$PER$$US-AMGEN-USASP2024139459$AMGEN$$$$$M$Y$$$20240718$$CN$US$US
241075791$24107579$1$I$$20240708$20240718$20240718$EXP$$US-AMGEN-USASP2024135592$AMGEN$Kaffenberger B.; Yan A.; Gallardo M. et. al.. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management. Archives of Dermatological Research. 2024;316 (7):1-10$59$YR$A$M$Y$$$20240718$$HP$US$US
241075801$24107580$1$I$$20240701$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06596$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241075811$24107581$1$I$20240101$20240705$20240718$20240718$EXP$$JP-AMGEN-JPNSP2024141148$AMGEN$$86$YR$E$F$Y$$$20240718$$CN$JP$JP
241075821$24107582$1$I$20240705$20240715$20240718$20240718$EXP$$CN-ROCHE-10000027562$ROCHE$$54$YR$A$F$Y$65$KG$20240718$$HP$CN$CN
241075831$24107583$1$I$20240430$20240715$20240718$20240718$EXP$FR-AFSSAPS-TO2024001230$FR-SANDOZ INC.-SDZ2024FR065754$SANDOZ$$75$YR$$M$Y$$$20240718$$PH$FR$FR
241075851$24107585$1$I$$20200824$20240718$20240718$EXP$$US-AstraZeneca-2020SF08418$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241075861$24107586$1$I$20240601$20240710$20240718$20240718$EXP$$CO-AMGEN-COLSL2024128584$AMGEN$$65$YR$E$F$Y$$$20240718$$CN$CO$CO
241075871$24107587$1$I$20200324$20200324$20240718$20240718$EXP$$US-AstraZeneca-2020SE34761$ASTRAZENECA$$21355$DY$$M$Y$81.6$KG$20240718$$HP$US$
241075881$24107588$1$I$20230501$20230615$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00681$TARO$$$$$$Y$$$20240718$$CN$US$US
241075891$24107589$1$I$$20200210$20240718$20240718$EXP$$CA-AstraZeneca-2020SE22388$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$CA$
241075901$24107590$1$I$$20201223$20240718$20240718$EXP$$BR-AstraZeneca-2020SF73405$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$BR$
241075911$24107591$1$I$$20201012$20240718$20240718$EXP$$US-AstraZeneca-2020SF33824$ASTRAZENECA$$$$$M$Y$$$20240718$$HP$US$
241075921$24107592$1$I$$20240711$20240718$20240718$EXP$$BE-ROCHE-10000024066$ROCHE$Meganck S, Raevens S, Ferdinande K, Verhelst X, Hoorens A, Degroote H, et al. Recurrent rejections after liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient. Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine Taylor and Francis Ltd. 2024;1-8. doi:10.1080/17843286.2024.2376304.$32$YR$A$F$Y$$$20240718$$HP$BE$BE
241075931$24107593$1$I$$20200312$20240718$20240718$EXP$$US-AstraZeneca-2020SE38772$ASTRAZENECA$$57$YR$$F$Y$$$20240718$$CN$US$
241075941$24107594$1$I$20240601$20240715$20240718$20240718$PER$$US-AstraZeneca-2024A161475$ASTRAZENECA$$23654$DY$$F$Y$$$20240718$$CN$US$
241075961$24107596$1$I$$20240710$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110691$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240718$$CN$US$US
241075971$24107597$1$I$$20210308$20240718$20240718$EXP$$US-AstraZeneca-2021A127999$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241075981$24107598$1$I$$20201006$20240718$20240718$EXP$$RU-AstraZeneca-2020SF30634$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$RU$
241075991$24107599$1$I$20200201$20200206$20240718$20240718$EXP$$US-AstraZeneca-2020SE20317$ASTRAZENECA$$912$MON$$F$Y$$$20240718$$CN$US$
241076001$24107600$1$I$$20210316$20240718$20240718$EXP$$US-AstraZeneca-2021A164669$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241076021$24107602$1$I$$20191204$20240718$20240718$EXP$$US-AstraZeneca-2019SF75640$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241076031$24107603$1$I$$20240717$20240718$20240718$EXP$$NVSC2024ES147450$NOVARTIS$$$$$M$Y$$$20240718$$HP$ES$ES
241076041$24107604$1$I$$20240710$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110071$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240718$$CN$US$US
241076051$24107605$1$I$20240201$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113753$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240718$$CN$US$US
241076061$24107606$1$I$$20240708$20240718$20240718$EXP$$GB-TEVA-VS-3220889$TEVA$Bulley SJ, Santarsieri A, Lentell IC, O^Sullivan B, Hodson A, Firth O, et al. Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study. EJHaem 2022; 3 (4): 1316-1320.; Bulley SJ, Santarsieri A, Lentell IC, O^Sullivan B, Hodson A, Firth O, et al. Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study. EJHaem 2022; 3 (4): 1316-1320.$$$$$Y$$$20240718$$HP$GB$GB
241076071$24107607$1$I$$20240709$20240718$20240718$EXP$US-MLMSERVICE-20240702-PI120109-00306-1$US-RDY-SPO/USA/24/0010244$DR REDDYS$Dilibe A, Subramanian L, Poyser TA, Oriaifo O, Brady R, Srikanth S, et al. Tacrolimus-induced posterior reversible encephalopathy syndrome following liver transplantation. World journal of transplantation. 2024;14(2):91146. DOI: 10.5500/wjt.v14.i2.91146.$66$YR$E$M$Y$$$20240718$$MD$US$US
241076081$24107608$1$I$20240701$20240710$20240718$20240718$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004849$SAREPTA THERAPEUTICS$$12$YR$$M$Y$$$20240718$$HP$US$US
241076092$24107609$2$F$$20240917$20240718$20240918$EXP$$CH-JNJFOC-20240638135$JOHNSON AND JOHNSON$$$$A$$Y$$$20240918$$MD$CH$CH
241076101$24107610$1$I$$20240624$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002953$ACADIA PHARMACEUTICALS$$$$$M$Y$74.83$KG$20240718$$CN$US$US
241076111$24107611$1$I$20210203$20210402$20240718$20240718$EXP$$US-AstraZeneca-2021A272223$ASTRAZENECA$$16831$DY$$M$Y$$$20240718$$CN$US$
241076121$24107612$1$I$$20210322$20240718$20240718$EXP$$US-AstraZeneca-2021A210739$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241076132$24107613$2$F$20240710$20240902$20240718$20240905$PER$$US-AstraZeneca-2024A159317$ASTRAZENECA$$17946$DY$$F$Y$$$20240905$$CN$US$
241076141$24107614$1$I$20210320$20210322$20240718$20240718$EXP$$US-AstraZeneca-2021A201705$ASTRAZENECA$$21614$DY$$F$Y$$$20240718$$CN$US$
241076151$24107615$1$I$$20230530$20240718$20240718$EXP$$US-AstraZeneca-2023A126132$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241076161$24107616$1$I$$20230118$20240718$20240718$EXP$$US-AstraZeneca-2023A015359$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241076171$24107617$1$I$$20230329$20240718$20240718$EXP$$US-AstraZeneca-2023A076139$ASTRAZENECA$$$$$$Y$$$20240718$$CN$US$
241076181$24107618$1$I$$20240623$20240718$20240718$EXP$$AU-ROCHE-10000029037$ROCHE$$56$YR$A$M$Y$$$20240718$$MD$AU$AU
241076191$24107619$1$I$$20200325$20240718$20240718$EXP$$CA-AstraZeneca-2020SE43818$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$CA$
241076201$24107620$1$I$$20240624$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002954$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241076211$24107621$1$I$$20191218$20240718$20240718$EXP$$US-AstraZeneca-2019SF86291$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241076222$24107622$2$F$20240101$20240709$20240718$20240802$EXP$$CA-CELLTRION INC.-2024CA002187$CELLTRION$$$$$$Y$$$20240802$$HP$CA$CA
241076231$24107623$1$I$$20240715$20240718$20240718$PER$$US-JNJFOC-20240739547$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$US$US
241076242$24107624$2$F$20240401$20240719$20240718$20240729$30DAY$$US-GSK-US2024084440$GLAXOSMITHKLINE$$58$YR$$M$Y$$$20240729$$CN$US$US
241076251$24107625$1$I$$20240717$20240718$20240718$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040429$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$CN$US$US
241076261$24107626$1$I$20240604$20240710$20240718$20240718$EXP$FR-AFSSAPS-AN2024000838$FR-RDY-SPO/FRA/24/0010241$DR REDDYS$$81$YR$E$M$Y$57$KG$20240718$$PH$FR$FR
241076271$24107627$1$I$20230126$20240709$20240718$20240718$EXP$$IT-CELLTRION INC.-2024IT017026$CELLTRION$$$$$$Y$$$20240718$$MD$IT$IT
241076281$24107628$1$I$$20240202$20240718$20240718$PER$$US-GRUNENTHAL-2024-115241$AVERITAS$$8$DEC$$F$Y$$$20240710$$HP$US$US
241076291$24107629$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187645$Haleon PLC$$80$YR$$$Y$$$20240718$$CN$US$US
241076302$24107630$2$F$$20240717$20240718$20240724$PER$US-MLMSERVICE-20240703-PI117503-00120-1$US-RDY-SPO/USA/24/0010254$DR REDDYS$Nguyen C, Stanek JL. Sternomanubrial joint pain secondary to ulcerative colitis treated with ultrasound-guided injection. PM and R. 2024;16(6):650-2. DOI: 10.1002/pmrj.13031.$31$YR$A$M$Y$$$20240724$$MD$US$US
241076312$24107631$2$F$$20240916$20240718$20240917$EXP$$FI-JNJFOC-20240610401$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240917$$PH$FI$FI
241076321$24107632$1$I$20240328$20240716$20240718$20240718$EXP$FR-AFSSAPS-BS2024000421$FR-JNJFOC-20240743802$JOHNSON AND JOHNSON$$75$YR$E$M$Y$85$KG$20240718$$MD$FR$FR
241076331$24107633$1$I$$20240714$20240718$20240718$PER$$US-AMGEN-USASP2024140542$AMGEN$$$$$$Y$$$20240718$$PH$US$US
241076341$24107634$1$I$20240701$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010526$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240718$$CN$US$US
241076351$24107635$1$I$20220101$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034070$AUROBINDO$Xu E, Thomas S, Habibi B.. Intrathecal Methotrexate-Induced Lumbosacral Polyradiculopathy: A Case Report. Pain Medicine Case Reports. 2024;8(1):31-5$69$YR$$F$Y$$$20240718$$MD$US$US
241076361$24107636$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009562$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240718$$CN$US$US
241076371$24107637$1$I$20240702$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010740$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240718$$CN$US$US
241076381$24107638$1$I$20240715$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009905$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240718$$CN$US$US
241076391$24107639$1$I$20240714$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010486$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240718$$CN$US$US
241076401$24107640$1$I$$20240704$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407005880$ELI LILLY AND CO$$$$E$F$Y$$$20240718$$CN$US$US
241076411$24107641$1$I$20220101$20240712$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407008779$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240718$$CN$US$US
241076421$24107642$1$I$$20240716$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US065989$SANDOZ$$$$$F$Y$$$20240718$$CN$US$US
241076441$24107644$1$I$$20240715$20240718$20240718$PER$$US-BIOGEN-2024BI01273202$BIOGEN$$$$$F$Y$$$20240718$$CN$US$US
241076451$24107645$1$I$20240611$20240711$20240718$20240718$PER$$US-BIOGEN-2024BI01271585$BIOGEN$$57$YR$$F$Y$$$20240718$$CN$US$US
241076461$24107646$1$I$20240101$20240711$20240718$20240718$PER$$US-BIOGEN-2024BI01273410$BIOGEN$$$$$F$Y$$$20240718$$CN$US$US
241076471$24107647$1$I$20240701$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113861$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$74.84$KG$20240718$$PH$US$US
241076481$24107648$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113769$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$80.74$KG$20240718$$CN$US$US
241076491$24107649$1$I$$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113463$BRISTOL MYERS SQUIBB$$29$YR$A$M$Y$$$20240718$$CN$US$US
241076501$24107650$1$I$$20240710$20240718$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113381$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$MD$JP$JP
241076511$24107651$1$I$$20240711$20240718$20240718$EXP$$NVSC2024US144264$NOVARTIS$$$$$F$Y$$$20240718$$CN$US$US
241076522$24107652$2$F$20240704$20240719$20240718$20240729$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004839$SAREPTA THERAPEUTICS$$24$YR$$M$Y$28.902$KG$20240729$$HP$US$US
241076531$24107653$1$I$$20240715$20240718$20240718$EXP$$GB-GSK-GB2024EME089257$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$GB$GB
241076541$24107654$1$I$$20240708$20240718$20240718$30DAY$$US-GSK-US2024084984$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241076551$24107655$1$I$$20201007$20240718$20240718$EXP$$US-AstraZeneca-2020SF30737$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241076561$24107656$1$I$$20200217$20240718$20240718$EXP$$US-AstraZeneca-2020SE24872$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241076571$24107657$1$I$$20200624$20240718$20240718$EXP$$US-AstraZeneca-2020SE81463$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241076581$24107658$1$I$20240328$20240716$20240718$20240718$EXP$FR-AFSSAPS-BS2024000421$FR-GSK-FR2024089373$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$FR$FR
241076591$24107659$1$I$$20210325$20240718$20240718$EXP$$US-AstraZeneca-2021A229079$ASTRAZENECA$$$$$F$Y$$$20240718$$HP$US$
241076601$24107660$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158271$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241076611$24107661$1$I$$20200326$20240718$20240718$EXP$$US-AstraZeneca-2020SE25218$ASTRAZENECA$$76$YR$$F$Y$$$20240718$$MD$US$
241076621$24107662$1$I$20191223$20191224$20240718$20240718$EXP$$TW-AstraZeneca-2019SF88243$ASTRAZENECA$$72$YR$$F$Y$$$20240718$$CN$TW$
241076631$24107663$1$I$$20240708$20240718$20240718$EXP$$IT-AUROBINDO-AUR-APL-2024-035368$AUROBINDO$Spacca B, Di Maurizio M, Grandoni M, Tempesti S, Genitori L.. Laser interstitial thermal therapy (LITT) for pediatric patients affected by intracranial tumors.. Frontiers in Neurology. 2023;1-11$11$YR$$F$Y$$$20240718$$HP$IT$IT
241076641$24107664$1$I$20240619$20240705$20240718$20240718$EXP$$CN-BEH-2024175319$CSL BEHRING$$46$YR$A$M$Y$70$KG$20240718$$HP$CN$CN
241076651$24107665$1$I$20240715$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140152$AMGEN$$68$YR$E$F$Y$$$20240718$$CN$US$US
241076661$24107666$1$I$20230201$20240709$20240718$20240718$EXP$$DE-AUROBINDO-AUR-APL-2024-034493$AUROBINDO$$64$YR$$F$Y$80$KG$20240718$$MD$DE$DE
241076671$24107667$1$I$$20240619$20240718$20240718$PER$$US-009507513-2406USA008326$MERCK$Bickenbach E, Pan J, King M. Emtricitabine/tenofovir alafenamide and doravirine in a virologically suppressed adult with HIV and on chronic ambulatory peritoneal dialysis: A case report. International Journal of STD and AIDS. 2024;0 (0):1-3$44$YR$$F$Y$$$20240718$$HP$US$US
241076681$24107668$1$I$20240518$20240710$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-034632$AUROBINDO$$68$YR$$M$Y$103$KG$20240718$$PH$FR$FR
241076691$24107669$1$I$20240116$20240710$20240718$20240718$EXP$$ES-AUROBINDO-AUR-APL-2024-034612$AUROBINDO$$50$YR$$M$Y$$$20240718$$MD$ES$ES
241076701$24107670$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034670$AUROBINDO$Laughter MR, Tegla CA, Pawar S, Moshiri AS, Orlow SJ. Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C. JAAD-Case-Rep. 2024;4928:31$37$YR$$M$Y$$$20240718$$MD$US$US
241076711$24107671$1$I$$20240201$20240718$20240718$PER$$US-GRUNENTHAL-2024-115162$AVERITAS$$$$$F$Y$$$20240710$$HP$US$US
241076721$24107672$1$I$$20231201$20240718$20240718$PER$$US-GRUNENTHAL-2023-312292$AVERITAS$$$$E$F$Y$$$20240710$$HP$US$US
241076731$24107673$1$I$$20231211$20240718$20240718$PER$$US-GRUNENTHAL-2023-317640$AVERITAS$$$$$F$Y$$$20240710$$MD$US$US
241076742$24107674$2$F$20240717$20240807$20240718$20240812$EXP$$CA-JNJFOC-20240735729$JOHNSON AND JOHNSON$$14$YR$T$F$Y$47$KG$20240812$$HP$CA$CA
241076751$24107675$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141840$AMGEN$$$$$$Y$$$20240718$$PH$US$US
241076761$24107676$1$I$$20240711$20240718$20240718$EXP$$NL-AUROBINDO-AUR-APL-2024-035391$AUROBINDO$$55$YR$$M$Y$96$KG$20240718$$MD$NL$NL
241076771$24107677$1$I$20220101$20240709$20240718$20240718$EXP$$US-ROCHE-10000021872$ROCHE$$68$YR$E$F$Y$61.68$KG$20240718$$CN$US$US
241076781$24107678$1$I$20240601$20240711$20240718$20240718$PER$$US-ROCHE-3576482$ROCHE$$53$YR$A$F$Y$77.11$KG$20240718$$CN$US$US
241076802$24107680$2$F$20240709$20240729$20240718$20240807$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-021738$UNITED THERAPEUTICS$$67$YR$$F$Y$$$20240807$$$JP$JP
241076811$24107681$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113379$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240718$$HP$US$US
241076821$24107682$1$I$$20240710$20240718$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113156$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$MD$JP$JP
241076831$24107683$1$I$$20240712$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111857$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240718$$CN$US$US
241076841$24107684$1$I$20240701$20240715$20240718$20240718$EXP$$US-ABBVIE-5841540$ABBVIE$$35$YR$$F$Y$$$20240718$$CN$US$US
241076851$24107685$1$I$$20240710$20240718$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113392$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$MD$JP$JP
241076861$24107686$1$I$$20240712$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112208$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$HP$US$US
241076872$24107687$2$F$$20240718$20240718$20240726$30DAY$$US-UCBSA-2024032960$UCB$$$$$F$Y$$$20240726$$CN$US$US
241076881$24107688$1$I$$20240621$20240718$20240718$30DAY$$DE-UCBSA-2024030994$UCB$$$$$F$Y$$$20240718$$MD$DE$DE
241076893$24107689$3$F$20240301$20240806$20240718$20240816$EXP$$CA-UCBSA-2024014394$UCB$$39$YR$$F$Y$$$20240816$$CN$CA$CA
241076901$24107690$1$I$20240125$20240214$20240718$20240718$PER$$US-GRUNENTHAL-2024-114914$AVERITAS$$82$YR$$F$Y$$$20240710$$MD$US$US
241076911$24107691$1$I$$20240708$20240718$20240718$EXP$$AR-SANDOZ INC.-NVSC2023AR145387$SANDOZ$Leonardi N, Gilligan G, Piemonte E, Panico R. Therapeutic alternatives of medication-related osteonecrosis of the jaw (MRONJ): reports of two clinical cases and review of the literature. JOURNAL OF THE FACULTY OF MEDICAL SCIENCES OF CORDOBA. 2022;79(4):379-82$72$YR$$F$Y$$$20240718$$MD$AR$AR
241076922$24107692$2$F$20240708$20240816$20240718$20240826$30DAY$$US-GSK-US2024084987$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
241076931$24107693$1$I$$20240710$20240718$20240718$PER$$US-ABBVIE-5838843$ABBVIE$$$$$M$Y$$$20240718$$HP$US$US
241076942$24107694$2$F$$20240815$20240718$20240822$30DAY$$US-SANDOZ INC.-SDZ2024US065921$SANDOZ$$$$$F$Y$$$20240822$$CN$US$US
241076952$24107695$2$F$$20240801$20240718$20240810$EXP$$US-TEVA-VS-3220187$TEVA$Natarajan S, Amjad M, Zaidi S, Shah A, Ochieng PO. Persistent Bilateral Spontaneous Pneumothorax in Combined Pulmonary Fibrosis and Emphysema. Am-J-Respir-Crit-Care-Med 2023; 207 (plus Poster).; Natarajan S, Amjad M, Zaidi S, Shah A, Ochieng PO. Persistent Bilateral Spontaneous Pneumothorax in Combined Pulmonary Fibrosis and Emphysema. Am-J-Respir-Crit-Care-Med 2023; 207 (plus Poster).$72$YR$$M$Y$$$20240810$$HP$US$US
241076962$24107696$2$F$20240622$20240717$20240718$20240729$EXP$$US-ROCHE-10000012701$ROCHE$$85$YR$E$F$Y$$$20240729$$CN$US$US
241076972$24107697$2$F$20240627$20240709$20240718$20240719$EXP$$US-TEVA-VS-3218787$TEVA$$86$YR$$F$Y$$$20240719$$PH$US$US
241076981$24107698$1$I$20240714$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141070$AMGEN$$85$YR$E$M$Y$$$20240718$$CN$US$US
241076991$24107699$1$I$$20240712$20240718$20240718$EXP$$CA-APOTEX-2024AP008314$APOTEX$$44$YR$$M$Y$$$20240718$$PH$CA$CA
241077001$24107700$1$I$$20200403$20240718$20240718$EXP$$US-AstraZeneca-2020SE48020$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241077011$24107701$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A160669$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241077021$24107702$1$I$$20200513$20240718$20240718$EXP$$US-AstraZeneca-2020SE64097$ASTRAZENECA$$$$$F$Y$$$20240718$$HP$US$
241077031$24107703$1$I$$20201008$20240718$20240718$EXP$$US-AstraZeneca-2020SF32332$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241077041$24107704$1$I$20240702$20240708$20240718$20240718$EXP$$SE-VANTIVE-2024VAN018124$Vantive US Healthcare$$72$YR$$F$Y$66.8$KG$20240718$$HP$SE$SE
241077051$24107705$1$I$$20191227$20240718$20240718$EXP$$RU-AstraZeneca-2019SF91372$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$RU$
241077061$24107706$1$I$$20200513$20240718$20240718$EXP$$US-AstraZeneca-2020SE64188$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241077071$24107707$1$I$20191101$20191203$20240718$20240718$EXP$$CO-AstraZeneca-2019SF75790$ASTRAZENECA$$23309$DY$$F$Y$$$20240718$$CN$CO$
241077081$24107708$1$I$$20200302$20240718$20240718$EXP$$US-AstraZeneca-2020SE01142$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241077091$24107709$1$I$$20200511$20240718$20240718$EXP$$US-AstraZeneca-2020SE64235$ASTRAZENECA$$70$YR$$F$Y$$$20240718$$CN$US$
241077101$24107710$1$I$$20240709$20240718$20240718$PER$$US-AstraZeneca-2024A157558$ASTRAZENECA$$$$$$Y$$$20240718$$CN$US$
241077111$24107711$1$I$$20240711$20240718$20240718$EXP$$TR-ROCHE-10000024398$ROCHE$Maflallah B, Ozgenc F, Berk O, Gokce D, Kavakli K, Yilmaz F, et al. Giant cell hepatitis and autoimmune hemolytic anemia after chickenpox. Turk J Gastroenterol. 2010;21 (4):448-51. doi:10.4318/tjg.2010.0135.$$$$F$Y$$$20240718$$HP$TR$TR
241077121$24107712$1$I$$20210201$20240718$20240718$EXP$$GB-AstraZeneca-2021A032450$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$GB$
241077131$24107713$1$I$20200923$20210315$20240718$20240718$EXP$$CA-AstraZeneca-2020SF57901$ASTRAZENECA$$18019$DY$$F$Y$$$20240718$$CN$CA$
241077141$24107714$1$I$$20191204$20240718$20240718$EXP$$US-AstraZeneca-2019SF76726$ASTRAZENECA$$$$$$Y$$$20240718$$CN$US$
241077153$24107715$3$F$20240628$20240822$20240718$20240904$PER$$US-AstraZeneca-2024A156272$ASTRAZENECA$$27537$DY$$M$Y$$$20240904$$CN$US$
241077161$24107716$1$I$$20240716$20240718$20240718$EXP$NL-LRB-00985993$NL-ORGANON-O2407NLD001403$ORGANON$$63$YR$$F$Y$66$KG$20240718$$CN$NL$NL
241077171$24107717$1$I$$20200514$20240718$20240718$EXP$$US-AstraZeneca-2020SE64801$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241077181$24107718$1$I$$20200109$20240718$20240718$EXP$$US-AstraZeneca-2020SE05689$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241077191$24107719$1$I$20191106$20200514$20240718$20240718$EXP$$CO-AstraZeneca-2020SE64220$ASTRAZENECA$$22128$DY$$F$Y$$$20240718$$CN$CO$
241077203$24107720$3$F$$20240906$20240718$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003370$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
241077211$24107721$1$I$$20201016$20240718$20240718$EXP$$AU-AstraZeneca-2020SF37404$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$AU$
241077221$24107722$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113387$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240718$$HP$US$US
241077231$24107723$1$I$20240609$20240704$20240718$20240718$EXP$$CN-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000168-2024$QILU PHARMACEUTICAL$$61$YR$A$M$Y$53$KG$20240718$$HP$CN$CN
241077241$24107724$1$I$20230809$20231115$20240718$20240718$EXP$$US-KHC-000029$Kilitch Healthcare$$59$YR$A$F$Y$$$20240718$$CN$US$US
241077251$24107725$1$I$20230901$20240209$20240718$20240718$EXP$$US-KHC-000030$Kilitch Healthcare$$59$YR$A$F$Y$$$20240718$$CN$US$US
241077261$24107726$1$I$20230701$20240112$20240718$20240718$EXP$$US-KHC-000028$Kilitch Healthcare$$60$YR$A$M$Y$$$20240718$$CN$US$US
241077271$24107727$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141276$AMGEN$$$$$F$Y$$$20240718$$HP$US$US
241077282$24107728$2$F$$20240820$20240718$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA065598$SANDOZ$$63$YR$$F$Y$$$20240823$$CN$CA$CA
241077292$24107729$2$F$20240603$20240722$20240718$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002972$ACADIA PHARMACEUTICALS$$88$YR$$M$Y$$$20240814$$CN$US$US
241077301$24107730$1$I$$20240708$20240718$20240718$30DAY$$US-GSK-US2024084950$GLAXOSMITHKLINE$$$$$M$Y$$$20240718$$CN$US$US
241077311$24107731$1$I$$20240708$20240718$20240718$EXP$$US-GSK-US2024084456$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241077321$24107732$1$I$$20240716$20240718$20240718$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-113253$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240718$$HP$CA$CA
241077331$24107733$1$I$$20240710$20240718$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113131$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$MD$JP$JP
241077341$24107734$1$I$$20240715$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113595$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240718$$CN$US$US
241077353$24107735$3$F$$20240730$20240718$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108547$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240801$$CN$US$US
241077362$24107736$2$F$20230101$20240723$20240718$20240726$EXP$$EG-SANDOZ INC.-SDZ2024EG064562$SANDOZ$$$$$M$Y$$$20240726$$CN$EG$EG
241077372$24107737$2$F$$20240710$20240718$20240819$PER$$US-ROCHE-10000023335$ROCHE$$$$E$F$Y$$$20240819$$CN$US$US
241077382$24107738$2$F$20231215$20240812$20240718$20240813$EXP$$MX-ROCHE-10000028292$ROCHE$$53$YR$A$M$Y$84$KG$20240813$$CN$MX$MX
241077393$24107739$3$F$20240601$20240729$20240718$20240731$EXP$$CA-UCBSA-2024032124$UCB$$54$YR$$F$Y$$$20240731$$CN$CA$CA
241077401$24107740$1$I$$20240716$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US066051$SANDOZ$$$$$$Y$$$20240718$$HP$US$US
241077421$24107742$1$I$$20240710$20240718$20240718$PER$$US-ROCHE-10000023310$ROCHE$$$$$$Y$$$20240718$$CN$US$US
241077431$24107743$1$I$$20240621$20240718$20240718$PER$$US-JNJFOC-20240662545$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
241077441$24107744$1$I$$20240711$20240718$20240718$EXP$$CN-ROCHE-10000027855$ROCHE$Xu J, Ding Y, Qu Z, Yu F. Differences in risk of serious infections between patients with secondary versus primary nephropathy following rituximab treatment: a retrospective cohort study. Frontiers in immunology. 2024-Jun-11;15:1-12. doi:10.3389/fimmu.2024.1390997.$32$YR$A$F$Y$$$20240718$$HP$CN$CN
241077452$24107745$2$F$20240708$20240712$20240718$20240725$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-21352$SAMSUNG BIOEPIS$$66$YR$$F$Y$$$20240725$$HP$CA$CA
241077471$24107747$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141286$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
241077481$24107748$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140187$AMGEN$$$$$M$Y$$$20240718$$CN$US$US
241077491$24107749$1$I$$20240621$20240718$20240718$30DAY$$DE-UCBSA-2024032058$UCB$$61$YR$$M$Y$$$20240718$$CN$DE$DE
241077521$24107752$1$I$$20240710$20240718$20240718$EXP$$US-SA-2024SA207704$SANOFI AVENTIS$$$$A$M$Y$68.94$KG$20240718$$MD$US$US
241077531$24107753$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187549$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241077541$24107754$1$I$$20240710$20240718$20240718$EXP$$US-SA-2024SA208949$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240718$$MD$US$US
241077551$24107755$1$I$$20240709$20240718$20240718$EXP$$US-APOTEX-2024AP008246$APOTEX$Raza HS, Love JS, Mikolajczyk AE. Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding. ACG Case Reports Journal. 2024;11 (6): e01378:1-3$38$YR$$M$Y$$$20240718$$MD$US$US
241077561$24107756$1$I$20200110$20200511$20240718$20240718$EXP$$CO-AstraZeneca-2020SE64847$ASTRAZENECA$$24172$DY$$F$Y$$$20240718$$CN$CO$
241077572$24107757$2$F$$20240821$20240718$20240905$PER$$US-AstraZeneca-2024A161609$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
241077581$24107758$1$I$$20200303$20240718$20240718$EXP$$MX-AstraZeneca-2020SE33450$ASTRAZENECA$$50$YR$$F$Y$55$KG$20240718$$CN$MX$
241077591$24107759$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158581$ASTRAZENECA$$$$$M$Y$$$20240718$$MD$US$
241077601$24107760$1$I$$20200511$20240718$20240718$EXP$$US-AstraZeneca-2020SE64988$ASTRAZENECA$$55$YR$$F$Y$$$20240718$$CN$US$
241077611$24107761$1$I$$20200803$20240718$20240718$EXP$$US-AstraZeneca-2020SE97950$ASTRAZENECA$$$$$F$Y$41$KG$20240718$$CN$US$
241077621$24107762$1$I$20200101$20201030$20240718$20240718$EXP$$US-AstraZeneca-2020SF44282$ASTRAZENECA$$59$YR$$F$Y$99.8$KG$20240718$$CN$US$
241077631$24107763$1$I$20240515$20240712$20240718$20240718$PER$$US-AstraZeneca-2024A114722$ASTRAZENECA$$21545$DY$$M$Y$$$20240718$$CN$US$
241077641$24107764$1$I$20200420$20200515$20240718$20240718$EXP$$US-AstraZeneca-2020SE65509$ASTRAZENECA$$31693$DY$$M$Y$$$20240718$$CN$US$
241077651$24107765$1$I$$20240712$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112573$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$PH$US$US
241077661$24107766$1$I$20240601$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112383$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240718$$HP$US$US
241077671$24107767$1$I$20240330$20240716$20240718$20240718$EXP$FR-AFSSAPS-PP2024000782$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-113739$BRISTOL MYERS SQUIBB$$68$YR$A$F$Y$66.5$KG$20240718$$MD$FR$FR
241077681$24107768$1$I$$20240712$20240718$20240718$PER$$US-ROCHE-10000025634$ROCHE$$$$$$Y$$$20240718$$PH$US$US
241077691$24107769$1$I$$20240712$20240718$20240718$EXP$$US-ROCHE-10000025805$ROCHE$$$$E$M$Y$$$20240718$$CN$US$US
241077701$24107770$1$I$20231220$20240711$20240718$20240718$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039372$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240718$$CN$US$US
241077711$24107771$1$I$$20240709$20240718$20240718$EXP$US-MLMSERVICE-20240703-PI119363-00175-1$US-RDY-SPO/USA/24/0010245$DR REDDYS$Weigle DP, Nielsen A, Braunecker S. Uncommon and Unfavorable: Heparin-Induced Hyperkalemia. Journal of cardiothoracic and vascular anesthesia. 2024;1-4. DOI:10.1053/j.jvca.2024.04.045.$56$YR$A$M$Y$$$20240718$$MD$US$US
241077721$24107772$1$I$$20240708$20240718$20240718$EXP$IN-MLMSERVICE-20240701-PI118521-00285-1$IN-JUBILANT CADISTA PHARMACEUTICALS-2024IN000970$JUBILANT$Ike IM, Jayaprakashan K, Raju R.. A case of Risperidone monotherapy causing serotonin syndrome in one of the monozygotic twins. . Indian Journal of Psychiatry.. 2024;66(Supplement 1:S52-3.$15$YR$$M$Y$$$20240718$$MD$IN$IN
241077731$24107773$1$I$$20240708$20240718$20240718$EXP$IN-MLMSERVICE-20240701-PI117712-00153-1$IN-JUBILANT CADISTA PHARMACEUTICALS-2024IN000967$JUBILANT$Dhobale M, Sarangi S, Yadav A. Khanande R. Hyperkinetic conduct disorder as a risk factor for switch from unipolar to bipolar disorder.. Indian Journal of Psychiatry.. 2024;66(Supple 1)$18$YR$$M$Y$$$20240718$$MD$IN$IN
241077741$24107774$1$I$$20240708$20240718$20240718$EXP$$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP001025$JUBILANT$Ide N, Hosoya Y, Yamamoto M, Shigeno A, Obayashi M, Asada K, Matsushima S. Central Nervous System Adverse Reactions to Amantadine Intoxication: A Case Report and Analysis of JADER. In Vivo. 2024;38(4):2090-2096$63$YR$$F$Y$36.7$KG$20240718$$HP$JP$JP
241077751$24107775$1$I$$20240712$20240718$20240718$PER$$US-ABBVIE-5840467$ABBVIE$$$$$$Y$$$20240718$$CN$US$US
241077763$24107776$3$F$$20240827$20240718$20240904$EXP$$JP-BEH-2024175569$CSL BEHRING$$74$YR$E$M$Y$$$20240904$$MD$JP$JP
241077771$24107777$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010807$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240718$$CN$US$US
241077781$24107778$1$I$20240712$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010651$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240718$$CN$US$US
241077791$24107779$1$I$20240201$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009629$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240718$$CN$US$US
241077801$24107780$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010359$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240718$$CN$US$US
241077811$24107781$1$I$20240701$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010354$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241077821$24107782$1$I$20240712$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010567$ELI LILLY AND CO$$$$A$F$Y$$$20240718$$CN$US$US
241077831$24107783$1$I$20240201$20240712$20240718$20240718$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007152$UNITED THERAPEUTICS$$68$YR$$M$Y$113.38$KG$20240718$$$US$US
241077841$24107784$1$I$$20240711$20240718$20240718$EXP$$CA-SA-2024SA205985$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240718$$HP$CA$CA
241077851$24107785$1$I$$20240709$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407006276$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240718$$CN$US$US
241077861$24107786$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009767$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240718$$CN$US$US
241077871$24107787$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009537$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240718$$CN$US$US
241077881$24107788$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010579$ELI LILLY AND CO$$$$$$Y$$$20240718$$CN$US$US
241077891$24107789$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010370$ELI LILLY AND CO$$$$$$Y$$$20240718$$CN$US$US
241077901$24107790$1$I$20240712$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009702$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240718$$CN$US$US
241077912$24107791$2$F$20240715$20240716$20240718$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407010352$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240723$$CN$US$US
241077921$24107792$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011051$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240718$$CN$US$US
241077931$24107793$1$I$$20240715$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113020$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240718$$CN$US$US
241077941$24107794$1$I$$20240710$20240718$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113410$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$MD$JP$JP
241077951$24107795$1$I$$20240712$20240718$20240718$EXP$$NVSC2024US099634$NOVARTIS$$$$$M$Y$$$20240718$$CN$US$US
241077963$24107796$3$F$20190422$20240808$20240718$20240812$EXP$$CA-TAKEDA-2024TUS071736$TAKEDA$$61$YR$$M$Y$$$20240812$$CN$CA$CA
241077971$24107797$1$I$$20240709$20240718$20240718$30DAY$$US-GSK-US2024084925$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241077981$24107798$1$I$20211001$20240710$20240718$20240718$EXP$$US-HORIZON THERAPEUTICS-HZN-2021-006847$AMGEN$$76$YR$E$M$Y$67.13$KG$20240718$$MD$US$US
241077991$24107799$1$I$$20240715$20240718$20240718$EXP$$CA-Bion-013453$BIONPHARMA$$7$YR$C$M$Y$$$20240718$$HP$CA$CA
241078001$24107800$1$I$$20240715$20240718$20240718$EXP$$JP-Bion-013457$BIONPHARMA$$3$DEC$A$F$Y$$$20240718$$HP$JP$JP
241078012$24107801$2$F$$20240711$20240718$20240801$EXP$$US-SA-2024SA206765$SANOFI AVENTIS$$$$E$F$Y$$$20240719$$MD$US$US
241078021$24107802$1$I$20230816$20240711$20240718$20240718$EXP$$CN-JNJFOC-20240732508$JOHNSON AND JOHNSON$$72$YR$E$M$Y$73$KG$20240718$$HP$CN$CN
241078031$24107803$1$I$$20240713$20240718$20240718$EXP$$MA-Bion-013451$BIONPHARMA$$37$YR$A$F$Y$$$20240718$$HP$MA$MA
241078041$24107804$1$I$$20240716$20240718$20240718$EXP$$CN-Bion-013462$BIONPHARMA$$22$YR$A$M$Y$$$20240718$$HP$CN$CN
241078051$24107805$1$I$$20240709$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109582$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$88.45$KG$20240718$$CN$US$US
241078061$24107806$1$I$$20240321$20240718$20240718$PER$$US-GRUNENTHAL-2024-118010$AVERITAS$$60$YR$$M$Y$$$20240710$$CN$US$US
241078071$24107807$1$I$$20220623$20240718$20240718$EXP$$US-AstraZeneca-2022A231251$ASTRAZENECA$$$$$$Y$$$20240718$$CN$US$
241078081$24107808$1$I$$20200520$20240718$20240718$EXP$$CA-AstraZeneca-2020SE66808$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$CA$
241078091$24107809$1$I$$20200519$20240718$20240718$EXP$$US-AstraZeneca-2020SE66868$ASTRAZENECA$$56$YR$$F$Y$$$20240718$$CN$US$
241078101$24107810$1$I$$20200629$20240718$20240718$EXP$$US-AstraZeneca-2020SE54831$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241078111$24107811$1$I$20200101$20201112$20240718$20240718$EXP$$BR-AstraZeneca-2020SF02069$ASTRAZENECA$$36$YR$$F$Y$$$20240718$$CN$BR$
241078121$24107812$1$I$$20200307$20240718$20240718$EXP$$US-AstraZeneca-2020SE36803$ASTRAZENECA$$72$YR$$M$Y$$$20240718$$CN$US$
241078131$24107813$1$I$$20200406$20240718$20240718$EXP$$US-AstraZeneca-2020SE31570$ASTRAZENECA$$$$$F$Y$$$20240718$$MD$US$
241078141$24107814$1$I$20200522$20200523$20240718$20240718$EXP$$CN-AstraZeneca-2020SE68517$ASTRAZENECA$$28008$DY$$M$Y$$$20240718$$CN$CN$
241078151$24107815$1$I$$20200608$20240718$20240718$EXP$$US-AstraZeneca-2020SE74656$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241078161$24107816$1$I$20240624$20240624$20240718$20240718$PER$$CA-TOLMAR, INC.-24CA050515$TOLMAR$$77$YR$$M$Y$$$20240718$$CN$CA$CA
241078171$24107817$1$I$$20240624$20240718$20240718$PER$$AU-TOLMAR, INC.-24AU050428$TOLMAR$$$$$M$Y$$$20240718$$CN$AU$AU
241078181$24107818$1$I$20240624$20240624$20240718$20240718$PER$$CA-TOLMAR, INC.-24CA050517$TOLMAR$$69$YR$$M$Y$$$20240718$$CN$CA$CA
241078202$24107820$2$F$$20240719$20240718$20240726$EXP$$CA-TOLMAR, INC.-24CA050523$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241078211$24107821$1$I$20240624$20240624$20240718$20240718$PER$$CA-TOLMAR, INC.-24CA050524$TOLMAR$$76$YR$$M$Y$$$20240718$$CN$CA$CA
241078241$24107824$1$I$20240605$20240624$20240718$20240718$PER$$CO-TOLMAR, INC.-24CO050507$TOLMAR$$8$YR$$F$Y$$$20240718$$CN$CO$CO
241078252$24107825$2$F$20240621$20240722$20240718$20240819$PER$$IT-TOLMAR, INC.-24IT050486$TOLMAR$$$$$M$Y$$$20240819$$PH$IT$IT
241078262$24107826$2$F$20240624$20240724$20240718$20240821$PER$$FR-TOLMAR, INC.-24FR050484$TOLMAR$$77$YR$$M$Y$$$20240821$$PH$FR$FR
241078271$24107827$1$I$20240624$20240624$20240718$20240718$PER$$TR-TOLMAR, INC.-24TR050435$TOLMAR$$86$YR$$M$Y$$$20240718$$HP$TR$TR
241078281$24107828$1$I$20240624$20240624$20240718$20240718$PER$$TR-TOLMAR, INC.-24TR050443$TOLMAR$$83$YR$$M$Y$$$20240718$$HP$TR$TR
241078291$24107829$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141734$AMGEN$$$$$F$Y$$$20240718$$HP$US$US
241078301$24107830$1$I$$20240328$20240718$20240718$PER$$US-GRUNENTHAL-2024-118273$AVERITAS$$$$A$F$Y$$$20240710$$HP$US$US
241078311$24107831$1$I$$20240321$20240718$20240718$PER$$US-GRUNENTHAL-2024-118011$AVERITAS$$81$YR$$F$Y$$$20240710$$MD$US$US
241078322$24107832$2$F$$20240802$20240718$20240810$EXP$$GB-CELLTRION INC.-2024GB017112$CELLTRION$$$$$$Y$$$20240810$$CN$GB$GB
241078332$24107833$2$F$20240604$20240805$20240718$20240828$PER$$US-ALK-ABELLO A/S-2024AA002633$ALK-ABELLO$$$$$$Y$$$20240828$$MD$US$US
241078342$24107834$2$F$$20240801$20240718$20240810$EXP$$US-TEVA-VS-3220451$TEVA$Malik T, Gordon B, Ramanathan R, Mcguire EL. A Tale of Broken Hearts: Cardiac Aspergillosis in an Immunocompromised Patient. Am-J-Respir-Crit-Care-Med 2023; 207.; Malik T, Gordon B, Ramanathan R, Mcguire EL. A Tale of Broken Hearts: Cardiac Aspergillosis in an Immunocompromised Patient. Am-J-Respir-Crit-Care-Med 2023; 207.$27$YR$$M$Y$$$20240810$$HP$US$US
241078351$24107835$1$I$$20240708$20240718$20240718$EXP$$FR-ROCHE-10000026665$ROCHE$$75$YR$E$M$Y$$$20240718$$PH$FR$FR
241078362$24107836$2$F$20240101$20240729$20240718$20240730$PER$$US-JNJFOC-20240742258$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$US$US
241078371$24107837$1$I$$20240716$20240718$20240718$PER$$US-JNJFOC-20240743031$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$MD$US$US
241078382$24107838$2$F$20240628$20240717$20240718$20240719$PER$$US-JNJFOC-20240745729$JOHNSON AND JOHNSON$$41$YR$A$$Y$$$20240719$$PH$US$US
241078391$24107839$1$I$20240307$20240711$20240718$20240718$EXP$$DE-ROCHE-3568312$ROCHE$$67$YR$E$F$Y$65$KG$20240718$$MD$DE$DE
241078401$24107840$1$I$$20240715$20240718$20240718$EXP$$GR-EMD Serono-2024038614$EMD SERONO INC$$69$YR$E$F$Y$$$20240718$$CN$GR$GR
241078411$24107841$1$I$20230401$20240711$20240718$20240718$EXP$$AU-EMD Serono-2024037968$EMD SERONO INC$$50$YR$A$F$Y$$$20240718$$CN$AU$AU
241078421$24107842$1$I$$20240711$20240718$20240718$EXP$$JP-AMGEN-JPNSP2024141304$AMGEN$Kawaguchi Y, Watanabe Y, Miyakita Y, Ohno M, Ogawa C, Takahashi M, et al.. Successful treatment of pediatric patients with high-grade gliomas featuring leptomeningeal metastases by targeting BRAF V600E mutations with dabrafenib plus trametinib: two illustrative cases. International Cancer Conference Journal. 2024;13:256-62$10$YR$C$F$Y$$$20240718$$MD$JP$JP
241078431$24107843$1$I$$20240709$20240718$20240718$EXP$$TW-AMGEN-TWNSP2024136936$AMGEN$Tsai C.; Lin C.; Chou Y. et al.. Clinical Applications of Comprehensive Genomic Profiling in Advanced Non-Small-Cell Lung Cancer-A Case Series. Current oncology. 2024;31 (6):3161-3176$70$YR$E$M$Y$$$20240718$$HP$TW$TW
241078441$24107844$1$I$$20240321$20240718$20240718$PER$$US-GRUNENTHAL-2024-118012$AVERITAS$$$$$M$Y$$$20240710$$MD$US$US
241078451$24107845$1$I$$20240410$20240718$20240718$PER$$US-GRUNENTHAL-2024-118764$AVERITAS$$65$YR$$M$Y$$$20240710$$HP$US$US
241078461$24107846$1$I$$20240412$20240718$20240718$PER$$US-GRUNENTHAL-2024-118870$AVERITAS$$70$YR$$F$Y$$$20240710$$CN$US$US
241078471$24107847$1$I$20240223$20240710$20240718$20240718$EXP$$FR-CELLTRION INC.-2024FR017066$CELLTRION$$$$$$Y$$$20240718$$PH$FR$FR
241078481$24107848$1$I$$20240710$20240718$20240718$EXP$$US-GSK-US2024AMR086819$GLAXOSMITHKLINE$$$$$F$Y$81.633$KG$20240718$$CN$US$US
241078492$24107849$2$F$$20240725$20240718$20240801$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001401$BLUEPRINT MEDICINES$$$$$M$Y$$$20240801$$CN$US$US
241078501$24107850$1$I$$20240710$20240718$20240718$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001402$BLUEPRINT MEDICINES$$$$$F$Y$$$20240718$$CN$US$US
241078511$24107851$1$I$$20240710$20240718$20240718$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001404$BLUEPRINT MEDICINES$$$$$F$Y$$$20240718$$HP$US$US
241078522$24107852$2$F$$20240923$20240718$20240924$EXP$$US-TAKEDA-2024TUS058288$TAKEDA$$$$$F$Y$$$20240924$$CN$US$US
241078531$24107853$1$I$$20240715$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113026$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240718$$MD$US$US
241078541$24107854$1$I$20240521$20240711$20240718$20240718$EXP$$CN-ROCHE-10000015880$ROCHE$$61$YR$A$M$Y$$$20240718$$MD$CN$CN
241078551$24107855$1$I$$20240712$20240718$20240718$EXP$$IN-ROCHE-10000027938$ROCHE$Kulkarni A, Kumaraswamy P, Menon B, Sekaran A, Rambhatl A, Rambhatl S, et al. Downstaging with Atezolizumab-Bevacizumab: A Case Series. Journal of liver cancer. 2024-May-27;1-30. doi:10.17998/jlc.2024.05.12.$41$YR$A$M$Y$$$20240718$$MD$IN$IN
241078561$24107856$1$I$$20240509$20240718$20240718$PER$$US-GRUNENTHAL-2024-119366$AVERITAS$$$$E$M$Y$$$20240710$$HP$US$US
241078572$24107857$2$F$$20240823$20240718$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002980$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
241078581$24107858$1$I$20200301$20200721$20240718$20240718$EXP$$US-AstraZeneca-2020SE78612$ASTRAZENECA$$27420$DY$$M$Y$$$20240718$$CN$US$
241078591$24107859$1$I$$20230613$20240718$20240718$EXP$$US-AstraZeneca-2023A138083$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241078601$24107860$1$I$20200803$20201012$20240718$20240718$EXP$$US-AstraZeneca-2020SF01040$ASTRAZENECA$$23305$DY$$F$Y$$$20240718$$CN$US$
241078611$24107861$1$I$20050101$20200819$20240718$20240718$EXP$$US-AstraZeneca-2020SF05946$ASTRAZENECA$$47$YR$$M$Y$$$20240718$$CN$US$
241078621$24107862$1$I$$20200928$20240718$20240718$EXP$$US-AstraZeneca-2020SF08670$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241078631$24107863$1$I$20200501$20200909$20240718$20240718$EXP$$US-AstraZeneca-2020SF16423$ASTRAZENECA$$52$YR$$F$Y$$$20240718$$CN$US$
241078641$24107864$1$I$20200826$20200827$20240718$20240718$EXP$$US-AstraZeneca-2020SF10592$ASTRAZENECA$$28687$DY$$F$Y$$$20240718$$CN$US$
241078651$24107865$1$I$$20221021$20240718$20240718$EXP$$US-AstraZeneca-2022A355798$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241078661$24107866$1$I$$20200915$20240718$20240718$EXP$$US-AstraZeneca-2020SF21160$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241078672$24107867$2$F$$20240807$20240718$20240807$PER$$US-ALXN-202407USA000774US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
241078681$24107868$1$I$$20240712$20240718$20240718$PER$$US-ALXN-202407USA000881US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241078691$24107869$1$I$20231201$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A159092$ASTRAZENECA$$977$MON$$F$Y$63.5$KG$20240718$$CN$US$
241078701$24107870$1$I$$20240711$20240718$20240718$PER$$US-HALEON-2187513$Haleon PLC$$31$YR$$F$Y$$$20240718$$HP$US$US
241078712$24107871$2$F$20240715$20240808$20240718$20240810$PER$$US-AMGEN-USASP2024140489$AMGEN$$81$YR$E$F$Y$$$20240810$$CN$US$US
241078721$24107872$1$I$$20240711$20240718$20240718$EXP$$US-ABBVIE-5840579$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241078731$24107873$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187554$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241078744$24107874$4$F$20240709$20240807$20240718$20240811$PER$$US-AMGEN-USASP2024140499$AMGEN$$68$YR$E$F$Y$$$20240811$$MD$US$US
241078761$24107876$1$I$20231101$20240711$20240718$20240718$EXP$$DE-BIOCON BIOLOGICS LIMITED-BBL2024005161$BIOCON$$$$$$Y$$$20240718$$MD$DE$DE
241078772$24107877$2$F$20220906$20240805$20240718$20240810$EXP$$AU-TAKEDA-2022TUS062962$TAKEDA$$56$YR$$F$Y$$$20240810$$CN$AU$AU
241078781$24107878$1$I$20240607$20240711$20240718$20240718$EXP$$CN-ROCHE-10000024666$ROCHE$$61$YR$A$M$Y$$$20240718$$MD$CN$CN
241078791$24107879$1$I$20220530$20240711$20240718$20240718$EXP$ES-AEMPS-1544782$ES-RDY-SPO/ESP/24/0010321$DR REDDYS$$61$YR$A$M$Y$$$20240718$$MD$ES$ES
241078801$24107880$1$I$$20240716$20240718$20240718$EXP$$NVSC2024US146860$NOVARTIS$$74$YR$$M$Y$$$20240718$$HP$US$US
241078812$24107881$2$F$20240713$20240814$20240718$20240818$PER$$US-AMGEN-USASP2024140503$AMGEN$$85$YR$E$M$Y$$$20240818$$CN$US$US
241078821$24107882$1$I$20240405$20240712$20240718$20240718$EXP$$JP-GENMAB-2024-01479AA$GENMAB$$43$YR$$F$Y$$$20240718$$MD$JP$JP
241078831$24107883$1$I$$20240716$20240718$20240718$EXP$$US-TAKEDA-2024TUS072057$TAKEDA$$$$$M$Y$$$20240718$$CN$US$US
241078841$24107884$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113762$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240718$$MD$US$US
241078852$24107885$2$F$20240704$20240822$20240718$20240824$EXP$$US-TAKEDA-2024TUS072313$TAKEDA$$69$YR$$M$Y$$$20240824$$HP$US$US
241078863$24107886$3$F$$20240705$20240718$20240906$PER$$US-FARMAPROD-202405-1931$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
241078881$24107888$1$I$$20240715$20240718$20240718$PER$$US-ABBVIE-5842172$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241078891$24107889$1$I$20221128$20240709$20240718$20240718$EXP$$FR-CELLTRION INC.-2024FR017010$CELLTRION$$$$$$Y$$$20240718$$MD$FR$FR
241078901$24107890$1$I$20240501$20240712$20240718$20240718$EXP$DE-CADRBFARM-2024328983$DE-HALEON-2186996$Haleon PLC$$48$YR$$M$Y$94$KG$20240717$$CN$DE$DE
241078911$24107891$1$I$20231212$20240715$20240718$20240718$EXP$DK-DKMA-30730561$DK-009507513-2407DNK010045$MERCK$$60$YR$$F$Y$$$20240718$$MD$DK$DK
241078922$24107892$2$F$20240101$20240715$20240718$20240723$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00141$CATALYST PHARMA$$$$$F$Y$76.644$KG$20240723$$CN$US$US
241078931$24107893$1$I$20240626$20240714$20240718$20240718$EXP$$IL-AMGEN-ISRSL2024141343$AMGEN$$91$YR$E$F$Y$$$20240718$$CN$IL$IL
241078941$24107894$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141384$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
241078951$24107895$1$I$20240201$20240229$20240718$20240718$PER$$US-GRUNENTHAL-2024-116754$AVERITAS$$88$YR$E$M$Y$$$20240710$$CN$US$US
241078962$24107896$2$F$20230101$20240718$20240718$20240725$EXP$$US-ABBVIE-5841555$ABBVIE$$70$YR$$F$Y$105$KG$20240725$$CN$US$US
241078974$24107897$4$F$20201008$20240905$20240718$20240912$EXP$$CA-TAKEDA-2020TUS033440$TAKEDA$$76$YR$$M$Y$$$20240912$$HP$CA$CA
241078981$24107898$1$I$$20240712$20240718$20240718$EXP$$CN-ROCHE-10000013990$ROCHE$Yin X, Liu X R. The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFRmutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study.. Cancer Immunol Immunotherapy. 2024;73 (134):1-12. doi:10.1007/s00262-024-03712-7.$$$$$Y$$$20240718$$HP$CN$CN
241078991$24107899$1$I$$20200903$20240718$20240718$EXP$$US-AstraZeneca-2020SF14425$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241079001$24107900$1$I$$20200701$20240718$20240718$EXP$$AU-AstraZeneca-2020SE84106$ASTRAZENECA$$$$$M$Y$$$20240718$$MD$AU$
241079011$24107901$1$I$20200101$20200923$20240718$20240718$EXP$$US-AstraZeneca-2020SF25090$ASTRAZENECA$$72$YR$$F$Y$$$20240718$$CN$US$
241079021$24107902$1$I$$20211123$20240718$20240718$EXP$$US-AstraZeneca-2021A828216$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241079031$24107903$1$I$$20200324$20240718$20240718$EXP$$US-AstraZeneca-2020SE42436$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241079041$24107904$1$I$$20200914$20240718$20240718$EXP$$US-AstraZeneca-2020SF18646$ASTRAZENECA$$60$YR$$F$Y$$$20240718$$CN$US$
241079051$24107905$1$I$20231101$20231109$20240718$20240718$EXP$$US-KHC-000044$Kilitch Healthcare$$$$$$Y$$$20240718$$CN$US$US
241079062$24107906$2$F$20230101$20240724$20240718$20240808$EXP$$US-KHC-000050$Kilitch Healthcare$$$$$F$Y$$$20240808$$CN$US$US
241079071$24107907$1$I$$20200304$20240718$20240718$EXP$$US-AstraZeneca-2020SE34809$ASTRAZENECA$$79$YR$$F$Y$$$20240718$$CN$US$
241079082$24107908$2$F$$20240802$20240718$20240806$EXP$$US-ABBVIE-5839277$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241079091$24107909$1$I$$20240708$20240718$20240718$EXP$$JP-CELLTRION INC.-2024JP016985$CELLTRION$Nakai T, Seki H, Makino A, Kadota Y, Kaburagi T, Okumura T, et. al.. Development of neuro-Behcet^s disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy. A case report. 2024;43 (1):223-229$$$$$Y$$$20240718$$HP$JP$JP
241079101$24107910$1$I$$20240710$20240718$20240718$EXP$CA-001086609-HPFB$CA-SERVIER-S24008891$SERVIER$$$$$$Y$$$20240718$$HP$CA$CA
241079111$24107911$1$I$20240620$20240715$20240718$20240718$EXP$FR-AFSSAPS-GR2024000883$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-113078$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240718$$PH$FR$FR
241079121$24107912$1$I$$20240710$20240718$20240718$PER$$US-HALEON-2186515$Haleon PLC$$$$$F$Y$$$20240718$$CN$US$US
241079132$24107913$2$F$20240101$20240725$20240718$20240731$EXP$$GB-ABBVIE-5833139$ABBVIE$$57$YR$$F$Y$$$20240731$$HP$GB$GB
241079141$24107914$1$I$$20240712$20240718$20240718$EXP$$US-ABBVIE-5841877$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241079151$24107915$1$I$$20240708$20240718$20240718$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06561$HIKMA$Chen F, Boominathan P.. Chen F, Boominathan P. Aortoesophageal Fistula Following a Cervical Epidural Steroid Injection: Case Report. Pain Medicine Case Reports. 2023;7(8):345-7$7$DEC$$M$Y$$$20240718$$MD$US$US
241079161$24107916$1$I$$20240712$20240718$20240718$EXP$$CA-TAKEDA-2024TUS051908$TAKEDA$$$$$F$Y$$$20240718$$CN$CA$CA
241079172$24107917$2$F$20240709$20240813$20240718$20240814$PER$$US-JNJFOC-20240726810$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240814$$CN$US$US
241079182$24107918$2$F$$20240828$20240718$20240906$EXP$$AT-TEVA-VS-3220932$TEVA$Muller A, Franzoi M, Enokl-Tomantschger U, Pollheimer M, Steidl K, Hatzenbichler P, et al. Case report: a man with a pancreatic adenocarcinoma and negative CA 19-9, but positive CA 125. Z-Gastroenterol 2024; 62 (5): e493.; Muller A, Franzoi M, Enokl-Tomantschger U, Pollheimer M, Steidl K, Hatzenbichler P, et al. Case report: a man with a pancreatic adenocarcinoma and negative CA 19-9, but positive CA 125. Z-Gastroenterol 2024; 62 (5): e493.$46$YR$$M$Y$$$20240906$$HP$AT$AT
241079202$24107920$2$F$20240710$20240731$20240718$20240808$EXP$$PA-TAKEDA-2024TUS071953$TAKEDA$$74$YR$$M$Y$95$KG$20240808$$CN$PA$PA
241079211$24107921$1$I$$20240711$20240718$20240718$PER$$US-ABBVIE-5838335$ABBVIE$$$$$$Y$$$20240718$$MD$US$US
241079221$24107922$1$I$20240423$20240515$20240718$20240718$PER$$US-GRUNENTHAL-2024-119613$AVERITAS$$77$YR$$F$Y$$$20240710$$HP$US$US
241079231$24107923$1$I$$20240711$20240718$20240718$EXP$$US-JNJFOC-20240731685$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$US$US
241079241$24107924$1$I$$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113362$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240718$$HP$US$US
241079252$24107925$2$F$20240611$20240805$20240718$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111656$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$66$KG$20240808$$PH$US$US
241079273$24107927$3$F$20240709$20240911$20240718$20240923$EXP$$JP-TAKEDA-2024TUS071533$TAKEDA$$73$YR$$F$Y$40$KG$20240923$$MD$JP$JP
241079281$24107928$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220174$TEVA$$74$YR$$M$Y$$$20240718$$MD$CA$CA
241079294$24107929$4$F$20240101$20240916$20240718$20240917$PER$$US-ALXN-202407USA000880US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
241079301$24107930$1$I$$20240619$20240718$20240718$PER$$US-STERISCIENCE B.V.-2024-ST-000927$Steriscience PTE$Treacy T, Taylor J, Philpotts YF. A Case of Fatal Asthma Exacerbation Leading to Cardiac Arrest.. Am-J-Respir-Crit-Care-Med. 2024;209$38$YR$$F$Y$$$20240718$$HP$US$US
241079312$24107931$2$F$20240617$20240805$20240718$20240813$EXP$$CA-TAKEDA-2024TUS071804$TAKEDA$$63$YR$$M$Y$97$KG$20240813$$HP$CA$CA
241079321$24107932$1$I$$20240715$20240718$20240718$PER$$NVSC2024US147476$NOVARTIS$$27$YR$$F$Y$$$20240718$$CN$US$US
241079332$24107933$2$F$$20240717$20240718$20240718$PER$$US-AMGEN-USASP2024141957$AMGEN$$$$$$Y$$$20240718$$CN$US$US
241079341$24107934$1$I$20240713$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140801$AMGEN$$46$YR$A$M$Y$$$20240718$$CN$US$US
241079351$24107935$1$I$$20240627$20240718$20240718$EXP$$ZA-ROCHE-10000024274$ROCHE$$$$A$F$Y$$$20240718$$CN$ZA$ZA
241079361$24107936$1$I$$20240716$20240718$20240718$EXP$GB-MHRA-MED-202407151749159160-VNJQH$GB-GSK-GB2024089442$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$GB$GB
241079371$24107937$1$I$$20240712$20240718$20240718$EXP$$US-JNJFOC-20240737788$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$MD$US$US
241079383$24107938$3$F$$20240715$20240718$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-021524$UNITED THERAPEUTICS$$$$$F$Y$68.934$KG$20240724$$$US$US
241079411$24107941$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140856$AMGEN$$$$$$Y$$$20240718$$CN$US$US
241079421$24107942$1$I$20240711$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141116$AMGEN$$42$YR$A$F$Y$$$20240718$$CN$US$US
241079431$24107943$1$I$20220908$20240712$20240718$20240718$EXP$$FR-SANDOZ INC.-SDZ2023FR001876$SANDOZ$$31$YR$$M$Y$$$20240718$$MD$FR$FR
241079441$24107944$1$I$20240101$20240712$20240718$20240718$EXP$$CO-ABBVIE-5841499$ABBVIE$$$$$F$Y$67$KG$20240718$$CN$CO$CO
241079451$24107945$1$I$20240622$20240703$20240718$20240718$EXP$$CA-VER-202400349$VERITY PHARMACEUTICALS$$64$YR$A$M$Y$$$20240718$$HP$CA$CA
241079461$24107946$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141456$AMGEN$$$$$$Y$$$20240718$$HP$US$US
241079473$24107947$3$F$20230120$20240807$20240718$20240821$EXP$$LT-VER-202400005$VERITY PHARMACEUTICALS$$78$YR$E$M$Y$98$KG$20240821$$HP$LT$LT
241079481$24107948$1$I$$20240709$20240718$20240718$EXP$$CA-CELLTRION INC.-2024CA017326$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
241079491$24107949$1$I$$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113556$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240718$$CN$US$US
241079501$24107950$1$I$20240214$20240715$20240718$20240718$EXP$$CA-ABBVIE-5842562$ABBVIE$$74$YR$$F$Y$$$20240718$$CN$CA$CA
241079511$24107951$1$I$20240526$20240712$20240718$20240718$EXP$EU-ADIENNEP-2024AD000585$EU-ADIENNEP-2024AD000585$ADIENNE PHARMA + BIOTECH$$19$YR$$F$Y$$$20240715$$MD$EU$EU
241079521$24107952$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187640$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241079531$24107953$1$I$20240329$20240716$20240718$20240718$EXP$FR-AFSSAPS-LL2024001296$FR-SANDOZ INC.-SDZ2024FR065931$SANDOZ$$69$YR$$F$Y$100$KG$20240718$$MD$FR$FR
241079541$24107954$1$I$$20240628$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06532$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241079551$24107955$1$I$20240101$20240712$20240718$20240718$EXP$$US-SA-2024SA207664$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240718$$MD$US$US
241079561$24107956$1$I$$20240712$20240718$20240718$PER$$US-ALXN-202407USA000877US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241079571$24107957$1$I$$20240708$20240718$20240718$EXP$$US-KERYX BIOPHARMACEUTICALS INC.-US-AKEB-24-001080$AKEBIA THERAPEUTICS$$$$$F$Y$$$20240718$$HP$US$US
241079581$24107958$1$I$$20240715$20240718$20240718$EXP$$FR-ADIENNEP-2024AD000591$ADIENNE PHARMA + BIOTECH$Furst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R et al. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease. Bone Marrow Transplant. 2024;59(7):918-27. DOI: 10.1038/s41409-024-02257-8$$$A$M$Y$$$20240716$$MD$FR$
241079591$24107959$1$I$20240612$20240711$20240718$20240718$EXP$$CN-ROCHE-10000024702$ROCHE$$55$YR$A$F$Y$65$KG$20240718$$HP$CN$CN
241079601$24107960$1$I$20240522$20240716$20240718$20240718$PER$$NVSC2024US147537$NOVARTIS$$$$$$Y$$$20240718$$CN$US$US
241079611$24107961$1$I$20240715$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010673$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240718$$CN$US$US
241079622$24107962$2$F$$20240722$20240718$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407010750$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240724$$CN$US$US
241079631$24107963$1$I$20240701$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010353$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240718$$CN$US$US
241079641$24107964$1$I$$20240701$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06618$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241079651$24107965$1$I$$20240626$20240718$20240718$EXP$$CA-JNJFOC-20240700599$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$CA$CA
241079661$24107966$1$I$$20240715$20240718$20240718$EXP$$IN-ADIENNEP-2024AD000586$ADIENNE PHARMA + BIOTECH$Kapoor R, Pandey P, Pande A, Dhingra N, Gaur L, Garg S et al. Successful Desensitization in a Patient with Donor-Specific Antibodies Persisting after Pretransplant Immunosuppression Using Intravenous Immunoglobulin and Plasma Exchange. Indian J Transpl. 2024;18(2):180-3. DOI: 10.4103/ijot.ijot_109_23$$$T$M$Y$$$20240715$$MD$IN$
241079671$24107967$1$I$$20240710$20240718$20240718$PER$$US-AstraZeneca-2024A159720$ASTRAZENECA$$55$YR$$F$Y$$$20240718$$MD$US$
241079681$24107968$1$I$$20201027$20240718$20240718$EXP$$US-AstraZeneca-2020SF43144$ASTRAZENECA$$$$$M$Y$68$KG$20240718$$CN$US$
241079691$24107969$1$I$$20240710$20240718$20240718$EXP$$ZA-AstraZeneca-2024A159254$ASTRAZENECA$$84$YR$$M$Y$$$20240718$$CN$ZA$
241079701$24107970$1$I$$20240708$20240718$20240718$PER$$US-AstraZeneca-2024A160587$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241079711$24107971$1$I$$20201124$20240718$20240718$EXP$$US-AstraZeneca-2020SF58674$ASTRAZENECA$$62$YR$$M$Y$$$20240718$$CN$US$
241079721$24107972$1$I$$20200326$20240718$20240718$EXP$$US-AstraZeneca-2020SE44248$ASTRAZENECA$$76$YR$$M$Y$$$20240718$$CN$US$
241079732$24107973$2$F$$20240730$20240718$20240803$PER$$US-AMGEN-USASP2024141948$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241079741$24107974$1$I$20240715$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141853$AMGEN$$81$YR$E$F$Y$$$20240718$$CN$US$US
241079751$24107975$1$I$$20240701$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06734$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241079771$24107977$1$I$$20240707$20240718$20240718$EXP$$US-ASPIRO-ASP2024US02258$ASPIRO PHARMA$Kwon D, Seu M, Barnes S, Kwon DK, Barnes IV S.. Mind the Anion Gap: 5-Oxoproline-Induced High Anion Gap Metabolic Acidosis in End-Stage Renal Disease. Cureus. 2024;16(5):e61328$74$YR$$F$Y$$$20240718$$HP$US$US
241079781$24107978$1$I$$20240711$20240718$20240718$EXP$$IN-ROCHE-3524551$ROCHE$Sadda S, Tyagi M. Suspected Retinal Toxicity After Multiple Intravitreal Ganciclovir Injections in a Patient of CMV Retinitis.. Ocular Immunology and Inflammation. 2024-Feb-26;32 (5):525-8. doi:10.1080/09273948.2024.2316754.$69$YR$E$M$Y$$$20240718$$HP$IN$IN
241079791$24107979$1$I$$20240715$20240718$20240718$EXP$$NVSC2024GB146622$NOVARTIS$$$$$M$Y$$$20240718$$CN$GB$GB
241079801$24107980$1$I$20240624$20240708$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-034526$AUROBINDO$$$$$$Y$$$20240718$$CN$GB$GB
241079811$24107981$1$I$$20240711$20240718$20240718$30DAY$$US-GSK-US2024086625$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241079822$24107982$2$F$$20240922$20240718$20240926$EXP$$CY-BIOGEN-2024BI01273689$BIOGEN$$$$$F$Y$$$20240926$$MD$CY$CY
241079841$24107984$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113921$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240718$$CN$US$US
241079851$24107985$1$I$$20240712$20240718$20240718$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-113046$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240718$$MD$IT$IT
241079862$24107986$2$F$$20240711$20240718$20240723$PER$$US-AMGEN-USASP2024138105$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241079871$24107987$1$I$20240706$20240708$20240718$20240718$PER$$US-Umedica-000082$UMEDICA LABS$$86$YR$$F$Y$$$20240717$$CN$US$
241079881$24107988$1$I$20240624$20240708$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-034336$AUROBINDO$$76$YR$$F$Y$67$KG$20240718$$MD$GB$GB
241079891$24107989$1$I$$20240621$20240718$20240718$30DAY$$DE-UCBSA-2024032610$UCB$$67$YR$$F$Y$$$20240718$$CN$DE$DE
241079901$24107990$1$I$$20240708$20240718$20240718$EXP$$IT-AUROBINDO-AUR-APL-2024-034862$AUROBINDO$Del Fabro V, Pennisi C, Leotta S, Petronaci A, Longo L, Elia F, et al.. PRACTICAL CONSIDERATIONS ON MANAGEMENT OF INFECTION IN PATIENTS RECEIVING BISPECIFIC ANTIBODIES: A SINGLE CENTER EXPERIENCE.. Haematologica. 2024;109 (Suppl.):33$$$$$Y$$$20240718$$HP$IT$IT
241079911$24107991$1$I$$20201104$20240718$20240718$EXP$$US-AstraZeneca-2020SF45934$ASTRAZENECA$$$$$M$Y$$$20240718$$HP$US$
241079922$24107992$2$F$$20240724$20240718$20240806$EXP$$PT-OCTA-LIT05124$OCTAPHARMA$In?s SF da Silva Ryan Costa Silva, In?s Sopa ,Catarina Greg?rio L?gia Peixoto. Um Caso Cl?nico de S?ndrome de Evans Provavelmente Desencadeada por Vacina BNT162b2 SARS-CoV-2. CASOS CL?NICOS 2024; 2. DOI: 10.60591/crspmi.170$18$YR$A$M$Y$$$20240805$$HP$EU$EU
241079931$24107993$1$I$$20200220$20240718$20240718$EXP$$US-AstraZeneca-2021A164395$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241079941$24107994$1$I$20240524$20240715$20240718$20240718$EXP$$US-AstraZeneca-2024A161495$ASTRAZENECA$$24365$DY$$$Y$$$20240718$$MD$US$
241079951$24107995$1$I$$20210322$20240718$20240718$EXP$$US-AstraZeneca-2021A198952$ASTRAZENECA$$57$YR$$M$Y$$$20240718$$CN$US$
241079961$24107996$1$I$$20240714$20240718$20240718$EXP$$EG-SANDOZ INC.-SDZ2024EG066021$SANDOZ$$$$$F$Y$$$20240718$$CN$EG$EG
241079971$24107997$1$I$$20201201$20240718$20240718$EXP$$US-AstraZeneca-2020SF48708$ASTRAZENECA$$73$YR$$F$Y$$$20240718$$CN$US$
241079981$24107998$1$I$$20201217$20240718$20240718$EXP$$US-AstraZeneca-2020SF70432$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241079991$24107999$1$I$$20240703$20240718$20240718$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06045$LUPIN$Al-Moussally F, Thompson BM, Masarweh OM, Shah N, Gaudi S, Restrepo J. Atorvastatin-associated eosinophilic spongiosis: A case report and a relevant literature review of dermatological manifestations. Cureus. 2024;16(5): e61071:1-5$72$YR$$M$Y$$$20240718$$MD$US$US
241080001$24108000$1$I$20201230$20210204$20240718$20240718$EXP$$CO-AstraZeneca-2021A035134$ASTRAZENECA$$27262$DY$$F$Y$$$20240718$$CN$CO$
241080011$24108001$1$I$$20201015$20240718$20240718$EXP$$RU-AstraZeneca-2020SF34764$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$RU$
241080021$24108002$1$I$20240702$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A159046$ASTRAZENECA$$0$YR$C$M$Y$33.6$KG$20240718$$CN$US$
241080031$24108003$1$I$20200305$20200312$20240718$20240718$EXP$$CO-AstraZeneca-2020SE38838$ASTRAZENECA$$9342$DY$$F$Y$$$20240718$$CN$CO$
241080041$24108004$1$I$$20240712$20240718$20240718$PER$$US-ALXN-202407USA000873US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241080051$24108005$1$I$$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113008$BRISTOL MYERS SQUIBB$$66$YR$A$F$Y$$$20240718$$CN$US$US
241080061$24108006$1$I$$20240715$20240718$20240718$PER$$US-JNJFOC-20240741580$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$MD$US$US
241080071$24108007$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-10000029106$ROCHE$$$$A$F$Y$$$20240718$$HP$US$US
241080084$24108008$4$F$20240101$20240918$20240718$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021200$UNITED THERAPEUTICS$$$$$F$Y$85.261$KG$20240926$$$US$US
241080112$24108011$2$F$20240716$20240717$20240718$20240723$PER$$US-AMGEN-USASP2024141561$AMGEN$$70$YR$E$M$Y$$$20240723$$CN$US$US
241080121$24108012$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140465$AMGEN$$56$YR$A$F$Y$$$20240718$$CN$US$US
241080131$24108013$1$I$$20240708$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-032653$AUROBINDO$$$$$$Y$$$20240718$$CN$GB$GB
241080141$24108014$1$I$$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002307J$MERCK$$58$YR$$F$Y$$$20240718$$MD$JP$JP
241080154$24108015$4$F$20240701$20240828$20240718$20240905$EXP$$US-BIOGEN-2024BI01273919$BIOGEN$$36$YR$$F$Y$$$20240905$$CN$US$US
241080171$24108017$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113580$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240718$$HP$US$US
241080181$24108018$1$I$20240101$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140962$AMGEN$$59$YR$A$F$Y$$$20240718$$CN$US$US
241080191$24108019$1$I$$20240708$20240718$20240718$EXP$$TR-ROCHE-10000026101$ROCHE$Cakmak S, Nural N. Efficacy of Propolis in the Prevention of Oral Mucositis in Patients Undergoing High-Dose Chemotherapy. Doi: 10.1097/NCC.0000000000001212. Cancer Nursing. 2024-Jul-01;47 (4):E255-68. doi:10.1097/NCC.0000000000001212.$$$$$Y$$$20240718$$MD$TR$TR
241080222$24108022$2$F$20230101$20240718$20240718$20240726$EXP$$BR-CELLTRION INC.-2024BR017187$CELLTRION$$$$$$Y$$$20240726$$CN$BR$BR
241080231$24108023$1$I$$20240710$20240718$20240718$EXP$$CA-APOTEX-2024AP008196$APOTEX$$42$YR$$F$Y$$$20240718$$HP$CA$CA
241080241$24108024$1$I$$20240712$20240718$20240718$EXP$$CA-BIOGEN-2023BI01200243$BIOGEN$$74$YR$$F$Y$$$20240718$$CN$CA$CA
241080251$24108025$1$I$$20240717$20240718$20240718$EXP$NL-LRB-00990226$NL-JNJFOC-20240748035$JOHNSON AND JOHNSON$$56$YR$A$M$Y$92$KG$20240718$$CN$NL$NL
241080261$24108026$1$I$$20240712$20240718$20240718$PER$$US-JNJFOC-20240734454$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$US$US
241080272$24108027$2$F$$20240717$20240718$20240723$EXP$$US-JNJFOC-20240741609$JOHNSON AND JOHNSON$$$$$F$Y$4.6$KG$20240723$$HP$US$US
241080281$24108028$1$I$$20240229$20240718$20240718$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002706$STRIDES$Simone C, Benjamin S, Marron RM.. A Rare Case of Herpes Simplex Virus Type1 Induced Hemophagocytic Lymphohistiocytosis in Adult Patient.. Am-J-Respir-Crit-Care-Med. 2023;207:A5242$66$YR$$M$Y$$$20240718$$HP$US$US
241080291$24108029$1$I$$20240313$20240718$20240718$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003265$STRIDES$Wu B, Lee S, Suter K, DiGiorgio B, Reece R. A Case of COVID-19 Associated Mucormycosis Initially Thought to Be bacterial Sinusitis. Am-J-Respir-Crit-Care-Med. 2023;207(plusPoster)$53$YR$$M$Y$$$20240718$$HP$US$US
241080301$24108030$1$I$$20240410$20240718$20240718$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004529$STRIDES$Abdulraheem E, Bansal N, Ghoniem AA, Awosika O.. Stercoral perforation of the sigmoid colon in pregnancy: A case report.. Case-Rep-Women-Health. 2024;41:1-3$39$YR$$F$Y$$$20240718$$HP$US$US
241080312$24108031$2$F$20240101$20240730$20240718$20240731$PER$$US-ABBVIE-5837988$ABBVIE$$$$$F$Y$$$20240731$$PH$US$US
241080321$24108032$1$I$$20240708$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-035321$AUROBINDO$Louisy A, Rochefort J, Plantier F, Kervarrec T, Quilhot P, Agbo Godeau S, et al. ^Plasma cell gingivitis^ encompasses multiple entities: a retrospective series of 37 cases. Eur-J-Dermatol. 2023;33(2):109-120.$$$E$$Y$$$20240718$$HP$FR$FR
241080331$24108033$1$I$$20240717$20240718$20240718$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040448$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$MD$US$US
241080341$24108034$1$I$$20240710$20240718$20240718$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP008727$STRIDES$Kaya Akca U, Sener S, Batu ED, Balik Z, Basaran O, Bilginer Y, et al. Drug-induced lupus erythematosus in childhood: Case-based review.. Lupus. 2024;33(7):737-748.$$$C$F$Y$$$20240718$$HP$TR$TR
241080362$24108036$2$F$20240702$20240731$20240718$20240813$EXP$$GB-AUROBINDO-AUR-APL-2024-034285$AUROBINDO$$45$YR$$M$Y$88$KG$20240813$$CN$GB$GB
241080371$24108037$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010864$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240718$$CN$US$US
241080381$24108038$1$I$20240715$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010307$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240718$$CN$US$US
241080403$24108040$3$F$$20240918$20240718$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112240$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240920$$CN$US$US
241080411$24108041$1$I$20240101$20240705$20240718$20240718$PER$$US-Encube-000811$ENCUBE ETHICALS$$86$YR$E$F$Y$$$20240717$$CN$US$
241080421$24108042$1$I$20240601$20240713$20240718$20240718$EXP$FR-AFSSAPS-AM2024000571$FR-BAUSCH-BL-2024-010725$BAUSCH AND LOMB$$82$YR$$M$Y$71$KG$20240718$$MD$FR$FR
241080441$24108044$1$I$20220901$20240715$20240718$20240718$EXP$FR-AFSSAPS-AVPO2024000133$FR-BAUSCH-BL-2024-010839$BAUSCH AND LOMB$$36$YR$$F$Y$$$20240718$$PH$FR$FR
241080451$24108045$1$I$$20240717$20240718$20240718$EXP$$US-BAUSCH-BL-2024-010968$BAUSCH AND LOMB$$59$YR$$M$Y$$$20240718$$HP$US$US
241080461$24108046$1$I$$20240715$20240718$20240718$EXP$$CA-BAUSCH-BL-2024-010911$BAUSCH AND LOMB$$58$YR$$F$Y$$$20240718$$CN$CA$CA
241080471$24108047$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187665$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241080483$24108048$3$F$20240101$20240712$20240718$20240722$PER$$US-AMGEN-USASP2024139084$AMGEN$$62$YR$A$M$Y$$$20240722$$CN$US$US
241080492$24108049$2$F$$20240716$20240718$20240721$PER$$US-AMGEN-USASP2024140442$AMGEN$$$$$F$Y$$$20240721$$CN$US$US
241080501$24108050$1$I$20240715$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141721$AMGEN$$68$YR$E$M$Y$$$20240718$$CN$US$US
241080511$24108051$1$I$$20240715$20240718$20240718$EXP$$CA-BAUSCH-BL-2024-010830$BAUSCH AND LOMB$$$$$M$Y$$$20240718$$CN$CA$CA
241080521$24108052$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-035365$AUROBINDO$Razia D, Moin A, Walia T, Arjuna A. Metastatic Large Cell Neuroendocrine Carcinoma of Unknown Primary in a Lung Transplant Recipient.. Am-J-Respir-CritCare-Med. 2024;209$73$YR$$M$Y$$$20240718$$MD$US$US
241080531$24108053$1$I$$20240715$20240718$20240718$EXP$$CA-BAUSCH-BL-2024-010795$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240718$$CN$CA$CA
241080544$24108054$4$F$$20240920$20240718$20240930$EXP$$ES-AUROBINDO-AUR-APL-2024-035107$AUROBINDO$Lizondo Lopez T, Font I Barcelo A, Garcia Gutierrez C, Blasco M, Grafia I, Bastida C, et al.. Clopidogrel-induced thrombotic microangiopathy: a case report. European journal of hospital pharmacy : science and practice. 2024;0:1-4$75$YR$$M$Y$$$20240930$$PH$ES$ES
241080553$24108055$3$F$20240701$20240820$20240718$20240822$PER$$US-AMGEN-USASP2024141917$AMGEN$$55$YR$A$F$Y$$$20240822$$CN$US$US
241080561$24108056$1$I$20200930$20201217$20240718$20240718$EXP$$AU-AstraZeneca-2020SF70150$ASTRAZENECA$$23806$DY$$M$Y$$$20240718$$CN$AU$
241080571$24108057$1$I$$20201012$20240718$20240718$EXP$$US-AstraZeneca-2020SF33663$ASTRAZENECA$$81$YR$$F$Y$$$20240718$$CN$US$
241080581$24108058$1$I$20201201$20210105$20240718$20240718$EXP$$US-AstraZeneca-2021A000169$ASTRAZENECA$$656$MON$$M$Y$$$20240718$$CN$US$
241080591$24108059$1$I$$20240712$20240718$20240718$PER$$US-ABBVIE-5838894$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241080601$24108060$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220199$TEVA$$89$YR$$F$Y$$$20240718$$PH$CA$CA
241080611$24108061$1$I$$20240708$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-034543$AUROBINDO$$7$YR$$M$Y$24$KG$20240718$$PH$GB$GB
241080621$24108062$1$I$$20210601$20240718$20240718$EXP$$PT-AstraZeneca-2021A488005$ASTRAZENECA$$$$$$Y$$$20240718$$MD$PT$
241080631$24108063$1$I$20200519$20200608$20240718$20240718$EXP$$CO-AstraZeneca-2020SE76250$ASTRAZENECA$$3820$WK$$F$Y$$$20240718$$CN$CO$
241080641$24108064$1$I$20210527$20210609$20240718$20240718$EXP$$US-AstraZeneca-2021A518119$ASTRAZENECA$$28541$DY$$F$Y$$$20240718$$CN$US$
241080651$24108065$1$I$$20210526$20240718$20240718$EXP$$CA-AstraZeneca-2021A472958$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$CA$
241080661$24108066$1$I$$20201007$20240718$20240718$EXP$$US-AstraZeneca-2020SF31394$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241080672$24108067$2$F$$20240723$20240718$20240730$EXP$$CA-GSK-CA2023AMR100527$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$CA$CA
241080681$24108068$1$I$20211102$20240710$20240718$20240718$EXP$$CA-GSK-CA2024086346$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$CA$CA
241080691$24108069$1$I$$20240711$20240718$20240718$30DAY$$US-GSK-US2024086609$GLAXOSMITHKLINE$$$$A$M$Y$$$20240718$$CN$US$US
241080701$24108070$1$I$20200712$20201006$20240718$20240718$EXP$$US-AstraZeneca-2020SF30640$ASTRAZENECA$$22003$DY$$F$Y$116.1$KG$20240718$$CN$US$
241080711$24108071$1$I$20240517$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158452$ASTRAZENECA$$$$$F$Y$$$20240718$$PH$US$
241080721$24108072$1$I$20210401$20210518$20240718$20240718$EXP$$US-AstraZeneca-2021A459393$ASTRAZENECA$$640$MON$$F$Y$$$20240718$$CN$US$
241080731$24108073$1$I$$20240709$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-034279$AUROBINDO$$72$YR$$M$Y$$$20240718$$MD$GB$GB
241080741$24108074$1$I$$20201009$20240718$20240718$EXP$$US-AstraZeneca-2020SF31798$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241080751$24108075$1$I$20231001$20240710$20240718$20240718$EXP$GB-MHRA-MED-202407101221271600-BQCKL$GB-862174955-ML2024-03973$Unknown Manufacturer$$75$YR$E$M$Y$90$KG$20240718$$CN$GB$GB
241080761$24108076$1$I$$20240709$20240718$20240718$EXP$GB-MHRA-MED-202407091039521900-GMQNV$GB-862174955-ML2024-03958$Unknown Manufacturer$$34$YR$A$F$Y$$$20240718$$CN$GB$GB
241080781$24108078$1$I$20240703$20240705$20240718$20240718$EXP$GB-MHRA-MED-202407041459345310-HBWCZ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15096$ALKEM$$58$YR$$F$Y$$$20240718$$HP$GB$GB
241080791$24108079$1$I$20231101$20240705$20240718$20240718$EXP$GB-MHRA-MED-202407041053066220-FWYTH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15092$ALKEM$$41$YR$$M$Y$65$KG$20240718$$CN$GB$GB
241080802$24108080$2$F$$20240716$20240718$20240730$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-15378$ALKEM$Pan L, Wang XH, Meng FQ, Su XM, Li Y, Xu MT, Su FY, Kong DL, Wang W.. Membranous Nephropathy Complicated with Disseminated Nocardia farcinica Infection: A Case Report and Literature Review. Infection and Drug Resistance. 2021;14:4157-4166$66$YR$$F$Y$$$20240730$$HP$CN$CN
241080811$24108081$1$I$$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405091127345870-KZJMW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15090$ALKEM$$$$$F$Y$$$20240718$$PH$GB$GB
241080823$24108082$3$F$20200401$20240821$20240718$20240904$EXP$AU-MLMSERVICE-20240628-PI112925-00232-1$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-15158$ALKEM$Thorburn S, Majumdar A, Smibert O.. Chronic hepatitis E masquerading as allograft rejection in a liver transplant recipient. Transplant Infectious Disease. 2024;26(3):e14303$41$YR$$M$Y$$$20240904$$MD$AU$AU
241080831$24108083$1$I$$20240704$20240718$20240718$EXP$$HR-ALKEM LABORATORIES LIMITED-HR-ALKEM-2024-15271$ALKEM$Simicevic L, Sliskovic AM, Kirhmajer MV, Ganoci L, Holik H, Palic J, Samardzic J, Bozina T.. Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series. Pharmacy. 2023;11:29$75$YR$$F$Y$$$20240718$$HP$HR$HR
241080841$24108084$1$I$$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405081127236150-GTRHJ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15089$ALKEM$$$$$F$Y$$$20240718$$HP$GB$GB
241080851$24108085$1$I$$20240704$20240718$20240718$EXP$$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-15427$ALKEM$Wu CS, Tong SH, Ong CT, et al. Serotonin Syndrome Induced by Combined Use of Mirtazapine and Olanzapine Complicated with Rhabdomyolysis, Acute Renal Failure, and Acute Pulmonary Edema-A Case Report. Acta Neurol Taiwan. 2015;24:117-121$$$$$Y$$$20240718$$HP$TW$TW
241080861$24108086$1$I$$20240704$20240718$20240718$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-15390$ALKEM$Bostankolu G, Ayhan Y, Cuhadaroglu F, et al.. Serotonin syndrome with a combination of aripiprazole and fluoxetine: a case report. Ther Adv Psychopharmacol. 2015;5:138-140$$$$$Y$$$20240718$$HP$TR$TR
241080873$24108087$3$F$$20240726$20240718$20240809$EXP$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15097$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15097$ALKEM$Attieh RM, Brumble L, Elwasila SM, Wadei HM. Disseminated Monkeypox Infection in a Kidney Transplant Recipient: A Case Report. Transplant Proc. 2023;55(3):667-671$44$YR$$M$Y$$$20240809$$HP$US$US
241080881$24108088$1$I$$20240704$20240718$20240718$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15118$ALKEM$Higgins E, Ranganath N, Mehkri O, Majeed A, Walker J, Spivack S, Bhaimia E, Benamu E, Hand J, Keswani S, Dunn D, Beam E, Razonable RR.. Clinical features, treatment, and outcomes of mpox in solid organ transplant recipients: A multicenter case series and literature review. American Journal of Transplantation. 2023;23:1972-1979$$$$M$Y$$$20240718$$HP$US$US
241080891$24108089$1$I$$20240704$20240718$20240718$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15115$ALKEM$Higgins E, Ranganath N, Mehkri O, Majeed A, Walker J, Spivack S, Bhaimia E, Benamu E, Hand J, Keswani S, Dunn D, Beam E, Razonable RR. Clinical features, treatment, and outcomes of mpox in solid organ transplant recipients: A multicenter case series and literature review. American Journal of Transplantation. 2023;23:1972-1979$$$$M$Y$$$20240718$$HP$US$US
241080901$24108090$1$I$$20240704$20240718$20240718$EXP$$HR-ALKEM LABORATORIES LIMITED-HR-ALKEM-2024-15274$ALKEM$Simicevic L, Sliskovic AM, Kirhmajer MV, Ganoci L, Holik H, Palic J, Samardzic J, Bozina T. Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series. Pharmacy. 2023;11:29$74$YR$$F$Y$$$20240718$$HP$HR$HR
241080911$24108091$1$I$20240423$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405011152303220-GPJSV$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15113$ALKEM$$64$YR$$M$Y$$$20240718$$MD$GB$GB
241080921$24108092$1$I$20150101$20240705$20240718$20240718$EXP$DE-EMA-DD-20211108-kumarvn_p-125809$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-15147$ALKEM$$73$YR$$F$Y$81.2$KG$20240718$$PH$DE$DE
241080931$24108093$1$I$20231113$20240709$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-034315$AUROBINDO$$62$YR$$M$Y$$$20240718$$HP$GB$GB
241080941$24108094$1$I$20240127$20240709$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-034496$AUROBINDO$$56$YR$$M$Y$77.2$KG$20240718$$HP$FR$FR
241080951$24108095$1$I$$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405091211578540-ZJCYF$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001760$IPCA$$$$$$Y$$$20240718$$PH$GB$GB
241080963$24108096$3$F$20240601$20240815$20240718$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002956$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$91$KG$20240830$$CN$US$US
241080971$24108097$1$I$20230701$20240708$20240718$20240718$EXP$FR-AFSSAPS-DJ2024000821$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109641$ZYDUS PHARM$$$$$$Y$$$20240718$$MD$FR$FR
241080981$24108098$1$I$20240614$20240708$20240718$20240718$EXP$FR-AFSSAPS-LL2024001248$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109652$ZYDUS PHARM$$$$$$Y$$$20240718$$PH$FR$FR
241080991$24108099$1$I$20240520$20240708$20240718$20240718$EXP$FR-AFSSAPS-NC2024000792$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109602$ZYDUS PHARM$$$$$$Y$$$20240718$$MD$FR$FR
241081001$24108100$1$I$20230909$20230912$20240718$20240718$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-098145$ZYDUS PHARM$$$$$$Y$$$20240718$$CN$US$US
241081011$24108101$1$I$20240414$20240515$20240718$20240718$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-107559$ZYDUS PHARM$$$$$$Y$$$20240718$$CN$US$US
241081021$24108102$1$I$20240101$20240603$20240718$20240718$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108319$ZYDUS PHARM$$$$$$Y$$$20240718$$CN$US$US
241081031$24108103$1$I$20240601$20240614$20240718$20240718$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108756$ZYDUS PHARM$$$$$$Y$$$20240718$$CN$US$US
241081041$24108104$1$I$$20240704$20240718$20240718$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109512$ZYDUS PHARM$Calderon Barahona GM, Ali R, Ortega Giron C, Ng W, Bobrysheva H, Calderon Martinez E, et al.. Beta-Blocked: A Severe Propranolol Overdose Case Report.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240718$$HP$US$US
241081053$24108105$3$F$20240809$20240830$20240718$20240909$EXP$$US-GSK-US2024AMR088470$GLAXOSMITHKLINE$$47$YR$$M$Y$$$20240909$$HP$US$US
241081061$24108106$1$I$$20240710$20240718$20240718$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008744$STRIDES$Vela-Casasempere P, Cano Alameda R, Gomez Sabater S, Cortell Aznar S, Perez Pascual E.. Considering belimumab during pregnancy: A more viable option over time. [Review].. Lupus. 2024;33(7):700-715$37$YR$$F$Y$$$20240718$$HP$ES$ES
241081072$24108107$2$F$$20240823$20240718$20240829$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-104996$BRISTOL MYERS SQUIBB$$23$YR$A$F$Y$$$20240829$$HP$FR$FR
241081081$24108108$1$I$$20240711$20240718$20240718$EXP$$US-GSK-US2024086391$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$US$US
241081093$24108109$3$F$$20240724$20240718$20240805$PER$$US-ABBVIE-5843459$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241081101$24108110$1$I$20240629$20240711$20240718$20240718$EXP$$CO-VANTIVE-2024VAN018308$Vantive US Healthcare$$73$YR$$F$Y$55$KG$20240718$$HP$CO$CO
241081111$24108111$1$I$$20240716$20240718$20240718$PER$$US-JNJFOC-20240742490$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
241081122$24108112$2$F$$20240828$20240718$20240906$EXP$$IE-TEVA-VS-3220837$TEVA$Dinneen B, Stack J. Atypical antinuclear matrix protein 2-positive dermatomyositis presenting with anasarca and bulbar weakness after COVID-19 infection requiring mechanical ventilation. Arch-Rheumatol 2024; 39 (2): 312-313.; Dinneen B, Stack J. Atypical antinuclear matrix protein 2-positive dermatomyositis presenting with anasarca and bulbar weakness after COVID-19 infection requiring mechanical ventilation. Arch-Rheumatol 2024; 39 (2): 312-313.$28$YR$$F$Y$$$20240906$$HP$IE$IE
241081131$24108113$1$I$$20240709$20240718$20240718$EXP$$US-LEO Pharma-371957$LEO PHARM$$69$YR$$F$Y$$$20240718$$CN$US$US
241081141$24108114$1$I$$20190819$20240718$20240718$EXP$$AU-TERSERA THERAPEUTICS LLC-2019TRS001564$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$MD$AU$AU
241081151$24108115$1$I$$20240711$20240718$20240718$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP008552$STRIDES$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J-Cardiovas-Thorac-Res. 2022;14(4):258-262.$5$DEC$$$Y$$$20240718$$HP$IR$IR
241081161$24108116$1$I$20200104$20200205$20240718$20240718$EXP$$CO-TERSERA THERAPEUTICS LLC-2020TRS000360$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$CN$CO$CO
241081171$24108117$1$I$20190401$20191009$20240718$20240718$EXP$$CO-TERSERA THERAPEUTICS LLC-2019TRS002313$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$CN$CO$CO
241081181$24108118$1$I$20220819$20220830$20240718$20240718$EXP$$NL-TERSERA THERAPEUTICS LLC-2022TRS003691$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$CN$NL$NL
241081191$24108119$1$I$20200124$20200303$20240718$20240718$EXP$$NL-TERSERA THERAPEUTICS LLC-2020TRS000633$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$MD$NL$NL
241081201$24108120$1$I$$20240709$20240718$20240718$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019128$UNITED THERAPEUTICS$$$$$F$Y$80.726$KG$20240718$$$US$US
241081211$24108121$1$I$20200715$20200416$20240718$20240718$EXP$$AU-TERSERA THERAPEUTICS LLC-2020TRS002078$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$HP$AU$AU
241081221$24108122$1$I$20190816$20190826$20240718$20240718$EXP$$CO-TERSERA THERAPEUTICS LLC-2019TRS001765$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$CN$CO$CO
241081231$24108123$1$I$20200319$20200320$20240718$20240718$EXP$$CO-TERSERA THERAPEUTICS LLC-2020TRS000744$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$CN$CO$CO
241081241$24108124$1$I$20190909$20191002$20240718$20240718$EXP$$CO-TERSERA THERAPEUTICS LLC-2019TRS002228$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$CN$CO$CO
241081251$24108125$1$I$20240620$20240708$20240718$20240718$EXP$$IN-ROCHE-10000021647$ROCHE$$75$YR$E$M$Y$$$20240718$$CN$IN$IN
241081261$24108126$1$I$20240707$20240710$20240718$20240718$EXP$$PK-ROCHE-10000026235$ROCHE$$$$A$M$Y$$$20240718$$CN$PK$PK
241081271$24108127$1$I$$20240709$20240718$20240718$30DAY$$US-GSK-US2024085139$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241081281$24108128$1$I$$20240711$20240718$20240718$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP008553$STRIDES$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J-Cardiovas-Thorac-Res. 2022;14(4):258-262.$5$DEC$$$Y$$$20240718$$HP$IR$IR
241081291$24108129$1$I$$20240306$20240718$20240718$PER$$US-GRUNENTHAL-2024-117200$AVERITAS$$$$E$M$Y$$$20240710$$CN$US$US
241081301$24108130$1$I$$20240610$20240718$20240718$PER$$US-GRUNENTHAL-2024-119611$AVERITAS$$64$YR$$M$Y$$$20240710$$MD$US$US
241081311$24108131$1$I$20240714$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141689$AMGEN$$55$YR$A$F$Y$$$20240718$$CN$US$US
241081321$24108132$1$I$$20240705$20240718$20240718$EXP$$NL-AMGEN-NLDNI2024141155$AMGEN$$$$E$F$Y$$$20240718$$HP$NL$NL
241081331$24108133$1$I$$20240715$20240718$20240718$EXP$$NL-AMGEN-NLDSP2024140094$AMGEN$$48$YR$A$F$Y$75$KG$20240718$$CN$NL$NL
241081341$24108134$1$I$$20240711$20240718$20240718$PER$$US-ABBVIE-5838272$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241081351$24108135$1$I$20240101$20240711$20240718$20240718$EXP$$US-JNJFOC-20240648259$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240718$$CN$US$US
241081361$24108136$1$I$$20240711$20240718$20240718$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP008645$STRIDES$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J-Cardiovas-Thorac-Res. 2022;14 (4):258-262$6$DEC$$$Y$$$20240718$$HP$IR$IR
241081371$24108137$1$I$20240430$20240710$20240718$20240718$EXP$$CA-CELLTRION INC.-2024CA011952$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
241081382$24108138$2$F$20240101$20240809$20240718$20240812$PER$$US-AMGEN-USASP2024140213$AMGEN$$69$YR$E$F$Y$$$20240812$$CN$US$US
241081394$24108139$4$F$20240715$20240826$20240718$20240829$PER$$US-AMGEN-USASP2024141838$AMGEN$$80$YR$E$F$Y$$$20240828$$CN$US$US
241081401$24108140$1$I$$20240711$20240718$20240718$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP008646$STRIDES$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J-Cardiovas-Thorac-Res. 2022;14(4):258-262$2$DEC$$$Y$$$20240718$$HP$IR$IR
241081412$24108141$2$F$20240704$20240729$20240718$20240805$EXP$$CA-ROCHE-10000026820$ROCHE$$46$YR$A$M$Y$$$20240805$$CN$CA$CA
241081431$24108143$1$I$$20240711$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009418$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240718$$CN$US$US
241081441$24108144$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010384$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240718$$PH$US$US
241081451$24108145$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010285$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240718$$CN$US$US
241081461$24108146$1$I$$20240710$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407007341$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240718$$CN$US$US
241081471$24108147$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010279$ELI LILLY AND CO$$55$YR$A$$Y$$$20240718$$CN$US$US
241081481$24108148$1$I$20240601$20240710$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407007152$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240718$$CN$US$US
241081491$24108149$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011048$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240718$$CN$US$US
241081501$24108150$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010315$ELI LILLY AND CO$$88$YR$E$F$Y$$$20240718$$CN$US$US
241081511$24108151$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009811$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240718$$CN$US$US
241081521$24108152$1$I$20240716$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010580$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240718$$CN$US$US
241081531$24108153$1$I$20240711$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009636$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240718$$CN$US$US
241081541$24108154$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009468$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240718$$CN$US$US
241081551$24108155$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010518$ELI LILLY AND CO$$35$YR$A$$Y$$$20240718$$CN$US$US
241081561$24108156$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010626$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240718$$CN$US$US
241081571$24108157$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010516$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240718$$CN$US$US
241081581$24108158$1$I$$20240321$20240718$20240718$PER$$US-GRUNENTHAL-2024-118009$AVERITAS$$$$$M$Y$$$20240710$$MD$US$US
241081591$24108159$1$I$$20201224$20240718$20240718$EXP$$US-AstraZeneca-2020SF74352$ASTRAZENECA$$52$YR$$F$Y$$$20240718$$CN$US$
241081601$24108160$1$I$$20200701$20240718$20240718$EXP$$US-AstraZeneca-2020SE84669$ASTRAZENECA$$80$YR$$F$Y$$$20240718$$CN$US$
241081611$24108161$1$I$20200309$20200318$20240718$20240718$EXP$$US-AstraZeneca-2020SE40181$ASTRAZENECA$$30531$DY$$M$Y$$$20240718$$CN$US$
241081621$24108162$1$I$$20210204$20240718$20240718$EXP$$US-AstraZeneca-2021A035104$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241081631$24108163$1$I$$20240710$20240718$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113393$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$MD$JP$JP
241081641$24108164$1$I$$20240710$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110664$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$75$KG$20240718$$CN$US$US
241081652$24108165$2$F$20240628$20240730$20240718$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113202$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240801$$MD$US$US
241081661$24108166$1$I$$20200114$20240718$20240718$EXP$$US-AstraZeneca-2020SE08924$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241081671$24108167$1$I$$20210510$20240718$20240718$EXP$$US-AstraZeneca-2021A424241$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241081681$24108168$1$I$$20200218$20240718$20240718$EXP$$US-AstraZeneca-2020SE11756$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241081691$24108169$1$I$20210222$20210309$20240718$20240718$EXP$$CO-AstraZeneca-2021A131175$ASTRAZENECA$$26567$DY$$F$Y$$$20240718$$CN$CO$
241081701$24108170$1$I$$20210317$20240718$20240718$EXP$$US-AstraZeneca-2021A175462$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241081711$24108171$1$I$$20210518$20240718$20240718$EXP$$AU-AstraZeneca-2021A204759$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$AU$
241081721$24108172$1$I$20240701$20240708$20240718$20240718$EXP$$US-RECORDATI RARE DISEASE INC.-2024005221$RECORDATI$$$$$$Y$$$20240718$$CN$US$US
241081731$24108173$1$I$$20210325$20240718$20240718$EXP$$US-AstraZeneca-2021A229575$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241081741$24108174$1$I$$20200831$20240718$20240718$EXP$$CA-AstraZeneca-2020SF12083$ASTRAZENECA$$82$YR$$F$Y$$$20240718$$MD$CA$
241081751$24108175$1$I$$20210323$20240718$20240718$EXP$$US-AstraZeneca-2021A210468$ASTRAZENECA$$$$$M$Y$93.4$KG$20240718$$CN$US$
241081761$24108176$1$I$20190606$20200406$20240718$20240718$EXP$$US-AstraZeneca-2020SE48906$ASTRAZENECA$$27779$DY$$F$Y$$$20240718$$CN$US$
241081772$24108177$2$F$20231229$20240904$20240718$20240906$EXP$$US-AstraZeneca-2024A161434$ASTRAZENECA$$$$$M$Y$$$20240906$$MD$US$
241081781$24108178$1$I$20231228$20240709$20240718$20240718$EXP$$GB-CELLTRION INC.-2024GB016972$CELLTRION$$$$$$Y$$$20240718$$MD$GB$GB
241081791$24108179$1$I$$20240711$20240718$20240718$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP008647$STRIDES$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J-Cardiovas-Thorac-Res. 2022;14(4):258-262$4$DEC$$$Y$$$20240718$$HP$IR$IR
241081802$24108180$2$F$20240714$20240717$20240718$20240722$PER$$US-AMGEN-USASP2024141677$AMGEN$$80$YR$E$F$Y$$$20240722$$CN$US$US
241081811$24108181$1$I$20240101$20240712$20240718$20240718$EXP$$BR-ORGANON-O2407BRA001366$ORGANON$$26$YR$$F$Y$49$KG$20240718$$CN$BR$BR
241081821$24108182$1$I$$20240321$20240718$20240718$PER$$US-GRUNENTHAL-2024-118006$AVERITAS$$$$$M$Y$$$20240710$$MD$US$US
241081831$24108183$1$I$$20240425$20240718$20240718$PER$$US-GRUNENTHAL-2024-119373$AVERITAS$$$$$M$Y$$$20240710$$CN$US$US
241081841$24108184$1$I$$20240708$20240718$20240718$EXP$$PL-STERISCIENCE B.V.-2024-ST-001040$Steriscience PTE$Skrobas U, Zie WS, Bielewicz J, Rejdak K. The rapidly progressing and fatal outcome of rhombencephalitis by listeriosis in a 61-year-old male.. Ann-Agricultural-Environ-Med. 2024;31 (2):311-314$61$YR$$M$Y$$$20240718$$HP$PL$PL
241081851$24108185$1$I$20240416$20240419$20240718$20240718$PER$$US-GRUNENTHAL-2024-119261$AVERITAS$$51$YR$$M$Y$$$20240710$$HP$US$US
241081861$24108186$1$I$$20240415$20240718$20240718$PER$$US-GRUNENTHAL-2024-118988$AVERITAS$$$$E$F$Y$$$20240710$$CN$US$US
241081871$24108187$1$I$$20240711$20240718$20240718$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP008694$STRIDES$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J-Cardiovas-Thorac-Res. 2022;14 (4):258-262$4$DEC$$$Y$$$20240718$$HP$IR$IR
241081881$24108188$1$I$20240101$20240710$20240718$20240718$PER$$US-ABBVIE-5839126$ABBVIE$$$$$$Y$$$20240718$$CN$US$US
241081891$24108189$1$I$$20240416$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00489$TARO$$$$$$Y$$$20240718$$CN$US$US
241081901$24108190$1$I$$20240410$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00474$TARO$$$$$$Y$$$20240718$$CN$US$US
241081911$24108191$1$I$20231101$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405160929377240-YBTNR$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001738$IPCA$$$$$$Y$$$20240718$$MD$GB$GB
241081921$24108192$1$I$20240717$20240717$20240718$20240718$PER$$US-AMGEN-USASP2024142148$AMGEN$$68$YR$E$M$Y$$$20240718$$CN$US$US
241081931$24108193$1$I$$20240712$20240718$20240718$PER$$US-LEO Pharma-372038$LEO PHARM$$35$YR$$F$Y$$$20240718$$CN$US$US
241081942$24108194$2$F$20240531$20240801$20240718$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-034508$AUROBINDO$$3$YR$$F$Y$$$20240809$$PH$FR$FR
241081951$24108195$1$I$20240426$20240715$20240718$20240718$EXP$FR-AFSSAPS-PO2024000745$FR-UCBSA-2024035730$UCB$$45$YR$$F$Y$$$20240718$$MD$FR$FR
241081961$24108196$1$I$20240621$20240708$20240718$20240718$EXP$$CN-HBP-2024CN030980$HELSINN HEALTHCARE$$58$YR$$F$Y$$$20240718$$HP$CN$CN
241081971$24108197$1$I$$20240712$20240718$20240718$30DAY$$US-GSK-US2024087705$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241081981$24108198$1$I$$20240705$20240718$20240718$PER$$US-RDY-SPO/USA/24/0010205$DR REDDYS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241081992$24108199$2$F$$20240711$20240718$20240724$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP008601$STRIDES$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J-Cardiovas-Thorac-Res. 2022;14(4):258-262$4$DEC$$$Y$$$20240724$$HP$IR$IR
241082001$24108200$1$I$$20240704$20240718$20240718$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06723$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241082011$24108201$1$I$20240101$20240515$20240718$20240718$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-107463$ZYDUS PHARM$$$$$$Y$$$20240718$$CN$US$US
241082021$24108202$1$I$20240622$20240715$20240718$20240718$EXP$$US-UCBSA-2024036156$UCB$$29$YR$$M$Y$$$20240718$$CN$US$US
241082031$24108203$1$I$$20240711$20240718$20240718$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP008604$STRIDES$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J-Cardiovas-Thorac-Res. 2022;14(4):258-262$4$DEC$$$Y$$$20240718$$HP$IR$IR
241082041$24108204$1$I$$20240710$20240718$20240718$PER$$US-ABBVIE-5843215$ABBVIE$$$$$$Y$$$20240718$$CN$US$US
241082052$24108205$2$F$20240710$20240712$20240718$20240718$EXP$$US-AMGEN-USASP2024139480$AMGEN$$$$A$F$Y$$$20240718$$CN$US$US
241082061$24108206$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141345$AMGEN$$$$$$Y$$$20240718$$PH$US$US
241082072$24108207$2$F$$20240705$20240718$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457337$RANBAXY$Salar T, Al-Hosainat N, Subedi R, Hameed M, Brodsky S, Dahhan A. A CASE OF HYDRALAZINE INDUCED SEVERE RENAL LIMITED ANCA VASCULITIS LEADING TO ESRD IN A 63-YEAR-OLD MAN. Am J Kidney Dis. 2023;81 (1) (4):S42/142$63$YR$$M$Y$$$20240719$$HP$US$US
241082082$24108208$2$F$20240708$20240722$20240718$20240729$EXP$$US-CELLTRION INC.-2024US016951$CELLTRION$$$$$$Y$$$20240729$$HP$US$US
241082091$24108209$1$I$$20240712$20240718$20240718$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008709$STRIDES$Tamil Selvi E, Rahangan A.. Methotrexate Induced Muco-Cutaneous Ulcer: A Case Report.. Int-J-Pharmaceut-Sci-Rev-Res. 2024;84 (5):75-76$59$YR$$F$Y$$$20240718$$MD$IN$IN
241082101$24108210$1$I$$20240710$20240718$20240718$EXP$$JP-JNJFOC-20240747633$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240718$$MD$JP$JP
241082113$24108211$3$F$$20240802$20240718$20240805$PER$$US-JNJFOC-20240664674$JOHNSON AND JOHNSON$$61$YR$A$F$Y$70.3$KG$20240805$$CN$US$US
241082121$24108212$1$I$$20240715$20240718$20240718$EXP$$US-TAKEDA-2024TUS072093$TAKEDA$$$$$M$Y$$$20240718$$MD$US$US
241082132$24108213$2$F$$20240829$20240718$20240903$EXP$$US-TAKEDA-2024TUS072163$TAKEDA$$$$$F$Y$$$20240903$$CN$US$US
241082141$24108214$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5841642$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241082151$24108215$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5841674$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241082161$24108216$1$I$20240101$20240715$20240718$20240718$EXP$$US-ABBVIE-5841851$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241082173$24108217$3$F$$20240816$20240718$20240823$EXP$$US-AMGEN-USASP2024139064$AMGEN$$64$YR$A$M$Y$$$20240823$$CN$US$US
241082181$24108218$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5842150$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241082192$24108219$2$F$20231216$20240724$20240718$20240819$EXP$$CO-UCBSA-2024000400$UCB$$56$YR$$F$Y$64$KG$20240819$$CN$CO$CO
241082201$24108220$1$I$20240620$20240709$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-034405$AUROBINDO$$72$YR$$F$Y$$$20240718$$MD$FR$FR
241082211$24108221$1$I$$20240710$20240718$20240718$EXP$$IT-CELLTRION INC.-2024IT017102$CELLTRION$$$$$$Y$$$20240718$$MD$IT$IT
241082221$24108222$1$I$$20240716$20240718$20240718$EXP$$US-ABBVIE-5842528$ABBVIE$$$$$M$Y$$$20240718$$HP$US$US
241082232$24108223$2$F$$20240716$20240718$20240722$PER$$US-ROCHE-10000027879$ROCHE$$$$E$$Y$$$20240719$$CN$US$US
241082241$24108224$1$I$20231204$20240708$20240718$20240718$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240700058$RIGEL PHARMACEUTICALS$$$$$M$Y$60$KG$20240718$$MD$JP$JP
241082251$24108225$1$I$$20240712$20240718$20240718$EXP$$CA-STRIDES ARCOLAB LIMITED-2024SP008713$STRIDES$Bodor TLW, Webber JC, Scheske JA.. Primary Cardiac Lymphoma in an 85-Year-Old Man, With Highly Suggestive Features on Imaging.. CJC-Open. 2023;5 (2):167-169$85$YR$$M$Y$$$20240718$$MD$CA$CA
241082261$24108226$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187650$Haleon PLC$$73$YR$$M$Y$$$20240718$$CN$US$US
241082271$24108227$1$I$20240101$20240708$20240718$20240718$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-002578$UNITED THERAPEUTICS$$$$$F$Y$58.499$KG$20240718$$MD$JP$JP
241082282$24108228$2$F$$20240717$20240718$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002987$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241082291$24108229$1$I$20240711$20240715$20240718$20240718$PER$$US-AstraZeneca-2024A161234$ASTRAZENECA$$25452$DY$$F$Y$81.6$KG$20240718$$HP$US$
241082301$24108230$1$I$20190701$20200319$20240718$20240718$EXP$$TW-AstraZeneca-2020SE18440$ASTRAZENECA$$57$YR$$F$Y$$$20240718$$CN$TW$
241082311$24108231$1$I$20240629$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113645$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240718$$HP$US$US
241082321$24108232$1$I$$20240712$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111782$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240718$$CN$US$US
241082331$24108233$1$I$$20210205$20240718$20240718$EXP$$PH-AstraZeneca-2021A033255$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$PH$
241082341$24108234$1$I$$20210406$20240718$20240718$EXP$$US-AstraZeneca-2021A283002$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241082351$24108235$1$I$20240501$20240510$20240718$20240718$PER$$US-GRUNENTHAL-2024-119940$AVERITAS$$55$YR$A$F$Y$$$20240710$$CN$US$US
241082361$24108236$1$I$$20230601$20240718$20240718$EXP$$US-AstraZeneca-2023A128195$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241082371$24108237$1$I$$20191219$20240718$20240718$EXP$$US-AstraZeneca-2019SF86729$ASTRAZENECA$$60$YR$$M$Y$$$20240718$$CN$US$
241082381$24108238$1$I$$20240709$20240718$20240718$EXP$$CN-STERISCIENCE B.V.-2024-ST-001033$Steriscience PTE$Wang X, Chen X, Liang Y, Hu L. Severe pneumonia with pleural effusion caused by co-infection of Paecilomyces variotii and Penicillium oxalicum in a diabetic patient. BMC-Infect-Dis. 2024;24 (1):605$56$YR$$F$Y$66.7$KG$20240718$$HP$CN$CN
241082391$24108239$1$I$$20210513$20240718$20240718$EXP$$US-AstraZeneca-2021A433964$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241082401$24108240$1$I$20200429$20210503$20240718$20240718$EXP$$US-AstraZeneca-2021A391787$ASTRAZENECA$$26790$DY$$F$Y$$$20240718$$CN$US$
241082411$24108241$1$I$$20200210$20240718$20240718$EXP$$US-AstraZeneca-2020SE21411$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241082421$24108242$1$I$$20210429$20240718$20240718$EXP$$US-AstraZeneca-2021A384793$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241082431$24108243$1$I$$20200211$20240718$20240718$EXP$$US-AstraZeneca-2020SE23516$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241082441$24108244$1$I$20240307$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405081048274840-ZSQNM$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001739$IPCA$$$$$$Y$$$20240718$$CN$GB$GB
241082451$24108245$1$I$$20240708$20240718$20240718$30DAY$$US-GSK-US2024084942$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241082461$24108246$1$I$20191009$20191223$20240718$20240718$EXP$$US-AstraZeneca-2019SF88713$ASTRAZENECA$$24090$DY$$F$Y$$$20240718$$CN$US$
241082471$24108247$1$I$$20220905$20240718$20240718$EXP$$TW-AstraZeneca-2022A310297$ASTRAZENECA$$79$YR$$M$Y$$$20240718$$CN$TW$
241082481$24108248$1$I$$20200214$20240718$20240718$EXP$$US-AstraZeneca-2020SE24547$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241082491$24108249$1$I$$20201001$20240718$20240718$EXP$$US-AstraZeneca-2020SF28990$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241082502$24108250$2$F$20240101$20240816$20240718$20240823$EXP$$GR-ABBVIE-5842278$ABBVIE$$68$YR$$F$Y$$$20240823$$CN$GR$GR
241082512$24108251$2$F$$20240801$20240718$20240810$EXP$$JP-TEVA-VS-3220038$TEVA$Okuzumi S, Suzuki H, Morinaga S, Tamura M, Minematsu N. Mesenchymal-epithelial Transition Exon 14-skipping Mutation-positive Invasive Mucinous Adenocarcinoma of the Lung: First Case Treated with Mesenchymal-epithelial Transition-tyrosine Kinase Inhibitors. Intern-Med 2024; 63 (12): 1789-1795.; Okuzumi S, Suzuki H, Morinaga S, Tamura M, Minematsu N. Mesenchymal-epithelial Transition Exon 14-skipping Mutation-positive Invasive Mucinous Adenocarcinoma of the Lung: First Case Treated with Mesench...$76$YR$$F$Y$$$20240810$$HP$JP$JP
241082521$24108252$1$I$$20240715$20240718$20240718$PER$$US-JNJFOC-20240740335$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$HP$US$US
241082531$24108253$1$I$$20240709$20240718$20240718$EXP$$CA-APOTEX-2024AP008136$APOTEX$$66$YR$$F$Y$54.422$KG$20240718$$MD$CA$CA
241082541$24108254$1$I$$20240528$20240718$20240718$PER$$US-GRUNENTHAL-2024-120984$AVERITAS$$$$E$M$Y$$$20240710$$HP$US$US
241082551$24108255$1$I$20240508$20240509$20240718$20240718$PER$$US-GRUNENTHAL-2024-120004$AVERITAS$$9$DEC$$F$Y$$$20240710$$HP$US$US
241082561$24108256$1$I$$20240313$20240718$20240718$PER$$US-GRUNENTHAL-2024-117474$AVERITAS$$53$YR$$M$Y$$$20240710$$HP$US$US
241082571$24108257$1$I$$20240710$20240718$20240718$EXP$$NL-CELLTRION INC.-2024NL017087$CELLTRION$Kwakernaak A, Hak A, Leeuwen E.. Auto-immunity and auto-inflammation as manifestations of a primary immunodeficiency: recognition, diagnosis and treatment.. NED TIJSCHR ALLERGIE, ASTMA, KLIN IMMUNOL.. 2024;24 (1):20-8$$$$$Y$$$20240718$$HP$NL$NL
241082581$24108258$1$I$20240701$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009984$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240718$$CN$US$US
241082591$24108259$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010475$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240718$$CN$US$US
241082602$24108260$2$F$$20240712$20240718$20240722$EXP$$VE-ROCHE-10000025521$ROCHE$$$$$$Y$$$20240722$$MD$VE$VE
241082611$24108261$1$I$$20240712$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011103$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240718$$HP$US$US
241082621$24108262$1$I$20240101$20240715$20240718$20240718$EXP$$CA-UCBSA-2024036018$UCB$$$$$F$Y$$$20240718$$CN$CA$CA
241082631$24108263$1$I$20240501$20240703$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407003557$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240718$$CN$US$US
241082641$24108264$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009995$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240718$$CN$US$US
241082651$24108265$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009794$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241082661$24108266$1$I$20240713$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009972$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240718$$CN$US$US
241082671$24108267$1$I$20220501$20240708$20240718$20240718$EXP$$CN-STERISCIENCE B.V.-2024-ST-001042$Steriscience PTE$Lu H, Yuan J, Wu Z, Wang L, Wu S, Chen Q, et al. Distribution of drug-resistant genes in alveolar lavage fluid from patients with psittacosis and traceability analysis of causative organisms. Front-Microbiol. 2023;14$73$YR$$M$Y$$$20240718$$HP$CN$CN
241082681$24108268$1$I$20240601$20240712$20240718$20240718$EXP$$JP-ROCHE-10000029801$ROCHE$$8$DEC$E$M$Y$$$20240718$$MD$JP$JP
241082692$24108269$2$F$$20240828$20240718$20240906$EXP$$BE-TEVA-VS-3220841$TEVA$Geusens D, Dierickx D, Carton S, Van Cutsem E, Dekervel J. Immunotherapy Rechallenge After Checkpoint Inhibitor Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review. Clin-Colorectal-Cancer 2024; 23 (2): 194-197.; Geusens D, Dierickx D, Carton S, Van Cutsem E, Dekervel J. Immunotherapy Rechallenge After Checkpoint Inhibitor Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review. Clin-Colorectal-Cancer 2024; 23 (2): 194-197.$48$YR$$M$Y$$$20240906$$MD$BE$BE
241082701$24108270$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141622$AMGEN$$$$A$F$Y$$$20240718$$CN$US$US
241082711$24108271$1$I$20240715$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141081$AMGEN$$$$$M$Y$$$20240718$$CN$US$US
241082721$24108272$1$I$$20240313$20240718$20240718$PER$$US-GRUNENTHAL-2024-117531$AVERITAS$$$$E$F$Y$$$20240710$$CN$US$US
241082731$24108273$1$I$$20240715$20240718$20240718$EXP$$NVSC2024CA146471$NOVARTIS$$78$YR$$F$Y$54.4$KG$20240718$$MD$CA$CA
241082742$24108274$2$F$$20240801$20240718$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109878$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$PH$JP$JP
241082751$24108275$1$I$20240327$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113655$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240718$$HP$US$US
241082761$24108276$1$I$20240711$20240711$20240718$20240718$EXP$$US-GSK-US2024086449$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240718$$HP$US$US
241082771$24108277$1$I$$20240710$20240718$20240718$EXP$$IT-STERISCIENCE B.V.-2024-ST-001055$Steriscience PTE$Linardos G, Coltella L, Ranno S, Di Maio VC, Colagrossi L, Pandolfi E, et al.. Whooping Cough Cases Increase in Central Italy after COVID-19 Pandemic.. Antibiotics-(Basel). 2024;13 (5)$25$DY$$F$Y$$$20240718$$HP$IT$IT
241082781$24108278$1$I$$20240703$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06737$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241082791$24108279$1$I$$20240716$20240718$20240718$PER$$US-HALEON-2187471$Haleon PLC$$68$YR$$M$Y$$$20240718$$CN$US$US
241082803$24108280$3$F$20240709$20240809$20240718$20240812$PER$$US-HALEON-2186473$Haleon PLC$$34$YR$$F$Y$$$20240812$$CN$US$US
241082812$24108281$2$F$20240620$20240722$20240718$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021210$UNITED THERAPEUTICS$$73$YR$$F$Y$$$20240726$$$US$US
241082822$24108282$2$F$$20240722$20240718$20240729$EXP$$NVSC2024US147340$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241082844$24108284$4$F$20240101$20240828$20240718$20240905$EXP$$CA-CELLTRION INC.-2024CA016907$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
241082851$24108285$1$I$$20240710$20240718$20240718$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113947$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$MD$JP$JP
241082861$24108286$1$I$$20240710$20240718$20240718$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089849$VIIV$$$$$$Y$$$20240718$$HP$US$US
241082871$24108287$1$I$$20240709$20240718$20240718$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089854$VIIV$$$$$$Y$$$20240718$$HP$US$US
241082882$24108288$2$F$20240807$20240807$20240718$20240809$EXP$$CA-TAKEDA-2024TUS071854$TAKEDA$$29$YR$$F$Y$$$20240809$$CN$CA$CA
241082892$24108289$2$F$$20240801$20240718$20240809$EXP$$US-TEVA-VS-3220448$TEVA$Androsov A, Leo T. ABLATION OF PERSISTENT ATRIAL FIBRILLATION IN A PATIENT WITH CARDIOGENIC SHOCK ON VA ECMO. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3968.; Androsov A, Leo T. ABLATION OF PERSISTENT ATRIAL FIBRILLATION IN A PATIENT WITH CARDIOGENIC SHOCK ON VA ECMO. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3968.$72$YR$$M$Y$$$20240809$$HP$US$US
241082901$24108290$1$I$20240623$20240708$20240718$20240718$EXP$$US-RECORDATI RARE DISEASE INC.-2024005315$RECORDATI$$$$$$Y$$$20240718$$CN$US$US
241082911$24108291$1$I$20240628$20240711$20240718$20240718$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2024JPN086033$VIIV$$$$$$Y$$$20240718$$MD$JP$JP
241082922$24108292$2$F$20240704$20240705$20240718$20240822$PER$$US-ROCHE-10000025094$ROCHE$$3$YR$C$M$Y$$$20240822$$CN$US$US
241082931$24108293$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5842324$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241082941$24108294$1$I$20240619$20240715$20240718$20240718$EXP$$US-ABBVIE-5841668$ABBVIE$$59$YR$$F$Y$$$20240718$$CN$US$US
241082951$24108295$1$I$$20240620$20240718$20240718$PER$$US-009507513-2406USA007124$MERCK$Vatterrodt Darrick, Lee Janelle, Ho Dooil, Stevig Craig, Chow Siu-Kei,. Misidentification and misreporting of antibiotic resistance in Kluyvera bacteremia by blood culture molecular identification panels. Microbiology Spectrum. 2024;12(6)$81$YR$$F$Y$$$20240718$$HP$US$US
241082961$24108296$1$I$$20240710$20240718$20240718$EXP$$CA-TOLMAR, INC.-24CA050959$TOLMAR$$$$$M$Y$$$20240718$$CN$CA$CA
241082971$24108297$1$I$$20240710$20240718$20240718$EXP$$US-TOLMAR, INC.-24US050915$TOLMAR$$$$$M$Y$73.016$KG$20240718$$MD$US$US
241082982$24108298$2$F$20240101$20240716$20240718$20240722$EXP$$CA-ABBVIE-5842475$ABBVIE$$52$YR$$F$Y$$$20240722$$CN$CA$CA
241082991$24108299$1$I$20240518$20240715$20240718$20240718$EXP$$CA-TAKEDA-2024TUS072054$TAKEDA$$41$YR$$M$Y$$$20240718$$MD$CA$CA
241083001$24108300$1$I$20240501$20240515$20240718$20240718$PER$$US-GRUNENTHAL-2024-120147$AVERITAS$$72$YR$E$F$Y$$$20240710$$CN$US$US
241083011$24108301$1$I$$20240711$20240718$20240718$PER$$US-GRUNENTHAL-2024-122885$AVERITAS$$$$$M$Y$$$20240712$$CN$US$US
241083021$24108302$1$I$$20240603$20240718$20240718$PER$$US-GRUNENTHAL-2024-120329$AVERITAS$$$$E$F$Y$$$20240710$$HP$US$US
241083031$24108303$1$I$$20240529$20240718$20240718$PER$$US-GRUNENTHAL-2024-120946$AVERITAS$$$$E$M$Y$$$20240710$$HP$US$US
241083041$24108304$1$I$$20240612$20240718$20240718$PER$$US-GRUNENTHAL-2024-121845$AVERITAS$$47$YR$$F$Y$$$20240710$$CN$US$US
241083051$24108305$1$I$20240601$20240628$20240718$20240718$PER$$US-GRUNENTHAL-2024-122374$AVERITAS$$$$$F$Y$$$20240710$$HP$US$US
241083061$24108306$1$I$$20240713$20240718$20240718$PER$$NVSC2024US147490$NOVARTIS$$49$YR$$F$Y$$$20240718$$CN$US$US
241083071$24108307$1$I$20231001$20240520$20240718$20240718$PER$$US-GRUNENTHAL-2024-120423$AVERITAS$$70$YR$$M$Y$$$20240710$$CN$US$US
241083081$24108308$1$I$20240101$20240712$20240718$20240718$EXP$$US-ABBVIE-5838838$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241083092$24108309$2$F$20240701$20240813$20240718$20240819$EXP$$US-ABBVIE-5841938$ABBVIE$$79$YR$$M$Y$$$20240819$$CN$US$US
241083101$24108310$1$I$$20240715$20240718$20240718$EXP$$CA-TAKEDA-2024TUS072001$TAKEDA$$$$$F$Y$$$20240718$$CN$CA$CA
241083111$24108311$1$I$$20240708$20240718$20240718$EXP$CA-MHPD-E2B_07098741$CA-Accord-435163$ACCORD$$$$$F$Y$$$20240718$$MD$CA$CA
241083121$24108312$1$I$20230419$20240706$20240718$20240718$EXP$FR-AFSSAPS-TS2024000773$FR-Accord-435205$ACCORD$$42$YR$A$F$Y$77$KG$20240718$$MD$FR$FR
241083131$24108313$1$I$$20240707$20240718$20240718$EXP$$JP-Accord-434856$ACCORD$Asano H, Horiguchi K, Kakinuma C, Yamada T, Nagaki T, Aishima K, et al. Neurolymphomatosis secondary to primary central nervous system lymphoma: illustrative case. Journal of neurosurgery. Case lessons. 2024;8(1):CASE24107.$4$DEC$A$F$Y$$$20240718$$MD$JP$JP
241083143$24108314$3$F$$20240723$20240718$20240801$EXP$$ES-Accord-435576$ACCORD$Lizondo Lopez T, Font I Barcelo A, Garcia Gutierrez C, Blasco M, Grafia I, Bastida C et al. Clopidogrel-induced thrombotic microangiopathy: a case report. Eur J Hosp Pharm. 2024 Jul 4:ejhpharm-2024-004209.$75$YR$E$M$Y$$$20240801$$HP$ES$ES
241083151$24108315$1$I$$20200612$20240718$20240718$EXP$$US-AstraZeneca-2020SE67172$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241083161$24108316$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158891$ASTRAZENECA$$$$$$Y$$$20240718$$HP$US$
241083173$24108317$3$F$20240601$20240808$20240718$20240812$EXP$$US-ABBVIE-5842504$ABBVIE$$76$YR$$F$Y$52$KG$20240812$$CN$US$US
241083181$24108318$1$I$$20200325$20240718$20240718$EXP$$US-AstraZeneca-2020SE44024$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241083191$24108319$1$I$20210320$20210525$20240718$20240718$EXP$$US-AstraZeneca-2021A475087$ASTRAZENECA$$22690$DY$$M$Y$$$20240718$$CN$US$
241083201$24108320$1$I$20200318$20200320$20240718$20240718$EXP$$CA-AstraZeneca-2020SE42021$ASTRAZENECA$$23299$DY$$F$Y$$$20240718$$CN$CA$
241083211$24108321$1$I$$20200214$20240718$20240718$EXP$$US-AstraZeneca-2020SE25400$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241083221$24108322$1$I$20170508$20200226$20240718$20240718$EXP$$CO-AstraZeneca-2020SE26949$ASTRAZENECA$$23603$DY$$M$Y$$$20240718$$CN$CO$
241083231$24108323$1$I$$20230203$20240718$20240718$EXP$$US-AstraZeneca-2023A031692$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241083241$24108324$1$I$$20191226$20240718$20240718$EXP$$US-AstraZeneca-2019SF92152$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241083251$24108325$1$I$20230331$20230412$20240718$20240718$EXP$$BR-AstraZeneca-2023A089679$ASTRAZENECA$$18825$DY$$F$Y$62$KG$20240718$$CN$BR$
241083261$24108326$1$I$$20220818$20240718$20240718$EXP$$US-AstraZeneca-2022A291773$ASTRAZENECA$$$$$F$Y$67.1$KG$20240718$$CN$US$
241083271$24108327$1$I$$20240711$20240718$20240718$30DAY$$US-GSK-US2024086309$GLAXOSMITHKLINE$$$$$M$Y$$$20240718$$CN$US$US
241083281$24108328$1$I$$20201021$20240718$20240718$EXP$$US-AstraZeneca-2020SF39281$ASTRAZENECA$$$$A$F$Y$101.3$KG$20240718$$HP$US$
241083291$24108329$1$I$20190306$20240705$20240718$20240718$EXP$$DE-ROCHE-2306196$ROCHE$$25$YR$A$F$Y$$$20240718$$CN$DE$DE
241083301$24108330$1$I$$20230118$20240718$20240718$EXP$$US-AstraZeneca-2023A017075$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241083313$24108331$3$F$20240821$20240815$20240718$20240823$EXP$$CA-TAKEDA-2024TUS072045$TAKEDA$$45$YR$$F$Y$$$20240823$$MD$CA$CA
241083321$24108332$1$I$$20201123$20240718$20240718$EXP$$US-AstraZeneca-2020SF58357$ASTRAZENECA$$$$$F$Y$77.1$KG$20240718$$CN$US$
241083332$24108333$2$F$20240101$20240828$20240718$20240915$EXP$$US-SA-2024SA208898$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240915$$MD$US$US
241083341$24108334$1$I$$20240710$20240718$20240718$EXP$$ES-CELLTRION INC.-2024ES017085$CELLTRION$Barrales CC, Lopez BE, Ruiz-Carrascosa JC and Ruiz-Villaverde R. Apremilast in the treatment of moderate-severepsoriasis in cancer patients. P I E L. 2019;34:375-384$$$$$Y$$$20240718$$HP$ES$ES
241083351$24108335$1$I$$20240716$20240718$20240718$PER$$US-HALEON-2187328$Haleon PLC$$45$YR$$M$Y$$$20240718$$CN$US$US
241083361$24108336$1$I$$20240606$20240718$20240718$PER$$US-GRUNENTHAL-2024-121330$AVERITAS$$$$A$M$Y$$$20240710$$HP$US$US
241083371$24108337$1$I$$20240708$20240718$20240718$EXP$$RU-AMGEN-RUSSP2024136350$AMGEN$Komarova A.A.; Sarkisyan H.A.; Khokhlova A.P. et al.. Severe forms of hereditary spherocytosis in children with congenital active cytomegalovirus infection. Children^s Infections. 2024;23 (1):55-61$$$C$$Y$$$20240718$$HP$RU$RU
241083383$24108338$3$F$20240620$20240919$20240718$20240924$EXP$$FR-JAZZ PHARMACEUTICALS-2024-FR-010594$JAZZ$$$$$$Y$$$20240923$$HP$FR$FR
241083391$24108339$1$I$$20240717$20240718$20240718$PER$$US-TAKEDA-2024TUS072404$TAKEDA$$$$$$Y$$$20240718$$CN$US$US
241083401$24108340$1$I$$20240624$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002986$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
241083411$24108341$1$I$$20240715$20240718$20240718$EXP$$CA-TAKEDA-2024TUS072265$TAKEDA$$$$$F$Y$$$20240718$$CN$CA$CA
241083421$24108342$1$I$20240701$20240715$20240718$20240718$EXP$$US-SA-2024SA208360$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240718$$MD$US$US
241083431$24108343$1$I$$20240715$20240718$20240718$EXP$PL-URPL-1-3696-2020$PL-SA-2024SA208295$SANOFI AVENTIS$$42$YR$A$M$Y$150$KG$20240718$$MD$PL$PL
241083451$24108345$1$I$20240620$20240620$20240718$20240718$PER$$US-GRUNENTHAL-2024-122154$AVERITAS$$83$YR$$M$Y$$$20240710$$CN$US$US
241083461$24108346$1$I$$20240628$20240718$20240718$PER$$US-GRUNENTHAL-2024-122391$AVERITAS$$69$YR$$M$Y$$$20240710$$HP$US$US
241083481$24108348$1$I$20140101$20240715$20240718$20240718$PER$$US-JNJFOC-20240741052$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240718$$HP$US$US
241083491$24108349$1$I$20240101$20240711$20240718$20240718$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039643$BOEHRINGER INGELHEIM$$52$YR$A$F$Y$88$KG$20240718$$CN$US$US
241083501$24108350$1$I$20240627$20240709$20240718$20240718$EXP$$CN-ROCHE-10000025116$ROCHE$$74$YR$E$F$Y$56$KG$20240718$$HP$CN$CN
241083511$24108351$1$I$$20240715$20240718$20240718$EXP$PT-INFARMED-F202407-116$PT-JNJFOC-20240744495$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240718$$PH$PT$PT
241083521$24108352$1$I$20240710$20240712$20240718$20240718$PER$$US-ALXN-202407USA000870US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241083531$24108353$1$I$20240101$20240709$20240718$20240718$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010872$JAZZ$$3$YR$$F$Y$$$20240718$$MD$JP$JP
241083542$24108354$2$F$$20240718$20240718$20240723$EXP$$US-ABBVIE-5838613$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241083551$24108355$1$I$$20240520$20240718$20240718$PER$$US-GRUNENTHAL-2024-120851$AVERITAS$$$$$M$Y$$$20240710$$CN$US$US
241083561$24108356$1$I$$20240710$20240718$20240718$EXP$$CA-APOTEX-2024AP008201$APOTEX$$63$YR$$F$Y$68$KG$20240718$$PH$CA$CA
241083571$24108357$1$I$20240101$20240513$20240718$20240718$PER$$US-GRUNENTHAL-2024-120025$AVERITAS$$$$E$M$Y$$$20240710$$HP$US$US
241083581$24108358$1$I$$20240717$20240718$20240718$PER$$US-ROCHE-10000029988$ROCHE$$68$YR$E$M$Y$$$20240718$$HP$US$US
241083591$24108359$1$I$20240613$20240624$20240718$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002969$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240718$$CN$US$US
241083602$24108360$2$F$$20240712$20240718$20240722$PER$$US-GRUNENTHAL-2024-122416$AVERITAS$$$$A$M$Y$$$20240722$$CN$US$US
241083611$24108361$1$I$$20240705$20240718$20240718$EXP$$GB-CIPLA LTD.-2024GB07327$CIPLA$$$$$$Y$$$20240718$$CN$GB$GB
241083621$24108362$1$I$20221105$20240716$20240718$20240718$EXP$$KR-009507513-2407KOR009457$MERCK$$51$YR$$M$Y$50.9$KG$20240718$$HP$KR$KR
241083631$24108363$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010392$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240718$$CN$US$US
241083641$24108364$1$I$$20240710$20240718$20240718$EXP$$CA-APOTEX-2024AP008215$APOTEX$$$$$M$Y$$$20240718$$MD$CA$CA
241083651$24108365$1$I$20240601$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009791$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240718$$CN$US$US
241083662$24108366$2$F$20240714$20240716$20240718$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407010482$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240722$$CN$US$US
241083671$24108367$1$I$$20240624$20240718$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002989$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241083681$24108368$1$I$$20240625$20240718$20240718$PER$$US-GLK-002355$GLAUKOS$$$$$$Y$$$20240718$$MD$US$US
241083691$24108369$1$I$20240219$20240711$20240718$20240718$EXP$ES-AEMPS-1541438$ES-CHEPLA-2024008838$CHEPLAPHARM$$61$YR$$F$Y$$$20240718$$MD$COUNTRY NOT SPECIFIED$ES
241083701$24108370$1$I$20240517$20240709$20240718$20240718$EXP$$JP-CHEPLA-2024008810$CHEPLAPHARM$$75$YR$$M$Y$76$KG$20240718$$PH$COUNTRY NOT SPECIFIED$JP
241083711$24108371$1$I$20240619$20240712$20240718$20240718$EXP$FR-AFSSAPS-RN2024000735$FR-CHEPLA-2024008882$CHEPLAPHARM$$49$YR$$M$Y$$$20240718$$MD$COUNTRY NOT SPECIFIED$FR
241083721$24108372$1$I$20240624$20240625$20240718$20240718$PER$$US-GLK-002356$GLAUKOS$$$$$$Y$$$20240718$$MD$US$US
241083741$24108374$1$I$$20240708$20240718$20240718$EXP$$US-EMD Serono-2024037836$EMD SERONO INC$$62$YR$A$M$Y$$$20240718$$CN$US$US
241083762$24108376$2$F$20240630$20240715$20240718$20240723$EXP$$US-ABBVIE-5841490$ABBVIE$$26$YR$$F$Y$$$20240723$$CN$US$US
241083774$24108377$4$F$$20240821$20240718$20240823$PER$$US-AMGEN-USASP2024141995$AMGEN$$$$$F$Y$$$20240823$$PH$US$US
241083782$24108378$2$F$20240627$20240905$20240718$20240913$EXP$$CA-CELLTRION INC.-2024CA017333$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
241083791$24108379$1$I$20240401$20240613$20240718$20240718$PER$$US-GRUNENTHAL-2024-121798$AVERITAS$$79$YR$$F$Y$$$20240710$$HP$US$US
241083801$24108380$1$I$$20240521$20240718$20240718$PER$$US-GRUNENTHAL-2024-120427$AVERITAS$$$$$F$Y$$$20240710$$CN$US$US
241083811$24108381$1$I$20240501$20240716$20240718$20240718$EXP$$UY-ABBVIE-5842739$ABBVIE$$61$YR$$F$Y$$$20240718$$CN$UY$UY
241083821$24108382$1$I$$20240624$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002971$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241083831$24108383$1$I$$20240715$20240718$20240718$PER$$US-JNJFOC-20240740941$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$HP$US$US
241083841$24108384$1$I$$20240715$20240718$20240718$EXP$$CA-ABBVIE-5842970$ABBVIE$$$$E$F$Y$$$20240718$$CN$CA$CA
241083861$24108386$1$I$$20201020$20240718$20240718$EXP$$CA-AstraZeneca-2020SF37701$ASTRAZENECA$$57$YR$$F$Y$$$20240718$$MD$CA$
241083871$24108387$1$I$$20200313$20240718$20240718$EXP$$US-AstraZeneca-2020SE39819$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241083881$24108388$1$I$$20240712$20240718$20240718$EXP$$BE-ROCHE-10000029469$ROCHE$$74$YR$E$F$Y$$$20240718$$MD$BE$BE
241083892$24108389$2$F$$20240911$20240718$20240914$EXP$$TR-ROCHE-10000026302$ROCHE$$48$YR$A$F$Y$$$20240914$$PH$TR$TR
241083901$24108390$1$I$$20200106$20240718$20240718$EXP$$CA-AstraZeneca-2020SE02555$ASTRAZENECA$$30$YR$$M$Y$122$KG$20240718$$MD$CA$
241083915$24108391$5$F$20240101$20240919$20240718$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019266$UNITED THERAPEUTICS$$$$$M$Y$81.633$KG$20240928$$$US$US
241083921$24108392$1$I$$20210402$20240718$20240718$EXP$$US-AstraZeneca-2021A272413$ASTRAZENECA$$$$$F$Y$$$20240718$$HP$US$
241083931$24108393$1$I$$20221007$20240718$20240718$EXP$$US-AstraZeneca-2022A342288$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241083941$24108394$1$I$$20200312$20240718$20240718$EXP$$US-AstraZeneca-2020SE37953$ASTRAZENECA$$33$YR$$F$Y$$$20240718$$CN$US$
241083951$24108395$1$I$20220609$20220613$20240718$20240718$EXP$$US-AstraZeneca-2022A222016$ASTRAZENECA$$22674$DY$$M$Y$$$20240718$$CN$US$
241083961$24108396$1$I$$20210615$20240718$20240718$EXP$$US-AstraZeneca-2021A532668$ASTRAZENECA$$$$$F$Y$$$20240718$$HP$US$
241083971$24108397$1$I$$20240708$20240718$20240718$EXP$$US-ROCHE-10000020626$ROCHE$$$$E$M$Y$$$20240718$$CN$US$US
241083981$24108398$1$I$20200518$20200520$20240718$20240718$EXP$$US-AstraZeneca-2020SE67256$ASTRAZENECA$$23344$DY$$F$Y$$$20240718$$CN$US$
241083991$24108399$1$I$$20240712$20240718$20240718$EXP$$US-ROCHE-10000025891$ROCHE$$66$YR$E$F$Y$$$20240718$$CN$US$US
241084001$24108400$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141658$AMGEN$$$$$$Y$$$20240718$$PH$US$US
241084012$24108401$2$F$20240711$20240805$20240718$20240813$30DAY$$US-AMGEN-USASP2024139549$AMGEN$$64$YR$A$F$Y$108$KG$20240813$$PH$US$US
241084021$24108402$1$I$20220101$20240705$20240718$20240718$EXP$$GB-CIPLA LTD.-2024GB07381$CIPLA$$$$$$Y$$$20240718$$CN$GB$GB
241084033$24108403$3$F$20240717$20240911$20240718$20240912$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040462$BOEHRINGER INGELHEIM$$54$YR$A$M$Y$72$KG$20240912$$MD$JP$JP
241084041$24108404$1$I$$20240711$20240718$20240718$EXP$$GB-GSK-GB2024086891$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$GB$GB
241084051$24108405$1$I$$20240717$20240718$20240718$EXP$$AU-ROCHE-10000029417$ROCHE$$3$YR$C$F$Y$$$20240718$$MD$AU$AU
241084061$24108406$1$I$20240712$20240712$20240718$20240718$PER$$US-ALXN-202407USA000868US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241084071$24108407$1$I$$20240710$20240718$20240718$EXP$$CA-CELLTRION INC.-2024CA016880$CELLTRION$$$$$$Y$$$20240718$$CN$CA$CA
241084081$24108408$1$I$$20240716$20240718$20240718$EXP$$US-ABBVIE-5843506$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241084092$24108409$2$F$20240531$20240802$20240718$20240806$EXP$$US-ROCHE-10000029307$ROCHE$$66$YR$E$F$Y$$$20240806$$CN$US$US
241084101$24108410$1$I$20240328$20240709$20240718$20240718$EXP$$DK-AUROBINDO-AUR-APL-2024-034535$AUROBINDO$$52$YR$$F$Y$104$KG$20240718$$MD$DK$DK
241084111$24108411$1$I$20240710$20240711$20240718$20240718$EXP$$JP-ROCHE-10000028508$ROCHE$$8$DEC$E$F$Y$$$20240718$$MD$JP$JP
241084121$24108412$1$I$20210901$20240711$20240718$20240718$EXP$$US-ROCHE-10000025133$ROCHE$$54$YR$A$F$Y$59.87$KG$20240718$$CN$US$US
241084132$24108413$2$F$20240711$20240715$20240718$20240725$EXP$$CN-ROCHE-10000027382$ROCHE$$70$YR$E$M$Y$65$KG$20240726$$HP$CN$CN
241084142$24108414$2$F$$20240729$20240718$20240806$EXP$$JP-009507513-2407JPN001397J$MERCK$$6$DEC$$M$Y$$$20240806$$MD$JP$JP
241084151$24108415$1$I$20240701$20240716$20240718$20240718$EXP$$US-ABBVIE-5843622$ABBVIE$$35$YR$$M$Y$$$20240718$$HP$US$US
241084161$24108416$1$I$$20240709$20240718$20240718$EXP$$HU-ROCHE-10000027076$ROCHE$Horvath L, Soter S, Temesi G. Transformation of adenocarcinoma with EGFR sensitizing mutation to small cell lung cancer - Case report. Medicina Thoracalis. 2024;77 (3):191.$26$YR$A$M$Y$$$20240718$$HP$HU$HU
241084171$24108417$1$I$$20240705$20240718$20240718$EXP$$US-ALVOGEN-2024095066$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$33$YR$$M$Y$$$20240718$$HP$US$US
241084182$24108418$2$F$$20240709$20240718$20240925$EXP$$TH-ALK-ABELLO A/S-2024AA002831$ALK-ABELLO$Suksawat Y, Wongteerasut A.. Eosinophilic esophagitis and gastritis as a result of dustmite sublingual immunotherapy. Allergo J Int. 2024$$$$$Y$$$20240925$$MD$TH$TH
241084191$24108419$1$I$$20240712$20240718$20240718$30DAY$$US-GSK-US2024087786$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241084201$24108420$1$I$20240622$20240716$20240718$20240718$EXP$$RO-ROCHE-10000029618$ROCHE$$37$YR$A$M$Y$$$20240718$$MD$RO$RO
241084211$24108421$1$I$$20240709$20240718$20240718$EXP$$CA-APOTEX-2024AP008172$APOTEX$$53$YR$$M$Y$$$20240718$$HP$CA$CA
241084222$24108422$2$F$20231201$20240726$20240718$20240801$EXP$$CO-UCBSA-2024035940$UCB$$0$YR$$F$Y$$$20240801$$CN$CO$CO
241084231$24108423$1$I$$20240710$20240718$20240718$EXP$$US-AMGEN-USASP2024137517$AMGEN$Demirci H. Posterior Uveitis in Ocular-Involving Chronic Lymphocytic Leukemia and the Utility of Negative MYD88 L265P Testing in the Diagnosis. Ocular Oncology and Pathology. 2024;10 (2):103-113$58$YR$A$F$Y$$$20240718$$HP$US$US
241084241$24108424$1$I$20240508$20240710$20240718$20240718$EXP$$IN-ROCHE-3212724$ROCHE$$74$YR$E$M$Y$59.5$KG$20240718$$CN$IN$IN
241084252$24108425$2$F$$20240716$20240718$20240723$EXP$$IE-JNJFOC-20240737756$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240723$$MD$IE$IE
241084261$24108426$1$I$$20240705$20240718$20240718$EXP$$US-ALVOGEN-2024095065$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$19$YR$$F$Y$$$20240718$$HP$US$US
241084271$24108427$1$I$$20240711$20240718$20240718$EXP$$CA-ABBVIE-5839520$ABBVIE$$$$E$F$Y$$$20240718$$CN$CA$CA
241084281$24108428$1$I$$20240709$20240718$20240718$PER$$US-ABBVIE-5839072$ABBVIE$$$$$$Y$$$20240716$$HP$US$US
241084291$24108429$1$I$$20240713$20240718$20240718$EXP$$IT-UCBSA-2024036285$UCB$$$$$M$Y$$$20240718$$CN$IT$IT
241084301$24108430$1$I$$20240705$20240718$20240718$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109578$ZYDUS PHARM$Hazique M, Grewal S.. A dance of hearts rhythm-unveiling lyme carditis. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):2882$$$$$Y$$$20240718$$HP$US$US
241084311$24108431$1$I$20240523$20240708$20240718$20240718$EXP$FR-AFSSAPS-NT2024000766$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109643$ZYDUS PHARM$$$$$$Y$$$20240718$$HP$FR$FR
241084321$24108432$1$I$20230101$20240710$20240718$20240718$EXP$$CA-ROCHE-3379622$ROCHE$$64$YR$A$M$Y$$$20240718$$CN$CA$CA
241084332$24108433$2$F$$20240820$20240718$20240829$30DAY$$US-GSK-US2024084949$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
241084342$24108434$2$F$20240715$20240722$20240718$20240726$PER$$US-AMGEN-USASP2024141044$AMGEN$$59$YR$A$M$Y$$$20240726$$CN$US$US
241084351$24108435$1$I$20230901$20240711$20240718$20240718$EXP$$FR-AMGEN-FRASP2024138025$AMGEN$$35$YR$A$M$Y$88$KG$20240718$$MD$FR$FR
241084361$24108436$1$I$20240101$20240712$20240718$20240718$PER$$US-ABBVIE-5841784$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241084371$24108437$1$I$20210101$20240708$20240718$20240718$EXP$$FR-AMGEN-FRASP2024138497$AMGEN$Smolenschi C. Case report: Microsatellite instability determination is not always black and white in Lynch syndrome diagnosis. Frontiers in Oncology. 2024;14:1-6$26$YR$A$M$Y$$$20240718$$HP$FR$FR
241084381$24108438$1$I$20240401$20240709$20240718$20240718$EXP$PT-INFARMED-R202406-678$PT-AMGEN-PRTSP2024135902$AMGEN$$48$YR$A$F$Y$67$KG$20240718$$MD$PT$PT
241084391$24108439$1$I$$20240712$20240718$20240718$EXP$$CL-EMD Serono-2024038457$EMD SERONO INC$$$$$$Y$$$20240718$$MD$CL$CL
241084401$24108440$1$I$$20240716$20240718$20240718$PER$$US-JNJFOC-20240741021$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
241084411$24108441$1$I$20110301$20240715$20240718$20240718$PER$$US-JNJFOC-20240741303$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20240718$$HP$US$US
241084422$24108442$2$F$20240710$20240806$20240718$20240812$30DAY$$US-AMGEN-USASP2024138598$AMGEN$$78$YR$E$M$Y$102$KG$20240812$$HP$US$US
241084433$24108443$3$F$20240514$20240809$20240718$20240821$EXP$$CA-CELLTRION INC.-2024CA017335$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
241084441$24108444$1$I$$20200225$20240718$20240718$EXP$$US-AstraZeneca-2020SE30488$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241084451$24108445$1$I$$20240705$20240718$20240718$EXP$$US-ALVOGEN-2024095064$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and  prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$23$YR$$M$Y$$$20240718$$HP$US$US
241084461$24108446$1$I$20240619$20240709$20240718$20240718$EXP$PT-INFARMED-R202406-538$PT-TEVA-VS-3219424$TEVA$$30$YR$$F$Y$$$20240718$$PH$PT$PT
241084471$24108447$1$I$$20210610$20240718$20240718$EXP$$US-AstraZeneca-2021A520058$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241084481$24108448$1$I$$20200107$20240718$20240718$EXP$$CA-AstraZeneca-2020SE03890$ASTRAZENECA$$65$YR$$M$Y$$$20240718$$MD$CA$
241084491$24108449$1$I$$20210314$20240718$20240718$EXP$$CA-AstraZeneca-2021A151894$ASTRAZENECA$$38$YR$$F$Y$$$20240718$$MD$CA$
241084501$24108450$1$I$$20240628$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06512$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241084511$24108451$1$I$$20240708$20240718$20240718$EXP$$CA-AMGEN-CANSP2024138017$AMGEN$Tam V.C.; Lim C.A.; Amaro C.P. et al.. Outcomes of hepatocellular carcinoma patients treated in the lenvatinib and immunotherapy era (2018-2021) compared to the sorafenib era (2008-2018). Cancer Medicine. 2024;13 (13):1-8$$$$$Y$$$20240718$$HP$CA$CA
241084522$24108452$2$F$20240716$20240719$20240718$20240724$PER$$US-AMGEN-USASP2024141821$AMGEN$$54$YR$A$M$Y$$$20240724$$CN$US$US
241084531$24108453$1$I$$20200520$20240718$20240718$EXP$$US-AstraZeneca-2020SE67652$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241084541$24108454$1$I$$20201022$20240718$20240718$EXP$$CA-AstraZeneca-2020SF40273$ASTRAZENECA$$$$$F$Y$$$20240718$$MD$CA$
241084551$24108455$1$I$$20240710$20240718$20240718$EXP$$CN-AMGEN-CHNSP2024138225$AMGEN$Xu F.; Li Y.; Gu R. et.al.. Low-dose atorvastatin calcium combined with evolocumab: effect on regulatory proteins, lipid profiles, and cardiac function in coronary heart disease patients. American Journal of Translational Research. 2024;16 (6):2334-2345$$$$$Y$$$20240718$$MD$CN$CN
241084561$24108456$1$I$$20200318$20240718$20240718$EXP$$US-AstraZeneca-2020SE42914$ASTRAZENECA$$59$YR$$F$Y$$$20240718$$CN$US$
241084571$24108457$1$I$$20210923$20240718$20240718$EXP$$US-AstraZeneca-2021A745061$ASTRAZENECA$$80$YR$$F$Y$122.5$KG$20240718$$CN$US$
241084581$24108458$1$I$$20210622$20240718$20240718$EXP$$US-AstraZeneca-2021A553594$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241084591$24108459$1$I$$20210908$20240718$20240718$EXP$$US-AstraZeneca-2021A721275$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241084601$24108460$1$I$20201008$20201012$20240718$20240718$EXP$$US-AstraZeneca-2020SF34669$ASTRAZENECA$$3$YR$C$F$Y$16.8$KG$20240718$$CN$US$
241084611$24108461$1$I$$20200109$20240718$20240718$EXP$$US-AstraZeneca-2020SE06090$ASTRAZENECA$$76$YR$$F$Y$$$20240718$$CN$US$
241084621$24108462$1$I$20210801$20210902$20240718$20240718$EXP$$ZA-AstraZeneca-2021A712281$ASTRAZENECA$$56$YR$$F$Y$$$20240718$$CN$ZA$
241084631$24108463$1$I$$20220915$20240718$20240718$EXP$$GB-AstraZeneca-2022A319467$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$GB$
241084641$24108464$1$I$$20240709$20240718$20240718$EXP$$CA-APOTEX-2024AP008144$APOTEX$$74$YR$$M$Y$$$20240718$$CN$CA$CA
241084651$24108465$1$I$$20220725$20240718$20240718$EXP$$RO-AstraZeneca-2022A267348$ASTRAZENECA$$72$YR$$F$Y$$$20240718$$CN$RO$
241084661$24108466$1$I$$20201105$20240718$20240718$EXP$$US-AstraZeneca-2020SF46453$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241084671$24108467$1$I$$20201218$20240718$20240718$EXP$$US-AstraZeneca-2020SF71258$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241084681$24108468$1$I$20200216$20200408$20240718$20240718$EXP$$CO-AstraZeneca-2020SE49325$ASTRAZENECA$$23476$DY$$F$Y$$$20240718$$CN$CO$
241084691$24108469$1$I$20240521$20240712$20240718$20240718$EXP$$US-RIGEL-20240700059$RIGEL PHARMACEUTICALS$$69$YR$$M$Y$$$20240718$$CN$US$US
241084701$24108470$1$I$$20240710$20240718$20240718$EXP$$JP-AstraZeneca-2024A159600$ASTRAZENECA$$67$YR$$M$Y$$$20240718$$MD$JP$
241084721$24108472$1$I$$20201210$20240718$20240718$EXP$$AU-AstraZeneca-2020SF67335$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$AU$
241084731$24108473$1$I$$20240711$20240718$20240718$EXP$$CN-ROCHE-10000027808$ROCHE$Xu J, Ding Y, Qu Z, Yu F. Differences in risk of serious infections between patients with secondary versus primary nephropathy following rituximab treatment: a retrospective cohort study. Frontiers in immunology. 2024-Jun-11;15:1-12. doi:10.3389/fimmu.2024.1390997.$27$YR$A$F$Y$$$20240718$$HP$CN$CN
241084741$24108474$1$I$$20240715$20240718$20240718$PER$$US-AstraZeneca-2024A161403$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241084751$24108475$1$I$$20221115$20240718$20240718$EXP$$US-AstraZeneca-2022A379673$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241084761$24108476$1$I$$20200117$20240718$20240718$EXP$$CA-AstraZeneca-2020SE10761$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$CA$
241084771$24108477$1$I$20240713$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113870$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240718$$CN$US$US
241084781$24108478$1$I$20240614$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113650$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240718$$CN$US$US
241084792$24108479$2$F$$20240827$20240718$20240828$PER$$US-JNJFOC-20240745096$JOHNSON AND JOHNSON$$70$YR$E$$Y$$$20240828$$CN$US$US
241084801$24108480$1$I$20240101$20240708$20240718$20240718$EXP$$JP-009507513-2407JPN001336J$MERCK$$65$YR$$F$Y$$$20240718$$MD$JP$JP
241084811$24108481$1$I$20221003$20240716$20240718$20240718$EXP$FR-AFSSAPS-MA2024001029$FR-ORGANON-O2407FRA001406$ORGANON$$71$YR$$F$Y$83$KG$20240718$$CN$FR$FR
241084821$24108482$1$I$$20240708$20240718$20240718$30DAY$$US-GSK-US2024084953$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241084831$24108483$1$I$$20240708$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-032203$AUROBINDO$$$$$$Y$$$20240718$$CN$GB$GB
241084841$24108484$1$I$$20240712$20240718$20240718$EXP$$US-GSK-US2024087715$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$US$US
241084851$24108485$1$I$$20240628$20240718$20240718$PER$$US-NOVITIUMPHARMA-2024USNVP01312$NOVITIUM PHARMA$$$$$F$Y$$$20240718$$CN$US$US
241084861$24108486$1$I$$20240716$20240718$20240718$EXP$$NVSC2024US147109$NOVARTIS$$$$$M$Y$93$KG$20240718$$CN$US$US
241084871$24108487$1$I$$20240705$20240718$20240718$EXP$$US-ALVOGEN-2024095063$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$36$YR$$M$Y$$$20240718$$HP$US$US
241084883$24108488$3$F$20240101$20240828$20240718$20240906$EXP$$CA-CELLTRION INC.-2024CA010738$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
241084891$24108489$1$I$20221024$20240710$20240718$20240718$EXP$$FR-CELLTRION INC.-2024FR017041$CELLTRION$$$$$$Y$$$20240718$$MD$FR$FR
241084901$24108490$1$I$20230710$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405031246208040-FRJDH$GB-MSNLABS-2024MSNSPO01543$MSN LABORATORIES$$$$$$Y$$$20240718$$CN$GB$GB
241084912$24108491$2$F$20240301$20240718$20240718$20240729$EXP$$PT-ASPEN-GLO2024PT004711$ASPEN$$$$$$Y$$$20240729$$MD$PT$PT
241084922$24108492$2$F$$20240801$20240718$20240809$EXP$$US-TEVA-VS-3219459$TEVA$Adams EW, Madison J, Bielick Kotkowski C. Nocardiosis With Rapid Radiographic Progression. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A2416.; Adams EW, Madison J, Bielick Kotkowski C. Nocardiosis With Rapid Radiographic Progression. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A2416.$85$YR$$M$Y$$$20240809$$HP$US$US
241084931$24108493$1$I$$20240715$20240718$20240718$PER$$US-ROCHE-10000027859$ROCHE$$$$$$Y$$$20240718$$CN$US$US
241084941$24108494$1$I$20240507$20240716$20240718$20240718$EXP$DE-PEI-CADR2024328024$DE-ROCHE-10000027759$ROCHE$$82$YR$E$F$Y$65$KG$20240718$$CN$DE$DE
241084951$24108495$1$I$20230625$20230626$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00727$TARO$$$$$$Y$$$20240718$$CN$US$US
241084961$24108496$1$I$$20230612$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00672$TARO$$$$$$Y$$$20240718$$CN$US$US
241084971$24108497$1$I$$20230623$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00715$TARO$$$$$$Y$$$20240718$$CN$US$US
241084981$24108498$1$I$$20230920$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01008$TARO$$$$$$Y$$$20240718$$CN$US$US
241084991$24108499$1$I$$20230922$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01010$TARO$$$$$$Y$$$20240718$$CN$US$US
241085001$24108500$1$I$$20230805$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00867$TARO$$$$$$Y$$$20240718$$CN$US$US
241085011$24108501$1$I$$20230817$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00903$TARO$$$$$$Y$$$20240718$$CN$US$US
241085021$24108502$1$I$$20230908$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00975$TARO$$$$$$Y$$$20240718$$PH$US$US
241085031$24108503$1$I$20231024$20231025$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01145$TARO$$$$$$Y$$$20240718$$CN$US$US
241085041$24108504$1$I$$20240205$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00161$TARO$$$$$$Y$$$20240718$$CN$US$US
241085051$24108505$1$I$$20240131$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00149$TARO$$$$$$Y$$$20240718$$CN$US$US
241085061$24108506$1$I$$20240104$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00039$TARO$$$$$$Y$$$20240718$$HP$US$US
241085071$24108507$1$I$$20231205$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01290$TARO$$$$$M$Y$$$20240718$$CN$US$US
241085081$24108508$1$I$20240523$20240710$20240718$20240718$EXP$$CA-CELLTRION INC.-2024CA013799$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
241085091$24108509$1$I$$20240715$20240718$20240718$EXP$$CA-GENMAB-2024-02561$GENMAB$$64$YR$$M$Y$$$20240718$$MD$CA$CA
241085101$24108510$1$I$20231005$20231009$20240718$20240718$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00987$TARO$$$$$$Y$$$20240718$$CN$US$US
241085113$24108511$3$F$20240701$20240725$20240718$20240802$EXP$$JP-AMGEN-JPNSP2024138974$AMGEN$$69$YR$E$M$Y$$$20240802$$MD$JP$JP
241085121$24108512$1$I$20240523$20240718$20240718$20240718$EXP$FR-AFSSAPS-AVLL2024000171$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040491$BOEHRINGER INGELHEIM$$52$YR$A$M$Y$$$20240718$$MD$FR$FR
241085131$24108513$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220217$TEVA$$64$YR$$F$Y$$$20240718$$HP$CA$CA
241085141$24108514$1$I$20240611$20240712$20240718$20240718$PER$$US-JNJFOC-20240733418$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240718$$HP$US$US
241085154$24108515$4$F$$20240905$20240718$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002973$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
241085161$24108516$1$I$20240715$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141674$AMGEN$$77$YR$E$M$Y$$$20240718$$CN$US$US
241085171$24108517$1$I$20240601$20240629$20240718$20240718$PER$$US-JNJFOC-20240703623$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
241085183$24108518$3$F$20230703$20240828$20240718$20240906$EXP$$NL-CELLTRION INC.-2024NL017065$CELLTRION$$$$$$Y$$$20240906$$MD$NL$NL
241085191$24108519$1$I$$20240710$20240718$20240718$EXP$$CA-SAMIL-GLO2024CA000203$ASPEN$$$$$$Y$$$20240718$$CN$CA$CA
241085211$24108521$1$I$20240603$20240715$20240718$20240718$EXP$$US-ROCHE-10000027407$ROCHE$$3$YR$C$M$Y$$$20240718$$CN$US$US
241085222$24108522$2$F$20230701$20240726$20240718$20240801$EXP$$CO-UCBSA-2024036022$UCB$$29$YR$$F$Y$68$KG$20240801$$CN$CO$CO
241085233$24108523$3$F$$20240822$20240718$20240903$EXP$$CZ-AUROBINDO-AUR-APL-2024-035127$AUROBINDO$Flanderov? I.. Canagliflozin ? the right  treatment for a rock band drummer  with type 2 diabetes(Canagliflozin - the right treatment for a rock  band drummer with type 2 diabetes). DIABETOLOGY. 2024;22(2):10-15$46$YR$$M$Y$101$KG$20240903$$MD$CZ$CZ
241085241$24108524$1$I$$20240709$20240718$20240718$EXP$$TW-AMGEN-TWNSP2024136976$AMGEN$Tsai C.; Lin C.; Chou Y. et al.. Clinical Applications of Comprehensive Genomic Profiling in Advanced Non-Small-Cell Lung Cancer-A Case Series. Current oncology. 2024;31 (6):3161-3176$51$YR$A$M$Y$$$20240718$$HP$TW$TW
241085251$24108525$1$I$$20240709$20240718$20240718$EXP$$TW-AMGEN-TWNSP2024136945$AMGEN$Tsai C.; Lin C.; Chou Y. et al.. Clinical Applications of Comprehensive Genomic Profiling in Advanced Non-Small-Cell Lung Cancer-A Case Series. Current oncology. 2024;31 (6):3161-3176$56$YR$A$M$Y$$$20240718$$HP$TW$TW
241085261$24108526$1$I$$20240711$20240718$20240718$EXP$$BE-ASPEN-GLO2020BE013236$ASPEN$Amant F, Vandenbroucke T, Verheecke M, Fumagalli M, Halaska M, Boere I et al. Pediatric outcome after maternal cancer diagnosed during pregnancy. THE NEW ENGLAND JOURNAL OF MEDICINE. 2015;11(1)$$$$$Y$$$20240718$$HP$BE$BE
241085271$24108527$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034600$AUROBINDO$Habib A, Butt K, Ibrahim R, Shaaban A, Lee HS. BRASH syndrome A rare but reversible cause of sinus node dysfunction. HeartRhythm. 2024;10(6):398-401$57$YR$$F$Y$$$20240718$$MD$US$US
241085281$24108528$1$I$$20240705$20240718$20240718$EXP$$US-ALVOGEN-2024095062$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$41$YR$$M$Y$$$20240718$$HP$US$US
241085291$24108529$1$I$$20240715$20240718$20240718$PER$$US-ABBVIE-5841450$ABBVIE$$$$$$Y$$$20240718$$HP$US$US
241085311$24108531$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-035347$AUROBINDO$Mccaughey C, Elezaby A, Varr B, Mendoza MD, Rajan SS, Nasiri HU. Pulmonary Artery Catheter Directed Alteplase Infusion to Treat Prosthetic Mitral Valve Thrombosis in a Patient on ECMO.. Am-JRespir-Crit-Care-Med. 2024$50$YR$$M$Y$$$20240718$$HP$US$US
241085332$24108533$2$F$20240613$20240708$20240718$20240718$EXP$IT-MINISAL02-993399$IT-STRIDES ARCOLAB LIMITED-2024SP008174$STRIDES$$77$YR$$M$Y$70$KG$20240718$$MD$IT$IT
241085342$24108534$2$F$20230101$20240812$20240718$20240826$EXP$$GB-AUROBINDO-AUR-APL-2024-034150$AUROBINDO$Teoh PJ, McGuire E, Borman AM, Gorton R, Wilson AJ, Merrion C, et al.. Invasive Trichoderma longibrachiatum infection in a neutropaenic patient.. Medical Mycology Case Reports.. 2024;45:100656$51$YR$$F$Y$$$20240826$$MD$GB$GB
241085351$24108535$1$I$$20240715$20240718$20240718$EXP$$NL-ABBVIE-5843673$ABBVIE$$78$YR$$M$Y$$$20240718$$CN$NL$NL
241085361$24108536$1$I$$20240712$20240718$20240718$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021685$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240718$$$US$US
241085371$24108537$1$I$$20240705$20240718$20240718$EXP$$US-ALVOGEN-2024095059$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$52$YR$$F$Y$$$20240718$$HP$US$US
241085381$24108538$1$I$20240101$20240716$20240718$20240718$EXP$$US-UCBSA-2024016908$UCB$$$$$M$Y$$$20240718$$CN$US$US
241085392$24108539$2$F$$20240726$20240718$20240807$EXP$$BE-AUROBINDO-AUR-APL-2024-034611$AUROBINDO$Geusens D, Dierickx D, Carton S, Van Cutsem E, Dekervel J.. Immunotherapy Rechallenge After Checkpoint Inhibitor Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review.. Clin-Colorectal-Cancer. 2024;23(2):194-197$48$YR$$M$Y$$$20240807$$HP$BE$BE
241085401$24108540$1$I$20240302$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405072058043420-FPMZN$GB-JUBILANT PHARMA LTD-2024GB000940$JUBILANT$$70$YR$$M$Y$122$KG$20240718$$CN$GB$GB
241085411$24108541$1$I$20240601$20240710$20240718$20240718$PER$$US-NOVITIUMPHARMA-2024USNVP01318$NOVITIUM PHARMA$$61$YR$A$F$Y$132$KG$20240718$$CN$US$US
241085422$24108542$2$F$20240710$20240716$20240718$20240726$EXP$$DE-TAKEDA-2024TUS071952$TAKEDA$$$$E$M$Y$71.4$KG$20240726$$MD$DE$DE
241085433$24108543$3$F$20240701$20240725$20240718$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-021705$UNITED THERAPEUTICS$$49$YR$$F$Y$48.073$KG$20240727$$$US$US
241085444$24108544$4$F$20230718$20240829$20240718$20240907$EXP$$JP-AMGEN-JPNSP2024140057$AMGEN$$77$YR$E$M$Y$$$20240906$$MD$JP$JP
241085452$24108545$2$F$$20240717$20240718$20240725$EXP$$BE-SA-2024SA206741$SANOFI AVENTIS$Meganck S, Raevens S, Ferdinande K, Verhelst X, Hoorens A, Degroote H et al.. Recurrent rejections after liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient.. Acta clinica Belgica.. 2024;Unknown:1-8$32$YR$A$F$Y$$$20240725$$HP$BE$BE
241085471$24108547$1$I$$20240714$20240718$20240718$PER$$US-ABBVIE-5841498$ABBVIE$$$$$F$Y$$$20240718$$HP$US$US
241085481$24108548$1$I$$20240715$20240718$20240718$PER$$US-ABBVIE-5841529$ABBVIE$$$$$$Y$$$20240718$$MD$US$US
241085491$24108549$1$I$$20240701$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06563$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241085501$24108550$1$I$$20240624$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002979$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
241085522$24108552$2$F$20240709$20240715$20240718$20240725$PER$$US-ABBVIE-5839928$ABBVIE$$37$YR$$F$Y$98.429$KG$20240725$$CN$US$US
241085531$24108553$1$I$$20240711$20240718$20240718$EXP$$US-009507513-2407USA007221$MERCK$Wix S, Scambler W, Trang V, Malik RA. TET2-mutant undifferentiated pleomorphic sarcoma metastatic to lung and brain. BMJ Case Reports. 2024;17(6)$$$E$F$Y$$$20240718$$HP$US$US
241085541$24108554$1$I$20240416$20240715$20240718$20240718$EXP$DE-PEI-CADR2024329200$DE-SA-2024SA208305$SANOFI AVENTIS$$57$YR$A$F$Y$65$KG$20240718$$MD$DE$DE
241085553$24108555$3$F$$20240723$20240718$20240731$EXP$$ES-ABBVIE-5843746$ABBVIE$$66$YR$$M$Y$$$20240731$$MD$ES$ES
241085561$24108556$1$I$20240604$20240704$20240718$20240718$EXP$$FR-CIPLA LTD.-2024FR06490$CIPLA$$$$$$Y$$$20240718$$MD$FR$FR
241085571$24108557$1$I$20240716$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010573$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240718$$CN$US$US
241085581$24108558$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010510$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240718$$CN$US$US
241085591$24108559$1$I$$20240705$20240718$20240718$EXP$$US-ALVOGEN-2024095058$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$64$YR$$M$Y$$$20240718$$HP$US$US
241085601$24108560$1$I$20240617$20240708$20240718$20240718$EXP$$SE-STRIDES PHARMA UK LTD.-2024SP008360$STRIDES$$1$YR$$M$Y$$$20240718$$MD$SE$SE
241085611$24108561$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141457$AMGEN$$$$$$Y$$$20240718$$HP$US$US
241085632$24108563$2$F$$20240718$20240718$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113649$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$51.71$KG$20240723$$CN$US$US
241085641$24108564$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113938$BRISTOL MYERS SQUIBB$$81$YR$E$$Y$$$20240718$$MD$US$US
241085651$24108565$1$I$$20240711$20240718$20240718$EXP$$CA-SA-2024SA205968$SANOFI AVENTIS$$48$YR$A$F$Y$68$KG$20240718$$HP$CA$CA
241085661$24108566$1$I$20240607$20240713$20240718$20240718$EXP$$CO-UCBSA-2024036274$UCB$$89$YR$$F$Y$$$20240718$$CN$CO$CO
241085674$24108567$4$F$$20240911$20240718$20240913$EXP$$ES-MYLANLABS-2024M1065666$MYLAN$Rubio-Mora E, Rodr?guez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transplant Infectious Disease: an Official Journal of the Transplantation Societ. 2024;26(3):1-3$5$MON$$M$Y$$$20240913$$HP$ES$ES
241085682$24108568$2$F$$20240801$20240718$20240810$EXP$$US-TEVA-VS-3220453$TEVA$Saleh A, D^Amico A, Hasnie A, Clarkson S, Heindl B. Atrial arrhythmias and acute pericarditis triggered by bleach ingestion-associated oesophageal perforation: a case report. Eur-Heart-J-Case-Rep 2024; 8 (2): no pagination.; Saleh A, D^Amico A, Hasnie A, Clarkson S, Heindl B. Atrial arrhythmias and acute pericarditis triggered by bleach ingestion-associated oesophageal perforation: a case report. Eur-Heart-J-Case-Rep 2024; 8 (2): no pagination.$36$YR$$M$Y$$$20240810$$HP$US$US
241085692$24108569$2$F$20240531$20240906$20240718$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-035299$AUROBINDO$$79$YR$$M$Y$64$KG$20240919$$MD$FR$FR
241085701$24108570$1$I$20221026$20240710$20240718$20240718$EXP$$JP-009507513-2212JPN004020J$MERCK$$63$YR$$M$Y$66$KG$20240718$$PH$JP$JP
241085711$24108571$1$I$$20240716$20240718$20240718$EXP$$US-GSK-US2024AMR089915$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241085721$24108572$1$I$$20240716$20240718$20240718$EXP$AU-TGA-0000813464$AU-SANDOZ INC.-SDZ2024AU065981$SANDOZ$$$$$$Y$$$20240718$$HP$AU$AU
241085741$24108574$1$I$20240501$20240624$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002977$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240718$$CN$US$US
241085751$24108575$1$I$20200203$20200730$20240718$20240718$EXP$$ZA-AstraZeneca-2020SE96627$ASTRAZENECA$$19511$DY$$F$Y$$$20240718$$CN$ZA$
241085761$24108576$1$I$20240101$20240716$20240718$20240718$EXP$$AU-SANDOZ INC.-SDZ2024AU065737$SANDOZ$$53$YR$$F$Y$$$20240718$$MD$AU$AU
241085771$24108577$1$I$20240313$20240716$20240718$20240718$EXP$FR-AFSSAPS-AN2024000668$FR-ORGANON-O2407FRA001435$ORGANON$$64$YR$$M$Y$$$20240718$$PH$FR$FR
241085811$24108581$1$I$$20230201$20240718$20240718$EXP$$US-AstraZeneca-2023A029000$ASTRAZENECA$$$$$F$Y$44$KG$20240718$$CN$US$
241085821$24108582$1$I$20240101$20240708$20240718$20240718$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014147$UNITED THERAPEUTICS$$$$$F$Y$$$20240718$$$US$US
241085831$24108583$1$I$$20240715$20240718$20240718$PER$$US-JNJFOC-20240739160$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$PH$US$US
241085841$24108584$1$I$$20191203$20240718$20240718$EXP$$US-AstraZeneca-2019SF75355$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241085851$24108585$1$I$$20221214$20240718$20240718$EXP$$US-AstraZeneca-2022A408360$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241085864$24108586$4$F$20240401$20240812$20240718$20240820$EXP$$MY-EMD Serono-2024037880$EMD SERONO INC$$11$YR$C$M$Y$$$20240820$$CN$MY$MY
241085872$24108587$2$F$$20240718$20240718$20240726$EXP$$CA-TAKEDA-2024TUS069911$TAKEDA$$$$$M$Y$$$20240726$$MD$CA$CA
241085881$24108588$1$I$20240323$20240708$20240718$20240718$EXP$FR-AFSSAPS-TO2024001222$FR-STRIDES ARCOLAB LIMITED-2024SP008397$STRIDES$$52$YR$$M$Y$84$KG$20240718$$PH$FR$FR
241085891$24108589$1$I$$20210615$20240718$20240718$EXP$$US-AstraZeneca-2021A534805$ASTRAZENECA$$$$$M$Y$66.2$KG$20240718$$MD$US$
241085902$24108590$2$F$$20240918$20240718$20240923$EXP$$CA-TAKEDA-2024TUS071676$TAKEDA$$$$$M$Y$$$20240923$$MD$CA$CA
241085911$24108591$1$I$20191201$20200415$20240718$20240718$EXP$$US-AstraZeneca-2020SE52229$ASTRAZENECA$$870$MON$$M$Y$$$20240718$$CN$US$
241085921$24108592$1$I$$20200415$20240718$20240718$EXP$$US-AstraZeneca-2020SE52694$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241085931$24108593$1$I$$20240705$20240718$20240718$EXP$$US-ALVOGEN-2024095057$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$48$YR$$M$Y$$$20240718$$HP$US$US
241085941$24108594$1$I$20200301$20200324$20240718$20240718$EXP$$US-AstraZeneca-2020SE42600$ASTRAZENECA$$25414$DY$$F$Y$43.1$KG$20240718$$CN$US$
241085951$24108595$1$I$$20200608$20240718$20240718$EXP$$US-AstraZeneca-2020SE74775$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241085961$24108596$1$I$20201030$20240710$20240718$20240718$EXP$PL-URPL-1-3481-2020$PL-TEVA-VS-3220302$TEVA$$96$YR$$F$Y$45$KG$20240718$$MD$PL$PL
241085971$24108597$1$I$$20200422$20240718$20240718$EXP$$GB-AstraZeneca-2020SE55012$ASTRAZENECA$$$$$F$Y$$$20240718$$HP$GB$
241085981$24108598$1$I$20240501$20240710$20240718$20240718$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00734$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240718$$CN$US$US
241085991$24108599$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A159044$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241086001$24108600$1$I$$20200226$20240718$20240718$EXP$$US-AstraZeneca-2020SE30476$ASTRAZENECA$$61$YR$$F$Y$$$20240718$$CN$US$
241086011$24108601$1$I$$20200324$20240718$20240718$EXP$$TH-AstraZeneca-2020SE43606$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$TH$
241086021$24108602$1$I$$20200522$20240718$20240718$EXP$$US-AstraZeneca-2020SE68439$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241086031$24108603$1$I$$20200417$20240718$20240718$EXP$$US-AstraZeneca-2020SE52896$ASTRAZENECA$$70$YR$$F$Y$$$20240718$$CN$US$
241086041$24108604$1$I$20240211$20240709$20240718$20240718$EXP$FR-AFSSAPS-PP2024000629$FR-ROCHE-10000021383$ROCHE$$56$YR$A$M$Y$78$KG$20240718$$MD$FR$FR
241086051$24108605$1$I$$20240710$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US066096$SANDOZ$$$$$M$Y$$$20240718$$CN$US$US
241086061$24108606$1$I$$20200526$20240718$20240718$EXP$$US-AstraZeneca-2020SE59780$ASTRAZENECA$$$$$M$Y$89.8$KG$20240718$$CN$US$
241086071$24108607$1$I$$20200505$20240718$20240718$EXP$$CN-AstraZeneca-2020SE61968$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$CN$
241086081$24108608$1$I$$20240708$20240718$20240718$EXP$FR-AFSSAPS-MP2024001059$FR-TEVA-VS-3218780$TEVA$$$$I$F$Y$2.36$KG$20240718$$MD$FR$FR
241086091$24108609$1$I$$20210927$20240718$20240718$EXP$$US-AstraZeneca-2021A750325$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241086101$24108610$1$I$$20200512$20240718$20240718$EXP$$US-AstraZeneca-2020SE63369$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241086111$24108611$1$I$$20220413$20240718$20240718$EXP$$US-AstraZeneca-2022A150825$ASTRAZENECA$$54$YR$$F$Y$70.3$KG$20240718$$CN$US$
241086121$24108612$1$I$$20210129$20240718$20240718$EXP$$US-AstraZeneca-2021A027149$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241086131$24108613$1$I$$20210208$20240718$20240718$EXP$$US-AstraZeneca-2021A051469$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241086141$24108614$1$I$20240716$20240716$20240718$20240718$EXP$$DE-ABBVIE-5843719$ABBVIE$$85$YR$$F$Y$$$20240718$$CN$DE$DE
241086153$24108615$3$F$20240619$20240827$20240718$20240903$EXP$$CO-GSK-CO2024AMR078258$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$CO$CO
241086161$24108616$1$I$$20240624$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002981$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241086171$24108617$1$I$$20240705$20240718$20240718$EXP$$US-ALVOGEN-2024095056$ALVOGEN$Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024;00:1-9. doi:https://doi.org/10.1093/jat/bkae053$37$YR$$F$Y$$$20240718$$HP$US$US
241086181$24108618$1$I$20240530$20240705$20240718$20240718$EXP$$AU-CIPLA LTD.-2024AU07535$CIPLA$$$$$$Y$$$20240718$$HP$AU$AU
241086192$24108619$2$F$20240713$20240826$20240718$20240904$EXP$$US-ABBVIE-5617445$ABBVIE$$75$YR$$F$Y$$$20240904$$CN$US$US
241086201$24108620$1$I$$20240710$20240718$20240718$EXP$$US-NOVITIUMPHARMA-2024USNVP01277$NOVITIUM PHARMA$Carlos Torrado.Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy.Frontiers in Immunology.08-MAY-2024;NA:1-9$$$A$M$Y$$$20240718$$HP$US$US
241086211$24108621$1$I$$20240709$20240718$20240718$EXP$$US-APOTEX-2024AP008334$APOTEX$Idowu D, Ezema K, Corcoran J, Farkas A.. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clinical Toxicology. 2024;62 (5):296-302$18$YR$$F$Y$$$20240718$$HP$US$US
241086222$24108622$2$F$20230101$20240917$20240718$20240924$EXP$$TN-ABBVIE-5838900$ABBVIE$$44$YR$$F$Y$$$20240924$$CN$TN$TN
241086232$24108623$2$F$20240101$20240820$20240718$20240903$EXP$$US-UCBSA-2024012151$UCB$$$$$M$Y$$$20240903$$CN$US$US
241086243$24108624$3$F$20240714$20240826$20240718$20240828$PER$$US-AMGEN-USASP2024140043$AMGEN$$70$YR$E$F$Y$$$20240828$$CN$US$US
241086252$24108625$2$F$20230201$20240716$20240718$20240720$EXP$$US-ABBVIE-5840712$ABBVIE$$79$YR$$F$Y$45$KG$20240720$$CN$US$US
241086261$24108626$1$I$$20240716$20240718$20240718$EXP$$JP-ASTELLAS-2024JP004979$ASTELLAS$$74$YR$$M$Y$$$20240718$$PH$JP$JP
241086271$24108627$1$I$$20240716$20240718$20240718$EXP$$US-ABBVIE-5843677$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241086281$24108628$1$I$$20240705$20240718$20240718$EXP$$US-CIPLA LTD.-2024US07512$CIPLA$Price MZ, Price RL.. Treating schizophrenia and bipolar I disorder in the real-world setting: effectiveness and safety of olanzapine/samidorphan combination.. Prim Care Companion CNS Disord.. 2024;26 (2) 23cr0366:e1 to e2$$$$$Y$$$20240718$$HP$US$US
241086302$24108630$2$F$$20240919$20240718$20240920$EXP$$NVSC2024US146985$NOVARTIS$$$$$F$Y$$$20240920$$MD$US$US
241086311$24108631$1$I$$20240704$20240718$20240718$EXP$$AU-CIPLA LTD.-2024AU07640$CIPLA$$$$$$Y$$$20240718$$CN$AU$AU
241086321$24108632$1$I$$20240708$20240718$20240718$PER$$NVSC2024US146785$NOVARTIS$$$$$F$Y$$$20240718$$PH$US$US
241086331$24108633$1$I$$20240717$20240718$20240718$PER$$NVSC2024US147773$NOVARTIS$$$$$M$Y$$$20240718$$HP$US$US
241086341$24108634$1$I$$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113702$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240718$$HP$US$US
241086351$24108635$1$I$$20240716$20240718$20240718$EXP$$US-ABBVIE-5842884$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241086361$24108636$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187675$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241086372$24108637$2$F$20240620$20240826$20240718$20240906$PER$$US-AstraZeneca-2024A144417$ASTRAZENECA$$74$YR$$F$Y$68.4$KG$20240906$$PH$US$
241086381$24108638$1$I$$20230105$20240718$20240718$EXP$$US-AstraZeneca-2023A004242$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241086392$24108639$2$F$20240325$20240817$20240718$20240829$EXP$$CA-ASTELLAS-2024US020162$ASTELLAS$$89$YR$E$M$Y$$$20240828$$MD$CA$CA
241086401$24108640$1$I$20211021$20211026$20240718$20240718$EXP$$US-AstraZeneca-2021A786799$ASTRAZENECA$$22887$DY$$M$Y$$$20240718$$CN$US$
241086411$24108641$1$I$$20220630$20240718$20240718$EXP$$US-AstraZeneca-2022A167947$ASTRAZENECA$$$$$M$Y$$$20240718$$MD$US$
241086421$24108642$1$I$20200301$20200422$20240718$20240718$EXP$$TH-AstraZeneca-2020SE56156$ASTRAZENECA$$668$MON$$M$Y$$$20240718$$CN$TH$
241086431$24108643$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158563$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241086441$24108644$1$I$20220927$20220927$20240718$20240718$EXP$$US-AstraZeneca-2022A333166$ASTRAZENECA$$28274$DY$$M$Y$$$20240718$$CN$US$
241086451$24108645$1$I$$20220201$20240718$20240718$EXP$$US-AstraZeneca-2022A055797$ASTRAZENECA$$$$$$Y$$$20240718$$CN$US$
241086461$24108646$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158609$ASTRAZENECA$$22645$DY$$F$Y$99$KG$20240718$$CN$US$
241086471$24108647$1$I$$20200908$20240718$20240718$EXP$$GB-AstraZeneca-2020SF15645$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$GB$
241086481$24108648$1$I$20221201$20230223$20240718$20240718$EXP$$IN-AstraZeneca-2023A047359$ASTRAZENECA$$877$MON$$F$Y$$$20240718$$CN$IN$
241086491$24108649$1$I$$20221109$20240718$20240718$EXP$$TW-AstraZeneca-2022A371230$ASTRAZENECA$$66$YR$$M$Y$$$20240718$$CN$TW$
241086501$24108650$1$I$20200624$20200708$20240718$20240718$EXP$$US-AstraZeneca-2020SE87195$ASTRAZENECA$$24092$DY$$F$Y$70.3$KG$20240718$$CN$US$
241086511$24108651$1$I$$20200512$20240718$20240718$EXP$$GB-AstraZeneca-2020SE63588$ASTRAZENECA$$$$$M$Y$$$20240718$$HP$GB$
241086521$24108652$1$I$$20201123$20240718$20240718$EXP$$US-AstraZeneca-2020SF55744$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241086531$24108653$1$I$$20220509$20240718$20240718$EXP$$US-AstraZeneca-2022A180134$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241086541$24108654$1$I$$20211012$20240718$20240718$EXP$$US-AstraZeneca-2021A771904$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241086551$24108655$1$I$20200601$20200720$20240718$20240718$EXP$$UA-AstraZeneca-2020SE91700$ASTRAZENECA$$66$YR$$M$Y$$$20240718$$CN$UA$
241086561$24108656$1$I$20200617$20200707$20240718$20240718$EXP$$US-AstraZeneca-2020SE82598$ASTRAZENECA$$23315$DY$$F$Y$$$20240718$$CN$US$
241086571$24108657$1$I$$20211103$20240718$20240718$EXP$$US-AstraZeneca-2021A797254$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241086581$24108658$1$I$$20240710$20240718$20240718$EXP$$JP-AstraZeneca-2024A159605$ASTRAZENECA$$$$$M$Y$$$20240718$$MD$JP$
241086591$24108659$1$I$$20240714$20240718$20240718$EXP$$GR-ABBVIE-5841031$ABBVIE$$$$$M$Y$$$20240718$$CN$GR$GR
241086601$24108660$1$I$$20240708$20240718$20240718$EXP$$ES-CLINIGEN-ES-CLI-2024-010418$CLINIGEN$Irene Carrasco Garcia, Johana Benedetti Pedroza, Isabel Miras Rodriguez, Inmaculada Rincon. Trabectedin and Radiotherapy in Endometrial Stromal Sarcoma: A Case Report. Case Reports in Oncology. 2024;17:1:82-90$47$YR$$F$Y$$$20240718$$MD$ES$ES
241086611$24108661$1$I$20240709$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN001900J$MERCK$$91$YR$$M$Y$$$20240718$$MD$JP$JP
241086622$24108662$2$F$20210421$20240826$20240718$20240828$EXP$$GR-ABBVIE-5843779$ABBVIE$$79$YR$$F$Y$$$20240828$$MD$GR$GR
241086642$24108664$2$F$$20240710$20240718$20240816$EXP$$GB-JNJFOC-20240729547$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$GB$GB
241086661$24108666$1$I$$20240715$20240718$20240718$EXP$NL-LRB-00981648$NL-ASTELLAS-2024EU007002$ASTELLAS$$65$YR$$F$Y$$$20240718$$CN$NL$NL
241086671$24108667$1$I$$20240624$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002982$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$HP$US$US
241086681$24108668$1$I$$20240710$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2023US002577$SANDOZ$$$$$F$Y$$$20240718$$CN$US$US
241086691$24108669$1$I$20240715$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113588$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240718$$CN$US$US
241086701$24108670$1$I$20230101$20240710$20240718$20240718$EXP$$JP-AMGEN-JPNSP2024137368$AMGEN$$$$$$Y$$$20240718$$MD$JP$JP
241086731$24108673$1$I$$20240711$20240718$20240718$PER$$US-BIOGEN-2024BI01273756$BIOGEN$$$$$F$Y$$$20240718$$CN$US$US
241086741$24108674$1$I$$20240711$20240718$20240718$EXP$$NL-EMD Serono-2024038140$EMD SERONO INC$$41$YR$A$F$Y$65$KG$20240718$$CN$NL$NL
241086751$24108675$1$I$20240601$20240711$20240718$20240718$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039365$BOEHRINGER INGELHEIM$$90$YR$E$F$Y$71.7$KG$20240718$$CN$US$US
241086761$24108676$1$I$20240712$20240715$20240718$20240718$EXP$$US-JNJFOC-20240737819$JOHNSON AND JOHNSON$$75$YR$E$M$Y$61.245$KG$20240718$$HP$US$US
241086781$24108678$1$I$$20240624$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002984$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240718$$HP$US$US
241086801$24108680$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141047$AMGEN$$$$$$Y$$$20240718$$PH$US$US
241086811$24108681$1$I$$20240713$20240718$20240718$EXP$$US-UCBSA-2024035881$UCB$$$$C$$Y$$$20240718$$MD$US$US
241086821$24108682$1$I$$20240715$20240718$20240718$EXP$$CA-UCBSA-2024036221$UCB$$$$$F$Y$$$20240718$$CN$CA$CA
241086831$24108683$1$I$20240101$20240705$20240718$20240718$PER$$US-Encube-000813$ENCUBE ETHICALS$$$$$F$Y$$$20240717$$CN$US$
241086841$24108684$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113729$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$51.26$KG$20240718$$HP$US$US
241086852$24108685$2$F$$20240812$20240718$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111096$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$71.67$KG$20240819$$CN$US$US
241086863$24108686$3$F$20240715$20240731$20240718$20240807$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-113831$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$70.76$KG$20240808$$CN$PR$PR
241086871$24108687$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113779$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240718$$PH$US$US
241086881$24108688$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113349$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240718$$CN$US$US
241086891$24108689$1$I$20240606$20240711$20240718$20240718$EXP$FR-AFSSAPS-MP2024001007$FR-ROCHE-10000024179$ROCHE$$55$YR$A$F$Y$$$20240718$$PH$FR$FR
241086902$24108690$2$F$20240501$20240916$20240718$20240921$EXP$$SG-ROCHE-10000029509$ROCHE$$80$YR$E$F$Y$$$20240921$$CN$SG$SG
241086911$24108691$1$I$20230926$20240710$20240718$20240718$PER$$US-ROCHE-10000026085$ROCHE$$68$YR$E$$Y$$$20240718$$MD$US$US
241086921$24108692$1$I$$20240624$20240718$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002307$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241086931$24108693$1$I$20240601$20240711$20240718$20240718$EXP$$JP-009507513-2407JPN002276J$MERCK$$7$DEC$$M$Y$$$20240718$$MD$JP$JP
241086941$24108694$1$I$20230101$20240711$20240718$20240718$EXP$CH-SM-2023-17189$CH-CHEPLA-2024008787$CHEPLAPHARM$$55$YR$$M$Y$$$20240718$$MD$COUNTRY NOT SPECIFIED$CH
241086952$24108695$2$F$20240624$20240716$20240718$20240723$EXP$$NL-EMD Serono-2024037666$EMD SERONO INC$$45$YR$A$F$Y$$$20240724$$CN$NL$NL
241086961$24108696$1$I$$20240712$20240718$20240718$EXP$$CA-CHEPLA-2024008869$CHEPLAPHARM$$41$YR$$M$Y$$$20240718$$HP$COUNTRY NOT SPECIFIED$CA
241086973$24108697$3$F$$20240814$20240718$20240821$EXP$$US-CELLTRION INC.-2024US017192$CELLTRION$$$$$$Y$$$20240821$$CN$US$US
241086981$24108698$1$I$20240701$20240711$20240718$20240718$EXP$$US-PADAGIS-2024PAD01141$PADAGIS$$$$$$Y$$$20240718$$CN$US$US
241086991$24108699$1$I$20231226$20240712$20240718$20240718$EXP$NO-NOMAADVRE-RELISSO-2024-00102$NO-ROCHE-10000024765$ROCHE$$55$YR$A$M$Y$$$20240718$$MD$NO$NO
241087001$24108700$1$I$20240715$20240715$20240718$20240718$PER$$US-ORGANON-O2407USA001439$ORGANON$$35$YR$$F$Y$82.54$KG$20240718$$HP$US$US
241087011$24108701$1$I$20240609$20240709$20240718$20240718$EXP$FR-AFSSAPS-LL2024001225$FR-TEVA-VS-3219432$TEVA$$12$YR$$M$Y$$$20240718$$PH$FR$FR
241087021$24108702$1$I$$20240705$20240718$20240718$EXP$$DE-ROCHE-10000029525$ROCHE$$$$$F$Y$$$20240718$$CN$DE$DE
241087041$24108704$1$I$$20240711$20240718$20240718$PER$$US-ABBVIE-5841239$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241087051$24108705$1$I$$20240711$20240718$20240718$PER$$US-ABBVIE-5841266$ABBVIE$$$$$F$Y$$$20240718$$MD$US$US
241087061$24108706$1$I$$20240712$20240718$20240718$PER$$US-ABBVIE-5840246$ABBVIE$$$$$$Y$$$20240718$$CN$US$US
241087072$24108707$2$F$$20240821$20240718$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA066001$SANDOZ$$70$YR$$F$Y$66$KG$20240822$$MD$CA$CA
241087081$24108708$1$I$$20240709$20240718$20240718$EXP$$US-KAMADA LIMITED-2018US006319$TAKEDA$$$$$M$Y$$$20240718$$CN$US$US
241087093$24108709$3$F$20240708$20240809$20240718$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-021036$UNITED THERAPEUTICS$$54$YR$$F$Y$75.737$KG$20240816$$$US$US
241087101$24108710$1$I$$20240703$20240718$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457174$RANBAXY$Ortello A, Comparato F, Puccio D, Corrado E. The intelligent use of adrenaline. Eur Heart JSuppl. 2024;26 (Suppl.):ii136$52$YR$$$Y$$$20240718$$HP$IT$IT
241087111$24108711$1$I$$20240703$20240718$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456920$RANBAXY$Claverie R, Perriguey M, Rico A, Boutiere C, Demortiere S, Durozard P, et al. Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?. Neurol Neuroimmunol Neuroinflamm. 2023;10 (5):e200152$32$YR$$F$Y$$$20240718$$HP$FR$FR
241087122$24108712$2$F$$20240801$20240718$20240816$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457144$RANBAXY$Fukasawa Y, Yamamoto H, Ito M, Saito A, Go K, Morimoto Y, et al. Case report: High-dose epoprostenol therapy in pediatric patients with pulmonary hypertension and developmental lung disease. Front Pediatr. 2023;11:01-07$$$N$M$Y$3$KG$20240816$$HP$JP$JP
241087131$24108713$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457028$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$65$YR$$M$Y$$$20240718$$HP$ES$ES
241087141$24108714$1$I$20240319$20240703$20240718$20240718$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456385$RANBAXY$$$$$F$Y$$$20240718$$CN$DE$DE
241087151$24108715$1$I$$20240703$20240718$20240718$EXP$$LT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457601$RANBAXY$Ruzelyte I, Vilkas V. The association between malignant neoplastic process and atypical psychotic disorder: a clinical case study. Biol Psychiatry Psychopharmacol. 2024;Jun;26 (1):14-17$53$YR$$M$Y$$$20240718$$HP$LT$LT
241087161$24108716$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457052$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$65$YR$$M$Y$$$20240718$$HP$ES$ES
241087191$24108719$1$I$$20240703$20240718$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456762$RANBAXY$Malavasi M, Notarianni G, Pontillo D, Luciani M, Petrungaro M, Zampi G, et al. THE CONUNDRUM OF DRUG INTERACTIONS AND HOLTER MONITORING: LAMIN GENE MUTATION DISCOVERED BY A TORSADE DE POINTES EPISODE FOLLOWED BY OUT-OF-THE-HOSPITAL RESUSCITATION.. Eur Heart J Suppl. 2024;26 (Suppl.):ii55-ii56$57$YR$$F$Y$$$20240718$$HP$IT$IT
241087201$24108720$1$I$$20240703$20240718$20240718$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457119$RANBAXY$Oshima S, Takahashi S, Kitano T. Cutaneous involvement in diffuse large B-cell lymphoma. Oxf Med Case Reports. 2024;2024 (6):266-267$85$YR$$M$Y$$$20240718$$HP$JP$JP
241087212$24108721$2$F$$20240716$20240718$20240731$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456905$RANBAXY$Rocanieres P, Lamure S, Geny C, Hillaire-Buys D, Faillie J-L, Bres V. Parkinsonian Patients Requiring Proteasome Inhibitors for Multiple Myeloma: Exceptional Circumstances Call for Extra Caution. JParkinsons Dis. 2022;12 (8):2601-2603$68$YR$$M$Y$$$20240731$$HP$FR$FR
241087221$24108722$1$I$$20240717$20240718$20240718$PER$$US-AMGEN-USASP2024142080$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
241087231$24108723$1$I$20240318$20240703$20240718$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456383$RANBAXY$$17$YR$$F$Y$$$20240718$$MD$FR$FR
241087241$24108724$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141083$AMGEN$$$$$M$Y$$$20240718$$CN$US$US
241087251$24108725$1$I$$20240708$20240718$20240718$EXP$$IN-AMGEN-INDSP2024138055$AMGEN$Tripathy S. K.; Majumdar S. D.; Pradhan S. S. et al.. A Short Course of Preoperative Denosumab Injection Followed by Surgery in High-Risk Giant Cell Tumors of the Extremities: A Retrospective Study. Indian Journal of Surgical Oncology. 2024;1- 12$52$YR$A$M$Y$$$20240718$$HP$IN$IN
241087261$24108726$1$I$$20201207$20240718$20240718$EXP$$US-AstraZeneca-2020SF60238$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241087271$24108727$1$I$$20240703$20240718$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457116$RANBAXY$Yeung SJ, Qdaisat A, Bischof JJ, Caterino JM, Kyriacou DN, Coyne Md C. A case series of adrenal insufficiency (likely due to hypophysitis) in cancer patients treated with immune checkpoint inhibitors. Am J Emerg Med. 2024;80 (0):227e1-227e5$56$YR$$F$Y$$$20240718$$MD$US$US
241087281$24108728$1$I$$20240703$20240718$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456940$RANBAXY$Piscione M, Dajana P, Crispino E, Frau L, Halasz G, Ussi G, et al. IF YOU WANT TO GO FAST, GO ALONE. IF YOU WANT TO GO FAR, ABLATE AF: A CASE REPORT. Eur Heart J Suppl. 2024;26 (Suppl.):ii195$70$YR$$F$Y$$$20240718$$HP$IT$IT
241087291$24108729$1$I$20240610$20240703$20240718$20240718$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457230$RANBAXY$$$$A$M$Y$70$KG$20240718$$CN$DE$DE
241087301$24108730$1$I$20231110$20240703$20240718$20240718$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456377$RANBAXY$$39$YR$$F$Y$$$20240718$$CN$GB$GB
241087311$24108731$1$I$$20240703$20240718$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456930$RANBAXY$Claverie R, Perriguey M, Rico A, Boutiere C, Demortiere S, Durozard P, et al. Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?. Neurol Neuroimmunol Neuroinflamm. 2023;10 (5):e200152$18$YR$$M$Y$$$20240718$$HP$FR$FR
241087321$24108732$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457023$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$62$YR$$F$Y$$$20240718$$HP$ES$ES
241087331$24108733$1$I$$20240703$20240718$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457117$RANBAXY$Yeung SJ, Qdaisat A, Bischof JJ, Caterino JM, Kyriacou DN, Coyne Md C. A case series of adrenal insufficiency (likely due to hypophysitis) in cancer patients treated with immune checkpoint inhibitors. Am J Emerg Med. 2024;80 (0):227e1-227e5$54$YR$$F$Y$$$20240718$$MD$US$US
241087341$24108734$1$I$$20240703$20240718$20240718$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457097$RANBAXY$Morin S, Boroli F,Vandenberghe-Durr  S,  Allali D, Masouridi-Levrat S, Chalandon Y,et al. Severe anaphylaxis after chimeric antigen receptor T-cell injection. EJHaem. 2024;5(3):603-606$77$YR$$M$Y$$$20240718$$HP$CH$CH
241087352$24108735$2$F$$20240730$20240718$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456748$RANBAXY$Kikkawa K, Wakamiya T, Kojima F, Kohjimoto Y, Hara I. Nephrectomy for emphysematous pyelonephritis in a nonfunctional renal allograft due to rejection after kidney transplantation. Afr J Urol. 2024;30 (1)$71$YR$$M$Y$$$20240814$$HP$JP$JP
241087361$24108736$1$I$20230801$20240703$20240718$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456685$RANBAXY$$25$YR$$F$Y$$$20240718$$MD$FR$FR
241087371$24108737$1$I$$20240703$20240718$20240718$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457098$RANBAXY$Li EW, Aklilu E, Potter A, Yang S, Ho PJ, Vanguru V, et al. Flow cytometric immunophenotype of CAR T-cells in pleural fluid and differences with peripheral blood CAR T-cells in a patient with large Bcell lymphoma. Pathology. 2024;Jun; 56 (4):582-585$56$YR$$M$Y$$$20240718$$HP$AU$AU
241087381$24108738$1$I$$20240703$20240718$20240718$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457880$RANBAXY$Deissler P,Berkovitch A, Rahm AK, Sikking M, Moersdorf M, Sohns C, et al. Temporal variability of electromechanical-window negativity in patients with inherited long-QT syndrome or drug-induced QT prolongation: relation to torsades de pointes. Europace. 2024;26 (Suppl1):i1093$$$A$$Y$$$20240718$$HP$NL$NL
241087391$24108739$1$I$$20240703$20240718$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457105$RANBAXY$Pickel L, Ji PX, Abdelazim A, Sivachandran N. From Hair Loss to Vision Loss: Minoxidil-Associated CRVO in a Young Female. Case Rep Ophthalmol. 2024;15:220-224$34$YR$$F$Y$$$20240718$$HP$CA$CA
241087401$24108740$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457050$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$68$YR$$M$Y$$$20240718$$HP$ES$ES
241087411$24108741$1$I$20230101$20240703$20240718$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457208$RANBAXY$$60$YR$$M$Y$$$20240718$$PH$FR$FR
241087421$24108742$1$I$$20240703$20240718$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457169$RANBAXY$Sorvillo G, Olivieri F, Rainone A, Quercia E, Violante A, Mazza A, et al. A VERY COMPLEX CLINICAL CASE OF ACUTE CORONARY SYNDROME COMPLICATED BY THROMBOSIS AND INTRACRANIAL HAEMORRHAGE. Eur Heart J Suppl. 2024;26 (Suppl.):ii127/ suae036.324$62$YR$$F$Y$$$20240718$$HP$IT$IT
241087431$24108743$1$I$$20200408$20240718$20240718$EXP$$GB-AstraZeneca-2020SE49787$ASTRAZENECA$$$$$M$Y$$$20240718$$HP$GB$
241087442$24108744$2$F$$20240715$20240718$20240730$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457027$RANBAXY$Amandine D, Luiza De Bortolli N, Cecilia N, Jessica L, Mary K, Emmanuelle R, et al. Hypokalemic paralysis a side-effect of short action beta2-agonist. Swiss Med Wkly. 2024;154 (S277):35S;P 45$6$YR$$F$Y$$$20240730$$HP$CH$CH
241087451$24108745$1$I$20190106$20240703$20240718$20240718$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456373$RANBAXY$$21$YR$$F$Y$$$20240718$$CN$GB$GB
241087461$24108746$1$I$$20240703$20240718$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457113$RANBAXY$Portuguese AJ, Gauthier J, Tykodi SS, Hall ET,Hirayama AV, Yeung CCS, et al. CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic review. Bone Marrow Transplant. 2023;5Dec;8 (4):353-359$47$YR$$M$Y$$$20240718$$HP$US$US
241087471$24108747$1$I$20240401$20240703$20240718$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457037$RANBAXY$$89$YR$$M$Y$$$20240718$$CN$FR$FR
241087481$24108748$1$I$20240211$20240703$20240718$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456225$RANBAXY$$3$YR$$F$Y$20$KG$20240718$$MD$FR$FR
241087491$24108749$1$I$$20240703$20240718$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456988$RANBAXY$-. Delayed Psychosis following snakebite Envenomation. Indian J Psychiatry. 2024;Jan;66 (Suppl1):S178$65$YR$$M$Y$$$20240718$$HP$IN$IN
241087502$24108750$2$F$$20240708$20240718$20240723$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457002$RANBAXY$Dhivagar S, Selvaraj A, Devi S. Is CARIPRAZINE a Mood elevator ? - A case series. Indian J Psychiatry. 2024;66 (Suppl.):S118$20$YR$$F$Y$$$20240723$$MD$IN$IN
241087511$24108751$1$I$$20240703$20240718$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457160$RANBAXY$Perriello VM, Falini L, Ruggeri L, Innocente A, Ballanti S, Costa C, et al. CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma. Am J Hematol. 2023;98 (1):212-219$63$YR$$M$Y$$$20240718$$HP$IT$IT
241087521$24108752$1$I$20230123$20240703$20240718$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457202$RANBAXY$$58$YR$$M$Y$86$KG$20240718$$MD$FR$FR
241087531$24108753$1$I$20240703$20240703$20240718$20240718$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456364$RANBAXY$$55$YR$$M$Y$80$KG$20240718$$MD$GB$GB
241087541$24108754$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457026$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$51$YR$$M$Y$$$20240718$$HP$ES$ES
241087551$24108755$1$I$$20240703$20240718$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457103$RANBAXY$Hogan KO. Preventative plasmapheresis in a diabetic pregnant patient with hypertriglyceridemia and distal pancreatectomy. Transfus Med. 2023;33 (5):413-415$23$YR$$F$Y$$$20240718$$HP$US$US
241087561$24108756$1$I$$20240703$20240718$20240718$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456807$RANBAXY$$$$$$Y$$$20240718$$CN$GB$GB
241087572$24108757$2$F$$20240712$20240718$20240726$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456980$RANBAXY$Meenakshi R, Balamurali K, Anbazhagan G. A unique case of galactorrhea caused by tramadol dependency in a 32-year-old female- a case report. Indian J Psychiatry. 2024;66 (Suppl.):S192$32$YR$$F$Y$$$20240726$$MD$IN$IN
241087581$24108758$1$I$$20210917$20240718$20240718$EXP$$US-AstraZeneca-2021A732760$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241087591$24108759$1$I$$20240703$20240718$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457110$RANBAXY$Gouda MA, Janku F, Somaiah N, Hunt KK, Yedururi S, Subbiah V. Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery. Oncoscience. 2023;Sep 20; 10:38-43$$$A$F$Y$$$20240718$$HP$US$US
241087601$24108760$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457017$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al.. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$64$YR$$F$Y$$$20240718$$HP$ES$ES
241087611$24108761$1$I$$20240703$20240718$20240718$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457069$RANBAXY$Lourenco J, Bertin L, Lacroix L. Prolonged QT interval following inhaled salbutamol. Swiss Med Wkly. 2024;154 (Suppl.):33S (P39)$13$YR$$M$Y$$$20240718$$HP$CH$CH
241087621$24108762$1$I$$20221010$20240718$20240718$EXP$$US-AstraZeneca-2022A343280$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241087631$24108763$1$I$$20240703$20240718$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456996$RANBAXY$Pedio E, Tauro S, Perfetti S, Zaccaro S, Greco G, Mandunzio D, et al. Renal infarction: an acute complication of apical thrombosis in a patient with stemi. Eur Heart J Suppl. 2024;26 (Suppl.):ii199-ii200 suae036.477$50$YR$$M$Y$$$20240718$$HP$IT$IT
241087641$24108764$1$I$$20240703$20240718$20240718$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457138$RANBAXY$Goda M, Schauer S, Laube GF, Altorfer U. Primary cutaneous Nocardiosis in an immunocompetent child. Swiss Med Wkly. 2024;154 (Suppl.):P36/32s$2$YR$$F$Y$$$20240718$$HP$CH$CH
241087652$24108765$2$F$$20240708$20240718$20240723$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457000$RANBAXY$Dhivagar S, Selvaraj A, Devi S. Is CARIPRAZINE a Mood elevator ? - A case series. Indian J Psychiatry. 2024;66 (Suppl.):S118$31$YR$$M$Y$$$20240723$$MD$IN$IN
241087661$24108766$1$I$$20240703$20240718$20240718$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457019$RANBAXY$Katrina E, Dimitra L, Alexandre D,Alexandra G.. Fanconi syndrome under ketogenic diet in a patient with NSF variant associated developmental and epileptic encephalopathy. Swiss Med Wkly. 2024;154 (Suppl.):30S-31S (P33)$20$MON$$F$Y$$$20240718$$HP$CH$CH
241087671$24108767$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457212$RANBAXY$Garcia Ruiz PJ, Feliz LD, Feliz CE, Sanchez IL, Fernandez AA, Kelly FB,et al. The enduring enigma of sporadic chorea: A single center case series. Tremor Other Hyperkinet Mov. 2023;13(1):1-10$60$YR$$F$Y$$$20240718$$MD$ES$ES
241087681$24108768$1$I$20240405$20240703$20240718$20240718$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456846$RANBAXY$$27$YR$$M$Y$$$20240718$$MD$SE$SE
241087691$24108769$1$I$$20240703$20240718$20240718$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457049$RANBAXY$Nechita L, Niculet E, Baroiu L, Balta AAS, Nechita A, Voinescu DC, et al. Acute Myocardial Infarction in COVID-19 Patients-A Review of Literature Data and Two-Case Report Series. J Clin Med. 2024;13 (10):2936$57$YR$$M$Y$$$20240718$$HP$RO$RO
241087702$24108770$2$F$$20240712$20240718$20240726$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457007$RANBAXY$Roh T, Jo H, Kim J-Y.. Maxillary bone necrosis in post-COVID-19 patients: possibility of medication related osteonecrosis of jaws (MRONJ) induced by tocilizumab. J Craniofac Surg. 2024;Jul/Aug; 35(5):e454-e457$36$YR$$M$Y$$$20240726$$MD$KR$KR
241087711$24108771$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457053$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$68$YR$$M$Y$$$20240718$$HP$ES$ES
241087721$24108772$1$I$$20240703$20240718$20240718$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456968$RANBAXY$Han X, Liu X, Zhang C, Wen Q, Zhang X. PD-1 blockade combined with decitabine to treat refractory peripheral T-cell lymphoma not other wise specified: A case report and review of literature. J Cancer Res Ther. 2023;19:1680-16884$43$YR$$F$Y$$$20240718$$HP$CN$CN
241087732$24108773$2$F$$20240708$20240718$20240723$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457001$RANBAXY$Dhivagar S, Selvaraj A, Devi S. Is CARIPRAZINE a Mood elevator ? - A case series. Indian J Psychiatry. 2024;66 (Suppl.):S118$26$YR$$M$Y$$$20240723$$MD$IN$IN
241087741$24108774$1$I$20240329$20240703$20240718$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457134$RANBAXY$$76$YR$$M$Y$71$KG$20240718$$MD$FR$FR
241087751$24108775$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457043$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$66$YR$$M$Y$$$20240718$$HP$ES$ES
241087761$24108776$1$I$20240615$20240703$20240718$20240718$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456808$RANBAXY$$63$YR$$F$Y$68$KG$20240718$$CN$GB$GB
241087771$24108777$1$I$$20240703$20240718$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457083$RANBAXY$Berry M, Wang AM, Lahham RF, Zhang X, Pacheco LD. Ischemic Hepatitis and Septic Shock Secondary toMurineTyphusInfectioninPregnancy. AJP Rep. 2024;14 (2):E185-E187$37$YR$$F$Y$$$20240718$$MD$US$US
241087781$24108778$1$I$$20240703$20240718$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457054$RANBAXY$Dei L, Re F, Gabrielli D, Sciarra L, Romano S. MYOCARDITIS: VIRUS OR DESMOSOME?. Eur Heart J Suppl. 2024;26 (Suppl.):ii70$56$YR$$F$Y$$$20240718$$HP$IT$IT
241087791$24108779$1$I$$20240703$20240718$20240718$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456964$RANBAXY$Chrobak J, Rodek P, Kucia K. Multiple-Monitored Electroconvulsive Therapy (MMECT) - does it really just belong in psychiatry^s past? A case report. Psychiatr Pol. 2024;58 (2):343-349$49$YR$$F$Y$$$20240718$$HP$PL$PL
241087801$24108780$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457045$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$64$YR$$M$Y$$$20240718$$HP$ES$ES
241087812$24108781$2$F$$20240715$20240718$20240730$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457024$RANBAXY$Sofia P, Fortesa M. Plasmapheresis in a pediatric case of multiorgan failure with suspected DRESS or TSS. Swiss Med Wkly. 2024;154 (S277):19S;P 01$7$YR$$F$Y$$$20240730$$HP$CH$CH
241087821$24108782$1$I$$20240703$20240718$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457109$RANBAXY$Matthews BJ, Froehlich A, Goicochea L, Levinson K. Postmenopausal mixed gestational trophoblastic neoplasia with complete response to immunotherapy - A case report. Gynecol Oncol Rep. 2023;46:101168 (1-4)$66$YR$$$Y$$$20240718$$HP$US$US
241087831$24108783$1$I$20240101$20240703$20240718$20240718$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457595$RANBAXY$Lamia A., Fiolitakis Sofopoulos M., Befon A.2, Plaka M., Stefanaki E et al. Melanoma in a Patient with Nodular Lymphoma. Melanoma Res. 2024;27-29 Jun:??09$76$YR$$M$Y$$$20240718$$HP$GR$GR
241087841$24108784$1$I$20240313$20240703$20240718$20240718$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456768$RANBAXY$$26$YR$$F$Y$$$20240718$$MD$SE$SE
241087851$24108785$1$I$20240124$20240703$20240718$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457177$RANBAXY$$69$YR$$F$Y$65$KG$20240718$$MD$FR$FR
241087861$24108786$1$I$$20240703$20240718$20240718$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457055$RANBAXY$Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A et al. PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer. Cold Spring Harb Mol Case Stud. 2023;9 (2):a006255 (1-16)$31$YR$$F$Y$$$20240718$$HP$BE$BE
241087871$24108787$1$I$$20240703$20240718$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457084$RANBAXY$Berry M, Wang AM, Lahham RF, Zhang X, Pacheco LD. Ischemic Hepatitis and Septic Shock Secondary to Murine Typhus Infection in Pregnancy. AJP Rep. 2024;14 (2):E185-E187$$$N$$Y$$$20240718$$MD$US$US
241087881$24108788$1$I$$20240703$20240718$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457060$RANBAXY$Roagna E, Angelini F, Gallone G, Vairo A, Bellettini M, Bocchino P, et al. ACQUIRED LQTS WITH VENTRICULAR ARRHYTMIAS IN METHADONE AND CARDIOMYOPATHY AT ONSET. Eur Heart J Suppl. 2024;26 (Suppl.):ii52/suae036.117$39$YR$$M$Y$$$20240718$$HP$IT$IT
241087891$24108789$1$I$$20240703$20240718$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457224$RANBAXY$Lazzeroni M, Reato S, Antinori S, Milazzo L, Pignataro L, Cantarella G. A Neglected, Emerging Disease in Northern Italy. J Voice. 2024;0(0):no pagination$56$YR$$F$Y$$$20240718$$HP$IT$IT
241087901$24108790$1$I$$20200916$20240718$20240718$EXP$$US-AstraZeneca-2020SF20490$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241087911$24108791$1$I$$20240703$20240718$20240718$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457057$RANBAXY$Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A et al. PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer. Cold Spring Harb Mol Case Stud. 2023;9 (2):a006255 (1-16)$30$YR$$F$Y$$$20240718$$HP$BE$BE
241087921$24108792$1$I$$20200713$20240718$20240718$EXP$$US-AstraZeneca-2020SE89851$ASTRAZENECA$$65$YR$$F$Y$$$20240718$$CN$US$
241087931$24108793$1$I$$20240711$20240718$20240718$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13972$IPSEN$$$$$F$Y$$$20240718$$MD$US$US
241087941$24108794$1$I$20231001$20240703$20240718$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456213$RANBAXY$$53$YR$$F$Y$90$KG$20240718$$MD$FR$FR
241087951$24108795$1$I$$20200820$20240718$20240718$EXP$$US-AstraZeneca-2020SE69184$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241087961$24108796$1$I$$20240710$20240718$20240718$EXP$$ZA-AstraZeneca-2024A159264$ASTRAZENECA$$85$YR$$M$Y$$$20240718$$CN$ZA$
241087981$24108798$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A161027$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241087991$24108799$1$I$20240709$20240712$20240718$20240718$30DAY$$US-GSK-US2024087726$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240718$$CN$US$US
241088002$24108800$2$F$20240131$20240827$20240718$20240830$EXP$$US-AstraZeneca-2024A161540$ASTRAZENECA$$$$$M$Y$$$20240830$$MD$US$
241088011$24108801$1$I$$20240703$20240718$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456909$RANBAXY$Anonymous. A case report of Escitalopram induced Euprolactinemic Galactorrhea. Indian J Psychiatry. 2024;66(Suppl.):S170$34$YR$$F$Y$$$20240718$$HP$IN$IN
241088021$24108802$1$I$$20240703$20240718$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456874$RANBAXY$Bharadwaj N, Munireddy J, Selvam S, Bharadwaj V, Prakash A. Dapsone for paediatric chronic immune thrombocytopenia:Short report from a tertiary centre in South India. Br J JHaematol. 2024;204 (3):1024-1028$$$C$$Y$$$20240718$$HP$IN$IN
241088031$24108803$1$I$$20240703$20240718$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456512$RANBAXY$Arnouk S, Huynh Q, Saric M, Papadopoulos J. A Case Report of Cardiac Arrest After Intravenous Administration of Sulfur Hexafluoride (Lumason R) Ultrasound Enhancing Agent. J Pharm Pract. 2024;37 (2):509-512$35$YR$$M$Y$$$20240718$$PH$US$US
241088041$24108804$1$I$$20240703$20240718$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456936$RANBAXY$Mitra P, Mishra S, Biswas T. Cutaneous adverse reactions and treatment challenges in a case of Treatment Resisitant Schizophrenia. Inidan J Psychiatry. 2024;66 (Suppl.):S177J$39$YR$$M$Y$$$20240718$$HP$IN$IN
241088051$24108805$1$I$$20240703$20240718$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456946$RANBAXY$Harpuneet, Saini VK, Meena PS, Jain M. A rare case report- risperidone induced retrograde ejaculation. Indian J Psychiatry. 2024;66 (Suppl.):S191-S192$29$YR$$M$Y$$$20240718$$HP$IN$IN
241088062$24108806$2$F$$20240712$20240718$20240726$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456908$RANBAXY$Ike IM, Jayaprakashan KP, Raju R. Risperidone monotherapy causing serotonin syndrome in one of the monozygotic twins. Indian J Psychiatry. 2024;66 (Suppl.):S52-S53$15$YR$$M$Y$$$20240726$$HP$IN$IN
241088071$24108807$1$I$$20240703$20240718$20240718$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456898$RANBAXY$Zhan Y, Liu T, Yan G-X. Distinct electrocardiographic findings of a drug-drug interaction (Distinct electrocardiographic signs of a drug interaction). Br Med J. 2024;Jun; 31(5);384:175; e077088$80$YR$$M$Y$$$20240718$$HP$CN$CN
241088082$24108808$2$F$$20240712$20240718$20240726$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456941$RANBAXY$Khanam A, Ahmad Wani Z, Ahmad S, Nazir N. Cyproheptadine and dexamethasone induced suicidality and obsessions Presenting To Liason Psychiatry- A Case Report. Indian J Psychiatry. 2024;66 (Suppl.):S177$20$YR$$M$Y$$$20240726$$HP$IN$IN
241088091$24108809$1$I$$20240703$20240718$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456965$RANBAXY$Jeel V, Jyrwa S, Khushoo V, Gohad D, Jaiswal SV. Crisis or psychosis?: A case report illustrating the shared symptoms between impending sickle cell crisis and psychosis. Indian J Psychiatry. 2024;66 (Suppl.):S200$30$YR$$M$Y$$$20240718$$HP$IN$IN
241088101$24108810$1$I$$20240703$20240718$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456861$RANBAXY$Khanna P, Singh VV, Parveen. Fluoxetine induced SVT: A case report. Indian J Psychiatry. 2024;66 (Suppl):S203$35$YR$$M$Y$$$20240718$$HP$IN$IN
241088111$24108811$1$I$$20240703$20240718$20240718$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456962$RANBAXY$Shai B, Morgane C, Guillaume M, Fabian S. An apple detergent a day doesn^t always keep the doctor away. Swiss Med Wkly. 2024;154 (S277):39S/P 56$10$MON$$M$Y$$$20240718$$HP$CH$CH
241088121$24108812$1$I$$20240703$20240718$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456945$RANBAXY$Anonymous. A rare case of Olanzapine induced paralytic ileus. Indian J Psychiatry. 2024;66(Suppl.):S191J$18$YR$$M$Y$$$20240718$$HP$IN$IN
241088131$24108813$1$I$$20240703$20240718$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456890$RANBAXY$Parmar S, Shatadal P, Mehta R.. Diagnostic dilemma: Systemic Lupus Erythematosus (SLE) induced psychosis vs Steroid-induced psychosis- A case report. Indian J Psychiatry. 2024;66 (Suppl.):S167$22$YR$$F$Y$$$20240718$$HP$IN$IN
241088141$24108814$1$I$$20240703$20240718$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456959$RANBAXY$Vecchio C, Zuffada F, Bianchi M, Nassiacos D. DISCOVERING PALPITATIONS. Eur Heart J Suppl. 2024;26 (Suppl):ii47$51$YR$$M$Y$$$20240718$$HP$IT$IT
241088151$24108815$1$I$$20240703$20240718$20240718$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456856$RANBAXY$Udupa ST, Vaidyanathan S, Munoli RN, Praharaj SK. Serotonin toxicity - A case report. Indian J Psychiatry. 2024;66 (S)$31$YR$$M$Y$$$20240718$$HP$IN$IN
241088161$24108816$1$I$$20200608$20240718$20240718$EXP$$US-AstraZeneca-2020SE74569$ASTRAZENECA$$3632$WK$$M$Y$$$20240718$$CN$US$
241088172$24108817$2$F$20240702$20240722$20240718$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456888$RANBAXY$$67$YR$E$M$Y$$$20240802$$CN$US$US
241088181$24108818$1$I$$20240703$20240718$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456038$RANBAXY$$67$YR$$F$Y$34$KG$20240718$$HP$CA$CA
241088192$24108819$2$F$$20240718$20240718$20240722$EXP$$GB-UCBSA-2024036233$UCB$$$$$M$Y$$$20240722$$CN$GB$GB
241088201$24108820$1$I$$20210518$20240718$20240718$EXP$$US-AstraZeneca-2021A455815$ASTRAZENECA$$69$YR$$M$Y$$$20240718$$HP$US$
241088211$24108821$1$I$$20190904$20240718$20240718$EXP$$US-AstraZeneca-2019SF27124$ASTRAZENECA$$$$$$Y$$$20240718$$CN$US$
241088221$24108822$1$I$$20200812$20240718$20240718$EXP$$US-AstraZeneca-2020SF02856$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241088232$24108823$2$F$20240501$20240904$20240718$20240910$EXP$$CA-CELLTRION INC.-2024CA017380$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
241088241$24108824$1$I$$20220128$20240718$20240718$EXP$$US-AstraZeneca-2022A051232$ASTRAZENECA$$$$$$Y$$$20240718$$CN$US$
241088251$24108825$1$I$$20240715$20240718$20240718$PER$$US-JNJFOC-20240740337$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$US$US
241088272$24108827$2$F$20240711$20240726$20240718$20240731$EXP$$CA-JNJFOC-20240735039$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240731$$CN$CA$CA
241088281$24108828$1$I$$20211102$20240718$20240718$EXP$$US-AstraZeneca-2021A795214$ASTRAZENECA$$$$$$Y$54.4$KG$20240718$$CN$US$
241088291$24108829$1$I$$20240703$20240718$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456015$RANBAXY$$53$YR$$M$Y$$$20240718$$HP$CA$CA
241088301$24108830$1$I$$20200610$20240718$20240718$EXP$$ZA-AstraZeneca-2020SE75372$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$ZA$
241088311$24108831$1$I$$20200528$20240718$20240718$EXP$$US-AstraZeneca-2020SE70457$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241088321$24108832$1$I$$20240709$20240718$20240718$EXP$$JP-AJANTA-2024AJA00128$AJANTA PHARMA$Kaga M, Amano H, Kon T, Harada S, Ogura K.Other iatrogenic immunodeficiency-associated lymphoproliferative disorder presenting with multiple facial tumors.JADD CASE REPORT.21-APR-2024;49:8-10$71$YR$E$F$Y$$$20240718$$MD$JP$JP
241088331$24108833$1$I$20240214$20240710$20240718$20240718$EXP$$SE-AstraZeneca-2024A157527$ASTRAZENECA$$80$YR$$F$Y$$$20240718$$MD$SE$
241088341$24108834$1$I$$20211130$20240718$20240718$EXP$$US-AstraZeneca-2021A852107$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241088351$24108835$1$I$$20200610$20240718$20240718$EXP$$CR-AstraZeneca-2020SE73480$ASTRAZENECA$$36$YR$$F$Y$$$20240718$$CN$CR$
241088361$24108836$1$I$$20211112$20240718$20240718$EXP$$US-AstraZeneca-2021A808412$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241088371$24108837$1$I$$20220301$20240718$20240718$EXP$$US-AstraZeneca-2022A097033$ASTRAZENECA$$$$$F$Y$$$20240718$$MD$US$
241088384$24108838$4$F$20240701$20240802$20240718$20240808$EXP$$CL-TAKEDA-2024TUS072044$TAKEDA$$13$YR$$M$Y$47.5$KG$20240808$$CN$CL$CL
241088391$24108839$1$I$20240715$20240715$20240718$20240718$PER$$US-HALEON-2187624$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241088401$24108840$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220189$TEVA$$91$YR$$F$Y$$$20240718$$HP$CA$CA
241088411$24108841$1$I$$20240710$20240718$20240718$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008759$STRIDES$Saigal K, Maleki A.. Intravitreal Fluocinolone Acetonide 0.19 mg Implant in a Patient with Resistant Blau Syndrome: A Case Report.. Case-Rep-Ophthal. 2024;15 (1):63-70$$$$$Y$$$20240718$$HP$US$US
241088431$24108843$1$I$20240101$20240713$20240718$20240718$EXP$$US-ABBVIE-5843952$ABBVIE$$$$$$Y$$$20240718$$HP$US$US
241088441$24108844$1$I$$20240708$20240718$20240718$EXP$$BE-AUROBINDO-AUR-APL-2024-034735$AUROBINDO$Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A, et al. PIK3CA copynumber gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer.. ColdSpring-Harb-Mol-Case-Stud. 2023;9(2):1-16$31$YR$$F$Y$$$20240718$$HP$BE$BE
241088451$24108845$1$I$20160101$20240716$20240718$20240718$EXP$$IL-SHIRE-IL201609420AA$TAKEDA$$25$YR$$F$Y$62.585$KG$20240718$$HP$IL$IL
241088462$24108846$2$F$20220304$20240916$20240718$20240924$EXP$$CZ-CELLTRION INC.-2024CZ017086$CELLTRION$$$$$$Y$$$20240924$$MD$CZ$CZ
241088471$24108847$1$I$$20240703$20240718$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455845$RANBAXY$$54$YR$$F$Y$$$20240718$$CN$CA$CA
241088481$24108848$1$I$20220705$20240703$20240718$20240718$EXP$$US-SUNPHARMA-2023R1-378217AA$RANBAXY$$92$YR$E$M$Y$$$20240718$$HP$US$US
241088491$24108849$1$I$$20240703$20240718$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456008$RANBAXY$$53$YR$$M$Y$$$20240718$$CN$CA$CA
241088501$24108850$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457047$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$63$YR$$F$Y$$$20240718$$HP$ES$ES
241088511$24108851$1$I$$20240703$20240718$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455976$RANBAXY$$53$YR$$M$Y$$$20240718$$HP$CA$CA
241088521$24108852$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457021$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$59$YR$$F$Y$$$20240718$$HP$ES$ES
241088531$24108853$1$I$$20240703$20240718$20240718$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457180$RANBAXY$$67$YR$$M$Y$$$20240718$$PH$FR$FR
241088541$24108854$1$I$$20240703$20240718$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457104$RANBAXY$Preventative plasmapheresis in a diabetic pregnant patient with hypertriglyceridemia and distal pancreatectomy. Transfusion Medicine$$$N$$Y$$$20240718$$HP$US$US
241088551$24108855$1$I$$20240703$20240718$20240718$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457194$RANBAXY$Xuan W, Wang Z, Lin J, Zou L, Yang X, Xu  Y, et al. Aggressive progression of acute heart failure due to juvenile tuberculosis associated Takayasu arteritis with aortic stenosis and  thrombosis. Front Cardiovasc Med. 2023;Mar;10:1076118(1-6)$10$YR$$M$Y$$$20240718$$HP$CN$CN
241088561$24108856$1$I$20220701$20240703$20240718$20240718$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457227$RANBAXY$$1$DY$$M$Y$1.4$KG$20240718$$MD$DE$DE
241088571$24108857$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457048$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$73$YR$$M$Y$$$20240718$$HP$ES$ES
241088581$24108858$1$I$$20240703$20240718$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456994$RANBAXY$Parmentier C, Cruz-Martinez R, Quintero-Quintero MJ, Vilatoba M. Mucormycosis in Liver Allograft Following Transplant for Secondary Biliary Cirrhosis. Exp Clin Transplant. 2024;4:314-317$57$YR$$M$Y$$$20240718$$HP$CA$CA
241088591$24108859$1$I$$20240703$20240718$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457041$RANBAXY$Catucci S, Lombardi M, Massari E, Maiorano A, Meliota G, Pirolo T. MULTIFOCAL ATRIAL TACHYCARDIA AND HYPERTROPHIC CARDIOMYOPATHY IN THREE PATIENTS WITH COSTELLO SYNDROME. Heart J Suppl. 2024;26 (Suppl.):ii48; Abstract suae036.108$$$N$$Y$$$20240718$$HP$IT$IT
241088601$24108860$1$I$$20240703$20240718$20240718$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457107$RANBAXY$Henry PJ, Wen JH, Feldman EB, Vargas J. Minocycline Induced Parenchymal Lung Disease with Peripheral Eosinophilia. Am J Respir Crit Care Med. 2024;May;209 (0):A1999 (A52)$70$YR$$M$Y$$$20240718$$HP$US$US
241088611$24108861$1$I$$20240703$20240718$20240718$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456759$RANBAXY$Scollo C, Rossi D, D^Andria R, Magnano R, Pezzi L, D^Alleva A, et al. CARDIOVASCULAR CONSIDERATIONS IN ANTIDEPRESSANT THERAPY: SINUS ARREST DUE TO SERTRALINE.. Eur Heart J Suppl. 2024;26 (Suppl.):ii78$39$YR$$F$Y$$$20240718$$HP$IT$IT
241088621$24108862$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457051$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$60$YR$$M$Y$$$20240718$$HP$ES$ES
241088631$24108863$1$I$$20240703$20240718$20240718$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457039$RANBAXY$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann Oncol. 2024;35:S60-S61$53$YR$$M$Y$$$20240718$$HP$ES$ES
241088641$24108864$1$I$$20240703$20240718$20240718$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457089$RANBAXY$Ding J, Gu H, Yang Z, Lu Y, Guo G. Breast metastasis from lung adenocarcinoma: a case report and review of the literature. Front Oncol. 2024;22 May, 14(0):1370453, 1-5$52$YR$$F$Y$$$20240718$$HP$CN$CN
241088651$24108865$1$I$$20240703$20240718$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457106$RANBAXY$Lee J, Chopra N, Costa T, George TP. Treatment of ketamine use disorder with combined gabapentin and topiramate: two case reports. Am J Drug Alcohol Abuse. 2024;0(0):No pagination$28$YR$$F$Y$$$20240718$$HP$CA$CA
241088674$24108867$4$F$20240716$20240722$20240718$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US066240$SANDOZ$$41$YR$$F$Y$$$20240724$$HP$US$US
241088682$24108868$2$F$$20240715$20240718$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457061$RANBAXY$Qu F-J, Kong Y, Yan X, Wang H. Elderly patients with advanced HER2-positive breastcancer with liver metastases benefit from low dosedisitamab vedotin (RC48): case series and literaturereview. Anticancer Drugs. 2024;35(7):658-665$79$YR$$F$Y$$$20240730$$MD$CN$CN
241088691$24108869$1$I$$20240703$20240718$20240718$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455989$RANBAXY$$53$YR$$M$Y$$$20240718$$CN$CA$CA
241088701$24108870$1$I$$20240708$20240718$20240718$EXP$$JP-ROCHE-10000026958$ROCHE$Hikino K, Ito S, Terao C, Et al.. Exploration of genes associated with severehypogammaglobulinemiaand agranulocytosis induced by rituximab and construction of a predictive model.. Recent Advances in Clinical Pharmacology. 2024-Jun-20;45:101-8.$$$$$Y$$$20240718$$HP$JP$JP
241088711$24108871$1$I$$20240712$20240718$20240718$EXP$$US-GSK-US2024087769$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$US$US
241088721$24108872$1$I$$20240709$20240718$20240718$EXP$$IT-MYLANLABS-2024M1065855$MYLAN$Chiavarino F, Pruccoli J, Cecconi I, Vancini N, Cordelli DM, Parmeggiani A. Eating disorders in young patients with neurofibromatosis type 1. J-Paediatr-Child-Health 2023; 59 (5): 723-728.$14$YR$$F$Y$$$20240718$$HP$IT$IT
241088731$24108873$1$I$$20240708$20240718$20240718$EXP$$US-MYLANLABS-2024M1065751$MYLAN$Boris J, Al-Sudani H, Brophy A. Flecainide overdose-induced wide-complex tachyarrhythmia treated with sodium bicarbonate infusion. BMJ-Case-Rep 2024; 17 (6).$5$DEC$$M$Y$$$20240718$$MD$US$US
241088741$24108874$1$I$$20240709$20240718$20240718$EXP$$US-MYLANLABS-2024M1065829$MYLAN$Edwards K, Nagy TR, Fabiano S, Jacotin J, Ellis D. Leptospirosis in the Air: A Case Review Series During Air Medical Transport in Haiti. Air-Med-J 2023; 42 (5): 380-383.$65$YR$$F$Y$$$20240718$$MD$US$US
241088751$24108875$1$I$$20240709$20240718$20240718$EXP$$FR-MYLANLABS-2024M1065873$MYLAN$El-Hussein M, Hamieh C, Nasrallah P, Revue E. The Rising Concern of Ethanol Intoxication from Easy Access to Hand Sanitizers: A Case Report. Am-J-Case-Rep 2024; 25 (0):.$26$YR$$M$Y$$$20240718$$HP$FR$FR
241088761$24108876$1$I$$20240708$20240718$20240718$EXP$$US-MYLANLABS-2024M1065827$MYLAN$Kishk OA, Kim I, Cheng C, Summan M, Munoz MA. Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients. Pediatr-Nephrol 2024; 39 (8): 2429-2433.$21$YR$$M$Y$$$20240718$$HP$US$US
241088771$24108877$1$I$20240715$20240715$20240718$20240718$PER$$US-HALEON-2187684$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241088781$24108878$1$I$$20240708$20240718$20240718$EXP$$US-MYLANLABS-2024M1065762$MYLAN$Andrade J, Sessa L, Ephrat M, Truong J, DiGregorio R. A Case Report of Sudden Sensorineural Hearing Loss (SSNHL) After Administration of the COVID-19 Vaccine. J-Pharm-Pract 2024; 37 (3): 753-757.$41$YR$$F$Y$$$20240718$$PH$US$US
241088791$24108879$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187643$Haleon PLC$$85$YR$$M$Y$$$20240718$$CN$US$US
241088803$24108880$3$F$$20240907$20240718$20240917$EXP$$US-BAUSCHBL-2024BNL001205$BAUSCH AND LOMB$$$$$F$Y$$$20240917$$CN$US$US
241088811$24108881$1$I$$20240708$20240718$20240718$EXP$$US-MYLANLABS-2024M1065293$MYLAN$Cabot RC, Rosenberg ES, Dudzinski DM, Baggett MV, Tran KM, Sgroi DC, et al. Case 11-2023: A 67-Year-Old Man with Mantle-Cell Lymphoma and Hypoxemia. N-Engl-J-Med 2023; 388 (15): 1416-1423.$67$YR$$M$Y$$$20240718$$MD$US$US
241088825$24108882$5$F$$20240823$20240718$20240823$PER$$US-ALXN-202407USA000883US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241088833$24108883$3$F$$20240806$20240718$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112688$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240812$$CN$US$US
241088841$24108884$1$I$20240714$20240714$20240718$20240718$PER$$US-ALXN-202407USA000973US$ALEXION PHARMACEUTICALS$$47$YR$$F$Y$$$20240718$$HP$US$US
241088851$24108885$1$I$$20240709$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108878$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240718$$CN$US$US
241088861$24108886$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113311$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240718$$CN$US$US
241088871$24108887$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113694$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240718$$HP$US$US
241088881$24108888$1$I$$20240712$20240718$20240718$EXP$$EU-BAUSCHBL-2024BNL030028$BAUSCH AND LOMB$$56$YR$$F$Y$$$20240718$$HP$EU$EU
241088893$24108889$3$F$$20240726$20240718$20240807$EXP$$IT-AUROBINDO-AUR-APL-2024-034766$AUROBINDO$Fabozzi F, Palumbo G, Di Pastena M, Zangari P, Bernardi S.. Prolonged neutropenia in patients with lymphoma treated with antiretroviral therapy: Raltegravir too? A single-case report. Pediatric Blood + Cancer. 2023;70:4$6$YR$$F$Y$$$20240807$$HP$IT$IT
241088901$24108890$1$I$20240421$20240709$20240718$20240718$EXP$PT-INFARMED-R202406-532$PT-TEVA-VS-3219547$TEVA$$39$YR$$F$Y$$$20240718$$PH$PT$PT
241088911$24108891$1$I$$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405081659194210-LKFVD$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001761$IPCA$$$$$$Y$$$20240718$$PH$GB$GB
241088942$24108894$2$F$20240101$20240823$20240718$20240829$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001407$BLUEPRINT MEDICINES$$57$YR$A$F$Y$$$20240829$$CN$US$US
241088951$24108895$1$I$$20240624$20240718$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001262$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
241088961$24108896$1$I$$20240706$20240718$20240718$EXP$GB-MHRA-MED-202407052204504620-HSCGN$GB-MSNLABS-2024MSNSPO01569$MSN LABORATORIES$$$$$$Y$$$20240718$$CN$GB$GB
241088972$24108897$2$F$$20240723$20240718$20240724$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040510$BOEHRINGER INGELHEIM$$$$$$Y$$$20240724$$MD$JP$JP
241088981$24108898$1$I$20240101$20240711$20240718$20240718$EXP$$US-JNJFOC-20240600640$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240718$$CN$US$US
241088992$24108899$2$F$$20240724$20240718$20240730$EXP$JP-MMM-LXWEYPK7$JP-GSK-JP2024086771$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$PH$JP$JP
241089002$24108900$2$F$20230310$20240709$20240718$20240719$EXP$$CA-CELLTRION INC.-2023CA005847$CELLTRION$$$$$$Y$$$20240719$$CN$CA$CA
241089015$24108901$5$F$20240705$20240905$20240718$20240912$EXP$$US-GSK-US2024086606$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$US$US
241089021$24108902$1$I$$20240711$20240718$20240718$EXP$$US-GSK-US2024086574$GLAXOSMITHKLINE$$$$$M$Y$$$20240718$$HP$US$US
241089031$24108903$1$I$20240609$20240708$20240718$20240718$EXP$FR-AFSSAPS-LL2024001225$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109596$ZYDUS PHARM$$$$$$Y$$$20240718$$PH$FR$FR
241089041$24108904$1$I$20240524$20240708$20240718$20240718$EXP$FR-AFSSAPS-ST2024001119$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109599$ZYDUS PHARM$$$$$$Y$$$20240718$$MD$FR$FR
241089051$24108905$1$I$20240207$20240708$20240718$20240718$EXP$FR-AFSSAPS-RE2024000648$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109604$ZYDUS PHARM$$$$$$Y$$$20240718$$MD$FR$FR
241089061$24108906$1$I$20240304$20240708$20240718$20240718$EXP$FR-AFSSAPS-RE2024000662$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109623$ZYDUS PHARM$$$$$$Y$$$20240718$$MD$FR$FR
241089071$24108907$1$I$20240319$20240708$20240718$20240718$EXP$FR-AFSSAPS-RE2024000646$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109605$ZYDUS PHARM$$$$$$Y$$$20240718$$MD$FR$FR
241089081$24108908$1$I$20240614$20240624$20240718$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002985$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240718$$CN$US$US
241089091$24108909$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034610$AUROBINDO$Qaiser S, Divanna M, Amir N, Luzuriaga A, Rodriguez C. Real-World Administration of Dantrolene: Harder Than a Board Exam.. Am-J-Respir-Crit-Care-Med. 2024;209:A3654$65$YR$$F$Y$$$20240718$$HP$US$US
241089101$24108910$1$I$20240604$20240624$20240718$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002976$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$72.6$KG$20240718$$CN$US$US
241089111$24108911$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010597$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240718$$CN$US$US
241089121$24108912$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010425$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240718$$CN$US$US
241089131$24108913$1$I$20240119$20240701$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407008596$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240718$$CN$US$US
241089141$24108914$1$I$20240715$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010413$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240718$$CN$US$US
241089152$24108915$2$F$20240701$20240716$20240718$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407010150$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240722$$CN$US$US
241089161$24108916$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011414$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240718$$CN$US$US
241089171$24108917$1$I$$20240712$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010517$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240718$$CN$US$US
241089181$24108918$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010602$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240718$$CN$US$US
241089191$24108919$1$I$20210801$20240710$20240718$20240718$EXP$$BR-ROCHE-3111468$ROCHE$$71$YR$E$M$Y$$$20240718$$MD$BR$BR
241089203$24108920$3$F$$20240822$20240718$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113701$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$42.64$KG$20240827$$CN$US$US
241089211$24108921$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034720$AUROBINDO$Alexander J, Soney H, Lopez D, Naik D, Azimi A. RUSH TO DE-LIVER: A CASE OF HSV HEPATITIS IN PREGNANCY. J-Hosp-Med. 2023;18:S635-S636$24$YR$$F$Y$$$20240718$$HP$US$US
241089221$24108922$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-035247$AUROBINDO$Gaur D, Michalopulos MG, Drake KA, Gattineni J. Acetaminophen induced high anion gap metabolic acidosis: a potentially under-recognized consequence from a common medication. Pediatric Nephrology. 2024$12$YR$$F$Y$$$20240718$$MD$US$US
241089231$24108923$1$I$20240601$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112696$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$86$KG$20240718$$PH$US$US
241089241$24108924$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158308$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241089261$24108926$1$I$$20200118$20240718$20240718$EXP$$US-AstraZeneca-2020SE10794$ASTRAZENECA$$56$YR$$F$Y$$$20240718$$CN$US$
241089271$24108927$1$I$20200511$20200618$20240718$20240718$EXP$$CO-AstraZeneca-2020SE79085$ASTRAZENECA$$26728$DY$$F$Y$$$20240718$$CN$CO$
241089281$24108928$1$I$$20200713$20240718$20240718$EXP$$US-AstraZeneca-2020SE89527$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241089291$24108929$1$I$$20211115$20240718$20240718$EXP$$CA-AstraZeneca-2021A802842$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$CA$
241089301$24108930$1$I$$20200623$20240718$20240718$EXP$$US-AstraZeneca-2020SE81068$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241089311$24108931$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158231$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241089321$24108932$1$I$20240710$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A159037$ASTRAZENECA$$83$YR$$F$Y$59.4$KG$20240718$$CN$US$
241089331$24108933$1$I$$20240710$20240718$20240718$EXP$$JP-AstraZeneca-2024A159102$ASTRAZENECA$$70$YR$$F$Y$$$20240718$$MD$JP$
241089342$24108934$2$F$$20240814$20240718$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06586$LUPIN$$$$$$Y$$$20240903$$CN$US$US
241089352$24108935$2$F$$20240816$20240718$20240820$PER$$US-HALEON-2187638$Haleon PLC$$$$$F$Y$$$20240820$$CN$US$US
241089361$24108936$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158237$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241089371$24108937$1$I$20230101$20240710$20240718$20240718$EXP$$AR-AstraZeneca-2024A160477$ASTRAZENECA$$73$YR$$F$Y$$$20240718$$CN$AR$
241089381$24108938$1$I$$20200922$20240718$20240718$EXP$$US-AstraZeneca-2020SF22418$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241089391$24108939$1$I$$20200629$20240718$20240718$EXP$$US-AstraZeneca-2020SE84064$ASTRAZENECA$$67$YR$$F$Y$$$20240718$$CN$US$
241089401$24108940$1$I$20220101$20240711$20240718$20240718$30DAY$$US-GSK-US2022109443$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241089411$24108941$1$I$$20240709$20240718$20240718$EXP$JP-MMM-W39EZSIT$JP-GSK-JP2024084788$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$JP$JP
241089421$24108942$1$I$$20240715$20240718$20240718$PER$$NVSC2024US147514$NOVARTIS$$$$$M$Y$$$20240718$$CN$US$US
241089432$24108943$2$F$$20240715$20240718$20240820$EXP$NL-LRB-00985652$NL-GILEAD-2024-0680797$GILEAD$$32$YR$A$F$Y$58$KG$20240820$$MD$NL$NL
241089441$24108944$1$I$$20240708$20240718$20240718$EXP$$MX-AMGEN-MEXSP2024137295$AMGEN$$43$YR$A$F$Y$$$20240718$$MD$MX$MX
241089452$24108945$2$F$20240130$20240827$20240718$20240903$EXP$$CA-GSK-CA2024013608$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$CA$CA
241089461$24108946$1$I$20240101$20240712$20240718$20240718$EXP$$US-ABBVIE-5838962$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241089471$24108947$1$I$$20240709$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109445$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240718$$HP$US$US
241089481$24108948$1$I$$20240709$20240718$20240718$EXP$$US-862174955-ML2024-03980$Unknown Manufacturer$Vallabhajosyula S, Ukrani H, Wersinger D, Malik H, Obaji A. Fighting the Recovering Heart While Drowning in Volume: Role of VA-V ECMO Configuration in Migrating Mixing Cloud Effect. Am J Respir Crit Care Med. 2024;209:$43$YR$A$F$Y$$$20240718$$HP$US$US
241089491$24108949$1$I$$20240709$20240718$20240718$EXP$$US-862174955-ML2024-03984$Unknown Manufacturer$Iqbal P, Sharma P, Alladin F, Al-Khazraji Y, Ahmed F, Nawaz S, et al. Managing Intermediate High-Risk Pulmonary Embolism in a Patient With Deep Venous Thrombosis: A Case Report. Am J Respir Crit Care Med. 2024;209:$35$YR$A$M$Y$$$20240718$$HP$US$US
241089502$24108950$2$F$20240709$20240826$20240718$20240904$EXP$$CN-Eisai-EC-2024-169898$EISAI$$70$YR$E$F$Y$$$20240904$$MD$CN$CN
241089511$24108951$1$I$20240101$20240711$20240718$20240718$EXP$$GB-ABBVIE-5839523$ABBVIE$$26$YR$$F$Y$$$20240718$$CN$GB$GB
241089521$24108952$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220099$TEVA$$66$YR$$F$Y$$$20240718$$MD$CA$CA
241089531$24108953$1$I$20240620$20240716$20240718$20240718$EXP$AU-TGA-0000813663$AU-SANDOZ INC.-SDZ2024AU065848$SANDOZ$$69$YR$$M$Y$$$20240718$$HP$AU$AU
241089541$24108954$1$I$20240101$20240715$20240718$20240718$EXP$$CO-ABBVIE-5842438$ABBVIE$$70$YR$$F$Y$50$KG$20240718$$CN$CO$CO
241089552$24108955$2$F$$20240807$20240718$20240808$PER$$US-ALXN-202407USA000830US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
241089561$24108956$1$I$20170704$20240711$20240718$20240718$EXP$$BE-ABBVIE-18K-013-3096910-00$ABBVIE$$73$YR$$M$Y$$$20240718$$MD$BE$BE
241089572$24108957$2$F$$20240812$20240718$20240812$PER$$US-ALXN-202407USA000842US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241089581$24108958$1$I$20230101$20240709$20240718$20240718$EXP$$CA-ABBVIE-5842454$ABBVIE$$45$YR$$F$Y$$$20240718$$CN$CA$CA
241089591$24108959$1$I$$20240716$20240718$20240718$EXP$$US-ABBVIE-5842616$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241089601$24108960$1$I$20240621$20240708$20240718$20240718$EXP$IT-MINISAL02-993798$IT-IBIGEN-2024-015526$ISTITUTO BICHIMICO ITALIANO GIOVANNI LORENZINI (IBIGEN)$$71$YR$$F$Y$$$20240708$$MD$IT$
241089621$24108962$1$I$20240704$20240709$20240718$20240718$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS003601$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$MD$CN$CN
241089631$24108963$1$I$20240302$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405072058043420-FPMZN$GB-MACLEODS PHARMA-MAC2024048234$MACLEODS$$$$$$Y$$$20240718$$CN$GB$GB
241089641$24108964$1$I$$20240624$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002978$ACADIA PHARMACEUTICALS$$$$$M$Y$102.04$KG$20240718$$CN$US$US
241089651$24108965$1$I$$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405091043499980-ZCLHQ$GB-MACLEODS PHARMA-MAC2024048239$MACLEODS$$$$$$Y$$$20240718$$PH$GB$GB
241089661$24108966$1$I$20240511$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405130952401190-ZKJHG$GB-MACLEODS PHARMA-MAC2024048243$MACLEODS$$$$$$Y$$$20240718$$MD$GB$GB
241089671$24108967$1$I$20170106$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405142045567050-ZYRQP$GB-MACLEODS PHARMA-MAC2024048250$MACLEODS$$$$$$Y$$$20240718$$CN$GB$GB
241089681$24108968$1$I$$20240715$20240718$20240718$30DAY$$US-GSK-US2024088654$GLAXOSMITHKLINE$$$$$M$Y$$$20240718$$CN$US$US
241089691$24108969$1$I$20240515$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405151322554580-JFDSQ$GB-MACLEODS PHARMA-MAC2024048258$MACLEODS$$$$$$Y$$$20240718$$CN$GB$GB
241089701$24108970$1$I$20240322$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405161416520420-JKQYG$GB-MACLEODS PHARMA-MAC2024048265$MACLEODS$$44$YR$A$M$Y$$$20240718$$CN$GB$GB
241089713$24108971$3$F$20240711$20240731$20240718$20240802$PER$$US-AMGEN-USASP2024141234$AMGEN$$42$YR$A$M$Y$$$20240802$$MD$US$US
241089721$24108972$1$I$$20240709$20240718$20240718$EXP$$AT-KOANAAP-SML-AT-2024-00723$Unknown Manufacturer$A M, M F, U ET, M P, K S, P H. Case report: a man with a pancreatic adenocarcinoma and negative CA 19-9, but positive CA 125. Z-Gastroenterol. 2024;62(5):$46$YR$A$M$Y$$$20240718$$MD$AT$AT
241089731$24108973$1$I$$20240709$20240718$20240718$EXP$$US-KOANAAP-SML-US-2024-00721$Unknown Manufacturer$Torrado C, Baysal MA, Chakraborty A, Norris BL, Khawaja F, Tsimberidou AM. Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy. Frontiers in Immunology. 2024 May 08;doi:10.3389/fimmu.2024.1366271.$4$DEC$A$M$Y$$$20240718$$MD$US$US
241089741$24108974$1$I$$20240715$20240718$20240718$EXP$$CA-Orion Corporation ORION PHARMA-24_00030882$ORION$$70$YR$E$M$Y$$$20240718$$MD$CA$
241089751$24108975$1$I$20240526$20240713$20240718$20240718$EXP$FR-AFSSAPS-PB2024000790$FR-KOANAAP-SML-FR-2024-00744$Unknown Manufacturer$$19$YR$A$F$Y$$$20240718$$MD$FR$FR
241089761$24108976$1$I$20230101$20240708$20240718$20240718$EXP$$CZ-TEVA-VS-3219836$TEVA$$64$YR$$F$Y$$$20240718$$CN$CZ$CZ
241089771$24108977$1$I$$20240711$20240718$20240718$EXP$$CA-APOTEX-2024AP008260$APOTEX$$77$YR$$F$Y$$$20240718$$HP$CA$CA
241089783$24108978$3$F$$20240820$20240718$20240821$EXP$$NVSC2024CA147215$NOVARTIS$$67$YR$$F$Y$$$20240821$$CN$CA$CA
241089792$24108979$2$F$$20240726$20240718$20240801$EXP$$NVSC2024CA147129$NOVARTIS$$55$YR$$F$Y$$$20240801$$HP$CA$CA
241089812$24108981$2$F$20180101$20240722$20240718$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2018-004896$UNITED THERAPEUTICS$$$$$F$Y$77.098$KG$20240731$$$US$US
241089821$24108982$1$I$20231005$20240708$20240718$20240718$EXP$$KR-TEVA-VS-3219941$TEVA$$54$YR$$M$Y$$$20240718$$MD$KR$KR
241089831$24108983$1$I$$20240712$20240718$20240718$PER$$US-HALEON-2186963$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241089841$24108984$1$I$20240207$20240711$20240718$20240718$EXP$GB-MHRA-MED-202407110744127450-CSZHF$GB-AMAROX PHARMA-AMR2024GB02274$HETERO$$37$YR$$M$Y$80$KG$20240718$$CN$GB$GB
241089851$24108985$1$I$$20240704$20240718$20240718$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06396$HIKMA$Peters MG, Apte N, Kalra DK.. Peters MG, Apte N, Kalra DK. Wide Complex Tachycardia in a Middle-Aged Woman with Diarrhea.. JAMA Cardiology. 2024;9(6):/$7$DEC$$F$Y$$$20240718$$MD$US$US
241089871$24108987$1$I$20231020$20240708$20240718$20240718$EXP$$KR-TEVA-VS-3219979$TEVA$$$$E$M$Y$$$20240718$$HP$KR$KR
241089881$24108988$1$I$$20240709$20240718$20240718$EXP$$US-APOTEX-2024AP008333$APOTEX$Idowu D, Ezema K, Corcoran J, Farkas A.. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clinical Toxicology. 2024;62 (5):296-302$63$YR$$M$Y$$$20240718$$HP$US$US
241089891$24108989$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187770$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241089901$24108990$1$I$20240522$20240706$20240718$20240718$EXP$FR-AFSSAPS-2024059102$FR-Accord-435081$ACCORD$$88$YR$E$F$Y$$$20240718$$PH$FR$FR
241089911$24108991$1$I$20240123$20240703$20240718$20240718$EXP$IT-MINISAL02-993281$IT-Accord-434233$ACCORD$$71$YR$E$M$Y$$$20240718$$MD$IT$IT
241089931$24108993$1$I$$20240708$20240718$20240718$EXP$$JP-Accord-435034$ACCORD$Tsukui D, Haga T, Abe K. Discordance Between Mucosal Appearances and Pathologic Findings in Intestinal Mycobacterial Infection in an Immunocompromised Patient. Mayo Clinic Proceedings. 2024;99(7):1112-3.$6$DEC$A$M$Y$$$20240718$$MD$JP$JP
241089941$24108994$1$I$$20240708$20240718$20240718$EXP$CA-MHPD-E2B_001085218$CA-Accord-435190$ACCORD$$75$YR$E$F$Y$$$20240718$$CN$CA$CA
241089951$24108995$1$I$$20240701$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06617$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241089961$24108996$1$I$20240606$20240710$20240718$20240718$EXP$$CN-AMGEN-CHNSP2024136874$AMGEN$$53$YR$A$F$Y$35$KG$20240718$$HP$CN$CN
241089971$24108997$1$I$20211001$20240708$20240718$20240718$EXP$$CN-Accord-435017$ACCORD$Li Q, Liu M, Liu Y, Shi F, Yuan S, Di G, et al. Lethal Immune-Related Pneumonitis after Durvalumab Therapy for Small Cell Lung Cancer: A First Case in China. Case Reports in Oncology. 2024;17(1):673-80. DOI: 10.1093/oncolo/oyac281.$68$YR$E$M$Y$$$20240718$$MD$CN$CN
241089981$24108998$1$I$$20240710$20240718$20240718$EXP$$GB-CELLTRION INC.-2024GB017189$CELLTRION$$$$$$Y$$$20240718$$CN$GB$GB
241090001$24109000$1$I$$20240703$20240718$20240718$EXP$$US-GRANULES-US-2024GRALIT00272$GRANULES INDIA$P Haghparast.Treatment-Resistant Priapism in a 61-Year-Old Male After Combined Use of Trazodone, Quetiapine and Fluoxetine..Journal of Clinical Psychopharmacology.JUN-2024;44:316-317$61$YR$A$M$Y$$$20240718$$HP$US$US
241090051$24109005$1$I$$20240708$20240718$20240718$30DAY$$US-GSK-US2024084476$GLAXOSMITHKLINE$$$$$M$Y$$$20240718$$CN$US$US
241090063$24109006$3$F$20240714$20240719$20240718$20240724$EXP$$US-SANDOZ INC.-SDZ2024US058502$SANDOZ$$72$YR$$F$Y$90.703$KG$20240724$$CN$US$US
241090071$24109007$1$I$$20240711$20240718$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-021728$UNITED THERAPEUTICS$$56$YR$$F$Y$$$20240718$$$US$US
241090082$24109008$2$F$$20240910$20240718$20240917$EXP$$CA-TERSERA THERAPEUTICS LLC-2024TRS003615$TERSERA THERAPEUTICS$$$$$$Y$$$20240917$$HP$CA$CA
241090092$24109009$2$F$20240715$20240724$20240718$20240731$EXP$$US-ABBVIE-5841878$ABBVIE$$90$YR$$F$Y$$$20240731$$CN$US$US
241090112$24109011$2$F$20240711$20240826$20240718$20240829$30DAY$$US-AMGEN-USASP2024139574$AMGEN$$$$$$Y$$$20240829$$HP$US$US
241090121$24109012$1$I$$20240711$20240718$20240718$EXP$$PL-AMGEN-POLSP2024139016$AMGEN$$45$YR$A$M$Y$$$20240718$$MD$PL$PL
241090141$24109014$1$I$20240101$20240715$20240718$20240718$EXP$$US-AMGEN-USASL2024140295$AMGEN$$62$YR$A$M$Y$$$20240718$$HP$US$US
241090154$24109015$4$F$$20240813$20240718$20240827$PER$$US-ROCHE-10000025566$ROCHE$$$$$M$Y$$$20240827$$MD$US$US
241090161$24109016$1$I$20240622$20240711$20240718$20240718$EXP$$JP-ROCHE-10000028678$ROCHE$$4$DEC$A$$Y$$$20240718$$MD$JP$JP
241090171$24109017$1$I$$20240624$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002034$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241090181$24109018$1$I$$20240712$20240718$20240718$EXP$$US-TAKEDA-2024TUS071532$TAKEDA$$$$A$M$Y$115.8$KG$20240718$$MD$US$US
241090191$24109019$1$I$$20240711$20240718$20240718$EXP$$IN-ROCHE-3557517$ROCHE$$69$YR$E$M$Y$64$KG$20240718$$CN$IN$IN
241090211$24109021$1$I$20240711$20240715$20240718$20240718$EXP$$US-ABBVIE-5843221$ABBVIE$$81$YR$$M$Y$$$20240718$$CN$US$US
241090221$24109022$1$I$$20240711$20240718$20240718$PER$$US-ALXN-202407USA000783US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240718$$CN$US$US
241090231$24109023$1$I$$20200908$20240718$20240718$EXP$$ZA-AstraZeneca-2020SF15857$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$ZA$
241090241$24109024$1$I$20200922$20200922$20240718$20240718$EXP$$US-AstraZeneca-2020SF23270$ASTRAZENECA$$0$DY$$F$Y$66.7$KG$20240718$$CN$US$
241090251$24109025$1$I$$20200617$20240718$20240718$EXP$$US-AstraZeneca-2020SE78980$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241090261$24109026$1$I$20240628$20240709$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-034364$AUROBINDO$$79$YR$$F$Y$75$KG$20240718$$PH$FR$FR
241090272$24109027$2$F$20240714$20240821$20240718$20240904$PER$$US-AstraZeneca-2024A162292$ASTRAZENECA$$21593$DY$$F$Y$$$20240904$$CN$US$
241090281$24109028$1$I$$20210305$20240718$20240718$EXP$$AU-AstraZeneca-2021A122875$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$AU$
241090291$24109029$1$I$$20240711$20240718$20240718$EXP$$US-AMGEN-USASP2024138715$AMGEN$$$$$M$Y$$$20240718$$MD$US$US
241090301$24109030$1$I$20210218$20210319$20240718$20240718$EXP$$CO-AstraZeneca-2021A187946$ASTRAZENECA$$21438$DY$$M$Y$74$KG$20240718$$CN$CO$
241090311$24109031$1$I$$20200817$20240718$20240718$EXP$$US-AstraZeneca-2020SE98774$ASTRAZENECA$$73$YR$$F$Y$$$20240718$$CN$US$
241090321$24109032$1$I$20201002$20201007$20240718$20240718$EXP$$US-AstraZeneca-2020SF31350$ASTRAZENECA$$33608$DY$$F$Y$$$20240718$$CN$US$
241090331$24109033$1$I$$20240715$20240718$20240718$EXP$$US-UCBSA-2024036291$UCB$$$$$M$Y$$$20240718$$CN$US$US
241090341$24109034$1$I$20240628$20240708$20240718$20240718$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090308$VIIV$$67$YR$$F$Y$$$20240718$$CN$US$US
241090351$24109035$1$I$$20240701$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06785$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241090362$24109036$2$F$20240228$20240729$20240718$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-034490$AUROBINDO$$80$YR$$M$Y$69$KG$20240808$$HP$FR$FR
241090371$24109037$1$I$20240524$20240705$20240718$20240718$EXP$$TH-ROCHE-10000029576$ROCHE$$87$YR$E$M$Y$$$20240718$$CN$TH$TH
241090381$24109038$1$I$20240613$20240708$20240718$20240718$EXP$$US-Accord-435308$ACCORD$$34$YR$A$M$Y$$$20240718$$HP$US$US
241090391$24109039$1$I$$20240708$20240718$20240718$EXP$CA-MHPD-E2B_07107882$CA-Accord-435197$ACCORD$$76$YR$E$M$Y$$$20240718$$MD$CA$CA
241090401$24109040$1$I$$20240708$20240718$20240718$EXP$$US-Accord-435041$ACCORD$Fenton GA, Dean EA. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case Reports in Oncology. 2024;17(1):75-81.$64$YR$A$F$Y$$$20240718$$MD$US$US
241090411$24109041$1$I$20240501$20240715$20240718$20240718$EXP$$ES-SA-2024SA206191$SANOFI AVENTIS$$58$YR$A$M$Y$90$KG$20240718$$MD$ES$ES
241090421$24109042$1$I$20240401$20240708$20240718$20240718$EXP$DK-DKMA-30730738$DK-Accord-435476$ACCORD$$78$YR$E$M$Y$$$20240718$$HP$DK$DK
241090431$24109043$1$I$$20240704$20240718$20240718$EXP$$US-Accord-434179$ACCORD$Khosla H, Bhatt S, Wang M, Gignac G, Mittal K, Patel J. Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis. Journal of Oncology Pharmacy Practice. 2024;30(5):941-4.$64$YR$A$M$Y$$$20240718$$MD$US$US
241090441$24109044$1$I$20210901$20240707$20240718$20240718$EXP$$CN-Accord-435328$ACCORD$Qin Y, Lu S, Chen J, Peng J, Yang J. Case report: A rare case of anti-PD-1 sintilimab-induced agranulocytosis/severe neutropenia in non-small cell lung cancer and literature review. Front Oncol. 2024 Jun 18;14:1415748.$68$YR$E$M$Y$$$20240718$$HP$CN$CN
241090451$24109045$1$I$20240601$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010786$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240718$$CN$US$US
241090461$24109046$1$I$$20240712$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010761$ELI LILLY AND CO$$$$$F$Y$$$20240718$$HP$US$US
241090471$24109047$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010684$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240718$$CN$US$US
241090481$24109048$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009929$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240718$$MD$US$US
241090491$24109049$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011349$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240718$$CN$US$US
241090503$24109050$3$F$20240709$20240828$20240718$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202407006375$ELI LILLY AND CO$$$$$M$Y$$$20240906$$CN$US$US
241090512$24109051$2$F$$20240802$20240718$20240805$EXP$$US-UCBSA-2024036278$UCB$$$$$F$Y$$$20240805$$CN$US$US
241090521$24109052$1$I$$20240710$20240718$20240718$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008752$STRIDES$Vela-Casasempere P, Cano Alameda R, Gomez Sabater S, Cortell Aznar S, Perez Pascual E.. Considering belimumab during pregnancy: A more viable option over time. [Review].. Lupus. 2024;33 (7):700-715.$34$YR$$F$Y$$$20240718$$HP$ES$ES
241090531$24109053$1$I$$20240708$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108740$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240718$$CN$US$US
241090571$24109057$1$I$20240623$20240710$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-034654$AUROBINDO$$36$YR$$M$Y$83$KG$20240718$$CN$GB$GB
241090581$24109058$1$I$20240530$20240709$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-034246$AUROBINDO$$26$YR$$F$Y$48$KG$20240718$$PH$FR$FR
241090591$24109059$1$I$20240101$20240711$20240718$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-018777$UNITED THERAPEUTICS$$$$$F$Y$56.236$KG$20240718$$$US$US
241090601$24109060$1$I$$20240710$20240718$20240718$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP008714$STRIDES$Ten Brinck MFM, Verheijen IWH, van de Wardt J, van Dijk GW, Nijhuis FAP, Verrips A.. Dilated fixed pupils and respiratory failure: a rare clinical course of Lambert-Eaton myasthenic syndrome. BMJ-Neurol-Open. 2023;5 (2):1-4$62$YR$$F$Y$$$20240718$$HP$NL$NL
241090611$24109061$1$I$$20240710$20240718$20240718$EXP$$BR-CELLTRION INC.-2024BR013880$CELLTRION$$$$$$Y$$$20240718$$CN$BR$BR
241090621$24109062$1$I$$20240715$20240718$20240718$PER$$US-ABBVIE-5841968$ABBVIE$$$$$$Y$$$20240718$$CN$US$US
241090631$24109063$1$I$$20240701$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06557$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241090641$24109064$1$I$20240101$20240711$20240718$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-021552$UNITED THERAPEUTICS$$$$$M$Y$64.853$KG$20240718$$$US$US
241090651$24109065$1$I$20240520$20240711$20240718$20240718$PER$$US-AMGEN-USASP2024141939$AMGEN$$75$YR$E$M$Y$$$20240718$$HP$US$US
241090663$24109066$3$F$20240716$20240826$20240718$20240828$PER$$US-AMGEN-USASP2024141704$AMGEN$$73$YR$E$F$Y$$$20240828$$CN$US$US
241090671$24109067$1$I$$20240624$20240718$20240718$EXP$$US-IBIGEN-2023-013689$ISTITUTO BICHIMICO ITALIANO GIOVANNI LORENZINI (IBIGEN)$Adisa O, Ananthaneni A, Rushing B, Rinehouse N, Morisetti P. Vancomycin-and piperacillin-induced acute interstitial nephritis in a patient with lupus: A case report showcasing rapid decline in renal function. Clinical Nephrology - Case Studies. 2023;11(1):99-103. DOI: 10.5414/CNCS111180.$41$YR$$F$Y$$$20240624$$MD$US$
241090681$24109068$1$I$$20240716$20240718$20240718$EXP$$CA-UCBSA-2024036261$UCB$$$$$M$Y$$$20240718$$CN$CA$CA
241090693$24109069$3$F$20240101$20240813$20240718$20240826$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700017$UPSHER SMITH LABORATORIES$$$$$M$Y$$$20240826$$HP$US$US
241090701$24109070$1$I$$20240710$20240718$20240718$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008716$STRIDES$Vela-Casasempere P, Cano Alameda R, Gomez Sabater S, Cortell Aznar S, Perez Pascual E.. Considering belimumab during pregnancy: A more viable option over time. [Review].. Lupus. 2024;33 (7):700-715$40$YR$$F$Y$$$20240718$$HP$ES$ES
241090712$24109071$2$F$$20240724$20240718$20240801$EXP$$BR-CELLTRION INC.-2024BR017016$CELLTRION$Kolodziejwski WT, Rosa CA, Guimaraes AM, da Silva PQ, de Araujo MR.. Mandibular fracture in medication-associated osteonecrosis following infliximab therapy: A case report.. Spec Care Dentist. 2024;1-6$$$$$Y$$$20240801$$HP$BR$BR
241090721$24109072$1$I$$20240626$20240718$20240718$EXP$$DE-ROCHE-10000024387$ROCHE$Al-Sawaf O, Robrecht S, Zhang C, Olivieri S, Chang N. Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized CLL14 study. Leuk Lymphoma. 2023;64 (S1):S113.$$$E$$Y$$$20240718$$MD$DE$DE
241090741$24109074$1$I$$20240710$20240718$20240718$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP008745$STRIDES$Kaya Akca U, Sener S, Batu ED, Balik Z, Basaran O, Bilginer Y, et al.. Drug-induced lupus erythematosus in childhood: Case-based review.. Lupus. 2024;33 (7):737-748$$$C$M$Y$$$20240718$$HP$TR$TR
241090751$24109075$1$I$$20240711$20240718$20240718$PER$$US-ABBVIE-5840154$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241090762$24109076$2$F$$20240806$20240718$20240818$30DAY$$TW-JNJFOC-20240737013$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$PH$TW$TW
241090771$24109077$1$I$$20240711$20240718$20240718$EXP$$JP-VIATRISJAPAN-2024M1064843AA$MYLAN$Maruyama T, Kondo S, Nomura H, and Hara H. Haemodynamics of BRASH Syndrome in the Very Elderly Patients. The 47th Annual Meeting of The Japanese Society of Biorheology. 2024;29$94$YR$$M$Y$$$20240718$$MD$JP$JP
241090782$24109078$2$F$$20240822$20240718$20240830$EXP$$CA-MYLANLABS-2024M1065782$MYLAN$Wu H, Hill V. Serotonin Syndrome and Catatonia in the Absence of a Serotonergic Agent Following Abrupt Withdrawal of Clozapine. Can-J-Hosp-Pharm 2024; 77 (1).$47$YR$$M$Y$$$20240830$$PH$CA$CA
241090802$24109080$2$F$$20240820$20240718$20240826$EXP$$FR-MYLANLABS-2024M1065491$MYLAN$Bohren Y., Timbolschi I.D.. Perineural botulinum toxin injection for cancer-related pain: Case report of two patient.. Pain Medicine Case Reports.. 2023;7 (5):261-264$56$YR$$M$Y$$$20240826$$MD$FR$FR
241090812$24109081$2$F$20240525$20240729$20240718$20240812$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700007$UPSHER SMITH LABORATORIES$$37$YR$$F$Y$61.678$KG$20240812$$MD$US$US
241090831$24109083$1$I$20240101$20240712$20240718$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-021681$UNITED THERAPEUTICS$$$$$M$Y$88.435$KG$20240718$$$US$US
241090871$24109087$1$I$20240216$20240704$20240718$20240718$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06376$HIKMA$$42$YR$$F$Y$$$20240718$$MD$IT$IT
241090881$24109088$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113802$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240718$$CN$US$US
241090891$24109089$1$I$$20240711$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110943$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240718$$HP$US$US
241090901$24109090$1$I$$20240716$20240718$20240718$EXP$$GR-ABBVIE-5842404$ABBVIE$$65$YR$$M$Y$$$20240718$$MD$GR$GR
241090911$24109091$1$I$20240101$20240712$20240718$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-021695$UNITED THERAPEUTICS$$$$$F$Y$47.619$KG$20240718$$$US$US
241090923$24109092$3$F$20240101$20240805$20240718$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-015829$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240809$$$US$US
241090931$24109093$1$I$20240714$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140516$AMGEN$$80$YR$E$F$Y$$$20240718$$CN$US$US
241090941$24109094$1$I$20240213$20240705$20240718$20240718$EXP$$AU-CIPLA LTD.-2024AU07601$CIPLA$$$$$$Y$$$20240718$$MD$AU$AU
241090951$24109095$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034770$AUROBINDO$Suresh S, Chaitanya G, Kachhvah AD, Vashin V, Saranathan M, Pati S.. Case report: Nocturnal low-frequency stimulation of the centromedian thalamic nucleus improves sleep quality and seizure control. Front-Hum-Neurosci. 2024$39$YR$$M$Y$$$20240718$$HP$US$US
241090961$24109096$1$I$$20240710$20240718$20240718$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008746$STRIDES$Vela-Casasempere P, Cano Alameda R, Gomez Sabater S, Cortell Aznar S, Perez Pascual E.. Considering belimumab during pregnancy: A more viable option over time. [Review].. Lupus. 2024;33 (7):700-715$$$$F$Y$$$20240718$$HP$ES$ES
241090981$24109098$1$I$20230704$20240708$20240718$20240718$EXP$ES-AEMPS-1545406$ES-Accord-435408$ACCORD$$42$YR$A$M$Y$95$KG$20240718$$PH$ES$ES
241090991$24109099$1$I$20240624$20240708$20240718$20240718$EXP$GB-MHRA-TPP14079978C122126YC1719231623037$GB-Accord-435274$ACCORD$$76$YR$E$F$Y$67$KG$20240718$$MD$GB$GB
241091001$24109100$1$I$20240423$20240706$20240718$20240718$EXP$FR-AFSSAPS-2024058587$FR-Accord-435175$ACCORD$$76$YR$E$F$Y$$$20240718$$PH$FR$FR
241091011$24109101$1$I$$20240706$20240718$20240718$EXP$$IT-Accord-435387$ACCORD$Munari S, Ciotti G, Cestaro W, Corsi L, Tonin S, Ballarin A, et al. Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review. Drugs-Cont 2024; 13 1-11.$64$YR$A$F$Y$$$20240718$$HP$IT$IT
241091021$24109102$1$I$20240501$20240706$20240718$20240718$EXP$FR-AFSSAPS-AM2024000551$FR-Accord-435203$ACCORD$$66$YR$E$M$Y$79$KG$20240718$$MD$FR$FR
241091031$24109103$1$I$$20240708$20240718$20240718$EXP$CA-MHPD-001082450$CA-Accord-435177$ACCORD$$70$YR$E$M$Y$92$KG$20240718$$PH$CA$CA
241091041$24109104$1$I$20240703$20240708$20240718$20240718$EXP$$US-Accord-435324$ACCORD$$59$YR$A$F$Y$$$20240718$$HP$US$US
241091051$24109105$1$I$20240630$20240706$20240718$20240718$EXP$$US-Accord-434425$ACCORD$$37$YR$A$M$Y$$$20240718$$HP$US$US
241091061$24109106$1$I$20240512$20240706$20240718$20240718$EXP$FR-AFSSAPS-PB2024000758$FR-Accord-435232$ACCORD$$18$YR$A$F$Y$59.5$KG$20240718$$MD$FR$FR
241091072$24109107$2$F$20240713$20240821$20240718$20240823$PER$$US-AMGEN-USASP2024140536$AMGEN$$61$YR$A$F$Y$$$20240823$$CN$US$US
241091081$24109108$1$I$20230101$20240709$20240718$20240718$EXP$$DE-AUROBINDO-AUR-APL-2024-033489$AUROBINDO$$62$YR$$M$Y$$$20240718$$PH$DE$DE
241091091$24109109$1$I$$20240708$20240718$20240718$EXP$CA-MHPD-E2B_07059321$CA-Accord-435153$ACCORD$$54$YR$A$F$Y$$$20240718$$HP$CA$CA
241091103$24109110$3$F$$20240725$20240718$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA065942$SANDOZ$$$$$F$Y$$$20240729$$MD$CA$CA
241091111$24109111$1$I$$20240710$20240718$20240718$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP008749$STRIDES$Vela-Casasempere P, Cano Alameda R, Gomez Sabater S, Cortell Aznar S, Perez Pascual E.. Considering belimumab during pregnancy: A more viable option over time. [Review].. Lupus. 2024;33 (7):700-715$$$$F$Y$$$20240718$$HP$ES$ES
241091121$24109112$1$I$$20240709$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-034307$AUROBINDO$$34$YR$$F$Y$$$20240718$$CN$GB$GB
241091141$24109114$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034647$AUROBINDO$Wu LW, Qasim Hussaini SM, Lee JW, Shu DH, Hruban RH, Laheru DA. Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma-two case reports. AnnPancreat-Cancer. 2022$69$YR$$M$Y$$$20240718$$HP$US$US
241091151$24109115$1$I$$20240705$20240718$20240718$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-15484$ALKEM$Lazzerini PE, Bertolozzi I, Rossi M, Capecchi PL, Laghi-Pasini F. Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk. J Am Coll Cardiol. 2017;69 (14):1873-81$$$$$Y$$$20240718$$MD$IT$IT
241091161$24109116$1$I$$20240705$20240718$20240718$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-15486$ALKEM$Lazzerini PE, Bertolozzi I, Rossi M, Capecchi PL, Laghi-Pasini F. Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk. J Am Coll Cardiol. 2017;69(14):1873-1881$$$$$Y$$$20240718$$MD$IT$IT
241091171$24109117$1$I$$20240705$20240718$20240718$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-15489$ALKEM$Lazzerini PE, Bertolozzi I, Rossi M, Capecchi PL, Laghi-Pasini F. Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk. J Am Coll Cardiol. 2017;69 (14):1876-1877$$$$$Y$$$20240718$$MD$IT$IT
241091181$24109118$1$I$$20240712$20240718$20240718$EXP$$US-TAKEDA-2024TUS069859$TAKEDA$$$$$F$Y$$$20240718$$CN$US$US
241091191$24109119$1$I$20240501$20240705$20240718$20240718$EXP$$AU-CIPLA LTD.-2024AU07561$CIPLA$$$$$$Y$$$20240718$$HP$AU$AU
241091201$24109120$1$I$20240101$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405011943502680-MHYWC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15164$ALKEM$$66$YR$$F$Y$$$20240718$$HP$GB$GB
241091211$24109121$1$I$20240401$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405061455541680-ZSDVW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15134$ALKEM$$25$YR$$M$Y$$$20240718$$MD$GB$GB
241091222$24109122$2$F$$20240715$20240718$20240729$EXP$JP-MLMSERVICE-20240628-PI112935-00232-1$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-15163$ALKEM$Tokuchi M, Yonishi H, Namba-Hamano T. Successful treatment of a renal allograft abscess with antimicrobial agents alone and appropriate follow-up imaging. Transplant Infectious Disease. 2024;26 (3):e14278$22$YR$$F$Y$$$20240729$$MD$JP$JP
241091231$24109123$1$I$20240601$20240709$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-034434$AUROBINDO$$95$YR$$F$Y$65$KG$20240718$$MD$FR$FR
241091241$24109124$1$I$$20240710$20240718$20240718$EXP$$CA-AstraZeneca-2024A158345$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$CA$
241091251$24109125$1$I$$20240710$20240718$20240718$EXP$$ZA-AstraZeneca-2024A159130$ASTRAZENECA$$54$YR$$M$Y$$$20240718$$CN$ZA$
241091261$24109126$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-035635$AUROBINDO$Sharp JA, Jones D, Rotow JK, Fidias PM, Bertino E, Owen DH.. Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non-Small Cell Lung Cancer.. J-Natl-Compr-Canc-Netw. 2024;22No. 3:1-5$79$YR$$F$Y$$$20240718$$MD$US$US
241091271$24109127$1$I$$20220127$20240718$20240718$EXP$$US-AstraZeneca-2022A052224$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241091281$24109128$1$I$20150601$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405021518569640-TZGLF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15167$ALKEM$$38$YR$$F$Y$$$20240718$$CN$GB$GB
241091291$24109129$1$I$20201123$20201124$20240718$20240718$EXP$$US-AstraZeneca-2020SF57284$ASTRAZENECA$$19397$DY$$F$Y$$$20240718$$CN$US$
241091301$24109130$1$I$$20240703$20240718$20240718$EXP$$US-Innogenix, LLC-2159235$INNOGENIX$Source document (Full text)$56$YR$$F$Y$$$20240718$$$US$US
241091311$24109131$1$I$$20210324$20240718$20240718$EXP$$US-AstraZeneca-2021A224278$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241091321$24109132$1$I$$20240715$20240718$20240718$PER$$US-TAKEDA-2024TUS071683$TAKEDA$$$$$$Y$$$20240718$$CN$US$US
241091331$24109133$1$I$$20240712$20240718$20240718$EXP$$CA-ASTELLAS-2024US020144$ASTELLAS$$$$$$Y$$$20240718$$HP$GB$CA
241091341$24109134$1$I$$20240709$20240718$20240718$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008648$STRIDES$Van Noord B, Samaan C, Flamm A.. A Case of Delayed and Immediate Hypersensitivity Reactions Induced by Corticosteroids.. Dermatitis. 2024;35(2):191-192$71$YR$$M$Y$$$20240718$$MD$US$US
241091351$24109135$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034727$AUROBINDO$Fan J, Thanedar S, Ovechko V, Jana B. Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers. Case-Rep-Oncol. 2024;17 (1):517-523$56$YR$$M$Y$$$20240718$$HP$US$US
241091361$24109136$1$I$20240602$20240712$20240718$20240718$EXP$AZ-AEC-300022871$AZ-SANDOZ INC.-SDZ2024AZ066002$SANDOZ$$$$$$Y$$$20240718$$HP$AZ$AZ
241091371$24109137$1$I$20240701$20240715$20240718$20240718$PER$$US-ABBVIE-5842109$ABBVIE$$32$YR$$F$Y$$$20240718$$HP$US$US
241091381$24109138$1$I$20180101$20240712$20240718$20240718$EXP$$CA-AMGEN-CANSL2024139132$AMGEN$$75$YR$E$F$Y$$$20240718$$CN$CA$CA
241091391$24109139$1$I$$20240711$20240718$20240718$EXP$$JP-AMGEN-JPNSP2024141249$AMGEN$$$$$F$Y$$$20240718$$CN$JP$JP
241091401$24109140$1$I$$20240703$20240718$20240718$PER$$US-AMGEN-USASP2024142491$AMGEN$$$$$M$Y$$$20240718$$CN$US$US
241091411$24109141$1$I$$20240703$20240718$20240718$EXP$$IR-Innogenix, LLC-2159238$INNOGENIX$Full text$19$YR$$F$Y$$$20240718$$MD$IR$IR
241091422$24109142$2$F$$20240726$20240718$20240807$EXP$$AU-AUROBINDO-AUR-APL-2024-034808$AUROBINDO$Ali SB, Vembar P, Sukumaran S, Gunawardane D, Hughes T, Smith A. Tocilizumab in grade 4 hepatitis secondary to immune checkpoint inhibitor: a case report and review of the literature. Immunotherapy. 2023;15(14):1125-1132$68$YR$$F$Y$52$KG$20240807$$HP$AU$AU
241091431$24109143$1$I$$20240703$20240718$20240718$EXP$$BR-Eywa Pharma Inc.-2159232$EYWA PHARMA$SD (Full text article)$55$YR$$M$Y$$$20240718$$$BR$BR
241091442$24109144$2$F$20240710$20240718$20240718$20240726$EXP$$US-GSK-US2024086317$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240726$$CN$US$US
241091451$24109145$1$I$$20240711$20240718$20240718$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024087720$VIIV$$$$$$Y$$$20240718$$MD$US$US
241091461$24109146$1$I$20210101$20240710$20240718$20240718$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008758$STRIDES$Xu X, Li Y, Han T, Zhao Y, Wang X, Fu X, et al.. The hidden dangers of short-term glucocorticoid use in children: A genomic analysis.. Int-Immunopharmacol. 2024;135 (0)$7$YR$$M$Y$40$KG$20240718$$HP$CN$CN
241091471$24109147$1$I$20240708$20240709$20240718$20240718$PER$$US-ABBVIE-5840731$ABBVIE$$23$YR$$F$Y$$$20240718$$MD$US$US
241091481$24109148$1$I$$20240711$20240718$20240718$EXP$$US-MYLANLABS-2024M1065807$MYLAN$Rodriguez C, Yosry N, Qaiser S, Luzuriaga A, Adelizzi A. BRASH: A Deadly Acronym. Am-J-Respir-Crit-Care-Med 2024; 209.$84$YR$$F$Y$$$20240718$$HP$US$US
241091491$24109149$1$I$$20240711$20240718$20240718$EXP$$US-MYLANLABS-2024M1066541$MYLAN$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.$$$A$$Y$$$20240718$$PH$US$US
241091521$24109152$1$I$20240710$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49646$$FDA-CTU$$64$YR$$F$N$69.9$KG$20240717$N$$US$
241091531$24109153$1$I$20240131$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49638$$FDA-CTU$$83$YR$$F$N$44.2$KG$20240716$N$$US$
241091541$24109154$1$I$20240617$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49636$$FDA-CTU$$71$YR$$F$N$73.75$KG$20240716$N$$US$
241091561$24109156$1$I$20240603$20240715$20240718$20240718$EXP$$PK-ROCHE-10000027463$ROCHE$$63$YR$A$M$Y$$$20240718$$CN$PK$PK
241091571$24109157$1$I$$20240709$20240718$20240718$EXP$$MT-AUROBINDO-AUR-APL-2024-034467$AUROBINDO$$69$YR$$F$Y$$$20240718$$PH$MT$MT
241091581$24109158$1$I$$20240709$20240718$20240718$EXP$$US-BAYER-2024A099933$BAYER$Nguyen A.; Norman M.; O^reilly E.; Robinson C.L.; Fonseca A.; Madabhushi S.; Phung A.; Raj V.; Galvin M.; Reddy R.; Viswanath O.; Orhurhu V.; Kaye A.D.; Dominguez M.; Hasoon J.; Simopoulos T.; Yazdi C. Case Series: Spinal Cord Stimulator Therapy Alleviates Neuropathic Pain in Patients with Failed Back Surgery Syndrome in the Setting of Spinal Cord Injury. Pain Medicine Case Reports. 2023;7:7:(337-340)$50$YR$A$M$Y$$$20240718$$MD$US$US
241091592$24109159$2$F$$20240724$20240718$20240725$EXP$$MY-BAYER-2024A101210$BAYER$$44$YR$A$F$Y$$$20240725$$MD$MY$MY
241091601$24109160$1$I$$20240710$20240718$20240718$EXP$$US-NOVITIUMPHARMA-2024USNVP01273$NOVITIUM PHARMA$Melissa R. Laughter.Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C.JAAD Case Reports.JUL-2024;49:28-31$37$YR$A$M$Y$$$20240718$$HP$US$US
241091611$24109161$1$I$$20240711$20240718$20240718$EXP$$IN-MYLANLABS-2024M1066556$MYLAN$Dwivedi S, Rakesh CR, Anand S, Dogra N, Singh BP. Intra-abdominal Inflammatory Myofibroblastic Tumour (IMFT)-Uncommon Entity. Ind-J-Surg-Oncol 2024; 15 (Suppl.) 344-348.$30$YR$$M$Y$$$20240718$$HP$IN$IN
241091622$24109162$2$F$$20240820$20240718$20240826$30DAY$$CA-MYLANLABS-2024M1066062$MYLAN$$$$$M$Y$$$20240826$$CN$CA$CA
241091631$24109163$1$I$$20240711$20240718$20240718$EXP$$IN-MYLANLABS-2024M1066560$MYLAN$Singhal S, Sharma R, Sharma S, Lodi AI, Bhandari V. Ovarian cancer with osteoblastic bone metastasis - A rare case report. J-Cancer-Res-Ther 2023; 19 S932-S934.$53$YR$$F$Y$$$20240718$$MD$IN$IN
241091641$24109164$1$I$$20240711$20240718$20240718$EXP$$NL-MYLANLABS-2024M1065309$MYLAN$Van der Veen S, Eggink H, Elting JW, Sival D, Verschuuren-Bemelmans CC, de Koning TJ et al.. The natural history of progressive myoclonus ataxia. Neurobiology of Disease. 2024;199:1-12$$$T$F$Y$$$20240718$$HP$NL$NL
241091651$24109165$1$I$$20240709$20240718$20240718$EXP$$US-PADAGIS-2024PAD01148$PADAGIS$$$$$$Y$$$20240718$$CN$US$US
241091661$24109166$1$I$$20240710$20240718$20240718$EXP$$US-PADAGIS-2024PAD01150$PADAGIS$Balasundaram P, Sakr M. Chromosomal Integration of HHV-6 in a Preterm Neonate: A Rare Case of Hyperleukocytosis and Clinical Implications. Pediatric Reports. 2024;16(2):432-437$$$$$Y$$$20240718$$HP$US$US
241091671$24109167$1$I$$20240708$20240718$20240718$EXP$$US-Accord-435044$ACCORD$Li S, Halloran P, Siref A. Concurrent Neutrophilic Eccrine Hidradenitis and Leukocytoclastic Vasculitis. American Journal of Dermatopathology. 2024;46(7):S20.$58$YR$A$F$Y$$$20240718$$MD$US$US
241091681$24109168$1$I$20240630$20240708$20240718$20240718$EXP$CN-HENLIUS-24CN015828$CN-Accord-436520$ACCORD$$57$YR$A$F$Y$64$KG$20240718$$MD$CN$CN
241091701$24109170$1$I$$20240707$20240718$20240718$EXP$$MX-Accord-435244$ACCORD$Gutierrez-Govea A, Jalomo-Martinez B, Evangelista-Carrillo LA, Cerrillos-Gutierrez JI, Medina-Perez M. Thrombotic microangiopathy associated with calcineurin inhibitor induction doses in patients with a kidney transplant. Clin Case Rep. 2024 Jun 28;12(7):e9125.$23$YR$A$M$Y$$$20240718$$HP$MX$MX
241091711$24109171$1$I$$20240708$20240718$20240718$EXP$$US-Accord-435043$ACCORD$Kuraitis D, Bogner P, Gopalakrishnan D, Pei S. Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis. JAAD Case Reports. 2024;50:33-6. DOI: 10.1016/j.jdcr.2024.05.012.$68$YR$E$M$Y$$$20240718$$MD$US$US
241091721$24109172$1$I$$20240711$20240718$20240718$EXP$$US-GSK-US2024086621$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241091731$24109173$1$I$$20240711$20240718$20240718$30DAY$$US-GSK-US2024086599$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241091741$24109174$1$I$20240606$20240710$20240718$20240718$EXP$$US-GSK-US2024085768$GLAXOSMITHKLINE$$30$YR$$F$Y$$$20240718$$CN$US$US
241091751$24109175$1$I$20240530$20240711$20240718$20240718$EXP$$JP-GSK-JP2024089093$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$JP$JP
241091762$24109176$2$F$$20240719$20240718$20240721$EXP$$BR-BAYER-2024A104179$BAYER$$$$$F$Y$$$20240719$$PH$BR$BR
241091771$24109177$1$I$$20240703$20240718$20240718$EXP$$US-Eywa Pharma Inc.-2159229$EYWA PHARMA$Source document (Full text)$56$YR$$F$Y$$$20240718$$$US$US
241091781$24109178$1$I$$20240703$20240718$20240718$EXP$$NL-Eywa Pharma Inc.-2159233$EYWA PHARMA$Full text$42$YR$$M$Y$65.9$KG$20240718$$$NL$NL
241091793$24109179$3$F$20240710$20240816$20240718$20240819$PER$$US-ALXN-202407USA000799US$ALEXION PHARMACEUTICALS$$56$YR$$F$Y$$$20240819$$CN$US$US
241091801$24109180$1$I$20240101$20240710$20240718$20240718$EXP$$JP-AMGEN-JPNSP2024043503$AMGEN$$69$YR$E$M$Y$49$KG$20240718$$PH$JP$JP
241091811$24109181$1$I$$20240711$20240718$20240718$EXP$$JP-AMGEN-JPNSP2024141253$AMGEN$$$$$F$Y$$$20240718$$CN$JP$JP
241091822$24109182$2$F$$20240725$20240718$20240727$PER$$US-AMGEN-USASP2024141733$AMGEN$$$$$M$Y$$$20240727$$MD$US$US
241091831$24109183$1$I$$20240703$20240718$20240718$EXP$$US-Innogenix, LLC-2159237$INNOGENIX$SD (Full text article).$72$YR$$F$Y$$$20240718$$$US$US
241091841$24109184$1$I$$20240711$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112248$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240718$$MD$US$US
241091851$24109185$1$I$$20240712$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111785$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240718$$CN$US$US
241091861$24109186$1$I$20240716$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114366$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240718$$HP$US$US
241091881$24109188$1$I$$20240704$20240718$20240718$EXP$$EE-B.Braun Medical Inc.-2159254$B BRAUN$$69$YR$$M$Y$$$20240718$$$EE$EE
241091891$24109189$1$I$20211019$20240716$20240718$20240718$EXP$$DE-ABBVIE-5842366$ABBVIE$$85$YR$$F$Y$$$20240718$$MD$DE$DE
241091911$24109191$1$I$$20240710$20240718$20240718$EXP$$US-BAYER-2024A099783$BAYER$$$$$F$Y$$$20240718$$CN$US$US
241091921$24109192$1$I$20231001$20240711$20240718$20240718$EXP$MT-ADM-02072024$MT-MYLANLABS-2024M1065482$MYLAN$$$$$F$Y$$$20240718$$MD$MT$MT
241091931$24109193$1$I$20240709$20240712$20240718$20240718$EXP$$US-ABBVIE-5841977$ABBVIE$$54$YR$$F$Y$$$20240718$$CN$US$US
241091941$24109194$1$I$20240610$20240711$20240718$20240718$EXP$FR-AFSSAPS-GR2024000858$FR-MYLANLABS-2024M1065357$MYLAN$$42$YR$$F$Y$62$KG$20240718$$PH$FR$FR
241091951$24109195$1$I$$20240704$20240718$20240718$EXP$$EE-B.Braun Medical Inc.-2159253$B BRAUN$$49$YR$$M$Y$$$20240718$$$EE$EE
241091961$24109196$1$I$$20240531$20240718$20240718$PER$$US-STI Pharma LLC-2159256$STI PHARMA$$75$YR$$F$Y$$$20240718$$MD$US$US
241091981$24109198$1$I$$20240531$20240718$20240718$PER$$US-STI Pharma LLC-2159259$STI PHARMA$$64$YR$$F$Y$$$20240718$$MD$US$US
241092001$24109200$1$I$$20240531$20240718$20240718$PER$$US-STI Pharma LLC-2159257$STI PHARMA$$75$YR$$F$Y$$$20240718$$MD$US$US
241092011$24109201$1$I$$20240606$20240718$20240718$PER$$US-STI Pharma LLC-2159260$STI PHARMA$$75$YR$$F$Y$$$20240718$$MD$US$US
241092021$24109202$1$I$$20240703$20240718$20240718$EXP$$US-Appco Pharma LLC-2159271$APPCO PHARMA$Initial$33$YR$$M$Y$$$20240718$$$FR$US
241092031$24109203$1$I$$20240715$20240718$20240718$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024088691$VIIV$$$$$M$Y$$$20240718$$MD$US$US
241092041$24109204$1$I$$20240705$20240718$20240718$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-05223$HIKMA$$69$YR$$F$Y$$$20240718$$HP$CA$CA
241092051$24109205$1$I$$20240711$20240718$20240718$EXP$$US-XGen Pharmaceuticals DJB, Inc.-2159262$X GEN PHARM$Literature article$52$YR$$F$Y$$$20240718$$$US$US
241092061$24109206$1$I$20240701$20240710$20240718$20240718$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159268$JIANGSU HANSOH PHARMACEUTICAL$$65$YR$$M$Y$43$KG$20240718$$MD$CN$CN
241092071$24109207$1$I$20240622$20240711$20240718$20240718$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159269$JIANGSU HANSOH PHARMACEUTICAL$$59$YR$$M$Y$52.8$KG$20240718$$MD$CN$CN
241092081$24109208$1$I$$20220322$20240718$20240718$EXP$$US-AstraZeneca-2022A124571$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241092091$24109209$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASL2024140602$AMGEN$$$$$$Y$$$20240718$$CN$US$US
241092101$24109210$1$I$$20240531$20240718$20240718$PER$$US-STI Pharma LLC-2159258$STI PHARMA$$76$YR$$F$Y$$$20240718$$MD$US$US
241092111$24109211$1$I$$20240715$20240718$20240718$EXP$$CA-Orion Corporation ORION PHARMA-24_00030874$ORION$$48$YR$A$F$Y$$$20240718$$HP$CA$
241092121$24109212$1$I$$20210504$20240718$20240718$EXP$$US-AstraZeneca-2021A298181$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241092131$24109213$1$I$$20210510$20240718$20240718$EXP$$US-AstraZeneca-2021A427442$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241092141$24109214$1$I$20240702$20240703$20240718$20240718$PER$$US-ROCHE-10000021555$ROCHE$$16$YR$T$F$Y$$$20240718$$HP$US$US
241092151$24109215$1$I$$20240711$20240718$20240718$PER$$US-ROCHE-10000026071$ROCHE$$$$E$F$Y$$$20240718$$CN$US$US
241092161$24109216$1$I$$20240712$20240718$20240718$PER$$US-ROCHE-3525106$ROCHE$$66$YR$E$M$Y$$$20240718$$CN$US$US
241092171$24109217$1$I$20210804$20210810$20240718$20240718$EXP$$RU-AstraZeneca-2021A678009$ASTRAZENECA$$27068$DY$$F$Y$70$KG$20240718$$CN$RU$
241092181$24109218$1$I$$20210831$20240718$20240718$EXP$$US-AstraZeneca-2021A708034$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241092191$24109219$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034839$AUROBINDO$Xiong J, Singh K, Zahid U, Embry E, Singh M. Extramedullary Plasmacytoma of the Pleura With Myelomatous Pleural Effusions. Am-J-Respir-Crit-Care-Med. 2024;209:A2676$65$YR$$F$Y$$$20240718$$HP$US$US
241092202$24109220$2$F$20240713$20240911$20240718$20240915$PER$$US-AstraZeneca-2024A161534$ASTRAZENECA$$22796$DY$$M$Y$$$20240915$$CN$US$
241092211$24109221$1$I$20210310$20210322$20240718$20240718$EXP$$US-AstraZeneca-2021A187934$ASTRAZENECA$$22304$DY$$F$Y$$$20240718$$CN$US$
241092221$24109222$1$I$$20240717$20240718$20240718$EXP$$CN-REGENERON PHARMACEUTICALS, INC.-2024-099335$REGENERON$$$$$$Y$$$20240718$$HP$CN$CN
241092231$24109223$1$I$20240626$20240710$20240718$20240718$PER$$US-BAYER-2024A099776$BAYER$$25$YR$A$F$Y$$$20240718$$MD$US$US
241092241$24109224$1$I$$20240715$20240718$20240718$EXP$$IT-UCBSA-2024036008$UCB$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$69$YR$$F$Y$$$20240718$$MD$IT$IT
241092252$24109225$2$F$$20240711$20240718$20240801$EXP$$IN-ROCHE-10000013889$ROCHE$$59$YR$A$F$Y$$$20240801$$CN$IN$IN
241092261$24109226$1$I$$20240711$20240718$20240718$EXP$FR-AFSSAPS-AVNT2024000511$FR-MYLANLABS-2024M1065455$MYLAN$$24$YR$$F$Y$$$20240718$$HP$FR$FR
241092271$24109227$1$I$20240706$20240707$20240718$20240718$EXP$GB-MHRA-MED-202407070842247880-VPJHY$GB-Accord-434966$ACCORD$$51$YR$A$M$Y$90$KG$20240718$$CN$GB$GB
241092281$24109228$1$I$20240624$20240708$20240718$20240718$EXP$GB-MHRA-MED-202407071011142080-CVHZM$GB-Accord-435280$ACCORD$$$$$$Y$$$20240718$$CN$GB$GB
241092291$24109229$1$I$$20240707$20240718$20240718$EXP$GB-MHRA-MED-202407072242561420-ZLKTH$GB-Accord-435172$ACCORD$$$$$$Y$$$20240718$$CN$GB$GB
241092302$24109230$2$F$$20240722$20240718$20240731$EXP$GB-MHRA-MED-202405151353006080-KDBHY$GB-Accord-435294$ACCORD$$93$YR$E$M$Y$$$20240731$$MD$GB$GB
241092311$24109231$1$I$$20240701$20240718$20240718$PER$$US-Eisai-EC-2024-169438$EISAI$$73$YR$E$F$Y$$$20240718$$CN$US$US
241092321$24109232$1$I$$20240715$20240718$20240718$PER$$US-ROCHE-3549928$ROCHE$$$$E$M$Y$$$20240718$$CN$US$US
241092331$24109233$1$I$20230810$20240706$20240718$20240718$EXP$IT-MINISAL02-993992$IT-Accord-435160$ACCORD$$68$YR$E$M$Y$$$20240718$$MD$IT$IT
241092341$24109234$1$I$$20240707$20240718$20240718$EXP$GB-MHRA-MED-202407072116268200-GDLRZ$GB-Accord-435166$ACCORD$$$$$F$Y$73$KG$20240718$$CN$GB$GB
241092351$24109235$1$I$20230303$20240707$20240718$20240718$EXP$GB-MHRA-MED-202407072305556260-SKFLV$GB-Accord-434961$ACCORD$$26$YR$A$M$Y$$$20240718$$CN$GB$GB
241092361$24109236$1$I$$20240717$20240718$20240718$EXP$$GB-SANDOZ INC.-SDZ2024GB066089$SANDOZ$$$$A$M$Y$$$20240718$$HP$GB$GB
241092371$24109237$1$I$$20240710$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2023US001141$SANDOZ$$$$$F$Y$$$20240718$$CN$US$US
241092381$24109238$1$I$$20240708$20240718$20240718$EXP$CA-MHPD-E2B_07056372$CA-Accord-435158$ACCORD$$$$$F$Y$$$20240718$$HP$CA$CA
241092391$24109239$1$I$20240628$20240708$20240718$20240718$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159274$JIANGSU HANSOH PHARMACEUTICAL$$30$YR$$M$Y$50$KG$20240718$$MD$CN$CN
241092412$24109241$2$F$20220101$20240715$20240718$20240724$EXP$$BR-Accord-434720$ACCORD$Aranda CS, Silvestre KMC, Marques KDS, Lee ML, Sole D. Methotrexate might become the sole treatment option for leukemia following the occurrence of Stevens-Johnson syndrome. Allergol Immunopathol (Madr). 2024 Jul 1;52(4):81-83.$3$YR$C$M$Y$$$20240724$$HP$BR$BR
241092421$24109242$1$I$$20240708$20240718$20240718$EXP$$CA-Accord-435015$ACCORD$Patton L, Monteith B, Heffernan P, Herzinger T, Wilson BE. Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study. Frontiers in Oncology. 2024;14:1394543. DOI:10.3389/fonc.2024.1394543.$40$YR$A$F$Y$$$20240718$$MD$CA$CA
241092431$24109243$1$I$20240101$20240711$20240718$20240718$PER$$US-ABBVIE-5840113$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241092442$24109244$2$F$$20240716$20240718$20240728$EXP$GB-drreddys-LIT/UKI/23/0161569$GB-RDY-LIT/UKI/23/0161569$DR REDDYS$$6$YR$C$F$Y$$$20240728$$HP$GB$GB
241092451$24109245$1$I$$20240709$20240718$20240718$EXP$$CA-BAXTER-2024BAX021403$BAXTER$$$$$$Y$$$20240718$$CN$CA$CA
241092461$24109246$1$I$20240507$20240708$20240718$20240718$PER$$US-RDY-SPO/USA/24/0010182$DR REDDYS$$55$YR$A$M$Y$$$20240718$$CN$US$US
241092471$24109247$1$I$$20240703$20240718$20240718$EXP$$FR-Appco Pharma LLC-2159270$APPCO PHARMA$Initial$49$YR$$M$Y$$$20240718$$$FR$FR
241092481$24109248$1$I$$20240709$20240718$20240718$EXP$$CA-BAXTER-2024BAX021398$BAXTER$$32$YR$$M$Y$$$20240718$$CN$CA$CA
241092491$24109249$1$I$20220101$20240708$20240718$20240718$EXP$$US-Accord-435046$ACCORD$Xu E, Thomas S, Habibi B. Intrathecal Methotrexate-Induced Lumbosacral Polyradiculopathy: A Case Report. Pain Medicine Case Reports. 2024;8(1):31-5$69$YR$E$F$Y$$$20240718$$MD$US$US
241092501$24109250$1$I$$20240709$20240718$20240718$EXP$$CA-BAXTER-2024BAX021395$BAXTER$$31$YR$$F$Y$$$20240718$$CN$CA$CA
241092511$24109251$1$I$$20240708$20240718$20240718$EXP$CA-MHPD-E2B_07104957$CA-Accord-435169$ACCORD$$66$YR$E$F$Y$$$20240718$$MD$CA$CA
241092521$24109252$1$I$$20240709$20240718$20240718$EXP$$CA-BAXTER-2024BAX021402$BAXTER$$68$YR$$F$Y$$$20240718$$CN$CA$CA
241092531$24109253$1$I$$20240709$20240718$20240718$EXP$$CA-BAXTER-2024BAX021399$BAXTER$$35$YR$$M$Y$$$20240718$$CN$CA$CA
241092541$24109254$1$I$20190425$20240711$20240718$20240718$EXP$$CA-TAKEDA-2024TUS072081$TAKEDA$$41$YR$$F$Y$$$20240718$$MD$CA$CA
241092571$24109257$1$I$$20240619$20240718$20240718$EXP$$IE-Appco Pharma LLC-2159276$APPCO PHARMA$Initial$41$YR$$M$Y$$$20240718$$$IE$IE
241092581$24109258$1$I$$20240711$20240718$20240718$EXP$$US-ROCHE-10000024258$ROCHE$$$$E$F$Y$$$20240718$$HP$US$US
241092591$24109259$1$I$$20240710$20240718$20240718$PER$$US-ROCHE-10000023694$ROCHE$$$$E$M$Y$$$20240718$$CN$US$US
241092601$24109260$1$I$$20240708$20240718$20240718$PER$$US-ROCHE-10000021011$ROCHE$$$$E$M$Y$$$20240718$$CN$US$US
241092611$24109261$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034677$AUROBINDO$Roman Perez HI, Pasiah S, Zero N, Coughlin C, Quinn SJ.. A Unique Presentation and Treatment of Prosthetic Aortic Valve Thrombosis in the Setting of Malignancy Induced Hypercoagulability. Am-JRespir-Crit-Care-Med. 2024;ISSN: 1073-449$55$YR$$F$Y$$$20240718$$HP$US$US
241092621$24109262$1$I$20240703$20240709$20240718$20240718$EXP$CN-NMPACDR-3501021028942202400351$CN-BAXTER-2024BAX021498$BAXTER$$9$YR$$M$Y$35$KG$20240718$$MD$CN$CN
241092641$24109264$1$I$$20240709$20240718$20240718$EXP$$US-BAXTER-2024BAX021545$BAXTER$$59$YR$$M$Y$$$20240718$$HP$US$US
241092651$24109265$1$I$$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002396J$MERCK$$76$YR$$F$Y$$$20240718$$MD$JP$JP
241092661$24109266$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140557$AMGEN$$$$$F$Y$$$20240718$$MD$US$US
241092671$24109267$1$I$$20240709$20240718$20240718$EXP$$US-BAXTER-2024BAX021482$BAXTER$$74$YR$$F$Y$$$20240718$$HP$US$US
241092691$24109269$1$I$20240716$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49532$$FDA-CTU$$45$YR$$M$N$108.86$KG$20240717$N$$US$
241092702$24109270$2$F$20240530$20240712$20240718$20240730$EXP$IT-MINISAL02-994221$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-113225$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240719$$MD$IT$IT
241092711$24109271$1$I$$20240708$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-035341$AUROBINDO$Abbas Z, Mahmood T, Bellman V, Koirala P, Myers T.. Relationship Between Pericallosal Lipoma and Neuropsychiatric Symptoms: A Case Report. J-Nerv-Ment-Dis. 2023;211(8):639-640$15$YR$$M$Y$$$20240718$$HP$US$US
241092721$24109272$1$I$20240617$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49623$$FDA-CTU$$70$YR$$F$N$73.75$KG$20240717$N$$US$
241092731$24109273$1$I$$20240708$20240718$20240718$EXP$$CA-BAXTER-2024BAX021332$BAXTER$$43$YR$$F$Y$68$KG$20240718$$HP$CA$CA
241092741$24109274$1$I$$20240709$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114062$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240718$$CN$US$US
241092761$24109276$1$I$$20240714$20240718$20240718$PER$$US-AMGEN-USASP2024139968$AMGEN$$$$$$Y$$$20240718$$PH$US$US
241092771$24109277$1$I$20240304$20240716$20240718$20240718$EXP$$DE-SANDOZ INC.-SDZ2024DE065898$SANDOZ$$74$YR$$M$Y$$$20240718$$MD$DE$DE
241092781$24109278$1$I$$20240712$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112238$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$61.6$KG$20240718$$PH$US$US
241092792$24109279$2$F$$20240726$20240718$20240807$EXP$$IT-AUROBINDO-AUR-APL-2024-034369$AUROBINDO$Liberatore C, Rossi E, Malerba L, Fioritoni F, Di Landro F, Fazio F, et al.. EARLY RESULTS OF TANDEM AUTOLOGOUS STEM-CELL TRANSPLANTATION AFTER DARATUMUMAB VTD INDUCTION IN NEWLY DIAGNOSED MULTIPLE MYELOMA.. Haematologica. 2024;109(2):22-23$$$A$$Y$$$20240807$$MD$IT$IT
241092801$24109280$1$I$$20240712$20240718$20240718$PER$$US-ABBVIE-5839358$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241092811$24109281$1$I$$20240715$20240718$20240718$EXP$$CA-EMD Serono-2024038613$EMD SERONO INC$$$$C$M$Y$$$20240718$$CN$CA$CA
241092822$24109282$2$F$$20240710$20240718$20240925$PER$$US-GSK-US2024AMR088684$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
241092835$24109283$5$F$20240617$20240829$20240718$20240903$EXP$$NVSC2024US131443$NOVARTIS$$17$YR$$F$Y$134.3$KG$20240903$$MD$US$US
241092841$24109284$1$I$$20240710$20240718$20240718$EXP$$GB-AMGEN-GBRSP2024138313$AMGEN$$$$$M$Y$$$20240718$$CN$GB$GB
241092852$24109285$2$F$$20240813$20240718$20240819$30DAY$$GB-JNJFOC-20240736831$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$GB$GB
241092861$24109286$1$I$$20240717$20240718$20240718$PER$$US-JNJFOC-20170416455$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$LW$US$US
241092871$24109287$1$I$$20240716$20240718$20240718$EXP$$CA-ABBVIE-5843714$ABBVIE$$$$E$M$Y$$$20240718$$CN$CA$CA
241092881$24109288$1$I$$20240619$20240718$20240718$EXP$$US-Appco Pharma LLC-2159277$APPCO PHARMA$Initial$71$YR$$F$Y$$$20240718$$MD$US$US
241092891$24109289$1$I$20240711$20240712$20240718$20240718$PER$$US-ROCHE-10000025992$ROCHE$$$$$$Y$$$20240718$$HP$US$US
241092901$24109290$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113773$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$110.68$KG$20240718$$CN$US$US
241092931$24109293$1$I$20240610$20240709$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-034379$AUROBINDO$$86$YR$$F$Y$91$KG$20240718$$PH$FR$FR
241092941$24109294$1$I$$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113275$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240718$$CN$US$US
241092952$24109295$2$F$20240701$20240723$20240718$20240730$PER$IT-MINISAL02-993956$IT-BRACCO-2024IT04261$BRACCO$$76$YR$$M$Y$$$20240730$$MD$IT$IT
241092961$24109296$1$I$20231128$20240709$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-034401$AUROBINDO$$65$YR$$F$Y$56.5$KG$20240718$$HP$FR$FR
241092972$24109297$2$F$20240701$20240725$20240718$20240727$PER$$US-AMGEN-USASP2024141729$AMGEN$$28$YR$A$F$Y$75.39$KG$20240727$$MD$US$US
241092981$24109298$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141826$AMGEN$$$$$$Y$$$20240718$$CN$US$US
241092991$24109299$1$I$$20240709$20240718$20240718$EXP$$US-APOTEX-2024AP008243$APOTEX$Liss DB, Phillips TM, Pizon AF, Schwarz ES. Delayed seizures in bupropion overdose with concomitant ingestion of alpha-2 agonist: a case report. Toxicology Communications. 2017;1 (1):15-17$16$YR$$M$Y$$$20240718$$HP$US$US
241093001$24109300$1$I$$20240717$20240718$20240718$PER$$NVSC2024US148034$NOVARTIS$$$$$M$Y$$$20240718$$MD$US$US
241093011$24109301$1$I$$20240710$20240718$20240718$EXP$$FR-MYLANLABS-2024M1065791$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$43$YR$$F$Y$$$20240718$$HP$FR$FR
241093021$24109302$1$I$$20240710$20240718$20240718$EXP$$FR-MYLANLABS-2024M1065753$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6).$57$YR$$M$Y$$$20240718$$HP$FR$FR
241093031$24109303$1$I$$20240710$20240718$20240718$EXP$$FR-MYLANLABS-2024M1065771$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6).$9$YR$$F$Y$$$20240718$$HP$FR$FR
241093041$24109304$1$I$$20240710$20240718$20240718$EXP$$IT-MYLANLABS-2024M1066224$MYLAN$Linardos G, Coltella L, Ranno S, Di Maio VC, Colagrossi L, Pandolfi E, et al. Whooping Cough Cases Increase in Central Italy after COVID-19 Pandemic. Antibiotics-(Basel) 2024; 13 (5).$$$N$F$Y$$$20240718$$HP$IT$IT
241093051$24109305$1$I$$20240710$20240718$20240718$EXP$$FR-MYLANLABS-2024M1065722$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6).$14$YR$$M$Y$$$20240718$$HP$FR$FR
241093061$24109306$1$I$$20240710$20240718$20240718$EXP$$FR-MYLANLABS-2024M1065779$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$55$YR$$M$Y$$$20240718$$HP$FR$FR
241093071$24109307$1$I$$20240710$20240718$20240718$EXP$$FR-MYLANLABS-2024M1065877$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$14$YR$$$Y$$$20240718$$HP$FR$FR
241093081$24109308$1$I$$20240710$20240718$20240718$EXP$$US-MYLANLABS-2024M1066230$MYLAN$Song JJ, Eyabi JC, Awatramani PD, Mitchell BG, Nene SY. Sudden Reduction in Caffeine Intake Increases Serum Lithium Concentration to Supratherapeutic Level: A Case Report. Prim-Care-Comp-CNS-Disorders 2024; 26 (2):.$59$YR$$M$Y$$$20240718$$HP$US$US
241093091$24109309$1$I$$20240710$20240718$20240718$EXP$$FR-MYLANLABS-2024M1065732$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$9$YR$$M$Y$$$20240718$$HP$FR$FR
241093101$24109310$1$I$$20240710$20240718$20240718$EXP$$FR-MYLANLABS-2024M1065783$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$6$YR$$M$Y$$$20240718$$HP$FR$FR
241093111$24109311$1$I$$20240710$20240718$20240718$EXP$$FR-MYLANLABS-2024M1065890$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$10$YR$$M$Y$$$20240718$$HP$FR$FR
241093121$24109312$1$I$$20240710$20240718$20240718$EXP$$FR-MYLANLABS-2024M1065891$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$21$YR$$F$Y$$$20240718$$HP$FR$FR
241093131$24109313$1$I$$20240710$20240718$20240718$EXP$$GB-MYLANLABS-2024M1066211$MYLAN$Abdolrasouli A, Borman AM, Johnson EM, Hay RJ, Arias M. Terbinafine-resistant Trichophyton indotineae causing extensive dermatophytosis in a returning traveller, London, UK. Clin-Exp-Dermatol 2024; 49 (6): 635-637.$26$YR$$M$Y$$$20240718$$HP$GB$GB
241093141$24109314$1$I$$20240710$20240718$20240718$EXP$$NL-MYLANLABS-2024M1065862$MYLAN$Wichers R, Heller HM, van Veen S. Deciding on life-saving treatment after a violent suicide attempt: an ethical case report. Gen-Psychiatr 2024; 37 (2):.$39$YR$$M$Y$$$20240718$$MD$NL$NL
241093151$24109315$1$I$$20240704$20240718$20240718$EXP$$ES-HIKMA PHARMACEUTICALS USA INC.-ES-H14001-24-06406$HIKMA$Sanchez-Guixe M, Muinos F, Pinheiro-Santin M, Gonzalez-Huici V, Rodriguez-Hernandez CJ, Avgustinova A,  Lavarino C, Gonzalez-Perez A, Mora J, Lopez-Bigas N. Sanchez-Guixe M, Muinos F, Pinheiro-Santin M, Gonzalez-Huici V, Rodriguez-Hernandez CJ, Avgustinova A,  Lavarino C, Gonz?lez-P?rez A, Mora J, L?pez-Bigas N Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer Discovery. 2024;14(6):953-64.:953-964.$2$DEC$$F$Y$$$20240718$$MD$ES$ES
241093161$24109316$1$I$$20240710$20240718$20240718$EXP$$FR-MYLANLABS-2024M1065790$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$23$YR$$M$Y$$$20240718$$HP$FR$FR
241093171$24109317$1$I$$20240710$20240718$20240718$EXP$$IT-MYLANLABS-2024M1066228$MYLAN$Zengarini C, Clarizio G, Bardazzi F, Mussi M, Baraldi C, Piraccini BM, et al. Unilateral eosinophilic fasciitis (Shulman syndrome) with excellent response to combined treatment with methotrexate therapy and compression brace. Dermatol-Rep 2024; 16.$78$YR$$M$Y$$$20240718$$HP$IT$IT
241093181$24109318$1$I$$20240710$20240718$20240718$EXP$$US-MYLANLABS-2024M1066137$MYLAN$Lee R, Gonsalves Z, Wang S, Hussain A, Herrera K. Case study: Autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks^ gestation. Case-Rep-Perinat-Med 2024; 13 (1):.$29$YR$$F$Y$$$20240718$$MD$US$US
241093191$24109319$1$I$$20220112$20240718$20240718$EXP$$US-AstraZeneca-2022A021931$ASTRAZENECA$$$$$$Y$87.1$KG$20240718$$CN$US$
241093201$24109320$1$I$$20210920$20240718$20240718$EXP$$US-AstraZeneca-2021A734135$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241093211$24109321$1$I$$20210923$20240718$20240718$EXP$$US-AstraZeneca-2021A748138$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241093221$24109322$1$I$$20210409$20240718$20240718$EXP$$ZA-AstraZeneca-2021A294380$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$ZA$
241093231$24109323$1$I$$20240710$20240718$20240718$EXP$$ZA-AstraZeneca-2024A159441$ASTRAZENECA$$66$YR$$F$Y$$$20240718$$CN$ZA$
241093241$24109324$1$I$$20210208$20240718$20240718$EXP$$GB-AstraZeneca-2021A049579$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$GB$
241093252$24109325$2$F$20240614$20240731$20240718$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-034657$AUROBINDO$$37$YR$$M$Y$72$KG$20240809$$CN$GB$GB
241093261$24109326$1$I$20230827$20240530$20240717$20240717$DIR$FDA-CDER-CTU-2024-49634$$FDA-CTU$$$$$F$N$77.11$KG$20240530$N$$US$
241093281$24109328$1$I$20240708$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49643$$FDA-CTU$$$$$F$N$70.9$KG$20240716$N$$US$
241093301$24109330$1$I$$20240610$20240718$20240718$PER$$US-STI Pharma LLC-2159279$STI PHARMA$$68$YR$$M$Y$$$20240718$$MD$US$US
241093321$24109332$1$I$20240627$20240710$20240718$20240718$EXP$$CN-BEIGENE-BGN-2024-010769$BEIGENE$$$$$$Y$$$20240718$$HP$CN$CN
241093331$24109333$1$I$$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114053$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240718$$HP$US$US
241093341$24109334$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113756$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240718$$HP$US$US
241093351$24109335$1$I$$20240708$20240718$20240718$EXP$$US-MYLANLABS-2024M1065810$MYLAN$Kishk OA, Kim I, Cheng C, Summan M, Munoz MA. Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients. Pediatr-Nephrol 2024; 39 (8): 2429-2433.$19$YR$$F$Y$$$20240718$$HP$US$US
241093361$24109336$1$I$$20240708$20240718$20240718$PER$$US-ROCHE-10000024072$ROCHE$$$$E$F$Y$$$20240718$$CN$US$US
241093371$24109337$1$I$20240101$20240703$20240718$20240718$EXP$$SG-ROCHE-10000028988$ROCHE$$61$YR$A$F$Y$$$20240718$$HP$SG$SG
241093381$24109338$1$I$20240301$20240426$20240718$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-024480$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240718$$CN$US$US
241093393$24109339$3$F$$20240812$20240718$20240812$PER$$US-ALXN-202407USA000914US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
241093411$24109341$1$I$$20240709$20240718$20240718$EXP$$AU-Orion Corporation ORION PHARMA-24_00030851$ORION$$59$YR$A$M$Y$95$KG$20240718$$MD$AU$
241093421$24109342$1$I$20240320$20240716$20240718$20240718$EXP$FR-AFSSAPS-NT2024000884$FR-ORGANON-O2407FRA001407$ORGANON$$75$YR$$F$Y$$$20240718$$MD$FR$FR
241093431$24109343$1$I$$20240712$20240718$20240718$EXP$$US-GSK-US2024AMR089264$GLAXOSMITHKLINE$$73$YR$$M$Y$$$20240718$$PH$US$US
241093441$24109344$1$I$20240101$20240712$20240718$20240718$PER$$US-ABBVIE-5840153$ABBVIE$$$$$$Y$$$20240718$$CN$US$US
241093451$24109345$1$I$$20240710$20240718$20240718$30DAY$$US-GSK-US2024085861$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241093461$24109346$1$I$20240701$20240709$20240718$20240718$PER$$US-JNJFOC-20240724789$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$US$US
241093472$24109347$2$F$$20240730$20240718$20240807$EXP$$JP-JNJFOC-20240748136$JOHNSON AND JOHNSON$Takai S, Kojima Y, Asahina Y, Nagasaka K, Murata T, Amano H, et al. [23 A case of ulcerative colitis with pulmonary aspergillosis] The 74th Annual Meeting of the Koshinetsu Branch of the Japanese Society of Gastroenterology, The 96th Annual Meeting of the Koshinetsu Branch of the Japan Gastroenterological Endoscopy Society. 2024.5.25,26;66$4$DEC$A$F$Y$$$20240808$$MD$JP$JP
241093481$24109348$1$I$$20240716$20240718$20240718$PER$$US-JNJFOC-20240745344$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$US$US
241093492$24109349$2$F$$20240812$20240718$20240822$30DAY$$BR-JNJFOC-20240735603$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$BR$BR
241093501$24109350$1$I$$20240716$20240718$20240718$EXP$$NVSC2024CA146922$NOVARTIS$$75$YR$$M$Y$$$20240718$$PH$CA$CA
241093511$24109351$1$I$20240417$20240709$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-034622$AUROBINDO$$$$A$F$Y$$$20240718$$MD$FR$FR
241093521$24109352$1$I$$20240716$20240718$20240718$EXP$$NVSC2024US147306$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
241093541$24109354$1$I$20240124$20240620$20240718$20240718$PER$$US-009507513-2406USA007218$MERCK$$62$YR$$F$Y$$$20240718$$CN$US$US
241093551$24109355$1$I$20240618$20240710$20240718$20240718$EXP$$CN-BEIGENE-BGN-2024-010783$BEIGENE$$$$$$Y$$$20240718$$HP$CN$CN
241093562$24109356$2$F$20190924$20240715$20240718$20240724$EXP$$FR-AUROBINDO-AUR-APL-2022-045968$AUROBINDO$Rocanieres P, Lamure S, Geny C, Faillie JL, Hillaire-Buys D, Bres V et al. Parkinson^s disease progression in a patient with multiple myeloma treated with ixazomib. Fundamental and Clinical Pharmacology. Clinical Pharmacology. 36:146$68$YR$$M$Y$$$20240724$$MD$FR$FR
241093571$24109357$1$I$20231101$20240712$20240718$20240718$EXP$$DE-ABBVIE-5839926$ABBVIE$$73$YR$$F$Y$$$20240718$$MD$DE$DE
241093581$24109358$1$I$20170627$20240708$20240718$20240718$EXP$DE-NOVPHSZ-PHHO2017DE014999$DE-RDY-SPO/DEU/24/0010137$DR REDDYS$$76$YR$E$F$Y$72$KG$20240718$$MD$DE$DE
241093592$24109359$2$F$20240707$20240815$20240718$20240820$PER$$US-ROCHE-10000027567$ROCHE$$75$YR$E$F$Y$82.1$KG$20240820$$CN$US$US
241093601$24109360$1$I$20090101$20240710$20240718$20240718$EXP$DE-DCGMA-24203575$DE-RDY-SPO/DEU/24/0010242$DR REDDYS$$39$YR$A$F$Y$77$KG$20240718$$MD$DE$DE
241093611$24109361$1$I$$20240711$20240718$20240718$EXP$$IE-NOVITIUMPHARMA-2024IENVP01302$NOVITIUM PHARMA$Grainne Mulkerrin.Nonsense mutation in DEPDC5 gene in a patient with carbamazepine-responsive focal epilepsy.Epilepsy + Behavior Reports.18-JUN-2024;27:100683$$$A$M$Y$$$20240718$$HP$IE$IE
241093621$24109362$1$I$20240425$20240426$20240718$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-024484$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240718$$MD$US$US
241093631$24109363$1$I$20240717$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49552$$FDA-CTU$$31$YR$$UNK$N$$$20240717$N$$US$
241093641$24109364$1$I$20240708$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49622$$FDA-CTU$$$$$F$N$62.5$KG$20240717$N$$US$
241093651$24109365$1$I$20240702$20240710$20240718$20240718$EXP$$GB-CELLTRION INC.-2024GB017133$CELLTRION$$$$$$Y$$$20240718$$HP$GB$GB
241093663$24109366$3$F$20240623$20240807$20240718$20240812$PER$$US-ROCHE-10000027181$ROCHE$$$$$F$Y$$$20240812$$CN$US$US
241093672$24109367$2$F$$20240731$20240718$20240801$PER$$NVSC2024US148029$NOVARTIS$$$$$$Y$$$20240802$$MD$US$US
241093681$24109368$1$I$20240717$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49536$$FDA-CTU$$74$YR$$M$N$$$20240717$N$$US$
241093691$24109369$1$I$20231211$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49629$$FDA-CTU$$82$YR$$F$N$44.2$KG$20240716$N$$US$
241093701$24109370$1$I$20240713$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49608$$FDA-CTU$$72$YR$$M$N$$$20240717$N$PH$US$
241093721$24109372$1$I$20240101$20240709$20240718$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-021195$UNITED THERAPEUTICS$$$$$M$Y$68.027$KG$20240718$$$US$US
241093741$24109374$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49601$$FDA-CTU$$68$YR$$M$N$$$20240717$Y$$US$
241093751$24109375$1$I$20240620$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49620$$FDA-CTU$$41$YR$$F$N$$$20240717$Y$PH$US$
241093771$24109377$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49565$$FDA-CTU$$$$$F$N$$$20240716$N$HP$US$
241093793$24109379$3$F$20240513$20240902$20240718$20240907$EXP$$JP-AMGEN-JPNSP2024141370$AMGEN$$8$DEC$E$F$Y$$$20240907$$MD$JP$JP
241093801$24109380$1$I$$20240715$20240718$20240718$EXP$$CA-ABBVIE-5842435$ABBVIE$$$$A$F$Y$$$20240718$$CN$CA$CA
241093811$24109381$1$I$$20240715$20240718$20240718$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-135761$DAIICHI$$$$$F$Y$$$20240718$$MD$US$US
241093822$24109382$2$F$$20240719$20240718$20240729$EXP$$CN-SA-2024SA204437$SANOFI AVENTIS$$$$A$$Y$$$20240729$$HP$CN$CN
241093832$24109383$2$F$$20240716$20240718$20240724$EXP$$BR-ABBVIE-5842495$ABBVIE$$$$$F$Y$$$20240724$$MD$BR$BR
241093841$24109384$1$I$20180101$20240709$20240718$20240718$EXP$$US-SA-2019SA063685$SANOFI AVENTIS$$10$YR$C$F$Y$56.69$KG$20240718$$MD$US$US
241093851$24109385$1$I$$20240711$20240718$20240718$EXP$$US-NEBO-663980$PHARMACOSMOS$$51$YR$$F$Y$$$20240718$$MD$US$US
241093861$24109386$1$I$$20240711$20240718$20240718$EXP$$CA-GSK-CA2024005669$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$CA$CA
241093871$24109387$1$I$$20240712$20240718$20240718$EXP$$DE-MYLANLABS-2024M1065789$MYLAN$$62$YR$$M$Y$$$20240718$$PH$DE$DE
241093881$24109388$1$I$$20240623$20240718$20240718$PER$$US-JNJFOC-20240733321$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
241093891$24109389$1$I$20190818$20240716$20240718$20240718$EXP$$US-GSK-US2021GSK265442$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$US$US
241093901$24109390$1$I$20240717$20240717$20240718$20240718$PER$$US-JNJFOC-20240745173$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240718$$CN$US$US
241093911$24109391$1$I$20231001$20240712$20240718$20240718$EXP$FR-AFSSAPS-PB2024000718$FR-CHEPLA-2024008958$CHEPLAPHARM$$62$YR$$F$Y$$$20240718$$MD$COUNTRY NOT SPECIFIED$FR
241093921$24109392$1$I$20240715$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141861$AMGEN$$21$YR$A$F$Y$$$20240718$$CN$US$US
241093931$24109393$1$I$20240715$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141061$AMGEN$$61$YR$A$F$Y$$$20240718$$CN$US$US
241093942$24109394$2$F$20240601$20240820$20240718$20240823$PER$$US-AMGEN-USASP2024141695$AMGEN$$29$YR$A$F$Y$$$20240823$$CN$US$US
241093957$24109395$7$F$$20240808$20240718$20240821$EXP$$US-SA-2024SA207686$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240821$$CN$US$US
241093961$24109396$1$I$$20240710$20240718$20240718$PER$$US-IGSA-BIG0029795$GRIFOLS$$$$$F$Y$$$20240718$$CN$US$US
241093981$24109398$1$I$$20240712$20240718$20240718$EXP$$PL-MYLANLABS-2024M1065962$MYLAN$$46$YR$$F$Y$$$20240718$$HP$PL$PL
241093991$24109399$1$I$$20240708$20240718$20240718$PER$$US-TEVA-VS-3220508$TEVA$$$$$F$Y$$$20240718$$CN$US$US
241094001$24109400$1$I$$20240712$20240718$20240718$EXP$$GR-MYLANLABS-2024M1065464$MYLAN$$76$YR$$M$Y$$$20240718$$MD$GR$GR
241094011$24109401$1$I$$20240708$20240718$20240718$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089714$VIIV$$$$$$Y$$$20240718$$HP$US$US
241094021$24109402$1$I$$20240715$20240718$20240718$EXP$$GB-ORGANON-O2407GBR001517$ORGANON$$60$YR$$M$Y$93$KG$20240718$$MD$GB$GB
241094033$24109403$3$F$20240601$20240806$20240718$20240809$EXP$$CO-ASTELLAS-2024US020165$ASTELLAS$$76$YR$$M$Y$167$KG$20240809$$CN$CO$CO
241094041$24109404$1$I$$20240712$20240718$20240718$PER$$US-ROCHE-10000026145$ROCHE$$$$A$F$Y$$$20240718$$CN$US$US
241094052$24109405$2$F$$20240911$20240718$20240919$EXP$$JP-ROCHE-10000023475$ROCHE$$47$YR$A$M$Y$$$20240919$$MD$JP$JP
241094061$24109406$1$I$$20240711$20240718$20240718$EXP$$AU-SA-2024SA205832$SANOFI AVENTIS$$$$$M$Y$$$20240718$$HP$AU$AU
241094071$24109407$1$I$20240708$20240711$20240718$20240718$PER$GB-MHRA-MED-202407111115450810-BPDHL$GB-Eisai-EC-2024-170008$EISAI$$82$YR$E$F$Y$50$KG$20240718$$CN$GB$GB
241094081$24109408$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220246$TEVA$$45$YR$$F$Y$$$20240718$$HP$CA$CA
241094091$24109409$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140217$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
241094101$24109410$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141259$AMGEN$$$$$$Y$$$20240718$$CN$US$US
241094114$24109411$4$F$20240601$20240729$20240718$20240806$EXP$$US-AMGEN-USASP2024141258$AMGEN$$75$YR$E$F$Y$65.2$KG$20240806$$HP$US$US
241094122$24109412$2$F$$20240911$20240718$20240926$30DAY$$US-LUPIN PHARMACEUTICALS INC.-2024-06062$LUPIN$$$$$$Y$$$20240926$$CN$US$US
241094131$24109413$1$I$20230702$20240715$20240718$20240718$EXP$FR-AFSSAPS-AM2024000568$FR-SA-2024SA210360$SANOFI AVENTIS$$51$YR$A$M$Y$77.7$KG$20240718$$MD$FR$FR
241094141$24109414$1$I$$20240524$20240718$20240718$PER$$US-LUNDBECK-DKLU3078561$LUNDBECK$$$$$$Y$$$20240718$$HP$US$US
241094153$24109415$3$F$20240314$20240826$20240718$20240830$EXP$$US-TAKEDA-2024TUS029058$TAKEDA$$0$YR$$M$Y$8.57$KG$20240830$$HP$US$US
241094161$24109416$1$I$20240701$20240709$20240718$20240718$PER$$US-ABBVIE-5836748$ABBVIE$$32$YR$$F$Y$$$20240718$$MD$US$US
241094171$24109417$1$I$$20240712$20240718$20240718$EXP$$US-MYLANLABS-2024M1066755$MYLAN$Kenneally A, Cummins M, Bailey A, Yackey K, Jones L, Carter C, et al. Intranasal Dexmedetomidine Use in Pediatric Patients for Anxiolysis in the Emergency Department. Pediatr-Emerg-Care 2023; 39 (9): 685-691.$7$YR$$M$Y$$$20240718$$HP$US$US
241094181$24109418$1$I$$20240715$20240718$20240718$PER$$US-ROCHE-10000028342$ROCHE$$$$E$F$Y$$$20240718$$CN$US$
241094193$24109419$3$F$$20240726$20240718$20240802$EXP$$FI-MYLANLABS-2024M1061242$MYLAN$Helin H, Huovinen S, Uusitalo T. Autoimmune myopathy is a rare muscle disease associated with statin treatment. Duodecim. 2024;140(13-14):1143-1147$7$DEC$$F$Y$$$20240802$$MD$FI$FI
241094201$24109420$1$I$$20240712$20240718$20240718$EXP$$US-MYLANLABS-2024M1065831$MYLAN$Voelz K, Miller G, Lee-Miller C. 6-Mercaptopurine-associated Sinusoidal Obstructive Syndrome During Interim Maintenance I: A Case Report. J-Pediatr-Hematol-Oncol 2024; 46 (5): e317-e321.$14$YR$$M$Y$$$20240718$$MD$US$US
241094211$24109421$1$I$$20240715$20240718$20240718$PER$$US-ROCHE-10000027904$ROCHE$$79$YR$E$F$Y$$$20240718$$CN$US$US
241094221$24109422$1$I$$20240715$20240718$20240718$PER$$US-ROCHE-10000027813$ROCHE$$79$YR$E$F$Y$$$20240718$$CN$US$US
241094232$24109423$2$F$20240101$20240712$20240718$20240722$PER$$US-ABBVIE-5840493$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241094241$24109424$1$I$20240701$20240717$20240718$20240718$EXP$$NVSC2024SK147664$NOVARTIS$$51$YR$$M$Y$$$20240718$$MD$SK$SK
241094252$24109425$2$F$$20240828$20240718$20240906$EXP$$ES-TEVA-VS-3220825$TEVA$Fernandez-Gordon Sanchez FM, Gomez Labrador C, Wong Becerra L, Paz Fernandez BA, Martinez Aguilar AP, Castano-Milla C. Active microscopic colitis precipitated by fluoxetine. Rev-Esp-Enferm-Dig 2024;.; Fernandez-Gordon Sanchez FM, Gomez Labrador C, Wong Becerra L, Paz Fernandez BA, Martinez Aguilar AP, Castano-Milla C. Active microscopic colitis precipitated by fluoxetine. Rev-Esp-Enferm-Dig 2024;.$41$YR$$F$Y$$$20240906$$HP$ES$ES
241094261$24109426$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010294$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240718$$CN$US$US
241094271$24109427$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010432$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240718$$CN$US$US
241094281$24109428$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011406$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240718$$CN$US$US
241094291$24109429$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010779$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241094301$24109430$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010861$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240718$$CN$US$US
241094311$24109431$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010421$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240718$$CN$US$US
241094321$24109432$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010261$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240718$$CN$US$US
241094331$24109433$1$I$20240401$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010349$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240718$$CN$US$US
241094341$24109434$1$I$$20240712$20240718$20240718$EXP$$US-BAYER-2024A101651$BAYER$$76$YR$E$F$Y$73.469$KG$20240718$$HP$US$US
241094351$24109435$1$I$$20240712$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009511$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240718$$CN$US$US
241094361$24109436$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010459$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240718$$CN$US$US
241094371$24109437$1$I$20240714$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009911$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240718$$CN$US$US
241094381$24109438$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010415$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240718$$CN$US$US
241094391$24109439$1$I$20240601$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011280$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240718$$HP$US$US
241094401$24109440$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011367$ELI LILLY AND CO$$$$$M$Y$$$20240718$$CN$US$US
241094411$24109441$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009968$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241094421$24109442$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010788$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240718$$CN$US$US
241094431$24109443$1$I$20240714$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011419$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240718$$CN$US$US
241094441$24109444$1$I$20240713$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010692$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240718$$CN$US$US
241094451$24109445$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009349$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240718$$CN$US$US
241094461$24109446$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010483$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240718$$CN$US$US
241094471$24109447$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010271$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240718$$CN$US$US
241094481$24109448$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010457$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240718$$CN$US$US
241094492$24109449$2$F$$20240722$20240718$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407010669$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240724$$CN$US$US
241094501$24109450$1$I$20240601$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010332$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240718$$CN$US$US
241094511$24109451$1$I$20240716$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011278$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240718$$HP$US$US
241094521$24109452$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010521$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241094541$24109454$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010263$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240718$$CN$US$US
241094551$24109455$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010810$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240718$$CN$US$US
241094561$24109456$1$I$20240701$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010796$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240718$$CN$US$US
241094571$24109457$1$I$20240712$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010427$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240718$$CN$US$US
241094581$24109458$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010330$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240718$$CN$US$US
241094591$24109459$1$I$20120418$20240717$20240718$20240718$PER$$US-JNJFOC-20240748099$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240718$$HP$US$US
241094602$24109460$2$F$$20240808$20240718$20240819$30DAY$$CL-JNJFOC-20240735531$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$CL$CL
241094611$24109461$1$I$$20240718$20240718$20240718$EXP$$GB-JNJFOC-20240748036$JOHNSON AND JOHNSON$$$$A$$Y$$$20240718$$HP$GB$GB
241094621$24109462$1$I$20240412$20240710$20240718$20240718$EXP$ES-AEMPS-1543179$ES-TEVA-VS-3220154$TEVA$$48$YR$$F$Y$$$20240718$$MD$ES$ES
241094631$24109463$1$I$$20240524$20240718$20240718$PER$$US-LUNDBECK-DKLU3078570$LUNDBECK$$$$$$Y$$$20240718$$CN$US$US
241094641$24109464$1$I$$20240711$20240718$20240718$PER$$US-ALXN-A202018609$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
241094651$24109465$1$I$$20240604$20240718$20240718$PER$$US-YILING-2024YPSPO0013$YILING PHARMACEUTICAL$$$$$F$Y$$$20240718$$CN$US$US
241094663$24109466$3$F$20240615$20240918$20240718$20240920$EXP$$NVSC2024US135909$NOVARTIS$$17$YR$$F$Y$$$20240920$$HP$US$US
241094672$24109467$2$F$20240401$20240725$20240718$20240731$EXP$$NVSJ2024JP008466$NOVARTIS$$$$$$Y$$$20240731$$MD$JP$JP
241094681$24109468$1$I$$20240612$20240718$20240718$PER$$US-STI Pharma LLC-2159281$STI PHARMA$$75$YR$$M$Y$$$20240718$$$US$US
241094691$24109469$1$I$$20240711$20240718$20240718$EXP$$NVSC2024IR145837$NOVARTIS$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients. JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH. 2022;14 (4):258-262$43$YR$$$Y$$$20240718$$HP$IR$IR
241094701$24109470$1$I$$20240716$20240718$20240718$EXP$$NVSC2024CA147347$NOVARTIS$$35$YR$$F$Y$$$20240718$$HP$CA$CA
241094711$24109471$1$I$$20240711$20240718$20240718$EXP$$NVSC2024IR145427$NOVARTIS$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients. JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH. 2022;14(4):258-262$34$YR$$$Y$$$20240718$$HP$IR$IR
241094721$24109472$1$I$$20240711$20240718$20240718$EXP$$NVSC2024IR145842$NOVARTIS$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients. JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH. 2022;14 (4):258-262$35$YR$$$Y$$$20240718$$HP$IR$IR
241094731$24109473$1$I$20240605$20240716$20240718$20240718$EXP$$US-ABBVIE-5843052$ABBVIE$$55$YR$$F$Y$$$20240718$$CN$US$US
241094741$24109474$1$I$$20240711$20240718$20240718$EXP$$NVSC2024IR146986$NOVARTIS$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients. JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH. 2022;14 (4):258-262$30$YR$$$Y$$$20240718$$HP$IR$IR
241094761$24109476$1$I$20240628$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49560$$FDA-CTU$$37$YR$$F$N$$$20240716$N$HP$US$
241094771$24109477$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49588$$FDA-CTU$$$$$F$N$$$20240716$N$HP$US$
241094801$24109480$1$I$$20240708$20240718$20240718$EXP$$US-GSK-US2024085084$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241094811$24109481$1$I$$20240716$20240718$20240718$EXP$$DE-ORGANON-O2407DEU001552$ORGANON$Makhmudova U, Schulze PC, Lorkowski S, Marz W, Geiling J, Weingartner O. Monogenic hypertriglyceridemia and recurrent pancreatitis in a homozygous carrier of a rare APOA5 mutation: a case report. Journal of Medical Case Reports [Electronic Resource].. 2024;18(1):278$25$YR$$M$Y$$$20240718$$HP$DE$DE
241094821$24109482$1$I$$20240708$20240718$20240718$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089709$VIIV$$$$$$Y$$$20240718$$HP$US$US
241094831$24109483$1$I$20191101$20210317$20240718$20240718$EXP$$US-AstraZeneca-2021A178268$ASTRAZENECA$$748$MON$$F$Y$$$20240718$$CN$US$
241094841$24109484$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158804$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241094851$24109485$1$I$$20221108$20240718$20240718$EXP$$US-AstraZeneca-2022A370367$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241094861$24109486$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49604$$FDA-CTU$$71$YR$$M$N$$$20240717$N$$US$
241094871$24109487$1$I$$20220204$20240718$20240718$EXP$$US-AstraZeneca-2022A061438$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241094881$24109488$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49562$$FDA-CTU$$$$$M$N$$$20240717$N$HP$US$
241094891$24109489$1$I$$20240717$20240717$20240717$DIR$710542$$FDA-CTU$$$$$UNK$N$$$20240717$N$CN$US$
241094901$24109490$1$I$20240702$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49586$$FDA-CTU$$61$YR$$F$N$45.6$KG$20240717$N$PH$US$
241094911$24109491$1$I$$20220307$20240718$20240718$EXP$$US-AstraZeneca-2022A105298$ASTRAZENECA$$$$$F$Y$42.2$KG$20240718$$MD$US$
241094921$24109492$1$I$20240608$20240717$20240717$20240717$DIR$710553$$FDA-CTU$$63$YR$$M$N$72.9$KG$20240717$N$HP$US$
241094931$24109493$1$I$$20200814$20240718$20240718$EXP$$US-AstraZeneca-2020SF04987$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241094941$24109494$1$I$20240703$20240717$20240717$20240717$DIR$710550$$FDA-CTU$$64$YR$$F$N$$$20240717$N$PH$US$
241094951$24109495$1$I$20240616$20240717$20240717$20240717$DIR$710554$$FDA-CTU$$63$YR$$M$N$70.2$KG$20240717$N$HP$US$
241094961$24109496$1$I$$20240709$20240718$20240718$EXP$$US-AUROBINDO-AUR-APL-2024-034365$AUROBINDO$Kwon D, Seu M, Barnes S.. Mind the Anion Gap: 5-Oxoproline-Induced High Anion Gap Metabolic Acidosis in End-Stage Renal Disease.. Cureus. 2024;16(5):e61328$74$YR$$F$Y$$$20240718$$MD$US$US
241094971$24109497$1$I$20240613$20240625$20240718$20240718$PER$$US-009507513-2406USA008821$MERCK$$65$YR$$F$Y$$$20240718$$CN$US$US
241094981$24109498$1$I$20240617$20240618$20240718$20240718$PER$$US-009507513-2406USA006250$MERCK$$32$YR$$F$Y$$$20240718$$HP$US$US
241094991$24109499$1$I$$20240717$20240718$20240718$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040456$BOEHRINGER INGELHEIM$Ishida M, Kiyota A, Yoshida J, Takeda Y, Hayashi Y, Imataki Y. A case of diabetic ketoacidosis triggered by a severe back abscess.$52$YR$A$M$Y$$$20240718$$MD$JP$JP
241095001$24109500$1$I$$20240717$20240717$20240717$DIR$710545$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241095011$24109501$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141830$AMGEN$$$$$$Y$$$20240718$$PH$US$US
241095022$24109502$2$F$$20240730$20240718$20240802$EXP$$CA-TAKEDA-2024TUS072335$TAKEDA$$$$$M$Y$$$20240802$$CN$CA$CA
241095031$24109503$1$I$$20240715$20240718$20240718$EXP$$CA-SHIRE-CA202022747$TAKEDA$$$$$F$Y$$$20240718$$CN$CA$CA
241095041$24109504$1$I$$20240715$20240718$20240718$PER$$US-ROCHE-10000027347$ROCHE$$$$E$F$Y$$$20240718$$CN$US$US
241095051$24109505$1$I$$20240710$20240718$20240718$EXP$$JP-JNJFOC-20240748010$JOHNSON AND JOHNSON$$7$DEC$E$M$Y$$$20240718$$MD$JP$JP
241095062$24109506$2$F$$20240724$20240718$20240802$30DAY$$NL-JNJFOC-20240735519$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$PH$NL$NL
241095071$24109507$1$I$$20240701$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06290$LUPIN$$$$$$Y$$$20240718$$MD$US$US
241095082$24109508$2$F$$20240719$20240718$20240719$EXP$$BR-BAYER-2024A103835$BAYER$$$$$F$Y$$$20240719$$CN$BR$BR
241095091$24109509$1$I$$20240717$20240718$20240718$PER$$US-ROCHE-10000030064$ROCHE$$$$$F$Y$$$20240718$$CN$US$US
241095102$24109510$2$F$20240711$20240718$20240718$20240809$EXP$$IL-ROCHE-10000029683$ROCHE$$44$YR$A$F$Y$$$20240809$$CN$IL$IL
241095111$24109511$1$I$$20240712$20240718$20240718$PER$$US-ABBVIE-5838916$ABBVIE$$$$$$Y$$$20240718$$HP$US$US
241095132$24109513$2$F$20240701$20240729$20240718$20240731$EXP$$CA-UCBSA-2024034822$UCB$$59$YR$$F$Y$$$20240731$$CN$CA$CA
241095141$24109514$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187718$Haleon PLC$$$$$F$Y$$$20240718$$CN$US$US
241095151$24109515$1$I$20210727$20240716$20240718$20240718$EXP$$DE-ABBVIE-5841727$ABBVIE$$68$YR$$F$Y$$$20240718$$MD$DE$DE
241095163$24109516$3$F$$20240726$20240718$20240925$PER$$US-GSK-US2024AMR087079$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
241095171$24109517$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220501$TEVA$$$$$F$Y$$$20240718$$HP$CA$CA
241095191$24109519$1$I$20240623$20240717$20240718$20240718$EXP$$US-TAKEDA-2023TUS104944$TAKEDA$$78$YR$$F$Y$$$20240718$$CN$US$US
241095201$24109520$1$I$20240710$20240715$20240718$20240718$PER$$US-JNJFOC-20240739735$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240718$$CN$US$US
241095221$24109522$1$I$$20240716$20240718$20240718$PER$$US-JNJFOC-20240740812$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$CN$US$US
241095231$24109523$1$I$20110101$20240715$20240718$20240718$EXP$$AU-JNJFOC-20240737775$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240718$$CN$AU$AU
241095241$24109524$1$I$20240628$20240712$20240718$20240718$EXP$$CN-BAYER-2024A101258$BAYER$$79$YR$E$F$Y$62$KG$20240718$$HP$CN$CN
241095251$24109525$1$I$$20240712$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112735$BRISTOL MYERS SQUIBB$$15$YR$T$F$Y$$$20240718$$HP$US$US
241095261$24109526$1$I$$20240718$20240718$20240718$PER$$US-HALEON-2187793$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241095281$24109528$1$I$$20240711$20240718$20240718$EXP$$GB-AUROBINDO-AUR-APL-2024-035050$AUROBINDO$$78$YR$$F$Y$$$20240718$$PH$GB$GB
241095291$24109529$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024142664$AMGEN$$$$$$Y$$$20240718$$CN$US$US
241095302$24109530$2$F$$20240717$20240718$20240722$PER$$US-ROCHE-10000029144$ROCHE$$$$A$F$Y$$$20240722$$CN$US$US
241095311$24109531$1$I$$20240708$20240718$20240718$EXP$$JP-TAKEDA-2024TUS072484$TAKEDA$$$$$$Y$$$20240718$$MD$JP$JP
241095322$24109532$2$F$$20240911$20240718$20240918$EXP$$US-TAKEDA-2024TUS072491$TAKEDA$$$$$M$Y$$$20240918$$MD$US$US
241095331$24109533$1$I$$20240717$20240718$20240718$EXP$$US-UCBSA-2024036243$UCB$$$$$F$Y$$$20240718$$CN$US$US
241095341$24109534$1$I$20240110$20240710$20240718$20240718$EXP$$GB-LABORATORIOS LICONSA S.A.-2407GB05535$INSUD PHARMA$$39$YR$$M$Y$$$20240718$$CN$GB$GB
241095351$24109535$1$I$20230301$20240710$20240718$20240718$EXP$GB-MHRA-MED-202407101640133760-ZJFLB$GB-LABORATORIOS LICONSA S.A.-2407GB05533$INSUD PHARMA$$62$YR$$M$Y$$$20240718$$CN$GB$GB
241095361$24109536$1$I$20240627$20240708$20240718$20240718$EXP$$BR-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2407BR05525$INSUD PHARMA$$33$YR$$F$Y$$$20240718$$CN$BR$BR
241095371$24109537$1$I$$20240711$20240718$20240718$EXP$$NL-AUROBINDO-AUR-APL-2024-035445$AUROBINDO$$43$YR$$F$Y$85$KG$20240718$$CN$NL$NL
241095381$24109538$1$I$$20240705$20240718$20240718$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-06341$HIKMA$$18$YR$$F$Y$$$20240718$$HP$CA$CA
241095391$24109539$1$I$$20240708$20240718$20240718$PER$$US-TEVA-VS-3219749$TEVA$$32$YR$$F$Y$$$20240718$$PH$US$US
241095401$24109540$1$I$20240701$20240715$20240718$20240718$EXP$$DE-BAYER-2024A103870$BAYER$$85$YR$E$F$Y$$$20240718$$CN$DE$DE
241095412$24109541$2$F$$20240829$20240718$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024084946$VIIV$$$$$$Y$$$20240905$$HP$US$US
241095421$24109542$1$I$20240509$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405091700043420-KWDZL$GB-USV-002539$USV PRIVATE$$55$YR$A$F$Y$89$KG$20240718$$CN$GB$GB
241095431$24109543$1$I$20240716$20240716$20240718$20240718$PER$$US-PFIZER INC-202400216527$PFIZER$$66$YR$$F$Y$$$20240718$$CN$US$US
241095451$24109545$1$I$20240716$20240716$20240718$20240718$PER$$US-PFIZER INC-202400216931$PFIZER$$36$YR$$M$Y$$$20240718$$HP$US$US
241095461$24109546$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-PV202400093606$PFIZER$$75$YR$$$Y$$$20240718$$CN$US$US
241095471$24109547$1$I$20240612$20240717$20240717$20240717$DIR$710557$$FDA-CTU$$50$YR$$M$N$122.7$KG$20240717$N$HP$US$
241095481$24109548$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49574$$FDA-CTU$$55$YR$$M$N$170.1$KG$20240717$N$$US$
241095491$24109549$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-202400215994$PFIZER$$65$YR$$F$Y$$$20240718$$CN$US$US
241095501$24109550$1$I$20240716$20240716$20240718$20240718$PER$$US-PFIZER INC-202400217718$PFIZER$$$$A$M$Y$$$20240718$$CN$US$US
241095511$24109551$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-PV202400093330$PFIZER$$65$YR$$M$Y$$$20240718$$HP$US$US
241095521$24109552$1$I$20240717$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217590$PFIZER$$64$YR$$F$Y$$$20240718$$HP$US$US
241095531$24109553$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-PV202400093700$PFIZER$$$$$$Y$$$20240718$$HP$US$US
241095541$24109554$1$I$20240601$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217742$PFIZER$$5$YR$$F$Y$$$20240718$$PH$US$US
241095551$24109555$1$I$20240716$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217712$PFIZER$$60$YR$$F$Y$61.69$KG$20240718$$CN$US$US
241095561$24109556$1$I$$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217740$PFIZER$$72$YR$$F$Y$$$20240718$$CN$US$US
241095572$24109557$2$F$20240101$20240726$20240718$20240801$PER$$US-PFIZER INC-PV202400058070$PFIZER$$30$YR$$F$Y$$$20240801$$HP$US$US
241095582$24109558$2$F$20240716$20240718$20240718$20240722$PER$$US-PFIZER INC-PV202400093803$PFIZER$$62$YR$$F$Y$$$20240722$$HP$US$US
241095591$24109559$1$I$20240601$20240716$20240718$20240718$PER$$US-PFIZER INC-PV202400093684$PFIZER$$22$YR$$F$Y$$$20240718$$HP$US$US
241095601$24109560$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-PV202400093765$PFIZER$$47$YR$$M$Y$$$20240718$$CN$US$US
241095611$24109561$1$I$$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217807$PFIZER$$70$YR$$F$Y$$$20240718$$CN$US$US
241095621$24109562$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-PV202400092851$PFIZER$$62$YR$$F$Y$$$20240718$$CN$US$US
241095631$24109563$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-202400216265$PFIZER$$44$YR$$F$Y$$$20240718$$HP$US$US
241095641$24109564$1$I$20240714$20240716$20240718$20240718$PER$$US-PFIZER INC-202400216452$PFIZER$$69$YR$$F$Y$$$20240718$$CN$US$US
241095651$24109565$1$I$$20240717$20240718$20240718$PER$$US-PFIZER INC-202400215054$PFIZER$$72$YR$$F$Y$$$20240718$$CN$US$US
241095661$24109566$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-202400214846$PFIZER$$38$YR$$F$Y$$$20240718$$CN$US$US
241095672$24109567$2$F$20240715$20240731$20240718$20240801$PER$$US-PFIZER INC-202400216531$PFIZER$$60$YR$$F$Y$69.841$KG$20240801$$PH$US$US
241095681$24109568$1$I$$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217852$PFIZER$$60$YR$$F$Y$$$20240718$$CN$US$US
241095691$24109569$1$I$$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217842$PFIZER$$57$YR$$M$Y$$$20240718$$CN$US$US
241095701$24109570$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-202400216492$PFIZER$$49$YR$$M$Y$$$20240718$$PH$US$US
241095712$24109571$2$F$$20240816$20240718$20240821$PER$$US-PFIZER INC-PV202400094153$PFIZER$$56$YR$$F$Y$$$20240821$$HP$US$US
241095721$24109572$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-PV202400092890$PFIZER$$75$YR$$F$Y$$$20240718$$CN$US$US
241095731$24109573$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-PV202400094009$PFIZER$$47$YR$$F$Y$$$20240718$$HP$US$US
241095741$24109574$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-PV202400093252$PFIZER$$52$YR$$F$Y$$$20240718$$HP$US$US
241095752$24109575$2$F$20240714$20240721$20240718$20240725$PER$$US-PFIZER INC-202400216520$PFIZER$$44$YR$$F$Y$$$20240725$$CN$US$US
241095761$24109576$1$I$$20240712$20240718$20240718$PER$$US-PFIZER INC-PV202400092760$PFIZER$$43$YR$$F$Y$$$20240718$$HP$US$US
241095771$24109577$1$I$20240601$20240716$20240718$20240718$PER$$US-PFIZER INC-202400217652$PFIZER$$65$YR$$F$Y$$$20240718$$HP$US$US
241095781$24109578$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-PV202400093532$PFIZER$$$$$$Y$$$20240718$$MD$US$US
241095793$24109579$3$F$20240715$20240920$20240718$20240924$PER$$US-PFIZER INC-202400215981$PFIZER$$66$YR$$F$Y$$$20240924$$HP$US$US
241095801$24109580$1$I$$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217750$PFIZER$$69$YR$$F$Y$$$20240718$$CN$US$US
241095811$24109581$1$I$20240101$20240712$20240718$20240718$PER$$US-PFIZER INC-202400214460$PFIZER$$62$YR$$F$Y$$$20240718$$HP$US$US
241095821$24109582$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-202400215039$PFIZER$$$$$M$Y$$$20240718$$CN$US$US
241095831$24109583$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-PV202400093535$PFIZER$$$$$$Y$$$20240718$$MD$US$US
241095841$24109584$1$I$20220101$20240715$20240718$20240718$PER$$US-PFIZER INC-PV202400093088$PFIZER$$66$YR$$M$Y$115.65$KG$20240718$$MD$US$US
241095851$24109585$1$I$$20240716$20240718$20240718$PER$$US-TAKEDA-2024TUS072433$TAKEDA$$$$$F$Y$69$KG$20240718$$MD$US$US
241095861$24109586$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113203$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240718$$HP$US$US
241095871$24109587$1$I$$20240715$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113661$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240718$$CN$US$US
241095881$24109588$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-PV202400093528$PFIZER$$66$YR$$F$Y$$$20240718$$HP$US$US
241095892$24109589$2$F$20240801$20240903$20240718$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114149$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240904$$HP$US$US
241095901$24109590$1$I$$20240710$20240718$20240718$EXP$$CA-APOTEX-2024AP008191$APOTEX$$12$YR$$F$Y$32$KG$20240718$$HP$CA$CA
241095911$24109591$1$I$20240625$20240701$20240717$20240717$DIR$FDA-CDER-CTU-2024-49632$$FDA-CTU$$5$YR$$F$N$16.8$KG$20240701$N$$US$
241095931$24109593$1$I$$20210729$20240718$20240718$EXP$$AU-AstraZeneca-2021A651208$ASTRAZENECA$$$$$F$Y$$$20240718$$MD$AU$
241095952$24109595$2$F$$20240828$20240718$20240905$EXP$$CA-AstraZeneca-2024A159583$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$CA$
241095961$24109596$1$I$$20200911$20240718$20240718$EXP$$US-AstraZeneca-2020SF17828$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241095971$24109597$1$I$$20210903$20240718$20240718$EXP$$US-AstraZeneca-2021A712069$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241095981$24109598$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158061$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241095991$24109599$1$I$$20240703$20240718$20240718$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00347$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$BR$BR
241096001$24109600$1$I$$20240710$20240718$20240718$EXP$NL-LRB-00976743$NL-JUBILANT CADISTA PHARMACEUTICALS-2024NL000980$JUBILANT$$55$YR$$M$Y$108$KG$20240718$$CN$NL$NL
241096011$24109601$1$I$$20220606$20240718$20240718$EXP$$US-AstraZeneca-2022A211394$ASTRAZENECA$$$$$$Y$$$20240718$$CN$US$
241096021$24109602$1$I$$20240711$20240718$20240718$EXP$$CA-AstraZeneca-2024A162187$ASTRAZENECA$$74$YR$$M$Y$$$20240718$$MD$CA$
241096031$24109603$1$I$20240715$20240715$20240718$20240718$PER$$US-BAYER-2024A103009$BAYER$$31$YR$A$F$Y$$$20240718$$MD$US$US
241096041$24109604$1$I$20240715$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141822$AMGEN$$35$YR$A$F$Y$$$20240718$$CN$US$US
241096051$24109605$1$I$$20210517$20240718$20240718$EXP$$US-AstraZeneca-2021A229651$ASTRAZENECA$$74$YR$$F$Y$67.6$KG$20240718$$CN$US$
241096061$24109606$1$I$$20240311$20240718$20240718$EXP$$PL-TEVA-VS-3214587$TEVA$lek W, Wrobel D. Cerebrovascular diseases: a 76-year-old man with sudden blindness in the right eye. Practical Medicine Neurology. 2023;5:73-8; Wrona P. 76-years old man with sudden blindness in the right eye. Practical Medicine - Neurology. 2023;83(5):73-8$76$YR$$M$Y$$$20240718$$HP$PL$PL
241096081$24109608$1$I$$20240711$20240718$20240718$EXP$$US-MYLANLABS-2024M1065806$MYLAN$Khadraoui H, Herzog TJ, Jackson A, Billingsley C. Acute pulmonary complications in the setting of high risk gestational trophoblastic neoplasia and induction of chemotherapy. Gynecol-Oncol-Rep 2023; 48.$33$YR$$F$Y$$$20240718$$HP$US$US
241096091$24109609$1$I$$20240711$20240718$20240718$EXP$$US-AMGEN-USASP2024138692$AMGEN$Fulco. P. P.; Ahern L. C.; Nixon D.. Antiretroviral therapeutic drug monitoring in a patient with small bowel resection and newHIV diagnosis. Frontiers in Pediatrics. 2024;3:1-3$28$YR$A$M$Y$$$20240718$$HP$US$US
241096101$24109610$1$I$$20240708$20240718$20240718$EXP$$GB-TEVA-VS-3220000$TEVA$$64$YR$$F$Y$77$KG$20240718$$PH$GB$GB
241096111$24109611$1$I$$20240711$20240718$20240718$EXP$$US-MYLANLABS-2024M1066288$MYLAN$Wireko FW, Ryu JH. Lung Transplant for Acute Exacerbation in Interstitial Pneumonia With Autoimmune Features (IPAF). Am-J-Respir-Crit-Care-Med 2024; 209.$63$YR$$M$Y$$$20240718$$HP$US$US
241096121$24109612$1$I$20240401$20240710$20240718$20240718$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-005390$AURINIA PHARMACEUTICALS$$35$YR$$F$Y$$$20240718$$CN$US$US
241096131$24109613$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-10000028558$ROCHE$$$$C$F$Y$$$20240718$$CN$US$US
241096141$24109614$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-3569324$ROCHE$$56$YR$A$F$Y$$$20240718$$CN$US$US
241096152$24109615$2$F$20240301$20240812$20240718$20240826$EXP$$CN-ROCHE-10000029060$ROCHE$$63$YR$A$M$Y$$$20240826$$MD$CN$CN
241096161$24109616$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-10000029869$ROCHE$$$$$F$Y$$$20240718$$CN$US$US
241096171$24109617$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-10000029009$ROCHE$$49$YR$A$F$Y$$$20240718$$CN$US$US
241096181$24109618$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-3561118$ROCHE$$62$YR$A$F$Y$$$20240718$$HP$US$US
241096192$24109619$2$F$$20240812$20240718$20240820$30DAY$$CA-JNJFOC-20240733633$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$CA$CA
241096201$24109620$1$I$20240101$20240716$20240718$20240718$PER$$US-ROCHE-10000029507$ROCHE$$51$YR$A$F$Y$120.2$KG$20240718$$CN$US$US
241096212$24109621$2$F$$20240822$20240718$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113003$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240826$$CN$US$US
241096222$24109622$2$F$$20240718$20240718$20240720$PER$$US-AMGEN-USASP2024142767$AMGEN$$$$$M$Y$$$20240720$$PH$US$US
241096231$24109623$1$I$$20240717$20240718$20240718$PER$$US-ROCHE-10000030215$ROCHE$$$$A$M$Y$$$20240718$$CN$US$US
241096241$24109624$1$I$$20240703$20240718$20240718$EXP$$TN-GRANULES-TN-2024GRALIT00278$GRANULES INDIA$Ben Hammamia S.Neurotoxicity Related to Multidrug Association: A Case Report.Journal of Clinical Psychopharmacology.JUN-2024;44:317-319$57$YR$A$F$Y$$$20240718$$HP$TN$TN
241096251$24109625$1$I$$20240715$20240718$20240718$EXP$$FR-TAKEDA-2024TUS072305$TAKEDA$$$$$F$Y$$$20240718$$MD$FR$FR
241096261$24109626$1$I$$20240715$20240718$20240718$EXP$$GB-MYLANLABS-2024M1066618$MYLAN$$$$$M$Y$$$20240718$$CN$GB$GB
241096275$24109627$5$F$20240706$20240822$20240718$20240826$EXP$$IE-MYLANLABS-2024M1066182$MYLAN$$$$$M$Y$$$20240826$$CN$IE$IE
241096282$24109628$2$F$20240801$20240812$20240718$20240816$EXP$$GB-MYLANLABS-2024M1066631$MYLAN$$$$$M$Y$$$20240816$$PH$GB$GB
241096291$24109629$1$I$20240101$20240715$20240718$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-019710$UNITED THERAPEUTICS$$$$$F$Y$77.098$KG$20240718$$$US$US
241096301$24109630$1$I$20240712$20240715$20240718$20240718$EXP$GB-MHRA-MED-202407121201536790-NFKPJ$GB-MYLANLABS-2024M1066126$MYLAN$$54$YR$$M$Y$110$KG$20240718$$CN$GB$GB
241096311$24109631$1$I$$20240710$20240718$20240718$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-099366$REGENERON$$67$YR$$M$Y$$$20240718$$HP$CO$CO
241096321$24109632$1$I$20240705$20240709$20240717$20240717$DIR$FDA-CDER-CTU-2024-49648$$FDA-CTU$$73$YR$$F$N$105.6$KG$20240709$N$$US$
241096331$24109633$1$I$$20240717$20240718$20240718$PER$$US-ROCHE-10000029911$ROCHE$$$$C$F$Y$$$20240718$$CN$US$US
241096341$24109634$1$I$20240713$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49639$$FDA-CTU$$83$YR$$M$N$80.1$KG$20240716$N$$US$
241096351$24109635$1$I$20240701$20240715$20240718$20240718$EXP$$US-BAYER-2024A101432$BAYER$$15$YR$T$M$Y$$$20240718$$HP$US$US
241096362$24109636$2$F$20240514$20240724$20240718$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111832$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240726$$HP$US$US
241096371$24109637$1$I$20240101$20240715$20240718$20240718$PER$$US-UNITED THERAPEUTICS-UNT-2024-021868$UNITED THERAPEUTICS$$$$$F$Y$49.887$KG$20240718$$$US$US
241096381$24109638$1$I$$20240717$20240718$20240718$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-114103$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240718$$CN$PR$PR
241096391$24109639$1$I$20230301$20240710$20240718$20240718$EXP$GB-MHRA-MED-202407101640133760-ZJFLB$GB-RDY-SPO/GBR/24/0010265$DR REDDYS$$62$YR$A$M$Y$$$20240718$$CN$GB$GB
241096404$24109640$4$F$20240101$20240814$20240718$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-020892$UNITED THERAPEUTICS$$$$$F$Y$67.574$KG$20240823$$$US$US
241096421$24109642$1$I$20240712$20240716$20240718$20240718$EXP$$US-BAYER-2024A104335$BAYER$$55$YR$A$F$Y$114.29$KG$20240718$$CN$US$US
241096432$24109643$2$F$$20240715$20240718$20240720$PER$$US-TAKEDA-2024TUS071643$TAKEDA$$$$$F$Y$86$KG$20240720$$MD$US$US
241096441$24109644$1$I$$20240703$20240718$20240718$EXP$$CH-GRANULES-CH-2024GRALIT00275$GRANULES INDIA$S. Jeltsch.How to differentiate erythema multiforme major from Stevens-Johnson syndrome?.Swiss Medical Weekly.MAY-2024;154:112S-113S$41$YR$A$M$Y$$$20240718$$HP$CH$CH
241096461$24109646$1$I$20240509$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49589$$FDA-CTU$$66$YR$$F$N$62.6$KG$20240716$N$HP$US$
241096491$24109649$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49587$$FDA-CTU$$52$YR$$F$N$84.82$KG$20240717$N$$US$
241096511$24109651$1$I$20210601$20240717$20240718$20240718$EXP$$US-INCYTE CORPORATION-2024IN007534$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241096521$24109652$1$I$$20220215$20240718$20240718$EXP$$US-AstraZeneca-2022A074115$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241096531$24109653$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49616$$FDA-CTU$$70$YR$$M$N$$$20240717$N$$US$
241096541$24109654$1$I$$20200901$20240718$20240718$EXP$$US-AstraZeneca-2020SF13962$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241096551$24109655$1$I$20201020$20201027$20240718$20240718$EXP$$US-AstraZeneca-2020SF42703$ASTRAZENECA$$25308$DY$$M$Y$$$20240718$$CN$US$
241096561$24109656$1$I$$20210525$20240718$20240718$EXP$$US-AstraZeneca-2021A483278$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241096602$24109660$2$F$20240605$20240719$20240718$20240730$EXP$$PK-ROCHE-10000022571$ROCHE$$51$YR$A$F$Y$$$20240730$$CN$PK$PK
241096621$24109662$1$I$$20240717$20240717$20240717$DIR$710537$$FDA-CTU$$$$$UNK$N$$$20240717$N$CN$US$
241096641$24109664$1$I$20240113$20240718$20240718$20240718$EXP$HR-HALMED-300086167$HR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040531$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240718$$PH$HR$HR
241096651$24109665$1$I$20240711$20240715$20240718$20240718$PER$$US-BAYER-2024A101738$BAYER$$34$YR$A$M$Y$$$20240718$$CN$US$US
241096661$24109666$1$I$$20240712$20240718$20240718$EXP$$NVSC2024US145801$NOVARTIS$$$$$$Y$$$20240718$$CN$US$US
241096673$24109667$3$F$$20240801$20240718$20240810$EXP$$PS-TEVA-VS-3220061$TEVA$Maqboul I, Daraghmeh L, Eleiwi MR, Qasrawi H, Akkawi M, AwadGhanem A. Atraumatic splenic rupture after administering aspirin, clopidogrel, and heparin to a patient with unstable angina: A case report. SAGE-Open-Med-Case-Rep 2024; 12.; Maqboul I, Daraghmeh L, Eleiwi MR, Qasrawi H, Akkawi M, AwadGhanem A. Atraumatic splenic rupture after administering aspirin, clopidogrel, and heparin to a patient with unstable angina: A case report. SAGE-Open-Med-Case-Rep 2024; 12.; Maqboul I, Daraghmeh L, Ele...$49$YR$$M$Y$$$20240810$$HP$PS$PS
241096682$24109668$2$F$20240501$20240724$20240718$20240802$30DAY$$US-GSK-US2024086397$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240802$$CN$US$US
241096691$24109669$1$I$$20240712$20240718$20240718$EXP$$CA-Orion Corporation ORION PHARMA-24_00030862$ORION$$72$YR$E$M$Y$$$20240718$$CN$CA$
241096702$24109670$2$F$$20240809$20240718$20240814$30DAY$$JP-JNJFOC-20240733522$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$HP$JP$JP
241096711$24109671$1$I$20240703$20240716$20240718$20240718$PER$$US-ABBVIE-5844134$ABBVIE$$$$$$Y$$$20240718$$HP$US$US
241096722$24109672$2$F$$20240730$20240718$20240803$PER$$US-AMGEN-USASP2024142374$AMGEN$$$$$F$Y$$$20240803$$CN$US$US
241096731$24109673$1$I$20240101$20240717$20240718$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040557$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240718$$MD$US$US
241096742$24109674$2$F$$20240801$20240718$20240810$EXP$$US-TEVA-VS-3220188$TEVA$Faircloth JM, Bhatt ND, Chartan CA, Coleman RD, Villafranco N, Ruiz FE, et al. Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration. Front-Pediatr 2023; 11 no pagination.; Faircloth JM, Bhatt ND, Chartan CA, Coleman RD, Villafranco N, Ruiz FE, et al. Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration. Front-Pediatr 2023; 11 no pagination.$5$YR$$F$Y$$$20240810$$HP$US$US
241096751$24109675$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220325$TEVA$$41$YR$$M$Y$$$20240718$$HP$CA$CA
241096761$24109676$1$I$20240704$20240709$20240718$20240718$EXP$$GB-CELLTRION INC.-2024GB015608$CELLTRION$$$$$$Y$$$20240718$$CN$GB$GB
241096771$24109677$1$I$20240405$20240712$20240718$20240718$EXP$$GB-AMGEN-GBRSP2024138884$AMGEN$$56$YR$A$F$Y$94$KG$20240718$$MD$GB$GB
241096831$24109683$1$I$$20240709$20240718$20240718$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001385$BLUEPRINT MEDICINES$$$$$M$Y$$$20240718$$CN$US$US
241096841$24109684$1$I$$20240716$20240718$20240718$EXP$$GB-MYLANLABS-2024M1066657$MYLAN$$$$$M$Y$$$20240718$$HP$GB$GB
241096851$24109685$1$I$20240715$20240716$20240718$20240718$EXP$$GB-MYLANLABS-2024M1067015$MYLAN$$$$$F$Y$$$20240718$$HP$GB$GB
241096862$24109686$2$F$$20240730$20240718$20240801$EXP$$GB-MYLANLABS-2024M1066640$MYLAN$$$$$F$Y$$$20240801$$MD$GB$GB
241096871$24109687$1$I$$20240716$20240718$20240718$EXP$$GB-MYLANLABS-2024M1066997$MYLAN$$$$$M$Y$$$20240718$$CN$GB$GB
241096881$24109688$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024142540$AMGEN$$$$$$Y$$$20240718$$CN$US$US
241096891$24109689$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114449$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240718$$CN$US$US
241096901$24109690$1$I$$20240705$20240718$20240718$PER$$US-RDY-SPO/USA/24/0010206$DR REDDYS$$$$$$Y$$$20240718$$CN$US$US
241096911$24109691$1$I$20240101$20240710$20240718$20240718$PER$$US-ABBVIE-5838537$ABBVIE$$$$$$Y$$$20240718$$HP$US$US
241096921$24109692$1$I$20240619$20240710$20240718$20240718$EXP$FR-AFSSAPS-RE2024000650$FR-TEVA-VS-3220347$TEVA$$24$YR$$M$Y$133$KG$20240718$$MD$FR$FR
241096931$24109693$1$I$$20240710$20240718$20240718$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001399$BLUEPRINT MEDICINES$$$$$M$Y$$$20240718$$CN$US$US
241096942$24109694$2$F$$20240924$20240718$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114484$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$79.38$KG$20240930$$PH$US$US
241096951$24109695$1$I$$20240709$20240718$20240718$EXP$$ES-ARGENX-2024-ARGX-ES005397$ARGENX BVBA$$$$$$Y$$$20240718$$MD$ES$ES
241096961$24109696$1$I$$20240709$20240718$20240718$EXP$$CA-BAXTER-2024BAX021396$BAXTER$$59$YR$$M$Y$$$20240718$$CN$CA$CA
241096971$24109697$1$I$$20240717$20240718$20240718$EXP$$CA-PFIZER INC-202400217609$PFIZER$$13$YR$$F$Y$42$KG$20240718$$PH$CA$CA
241096981$24109698$1$I$$20240716$20240718$20240718$EXP$$PE-PFIZER INC-PV202400081435$PFIZER$$52$YR$$M$Y$$$20240718$$MD$PE$PE
241096992$24109699$2$F$20240501$20240724$20240718$20240725$EXP$IT-MINISAL02-994749$IT-PFIZER INC-202400214700$PFIZER$$66$YR$$F$Y$$$20240725$$MD$IT$IT
241097001$24109700$1$I$$20240714$20240718$20240718$EXP$$IN-PFIZER INC-2021902973$PFIZER$$69$YR$$F$Y$$$20240718$$CN$IN$IN
241097011$24109701$1$I$20230301$20240717$20240718$20240718$EXP$IT-MINISAL02-995017$IT-PFIZER INC-202400217242$PFIZER$$59$YR$$F$Y$$$20240718$$PH$IT$IT
241097021$24109702$1$I$$20240717$20240718$20240718$EXP$$JP-PFIZER INC-202400216783$PFIZER$$$$$$Y$$$20240718$$MD$JP$JP
241097032$24109703$2$F$$20240718$20240718$20240719$EXP$$JP-PFIZER INC-PV202400093880$PFIZER$$75$YR$$M$Y$$$20240719$$MD$JP$JP
241097041$24109704$1$I$20240701$20240715$20240718$20240718$EXP$$CA-PFIZER INC-202400216630$PFIZER$$68$YR$$F$Y$$$20240718$$HP$CA$CA
241097051$24109705$1$I$20230607$20240712$20240718$20240718$EXP$$CR-PFIZER INC-202400215317$PFIZER$$60$YR$$M$Y$$$20240718$$CN$CR$CR
241097071$24109707$1$I$20240713$20240716$20240718$20240718$EXP$$CN-PFIZER INC-PV202400093373$PFIZER$$8$YR$$F$Y$22.5$KG$20240718$$HP$CN$CN
241097081$24109708$1$I$$20240710$20240718$20240718$EXP$$US-PFIZER INC-202400210374$PFIZER$Cohen, S.. Multidisciplinary Approach for the Management of Metastatic Poorly Differentiated Neuroendocrine Carcinoma of the Pancreas A Case Report of an Exceptional Responder. Pancreas. 2024;53(6):e487-91$51$YR$$M$Y$$$20240718$$MD$US$US
241097091$24109709$1$I$$20240713$20240718$20240718$EXP$$CA-PFIZER INC-202400214863$PFIZER$Adamo, A.. Fentanyl-Related Deaths in Ontario, Canada: Toxicological Findings and Circumstances of Death in 4395 Cases (2020-2022). Journal of analytical toxicology. 2024;10.1093/jat/bkae061$62$YR$$F$Y$$$20240718$$HP$CA$CA
241097101$24109710$1$I$20240523$20240715$20240718$20240718$EXP$FR-AFSSAPS-LL2024001276$FR-PFIZER INC-202400214762$PFIZER$$73$YR$$F$Y$$$20240718$$PH$FR$FR
241097111$24109711$1$I$20240613$20240716$20240718$20240718$EXP$$CN-PFIZER INC-PV202400093398$PFIZER$$8$YR$$M$Y$29$KG$20240718$$HP$CN$CN
241097122$24109712$2$F$20240501$20240823$20240718$20240828$EXP$$US-PFIZER INC-PV202400093533$PFIZER$$63$YR$$F$Y$$$20240828$$CN$US$US
241097132$24109713$2$F$$20240724$20240718$20240724$EXP$$US-PFIZER INC-PV202400093585$PFIZER$$70$YR$$M$Y$$$20240724$$CN$US$US
241097141$24109714$1$I$20240621$20240715$20240718$20240718$EXP$FR-AFSSAPS-ST2024001167$FR-PFIZER INC-202400214770$PFIZER$$71$YR$$M$Y$$$20240718$$MD$FR$FR
241097151$24109715$1$I$20240617$20240716$20240718$20240718$EXP$$CN-PFIZER INC-PV202400093390$PFIZER$$15$YR$$M$Y$90$KG$20240718$$HP$CN$CN
241097161$24109716$1$I$20240101$20240717$20240718$20240718$EXP$$US-PFIZER INC-202400217775$PFIZER$$29$YR$$M$Y$$$20240718$$HP$US$US
241097171$24109717$1$I$20240516$20240715$20240718$20240718$EXP$NL-LRB-00984864$NL-PFIZER INC-202400214742$PFIZER$$63$YR$$M$Y$85$KG$20240718$$MD$NL$NL
241097181$24109718$1$I$$20240717$20240718$20240718$EXP$$JP-PFIZER INC-PV202400093441$PFIZER$$65$YR$$F$Y$$$20240718$$CN$JP$JP
241097191$24109719$1$I$20240522$20240716$20240718$20240718$EXP$FR-AFSSAPS-MA2024000972$FR-PFIZER INC-202400215934$PFIZER$$3$MON$$F$Y$3.58$KG$20240718$$MD$FR$FR
241097202$24109720$2$F$$20240717$20240718$20240726$EXP$$CA-PFIZER INC-202400217610$PFIZER$$50$YR$$M$Y$$$20240726$$HP$CA$CA
241097211$24109721$1$I$$20240713$20240718$20240718$EXP$$CA-PFIZER INC-PV202400092373$PFIZER$Adamo, A.. Fentanyl-Related Deaths in Ontario, Canada: Toxicological Findings and Circumstances of Death in 4395 Cases (2020-2022). Journal of analytical toxicology. 2024;10.1093/jat/bkae061$21$YR$$F$Y$$$20240718$$HP$CA$CA
241097221$24109722$1$I$20230403$20240715$20240718$20240718$EXP$FR-AFSSAPS-MA2024000808$FR-PFIZER INC-202400214771$PFIZER$$39$YR$$M$Y$$$20240718$$MD$FR$FR
241097232$24109723$2$F$20230517$20240911$20240718$20240911$EXP$$CA-PFIZER INC-202400217273$PFIZER$$61$YR$$F$Y$$$20240911$$MD$CA$CA
241097242$24109724$2$F$20240626$20240721$20240718$20240724$EXP$ES-AEMPS-1549106$ES-PFIZER INC-202400215916$PFIZER$$83$YR$$M$Y$$$20240724$$PH$ES$ES
241097251$24109725$1$I$$20240715$20240718$20240718$EXP$$CA-PFIZER INC-PV202400093248$PFIZER$$62$YR$$F$Y$$$20240718$$CN$CA$CA
241097262$24109726$2$F$20230823$20240911$20240718$20240911$EXP$$CA-PFIZER INC-202300285568$PFIZER$$59$YR$$F$Y$67.1$KG$20240911$$MD$CA$CA
241097271$24109727$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-PV202400093782$PFIZER$$85$YR$$F$Y$$$20240718$$HP$US$US
241097281$24109728$1$I$20240501$20240715$20240718$20240718$EXP$FR-AFSSAPS-RN2024000770$FR-PFIZER INC-202400214775$PFIZER$$80$YR$$M$Y$$$20240718$$MD$FR$FR
241097291$24109729$1$I$20170101$20240712$20240718$20240718$EXP$$BR-PFIZER INC-2019SGN01571$PFIZER$Ferreira, A.. Pneumocystis jirovecii pneumonia during brentuximab vedotin therapy: a case report and literature review. Case Reports in Hematology. 2019$45$YR$$M$Y$$$20240718$$HP$BR$BR
241097301$24109730$1$I$20240709$20240716$20240718$20240718$EXP$$CN-PFIZER INC-PV202400093413$PFIZER$$87$YR$$F$Y$$$20240718$$HP$CN$CN
241097311$24109731$1$I$20170401$20240712$20240718$20240718$EXP$$BR-PFIZER INC-2019SGN03245$PFIZER$Ferreira, A.. Pneumocystis jirovecii pneumonia during brentuximab vedotin therapy: a case report and literature review. Case Reports in Hematology. 2019$43$YR$$M$Y$$$20240718$$MD$BR$BR
241097332$24109733$2$F$$20240801$20240718$20240808$EXP$$CN-PFIZER INC-202400208623$PFIZER$Chen, W.. Electroacupuncture for oculomotor nerve palsy after chemotherapy: A case report. Medicine (United States). 2024;103(24):e38547$56$YR$$F$Y$$$20240808$$MD$CN$CN
241097341$24109734$1$I$20240618$20240712$20240718$20240718$EXP$$CN-PFIZER INC-PV202400093052$PFIZER$$13$YR$$M$Y$58$KG$20240718$$HP$CN$CN
241097352$24109735$2$F$20240527$20240729$20240718$20240802$EXP$$FR-PFIZER INC-202400214808$PFIZER$$60$YR$$M$Y$$$20240802$$MD$FR$FR
241097361$24109736$1$I$20240110$20240716$20240718$20240718$EXP$NO-NOMAADVRE-PASRAPP-2024-V9za5j$NO-PFIZER INC-202400215946$PFIZER$$31$YR$$F$Y$79$KG$20240718$$CN$NO$NO
241097371$24109737$1$I$$20240716$20240718$20240718$EXP$$BG-PFIZER INC-202400216201$PFIZER$$76$YR$$F$Y$$$20240718$$CN$BG$BG
241097381$24109738$1$I$20240702$20240715$20240718$20240718$EXP$ES-AEMPS-1548344$ES-PFIZER INC-202400214695$PFIZER$$69$YR$$F$Y$$$20240718$$HP$ES$ES
241097391$24109739$1$I$20230519$20240715$20240718$20240718$EXP$DK-DKMA-30735509$DK-PFIZER INC-202400214612$PFIZER$$60$YR$$F$Y$$$20240718$$MD$DK$DK
241097401$24109740$1$I$20240401$20240711$20240718$20240718$EXP$$US-AGIOS-2407US03829$AGIOS PHARMACEUTICALS$$46$YR$$M$Y$$$20240718$$CN$US$US
241097411$24109741$1$I$$20240716$20240718$20240718$EXP$$US-PFIZER INC-PV202400065549$PFIZER$$91$YR$$F$Y$$$20240718$$CN$US$US
241097421$24109742$1$I$20240101$20240710$20240718$20240718$EXP$$US-PFIZER INC-202400212565$PFIZER$$59$YR$$F$Y$$$20240718$$HP$US$US
241097432$24109743$2$F$$20240729$20240718$20240731$EXP$$US-PFIZER INC-PV202400091538$PFIZER$$64$YR$$F$Y$$$20240731$$CN$US$US
241097441$24109744$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010487$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240718$$CN$US$US
241097451$24109745$1$I$20180601$20240711$20240718$20240718$EXP$$FR-PFIZER INC-2023SGN11327$PFIZER$Valyraki, N.. Human pegivirus identified in severe myelitis and optic neuritis in immunocompromised patients: A pathogenic role for a forgotten virus.. Rev-Neurol-Paris. 2023;179(4):361-7$46$YR$$F$Y$$$20240718$$HP$FR$FR
241097464$24109746$4$F$20230731$20240807$20240718$20240812$EXP$$JP-PFIZER INC-PV202400091892$PFIZER$Naganawa, H.. Influence of ensitrelvir or nirmatrelvir/ritonavir on tacrolimus clearance in kidney transplant recipients: a single-center case series. Journal of Pharmaceutical Health Care and Sciences. 2024;10(1):10.1186/s40780-024-00361-x$52$YR$$F$Y$54.6$KG$20240812$$PH$JP$JP
241097471$24109747$1$I$20240501$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010808$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240718$$CN$US$US
241097481$24109748$1$I$$20240712$20240718$20240718$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407009253$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240718$$CN$JP$JP
241097491$24109749$1$I$20230801$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009749$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240718$$CN$US$US
241097501$24109750$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010464$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240718$$CN$US$US
241097512$24109751$2$F$$20240828$20240718$20240906$EXP$$GB-TEVA-VS-3220848$TEVA$Bulley SJ, Santarsieri A, Lentell IC, O^Sullivan B, Hodson A, Firth O, et al. Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study. EJHaem 2022; 3 (4): 1316-1320.; Bulley SJ, Santarsieri A, Lentell IC, O^Sullivan B, Hodson A, Firth O, et al. Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study. EJHaem 2022; 3 (4): 1316-1320.; Bulley SJ, Santarsieri A, Lentell IC, O^Sullivan B, Hodson A,...$$$$$Y$$$20240906$$HP$GB$GB
241097521$24109752$1$I$$20240709$20240718$20240718$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407011110$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240718$$CN$JP$JP
241097531$24109753$1$I$20240601$20240708$20240718$20240718$EXP$GB-MHRA-MED-202407072318321420-JRYWF$GB-ELI_LILLY_AND_COMPANY-GB202407005764$ELI LILLY AND CO$$26$YR$A$$Y$113$KG$20240718$$CN$GB$GB
241097541$24109754$1$I$$20240708$20240718$20240718$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004892$ELI LILLY AND CO$$$$$M$Y$$$20240718$$CN$US$US
241097551$24109755$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011206$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240718$$CN$US$US
241097561$24109756$1$I$20240501$20240709$20240718$20240718$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407006731$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240718$$CN$CN$CN
241097571$24109757$1$I$20240712$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009748$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240718$$CN$US$US
241097581$24109758$1$I$20240712$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010488$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240718$$CN$US$US
241097591$24109759$1$I$$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405071553569550-YJPHB$GB-ELI_LILLY_AND_COMPANY-GB202407004631$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$GB$GB
241097601$24109760$1$I$20231128$20240709$20240718$20240718$EXP$FR-AFSSAPS-ST2024001137$FR-ELI_LILLY_AND_COMPANY-FR202407006729$ELI LILLY AND CO$$65$YR$E$F$Y$56.5$KG$20240718$$CN$FR$FR
241097611$24109761$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010328$ELI LILLY AND CO$$$$A$F$Y$$$20240718$$CN$US$US
241097621$24109762$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010256$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240718$$CN$US$US
241097631$24109763$1$I$20240501$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010842$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240718$$CN$US$US
241097641$24109764$1$I$$20240715$20240718$20240718$PER$$US-JNJFOC-20170422730$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$LW$US$US
241097651$24109765$1$I$$20240716$20240718$20240718$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202305017063$ELI LILLY AND CO$$$$$$Y$$$20240718$$CN$JP$JP
241097661$24109766$1$I$20240601$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009903$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240718$$CN$US$US
241097671$24109767$1$I$$20240711$20240718$20240718$EXP$$BR-JNJFOC-20240734359$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$BR$BR
241097681$24109768$1$I$$20240712$20240718$20240718$PER$$US-JNJFOC-20240744568$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$HP$US$US
241097692$24109769$2$F$$20240816$20240718$20240822$30DAY$$JP-JNJFOC-20240733310$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$MD$JP$JP
241097701$24109770$1$I$$20240716$20240718$20240718$EXP$$NVSC2024AT147475$NOVARTIS$$$$$F$Y$$$20240718$$MD$AT$AT
241097711$24109771$1$I$$20240708$20240718$20240718$EXP$$GR-EMD Serono-2024037403$EMD SERONO INC$Tsotsorou O, Kalogeropoulos P, Lionaki S. Lactic Acidosis and Acute Kidney Injury in patients receiving metformin: Description of 2 clinical cases. Poster no: P06. 25th Panhellenic Congress of Nephrology, 19-21 Jun 2024$74$YR$E$F$Y$$$20240718$$HP$GR$GR
241097721$24109772$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-202400216594$PFIZER$$46$YR$$M$Y$$$20240718$$CN$US$US
241097731$24109773$1$I$$20240711$20240718$20240718$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407009023$ELI LILLY AND CO$$$$E$M$Y$$$20240718$$CN$DE$DE
241097743$24109774$3$F$20240629$20240808$20240718$20240810$EXP$$US-ROCHE-10000030343$ROCHE$$75$YR$E$F$Y$$$20240810$$CN$US$US
241097752$24109775$2$F$20240705$20240716$20240718$20240719$PER$$US-PFIZER INC-202101500279$PFIZER$$76$YR$$F$Y$$$20240719$$CN$US$US
241097761$24109776$1$I$20240626$20240716$20240718$20240718$PER$$US-PFIZER INC-202400217666$PFIZER$$87$YR$$F$Y$$$20240718$$HP$US$US
241097774$24109777$4$F$$20240802$20240718$20240805$PER$$US-PFIZER INC-PV202400092841$PFIZER$$57$YR$$F$Y$$$20240805$$HP$US$US
241097781$24109778$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-202400215122$PFIZER$$$$$F$Y$$$20240718$$MD$US$US
241097791$24109779$1$I$$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217769$PFIZER$$68$YR$$F$Y$55.34$KG$20240718$$CN$US$US
241097801$24109780$1$I$20220201$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217772$PFIZER$$$$A$F$Y$$$20240718$$MD$US$US
241097821$24109782$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-PV202400093563$PFIZER$$79$YR$$F$Y$$$20240718$$CN$US$US
241097834$24109783$4$F$20240101$20240918$20240718$20240920$PER$$US-PFIZER INC-PV202400093570$PFIZER$$51$YR$$F$Y$$$20240920$$HP$US$US
241097842$24109784$2$F$$20240725$20240718$20240730$PER$$US-PFIZER INC-202400217634$PFIZER$$$$$F$Y$$$20240730$$CN$US$US
241097851$24109785$1$I$$20240715$20240718$20240718$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700578$MYOVANT SCIENCES$$$$$M$Y$$$20240718$$HP$US$US
241097861$24109786$1$I$$20220408$20240718$20240718$EXP$$US-AstraZeneca-2022A145294$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241097871$24109787$1$I$$20211110$20240718$20240718$EXP$$US-AstraZeneca-2021A803576$ASTRAZENECA$$$$$M$Y$$$20240718$$MD$US$
241097881$24109788$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-202400216479$PFIZER$$$$$$Y$$$20240718$$CN$US$US
241097891$24109789$1$I$20240101$20240715$20240718$20240718$PER$$US-ABBVIE-5842667$ABBVIE$$32$YR$$F$Y$$$20240718$$PH$US$US
241097901$24109790$1$I$$20240708$20240718$20240718$EXP$$GR-EMD Serono-2024037395$EMD SERONO INC$Tsotsorou O, Kalogeropoulos P, Lionaki S. Euglycaemic Ketoacidosis, Lactic Acidosis and Acute Kidney Injury in patients receiving metformin: Description of 2 clinical cases. 25th Panhellenic Congress of Nephrology.$71$YR$E$F$Y$$$20240718$$HP$GR$GR
241097911$24109791$1$I$$20210727$20240718$20240718$EXP$$US-AstraZeneca-2021A652209$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241097921$24109792$1$I$$20240703$20240718$20240718$EXP$$US-GRANULES-US-2024GRALIT00269$GRANULES INDIA$U. D. Gupta.Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care.American Journal of Respiratory and Critical Care Medicine.2024;209:A3415$43$YR$A$F$Y$$$20240718$$HP$US$US
241097934$24109793$4$F$20231220$20240924$20240718$20240930$EXP$$AR-MYLANLABS-2023M1137172$MYLAN$$49$YR$$F$Y$$$20240930$$CN$AR$AR
241097941$24109794$1$I$$20240715$20240718$20240718$EXP$$CA-BAYER-2024A102503$BAYER$$52$YR$A$F$Y$$$20240718$$CN$CA$CA
241097951$24109795$1$I$$20201007$20240718$20240718$EXP$$US-AstraZeneca-2020SF30523$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241097982$24109798$2$F$20230801$20240813$20240718$20240826$PER$$US-ROCHE-10000022318$ROCHE$$17$YR$T$F$Y$106.59$KG$20240826$$CN$US$US
241097991$24109799$1$I$20240701$20240711$20240718$20240718$EXP$$US-Stemline Therapeutics, Inc.-2024ST004261$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240716$$CN$US$US
241098001$24109800$1$I$20190114$20240711$20240718$20240718$EXP$FR-AFSSAPS-MP20190156$FR-RDY-GER/FRA/19/0107916$DR REDDYS$$50$YR$A$F$Y$72.5$KG$20240718$$MD$FR$FR
241098021$24109802$1$I$$20240712$20240718$20240718$EXP$$PL-AMGEN-POLSP2024139304$AMGEN$$15$YR$T$M$Y$72$KG$20240718$$MD$PL$PL
241098031$24109803$1$I$$20240710$20240718$20240718$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001403$BLUEPRINT MEDICINES$$$$$M$Y$$$20240718$$CN$US$US
241098041$24109804$1$I$20240612$20240717$20240717$20240717$DIR$710560$$FDA-CTU$$55$YR$$F$N$67.8$KG$20240717$N$HP$US$
241098051$24109805$1$I$20240615$20240717$20240717$20240717$DIR$710561$$FDA-CTU$$56$YR$$F$N$67.8$KG$20240717$N$HP$US$
241098061$24109806$1$I$$20240710$20240718$20240718$EXP$$US-AMGEN-USASP2024139029$AMGEN$Pommert L.; Leblanc F.R.; Grier D.D. et al.. A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome. Pediatric Blood + Cancer. 2024;71 (8):1-4$27$YR$A$M$Y$$$20240718$$HP$US$US
241098072$24109807$2$F$20240601$20240801$20240718$20240806$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-003447$BOEHRINGER INGELHEIM$$47$YR$A$F$Y$31.75$KG$20240806$$CN$US$US
241098081$24109808$1$I$20240712$20240717$20240717$20240717$DIR$710572$$FDA-CTU$$61$YR$$M$N$139.5$KG$20240717$N$PH$US$
241098102$24109810$2$F$$20240823$20240718$20240904$EXP$$CA-AKCEA THERAPEUTICS, INC.-2024IS005976$AKCEA THERAPEUTICS$$$$$$Y$$$20240830$$CN$CA$CA
241098111$24109811$1$I$20220101$20240712$20240718$20240718$EXP$$US-AMGEN-USASP2024138980$AMGEN$Shaheen Z.R.; Wiersma R.; Correll C.K. et al.. Case Report- Contiguous presentation of anti-MA5 juvenile dermatomyositis and anti-AQP4 neuromyelitis optica spectrum disorder in an adolescent patient. Frontiers in Pediatrics. 2024;12:1-7$17$YR$T$M$Y$$$20240718$$HP$US$US
241098121$24109812$1$I$$20240711$20240718$20240718$EXP$$US-MYLANLABS-2024M1066583$MYLAN$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.$$$A$$Y$$$20240718$$PH$US$US
241098132$24109813$2$F$$20240716$20240718$20240719$EXP$$US-Stemline Therapeutics, Inc.-2024ST004249$STEMLINE THERAPEUTICS$$49$YR$A$F$Y$$$20240718$$CN$US$US
241098141$24109814$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49594$$FDA-CTU$$72$YR$$F$N$92.08$KG$20240717$N$$US$
241098172$24109817$2$F$20240620$20240805$20240718$20240815$EXP$PT-INFARMED-T202406-716$PT-ROCHE-10000030017$ROCHE$$77$YR$E$F$Y$60$KG$20240815$$PH$PT$PT
241098192$24109819$2$F$$20240731$20240718$20240801$EXP$$CA-SANDOZ INC.-NVSC2021CA040029$SANDOZ$$59$YR$$M$Y$$$20240801$$PH$CA$CA
241098201$24109820$1$I$20240711$20240711$20240718$20240718$EXP$$US-Stemline Therapeutics, Inc.-2024ST004271$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240716$$CN$US$US
241098211$24109821$1$I$20200101$20240216$20240718$20240718$EXP$FR-AFSSAPS-SE2024000037$FR-TEVA-VS-3161450$TEVA$$62$YR$$F$Y$$$20240718$$MD$FR$FR
241098223$24109822$3$F$20240210$20240807$20240718$20240812$EXP$$NVSC2024DE055071$NOVARTIS$$$$E$F$Y$$$20240812$$HP$DE$DE
241098231$24109823$1$I$$20240711$20240718$20240718$EXP$$US-Stemline Therapeutics, Inc.-2024ST004259$STEMLINE THERAPEUTICS$$78$YR$E$M$Y$$$20240717$$CN$US$US
241098241$24109824$1$I$$20240710$20240718$20240718$EXP$$CH-SERVIER-S24009064$SERVIER$$$$$$Y$$$20240718$$MD$CH$CH
241098251$24109825$1$I$$20240708$20240718$20240718$EXP$$RU-EMD Serono-2024037228$EMD SERONO INC$Makova TN. Terminal stage of chronic kidney disease in the practice of an endocrinologist. Effektivnaya farmakoterapiya. 2024;50-54.$5$DEC$A$F$Y$$$20240718$$MD$RU$RU
241098261$24109826$1$I$$20240710$20240718$20240718$PER$$US-ROCHE-10000023089$ROCHE$$$$$$Y$$$20240718$$PH$US$US
241098271$24109827$1$I$$20240703$20240718$20240718$EXP$$US-GRANULES-US-2024GRALIT00266$GRANULES INDIA$K A Williamson.Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease.Rheumatology.MAY-2024;63:1291-1296$35$YR$A$M$Y$$$20240718$$HP$US$US
241098281$24109828$1$I$$20240710$20240718$20240718$EXP$$US-Stemline Therapeutics, Inc.-2024ST003799$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240716$$CN$US$US
241098292$24109829$2$F$20240501$20240610$20240718$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003078$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240718$$CN$US$US
241098301$24109830$1$I$20230101$20240715$20240718$20240718$EXP$DK-DKMA-30734572$DK-UCBSA-2024035782$UCB$$$$$$Y$$$20240718$$MD$DK$DK
241098311$24109831$1$I$20240715$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113984$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$87.5$KG$20240718$$CN$US$US
241098321$24109832$1$I$20240506$20240711$20240718$20240718$PER$FR-FINLAND-2024ST004031$FR-Stemline Therapeutics, Inc.-2024ST004031$STEMLINE THERAPEUTICS$$$$$F$Y$52$KG$20240717$$PH$FR$FR
241098331$24109833$1$I$20240711$20240712$20240718$20240718$EXP$$US-JNJFOC-20240740623$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240718$$HP$US$US
241098343$24109834$3$F$20240101$20240719$20240718$20240801$30DAY$$CO-JNJFOC-20240719299$JOHNSON AND JOHNSON$$55$YR$A$F$Y$60$KG$20240801$$HP$CO$CO
241098353$24109835$3$F$20240801$20240914$20240718$20240923$EXP$$US-Rhythm Pharmaceuticals, Inc.-2024RHM000301$RHYTHM PHARMACEUTICALS$$8$YR$C$M$Y$$$20240923$$CN$US$US
241098361$24109836$1$I$$20240717$20240717$20240717$DIR$710562$$FDA-CTU$$61$YR$$M$N$$$20240717$N$PH$US$
241098371$24109837$1$I$20240701$20240717$20240717$20240717$DIR$710544$$FDA-CTU$$35$YR$$F$N$50.4$KG$20240717$N$CN$US$
241098381$24109838$1$I$20231003$20240710$20240718$20240718$EXP$$IN-ROCHE-10000028825$ROCHE$$57$YR$A$M$Y$55$KG$20240718$$CN$IN$IN
241098391$24109839$1$I$$20240710$20240718$20240718$EXP$$FR-AMGEN-FRASP2024137451$AMGEN$Celant A.; Vinson M.; Daude S. et al.. Sherlo^Crohn. Letter from the Hepato-Gastroenterologist. 2024;XXVII (3):158-161$67$YR$E$M$Y$$$20240718$$HP$FR$FR
241098401$24109840$1$I$20240617$20240717$20240717$20240717$DIR$710567$$FDA-CTU$$73$YR$$M$N$92.4$KG$20240717$N$HP$US$
241098411$24109841$1$I$20240715$20240717$20240717$20240717$DIR$710571$$FDA-CTU$$76$YR$$F$N$103$KG$20240717$N$PH$US$
241098421$24109842$1$I$$20240717$20240717$20240717$DIR$710538$$FDA-CTU$$$$$UNK$N$$$20240717$N$CN$US$
241098431$24109843$1$I$$20240710$20240718$20240718$EXP$$US-Stemline Therapeutics, Inc.-2024ST004237$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240716$$HP$US$US
241098441$24109844$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49557$$FDA-CTU$$43$YR$$F$N$$$20240717$N$$US$
241098451$24109845$1$I$$20240710$20240718$20240718$EXP$$US-Stemline Therapeutics, Inc.-2024ST004229$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240716$$CN$US$US
241098462$24109846$2$F$20240710$20240809$20240718$20240815$EXP$$US-009507513-2407USA010052$MERCK$$45$YR$$M$Y$$$20240815$$HP$US$US
241098471$24109847$1$I$20240520$20240717$20240717$20240717$DIR$710569$$FDA-CTU$$76$YR$$F$N$63$KG$20240717$N$CN$US$
241098491$24109849$1$I$$20240717$20240718$20240718$EXP$$US-TAKEDA-US201937108$TAKEDA$$$$$F$Y$$$20240718$$HP$US$US
241098502$24109850$2$F$$20240730$20240718$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004128$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240802$$CN$US$US
241098511$24109851$1$I$$20240715$20240718$20240718$EXP$$CA-TAKEDA-2022TUS002074$TAKEDA$$$$$M$Y$$$20240718$$CN$CA$CA
241098521$24109852$1$I$$20240712$20240718$20240718$EXP$$US-AMGEN-USASP2024138828$AMGEN$Chase D. M.; Ladeluca L.; Lim J. et al.. Prescribers and patients drive maintenance therapy patterns in a community oncology practice: National guidelines versus the real-world experience. Gynecologic Oncology Reports. 2024;54:1-9$$$$$Y$$$20240718$$HP$US$US
241098531$24109853$1$I$20240101$20240712$20240718$20240718$EXP$$US-SA-2024SA208105$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240718$$CN$US$US
241098541$24109854$1$I$$20240708$20240718$20240718$EXP$$LK-INSUD PHARMA-2407LK05558$INSUD PHARMA$Abeyagunawardena I, Madurapperuma C, Poobalasingham T, Thowfeek Z, Sujeewa N, Katulanda G, Karunatilake H. Uncommon triggers of insulin autoimmune syndrome:  a case report. Journal of Medical Case Reports. 2024;18:292:1-4$$$$$Y$$$20240718$$HP$LK$LK
241098551$24109855$1$I$20240401$20240704$20240718$20240718$EXP$$PT-AMGEN-PRTSP2024134304$AMGEN$$48$YR$A$F$Y$$$20240718$$MD$PT$PT
241098562$24109856$2$F$20181008$20240718$20240718$20240727$EXP$$GB-TEVA-VS-3220232$TEVA$$74$YR$$M$Y$$$20240727$$MD$GB$GB
241098571$24109857$1$I$$20240709$20240718$20240718$PER$$US-ABBVIE-5840973$ABBVIE$$$$$$Y$$$20240718$$CN$US$US
241098591$24109859$1$I$$20240712$20240718$20240718$EXP$$US-LUNDBECK-DKLU4001733$LUNDBECK$$$$$$Y$$$20240718$$HP$US$US
241098601$24109860$1$I$$20240708$20240718$20240718$PER$$US-MYLANLABS-2024M1065504$MYLAN$$42$YR$$$Y$$$20240718$$CN$US$US
241098612$24109861$2$F$20240405$20240711$20240718$20240726$EXP$$CN-TAKEDA-2024TUS072234$TAKEDA$$52$YR$$M$Y$$$20240726$$HP$CN$CN
241098621$24109862$1$I$$20240715$20240718$20240718$EXP$$CA-TAKEDA-2024TUS072120$TAKEDA$$$$$F$Y$$$20240718$$MD$CA$CA
241098631$24109863$1$I$$20240711$20240718$20240718$EXP$$US-SA-2024SA207015$SANOFI AVENTIS$$$$$F$Y$$$20240718$$CN$US$US
241098642$24109864$2$F$$20240904$20240718$20240909$EXP$$JP-BEH-2024175479$CSL BEHRING$$4$YR$C$M$Y$$$20240909$$MD$JP$JP
241098651$24109865$1$I$20240715$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010430$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240718$$CN$US$US
241098661$24109866$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010361$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241098671$24109867$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011390$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240718$$CN$US$US
241098681$24109868$1$I$20240716$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010806$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240718$$CN$US$US
241098691$24109869$1$I$20240712$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011251$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240718$$CN$US$US
241098701$24109870$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011152$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241098711$24109871$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011352$ELI LILLY AND CO$$$$$$Y$$$20240718$$CN$US$US
241098721$24109872$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010501$ELI LILLY AND CO$$57$YR$A$$Y$$$20240718$$CN$US$US
241098731$24109873$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010362$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240718$$CN$US$US
241098741$24109874$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011153$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240718$$CN$US$US
241098751$24109875$1$I$$20240711$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010254$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240718$$CN$US$US
241098761$24109876$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009904$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240718$$CN$US$US
241098771$24109877$1$I$20240517$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009683$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240718$$CN$US$US
241098781$24109878$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010151$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241098791$24109879$1$I$20200916$20201119$20240718$20240718$EXP$$CO-AstraZeneca-2020SF54939$ASTRAZENECA$$24275$DY$$F$Y$$$20240718$$CN$CO$
241098801$24109880$1$I$$20211117$20240718$20240718$EXP$$US-AstraZeneca-2021A811696$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241098811$24109881$1$I$$20210511$20240718$20240718$EXP$$US-AstraZeneca-2021A435276$ASTRAZENECA$$$$$F$Y$$$20240718$$HP$US$
241098821$24109882$1$I$20240710$20240712$20240718$20240718$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001413$BLUEPRINT MEDICINES$$73$YR$E$M$Y$$$20240718$$CN$US$US
241098831$24109883$1$I$$20200820$20240718$20240718$EXP$$ZA-AstraZeneca-2020SF06484$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$ZA$
241098841$24109884$1$I$$20240712$20240718$20240718$EXP$$LB-BRISTOL-MYERS SQUIBB COMPANY-2024-111537$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240718$$MD$LB$LB
241098851$24109885$1$I$20190401$20190725$20240718$20240718$EXP$$RU-TOPROL-2019000794$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$RU$RU
241098871$24109887$1$I$$20240715$20240718$20240718$EXP$GB-GILEAD-2024-0679788$GB-SA-2024SA208422$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240718$$HP$GB$GB
241098891$24109889$1$I$$20240717$20240717$20240717$DIR$710578$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241098921$24109892$1$I$$20240717$20240717$20240717$DIR$710620$$FDA-CTU$$64$YR$$F$N$78.3$KG$20240717$N$$US$
241098931$24109893$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49605$$FDA-CTU$$$$$M$N$$$20240716$N$HP$US$
241098941$24109894$1$I$20240703$20240715$20240717$20240717$DIR$FDA-CDER-CTU-2024-49581$$FDA-CTU$$53$YR$$F$N$$$20240715$N$HP$US$
241098951$24109895$1$I$20240701$20240717$20240717$20240717$DIR$710565$$FDA-CTU$$70$YR$$F$N$82.35$KG$20240717$N$CN$US$
241098961$24109896$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49569$$FDA-CTU$$$$$M$N$$$20240716$N$HP$US$
241098971$24109897$1$I$20231102$20240717$20240717$20240717$DIR$710543$$FDA-CTU$$23$YR$$F$N$53.1$KG$20240717$N$CN$VI$
241098981$24109898$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49614$$FDA-CTU$$$$$M$N$$$20240717$N$HP$US$
241099001$24109900$1$I$$20240716$20240718$20240718$PER$$US-009507513-2407USA010214$MERCK$Valasapalli S, Aslam H, Younes AI, Muzaffar M. Delayed Pembrolizumab-Associated Sarcoidosis. American journal of therapeutics. 2024;31 (4):e465-8$71$YR$$F$Y$$$20240718$$MD$US$US
241099011$24109901$1$I$$20240703$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06311$LUPIN$$$$$$Y$$$20240718$$MD$US$US
241099023$24109902$3$F$$20240723$20240718$20240726$EXP$$ES-SA-2024SA210161$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240726$$PH$ES$ES
241099031$24109903$1$I$20240712$20240712$20240718$20240718$PER$$US-ABBVIE-5841328$ABBVIE$$65$YR$$F$Y$$$20240718$$CN$US$US
241099041$24109904$1$I$20240215$20240715$20240718$20240718$EXP$$US-EXELIXIS-CABO-24079451$EXELIXIS$$58$YR$$M$Y$$$20240718$$HP$US$US
241099052$24109905$2$F$20240625$20240729$20240718$20240801$PER$$US-FreseniusKabi-FK202410519$FRESENIUS KABI$$34$YR$A$M$Y$158$KG$20240801$$PH$US$US
241099061$24109906$1$I$20240717$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49615$$FDA-CTU$$60$YR$$F$N$$$20240717$Y$PH$US$
241099071$24109907$1$I$20240501$20240713$20240718$20240718$EXP$$CA-LUNDBECK-DKLU4001816$LUNDBECK$$$$$$Y$$$20240718$$HP$CA$CA
241099081$24109908$1$I$20240426$20240710$20240718$20240718$EXP$IT-MINISAL02-993357$IT-TEVA-VS-3220218$TEVA$$56$YR$$M$Y$$$20240718$$MD$IT$IT
241099091$24109909$1$I$20240114$20240718$20240718$20240718$EXP$SE-SEMPA-2024-002393$SE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040542$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240718$$MD$SE$SE
241099101$24109910$1$I$20240709$20240713$20240718$20240718$EXP$$CN-JNJFOC-20240737481$JOHNSON AND JOHNSON$$85$YR$E$F$Y$40$KG$20240718$$HP$CN$CN
241099111$24109911$1$I$20240717$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49613$$FDA-CTU$$81$YR$$M$N$$$20240717$Y$HP$US$
241099121$24109912$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49582$$FDA-CTU$$56$YR$$M$N$$$20240717$N$$US$
241099132$24109913$2$F$20240601$20240729$20240718$20240801$PER$$US-AMGEN-USASP2024142066$AMGEN$$86$YR$E$M$Y$$$20240801$$CN$US$US
241099141$24109914$1$I$20240703$20240712$20240718$20240718$PER$$US-AMGEN-USASP2024139719$AMGEN$$$$$$Y$$$20240718$$PH$US$US
241099151$24109915$1$I$$20240712$20240718$20240718$EXP$$US-AMGEN-USASP2024139850$AMGEN$$71$YR$E$F$Y$$$20240718$$HP$US$US
241099161$24109916$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49567$$FDA-CTU$$$$$M$N$$$20240717$N$HP$US$
241099171$24109917$1$I$20240701$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49617$$FDA-CTU$$51$YR$$F$N$$$20240717$Y$PH$US$
241099181$24109918$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49563$$FDA-CTU$$58$YR$$F$N$$$20240717$N$$US$
241099191$24109919$1$I$$20240717$20240718$20240718$EXP$$GB-MYLANLABS-2024M1067018$MYLAN$$$$$F$Y$$$20240718$$CN$GB$GB
241099201$24109920$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49625$$FDA-CTU$$74$YR$$F$N$$$20240717$N$$US$
241099211$24109921$1$I$$20240717$20240718$20240718$EXP$GB-MHRA-MED-202407171042467250-HLSVN$GB-MYLANLABS-2024M1066844$MYLAN$$60$YR$$F$Y$$$20240718$$PH$GB$GB
241099221$24109922$1$I$$20240709$20240718$20240718$PER$$US-TAKEDA-2024TUS070483$TAKEDA$$30$YR$$M$Y$59$KG$20240718$$MD$US$US
241099232$24109923$2$F$$20240730$20240718$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113513$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$102.06$KG$20240807$$CN$US$US
241099242$24109924$2$F$$20240801$20240718$20240810$EXP$$US-TEVA-VS-3220114$TEVA$Deanda S, Razia D, Zaidi W, Lee R, Arjuna A. Post-transplant Lymphoproliferative Disorder: A Nodular Area That Kept Growing!. Am-J-Respir-Crit-Care-Med 2024; 209 A5942.; Deanda S, Razia D, Zaidi W, Lee R, Arjuna A. Post-transplant Lymphoproliferative Disorder: A Nodular Area That Kept Growing!. Am-J-Respir-Crit-Care-Med 2024; 209 A5942.$79$YR$$F$Y$$$20240810$$HP$US$US
241099251$24109925$1$I$20240606$20240624$20240718$20240718$EXP$$BR-ROCHE-10000022874$ROCHE$$64$YR$A$M$Y$65$KG$20240718$$MD$BR$BR
241099261$24109926$1$I$$20240712$20240718$20240718$EXP$$FR-GILEAD-2024-0680559$GILEAD$$$$$F$Y$$$20240718$$MD$FR$FR
241099271$24109927$1$I$$20240712$20240718$20240718$PER$$US-AMGEN-USASP2024138791$AMGEN$Andre N.; Donze C.; Revon-riviere G. et al.. Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide. Pediatric Blood + Cancer. 2024;71:1 to 6$12$YR$T$M$Y$$$20240718$$HP$US$US
241099291$24109929$1$I$20231111$20240711$20240718$20240718$EXP$$JP-OTSUKA-2023_030182$OTSUKA$$46$YR$$M$Y$$$20240718$$MD$JP$JP
241099301$24109930$1$I$$20240712$20240718$20240718$EXP$$US-TAKEDA-2024TUS071479$TAKEDA$$$$$M$Y$$$20240718$$CN$US$US
241099311$24109931$1$I$$20240716$20240718$20240718$EXP$$US-PFIZER INC-PV202400093275$PFIZER$Li, X.. Successful Treatment of Rituximab-Induced Crohn^s Disease with Ustekinumab.. ACG Case Reports Journal. 2024;11(7):e01403$51$YR$$M$Y$$$20240718$$MD$US$US
241099322$24109932$2$F$20240621$20240722$20240718$20240724$EXP$$TH-PFIZER INC-2024SGN05773$PFIZER$$51$YR$$F$Y$$$20240724$$CN$TH$TH
241099332$24109933$2$F$$20240717$20240718$20240723$EXP$$IT-PFIZER INC-202400216035$PFIZER$Delbon, P.. Ethical and legal issues in haematopoietic stem cells (HSC) donation: the controversial and problematic aspects in minors. Acta Biomedica. 2024;95(3):10.23750/abm.v95i3.15820$62$YR$$M$Y$$$20240723$$MD$IT$IT
241099342$24109934$2$F$20230310$20240910$20240718$20240912$EXP$$DE-PFIZER INC-PV202300181738$PFIZER$$87$YR$$F$Y$$$20240912$$MD$DE$DE
241099361$24109936$1$I$$20240716$20240718$20240718$EXP$$CN-PFIZER INC-202400216862$PFIZER$Zhang, H.. Three cases of severe pneumonia caused by Trichosporon asahii and literature review. Chinese Journal of Mycology. 2024;19(2):161-165, 172$50$YR$$M$Y$$$20240718$$MD$CN$CN
241099371$24109937$1$I$20220422$20240712$20240718$20240718$EXP$$CN-PFIZER INC-2022SGN07856$PFIZER$$68$YR$$M$Y$76$KG$20240718$$MD$CN$CN
241099381$24109938$1$I$$20240716$20240718$20240718$EXP$$US-PFIZER INC-PV202400093269$PFIZER$Barnett, B.. Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine. JOURNAL OF PSYCHOACTIVE DRUGS. 2024;10.1080/02791072.2024.2368617$42$YR$$M$Y$$$20240718$$HP$US$US
241099392$24109939$2$F$20220101$20240717$20240718$20240723$EXP$$CN-PFIZER INC-202400216591$PFIZER$Fang, Y.. Salvage treatment of ruxolitinib for refractory adenovirus-associated hemophagocytic syndrome post-haploidentical allogeneic stem cell transplantation: a case report.. Translational pediatrics. 2024;13(6):994-1000$11$YR$$M$Y$$$20240723$$MD$CN$CN
241099401$24109940$1$I$$20240716$20240718$20240718$EXP$$CA-PFIZER INC-202400174192$PFIZER$$59$YR$$F$Y$$$20240718$$CN$CA$CA
241099412$24109941$2$F$$20240918$20240718$20240920$EXP$$CA-PFIZER INC-202400042857$PFIZER$$47$YR$$M$Y$$$20240920$$HP$CA$CA
241099421$24109942$1$I$$20240716$20240718$20240718$EXP$$CN-PFIZER INC-202400216861$PFIZER$Zhang, H.. Three cases of severe pneumonia caused by Trichosporon asahii and literature review. Chinese Journal of Mycology. 2024;19(2):161-165, 172$74$YR$$M$Y$$$20240718$$MD$CN$CN
241099431$24109943$1$I$$20240716$20240718$20240718$EXP$$CN-PFIZER INC-PV202400093078$PFIZER$Zhang, H.. Three cases of severe pneumonia caused by Trichosporon asahii and literature review. Chinese Journal of Mycology. 2024;19(2):161-165, 172$60$YR$$M$Y$$$20240718$$MD$CN$CN
241099441$24109944$1$I$20211215$20240715$20240718$20240718$EXP$$PL-PFIZER INC-202200002393$PFIZER$$73$YR$$M$Y$78$KG$20240718$$MD$PL$PL
241099451$24109945$1$I$20240527$20240710$20240718$20240718$EXP$$BR-ROCHE-10000022898$ROCHE$$70$YR$E$M$Y$$$20240718$$MD$BR$BR
241099461$24109946$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113646$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240718$$CN$US$US
241099471$24109947$1$I$$20240708$20240718$20240718$EXP$$HR-FreseniusKabi-FK202110553$FRESENIUS KABI$$63$YR$A$M$Y$$$20240718$$MD$HR$HR
241099481$24109948$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49609$$FDA-CTU$$81$YR$$F$N$$$20240717$N$$US$
241099491$24109949$1$I$20240714$20240717$20240717$20240717$DIR$710671$$FDA-CTU$$43$YR$$F$N$$$20240717$N$CN$US$
241099501$24109950$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49596$$FDA-CTU$$$$$M$N$$$20240716$N$HP$US$
241099511$24109951$1$I$20240701$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49585$$FDA-CTU$$16$YR$$M$N$$$20240717$N$HP$US$
241099521$24109952$1$I$20240715$20240717$20240717$20240717$DIR$710651$$FDA-CTU$$74$YR$$M$N$62.55$KG$20240717$N$CN$US$
241099531$24109953$1$I$20240716$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49561$$FDA-CTU$$60$YR$$M$N$$$20240717$Y$PH$US$
241099541$24109954$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49584$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241099551$24109955$1$I$20240531$20240717$20240717$20240717$DIR$710584$$FDA-CTU$$72$YR$$M$N$91.35$KG$20240717$Y$CN$US$
241099561$24109956$1$I$$20240605$20240717$20240717$DIR$FDA-CDER-CTU-2024-49597$$FDA-CTU$$$$$M$N$$$20240605$N$HP$US$
241099591$24109959$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49564$$FDA-CTU$$$$$M$N$$$20240717$N$HP$US$
241099601$24109960$1$I$20240215$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49577$$FDA-CTU$$62$YR$$F$N$$$20240717$N$PH$US$
241099624$24109962$4$F$20240710$20240814$20240718$20240829$30DAY$$US-JNJFOC-20240739705$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240830$$CN$US$US
241099631$24109963$1$I$$20240708$20240718$20240718$EXP$$HU-JNJFOC-20240725276$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$HU$HU
241099641$24109964$1$I$$20240716$20240718$20240718$EXP$$ES-JNJFOC-20240743893$JOHNSON AND JOHNSON$$89$YR$E$F$Y$38.56$KG$20240718$$CN$ES$ES
241099651$24109965$1$I$$20240710$20240718$20240718$PER$$US-MYLANLABS-2024M1065205$MYLAN$$$$$M$Y$$$20240718$$CN$US$US
241099661$24109966$1$I$$20200916$20240718$20240718$EXP$$US-AstraZeneca-2020SF19882$ASTRAZENECA$$71$YR$$M$Y$$$20240718$$CN$US$
241099671$24109967$1$I$$20220110$20240718$20240718$EXP$$US-AstraZeneca-2021A795392$ASTRAZENECA$$23974$DY$$F$Y$$$20240718$$CN$US$
241099681$24109968$1$I$20240608$20240710$20240718$20240718$EXP$$ES-AstraZeneca-2024A157650$ASTRAZENECA$$84$YR$$M$Y$$$20240718$$MD$ES$
241099691$24109969$1$I$20240625$20240711$20240718$20240718$EXP$$NVSC2024US147413$NOVARTIS$$71$YR$$F$Y$57.3$KG$20240718$$CN$US$US
241099701$24109970$1$I$$20240718$20240718$20240718$EXP$$PL-PFIZER INC-202400218565$PFIZER$$$$$F$Y$$$20240718$$MD$PL$PL
241099712$24109971$2$F$20240408$20240716$20240718$20240724$EXP$$DE-PFIZER INC-202400217153$PFIZER$$$$A$F$Y$106$KG$20240724$$HP$DE$DE
241099721$24109972$1$I$20240408$20240710$20240718$20240718$EXP$$AR-PFIZER INC-202400218138$PFIZER$$31$YR$$F$Y$96$KG$20240718$$MD$AR$AR
241099731$24109973$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141964$AMGEN$$$$$F$Y$$$20240718$$MD$US$US
241099741$24109974$1$I$$20240710$20240718$20240718$EXP$$CA-CELLTRION INC.-2024CA016823$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
241099751$24109975$1$I$$20240626$20240718$20240718$EXP$$DE-ROCHE-10000024415$ROCHE$$79$YR$E$$Y$$$20240718$$MD$DE$DE
241099762$24109976$2$F$$20240726$20240718$20240731$PER$$US-AMGEN-USASP2024141803$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241099771$24109977$1$I$20240101$20240717$20240718$20240718$PER$$US-AMGEN-USASP2024142086$AMGEN$$60$YR$A$F$Y$$$20240718$$HP$US$US
241099781$24109978$1$I$20170101$20240711$20240718$20240718$EXP$$FR-EMD Serono-9088327$EMD SERONO INC$$68$YR$E$F$Y$$$20240718$$CN$FR$FR
241099791$24109979$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011180$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240718$$CN$US$US
241099801$24109980$1$I$20240716$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011221$ELI LILLY AND CO$$42$YR$A$$Y$$$20240718$$CN$US$US
241099811$24109981$1$I$$20240710$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407007099$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240718$$CN$US$US
241099821$24109982$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011238$ELI LILLY AND CO$$$$$$Y$$$20240718$$CN$US$US
241099831$24109983$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011314$ELI LILLY AND CO$$$$$$Y$$$20240718$$CN$US$US
241099841$24109984$1$I$20240301$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010465$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240718$$CN$US$US
241099851$24109985$1$I$$20240712$20240718$20240718$30DAY$$US-GSK-US2024087725$GLAXOSMITHKLINE$$$$$M$Y$$$20240718$$CN$US$US
241099862$24109986$2$F$20240820$20240821$20240718$20240827$30DAY$$CA-JNJFOC-20240717009$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240827$$HP$CA$CA
241099871$24109987$1$I$$20240703$20240718$20240718$EXP$$US-GRANULES-US-2024GRALIT00267$GRANULES INDIA$K A Williamson.Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple^s disease.Rheumatology.MAY-2024;63:1291-1296$68$YR$E$M$Y$$$20240718$$HP$US$US
241099881$24109988$1$I$$20240710$20240718$20240718$EXP$$NVSC2024AT144950$NOVARTIS$$$$$F$Y$$$20240718$$MD$AT$AT
241099894$24109989$4$F$20240710$20240910$20240718$20240919$EXP$$DE-EMD Serono-2024038085$EMD SERONO INC$$41$YR$A$F$Y$$$20240919$$MD$DE$DE
241099902$24109990$2$F$$20240914$20240718$20240924$EXP$$US-BEH-2024175720$CSL BEHRING$$$$A$M$Y$$$20240924$$HP$US$US
241099911$24109991$1$I$$20240712$20240718$20240718$EXP$$US-AMGEN-USASP2024138819$AMGEN$Andre N.; Donze C.; Revon-riviere G. et al.. Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide. Pediatric Blood + Cancer. 2024;71:1 to 6$14$YR$T$M$Y$$$20240718$$HP$US$US
241099921$24109992$1$I$$20240712$20240718$20240718$EXP$$US-AMGEN-USASP2024138831$AMGEN$Andre N.; Donze C.; Revon-riviere G. et al.. Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide. Pediatric Blood + Cancer. 2024;71:1 to 6$18$YR$A$M$Y$$$20240718$$HP$US$US
241099932$24109993$2$F$20240702$20240805$20240718$20240808$EXP$FR-AFSSAPS-MA2024001198$FR-PFIZER INC-202400215862$PFIZER$$82$YR$$M$Y$$$20240808$$HP$FR$FR
241099941$24109994$1$I$$20240716$20240718$20240718$EXP$$TW-PFIZER INC-PV202400092863$PFIZER$$72$YR$$F$Y$$$20240718$$HP$TW$TW
241099951$24109995$1$I$20240712$20240716$20240718$20240718$EXP$$TW-PFIZER INC-PV202400093058$PFIZER$$77$YR$$F$Y$$$20240718$$HP$TW$TW
241099961$24109996$1$I$20240501$20240716$20240718$20240718$EXP$IE-HPRA-2024-114186$IE-PFIZER INC-202400215947$PFIZER$$51$YR$$F$Y$$$20240718$$PH$IE$IE
241099971$24109997$1$I$20240618$20240716$20240718$20240718$EXP$FR-AFSSAPS-LY2024001045$FR-PFIZER INC-202400215922$PFIZER$$83$YR$$F$Y$51$KG$20240718$$PH$FR$FR
241100001$24110000$1$I$20240627$20240716$20240718$20240718$EXP$$CN-PFIZER INC-PV202400093360$PFIZER$$8$YR$$M$Y$24.1$KG$20240718$$HP$CN$CN
241100011$24110001$1$I$20240628$20240712$20240718$20240718$EXP$$BR-PFIZER INC-202400213441$PFIZER$$64$YR$$M$Y$68.2$KG$20240718$$PH$BR$BR
241100021$24110002$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49573$$FDA-CTU$$$$$M$N$$$20240717$N$HP$US$
241100031$24110003$1$I$20240601$20240715$20240718$20240718$EXP$$US-PFIZER INC-PV202400081269$PFIZER$$62$YR$$F$Y$$$20240718$$HP$US$US
241100041$24110004$1$I$$20240622$20240718$20240718$30DAY$$US-VEROBIOTECH-2024USVEROSPO00145$VERO BIOTECH$$$$$F$Y$$$20240718$$HP$US$US
241100051$24110005$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49570$$FDA-CTU$$$$$F$N$$$20240716$N$HP$US$
241100061$24110006$1$I$$20240712$20240718$20240718$EXP$$US-FreseniusKabi-FK202411215$FRESENIUS KABI$Chen F, Boominathan P. Aortoesophageal Fistula Following a Cervical Epidural Steroid Injection: Case Report. Pain Medicine Case Reports. 2023;7(8): 345-347. doi:https://www.painmedicine-casereports.com/current/pdf?article=Njk2+journal=49.$$$$M$Y$$$20240718$$MD$US$US
241100071$24110007$1$I$20240624$20240624$20240718$20240718$30DAY$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00326$XERIS PHARMACEUTICALS$$64$YR$$F$Y$68.039$KG$20240718$$CN$US$US
241100081$24110008$1$I$$20240703$20240718$20240718$EXP$$CN-GRANULES-CN-2024GRALIT00264$GRANULES INDIA$Jianbo Lai.Clinical characteristics and outcomes of patients with mental illnesses who attempted suicide by drug overdose: A retrospective analysis of 109 cases.Brain and Behavior.27-APR-2023;13:1-6$82$YR$E$F$Y$$$20240718$$HP$CN$CN
241100091$24110009$1$I$$20240712$20240718$20240718$EXP$$US-TAKEDA-2024TUS056995$TAKEDA$$$$$M$Y$$$20240718$$CN$US$US
241100101$24110010$1$I$$20240710$20240718$20240718$PER$$US-ALXN-202407USA000933US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
241100111$24110011$1$I$20240418$20240711$20240718$20240718$EXP$$GR-FreseniusKabi-FK202407477$FRESENIUS KABI$$68$YR$E$M$Y$74.3$KG$20240718$$MD$GR$GR
241100121$24110012$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49607$$FDA-CTU$$$$$M$N$$$20240717$N$HP$US$
241100131$24110013$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49593$$FDA-CTU$$$$$M$N$$$20240716$N$HP$US$
241100141$24110014$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49568$$FDA-CTU$$$$$F$N$$$20240716$N$HP$US$
241100151$24110015$1$I$20240626$20240702$20240717$20240717$DIR$FDA-CDER-CTU-2024-49628$$FDA-CTU$$64$YR$$M$N$116.5$KG$20240702$N$$US$
241100161$24110016$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49606$$FDA-CTU$$82$YR$$M$N$$$20240717$N$$US$
241100171$24110017$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49575$$FDA-CTU$$81$YR$$F$N$65.77$KG$20240717$N$$US$
241100181$24110018$1$I$20240617$20240717$20240717$20240717$DIR$710574$$FDA-CTU$$59$YR$$F$N$69.3$KG$20240717$N$CN$US$
241100201$24110020$1$I$20240626$20240715$20240718$20240718$EXP$$ES-AUROBINDO-AUR-APL-2024-035295$AUROBINDO$$83$YR$$M$Y$$$20240718$$PH$ES$ES
241100212$24110021$2$F$20170101$20240813$20240718$20240819$EXP$$NVSC2022MX104550$NOVARTIS$$$$$F$Y$56$KG$20240819$$CN$MX$MX
241100221$24110022$1$I$20230601$20240717$20240718$20240718$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040469$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$MD$JP$JP
241100231$24110023$1$I$20240531$20240712$20240718$20240718$EXP$FR-AFSSAPS-BS2024000419$FR-MYLANLABS-2024M1065704$MYLAN$$42$YR$$F$Y$60$KG$20240718$$MD$FR$FR
241100241$24110024$1$I$$20240710$20240718$20240718$EXP$$CA-CELLTRION INC.-2024CA016844$CELLTRION$$$$$$Y$$$20240718$$MD$CA$CA
241100251$24110025$1$I$$20200814$20240718$20240718$EXP$$US-AstraZeneca-2020SF04471$ASTRAZENECA$$89$YR$$F$Y$$$20240718$$CN$US$
241100261$24110026$1$I$$20240715$20240718$20240718$EXP$$CA-AstraZeneca-2024A162289$ASTRAZENECA$$$$$F$Y$$$20240718$$MD$CA$
241100271$24110027$1$I$$20240710$20240718$20240718$EXP$$VN-AstraZeneca-2024A160250$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$VN$
241100291$24110029$1$I$20240601$20240709$20240718$20240718$EXP$$US-INSMED, INC.-2024-02598-US$INSMED$$78$YR$$F$Y$$$20240718$$CN$US$US
241100302$24110030$2$F$$20240716$20240718$20240723$EXP$$PL-MYLANLABS-2024M1065915$MYLAN$Chrzastek A. ^Strange^ wounds in a patient with morbid obesity.. MEDYCYNA PALIATYWNA. 2024;16(2):129 -130$71$YR$$M$Y$200$KG$20240723$$MD$PL$PL
241100312$24110031$2$F$20240201$20240723$20240718$20240729$EXP$$RO-MYLANLABS-2024M1065448$MYLAN$Vazar-Tripon DA, Muntean MM, Filimon RA, Jimbu IL.. A rare case of acute myeloid leukemia with central nervous system involvement.. Acta Medica Marisiensis. 2024;70(Suppl.3):216-217$73$YR$$F$Y$$$20240729$$HP$RO$RO
241100321$24110032$1$I$20240706$20240716$20240718$20240718$EXP$$US-INCYTE CORPORATION-2024IN007478$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241100332$24110033$2$F$20231219$20240917$20240718$20240921$EXP$AT-STADA-01262402$AT-ROCHE-10000030127$ROCHE$$60$YR$A$F$Y$80$KG$20240921$$HP$AT$AT
241100341$24110034$1$I$20240602$20240712$20240718$20240718$EXP$$IT-Blueprint Medicines Corporation-SP-IT-2024-001428$BLUEPRINT MEDICINES$$71$YR$E$F$Y$$$20240718$$CN$IT$IT
241100351$24110035$1$I$20240712$20240712$20240718$20240718$EXP$$US-VANTIVE-2024VAN018323$Vantive US Healthcare$$$$$F$Y$$$20240718$$CN$US$US
241100362$24110036$2$F$$20240822$20240718$20240829$EXP$$US-EMD Serono-2024038255$EMD SERONO INC$$$$A$M$Y$$$20240829$$CN$US$US
241100371$24110037$1$I$$20240716$20240718$20240718$EXP$NL-LRB-00981114$NL-ORGANON-O2407NLD001418$ORGANON$$75$YR$$F$Y$63$KG$20240718$$CN$NL$NL
241100381$24110038$1$I$$20240715$20240718$20240718$EXP$$CA-BAUSCH-BL-2024-010821$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240718$$CN$CA$CA
241100391$24110039$1$I$$20240708$20240718$20240718$EXP$$NVSC2024CN144617$NOVARTIS$Wu X, Yan T, Han C, Ma L, Zeng L, Chen X et al.. Rapid and sustained response of acute generalized pustular psoriasis of von Zumbusch to Secukinumab. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023;37(3):e338-41$70$YR$$M$Y$$$20240718$$HP$CN$CN
241100402$24110040$2$F$$20240719$20240718$20240725$EXP$$FR-BAUSCH-BL-2024-010890$BAUSCH AND LOMB$Obada E, Level G, Mathieu P, Parent X, Gilson B, Bindi P. Insuffisance renale aigue lors d^un traitement par aciclovir. Nephrologie and Therapeutique. 2010;6(2):125-127. doi:10.1016/j.nephro.2009.12.001$30$YR$$F$Y$$$20240725$$HP$FR$FR
241100411$24110041$1$I$$20240715$20240718$20240718$EXP$$CA-BAUSCH-BL-2024-010865$BAUSCH AND LOMB$$55$YR$$F$Y$$$20240718$$CN$CA$CA
241100421$24110042$1$I$20240712$20240712$20240718$20240718$EXP$$FR-ORGANON-O2407FRA001521$ORGANON$$$$$F$Y$$$20240718$$MD$FR$FR
241100431$24110043$1$I$$20240715$20240718$20240718$30DAY$$US-GSK-US2024088770$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241100443$24110044$3$F$$20240711$20240718$20240828$PER$$US-MYLANLABS-2024M1065685$MYLAN$$$$$$Y$$$20240828$$PH$US$US
241100461$24110046$1$I$$20240715$20240718$20240718$EXP$$CA-MYLANLABS-2024M1066471$MYLAN$$$$$M$Y$$$20240718$$HP$CA$CA
241100471$24110047$1$I$$20240708$20240718$20240718$EXP$$US-MYLANLABS-2024M1065038$MYLAN$Gondek S, Ogledzinski M, Lin W, Milejczyk K, Juengel B, Potter L, et al. Persistence of long-term insulin independence after islet transplantation and two subsequent pregnancies. Eur-J-Transl-Clin-Med 2023; 6 (1): 9-13.$34$YR$$F$Y$66$KG$20240718$$HP$US$US
241100501$24110050$1$I$20240101$20240708$20240718$20240718$PER$$US-Eisai-EC-2024-169801$EISAI$$71$YR$E$F$Y$$$20240718$$HP$US$US
241100511$24110051$1$I$$20240710$20240718$20240718$EXP$$US-MYLANLABS-2024M1066143$MYLAN$Lee R, Gonsalves Z, Wang S, Hussain A, Herrera K. Case study: Autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks^ gestation. Case-Rep-Perinat-Med 2024; 13 (1).$1$DY$$$Y$$$20240718$$MD$US$US
241100521$24110052$1$I$$20240704$20240718$20240718$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06142$LUPIN$Fink NS, Abubshait L, Deshisky A. Anti-HMGCR (Hydroxy-3-Methylglutaryl-CoA Reductase) myopathy: A rare cause of proximal muscle weakness. Cureus. 2024;16(5):1-6$65$YR$$F$Y$$$20240718$$MD$US$US
241100531$24110053$1$I$20240704$20240710$20240718$20240718$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009962$JAZZ$$4$YR$$F$Y$$$20240718$$CN$US$US
241100541$24110054$1$I$$20240710$20240718$20240718$EXP$$CA-CELLTRION INC.-2024CA016847$CELLTRION$$$$$$Y$$$20240718$$CN$CA$CA
241100551$24110055$1$I$$20240705$20240718$20240718$EXP$$US-UCBSA-2024035094$UCB$$$$$M$Y$$$20240718$$HP$US$US
241100561$24110056$1$I$$20240713$20240718$20240718$EXP$$CN-JNJFOC-20240737886$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$CN$CN
241100572$24110057$2$F$$20240927$20240718$20240927$PER$$NVSC2024US147676$NOVARTIS$$$$$F$Y$$$20240927$$MD$US$US
241100581$24110058$1$I$$20240711$20240718$20240718$PER$$US-ABBVIE-5838861$ABBVIE$$$$$M$Y$3.629$KG$20240718$$CN$US$US
241100592$24110059$2$F$$20240730$20240718$20240807$PER$$US-IDORSIA-008247-2024-US$IDORSIA PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241100601$24110060$1$I$$20240709$20240718$20240718$EXP$$US-MYLANLABS-2024M1065765$MYLAN$Raza HS, Love JS, Mikolajczyk AE. Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding. ACG-Case-Rep-J 2024; 11 (6):.$38$YR$$M$Y$$$20240718$$MD$US$US
241100611$24110061$1$I$20240501$20240712$20240718$20240718$EXP$$US-ROCHE-3510689$ROCHE$$71$YR$E$M$Y$70.31$KG$20240718$$CN$US$US
241100622$24110062$2$F$$20240803$20240718$20240812$EXP$$RO-OTSUKA-2024_019576$OTSUKA$Iordan I, Vladareanu AM, Mambet C, Dumitru I, Onisai M, Cisleanu D et al.. Atypical Presentation for Adult T-Cell Leukemia/Lymphoma: a Case Report and Short Review of the Literature.. MAEDICA a Journal of Clinical Medicine. 2024;19(2):420-25$32$YR$$M$Y$$$20240812$$MD$RO$RO
241100632$24110063$2$F$20240621$20240821$20240718$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021564$UNITED THERAPEUTICS$$62$YR$$F$Y$53.061$KG$20240828$$$US$US
241100641$24110064$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49580$$FDA-CTU$$59$YR$$F$N$$$20240717$N$$US$
241100651$24110065$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010698$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240718$$CN$US$US
241100662$24110066$2$F$$20240730$20240718$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110881$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240807$$CN$US$US
241100672$24110067$2$F$20231001$20240805$20240718$20240808$EXP$$US-UCBSA-2024035804$UCB$$65$YR$$M$Y$200$KG$20240808$$CN$US$US
241100681$24110068$1$I$$20240705$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06969$LUPIN$$$$$F$Y$$$20240718$$CN$US$US
241100691$24110069$1$I$$20240715$20240718$20240718$EXP$$CA-EMD Serono-2024038548$EMD SERONO INC$$63$YR$A$M$Y$$$20240718$$PH$CA$CA
241100701$24110070$1$I$$20240711$20240718$20240718$EXP$$CA-OTSUKA-2024_019734$OTSUKA$$$$$F$Y$$$20240718$$CN$CA$CA
241100712$24110071$2$F$20230101$20240722$20240718$20240729$PER$$US-BIOGEN-2024BI01273511$BIOGEN$$$$$F$Y$$$20240729$$CN$US$US
241100721$24110072$1$I$$20240712$20240718$20240718$EXP$$CA-TAKEDA-2024TUS060800$TAKEDA$$$$$M$Y$$$20240718$$CN$CA$CA
241100731$24110073$1$I$$20240715$20240718$20240718$EXP$$DE-PFIZER INC-202400214825$PFIZER$$$$A$F$Y$65$KG$20240718$$MD$DE$DE
241100741$24110074$1$I$$20240716$20240718$20240718$EXP$$IT-PFIZER INC-0005498402PHAMED$PFIZER$Bettinell, A.. SEIZURES AND TRANSIENT BLINDNESS FOLLOWING INTRAVENOUS PULSE METHYLPREDNISOLONE IN CHILDREN WITH PRIMARY GLOMERULONEPHRITIS. CHILD NEPHROL UROL. 1991;11(1):41-43$7$YR$$M$Y$$$20240718$$MD$IT$IT
241100754$24110075$4$F$20240705$20240808$20240718$20240819$30DAY$$US-JNJFOC-20240716236$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$US$US
241100761$24110076$1$I$20240101$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140093$AMGEN$$70$YR$E$M$Y$$$20240718$$CN$US$US
241100771$24110077$1$I$$20240711$20240718$20240718$PER$$US-AMGEN-USASP2024138376$AMGEN$$$$$$Y$$$20240718$$HP$US$US
241100781$24110078$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158241$ASTRAZENECA$$$$$M$Y$108.1$KG$20240718$$CN$US$
241100791$24110079$1$I$$20240715$20240718$20240718$EXP$$US-AstraZeneca-2024A161510$ASTRAZENECA$$$$$M$Y$$$20240718$$MD$US$
241100801$24110080$1$I$$20200605$20240718$20240718$EXP$$US-AstraZeneca-2020SE74602$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241100811$24110081$1$I$$20240710$20240718$20240718$EXP$$CA-AstraZeneca-2024A159872$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$CA$
241100821$24110082$1$I$20240613$20240711$20240718$20240718$EXP$$GB-MYLANLABS-2024M1065317$MYLAN$$$$$M$Y$$$20240718$$CN$GB$GB
241100831$24110083$1$I$$20240715$20240718$20240718$EXP$$CA-TAKEDA-2022TUS035217$TAKEDA$$$$$F$Y$$$20240718$$CN$CA$CA
241100842$24110084$2$F$20240705$20240829$20240718$20240902$PER$$US-ROCHE-10000026570$ROCHE$$17$YR$T$M$Y$$$20240902$$CN$US$US
241100851$24110085$1$I$$20240710$20240718$20240718$PER$$GB-Eisai-EC-2024-169974$EISAI$Allsopp RC, Guo Q, Page K, Bhagani S, Kasim A, Badman P, et al. Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study. Breast Cancer Research and Treatment. 2024 Apr 06;(206): 377-385. doi:10.1007/s10549-024-07316-8.$$$$F$Y$$$20240718$$MD$GB$GB
241100861$24110086$1$I$20240521$20240715$20240718$20240718$EXP$FR-AFSSAPS-DJ2024000824$FR-FreseniusKabi-FK202411168$FRESENIUS KABI$$$$N$M$Y$$$20240718$$HP$FR$FR
241100871$24110087$1$I$20240705$20240715$20240718$20240718$EXP$IT-MINISAL02-994398$IT-FreseniusKabi-FK202411105$FRESENIUS KABI$$55$YR$A$F$Y$$$20240718$$MD$IT$IT
241100882$24110088$2$F$20240710$20240718$20240718$20240725$PER$$US-HALEON-2187787$Haleon PLC$$22$YR$$F$Y$$$20240719$$CN$US$US
241100891$24110089$1$I$20240714$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140297$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
241100901$24110090$1$I$20240627$20240715$20240718$20240718$EXP$FR-AFSSAPS-BX2024001422$FR-FreseniusKabi-FK202411201$FRESENIUS KABI$$20$YR$A$F$Y$$$20240718$$MD$FR$FR
241100911$24110091$1$I$20240127$20240715$20240718$20240718$EXP$FR-AFSSAPS-ST2024001138$FR-FreseniusKabi-FK202411162$FRESENIUS KABI$$56$YR$A$M$Y$77.2$KG$20240718$$HP$FR$FR
241100921$24110092$1$I$20240501$20240711$20240718$20240718$PER$$US-BAYER-2024A100643$BAYER$$26$YR$A$F$Y$$$20240718$$CN$US$US
241100931$24110093$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49600$$FDA-CTU$$33$YR$$F$N$$$20240717$N$$US$
241100941$24110094$1$I$20240620$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49618$$FDA-CTU$$22$MON$$M$N$$$20240716$N$HP$US$
241100953$24110095$3$F$20230105$20240730$20240718$20240807$EXP$$CA-TAKEDA-2022TUS095872$TAKEDA$$80$YR$$F$Y$$$20240807$$HP$CA$CA
241100961$24110096$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49599$$FDA-CTU$$69$YR$$F$N$$$20240717$N$HP$US$
241100971$24110097$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49611$$FDA-CTU$$85$YR$$M$N$$$20240717$N$$US$
241100981$24110098$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49621$$FDA-CTU$$77$YR$$F$N$$$20240717$N$$US$
241100991$24110099$1$I$$20240716$20240717$20240717$DIR$FDA-CDER-CTU-2024-49619$$FDA-CTU$$$$$F$N$$$20240716$N$HP$US$
241101001$24110100$1$I$20240715$20240717$20240717$20240717$DIR$710610$$FDA-CTU$$80$YR$$F$N$59.4$KG$20240717$N$$US$
241101011$24110101$1$I$20240717$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49723$$FDA-CTU$$8$MON$$M$N$$$20240717$N$HP$US$
241101021$24110102$1$I$20240717$20240717$20240717$20240717$DIR$710643$$FDA-CTU$$85$YR$$F$N$$$20240717$N$$US$
241101041$24110104$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49717$$FDA-CTU$$85$YR$$F$N$$$20240718$N$$US$
241101051$24110105$1$I$20221101$20240715$20240718$20240718$EXP$$NVSC2024US146062$NOVARTIS$$47$YR$$M$Y$$$20240718$$CN$US$US
241101061$24110106$1$I$20240609$20240609$20240718$20240718$EXP$$US-ASCENDIS PHARMA-2024US005671$ASCENDIS PHARMA$$$$$$Y$$$20240718$$MD$US$US
241101071$24110107$1$I$$20240710$20240718$20240718$EXP$$CA-CELLTRION INC.-2024CA016898$CELLTRION$$$$$$Y$$$20240718$$MD$CA$CA
241101081$24110108$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-10000029154$ROCHE$$$$A$M$Y$$$20240718$$CN$US$US
241101121$24110112$1$I$20230101$20240708$20240718$20240718$EXP$$US-TEVA-VS-3220278$TEVA$$20$YR$$F$Y$$$20240718$$HP$US$US
241101131$24110113$1$I$$20240712$20240718$20240718$PER$$US-BAYER-2024A100931$BAYER$$34$YR$A$F$Y$$$20240718$$MD$US$US
241101144$24110114$4$F$$20240905$20240718$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112876$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240912$$CN$US$US
241101161$24110116$1$I$20240411$20240718$20240718$20240718$EXP$NO-NOMAADVRE-RELISSO-2024-Vake68$NVSC2024NO147966$NOVARTIS$$59$YR$$M$Y$$$20240718$$MD$NO$NO
241101181$24110118$1$I$$20240711$20240718$20240718$EXP$$BR-GSK-BR2024AMR088454$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$BR$BR
241101191$24110119$1$I$20240715$20240717$20240718$20240718$EXP$$CN-BAYER-2024A104374$BAYER$$66$YR$E$F$Y$$$20240718$$HP$CN$CN
241101201$24110120$1$I$$20240703$20240718$20240718$EXP$$US-GRANULES-US-2024GRALIT00265$GRANULES INDIA$M. Simpson.Early Extra Corporeal Membrane Oxygenation (ECMO) and Esophagogastroduodenoscopy (EGD) Implementation: A Timely Intervention in a Patient With Extended-Release Bupropion Overdose.American Journal of Respiratory and Critical Care Medicine.2024;209:A5672$41$YR$A$M$Y$$$20240718$$HP$US$US
241101211$24110121$1$I$$20240714$20240718$20240718$PER$$US-BAYER-2024A101307$BAYER$$$$$$Y$$$20240718$$CN$US$US
241101221$24110122$1$I$$20240710$20240718$20240718$EXP$$US-SA-2024SA209105$SANOFI AVENTIS$$$$A$M$Y$145$KG$20240718$$MD$US$US
241101231$24110123$1$I$20240713$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141099$AMGEN$$64$YR$A$M$Y$$$20240718$$CN$US$US
241101251$24110125$1$I$20240601$20240712$20240718$20240718$EXP$$US-SA-2024SA208974$SANOFI AVENTIS$$94$YR$E$M$Y$83.9$KG$20240718$$MD$US$US
241101262$24110126$2$F$20240712$20240816$20240718$20240817$PER$$US-JNJFOC-20240739286$JOHNSON AND JOHNSON$$62$YR$A$$Y$$$20240817$$PH$US$US
241101271$24110127$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024142425$AMGEN$$$$$$Y$$$20240718$$CN$US$US
241101281$24110128$1$I$$20240710$20240718$20240718$EXP$$CA-CELLTRION INC.-2024CA016899$CELLTRION$$$$$$Y$$$20240718$$HP$CA$CA
241101291$24110129$1$I$$20240710$20240718$20240718$EXP$$GB-Eisai-EC-2024-169979$EISAI$Allsopp RC, Guo Q, Page K, Bhagani S, Kasim A, Badman P, et al. Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study. Breast Cancer Research and Treatment. 2024 Apr 06;(206): 377-385. doi:10.1007/s10549-024-07316-8.$$$$F$Y$$$20240718$$MD$GB$GB
241101301$24110130$1$I$20240101$20240715$20240718$20240718$EXP$SE-SEMPA-2024-004396$SE-009507513-2407SWE009604$MERCK$$53$YR$$M$Y$$$20240718$$MD$SE$SE
241101311$24110131$1$I$$20240710$20240718$20240718$EXP$$GB-Eisai-EC-2024-169977$EISAI$Allsopp RC, Guo Q, Page K, Bhagani S, Kasim A, Badman P, et al. Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study. Breast Cancer Research and Treatment. 2024 Apr 06;(206): 377-385. doi:10.1007/s10549-024-07316-8.$$$$F$Y$$$20240718$$MD$GB$GB
241101321$24110132$1$I$20240621$20240710$20240718$20240718$EXP$$JP-Eisai-EC-2024-169941$EISAI$$$$E$M$Y$$$20240718$$MD$JP$JP
241101331$24110133$1$I$$20240705$20240718$20240718$PER$$US-RDY-LIT/USA/24/0010273$DR REDDYS$Baker M, Thakker S, Cardis M, DeSimone J, Larson A. A Vexing Case of a Treatment-Refractory, Idiopathic Rash Resembling Histiocytoid Sweet Syndrome: Insights into the Diagnostic Challenge of Vexas Syndrome. American Journal of Dermatopathology. 2024;46(7): doi:10.1097/DAD.0000000000002755.$71$YR$E$M$Y$$$20240718$$HP$US$US
241101341$24110134$1$I$20231001$20240711$20240718$20240718$EXP$FR-AFSSAPS-LL2024001270$FR-RDY-SPO/FRA/24/0010305$DR REDDYS$$46$YR$A$F$Y$$$20240718$$MD$FR$FR
241101351$24110135$1$I$20240623$20240710$20240718$20240718$EXP$IT-MINISAL02-993798$IT-FreseniusKabi-FK202410952$FRESENIUS KABI$$71$YR$E$F$Y$$$20240718$$MD$IT$IT
241101361$24110136$1$I$$20240709$20240718$20240718$EXP$$IT-MYLANLABS-2024M1064515$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study. Int. J. Mol. Sci.. 2024;21:25$80$YR$$M$Y$$$20240718$$HP$IT$IT
241101371$24110137$1$I$$20240716$20240718$20240718$EXP$$AU-SANDOZ INC.-SDZ2024AU065610$SANDOZ$$44$YR$$F$Y$$$20240718$$HP$AU$AU
241101381$24110138$1$I$$20240703$20240718$20240718$EXP$$IT-GRANULES-IT-2024GRALIT00276$GRANULES INDIA$Francesca Remell.Delirium in hip fractured patients.Journal of Gerontology and Geriatrics.2023;71:8-14$70$YR$E$M$Y$$$20240718$$HP$IT$IT
241101391$24110139$1$I$20240709$20240715$20240718$20240718$PER$$US-BAYER-2024A101498$BAYER$$46$YR$A$F$Y$$$20240718$$HP$US$US
241101402$24110140$2$F$$20240828$20240718$20240905$EXP$$JP-BEH-2024175572$CSL BEHRING$$1$YR$I$M$Y$$$20240905$$HP$JP$JP
241101413$24110141$3$F$$20240820$20240718$20240904$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-21019$SAMSUNG BIOEPIS$$75$YR$E$F$Y$96$KG$20240904$$HP$CA$CA
241101421$24110142$1$I$$20240705$20240718$20240718$EXP$$TN-FDC-2024TNLIT00542$FDC LIMITED$S Ben Hammamia.Neurotoxicity Related to Multidrug Association: A Case Report.Journal of Clinical Psychopharmacology.JUN-2024;44:317-319$57$YR$A$F$Y$$$20240718$$HP$TN$TN
241101431$24110143$1$I$$20240703$20240718$20240718$PER$$US-Nobelpharma America, LLC-NPA-2024-01196$NOBELPHARMA$$$$$F$Y$$$20240716$$HP$US$US
241101452$24110145$2$F$20230712$20240719$20240718$20240729$PER$$US-BAYER-2024A101508$BAYER$$39$YR$A$F$Y$$$20240729$$MD$US$US
241101461$24110146$1$I$20240715$20240717$20240717$20240717$DIR$710616$$FDA-CTU$$73$YR$$UNK$N$$$20240717$N$$US$
241101471$24110147$1$I$$20240711$20240718$20240718$PER$$US-BAYER-2024A100305$BAYER$$74$YR$E$F$Y$$$20240718$$CN$US$US
241101491$24110149$1$I$$20240523$20240718$20240718$PER$$US-LUNDBECK-DKLU3078530$LUNDBECK$$$$$$Y$$$20240718$$CN$US$US
241101502$24110150$2$F$$20240729$20240718$20240807$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407005698$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240807$$CN$GB$GB
241101512$24110151$2$F$20231201$20240725$20240718$20240807$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202405001950$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240807$$CN$DE$BR
241101521$24110152$1$I$$20230823$20240718$20240718$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64783$HIKMA$$$$$$Y$$$20240718$$CN$US$US
241101532$24110153$2$F$$20240723$20240718$20240723$EXP$$JP-SA-2024SA208845$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240723$$MD$JP$JP
241101541$24110154$1$I$$20230816$20240718$20240718$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64633$HIKMA$$$$$$Y$$$20240718$$HP$US$US
241101551$24110155$1$I$$20230919$20240718$20240718$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64792$HIKMA$$$$$$Y$$$20240718$$PH$US$US
241101561$24110156$1$I$$20240710$20240718$20240718$EXP$$US-009507513-2407USA004752$MERCK$$60$YR$$M$Y$$$20240718$$MD$US$US
241101571$24110157$1$I$$20231011$20240718$20240718$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66326$HIKMA$$$$$$Y$$$20240718$$CN$US$US
241101581$24110158$1$I$$20231019$20240718$20240718$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66488$HIKMA$$$$$$Y$$$20240718$$HP$US$US
241101591$24110159$1$I$$20230919$20240718$20240718$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64793$HIKMA$$$$$$Y$$$20240718$$PH$US$US
241101601$24110160$1$I$$20240716$20240718$20240718$EXP$$AU-SANDOZ INC.-SDZ2024AU065722$SANDOZ$$3$YR$$$Y$$$20240718$$HP$AU$AU
241101611$24110161$1$I$20240711$20240711$20240718$20240718$PER$$US-BAYER-2024A100504$BAYER$$$$$M$Y$$$20240718$$CN$US$US
241101621$24110162$1$I$$20231222$20240718$20240718$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-68534$HIKMA$$$$$$Y$$$20240718$$HP$US$US
241101631$24110163$1$I$$20240715$20240718$20240718$EXP$NL-LRB-00981719$NL-PFIZER INC-202400214797$PFIZER$$33$YR$$F$Y$75$KG$20240718$$CN$NL$NL
241101642$24110164$2$F$$20240717$20240718$20240722$EXP$$JP-PFIZER INC-202400216662$PFIZER$Katayama, H.. A case of testicular tumor and respiratory failure caused by choriocarcinoma syndrome managed through modified chemotherapy and extracorporeal membrane oxygenation. IJU case reports. 2024;7(4):285-288$35$YR$$M$Y$$$20240722$$MD$JP$JP
241101652$24110165$2$F$$20240801$20240718$20240810$EXP$$US-TEVA-VS-3219466$TEVA$Torelli VA, Ernest Jean R, Tran E. Rapidly Progressive Interstitial Lung Disease Due to Silicosis in an Otherwise Healthy Jeweler. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Torelli VA, Ernest Jean R, Tran E. Rapidly Progressive Interstitial Lung Disease Due to Silicosis in an Otherwise Healthy Jeweler. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$83$YR$$F$Y$$$20240810$$HP$US$US
241101661$24110166$1$I$20240301$20240703$20240718$20240718$EXP$$US-UCBSA-2024024345$UCB$$85$YR$$M$Y$$$20240718$$CN$US$US
241101671$24110167$1$I$$20240715$20240718$20240718$PER$$US-BAYER-2024A101640$BAYER$$$$$$Y$$$20240718$$CN$US$US
241101683$24110168$3$F$20240101$20240904$20240718$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111908$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240906$$CN$US$US
241101691$24110169$1$I$$20240711$20240718$20240718$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06900$LUPIN$Allonce J, Patel V. New-onset refractory status epilepticus induced by synthetic marijuana: A case report. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2117$26$YR$$M$Y$$$20240718$$HP$US$US
241101701$24110170$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113070$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240718$$CN$US$US
241101711$24110171$1$I$20231001$20240711$20240718$20240718$EXP$$CH-TAKEDA-2024TUS072032$TAKEDA$$35$YR$$F$Y$$$20240718$$CN$CH$CH
241101721$24110172$1$I$20240701$20240716$20240718$20240718$EXP$FR-AFSSAPS-RS2024000678$FR-SA-2024SA207650$SANOFI AVENTIS$$80$YR$E$M$Y$60$KG$20240718$$MD$FR$FR
241101731$24110173$1$I$$20240715$20240718$20240718$EXP$$TR-UCBSA-2024035774$UCB$Erturk Cetin O, Algedik P, Akyuz G, Surmeli R, Zanapal?oglu U, Alev Saltak G et al. Minor/Major Congenital Malformations and Neurodevelopmental Outcomes in Children Prenatally Exposed to Levetiracetam, Lamotrigine, and Carbamazepine Monotherapy. Clinical neuropharmacology. 2024;1-6$$$$$Y$$$20240718$$MD$TR$TR
241101743$24110174$3$F$$20240809$20240718$20240819$EXP$$JP-INCYTE CORPORATION-2024IN007547$INCYTE$$$$$$Y$$$20240819$$PH$JP$JP
241101751$24110175$1$I$20240629$20240711$20240718$20240718$EXP$$NVSC2024FR141850$NOVARTIS$$16$YR$$M$Y$$$20240718$$MD$FR$FR
241101761$24110176$1$I$$20240715$20240718$20240718$PER$$US-BAYER-2024A101683$BAYER$$$$$$Y$$$20240718$$CN$US$US
241101771$24110177$1$I$20240610$20240717$20240718$20240718$EXP$IS-IMA-8735$IS-ROCHE-10000029238$ROCHE$$57$YR$A$F$Y$$$20240718$$PH$IS$IS
241101781$24110178$1$I$$20240716$20240718$20240718$EXP$$GB-SANDOZ INC.-NVSC2023GB012168$SANDOZ$$6$YR$$F$Y$$$20240718$$HP$GB$GB
241101791$24110179$1$I$$20240715$20240718$20240718$EXP$$CA-SANDOZ INC.-SDZ2024CA065400$SANDOZ$$72$YR$$M$Y$$$20240718$$CN$CA$CA
241101801$24110180$1$I$20240717$20240717$20240717$20240717$DIR$710618$$FDA-CTU$$95$YR$$F$N$$$20240717$N$$US$
241101821$24110182$1$I$20240606$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49710$$FDA-CTU$$52$YR$$M$N$$$20240717$N$HP$US$
241101831$24110183$1$I$20240717$20240717$20240717$20240717$DIR$710678$$FDA-CTU$$31$YR$$F$N$67.5$KG$20240717$N$CN$US$
241101841$24110184$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024142550$AMGEN$$$$$$Y$$$20240718$$HP$US$US
241101851$24110185$1$I$$20240703$20240718$20240718$EXP$$ES-GRANULES-ES-2024GRALIT00277$GRANULES INDIA$Izaskun Rubio.Green neutrophilic inclusions in patient with drug intoxication: a case report..Journal of laboratory and precision medicine.20-NOV-2023;9:1-4$54$YR$A$F$Y$$$20240718$$HP$ES$ES
241101862$24110186$2$F$$20240719$20240718$20240724$EXP$$NVSC2024AR145617$NOVARTIS$$79$YR$$F$Y$$$20240724$$CN$AR$AR
241101872$24110187$2$F$20240101$20240813$20240718$20240820$EXP$$CN-PFIZER INC-PV202400091413$PFIZER$$56$YR$$M$Y$$$20240820$$CN$CN$CN
241101881$24110188$1$I$20200101$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140185$AMGEN$$16$YR$T$F$Y$$$20240718$$CN$US$US
241101891$24110189$1$I$20230101$20240711$20240718$20240718$EXP$$US-AMGEN-USASP2024138948$AMGEN$$57$YR$A$F$Y$$$20240718$$HP$US$US
241101901$24110190$1$I$$20240715$20240718$20240718$PER$$US-BAYER-2024A103570$BAYER$$46$YR$A$F$Y$$$20240718$$PH$US$US
241101911$24110191$1$I$20240214$20240711$20240718$20240718$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006248$AURINIA PHARMACEUTICALS$$36$YR$$M$Y$$$20240718$$MD$US$US
241101921$24110192$1$I$20240710$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49642$$FDA-CTU$$54$YR$$F$N$54.9$KG$20240717$N$$US$
241101931$24110193$1$I$20240627$20240715$20240718$20240718$EXP$IT-MINISAL02-994171$IT-FreseniusKabi-FK202411122$FRESENIUS KABI$$68$YR$E$M$Y$$$20240718$$MD$IT$IT
241101951$24110195$1$I$$20240711$20240718$20240718$EXP$$DE-FreseniusKabi-FK202411294$FRESENIUS KABI$Hans FP, Benning L, Pooth JS, Busch HJ. A potentially lifesaving error: unintentional high-dose adrenaline administration in anaphylaxis-induced cardiac arrest; a case report. International Journal of Emergency Medicine. 2024 Jun 28;78(17): 1-5. doi:https://doi.org/10.1186/s12245-024-00663-9.$66$YR$E$F$Y$$$20240718$$HP$DE$DE
241101961$24110196$1$I$20240701$20240708$20240718$20240718$EXP$$US-RDY-CLI/USA/24/0010227$DR REDDYS$$3$YR$C$F$Y$$$20240718$$CN$US$US
241101971$24110197$1$I$$20240708$20240718$20240718$EXP$CA-HEALTHCANVIG-E2B_07187401$CA-NOVOPROD-1254555$NOVO NORDISK$$58$YR$$F$Y$$$20240718$$HP$CA$CA
241101981$24110198$1$I$$20240712$20240718$20240718$EXP$$IN-SANDOZ INC.-SDZ2024IN065752$SANDOZ$$$$$M$Y$$$20240718$$CN$IN$IN
241101991$24110199$1$I$20240601$20240715$20240718$20240718$EXP$$US-UCBSA-2024035956$UCB$$32$YR$$F$Y$$$20240718$$HP$US$US
241102001$24110200$1$I$$20240715$20240718$20240718$PER$$US-ABBVIE-5843768$ABBVIE$$$$$$Y$$$20240718$$MD$US$US
241102011$24110201$1$I$20240715$20240715$20240718$20240718$PER$$US-BAYER-2024A103907$BAYER$$31$YR$A$F$Y$$$20240718$$HP$US$US
241102021$24110202$1$I$20190906$20240716$20240718$20240718$EXP$$JP-PFIZER INC-2021229786$PFIZER$$77$YR$$F$Y$63$KG$20240718$$MD$JP$JP
241102032$24110203$2$F$20240301$20240731$20240718$20240805$EXP$$US-PFIZER INC-PV202400094094$PFIZER$$58$YR$$F$Y$79.819$KG$20240805$$CN$US$US
241102041$24110204$1$I$$20240711$20240718$20240718$PER$$US-JNJFOC-20240745201$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240718$$CN$US$US
241102051$24110205$1$I$20210414$20210727$20240718$20240718$EXP$$US-AstraZeneca-2021A651844$ASTRAZENECA$$16519$DY$$F$Y$$$20240718$$CN$US$
241102061$24110206$1$I$20240411$20240703$20240718$20240718$PER$$US-AstraZeneca-2024A155539$ASTRAZENECA$$70$YR$$M$Y$75.3$KG$20240718$$MD$US$
241102071$24110207$1$I$$20240628$20240718$20240718$PER$$US-BEH-2024175024$CSL BEHRING$$$$$M$Y$$$20240718$$CN$US$US
241102082$24110208$2$F$20230509$20240912$20240718$20240912$EXP$$CA-PFIZER INC-202400216163$PFIZER$$53$YR$$M$Y$$$20240912$$HP$CA$CA
241102092$24110209$2$F$$20240907$20240718$20240909$EXP$$US-PFIZER INC-202400210201$PFIZER$$14$YR$$M$Y$49.9$KG$20240909$$CN$US$US
241102101$24110210$1$I$$20210324$20240718$20240718$EXP$$US-AstraZeneca-2021A208831$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241102111$24110211$1$I$20240610$20240716$20240718$20240718$EXP$SE-SEMPA-2024-005019$SE-PFIZER INC-202400215852$PFIZER$$76$YR$$M$Y$$$20240718$$MD$SE$SE
241102121$24110212$1$I$20200807$20201012$20240718$20240718$EXP$$AU-AstraZeneca-2020SF01319$ASTRAZENECA$$26831$DY$$M$Y$$$20240718$$CN$AU$
241102131$24110213$1$I$20190215$20200416$20240718$20240718$EXP$$US-AstraZeneca-2019SE29003$ASTRAZENECA$$25658$DY$$M$Y$$$20240718$$CN$US$
241102141$24110214$1$I$20240716$20240716$20240718$20240718$PER$$US-BAYER-2024A103559$BAYER$$$$$F$Y$$$20240718$$HP$US$US
241102151$24110215$1$I$$20240701$20240718$20240718$PER$$US-BEH-2024175059$CSL BEHRING$$$$$F$Y$$$20240718$$CN$US$US
241102161$24110216$1$I$$20240716$20240718$20240718$PER$$US-BAYER-2024A103610$BAYER$$$$$M$Y$$$20240718$$CN$US$US
241102171$24110217$1$I$$20240712$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112133$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240718$$CN$US$US
241102181$24110218$1$I$20240101$20240712$20240718$20240718$EXP$$US-BAUSCH-BL-2024-010762$BAUSCH AND LOMB$$$$$F$Y$$$20240718$$HP$US$US
241102191$24110219$1$I$20180915$20240713$20240718$20240718$EXP$$IT-BAUSCH-BL-2024-010730$BAUSCH AND LOMB$$$$$$Y$$$20240718$$MD$IT$IT
241102201$24110220$1$I$$20240703$20240718$20240718$EXP$$US-GRANULES-US-2024GRALIT00270$GRANULES INDIA$Leore Lavin.Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect.JAAD Case Reports.2024;49:40-43$$$$F$Y$$$20240718$$HP$US$US
241102211$24110221$1$I$$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114249$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240718$$HP$US$US
241102221$24110222$1$I$20240701$20240715$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112500$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$91.63$KG$20240718$$CN$US$US
241102231$24110223$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5843165$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241102241$24110224$1$I$$20240712$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-045707$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240718$$CN$US$US
241102251$24110225$1$I$$20240716$20240718$20240718$EXP$GB-MHRA-MED-202407161425300610-ZNYCK$GB-MYLANLABS-2024M1066611$MYLAN$$41$YR$$F$Y$$$20240718$$PH$GB$GB
241102261$24110226$1$I$20240522$20240712$20240718$20240718$EXP$FR-AFSSAPS-TO2024001158$FR-MYLANLABS-2024M1065616$MYLAN$$64$YR$$M$Y$88$KG$20240718$$PH$FR$FR
241102271$24110227$1$I$20240614$20240712$20240718$20240718$EXP$PT-INFARMED-R202407-61$PT-MYLANLABS-2024M1065393$MYLAN$$77$YR$$F$Y$$$20240718$$MD$PT$PT
241102281$24110228$1$I$$20240715$20240718$20240718$EXP$$CA-BAUSCH-BL-2024-010918$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240718$$CN$CA$CA
241102291$24110229$1$I$$20240715$20240718$20240718$EXP$$CA-BAUSCH-BL-2024-010820$BAUSCH AND LOMB$$58$YR$$M$Y$$$20240718$$HP$CA$CA
241102322$24110232$2$F$20020101$20240908$20240718$20240909$EXP$$US-PFIZER INC-202400216507$PFIZER$$60$YR$$F$Y$64$KG$20240909$$CN$US$US
241102341$24110234$1$I$$20240715$20240718$20240718$EXP$$CA-BAUSCH-BL-2024-010812$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240718$$CN$CA$CA
241102351$24110235$1$I$20221205$20240717$20240717$20240717$DIR$710677$$FDA-CTU$$16$YR$$M$N$63$KG$20240717$N$CN$US$
241102361$24110236$1$I$$20240703$20240718$20240718$EXP$$PT-VALIDUS PHARMACEUTICALS LLC-PT-VDP-2024-019322$VALIDUS$Lobato CT, Castelo Branco S, Camoes J, Molinos E. Rhabdomyolysis secondary to a weight-loss prescription. BMJ Case Rep. 2024;17(6):1-5$$$$$Y$$$20240718$$MD$PT$PT
241102384$24110238$4$F$$20240908$20240718$20240909$EXP$$US-PFIZER INC-202400213865$PFIZER$$80$YR$$F$Y$$$20240909$$CN$US$US
241102391$24110239$1$I$$20240716$20240718$20240718$EXP$$DE-PFIZER INC-202400215909$PFIZER$$$$A$F$Y$$$20240718$$MD$DE$DE
241102401$24110240$1$I$20240603$20240717$20240717$20240717$DIR$710668$$FDA-CTU$$59$YR$$F$N$78.75$KG$20240717$N$CN$US$
241102411$24110241$1$I$$20240717$20240717$20240717$DIR$710641$$FDA-CTU$$$$$UNK$N$$$20240717$$CN$US$
241102431$24110243$1$I$20220501$20240709$20240718$20240718$EXP$$JP-009507513-2407JPN001865J$MERCK$$56$YR$$F$Y$44$KG$20240718$$PH$JP$JP
241102441$24110244$1$I$20190101$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002379J$MERCK$$68$YR$$F$Y$$$20240718$$MD$JP$JP
241102452$24110245$2$F$$20240716$20240718$20240731$PER$$US-GRANULES-US-2024GRASPO00274$GRANULES INDIA$$$$$M$Y$$$20240731$$CN$US$US
241102461$24110246$1$I$$20240708$20240718$20240718$EXP$$US-TEVA-VS-3219982$TEVA$$$$A$F$Y$$$20240718$$HP$US$US
241102471$24110247$1$I$$20240715$20240718$20240718$EXP$$CZ-FreseniusKabi-FK202411150$FRESENIUS KABI$$$$$M$Y$$$20240718$$CN$CZ$CZ
241102481$24110248$1$I$$20240711$20240718$20240718$EXP$$US-AMGEN-USASP2024138977$AMGEN$Lee E. J.; Hartjes K.;  Koo D. et al.. Early Graft Loss With Suspected Seventh-Day Syndrome Following Pediatric Liver Transplantation. Pediatric Transplantation. 2024;28 (5):1-12$14$YR$T$F$Y$$$20240718$$HP$US$US
241102491$24110249$1$I$20240603$20240716$20240718$20240718$EXP$$PT-PFIZER INC-202400203956$PFIZER$$$$A$F$Y$95.5$KG$20240718$$MD$PT$PT
241102531$24110253$1$I$20240404$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49624$$FDA-CTU$$$$$M$N$125.2$KG$20240717$N$$US$
241102541$24110254$1$I$$20240715$20240718$20240718$PER$$US-LEO Pharma-372017$LEO PHARM$$74$YR$$F$Y$$$20240718$$CN$US$US
241102551$24110255$1$I$$20240716$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US066278$SANDOZ$$$$$F$Y$$$20240718$$CN$US$US
241102561$24110256$1$I$20240614$20240716$20240718$20240718$EXP$HR-HALMED-300086085$HR-SANDOZ INC.-SDZ2024HR065836$SANDOZ$$29$YR$$F$Y$$$20240718$$MD$HR$HR
241102571$24110257$1$I$20240629$20240717$20240718$20240718$EXP$$US-INCYTE CORPORATION-2024IN005770$INCYTE$$$$$$Y$$$20240718$$HP$US$US
241102581$24110258$1$I$$20240626$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06525$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241102601$24110260$1$I$20210518$20240709$20240718$20240718$EXP$$JP-009507513-2407JPN001829J$MERCK$$69$YR$$M$Y$$$20240718$$MD$JP$JP
241102611$24110261$1$I$20240101$20240618$20240718$20240718$PER$$US-009507513-2406USA006449$MERCK$$$$$M$Y$$$20240718$$CN$US$US
241102621$24110262$1$I$20240627$20240717$20240718$20240718$PER$$US-BAYER-2024A104234$BAYER$$24$YR$A$F$Y$$$20240718$$CN$US$US
241102631$24110263$1$I$$20240715$20240718$20240718$EXP$$US-DSJP-DSU-2024-135964$DAIICHI$$$$$F$Y$$$20240718$$HP$US$US
241102643$24110264$3$F$$20240913$20240718$20240918$30DAY$$JP-PFIZER INC-202400108031$PFIZER$$79$YR$$M$Y$$$20240918$$PH$JP$JP
241102653$24110265$3$F$20240706$20240911$20240718$20240916$30DAY$$JP-PFIZER INC-PV202400088865$PFIZER$$$$T$M$Y$$$20240916$$CN$JP$JP
241102683$24110268$3$F$$20240918$20240718$20240926$30DAY$$US-PFIZER INC-202400208903$PFIZER$$8$YR$$M$Y$$$20240926$$CN$US$US
241102693$24110269$3$F$20240628$20240909$20240718$20240910$30DAY$$CL-PFIZER INC-202400206889$PFIZER$$13$YR$$$Y$$$20240910$$CN$CL$CL
241102702$24110270$2$F$20240708$20240913$20240718$20240919$30DAY$$US-PFIZER INC-202400209066$PFIZER$$10$YR$$M$Y$$$20240919$$CN$US$US
241102711$24110271$1$I$20240307$20240711$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407008019$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240718$$CN$US$US
241102721$24110272$1$I$20230101$20240703$20240718$20240718$EXP$$CA-HLS-202401679$HLS THERAPEUTICS$$46$YR$A$M$Y$$$20240718$$MD$CA$CA
241102731$24110273$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010301$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240718$$CN$US$US
241102741$24110274$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010530$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240718$$CN$US$US
241102751$24110275$1$I$$20240711$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407008465$ELI LILLY AND CO$$$$A$F$Y$$$20240718$$CN$US$US
241102761$24110276$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011308$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240718$$CN$US$US
241102771$24110277$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009850$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240718$$HP$US$US
241102782$24110278$2$F$$20240925$20240718$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202407011132$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240927$$CN$US$US
241102791$24110279$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010839$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240718$$CN$US$US
241102801$24110280$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011353$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240718$$CN$US$US
241102813$24110281$3$F$$20240925$20240718$20240927$30DAY$$US-PFIZER INC-PV202400084037$PFIZER$$$$$M$Y$$$20240927$$CN$US$US
241102821$24110282$1$I$20240418$20240717$20240717$20240717$DIR$710604$$FDA-CTU$$70$YR$$F$N$78.3$KG$20240717$N$PH$US$
241102832$24110283$2$F$$20240911$20240718$20240913$30DAY$$US-PFIZER INC-202400207790$PFIZER$$13$YR$$F$Y$$$20240913$$CN$US$US
241102842$24110284$2$F$$20240817$20240718$20240819$30DAY$$US-PFIZER INC-PV202400089297$PFIZER$$12$YR$$F$Y$$$20240819$$CN$US$US
241102852$24110285$2$F$$20240913$20240718$20240917$30DAY$$CH-PFIZER INC-202400208649$PFIZER$$$$$$Y$$$20240917$$PH$CH$CH
241102861$24110286$1$I$20230715$20240717$20240717$20240717$DIR$710665$$FDA-CTU$$65$YR$$F$N$93.15$KG$20240717$N$CN$US$
241102873$24110287$3$F$20240101$20240729$20240718$20240801$PER$$US-AMGEN-USASP2024136177$AMGEN$$60$YR$A$F$Y$$$20240801$$CN$US$US
241102881$24110288$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024142015$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
241102891$24110289$1$I$$20240711$20240718$20240718$PER$$US-BAYER-2024A101056$BAYER$$72$YR$E$F$Y$$$20240718$$CN$US$US
241102901$24110290$1$I$$20240712$20240718$20240718$EXP$$CA-SANDOZ INC.-SDZ2024CA039256$SANDOZ$$$$$F$Y$$$20240718$$MD$CA$CA
241102911$24110291$1$I$$20240716$20240718$20240718$EXP$$UY-ROCHE-10000029551$ROCHE$$17$YR$T$$Y$$$20240718$$MD$UY$UY
241102921$24110292$1$I$$20240716$20240718$20240718$EXP$$BE-SANDOZ INC.-NVSC2020BE171378$SANDOZ$$$$E$F$Y$71.6$KG$20240718$$MD$BE$BE
241102932$24110293$2$F$20240612$20240808$20240718$20240818$EXP$FR-AFSSAPS-AN2024000835$FR-TEVA-VS-3219819$TEVA$$74$YR$$M$Y$87$KG$20240818$$MD$FR$FR
241102941$24110294$1$I$20240606$20240710$20240718$20240718$EXP$IT-MINISAL02-993324$IT-TEVA-VS-3220163$TEVA$$53$YR$$M$Y$$$20240718$$MD$IT$IT
241102952$24110295$2$F$$20240812$20240718$20240819$EXP$$HR-BRISTOL-MYERS SQUIBB COMPANY-2024-113347$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$96$KG$20240819$$MD$HR$HR
241102961$24110296$1$I$$20240714$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112619$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$CN$US$US
241102971$24110297$1$I$$20240703$20240718$20240718$PER$$US-EPICPHARMA-US-2024EPCSPO00820$EPIC PHARM$$$$A$F$Y$$$20240718$$MD$US$US
241102981$24110298$1$I$20240717$20240717$20240718$20240718$PER$$US-BAYER-2024A104479$BAYER$$42$YR$A$F$Y$$$20240718$$CN$US$US
241102991$24110299$1$I$$20240716$20240718$20240718$EXP$$CA-ABBVIE-5843721$ABBVIE$$$$E$M$Y$$$20240718$$HP$CA$CA
241103013$24110301$3$F$20240101$20240917$20240718$20240926$EXP$$JP-009507513-2405JPN002332J$MERCK$$61$YR$$M$Y$$$20240926$$MD$JP$JP
241103021$24110302$1$I$20240604$20240708$20240718$20240718$EXP$AT-BASGAGES-2024-004941$AT-PERRIGO-24AT006394$PERRIGO$$17$YR$$F$Y$$$20240718$$CN$AT$AT
241103031$24110303$1$I$20220101$20240708$20240718$20240718$EXP$IE-HPRA-2024-114142$IE-PERRIGO-24IE006390$PERRIGO$$77$YR$$M$Y$$$20240718$$PH$IE$IE
241103043$24110304$3$F$$20240812$20240718$20240812$PER$$US-ALXN-202407USA000996US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241103051$24110305$1$I$$20240711$20240718$20240718$PER$$US-VERTEX PHARMACEUTICALS-2024-011606$VERTEX$$$$$$Y$$$20240718$$CN$US$US
241103061$24110306$1$I$$20240712$20240718$20240718$PER$$US-VERTEX PHARMACEUTICALS-2024-000440$VERTEX$$33$YR$$F$Y$$$20240718$$CN$US$US
241103071$24110307$1$I$$20240712$20240718$20240718$PER$$US-VERTEX PHARMACEUTICALS-2024-011660$VERTEX$$19$YR$$$Y$$$20240718$$CN$US$US
241103081$24110308$1$I$$20240709$20240718$20240718$EXP$$US-VERTEX PHARMACEUTICALS-2024-011409$VERTEX$$$$$M$Y$$$20240718$$CN$US$US
241103091$24110309$1$I$$20240712$20240718$20240718$PER$$US-VERTEX PHARMACEUTICALS-2024-011697$VERTEX$$$$$$Y$$$20240718$$CN$US$US
241103111$24110311$1$I$$20240712$20240718$20240718$PER$$US-VERTEX PHARMACEUTICALS-2024-011702$VERTEX$$$$$$Y$$$20240718$$CN$US$US
241103121$24110312$1$I$$20240712$20240718$20240718$PER$$US-VERTEX PHARMACEUTICALS-2024-011704$VERTEX$$$$$$Y$$$20240718$$CN$US$US
241103131$24110313$1$I$$20240708$20240718$20240718$PER$$US-VERTEX PHARMACEUTICALS-2024-011356$VERTEX$$29$YR$$$Y$$$20240718$$CN$US$US
241103141$24110314$1$I$$20240712$20240718$20240718$PER$$US-VERTEX PHARMACEUTICALS-2024-011730$VERTEX$$$$$$Y$$$20240718$$CN$US$US
241103151$24110315$1$I$$20240717$20240718$20240718$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040427$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$PH$US$US
241103161$24110316$1$I$$20240619$20240718$20240718$EXP$$CA-ROCHE-10000008727$ROCHE$$$$A$M$Y$$$20240718$$MD$CA$CA
241103171$24110317$1$I$$20240626$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006889$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241103181$24110318$1$I$$20240712$20240718$20240718$EXP$$US-AMGEN-USASP2024139978$AMGEN$$$$$F$Y$$$20240718$$MD$US$US
241103191$24110319$1$I$$20240716$20240718$20240718$EXP$$DE-SANDOZ INC.-SDZ2024DE066085$SANDOZ$$78$YR$$M$Y$$$20240718$$HP$DE$DE
241103201$24110320$1$I$20230601$20240717$20240717$20240717$DIR$710613$$FDA-CTU$$$$$F$N$$$20240717$N$CN$US$
241103211$24110321$1$I$20240717$20240717$20240717$20240717$DIR$710673$$FDA-CTU$$58$YR$$F$N$121.05$KG$20240717$N$CN$US$
241103221$24110322$1$I$$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49695$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241103241$24110324$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49719$$FDA-CTU$$60$YR$$F$N$54.43$KG$20240718$N$HP$US$
241103251$24110325$1$I$20240717$20240717$20240717$20240717$DIR$710669$$FDA-CTU$$29$YR$$F$N$59$KG$20240717$N$PH$US$
241103271$24110327$1$I$20240601$20240716$20240718$20240718$EXP$FR-AFSSAPS-LL2024001254$FR-DAIICHI SANKYO, INC.-DSE-2024-135973$DAIICHI$$65$YR$$F$Y$89$KG$20240718$$MD$FR$FR
241103281$24110328$1$I$20240101$20240715$20240718$20240718$EXP$$US-JNJFOC-20240739645$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240718$$CN$US$US
241103292$24110329$2$F$$20240627$20240718$20240925$PER$$US-INCYTE CORPORATION-2024IN006892$INCYTE$$$$$$Y$$$20240925$$CN$US$US
241103301$24110330$1$I$$20240709$20240718$20240718$EXP$$US-Calliditas-2024CAL01290$CALLIDITAS THERAPEUTICS$$69$YR$E$M$Y$$$20240718$$HP$US$US
241103311$24110331$1$I$20240529$20240705$20240718$20240718$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000594$PAREXEL$$$$$$Y$$$20240718$$HP$CN$CN
241103321$24110332$1$I$$20240711$20240718$20240718$EXP$$US-MYLANLABS-2024M1066292$MYLAN$Hebert BJ, Gallegos MA, Hartman E, Bradley J, Shelley P, Ng A, et al. Severe Pre-capillary Pulmonary Arterial Hypertension in a Patient With Common Variable Immunodeficiency With Granulomatous Lymphocytic Interstitial Lung Disease. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. C52.$45$YR$$F$Y$$$20240718$$HP$US$US
241103342$24110334$2$F$20240101$20240715$20240718$20240723$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003380$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$CA$CA
241103351$24110335$1$I$20240601$20240711$20240718$20240718$EXP$NL-LRB-00984858$NL-NALPROPION PHARMACEUTICALS INC.-NL-2024CUR003316$CURRAX PHARMACEUTICALS$$54$YR$$F$Y$104$KG$20240718$$CN$NL$NL
241103361$24110336$1$I$$20240712$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US066350$SANDOZ$$$$$$Y$$$20240718$$PH$US$US
241103371$24110337$1$I$$20240712$20240718$20240718$PER$$US-AMGEN-USASP2024140007$AMGEN$$$$$$Y$$$20240718$$PH$US$US
241103383$24110338$3$F$20240714$20240802$20240718$20240806$PER$$US-AMGEN-USASP2024142407$AMGEN$$69$YR$E$F$Y$$$20240806$$CN$US$US
241103391$24110339$1$I$$20240712$20240718$20240718$PER$$US-LEO Pharma-372022$LEO PHARM$$43$YR$$F$Y$$$20240718$$PH$US$US
241103411$24110341$1$I$$20240712$20240718$20240718$EXP$$CA-ROCHE-10000027803$ROCHE$$45$YR$A$M$Y$$$20240718$$HP$CA$CA
241103431$24110343$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49711$$FDA-CTU$$56$YR$$F$N$$$20240718$N$$US$
241103441$24110344$1$I$$20240626$20240718$20240718$PER$$US-009507513-2406USA009488$MERCK$$$$$M$Y$$$20240718$$CN$US$US
241103451$24110345$1$I$$20200512$20240718$20240718$EXP$$US-AstraZeneca-2020SE63583$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241103462$24110346$2$F$$20240909$20240718$20240919$EXP$$CA-ULTRAGENYX PHARMACEUTICAL INC.-CA-UGX-24-01355$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$$$20240919$$HP$CA$CA
241103471$24110347$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49699$$FDA-CTU$$75$YR$$M$N$$$20240718$N$$US$
241103481$24110348$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49713$$FDA-CTU$$75$YR$$F$N$67.13$KG$20240718$N$$US$
241103491$24110349$1$I$$20240717$20240717$20240717$DIR$710583$$FDA-CTU$$$$$UNK$N$$$20240717$$CN$US$
241103501$24110350$1$I$20240417$20240717$20240717$20240717$DIR$710602$$FDA-CTU$$8$YR$$F$N$55.35$KG$20240717$N$$US$
241103511$24110351$1$I$$20190717$20240718$20240718$EXP$$US-AstraZeneca-2019SF04484$ASTRAZENECA$$$$$M$Y$49$KG$20240718$$CN$US$
241103521$24110352$1$I$$20201103$20240718$20240718$EXP$$US-AstraZeneca-2020SF45454$ASTRAZENECA$$62$YR$$F$Y$$$20240718$$CN$US$
241103531$24110353$1$I$$20240710$20240718$20240718$EXP$$ZA-AstraZeneca-2024A159265$ASTRAZENECA$$29220$DY$$F$Y$$$20240718$$CN$ZA$
241103541$24110354$1$I$$20240627$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006895$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241103551$24110355$1$I$$20240627$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006894$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241103561$24110356$1$I$$20200403$20240718$20240718$EXP$$US-AstraZeneca-2020SE47832$ASTRAZENECA$$75$YR$$M$Y$$$20240718$$CN$US$
241103573$24110357$3$F$20240715$20240718$20240718$20240723$PER$$NVSC2024US147703$NOVARTIS$$79$YR$$F$Y$$$20240723$$CN$US$US
241103582$24110358$2$F$$20240710$20240718$20240723$EXP$$GB-AstraZeneca-2024A160246$ASTRAZENECA$$$$$$Y$$$20240723$$HP$GB$
241103591$24110359$1$I$$20240523$20240718$20240718$PER$$US-LUNDBECK-DKLU3078538$LUNDBECK$$$$$$Y$$$20240718$$HP$US$US
241103601$24110360$1$I$20200401$20200416$20240718$20240718$EXP$$TW-AstraZeneca-2020SE52143$ASTRAZENECA$$66$YR$$M$Y$$$20240718$$CN$TW$
241103611$24110361$1$I$$20200609$20240718$20240718$EXP$$US-AstraZeneca-2020SE75351$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241103621$24110362$1$I$20201207$20210312$20240718$20240718$EXP$$US-AstraZeneca-2020SF73321$ASTRAZENECA$$20463$DY$$F$Y$$$20240718$$CN$US$
241103631$24110363$1$I$20240610$20240717$20240718$20240718$EXP$FR-AFSSAPS-PB2024000785$FR-JNJFOC-20240744965$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240718$$MD$FR$FR
241103641$24110364$1$I$20200616$20200623$20240718$20240718$EXP$$US-AstraZeneca-2020SE80799$ASTRAZENECA$$21497$DY$$F$Y$82.6$KG$20240718$$CN$US$
241103651$24110365$1$I$20200116$20200121$20240718$20240718$EXP$$US-AstraZeneca-2020SE12079$ASTRAZENECA$$31161$DY$$M$Y$$$20240718$$CN$US$
241103671$24110367$1$I$$20201106$20240718$20240718$EXP$$US-AstraZeneca-2020SF48229$ASTRAZENECA$$71$YR$$F$Y$$$20240718$$CN$US$
241103681$24110368$1$I$20240601$20240628$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006924$INCYTE$$$$$$Y$$$20240718$$PH$US$US
241103691$24110369$1$I$20190615$20190911$20240718$20240718$EXP$$CO-AstraZeneca-2019SF01216$ASTRAZENECA$$28068$DY$$M$Y$$$20240718$$CN$CO$
241103701$24110370$1$I$$20240714$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN007401$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241103712$24110371$2$F$$20200910$20240718$20240726$EXP$$CA-AstraZeneca-2020SF16562$ASTRAZENECA$$66$YR$$F$Y$$$20240726$$MD$CA$
241103722$24110372$2$F$20240622$20240719$20240718$20240812$PER$$FR-TOLMAR, INC.-24FR050446$TOLMAR$$79$YR$$M$Y$$$20240812$$PH$FR$FR
241103731$24110373$1$I$20240625$20240625$20240718$20240718$PER$$FR-TOLMAR, INC.-24FR050485$TOLMAR$$65$YR$$M$Y$$$20240718$$PH$FR$FR
241103742$24110374$2$F$20240626$20240722$20240718$20240819$PER$$FR-TOLMAR, INC.-24FR050512$TOLMAR$$85$YR$$M$Y$$$20240819$$PH$FR$FR
241103752$24110375$2$F$20240626$20240722$20240718$20240819$PER$$FR-TOLMAR, INC.-24FR050518$TOLMAR$$57$YR$$M$Y$$$20240819$$PH$FR$FR
241103762$24110376$2$F$20240627$20240723$20240718$20240819$PER$$FR-TOLMAR, INC.-24FR050558$TOLMAR$$76$YR$$M$Y$$$20240819$$HP$FR$FR
241103772$24110377$2$F$20240627$20240723$20240718$20240819$PER$$FR-TOLMAR, INC.-24FR050577$TOLMAR$$$$E$M$Y$$$20240819$$PH$FR$FR
241103781$24110378$1$I$20240528$20240625$20240718$20240718$PER$$NL-TOLMAR, INC.-24NL050479$TOLMAR$$78$YR$$M$Y$$$20240718$$CN$NL$NL
241103791$24110379$1$I$$20240625$20240718$20240718$PER$$PL-TOLMAR, INC.-24PL050607$TOLMAR$$$$$$Y$$$20240718$$HP$PL$PL
241103802$24110380$2$F$20240612$20240710$20240718$20240808$PER$$NO-TOLMAR, INC.-24NO050325$TOLMAR$$$$$M$Y$$$20240808$$HP$NO$NO
241103811$24110381$1$I$$20240625$20240718$20240718$PER$$PL-TOLMAR, INC.-24PL050609$TOLMAR$$$$$$Y$$$20240718$$HP$PL$PL
241103821$24110382$1$I$20240625$20240625$20240718$20240718$PER$$TR-TOLMAR, INC.-24TR050528$TOLMAR$$69$YR$$$Y$$$20240718$$HP$TR$TR
241103831$24110383$1$I$$20240625$20240718$20240718$PER$$PL-TOLMAR, INC.-24PL050612$TOLMAR$$$$$$Y$$$20240718$$HP$PL$PL
241103841$24110384$1$I$20240627$20240627$20240718$20240718$PER$$US-TOLMAR, INC.-24US050563$TOLMAR$$7$YR$$F$Y$$$20240717$$MD$US$US
241103851$24110385$1$I$20200101$20240711$20240718$20240718$EXP$$HK-INCYTE CORPORATION-2024IN007425$INCYTE$$$$$$Y$$$20240718$$MD$HK$HK
241103861$24110386$1$I$20240501$20240523$20240718$20240718$PER$$US-LUNDBECK-DKLU3078486$LUNDBECK$$$$$$Y$$$20240718$$CN$US$US
241103872$24110387$2$F$20240618$20240722$20240718$20240730$EXP$$US-RDY-SPO/USA/24/0010295$DR REDDYS$$16$YR$T$F$Y$$$20240730$$CN$US$US
241103891$24110389$1$I$20240707$20240715$20240718$20240718$EXP$$NVSC2024GB125485$NOVARTIS$$$$$F$Y$$$20240718$$CN$GB$GB
241103911$24110391$1$I$$20240711$20240718$20240718$PER$$US-BIOGEN-2024BI01273415$BIOGEN$$$$$M$Y$$$20240718$$CN$US$US
241103931$24110393$1$I$20240628$20240712$20240718$20240718$EXP$$GB-AMGEN-GBRSP2024138906$AMGEN$$36$YR$A$F$Y$106$KG$20240718$$MD$GB$GB
241103941$24110394$1$I$$20240716$20240718$20240718$EXP$$US-INCYTE CORPORATION-2024IN007486$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241103951$24110395$1$I$$20240711$20240718$20240718$EXP$$IN-ROCHE-10000021612$ROCHE$$65$YR$E$M$Y$$$20240718$$CN$IN$IN
241103961$24110396$1$I$20240512$20240705$20240718$20240718$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000616$PAREXEL$$$$$$Y$$$20240718$$HP$CN$CN
241103981$24110398$1$I$20240716$20240717$20240717$20240717$DIR$710570$$FDA-CTU$$73$YR$$M$N$78$KG$20240717$N$PH$US$
241104001$24110400$1$I$20240714$20240717$20240717$20240717$DIR$710576$$FDA-CTU$$58$YR$$F$N$81$KG$20240717$N$CN$US$
241104011$24110401$1$I$20220909$20240517$20240718$20240718$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407009643$ELI LILLY AND CO$$29$YR$A$F$Y$62.7$KG$20240718$$CN$JP$JP
241104022$24110402$2$F$20240101$20240730$20240718$20240801$PER$$US-AMGEN-USASP2024139607$AMGEN$$$$A$F$Y$$$20240801$$MD$US$US
241104032$24110403$2$F$$20240808$20240718$20240812$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113271$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$41.9$KG$20240812$$MD$JP$JP
241104041$24110404$1$I$$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112491$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240718$$CN$US$US
241104051$24110405$1$I$$20240712$20240718$20240718$PER$$US-BAYER-2024A100932$BAYER$$37$YR$A$F$Y$$$20240718$$MD$US$US
241104063$24110406$3$F$20190726$20240823$20240718$20240830$EXP$$BR-SANDOZ INC.-PHHY2019BR179680$SANDOZ$$49$YR$$M$Y$95$KG$20240830$$CN$BR$BR
241104071$24110407$1$I$$20240717$20240718$20240718$PER$$US-PFIZER INC-PV202400094104$PFIZER$$62$YR$$F$Y$$$20240718$$CN$US$US
241104081$24110408$1$I$20240711$20240715$20240718$20240718$PER$$US-PFIZER INC-202400215091$PFIZER$$40$YR$$F$Y$59.87$KG$20240718$$CN$US$US
241104091$24110409$1$I$$20240705$20240718$20240718$PER$$US-PFIZER INC-PV202400092815$PFIZER$$$$E$F$Y$$$20240718$$HP$US$US
241104101$24110410$1$I$20240711$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217594$PFIZER$$44$YR$$M$Y$$$20240718$$CN$US$US
241104111$24110411$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-PV202400093489$PFIZER$$74$YR$$F$Y$$$20240718$$HP$US$US
241104122$24110412$2$F$$20240818$20240718$20240819$PER$$US-PFIZER INC-202400217788$PFIZER$$30$YR$$M$Y$$$20240819$$MD$US$US
241104131$24110413$1$I$20240613$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217803$PFIZER$$76$YR$$F$Y$70.31$KG$20240718$$PH$US$US
241104141$24110414$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-PV202400093012$PFIZER$$65$YR$$F$Y$$$20240718$$CN$US$US
241104152$24110415$2$F$20240716$20240809$20240718$20240813$PER$$US-PFIZER INC-202400217608$PFIZER$$63$YR$$F$Y$68.027$KG$20240813$$CN$US$US
241104161$24110416$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-202400216312$PFIZER$$41$YR$$M$Y$$$20240718$$CN$US$US
241104171$24110417$1$I$20230601$20240716$20240718$20240718$PER$$US-PFIZER INC-202300253936$PFIZER$$21$YR$$F$Y$$$20240718$$CN$US$US
241104181$24110418$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-202400217739$PFIZER$$84$YR$$F$Y$$$20240718$$HP$US$US
241104194$24110419$4$F$20240101$20240919$20240718$20240928$EXP$$CA-CELLTRION INC.-2024CA003256$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
241104201$24110420$1$I$20230327$20240716$20240718$20240718$EXP$FR-AFSSAPS-PO2024000789$FR-ABBVIE-5842368$ABBVIE$$39$YR$$F$Y$110$KG$20240717$$MD$FR$FR
241104211$24110421$1$I$20200609$20200716$20240718$20240718$EXP$$CA-AstraZeneca-2020SE82688$ASTRAZENECA$$19463$DY$$M$Y$$$20240718$$CN$CA$
241104221$24110422$1$I$$20201120$20240718$20240718$EXP$$US-AstraZeneca-2020SF55759$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241104231$24110423$1$I$$20240712$20240718$20240718$EXP$$ZA-AstraZeneca-2024A161194$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$ZA$
241104241$24110424$1$I$$20240715$20240718$20240718$EXP$$CA-BAYER-2024A103803$BAYER$$74$YR$E$M$Y$$$20240718$$CN$CA$CA
241104251$24110425$1$I$$20200602$20240718$20240718$EXP$$US-AstraZeneca-2020SE72578$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241104261$24110426$1$I$20240630$20240712$20240718$20240718$EXP$$MA-ROCHE-10000027526$ROCHE$$38$YR$A$F$Y$$$20240718$$MD$MA$MA
241104271$24110427$1$I$20240101$20240712$20240718$20240718$EXP$$US-AMGEN-USASP2024139086$AMGEN$$80$YR$E$$Y$$$20240718$$CN$US$US
241104282$24110428$2$F$20240608$20240726$20240718$20240803$EXP$FR-AFSSAPS-ST2024001108$FR-TEVA-VS-3220320$TEVA$$70$YR$$M$Y$74$KG$20240803$$PH$FR$FR
241104291$24110429$1$I$$20240716$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US066000$SANDOZ$$$$$F$Y$$$20240718$$MD$US$US
241104301$24110430$1$I$20240705$20240709$20240718$20240718$EXP$$CN-FreseniusKabi-FK202410964$FRESENIUS KABI$$62$YR$A$M$Y$59$KG$20240718$$HP$CN$CN
241104311$24110431$1$I$$20240709$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111545$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$56.15$KG$20240718$$HP$US$US
241104321$24110432$1$I$$20240715$20240718$20240718$EXP$$PT-FreseniusKabi-FK202411126$FRESENIUS KABI$$48$YR$A$F$Y$$$20240718$$MD$PT$PT
241104334$24110433$4$F$20230401$20240822$20240718$20240902$EXP$$CA-GSK-CA2023147198$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$CA$CA
241104341$24110434$1$I$20240701$20240712$20240718$20240718$EXP$$US-BAYER-2024A101713$BAYER$$34$YR$A$F$Y$$$20240718$$CN$US$US
241104351$24110435$1$I$20240714$20240717$20240717$20240717$DIR$710659$$FDA-CTU$$58$YR$$F$N$87.75$KG$20240717$N$CN$US$
241104362$24110436$2$F$$20240722$20240718$20240725$EXP$$US-UCBSA-2024034053$UCB$$$$$F$Y$$$20240725$$HP$US$US
241104374$24110437$4$F$20240812$20240913$20240718$20240916$EXP$$NVSC2024US146614$NOVARTIS$$59$YR$$F$Y$$$20240916$$CN$US$US
241104382$24110438$2$F$$20240710$20240718$20240723$PER$$NVSC2024US147486$NOVARTIS$$$$$M$Y$$$20240723$$CN$US$US
241104393$24110439$3$F$$20240807$20240718$20240809$EXP$FR-AFSSAPS-NT2024000885$FR-JNJFOC-20240748780$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240809$$MD$FR$FR
241104401$24110440$1$I$20240309$20240703$20240718$20240718$EXP$EU-AFSSAPS-AVMA2024000274$EU-ETHYPHARM-2024001749$ETHYPHARM$$$$$$Y$$$20240718$$PH$EU$
241104421$24110442$1$I$20240101$20240710$20240718$20240718$EXP$$JP-ROCHE-10000027659$ROCHE$$83$YR$E$M$Y$$$20240718$$MD$JP$JP
241104431$24110443$1$I$$20240716$20240718$20240718$EXP$$PH-BAYER-2024A101907$BAYER$$$$$$Y$$$20240718$$MD$PH$PH
241104441$24110444$1$I$$20240704$20240718$20240718$EXP$$US-ETHYPHARM-2024001857$ETHYPHARM$Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. Journal of medical toxicology. 2024. DOI: 10.1007/s13181-024-01016-x$$$N$$Y$$$20240718$$MD$US$
241104451$24110445$1$I$20231201$20240708$20240718$20240718$EXP$NO-NOMAADVRE-RELISM-2024-V8b58k$NO-TEVA-VS-3219122$TEVA$$51$YR$$F$Y$$$20240718$$MD$NO$NO
241104462$24110446$2$F$$20240927$20240718$20240927$PER$$NVSC2024US147542$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
241104471$24110447$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024142333$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
241104484$24110448$4$F$20240718$20240801$20240718$20240812$PER$$US-AMGEN-USASP2024142439$AMGEN$$64$YR$A$F$Y$$$20240812$$CN$US$US
241104491$24110449$1$I$20240607$20240710$20240718$20240718$EXP$$CN-SA-2024SA205616$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240718$$HP$CN$CN
241104511$24110451$1$I$20240629$20240717$20240717$20240717$DIR$710633$$FDA-CTU$$56$YR$$M$N$91.8$KG$20240717$N$CN$US$
241104531$24110453$1$I$20240709$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49720$$FDA-CTU$$87$YR$$F$N$$$20240718$N$HP$US$
241104541$24110454$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49706$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241104551$24110455$1$I$20240629$20240717$20240717$20240717$DIR$710577$$FDA-CTU$$73$YR$$F$N$67.5$KG$20240717$N$CN$US$
241104581$24110458$1$I$$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49694$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241104591$24110459$1$I$20240423$20240717$20240717$20240717$DIR$710573$$FDA-CTU$$77$YR$$F$N$84.6$KG$20240717$N$CN$US$
241104601$24110460$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49721$$FDA-CTU$$42$YR$$F$N$$$20240718$N$$US$
241104611$24110461$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49715$$FDA-CTU$$62$YR$$F$N$$$20240718$N$$US$
241104621$24110462$1$I$20230621$20240711$20240718$20240718$EXP$$AR-GSK-AR2023AMR090542$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$AR$AR
241104631$24110463$1$I$20090101$20240716$20240718$20240718$EXP$$US-UCBSA-2024036188$UCB$$$$$M$Y$$$20240718$$HP$US$US
241104641$24110464$1$I$$20240704$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06905$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241104661$24110466$1$I$$20240709$20240718$20240718$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06133$VIFOR$$$$A$M$Y$$$20240718$$HP$ZA$ZA
241104672$24110467$2$F$$20240802$20240718$20240809$EXP$$US-Vifor (International) Inc.-VIT-2024-06231$VIFOR$$$$E$F$Y$$$20240809$$CN$US$US
241104691$24110469$1$I$20240510$20240711$20240718$20240718$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06212$VIFOR$$64$YR$$M$Y$$$20240718$$HP$ZA$ZA
241104701$24110470$1$I$$20240710$20240718$20240718$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06178$VIFOR$$$$A$M$Y$$$20240718$$HP$ZA$ZA
241104711$24110471$1$I$$20240709$20240718$20240718$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06139$VIFOR$$$$A$M$Y$$$20240718$$CN$ZA$ZA
241104721$24110472$1$I$20240501$20240713$20240718$20240718$EXP$$US-SA-2024SA209287$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240718$$MD$US$US
241104731$24110473$1$I$20240101$20240712$20240718$20240718$PER$$US-BAUSCH-BL-2024-010714$BAUSCH AND LOMB$$68$YR$$F$Y$95.7$KG$20240718$$CN$US$US
241104741$24110474$1$I$20240716$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114520$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240718$$HP$US$US
241104751$24110475$1$I$$20240717$20240718$20240718$EXP$GB-MHRA-MED-202407171042467250-HLSVN$GB-ORGANON-O2407GBR001681$ORGANON$$60$YR$$F$Y$$$20240718$$PH$GB$GB
241104761$24110476$1$I$20230701$20240708$20240718$20240718$EXP$$US-RADIUS HEALTH INC.-2023US005496$RADIUS PHARM$$78$YR$$M$Y$$$20240718$$CN$US$US
241104771$24110477$1$I$20240712$20240712$20240718$20240718$PER$$US-ABBVIE-5841836$ABBVIE$$38$YR$$F$Y$$$20240718$$CN$US$US
241104791$24110479$1$I$20240423$20240710$20240718$20240718$EXP$FR-AFSSAPS-PV2024000548$FR-TEVA-VS-3219870$TEVA$$11$MON$$M$Y$10$KG$20240718$$MD$FR$FR
241104801$24110480$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011273$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240718$$CN$US$US
241104814$24110481$4$F$$20240809$20240718$20240816$EXP$$CA-GSK-CA2024004580$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$CA$CA
241104821$24110482$1$I$$20210430$20240718$20240718$EXP$$BR-ASTELLAS-2024EU007022$ASTELLAS$De Sousa MV, de Siqueira Guida JP, de Castro Surita FG, Parpinelli MA, do Nascimento MLC, Mazzali M. Twin pregnancy after kidney transplantation: case report and systematic review. Brazilian Journal of Nephrology. 2021;43(1):121-7$$$$$Y$$$20240718$$HP$BR$BR
241104831$24110483$1$I$$20240711$20240718$20240718$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003893$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240718$$CN$FR$FR
241104841$24110484$1$I$20240101$20240715$20240718$20240718$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003933$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240718$$CN$US$US
241104851$24110485$1$I$$20240712$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010778$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241104861$24110486$1$I$$20240716$20240718$20240718$PER$$US-PFIZER INC-202400216234$PFIZER$$$$$M$Y$$$20240718$$HP$US$US
241104881$24110488$1$I$$20240717$20240718$20240718$PER$$US-PFIZER INC-202400217233$PFIZER$$$$$F$Y$$$20240718$$CN$US$US
241104891$24110489$1$I$$20240717$20240718$20240718$EXP$$JP-PFIZER INC-202400217704$PFIZER$$85$YR$$M$Y$$$20240718$$MD$JP$JP
241104901$24110490$1$I$20240715$20240716$20240718$20240718$PER$$US-PFIZER INC-202400216276$PFIZER$$27$YR$$F$Y$99.79$KG$20240718$$CN$US$US
241104911$24110491$1$I$20240716$20240716$20240718$20240718$PER$$US-PFIZER INC-202400216568$PFIZER$$$$$$Y$$$20240718$$CN$US$US
241104921$24110492$1$I$$20240717$20240718$20240718$PER$$US-PFIZER INC-PV202400093785$PFIZER$$62$YR$$F$Y$113.85$KG$20240718$$HP$US$US
241104932$24110493$2$F$20240709$20240717$20240718$20240722$PER$$US-PFIZER INC-202400216295$PFIZER$$$$A$F$Y$$$20240722$$HP$US$US
241104941$24110494$1$I$$20240717$20240718$20240718$EXP$$AR-PFIZER INC-202400218592$PFIZER$$48$YR$$F$Y$$$20240718$$CN$AR$AR
241104951$24110495$1$I$20240520$20240717$20240717$20240717$DIR$710656$$FDA-CTU$$87$YR$$F$N$$$20240717$Y$PH$US$
241104961$24110496$1$I$$20240712$20240718$20240718$PER$$US-PFIZER INC-202400215105$PFIZER$$$$$F$Y$$$20240718$$CN$US$US
241104991$24110499$1$I$$20240717$20240717$20240717$DIR$710586$$FDA-CTU$$$$$UNK$N$$$20240717$$CN$US$
241105001$24110500$1$I$20240101$20240715$20240718$20240718$EXP$$US-JNJFOC-20240739777$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240718$$HP$US$US
241105022$24110502$2$F$20240612$20240726$20240718$20240730$EXP$$US-PHARMING-PHAUS2024000594$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
241105031$24110503$1$I$$20240711$20240718$20240718$PER$$US-PHARMING-PHAUS2024000587$PHARMING GROUP$$$$$$Y$$$20240718$$CN$US$US
241105042$24110504$2$F$$20240910$20240718$20240916$PER$$US-PHARMING-PHAUS2024000595$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
241105051$24110505$1$I$$20240709$20240718$20240718$PER$$US-PHARMING-PHAUS2024000585$PHARMING GROUP$$$$$$Y$$$20240718$$CN$US$US
241105061$24110506$1$I$$20240708$20240718$20240718$EXP$$RU-EMD Serono-2024037214$EMD SERONO INC$$59$YR$A$M$Y$$$20240718$$MD$RU$RU
241105071$24110507$1$I$$20240712$20240718$20240718$EXP$$ZA-ABBVIE-5842313$ABBVIE$$60$YR$$M$Y$$$20240718$$CN$ZA$ZA
241105082$24110508$2$F$20240711$20240719$20240718$20240730$EXP$$US-PHARMING-PHAUS2024000598$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
241105102$24110510$2$F$$20240908$20240718$20240909$PER$$US-PFIZER INC-PV202400093094$PFIZER$$54$YR$$F$Y$$$20240909$$CN$US$US
241105112$24110511$2$F$$20240906$20240718$20240906$PER$$US-PFIZER INC-2018277878$PFIZER$$33$YR$$M$Y$$$20240906$$CN$US$US
241105121$24110512$1$I$20240101$20240713$20240718$20240718$PER$$US-PFIZER INC-PV202400092567$PFIZER$$20$YR$$$Y$$$20240718$$CN$US$US
241105131$24110513$1$I$20240101$20240710$20240718$20240718$EXP$$US-AMGEN-USASP2024137373$AMGEN$$63$YR$A$F$Y$$$20240718$$CN$US$US
241105141$24110514$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5841813$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241105151$24110515$1$I$$20240712$20240718$20240718$PER$$US-ABBVIE-5841796$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241105161$24110516$1$I$$20240712$20240718$20240718$EXP$$US-PHARMING-PHAUS2024000591$PHARMING GROUP$$$$$$Y$$$20240718$$CN$US$US
241105171$24110517$1$I$$20240711$20240718$20240718$EXP$$CA-SA-2024SA205688$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240718$$HP$CA$CA
241105181$24110518$1$I$20240615$20240711$20240718$20240718$DIR$FDA-CDER-CTU-2024-49707$$FDA-CTU$$32$YR$$M$N$$$20240711$N$HP$US$
241105191$24110519$1$I$20240625$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49733$$FDA-CTU$$77$YR$$M$N$$$20240718$N$HP$US$
241105201$24110520$1$I$20240715$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49705$$FDA-CTU$$35$YR$$F$N$$$20240717$N$HP$US$
241105211$24110521$1$I$20240715$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49722$$FDA-CTU$$35$YR$$M$N$$$20240718$N$$US$
241105231$24110523$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49751$$FDA-CTU$$35$YR$$M$N$$$20240718$N$$US$
241105241$24110524$1$I$20240401$20240717$20240718$20240718$PER$$NVSC2024US148170$NOVARTIS$$80$YR$$M$Y$$$20240718$$MD$US$US
241105251$24110525$1$I$20240101$20240716$20240718$20240718$EXP$$US-ABBVIE-5843024$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241105261$24110526$1$I$20230101$20240716$20240718$20240718$EXP$$US-ABBVIE-5843612$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241105271$24110527$1$I$$20240714$20240718$20240718$EXP$$CA-ASTELLAS-2024US020208$ASTELLAS$$7$YR$$F$Y$$$20240718$$CN$CA$CA
241105281$24110528$1$I$$20240716$20240718$20240718$EXP$$NVSC2024CA147251$NOVARTIS$$37$YR$$F$Y$$$20240718$$HP$CA$CA
241105311$24110531$1$I$$20240710$20240718$20240718$EXP$$US-AMGEN-USASP2024137948$AMGEN$Kodati S.; Oyeniran E.; Wiley H. et al.. Extensive subretinal fibrosis associated with pseudoxanthoma elasticum. Retinal Cases + Brief Reports. 2024;18 (4):512-516$24$YR$A$F$Y$$$20240718$$MD$US$US
241105321$24110532$1$I$$20240626$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006887$INCYTE$$$$$$Y$$$20240718$$MD$US$US
241105331$24110533$1$I$$20240717$20240717$20240717$DIR$710607$$FDA-CTU$$$$$UNK$N$$$20240717$N$CN$US$
241105341$24110534$1$I$$20240715$20240718$20240718$PER$$US-ROCHE-10000030724$ROCHE$Krooks J, Weatherall A. Angela Weatherall MD. Rituximab-induced serum sickness in pemphigus vulgaris: a case report and literature review. Pract Dermatol. 2019;(2):75-8.$38$YR$A$F$Y$$$20240718$$HP$US$US
241105362$24110536$2$F$$20240716$20240718$20240726$EXP$$JP-TAKEDA-2024TUS072356$TAKEDA$$75$YR$$M$Y$$$20240726$$PH$JP$JP
241105372$24110537$2$F$20240614$20240723$20240718$20240726$EXP$$NVSC2024BR133674$NOVARTIS$$44$YR$$F$Y$$$20240726$$CN$BR$BR
241105382$24110538$2$F$20240716$20240716$20240718$20240720$PER$$US-JNJFOC-20240743223$JOHNSON AND JOHNSON$$95$YR$E$F$Y$$$20240719$$CN$US$US
241105393$24110539$3$F$20240711$20240726$20240718$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113102$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240805$$PH$JP$JP
241105401$24110540$1$I$20240715$20240717$20240718$20240718$EXP$$PH-ABBVIE-5844644$ABBVIE$$72$YR$$F$Y$$$20240718$$MD$PH$PH
241105411$24110541$1$I$$20240715$20240718$20240718$EXP$$NVSC2024IL148032$NOVARTIS$$$$$M$Y$$$20240718$$MD$IL$IL
241105422$24110542$2$F$20240719$20240719$20240718$20240812$PER$$US-AMGEN-USASP2024142034$AMGEN$$71$YR$E$F$Y$$$20240812$$CN$US$US
241105431$24110543$1$I$$20240612$20240718$20240718$EXP$$SG-ROCHE-10000002682$ROCHE$$56$YR$A$$Y$$$20240718$$CN$SG$SG
241105441$24110544$1$I$20240711$20240711$20240718$20240718$EXP$$IT-AstraZeneca-2024A162146$ASTRAZENECA$$$$$F$Y$$$20240718$$MD$IT$
241105452$24110545$2$F$$20240729$20240718$20240806$EXP$$US-ZENPEP LLC-2024AIMT01083$AIMMUNE$$$$$$Y$$$20240806$$HP$US$US
241105461$24110546$1$I$20240601$20240711$20240718$20240718$EXP$$US-Vifor (International) Inc.-VIT-2024-06233$VIFOR$$43$YR$$M$Y$89$KG$20240718$$HP$US$US
241105471$24110547$1$I$$20240716$20240718$20240718$EXP$$AU-SANDOZ INC.-SDZ2024AU065814$SANDOZ$$13$YR$$$Y$$$20240718$$HP$AU$AU
241105481$24110548$1$I$$20240716$20240718$20240718$EXP$$US-UCBSA-2024036275$UCB$$$$$$Y$$$20240718$$CN$US$US
241105501$24110550$1$I$$20240712$20240718$20240718$EXP$$JP-009507513-2407JPN002811J$MERCK$$60$YR$$F$Y$$$20240718$$MD$JP$JP
241105521$24110552$1$I$20240717$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49714$$FDA-CTU$$72$YR$$M$N$$$20240718$N$HP$US$
241105531$24110553$1$I$20240612$20240717$20240717$20240717$DIR$710675$$FDA-CTU$$59$YR$$F$N$$$20240717$Y$PH$US$
241105541$24110554$1$I$20240716$20240717$20240717$20240717$DIR$710591$$FDA-CTU$$59$YR$$F$N$71.3$KG$20240717$N$PH$US$
241105551$24110555$1$I$20240717$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49704$$FDA-CTU$$75$YR$$F$N$$$20240717$N$HP$US$
241105561$24110556$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49718$$FDA-CTU$$80$YR$$F$N$$$20240718$N$$US$
241105571$24110557$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49737$$FDA-CTU$$55$YR$$M$N$$$20240718$N$$US$
241105591$24110559$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114560$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240718$$CN$US$US
241105601$24110560$1$I$20240601$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114154$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240718$$HP$US$US
241105611$24110561$1$I$$20240716$20240718$20240718$EXP$$NVSC2024CA147120$NOVARTIS$$70$YR$$F$Y$65$KG$20240718$$MD$CA$CA
241105632$24110563$2$F$$20240911$20240718$20240913$EXP$$NVSC2024CA147233$NOVARTIS$$74$YR$$F$Y$$$20240913$$HP$CA$CA
241105641$24110564$1$I$$20240707$20240718$20240718$PER$$US-JNJFOC-20240721416$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
241105653$24110565$3$F$20240701$20240828$20240718$20240910$PER$$US-JNJFOC-20240739514$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240910$$PH$US$US
241105661$24110566$1$I$20240601$20240716$20240718$20240718$EXP$$CA-JNJFOC-20240748102$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240718$$HP$CA$CA
241105671$24110567$1$I$20220801$20240712$20240718$20240718$EXP$$US-ABBVIE-5784311$ABBVIE$$71$YR$$M$Y$70.306$KG$20240718$$CN$US$US
241105681$24110568$1$I$$20240712$20240718$20240718$EXP$$US-ROCHE-10000025923$ROCHE$$62$YR$A$F$Y$$$20240718$$CN$US$US
241105691$24110569$1$I$20240521$20240709$20240718$20240718$EXP$$EG-TERSERA THERAPEUTICS LLC-2024TRS003621$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$CN$EG$EG
241105701$24110570$1$I$$20240711$20240718$20240718$EXP$$NVSC2024US145224$NOVARTIS$$$$$F$Y$$$20240718$$CN$US$US
241105712$24110571$2$F$20240409$20240719$20240718$20240726$EXP$$NVSC2024US104422$NOVARTIS$$51$YR$$M$Y$$$20240726$$CN$US$US
241105721$24110572$1$I$$20240715$20240718$20240718$PER$$US-ROCHE-10000027148$ROCHE$$$$$$Y$$$20240718$$PH$US$US
241105731$24110573$1$I$$20240715$20240718$20240718$PER$$US-ROCHE-10000027289$ROCHE$$$$$$Y$$$20240718$$PH$US$US
241105741$24110574$1$I$$20240712$20240718$20240718$PER$$US-ROCHE-10000025938$ROCHE$$$$$$Y$$$20240718$$PH$US$US
241105751$24110575$1$I$$20240712$20240718$20240718$EXP$$US-GSK-US2024087717$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$CN$US$US
241105762$24110576$2$F$$20240715$20240718$20240803$PER$$US-ROCHE-10000028481$ROCHE$$$$$$Y$$$20240803$$CN$US$US
241105771$24110577$1$I$$20240715$20240718$20240718$PER$$US-ROCHE-10000027883$ROCHE$$$$A$F$Y$$$20240718$$CN$US$US
241105781$24110578$1$I$20240101$20240715$20240718$20240718$PER$$US-ROCHE-10000028841$ROCHE$$74$YR$E$F$Y$$$20240718$$CN$US$US
241105791$24110579$1$I$$20240705$20240718$20240718$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06523$LUPIN$Oomrigar SC, Fernandez J, Rivera Ortiz C, Rajen H, Toll A, Perez Colome E, et al. The highest form of flattery: Bupropion overdose mimicking brain death. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5653$$$$F$Y$$$20240718$$HP$US$US
241105801$24110580$1$I$$20240709$20240718$20240718$EXP$$US-INDIVIOR US-INDV-145904-2024$RECKITT BENCKISER$Jessica Moore, Kalvin Foo, Ernest Egu, Xin Gao, Rachel Ehrman-Dupre, Matthew Salzman. Diagnosis and treatment of presumed Naltrexone-XR-precipitated Opioid withdrawal in a patient chronically treated with Buprenorphine-XR: A Case Report. Journal of addiction medicine. 2024$61$YR$$M$Y$$$20240718$$MD$US$US
241105812$24110581$2$F$$20240611$20240718$20240729$PER$$US-TRAVERE-2024TVT00577$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240729$$CN$US$US
241105823$24110582$3$F$20240606$20240710$20240718$20240815$PER$$US-TRAVERE-2024TVT00578$TRAVERE THERAPEUTICS$$49$YR$A$F$Y$$$20240815$$CN$US$US
241105831$24110583$1$I$20210101$20240713$20240718$20240718$EXP$$IT-ORGANON-O2305ITA002839$ORGANON$$30$YR$$F$Y$$$20240718$$MD$IT$IT
241105841$24110584$1$I$$20240716$20240718$20240718$EXP$SK-SUKLSK-20240437$SK-DSJP-DSE-2024-135955$DAIICHI$$71$YR$$F$Y$$$20240718$$MD$SK$SK
241105852$24110585$2$F$20240402$20240719$20240718$20240724$EXP$$JP-DSJP-DSJ-2024-114964AA$DAIICHI$$82$YR$$M$Y$$$20240724$$MD$JP$JP
241105861$24110586$1$I$20240625$20240626$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006854$INCYTE$$$$$$Y$$$20240718$$PH$US$US
241105871$24110587$1$I$20050101$20240712$20240718$20240718$EXP$FR-AFSSAPS-AVCN2024000536$FR-INDIVIOR UK LIMITED-INDV-145962-2024$RECKITT BENCKISER$$$$$$Y$$$20240718$$MD$FR$FR
241105881$24110588$1$I$$20240717$20240718$20240718$EXP$$AU-SANDOZ INC.-SDZ2024AU066069$SANDOZ$$$$$$Y$$$20240718$$HP$AU$AU
241105891$24110589$1$I$20240531$20240718$20240718$20240718$EXP$ES-AEMPS-1547648$ES-BAYER-2024A104705$BAYER$$75$YR$E$F$Y$$$20240718$$HP$ES$ES
241105901$24110590$1$I$$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002332J$MERCK$$66$YR$$M$Y$$$20240718$$MD$JP$JP
241105911$24110591$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49754$$FDA-CTU$$60$YR$$M$N$195.95$KG$20240718$N$$US$
241105921$24110592$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49712$$FDA-CTU$$70$YR$$F$N$$$20240718$N$$US$
241105931$24110593$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49724$$FDA-CTU$$77$YR$$F$N$$$20240718$N$$US$
241105941$24110594$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49750$$FDA-CTU$$68$YR$$M$N$$$20240718$N$$US$
241105951$24110595$1$I$20240319$20240717$20240717$20240717$DIR$710551$$FDA-CTU$$37$YR$$F$N$142.65$KG$20240717$N$PH$US$
241105961$24110596$1$I$$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49703$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241105971$24110597$1$I$$20240717$20240717$20240717$DIR$710628$$FDA-CTU$$$$$UNK$N$$$20240717$N$CN$US$
241105981$24110598$1$I$20230101$20240715$20240718$20240718$EXP$DK-DKMA-30734572$DK-UCBSA-2024035728$UCB$$27$YR$$F$Y$$$20240718$$MD$DK$DK
241105991$24110599$1$I$20240401$20240614$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006426$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241106001$24110600$1$I$$20240709$20240718$20240718$EXP$$CA-BAXTER-2024BAX021397$BAXTER$$54$YR$$F$Y$$$20240718$$CN$CA$CA
241106011$24110601$1$I$20240427$20240710$20240718$20240718$EXP$$EG-BAXTER-2024BAX021588$BAXTER$$8$YR$$M$Y$22$KG$20240718$$PH$EG$EG
241106021$24110602$1$I$20240630$20240711$20240718$20240718$EXP$CN-NMPACDR-3708281020400202400536$CN-BAXTER-2024BAX021632$BAXTER$$52$YR$$F$Y$65$KG$20240718$$MD$CN$CN
241106031$24110603$1$I$$20240614$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006408$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241106041$24110604$1$I$$20240708$20240718$20240718$EXP$$US-BAXTER-2024BAX021322$BAXTER$$58$YR$$F$Y$$$20240718$$CN$US$US
241106051$24110605$1$I$20240501$20240612$20240718$20240718$EXP$$NVSC2024IN147429$NOVARTIS$$32$YR$$F$Y$$$20240718$$CN$IN$IN
241106061$24110606$1$I$20240603$20240715$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112867$BRISTOL MYERS SQUIBB$$37$YR$A$M$Y$$$20240718$$CN$US$US
241106072$24110607$2$F$20240101$20240919$20240718$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109363$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240928$$CN$US$US
241106081$24110608$1$I$$20201214$20240718$20240718$EXP$$US-AstraZeneca-2020SF69700$ASTRAZENECA$$43$YR$$F$Y$$$20240718$$HP$US$
241106092$24110609$2$F$20240523$20240904$20240718$20240906$PER$$US-AstraZeneca-2024A161616$ASTRAZENECA$$78$YR$$M$Y$70.3$KG$20240906$$CN$US$
241106101$24110610$1$I$$20240712$20240718$20240718$EXP$$IT-AstraZeneca-2024A162176$ASTRAZENECA$$$$$M$Y$$$20240718$$MD$IT$
241106111$24110611$1$I$20240613$20240716$20240718$20240718$EXP$$US-AstraZeneca-2024A162559$ASTRAZENECA$$27840$DY$$M$Y$$$20240718$$MD$US$
241106131$24110613$1$I$20240711$20240711$20240718$20240718$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS003628$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$CN$NL$NL
241106141$24110614$1$I$$20240709$20240718$20240718$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003622$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$CN$AU$AU
241106151$24110615$1$I$20240515$20240712$20240718$20240718$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS003636$TERSERA THERAPEUTICS$$$$$$Y$$$20240718$$PH$NL$NL
241106161$24110616$1$I$$20240716$20240718$20240718$EXP$IT-MINISAL02-990090$IT-ORGANON-O2406ITA001725$ORGANON$$48$YR$$F$Y$65$KG$20240718$$MD$IT$IT
241106171$24110617$1$I$20231001$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002306J$MERCK$$72$YR$$F$Y$$$20240718$$MD$JP$JP
241106181$24110618$1$I$20230101$20240709$20240718$20240718$EXP$$US-UNITED THERAPEUTICS-UNT-2023-036768$UNITED THERAPEUTICS$$$$$M$Y$$$20240718$$$US$US
241106191$24110619$1$I$$20240607$20240718$20240718$PER$$US-TRAVERE-2024TVT00579$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240718$$CN$US$US
241106203$24110620$3$F$$20240919$20240718$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111296$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240924$$CN$US$US
241106211$24110621$1$I$20240713$20240715$20240718$20240718$EXP$$CN-FreseniusKabi-FK202411225$FRESENIUS KABI$$39$YR$A$M$Y$71$KG$20240718$$HP$CN$CN
241106221$24110622$1$I$$20240715$20240718$20240718$EXP$$CA-ROCHE-10000028921$ROCHE$$$$A$F$Y$$$20240718$$HP$CA$CA
241106231$24110623$1$I$$20240712$20240718$20240718$30DAY$$TW-SA-2024SA207318$SANOFI AVENTIS$$$$A$$Y$$$20240718$$HP$TW$TW
241106241$24110624$1$I$$20240716$20240718$20240718$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040148$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$CN$JP$JP
241106251$24110625$1$I$$20240715$20240718$20240718$PER$$NVSC2024US147361$NOVARTIS$$$$$F$Y$$$20240718$$CN$US$US
241106261$24110626$1$I$20230517$20240626$20240718$20240718$EXP$ES-AEMPS-1539146$NVSC2024ES140083$NOVARTIS$$84$YR$$F$Y$$$20240718$$PH$ES$ES
241106274$24110627$4$F$20240711$20240820$20240718$20240825$30DAY$$US-AMGEN-USASL2024139229$AMGEN$$69$YR$E$M$Y$$$20240825$$PH$US$US
241106281$24110628$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49716$$FDA-CTU$$62$YR$$F$N$$$20240718$N$$US$
241106292$24110629$2$F$20240621$20240812$20240718$20240816$EXP$$US-AstraZeneca-2024A162703$ASTRAZENECA$$29373$DY$$F$Y$$$20240816$$MD$US$
241106302$24110630$2$F$20240425$20240905$20240718$20240906$EXP$$US-AstraZeneca-2024A161644$ASTRAZENECA$$$$$F$Y$$$20240906$$MD$US$
241106311$24110631$1$I$20210930$20240710$20240718$20240718$EXP$$JP-AstraZeneca-2021A853141$ASTRAZENECA$$70$YR$$F$Y$$$20240718$$MD$JP$
241106342$24110634$2$F$$20240710$20240718$20240815$EXP$$US-AstraZeneca-2024A159454$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
241106351$24110635$1$I$$20190926$20240718$20240718$EXP$$US-AstraZeneca-2019SF39296$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241106361$24110636$1$I$20240716$20240717$20240717$20240717$DIR$710649$$FDA-CTU$$70$YR$$M$N$99.1$KG$20240717$Y$MD$US$
241106371$24110637$1$I$$20240717$20240717$20240717$DIR$710582$$FDA-CTU$$$$$UNK$N$$$20240717$$CN$US$
241106381$24110638$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011415$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240718$$CN$US$US
241106391$24110639$1$I$$20240713$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010255$ELI LILLY AND CO$$$$$$Y$$$20240718$$CN$US$US
241106401$24110640$1$I$20231105$20240715$20240718$20240718$EXP$$FR-AstraZeneca-2024A162220$ASTRAZENECA$$1$WK$$F$Y$3.7$KG$20240718$$MD$FR$
241106411$24110641$1$I$$20200727$20240718$20240718$EXP$$US-AstraZeneca-2020SE96224$ASTRAZENECA$$42$YR$$F$Y$$$20240718$$CN$US$
241106421$24110642$1$I$20240717$20240717$20240717$20240717$DIR$710646$$FDA-CTU$$56$YR$$M$N$72.9$KG$20240717$N$MD$US$
241106431$24110643$1$I$20240227$20240717$20240717$20240717$DIR$710648$$FDA-CTU$$83$YR$$M$N$$$20240717$N$HP$US$
241106451$24110645$1$I$20240715$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49772$$FDA-CTU$$12$YR$$F$N$$$20240718$N$HP$US$
241106461$24110646$1$I$20240713$20240717$20240717$20240717$DIR$710611$$FDA-CTU$$39$YR$$M$N$83.25$KG$20240717$N$CN$US$
241106482$24110648$2$F$$20240819$20240718$20240820$PER$$US-AstraZeneca-2024A158351$ASTRAZENECA$$33$YR$$F$Y$100.1$KG$20240820$$HP$US$
241106491$24110649$1$I$$20240708$20240718$20240718$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02541$AMNEAL$$$$$F$Y$$$20240718$$CN$US$US
241106502$24110650$2$F$20240628$20240820$20240718$20240822$PER$$US-JNJFOC-20240738363$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240822$$MD$US$US
241106511$24110651$1$I$$20240716$20240718$20240718$PER$$US-JNJFOC-20240743828$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$MD$US$US
241106521$24110652$1$I$$20240715$20240718$20240718$EXP$$US-JNJFOC-20240743119$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$HP$US$US
241106532$24110653$2$F$$20240711$20240718$20240725$EXP$$US-CIPLA (EU) LIMITED-2024US07331$CIPLA$$$$$$Y$$$20240725$$MD$US$US
241106541$24110654$1$I$20221101$20240705$20240718$20240718$EXP$$AU-CIPLA LTD.-2024AU07603$CIPLA$$$$$$Y$$$20240718$$CN$AU$AU
241106554$24110655$4$F$$20240819$20240718$20240820$EXP$$CZ-SANDOZ INC.-SDZ2024CZ065668$SANDOZ$$7$WK$$M$Y$$$20240820$$HP$CZ$CZ
241106561$24110656$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113562$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240718$$CN$US$US
241106571$24110657$1$I$$20240704$20240718$20240718$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06459$LUPIN$Zardoost P, Buckman Z, Weaver J, Elston S, Prouty A, Stuart R, et al. Continuous renal replacement therapy for lithium toxicity: A worthy treatment to avoid intradialytic hypotension and vasopressors. Clinical Case Reports. 2024;12 (4):1-4$54$YR$$F$Y$$$20240718$$HP$US$US
241106581$24110658$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113254$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240718$$HP$US$US
241106591$24110659$1$I$$20240705$20240718$20240718$EXP$$AU-CIPLA LTD.-2024AU07605$CIPLA$$$$$$Y$$$20240718$$MD$AU$AU
241106601$24110660$1$I$$20240705$20240718$20240718$EXP$$AU-CIPLA LTD.-2024AU07541$CIPLA$$$$$$Y$$$20240718$$HP$AU$AU
241106611$24110661$1$I$20240101$20240708$20240718$20240718$EXP$$US-TEVA-VS-3219914$TEVA$$$$$F$Y$$$20240718$$CN$US$US
241106621$24110662$1$I$20240607$20240705$20240718$20240718$EXP$$AU-CIPLA LTD.-2024AU07530$CIPLA$$$$$$Y$$$20240718$$MD$AU$AU
241106631$24110663$1$I$20240101$20240621$20240718$20240718$PER$$US-009507513-2406USA007694$MERCK$$$$$M$Y$$$20240718$$MD$US$US
241106641$24110664$1$I$20240311$20240711$20240718$20240718$EXP$$TW-DSJP-DSJ-2024-135272$DAIICHI$$79$YR$$M$Y$67$KG$20240718$$MD$TW$TW
241106651$24110665$1$I$$20240703$20240718$20240718$EXP$$US-COOPERSURGICAL, INC.-2024CPS002104$COOPERSURGICAL$$$$$F$Y$$$20240718$$MD$US$US
241106661$24110666$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-PV202400093260$PFIZER$$86$YR$$M$Y$$$20240718$$MD$US$US
241106671$24110667$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-202400217193$PFIZER$$51$YR$$F$Y$$$20240718$$HP$US$US
241106681$24110668$1$I$20240101$20240708$20240718$20240718$PER$$US-BIOMARINAP-US-2024-159195$BIOMARIN$$$$$$Y$$$20240718$$CN$US$US
241106692$24110669$2$F$20240101$20240731$20240718$20240808$PER$$US-UNITED THERAPEUTICS-UNT-2024-015120$UNITED THERAPEUTICS$$$$$F$Y$83.9$KG$20240808$$$US$US
241106701$24110670$1$I$20240712$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141744$AMGEN$$$$$$Y$$$20240718$$HP$US$US
241106717$24110671$7$F$20240101$20240913$20240718$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-019909$UNITED THERAPEUTICS$$$$$M$Y$107.03$KG$20240920$$$US$US
241106721$24110672$1$I$20231205$20240206$20240718$20240718$EXP$FR-AFSSAPS-AN2023001684$FR-TEVA-VS-3157012$TEVA$$1$YR$$F$Y$9$KG$20240718$$MD$FR$FR
241106731$24110673$1$I$$20240711$20240718$20240718$EXP$$NVSC2024US144631$NOVARTIS$Kuruppu D, Nguyen J, Milas M, Nasr C, Niu J, Shellenberger T.. Neoadjuvant Tyrosine Kinase Inhibitor Therapy Enables Surgery for Previously Unresectable 15cm Anaplastic Thyroid Cancer. ENDOCRINE PRACTICE. 2024;30:S163$63$YR$$M$Y$$$20240718$$HP$US$US
241106741$24110674$1$I$20240607$20240705$20240718$20240718$PER$$US-SA-2024SA203178$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240718$$MD$US$US
241106753$24110675$3$F$$20240809$20240718$20240813$EXP$IE-ASPEN-GLO2020IE008156$NVSC2020IE357640$NOVARTIS$Keane NA, Lane LM, Canniff E, Hare D, Doran S, Wallace E et al. A Surviving Case of Acanthamoeba Granulomatous Amebic Encephalitis in a Hematopoietic Stem Cell Transplant Recipient. AM J CASE REP. 2020;21 (1-6):e923219-6$32$YR$$M$Y$$$20240813$$HP$IE$IE
241106761$24110676$1$I$20240714$20240715$20240718$20240718$PER$$US-PFIZER INC-202400215396$PFIZER$$78$YR$$M$Y$$$20240718$$CN$US$US
241106771$24110677$1$I$20240701$20240717$20240718$20240718$EXP$$US-PFIZER INC-PV202400093919$PFIZER$$85$YR$$F$Y$$$20240718$$HP$US$US
241106781$24110678$1$I$20240315$20240715$20240718$20240718$EXP$$FR-PFIZER INC-202400214810$PFIZER$$51$YR$$F$Y$83$KG$20240718$$HP$FR$FR
241106791$24110679$1$I$20231001$20240717$20240717$20240717$DIR$710654$$FDA-CTU$$67$YR$$M$N$135$KG$20240717$N$CN$US$
241106801$24110680$1$I$20240628$20240716$20240718$20240718$EXP$$CN-PFIZER INC-PV202400093369$PFIZER$$8$YR$$M$Y$24.1$KG$20240718$$HP$CN$CN
241106811$24110681$1$I$$20240711$20240718$20240718$EXP$$CA-PFIZER INC-202400213579$PFIZER$$81$YR$$M$Y$78.458$KG$20240718$$HP$CA$CA
241106821$24110682$1$I$20240711$20240717$20240717$20240717$DIR$710596$$FDA-CTU$$75$YR$$M$N$104.8$KG$20240717$Y$PH$US$
241106831$24110683$1$I$20221111$20240716$20240718$20240718$EXP$ES-AEMPS-1545914$ES-PFIZER INC-202400215910$PFIZER$$59$YR$$M$Y$$$20240718$$MD$ES$ES
241106843$24110684$3$F$$20240906$20240718$20240911$PER$$US-PFIZER INC-202400217751$PFIZER$$63$YR$$F$Y$$$20240911$$HP$US$US
241106851$24110685$1$I$20240710$20240710$20240718$20240718$PER$$US-SA-2024SA209571$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240718$$MD$US$US
241106861$24110686$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207588$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240718$$MD$US$US
241106881$24110688$1$I$20221001$20240710$20240718$20240718$PER$$US-SA-2024SA207826$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240718$$MD$US$US
241106891$24110689$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA206612$SANOFI AVENTIS$$$$T$M$Y$74.7$KG$20240718$$MD$US$US
241106902$24110690$2$F$20240601$20240717$20240718$20240724$PER$$US-SA-2024SA206621$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240724$$MD$US$US
241106911$24110691$1$I$20240701$20240709$20240718$20240718$PER$$US-SA-2024SA206538$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240718$$MD$US$US
241106921$24110692$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA209696$SANOFI AVENTIS$$$$A$M$Y$$$20240718$$MD$US$US
241106931$24110693$1$I$20240601$20240710$20240718$20240718$PER$$US-SA-2024SA014035$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240718$$MD$US$US
241106941$24110694$1$I$20240521$20240710$20240718$20240718$PER$$US-SA-2024SA209654$SANOFI AVENTIS$$43$YR$A$M$Y$98.883$KG$20240718$$MD$US$US
241106951$24110695$1$I$20240518$20240715$20240718$20240718$EXP$$DE-FreseniusKabi-FK202411101$FRESENIUS KABI$$69$YR$E$F$Y$42$KG$20240718$$CN$DE$DE
241106961$24110696$1$I$20240601$20240709$20240718$20240718$PER$$US-SA-2024SA206606$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240718$$MD$US$US
241106971$24110697$1$I$20240101$20240710$20240718$20240718$PER$$US-SA-2024SA207351$SANOFI AVENTIS$$14$YR$T$F$Y$65.7$KG$20240718$$MD$US$US
241106982$24110698$2$F$$20240724$20240718$20240725$EXP$$DE-ORGANON-O2407DEU001466$ORGANON$$63$YR$$F$Y$$$20240725$$CN$DE$DE
241106991$24110699$1$I$20230607$20240716$20240718$20240718$EXP$CH-SM-2024-12996$CH-ORGANON-O2407CHE001515$ORGANON$$$$N$F$Y$2.15$KG$20240718$$PH$CH$CH
241107001$24110700$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207728$SANOFI AVENTIS$$$$A$F$Y$65$KG$20240718$$MD$US$US
241107011$24110701$1$I$20240628$20240710$20240718$20240718$PER$$US-SA-2024SA207593$SANOFI AVENTIS$$59$YR$A$M$Y$80$KG$20240718$$MD$US$US
241107021$24110702$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA206295$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240718$$MD$US$US
241107031$24110703$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA206131$SANOFI AVENTIS$$$$A$M$Y$$$20240718$$MD$US$US
241107042$24110704$2$F$$20240828$20240718$20240919$PER$$US-SA-2024SA207621$SANOFI AVENTIS$$14$YR$T$F$Y$61.23$KG$20240919$$MD$US$US
241107051$24110705$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA206861$SANOFI AVENTIS$$$$A$F$Y$77$KG$20240718$$MD$US$US
241107061$24110706$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA205808$SANOFI AVENTIS$$$$A$M$Y$99.7$KG$20240718$$MD$US$US
241107071$24110707$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA205966$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241107081$24110708$1$I$20240501$20240710$20240718$20240718$PER$$US-SA-2024SA207456$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240718$$MD$US$US
241107091$24110709$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207466$SANOFI AVENTIS$$$$A$M$Y$$$20240718$$MD$US$US
241107101$24110710$1$I$20240601$20240710$20240718$20240718$PER$$US-SA-2024SA207561$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240718$$MD$US$US
241107111$24110711$1$I$$20240710$20240718$20240718$PER$$US-SA-2021SA056697$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240718$$MD$US$US
241107121$24110712$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA205812$SANOFI AVENTIS$$$$A$F$Y$81.64$KG$20240718$$MD$US$US
241107131$24110713$1$I$20230101$20240709$20240718$20240718$PER$$US-SA-2024SA207212$SANOFI AVENTIS$$47$YR$A$F$Y$78$KG$20240718$$MD$US$US
241107141$24110714$1$I$20240710$20240710$20240718$20240718$PER$$US-SA-2024SA206997$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240718$$MD$US$US
241107151$24110715$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA206000$SANOFI AVENTIS$$$$E$F$Y$86$KG$20240718$$MD$US$US
241107161$24110716$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207301$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240718$$MD$US$US
241107211$24110721$1$I$20240613$20240717$20240717$20240717$DIR$710660$$FDA-CTU$$63$YR$$F$N$80.1$KG$20240717$N$CN$US$
241107221$24110722$1$I$20240717$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49773$$FDA-CTU$$57$YR$$F$N$$$20240718$N$PH$US$
241107231$24110723$1$I$20240621$20240717$20240717$20240717$DIR$710653$$FDA-CTU$$$$$F$N$67.5$KG$20240717$N$$US$
241107241$24110724$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49778$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241107251$24110725$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49774$$FDA-CTU$$33$YR$$F$N$$$20240718$N$$US$
241107271$24110727$1$I$20240708$20240717$20240717$20240717$DIR$710638$$FDA-CTU$$72$YR$$M$N$$$20240717$Y$HP$US$
241107281$24110728$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49776$$FDA-CTU$$74$YR$$F$N$76.66$KG$20240718$N$$US$
241107301$24110730$1$I$20240626$20240712$20240718$20240718$EXP$GB-MHRA-MED-202407121035475230-VWCPD$GB-RDY-SPO/GBR/24/0010431$DR REDDYS$$88$YR$E$M$Y$66$KG$20240718$$MD$GB$GB
241107311$24110731$1$I$20240525$20240710$20240718$20240718$PER$$US-SA-2024SA206744$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240718$$MD$US$US
241107321$24110732$1$I$20231201$20240710$20240718$20240718$PER$$US-SA-2024SA209512$SANOFI AVENTIS$$39$YR$A$F$Y$83$KG$20240718$$MD$US$US
241107331$24110733$1$I$20240101$20240710$20240718$20240718$PER$$US-SA-2024SA207863$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240718$$MD$US$US
241107341$24110734$1$I$20240601$20240710$20240718$20240718$PER$$US-SA-2024SA207716$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240718$$MD$US$US
241107351$24110735$1$I$20240627$20240709$20240718$20240718$PER$$US-SA-2024SA206046$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240718$$MD$US$US
241107362$24110736$2$F$$20240808$20240718$20240814$PER$$US-SA-2024SA205904$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240814$$CN$US$US
241107371$24110737$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA206627$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240718$$MD$US$US
241107381$24110738$1$I$20240601$20240710$20240718$20240718$PER$$US-SA-2024SA207773$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240718$$MD$US$US
241107391$24110739$1$I$20240101$20240709$20240718$20240718$PER$$US-SA-2024SA205950$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240718$$MD$US$US
241107401$24110740$1$I$20240601$20240709$20240718$20240718$PER$$US-SA-2024SA205862$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240718$$MD$US$US
241107411$24110741$1$I$20231001$20240710$20240718$20240718$PER$$US-SA-2024SA207807$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240718$$MD$US$US
241107421$24110742$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207422$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241107432$24110743$2$F$20240701$20240825$20240718$20240906$PER$$US-SA-2024SA207159$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240906$$MD$US$US
241107442$24110744$2$F$$20240822$20240718$20240917$PER$$US-SA-2024SA205777$SANOFI AVENTIS$$67$YR$E$F$Y$76.2$KG$20240918$$CN$US$US
241107451$24110745$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA206033$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240718$$MD$US$US
241107461$24110746$1$I$20240501$20240710$20240718$20240718$PER$$US-SA-2024SA207330$SANOFI AVENTIS$$15$YR$T$F$Y$69.39$KG$20240718$$MD$US$US
241107471$24110747$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207244$SANOFI AVENTIS$$$$A$M$Y$111$KG$20240718$$MD$US$US
241107481$24110748$1$I$20220615$20240710$20240718$20240718$PER$$US-SA-2024SA206036$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240718$$MD$US$US
241107491$24110749$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA206546$SANOFI AVENTIS$$$$A$M$Y$87.99$KG$20240718$$MD$US$US
241107521$24110752$1$I$$20240708$20240718$20240718$30DAY$$AR-PFIZER INC-202400209697$PFIZER$$4$YR$$M$Y$$$20240718$$CN$AR$AR
241107531$24110753$1$I$$20240712$20240718$20240718$PER$$US-ABBVIE-5842733$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241107541$24110754$1$I$20240701$20240709$20240718$20240718$PER$$US-SA-2024SA207479$SANOFI AVENTIS$$66$YR$E$F$Y$61.2$KG$20240718$$MD$US$US
241107552$24110755$2$F$20240405$20240730$20240718$20240802$EXP$$NI-BAYER-2024A103704$BAYER$$61$YR$A$M$Y$$$20240802$$CN$NI$NI
241107561$24110756$1$I$$20240710$20240718$20240718$EXP$$US-AMGEN-USASP2024137495$AMGEN$Demirci H.; Balikov D.A.; Brown N.A. et.al.. Posterior Uveitis in Ocular-Involving Chronic Lymphocytic Leukemia and the Utility of Negative MYD88 L265P Testing in the Diagnosis. Ocular Oncology and Pathology. 2024;10 (2):103-113$60$YR$A$M$Y$$$20240718$$HP$US$US
241107572$24110757$2$F$20240711$20240827$20240718$20240902$30DAY$$US-AMGEN-USASP2024139726$AMGEN$$45$YR$A$F$Y$53.1$KG$20240902$$HP$US$US
241107592$24110759$2$F$20240701$20240820$20240718$20240823$PER$$US-AMGEN-USASP2024140656$AMGEN$$50$YR$A$F$Y$$$20240822$$CN$US$US
241107601$24110760$1$I$$20240621$20240718$20240718$PER$$US-JNJFOC-20240704377$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$US$US
241107612$24110761$2$F$$20240801$20240718$20240810$EXP$$US-TEVA-VS-3219739$TEVA$Stratman S, Zhou L, Kim RH, Phelps RG, Glickman J, Mikhaylov D, et al. Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic symptoms. JAAD-Case-Rep 2024; 49 36-39.; Stratman S, Zhou L, Kim RH, Phelps RG, Glickman J, Mikhaylov D, et al. Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of dru...$77$YR$$F$Y$$$20240810$$MD$US$US
241107621$24110762$1$I$$20240711$20240718$20240718$EXP$CA-SA-SAC20240712000707$CA-SA-2024SA205681$SANOFI AVENTIS$$43$YR$A$F$Y$68$KG$20240718$$HP$CA$CA
241107631$24110763$1$I$$20240713$20240718$20240718$PER$$US-TAKEDA-2024TUS071730$TAKEDA$$$$$M$Y$$$20240718$$CN$US$US
241107642$24110764$2$F$$20240729$20240718$20240807$EXP$$JP-SA-2024SA207200$SANOFI AVENTIS$$$$$$Y$$$20240807$$MD$JP$JP
241107651$24110765$1$I$20240101$20240708$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-096307$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240718$$CN$US$US
241107661$24110766$1$I$$20240712$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112109$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$60.06$KG$20240718$$MD$US$US
241107671$24110767$1$I$$20240713$20240718$20240718$EXP$$CO-SA-2024SA207638$SANOFI AVENTIS$$39$YR$A$M$Y$175$KG$20240718$$HP$CO$CO
241107681$24110768$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220714$TEVA$$36$YR$$M$Y$$$20240718$$CN$CA$CA
241107691$24110769$1$I$$20240716$20240718$20240718$EXP$$IT-PFIZER INC-0005498401PHAMED$PFIZER$Bettinell, A.. SEIZURES AND TRANSIENT BLINDNESS FOLLOWING INTRAVENOUS PULSE METHYLPREDNISOLONE IN CHILDREN WITH PRIMARY GLOMERULONEPHRITIS. CHILD NEPHROLOGY UROLOGY. 1991;11(1):41-43$9$YR$$F$Y$$$20240718$$MD$IT$IT
241107701$24110770$1$I$$20240712$20240718$20240718$PER$$US-BIOGEN-2024BI01273674$BIOGEN$$$$$F$Y$$$20240718$$CN$US$US
241107711$24110771$1$I$20240713$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140853$AMGEN$$61$YR$A$F$Y$$$20240718$$CN$US$US
241107721$24110772$1$I$20240624$20240715$20240718$20240718$EXP$$FR-AMERICAN REGENT INC-2024002715$AMERICAN REGENT$$85$YR$$M$Y$$$20240718$$PH$FR$FR
241107731$24110773$1$I$$20240701$20240718$20240718$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06556$LUPIN$$$$$$Y$$$20240718$$CN$US$US
241107741$24110774$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA206634$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240718$$MD$US$US
241107761$24110776$1$I$20240601$20240710$20240718$20240718$PER$$US-SA-2024SA207813$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240718$$MD$US$US
241107771$24110777$1$I$20240301$20240717$20240717$20240717$DIR$710664$$FDA-CTU$$59$YR$$F$N$63$KG$20240717$N$CN$US$
241107781$24110778$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49780$$FDA-CTU$$71$YR$$F$N$$$20240718$N$$US$
241107792$24110779$2$F$20240101$20240802$20240718$20240813$PER$$US-SA-2024SA207282$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240814$$MD$US$US
241107801$24110780$1$I$20240101$20240710$20240718$20240718$PER$$US-SA-2024SA207541$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240718$$MD$US$US
241107811$24110781$1$I$20240708$20240717$20240717$20240717$DIR$710594$$FDA-CTU$$30$YR$$M$N$63.8$KG$20240717$Y$HP$US$
241107821$24110782$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207819$SANOFI AVENTIS$$$$I$M$Y$$$20240718$$MD$US$US
241107831$24110783$1$I$20191001$20240710$20240718$20240718$PER$$US-SA-2024SA207776$SANOFI AVENTIS$$$$C$F$Y$$$20240718$$MD$US$US
241107841$24110784$1$I$20240707$20240709$20240718$20240718$PER$$US-SA-2024SA207141$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240718$$MD$US$US
241107851$24110785$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA207875$SANOFI AVENTIS$$$$A$F$Y$107.95$KG$20240718$$MD$US$US
241107861$24110786$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207482$SANOFI AVENTIS$$39$YR$A$F$Y$55$KG$20240718$$CN$US$US
241107871$24110787$1$I$20240101$20240710$20240718$20240718$PER$$US-SA-2024SA207496$SANOFI AVENTIS$$62$YR$A$M$Y$122.47$KG$20240718$$MD$US$US
241107881$24110788$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207228$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240718$$MD$US$US
241107892$24110789$2$F$20230101$20240802$20240718$20240811$PER$$US-SA-2024SA206931$SANOFI AVENTIS$$29$YR$A$F$Y$98.43$KG$20240811$$MD$US$US
241107901$24110790$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207824$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240718$$MD$US$US
241107911$24110791$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207431$SANOFI AVENTIS$$$$A$F$Y$78$KG$20240718$$MD$US$US
241107921$24110792$1$I$$20240708$20240718$20240718$PER$$US-SA-2024SA206056$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240718$$MD$US$US
241107931$24110793$1$I$20240101$20240710$20240718$20240718$PER$$US-SA-2024SA206645$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240718$$MD$US$US
241107941$24110794$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA205501$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240718$$MD$US$US
241107951$24110795$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA206007$SANOFI AVENTIS$$$$C$M$Y$$$20240718$$MD$US$US
241107962$24110796$2$F$20240508$20240909$20240718$20240911$EXP$$US-BAYER-2024A101189$BAYER$$68$YR$E$M$Y$100$KG$20240911$$HP$US$US
241107971$24110797$1$I$20240301$20240710$20240718$20240718$PER$$US-SA-2024SA207249$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240718$$MD$US$US
241107981$24110798$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA206027$SANOFI AVENTIS$$$$$F$Y$$$20240718$$CN$US$US
241107991$24110799$1$I$20240101$20240709$20240718$20240718$PER$$US-SA-2024SA207856$SANOFI AVENTIS$$11$YR$C$M$Y$63$KG$20240718$$MD$US$US
241108001$24110800$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207416$SANOFI AVENTIS$$$$A$M$Y$68$KG$20240718$$MD$US$US
241108011$24110801$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA207271$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240718$$MD$US$US
241108021$24110802$1$I$20240625$20240709$20240718$20240718$PER$$US-SA-2023SA376637$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240718$$MD$US$US
241108032$24110803$2$F$20240101$20240918$20240718$20240925$PER$$US-SA-2024SA206544$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240925$$MD$US$US
241108041$24110804$1$I$20240702$20240709$20240718$20240718$PER$$US-SA-2024SA206039$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240718$$MD$US$US
241108051$24110805$1$I$20240601$20240709$20240718$20240718$PER$$US-SA-2024SA207146$SANOFI AVENTIS$$71$YR$E$M$Y$83.9$KG$20240718$$MD$US$US
241108061$24110806$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA209461$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241108071$24110807$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA206598$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240718$$MD$US$US
241108081$24110808$1$I$20240501$20240709$20240718$20240718$PER$$US-SA-2024SA206533$SANOFI AVENTIS$$45$YR$A$F$Y$68.9$KG$20240718$$MD$US$US
241108091$24110809$1$I$20240101$20240710$20240718$20240718$PER$$US-SA-2024SA207495$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240718$$MD$US$US
241108101$24110810$1$I$20230101$20240710$20240718$20240718$PER$$US-SA-2024SA207816$SANOFI AVENTIS$$$$A$M$Y$$$20240718$$MD$US$US
241108111$24110811$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207278$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241108121$24110812$1$I$20240701$20240709$20240718$20240718$PER$$US-SA-2024SA205818$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240718$$MD$US$US
241108132$24110813$2$F$20240708$20240709$20240718$20240722$PER$$US-SA-2024SA204293$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240722$$MD$US$US
241108141$24110814$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA206618$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240718$$MD$US$US
241108152$24110815$2$F$$20240903$20240718$20240926$PER$$US-SA-2024SA207791$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240926$$MD$US$US
241108161$24110816$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207761$SANOFI AVENTIS$$$$E$M$Y$92.07$KG$20240718$$MD$US$US
241108172$24110817$2$F$20240601$20240717$20240718$20240726$PER$$US-SA-2024SA207715$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240726$$MD$US$US
241108181$24110818$1$I$20240701$20240712$20240718$20240718$EXP$$US-ORGANON-O2407USA001413$ORGANON$$$$$$Y$$$20240718$$CN$US$US
241108191$24110819$1$I$$20240617$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114401$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$107.05$KG$20240718$$CN$US$US
241108201$24110820$1$I$20240714$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113911$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240718$$CN$US$US
241108211$24110821$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207310$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240718$$HP$US$US
241108221$24110822$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA207126$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240718$$MD$US$US
241108231$24110823$1$I$20240430$20240705$20240718$20240718$EXP$$GB-CIPLA LTD.-2024GB07366$CIPLA$$$$$$Y$$$20240718$$PH$GB$GB
241108251$24110825$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207899$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241108261$24110826$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA209725$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240718$$MD$US$US
241108271$24110827$1$I$20240601$20240711$20240718$20240718$PER$$US-SA-2024SA208089$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240718$$MD$US$US
241108281$24110828$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA209595$SANOFI AVENTIS$$$$A$F$Y$90$KG$20240718$$MD$US$US
241108291$24110829$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA209801$SANOFI AVENTIS$$$$E$F$Y$95.2$KG$20240718$$MD$US$US
241108304$24110830$4$F$$20240805$20240718$20240810$EXP$$US-SA-2024SA207027$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240810$$MD$US$US
241108311$24110831$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207332$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240718$$CN$US$US
241108321$24110832$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA209730$SANOFI AVENTIS$$7$YR$C$F$Y$35$KG$20240718$$MD$US$US
241108331$24110833$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA209769$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240718$$MD$US$US
241108341$24110834$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207492$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240718$$MD$US$US
241108351$24110835$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207190$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240718$$MD$US$US
241108361$24110836$1$I$20240425$20240711$20240718$20240718$PER$$US-SA-2024SA209427$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240718$$MD$US$US
241108371$24110837$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA206409$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240718$$MD$US$US
241108381$24110838$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207089$SANOFI AVENTIS$$$$$M$Y$$$20240718$$HP$US$US
241108391$24110839$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA206626$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240718$$MD$US$US
241108401$24110840$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207287$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240718$$MD$US$US
241108412$24110841$2$F$20240901$20240911$20240718$20240920$PER$$US-SA-2024SA207162$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240920$$MD$US$US
241108421$24110842$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA207191$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241108431$24110843$1$I$20240501$20240711$20240718$20240718$PER$$US-SA-2024SA209791$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240718$$MD$US$US
241108441$24110844$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA205971$SANOFI AVENTIS$$$$C$M$Y$$$20240718$$HP$US$US
241108451$24110845$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA207602$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240718$$MD$US$US
241108461$24110846$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA206459$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240718$$MD$US$US
241108471$24110847$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207560$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240718$$MD$US$US
241108481$24110848$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA209443$SANOFI AVENTIS$$$$A$F$Y$70$KG$20240718$$CN$US$US
241108491$24110849$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207143$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240718$$MD$US$US
241108501$24110850$1$I$20240711$20240711$20240718$20240718$PER$$US-SA-2024SA207184$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240718$$CN$US$US
241108511$24110851$1$I$20240701$20240711$20240718$20240718$PER$$US-SA-2024SA207504$SANOFI AVENTIS$$74$YR$E$F$Y$72.1$KG$20240718$$MD$US$US
241108521$24110852$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA206914$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240718$$CN$US$US
241108531$24110853$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA208881$SANOFI AVENTIS$$$$A$M$Y$106.5$KG$20240718$$MD$US$US
241108541$24110854$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA209549$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240718$$CN$US$US
241108561$24110856$1$I$20200801$20240711$20240718$20240718$PER$$US-SA-2024SA207692$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240718$$MD$US$US
241108571$24110857$1$I$20240501$20240716$20240718$20240718$EXP$$US-KYOWAKIRIN-2024KK017153$KYOWA$$$$$$Y$$$20240718$$HP$US$US
241108581$24110858$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA206498$SANOFI AVENTIS$$15$YR$T$M$Y$54.422$KG$20240718$$MD$US$US
241108591$24110859$1$I$20240601$20240711$20240718$20240718$PER$$US-SA-2024SA207328$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240718$$MD$US$US
241108601$24110860$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207782$SANOFI AVENTIS$$$$A$F$Y$52.16$KG$20240718$$MD$US$US
241108611$24110861$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207679$SANOFI AVENTIS$$$$A$M$Y$$$20240718$$MD$US$US
241108621$24110862$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207535$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240718$$CN$US$US
241108631$24110863$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA208943$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240718$$MD$US$US
241108641$24110864$1$I$20240601$20240711$20240718$20240718$PER$$US-SA-2024SA207245$SANOFI AVENTIS$$62$YR$A$F$Y$68$KG$20240718$$CN$US$US
241108651$24110865$1$I$20240501$20240711$20240718$20240718$PER$$US-SA-2024SA207034$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240718$$MD$US$US
241108661$24110866$1$I$20240601$20240711$20240718$20240718$PER$$US-SA-2024SA206941$SANOFI AVENTIS$$7$YR$C$F$Y$24.9$KG$20240718$$MD$US$US
241108671$24110867$1$I$20240711$20240711$20240718$20240718$PER$$US-SA-2024SA206396$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240718$$CN$US$US
241108681$24110868$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA206864$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240718$$MD$US$US
241108691$24110869$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA208888$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240718$$MD$US$US
241108701$24110870$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207344$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240718$$MD$US$US
241108711$24110871$1$I$20230101$20240711$20240718$20240718$PER$$US-SA-2024SA206316$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240718$$CN$US$US
241108721$24110872$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207404$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240718$$MD$US$US
241108732$24110873$2$F$20240701$20240711$20240718$20240722$PER$$US-SA-2024SA206937$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240722$$MD$US$US
241108741$24110874$1$I$20240601$20240711$20240718$20240718$PER$$US-SA-2024SA207860$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240718$$MD$US$US
241108751$24110875$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA206979$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$CN$US$US
241108762$24110876$2$F$20240703$20240903$20240718$20240924$PER$$US-SA-2024SA209070$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240924$$MD$US$US
241108771$24110877$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207835$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241108781$24110878$1$I$20240712$20240717$20240717$20240717$DIR$710601$$FDA-CTU$$63$YR$$M$N$95$KG$20240717$Y$HP$US$
241108801$24110880$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207491$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240718$$MD$US$US
241108811$24110881$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA209520$SANOFI AVENTIS$$$$A$M$Y$92.98$KG$20240718$$MD$US$US
241108822$24110882$2$F$$20240813$20240718$20240827$PER$$US-SA-2024SA209619$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240827$$CN$US$US
241108831$24110883$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA206391$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241108841$24110884$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA205822$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240718$$MD$US$US
241108851$24110885$1$I$20240713$20240717$20240717$20240717$DIR$710637$$FDA-CTU$$73$YR$$F$N$54$KG$20240717$N$HP$US$
241108861$24110886$1$I$20240701$20240712$20240718$20240718$PER$$US-SA-2024SA208079$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240718$$HP$US$US
241108871$24110887$1$I$20240710$20240711$20240718$20240718$PER$$US-SA-2024SA207611$SANOFI AVENTIS$$37$YR$A$F$Y$87.075$KG$20240718$$MD$US$US
241108881$24110888$1$I$20240515$20240711$20240718$20240718$PER$$US-SA-2024SA208558$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240718$$MD$US$US
241108891$24110889$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207514$SANOFI AVENTIS$$$$$F$Y$$$20240718$$CN$US$US
241108901$24110890$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA206769$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240718$$MD$US$US
241108911$24110891$1$I$20240711$20240711$20240718$20240718$PER$$US-SA-2024SA209352$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240718$$CN$US$US
241108921$24110892$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA206763$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240718$$MD$US$US
241108931$24110893$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA209741$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241108942$24110894$2$F$20240101$20240813$20240718$20240826$PER$$US-SA-2024SA207719$SANOFI AVENTIS$$10$YR$C$F$Y$51.7$KG$20240826$$MD$US$US
241108951$24110895$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA208874$SANOFI AVENTIS$$46$YR$A$F$Y$97$KG$20240718$$MD$US$US
241108961$24110896$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA209101$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240718$$MD$US$US
241108971$24110897$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207873$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240718$$MD$US$US
241108981$24110898$1$I$20240501$20240711$20240718$20240718$PER$$US-SA-2024SA206318$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240718$$CN$US$US
241108991$24110899$1$I$$20240715$20240718$20240718$EXP$AU-TGA-0000811750$AU-SAMIL-GLO2024AU003453$SANDOZ$$32$YR$$F$Y$$$20240718$$HP$AU$AU
241109001$24110900$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA190405$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240718$$MD$US$US
241109011$24110901$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA209456$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240718$$MD$US$US
241109031$24110903$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA208444$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241109041$24110904$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA208478$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241109051$24110905$1$I$20240621$20240716$20240718$20240718$EXP$$FR-AUROBINDO-AUR-APL-2024-035605$AUROBINDO$$39$YR$$M$Y$125$KG$20240718$$MD$FR$FR
241109061$24110906$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207477$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240718$$CN$US$US
241109071$24110907$1$I$20240701$20240712$20240718$20240718$PER$$US-SA-2024SA207818$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240718$$MD$US$US
241109081$24110908$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA208791$SANOFI AVENTIS$$$$A$M$Y$$$20240718$$MD$US$US
241109104$24110910$4$F$$20240808$20240718$20240817$PER$$US-SA-2024SA206718$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240817$$CN$US$US
241109111$24110911$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207229$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240718$$CN$US$US
241109121$24110912$1$I$20240101$20240712$20240718$20240718$PER$$US-SA-2024SA209744$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240718$$MD$US$US
241109131$24110913$1$I$20240101$20240712$20240718$20240718$PER$$US-SA-2024SA208781$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240718$$MD$US$US
241109141$24110914$1$I$20240301$20240712$20240718$20240718$PER$$US-SA-2024SA209112$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240718$$MD$US$US
241109151$24110915$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207857$SANOFI AVENTIS$$$$E$F$Y$83$KG$20240718$$MD$US$US
241109161$24110916$1$I$20240101$20240712$20240718$20240718$PER$$US-SA-2024SA206724$SANOFI AVENTIS$$76$YR$E$M$Y$74.38$KG$20240718$$CN$US$US
241109171$24110917$1$I$20240101$20240712$20240718$20240718$PER$$US-SA-2024SA206985$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240718$$CN$US$US
241109182$24110918$2$F$20240101$20240725$20240718$20240805$PER$$US-SA-2024SA205954$SANOFI AVENTIS$$16$YR$T$M$Y$71.07$KG$20240805$$MD$US$US
241109191$24110919$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA209540$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240718$$MD$US$US
241109201$24110920$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA209103$SANOFI AVENTIS$$3$YR$C$M$Y$16.4$KG$20240718$$MD$US$US
241109213$24110921$3$F$20240801$20240824$20240718$20240916$PER$$US-SA-2024SA207874$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240916$$MD$US$US
241109221$24110922$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA209760$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240718$$MD$US$US
241109231$24110923$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA209236$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240718$$MD$US$US
241109241$24110924$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207082$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240718$$CN$US$US
241109251$24110925$1$I$20240701$20240712$20240718$20240718$PER$$US-SA-2024SA209417$SANOFI AVENTIS$$$$$$Y$$$20240718$$CN$US$US
241109261$24110926$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA209296$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240718$$MD$US$US
241109271$24110927$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA209038$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241109281$24110928$1$I$20240501$20240712$20240718$20240718$PER$$US-SA-2024SA208547$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240718$$MD$US$US
241109291$24110929$1$I$20240708$20240717$20240717$20240717$DIR$710635$$FDA-CTU$$72$YR$$M$N$$$20240717$Y$PH$US$
241109302$24110930$2$F$$20240819$20240718$20240828$PER$$US-SA-2024SA209030$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240828$$MD$US$US
241109312$24110931$2$F$20240711$20240729$20240718$20240807$PER$$US-SA-2024SA207304$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240807$$MD$US$US
241109321$24110932$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207869$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240718$$CN$US$US
241109331$24110933$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA208019$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240718$$CN$US$US
241109341$24110934$1$I$20240709$20240712$20240718$20240718$PER$$US-SA-2024SA208490$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240718$$MD$US$US
241109351$24110935$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA208584$SANOFI AVENTIS$$$$$$Y$$$20240718$$MD$US$US
241109361$24110936$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207797$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240718$$PH$US$US
241109371$24110937$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207051$SANOFI AVENTIS$$$$$M$Y$$$20240718$$CN$US$US
241109381$24110938$1$I$20240101$20240712$20240718$20240718$PER$$US-SA-2024SA208765$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240718$$MD$US$US
241109391$24110939$1$I$20240629$20240712$20240718$20240718$PER$$US-SA-2024SA207454$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240718$$HP$US$US
241109401$24110940$1$I$$20240717$20240717$20240717$DIR$710585$$FDA-CTU$$$$$UNK$N$$$20240717$$CN$US$
241109411$24110941$1$I$$20240717$20240717$20240717$DIR$710555$$FDA-CTU$$$$$UNK$N$$$20240717$$CN$US$
241109421$24110942$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207793$SANOFI AVENTIS$$$$$M$Y$$$20240718$$HP$US$US
241109441$24110944$1$I$20240711$20240712$20240718$20240718$PER$$US-SA-2024SA209495$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240718$$MD$US$US
241109451$24110945$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207790$SANOFI AVENTIS$$$$$$Y$$$20240718$$HP$US$US
241109461$24110946$1$I$20240711$20240712$20240718$20240718$PER$$US-SA-2024SA207786$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240718$$CN$US$US
241109472$24110947$2$F$$20240821$20240718$20240912$PER$$US-SA-2024SA209213$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240912$$MD$US$US
241109481$24110948$1$I$20230501$20240712$20240718$20240718$PER$$US-SA-2024SA209529$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240718$$MD$US$US
241109491$24110949$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA209231$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240718$$MD$US$US
241109511$24110951$1$I$20221201$20230103$20240718$20240718$EXP$$KW-BIOVITRUM-2023KW00371$BIOVITRUM$$4$MON$$F$Y$$$20240718$$CN$KW$KW
241109523$24110952$3$F$20240708$20240906$20240718$20240909$EXP$GB-MHRA-MED-202407081623476080-TCFKN$GB-SANDOZ INC.-SDZ2024GB066121$SANDOZ$$77$YR$$M$Y$116$KG$20240909$$MD$GB$GB
241109531$24110953$1$I$$20240715$20240718$20240718$PER$$US-SA-2024SA208758$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240718$$CN$US$US
241109541$24110954$1$I$20240715$20240715$20240718$20240718$PER$$US-SA-2024SA209040$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240718$$MD$US$US
241109551$24110955$1$I$$20240715$20240718$20240718$PER$$US-SA-2024SA208199$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240718$$CN$US$US
241109561$24110956$1$I$$20240715$20240718$20240718$PER$$US-SA-2024SA209763$SANOFI AVENTIS$$$$$M$Y$$$20240718$$CN$US$US
241109571$24110957$1$I$$20240715$20240718$20240718$PER$$US-SA-2024SA208728$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$CN$US$US
241109581$24110958$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA209508$SANOFI AVENTIS$$$$A$F$Y$74.376$KG$20240718$$MD$US$US
241109591$24110959$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA209227$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240718$$MD$US$US
241109601$24110960$1$I$$20240715$20240718$20240718$PER$$US-SA-2024SA209121$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241109611$24110961$1$I$$20240713$20240718$20240718$PER$$US-SA-2024SA207749$SANOFI AVENTIS$$$$$$Y$$$20240718$$MD$US$US
241109621$24110962$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207337$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241109632$24110963$2$F$$20240806$20240718$20240813$PER$$US-SA-2024SA209793$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240814$$CN$US$US
241109641$24110964$1$I$$20240715$20240718$20240718$PER$$US-SA-2024SA208886$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240718$$MD$US$US
241109651$24110965$1$I$20240715$20240716$20240718$20240718$PER$$US-SA-2024SA209912$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240718$$MD$US$US
241109661$24110966$1$I$$20240715$20240718$20240718$PER$$US-SA-2023SA364260$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241109671$24110967$1$I$$20240715$20240718$20240718$PER$$US-SA-2024SA208604$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240718$$CN$US$US
241109681$24110968$1$I$20240703$20240712$20240718$20240718$PER$$US-SA-2024SA209426$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240718$$MD$US$US
241109691$24110969$1$I$$20240713$20240718$20240718$PER$$US-SA-2024SA208453$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240718$$MD$US$US
241109701$24110970$1$I$20231230$20240717$20240717$20240717$DIR$710667$$FDA-CTU$$49$YR$$F$N$49.5$KG$20240717$N$CN$US$
241109711$24110971$1$I$20240101$20240713$20240718$20240718$PER$$US-SA-2024SA209290$SANOFI AVENTIS$$64$YR$A$F$Y$90.7$KG$20240718$$MD$US$US
241109722$24110972$2$F$20231201$20240715$20240718$20240722$PER$$US-SA-2024SA208183$SANOFI AVENTIS$$$$A$M$Y$$$20240722$$CN$US$US
241109731$24110973$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207817$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240718$$MD$US$US
241109741$24110974$1$I$$20240715$20240718$20240718$PER$$US-SA-2024SA208639$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241109752$24110975$2$F$$20240726$20240718$20240806$PER$$US-SA-2024SA208400$SANOFI AVENTIS$$$$E$M$Y$87.08$KG$20240806$$MD$US$US
241109761$24110976$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207289$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$CN$US$US
241109771$24110977$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA208112$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240718$$MD$US$US
241109781$24110978$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA208398$SANOFI AVENTIS$$$$E$F$Y$$$20240718$$MD$US$US
241109792$24110979$2$F$$20240802$20240718$20240813$PER$$US-SA-2024SA209755$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240814$$MD$US$US
241109801$24110980$1$I$$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002315J$MERCK$$75$YR$$F$Y$$$20240718$$MD$JP$JP
241109811$24110981$1$I$20240615$20240717$20240717$20240717$DIR$710619$$FDA-CTU$$74$YR$$M$N$$$20240717$N$$US$
241109821$24110982$1$I$$20240710$20240718$20240718$EXP$$US-Calliditas-2024CAL01286$CALLIDITAS THERAPEUTICS$$37$YR$A$F$Y$50.7$KG$20240718$$CN$US$US
241109832$24110983$2$F$$20240715$20240718$20240820$PER$$US-AstraZeneca-2024A116754$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
241109841$24110984$1$I$$20200207$20240718$20240718$EXP$$US-AstraZeneca-2020SE21352$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241109851$24110985$1$I$$20200506$20240718$20240718$EXP$$US-AstraZeneca-2020SE60684$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241109861$24110986$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158679$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241109871$24110987$1$I$20200504$20200508$20240718$20240718$EXP$$US-AstraZeneca-2020SE62963$ASTRAZENECA$$21889$DY$$F$Y$$$20240718$$CN$US$
241109881$24110988$1$I$$20240717$20240717$20240717$DIR$710568$$FDA-CTU$$54$YR$$F$N$$$20240717$N$PH$US$
241109892$24110989$2$F$20240301$20240821$20240718$20240829$PER$$US-Aprecia Pharmaceuticals-APRE20241035$APRECIA PHARMACEUTICALS$$13$YR$T$F$Y$$$20240829$$CN$US$US
241109901$24110990$1$I$20240101$20240709$20240718$20240718$PER$$US-SA-2024SA206023$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240718$$MD$US$US
241109911$24110991$1$I$20240701$20240710$20240718$20240718$PER$$US-SA-2024SA207399$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240718$$MD$US$US
241109921$24110992$1$I$20240516$20240717$20240717$20240717$DIR$710631$$FDA-CTU$$45$YR$$M$N$$$20240717$N$PH$US$
241109931$24110993$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA209672$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240718$$MD$US$US
241109941$24110994$1$I$20220916$20220921$20240718$20240718$EXP$$CO-BIOVITRUM-2022CO11110$BIOVITRUM$$26$WK$$F$Y$$$20240718$$CN$CO$CO
241109951$24110995$1$I$20211013$20211102$20240718$20240718$EXP$$NL-BIOVITRUM-2021NL10591$BIOVITRUM$$4$MON$$M$Y$6$KG$20240718$$HP$NL$NL
241109961$24110996$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207463$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240718$$MD$US$US
241109971$24110997$1$I$$20240709$20240718$20240718$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-111152$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240718$$MD$GB$GB
241109982$24110998$2$F$$20240724$20240718$20240805$PER$$US-SA-2024SA207279$SANOFI AVENTIS$$60$YR$A$F$Y$71.2$KG$20240805$$MD$US$US
241109991$24110999$1$I$20240601$20240711$20240718$20240718$PER$$US-SA-2024SA207765$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240718$$MD$US$US
241110001$24111000$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207324$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240718$$MD$US$US
241110011$24111001$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207455$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240718$$MD$US$US
241110027$24111002$7$F$20240101$20240913$20240718$20240926$PER$$US-SA-2024SA208522$SANOFI AVENTIS$$70$YR$E$M$Y$90.703$KG$20240926$$MD$US$US
241110031$24111003$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207840$SANOFI AVENTIS$$$$A$F$Y$51.7$KG$20240718$$MD$US$US
241110041$24111004$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA209429$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240718$$MD$US$US
241110051$24111005$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207329$SANOFI AVENTIS$$$$A$$Y$$$20240718$$CN$US$US
241110061$24111006$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA209844$SANOFI AVENTIS$$$$$$Y$$$20240718$$HP$US$US
241110071$24111007$1$I$20240703$20240712$20240718$20240718$EXP$$CN-ALCON LABORATORIES-ALC2024CN003386$ALCON$$59$YR$$F$Y$55$KG$20240718$$HP$CN$CN
241110082$24111008$2$F$20240701$20240719$20240718$20240728$PER$$US-SA-2024SA208114$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240728$$MD$US$US
241110091$24111009$1$I$$20240716$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US065863$SANDOZ$$$$$F$Y$$$20240718$$HP$US$US
241110101$24111010$1$I$20240701$20240712$20240718$20240718$EXP$$JP-009507513-2407JPN002375J$MERCK$$7$DEC$$M$Y$$$20240718$$MD$JP$JP
241110111$24111011$1$I$$20210409$20240718$20240718$EXP$$NL-BIOVITRUM-2021NL3820$BIOVITRUM$$$$I$M$Y$7.6$KG$20240718$$CN$NL$NL
241110121$24111012$1$I$$20200304$20240718$20240718$EXP$$US-BIOVITRUM-2020SE35372$BIOVITRUM$$$$C$F$Y$$$20240718$$HP$US$US
241110132$24111013$2$F$20240703$20240722$20240718$20240730$PER$$US-AMGEN-USASP2024138351$AMGEN$$$$$$Y$$$20240730$$HP$US$US
241110141$24111014$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187671$Haleon PLC$$$$$$Y$$$20240718$$CN$US$US
241110152$24111015$2$F$20240628$20240718$20240718$20240723$PER$$US-AMGEN-USASP2024139158$AMGEN$$60$YR$A$F$Y$51.8$KG$20240723$$HP$US$US
241110162$24111016$2$F$20240711$20240801$20240718$20240806$PER$$US-AMGEN-USASP2024138346$AMGEN$$55$YR$A$M$Y$65.77$KG$20240806$$HP$US$US
241110172$24111017$2$F$20240628$20240724$20240718$20240731$PER$$US-AMGEN-USASP2024138531$AMGEN$$70$YR$E$F$Y$79$KG$20240731$$PH$US$US
241110181$24111018$1$I$20181004$20240716$20240718$20240718$EXP$FR-AFSSAPS-AM2024000569$FR-SANDOZ INC.-SDZ2024FR066082$SANDOZ$$67$YR$$F$Y$60$KG$20240718$$MD$FR$FR
241110192$24111019$2$F$$20240819$20240718$20240821$PER$$US-BIOVITRUM-2024-US-009889$BIOVITRUM$$79$YR$$F$Y$$$20240821$$CN$US$US
241110202$24111020$2$F$20240701$20240812$20240718$20240816$30DAY$$US-AMGEN-USASP2024139445$AMGEN$$83$YR$E$M$Y$64.4$KG$20240816$$PH$US$US
241110211$24111021$1$I$$20240716$20240718$20240718$EXP$$US-KYOWAKIRIN-2024KK017194$KYOWA$$$$$$Y$$$20240718$$HP$US$US
241110221$24111022$1$I$$20240715$20240718$20240718$PER$$US-ABBVIE-5843567$ABBVIE$$33$YR$$M$Y$$$20240718$$CN$US$US
241110232$24111023$2$F$20240604$20240718$20240718$20240724$EXP$$CA-Eisai-EC-2024-169855$EISAI$$42$YR$A$M$Y$$$20240724$$CN$CA$CA
241110241$24111024$1$I$$20240709$20240718$20240718$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001395$BLUEPRINT MEDICINES$$$$A$$Y$$$20240718$$MD$US$US
241110251$24111025$1$I$20240619$20240715$20240718$20240718$EXP$FR-AFSSAPS-PP2024000766$FR-FreseniusKabi-FK202411172$FRESENIUS KABI$$75$YR$E$F$Y$80$KG$20240718$$MD$FR$FR
241110261$24111026$1$I$$20240630$20240718$20240718$PER$$US-JNJFOC-20240700924$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$CN$US$US
241110271$24111027$1$I$$20240709$20240718$20240718$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001394$BLUEPRINT MEDICINES$$$$$$Y$$$20240718$$MD$US$US
241110291$24111029$1$I$$20240716$20240718$20240718$PER$$US-ABBVIE-5843083$ABBVIE$$$$$F$Y$$$20240718$$HP$US$US
241110301$24111030$1$I$$20240716$20240718$20240718$EXP$AU-TGA-0000812090$AU-SANDOZ INC.-SDZ2024AU065993$SANDOZ$$13$YR$$M$Y$$$20240718$$HP$AU$AU
241110311$24111031$1$I$$20240716$20240718$20240718$EXP$$AU-SANDOZ INC.-SDZ2024AU065958$SANDOZ$$$$$$Y$$$20240718$$HP$AU$AU
241110322$24111032$2$F$20240517$20240724$20240718$20240731$PER$$US-BAYER-2024A104114$BAYER$$88$YR$E$M$Y$$$20240731$$PH$US$US
241110331$24111033$1$I$20240101$20240715$20240718$20240718$EXP$$US-ABBVIE-5841427$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241110341$24111034$1$I$$20240715$20240718$20240718$EXP$$NZ-AstraZeneca-2024A163096$ASTRAZENECA$$$$$F$Y$$$20240718$$PH$NZ$
241110351$24111035$1$I$20230101$20240715$20240718$20240718$EXP$$IL-ABBVIE-5796286$ABBVIE$$$$$M$Y$$$20240718$$CN$IL$IL
241110363$24111036$3$F$20240606$20240909$20240718$20240912$30DAY$$US-PFIZER INC-PV202400087205$PFIZER$$$$$$Y$$$20240912$$HP$US$US
241110371$24111037$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49783$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241110381$24111038$1$I$20240706$20240717$20240717$20240717$DIR$710674$$FDA-CTU$$59$YR$$F$N$78.75$KG$20240717$Y$CN$US$
241110391$24111039$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49795$$FDA-CTU$$49$YR$$F$N$320$LBS$20240718$N$$US$
241110403$24111040$3$F$$20240911$20240718$20240913$30DAY$$US-PFIZER INC-202400213548$PFIZER$$12$YR$$M$Y$$$20240913$$CN$US$US
241110413$24111041$3$F$$20240718$20240718$20240729$30DAY$$CO-PFIZER INC-202400213449$PFIZER$$54$YR$$M$Y$$$20240729$$MD$CO$CO
241110421$24111042$1$I$$20190719$20240718$20240718$EXP$$US-AstraZeneca-2019SE83746$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241110431$24111043$1$I$20240717$20240717$20240717$20240717$DIR$710605$$FDA-CTU$$60$YR$$F$N$$$20240717$N$HP$US$
241110441$24111044$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49803$$FDA-CTU$$62$YR$$M$N$$$20240718$N$$US$
241110451$24111045$1$I$20240628$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49804$$FDA-CTU$$71$YR$$M$N$$$20240718$N$$US$
241110464$24111046$4$F$$20240911$20240718$20240916$30DAY$$US-PFIZER INC-202400213869$PFIZER$$13$YR$$F$Y$$$20240916$$CN$US$US
241110472$24111047$2$F$$20240721$20240718$20240723$30DAY$$CO-PFIZER INC-PV202400092450$PFIZER$$16$YR$$M$Y$$$20240723$$CN$CO$CO
241110481$24111048$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49794$$FDA-CTU$$22$YR$$F$N$$$20240718$N$$US$
241110491$24111049$1$I$20240101$20240713$20240718$20240718$EXP$$US-SA-2024SA208066$SANOFI AVENTIS$$$$$F$Y$$$20240718$$HP$US$US
241110501$24111050$1$I$$20201008$20240718$20240718$EXP$$US-AstraZeneca-2020SF31701$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241110511$24111051$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A158741$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241110521$24111052$1$I$$20201019$20240718$20240718$EXP$$US-AstraZeneca-2020SF39434$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241110531$24111053$1$I$20201020$20201024$20240718$20240718$EXP$$US-AstraZeneca-2020SF41461$ASTRAZENECA$$25277$DY$$M$Y$$$20240718$$CN$US$
241110541$24111054$1$I$$20240716$20240718$20240718$PER$$US-JNJFOC-20240743970$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$CN$US$US
241110552$24111055$2$F$$20240725$20240718$20240729$EXP$$US-TAKEDA-2024TUS071412$TAKEDA$$$$$F$Y$$$20240729$$MD$US$US
241110562$24111056$2$F$20240707$20240802$20240718$20240808$EXP$$CO-BIOMARINAP-CO-2024-159184$BIOMARIN$$$$$$Y$$$20240808$$CN$CO$CO
241110571$24111057$1$I$$20240711$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111338$BRISTOL MYERS SQUIBB$$62$YR$A$$Y$$$20240718$$CN$US$US
241110581$24111058$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA205897$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240718$$MD$US$US
241110592$24111059$2$F$20240101$20240808$20240718$20240817$PER$$US-SA-2024SA206624$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240817$$MD$US$US
241110601$24111060$1$I$$20240711$20240718$20240718$EXP$$CA-SA-2024SA205702$SANOFI AVENTIS$$43$YR$A$F$Y$43$KG$20240718$$MD$CA$CA
241110611$24111061$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207573$SANOFI AVENTIS$$$$E$F$Y$$$20240718$$CN$US$US
241110621$24111062$1$I$20240701$20240711$20240718$20240718$PER$$US-SA-2024SA207607$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240718$$MD$US$US
241110631$24111063$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA206988$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240718$$MD$US$US
241110642$24111064$2$F$20240216$20240722$20240718$20240725$EXP$$JP-BAYER-2024A101766$BAYER$$74$YR$E$M$Y$$$20240725$$MD$JP$JP
241110673$24111067$3$F$20240701$20240912$20240718$20240916$30DAY$$US-PFIZER INC-202400213886$PFIZER$$6$YR$$M$Y$$$20240916$$CN$US$US
241110683$24111068$3$F$20240710$20240919$20240718$20240923$30DAY$$US-PFIZER INC-202400213857$PFIZER$$63$YR$$F$Y$$$20240923$$CN$US$US
241110703$24111070$3$F$20240711$20240821$20240718$20240821$30DAY$$US-PFIZER INC-202400213977$PFIZER$$15$YR$$M$Y$$$20240821$$CN$US$US
241110714$24111071$4$F$20240101$20240911$20240718$20240913$30DAY$$US-PFIZER INC-202400212737$PFIZER$$3$YR$$F$Y$$$20240913$$CN$US$US
241110721$24111072$1$I$$20240712$20240718$20240718$30DAY$$KR-PFIZER INC-PV202400092049$PFIZER$$13$YR$$M$Y$$$20240718$$CN$KR$KR
241110733$24111073$3$F$$20240824$20240718$20240826$30DAY$$US-PFIZER INC-202400213870$PFIZER$$$$$$Y$$$20240826$$CN$US$US
241110741$24111074$1$I$20220613$20240715$20240718$20240718$EXP$FR-AFSSAPS-RN2024000744$FR-009507513-2407FRA009538$MERCK$$74$YR$$M$Y$$$20240718$$MD$FR$FR
241110751$24111075$1$I$$20240710$20240718$20240718$EXP$$US-MYLANLABS-2024M1066172$MYLAN$Jackson LK, Poon IO, Garcia MA, Imam S, Braun UK. Buprenorphine Use for Analgesia in Palliative Care. Pharmacy-(Basel) 2024; 12 (3).$70$YR$$M$Y$$$20240718$$HP$US$US
241110781$24111078$1$I$20231201$20240712$20240718$20240718$EXP$FR-AFSSAPS-PP2024000770$FR-MYLANLABS-2024M1065626$MYLAN$$26$YR$$F$Y$$$20240718$$MD$FR$FR
241110792$24111079$2$F$20240711$20240717$20240718$20240724$EXP$$US-KYOWAKIRIN-2024KK017215$KYOWA$$$$$$Y$$$20240724$$HP$US$US
241110801$24111080$1$I$20240127$20240712$20240718$20240718$EXP$FR-AFSSAPS-ST2024001138$FR-MYLANLABS-2024M1065610$MYLAN$$56$YR$$M$Y$77.2$KG$20240718$$HP$FR$FR
241110811$24111081$1$I$20141202$20171011$20240718$20240718$EXP$$NVSC2017DE030314$NOVARTIS$$$$A$F$Y$$$20240718$$MD$DE$DE
241110821$24111082$1$I$20240702$20240712$20240718$20240718$EXP$IT-MINISAL02-994240$IT-MYLANLABS-2024M1065545$MYLAN$$80$YR$$M$Y$$$20240718$$PH$IT$IT
241110831$24111083$1$I$$20240709$20240718$20240718$EXP$$NVSC2024US144526$NOVARTIS$Collet D, Canestraro J, Abou-Alfa GK, Abramson DH, Diamond EL, Francis JH. MEK Inhibitor-Associated Ocular Hypertension. OCUL-ONCOL-PATHOL. 2024;10 (2):98-102$69$YR$$F$Y$$$20240718$$HP$US$US
241110843$24111084$3$F$$20240718$20240718$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112746$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$62.6$KG$20240729$$CN$US$US
241110861$24111086$1$I$20230801$20240716$20240718$20240718$EXP$$GB-UCBSA-2023055730$UCB$$70$YR$$F$Y$$$20240718$$CN$GB$GB
241110873$24111087$3$F$$20240726$20240718$20240801$EXP$$CA-TAKEDA-2024TUS072554$TAKEDA$$$$$F$Y$$$20240801$$CN$CA$CA
241110881$24111088$1$I$20180201$20240708$20240718$20240718$EXP$$CZ-MYLANLABS-2024M1065412$MYLAN$Novakova M.. Experience with the administration of clozapine and long-acting paliperidone palmitate in combination in a patient with paranoid schizophrenia and marijuana abuse. CESKA A SLOVENSKA PSYCHIATRIE. 2024;120(3):151-156$45$YR$$M$Y$$$20240718$$MD$CZ$CZ
241110892$24111089$2$F$$20240828$20240718$20240830$EXP$$CA-ROCHE-3104677$ROCHE$$$$A$M$Y$$$20240830$$CN$CA$CA
241110901$24111090$1$I$20240703$20240717$20240718$20240718$PER$$US-JNJFOC-20240745526$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240718$$HP$US$US
241110913$24111091$3$F$$20240903$20240718$20240910$EXP$$BR-SANDOZ INC.-SDZ2024BR064726$SANDOZ$$$$$F$Y$$$20240910$$CN$BR$BR
241110921$24111092$1$I$$20240717$20240718$20240718$EXP$$US-ROCHE-10000030181$ROCHE$$68$YR$E$F$Y$$$20240718$$CN$US$US
241110931$24111093$1$I$20240709$20240712$20240718$20240718$EXP$$CA-BIOGEN-2024BI01273930$BIOGEN$$69$YR$$M$Y$$$20240718$$PH$CA$CA
241110941$24111094$1$I$20240101$20240717$20240718$20240718$EXP$$US-PFIZER INC-202400217563$PFIZER$$$$$$Y$$$20240718$$CN$US$US
241110951$24111095$1$I$$20240711$20240718$20240718$PER$$US-ALXN-202407USA000950US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
241110961$24111096$1$I$$20240708$20240718$20240718$EXP$$DE-GILEAD-2024-0679851$GILEAD$$$$$M$Y$$$20240718$$CN$DE$DE
241110972$24111097$2$F$20240717$20240717$20240718$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011838$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240723$$CN$US$US
241110981$24111098$1$I$20240715$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009691$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240718$$CN$US$US
241110991$24111099$1$I$$20240717$20240718$20240718$EXP$$GB-BEIGENE-BGN-2024-011154$BEIGENE$Erblich T, Manisty C, Gribben J. Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated Risk. Case Reports in Hematology. 2024;2024$$$$$Y$$$20240718$$MD$GB$GB
241111001$24111100$1$I$20240101$20240715$20240718$20240718$PER$$US-GRUNENTHAL-2024-122522$AVERITAS$$62$YR$$M$Y$$$20240717$$HP$US$US
241111011$24111101$1$I$$20240717$20240718$20240718$PER$$NVSC2024US148194$NOVARTIS$$60$YR$$M$Y$$$20240718$$HP$US$US
241111022$24111102$2$F$20240701$20240903$20240718$20240905$EXP$$CA-BAUSCH-BL-2024-010867$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240905$$CN$CA$CA
241111031$24111103$1$I$$20240710$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407006875$ELI LILLY AND CO$$69$YR$E$F$Y$160.59$KG$20240718$$MD$US$US
241111041$24111104$1$I$20240320$20240711$20240718$20240718$EXP$IT-MINISAL02-993584$IT-TEVA-VS-3220596$TEVA$$32$YR$$F$Y$$$20240718$$PH$IT$IT
241111051$24111105$1$I$$20240712$20240718$20240718$EXP$$SK-MYLANLABS-2024M1065468$MYLAN$$41$YR$$M$Y$$$20240718$$CN$SK$SK
241111061$24111106$1$I$20240624$20240717$20240718$20240718$EXP$HR-HALMED-300086118$HR-GSK-HR2024089770$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$HR$HR
241111071$24111107$1$I$20240529$20240715$20240718$20240718$EXP$FR-AFSSAPS-LY2024001070$FR-BAUSCH-BL-2024-010840$BAUSCH AND LOMB$$0$DY$$M$Y$4.135$KG$20240718$$HP$FR$FR
241111081$24111108$1$I$20240619$20240709$20240718$20240718$EXP$FR-AFSSAPS-RE2024000650$FR-009507513-2407FRA004736$MERCK$$24$YR$$M$Y$133$KG$20240718$$MD$FR$FR
241111092$24111109$2$F$20220501$20240815$20240718$20240820$EXP$FR-BEH-2022144964$FR-TAKEDA-2024TUS072395$TAKEDA$$52$YR$$M$Y$59$KG$20240820$$HP$FR$FR
241111101$24111110$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-PV202400093225$PFIZER$$$$$$Y$$$20240718$$CN$US$US
241111111$24111111$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-202400216600$PFIZER$$57$YR$$F$Y$$$20240718$$HP$US$US
241111121$24111112$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-202400194252$PFIZER$$23$YR$$F$Y$$$20240718$$HP$US$US
241111131$24111113$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-PV202400093000$PFIZER$$$$$$Y$$$20240718$$HP$US$US
241111141$24111114$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-PV202400092799$PFIZER$$$$$$Y$$$20240718$$CN$US$US
241111151$24111115$1$I$20240712$20240715$20240718$20240718$PER$$US-PFIZER INC-202400215408$PFIZER$$75$YR$$F$Y$$$20240718$$CN$US$US
241111161$24111116$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-202400216516$PFIZER$$$$$F$Y$$$20240718$$HP$US$US
241111171$24111117$1$I$$20240715$20240718$20240718$PER$$US-PFIZER INC-202400215124$PFIZER$$13$YR$$M$Y$$$20240718$$CN$US$US
241111182$24111118$2$F$$20240725$20240718$20240729$PER$$US-PFIZER INC-202400215119$PFIZER$$25$YR$$M$Y$86.18$KG$20240729$$CN$US$US
241111191$24111119$1$I$$20240715$20240718$20240718$PER$$UM-PFIZER INC-202400215619$PFIZER$$72$YR$$F$Y$$$20240718$$CN$UM$UM
241111202$24111120$2$F$20240715$20240816$20240718$20240819$PER$$US-PFIZER INC-202400215617$PFIZER$$43$YR$$F$Y$$$20240819$$CN$US$US
241111223$24111122$3$F$$20240808$20240718$20240809$PER$$US-PFIZER INC-PV202400092887$PFIZER$$64$YR$$F$Y$$$20240809$$HP$US$US
241111241$24111124$1$I$20240715$20240715$20240718$20240718$PER$$US-PFIZER INC-202400215519$PFIZER$$53$YR$$F$Y$$$20240718$$HP$US$US
241111251$24111125$1$I$20240715$20240715$20240718$20240718$PER$$US-PFIZER INC-202400216015$PFIZER$$62$YR$$F$Y$$$20240718$$CN$US$US
241111263$24111126$3$F$$20240722$20240718$20240731$EXP$$ALC2024US003078$ALCON$$71$YR$$F$Y$$$20240731$$CN$US$US
241111271$24111127$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114573$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240718$$CN$US$US
241111281$24111128$1$I$$20240712$20240718$20240718$EXP$$US-AMGEN-USASP2024138854$AMGEN$Dahiya, S.. Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma. Journal of immunotherapy of cancer. 2024;12 (7):008-975$$$$$Y$$$20240718$$MD$US$US
241111291$24111129$1$I$$20240717$20240718$20240718$PER$$US-HALEON-2187662$Haleon PLC$$79$YR$$F$Y$$$20240718$$CN$US$US
241111301$24111130$1$I$20230301$20240715$20240718$20240718$EXP$$CO-ABBVIE-5842443$ABBVIE$$36$YR$$F$Y$83$KG$20240718$$CN$CO$CO
241111311$24111131$1$I$20240711$20240711$20240718$20240718$EXP$GB-MHRA-TPP14366369C7225055YC1720702054335$GB-RDY-SPO/GBR/24/0010351$DR REDDYS$$54$YR$A$F$Y$$$20240718$$MD$GB$GB
241111321$24111132$1$I$$20240716$20240718$20240718$EXP$$US-ROCHE-10000028590$ROCHE$$79$YR$E$F$Y$$$20240718$$CN$US$US
241111333$24111133$3$F$20240101$20240722$20240718$20240722$PER$$US-JNJFOC-20240745150$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240722$$CN$US$US
241111341$24111134$1$I$20240701$20240715$20240718$20240718$PER$$US-JNJFOC-20240739218$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240718$$MD$US$US
241111351$24111135$1$I$$20240717$20240718$20240718$PER$$US-JNJFOC-20240746342$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$PH$US$US
241111361$24111136$1$I$20180411$20240709$20240718$20240718$EXP$$KR-TAKEDA-2024TUS072689$TAKEDA$$$$A$M$Y$86$KG$20240718$$HP$KR$KR
241111371$24111137$1$I$20231105$20240709$20240718$20240718$EXP$$KR-TAKEDA-2024TUS072688$TAKEDA$$$$A$M$Y$$$20240718$$HP$KR$KR
241111381$24111138$1$I$$20240716$20240718$20240718$EXP$$US-ABBVIE-5843692$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241111391$24111139$1$I$20240710$20240711$20240718$20240718$EXP$$NL-GRUNENTHAL-2024-122955$AVERITAS$$21$YR$$F$Y$$$20240717$$HP$NL$NL
241111401$24111140$1$I$$20240715$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US065568$SANDOZ$Zieneldien T, Kim J, Greene J. Breakthrough Pneumocystis jirovecii Pneumoniain an Allogeneic Hematopoietic Stem CellTransplant Recipient. Cureus. 2024;16(6):61890$50$YR$$F$Y$$$20240718$$HP$US$US
241111411$24111141$1$I$20240301$20240716$20240718$20240718$EXP$$NL-SANDOZ INC.-SDZ2024NL065787$SANDOZ$$$$A$F$Y$67.5$KG$20240718$$MD$NL$NL
241111431$24111143$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49785$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241111441$24111144$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49788$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241111451$24111145$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49810$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241111463$24111146$3$F$20240601$20240726$20240718$20240730$EXP$$US-SANDOZ INC.-SDZ2024US065544$SANDOZ$$21$YR$$F$Y$$$20240730$$CN$US$US
241111471$24111147$1$I$$20240712$20240718$20240718$EXP$$NVSC2024US147194$NOVARTIS$Sanjeevi A, Clark BL, Aguirre A, Verghese BG. Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature. CLINICAL IMMUNOLOGY COMMUNICATIONS. 2024;6:1-4$65$YR$$F$Y$$$20240718$$HP$US$US
241111482$24111148$2$F$20240715$20240722$20240718$20240729$30DAY$$US-PFIZER INC-202400215330$PFIZER$$59$YR$$M$Y$83.91$KG$20240729$$CN$US$US
241111491$24111149$1$I$20240605$20240717$20240718$20240718$EXP$IE-HPRA-2024-114065$IE-GSK-IE2024089802$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$PH$IE$IE
241111501$24111150$1$I$20240607$20240718$20240718$20240718$EXP$$ES-GILEAD-2024-0681207$GILEAD$$$$$$Y$$$20240718$$MD$ES$ES
241111511$24111151$1$I$20240101$20240716$20240718$20240718$PER$$US-ABBVIE-5842487$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241111521$24111152$1$I$$20240711$20240718$20240718$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001410$BLUEPRINT MEDICINES$$$$$F$Y$$$20240718$$CN$US$US
241111531$24111153$1$I$$20240716$20240718$20240718$PER$$NVSC2024US148255$NOVARTIS$$$$$$Y$$$20240718$$MD$US$US
241111541$24111154$1$I$20240601$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114140$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240718$$HP$US$US
241111552$24111155$2$F$20240707$20240717$20240718$20240722$EXP$$CA-ROCHE-10000028128$ROCHE$$24$YR$A$F$Y$$$20240722$$CN$CA$CA
241111563$24111156$3$F$$20240917$20240718$20240923$30DAY$$US-PFIZER INC-202400215744$PFIZER$$25$YR$$F$Y$$$20240923$$CN$US$US
241111572$24111157$2$F$$20240818$20240718$20240819$30DAY$$US-PFIZER INC-202400215515$PFIZER$$15$YR$$M$Y$$$20240819$$CN$US$US
241111581$24111158$1$I$$20240715$20240718$20240718$30DAY$$US-PFIZER INC-202400215740$PFIZER$$9$YR$$M$Y$$$20240718$$CN$US$US
241111592$24111159$2$F$$20240821$20240718$20240821$30DAY$$US-PFIZER INC-202400215069$PFIZER$$16$YR$$M$Y$$$20240821$$CN$US$US
241111602$24111160$2$F$$20240917$20240718$20240920$30DAY$$US-PFIZER INC-202400215908$PFIZER$$74$YR$$F$Y$$$20240920$$CN$US$US
241111611$24111161$1$I$20230513$20240709$20240718$20240718$EXP$$KR-TAKEDA-2024TUS072669$TAKEDA$$$$E$F$Y$50$KG$20240718$$HP$KR$KR
241111623$24111162$3$F$20240101$20240805$20240718$20240820$EXP$$US-PARI RESPIRATORY EQUIPMENT, INC.-2024PAR00052$PARI RESPIRATORY EQUIPMENT$$$$$M$Y$45.351$KG$20240820$$HP$US$US
241111631$24111163$1$I$$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-49801$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241111641$24111164$1$I$$20240711$20240718$20240718$EXP$$IN-ROCHE-3530533$ROCHE$$63$YR$A$M$Y$$$20240718$$MD$IN$IN
241111651$24111165$1$I$$20240629$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006929$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241111661$24111166$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49791$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241111671$24111167$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49809$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241111681$24111168$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49802$$FDA-CTU$$66$YR$$F$N$$$20240718$N$$US$
241111691$24111169$1$I$20240601$20240711$20240718$20240718$EXP$$JP-EMD Serono-2024038076$EMD SERONO INC$$85$YR$E$F$Y$$$20240718$$MD$JP$JP
241111701$24111170$1$I$$20240716$20240718$20240718$PER$$US-TAKEDA-2024TUS072454$TAKEDA$$$$$F$Y$118$KG$20240718$$MD$US$US
241111711$24111171$1$I$$20240703$20240718$20240718$EXP$$US-JOURNEY MEDICAL CORPORATION-2024JNY00154$JOURNEY MEDICAL CORPORATION$D. Grand. Lymphomatoid Drug-Induced Hypersensitivity Syndrome to Minocycline. Am. J. Dermatopathol.. 2024;46(7):S16$18$YR$$M$Y$$$20240718$$HP$US$US
241111721$24111172$1$I$20240601$20240710$20240718$20240718$PER$$US-SA-2024SA207580$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240718$$MD$US$US
241111751$24111175$1$I$$20240712$20240718$20240718$30DAY$$EG-SANDOZ INC.-SDZ2023EG073294$SANDOZ$$$$$M$Y$$$20240718$$CN$EG$EG
241111765$24111176$5$F$20240101$20240904$20240718$20240909$EXP$$DE-Ipsen Biopharmaceuticals, Inc.-2024-14144$IPSEN$$73$YR$E$F$Y$$$20240909$$PH$DE$DE
241111771$24111177$1$I$$20240710$20240718$20240718$EXP$$DE-PFIZER INC-PV202400090828$PFIZER$Toskov, V.. Variable Clinical Courses of Varicella Zoster Virus Infection-related or Vaccination related Bone Marrow Failure. Journal of Pediatric Hematology/Oncology. 2024;46(5):e354-e359$4$YR$$F$Y$$$20240718$$MD$DE$DE
241111781$24111178$1$I$$20240716$20240718$20240718$EXP$$NVSC2024CA147229$NOVARTIS$$36$YR$$F$Y$$$20240718$$PH$CA$CA
241111793$24111179$3$F$$20240719$20240718$20240726$EXP$$CA-ROCHE-10000029968$ROCHE$$$$A$F$Y$$$20240726$$CN$CA$CA
241111801$24111180$1$I$20200109$20240712$20240718$20240718$EXP$$IN-INCYTE CORPORATION-2020IN013605$INCYTE$$$$$$Y$$$20240718$$CN$IN$IN
241111811$24111181$1$I$20240703$20240715$20240718$20240718$EXP$$RU-GSK-RU2024GSK089418$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$MD$RU$RU
241111831$24111183$1$I$20200723$20200731$20240718$20240718$EXP$$US-AstraZeneca-2020SE97935$ASTRAZENECA$$18427$DY$$F$Y$85.3$KG$20240718$$CN$US$
241111841$24111184$1$I$20240711$20240711$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407007702$ELI LILLY AND CO$$$$A$F$Y$$$20240718$$CN$US$US
241111853$24111185$3$F$20230417$20240912$20240718$20240917$EXP$$JP-AstraZeneca-2024A148772$ASTRAZENECA$$87$YR$$F$Y$35$KG$20240918$$MD$JP$
241111861$24111186$1$I$$20240717$20240718$20240718$PER$$US-PFIZER INC-PV202400094027$PFIZER$$15$YR$$F$Y$$$20240718$$HP$US$US
241111881$24111188$1$I$$20240717$20240718$20240718$PER$$US-PFIZER INC-202400015323$PFIZER$$69$YR$$M$Y$$$20240718$$MD$US$US
241111901$24111190$1$I$$20240715$20240718$20240718$PER$$NVSC2024US146388$NOVARTIS$$$$$F$Y$$$20240718$$CN$US$US
241111911$24111191$1$I$20240714$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112538$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240718$$CN$US$US
241111921$24111192$1$I$$20240711$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112181$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240718$$CN$US$US
241111931$24111193$1$I$$20240712$20240718$20240718$EXP$$CA-ROCHE-3363781$ROCHE$$$$A$F$Y$$$20240718$$CN$CA$CA
241111941$24111194$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141720$AMGEN$$$$$$Y$$$20240718$$PH$US$US
241111952$24111195$2$F$$20240715$20240718$20240718$EXP$$US-GILEAD-2024-0680828$GILEAD$$$$A$M$Y$$$20240718$$CN$US$US
241111961$24111196$1$I$20230110$20240709$20240718$20240718$EXP$$KR-TAKEDA-2024TUS072686$TAKEDA$$$$E$M$Y$79$KG$20240718$$HP$KR$KR
241111971$24111197$1$I$$20240628$20240718$20240718$EXP$$CA-TEVA-VS-3214893$TEVA$$15$YR$$F$Y$54$KG$20240718$$HP$CA$CA
241111982$24111198$2$F$$20240920$20240718$20240923$30DAY$$KR-PFIZER INC-202400217234$PFIZER$$$$$$Y$$$20240923$$HP$KR$KR
241111992$24111199$2$F$$20240808$20240718$20240812$30DAY$$AU-PFIZER INC-202400209221$PFIZER$$$$$$Y$$$20240812$$PH$AU$AU
241112003$24111200$3$F$$20240912$20240718$20240917$30DAY$$US-PFIZER INC-202400209878$PFIZER$$$$$$Y$$$20240917$$CN$US$US
241112012$24111201$2$F$$20240801$20240718$20240805$PER$$US-PFIZER INC-202400215888$PFIZER$$13$YR$$M$Y$$$20240805$$MD$US$US
241112021$24111202$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49806$$FDA-CTU$$58$YR$$M$N$$$20240718$N$$US$
241112031$24111203$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49812$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241112042$24111204$2$F$20240129$20240711$20240718$20240802$EXP$$CO-GSK-CO2024AMR014756$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$CO$CO
241112051$24111205$1$I$$20240716$20240718$20240718$PER$$US-ABBVIE-5843901$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241112061$24111206$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49813$$FDA-CTU$$51$YR$$F$N$83.46$KG$20240718$N$$US$
241112071$24111207$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49808$$FDA-CTU$$80$YR$$M$N$$$20240718$N$$US$
241112081$24111208$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49805$$FDA-CTU$$63$YR$$F$N$$$20240718$N$$US$
241112091$24111209$1$I$$20240709$20240718$20240718$PER$$US-RDY-SPO/USA/24/0010322$DR REDDYS$$$$$F$Y$$$20240718$$CN$US$US
241112101$24111210$1$I$$20240709$20240718$20240718$PER$$US-RDY-SPO/USA/24/0010307$DR REDDYS$$22$YR$A$F$Y$$$20240718$$MD$US$US
241112111$24111211$1$I$$20240709$20240718$20240718$PER$$US-RDY-SPO/USA/24/0010296$DR REDDYS$$24$YR$A$F$Y$$$20240718$$MD$US$US
241112122$24111212$2$F$$20240731$20240718$20240806$PER$$US-RDY-SPO/USA/24/0010300$DR REDDYS$$19$YR$A$F$Y$$$20240806$$MD$US$US
241112131$24111213$1$I$20220104$20240709$20240718$20240718$EXP$$KR-TAKEDA-2024TUS072694$TAKEDA$$$$A$F$Y$$$20240718$$HP$KR$KR
241112141$24111214$1$I$20230801$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002310J$MERCK$$76$YR$$M$Y$$$20240718$$MD$JP$JP
241112152$24111215$2$F$$20240820$20240718$20240821$PER$$US-HALEON-2187741$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
241112161$24111216$1$I$$20240716$20240718$20240718$EXP$$US-AMERICAN REGENT INC-2024002757$AMERICAN REGENT$$5$DEC$$F$Y$$$20240718$$HP$US$US
241112171$24111217$1$I$$20240712$20240718$20240718$PER$$US-BAYER-2024A100864$BAYER$$$$$F$Y$$$20240718$$CN$US$US
241112181$24111218$1$I$20240712$20240715$20240718$20240718$EXP$GB-MHRA-MED-202407151013203930-NSPGR$GB-009507513-2407GBR009767$MERCK$$67$YR$$F$Y$64$KG$20240718$$PH$GB$GB
241112201$24111220$1$I$$20240711$20240718$20240718$EXP$$HR-BRISTOL-MYERS SQUIBB COMPANY-2024-112077$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240718$$HP$HR$HR
241112212$24111221$2$F$$20240708$20240718$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-110892$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$CN$JP$JP
241112222$24111222$2$F$$20240909$20240718$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113865$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$73.48$KG$20240913$$CN$US$US
241112231$24111223$1$I$20240101$20240710$20240718$20240718$PER$$US-SA-2024SA207340$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240718$$MD$US$US
241112241$24111224$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA206613$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240718$$MD$US$US
241112251$24111225$1$I$20240601$20240710$20240718$20240718$PER$$US-SA-2024SA207533$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240718$$MD$US$US
241112261$24111226$1$I$20240101$20240712$20240718$20240718$PER$$US-SA-2024SA209723$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240718$$MD$US$US
241112271$24111227$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207186$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240718$$MD$US$US
241112281$24111228$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA207855$SANOFI AVENTIS$$$$E$M$Y$$$20240718$$MD$US$US
241112291$24111229$1$I$20240101$20240710$20240718$20240718$PER$$US-SA-2024SA206495$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240718$$MD$US$US
241112301$24111230$1$I$$20240716$20240718$20240718$PER$$NVSC2024US148258$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
241112311$24111231$1$I$20240612$20240711$20240718$20240718$EXP$IT-MINISAL02-993030$IT-TEVA-VS-3220609$TEVA$$70$YR$$M$Y$$$20240718$$MD$IT$IT
241112321$24111232$1$I$20240624$20240709$20240718$20240718$EXP$$GB-TEVA-VS-3219893$TEVA$$66$YR$$M$Y$73$KG$20240718$$MD$GB$GB
241112331$24111233$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49818$$FDA-CTU$$65$YR$$F$N$$$20240718$N$$US$
241112341$24111234$1$I$20240711$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49814$$FDA-CTU$$75$YR$$M$N$$$20240718$Y$PH$US$
241112361$24111236$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49816$$FDA-CTU$$71$YR$$F$N$103.42$KG$20240718$N$$US$
241112381$24111238$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49820$$FDA-CTU$$73$YR$$F$N$$$20240718$N$$US$
241112391$24111239$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49807$$FDA-CTU$$76$YR$$F$N$$$20240718$N$$US$
241112421$24111242$1$I$$20240717$20240718$20240718$EXP$$CA-PFIZER INC-202400218624$PFIZER$$57$YR$$F$Y$101$KG$20240718$$HP$CA$CA
241112431$24111243$1$I$$20240716$20240718$20240718$EXP$$US-PFIZER INC-202400217602$PFIZER$$33$YR$$M$Y$$$20240718$$CN$US$US
241112442$24111244$2$F$$20240731$20240718$20240810$EXP$$GB-TEVA-VS-3219967$TEVA$$10$YR$$M$Y$28$KG$20240810$$HP$GB$GB
241112451$24111245$1$I$20240701$20240716$20240718$20240718$EXP$$TW-BAYER-2024A104462$BAYER$$$$$M$Y$$$20240718$$HP$TW$TW
241112461$24111246$1$I$20240702$20240709$20240718$20240718$EXP$$GB-TEVA-VS-3219860$TEVA$$65$YR$$M$Y$70$KG$20240718$$MD$GB$GB
241112471$24111247$1$I$20240706$20240709$20240718$20240718$EXP$GB-MHRA-MED-202407081406081170-LSBRC$GB-TEVA-VS-3219958$TEVA$$73$YR$$F$Y$$$20240718$$PH$GB$GB
241112481$24111248$1$I$20240409$20240711$20240718$20240718$EXP$$CH-AstraZeneca-2024A162254$ASTRAZENECA$$64$YR$$F$Y$$$20240718$$MD$CH$
241112491$24111249$1$I$$20220126$20240718$20240718$EXP$$CA-AstraZeneca-2020SF34506$ASTRAZENECA$$36$YR$$M$Y$$$20240718$$MD$CA$
241112501$24111250$1$I$$20240711$20240718$20240718$EXP$$DE-AstraZeneca-2024A159019$ASTRAZENECA$$$$$M$Y$$$20240718$$MD$DE$
241112511$24111251$1$I$$20240710$20240718$20240718$EXP$$US-AstraZeneca-2024A159300$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241112522$24111252$2$F$$20240717$20240718$20240722$PER$$US-AMGEN-USASP2024142025$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241112532$24111253$2$F$20240715$20240801$20240718$20240807$PER$$US-AMGEN-USASP2024141653$AMGEN$$79$YR$E$F$Y$$$20240806$$CN$US$US
241112541$24111254$1$I$$20240705$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107988$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240718$$HP$US$US
241112551$24111255$1$I$20240706$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114129$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$92.1$KG$20240718$$HP$US$US
241112561$24111256$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-10000029130$ROCHE$$$$A$M$Y$$$20240718$$CN$US$US
241112571$24111257$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207098$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240718$$MD$US$US
241112581$24111258$1$I$$20240704$20240718$20240718$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06246$LUPIN$Shukla P, Lubrin SI, Subramanian R, Joshi H. Severe ARDS and immune reconstitution syndrome in a rare case of multidrug-resistant tuberculosis: A case report and review. Chest. 2023;164 (4):A1514.$42$YR$$F$Y$$$20240718$$HP$US$US
241112594$24111259$4$F$$20240703$20240718$20240815$PER$$US-TRAVERE-2024TVT00580$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240815$$CN$US$US
241112602$24111260$2$F$20240701$20240821$20240718$20240821$EXP$$TW-BAYER-2024A104476$BAYER$$80$YR$E$M$Y$$$20240821$$HP$TW$TW
241112612$24111261$2$F$$20240830$20240718$20240905$EXP$CZ-CZSUKL-24001988$CZ-MYLANLABS-2024M1065971$MYLAN$$52$YR$$F$Y$$$20240905$$CN$CZ$CZ
241112621$24111262$1$I$$20240715$20240718$20240718$EXP$$CA-ABBVIE-5841082$ABBVIE$$17$YR$$M$Y$$$20240718$$CN$CA$CA
241112633$24111263$3$F$20240603$20240814$20240718$20240815$EXP$$US-GILEAD-2024-0678683$GILEAD$$$$$M$Y$$$20240815$$MD$US$US
241112641$24111264$1$I$20240611$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49826$$FDA-CTU$$76$YR$$F$N$$$20240718$Y$PH$US$
241112652$24111265$2$F$$20240821$20240718$20240827$30DAY$$AU-PFIZER INC-202400209372$PFIZER$$$$$$Y$$$20240827$$PH$AU$AU
241112661$24111266$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49830$$FDA-CTU$$71$YR$$F$N$81.65$KG$20240718$N$$US$
241112671$24111267$1$I$$20240710$20240718$20240718$EXP$$EE-BAYER-2024A100190$BAYER$$$$$$Y$$$20240718$$CN$EE$EE
241112682$24111268$2$F$20230701$20240812$20240718$20240813$EXP$FR-JAZZ PHARMACEUTICALS-2023-FR-018514$FR-UCBSA-2024036386$UCB$$23$YR$$F$Y$38$KG$20240813$$MD$FR$FR
241112691$24111269$1$I$$20240712$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009323$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240718$$CN$US$US
241112701$24111270$1$I$$20240716$20240718$20240718$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-113956$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240718$$MD$TW$TW
241112711$24111271$1$I$20230501$20240708$20240718$20240718$EXP$$RO-BRISTOL-MYERS SQUIBB COMPANY-2024-109162$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240718$$MD$RO$RO
241112721$24111272$1$I$20240417$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114492$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$51.71$KG$20240718$$HP$US$US
241112741$24111274$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113335$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240718$$HP$US$US
241112781$24111278$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA209721$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240718$$CN$US$US
241112791$24111279$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA209805$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240718$$MD$US$US
241112802$24111280$2$F$$20240823$20240718$20240906$PER$$US-SA-2024SA208482$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240906$$MD$US$US
241112814$24111281$4$F$20220101$20240916$20240718$20240923$EXP$$US-SA-2022SA023677$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240923$$MD$US$US
241112821$24111282$1$I$20240701$20240710$20240718$20240718$PER$$US-SA-2024SA205047$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240718$$CN$US$US
241112831$24111283$1$I$$20240712$20240718$20240718$PER$$US-BIOGEN-2023BI01211991$BIOGEN$$$$$F$Y$$$20240718$$CN$US$US
241112842$24111284$2$F$20140101$20240909$20240718$20240912$EXP$$GB-MYLANLABS-2024M1066352$MYLAN$$$$A$M$Y$73$KG$20240912$$MD$GB$GB
241112851$24111285$1$I$20240612$20240711$20240718$20240718$EXP$ES-AEMPS-1542613$ES-TEVA-VS-3220590$TEVA$$94$YR$$F$Y$63$KG$20240718$$MD$ES$ES
241112861$24111286$1$I$20240509$20240710$20240718$20240718$EXP$$US-BAYER-2024A079409$BAYER$$75$YR$E$F$Y$64.399$KG$20240718$$CN$US$US
241112881$24111288$1$I$$20240717$20240718$20240718$EXP$$CA-PFIZER INC-202400217593$PFIZER$$6$YR$$M$Y$$$20240718$$PH$CA$CA
241112891$24111289$1$I$$20240712$20240718$20240718$PER$$NVSC2024US147449$NOVARTIS$$$$$F$Y$94$KG$20240718$$CN$US$US
241112902$24111290$2$F$$20240807$20240718$20240807$PER$$US-ALXN-202407USA000956US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$MD$US$US
241112911$24111291$1$I$20240502$20240711$20240718$20240718$EXP$ES-AEMPS-1543970$ES-TEVA-VS-3221039$TEVA$$70$YR$$M$Y$$$20240718$$MD$ES$ES
241112921$24111292$1$I$20240101$20240710$20240718$20240718$PER$$US-SA-2024SA207848$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240718$$MD$US$US
241112931$24111293$1$I$20240101$20240708$20240718$20240718$PER$$US-SA-2024SA204799$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240718$$MD$US$US
241112942$24111294$2$F$20240706$20240730$20240718$20240805$EXP$$IN-VANTIVE-2024VAN018375$Vantive US Healthcare$$70$YR$$M$Y$$$20240805$$CN$IN$IN
241112951$24111295$1$I$$20240712$20240718$20240718$EXP$$IN-VANTIVE-2024VAN018053$Vantive US Healthcare$$66$YR$$M$Y$$$20240718$$CN$IN$IN
241112961$24111296$1$I$20240307$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405161110176040-VBSDZ$GB-ADVANZ PHARMA-202407005680$ADVANZ PHARMA$$$$$$Y$$$20240718$$CN$GB$GB
241112971$24111297$1$I$$20240716$20240718$20240718$EXP$$US-PURDUE-USA-2024-0310826$PURDUE$Riedl MA, Farkas H, Aygoren-Pursun E, Psarros F, Soteres DF, Staevska M., et. al.. Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks. The New England Journal of Medicine. 2024;391(1):32-43$$$$$Y$$$20240718$$MD$US$US
241112981$24111298$1$I$20240217$20240715$20240718$20240718$EXP$PL-URPL-DML-MLP.4401.1.153.2024$PL-PURDUE-USA-2024-0310815$PURDUE$$73$YR$$F$Y$$$20240718$$PH$PL$PL
241113012$24111301$2$F$$20240818$20240718$20240819$30DAY$$US-PFIZER INC-202400211258$PFIZER$$7$YR$$F$Y$$$20240819$$PH$US$US
241113021$24111302$1$I$20240710$20240710$20240718$20240718$EXP$$GB-AstraZeneca-2024A157974$ASTRAZENECA$$88$YR$$M$Y$$$20240718$$MD$GB$
241113031$24111303$1$I$20240624$20240710$20240718$20240718$EXP$$IT-AstraZeneca-2024A157741$ASTRAZENECA$$54$YR$$F$Y$$$20240718$$MD$IT$
241113041$24111304$1$I$$20240717$20240718$20240718$EXP$$CA-PFIZER INC-2021171010$PFIZER$$69$YR$$F$Y$$$20240718$$HP$CA$CA
241113051$24111305$1$I$20230301$20240711$20240718$20240718$EXP$$GB-AstraZeneca-2024A162629$ASTRAZENECA$$62$YR$$M$Y$$$20240718$$MD$GB$
241113072$24111307$2$F$$20240817$20240718$20240819$30DAY$$FR-PFIZER INC-202400213389$PFIZER$$7$YR$$F$Y$$$20240819$$PH$FR$FR
241113081$24111308$1$I$$20240712$20240718$20240718$PER$$US-ABBVIE-5839562$ABBVIE$$$$$$Y$$$20240718$$CN$US$US
241113091$24111309$1$I$20240101$20240710$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110992$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$97.07$KG$20240718$$CN$US$US
241113102$24111310$2$F$20240101$20240904$20240718$20240917$PER$$US-SA-2024SA207366$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240918$$MD$US$US
241113111$24111311$1$I$20240101$20240419$20240718$20240718$PER$$US-TEVA-VS-3187491$TEVA$$54$YR$$M$Y$$$20240718$$CN$US$US
241113121$24111312$1$I$20220301$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114495$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240718$$CN$US$US
241113131$24111313$1$I$20240701$20240715$20240718$20240718$EXP$$US-SA-2024SA210448$SANOFI AVENTIS$$7$YR$C$F$Y$24.49$KG$20240718$$MD$US$US
241113142$24111314$2$F$20240101$20240816$20240718$20240830$PER$$US-SA-2024SA208976$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240830$$MD$US$US
241113151$24111315$1$I$20231002$20240716$20240718$20240718$EXP$$US-ABBVIE-5842776$ABBVIE$$27$YR$$M$Y$$$20240718$$CN$US$US
241113161$24111316$1$I$$20240618$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006845$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241113182$24111318$2$F$$20240817$20240718$20240819$30DAY$$US-PFIZER INC-202400213047$PFIZER$$8$YR$$M$Y$$$20240819$$CN$US$US
241113192$24111319$2$F$$20240817$20240718$20240819$30DAY$$US-PFIZER INC-202400213332$PFIZER$$11$YR$$F$Y$$$20240819$$CN$US$US
241113212$24111321$2$F$20240710$20240912$20240718$20240917$30DAY$$KR-PFIZER INC-PV202400091475$PFIZER$$11$YR$$F$Y$$$20240917$$CN$KR$KR
241113221$24111322$1$I$20240215$20240215$20240718$20240718$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00082$Unknown Manufacturer$$31$YR$$F$Y$$$20240718$$PH$US$US
241113231$24111323$1$I$$20240324$20240718$20240718$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00083$Unknown Manufacturer$$$$$F$Y$$$20240718$$CN$US$US
241113241$24111324$1$I$20240512$20240515$20240718$20240718$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00219$Unknown Manufacturer$$69$YR$$F$Y$$$20240718$$CN$US$US
241113252$24111325$2$F$20240716$20240719$20240718$20240721$EXP$$CA-BAYER-2024A104206$BAYER$$35$YR$A$F$Y$$$20240719$$MD$CA$CA
241113261$24111326$1$I$20240430$20240430$20240718$20240718$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00201$Unknown Manufacturer$$76$YR$$F$Y$76.19$KG$20240715$$CN$US$US
241113271$24111327$1$I$20230301$20240718$20240718$20240718$EXP$$AU-ROCHE-3360844$ROCHE$$56$YR$A$F$Y$$$20240718$$CN$AU$AU
241113281$24111328$1$I$$20240703$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN007058$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241113291$24111329$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220421$TEVA$$57$YR$$M$Y$$$20240718$$PH$CA$CA
241113301$24111330$1$I$20240401$20240715$20240718$20240718$EXP$FR-AFSSAPS-LL2024001314$FR-INCYTE CORPORATION-2024IN007426$INCYTE$$$$$$Y$$$20240718$$PH$FR$FR
241113311$24111331$1$I$20240701$20240716$20240718$20240718$EXP$FR-AFSSAPS-RS2024000678$FR-LUNDBECK-DKLU4001867$LUNDBECK$$$$$$Y$$$20240718$$MD$FR$FR
241113321$24111332$1$I$$20240718$20240718$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040602$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$HP$US$US
241113331$24111333$1$I$20240531$20240711$20240718$20240718$EXP$CN-91110000556821568D-2024DRL001283$CN-RDY-SPO/CHN/24/0010413$DR REDDYS$$72$YR$E$F$Y$65$KG$20240718$$HP$CN$CN
241113341$24111334$1$I$20240717$20240718$20240718$20240718$DIR$710760$$FDA-CTU$$64$YR$$M$N$74.3$KG$20240718$N$PH$US$
241113352$24111335$2$F$20240619$20240807$20240718$20240821$EXP$$CA-HLS-202401683$HLS THERAPEUTICS$$36$YR$A$M$Y$$$20240821$$PH$CA$CA
241113361$24111336$1$I$20240525$20240711$20240718$20240718$EXP$FR-AFSSAPS-ST2024001134$FR-TEVA-VS-3220457$TEVA$$76$YR$$M$Y$64.8$KG$20240718$$HP$FR$FR
241113371$24111337$1$I$20240601$20240712$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009477$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240718$$CN$US$US
241113381$24111338$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011172$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240718$$CN$US$US
241113391$24111339$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010513$ELI LILLY AND CO$$35$YR$A$$Y$$$20240718$$MD$US$US
241113401$24111340$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220118$TEVA$$68$YR$$F$Y$$$20240718$$PH$CA$CA
241113421$24111342$1$I$$20240717$20240718$20240718$PER$$NVSC2024US148271$NOVARTIS$$$$$$Y$$$20240718$$MD$US$US
241113431$24111343$1$I$$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114409$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240718$$CN$US$US
241113442$24111344$2$F$20230905$20240806$20240718$20240807$EXP$$CA-ABBVIE-5843679$ABBVIE$$$$A$M$Y$$$20240807$$CN$CA$CA
241113452$24111345$2$F$$20240715$20240718$20240726$EXP$$US-GSK-US2024AMR089693$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241113462$24111346$2$F$20221215$20240831$20240718$20240904$EXP$$TW-009507513-2407TWN009752$MERCK$$64$YR$$F$Y$$$20240904$$MD$TW$TW
241113473$24111347$3$F$20240613$20240718$20240718$20240727$PER$$US-SA-2024SA203170$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240727$$MD$US$US
241113481$24111348$1$I$20240601$20240711$20240718$20240718$PER$$US-SA-2024SA204397$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240718$$MD$US$US
241113492$24111349$2$F$20240716$20240801$20240718$20240808$EXP$$US-JNJFOC-20240743609$JOHNSON AND JOHNSON$$42$YR$A$F$Y$51.302$KG$20240808$$HP$US$US
241113501$24111350$1$I$$20240710$20240718$20240718$EXP$$US-ROCHE-10000024086$ROCHE$$77$YR$E$F$Y$$$20240718$$CN$US$US
241113512$24111351$2$F$20180728$20220401$20240718$20240726$EXP$$CA-AstraZeneca-2020SF17976$ASTRAZENECA$$54$YR$$M$Y$$$20240726$$MD$CA$
241113523$24111352$3$F$20240506$20240724$20240718$20240729$EXP$$US-AstraZeneca-2024A159810$ASTRAZENECA$$61$YR$$M$Y$103$KG$20240729$$HP$US$
241113531$24111353$1$I$20240403$20240715$20240718$20240718$EXP$$IN-AstraZeneca-2024A162420$ASTRAZENECA$$15431$DY$$M$Y$$$20240718$$CN$IN$
241113541$24111354$1$I$$20200414$20240718$20240718$EXP$$US-AstraZeneca-2020SE52354$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241113551$24111355$1$I$$20240715$20240718$20240718$PER$$US-ALXN-202407USA000981US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240718$$CN$US$US
241113561$24111356$1$I$$20240716$20240718$20240718$EXP$$GB-TAKEDA-2024TUS072649$TAKEDA$$$$$F$Y$$$20240718$$CN$GB$GB
241113571$24111357$1$I$$20240716$20240718$20240718$PER$$US-ROCHE-10000030580$ROCHE$$$$$$Y$$$20240718$$CN$US$US
241113602$24111360$2$F$$20240715$20240718$20240726$EXP$$US-GSK-US2024AMR089804$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241113611$24111361$1$I$$20240715$20240718$20240718$EXP$$CA-TAKEDA-2024TUS072061$TAKEDA$$$$$F$Y$$$20240718$$CN$CA$CA
241113631$24111363$1$I$$20240709$20240718$20240718$EXP$$CA-BAXTER-2024BAX021400$BAXTER$$55$YR$$M$Y$$$20240718$$PH$CA$CA
241113661$24111366$1$I$$20240710$20240718$20240718$PER$$US-MYLANLABS-2024M1065960$MYLAN$$$$$F$Y$$$20240718$$CN$US$US
241113671$24111367$1$I$$20240703$20240718$20240718$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06709$NEUROCRINE BIOSCIENCES$$59$YR$$F$Y$$$20240718$$HP$US$US
241113682$24111368$2$F$20240601$20240711$20240718$20240916$EXP$GB-MHRA-MED-202407101331202810-CPYMB$GB-SA-2024SA205118$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240916$$HP$GB$GB
241113691$24111369$1$I$$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114246$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$$$20240718$$CN$US$US
241113701$24111370$1$I$20240701$20240715$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113076$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240718$$CN$US$US
241113711$24111371$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114593$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240718$$CN$US$US
241113722$24111372$2$F$$20240813$20240718$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113868$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240822$$CN$US$US
241113731$24111373$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113883$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240718$$CN$US$US
241113742$24111374$2$F$20240601$20240910$20240718$20240916$EXP$$CA-TAKEDA-2023TUS123152$TAKEDA$$26$YR$$F$Y$$$20240916$$CN$CA$CA
241113751$24111375$1$I$$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114277$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240718$$CN$US$US
241113761$24111376$1$I$$20240717$20240718$20240718$PER$$NVSC2024US148268$NOVARTIS$$60$YR$$F$Y$$$20240718$$HP$US$US
241113771$24111377$1$I$$20240716$20240718$20240718$PER$$US-ABBVIE-5843448$ABBVIE$$$$$$Y$$$20240718$$CN$US$US
241113781$24111378$1$I$$20240710$20240718$20240718$PER$$US-MYLANLABS-2024M1065522$MYLAN$$$$$F$Y$$$20240718$$CN$US$US
241113791$24111379$1$I$$20240716$20240718$20240718$EXP$$US-ABBVIE-5844791$ABBVIE$$$$$$Y$$$20240718$$CN$US$US
241113811$24111381$1$I$$20240712$20240718$20240718$EXP$$GB-AMGEN-GBRSP2024139007$AMGEN$$30$YR$A$M$Y$$$20240718$$HP$GB$GB
241113821$24111382$1$I$20210422$20240715$20240718$20240718$EXP$$IT-AMGEN-ITANI2024140052$AMGEN$$68$YR$E$F$Y$62$KG$20240718$$MD$IT$IT
241113831$24111383$1$I$$20240716$20240718$20240718$EXP$$US-OTSUKA-2024_020074$OTSUKA$$$$$M$Y$$$20240718$$HP$US$US
241113841$24111384$1$I$$20240712$20240718$20240718$PER$$US-BAYER-2024A101473$BAYER$$23$YR$A$F$Y$$$20240718$$HP$US$US
241113852$24111385$2$F$20180910$20240711$20240718$20240724$EXP$$NVSC2024KR146201$NOVARTIS$$87$YR$$F$Y$$$20240724$$MD$KR$KR
241113861$24111386$1$I$$20240715$20240718$20240718$EXP$$CN-OTSUKA-2024_019977$OTSUKA$Jiang J, Li X, Wu D, Lu Q, Miao K, Wang H et. al.. Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study. eJHaem. 2024;1-11$$$A$$Y$$$20240718$$HP$CN$CN
241113871$24111387$1$I$$20240715$20240718$20240718$EXP$$CN-OTSUKA-2024_019975$OTSUKA$Jiang J, Li X, Wu D, Lu Q, Miao K, Yin X, et.al. Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study. eJHaem. 2024;1-11$$$A$$Y$$$20240718$$HP$CN$CN
241113881$24111388$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA204696$SANOFI AVENTIS$$$$A$M$Y$85.81$KG$20240718$$MD$US$US
241113891$24111389$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA208829$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240718$$MD$US$US
241113901$24111390$1$I$$20240705$20240718$20240718$PER$$US-SA-2024SA204185$SANOFI AVENTIS$$$$A$F$Y$49$KG$20240718$$MD$US$US
241113911$24111391$1$I$$20240718$20240718$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040631$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240718$$HP$US$US
241113921$24111392$1$I$$20240709$20240718$20240718$PER$$US-RDY-SPO/USA/24/0010299$DR REDDYS$$17$YR$T$$Y$$$20240718$$MD$US$US
241113941$24111394$1$I$20240629$20240711$20240718$20240718$EXP$ES-AEMPS-1543621$ES-TEVA-VS-3220500$TEVA$$26$YR$$F$Y$$$20240718$$MD$ES$ES
241113961$24111396$1$I$$20240712$20240718$20240718$EXP$$US-ABBVIE-5840587$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241113971$24111397$1$I$$20240712$20240718$20240718$EXP$$IT-MYLANLABS-2024M1066993$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$3$YR$$F$Y$$$20240718$$HP$IT$IT
241113982$24111398$2$F$$20240819$20240718$20240826$EXP$$DE-AstraZeneca-2024A160921$ASTRAZENECA$$$$$F$Y$$$20240826$$MD$DE$
241113991$24111399$1$I$20201105$20201210$20240718$20240718$EXP$$AU-AstraZeneca-2020SF67437$ASTRAZENECA$$23470$DY$$F$Y$$$20240718$$CN$AU$
241114001$24111400$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011305$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240718$$CN$US$US
241114011$24111401$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011158$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240718$$CN$US$US
241114021$24111402$1$I$20240717$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011555$ELI LILLY AND CO$$$$$$Y$$$20240718$$CN$US$US
241114032$24111403$2$F$$20240829$20240718$20240906$EXP$$DE-TEVA-VS-3220783$TEVA$Zwaan I, Soror T, Idel C, Pries R, Bruchhage KL, Hakim SG, et al. First Results of Concurrent Chemoradiation with Two Courses of 5 x 25 mg/m2 Cisplatin for Locally Advanced Head and Neck Cancer. J-Pers-Med 2023; 13 (6):.; Zwaan I, Soror T, Idel C, Pries R, Bruchhage KL, Hakim SG, et al. First Results of Concurrent Chemoradiation with Two Courses of 5 x 25 mg/m2 Cisplatin for Locally Advanced Head and Neck Cancer. J-Pers-Med 2023; 13 (6):.; Zwaan I, Soror T, Idel C, Pries R, Bruchhage KL, Haki...$$$$$Y$$$20240906$$HP$DE$DE
241114041$24111404$1$I$$20200511$20240718$20240718$EXP$$US-AstraZeneca-2020SE61207$ASTRAZENECA$$56$YR$$F$Y$$$20240718$$CN$US$
241114051$24111405$1$I$$20240711$20240718$20240718$EXP$$CA-AstraZeneca-2024A160459$ASTRAZENECA$$44$YR$$F$Y$$$20240718$$MD$CA$
241114061$24111406$1$I$20240101$20240715$20240718$20240718$PER$$US-PFIZER INC-202400215663$PFIZER$$56$YR$$F$Y$$$20240718$$CN$US$US
241114071$24111407$1$I$20240429$20240716$20240718$20240718$PER$$US-PFIZER INC-PV202400075234$PFIZER$$79$YR$$F$Y$$$20240718$$MD$US$US
241114091$24111409$1$I$$20240711$20240718$20240718$EXP$$US-SA-2024SA207694$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240718$$CN$US$US
241114101$24111410$1$I$$20240710$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111477$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240718$$CN$US$US
241114111$24111411$1$I$20240614$20240711$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112110$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240718$$PH$US$US
241114121$24111412$1$I$20240613$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114502$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240718$$HP$US$US
241114131$24111413$1$I$20240601$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114211$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240718$$PH$US$US
241114141$24111414$1$I$$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114384$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$56.7$KG$20240718$$CN$US$US
241114151$24111415$1$I$$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114398$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240718$$CN$US$US
241114161$24111416$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113892$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240718$$PH$US$US
241114172$24111417$2$F$20240716$20240820$20240718$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113758$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240823$$CN$US$US
241114181$24111418$1$I$$20240711$20240718$20240718$EXP$$US-AMGEN-USASP2024138467$AMGEN$Sheehan J.; Dumot C.; Mantziaris G. et al.. Stereotactic radiosurgery for haemorrhagic cerebral cavernous malformation: a multi-institutional, retrospective study. Stroke and Vascular Neurology. 2024;9 (3):221-229$$$$$Y$$$20240718$$HP$US$US
241114191$24111419$1$I$20240618$20240709$20240718$20240718$EXP$$US-AMGEN-USASP2024137793$AMGEN$$36$YR$A$F$Y$$$20240718$$CN$US$US
241114202$24111420$2$F$20240419$20240724$20240718$20240726$EXP$$CA-GSK-CA2024042015$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$HP$CA$CA
241114211$24111421$1$I$$20240617$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006461$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241114221$24111422$1$I$20240101$20240712$20240718$20240718$PER$$US-SA-2024SA207827$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240718$$MD$US$US
241114231$24111423$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220363$TEVA$$32$YR$$F$Y$$$20240718$$HP$CA$CA
241114241$24111424$1$I$$20240711$20240718$20240718$PER$$US-SA-2024SA207808$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240718$$MD$US$US
241114251$24111425$1$I$20230101$20240717$20240718$20240718$EXP$$CN-Eisai-EC-2024-170342$EISAI$Yang J, Qin Y, Lv Z, Xiao Q, Miao Y, Wei B, et al. Hepatic infarction occurred after 125 I particle stent treatment for hepatocellular carcinoma with portal vein tumor thrombus: A case report. Journal of Cancer Research and Clinical Oncology. 2024 Jun 17;150(308): 1-9. doi:https://doi.orgl1 0.1 007 / s00432-024-05826-y.$52$YR$A$M$Y$$$20240718$$MD$CN$CN
241114261$24111426$1$I$$20240717$20240718$20240718$EXP$$CN-TAKEDA-2024TUS072700$TAKEDA$$$$$M$Y$$$20240718$$CN$CN$CN
241114273$24111427$3$F$20240710$20240906$20240718$20240911$EXP$$NVSC2024US147017$NOVARTIS$$73$YR$$F$Y$113$KG$20240911$$HP$US$US
241114281$24111428$1$I$20220101$20240711$20240718$20240718$EXP$$AT-TEVA-VS-3220809$TEVA$$46$YR$$F$Y$$$20240718$$MD$AT$AT
241114292$24111429$2$F$20200901$20240814$20240718$20240820$EXP$$US-TAKEDA-2024TUS072233$TAKEDA$$57$YR$$F$Y$73$KG$20240820$$CN$US$US
241114301$24111430$1$I$$20240716$20240718$20240718$PER$$NVSC2024US148228$NOVARTIS$$$$$M$Y$$$20240718$$CN$US$US
241114311$24111431$1$I$$20240621$20240718$20240718$PER$$US-009507513-2406USA009544$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$3$YR$$$Y$$$20240718$$HP$US$US
241114331$24111433$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113325$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240718$$CN$US$US
241114342$24111434$2$F$$20240718$20240718$20240725$EXP$$CA-SA-2024SA205938$SANOFI AVENTIS$$72$YR$E$F$Y$111.5$KG$20240725$$MD$CA$CA
241114361$24111436$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113658$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$101.15$KG$20240718$$CN$US$US
241114381$24111438$1$I$20240714$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113904$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240718$$CN$US$US
241114391$24111439$1$I$$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113593$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240718$$CN$US$US
241114401$24111440$1$I$$20240716$20240718$20240718$PER$$NVSC2024US147587$NOVARTIS$$$$$$Y$$$20240718$$CN$US$US
241114411$24111441$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024140559$AMGEN$$$$$M$Y$$$20240718$$CN$US$US
241114423$24111442$3$F$$20240809$20240718$20240816$EXP$$JP-ALXN-202407JPN000501JP$ALEXION PHARMACEUTICALS$$6$DEC$$F$Y$$$20240816$$MD$JP$JP
241114432$24111443$2$F$20230101$20240716$20240718$20240719$PER$$NVSC2024US147545$NOVARTIS$$$$$F$Y$$$20240719$$HP$US$US
241114445$24111444$5$F$$20240903$20240718$20240905$EXP$$NVSC2024US148178$NOVARTIS$$$$$F$Y$$$20240905$$HP$US$US
241114451$24111445$1$I$$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114476$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$86.64$KG$20240718$$CN$US$US
241114461$24111446$1$I$20240619$20240716$20240718$20240718$EXP$FR-AFSSAPS-NY2024000762$FR-009507513-2407FRA010117$MERCK$$63$YR$$F$Y$94.6$KG$20240718$$PH$FR$FR
241114482$24111448$2$F$20240301$20240723$20240718$20240726$EXP$$US-MYLANLABS-2024M1066763$MYLAN$$32$YR$$F$Y$$$20240726$$CN$US$US
241114492$24111449$2$F$$20240717$20240718$20240720$PER$$NVSC2024US148292$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241114501$24111450$1$I$$20240702$20240718$20240718$EXP$$JP-JNJFOC-20240748509$JOHNSON AND JOHNSON$$$$$F$Y$$$20240718$$HP$JP$JP
241114511$24111451$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220260$TEVA$$60$YR$$M$Y$$$20240718$$HP$CA$CA
241114522$24111452$2$F$$20240828$20240718$20240906$EXP$$CH-TEVA-VS-3220751$TEVA$Morin S, Boroli F, Vandenberghe-Durr S, Allali D, Masouridi-Levrat S, Chalandon Y, et al. Severe anaphylaxis after chimeric antigen receptor T-cell injection: a case report. EJHaem 2024; 5 (3): 603-606.; Morin S, Boroli F, Vandenberghe-Durr S, Allali D, Masouridi-Levrat S, Chalandon Y, et al. Severe anaphylaxis after chimeric antigen receptor T-cell injection: a case report. EJHaem 2024; 5 (3): 603-606.$77$YR$$M$Y$$$20240906$$HP$CH$CH
241114533$24111453$3$F$$20240927$20240718$20240927$PER$$NVSC2024US147539$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
241114541$24111454$1$I$$20200511$20240718$20240718$EXP$$US-AstraZeneca-2020SE62995$ASTRAZENECA$$$$$F$Y$59$KG$20240718$$CN$US$
241114551$24111455$1$I$20240620$20240620$20240718$20240718$PER$$US-Kaleo, Inc.-2024KL000016$KALEO$$38$YR$A$F$Y$60.78$KG$20240718$$CN$US$US
241114561$24111456$1$I$$20240716$20240718$20240718$EXP$AU-SAMIL-GLO2024AU003717$AU-SANDOZ INC.-SDZ2024AU065648$SANDOZ$$58$YR$$M$Y$$$20240718$$HP$AU$AU
241114571$24111457$1$I$$20240708$20240718$20240718$30DAY$$DE-PFIZER INC-202400209447$PFIZER$$$$$$Y$$$20240718$$HP$DE$DE
241114581$24111458$1$I$20240413$20240711$20240718$20240718$EXP$ES-AEMPS-1543328$ES-TEVA-VS-3220515$TEVA$$95$YR$$M$Y$$$20240718$$MD$ES$ES
241114593$24111459$3$F$20240101$20240923$20240718$20240925$PER$$US-PFIZER INC-202400217922$PFIZER$$84$YR$$F$Y$65.77$KG$20240925$$CN$US$US
241114601$24111460$1$I$20240516$20240711$20240718$20240718$EXP$SE-SEMPA-2024-005318$SE-TEVA-VS-3220747$TEVA$$82$YR$$F$Y$$$20240718$$MD$SE$SE
241114611$24111461$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220368$TEVA$$$$$M$Y$$$20240718$$HP$CA$CA
241114622$24111462$2$F$20240717$20240722$20240718$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114388$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240723$$HP$US$US
241114631$24111463$1$I$20240618$20240708$20240718$20240718$PER$$CN-Eisai-EC-2024-169876$EISAI$$70$YR$E$M$Y$$$20240718$$HP$CN$CN
241114641$24111464$1$I$$20240711$20240718$20240718$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2024-096750$REGENERON$$$$$$Y$$$20240718$$MD$GB$GB
241114651$24111465$1$I$$20240716$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US065930$SANDOZ$$$$$F$Y$$$20240718$$HP$US$US
241114661$24111466$1$I$$20240708$20240718$20240718$PER$$JP-Eisai-EC-2024-169841$EISAI$$$$E$M$Y$$$20240718$$MD$JP$JP
241114671$24111467$1$I$20230101$20240710$20240718$20240718$PER$$JP-Eisai-EC-2023-143133$EISAI$$$$E$M$Y$$$20240718$$MD$JP$JP
241114682$24111468$2$F$20240401$20240917$20240718$20240925$EXP$$JP-Eisai-EC-2024-166553$EISAI$$61$YR$A$M$Y$$$20240925$$MD$JP$JP
241114691$24111469$1$I$20230815$20240709$20240718$20240718$EXP$$JP-Eisai-EC-2024-169931$EISAI$Experience with LEN+PEN: Case 2: A case in which almost CR was achieved$$$E$M$Y$$$20240718$$MD$JP$JP
241114701$24111470$1$I$$20240716$20240718$20240718$EXP$$CA-Eisai-EC-2023-149321$EISAI$$25$YR$A$F$Y$$$20240718$$HP$CA$CA
241114712$24111471$2$F$$20240709$20240718$20240722$EXP$$JP-Eisai-EC-2024-169848$EISAI$$$$A$F$Y$$$20240722$$MD$JP$JP
241114721$24111472$1$I$$20240708$20240718$20240718$PER$$US-ABBVIE-5832318$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241114731$24111473$1$I$20231116$20240712$20240718$20240718$EXP$IT-MINISAL02-994202$IT-MYLANLABS-2024M1065544$MYLAN$$54$YR$$F$Y$$$20240718$$MD$IT$IT
241114741$24111474$1$I$$20240712$20240718$20240718$PER$$US-ABBVIE-5840308$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241114751$24111475$1$I$$20240717$20240718$20240718$PER$$NVSC2024US148294$NOVARTIS$$$$$$Y$$$20240718$$HP$US$US
241114762$24111476$2$F$$20240919$20240718$20240920$EXP$$NVSC2024GB146771$NOVARTIS$$$$A$M$Y$$$20240920$$CN$GB$GB
241114771$24111477$1$I$$20240618$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006539$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241114792$24111479$2$F$$20240828$20240718$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112954$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240904$$CN$US$US
241114801$24111480$1$I$$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113079$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$85$KG$20240718$$CN$US$US
241114811$24111481$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220336$TEVA$$65$YR$$M$Y$$$20240718$$HP$CA$CA
241114821$24111482$1$I$$20240711$20240718$20240718$EXP$$US-MYLANLABS-2024M1066544$MYLAN$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.$$$A$$Y$$$20240718$$PH$US$US
241114831$24111483$1$I$$20240625$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000234$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241114841$24111484$1$I$20240601$20240624$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000227$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241114851$24111485$1$I$20240618$20240624$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000231$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241114862$24111486$2$F$20240101$20240819$20240718$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000235$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
241114871$24111487$1$I$20240501$20240620$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000222$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241114883$24111488$3$F$20240620$20240814$20240718$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000230$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
241114901$24111490$1$I$$20240625$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000233$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241114911$24111491$1$I$$20240717$20240718$20240718$PER$$US-JNJFOC-20240746984$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$US$US
241114921$24111492$1$I$20240101$20240712$20240718$20240718$EXP$SE-SEMPA-2024-005425$SE-MYLANLABS-2024M1065755$MYLAN$$76$YR$$F$Y$$$20240718$$MD$SE$SE
241114931$24111493$1$I$20240519$20240712$20240718$20240718$EXP$FR-AFSSAPS-BX2024001319$FR-MYLANLABS-2024M1065498$MYLAN$$75$YR$$F$Y$$$20240718$$MD$FR$FR
241114941$24111494$1$I$20230826$20240712$20240718$20240718$EXP$FR-AFSSAPS-TO2024001046$FR-MYLANLABS-2024M1065622$MYLAN$$91$YR$$F$Y$$$20240718$$PH$FR$FR
241114953$24111495$3$F$$20240828$20240718$20240902$PER$$US-ROCHE-10000027927$ROCHE$$$$E$F$Y$$$20240902$$CN$US$US
241115001$24111500$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113274$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240718$$HP$US$US
241115012$24111501$2$F$20240808$20240826$20240718$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113341$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240828$$CN$US$US
241115024$24111502$4$F$20240601$20240724$20240718$20240823$EXP$$BD-SANDOZ INC.-SDZ2024BD065360$SANDOZ$$29$YR$$M$Y$$$20240823$$CN$BD$BD
241115031$24111503$1$I$20240628$20240708$20240718$20240718$PER$$CN-Eisai-EC-2024-169879$EISAI$$31$YR$A$F$Y$50$KG$20240718$$HP$CN$CN
241115041$24111504$1$I$$20240708$20240718$20240718$PER$$JP-Eisai-EC-2024-169846$EISAI$Matsuura M, et al.. Therapeutic efficacy of a four-year treatment with eribulin in a patient with uterine leiomyosarcoma: A case report.. Gynecologic Oncology Reports.$31$YR$A$F$Y$$$20240718$$MD$JP$JP
241115061$24111506$1$I$20240601$20240708$20240718$20240718$PER$$JP-Eisai-EC-2024-169824$EISAI$$75$YR$E$M$Y$$$20240718$$MD$JP$JP
241115071$24111507$1$I$$20240715$20240718$20240718$30DAY$$US-GSK-US2024088767$GLAXOSMITHKLINE$$$$$F$Y$$$20240718$$CN$US$US
241115081$24111508$1$I$20240617$20240618$20240718$20240718$PER$$US-009507513-2406USA006899$MERCK$$$$$M$Y$$$20240718$$CN$US$US
241115091$24111509$1$I$20240623$20240715$20240718$20240718$EXP$$BR-SANDOZ INC.-SDZ2024BR066130$SANDOZ$$65$YR$$F$Y$$$20240718$$CN$BR$BR
241115102$24111510$2$F$20240705$20240721$20240718$20240724$PER$$NVSC2024US146689$NOVARTIS$$79$YR$$F$Y$84$KG$20240724$$HP$US$US
241115113$24111511$3$F$$20240729$20240718$20240805$PER$$US-BIOGEN-2024BI01273489$BIOGEN$$$$$M$Y$$$20240804$$HP$US$US
241115121$24111512$1$I$$20240712$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407008931$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241115131$24111513$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011309$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240718$$CN$US$US
241115141$24111514$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011684$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240718$$CN$US$US
241115151$24111515$1$I$20240513$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010741$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240718$$CN$US$US
241115161$24111516$1$I$20240606$20240607$20240718$20240718$EXP$$US-ELI_LILLY_AND_COMPANY-US202406005682$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240718$$CN$US$US
241115171$24111517$1$I$20240714$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010915$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240718$$CN$US$US
241115182$24111518$2$F$20231022$20240808$20240718$20240809$EXP$$CA-AMERICAN REGENT INC-2024002727$AMERICAN REGENT$$45$YR$$M$Y$$$20240809$$HP$CA$CA
241115191$24111519$1$I$$20240716$20240718$20240718$EXP$$NZ-INCYTE CORPORATION-2024IN007531$INCYTE$$$$$$Y$$$20240718$$HP$NZ$NZ
241115201$24111520$1$I$20231003$20240716$20240718$20240718$EXP$$AU-SANDOZ INC.-SDZ2024AU065663$SANDOZ$$51$YR$$F$Y$63.75$KG$20240718$$MD$AU$AU
241115211$24111521$1$I$20240622$20240716$20240718$20240718$EXP$HR-HALMED-300086113$HR-SANDOZ INC.-SDZ2024HR066173$SANDOZ$$32$YR$$F$Y$$$20240718$$MD$HR$HR
241115221$24111522$1$I$$20240712$20240718$20240718$PER$$US-SA-2023SA170432$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240718$$HP$US$US
241115231$24111523$1$I$$20240711$20240718$20240718$EXP$$US-UROVANT SCIENCES GMBH-202407-URV-001051$UROVANT SCIENCES$$$$$F$Y$$$20240718$$CN$US$US
241115241$24111524$1$I$$20240715$20240718$20240718$PER$$US-ABBVIE-5841770$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241115261$24111526$1$I$$20240717$20240718$20240718$EXP$$AU-SANDOZ INC.-SDZ2024AU066233$SANDOZ$$$$$$Y$$$20240718$$HP$AU$AU
241115271$24111527$1$I$$20240716$20240718$20240718$EXP$$CA-INCYTE CORPORATION-2024IN007524$INCYTE$$$$$$Y$$$20240718$$HP$CA$CA
241115281$24111528$1$I$20240628$20240716$20240718$20240718$EXP$FR-AFSSAPS-GR2024000885$FR-SANDOZ INC.-SDZ2024FR066176$SANDOZ$$72$YR$$M$Y$83$KG$20240718$$PH$FR$FR
241115291$24111529$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220228$TEVA$$72$YR$$F$Y$$$20240718$$MD$CA$CA
241115302$24111530$2$F$$20240821$20240718$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA066276$SANDOZ$$59$YR$$M$Y$92$KG$20240822$$PH$CA$CA
241115311$24111531$1$I$$20240710$20240718$20240718$EXP$$CA-TEVA-VS-3220202$TEVA$$71$YR$$F$Y$$$20240718$$HP$CA$CA
241115321$24111532$1$I$$20240717$20240718$20240718$EXP$$AU-SANDOZ INC.-SDZ2024AU066396$SANDOZ$$$$$$Y$$$20240718$$HP$AU$AU
241115331$24111533$1$I$$20240716$20240718$20240718$EXP$$CA-INCYTE CORPORATION-2024IN007523$INCYTE$$$$$$Y$$$20240718$$CN$CA$CA
241115341$24111534$1$I$20240101$20240715$20240718$20240718$EXP$$US-ABBVIE-5841743$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241115351$24111535$1$I$$20240715$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US066390$SANDOZ$$$$$M$Y$$$20240718$$CN$US$US
241115361$24111536$1$I$$20240712$20240718$20240718$EXP$$CA-AstraZeneca-2024A161225$ASTRAZENECA$$$$$F$Y$$$20240718$$PH$CA$
241115371$24111537$1$I$20240710$20240716$20240718$20240718$EXP$$US-BAYER-2024A103789$BAYER$$56$YR$A$M$Y$$$20240718$$CN$US$US
241115381$24111538$1$I$$20240717$20240718$20240718$EXP$$AU-TGA-0000813830$SANDOZ$$$$$$Y$$$20240718$$HP$AU$AU
241115391$24111539$1$I$$20240716$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US066299$SANDOZ$$$$$F$Y$$$20240718$$CN$US$US
241115401$24111540$1$I$20240502$20240705$20240718$20240718$PER$$JP-Eisai-EC-2024-165676$EISAI$$65$YR$E$M$Y$$$20240718$$MD$JP$JP
241115416$24111541$6$F$20240710$20240904$20240718$20240917$PER$$JP-Eisai-EC-2024-169940$EISAI$$$$E$M$Y$$$20240917$$MD$JP$JP
241115421$24111542$1$I$20220601$20240717$20240718$20240718$EXP$AU-TGA-0000813063$AU-SANDOZ INC.-SDZ2024AU066087$SANDOZ$$$$$M$Y$$$20240718$$CN$AU$AU
241115431$24111543$1$I$$20240718$20240718$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040648$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$CN$US$US
241115441$24111544$1$I$20240101$20240715$20240718$20240718$EXP$$US-ABBVIE-5842871$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241115452$24111545$2$F$20240717$20240809$20240718$20240814$PER$$US-JNJFOC-20240746665$JOHNSON AND JOHNSON$$74$YR$E$M$Y$80.3$KG$20240814$$PH$US$US
241115461$24111546$1$I$20240623$20240716$20240718$20240718$EXP$HR-HALMED-300086117$HR-SANDOZ INC.-SDZ2024HR066162$SANDOZ$$15$YR$$F$Y$60$KG$20240718$$MD$HR$HR
241115471$24111547$1$I$$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114339$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240718$$CN$US$US
241115481$24111548$1$I$$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114385$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$82.55$KG$20240718$$CN$US$US
241115491$24111549$1$I$$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113201$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240718$$HP$US$US
241115503$24111550$3$F$$20240807$20240718$20240812$PER$$US-BAUSCH-BL-2024-010668$BAUSCH AND LOMB$$43$YR$$M$Y$$$20240812$$CN$US$US
241115512$24111551$2$F$$20240716$20240718$20240827$PER$$US-LUNDBECK-DKLU4001527$LUNDBECK$$$$$$Y$$$20240827$$CN$US$US
241115521$24111552$1$I$20240701$20240716$20240718$20240718$PER$$US-BAUSCH-BL-2024-010902$BAUSCH AND LOMB$$43$YR$$F$Y$$$20240718$$CN$US$US
241115531$24111553$1$I$20240621$20240712$20240718$20240718$EXP$FI-FIMEA-202402557$FI-NALPROPION PHARMACEUTICALS INC.-FI-2024CUR003333$CURRAX PHARMACEUTICALS$$56$YR$$F$Y$$$20240718$$HP$FI$FI
241115541$24111554$1$I$20240401$20240715$20240718$20240718$EXP$$US-ABBVIE-5842484$ABBVIE$$77$YR$$F$Y$$$20240718$$CN$US$US
241115551$24111555$1$I$$20240717$20240718$20240718$EXP$$JP-PFIZER INC-PV202400093427$PFIZER$$54$YR$$M$Y$$$20240718$$CN$JP$JP
241115561$24111556$1$I$20240627$20240711$20240718$20240718$EXP$FR-AFSSAPS-BR2024000543$FR-TEVA-VS-3220673$TEVA$$50$YR$$M$Y$82$KG$20240718$$HP$FR$FR
241115571$24111557$1$I$20240101$20240716$20240718$20240718$EXP$$CA-PFIZER INC-PV202400027385$PFIZER$$38$YR$$F$Y$$$20240718$$HP$CA$CA
241115581$24111558$1$I$$20240711$20240718$20240718$EXP$$CA-TEVA-VS-3221222$TEVA$$$$$F$Y$$$20240718$$MD$CA$CA
241115591$24111559$1$I$20240708$20240708$20240718$20240718$PER$$US-APELLIS-2024-APL-0000448$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240718$$CN$US$US
241115602$24111560$2$F$20230101$20240716$20240718$20240917$EXP$$IT-SANDOZ INC.-SDZ2024IT066090$SANDOZ$$39$YR$$F$Y$$$20240917$$MD$IT$IT
241115611$24111561$1$I$20240522$20240711$20240718$20240718$EXP$FR-AFSSAPS-AVTO2024000104$FR-TEVA-VS-3220533$TEVA$$25$YR$$F$Y$$$20240718$$MD$FR$FR
241115621$24111562$1$I$20240712$20240712$20240718$20240718$EXP$$US-CSL-2024-006682$CSL Plasma$$48$YR$$M$Y$$$20240718$$HP$US$US
241115631$24111563$1$I$$20240710$20240718$20240718$EXP$$BR-JNJFOC-20240733000$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$MD$BR$BR
241115641$24111564$1$I$20240708$20240712$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US066357$SANDOZ$$$$$$Y$$$20240718$$CN$US$US
241115651$24111565$1$I$$20240710$20240718$20240718$PER$$US-SA-2024SA206035$SANOFI AVENTIS$$$$A$F$Y$$$20240718$$MD$US$US
241115662$24111566$2$F$$20240716$20240718$20240827$PER$$US-LUNDBECK-DKLU4001809$LUNDBECK$$$$$$Y$$$20240827$$CN$US$US
241115671$24111567$1$I$$20240717$20240718$20240718$EXP$$BE-ABBVIE-5843173$ABBVIE$$32$YR$$$Y$$$20240718$$MD$BE$BE
241115681$24111568$1$I$20240109$20240613$20240718$20240718$EXP$$IE-ROCHE-3490352$ROCHE$$$$$F$Y$$$20240718$$HP$IE$IE
241115691$24111569$1$I$20240628$20240712$20240718$20240718$EXP$FR-AFSSAPS-MP2024001121$FR-MYLANLABS-2024M1065617$MYLAN$$79$YR$$F$Y$75$KG$20240718$$PH$FR$FR
241115702$24111570$2$F$$20240918$20240718$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113049$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240920$$CN$US$US
241115711$24111571$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113358$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240718$$HP$US$US
241115721$24111572$1$I$20240101$20240708$20240718$20240718$PER$$IT-Eisai-EC-2024-169766$EISAI$$79$YR$E$F$Y$$$20240718$$MD$IT$IT
241115731$24111573$1$I$$20240711$20240718$20240718$EXP$$US-MYLANLABS-2024M1066592$MYLAN$Jackson DL, Coke L, Zhang SX, Steenbergen C, Khan G, Gorfu G, et al. Myocarditis and brain abscess caused by disseminated Scedosporium boydii infection. J-Natl-Med-Assoc 2024; 116 (3): 238-246.$52$YR$$M$Y$$$20240718$$HP$US$US
241115741$24111574$1$I$20200405$20240716$20240718$20240718$EXP$$IL-TAKEDA-IL202008257$TAKEDA$$29$YR$$F$Y$$$20240718$$HP$IL$IL
241115753$24111575$3$F$$20240806$20240718$20240812$PER$$US-SA-2024SA209447$SANOFI AVENTIS$$$$A$F$Y$73.02$KG$20240812$$MD$US$US
241115761$24111576$1$I$20240610$20240711$20240718$20240718$PER$$US-ALXN-202407USA000869US$ALEXION PHARMACEUTICALS$$4$YR$$M$Y$$$20240718$$CN$US$US
241115781$24111578$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113742$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240718$$CN$US$US
241115791$24111579$1$I$$20240715$20240718$20240718$EXP$$CA-BAUSCH-BL-2024-010798$BAUSCH AND LOMB$$69$YR$$F$Y$$$20240718$$CN$CA$CA
241115801$24111580$1$I$$20240711$20240718$20240718$EXP$$CA-TEVA-VS-3221275$TEVA$$84$YR$$F$Y$$$20240718$$HP$CA$CA
241115811$24111581$1$I$$20240710$20240718$20240718$EXP$$US-MYLANLABS-2024M1065914$MYLAN$Kraus MJ, Nguyen J. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report. Case-Rep-Neurol 2024; 16 (1): 142-147.$38$YR$$F$Y$$$20240718$$HP$US$US
241115821$24111582$1$I$$20240709$20240718$20240718$EXP$$IT-MYLANLABS-2024M1064465$MYLAN$Detassis S, Grasso M, Vescovo V, Maines F, Caffo O, Campomenosi P, Denti M, Precazzini F. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer. A Pilot Study. Int J Mol Sci$84$YR$$M$Y$$$20240718$$HP$IT$IT
241115831$24111583$1$I$$20240710$20240718$20240718$EXP$$US-MYLANLABS-2024M1066054$MYLAN$Attah A, Peterson C, Jacobs M, Bhagavatula R, Shah D, Kaplan R, et al. Anti-PF4 ELISA-Negative, SRA-Positive Heparin-Induced Thrombocytopenia. Hematol-Rep 2024; 16 (2): 295-298.$74$YR$$F$Y$$$20240718$$HP$US$US
241115841$24111584$1$I$20240601$20240709$20240718$20240718$EXP$$FR-JNJFOC-20240727964$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240718$$MD$FR$FR
241115851$24111585$1$I$20240101$20240711$20240718$20240718$EXP$$US-ABBVIE-5838460$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241115861$24111586$1$I$$20240709$20240718$20240718$EXP$$US-MYLANLABS-2024M1065823$MYLAN$Xu E, Thomas S, Habibi B. Intrathecal Methotrexate-Induced Lumbosacral Polyradiculopathy: A Case Report. Pain-Med-Case-Rep 2024; 8 (1): 31-35.$68$YR$$F$Y$$$20240718$$HP$US$US
241115881$24111588$1$I$20240603$20240711$20240718$20240718$PER$$US-Eisai-EC-2024-170025$EISAI$$76$YR$E$M$Y$83$KG$20240718$$MD$US$US
241115892$24111589$2$F$$20240719$20240718$20240726$EXP$ES-GERMAN-LIT/ESP/24/0010391$ES-RDY-LIT/ESP/24/0010391$DR REDDYS$Gonzalez-Gomez A, Caro-Teller JM, Gonzalez-Barrios I, Castro-Frontinan A, Rodriguez-Quesada PP, Ferrari-Piquero JM. Safety profile of nirmatrelvir-ritonavir: Evidence of adverse events due to drug-drug interactions. Farmacia Hospitalaria. 2024 Mar;48(2): 70-74. doi:10.1016/j.farma.2023.08.005.$$$E$$Y$$$20240726$$HP$ES$ES
241115901$24111590$1$I$$20240711$20240718$20240718$EXP$$CA-TEVA-VS-3221315$TEVA$$76$YR$$M$Y$$$20240718$$HP$CA$CA
241115911$24111591$1$I$20240101$20240715$20240718$20240718$EXP$$PL-ABBVIE-5842418$ABBVIE$$33$YR$$F$Y$$$20240718$$MD$PL$PL
241115923$24111592$3$F$20240415$20240828$20240718$20240904$EXP$$CA-OTSUKA-2024_015526$OTSUKA$$27$YR$$F$Y$$$20240904$$MD$CA$CA
241115931$24111593$1$I$$20240718$20240718$20240718$EXP$GB-MHRA-MED-202407180940550910-ZYRGB$GB-MYLANLABS-2024M1067312$MYLAN$$28$YR$$M$Y$$$20240718$$CN$GB$GB
241115941$24111594$1$I$$20240701$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105613$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240718$$CN$US$US
241115951$24111595$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113170$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240718$$HP$US$US
241115961$24111596$1$I$20240101$20240712$20240718$20240718$PER$$US-BAYER-2024A101896$BAYER$$$$$F$Y$$$20240718$$CN$US$US
241115971$24111597$1$I$20240622$20240711$20240718$20240718$EXP$NO-NOMAADVRE-RELISM-2024-Vbkqn3$NO-TEVA-VS-3220618$TEVA$$58$YR$$M$Y$$$20240718$$MD$NO$NO
241115981$24111598$1$I$20240701$20240703$20240718$20240718$EXP$$US-HLS-202400226$HLS THERAPEUTICS$$64$YR$A$M$Y$$$20240718$$HP$US$US
241116002$24111600$2$F$$20240726$20240718$20240802$PER$$US-JNJFOC-20240742589$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$CN$US$US
241116011$24111601$1$I$$20240712$20240718$20240718$PER$$US-BAYER-2024A100870$BAYER$$$$$F$Y$$$20240718$$CN$US$US
241116021$24111602$1$I$$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002317J$MERCK$$67$YR$$M$Y$$$20240718$$MD$JP$JP
241116031$24111603$1$I$20200901$20210209$20240718$20240718$EXP$$US-AstraZeneca-2021A054047$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241116041$24111604$1$I$20240708$20240715$20240718$20240718$EXP$$US-OTSUKA-2024_019903$OTSUKA$$66$YR$$M$Y$$$20240718$$CN$US$US
241116051$24111605$1$I$20240701$20240701$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN007017$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241116061$24111606$1$I$$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114340$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240718$$CN$US$US
241116072$24111607$2$F$$20240701$20240718$20240729$PER$$US-INCYTE CORPORATION-2024IN006969$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241116081$24111608$1$I$20230919$20240716$20240718$20240718$EXP$$US-DSJP-DSU-2024-106681$DAIICHI$$66$YR$$F$Y$$$20240718$$HP$US$US
241116091$24111609$1$I$20240701$20240701$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006966$INCYTE$$$$$$Y$$$20240718$$PH$US$US
241116102$24111610$2$F$20240704$20240717$20240718$20240724$EXP$$US-APELLIS-2024-APL-0000459$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241116111$24111611$1$I$$20240712$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010081$ELI LILLY AND CO$$$$$$Y$$$20240718$$CN$US$US
241116121$24111612$1$I$20240712$20240714$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010714$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240718$$CN$US$US
241116134$24111613$4$F$$20240913$20240718$20240919$EXP$$PT-MYLANLABS-2024M1066791$MYLAN$Silva P, Ferreira M, Grilo A, Gon?alves F.. Serotonin syndrome: the purpose of a clinical case.. Emergency, intermediate care and critically ill patients | Clinical case. 2024;30(Sup 1):481$79$YR$$F$Y$$$20240919$$MD$PT$PT
241116141$24111614$1$I$$20240619$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006583$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241116151$24111615$1$I$$20240716$20240718$20240718$EXP$$US-DSJP-DSU-2024-135988$DAIICHI$$$$$F$Y$$$20240718$$HP$US$US
241116161$24111616$1$I$$20240619$20240718$20240718$PER$$US-INCYTE CORPORATION-2024IN006570$INCYTE$$$$$$Y$$$20240718$$CN$US$US
241116171$24111617$1$I$$20240703$20240718$20240718$EXP$$US-HLS-202400228$HLS THERAPEUTICS$$38$YR$A$M$Y$$$20240718$$HP$US$US
241116181$24111618$1$I$$20240708$20240718$20240718$PER$$US-EMERGENT BIOSOLUTIONS,-24000113$EMERGENT BIOSOLUTIONS$Skolnick P, Ellison M, Hutton E, Webster L. Reversal of Opioid?Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone. J Clin Pharmacol. 2024;64(7):828-39$$$A$$Y$$$20240718$$HP$US$US
241116191$24111619$1$I$$20240708$20240718$20240718$PER$$US-EMERGENT BIOSOLUTIONS,-24000112$EMERGENT BIOSOLUTIONS$Skolnick P, Ellison M, Hutton E, Webster L. Reversal of Opioid?Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone. J Clin Pharmacol. 2024;64(7):828-39$$$A$$Y$$$20240718$$HP$US$US
241116201$24111620$1$I$$20240716$20240718$20240718$EXP$$CZ-PURDUE-USA-2024-0310827$PURDUE$Handlosova K, Sistik P, Uvira M, Andelova K, Handlos P, Stejskal D.. Contribution of methamphetamine and insulin to the death of a woman suffering from type I diabetes - which played the greater role?. Forensic science, Medicine, and Pathology. 2024$27$YR$$F$Y$$$20240718$$HP$CZ$CZ
241116211$24111621$1$I$$20240715$20240718$20240718$EXP$$FR-PURDUE-USA-2024-0310817$PURDUE$Bohren Y., Timbolschi I.D.. Perineural botulinum toxin injection for cancer-related pain: Case report of two patient. Pain Medicine Case Reports.. ; Pain Medicine Case Reports.. 2023;7(5):261-264.$56$YR$$M$Y$$$20240718$$MD$FR$FR
241116222$24111622$2$F$$20240717$20240718$20240719$PER$$US-PURDUE-USA-2024-0310810$PURDUE$$$$$M$Y$$$20240719$$CN$US$US
241116232$24111623$2$F$20240101$20240718$20240718$20240726$PER$$US-AMGEN-USASP2024142345$AMGEN$$74$YR$E$M$Y$$$20240725$$CN$US$US
241116241$24111624$1$I$$20240716$20240718$20240718$EXP$$CA-PURDUE-USA-2024-0310819$PURDUE$$48$YR$$F$Y$68$KG$20240718$$HP$CA$CA
241116271$24111627$1$I$20240607$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114346$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$78.93$KG$20240718$$CN$US$US
241116281$24111628$1$I$$20240717$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114360$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240718$$HP$US$US
241116301$24111630$1$I$$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113252$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240718$$HP$US$US
241116322$24111632$2$F$20240712$20240906$20240718$20240912$PER$$JP-Eisai-EC-2024-170225$EISAI$$$$E$M$Y$$$20240912$$MD$JP$JP
241116341$24111634$1$I$$20240717$20240718$20240718$PER$$NVSC2024US148269$NOVARTIS$$$$$$Y$$$20240718$$CN$US$US
241116351$24111635$1$I$20240628$20240712$20240718$20240718$EXP$$CN-ROCHE-10000027828$ROCHE$$67$YR$E$M$Y$$$20240718$$HP$CN$CN
241116361$24111636$1$I$20240101$20240716$20240718$20240718$EXP$$US-BIOMARINAP-US-2024-158031$BIOMARIN$$$$$$Y$$$20240718$$CN$US$US
241116371$24111637$1$I$20240626$20240711$20240718$20240718$EXP$IT-MINISAL02-993575$IT-TEVA-VS-3220601$TEVA$$74$YR$$F$Y$$$20240718$$PH$IT$IT
241116382$24111638$2$F$$20240718$20240718$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040661$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240719$$CN$US$US
241116391$24111639$1$I$$20240711$20240718$20240718$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-08339$IPSEN$$$$$$Y$$$20240718$$HP$US$US
241116411$24111641$1$I$20240101$20240622$20240718$20240718$PER$$US-009507513-2406USA008448$MERCK$$$$$M$Y$$$20240718$$CN$US$US
241116421$24111642$1$I$20231128$20240715$20240718$20240718$EXP$FR-AFSSAPS-ST2024001137$FR-009507513-2407FRA009494$MERCK$$65$YR$$F$Y$56.5$KG$20240718$$HP$FR$FR
241116431$24111643$1$I$$20240710$20240718$20240718$PER$$BR-DAIICHI SANKYO, INC.-DSU-2024-135919$DAIICHI$$46$YR$$$Y$$$20240718$$MD$BR$US
241116442$24111644$2$F$20220101$20240816$20240718$20240823$EXP$$PH-009507513-2201PHL004118$MERCK$$74$YR$$F$Y$$$20240823$$MD$PH$PH
241116451$24111645$1$I$$20240712$20240718$20240718$PER$$US-MYLANLABS-2024M1066059$MYLAN$$$$$F$Y$$$20240718$$CN$US$US
241116471$24111647$1$I$$20201125$20240718$20240718$EXP$$US-AstraZeneca-2020SF58320$ASTRAZENECA$$$$$M$Y$$$20240718$$CN$US$
241116481$24111648$1$I$20240601$20240716$20240718$20240718$EXP$HR-HALMED-300086138$HR-INDIVIOR UK LIMITED-INDV-146003-2024$RECKITT BENCKISER$$$$$$Y$$$20240718$$MD$HR$HR
241116491$24111649$1$I$20240506$20240716$20240718$20240718$EXP$FR-AFSSAPS-AVNY2024000188$FR-INDIVIOR UK LIMITED-INDV-146007-2024$RECKITT BENCKISER$$$$$$Y$$$20240718$$MD$FR$FR
241116501$24111650$1$I$$20210308$20240718$20240718$EXP$$US-AstraZeneca-2021A127144$ASTRAZENECA$$$$$F$Y$64$KG$20240718$$CN$US$
241116511$24111651$1$I$$20240708$20240718$20240718$EXP$$US-BAYER-2024A095090$BAYER$$42$YR$A$F$Y$$$20240718$$CN$US$US
241116521$24111652$1$I$$20240712$20240718$20240718$EXP$$MY-AstraZeneca-2024A159944$ASTRAZENECA$$67$YR$$M$Y$$$20240718$$MD$MY$
241116531$24111653$1$I$$20240715$20240718$20240718$PER$$US-DSJP-DSU-2024-136202$DAIICHI$$$$$F$Y$$$20240718$$MD$US$US
241116541$24111654$1$I$20240506$20240708$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000144$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241116551$24111655$1$I$20240501$20240701$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000242$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241116561$24111656$1$I$20240705$20240708$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000250$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241116571$24111657$1$I$20240408$20240710$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000253$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241116581$24111658$1$I$$20240702$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000243$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241116591$24111659$1$I$20240501$20240624$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000154$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241116601$24111660$1$I$20240301$20240626$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000240$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241116611$24111661$1$I$20240101$20240712$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000257$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241116622$24111662$2$F$20240425$20240723$20240718$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000132$THERATECHNOLOGIES$$$$$$Y$$$20240805$$CN$US$US
241116631$24111663$1$I$$20240703$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000248$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241116642$24111664$2$F$$20240709$20240718$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000252$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
241116651$24111665$1$I$20231015$20240705$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000502$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241116661$24111666$1$I$20240706$20240712$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112409$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240718$$CN$US$US
241116671$24111667$1$I$$20240705$20240718$20240718$PER$$US-Calliditas-2024CAL01262$CALLIDITAS THERAPEUTICS$$73$YR$E$M$Y$$$20240718$$CN$US$US
241116681$24111668$1$I$20240621$20240705$20240718$20240718$EXP$$DE-EMD Serono-2024034882$EMD SERONO INC$$39$YR$A$F$Y$$$20240718$$MD$DE$DE
241116691$24111669$1$I$20240601$20240708$20240718$20240718$EXP$$US-RADIUS HEALTH, INC.-2024US005090$RADIUS PHARM$$84$YR$$F$Y$$$20240718$$CN$US$US
241116701$24111670$1$I$$20240701$20240718$20240718$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000245$Unknown Manufacturer$$$$$$Y$$$20240718$$CN$US$US
241116721$24111672$1$I$20240614$20240710$20240718$20240718$EXP$FR-AFSSAPS-MA2024001145$FR-009507513-2407FRA004796$MERCK$$77$YR$$F$Y$62$KG$20240718$$MD$FR$FR
241116732$24111673$2$F$20240710$20240722$20240718$20240726$EXP$$DE-BIOMARINAP-DE-2024-159228$BIOMARIN$$$$$$Y$$$20240726$$HP$DE$DE
241116741$24111674$1$I$$20240621$20240718$20240718$PER$$US-009507513-2406USA009545$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$4$YR$$$Y$$$20240718$$HP$US$US
241116752$24111675$2$F$20230101$20240801$20240718$20240810$EXP$$TR-TEVA-VS-3219504$TEVA$Kayabasi M, Gorken IB, Durak I, Karaoglu A, Saatci AO. ERDAFITINIB-INDUCED BILATERAL MULTIFOCAL SEROUS RETINAL DETACHMENTS AND SEVERE DRY EYE RELATED UNILATERAL PERIPHERAL ULCERATIVE KERATITIS IN A PATIENT WITH METASTATIC UROTHELIAL CARCINOMA. Eur-J-Case-Rep-Intern-Med 2024; 11 (6):.; Kayabasi M, Gorken IB, Durak I, Karaoglu A, Saatci AO. ERDAFITINIB-INDUCED BILATERAL MULTIFOCAL SEROUS RETINAL DETACHMENTS AND SEVERE DRY EYE RELATED UNILATERAL PERIPHERAL ULCERATIVE KERATITIS IN A PATIENT WITH ...$76$YR$$M$Y$$$20240810$$HP$TR$TR
241116761$24111676$1$I$$20240710$20240718$20240718$EXP$$CA-AstraZeneca-2024A159366$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$CA$
241116771$24111677$1$I$20240706$20240713$20240718$20240718$EXP$$CN-AstraZeneca-2024A162079$ASTRAZENECA$$52$YR$$F$Y$72$KG$20240718$$MD$CN$
241116781$24111678$1$I$20200213$20210316$20240718$20240718$EXP$$US-AstraZeneca-2021A162640$ASTRAZENECA$$20809$DY$$M$Y$$$20240718$$CN$US$
241116801$24111680$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011017$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240718$$CN$US$US
241116811$24111681$1$I$20240716$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011602$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240718$$CN$US$US
241116821$24111682$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010543$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240718$$CN$US$US
241116831$24111683$1$I$$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009831$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240718$$CN$US$US
241116841$24111684$1$I$20240713$20240713$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010083$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241116851$24111685$1$I$20230801$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002304J$MERCK$$70$YR$$M$Y$$$20240718$$MD$JP$JP
241116861$24111686$1$I$$20240708$20240718$20240718$EXP$$GB-SA-2024SA208155$SANOFI AVENTIS$$57$YR$A$M$Y$137$KG$20240718$$MD$GB$GB
241116871$24111687$1$I$20230101$20240617$20240718$20240718$PER$$US-009507513-2406USA005975$MERCK$$84$YR$$F$Y$$$20240718$$CN$US$US
241116881$24111688$1$I$20231201$20240718$20240718$20240718$EXP$$ES-GILEAD-2024-0681208$GILEAD$$$$$$Y$$$20240718$$MD$ES$ES
241116891$24111689$1$I$20240525$20240718$20240718$20240718$EXP$SK-SUKLSK-20240436$SK-PFIZER INC-202400218057$PFIZER$$77$YR$$F$Y$$$20240718$$CN$SK$SK
241116901$24111690$1$I$$20240717$20240718$20240718$EXP$$CA-PFIZER INC-202400217614$PFIZER$$5$YR$$M$Y$18$KG$20240718$$PH$CA$CA
241116913$24111691$3$F$20240709$20240919$20240718$20240926$EXP$$FR-PFIZER INC-202400217887$PFIZER$$76$YR$$$Y$90$KG$20240926$$MD$FR$FR
241116921$24111692$1$I$20240506$20240717$20240718$20240718$EXP$ES-AEMPS-1549634$ES-PFIZER INC-202400216896$PFIZER$$68$YR$$M$Y$$$20240718$$MD$ES$ES
241116941$24111694$1$I$$20240717$20240718$20240718$EXP$$CA-PFIZER INC-202400217576$PFIZER$$11$YR$$M$Y$53$KG$20240718$$PH$CA$CA
241116951$24111695$1$I$20240710$20240712$20240718$20240718$PER$$US-SA-2024SA206891$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240718$$MD$US$US
241116961$24111696$1$I$$20240708$20240718$20240718$EXP$$US-RADIUS HEALTH INC.-2024US005099$RADIUS PHARM$$$$$F$Y$$$20240718$$CN$US$US
241116971$24111697$1$I$$20240717$20240718$20240718$PER$$US-JNJFOC-20240745594$JOHNSON AND JOHNSON$$$$$M$Y$$$20240718$$CN$US$US
241116981$24111698$1$I$20230909$20240711$20240718$20240718$EXP$ES-AEMPS-1543140$ES-TEVA-VS-3220507$TEVA$$59$YR$$M$Y$$$20240718$$MD$ES$ES
241116992$24111699$2$F$$20240807$20240718$20240808$PER$$US-ALXN-202407USA000885US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241117001$24111700$1$I$20240201$20240715$20240718$20240718$EXP$$NVSC2024MX043860$NOVARTIS$$34$YR$$F$Y$69$KG$20240718$$CN$MX$MX
241117011$24111701$1$I$20240625$20240715$20240718$20240718$EXP$PT-INFARMED-T202406-695$PT-DUCHESNAY-2024PT000288$DUCHESNAY$$$$$$Y$$$20240718$$CN$PT$PT
241117021$24111702$1$I$$20240718$20240718$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040642$BOEHRINGER INGELHEIM$$$$$$Y$$$20240718$$CN$US$US
241117031$24111703$1$I$20240608$20240710$20240718$20240718$PER$$US-AstraZeneca-2024A158281$ASTRAZENECA$$61$YR$$M$Y$131.1$KG$20240718$$HP$US$
241117041$24111704$1$I$$20240712$20240718$20240718$EXP$$US-009507513-2407USA008672$MERCK$$$$$M$Y$$$20240718$$MD$US$US
241117051$24111705$1$I$$20240621$20240718$20240718$PER$$US-009507513-2406USA009546$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$5$YR$$$Y$$$20240718$$HP$US$US
241117061$24111706$1$I$20211004$20240709$20240718$20240718$EXP$$CN-009507513-2407CHN008738$MERCK$Sun D, Wang K, Wang Z, Qu Q.. A case of pulmonary Rhizopus microporus infection after kidney transplantation.. Chin J Mycol.. 2024;19 (2):169-72$45$YR$$M$Y$$$20240718$$MD$CN$CN
241117071$24111707$1$I$$20210322$20240718$20240718$EXP$$GB-AstraZeneca-2021A190039$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$GB$
241117081$24111708$1$I$$20240710$20240718$20240718$EXP$$US-BAUSCHBL-2024BNL029889$BAUSCH AND LOMB$Zhou Y, Guiseppi R, Banaee T. A Case of Incidental and Uncomplicated Subretinal Triamcinolone Acetonide. Case Reports in Ophthalmology. 2024 JUN 07;15:465-470. doi:10.1159/000539190$67$YR$$M$Y$$$20240718$$HP$US$US
241117101$24111710$1$I$$20240711$20240718$20240718$PER$$US-ALXN-202407USA000796US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241117111$24111711$1$I$$20240711$20240718$20240718$PER$$US-ALXN-202407USA000890US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241117121$24111712$1$I$20240705$20240704$20240718$20240718$EXP$$US-FMCRTG-FMC-2407-000813$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240718$$HP$US$US
241117141$24111714$1$I$20201228$20210323$20240718$20240718$EXP$$CO-AstraZeneca-2021A224545$ASTRAZENECA$$24420$DY$$F$Y$78$KG$20240718$$CN$CO$
241117151$24111715$1$I$$20240621$20240718$20240718$PER$$US-009507513-2406USA009547$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$8$YR$$$Y$$$20240718$$HP$US$US
241117161$24111716$1$I$$20240715$20240718$20240718$EXP$$NL-AMGEN-NLDSP2024140134$AMGEN$$82$YR$E$M$Y$80$KG$20240718$$MD$NL$NL
241117172$24111717$2$F$$20240807$20240718$20240808$PER$$US-ALXN-202407USA000829US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241117184$24111718$4$F$$20240801$20240718$20240806$EXP$$US-ABBVIE-5840927$ABBVIE$$47$YR$$F$Y$$$20240806$$CN$US$US
241117191$24111719$1$I$$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002303J$MERCK$$74$YR$$M$Y$$$20240718$$MD$JP$JP
241117201$24111720$1$I$20240101$20240715$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009633$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240718$$CN$US$US
241117211$24111721$1$I$20240717$20240718$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011909$ELI LILLY AND CO$$$$$$Y$$$20240718$$CN$US$US
241117221$24111722$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011287$ELI LILLY AND CO$$$$$M$Y$$$20240718$$CN$US$US
241117231$24111723$1$I$20240715$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010160$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240718$$CN$US$US
241117241$24111724$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010556$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241117251$24111725$1$I$$20240708$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407009011$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240718$$CN$US$US
241117261$24111726$1$I$$20240710$20240718$20240718$EXP$$US-BEH-2024175501$CSL BEHRING$$84$YR$E$F$Y$$$20240718$$PH$US$US
241117271$24111727$1$I$$20240704$20240718$20240718$EXP$$CA-HLS-202401682$HLS THERAPEUTICS$$$$A$M$Y$$$20240718$$PH$CA$CA
241117281$24111728$1$I$$20210412$20240718$20240718$EXP$$US-AstraZeneca-2021A309222$ASTRAZENECA$$$$$F$Y$$$20240718$$CN$US$
241117301$24111730$1$I$20201018$20201124$20240718$20240718$EXP$$US-AstraZeneca-2020SF57407$ASTRAZENECA$$17790$DY$$M$Y$$$20240718$$CN$US$
241117312$24111731$2$F$$20240807$20240718$20240808$PER$$US-ALXN-202407USA000923US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241117321$24111732$1$I$$20240712$20240718$20240718$PER$$US-ALXN-202407USA000876US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240718$$CN$US$US
241117331$24111733$1$I$20240718$20240718$20240718$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040678$BOEHRINGER INGELHEIM$$58$YR$A$F$Y$$$20240718$$CN$US$US
241117341$24111734$1$I$$20240621$20240718$20240718$PER$$US-009507513-2406USA009548$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$11$YR$$$Y$$$20240718$$HP$US$US
241117351$24111735$1$I$$20240716$20240718$20240718$PER$$NVSC2024US147072$NOVARTIS$$$$$M$Y$$$20240718$$HP$US$US
241117362$24111736$2$F$20100101$20240828$20240718$20240906$EXP$$IL-TEVA-VS-3220743$TEVA$Hijab A, Taha T, Charas T, Bar-Sela G, Stein P, Agbarya A. Anti-androgen for myoepithelial tumor: a potent therapy yet a potential misleader. Anticancer-Drugs 2022; 33 (1): E747-E751.; Hijab A, Taha T, Charas T, Bar-Sela G, Stein P, Agbarya A. Anti-androgen for myoepithelial tumor: a potent therapy yet a potential misleader. Anticancer-Drugs 2022; 33 (1): E747-E751.$74$YR$$M$Y$$$20240906$$HP$IL$IL
241117371$24111737$1$I$$20240717$20240718$20240718$EXP$$ES-PAIPHARMA-2024-ES-000072$PHARMACEUTICAL ASSOC$Fernandez-Gordon Sanchez FM, Gomez Labrador C, Wong Becerra L, et al.Active microscopic colitis precipitated by fluoxetine..Revista Espanola De Enfermedades Digestivas.2024;.$41$YR$$F$Y$$$20240718$$HP$ES$ES
241117381$24111738$1$I$$20240717$20240718$20240718$EXP$$IN-PAIPHARMA-2024-IN-000119$PHARMACEUTICAL ASSOC$Khanam, A, Wani ZA, Ahmad S, Nazir N.Cyproheptadine and dexamethasone induced suicidality and obsessions presenting to liason psychiatry-a case report.Indian Journal of Psychiatry.2024;66(Suppl1):S177.$20$YR$$M$Y$$$20240718$$HP$IN$IN
241117401$24111740$1$I$$20240717$20240718$20240718$EXP$$IN-PAIPHARMA-2024-IN-000118$PHARMACEUTICAL ASSOC$Ike IM, Jayaprakashan KP, Raju R.A case of risperidone monotherapy causing serotonin syndrome in one of the monozygotic twins..Indian Journal of Psychiatry.2024;66(Suppl1):S52-S53.$15$YR$$M$Y$$$20240718$$MD$IN$IN
241117411$24111741$1$I$$20240718$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011901$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240718$$CN$US$US
241117421$24111742$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011644$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240718$$CN$US$US
241117432$24111743$2$F$20230601$20240903$20240718$20240909$EXP$$GB-VERTEX PHARMACEUTICALS-2023-009647$VERTEX$$$$C$M$Y$$$20240909$$CN$GB$GB
241117451$24111745$1$I$$20240618$20240718$20240718$PER$$US-009507513-2406USA009598$MERCK$Yuen C.A, Pekmezci M, Bao S, Kong X.T.. Metastatic glioblastoma to the lungs: a case report and literature review. CNS oncology. 2024;13(1):1-15$63$YR$$F$Y$$$20240718$$HP$US$US
241117461$24111746$1$I$20240601$20240712$20240718$20240718$PER$$US-ABBVIE-5840125$ABBVIE$$22$YR$$F$Y$74.843$KG$20240718$$CN$US$US
241117481$24111748$1$I$$20240710$20240718$20240718$PER$$US-APELLIS-2024-APL-0000460$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240718$$CN$US$US
241117491$24111749$1$I$20240718$20240718$20240718$20240718$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040681$BOEHRINGER INGELHEIM$$68$YR$E$$Y$$$20240718$$CN$US$US
241117501$24111750$1$I$20240401$20240717$20240718$20240718$EXP$$CA-GILEAD-2024-0680709$GILEAD$$60$YR$A$M$Y$$$20240718$$CN$CA$CA
241117511$24111751$1$I$$20210302$20240718$20240718$EXP$$US-AstraZeneca-2021A111058$ASTRAZENECA$$63$YR$$F$Y$$$20240718$$CN$US$
241117521$24111752$1$I$20200323$20240710$20240718$20240718$EXP$$JP-009507513-2004JPN000941J$MERCK$$76$YR$$M$Y$52$KG$20240718$$MD$JP$JP
241117531$24111753$1$I$$20240621$20240718$20240718$PER$$US-009507513-2406USA009549$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$14$YR$$$Y$$$20240718$$HP$US$US
241117541$24111754$1$I$$20240717$20240718$20240718$PER$$US-JNJFOC-20240748681$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$HP$US$US
241117551$24111755$1$I$$20240702$20240718$20240718$PER$$US-JNJFOC-20240710820$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240718$$CN$US$US
241117561$24111756$1$I$$20240716$20240718$20240718$PER$$US-JNJFOC-20240741812$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240718$$CN$US$US
241117571$24111757$1$I$20240628$20240708$20240718$20240718$PER$$US-JNJFOC-20240748619$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240718$$CN$US$US
241117582$24111758$2$F$$20240807$20240718$20240807$PER$$US-ALXN-202407USA000764US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240807$$CN$US$US
241117591$24111759$1$I$$20240711$20240718$20240718$PER$$US-JNJFOC-20240748660$JOHNSON AND JOHNSON$$$$$$Y$$$20240718$$MD$US$US
241117602$24111760$2$F$$20240829$20240718$20240905$PER$$US-JNJFOC-20240748848$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$HP$US$US
241117611$24111761$1$I$20170101$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002408J$MERCK$$70$YR$$M$Y$$$20240718$$MD$JP$JP
241117631$24111763$1$I$$20240713$20240718$20240718$PER$$NVSC2024US147516$NOVARTIS$$33$YR$$M$Y$361$KG$20240719$$HP$US$US
241117641$24111764$1$I$$20240712$20240718$20240718$EXP$$US-GILEAD-2024-0680845$GILEAD$$$$E$F$Y$$$20240718$$CN$US$US
241117661$24111766$1$I$$20240717$20240718$20240718$PER$$US-JNJFOC-20240746278$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240718$$PH$US$US
241117671$24111767$1$I$$20240716$20240718$20240718$PER$$US-JNJFOC-20240742432$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20240718$$CN$US$US
241117693$24111769$3$F$20240712$20240912$20240718$20240918$EXP$$JP-009507513-2407JPN002402J$MERCK$$7$DEC$$M$Y$$$20240918$$MD$JP$JP
241117703$24111770$3$F$20240101$20240816$20240718$20240909$PER$$US-SA-2024SA207764$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240909$$MD$US$US
241117711$24111771$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207217$SANOFI AVENTIS$$$$C$$Y$$$20240719$$MD$US$US
241117722$24111772$2$F$$20240806$20240718$20240809$EXP$$IT-AstraZeneca-2024A161084$ASTRAZENECA$$$$$$Y$$$20240809$$MD$IT$
241117731$24111773$1$I$$20240628$20240718$20240718$PER$$US-BEH-2024175026$CSL BEHRING$$$$E$F$Y$$$20240718$$CN$US$US
241117743$24111774$3$F$$20240812$20240718$20240812$PER$$US-ALXN-202407USA000800US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241117751$24111775$1$I$$20240705$20240718$20240718$PER$$US-RDY-SPO/USA/24/0010184$DR REDDYS$$$$$F$Y$$$20240718$$CN$US$US
241117761$24111776$1$I$$20240710$20240718$20240718$PER$$US-PHARMING-PHAUS2024000588$PHARMING GROUP$$$$$$Y$$$20240718$$CN$US$US
241117771$24111777$1$I$$20240715$20240718$20240718$EXP$$NVSC2024CA146302$NOVARTIS$$$$$F$Y$$$20240719$$HP$CA$CA
241117782$24111778$2$F$$20240807$20240718$20240808$PER$$US-ALXN-202407USA000920US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241117791$24111779$1$I$$20240716$20240718$20240718$PER$$NVSC2024US148244$NOVARTIS$$$$$F$Y$$$20240719$$HP$US$US
241117801$24111780$1$I$$20240712$20240718$20240718$PER$$US-ALXN-202407USA000938US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240718$$CN$US$US
241117811$24111781$1$I$$20240715$20240718$20240718$EXP$$US-AstraZeneca-2024A161122$ASTRAZENECA$$$$$$Y$$$20240718$$MD$US$
241117821$24111782$1$I$$20240715$20240718$20240718$EXP$GB-MHRA-MED-202407151630155470-WGSTF$GB-ELI_LILLY_AND_COMPANY-GB202407010011$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$GB$GB
241117831$24111783$1$I$$20240715$20240718$20240718$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009566$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240718$$HP$US$US
241117841$24111784$1$I$20240401$20240705$20240718$20240718$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004148$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240718$$CN$US$US
241117851$24111785$1$I$$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011006$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240718$$CN$US$US
241117861$24111786$1$I$$20240709$20240718$20240718$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006210$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240718$$CN$US$US
241117871$24111787$1$I$$20240715$20240718$20240718$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009730$ELI LILLY AND CO$$82$YR$E$$Y$$$20240718$$CN$US$US
241117881$24111788$1$I$20240630$20240714$20240718$20240718$EXP$GB-MHRA-MED-202407141348146440-HGMPB$GB-ELI_LILLY_AND_COMPANY-GB202407009118$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240718$$CN$GB$GB
241117891$24111789$1$I$20240715$20240716$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407010078$ELI LILLY AND CO$$$$$M$Y$$$20240718$$CN$US$US
241117901$24111790$1$I$$20240708$20240718$20240718$EXP$$US-ELI_LILLY_AND_COMPANY-US202407005719$ELI LILLY AND CO$$$$$F$Y$$$20240718$$CN$US$US
241117911$24111791$1$I$20230101$20240709$20240718$20240718$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407003745$ELI LILLY AND CO$$70$YR$E$F$Y$90$KG$20240718$$CN$CN$CN
241117921$24111792$1$I$20240701$20240705$20240718$20240718$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407004713$ELI LILLY AND CO$$63$YR$A$F$Y$65$KG$20240718$$CN$CN$CN
241117931$24111793$1$I$$20240705$20240718$20240718$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407004335$ELI LILLY AND CO$$$$$M$Y$$$20240718$$MD$DE$DE
241117941$24111794$1$I$$20240705$20240718$20240718$EXP$GB-MHRA-MED-202405151451419460-DRWJT$GB-ELI_LILLY_AND_COMPANY-GB202407004846$ELI LILLY AND CO$$$$$F$Y$122$KG$20240718$$CN$GB$GB
241117951$24111795$1$I$20240404$20240705$20240718$20240718$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004209$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240718$$CN$US$US
241117961$24111796$1$I$20210101$20240708$20240718$20240718$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006945$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240718$$CN$US$US
241117982$24111798$2$F$$20240716$20240718$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010883$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241117991$24111799$1$I$20240624$20240705$20240718$20240718$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407004850$ELI LILLY AND CO$$63$YR$A$F$Y$86$KG$20240718$$CN$GB$GB
241118002$24111800$2$F$$20240712$20240718$20240813$EXP$$CN-AstraZeneca-2024A162100$ASTRAZENECA$$$$$M$Y$66$KG$20240813$$MD$CN$
241118011$24111801$1$I$20240628$20240705$20240718$20240718$EXP$GB-MHRA-MED-202407041658175330-VZRGK$GB-ELI_LILLY_AND_COMPANY-GB202407005611$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240718$$CN$GB$GB
241118032$24111803$2$F$$20240807$20240718$20240808$PER$$US-ALXN-202407USA000940US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241118042$24111804$2$F$$20240821$20240718$20240827$PER$$US-PHARMING-PHAUS2024000590$PHARMING GROUP$$$$$$Y$$$20240827$$CN$US$US
241118051$24111805$1$I$$20240714$20240718$20240718$EXP$$PT-009507513-2407PRT010556$MERCK$$57$YR$$M$Y$$$20240718$$MD$PT$PT
241118062$24111806$2$F$$20240828$20240718$20240906$EXP$$RU-TEVA-VS-3220925$TEVA$Goloshchapov OV, Chukhlovin AB, Bug DS, Polev DE, Kosarev OV, Klementeva RV, et al. Safety, Feasibility, and Advantages of Oral Microbiota Transplantation: The First Clinical Case. J-Pediatr-Hematol-Oncol 2024;.; Goloshchapov OV, Chukhlovin AB, Bug DS, Polev DE, Kosarev OV, Klementeva RV, et al. Safety, Feasibility, and Advantages of Oral Microbiota Transplantation: The First Clinical Case. J-Pediatr-Hematol-Oncol 2024;.; Goloshchapov OV, Chukhlovin AB, Bug DS, Polev DE, Kosarev OV, Klementev...$6$MON$$F$Y$$$20240906$$MD$RU$RU
241118072$24111807$2$F$$20240807$20240718$20240808$PER$$US-ALXN-202407USA000943US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241118092$24111809$2$F$$20240807$20240718$20240808$PER$$US-ALXN-202407USA000793US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
241118111$24111811$1$I$$20240710$20240718$20240718$EXP$$MX-BIOMARINAP-MX-2024-159293$BIOMARIN$$$$$$Y$$$20240718$$CN$US$MX
241118121$24111812$1$I$$20240716$20240718$20240718$PER$$US-BIOMARINAP-US-2024-159246$BIOMARIN$$$$$$Y$$$20240718$$CN$US$US
241118131$24111813$1$I$$20240716$20240718$20240718$PER$$US-BIOMARINAP-US-2024-159239$BIOMARIN$$$$$$Y$$$20240718$$CN$US$US
241118141$24111814$1$I$$20240717$20240718$20240718$PER$$US-BIOMARINAP-US-2024-159253$BIOMARIN$$$$$$Y$$$20240718$$CN$US$US
241118172$24111817$2$F$$20240815$20240718$20240816$PER$$NVSC2024US148295$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
241118181$24111818$1$I$$20240704$20240718$20240718$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR00973$TARO$$$$$$Y$$$20240719$$HP$CA$CA
241118191$24111819$1$I$20240101$20240715$20240718$20240718$EXP$$CN-PURDUE-USA-2024-0310818$PURDUE$$65$YR$$M$Y$48$KG$20240719$$HP$CN$CN
241118201$24111820$1$I$$20240704$20240718$20240718$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR00971$TARO$$$$$$Y$$$20240719$$PH$CA$CA
241118232$24111823$2$F$$20240807$20240718$20240808$PER$$US-ALXN-202407USA000930US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241118241$24111824$1$I$$20240712$20240718$20240718$EXP$$GB-EMD Serono-2024038627$EMD SERONO INC$$$$A$M$Y$$$20240719$$CN$GB$GB
241118252$24111825$2$F$20240614$20240809$20240718$20240820$PER$$US-SA-2024SA207842$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240820$$MD$US$US
241118261$24111826$1$I$$20240717$20240718$20240718$EXP$$US-BIOMARINAP-US-2024-159261$BIOMARIN$$$$$$Y$$$20240718$$CN$US$US
241118271$24111827$1$I$$20240717$20240718$20240718$PER$$US-BIOMARINAP-US-2024-159263$BIOMARIN$$$$$$Y$$$20240718$$CN$US$US
241118282$24111828$2$F$20240501$20240809$20240718$20240814$EXP$$JP-TAKEDA-2024TJP008958$TAKEDA$$$$$F$Y$$$20240813$$MD$JP$JP
241118301$24111830$1$I$20240523$20240717$20240718$20240718$EXP$$JP-TAKEDA-2024TJP010671$TAKEDA$$53$YR$$M$Y$$$20240718$$MD$JP$JP
241118311$24111831$1$I$20240603$20240718$20240718$20240718$EXP$FR-AFSSAPS-BS2024000430$FR-JNJFOC-20240748351$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240719$$MD$FR$FR
241118321$24111832$1$I$20240707$20240712$20240718$20240718$EXP$$US-ABBVIE-5839438$ABBVIE$$60$YR$$F$Y$$$20240718$$CN$US$US
241118331$24111833$1$I$$20240711$20240718$20240718$EXP$$US-ABBVIE-5843801$ABBVIE$$$$$M$Y$$$20240718$$MD$US$US
241118341$24111834$1$I$$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011336$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240718$$CN$US$US
241118351$24111835$1$I$20240101$20240716$20240718$20240718$EXP$$CN-JNJFOC-20240748357$JOHNSON AND JOHNSON$$77$YR$E$M$Y$75$KG$20240719$$HP$CN$CN
241118364$24111836$4$F$20240101$20240902$20240718$20240912$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00275$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240912$$CN$US$US
241118371$24111837$1$I$$20240712$20240718$20240718$EXP$$US-JNJFOC-20240733999$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$HP$US$US
241118382$24111838$2$F$20240427$20240918$20240718$20240918$EXP$$UY-BRISTOL-MYERS SQUIBB COMPANY-2024-114608$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240918$$HP$UY$UY
241118401$24111840$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141134$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
241118411$24111841$1$I$$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002383J$MERCK$$76$YR$$M$Y$$$20240718$$MD$JP$JP
241118421$24111842$1$I$$20240717$20240718$20240718$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040639$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240719$$HP$CO$CO
241118431$24111843$1$I$$20240718$20240718$20240718$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040477$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240719$$MD$AU$AU
241118441$24111844$1$I$$20240712$20240718$20240718$EXP$$US-JNJFOC-20240625044$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$CN$US$US
241118451$24111845$1$I$$20240716$20240718$20240718$EXP$$KR-JNJFOC-20240741847$JOHNSON AND JOHNSON$$48$YR$A$F$Y$58$KG$20240719$$HP$KR$KR
241118462$24111846$2$F$$20240718$20240718$20240726$EXP$$JP-ABBVIE-5835574$ABBVIE$Otsuru S, Terada T, Yamasaki K, et al. A-09: Experience with the use of enteral solution of levodopa/carbidopa hydrate and continuous subcutaneous injection of foslevodopa/foscarbidopa in the same patient with Parkinson^s disease. The 115th Chugoku-Shikoku Regional Meeting of the Japanese Society of Neurology. 2024;27.$60$YR$$F$Y$$$20240726$$MD$JP$JP
241118471$24111847$1$I$$20240712$20240718$20240718$PER$$US-ABBVIE-5838879$ABBVIE$$$$$$Y$$$20240718$$HP$US$US
241118486$24111848$6$F$20240617$20240828$20240718$20240903$EXP$$US-JNJFOC-20240663690$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240903$$CN$US$US
241118491$24111849$1$I$$20240717$20240718$20240718$EXP$$BR-BEIGENE-BGN-2024-011201$BEIGENE$$$$$$Y$$$20240718$$MD$BR$BR
241118502$24111850$2$F$$20240802$20240718$20240818$PER$$US-AstraZeneca-2024A147174$ASTRAZENECA$$$$$$Y$$$20240818$$CN$US$
241118511$24111851$1$I$$20240709$20240718$20240718$PER$$US-ABBVIE-5834421$ABBVIE$$41$YR$$F$Y$$$20240718$$HP$US$US
241118531$24111853$1$I$20240709$20240718$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114645$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240719$$CN$US$US
241118541$24111854$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114241$BRISTOL MYERS SQUIBB$$26$YR$A$M$Y$$$20240719$$CN$US$US
241118551$24111855$1$I$20230601$20240712$20240718$20240718$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114612$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240719$$MD$CA$CA
241118561$24111856$1$I$$20240717$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114040$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240719$$PH$US$US
241118571$24111857$1$I$20200101$20240711$20240718$20240718$EXP$$FR-CELLTRION INC.-2024FR017249$CELLTRION$$$$$$Y$$$20240719$$MD$FR$FR
241118581$24111858$1$I$$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114582$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240719$$CN$US$US
241118591$24111859$1$I$20240101$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114344$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240719$$CN$US$US
241118614$24111861$4$F$$20240819$20240718$20240823$EXP$$NVSC2024US146617$NOVARTIS$$$$$M$Y$$$20240824$$CN$US$US
241118621$24111862$1$I$$20240709$20240718$20240718$PER$$US-JNJFOC-20240741599$JOHNSON AND JOHNSON$$$$A$M$Y$101.2$KG$20240719$$MD$US$US
241118631$24111863$1$I$20240627$20240717$20240718$20240718$PER$$US-ELI_LILLY_AND_COMPANY-US202407011762$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240718$$CN$US$US
241118641$24111864$1$I$20240522$20240717$20240718$20240718$EXP$FR-AFSSAPS-RN2024000764$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-114465$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240719$$HP$FR$FR
241118651$24111865$1$I$20230607$20240711$20240718$20240718$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114508$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240719$$MD$CA$CA
241118661$24111866$1$I$$20240711$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112497$BRISTOL MYERS SQUIBB$Okeleji O, Gibson A, Nunez C, Garcia MB, Roth M, Cuglievan B, et al. Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma: nivolumab or brentuximab vedotin with the AVD regimen. Pediatric Blood and Cancer. 2024;71(8):1-4. doi:10.1002/pbc.31091.$11$YR$C$M$Y$$$20240719$$MD$US$US
241118672$24111867$2$F$$20240715$20240718$20240722$PER$$US-LEO Pharma-372016$LEO PHARM$$57$YR$$F$Y$$$20240722$$PH$US$US
241118683$24111868$3$F$$20240924$20240718$20240926$PER$$US-JNJFOC-20240743499$JOHNSON AND JOHNSON$$57$YR$A$M$Y$71.3$KG$20240926$$MD$US$US
241118691$24111869$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141427$AMGEN$$80$YR$E$F$Y$$$20240718$$HP$US$US
241118701$24111870$1$I$$20240708$20240718$20240718$EXP$$US-ABBVIE-5357625$ABBVIE$$$$$M$Y$$$20240718$$MD$US$US
241118711$24111871$1$I$$20240717$20240718$20240718$EXP$$AU-ABBVIE-5843709$ABBVIE$$$$$M$Y$$$20240718$$CN$AU$AU
241118721$24111872$1$I$$20240717$20240718$20240718$EXP$$US-ABBVIE-5843961$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241118731$24111873$1$I$$20240711$20240718$20240718$EXP$$NVSC2024GB146114$NOVARTIS$$43$YR$$F$Y$$$20240719$$CN$GB$GB
241118741$24111874$1$I$$20240716$20240718$20240718$EXP$$US-SANDOZ INC.-SDZ2024US066289$SANDOZ$$$$$M$Y$$$20240718$$CN$US$US
241118754$24111875$4$F$20240715$20240917$20240718$20240918$30DAY$$IT-SANDOZ INC.-SDZ2024IT066128$SANDOZ$$11$YR$$F$Y$48$KG$20240918$$CN$IT$IT
241118761$24111876$1$I$$20240718$20240718$20240718$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040565$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240719$$MD$DE$DE
241118773$24111877$3$F$20240701$20240813$20240718$20240814$EXP$FR-AFSSAPS-AN2024000928$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-114513$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240814$$MD$FR$FR
241118781$24111878$1$I$$20240704$20240718$20240718$EXP$$IT-Unichem Pharmaceuticals (USA) Inc-UCM202407-000889$UNICHEM$$62$YR$A$M$Y$$$20240719$$HP$IT$
241118791$24111879$1$I$$20240715$20240718$20240718$EXP$$NVSC2024US146522$NOVARTIS$$64$YR$$F$Y$$$20240719$$HP$US$US
241118802$24111880$2$F$20230901$20240801$20240718$20240816$PER$$US-ABBVIE-5838931$ABBVIE$$70$YR$$M$Y$$$20240816$$CN$US$US
241118811$24111881$1$I$$20240708$20240718$20240718$EXP$$CA-Unichem Pharmaceuticals (USA) Inc-UCM202407-000887$UNICHEM$$29$YR$A$F$Y$55$KG$20240719$$CN$CA$
241118822$24111882$2$F$20240711$20240726$20240718$20240730$PER$$US-JNJFOC-20240734338$JOHNSON AND JOHNSON$$34$YR$A$$Y$$$20240730$$HP$US$US
241118831$24111883$1$I$$20240711$20240718$20240718$EXP$$US-JNJFOC-20240747525$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$HP$US$US
241118841$24111884$1$I$$20240718$20240718$20240718$EXP$$FR-JNJFOC-20240749290$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$HP$FR$FR
241118851$24111885$1$I$$20240717$20240718$20240718$EXP$$NVSC2024US148190$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241118861$24111886$1$I$$20240711$20240718$20240718$EXP$$US-BAUSCHBL-2024BNL030094$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240719$$CN$US$US
241118871$24111887$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114317$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240719$$CN$US$US
241118883$24111888$3$F$20240201$20240902$20240718$20240904$EXP$FR-AFSSAPS-GR2024000886$FR-JNJFOC-20240748726$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$MD$FR$FR
241118891$24111889$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA208362$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240719$$PH$US$US
241118901$24111890$1$I$20240330$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113888$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240719$$CN$US$US
241118911$24111891$1$I$$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112209$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240719$$CN$US$US
241118921$24111892$1$I$$20240715$20240718$20240718$PER$$US-AMGEN-USASP2024141639$AMGEN$$$$$$Y$$$20240718$$PH$US$US
241118932$24111893$2$F$$20240717$20240718$20240718$EXP$$US-ROCHE-10000030129$ROCHE$$$$A$F$Y$$$20240719$$CN$US$US
241118941$24111894$1$I$$20240713$20240718$20240718$PER$$US-SA-2024SA208853$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240719$$CN$US$US
241118951$24111895$1$I$20240701$20240712$20240718$20240718$PER$$US-SA-2024SA209794$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240719$$MD$US$US
241118961$24111896$1$I$$20240715$20240718$20240718$EXP$$FR-ABBVIE-5840642$ABBVIE$$$$$F$Y$$$20240718$$MD$FR$FR
241118971$24111897$1$I$$20240715$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112246$BRISTOL MYERS SQUIBB$$20$YR$A$M$Y$$$20240719$$HP$US$US
241118982$24111898$2$F$$20240821$20240718$20240823$EXP$$NVSC2024CA148227$NOVARTIS$$70$YR$$F$Y$66$KG$20240823$$MD$CA$CA
241118994$24111899$4$F$20190101$20240808$20240718$20240815$EXP$$US-ABBVIE-5844509$ABBVIE$$59$YR$$F$Y$$$20240815$$CN$US$US
241119011$24111901$1$I$$20240713$20240718$20240718$PER$$US-BAUSCHBL-2024BNL030124$BAUSCH AND LOMB$$$$$F$Y$$$20240719$$MD$US$US
241119022$24111902$2$F$20240601$20240731$20240718$20240806$EXP$$TR-ABBVIE-5838936$ABBVIE$$58$YR$$M$Y$$$20240806$$MD$TR$TR
241119034$24111903$4$F$20240101$20240911$20240718$20240920$PER$$US-BAUSCHBL-2024BNL029932$BAUSCH AND LOMB$$$$$M$Y$$$20240920$$MD$US$US
241119041$24111904$1$I$$20240711$20240718$20240718$PER$$US-BAUSCHBL-2024BNL030095$BAUSCH AND LOMB$$$$$F$Y$$$20240719$$CN$US$US
241119051$24111905$1$I$20240101$20240715$20240718$20240718$EXP$$ES-ABBVIE-5842706$ABBVIE$$$$$M$Y$$$20240718$$CN$ES$ES
241119061$24111906$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5841260$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241119081$24111908$1$I$$20240716$20240718$20240718$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114407$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$112$KG$20240719$$HP$CA$CA
241119091$24111909$1$I$20240601$20240715$20240718$20240718$EXP$$AR-ABBVIE-5842421$ABBVIE$$78$YR$$F$Y$$$20240718$$CN$AR$AR
241119102$24111910$2$F$$20240730$20240718$20240808$EXP$$JP-AMGEN-JPNSP2024142217$AMGEN$Abstract of the 32nd Annual Meeting of the Japanese Breast Cancer Society$55$YR$A$F$Y$$$20240808$$MD$JP$JP
241119111$24111911$1$I$$20240712$20240718$20240718$EXP$$NVSC2024ES146881$NOVARTIS$Fernandez-Cuerva C, Chinchilla-Alarcon T, Alcaraz-Sanchez JJ. Real-world effectiveness of ribociclib in metastatic breast cancer patients: Does dose affect survival?. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2022;1-9$$$$F$Y$$$20240719$$HP$ES$ES
241119122$24111912$2$F$20240101$20240715$20240718$20240723$EXP$$CA-ABBVIE-5798500$ABBVIE$$45$YR$$F$Y$$$20240723$$CN$CA$CA
241119131$24111913$1$I$20240101$20240715$20240718$20240718$EXP$$ZA-ABBVIE-5842687$ABBVIE$$49$YR$$F$Y$$$20240718$$MD$ZA$ZA
241119141$24111914$1$I$20240101$20240715$20240718$20240718$EXP$$NVSC2024BR147431$NOVARTIS$$$$$F$Y$$$20240719$$CN$BR$BR
241119151$24111915$1$I$$20240709$20240718$20240718$PER$$US-SA-2024SA207574$SANOFI AVENTIS$$$$E$F$Y$92.986$KG$20240719$$MD$US$US
241119161$24111916$1$I$20240716$20240716$20240718$20240718$PER$$US-009507513-2407USA010450$MERCK$$$$$F$Y$$$20240718$$CN$US$US
241119171$24111917$1$I$20240301$20240712$20240718$20240718$EXP$FR-AFSSAPS-TO2024000656$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-112138$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$75$KG$20240719$$PH$FR$FR
241119182$24111918$2$F$20240601$20240819$20240718$20240820$EXP$$NVSJ2024JP008563$NOVARTIS$$$$A$M$Y$$$20240821$$MD$JP$JP
241119191$24111919$1$I$$20240717$20240718$20240718$PER$$US-JNJFOC-20240745929$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$PH$US$US
241119211$24111921$1$I$20240710$20240717$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114402$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240719$$CN$US$US
241119222$24111922$2$F$$20240923$20240718$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111742$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240924$$CN$US$US
241119232$24111923$2$F$20240620$20240717$20240718$20240824$PER$$US-AMGEN-USASP2024141514$AMGEN$$84$YR$E$M$Y$$$20240824$$CN$US$US
241119241$24111924$1$I$20240715$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141712$AMGEN$$49$YR$A$M$Y$$$20240718$$CN$US$US
241119253$24111925$3$F$$20240711$20240718$20240814$EXP$$FR-AstraZeneca-2024A161089$ASTRAZENECA$$$$$M$Y$107$KG$20240814$$CN$FR$
241119261$24111926$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5841079$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241119271$24111927$1$I$20240101$20240715$20240718$20240718$EXP$$CA-ABBVIE-5842952$ABBVIE$$75$YR$$F$Y$$$20240718$$CN$CA$CA
241119281$24111928$1$I$$20230801$20240718$20240718$EXP$$TR-ALXN-202308GLO000046TR$ALEXION PHARMACEUTICALS$Nazmi F, Ucku D, Armutlu A, Yuksel M, Arikan C. Cholestatic Liver Injury during Atypical Hemolytic Uremic Syndrome: Is it related to disease or drug?. Journal of Pediatric Gastroenterology and Nutrition. 2023;76 (1):909-910$$$$F$Y$$$20240719$$HP$TR$TR
241119291$24111929$1$I$$20240716$20240718$20240718$EXP$$US-ABBVIE-5842612$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241119301$24111930$1$I$$20240716$20240718$20240718$30DAY$$US-SANDOZ INC.-SDZ2024US066251$SANDOZ$$$$$M$Y$$$20240718$$CN$US$US
241119311$24111931$1$I$$20240703$20240718$20240718$PER$$US-TEVA-VS-3217710$TEVA$$$$A$F$Y$$$20240718$$CN$US$US
241119321$24111932$1$I$$20240716$20240718$20240718$EXP$$US-ABBVIE-5844143$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241119331$24111933$1$I$20240701$20240711$20240718$20240718$PER$$US-SA-2024SA207839$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240719$$MD$US$US
241119341$24111934$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207464$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240719$$MD$US$US
241119351$24111935$1$I$$20240712$20240718$20240718$PER$$US-JNJFOC-20240748617$JOHNSON AND JOHNSON$$$$A$M$Y$115.8$KG$20240719$$MD$US$US
241119361$24111936$1$I$$20230801$20240718$20240718$EXP$$TR-ALXN-202308GLO000044TR$ALEXION PHARMACEUTICALS$Nazmi F, Ucku D, Armutlu A, Yuksel M, Arikan C. Cholestatic Liver Injury during Atypical Hemolytic Uremic Syndrome: Is it related to disease or drug?. Journal of Pediatric Gastroenterology and Nutrition. 2023;76:909-910$$$$$Y$$$20240719$$HP$TR$TR
241119373$24111937$3$F$20240717$20240717$20240718$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040603$BOEHRINGER INGELHEIM$$59$YR$A$F$Y$$$20240719$$CN$US$US
241119381$24111938$1$I$$20240716$20240718$20240718$EXP$$NVSC2024CA146903$NOVARTIS$$68$YR$$F$Y$63.492$KG$20240719$$CN$CA$CA
241119391$24111939$1$I$$20240716$20240718$20240718$PER$$US-AMGEN-USASP2024141990$AMGEN$$$$$F$Y$$$20240718$$CN$US$US
241119402$24111940$2$F$20240712$20240718$20240718$20240723$PER$$US-AMGEN-USASP2024141473$AMGEN$$$$$$Y$$$20240723$$PH$US$US
241119411$24111941$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA207315$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240719$$MD$US$US
241119421$24111942$1$I$$20240717$20240718$20240718$PER$$US-JNJFOC-20240748980$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$LW$US$US
241119431$24111943$1$I$$20240716$20240718$20240718$EXP$$US-JNJFOC-20240741401$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240719$$CN$US$US
241119442$24111944$2$F$$20240716$20240718$20240729$PER$$US-JNJFOC-20240746495$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$HP$US$US
241119451$24111945$1$I$20240504$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114330$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240719$$CN$US$US
241119461$24111946$1$I$$20240716$20240718$20240718$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114486$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240719$$CN$US$US
241119472$24111947$2$F$20240604$20240725$20240718$20240726$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040651$BOEHRINGER INGELHEIM$$90$YR$E$M$Y$60$KG$20240726$$HP$CO$CO
241119481$24111948$1$I$20240501$20240712$20240718$20240718$EXP$$US-ABBVIE-5840856$ABBVIE$$68$YR$$M$Y$$$20240718$$CN$US$US
241119491$24111949$1$I$20240624$20240717$20240718$20240718$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040671$BOEHRINGER INGELHEIM$$63$YR$A$F$Y$$$20240719$$HP$CO$CO
241119511$24111951$1$I$20240401$20240705$20240718$20240718$EXP$$GB-CIPLA LTD.-2024GB07387$CIPLA$$$$$$Y$$$20240719$$MD$GB$GB
241119521$24111952$1$I$20240605$20240705$20240718$20240718$EXP$$AU-CIPLA LTD.-2024AU07529$CIPLA$$$$$$Y$$$20240719$$MD$AU$AU
241119531$24111953$1$I$20240521$20240705$20240718$20240718$EXP$$AU-CIPLA LTD.-2024AU07602$CIPLA$$$$$$Y$$$20240719$$HP$AU$AU
241119541$24111954$1$I$20240717$20240717$20240718$20240718$EXP$$NVSJ2024JP008738$NOVARTIS$$85$YR$$M$Y$$$20240719$$MD$JP$JP
241119551$24111955$1$I$$20240716$20240718$20240718$PER$$NVSC2024US148253$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
241119561$24111956$1$I$$20240715$20240718$20240718$EXP$GB-MHRA-MED-202407151547157910-PSZNR$GB-PFIZER INC-202400215052$PFIZER$$$$$$Y$73$KG$20240718$$PH$GB$GB
241119571$24111957$1$I$$20240715$20240718$20240718$EXP$$US-PFIZER INC-202400216453$PFIZER$$60$YR$$M$Y$$$20240718$$HP$US$US
241119592$24111959$2$F$20240624$20240821$20240718$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003005$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240913$$CN$US$US
241119601$24111960$1$I$20240615$20240625$20240718$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003006$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240719$$CN$US$US
241119611$24111961$1$I$$20240625$20240718$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003003$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
241119621$24111962$1$I$20240320$20240625$20240718$20240718$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003008$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240719$$CN$US$US
241119631$24111963$1$I$20240601$20240625$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003009$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240719$$CN$US$US
241119641$24111964$1$I$20240614$20240625$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003010$ACADIA PHARMACEUTICALS$$67$YR$$F$Y$$$20240719$$CN$US$US
241119651$24111965$1$I$$20240625$20240718$20240718$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003007$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241119661$24111966$1$I$20190101$20240710$20240718$20240718$EXP$$JP-009507513-2407JPN002389J$MERCK$$79$YR$$F$Y$$$20240718$$MD$JP$JP
241119681$24111968$1$I$20240501$20240716$20240718$20240718$EXP$$CA-ABBVIE-5843854$ABBVIE$$72$YR$$F$Y$$$20240718$$CN$CA$CA
241119691$24111969$1$I$20240101$20240708$20240718$20240718$EXP$$US-Emmaus Medical, Inc.-EMM202406-000306$EMMAUS LIFE SCIENCES$$33$YR$A$F$Y$$$20240719$$CN$US$
241119701$24111970$1$I$$20240716$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114600$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240719$$CN$US$US
241119711$24111971$1$I$20240718$20240718$20240718$20240718$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040613$BOEHRINGER INGELHEIM$$56$YR$A$M$Y$$$20240719$$CN$US$US
241119721$24111972$1$I$20240412$20240709$20240718$20240718$EXP$$FR-DENTSPLY-2024SCDP000208$DENTSPLY$$29$YR$$F$Y$50$KG$20240717$$PH$FR$FR
241119731$24111973$1$I$20221004$20240708$20240718$20240718$EXP$$GB-DENTSPLY PHARMACEUTICALS-2024SCDP000203$DENTSPLY$$$$$M$Y$$$20240717$$HP$GB$GB
241119741$24111974$1$I$20211201$20211230$20240718$20240718$EXP$$US-AstraZeneca-2021A909556$ASTRAZENECA$$740$MON$$F$Y$$$20240719$$CN$US$
241119751$24111975$1$I$$20230331$20240718$20240718$EXP$$US-AstraZeneca-2023A077176$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241119761$24111976$1$I$$20230130$20240718$20240718$EXP$$US-AstraZeneca-2023A025427$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241119771$24111977$1$I$$20230404$20240718$20240718$EXP$$US-AstraZeneca-2023A041584$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241119781$24111978$1$I$20240715$20240715$20240718$20240718$EXP$$FR-ABBVIE-5842622$ABBVIE$$71$YR$$M$Y$$$20240718$$CN$FR$FR
241119791$24111979$1$I$20240101$20240715$20240718$20240718$EXP$$AU-ABBVIE-5842671$ABBVIE$$$$$M$Y$$$20240718$$CN$AU$AU
241119801$24111980$1$I$$20240717$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114482$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240719$$HP$US$US
241119812$24111981$2$F$$20240719$20240718$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-108401$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240729$$MD$JP$JP
241119821$24111982$1$I$$20240716$20240718$20240718$EXP$$US-ABBVIE-5842462$ABBVIE$$$$$M$Y$$$20240718$$CN$US$US
241119841$24111984$1$I$$20240716$20240718$20240718$EXP$$US-ABBVIE-5842870$ABBVIE$$$$$F$Y$$$20240718$$CN$US$US
241119851$24111985$1$I$$20240718$20240718$20240718$EXP$$NVSC2024US148272$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241119861$24111986$1$I$$20240712$20240718$20240718$EXP$$US-GSK-US2024AMR090207$GLAXOSMITHKLINE$$$$$$Y$$$20240718$$HP$US$US
241119873$24111987$3$F$20240101$20240904$20240718$20240918$PER$$US-BAUSCHBL-2024BNL029923$BAUSCH AND LOMB$$87$YR$$F$Y$$$20240918$$CN$US$US
241119881$24111988$1$I$$20240712$20240718$20240718$PER$$US-ABBVIE-5841206$ABBVIE$$$$$F$Y$$$20240718$$MD$US$US
241119891$24111989$1$I$20231201$20240711$20240718$20240718$EXP$$CA-ABBVIE-5838553$ABBVIE$$$$A$M$Y$$$20240718$$CN$CA$CA
241119903$24111990$3$F$20240709$20240830$20240718$20240903$PER$$US-AMGEN-USASP2024139104$AMGEN$$67$YR$E$M$Y$$$20240903$$CN$US$US
241119912$24111991$2$F$20240715$20240718$20240718$20240802$PER$$US-AMGEN-USASP2024141992$AMGEN$$83$YR$E$F$Y$$$20240802$$CN$US$US
241119922$24111992$2$F$$20240801$20240718$20240806$PER$$US-AMGEN-USASP2024139720$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241119931$24111993$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA208436$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240719$$MD$US$US
241119941$24111994$1$I$20240101$20240711$20240718$20240718$PER$$US-SA-2024SA207802$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240719$$MD$US$US
241119951$24111995$1$I$$20240712$20240718$20240718$PER$$US-SA-2024SA207908$SANOFI AVENTIS$$46$YR$A$F$Y$74.843$KG$20240719$$HP$US$US
241119961$24111996$1$I$20230707$20240712$20240718$20240718$EXP$$US-ABBVIE-5840485$ABBVIE$$42$YR$$F$Y$$$20240718$$CN$US$US
241119971$24111997$1$I$$20240709$20240718$20240718$PER$$US-BAUSCHBL-2024BNL029902$BAUSCH AND LOMB$$$$$M$Y$$$20240717$$CN$US$US
241119983$24111998$3$F$$20240904$20240718$20240913$EXP$$DE-ASTELLAS-2024EU006979$ASTELLAS$Fuessl L, Kreuzer L, Nierychlewski K, Seibt T, Stangl MJ, Kemmner S et al. The use of extended-release tacrolimus twice a day might be beneficial for selected kidney transplant recipients: a case report. Frontiers in medicine 2024;11:1-5.$47$YR$A$F$Y$60$KG$20240913$$HP$DE$DE
241120001$24112000$1$I$$20240715$20240718$20240718$EXP$$US-ABBVIE-5843864$ABBVIE$$$$$F$Y$$$20240718$$HP$US$US
241120011$24112001$1$I$$20240711$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112453$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240719$$CN$US$US
241120021$24112002$1$I$20240716$20240717$20240718$20240718$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114263$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240719$$CN$US$US
241120032$24112003$2$F$20240301$20240716$20240718$20240723$EXP$$EG-ABBVIE-5797558$ABBVIE$$55$YR$$M$Y$84$KG$20240723$$CN$EG$EG
241120041$24112004$1$I$$20240713$20240718$20240718$EXP$$US-AMGEN-USASP2024139827$AMGEN$$$$$M$Y$$$20240718$$CN$US$US
241120062$24112006$2$F$$20240807$20240718$20240807$PER$$US-ALXN-202407USA000778US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
241120076$24112007$6$F$20240708$20240917$20240719$20240924$EXP$$CA-TAKEDA-2024TUS072159$TAKEDA$$74$YR$$F$Y$77$KG$20240924$$HP$CA$CA
241120081$24112008$1$I$$20221206$20240719$20240719$EXP$$US-AstraZeneca-2022A400528$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241120091$24112009$1$I$$20240528$20240719$20240719$PER$$US-AstraZeneca-2024A125985$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241120101$24112010$1$I$20240101$20240710$20240719$20240719$PER$$US-SA-2024SA189866$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240719$$MD$US$US
241120111$24112011$1$I$20240101$20240715$20240719$20240719$EXP$$US-ABBVIE-5841663$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241120121$24112012$1$I$$20240717$20240719$20240719$PER$$NVSC2024US148404$NOVARTIS$$$$$$Y$$$20240719$$PH$US$US
241120131$24112013$1$I$20230101$20240709$20240719$20240719$EXP$$US-BAUSCHBL-2024BNL002119$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240717$$CN$US$US
241120141$24112014$1$I$20240607$20240716$20240719$20240719$EXP$HR-HALMED-300086066$HR-GSK-HR2024089372$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$MD$HR$HR
241120151$24112015$1$I$20240701$20240716$20240719$20240719$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114005$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240719$$MD$US$US
241120161$24112016$1$I$20240101$20240708$20240719$20240719$PER$$US-BAUSCHBL-2024BNL029863$BAUSCH AND LOMB$$71$YR$$F$Y$63.5$KG$20240717$$CN$US$US
241120171$24112017$1$I$$20240712$20240719$20240719$EXP$$FR-ABBVIE-5842488$ABBVIE$$74$YR$$F$Y$$$20240719$$HP$FR$FR
241120181$24112018$1$I$20240101$20240716$20240719$20240719$EXP$NL-LRB-00982760$NL-GSK-NL2024089298$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$MD$NL$NL
241120191$24112019$1$I$20240201$20240715$20240719$20240719$EXP$$US-ABBVIE-5843934$ABBVIE$$$$A$M$Y$$$20240719$$CN$US$US
241120201$24112020$1$I$20240301$20240713$20240719$20240719$EXP$$EU-BAUSCHBL-2024BNL029707$BAUSCH AND LOMB$$69$YR$$F$Y$$$20240717$$MD$EU$EU
241120211$24112021$1$I$20181206$20240711$20240719$20240719$EXP$$EU-BAUSCHBL-2024BNL029972$BAUSCH AND LOMB$$$$$$Y$$$20240716$$MD$EU$EU
241120221$24112022$1$I$$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011680$ELI LILLY AND CO$$91$YR$E$F$Y$$$20240718$$CN$US$US
241120231$24112023$1$I$20220203$20240711$20240719$20240719$EXP$$EU-BAUSCHBL-2024BNL029975$BAUSCH AND LOMB$$$$$$Y$$$20240716$$MD$EU$EU
241120242$24112024$2$F$$20240807$20240719$20240818$PER$$US-BAUSCHBL-2024BNL029915$BAUSCH AND LOMB$$$$$F$Y$$$20240819$$CN$US$US
241120251$24112025$1$I$20240709$20240716$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113855$BRISTOL MYERS SQUIBB$$37$YR$A$M$Y$$$20240719$$HP$US$US
241120261$24112026$1$I$20240501$20240716$20240719$20240719$EXP$NL-LRB-00981761$NL-GSK-NL2024089363$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$CN$NL$NL
241120271$24112027$1$I$20240101$20240709$20240719$20240719$PER$$US-BAUSCHBL-2024BNL029969$BAUSCH AND LOMB$$$$$F$Y$$$20240717$$CN$US$US
241120281$24112028$1$I$$20240709$20240719$20240719$PER$$US-BAUSCHBL-2024BNL029869$BAUSCH AND LOMB$$$$$F$Y$$$20240715$$CN$US$US
241120291$24112029$1$I$$20240711$20240719$20240719$EXP$$IR-STERISCIENCE B.V.-2024-ST-001049$Steriscience PTE$Shafiepour M, Najafzadeh MJ, Hashemi Bajgani SM, Dalfardi B.. Pneumoscrotum, a Rare Presentation of Barotrauma Following Noninvasive Positive Pressure Ventilation in Patients with Severe COVID-19 Pneumonia.. Galen. 2022;11$43$YR$$M$Y$$$20240719$$HP$IR$IR
241120301$24112030$1$I$$20240715$20240719$20240719$EXP$$CA-002147023-NVSC2024CA009468$Haleon PLC$$40$YR$$F$Y$96$KG$20240718$$HP$CA$CA
241120311$24112031$1$I$$20240709$20240719$20240719$PER$$US-BAUSCHBL-2024BNL029904$BAUSCH AND LOMB$$$$$F$Y$$$20240717$$CN$US$US
241120321$24112032$1$I$20240701$20240709$20240719$20240719$PER$$US-BAUSCHBL-2024BNL029903$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240717$$CN$US$US
241120332$24112033$2$F$20240612$20240730$20240719$20240802$PER$$US-AMGEN-USASP2024141958$AMGEN$$80$YR$E$F$Y$$$20240802$$CN$US$US
241120342$24112034$2$F$$20240717$20240719$20240723$PER$$US-BAUSCHBL-2024BNL029905$BAUSCH AND LOMB$$$$$F$Y$$$20240723$$CN$US$US
241120352$24112035$2$F$$20240715$20240719$20240729$EXP$$CA-HALEON-2187454$Haleon PLC$$53$YR$$M$Y$$$20240729$$CN$CA$CA
241120361$24112036$1$I$20240101$20240707$20240719$20240719$PER$$US-BAUSCHBL-2024BNL029824$BAUSCH AND LOMB$$94$YR$$F$Y$$$20240717$$CN$US$US
241120371$24112037$1$I$$20240711$20240719$20240719$PER$$US-ABBVIE-5844030$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241120381$24112038$1$I$$20240710$20240719$20240719$PER$$US-BAUSCHBL-2024BNL029963$BAUSCH AND LOMB$$$$$F$Y$$$20240717$$CN$US$US
241120391$24112039$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A163703$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241120401$24112040$1$I$20240612$20240715$20240719$20240719$EXP$$US-AstraZeneca-2024A161541$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241120411$24112041$1$I$$20240716$20240719$20240719$PER$$US-HALEON-2187639$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
241120421$24112042$1$I$$20240708$20240719$20240719$PER$$US-BAUSCHBL-2024BNL029846$BAUSCH AND LOMB$$49$YR$$F$Y$$$20240717$$CN$US$US
241120431$24112043$1$I$$20240715$20240719$20240719$EXP$$US-ABBVIE-5843813$ABBVIE$$$$$F$Y$$$20240719$$HP$US$US
241120441$24112044$1$I$20240601$20240708$20240719$20240719$PER$$US-BAUSCHBL-2024BNL029791$BAUSCH AND LOMB$$54$YR$$F$Y$$$20240715$$CN$US$US
241120451$24112045$1$I$$20240717$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114396$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240719$$HP$US$US
241120461$24112046$1$I$$20240714$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112464$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$72.57$KG$20240719$$CN$US$US
241120471$24112047$1$I$20231213$20240711$20240719$20240719$EXP$$EU-BAUSCHBL-2024BNL029331$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240716$$HP$EU$EU
241120484$24112048$4$F$$20240910$20240719$20240930$EXP$$CA-HALEON-2179225$Haleon PLC$$43$YR$$F$Y$96$KG$20240927$$HP$CA$CA
241120492$24112049$2$F$20240101$20240719$20240719$20240725$EXP$$GB-ABBVIE-5842166$ABBVIE$$63$YR$$M$Y$$$20240725$$CN$GB$GB
241120501$24112050$1$I$$20240715$20240719$20240719$EXP$$US-ABBVIE-5842531$ABBVIE$$$$$M$Y$$$20240719$$HP$US$US
241120511$24112051$1$I$$20240708$20240719$20240719$PER$$US-BAUSCHBL-2024BNL029893$BAUSCH AND LOMB$$$$$F$Y$$$20240717$$CN$US$US
241120521$24112052$1$I$20240709$20240709$20240719$20240719$PER$$US-BAUSCHBL-2024BNL029877$BAUSCH AND LOMB$$$$$F$Y$$$20240717$$CN$US$US
241120531$24112053$1$I$20090301$20240712$20240719$20240719$PER$$US-SA-200912942US$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240719$$CN$US$US
241120541$24112054$1$I$$20240710$20240719$20240719$EXP$$JP-009507513-2407JPN002329J$MERCK$$68$YR$$M$Y$$$20240719$$MD$JP$JP
241120551$24112055$1$I$$20240710$20240719$20240719$PER$$US-BAUSCHBL-2024BNL030038$BAUSCH AND LOMB$$$$$F$Y$$$20240717$$CN$US$US
241120563$24112056$3$F$20200501$20240912$20240719$20240917$EXP$$US-ABBVIE-5843891$ABBVIE$$79$YR$$M$Y$88$KG$20240917$$CN$US$US
241120571$24112057$1$I$20240707$20240712$20240719$20240719$EXP$$US-VIIV HEALTHCARE LIMITED-US2024087782$VIIV$$30$YR$$M$Y$$$20240719$$HP$US$US
241120581$24112058$1$I$20240713$20240715$20240719$20240719$EXP$$CA-ABBVIE-5842258$ABBVIE$$$$E$F$Y$$$20240719$$CN$CA$CA
241120591$24112059$1$I$$20240715$20240719$20240719$EXP$$US-GSK-US2024AMR089669$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$CN$US$US
241120601$24112060$1$I$$20240712$20240719$20240719$EXP$$EU-BAUSCHBL-2024BNL029300$BAUSCH AND LOMB$$90$YR$$$Y$63$KG$20240717$$MD$EU$EU
241120611$24112061$1$I$20180409$20240711$20240719$20240719$EXP$$BE-ABBVIE-18K-013-3118593-00$ABBVIE$$78$YR$$F$Y$$$20240719$$MD$BE$BE
241120622$24112062$2$F$20240501$20240719$20240719$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040723$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240722$$CN$US$US
241120631$24112063$1$I$$20240715$20240719$20240719$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-113985$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240719$$HP$CO$CO
241120643$24112064$3$F$$20240725$20240719$20240730$EXP$$CA-ABBVIE-5842657$ABBVIE$$$$E$F$Y$$$20240730$$CN$CA$CA
241120651$24112065$1$I$20240101$20240717$20240719$20240719$EXP$$CO-ABBVIE-5740227$ABBVIE$$$$$M$Y$55$KG$20240719$$CN$CO$CO
241120661$24112066$1$I$$20240628$20240719$20240719$EXP$$DE-ROCHE-10000029625$ROCHE$$$$$$Y$$$20240719$$CN$DE$DE
241120672$24112067$2$F$20240714$20240717$20240719$20240720$EXP$$US-ABBVIE-5843914$ABBVIE$$75$YR$$M$Y$$$20240720$$CN$US$US
241120681$24112068$1$I$$20240712$20240719$20240719$PER$$US-ABBVIE-5840319$ABBVIE$$$$$$Y$$$20240719$$CN$US$US
241120691$24112069$1$I$20240101$20240712$20240719$20240719$EXP$$US-ABBVIE-5839188$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241120701$24112070$1$I$$20240716$20240719$20240719$PER$$NVSC2024US148418$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241120712$24112071$2$F$$20240712$20240719$20240722$PER$$NVSC2024US145023$NOVARTIS$$16$YR$$F$Y$$$20240722$$CN$US$US
241120721$24112072$1$I$$20240712$20240719$20240719$EXP$$ZA-ABBVIE-5842537$ABBVIE$$50$YR$$F$Y$$$20240719$$PH$ZA$ZA
241120731$24112073$1$I$$20240717$20240719$20240719$EXP$$US-ABBVIE-5844772$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241120741$24112074$1$I$$20240717$20240719$20240719$PER$$US-AMGEN-USASP2024142880$AMGEN$$$$$$Y$$$20240718$$CN$US$US
241120751$24112075$1$I$$20240513$20240719$20240719$EXP$$CA-HALEON-2175617$Haleon PLC$$44$YR$$F$Y$68$KG$20240718$$HP$CA$CA
241120763$24112076$3$F$20231023$20240730$20240719$20240821$EXP$$JP-AstraZeneca-2024A159736$ASTRAZENECA$$90$YR$$M$Y$$$20240821$$MD$JP$
241120771$24112077$1$I$$20221221$20240719$20240719$EXP$$US-AstraZeneca-2022A360331$ASTRAZENECA$$$$$M$Y$$$20240719$$MD$US$
241120781$24112078$1$I$20240711$20240715$20240719$20240719$EXP$$US-AstraZeneca-2024A161626$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241120791$24112079$1$I$$20230413$20240719$20240719$EXP$$US-AstraZeneca-2023A087291$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241120802$24112080$2$F$20230208$20240725$20240719$20240729$EXP$$CA-UCBSA-2023025219$UCB$$49$YR$$M$Y$$$20240729$$MD$CA$CA
241120811$24112081$1$I$$20240717$20240719$20240719$EXP$$SK-ABBVIE-5844921$ABBVIE$$84$YR$$F$Y$$$20240719$$CN$SK$SK
241120833$24112083$3$F$20240601$20240904$20240719$20240909$EXP$$US-ABBVIE-5803641$ABBVIE$$77$YR$$F$Y$61$KG$20240909$$CN$US$US
241120841$24112084$1$I$20240701$20240715$20240719$20240719$EXP$$US-ABBVIE-5841957$ABBVIE$$62$YR$$M$Y$$$20240719$$CN$US$US
241120851$24112085$1$I$20240710$20240710$20240719$20240719$EXP$$US-BEH-2024175518$CSL BEHRING$$74$YR$E$F$Y$$$20240719$$CN$US$US
241120861$24112086$1$I$$20240715$20240719$20240719$EXP$$US-ABBVIE-5843318$ABBVIE$$$$$F$Y$$$20240719$$HP$US$US
241120871$24112087$1$I$20240101$20240716$20240719$20240719$EXP$$US-ABBVIE-5843473$ABBVIE$$$$$M$Y$$$20240719$$CN$US$US
241120891$24112089$1$I$20240101$20240716$20240719$20240719$EXP$$US-ABBVIE-5844559$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241120901$24112090$1$I$$20240717$20240719$20240719$EXP$$US-ABBVIE-5844590$ABBVIE$$$$$M$Y$$$20240719$$HP$US$US
241120911$24112091$1$I$20240101$20240716$20240719$20240719$EXP$$BG-ABBVIE-5843953$ABBVIE$$74$YR$$M$Y$$$20240719$$CN$BG$BG
241120922$24112092$2$F$20240101$20240717$20240719$20240725$EXP$$HU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-030111$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240725$$MD$HU$HU
241120942$24112094$2$F$20230601$20240704$20240719$20240722$EXP$$DE-VER-202400005$VERITY PHARMACEUTICALS$$$$$F$Y$$$20240722$$HP$DE$DE
241120951$24112095$1$I$$20240711$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112156$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240719$$HP$US$US
241120961$24112096$1$I$$20240716$20240719$20240719$EXP$$CA-ABBVIE-5843975$ABBVIE$$$$A$M$Y$$$20240719$$CN$CA$CA
241120971$24112097$1$I$20240101$20240711$20240719$20240719$PER$$US-SA-2024SA210112$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240719$$MD$US$US
241120983$24112098$3$F$20240101$20240827$20240719$20240830$EXP$$US-ABBVIE-5720135$ABBVIE$$$$$F$Y$74$KG$20240830$$CN$US$US
241120992$24112099$2$F$20240715$20240718$20240719$20240723$PER$$US-AMGEN-USASP2024142145$AMGEN$$70$YR$E$F$Y$$$20240723$$CN$US$US
241121001$24112100$1$I$$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024142544$AMGEN$$$$$$Y$$$20240718$$CN$US$US
241121011$24112101$1$I$$20240715$20240719$20240719$PER$$US-SA-2024SA208882$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240719$$MD$US$US
241121021$24112102$1$I$20231110$20240712$20240719$20240719$PER$$US-SA-2024SA209436$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240719$$MD$US$US
241121032$24112103$2$F$$20240812$20240719$20240822$EXP$$US-Axsome Therapeutics, Inc.-AXS202405-000707$AXSOME THERAPEUTICS$$$$$F$Y$$$20240822$$$US$
241121051$24112105$1$I$20230101$20240711$20240719$20240719$EXP$$US-ABBVIE-5842648$ABBVIE$$$$$M$Y$81.65$KG$20240719$$HP$US$US
241121061$24112106$1$I$$20240704$20240719$20240719$EXP$$CA-HLS-202401681$HLS THERAPEUTICS$$$$E$M$Y$$$20240719$$HP$CA$CA
241121071$24112107$1$I$20210101$20240712$20240719$20240719$EXP$$US-ABBVIE-5831090$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241121091$24112109$1$I$$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024142578$AMGEN$$$$$$Y$$$20240718$$CN$US$US
241121101$24112110$1$I$$20220627$20240719$20240719$EXP$$US-AstraZeneca-2022A202221$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241121111$24112111$1$I$20240712$20240718$20240719$20240719$EXP$GB-MHRA-MED-202407181042277560-SJFRK$GB-JNJFOC-20240748671$JOHNSON AND JOHNSON$$28$YR$A$$Y$$$20240719$$CN$GB$GB
241121121$24112112$1$I$$20240711$20240719$20240719$PER$$US-JNJFOC-20240741605$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$CN$US$US
241121131$24112113$1$I$20240101$20240718$20240719$20240719$EXP$GB-MHRA-MED-202407181602120400-JGMYK$GB-JNJFOC-20240749704$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$CN$GB$GB
241121142$24112114$2$F$$20240730$20240719$20240801$PER$$NVSC2024US148435$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241121152$24112115$2$F$20240101$20240812$20240719$20240814$EXP$$US-ABBVIE-5842608$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
241121161$24112116$1$I$20240713$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024141392$AMGEN$$$$$$Y$$$20240718$$PH$US$US
241121171$24112117$1$I$$20240705$20240719$20240719$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR00998$TARO$$$$$$Y$$$20240719$$HP$CA$CA
241121181$24112118$1$I$20230101$20240708$20240719$20240719$EXP$$CA-BEH-2024175551$CSL BEHRING$$62$YR$A$F$Y$51.3$KG$20240719$$CN$CA$CA
241121191$24112119$1$I$$20240716$20240719$20240719$EXP$$US-PFIZER INC-202400216357$PFIZER$$$$E$M$Y$$$20240719$$PH$US$US
241121201$24112120$1$I$20240516$20240716$20240719$20240719$EXP$$CA-PFIZER INC-202400173285$PFIZER$$87$YR$$M$Y$$$20240719$$CN$CA$CA
241121211$24112121$1$I$20240329$20240716$20240719$20240719$EXP$FR-AFSSAPS-LL2024001296$FR-PFIZER INC-202400215932$PFIZER$$69$YR$$F$Y$100$KG$20240719$$MD$FR$FR
241121221$24112122$1$I$20240710$20240712$20240719$20240719$EXP$$US-JAZZ-2021-US-017805$JAZZ$$69$YR$$M$Y$$$20240718$$CN$US$US
241121232$24112123$2$F$20240101$20240719$20240719$20240723$PER$$US-PFIZER INC-202400217574$PFIZER$$17$YR$$M$Y$81.633$KG$20240723$$CN$US$US
241121242$24112124$2$F$$20240717$20240719$20240722$EXP$$US-PFIZER INC-PV202400094299$PFIZER$$24$YR$$M$Y$$$20240722$$CN$US$US
241121251$24112125$1$I$$20240710$20240719$20240719$EXP$$JP-AMGEN-JPNSP2024137362$AMGEN$$$$$$Y$$$20240719$$PH$JP$JP
241121262$24112126$2$F$20240711$20240911$20240719$20240911$30DAY$$CO-PFIZER INC-202400216173$PFIZER$$12$YR$$M$Y$$$20240911$$CN$CO$CO
241121271$24112127$1$I$$20240718$20240719$20240719$PER$$US-PFIZER INC-202400218688$PFIZER$$$$$F$Y$$$20240719$$CN$US$US
241121281$24112128$1$I$$20240705$20240719$20240719$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR00996$TARO$$$$$$Y$$$20240719$$PH$CA$CA
241121293$24112129$3$F$$20240921$20240719$20240925$30DAY$$US-PFIZER INC-202400215413$PFIZER$$14$YR$$F$Y$$$20240925$$CN$US$US
241121302$24112130$2$F$20240715$20240912$20240719$20240918$30DAY$$US-PFIZER INC-202400216533$PFIZER$$10$YR$$F$Y$25.85$KG$20240918$$CN$US$US
241121311$24112131$1$I$$20240705$20240719$20240719$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR00999$TARO$$$$$$Y$$$20240719$$PH$CA$CA
241121322$24112132$2$F$$20240717$20240719$20240725$EXP$$CA-PFIZER INC-202400217611$PFIZER$$55$YR$$M$Y$$$20240725$$HP$CA$CA
241121333$24112133$3$F$20240711$20240911$20240719$20240913$30DAY$$US-PFIZER INC-PV202400092859$PFIZER$$21$YR$$F$Y$68.027$KG$20240913$$HP$US$US
241121345$24112134$5$F$20240101$20240825$20240719$20240826$30DAY$$US-PFIZER INC-202400216937$PFIZER$$14$YR$$M$Y$$$20240826$$CN$US$US
241121351$24112135$1$I$20240623$20240718$20240719$20240719$EXP$DK-DKMA-30735632$DK-PFIZER INC-202400218074$PFIZER$$67$YR$$F$Y$61$KG$20240719$$CN$DK$DK
241121363$24112136$3$F$$20240824$20240719$20240826$30DAY$$US-PFIZER INC-PV202400092871$PFIZER$$9$YR$$M$Y$$$20240826$$CN$US$US
241121382$24112138$2$F$$20240821$20240719$20240821$30DAY$$US-PFIZER INC-202400216336$PFIZER$$10$YR$$M$Y$$$20240821$$CN$US$US
241121391$24112139$1$I$20240709$20240711$20240719$20240719$30DAY$$GB-PFIZER INC-PV202400091713$PFIZER$$17$YR$$F$Y$$$20240719$$PH$GB$GB
241121404$24112140$4$F$20240301$20240824$20240719$20240826$EXP$$AT-PFIZER INC-PV202400093151$PFIZER$$29$YR$$M$Y$$$20240826$$CN$AT$AT
241121413$24112141$3$F$$20240916$20240719$20240919$30DAY$$US-PFIZER INC-202400213333$PFIZER$$12$YR$$M$Y$32.66$KG$20240919$$MD$US$US
241121422$24112142$2$F$20240717$20240722$20240719$20240723$30DAY$$GB-PFIZER INC-PV202400093766$PFIZER$$74$YR$$M$Y$$$20240723$$CN$GB$GB
241121432$24112143$2$F$$20240821$20240719$20240821$30DAY$$US-PFIZER INC-202400213969$PFIZER$$20$YR$$M$Y$$$20240821$$HP$US$US
241121441$24112144$1$I$$20240716$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113751$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240719$$CN$US$US
241121451$24112145$1$I$$20240717$20240719$20240719$EXP$$US-BAUSCH-BL-2024-010982$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240719$$CN$US$US
241121463$24112146$3$F$$20240823$20240719$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113805$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240827$$HP$US$US
241121471$24112147$1$I$20240426$20240719$20240719$20240719$EXP$AT-BASGAGES-2024-002848$NVSC2024AT148660$NOVARTIS$$48$YR$$F$Y$56$KG$20240719$$PH$AT$AT
241121482$24112148$2$F$$20240719$20240719$20240722$PER$$NVSC2024US148781$NOVARTIS$$$$$F$Y$$$20240722$$CN$US$US
241121491$24112149$1$I$$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024141221$AMGEN$$$$$$Y$$$20240719$$CN$US$US
241121504$24112150$4$F$20240510$20240828$20240719$20240913$PER$$NVSJ2024JP005693$NOVARTIS$$$$$M$Y$$$20240913$$MD$JP$JP
241121511$24112151$1$I$$20240717$20240719$20240719$EXP$$CA-PFIZER INC-202400218644$PFIZER$$8$YR$$M$Y$30$KG$20240719$$HP$CA$CA
241121521$24112152$1$I$$20240718$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115312$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$95.71$KG$20240719$$CN$US$US
241121531$24112153$1$I$$20240712$20240719$20240719$EXP$$HN-BRISTOL-MYERS SQUIBB COMPANY-2024-111869$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240719$$CN$HN$HN
241121541$24112154$1$I$$20240711$20240719$20240719$PER$$US-INCYTE CORPORATION-2024IN007442$INCYTE$$$$$$Y$$$20240719$$MD$US$US
241121551$24112155$1$I$$20240716$20240719$20240719$EXP$$US-TAKEDA-2024TUS021564$TAKEDA$$$$$F$Y$$$20240719$$MD$US$US
241121561$24112156$1$I$$20240713$20240719$20240719$EXP$$NVSC2024IN148332$NOVARTIS$$$$$M$Y$$$20240719$$CN$IN$IN
241121572$24112157$2$F$$20240819$20240719$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115350$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240821$$CN$US$US
241121581$24112158$1$I$20240703$20240704$20240719$20240719$EXP$$HU-BEH-2024175509$CSL BEHRING$$74$YR$E$M$Y$47$KG$20240719$$MD$HU$HU
241121591$24112159$1$I$$20240715$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113174$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240719$$CN$US$US
241121621$24112162$1$I$20240713$20240717$20240719$20240719$PER$$US-PFIZER INC-202400218146$PFIZER$$60$YR$$F$Y$$$20240719$$CN$US$US
241121631$24112163$1$I$20240716$20240718$20240719$20240719$PER$$US-PFIZER INC-202400219089$PFIZER$$49$YR$$F$Y$$$20240719$$CN$US$US
241121641$24112164$1$I$20240713$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024140545$AMGEN$$65$YR$E$M$Y$$$20240719$$CN$US$US
241121651$24112165$1$I$$20240717$20240719$20240719$PER$$US-PFIZER INC-202400217692$PFIZER$$71$YR$$F$Y$81.65$KG$20240719$$PH$US$US
241121661$24112166$1$I$20240712$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024141759$AMGEN$$69$YR$E$F$Y$$$20240719$$CN$US$US
241121681$24112168$1$I$$20240712$20240719$20240719$PER$$US-AMGEN-USASP2024139934$AMGEN$$$$$$Y$$$20240719$$CN$US$US
241121691$24112169$1$I$$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024142279$AMGEN$$$$$F$Y$$$20240719$$CN$US$US
241121701$24112170$1$I$20240201$20240716$20240719$20240719$EXP$$US-GSK-US2024089512$GLAXOSMITHKLINE$$64$YR$$M$Y$$$20240719$$CN$US$US
241121711$24112171$1$I$$20240718$20240719$20240719$PER$$US-PFIZER INC-PV202400094391$PFIZER$$72$YR$$F$Y$$$20240719$$HP$US$US
241121721$24112172$1$I$20240618$20240716$20240719$20240719$EXP$FR-AFSSAPS-LL2024001298$FR-PFIZER INC-202400215937$PFIZER$$59$YR$$F$Y$50$KG$20240719$$MD$FR$FR
241121731$24112173$1$I$20240101$20240715$20240719$20240719$EXP$$US-ABBVIE-5843125$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241121741$24112174$1$I$20240705$20240711$20240719$20240719$EXP$$GB-PFIZER INC-202400217869$PFIZER$$$$$$Y$$$20240719$$PH$GB$GB
241121751$24112175$1$I$20240701$20240711$20240719$20240719$EXP$$US-PFIZER INC-202400212630$PFIZER$$19$YR$$F$Y$47.63$KG$20240719$$HP$US$US
241121762$24112176$2$F$20240701$20240821$20240719$20240821$30DAY$$US-PFIZER INC-202400215362$PFIZER$$10$YR$$F$Y$$$20240821$$CN$US$US
241121771$24112177$1$I$$20240715$20240719$20240719$EXP$$CA-BAUSCH-BL-2024-010909$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240719$$HP$CA$CA
241121781$24112178$1$I$20240703$20240712$20240719$20240719$EXP$$US-SA-2024SA209228$SANOFI AVENTIS$$59$YR$A$F$Y$65.77$KG$20240719$$MD$US$US
241121793$24112179$3$F$20240713$20240828$20240719$20240903$PER$$US-PFIZER INC-202400213945$PFIZER$$13$YR$$M$Y$27$KG$20240903$$HP$US$US
241121801$24112180$1$I$20231128$20240715$20240719$20240719$EXP$$BR-TAKEDA-2023TUS117155$TAKEDA$$7$YR$$M$Y$$$20240719$$CN$BR$BR
241121811$24112181$1$I$$20240718$20240719$20240719$PER$$US-PFIZER INC-202400218936$PFIZER$$$$$$Y$$$20240719$$MD$US$US
241121821$24112182$1$I$20240624$20240716$20240719$20240719$EXP$GB-MHRA-MED-202407161310431130-BFNHC$GB-PFIZER INC-202400216267$PFIZER$$51$YR$$F$Y$56$KG$20240719$$HP$GB$GB
241121831$24112183$1$I$20240610$20240715$20240719$20240719$EXP$FR-AFSSAPS-RS2024000686$FR-PFIZER INC-202400218365$PFIZER$$85$YR$$F$Y$$$20240719$$MD$FR$FR
241121841$24112184$1$I$$20240711$20240719$20240719$EXP$$CA-TEVA-VS-3221224$TEVA$$44$YR$$F$Y$$$20240719$$MD$CA$CA
241121851$24112185$1$I$$20240715$20240719$20240719$EXP$$US-PFIZER INC-202400216474$PFIZER$$60$YR$$M$Y$$$20240719$$HP$US$US
241121862$24112186$2$F$20240717$20240806$20240719$20240808$PER$$US-PFIZER INC-202400217238$PFIZER$$47$YR$$F$Y$60.317$KG$20240808$$CN$US$US
241121872$24112187$2$F$20240412$20240705$20240719$20240719$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000593$PAREXEL$$$$$$Y$$$20240720$$HP$CN$CN
241121881$24112188$1$I$20240625$20240626$20240719$20240719$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000575$PAREXEL$$$$$$Y$$$20240719$$PH$US$US
241121891$24112189$1$I$$20240703$20240719$20240719$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000549$PAREXEL$$$$$$Y$$$20240719$$HP$US$US
241121911$24112191$1$I$$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024142785$AMGEN$$$$$$Y$$$20240719$$PH$US$US
241121921$24112192$1$I$$20240718$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115257$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240719$$CN$US$US
241121932$24112193$2$F$20240707$20240723$20240719$20240802$EXP$$SA-AMRYT PHARMACEUTICALS DAC-AEGR007277$AEGERION$$$$$$Y$$$20240802$$CN$SA$SA
241121941$24112194$1$I$20230315$20240718$20240719$20240719$PER$$NVSC2024US148853$NOVARTIS$$22$YR$$F$Y$$$20240719$$MD$US$US
241121952$24112195$2$F$$20240910$20240719$20240918$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-110326$BRISTOL MYERS SQUIBB$Fernandez-Concha I, Pose K, De las Vecillas L, Lluch-Bernal M, Tomas-Perez M, Soto T, et al. Successful desensitization to lenalidomide in leukocytoclastic vasculitis. Journal of Investigational Allergology + Clinical Immunology. 2024 Jul 08;34(5):1-2. doi:10.18176/jiaci.1002.$82$YR$E$F$Y$$$20240918$$HP$ES$ES
241121964$24112196$4$F$$20240916$20240719$20240919$EXP$$CA-TAKEDA-2024TUS072434$TAKEDA$$$$$F$Y$$$20240919$$CN$CA$CA
241121984$24112198$4$F$20240101$20240902$20240719$20240913$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407006023$ELI LILLY AND CO$$58$YR$A$M$Y$74$KG$20240913$$CN$DE$DE
241121992$24112199$2$F$20240626$20240716$20240719$20240729$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407008058$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240729$$CN$DE$DE
241122002$24112200$2$F$20240716$20240821$20240719$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202407011064$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
241122011$24112201$1$I$$20240709$20240719$20240719$EXP$$HR-ELI_LILLY_AND_COMPANY-HR202407006379$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240719$$CN$HR$HR
241122021$24112202$1$I$$20240709$20240719$20240719$EXP$$MY-ELI_LILLY_AND_COMPANY-MY202407006370$ELI LILLY AND CO$$$$A$F$Y$$$20240719$$HP$MY$MY
241122031$24112203$1$I$20220101$20240709$20240719$20240719$EXP$FR-AFSSAPS-TS2024000775$FR-ELI_LILLY_AND_COMPANY-FR202407006733$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240719$$CN$FR$FR
241122041$24112204$1$I$20240626$20240712$20240719$20240719$EXP$$HU-ELI_LILLY_AND_COMPANY-HU202407009783$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240719$$CN$HU$HU
241122051$24112205$1$I$20240613$20240712$20240719$20240719$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202407008278$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240719$$CN$ES$ES
241122061$24112206$1$I$20240501$20240715$20240719$20240719$EXP$$CN-TAKEDA-2024TUS072013$TAKEDA$$48$YR$$M$Y$$$20240719$$CN$CN$CN
241122071$24112207$1$I$20240419$20240709$20240719$20240719$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407006294$ELI LILLY AND CO$$77$YR$E$M$Y$81.7$KG$20240719$$CN$JP$JP
241122081$24112208$1$I$20240608$20240710$20240719$20240719$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407012004$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240719$$CN$JP$JP
241122091$24112209$1$I$20240120$20240710$20240719$20240719$EXP$IT-MINISAL02-994464$IT-ELI_LILLY_AND_COMPANY-IT202407007548$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240719$$CN$IT$IT
241122101$24112210$1$I$$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024141945$AMGEN$$$$A$$Y$$$20240718$$HP$US$US
241122111$24112211$1$I$$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024141942$AMGEN$$$$$F$Y$$$20240719$$CN$US$US
241122121$24112212$1$I$$20240716$20240719$20240719$EXP$IT-MINISAL02-994828$IT-009507513-2407ITA011359$MERCK$$72$YR$$F$Y$$$20240719$$MD$IT$IT
241122132$24112213$2$F$20240710$20240820$20240719$20240827$30DAY$$US-AMGEN-USASP2024139562$AMGEN$$54$YR$A$F$Y$123$KG$20240827$$PH$US$US
241122143$24112214$3$F$20240701$20240814$20240719$20240820$30DAY$$US-AMGEN-USASP2024139601$AMGEN$$58$YR$A$F$Y$185$KG$20240820$$PH$US$US
241122152$24112215$2$F$20240709$20240823$20240719$20240828$EXP$$US-AMGEN-USASP2024140208$AMGEN$$68$YR$E$F$Y$$$20240828$$CN$US$US
241122161$24112216$1$I$20240715$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024141113$AMGEN$$48$YR$A$F$Y$$$20240719$$CN$US$US
241122172$24112217$2$F$$20240819$20240719$20240823$EXP$$AU-ABBVIE-5842458$ABBVIE$$57$YR$$F$Y$$$20240823$$MD$AU$AU
241122182$24112218$2$F$$20240726$20240719$20240729$PER$$AU-JAZZ PHARMACEUTICALS-2024-AU-010798$JAZZ$$$$$F$Y$$$20240729$$MD$AU$AU
241122192$24112219$2$F$$20240823$20240719$20240826$PER$$US-TAKEDA-2024TUS072423$TAKEDA$$$$$M$Y$96$KG$20240826$$MD$US$US
241122201$24112220$1$I$20240703$20240716$20240719$20240719$EXP$FR-AFSSAPS-MP2024001140$FR-JNJFOC-20240743612$JOHNSON AND JOHNSON$$21$YR$A$F$Y$60$KG$20240719$$PH$FR$FR
241122212$24112221$2$F$$20240807$20240719$20240807$PER$$NVSC2024US149049$NOVARTIS$$$$$M$Y$$$20240807$$HP$US$US
241122221$24112222$1$I$$20240712$20240719$20240719$EXP$$DE-ALXN-202407EEA000806DE$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240719$$MD$DE$DE
241122232$24112223$2$F$20240101$20240807$20240719$20240808$PER$$US-ALXN-202407USA000929US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241122242$24112224$2$F$20240101$20240826$20240719$20240903$EXP$$US-ABBVIE-5843009$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
241122252$24112225$2$F$$20240827$20240719$20240829$PER$$US-AMGEN-USASP2024141540$AMGEN$$$$$F$Y$74.376$KG$20240829$$CN$US$US
241122261$24112226$1$I$20240619$20240716$20240719$20240719$EXP$$US-AstraZeneca-2024A162484$ASTRAZENECA$$33505$DY$$F$Y$$$20240719$$MD$US$
241122271$24112227$1$I$$20210615$20240719$20240719$EXP$$US-AstraZeneca-2021A536295$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122281$24112228$1$I$$20221025$20240719$20240719$EXP$$US-AstraZeneca-2022A357423$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241122291$24112229$1$I$$20220323$20240719$20240719$EXP$$TW-AstraZeneca-2022A128018$ASTRAZENECA$$73$YR$$M$Y$$$20240719$$CN$TW$
241122301$24112230$1$I$20220627$20220630$20240719$20240719$EXP$$US-AstraZeneca-2022A241165$ASTRAZENECA$$24755$DY$$F$Y$$$20240719$$CN$US$
241122311$24112231$1$I$20240709$20240712$20240719$20240719$EXP$$CN-AstraZeneca-2024A162103$ASTRAZENECA$$60$YR$$M$Y$67.5$KG$20240719$$MD$CN$
241122321$24112232$1$I$$20240705$20240719$20240719$EXP$$US-HLS-202400248$HLS THERAPEUTICS$$36$YR$A$M$Y$$$20240719$$MD$US$US
241122331$24112233$1$I$$20210629$20240719$20240719$EXP$$US-AstraZeneca-2021A578577$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122341$24112234$1$I$$20210629$20240719$20240719$EXP$$FR-AstraZeneca-2021A588004$ASTRAZENECA$$58$YR$$M$Y$110$KG$20240719$$MD$FR$
241122351$24112235$1$I$$20210723$20240719$20240719$EXP$$US-AstraZeneca-2021A646388$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241122361$24112236$1$I$$20210923$20240719$20240719$EXP$$US-AstraZeneca-2021A745094$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122371$24112237$1$I$$20211012$20240719$20240719$EXP$$US-AstraZeneca-2021A712891$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241122381$24112238$1$I$$20230317$20240719$20240719$EXP$$CA-AstraZeneca-2022A225544$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$CA$
241122391$24112239$1$I$$20200210$20240719$20240719$EXP$$US-AstraZeneca-2020SE21431$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122401$24112240$1$I$$20240715$20240719$20240719$EXP$$US-AstraZeneca-2024A161265$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241122411$24112241$1$I$20240509$20240715$20240719$20240719$EXP$$US-AstraZeneca-2024A161692$ASTRAZENECA$$30129$DY$$F$Y$$$20240719$$MD$US$
241122422$24112242$2$F$$20240909$20240719$20240912$EXP$$US-AstraZeneca-2024A161413$ASTRAZENECA$$$$$$Y$$$20240912$$MD$US$
241122431$24112243$1$I$$20240711$20240719$20240719$PER$$US-AstraZeneca-2024A159377$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122441$24112244$1$I$$20200217$20240719$20240719$EXP$$US-AstraZeneca-2020SE24558$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241122451$24112245$1$I$$20221010$20240719$20240719$EXP$$US-AstraZeneca-2022A343288$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241122461$24112246$1$I$20210801$20211004$20240719$20240719$EXP$$US-AstraZeneca-2021A759322$ASTRAZENECA$$27397$DY$$M$Y$$$20240719$$CN$US$
241122472$24112247$2$F$$20240808$20240719$20240814$EXP$$DE-PURDUE-USA-2024-0310821$PURDUE$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology;. 2024;48:299-313.$39$YR$$F$Y$$$20240814$$HP$DE$DE
241122481$24112248$1$I$$20230525$20240719$20240719$EXP$$US-AstraZeneca-2023A122005$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122492$24112249$2$F$20240405$20240722$20240719$20240726$EXP$$US-AstraZeneca-2024A163351$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241122501$24112250$1$I$$20221220$20240719$20240719$EXP$$US-AstraZeneca-2022A414132$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241122521$24112252$1$I$$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024141557$AMGEN$$$$$M$Y$$$20240719$$HP$US$US
241122531$24112253$1$I$$20231114$20240719$20240719$EXP$$US-AstraZeneca-2023A260013$ASTRAZENECA$$$$$$Y$$$20240719$$CN$US$
241122541$24112254$1$I$$20220727$20240719$20240719$EXP$$US-AstraZeneca-2022A269291$ASTRAZENECA$$$$$$Y$$$20240719$$CN$US$
241122551$24112255$1$I$20200629$20201001$20240719$20240719$EXP$$US-AstraZeneca-2020SE83865$ASTRAZENECA$$29052$DY$$M$Y$$$20240719$$CN$US$
241122561$24112256$1$I$$20240716$20240719$20240719$PER$$US-SA-2024SA210054$SANOFI AVENTIS$$$$$$Y$$$20240719$$MD$US$US
241122571$24112257$1$I$$20210317$20240719$20240719$EXP$$ZA-AstraZeneca-2021A164152$ASTRAZENECA$$$$$F$Y$$$20240719$$HP$ZA$
241122581$24112258$1$I$$20210318$20240719$20240719$EXP$$US-AstraZeneca-2021A188554$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122591$24112259$1$I$20240713$20240716$20240719$20240719$EXP$$US-AstraZeneca-2024A162558$ASTRAZENECA$$28795$DY$$F$Y$$$20240719$$CN$US$
241122601$24112260$1$I$$20200630$20240719$20240719$EXP$$GB-AstraZeneca-2020SE83874$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$GB$
241122611$24112261$1$I$20240702$20240715$20240719$20240719$EXP$$US-AstraZeneca-2024A161430$ASTRAZENECA$$27301$DY$$F$Y$$$20240719$$HP$US$
241122621$24112262$1$I$$20200528$20240719$20240719$EXP$$US-AstraZeneca-2020SE35420$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122632$24112263$2$F$$20240927$20240719$20240927$PER$$NVSC2024US148963$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
241122641$24112264$1$I$$20240712$20240719$20240719$EXP$DE-SEATTLE GENETICS-2021SGN03579$DE-RDY-SPO/DEU/24/0010374$DR REDDYS$$$$A$F$Y$$$20240719$$MD$DE$DE
241122691$24112269$1$I$$20200831$20240719$20240719$EXP$$US-AstraZeneca-2020SF13726$ASTRAZENECA$$89$YR$$F$Y$$$20240719$$CN$US$
241122701$24112270$1$I$$20220118$20240719$20240719$EXP$$US-AstraZeneca-2022A031091$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241122711$24112271$1$I$20200823$20200923$20240719$20240719$EXP$$US-AstraZeneca-2020SF23106$ASTRAZENECA$$25320$DY$$F$Y$$$20240719$$CN$US$
241122721$24112272$1$I$$20221021$20240719$20240719$EXP$$US-AstraZeneca-2022A355103$ASTRAZENECA$$$$$F$Y$63.5$KG$20240719$$CN$US$
241122731$24112273$1$I$20140101$20221010$20240719$20240719$EXP$$US-AstraZeneca-2022A348002$ASTRAZENECA$$56$YR$$F$Y$$$20240719$$CN$US$
241122741$24112274$1$I$20210805$20210810$20240719$20240719$EXP$$US-AstraZeneca-2021A676803$ASTRAZENECA$$68$YR$$M$Y$$$20240719$$CN$US$
241122751$24112275$1$I$20210201$20210324$20240719$20240719$EXP$$US-AstraZeneca-2021A208990$ASTRAZENECA$$644$MON$$F$Y$$$20240719$$CN$US$
241122761$24112276$1$I$$20240716$20240719$20240719$EXP$$SK-AstraZeneca-2024A163772$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$SK$
241122771$24112277$1$I$$20190812$20240719$20240719$EXP$$RU-AstraZeneca-2019SF16190$ASTRAZENECA$$69$YR$$M$Y$75$KG$20240719$$CN$RU$
241122781$24112278$1$I$$20200928$20240719$20240719$EXP$$GB-AstraZeneca-2020SF26278$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$GB$
241122791$24112279$1$I$$20230417$20240719$20240719$EXP$$US-AstraZeneca-2023A091065$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122801$24112280$1$I$$20220919$20240719$20240719$EXP$$US-AstraZeneca-2022A323949$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122811$24112281$1$I$$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A160244$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122821$24112282$1$I$$20220420$20240719$20240719$EXP$$BR-AstraZeneca-2022A022435$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$BR$
241122831$24112283$1$I$20240611$20240709$20240719$20240719$EXP$$GB-JNJFOC-20240700636$JOHNSON AND JOHNSON$$63$YR$A$F$Y$65.6$KG$20240719$$PH$GB$GB
241122841$24112284$1$I$$20201001$20240719$20240719$EXP$$US-AstraZeneca-2020SF28762$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122851$24112285$1$I$$20201003$20240719$20240719$EXP$$US-AstraZeneca-2020SF30154$ASTRAZENECA$$53$YR$$F$Y$$$20240719$$CN$US$
241122861$24112286$1$I$$20191008$20240719$20240719$EXP$$US-AstraZeneca-2019SF39953$ASTRAZENECA$$71$YR$$F$Y$$$20240719$$CN$US$
241122871$24112287$1$I$$20201012$20240719$20240719$EXP$$US-AstraZeneca-2020SF33458$ASTRAZENECA$$$$$M$Y$82.6$KG$20240719$$CN$US$
241122881$24112288$1$I$$20200130$20240719$20240719$EXP$$US-AstraZeneca-2020SE17318$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122891$24112289$1$I$$20221101$20240719$20240719$EXP$$US-AstraZeneca-2022A321267$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241122901$24112290$1$I$$20230102$20240719$20240719$EXP$$IN-AstraZeneca-2023A004596$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$IN$
241122911$24112291$1$I$$20240713$20240719$20240719$PER$$US-AstraZeneca-2024A161499$ASTRAZENECA$$$$$$Y$$$20240719$$CN$US$
241122921$24112292$1$I$$20220117$20240719$20240719$EXP$$US-AstraZeneca-2021A866927$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122931$24112293$1$I$$20220511$20240719$20240719$EXP$$US-AstraZeneca-2022A184356$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241122941$24112294$1$I$$20220224$20240719$20240719$EXP$$US-AstraZeneca-2022A087763$ASTRAZENECA$$$$$$Y$$$20240719$$CN$US$
241122951$24112295$1$I$$20200203$20240719$20240719$EXP$$CA-AstraZeneca-2020SE18814$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$CA$
241122961$24112296$1$I$20201007$20201008$20240719$20240719$EXP$$US-AstraZeneca-2020SF31326$ASTRAZENECA$$18477$DY$$F$Y$$$20240719$$CN$US$
241122971$24112297$1$I$$20210408$20240719$20240719$EXP$$US-AstraZeneca-2021A299901$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241122981$24112298$1$I$$20200427$20240719$20240719$EXP$$US-AstraZeneca-2020SE58700$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241122991$24112299$1$I$$20210331$20240719$20240719$EXP$$US-AstraZeneca-2021A256138$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123001$24112300$1$I$20240626$20240716$20240719$20240719$EXP$$US-AstraZeneca-2024A162231$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123011$24112301$1$I$20240707$20240711$20240719$20240719$EXP$$CO-AstraZeneca-2024A160763$ASTRAZENECA$$70$YR$$M$Y$40$KG$20240719$$CN$CO$
241123021$24112302$1$I$$20210402$20240719$20240719$EXP$$US-AstraZeneca-2021A280800$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123031$24112303$1$I$$20190827$20240719$20240719$EXP$$US-AstraZeneca-2019SF24974$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241123041$24112304$1$I$20190910$20190919$20240719$20240719$EXP$$US-AstraZeneca-2019SF35577$ASTRAZENECA$$26196$DY$$M$Y$$$20240719$$CN$US$
241123051$24112305$1$I$20210316$20210323$20240719$20240719$EXP$$CO-AstraZeneca-2021A225040$ASTRAZENECA$$20469$DY$$F$Y$85$KG$20240719$$CN$CO$
241123061$24112306$1$I$$20200313$20240719$20240719$EXP$$US-AstraZeneca-2020SE39860$ASTRAZENECA$$$$$F$Y$59$KG$20240719$$CN$US$
241123071$24112307$1$I$$20210401$20240719$20240719$EXP$$GB-AstraZeneca-2021A272656$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$GB$
241123081$24112308$1$I$$20210408$20240719$20240719$EXP$$US-AstraZeneca-2021A299897$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123091$24112309$1$I$$20220511$20240719$20240719$EXP$$US-AstraZeneca-2022A184755$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123101$24112310$1$I$$20220506$20240719$20240719$EXP$$US-AstraZeneca-2022A178479$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123111$24112311$1$I$20190729$20190905$20240719$20240719$EXP$$US-AstraZeneca-2019SF14828$ASTRAZENECA$$21352$DY$$M$Y$$$20240719$$CN$US$
241123121$24112312$1$I$$20220602$20240719$20240719$EXP$$US-AstraZeneca-2022A208790$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123131$24112313$1$I$20240714$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024141435$AMGEN$$77$YR$E$F$Y$$$20240719$$PH$US$US
241123141$24112314$1$I$20240426$20240712$20240719$20240719$EXP$$GB-AstraZeneca-2024A159759$ASTRAZENECA$$58$YR$$F$Y$78$KG$20240719$$MD$GB$
241123151$24112315$1$I$$20221010$20240719$20240719$EXP$$US-AstraZeneca-2022A343554$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123161$24112316$1$I$$20220607$20240719$20240719$EXP$$US-AstraZeneca-2022A214440$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123171$24112317$1$I$$20221128$20240719$20240719$EXP$$US-AstraZeneca-2022A393203$ASTRAZENECA$$$$$$Y$$$20240719$$CN$US$
241123183$24112318$3$F$$20240902$20240719$20240910$PER$$US-AstraZeneca-2024A164593$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
241123191$24112319$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160305$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123201$24112320$1$I$$20221122$20240719$20240719$EXP$$US-AstraZeneca-2022A387330$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123211$24112321$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A162627$ASTRAZENECA$$$$$$Y$$$20240719$$MD$US$
241123223$24112322$3$F$$20240829$20240719$20240916$EXP$$JP-AMGEN-JPNSP2024140770$AMGEN$$$$E$F$Y$$$20240916$$MD$JP$JP
241123231$24112323$1$I$$20220627$20240719$20240719$EXP$$CA-AstraZeneca-2022A239486$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$CA$
241123244$24112324$4$F$20240401$20240913$20240719$20240918$EXP$$JP-AstraZeneca-2024A159815$ASTRAZENECA$$75$YR$$M$Y$$$20240918$$MD$JP$
241123251$24112325$1$I$$20240715$20240719$20240719$EXP$$US-AstraZeneca-2024A161300$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123261$24112326$1$I$20200501$20200818$20240719$20240719$EXP$$US-AstraZeneca-2020SF05657$ASTRAZENECA$$955$MON$$M$Y$$$20240719$$CN$US$
241123271$24112327$1$I$20210301$20211216$20240719$20240719$EXP$$US-AstraZeneca-2021A882778$ASTRAZENECA$$733$MON$$F$Y$85.3$KG$20240719$$CN$US$
241123281$24112328$1$I$20220601$20220708$20240719$20240719$EXP$$SG-AstraZeneca-2022A253454$ASTRAZENECA$$645$MON$$$Y$$$20240719$$CN$SG$
241123291$24112329$1$I$$20240712$20240719$20240719$EXP$$BE-AstraZeneca-2024A162489$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$BE$
241123301$24112330$1$I$$20240711$20240719$20240719$EXP$$ZA-AstraZeneca-2024A159311$ASTRAZENECA$$30315$DY$$M$Y$$$20240719$$CN$ZA$
241123311$24112331$1$I$$20240716$20240719$20240719$EXP$$VN-AstraZeneca-2024A163438$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$VN$
241123321$24112332$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160329$ASTRAZENECA$$$$$M$Y$$$20240719$$MD$US$
241123331$24112333$1$I$$20221123$20240719$20240719$EXP$$US-AstraZeneca-2022A389792$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123341$24112334$1$I$$20190705$20240719$20240719$EXP$$GT-AstraZeneca-2019SE98864$ASTRAZENECA$$73$YR$$F$Y$$$20240719$$CN$GT$
241123351$24112335$1$I$20201022$20201022$20240719$20240719$EXP$$ID-AstraZeneca-2020SF39415$ASTRAZENECA$$19166$DY$$F$Y$$$20240719$$CN$ID$
241123361$24112336$1$I$$20201026$20240719$20240719$EXP$$US-AstraZeneca-2020SF41192$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123371$24112337$1$I$$20240715$20240719$20240719$EXP$$US-TAKEDA-2024TUS072301$TAKEDA$$40$YR$$M$Y$$$20240719$$CN$US$US
241123381$24112338$1$I$$20240710$20240719$20240719$PER$$US-AstraZeneca-2024A159396$ASTRAZENECA$$$$$M$Y$$$20240719$$MD$US$
241123391$24112339$1$I$$20200218$20240719$20240719$EXP$$US-AstraZeneca-2020SE26982$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123401$24112340$1$I$20240714$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024141013$AMGEN$$$$$$Y$$$20240719$$CN$US$US
241123411$24112341$1$I$20230101$20240712$20240719$20240719$EXP$$GB-AstraZeneca-2024A159908$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$GB$
241123431$24112343$1$I$$20201030$20240719$20240719$EXP$$US-AstraZeneca-2020SF44272$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123441$24112344$1$I$$20240711$20240719$20240719$EXP$$ZA-AstraZeneca-2024A159546$ASTRAZENECA$$50$YR$$M$Y$$$20240719$$CN$ZA$
241123451$24112345$1$I$$20201102$20240719$20240719$EXP$$US-AstraZeneca-2020SF46432$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123462$24112346$2$F$$20240812$20240719$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112004$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240819$$CN$US$US
241123471$24112347$1$I$$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024141988$AMGEN$$$$$M$Y$$$20240719$$CN$US$US
241123481$24112348$1$I$$20240718$20240719$20240719$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114824$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$67$KG$20240719$$HP$CA$CA
241123492$24112349$2$F$20240627$20240722$20240719$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106598$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240726$$PH$JP$JP
241123501$24112350$1$I$20180401$20201119$20240719$20240719$EXP$$US-AstraZeneca-2020SF54998$ASTRAZENECA$$658$MON$$F$Y$77.1$KG$20240719$$CN$US$
241123511$24112351$1$I$20200707$20200707$20240719$20240719$EXP$$AU-AstraZeneca-2020SE87809$ASTRAZENECA$$24258$DY$$F$Y$$$20240719$$CN$AU$
241123521$24112352$1$I$$20201125$20240719$20240719$EXP$$US-AstraZeneca-2020SF58777$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123531$24112353$1$I$$20201221$20240719$20240719$EXP$$US-AstraZeneca-2020SF72399$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241123541$24112354$1$I$$20201207$20240719$20240719$EXP$$GB-AstraZeneca-2020SF65237$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$GB$
241123551$24112355$1$I$$20200811$20240719$20240719$EXP$$US-AstraZeneca-2020SF02790$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123561$24112356$1$I$$20200720$20240719$20240719$EXP$$US-AstraZeneca-2020SE92220$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123601$24112360$1$I$$20230324$20240719$20240719$EXP$$US-AstraZeneca-2023A071012$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123611$24112361$1$I$$20240711$20240719$20240719$EXP$$ZA-AstraZeneca-2024A159472$ASTRAZENECA$$23376$DY$$F$Y$$$20240719$$CN$ZA$
241123621$24112362$1$I$$20210111$20240719$20240719$EXP$$US-AstraZeneca-2021A005484$ASTRAZENECA$$$$$$Y$$$20240719$$HP$US$
241123631$24112363$1$I$$20200721$20240719$20240719$EXP$$US-AstraZeneca-2020SE93036$ASTRAZENECA$$$$$F$Y$73.5$KG$20240719$$CN$US$
241123641$24112364$1$I$$20191222$20240719$20240719$EXP$$RU-AstraZeneca-2019SF88249$ASTRAZENECA$$78$YR$$M$Y$67$KG$20240719$$CN$RU$
241123651$24112365$1$I$$20240715$20240719$20240719$EXP$$GR-AMGEN-GRCSP2024140929$AMGEN$$28$YR$A$F$Y$$$20240719$$MD$GR$GR
241123661$24112366$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160441$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241123671$24112367$1$I$$20240715$20240719$20240719$EXP$$ZA-AstraZeneca-2024A161247$ASTRAZENECA$$73$YR$$M$Y$$$20240719$$CN$ZA$
241123681$24112368$1$I$$20240712$20240719$20240719$EXP$$US-AMGEN-USASP2024139110$AMGEN$$$$$M$Y$$$20240719$$CN$US$US
241123691$24112369$1$I$$20210223$20240719$20240719$EXP$$US-AstraZeneca-2021A087543$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241123701$24112370$1$I$$20200825$20240719$20240719$EXP$$US-AstraZeneca-2020SF09241$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123711$24112371$1$I$$20201006$20240719$20240719$EXP$$US-AstraZeneca-2020SF31250$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123721$24112372$1$I$$20230404$20240719$20240719$EXP$$US-AstraZeneca-2023A081042$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241123731$24112373$1$I$$20240712$20240719$20240719$EXP$$ZA-AstraZeneca-2024A160105$ASTRAZENECA$$57$YR$$M$Y$$$20240719$$CN$ZA$
241123741$24112374$1$I$$20201119$20240719$20240719$EXP$$US-AstraZeneca-2020SF55078$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123751$24112375$1$I$$20201125$20240719$20240719$EXP$$US-AstraZeneca-2020SF58866$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241123761$24112376$1$I$$20201223$20240719$20240719$EXP$$US-AstraZeneca-2020SF73885$ASTRAZENECA$$$$$F$Y$77.1$KG$20240719$$CN$US$
241123771$24112377$1$I$$20240712$20240719$20240719$EXP$$US-AMGEN-USASP2024140757$AMGEN$Sener U.; Webb L.M.; Webb M.J. et al.. A case series of osseous metastases in patients with glioblastoma. Medicine. 2024;103 (27):1-7$51$YR$A$F$Y$$$20240719$$MD$US$US
241123781$24112378$1$I$$20230103$20240719$20240719$EXP$$US-AstraZeneca-2022A382138$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241123791$24112379$1$I$$20200625$20240719$20240719$EXP$$US-AstraZeneca-2020SE76312$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241123801$24112380$1$I$$20230419$20240719$20240719$EXP$$US-AstraZeneca-2023A092557$ASTRAZENECA$$$$$F$Y$39.9$KG$20240719$$CN$US$
241123811$24112381$1$I$$20240716$20240719$20240719$EXP$$US-AstraZeneca-2024A162477$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241123821$24112382$1$I$$20210113$20240719$20240719$EXP$$TW-AstraZeneca-2021A007430$ASTRAZENECA$$46$YR$$F$Y$$$20240719$$CN$TW$
241123831$24112383$1$I$20240604$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024141077$AMGEN$$66$YR$E$F$Y$$$20240719$$CN$US$US
241123841$24112384$1$I$$20221213$20240719$20240719$EXP$$US-AstraZeneca-2022A407567$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123851$24112385$1$I$$20210311$20240719$20240719$EXP$$CA-AstraZeneca-2021A131404$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$CA$
241123861$24112386$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160084$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123871$24112387$1$I$$20200130$20240719$20240719$EXP$$US-AstraZeneca-2019SF46404$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241123883$24112388$3$F$20240701$20240809$20240719$20240904$PER$$US-AstraZeneca-2024A158263$ASTRAZENECA$$908$MON$$F$Y$$$20240904$$CN$US$
241123891$24112389$1$I$$20210121$20240719$20240719$EXP$$US-AstraZeneca-2021A016264$ASTRAZENECA$$$$$F$Y$$$20240719$$HP$US$
241123901$24112390$1$I$$20221209$20240719$20240719$EXP$$RU-AstraZeneca-2022A408220$ASTRAZENECA$$50$YR$$F$Y$$$20240719$$MD$RU$
241123911$24112391$1$I$20190911$20191230$20240719$20240719$EXP$$CO-AstraZeneca-2019SF91731$ASTRAZENECA$$28242$DY$$M$Y$$$20240719$$CN$CO$
241123921$24112392$1$I$20240402$20240712$20240719$20240719$EXP$$FR-AstraZeneca-2024A159680$ASTRAZENECA$$79$YR$$M$Y$69.2$KG$20240719$$MD$FR$
241123931$24112393$1$I$$20201210$20240719$20240719$EXP$$ZA-AstraZeneca-2020SF66381$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$ZA$
241123941$24112394$1$I$$20200827$20240719$20240719$EXP$$GB-AstraZeneca-2020SF10926$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$GB$
241123951$24112395$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160081$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241123961$24112396$1$I$20200801$20201006$20240719$20240719$EXP$$US-AstraZeneca-2020SF31382$ASTRAZENECA$$694$MON$$M$Y$77.1$KG$20240719$$CN$US$
241123971$24112397$1$I$$20201116$20240719$20240719$EXP$$US-AstraZeneca-2020SF54105$ASTRAZENECA$$48$YR$$F$Y$$$20240719$$CN$US$
241123981$24112398$1$I$20230701$20240716$20240719$20240719$EXP$$US-AMGEN-USASP2024142536$AMGEN$$$$$F$Y$$$20240719$$MD$US$US
241123991$24112399$1$I$20240617$20240717$20240719$20240719$PER$$US-AMGEN-USASP2024142099$AMGEN$$84$YR$E$F$Y$$$20240719$$CN$US$US
241124001$24112400$1$I$$20210224$20240719$20240719$EXP$$US-AstraZeneca-2021A092639$ASTRAZENECA$$72$YR$$F$Y$$$20240719$$CN$US$
241124011$24112401$1$I$$20191209$20240719$20240719$EXP$$US-AstraZeneca-2019SF79659$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241124021$24112402$1$I$$20220816$20240719$20240719$EXP$$US-AstraZeneca-2022A289523$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124031$24112403$1$I$$20190813$20240719$20240719$EXP$$US-AstraZeneca-2019SF17201$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124041$24112404$1$I$$20230524$20240719$20240719$EXP$$US-AstraZeneca-2023A123312$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124051$24112405$1$I$20240701$20240711$20240719$20240719$EXP$$BE-AstraZeneca-2024A161396$ASTRAZENECA$$$$$M$Y$$$20240719$$MD$BE$
241124061$24112406$1$I$20200815$20200915$20240719$20240719$EXP$$US-AstraZeneca-2020SF19072$ASTRAZENECA$$16236$DY$$F$Y$95.7$KG$20240719$$CN$US$
241124071$24112407$1$I$$20190718$20240719$20240719$EXP$$US-AstraZeneca-2019SF05252$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124081$24112408$1$I$$20201124$20240719$20240719$EXP$$US-AstraZeneca-2020SF61279$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$US$
241124091$24112409$1$I$$20230524$20240719$20240719$EXP$$US-AstraZeneca-2023A120972$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241124101$24112410$1$I$20200830$20201030$20240719$20240719$EXP$$SG-AstraZeneca-2020SF44460$ASTRAZENECA$$26173$DY$$M$Y$$$20240719$$CN$SG$
241124111$24112411$1$I$$20240711$20240719$20240719$EXP$$JP-AstraZeneca-2024A159636$ASTRAZENECA$$84$YR$$M$Y$$$20240719$$MD$JP$
241124121$24112412$1$I$$20210104$20240719$20240719$EXP$$US-AstraZeneca-2021A002430$ASTRAZENECA$$51$YR$$F$Y$$$20240719$$HP$US$
241124132$24112413$2$F$20240601$20240716$20240719$20240724$EXP$$JP-AstraZeneca-2024A159622$ASTRAZENECA$$$$$$Y$$$20240724$$MD$JP$
241124141$24112414$1$I$$20240712$20240719$20240719$EXP$$ZA-AstraZeneca-2024A160184$ASTRAZENECA$$22$YR$$F$Y$$$20240719$$CN$ZA$
241124151$24112415$1$I$20190904$20190905$20240719$20240719$EXP$$US-AstraZeneca-2019SF27886$ASTRAZENECA$$19517$DY$$F$Y$$$20240719$$HP$US$
241124161$24112416$1$I$20190601$20190731$20240719$20240719$EXP$$MX-AstraZeneca-2019SF11414$ASTRAZENECA$$802$MON$$M$Y$74$KG$20240719$$CN$MX$
241124171$24112417$1$I$$20191022$20240719$20240719$EXP$$US-AstraZeneca-2019SF52102$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124181$24112418$1$I$20190601$20191204$20240719$20240719$EXP$$CO-AstraZeneca-2019SF76481$ASTRAZENECA$$25512$DY$$F$Y$$$20240719$$CN$CO$
241124191$24112419$1$I$20210101$20210219$20240719$20240719$EXP$$US-AstraZeneca-2021A077639$ASTRAZENECA$$944$MON$$F$Y$69.9$KG$20240719$$CN$US$
241124201$24112420$1$I$20210401$20210610$20240719$20240719$EXP$$US-AstraZeneca-2021A173967$ASTRAZENECA$$28063$DY$$F$Y$$$20240719$$CN$US$
241124211$24112421$1$I$20201215$20210323$20240719$20240719$EXP$$CA-AstraZeneca-2021A207920$ASTRAZENECA$$19809$DY$$F$Y$$$20240719$$CN$CA$
241124221$24112422$1$I$$20200108$20240719$20240719$EXP$$US-AstraZeneca-2019SF75679$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124231$24112423$1$I$$20210202$20240719$20240719$EXP$$US-AstraZeneca-2021A032239$ASTRAZENECA$$43$YR$$F$Y$$$20240719$$CN$US$
241124242$24112424$2$F$$20240813$20240719$20240828$PER$$US-AstraZeneca-2024A143563$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
241124252$24112425$2$F$20240505$20240816$20240719$20240824$EXP$$US-AstraZeneca-2024A163696$ASTRAZENECA$$25247$DY$$M$Y$61.2$KG$20240823$$HP$US$
241124261$24112426$1$I$20200828$20200831$20240719$20240719$EXP$$US-AstraZeneca-2020SF11859$ASTRAZENECA$$20722$DY$$F$Y$$$20240719$$CN$US$
241124271$24112427$1$I$$20200312$20240719$20240719$EXP$$US-AstraZeneca-2020SE37832$ASTRAZENECA$$62$YR$$F$Y$$$20240719$$CN$US$
241124281$24112428$1$I$$20191214$20240719$20240719$EXP$$RU-AstraZeneca-2019SF82527$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$RU$
241124291$24112429$1$I$20240225$20240711$20240719$20240719$EXP$$FR-AstraZeneca-2024A158801$ASTRAZENECA$$17$YR$$M$Y$53$KG$20240719$$MD$FR$
241124301$24112430$1$I$$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024142215$AMGEN$$$$A$$Y$$$20240719$$HP$US$US
241124322$24112432$2$F$20240101$20240719$20240719$20240726$PER$$US-AMGEN-USASP2024142082$AMGEN$$68$YR$E$F$Y$$$20240726$$CN$US$US
241124331$24112433$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A161578$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124341$24112434$1$I$$20221228$20240719$20240719$EXP$$US-AstraZeneca-2022A419675$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124351$24112435$1$I$20240611$20240711$20240719$20240719$EXP$$SI-AstraZeneca-2024A158652$ASTRAZENECA$$80$YR$$F$Y$$$20240719$$MD$SI$
241124361$24112436$1$I$20230401$20230612$20240719$20240719$EXP$$US-AstraZeneca-2023A136196$ASTRAZENECA$$855$MON$$F$Y$$$20240719$$CN$US$
241124372$24112437$2$F$$20221222$20240719$20240821$EXP$$US-AstraZeneca-2022A415369$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
241124381$24112438$1$I$$20240711$20240719$20240719$EXP$$CA-AstraZeneca-2024A160513$ASTRAZENECA$$15$YR$$F$Y$$$20240719$$MD$CA$
241124391$24112439$1$I$20170101$20210113$20240719$20240719$EXP$$US-AstraZeneca-2021A008534$ASTRAZENECA$$66$YR$$M$Y$73$KG$20240719$$CN$US$
241124401$24112440$1$I$20210517$20210517$20240719$20240719$EXP$$ZA-AstraZeneca-2021A442731$ASTRAZENECA$$23948$DY$$F$Y$$$20240719$$CN$ZA$
241124411$24112441$1$I$$20240711$20240719$20240719$EXP$$AT-AstraZeneca-2024A161629$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$AT$
241124421$24112442$1$I$$20240711$20240719$20240719$PER$$US-AstraZeneca-2024A160256$ASTRAZENECA$$$$$M$Y$$$20240719$$MD$US$
241124431$24112443$1$I$$20210314$20240719$20240719$EXP$$CA-AstraZeneca-2021A151836$ASTRAZENECA$$70$YR$$M$Y$$$20240719$$MD$CA$
241124441$24112444$1$I$$20200107$20240719$20240719$EXP$$US-AstraZeneca-2020SE03802$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241124461$24112446$1$I$$20211130$20240719$20240719$EXP$$US-AstraZeneca-2021A850225$ASTRAZENECA$$$$$$Y$$$20240719$$CN$US$
241124471$24112447$1$I$$20200227$20240719$20240719$EXP$$US-AstraZeneca-2020SE31314$ASTRAZENECA$$85$YR$$M$Y$$$20240719$$CN$US$
241124481$24112448$1$I$20221105$20230410$20240719$20240719$EXP$$US-AstraZeneca-2023A045047$ASTRAZENECA$$18618$DY$$$Y$$$20240719$$CN$US$
241124491$24112449$1$I$20240707$20240712$20240719$20240719$EXP$$JP-AstraZeneca-2024A161832$ASTRAZENECA$$71$YR$$M$Y$$$20240719$$MD$JP$
241124501$24112450$1$I$$20201007$20240719$20240719$EXP$$CA-AstraZeneca-2020SF30943$ASTRAZENECA$$74$YR$$M$Y$$$20240719$$MD$CA$
241124511$24112451$1$I$$20230302$20240719$20240719$EXP$$US-AstraZeneca-2023A053187$ASTRAZENECA$$$$$$Y$$$20240719$$CN$US$
241124521$24112452$1$I$$20211229$20240719$20240719$EXP$$US-AstraZeneca-2021A909700$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124531$24112453$1$I$$20190813$20240719$20240719$EXP$$US-AstraZeneca-2019SF17360$ASTRAZENECA$$$$$F$Y$60.3$KG$20240719$$CN$US$
241124541$24112454$1$I$$20240710$20240719$20240719$PER$$US-APELLIS-2024-APL-0000447$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240719$$CN$US$US
241124551$24112455$1$I$$20240712$20240719$20240719$EXP$$JP-AstraZeneca-2024A162270$ASTRAZENECA$$$$$$Y$$$20240719$$PH$JP$
241124561$24112456$1$I$$20230301$20240719$20240719$EXP$$US-AstraZeneca-2023A051554$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124571$24112457$1$I$$20240716$20240719$20240719$EXP$$VN-AstraZeneca-2024A163429$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$VN$
241124581$24112458$1$I$$20240712$20240719$20240719$EXP$$ZA-AstraZeneca-2024A160158$ASTRAZENECA$$20454$DY$$M$Y$$$20240719$$CN$ZA$
241124591$24112459$1$I$20240320$20240717$20240719$20240719$PER$$US-AMGEN-USASP2024143129$AMGEN$$67$YR$E$F$Y$$$20240719$$CN$US$US
241124601$24112460$1$I$$20220316$20240719$20240719$EXP$$TW-AstraZeneca-2022A116199$ASTRAZENECA$$40$YR$$M$Y$$$20240719$$CN$TW$
241124611$24112461$1$I$$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A160111$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241124621$24112462$1$I$$20190717$20240719$20240719$EXP$$AU-AstraZeneca-2019SF03182$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$AU$
241124631$24112463$1$I$$20240715$20240719$20240719$EXP$$US-AstraZeneca-2024A161537$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241124641$24112464$1$I$$20210402$20240719$20240719$EXP$$US-AstraZeneca-2021A280433$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124651$24112465$1$I$$20240716$20240719$20240719$EXP$$ZA-AstraZeneca-2024A162348$ASTRAZENECA$$66$YR$$F$Y$$$20240719$$CN$ZA$
241124663$24112466$3$F$20240718$20240805$20240719$20240806$PER$$US-AMGEN-USASP2024143426$AMGEN$$72$YR$E$F$Y$$$20240806$$CN$US$US
241124671$24112467$1$I$$20220413$20240719$20240719$EXP$$US-AstraZeneca-2022A150571$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124681$24112468$1$I$$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024141824$AMGEN$$$$$F$Y$$$20240719$$HP$US$US
241124691$24112469$1$I$$20200402$20240719$20240719$EXP$$CA-AstraZeneca-2019SF75700$ASTRAZENECA$$$$$F$Y$$$20240719$$HP$CA$
241124701$24112470$1$I$20200101$20210430$20240719$20240719$EXP$$US-AstraZeneca-2021A324710$ASTRAZENECA$$67$YR$$F$Y$$$20240719$$CN$US$
241124721$24112472$1$I$$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A160189$ASTRAZENECA$$$$$F$Y$90.7$KG$20240719$$CN$US$
241124731$24112473$1$I$$20220422$20240719$20240719$EXP$$TW-AstraZeneca-2022A160559$ASTRAZENECA$$64$YR$$M$Y$$$20240719$$CN$TW$
241124741$24112474$1$I$$20240716$20240719$20240719$PER$$US-AstraZeneca-2024A163004$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241124751$24112475$1$I$20230801$20240711$20240719$20240719$EXP$$JP-AstraZeneca-2024A159829$ASTRAZENECA$$80$YR$$M$Y$$$20240719$$HP$JP$
241124761$24112476$1$I$$20191219$20240719$20240719$EXP$$US-AstraZeneca-2019SF67179$ASTRAZENECA$$72$YR$$F$Y$97.5$KG$20240719$$HP$US$
241124771$24112477$1$I$$20240711$20240719$20240719$EXP$$DE-AstraZeneca-2024A159437$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$DE$
241124781$24112478$1$I$20190901$20191126$20240719$20240719$EXP$$US-AstraZeneca-2019SF50979$ASTRAZENECA$$725$MON$$F$Y$$$20240719$$MD$US$
241124791$24112479$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160121$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124802$24112480$2$F$20240710$20240725$20240719$20240801$30DAY$$US-AMGEN-USASP2024139441$AMGEN$$44$YR$A$F$Y$58.957$KG$20240801$$PH$US$US
241124811$24112481$1$I$$20240711$20240719$20240719$EXP$$JP-AstraZeneca-2024A161732$ASTRAZENECA$$$$A$$Y$$$20240719$$MD$JP$
241124821$24112482$1$I$$20230524$20240719$20240719$EXP$$US-AstraZeneca-2023A123363$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124831$24112483$1$I$$20190829$20240719$20240719$EXP$$US-AstraZeneca-2019SE86666$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124842$24112484$2$F$$20240801$20240719$20240808$PER$$US-TRAVERE-2024TVT00714$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240808$$CN$US$US
241124851$24112485$1$I$$20240715$20240719$20240719$EXP$$US-ABBVIE-5843535$ABBVIE$$$$$M$Y$$$20240719$$CN$US$US
241124861$24112486$1$I$$20220629$20240719$20240719$EXP$$US-AstraZeneca-2022A239949$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124871$24112487$1$I$$20200304$20240719$20240719$EXP$$US-AstraZeneca-2020SE35308$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124881$24112488$1$I$$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024142282$AMGEN$$$$$$Y$$$20240718$$CN$US$US
241124891$24112489$1$I$$20220713$20240719$20240719$EXP$$US-AstraZeneca-2022A255341$ASTRAZENECA$$$$$$Y$$$20240719$$HP$US$
241124901$24112490$1$I$$20220923$20240719$20240719$EXP$$US-AstraZeneca-2022A329777$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241124911$24112491$1$I$20240609$20240715$20240719$20240719$EXP$$US-AstraZeneca-2024A161408$ASTRAZENECA$$$$$M$Y$$$20240719$$MD$US$
241124921$24112492$1$I$$20191108$20240719$20240719$EXP$$US-AstraZeneca-2019SF61407$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241124931$24112493$1$I$20220830$20220902$20240719$20240719$EXP$$US-AstraZeneca-2022A307561$ASTRAZENECA$$86$YR$$M$Y$75.4$KG$20240719$$CN$US$
241124951$24112495$1$I$$20230420$20240719$20240719$EXP$$US-AstraZeneca-2023A094509$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241124961$24112496$1$I$20240701$20240708$20240719$20240719$EXP$$CA-HLS-202401700$HLS THERAPEUTICS$$50$YR$A$F$Y$$$20240719$$PH$CA$CA
241124971$24112497$1$I$20240501$20240711$20240719$20240719$EXP$$FR-AstraZeneca-2024A163790$ASTRAZENECA$$51$YR$$F$Y$$$20240719$$MD$FR$
241124981$24112498$1$I$$20240709$20240719$20240719$EXP$$US-RDY-LIT/USA/24/0010387$DR REDDYS$Raza HS, Love JS, Mikolajczyk AE. Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding. ACG Case Reports Journal. 2024 Jun 07;11(6): doi:10.14309/crj.0000000000001378.$38$YR$A$M$Y$$$20240719$$MD$US$US
241125011$24112501$1$I$$20220813$20240719$20240719$EXP$$US-AstraZeneca-2022A287331$ASTRAZENECA$$$$$M$Y$$$20240719$$HP$US$
241125021$24112502$1$I$$20220929$20240719$20240719$EXP$$ES-AstraZeneca-2022A288502$ASTRAZENECA$$48$YR$$F$Y$$$20240719$$CN$ES$
241125031$24112503$1$I$$20240709$20240719$20240719$EXP$$JP-TAKEDA-2024TUS072538$TAKEDA$$5$DEC$$M$Y$$$20240719$$MD$JP$JP
241125041$24112504$1$I$20220101$20220728$20240719$20240719$EXP$$US-AstraZeneca-2022A271448$ASTRAZENECA$$81$YR$$F$Y$$$20240719$$CN$US$
241125051$24112505$1$I$20221103$20221214$20240719$20240719$EXP$$US-AstraZeneca-2022A407930$ASTRAZENECA$$26587$DY$$M$Y$$$20240719$$CN$US$
241125061$24112506$1$I$$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A160185$ASTRAZENECA$$$$$M$Y$$$20240719$$HP$US$
241125071$24112507$1$I$20210503$20210518$20240719$20240719$EXP$$AR-AstraZeneca-2021A448628$ASTRAZENECA$$3287$WK$$F$Y$$$20240719$$CN$AR$
241125081$24112508$1$I$$20211105$20240719$20240719$EXP$$US-AstraZeneca-2021A800784$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125091$24112509$1$I$$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A160639$ASTRAZENECA$$$$$$Y$$$20240719$$MD$US$
241125101$24112510$1$I$$20230203$20240719$20240719$EXP$$US-AstraZeneca-2023A030784$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241125111$24112511$1$I$$20230131$20240719$20240719$EXP$$US-AstraZeneca-2023A026543$ASTRAZENECA$$$$$M$Y$$$20240719$$MD$US$
241125121$24112512$1$I$$20190831$20240719$20240719$EXP$$RU-AstraZeneca-2019SF26139$ASTRAZENECA$$69$YR$$M$Y$60$KG$20240719$$CN$RU$
241125131$24112513$1$I$$20240711$20240719$20240719$PER$$US-APELLIS-2024-APL-0000462$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240719$$CN$US$US
241125141$24112514$1$I$$20200827$20240719$20240719$EXP$$US-AstraZeneca-2020SF10353$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125151$24112515$1$I$$20230306$20240719$20240719$EXP$$US-AstraZeneca-2023A055537$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241125161$24112516$1$I$$20240101$20240719$20240719$EXP$$IL-TEVA-VS-3217091$TEVA$$50$YR$$M$Y$$$20240719$$MD$IL$IL
241125171$24112517$1$I$$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A160435$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125181$24112518$1$I$$20200224$20240719$20240719$EXP$$US-AstraZeneca-2020SE28215$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241125191$24112519$1$I$$20201102$20240719$20240719$EXP$$US-AstraZeneca-2020SF46425$ASTRAZENECA$$$$$F$Y$110.2$KG$20240719$$CN$US$
241125201$24112520$1$I$$20230920$20240719$20240719$EXP$$US-AstraZeneca-2023A215363$ASTRAZENECA$$$$$$Y$$$20240719$$CN$US$
241125211$24112521$1$I$$20240711$20240719$20240719$EXP$$JP-AstraZeneca-2024A159740$ASTRAZENECA$$$$$$Y$$$20240719$$PH$JP$
241125222$24112522$2$F$$20240826$20240719$20240902$EXP$$US-AstraZeneca-2024A160302$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
241125231$24112523$1$I$20240711$20240711$20240719$20240719$EXP$$TH-AstraZeneca-2024A162526$ASTRAZENECA$$23380$DY$$F$Y$$$20240719$$HP$TH$
241125241$24112524$1$I$$20240711$20240719$20240719$EXP$$ZA-AstraZeneca-2024A159393$ASTRAZENECA$$66$YR$$M$Y$$$20240719$$CN$ZA$
241125251$24112525$1$I$20200506$20240716$20240719$20240719$EXP$$PL-AstraZeneca-2024A163241$ASTRAZENECA$$40$YR$$M$Y$80$KG$20240719$$MD$PL$
241125261$24112526$1$I$20200322$20200520$20240719$20240719$EXP$$CA-AstraZeneca-2020SE41929$ASTRAZENECA$$29511$DY$$M$Y$$$20240719$$CN$CA$
241125272$24112527$2$F$$20240716$20240719$20240722$EXP$$DE-AstraZeneca-2024A162732$ASTRAZENECA$$$$$F$Y$$$20240722$$MD$DE$
241125281$24112528$1$I$$20240717$20240719$20240719$PER$$US-JNJFOC-20240747656$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$HP$US$US
241125291$24112529$1$I$$20240718$20240719$20240719$PER$$US-JNJFOC-20240750570$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$HP$US$US
241125301$24112530$1$I$$20230816$20240719$20240719$EXP$$CA-AstraZeneca-2023A169043$ASTRAZENECA$$$$$M$Y$$$20240719$$PH$CA$
241125311$24112531$1$I$20240628$20240712$20240719$20240719$EXP$$JP-AstraZeneca-2024A161804$ASTRAZENECA$$69$YR$$M$Y$$$20240719$$MD$JP$
241125321$24112532$1$I$20240701$20240717$20240719$20240719$EXP$$JP-AstraZeneca-2024A163811$ASTRAZENECA$$66$YR$$M$Y$$$20240719$$MD$JP$
241125331$24112533$1$I$20240701$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160947$ASTRAZENECA$$935$MON$$F$Y$98.9$KG$20240719$$HP$US$
241125341$24112534$1$I$$20200721$20240719$20240719$EXP$$US-AstraZeneca-2020SE92823$ASTRAZENECA$$84$YR$$F$Y$$$20240719$$CN$US$
241125351$24112535$1$I$20240705$20240717$20240719$20240719$EXP$$US-AstraZeneca-2024A163760$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241125362$24112536$2$F$$20240827$20240719$20240903$EXP$$US-AstraZeneca-2024A160257$ASTRAZENECA$$$$$M$Y$99$KG$20240903$$CN$US$
241125371$24112537$1$I$$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A160122$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125381$24112538$1$I$$20200122$20240719$20240719$EXP$$US-AstraZeneca-2020SE12336$ASTRAZENECA$$$$$$Y$$$20240719$$MD$US$
241125392$24112539$2$F$20240127$20240715$20240719$20240813$EXP$$FR-AstraZeneca-2024A164357$ASTRAZENECA$$4$MON$$M$Y$6.1$KG$20240813$$MD$FR$
241125401$24112540$1$I$$20210921$20240719$20240719$EXP$$US-AstraZeneca-2021A735772$ASTRAZENECA$$66$YR$$F$Y$55.8$KG$20240719$$CN$US$
241125411$24112541$1$I$20200407$20200504$20240719$20240719$EXP$$AU-AstraZeneca-2020SE40078$ASTRAZENECA$$2100$WK$$F$Y$$$20240719$$CN$AU$
241125421$24112542$1$I$20240628$20240712$20240719$20240719$EXP$$MX-AstraZeneca-2024A162044$ASTRAZENECA$$15130$DY$$F$Y$87$KG$20240719$$CN$MX$
241125431$24112543$1$I$$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A160816$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$US$
241125441$24112544$1$I$20240626$20240716$20240719$20240719$EXP$$FR-AstraZeneca-2024A163272$ASTRAZENECA$$72$YR$$F$Y$52$KG$20240719$$MD$FR$
241125451$24112545$1$I$20240603$20240712$20240719$20240719$EXP$$CA-AstraZeneca-2024A134243$ASTRAZENECA$$24015$DY$$F$Y$$$20240719$$CN$CA$
241125461$24112546$1$I$20240712$20240712$20240719$20240719$EXP$$CO-AstraZeneca-2024A161543$ASTRAZENECA$$3691$WK$$F$Y$42$KG$20240719$$CN$CO$
241125471$24112547$1$I$$20240716$20240719$20240719$EXP$$US-AstraZeneca-2024A162438$ASTRAZENECA$$$$$M$Y$$$20240719$$MD$US$
241125481$24112548$1$I$20210101$20210927$20240719$20240719$EXP$$US-AstraZeneca-2021A750123$ASTRAZENECA$$62$YR$$$Y$$$20240719$$CN$US$
241125491$24112549$1$I$$20240713$20240719$20240719$EXP$$US-AstraZeneca-2024A164685$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125502$24112550$2$F$20240628$20240809$20240719$20240809$EXP$$MY-AstraZeneca-2024A160402$ASTRAZENECA$$$$$F$Y$$$20240810$$MD$MY$
241125512$24112551$2$F$$20240820$20240719$20240828$EXP$$BR-AstraZeneca-2024A163535$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$BR$
241125531$24112553$1$I$$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A159531$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241125541$24112554$1$I$$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A160336$ASTRAZENECA$$$$$F$Y$$$20240719$$HP$US$
241125551$24112555$1$I$$20240711$20240719$20240719$EXP$$ZA-AstraZeneca-2024A159230$ASTRAZENECA$$78$YR$$F$Y$$$20240719$$CN$ZA$
241125562$24112556$2$F$$20240826$20240719$20240905$PER$$US-AstraZeneca-2024A160243$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
241125571$24112557$1$I$20240614$20240711$20240719$20240719$EXP$$GB-AstraZeneca-2024A158982$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$GB$
241125581$24112558$1$I$$20240712$20240719$20240719$EXP$$DE-AstraZeneca-2024A162863$ASTRAZENECA$$$$$M$Y$$$20240719$$HP$DE$
241125591$24112559$1$I$20240701$20240713$20240719$20240719$EXP$$GB-AstraZeneca-2024A160012$ASTRAZENECA$$26$YR$$F$Y$57$KG$20240719$$MD$GB$
241125601$24112560$1$I$$20240712$20240719$20240719$EXP$$RU-AstraZeneca-2024A161233$ASTRAZENECA$$80$YR$$M$Y$84$KG$20240719$$MD$RU$
241125611$24112561$1$I$$20240712$20240719$20240719$EXP$$VN-AstraZeneca-2024A163121$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$VN$
241125621$24112562$1$I$$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A159269$ASTRAZENECA$$$$$$Y$$$20240719$$CN$US$
241125631$24112563$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160082$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125641$24112564$1$I$$20240711$20240719$20240719$EXP$$ZA-AstraZeneca-2024A160346$ASTRAZENECA$$45$YR$$F$Y$$$20240719$$CN$ZA$
241125651$24112565$1$I$$20211025$20240719$20240719$EXP$$US-AstraZeneca-2021A786190$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241125661$24112566$1$I$20240623$20240712$20240719$20240719$EXP$$CN-AstraZeneca-2024A162092$ASTRAZENECA$$19809$DY$$F$Y$64$KG$20240719$$MD$CN$
241125672$24112567$2$F$$20240906$20240719$20240909$EXP$$AU-AstraZeneca-2024A164182$ASTRAZENECA$Bennett GD, Rosmalen-Brinkley K, Johnstone K, Messina G. Two instances of successful oral desensitisation following hypersensitivity reaction in a patient receiving osimertinib: a case report. Journal of Pharmacy Practice and Research 2024;54(4):328-332.$70$YR$$F$Y$$$20240909$$PH$AU$
241125681$24112568$1$I$$20240712$20240719$20240719$EXP$$DE-AstraZeneca-2024A162599$ASTRAZENECA$$$$$M$Y$$$20240719$$HP$DE$
241125691$24112569$1$I$$20240712$20240719$20240719$EXP$$BR-AstraZeneca-2024A163383$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$BR$
241125701$24112570$1$I$20231101$20240715$20240719$20240719$EXP$$FR-AstraZeneca-2024A164297$ASTRAZENECA$$5$MON$$F$Y$7.3$KG$20240719$$MD$FR$
241125711$24112571$1$I$$20191231$20240719$20240719$EXP$$US-AstraZeneca-2020SE01078$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125721$24112572$1$I$20240702$20240713$20240719$20240719$EXP$$GB-AstraZeneca-2024A160011$ASTRAZENECA$$73$YR$$F$Y$66$KG$20240719$$MD$GB$
241125731$24112573$1$I$$20240716$20240719$20240719$EXP$$JP-AstraZeneca-2024A163210$ASTRAZENECA$$29$YR$$F$Y$$$20240719$$HP$JP$
241125741$24112574$1$I$20181101$20190705$20240719$20240719$EXP$$TH-AstraZeneca-2019SE98500$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$TH$
241125751$24112575$1$I$$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A160252$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125761$24112576$1$I$20240626$20240715$20240719$20240719$EXP$$GB-AstraZeneca-2024A164598$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$GB$
241125801$24112580$1$I$$20230309$20240719$20240719$EXP$$US-AstraZeneca-2023A059320$ASTRAZENECA$$$$$$Y$$$20240719$$CN$US$
241125811$24112581$1$I$20230212$20230217$20240719$20240719$EXP$$US-AstraZeneca-2023A041685$ASTRAZENECA$$25900$DY$$F$Y$$$20240719$$MD$US$
241125821$24112582$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160275$ASTRAZENECA$$$$$M$Y$$$20240719$$MD$US$
241125831$24112583$1$I$$20210415$20240719$20240719$EXP$$AU-AstraZeneca-2021A320524$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$AU$
241125851$24112585$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A162657$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125861$24112586$1$I$$20240711$20240719$20240719$EXP$$ZA-AstraZeneca-2024A160359$ASTRAZENECA$$69$YR$$M$Y$$$20240719$$CN$ZA$
241125871$24112587$1$I$$20200112$20240719$20240719$EXP$$RU-AstraZeneca-2020SE06087$ASTRAZENECA$$65$YR$$M$Y$65$KG$20240719$$CN$RU$
241125881$24112588$1$I$$20190819$20240719$20240719$EXP$$US-AstraZeneca-2019SF19957$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125891$24112589$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A125496$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241125901$24112590$1$I$$20190807$20240719$20240719$EXP$$US-AstraZeneca-2019SF14355$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125911$24112591$1$I$20240628$20240712$20240719$20240719$EXP$$CO-AstraZeneca-2024A162899$ASTRAZENECA$$22458$DY$$F$Y$$$20240719$$CN$CO$
241125921$24112592$1$I$20240612$20240715$20240719$20240719$EXP$$ZA-AstraZeneca-2024A162566$ASTRAZENECA$$72$YR$$F$Y$$$20240719$$CN$ZA$
241125931$24112593$1$I$20190901$20191003$20240719$20240719$EXP$$RU-AstraZeneca-2019SF41716$ASTRAZENECA$$55$YR$$M$Y$$$20240719$$CN$RU$
241125941$24112594$1$I$20191115$20191202$20240719$20240719$EXP$$RU-AstraZeneca-2019SF73155$ASTRAZENECA$$59$YR$$M$Y$$$20240719$$CN$RU$
241125951$24112595$1$I$$20240711$20240719$20240719$EXP$$FR-AstraZeneca-2024A163856$ASTRAZENECA$$31$YR$$M$Y$76$KG$20240719$$MD$FR$
241125961$24112596$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160136$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125973$24112597$3$F$20231215$20240725$20240719$20240811$PER$$US-AMGEN-USASP2024137515$AMGEN$$64$YR$A$M$Y$52.6$KG$20240811$$PH$US$US
241125981$24112598$1$I$$20191226$20240719$20240719$EXP$$US-AstraZeneca-2019SF86683$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241125992$24112599$2$F$20240715$20240719$20240719$20240720$PER$$US-AMGEN-USASP2024143469$AMGEN$$65$YR$E$F$Y$$$20240720$$CN$US$US
241126002$24112600$2$F$$20240719$20240719$20240722$PER$$US-AMGEN-USASP2024143396$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241126011$24112601$1$I$$20240716$20240719$20240719$PER$$US-AstraZeneca-2024A163835$ASTRAZENECA$$68$YR$$F$Y$$$20240719$$HP$US$
241126021$24112602$1$I$$20240712$20240719$20240719$EXP$$US-AMGEN-USASP2024140754$AMGEN$Sener U.; Webb L.M.; Webb M.J. et al.. A case series of osseous metastases in patients with glioblastoma. Medicine. 2024;103 (27):1-7$41$YR$A$M$Y$$$20240719$$MD$US$US
241126032$24112603$2$F$$20240826$20240719$20240831$EXP$$US-AMGEN-USASP2024140709$AMGEN$Sener U.; Webb L.M.; Webb M.J. et al.. A case series of osseous metastases in patients with glioblastoma. Medicine. 2024;103 (27):1-7$20$YR$A$M$Y$$$20240831$$MD$US$US
241126041$24112604$1$I$20240525$20240711$20240719$20240719$EXP$$GB-AstraZeneca-2024A158991$ASTRAZENECA$$72$YR$$M$Y$$$20240719$$MD$GB$
241126051$24112605$1$I$$20240712$20240719$20240719$EXP$$CA-AstraZeneca-2024A163800$ASTRAZENECA$$74$YR$$M$Y$$$20240719$$CN$CA$
241126061$24112606$1$I$20240326$20240626$20240719$20240719$EXP$$SG-AstraZeneca-2024A165074$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$SG$
241126072$24112607$2$F$20240301$20240814$20240719$20240822$EXP$$BR-AstraZeneca-2024A161261$ASTRAZENECA$$79$YR$$F$Y$$$20240822$$CN$BR$
241126081$24112608$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160469$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241126091$24112609$1$I$$20230324$20240719$20240719$EXP$$US-AstraZeneca-2023A034066$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241126101$24112610$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A162304$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241126112$24112611$2$F$$20240911$20240719$20240915$EXP$$CH-AstraZeneca-2024A162214$ASTRAZENECA$$$$$F$Y$$$20240915$$HP$CH$
241126121$24112612$1$I$$20240712$20240719$20240719$EXP$$DE-AstraZeneca-2024A160724$ASTRAZENECA$$$$C$F$Y$$$20240719$$MD$DE$
241126131$24112613$1$I$20240501$20240712$20240719$20240719$EXP$$SE-AstraZeneca-2024A159746$ASTRAZENECA$$73$YR$$M$Y$$$20240719$$MD$SE$
241126141$24112614$1$I$20190816$20191203$20240719$20240719$EXP$$BR-AstraZeneca-2019SF22997$ASTRAZENECA$$21245$DY$$F$Y$$$20240719$$CN$BR$
241126151$24112615$1$I$$20191111$20240719$20240719$EXP$$US-AstraZeneca-2019SF62151$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241126161$24112616$1$I$20230801$20240716$20240719$20240719$EXP$$JP-AstraZeneca-2023A257476$ASTRAZENECA$$$$$F$Y$$$20240719$$MD$JP$
241126171$24112617$1$I$$20220113$20240719$20240719$EXP$$US-AstraZeneca-2022A023713$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241126181$24112618$1$I$20240701$20240716$20240719$20240719$EXP$$ZA-AstraZeneca-2024A162375$ASTRAZENECA$$86$YR$$F$Y$$$20240719$$CN$ZA$
241126192$24112619$2$F$$20240902$20240719$20240910$EXP$$JP-AstraZeneca-2024A159291$ASTRAZENECA$$$$$$Y$$$20240910$$PH$JP$
241126201$24112620$1$I$20240602$20240715$20240719$20240719$EXP$$US-AstraZeneca-2024A161681$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241126211$24112621$1$I$$20240115$20240719$20240719$EXP$$CA-AstraZeneca-2023A095388$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$CA$
241126222$24112622$2$F$20231231$20240709$20240719$20240726$EXP$$BE-AstraZeneca-2024A160572$ASTRAZENECA$$85$YR$$M$Y$$$20240726$$CN$BE$
241126241$24112624$1$I$20240625$20240711$20240719$20240719$EXP$$ES-AstraZeneca-2024A165063$ASTRAZENECA$$22$YR$$M$Y$$$20240719$$MD$ES$
241126252$24112625$2$F$$20240731$20240719$20240812$EXP$$CA-AstraZeneca-2024A160806$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$CA$
241126261$24112626$1$I$$20240716$20240719$20240719$EXP$$US-AstraZeneca-2024A162485$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241126271$24112627$1$I$20240407$20240711$20240719$20240719$EXP$$US-AstraZeneca-2024A135215$ASTRAZENECA$$75$YR$$M$Y$61.2$KG$20240719$$CN$US$
241126282$24112628$2$F$20240501$20240716$20240719$20240722$EXP$$JP-AstraZeneca-2024A163303$ASTRAZENECA$$$$E$F$Y$$$20240722$$MD$JP$
241126291$24112629$1$I$20220201$20230123$20240719$20240719$EXP$$US-AstraZeneca-2023A020290$ASTRAZENECA$$949$MON$$F$Y$$$20240719$$CN$US$
241126301$24112630$1$I$$20240712$20240719$20240719$PER$$US-INCYTE CORPORATION-2024IN007387$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241126311$24112631$1$I$20240706$20240716$20240719$20240719$EXP$$CO-AstraZeneca-2024A163796$ASTRAZENECA$$20286$DY$$F$Y$$$20240719$$CN$CO$
241126321$24112632$1$I$20190101$20200903$20240719$20240719$EXP$$BR-AstraZeneca-2020SF13703$ASTRAZENECA$$$$E$M$Y$$$20240719$$CN$BR$
241126331$24112633$1$I$20240101$20240712$20240719$20240719$PER$$US-ALXN-202407USA000934US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$HP$US$US
241126341$24112634$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160133$ASTRAZENECA$$$$A$F$Y$122.5$KG$20240719$$CN$US$
241126351$24112635$1$I$20240704$20240715$20240719$20240719$30DAY$$US-GSK-US2024088628$GLAXOSMITHKLINE$$61$YR$$M$Y$$$20240719$$CN$US$US
241126361$24112636$1$I$$20210325$20240719$20240719$EXP$$AU-AstraZeneca-2021A224664$ASTRAZENECA$$$$E$M$Y$$$20240719$$CN$AU$
241126371$24112637$1$I$$20240716$20240719$20240719$EXP$$VN-AstraZeneca-2024A163458$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$VN$
241126381$24112638$1$I$$20200923$20240719$20240719$EXP$$US-AstraZeneca-2020SF24519$ASTRAZENECA$$62$YR$$F$Y$$$20240719$$CN$US$
241126391$24112639$1$I$$20191030$20240719$20240719$EXP$$US-AstraZeneca-2019SF55500$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241126401$24112640$1$I$20240101$20240712$20240719$20240719$EXP$$RU-BAYER-2024A101253$BAYER$$36$YR$A$F$Y$$$20240719$$PH$RU$RU
241126411$24112641$1$I$20220101$20240711$20240719$20240719$EXP$$MX-AstraZeneca-2024A139762$ASTRAZENECA$$657$MON$$F$Y$$$20240719$$CN$MX$
241126421$24112642$1$I$20240708$20240712$20240719$20240719$EXP$$CO-AstraZeneca-2024A161472$ASTRAZENECA$$31696$DY$$F$Y$$$20240719$$CN$CO$
241126431$24112643$1$I$$20240715$20240719$20240719$EXP$$US-AstraZeneca-2024A161489$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241126441$24112644$1$I$$20210331$20240719$20240719$EXP$$CA-AstraZeneca-2020SE02389$ASTRAZENECA$$41$YR$$M$Y$$$20240719$$MD$CA$
241126452$24112645$2$F$$20240717$20240719$20240722$PER$$NVSC2024US147894$NOVARTIS$$$$$$Y$$$20240722$$CN$US$US
241126461$24112646$1$I$$20240715$20240719$20240719$EXP$$GB-ABBVIE-5842391$ABBVIE$$$$A$F$Y$$$20240719$$CN$GB$GB
241126471$24112647$1$I$$20240709$20240719$20240719$PER$$US-MYLANLABS-2024M1065079$MYLAN$$$$$F$Y$68.04$KG$20240719$$CN$US$US
241126491$24112649$1$I$20240219$20240712$20240719$20240719$EXP$$FR-AstraZeneca-2024A164649$ASTRAZENECA$$21$YR$$F$Y$$$20240719$$MD$FR$
241126501$24112650$1$I$$20191011$20240719$20240719$EXP$$US-AstraZeneca-2019SF46888$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241126521$24112652$1$I$20240609$20240711$20240719$20240719$EXP$$CN-AstraZeneca-2024A161914$ASTRAZENECA$$30061$DY$$M$Y$58$KG$20240719$$MD$CN$
241126531$24112653$1$I$20240711$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024142488$AMGEN$$80$YR$E$F$Y$$$20240718$$CN$US$US
241126541$24112654$1$I$20240708$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024141402$AMGEN$$75$YR$E$F$Y$$$20240719$$CN$US$US
241126551$24112655$1$I$$20240716$20240719$20240719$EXP$$US-AMGEN-USASP2024141952$AMGEN$$$$$M$Y$$$20240719$$HP$US$US
241126561$24112656$1$I$20240711$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024142620$AMGEN$$$$$$Y$$$20240719$$CN$US$US
241126574$24112657$4$F$20240709$20240724$20240719$20240731$EXP$$US-AMGEN-USASP2024139440$AMGEN$$78$YR$E$M$Y$$$20240731$$PH$US$US
241126581$24112658$1$I$20240716$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024142294$AMGEN$$68$YR$E$M$Y$$$20240719$$CN$US$US
241126591$24112659$1$I$20240716$20240717$20240719$20240719$PER$$US-AMGEN-USASP2024142793$AMGEN$$77$YR$E$M$Y$$$20240719$$CN$US$US
241126614$24112661$4$F$20240716$20240830$20240719$20240902$PER$$US-AMGEN-USASP2024142308$AMGEN$$63$YR$A$F$Y$$$20240902$$CN$US$US
241126622$24112662$2$F$20240101$20240722$20240719$20240726$EXP$$US-ABBVIE-5843662$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241126631$24112663$1$I$$20240703$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107296$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240719$$HP$US$US
241126641$24112664$1$I$20240709$20240711$20240719$20240719$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-112253$BRISTOL MYERS SQUIBB$$97$YR$E$F$Y$57.6$KG$20240719$$PH$CA$CA
241126652$24112665$2$F$20240701$20240717$20240719$20240726$PER$$US-AMGEN-USASP2024142868$AMGEN$$45$YR$A$M$Y$$$20240726$$CN$US$US
241126661$24112666$1$I$$20240716$20240719$20240719$EXP$$US-TAKEDA-2024TUS072134$TAKEDA$$$$$M$Y$$$20240719$$CN$US$US
241126671$24112667$1$I$20240715$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024141562$AMGEN$$59$YR$A$F$Y$$$20240719$$HP$US$US
241126682$24112668$2$F$20240101$20240726$20240719$20240731$PER$$US-AMGEN-USASP2024141231$AMGEN$$72$YR$E$F$Y$$$20240731$$MD$US$US
241126691$24112669$1$I$20240506$20240712$20240719$20240719$EXP$$ES-AstraZeneca-2024A165023$ASTRAZENECA$$67$YR$$F$Y$69.1$KG$20240719$$MD$ES$
241126701$24112670$1$I$$20240711$20240719$20240719$PER$$US-SMPA-2024SPA000137$SUNOVION$$$$$$Y$$$20240719$$CN$US$US
241126711$24112671$1$I$$20240708$20240719$20240719$PER$$US-SMPA-2024SPA000124$SUNOVION$$$$$$Y$$$20240719$$CN$US$US
241126721$24112672$1$I$20240101$20240715$20240719$20240719$EXP$SE-SEMPA-2024-005389$SE-BAYER-2024A101167$BAYER$$24$YR$A$F$Y$65$KG$20240719$$CN$SE$SE
241126731$24112673$1$I$20240616$20240715$20240719$20240719$EXP$$CO-ABBVIE-5844431$ABBVIE$$52$YR$$M$Y$70$KG$20240719$$HP$CO$CO
241126741$24112674$1$I$$20240716$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113681$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240719$$HP$US$US
241126751$24112675$1$I$$20240710$20240719$20240719$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111702$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240719$$CN$US$US
241126761$24112676$1$I$$20240711$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111453$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240719$$PH$US$US
241126781$24112678$1$I$$20240719$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115134$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240719$$CN$US$US
241126791$24112679$1$I$20240707$20240717$20240719$20240719$PER$$US-AMGEN-USASP2024142538$AMGEN$$62$YR$A$F$Y$$$20240719$$CN$US$US
241126801$24112680$1$I$20240301$20240716$20240719$20240719$EXP$$EG-ABBVIE-5843949$ABBVIE$$41$YR$$F$Y$$$20240719$$CN$EG$EG
241126811$24112681$1$I$20240101$20240715$20240719$20240719$EXP$$GB-AMGEN-GBRSP2024140357$AMGEN$$27$YR$A$F$Y$$$20240719$$PH$GB$GB
241126821$24112682$1$I$$20240710$20240719$20240719$EXP$$FR-AMGEN-FRASP2024138907$AMGEN$$$$$F$Y$$$20240719$$MD$FR$FR
241126831$24112683$1$I$20240527$20240712$20240719$20240719$EXP$$US-Vifor (International) Inc.-VIT-2024-06299$VIFOR$$81$YR$$F$Y$61.5$KG$20240719$$HP$US$US
241126841$24112684$1$I$20240715$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024140087$AMGEN$$$$$F$Y$$$20240719$$CN$US$US
241126852$24112685$2$F$$20240726$20240719$20240731$EXP$$US-BAYER-2024A105213$BAYER$$$$$M$Y$$$20240731$$CN$US$US
241126861$24112686$1$I$$20240711$20240719$20240719$EXP$$IL-AMGEN-ISRSP2024140587$AMGEN$$76$YR$E$M$Y$$$20240719$$MD$IL$IL
241126872$24112687$2$F$$20240726$20240719$20240731$EXP$$US-AMGEN-USASP2024140640$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241126881$24112688$1$I$$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024141697$AMGEN$$$$A$F$Y$$$20240719$$CN$US$US
241126891$24112689$1$I$$20240717$20240719$20240719$PER$$US-JNJFOC-20240749702$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$HP$US$US
241126901$24112690$1$I$$20240718$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115210$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240719$$CN$US$US
241126921$24112692$1$I$$20240718$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115315$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240719$$HP$US$US
241126931$24112693$1$I$$20240717$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115274$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240719$$CN$US$US
241126941$24112694$1$I$$20240718$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115440$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240719$$CN$US$US
241126952$24112695$2$F$$20240816$20240719$20240823$PER$$US-RDY-CLI/USA/23/0161672$DR REDDYS$$25$YR$A$F$Y$$$20240823$$MD$US$US
241126961$24112696$1$I$20240622$20240705$20240719$20240719$EXP$$CA-HLS-202401688$HLS THERAPEUTICS$$67$YR$E$F$Y$$$20240719$$HP$CA$CA
241126971$24112697$1$I$20240716$20240716$20240719$20240719$PER$$NVSC2024US147506$NOVARTIS$$63$YR$$F$Y$$$20240719$$CN$US$US
241126981$24112698$1$I$20240716$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024143178$AMGEN$$63$YR$A$F$Y$$$20240719$$CN$US$US
241126991$24112699$1$I$$20240712$20240719$20240719$PER$$US-AMGEN-USASP2024140590$AMGEN$$$$$$Y$$$20240719$$HP$US$US
241127001$24112700$1$I$$20240711$20240719$20240719$EXP$$DE-AMGEN-DEUSP2024138710$AMGEN$Reichel F.; Tesch F.; Berger S. et al.. Epidemiology and risk factors of community-acquired pneumonia in patients with different causes of immunosuppression. Infection. 2024;1-12$$$$$Y$$$20240719$$HP$DE$DE
241127012$24112701$2$F$$20240719$20240719$20240723$PER$$US-AMGEN-USASP2024143134$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241127021$24112702$1$I$20240714$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024141098$AMGEN$$60$YR$A$M$Y$$$20240719$$CN$US$US
241127031$24112703$1$I$$20240710$20240719$20240719$EXP$$US-JNJFOC-20240729703$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$HP$US$US
241127041$24112704$1$I$$20240718$20240719$20240719$PER$$NVSC2024US149088$NOVARTIS$$$$$F$Y$$$20240719$$MD$US$US
241127051$24112705$1$I$20240715$20240716$20240719$20240719$EXP$$NVSC2024GH148275$NOVARTIS$$10$YR$$M$Y$51$KG$20240719$$MD$GH$GH
241127071$24112707$1$I$$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024141366$AMGEN$$$$$$Y$$$20240719$$CN$US$US
241127081$24112708$1$I$20240715$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024140615$AMGEN$$83$YR$E$M$Y$$$20240719$$CN$US$US
241127091$24112709$1$I$20240701$20240715$20240719$20240719$EXP$$MX-AMGEN-MEXSP2024141568$AMGEN$$$$A$M$Y$$$20240719$$MD$MX$MX
241127101$24112710$1$I$20240713$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024142323$AMGEN$$66$YR$E$F$Y$$$20240719$$CN$US$US
241127112$24112711$2$F$20240501$20240731$20240719$20240808$EXP$$JP-AstraZeneca-2024A161729$ASTRAZENECA$$77$YR$$M$Y$$$20240808$$MD$JP$
241127121$24112712$1$I$20220601$20240715$20240719$20240719$EXP$$PL-BAYER-2024A104484$BAYER$$$$$M$Y$$$20240719$$HP$PL$PL
241127131$24112713$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A164233$ASTRAZENECA$Athipatla V., Hall A., Dahiya M., Narra K.. PP01.93 RET fusion as a treatable resistance mechanism in EGFR mutation lung cancer - A case report. Journal of Thoracic Oncology 2024;19(7):e41-.$60$YR$$M$Y$$$20240719$$HP$US$
241127141$24112714$1$I$$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024141772$AMGEN$$$$$M$Y$$$20240718$$CN$US$US
241127151$24112715$1$I$20240705$20240712$20240719$20240719$EXP$$CN-AstraZeneca-2024A163146$ASTRAZENECA$$27899$DY$$F$Y$55$KG$20240719$$MD$CN$
241127161$24112716$1$I$20240715$20240715$20240719$20240719$EXP$$US-OTSUKA-2024_017123$OTSUKA$$$$$F$Y$$$20240719$$CN$US$US
241127172$24112717$2$F$$20240712$20240719$20240805$PER$$US-INCYTE CORPORATION-2024IN007386$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241127191$24112719$1$I$20240717$20240717$20240719$20240719$PER$$US-AMGEN-USASP2024142616$AMGEN$$67$YR$E$M$Y$$$20240719$$CN$US$US
241127202$24112720$2$F$$20240719$20240719$20240726$EXP$$US-AMGEN-USASL2024139167$AMGEN$$62$YR$A$M$Y$$$20240726$$CN$US$US
241127211$24112721$1$I$20240715$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024141193$AMGEN$$51$YR$A$F$Y$$$20240719$$CN$US$US
241127221$24112722$1$I$$20240718$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115351$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240719$$CN$US$US
241127231$24112723$1$I$$20240712$20240719$20240719$PER$$US-INCYTE CORPORATION-2024IN007382$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241127241$24112724$1$I$20230913$20240715$20240719$20240719$EXP$$AU-009507513-2407AUS011283$MERCK$$43$YR$$F$Y$$$20240719$$MD$AU$AU
241127251$24112725$1$I$20230113$20240712$20240719$20240719$EXP$$US-AMGEN-USASP2024139892$AMGEN$$58$YR$A$F$Y$$$20240719$$HP$US$US
241127262$24112726$2$F$20240101$20240806$20240719$20240813$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003938$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240813$$CN$US$US
241127271$24112727$1$I$20240501$20240716$20240719$20240719$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003950$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240719$$CN$US$US
241127291$24112729$1$I$$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024141459$AMGEN$$$$$$Y$$$20240719$$PH$US$US
241127301$24112730$1$I$20240717$20240717$20240719$20240719$PER$$US-AMGEN-USASP2024142655$AMGEN$$67$YR$E$M$Y$$$20240719$$CN$US$US
241127315$24112731$5$F$20240628$20240819$20240719$20240823$EXP$$FR-AMGEN-FRASP2024142206$AMGEN$$53$YR$A$F$Y$$$20240823$$MD$FR$FR
241127322$24112732$2$F$$20240801$20240719$20240812$PER$$US-MYLANLABS-2024M1065131$MYLAN$$$$$F$Y$$$20240812$$MD$US$US
241127333$24112733$3$F$20211001$20240723$20240719$20240731$EXP$$FR-DSJP-DSE-2024-135986$DAIICHI$$$$$F$Y$$$20240731$$MD$FR$FR
241127341$24112734$1$I$20240716$20240716$20240719$20240719$EXP$$CA-AstraZeneca-2024A163575$ASTRAZENECA$$10727$DY$$F$Y$$$20240719$$CN$CA$
241127355$24112735$5$F$20230101$20240920$20240719$20240925$EXP$$CN-TAKEDA-2023TUS052791$TAKEDA$$79$YR$$M$Y$65$KG$20240925$$MD$CN$CN
241127361$24112736$1$I$$20240716$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113600$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240719$$CN$US$US
241127371$24112737$1$I$$20240711$20240719$20240719$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110818$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240719$$HP$CA$CA
241127381$24112738$1$I$20240501$20240711$20240719$20240719$EXP$$US-BEH-2024173850$CSL BEHRING$$66$YR$E$F$Y$100.68$KG$20240719$$HP$US$US
241127392$24112739$2$F$$20240712$20240719$20240719$EXP$$US-OTSUKA-2024_019880$OTSUKA$$$$$F$Y$$$20240719$$CN$US$US
241127402$24112740$2$F$20220708$20240809$20240719$20240813$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136614$DAIICHI$$77$YR$$F$Y$$$20240813$$MD$US$US
241127411$24112741$1$I$20240715$20240716$20240719$20240719$PER$$US-AMGEN-USASP2024142103$AMGEN$$50$YR$A$M$Y$$$20240719$$CN$US$US
241127421$24112742$1$I$$20240712$20240719$20240719$PER$$US-INCYTE CORPORATION-2024IN007378$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241127431$24112743$1$I$20240615$20240715$20240719$20240719$EXP$$CN-DSJP-DSJ-2024-135789$DAIICHI$$53$YR$$F$Y$74$KG$20240719$$HP$CN$CN
241127441$24112744$1$I$20240515$20240716$20240719$20240719$EXP$FR-AFSSAPS-LL2024001262$FR-DSJP-DSE-2024-135952$DAIICHI$$47$YR$$F$Y$84$KG$20240719$$MD$FR$FR
241127452$24112745$2$F$$20240731$20240719$20240806$EXP$$JP-DSJP-DSJ-2024-135541$DAIICHI$Akamatsu K, Hirata M, Kato S, Katayama Y. EP-0713 A case of Trastuzumab Deruxtecan for HER2 low metastatic recurrent breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024$73$YR$$F$Y$$$20240806$$MD$JP$JP
241127461$24112746$1$I$20230411$20240716$20240719$20240719$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-099750$REGENERON$$88$YR$$F$Y$$$20240719$$CN$CH$CH
241127471$24112747$1$I$$20240711$20240719$20240719$PER$$US-INCYTE CORPORATION-2024IN007333$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241127482$24112748$2$F$$20240809$20240719$20240823$PER$$US-INCYTE CORPORATION-2024IN007332$INCYTE$$$$$$Y$$$20240823$$MD$US$US
241127492$24112749$2$F$$20240710$20240719$20240724$EXP$$CH-ELI_LILLY_AND_COMPANY-CH202407007026$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240723$$MD$CH$CH
241127501$24112750$1$I$20230705$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011706$ELI LILLY AND CO$$$$A$M$Y$$$20240719$$CN$US$US
241127511$24112751$1$I$$20240711$20240719$20240719$PER$$US-INCYTE CORPORATION-2024IN007330$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241127531$24112753$1$I$$20240711$20240719$20240719$EXP$$US-BAYER-2024A100488$BAYER$$80$YR$E$M$Y$$$20240719$$CN$US$US
241127541$24112754$1$I$20240101$20240712$20240719$20240719$EXP$$US-OTSUKA-2024_018091$OTSUKA$$$$$F$Y$88.45$KG$20240719$$MD$US$US
241127552$24112755$2$F$$20240822$20240719$20240829$EXP$$JP-OTSUKA-2024_019814$OTSUKA$$$$$$Y$$$20240829$$HP$JP$JP
241127561$24112756$1$I$20231004$20240715$20240719$20240719$EXP$$US-OTSUKA-2023_026183$OTSUKA$$$$$M$Y$$$20240719$$CN$US$US
241127572$24112757$2$F$$20240802$20240719$20240809$EXP$$CA-OTSUKA-2024_019832$OTSUKA$$$$$F$Y$$$20240809$$HP$CA$CA
241127581$24112758$1$I$$20240717$20240719$20240719$PER$$US-TAKEDA-2024TUS072679$TAKEDA$$$$$$Y$$$20240719$$CN$US$US
241127591$24112759$1$I$$20230118$20240719$20240719$EXP$$US-AstraZeneca-2023A015856$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241127601$24112760$1$I$20240704$20240713$20240719$20240719$EXP$$CN-AstraZeneca-2024A163098$ASTRAZENECA$$70$YR$$M$Y$65.5$KG$20240719$$MD$CN$
241127611$24112761$1$I$$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A160293$ASTRAZENECA$$$$$$Y$$$20240719$$CN$US$
241127631$24112763$1$I$$20230331$20240719$20240719$EXP$$US-AstraZeneca-2023A039399$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241127641$24112764$1$I$$20230616$20240719$20240719$EXP$$US-AstraZeneca-2023A104075$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241127651$24112765$1$I$20240418$20240711$20240719$20240719$EXP$$US-BAYER-2024A100713$BAYER$$75$YR$E$M$Y$$$20240719$$CN$US$US
241127661$24112766$1$I$$20240718$20240719$20240719$EXP$$US-DSJP-DSU-2024-136465$DAIICHI$$$$$F$Y$$$20240719$$MD$US$US
241127671$24112767$1$I$$20240711$20240719$20240719$PER$$US-INCYTE CORPORATION-2024IN007326$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241127681$24112768$1$I$20240708$20240708$20240719$20240719$EXP$$PL-GUERBET / LLC-PL-20240045$GUERBET$$55$YR$A$M$Y$$$20240719$$HP$PL$PL
241127691$24112769$1$I$20240624$20240711$20240719$20240719$PER$$US-Eisai-EC-2024-169994$EISAI$$64$YR$A$F$Y$50.1$KG$20240719$$MD$US$US
241127701$24112770$1$I$20240201$20240712$20240719$20240719$PER$$AU-Eisai-EC-2024-170161$EISAI$$62$YR$A$F$Y$$$20240719$$MD$AU$AU
241127711$24112771$1$I$20240705$20240712$20240719$20240719$EXP$IT-MINISAL02-994235$IT-GUERBET / LLC-IT-20240068$GUERBET$$5$YR$C$F$Y$$$20240719$$MD$IT$IT
241127722$24112772$2$F$$20240718$20240719$20240801$EXP$$CH-GUERBET / LLC-CH-20240016$GUERBET$$52$YR$A$M$Y$$$20240801$$HP$CH$CH
241127732$24112773$2$F$$20240710$20240719$20240805$PER$$US-INCYTE CORPORATION-2024IN007324$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241127742$24112774$2$F$$20240809$20240719$20240813$EXP$$JP-OTSUKA-2024_020106$OTSUKA$$41$YR$$F$Y$$$20240813$$PH$JP$JP
241127751$24112775$1$I$20240627$20240718$20240719$20240719$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114808$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240719$$HP$US$US
241127761$24112776$1$I$$20240716$20240719$20240719$PER$$NVSC2024US148155$NOVARTIS$$77$YR$$F$Y$67.986$KG$20240719$$CN$US$US
241127772$24112777$2$F$$20240724$20240719$20240802$EXP$$PT-009507513-2407PRT004772$MERCK$Maia S, Xavier B, Sa M, Antunes E, Morais D, Sampaio J.. Negative Pressure Pulmonary Oedema: An Unexpected Intercurrence.. JOURNAL OF THE PORTUGUESE SOCIETY OF ANAESTHESIOLOGY/REVISTA DA SOCIEDADE PORTUG. 2024;33(S1):49$19$YR$$M$Y$$$20240802$$HP$PT$PT
241127783$24112778$3$F$$20240920$20240719$20240920$30DAY$$CO-PFIZER INC-202400216421$PFIZER$$12$YR$$F$Y$$$20240920$$CN$CO$CO
241127791$24112779$1$I$20240620$20240716$20240719$20240719$EXP$FR-AFSSAPS-LL2024001308$FR-PFIZER INC-202400215930$PFIZER$$76$YR$$F$Y$$$20240719$$MD$FR$FR
241127801$24112780$1$I$$20240712$20240719$20240719$EXP$$JP-PFIZER INC-PV202400091419$PFIZER$$$$$$Y$$$20240719$$PH$JP$JP
241127811$24112781$1$I$$20240717$20240719$20240719$PER$$US-PFIZER INC-PV202400094001$PFIZER$$54$YR$$F$Y$$$20240719$$HP$US$US
241127821$24112782$1$I$$20240712$20240719$20240719$EXP$$CZ-MYLANLABS-2024M1065882$MYLAN$$63$YR$$F$Y$$$20240719$$MD$CZ$CZ
241127831$24112783$1$I$$20240715$20240719$20240719$EXP$$NZ-OTSUKA-2024_020065$OTSUKA$$14$YR$$M$Y$$$20240719$$CN$NZ$NZ
241127844$24112784$4$F$20240901$20240917$20240719$20240920$PER$$US-PFIZER INC-PV202400094541$PFIZER$$65$YR$$F$Y$$$20240920$$HP$US$US
241127851$24112785$1$I$20240601$20240716$20240719$20240719$PER$$US-PFIZER INC-202400216549$PFIZER$$54$YR$$F$Y$68.49$KG$20240719$$CN$US$US
241127865$24112786$5$F$20240201$20240830$20240719$20240904$EXP$$CR-PFIZER INC-PV202400094320$PFIZER$$77$YR$$F$Y$$$20240904$$HP$CR$CR
241127871$24112787$1$I$20200310$20240716$20240719$20240719$EXP$$DE-PFIZER INC-202400215893$PFIZER$$70$YR$$F$Y$$$20240719$$MD$DE$DE
241127882$24112788$2$F$$20240718$20240719$20240723$EXP$$IN-PFIZER INC-PV202400094620$PFIZER$$52$YR$$M$Y$$$20240723$$CN$IN$IN
241127891$24112789$1$I$20230101$20240717$20240719$20240719$EXP$$US-PFIZER INC-202400217605$PFIZER$$$$$F$Y$$$20240719$$CN$US$US
241127903$24112790$3$F$20220101$20240910$20240719$20240913$EXP$$IN-PFIZER INC-PV202200113342$PFIZER$$38$YR$$F$Y$71$KG$20240913$$CN$IN$IN
241127911$24112791$1$I$20240701$20240716$20240719$20240719$EXP$$US-PFIZER INC-202400216352$PFIZER$$88$YR$$M$Y$88.45$KG$20240719$$CN$US$US
241127922$24112792$2$F$$20240807$20240719$20240809$EXP$$HK-PFIZER INC-202400217152$PFIZER$$$$$$Y$$$20240809$$MD$HK$HK
241127931$24112793$1$I$20240701$20240717$20240719$20240719$EXP$$CN-PFIZER INC-PV202400093962$PFIZER$$66$YR$$F$Y$50$KG$20240719$$HP$CN$CN
241127941$24112794$1$I$20240201$20240716$20240719$20240719$EXP$$CA-PFIZER INC-202400192214$PFIZER$$59$YR$$F$Y$$$20240719$$MD$CA$CA
241127951$24112795$1$I$20240428$20240718$20240719$20240719$EXP$$IN-PFIZER INC-PV202400094595$PFIZER$$50$YR$$M$Y$$$20240719$$CN$IN$IN
241127961$24112796$1$I$$20240717$20240719$20240719$PER$$US-PFIZER INC-PV202400094233$PFIZER$$61$YR$$M$Y$$$20240719$$HP$US$US
241127971$24112797$1$I$20240101$20240716$20240719$20240719$EXP$$CA-PFIZER INC-202400217800$PFIZER$$$$$$Y$$$20240719$$HP$CA$CA
241127981$24112798$1$I$$20240718$20240719$20240719$EXP$$PL-PFIZER INC-202400218192$PFIZER$$$$$M$Y$$$20240719$$MD$PL$PL
241127992$24112799$2$F$20240716$20240924$20240719$20240930$EXP$$CA-PFIZER INC-202400216534$PFIZER$$81$YR$$M$Y$$$20240929$$MD$CA$CA
241128001$24112800$1$I$$20240717$20240719$20240719$EXP$$CA-PFIZER INC-202400217675$PFIZER$$$$$F$Y$101$KG$20240719$$CN$CA$CA
241128011$24112801$1$I$$20240717$20240719$20240719$EXP$$JP-PFIZER INC-202400217857$PFIZER$$$$$$Y$$$20240719$$MD$JP$JP
241128021$24112802$1$I$$20240716$20240719$20240719$EXP$$CA-PFIZER INC-PV202300065615$PFIZER$$57$YR$$M$Y$74.5$KG$20240719$$HP$CA$CA
241128031$24112803$1$I$$20240717$20240719$20240719$PER$$US-PFIZER INC-202400217929$PFIZER$$62$YR$$M$Y$113.4$KG$20240719$$PH$US$US
241128041$24112804$1$I$20240301$20240717$20240719$20240719$EXP$$US-PFIZER INC-PV202400094216$PFIZER$$81$YR$$M$Y$$$20240719$$CN$US$US
241128051$24112805$1$I$$20240717$20240719$20240719$PER$$US-BAYER-2024A104228$BAYER$$$$$F$Y$$$20240719$$CN$US$US
241128061$24112806$1$I$$20240718$20240719$20240719$PER$$US-PFIZER INC-PV202400094516$PFIZER$$65$YR$$F$Y$$$20240719$$CN$US$US
241128071$24112807$1$I$$20240717$20240719$20240719$EXP$$CA-PFIZER INC-202400218567$PFIZER$$7$YR$$M$Y$35$KG$20240719$$HP$CA$CA
241128082$24112808$2$F$$20240709$20240719$20240722$EXP$$US-PFIZER INC-PV202400094342$PFIZER$$84$YR$$F$Y$$$20240722$$PH$US$US
241128101$24112810$1$I$$20240717$20240719$20240719$PER$$US-PFIZER INC-PV202400094393$PFIZER$$$$$$Y$$$20240719$$CN$US$US
241128112$24112811$2$F$$20240723$20240719$20240724$PER$$US-PFIZER INC-202400218771$PFIZER$$$$A$F$Y$$$20240724$$MD$US$US
241128121$24112812$1$I$$20240717$20240719$20240719$PER$$US-PFIZER INC-202400217790$PFIZER$$10$YR$$M$Y$$$20240719$$CN$US$US
241128131$24112813$1$I$$20240715$20240719$20240719$EXP$$ES-MYLANLABS-2024M1065984$MYLAN$$$$E$F$Y$$$20240719$$MD$ES$ES
241128141$24112814$1$I$$20240715$20240719$20240719$EXP$PL-URPL-1-3696-2020$PL-MYLANLABS-2024M1066001$MYLAN$$42$YR$$M$Y$150$KG$20240719$$MD$PL$PL
241128151$24112815$1$I$$20240715$20240719$20240719$EXP$$CR-MYLANLABS-2024M1066788$MYLAN$$$$$F$Y$$$20240719$$CN$CR$CR
241128171$24112817$1$I$$20240709$20240719$20240719$EXP$$FR-RDY-LIT/FRA/24/0010376$DR REDDYS$Sahloul O, Louapre C, Beigneux Y, Lubetzki C, Maillart E, Roux T. Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapies. Multiple Sclerosis and Related Disorders. 85: doi:10.1016/j.msard.2024.105557.$$$A$F$Y$$$20240719$$HP$FR$FR
241128181$24112818$1$I$$20240709$20240719$20240719$EXP$$US-RDY-LIT/USA/24/0010383$DR REDDYS$Menon A, Enunwa CA, Read WL, James KP. Rare Delayed Ifosfamide Encephalopathy: A Case Report of Chemotherapeutic Neurotoxicity. Case Reports in Oncology. 2024 Feb 06;17(1): 202-207. doi:10.1159/000535952.$25$YR$A$F$Y$$$20240719$$HP$US$US
241128191$24112819$1$I$20240717$20240718$20240719$20240719$PER$$US-PFIZER INC-202400218914$PFIZER$$56$YR$$M$Y$$$20240719$$CN$US$US
241128203$24112820$3$F$20240920$20240920$20240719$20240925$EXP$$US-PFIZER INC-202400217881$PFIZER$$77$YR$$F$Y$$$20240925$$HP$US$US
241128211$24112821$1$I$20240101$20240716$20240719$20240719$PER$$US-PFIZER INC-202400218257$PFIZER$$20$YR$$M$Y$$$20240719$$MD$US$US
241128221$24112822$1$I$20240601$20240715$20240719$20240719$PER$$US-PFIZER INC-202400216231$PFIZER$$41$YR$$F$Y$$$20240719$$HP$US$US
241128231$24112823$1$I$$20240717$20240719$20240719$PER$$US-PFIZER INC-202400217900$PFIZER$$82$YR$$F$Y$$$20240719$$CN$US$US
241128241$24112824$1$I$$20240718$20240719$20240719$PER$$US-PFIZER INC-202400219000$PFIZER$$36$YR$$F$Y$$$20240719$$HP$US$US
241128251$24112825$1$I$20231215$20240716$20240719$20240719$EXP$$FR-PFIZER INC-202400215938$PFIZER$$60$YR$$F$Y$51$KG$20240719$$MD$FR$FR
241128261$24112826$1$I$$20240717$20240719$20240719$EXP$$CA-PFIZER INC-202400217643$PFIZER$$54$YR$$F$Y$61$KG$20240719$$MD$CA$CA
241128271$24112827$1$I$$20240717$20240719$20240719$PER$$US-PFIZER INC-PV202400094118$PFIZER$$61$YR$$M$Y$$$20240719$$HP$US$US
241128283$24112828$3$F$$20240730$20240719$20240801$PER$$US-PFIZER INC-PV202400094539$PFIZER$$77$YR$$F$Y$$$20240801$$HP$US$US
241128291$24112829$1$I$$20240717$20240719$20240719$PER$$US-PFIZER INC-PV202400094143$PFIZER$$29$YR$$F$Y$$$20240719$$CN$US$US
241128303$24112830$3$F$$20240808$20240719$20240812$PER$$US-PFIZER INC-2024SGN05319$PFIZER$$65$YR$$F$Y$$$20240812$$CN$US$US
241128311$24112831$1$I$$20240718$20240719$20240719$PER$$US-PFIZER INC-202400218995$PFIZER$$51$YR$$M$Y$$$20240719$$CN$US$US
241128335$24112833$5$F$20240628$20240819$20240719$20240822$EXP$$FR-PFIZER INC-202400215928$PFIZER$$53$YR$$F$Y$$$20240822$$MD$FR$FR
241128341$24112834$1$I$20240601$20240715$20240719$20240719$EXP$FR-AFSSAPS-AVNT2024000506$FR-MYLANLABS-2024M1065898$MYLAN$$44$YR$$F$Y$$$20240719$$PH$FR$FR
241128353$24112835$3$F$$20240912$20240719$20240916$30DAY$$US-PFIZER INC-202400213874$PFIZER$$8$YR$$M$Y$$$20240916$$CN$US$US
241128361$24112836$1$I$20240716$20240718$20240719$20240719$PER$$US-PFIZER INC-202400218824$PFIZER$$53$YR$$M$Y$$$20240719$$CN$US$US
241128371$24112837$1$I$$20240717$20240719$20240719$PER$$US-PFIZER INC-PV202400094197$PFIZER$$29$YR$$F$Y$61.23$KG$20240719$$CN$US$US
241128381$24112838$1$I$20240717$20240718$20240719$20240719$PER$$US-PFIZER INC-202400218828$PFIZER$$56$YR$$M$Y$$$20240719$$CN$US$US
241128393$24112839$3$F$20240714$20240914$20240719$20240916$30DAY$$CO-PFIZER INC-PV202400093144$PFIZER$$14$YR$$M$Y$$$20240916$$CN$CO$CO
241128401$24112840$1$I$$20240717$20240719$20240719$PER$$US-PFIZER INC-PV202400094519$PFIZER$$$$$F$Y$$$20240719$$CN$US$US
241128411$24112841$1$I$$20240716$20240719$20240719$PER$$US-PFIZER INC-PV202400093494$PFIZER$$68$YR$$F$Y$$$20240719$$HP$US$US
241128421$24112842$1$I$20240702$20240717$20240719$20240719$PER$$US-PFIZER INC-202400218136$PFIZER$$67$YR$$M$Y$$$20240719$$HP$US$US
241128431$24112843$1$I$20240718$20240718$20240719$20240719$PER$$US-PFIZER INC-202400218817$PFIZER$$45$YR$$M$Y$$$20240719$$CN$US$US
241128442$24112844$2$F$$20240715$20240719$20240730$EXP$$IT-VIIV HEALTHCARE LIMITED-IT2024090550$VIIV$Muccini C, Gianotti N, Diotallevi S, Lolatto R, Spagnuolo V, Canetti D et al. One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study. Open Forum Infectious Diseases. 2024;11 (7)$$$$$Y$$$20240730$$MD$IT$IT
241128451$24112845$1$I$20240201$20240712$20240719$20240719$EXP$$US-AstraZeneca-2024A124948$ASTRAZENECA$$806$MON$$F$Y$$$20240719$$CN$US$
241128471$24112847$1$I$$20240718$20240719$20240719$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115188$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240719$$CN$US$US
241128481$24112848$1$I$$20240716$20240719$20240719$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114003$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240719$$HP$CA$CA
241128491$24112849$1$I$$20240711$20240719$20240719$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110843$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240719$$CN$US$US
241128501$24112850$1$I$$20240712$20240719$20240719$EXP$$US-009507513-2407USA009779$MERCK$$$$$M$Y$$$20240719$$CN$US$US
241128511$24112851$1$I$20240501$20240712$20240719$20240719$EXP$$JP-009507513-2405JPN003972J$MERCK$$78$YR$$M$Y$$$20240719$$MD$JP$JP
241128521$24112852$1$I$$20240718$20240719$20240719$EXP$$NVSC2024ET148305$NOVARTIS$$$$$F$Y$$$20240719$$MD$ET$ET
241128531$24112853$1$I$20240709$20240710$20240719$20240719$PER$$NVSC2024US145103$NOVARTIS$$54$YR$$F$Y$$$20240719$$PH$US$US
241128541$24112854$1$I$$20240715$20240719$20240719$EXP$$AR-GSK-AR2024AMR089001$GLAXOSMITHKLINE$Carrieri VA, de Barayazarra S. Hipersensibilidad a medicamentos: epidemiologia, manifestaciones clinicas y diagnostico en un hospital publico de cordoba. Archivos de Alergia e Inmunologia Clinica. 2023;54(4):112-125$$$$$Y$$$20240719$$HP$AR$AR
241128552$24112855$2$F$20240722$20240725$20240719$20240731$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003948$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240731$$MD$US$US
241128563$24112856$3$F$$20240904$20240719$20240909$EXP$$SE-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003907$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240909$$MD$SE$SE
241128571$24112857$1$I$20240611$20240717$20240719$20240719$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003979$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240719$$HP$US$US
241128582$24112858$2$F$20240711$20240731$20240719$20240805$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003906$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240805$$HP$US$US
241128592$24112859$2$F$20240715$20240719$20240719$20240725$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003941$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240725$$HP$US$US
241128603$24112860$3$F$20240601$20240823$20240719$20240829$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003940$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240829$$MD$US$US
241128612$24112861$2$F$$20240809$20240719$20240819$30DAY$$US-JNJFOC-20240722065$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240819$$CN$US$US
241128622$24112862$2$F$$20240713$20240719$20240723$EXP$$JP-009507513-2407JPN002119J$MERCK$$$$$F$Y$$$20240723$$MD$JP$JP
241128631$24112863$1$I$$20240718$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115036$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$75.75$KG$20240719$$CN$US$US
241128651$24112865$1$I$$20240704$20240719$20240719$EXP$$GB-VERTICAL PHARMACEUTICALS-2024ALO00321$Unknown Manufacturer$$$$$F$Y$$$20240719$$CN$GB$GB
241128661$24112866$1$I$20240525$20240709$20240719$20240719$EXP$$US-RADIUS HEALTH, INC.-2024US004290$RADIUS PHARM$$49$YR$$M$Y$$$20240719$$CN$US$US
241128671$24112867$1$I$$20240711$20240719$20240719$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115289$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240719$$MD$JP$JP
241128681$24112868$1$I$$20240717$20240719$20240719$PER$$US-009507513-2407USA011312$MERCK$$$$$F$Y$$$20240719$$CN$US$US
241128693$24112869$3$F$$20240812$20240719$20240816$EXP$$US-TAKEDA-2024TUS071950$TAKEDA$$$$$F$Y$$$20240816$$CN$US$US
241128701$24112870$1$I$$20240716$20240719$20240719$EXP$$US-KYOWAKIRIN-2024KK017214$KYOWA$$$$$$Y$$$20240719$$HP$US$US
241128711$24112871$1$I$20240101$20240711$20240719$20240719$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011001$JAZZ$$63$YR$$M$Y$$$20240719$$MD$JP$JP
241128721$24112872$1$I$20240701$20240715$20240719$20240719$EXP$FR-AFSSAPS-AN2024000911$FR-MYLANLABS-2024M1065892$MYLAN$$51$YR$$F$Y$$$20240719$$MD$FR$FR
241128731$24112873$1$I$19990101$20240709$20240719$20240719$EXP$$NVSC2024ZA143401$NOVARTIS$$63$YR$$F$Y$$$20240719$$HP$ZA$ZA
241128741$24112874$1$I$$20240718$20240719$20240719$PER$$US-JNJFOC-20240751614$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$CN$US$US
241128751$24112875$1$I$20240313$20240716$20240719$20240719$EXP$FR-AFSSAPS-AN2024000668$FR-MYLANLABS-2024M1066428$MYLAN$$64$YR$$M$Y$$$20240719$$PH$FR$FR
241128761$24112876$1$I$20230930$20240717$20240719$20240719$EXP$$US-OTSUKA-2024_020147$OTSUKA$$81$YR$$F$Y$$$20240719$$HP$US$US
241128773$24112877$3$F$20240625$20240801$20240719$20240802$EXP$ES-AEMPS-1546781$ES-OTSUKA-2024_019938$OTSUKA$$67$YR$$M$Y$$$20240802$$MD$ES$ES
241128781$24112878$1$I$20231201$20240712$20240719$20240719$EXP$$BR-TAKEDA-2024TUS072505$TAKEDA$$45$YR$$M$Y$$$20240719$$CN$BR$BR
241128801$24112880$1$I$20240702$20240716$20240719$20240719$EXP$FR-AFSSAPS-AN2024000909$FR-MYLANLABS-2024M1066312$MYLAN$$86$YR$$F$Y$$$20240719$$MD$FR$FR
241128811$24112881$1$I$$20240711$20240719$20240719$PER$$US-MYLANLABS-2024M1066426$MYLAN$$$$$M$Y$$$20240719$$CN$US$US
241128821$24112882$1$I$$20240715$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114066$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240719$$CN$US$US
241128831$24112883$1$I$$20240718$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115484$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240719$$CN$US$US
241128842$24112884$2$F$$20240801$20240719$20240813$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202407010795$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240813$$CN$DE$IN
241128851$24112885$1$I$20231101$20240708$20240719$20240719$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202407011677$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240719$$CN$IN$IN
241128862$24112886$2$F$20240108$20240725$20240719$20240730$EXP$$US-OTSUKA-2024_019900$OTSUKA$$56$YR$$F$Y$$$20240730$$CN$US$US
241128872$24112887$2$F$20240221$20240821$20240719$20240904$EXP$$US-RADIUS HEALTH, INC.-2024US005224$RADIUS PHARM$$78$YR$$F$Y$$$20240904$$CN$US$US
241128881$24112888$1$I$$20240717$20240719$20240719$PER$$US-PURDUE PHARMA-USA-2024-0310833$PURDUE$$$$$M$Y$$$20240719$$HP$US$US
241128891$24112889$1$I$$20240717$20240719$20240719$PER$$US-PURDUE-USA-2024-0310832$PURDUE$$$$$F$Y$$$20240719$$PH$US$US
241128901$24112890$1$I$20240501$20240603$20240719$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00469$UPSHER-SMITH$$$$$M$Y$$$20240618$$CN$US$US
241128911$24112891$1$I$$20230720$20240719$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00691$UPSHER-SMITH$$65$YR$$M$Y$72.562$KG$20240719$$CN$US$US
241128921$24112892$1$I$$20230728$20240719$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00702$UPSHER-SMITH$$$$$M$Y$76.19$KG$20240719$$CN$US$US
241128931$24112893$1$I$20231108$20231111$20240719$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00941$UPSHER-SMITH$$64$YR$$M$Y$77.098$KG$20240719$$CN$US$US
241128941$24112894$1$I$20230901$20231122$20240719$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00982$UPSHER-SMITH$$66$YR$$M$Y$86.168$KG$20240719$$CN$US$US
241128951$24112895$1$I$20231001$20240101$20240719$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00003$UPSHER-SMITH$$53$YR$$M$Y$74.83$KG$20240719$$CN$US$US
241128961$24112896$1$I$20240101$20240429$20240719$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00373$UPSHER-SMITH$$$$$M$Y$$$20240719$$CN$US$US
241128971$24112897$1$I$$20231003$20240719$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00855$UPSHER-SMITH$$72$YR$$M$Y$$$20240719$$CN$US$US
241128981$24112898$1$I$$20231009$20240719$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00870$UPSHER-SMITH$$$$$$Y$$$20240719$$CN$US$US
241128991$24112899$1$I$20230101$20231013$20240719$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00883$UPSHER-SMITH$$$$$M$Y$$$20240719$$CN$US$US
241129001$24112900$1$I$$20231119$20240719$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00963$UPSHER-SMITH$$$$$M$Y$$$20240719$$CN$US$US
241129011$24112901$1$I$$20240416$20240719$20240719$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00354$UPSHER-SMITH$$$$$M$Y$104.31$KG$20240719$$CN$US$US
241129021$24112902$1$I$20231212$20240715$20240719$20240719$EXP$$US-Stemline Therapeutics, Inc.-2024ST004315$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241129031$24112903$1$I$$20240630$20240719$20240719$EXP$$US-PFIZER INC-PV202400094537$PFIZER$$69$YR$$F$Y$$$20240719$$CN$US$US
241129041$24112904$1$I$$20240718$20240719$20240719$PER$$US-JNJFOC-20240751233$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$HP$US$US
241129052$24112905$2$F$$20240731$20240719$20240805$EXP$$BR-009507513-2305BRA004528$MERCK$$72$YR$$F$Y$$$20240805$$CN$BR$BR
241129061$24112906$1$I$20211110$20240715$20240719$20240719$EXP$$CN-009507513-2407CHN011635$MERCK$$73$YR$$M$Y$$$20240719$$HP$CN$CN
241129071$24112907$1$I$$20240715$20240719$20240719$EXP$$NVSC2024US146533$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
241129081$24112908$1$I$20210901$20240712$20240719$20240719$EXP$GB-MHRA-MED-202407121200052970-HPVRW$GB-GE HEALTHCARE-2024CSU007956$GE HEALTHCARE$$73$YR$$F$Y$$$20240719$$PH$GB$GB
241129091$24112909$1$I$20240708$20240717$20240719$20240719$EXP$$US-TAKEDA-2024TUS017499$TAKEDA$$66$YR$$F$Y$53$KG$20240719$$CN$US$US
241129102$24112910$2$F$20240208$20240731$20240719$20240808$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-089840$REGENERON$$85$YR$$M$Y$$$20240808$$MD$DE$DE
241129121$24112912$1$I$$20240705$20240719$20240719$EXP$$US-HLS-202400250$HLS THERAPEUTICS$$$$A$M$Y$$$20240719$$HP$US$US
241129142$24112914$2$F$20240101$20240904$20240719$20240919$PER$$US-RADIUS HEALTH, INC.-2024US005261$RADIUS PHARM$$$$$F$Y$$$20240919$$MD$US$US
241129151$24112915$1$I$20240703$20240712$20240719$20240719$EXP$IT-MINISAL02-994005$IT-GUERBET / LLC-IT-20240067$GUERBET$$74$YR$E$M$Y$$$20240719$$HP$IT$IT
241129161$24112916$1$I$20240101$20240717$20240719$20240719$EXP$$US-DSJP-DSU-2024-136238$DAIICHI$$$$$F$Y$$$20240719$$HP$US$US
241129171$24112917$1$I$$20240712$20240719$20240719$EXP$$NVSC2024HU146767$NOVARTIS$Voros KM. Disszeminalt cutan melanoma celzott terapiajanak hatasara kialakult cisztoid makulaodema  kezelese es nyomon kovetese [Management and follow-up of cystoid macular edema which developed due to targeted oncotherapy for disseminated cutaneous melanoma]. SZEMESZET. 2024;2:94-8$52$YR$$M$Y$$$20240719$$HP$HU$HU
241129181$24112918$1$I$20240101$20240710$20240719$20240719$EXP$$SI-DSJP-DSE-2024-135725$DAIICHI$$$$$F$Y$$$20240719$$MD$SI$SI
241129191$24112919$1$I$$20240712$20240719$20240719$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112131$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$79.38$KG$20240719$$CN$US$US
241129201$24112920$1$I$20240714$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011704$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240719$$CN$US$US
241129212$24112921$2$F$$20240807$20240719$20240808$PER$$US-ALXN-202407USA000921US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241129221$24112922$1$I$$20240705$20240719$20240719$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06312$HIKMA$$$$$$Y$$$20240719$$MD$CA$CA
241129231$24112923$1$I$$20240710$20240719$20240719$EXP$$SI-DSJP-DSE-2024-135719$DAIICHI$$$$$F$Y$$$20240719$$MD$SI$SI
241129241$24112924$1$I$$20240717$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114386$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240719$$CN$US$US
241129252$24112925$2$F$$20240829$20240719$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113601$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240902$$CN$US$US
241129271$24112927$1$I$20240203$20240715$20240719$20240719$PER$FR-AFSSAPS-ST2024001157$FR-Eisai-EC-2024-170150$EISAI$$83$YR$E$F$Y$62.4$KG$20240719$$HP$FR$FR
241129281$24112928$1$I$20240627$20240715$20240719$20240719$PER$$CN-Eisai-EC-2024-170238$EISAI$$53$YR$A$M$Y$65$KG$20240719$$HP$CN$CN
241129291$24112929$1$I$$20240708$20240719$20240719$EXP$$FR-GUERBET / LLC-FR-20240262$GUERBET$Treatment of uterine artery (pseudo)aneurysm during pregnancy: A case report and review of the literature. European Journal of Obstetrics and Gynecology and Reproductive Biology 2024; 299: 240-247.$$$N$M$Y$0.7$KG$20240719$$MD$FR$FR
241129302$24112930$2$F$$20240913$20240719$20240920$EXP$$US-TAKEDA-2024TUS068256$TAKEDA$$$$$F$Y$52.608$KG$20240920$$HP$US$US
241129312$24112931$2$F$20240523$20240911$20240719$20240916$EXP$$US-ABBVIE-5843790$ABBVIE$$24$YR$$F$Y$66$KG$20240916$$HP$US$US
241129322$24112932$2$F$$20240822$20240719$20240823$PER$$US-ALXN-202407USA000809US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
241129331$24112933$1$I$$20240705$20240719$20240719$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06308$HIKMA$$$$$$Y$$$20240719$$PH$CA$CA
241129351$24112935$1$I$$20240712$20240719$20240719$EXP$$NVSC2024US145733$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
241129361$24112936$1$I$20240117$20240717$20240719$20240719$EXP$FR-AFSSAPS-PC2024000572$FR-MYLANLABS-2024M1066843$MYLAN$$75$YR$$F$Y$$$20240719$$HP$FR$FR
241129371$24112937$1$I$20240526$20240715$20240719$20240719$PER$$US-009507513-2407USA009621$MERCK$$58$YR$$M$Y$$$20240719$$CN$US$US
241129381$24112938$1$I$20240601$20240710$20240719$20240719$EXP$$CN-009507513-2407CHN008866$MERCK$$32$YR$$M$Y$90$KG$20240719$$HP$CN$CN
241129391$24112939$1$I$$20240715$20240719$20240719$EXP$$US-OTSUKA-2024_019999$OTSUKA$Filioglou D, Truscott L, Reddivalla N, Katsanis E. Outcomes of haploidentical bone marrow transplantation in infant acute leukemia: a single center experience. Bone Marrow Transplantation. 2024;59(7):1028-30$20$MON$$M$Y$$$20240719$$HP$US$US
241129401$24112940$1$I$20231215$20240712$20240719$20240719$EXP$$US-APELLIS-APL-2023-003459$APELLIS PHARMACEUTICALS$$$$$$Y$74.843$KG$20240719$$HP$US$US
241129411$24112941$1$I$20230101$20240713$20240719$20240719$EXP$$JP-009507513-2302JPN001275J$MERCK$$85$YR$$F$Y$$$20240719$$MD$JP$JP
241129421$24112942$1$I$20240711$20240718$20240719$20240719$PER$$JP-Eisai-EC-2024-170518$EISAI$$42$YR$A$F$Y$$$20240719$$MD$JP$JP
241129431$24112943$1$I$20240601$20240711$20240719$20240719$EXP$$IL-Taiho Oncology Inc-2024-006766$TAIHO ONCOLOGY INC$$61$YR$A$M$Y$$$20240719$$CN$IL$IL
241129441$24112944$1$I$$20240711$20240719$20240719$EXP$$BR-ALXN-202407SAM000866BR$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$MD$BR$BR
241129451$24112945$1$I$20240524$20240718$20240719$20240719$EXP$$US-GSK-US2024090647$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$MD$US$US
241129461$24112946$1$I$$20240712$20240719$20240719$EXP$$FR-GSK-FR2024087674$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$PH$FR$FR
241129472$24112947$2$F$$20240731$20240719$20240806$EXP$$CA-GSK-CA2024087764$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$CA$CA
241129481$24112948$1$I$20231201$20240712$20240719$20240719$EXP$$CA-GSK-CA2024000239$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$CN$CA$CA
241129492$24112949$2$F$$20240820$20240719$20240827$EXP$$CA-GSK-CA2024088607$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$CA$CA
241129501$24112950$1$I$$20240712$20240719$20240719$EXP$$CA-GSK-CA2023127373$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$CN$CA$CA
241129511$24112951$1$I$$20240709$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR086365$VIIV$$$$$F$Y$$$20240719$$PH$US$US
241129521$24112952$1$I$20240707$20240709$20240719$20240719$EXP$$US-VIIV HEALTHCARE LIMITED-US2024068268$VIIV$$46$YR$$F$Y$$$20240719$$CN$US$US
241129531$24112953$1$I$20240301$20240709$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR085394$VIIV$$29$YR$$F$Y$$$20240719$$HP$US$US
241129543$24112954$3$F$20240617$20240814$20240719$20240821$EXP$$CO-GSK-CO2024AMR089880$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$CO$CO
241129551$24112955$1$I$20240206$20240715$20240719$20240719$EXP$$US-GSK-US2024088602$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$CN$US$US
241129562$24112956$2$F$20240101$20240712$20240719$20240722$EXP$$US-RADIUS HEALTH, INC.-2024US005185$RADIUS PHARM$$$$$F$Y$$$20240722$$CN$US$US
241129571$24112957$1$I$20240618$20240712$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089071$VIIV$$46$YR$$M$Y$$$20240719$$MD$US$US
241129583$24112958$3$F$$20240809$20240719$20240816$EXP$$CA-GSK-CA2024074338$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$HP$CA$CA
241129591$24112959$1$I$20240711$20240718$20240719$20240719$EXP$$US-GSK-US2024090671$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$HP$US$US
241129601$24112960$1$I$$20240709$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090876$VIIV$$$$$$Y$$$20240719$$MD$US$US
241129611$24112961$1$I$20240514$20240711$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024086580$VIIV$$50$YR$$M$Y$$$20240719$$HP$US$US
241129623$24112962$3$F$20240811$20240813$20240719$20240823$EXP$$US-VIIV HEALTHCARE LIMITED-US2024086441$VIIV$$26$YR$$F$Y$$$20240823$$PH$US$US
241129631$24112963$1$I$$20240709$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR086051$VIIV$$$$$M$Y$$$20240719$$CN$US$US
241129642$24112964$2$F$20240717$20240718$20240719$20240723$PER$$NVSC2024US148479$NOVARTIS$$51$YR$$M$Y$$$20240723$$CN$US$US
241129651$24112965$1$I$20240625$20240711$20240719$20240719$PER$$US-JNJFOC-20240752809$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240719$$HP$US$US
241129661$24112966$1$I$20240618$20240712$20240719$20240719$PER$$US-JNJFOC-20240752793$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240719$$MD$US$US
241129671$24112967$1$I$20240706$20240715$20240719$20240719$EXP$$CN-GSK-CN2024GSK090360$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$HP$CN$CN
241129681$24112968$1$I$$20240712$20240719$20240719$EXP$$US-GSK-US2024087740$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241129691$24112969$1$I$$20240712$20240719$20240719$30DAY$$US-GSK-US2024086985$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241129701$24112970$1$I$$20240712$20240719$20240719$EXP$$US-GSK-US2024AMR089274$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$PH$US$US
241129711$24112971$1$I$$20240709$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR085451$VIIV$$$$$$Y$$$20240719$$MD$US$US
241129731$24112973$1$I$$20240718$20240719$20240719$PER$$US-DSJP-DSU-2024-136458$DAIICHI$$$$$F$Y$$$20240719$$CN$US$US
241129741$24112974$1$I$$20240717$20240719$20240719$PER$$US-DSJP-DSU-2024-136447$DAIICHI$$$$$F$Y$$$20240719$$HP$US$US
241129751$24112975$1$I$$20240718$20240719$20240719$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136457$DAIICHI$$$$$F$Y$$$20240719$$HP$US$US
241129761$24112976$1$I$$20240717$20240719$20240719$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136441$DAIICHI$$$$$F$Y$$$20240719$$HP$US$US
241129771$24112977$1$I$20220629$20240717$20240719$20240719$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136438$DAIICHI$$$$$F$Y$$$20240719$$CN$US$US
241129781$24112978$1$I$$20240709$20240719$20240719$30DAY$$US-GSK-US2024AMR085388$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241129801$24112980$1$I$$20240712$20240719$20240719$30DAY$$US-GSK-US2024087704$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241129811$24112981$1$I$20220428$20240717$20240719$20240719$EXP$$CA-GSK-CA2022071726$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$HP$CA$CA
241129821$24112982$1$I$20240101$20240717$20240719$20240719$PER$$US-DSJP-DSU-2024-136245$DAIICHI$$$$$F$Y$$$20240719$$HP$US$US
241129831$24112983$1$I$$20240717$20240719$20240719$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136237$DAIICHI$$$$$F$Y$$$20240719$$MD$US$US
241129841$24112984$1$I$$20240711$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024086612$VIIV$$30$YR$$F$Y$$$20240719$$HP$US$US
241129851$24112985$1$I$$20240709$20240719$20240719$30DAY$$US-GSK-US2024085142$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241129861$24112986$1$I$$20240717$20240719$20240719$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136259$DAIICHI$$62$YR$$F$Y$$$20240719$$HP$US$US
241129882$24112988$2$F$20240701$20240716$20240719$20240723$PER$$US-DSJP-DSU-2024-136239$DAIICHI$$42$YR$$F$Y$$$20240723$$CN$US$US
241129892$24112989$2$F$$20240716$20240719$20240927$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136240$DAIICHI$$$$$M$Y$$$20240927$$CN$US$US
241129901$24112990$1$I$20240101$20240716$20240719$20240719$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136233$DAIICHI$$$$$F$Y$$$20240719$$HP$US$US
241129921$24112992$1$I$$20240709$20240719$20240719$30DAY$$US-GSK-US2024AMR085954$GLAXOSMITHKLINE$$$$$M$Y$$$20240719$$CN$US$US
241129935$24112993$5$F$$20240916$20240719$20240924$EXP$$US-GSK-US2024AMR086106$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$US$US
241129941$24112994$1$I$20240625$20240711$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024086571$VIIV$$68$YR$$M$Y$$$20240719$$HP$US$US
241129952$24112995$2$F$20240715$20240822$20240719$20240827$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-125341$DAIICHI$$50$YR$$M$Y$$$20240827$$CN$US$US
241129961$24112996$1$I$$20240709$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024085042$VIIV$$$$$M$Y$$$20240719$$MD$US$US
241129971$24112997$1$I$$20240712$20240719$20240719$30DAY$$US-GSK-US2024087788$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241129981$24112998$1$I$20240621$20240715$20240719$20240719$EXP$$FR-DSJP-DSE-2024-136201$DAIICHI$$$$A$F$Y$68$KG$20240719$$MD$FR$FR
241129991$24112999$1$I$20240212$20240712$20240719$20240719$EXP$$FR-DSJP-DSE-2024-135743$DAIICHI$$$$E$F$Y$40$KG$20240719$$MD$FR$FR
241130001$24113000$1$I$20240624$20240624$20240719$20240719$PER$$US-009507513-2406USA009060$MERCK$$$$C$$Y$$$20240719$$CN$US$US
241130011$24113001$1$I$20240708$20240709$20240719$20240719$EXP$$US-VIIV HEALTHCARE LIMITED-US2024085006$VIIV$$55$YR$$M$Y$$$20240719$$CN$US$US
241130021$24113002$1$I$20240701$20240711$20240719$20240719$30DAY$$US-GSK-US2024AMR088629$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$CN$US$US
241130031$24113003$1$I$$20240709$20240719$20240719$EXP$$US-GSK-US2024AMR086302$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$HP$US$US
241130041$24113004$1$I$$20240710$20240719$20240719$EXP$$US-GSK-US2024AMR085981$GLAXOSMITHKLINE$$32$YR$$F$Y$$$20240719$$CN$US$US
241130051$24113005$1$I$$20240710$20240719$20240719$EXP$$US-GSK-US2024AMR086687$GLAXOSMITHKLINE$$$$$F$Y$112.3$KG$20240719$$CN$US$US
241130061$24113006$1$I$20231225$20240717$20240719$20240719$EXP$$CA-GSK-CA2024005029$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$CN$CA$CA
241130072$24113007$2$F$20231102$20240725$20240719$20240729$EXP$$US-GSK-US2024090045$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241130081$24113008$1$I$20240707$20240712$20240719$20240719$EXP$GB-MHRA-MED-202407091352085410-HRCLP$GB-BAUSCH-BL-2024-011062$BAUSCH AND LOMB$$71$YR$$F$Y$88$KG$20240719$$CN$GB$GB
241130091$24113009$1$I$20240601$20240709$20240719$20240719$EXP$$US-GSK-US2024AMR086282$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241130101$24113010$1$I$20240712$20240715$20240719$20240719$EXP$$US-GSK-US2024088664$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$CN$US$US
241130111$24113011$1$I$$20240711$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089855$VIIV$$$$$$Y$$$20240719$$HP$US$US
241130122$24113012$2$F$$20240806$20240719$20240816$30DAY$$US-GSK-US2024AMR088512$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
241130131$24113013$1$I$$20240717$20240719$20240719$EXP$$GB-GSK-GB2024EME090285$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$CN$GB$GB
241130141$24113014$1$I$$20240717$20240719$20240719$EXP$$JP-GSK-JP2024JPN090195$GLAXOSMITHKLINE$$$$$$Y$$$20240719$$MD$JP$JP
241130151$24113015$1$I$$20240710$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089879$VIIV$$$$$$Y$$$20240719$$HP$US$US
241130161$24113016$1$I$20240501$20240716$20240719$20240719$EXP$$JP-Eisai-EC-2024-170426$EISAI$$$$E$F$Y$$$20240719$$MD$JP$JP
241130171$24113017$1$I$20240101$20240716$20240719$20240719$EXP$$JP-Eisai-EC-2024-170427$EISAI$$$$$$Y$$$20240719$$MD$JP$JP
241130181$24113018$1$I$$20240626$20240719$20240719$PER$$US-Eisai-EC-2024-168992$EISAI$$$$$$Y$$$20240719$$MD$US$US
241130191$24113019$1$I$20240601$20240715$20240719$20240719$EXP$FR-AFSSAPS-PB2024000799$FR-Eisai-EC-2024-170157$EISAI$$59$YR$A$M$Y$64$KG$20240719$$MD$FR$FR
241130201$24113020$1$I$20240531$20240715$20240719$20240719$PER$FR-AFSSAPS-PP2024000784$FR-Eisai-EC-2024-170154$EISAI$$37$YR$A$M$Y$87$KG$20240719$$MD$FR$FR
241130212$24113021$2$F$$20240821$20240719$20240830$30DAY$$US-GSK-US2024088740$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
241130221$24113022$1$I$$20240710$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089851$VIIV$$$$$$Y$$$20240719$$HP$US$US
241130231$24113023$1$I$$20240717$20240719$20240719$EXP$$US-Taiho Oncology Inc-2024-007017$TAIHO ONCOLOGY INC$$82$YR$E$M$Y$$$20240719$$CN$US$US
241130242$24113024$2$F$$20240807$20240719$20240816$30DAY$$US-GSK-US2024AMR088572$GLAXOSMITHKLINE$$$$$M$Y$$$20240816$$CN$US$US
241130251$24113025$1$I$20240708$20240711$20240719$20240719$30DAY$$US-GSK-US2024086619$GLAXOSMITHKLINE$$63$YR$$M$Y$$$20240719$$CN$US$US
241130261$24113026$1$I$$20240711$20240719$20240719$30DAY$$US-GSK-US2024086593$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241130272$24113027$2$F$20240628$20240731$20240719$20240815$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01133$INTRA-CELLULAR THERAPIES$$43$YR$$F$Y$126.98$KG$20240815$$HP$US$US
241130282$24113028$2$F$$20240724$20240719$20240801$EXP$$US-TAKEDA-2024TUS049109$TAKEDA$$$$$M$Y$70$KG$20240801$$HP$US$US
241130291$24113029$1$I$20240301$20240716$20240719$20240719$EXP$$JP-009507513-2405JPN000863J$MERCK$$8$DEC$$F$Y$$$20240719$$MD$JP$JP
241130302$24113030$2$F$20231201$20240814$20240719$20240824$30DAY$$US-GSK-US2024085144$GLAXOSMITHKLINE$$84$YR$$M$Y$$$20240824$$HP$US$US
241130311$24113031$1$I$$20240710$20240719$20240719$30DAY$$US-GSK-US2024085856$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241130321$24113032$1$I$20240708$20240710$20240719$20240719$30DAY$$US-GSK-US2024085720$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240719$$CN$US$US
241130332$24113033$2$F$$20240716$20240719$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR086374$VIIV$$$$$M$Y$$$20240726$$HP$US$US
241130341$24113034$1$I$$20240710$20240719$20240719$30DAY$$US-GSK-US2024AMR086265$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241130351$24113035$1$I$$20240709$20240719$20240719$30DAY$$US-GSK-US2024AMR086314$GLAXOSMITHKLINE$$$$$M$Y$$$20240719$$CN$US$US
241130362$24113036$2$F$$20240613$20240719$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003714$STEMLINE THERAPEUTICS$$41$YR$A$F$Y$$$20240718$$CN$US$US
241130371$24113037$1$I$$20240715$20240719$20240719$EXP$$US-Stemline Therapeutics, Inc.-2024ST004316$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$HP$US$US
241130381$24113038$1$I$$20240715$20240719$20240719$EXP$$US-Stemline Therapeutics, Inc.-2024ST004319$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241130391$24113039$1$I$$20240716$20240719$20240719$EXP$$US-Stemline Therapeutics, Inc.-2024ST004347$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241130401$24113040$1$I$20240709$20240715$20240719$20240719$EXP$$US-Stemline Therapeutics, Inc.-2024ST004326$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240718$$HP$US$US
241130411$24113041$1$I$20240704$20240716$20240719$20240719$EXP$$US-Stemline Therapeutics, Inc.-2024ST004354$STEMLINE THERAPEUTICS$$90$YR$E$F$Y$$$20240718$$CN$US$US
241130421$24113042$1$I$$20240716$20240719$20240719$EXP$$US-Stemline Therapeutics, Inc.-2024ST004355$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241130432$24113043$2$F$$20240712$20240719$20240723$EXP$$US-VERTEX PHARMACEUTICALS-2024-011646$VERTEX$$$$$F$Y$$$20240723$$HP$US$US
241130441$24113044$1$I$$20240718$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115147$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240719$$CN$US$US
241130451$24113045$1$I$$20240718$20240719$20240719$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114749$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$98$KG$20240719$$HP$CA$CA
241130471$24113047$1$I$20240528$20240709$20240719$20240719$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR085725$VIIV$$29$YR$$M$Y$$$20240719$$PH$US$US
241130481$24113048$1$I$$20240710$20240719$20240719$EXP$$US-GSK-US2024AMR088702$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241130491$24113049$1$I$$20240709$20240719$20240719$30DAY$$US-GSK-US2024AMR086657$GLAXOSMITHKLINE$$$$$M$Y$$$20240719$$CN$US$US
241130501$24113050$1$I$$20240709$20240719$20240719$30DAY$$US-GSK-US2024085128$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241130512$24113051$2$F$$20240917$20240719$20240927$PER$$US-GSK-US2024AMR086652$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
241130521$24113052$1$I$$20240711$20240719$20240719$EXP$$IN-GSK-IN2024GSK086863$GLAXOSMITHKLINE$Babu BS, Fernandes CZ, Bhat B. Acitretin induced primary hypothyroidism in Darier^s disease: A rare case report. Indian Journal of Pharmacology. 2024;56(3):220-223$$$$$Y$$$20240719$$HP$IN$IN
241130531$24113053$1$I$$20240710$20240719$20240719$30DAY$$US-GSK-US2024085865$GLAXOSMITHKLINE$$$$$F$Y$$$20240719$$CN$US$US
241130541$24113054$1$I$$20240713$20240719$20240719$EXP$$NVSC2024IN142042$NOVARTIS$$$$$F$Y$$$20240719$$CN$IN$IN
241130551$24113055$1$I$20240709$20240711$20240719$20240719$EXP$$US-RADIUS HEALTH, INC.-2024US005327$RADIUS PHARM$$$$$$Y$$$20240719$$CN$US$US
241130562$24113056$2$F$20240703$20240723$20240719$20240730$PER$$US-Eisai-EC-2024-170004$EISAI$$56$YR$A$M$Y$$$20240730$$MD$US$US
241130571$24113057$1$I$20240712$20240715$20240719$20240719$EXP$$ID-Eisai-EC-2024-170246$EISAI$$70$YR$E$M$Y$$$20240719$$MD$ID$ID
241130581$24113058$1$I$$20240718$20240719$20240719$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115065$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$128.82$KG$20240719$$CN$US$US
241130591$24113059$1$I$$20240621$20240719$20240719$PER$$US-AstraZeneca-2024A144960$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241130601$24113060$1$I$$20240716$20240719$20240719$PER$$NVSC2024US147277$NOVARTIS$$$$$$Y$$$20240719$$CN$US$US
241130611$24113061$1$I$20231101$20240716$20240719$20240719$EXP$FR-AFSSAPS-BR2024000559$FR-009507513-2407FRA010118$MERCK$$67$YR$$M$Y$75$KG$20240719$$MD$FR$FR
241130622$24113062$2$F$$20240812$20240719$20240812$PER$$US-ALXN-202407USA000813US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241130631$24113063$1$I$$20240716$20240719$20240719$PER$$US-ABBVIE-5843280$ABBVIE$$$$$$Y$$$20240719$$CN$US$US
241130641$24113064$1$I$$20240712$20240719$20240719$EXP$$US-Eisai-EC-2024-170125$EISAI$$$$$$Y$$$20240719$$HP$US$US
241130653$24113065$3$F$$20240712$20240719$20240726$EXP$$DE-Eisai-EC-2024-170178$EISAI$$$$C$M$Y$14.3$KG$20240726$$MD$DE$DE
241130661$24113066$1$I$20240624$20240712$20240719$20240719$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-135808$DAIICHI$$9$DEC$$$Y$$$20240719$$PH$JP$JP
241130671$24113067$1$I$$20240619$20240719$20240719$PER$$AT-APELLIS-2024-APL-0000354$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240719$$CN$AT$AT
241130681$24113068$1$I$20240613$20240716$20240719$20240719$EXP$FR-AFSSAPS-MP2024001130$FR-009507513-2407FRA010181$MERCK$$88$YR$$F$Y$46.6$KG$20240719$$PH$FR$FR
241130693$24113069$3$F$20240630$20240729$20240719$20240828$PER$$US-AstraZeneca-2024A153356$ASTRAZENECA$$8402$DY$$F$Y$$$20240828$$PH$US$
241130701$24113070$1$I$$20230227$20240719$20240719$EXP$$AU-AstraZeneca-2023A053057$ASTRAZENECA$$$$$$Y$$$20240719$$MD$AU$
241130711$24113071$1$I$20220921$20240702$20240719$20240719$EXP$$DE-ROCHE-3188520$ROCHE$$45$YR$A$F$Y$$$20240719$$CN$DE$DE
241130721$24113072$1$I$$20240711$20240719$20240719$PER$$US-ALXN-202407USA000826US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
241130732$24113073$2$F$$20240816$20240719$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115106$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240821$$CN$US$US
241130742$24113074$2$F$$20240808$20240719$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111826$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240812$$HP$US$US
241130751$24113075$1$I$$20240610$20240719$20240719$PER$$US-CBFLEET-202407-US-002122$CB FLEET$$$$$F$Y$$$20240719$$CN$US$US
241130761$24113076$1$I$20240717$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011955$ELI LILLY AND CO$$$$$M$Y$$$20240719$$MD$US$US
241130771$24113077$1$I$$20240718$20240719$20240719$PER$$NVSC2024US149095$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241130781$24113078$1$I$$20240718$20240719$20240719$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114791$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240719$$HP$US$US
241130791$24113079$1$I$$20230320$20240719$20240719$EXP$$US-AstraZeneca-2023A067510$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241130801$24113080$1$I$$20240717$20240719$20240719$EXP$$ES-AstraZeneca-2024A165171$ASTRAZENECA$$78$YR$$M$Y$$$20240719$$MD$ES$
241130811$24113081$1$I$$20230424$20240719$20240719$EXP$$US-AstraZeneca-2023A096225$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241130823$24113082$3$F$20240424$20240810$20240719$20240820$EXP$$JP-009507513-2407JPN011697$MERCK$$43$YR$$M$Y$85$KG$20240820$$MD$JP$JP
241130841$24113084$1$I$20240701$20240712$20240719$20240719$EXP$$DE-DSJP-DSE-2024-135736$DAIICHI$$$$$M$Y$$$20240719$$MD$DE$DE
241130853$24113085$3$F$20240101$20240807$20240719$20240822$EXP$$US-RADIUS HEALTH, INC.-2024US004079$RADIUS PHARM$$$$$F$Y$$$20240822$$CN$US$US
241130862$24113086$2$F$$20240903$20240719$20240903$EXP$$GB-ALXN-202407GBR000893GB$ALEXION PHARMACEUTICALS$$$$C$$Y$$$20240903$$HP$GB$GB
241130871$24113087$1$I$20240707$20240712$20240719$20240719$PER$$US-EMD Serono-2024038239$EMD SERONO INC$$61$YR$A$F$Y$$$20240719$$CN$US$US
241130891$24113089$1$I$20240501$20240711$20240719$20240719$EXP$$CN-ROCHE-10000027486$ROCHE$$74$YR$E$F$Y$81$KG$20240719$$HP$CN$CN
241130901$24113090$1$I$$20230419$20240719$20240719$EXP$$US-AstraZeneca-2023A092419$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241130911$24113091$1$I$$20240705$20240719$20240719$EXP$$VN-AstraZeneca-2024A155824$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$VN$
241130921$24113092$1$I$$20230508$20240719$20240719$EXP$$US-AstraZeneca-2023A107549$ASTRAZENECA$$$$$F$Y$$$20240719$$CN$US$
241130932$24113093$2$F$20240701$20240718$20240719$20240730$EXP$$NO-BEH-2024173524$CSL BEHRING$$$$A$M$Y$$$20240730$$PH$NO$NO
241130942$24113094$2$F$20200501$20240718$20240719$20240726$EXP$SE-SEMPA-2024-005495$SE-ORGANON-O2407SWE001467$ORGANON$$24$YR$$F$Y$60$KG$20240726$$CN$SE$SE
241130952$24113095$2$F$$20240917$20240719$20240919$EXP$$CA-ORGANON-O2407CAN001813$ORGANON$$54$YR$$M$Y$$$20240919$$MD$CA$CA
241130961$24113096$1$I$$20240718$20240719$20240719$PER$$NVSC2024US148870$NOVARTIS$$$$$$Y$$$20240719$$CN$US$US
241130972$24113097$2$F$$20240723$20240719$20240724$PER$$US-ROCHE-10000023941$ROCHE$$$$$$Y$$$20240724$$PH$US$US
241130981$24113098$1$I$$20240710$20240719$20240719$PER$$US-ROCHE-10000023952$ROCHE$$$$$$Y$$$20240719$$HP$US$US
241130991$24113099$1$I$$20240621$20240719$20240719$PER$$US-GILEAD-2024-0681290$GILEAD$$$$$$Y$$$20240719$$CN$US$US
241131002$24113100$2$F$$20240710$20240719$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110700$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$68.04$KG$20240723$$PH$US$US
241131011$24113101$1$I$20240711$20240718$20240719$20240719$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136461$DAIICHI$$46$YR$$F$Y$$$20240719$$PH$US$US
241131022$24113102$2$F$20240717$20240718$20240719$20240723$PER$$NVSC2024US148785$NOVARTIS$$44$YR$$M$Y$$$20240723$$CN$US$US
241131031$24113103$1$I$$20230324$20240719$20240719$EXP$$US-AstraZeneca-2023A071250$ASTRAZENECA$$$$$M$Y$$$20240719$$CN$US$
241131041$24113104$1$I$20230820$20240715$20240719$20240719$EXP$$US-ABBVIE-5646221$ABBVIE$$65$YR$$F$Y$$$20240719$$CN$US$US
241131051$24113105$1$I$$20240705$20240719$20240719$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06346$HIKMA$$45$YR$$$Y$$$20240719$$MD$CA$CA
241131061$24113106$1$I$$20240705$20240719$20240719$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06347$HIKMA$$30$YR$$F$Y$$$20240719$$MD$CA$CA
241131071$24113107$1$I$20240530$20240717$20240719$20240719$EXP$FR-AFSSAPS-CN2024000599$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-114368$BRISTOL MYERS SQUIBB$$72$YR$A$M$Y$$$20240719$$MD$FR$FR
241131081$24113108$1$I$20240530$20240715$20240719$20240719$EXP$$US-ABBVIE-5792471$ABBVIE$$75$YR$$F$Y$$$20240719$$CN$US$US
241131092$24113109$2$F$$20230613$20240719$20240722$EXP$$JP-009507513-2407JPN002411J$MERCK$$75$YR$$F$Y$$$20240722$$MD$JP$JP
241131101$24113110$1$I$20240401$20240715$20240719$20240719$EXP$$US-ABBVIE-5768982$ABBVIE$$64$YR$$F$Y$$$20240719$$CN$US$US
241131113$24113111$3$F$20240219$20240723$20240719$20240807$EXP$$JP-APELLIS-2024-APL-0000456$APELLIS PHARMACEUTICALS$$$$$$Y$59$KG$20240807$$MD$JP$JP
241131121$24113112$1$I$$20240715$20240719$20240719$EXP$$US-ABBVIE-5842742$ABBVIE$$$$$M$Y$$$20240719$$CN$US$US
241131131$24113113$1$I$$20240705$20240719$20240719$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06348$HIKMA$$51$YR$$F$Y$$$20240719$$MD$CA$CA
241131142$24113114$2$F$$20240725$20240719$20240802$PER$$US-ALXN-202407USA000835US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241131153$24113115$3$F$$20240812$20240719$20240812$PER$$US-ALXN-202407USA000852US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241131162$24113116$2$F$$20240812$20240719$20240814$EXP$$US-ABBVIE-5842722$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
241131172$24113117$2$F$20240611$20240821$20240719$20240824$EXP$$US-ABBVIE-5842802$ABBVIE$$71$YR$$F$Y$$$20240824$$CN$US$US
241131181$24113118$1$I$$20240705$20240719$20240719$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06349$HIKMA$$54$YR$$M$Y$$$20240719$$MD$CA$CA
241131191$24113119$1$I$$20240715$20240719$20240719$EXP$$US-AstraZeneca-2024A132453$ASTRAZENECA$$69$YR$$M$Y$122.5$KG$20240719$$MD$US$
241131201$24113120$1$I$20240206$20240717$20240719$20240719$EXP$$CA-ABBVIE-5638417$ABBVIE$$72$YR$$F$Y$$$20240719$$CN$CA$CA
241131211$24113121$1$I$20240604$20240715$20240719$20240719$EXP$FR-AFSSAPS-AN2024000838$FR-009507513-2407FRA009799$MERCK$$81$YR$$M$Y$57$KG$20240719$$PH$FR$FR
241131221$24113122$1$I$20240101$20240717$20240719$20240719$EXP$$MX-ABBVIE-5845111$ABBVIE$$$$$F$Y$$$20240719$$CN$MX$MX
241131231$24113123$1$I$20240501$20240712$20240719$20240719$EXP$$US-009507513-2407USA009213$MERCK$$$$$F$Y$$$20240719$$CN$US$US
241131242$24113124$2$F$$20240806$20240719$20240808$PER$$NVSC2024US147273$NOVARTIS$$37$YR$$$Y$$$20240808$$CN$US$US
241131252$24113125$2$F$$20240723$20240719$20240726$EXP$$US-GILEAD-2024-0681285$GILEAD$$$$$M$Y$$$20240726$$MD$US$US
241131271$24113127$1$I$$20240709$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007128$ELI LILLY AND CO$$54$YR$A$$Y$$$20240719$$CN$US$US
241131281$24113128$1$I$20240601$20240708$20240719$20240719$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407007500$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$CN$CN
241131291$24113129$1$I$$20240716$20240719$20240719$EXP$$US-PURDUE PHARMA-USA-2024-0310824$PURDUE$Weigel B, Bryant SM, Schultz E, Deitche A, Wahl M.. Beyond One Pill Can Kill: A Decade of Pediatric Deaths Reported to America^s Poison Centers. Pediatric Emergency Care. 2024;40(7):e108-e109$$$C$$Y$$$20240719$$MD$US$US
241131302$24113130$2$F$$20240803$20240719$20240809$EXP$$US-ALXN-202407USA000966US$ALEXION PHARMACEUTICALS$$$$$F$Y$65.76$KG$20240809$$CN$US$US
241131311$24113131$1$I$$20240708$20240719$20240719$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202407006495$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240719$$PH$ES$ES
241131321$24113132$1$I$20240702$20240708$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407005756$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240719$$CN$US$US
241131334$24113133$4$F$$20240815$20240719$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009146$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240822$$CN$US$US
241131341$24113134$1$I$$20240709$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006165$ELI LILLY AND CO$$$$$M$Y$$$20240719$$CN$US$US
241131351$24113135$1$I$20180101$20240708$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407005734$ELI LILLY AND CO$$54$YR$A$$Y$$$20240719$$CN$US$US
241131361$24113136$1$I$$20240709$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006360$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240719$$CN$US$US
241131371$24113137$1$I$$20240709$20240719$20240719$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407006597$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240719$$CN$FR$FR
241131381$24113138$1$I$$20240716$20240719$20240719$EXP$$CA-ORGANON-O2407CAN001421$ORGANON$$$$$F$Y$$$20240719$$HP$CA$CA
241131391$24113139$1$I$$20240709$20240719$20240719$EXP$GB-MHRA-MED-202407081108564390-WTDHM$GB-ELI_LILLY_AND_COMPANY-GB202407005849$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240719$$CN$GB$GB
241131402$24113140$2$F$$20240826$20240719$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007190$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240906$$HP$US$US
241131411$24113141$1$I$$20240709$20240719$20240719$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202407007016$ELI LILLY AND CO$$$$$F$Y$$$20240719$$MD$AE$AE
241131421$24113142$1$I$$20240709$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006756$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240719$$CN$US$US
241131431$24113143$1$I$20240715$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011057$ELI LILLY AND CO$$$$$$Y$$$20240719$$CN$US$US
241131441$24113144$1$I$$20240709$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006400$ELI LILLY AND CO$$73$YR$E$$Y$$$20240719$$CN$US$US
241131451$24113145$1$I$$20240709$20240719$20240719$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407007398$ELI LILLY AND CO$$$$$M$Y$$$20240719$$CN$FR$FR
241131461$24113146$1$I$20200101$20240708$20240719$20240719$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407007296$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$CN$CN
241131472$24113147$2$F$20240717$20240717$20240719$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011572$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240729$$CN$US$US
241131481$24113148$1$I$20240707$20240715$20240719$20240719$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202407011458$ELI LILLY AND CO$$$$A$M$Y$$$20240719$$CN$CO$CO
241131491$24113149$1$I$$20240709$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006601$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240719$$CN$US$US
241131501$24113150$1$I$$20240709$20240719$20240719$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407005675$ELI LILLY AND CO$$32$YR$A$M$Y$$$20240719$$CN$DE$DE
241131511$24113151$1$I$20240621$20240708$20240719$20240719$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407005696$ELI LILLY AND CO$$36$YR$A$F$Y$102$KG$20240719$$CN$GB$GB
241131521$24113152$1$I$20240705$20240711$20240719$20240719$EXP$$CN-BEIGENE-BGN-2024-010850$BEIGENE$$$$$$Y$$$20240719$$HP$CN$CN
241131534$24113153$4$F$$20240821$20240719$20240829$EXP$$IT-ORGANON-O2407ITA000650$ORGANON$Daus F, Maloberti A, Pavanello C, Toscani G, Riccio A, Fabbri S, et al.. MULTIDRUG RESISTANT DYSLIPIDEMIA: A CASE REPORT.. European Heart Journal Supplements.. 2024;26 (2):155$71$YR$$F$Y$$$20240829$$MD$IT$IT
241131541$24113154$1$I$20240708$20240715$20240719$20240719$EXP$$CN-ORGANON-O2407CHN001572$ORGANON$$72$YR$$M$Y$54.9$KG$20240719$$HP$CN$CN
241131551$24113155$1$I$$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011973$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$US$US
241131561$24113156$1$I$20240312$20240716$20240719$20240719$EXP$FR-AFSSAPS-BR2024000560$FR-ORGANON-O2407FRA001396$ORGANON$$73$YR$$F$Y$$$20240719$$MD$FR$FR
241131571$24113157$1$I$20240716$20240717$20240719$20240719$EXP$$US-BIOMARINAP-US-2024-159268$BIOMARIN$$$$$$Y$$$20240719$$CN$US$US
241131581$24113158$1$I$$20240716$20240719$20240719$EXP$NL-LRB-00992769$NL-ORGANON-O2407NLD001455$ORGANON$$59$YR$$M$Y$90$KG$20240719$$CN$NL$NL
241131591$24113159$1$I$20240701$20240716$20240719$20240719$EXP$FR-AFSSAPS-AN2024000893$FR-ORGANON-O2407FRA001380$ORGANON$$52$YR$$M$Y$82$KG$20240719$$MD$FR$FR
241131601$24113160$1$I$$20240716$20240719$20240719$EXP$$CA-ORGANON-O2407CAN001391$ORGANON$$44$YR$$F$Y$97$KG$20240719$$MD$CA$CA
241131612$24113161$2$F$$20240812$20240719$20240812$EXP$$US-BIOMARINAP-US-2024-159300$BIOMARIN$$$$$$Y$$$20240812$$CN$US$US
241131622$24113162$2$F$$20240820$20240719$20240821$PER$$US-PURDUE PHARMA-USA-2024-0310834$PURDUE$$70$YR$$F$Y$$$20240821$$CN$US$US
241131631$24113163$1$I$$20240716$20240719$20240719$EXP$$CA-ORGANON-O2407CAN001415$ORGANON$$62$YR$$M$Y$$$20240719$$HP$CA$CA
241131644$24113164$4$F$20240621$20240724$20240719$20240725$PER$$US-GILEAD-2024-0680550$GILEAD$$55$YR$A$F$Y$67$KG$20240725$$MD$US$US
241131651$24113165$1$I$$20240718$20240719$20240719$EXP$$CA-ORGANON-O2407CAN001807$ORGANON$Unknown. Unknown. Unknown. UNK$5$DY$$F$Y$$$20240719$$HP$CA$CA
241131662$24113166$2$F$$20240909$20240719$20240916$EXP$$JP-009507513-2407JPN002114J$MERCK$Wanifuchi Y, Fujita T, Asano T, Mori M, Matsumoto N, Isogai A, et al.. SY2-7 Long-term clinical outcome of triple-negative breast cancer treatment and future challenges. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 9$$$$F$Y$$$20240916$$MD$JP$JP
241131671$24113167$1$I$$20240705$20240719$20240719$EXP$$US-HLS-202400252$HLS THERAPEUTICS$$$$A$M$Y$$$20240719$$HP$US$US
241131681$24113168$1$I$$20240715$20240719$20240719$EXP$$US-EXELIXIS-CABO-24079418$EXELIXIS$$63$YR$$M$Y$$$20240719$$CN$US$US
241131691$24113169$1$I$$20240715$20240719$20240719$EXP$$US-EXELIXIS-CABO-24079462$EXELIXIS$$$$$F$Y$$$20240719$$CN$US$US
241131701$24113170$1$I$20240624$20240718$20240719$20240719$EXP$GB-MHRA-MED-202407180938492990-GYTMS$GB-ORGANON-O2407GBR001815$ORGANON$$30$YR$$F$Y$54$KG$20240719$$CN$GB$GB
241131711$24113171$1$I$$20240709$20240719$20240719$EXP$$GR-AMGEN-GRCSP2024136347$AMGEN$Alexandraki K. I.; Violetis O.; Konstantakou P. et. al.. The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review. Journal of Personalized Medicine. 2024;14 (6):1-28$45$YR$A$M$Y$$$20240719$$HP$GR$GR
241131721$24113172$1$I$$20240716$20240719$20240719$EXP$$GB-ORGANON-O2407GBR001696$ORGANON$$$$$F$Y$$$20240719$$CN$GB$GB
241131731$24113173$1$I$20240101$20240715$20240719$20240719$PER$$US-ORGANON-O2407USA001703$ORGANON$$$$$F$Y$$$20240719$$CN$US$US
241131741$24113174$1$I$20220101$20240709$20240719$20240719$EXP$FR-AFSSAPS-MP2024001110$FR-AMGEN-FRASP2024135905$AMGEN$$56$YR$A$M$Y$97$KG$20240719$$CN$FR$FR
241131751$24113175$1$I$20240521$20240709$20240719$20240719$EXP$FR-AFSSAPS-SE2024000539$FR-AMGEN-FRASP2024135895$AMGEN$$61$YR$A$M$Y$85$KG$20240719$$MD$FR$FR
241131761$24113176$1$I$20230528$20240712$20240719$20240719$EXP$$NVSC2023DO129392$NOVARTIS$$53$YR$$F$Y$$$20240720$$CN$DO$DO
241131771$24113177$1$I$$20240705$20240719$20240719$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109579$ZYDUS PHARM$Mignone D, Shah K, Alawneh B, Papadakos SP, Michelakis N.. A RUDE AWAKENING: A CASE OF SUGAMMADEX CAUSING TRANSIENT CARDIOMYOPATHY MIMICKING STEMI.. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):3618.$$$$$Y$$$20240719$$HP$US$US
241131781$24113178$1$I$$20240704$20240719$20240719$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109518$ZYDUS PHARM$Wu LW, Qasim Hussaini SM, Lee JW, Shu DH, Hruban RH, Laheru DA.. Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma-two case reports.. Ann- Pancreat-Cancer. 2022$$$$$Y$$$20240719$$MD$US$US
241131791$24113179$1$I$$20240705$20240719$20240719$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109531$ZYDUS PHARM$Ouyang J, Sasidharan S, Jatoi T, Salifu M.. How High Can Anion Gaps Be in Patients With Metabolic Acidosis? A Case Report.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240719$$HP$US$US
241131801$24113180$1$I$$20240708$20240719$20240719$EXP$$ES-THE J. MOLNER COMPANY-202407000011$The J.Molner Company$L. Aceituno. Oral quinolones versus intravenous ?-lactam for the treatment of acute focal bacterial nephritis: a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2024$$$$$Y$$$20240719$$HP$ES$ES
241131811$24113181$1$I$$20240705$20240719$20240719$EXP$$CN-RK PHARMA, INC-20240700033$RK PHARMA$Fengping Peng. Case report: Carbamazepine-induced thrombocytopenia complicated with severe skin reactions. Curr Res Transl Med. 2024;72(3)$$$$$Y$$$20240719$$HP$CN$CN
241131821$24113182$1$I$20231102$20240202$20240719$20240719$EXP$FR-AFSSAPS-RN2023001375$FR-TEVA-VS-3155996$TEVA$$49$YR$$M$Y$$$20240719$$MD$FR$FR
241131831$24113183$1$I$$20230817$20240719$20240719$EXP$$US-NOVOPROD-1245708$NOVO NORDISK$$$$$$Y$$$20240720$$CN$US$US
241131841$24113184$1$I$$20240709$20240719$20240719$EXP$$DE-009507513-2407DEU005463$MERCK$$$$$F$Y$$$20240719$$MD$DE$DE
241131851$24113185$1$I$$20240710$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407007622$ELI LILLY AND CO$$$$$M$Y$$$20240719$$CN$US$US
241131861$24113186$1$I$20240617$20240715$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407009983$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$US$US
241131871$24113187$1$I$$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011163$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$US$US
241131881$24113188$1$I$$20240712$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407008708$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240719$$CN$US$US
241131891$24113189$1$I$$20240712$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407009263$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240719$$CN$US$US
241131901$24113190$1$I$20240627$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011392$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240719$$CN$US$US
241131911$24113191$1$I$20240714$20240715$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407009700$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240719$$CN$US$US
241131921$24113192$1$I$$20240712$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407009510$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240719$$CN$US$US
241131931$24113193$1$I$20240701$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011553$ELI LILLY AND CO$$26$YR$A$M$Y$$$20240719$$CN$US$US
241131941$24113194$1$I$$20240709$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407007220$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240719$$CN$US$US
241131951$24113195$1$I$$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011224$ELI LILLY AND CO$$$$$$Y$$$20240719$$CN$US$US
241131961$24113196$1$I$20240618$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011830$ELI LILLY AND CO$$$$A$F$Y$$$20240719$$CN$US$US
241131972$24113197$2$F$20240707$20240715$20240719$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407009826$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240722$$CN$US$US
241131981$24113198$1$I$20240713$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011568$ELI LILLY AND CO$$$$$M$Y$$$20240719$$CN$US$US
241131991$24113199$1$I$$20240712$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407009503$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240719$$CN$US$US
241132001$24113200$1$I$20240717$20240718$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407012062$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240719$$CN$US$US
241132011$24113201$1$I$20240501$20240621$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202406015735$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$US$US
241132021$24113202$1$I$$20240715$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011142$ELI LILLY AND CO$$$$A$F$Y$$$20240719$$CN$US$US
241132031$24113203$1$I$$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011133$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$US$US
241132041$24113204$1$I$$20240712$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407008929$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240719$$CN$US$US
241132051$24113205$1$I$$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407010357$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240719$$MD$US$US
241132061$24113206$1$I$$20240228$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011951$ELI LILLY AND CO$$$$$$Y$$$20240719$$PH$US$US
241132071$24113207$1$I$20240715$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011471$ELI LILLY AND CO$$49$YR$A$$Y$$$20240719$$CN$US$US
241132082$24113208$2$F$20240714$20240813$20240719$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202407010983$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240817$$CN$US$US
241132091$24113209$1$I$$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407010982$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240719$$CN$US$US
241132101$24113210$1$I$$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011070$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$US$US
241132112$24113211$2$F$$20240729$20240719$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407011885$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240801$$HP$US$US
241132121$24113212$1$I$20240717$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011529$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240719$$CN$US$US
241132131$24113213$1$I$20240706$20240706$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407004881$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240719$$CN$US$US
241132142$24113214$2$F$$20240717$20240719$20240722$30DAY$$US-ELI_LILLY_AND_COMPANY-US202407012468$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240722$$HP$US$US
241132151$24113215$1$I$$20240619$20240719$20240719$30DAY$$US-VEROBIOTECH-2024USVEROSPO00146$VERO BIOTECH$$$$$$Y$$$20240719$$HP$US$US
241132161$24113216$1$I$20240713$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011361$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240719$$CN$US$US
241132171$24113217$1$I$20230101$20240621$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011941$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240719$$CN$US$US
241132181$24113218$1$I$$20240709$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407007834$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240719$$CN$US$US
241132191$24113219$1$I$20240718$20240718$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407012339$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240719$$CN$US$US
241132201$24113220$1$I$$20240709$20240719$20240719$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407006672$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$DE$DE
241132221$24113222$1$I$20240713$20240718$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407012615$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240719$$CN$US$US
241132231$24113223$1$I$20231222$20240708$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006448$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240719$$CN$US$US
241132241$24113224$1$I$$20240709$20240719$20240719$EXP$GB-MHRA-MED-202407091236321830-TZHYJ$GB-ELI_LILLY_AND_COMPANY-GB202407007346$ELI LILLY AND CO$$39$YR$A$F$Y$78$KG$20240719$$CN$GB$GB
241132253$24113225$3$F$$20240813$20240719$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006338$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240823$$CN$US$US
241132261$24113226$1$I$$20240707$20240719$20240719$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407006654$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$BR$BR
241132271$24113227$1$I$$20240708$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407005802$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240719$$CN$US$US
241132281$24113228$1$I$$20240709$20240719$20240719$EXP$GB-MHRA-MED-202407091150235470-QGFDP$GB-ELI_LILLY_AND_COMPANY-GB202407005770$ELI LILLY AND CO$$$$$M$Y$$$20240719$$CN$GB$GB
241132291$24113229$1$I$$20240709$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006739$ELI LILLY AND CO$$$$$M$Y$$$20240719$$MD$US$US
241132301$24113230$1$I$20231201$20240708$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006514$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240719$$CN$US$US
241132311$24113231$1$I$$20240708$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407005289$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240719$$CN$US$US
241132321$24113232$1$I$$20240709$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007150$ELI LILLY AND CO$$$$$$Y$$$20240719$$CN$US$US
241132332$24113233$2$F$20231201$20240726$20240719$20240807$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407006754$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240807$$CN$JP$JP
241132341$24113234$1$I$$20240709$20240719$20240719$EXP$GB-MHRA-MED-202407091108503480-BGRKY$GB-ELI_LILLY_AND_COMPANY-GB202407005769$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$GB$GB
241132351$24113235$1$I$$20240709$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006761$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240719$$CN$US$US
241132361$24113236$1$I$$20240709$20240719$20240719$EXP$GB-MHRA-MED-202407081252414430-ZPGRC$GB-ELI_LILLY_AND_COMPANY-GB202407005850$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240719$$CN$GB$GB
241132371$24113237$1$I$$20240301$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407012143$ELI LILLY AND CO$$$$$$Y$$$20240719$$CN$US$US
241132381$24113238$1$I$20240709$20240710$20240719$20240719$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406004928$ELI LILLY AND CO$$$$$M$Y$$$20240719$$CN$JP$JP
241132391$24113239$1$I$$20240708$20240719$20240719$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202407005581$ELI LILLY AND CO$$$$$F$Y$$$20240719$$MD$SA$SA
241132401$24113240$1$I$$20240708$20240719$20240719$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202407005528$ELI LILLY AND CO$$$$$F$Y$$$20240719$$MD$SA$SA
241132411$24113241$1$I$$20240708$20240719$20240719$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407006491$ELI LILLY AND CO$$$$$F$Y$$$20240719$$MD$GB$GB
241132421$24113242$1$I$$20240709$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007038$ELI LILLY AND CO$$$$$M$Y$$$20240719$$CN$US$US
241132431$24113243$1$I$20240716$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011187$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240719$$CN$US$US
241132441$24113244$1$I$20240709$20240709$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006520$ELI LILLY AND CO$$$$$$Y$$$20240719$$CN$US$US
241132451$24113245$1$I$$20240708$20240719$20240719$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407005404$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240719$$MD$GB$GB
241132461$24113246$1$I$$20240709$20240719$20240719$EXP$GB-MHRA-MED-202407091036186020-YZHTP$GB-ELI_LILLY_AND_COMPANY-GB202407005766$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$GB$GB
241132471$24113247$1$I$20240701$20240709$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006008$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240719$$HP$US$US
241132481$24113248$1$I$$20240709$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407006413$ELI LILLY AND CO$$57$YR$A$$Y$$$20240719$$LW$US$US
241132491$24113249$1$I$20240716$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011598$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240719$$CN$US$US
241132501$24113250$1$I$20240702$20240707$20240719$20240719$EXP$GB-MHRA-MED-202407071313201300-PLKCM$GB-ELI_LILLY_AND_COMPANY-GB202407005759$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240719$$CN$GB$GB
241132511$24113251$1$I$$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011274$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240719$$CN$US$US
241132521$24113252$1$I$$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011266$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240719$$CN$US$US
241132531$24113253$1$I$$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011245$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240719$$CN$US$US
241132541$24113254$1$I$$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407010755$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240719$$CN$US$US
241132551$24113255$1$I$20240717$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011386$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240719$$CN$US$US
241132561$24113256$1$I$$20240709$20240719$20240719$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407009255AA$ELI LILLY AND CO$Iizuka N, et al..A case of lung adenocarcinoma in which infliximab was effective against drug-induced lung injury caused by combined immunotherapy.lung cancer 2024;64:258.$51$YR$A$M$Y$$$20240719$$MD$JP$JP
241132571$24113257$1$I$$20240707$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007425$ELI LILLY AND CO$Bobbs S.,Howland J..A Case of Compounded Tirzepatide-induced Psychiatric Adverse Effects..Current Developments in Nutrition. Conference: NUTRITION 2024;8(Supplement 2):102316.DOI:https://doi.org/10.1016/j.cdnut.2024.102318$61$YR$A$F$Y$$$20240719$$HP$US$US
241132581$24113258$1$I$$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407010471$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240719$$CN$US$US
241132591$24113259$1$I$20240612$20240708$20240719$20240719$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407005607$ELI LILLY AND CO$$68$YR$E$M$Y$62.5$KG$20240719$$CN$CN$CN
241132601$24113260$1$I$20240716$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407010298$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240719$$CN$US$US
241132611$24113261$1$I$$20240715$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407009975$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240719$$CN$US$US
241132621$24113262$1$I$20240601$20240710$20240719$20240719$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407010730$ELI LILLY AND CO$$63$YR$A$F$Y$90$KG$20240719$$CN$DE$CN
241132631$24113263$1$I$$20240705$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407004373$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240719$$CN$US$US
241132641$24113264$1$I$20240706$20240715$20240719$20240719$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009314$ELI LILLY AND CO$$80$YR$E$F$Y$65$KG$20240719$$PH$US$US
241132651$24113265$1$I$$20240710$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407009002$ELI LILLY AND CO$$61$YR$A$$Y$$$20240719$$CN$US$US
241132661$24113266$1$I$$20240716$20240719$20240719$EXP$$CH-ELI_LILLY_AND_COMPANY-CH202407010550$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240719$$CN$CH$CH
241132671$24113267$1$I$$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011004$ELI LILLY AND CO$$$$$M$Y$$$20240719$$CN$US$US
241132681$24113268$1$I$20240717$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011447$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240719$$CN$US$US
241132691$24113269$1$I$$20240709$20240719$20240719$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407005997$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240719$$PH$JP$JP
241132702$24113270$2$F$$20240808$20240719$20240815$EXP$$SZ-ELI_LILLY_AND_COMPANY-CH202407010666$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240815$$CN$CH$CH
241132711$24113271$1$I$20240601$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011452$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240719$$CN$US$US
241132721$24113272$1$I$20240713$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011394$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240719$$CN$US$US
241132732$24113273$2$F$20221122$20240731$20240719$20240806$EXP$$CH-ELI_LILLY_AND_COMPANY-CH202407010155$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240806$$CN$CH$CH
241132741$24113274$1$I$$20240708$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407006320$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$US$US
241132751$24113275$1$I$$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011460$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240719$$CN$US$US
241132761$24113276$1$I$20240501$20240708$20240719$20240719$EXP$FR-AFSSAPS-AM2024000551$FR-ELI_LILLY_AND_COMPANY-FR202407005817$ELI LILLY AND CO$$66$YR$E$M$Y$79$KG$20240719$$CN$FR$FR
241132774$24113277$4$F$20240615$20240826$20240719$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007544$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240904$$CN$US$US
241132781$24113278$1$I$$20240709$20240719$20240719$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202407007581$ELI LILLY AND CO$Elisa Bellis, Piero Ruscitti, Denise Donzella, Gloria Crepaldi, Valeria Data, Marinella Gammino, Mariele Gatto, Valeria Guardo, Claudia Lomater, Elena Marucco, Marta Saracco and Annamaria Iagnocco..Retention Rate of Ixekizumab in Psoriatic Arthritis: A Real-World Study.J. Pers. Med. 2024;14:716.DOI:10.3390/jpm14070716$$$A$$Y$$$20240719$$HP$IT$IT
241132791$24113279$1$I$$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407010417$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240719$$CN$US$US
241132801$24113280$1$I$$20240709$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407006645$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240719$$CN$US$US
241132811$24113281$1$I$20221101$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011146$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240719$$CN$US$US
241132821$24113282$1$I$$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407010347$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240719$$CN$US$US
241132831$24113283$1$I$$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011263$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240719$$CN$US$US
241132841$24113284$1$I$$20240718$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407012124$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$US$US
241132851$24113285$1$I$$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011980$ELI LILLY AND CO$$$$$F$Y$$$20240719$$CN$US$US
241132861$24113286$1$I$$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011200$ELI LILLY AND CO$$$$$F$Y$$$20240719$$HP$US$US
241132871$24113287$1$I$$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011173$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240719$$HP$US$US
241132881$24113288$1$I$$20240717$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011570$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240719$$CN$US$US
241132891$24113289$1$I$$20240716$20240719$20240719$PER$$US-ELI_LILLY_AND_COMPANY-US202407011241$ELI LILLY AND CO$$$$$$Y$$$20240719$$CN$US$US
241132901$24113290$1$I$20240701$20240716$20240719$20240719$PER$$US-ABBVIE-5843306$ABBVIE$$29$YR$$F$Y$$$20240719$$MD$US$US
241132911$24113291$1$I$$20240716$20240719$20240719$EXP$$CA-ABBVIE-5845062$ABBVIE$$$$E$M$Y$$$20240719$$CN$CA$CA
241132921$24113292$1$I$20240626$20240705$20240719$20240719$EXP$GB-MHRA-MED-202406260823074440-ZTJLM$GB-MACLEODS PHARMA-MAC2024048277$MACLEODS$$$$$$Y$$$20240719$$CN$GB$GB
241132931$24113293$1$I$20240319$20240717$20240719$20240719$EXP$$DE-ABBVIE-5845093$ABBVIE$$68$YR$$M$Y$$$20240719$$CN$DE$DE
241132942$24113294$2$F$$20240723$20240719$20240802$EXP$$IT-MACLEODS PHARMA-MAC2024048251$MACLEODS$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et al..Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars.Toxicology Reports.2024;13:101683$$$$$Y$$$20240802$$MD$IT$IT
241132951$24113295$1$I$$20240620$20240719$20240719$PER$$US-009507513-2407USA001371$MERCK$Pandhair O.. Confoundingly Persistent Pneumonia in a Heart Transplant Patient. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2442$67$YR$$M$Y$$$20240719$$HP$US$US
241132971$24113297$1$I$20240703$20240712$20240719$20240719$EXP$$CA-ABBVIE-5839958$ABBVIE$$76$YR$$F$Y$$$20240719$$HP$CA$CA
241132981$24113298$1$I$$20240712$20240719$20240719$EXP$$JP-MALLINCKRODT-MNK202404635$MALLINCKRODT$Uchida Y, Hiromura S, Matsuzaki Y, Katayama Y, Oida N, Furuya T, Kimura Y, Kondo U, Kushima R..A case of extremely low birth weight infant with severe neonatal asphyxia and posthemorrhagic hydrocephalus born to a foreign tourist with eclampsia who travelled internationally.Journal of Japan Society of Perinatal and Neonatal Medicine.22-JUN-2024;60 (S1):359$1$DY$N$$Y$1$KG$20240719$$HP$JP$JP
241132991$24113299$1$I$$20240705$20240719$20240719$EXP$GB-MHRA-MED-202405140857136860-LVHKT$GB-MACLEODS PHARMA-MAC2024048388$MACLEODS$$$$$$Y$$$20240719$$HP$GB$GB
241133001$24113300$1$I$$20240712$20240719$20240719$EXP$$NO-ABBVIE-5845057$ABBVIE$$$$$M$Y$$$20240719$$MD$NO$NO
241133011$24113301$1$I$20240616$20240717$20240719$20240719$EXP$$CO-ABBVIE-5845219$ABBVIE$$60$YR$$F$Y$40$KG$20240719$$CN$CO$CO
241133021$24113302$1$I$$20231030$20240719$20240719$EXP$$US-NOVOPROD-1247625$NOVO NORDISK$$$$$$Y$$$20240720$$CN$US$US
241133031$24113303$1$I$$20240709$20240719$20240719$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0250$GRAVITI PHARMACEUTICALS$Natarajan S, Amjad M, Zaidi S, Shah A, Ochieng PO.Persistent Bilateral Spontaneous Pneumothorax in Combined Pulmonary Fibrosis and Emphysema.Am-J-Respir-Crit-Care-Med.2023;207:A3218$72$YR$E$M$Y$$$20240719$$HP$US$US
241133042$24113304$2$F$20240715$20240718$20240719$20240721$EXP$$CH-ABBVIE-5845076$ABBVIE$$84$YR$$F$Y$$$20240721$$CN$CH$CH
241133051$24113305$1$I$20240717$20240717$20240719$20240719$EXP$$DE-ABBVIE-5845080$ABBVIE$$78$YR$$M$Y$$$20240719$$CN$DE$DE
241133061$24113306$1$I$$20240705$20240719$20240719$EXP$$US-QUAGEN-2024QUALIT00209$QUAGEN PHARMACEUTICALS$Simone C.Levetiracetam-associated Rhabdomyolysis.American Journal of Respiratory and Critical Care Medicine.MAY-2021;209$20$YR$A$M$Y$$$20240719$$HP$US$US
241133073$24113307$3$F$$20240719$20240719$20240726$EXP$$JP-009507513-2407JPN002410J$MERCK$$72$YR$$F$Y$$$20240726$$MD$JP$JP
241133081$24113308$1$I$$20240705$20240719$20240719$EXP$$US-QUAGEN-2024QUALIT00211$QUAGEN PHARMACEUTICALS$R. Hoerle.Lipid Emulsion Therapy in Lidocaine Anesthetic Systemic Toxicity (LAST).American Journal of Respiratory and Critical Care Medicine.NAY-2021;209:A5683$81$YR$E$F$Y$$$20240719$$HP$US$US
241133091$24113309$1$I$$20240711$20240719$20240719$EXP$$CA-TEVA-VS-3221221$TEVA$$$$$$Y$$$20240719$$CN$CA$CA
241133101$24113310$1$I$20190401$20240709$20240719$20240719$EXP$$DE-TEVA-VS-3219364$TEVA$$67$YR$$M$Y$$$20240719$$LW$DE$DE
241133112$24113311$2$F$20230801$20240730$20240719$20240812$EXP$$US-NOVOPROD-1255169$NOVO NORDISK$$52$YR$$F$Y$$$20240812$$CN$US$US
241133121$24113312$1$I$$20240709$20240719$20240719$EXP$$US-TEVA-VS-3220094$TEVA$$57$YR$$F$Y$$$20240719$$CN$US$US
241133131$24113313$1$I$20240613$20240709$20240719$20240719$EXP$GB-MHRA-MED-202407081335013570-NFGKM$GB-TEVA-VS-3219971$TEVA$$58$YR$$M$Y$$$20240719$$HP$GB$GB
241133141$24113314$1$I$20230101$20240421$20240719$20240719$EXP$$DE-TEVA-VS-3137742$TEVA$$51$YR$$M$Y$$$20240719$$CN$DE$DE
241133151$24113315$1$I$$20240711$20240719$20240719$EXP$$CA-TEVA-VS-3221552$TEVA$$71$YR$$M$Y$$$20240719$$PH$CA$CA
241133161$24113316$1$I$$20240711$20240719$20240719$EXP$$CA-TEVA-VS-3221405$TEVA$$32$YR$$F$Y$$$20240719$$PH$CA$CA
241133171$24113317$1$I$20240629$20240709$20240719$20240719$EXP$GB-MHRA-MED-202407092045395210-CQDTR$GB-TEVA-VS-3219833$TEVA$$52$YR$$F$Y$105$KG$20240719$$CN$GB$GB
241133181$24113318$1$I$$20240705$20240719$20240719$EXP$$BR-QUAGEN-2024QUALIT00219$QUAGEN PHARMACEUTICALS$P. M. Cavalcante Neto.Non-Eosinophilic Exudative Pleural Effusion Induced by Valproic Acid.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:abstr. A50$55$YR$A$M$Y$$$20240719$$HP$BR$BR
241133192$24113319$2$F$$20240801$20240719$20240810$EXP$$US-TEVA-VS-3219597$TEVA$Razia D, Moin A, Walia T, Arjuna A. Metastatic Large Cell Neuroendocrine Carcinoma of Unknown Primary in a Lung Transplant Recipient. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A5947.; Razia D, Moin A, Walia T, Arjuna A. Metastatic Large Cell Neuroendocrine Carcinoma of Unknown Primary in a Lung Transplant Recipient. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A5947.$73$YR$$M$Y$$$20240810$$HP$US$US
241133201$24113320$1$I$20240501$20240709$20240719$20240719$EXP$$US-TEVA-VS-3198950$TEVA$$65$YR$$M$Y$$$20240719$$CN$US$US
241133211$24113321$1$I$20240523$20240711$20240719$20240719$EXP$FR-AFSSAPS-NT2024000766$FR-TEVA-VS-3220683$TEVA$$63$YR$$F$Y$32$KG$20240719$$HP$FR$FR
241133221$24113322$1$I$$20240705$20240719$20240719$EXP$$US-QUAGEN-2024QUALIT00220$QUAGEN PHARMACEUTICALS$H Huang.Traumatic lens subluxation from pickleball injury: a case series..Retinal cases and brief reports.JAN-2024;18:15-17$76$YR$E$F$Y$$$20240719$$HP$US$US
241133231$24113323$1$I$$20240711$20240719$20240719$EXP$$CA-TEVA-VS-3221231$TEVA$$34$YR$$F$Y$$$20240719$$HP$CA$CA
241133241$24113324$1$I$20240704$20240709$20240719$20240719$EXP$GB-MHRA-MED-202407091509566330-KSMBH$GB-TEVA-VS-3219962$TEVA$$71$YR$$M$Y$$$20240719$$PH$GB$GB
241133251$24113325$1$I$20200128$20240710$20240719$20240719$EXP$$ES-TEVA-VS-3220362$TEVA$$58$YR$$M$Y$$$20240719$$MD$ES$ES
241133261$24113326$1$I$$20240711$20240719$20240719$EXP$$CA-TEVA-VS-3221258$TEVA$$64$YR$$F$Y$$$20240719$$HP$CA$CA
241133271$24113327$1$I$$20240711$20240719$20240719$EXP$$CA-TEVA-VS-3221266$TEVA$$32$YR$$F$Y$$$20240719$$HP$CA$CA
241133281$24113328$1$I$$20240711$20240719$20240719$EXP$$CA-TEVA-VS-3221373$TEVA$$75$YR$$F$Y$$$20240719$$HP$CA$CA
241133291$24113329$1$I$$20240711$20240719$20240719$EXP$$CA-TEVA-VS-3221553$TEVA$$3$YR$$F$Y$$$20240719$$MD$CA$CA
241133301$24113330$1$I$$20240711$20240719$20240719$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01299$NOVITIUM PHARMA$Ying-Chi Shen.Case Report: Lacosamide unmasking SCN5A-associated Brugada syndrome in a young female with epilepsy.Frontiers in Cardiovascular Medicine.31-MAY-2024;11:1-6$33$YR$A$F$Y$$$20240719$$HP$CN$CN
241133311$24113331$1$I$$20240705$20240719$20240719$EXP$$NL-QUAGEN-2024QUALIT00223$QUAGEN PHARMACEUTICALS$Geke van Weringh.Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/norclozapine ratio after switching valproic acid to carbamazepine: a case report.Therapeutic Advances in Psychopharmacology .19-APR-2024;14:1-8$42$YR$A$M$Y$65.9$KG$20240719$$HP$NL$NL
241133321$24113332$1$I$$20240712$20240719$20240719$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01311$NOVITIUM PHARMA$M Malavasi.THE CONUNDRUM OF DRUG INTERACTIONS AND HOLTER MONITORING: LAMIN GENE MUTATION DISCOVERED BY A TORSADE DE POINTES EPISODE FOLLOWED BY OUT-OF-THE-HOSPITAL RESUSCITATION.European Heart Journal Supplements.16-MAY-2024;26(2):ii55-ii56$57$YR$A$F$Y$$$20240719$$HP$IT$IT
241133331$24113333$1$I$20240628$20240709$20240719$20240719$EXP$GB-MHRA-MED-202407082130010460-VKNDG$GB-TEVA-VS-3219965$TEVA$$73$YR$$F$Y$61$KG$20240719$$CN$GB$GB
241133341$24113334$1$I$$20240711$20240719$20240719$EXP$$US-NOVITIUMPHARMA-2024USNVP01295$NOVITIUM PHARMA$Pooya Zardoost.Continuous renal replacement therapy for lithium toxicity: A worthy treatment to avoid intradialytic hypotension and vasopressors.Clinical Case Reports.23-APR-2024;12:e8775$54$YR$A$F$Y$$$20240719$$HP$US$US
241133351$24113335$1$I$$20240711$20240719$20240719$EXP$$CA-TEVA-VS-3221245$TEVA$$$$$F$Y$$$20240719$$HP$CA$CA
241133361$24113336$1$I$20240319$20240711$20240719$20240719$EXP$FR-AFSSAPS-AVPA2024000621$FR-TEVA-VS-3220531$TEVA$$47$YR$$M$Y$$$20240719$$MD$FR$FR
241133371$24113337$1$I$$20240711$20240719$20240719$EXP$$US-NOVITIUMPHARMA-2024USNVP01300$NOVITIUM PHARMA$Alexander J.RUSH TO DE-LIVER: A CASE OF HSV HEPATITIS IN PREGNANCY.Journal of Hospital Medicine.07-APR-2023;18(S1):S635-S636$24$YR$A$F$Y$$$20240719$$HP$US$US
241133381$24113338$1$I$$20240712$20240719$20240719$EXP$$US-NOVITIUMPHARMA-2024USNVP01308$NOVITIUM PHARMA$Christopher Siler.Polypharmacy in Older Adults: A Case Study.S D Med.MAR-2023;76:124-127$64$YR$A$F$Y$$$20240719$$HP$US$US
241133391$24113339$1$I$20240518$20240711$20240719$20240719$EXP$FR-AFSSAPS-AVTO2024000105$FR-TEVA-VS-3220371$TEVA$$50$YR$$M$Y$$$20240719$$MD$FR$FR
241133411$24113341$1$I$20240602$20240711$20240719$20240719$EXP$IT-MINISAL02-993623$IT-TEVA-VS-3220607$TEVA$$74$YR$$F$Y$$$20240719$$MD$IT$IT
241133421$24113342$1$I$20240429$20240715$20240719$20240719$EXP$$US-ABBVIE-5843945$ABBVIE$$84$YR$$F$Y$$$20240719$$CN$US$US
241133431$24113343$1$I$$20240708$20240719$20240719$EXP$$US-SLATERUN-2024SRLIT00129$SLATE RUN$Prabhu S, et al.Amlodipine: Not an Ace in the Hole.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209 (1):A1361$56$YR$A$M$Y$$$20240719$$HP$US$US
241133441$24113344$1$I$20230601$20240711$20240719$20240719$EXP$FR-AFSSAPS-DJ2024000816$FR-TEVA-VS-3220662$TEVA$$68$YR$$F$Y$$$20240719$$MD$FR$FR
241133451$24113345$1$I$$20240604$20240719$20240719$PER$$US-ASCENT-2024ASREG00004$ASCENT$$$$$$Y$$$20240719$$CN$US$US
241133461$24113346$1$I$20240612$20240711$20240719$20240719$EXP$FR-AFSSAPS-AN2024000875$FR-TEVA-VS-3220659$TEVA$$65$YR$$M$Y$$$20240719$$PH$FR$FR
241133471$24113347$1$I$20240626$20240711$20240719$20240719$EXP$FR-AFSSAPS-BX2024001344$FR-TEVA-VS-3220424$TEVA$$72$YR$$M$Y$76$KG$20240719$$CN$FR$FR
241133481$24113348$1$I$$20240604$20240719$20240719$PER$$US-ASCENT-2024ASREG00005$ASCENT$$$$$M$Y$$$20240719$$CN$US$US
241133491$24113349$1$I$$20240709$20240719$20240719$EXP$$GB-TEVA-VS-3220036$TEVA$$$$$M$Y$$$20240719$$CN$GB$GB
241133501$24113350$1$I$$20240708$20240719$20240719$PER$$US-TEVA-VS-3219596$TEVA$$66$YR$$F$Y$$$20240719$$PH$US$US
241133511$24113351$1$I$$20240604$20240719$20240719$PER$$US-ASCENT-2024ASSPO00003$ASCENT$$91$YR$E$M$Y$$$20240719$$CN$US$US
241133521$24113352$1$I$20240219$20240711$20240719$20240719$EXP$FR-AFSSAPS-AN2024000874$FR-TEVA-VS-3220670$TEVA$$15$YR$$M$Y$38.1$KG$20240719$$MD$FR$FR
241133532$24113353$2$F$20231101$20240807$20240719$20240815$EXP$FR-AFSSAPS-TS2024000765$FR-TEVA-VS-3220669$TEVA$$78$YR$$F$Y$$$20240815$$MD$FR$FR
241133541$24113354$1$I$$20240711$20240719$20240719$EXP$$CA-TEVA-VS-3221333$TEVA$$58$YR$$M$Y$$$20240719$$HP$CA$CA
241133551$24113355$1$I$20240607$20240711$20240719$20240719$EXP$FR-AFSSAPS-GR2024000832$FR-TEVA-VS-3220675$TEVA$$10$YR$$M$Y$35$KG$20240719$$PH$FR$FR
241133561$24113356$1$I$$20240709$20240719$20240719$EXP$$HR-TEVA-VS-3221102$TEVA$$$$$M$Y$$$20240719$$CN$HR$HR
241133571$24113357$1$I$$20240711$20240719$20240719$EXP$$CA-TEVA-VS-3221274$TEVA$$79$YR$$F$Y$$$20240719$$HP$CA$CA
241133582$24113358$2$F$$20240801$20240719$20240810$EXP$$US-TEVA-VS-3220110$TEVA$Chan W, Park S, Shirkhoda L, O^Connell R, Houshyar R. Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells: a case report. J-Med-Case-Rep 2023; 17.; Chan W, Park S, Shirkhoda L, O^Connell R, Houshyar R. Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells: a case report. J-Med-Case-Rep 2023; 17.; Chan W, Park S, Shirkhoda L, O^Connell R, Houshyar R. Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells: a case report. J-Med-C...$54$YR$$M$Y$$$20240810$$HP$US$US
241133592$24113359$2$F$$20240801$20240719$20240810$EXP$$US-TEVA-VS-3220144$TEVA$Goudie MP, Khawam S, Levy JM, Hartfield R, Hassan S, Dawson M. A Storm is Brewing: A Case of Thyrotoxic Crisis. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Goudie MP, Khawam S, Levy JM, Hartfield R, Hassan S, Dawson M. A Storm is Brewing: A Case of Thyrotoxic Crisis. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$27$YR$$M$Y$$$20240810$$HP$US$US
241133611$24113361$1$I$20230701$20240711$20240719$20240719$EXP$FR-AFSSAPS-DJ2024000821$FR-TEVA-VS-3220661$TEVA$$66$YR$$M$Y$$$20240719$$MD$FR$FR
241133621$24113362$1$I$20240703$20240709$20240719$20240719$EXP$GB-MHRA-MED-202407081358055900-NCHJG$GB-TEVA-VS-3219554$TEVA$$61$YR$$F$Y$71$KG$20240719$$PH$GB$GB
241133631$24113363$1$I$$20240710$20240719$20240719$EXP$$CA-TEVA-VS-3220282$TEVA$$71$YR$$F$Y$$$20240719$$PH$CA$CA
241133641$24113364$1$I$$20240710$20240719$20240719$EXP$$CA-TEVA-VS-3220269$TEVA$$$$$$Y$$$20240719$$HP$CA$CA
241133651$24113365$1$I$$20240710$20240719$20240719$EXP$$CA-TEVA-VS-3220134$TEVA$$61$YR$$F$Y$$$20240719$$HP$CA$CA
241133661$24113366$1$I$20240716$20240716$20240719$20240719$EXP$$NL-ABBVIE-5845059$ABBVIE$$66$YR$$F$Y$$$20240719$$CN$NL$NL
241133671$24113367$1$I$20240125$20240709$20240719$20240719$EXP$GB-MHRA-MED-202407081950377100-MCSQK$GB-TEVA-VS-3219698$TEVA$$4$YR$$M$Y$16$KG$20240719$$CN$GB$GB
241133681$24113368$1$I$$20240710$20240719$20240719$EXP$$CA-TEVA-VS-3220082$TEVA$$$$A$$Y$$$20240719$$HP$CA$CA
241133691$24113369$1$I$20240617$20240711$20240719$20240719$EXP$SE-SEMPA-2024-005289$SE-TEVA-VS-3220523$TEVA$$1$YR$$M$Y$$$20240719$$MD$SE$SE
241133701$24113370$1$I$$20240717$20240719$20240719$EXP$$US-ABBVIE-5845122$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241133712$24113371$2$F$20240718$20240719$20240719$20240720$PER$$US-AMGEN-USASP2024143474$AMGEN$$69$YR$E$F$Y$$$20240720$$CN$US$US
241133721$24113372$1$I$$20240715$20240719$20240719$PER$$US-ABBVIE-5843188$ABBVIE$$$$$$Y$$$20240719$$CN$US$US
241133731$24113373$1$I$20240621$20240626$20240719$20240719$PER$$US-009507513-2406USA009139$MERCK$$46$YR$$M$Y$$$20240719$$HP$US$US
241133741$24113374$1$I$20240715$20240717$20240719$20240719$EXP$$US-ROCHE-10000030278$ROCHE$$73$YR$E$F$Y$$$20240720$$HP$US$US
241133751$24113375$1$I$$20240715$20240719$20240719$EXP$$US-ABBVIE-5761625$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241133761$24113376$1$I$20240711$20240717$20240719$20240719$EXP$$CA-ABBVIE-5845061$ABBVIE$$75$YR$$F$Y$$$20240719$$HP$CA$CA
241133771$24113377$1$I$20240715$20240715$20240719$20240719$PER$$US-AMGEN-USASP2024140099$AMGEN$$$$$F$Y$$$20240719$$CN$US$US
241133781$24113378$1$I$$20240712$20240719$20240719$PER$$US-ABBVIE-5840208$ABBVIE$$$$$$Y$$$20240719$$CN$US$US
241133791$24113379$1$I$20240101$20240716$20240719$20240719$EXP$$CA-ABBVIE-5843981$ABBVIE$$$$A$M$Y$$$20240719$$CN$CA$CA
241133801$24113380$1$I$$20240710$20240719$20240719$EXP$$US-Axsome Therapeutics, Inc.-AXS202407-001000$AXSOME THERAPEUTICS$$22$YR$A$M$Y$$$20240719$$MD$US$
241133811$24113381$1$I$$20240717$20240719$20240719$PER$$US-AMGEN-USASP2024143022$AMGEN$$$$$$Y$$$20240719$$CN$US$US
241133821$24113382$1$I$$20240715$20240719$20240719$EXP$$JP-ROCHE-10000030425$ROCHE$Matsuoka A, Tate S, Nishikimi K, Otsuka S, Usui H, Tajima S, et al. Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series. Journal of Obstetrics and Gynaecology Research. 2024-Jul;50 (7):1148-54. doi:10.1111/jog.15954.$57$YR$A$F$Y$$$20240720$$HP$JP$JP
241133833$24113383$3$F$20240101$20240912$20240719$20240917$EXP$$US-ABBVIE-5843383$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
241133841$24113384$1$I$20240408$20240715$20240719$20240719$EXP$$CA-ABBVIE-5842888$ABBVIE$$49$YR$$F$Y$$$20240719$$CN$CA$CA
241133851$24113385$1$I$$20240715$20240719$20240719$PER$$US-ABBVIE-5841246$ABBVIE$$$$$$Y$$$20240719$$CN$US$US
241133861$24113386$1$I$20240702$20240707$20240719$20240719$EXP$GB-MHRA-MED-202407051853168380-KVPCG$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15332$ALKEM$$$$$F$Y$57$KG$20240719$$CN$GB$GB
241133871$24113387$1$I$$20240707$20240719$20240719$EXP$GB-MHRA-MED-202406261659083070-WNLCP$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15324$ALKEM$$$$$M$Y$$$20240719$$PH$GB$GB
241133881$24113388$1$I$20240201$20240706$20240719$20240719$EXP$GB-MHRA-MED-202405091711040630-QMNWC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15359$ALKEM$$36$YR$$M$Y$$$20240719$$CN$GB$GB
241133891$24113389$1$I$20230915$20240707$20240719$20240719$EXP$GB-MHRA-WEBCOVID-202405031001175710-NGDRS$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15290$ALKEM$$70$YR$$$Y$83$KG$20240719$$CN$GB$GB
241133901$24113390$1$I$20170106$20240706$20240719$20240719$EXP$GB-MHRA-MED-202405142045567050-ZYRQP$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15346$ALKEM$$18$YR$$F$Y$55$KG$20240719$$CN$GB$GB
241133911$24113391$1$I$20240509$20240706$20240719$20240719$EXP$GB-MHRA-MED-202405171415438930-CKYNW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15539$ALKEM$$$$$M$Y$2$KG$20240719$$MD$GB$GB
241133921$24113392$1$I$20220101$20240706$20240719$20240719$EXP$GB-MHRA-MED-202405071957286520-FKGWQ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15380$ALKEM$$72$YR$$M$Y$64$KG$20240719$$CN$GB$GB
241133931$24113393$1$I$$20240715$20240719$20240719$EXP$$JP-ROCHE-10000030422$ROCHE$Matsuoka A, Tate S, Nishikimi K, Otsuka S, Usui H, Tajima S, et al. Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series. Journal of Obstetrics and Gynaecology Research. 2024-Jul;50 (7):1148-54. doi:10.1111/jog.15954.$61$YR$A$F$Y$$$20240720$$HP$JP$JP
241133942$24113394$2$F$$20240807$20240719$20240812$EXP$$NL-AMGEN-NLDSP2024140146$AMGEN$$79$YR$E$F$Y$55$KG$20240812$$HP$NL$NL
241133951$24113395$1$I$$20240707$20240719$20240719$EXP$GB-MHRA-MED-202405021301408190-MKGLP$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15314$ALKEM$$$$$F$Y$$$20240719$$CN$GB$GB
241133961$24113396$1$I$$20240706$20240719$20240719$EXP$GB-MHRA-MED-202405082345420790-DRFMC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15355$ALKEM$$$$$F$Y$62$KG$20240719$$CN$GB$GB
241133971$24113397$1$I$$20240706$20240719$20240719$EXP$GB-MHRA-MED-202405081535377470-TPYSN$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15354$ALKEM$$$$$F$Y$87$KG$20240719$$PH$GB$GB
241133981$24113398$1$I$20240620$20240707$20240719$20240719$EXP$GB-MHRA-TPP10612736C20742220YC1719223259190$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15285$ALKEM$$61$YR$$F$Y$60$KG$20240719$$MD$GB$GB
241133991$24113399$1$I$20240617$20240717$20240719$20240719$EXP$$US-ABBVIE-5845077$ABBVIE$$66$YR$$M$Y$$$20240719$$CN$US$US
241134001$24113400$1$I$$20231124$20240719$20240719$EXP$GB-MHRA-MED-202311231642015740-KJSVR$GB-TEVA-2023-GB-2949470$TEVA$$74$YR$$M$Y$$$20240719$$PH$GB$GB
241134012$24113401$2$F$$20240709$20240719$20240719$PER$$US-AMGEN-USASP2024137403$AMGEN$Lapite A.; Bhar S.; Fasipe T.. Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: Asingle-center case series. Pediatric Blood + Cancer. 2024;71 (8):1-5$18$YR$A$F$Y$$$20240719$$HP$US$US
241134021$24113402$1$I$20240608$20240711$20240719$20240719$PER$$US-ABBVIE-5840787$ABBVIE$$23$YR$$F$Y$$$20240719$$HP$US$US
241134031$24113403$1$I$$20240708$20240719$20240719$EXP$$BE-PBT-009533$PANACEA BIOTEC$Meganck S, Raevens S, Ferdinande K, Verhelst X, Hoorens A, Degroote H, et al. Recurrent rejections after liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient. Acta Clin Belg. 2024 Jul 3:1-8. doi: 10.1080/17843286.2024.2376304.$32$YR$A$F$Y$$$20240720$$HP$BE$BE
241134041$24113404$1$I$20240401$20240712$20240719$20240719$EXP$$US-ABBVIE-5841268$ABBVIE$$41$YR$$M$Y$$$20240719$$CN$US$US
241134052$24113405$2$F$20240101$20240812$20240719$20240815$EXP$$CA-ABBVIE-5842539$ABBVIE$$78$YR$$M$Y$$$20240815$$CN$CA$CA
241134061$24113406$1$I$$20240715$20240719$20240719$EXP$$US-ABBVIE-5843257$ABBVIE$$$$$M$Y$$$20240719$$CN$US$US
241134072$24113407$2$F$$20240903$20240719$20240904$PER$$NVSC2024US148452$NOVARTIS$$$$$M$Y$$$20240904$$HP$US$US
241134081$24113408$1$I$20240713$20240717$20240720$20240720$EXP$$US-ABBVIE-5845180$ABBVIE$$33$YR$$F$Y$$$20240720$$CN$US$US
241134091$24113409$1$I$20240702$20240717$20240720$20240720$EXP$$CO-ABBVIE-5845202$ABBVIE$$66$YR$$M$Y$$$20240720$$CN$CO$CO
241134102$24113410$2$F$20240101$20240730$20240720$20240807$PER$$US-ABBVIE-5843147$ABBVIE$$$$$F$Y$75$KG$20240807$$CN$US$US
241134111$24113411$1$I$20220701$20240715$20240720$20240720$EXP$$EU-BAUSCHBL-2022BNL002969$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240719$$HP$EU$EU
241134122$24113412$2$F$$20240926$20240720$20240926$PER$$NVSC2024US149073$NOVARTIS$$$$$F$Y$$$20240926$$HP$US$US
241134131$24113413$1$I$20240301$20240716$20240720$20240720$EXP$$US-ABBVIE-5843138$ABBVIE$$$$A$M$Y$$$20240720$$HP$US$US
241134141$24113414$1$I$$20240718$20240720$20240720$PER$$NVSC2024US149027$NOVARTIS$$69$YR$$F$Y$$$20240719$$MD$US$US
241134153$24113415$3$F$$20240829$20240720$20240906$EXP$$NVSC2024ES147138$NOVARTIS$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. TRANSPLANT INFECTIOUS DISEASE. 2024;26(3):1-3$6$MON$$M$Y$$$20240906$$HP$ES$ES
241134162$24113416$2$F$20231003$20240719$20240720$20240723$EXP$$NVSC2024AU148622$NOVARTIS$$51$YR$$F$Y$63.75$KG$20240723$$MD$AU$AU
241134172$24113417$2$F$$20240717$20240720$20240723$EXP$$NVSC2024AT146154$NOVARTIS$Powollik W. Seit drei jahren ohne ZNS progression [For three years without central nervous system progression]. ONCOLOGY. 2024;4:20-1$50$YR$$F$Y$$$20240723$$HP$AT$AT
241134182$24113418$2$F$$20240716$20240720$20240722$PER$$NVSC2024US148252$NOVARTIS$$62$YR$$M$Y$$$20240722$$CN$US$US
241134192$24113419$2$F$$20240813$20240720$20240815$PER$$NVSC2024US149042$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
241134204$24113420$4$F$$20240926$20240720$20240926$EXP$$NVSC2024US148822$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
241134212$24113421$2$F$$20240802$20240720$20240805$PER$$NVSC2024US149050$NOVARTIS$$$$$M$Y$$$20240805$$HP$US$US
241134222$24113422$2$F$20240627$20240723$20240720$20240730$EXP$$NVSC2024KR148504$NOVARTIS$$57$YR$$F$Y$$$20240730$$MD$KR$KR
241134231$24113423$1$I$$20240717$20240720$20240720$PER$$NVSC2024US149021$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241134241$24113424$1$I$$20240715$20240720$20240720$PER$$NVSC2024US146756$NOVARTIS$$$$$$Y$$$20240719$$CN$US$US
241134251$24113425$1$I$$20240717$20240720$20240720$PER$$NVSC2024US147650$NOVARTIS$$$$$$Y$$$20240719$$CN$US$US
241134261$24113426$1$I$20240615$20240717$20240720$20240720$EXP$$NVSC2024CN148808$NOVARTIS$$57$YR$$F$Y$60$KG$20240719$$HP$CN$CN
241134271$24113427$1$I$$20240718$20240720$20240720$PER$$NVSC2024US148991$NOVARTIS$$$$$F$Y$$$20240719$$HP$US$US
241134286$24113428$6$F$20240716$20240830$20240720$20240902$PER$$NVSC2024US148162$NOVARTIS$$58$YR$$F$Y$$$20240902$$CN$US$US
241134293$24113429$3$F$$20240813$20240720$20240820$EXP$$NVSC2024EG140310$NOVARTIS$$$$$M$Y$$$20240820$$MD$EG$EG
241134303$24113430$3$F$$20240919$20240720$20240920$EXP$$NVSC2024GB146585$NOVARTIS$$$$$$Y$$$20240920$$MD$GB$GB
241134312$24113431$2$F$$20240717$20240720$20240722$PER$$NVSC2024US148535$NOVARTIS$$44$YR$$F$Y$$$20240722$$CN$US$US
241134321$24113432$1$I$$20240717$20240720$20240720$PER$$NVSC2024US148975$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241134331$24113433$1$I$20240601$20240717$20240720$20240720$EXP$$NVSC2024US148150$NOVARTIS$$72$YR$$$Y$$$20240719$$MD$US$US
241134351$24113435$1$I$20240706$20240717$20240720$20240720$EXP$$NVSC2024CN148491$NOVARTIS$$82$YR$$F$Y$39.9$KG$20240719$$HP$CN$CN
241134373$24113437$3$F$$20240920$20240720$20240923$EXP$$NVSC2024US148030$NOVARTIS$$$$$$Y$$$20240923$$MD$US$US
241134381$24113438$1$I$$20240717$20240720$20240720$PER$$NVSC2024US148365$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
241134391$24113439$1$I$$20240716$20240720$20240720$EXP$$NVSC2024CA147125$NOVARTIS$$40$YR$$$Y$119$KG$20240719$$MD$CA$CA
241134401$24113440$1$I$$20240717$20240720$20240720$PER$$NVSC2024US148311$NOVARTIS$$$$$M$Y$$$20240719$$CN$US$US
241134432$24113443$2$F$$20240910$20240720$20240918$EXP$$NVSC2024CA146466$NOVARTIS$$69$YR$$F$Y$$$20240918$$CN$CA$CA
241134442$24113444$2$F$$20240802$20240720$20240806$EXP$$NVSC2024SK147154$NOVARTIS$Slizkova B. Alopecia areata, the treatment with baricitinib. LIECBA DERMATOVENEROLOGICKYCH OCHORENI. 2024;12(2):3-5$30$YR$$F$Y$60$KG$20240806$$HP$SK$SK
241134452$24113445$2$F$$20240718$20240720$20240720$PER$$NVSC2024US148076$NOVARTIS$$$$$F$Y$$$20240720$$CN$US$US
241134462$24113446$2$F$20240716$20240718$20240720$20240725$PER$$US-AMGEN-USASP2024142402$AMGEN$$77$YR$E$M$Y$$$20240725$$CN$US$US
241134482$24113448$2$F$$20240710$20240720$20240722$PER$$NVSC2024US143798$NOVARTIS$$$$$$Y$$$20240722$$CN$US$US
241134501$24113450$1$I$$20240717$20240720$20240720$PER$$NVSC2024US148924$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241134511$24113451$1$I$$20240716$20240720$20240720$EXP$$NVSC2024CA147195$NOVARTIS$$38$YR$$F$Y$$$20240719$$HP$CA$CA
241134521$24113452$1$I$20240515$20240712$20240720$20240720$EXP$$NVSC2024ES112526$NOVARTIS$$38$YR$$M$Y$$$20240719$$MD$ES$ES
241134531$24113453$1$I$$20240716$20240720$20240720$EXP$$NVSC2024CA147189$NOVARTIS$$38$YR$$F$Y$$$20240719$$PH$CA$CA
241134542$24113454$2$F$$20240729$20240720$20240801$PER$$NVSC2024US147282$NOVARTIS$$$$$$Y$$$20240801$$CN$US$US
241134552$24113455$2$F$20231201$20240910$20240720$20240912$PER$$NVSC2024US148834$NOVARTIS$$76$YR$$M$Y$$$20240913$$CN$US$US
241134562$24113456$2$F$$20240722$20240720$20240729$EXP$$NVSC2024UY146459$NOVARTIS$$$$$$Y$$$20240729$$HP$UY$UY
241134571$24113457$1$I$$20240716$20240720$20240720$EXP$$NVSC2024CA146821$NOVARTIS$$90$YR$$M$Y$$$20240719$$PH$CA$CA
241134582$24113458$2$F$20240713$20240722$20240720$20240725$EXP$$NVSJ2024JP008719$NOVARTIS$$75$YR$$F$Y$48$KG$20240725$$MD$JP$JP
241134591$24113459$1$I$$20240711$20240720$20240720$EXP$$NVSC2024IR145434$NOVARTIS$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients. JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH. 2022;14(4):258-262$51$YR$$$Y$$$20240719$$HP$IR$IR
241134601$24113460$1$I$$20240716$20240720$20240720$EXP$$NVSJ2024JP007001$NOVARTIS$$2$YR$$F$Y$$$20240719$$MD$JP$JP
241134611$24113461$1$I$$20240718$20240720$20240720$EXP$$NVSC2024US148477$NOVARTIS$$$$$F$Y$$$20240719$$HP$US$US
241134621$24113462$1$I$$20240717$20240720$20240720$EXP$$CA-ABBVIE-5845067$ABBVIE$$$$E$$Y$$$20240720$$CN$CA$CA
241134632$24113463$2$F$$20240912$20240720$20240918$EXP$$NVSJ2024JP008557$NOVARTIS$$46$YR$$F$Y$$$20240918$$MD$JP$JP
241134641$24113464$1$I$20240710$20240715$20240720$20240720$EXP$$NVSC2024US146477$NOVARTIS$$56$YR$$M$Y$$$20240719$$HP$US$US
241134652$24113465$2$F$20220101$20240823$20240720$20240829$EXP$$NVSC2024MX147498$NOVARTIS$$$$$M$Y$88$KG$20240829$$CN$MX$MX
241134662$24113466$2$F$20240601$20240806$20240720$20240809$EXP$$NVSJ2024JP008548$NOVARTIS$$$$A$$Y$$$20240809$$MD$JP$JP
241134671$24113467$1$I$$20240712$20240720$20240720$EXP$$NVSJ2024JP008482$NOVARTIS$$$$$M$Y$$$20240719$$CN$JP$JP
241134682$24113468$2$F$$20240718$20240720$20240722$PER$$NVSC2024US148790$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
241134701$24113470$1$I$$20240716$20240720$20240720$EXP$$NVSC2024CA133100$NOVARTIS$$69$YR$$M$Y$$$20240719$$CN$CA$CA
241134711$24113471$1$I$$20240716$20240720$20240720$EXP$$NVSC2024CA147213$NOVARTIS$$57$YR$$F$Y$68$KG$20240719$$PH$CA$CA
241134723$24113472$3$F$20240805$20240805$20240720$20240808$EXP$$NVSC2024US147494$NOVARTIS$$48$YR$$M$Y$$$20240808$$CN$US$US
241134731$24113473$1$I$$20240716$20240720$20240720$PER$$NVSC2024US148609$NOVARTIS$$$$$M$Y$$$20240719$$CN$US$US
241134741$24113474$1$I$$20240718$20240720$20240720$EXP$$NVSC2024US148498$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241134751$24113475$1$I$$20240716$20240720$20240720$EXP$$NVSC2024CA146936$NOVARTIS$$64$YR$$M$Y$$$20240719$$HP$CA$CA
241134761$24113476$1$I$$20240716$20240720$20240720$EXP$$NVSC2024KR147787$NOVARTIS$$$$$$Y$$$20240719$$MD$KR$KR
241134771$24113477$1$I$$20240715$20240720$20240720$EXP$$NVSC2024CH146530$NOVARTIS$$$$$$Y$$$20240719$$HP$CH$CH
241134783$24113478$3$F$$20240723$20240720$20240725$PER$$NVSC2024US146308$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
241134791$24113479$1$I$$20240718$20240720$20240720$PER$$NVSC2024US148645$NOVARTIS$$$$$M$Y$$$20240719$$CN$US$US
241134801$24113480$1$I$$20240717$20240720$20240720$PER$$NVSC2024US148577$NOVARTIS$$$$$M$Y$$$20240719$$CN$US$US
241134811$24113481$1$I$20231001$20240715$20240720$20240720$EXP$$NVSC2024US146932$NOVARTIS$$55$YR$$F$Y$72.57$KG$20240719$$CN$US$US
241134831$24113483$1$I$$20240716$20240720$20240720$EXP$$NVSC2024CA147173$NOVARTIS$$40$YR$$F$Y$$$20240719$$CN$CA$CA
241134841$24113484$1$I$$20240716$20240720$20240720$PER$$NVSC2024US148420$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
241134851$24113485$1$I$20220604$20240714$20240720$20240720$EXP$$NVSC2023DE080747$NOVARTIS$$$$A$F$Y$92$KG$20240719$$MD$DE$DE
241134862$24113486$2$F$20240710$20240730$20240720$20240808$PER$$NVSC2024US144517$NOVARTIS$$38$YR$$F$Y$$$20240808$$CN$US$US
241134871$24113487$1$I$20240709$20240709$20240720$20240720$PER$$NVSC2024US148328$NOVARTIS$$44$YR$$M$Y$$$20240719$$CN$US$US
241134882$24113488$2$F$$20240919$20240720$20240920$EXP$$NVSC2024US145812$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
241134892$24113489$2$F$20240101$20240820$20240720$20240826$EXP$$NVSC2024DE123409$NOVARTIS$$77$YR$$F$Y$80$KG$20240827$$PH$DE$DE
241134901$24113490$1$I$$20240715$20240720$20240720$EXP$$NVSC2024EG147493$NOVARTIS$$$$$M$Y$$$20240719$$CN$EG$EG
241134911$24113491$1$I$$20240710$20240720$20240720$PER$$NVSC2024US143659$NOVARTIS$$$$$M$Y$$$20240719$$CN$US$US
241134922$24113492$2$F$$20240718$20240720$20240722$PER$$NVSC2024US148626$NOVARTIS$$$$$F$Y$$$20240722$$HP$US$US
241134932$24113493$2$F$$20240814$20240720$20240815$PER$$NVSC2024US148606$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
241134941$24113494$1$I$$20240717$20240720$20240720$PER$$NVSC2024US148405$NOVARTIS$$71$YR$$M$Y$73$KG$20240719$$CN$US$US
241134951$24113495$1$I$$20240715$20240720$20240720$PER$$US-ABBVIE-5843713$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241134963$24113496$3$F$$20240829$20240720$20240902$EXP$$NVSC2024US148599$NOVARTIS$$$$$$Y$$$20240902$$HP$US$US
241134972$24113497$2$F$$20240830$20240720$20240830$PER$$NVSC2024US148026$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
241134981$24113498$1$I$$20240717$20240720$20240720$PER$$NVSC2024US148576$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241134992$24113499$2$F$20240415$20240717$20240720$20240721$PER$$NVSC2024US148166$NOVARTIS$$74$YR$$F$Y$37.6$KG$20240721$$CN$US$US
241135001$24113500$1$I$$20240716$20240720$20240720$EXP$$NVSJ2024JP008519$NOVARTIS$$$$$$Y$$$20240719$$PH$JP$JP
241135011$24113501$1$I$$20240715$20240720$20240720$PER$$NVSC2024US148160$NOVARTIS$$54$YR$$F$Y$$$20240719$$CN$US$US
241135021$24113502$1$I$$20240715$20240720$20240720$EXP$$NVSC2024US146625$NOVARTIS$$$$$F$Y$$$20240719$$CN$US$US
241135031$24113503$1$I$$20240717$20240720$20240720$PER$$NVSC2024US148503$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241135041$24113504$1$I$$20240717$20240720$20240720$PER$$NVSC2024US148490$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241135052$24113505$2$F$$20240731$20240720$20240807$EXP$$NVSC2024FR147689$NOVARTIS$$86$YR$$F$Y$61$KG$20240807$$MD$FR$FR
241135061$24113506$1$I$$20240718$20240720$20240720$PER$$NVSC2024US148482$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241135071$24113507$1$I$$20240716$20240720$20240720$PER$$NVSC2024US148444$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241135082$24113508$2$F$$20240712$20240720$20240722$PER$$NVSC2024US146354$NOVARTIS$$$$E$F$Y$$$20240722$$MD$US$US
241135091$24113509$1$I$$20240718$20240720$20240720$PER$$NVSC2024US148463$NOVARTIS$$$$$$Y$$$20240719$$HP$US$US
241135101$24113510$1$I$$20240713$20240720$20240720$PER$$NVSC2024US148050$NOVARTIS$$51$YR$$F$Y$94.8$KG$20240719$$CN$US$US
241135111$24113511$1$I$$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024142879$AMGEN$$$$$$Y$$$20240719$$CN$US$US
241135121$24113512$1$I$$20240715$20240720$20240720$EXP$$IN-ABBVIE-5845341$ABBVIE$Johri N, Choudhary A, Rawat U, Vengat M. Amphotericin-b-induced chronic kidney disease in a post-covid-19 patient with widespread rhinocerebral mucormycosis and pneumonia: a case report. CDS. 2024;19(4):474-477.$67$YR$$M$Y$$$20240720$$HP$IN$IN
241135141$24113514$1$I$20240101$20240716$20240720$20240720$EXP$$US-ABBVIE-5844562$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
241135151$24113515$1$I$20240701$20240716$20240720$20240720$EXP$$US-ABBVIE-5844171$ABBVIE$$69$YR$$F$Y$$$20240720$$CN$US$US
241135162$24113516$2$F$20240101$20240716$20240720$20240724$EXP$$US-ABBVIE-5844395$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241135171$24113517$1$I$20240101$20240717$20240720$20240720$EXP$$US-ABBVIE-5844782$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241135181$24113518$1$I$$20240717$20240720$20240720$EXP$$US-ABBVIE-5845174$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241135191$24113519$1$I$20230829$20240122$20240720$20240720$EXP$$FR-ABBVIE-5845046$ABBVIE$$$$$$Y$$$20240720$$MD$FR$FR
241135202$24113520$2$F$20240101$20240726$20240720$20240730$PER$$US-HETERO-HET2024US02276$HETERO$$$$$F$Y$$$20240730$$CN$US$US
241135211$24113521$1$I$$20240715$20240720$20240720$PER$$US-HETERO-HET2024US02325$HETERO$$$$$F$Y$$$20240720$$CN$US$US
241135221$24113522$1$I$$20240712$20240720$20240720$EXP$$IN-HETERO-HET2024IN02310$HETERO$Athish KK, Nayak Rao S, Marimuthu VH, Krishna V, Arun A.. Tenofovir-Associated Kidney  Dysfunction and Bone Fracture: A Case Report and Literature Review. Cureus. 2024;16(6):e61562$65$YR$$F$Y$$$20240720$$MD$IN$IN
241135231$24113523$1$I$20240701$20240717$20240720$20240720$EXP$$US-ABBVIE-5845089$ABBVIE$$53$YR$$M$Y$$$20240720$$CN$US$US
241135241$24113524$1$I$$20240717$20240720$20240720$EXP$$AU-ABBVIE-5845087$ABBVIE$$$$$F$Y$$$20240720$$HP$AU$AU
241135252$24113525$2$F$20240101$20240917$20240720$20240920$EXP$$US-ABBVIE-5825997$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
241135262$24113526$2$F$20240701$20240722$20240720$20240724$EXP$$CO-ABBVIE-5845229$ABBVIE$$79$YR$$F$Y$$$20240724$$CN$CO$CO
241135271$24113527$1$I$20240702$20240717$20240720$20240720$EXP$$CN-ABBVIE-5844997$ABBVIE$$60$YR$$M$Y$71$KG$20240720$$MD$CN$CN
241135281$24113528$1$I$20240601$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407012481$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240720$$CN$US$US
241135291$24113529$1$I$$20240710$20240720$20240720$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000620$PAREXEL$$$$$$Y$$$20240720$$HP$CN$CN
241135301$24113530$1$I$20240628$20240628$20240720$20240720$PER$$US-ABBVIE-5844484$ABBVIE$$45$YR$$F$Y$$$20240720$$HP$US$US
241135311$24113531$1$I$20240515$20240716$20240720$20240720$EXP$$US-ABBVIE-5844006$ABBVIE$$74$YR$$F$Y$$$20240720$$CN$US$US
241135321$24113532$1$I$$20240716$20240720$20240720$PER$$US-AMGEN-USASP2024141991$AMGEN$$$$$$Y$$$20240719$$CN$US$US
241135331$24113533$1$I$20240708$20240716$20240720$20240720$EXP$$CA-ABBVIE-5843706$ABBVIE$$35$YR$$M$Y$$$20240720$$CN$CA$CA
241135341$24113534$1$I$20240101$20240717$20240720$20240720$EXP$$US-ABBVIE-5845170$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
241135351$24113535$1$I$$20240716$20240720$20240720$EXP$$DE-ABBVIE-5845056$ABBVIE$$$$$F$Y$$$20240720$$CN$DE$DE
241135362$24113536$2$F$20240101$20240809$20240720$20240814$EXP$$CA-ABBVIE-5844933$ABBVIE$$53$YR$$F$Y$$$20240814$$CN$CA$CA
241135371$24113537$1$I$20240701$20240715$20240720$20240720$PER$$US-JNJFOC-20240739884$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$CN$US$US
241135381$24113538$1$I$$20240716$20240720$20240720$EXP$$CA-JNJFOC-20240615155$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240719$$HP$CA$CA
241135391$24113539$1$I$$20240710$20240720$20240720$EXP$$US-JNJFOC-20240729653$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$HP$US$US
241135401$24113540$1$I$$20240716$20240720$20240720$PER$$PR-JNJFOC-20240745363$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$MD$PR$PR
241135411$24113541$1$I$$20240716$20240720$20240720$EXP$$CA-JNJFOC-20240748260$JOHNSON AND JOHNSON$$68$YR$E$F$Y$70$KG$20240719$$HP$CA$CA
241135421$24113542$1$I$$20240710$20240720$20240720$EXP$$DE-MPL-000051$MLV PHARMA$$18$YR$A$F$Y$$$20240712$$HP$DE$DE
241135451$24113545$1$I$20240701$20240708$20240720$20240720$EXP$$US-JNJFOC-20240723494$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240719$$CN$US$US
241135461$24113546$1$I$20240101$20240717$20240720$20240720$EXP$$US-ABBVIE-5845203$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241135471$24113547$1$I$$20240712$20240720$20240720$EXP$$US-JNJFOC-20240740986$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$CN$US$US
241135481$24113548$1$I$$20240716$20240720$20240720$PER$$US-JNJFOC-20240743217$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240719$$HP$US$US
241135491$24113549$1$I$20240711$20240718$20240720$20240720$PER$$US-AMGEN-USASP2024143614$AMGEN$$61$YR$A$M$Y$$$20240719$$CN$US$US
241135501$24113550$1$I$20240712$20240715$20240720$20240720$PER$$US-ABBVIE-5844498$ABBVIE$$44$YR$$F$Y$$$20240720$$HP$US$US
241135512$24113551$2$F$$20240808$20240720$20240813$EXP$$JP-JNJFOC-20240730679$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240814$$MD$JP$JP
241135521$24113552$1$I$$20240707$20240720$20240720$EXP$$MX-JNJFOC-20240732966$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20240719$$MD$US$MX
241135541$24113554$1$I$$20240710$20240720$20240720$30DAY$$US-JNJFOC-20240727128$JOHNSON AND JOHNSON$$83$YR$E$$Y$$$20240719$$CN$US$US
241135551$24113555$1$I$$20240702$20240720$20240720$PER$$US-JNJFOC-20240707255$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$CN$US$US
241135572$24113557$2$F$20231207$20240715$20240720$20240723$EXP$$FR-JNJFOC-20240737526$JOHNSON AND JOHNSON$$14$YR$T$F$Y$$$20240723$$MD$FR$FR
241135581$24113558$1$I$$20240716$20240720$20240720$PER$$US-JNJFOC-20240744411$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240719$$HP$US$US
241135592$24113559$2$F$$20240802$20240720$20240806$EXP$$JP-JNJFOC-20240750921$JOHNSON AND JOHNSON$$73$YR$E$F$Y$48$KG$20240806$$MD$JP$JP
241135601$24113560$1$I$$20240701$20240720$20240720$PER$$US-JNJFOC-20240703910$JOHNSON AND JOHNSON$$75$YR$E$$Y$$$20240719$$CN$US$US
241135611$24113561$1$I$$20240703$20240720$20240720$PER$$US-JNJFOC-20240714599$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$CN$US$US
241135621$24113562$1$I$$20240712$20240720$20240720$EXP$$US-ABBVIE-5843908$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
241135632$24113563$2$F$20240601$20240719$20240720$20240809$PER$$US-JNJFOC-20240708580$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240809$$CN$US$US
241135641$24113564$1$I$$20240718$20240720$20240720$PER$$US-JNJFOC-20240748687$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$CN$US$US
241135651$24113565$1$I$$20240709$20240720$20240720$PER$$US-AMGEN-USANI2024140054$AMGEN$Moravan, M.. Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology. 2009;72:337-340$54$YR$A$F$Y$$$20240719$$HP$US$US
241135672$24113567$2$F$20240101$20240807$20240720$20240813$EXP$$US-JNJFOC-20240742343$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240813$$HP$US$US
241135681$24113568$1$I$20240701$20240715$20240720$20240720$EXP$$TW-JNJFOC-20240738180$JOHNSON AND JOHNSON$$63$YR$A$F$Y$52$KG$20240719$$CN$TW$TW
241135691$24113569$1$I$20240717$20240717$20240720$20240720$PER$$US-JNJFOC-20240748957$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$MD$US$US
241135702$24113570$2$F$$20240725$20240720$20240730$PER$$US-JNJFOC-20240747663$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$HP$US$US
241135713$24113571$3$F$$20240821$20240720$20240909$30DAY$$DE-JNJFOC-20240728112$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$PH$DE$DE
241135721$24113572$1$I$20240601$20240716$20240720$20240720$EXP$$AR-JNJFOC-20240746507$JOHNSON AND JOHNSON$$78$YR$E$F$Y$70$KG$20240719$$CN$AR$AR
241135731$24113573$1$I$$20240717$20240720$20240720$PER$$US-JNJFOC-20240746188$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$MD$US$US
241135752$24113575$2$F$$20240808$20240720$20240818$30DAY$$IN-JNJFOC-20240735680$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$IN$IN
241135761$24113576$1$I$$20240709$20240720$20240720$EXP$$TN-AMNEAL PHARMACEUTICALS-2024-AMRX-02593$AMNEAL$Chabbouh A, Rebhi F, Slimene MB, Jaber K, Dhaoui A.. Sildenafil-induced drug reaction with eosinophilia and systemic symptoms. Urol Case Rep. 2024;55$50$YR$$M$Y$$$20240720$$HP$TN$TN
241135771$24113577$1$I$$20240704$20240720$20240720$EXP$$IT-JNJFOC-20130803658$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240719$$HP$IT$IT
241135781$24113578$1$I$20240708$20240711$20240720$20240720$PER$$US-ABBVIE-5844321$ABBVIE$$36$YR$$F$Y$$$20240720$$HP$US$US
241135791$24113579$1$I$20240715$20240715$20240720$20240720$EXP$$US-JNJFOC-20240744387$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240719$$HP$US$US
241135811$24113581$1$I$20240709$20240712$20240720$20240720$EXP$$GB-AUROBINDO-AUR-APL-2024-034829$AUROBINDO$$55$YR$$M$Y$$$20240720$$MD$GB$GB
241135821$24113582$1$I$20221101$20240716$20240720$20240720$EXP$$RU-ABBVIE-5843770$ABBVIE$$5$YR$$F$Y$17$KG$20240720$$MD$RU$RU
241135833$24113583$3$F$$20240726$20240720$20240805$PER$$US-AMGEN-USASP2024140903$AMGEN$$$$$$Y$$$20240805$$PH$US$US
241135842$24113584$2$F$$20240724$20240720$20240729$30DAY$$BR-AMGEN-BRASP2024140211$AMGEN$$$$$$Y$$$20240729$$PH$BR$BR
241135851$24113585$1$I$$20240716$20240720$20240720$PER$$US-JNJFOC-20240743309$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240719$$HP$US$US
241135863$24113586$3$F$20240622$20240717$20240720$20240723$EXP$$DE-BEIGENE-BGN-2024-011238$BEIGENE$$$$$$Y$$$20240723$$MD$DE$DE
241135871$24113587$1$I$20240601$20240711$20240720$20240720$EXP$$DO-JNJFOC-20240734159$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240719$$HP$DO$DO
241135891$24113589$1$I$20240711$20240711$20240720$20240720$EXP$$CA-JNJFOC-20240732498$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240719$$HP$CA$CA
241135901$24113590$1$I$20230301$20240716$20240720$20240720$EXP$$US-JNJFOC-20240743691$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$CN$US$US
241135911$24113591$1$I$$20240715$20240720$20240720$EXP$$CA-JNJFOC-20240741229$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240719$$HP$CA$CA
241135921$24113592$1$I$$20240708$20240720$20240720$30DAY$$JP-JNJFOC-20240739931$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$PH$JP$JP
241135932$24113593$2$F$20240510$20240723$20240720$20240730$EXP$$PH-JNJFOC-20240738056$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240730$$CN$PH$PH
241135941$24113594$1$I$$20240716$20240720$20240720$EXP$$US-JNJFOC-20240746260$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240719$$MD$US$US
241135952$24113595$2$F$$20240806$20240720$20240826$30DAY$$EG-JNJFOC-20240739570$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$EG$EG
241135961$24113596$1$I$20230101$20240709$20240720$20240720$EXP$$US-ENDO USA, INC.-2024-002899$ENDO$Ahuja J, Leontieva L.. Ketamine Therapy in Complex Cases: A Cautionary Tale of Exacerbated Personality Traits and the Crucial Role of Comprehensive Follow-Up and Psychosocial Interventions. Case Reports in Psychiatry. 2024;1-6$75$YR$$F$Y$$$20240720$$MD$US$US
241135981$24113598$1$I$$20240711$20240720$20240720$EXP$$US-JNJFOC-20240732443$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$CN$US$US
241135991$24113599$1$I$$20240709$20240720$20240720$PER$$US-TEVA-VS-3220648$TEVA$$$$$$Y$$$20240720$$CN$US$US
241136001$24113600$1$I$$20240715$20240720$20240720$PER$$US-JNJFOC-20240743925$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$PH$US$US
241136011$24113601$1$I$$20240715$20240720$20240720$PER$$US-JNJFOC-20240743810$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$PH$US$US
241136021$24113602$1$I$$20240710$20240720$20240720$EXP$$CA-JNJFOC-20240729294$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$MD$CA$CA
241136031$24113603$1$I$$20240715$20240720$20240720$PER$$US-JNJFOC-20240739657$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$PH$US$US
241136041$24113604$1$I$$20240708$20240720$20240720$30DAY$$US-JNJFOC-20240741048$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$CN$US$US
241136062$24113606$2$F$$20240723$20240720$20240731$PER$$US-ABBVIE-5841088$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241136072$24113607$2$F$$20240715$20240720$20240725$EXP$$GB-AMGEN-GBRSP2024141748$AMGEN$Mcmullin M.F.; Harrison C.N.; Niederwieser D. et al.. The Use of Erythropoietic-Stimulating Agents (ESAs) with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), and Post-Essential Thrombocythemia Myelofibrosis (PET-MF). Blood. 2012;120 (21):2838$$$$$Y$$$20240725$$MD$GB$GB
241136081$24113608$1$I$$20240716$20240720$20240720$EXP$$US-AMGEN-USASP2024141437$AMGEN$Larochelle M. B.; Hu W. F.; Etheridge T.. Use of Intracameral Tissue Plasminogen Activator During Uveitic Cataract Surgery. Ocular Immunology and Inflammation. 2024;32(5):673-677$$$$$Y$$$20240719$$MD$US$US
241136091$24113609$1$I$$20231206$20240720$20240720$EXP$NL-LRB-00924129$NL-TEVA-VS-3139248$TEVA$$31$YR$$F$Y$70$KG$20240720$$MD$NL$NL
241136101$24113610$1$I$$20240716$20240720$20240720$EXP$$US-ABBVIE-5845085$ABBVIE$$70$YR$$$Y$$$20240720$$CN$US$US
241136111$24113611$1$I$$20240712$20240720$20240720$PER$$US-JNJFOC-20240737119$JOHNSON AND JOHNSON$$$$$M$Y$$$20240720$$CN$US$US
241136121$24113612$1$I$20240701$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024142072$AMGEN$$$$$M$Y$$$20240719$$CN$US$US
241136132$24113613$2$F$$20240918$20240720$20240923$EXP$$AU-SANDOZ INC.-SDZ2024AU066190$SANDOZ$$$$$$Y$$$20240923$$HP$AU$AU
241136141$24113614$1$I$$20240711$20240720$20240720$EXP$$CN-JNJFOC-20240733757$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$MD$CN$CN
241136151$24113615$1$I$$20240711$20240720$20240720$PER$$US-JNJFOC-20240748161$JOHNSON AND JOHNSON$$$$$F$Y$$$20240719$$CN$US$US
241136162$24113616$2$F$20240614$20240724$20240720$20240729$EXP$$US-JNJFOC-20240740071$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240729$$HP$US$US
241136172$24113617$2$F$$20240731$20240720$20240807$30DAY$$RU-JNJFOC-20240743308$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$RU$RU
241136182$24113618$2$F$$20240730$20240720$20240806$EXP$$US-JNJFOC-20240739024$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$CN$US$US
241136191$24113619$1$I$$20240711$20240720$20240720$PER$$US-ABBVIE-5837522$ABBVIE$$$$$$Y$$$20240720$$CN$US$US
241136201$24113620$1$I$20231101$20240715$20240720$20240720$EXP$$AR-JNJFOC-20240448152$JOHNSON AND JOHNSON$$59$YR$A$F$Y$78$KG$20240719$$CN$AR$AR
241136211$24113621$1$I$20240712$20240715$20240720$20240720$PER$$US-AMGEN-USASP2024140873$AMGEN$$70$YR$E$F$Y$$$20240719$$CN$US$US
241136221$24113622$1$I$$20240716$20240720$20240720$EXP$$US-JNJFOC-20240742949$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$CN$US$US
241136231$24113623$1$I$$20240716$20240720$20240720$EXP$$AU-SANDOZ INC.-SDZ2024AU065843$SANDOZ$$$$$$Y$$$20240720$$HP$AU$AU
241136241$24113624$1$I$$20240716$20240720$20240720$PER$$US-AMGEN-USASP2024141778$AMGEN$$$$$F$Y$$$20240719$$PH$US$US
241136251$24113625$1$I$20240601$20240718$20240720$20240720$EXP$$CO-ABBVIE-5845239$ABBVIE$$69$YR$$M$Y$61$KG$20240720$$CN$CO$CO
241136261$24113626$1$I$$20240708$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-035814$AUROBINDO$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donorspecific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$15$YR$$F$Y$$$20240720$$HP$US$US
241136271$24113627$1$I$20240101$20240717$20240720$20240720$EXP$$US-ABBVIE-5843912$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241136281$24113628$1$I$$20240709$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035276$AUROBINDO$Sallee L, Souchet L, Boutolleau D, Nguyen S. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus. Int-J-Antimicrob-Agents. 2024;63(6):1 to 2$54$YR$$F$Y$$$20240720$$HP$FR$FR
241136291$24113629$1$I$$20240709$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-034088$AUROBINDO$Diercks GFH, Meijer JM, Bolling MC, Scholtens-Jaegers SMHJ, Bremer J, Horvath B.. Absence of Epidermal Antibodies in Stevens?Johnson Syndrome/ Toxic Epidermal Necrolysis Patients but Beware of Single Positive Results.. Dermatology Research and Practice.. 2024;2024:1?5.$34$YR$$M$Y$$$20240720$$HP$NL$NL
241136301$24113630$1$I$$20240710$20240720$20240720$EXP$$GB-AUROBINDO-AUR-APL-2024-034604$AUROBINDO$$32$YR$$M$Y$$$20240720$$MD$GB$GB
241136311$24113631$1$I$20240201$20240208$20240720$20240720$EXP$GB-MHRA-MED-202402062015195830-RKBNY$GB-TEVA-VS-3154937$TEVA$$53$YR$$F$Y$56$KG$20240720$$CN$GB$GB
241136322$24113632$2$F$20210701$20240906$20240720$20240912$EXP$$DE-SANDOZ INC.-NVSC2022DE105730$SANDOZ$$$$E$F$Y$$$20240912$$HP$DE$DE
241136331$24113633$1$I$20240110$20240710$20240720$20240720$EXP$$GB-TEVA-VS-3220194$TEVA$$39$YR$$M$Y$$$20240720$$CN$GB$GB
241136351$24113635$1$I$20230713$20240130$20240720$20240720$EXP$FR-AFSSAPS-AVNY2023000164$FR-TEVA-VS-3153567$TEVA$$16$YR$$M$Y$65$KG$20240720$$MD$FR$FR
241136361$24113636$1$I$20240601$20240710$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-034701$AUROBINDO$$80$YR$$M$Y$75$KG$20240720$$MD$FR$FR
241136374$24113637$4$F$$20240819$20240720$20240824$EXP$$US-JNJFOC-20240743264$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240824$$CN$US$US
241136381$24113638$1$I$$20240716$20240720$20240720$EXP$$ZA-JNJFOC-20240747910$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240719$$HP$ZA$ZA
241136391$24113639$1$I$$20240710$20240720$20240720$EXP$$GB-AUROBINDO-AUR-APL-2024-034606$AUROBINDO$$96$YR$$F$Y$54$KG$20240720$$HP$GB$GB
241136401$24113640$1$I$20240621$20240712$20240720$20240720$PER$$US-ABBVIE-5841758$ABBVIE$$75$YR$$F$Y$$$20240720$$CN$US$US
241136411$24113641$1$I$20240622$20240715$20240720$20240720$EXP$$GB-JNJFOC-20240740221$JOHNSON AND JOHNSON$$28$YR$A$F$Y$88$KG$20240719$$PH$GB$GB
241136421$24113642$1$I$$20240716$20240720$20240720$EXP$$US-JNJFOC-20240742781$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$MD$US$US
241136432$24113643$2$F$$20240802$20240720$20240806$EXP$$GR-ABBVIE-5843834$ABBVIE$$$$$F$Y$65$KG$20240806$$MD$GR$GR
241136442$24113644$2$F$$20240802$20240720$20240813$PER$$US-JNJFOC-20240665594$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240813$$CN$US$US
241136452$24113645$2$F$20240717$20240719$20240720$20240720$PER$$US-AMGEN-USASP2024143608$AMGEN$$62$YR$A$F$Y$$$20240720$$CN$US$US
241136462$24113646$2$F$$20240814$20240720$20240821$EXP$$CA-JNJFOC-20240745092$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240821$$CN$CA$CA
241136471$24113647$1$I$$20240710$20240720$20240720$EXP$$US-JNJFOC-20240737629$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$LW$US$US
241136481$24113648$1$I$$20240715$20240720$20240720$PER$$US-JNJFOC-20240743708$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$MD$US$US
241136491$24113649$1$I$$20240708$20240720$20240720$EXP$$US-JNJFOC-20240724331$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$HP$US$US
241136502$24113650$2$F$20230403$20240711$20240720$20240723$EXP$$US-JNJFOC-20240740101$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$HP$US$US
241136511$24113651$1$I$20240714$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024142434$AMGEN$$70$YR$E$F$Y$$$20240719$$CN$US$US
241136522$24113652$2$F$$20240731$20240720$20240807$EXP$$JP-JNJFOC-20240750888$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240807$$PH$JP$JP
241136531$24113653$1$I$20240623$20240710$20240720$20240720$EXP$$CN-JNJFOC-20240740228$JOHNSON AND JOHNSON$$41$YR$A$M$Y$56$KG$20240719$$HP$CN$CN
241136553$24113655$3$F$20240101$20240828$20240720$20240904$EXP$$US-ABBVIE-5842838$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
241136561$24113656$1$I$$20240712$20240720$20240720$PER$$US-JNJFOC-20240733432$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$CN$US$US
241136571$24113657$1$I$$20240712$20240720$20240720$EXP$$US-JNJFOC-20240733579$JOHNSON AND JOHNSON$$$$$M$Y$$$20240719$$CN$US$US
241136581$24113658$1$I$20240101$20240715$20240720$20240720$EXP$$US-JNJFOC-20240740425$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240719$$CN$US$US
241136591$24113659$1$I$20240221$20240712$20240720$20240720$EXP$$CA-JNJFOC-20240265897$JOHNSON AND JOHNSON$$11$YR$C$F$Y$35$KG$20240719$$HP$CA$CA
241136603$24113660$3$F$20240515$20240827$20240720$20240904$EXP$$CA-JNJFOC-20240559995$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240904$$HP$CA$CA
241136612$24113661$2$F$20240620$20240923$20240720$20240927$EXP$$SA-JNJFOC-20240737226$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240927$$CN$SA$SA
241136624$24113662$4$F$20240702$20240806$20240720$20240813$30DAY$$US-JNJFOC-20240709486$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240813$$CN$US$US
241136631$24113663$1$I$$20240711$20240720$20240720$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR087305$VIIV$$$$A$M$Y$$$20240720$$CN$US$US
241136643$24113664$3$F$20240628$20240719$20240720$20240730$30DAY$$US-JNJFOC-20240709356$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240730$$CN$US$US
241136651$24113665$1$I$20240523$20240715$20240720$20240720$EXP$$RU-JNJFOC-20240741677$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240719$$HP$RU$RU
241136662$24113666$2$F$$20240723$20240720$20240725$PER$$US-AMGEN-USASP2024140649$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241136671$24113667$1$I$20240501$20240711$20240720$20240720$EXP$$CA-JNJFOC-20240381245$JOHNSON AND JOHNSON$$43$YR$$F$Y$74$KG$20240719$$HP$CA$CA
241136681$24113668$1$I$$20240715$20240720$20240720$EXP$$CA-JNJFOC-20240741146$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240719$$HP$CA$CA
241136693$24113669$3$F$$20240917$20240720$20240923$EXP$$FR-JNJFOC-20240740139$JOHNSON AND JOHNSON$$$$E$$Y$$$20240923$$MD$FR$FR
241136701$24113670$1$I$$20240717$20240720$20240720$EXP$$US-JNJFOC-20240745651$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$MD$US$US
241136711$24113671$1$I$20240709$20240717$20240720$20240720$EXP$IT-MINISAL02-995195$IT-JNJFOC-20240745246$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240719$$PH$IT$IT
241136721$24113672$1$I$$20240710$20240720$20240720$PER$$US-JNJFOC-20240744798$JOHNSON AND JOHNSON$$$$$M$Y$105.5$KG$20240719$$MD$US$US
241136731$24113673$1$I$20240101$20240716$20240720$20240720$EXP$$CA-ABBVIE-5843861$ABBVIE$$53$YR$$$Y$$$20240720$$CN$CA$CA
241136751$24113675$1$I$$20240717$20240720$20240720$EXP$$US-ABBVIE-5845106$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241136762$24113676$2$F$$20240724$20240720$20240802$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024086628$VIIV$$$$$F$Y$$$20240802$$MD$US$US
241136771$24113677$1$I$$20240716$20240720$20240720$EXP$$US-ABBVIE-5843923$ABBVIE$$$$$M$Y$$$20240720$$HP$US$US
241136781$24113678$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035379$AUROBINDO$$47$YR$$F$Y$60$KG$20240720$$CN$NL$NL
241136801$24113680$1$I$$20240709$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-035498$AUROBINDO$Devine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. J-PediatrPharmacol-Ther. 2023;28(2):161-166$29$DY$$$Y$$$20240720$$HP$US$US
241136812$24113681$2$F$$20240716$20240720$20240722$PER$$US-JNJFOC-20240741482$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
241136821$24113682$1$I$20240613$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035512$AUROBINDO$$83$YR$$F$Y$$$20240720$$MD$FR$FR
241136831$24113683$1$I$$20240709$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-034050$AUROBINDO$Diercks GFH, Meijer JM, Bolling MC, Scholtens-Jaegers SMHJ, Bremer J, Horvath B.. Absence of Epidermal Antibodies in Stevens?Johnson Syndrome/ Toxic Epidermal Necrolysis Patients but Beware of Single Positive Results. Dermatology Research and Practice. 2024;2024:1?5.$41$YR$$F$Y$$$20240720$$HP$NL$NL
241136841$24113684$1$I$$20240710$20240720$20240720$EXP$GB-MHRA-MED-202407101209001950-WRHFP$GB-TEVA-VS-3220369$TEVA$$25$YR$$F$Y$60$KG$20240720$$CN$GB$GB
241136851$24113685$1$I$$20240712$20240720$20240720$EXP$$JP-SANDOZ INC.-NVSJ2022JP101166$SANDOZ$Kitayama S, Torai R, Kataoka K, Mori S, Furukawa F, Mizawa M, et al. Valaciclovir-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). WESTERN DIVISION OF JAPANESE DERMATOLOGICAL ASSOCIATION, 74TH ANNUAL MEETING. 2022;142$101$YR$$F$Y$$$20240720$$MD$JP$JP
241136861$24113686$1$I$$20240709$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-035085$AUROBINDO$Marino-Nunez D, Chadha A, Onajin O.. A Fatal Case of Cryptococcoid Vasculopathy.. Am-JDermatopathol. 2024;46(7):S7$$$$M$Y$$$20240720$$HP$US$US
241136871$24113687$1$I$$20240715$20240720$20240720$PER$$US-ABBVIE-5841549$ABBVIE$$$$$$Y$$$20240720$$MD$US$US
241136881$24113688$1$I$20220821$20240710$20240720$20240720$EXP$$IT-AUROBINDO-AUR-APL-2024-034524$AUROBINDO$$64$YR$$M$Y$$$20240720$$MD$IT$IT
241136891$24113689$1$I$$20240710$20240720$20240720$EXP$$CA-TEVA-VS-3220155$TEVA$$$$A$$Y$$$20240720$$HP$CA$CA
241136901$24113690$1$I$20240207$20240711$20240720$20240720$EXP$$GB-AUROBINDO-AUR-APL-2024-034946$AUROBINDO$$37$YR$$M$Y$80$KG$20240720$$CN$GB$GB
241136911$24113691$1$I$20240604$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-034581$AUROBINDO$$85$YR$$F$Y$45$KG$20240720$$MD$FR$FR
241136921$24113692$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011536$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240720$$CN$US$US
241136941$24113694$1$I$$20240715$20240720$20240720$PER$$US-JNJFOC-20240744058$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240720$$CN$US$US
241136951$24113695$1$I$$20240711$20240720$20240720$EXP$$US-APOTEX-2024AP008531$APOTEX$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. Journal of Pain and Symptom Management. 2023;66(4):e455-e459$$$A$$Y$$$20240720$$PH$US$US
241136961$24113696$1$I$20240528$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035426$AUROBINDO$$83$YR$$M$Y$$$20240720$$MD$FR$FR
241136971$24113697$1$I$$20240715$20240720$20240720$EXP$$US-ABBVIE-5844122$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241136981$24113698$1$I$20240101$20240715$20240720$20240720$EXP$$US-ABBVIE-5842566$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
241136991$24113699$1$I$20230101$20240205$20240720$20240720$EXP$GB-MHRA-MED-202402042254510280-KTFGJ$GB-TEVA-VS-3153374$TEVA$$$$$M$Y$$$20240720$$CN$GB$GB
241137011$24113701$1$I$$20240715$20240720$20240720$30DAY$$US-SANDOZ INC.-SDZ2024US066254$SANDOZ$$$$$F$Y$$$20240720$$CN$US$US
241137021$24113702$1$I$$20240709$20240720$20240720$PER$$US-TEVA-VS-3219121$TEVA$$$$A$F$Y$$$20240720$$PH$US$US
241137031$24113703$1$I$20240201$20240715$20240720$20240720$EXP$$US-ABBVIE-5842215$ABBVIE$$77$YR$$F$Y$$$20240720$$CN$US$US
241137041$24113704$1$I$$20240711$20240720$20240720$EXP$$US-APOTEX-2024AP008573$APOTEX$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. Journal of Pain and Symptom Management. 2023;66(4):e455-e459$$$A$$Y$$$20240720$$PH$US$US
241137061$24113706$1$I$$20240607$20240720$20240720$PER$$US-ASCENT-2024ASREG00007$ASCENT$$$$$$Y$$$20240720$$CN$US$US
241137071$24113707$1$I$$20240607$20240720$20240720$PER$$US-ASCENT-2024ASREG00008$ASCENT$$$$$$Y$$$20240720$$CN$US$US
241137082$24113708$2$F$20240708$20240725$20240720$20240729$PER$$US-AMGEN-USASP2024142746$AMGEN$$56$YR$A$M$Y$$$20240729$$CN$US$US
241137091$24113709$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035383$AUROBINDO$$42$YR$$M$Y$$$20240720$$PH$NL$NL
241137101$24113710$1$I$20231101$20240711$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-035549$AUROBINDO$$$$$M$Y$$$20240720$$CN$ES$ES
241137111$24113711$1$I$20230101$20240717$20240720$20240720$30DAY$$US-SANDOZ INC.-SDZ2024US066397$SANDOZ$$$$$F$Y$$$20240720$$CN$US$US
241137121$24113712$1$I$$20240715$20240720$20240720$PER$$US-AMGEN-USASP2024140629$AMGEN$$$$$$Y$$$20240720$$CN$US$US
241137131$24113713$1$I$$20240717$20240720$20240720$EXP$$AU-SANDOZ INC.-SDZ2024AU066345$SANDOZ$$$$$$Y$$$20240720$$HP$AU$AU
241137151$24113715$1$I$$20240710$20240720$20240720$EXP$$CA-TEVA-VS-3221880$TEVA$$91$YR$$F$Y$$$20240720$$PH$CA$CA
241137162$24113716$2$F$$20240721$20240720$20240723$PER$$US-HALEON-2187963$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241137171$24113717$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035202$AUROBINDO$$36$YR$$F$Y$105$KG$20240720$$CN$NL$NL
241137181$24113718$1$I$20240516$20240710$20240720$20240720$EXP$GB-MHRA-MED-202407102102341960-WSBCG$GB-TEVA-VS-3220180$TEVA$$$$$F$Y$58$KG$20240720$$CN$GB$GB
241137191$24113719$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035567$AUROBINDO$$31$YR$$F$Y$78$KG$20240720$$CN$NL$NL
241137211$24113721$1$I$20230101$20240201$20240720$20240720$EXP$FR-AFSSAPS-AVMP2023000430$FR-TEVA-VS-3154768$TEVA$$33$YR$$M$Y$$$20240720$$PH$FR$FR
241137221$24113722$1$I$20231219$20240710$20240720$20240720$EXP$$AT-TEVA-VS-3221043$TEVA$$60$YR$$F$Y$80$KG$20240720$$HP$AT$AT
241137231$24113723$1$I$$20240711$20240720$20240720$EXP$$US-APOTEX-2024AP008574$APOTEX$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. Journal of Pain and Symptom Management. 2023;66(4):e455-e459$$$A$$Y$$$20240720$$PH$US$US
241137242$24113724$2$F$$20240805$20240720$20240816$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK092261$GLENMARK$$$$$$Y$$$20240816$$HP$CA$CA
241137252$24113725$2$F$20240710$20240916$20240720$20240917$EXP$$BE-GILEAD-2024-0680544$GILEAD$$68$YR$E$M$Y$57$KG$20240917$$HP$BE$BE
241137261$24113726$1$I$$20240712$20240720$20240720$EXP$$US-AMGEN-USASP2024141066$AMGEN$Ohls.R.K.. Recombinant erythropoietin as Treatment for the Late Hyporegenerative Anemia of Rh Hemolytic Disease. Pediatrics. 1992;90 (No. 5):678-80$85$DY$I$M$Y$$$20240720$$HP$US$US
241137271$24113727$1$I$$20240717$20240720$20240720$EXP$$US-GILEAD-2024-0681063$GILEAD$$$$$F$Y$$$20240719$$CN$US$US
241137281$24113728$1$I$$20240711$20240720$20240720$EXP$$US-APOTEX-2024AP008575$APOTEX$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. Journal of Pain and Symptom Management. 2023;66(4):e455-e459$$$A$$Y$$$20240720$$PH$US$US
241137292$24113729$2$F$20240702$20240725$20240720$20240729$EXP$$US-AMGEN-USASP2024139558$AMGEN$$65$YR$E$F$Y$130$KG$20240729$$HP$US$US
241137301$24113730$1$I$20240710$20240710$20240720$20240720$PER$$US-RDY-SPO/USA/24/0010314$DR REDDYS$$15$YR$T$$Y$$$20240720$$CN$US$US
241137311$24113731$1$I$20240716$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011537$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240720$$CN$US$US
241137321$24113732$1$I$$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024142886$AMGEN$$$$$M$Y$$$20240720$$PH$US$US
241137331$24113733$1$I$20240714$20240716$20240720$20240720$PER$$US-AMGEN-USASP2024141403$AMGEN$$65$YR$E$F$Y$$$20240720$$CN$US$US
241137341$24113734$1$I$20220110$20240718$20240720$20240720$EXP$$US-ABBVIE-5845851$ABBVIE$$62$YR$$F$Y$$$20240720$$CN$US$US
241137351$24113735$1$I$$20240705$20240720$20240720$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06301$HIKMA$$$$$$Y$$$20240719$$PH$CA$CA
241137363$24113736$3$F$20190101$20240717$20240720$20240726$EXP$$US-ABBVIE-5844828$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241137371$24113737$1$I$$20240709$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-035264$AUROBINDO$Henry PJ, Wen JH, Feldman EB, Vargas J. Minocycline Induced Parenchymal Lung Disease with Peripheral Eosinophilia. Am-J-Respir-Crit-Care-Med. 2024;209:A1999$70$YR$$M$Y$$$20240720$$HP$US$US
241137382$24113738$2$F$20240713$20240725$20240720$20240729$PER$$US-AMGEN-USASP2024142927$AMGEN$$67$YR$E$$Y$$$20240729$$CN$US$US
241137391$24113739$1$I$$20240715$20240720$20240720$PER$$US-ABBVIE-5841197$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
241137401$24113740$1$I$$20240710$20240720$20240720$EXP$$IN-AMGEN-INDSP2024138035$AMGEN$Arora, K.. Navigating the Uncharted: A Rare Case of Ocular Flutter and Intermittent Jaw Movements in a Case of Chronic Lymphoid Leukemia. Annals of Indian Academy of Neurology. 2024;27 (3):313-315$63$YR$A$F$Y$$$20240720$$MD$IN$IN
241137411$24113741$1$I$$20240705$20240720$20240720$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06310$HIKMA$$$$$$Y$$$20240719$$HP$CA$CA
241137421$24113742$1$I$$20240705$20240720$20240720$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-06261$HIKMA$$$$$$Y$$$20240719$$HP$CA$CA
241137432$24113743$2$F$$20240802$20240720$20240816$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06309$HIKMA$$60$YR$$M$Y$$$20240816$$HP$CA$CA
241137441$24113744$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011674$ELI LILLY AND CO$$$$$F$Y$$$20240720$$CN$US$US
241137451$24113745$1$I$$20240709$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-035499$AUROBINDO$Devine MN, Gordon SE, Press CA.. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. J-PediatrPharmacol-Ther. 2023;28(2):161-166$60$DY$$$Y$$$20240720$$MD$US$US
241137461$24113746$1$I$$20240711$20240720$20240720$EXP$$US-APOTEX-2024AP008576$APOTEX$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. Journal of Pain and Symptom Management. 2023;66(4):e455-e459$$$A$$Y$$$20240720$$PH$US$US
241137471$24113747$1$I$20240614$20240710$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-034629$AUROBINDO$$72$YR$$F$Y$52$KG$20240720$$MD$FR$FR
241137484$24113748$4$F$20240716$20240830$20240720$20240902$PER$$US-AMGEN-USASP2024142017$AMGEN$$81$YR$E$F$Y$$$20240902$$CN$US$US
241137491$24113749$1$I$20230101$20240715$20240720$20240720$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010732$JAZZ$$$$$M$Y$60.771$KG$20240720$$CN$US$US
241137501$24113750$1$I$$20240711$20240720$20240720$PER$$US-RDY-SPO/USA/24/0010310$DR REDDYS$$72$YR$E$$Y$$$20240720$$MD$US$US
241137511$24113751$1$I$20240710$20240711$20240720$20240720$PER$$US-RDY-SPO/USA/24/0010308$DR REDDYS$$34$YR$A$F$Y$$$20240720$$CN$US$US
241137533$24113753$3$F$20240619$20240808$20240720$20240816$EXP$$JP-ARGENX-2024-ARGX-JP005477AA$ARGENX BVBA$$$$$$Y$$$20240816$$CN$JP$JP
241137541$24113754$1$I$$20240715$20240720$20240720$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010725$JAZZ$$$$$M$Y$$$20240720$$CN$US$US
241137551$24113755$1$I$$20240715$20240720$20240720$PER$$US-AMGEN-USASP2024141564$AMGEN$$$$$$Y$$$20240720$$PH$US$US
241137561$24113756$1$I$$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024143421$AMGEN$$$$$$Y$$$20240720$$MD$US$US
241137572$24113757$2$F$$20240718$20240720$20240723$PER$$US-AMGEN-USASP2024142905$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241137581$24113758$1$I$$20240716$20240720$20240720$EXP$$US-SANDOZ INC.-SDZ2024US065986$SANDOZ$$$$$F$Y$$$20240720$$CN$US$US
241137591$24113759$1$I$$20240710$20240720$20240720$EXP$$CA-TEVA-VS-3220493$TEVA$$76$YR$$F$Y$$$20240720$$MD$CA$CA
241137601$24113760$1$I$$20240709$20240720$20240720$EXP$$CN-009507513-2407CHN008739$MERCK$Fu H, Wang S, Jiang L. Treatment of type 2 diabetes patients with poor blood glucose control by oral hypoglycemic drugs converted to insulin degludec and liraglutide injection: 3 cases report. Chin J Diabetes Mellitus. 2023;15 suppl 1:10-2$61$YR$$M$Y$78$KG$20240720$$HP$CN$CN
241137611$24113761$1$I$20240625$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024142941$AMGEN$$69$YR$E$M$Y$$$20240720$$HP$US$US
241137621$24113762$1$I$$20240715$20240720$20240720$PER$$US-AMGEN-USASP2024141629$AMGEN$$$$$$Y$$$20240720$$CN$US$US
241137631$24113763$1$I$$20240711$20240720$20240720$EXP$$US-APOTEX-2024AP008577$APOTEX$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. Journal of Pain and Symptom Management. 2023;66(4):e455-e459$$$A$$Y$$$20240720$$PH$US$US
241137641$24113764$1$I$20240201$20240705$20240720$20240720$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06536$HIKMA$$$$$$Y$$$20240719$$CN$US$US
241137651$24113765$1$I$20240715$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024142397$AMGEN$$55$YR$A$M$Y$$$20240720$$CN$US$US
241137661$24113766$1$I$$20240705$20240720$20240720$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-06338$HIKMA$$61$YR$$F$Y$70$KG$20240719$$HP$CA$CA
241137671$24113767$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011549$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240720$$CN$US$US
241137681$24113768$1$I$$20240708$20240720$20240720$PER$$US-TEVA-VS-3219645$TEVA$$$$A$F$Y$$$20240720$$CN$US$US
241137691$24113769$1$I$20240526$20240709$20240720$20240720$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-06512$HIKMA$$$$$$Y$$$20240719$$PH$EG$EG
241137701$24113770$1$I$$20240705$20240720$20240720$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK091667$GLENMARK$$$$$$Y$$$20240720$$PH$US$US
241137712$24113771$2$F$$20240802$20240720$20240815$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-06337$HIKMA$$47$YR$$F$Y$95$KG$20240815$$HP$CA$CA
241137721$24113772$1$I$$20240715$20240720$20240720$PER$$US-ABBVIE-5841597$ABBVIE$$$$$$Y$$$20240720$$HP$US$US
241137731$24113773$1$I$20210820$20240717$20240720$20240720$EXP$$JP-ABBVIE-4191786$ABBVIE$$57$YR$$M$Y$61$KG$20240720$$MD$JP$JP
241137741$24113774$1$I$20230328$20240130$20240720$20240720$EXP$FR-AFSSAPS-AN2023001598$FR-TEVA-VS-3153369$TEVA$$30$YR$$F$Y$$$20240720$$MD$FR$FR
241137752$24113775$2$F$$20240729$20240720$20240810$EXP$$SE-GLENMARK PHARMACEUTICALS-2024GMK092252$GLENMARK$$$$$$Y$$$20240810$$CN$SE$SE
241137761$24113776$1$I$$20240710$20240720$20240720$PER$$US-RDY-SPO/USA/24/0010320$DR REDDYS$$67$YR$E$$Y$$$20240720$$HP$US$US
241137771$24113777$1$I$$20240711$20240720$20240720$EXP$$JP-AMGEN-JPNSP2024143095$AMGEN$$$$$$Y$$$20240720$$MD$JP$JP
241137781$24113778$1$I$20231226$20240711$20240720$20240720$EXP$$FR-CELLTRION INC.-2024FR017163$CELLTRION$$$$$$Y$$$20240720$$PH$FR$FR
241137791$24113779$1$I$$20240709$20240720$20240720$EXP$$CO-CELLTRION INC.-2024CO017473$CELLTRION$Canas CA, Posso-Osorio I, Perez-Uribe V, Erazo-Martinez V. Bronchiectasis, lymphadenopathies related to BAFF overexpression and lymphoplasmacytic cystitis as adverse events associated with prolonged use of rituximab in systemic autoimmune rheumatic diseases. Revista Clinica Espanola. 2024;S2254-8874(24)0$$$$$Y$$$20240720$$HP$CO$CO
241137801$24113780$1$I$$20240712$20240720$20240720$EXP$$US-GSK-US2024AMR088696$GLAXOSMITHKLINE$$$$$$Y$$$20240720$$CN$US$US
241137811$24113781$1$I$20240501$20240718$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407012157$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240720$$CN$US$US
241137821$24113782$1$I$$20240718$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407012485$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240720$$CN$US$US
241137831$24113783$1$I$$20240708$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407006012$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240720$$CN$US$US
241137842$24113784$2$F$$20240829$20240720$20240831$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010913$JAZZ$$$$$M$Y$$$20240831$$HP$US$US
241137851$24113785$1$I$20230101$20240712$20240720$20240720$PER$$US-ABBVIE-5844602$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
241137861$24113786$1$I$$20240710$20240720$20240720$EXP$$CA-TEVA-VS-3220291$TEVA$$62$YR$$M$Y$$$20240720$$MD$CA$CA
241137873$24113787$3$F$20230801$20240917$20240720$20240928$EXP$$CA-CELLTRION INC.-2022CA022416$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
241137882$24113788$2$F$20240703$20240723$20240720$20240725$PER$$US-AMGEN-USASP2024141928$AMGEN$$68$YR$E$M$Y$$$20240725$$CN$US$US
241137891$24113789$1$I$20220601$20240711$20240720$20240720$EXP$$ES-CELLTRION INC.-2024ES017162$CELLTRION$Fernandez Fournier M, Sorriguieta R, Puertas I, Pollan B, Iglesias G, Barranco A et al.. Treatment with anti-CD20 therapies and the risk of cryptogenic organising pneumonia in patients with multiple sclerosis.. Systematic review. LXXV Annual Meeting Of The Spanish Society Of Neurology$$$$$Y$$$20240720$$MD$ES$ES
241137912$24113791$2$F$20240715$20240717$20240720$20240726$PER$$US-AMGEN-USASP2024142581$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241137921$24113792$1$I$$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024143009$AMGEN$$$$$M$Y$$$20240720$$CN$US$US
241137936$24113793$6$F$20240101$20240912$20240720$20240919$EXP$$US-009507513-2406USA009155$MERCK$$$$$F$Y$90.703$KG$20240919$$CN$US$US
241137942$24113794$2$F$20230701$20240806$20240720$20240813$EXP$$GB-ABBVIE-5798609$ABBVIE$$17$YR$$M$Y$$$20240813$$MD$GB$GB
241137951$24113795$1$I$$20240710$20240720$20240720$EXP$$CA-TEVA-VS-3220221$TEVA$$$$A$$Y$$$20240720$$HP$CA$CA
241137961$24113796$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035363$AUROBINDO$$52$YR$$F$Y$95$KG$20240720$$CN$NL$NL
241137971$24113797$1$I$$20240716$20240720$20240720$PER$$US-ABBVIE-5844302$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241137981$24113798$1$I$$20240714$20240720$20240720$EXP$$US-GSK-US2024AMR089103$GLAXOSMITHKLINE$$$$$$Y$$$20240720$$HP$US$US
241137991$24113799$1$I$20240717$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024142963$AMGEN$$73$YR$E$M$Y$$$20240720$$PH$US$US
241138001$24113800$1$I$$20240712$20240720$20240720$EXP$$US-GSK-US2024087730$GLAXOSMITHKLINE$$$$$$Y$$$20240720$$CN$US$US
241138011$24113801$1$I$20240612$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035490$AUROBINDO$$45$YR$$F$Y$65$KG$20240720$$HP$FR$FR
241138021$24113802$1$I$$20240715$20240720$20240720$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2022-103958$REGENERON$$$$$F$Y$$$20240719$$PH$GB$GB
241138032$24113803$2$F$20240305$20240913$20240720$20240920$EXP$$JP-AMGEN-JPNSP2024140668$AMGEN$$9$DEC$E$F$Y$$$20240920$$MD$JP$JP
241138042$24113804$2$F$20230529$20240729$20240720$20240802$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-099309$REGENERON$$$$$F$Y$$$20240802$$CN$CH$CH
241138052$24113805$2$F$20240523$20240731$20240720$20240812$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-099710$REGENERON$$$$$F$Y$$$20240812$$CN$CA$CA
241138061$24113806$1$I$20240301$20240716$20240720$20240720$EXP$FR-AFSSAPS-TO2024000729$FR-REGENERON PHARMACEUTICALS, INC.-2024-099823$REGENERON$$76$YR$$M$Y$$$20240719$$MD$FR$FR
241138071$24113807$1$I$20240101$20240710$20240720$20240720$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-099822$REGENERON$$66$YR$$F$Y$$$20240719$$MD$DE$DE
241138082$24113808$2$F$$20240719$20240720$20240724$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2024-099818$REGENERON$$$$$M$Y$$$20240724$$CN$CO$CO
241138092$24113809$2$F$$20240822$20240720$20240827$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-099337$REGENERON$$88$YR$$F$Y$$$20240827$$CN$CH$CH
241138101$24113810$1$I$$20240716$20240720$20240720$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-099679$REGENERON$$$$$$Y$$$20240719$$MD$JP$JP
241138112$24113811$2$F$20240627$20240809$20240720$20240814$PER$$US-AMGEN-USASP2024141012$AMGEN$$44$YR$A$M$Y$$$20240814$$CN$US$US
241138121$24113812$1$I$20240716$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011731$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240720$$CN$US$US
241138131$24113813$1$I$$20240711$20240720$20240720$EXP$$CA-SANDOZ INC.-SDZ2024CA065403$SANDOZ$$$$$M$Y$$$20240720$$MD$CA$CA
241138141$24113814$1$I$20240405$20240711$20240720$20240720$EXP$$GB-CELLTRION INC.-2024GB017258$CELLTRION$$$$$$Y$$$20240720$$MD$GB$GB
241138152$24113815$2$F$20220510$20240723$20240720$20240731$EXP$$CA-CELLTRION INC.-2024CA017494$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
241138162$24113816$2$F$20240625$20240816$20240720$20240822$EXP$$BR-CELLTRION INC.-2024BR017185$CELLTRION$$$$$$Y$$$20240822$$CN$BR$BR
241138171$24113817$1$I$$20240718$20240720$20240720$PER$$US-AMGEN-USASP2024143215$AMGEN$$$$$$Y$$$20240720$$CN$US$US
241138181$24113818$1$I$$20240711$20240720$20240720$EXP$$GB-CELLTRION INC.-2024GB017327$CELLTRION$$$$$$Y$$$20240720$$CN$GB$GB
241138191$24113819$1$I$20240101$20240711$20240720$20240720$EXP$$CA-CELLTRION INC.-2024CA006503$CELLTRION$$$$$$Y$$$20240720$$CN$CA$CA
241138201$24113820$1$I$20240529$20240711$20240720$20240720$EXP$$GB-CELLTRION INC.-2024GB013006$CELLTRION$$$$$$Y$$$20240720$$CN$GB$GB
241138211$24113821$1$I$$20240710$20240720$20240720$EXP$$US-TEVA-VS-3221215$TEVA$$$$$$Y$$$20240720$$CN$US$US
241138221$24113822$1$I$20240101$20240716$20240720$20240720$EXP$$US-ABBVIE-5842663$ABBVIE$$72$YR$$M$Y$$$20240720$$CN$US$US
241138231$24113823$1$I$20240308$20240712$20240720$20240720$EXP$$JP-AMGEN-JPNSP2024141422$AMGEN$$$$E$$Y$$$20240720$$MD$JP$JP
241138241$24113824$1$I$20240101$20240717$20240720$20240720$EXP$$US-ABBVIE-5844703$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
241138251$24113825$1$I$20240101$20240717$20240720$20240720$EXP$$CA-ABBVIE-5845001$ABBVIE$$55$YR$$F$Y$$$20240720$$CN$CA$CA
241138261$24113826$1$I$20240330$20240711$20240720$20240720$EXP$$GB-AUROBINDO-AUR-APL-2024-034952$AUROBINDO$$$$$F$Y$$$20240720$$CN$GB$GB
241138271$24113827$1$I$20231001$20240710$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-034597$AUROBINDO$$84$YR$$M$Y$$$20240720$$PH$FR$FR
241138281$24113828$1$I$$20240716$20240720$20240720$EXP$$GB-ABBVIE-5844196$ABBVIE$$$$A$M$Y$$$20240720$$HP$GB$GB
241138291$24113829$1$I$20240626$20240710$20240720$20240720$EXP$$GB-AUROBINDO-AUR-APL-2024-034560$AUROBINDO$$15$YR$$F$Y$$$20240720$$MD$GB$GB
241138302$24113830$2$F$20240520$20240717$20240720$20240725$PER$$US-AMGEN-USASP2024142553$AMGEN$$87$YR$E$F$Y$$$20240725$$HP$US$US
241138311$24113831$1$I$$20240710$20240720$20240720$EXP$$GB-TEVA-VS-3220307$TEVA$$86$YR$$F$Y$57$KG$20240720$$MD$GB$GB
241138321$24113832$1$I$20230911$20240718$20240720$20240720$EXP$$KW-ABBVIE-5845446$ABBVIE$$67$YR$$F$Y$$$20240720$$CN$KW$KW
241138331$24113833$1$I$$20230626$20240720$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02125$AMNEAL$$$$$F$Y$$$20240720$$CN$US$US
241138341$24113834$1$I$20230604$20230713$20240720$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02014$AMNEAL$$51$YR$$M$Y$$$20240720$$CN$US$US
241138351$24113835$1$I$$20231018$20240720$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03385$AMNEAL$$42$YR$$F$Y$86.168$KG$20240720$$PH$US$US
241138367$24113836$7$F$20240101$20240913$20240720$20240923$EXP$$CA-CELLTRION INC.-2024CA011881$CELLTRION$$$$$$Y$$$20240923$$MD$CA$CA
241138371$24113837$1$I$20240521$20240605$20240720$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01943$AMNEAL$$68$YR$$F$Y$$$20240720$$CN$US$US
241138381$24113838$1$I$20230915$20231019$20240720$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03292$AMNEAL$$21$YR$$F$Y$$$20240720$$CN$US$US
241138391$24113839$1$I$$20240217$20240720$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00365$AMNEAL$$$$$$Y$$$20240720$$CN$US$US
241138401$24113840$1$I$20230810$20230828$20240720$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02873$AMNEAL$$19$YR$$M$Y$80.726$KG$20240720$$CN$US$US
241138411$24113841$1$I$$20240416$20240720$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01277$AMNEAL$$$$$$Y$$$20240720$$CN$US$US
241138421$24113842$1$I$$20240417$20240720$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01132$AMNEAL$$$$$$Y$$$20240720$$HP$US$US
241138431$24113843$1$I$20210101$20240717$20240720$20240720$EXP$$US-ABBVIE-5845481$ABBVIE$$53$YR$$F$Y$$$20240720$$CN$US$US
241138442$24113844$2$F$20240501$20240722$20240720$20240728$EXP$$US-ABBVIE-5844479$ABBVIE$$76$YR$$M$Y$72$KG$20240728$$CN$US$US
241138451$24113845$1$I$20240318$20240710$20240720$20240720$EXP$$DE-AUROBINDO-AUR-APL-2024-034664$AUROBINDO$$31$YR$$F$Y$51$KG$20240720$$MD$DE$DE
241138461$24113846$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035334$AUROBINDO$$22$YR$$F$Y$91$KG$20240720$$CN$NL$NL
241138471$24113847$1$I$20230101$20240716$20240720$20240720$EXP$$US-ABBVIE-5844354$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241138482$24113848$2$F$$20240722$20240720$20240726$EXP$$US-ABBVIE-5844832$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241138491$24113849$1$I$$20240715$20240720$20240720$PER$$US-ABBVIE-5842426$ABBVIE$$$$A$F$Y$$$20240720$$MD$US$US
241138503$24113850$3$F$20240601$20240912$20240720$20240921$EXP$$US-ARDELYX-2024ARDX005088$ARDELYX$$69$YR$$F$Y$$$20240921$$HP$US$US
241138511$24113851$1$I$20240617$20240710$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-034687$AUROBINDO$$86$YR$$F$Y$65$KG$20240720$$MD$FR$FR
241138521$24113852$1$I$$20240709$20240720$20240720$EXP$$US-ARDELYX-2024ARDX005176$ARDELYX$$$$$M$Y$$$20240718$$HP$US$US
241138532$24113853$2$F$20240717$20240826$20240720$20240829$PER$$US-AMGEN-USASP2024142972$AMGEN$$73$YR$E$F$Y$$$20240829$$CN$US$US
241138542$24113854$2$F$20240601$20240917$20240720$20240924$EXP$$US-ABBVIE-5844550$ABBVIE$$86$YR$$F$Y$$$20240924$$CN$US$US
241138552$24113855$2$F$20240601$20240821$20240720$20240830$EXP$$US-ARDELYX-2024ARDX005276$ARDELYX$$52$YR$$F$Y$$$20240830$$MD$US$US
241138561$24113856$1$I$$20240628$20240720$20240720$PER$$US-JNJFOC-20240700913$JOHNSON AND JOHNSON$$$$$F$Y$$$20240720$$CN$US$US
241138572$24113857$2$F$20240101$20240805$20240720$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-035480$AUROBINDO$$58$YR$$M$Y$$$20240816$$MD$FR$FR
241138582$24113858$2$F$$20240812$20240720$20240822$EXP$$US-ARDELYX-2024ARDX005317$ARDELYX$$86$YR$$F$Y$$$20240822$$HP$US$US
241138591$24113859$1$I$20240701$20240711$20240720$20240720$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR086696$VIIV$$$$$M$Y$$$20240720$$HP$US$US
241138601$24113860$1$I$$20240710$20240720$20240720$EXP$$CA-CELLTRION INC.-2024CA016845$CELLTRION$$$$$$Y$$$20240720$$CN$CA$CA
241138611$24113861$1$I$$20240711$20240720$20240720$30DAY$$US-GSK-US2024AMR088835$GLAXOSMITHKLINE$$$$$M$Y$$$20240720$$CN$US$US
241138622$24113862$2$F$$20240717$20240720$20240724$EXP$$AU-TGA-0000814096$SANDOZ$$$$$$Y$$$20240724$$HP$AU$AU
241138631$24113863$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035418$AUROBINDO$$46$YR$$F$Y$74$KG$20240720$$CN$NL$NL
241138642$24113864$2$F$$20240719$20240720$20240722$PER$$US-AMGEN-USASP2024142915$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241138651$24113865$1$I$20240101$20240718$20240720$20240720$EXP$GB-MHRA-MED-202407180957294170-SPRYQ$GB-ABBVIE-5844926$ABBVIE$$63$YR$$F$Y$$$20240720$$MD$GB$GB
241138661$24113866$1$I$20210101$20240708$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-031545$AUROBINDO$Schumaier NP, Heidemann DG, Gupta C.. Durvalumab-associated limbal stem cell deficiency and secondary corneal perforation.. American Journal of Ophthalmology Case Report. 2024;35:102074$65$YR$$M$Y$$$20240720$$MD$US$US
241138671$24113867$1$I$20240101$20240715$20240720$20240720$PER$$US-ABBVIE-5841562$ABBVIE$$$$$F$Y$92.079$KG$20240720$$CN$US$US
241138681$24113868$1$I$$20240710$20240720$20240720$EXP$$CA-CELLTRION INC.-2024CA016833$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
241138692$24113869$2$F$$20240712$20240720$20240723$EXP$$CA-CELLTRION INC.-2024CA017365$CELLTRION$$$$$$Y$$$20240723$$HP$CA$CA
241138701$24113870$1$I$$20240710$20240720$20240720$EXP$$CA-CELLTRION INC.-2024CA016829$CELLTRION$$$$$$Y$$$20240720$$CN$CA$CA
241138711$24113871$1$I$$20240710$20240720$20240720$EXP$$CA-CELLTRION INC.-2024CA016820$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
241138721$24113872$1$I$$20240710$20240720$20240720$EXP$$CA-CELLTRION INC.-2024CA016838$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
241138731$24113873$1$I$20221119$20240711$20240720$20240720$EXP$$FR-CELLTRION INC.-2024FR017190$CELLTRION$$$$$$Y$$$20240720$$MD$FR$FR
241138741$24113874$1$I$$20240710$20240720$20240720$EXP$$CA-CELLTRION INC.-2024CA016825$CELLTRION$$$$$$Y$$$20240720$$PH$CA$CA
241138763$24113876$3$F$$20240903$20240720$20240913$EXP$$DE-CELLTRION INC.-2024DE017296$CELLTRION$$$$$$Y$$$20240913$$MD$DE$DE
241138771$24113877$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011436$ELI LILLY AND CO$$$$$M$Y$$$20240720$$CN$US$US
241138781$24113878$1$I$$20240716$20240720$20240720$EXP$$GB-SANDOZ INC.-SDZ2024GB045797$SANDOZ$$$$$M$Y$$$20240720$$CN$GB$GB
241138791$24113879$1$I$$20240715$20240720$20240720$EXP$$CA-GENMAB-2024-02633$GENMAB$$77$YR$$M$Y$$$20240720$$CN$CA$CA
241138801$24113880$1$I$20240718$20240718$20240720$20240720$PER$$US-AMGEN-USASP2024143699$AMGEN$$$$$F$Y$$$20240720$$CN$US$US
241138813$24113881$3$F$20240101$20240909$20240720$20240917$EXP$$CA-CELLTRION INC.-2024CA015467$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
241138821$24113882$1$I$20240627$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035485$AUROBINDO$$19$YR$$F$Y$$$20240720$$MD$FR$FR
241138831$24113883$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035425$AUROBINDO$$$DY$$M$Y$4$KG$20240720$$MD$NL$NL
241138841$24113884$1$I$20221121$20240718$20240720$20240720$EXP$FR-AFSSAPS-LM2024000402$FR-ABBVIE-5845484$ABBVIE$$75$YR$$M$Y$$$20240720$$MD$FR$FR
241138851$24113885$1$I$$20240709$20240720$20240720$30DAY$$US-GSK-US2024085154$GLAXOSMITHKLINE$$$$$F$Y$$$20240720$$CN$US$US
241138871$24113887$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-034964$AUROBINDO$$43$YR$$F$Y$72$KG$20240720$$CN$NL$NL
241138881$24113888$1$I$20231101$20240716$20240720$20240720$EXP$$DE-SANDOZ INC.-SDZ2024DE066102$SANDOZ$$1$DY$$M$Y$2.69$KG$20240720$$MD$DE$DE
241138891$24113889$1$I$20240419$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035461$AUROBINDO$$55$YR$$F$Y$$$20240720$$MD$FR$FR
241138901$24113890$1$I$20240716$20240716$20240720$20240720$PER$$US-AMGEN-USASP2024141709$AMGEN$$65$YR$E$F$Y$$$20240720$$CN$US$US
241138911$24113891$1$I$20240702$20240716$20240720$20240720$PER$$US-AMGEN-USASP2024141233$AMGEN$$68$YR$E$F$Y$$$20240720$$PH$US$US
241138921$24113892$1$I$20240626$20240710$20240720$20240720$EXP$IT-MINISAL02-993334$IT-TEVA-VS-3220429$TEVA$$57$YR$$F$Y$60$KG$20240720$$MD$IT$IT
241138941$24113894$1$I$$20240711$20240720$20240720$EXP$$CA-CELLTRION INC.-2024CA017375$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
241138951$24113895$1$I$$20240710$20240720$20240720$EXP$CA-MHPD-E2B_07094454$CA-Accord-435486$ACCORD$$68$YR$E$M$Y$$$20240720$$HP$CA$CA
241138961$24113896$1$I$$20240711$20240720$20240720$30DAY$$US-GSK-US2024AMR088361$GLAXOSMITHKLINE$$$$$M$Y$$$20240720$$CN$US$US
241138971$24113897$1$I$20240702$20240711$20240720$20240720$30DAY$$US-GSK-US2024086610$GLAXOSMITHKLINE$$$$$F$Y$$$20240720$$CN$US$US
241138981$24113898$1$I$20240101$20240711$20240720$20240720$EXP$$US-GSK-US2024086586$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240720$$CN$US$US
241138992$24113899$2$F$20230101$20240729$20240720$20240731$EXP$$NL-SANDOZ INC.-SDZ2024NL065913$SANDOZ$$46$YR$$F$Y$$$20240731$$HP$NL$NL
241139001$24113900$1$I$$20240711$20240720$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02572$AMNEAL$$$$$F$Y$$$20240720$$MD$US$US
241139011$24113901$1$I$$20230510$20240720$20240720$EXP$$CA-CELLTRION INC.-2022CA022572$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
241139023$24113902$3$F$$20240722$20240720$20240731$EXP$$BR-CELLTRION INC.-2024BR017317$CELLTRION$$$$$$Y$$$20240731$$CN$BR$BR
241139031$24113903$1$I$20240418$20240711$20240720$20240720$EXP$$DE-AUROBINDO-AUR-APL-2024-035442$AUROBINDO$$$$E$F$Y$$$20240720$$MD$DE$DE
241139041$24113904$1$I$20240719$20240719$20240720$20240720$PER$$NVSC2024US149120$NOVARTIS$$62$YR$$F$Y$$$20240720$$CN$US$US
241139052$24113905$2$F$$20240919$20240720$20240920$EXP$$NVSC2024US092628$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
241139061$24113906$1$I$20230407$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035501$AUROBINDO$$82$YR$$M$Y$75$KG$20240720$$PH$FR$FR
241139071$24113907$1$I$20240610$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035458$AUROBINDO$$62$YR$$F$Y$$$20240720$$PH$FR$FR
241139081$24113908$1$I$$20240709$20240720$20240720$PER$$US-TEVA-VS-3219686$TEVA$$$$E$F$Y$70.31$KG$20240720$$CN$US$US
241139092$24113909$2$F$$20240719$20240720$20240723$30DAY$$US-SANDOZ INC.-SDZ2024US066461$SANDOZ$$$$$M$Y$$$20240723$$CN$US$US
241139101$24113910$1$I$$20240717$20240720$20240720$PER$$US-ABBVIE-5843969$ABBVIE$$$$$$Y$$$20240720$$CN$US$US
241139111$24113911$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035239$AUROBINDO$$33$YR$$F$Y$75$KG$20240720$$CN$NL$NL
241139121$24113912$1$I$$20240715$20240720$20240720$PER$$US-AMGEN-USASP2024140367$AMGEN$$$$$$Y$$$20240720$$PH$US$US
241139142$24113914$2$F$20240713$20240731$20240720$20240806$EXP$$TR-ABBVIE-5843665$ABBVIE$$54$YR$$M$Y$75$KG$20240806$$CN$TR$TR
241139154$24113915$4$F$20230801$20240821$20240720$20240828$EXP$$CA-CELLTRION INC.-2023CA025673$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
241139163$24113916$3$F$20240716$20240731$20240720$20240807$EXP$$TW-ABBVIE-5843589$ABBVIE$$55$YR$$F$Y$51$KG$20240807$$CN$TW$TW
241139177$24113917$7$F$20240101$20240920$20240720$20240930$EXP$$CA-CELLTRION INC.-2024CA017449$CELLTRION$$$$$$Y$$$20240930$$CN$CA$CA
241139202$24113920$2$F$20200503$20240711$20240720$20240724$EXP$$PL-AUROBINDO-AUR-APL-2024-035350$AUROBINDO$$26$YR$$F$Y$53$KG$20240724$$MD$PL$PL
241139211$24113921$1$I$$20240710$20240720$20240720$EXP$$CN-STERISCIENCE B.V.-2024-ST-001056$Steriscience PTE$Zhang X, Jiao F, Li G, Yu X, Pei Y, Zhang Y, et al.. Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants.. Front-Pharmacol. 2023;14.$70$YR$$M$Y$65$KG$20240719$$HP$CN$CN
241139222$24113922$2$F$$20240711$20240720$20240722$EXP$$CA-TEVA-VS-3221551$TEVA$$73$YR$$F$Y$$$20240722$$MD$CA$CA
241139232$24113923$2$F$$20240709$20240720$20240724$EXP$$CN-AUROBINDO-AUR-APL-2024-035524$AUROBINDO$Qu F-J, Kong Y, Yan X, Wang H. Elderly patients with advanced HER2-positive breast cancer with liver metastases benefit from low dose disitamab vedotin (RC48): case series and literature review. Anticancer-Drugs. 2024$81$YR$$F$Y$$$20240724$$HP$CN$CN
241139242$24113924$2$F$20240527$20240711$20240720$20240724$EXP$$ES-AUROBINDO-AUR-APL-2024-034897$AUROBINDO$$53$YR$$F$Y$$$20240724$$MD$ES$ES
241139251$24113925$1$I$20240717$20240717$20240720$20240720$EXP$$DE-ABBVIE-5845092$ABBVIE$$72$YR$$M$Y$$$20240720$$MD$DE$DE
241139261$24113926$1$I$$20240715$20240720$20240720$EXP$$US-ABBVIE-5844491$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
241139271$24113927$1$I$$20240716$20240720$20240720$EXP$$CA-ABBVIE-5843931$ABBVIE$$$$A$F$Y$$$20240720$$CN$CA$CA
241139281$24113928$1$I$$20240717$20240720$20240720$EXP$$US-ABBVIE-5844185$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241139291$24113929$1$I$20240101$20240717$20240720$20240720$EXP$$US-ABBVIE-5844070$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241139301$24113930$1$I$20240711$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011393$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240720$$CN$US$US
241139311$24113931$1$I$20240709$20240716$20240720$20240720$EXP$$US-ABBVIE-5844226$ABBVIE$$45$YR$$M$Y$$$20240720$$CN$US$US
241139321$24113932$1$I$$20240709$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035593$AUROBINDO$Gigante E, Bouattour M, Bedoya JU, Regnault H, Ziol M, JC Nault, et al. Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellularcholangiocarcinoma: A multicentric retrospective study.. United-European-Gastroenterol-J. 2024;12(4):429-439$66$YR$$M$Y$$$20240720$$HP$FR$FR
241139332$24113933$2$F$$20240712$20240720$20240722$PER$$US-ABBVIE-5841207$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241139341$24113934$1$I$20240101$20240716$20240720$20240720$EXP$$US-ABBVIE-5844496$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241139351$24113935$1$I$$20240710$20240720$20240720$EXP$$IT-AUROBINDO-AUR-APL-2024-035322$AUROBINDO$Messina A, Rodolico A, Caraci F, Signorelli MS.. Vortioxetine in Patients with Schizophrenia and Suicidal Ideation.. System-Rev-Pharm. 2023;14(6):393-395$19$YR$$F$Y$$$20240720$$HP$IT$IT
241139361$24113936$1$I$$20240710$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-036056$AUROBINDO$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol. 2024;35 (Suppl. 1):S60-S61 abstr. 130P$62$YR$$F$Y$$$20240720$$HP$ES$ES
241139371$24113937$1$I$20230702$20240710$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-034421$AUROBINDO$$51$YR$$M$Y$77.7$KG$20240720$$MD$FR$FR
241139382$24113938$2$F$20240101$20240906$20240720$20240912$EXP$$CA-ABBVIE-5844998$ABBVIE$$52$YR$$F$Y$$$20240912$$CN$CA$CA
241139393$24113939$3$F$20240101$20240827$20240720$20240904$EXP$$CA-CELLTRION INC.-2023CA021366$CELLTRION$$$$$$Y$$$20240904$$MD$CA$CA
241139401$24113940$1$I$$20240709$20240720$20240720$EXP$$CO-CELLTRION INC.-2024CO017475$CELLTRION$Canas CA, Posso-Osorio I, Perez-Uribe V, and Erazo-Martinez V. Bronchiectasis, lymphadenopathies related to BAFF overexpression and lymphoplasmacytic cystitis as adverse events associated with prolonged use of rituximab in systemic autoimmune rheumatic diseases. Revista Clinica Espanola. 2024$$$$$Y$$$20240720$$HP$CO$CO
241139411$24113941$1$I$20240601$20240717$20240720$20240720$EXP$$US-ABBVIE-5845149$ABBVIE$$68$YR$$F$Y$$$20240720$$CN$US$US
241139421$24113942$1$I$$20240709$20240720$20240720$PER$$US-TEVA-VS-3220096$TEVA$$39$YR$$F$Y$$$20240720$$HP$US$US
241139431$24113943$1$I$$20240710$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-036060$AUROBINDO$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol. 2024;35 (Suppl. 1):S60-S61 abstr. 130P$66$YR$$M$Y$$$20240720$$HP$ES$ES
241139441$24113944$1$I$$20240717$20240720$20240720$EXP$$US-SANDOZ INC.-SDZ2024US066513$SANDOZ$$$$$M$Y$$$20240720$$HP$US$US
241139451$24113945$1$I$$20240716$20240720$20240720$EXP$$US-ABBVIE-5843794$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241139462$24113946$2$F$20240714$20240722$20240720$20240725$PER$$US-AMGEN-USASP2024141813$AMGEN$$81$YR$E$M$Y$$$20240725$$CN$US$US
241139471$24113947$1$I$20230926$20240711$20240720$20240720$EXP$$GB-AUROBINDO-AUR-APL-2024-035006$AUROBINDO$$$$$F$Y$$$20240720$$MD$GB$GB
241139484$24113948$4$F$20240401$20240730$20240720$20240807$EXP$$BR-CELLTRION INC.-2023BR000894$CELLTRION$$$$$$Y$$$20240807$$CN$BR$BR
241139493$24113949$3$F$$20240807$20240720$20240814$PER$$US-ABBVIE-5840111$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
241139501$24113950$1$I$$20240710$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-034669$AUROBINDO$$59$YR$$F$Y$$$20240720$$MD$FR$FR
241139511$24113951$1$I$20240211$20240710$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-034643$AUROBINDO$$80$YR$$M$Y$82$KG$20240720$$MD$FR$FR
241139531$24113953$1$I$$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024143594$AMGEN$$$$$$Y$$$20240720$$CN$US$US
241139541$24113954$1$I$$20240710$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-034469$AUROBINDO$Guy DR, DeVore S, Kirtani V, Duffy N. Generalized pustular psoriasis successfully treated with spesolimab in the setting of metastatic colon cancer. JAAD Case Reports. 2024;50:6-8$76$YR$$M$Y$$$20240720$$MD$US$US
241139551$24113955$1$I$$20240715$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407010726$ELI LILLY AND CO$$$$A$F$Y$$$20240720$$CN$US$US
241139561$24113956$1$I$20240502$20240710$20240720$20240720$EXP$FR-AFSSAPS-RS2024000657$FR-TEVA-VS-3219847$TEVA$$23$YR$$F$Y$$$20240720$$MD$FR$FR
241139571$24113957$1$I$20240101$20240705$20240720$20240720$PER$$US-INSUD PHARMA-2407US05404$INSUD PHARMA$$$$$$Y$$$20240720$$CN$US$US
241139581$24113958$1$I$20240630$20240705$20240720$20240720$PER$$US-INSUD PHARMA-2407US05403$INSUD PHARMA$$$$$$Y$$$20240720$$CN$US$US
241139591$24113959$1$I$20240615$20240706$20240720$20240720$PER$$US-INSUD PHARMA-2407US05408$INSUD PHARMA$$$$$$Y$$$20240720$$CN$US$US
241139601$24113960$1$I$$20240705$20240720$20240720$PER$$US-INSUD PHARMA-2407US05402$INSUD PHARMA$$$$$$Y$$$20240720$$CN$US$US
241139611$24113961$1$I$$20240705$20240720$20240720$PER$$US-INSUD PHARMA-2407US05406$INSUD PHARMA$$$$$$Y$$$20240720$$CN$US$US
241139621$24113962$1$I$$20240705$20240720$20240720$PER$$US-INSUD PHARMA-2407US05400$INSUD PHARMA$$$$$$Y$$$20240720$$CN$US$US
241139631$24113963$1$I$20240701$20240706$20240720$20240720$PER$$US-INSUD PHARMA-2407US05407$INSUD PHARMA$$$$$$Y$$$20240720$$CN$US$US
241139641$24113964$1$I$20240101$20240706$20240720$20240720$PER$$US-INSUD PHARMA-2407US05405$INSUD PHARMA$$$$$$Y$$$20240720$$CN$US$US
241139651$24113965$1$I$20240501$20240703$20240720$20240720$PER$$US-INSUD PHARMA-2407US05397$INSUD PHARMA$$$$$$Y$$$20240720$$CN$US$US
241139661$24113966$1$I$$20240705$20240720$20240720$PER$$US-INSUD PHARMA-2407US05401$INSUD PHARMA$$$$$$Y$$$20240720$$CN$US$US
241139671$24113967$1$I$20231204$20240710$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-034613$AUROBINDO$$58$YR$$F$Y$$$20240720$$MD$ES$ES
241139681$24113968$1$I$$20240711$20240720$20240720$EXP$$TR-AMNEAL PHARMACEUTICALS-2024-AMRX-02576$AMNEAL$Visneci EF, Aydin T, Tekin FC, Acar D.. A Case of Pulmonary Embolism after to Receiving a Dose of Sildenafil. J Emerg Med.. 2024;15(2):53-5$81$YR$$M$Y$$$20240720$$HP$TR$TR
241139691$24113969$1$I$$20240717$20240720$20240720$EXP$$AU-TGA-0000813370$SANDOZ$$$$$$Y$$$20240720$$HP$AU$AU
241139701$24113970$1$I$$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024142056$AMGEN$$$$$$Y$$$20240720$$CN$US$US
241139721$24113972$1$I$20240601$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035488$AUROBINDO$$82$YR$$M$Y$71$KG$20240720$$MD$FR$FR
241139741$24113974$1$I$$20240709$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-035086$AUROBINDO$Ala A, Abdelrahim S, Al Shaarani M, Lu H, Ahmad R, Goswami S, et al. mmune Checkpoint Therapy-Induced Lupus Nephritis. Kidney-Int-Rep. 2024;9(5):1534-1537$$$E$M$Y$$$20240720$$HP$US$US
241139751$24113975$1$I$20220801$20240717$20240720$20240720$EXP$$AU-SANDOZ INC.-SDZ2024AU066406$SANDOZ$$$$$M$Y$$$20240720$$CN$AU$AU
241139771$24113977$1$I$20230801$20240708$20240720$20240720$EXP$$CN-PBT-009534$PANACEA BIOTEC$Jiang C, Yan X, Xia P, Luo X, Zheng H, Tong H, et al. Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus. Front Pharmacol. 2024 Jun 19;15:1364121. doi: 10.3389/fphar.2024.1364121.$32$YR$A$M$Y$$$20240720$$HP$CN$CN
241139781$24113978$1$I$$20240718$20240720$20240720$EXP$$US-SANDOZ INC.-SDZ2024US066687$SANDOZ$$$$$M$Y$$$20240720$$CN$US$US
241139791$24113979$1$I$$20240709$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-035217$AUROBINDO$Natarajan S, Amjad M, Zaidi S, Shah A, Ochieng PO. Persistent Bilateral Spontaneous Pneumothorax in Combined Pulmonary. Am-J-Respir-Crit-Care-Med. 2023;207:A3218$72$YR$$M$Y$$$20240720$$HP$US$US
241139804$24113980$4$F$20240101$20240908$20240720$20240916$EXP$$CA-CELLTRION INC.-2024CA011056$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
241139811$24113981$1$I$$20240709$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-035252$AUROBINDO$Mignone D, Shah K, Alawneh B, Papadakos SP, Michelakis N. A RUDE AWAKENING: A CASE OF SUGAMMADEX CAUSING TRANSIENT CARDIOMYOPATHY MIMICKING STEMI. J-Am-CollCardiol. 2024;83 (Suppl.)(13):3618$43$YR$$M$Y$$$20240720$$HP$US$US
241139821$24113982$1$I$$20240710$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-036058$AUROBINDO$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol. 2024;35 (Suppl. 1):S60-S61 abstr. 130P$65$YR$$M$Y$$$20240720$$HP$ES$ES
241139831$24113983$1$I$20240308$20240710$20240720$20240720$EXP$FR-AFSSAPS-LL2024001220$FR-TEVA-VS-3220315$TEVA$$35$YR$$F$Y$$$20240720$$MD$FR$FR
241139841$24113984$1$I$$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024142087$AMGEN$$$$$F$Y$$$20240720$$CN$US$US
241139861$24113986$1$I$20240707$20240712$20240720$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021660$UNITED THERAPEUTICS$$86$YR$$M$Y$104.76$KG$20240719$$$US$US
241139871$24113987$1$I$20240101$20240712$20240720$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020138$UNITED THERAPEUTICS$$$$$F$Y$$$20240719$$$US$US
241139882$24113988$2$F$20240711$20240718$20240720$20240722$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022047$UNITED THERAPEUTICS$$71$YR$$F$Y$$$20240722$$$US$US
241139892$24113989$2$F$20240501$20240806$20240720$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-016558$UNITED THERAPEUTICS$$77$YR$$F$Y$78.912$KG$20240809$$$US$US
241139901$24113990$1$I$20240101$20240711$20240720$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008740$UNITED THERAPEUTICS$$$$$F$Y$60.771$KG$20240719$$$US$US
241139911$24113991$1$I$20240703$20240710$20240720$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021355$UNITED THERAPEUTICS$$85$YR$$F$Y$59.41$KG$20240719$$$US$US
241139922$24113992$2$F$20240101$20240726$20240720$20240802$PER$$US-UNITED THERAPEUTICS-UNT-2024-019081$UNITED THERAPEUTICS$$$$$F$Y$59.864$KG$20240802$$$US$US
241139934$24113993$4$F$20240101$20240729$20240720$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020814$UNITED THERAPEUTICS$$$$$F$Y$53.061$KG$20240807$$$US$US
241139946$24113994$6$F$20240101$20240917$20240720$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020653$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240927$$$US$US
241139951$24113995$1$I$20240711$20240711$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-021496$UNITED THERAPEUTICS$$40$YR$$F$Y$43.537$KG$20240719$$$US$US
241139962$24113996$2$F$20240101$20240717$20240720$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-021711$UNITED THERAPEUTICS$$$$$F$Y$80.726$KG$20240724$$$US$US
241139972$24113997$2$F$20240624$20240812$20240720$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019591$UNITED THERAPEUTICS$$37$YR$$M$Y$65.76$KG$20240821$$$US$US
241139982$24113998$2$F$20240101$20240718$20240720$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021757$UNITED THERAPEUTICS$$$$$F$Y$71.202$KG$20240726$$$US$US
241140001$24114000$1$I$20240101$20240715$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-018253$UNITED THERAPEUTICS$$$$$M$Y$68.027$KG$20240719$$$US$US
241140013$24114001$3$F$20240708$20240829$20240720$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021255$UNITED THERAPEUTICS$$47$YR$$F$Y$91.61$KG$20240906$$PH$US$US
241140021$24114002$1$I$$20240711$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-021486$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240719$$$US$US
241140032$24114003$2$F$20240101$20240717$20240720$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014455$UNITED THERAPEUTICS$$$$$F$Y$73.923$KG$20240725$$$US$US
241140041$24114004$1$I$20230101$20240710$20240720$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2023-025045$UNITED THERAPEUTICS$$$$$M$Y$156.46$KG$20240719$$$US$US
241140051$24114005$1$I$20190901$20240711$20240720$20240720$EXP$$CN-ABBVIE-5844377$ABBVIE$Qin LY, Geng Y, Mu JF, Wang WJ, Zhang CX, Gao YN, et al. Central nervous system involvement in chronic lymphocytic leukemia: a case report and review of literature. J Med Case Reports. 2024;18(1):315.$67$YR$$M$Y$$$20240720$$HP$CN$CN
241140061$24114006$1$I$20240601$20240715$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-019572$UNITED THERAPEUTICS$$75$YR$$M$Y$61.224$KG$20240719$$$US$US
241140071$24114007$1$I$20240701$20240713$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-021898$UNITED THERAPEUTICS$$69$YR$$F$Y$52.608$KG$20240719$$$US$US
241140081$24114008$1$I$20240615$20240716$20240720$20240720$EXP$$CN-ABBVIE-5844548$ABBVIE$$92$YR$$M$Y$65$KG$20240720$$HP$CN$CN
241140094$24114009$4$F$20230517$20240919$20240720$20240928$EXP$$CA-CELLTRION INC.-2023CA008894$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
241140101$24114010$1$I$$20240710$20240720$20240720$EXP$CA-MHPD-E2B_07098708$CA-Accord-435551$ACCORD$$42$YR$A$F$Y$$$20240720$$CN$CA$CA
241140111$24114011$1$I$20240628$20240710$20240720$20240720$EXP$$US-Accord-435840$ACCORD$$64$YR$A$F$Y$$$20240720$$PH$US$US
241140121$24114012$1$I$20240614$20240709$20240720$20240720$EXP$$US-Accord-435366$ACCORD$$23$YR$A$F$Y$$$20240720$$HP$US$US
241140131$24114013$1$I$$20240711$20240720$20240720$30DAY$$US-GSK-US2024086622$GLAXOSMITHKLINE$$$$$F$Y$$$20240720$$CN$US$US
241140141$24114014$1$I$$20240710$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-033101$AUROBINDO$$$$A$F$Y$$$20240720$$MD$US$US
241140151$24114015$1$I$$20240710$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-036059$AUROBINDO$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol. 2024;35 (Suppl. 1):S60-S61 abstr. 130P$53$YR$$M$Y$$$20240720$$HP$ES$ES
241140161$24114016$1$I$20240502$20240710$20240720$20240720$EXP$$GB-AUROBINDO-AUR-APL-2024-033916$AUROBINDO$$$$$F$Y$$$20240720$$MD$GB$GB
241140171$24114017$1$I$$20240705$20240720$20240720$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK092342$GLENMARK$$$$$$Y$$$20240720$$HP$CA$CA
241140181$24114018$1$I$$20240716$20240720$20240720$EXP$$US-TAKEDA-2024TUS072488$TAKEDA$$$$$M$Y$$$20240720$$CN$US$US
241140201$24114020$1$I$20240708$20240715$20240720$20240720$PER$$US-AMGEN-USASP2024140868$AMGEN$$71$YR$E$F$Y$$$20240720$$CN$US$US
241140212$24114021$2$F$20190101$20240823$20240720$20240826$EXP$$US-JAZZ-2022-US-029455$JAZZ$$$$$F$Y$$$20240826$$MD$US$US
241140221$24114022$1$I$$20240716$20240720$20240720$EXP$$US-ABBVIE-5844420$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241140233$24114023$3$F$$20240729$20240720$20240806$EXP$$DE-UNITED THERAPEUTICS-UNT-2024-022152$UNITED THERAPEUTICS$$$$E$$Y$$$20240806$$$DE$DE
241140242$24114024$2$F$$20240801$20240720$20240806$EXP$$DE-UNITED THERAPEUTICS-UNT-2024-022147$UNITED THERAPEUTICS$$$$E$$Y$$$20240806$$$DE$DE
241140255$24114025$5$F$20240710$20240905$20240720$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021884$UNITED THERAPEUTICS$$53$YR$$M$Y$65.76$KG$20240913$$$US$US
241140261$24114026$1$I$$20240715$20240720$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021404$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240720$$PH$US$US
241140271$24114027$1$I$20240711$20240715$20240720$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022084$UNITED THERAPEUTICS$$63$YR$$F$Y$63.492$KG$20240720$$$US$US
241140282$24114028$2$F$20240101$20240813$20240720$20240822$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021532$UNITED THERAPEUTICS$$$$$F$Y$74.376$KG$20240822$$PH$US$US
241140291$24114029$1$I$20240101$20240717$20240720$20240720$EXP$$US-ABBVIE-5844615$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
241140301$24114030$1$I$$20240716$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-022000$UNITED THERAPEUTICS$$$$$F$Y$$$20240720$$$US$US
241140311$24114031$1$I$20240101$20240713$20240720$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019364$UNITED THERAPEUTICS$$$$$F$Y$72.109$KG$20240720$$PH$US$US
241140322$24114032$2$F$20240101$20240806$20240720$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-021819$UNITED THERAPEUTICS$$$$$F$Y$$$20240814$$$US$US
241140331$24114033$1$I$$20240715$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-022046$UNITED THERAPEUTICS$$$$$F$Y$78.912$KG$20240720$$$US$US
241140341$24114034$1$I$20240701$20240716$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-022051$UNITED THERAPEUTICS$$54$YR$$F$Y$58.957$KG$20240720$$$US$US
241140352$24114035$2$F$$20240909$20240720$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-016922$UNITED THERAPEUTICS$$$$$M$Y$$$20240914$$$US$US
241140361$24114036$1$I$$20240716$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-022023$UNITED THERAPEUTICS$$$$$M$Y$95.238$KG$20240720$$$US$US
241140372$24114037$2$F$$20240916$20240720$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-021721$UNITED THERAPEUTICS$$$$$F$Y$74.376$KG$20240925$$$US$US
241140382$24114038$2$F$20240101$20240730$20240720$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-021227$UNITED THERAPEUTICS$$$$$M$Y$$$20240807$$$US$US
241140401$24114040$1$I$20240101$20240713$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-020881$UNITED THERAPEUTICS$$$$$F$Y$53.061$KG$20240720$$$US$US
241140411$24114041$1$I$20240101$20240716$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-011858$UNITED THERAPEUTICS$$$$$F$Y$70.295$KG$20240720$$$US$US
241140421$24114042$1$I$20240701$20240708$20240720$20240720$PER$$US-TEVA-VS-3219605$TEVA$$77$YR$$F$Y$$$20240720$$CN$US$US
241140433$24114043$3$F$20240101$20240731$20240720$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-021384$UNITED THERAPEUTICS$$$$$F$Y$49.887$KG$20240803$$$US$US
241140441$24114044$1$I$20240701$20240716$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-013922$UNITED THERAPEUTICS$$68$YR$$F$Y$118.37$KG$20240720$$$US$US
241140452$24114045$2$F$20240501$20240905$20240720$20240913$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-019603$UNITED THERAPEUTICS$$71$YR$$F$Y$$$20240913$$$JP$JP
241140462$24114046$2$F$$20240917$20240720$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021706$UNITED THERAPEUTICS$$$$$F$Y$52.608$KG$20240926$$$US$US
241140471$24114047$1$I$20240101$20240711$20240720$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007974$UNITED THERAPEUTICS$$$$$F$Y$47.166$KG$20240720$$$US$US
241140481$24114048$1$I$20240604$20240708$20240720$20240720$EXP$FR-AFSSAPS-MP2024001092$FR-ALCON LABORATORIES-ALC2024FR003295$ALCON$$$$$$Y$$$20240720$$HP$FR$FR
241140493$24114049$3$F$20240101$20240827$20240720$20240902$EXP$$US-ABBVIE-5602197$ABBVIE$$$$$F$Y$76.657$KG$20240902$$CN$US$US
241140501$24114050$1$I$$20240717$20240720$20240720$EXP$$US-ABBVIE-5845926$ABBVIE$$$$$M$Y$$$20240720$$HP$US$US
241140511$24114051$1$I$$20240716$20240720$20240720$PER$$US-TAKEDA-2024TUS072601$TAKEDA$$26$YR$$F$Y$$$20240720$$CN$US$US
241140523$24114052$3$F$20240101$20240718$20240720$20240727$EXP$$CA-CELLTRION INC.-2024CA001645$CELLTRION$$$$$$Y$$$20240727$$PH$CA$CA
241140531$24114053$1$I$20240707$20240717$20240720$20240720$EXP$$US-ABBVIE-5845378$ABBVIE$$67$YR$$F$Y$$$20240720$$CN$US$US
241140541$24114054$1$I$$20240717$20240720$20240720$EXP$$US-ABBVIE-5845929$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241140552$24114055$2$F$20231114$20240716$20240720$20240727$EXP$$US-ABBVIE-22K-163-4425685-00$ABBVIE$$80$YR$$M$Y$$$20240727$$CN$US$US
241140561$24114056$1$I$$20240129$20240720$20240720$EXP$GB-MHRA-MED-202401261101599320-HWCFQ$GB-TEVA-VS-3150586$TEVA$$90$YR$$M$Y$$$20240720$$HP$GB$GB
241140571$24114057$1$I$$20240712$20240720$20240720$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021520$UNITED THERAPEUTICS$$$$$F$Y$$$20240720$$MD$US$US
241140581$24114058$1$I$$20240717$20240720$20240720$PER$$US-TAKEDA-2024TUS072435$TAKEDA$$$$$$Y$$$20240720$$CN$US$US
241140591$24114059$1$I$$20240716$20240720$20240720$PER$$US-AMGEN-USASP2024141756$AMGEN$$$$$F$Y$$$20240720$$CN$US$US
241140603$24114060$3$F$20240703$20240803$20240720$20240812$EXP$$CO-CELLTRION INC.-2024CO017295$CELLTRION$$$$$$Y$$$20240812$$HP$CO$CO
241140612$24114061$2$F$$20240806$20240720$20240813$EXP$$US-CELLTRION INC.-2024US017290$CELLTRION$$$$$$Y$$$20240813$$HP$US$US
241140621$24114062$1$I$20221107$20240710$20240720$20240720$EXP$PL-URPL-DML-MLP.4401.1.775.2022$PL-TEVA-VS-3220383$TEVA$$82$YR$$F$Y$61$KG$20240720$$MD$PL$PL
241140631$24114063$1$I$$20240711$20240720$20240720$EXP$$FR-CELLTRION INC.-2024FR017167$CELLTRION$Farina A, Escalere M, Dion M, Moussy M, Pegat A, Villagran-Garcia M, et al.. Mononeuritis multiplex following immune checkpoint inhibitors in malignant pleural mesothelioma. Frontiers in Neurology. 2024;15$$$$$Y$$$20240720$$HP$FR$FR
241140641$24114064$1$I$$20240707$20240720$20240720$EXP$$US-Inventia-000731$INVENTIA HEALTHCARE$Mikhail ES, Jankowski M, Alexander D, Pandya D, Kunadi A. Survival and Vision Restoration Following Severe Metformin-associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature. J Community Hosp Intern Med Perspect. 2024 Mar 4;14(2):96-99$72$YR$E$F$Y$$$20240720$$HP$US$US
241140652$24114065$2$F$20240716$20240717$20240720$20240729$PER$$US-AMGEN-USASP2024142071$AMGEN$$77$YR$E$F$Y$$$20240729$$CN$US$US
241140661$24114066$1$I$20240713$20240717$20240720$20240720$EXP$$US-ARIAD-2016US005978$TAKEDA$$75$YR$$F$Y$$$20240720$$CN$US$US
241140671$24114067$1$I$20240715$20240715$20240720$20240720$PER$$US-AMGEN-USASP2024141899$AMGEN$$78$YR$E$M$Y$$$20240720$$CN$US$US
241140681$24114068$1$I$$20240715$20240720$20240720$EXP$$US-ABBVIE-5842929$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
241140691$24114069$1$I$$20240715$20240720$20240720$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02583$AMNEAL$$$$$M$Y$$$20240720$$CN$US$US
241140701$24114070$1$I$20230517$20240715$20240720$20240720$EXP$$CA-TAKEDA-2023TUS032968$TAKEDA$$35$YR$$F$Y$$$20240720$$CN$CA$CA
241140711$24114071$1$I$20240613$20240709$20240720$20240720$PER$$US-ABBVIE-5840045$ABBVIE$$29$YR$$F$Y$$$20240720$$MD$US$US
241140721$24114072$1$I$20231001$20240710$20240720$20240720$EXP$GB-MHRA-MED-202407101221271600-BQCKL$GB-TEVA-VS-3220391$TEVA$$75$YR$$M$Y$90$KG$20240720$$CN$GB$GB
241140731$24114073$1$I$$20240705$20240720$20240720$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK092256$GLENMARK$$$$$$Y$$$20240720$$CN$CA$CA
241140741$24114074$1$I$20240701$20240718$20240720$20240720$PER$$US-AMGEN-USASP2024143181$AMGEN$$58$YR$A$F$Y$$$20240720$$CN$US$US
241140752$24114075$2$F$$20240705$20240720$20240720$EXP$GB-MHRA-MED-202405101132538610-LZDKT$GB-GLENMARK PHARMACEUTICALS-2024GMK092236$GLENMARK$$$$$$Y$$$20240720$$CN$GB$GB
241140761$24114076$1$I$$20240710$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-034478$AUROBINDO$Ghoussaini R, Saleh OA, Tabaja H.. Graft versus histoplasma disease: A case of vascular graft infection. IDCases. 2024;37:e02013$72$YR$$M$Y$$$20240720$$MD$US$US
241140771$24114077$1$I$20230101$20240705$20240720$20240720$EXP$GB-MHRA-MED-202405141535269460-GHJNZ$GB-GLENMARK PHARMACEUTICALS-2024GMK092241$GLENMARK$$$$$$Y$$$20240720$$HP$GB$GB
241140781$24114078$1$I$20240716$20240718$20240720$20240720$PER$$US-UNITED THERAPEUTICS-UNT-2024-022261$UNITED THERAPEUTICS$$34$YR$$F$Y$$$20240720$$$US$US
241140791$24114079$1$I$$20240717$20240720$20240720$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136251$DAIICHI$$$$$F$Y$$$20240720$$HP$US$US
241140801$24114080$1$I$20240601$20240715$20240720$20240720$PER$$US-ABBVIE-5842152$ABBVIE$$32$YR$$F$Y$61$KG$20240720$$CN$US$US
241140811$24114081$1$I$20180101$20240715$20240720$20240720$EXP$$CA-TAKEDA-2018TUS024508$TAKEDA$$$$$F$Y$$$20240720$$MD$CA$CA
241140821$24114082$1$I$20240502$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035507$AUROBINDO$$71$YR$$M$Y$74.5$KG$20240720$$MD$FR$FR
241140831$24114083$1$I$$20240711$20240720$20240720$EXP$$US-TAKEDA-2024TUS068268$TAKEDA$$61$YR$$M$Y$74.2$KG$20240720$$CN$US$US
241140841$24114084$1$I$$20240715$20240720$20240720$PER$$US-TAKEDA-2024TUS072175$TAKEDA$$$$$F$Y$$$20240720$$HP$US$US
241140851$24114085$1$I$$20240715$20240720$20240720$PER$$US-AMGEN-USASP2024141588$AMGEN$$$$$$Y$$$20240720$$PH$US$US
241140863$24114086$3$F$20240710$20240923$20240720$20240924$PER$$US-AMGEN-USASP2024143680$AMGEN$$64$YR$A$F$Y$$$20240924$$CN$US$US
241140871$24114087$1$I$$20240716$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011239$ELI LILLY AND CO$$40$YR$A$$Y$$$20240720$$HP$US$US
241140881$24114088$1$I$20240627$20240716$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011265$ELI LILLY AND CO$$$$$$Y$$$20240720$$CN$US$US
241140891$24114089$1$I$20240716$20240716$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011268$ELI LILLY AND CO$$$$A$F$Y$$$20240720$$CN$US$US
241140901$24114090$1$I$20240101$20240715$20240720$20240720$EXP$$US-ABBVIE-5683342$ABBVIE$$$$$M$Y$73$KG$20240720$$CN$US$US
241140911$24114091$1$I$$20240718$20240720$20240720$EXP$$NVSC2024CN148922$NOVARTIS$$53$YR$$M$Y$$$20240720$$CN$CN$CN
241140921$24114092$1$I$20240701$20240717$20240720$20240720$EXP$$US-ABBVIE-5845069$ABBVIE$$$$$$Y$$$20240720$$CN$US$US
241140931$24114093$1$I$$20240717$20240720$20240720$EXP$$CA-ABBVIE-5845689$ABBVIE$$$$E$M$Y$$$20240720$$CN$CA$CA
241140942$24114094$2$F$20240701$20240923$20240720$20240928$EXP$$CA-ABBVIE-5845527$ABBVIE$$63$YR$$F$Y$$$20240928$$CN$CA$CA
241140951$24114095$1$I$20231101$20240712$20240720$20240720$EXP$$PL-TAKEDA-2024TUS064292$TAKEDA$$$$$$Y$$$20240720$$CN$PL$PL
241140961$24114096$1$I$20240128$20240129$20240720$20240720$EXP$GB-MHRA-MED-202401290422236650-DZPGF$GB-TEVA-VS-3150654$TEVA$$91$YR$$F$Y$$$20240720$$MD$GB$GB
241140973$24114097$3$F$20240101$20240828$20240720$20240903$EXP$$US-ABBVIE-5845655$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
241140981$24114098$1$I$$20240705$20240720$20240720$PER$$US-COSETTE-CP2024US000159$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240720$$CN$US$US
241140991$24114099$1$I$$20240710$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-036067$AUROBINDO$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol. 2024;35 (Suppl. 1):S60-S61 abstr. 130P$68$YR$$M$Y$$$20240720$$HP$ES$ES
241141001$24114100$1$I$$20240524$20240720$20240720$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000071$UROGEN PHARMA$$$$$$Y$$$20240720$$MD$US$US
241141011$24114101$1$I$20240501$20240611$20240720$20240720$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000070$UROGEN PHARMA$$$$$$Y$$$20240720$$PH$US$US
241141021$24114102$1$I$20240523$20240606$20240720$20240720$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000067$UROGEN PHARMA$$$$$$Y$$$20240720$$CN$US$US
241141031$24114103$1$I$20240522$20240522$20240720$20240720$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000068$UROGEN PHARMA$$$$$$Y$$$20240720$$MD$US$US
241141041$24114104$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035381$AUROBINDO$$23$YR$$F$Y$46$KG$20240720$$MD$NL$NL
241141051$24114105$1$I$$20230227$20240720$20240720$PER$$ES-COSETTE-CP2023ES000041$COSETTE PHARMACEUTICALS$$76$YR$E$M$Y$$$20240720$$MD$ES$ES
241141061$24114106$1$I$$20240710$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-034475$AUROBINDO$Moshirfar M, Kelkar N, Ronquillo YC, Hoopes PC.. Implication of Corneal Refractive Surgery in Duchenne Muscular Dystrophy.. Case Reports in Ophthalmology.. 2024;15(1):374-82$21$YR$$M$Y$$$20240720$$MD$US$US
241141073$24114107$3$F$20240401$20240801$20240720$20240808$EXP$$US-ABBVIE-5845071$ABBVIE$$39$YR$$F$Y$$$20240808$$CN$US$US
241141081$24114108$1$I$$20240710$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-036066$AUROBINDO$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol. 2024;35 (Suppl. 1):S60-S61 abstr. 130P$65$YR$$M$Y$$$20240720$$HP$ES$ES
241141092$24114109$2$F$20231201$20240717$20240720$20240723$EXP$$US-ABBVIE-5557479$ABBVIE$$68$YR$$F$Y$$$20240723$$CN$US$US
241141101$24114110$1$I$20240601$20240713$20240720$20240720$PER$$US-TAKEDA-2024TUS071366$TAKEDA$$17$YR$$F$Y$58.967$KG$20240720$$PH$US$US
241141111$24114111$1$I$$20240708$20240720$20240720$PER$$US-TEVA-VS-3220538$TEVA$$$$A$M$Y$$$20240720$$CN$US$US
241141121$24114112$1$I$$20240710$20240720$20240720$EXP$GB-MHRA-MED-202407101040248900-LGHCQ$GB-TEVA-VS-3220331$TEVA$$56$YR$$M$Y$78$KG$20240720$$PH$GB$GB
241141131$24114113$1$I$$20240710$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-035293$AUROBINDO$Pokhriyal SC, Chowdhury T, Al-Ghuraibawi MM, Aryal B, Bellamkonda A, Nagpal S, et al.. Navigating Antiphospholipid Syndrome- Failure of Suction Thrombectomy and Recurrent Saddle Embolus. Am-J-Respir-Crit-Care-Med. 2024;209:A2240$41$YR$$F$Y$$$20240720$$HP$US$US
241141141$24114114$1$I$$20240711$20240720$20240720$EXP$$BR-CELLTRION INC.-2023BR000724$CELLTRION$$$$$$Y$$$20240720$$CN$BR$BR
241141152$24114115$2$F$20240704$20240808$20240720$20240813$EXP$$DE-ABBVIE-5838382$ABBVIE$$65$YR$$M$Y$$$20240813$$MD$DE$DE
241141171$24114117$1$I$$20240706$20240720$20240720$PER$$US-GRANULES-US-2024GRASPO00280$GRANULES INDIA$$$$$$Y$$$20240720$$CN$US$US
241141181$24114118$1$I$20240304$20240710$20240720$20240720$EXP$FR-AFSSAPS-RE2024000662$FR-TEVA-VS-3220344$TEVA$$19$YR$$F$Y$55.8$KG$20240720$$MD$FR$FR
241141191$24114119$1$I$$20240716$20240720$20240720$PER$$US-AMGEN-USASP2024142475$AMGEN$$$$$$Y$$$20240720$$HP$US$US
241141203$24114120$3$F$$20240725$20240720$20240727$PER$$US-AMGEN-USASP2024143723$AMGEN$$$$$M$Y$$$20240727$$CN$US$US
241141211$24114121$1$I$20240101$20240712$20240720$20240720$EXP$$CA-AMGEN-CANSP2024139900$AMGEN$$64$YR$A$M$Y$$$20240720$$CN$CA$CA
241141221$24114122$1$I$$20240716$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011365$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240720$$CN$US$US
241141231$24114123$1$I$$20240710$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-036064$AUROBINDO$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol. 2024;35 (Suppl. 1):S60-S61 abstr. 130P$68$YR$$M$Y$$$20240720$$HP$ES$ES
241141241$24114124$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011301$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240720$$CN$US$US
241141251$24114125$1$I$$20240718$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407012417$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240720$$CN$US$US
241141261$24114126$1$I$$20240716$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011558$ELI LILLY AND CO$$$$$$Y$$$20240720$$CN$US$US
241141272$24114127$2$F$$20240711$20240720$20240731$PER$$US-TEVA-VS-3216818$TEVA$$$$$F$Y$72.57$KG$20240731$$CN$US$US
241141281$24114128$1$I$$20240717$20240720$20240720$EXP$$NVSC2024IL102838$NOVARTIS$$67$YR$$F$Y$$$20240720$$HP$IL$IL
241141292$24114129$2$F$20240713$20240722$20240720$20240723$PER$$US-AMGEN-USASP2024142009$AMGEN$$71$YR$E$M$Y$$$20240723$$CN$US$US
241141302$24114130$2$F$20240710$20240722$20240720$20240730$EXP$$CA-CELLTRION INC.-2024CA017196$CELLTRION$$$$$$Y$$$20240730$$CN$CA$CA
241141311$24114131$1$I$20240401$20240710$20240720$20240720$EXP$$DE-AUROBINDO-AUR-APL-2024-028158$AUROBINDO$$82$YR$$F$Y$51$KG$20240720$$PH$DE$DE
241141322$24114132$2$F$$20240801$20240720$20240806$PER$$US-AMGEN-USASP2024142965$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241141332$24114133$2$F$20240716$20240726$20240720$20240730$PER$$US-AMGEN-USASP2024141187$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241141341$24114134$1$I$$20240710$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-036061$AUROBINDO$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol. 2024;35 (Suppl. 1):S60-S61 abstr. 130P$64$YR$$M$Y$$$20240720$$HP$ES$ES
241141351$24114135$1$I$$20240707$20240720$20240720$EXP$$US-Indicus Pharma-001024$INDICUS$Mikhail ES, Jankowski M, Alexander D, Pandya D, Kunadi A. Survival and Vision Restoration Following Severe Metformin-associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature. J Community Hosp Intern Med Perspect. 2024 Mar 4;14(2):96-99$72$YR$E$F$Y$$$20240720$$HP$US$US
241141361$24114136$1$I$20240703$20240710$20240720$20240720$EXP$$US-Accord-435842$ACCORD$$56$YR$A$M$Y$$$20240720$$HP$US$US
241141371$24114137$1$I$20240703$20240708$20240720$20240720$EXP$$US-Accord-435857$ACCORD$$39$YR$A$$Y$$$20240720$$HP$US$US
241141383$24114138$3$F$$20240830$20240720$20240911$EXP$$JP-Accord-435881$ACCORD$Kita Y, Shirai S, Koyama T, Makinouchi R, Machida S, Matsui K, et al. Fanconi syndrome with karyomegalic interstitial nephritis after ifosfamide treatment for osteosarcoma: a case report. CEN Case Rep. 2024 Jul 2. doi: 10.1007/s13730-024-00907-w.$18$YR$A$M$Y$$$20240911$$MD$JP$JP
241141391$24114139$1$I$$20240716$20240720$20240720$EXP$$US-ABBVIE-5842583$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241141401$24114140$1$I$20240702$20240716$20240720$20240720$PER$$US-ABBVIE-5843950$ABBVIE$$40$YR$$M$Y$$$20240720$$HP$US$US
241141412$24114141$2$F$20240606$20240809$20240720$20240813$PER$$US-AMGEN-USASP2024141877$AMGEN$$38$YR$A$M$Y$54.422$KG$20240813$$HP$US$US
241141421$24114142$1$I$20230223$20240125$20240720$20240720$EXP$FR-AFSSAPS-PO2023001222$FR-TEVA-VS-3152415$TEVA$$60$YR$$F$Y$62$KG$20240720$$MD$FR$FR
241141431$24114143$1$I$$20240717$20240720$20240720$EXP$$US-TAKEDA-2024TUS072998$TAKEDA$$$$$F$Y$$$20240720$$CN$US$US
241141441$24114144$1$I$20240703$20240709$20240720$20240720$EXP$$US-Accord-435717$ACCORD$$39$YR$A$F$Y$$$20240720$$HP$US$US
241141451$24114145$1$I$20240612$20240710$20240720$20240720$EXP$CN-HENLIUS-24CN015859$CN-Accord-437017$ACCORD$$55$YR$A$F$Y$65$KG$20240720$$MD$CN$CN
241141461$24114146$1$I$20240501$20240711$20240720$20240720$EXP$$GB-AUROBINDO-AUR-APL-2024-034972$AUROBINDO$$73$YR$$M$Y$94$KG$20240720$$CN$GB$GB
241141471$24114147$1$I$$20240710$20240720$20240720$EXP$$US-Accord-436361$ACCORD$$53$YR$A$F$Y$$$20240720$$CN$US$US
241141511$24114151$1$I$20240507$20240711$20240720$20240720$EXP$FR-AFSSAPS-AN2024000913$FR-Accord-435936$ACCORD$$68$YR$E$M$Y$105.6$KG$20240720$$PH$FR$FR
241141521$24114152$1$I$$20240718$20240720$20240720$EXP$DE-EMA-2024713-AUTODUP-1720821985761$DE-Accord-436920$ACCORD$$34$YR$A$F$Y$$$20240720$$MD$DE$DE
241141531$24114153$1$I$$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035580$AUROBINDO$Chimenti G, Magli A, Njandjo L, Fois A, Santagati G, Piccoli G et al.. New onset proteinuria in two pregnancies: glomerulopathy or preeclampsia?. NEPHROL-DIAL-TRANSPLANT.. 2024;39(Suppl.1):2048-9$$$N$$Y$$$20240720$$HP$FR$FR
241141541$24114154$1$I$$20240710$20240720$20240720$EXP$CA-MHPD-E2B_07094682$CA-Accord-435335$ACCORD$$27$YR$A$M$Y$$$20240720$$HP$CA$CA
241141551$24114155$1$I$20220101$20240710$20240720$20240720$EXP$$CZ-Accord-436422$ACCORD$Kufa J, Novotna J, Lukasova M, Latal V, Hanackova V, Tichy T, et al. Rare granulomatous processes. TRANSFUZE A HEMATOLOGIE DNES. 2024;30(2):122-130.$48$YR$A$M$Y$$$20240720$$MD$CZ$CZ
241141561$24114156$1$I$$20240713$20240720$20240720$PER$$US-AMGEN-USASP2024141493$AMGEN$$39$YR$A$M$Y$$$20240720$$HP$US$US
241141571$24114157$1$I$20240101$20240711$20240720$20240720$EXP$$CA-CELLTRION INC.-2024CA017464$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
241141581$24114158$1$I$$20240710$20240720$20240720$EXP$$IT-AUROBINDO-AUR-APL-2024-034831$AUROBINDO$Volpicelli L, Cairoli S, Al Ismail D, Baisi F, Sacco F, Oliva A, et al.. Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. Pneumoniae successfully treated with meropenem/vaborbactam and high dose of fosfomycin.. Journal of Global Antimicrobial Resistance.. 2024;37:86-90.$27$YR$$M$Y$$$20240720$$MD$IT$IT
241141591$24114159$1$I$$20240716$20240720$20240720$EXP$$CA-ABBVIE-5843871$ABBVIE$$$$E$M$Y$$$20240720$$MD$CA$CA
241141602$24114160$2$F$$20240716$20240720$20240731$PER$$US-GRANULES-US-2024GRASPO00281$GRANULES INDIA$$$$$F$Y$$$20240731$$CN$US$US
241141611$24114161$1$I$20240601$20240716$20240720$20240720$EXP$$GR-ABBVIE-5843873$ABBVIE$$66$YR$$$Y$$$20240720$$MD$GR$GR
241141621$24114162$1$I$$20240716$20240720$20240720$PER$$US-AMGEN-USASP2024141176$AMGEN$$$$$F$Y$$$20240720$$CN$US$US
241141631$24114163$1$I$$20240716$20240720$20240720$PER$$US-AMGEN-USASP2024141608$AMGEN$$$$$M$Y$$$20240720$$CN$US$US
241141642$24114164$2$F$20240705$20240802$20240720$20240808$EXP$$CA-ABBVIE-5844598$ABBVIE$$75$YR$$M$Y$$$20240808$$CN$CA$CA
241141651$24114165$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011463$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240720$$CN$US$US
241141661$24114166$1$I$20240702$20240718$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407012161$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240720$$HP$US$US
241141671$24114167$1$I$20240507$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035408$AUROBINDO$$68$YR$$M$Y$105.6$KG$20240720$$PH$FR$FR
241141683$24114168$3$F$$20240828$20240720$20240901$30DAY$$US-GSK-US2024AMR089719$GLAXOSMITHKLINE$$$$$F$Y$$$20240901$$PH$US$US
241141691$24114169$1$I$20240612$20240710$20240720$20240720$EXP$$US-Accord-435869$ACCORD$$63$YR$A$M$Y$$$20240720$$HP$US$US
241141701$24114170$1$I$20240628$20240710$20240720$20240720$EXP$$ES-Accord-435790$ACCORD$$67$YR$E$M$Y$65.5$KG$20240720$$HP$ES$ES
241141711$24114171$1$I$20231128$20240710$20240720$20240720$EXP$FR-AFSSAPS-ST2024001137$FR-Accord-435489$ACCORD$$65$YR$E$F$Y$56.5$KG$20240720$$HP$FR$FR
241141721$24114172$1$I$$20240710$20240720$20240720$EXP$CA-MHPD-E2B_07096610$CA-Accord-435459$ACCORD$$52$YR$A$F$Y$$$20240720$$HP$CA$CA
241141731$24114173$1$I$20240704$20240709$20240720$20240720$EXP$$US-Accord-435652$ACCORD$$36$YR$A$F$Y$$$20240720$$HP$US$US
241141741$24114174$1$I$$20240710$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-036057$AUROBINDO$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol. 2024;35 (Suppl. 1):S60-S61 abstr. 130P$51$YR$$M$Y$$$20240720$$HP$ES$ES
241141751$24114175$1$I$$20240715$20240720$20240720$EXP$$CA-JNJFOC-20240741319$JOHNSON AND JOHNSON$$$$$F$Y$$$20240720$$HP$CA$CA
241141761$24114176$1$I$$20240710$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-035290$AUROBINDO$Rockhold M, Kunkel L, Lacoste JL, Szymanski T, Rothenberg P, Zimmerman P, et al.. Comparison of direct oral anticoagulants and warfarin in chronic limb-threatening ischemia.. J-Vasc-Surg. 2024;79(6):1466-1472$$$$$Y$$$20240720$$HP$US$US
241141771$24114177$1$I$$20240716$20240720$20240720$EXP$$CA-ABBVIE-5843915$ABBVIE$$$$A$M$Y$$$20240720$$CN$CA$CA
241141781$24114178$1$I$20240119$20240710$20240720$20240720$EXP$FR-AFSSAPS-BX2024001301$FR-TEVA-VS-3219810$TEVA$$56$YR$$F$Y$$$20240720$$MD$FR$FR
241141791$24114179$1$I$20240101$20240711$20240720$20240720$EXP$$GB-AMGEN-GBRSP2024138299$AMGEN$$68$YR$E$M$Y$$$20240720$$CN$GB$GB
241141801$24114180$1$I$20230401$20240708$20240720$20240720$EXP$$RS-Accord-435039$ACCORD$Pesic A, Vukovic V, Kozarac S, Otasevic V, Bibic T, Mihaljevic B, et al. UNIQUE PRESENTATION OF T-CELL/HISTIOCYTE-RICH LARGE B CELL LYMPHOMA COMPLICATED WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: CASE REPORT AND REVIEW OF THE LITERATURE. Journal of Medical Biochemistry. 2024;43(4):631-7.$32$YR$A$M$Y$$$20240720$$MD$RS$RS
241141811$24114181$1$I$$20240708$20240720$20240720$EXP$$IN-MACLEODS PHARMA-MAC2024048281$MACLEODS$Meenakshi R, Balamurali K, Anbazhagan G..A unique case of galactorrhea caused by tramadol dependency in a 32-year-old female- a case report..Indian Journal of  Psychiatry.2024;66(Supplement 1):S192$$$$$Y$$$20240720$$MD$IN$IN
241141821$24114182$1$I$$20240708$20240720$20240720$EXP$$US-MACLEODS PHARMA-MAC2024048268$MACLEODS$Li S, Halloran P, Siref A.Concurrent Neutrophilic Eccrine Hidradenitis and Leukocytoclastic Vasculitis.American Journal of Dermatopathology.2024;46(7):S20$$$$$Y$$$20240720$$MD$US$US
241141833$24114183$3$F$$20240725$20240720$20240805$EXP$$AU-MACLEODS PHARMA-MAC2024048289$MACLEODS$Cook AM, Patuzzi RB..One mechanism of sudden sensorineural hearing loss after sildenafil and sexual activity.International journal of audiology.01-JUL-2024;1-4$$$$$Y$$$20240805$$HP$AU$AU
241141841$24114184$1$I$$20240708$20240720$20240720$EXP$$IN-MACLEODS PHARMA-MAC2024048275$MACLEODS$Dhobale M, Sarangi S, Yadav A, Khanande R..Hyperkinetic conduct disorder as a risk factor for switch from unipolar to bipolar disorder..Indian Journal of Psychiatry.2024;66(1):S180$$$$$Y$$$20240720$$MD$IN$IN
241141851$24114185$1$I$$20240710$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-035338$AUROBINDO$Chu AF, Sagi V, Amin AK, Rajagopal G, Shantanu S, Pederson KS, et al.. Continuous QT interval monitoring using insertable cardiac monitors during antiarrhythmic loading hospitalization: Results from the ^LINQ QT^ Study.. Europace. 2024;26 (Suppl.):i43-i44$75$YR$$M$Y$$$20240720$$HP$US$US
241141861$24114186$1$I$$20240708$20240720$20240720$EXP$$GB-MACLEODS PHARMA-MAC2024048294$MACLEODS$$$$$$Y$$$20240720$$MD$GB$GB
241141871$24114187$1$I$$20240708$20240720$20240720$EXP$$CN-MACLEODS PHARMA-MAC2024048297$MACLEODS$Zhang Y, Cong Y, Teng Y..Acute renal injury induced by valacyclovir hydrochloride: A case report.Experimental and Therapeutic Medicine.2016;12(6):4025-8$$$$$Y$$$20240720$$MD$CN$CN
241141881$24114188$1$I$20240623$20240708$20240720$20240720$EXP$GB-MHRA-MED-202407051440050980-KRQWM$GB-MACLEODS PHARMA-MAC2024048302$MACLEODS$$$$$$Y$$$20240720$$MD$GB$GB
241141891$24114189$1$I$$20240709$20240720$20240720$EXP$GB-MHRA-MED-202407090046268750-HCSGP$GB-MACLEODS PHARMA-MAC2024048309$MACLEODS$$18$YR$A$M$Y$$$20240720$$CN$GB$GB
241141902$24114190$2$F$$20240723$20240720$20240802$EXP$$ES-MACLEODS PHARMA-MAC2024048295$MACLEODS$$$$$$Y$$$20240802$$PH$ES$ES
241141911$24114191$1$I$$20240710$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-036062$AUROBINDO$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol. 2024;35 (Suppl. 1):S60-S61 abstr. 130P$63$YR$$F$Y$$$20240720$$HP$ES$ES
241141921$24114192$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035017$AUROBINDO$$31$YR$$F$Y$69$KG$20240720$$MD$NL$NL
241141931$24114193$1$I$$20240708$20240720$20240720$PER$$IN-MACLEODS PHARMA-MAC2024048292$MACLEODS$Sinha N, Patil R, Kotla R, Sahu N, Sahu Jr N..Yawning as a Rare Side Effect With Increased Escitalopram Dose: A Case Report.Cureus.03-JUN-2024;16(6):e61559$$$$$Y$$$20240720$$HP$IN$IN
241141941$24114194$1$I$20240417$20240708$20240720$20240720$EXP$GB-MHRA-MED-202405101735297400-BRCGK$GB-MACLEODS PHARMA-MAC2024048299$MACLEODS$$$$$$Y$$$20240720$$MD$GB$GB
241141951$24114195$1$I$20231201$20240711$20240720$20240720$EXP$$CA-CELLTRION INC.-2023CA022083$CELLTRION$$$$$$Y$$$20240720$$MD$CA$CA
241141961$24114196$1$I$$20240701$20240720$20240720$PER$$US-TEVA-VS-3214659$TEVA$$$$$M$Y$$$20240720$$CN$US$US
241141971$24114197$1$I$$20240710$20240720$20240720$EXP$$IT-AUROBINDO-AUR-APL-2024-035369$AUROBINDO$Catucci S, Lombardi M, Massari E, Maiorano A, Meliota G, Pirolo T. MULTIFOCAL ATRIAL TACHYCARDIA AND HYPERTROPHIC CARDIOMYOPATHYIN THREE PATIENTS WITH COSTELLO SYNDROME. Eur-Heart-J-Suppl. 2024;26 (Suppl. 2):ii48$10$DY$$M$Y$$$20240720$$HP$IT$IT
241141981$24114198$1$I$20211108$20240710$20240720$20240720$EXP$$US-Accord-435866$ACCORD$$44$YR$A$M$Y$$$20240720$$HP$US$US
241141991$24114199$1$I$20220328$20240717$20240720$20240720$EXP$FR-EMA-2024710-AUTODUP-1720641414810$FR-Accord-436864$ACCORD$$50$YR$A$F$Y$$$20240720$$HP$FR$FR
241142001$24114200$1$I$20240527$20240711$20240720$20240720$EXP$ES-AEMPS-1547650$ES-Accord-436054$ACCORD$$38$YR$A$F$Y$$$20240720$$MD$ES$ES
241142011$24114201$1$I$20240708$20240710$20240720$20240720$EXP$$US-Accord-435884$ACCORD$$29$YR$A$M$Y$$$20240720$$HP$US$US
241142021$24114202$1$I$20231204$20240711$20240720$20240720$EXP$ES-AEMPS-1543334$ES-Accord-436043$ACCORD$$30$YR$A$F$Y$$$20240720$$MD$ES$ES
241142031$24114203$1$I$20240708$20240710$20240720$20240720$EXP$$US-Accord-435864$ACCORD$$34$YR$A$M$Y$$$20240720$$HP$US$US
241142041$24114204$1$I$20240701$20240710$20240720$20240720$EXP$$CN-Alcon Laboratories-ALC2024CN003358$ALCON$$4$YR$$M$Y$16$KG$20240720$$HP$CN$CN
241142051$24114205$1$I$20240622$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-034576$AUROBINDO$$76$YR$$M$Y$$$20240720$$MD$FR$FR
241142061$24114206$1$I$20240118$20240710$20240720$20240720$EXP$CN-NMPACDR-3303011655707202400465$CN-BAXTER-2024BAX021568$BAXTER$$91$YR$$M$Y$60$KG$20240720$$MD$CN$CN
241142071$24114207$1$I$20240611$20240710$20240720$20240720$EXP$CN-NMPACDR-3303821059132202400076$CN-BAXTER-2024BAX021565$BAXTER$$77$YR$$M$Y$$$20240720$$MD$CN$CN
241142081$24114208$1$I$20240630$20240710$20240720$20240720$EXP$CN-NMPACDR-4403051004694202400320$CN-BAXTER-2024BAX021576$BAXTER$$55$YR$$M$Y$$$20240720$$MD$CN$CN
241142091$24114209$1$I$20190603$20240710$20240720$20240720$EXP$$US-BAXTER-2024BAX021421$BAXTER$$30$YR$$M$Y$120.7$KG$20240720$$MD$US$US
241142102$24114210$2$F$20240717$20240717$20240720$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011476$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240722$$CN$US$US
241142111$24114211$1$I$20240715$20240716$20240720$20240720$PER$$US-AMGEN-USASP2024142101$AMGEN$$83$YR$E$M$Y$$$20240720$$CN$US$US
241142121$24114212$1$I$20240619$20240710$20240720$20240720$EXP$FR-AFSSAPS-AN2024000834$FR-TEVA-VS-3220330$TEVA$$68$YR$$F$Y$57.4$KG$20240720$$PH$FR$FR
241142131$24114213$1$I$20240420$20240716$20240720$20240720$EXP$$RO-ABBVIE-5844035$ABBVIE$$55$YR$$M$Y$105$KG$20240720$$MD$RO$RO
241142141$24114214$1$I$$20240710$20240720$20240720$PER$$US-TEVA-VS-3221384$TEVA$$$$$M$Y$$$20240720$$HP$US$US
241142155$24114215$5$F$20240101$20240912$20240720$20240921$EXP$$CA-CELLTRION INC.-2024CA004261$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
241142162$24114216$2$F$$20240620$20240720$20240720$PER$$US-009507513-2406USA007712$MERCK$$$$$F$Y$59$KG$20240720$$CN$US$US
241142172$24114217$2$F$$20240725$20240720$20240726$PER$$US-JNJFOC-20240752078$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$HP$US$US
241142181$24114218$1$I$20240629$20240711$20240720$20240720$EXP$$GB-AUROBINDO-AUR-APL-2024-034988$AUROBINDO$$83$YR$$M$Y$83$KG$20240720$$CN$GB$GB
241142191$24114219$1$I$20111201$20240711$20240720$20240720$EXP$$BR-TAKEDA-2024TUS015492$TAKEDA$$56$YR$$F$Y$$$20240720$$CN$BR$BR
241142212$24114221$2$F$20230707$20240729$20240720$20240811$EXP$$JP-AMGEN-JPNSP2024143955$AMGEN$$67$YR$E$F$Y$$$20240811$$MD$JP$JP
241142221$24114222$1$I$$20240719$20240720$20240720$PER$$US-ABBVIE-5846152$ABBVIE$$45$YR$$F$Y$$$20240720$$HP$US$US
241142232$24114223$2$F$20240101$20240805$20240720$20240813$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021437$UNITED THERAPEUTICS$$$$$F$Y$91.61$KG$20240813$$$US$US
241142241$24114224$1$I$20220101$20240711$20240720$20240720$EXP$$DE-AUROBINDO-AUR-APL-2023-080250$AUROBINDO$$35$YR$$F$Y$$$20240720$$MD$DE$DE
241142251$24114225$1$I$20240101$20240711$20240720$20240720$EXP$$CA-CELLTRION INC.-2024CA017453$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
241142261$24114226$1$I$20240301$20240710$20240720$20240720$EXP$FR-AFSSAPS-LL2024001238$FR-TEVA-VS-3220245$TEVA$$57$YR$$F$Y$$$20240720$$MD$FR$FR
241142271$24114227$1$I$20240701$20240711$20240720$20240720$EXP$$DE-AUROBINDO-AUR-APL-2024-034899$AUROBINDO$$$$A$F$Y$87$KG$20240720$$MD$DE$DE
241142281$24114228$1$I$20190114$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035280$AUROBINDO$$50$YR$$F$Y$72.5$KG$20240720$$MD$FR$FR
241142291$24114229$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035384$AUROBINDO$$32$YR$$F$Y$58$KG$20240720$$MD$NL$NL
241142301$24114230$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035423$AUROBINDO$$62$YR$$M$Y$84$KG$20240720$$CN$NL$NL
241142311$24114231$1$I$$20240710$20240720$20240720$EXP$$US-TEVA-VS-3221235$TEVA$$$$$$Y$$$20240720$$MD$US$US
241142321$24114232$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035343$AUROBINDO$$85$YR$$F$Y$$$20240720$$MD$NL$NL
241142331$24114233$1$I$20240716$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011823$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240720$$CN$US$US
241142341$24114234$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011591$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240720$$CN$US$US
241142351$24114235$1$I$$20240712$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407009136$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240720$$CN$US$US
241142361$24114236$1$I$$20240719$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407012942$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240720$$CN$US$US
241142371$24114237$1$I$20240718$20240718$20240720$20240720$PER$$US-AMGEN-USASP2024143695$AMGEN$$77$YR$E$M$Y$$$20240720$$CN$US$US
241142381$24114238$1$I$$20240718$20240720$20240720$PER$$US-AMGEN-USASP2024143190$AMGEN$$$$$F$Y$$$20240720$$CN$US$US
241142391$24114239$1$I$$20240715$20240720$20240720$EXP$$US-ABBVIE-5804480$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
241142401$24114240$1$I$$20240711$20240720$20240720$EXP$$NL-AUROBINDO-AUR-APL-2024-035260$AUROBINDO$$75$YR$$F$Y$63$KG$20240720$$CN$NL$NL
241142412$24114241$2$F$$20240816$20240720$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-034649$AUROBINDO$Anuforo A, Charlamb J, Draytsel D, Charlamb M. Massive inferior wall aneurysm presenting with ventricular tachycardia and refractory cardiomyopathy requiring multiple interventions: A case report. World Journal of Cardiology. 2024;16(6):363-369$59$YR$$M$Y$$$20240829$$MD$US$US
241142421$24114242$1$I$20240620$20240719$20240720$20240720$EXP$FR-AFSSAPS-RN2024000778$NVSC2024FR148774$NOVARTIS$$38$YR$$F$Y$$$20240720$$HP$FR$FR
241142431$24114243$1$I$20240619$20240711$20240720$20240720$EXP$$ES-AUROBINDO-AUR-APL-2024-034905$AUROBINDO$$83$YR$$F$Y$52.7$KG$20240720$$MD$ES$ES
241142441$24114244$1$I$20231127$20240715$20240720$20240720$EXP$$NVSC2024CA147471$NOVARTIS$$53$YR$$F$Y$$$20240720$$MD$CA$CA
241142451$24114245$1$I$20220315$20240711$20240720$20240720$EXP$$PL-AUROBINDO-AUR-APL-2024-035301$AUROBINDO$$17$YR$$F$Y$53$KG$20240720$$MD$PL$PL
241142461$24114246$1$I$20240710$20240711$20240720$20240720$EXP$CN-NMPACDR-1201031025267202400219$CN-BAXTER-2024BAX021634$BAXTER$$38$YR$$F$Y$$$20240720$$MD$CN$CN
241142471$24114247$1$I$20220101$20240709$20240720$20240720$EXP$$US-AUROBINDO-AUR-APL-2024-034391$AUROBINDO$Meller L, Jagadeesh V, Oca M, Wilson K, Zuraski C, Koretz ZA, et al.. Cytomegalovirus Retinitis in an Eye with Unilateral Retinoblastoma: A Case Report.. Case Reports in Ophthalmology.. 2024;15(1):476-82$2$YR$$M$Y$$$20240720$$MD$US$US
241142482$24114248$2$F$20210301$20240816$20240720$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-035823$AUROBINDO$$$$$F$Y$2.7$KG$20240820$$MD$FR$FR
241142491$24114249$1$I$20240224$20240711$20240720$20240720$EXP$$NL-CELLTRION INC.-2024NL017219$CELLTRION$$$$$$Y$$$20240720$$MD$NL$NL
241142501$24114250$1$I$20240612$20240523$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407012453$ELI LILLY AND CO$$$$$$Y$$$20240720$$CN$US$US
241142511$24114251$1$I$20240717$20240718$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407012354$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240720$$CN$US$US
241142521$24114252$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011617$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240720$$CN$US$US
241142531$24114253$1$I$$20240718$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407012169$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240720$$CN$US$US
241142541$24114254$1$I$20240710$20240710$20240720$20240720$PER$$US-ABBVIE-5845933$ABBVIE$$38$YR$$$Y$$$20240720$$CN$US$US
241142552$24114255$2$F$20211201$20240709$20240720$20240729$PER$$US-TEVA-VS-3221279$TEVA$$28$YR$$F$Y$$$20240729$$CN$US$US
241142571$24114257$1$I$$20240716$20240720$20240720$PER$$US-AMGEN-USASP2024142519$AMGEN$$$$$$Y$$$20240720$$CN$US$US
241142581$24114258$1$I$$20240711$20240720$20240720$EXP$$JP-TAKEDA-2024TUS070627$TAKEDA$$6$DEC$$F$Y$$$20240720$$PH$JP$JP
241142591$24114259$1$I$20230403$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-034625$AUROBINDO$$39$YR$$M$Y$$$20240720$$MD$FR$FR
241142601$24114260$1$I$$20240709$20240720$20240720$PER$$US-TAKEDA-2024TUS070140$TAKEDA$$44$YR$$F$Y$66$KG$20240720$$CN$US$US
241142611$24114261$1$I$20240601$20240708$20240720$20240720$EXP$DE-BFARM-24004754$DE-GLENMARK PHARMACEUTICALS-2024GMK092214$GLENMARK$$$$$$Y$$$20240720$$MD$DE$DE
241142623$24114262$3$F$$20240912$20240720$20240913$PER$$US-AMGEN-USASP2024142041$AMGEN$$$$$$Y$$$20240913$$CN$US$US
241142632$24114263$2$F$20240716$20240716$20240720$20240726$PER$$US-AMGEN-USASP2024141256$AMGEN$$60$YR$A$M$Y$110$KG$20240726$$PH$US$US
241142641$24114264$1$I$20221230$20240711$20240720$20240720$EXP$$CN-TAKEDA-2024TUS072236$TAKEDA$$64$YR$$M$Y$72.5$KG$20240720$$HP$CN$CN
241142651$24114265$1$I$20220328$20240711$20240720$20240720$EXP$$FR-AUROBINDO-AUR-APL-2024-035231$AUROBINDO$$$$$F$Y$$$20240720$$MD$FR$FR
241142661$24114266$1$I$20230101$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011307$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240720$$CN$US$US
241142671$24114267$1$I$$20240710$20240720$20240720$EXP$$PL-AUROBINDO-AUR-APL-2024-035306$AUROBINDO$Chrobak J, Rodek P, Kucia K. Multiple-Monitored Electroconvulsive Therapy (MMECT) - does it really just belong in psychiatry^s past? A case report. Psychiatr-Pol. 2024;58(2):343-349$49$YR$$F$Y$$$20240720$$HP$PL$PL
241142681$24114268$1$I$$20240718$20240720$20240720$EXP$$CN-TAKEDA-2024TUS072908$TAKEDA$$$$$M$Y$$$20240720$$CN$CN$CN
241142691$24114269$1$I$20240714$20240719$20240720$20240720$EXP$$US-TAKEDA-2024TUS072925$TAKEDA$$32$YR$$M$Y$$$20240720$$CN$US$US
241142702$24114270$2$F$20240709$20240709$20240720$20240806$PER$$US-ABBVIE-5845932$ABBVIE$$43$YR$$$Y$124$KG$20240806$$HP$US$US
241142711$24114271$1$I$$20240717$20240720$20240720$PER$$US-TAKEDA-2024TUS073097$TAKEDA$$$$$M$Y$$$20240720$$HP$US$US
241142722$24114272$2$F$$20240808$20240720$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-034661$AUROBINDO$Martin CE, Kuhn AK, Leopold KN, Creo AL, Schoettler PJ, Allen-Rhoades WA.. Exogenous steroid replacement in a pediatric patient with adrenocortical carcinoma receiving mitotane.. Pediatric Blood and Cancer.. 2024;71(8):e31072$16$YR$$F$Y$$$20240820$$PH$US$US
241142731$24114273$1$I$$20240709$20240720$20240720$PER$$US-ABBVIE-5839975$ABBVIE$$$$$$Y$$$20240720$$CN$US$US
241142741$24114274$1$I$$20240708$20240720$20240720$PER$$US-TEVA-VS-3219741$TEVA$$$$$F$Y$$$20240720$$CN$US$US
241142752$24114275$2$F$20240712$20240715$20240720$20240728$PER$$US-AMGEN-USASP2024140175$AMGEN$$72$YR$E$F$Y$$$20240728$$CN$US$US
241142761$24114276$1$I$20221201$20240709$20240720$20240720$PER$$US-JNJFOC-20240751122$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240720$$MD$US$US
241142772$24114277$2$F$20240702$20240812$20240720$20240815$EXP$$US-TAKEDA-US202025564$TAKEDA$$52$YR$$F$Y$$$20240815$$HP$US$US
241142781$24114278$1$I$20181225$20240715$20240720$20240720$EXP$$CA-TAKEDA-2019TUS019450$TAKEDA$$52$YR$$F$Y$$$20240720$$MD$CA$CA
241142791$24114279$1$I$$20240716$20240720$20240720$EXP$$US-TAKEDA-2024TUS013342$TAKEDA$$$$$F$Y$$$20240720$$MD$US$US
241142801$24114280$1$I$$20240710$20240720$20240720$EXP$$CA-CELLTRION INC.-2024CA017354$CELLTRION$$$$$$Y$$$20240720$$HP$CA$CA
241142811$24114281$1$I$$20240712$20240720$20240720$EXP$$NVSC2024BR003288$NOVARTIS$$$$$F$Y$$$20240720$$CN$BR$BR
241142823$24114282$3$F$20230101$20240917$20240720$20240925$EXP$$US-AMGEN-USASP2024141257$AMGEN$$66$YR$E$F$Y$79.2$KG$20240925$$HP$US$US
241142831$24114283$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011628$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240720$$CN$US$US
241142841$24114284$1$I$$20240712$20240720$20240720$EXP$$US-TAKEDA-2023TUS096929$TAKEDA$$$$$M$Y$92$KG$20240720$$CN$US$US
241142852$24114285$2$F$$20240715$20240720$20240802$EXP$$NVSC2024CA145989$NOVARTIS$$44$YR$$F$Y$97$KG$20240802$$MD$CA$CA
241142862$24114286$2$F$$20240802$20240720$20240805$EXP$$US-TAKEDA-2024TUS071327$TAKEDA$$$$$F$Y$$$20240805$$MD$US$US
241142872$24114287$2$F$20240110$20240802$20240720$20240814$EXP$GB-MHRA-MED-202405161316449030-BKDSY$GB-GLENMARK PHARMACEUTICALS-2024GMK092230$GLENMARK$$$$$$Y$$$20240814$$CN$GB$GB
241142882$24114288$2$F$20230921$20240912$20240720$20240926$EXP$$JP-AMGEN-JPNSP2024143096$AMGEN$$60$YR$A$F$Y$$$20240926$$MD$JP$JP
241142892$24114289$2$F$$20240802$20240720$20240815$EXP$GB-MHRA-MED-202405162318157690-FNGQT$GB-GLENMARK PHARMACEUTICALS-2024GMK092234$GLENMARK$$$$$$Y$$$20240815$$CN$GB$GB
241142901$24114290$1$I$20231201$20240705$20240720$20240720$EXP$GB-MHRA-MED-202405060341067210-TCMHK$GB-GLENMARK PHARMACEUTICALS-2024GMK092235$GLENMARK$$$$$$Y$$$20240720$$CN$GB$GB
241142911$24114291$1$I$$20240717$20240720$20240720$EXP$$NVSC2024US074960$NOVARTIS$$$$$F$Y$$$20240720$$CN$US$US
241142921$24114292$1$I$20240710$20240717$20240720$20240720$EXP$$US-ABBVIE-5844490$ABBVIE$$84$YR$$F$Y$$$20240720$$CN$US$US
241142931$24114293$1$I$20240701$20240716$20240720$20240720$EXP$$FR-ABBVIE-5842463$ABBVIE$$72$YR$$M$Y$$$20240720$$CN$FR$FR
241142941$24114294$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011524$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240720$$CN$US$US
241142951$24114295$1$I$20240601$20240711$20240720$20240720$EXP$$US-AMGEN-USASP2024138295$AMGEN$$9$YR$C$M$Y$$$20240720$$CN$US$US
241142961$24114296$1$I$20240423$20240716$20240720$20240720$EXP$$US-ABBVIE-5844452$ABBVIE$$50$YR$$F$Y$$$20240720$$CN$US$US
241142971$24114297$1$I$$20240716$20240720$20240720$EXP$$US-ABBVIE-5845095$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241142981$24114298$1$I$20230930$20240710$20240720$20240720$EXP$$ES-ABBVIE-5845050$ABBVIE$$55$YR$$M$Y$$$20240720$$MD$ES$ES
241142992$24114299$2$F$$20240729$20240720$20240802$EXP$$US-ABBVIE-5843112$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241143001$24114300$1$I$$20240711$20240720$20240720$EXP$$CA-SANDOZ INC.-SDZ2024CA064919$SANDOZ$$43$YR$$F$Y$68$KG$20240720$$HP$CA$CA
241143011$24114301$1$I$$20240705$20240720$20240720$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457727$RANBAXY$Masbough F, Shadnia S, Rahimi M, Roshanzamiri S, Evini PE, Mostafazadeh B. A rare case report of lead encephalopathy due to high blood lead level. Clin Case Rep. 2023;11 (7):1-4$27$YR$$M$Y$$$20240719$$HP$IR$IR
241143021$24114302$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457545$RANBAXY$Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, et al. Early Clinical Experience with Dapagliflozin in Children with Heart Failure. Pediatr Cardiol. 2023;44 (1):146-152$$$T$$Y$$$20240719$$HP$US$US
241143031$24114303$1$I$$20240704$20240720$20240720$EXP$$RS-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457293$RANBAXY$Sada F, Kavaja F, Hamza A, Ukperaj BM. Immediate allergic reaction to thiocolchicoside confirmed by skin testing and basophil activation test: A case report and literature review. Am J Case Rep. 2024;25 (0):e943702 (1-4)$74$YR$$M$Y$$$20240719$$HP$RS$RS
241143041$24114304$1$I$20240422$20240704$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457467$RANBAXY$$72$YR$$F$Y$78$KG$20240719$$PH$GB$GB
241143051$24114305$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457550$RANBAXY$Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, et al. Early Clinical Experience with Dapagliflozin in Children with Heart Failure. Pediatr Cardiol. 2023;44 (1):146-152$$$T$$Y$$$20240719$$HP$US$US
241143062$24114306$2$F$$20240709$20240720$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457314$RANBAXY$Ibarra F, Holzmann S, Shah S, Fountain C, Saleh S, Kapoor V, et al. Utility of nicardipine in the management of hypertensive crises in adults with reduced ejection fractions. Am J Emerg Med. 2024;75:79-82$$$A$$Y$$$20240724$$HP$US$US
241143071$24114307$1$I$$20240704$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457185$RANBAXY$Loap P, Johnson N, Birsen R, Decroocq J, Kirova Y. Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case report. Strahlenther Onkol. 2024;Jul 2:Online ahead of print$68$YR$$F$Y$$$20240719$$HP$FR$FR
241143081$24114308$1$I$$20240704$20240720$20240720$EXP$$PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457441$RANBAXY$Shah SYM, Ajmal, Nawaz D, Lodhi AU, Rehman J, Banaras F, et al. The responsiveness of childhood/adolescent chronic myeloid leukaemia patients of pakistani origin to tyrosine kinase inhibitor. J Ayub Med Col Abbottabad. 2023;35(2):313-315$17$YR$$M$Y$$$20240719$$HP$PK$PK
241143092$24114309$2$F$$20240715$20240720$20240730$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457140$RANBAXY$Martin-Aguilar S, Lopez-Rodriguez E, Puentes-Zarzuela MC. Complete response to switch immunodepression of late-onset post-transplant lymphoproliferative disease. Med Clin Barc. 2023;161 (2):86-87$46$YR$$M$Y$$$20240730$$HP$ES$ES
241143101$24114310$1$I$$20240704$20240720$20240720$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457171$RANBAXY$Marshall S, Imada H, Kimura A, Ito T, Ogasawara T, Kazama H et al. Successful treatment of acute promyelocytic leukemia with all-trans retinoic acid on hemodialysis for acute renal failure. JPN J CLIN HEMATOL. 2023;64 (3):193-197$49$YR$$M$Y$$$20240719$$HP$JP$JP
241143111$24114311$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457298$RANBAXY$McMullan P, Brown R, Bibb L, Ferenczi K. Cutaneous CD30 positive anaplastic large cell lymphoma mimicking breast carcinoma en cuirasse. JAAD CASE REP. 2024;40:37-40$80$YR$$F$Y$$$20240719$$HP$US$US
241143121$24114312$1$I$$20240704$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451171$RANBAXY$Ting X, Yuwen Z. A case report of hyperthyroidism with intolerance of oral medication with methimazole cream. J Shanghai Jiaotong Univ (Med Sci). 2024;Mar; 44(3):412-416$68$YR$$M$Y$48$KG$20240719$$HP$CN$CN
241143131$24114313$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457558$RANBAXY$Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, et al. Early Clinical Experience with Dapagliflozin in Children with Heart Failure. Pediatr Cardiol. 2023;Aug;44 (1):146-152$$$C$$Y$$$20240719$$HP$US$US
241143141$24114314$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457555$RANBAXY$Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, et al. Early Clinical Experience with Dapagliflozin in Children with Heart Failure. Pediatr Cardiol. 2023;Aug;44 (1):146-152$$$T$$Y$$$20240719$$HP$US$US
241143151$24114315$1$I$$20240705$20240720$20240720$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458040$RANBAXY$Selvan AT, Agarwal I, Behera B, Singh S. Scrub typhus in pregnancy: A report of two cases. Obstet-Med. 2024;17(1):58-60$24$YR$$F$Y$$$20240719$$HP$IN$IN
241143161$24114316$1$I$20240401$20240704$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457465$RANBAXY$$$$$M$Y$100$KG$20240719$$CN$GB$GB
241143171$24114317$1$I$$20240704$20240720$20240720$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457631$RANBAXY$Pinto FPJ, Dutra RM, Almeida  LC, Craveiro MMS, Baima JP, Saad-Hossne R, et al. Vedolizumab Safety During Pregnancy and Lactation in a Patient with Ulcerative Colitis: A Case Report. Clin Exp Gastro. 2024;17 (0):165-171$38$YR$$F$Y$$$20240719$$HP$BR$BR
241143181$24114318$1$I$$20240704$20240720$20240720$EXP$$PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457445$RANBAXY$Shah SYM, Ajmal, Nawaz D, Lodhi AU, Rehman J, Banaras F, et al. The responsiveness of childhood/adolescent chronic myeloid leukaemia patients of pakistani origin to tyrosine kinase inhibitor. J Ayub Med Col Abbottabad. 2023;35(2):313-315$18$YR$$M$Y$$$20240719$$HP$PK$PK
241143192$24114319$2$F$$20240709$20240720$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457315$RANBAXY$Kumar AM, Sheets AR, Murphy GF, Nambudiri VE. Complex Histopathology of Papular Eruption in a Patient With Susac Autoimmune Endotheliopathy. Am J Dermatopathol. 2024;Jul;46 (7):S3-S4$51$YR$$M$Y$$$20240724$$HP$US$US
241143201$24114320$1$I$$20240704$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457629$RANBAXY$Du X, Tian G, Lu X. Successful pregnancy in a patient with IgA nephropathy treated with telitacicept: a case report. BMC Pregnancy Childbirth. 2024;24(1):432 (1-7)$32$YR$$F$Y$$$20240719$$HP$CN$CN
241143211$24114321$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458173$RANBAXY$Yang M, Khalifa A, Giacaman M, Kiwan W. A RARE CASE OF COMPLICATED CANDIDIASIS-RELATED EXTENSIVE UPPER AND LOWER GASTROINTESTINAL TRACT ULCERATION, STOMACH PERFORATION, AND LIVER ABSCESSES. Gastrointest Endosc. 2024;99(6S):AB109;Tu1040$36$YR$$F$Y$$$20240719$$HP$US$US
241143221$24114322$1$I$20200601$20240704$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457480$RANBAXY$$29$YR$$M$Y$90$KG$20240719$$CN$GB$GB
241143231$24114323$1$I$20240501$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457883$RANBAXY$$42$YR$$M$Y$$$20240719$$CN$GB$GB
241143241$24114324$1$I$$20240705$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457899$RANBAXY$Fore R, Liozon E, Dumonteil S, Sene T, Heron E, Lacombe V, et al. BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score analysis. Joint Bone Spine. 2024;91(1):105641(1-8)$$$$F$Y$$$20240719$$HP$FR$FR
241143251$24114325$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458048$RANBAXY$Zou QH, Liu H, Huang CW, Kang LP, Qiu B, Mai JL, et al. Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study. Transl Lung Cancer Res. 2023;12(1):96-108$52$YR$$F$Y$$$20240719$$HP$CN$CN
241143261$24114326$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458059$RANBAXY$Zou QH, Liu H, Huang CW, Kang LP, Qiu B, Mai JL, et al. Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study. Transl Lung Cancer Res. 2023;12(1):96-108$45$YR$$F$Y$$$20240719$$HP$CN$CN
241143271$24114327$1$I$20240621$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457898$RANBAXY$$24$YR$$M$Y$126$KG$20240719$$CN$GB$GB
241143281$24114328$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457549$RANBAXY$Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, et al. Early Clinical Experience with Dapagliflozin in Children with Heart Failure. Pediatr Cardiol. 2023;44 (1):146-152$$$C$$Y$$$20240719$$HP$US$US
241143291$24114329$1$I$20230910$20240704$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457537$RANBAXY$$$$$F$Y$$$20240719$$PH$GB$GB
241143301$24114330$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457552$RANBAXY$Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, et al. Early Clinical Experience with Dapagliflozin in Children with Heart Failure. Pediatr Cardiol. 2023;44 (1):146-152$$$C$$Y$$$20240719$$HP$US$US
241143312$24114331$2$F$20240405$20240715$20240720$20240730$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457190$RANBAXY$$$$A$M$Y$$$20240730$$MD$IT$IT
241143321$24114332$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458052$RANBAXY$Zou QH, Liu H, Huang CW, Kang LP, Qiu B, Mai JL, et al. Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study. Transl Lung Cancer Res. 2023;12(1):96-108$48$YR$$F$Y$$$20240719$$HP$CN$CN
241143331$24114333$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457551$RANBAXY$Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, et al. Early Clinical Experience with Dapagliflozin in Children with Heart Failure. Pediatr Cardiol. 2023;44 (1):146-152$$$A$$Y$$$20240719$$HP$US$US
241143341$24114334$1$I$$20240704$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457515$RANBAXY$$$$$F$Y$$$20240719$$CN$GB$GB
241143351$24114335$1$I$$20240704$20240720$20240720$EXP$$PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457447$RANBAXY$Shah SYM, Ajmal, Nawaz D, Lodhi AU, Rehman J, Banaras F, et al. The responsiveness of childhood/adolescent chronic myeloid leukaemia patients of pakistani origin to tyrosine kinase inhibitor. J Ayub Med Col Abbottabad. 2023;35(2):313-315$14$YR$$$Y$$$20240719$$HP$PK$PK
241143361$24114336$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458051$RANBAXY$Zou QH, Liu H, Huang CW, Kang LP, Qiu B, Mai JL, et al. Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study. Transl Lung Cancer Res. 2023;12(1):96-108$45$YR$$F$Y$$$20240719$$HP$CN$CN
241143371$24114337$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458046$RANBAXY$Zou QH, Liu H, Huang CW, Kang LP, Qiu B, Mai JL, et al. Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study. Transl Lung Cancer Res. 2023;12(1):96-108$62$YR$$M$Y$$$20240719$$HP$CN$CN
241143381$24114338$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457998$RANBAXY$Zou QH, Liu H, Huang CW, Kang LP, Qiu B, Mai JL, et al. Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study. Transl Lung Cancer Res. 2023;12(1):96-108$46$YR$$M$Y$$$20240719$$HP$CN$CN
241143391$24114339$1$I$$20240705$20240720$20240720$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457328$RANBAXY$Ceetheerakath N, George C. Motor Neuron Disease in an individual with Lithium responsive bipolar disorder: A therapeutic challenge. Indian J Psychiatry. 2024;66 (Suppl.):S182; 37-38$61$YR$$F$Y$$$20240719$$HP$IN$IN
241143401$24114340$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458057$RANBAXY$Zou QH, Liu H, Huang CW, Kang LP, Qiu B, Mai JL, et al. Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study. Transl Lung Cancer Res. 2023;12(1):96-108$37$YR$$M$Y$$$20240719$$HP$CN$CN
241143411$24114341$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457856$RANBAXY$$$$$M$Y$$$20240719$$CN$GB$GB
241143423$24114342$3$F$20240621$20240823$20240720$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456055$RANBAXY$-. A RANDOMIZED, OPEN-LABEL, PHASE 3 TRIAL OF TISOTUMAB VEDOTIN VS INVESTIGATORS CHOICE CHEMOTHERAPY IN SECOND- OR THIRD-LINE RECURRENT OR METASTATIC CERVICAL CANCER. -. -;-:-$62$YR$$F$Y$64$KG$20240906$$MD$CN$CN
241143431$24114343$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457415$RANBAXY$Falla-Zuniga LF, Sardi A, King MC, Lopez-Ramirez F, Barakat P, Nieroda C, et al. Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Pleura Peritoneum. 2024;9 (1):15-22$58$YR$$F$Y$$$20240719$$HP$US$US
241143441$24114344$1$I$$20240705$20240720$20240720$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457431$RANBAXY$Schonharting W, Roehnisch T, Manoochehri M, Christoph J, Sieger M, Nogueira M, et al. Improved Survival of a HER2-Positive Metastatic Breast Cancer Patient Following a Personalized Peptide Immunization. Vaccines (Basel). 2023;11 (6):1023$40$YR$$F$Y$$$20240719$$HP$DE$DE
241143451$24114345$1$I$20240101$20240705$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456943$RANBAXY$$44$YR$$M$Y$$$20240719$$PH$FR$FR
241143461$24114346$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457370$RANBAXY$Tang M, Zhang Z, Wang L, Qian H, Wu W, Liu Z, et al. Coronary artery ectasia associated with IgG4- related disease: a case report and literature review. BMC Cardiovasc Disord. 2023;23 (1):347(1-7)$77$YR$$M$Y$$$20240719$$HP$CN$CN
241143472$24114347$2$F$$20240716$20240720$20240731$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457387$RANBAXY$Ricciardulli S, Lattanzi L, Barbuti M, Ceravolo R, Perugi G. Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report. Int Clin Psychopharmacol. 2023;38(2):117-120$69$YR$$F$Y$$$20240731$$HP$IT$IT
241143481$24114348$1$I$20190101$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456356$RANBAXY$$$$$F$Y$$$20240719$$CN$GB$GB
241143491$24114349$1$I$$20240705$20240720$20240720$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457430$RANBAXY$Tie T-H, Lin W-H, Huang M-T, Wu P-T, Tsai M-C, Chou Y-Y, et al. Non-Surgical Strategies for Managing Skeletal Deformities in a Child with X-Linked Hereditary Hypophosphatemic Ricket: Insights and Perspectives. Children (Basel). 2024;11(4):487(1-10)$$$C$F$Y$9.1$KG$20240719$$HP$TW$TW
241143501$24114350$1$I$20240329$20240705$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456836$RANBAXY$$96$YR$$F$Y$50$KG$20240719$$PH$FR$FR
241143511$24114351$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457350$RANBAXY$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD Case Rep. 2023;Oct; 40:14-18$55$YR$$F$Y$$$20240719$$HP$US$US
241143521$24114352$1$I$$20240705$20240720$20240720$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457734$RANBAXY$Drejer LA, El-Masri BM, Ejersted C, Andreasen CM, Thomsen LK, Thomsen JS, et al. Trabecular bone deterioration in a postmenopausal female suffering multiple spontaneous vertebral fractures due to a delayed denosumab injection ? A post-treatment re-initiation bone biopsy-based case study. Bone Rep. 2023;19:101703(1-11)$64$YR$$F$Y$$$20240719$$HP$DK$DK
241143532$24114353$2$F$$20240709$20240720$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457639$RANBAXY$Sanchez A, Elliott EI, Wang P, Spichler-Moffarah A. Legionella pneumophila and Staphylococcus aureus co-infections in a patient with SARS-CoV-2. BMJ Case Rep. 2023;15:e248536 (1-4)$6$DEC$$M$Y$$$20240724$$HP$US$US
241143541$24114354$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457866$RANBAXY$Hutton D, Kameda-Smith M, Afshari FT, Elawadly A, Hogg F, Mehta S, et al. Intracranial invasive group A streptococcus : a neurosurgical emergency in children. J Neurosurg Pediatr. 2023;32:478-487$5$YR$$F$Y$$$20240719$$HP$GB$GB
241143551$24114355$1$I$20240101$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456401$RANBAXY$$42$YR$$F$Y$$$20240719$$CN$GB$GB
241143561$24114356$1$I$20240503$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457228$RANBAXY$$25$YR$$F$Y$95$KG$20240719$$CN$GB$GB
241143571$24114357$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457473$RANBAXY$$$$$$Y$$$20240719$$HP$GB$GB
241143581$24114358$1$I$20240418$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457470$RANBAXY$$$$$M$Y$$$20240719$$HP$GB$GB
241143592$24114359$2$F$20240328$20240719$20240720$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456458$RANBAXY$$61$YR$$M$Y$61$KG$20240802$$MD$FR$FR
241143601$24114360$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457757$RANBAXY$$$$$F$Y$$$20240719$$HP$GB$GB
241143611$24114361$1$I$20230606$20240705$20240720$20240720$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456871$RANBAXY$$93$YR$$F$Y$$$20240719$$MD$IT$IT
241143621$24114362$1$I$20240508$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457275$RANBAXY$$34$YR$$M$Y$100$KG$20240719$$CN$GB$GB
241143631$24114363$1$I$20230601$20240705$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456630$RANBAXY$$66$YR$$M$Y$$$20240719$$PH$FR$FR
241143642$24114364$2$F$20210301$20240708$20240720$20240723$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457908$RANBAXY$Sokolowska A, Iwanski M Dabrowski P. A patient with overlap syndrome: systemic lupus erythematosus, dermatomyositis, and Sj?gren?s syndrome - a rare overlapping diseases case report. Eur J Clin Exp Med. 2023;21 (3):659-662$27$YR$$M$Y$88.7$KG$20240723$$HP$PL$PL
241143651$24114365$1$I$20230701$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457235$RANBAXY$$$$$M$Y$$$20240719$$CN$GB$GB
241143661$24114366$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457336$RANBAXY$$$$$M$Y$89$KG$20240719$$CN$GB$GB
241143672$24114367$2$F$$20240716$20240720$20240731$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457206$RANBAXY$$$$$$Y$$$20240731$$MD$GB$GB
241143681$24114368$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457283$RANBAXY$$$$$M$Y$69$KG$20240719$$CN$GB$GB
241143691$24114369$1$I$20240306$20240705$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457690$RANBAXY$$24$YR$$F$Y$$$20240719$$MD$FR$FR
241143701$24114370$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457422$RANBAXY$$$$$F$Y$$$20240719$$PH$GB$GB
241143711$24114371$1$I$20240511$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457281$RANBAXY$$$$$$Y$$$20240719$$PH$GB$GB
241143722$24114372$2$F$$20240913$20240720$20240927$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457700$RANBAXY$Daus F, Maloberti A, Pavanello C, Toscani G, Riccio A, Fabbri S, et al. MULTIDRUG RESISTANT DYSLIPIDEMIA: A CASE REPORT. Eur Heart J Suppl. 2024;26 (Suppl.):ii155$71$YR$$F$Y$$$20240927$$HP$IT$IT
241143731$24114373$1$I$$20240705$20240720$20240720$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457705$RANBAXY$Shunsuke Nakamura, Shingo Masuda, Shinya Oda, Daisuke Yamakawa Shota Yamaguchi Tamaki Ishima Natsuka Kimura, et. al. Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine. Intern Med. 2024;63:1829-1835$72$YR$$F$Y$$$20240719$$HP$JP$JP
241143741$24114374$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457236$RANBAXY$$$$$F$Y$$$20240719$$CN$GB$GB
241143751$24114375$1$I$20231201$20240705$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456782$RANBAXY$$69$YR$$M$Y$$$20240719$$MD$FR$FR
241143761$24114376$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457243$RANBAXY$$$$$F$Y$56$KG$20240719$$MD$GB$GB
241143771$24114377$1$I$$20240705$20240720$20240720$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457732$RANBAXY$Tanimura K, Nakajima M, Shirakawa N, Tao K, Sugiyama M, Watanabe Y, et al. Surgical site infection caused by Rhizopus caespitosus after metastasectomy for osteosarcoma: First report of infection in humans. Pediatr Blood Cancer. 2023;70:1-3$11$YR$$M$Y$$$20240719$$HP$JP$JP
241143781$24114378$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457377$RANBAXY$$74$YR$$M$Y$68$KG$20240719$$MD$GB$GB
241143791$24114379$1$I$20240331$20240705$20240720$20240720$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456952$RANBAXY$$44$YR$$M$Y$$$20240719$$MD$ES$ES
241143801$24114380$1$I$$20240704$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457277$RANBAXY$Bernhardt I, Van Dorp L, Dixon M, McSweeney M, Gan C, Baruteau J, et al. Pyruvate carboxylase deficiency type C; variable presentation and beneficial effect of triheptanoin. JIMD Rep. 2024;65:10-16$$$C$F$Y$$$20240719$$HP$GB$GB
241143811$24114381$1$I$20240408$20240705$20240720$20240720$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457698$RANBAXY$$30$YR$$F$Y$52$KG$20240719$$CN$IT$IT
241143821$24114382$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457634$RANBAXY$$$$$F$Y$$$20240719$$CN$GB$GB
241143832$24114383$2$F$$20240720$20240720$20240802$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457755$RANBAXY$Cighir A.,Budin C. E.,Cighir T., Mare A. D., Man A. Beyond the gut - Atypical presentation of Salmonella spp. infection. Acta Medica. 2024;70(2):87-94$61$YR$$M$Y$$$20240802$$HP$RO$RO
241143841$24114384$1$I$20230401$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457787$RANBAXY$$64$YR$$F$Y$67$KG$20240719$$CN$GB$GB
241143851$24114385$1$I$20240704$20240704$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457484$RANBAXY$$54$YR$$M$Y$73$KG$20240719$$CN$GB$GB
241143861$24114386$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457137$RANBAXY$$$$$F$Y$54$KG$20240719$$CN$GB$GB
241143871$24114387$1$I$$20240705$20240720$20240720$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457622$RANBAXY$Kurahara Y, Tanaka Y, Kobayashi T, Yoshida S, Tsuyuguchi K. Efficacy of an oscillating positive expiratory pressure device in patients with Mycobacterium avium complex pulmonary disease. J InfectChemother. 2024;30(8):780-784$69$YR$$F$Y$$$20240719$$HP$JP$JP
241143881$24114388$1$I$$20240705$20240720$20240720$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457721$RANBAXY$$$$$M$Y$$$20240719$$CN$DE$DE
241143891$24114389$1$I$$20240705$20240720$20240720$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457736$RANBAXY$$67$YR$$M$Y$79$KG$20240719$$CN$NL$NL
241143901$24114390$1$I$$20240704$20240720$20240720$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457200$RANBAXY$Jena SS, Nundy S. Synchronous multiple primary neoplasms of the esophagus, rectosigmoid and central nervous system. Int J Surg Case Rep. 2024;117 (0):1-4 (109566)$77$YR$$M$Y$$$20240719$$HP$IN$IN
241143911$24114391$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457547$RANBAXY$Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, et al. Early Clinical Experience with Dapagliflozin in Children with Heart Failure. Pediatr Cardiol. 2023;44 (1):146-152$$$A$$Y$$$20240719$$HP$US$US
241143921$24114392$1$I$20240326$20240705$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457518$RANBAXY$$60$YR$$M$Y$$$20240719$$MD$FR$FR
241143931$24114393$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457380$RANBAXY$$$$$M$Y$$$20240719$$MD$GB$GB
241143941$24114394$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457855$RANBAXY$$$$$M$Y$$$20240719$$CN$GB$GB
241143951$24114395$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457252$RANBAXY$$$$$F$Y$$$20240719$$PH$GB$GB
241143961$24114396$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457559$RANBAXY$Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, et al. Early Clinical Experience with Dapagliflozin in Children with Heart Failure. Pediatr Cardiol. 2023;Aug;44 (1):146-152$$$C$$Y$$$20240719$$HP$US$US
241143971$24114397$1$I$20231107$20240704$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457466$RANBAXY$$71$YR$$F$Y$$$20240719$$HP$GB$GB
241143981$24114398$1$I$20240624$20240704$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457546$RANBAXY$$2$DY$$F$Y$$$20240719$$MD$GB$GB
241143992$24114399$2$F$$20240710$20240720$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457433$RANBAXY$Pinchman EV, Lende MN, Feustel P, Lynch T. Evaluating the Association between Prenatal Care Visits and Adverse Perinatal Outcome in Pregnancies Complicated by Opioid Use Disorder. Am J Perinatol. 2024;41 (S 01):e2225-e2229$$$$F$Y$$$20240725$$HP$US$US
241144001$24114400$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457543$RANBAXY$Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, et al. Early Clinical Experience with Dapagliflozin in Children with Heart Failure. Pediatr Cardiol. 2023;44 (1):146-152$$$A$$Y$$$20240719$$HP$US$US
241144011$24114401$1$I$$20240704$20240720$20240720$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457220$RANBAXY$Park KA, Jeon H, Choi DG, Jung JH, Shin HJ, Lee BJ, et al. Ocular motility disorders following coronavirus disease?19 vaccination. Graefes Arch Clin Exp Ophthalmol. 2023;261 (4):1127-1139$76$YR$$M$Y$$$20240719$$HP$KR$KR
241144021$24114402$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457294$RANBAXY$Zardoost P, Buckman Z, Weaver J, Elston S, Prouty A, Stuart R, et al. Continuous renal replacement therapy for lithium toxicity: A worthy treatment to avoid intradialytic hypotension and vasopressors. Clin Case Rep. 2024;12 (4)::1-4$54$YR$$F$Y$$$20240719$$HP$US$US
241144031$24114403$1$I$20240701$20240717$20240720$20240720$EXP$$US-ABBVIE-5844727$ABBVIE$$25$YR$$F$Y$$$20240720$$CN$US$US
241144051$24114405$1$I$$20240711$20240720$20240720$EXP$$JP-SANDOZ INC.-SDZ2024JP066583$SANDOZ$Takada J, Sato S, Arai K, Kito Y, Oshita Y, Saito K et al. Safety and effectiveness of once-yearly zoledronic acid in Japanese osteoporosis patients: three-year post-marketing surveillance. JOURNAL OF BONE AND MINERAL METABOLISM. 2023;41:268-77$$$E$$Y$$$20240720$$HP$JP$JP
241144061$24114406$1$I$$20240717$20240720$20240720$EXP$$US-SANDOZ INC.-SDZ2024US066501$SANDOZ$$$$$F$Y$$$20240720$$HP$US$US
241144071$24114407$1$I$$20240718$20240720$20240720$EXP$$CA-ABBVIE-5846011$ABBVIE$$66$YR$$M$Y$$$20240720$$HP$CA$CA
241144081$24114408$1$I$$20240704$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457318$RANBAXY$Li F, Lu H, Zhao D, Shen Z. Treatment of a case of primary alveolar soft part sarcoma of the lung: Case report and literature review. J Int Med Res. 2023;51 (6):1-11$15$YR$$M$Y$$$20240719$$HP$CN$CN
241144091$24114409$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458056$RANBAXY$Zou QH, Liu H, Huang CW, Kang LP, Qiu B, Mai JL, et al. Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study. Transl Lung Cancer Res. 2023;12(1):96-108$56$YR$$M$Y$$$20240719$$HP$CN$CN
241144101$24114410$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457384$RANBAXY$Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, et al. Early Clinical Experience with Dapagliflozin in Children with Heart Failure. Pediatr Cardiol. 2023;44 (1):146-152$$$C$$Y$$$20240719$$HP$US$US
241144112$24114411$2$F$$20240801$20240720$20240816$EXP$$NZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454084$RANBAXY$March de Ribot F, Jirapanyayut P, March de Ribot A. Bilateral macular oedema secondary to docetaxel treatment. N Z Med J. 2024;Jun 7;137(1596):94-98$67$YR$$M$Y$$$20240816$$HP$NZ$NZ
241144121$24114412$1$I$$20240705$20240720$20240720$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458043$RANBAXY$Selvan AT, Agarwal I, Behera B, Singh S. Scrub typhus in pregnancy: A report of two cases. Obstet-Med. 2024;17(1):58-60$$$N$F$Y$1.545$KG$20240719$$HP$IN$IN
241144131$24114413$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458055$RANBAXY$Zou QH, Liu H, Huang CW, Kang LP, Qiu B, Mai JL, et al. Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study. Transl Lung Cancer Res. 2023;12(1):96-108$43$YR$$M$Y$$$20240719$$HP$CN$CN
241144141$24114414$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457425$RANBAXY$Falla-Zuniga LF, Sardi A, King MC, Lopez-Ramirez F, Barakat P, Nieroda C, et al. Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Pleura Peritoneum. 2024;9 (1):15-22$74$YR$$F$Y$$$20240719$$HP$US$US
241144151$24114415$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455451$RANBAXY$Zhang X, Xu L, Pan E, Sun X, Ding X. Partial remission with sintilimab monotherapy in a patient carrying a CD274 amplification in refractory diffuse large B-cell lymphoma: A case report. Oncol Lett. 2024;27 (6):289$60$YR$$M$Y$$$20240719$$HP$CN$CN
241144161$24114416$1$I$$20240706$20240720$20240720$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457905$RANBAXY$Chen C-T, Liang Y-H, Hung C-W, Yeh K-H. Multiple immunosuppressants for immune-related acholia in a patient with metastatic colorectal cancer. J Cancer Res Pract. 2023;10 (1):38-43$68$YR$$M$Y$$$20240719$$HP$TW$TW
241144171$24114417$1$I$$20240706$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457523$RANBAXY$$$$$F$Y$$$20240719$$CN$GB$GB
241144181$24114418$1$I$$20240705$20240720$20240720$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457948$RANBAXY$Unler M, Ertek IE, Cosar B, Arikan Z. A case of psychosis with catatonic properties in a patient with anabolic steroid and HcG abuse. Psychiatr Clin Psychopharmacol. 2022;34(1):133;Abstract:0038$17$YR$$M$Y$$$20240719$$HP$TR$TR
241144211$24114421$1$I$20240702$20240704$20240720$20240720$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457954$RANBAXY$-. -. -. -;-:-$57$YR$$M$Y$72$KG$20240719$$HP$TR$TR
241144222$24114422$2$F$$20240711$20240720$20240726$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456248$RANBAXY$Takei S, Kinoshita H, Jamal M, Yamashita T, Tanaka E, Kawahara S, et al. An autopsy case of intoxication caused by drug interaction with multiple psychotropic drugs, fluvoxamine, levomepromazine, and trihexyphenidyl. Leg Med. 2024;Jul 1:70:102482$30$YR$$F$Y$$$20240726$$HP$JP$JP
241144231$24114423$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458054$RANBAXY$Zou QH, Liu H, Huang CW, Kang LP, Qiu B, Mai JL, et al. Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study. Transl Lung Cancer Res. 2023;12(1):96-108$38$YR$$F$Y$$$20240719$$HP$CN$CN
241144241$24114424$1$I$$20240717$20240720$20240720$EXP$$US-ABBVIE-5845201$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241144251$24114425$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457645$RANBAXY$Oomrigar SC, Fernandez J, Rivera Ortiz C, Rajen H, Toll A, Perez Colome E, et al. The Highest Form of Flattery:Bupropion Overdose Mimicking Brain Death. Am J Respir Crit Care Med. 2024;209 (0):A5653$$$$F$Y$$$20240719$$HP$US$US
241144261$24114426$1$I$20220906$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457874$RANBAXY$$71$YR$$M$Y$70$KG$20240719$$CN$GB$GB
241144271$24114427$1$I$$20240705$20240720$20240720$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457331$RANBAXY$Carpenedo M, Zappaterra A, Ferrari B, Cotilli G. Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists. Mediterr J Hematol Infect Dis. 2023;15(1):e2023021/1-4$$$A$F$Y$$$20240719$$HP$IT$IT
241144282$24114428$2$F$$20240712$20240720$20240726$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457334$RANBAXY$Mukherjee A. Combined Cyproheptadine and Dexamethasone dependence, a rare dependence syndrome or underreported? - A case series. Indian J Psychiatry. 2024;JAN; 66 (S.1):S91; 155$24$YR$$M$Y$$$20240726$$HP$IN$IN
241144291$24114429$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457879$RANBAXY$$40$YR$$F$Y$$$20240719$$HP$GB$GB
241144302$24114430$2$F$$20240712$20240720$20240726$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457332$RANBAXY$Mukherjee A. Combined Cyproheptadine and Dexamethasone dependence, a rare dependence syndrome or underreported? - A case series. Indian J Psychiatry. 2024;JAN; 66 (S.1):S91; 155$27$YR$$M$Y$$$20240726$$HP$IN$IN
241144311$24114431$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457379$RANBAXY$Yi Z, Chen L, Zheng H, Chen C. Retinal Vasculitis Following COVID-19 Vaccination: Causation or Coincidence ?. Ocular Immunol Inflamm. 2023;31(6):1283-1285$37$YR$$M$Y$$$20240719$$MD$CN$CN
241144321$24114432$1$I$$20240705$20240720$20240720$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457330$RANBAXY$Boyaci F, Arslan U. Causation or Coincidence? A Case of Coexisting Spontaneous Coronary Artery Dissection and Coronary Thrombosis in a Patient with Kounis Syndrome. Int J Cardiovasc Acad. 2023;9(2):48-51$39$YR$$M$Y$$$20240719$$HP$TR$TR
241144331$24114433$1$I$$20240705$20240720$20240720$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457578$RANBAXY$Singh P, Krishnaprasad R, Ayachit G, Joshi S. Evaluation of clinical outcomes of raised intraocular pressure following intravitreal triamcinolone acetonide injection. Rom J Ophthalmol. 2024;Jan-Mar 68(1):37-44$$$$$Y$$$20240719$$MD$IN$IN
241144341$24114434$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457354$RANBAXY$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD Case Rep. 2023;Oct; 40:14-18$35$YR$$F$Y$$$20240719$$HP$US$US
241144351$24114435$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457646$RANBAXY$Moga T, Robillard K, Prabhu A, Jamot S, Bain A. HSV Esophagitis With Hematemesis and Recalcitrant Food Bolus. Am J Gastroenterol. 2022;117(10):S1570/S2332$58$YR$$F$Y$$$20240719$$MD$US$US
241144362$24114436$2$F$$20240717$20240720$20240801$EXP$$MA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439034$RANBAXY$Koubaa I, Moustatia M, Oneib B. Severe Urinary Retention Associated With Combined Treatment With Escitalopram and Quetiapine: A Case Report. J Clin Psychopharmacol. 2024;Mar/Jun;18/44/3:3/328-330$18$YR$$M$Y$$$20240801$$MD$MA$MA
241144371$24114437$1$I$$20240705$20240720$20240720$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457575$RANBAXY$Selvan AT, Agarwal I, Behera B, Singh S. Scrub typhus in pregnancy: A report of two cases. Obstet-Med. 2024;17(1):58-60$25$YR$$F$Y$$$20240719$$HP$IN$IN
241144381$24114438$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457416$RANBAXY$Falla-Zuniga LF, Sardi A, King MC, Lopez-Ramirez F, Barakat P, Nieroda C, et al. Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Pleura Peritoneum. 2024;9 (1):15-22$58$YR$$F$Y$$$20240719$$HP$US$US
241144402$24114440$2$F$$20240712$20240720$20240730$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457335$RANBAXY$Mukherjee A. Combined Cyproheptadine and Dexamethasone dependence, a rare dependence syndrome or underreported? - A case series. Indian J Psychiatry. 2024;JAN; 66 (S.1):S91; 155$38$YR$$F$Y$$$20240730$$HP$IN$IN
241144412$24114441$2$F$$20240715$20240720$20240730$EXP$$UA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457420$RANBAXY$Chernyshova L, Lysytsia O, Stryha N, Beglaryan S, Shadrin O. Bone Marrow Transplantation as a Method of Choice in Treatment of Gain-of-Function Mutations in STAT1. Case Report. Paeditr East Eur. 2021;9 (3):414-423$$$C$M$Y$3.9$KG$20240730$$HP$UA$UA
241144421$24114442$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457409$RANBAXY$Falla-Zuniga LF, Sardi A, King MC, Lopez-Ramirez F, Barakat P, Nieroda C, et al. Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Pleura Peritoneum. 2024;9 (1):15-22$55$YR$$F$Y$$$20240719$$HP$US$US
241144431$24114443$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457421$RANBAXY$Falla-Zuniga LF, Sardi A, King MC, Lopez-Ramirez F, Barakat P, Nieroda C, et al. Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Pleura Peritoneum. 2024;9 (1):15-22$59$YR$$F$Y$$$20240719$$HP$US$US
241144441$24114444$1$I$$20240705$20240720$20240720$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457329$RANBAXY$Carpenedo M, Zappaterra A, Ferrari B, Cotilli G. Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists. Mediterr J Hematol Infect Dis. 2023;15(1):e2023021/1-4$$$$M$Y$$$20240719$$HP$IT$IT
241144451$24114445$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457347$RANBAXY$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD Case Rep. 2023;Oct; 40:14-18$58$YR$$F$Y$$$20240719$$HP$US$US
241144461$24114446$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457339$RANBAXY$Sannapaneni S, Damian L, Colbert GB,Hebert C. A UNIQUE CASE OF TARGETED THERAPY CAUSING IMMUNE COMPLEX GLOMERULONEPHRITIS. Am J Kidney Dis. 2023;APR 81 (1) (4):S43(148)$44$YR$$F$Y$$$20240719$$HP$US$US
241144471$24114447$1$I$$20240705$20240720$20240720$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457338$RANBAXY$De Marchi A, Raccis M, Sanna G, Decandia F, Navarese E, Casu G. Multiple left atrial thrombi despite oral anticoagulation and antiplatelet therapy in a patient candidate for left atrial appendage occlusion. Eur Heart J Suppl. 2024;26 (Suppl. 2):ii150-ii151;suae036.374$76$YR$$F$Y$$$20240719$$HP$IT$IT
241144481$24114448$1$I$20240701$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456372$RANBAXY$$$$E$F$Y$$$20240719$$HP$GB$GB
241144491$24114449$1$I$20220112$20240705$20240720$20240720$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456646$RANBAXY$$36$YR$$M$Y$$$20240719$$PH$ES$ES
241144501$24114450$1$I$$20240705$20240720$20240720$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457607$RANBAXY$Fischer A. Metaplastic breast cancer. German guidelines for triple-negative breast carcinoma.. Oncolog Hematolog ro. 2024;67(2):34-37$53$YR$$$Y$$$20240719$$MD$DE$DE
241144511$24114451$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457424$RANBAXY$Falla-Zuniga LF, Sardi A, King MC, Lopez-Ramirez F, Barakat P, Nieroda C, et al. Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Pleura Peritoneum. 2024;9 (1):15-22$54$YR$$F$Y$$$20240719$$HP$US$US
241144522$24114452$2$F$$20240709$20240720$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457750$RANBAXY$Baker M, Thakker S, Cardis M, DeSimone J, Larson A. A Vexing Case of a Treatment-Refractory, Idiopathic Rash Resembling Histiocytoid Sweet Syndrome: Insights into the Diagnostic Challenge of Vexas Syndrome. Am J Dermatopathol. 2024;Jul, 46 (7):S1-S2$71$YR$$M$Y$$$20240724$$MD$US$US
241144531$24114453$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457348$RANBAXY$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD Case Rep. 2023;Oct; 40:14-18$71$YR$$F$Y$$$20240719$$HP$US$US
241144543$24114454$3$F$20240703$20240804$20240720$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456692$RANBAXY$$67$YR$E$M$Y$$$20240816$$MD$CN$CN
241144551$24114455$1$I$20240321$20240705$20240720$20240720$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456640$RANBAXY$$62$YR$$M$Y$$$20240719$$MD$ES$ES
241144561$24114456$1$I$$20240705$20240720$20240720$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457576$RANBAXY$Selvan AT, Agarwal I, Behera B, Singh S. Scrub typhus in pregnancy: A report of two cases. Obstet-Med. 2024;17(1):58-60$$$N$F$Y$1.58$KG$20240719$$HP$IN$IN
241144571$24114457$1$I$20240406$20240705$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456472$RANBAXY$$9$YR$$F$Y$$$20240719$$PH$FR$FR
241144581$24114458$1$I$$20240705$20240720$20240720$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457740$RANBAXY$Mishra V, Chaubey M, Gupta KM,  Kumar V, Chakravarty J. Gastrointestinal mucormycosis presenting as melena in a patient with severe COVID-19. JGLD. 2024;Jun, 33(4):282-284$79$YR$$M$Y$$$20240719$$HP$IN$IN
241144591$24114459$1$I$20240402$20240705$20240720$20240720$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456753$RANBAXY$$53$YR$$M$Y$91$KG$20240719$$MD$IT$IT
241144601$24114460$1$I$$20240705$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457418$RANBAXY$Falla-Zuniga LF, Sardi A, King MC, Lopez-Ramirez F, Barakat P, Nieroda C, et al. Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Pleura Peritoneum. 2024;9 (1):15-22$56$YR$$F$Y$$$20240719$$HP$US$US
241144611$24114461$1$I$$20240705$20240720$20240720$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457419$RANBAXY$Shimizu A, Asai S. Spinous process osteomyelitis of the thoracic vertebrae. Pediatr Int. 2022;64 (1):e15367; 1-2$13$YR$$M$Y$$$20240719$$HP$JP$JP
241144621$24114462$1$I$$20240705$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457374$RANBAXY$Ping Y, Jian Bo Z, Xing Yun Z, Ali K, Jun C, Xu Lou I, et al. Case report: Acne vulgaris treatment with 5-Aminolaevulinic acid photodynamic therapy and adalimumab: a novel approach. Front Med. 2023;10:1187186(1-7)$18$YR$$M$Y$$$20240719$$HP$CN$CN
241144631$24114463$1$I$20230801$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456865$RANBAXY$$25$YR$$F$Y$54$KG$20240719$$CN$GB$GB
241144641$24114464$1$I$20240109$20240705$20240720$20240720$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456951$RANBAXY$$90$YR$$F$Y$$$20240719$$MD$ES$ES
241144651$24114465$1$I$20240511$20240705$20240720$20240720$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456895$RANBAXY$$73$YR$$F$Y$$$20240719$$HP$DE$DE
241144661$24114466$1$I$20240101$20240705$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457522$RANBAXY$$77$YR$$F$Y$75$KG$20240719$$MD$FR$FR
241144671$24114467$1$I$20240411$20240705$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456774$RANBAXY$$79$YR$$F$Y$46.4$KG$20240719$$PH$FR$FR
241144681$24114468$1$I$$20240705$20240720$20240720$EXP$$AT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457615$RANBAXY$Vernava I, Schmitt CA. Daratumumab as a novel treatment option in refractory ITP. Blood Cell Mol Dis. 2023;99:1-6 (102724)$82$YR$$F$Y$$$20240719$$HP$AT$AT
241144691$24114469$1$I$$20240705$20240720$20240720$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457434$RANBAXY$Korytnikova E, Katz ME, Gabizon I, Eshkoli T. Normal term deliveries in a patient with Phosphoglucomutase 1 Deficiency. Isr Med Assoc J. 2024;26(5):311-315$$$$F$Y$$$20240719$$MD$IL$IL
241144701$24114470$1$I$20240513$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457232$RANBAXY$$45$YR$$F$Y$91$KG$20240719$$CN$GB$GB
241144711$24114471$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456860$RANBAXY$$$$$F$Y$$$20240719$$PH$GB$GB
241144721$24114472$1$I$$20240705$20240720$20240720$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457714$RANBAXY$Otsuka S, Hiraoka K, Iwashiro N, Kimura N, Ohara M. Mixed invasive mucinous and non-mucinous adenocarcinoma of the lung with hematogenous metastases to multiple organs. Respirat Med CaseReport. 2024;49 (0):1-6$68$YR$$M$Y$$$20240719$$HP$JP$JP
241144731$24114473$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457860$RANBAXY$Hutton D, Kameda-Smith M, Afshari FT, Elawadly A, Hogg F, Mehta S, et al. Intracranial invasive group A streptococcus a neurosurgical emergency in children. J Neurosurg Pediatr. 2023;32:478-487$9$YR$$F$Y$$$20240719$$HP$GB$GB
241144741$24114474$1$I$20210801$20240705$20240720$20240720$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457765$RANBAXY$Grimaudo MS, Laffi A, Gennaro N, Fazio R, D^Orazio F, Sama L, et al. Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule.. Front Oncol. 2023;13:no pagination$63$YR$$M$Y$$$20240719$$HP$IT$IT
241144751$24114475$1$I$20240612$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457490$RANBAXY$$33$YR$$F$Y$83$KG$20240719$$CN$GB$GB
241144761$24114476$1$I$20231101$20240705$20240720$20240720$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456352$RANBAXY$$1$DY$$F$Y$2.92$KG$20240719$$MD$DE$DE
241144771$24114477$1$I$20240507$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457475$RANBAXY$$26$YR$$M$Y$108$KG$20240719$$CN$GB$GB
241144781$24114478$1$I$20240506$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457276$RANBAXY$$29$YR$$M$Y$161$KG$20240719$$MD$GB$GB
241144791$24114479$1$I$20240203$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457494$RANBAXY$$$$$F$Y$$$20240719$$CN$GB$GB
241144801$24114480$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457217$RANBAXY$$$$$M$Y$$$20240719$$PH$GB$GB
241144811$24114481$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457249$RANBAXY$$30$YR$$$Y$69$KG$20240719$$CN$GB$GB
241144822$24114482$2$F$20240403$20240911$20240720$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456924$RANBAXY$$60$YR$$F$Y$75.8$KG$20240926$$PH$FR$FR
241144831$24114483$1$I$20240410$20240705$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457684$RANBAXY$$6$YR$$M$Y$$$20240719$$MD$FR$FR
241144841$24114484$1$I$20240307$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457254$RANBAXY$$33$YR$$F$Y$73$KG$20240719$$CN$GB$GB
241144851$24114485$1$I$20100101$20240705$20240720$20240720$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457678$RANBAXY$$29$YR$$M$Y$$$20240719$$MD$FR$FR
241144861$24114486$1$I$$20240705$20240720$20240720$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457783$RANBAXY$Obata Y, Takemoto M, Sakaue T-A, Kawata S, Mukai K, Miyashita K, et al. Immune checkpoint inhibitor-related type 1 diabetes mellitus which develops long after treatment discontinuation: a case report and review of literature. Diabet Int. 2024;1-6$76$YR$$F$Y$$$20240719$$HP$JP$JP
241144871$24114487$1$I$$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457795$RANBAXY$$$$$F$Y$75$KG$20240719$$CN$GB$GB
241144881$24114488$1$I$$20240705$20240720$20240720$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457758$RANBAXY$Grimaudo MS, Laffi A, Gennaro N, Fazio R, D^Orazio F, Sama L, et al. Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule.. Front Oncol. 2023;13:1-7$53$YR$$M$Y$$$20240719$$HP$IT$IT
241144892$24114489$2$F$$20240715$20240720$20240730$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457127$RANBAXY$$$$$F$Y$$$20240730$$MD$GB$GB
241144901$24114490$1$I$$20240705$20240720$20240720$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457651$RANBAXY$van der HeideDH, Bogers JPAM, Schulte PRFJ. Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma. Schizophr Res. 2024;267 (0):72-74$54$YR$$M$Y$$$20240719$$HP$NL$NL
241144911$24114491$1$I$20240505$20240705$20240720$20240720$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457280$RANBAXY$$47$YR$$F$Y$117$KG$20240719$$PH$GB$GB
241144922$24114492$2$F$$20240816$20240720$20240830$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457774$RANBAXY$$$$A$F$Y$85$KG$20240830$$CN$DE$DE
241144931$24114493$1$I$20200101$20240705$20240720$20240720$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457717$RANBAXY$Grimaudo MS, Laffi A, Gennaro N, Fazio R, D^Orazio F, Sama L, et al. Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule.. Front Oncol. 2023;13:1-7$50$YR$$M$Y$$$20240719$$HP$IT$IT
241144941$24114494$1$I$$20240704$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457163$RANBAXY$Zhou H-Z, Liu X-F, Lu C-W, Hao J-L. Misdiagnosed as Fungal Keratitis: Herpes Simplex Virus-1 Keratitis Confirmed by Next-Generation Sequencing. Surg Infect. 2024;-:Online ahead of print$59$YR$$M$Y$$$20240719$$HP$CN$CN
241144951$24114495$1$I$20240201$20240705$20240720$20240720$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-456977$RANBAXY$$60$YR$$M$Y$89$KG$20240719$$HP$DE$DE
241144961$24114496$1$I$$20240704$20240720$20240720$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457538$RANBAXY$Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, et al. Early Clinical Experience with Dapagliflozin in Children with Heart Failure. Pediatr Cardiol. 2023;44 (1):146-152$11$YR$$$Y$$$20240719$$HP$US$US
241144971$24114497$1$I$$20240704$20240720$20240720$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457614$RANBAXY$Xiao J, Li X, Wang X, Guan Y, Liu H, Liang J, et al. Clinical characteristics and management of immune checkpoint inhibitor-related cardiotoxicity: A single-center experience. Front Cardiovasc Med. 2023;10:1093383;01-12$57$YR$$M$Y$$$20240719$$HP$CN$CN
241144981$24114498$1$I$$20240704$20240720$20240720$EXP$$SK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457255$RANBAXY$Repkova Z. Therapeutic menu in the labyrinth of depression. Psychiatria pre prax. 2024;25 (2):68-71$85$YR$$F$Y$$$20240719$$MD$SK$SK
241144991$24114499$1$I$$20240717$20240720$20240720$EXP$$US-ABBVIE-5845486$ABBVIE$$$$$F$Y$$$20240720$$CN$US$US
241145001$24114500$1$I$20240617$20240717$20240720$20240720$EXP$$US-ABBVIE-5844530$ABBVIE$$67$YR$$F$Y$$$20240720$$CN$US$US
241145013$24114501$3$F$20240717$20240813$20240720$20240819$EXP$$US-ABBVIE-5845675$ABBVIE$$72$YR$$F$Y$73$KG$20240819$$CN$US$US
241145021$24114502$1$I$20240101$20240718$20240720$20240720$EXP$$CA-ABBVIE-5845528$ABBVIE$$$$E$M$Y$$$20240720$$HP$CA$CA
241145032$24114503$2$F$20240701$20240919$20240720$20240925$EXP$$US-ABBVIE-5845690$ABBVIE$$82$YR$$F$Y$$$20240925$$CN$US$US
241145041$24114504$1$I$$20240718$20240720$20240720$EXP$$CA-ABBVIE-5846104$ABBVIE$$$$E$M$Y$$$20240720$$CN$CA$CA
241145052$24114505$2$F$20240801$20240829$20240720$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202407011517$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240903$$CN$US$US
241145061$24114506$1$I$$20240716$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407010724$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240720$$CN$US$US
241145071$24114507$1$I$$20240718$20240720$20240720$PER$$US-DSJP-DSU-2024-136641$DAIICHI$$$$E$F$Y$$$20240720$$MD$US$US
241145081$24114508$1$I$$20240717$20240720$20240720$EXP$$GB-SANDOZ INC.-NVSC2020GB124212$SANDOZ$$$$$F$Y$$$20240720$$CN$GB$GB
241145091$24114509$1$I$$20240705$20240720$20240720$EXP$$BE-GLENMARK PHARMACEUTICALS-2024GMK092207$GLENMARK$$$$$$Y$$$20240720$$MD$BE$BE
241145101$24114510$1$I$$20240718$20240720$20240720$PER$$US-TAKEDA-2024TUS073058$TAKEDA$$$$$$Y$$$20240720$$CN$US$US
241145111$24114511$1$I$$20240717$20240720$20240720$EXP$$US-SANDOZ INC.-SDZ2024US066635$SANDOZ$$$$$M$Y$$$20240720$$MD$US$US
241145122$24114512$2$F$20240101$20240723$20240720$20240724$EXP$$RO-ABBVIE-5845070$ABBVIE$$62$YR$$M$Y$$$20240724$$MD$RO$RO
241145131$24114513$1$I$$20240716$20240720$20240720$EXP$$AU-SANDOZ INC.-SDZ2024AU065750$SANDOZ$$14$YR$$$Y$$$20240720$$HP$AU$AU
241145141$24114514$1$I$20240601$20240716$20240720$20240720$EXP$HR-HALMED-300086105$HR-SANDOZ INC.-SDZ2024HR066175$SANDOZ$$68$YR$$F$Y$$$20240720$$MD$HR$HR
241145151$24114515$1$I$$20240717$20240720$20240720$30DAY$$US-SANDOZ INC.-SDZ2024US066267$SANDOZ$$$$$M$Y$$$20240720$$CN$US$US
241145161$24114516$1$I$$20240710$20240720$20240720$EXP$$US-BAYER-2024A099790$BAYER$$88$YR$E$F$Y$$$20240720$$MD$US$US
241145171$24114517$1$I$$20240719$20240720$20240720$PER$$US-DSJP-DSU-2024-136656$DAIICHI$$$$$F$Y$$$20240720$$HP$US$US
241145181$24114518$1$I$$20240717$20240720$20240720$EXP$$AU-SANDOZ INC.-SDZ2024AU066326$SANDOZ$$76$YR$$M$Y$$$20240720$$HP$AU$AU
241145192$24114519$2$F$20240712$20240904$20240720$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-021506$UNITED THERAPEUTICS$$79$YR$$F$Y$68.934$KG$20240912$$$US$US
241145202$24114520$2$F$20240601$20240924$20240720$20240927$PER$$US-BAYER-2024A104920$BAYER$$17$YR$T$F$Y$$$20240927$$CN$US$US
241145211$24114521$1$I$$20240715$20240720$20240720$EXP$$CA-TAKEDA-2024TUS044650$TAKEDA$$$$$F$Y$$$20240720$$CN$CA$CA
241145221$24114522$1$I$20240601$20240620$20240720$20240720$PER$$US-JNJFOC-20240656308$JOHNSON AND JOHNSON$$$$$F$Y$$$20240720$$CN$US$US
241145231$24114523$1$I$$20240708$20240720$20240720$PER$$US-TEVA-VS-3220621$TEVA$$$$$F$Y$$$20240720$$CN$US$US
241145241$24114524$1$I$20240515$20240606$20240720$20240720$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000069$UROGEN PHARMA$$$$$$Y$$$20240720$$MD$US$US
241145251$24114525$1$I$$20240716$20240720$20240720$EXP$$AU-SANDOZ INC.-SDZ2024AU065878$SANDOZ$$43$YR$$M$Y$$$20240720$$HP$AU$AU
241145261$24114526$1$I$$20240709$20240720$20240720$PER$$US-BAYER-2024A101558$BAYER$$80$YR$E$M$Y$$$20240720$$CN$US$US
241145271$24114527$1$I$$20240710$20240720$20240720$EXP$$JP-009507513-2407JPN002404J$MERCK$$73$YR$$M$Y$$$20240720$$MD$JP$JP
241145281$24114528$1$I$$20240715$20240720$20240720$EXP$$BR-TAKEDA-2023TUS065764$TAKEDA$$$$$$Y$$$20240720$$CN$BR$BR
241145292$24114529$2$F$20240713$20240719$20240720$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021606$UNITED THERAPEUTICS$$77$YR$$M$Y$79.819$KG$20240725$$$US$US
241145301$24114530$1$I$20240101$20240712$20240720$20240720$EXP$$US-BAYER-2024A100935$BAYER$$39$YR$A$F$Y$74.739$KG$20240720$$CN$US$US
241145311$24114531$1$I$$20240623$20240720$20240720$PER$$US-JNJFOC-20240748108$JOHNSON AND JOHNSON$$$$$$Y$$$20240720$$CN$US$US
241145324$24114532$4$F$20240419$20240828$20240720$20240904$EXP$$CA-TAKEDA-2024TUS002670$TAKEDA$$36$YR$$F$Y$$$20240904$$MD$CA$CA
241145333$24114533$3$F$20201022$20240902$20240720$20240905$EXP$$CO-TAKEDA-CO202006200$TAKEDA$$41$YR$$F$Y$69.84$KG$20240905$$MD$CO$CO
241145341$24114534$1$I$$20240625$20240720$20240720$PER$$US-JNJFOC-20240667766$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240720$$CN$US$US
241145351$24114535$1$I$20200201$20240716$20240720$20240720$EXP$$IL-SHIRE-IL202002427AA$TAKEDA$$$$A$F$Y$$$20240720$$HP$IL$IL
241145363$24114536$3$F$20240906$20240906$20240720$20240910$EXP$$CA-TAKEDA-2024TUS072119$TAKEDA$$33$YR$$F$Y$$$20240910$$CN$CA$CA
241145371$24114537$1$I$20240716$20240717$20240720$20240720$EXP$$GR-ABBVIE-5845082$ABBVIE$$68$YR$$M$Y$$$20240720$$CN$GR$GR
241145381$24114538$1$I$20240708$20240715$20240720$20240720$EXP$$DE-JNJFOC-20240741774$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240720$$MD$DE$DE
241145391$24114539$1$I$20240626$20240626$20240720$20240720$PER$$US-JNJFOC-20240673753$JOHNSON AND JOHNSON$$$$$F$Y$$$20240720$$CN$US$US
241145401$24114540$1$I$$20240626$20240720$20240720$PER$$US-JNJFOC-20240673741$JOHNSON AND JOHNSON$$$$$F$Y$$$20240720$$CN$US$US
241145412$24114541$2$F$20230101$20240717$20240720$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407011599$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240724$$CN$US$US
241145432$24114543$2$F$$20240819$20240720$20240822$EXP$$AU-SANDOZ INC.-SDZ2024AU065512$SANDOZ$$78$YR$$F$Y$$$20240822$$MD$AU$AU
241145442$24114544$2$F$$20240719$20240720$20240725$EXP$$CA-TAKEDA-2023TUS060803$TAKEDA$$$$$F$Y$$$20240725$$CN$CA$CA
241145451$24114545$1$I$20181104$20240716$20240720$20240720$EXP$$GB-SANDOZ INC.-PHHY2018GB152202$SANDOZ$$44$YR$$F$Y$$$20240720$$CN$GB$GB
241145462$24114546$2$F$20240201$20240723$20240720$20240726$PER$$US-GRUNENTHAL-2024-123091$AVERITAS$$$$E$M$Y$$$20240726$$CN$US$US
241145471$24114547$1$I$20240101$20240626$20240720$20240720$PER$$US-JNJFOC-20240673532$JOHNSON AND JOHNSON$$$$$$Y$$$20240720$$CN$US$US
241145481$24114548$1$I$$20240709$20240720$20240720$EXP$$US-CORIUM, LLC-2024COR000143$CORIUM$$$$$$Y$$$20240719$$$US$US
241145491$24114549$1$I$20240701$20240714$20240720$20240720$EXP$$PL-AMGEN-POLSP2024142293$AMGEN$$73$YR$E$F$Y$$$20240720$$MD$PL$PL
241145501$24114550$1$I$$20240715$20240720$20240720$PER$$US-TAKEDA-2024TUS072417$TAKEDA$$$$$$Y$$$20240720$$CN$US$US
241145511$24114551$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011286$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240720$$CN$US$US
241145521$24114552$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011293$ELI LILLY AND CO$$65$YR$E$$Y$$$20240720$$CN$US$US
241145531$24114553$1$I$$20240718$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407012390$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240720$$HP$US$US
241145541$24114554$1$I$20240501$20240717$20240720$20240720$EXP$HR-HALMED-300086150$HR-TAKEDA-2024TUS072342$TAKEDA$$63$YR$$M$Y$70$KG$20240720$$HP$HR$HR
241145552$24114555$2$F$20240712$20240729$20240720$20240802$30DAY$$US-AMGEN-USASP2024140071$AMGEN$$$$$$Y$$$20240802$$HP$US$US
241145561$24114556$1$I$$20240715$20240720$20240720$EXP$$BR-TAKEDA-2024TUS072456$TAKEDA$$$$$$Y$$$20240720$$CN$BR$BR
241145571$24114557$1$I$20240101$20240716$20240720$20240720$PER$$US-AMGEN-USASP2024141430$AMGEN$$76$YR$E$F$Y$$$20240720$$CN$US$US
241145581$24114558$1$I$$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024142985$AMGEN$$$$$$Y$$$20240720$$CN$US$US
241145591$24114559$1$I$$20240718$20240720$20240720$PER$$US-AMGEN-USASP2024143434$AMGEN$$63$YR$A$F$Y$$$20240720$$CN$US$US
241145601$24114560$1$I$20231001$20240716$20240720$20240720$EXP$$US-AMGEN-USASP2024141244$AMGEN$$78$YR$E$F$Y$$$20240720$$CN$US$US
241145611$24114561$1$I$20240716$20240716$20240720$20240720$EXP$$US-AMGEN-USASP2024142487$AMGEN$$$$A$$Y$$$20240720$$HP$US$US
241145624$24114562$4$F$20240907$20240907$20240720$20240911$EXP$$CA-TAKEDA-2022TUS011887$TAKEDA$$48$YR$$M$Y$$$20240911$$CN$CA$CA
241145632$24114563$2$F$20240723$20240723$20240720$20240726$EXP$$CA-TAKEDA-2024TUS071609$TAKEDA$$42$YR$$M$Y$$$20240726$$CN$CA$CA
241145643$24114564$3$F$20240829$20240916$20240720$20240919$EXP$$CA-TAKEDA-2023TUS075528$TAKEDA$$60$YR$$M$Y$$$20240919$$CN$CA$CA
241145653$24114565$3$F$$20240816$20240720$20240824$PER$$US-AMGEN-USASP2024142535$AMGEN$$$$$F$Y$$$20240824$$HP$US$US
241145661$24114566$1$I$20240716$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011428$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240720$$CN$US$US
241145671$24114567$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011769$ELI LILLY AND CO$$$$$M$Y$$$20240720$$CN$US$US
241145681$24114568$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011479$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240720$$CN$US$US
241145691$24114569$1$I$$20240716$20240720$20240720$EXP$AU-SUN PHARMACEUTICAL INDUSTRIES  LTD-2024RR-450679$AU-SANDOZ INC.-SDZ2024AU065719$SANDOZ$$52$YR$$M$Y$$$20240720$$HP$AU$AU
241145701$24114570$1$I$20240618$20240710$20240720$20240720$EXP$$CN-TAKEDA-2024TUS072618$TAKEDA$$68$YR$$F$Y$68$KG$20240720$$HP$CN$CN
241145711$24114571$1$I$20230701$20240713$20240720$20240720$EXP$$CA-SANDOZ INC.-PHHY2019CA006434$SANDOZ$$47$YR$$F$Y$$$20240720$$MD$CA$CA
241145721$24114572$1$I$$20240717$20240720$20240720$EXP$$AU-TGA-0000813832$SANDOZ$$$$$$Y$$$20240720$$HP$AU$AU
241145731$24114573$1$I$$20240715$20240720$20240720$EXP$$ES-TAKEDA-2024TUS072007$TAKEDA$Morales BC, Varas CM, Garcia LC, Gomez AR, Alonso CS, Garrote PS et al.. Alogliptin and tubulointerstitial nephritis: aMorales potential complication. Journal of the Spanish Society of Nephrology. 2024;1253:1-2$57$YR$$F$Y$$$20240720$$HP$ES$ES
241145741$24114574$1$I$$20240717$20240720$20240720$EXP$$CA-SANDOZ INC.-SDZ2024CA066718$SANDOZ$$$$$M$Y$$$20240720$$MD$CA$CA
241145751$24114575$1$I$$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024142989$AMGEN$$$$$F$Y$$$20240720$$CN$US$US
241145761$24114576$1$I$20240701$20240712$20240720$20240720$PER$$US-AMGEN-USASP2024143750$AMGEN$$$$$M$Y$$$20240720$$CN$US$US
241145771$24114577$1$I$20190821$20240715$20240720$20240720$EXP$$CA-SANDOZ INC.-PHHY2019CA198657$SANDOZ$$38$YR$$F$Y$84$KG$20240720$$CN$CA$CA
241145781$24114578$1$I$$20240715$20240720$20240720$PER$$US-AMGEN-USASP2024141057$AMGEN$$$$$$Y$$$20240720$$CN$US$US
241145791$24114579$1$I$20240711$20240717$20240720$20240720$EXP$$AR-JNJFOC-20240749743$JOHNSON AND JOHNSON$$64$YR$A$F$Y$66$KG$20240720$$CN$AR$AR
241145801$24114580$1$I$20231223$20240710$20240720$20240720$EXP$FR-AFSSAPS-NY2024000761$FR-TEVA-VS-3220337$TEVA$$30$YR$$F$Y$50$KG$20240720$$MD$FR$FR
241145811$24114581$1$I$20180425$20240716$20240720$20240720$EXP$$CA-TAKEDA-2024TUS070417$TAKEDA$$46$YR$$F$Y$$$20240720$$CN$CA$CA
241145831$24114583$1$I$$20240716$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011220$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240720$$CN$US$US
241145841$24114584$1$I$$20240716$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011589$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240720$$CN$US$US
241145852$24114585$2$F$20240716$20240802$20240720$20240806$PER$$US-AMGEN-USASP2024142051$AMGEN$$75$YR$E$F$Y$$$20240806$$HP$US$US
241145862$24114586$2$F$20240709$20240729$20240720$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407007352$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240801$$CN$US$US
241145871$24114587$1$I$$20240716$20240720$20240720$EXP$$RO-TAKEDA-2024TUS072317$TAKEDA$$71$YR$$M$Y$$$20240720$$CN$RO$RO
241145881$24114588$1$I$$20240716$20240720$20240720$EXP$$JP-ARGENX-2024-ARGX-JP005597$ARGENX BVBA$$$$$$Y$$$20240720$$MD$JP$JP
241145891$24114589$1$I$$20240718$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407012298$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240720$$CN$US$US
241145901$24114590$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011556$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240720$$CN$US$US
241145911$24114591$1$I$$20240717$20240720$20240720$PER$$US-AMGEN-USASP2024142969$AMGEN$$$$$F$Y$$$20240720$$CN$US$US
241145921$24114592$1$I$20220219$20240717$20240720$20240720$EXP$FR-AFSSAPS-TO20223642$FR-TAKEDA-2022TUS102524$TAKEDA$$15$YR$$M$Y$$$20240720$$HP$FR$FR
241145931$24114593$1$I$$20240717$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407011826$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240720$$CN$US$US
241145941$24114594$1$I$$20240702$20240720$20240720$PER$$US-009507513-2407USA001669$MERCK$Jamshidi F, Lozano L, Tucker B, Andorf J, Sohn E, Stone E, et al.. Belzutifan in Individuals with von Hippel-Lindau Retinal Hemangioblastomas: Institutional Experience and Review of the Literature. Ocular Oncology and Pathology. 2024;1-8$$$C$$Y$$$20240720$$HP$US$US
241145951$24114595$1$I$$20240717$20240720$20240720$EXP$$GB-JNJFOC-20240751778$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240720$$CN$GB$GB
241145961$24114596$1$I$20240501$20240711$20240720$20240720$EXP$$SE-AMGEN-SWESP2024137955$AMGEN$$75$YR$E$F$Y$$$20240720$$MD$SE$SE
241145971$24114597$1$I$20240715$20240717$20240720$20240720$EXP$$US-TAKEDA-2024TUS072735$TAKEDA$$64$YR$$F$Y$$$20240720$$CN$US$US
241145982$24114598$2$F$20151021$20240828$20240720$20240906$EXP$$JP-TEVA-VS-3220494$TEVA$Watanabe, K, Yamamoto M, Uchida E, Suzuki S, Miura S, Fukuda T et al.. Two cases of pneumocystis pneumonia during the treatment with brentuximab vedotin.. The Japanese Journal Of Clinical Hematology. 2016;57(9):1738-1738.; Watanabe, K, Yamamoto M, Uchida E, Suzuki S, Miura S, Fukuda T et al.. Two cases of pneumocystis pneumonia during the treatment with brentuximab vedotin.. The Japanese Journal Of Clinical Hematology. 2016;57(9):1738-1738$28$YR$$F$Y$58$KG$20240906$$MD$JP$JP
241145991$24114599$1$I$$20240702$20240720$20240720$PER$$US-009507513-2407USA009666$MERCK$Jamshidi F, Lozano L, Tucker B, Andorf J, Sohn E, Stone E, et al.. Belzutifan in Individuals with von Hippel-Lindau Retinal Hemangioblastomas: Institutional Experience and Review of the Literature. Ocular Oncology and Pathology. 2024;1-8$4$DEC$$$Y$$$20240720$$HP$US$US
241146001$24114600$1$I$$20240712$20240720$20240720$EXP$$US-UROVANT SCIENCES GMBH-202407-URV-001062$UROVANT SCIENCES$$79$YR$$M$Y$$$20240720$$HP$US$US
241146011$24114601$1$I$$20240712$20240720$20240720$EXP$$US-UROVANT SCIENCES GMBH-202407-URV-001064$UROVANT SCIENCES$$$$$M$Y$$$20240720$$MD$US$US
241146021$24114602$1$I$$20240717$20240720$20240720$EXP$$SI-ARGENX-2024-ARGX-SI005707$ARGENX BVBA$$$$$$Y$$$20240720$$MD$SI$SI
241146031$24114603$1$I$$20240702$20240720$20240720$PER$$US-009507513-2407USA009667$MERCK$Jamshidi F, Lozano L, Tucker B, Andorf J, Sohn E, Stone E, et al.. Belzutifan in Individuals with von Hippel-Lindau Retinal Hemangioblastomas: Institutional Experience and Review of the Literature. Ocular Oncology and Pathology. 2024;1-8$$$A$$Y$$$20240720$$HP$US$US
241146042$24114604$2$F$$20240731$20240720$20240812$EXP$$NVSC2024CA146143$NOVARTIS$$44$YR$$F$Y$$$20240812$$MD$CA$CA
241146051$24114605$1$I$$20240625$20240720$20240720$PER$$US-009507513-2406USA009633$MERCK$Auen, T, Cathcart, S, Shonka, N, Chen, J.. Astrocytoma, IDH-mutant, CNS WHO grade 3 with novel non-canonical IDH2 mutation. Journal of Neuropathology and Experimental Neurology. 2024;83 (6):498-9$32$YR$$M$Y$$$20240720$$HP$US$US
241146061$24114606$1$I$20240501$20240710$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407007365$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240720$$CN$US$US
241146071$24114607$1$I$20240708$20240717$20240720$20240720$EXP$$NVSC2024IE147456$NOVARTIS$$65$YR$$F$Y$$$20240720$$CN$IE$IE
241146083$24114608$3$F$$20240807$20240720$20240816$30DAY$$CA-JNJFOC-20240735031$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240816$$CN$CA$CA
241146091$24114609$1$I$20240718$20240719$20240720$20240720$PER$$US-ELI_LILLY_AND_COMPANY-US202407013021$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240720$$CN$US$US
241146101$24114610$1$I$$20240710$20240720$20240720$EXP$$JP-009507513-2407JPN002335J$MERCK$$76$YR$$M$Y$$$20240720$$MD$JP$JP
241146111$24114611$1$I$$20240703$20240720$20240720$PER$$US-009507513-2407USA002782$MERCK$$$$$M$Y$$$20240720$$CN$US$US
241146121$24114612$1$I$20240708$20240709$20240720$20240720$EXP$$GB-TEVA-VS-3220010$TEVA$$58$YR$$F$Y$91$KG$20240720$$PH$GB$GB
241146131$24114613$1$I$$20240705$20240720$20240720$PER$$US-STI Pharma LLC-2159353$STI PHARMA$$75$YR$$F$Y$$$20240720$$MD$US$US
241146141$24114614$1$I$$20240705$20240720$20240720$EXP$$US-ACI HealthCare Limited-2159367$ACI HEALTHCARE$Full text$20$YR$$M$Y$$$20240720$$$US$US
241146151$24114615$1$I$$20240704$20240720$20240720$EXP$$US-Nuvo Pharmaceuticals Inc-2159365$NUVO PHARMACEUTICALS$Full text article.$75$YR$$M$Y$$$20240720$$$US$US
241146161$24114616$1$I$$20240705$20240720$20240720$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2159362$BRECKENRIDGE$$$$$F$Y$$$20240720$$$ES$A1
241146171$24114617$1$I$$20240705$20240720$20240720$EXP$$GB-Ascend Therapeutics US, LLC-2159373$ASCEND$$$$$F$Y$$$20240720$$$GB$GB
241146181$24114618$1$I$$20240704$20240720$20240720$EXP$$IT-Nuvo Pharmaceuticals Inc-2159366$NUVO PHARMACEUTICALS$Source document (Abstract)$31$YR$$M$Y$$$20240720$$$IT$IT
241146191$24114619$1$I$$20240711$20240720$20240720$EXP$GB-MHRA-MED-202407110823316370-YMRDP$GB-TEVA-VS-3220318$TEVA$$47$YR$$F$Y$70$KG$20240720$$CN$GB$GB
241146201$24114620$1$I$$20240708$20240720$20240720$EXP$$CN-ROCHE-10000019581$ROCHE$$73$YR$E$M$Y$$$20240719$$CN$CN$CN
241146211$24114621$1$I$$20240708$20240720$20240720$PER$$US-TEVA-VS-3219617$TEVA$$$$A$M$Y$$$20240720$$HP$US$US
241146222$24114622$2$F$20240401$20240626$20240720$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240960$IRONSHORE PHARMA$$15$YR$T$M$Y$65.4$KG$20240810$$MD$US$US
241146232$24114623$2$F$20230227$20240626$20240720$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240961$IRONSHORE PHARMA$$16$YR$T$M$Y$75$KG$20240810$$MD$US$US
241146242$24114624$2$F$$20240626$20240720$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240962$IRONSHORE PHARMA$$14$YR$T$F$Y$56.6$KG$20240810$$MD$US$US
241146251$24114625$1$I$20211026$20240711$20240720$20240720$EXP$$GB-TEVA-VS-3220539$TEVA$$75$YR$$M$Y$92$KG$20240720$$PH$GB$GB
241146261$24114626$1$I$20240707$20240711$20240720$20240720$EXP$GB-MHRA-MED-202407091352085410-HRCLP$GB-TEVA-VS-3220372$TEVA$$71$YR$$F$Y$88$KG$20240720$$CN$GB$GB
241146271$24114627$1$I$$20240717$20240720$20240720$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-14206$IPSEN$$$$$M$Y$$$20240721$$CN$GB$GB
241146281$24114628$1$I$20240707$20240711$20240720$20240720$EXP$GB-MHRA-MED-202407112158541270-CKJVM$GB-TEVA-VS-3220754$TEVA$$38$YR$$F$Y$98$KG$20240720$$CN$GB$GB
241146291$24114629$1$I$20240605$20240715$20240720$20240720$EXP$$PK-ROCHE-10000027837$ROCHE$$60$YR$A$F$Y$$$20240721$$CN$PK$PK
241146302$24114630$2$F$20240321$20240715$20240720$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240844$IRONSHORE PHARMA$$9$YR$C$M$Y$30.4$KG$20240810$$HP$US$US
241146311$24114631$1$I$$20240716$20240721$20240721$EXP$$NVSC2024CA147035$NOVARTIS$$56$YR$$F$Y$$$20240720$$HP$CA$CA
241146331$24114633$1$I$$20240711$20240721$20240721$EXP$GB-MHRA-MED-202407111454382940-HMYKC$GB-TEVA-VS-3220535$TEVA$$78$YR$$F$Y$$$20240721$$PH$GB$GB
241146342$24114634$2$F$$20240902$20240721$20240909$PER$$US-AstraZeneca-2024A162689$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
241146351$24114635$1$I$$20240715$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407008617$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240721$$CN$US$US
241146361$24114636$1$I$$20240716$20240721$20240721$PER$$US-AstraZeneca-2024A162296$ASTRAZENECA$$$$$F$Y$$$20240721$$CN$US$
241146373$24114637$3$F$20240216$20240731$20240721$20240806$30DAY$$US-AMGEN-USASP2024140223$AMGEN$$41$YR$A$F$Y$$$20240806$$HP$US$US
241146381$24114638$1$I$$20240715$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407010850$ELI LILLY AND CO$$$$$$Y$$$20240721$$CN$US$US
241146391$24114639$1$I$20240704$20240711$20240721$20240721$EXP$$GB-TEVA-VS-3220545$TEVA$$55$YR$$F$Y$149$KG$20240721$$HP$GB$GB
241146401$24114640$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011483$ELI LILLY AND CO$$41$YR$A$$Y$$$20240721$$CN$US$US
241146411$24114641$1$I$20240711$20240711$20240721$20240721$30DAY$$US-GSK-US2024076430$GLAXOSMITHKLINE$$76$YR$$M$Y$$$20240721$$CN$US$US
241146421$24114642$1$I$$20240716$20240721$20240721$EXP$$GB-MYLANLABS-2024M1067070$MYLAN$$$$$M$Y$$$20240719$$MD$GB$GB
241146431$24114643$1$I$20240627$20240716$20240721$20240721$EXP$FR-AFSSAPS-AM2024000555$FR-MYLANLABS-2024M1066276$MYLAN$$35$YR$$F$Y$80$KG$20240719$$MD$FR$FR
241146441$24114644$1$I$$20240715$20240721$20240721$EXP$$PL-MYLANLABS-2024M1066220$MYLAN$Zaborowska M, Pawelas A, Zagorowicz E. Colitis after immunotherapy. Clinical Gastroenterology. 2023;15 (26):44-49$40$YR$$M$Y$$$20240719$$HP$PL$PL
241146451$24114645$1$I$$20240715$20240721$20240721$EXP$$PT-MYLANLABS-2024M1066260$MYLAN$$48$YR$$F$Y$$$20240719$$MD$PT$PT
241146461$24114646$1$I$20240421$20240715$20240721$20240721$EXP$FR-AFSSAPS-AVMA2024000307$FR-MYLANLABS-2024M1066209$MYLAN$$35$YR$$M$Y$$$20240719$$MD$FR$FR
241146471$24114647$1$I$$20240712$20240721$20240721$PER$$US-MYLANLABS-2024M1066460$MYLAN$$$$$F$Y$$$20240719$$CN$US$US
241146481$24114648$1$I$20231204$20240715$20240721$20240721$EXP$ES-AEMPS-1543556$ES-MYLANLABS-2024M1066123$MYLAN$$58$YR$$F$Y$$$20240719$$MD$ES$ES
241146491$24114649$1$I$20240602$20240709$20240721$20240721$EXP$IT-MINISAL02-993623$IT-MYLANLABS-2024M1064673$MYLAN$$74$YR$$F$Y$$$20240719$$MD$IT$IT
241146501$24114650$1$I$20240614$20240715$20240721$20240721$EXP$FR-AFSSAPS-AN2024000900$FR-MYLANLABS-2024M1066026$MYLAN$$72$YR$$F$Y$52$KG$20240719$$MD$FR$FR
241146511$24114651$1$I$20230401$20240715$20240721$20240721$EXP$FR-AFSSAPS-PO2024000764$FR-MYLANLABS-2024M1066022$MYLAN$$45$YR$$F$Y$$$20240719$$MD$FR$FR
241146521$24114652$1$I$$20240715$20240721$20240721$EXP$$PL-MYLANLABS-2024M1066215$MYLAN$$$$$M$Y$$$20240719$$CN$PL$PL
241146531$24114653$1$I$$20240715$20240721$20240721$EXP$NO-NOMAADVRE-PASRAPP-2024-Vp3xj3$NO-MYLANLABS-2024M1065992$MYLAN$$45$YR$$F$Y$$$20240719$$CN$NO$NO
241146541$24114654$1$I$20090101$20240715$20240721$20240721$EXP$$DE-MYLANLABS-2024M1065985$MYLAN$$39$YR$$F$Y$77$KG$20240719$$MD$DE$DE
241146551$24114655$1$I$20240716$20240718$20240721$20240721$EXP$GB-MHRA-MED-202407181214568440-TJQDG$GB-MYLANLABS-2024M1067367$MYLAN$$54$YR$$M$Y$82$KG$20240719$$CN$GB$GB
241146561$24114656$1$I$20240715$20240718$20240721$20240721$EXP$GB-MHRA-MED-202407161003047020-YVRCW$GB-MYLANLABS-2024M1067323$MYLAN$$35$YR$$M$Y$96$KG$20240719$$MD$GB$GB
241146571$24114657$1$I$$20240717$20240721$20240721$EXP$GB-MHRA-MED-202407171056261430-WSPDC$GB-MYLANLABS-2024M1066848$MYLAN$$59$YR$$F$Y$$$20240719$$PH$GB$GB
241146582$24114658$2$F$$20240808$20240721$20240812$EXP$$DE-MYLANLABS-2024M1066864$MYLAN$Bakhtiar, shahrzad. The incidence and type of cancer in patients with ataxia-telangiectasia via a retrospective single-centre study. British Journal of Haematology. 2021;194 (5):879-887$9$YR$$M$Y$$$20240812$$MD$DE$DE
241146591$24114659$1$I$20200503$20240716$20240721$20240721$EXP$PL-URPL-1-3709-2020$PL-MYLANLABS-2024M1066357$MYLAN$$26$YR$$F$Y$53$KG$20240719$$MD$PL$PL
241146601$24114660$1$I$20200503$20240716$20240721$20240721$EXP$PL-URPL-1-3712-2020$PL-MYLANLABS-2024M1066374$MYLAN$$39$YR$$M$Y$75$KG$20240719$$MD$PL$PL
241146613$24114661$3$F$20240618$20240828$20240721$20240903$EXP$$GB-MYLANLABS-2024M1062990$MYLAN$$$$$M$Y$$$20240903$$HP$GB$GB
241146621$24114662$1$I$20240305$20240716$20240721$20240721$EXP$FR-AFSSAPS-AN2024000918$FR-MYLANLABS-2024M1066372$MYLAN$$15$YR$$M$Y$$$20240719$$PH$FR$FR
241146631$24114663$1$I$20240708$20240716$20240721$20240721$EXP$GB-MHRA-MED-202407111532460510-RSCLJ$GB-MYLANLABS-2024M1066558$MYLAN$$48$YR$$F$Y$$$20240719$$PH$GB$GB
241146643$24114664$3$F$$20240723$20240721$20240729$EXP$$CA-MYLANLABS-2024M1067306$MYLAN$$$$$F$Y$$$20240729$$MD$CA$CA
241146651$24114665$1$I$$20240715$20240721$20240721$EXP$$BE-MYLANLABS-2024M1066420$MYLAN$Boland, L.. Adaptative strategy of immunosuppressive drugs dosage adjustments when combined with nirmatrelvir/ritonavir in solid organ transplant recipients with covid-19. Transplant International. 2024;37$$$A$$Y$$$20240719$$HP$BE$BE
241146661$24114666$1$I$$20240715$20240721$20240721$EXP$$ZA-MYLANLABS-2024M1067444$MYLAN$Nkoane MA, Adefolalu AO. Rapid-onset diarrhoea in HIV patient: The importance of suspecting cholera in non-endemic areas. S-Afr-J-Infect-Dis 2024; 39 (1).$48$YR$$M$Y$$$20240719$$HP$ZA$ZA
241146671$24114667$1$I$$20240715$20240721$20240721$EXP$GB-MHRA-MED-202407151320228720-VFYJD$GB-MYLANLABS-2024M1066270$MYLAN$$25$YR$$F$Y$$$20240719$$CN$GB$GB
241146681$24114668$1$I$$20240715$20240721$20240721$EXP$NL-LRB-00980695$NL-MYLANLABS-2024M1066461$MYLAN$$89$YR$$M$Y$75$KG$20240719$$MD$NL$NL
241146691$24114669$1$I$$20240715$20240721$20240721$EXP$$US-MYLANLABS-2024M1066491$MYLAN$$$$$F$Y$$$20240719$$CN$US$US
241146701$24114670$1$I$20240101$20240715$20240721$20240721$EXP$$CA-MYLANLABS-2024M1066113$MYLAN$$$$$M$Y$$$20240719$$PH$CA$CA
241146711$24114671$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067035$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$13$YR$$M$Y$$$20240719$$HP$IT$IT
241146721$24114672$1$I$$20240715$20240721$20240721$EXP$$GB-MYLANLABS-2024M1065959$MYLAN$$$$$M$Y$$$20240719$$HP$GB$GB
241146731$24114673$1$I$$20240708$20240721$20240721$EXP$$US-MYLANLABS-2024M1065743$MYLAN$Kishk OA, Kim I, Cheng C, Summan M, Munoz MA. Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients. Pediatr-Nephrol 2024; 39 (8): 2429-2433.$9$YR$$F$Y$25$KG$20240719$$HP$US$US
241146741$24114674$1$I$$20240708$20240721$20240721$EXP$$US-MYLANLABS-2024M1065903$MYLAN$Hutchinson A, Eskens D, Chan A, Bhargava A, Bycroft R. Managing suspected myasthenia gravis and myositis induced by pembrolizumab in a Jehovah^s Witness sarcoma patient. J-Oncol-Pharm-Pract 2024; 30 (5): 950-953.$73$YR$$M$Y$$$20240719$$HP$US$US
241146752$24114675$2$F$$20240910$20240721$20240913$30DAY$$AU-MYLANLABS-2024M1065825$MYLAN$$$$$$Y$$$20240913$$CN$AU$AU
241146761$24114676$1$I$20240604$20240715$20240721$20240721$EXP$FR-AFSSAPS-PO2024000767$FR-MYLANLABS-2024M1066061$MYLAN$$76$YR$$M$Y$76$KG$20240719$$MD$FR$FR
241146771$24114677$1$I$$20240715$20240721$20240721$EXP$$US-MYLANLABS-2024M1066826$MYLAN$$70$YR$$F$Y$62.9$KG$20240719$$HP$US$US
241146781$24114678$1$I$$20240715$20240721$20240721$EXP$FR-AFSSAPS-AVNT2024000459$FR-MYLANLABS-2024M1066115$MYLAN$$35$YR$$F$Y$$$20240719$$MD$FR$FR
241146791$24114679$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067040$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$17$YR$$F$Y$$$20240719$$HP$IT$IT
241146801$24114680$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067069$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$11$YR$$F$Y$$$20240719$$HP$IT$IT
241146811$24114681$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067057$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$17$YR$$F$Y$$$20240719$$HP$IT$IT
241146821$24114682$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067046$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$4$YR$$F$Y$$$20240719$$HP$IT$IT
241146831$24114683$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067045$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$19$YR$$M$Y$$$20240719$$HP$IT$IT
241146841$24114684$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067048$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$10$YR$$F$Y$$$20240719$$HP$IT$IT
241146851$24114685$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067028$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$16$YR$$F$Y$$$20240719$$HP$IT$IT
241146861$24114686$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067005$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$12$YR$$F$Y$$$20240719$$HP$IT$IT
241146871$24114687$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067050$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$10$YR$$M$Y$$$20240719$$HP$IT$IT
241146881$24114688$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067056$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$6$YR$$M$Y$$$20240719$$HP$IT$IT
241146891$24114689$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067017$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$4$YR$$M$Y$$$20240719$$HP$IT$IT
241146901$24114690$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067019$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$17$YR$$M$Y$$$20240719$$HP$IT$IT
241146911$24114691$1$I$$20240712$20240721$20240721$EXP$$IT-MYLANLABS-2024M1067058$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$11$YR$$F$Y$$$20240719$$HP$IT$IT
241146921$24114692$1$I$$20240712$20240721$20240721$EXP$$IN-MYLANLABS-2024M1067002$MYLAN$Kene R, Singhai P, Raman R, Dutta Majumder P. Presumed Fungal Retinitis Following Adalimumab Therapy for Juvenile Idiopathic Arthritis: A Rare Case Report. Ocular-Immunol-Inflamm 2024;.$20$YR$$F$Y$$$20240719$$MD$IN$IN
241146931$24114693$1$I$$20240712$20240721$20240721$EXP$$US-MYLANLABS-2024M1066986$MYLAN$Gupta A, Wojnowski K, Gurung P. Mucormycosis - A Rare Etiology of Empyema Nessisitans. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$55$YR$$M$Y$$$20240719$$HP$US$US
241146942$24114694$2$F$20240701$20240715$20240721$20240723$EXP$IT-MINISAL02-994241$IT-MYLANLABS-2024M1066072$MYLAN$$71$YR$$M$Y$$$20240723$$PH$IT$IT
241146951$24114695$1$I$$20240712$20240721$20240721$EXP$$US-MYLANLABS-2024M1066734$MYLAN$Noe G, Shah K, Cinderella M, Munjal S. Multiple Medication Use Resulting in Serotonin Syndrome with Deprescribing Resulting in Acute Dystonia. J-Clin-Psychopharmacol 2024; 44 (3): 326-328.$42$YR$$F$Y$$$20240719$$HP$US$US
241146961$24114696$1$I$$20240711$20240721$20240721$EXP$$US-MYLANLABS-2024M1066573$MYLAN$Mak J, Gandhi R, Zaidan MF, Murthy V. Rituximab for Rapidly Progressive MDA5 Dermatomyositis-Associated Interstitial Lung Disease. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$47$YR$$M$Y$$$20240719$$HP$US$US
241146971$24114697$1$I$$20240711$20240721$20240721$EXP$$US-MYLANLABS-2024M1066581$MYLAN$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.$$$A$$Y$$$20240719$$PH$US$US
241146981$24114698$1$I$$20240711$20240721$20240721$EXP$$US-MYLANLABS-2024M1066576$MYLAN$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.$$$A$$Y$$$20240719$$PH$US$US
241146991$24114699$1$I$$20240711$20240721$20240721$EXP$$US-MYLANLABS-2024M1066555$MYLAN$Moussa MJ, Khandelwal J, Wilson NR, Naik SA, Subbiah V, Campbell MT, et al. Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Curr-Oncol 2024; 31 (6): 3342-3349.$71$YR$$F$Y$$$20240719$$HP$US$US
241147001$24114700$1$I$$20240709$20240721$20240721$EXP$$US-MYLANLABS-2024M1065830$MYLAN$Van Noord B, Samaan C, Flamm A. A Case of Delayed and Immediate Hypersensitivity Reactions Induced by Corticosteroids. Dermatitis 2024; 35 (2): 191-192.$71$YR$$M$Y$$$20240719$$MD$US$US
241147011$24114701$1$I$$20240710$20240721$20240721$EXP$$AU-MYLANLABS-2024M1065920$MYLAN$Goh DSL, Yuson R, Gounder P, Yun J, Limaye S. Strategic testing following toxic epidermal necrolysis allows reintroduction of chemotherapy in a patient with progressive myeloma. Asia-Pac-Allergy 2024; 14 (2): 90-92.$$$$M$Y$$$20240719$$HP$AU$AU
241147021$24114702$1$I$$20240711$20240721$20240721$EXP$$US-MYLANLABS-2024M1066590$MYLAN$Allonce J, Patel V. New-onset Refractory Status Epilepticus Induced by Synthetic Marijuana: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 A2117.$26$YR$$M$Y$$$20240719$$HP$US$US
241147031$24114703$1$I$$20240709$20240721$20240721$EXP$$JP-MYLANLABS-2024M1066082$MYLAN$Suzuki T, Einama T, Takushima M, Araki Y, Wakamatsu K, Kobayashi K, et al. Multiple metastases of human epidermal growth factor receptor 2-positive, hormone receptor-positive, pT1a pN0 breast cancer within 1 year after surgery: A case report. Oncol-Lett 2024; 28 (2):.. 2024;28 (2)$58$YR$$F$Y$$$20240719$$HP$JP$JP
241147041$24114704$1$I$20230828$20240715$20240721$20240721$EXP$FR-AFSSAPS-AVCN2024000524$FR-MYLANLABS-2024M1065964$MYLAN$$37$YR$$M$Y$$$20240719$$MD$FR$FR
241147051$24114705$1$I$$20240711$20240721$20240721$EXP$$IT-MYLANLABS-2024M1066562$MYLAN$Di Rauso G, Orlandi N, Jacopetti M, Bigliardi G, Antonelli F, Meletti S, et al. Botulinum neurotoxin as early treatment in acute-onset lesional hemiballism. Neurol-Sci 2024; 45 3509-3511.$78$YR$$M$Y$$$20240719$$HP$IT$IT
241147061$24114706$1$I$$20240716$20240721$20240721$EXP$$GB-MYLANLABS-2024M1067089$MYLAN$$$$$M$Y$$$20240719$$HP$GB$GB
241147071$24114707$1$I$$20240715$20240721$20240721$EXP$$CA-MYLANLABS-2024M1066051$MYLAN$$71$YR$$F$Y$$$20240719$$PH$CA$CA
241147081$24114708$1$I$$20240711$20240721$20240721$EXP$$JP-VIATRISJAPAN-2024M1064897AA$MYLAN$Kijima M, Fukuda Y, Kawamura Y, Shinohara J, Yamaoka S, Ashida A, et al. A case of transient myocardial ischaemia in the early postnatal period triggered by poor neonatal adaptation syndrome due to the use of antidepressants by the mother. Journal of Japan Society of Perinatal and Neonatal Medicine. 2024;60(S1):408$$$N$$Y$2.7$KG$20240719$$MD$JP$JP
241147092$24114709$2$F$$20240711$20240721$20240724$EXP$$FR-MYLANLABS-2024M1061031$MYLAN$M. Chappuy, I. Merah, D. Ragonnet, J. de Ternay, B. Rolland. Lyon resource center for prescription drug use disorder. Le courrier des Addictions. 2024;XXVI (2):24-27$30$YR$$M$Y$$$20240724$$PH$FR$FR
241147101$24114710$1$I$$20240719$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012952$ELI LILLY AND CO$$11$YR$C$F$Y$$$20240721$$CN$US$US
241147111$24114711$1$I$$20240715$20240721$20240721$EXP$$US-MYLANLABS-2024M1066803$MYLAN$$$$$M$Y$79.38$KG$20240719$$CN$US$US
241147121$24114712$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011329$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240721$$CN$US$US
241147131$24114713$1$I$$20240715$20240721$20240721$EXP$$CA-MYLANLABS-2024M1066483$MYLAN$$$$$F$Y$$$20240719$$HP$CA$CA
241147141$24114714$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011573$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240721$$CN$US$US
241147151$24114715$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011615$ELI LILLY AND CO$$$$A$F$Y$$$20240721$$CN$US$US
241147161$24114716$1$I$20240705$20240714$20240721$20240721$EXP$PT-INFARMED-T202407-156$PT-GE HEALTHCARE-2024CSU007975$GE HEALTHCARE$$50$YR$$M$Y$110$KG$20240721$$HP$PT$PT
241147171$24114717$1$I$20211221$20240708$20240721$20240721$EXP$FR-AFSSAPS-AN2024000836$FR-GE HEALTHCARE-2024CSU007734$GE HEALTHCARE$$32$YR$$F$Y$60$KG$20240721$$MD$FR$FR
241147181$24114718$1$I$20240429$20240429$20240721$20240721$PER$$US-GE HEALTHCARE-2024CSU004604$GE HEALTHCARE$$67$YR$$M$Y$$$20240721$$HP$US$US
241147191$24114719$1$I$20190412$20240712$20240721$20240721$EXP$$GB-GE HEALTHCARE-2024CSU007931$GE HEALTHCARE$$66$YR$$F$Y$71$KG$20240721$$PH$GB$GB
241147201$24114720$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011571$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240721$$CN$US$US
241147222$24114722$2$F$$20240815$20240721$20240825$EXP$$US-ARDELYX-2024ARDX005327$ARDELYX$$56$YR$$M$Y$$$20240825$$HP$US$US
241147231$24114723$1$I$$20240711$20240721$20240721$EXP$$US-ARDELYX-2024ARDX005281$ARDELYX$$$$$M$Y$$$20240721$$CN$US$US
241147241$24114724$1$I$20240501$20240716$20240721$20240721$EXP$$CA-AMGEN-CANSP2024141162$AMGEN$$$$$F$Y$$$20240721$$CN$CA$CA
241147251$24114725$1$I$20240716$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011316$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240721$$CN$US$US
241147261$24114726$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011604$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240721$$CN$US$US
241147271$24114727$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011610$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240721$$CN$US$US
241147281$24114728$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011640$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240721$$CN$US$US
241147291$24114729$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011356$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240721$$CN$US$US
241147301$24114730$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011745$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240721$$CN$US$US
241147311$24114731$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011603$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240721$$CN$US$US
241147321$24114732$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011380$ELI LILLY AND CO$$$$$$Y$$$20240721$$CN$US$US
241147331$24114733$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011369$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240721$$CN$US$US
241147341$24114734$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011565$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240721$$CN$US$US
241147351$24114735$1$I$$20240710$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010478$DR REDDYS$Meeder R, Peterson A, Reynard H, Andersen L. Dyadic Work in Conjunction With Electroconvulsive Therapy in a 12-Year-Old Female With Autism Spectrum Disorder and Catatonia. Ochsner Journal. 24(2): 141-146. doi:10.31486/toj.23.0095.$12$YR$T$F$Y$$$20240721$$MD$US$US
241147361$24114736$1$I$$20240708$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010348$DR REDDYS$Siler C, Fuller W, Whaley D, Keating J. Polypharmacy in Older Adults: A Case Study. South Dakota Medicine. 2023 Mar;76(3): 124-127.$64$YR$A$F$Y$$$20240721$$MD$US$US
241147371$24114737$1$I$20240601$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011448$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240721$$HP$US$US
241147381$24114738$1$I$20240618$20240711$20240721$20240721$EXP$$DE-TEVA-VS-3220619$TEVA$$85$YR$$F$Y$52$KG$20240721$$MD$DE$DE
241147391$24114739$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011679$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240721$$CN$US$US
241147401$24114740$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011809$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240721$$CN$US$US
241147411$24114741$1$I$$20240710$20240721$20240721$EXP$$US-STERISCIENCE B.V.-2024-ST-001054$Steriscience PTE$Kraus MJ, Nguyen J.. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report.. Case-Rep-Neurol. 2024;16(1):142-147$38$YR$$F$Y$$$20240719$$HP$US$US
241147431$24114743$1$I$$20240708$20240721$20240721$EXP$$IN-STERISCIENCE B.V.-2024-ST-001030$Steriscience PTE$Abdullah, Behera MR, Kaul A, Agarwal V, Prasad P, Prasad N, et al.. The Unusual Adverse Effects of Antituberculosis Therapy in Kidney Patients.. Int-J-Mycobacteriol. 2024;13 (2):183-190$16$YR$$M$Y$$$20240719$$HP$IN$IN
241147441$24114744$1$I$20240711$20240717$20240721$20240721$EXP$GB-MHRA-MED-202407112204104930-KSJYC$GB-STRIDES ARCOLAB LIMITED-2024SP008882$STRIDES$$47$YR$$F$Y$$$20240719$$CN$GB$GB
241147451$24114745$1$I$$20240708$20240721$20240721$EXP$$IN-STERISCIENCE B.V.-2024-ST-001029$Steriscience PTE$Bhanuman R, Varadharajan S, Kumar K, Shah VM. Lethal mycotic pseudoaneurysm presenting as isolated sixth nerve palsy. Digit-J-Ophthalmol. 2024;30 (1):19-21$62$YR$$F$Y$$$20240719$$MD$IN$IN
241147461$24114746$1$I$$20240709$20240721$20240721$EXP$$CH-STERISCIENCE B.V.-2024-ST-001046$Steriscience PTE$Burgener A-V, Seth-Smith HMB, Kern-Baumann S, Durovic A, Blaich A, Menter T, et al.. A Case Study of Zoonotic Chlamydia abortus Infection: Diagnostic Challenges From Clinical and Microbiological Perspectives.. Open-Forum-Infect-Dis. 2022;9 (10):ofac524.$33$YR$$F$Y$$$20240719$$MD$CH$CH
241147472$24114747$2$F$$20240717$20240721$20240726$EXP$IR-MLMSERVICE-20240705-PI124397-00097-1$IR-STRIDES ARCOLAB LIMITED-2024SP008790$STRIDES$Rahbar M, Latifi M, Pourhosein E, Mahmoudi E, Seyhoun I, Dehghani S.. Long-term graft survival in a kidney transplant recipient with glioblastoma: Case report.. Transplantation Reports. 2024;9(3):100158$61$YR$$F$Y$$$20240726$$MD$IR$IR
241147481$24114748$1$I$$20240711$20240721$20240721$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008818$STRIDES$Acharya R, Clapp W, Upadhyay K.. Safety and Efficacy of Very Early Conversion to Belatacept in Pediatric Kidney Transplantation with Transplant-Associated Thrombotic Microangiopathy: Case Study and Review of Literature.. Clinics-Practice. 2024;14 (3):882-891.$17$YR$$M$Y$$$20240719$$HP$US$US
241147492$24114749$2$F$$20240717$20240721$20240724$EXP$CO-MLMSERVICE-20240705-PI124403-00059-1$CO-STRIDES ARCOLAB LIMITED-2024SP008792$STRIDES$Tabares B, Sarmiento-Suarez AD, Gil O, Hernandez-Pabon JC, Firacative C.. Fatal co-infection by multiple pathogens in an indigenous woman with autoimmune hemolytic anemia and tuberculosis: a case report. BMC Infectious Diseases. 2024;24(1):645$28$YR$$F$Y$$$20240724$$MD$CO$CO
241147501$24114750$1$I$$20240711$20240721$20240721$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008813$STRIDES$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF.. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult.. J-Pain-Symptom-Manage. 2023;66 (4):e455-e459$$$A$$Y$$$20240719$$PH$US$US
241147511$24114751$1$I$$20240712$20240721$20240721$EXP$$TW-STRIDES ARCOLAB LIMITED-2024SP008720$STRIDES$You M-W, Chuang S-C, Liang H-R, Chuang S-H, Chen Y-L, Wang S-N.. Tacrolimus-Induced Hepatic Vein Occlusive Disease After Deceased Donor Liver Transplantation: A Case Report. Transplant-Proc. 2024$66$YR$$M$Y$$$20240719$$HP$TW$TW
241147521$24114752$1$I$$20240711$20240721$20240721$EXP$IN-MLMSERVICE-20240621-PI108709-00153-1$IN-STRIDES ARCOLAB LIMITED-2024SP007911$STRIDES$Arora S, Faaez A, Pyda PK, Suhas S, Sreeraj VS, Mehta UM, et al.. A case report of continuous theta-burst transcranial magnetic stimulation induced seizures in a patient with bipolar depression on selective serotonin reuptake inhibitors.. Brain Stimulation.. 2024;17(4):731-733$22$YR$$M$Y$74$KG$20240719$$MD$IN$IN
241147532$24114753$2$F$$20240717$20240721$20240724$EXP$$QA-STRIDES ARCOLAB LIMITED-2024SP008791$STRIDES$Kannappilly N, Peediyakkal MZ, Khatib MY, Ananthegowda DC, Elshafei MS, El Zeer H, et al.. Ibuprofen-Induced Toxic Epidermal Necrolysis: A Case Report. International Journal of Dermatology and Venereology. 2024;7(2):108-110$41$YR$$M$Y$$$20240724$$MD$QA$QA
241147541$24114754$1$I$$20240711$20240721$20240721$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008800$STRIDES$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF.. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult.. J-Pain-Symptom-Manage. 2023;66 (4):e455-e459.$$$A$$Y$$$20240719$$PH$US$US
241147551$24114755$1$I$$20240711$20240721$20240721$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008796$STRIDES$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF.. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult.. J-Pain-Symptom-Manage. 2023;66 (4):e455-e459$$$A$$Y$$$20240719$$PH$US$US
241147561$24114756$1$I$$20240710$20240721$20240721$EXP$PL-MLMSERVICE-20240704-PI120194-00270-1$PL-STRIDES ARCOLAB LIMITED-2024SP008822$STRIDES$Chadzynski PR, Stopinska K, Domitrz I.. Tolosa-Hunt syndrome: a review of diagnostic criteria based on a case series.. Adv Psychiatry Neurol. 2024;33(1):26-34$66$YR$$F$Y$$$20240719$$MD$PL$PL
241147572$24114757$2$F$$20240710$20240721$20240723$EXP$IR-STRIDES ARCOLAB LIMITED-2024SP008719$IR-STRIDES ARCOLAB LIMITED-2024SP008719$STRIDES$Modarresi ZS, Hajiani N, Bakhtiari Z, Mohammadi F.. Unexpected massive bleeding during the modified LeFort III advancement surgery for Crouzon syndrome: A case report.. Clinical Case Reports. 2024;12 (7):e9001$14$YR$$F$Y$$$20240723$$MD$IR$IR
241147581$24114758$1$I$$20240711$20240721$20240721$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008812$STRIDES$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF.. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult.. J-Pain-Symptom-Manage. 2023;66 (4):e455-e459$$$A$$Y$$$20240719$$PH$US$US
241147591$24114759$1$I$$20240711$20240721$20240721$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008811$STRIDES$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF.. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult.. J-Pain-Symptom-Manage. 2023;66 (4):e455-e459$$$A$$Y$$$20240719$$PH$US$US
241147601$24114760$1$I$$20240710$20240721$20240721$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP008678$STRIDES$Lin L, Houwink API, van Dieren JM, Wolthuis EK, van Thienen JV, van der HeijdenMS, et al.. Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitors.. Cancer-Med. 2024;13 (12)$$$$$Y$$$20240719$$HP$NL$NL
241147611$24114761$1$I$$20240710$20240721$20240721$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP008636$STRIDES$Lin L, Houwink API, van Dieren JM, Wolthuis EK, van Thienen JV, van der HeijdenMS, et al.. Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitors.. Cancer-Med. 2024;13(12)$$$$$Y$$$20240719$$HP$NL$NL
241147621$24114762$1$I$$20240711$20240721$20240721$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008801$STRIDES$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF.. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult.. J-Pain-Symptom-Manage. 2023;66 (4):e455-e459$$$A$$Y$$$20240719$$PH$US$US
241147631$24114763$1$I$20230101$20240709$20240721$20240721$EXP$$RS-STRIDES ARCOLAB LIMITED-2024SP008605$STRIDES$Pesic A, Vukovic V, Kozarac S, Otasevic V, Bibic T, Mihaljevic B, et al.. UNIQUE PRESENTATION OF T-CELL/HISTIOCYTE-RICH LARGE B CELL LYMPHOMA COMPLICATED WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: CASE REPORT AND REVIEW OF THE LITERATURE.. J-Medicin-Biochem. 2024;43(4):631-637$32$YR$$M$Y$$$20240719$$HP$RS$RS
241147641$24114764$1$I$$20240710$20240721$20240721$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008721$STRIDES$Lee R, Gonsalves Z, Wang S, Hussain A, Herrera K.. Case study: Autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks^ gestation. Case-Rep-Perinat-Med. 2024;13 (1)$$$$$Y$$$20240719$$MD$US$US
241147651$24114765$1$I$$20240705$20240721$20240721$EXP$GB-MHRA-MED-202405101423535400-WTCJS$GB-JUBILANT PHARMA LTD-2024GB000945$JUBILANT$$$$A$$Y$$$20240719$$HP$GB$GB
241147661$24114766$1$I$20240328$20240709$20240721$20240721$EXP$DK-DKMA-30734524$DK-JUBILANT CADISTA PHARMACEUTICALS-2024DK000965$JUBILANT$$52$YR$$F$Y$104$KG$20240719$$MD$DK$DK
241147671$24114767$1$I$$20240710$20240721$20240721$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP008734$STRIDES$Hoorshad N, Tarafdari A, Zamani N, Hasani SS, Pasikhani MD.. Bilateral tubal ectopic pregnancy following induction ovulation can be missed in emergent ultrasonography: Case report.. Int-J-Surg-Case-Rep. 2024;121$25$YR$$F$Y$$$20240719$$HP$IR$IR
241147681$24114768$1$I$$20240712$20240721$20240721$EXP$US-MLMSERVICE-20240628-PI116687-00270-4$US-STRIDES ARCOLAB LIMITED-2024SP008794$STRIDES$Kraus MJ, Nguyen J.. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report.. Case Reports in Neurology. 2024;16(1):142-7$$$$F$Y$$$20240719$$MD$US$US
241147691$24114769$1$I$$20240709$20240721$20240721$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008663$STRIDES$Wilkinson AJ, Yang A, Chen GH.. Stellate ganglion block to mitigate thalamic pain syndrome of an oncological origin. Pain-Pract. 2024;24 (1):231-234$$$$$Y$$$20240719$$MD$US$US
241147702$24114770$2$F$20220101$20240717$20240721$20240724$EXP$IN-MLMSERVICE-20240710-PI124734-00232-2$IN-STRIDES ARCOLAB LIMITED-2024SP008789$STRIDES$Sivagnanam H, Kumar PK, Velu KB, Viswanathan R.. Mucormycosis-Associated Colon Perforation in the Early Postrenal Transplant Period.. Indian Journal of Transplantation.. 2024;18(2)::189-193$32$YR$$M$Y$$$20240724$$MD$IN$IN
241147711$24114771$1$I$$20240710$20240721$20240721$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008730$STRIDES$Tambe S, Jangid K, Shinde G, Jadhav S, Mahobia S, Lala M, et al.. Drug-induced systemic lupus erythematosus in a child living with HIV.. India-J-Sex-Transm-Dis. 2024;45(1):59-61$12$YR$$M$Y$$$20240719$$MD$IN$IN
241147721$24114772$1$I$$20240604$20240721$20240721$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP006668$STRIDES$Bonnet U, Kanti AK, Scherbaum N, Specka M.. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study.. J-Psychoactive-Drugs. 2022;55 (1):102-111$46$YR$$M$Y$$$20240719$$HP$DE$DE
241147731$24114773$1$I$$20240711$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010517$DR REDDYS$Jackson DL, Coke L, Zhang SX, Steenbergen C, Khan G, Gorfu G, et al. Myocarditis and brain abscess caused by disseminated Scedosporium boydii infection. Journal of the National Medical Association. 116(3): 238. doi:10.1016/j.jnma.2024.01.012.$52$YR$A$M$Y$$$20240721$$HP$US$US
241147741$24114774$1$I$$20240712$20240721$20240721$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008728$STRIDES$Tanomogi N, Ota T, Sato D, Itagaki S, Shimada K.. Fatal cerebral venous sinus thrombosis with preceding thrombocytopenia in a patient with new-onset eosinophilic granulomatosis with polyangiitis.. Mod-Rheumatol-Case-Rep. 2023;7(2):410-415$44$YR$$F$Y$$$20240719$$HP$JP$JP
241147752$24114775$2$F$20240701$20240716$20240721$20240725$EXP$IT-MINISAL02-994216$IT-BAXTER-2024BAX021508$BAXTER$$75$YR$$M$Y$$$20240725$$MD$IT$IT
241147761$24114776$1$I$$20240709$20240721$20240721$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008706$STRIDES$Xiao Y, Wang M.. A case of Hemophagocytic syndrome due to reactivation of Epstein-Barr virus after novel coronavirus infection.. Respiratory Medicine Case Reports. 2024;50:102067$73$YR$$M$Y$$$20240719$$HP$CN$CN
241147771$24114777$1$I$$20240710$20240721$20240721$EXP$$US-BAXTER-2024BAX021452$BAXTER$$$$$F$Y$$$20240719$$HP$US$US
241147792$24114779$2$F$20240606$20240709$20240721$20240826$EXP$PT-INFARMED-T202406-160$PT-BAXTER-2024BAX021492$BAXTER$$62$YR$$F$Y$75$KG$20240826$$HP$PT$PT
241147801$24114780$1$I$20230518$20240712$20240721$20240721$EXP$$US-BAXTER-2023BAX026395$BAXTER$$82$YR$$M$Y$$$20240719$$MD$US$US
241147811$24114781$1$I$$20240711$20240721$20240721$EXP$AU-MLMSERVICE-20240710-PI122722-00177-1$AU-STRIDES ARCOLAB LIMITED-2024SP008787$STRIDES$Goradia S, Holper S, Lim YZ, Brady SR.. Anti-melanoma differentiation-associated gene 5 (anti-MDA5) positive dermatomyositis: early detection is crucial.. BMJ Case Reports. 2024;17(6):e259338$7$DEC$$F$Y$50$KG$20240719$$MD$AU$AU
241147821$24114782$1$I$20190608$20240710$20240721$20240721$EXP$$US-BAXTER-2024BAX021543$BAXTER$$56$YR$$M$Y$57.9$KG$20240719$$MD$US$US
241147831$24114783$1$I$$20240709$20240721$20240721$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP008449$STRIDES$Van der Veen S, Eggink H, Elting JW, Sival D, Verschuuren-Bemelmans CC, de Koning TJ et al.. The natural history of progressive myoclonus ataxia.. Neurobiology of Disease. 2024;199:1-12$$$T$F$Y$$$20240719$$HP$NL$NL
241147841$24114784$1$I$20240613$20240709$20240721$20240721$EXP$CN-NMPACDR-5301001002141202400518$CN-BAXTER-2024BAX021497$BAXTER$$57$YR$$F$Y$57$KG$20240719$$MD$CN$CN
241147851$24114785$1$I$$20240713$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407010411$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240721$$CN$US$US
241147861$24114786$1$I$$20240718$20240721$20240721$PER$$US-AstraZeneca-2024A164868$ASTRAZENECA$$$$$F$Y$$$20240721$$CN$US$
241147871$24114787$1$I$$20240712$20240721$20240721$EXP$$CA-RDY-CLI/CAN/24/0010368$DR REDDYS$$66$YR$E$F$Y$$$20240721$$CN$CA$CA
241147881$24114788$1$I$$20240715$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407009470$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240721$$CN$US$US
241147891$24114789$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011249$ELI LILLY AND CO$$49$YR$A$$Y$$$20240721$$CN$US$US
241147901$24114790$1$I$$20240710$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010466$DR REDDYS$Garman JC, Mahgoub Y, Pathare A. Psychogenic Hyperphagia: Excessive Eating as Stereotypy in a Patient with Catatonia. Journal of Psychiatric Practice. 2024 May;30(3): 242-244. doi:10.1097/PRA.0000000000000786.$30$YR$A$M$Y$$$20240721$$MD$US$US
241147912$24114791$2$F$$20240723$20240721$20240801$EXP$US-MLMSERVICE-20240708-PI125181-00145-2$US-RDY-SPO/USA/24/0010508$DR REDDYS$Kumar P, Kaliamurthy S, Thomas J. Initiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments. Pediatrics. 2024. Doi: 10.1542/peds.2024-066226.$17$YR$T$F$Y$$$20240801$$MD$US$US
241147921$24114792$1$I$20240707$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011256$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240721$$CN$US$US
241147932$24114793$2$F$$20240723$20240721$20240802$EXP$US-MLMSERVICE-20240708-PI125181-00145-1$US-RDY-SPO/USA/24/0010507$DR REDDYS$Kumar P, Kaliamurthy S, Thomas J. Initiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments. Pediatrics. 2024;154(2):e2024066226. DOI:10.1542/peds.2024-066226.$16$YR$T$M$Y$$$20240802$$MD$US$US
241147941$24114794$1$I$20240717$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011306$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240721$$CN$US$US
241147951$24114795$1$I$$20240712$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010632$DR REDDYS$Brenneman E, Keil E, Advani SD, Campbell KB, Wrenn R. A Turtle Disaster: Salmonella enteritidis Cardiovascular Implantable Electronic Device Infection. Open Forum Infectious Diseases. 9(12): doi:10.1093/ofid/ofac668.$60$YR$A$M$Y$$$20240721$$PH$US$US
241147961$24114796$1$I$$20240711$20240721$20240721$EXP$$CA-BAXTER-2024BAX021527$BAXTER$$74$YR$$M$Y$$$20240721$$HP$CA$CA
241147971$24114797$1$I$$20240711$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010523$DR REDDYS$Bonar S, SchneiderIII HL, Cook K, Samala RV, Poole MF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. Journal of Pain and Symptom Management. 2023;66(4): e455-e459. doi:10.1016/j.jpainsymman.2023.06.019.$$$A$$Y$$$20240721$$PH$US$US
241147981$24114798$1$I$$20240710$20240721$20240721$EXP$$GB-BAXTER-2024BAX021551$BAXTER$$$$$F$Y$$$20240721$$CN$GB$GB
241147991$24114799$1$I$$20240711$20240721$20240721$EXP$GB-MHRA-MED-202407110823316370-YMRDP$GB-BAXTER-2024BAX021483$BAXTER$$47$YR$$F$Y$70$KG$20240721$$CN$GB$GB
241148002$24114800$2$F$20240706$20240729$20240721$20240806$EXP$$US-BAXTER-2024BAX021472$BAXTER$$$$$F$Y$67.2$KG$20240806$$PH$US$US
241148011$24114801$1$I$20240710$20240712$20240721$20240721$EXP$CN-NMPACDR-1403021020433202400197$CN-BAXTER-2024BAX021730$BAXTER$$69$YR$$F$Y$76$KG$20240721$$MD$CN$CN
241148021$24114802$1$I$20240710$20240712$20240721$20240721$EXP$CN-NMPACDR-3704011509867202400639$CN-BAXTER-2024BAX021739$BAXTER$$45$YR$$F$Y$67$KG$20240721$$MD$CN$CN
241148031$24114803$1$I$20240521$20240712$20240721$20240721$EXP$CN-NMPACDR-3310021059353202400297$CN-BAXTER-2024BAX021723$BAXTER$$72$YR$$M$Y$72$KG$20240721$$MD$CN$CN
241148041$24114804$1$I$20240104$20240711$20240721$20240721$EXP$$US-BAXTER-2024BAX021518$BAXTER$$62$YR$$M$Y$$$20240721$$MD$US$US
241148051$24114805$1$I$$20240712$20240721$20240721$EXP$$CA-BAXTER-2024BAX021673$BAXTER$$83$YR$$F$Y$$$20240721$$HP$CA$CA
241148071$24114807$1$I$$20240711$20240721$20240721$EXP$$US-AMGEN-USASL2024139272$AMGEN$$$$A$F$Y$$$20240721$$CN$US$US
241148081$24114808$1$I$20240719$20240719$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012959$ELI LILLY AND CO$$$$$$Y$$$20240721$$CN$US$US
241148091$24114809$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011104$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240721$$CN$US$US
241148101$24114810$1$I$$20240711$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010524$DR REDDYS$Bonar S, SchneiderIII HL, Poole MF, Samala RV, Cook K. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. Journal of Pain and Symptom Management. 2023;66(4): e455-e459. doi:10.1016/j.jpainsymman.2023.06.019.$$$A$$Y$$$20240721$$PH$US$US
241148111$24114811$1$I$20240713$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011258$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240721$$CN$US$US
241148121$24114812$1$I$$20240711$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010526$DR REDDYS$Bonar S, SchneiderIII HL, Cook K, Samala RV, Poole MF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. Journal of Pain and Symptom Management. 2023;66(4): e455-e459. doi:10.1016/j.jpainsymman.2023.06.019.$$$A$$Y$$$20240721$$PH$US$US
241148131$24114813$1$I$$20240711$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010525$DR REDDYS$Bonar S, SchneiderIII HL, Katherine Cook K, Samala RV, Poole MF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. Journal of Pain and Symptom Management. 2023;66(4): e455-e459. doi:10.1016/j.jpainsymman.2023.06.019.$$$A$$Y$$$20240721$$PH$US$US
241148141$24114814$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011435$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240721$$CN$US$US
241148151$24114815$1$I$$20240717$20240721$20240721$PER$$US-AMGEN-USASP2024143704$AMGEN$$$$$$Y$$$20240721$$PH$US$US
241148161$24114816$1$I$20240708$20240715$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407009447$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240721$$CN$US$US
241148171$24114817$1$I$$20240709$20240721$20240721$PER$$US-RDY-LIT/USA/24/0010456$DR REDDYS$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clinical Toxicology. 2024;62(5): 296-302. doi:10.1080/15563650.2024.2347514.$25$YR$A$F$Y$$$20240721$$HP$US$US
241148182$24114818$2$F$$20240812$20240721$20240819$EXP$$US-GSK-US2024088785$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$CN$US$US
241148191$24114819$1$I$20240417$20240708$20240721$20240721$EXP$DE-CADRBFARM-2024327655$DE-BEH-2024175161$CSL BEHRING$$40$YR$A$F$Y$82$KG$20240721$$CN$DE$DE
241148201$24114820$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011626$ELI LILLY AND CO$$$$A$$Y$$$20240721$$CN$US$US
241148211$24114821$1$I$$20240718$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012666$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240721$$CN$US$US
241148221$24114822$1$I$20240526$20240715$20240721$20240721$EXP$FR-AFSSAPS-PB2024000790$FR-RDY-SPO/FRA/24/0010441$DR REDDYS$$19$YR$A$F$Y$$$20240721$$MD$FR$FR
241148232$24114823$2$F$$20240728$20240721$20240802$EXP$$US-APELLIS-2024-APL-0000480$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240802$$CN$US$US
241148241$24114824$1$I$$20240712$20240721$20240721$PER$US-MLMSERVICE-20240705-PI124430-00030-2$US-RDY-SPO/USA/24/0010428$DR REDDYS$Tallmadge M, MacBeth M, Palatnik A. New Onset of Symptomatic Peptic Ulcer Disease Postpartum Secondary to Nonsteroidal Anti-Inflammatory Drug Use. Case reports in obstetrics and gynecology. 2024;2024:6422824. DOI: 10.1155/2024/6422824.$27$YR$A$F$Y$$$20240721$$MD$US$US
241148251$24114825$1$I$$20240711$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010528$DR REDDYS$Bonar S, SchneiderIII HL, Cook K, Samala RV, Poole MF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. Journal of Pain and Symptom Management. 2023;66(4): e455-e459. doi:10.1016/j.jpainsymman.2023.06.019.$$$A$$Y$$$20240721$$PH$US$US
241148261$24114826$1$I$$20240711$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010527$DR REDDYS$Bonar S, SchneiderIII HL, Cook K, Samala RV, Poole MF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. Journal of Pain and Symptom Management. 2023;66(4): e455-e459. doi:10.1016/j.jpainsymman.2023.06.019.$$$A$$Y$$$20240721$$PH$US$US
241148271$24114827$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011639$ELI LILLY AND CO$$$$$F$Y$$$20240721$$CN$US$US
241148281$24114828$1$I$20240717$20240718$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012173$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240721$$CN$US$US
241148291$24114829$1$I$$20240710$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010464$DR REDDYS$Fenton GA, Dean EA. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case Reports in Oncology. 2024 Jan 09;17(1): 75-81. doi:10.1159/000535426.$64$YR$A$F$Y$$$20240721$$HP$US$US
241148301$24114830$1$I$$20240710$20240721$20240721$PER$US-MLMSERVICE-20240703-PI120847-00083-1$US-RDY-SPO/USA/24/0010315$DR REDDYS$Sisson TM, Sublett-Smith J, Dupont E, Hirsch R, Lorts A, Villa C. Wireless Pulmonary Artery Pressure Monitor Implantation in a Patient with Duchenne Muscular Dystrophy. Pediatric Cardiology. 2024;45(5):1151-3. DOI: 10.1007/s00246-024-03459-z.$18$YR$A$M$Y$$$20240721$$MD$US$US
241148311$24114831$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011816$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240721$$CN$US$US
241148321$24114832$1$I$20240716$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011330$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240721$$MD$US$US
241148331$24114833$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011440$ELI LILLY AND CO$$$$$F$Y$$$20240721$$HP$US$US
241148341$24114834$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011654$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240721$$CN$US$US
241148351$24114835$1$I$20240714$20240715$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011712$ELI LILLY AND CO$$92$YR$E$F$Y$$$20240721$$CN$US$US
241148361$24114836$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011350$ELI LILLY AND CO$$55$YR$A$$Y$$$20240721$$CN$US$US
241148371$24114837$1$I$$20240717$20240721$20240721$EXP$CA-DRL-USA-SPO/CAN/24/0010550$CA-RDY-SPO/CAN/24/0010550$DR REDDYS$$72$YR$E$M$Y$71$KG$20240721$$HP$CA$CA
241148381$24114838$1$I$$20240717$20240721$20240721$EXP$CA-DRL-USA-SPO/CAN/24/0010548$CA-RDY-SPO/CAN/24/0010548$DR REDDYS$$71$YR$E$M$Y$60$KG$20240721$$HP$CA$CA
241148391$24114839$1$I$$20240717$20240721$20240721$EXP$CA-DRL-USA-SPO/CAN/24/0010552$CA-RDY-SPO/CAN/24/0010552$DR REDDYS$$72$YR$E$M$Y$171$KG$20240721$$HP$CA$CA
241148401$24114840$1$I$$20240717$20240721$20240721$EXP$CA-DRL-USA-SPO/CAN/24/0010555$CA-RDY-SPO/CAN/24/0010555$DR REDDYS$$70$YR$E$F$Y$66$KG$20240721$$HP$CA$CA
241148411$24114841$1$I$$20240716$20240721$20240721$PER$$US-AstraZeneca-2024A162568$ASTRAZENECA$$$$$F$Y$$$20240721$$CN$US$
241148421$24114842$1$I$20240716$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011445$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240721$$CN$US$US
241148431$24114843$1$I$$20240710$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010469$DR REDDYS$Naumann J, Naumann T. Acute Precipitated Opioid Withdrawal With Akathisia, Delirium, and Lactic Acidosis from Low-Dose Naltrexone for Chronic Pain: Case Report. Pain Medicine Case Reports. 2023;7(8): 353-356.$66$YR$E$M$Y$$$20240721$$HP$US$US
241148441$24114844$1$I$20240301$20240715$20240721$20240721$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-007483$JAZZ$$15$YR$$M$Y$$$20240721$$CN$US$US
241148452$24114845$2$F$$20230628$20240721$20240721$PER$$US-NOVOPROD-1092631$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148461$24114846$1$I$$20230705$20240721$20240721$PER$$US-NOVOPROD-1097695$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241148471$24114847$1$I$20230713$20230721$20240721$20240721$PER$$US-NOVOPROD-1098907$NOVO NORDISK$$57$YR$$$Y$$$20240721$$CN$US$US
241148481$24114848$1$I$$20230706$20240721$20240721$PER$$US-NOVOPROD-1083665$NOVO NORDISK$$73$YR$$F$Y$$$20240721$$CN$US$US
241148491$24114849$1$I$$20231204$20240721$20240721$PER$$US-NOVOPROD-1148913$NOVO NORDISK$$$$$F$Y$$$20240721$$PH$US$US
241148501$24114850$1$I$$20231201$20240721$20240721$PER$$US-NOVOPROD-1148651$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148511$24114851$1$I$$20230620$20240721$20240721$PER$$US-NOVOPROD-1084235$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148523$24114852$3$F$20231127$20240509$20240721$20240721$PER$$US-NOVOPROD-1148429$NOVO NORDISK$$38$YR$$F$Y$$$20240721$$CN$US$US
241148531$24114853$1$I$$20230705$20240721$20240721$PER$$US-NOVOPROD-1097849$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148541$24114854$1$I$$20240715$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407009688$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240721$$CN$US$US
241148551$24114855$1$I$$20230616$20240721$20240721$PER$$US-NOVOPROD-1091000$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241148561$24114856$1$I$$20231201$20240721$20240721$PER$$US-NOVOPROD-1149179$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148571$24114857$1$I$20231204$20240522$20240721$20240721$PER$$US-NOVOPROD-1150020$NOVO NORDISK$$43$YR$$F$Y$$$20240721$$CN$US$US
241148581$24114858$1$I$$20231205$20240721$20240721$PER$$US-NOVOPROD-1149321$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241148591$24114859$1$I$$20231204$20240721$20240721$PER$$US-NOVOPROD-1149748$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148602$24114860$2$F$20230623$20240425$20240721$20240721$PER$$US-NOVOPROD-1088243$NOVO NORDISK$$72$YR$$F$Y$$$20240721$$CN$US$US
241148611$24114861$1$I$20230301$20231201$20240721$20240721$PER$$US-NOVOPROD-1148951$NOVO NORDISK$$70$YR$$F$Y$$$20240721$$CN$US$US
241148621$24114862$1$I$20230419$20230727$20240721$20240721$PER$$US-NOVOPROD-1100953$NOVO NORDISK$$33$YR$$F$Y$$$20240721$$CN$US$US
241148631$24114863$1$I$20230411$20231206$20240721$20240721$PER$$US-NOVOPROD-1149829$NOVO NORDISK$$48$YR$$F$Y$$$20240721$$CN$US$US
241148641$24114864$1$I$20230614$20230803$20240721$20240721$PER$$US-NOVOPROD-1110234$NOVO NORDISK$$58$YR$$F$Y$$$20240721$$CN$US$US
241148651$24114865$1$I$$20230815$20240721$20240721$PER$$US-NOVOPROD-1109283$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148661$24114866$1$I$20230801$20230804$20240721$20240721$PER$$US-NOVOPROD-1110163$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148672$24114867$2$F$$20230814$20240721$20240721$PER$$US-NOVOPROD-1110548$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148681$24114868$1$I$20230726$20230728$20240721$20240721$PER$$US-NOVOPROD-1102089$NOVO NORDISK$$44$YR$$F$Y$$$20240721$$CN$US$US
241148692$24114869$2$F$$20240530$20240721$20240721$PER$$US-NOVOPROD-1108106$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241148701$24114870$1$I$$20230719$20240721$20240721$PER$$US-NOVOPROD-1102241$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148711$24114871$1$I$$20230804$20240721$20240721$PER$$US-NOVOPROD-1102050$NOVO NORDISK$$$$$F$Y$$$20240721$$PH$US$US
241148721$24114872$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1105698$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241148731$24114873$1$I$$20230822$20240721$20240721$PER$$US-NOVOPROD-1110754$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148741$24114874$1$I$$20230905$20240721$20240721$PER$$US-NOVOPROD-1111196$NOVO NORDISK$$39$YR$$F$Y$$$20240721$$CN$US$US
241148751$24114875$1$I$$20230913$20240721$20240721$PER$$US-NOVOPROD-1116967$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241148761$24114876$1$I$$20230825$20240721$20240721$PER$$US-NOVOPROD-1113210$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148771$24114877$1$I$20230914$20230914$20240721$20240721$PER$$US-NOVOPROD-1119730$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241148781$24114878$1$I$20230725$20230907$20240721$20240721$PER$$US-NOVOPROD-1118201$NOVO NORDISK$$66$YR$$F$Y$$$20240721$$CN$US$US
241148792$24114879$2$F$20230501$20230912$20240721$20240721$PER$$US-NOVOPROD-1119543$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148801$24114880$1$I$$20230921$20240721$20240721$PER$$US-NOVOPROD-1124332$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241148811$24114881$1$I$$20230920$20240721$20240721$PER$$US-NOVOPROD-1121982$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241148821$24114882$1$I$$20240510$20240721$20240721$PER$$US-NOVOPROD-1141258$NOVO NORDISK$$31$YR$$F$Y$$$20240721$$CN$US$US
241148831$24114883$1$I$20231117$20240122$20240721$20240721$PER$$US-NOVOPROD-1150584$NOVO NORDISK$$42$YR$$F$Y$$$20240721$$HP$US$US
241148841$24114884$1$I$$20231211$20240721$20240721$PER$$US-NOVOPROD-1153383$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148851$24114885$1$I$20231128$20231205$20240721$20240721$PER$$US-NOVOPROD-1150025$NOVO NORDISK$$30$YR$$F$Y$$$20240721$$CN$US$US
241148861$24114886$1$I$$20231214$20240721$20240721$PER$$US-NOVOPROD-1153411$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241148871$24114887$1$I$$20231214$20240721$20240721$PER$$US-NOVOPROD-1153091$NOVO NORDISK$$44$YR$$F$Y$$$20240721$$CN$US$US
241148881$24114888$1$I$20231124$20231214$20240721$20240721$PER$$US-NOVOPROD-1150856$NOVO NORDISK$$55$YR$$F$Y$$$20240721$$CN$US$US
241148891$24114889$1$I$$20231201$20240721$20240721$PER$$US-NOVOPROD-1150806$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148901$24114890$1$I$$20231201$20240721$20240721$PER$$US-NOVOPROD-1148237$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241148911$24114891$1$I$$20231211$20240721$20240721$PER$$US-NOVOPROD-1153292$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148921$24114892$1$I$$20231212$20240721$20240721$PER$$US-NOVOPROD-1153172$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241148932$24114893$2$F$$20240520$20240721$20240721$PER$$US-NOVOPROD-1150828$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148941$24114894$1$I$$20231204$20240721$20240721$PER$$US-NOVOPROD-1150549$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241148951$24114895$1$I$$20231208$20240721$20240721$PER$$US-NOVOPROD-1150918$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241148961$24114896$1$I$$20231206$20240721$20240721$PER$$US-NOVOPROD-1150953$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241148971$24114897$1$I$$20231229$20240721$20240721$PER$$US-NOVOPROD-1150252$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241148981$24114898$1$I$20231012$20231212$20240721$20240721$PER$$US-NOVOPROD-1153165$NOVO NORDISK$$55$YR$$F$Y$$$20240721$$CN$US$US
241148991$24114899$1$I$20231101$20240104$20240721$20240721$PER$$US-NOVOPROD-1153352$NOVO NORDISK$$51$YR$$F$Y$$$20240721$$CN$US$US
241149001$24114900$1$I$$20231201$20240721$20240721$PER$$US-NOVOPROD-1148366$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241149011$24114901$1$I$20231101$20231215$20240721$20240721$PER$$US-NOVOPROD-1154967$NOVO NORDISK$$49$YR$$M$Y$$$20240721$$CN$US$US
241149021$24114902$1$I$$20231212$20240721$20240721$PER$$US-NOVOPROD-1152438$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149031$24114903$1$I$20231112$20231220$20240721$20240721$PER$$US-NOVOPROD-1152000$NOVO NORDISK$$38$YR$$F$Y$$$20240721$$CN$US$US
241149041$24114904$1$I$$20231206$20240721$20240721$PER$$US-NOVOPROD-1151361$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149051$24114905$1$I$$20231219$20240721$20240721$PER$$US-NOVOPROD-1154257$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149061$24114906$1$I$$20231212$20240721$20240721$PER$$US-NOVOPROD-1152221$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241149071$24114907$1$I$20230901$20231211$20240721$20240721$PER$$US-NOVOPROD-1151908$NOVO NORDISK$$55$YR$$F$Y$$$20240721$$HP$US$US
241149081$24114908$1$I$$20231211$20240721$20240721$PER$$US-NOVOPROD-1152352$NOVO NORDISK$$55$YR$$F$Y$$$20240721$$HP$US$US
241149091$24114909$1$I$$20231208$20240721$20240721$PER$$US-NOVOPROD-1151493$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241149101$24114910$1$I$$20231211$20240721$20240721$PER$$US-NOVOPROD-1151914$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241149111$24114911$1$I$20231210$20240131$20240721$20240721$PER$$US-NOVOPROD-1154418$NOVO NORDISK$$33$YR$$F$Y$$$20240721$$CN$US$US
241149121$24114912$1$I$$20231211$20240721$20240721$PER$$US-NOVOPROD-1151799$NOVO NORDISK$$$$$$Y$$$20240721$$HP$US$US
241149131$24114913$1$I$20231001$20231212$20240721$20240721$PER$$US-NOVOPROD-1152336$NOVO NORDISK$$27$YR$$F$Y$$$20240721$$PH$US$US
241149141$24114914$1$I$$20231215$20240721$20240721$PER$$US-NOVOPROD-1154308$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$HP$US$US
241149151$24114915$1$I$$20231211$20240721$20240721$PER$$US-NOVOPROD-1151838$NOVO NORDISK$$60$YR$$M$Y$$$20240721$$HP$US$US
241149161$24114916$1$I$$20231214$20240721$20240721$PER$$US-NOVOPROD-1153416$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149171$24114917$1$I$20231210$20231213$20240721$20240721$PER$$US-NOVOPROD-1152625$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241149181$24114918$1$I$20230601$20231218$20240721$20240721$PER$$US-NOVOPROD-1154857$NOVO NORDISK$$48$YR$$F$Y$$$20240721$$CN$US$US
241149191$24114919$1$I$$20231213$20240721$20240721$PER$$US-NOVOPROD-1154450$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149201$24114920$1$I$$20231214$20240721$20240721$PER$$US-NOVOPROD-1153413$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149211$24114921$1$I$20231001$20231211$20240721$20240721$PER$$US-NOVOPROD-1151271$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
241149221$24114922$1$I$$20231214$20240721$20240721$PER$$US-NOVOPROD-1152713$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241149231$24114923$1$I$$20231206$20240721$20240721$PER$$US-NOVOPROD-1151887$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149241$24114924$1$I$$20231218$20240721$20240721$PER$$US-NOVOPROD-1154842$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241149251$24114925$1$I$$20231205$20240721$20240721$PER$$US-NOVOPROD-1151684$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241149261$24114926$1$I$20231127$20231212$20240721$20240721$PER$$US-NOVOPROD-1152381$NOVO NORDISK$$54$YR$$F$Y$$$20240721$$CN$US$US
241149271$24114927$1$I$$20231209$20240721$20240721$PER$$US-NOVOPROD-1151925$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241149281$24114928$1$I$$20231211$20240721$20240721$PER$$US-NOVOPROD-1152209$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149291$24114929$1$I$$20231222$20240721$20240721$PER$$US-NOVOPROD-1157162$NOVO NORDISK$$54$YR$$M$Y$$$20240721$$CN$US$US
241149301$24114930$1$I$$20231220$20240721$20240721$PER$$US-NOVOPROD-1157503$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149311$24114931$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011595$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240721$$CN$US$US
241149321$24114932$1$I$20231220$20240213$20240721$20240721$PER$$US-NOVOPROD-1158411$NOVO NORDISK$$52$YR$$F$Y$$$20240721$$CN$US$US
241149331$24114933$1$I$20231101$20240101$20240721$20240721$PER$$US-NOVOPROD-1159986$NOVO NORDISK$$64$YR$$F$Y$$$20240721$$CN$US$US
241149342$24114934$2$F$20231101$20231228$20240721$20240721$PER$$US-NOVOPROD-1155467$NOVO NORDISK$$39$YR$$F$Y$$$20240721$$CN$US$US
241149351$24114935$1$I$$20240213$20240721$20240721$PER$$US-NOVOPROD-1159742$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149361$24114936$1$I$20231220$20240103$20240721$20240721$PER$$US-NOVOPROD-1159418$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241149371$24114937$1$I$20231228$20231229$20240721$20240721$PER$$US-NOVOPROD-1158937$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$CN$US$US
241149381$24114938$1$I$20231210$20240509$20240721$20240721$PER$$US-NOVOPROD-1155540$NOVO NORDISK$$45$YR$$F$Y$$$20240721$$CN$US$US
241149391$24114939$1$I$20230101$20231221$20240721$20240721$PER$$US-NOVOPROD-1156616$NOVO NORDISK$$38$YR$$M$Y$$$20240721$$CN$US$US
241149401$24114940$1$I$20231215$20231220$20240721$20240721$PER$$US-NOVOPROD-1155357$NOVO NORDISK$$67$YR$$M$Y$$$20240721$$CN$US$US
241149411$24114941$1$I$$20231229$20240721$20240721$PER$$US-NOVOPROD-1159160$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241149421$24114942$1$I$20231225$20240129$20240721$20240721$PER$$US-NOVOPROD-1159600$NOVO NORDISK$$51$YR$$F$Y$$$20240721$$HP$US$US
241149431$24114943$1$I$20231228$20240616$20240721$20240721$PER$$US-NOVOPROD-1159005$NOVO NORDISK$$43$YR$$F$Y$$$20240721$$CN$US$US
241149442$24114944$2$F$20230601$20240228$20240721$20240721$PER$$US-NOVOPROD-1160917$NOVO NORDISK$$62$YR$$F$Y$$$20240721$$CN$US$US
241149453$24114945$3$F$20231030$20240124$20240721$20240721$PER$$US-NOVOPROD-1160064$NOVO NORDISK$$62$YR$$F$Y$$$20240721$$CN$US$US
241149462$24114946$2$F$$20240118$20240721$20240721$PER$$US-NOVOPROD-1160815$NOVO NORDISK$$25$YR$$F$Y$$$20240721$$CN$US$US
241149471$24114947$1$I$$20240104$20240721$20240721$PER$$US-NOVOPROD-1160445$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149481$24114948$1$I$20231120$20240105$20240721$20240721$PER$$US-NOVOPROD-1160874$NOVO NORDISK$$57$YR$$F$Y$$$20240721$$CN$US$US
241149491$24114949$1$I$20231101$20240304$20240721$20240721$PER$$US-NOVOPROD-1160818$NOVO NORDISK$$35$YR$$F$Y$$$20240721$$HP$US$US
241149501$24114950$1$I$$20240104$20240721$20240721$PER$$US-NOVOPROD-1160061$NOVO NORDISK$$$$$M$Y$$$20240721$$HP$US$US
241149511$24114951$1$I$20230503$20240102$20240721$20240721$PER$$US-NOVOPROD-1160354$NOVO NORDISK$$40$YR$$M$Y$$$20240721$$MD$US$US
241149521$24114952$1$I$$20240104$20240721$20240721$PER$$US-NOVOPROD-1160323$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241149531$24114953$1$I$$20240104$20240721$20240721$PER$$US-NOVOPROD-1160062$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241149541$24114954$1$I$$20240108$20240721$20240721$PER$$US-NOVOPROD-1161652$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241149553$24114955$3$F$20230501$20240103$20240721$20240721$PER$$US-NOVOPROD-1161003$NOVO NORDISK$$46$YR$$F$Y$$$20240721$$CN$US$US
241149563$24114956$3$F$20231101$20240105$20240721$20240721$PER$$US-NOVOPROD-1162497$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241149571$24114957$1$I$$20240106$20240721$20240721$PER$$US-NOVOPROD-1161213$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149581$24114958$1$I$$20240106$20240721$20240721$PER$$US-NOVOPROD-1161906$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241149592$24114959$2$F$$20240108$20240721$20240721$PER$$US-NOVOPROD-1162112$NOVO NORDISK$$55$YR$$F$Y$$$20240721$$CN$US$US
241149601$24114960$1$I$$20240315$20240721$20240721$PER$$US-NOVOPROD-1162099$NOVO NORDISK$$52$YR$$F$Y$$$20240721$$MD$US$US
241149611$24114961$1$I$20240101$20240213$20240721$20240721$PER$$US-NOVOPROD-1162637$NOVO NORDISK$$62$YR$$M$Y$$$20240721$$CN$US$US
241149621$24114962$1$I$20240101$20240108$20240721$20240721$PER$$US-NOVOPROD-1161487$NOVO NORDISK$$35$YR$$F$Y$$$20240721$$MD$US$US
241149631$24114963$1$I$$20240109$20240721$20240721$PER$$US-NOVOPROD-1162428$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241149641$24114964$1$I$$20240108$20240721$20240721$PER$$US-NOVOPROD-1161723$NOVO NORDISK$$64$YR$$F$Y$$$20240721$$HP$US$US
241149651$24114965$1$I$$20240109$20240721$20240721$PER$$US-NOVOPROD-1162102$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241149661$24114966$1$I$$20240110$20240721$20240721$PER$$US-NOVOPROD-1163349$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149671$24114967$1$I$20240101$20240319$20240721$20240721$PER$$US-NOVOPROD-1163392$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149681$24114968$1$I$$20240110$20240721$20240721$PER$$US-NOVOPROD-1163500$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241149691$24114969$1$I$20231120$20240110$20240721$20240721$PER$$US-NOVOPROD-1163835$NOVO NORDISK$$33$YR$$M$Y$$$20240721$$CN$US$US
241149701$24114970$1$I$20240102$20240108$20240721$20240721$PER$$US-NOVOPROD-1162889$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241149711$24114971$1$I$$20240112$20240721$20240721$PER$$US-NOVOPROD-1164035$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241149721$24114972$1$I$$20240108$20240721$20240721$PER$$US-NOVOPROD-1162908$NOVO NORDISK$$$$A$M$Y$$$20240721$$MD$US$US
241149731$24114973$1$I$$20240110$20240721$20240721$PER$$US-NOVOPROD-1164047$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149741$24114974$1$I$20231223$20240110$20240721$20240721$PER$$US-NOVOPROD-1162697$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149751$24114975$1$I$20240104$20240315$20240721$20240721$PER$$US-NOVOPROD-1163613$NOVO NORDISK$$55$YR$$F$Y$$$20240721$$CN$US$US
241149761$24114976$1$I$20240103$20240110$20240721$20240721$PER$$US-NOVOPROD-1163978$NOVO NORDISK$$60$YR$$F$Y$$$20240721$$CN$US$US
241149771$24114977$1$I$20240107$20240115$20240721$20240721$PER$$US-NOVOPROD-1164767$NOVO NORDISK$$56$YR$$F$Y$$$20240721$$CN$US$US
241149781$24114978$1$I$20231220$20240110$20240721$20240721$PER$$US-NOVOPROD-1163503$NOVO NORDISK$$76$YR$$F$Y$$$20240721$$CN$US$US
241149791$24114979$1$I$$20240205$20240721$20240721$PER$$US-NOVOPROD-1163362$NOVO NORDISK$$50$YR$$F$Y$$$20240721$$CN$US$US
241149801$24114980$1$I$20240107$20240111$20240721$20240721$PER$$US-NOVOPROD-1164113$NOVO NORDISK$$44$YR$$F$Y$$$20240721$$CN$US$US
241149811$24114981$1$I$$20240112$20240721$20240721$PER$$US-NOVOPROD-1163989$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149821$24114982$1$I$$20240112$20240721$20240721$PER$$US-NOVOPROD-1164810$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241149831$24114983$1$I$$20240408$20240721$20240721$PER$$US-NOVOPROD-1163165$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241149841$24114984$1$I$$20240110$20240721$20240721$PER$$US-NOVOPROD-1164858$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149851$24114985$1$I$20240103$20240110$20240721$20240721$PER$$US-NOVOPROD-1163780$NOVO NORDISK$$48$YR$$F$Y$$$20240721$$CN$US$US
241149861$24114986$1$I$$20240111$20240721$20240721$PER$$US-NOVOPROD-1164423$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241149871$24114987$1$I$20230328$20240117$20240721$20240721$PER$$US-NOVOPROD-1165212$NOVO NORDISK$$28$YR$$F$Y$$$20240721$$MD$US$US
241149881$24114988$1$I$20231231$20240117$20240721$20240721$PER$$US-NOVOPROD-1165232$NOVO NORDISK$$39$YR$$F$Y$$$20240721$$CN$US$US
241149891$24114989$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1165131$NOVO NORDISK$$$$$$Y$$$20240721$$HP$US$US
241149901$24114990$1$I$$20240116$20240721$20240721$PER$$US-NOVOPROD-1165595$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241149911$24114991$1$I$$20240116$20240721$20240721$PER$$US-NOVOPROD-1165419$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149921$24114992$1$I$$20240118$20240721$20240721$PER$$US-NOVOPROD-1165894$NOVO NORDISK$$48$YR$$M$Y$$$20240721$$CN$US$US
241149931$24114993$1$I$$20240119$20240721$20240721$PER$$US-NOVOPROD-1165701$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241149951$24114995$1$I$20240109$20240118$20240721$20240721$PER$$US-NOVOPROD-1165883$NOVO NORDISK$$49$YR$$F$Y$$$20240721$$HP$US$US
241149961$24114996$1$I$$20240223$20240721$20240721$PER$$US-NOVOPROD-1165473$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241149971$24114997$1$I$$20240114$20240721$20240721$PER$$US-NOVOPROD-1165480$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241149981$24114998$1$I$20240102$20240118$20240721$20240721$PER$$US-NOVOPROD-1165824$NOVO NORDISK$$41$YR$$F$Y$$$20240721$$CN$US$US
241149991$24114999$1$I$20240117$20240118$20240721$20240721$PER$$US-NOVOPROD-1165876$NOVO NORDISK$$48$YR$$F$Y$$$20240721$$CN$US$US
241150001$24115000$1$I$20231015$20240223$20240721$20240721$PER$$US-NOVOPROD-1166231$NOVO NORDISK$$38$YR$$M$Y$$$20240721$$CN$US$US
241150014$24115001$4$F$$20240105$20240721$20240721$PER$$US-NOVOPROD-1166284$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150021$24115002$1$I$$20240122$20240721$20240721$PER$$US-NOVOPROD-1169283$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150031$24115003$1$I$20230701$20240124$20240721$20240721$PER$$US-NOVOPROD-1167984$NOVO NORDISK$$$$A$M$Y$$$20240721$$HP$US$US
241150041$24115004$1$I$20231103$20240120$20240721$20240721$PER$$US-NOVOPROD-1168723$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150051$24115005$1$I$$20240119$20240721$20240721$PER$$US-NOVOPROD-1168127$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150061$24115006$1$I$$20240125$20240721$20240721$PER$$US-NOVOPROD-1168503$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150071$24115007$1$I$$20240118$20240721$20240721$PER$$US-NOVOPROD-1167360$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241150081$24115008$1$I$$20240125$20240721$20240721$PER$$US-NOVOPROD-1168614$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241150091$24115009$1$I$20230101$20240628$20240721$20240721$PER$$US-NOVOPROD-1167770$NOVO NORDISK$$76$YR$$F$Y$$$20240721$$CN$US$US
241150101$24115010$1$I$$20240119$20240721$20240721$PER$$US-NOVOPROD-1166425$NOVO NORDISK$$13$YR$$F$Y$$$20240721$$HP$US$US
241150111$24115011$1$I$$20240124$20240721$20240721$PER$$US-NOVOPROD-1168637$NOVO NORDISK$$56$YR$$F$Y$$$20240721$$HP$US$US
241150121$24115012$1$I$$20240119$20240721$20240721$PER$$US-NOVOPROD-1166871$NOVO NORDISK$$$$$M$Y$$$20240721$$MD$US$US
241150131$24115013$1$I$$20240125$20240721$20240721$PER$$US-NOVOPROD-1168606$NOVO NORDISK$$$$$M$Y$$$20240721$$MD$US$US
241150141$24115014$1$I$20240109$20240122$20240721$20240721$PER$$US-NOVOPROD-1167937$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241150151$24115015$1$I$$20240119$20240721$20240721$PER$$US-NOVOPROD-1167201$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241150161$24115016$1$I$20240116$20240117$20240721$20240721$PER$$US-NOVOPROD-1168114$NOVO NORDISK$$73$YR$$F$Y$$$20240721$$CN$US$US
241150171$24115017$1$I$$20240125$20240721$20240721$PER$$US-NOVOPROD-1168590$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241150181$24115018$1$I$$20240119$20240721$20240721$PER$$US-NOVOPROD-1166822$NOVO NORDISK$$$$A$F$Y$$$20240721$$HP$US$US
241150191$24115019$1$I$20230808$20240207$20240721$20240721$PER$$US-NOVOPROD-1166469$NOVO NORDISK$$51$YR$$F$Y$$$20240721$$CN$US$US
241150201$24115020$1$I$$20240119$20240721$20240721$PER$$US-NOVOPROD-1166819$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150212$24115021$2$F$20240121$20240327$20240721$20240721$PER$$US-NOVOPROD-1169322$NOVO NORDISK$$35$YR$$F$Y$$$20240721$$CN$US$US
241150221$24115022$1$I$$20240126$20240721$20240721$PER$$US-NOVOPROD-1170144$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241150231$24115023$1$I$20230410$20240220$20240721$20240721$PER$$US-NOVOPROD-1166451$NOVO NORDISK$$32$YR$$F$Y$$$20240721$$CN$US$US
241150241$24115024$1$I$20240101$20240304$20240721$20240721$PER$$US-NOVOPROD-1169670$NOVO NORDISK$$65$YR$$M$Y$$$20240721$$CN$US$US
241150251$24115025$1$I$$20240123$20240721$20240721$PER$$US-NOVOPROD-1169880$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150261$24115026$1$I$20240102$20240129$20240721$20240721$PER$$US-NOVOPROD-1171091$NOVO NORDISK$$29$YR$$F$Y$$$20240721$$HP$US$US
241150271$24115027$1$I$20231201$20240220$20240721$20240721$PER$$US-NOVOPROD-1169904$NOVO NORDISK$$51$YR$$F$Y$$$20240721$$CN$US$US
241150281$24115028$1$I$20240109$20240129$20240721$20240721$PER$$US-NOVOPROD-1170135$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150291$24115029$1$I$$20240113$20240721$20240721$PER$$US-NOVOPROD-1169545$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150301$24115030$1$I$$20240128$20240721$20240721$PER$$US-NOVOPROD-1171365$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241150311$24115031$1$I$$20230605$20240721$20240721$PER$$US-NOVOPROD-1169824$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241150321$24115032$1$I$20240121$20240122$20240721$20240721$PER$$US-NOVOPROD-1170244$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150331$24115033$1$I$20240125$20240126$20240721$20240721$PER$$US-NOVOPROD-1171404$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150342$24115034$2$F$$20240129$20240721$20240721$PER$$US-NOVOPROD-1171355$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150351$24115035$1$I$$20240126$20240721$20240721$PER$$US-NOVOPROD-1170529$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241150361$24115036$1$I$$20230612$20240721$20240721$PER$$US-NOVOPROD-1171022$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241150371$24115037$1$I$20240101$20240318$20240721$20240721$PER$$US-NOVOPROD-1171491$NOVO NORDISK$$55$YR$$M$Y$$$20240721$$CN$US$US
241150381$24115038$1$I$20240122$20240129$20240721$20240721$PER$$US-NOVOPROD-1170584$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
241150391$24115039$1$I$$20240130$20240721$20240721$PER$$US-NOVOPROD-1171050$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241150401$24115040$1$I$$20240130$20240721$20240721$PER$$US-NOVOPROD-1171191$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241150411$24115041$1$I$$20240129$20240721$20240721$PER$$US-NOVOPROD-1171283$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150421$24115042$1$I$$20240123$20240721$20240721$PER$$US-NOVOPROD-1170871$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241150431$24115043$1$I$20230728$20240226$20240721$20240721$PER$$US-NOVOPROD-1169524$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150441$24115044$1$I$$20240124$20240721$20240721$PER$$US-NOVOPROD-1170976$NOVO NORDISK$$36$YR$$M$Y$$$20240721$$MD$US$US
241150451$24115045$1$I$20240124$20240125$20240721$20240721$PER$$US-NOVOPROD-1169637$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241150461$24115046$1$I$$20230706$20240721$20240721$PER$$US-NOVOPROD-1171140$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241150471$24115047$1$I$$20240130$20240721$20240721$PER$$US-NOVOPROD-1171048$NOVO NORDISK$$$$$M$Y$$$20240721$$HP$US$US
241150481$24115048$1$I$$20240126$20240721$20240721$PER$$US-NOVOPROD-1169428$NOVO NORDISK$$$$$M$Y$$$20240721$$MD$US$US
241150501$24115050$1$I$20231103$20240123$20240721$20240721$PER$$US-NOVOPROD-1169925$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150511$24115051$1$I$20230901$20240123$20240721$20240721$PER$$US-NOVOPROD-1171573$NOVO NORDISK$$59$YR$$F$Y$$$20240721$$CN$US$US
241150521$24115052$1$I$20230726$20230727$20240721$20240721$PER$$US-NOVOPROD-1172434$NOVO NORDISK$$40$YR$$F$Y$$$20240721$$CN$US$US
241150531$24115053$1$I$$20240205$20240721$20240721$PER$$US-NOVOPROD-1173540$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150541$24115054$1$I$$20240201$20240721$20240721$PER$$US-NOVOPROD-1173589$NOVO NORDISK$$51$YR$$M$Y$$$20240721$$MD$US$US
241150552$24115055$2$F$$20230616$20240721$20240721$PER$$US-NOVOPROD-1173008$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241150561$24115056$1$I$$20240130$20240721$20240721$PER$$US-NOVOPROD-1173852$NOVO NORDISK$$47$YR$$F$Y$$$20240721$$CN$US$US
241150571$24115057$1$I$$20240131$20240721$20240721$PER$$US-NOVOPROD-1172245$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150581$24115058$1$I$$20240201$20240721$20240721$PER$$US-NOVOPROD-1172374$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150591$24115059$1$I$20231201$20240201$20240721$20240721$PER$$US-NOVOPROD-1172403$NOVO NORDISK$$39$YR$$M$Y$$$20240721$$CN$US$US
241150601$24115060$1$I$20230107$20240322$20240721$20240721$PER$$US-NOVOPROD-1173702$NOVO NORDISK$$38$YR$$F$Y$$$20240721$$CN$US$US
241150611$24115061$1$I$20240129$20240131$20240721$20240721$PER$$US-NOVOPROD-1172145$NOVO NORDISK$$45$YR$$F$Y$$$20240721$$CN$US$US
241150621$24115062$1$I$20240116$20240130$20240721$20240721$PER$$US-NOVOPROD-1172390$NOVO NORDISK$$58$YR$$F$Y$$$20240721$$CN$US$US
241150631$24115063$1$I$20240117$20240214$20240721$20240721$PER$$US-NOVOPROD-1172380$NOVO NORDISK$$55$YR$$F$Y$$$20240721$$CN$US$US
241150641$24115064$1$I$$20240201$20240721$20240721$PER$$US-NOVOPROD-1171904$NOVO NORDISK$$48$YR$$F$Y$$$20240721$$HP$US$US
241150651$24115065$1$I$$20240220$20240721$20240721$PER$$US-NOVOPROD-1171726$NOVO NORDISK$$62$YR$$F$Y$$$20240721$$CN$US$US
241150661$24115066$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1173734$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150671$24115067$1$I$20240117$20240223$20240721$20240721$PER$$US-NOVOPROD-1172398$NOVO NORDISK$$29$YR$$F$Y$$$20240721$$HP$US$US
241150681$24115068$1$I$20240203$20240205$20240721$20240721$PER$$US-NOVOPROD-1173034$NOVO NORDISK$$65$YR$$F$Y$$$20240721$$CN$US$US
241150692$24115069$2$F$20240205$20240206$20240721$20240721$PER$$US-NOVOPROD-1173996$NOVO NORDISK$$45$YR$$$Y$$$20240721$$CN$US$US
241150701$24115070$1$I$20240115$20240127$20240721$20240721$PER$$US-NOVOPROD-1171728$NOVO NORDISK$$39$YR$$F$Y$$$20240721$$CN$US$US
241150711$24115071$1$I$$20240201$20240721$20240721$PER$$US-NOVOPROD-1172929$NOVO NORDISK$$38$YR$$M$Y$$$20240721$$HP$US$US
241150721$24115072$1$I$$20240201$20240721$20240721$PER$$US-NOVOPROD-1172626$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241150731$24115073$1$I$$20240630$20240721$20240721$PER$$US-NOVOPROD-1172900$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150741$24115074$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1173007$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150751$24115075$1$I$$20240207$20240721$20240721$PER$$US-NOVOPROD-1175311$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150761$24115076$1$I$20240201$20240206$20240721$20240721$PER$$US-NOVOPROD-1175212$NOVO NORDISK$$34$YR$$F$Y$$$20240721$$CN$US$US
241150771$24115077$1$I$$20240116$20240721$20240721$PER$$US-NOVOPROD-1174798$NOVO NORDISK$$45$YR$$F$Y$$$20240721$$CN$US$US
241150781$24115078$1$I$$20230608$20240721$20240721$PER$$US-NOVOPROD-1175253$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150791$24115079$1$I$$20240208$20240721$20240721$PER$$US-NOVOPROD-1174952$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241150801$24115080$1$I$$20240213$20240721$20240721$PER$$US-NOVOPROD-1176500$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241150811$24115081$1$I$$20240205$20240721$20240721$PER$$US-NOVOPROD-1174641$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241150821$24115082$1$I$$20240124$20240721$20240721$PER$$US-NOVOPROD-1169262$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241150831$24115083$1$I$$20240124$20240721$20240721$PER$$US-NOVOPROD-1169015$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241150841$24115084$1$I$20231122$20240220$20240721$20240721$PER$$US-NOVOPROD-1174364$NOVO NORDISK$$29$YR$$F$Y$$$20240721$$CN$US$US
241150851$24115085$1$I$20240205$20240415$20240721$20240721$PER$$US-NOVOPROD-1174831$NOVO NORDISK$$45$YR$$F$Y$$$20240721$$CN$US$US
241150861$24115086$1$I$20230929$20240215$20240721$20240721$PER$$US-NOVOPROD-1176082$NOVO NORDISK$$26$YR$$F$Y$$$20240721$$CN$US$US
241150871$24115087$1$I$$20240311$20240721$20240721$PER$$US-NOVOPROD-1176307$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150881$24115088$1$I$20240131$20240211$20240721$20240721$PER$$US-NOVOPROD-1175910$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
241150891$24115089$1$I$$20240210$20240721$20240721$PER$$US-NOVOPROD-1175334$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241150901$24115090$1$I$$20240208$20240721$20240721$PER$$US-NOVOPROD-1175913$NOVO NORDISK$$$$$M$Y$$$20240721$$HP$US$US
241150911$24115091$1$I$20240121$20240130$20240721$20240721$PER$$US-NOVOPROD-1168732$NOVO NORDISK$$14$YR$$F$Y$$$20240721$$CN$US$US
241150921$24115092$1$I$$20240204$20240721$20240721$PER$$US-NOVOPROD-1174069$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150931$24115093$1$I$$20240206$20240721$20240721$PER$$US-NOVOPROD-1175787$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241150941$24115094$1$I$$20240205$20240721$20240721$PER$$US-NOVOPROD-1174230$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241150951$24115095$1$I$20230809$20230809$20240721$20240721$PER$$US-NOVOPROD-1174617$NOVO NORDISK$$37$YR$$M$Y$$$20240721$$CN$US$US
241150961$24115096$1$I$20231009$20240205$20240721$20240721$PER$$US-NOVOPROD-1175482$NOVO NORDISK$$53$YR$$M$Y$$$20240721$$CN$US$US
241150971$24115097$1$I$$20240205$20240721$20240721$PER$$US-NOVOPROD-1175205$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150981$24115098$1$I$20231004$20240211$20240721$20240721$PER$$US-NOVOPROD-1176078$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241150991$24115099$1$I$$20240123$20240721$20240721$PER$$US-NOVOPROD-1169174$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151001$24115100$1$I$$20230804$20240721$20240721$PER$$US-NOVOPROD-1176548$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151011$24115101$1$I$20230101$20240222$20240721$20240721$PER$$US-NOVOPROD-1182286$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241151021$24115102$1$I$20240223$20240223$20240721$20240721$PER$$US-NOVOPROD-1182108$NOVO NORDISK$$44$YR$$F$Y$$$20240721$$CN$US$US
241151031$24115103$1$I$$20240627$20240721$20240721$PER$$US-NOVOPROD-1165351$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151041$24115104$1$I$$20240225$20240721$20240721$PER$$US-NOVOPROD-1183566$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151051$24115105$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1182680$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151061$24115106$1$I$$20240503$20240721$20240721$PER$$US-NOVOPROD-1183415$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241151071$24115107$1$I$$20240222$20240721$20240721$PER$$US-NOVOPROD-1182181$NOVO NORDISK$$$$A$F$Y$$$20240721$$MD$US$US
241151081$24115108$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1181932$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151091$24115109$1$I$$20240223$20240721$20240721$PER$$US-NOVOPROD-1183500$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151101$24115110$1$I$$20240701$20240721$20240721$PER$$US-NOVOPROD-1165335$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151111$24115111$1$I$$20240318$20240721$20240721$PER$$US-NOVOPROD-1181831$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151122$24115112$2$F$20231101$20240223$20240721$20240721$PER$$US-NOVOPROD-1183495$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151131$24115113$1$I$20240221$20240222$20240721$20240721$PER$$US-NOVOPROD-1183435$NOVO NORDISK$$34$YR$$F$Y$$$20240721$$CN$US$US
241151141$24115114$1$I$20230101$20240221$20240721$20240721$PER$$US-NOVOPROD-1181942$NOVO NORDISK$$43$YR$$F$Y$$$20240721$$CN$US$US
241151151$24115115$1$I$$20240113$20240721$20240721$PER$$US-NOVOPROD-1165346$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241151161$24115116$1$I$20240101$20240226$20240721$20240721$PER$$US-NOVOPROD-1183534$NOVO NORDISK$$41$YR$$F$Y$$$20240721$$CN$US$US
241151171$24115117$1$I$20240130$20240222$20240721$20240721$PER$$US-NOVOPROD-1182728$NOVO NORDISK$$52$YR$$F$Y$$$20240721$$CN$US$US
241151181$24115118$1$I$$20240221$20240721$20240721$PER$$US-NOVOPROD-1182097$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151191$24115119$1$I$$20240223$20240721$20240721$PER$$US-NOVOPROD-1183499$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151201$24115120$1$I$20240218$20240222$20240721$20240721$PER$$US-NOVOPROD-1181776$NOVO NORDISK$$74$YR$$F$Y$$$20240721$$CN$US$US
241151211$24115121$1$I$$20240222$20240721$20240721$PER$$US-NOVOPROD-1181944$NOVO NORDISK$$$$$$Y$$$20240721$$HP$US$US
241151221$24115122$1$I$$20240221$20240721$20240721$PER$$US-NOVOPROD-1181967$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241151231$24115123$1$I$$20240226$20240721$20240721$PER$$US-NOVOPROD-1184315$NOVO NORDISK$$30$YR$$F$Y$$$20240721$$CN$US$US
241151242$24115124$2$F$20231227$20240227$20240721$20240721$PER$$US-NOVOPROD-1184839$NOVO NORDISK$$62$YR$$F$Y$$$20240721$$CN$US$US
241151251$24115125$1$I$20240218$20240408$20240721$20240721$PER$$US-NOVOPROD-1183667$NOVO NORDISK$$62$YR$$F$Y$118.6$KG$20240721$$HP$US$US
241151261$24115126$1$I$20240212$20240320$20240721$20240721$PER$$US-NOVOPROD-1183813$NOVO NORDISK$$79$YR$$M$Y$$$20240721$$CN$US$US
241151271$24115127$1$I$$20230608$20240721$20240721$PER$$US-NOVOPROD-1184881$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241151283$24115128$3$F$20231214$20240223$20240721$20240721$PER$$US-NOVOPROD-1184427$NOVO NORDISK$$42$YR$$F$Y$$$20240721$$CN$US$US
241151291$24115129$1$I$$20240228$20240721$20240721$PER$$US-NOVOPROD-1184470$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241151301$24115130$1$I$20231001$20240320$20240721$20240721$PER$$US-NOVOPROD-1184449$NOVO NORDISK$$31$YR$$F$Y$$$20240721$$CN$US$US
241151311$24115131$1$I$20230501$20240329$20240721$20240721$PER$$US-NOVOPROD-1185155$NOVO NORDISK$$44$YR$$$Y$$$20240721$$MD$US$US
241151321$24115132$1$I$$20230602$20240721$20240721$PER$$US-NOVOPROD-1184996$NOVO NORDISK$$22$YR$$F$Y$$$20240721$$CN$US$US
241151331$24115133$1$I$20231201$20240329$20240721$20240721$PER$$US-NOVOPROD-1185156$NOVO NORDISK$$40$YR$$$Y$$$20240721$$MD$US$US
241151341$24115134$1$I$$20240226$20240721$20240721$PER$$US-NOVOPROD-1183825$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241151351$24115135$1$I$20240223$20240301$20240721$20240721$PER$$US-NOVOPROD-1184782$NOVO NORDISK$$21$YR$$F$Y$$$20240721$$CN$US$US
241151361$24115136$1$I$20240225$20240226$20240721$20240721$PER$$US-NOVOPROD-1185072$NOVO NORDISK$$25$YR$$F$Y$$$20240721$$CN$US$US
241151371$24115137$1$I$$20240226$20240721$20240721$PER$$US-NOVOPROD-1185136$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241151383$24115138$3$F$$20240401$20240721$20240721$PER$$US-NOVOPROD-1185533$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151391$24115139$1$I$$20240229$20240721$20240721$PER$$US-NOVOPROD-1186150$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241151402$24115140$2$F$20230601$20240226$20240721$20240721$PER$$US-NOVOPROD-1185468$NOVO NORDISK$$43$YR$$F$Y$$$20240721$$CN$US$US
241151411$24115141$1$I$$20240122$20240721$20240721$PER$$US-NOVOPROD-1185950$NOVO NORDISK$$31$YR$$F$Y$$$20240721$$CN$US$US
241151421$24115142$1$I$$20240228$20240721$20240721$PER$$US-NOVOPROD-1185705$NOVO NORDISK$$49$YR$$F$Y$$$20240721$$HP$US$US
241151431$24115143$1$I$$20240326$20240721$20240721$PER$$US-NOVOPROD-1176590$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151441$24115144$1$I$$20240209$20240721$20240721$PER$$US-NOVOPROD-1176740$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151451$24115145$1$I$$20230607$20240721$20240721$PER$$US-NOVOPROD-1185706$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241151461$24115146$1$I$$20240426$20240721$20240721$PER$$US-NOVOPROD-1175883$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151471$24115147$1$I$$20240325$20240721$20240721$PER$$US-NOVOPROD-1186237$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151481$24115148$1$I$20230401$20240220$20240721$20240721$PER$$US-NOVOPROD-1186000$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
241151492$24115149$2$F$$20240305$20240721$20240721$PER$$US-NOVOPROD-1185616$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151501$24115150$1$I$20240207$20240430$20240721$20240721$PER$$US-NOVOPROD-1175815$NOVO NORDISK$$49$YR$$F$Y$$$20240721$$CN$US$US
241151511$24115151$1$I$20240201$20240227$20240721$20240721$PER$$US-NOVOPROD-1185562$NOVO NORDISK$$37$YR$$F$Y$$$20240721$$CN$US$US
241151521$24115152$1$I$$20240126$20240721$20240721$PER$$US-NOVOPROD-1186411$NOVO NORDISK$$$$A$$Y$$$20240721$$CN$US$US
241151531$24115153$1$I$$20240309$20240721$20240721$PER$$US-NOVOPROD-1185649$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151541$24115154$1$I$20230926$20240215$20240721$20240721$PER$$US-NOVOPROD-1178629$NOVO NORDISK$$43$YR$$F$Y$$$20240721$$CN$US$US
241151551$24115155$1$I$20230101$20230721$20240721$20240721$PER$$US-NOVOPROD-1178523$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241151561$24115156$1$I$20240119$20240214$20240721$20240721$PER$$US-NOVOPROD-1178116$NOVO NORDISK$$69$YR$$F$Y$$$20240721$$MD$US$US
241151571$24115157$1$I$$20240206$20240721$20240721$PER$$US-NOVOPROD-1177373$NOVO NORDISK$$$$$$Y$$$20240721$$MD$US$US
241151582$24115158$2$F$20230501$20240520$20240721$20240721$PER$$US-NOVOPROD-1176944$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$CN$US$US
241151591$24115159$1$I$$20240118$20240721$20240721$PER$$US-NOVOPROD-1178457$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241151601$24115160$1$I$$20240426$20240721$20240721$PER$$US-NOVOPROD-1177729$NOVO NORDISK$$30$YR$$F$Y$$$20240721$$CN$US$US
241151611$24115161$1$I$$20240210$20240721$20240721$PER$$US-NOVOPROD-1177081$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241151621$24115162$1$I$20240201$20240214$20240721$20240721$PER$$US-NOVOPROD-1178136$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241151631$24115163$1$I$$20240304$20240721$20240721$PER$$US-NOVOPROD-1178496$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151641$24115164$1$I$20240110$20240212$20240721$20240721$PER$$US-NOVOPROD-1177809$NOVO NORDISK$$24$YR$$F$Y$$$20240721$$CN$US$US
241151651$24115165$1$I$$20240212$20240721$20240721$PER$$US-NOVOPROD-1177656$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241151661$24115166$1$I$$20240212$20240721$20240721$PER$$US-NOVOPROD-1176962$NOVO NORDISK$$56$YR$$M$Y$$$20240721$$HP$US$US
241151671$24115167$1$I$$20240212$20240721$20240721$PER$$US-NOVOPROD-1176967$NOVO NORDISK$$31$YR$$F$Y$$$20240721$$CN$US$US
241151681$24115168$1$I$$20240212$20240721$20240721$PER$$US-NOVOPROD-1178232$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151691$24115169$1$I$$20240213$20240721$20240721$PER$$US-NOVOPROD-1178284$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151701$24115170$1$I$20231201$20240213$20240721$20240721$PER$$US-NOVOPROD-1177665$NOVO NORDISK$$63$YR$$M$Y$$$20240721$$CN$US$US
241151711$24115171$1$I$20240208$20240212$20240721$20240721$PER$$US-NOVOPROD-1177182$NOVO NORDISK$$48$YR$$F$Y$$$20240721$$CN$US$US
241151721$24115172$1$I$$20240213$20240721$20240721$PER$$US-NOVOPROD-1178476$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241151731$24115173$1$I$20240211$20240325$20240721$20240721$PER$$US-NOVOPROD-1176968$NOVO NORDISK$$54$YR$$F$Y$$$20240721$$CN$US$US
241151741$24115174$1$I$$20240213$20240721$20240721$PER$$US-NOVOPROD-1178671$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241151751$24115175$1$I$20231001$20240307$20240721$20240721$PER$$US-NOVOPROD-1177624$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241151761$24115176$1$I$20240701$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407010365$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240721$$CN$US$US
241151771$24115177$1$I$$20240219$20240721$20240721$PER$$US-NOVOPROD-1180029$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241151781$24115178$1$I$$20240217$20240721$20240721$PER$$US-NOVOPROD-1180292$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151791$24115179$1$I$20240215$20240216$20240721$20240721$PER$$US-NOVOPROD-1179253$NOVO NORDISK$$39$YR$$F$Y$$$20240721$$CN$US$US
241151801$24115180$1$I$$20240214$20240721$20240721$PER$$US-NOVOPROD-1179864$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241151811$24115181$1$I$20240208$20240216$20240721$20240721$PER$$US-NOVOPROD-1179113$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151821$24115182$1$I$20240201$20240222$20240721$20240721$PER$$US-NOVOPROD-1178992$NOVO NORDISK$$46$YR$$F$Y$$$20240721$$CN$US$US
241151831$24115183$1$I$$20240214$20240721$20240721$PER$$US-NOVOPROD-1178886$NOVO NORDISK$$22$YR$$F$Y$$$20240721$$MD$US$US
241151841$24115184$1$I$20230711$20240214$20240721$20240721$PER$$US-NOVOPROD-1179304$NOVO NORDISK$$59$YR$$F$Y$$$20240721$$HP$US$US
241151851$24115185$1$I$20240212$20240215$20240721$20240721$PER$$US-NOVOPROD-1179057$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241151861$24115186$1$I$$20240311$20240721$20240721$PER$$US-NOVOPROD-1179824$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151871$24115187$1$I$20221107$20240229$20240721$20240721$PER$$US-NOVOPROD-1179220$NOVO NORDISK$$44$YR$$F$Y$$$20240721$$CN$US$US
241151881$24115188$1$I$20240221$20240308$20240721$20240721$PER$$US-NOVOPROD-1178693$NOVO NORDISK$$54$YR$$F$Y$$$20240721$$CN$US$US
241151891$24115189$1$I$$20240220$20240721$20240721$PER$$US-NOVOPROD-1180049$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241151901$24115190$1$I$$20240216$20240721$20240721$PER$$US-NOVOPROD-1179095$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241151911$24115191$1$I$$20230614$20240721$20240721$PER$$US-NOVOPROD-1180011$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151921$24115192$1$I$$20240214$20240721$20240721$PER$$US-NOVOPROD-1179175$NOVO NORDISK$$25$YR$$F$Y$$$20240721$$HP$US$US
241151931$24115193$1$I$$20240304$20240721$20240721$PER$$US-NOVOPROD-1179358$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151941$24115194$1$I$$20240117$20240721$20240721$PER$$US-NOVOPROD-1179728$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241151951$24115195$1$I$20230421$20240304$20240721$20240721$PER$$US-NOVOPROD-1179743$NOVO NORDISK$$59$YR$$M$Y$$$20240721$$MD$US$US
241151961$24115196$1$I$$20240219$20240721$20240721$PER$$US-NOVOPROD-1180198$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241151971$24115197$1$I$20240220$20240404$20240721$20240721$PER$$US-NOVOPROD-1180157$NOVO NORDISK$$78$YR$$F$Y$$$20240721$$CN$US$US
241151981$24115198$1$I$20240101$20240215$20240721$20240721$PER$$US-NOVOPROD-1179691$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241151992$24115199$2$F$20240710$20240718$20240721$20240726$EXP$$AU-BAXTER-2024BAX021536$BAXTER$$60$YR$$F$Y$94.6$KG$20240726$$HP$AU$AU
241152001$24115200$1$I$$20240711$20240721$20240721$EXP$$CA-BAXTER-2024BAX021586$BAXTER$$48$YR$$F$Y$68$KG$20240721$$HP$CA$CA
241152021$24115202$1$I$20230901$20240411$20240721$20240721$PER$$US-NOVOPROD-1186418$NOVO NORDISK$$63$YR$$M$Y$$$20240721$$CN$US$US
241152031$24115203$1$I$20240221$20240415$20240721$20240721$PER$$US-NOVOPROD-1186978$NOVO NORDISK$$60$YR$$F$Y$$$20240721$$CN$US$US
241152041$24115204$1$I$20240101$20240701$20240721$20240721$PER$$US-NOVOPROD-1180866$NOVO NORDISK$$57$YR$$F$Y$$$20240721$$CN$US$US
241152051$24115205$1$I$$20240213$20240721$20240721$PER$$US-NOVOPROD-1181646$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241152061$24115206$1$I$$20240227$20240721$20240721$PER$$US-NOVOPROD-1187019$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152071$24115207$1$I$$20240216$20240721$20240721$PER$$US-NOVOPROD-1181148$NOVO NORDISK$$$$$M$Y$$$20240721$$MD$US$US
241152081$24115208$1$I$$20240304$20240721$20240721$PER$$US-NOVOPROD-1186797$NOVO NORDISK$$43$YR$$F$Y$$$20240721$$CN$US$US
241152091$24115209$1$I$$20240221$20240721$20240721$PER$$US-NOVOPROD-1181574$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241152101$24115210$1$I$20240215$20240218$20240721$20240721$PER$$US-NOVOPROD-1180956$NOVO NORDISK$$52$YR$$M$Y$$$20240721$$CN$US$US
241152111$24115211$1$I$$20230815$20240721$20240721$PER$$US-NOVOPROD-1181413$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152121$24115212$1$I$$20240221$20240721$20240721$PER$$US-NOVOPROD-1181570$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152132$24115213$2$F$20240110$20240417$20240721$20240721$PER$$US-NOVOPROD-1180346$NOVO NORDISK$$46$YR$$F$Y$$$20240721$$HP$US$US
241152141$24115214$1$I$$20240219$20240721$20240721$PER$$US-NOVOPROD-1180977$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241152151$24115215$1$I$$20240221$20240721$20240721$PER$$US-NOVOPROD-1181135$NOVO NORDISK$$$$A$$Y$$$20240721$$CN$US$US
241152161$24115216$1$I$$20240304$20240721$20240721$PER$$US-NOVOPROD-1186845$NOVO NORDISK$$$$$$Y$$$20240721$$HP$US$US
241152171$24115217$1$I$20240202$20240212$20240721$20240721$PER$$US-NOVOPROD-1180297$NOVO NORDISK$$33$YR$$F$Y$$$20240721$$CN$US$US
241152181$24115218$1$I$$20240301$20240721$20240721$PER$$US-NOVOPROD-1186938$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152191$24115219$1$I$20231121$20240219$20240721$20240721$PER$$US-NOVOPROD-1180864$NOVO NORDISK$$46$YR$$F$Y$$$20240721$$CN$US$US
241152201$24115220$1$I$20240210$20240216$20240721$20240721$PER$$US-NOVOPROD-1180457$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152211$24115221$1$I$20240201$20240214$20240721$20240721$PER$$US-NOVOPROD-1180933$NOVO NORDISK$$44$YR$$F$Y$$$20240721$$CN$US$US
241152221$24115222$1$I$$20240229$20240721$20240721$PER$$US-NOVOPROD-1186790$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241152231$24115223$1$I$20240210$20240303$20240721$20240721$PER$$US-NOVOPROD-1186472$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241152241$24115224$1$I$20240323$20240324$20240721$20240721$PER$$US-NOVOPROD-1196895$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152251$24115225$1$I$20240220$20240305$20240721$20240721$PER$$US-NOVOPROD-1187324$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152261$24115226$1$I$20240101$20240304$20240721$20240721$PER$$US-NOVOPROD-1187053$NOVO NORDISK$$60$YR$$M$Y$$$20240721$$CN$US$US
241152271$24115227$1$I$$20240319$20240721$20240721$PER$$US-NOVOPROD-1196603$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241152281$24115228$1$I$$20240320$20240721$20240721$PER$$US-NOVOPROD-1196787$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241152291$24115229$1$I$$20240321$20240721$20240721$PER$$US-NOVOPROD-1196961$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241152301$24115230$1$I$20240319$20240322$20240721$20240721$PER$$US-NOVOPROD-1196663$NOVO NORDISK$$48$YR$$F$Y$$$20240721$$CN$US$US
241152311$24115231$1$I$20230728$20240417$20240721$20240721$PER$$US-NOVOPROD-1187200$NOVO NORDISK$$29$YR$$F$Y$$$20240721$$CN$US$US
241152323$24115232$3$F$20231001$20240313$20240721$20240721$PER$$US-NOVOPROD-1187103$NOVO NORDISK$$50$YR$$F$Y$$$20240721$$CN$US$US
241152331$24115233$1$I$$20240326$20240721$20240721$PER$$US-NOVOPROD-1197674$NOVO NORDISK$$39$YR$$F$Y$$$20240721$$CN$US$US
241152341$24115234$1$I$20240302$20240506$20240721$20240721$PER$$US-NOVOPROD-1196513$NOVO NORDISK$$45$YR$$M$Y$$$20240721$$CN$US$US
241152351$24115235$1$I$20230901$20240320$20240721$20240721$PER$$US-NOVOPROD-1196268$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
241152361$24115236$1$I$$20240301$20240721$20240721$PER$$US-NOVOPROD-1187152$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241152371$24115237$1$I$20240311$20240322$20240721$20240721$PER$$US-NOVOPROD-1197029$NOVO NORDISK$$52$YR$$F$Y$$$20240721$$CN$US$US
241152381$24115238$1$I$20240101$20240326$20240721$20240721$PER$$US-NOVOPROD-1197883$NOVO NORDISK$$51$YR$$F$Y$$$20240721$$CN$US$US
241152391$24115239$1$I$20240101$20240306$20240721$20240721$PER$$US-NOVOPROD-1187583$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
241152401$24115240$1$I$$20240318$20240721$20240721$PER$$US-NOVOPROD-1196808$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152411$24115241$1$I$$20240320$20240721$20240721$PER$$US-NOVOPROD-1196865$NOVO NORDISK$$$$$M$Y$$$20240721$$PH$US$US
241152421$24115242$1$I$$20240322$20240721$20240721$PER$$US-NOVOPROD-1197856$NOVO NORDISK$$54$YR$$F$Y$$$20240721$$CN$US$US
241152431$24115243$1$I$20240101$20240326$20240721$20240721$PER$$US-NOVOPROD-1200314$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152441$24115244$1$I$$20240323$20240721$20240721$PER$$US-NOVOPROD-1197962$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152451$24115245$1$I$$20240328$20240721$20240721$PER$$US-NOVOPROD-1199046$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241152461$24115246$1$I$$20230628$20240721$20240721$PER$$US-NOVOPROD-1201908$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241152471$24115247$1$I$20240221$20240327$20240721$20240721$PER$$US-NOVOPROD-1200309$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$CN$US$US
241152481$24115248$1$I$$20240327$20240721$20240721$PER$$US-NOVOPROD-1200407$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241152491$24115249$1$I$20240330$20240401$20240721$20240721$PER$$US-NOVOPROD-1201886$NOVO NORDISK$$66$YR$$F$Y$$$20240721$$CN$US$US
241152501$24115250$1$I$20240101$20240331$20240721$20240721$PER$$US-NOVOPROD-1201973$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152511$24115251$1$I$20240326$20240402$20240721$20240721$PER$$US-NOVOPROD-1201664$NOVO NORDISK$$56$YR$$M$Y$$$20240721$$CN$US$US
241152521$24115252$1$I$20230301$20240326$20240721$20240721$PER$$US-NOVOPROD-1199274$NOVO NORDISK$$65$YR$$M$Y$$$20240721$$CN$US$US
241152531$24115253$1$I$20240317$20240326$20240721$20240721$PER$$US-NOVOPROD-1199076$NOVO NORDISK$$44$YR$$F$Y$$$20240721$$CN$US$US
241152541$24115254$1$I$20240101$20240327$20240721$20240721$PER$$US-NOVOPROD-1199157$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$CN$US$US
241152551$24115255$1$I$$20240327$20240721$20240721$PER$$US-NOVOPROD-1199123$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241152561$24115256$1$I$$20230616$20240721$20240721$PER$$US-NOVOPROD-1201394$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241152571$24115257$1$I$$20230614$20240721$20240721$PER$$US-NOVOPROD-1200850$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241152581$24115258$1$I$$20240401$20240721$20240721$PER$$US-NOVOPROD-1200408$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241152591$24115259$1$I$20240313$20240329$20240721$20240721$PER$$US-NOVOPROD-1201666$NOVO NORDISK$$$$$M$Y$$$20240721$$HP$US$US
241152601$24115260$1$I$20240403$20240405$20240721$20240721$PER$$US-NOVOPROD-1202023$NOVO NORDISK$$46$YR$$F$Y$$$20240721$$HP$US$US
241152611$24115261$1$I$$20240326$20240721$20240721$PER$$US-NOVOPROD-1198361$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152621$24115262$1$I$20230601$20240326$20240721$20240721$PER$$US-NOVOPROD-1198591$NOVO NORDISK$$63$YR$$F$Y$$$20240721$$CN$US$US
241152631$24115263$1$I$20240307$20240326$20240721$20240721$PER$$US-NOVOPROD-1197891$NOVO NORDISK$$44$YR$$M$Y$$$20240721$$CN$US$US
241152641$24115264$1$I$$20240329$20240721$20240721$PER$$US-NOVOPROD-1199840$NOVO NORDISK$$56$YR$$F$Y$$$20240721$$MD$US$US
241152651$24115265$1$I$20240326$20240326$20240721$20240721$PER$$US-NOVOPROD-1199575$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241152661$24115266$1$I$20230604$20240426$20240721$20240721$PER$$US-NOVOPROD-1201112$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241152671$24115267$1$I$$20240401$20240721$20240721$PER$$US-NOVOPROD-1203628$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152681$24115268$1$I$$20240329$20240721$20240721$PER$$US-NOVOPROD-1202478$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152691$24115269$1$I$$20240402$20240721$20240721$PER$$US-NOVOPROD-1202107$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241152701$24115270$1$I$20231001$20240401$20240721$20240721$PER$$US-NOVOPROD-1203181$NOVO NORDISK$$50$YR$$M$Y$$$20240721$$CN$US$US
241152711$24115271$1$I$20240401$20240404$20240721$20240721$PER$$US-NOVOPROD-1202495$NOVO NORDISK$$42$YR$$F$Y$$$20240721$$HP$US$US
241152721$24115272$1$I$$20240401$20240721$20240721$PER$$US-NOVOPROD-1203144$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241152731$24115273$1$I$$20240401$20240721$20240721$PER$$US-NOVOPROD-1203632$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152741$24115274$1$I$$20230606$20240721$20240721$PER$$US-NOVOPROD-1202929$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241152751$24115275$1$I$$20230630$20240721$20240721$PER$$US-NOVOPROD-1203352$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241152761$24115276$1$I$$20230626$20240721$20240721$PER$$US-NOVOPROD-1203796$NOVO NORDISK$$57$YR$$F$Y$$$20240721$$CN$US$US
241152771$24115277$1$I$20240314$20240401$20240721$20240721$PER$$US-NOVOPROD-1203531$NOVO NORDISK$$67$YR$$F$Y$$$20240721$$CN$US$US
241152781$24115278$1$I$$20230705$20240721$20240721$PER$$US-NOVOPROD-1203013$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241152791$24115279$1$I$$20230728$20240721$20240721$PER$$US-NOVOPROD-1203020$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152801$24115280$1$I$20240331$20240410$20240721$20240721$PER$$US-NOVOPROD-1203636$NOVO NORDISK$$18$YR$$F$Y$$$20240721$$CN$US$US
241152811$24115281$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1202521$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152821$24115282$1$I$$20240403$20240721$20240721$PER$$US-NOVOPROD-1202662$NOVO NORDISK$$42$YR$$F$Y$$$20240721$$HP$US$US
241152831$24115283$1$I$$20230607$20240721$20240721$PER$$US-NOVOPROD-1202144$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152841$24115284$1$I$20240327$20240402$20240721$20240721$PER$$US-NOVOPROD-1203670$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$CN$US$US
241152851$24115285$1$I$$20230622$20240721$20240721$PER$$US-NOVOPROD-1202705$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241152861$24115286$1$I$20240401$20240401$20240721$20240721$PER$$US-NOVOPROD-1203405$NOVO NORDISK$$46$YR$$F$Y$$$20240721$$CN$US$US
241152871$24115287$1$I$$20230703$20240721$20240721$PER$$US-NOVOPROD-1202226$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241152881$24115288$1$I$20240403$20240405$20240721$20240721$PER$$US-NOVOPROD-1202825$NOVO NORDISK$$16$YR$$F$Y$$$20240721$$CN$US$US
241152892$24115289$2$F$$20230616$20240721$20240721$PER$$US-NOVOPROD-1203880$NOVO NORDISK$$$YR$$$Y$$$20240721$$CN$US$US
241152901$24115290$1$I$20240101$20240717$20240721$20240721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113954$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240721$$HP$US$US
241152911$24115291$1$I$$20240422$20240721$20240721$PER$$US-NOVOPROD-1205085$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241152921$24115292$1$I$20230101$20230607$20240721$20240721$PER$$US-NOVOPROD-1204292$NOVO NORDISK$$54$YR$$F$Y$$$20240721$$CN$US$US
241152931$24115293$1$I$$20230609$20240721$20240721$PER$$US-NOVOPROD-1204316$NOVO NORDISK$$46$YR$$M$Y$$$20240721$$CN$US$US
241152943$24115294$3$F$20230101$20240402$20240721$20240721$PER$$US-NOVOPROD-1205033$NOVO NORDISK$$36$YR$$F$Y$$$20240721$$CN$US$US
241152951$24115295$1$I$$20230612$20240721$20240721$PER$$US-NOVOPROD-1205193$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241152961$24115296$1$I$20240101$20240329$20240721$20240721$PER$$US-NOVOPROD-1204272$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152971$24115297$1$I$20240404$20240405$20240721$20240721$PER$$US-NOVOPROD-1204832$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241152981$24115298$1$I$20240331$20240409$20240721$20240721$PER$$US-NOVOPROD-1203936$NOVO NORDISK$$53$YR$$M$Y$$$20240721$$CN$US$US
241152991$24115299$1$I$$20240401$20240721$20240721$PER$$US-NOVOPROD-1204894$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241153001$24115300$1$I$20240101$20240405$20240721$20240721$PER$$US-NOVOPROD-1205229$NOVO NORDISK$$75$YR$$M$Y$$$20240721$$CN$US$US
241153011$24115301$1$I$$20230608$20240721$20240721$PER$$US-NOVOPROD-1205412$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241153021$24115302$1$I$$20240402$20240721$20240721$PER$$US-NOVOPROD-1204122$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153031$24115303$1$I$$20240402$20240721$20240721$PER$$US-NOVOPROD-1203974$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153041$24115304$1$I$20230620$20230621$20240721$20240721$PER$$US-NOVOPROD-1204673$NOVO NORDISK$$64$YR$$F$Y$$$20240721$$CN$US$US
241153052$24115305$2$F$20240101$20240524$20240721$20240721$PER$$US-NOVOPROD-1203932$NOVO NORDISK$$56$YR$$F$Y$$$20240721$$CN$US$US
241153061$24115306$1$I$20240101$20240604$20240721$20240721$PER$$US-NOVOPROD-1203975$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153071$24115307$1$I$20240325$20240507$20240721$20240721$PER$$US-NOVOPROD-1205145$NOVO NORDISK$$25$YR$$F$Y$171.7$KG$20240721$$MD$US$US
241153081$24115308$1$I$$20230629$20240721$20240721$PER$$US-NOVOPROD-1204614$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241153091$24115309$1$I$20240101$20240426$20240721$20240721$PER$$US-NOVOPROD-1207101$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241153101$24115310$1$I$$20240425$20240721$20240721$PER$$US-NOVOPROD-1216362$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153111$24115311$1$I$$20240403$20240721$20240721$PER$$US-NOVOPROD-1206055$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153121$24115312$1$I$20231001$20240416$20240721$20240721$PER$$US-NOVOPROD-1208526$NOVO NORDISK$$50$YR$$F$Y$$$20240721$$MD$US$US
241153131$24115313$1$I$20240409$20240410$20240721$20240721$PER$$US-NOVOPROD-1205683$NOVO NORDISK$$69$YR$$F$Y$$$20240721$$CN$US$US
241153141$24115314$1$I$20240324$20240406$20240721$20240721$PER$$US-NOVOPROD-1207497$NOVO NORDISK$$69$YR$$F$Y$$$20240721$$CN$US$US
241153151$24115315$1$I$20240401$20240529$20240721$20240721$PER$$US-NOVOPROD-1215741$NOVO NORDISK$$65$YR$$F$Y$180$KG$20240721$$MD$US$US
241153161$24115316$1$I$$20240404$20240721$20240721$PER$$US-NOVOPROD-1207633$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241153171$24115317$1$I$$20240515$20240721$20240721$PER$$US-NOVOPROD-1206609$NOVO NORDISK$$65$YR$$F$Y$$$20240721$$CN$US$US
241153181$24115318$1$I$$20240426$20240721$20240721$PER$$US-NOVOPROD-1216286$NOVO NORDISK$$45$YR$$M$Y$$$20240721$$HP$US$US
241153191$24115319$1$I$$20240403$20240721$20240721$PER$$US-NOVOPROD-1206233$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153201$24115320$1$I$$20240423$20240721$20240721$PER$$US-NOVOPROD-1215735$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153211$24115321$1$I$$20240405$20240721$20240721$PER$$US-NOVOPROD-1208373$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153221$24115322$1$I$20240403$20240403$20240721$20240721$PER$$US-NOVOPROD-1206115$NOVO NORDISK$$56$YR$$F$Y$$$20240721$$CN$US$US
241153231$24115323$1$I$$20240419$20240721$20240721$PER$$US-NOVOPROD-1215706$NOVO NORDISK$$$$$M$Y$$$20240721$$HP$US$US
241153241$24115324$1$I$20240421$20240423$20240721$20240721$PER$$US-NOVOPROD-1215750$NOVO NORDISK$$12$YR$$F$Y$$$20240721$$CN$US$US
241153251$24115325$1$I$$20240408$20240721$20240721$PER$$US-NOVOPROD-1207786$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153261$24115326$1$I$$20240412$20240721$20240721$PER$$US-NOVOPROD-1206260$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153271$24115327$1$I$$20230612$20240721$20240721$PER$$US-NOVOPROD-1206400$NOVO NORDISK$$72$YR$$$Y$$$20240721$$CN$US$US
241153281$24115328$1$I$$20240422$20240721$20240721$PER$$US-NOVOPROD-1216212$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241153291$24115329$1$I$$20240403$20240721$20240721$PER$$US-NOVOPROD-1206585$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241153301$24115330$1$I$20240404$20240707$20240721$20240721$PER$$US-NOVOPROD-1207644$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$CN$US$US
241153311$24115331$1$I$20240331$20240404$20240721$20240721$PER$$US-NOVOPROD-1206028$NOVO NORDISK$$65$YR$$F$Y$$$20240721$$CN$US$US
241153321$24115332$1$I$$20240403$20240721$20240721$PER$$US-NOVOPROD-1206551$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241153331$24115333$1$I$$20240409$20240721$20240721$PER$$US-NOVOPROD-1208302$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153341$24115334$1$I$$20240715$20240721$20240721$PER$$US-BIOGEN-2024BI01273788$BIOGEN$$$$$F$Y$$$20240721$$CN$US$US
241153351$24115335$1$I$$20240718$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012260$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240721$$CN$US$US
241153361$24115336$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407010725$ELI LILLY AND CO$$86$YR$E$F$Y$$$20240721$$CN$US$US
241153371$24115337$1$I$20240401$20240516$20240721$20240721$PER$$US-NOVOPROD-1217081$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$CN$US$US
241153381$24115338$1$I$20240401$20240427$20240721$20240721$PER$$US-NOVOPROD-1217198$NOVO NORDISK$$38$YR$$F$Y$$$20240721$$CN$US$US
241153391$24115339$1$I$$20240425$20240721$20240721$PER$$US-NOVOPROD-1216574$NOVO NORDISK$$$$$$Y$$$20240721$$MD$US$US
241153401$24115340$1$I$$20230929$20240721$20240721$PER$$US-NOVOPROD-1218239$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153411$24115341$1$I$$20240423$20240721$20240721$PER$$US-NOVOPROD-1217641$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153421$24115342$1$I$$20240426$20240721$20240721$PER$$US-NOVOPROD-1217794$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153431$24115343$1$I$20240405$20240429$20240721$20240721$PER$$US-NOVOPROD-1216385$NOVO NORDISK$$50$YR$$F$Y$$$20240721$$CN$US$US
241153441$24115344$1$I$$20240611$20240721$20240721$PER$$US-NOVOPROD-1219656$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153451$24115345$1$I$$20240501$20240721$20240721$PER$$US-NOVOPROD-1217339$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241153461$24115346$1$I$20240201$20240426$20240721$20240721$PER$$US-NOVOPROD-1217400$NOVO NORDISK$$34$YR$$F$Y$$$20240721$$CN$US$US
241153471$24115347$1$I$20240424$20240428$20240721$20240721$PER$$US-NOVOPROD-1217446$NOVO NORDISK$$34$YR$$F$Y$$$20240721$$CN$US$US
241153481$24115348$1$I$$20230927$20240721$20240721$PER$$US-NOVOPROD-1218342$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241153491$24115349$1$I$$20240426$20240721$20240721$PER$$US-NOVOPROD-1217424$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241153501$24115350$1$I$20231008$20240531$20240721$20240721$PER$$US-NOVOPROD-1217224$NOVO NORDISK$$49$YR$$F$Y$$$20240721$$CN$US$US
241153511$24115351$1$I$$20231005$20240721$20240721$PER$$US-NOVOPROD-1218906$NOVO NORDISK$$45$YR$$F$Y$$$20240721$$CN$US$US
241153521$24115352$1$I$$20240425$20240721$20240721$PER$$US-NOVOPROD-1216763$NOVO NORDISK$$27$YR$$F$Y$$$20240721$$HP$US$US
241153531$24115353$1$I$20240504$20240507$20240721$20240721$PER$$US-NOVOPROD-1218579$NOVO NORDISK$$55$YR$$F$Y$$$20240721$$CN$US$US
241153541$24115354$1$I$$20240428$20240721$20240721$PER$$US-NOVOPROD-1217395$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241153551$24115355$1$I$$20240426$20240721$20240721$PER$$US-NOVOPROD-1217634$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153561$24115356$1$I$20240411$20240510$20240721$20240721$PER$$US-NOVOPROD-1218109$NOVO NORDISK$$73$YR$$F$Y$$$20240721$$CN$US$US
241153571$24115357$1$I$$20240429$20240721$20240721$PER$$US-NOVOPROD-1216459$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153581$24115358$1$I$$20230918$20240721$20240721$PER$$US-NOVOPROD-1218843$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241153591$24115359$1$I$$20230926$20240721$20240721$PER$$US-NOVOPROD-1218048$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241153601$24115360$1$I$$20240501$20240721$20240721$PER$$US-NOVOPROD-1219307$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153611$24115361$1$I$20240410$20240410$20240721$20240721$PER$$US-NOVOPROD-1209530$NOVO NORDISK$$26$YR$$F$Y$$$20240721$$CN$US$US
241153621$24115362$1$I$$20240409$20240721$20240721$PER$$US-NOVOPROD-1208956$NOVO NORDISK$$40$YR$$F$Y$$$20240721$$PH$US$US
241153631$24115363$1$I$$20230918$20240721$20240721$PER$$US-NOVOPROD-1220100$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241153641$24115364$1$I$20240415$20240502$20240721$20240721$PER$$US-NOVOPROD-1221161$NOVO NORDISK$$50$YR$$F$Y$$$20240721$$CN$US$US
241153651$24115365$1$I$$20240410$20240721$20240721$PER$$US-NOVOPROD-1209266$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153661$24115366$1$I$$20240402$20240721$20240721$PER$$US-NOVOPROD-1208766$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153671$24115367$1$I$$20230913$20240721$20240721$PER$$US-NOVOPROD-1219907$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241153681$24115368$1$I$$20240503$20240721$20240721$PER$$US-NOVOPROD-1221145$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153691$24115369$1$I$$20240502$20240721$20240721$PER$$US-NOVOPROD-1221255$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153701$24115370$1$I$$20240502$20240721$20240721$PER$$US-NOVOPROD-1220292$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153711$24115371$1$I$20240501$20240501$20240721$20240721$PER$$US-NOVOPROD-1220051$NOVO NORDISK$$61$YR$$M$Y$$$20240721$$PH$US$US
241153721$24115372$1$I$20240401$20240605$20240721$20240721$PER$$US-NOVOPROD-1220311$NOVO NORDISK$$50$YR$$F$Y$$$20240721$$CN$US$US
241153731$24115373$1$I$$20240409$20240721$20240721$PER$$US-NOVOPROD-1209527$NOVO NORDISK$$64$YR$$M$Y$$$20240721$$MD$US$US
241153741$24115374$1$I$20240429$20240501$20240721$20240721$PER$$US-NOVOPROD-1219766$NOVO NORDISK$$56$YR$$F$Y$$$20240721$$CN$US$US
241153751$24115375$1$I$$20230921$20240721$20240721$PER$$US-NOVOPROD-1221156$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153761$24115376$1$I$$20240509$20240721$20240721$PER$$US-NOVOPROD-1220735$NOVO NORDISK$$52$YR$$F$Y$$$20240721$$HP$US$US
241153771$24115377$1$I$$20230731$20240721$20240721$PER$$US-NOVOPROD-1219750$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241153781$24115378$1$I$$20230914$20240721$20240721$PER$$US-NOVOPROD-1220709$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241153791$24115379$1$I$20240420$20240501$20240721$20240721$PER$$US-NOVOPROD-1219834$NOVO NORDISK$$58$YR$$F$Y$$$20240721$$CN$US$US
241153801$24115380$1$I$$20240328$20240721$20240721$PER$$US-NOVOPROD-1209092$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153811$24115381$1$I$$20240509$20240721$20240721$PER$$US-NOVOPROD-1220602$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153821$24115382$1$I$$20240418$20240721$20240721$PER$$US-NOVOPROD-1209414$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241153831$24115383$1$I$$20240502$20240721$20240721$PER$$US-NOVOPROD-1220614$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241153841$24115384$1$I$$20240502$20240721$20240721$PER$$US-NOVOPROD-1220551$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241153851$24115385$1$I$$20240409$20240721$20240721$PER$$US-NOVOPROD-1208651$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241153861$24115386$1$I$$20240501$20240721$20240721$PER$$US-NOVOPROD-1219849$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153871$24115387$1$I$20240228$20240614$20240721$20240721$PER$$US-NOVOPROD-1219673$NOVO NORDISK$$$$$F$Y$94.331$KG$20240721$$MD$US$US
241153881$24115388$1$I$$20230924$20240721$20240721$PER$$US-NOVOPROD-1220014$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241153891$24115389$1$I$$20240411$20240721$20240721$PER$$US-NOVOPROD-1209534$NOVO NORDISK$$$$$M$Y$$$20240721$$HP$US$US
241153901$24115390$1$I$$20240421$20240721$20240721$PER$$US-NOVOPROD-1211042$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153911$24115391$1$I$20240405$20240416$20240721$20240721$PER$$US-NOVOPROD-1210929$NOVO NORDISK$$56$YR$$F$Y$$$20240721$$CN$US$US
241153921$24115392$1$I$20240415$20240418$20240721$20240721$PER$$US-NOVOPROD-1213273$NOVO NORDISK$$41$YR$$F$Y$$$20240721$$CN$US$US
241153931$24115393$1$I$$20240412$20240721$20240721$PER$$US-NOVOPROD-1211048$NOVO NORDISK$$67$YR$$F$Y$78.912$KG$20240721$$CN$US$US
241153941$24115394$1$I$$20240416$20240721$20240721$PER$$US-NOVOPROD-1212720$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153951$24115395$1$I$$20240411$20240721$20240721$PER$$US-NOVOPROD-1210884$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241153961$24115396$1$I$$20240415$20240721$20240721$PER$$US-NOVOPROD-1211088$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241153971$24115397$1$I$$20240416$20240721$20240721$PER$$US-NOVOPROD-1210909$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241153981$24115398$1$I$20230101$20240424$20240721$20240721$PER$$US-NOVOPROD-1212166$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241153991$24115399$1$I$$20240411$20240721$20240721$PER$$US-NOVOPROD-1211531$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241154001$24115400$1$I$$20240419$20240721$20240721$PER$$US-NOVOPROD-1213386$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241154011$24115401$1$I$$20240418$20240721$20240721$PER$$US-NOVOPROD-1213578$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241154021$24115402$1$I$$20240411$20240721$20240721$PER$$US-NOVOPROD-1210392$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241154031$24115403$1$I$$20240411$20240721$20240721$PER$$US-NOVOPROD-1210980$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241154041$24115404$1$I$$20240415$20240721$20240721$PER$$US-NOVOPROD-1212053$NOVO NORDISK$$38$YR$$F$Y$$$20240721$$CN$US$US
241154051$24115405$1$I$20240405$20240529$20240721$20240721$PER$$US-NOVOPROD-1213553$NOVO NORDISK$$54$YR$$F$Y$$$20240721$$CN$US$US
241154061$24115406$1$I$$20240417$20240721$20240721$PER$$US-NOVOPROD-1212533$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241154071$24115407$1$I$$20240415$20240721$20240721$PER$$US-NOVOPROD-1211332$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241154081$24115408$1$I$$20240411$20240721$20240721$PER$$US-NOVOPROD-1213048$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241154091$24115409$1$I$$20240411$20240721$20240721$PER$$US-NOVOPROD-1211267$NOVO NORDISK$$$$A$$Y$$$20240721$$CN$US$US
241154101$24115410$1$I$20240413$20240718$20240721$20240721$PER$$US-NOVOPROD-1213259$NOVO NORDISK$$33$YR$$F$Y$$$20240721$$CN$US$US
241154111$24115411$1$I$$20240415$20240721$20240721$PER$$US-NOVOPROD-1210954$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154121$24115412$1$I$$20240418$20240721$20240721$PER$$US-NOVOPROD-1213559$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241154131$24115413$1$I$$20240418$20240721$20240721$PER$$US-NOVOPROD-1213191$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154141$24115414$1$I$$20240417$20240721$20240721$PER$$US-NOVOPROD-1210116$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154151$24115415$1$I$20240412$20240429$20240721$20240721$PER$$US-NOVOPROD-1211473$NOVO NORDISK$$68$YR$$F$Y$$$20240721$$CN$US$US
241154161$24115416$1$I$$20240418$20240721$20240721$PER$$US-NOVOPROD-1213180$NOVO NORDISK$$$$$$Y$$$20240721$$MD$US$US
241154171$24115417$1$I$$20240410$20240721$20240721$PER$$US-NOVOPROD-1209850$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154181$24115418$1$I$20240301$20240416$20240721$20240721$PER$$US-NOVOPROD-1211811$NOVO NORDISK$$42$YR$$M$Y$$$20240721$$CN$US$US
241154191$24115419$1$I$$20240422$20240721$20240721$PER$$US-NOVOPROD-1214449$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241154201$24115420$1$I$20230901$20240513$20240721$20240721$PER$$US-NOVOPROD-1214133$NOVO NORDISK$$26$YR$$F$Y$$$20240721$$CN$US$US
241154213$24115421$3$F$20230501$20240422$20240721$20240721$PER$$US-NOVOPROD-1214615$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154221$24115422$1$I$20230801$20240427$20240721$20240721$PER$$US-NOVOPROD-1213829$NOVO NORDISK$$54$YR$$M$Y$$$20240721$$CN$US$US
241154231$24115423$1$I$20240401$20240520$20240721$20240721$PER$$US-NOVOPROD-1214494$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154241$24115424$1$I$20240411$20240515$20240721$20240721$PER$$US-NOVOPROD-1215352$NOVO NORDISK$$55$YR$$F$Y$$$20240721$$CN$US$US
241154251$24115425$1$I$20240412$20240420$20240721$20240721$PER$$US-NOVOPROD-1213990$NOVO NORDISK$$57$YR$$F$Y$$$20240721$$CN$US$US
241154261$24115426$1$I$$20240423$20240721$20240721$PER$$US-NOVOPROD-1214935$NOVO NORDISK$$$$$M$Y$$$20240721$$HP$US$US
241154271$24115427$1$I$20240417$20240423$20240721$20240721$PER$$US-NOVOPROD-1215152$NOVO NORDISK$$64$YR$$F$Y$$$20240721$$CN$US$US
241154281$24115428$1$I$20230701$20240422$20240721$20240721$PER$$US-NOVOPROD-1214124$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154291$24115429$1$I$20240422$20240620$20240721$20240721$PER$$US-NOVOPROD-1214423$NOVO NORDISK$$74$YR$$M$Y$$$20240721$$CN$US$US
241154301$24115430$1$I$$20240416$20240721$20240721$PER$$US-NOVOPROD-1215076$NOVO NORDISK$$$$$F$Y$$$20240721$$PH$US$US
241154312$24115431$2$F$20240418$20240422$20240721$20240721$PER$$US-NOVOPROD-1214500$NOVO NORDISK$$75$YR$$F$Y$$$20240721$$CN$US$US
241154321$24115432$1$I$20240421$20240422$20240721$20240721$PER$$US-NOVOPROD-1214318$NOVO NORDISK$$54$YR$$F$Y$$$20240721$$CN$US$US
241154331$24115433$1$I$$20240424$20240721$20240721$PER$$US-NOVOPROD-1215282$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241154341$24115434$1$I$$20240514$20240721$20240721$PER$$US-NOVOPROD-1214993$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154351$24115435$1$I$$20240424$20240721$20240721$PER$$US-NOVOPROD-1215659$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154361$24115436$1$I$$20240423$20240721$20240721$PER$$US-NOVOPROD-1215467$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241154371$24115437$1$I$20240420$20240422$20240721$20240721$PER$$US-NOVOPROD-1215478$NOVO NORDISK$$64$YR$$F$Y$$$20240721$$CN$US$US
241154381$24115438$1$I$$20240513$20240721$20240721$PER$$US-NOVOPROD-1226124$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241154391$24115439$1$I$20240401$20240514$20240721$20240721$PER$$US-NOVOPROD-1227288$NOVO NORDISK$$45$YR$$F$Y$$$20240721$$CN$US$US
241154401$24115440$1$I$$20240517$20240721$20240721$PER$$US-NOVOPROD-1227889$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154411$24115441$1$I$$20240514$20240721$20240721$PER$$US-NOVOPROD-1226267$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241154421$24115442$1$I$$20240515$20240721$20240721$PER$$US-NOVOPROD-1227164$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154431$24115443$1$I$$20240515$20240721$20240721$PER$$US-NOVOPROD-1227177$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154441$24115444$1$I$$20240521$20240721$20240721$PER$$US-NOVOPROD-1227525$NOVO NORDISK$$$$$M$Y$$$20240721$$MD$US$US
241154451$24115445$1$I$20240401$20240422$20240721$20240721$PER$$US-NOVOPROD-1215541$NOVO NORDISK$$59$YR$$F$Y$$$20240721$$CN$US$US
241154461$24115446$1$I$$20231004$20240721$20240721$PER$$US-NOVOPROD-1221375$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154471$24115447$1$I$20240101$20240514$20240721$20240721$PER$$US-NOVOPROD-1226628$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154481$24115448$1$I$20240429$20240520$20240721$20240721$PER$$US-NOVOPROD-1226810$NOVO NORDISK$$57$YR$$F$Y$$$20240721$$CN$US$US
241154491$24115449$1$I$20240430$20240708$20240721$20240721$PER$$US-NOVOPROD-1226708$NOVO NORDISK$$59$YR$$F$Y$$$20240721$$MD$US$US
241154501$24115450$1$I$20230801$20240708$20240721$20240721$PER$$US-NOVOPROD-1227306$NOVO NORDISK$$59$YR$$F$Y$$$20240721$$CN$US$US
241154511$24115451$1$I$$20231005$20240721$20240721$PER$$US-NOVOPROD-1226073$NOVO NORDISK$$37$YR$$$Y$$$20240721$$CN$US$US
241154521$24115452$1$I$$20240518$20240721$20240721$PER$$US-NOVOPROD-1226109$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154531$24115453$1$I$$20230925$20240721$20240721$PER$$US-NOVOPROD-1221384$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154541$24115454$1$I$$20240503$20240721$20240721$PER$$US-NOVOPROD-1221462$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241154551$24115455$1$I$20240512$20240514$20240721$20240721$PER$$US-NOVOPROD-1226999$NOVO NORDISK$$35$YR$$F$Y$$$20240721$$CN$US$US
241154561$24115456$1$I$$20240516$20240721$20240721$PER$$US-NOVOPROD-1227893$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154571$24115457$1$I$$20240415$20240721$20240721$PER$$US-NOVOPROD-1215581$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154581$24115458$1$I$$20240515$20240721$20240721$PER$$US-NOVOPROD-1227357$NOVO NORDISK$$39$YR$$F$Y$$$20240721$$HP$US$US
241154591$24115459$1$I$$20240701$20240721$20240721$PER$$US-NOVOPROD-1227971$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241154601$24115460$1$I$$20240515$20240721$20240721$PER$$US-NOVOPROD-1227187$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241154611$24115461$1$I$20240406$20240415$20240721$20240721$PER$$US-NOVOPROD-1215544$NOVO NORDISK$$34$YR$$F$Y$$$20240721$$CN$US$US
241154621$24115462$1$I$$20240514$20240721$20240721$PER$$US-NOVOPROD-1226758$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154631$24115463$1$I$$20240522$20240721$20240721$PER$$US-NOVOPROD-1228136$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241154641$24115464$1$I$$20230927$20240721$20240721$PER$$US-NOVOPROD-1221476$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154651$24115465$1$I$$20240516$20240721$20240721$PER$$US-NOVOPROD-1228455$NOVO NORDISK$$$$E$F$Y$$$20240721$$HP$US$US
241154661$24115466$1$I$$20230626$20240721$20240721$PER$$US-NOVOPROD-1228247$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154671$24115467$1$I$$20240516$20240721$20240721$PER$$US-NOVOPROD-1228217$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241154681$24115468$1$I$$20240516$20240721$20240721$PER$$US-NOVOPROD-1228028$NOVO NORDISK$$38$YR$$F$Y$$$20240721$$CN$US$US
241154691$24115469$1$I$$20230602$20240721$20240721$PER$$US-NOVOPROD-1221599$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241154701$24115470$1$I$$20230619$20240721$20240721$PER$$US-NOVOPROD-1228371$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241154711$24115471$1$I$20240515$20240516$20240721$20240721$PER$$US-NOVOPROD-1228291$NOVO NORDISK$$45$YR$$F$Y$$$20240721$$CN$US$US
241154721$24115472$1$I$20240501$20240526$20240721$20240721$PER$$US-NOVOPROD-1228319$NOVO NORDISK$$51$YR$$F$Y$$$20240721$$CN$US$US
241154731$24115473$1$I$$20240506$20240721$20240721$PER$$US-NOVOPROD-1222085$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241154741$24115474$1$I$20240509$20240516$20240721$20240721$PER$$US-NOVOPROD-1228276$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154751$24115475$1$I$20240508$20240710$20240721$20240721$PER$$US-NOVOPROD-1222063$NOVO NORDISK$$57$YR$$F$Y$$$20240721$$CN$US$US
241154761$24115476$1$I$$20240506$20240721$20240721$PER$$US-NOVOPROD-1221887$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241154771$24115477$1$I$20240506$20240506$20240721$20240721$PER$$US-NOVOPROD-1221927$NOVO NORDISK$$56$YR$$F$Y$$$20240721$$CN$US$US
241154781$24115478$1$I$$20230622$20240721$20240721$PER$$US-NOVOPROD-1228366$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154791$24115479$1$I$$20230912$20240721$20240721$PER$$US-NOVOPROD-1221574$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241154801$24115480$1$I$$20240517$20240721$20240721$PER$$US-NOVOPROD-1228439$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241154811$24115481$1$I$$20240517$20240721$20240721$PER$$US-NOVOPROD-1228500$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154821$24115482$1$I$20230901$20240526$20240721$20240721$PER$$US-NOVOPROD-1228274$NOVO NORDISK$$24$YR$$M$Y$$$20240721$$CN$US$US
241154831$24115483$1$I$$20240507$20240721$20240721$PER$$US-NOVOPROD-1222463$NOVO NORDISK$$35$YR$$F$Y$$$20240721$$HP$US$US
241154841$24115484$1$I$$20240506$20240721$20240721$PER$$US-NOVOPROD-1222267$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241154851$24115485$1$I$20230801$20240528$20240721$20240721$PER$$US-NOVOPROD-1229405$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241154861$24115486$1$I$$20230912$20240721$20240721$PER$$US-NOVOPROD-1222222$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154871$24115487$1$I$$20240520$20240721$20240721$PER$$US-NOVOPROD-1229288$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154881$24115488$1$I$20240412$20240506$20240721$20240721$PER$$US-NOVOPROD-1222137$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154891$24115489$1$I$$20240520$20240721$20240721$PER$$US-NOVOPROD-1229394$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154901$24115490$1$I$20240401$20240520$20240721$20240721$PER$$US-NOVOPROD-1229761$NOVO NORDISK$$15$YR$$F$Y$$$20240721$$CN$US$US
241154911$24115491$1$I$20240520$20240520$20240721$20240721$PER$$US-NOVOPROD-1228777$NOVO NORDISK$$60$YR$$F$Y$$$20240721$$MD$US$US
241154921$24115492$1$I$20240505$20240507$20240721$20240721$PER$$US-NOVOPROD-1222092$NOVO NORDISK$$42$YR$$F$Y$$$20240721$$CN$US$US
241154931$24115493$1$I$20240506$20240520$20240721$20240721$PER$$US-NOVOPROD-1229922$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154941$24115494$1$I$$20240516$20240721$20240721$PER$$US-NOVOPROD-1228564$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154951$24115495$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1229764$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241154961$24115496$1$I$$20230721$20240721$20240721$PER$$US-NOVOPROD-1228953$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241154971$24115497$1$I$$20240519$20240721$20240721$PER$$US-NOVOPROD-1228801$NOVO NORDISK$$$$$$Y$$$20240721$$HP$US$US
241154981$24115498$1$I$20240504$20240508$20240721$20240721$PER$$US-NOVOPROD-1223693$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241154991$24115499$1$I$$20240705$20240721$20240721$PER$$US-NOVOPROD-1229436$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155001$24115500$1$I$20240408$20240624$20240721$20240721$PER$$US-NOVOPROD-1229089$NOVO NORDISK$$28$YR$$F$Y$92.063$KG$20240721$$MD$US$US
241155011$24115501$1$I$$20240520$20240721$20240721$PER$$US-NOVOPROD-1229153$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241155021$24115502$1$I$$20240520$20240721$20240721$PER$$US-NOVOPROD-1229121$NOVO NORDISK$$50$YR$$F$Y$$$20240721$$HP$US$US
241155031$24115503$1$I$20240401$20240603$20240721$20240721$PER$$US-NOVOPROD-1228677$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241155041$24115504$1$I$20231215$20240523$20240721$20240721$PER$$US-NOVOPROD-1229700$NOVO NORDISK$$39$YR$$F$Y$$$20240721$$CN$US$US
241155051$24115505$1$I$$20230915$20240721$20240721$PER$$US-NOVOPROD-1222248$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241155061$24115506$1$I$$20230912$20240721$20240721$PER$$US-NOVOPROD-1222279$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155071$24115507$1$I$20230718$20230718$20240721$20240721$PER$$US-NOVOPROD-1229077$NOVO NORDISK$$56$YR$$F$Y$$$20240721$$CN$US$US
241155081$24115508$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407010783$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240721$$CN$US$US
241155091$24115509$1$I$$20240508$20240721$20240721$PER$$US-NOVOPROD-1223743$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155101$24115510$1$I$$20240719$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012960$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240721$$CN$US$US
241155111$24115511$1$I$20240717$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012187$ELI LILLY AND CO$$$$$$Y$$$20240721$$CN$US$US
241155121$24115512$1$I$20240301$20240507$20240721$20240721$PER$$US-NOVOPROD-1223080$NOVO NORDISK$$59$YR$$F$Y$$$20240721$$CN$US$US
241155131$24115513$1$I$$20230911$20240721$20240721$PER$$US-NOVOPROD-1222480$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241155141$24115514$1$I$20240501$20240507$20240721$20240721$PER$$US-NOVOPROD-1223321$NOVO NORDISK$$75$YR$$F$Y$$$20240721$$CN$US$US
241155152$24115515$2$F$$20240506$20240721$20240721$PER$$US-NOVOPROD-1223373$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241155161$24115516$1$I$$20230911$20240721$20240721$PER$$US-NOVOPROD-1223507$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155171$24115517$1$I$$20240607$20240721$20240721$PER$$US-NOVOPROD-1223178$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155181$24115518$1$I$$20240514$20240721$20240721$PER$$US-NOVOPROD-1223126$NOVO NORDISK$$35$YR$$M$Y$$$20240721$$MD$US$US
241155191$24115519$1$I$20240421$20240515$20240721$20240721$PER$$US-NOVOPROD-1224361$NOVO NORDISK$$42$YR$$M$Y$$$20240721$$HP$US$US
241155201$24115520$1$I$$20240508$20240721$20240721$PER$$US-NOVOPROD-1223759$NOVO NORDISK$$$$$$Y$$$20240721$$HP$US$US
241155211$24115521$1$I$20240503$20240507$20240721$20240721$PER$$US-NOVOPROD-1222504$NOVO NORDISK$$49$YR$$F$Y$$$20240721$$CN$US$US
241155221$24115522$1$I$$20230919$20240721$20240721$PER$$US-NOVOPROD-1222886$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155231$24115523$1$I$20240509$20240512$20240721$20240721$PER$$US-NOVOPROD-1223446$NOVO NORDISK$$24$YR$$F$Y$$$20240721$$CN$US$US
241155241$24115524$1$I$$20240506$20240721$20240721$PER$$US-NOVOPROD-1223363$NOVO NORDISK$$45$YR$$F$Y$$$20240721$$MD$US$US
241155251$24115525$1$I$$20240508$20240721$20240721$PER$$US-NOVOPROD-1223895$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241155261$24115526$1$I$$20240506$20240721$20240721$PER$$US-NOVOPROD-1223396$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241155271$24115527$1$I$$20230908$20240721$20240721$PER$$US-NOVOPROD-1222644$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241155281$24115528$1$I$$20240507$20240721$20240721$PER$$US-NOVOPROD-1223146$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241155291$24115529$1$I$$20240508$20240721$20240721$PER$$US-NOVOPROD-1224165$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155301$24115530$1$I$$20230816$20240721$20240721$PER$$US-NOVOPROD-1223573$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155311$24115531$1$I$20240509$20240512$20240721$20240721$PER$$US-NOVOPROD-1223487$NOVO NORDISK$$24$YR$$F$Y$$$20240721$$CN$US$US
241155321$24115532$1$I$$20240506$20240721$20240721$PER$$US-NOVOPROD-1223310$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241155331$24115533$1$I$$20230829$20240721$20240721$PER$$US-NOVOPROD-1223574$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241155341$24115534$1$I$$20240611$20240721$20240721$PER$$US-NOVOPROD-1224182$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241155351$24115535$1$I$$20240509$20240721$20240721$PER$$US-NOVOPROD-1224458$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241155361$24115536$1$I$$20240512$20240721$20240721$PER$$US-NOVOPROD-1223428$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155371$24115537$1$I$20230511$20240530$20240721$20240721$PER$$US-NOVOPROD-1225369$NOVO NORDISK$$42$YR$$M$Y$$$20240721$$CN$US$US
241155381$24115538$1$I$$20240513$20240721$20240721$PER$$US-NOVOPROD-1225971$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241155391$24115539$1$I$$20230621$20240721$20240721$PER$$US-NOVOPROD-1226060$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241155401$24115540$1$I$$20240529$20240721$20240721$PER$$US-NOVOPROD-1234201$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155411$24115541$1$I$$20240510$20240721$20240721$PER$$US-NOVOPROD-1225182$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241155421$24115542$1$I$20240513$20240513$20240721$20240721$PER$$US-NOVOPROD-1225821$NOVO NORDISK$$41$YR$$F$Y$$$20240721$$CN$US$US
241155431$24115543$1$I$$20240513$20240721$20240721$PER$$US-NOVOPROD-1225820$NOVO NORDISK$$$$A$$Y$$$20240721$$CN$US$US
241155441$24115544$1$I$$20230828$20240721$20240721$PER$$US-NOVOPROD-1223582$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241155451$24115545$1$I$20240514$20240528$20240721$20240721$PER$$US-NOVOPROD-1234177$NOVO NORDISK$$54$YR$$F$Y$$$20240721$$CN$US$US
241155462$24115546$2$F$20240321$20240515$20240721$20240721$PER$$US-NOVOPROD-1224985$NOVO NORDISK$$37$YR$$F$Y$$$20240721$$CN$US$US
241155471$24115547$1$I$$20240509$20240721$20240721$PER$$US-NOVOPROD-1224734$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155481$24115548$1$I$$20230610$20240721$20240721$PER$$US-NOVOPROD-1225841$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155492$24115549$2$F$$20240509$20240721$20240721$PER$$US-NOVOPROD-1224522$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155501$24115550$1$I$$20230727$20240721$20240721$PER$$US-NOVOPROD-1225150$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155511$24115551$1$I$$20240513$20240721$20240721$PER$$US-NOVOPROD-1225948$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155521$24115552$1$I$$20230817$20240721$20240721$PER$$US-NOVOPROD-1224634$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241155531$24115553$1$I$$20240513$20240721$20240721$PER$$US-NOVOPROD-1226023$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155541$24115554$1$I$$20240513$20240721$20240721$PER$$US-NOVOPROD-1225658$NOVO NORDISK$$$$A$M$Y$$$20240721$$MD$US$US
241155551$24115555$1$I$$20230808$20240721$20240721$PER$$US-NOVOPROD-1224609$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241155561$24115556$1$I$$20240528$20240721$20240721$PER$$US-NOVOPROD-1234149$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241155571$24115557$1$I$20240513$20240513$20240721$20240721$PER$$US-NOVOPROD-1225909$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155581$24115558$1$I$20240126$20240617$20240721$20240721$PER$$US-NOVOPROD-1225929$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
241155591$24115559$1$I$$20230824$20240721$20240721$PER$$US-NOVOPROD-1225751$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155601$24115560$1$I$20230401$20230615$20240721$20240721$PER$$US-NOVOPROD-1226061$NOVO NORDISK$$56$YR$$F$Y$102.05$KG$20240721$$CN$US$US
241155611$24115561$1$I$$20240510$20240721$20240721$PER$$US-NOVOPROD-1224810$NOVO NORDISK$$$$$F$Y$$$20240721$$PH$US$US
241155621$24115562$1$I$$20240511$20240721$20240721$PER$$US-NOVOPROD-1225300$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155631$24115563$1$I$$20230817$20240721$20240721$PER$$US-NOVOPROD-1224637$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241155641$24115564$1$I$$20240711$20240721$20240721$EXP$$CA-TEVA-VS-3221307$TEVA$$70$YR$$F$Y$$$20240721$$HP$CA$CA
241155651$24115565$1$I$$20240529$20240721$20240721$PER$$US-NOVOPROD-1234746$NOVO NORDISK$$$$A$$Y$$$20240721$$CN$US$US
241155661$24115566$1$I$$20240529$20240721$20240721$PER$$US-NOVOPROD-1235293$NOVO NORDISK$$51$YR$$F$Y$$$20240721$$HP$US$US
241155671$24115567$1$I$20240527$20240529$20240721$20240721$PER$$US-NOVOPROD-1234801$NOVO NORDISK$$54$YR$$M$Y$$$20240721$$CN$US$US
241155681$24115568$1$I$$20240531$20240721$20240721$PER$$US-NOVOPROD-1236769$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155691$24115569$1$I$$20240415$20240721$20240721$PER$$US-NOVOPROD-1246064$NOVO NORDISK$$$$A$F$Y$$$20240721$$HP$US$US
241155701$24115570$1$I$20240518$20240529$20240721$20240721$PER$$US-NOVOPROD-1235387$NOVO NORDISK$$62$YR$$$Y$$$20240721$$CN$US$US
241155711$24115571$1$I$$20240531$20240721$20240721$PER$$US-NOVOPROD-1236887$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155721$24115572$1$I$20240302$20240327$20240721$20240721$PER$$US-NOVOPROD-1241162$NOVO NORDISK$$76$YR$$M$Y$$$20240721$$CN$US$US
241155731$24115573$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1236501$NOVO NORDISK$$$$$$Y$$$20240721$$MD$US$US
241155741$24115574$1$I$$20240529$20240721$20240721$PER$$US-NOVOPROD-1235459$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155751$24115575$1$I$20240503$20240606$20240721$20240721$PER$$US-NOVOPROD-1240338$NOVO NORDISK$$71$YR$$F$Y$$$20240721$$CN$US$US
241155761$24115576$1$I$20240423$20240424$20240721$20240721$PER$$US-NOVOPROD-1241541$NOVO NORDISK$$40$YR$$F$Y$$$20240721$$CN$US$US
241155771$24115577$1$I$$20240531$20240721$20240721$PER$$US-NOVOPROD-1236424$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155781$24115578$1$I$$20240528$20240721$20240721$PER$$US-NOVOPROD-1234484$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241155791$24115579$1$I$$20240531$20240721$20240721$PER$$US-NOVOPROD-1235873$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155801$24115580$1$I$20230901$20240528$20240721$20240721$PER$$US-NOVOPROD-1234373$NOVO NORDISK$$64$YR$$F$Y$$$20240721$$CN$US$US
241155811$24115581$1$I$$20240529$20240721$20240721$PER$$US-NOVOPROD-1234521$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155821$24115582$1$I$$20240531$20240721$20240721$PER$$US-NOVOPROD-1236947$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241155831$24115583$1$I$$20240228$20240721$20240721$PER$$US-NOVOPROD-1242064$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155841$24115584$1$I$20231101$20240410$20240721$20240721$PER$$US-NOVOPROD-1241060$NOVO NORDISK$$31$YR$$F$Y$$$20240721$$CN$US$US
241155851$24115585$1$I$20240414$20240529$20240721$20240721$PER$$US-NOVOPROD-1235311$NOVO NORDISK$$41$YR$$F$Y$$$20240721$$CN$US$US
241155861$24115586$1$I$20240501$20240531$20240721$20240721$PER$$US-NOVOPROD-1236839$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155871$24115587$1$I$20240419$20240531$20240721$20240721$PER$$US-NOVOPROD-1236557$NOVO NORDISK$$47$YR$$$Y$$$20240721$$CN$US$US
241155881$24115588$1$I$$20240529$20240721$20240721$PER$$US-NOVOPROD-1235164$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241155891$24115589$1$I$20240526$20240531$20240721$20240721$PER$$US-NOVOPROD-1236813$NOVO NORDISK$$76$YR$$M$Y$$$20240721$$CN$US$US
241155901$24115590$1$I$20230318$20240318$20240721$20240721$PER$$US-NOVOPROD-1063296$NOVO NORDISK$$47$YR$$M$Y$$$20240721$$MD$US$US
241155911$24115591$1$I$20240220$20240221$20240721$20240721$PER$$US-NOVOPROD-1242031$NOVO NORDISK$$72$YR$$F$Y$$$20240721$$CN$US$US
241155921$24115592$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1247606$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241155932$24115593$2$F$20240408$20240412$20240721$20240721$PER$$US-NOVOPROD-1246761$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241155941$24115594$1$I$$20240429$20240721$20240721$PER$$US-NOVOPROD-1247084$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241155951$24115595$1$I$$20240509$20240721$20240721$PER$$US-NOVOPROD-1247219$NOVO NORDISK$$52$YR$$F$Y$$$20240721$$HP$US$US
241155961$24115596$1$I$$20240521$20240721$20240721$PER$$US-NOVOPROD-1247528$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155971$24115597$1$I$$20240525$20240721$20240721$PER$$US-NOVOPROD-1247094$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241155981$24115598$1$I$$20240522$20240721$20240721$PER$$US-NOVOPROD-1230680$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241155991$24115599$1$I$20240518$20240521$20240721$20240721$PER$$US-NOVOPROD-1230153$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$CN$US$US
241156001$24115600$1$I$$20240521$20240721$20240721$PER$$US-NOVOPROD-1230128$NOVO NORDISK$$$$A$M$Y$$$20240721$$MD$US$US
241156011$24115601$1$I$$20240528$20240721$20240721$PER$$US-NOVOPROD-1230279$NOVO NORDISK$$29$YR$$F$Y$$$20240721$$MD$US$US
241156021$24115602$1$I$$20240522$20240721$20240721$PER$$US-NOVOPROD-1231041$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241156031$24115603$1$I$20240507$20240522$20240721$20240721$PER$$US-NOVOPROD-1230697$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156041$24115604$1$I$$20240617$20240721$20240721$PER$$US-NOVOPROD-1230700$NOVO NORDISK$$62$YR$$F$Y$$$20240721$$CN$US$US
241156051$24115605$1$I$$20240521$20240721$20240721$PER$$US-NOVOPROD-1230387$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241156061$24115606$1$I$$20240521$20240721$20240721$PER$$US-NOVOPROD-1230309$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241156071$24115607$1$I$$20240528$20240721$20240721$PER$$US-NOVOPROD-1230562$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241156081$24115608$1$I$20240424$20240511$20240721$20240721$PER$$US-NOVOPROD-1231063$NOVO NORDISK$$70$YR$$F$Y$$$20240721$$CN$US$US
241156091$24115609$1$I$$20240522$20240721$20240721$PER$$US-NOVOPROD-1230920$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156101$24115610$1$I$$20240521$20240721$20240721$PER$$US-NOVOPROD-1230116$NOVO NORDISK$$23$YR$$F$Y$$$20240721$$CN$US$US
241156111$24115611$1$I$$20240520$20240721$20240721$PER$$US-NOVOPROD-1230494$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241156121$24115612$1$I$$20240522$20240721$20240721$PER$$US-NOVOPROD-1230823$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241156131$24115613$1$I$$20240521$20240721$20240721$PER$$US-NOVOPROD-1230358$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156141$24115614$1$I$$20240524$20240721$20240721$PER$$US-NOVOPROD-1232781$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156151$24115615$1$I$$20240522$20240721$20240721$PER$$US-NOVOPROD-1231485$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156161$24115616$1$I$20240524$20240528$20240721$20240721$PER$$US-NOVOPROD-1232573$NOVO NORDISK$$67$YR$$F$Y$$$20240721$$CN$US$US
241156171$24115617$1$I$20240522$20240523$20240721$20240721$PER$$US-NOVOPROD-1232000$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156181$24115618$1$I$$20231005$20240721$20240721$PER$$US-NOVOPROD-1231410$NOVO NORDISK$$51$YR$$F$Y$$$20240721$$CN$US$US
241156191$24115619$1$I$$20240523$20240721$20240721$PER$$US-NOVOPROD-1232465$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241156201$24115620$1$I$$20240523$20240721$20240721$PER$$US-NOVOPROD-1232534$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156211$24115621$1$I$$20240524$20240721$20240721$PER$$US-NOVOPROD-1232783$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156221$24115622$1$I$$20240624$20240721$20240721$PER$$US-NOVOPROD-1231248$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156232$24115623$2$F$$20240523$20240721$20240721$PER$$US-NOVOPROD-1232045$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156241$24115624$1$I$20240518$20240530$20240721$20240721$PER$$US-NOVOPROD-1231824$NOVO NORDISK$$49$YR$$M$Y$$$20240721$$CN$US$US
241156251$24115625$1$I$20240515$20240523$20240721$20240721$PER$$US-NOVOPROD-1231982$NOVO NORDISK$$35$YR$$F$Y$$$20240721$$CN$US$US
241156261$24115626$1$I$$20240522$20240721$20240721$PER$$US-NOVOPROD-1231273$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241156271$24115627$1$I$$20240528$20240721$20240721$PER$$US-NOVOPROD-1231353$NOVO NORDISK$$$$A$F$Y$$$20240721$$HP$US$US
241156281$24115628$1$I$$20240522$20240721$20240721$PER$$US-NOVOPROD-1231912$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241156291$24115629$1$I$$20230607$20240721$20240721$PER$$US-NOVOPROD-1232033$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156301$24115630$1$I$$20240522$20240721$20240721$PER$$US-NOVOPROD-1231289$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156311$24115631$1$I$$20240522$20240721$20240721$PER$$US-NOVOPROD-1231778$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156321$24115632$1$I$$20240524$20240721$20240721$PER$$US-NOVOPROD-1232761$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156331$24115633$1$I$20240523$20240524$20240721$20240721$PER$$US-NOVOPROD-1232040$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$CN$US$US
241156341$24115634$1$I$$20240522$20240721$20240721$PER$$US-NOVOPROD-1231556$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156351$24115635$1$I$20240517$20240524$20240721$20240721$PER$$US-NOVOPROD-1232778$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156361$24115636$1$I$20240527$20240528$20240721$20240721$PER$$US-NOVOPROD-1233756$NOVO NORDISK$$34$YR$$F$Y$$$20240721$$CN$US$US
241156371$24115637$1$I$$20240430$20240721$20240721$PER$$US-NOVOPROD-1247718$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241156381$24115638$1$I$$20230609$20240721$20240721$PER$$US-NOVOPROD-1233308$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156391$24115639$1$I$$20230707$20240721$20240721$PER$$US-NOVOPROD-1247916$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241156401$24115640$1$I$$20240531$20240721$20240721$PER$$US-NOVOPROD-1233492$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156411$24115641$1$I$$20240506$20240721$20240721$PER$$US-NOVOPROD-1247999$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241156421$24115642$1$I$20240305$20240307$20240721$20240721$PER$$US-NOVOPROD-1247643$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156431$24115643$1$I$$20240613$20240721$20240721$PER$$US-NOVOPROD-1233216$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241156441$24115644$1$I$$20240528$20240721$20240721$PER$$US-NOVOPROD-1234139$NOVO NORDISK$$49$YR$$F$Y$$$20240721$$HP$US$US
241156451$24115645$1$I$$20230912$20240721$20240721$PER$$US-NOVOPROD-1257792$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241156462$24115646$2$F$$20240530$20240721$20240721$PER$$US-NOVOPROD-1248024$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241156471$24115647$1$I$20240423$20240524$20240721$20240721$PER$$US-NOVOPROD-1233268$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
241156481$24115648$1$I$$20240525$20240721$20240721$PER$$US-NOVOPROD-1233834$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241156491$24115649$1$I$20240528$20240528$20240721$20240721$PER$$US-NOVOPROD-1233687$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
241156501$24115650$1$I$20240506$20240524$20240721$20240721$PER$$US-NOVOPROD-1232937$NOVO NORDISK$$54$YR$$F$Y$$$20240721$$CN$US$US
241156511$24115651$1$I$$20240527$20240721$20240721$PER$$US-NOVOPROD-1233393$NOVO NORDISK$$30$YR$$F$Y$$$20240721$$CN$US$US
241156521$24115652$1$I$$20240311$20240721$20240721$PER$$US-NOVOPROD-1247630$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241156531$24115653$1$I$$20240527$20240721$20240721$PER$$US-NOVOPROD-1233382$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156541$24115654$1$I$$20240227$20240721$20240721$PER$$US-NOVOPROD-1247647$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156551$24115655$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1248021$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156561$24115656$1$I$$20240716$20240721$20240721$PER$$US-AstraZeneca-2024A162552$ASTRAZENECA$$$$$M$Y$$$20240721$$CN$US$
241156571$24115657$1$I$$20231121$20240721$20240721$PER$$US-NOVOPROD-1247722$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241156581$24115658$1$I$$20240524$20240721$20240721$PER$$US-NOVOPROD-1232940$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156591$24115659$1$I$$20240320$20240721$20240721$PER$$US-NOVOPROD-1194964$NOVO NORDISK$$$$$$Y$122.07$KG$20240721$$MD$US$US
241156602$24115660$2$F$20240717$20240903$20240721$20240911$PER$$US-AstraZeneca-2024A163754$ASTRAZENECA$$$$$F$Y$$$20240911$$HP$US$
241156611$24115661$1$I$20231201$20240311$20240721$20240721$PER$$US-NOVOPROD-1195384$NOVO NORDISK$$49$YR$$F$Y$$$20240721$$CN$US$US
241156621$24115662$1$I$$20230607$20240721$20240721$PER$$US-NOVOPROD-1078548$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241156631$24115663$1$I$$20240319$20240721$20240721$PER$$US-NOVOPROD-1195899$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241156641$24115664$1$I$$20230602$20240721$20240721$PER$$US-NOVOPROD-1078303$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156651$24115665$1$I$$20230714$20240721$20240721$PER$$US-NOVOPROD-1195533$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241156661$24115666$1$I$20230926$20240320$20240721$20240721$PER$$US-NOVOPROD-1195185$NOVO NORDISK$$30$YR$$F$Y$$$20240721$$CN$US$US
241156671$24115667$1$I$$20240319$20240721$20240721$PER$$US-NOVOPROD-1195232$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156681$24115668$1$I$$20240318$20240721$20240721$PER$$US-NOVOPROD-1195335$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156691$24115669$1$I$20240320$20240320$20240721$20240721$PER$$US-NOVOPROD-1196155$NOVO NORDISK$$49$YR$$M$Y$$$20240721$$CN$US$US
241156701$24115670$1$I$$20240304$20240721$20240721$PER$$US-NOVOPROD-1187977$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156711$24115671$1$I$20240209$20240319$20240721$20240721$PER$$US-NOVOPROD-1195697$NOVO NORDISK$$62$YR$$F$Y$$$20240721$$CN$US$US
241156721$24115672$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1195235$NOVO NORDISK$$56$YR$$F$Y$$$20240721$$CN$US$US
241156731$24115673$1$I$$20240318$20240721$20240721$PER$$US-NOVOPROD-1195977$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241156741$24115674$1$I$$20240625$20240721$20240721$PER$$US-NOVOPROD-1195943$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156751$24115675$1$I$$20240321$20240721$20240721$PER$$US-NOVOPROD-1195413$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156761$24115676$1$I$20240301$20240320$20240721$20240721$PER$$US-NOVOPROD-1195407$NOVO NORDISK$$72$YR$$F$Y$$$20240721$$CN$US$US
241156771$24115677$1$I$$20240214$20240721$20240721$PER$$US-NOVOPROD-1195429$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241156781$24115678$1$I$20240101$20240322$20240721$20240721$PER$$US-NOVOPROD-1196086$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
241156791$24115679$1$I$$20240319$20240721$20240721$PER$$US-NOVOPROD-1195330$NOVO NORDISK$$27$YR$$M$Y$$$20240721$$HP$US$US
241156801$24115680$1$I$$20240714$20240721$20240721$EXP$GB-MHRA-MED-202407141650513870-WRJLM$GB-RDY-SPO/GBR/24/0010412$DR REDDYS$$$$$M$Y$$$20240721$$CN$GB$GB
241156812$24115681$2$F$$20240425$20240721$20240721$PER$$US-NOVOPROD-1188031$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156821$24115682$1$I$20230301$20230522$20240721$20240721$PER$$US-NOVOPROD-1080852$NOVO NORDISK$$61$YR$$$Y$$$20240721$$CN$US$US
241156831$24115683$1$I$$20240305$20240721$20240721$PER$$US-NOVOPROD-1188821$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241156842$24115684$2$F$20240221$20240305$20240721$20240721$PER$$US-NOVOPROD-1187712$NOVO NORDISK$$28$YR$$F$Y$$$20240721$$CN$US$US
241156853$24115685$3$F$20230201$20240307$20240721$20240721$PER$$US-NOVOPROD-1187728$NOVO NORDISK$$69$YR$$F$Y$$$20240721$$CN$US$US
241156861$24115686$1$I$20240201$20240306$20240721$20240721$PER$$US-NOVOPROD-1188526$NOVO NORDISK$$60$YR$$F$Y$$$20240721$$CN$US$US
241156871$24115687$1$I$20240124$20240321$20240721$20240721$PER$$US-NOVOPROD-1188614$NOVO NORDISK$$22$YR$$F$Y$$$20240721$$PH$US$US
241156881$24115688$1$I$$20240530$20240721$20240721$PER$$US-NOVOPROD-1188410$NOVO NORDISK$$$$$$Y$$$20240721$$CN$US$US
241156891$24115689$1$I$$20240301$20240721$20240721$PER$$US-NOVOPROD-1188636$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156901$24115690$1$I$20240308$20240308$20240721$20240721$PER$$US-NOVOPROD-1189784$NOVO NORDISK$$38$YR$$F$Y$$$20240721$$HP$US$US
241156911$24115691$1$I$20220801$20240307$20240721$20240721$PER$$US-NOVOPROD-1191258$NOVO NORDISK$$41$YR$$F$Y$$$20240721$$CN$US$US
241156921$24115692$1$I$20231001$20240307$20240721$20240721$PER$$US-NOVOPROD-1189974$NOVO NORDISK$$53$YR$$F$Y$$$20240721$$CN$US$US
241156931$24115693$1$I$$20240611$20240721$20240721$PER$$US-NOVOPROD-1189814$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241156941$24115694$1$I$$20240515$20240721$20240721$PER$$US-NOVOPROD-1190635$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241156951$24115695$1$I$20240308$20240314$20240721$20240721$PER$$US-NOVOPROD-1191786$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$CN$US$US
241156961$24115696$1$I$$20240308$20240721$20240721$PER$$US-NOVOPROD-1191123$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156971$24115697$1$I$20230901$20240311$20240721$20240721$PER$$US-NOVOPROD-1191030$NOVO NORDISK$$48$YR$$F$Y$$$20240721$$CN$US$US
241156981$24115698$1$I$$20240307$20240721$20240721$PER$$US-NOVOPROD-1189581$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241156991$24115699$1$I$$20240312$20240721$20240721$PER$$US-NOVOPROD-1191955$NOVO NORDISK$$$$$M$Y$$$20240721$$CN$US$US
241157001$24115700$1$I$$20240313$20240721$20240721$PER$$US-NOVOPROD-1190976$NOVO NORDISK$$$$$F$Y$$$20240721$$HP$US$US
241157011$24115701$1$I$$20240308$20240721$20240721$PER$$US-NOVOPROD-1190509$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241157021$24115702$1$I$20240222$20240307$20240721$20240721$PER$$US-NOVOPROD-1190530$NOVO NORDISK$$49$YR$$F$Y$$$20240721$$CN$US$US
241157031$24115703$1$I$$20240308$20240721$20240721$PER$$US-NOVOPROD-1189628$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241157041$24115704$1$I$20230901$20240305$20240721$20240721$PER$$US-NOVOPROD-1187797$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241157051$24115705$1$I$$20240308$20240721$20240721$PER$$US-NOVOPROD-1190487$NOVO NORDISK$$$$$$Y$$$20240721$$HP$US$US
241157061$24115706$1$I$$20240312$20240721$20240721$PER$$US-NOVOPROD-1190997$NOVO NORDISK$$$$A$$Y$$$20240721$$CN$US$US
241157071$24115707$1$I$20240304$20240507$20240721$20240721$PER$$US-NOVOPROD-1187731$NOVO NORDISK$$67$YR$$F$Y$$$20240721$$CN$US$US
241157081$24115708$1$I$$20240313$20240721$20240721$PER$$US-NOVOPROD-1193264$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241157091$24115709$1$I$$20240520$20240721$20240721$PER$$US-NOVOPROD-1192053$NOVO NORDISK$$$$A$F$Y$82$KG$20240721$$MD$US$US
241157102$24115710$2$F$20231101$20240314$20240721$20240721$PER$$US-NOVOPROD-1192515$NOVO NORDISK$$61$YR$$F$Y$$$20240721$$CN$US$US
241157111$24115711$1$I$$20240314$20240721$20240721$PER$$US-NOVOPROD-1192640$NOVO NORDISK$$$$$F$Y$$$20240721$$MD$US$US
241157122$24115712$2$F$$20240314$20240721$20240721$PER$$US-NOVOPROD-1192642$NOVO NORDISK$$$$$M$Y$$$20240721$$MD$US$US
241157133$24115713$3$F$$20240313$20240721$20240721$PER$$US-NOVOPROD-1193769$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241157141$24115714$1$I$20240311$20240314$20240721$20240721$PER$$US-NOVOPROD-1192483$NOVO NORDISK$$34$YR$$F$Y$$$20240721$$CN$US$US
241157151$24115715$1$I$$20240312$20240721$20240721$PER$$US-NOVOPROD-1192162$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241157161$24115716$1$I$20240313$20240313$20240721$20240721$PER$$US-NOVOPROD-1192712$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241157171$24115717$1$I$$20240312$20240721$20240721$PER$$US-NOVOPROD-1192422$NOVO NORDISK$$$$A$F$Y$123.8$KG$20240721$$CN$US$US
241157181$24115718$1$I$$20240316$20240721$20240721$PER$$US-NOVOPROD-1193700$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241157191$24115719$1$I$$20240312$20240721$20240721$PER$$US-NOVOPROD-1192718$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241157201$24115720$1$I$20240301$20240325$20240721$20240721$PER$$US-NOVOPROD-1192362$NOVO NORDISK$$49$YR$$F$Y$$$20240721$$CN$US$US
241157211$24115721$1$I$$20240312$20240721$20240721$PER$$US-NOVOPROD-1192059$NOVO NORDISK$$$$A$M$Y$$$20240721$$CN$US$US
241157221$24115722$1$I$$20240313$20240721$20240721$PER$$US-NOVOPROD-1193608$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241157231$24115723$1$I$$20240315$20240721$20240721$PER$$US-NOVOPROD-1193669$NOVO NORDISK$$44$YR$$F$Y$$$20240721$$HP$US$US
241157241$24115724$1$I$$20240316$20240721$20240721$PER$$US-NOVOPROD-1193705$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241157251$24115725$1$I$$20240319$20240721$20240721$PER$$US-NOVOPROD-1194865$NOVO NORDISK$$52$YR$$F$Y$$$20240721$$MD$US$US
241157261$24115726$1$I$$20240112$20240721$20240721$PER$$US-NOVOPROD-1194511$NOVO NORDISK$$$$A$F$Y$$$20240721$$CN$US$US
241157271$24115727$1$I$$20240304$20240721$20240721$PER$$US-NOVOPROD-1193926$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241157281$24115728$1$I$$20240320$20240721$20240721$PER$$US-NOVOPROD-1194568$NOVO NORDISK$$$$$F$Y$$$20240721$$PH$US$US
241157291$24115729$1$I$20240127$20240313$20240721$20240721$PER$$US-NOVOPROD-1193788$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241157301$24115730$1$I$20220101$20240306$20240721$20240721$PER$$US-NOVOPROD-1194604$NOVO NORDISK$$26$YR$$M$Y$$$20240721$$CN$US$US
241157311$24115731$1$I$20240210$20240315$20240721$20240721$PER$$US-NOVOPROD-1193841$NOVO NORDISK$$39$YR$$F$Y$$$20240721$$CN$US$US
241157321$24115732$1$I$20230601$20240426$20240721$20240721$PER$$US-NOVOPROD-1194504$NOVO NORDISK$$55$YR$$M$Y$139.68$KG$20240721$$MD$US$US
241157331$24115733$1$I$$20240315$20240721$20240721$PER$$US-NOVOPROD-1194015$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241157341$24115734$1$I$$20240313$20240721$20240721$PER$$US-NOVOPROD-1193820$NOVO NORDISK$$$$$F$Y$$$20240721$$CN$US$US
241157351$24115735$1$I$20240310$20240320$20240721$20240721$PER$$US-NOVOPROD-1194318$NOVO NORDISK$$42$YR$$F$Y$$$20240721$$CN$US$US
241157361$24115736$1$I$$20240711$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010377$DR REDDYS$Khadraoui H, Herzog TJ, Jackson A, Billingsley C. Acute pulmonary complications in the setting of high risk gestational trophoblastic neoplasia and induction of chemotherapy. Gynecologic Oncology Reports. 2023;48: doi:10.1016/j.gore.2023.101224.$33$YR$A$F$Y$$$20240721$$HP$US$US
241157371$24115737$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407010529$ELI LILLY AND CO$$$$$F$Y$$$20240721$$CN$US$US
241157381$24115738$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011096$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240721$$CN$US$US
241157392$24115739$2$F$$20240715$20240721$20240731$PER$$US-AstraZeneca-2024A161365$ASTRAZENECA$$$$$$Y$$$20240731$$CN$US$
241157401$24115740$1$I$$20240711$20240721$20240721$PER$$US-009507513-2407USA008682$MERCK$$$$$$Y$$$20240721$$CN$US$US
241157412$24115741$2$F$20240101$20240806$20240721$20240809$PER$$US-AMGEN-USASL2024125621$AMGEN$$76$YR$E$F$Y$$$20240809$$CN$US$US
241157421$24115742$1$I$$20240711$20240721$20240721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111430$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240721$$HP$US$US
241157433$24115743$3$F$20240501$20240723$20240721$20240802$EXP$$BR-BAYER-2024A100334$BAYER$$61$YR$A$M$Y$$$20240802$$CN$BR$BR
241157441$24115744$1$I$$20240711$20240721$20240721$PER$$US-BAYER-2024A105344$BAYER$$$$$F$Y$$$20240719$$CN$US$US
241157451$24115745$1$I$20240714$20240718$20240721$20240721$EXP$$JP-BAYER-2024A105165$BAYER$$7$DEC$E$M$Y$$$20240719$$MD$JP$JP
241157461$24115746$1$I$$20240711$20240721$20240721$PER$$US-BAYER-2024A105364$BAYER$$$$$M$Y$$$20240719$$CN$US$US
241157471$24115747$1$I$$20240716$20240721$20240721$EXP$$US-BAYER-2024A104162$BAYER$$55$YR$A$M$Y$$$20240719$$CN$US$US
241157481$24115748$1$I$$20240717$20240721$20240721$EXP$$US-BAYER-2024A104093$BAYER$$$$$$Y$$$20240719$$CN$US$US
241157493$24115749$3$F$$20240820$20240721$20240821$PER$$US-BAYER-2024A101514$BAYER$$$$$$Y$$$20240821$$CN$US$US
241157501$24115750$1$I$20210102$20240715$20240721$20240721$EXP$LV-SAM-2024078282$LV-BAYER-2024A101407$BAYER$$21$YR$A$F$Y$60$KG$20240719$$CN$LV$LV
241157511$24115751$1$I$20240715$20240718$20240721$20240721$PER$$US-BAYER-2024A104904$BAYER$$23$YR$A$F$Y$$$20240719$$MD$US$US
241157521$24115752$1$I$$20240712$20240721$20240721$EXP$$ZA-BAYER-2024A100968$BAYER$$45$YR$A$F$Y$$$20240719$$CN$ZA$ZA
241157531$24115753$1$I$$20240717$20240721$20240721$PER$$US-BAYER-2024A104070$BAYER$$$$$$Y$$$20240719$$CN$US$US
241157541$24115754$1$I$20240627$20240718$20240721$20240721$PER$$US-BAYER-2024A104901$BAYER$$37$YR$A$F$Y$$$20240719$$MD$US$US
241157552$24115755$2$F$$20240715$20240721$20240724$EXP$$CA-BAYER-2024A104069$BAYER$$83$YR$E$M$Y$$$20240724$$HP$CA$CA
241157561$24115756$1$I$20221201$20240530$20240721$20240721$EXP$$FR-BAYER-2024A066372$BAYER$$71$YR$E$M$Y$$$20240719$$PH$FR$FR
241157571$24115757$1$I$20240425$20240712$20240721$20240721$EXP$$CN-BAYER-2024A101200$BAYER$$4$WK$I$M$Y$4$KG$20240719$$HP$CN$CN
241157581$24115758$1$I$$20240717$20240721$20240721$PER$$US-BAYER-2024A104251$BAYER$$31$YR$A$F$Y$$$20240719$$HP$US$US
241157591$24115759$1$I$20240715$20240717$20240721$20240721$PER$$US-BAYER-2024A104250$BAYER$$21$YR$A$F$Y$$$20240719$$CN$US$US
241157601$24115760$1$I$20240603$20240717$20240721$20240721$PER$$US-BAYER-2024A104232$BAYER$$18$YR$A$F$Y$$$20240719$$MD$US$US
241157611$24115761$1$I$$20240716$20240721$20240721$PER$$US-BAYER-2024A104064$BAYER$$37$YR$A$F$Y$$$20240719$$MD$US$US
241157622$24115762$2$F$$20240724$20240721$20240730$PER$$US-BAYER-2024A104059$BAYER$$22$YR$A$F$Y$61.9$KG$20240730$$HP$US$US
241157631$24115763$1$I$20240620$20240716$20240721$20240721$PER$$US-BAYER-2024A103566$BAYER$$34$YR$A$F$Y$$$20240719$$HP$US$US
241157643$24115764$3$F$$20240723$20240721$20240809$EXP$$US-BAYER-2024A101314$BAYER$$61$YR$A$F$Y$90.703$KG$20240809$$CN$US$US
241157651$24115765$1$I$$20240716$20240721$20240721$PER$$US-BAYER-2024A103402$BAYER$$40$YR$A$F$Y$$$20240719$$HP$US$US
241157661$24115766$1$I$20240101$20240715$20240721$20240721$PER$$US-BAYER-2024A101512$BAYER$$39$YR$A$F$Y$$$20240719$$MD$US$US
241157671$24115767$1$I$$20240716$20240721$20240721$EXP$$CO-BAYER-2024A104345$BAYER$$45$YR$A$F$Y$$$20240719$$CN$CO$CO
241157681$24115768$1$I$20240501$20240718$20240721$20240721$EXP$FR-AFSSAPS-RN2024000770$FR-BAYER-2024A104699$BAYER$$80$YR$E$M$Y$$$20240719$$MD$FR$FR
241157691$24115769$1$I$$20240708$20240721$20240721$EXP$$TH-BAYER-2024A097942$BAYER$$$$$$Y$$$20240719$$HP$TH$TH
241157701$24115770$1$I$20240701$20240717$20240721$20240721$EXP$RU-RZN-2461497$RU-BAYER-2024A104708$BAYER$$82$YR$E$M$Y$98$KG$20240719$$HP$RU$RU
241157711$24115771$1$I$$20240708$20240721$20240721$EXP$$US-BAYER-2024A098467$BAYER$$45$YR$A$F$Y$45.5$KG$20240719$$CN$US$US
241157722$24115772$2$F$$20240708$20240721$20240725$EXP$$HU-BAYER-2024A100325$BAYER$$$$$$Y$$$20240725$$CN$HU$HU
241157731$24115773$1$I$20240624$20240712$20240721$20240721$EXP$$CN-BAYER-2024A101794$BAYER$$32$YR$A$F$Y$$$20240719$$HP$CN$CN
241157751$24115775$1$I$$20240710$20240721$20240721$EXP$$US-BAYER-2024A104560$BAYER$Opaskar A.; Shammassian B.; Yaghmoor B.; Sundararajan S.. Postcarotid Endarterectomy Reperfusion Injury and Hemorrhage. Stroke. 2024;55:7:e195-e198$71$YR$E$F$Y$$$20240719$$MD$US$US
241157761$24115776$1$I$20240628$20240711$20240721$20240721$EXP$$US-BAYER-2024A101002$BAYER$$57$YR$A$M$Y$$$20240719$$CN$US$US
241157772$24115777$2$F$20240627$20240726$20240721$20240731$EXP$$US-BAYER-2024A104321$BAYER$$72$YR$E$M$Y$57.596$KG$20240731$$HP$US$US
241157781$24115778$1$I$$20240709$20240721$20240721$EXP$$DE-RDY-LIT/DEU/24/0010388$DR REDDYS$Cremer A, Enssle JC, Pfaff S, Kouidri K, Brandts C, Zeiher A, et al. Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML. Annals of Hematology. 2023 Oct;102: 2903-2908. doi:10.1007/s00277-023-05396-y.$$$$$Y$$$20240721$$HP$DE$DE
241157791$24115779$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012077$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240721$$CN$US$US
241157801$24115780$1$I$$20240710$20240721$20240721$EXP$$US-RDY-LIT/USA/24/0010467$DR REDDYS$Saigal K, Maleki A. Intravitreal Fluocinolone Acetonide 0.19 mg Implant in a Patient with Resistant Blau Syndrome: A Case Report. Case Reports in Ophthalmology. 2024 Jan 19;15(1): 63-70. doi:10.1159/000535984.$$$$F$Y$$$20240721$$HP$US$US
241157811$24115781$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012107$ELI LILLY AND CO$$$$$F$Y$$$20240721$$CN$US$US
241157821$24115782$1$I$$20240716$20240721$20240721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113844$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240721$$HP$US$US
241157831$24115783$1$I$20240716$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012130$ELI LILLY AND CO$$$$$$Y$$$20240721$$CN$US$US
241157841$24115784$1$I$$20240717$20240721$20240721$PER$$US-ROCHE-10000030721$ROCHE$$13$YR$T$M$Y$67.7$KG$20240721$$CN$US$US
241157851$24115785$1$I$$20240708$20240721$20240721$PER$$US-RDY-SPO/USA/24/0010176$DR REDDYS$$75$YR$E$F$Y$$$20240721$$CN$US$US
241157862$24115786$2$F$$20240821$20240721$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113537$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240826$$CN$US$US
241157871$24115787$1$I$20240715$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011593$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240721$$CN$US$US
241157881$24115788$1$I$20240708$20240718$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012181$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240721$$CN$US$US
241157892$24115789$2$F$20240706$20240826$20240721$20240827$PER$$US-ROCHE-10000030098$ROCHE$$14$YR$T$M$Y$$$20240827$$CN$US$US
241157901$24115790$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011514$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240721$$CN$US$US
241157911$24115791$1$I$20240718$20240718$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012211$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240721$$CN$US$US
241157921$24115792$1$I$20240619$20240718$20240721$20240721$EXP$FR-AFSSAPS-BX2024001334$FR-ROCHE-10000030708$ROCHE$$82$YR$E$F$Y$57$KG$20240721$$HP$FR$FR
241157931$24115793$1$I$$20240718$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407012353$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240721$$CN$US$US
241157941$24115794$1$I$$20240716$20240721$20240721$PER$$US-ROCHE-10000028595$ROCHE$$$$E$M$Y$96$KG$20240721$$CN$US$US
241157951$24115795$1$I$20240118$20240715$20240721$20240721$EXP$FR-AFSSAPS-TO2024001132$FR-ROCHE-10000026934$ROCHE$$63$YR$A$F$Y$$$20240721$$PH$FR$FR
241157961$24115796$1$I$$20240716$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407010532$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240721$$CN$US$US
241157971$24115797$1$I$$20240715$20240721$20240721$EXP$$JP-ROCHE-10000031047$ROCHE$$$$A$$Y$$$20240721$$MD$JP$JP
241157991$24115799$1$I$20240705$20240712$20240721$20240721$EXP$$CN-ROCHE-10000026480$ROCHE$$55$YR$A$F$Y$55$KG$20240721$$HP$CN$CN
241158001$24115800$1$I$$20240712$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202406002536$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240721$$CN$US$US
241158011$24115801$1$I$$20240718$20240721$20240721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115219$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$108$KG$20240721$$PH$US$US
241158021$24115802$1$I$$20240717$20240721$20240721$EXP$$NVSC2024US044589$NOVARTIS$$$$$M$Y$$$20240721$$CN$US$US
241158031$24115803$1$I$20161201$20240719$20240721$20240721$EXP$$PHHY2019FR001207$NOVARTIS$$51$YR$$F$Y$94$KG$20240721$$MD$FR$FR
241158042$24115804$2$F$$20240715$20240721$20240801$EXP$$NVSC2024CN148654$NOVARTIS$Zhao Y, Ma HH, Wang D, Lian HY, Wang TY, Zhang R.. [Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis]. [Chinese]. ZHONGHUA-ER-KE-ZA-ZHI. 2024;62:60-5$3$YR$$M$Y$$$20240801$$HP$CN$CN
241158052$24115805$2$F$20240306$20240715$20240721$20240724$EXP$$IT-HQ SPECIALTY-IT-2024INT000070$INTERCHEM$$8$DY$$F$Y$$$20240724$$MD$IT$IT
241158061$24115806$1$I$20240306$20240709$20240721$20240721$EXP$$IT-HQ SPECIALTY-IT-2024INT000069$INTERCHEM$$14$DY$$F$Y$$$20240719$$MD$IT$IT
241158071$24115807$1$I$$20231120$20240721$20240721$EXP$$US-ALIMERA SCIENCES LIMITED-US-A16013-23-000765$ALIMERA$Nita Valikodath and Lejla Vajzovic. Fluocinolone Acetonide Implant Removal From the Vitreous Cavity. Journal of VitreoRetinal Diseases. 2023;7(6):533- 53$73$YR$$F$Y$$$20240719$$MD$US$US
241158081$24115808$1$I$$20240708$20240721$20240721$EXP$$US-ACORDA-ACO_177537_2024$ACORDA$$$$$F$Y$$$20240719$$CN$US$US
241158095$24115809$5$F$20240101$20240906$20240721$20240918$EXP$$US-INSMED, INC.-2024-02281-US$INSMED$$$$$M$Y$$$20240918$$CN$US$US
241158101$24115810$1$I$20221224$20240709$20240721$20240721$EXP$$US-LANNETT COMPANY, INC.-US-2024LAN000162$LANNETT$$33$YR$$F$Y$101.59$KG$20240719$$CN$US$US
241158111$24115811$1$I$$20240711$20240721$20240721$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001107$AKEBIA THERAPEUTICS$$9$DEC$$F$Y$$$20240719$$PH$JP$JP
241158121$24115812$1$I$$20240707$20240721$20240721$EXP$$JP-INSMED, INC.-2024-02797-JP$INSMED$$$$$F$Y$$$20240719$$MD$JP$JP
241158131$24115813$1$I$$20240709$20240721$20240721$EXP$$US-INSMED, INC.-2024-02826-US$INSMED$$$$$F$Y$$$20240719$$CN$US$US
241158144$24115814$4$F$20240101$20240912$20240721$20240923$EXP$$US-INSMED, INC.-2024-02823-US$INSMED$$$$$M$Y$$$20240923$$CN$US$US
241158152$24115815$2$F$$20240723$20240721$20240806$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001104$AKEBIA THERAPEUTICS$$$$$$Y$$$20240806$$MD$JP$JP
241158162$24115816$2$F$20210217$20240723$20240721$20240806$EXP$$JP-AKEBIA THERAPEUTICS, INC.-JP-AKEB-22-022457$AKEBIA THERAPEUTICS$$$$$$Y$$$20240806$$MD$JP$JP
241158171$24115817$1$I$$20240709$20240721$20240721$EXP$$US-KERYX BIOPHARMACEUTICALS INC.-US-AKEB-24-001090$AKEBIA THERAPEUTICS$$$$$M$Y$$$20240719$$HP$US$US
241158181$24115818$1$I$$20240718$20240721$20240721$PER$$US-AstraZeneca-2024A164460$ASTRAZENECA$$$$$F$Y$$$20240721$$HP$US$
241158191$24115819$1$I$$20240712$20240721$20240721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113404$BRISTOL MYERS SQUIBB$$59$YR$A$$Y$$$20240721$$PH$US$US
241158201$24115820$1$I$$20240712$20240721$20240721$EXP$$CN-ROCHE-10000026242$ROCHE$Tang Y. Effect of emergency intravenous thrombolysis with alteplase on prognosis in elderly patients with acute ischemic stroke. Contemporary Medical Symposium. 2024 Apr;22(10): 81-84.$$$E$$Y$$$20240721$$MD$CN$CN
241158214$24115821$4$F$$20240723$20240721$20240726$EXP$$US-AMGEN-USASP2024138596$AMGEN$$$$A$F$Y$$$20240726$$PH$US$US
241158222$24115822$2$F$20240704$20240722$20240721$20240725$EXP$$US-LEX-000394$LEXICON PHARMACEUTICALS$$72$YR$$M$Y$$$20240725$$CN$US$US
241158231$24115823$1$I$20240607$20240708$20240721$20240721$PER$$US-RDY-SPO/USA/24/0010174$DR REDDYS$$20$YR$A$F$Y$$$20240722$$MD$US$US
241158241$24115824$1$I$20240614$20240708$20240721$20240721$PER$$US-RDY-SPO/USA/24/0010214$DR REDDYS$$16$YR$T$$Y$$$20240722$$HP$US$US
241158251$24115825$1$I$$20240709$20240721$20240721$PER$$US-RDY-SPO/USA/24/0010215$DR REDDYS$$63$YR$A$F$Y$$$20240722$$MD$US$US
241158262$24115826$2$F$$20240718$20240721$20240724$EXP$$BD-SANDOZ INC.-SDZ2024BD066223$SANDOZ$$$$$F$Y$$$20240724$$CN$BD$BD
241158271$24115827$1$I$20240511$20240718$20240721$20240721$EXP$$GB-SANDOZ INC.-SDZ2024GB066576$SANDOZ$$64$YR$$M$Y$78$KG$20240721$$MD$GB$GB
241158282$24115828$2$F$20240610$20240805$20240721$20240806$EXP$$JP-TAKEDA-2024TJP010680$TAKEDA$$19$YR$$F$Y$$$20240806$$MD$JP$JP
241158291$24115829$1$I$20240101$20240715$20240721$20240721$PER$$US-AMGEN-USASP2024141602$AMGEN$$45$YR$A$F$Y$$$20240721$$HP$US$US
241158301$24115830$1$I$$20240716$20240721$20240721$PER$$US-AMGEN-USASP2024143446$AMGEN$$$$A$M$Y$$$20240721$$HP$US$US
241158311$24115831$1$I$$20240715$20240721$20240721$EXP$AU-TAKEDA-2024TUS062705$AU-SANDOZ INC.-SDZ2024AU065604$SANDOZ$$68$YR$$M$Y$$$20240721$$MD$AU$AU
241158321$24115832$1$I$20240626$20240717$20240721$20240721$EXP$$JP-TAKEDA-2024TJP010740$TAKEDA$$10$DEC$$F$Y$$$20240721$$MD$JP$JP
241158331$24115833$1$I$$20240719$20240721$20240721$PER$$NVSC2024US149227$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
241158342$24115834$2$F$20240606$20240806$20240721$20240902$PER$$US-BEIGENE-BGN-2024-010066$BEIGENE$$$$$$Y$$$20240902$$PH$US$US
241158353$24115835$3$F$20240701$20240829$20240721$20240903$30DAY$$US-AMGEN-USASP2024141645$AMGEN$$65$YR$E$M$Y$85.714$KG$20240903$$PH$US$US
241158361$24115836$1$I$$20240719$20240721$20240721$PER$$NVSC2024US149228$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
241158371$24115837$1$I$$20240701$20240721$20240721$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06565$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241158381$24115838$1$I$$20240219$20240721$20240721$PER$$US-NOVOPROD-1180690$NOVO NORDISK$$$$A$M$Y$$$20240722$$CN$US$US
241158391$24115839$1$I$20240628$20240705$20240721$20240721$EXP$GB-MHRA-MED-202407051751398890-PQYDJ$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001770$IPCA$$$$$$Y$$$20240719$$CN$GB$GB
241158401$24115840$1$I$$20240716$20240721$20240721$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-113949$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240722$$HP$CA$CA
241158411$24115841$1$I$$20240716$20240721$20240721$EXP$$CA-SANDOZ INC.-SDZ2024CA066200$SANDOZ$$73$YR$$F$Y$47$KG$20240721$$HP$CA$CA
241158421$24115842$1$I$20240409$20240705$20240721$20240721$EXP$GB-MHRA-MED-202405031722069410-PYKRH$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001764$IPCA$$$$$$Y$$$20240719$$CN$GB$GB
241158431$24115843$1$I$20240328$20240716$20240721$20240721$EXP$FR-AFSSAPS-BS2024000421$FR-SANDOZ INC.-SDZ2024FR066277$SANDOZ$$75$YR$$M$Y$85$KG$20240721$$MD$FR$FR
241158441$24115844$1$I$20240715$20240715$20240721$20240721$EXP$$US-SANDOZ INC.-SDZ2024US066455$SANDOZ$$42$YR$$M$Y$$$20240721$$CN$US$US
241158451$24115845$1$I$$20240705$20240721$20240721$EXP$GB-MHRA-MED-202405161648088610-SHLVP$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001759$IPCA$$$$$$Y$$$20240719$$PH$GB$GB
241158463$24115846$3$F$$20240910$20240721$20240918$EXP$$CA-SANDOZ INC.-SDZ2024CA055506$SANDOZ$$43$YR$$F$Y$96$KG$20240918$$MD$CA$CA
241158472$24115847$2$F$$20240726$20240721$20240731$EXP$NL-LRB-00981554$NL-ABBVIE-5844571$ABBVIE$$57$YR$$M$Y$70$KG$20240731$$CN$NL$NL
241158484$24115848$4$F$$20240830$20240721$20240903$EXP$$AU-SANDOZ INC.-SDZ2024AU065911$SANDOZ$$52$YR$$M$Y$$$20240903$$HP$AU$AU
241158491$24115849$1$I$20240702$20240712$20240721$20240721$EXP$$CN-BEIGENE-BGN-2024-010922$BEIGENE$$$$$$Y$$$20240721$$HP$CN$CN
241158501$24115850$1$I$20240627$20240712$20240721$20240721$EXP$$CN-BEIGENE-BGN-2024-010903$BEIGENE$$$$$$Y$$$20240721$$HP$CN$CN
241158511$24115851$1$I$20240613$20240712$20240721$20240721$EXP$$CN-BEIGENE-BGN-2024-010989$BEIGENE$$$$$$Y$$$20240721$$MD$CN$CN
241158521$24115852$1$I$$20240717$20240721$20240721$EXP$$JP-TAKEDA-2024TJP010651$TAKEDA$$$$C$M$Y$$$20240721$$MD$JP$JP
241158531$24115853$1$I$20240604$20240712$20240721$20240721$EXP$$CN-BEIGENE-BGN-2024-010931$BEIGENE$$$$$$Y$$$20240721$$HP$CN$CN
241158541$24115854$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011532$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240721$$CN$US$US
241158551$24115855$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011351$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240721$$CN$US$US
241158563$24115856$3$F$20220617$20240718$20240721$20240730$EXP$$AT-TEVA-VS-3221044$TEVA$$29$YR$$M$Y$88.2$KG$20240730$$HP$AT$AT
241158571$24115857$1$I$$20240716$20240721$20240721$PER$$US-AMGEN-USASP2024141623$AMGEN$$$$$$Y$$$20240721$$PH$US$US
241158581$24115858$1$I$20240705$20240712$20240721$20240721$EXP$$CN-BEIGENE-BGN-2024-010911$BEIGENE$$$$$$Y$$$20240721$$HP$CN$CN
241158591$24115859$1$I$$20240718$20240721$20240721$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115306$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$65$KG$20240722$$PH$CA$CA
241158601$24115860$1$I$20240628$20240712$20240721$20240721$EXP$$CN-BEIGENE-BGN-2024-010921$BEIGENE$$$$$$Y$$$20240721$$HP$CN$CN
241158621$24115862$1$I$$20240711$20240721$20240721$EXP$$GB-CELLTRION INC.-2024GB017215$CELLTRION$$$$$$Y$$$20240722$$CN$GB$GB
241158631$24115863$1$I$$20240711$20240721$20240721$EXP$$US-SANDOZ INC.-SDZ2024US066601$SANDOZ$$$$$$Y$$$20240721$$PH$US$US
241158643$24115864$3$F$$20240816$20240721$20240821$PER$$US-AMGEN-USASP2024142362$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
241158651$24115865$1$I$$20240717$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202407011670$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240721$$CN$US$US
241158671$24115867$1$I$20240101$20240710$20240721$20240721$EXP$$CA-CELLTRION INC.-2023CA012698$CELLTRION$$$$$$Y$$$20240722$$MD$CA$CA
241158681$24115868$1$I$$20240717$20240721$20240721$EXP$$US-ABBVIE-5844372$ABBVIE$$$$$F$Y$$$20240721$$CN$US$US
241158691$24115869$1$I$$20240718$20240721$20240721$EXP$$US-SANDOZ INC.-SDZ2024US066762$SANDOZ$$$$$$Y$$$20240721$$CN$US$US
241158701$24115870$1$I$20240620$20240719$20240721$20240721$EXP$$NVSC2024DE149028$NOVARTIS$$77$YR$$M$Y$$$20240722$$CN$DE$DE
241158711$24115871$1$I$$20240624$20240721$20240721$EXP$$ES-ABBVIE-21K-144-3823640-00$ABBVIE$Rey Bua B, Jimenez Ubieto A, Javier Sanchez Blanco J, Abrisqueta P, Gutierrez A, Ramirez Payer A et al. Ibrutinib in Combination with R-Gemox-D in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Phase II Clinical Trial of the Geltamo Group. Blood. 2020; 136 (SUPPL1):16-17.$$$$$Y$$$20240721$$HP$ES$ES
241158721$24115872$1$I$$20240716$20240721$20240721$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114075$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240722$$MD$US$US
241158731$24115873$1$I$$20240717$20240721$20240721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114633$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$95.71$KG$20240722$$HP$US$US
241158741$24115874$1$I$20240703$20240705$20240721$20240721$EXP$$JP-CHATTEMPRD-2024OHG024365$CHATTEM$$34$YR$A$F$Y$$$20240719$$PH$JP$JP
241158751$24115875$1$I$$20240711$20240721$20240721$EXP$$CA-APOTEX-2024AP008277$APOTEX$$71$YR$$F$Y$$$20240721$$HP$CA$CA
241158761$24115876$1$I$20240620$20240715$20240721$20240721$PER$$US-AMGEN-USASP2024140583$AMGEN$$69$YR$E$F$Y$$$20240721$$CN$US$US
241158772$24115877$2$F$20240603$20240814$20240721$20240819$EXP$$PE-AMGEN-PERSP2024120052$AMGEN$$70$YR$E$F$Y$$$20240818$$CN$PE$PE
241158782$24115878$2$F$20240627$20240729$20240721$20240801$EXP$$US-SANDOZ INC.-SDZ2024US065785$SANDOZ$$64$YR$$F$Y$58.5$KG$20240801$$MD$US$US
241158791$24115879$1$I$20240620$20240719$20240721$20240721$PER$$US-AMGEN-USASP2024144399$AMGEN$$21$YR$A$F$Y$$$20240721$$HP$US$US
241158801$24115880$1$I$20240629$20240710$20240721$20240721$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2159394$JIANGSU HENGRUI MEDICINE$$73$YR$$M$Y$68$KG$20240721$$MD$CN$CN
241158811$24115881$1$I$$20240718$20240721$20240721$EXP$$US-ABBVIE-5845385$ABBVIE$$$$$M$Y$$$20240721$$CN$US$US
241158821$24115882$1$I$20240626$20240717$20240721$20240721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114361$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240722$$CN$US$US
241158831$24115883$1$I$20240710$20240712$20240721$20240721$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-112075$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240722$$HP$RU$RU
241158842$24115884$2$F$20240301$20240731$20240721$20240803$EXP$$US-ABBVIE-5844411$ABBVIE$$66$YR$$F$Y$83.915$KG$20240803$$CN$US$US
241158851$24115885$1$I$20240101$20240711$20240721$20240721$EXP$$CA-ABBVIE-5845989$ABBVIE$$63$YR$$M$Y$$$20240721$$CN$CA$CA
241158861$24115886$1$I$$20240712$20240721$20240721$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001414$BLUEPRINT MEDICINES$$$$$F$Y$$$20240719$$MD$US$US
241158871$24115887$1$I$$20240711$20240721$20240721$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001409$BLUEPRINT MEDICINES$$$$$F$Y$$$20240719$$CN$US$US
241158881$24115888$1$I$$20240711$20240721$20240721$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001408$BLUEPRINT MEDICINES$$$$$F$Y$$$20240719$$CN$US$US
241158891$24115889$1$I$$20240712$20240721$20240721$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001420$BLUEPRINT MEDICINES$$$$$F$Y$$$20240719$$CN$US$US
241158901$24115890$1$I$$20240711$20240721$20240721$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-000946$BLUEPRINT MEDICINES$$$$$F$Y$$$20240719$$CN$US$US
241158921$24115892$1$I$$20240712$20240721$20240721$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001412$BLUEPRINT MEDICINES$$$$$F$Y$$$20240719$$CN$US$US
241158931$24115893$1$I$20240616$20240712$20240721$20240721$EXP$$CN-BEIGENE-BGN-2024-010910$BEIGENE$$$$$$Y$$$20240721$$HP$CN$CN
241158941$24115894$1$I$20240601$20240715$20240721$20240721$EXP$$US-ABBVIE-5842279$ABBVIE$$27$YR$$M$Y$$$20240721$$CN$US$US
241158951$24115895$1$I$$20240710$20240721$20240721$PER$$US-ELI_LILLY_AND_COMPANY-US202404011251$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240721$$HP$US$US
241158961$24115896$1$I$$20240715$20240721$20240721$PER$$US-ALXN-202407USA000937US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
241158971$24115897$1$I$20240711$20240716$20240721$20240721$EXP$$US-ABBVIE-5844614$ABBVIE$$52$YR$$M$Y$$$20240721$$CN$US$US
241158981$24115898$1$I$$20240717$20240721$20240721$PER$$NVSC2024US149283$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
241158992$24115899$2$F$20240101$20240710$20240721$20240803$EXP$$CA-CELLTRION INC.-2024CA017292$CELLTRION$$$$$$Y$$$20240803$$CN$CA$CA
241159001$24115900$1$I$$20240716$20240721$20240721$EXP$$DE-ABBVIE-5845663$ABBVIE$$$$$F$Y$$$20240721$$CN$DE$DE
241159011$24115901$1$I$$20240715$20240721$20240721$EXP$$CA-GENMAB-2024-02605$GENMAB$$75$YR$$F$Y$$$20240722$$HP$CA$CA
241159021$24115902$1$I$$20240702$20240721$20240721$PER$$US-BEH-2024175179$CSL BEHRING$$$$A$F$Y$136.05$KG$20240721$$HP$US$US
241159032$24115903$2$F$$20240718$20240721$20240724$EXP$$IT-GENMAB-2024-02606$GENMAB$$$$$F$Y$$$20240724$$MD$IT$IT
241159051$24115905$1$I$20230101$20240712$20240721$20240721$PER$$US-BAUSCHBL-2024BNL014573$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240722$$CN$US$US
241159061$24115906$1$I$$20240717$20240721$20240721$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114331$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240722$$HP$US$US
241159071$24115907$1$I$$20240717$20240721$20240721$PER$$US-AMGEN-USASP2024142104$AMGEN$$$$$F$Y$$$20240721$$CN$US$US
241159081$24115908$1$I$$20240717$20240721$20240721$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115150$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240722$$CN$US$US
241159092$24115909$2$F$20240716$20240725$20240721$20240730$PER$$US-AMGEN-USASP2024142968$AMGEN$$68$YR$E$F$Y$$$20240730$$CN$US$US
241159102$24115910$2$F$$20240716$20240721$20240721$PER$$US-ROCHE-10000029498$ROCHE$$66$YR$E$F$Y$$$20240722$$MD$US$US
241159111$24115911$1$I$20240601$20240716$20240721$20240721$EXP$$JP-009507513-2407JPN003186J$MERCK$$$$$F$Y$$$20240721$$MD$JP$JP
241159121$24115912$1$I$$20240715$20240721$20240721$30DAY$$US-SANDOZ INC.-SDZ2024US065510$SANDOZ$$$$$F$Y$$$20240721$$CN$US$US
241159131$24115913$1$I$$20240712$20240721$20240721$EXP$$CZ-PFIZER INC-202400218745$PFIZER$$$$A$M$Y$$$20240721$$CN$CZ$CZ
241159143$24115914$3$F$20240101$20240807$20240721$20240812$EXP$$US-PFIZER INC-2023SGN12319$PFIZER$$61$YR$$F$Y$$$20240812$$CN$US$US
241159152$24115915$2$F$$20240830$20240721$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115492$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240904$$CN$US$US
241159162$24115916$2$F$$20240811$20240721$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115117$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$55.79$KG$20240813$$CN$US$US
241159172$24115917$2$F$20240101$20240725$20240721$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114013$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240726$$HP$US$US
241159181$24115918$1$I$$20240718$20240721$20240721$PER$$NVSC2024US149308$NOVARTIS$$$$$$Y$$$20240722$$MD$US$US
241159191$24115919$1$I$$20240709$20240721$20240721$PER$$US-EMD Serono-2024037512$EMD SERONO INC$$55$YR$A$F$Y$107$KG$20240722$$MD$US$US
241159201$24115920$1$I$20240501$20240710$20240721$20240721$EXP$$US-TG THERAPEUTICS INC.-TGT003789$TG THERAPEUTICS$$$$$$Y$$$20240719$$CN$US$US
241159214$24115921$4$F$20240101$20240905$20240721$20240910$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004871$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240910$$HP$US$US
241159222$24115922$2$F$20240626$20240725$20240721$20240805$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004794$SAREPTA THERAPEUTICS$$16$YR$$M$Y$66$KG$20240805$$HP$US$US
241159232$24115923$2$F$$20240812$20240721$20240813$EXP$$US-ALXN-202407USA000984US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241159241$24115924$1$I$$20240715$20240721$20240721$EXP$$CA-GENMAB-2024-02610$GENMAB$$70$YR$$M$Y$$$20240722$$CN$CA$CA
241159252$24115925$2$F$$20240731$20240721$20240808$EXP$$CA-CELLTRION INC.-2024CA017079$CELLTRION$$$$$$Y$$$20240808$$CN$CA$CA
241159261$24115926$1$I$20240601$20240712$20240721$20240721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111767$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240722$$HP$US$US
241159271$24115927$1$I$20240530$20240718$20240721$20240721$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115459$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240722$$CN$US$US
241159281$24115928$1$I$20240519$20240719$20240722$20240722$EXP$FR-AFSSAPS-CN2024000605$NVSC2024FR148737$NOVARTIS$$58$YR$$F$Y$58$KG$20240722$$MD$FR$FR
241159291$24115929$1$I$$20240710$20240722$20240722$EXP$$TN-OrBion Pharmaceuticals Private Limited-2159398$ORBION PHARMACEUTICALS$Brahmi N, Ben Ghezala H, Mrad A, Ben Jazia A. High-dose norepinephrine infusion (100 ?g/kg/min) in a near-fatal amlodipine and perindopril poisoning: are there any limits? Clin Toxicol (Phila). 2024 Apr;62(4):273-274. doi: 10.1080/15563650.2024.2339483.$23$YR$$F$Y$$$20240722$$MD$TN$TN
241159302$24115930$2$F$20240718$20240808$20240722$20240813$EXP$$NVSC2024HR148862$NOVARTIS$$78$YR$$M$Y$$$20240813$$MD$HR$HR
241159311$24115931$1$I$$20240714$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2024US065824$SANDOZ$$$$$$Y$$$20240722$$CN$US$US
241159321$24115932$1$I$$20240717$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115390$BRISTOL MYERS SQUIBB$$40$YR$A$M$Y$$$20240722$$CN$US$US
241159331$24115933$1$I$20240401$20240716$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113226$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240722$$HP$US$US
241159342$24115934$2$F$$20240719$20240722$20240724$PER$$US-AMGEN-USASP2024141513$AMGEN$$$$$F$Y$$$20240724$$MD$US$US
241159351$24115935$1$I$$20240718$20240722$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115382$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$58$KG$20240722$$PH$CA$CA
241159361$24115936$1$I$$20240711$20240722$20240722$EXP$$US-ROCHE-10000024358$ROCHE$$80$YR$E$F$Y$$$20240722$$CN$US$US
241159371$24115937$1$I$$20240710$20240722$20240722$EXP$$CN-OrBion Pharmaceuticals Private Limited-2159399$ORBION PHARMACEUTICALS$Gao Y, Wu C, Zhai X, Niu M, Bai Z, Song H, Zhao X, Wang J, Xiao X. Aripiprazole-induced liver injury: a spontaneous reporting database study. Front Pharmacol. 2023 Aug 24; 14:1226386. doi: 10.3389/fphar.2023.1226386.$$$$$Y$$$20240722$$PH$CN$CN
241159381$24115938$1$I$$20240710$20240722$20240722$EXP$$CN-OrBion Pharmaceuticals Private Limited-2159400$ORBION PHARMACEUTICALS$Gao Y, Wu C, Zhai X, Niu M, Bai Z, Song H, Zhao X, Wang J, Xiao X. Aripiprazole-induced liver injury: a spontaneous reporting database study. Front Pharmacol. 2023 Aug 24; 14:1226386. doi: 10.3389/fphar.2023.1226386.$$$$$Y$$$20240722$$PH$CN$CN
241159391$24115939$1$I$$20240708$20240722$20240722$EXP$$DE-ROCHE-10000028553$ROCHE$$$$A$F$Y$$$20240722$$MD$DE$DE
241159401$24115940$1$I$$20240710$20240722$20240722$EXP$$US-OrBion Pharmaceuticals Private Limited-2159401$ORBION PHARMACEUTICALS$Gullapalli D, Raza A, Khan A, Ganti SS, Pervaiz A. Battling the breath-stealers: Blastomyces and Pseudomonas triggering acute respiratory distress syndrome (ARDS). Med Mycol Case Reports. June 2024 (45); doi.org/10.1016/j.mmcr.2024.100655.$46$YR$$M$Y$$$20240722$$MD$US$US
241159411$24115941$1$I$$20240710$20240722$20240722$EXP$$CH-OrBion Pharmaceuticals Private Limited-2159402$ORBION PHARMACEUTICALS$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. Unhappy Hearts with the Antidepressant Venlafaxine. Swiss Med Wkly 2024; 154 (Suppl.) (6):63S-64S abstr.P27. - [abstract]$82$YR$$M$Y$$$20240722$$MD$CH$CH
241159421$24115942$1$I$20240715$20240717$20240722$20240722$EXP$$GB-HALEON-2187830$Haleon PLC$$80$YR$$F$Y$77$KG$20240719$$HP$GB$GB
241159431$24115943$1$I$$20240710$20240722$20240722$EXP$$CH-OrBion Pharmaceuticals Private Limited-2159403$ORBION PHARMACEUTICALS$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. Unhappy Hearts with the Antidepressant Venlafaxine. Swiss Med Wkly 2024; 154 (Suppl.) (6):63S-64S abstr.P27. - [abstract]$77$YR$$F$Y$$$20240722$$MD$CH$CH
241159441$24115944$1$I$$20230118$20240722$20240722$EXP$$US-AstraZeneca-2023A016164$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241159451$24115945$1$I$$20210607$20240722$20240722$EXP$$US-AstraZeneca-2021A514877$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241159461$24115946$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115345$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240722$$CN$US$US
241159471$24115947$1$I$$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115431$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240722$$CN$US$US
241159481$24115948$1$I$$20240711$20240722$20240722$EXP$$IT-ESPERIONTHERAPEUTICS-2024ITA01118$ESPERION THERAPEUTICS$$$$$$Y$$$20240722$$MD$IT$IT
241159492$24115949$2$F$$20240911$20240722$20240918$EXP$$US-ABBVIE-5844689$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
241159501$24115950$1$I$20240710$20240717$20240722$20240722$EXP$IT-MINISAL02-994933$IT-GSK-IT2024089786$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$MD$IT$IT
241159511$24115951$1$I$20240101$20240711$20240722$20240722$EXP$$IT-CELLTRION INC.-2024IT017222$CELLTRION$$$$$$Y$$$20240722$$MD$IT$IT
241159521$24115952$1$I$20090101$20240712$20240722$20240722$EXP$$DE-ESPERIONTHERAPEUTICS-2024DEU01107$ESPERION THERAPEUTICS$$39$YR$$F$Y$77$KG$20240722$$MD$DE$DE
241159531$24115953$1$I$20210701$20240710$20240722$20240722$EXP$$CH-OrBion Pharmaceuticals Private Limited-2159404$ORBION PHARMACEUTICALS$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. Unhappy Hearts with the Antidepressant Venlafaxine. Swiss Med Wkly 2024; 154 (Suppl.) (6):63S-64S abstr.P27. - [abstract]$52$YR$$F$Y$$$20240722$$MD$CH$CH
241159541$24115954$1$I$20240409$20240717$20240722$20240722$EXP$$CO-ABBVIE-5845826$ABBVIE$$56$YR$$F$Y$100$KG$20240722$$CN$CO$CO
241159551$24115955$1$I$20230501$20240710$20240722$20240722$EXP$$CH-OrBion Pharmaceuticals Private Limited-2159405$ORBION PHARMACEUTICALS$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. Unhappy Hearts with the Antidepressant Venlafaxine. Swiss Med Wkly 2024; 154 (Suppl.) (6):63S-64S abstr.P27. - [abstract]$51$YR$$F$Y$$$20240722$$MD$CH$CH
241159562$24115956$2$F$20231201$20240716$20240722$20240724$EXP$$CO-ABBVIE-5845938$ABBVIE$$84$YR$$M$Y$78$KG$20240724$$CN$CO$CO
241159572$24115957$2$F$20240626$20240722$20240722$20240726$EXP$FR-AFSSAPS-BX2024001420$FR-GSK-FR2024089749$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$MD$FR$FR
241159581$24115958$1$I$$20240716$20240722$20240722$EXP$$US-GILEAD-2024-0681021$GILEAD$$$$E$M$Y$$$20240719$$MD$US$US
241159592$24115959$2$F$$20240905$20240722$20240923$PER$$US-GILEAD-2024-0680579$GILEAD$$$$$$Y$$$20240923$$CN$US$US
241159601$24115960$1$I$$20240716$20240722$20240722$EXP$$SG-GILEAD-2024-0680917$GILEAD$$$$$F$Y$$$20240719$$CN$SG$SG
241159612$24115961$2$F$20240620$20240721$20240722$20240730$EXP$$CN-GILEAD-2024-0680982$GILEAD$$52$YR$A$M$Y$$$20240730$$CN$CN$CN
241159622$24115962$2$F$$20240905$20240722$20240912$EXP$$US-GILEAD-2024-0680713$GILEAD$$$$A$F$Y$$$20240912$$CN$US$US
241159631$24115963$1$I$$20240704$20240722$20240722$EXP$$US-GILEAD-2024-0679626$GILEAD$Storgard R, Dusza S, Shouval R, Scordo M, Markova A. Dermatologic adverse events associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA reporting system. The American Society for Transplantation and Cellular Therapy. 2024;JUN:1-16. doi:doi.org/10.1016/j.jtct.2024.06.024$$$A$$Y$$$20240719$$MD$US$US
241159641$24115964$1$I$$20240625$20240722$20240722$PER$$US-OrBion Pharmaceuticals Private Limited-2159406$ORBION PHARMACEUTICALS$$80$YR$$M$Y$$$20240722$$$US$US
241159651$24115965$1$I$20220101$20240711$20240722$20240722$EXP$$FR-ROCHE-10000027532$ROCHE$Furst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R, et al. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLAimmunized adults with sickle cell disease. Bone Marrow Transplantation. 2024-Jul;59 (7):918-27. doi:10.1038/s41409-024-02257-8.$30$YR$A$F$Y$$$20240722$$HP$FR$FR
241159661$24115966$1$I$$20240715$20240722$20240722$EXP$$AR-AMGEN-ARGSP2024140920$AMGEN$$$$A$F$Y$$$20240721$$MD$AR$AR
241159673$24115967$3$F$20240709$20240917$20240722$20240919$EXP$$NVSC2024DE147532$NOVARTIS$$$$A$F$Y$$$20240919$$MD$DE$DE
241159681$24115968$1$I$20240501$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115322$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240722$$CN$US$US
241159692$24115969$2$F$20240715$20240723$20240722$20240726$EXP$$AR-CHATTEMPRD-2024OHG024202$CHATTEM$$55$YR$A$F$Y$$$20240726$$CN$AR$AR
241159701$24115970$1$I$$20240710$20240722$20240722$EXP$$JP-009507513-2407JPN002316J$MERCK$$71$YR$$M$Y$$$20240722$$MD$JP$JP
241159711$24115971$1$I$$20240717$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114728$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240722$$CN$US$US
241159721$24115972$1$I$$20240719$20240722$20240722$EXP$$NVSC2024AM148931$NOVARTIS$$$$$M$Y$$$20240722$$MD$AM$AM
241159731$24115973$1$I$20240611$20240614$20240722$20240722$EXP$$US-ABBVIE-5846200$ABBVIE$$50$YR$$F$Y$57.606$KG$20240722$$HP$US$US
241159741$24115974$1$I$$20240710$20240722$20240722$PER$$US-ABBVIE-5845963$ABBVIE$$$$$F$Y$$$20240722$$HP$US$US
241159752$24115975$2$F$20240601$20240815$20240722$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003022$ACADIA PHARMACEUTICALS$$90$YR$$F$Y$54.431$KG$20240909$$CN$US$US
241159763$24115976$3$F$$20240814$20240722$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115126$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240823$$CN$US$US
241159771$24115977$1$I$$20240717$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115216$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240722$$CN$US$US
241159781$24115978$1$I$$20240717$20240722$20240722$EXP$$US-TAKEDA-2024TUS072613$TAKEDA$$$$$F$Y$$$20240722$$CN$US$US
241159791$24115979$1$I$$20240712$20240722$20240722$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001424$BLUEPRINT MEDICINES$$$$$M$Y$$$20240722$$CN$US$US
241159811$24115981$1$I$$20240713$20240722$20240722$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001417$BLUEPRINT MEDICINES$$$$$F$Y$$$20240722$$CN$US$US
241159822$24115982$2$F$20240701$20240724$20240722$20240730$PER$$US-AMGEN-USASL2024141532$AMGEN$$$$$M$Y$$$20240729$$CN$US$US
241159831$24115983$1$I$$20240712$20240722$20240722$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001425$BLUEPRINT MEDICINES$$$$$M$Y$$$20240722$$CN$US$US
241159852$24115985$2$F$$20240828$20240722$20240909$EXP$$US-UCBSA-2024036619$UCB$$$$$F$Y$$$20240909$$MD$US$US
241159861$24115986$1$I$20240221$20240708$20240722$20240722$EXP$$JP-AMGEN-JPNNI2024143963$AMGEN$$92$YR$E$M$Y$55.3$KG$20240721$$MD$JP$JP
241159871$24115987$1$I$$20240712$20240722$20240722$PER$$NVSC2024US147287$NOVARTIS$$$$$F$Y$$$20240722$$CN$US$US
241159881$24115988$1$I$20240627$20240715$20240722$20240722$EXP$GB-MHRA-MED-202407140013291230-GPBMN$GB-GSK-GB2024088644$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$GB$GB
241159891$24115989$1$I$20240601$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115271$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240722$$CN$US$US
241159902$24115990$2$F$$20240716$20240722$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114151$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240725$$HP$US$US
241159911$24115991$1$I$$20240715$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011009$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240722$$CN$US$US
241159921$24115992$1$I$$20240712$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407009066$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240722$$CN$US$US
241159931$24115993$1$I$$20240717$20240722$20240722$EXP$$US-CHATTEMPRD-2024OHG024556$CHATTEM$$$$$M$Y$$$20240722$$CN$US$US
241159941$24115994$1$I$20240101$20240708$20240722$20240722$EXP$$US-CHATTEMPRD-2024OHG024183$CHATTEM$$$$A$$Y$$$20240722$$CN$US$US
241159952$24115995$2$F$$20240722$20240722$20240723$PER$$US-AMGEN-USASP2024144343$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241159961$24115996$1$I$20240704$20240715$20240722$20240722$PER$$US-AMGEN-USASP2024140899$AMGEN$$$$$$Y$$$20240721$$PH$US$US
241159971$24115997$1$I$20230501$20240718$20240722$20240722$EXP$$US-UCBSA-2024029983$UCB$$78$YR$$M$Y$$$20240719$$CN$US$US
241159981$24115998$1$I$20240101$20240718$20240722$20240722$EXP$$US-UCBSA-2024010493$UCB$$$$$F$Y$$$20240719$$CN$US$US
241159993$24115999$3$F$20240601$20240822$20240722$20240823$EXP$$US-UCBSA-2024036492$UCB$$73$YR$$F$Y$$$20240823$$CN$US$US
241160001$24116000$1$I$20240101$20240717$20240722$20240722$EXP$$AU-UCBSA-2024022324$UCB$$$$$M$Y$$$20240719$$CN$AU$AU
241160012$24116001$2$F$20240626$20240904$20240722$20240918$EXP$$US-UCBSA-2024036493$UCB$$33$YR$$F$Y$$$20240918$$CN$US$US
241160022$24116002$2$F$20240712$20240802$20240722$20240807$30DAY$$US-AMGEN-USASP2024140799$AMGEN$$33$YR$A$M$Y$100.9$KG$20240807$$PH$US$US
241160031$24116003$1$I$$20240717$20240722$20240722$PER$$US-TAKEDA-2024TUS073165$TAKEDA$$$$$$Y$$$20240722$$CN$US$US
241160041$24116004$1$I$$20240712$20240722$20240722$EXP$$TR-NOVITIUMPHARMA-2024TRNVP01309$NOVITIUM PHARMA$Enes Elvin Gul.Brugada phenocopy associated with multiple psychotic drugs.Journal of Electrocardiology .19-SEP-2023;81:156-158$17$YR$T$F$Y$$$20240722$$HP$TR$TR
241160051$24116005$1$I$$20240710$20240722$20240722$PER$$US-AMGEN-USASP2024142861$AMGEN$$$$$$Y$$$20240721$$CN$US$US
241160062$24116006$2$F$20240101$20240723$20240722$20240802$30DAY$$US-UCBSA-2024030499$UCB$$$$$F$Y$$$20240802$$HP$US$US
241160071$24116007$1$I$20240713$20240717$20240722$20240722$EXP$$CA-UCBSA-2024036519$UCB$$63$YR$$F$Y$$$20240719$$CN$CA$CA
241160081$24116008$1$I$$20240715$20240722$20240722$EXP$$IT-UCBSA-2024036005$UCB$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$49$YR$$M$Y$$$20240719$$MD$IT$IT
241160101$24116010$1$I$20240711$20240716$20240722$20240722$EXP$$US-UCBSA-2024036482$UCB$$16$YR$$F$Y$44.9$KG$20240719$$MD$US$US
241160111$24116011$1$I$20240101$20240717$20240722$20240722$EXP$$US-UCBSA-2024030654$UCB$$$$$M$Y$$$20240719$$CN$US$US
241160121$24116012$1$I$$20240715$20240722$20240722$EXP$$IT-UCBSA-2024036430$UCB$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$87$YR$$F$Y$$$20240719$$MD$IT$IT
241160131$24116013$1$I$$20240715$20240722$20240722$EXP$$IT-UCBSA-2024036428$UCB$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$83$YR$$M$Y$$$20240719$$MD$IT$IT
241160141$24116014$1$I$$20240712$20240722$20240722$EXP$$BR-UCBSA-2024036084$UCB$$$$$F$Y$$$20240719$$CN$BR$BR
241160151$24116015$1$I$20240621$20240715$20240722$20240722$PER$$US-ABBVIE-5841037$ABBVIE$$43$YR$$F$Y$$$20240722$$HP$US$US
241160161$24116016$1$I$$20240708$20240722$20240722$EXP$$SE-UCBSA-2024036323$UCB$$$$$F$Y$$$20240719$$CN$SE$SE
241160172$24116017$2$F$20240101$20240815$20240722$20240829$EXP$$US-UCBSA-2024036425$UCB$$$$$F$Y$65$KG$20240829$$MD$US$US
241160182$24116018$2$F$20230501$20240718$20240722$20240722$EXP$$US-UCBSA-2024027672$UCB$$48$YR$$F$Y$$$20240722$$CN$US$US
241160191$24116019$1$I$$20240717$20240722$20240722$EXP$$US-UCBSA-2024036420$UCB$$$$$F$Y$$$20240719$$CN$US$US
241160201$24116020$1$I$20240710$20240712$20240722$20240722$EXP$$AR-UCBSA-2024035766$UCB$$58$YR$$M$Y$$$20240719$$CN$AR$AR
241160211$24116021$1$I$$20240715$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113881$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$72.12$KG$20240722$$CN$US$US
241160221$24116022$1$I$$20240715$20240722$20240722$EXP$$US-UCBSA-2024035892$UCB$$$$$M$Y$$$20240719$$CN$US$US
241160231$24116023$1$I$20240624$20240716$20240722$20240722$EXP$$US-UCBSA-2024036380$UCB$$54$YR$$M$Y$$$20240719$$CN$US$US
241160251$24116025$1$I$20240201$20240717$20240722$20240722$EXP$$US-UCBSA-2024036412$UCB$$48$YR$$F$Y$$$20240719$$HP$US$US
241160262$24116026$2$F$20240101$20240821$20240722$20240904$EXP$$US-UCBSA-2024036236$UCB$$$$$M$Y$$$20240904$$HP$US$US
241160271$24116027$1$I$$20240710$20240722$20240722$EXP$$US-APOTEX-2024AP008354$APOTEX$Song JJ, Eyabi JC, Awatramani PD, Mitchell BG, Nene SY. Sudden Reduction in Caffeine Intake Increases Serum LithiumConcentration to Supratherapeutic Level: A Case Report. Prim Care Companion CNS Disord. 2024;26(2):23cr03642:1-4$59$YR$$M$Y$$$20240722$$HP$US$US
241160282$24116028$2$F$20240601$20240731$20240722$20240806$EXP$$US-UCBSA-2024036407$UCB$$6$YR$$F$Y$$$20240806$$CN$US$US
241160291$24116029$1$I$$20240715$20240722$20240722$EXP$$GB-UCBSA-2024036485$UCB$$$$A$M$Y$$$20240719$$MD$GB$GB
241160301$24116030$1$I$20240101$20240716$20240722$20240722$EXP$$US-UCBSA-2024036227$UCB$$$$$F$Y$122.45$KG$20240719$$HP$US$US
241160311$24116031$1$I$$20240715$20240722$20240722$EXP$$US-UCBSA-2024036043$UCB$$$$$F$Y$$$20240719$$HP$US$US
241160321$24116032$1$I$$20240710$20240722$20240722$EXP$$US-UCBSA-2024035376$UCB$$$$$F$Y$$$20240719$$HP$US$US
241160331$24116033$1$I$$20240718$20240722$20240722$PER$$US-TAKEDA-2024TUS073026$TAKEDA$$$$$F$Y$$$20240722$$CN$US$US
241160341$24116034$1$I$$20240718$20240722$20240722$PER$$US-TAKEDA-2024TUS073117$TAKEDA$$$$$$Y$$$20240722$$HP$US$US
241160351$24116035$1$I$$20240717$20240722$20240722$EXP$$US-ROCHE-10000030050$ROCHE$$74$YR$E$F$Y$$$20240722$$CN$US$US
241160361$24116036$1$I$$20240717$20240722$20240722$EXP$$US-UCBSA-2024036252$UCB$$$$$M$Y$$$20240719$$CN$US$US
241160371$24116037$1$I$20240702$20240715$20240722$20240722$EXP$IT-MINISAL02-994240$IT-CHEPLA-2024009012$CHEPLAPHARM$$80$YR$$M$Y$$$20240718$$PH$COUNTRY NOT SPECIFIED$IT
241160382$24116038$2$F$20221025$20240903$20240722$20240904$EXP$$US-UCBSA-2024036229$UCB$$74$YR$$M$Y$$$20240904$$HP$US$US
241160393$24116039$3$F$20240101$20240828$20240722$20240910$EXP$$CA-UCBSA-2024014327$UCB$$$$$F$Y$$$20240910$$CN$CA$CA
241160402$24116040$2$F$20240715$20240722$20240722$20240730$EXP$$US-ALXN-202407USA000958US$ALEXION PHARMACEUTICALS$$68$YR$$F$Y$$$20240730$$CN$US$US
241160411$24116041$1$I$20231001$20240717$20240722$20240722$EXP$$US-ABBVIE-5844686$ABBVIE$$28$YR$$F$Y$$$20240722$$CN$US$US
241160421$24116042$1$I$20240423$20240718$20240722$20240722$EXP$FR-AFSSAPS-RS2024000644$FR-ROCHE-10000030727$ROCHE$$71$YR$E$M$Y$97$KG$20240722$$MD$FR$FR
241160431$24116043$1$I$20240101$20240712$20240722$20240722$EXP$$US-UCBSA-2024035795$UCB$$$$$F$Y$81.65$KG$20240719$$HP$US$US
241160441$24116044$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024143795$AMGEN$$$$$$Y$$$20240721$$CN$US$US
241160452$24116045$2$F$$20240709$20240722$20240722$EXP$$US-862174955-ML2024-03982$Unknown Manufacturer$Hazique M, Grewal S. A DANCE OF HEARTS RHYTHM-UNVEILING LYME CARDITIS. J-Am-Coll-Cardiol. 2024 Apr 06;83(13 Suppl A): 2882-2882.$56$YR$A$M$Y$$$20240719$$HP$US$US
241160462$24116046$2$F$$20240709$20240722$20240722$EXP$$ES-862174955-ML2024-03985$Unknown Manufacturer$Sanchez FG, Labrador CG, Becerra LW, Fernandez BA, Aguilar AM, Milla CC. Active microscopic colitis precipitated by fluoxetine. The Spanish Journal of Gastroenterology. 2024;doi:10.17235/reed.2024.10336/2024.$41$YR$A$F$Y$$$20240719$$HP$ES$ES
241160472$24116047$2$F$20240704$20240717$20240722$20240822$EXP$AT-BASGAGES-2024-005381$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-114421$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240823$$PH$AT$AT
241160481$24116048$1$I$$20240715$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113438$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$PH$US$US
241160491$24116049$1$I$$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115229$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240722$$CN$US$US
241160501$24116050$1$I$$20230508$20240722$20240722$EXP$$US-AstraZeneca-2023A107401$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241160511$24116051$1$I$$20240715$20240722$20240722$EXP$$CA-AMGEN-CANSP2024141040$AMGEN$$$$$M$Y$79$KG$20240721$$MD$CA$CA
241160521$24116052$1$I$$20240712$20240722$20240722$EXP$$US-ASPIRO-ASP2024US02320$ASPIRO PHARMA$Kraus MJ, Nguyen J.. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report. Case Reports in Neurology. 2024;16(1):142-7$38$YR$$F$Y$63.5$KG$20240722$$MD$US$US
241160531$24116053$1$I$$20240718$20240722$20240722$EXP$$US-TAKEDA-2023TUS035839$TAKEDA$$$$$F$Y$$$20240722$$HP$US$US
241160541$24116054$1$I$20240615$20240718$20240722$20240722$EXP$FR-AFSSAPS-RE2024000623$FR-ROCHE-10000030719$ROCHE$$67$YR$E$M$Y$80.6$KG$20240722$$MD$FR$FR
241160551$24116055$1$I$$20240716$20240722$20240722$EXP$$US-TAKEDA-2024TUS023449$TAKEDA$$$$$F$Y$79$KG$20240722$$HP$US$US
241160561$24116056$1$I$20240213$20240713$20240722$20240722$EXP$$CN-BEIGENE-BGN-2024-010929$BEIGENE$$$$$$Y$$$20240722$$HP$CN$CN
241160571$24116057$1$I$$20240716$20240722$20240722$EXP$$CH-Bion-013463$BIONPHARMA$$11$YR$C$M$Y$$$20240719$$HP$CH$CH
241160581$24116058$1$I$20231201$20240626$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050152$TOLMAR$$59$YR$$M$Y$$$20240719$$CN$CA$CA
241160591$24116059$1$I$20240611$20240626$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050153$TOLMAR$$78$YR$$M$Y$$$20240719$$CN$CA$CA
241160601$24116060$1$I$20240101$20240626$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050154$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241160611$24116061$1$I$$20240716$20240722$20240722$EXP$$US-TAKEDA-2024TUS072245$TAKEDA$$$$$F$Y$102$KG$20240722$$MD$US$US
241160621$24116062$1$I$$20240717$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115068$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240722$$CN$US$US
241160631$24116063$1$I$$20240712$20240722$20240722$EXP$$US-Bion-013449$BIONPHARMA$$$$$F$Y$$$20240719$$CN$US$US
241160641$24116064$1$I$$20240710$20240722$20240722$EXP$$US-Bion-013450$BIONPHARMA$$50$YR$A$F$Y$$$20240719$$CN$US$US
241160651$24116065$1$I$20230124$20240716$20240722$20240722$EXP$$CA-TAKEDA-2024TUS072436$TAKEDA$$78$YR$$F$Y$$$20240722$$MD$CA$CA
241160661$24116066$1$I$$20230426$20240722$20240722$EXP$$US-AstraZeneca-2023A098908$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241160671$24116067$1$I$$20230512$20240722$20240722$EXP$$US-AstraZeneca-2023A112005$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241160681$24116068$1$I$20200308$20200325$20240722$20240722$EXP$$US-AstraZeneca-2020SE43228$ASTRAZENECA$$85$YR$$F$Y$$$20240722$$CN$US$
241160691$24116069$1$I$20240617$20240718$20240722$20240722$EXP$FR-AFSSAPS-PB2024000743$FR-ROCHE-10000030712$ROCHE$$90$YR$E$F$Y$54$KG$20240722$$MD$FR$FR
241160701$24116070$1$I$20240415$20240716$20240722$20240722$EXP$$NVSC2024GB086338$NOVARTIS$$54$YR$$F$Y$$$20240722$$CN$GB$GB
241160711$24116071$1$I$20240613$20240715$20240722$20240722$EXP$FR-AFSSAPS-RN2024000743$FR-CHEPLA-2024008917$CHEPLAPHARM$$48$YR$$M$Y$74$KG$20240719$$PH$COUNTRY NOT SPECIFIED$FR
241160721$24116072$1$I$20240327$20240711$20240722$20240722$EXP$$FR-VIIV HEALTHCARE LIMITED-FR2024EME075487$VIIV$$$$$$Y$$$20240722$$MD$FR$FR
241160731$24116073$1$I$20231116$20240715$20240722$20240722$EXP$IT-MINISAL02-994202$IT-CHEPLA-2024008920$CHEPLAPHARM$$54$YR$$F$Y$$$20240719$$MD$COUNTRY NOT SPECIFIED$IT
241160744$24116074$4$F$20240703$20240819$20240722$20240822$EXP$$JP-ABBVIE-5844364$ABBVIE$$29$YR$$M$Y$$$20240822$$PH$JP$JP
241160751$24116075$1$I$$20240710$20240722$20240722$EXP$$US-Bion-013452$BIONPHARMA$$$$$M$Y$$$20240719$$CN$US$US
241160761$24116076$1$I$$20240716$20240722$20240722$EXP$$US-Bion-013466$BIONPHARMA$$38$YR$A$M$Y$$$20240719$$HP$US$US
241160771$24116077$1$I$20240701$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024144196$AMGEN$$$$$F$Y$$$20240721$$HP$US$US
241160781$24116078$1$I$20240617$20240704$20240722$20240722$EXP$$SI-OCTA-NGAM02424$OCTAPHARMA$$$$A$F$Y$85$KG$20240719$$MD$EU$EU
241160791$24116079$1$I$20240523$20240717$20240722$20240722$EXP$FR-AFSSAPS-LL2024001283$FR-GSK-FR2024090288$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$MD$FR$FR
241160801$24116080$1$I$$20240712$20240722$20240722$EXP$$GB-GSK-GB2024EME088541$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$GB$GB
241160811$24116081$1$I$20240105$20240713$20240722$20240722$EXP$$CN-BEIGENE-BGN-2024-010927$BEIGENE$$$$$$Y$$$20240722$$HP$CN$CN
241160821$24116082$1$I$20240610$20240715$20240722$20240722$PER$$US-AMGEN-USASP2024140918$AMGEN$$65$YR$E$F$Y$$$20240721$$PH$US$US
241160832$24116083$2$F$$20240802$20240722$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115110$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240807$$CN$US$US
241160844$24116084$4$F$$20240905$20240722$20240911$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000602$DECIPHERA PHARMACEUTICALS$$47$YR$A$M$Y$69.4$KG$20240911$$CN$US$US
241160853$24116085$3$F$20240714$20240808$20240722$20240810$PER$$US-AMGEN-USASP2024141753$AMGEN$$82$YR$E$M$Y$$$20240810$$CN$US$US
241160861$24116086$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011225$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240722$$CN$US$US
241160882$24116088$2$F$20240718$20240718$20240722$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407012404$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240724$$CN$US$US
241160891$24116089$1$I$20240710$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012286$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241160901$24116090$1$I$20081017$20240715$20240722$20240722$EXP$$HK-CHEPLA-2024008926$CHEPLAPHARM$$34$YR$$M$Y$$$20240719$$CN$COUNTRY NOT SPECIFIED$HK
241160911$24116091$1$I$20110101$20240715$20240722$20240722$EXP$$BG-CHEPLA-2024009007$CHEPLAPHARM$Nikolova M, Grashnov E. Aripiprazole in the therapy of patients diagnosed with schizophrenia and bipolar affective disorder. Medic Plus. 2024;2:56-58.$50$YR$$F$Y$$$20240719$$HP$COUNTRY NOT SPECIFIED$BG
241160921$24116092$1$I$20240611$20240626$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050166$TOLMAR$$78$YR$$M$Y$$$20240719$$CN$CA$CA
241160931$24116093$1$I$20240201$20240626$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050189$TOLMAR$$78$YR$$M$Y$$$20240719$$CN$CA$CA
241160941$24116094$1$I$20240101$20240627$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050213$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241160952$24116095$2$F$20240613$20240718$20240722$20240726$EXP$$CA-TOLMAR, INC.-24CA050244$TOLMAR$$66$YR$$M$Y$$$20240726$$CN$CA$CA
241160961$24116096$1$I$$20240626$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050547$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241160971$24116097$1$I$$20240627$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050270$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241160981$24116098$1$I$20240101$20240626$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050555$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241161001$24116100$1$I$20240627$20240627$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050565$TOLMAR$$76$YR$$M$Y$$$20240719$$CN$CA$CA
241161021$24116102$1$I$$20240626$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050583$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241161031$24116103$1$I$$20240626$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050584$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241161041$24116104$1$I$$20240627$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050589$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241161051$24116105$1$I$$20240627$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050592$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241161061$24116106$1$I$$20240709$20240722$20240722$EXP$$US-BAXTER-2024BAX021504$BAXTER$$$$$$Y$$$20240722$$CN$US$US
241161071$24116107$1$I$$20240628$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050593$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241161081$24116108$1$I$$20190403$20240722$20240722$EXP$$BR-AstraZeneca-2019SE53021$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$BR$
241161091$24116109$1$I$$20240710$20240722$20240722$EXP$$US-BAXTER-2024BAX021474$BAXTER$$$$$$Y$76.2$KG$20240722$$PH$US$US
241161101$24116110$1$I$20240710$20240712$20240722$20240722$EXP$CN-NMPACDR-1403021020433202400198$CN-BAXTER-2024BAX021735$BAXTER$$53$YR$$F$Y$81$KG$20240722$$MD$CN$CN
241161111$24116111$1$I$20240611$20240708$20240722$20240722$30DAY$$US-BAXTER-2024BAX021532$BAXTER$$$$$$Y$$$20240722$$MD$US$US
241161121$24116112$1$I$20230107$20230111$20240722$20240722$EXP$$US-AstraZeneca-2023A008167$ASTRAZENECA$$32659$DY$$$Y$$$20240722$$CN$US$
241161131$24116113$1$I$20240519$20240718$20240722$20240722$EXP$$US-AstraZeneca-2024A164786$ASTRAZENECA$$26205$DY$$F$Y$$$20240722$$CN$US$
241161141$24116114$1$I$20230501$20230525$20240722$20240722$EXP$$US-AstraZeneca-2023A122764$ASTRAZENECA$$873$MON$$F$Y$$$20240722$$CN$US$
241161151$24116115$1$I$$20230314$20240722$20240722$EXP$$US-AstraZeneca-2023A062323$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241161161$24116116$1$I$$20240712$20240722$20240722$EXP$$US-BAXTER-2024BAX021595$BAXTER$$$$$F$Y$$$20240722$$MD$US$US
241161171$24116117$1$I$$20230525$20240722$20240722$EXP$$CO-AstraZeneca-2023A124843$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$CO$
241161181$24116118$1$I$$20191230$20240722$20240722$EXP$$US-AstraZeneca-2020SE01361$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241161191$24116119$1$I$$20230316$20240722$20240722$EXP$$US-AstraZeneca-2023A064381$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241161201$24116120$1$I$$20240712$20240722$20240722$EXP$$CA-BAXTER-2024BAX021669$BAXTER$$43$YR$$F$Y$97$KG$20240722$$MD$CA$CA
241161211$24116121$1$I$$20240711$20240722$20240722$EXP$$GB-BAXTER-2024BAX021529$BAXTER$$$$$F$Y$$$20240722$$CN$GB$GB
241161222$24116122$2$F$20240708$20240718$20240722$20240801$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2024-099476$REGENERON$$80$YR$$F$Y$$$20240801$$HP$CO$CO
241161231$24116123$1$I$$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407121609474360-QJFYN$GB-RDY-SPO/GBR/24/0010402$DR REDDYS$$45$YR$A$F$Y$$$20240722$$CN$GB$GB
241161242$24116124$2$F$$20240821$20240722$20240829$PER$$US-MTPC-MTDA2024-0014884$MITSUBISHI TANABE PHARMA$$$$A$F$Y$$$20240829$$CN$US$US
241161251$24116125$1$I$20240701$20240717$20240722$20240722$EXP$$US-MTPC-MTDA2024-0014981$Unknown Manufacturer$$49$YR$$F$Y$$$20240722$$CN$US$US
241161262$24116126$2$F$20240713$20240725$20240722$20240801$EXP$$PR-MTPC-MTDA2024-0014911$MITSUBISHI TANABE PHARMA$$67$YR$$F$Y$$$20240801$$CN$PR$PR
241161271$24116127$1$I$$20240711$20240722$20240722$EXP$$CA-BAXTER-2024BAX021587$BAXTER$$$$$F$Y$$$20240722$$HP$CA$CA
241161281$24116128$1$I$$20240711$20240722$20240722$EXP$$CA-BAXTER-2024BAX021672$BAXTER$$48$YR$$F$Y$68$KG$20240722$$HP$CA$CA
241161291$24116129$1$I$$20240710$20240722$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-035296$AUROBINDO$Ozueh P, Agogbuo O, Walnofer A, Umezurike I, John L, Hammond TC, et al.. Breathtaking Intrathoracic Rhabdoid Tumor.. Am-J-Respir-Crit-Care-Med. 2024;209:A6 5 5 9$63$YR$$M$Y$$$20240722$$HP$US$US
241161301$24116130$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089219$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241161311$24116131$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089218$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241161321$24116132$1$I$$20240715$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2020-056137$AUROBINDO$Dufayet L, Monnet F, Laborde-Casterot H, Care W, Lekens B, Vodovar D, et al.. Unintentional exposure to pregabalin in ?6-year-old children: a nationwide French Poison Control Center study. Clinical toxicology-(Phila). 2021;59(5):433-439$3$YR$$F$Y$14.08$KG$20240722$$MD$FR$FR
241161331$24116133$1$I$$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143675$AMGEN$$$$A$F$Y$$$20240721$$CN$US$US
241161341$24116134$1$I$$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142093$AMGEN$$$$$F$Y$$$20240721$$PH$US$US
241161351$24116135$1$I$$20240715$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2021-037145$AUROBINDO$Dufayet L, Monnet F, Laborde-Casterot H, Care W, Lekens B, Langrand J, et al.. Unintentional exposure to pregabalin in ?6-year-old children: a nationwide French Poison Control Center study. Clin-Toxicol-(Phila). 2021;59(5):433-439$3$YR$$F$Y$$$20240722$$HP$FR$FR
241161361$24116136$1$I$$20240702$20240722$20240722$PER$$US-ROCHE-10000016748$ROCHE$$$$$F$Y$$$20240722$$CN$US$US
241161371$24116137$1$I$$20230629$20240722$20240722$EXP$$US-AstraZeneca-2023A150758$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241161381$24116138$1$I$20180420$20230428$20240722$20240722$EXP$$US-AstraZeneca-2023A100608$ASTRAZENECA$$20306$DY$$F$Y$$$20240722$$CN$US$
241161391$24116139$1$I$$20230608$20240722$20240722$EXP$$US-AstraZeneca-2023A134659$ASTRAZENECA$$$$$$Y$$$20240722$$CN$US$
241161401$24116140$1$I$$20200211$20240722$20240722$EXP$$US-AstraZeneca-2020SE23534$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241161411$24116141$1$I$$20191109$20240722$20240722$EXP$$US-AstraZeneca-2019SF61539$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241161422$24116142$2$F$$20230628$20240722$20240815$EXP$$US-AstraZeneca-2023A149843$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
241161431$24116143$1$I$$20231220$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2023-081170$AUROBINDO$$$$$M$Y$$$20240722$$CN$US$US
241161441$24116144$1$I$20230730$20230731$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2023-052043$AUROBINDO$$58$YR$$M$Y$222$KG$20240722$$CN$US$US
241161451$24116145$1$I$$20230123$20240722$20240722$EXP$$US-AstraZeneca-2023A019823$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241161461$24116146$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012665$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241161471$24116147$1$I$$20230725$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2023-045405$AUROBINDO$$83$YR$$M$Y$76.6$KG$20240722$$CN$US$US
241161482$24116148$2$F$$20240725$20240722$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110310$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240806$$HP$US$US
241161491$24116149$1$I$20240717$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012961$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240722$$CN$US$US
241161501$24116150$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011965$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240722$$CN$US$US
241161512$24116151$2$F$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011525$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240722$$CN$US$US
241161521$24116152$1$I$20240716$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011434$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240722$$CN$US$US
241161531$24116153$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012074$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240722$$CN$US$US
241161541$24116154$1$I$20240707$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012238$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240722$$CN$US$US
241161551$24116155$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013020$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240722$$CN$US$US
241161561$24116156$1$I$$20240418$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2024-020987$AUROBINDO$$88$YR$$F$Y$$$20240722$$CN$US$US
241161571$24116157$1$I$20240126$20240130$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2024-005750$AUROBINDO$$78$YR$$M$Y$86.18$KG$20240722$$CN$US$US
241161581$24116158$1$I$$20240615$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2024-021425$AUROBINDO$$$$$$Y$$$20240722$$CN$US$US
241161591$24116159$1$I$$20240508$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2024-024418$AUROBINDO$$79$YR$$M$Y$$$20240722$$CN$US$US
241161601$24116160$1$I$$20231220$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2023-081175$AUROBINDO$$$$$F$Y$$$20240722$$CN$US$US
241161611$24116161$1$I$$20240409$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2024-018500$AUROBINDO$$$$$M$Y$$$20240722$$CN$US$US
241161621$24116162$1$I$$20230710$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2023-046277$AUROBINDO$$$$$M$Y$$$20240722$$HP$US$US
241161632$24116163$2$F$$20240822$20240722$20240829$EXP$$US-TEVA-VS-3220240$TEVA$Pien I, Mudgal CS. Osteonecrosis of Trapezium Occurring in Patient with History of Recurrent Carpometacarpal Corticosteroid Injection. J-Hand-Surg-Asian-Pac-Vol 2023; 28 (1): 129-133.; Pien I, Mudgal CS. Osteonecrosis of Trapezium Occurring in Patient with History of Recurrent Carpometacarpal Corticosteroid Injection. J-Hand-Surg-Asian-Pac-Vol 2023; 28 (1): 129-133.; Pien I, Mudgal CS. Osteonecrosis of Trapezium Occurring in Patient with History of Recurrent Carpometacarpal Corticosteroid Inj...$59$YR$$F$Y$$$20240829$$HP$US$US
241161641$24116164$1$I$$20240323$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2024-014864$AUROBINDO$$89$YR$$M$Y$$$20240722$$MD$US$US
241161651$24116165$1$I$$20240411$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2024-019502$AUROBINDO$$90$YR$$F$Y$83.9$KG$20240722$$CN$US$US
241161661$24116166$1$I$20230203$20240315$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2024-013799$AUROBINDO$$$$E$M$Y$81.646$KG$20240722$$CN$US$US
241161671$24116167$1$I$$20240715$20240722$20240722$PER$$US-ABBVIE-5841240$ABBVIE$$$$$$Y$$$20240722$$CN$US$US
241161681$24116168$1$I$$20240116$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2024-003021$AUROBINDO$$79$YR$$F$Y$62.59$KG$20240722$$CN$US$US
241161691$24116169$1$I$$20240712$20240722$20240722$EXP$$US-GSK-US2024AMR088502$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$MD$US$US
241161701$24116170$1$I$$20240703$20240722$20240722$PER$$US-ALKERMES INC.-ALK-2024-001830$ALKERMES$$7$DEC$$M$Y$$$20240719$$MD$US$US
241161711$24116171$1$I$$20240715$20240722$20240722$PER$$US-ROCHE-10000028010$ROCHE$$21$YR$A$M$Y$$$20240722$$CN$US$US
241161721$24116172$1$I$$20240711$20240722$20240722$EXP$$CA-APOTEX-2024AP008268$APOTEX$$28$YR$$M$Y$$$20240722$$HP$CA$CA
241161731$24116173$1$I$$20240710$20240722$20240722$EXP$$JP-SPECGX-T202401532$SPECGX$$5$DEC$$M$Y$$$20240722$$MD$JP$JP
241161741$24116174$1$I$20240101$20240712$20240722$20240722$EXP$$JP-009507513-2407JPN002838J$MERCK$$$$$F$Y$$$20240722$$MD$JP$JP
241161751$24116175$1$I$$20240716$20240722$20240722$PER$$US-ABBVIE-5842896$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241161761$24116176$1$I$$20240717$20240722$20240722$EXP$CA-DRL-USA-SPO/CAN/24/0010569$CA-RDY-SPO/CAN/24/0010569$DR REDDYS$$75$YR$E$F$Y$$$20240722$$HP$CA$CA
241161771$24116177$1$I$$20240708$20240722$20240722$EXP$$US-ENDO USA, INC.-2024-002910$ENDO$$$$$$Y$$$20240722$$MD$US$US
241161781$24116178$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000030806$ROCHE$$15$YR$T$F$Y$$$20240722$$MD$US$US
241161791$24116179$1$I$$20240716$20240722$20240722$EXP$$US-PCCINC-2024-PPL-000541$PIRAMAL$$$$$$Y$$$20240722$$HP$US$US
241161801$24116180$1$I$$20240716$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113367$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240722$$HP$US$US
241161811$24116181$1$I$20240712$20240712$20240722$20240722$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-115470$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240722$$HP$RU$RU
241161821$24116182$1$I$$20240711$20240722$20240722$EXP$$NL-AUROBINDO-AUR-APL-2024-035238$AUROBINDO$$13$YR$$F$Y$$$20240722$$MD$NL$NL
241161831$24116183$1$I$$20240717$20240722$20240722$EXP$$US-UCBSA-2024036455$UCB$$$$$F$Y$126.98$KG$20240722$$HP$US$US
241161841$24116184$1$I$$20240626$20240722$20240722$PER$$US-BEIGENE-BGN-2024-009997$BEIGENE$$$$$$Y$$$20240722$$CN$US$US
241161851$24116185$1$I$20240707$20240716$20240722$20240722$EXP$$US-PCCINC-2024-PPL-000543$PIRAMAL$$$$$$Y$$$20240722$$HP$US$US
241161861$24116186$1$I$20240702$20240711$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035410$AUROBINDO$$86$YR$$F$Y$$$20240722$$MD$FR$FR
241161871$24116187$1$I$$20240715$20240722$20240722$EXP$$CA-GSK-CA2024033533$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$CA$CA
241161891$24116189$1$I$$20200309$20240722$20240722$EXP$$NL-TERSERA THERAPEUTICS LLC-2020TRS000658$TERSERA THERAPEUTICS$$$$$$Y$$$20240722$$CN$NL$NL
241161901$24116190$1$I$20200227$20200317$20240722$20240722$EXP$$CO-TERSERA THERAPEUTICS LLC-2020TRS000710$TERSERA THERAPEUTICS$$$$$$Y$$$20240722$$CN$CO$CO
241161911$24116191$1$I$$20200518$20240722$20240722$EXP$$NL-TERSERA THERAPEUTICS LLC-2020TRS001350$TERSERA THERAPEUTICS$$$$$$Y$$$20240722$$CN$NL$NL
241161921$24116192$1$I$20200512$20200519$20240722$20240722$EXP$$CO-TERSERA THERAPEUTICS LLC-2020TRS001338$TERSERA THERAPEUTICS$$$$$$Y$$$20240722$$CN$CO$CO
241161931$24116193$1$I$$20191030$20240722$20240722$EXP$$RU-AstraZeneca-2019SF56093$ASTRAZENECA$$59$YR$$M$Y$80$KG$20240722$$CN$RU$
241161941$24116194$1$I$$20240716$20240722$20240722$PER$$US-AstraZeneca-2024A164979$ASTRAZENECA$$73$YR$$M$Y$$$20240722$$CN$US$
241161951$24116195$1$I$$20200706$20240722$20240722$EXP$$US-AstraZeneca-2020SE87764$ASTRAZENECA$$$$$F$Y$81.6$KG$20240722$$CN$US$
241161962$24116196$2$F$$20240719$20240722$20240724$PER$$US-AMGEN-USASP2024143717$AMGEN$$$$$F$Y$$$20240724$$PH$US$US
241161971$24116197$1$I$20240706$20240712$20240722$20240722$EXP$$ES-AUROBINDO-AUR-APL-2024-035764$AUROBINDO$$86$YR$$F$Y$$$20240722$$MD$ES$ES
241161981$24116198$1$I$20240117$20240712$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035720$AUROBINDO$$75$YR$$F$Y$$$20240722$$HP$FR$FR
241161993$24116199$3$F$20240101$20240909$20240722$20240912$PER$$US-ROCHE-3579838$ROCHE$$57$YR$A$F$Y$65.77$KG$20240912$$CN$US$US
241162001$24116200$1$I$20240625$20240625$20240722$20240722$PER$$US-CSL-2024-006316$CSL Plasma$$33$YR$$M$Y$$$20240722$$HP$US$US
241162011$24116201$1$I$$20240710$20240722$20240722$PER$$US-BEIGENE-BGN-2024-010935$BEIGENE$$$$$$Y$$$20240722$$MD$US$US
241162021$24116202$1$I$$20240715$20240722$20240722$EXP$$US-HETERO-HET2024US02345$HETERO$Salar T, Al-Hosainat N, Subedi R, Hameed M, Tabrizi NS, Dekmak B et al.. A CASE OF HYDRALAZINE INDUCED SEVERE RENAL-LIMITED ANCA VASCULITIS LEADING TO ESRD IN A 63-YEAR-OLD MAN. InAmerican Journal of Kidney Diseases. 2023;81(4):S42$63$YR$$M$Y$$$20240722$$HP$US$US
241162032$24116203$2$F$$20240807$20240722$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024087749$VIIV$$$$$M$Y$$$20240816$$HP$US$US
241162041$24116204$1$I$$20240712$20240722$20240722$PER$$US-BEIGENE-BGN-2024-011017$BEIGENE$$$$$$Y$$$20240722$$CN$US$US
241162051$24116205$1$I$20240616$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114224$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240722$$CN$US$US
241162061$24116206$1$I$20240601$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114793$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240722$$HP$US$US
241162071$24116207$1$I$20240718$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012096$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240722$$CN$US$US
241162081$24116208$1$I$20240712$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012202$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240722$$CN$US$US
241162091$24116209$1$I$20240717$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013017$ELI LILLY AND CO$$34$YR$A$$Y$$$20240722$$CN$US$US
241162101$24116210$1$I$20240718$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012742$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240722$$CN$US$US
241162111$24116211$1$I$20240716$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013025$ELI LILLY AND CO$$$$A$$Y$$$20240722$$CN$US$US
241162121$24116212$1$I$20240717$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012290$ELI LILLY AND CO$$$$A$F$Y$$$20240722$$CN$US$US
241162132$24116213$2$F$$20240719$20240722$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012492$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240723$$CN$US$US
241162142$24116214$2$F$20240709$20240710$20240722$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202407007294$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
241162152$24116215$2$F$20240301$20240809$20240722$20240815$EXP$$JP-009507513-2407JPN003194J$MERCK$$$$E$M$Y$$$20240815$$MD$JP$JP
241162161$24116216$1$I$$20240702$20240722$20240722$PER$$US-TEVA-VS-3216707$TEVA$$$$$$Y$$$20240722$$HP$US$US
241162171$24116217$1$I$$20240709$20240722$20240722$EXP$$DE-USP-004884$USPHARMA$Heinz P, Wolf B, Schuldes S. Locked-in Syndrome After Pontine Hemorrhage in an Amphetamine Abuser. Dtsch Arztebl Int. 2024 May 17;121(10):330. doi: 10.3238/arztebl.m2023.0330.$37$YR$A$F$Y$$$20240722$$MD$DE$DE
241162181$24116218$1$I$$20240710$20240722$20240722$EXP$$CN-PDX-000373$PHARMADAX$Zhu F, Wang WF, Ma CH, Liang H, Jiang YQ. Resolution of anti-LGI1-associated autoimmune encephalitis in a patient after treatment with efgartigimod. J Neurol. 2024 Jul 9. doi: 10.1007/s00415-024-12556-1.$$$$$Y$$$20240722$$HP$CN$CN
241162191$24116219$1$I$$20240715$20240722$20240722$EXP$$IT-UCBSA-2024036632$UCB$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$77$YR$$F$Y$$$20240722$$MD$IT$IT
241162201$24116220$1$I$20240603$20240719$20240722$20240722$EXP$IT-MINISAL02-995361$NVSC2024IT148770$NOVARTIS$$42$YR$$M$Y$$$20240722$$MD$IT$IT
241162213$24116221$3$F$20240702$20240823$20240722$20240829$EXP$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00346$MELINTA THERAPEUTICS$$$$$$Y$$$20240829$$PH$US$US
241162222$24116222$2$F$$20240819$20240722$20240823$EXP$$CA-HALEON-2187726$Haleon PLC$$44$YR$$F$Y$70$KG$20240823$$HP$CA$CA
241162231$24116223$1$I$$20240716$20240722$20240722$EXP$$CH-DEXPHARM-2024-2389$DEXCEL$Sopi, B. B.; Yonekawa, K.; Bernheim, J.; Caselli, S.; Schmied, C.; Lam, A.; Hammer, H.; Jost, C. A.  UNHAPPY HEARTS WITH THE ANTIDEPRESSANT VENLAFAXINE. Swiss Medical Weekly 2024, V154 (Suppl.), P63S-64S abstr. P27$51$YR$A$F$Y$$$20240722$$HP$CH$CH
241162242$24116224$2$F$$20240809$20240722$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114000$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$78.47$KG$20240813$$CN$US$US
241162251$24116225$1$I$20240101$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115014$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$95.7$KG$20240722$$PH$US$US
241162261$24116226$1$I$20240702$20240712$20240722$20240722$EXP$CN-91110000556821568D-2024DRL001299$CN-MSNLABS-2024MSNSPO01621$MSN LABORATORIES$$$$$$Y$$$20240722$$HP$CN$CN
241162271$24116227$1$I$$20240709$20240722$20240722$EXP$$JP-Oxford Pharmaceuticals, LLC-2159408$OXFORD PHARMACEUTICALS$Source document$25$YR$$M$Y$$$20240722$$MD$JP$JP
241162281$24116228$1$I$$20240715$20240722$20240722$EXP$$CA-HALEON-2187703$Haleon PLC$$43$YR$$F$Y$68$KG$20240722$$HP$CA$CA
241162291$24116229$1$I$20240703$20240712$20240722$20240722$EXP$$IT-AUROBINDO-AUR-APL-2024-035896$AUROBINDO$$76$YR$$F$Y$$$20240722$$PH$IT$IT
241162301$24116230$1$I$$20240715$20240722$20240722$PER$$US-AstraZeneca-2024A164913$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241162311$24116231$1$I$$20230802$20240722$20240722$EXP$$US-AstraZeneca-2023A176932$ASTRAZENECA$$$$$F$Y$$$20240722$$HP$US$
241162322$24116232$2$F$$20240920$20240722$20240926$EXP$$BR-EMD Serono-2024038610$EMD SERONO INC$$$$A$F$Y$$$20240927$$CN$BR$BR
241162331$24116233$1$I$20240101$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114942$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$$$20240722$$HP$US$US
241162341$24116234$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114797$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240722$$HP$US$US
241162351$24116235$1$I$$20240710$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113852$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240722$$CN$US$US
241162361$24116236$1$I$$20240712$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115263$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$74.83$KG$20240722$$CN$US$US
241162371$24116237$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5835790$ABBVIE$$$$$M$Y$73.481$KG$20240722$$CN$US$US
241162382$24116238$2$F$$20240822$20240722$20240829$EXP$$US-TEVA-VS-3220069$TEVA$Vallabhajosyula S, Ukrani H, Wersinger D, Malik H, Obaji A. Fighting the Recovering Heart While Drowning in Volume: Role of VA-V ECMO Configuration in Migrating Mixing Cloud Effect. Am-J-Respir-Crit-Care-Med 2024; 209 A5582.; Vallabhajosyula S, Ukrani H, Wersinger D, Malik H, Obaji A. Fighting the Recovering Heart While Drowning in Volume: Role of VA-V ECMO Configuration in Migrating Mixing Cloud Effect. Am-J-Respir-Crit-Care-Med 2024; 209 A5582.$43$YR$$F$Y$$$20240829$$HP$US$US
241162391$24116239$1$I$$20240715$20240722$20240722$PER$$US-CHATTEMPRD-2024OHG024374$CHATTEM$$$$$F$Y$$$20240722$$CN$US$US
241162401$24116240$1$I$20240701$20240711$20240722$20240722$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2159409$JIANGSU HENGRUI MEDICINE$$65$YR$$F$Y$$$20240722$$MD$CN$CN
241162412$24116241$2$F$$20240807$20240722$20240808$PER$$US-ALXN-202407USA001010US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241162421$24116242$1$I$$20240712$20240722$20240722$PER$$NVSC2024US148887$NOVARTIS$$$$$$Y$$$20240722$$CN$US$US
241162431$24116243$1$I$$20240708$20240722$20240722$EXP$$TW-MSNLABS-2024MSNLIT01599$MSN LABORATORIES$$$$$$Y$$$20240722$$HP$TW$TW
241162441$24116244$1$I$$20240710$20240722$20240722$EXP$$US-NOVOPROD-1255173$NOVO NORDISK$$$$A$F$Y$$$20240719$$CN$US$US
241162452$24116245$2$F$$20240715$20240722$20240724$PER$$US-CHATTEMPRD-2024OHG024373$CHATTEM$$$$$F$Y$$$20240724$$CN$US$US
241162462$24116246$2$F$20240701$20240726$20240722$20240730$EXP$$CA-UCBSA-2024036253$UCB$$72$YR$$F$Y$$$20240730$$CN$CA$CA
241162472$24116247$2$F$20200101$20240715$20240722$20240725$EXP$$US-NOVOPROD-1256031$NOVO NORDISK$$$$$F$Y$$$20240725$$CN$US$US
241162481$24116248$1$I$20230701$20240710$20240722$20240722$EXP$$US-NOVOPROD-1254536$NOVO NORDISK$$$$$F$Y$$$20240719$$CN$US$US
241162491$24116249$1$I$20230621$20240710$20240722$20240722$EXP$$US-NOVOPROD-1254548$NOVO NORDISK$$59$YR$$F$Y$$$20240719$$CN$US$US
241162501$24116250$1$I$$20240710$20240722$20240722$EXP$$US-NOVOPROD-1255164$NOVO NORDISK$$$$$F$Y$$$20240719$$CN$US$US
241162511$24116251$1$I$20240616$20240710$20240722$20240722$EXP$DK-DKMA-30735182$DK-NOVOPROD-1253592$NOVO NORDISK$$53$YR$$M$Y$106$KG$20240719$$HP$DK$DK
241162521$24116252$1$I$20240501$20240710$20240722$20240722$EXP$$US-NOVOPROD-1254905$NOVO NORDISK$$$$$F$Y$$$20240719$$CN$US$US
241162531$24116253$1$I$20240101$20240709$20240722$20240722$EXP$$US-NOVOPROD-1255172$NOVO NORDISK$$80$YR$$F$Y$$$20240719$$CN$US$US
241162541$24116254$1$I$$20240709$20240722$20240722$EXP$$US-NOVOPROD-1254973$NOVO NORDISK$$$$$M$Y$$$20240719$$HP$US$US
241162551$24116255$1$I$20240627$20240710$20240722$20240722$EXP$$US-NOVOPROD-1255706$NOVO NORDISK$$57$YR$$M$Y$$$20240719$$MD$US$US
241162563$24116256$3$F$20240620$20240910$20240722$20240920$EXP$$US-NOVOPROD-1255023$NOVO NORDISK$$68$YR$$F$Y$$$20240920$$CN$US$US
241162571$24116257$1$I$$20240710$20240722$20240722$EXP$$US-NOVOPROD-1254898$NOVO NORDISK$$18$YR$$F$Y$$$20240719$$CN$US$US
241162582$24116258$2$F$$20240808$20240722$20240819$EXP$$US-NOVOPROD-1254971$NOVO NORDISK$$$$$F$Y$$$20240819$$CN$US$US
241162591$24116259$1$I$20240301$20240709$20240722$20240722$EXP$$CA-NOVOPROD-1255276$NOVO NORDISK$$$$$F$Y$$$20240719$$CN$CA$CA
241162601$24116260$1$I$$20240710$20240722$20240722$EXP$$US-NOVOPROD-1255829$NOVO NORDISK$$$$$M$Y$$$20240719$$MD$US$US
241162611$24116261$1$I$20240709$20240710$20240722$20240722$EXP$$FR-NOVOPROD-1256283$NOVO NORDISK$$50$YR$$M$Y$$$20240719$$MD$FR$FR
241162621$24116262$1$I$$20240709$20240722$20240722$EXP$$US-NOVOPROD-1254874$NOVO NORDISK$$31$YR$$F$Y$$$20240719$$CN$US$US
241162631$24116263$1$I$20190101$20240709$20240722$20240722$EXP$$US-NOVOPROD-1255192$NOVO NORDISK$$56$YR$$M$Y$$$20240719$$CN$US$US
241162641$24116264$1$I$20231209$20240709$20240722$20240722$EXP$$US-NOVOPROD-1255202$NOVO NORDISK$$56$YR$$F$Y$$$20240719$$CN$US$US
241162651$24116265$1$I$20240405$20240710$20240722$20240722$EXP$ES-AEMPS-1538611$ES-NOVOPROD-1253547$NOVO NORDISK$$$$A$F$Y$104$KG$20240719$$CN$ES$ES
241162661$24116266$1$I$20240703$20240710$20240722$20240722$EXP$$US-NOVOPROD-1256488$NOVO NORDISK$$68$YR$$M$Y$$$20240719$$CN$US$US
241162671$24116267$1$I$20240703$20240710$20240722$20240722$EXP$CN-NMPA-6204211005655202400332$CN-NOVOPROD-1254933$NOVO NORDISK$$56$YR$$M$Y$86$KG$20240719$$HP$CN$CN
241162681$24116268$1$I$20231205$20240710$20240722$20240722$EXP$$US-NOVOPROD-1255198$NOVO NORDISK$$50$YR$$F$Y$$$20240719$$CN$US$US
241162692$24116269$2$F$20220301$20240711$20240722$20240723$EXP$$US-NOVOPROD-1254485$NOVO NORDISK$$43$YR$$F$Y$$$20240723$$HP$US$US
241162701$24116270$1$I$$20240709$20240722$20240722$EXP$$US-NOVOPROD-1254545$NOVO NORDISK$$$$E$F$Y$$$20240719$$CN$US$US
241162711$24116271$1$I$20240615$20240709$20240722$20240722$EXP$GB-MHRA-MED-202407081756268030-SMTKB$GB-NOVOPROD-1252971$NOVO NORDISK$$59$YR$$M$Y$$$20240719$$CN$GB$GB
241162721$24116272$1$I$20240704$20240709$20240722$20240722$EXP$GB-MHRA-MED-202407090925595650-BFNGR$GB-NOVOPROD-1252969$NOVO NORDISK$$$$$F$Y$$$20240719$$HP$GB$GB
241162731$24116273$1$I$$20240709$20240722$20240722$EXP$$US-NOVOPROD-1254539$NOVO NORDISK$$42$YR$$$Y$$$20240719$$MD$US$US
241162741$24116274$1$I$$20240709$20240722$20240722$EXP$$US-NOVOPROD-1254693$NOVO NORDISK$$$$$M$Y$$$20240719$$HP$US$US
241162751$24116275$1$I$20240601$20240709$20240722$20240722$EXP$$US-NOVOPROD-1254804$NOVO NORDISK$$$$$F$Y$$$20240719$$CN$US$US
241162761$24116276$1$I$20240401$20240708$20240722$20240722$EXP$$US-NOVOPROD-1255119$NOVO NORDISK$$44$YR$$F$Y$$$20240719$$HP$US$US
241162771$24116277$1$I$$20240709$20240722$20240722$EXP$$US-NOVOPROD-1254397$NOVO NORDISK$$$$$F$Y$$$20240719$$CN$US$US
241162791$24116279$1$I$20240601$20240709$20240722$20240722$EXP$DK-DKMA-30734568$DK-NOVOPROD-1252372$NOVO NORDISK$$30$YR$$M$Y$126$KG$20240719$$CN$DK$DK
241162801$24116280$1$I$20240301$20240709$20240722$20240722$EXP$DK-DKMA-30729533$DK-NOVOPROD-1252454$NOVO NORDISK$$58$YR$$M$Y$70$KG$20240719$$MD$DK$DK
241162811$24116281$1$I$20240625$20240708$20240722$20240722$EXP$CN-NMPA-5101061025434202400245$CN-NOVOPROD-1252778$NOVO NORDISK$$73$YR$$M$Y$62$KG$20240719$$HP$CN$CN
241162831$24116283$1$I$$20240708$20240722$20240722$EXP$$US-NOVOPROD-1254617$NOVO NORDISK$Winston, David C.. Suicide Via Insulin Overdose in Nondiabetics-The New Mexico Experience. The American Journal of Forensic Medicine and Pathology. 2000;21(3):237-240$48$YR$$M$Y$$$20240719$$MD$US$US
241162841$24116284$1$I$20240415$20240708$20240722$20240722$EXP$$CO-NOVOPROD-1253813$NOVO NORDISK$$83$YR$$M$Y$84$KG$20240719$$CN$CO$CO
241162852$24116285$2$F$$20240826$20240722$20240904$EXP$$PE-TEVA-VS-3220819$TEVA$Contreras-Pizarro CH, Chumpitaz-Anchiraico G, Ticona Sanjinez R, Pena-Diaz C. POSTPARTUM-ACQUIRED HEMOPHILIA A: CASE REPORT. Revista-Peru-Med-Exp-Salud-Publ 2023; 40 (2): 242-246.; Contreras-Pizarro CH, Chumpitaz-Anchiraico G, Ticona Sanjinez R, Pena-Diaz C. POSTPARTUM-ACQUIRED HEMOPHILIA A: CASE REPORT. Revista-Peru-Med-Exp-Salud-Publ 2023; 40 (2): 242-246.; Contreras-Pizarro CH, Chumpitaz-Anchiraico G, Ticona Sanjinez R, Pena-Diaz C. POSTPARTUM-ACQUIRED HEMOPHILIA A: CASE REPORT. Revista-Pe...$34$YR$$F$Y$$$20240904$$MD$PE$PE
241162862$24116286$2$F$$20240809$20240722$20240814$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-114971$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240814$$MD$BR$BR
241162871$24116287$1$I$20240101$20240715$20240722$20240722$EXP$$US-ABBVIE-5843087$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241162882$24116288$2$F$$20240717$20240722$20240722$PER$$US-ROCHE-10000030778$ROCHE$$$$A$F$Y$$$20240722$$CN$US$US
241162891$24116289$1$I$$20240717$20240722$20240722$EXP$CA-DRL-USA-SPO/CAN/24/0010559$CA-RDY-SPO/CAN/24/0010559$DR REDDYS$$66$YR$E$M$Y$$$20240722$$HP$CA$CA
241162901$24116290$1$I$$20240708$20240722$20240722$EXP$CA-HEALTHCANVIG-E2B_07141261$CA-NOVOPROD-1254574$NOVO NORDISK$$65$YR$$M$Y$$$20240719$$HP$CA$CA
241162911$24116291$1$I$$20240718$20240722$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115401$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240722$$HP$CA$CA
241162921$24116292$1$I$$20240716$20240722$20240722$EXP$$MY-BEH-2024175928$CSL BEHRING$$$$$$Y$$$20240722$$HP$MY$MY
241162931$24116293$1$I$$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024143057$AMGEN$$$$$$Y$$$20240721$$HP$US$US
241162941$24116294$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141559$AMGEN$Sarraf D.; Fossataro F.; Fossataro C. et al.. Pathogenesis of Central Serous Chorioretinopathy and the Link Between Choroidal Hyperpermeability and Retinal Pigment Epithelium Pump Reversal. American Journal of Ophthalmology. 2024;266:206-217$36$YR$A$M$Y$$$20240721$$MD$US$US
241162962$24116296$2$F$$20240903$20240722$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115124$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$82.1$KG$20240906$$PH$US$US
241162971$24116297$1$I$$20240709$20240722$20240722$EXP$GB-MHRA-MED-202405030809039230-SNHVD$GB-MSNLABS-2024MSNSPO01580$MSN LABORATORIES$$$$$$Y$$$20240722$$HP$GB$GB
241162981$24116298$1$I$20240701$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115064$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$62.96$KG$20240722$$PH$US$US
241162992$24116299$2$F$$20240714$20240722$20240921$EXP$$US-ROCHE-10000027919$ROCHE$$$$$$Y$$$20240921$$CN$US$US
241163001$24116300$1$I$$20240717$20240722$20240722$EXP$$JP-ASTELLAS-2024JP005088$ASTELLAS$$8$DEC$$M$Y$$$20240719$$MD$JP$JP
241163011$24116301$1$I$20230623$20240715$20240722$20240722$EXP$$KR-TAKEDA-2024TUS072409$TAKEDA$$$$E$F$Y$$$20240722$$MD$KR$KR
241163024$24116302$4$F$20240716$20240814$20240722$20240902$EXP$$KR-ASTELLAS-2024US020406$ASTELLAS$$34$YR$A$M$Y$89.8$KG$20240902$$MD$KR$KR
241163031$24116303$1$I$20240208$20240709$20240722$20240722$EXP$$TR-ASTELLAS-2024US020093$ASTELLAS$$56$YR$$M$Y$$$20240719$$CN$TR$TR
241163041$24116304$1$I$20230101$20240718$20240722$20240722$EXP$ES-AEMPS-1549452$ES-ASTELLAS-2024EU007167$ASTELLAS$$2$YR$$M$Y$$$20240722$$CN$ES$ES
241163052$24116305$2$F$20201001$20240710$20240722$20240723$EXP$$IT-ASTELLAS-2024EU006944$ASTELLAS$$28$YR$$F$Y$$$20240723$$MD$IT$IT
241163064$24116306$4$F$$20240909$20240722$20240919$EXP$$US-ASTELLAS-2024EU007066$ASTELLAS$$$$E$M$Y$$$20240919$$CN$US$US
241163071$24116307$1$I$$20240705$20240722$20240722$EXP$GB-MHRA-TPP14865475C12380078YC1720093148546$GB-Accord-434468$ACCORD$$52$YR$A$M$Y$102$KG$20240720$$PH$GB$GB
241163081$24116308$1$I$$20240716$20240722$20240722$EXP$$US-GSK-US2024089365$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
241163091$24116309$1$I$$20240712$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089077$VIIV$$$$$M$Y$86.6$KG$20240722$$CN$US$US
241163101$24116310$1$I$$20240711$20240722$20240722$EXP$$US-TAKEDA-2024TUS071565$TAKEDA$$$$$M$Y$$$20240722$$CN$US$US
241163111$24116311$1$I$$20240711$20240722$20240722$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-000338$Alvotech$$67$YR$$F$Y$$$20240719$$CN$CA$CA
241163121$24116312$1$I$$20240717$20240722$20240722$EXP$$GB-ABBVIE-5844568$ABBVIE$$$$A$F$Y$$$20240722$$CN$GB$GB
241163131$24116313$1$I$$20210113$20240722$20240722$EXP$$CN-AstraZeneca-2020SF70118$ASTRAZENECA$$57$YR$$F$Y$65$KG$20240722$$HP$CN$
241163141$24116314$1$I$$20240717$20240722$20240722$EXP$$CA-UCBSA-2024036535$UCB$$40$YR$$F$Y$$$20240722$$HP$CA$CA
241163151$24116315$1$I$20210901$20210920$20240722$20240722$EXP$$US-AstraZeneca-2021A743404$ASTRAZENECA$$27433$DY$$M$Y$$$20240722$$CN$US$
241163161$24116316$1$I$$20190731$20240722$20240722$EXP$$CA-AstraZeneca-2019SF11617$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$CA$
241163171$24116317$1$I$$20230516$20240722$20240722$EXP$$US-AstraZeneca-2023A114781$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241163181$24116318$1$I$$20201203$20240722$20240722$EXP$$US-AstraZeneca-2020SF63454$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241163191$24116319$1$I$$20230503$20240722$20240722$EXP$$US-AstraZeneca-2023A104420$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241163201$24116320$1$I$20240626$20240709$20240722$20240722$EXP$$DE-ALK-ABELLO A/S-2024AA002845$ALK-ABELLO$$$$$$Y$$$20240722$$MD$DE$DE
241163211$24116321$1$I$20240718$20240718$20240722$20240722$EXP$$CN-ROCHE-10000030982$ROCHE$$69$YR$E$F$Y$$$20240722$$MD$CN$CN
241163221$24116322$1$I$$20240715$20240722$20240722$PER$$US-ABBVIE-5845645$ABBVIE$$$$$$Y$$$20240722$$HP$US$US
241163232$24116323$2$F$$20240916$20240722$20240926$EXP$CA-HPFB-001089100$CA-SERVIER-S24008878$SERVIER$$$$$$Y$$$20240926$$PH$CA$CA
241163241$24116324$1$I$20210101$20240715$20240722$20240722$EXP$$US-AUROBINDO-AUR-APL-2021-044225$AUROBINDO$Baker MC, Mallajosyula V, Davis MM, Boyd SD, Nadeau KC, Robinson WH. Effective Viral Vector SARS-CoV-2 Booster Vaccination in a Patient with Rheumatoid Arthritis after Initial Ineffective mRNA Vaccine Response. Arthritis-Rheumatol. 2021$74$YR$$M$Y$$$20240722$$MD$US$US
241163252$24116325$2$F$20240412$20240913$20240722$20240921$EXP$$CA-TAKEDA-2024TUS035602$TAKEDA$$66$YR$$F$Y$$$20240921$$MD$CA$CA
241163261$24116326$1$I$20240101$20240712$20240722$20240722$PER$DE-BFARM-24004819$DE-PFM-2024-04021$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240722$$CN$DE$DE
241163271$24116327$1$I$$20240711$20240722$20240722$EXP$$FR-COLLEGIUM PHARMACEUTICAL, INC.-20240700529$COLLEGIUM PHARMACEUTICAL$$55$YR$$F$Y$$$20240722$$MD$FR$FR
241163281$24116328$1$I$20220307$20240708$20240722$20240722$EXP$AU-TGA-0000795554$AU-COLLEGIUM PHARMACEUTICAL, INC.-20240700513$COLLEGIUM PHARMACEUTICAL$$64$YR$$F$Y$$$20240722$$CN$AU$AU
241163291$24116329$1$I$20220629$20240709$20240722$20240722$EXP$AU-TGA-0000795504$AU-COLLEGIUM PHARMACEUTICAL, INC.-20240700517$COLLEGIUM PHARMACEUTICAL$$46$YR$$M$Y$$$20240722$$CN$AU$AU
241163301$24116330$1$I$20220705$20240709$20240722$20240722$EXP$AU-TGA-0000795530$AU-COLLEGIUM PHARMACEUTICAL, INC.-20240700518$COLLEGIUM PHARMACEUTICAL$$52$YR$$F$Y$$$20240722$$CN$AU$AU
241163313$24116331$3$F$$20240806$20240722$20240809$EXP$$CA-TAKEDA-2024TUS013519$TAKEDA$$$$$F$Y$$$20240809$$CN$CA$CA
241163321$24116332$1$I$$20240708$20240722$20240722$EXP$$FR-NOVOPROD-1257628$NOVO NORDISK$Nadia Arbouche et al.. Influence of Preservatives on Insulin in Postmortem Blood:Application to a Case of Insulin Aspart Suicide. Journal of Analytical Toxicology. 2022;46:300-306$64$YR$$M$Y$$$20240722$$HP$FR$FR
241163331$24116333$1$I$$20240708$20240722$20240722$EXP$$TR-NOVOPROD-1257638$NOVO NORDISK$$$$$M$Y$$$20240722$$CN$TR$TR
241163341$24116334$1$I$$20240625$20240722$20240722$PER$$US-ROCHE-10000031296$ROCHE$$14$YR$T$F$Y$$$20240722$$CN$US$US
241163351$24116335$1$I$20220801$20240708$20240722$20240722$EXP$$US-NOVOPROD-1254451$NOVO NORDISK$$69$YR$$F$Y$$$20240722$$CN$US$US
241163361$24116336$1$I$$20240709$20240722$20240722$PER$$US-CHATTEMPRD-2024OHG023875$CHATTEM$$$$$$Y$$$20240722$$CN$US$US
241163371$24116337$1$I$20231017$20240718$20240722$20240722$EXP$$FR-AMGEN-FRASP2024143231$AMGEN$$$$$F$Y$$$20240721$$MD$FR$FR
241163381$24116338$1$I$$20240712$20240722$20240722$EXP$$NL-CELLTRION INC.-2024NL017310$CELLTRION$$$$$$Y$$$20240722$$CN$NL$NL
241163401$24116340$1$I$$20240710$20240722$20240722$EXP$$CA-APOTEX-2024AP008208$APOTEX$$17$YR$$F$Y$$$20240722$$MD$CA$CA
241163411$24116341$1$I$$20240718$20240722$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114769$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$95$KG$20240722$$HP$CA$CA
241163422$24116342$2$F$$20240715$20240722$20240726$PER$$US-CHATTEMPRD-2024OHG024319$CHATTEM$$$$$F$Y$$$20240726$$CN$US$US
241163431$24116343$1$I$20201210$20240709$20240722$20240722$EXP$$US-NOVOPROD-1255188$NOVO NORDISK$$39$YR$$F$Y$$$20240722$$CN$US$US
241163442$24116344$2$F$20230829$20240913$20240722$20240924$EXP$$US-NOVOPROD-1255584$NOVO NORDISK$$61$YR$$M$Y$102.9$KG$20240924$$MD$US$US
241163451$24116345$1$I$20240626$20240710$20240722$20240722$EXP$$ES-NOVOPROD-1254571$NOVO NORDISK$$24$YR$$F$Y$82$KG$20240722$$MD$ES$ES
241163461$24116346$1$I$$20240710$20240722$20240722$EXP$$US-NOVOPROD-1255938$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$US$US
241163471$24116347$1$I$20240701$20240709$20240722$20240722$EXP$$US-NOVOPROD-1254450$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$US$US
241163481$24116348$1$I$$20240710$20240722$20240722$EXP$$US-NOVOPROD-1255656$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$US$US
241163492$24116349$2$F$$20240715$20240722$20240725$EXP$$MX-NOVOPROD-1254711$NOVO NORDISK$$$$$M$Y$$$20240725$$CN$MX$MX
241163501$24116350$1$I$20240208$20240709$20240722$20240722$EXP$$DE-NOVOPROD-1254606$NOVO NORDISK$$732$MON$$F$Y$96$KG$20240722$$HP$DE$DE
241163513$24116351$3$F$20240609$20240911$20240722$20240920$EXP$$JP-NOVOPROD-1255266$NOVO NORDISK$$18$YR$$F$Y$28.4$KG$20240920$$MD$JP$JP
241163521$24116352$1$I$$20240710$20240722$20240722$EXP$$US-NOVOPROD-1255935$NOVO NORDISK$$$$A$M$Y$$$20240722$$CN$US$US
241163531$24116353$1$I$$20240709$20240722$20240722$EXP$$US-NOVOPROD-1254673$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$US$US
241163541$24116354$1$I$20240705$20240710$20240722$20240722$EXP$CN-NMPA-3711221017081202400257$CN-NOVOPROD-1254939$NOVO NORDISK$$58$YR$$M$Y$80$KG$20240722$$HP$CN$CN
241163551$24116355$1$I$$20240710$20240722$20240722$EXP$$US-NOVOPROD-1255622$NOVO NORDISK$$63$YR$$M$Y$$$20240722$$PH$US$US
241163561$24116356$1$I$20240619$20240710$20240722$20240722$EXP$GB-MHRA-MED-202407101702233410-DNGTY$GB-NOVOPROD-1253749$NOVO NORDISK$$43$YR$$M$Y$109$KG$20240722$$CN$GB$GB
241163571$24116357$1$I$$20240710$20240722$20240722$EXP$$EG-NOVOPROD-1254564$NOVO NORDISK$$83$MON$$F$Y$18$KG$20240722$$CN$EG$EG
241163581$24116358$1$I$$20240710$20240722$20240722$EXP$$EG-NOVOPROD-1254568$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$EG$EG
241163591$24116359$1$I$20240627$20240710$20240722$20240722$EXP$CN-NMPA-3201271057354202400248$CN-NOVOPROD-1254856$NOVO NORDISK$$56$YR$$M$Y$76$KG$20240722$$HP$CN$CN
241163601$24116360$1$I$20240616$20240710$20240722$20240722$EXP$NO-NOMAADVRE-RELISV-2024-Vj8jmd$NO-NOVOPROD-1253594$NOVO NORDISK$$53$YR$$M$Y$$$20240722$$MD$NO$NO
241163611$24116361$1$I$20240704$20240710$20240722$20240722$EXP$$CA-NOVOPROD-1255449$NOVO NORDISK$$70$YR$$F$Y$88.5$KG$20240722$$CN$CA$CA
241163631$24116363$1$I$20221201$20240710$20240722$20240722$EXP$$JP-NOVOPROD-1240252$NOVO NORDISK$T Yamazaki. A case of a patient who experienced recurrent diabetic chorea at low glucose levels due to decreased injection adherence and after treatment intensification. The 61st Japan Diabetes Society Kanto Koshinetsu Regional Association. 2024;pO-169$81$YR$$F$Y$$$20240722$$MD$JP$JP
241163642$24116364$2$F$20210401$20240717$20240722$20240806$EXP$$BR-HALEON-2187835$Haleon PLC$$47$YR$$M$Y$$$20240806$$CN$BR$BR
241163651$24116365$1$I$$20240717$20240722$20240722$EXP$$JP-ORGANON-O2407JPN001523$ORGANON$$61$YR$$F$Y$$$20240722$$PH$JP$JP
241163661$24116366$1$I$20240708$20240708$20240722$20240722$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-001189$Alvotech$$36$YR$$M$Y$$$20240722$$HP$CA$CA
241163673$24116367$3$F$20210624$20240821$20240722$20240827$EXP$$DE-ROCHE-10000012359$ROCHE$$50$YR$A$M$Y$105$KG$20240827$$MD$DE$DE
241163681$24116368$1$I$$20240715$20240722$20240722$EXP$$US-ABBVIE-5843540$ABBVIE$$$$$F$Y$$$20240722$$HP$US$US
241163691$24116369$1$I$$20240212$20240722$20240722$PER$$US-ASTELLAS-2024US004929$ASTELLAS$$96$YR$$F$Y$$$20240722$$CN$US$US
241163701$24116370$1$I$$20240305$20240722$20240722$PER$$US-ASTELLAS-2024US007462$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
241163711$24116371$1$I$20220101$20231102$20240722$20240722$PER$$US-ASTELLAS-2023US033198$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
241163721$24116372$1$I$$20240108$20240722$20240722$PER$$US-ASTELLAS-2024US000879$ASTELLAS$$60$YR$$M$Y$$$20240722$$CN$US$US
241163731$24116373$1$I$20240201$20240229$20240722$20240722$PER$$US-ASTELLAS-2024US005402$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
241163742$24116374$2$F$$20240206$20240722$20240722$PER$$US-ASTELLAS-2024US004514$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241163752$24116375$2$F$20231023$20231023$20240722$20240722$PER$$US-ASTELLAS-2023US032249$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241163761$24116376$1$I$$20240109$20240722$20240722$PER$$US-ASTELLAS-2024US001136$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241163771$24116377$1$I$$20240205$20240722$20240722$PER$$US-ASTELLAS-2024US003958$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241163781$24116378$1$I$$20240105$20240722$20240722$PER$$US-ASTELLAS-2024US000683$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
241163791$24116379$1$I$$20240115$20240722$20240722$PER$$US-ASTELLAS-2024US001484$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
241163801$24116380$1$I$20240101$20240412$20240722$20240722$PER$$US-ASTELLAS-2024US008563$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
241163811$24116381$1$I$20240201$20240226$20240722$20240722$PER$$US-ASTELLAS-2024US006860$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241163821$24116382$1$I$$20231113$20240722$20240722$PER$$US-ASTELLAS-2023US034614$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241163831$24116383$1$I$20240101$20240130$20240722$20240722$PER$$US-ASTELLAS-2024US003464$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241163841$24116384$1$I$20230101$20231025$20240722$20240722$PER$$US-ASTELLAS-2023US032276$ASTELLAS$$66$YR$$M$Y$$$20240722$$CN$US$US
241163851$24116385$1$I$20240101$20240115$20240722$20240722$PER$$US-ASTELLAS-2024US001488$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241163861$24116386$1$I$20231001$20231106$20240722$20240722$PER$$US-ASTELLAS-2023US033599$ASTELLAS$$75$YR$$M$Y$$$20240722$$CN$US$US
241163871$24116387$1$I$$20240206$20240722$20240722$PER$$US-ASTELLAS-2024US004310$ASTELLAS$$8$DEC$$M$Y$$$20240722$$CN$US$US
241163881$24116388$1$I$$20231102$20240722$20240722$PER$$US-ASTELLAS-2023US033187$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241163891$24116389$1$I$20230101$20240115$20240722$20240722$PER$$US-ASTELLAS-2024US001496$ASTELLAS$$47$YR$$F$Y$$$20240722$$CN$US$US
241163901$24116390$1$I$$20240322$20240722$20240722$PER$$US-ASTELLAS-2024US009477$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
241163911$24116391$1$I$20231024$20231028$20240722$20240722$PER$$US-ASTELLAS-2023US032822$ASTELLAS$$87$YR$$F$Y$$$20240722$$CN$US$US
241163921$24116392$1$I$$20240328$20240722$20240722$PER$$US-ASTELLAS-2024US010139$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241163931$24116393$1$I$$20240212$20240722$20240722$PER$$US-ASTELLAS-2024US001231$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241163941$24116394$1$I$20230101$20231110$20240722$20240722$PER$$US-ASTELLAS-2023US034252$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
241163951$24116395$1$I$$20240117$20240722$20240722$PER$$US-ASTELLAS-2024US001881$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241163961$24116396$1$I$$20231113$20240722$20240722$PER$$US-ASTELLAS-2023US034247$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
241163971$24116397$1$I$20240222$20240222$20240722$20240722$PER$$US-ASTELLAS-2024US006085$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
241163981$24116398$1$I$20190101$20240401$20240722$20240722$PER$$US-ASTELLAS-2024US006046$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
241163991$24116399$1$I$$20231213$20240722$20240722$PER$$US-ASTELLAS-2023US037839$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241164001$24116400$1$I$$20231025$20240722$20240722$PER$$US-ASTELLAS-2023US032260$ASTELLAS$$93$YR$$F$Y$$$20240722$$CN$US$US
241164011$24116401$1$I$$20231113$20240722$20240722$PER$$US-ASTELLAS-2023US034795$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164021$24116402$1$I$$20240219$20240722$20240722$PER$$US-ASTELLAS-2024US005443$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
241164031$24116403$1$I$$20240221$20240722$20240722$PER$$US-ASTELLAS-2024US005873$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164042$24116404$2$F$20231001$20231025$20240722$20240722$PER$$US-ASTELLAS-2023US032254$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241164051$24116405$1$I$$20240328$20240722$20240722$PER$$US-ASTELLAS-2024US009817$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164061$24116406$1$I$20231117$20231120$20240722$20240722$PER$$US-ASTELLAS-2023US035304$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
241164071$24116407$1$I$$20240209$20240722$20240722$PER$$US-ASTELLAS-2024US004924$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164081$24116408$1$I$20240109$20240110$20240722$20240722$PER$$US-ASTELLAS-2024US001223$ASTELLAS$$42$YR$$F$Y$$$20240722$$CN$US$US
241164091$24116409$1$I$20231113$20231113$20240722$20240722$PER$$US-ASTELLAS-2023US034542$ASTELLAS$$86$YR$$F$Y$$$20240722$$HP$US$US
241164101$24116410$1$I$$20231113$20240722$20240722$PER$$US-ASTELLAS-2023US034246$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
241164111$24116411$1$I$$20231212$20240722$20240722$PER$$US-ASTELLAS-2023US037470$ASTELLAS$$89$YR$$F$Y$$$20240722$$CN$US$US
241164121$24116412$1$I$20240408$20240409$20240722$20240722$PER$$US-ASTELLAS-2024US011013$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
241164131$24116413$1$I$$20240318$20240722$20240722$PER$$US-ASTELLAS-2024US008829$ASTELLAS$$$$$F$Y$$$20240722$$HP$US$US
241164141$24116414$1$I$$20231020$20240722$20240722$PER$$US-ASTELLAS-2023US037483$ASTELLAS$$87$YR$$M$Y$$$20240722$$CN$US$US
241164151$24116415$1$I$$20240307$20240722$20240722$PER$$US-ASTELLAS-2024US007742$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
241164161$24116416$1$I$$20240220$20240722$20240722$PER$$US-ASTELLAS-2024US005649$ASTELLAS$$87$YR$$F$Y$$$20240722$$HP$US$US
241164171$24116417$1$I$$20231107$20240722$20240722$PER$$US-ASTELLAS-2023US033921$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
241164181$24116418$1$I$20240101$20240312$20240722$20240722$PER$$US-ASTELLAS-2024US005418$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
241164191$24116419$1$I$$20240102$20240722$20240722$PER$$US-ASTELLAS-2024US000272$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
241164201$24116420$1$I$$20240419$20240722$20240722$PER$$US-ASTELLAS-2024US011985$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
241164211$24116421$1$I$20231119$20231120$20240722$20240722$PER$$US-ASTELLAS-2023US035487$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
241164221$24116422$1$I$$20240115$20240722$20240722$PER$$US-ASTELLAS-2024US001705$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
241164231$24116423$1$I$$20240219$20240722$20240722$PER$$US-ASTELLAS-2024US005539$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164242$24116424$2$F$$20240118$20240722$20240722$PER$$US-ASTELLAS-2024US001429$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
241164251$24116425$1$I$$20240417$20240722$20240722$PER$$US-ASTELLAS-2024US011981$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
241164261$24116426$1$I$$20231207$20240722$20240722$PER$$US-ASTELLAS-2023US037051$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164271$24116427$1$I$20230101$20231109$20240722$20240722$PER$$US-ASTELLAS-2023US034164$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164281$24116428$1$I$20231001$20231031$20240722$20240722$PER$$US-ASTELLAS-2023US032836$ASTELLAS$$87$YR$$F$Y$$$20240722$$CN$US$US
241164291$24116429$1$I$$20240319$20240722$20240722$PER$$US-ASTELLAS-2024US008752$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164301$24116430$1$I$$20231212$20240722$20240722$PER$$US-ASTELLAS-2023US037507$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164311$24116431$1$I$20240301$20240321$20240722$20240722$PER$$US-ASTELLAS-2024US009280$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164321$24116432$1$I$20240301$20240329$20240722$20240722$PER$$US-ASTELLAS-2024US010153$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164331$24116433$1$I$20230201$20240122$20240722$20240722$PER$$US-ASTELLAS-2023US032727$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
241164341$24116434$1$I$$20231219$20240722$20240722$PER$$US-ASTELLAS-2023US038513$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164351$24116435$1$I$$20240125$20240722$20240722$PER$$US-ASTELLAS-2024US003037$ASTELLAS$$85$YR$$M$Y$$$20240722$$CN$US$US
241164361$24116436$1$I$$20240117$20240722$20240722$PER$$US-ASTELLAS-2024US002068$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164371$24116437$1$I$20240215$20240216$20240722$20240722$PER$$US-ASTELLAS-2024US005543$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164381$24116438$1$I$20240301$20240322$20240722$20240722$PER$$US-ASTELLAS-2024US009474$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
241164391$24116439$1$I$20230101$20231220$20240722$20240722$PER$$US-ASTELLAS-2023US037122$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164401$24116440$1$I$$20240416$20240722$20240722$PER$$US-ASTELLAS-2024US009760$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164411$24116441$1$I$20231210$20231211$20240722$20240722$PER$$US-ASTELLAS-2023US037367$ASTELLAS$$9$DEC$$F$Y$$$20240722$$CN$US$US
241164421$24116442$1$I$$20240119$20240722$20240722$PER$$US-ASTELLAS-2023US034593$ASTELLAS$$44$YR$$F$Y$$$20240722$$HP$US$US
241164431$24116443$1$I$$20240124$20240722$20240722$PER$$US-ASTELLAS-2024US002925$ASTELLAS$$83$YR$$M$Y$$$20240722$$CN$US$US
241164441$24116444$1$I$20231101$20240524$20240722$20240722$PER$$US-ASTELLAS-2023US037218$ASTELLAS$$78$YR$$F$Y$$$20240722$$MD$US$US
241164451$24116445$1$I$20231120$20231120$20240722$20240722$PER$$US-ASTELLAS-2023US035323$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
241164461$24116446$1$I$$20240424$20240722$20240722$PER$$US-ASTELLAS-2024US010123$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164471$24116447$1$I$20231101$20240104$20240722$20240722$PER$$US-ASTELLAS-2023US038954$ASTELLAS$$67$YR$$F$Y$$$20240722$$HP$US$US
241164481$24116448$1$I$$20231122$20240722$20240722$PER$$US-ASTELLAS-2023US035423$ASTELLAS$$70$YR$$M$Y$$$20240722$$CN$US$US
241164491$24116449$1$I$$20240322$20240722$20240722$PER$$US-ASTELLAS-2024US007191$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164501$24116450$1$I$$20231102$20240722$20240722$PER$$US-ASTELLAS-2023US033203$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241164511$24116451$1$I$20230901$20240328$20240722$20240722$PER$$US-ASTELLAS-2024US003680$ASTELLAS$$87$YR$$M$Y$$$20240722$$CN$US$US
241164521$24116452$1$I$20240125$20240126$20240722$20240722$PER$$US-ASTELLAS-2024US003198$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241164531$24116453$1$I$$20231113$20240722$20240722$PER$$US-ASTELLAS-2023US034771$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241164541$24116454$1$I$$20231211$20240722$20240722$PER$$US-ASTELLAS-2023US037508$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164551$24116455$1$I$$20240308$20240722$20240722$PER$$US-ASTELLAS-2024US007823$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164561$24116456$1$I$$20240220$20240722$20240722$PER$$US-ASTELLAS-2024US005848$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
241164571$24116457$1$I$20221201$20231116$20240722$20240722$PER$$US-ASTELLAS-2023US035062$ASTELLAS$$84$YR$$M$Y$$$20240722$$HP$US$US
241164581$24116458$1$I$20240716$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142912$AMGEN$$$$$$Y$$$20240721$$PH$US$US
241164593$24116459$3$F$20240101$20240821$20240722$20240902$PER$$US-CHATTEMPRD-2024OHG024486$CHATTEM$$79$YR$E$F$Y$$$20240902$$CN$US$US
241164601$24116460$1$I$$20240711$20240722$20240722$EXP$$CA-APOTEX-2024AP008259$APOTEX$$55$YR$$M$Y$$$20240722$$HP$CA$CA
241164611$24116461$1$I$$20240716$20240722$20240722$PER$$US-CHATTEMPRD-2024OHG024507$CHATTEM$$$$$F$Y$$$20240722$$CN$US$US
241164621$24116462$1$I$$20240710$20240722$20240722$EXP$$EG-Oxford Pharmaceuticals, LLC-2159410$OXFORD PHARMACEUTICALS$Source document$58$YR$$M$Y$$$20240722$$$EG$EG
241164631$24116463$1$I$$20240108$20240722$20240722$PER$$US-ASTELLAS-2024US000880$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164642$24116464$2$F$$20240105$20240722$20240722$PER$$US-ASTELLAS-2024US000677$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
241164651$24116465$1$I$$20240206$20240722$20240722$PER$$US-ASTELLAS-2024US004162$ASTELLAS$$$$E$$Y$$$20240722$$CN$US$US
241164661$24116466$1$I$$20231107$20240722$20240722$PER$$US-ASTELLAS-2023US033894$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
241164671$24116467$1$I$$20240311$20240722$20240722$PER$$US-ASTELLAS-2024US008073$ASTELLAS$$32$YR$$M$Y$$$20240722$$HP$US$US
241164681$24116468$1$I$20231001$20231114$20240722$20240722$PER$$US-ASTELLAS-2023US034601$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
241164691$24116469$1$I$$20231218$20240722$20240722$PER$$US-ASTELLAS-2023US036873$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164701$24116470$1$I$$20231211$20240722$20240722$PER$$US-ASTELLAS-2023US037370$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164711$24116471$1$I$20240129$20240514$20240722$20240722$PER$$US-ASTELLAS-2024US006628$ASTELLAS$$88$YR$$M$Y$$$20240722$$MD$US$US
241164721$24116472$1$I$$20240416$20240722$20240722$PER$$US-ASTELLAS-2024US011719$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164731$24116473$1$I$$20240213$20240722$20240722$PER$$US-ASTELLAS-2024US005308$ASTELLAS$$79$YR$$M$Y$$$20240722$$CN$US$US
241164742$24116474$2$F$$20240129$20240722$20240722$PER$$US-ASTELLAS-2024US001116$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
241164751$24116475$1$I$$20240425$20240722$20240722$PER$$US-ASTELLAS-2024US011817$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164761$24116476$1$I$20240201$20240216$20240722$20240722$PER$$US-ASTELLAS-2024US005437$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164771$24116477$1$I$20231206$20231206$20240722$20240722$PER$$US-ASTELLAS-2023US036680$ASTELLAS$$73$YR$$F$Y$$$20240722$$HP$US$US
241164781$24116478$1$I$$20240109$20240722$20240722$PER$$US-ASTELLAS-2024US001149$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
241164791$24116479$1$I$$20240411$20240722$20240722$PER$$US-ASTELLAS-2024US011213$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
241164801$24116480$1$I$$20240109$20240722$20240722$PER$$US-ASTELLAS-2024US001092$ASTELLAS$$84$YR$$M$Y$$$20240722$$CN$US$US
241164811$24116481$1$I$20231101$20231116$20240722$20240722$PER$$US-ASTELLAS-2023US035074$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
241164821$24116482$1$I$$20240322$20240722$20240722$PER$$US-ASTELLAS-2024US007566$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
241164831$24116483$1$I$$20240412$20240722$20240722$PER$$US-ASTELLAS-2024US009712$ASTELLAS$$89$YR$$M$Y$$$20240722$$CN$US$US
241164841$24116484$1$I$20231201$20240216$20240722$20240722$PER$$US-ASTELLAS-2024US005273$ASTELLAS$$80$YR$$M$Y$$$20240722$$HP$US$US
241164851$24116485$1$I$20231201$20240311$20240722$20240722$PER$$US-ASTELLAS-2024US005122$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
241164861$24116486$1$I$$20231107$20240722$20240722$PER$$US-ASTELLAS-2023US033900$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164871$24116487$1$I$$20240321$20240722$20240722$PER$$US-ASTELLAS-2024US007546$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164881$24116488$1$I$$20231211$20240722$20240722$PER$$US-ASTELLAS-2023US033225$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164891$24116489$1$I$$20231215$20240722$20240722$PER$$US-ASTELLAS-2023US037943$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164901$24116490$1$I$20231001$20231025$20240722$20240722$PER$$US-ASTELLAS-2023US032279$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
241164911$24116491$1$I$20230901$20231102$20240722$20240722$PER$$US-ASTELLAS-2023US033342$ASTELLAS$$69$YR$$M$Y$$$20240722$$CN$US$US
241164921$24116492$1$I$$20231221$20240722$20240722$PER$$US-ASTELLAS-2023US038515$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164931$24116493$1$I$$20231110$20240722$20240722$PER$$US-ASTELLAS-2023US032258$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164942$24116494$2$F$$20240111$20240722$20240722$PER$$US-ASTELLAS-2024US001226$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
241164951$24116495$1$I$$20240401$20240722$20240722$PER$$US-ASTELLAS-2024US009980$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241164961$24116496$1$I$20240201$20240202$20240722$20240722$PER$$US-ASTELLAS-2024US003925$ASTELLAS$$$$C$M$Y$$$20240722$$CN$US$US
241164971$24116497$1$I$20240101$20240326$20240722$20240722$PER$$US-ASTELLAS-2024US003923$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241164981$24116498$1$I$20231201$20240418$20240722$20240722$PER$$US-ASTELLAS-2024US009977$ASTELLAS$$66$YR$$F$Y$$$20240722$$CN$US$US
241164991$24116499$1$I$$20240207$20240722$20240722$PER$$US-ASTELLAS-2024US003717$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241165001$24116500$1$I$20240320$20240411$20240722$20240722$PER$$US-ASTELLAS-2024US009469$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
241165011$24116501$1$I$$20231108$20240722$20240722$PER$$US-ASTELLAS-2023US033916$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
241165021$24116502$1$I$20230101$20240221$20240722$20240722$PER$$US-ASTELLAS-2024US000255$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165031$24116503$1$I$$20240126$20240722$20240722$PER$$US-ASTELLAS-2023US036319$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165041$24116504$1$I$$20240201$20240722$20240722$PER$$US-ASTELLAS-2024US003675$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165051$24116505$1$I$$20240226$20240722$20240722$PER$$US-ASTELLAS-2024US006423$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165061$24116506$1$I$$20240214$20240722$20240722$PER$$US-ASTELLAS-2024US005314$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165071$24116507$1$I$$20231110$20240722$20240722$PER$$US-ASTELLAS-2023US034646$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
241165081$24116508$1$I$$20240318$20240722$20240722$PER$$US-ASTELLAS-2024US008595$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165091$24116509$1$I$20220901$20240320$20240722$20240722$PER$$US-ASTELLAS-2024US003927$ASTELLAS$$78$YR$$M$Y$$$20240722$$CN$US$US
241165101$24116510$1$I$$20231127$20240722$20240722$PER$$US-ASTELLAS-2023US035769$ASTELLAS$$73$YR$$M$Y$$$20240722$$PH$US$US
241165111$24116511$1$I$$20240429$20240722$20240722$PER$$US-ASTELLAS-2024US009067$ASTELLAS$$88$YR$$M$Y$$$20240722$$CN$US$US
241165121$24116512$1$I$$20240216$20240722$20240722$PER$$US-ASTELLAS-2024US005289$ASTELLAS$$70$YR$$F$Y$$$20240722$$HP$US$US
241165131$24116513$1$I$$20240322$20240722$20240722$PER$$US-ASTELLAS-2024US009472$ASTELLAS$$65$YR$$M$Y$$$20240722$$CN$US$US
241165141$24116514$1$I$20240201$20240223$20240722$20240722$PER$$US-ASTELLAS-2024US006223$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165151$24116515$1$I$$20231121$20240722$20240722$PER$$US-ASTELLAS-2023US035315$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165161$24116516$1$I$$20240415$20240722$20240722$PER$$US-ASTELLAS-2024US011708$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
241165171$24116517$1$I$20230801$20240104$20240722$20240722$PER$$US-ASTELLAS-2023US037859$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165181$24116518$1$I$20230101$20240403$20240722$20240722$PER$$US-ASTELLAS-2024US010536$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165192$24116519$2$F$$20231110$20240722$20240722$PER$$US-ASTELLAS-2023US032272$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
241165201$24116520$1$I$$20231218$20240722$20240722$PER$$US-ASTELLAS-2023US038121$ASTELLAS$$$$A$$Y$$$20240722$$CN$US$US
241165211$24116521$1$I$20231204$20231204$20240722$20240722$PER$$US-ASTELLAS-2023US036651$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165221$24116522$1$I$20231001$20231127$20240722$20240722$PER$$US-ASTELLAS-2023US035767$ASTELLAS$$67$YR$$M$Y$$$20240722$$CN$US$US
241165231$24116523$1$I$$20240321$20240722$20240722$PER$$US-ASTELLAS-2024US009269$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165241$24116524$1$I$$20231128$20240722$20240722$PER$$US-ASTELLAS-2023US035846$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
241165251$24116525$1$I$$20240117$20240722$20240722$PER$$US-ASTELLAS-2024US001912$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165261$24116526$1$I$$20240124$20240722$20240722$PER$$US-ASTELLAS-2024US001297$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
241165271$24116527$1$I$20240211$20240212$20240722$20240722$PER$$US-ASTELLAS-2024US005331$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
241165281$24116528$1$I$$20240307$20240722$20240722$PER$$US-ASTELLAS-2024US005626$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165291$24116529$1$I$$20231215$20240722$20240722$PER$$US-ASTELLAS-2023US037970$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
241165301$24116530$1$I$20240101$20240118$20240722$20240722$PER$$US-ASTELLAS-2024US002073$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
241165311$24116531$1$I$$20240201$20240722$20240722$PER$$US-ASTELLAS-2024US003701$ASTELLAS$$75$YR$$F$Y$$$20240722$$HP$US$US
241165321$24116532$1$I$20231101$20231219$20240722$20240722$PER$$US-ASTELLAS-2023US035317$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
241165331$24116533$1$I$$20231109$20240722$20240722$PER$$US-ASTELLAS-2023US034196$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165341$24116534$1$I$$20240411$20240722$20240722$PER$$US-ASTELLAS-2024US011161$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165351$24116535$1$I$$20231107$20240722$20240722$PER$$US-ASTELLAS-2023US033641$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165365$24116536$5$F$$20240831$20240722$20240905$EXP$$PT-AUROBINDO-AUR-APL-2024-035821$AUROBINDO$Sousa CC, Olim C, Moniz ME, Ferreira MV, Neto CT, Faria T. A state of hyponatremic illness - a rare case (Um estado de mal hiponatr?mico - um caso raro. Medicina Interna). Internal medicine(Medicina Interna). 2024;30(Sup 1 ):224$$$$F$Y$$$20240905$$MD$PT$PT
241165371$24116537$1$I$$20231116$20240722$20240722$PER$$US-ASTELLAS-2023US032702$ASTELLAS$$92$YR$$F$Y$$$20240722$$CN$US$US
241165381$24116538$1$I$$20240312$20240722$20240722$PER$$US-ASTELLAS-2024US008075$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165391$24116539$1$I$20240201$20240307$20240722$20240722$PER$$US-ASTELLAS-2024US007746$ASTELLAS$$72$YR$$F$Y$$$20240722$$HP$US$US
241165401$24116540$1$I$$20240307$20240722$20240722$PER$$US-ASTELLAS-2024US007473$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165411$24116541$1$I$$20231128$20240722$20240722$PER$$US-ASTELLAS-2023US036210$ASTELLAS$$84$YR$$M$Y$$$20240722$$CN$US$US
241165421$24116542$1$I$20240301$20240312$20240722$20240722$PER$$US-ASTELLAS-2024US008096$ASTELLAS$$91$YR$$F$Y$$$20240722$$CN$US$US
241165431$24116543$1$I$$20231121$20240722$20240722$PER$$US-ASTELLAS-2023US035327$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241165441$24116544$1$I$20231001$20231031$20240722$20240722$PER$$US-ASTELLAS-2023US032812$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165451$24116545$1$I$20240325$20240426$20240722$20240722$PER$$US-ASTELLAS-2024US008757$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
241165461$24116546$1$I$$20240219$20240722$20240722$PER$$US-ASTELLAS-2024US005714$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165471$24116547$1$I$20240201$20240222$20240722$20240722$PER$$US-ASTELLAS-2024US006075$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165481$24116548$1$I$$20240126$20240722$20240722$PER$$US-ASTELLAS-2024US003249$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165491$24116549$1$I$20240101$20240320$20240722$20240722$PER$$US-ASTELLAS-2024US009066$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241165501$24116550$1$I$$20231220$20240722$20240722$PER$$US-ASTELLAS-2023US036790$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
241165511$24116551$1$I$$20240221$20240722$20240722$PER$$US-ASTELLAS-2024US005694$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165521$24116552$1$I$20240201$20240220$20240722$20240722$PER$$US-ASTELLAS-2024US004623$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
241165531$24116553$1$I$20231201$20240112$20240722$20240722$PER$$US-ASTELLAS-2024US001426$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
241165541$24116554$1$I$20231130$20240202$20240722$20240722$PER$$US-ASTELLAS-2023US037336$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165551$24116555$1$I$$20240411$20240722$20240722$PER$$US-ASTELLAS-2024US011176$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
241165561$24116556$1$I$20170101$20240307$20240722$20240722$PER$$US-ASTELLAS-2024US006544$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165571$24116557$1$I$$20231113$20240722$20240722$PER$$US-ASTELLAS-2023US034651$ASTELLAS$$89$YR$$F$Y$$$20240722$$CN$US$US
241165581$24116558$1$I$20220101$20231114$20240722$20240722$PER$$US-ASTELLAS-2023US032820$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165591$24116559$1$I$20231110$20231115$20240722$20240722$PER$$US-ASTELLAS-2023US034924$ASTELLAS$$62$YR$$M$Y$$$20240722$$CN$US$US
241165601$24116560$1$I$$20240206$20240722$20240722$PER$$US-ASTELLAS-2024US002690$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165612$24116561$2$F$$20240812$20240722$20240812$PER$$US-ALXN-202407USA000986US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241165621$24116562$1$I$$20240710$20240722$20240722$EXP$$US-NOVOPROD-1255973$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$US$US
241165632$24116563$2$F$20240601$20240823$20240722$20240827$EXP$$JP-TAKEDA-2024TJP010826$TAKEDA$$8$DEC$$F$Y$$$20240826$$MD$JP$JP
241165641$24116564$1$I$20240701$20240712$20240722$20240722$EXP$FR-AFSSAPS-AN2024000911$FR-TERSERA THERAPEUTICS LLC-2024TRS003634$TERSERA THERAPEUTICS$$$$$$Y$$$20240722$$MD$FR$FR
241165652$24116565$2$F$20240704$20240819$20240722$20240828$EXP$$US-NOVOPROD-1255939$NOVO NORDISK$$66$YR$$F$Y$$$20240828$$MD$US$US
241165661$24116566$1$I$$20240710$20240722$20240722$EXP$$CA-NOVOPROD-1256053$NOVO NORDISK$$$$$F$Y$$$20240722$$MD$CA$CA
241165671$24116567$1$I$$20240206$20240722$20240722$PER$$US-ASTELLAS-2024US004099$ASTELLAS$$$$$M$Y$$$20240722$$PH$US$US
241165681$24116568$1$I$$20231213$20240722$20240722$PER$$US-ASTELLAS-2023US037534$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241165691$24116569$1$I$$20240102$20240722$20240722$PER$$US-ASTELLAS-2024US000274$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165701$24116570$1$I$$20240109$20240722$20240722$PER$$US-ASTELLAS-2024US001118$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165711$24116571$1$I$$20240206$20240722$20240722$PER$$US-ASTELLAS-2024US003978$ASTELLAS$$90$YR$$M$Y$$$20240722$$CN$US$US
241165721$24116572$1$I$20240301$20240409$20240722$20240722$PER$$US-ASTELLAS-2024US011006$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165731$24116573$1$I$20231201$20240315$20240722$20240722$PER$$US-ASTELLAS-2024US005125$ASTELLAS$$91$YR$$F$Y$$$20240722$$CN$US$US
241165741$24116574$1$I$20230101$20231207$20240722$20240722$PER$$US-ASTELLAS-2023US033941$ASTELLAS$$89$YR$$M$Y$$$20240722$$CN$US$US
241165751$24116575$1$I$$20240103$20240722$20240722$PER$$US-ASTELLAS-2024US000323$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165761$24116576$1$I$$20240116$20240722$20240722$PER$$US-ASTELLAS-2024US001709$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
241165771$24116577$1$I$20240321$20240429$20240722$20240722$PER$$US-ASTELLAS-2024US012737$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165781$24116578$1$I$20240316$20240418$20240722$20240722$PER$$US-ASTELLAS-2024US009884$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
241165791$24116579$1$I$$20240411$20240722$20240722$PER$$US-ASTELLAS-2024US011186$ASTELLAS$$50$YR$$F$Y$$$20240722$$CN$US$US
241165801$24116580$1$I$20240301$20240716$20240722$20240722$PER$$US-ASTELLAS-2024US010399$ASTELLAS$$74$YR$$M$Y$$$20240722$$HP$US$US
241165811$24116581$1$I$20240201$20240207$20240722$20240722$PER$$US-ASTELLAS-2024US004525$ASTELLAS$$70$YR$$F$Y$$$20240722$$CN$US$US
241165821$24116582$1$I$$20231028$20240722$20240722$PER$$US-ASTELLAS-2023US033148$ASTELLAS$$$$$$Y$$$20240722$$CN$US$US
241165831$24116583$1$I$20231101$20231212$20240722$20240722$PER$$US-ASTELLAS-2023US037546$ASTELLAS$$72$YR$$M$Y$$$20240722$$CN$US$US
241165841$24116584$1$I$20240301$20240417$20240722$20240722$PER$$US-ASTELLAS-2024US011822$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165851$24116585$1$I$$20240105$20240722$20240722$PER$$US-ASTELLAS-2024US000690$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165861$24116586$1$I$$20231107$20240722$20240722$PER$$US-ASTELLAS-2023US033925$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165871$24116587$1$I$$20240318$20240722$20240722$PER$$US-ASTELLAS-2024US008818$ASTELLAS$$$$$F$Y$$$20240722$$HP$US$US
241165881$24116588$1$I$20240101$20240129$20240722$20240722$PER$$US-ASTELLAS-2024US003367$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
241165891$24116589$1$I$20230101$20231114$20240722$20240722$PER$$US-ASTELLAS-2023US034605$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
241165901$24116590$1$I$20240520$20240521$20240722$20240722$PER$$US-ASTELLAS-2024US014781$ASTELLAS$$82$YR$$M$Y$$$20240722$$CN$US$US
241165911$24116591$1$I$$20240319$20240722$20240722$PER$$US-ASTELLAS-2024US008771$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165921$24116592$1$I$$20231127$20240722$20240722$PER$$US-ASTELLAS-2023US035756$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241165931$24116593$1$I$20240101$20240201$20240722$20240722$PER$$US-ASTELLAS-2024US003685$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
241165941$24116594$1$I$$20240418$20240722$20240722$PER$$US-ASTELLAS-2024US011983$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241165951$24116595$1$I$$20240104$20240722$20240722$PER$$US-ASTELLAS-2024US000674$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
241165961$24116596$1$I$$20240415$20240722$20240722$PER$$US-ASTELLAS-2024US011713$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
241165971$24116597$1$I$$20240102$20240722$20240722$PER$$US-ASTELLAS-2024US000242$ASTELLAS$$$$$$Y$$$20240722$$CN$US$US
241165982$24116598$2$F$$20230817$20240722$20240722$PER$$US-ASTELLAS-2023US025046$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241165991$24116599$1$I$$20230809$20240722$20240722$PER$$US-ASTELLAS-2023US024247$ASTELLAS$$66$YR$$F$Y$$$20240722$$CN$US$US
241166001$24116600$1$I$20230501$20240315$20240722$20240722$PER$$US-ASTELLAS-2024US004532$ASTELLAS$$43$YR$$F$Y$$$20240722$$CN$US$US
241166011$24116601$1$I$$20240618$20240722$20240722$PER$$US-ASTELLAS-2024US011717$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
241166022$24116602$2$F$$20230804$20240722$20240722$PER$$US-ASTELLAS-2023US019441$ASTELLAS$$69$YR$$F$Y$$$20240722$$CN$US$US
241166031$24116603$1$I$20240401$20240419$20240722$20240722$PER$$US-ASTELLAS-2024US011987$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
241166041$24116604$1$I$$20230925$20240722$20240722$PER$$US-ASTELLAS-2023US028947$ASTELLAS$$72$YR$$M$Y$$$20240722$$CN$US$US
241166051$24116605$1$I$20230101$20240614$20240722$20240722$PER$$US-ASTELLAS-2024US017622$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166061$24116606$1$I$$20230811$20240722$20240722$PER$$US-ASTELLAS-2023US022568$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166071$24116607$1$I$20240611$20240612$20240722$20240722$PER$$US-ASTELLAS-2024US017129$ASTELLAS$$89$YR$$M$Y$$$20240722$$CN$US$US
241166081$24116608$1$I$$20240516$20240722$20240722$PER$$US-ASTELLAS-2024US014357$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241166092$24116609$2$F$20240501$20240903$20240722$20240905$EXP$$US-ASTELLAS-2024US017099$ASTELLAS$$92$YR$E$M$Y$$$20240905$$CN$US$US
241166101$24116610$1$I$20230801$20231010$20240722$20240722$PER$$US-ASTELLAS-2023US029083$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
241166111$24116611$1$I$20230901$20231010$20240722$20240722$PER$$US-ASTELLAS-2023US027669$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
241166121$24116612$1$I$$20230726$20240722$20240722$PER$$US-ASTELLAS-2023US022777$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166131$24116613$1$I$20230914$20230914$20240722$20240722$PER$$US-ASTELLAS-2023US027921$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
241166141$24116614$1$I$20240601$20240618$20240722$20240722$PER$$US-ASTELLAS-2024US017714$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166151$24116615$1$I$20230701$20230726$20240722$20240722$PER$$US-ASTELLAS-2023US022655$ASTELLAS$$32$YR$$F$Y$$$20240722$$CN$US$US
241166161$24116616$1$I$20240614$20240712$20240722$20240722$PER$$US-ASTELLAS-2024US017574$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
241166172$24116617$2$F$20230601$20230802$20240722$20240722$PER$$US-ASTELLAS-2023US021220$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
241166181$24116618$1$I$$20230727$20240722$20240722$PER$$US-ASTELLAS-2023US022846$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
241166192$24116619$2$F$$20230710$20240722$20240722$PER$$US-ASTELLAS-2023US020810$ASTELLAS$$85$YR$$F$Y$$$20240722$$CN$US$US
241166201$24116620$1$I$$20240613$20240722$20240722$PER$$US-ASTELLAS-2024US017294$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241166211$24116621$1$I$20240326$20240708$20240722$20240722$EXP$FR-AFSSAPS-CN2024000635$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109608$ZYDUS PHARM$$$$$$Y$$$20240722$$MD$FR$FR
241166221$24116622$1$I$20240613$20240708$20240722$20240722$EXP$FR-AFSSAPS-GR2024000860$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109663$ZYDUS PHARM$$$$$$Y$$$20240722$$PH$FR$FR
241166231$24116623$1$I$20240101$20240711$20240722$20240722$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109628$ZYDUS PHARM$$$$$$Y$$$20240722$$CN$US$US
241166241$24116624$1$I$$20240712$20240722$20240722$PER$$US-CHATTEMPRD-2024OHG024105$CHATTEM$$$$$M$Y$$$20240722$$CN$US$US
241166251$24116625$1$I$20240610$20240614$20240722$20240722$PER$$US-ASTELLAS-2024US017578$ASTELLAS$$57$YR$$M$Y$$$20240722$$CN$US$US
241166261$24116626$1$I$$20240506$20240722$20240722$PER$$US-ASTELLAS-2024US013437$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
241166271$24116627$1$I$$20240611$20240722$20240722$PER$$US-ASTELLAS-2024US017009$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241166281$24116628$1$I$20230901$20230929$20240722$20240722$PER$$US-ASTELLAS-2023US028340$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
241166291$24116629$1$I$20240501$20240612$20240722$20240722$PER$$US-ASTELLAS-2024US017282$ASTELLAS$$88$YR$$M$Y$$$20240722$$CN$US$US
241166301$24116630$1$I$$20240712$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112297$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240722$$CN$US$US
241166311$24116631$1$I$20240501$20240523$20240722$20240722$PER$$US-ASTELLAS-2024US013829$ASTELLAS$$70$YR$$M$Y$$$20240722$$CN$US$US
241166321$24116632$1$I$$20231024$20240722$20240722$PER$$US-ASTELLAS-2023US032217$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
241166332$24116633$2$F$$20230921$20240722$20240722$PER$$US-ASTELLAS-2023US028652$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166341$24116634$1$I$$20240528$20240722$20240722$PER$$US-ASTELLAS-2024US015513$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
241166351$24116635$1$I$$20231009$20240722$20240722$PER$$US-ASTELLAS-2023US030406$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
241166361$24116636$1$I$$20240621$20240722$20240722$PER$$US-ASTELLAS-2024US017920$ASTELLAS$$60$YR$$M$Y$$$20240722$$CN$US$US
241166372$24116637$2$F$$20231006$20240722$20240722$PER$$US-ASTELLAS-2023US030332$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241166382$24116638$2$F$$20231024$20240722$20240722$PER$$US-ASTELLAS-2023US032073$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
241166391$24116639$1$I$20240401$20240628$20240722$20240722$PER$$US-ASTELLAS-2024US017133$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
241166401$24116640$1$I$$20240708$20240722$20240722$PER$$US-ASTELLAS-2024US017719$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
241166411$24116641$1$I$$20230718$20240722$20240722$PER$$US-ASTELLAS-2023US021728$ASTELLAS$$8$DEC$$F$Y$$$20240722$$CN$US$US
241166421$24116642$1$I$$20240509$20240722$20240722$PER$$US-ASTELLAS-2024US013876$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241166431$24116643$1$I$$20231018$20240722$20240722$PER$$US-ASTELLAS-2023US031795$ASTELLAS$$$$$$Y$$$20240722$$CN$US$US
241166441$24116644$1$I$$20240501$20240722$20240722$PER$$US-ASTELLAS-2024US012841$ASTELLAS$$$$$$Y$$$20240722$$CN$US$US
241166451$24116645$1$I$20230101$20230807$20240722$20240722$PER$$US-ASTELLAS-2023US023997$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
241166461$24116646$1$I$20240129$20240429$20240722$20240722$PER$$US-ASTELLAS-2024US012691$ASTELLAS$$66$YR$$$Y$$$20240722$$CN$US$US
241166471$24116647$1$I$$20230818$20240722$20240722$PER$$US-ASTELLAS-2023US025202$ASTELLAS$$93$YR$$F$Y$$$20240722$$CN$US$US
241166481$24116648$1$I$20210112$20240510$20240722$20240722$PER$$US-ASTELLAS-2024US013737$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241166491$24116649$1$I$$20231101$20240722$20240722$PER$$US-ASTELLAS-2023US031819$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241166501$24116650$1$I$20230901$20230928$20240722$20240722$PER$$US-ASTELLAS-2023US029400$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166511$24116651$1$I$20240101$20240711$20240722$20240722$PER$$US-ASTELLAS-2024US013185$ASTELLAS$$89$YR$$F$Y$$$20240722$$CN$US$US
241166522$24116652$2$F$$20240422$20240722$20240722$PER$$US-ASTELLAS-2024US012284$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166531$24116653$1$I$20240501$20240520$20240722$20240722$PER$$US-ASTELLAS-2024US014661$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166541$24116654$1$I$20230701$20230719$20240722$20240722$PER$$US-ASTELLAS-2023US022031$ASTELLAS$$91$YR$$F$Y$$$20240722$$CN$US$US
241166551$24116655$1$I$20231001$20231127$20240722$20240722$PER$$US-ASTELLAS-2023US031825$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
241166561$24116656$1$I$$20230814$20240722$20240722$PER$$US-ASTELLAS-2023US024659$ASTELLAS$$60$YR$$F$Y$$$20240722$$CN$US$US
241166572$24116657$2$F$$20231019$20240722$20240722$PER$$US-ASTELLAS-2023US031653$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166581$24116658$1$I$20240520$20240520$20240722$20240722$PER$$US-ASTELLAS-2024US014669$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
241166591$24116659$1$I$20230221$20240422$20240722$20240722$PER$$US-ASTELLAS-2024US012599$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
241166601$24116660$1$I$20231022$20231106$20240722$20240722$PER$$US-ASTELLAS-2023US032092$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
241166611$24116661$1$I$20230901$20230926$20240722$20240722$PER$$US-ASTELLAS-2023US029089$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241166621$24116662$1$I$$20230813$20240722$20240722$PER$$US-ASTELLAS-2023US024469$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166632$24116663$2$F$20240101$20240913$20240722$20240917$EXP$$US-ASTELLAS-2024US016480$ASTELLAS$$80$YR$E$F$Y$$$20240917$$CN$US$US
241166641$24116664$1$I$$20230905$20240722$20240722$PER$$US-ASTELLAS-2023US025383$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
241166651$24116665$1$I$$20240423$20240722$20240722$PER$$US-ASTELLAS-2024US012198$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166661$24116666$1$I$$20230713$20240722$20240722$PER$$US-ASTELLAS-2023US021309$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
241166671$24116667$1$I$20240101$20240604$20240722$20240722$PER$$US-ASTELLAS-2024US016507$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166681$24116668$1$I$$20230922$20240722$20240722$PER$$US-ASTELLAS-2023US028636$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166691$24116669$1$I$20230701$20230825$20240722$20240722$PER$$US-ASTELLAS-2023US025925$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241166701$24116670$1$I$20230801$20231204$20240722$20240722$PER$$US-ASTELLAS-2023US026382$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
241166711$24116671$1$I$$20230825$20240722$20240722$PER$$US-ASTELLAS-2023US025897$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166721$24116672$1$I$20231001$20231010$20240722$20240722$PER$$US-ASTELLAS-2023US030774$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
241166731$24116673$1$I$$20230821$20240722$20240722$PER$$US-ASTELLAS-2023US025387$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241166741$24116674$1$I$20240601$20240607$20240722$20240722$PER$$US-ASTELLAS-2024US016836$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166751$24116675$1$I$20230706$20230707$20240722$20240722$PER$$US-ASTELLAS-2023US020554$ASTELLAS$$89$YR$$M$Y$$$20240722$$CN$US$US
241166761$24116676$1$I$$20230711$20240722$20240722$PER$$US-ASTELLAS-2023US021088$ASTELLAS$$72$YR$$M$Y$$$20240722$$CN$US$US
241166772$24116677$2$F$20230901$20231004$20240722$20240722$PER$$US-ASTELLAS-2023US028783$ASTELLAS$$67$YR$$M$Y$$$20240722$$CN$US$US
241166781$24116678$1$I$$20240529$20240722$20240722$PER$$US-ASTELLAS-2024US015879$ASTELLAS$$91$YR$$F$Y$$$20240722$$CN$US$US
241166791$24116679$1$I$20231001$20231113$20240722$20240722$PER$$US-ASTELLAS-2023US032088$ASTELLAS$$74$YR$$M$Y$$$20240722$$CN$US$US
241166802$24116680$2$F$$20230920$20240722$20240722$PER$$US-ASTELLAS-2023US028504$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166812$24116681$2$F$20231017$20231018$20240722$20240722$PER$$US-ASTELLAS-2023US031520$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241166821$24116682$1$I$$20231023$20240722$20240722$PER$$US-ASTELLAS-2023US032022$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
241166831$24116683$1$I$$20231018$20240722$20240722$PER$$US-ASTELLAS-2023US031640$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166841$24116684$1$I$$20231009$20240722$20240722$PER$$US-ASTELLAS-2023US030470$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
241166851$24116685$1$I$$20231024$20240722$20240722$PER$$US-ASTELLAS-2023US032137$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166861$24116686$1$I$$20230717$20240722$20240722$PER$$US-ASTELLAS-2023US021873$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
241166871$24116687$1$I$$20230718$20240722$20240722$PER$$US-ASTELLAS-2023US021747$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241166881$24116688$1$I$20240625$20240625$20240722$20240722$PER$$US-CSL-2024-006279$CSL Plasma$$44$YR$$F$Y$$$20240722$$HP$US$US
241166891$24116689$1$I$$20240711$20240722$20240722$EXP$$CA-HALEON-2187482$Haleon PLC$$44$YR$$M$Y$$$20240722$$CN$CA$CA
241166901$24116690$1$I$$20231011$20240722$20240722$PER$$US-ASTELLAS-2023US030819$ASTELLAS$$64$YR$$F$Y$$$20240722$$HP$US$US
241166911$24116691$1$I$20230817$20231017$20240722$20240722$PER$$US-ASTELLAS-2023US027976$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
241166921$24116692$1$I$$20231017$20240722$20240722$PER$$US-ASTELLAS-2023US031351$ASTELLAS$$73$YR$$F$Y$$$20240722$$CN$US$US
241166931$24116693$1$I$20230701$20230720$20240722$20240722$PER$$US-ASTELLAS-2023US022332$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166941$24116694$1$I$$20230825$20240722$20240722$PER$$US-ASTELLAS-2023US025935$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241166951$24116695$1$I$20230801$20230821$20240722$20240722$PER$$US-ASTELLAS-2023US025538$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241166962$24116696$2$F$$20230804$20240722$20240722$PER$$US-ASTELLAS-2023US021681$ASTELLAS$$69$YR$$F$Y$$$20240722$$CN$US$US
241166971$24116697$1$I$$20240426$20240722$20240722$PER$$US-ASTELLAS-2024US012808$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241166981$24116698$1$I$20240501$20240518$20240722$20240722$PER$$US-ASTELLAS-2024US014549$ASTELLAS$$91$YR$$M$Y$$$20240722$$CN$US$US
241166991$24116699$1$I$20240101$20240516$20240722$20240722$PER$$US-ASTELLAS-2024US014409$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167001$24116700$1$I$20230907$20231023$20240722$20240722$PER$$US-ASTELLAS-2023US027943$ASTELLAS$$76$YR$$F$Y$$$20240722$$MD$US$US
241167011$24116701$1$I$20230907$20231002$20240722$20240722$PER$$US-ASTELLAS-2023US027955$ASTELLAS$$69$YR$$F$Y$$$20240722$$CN$US$US
241167021$24116702$1$I$$20230726$20240722$20240722$PER$$US-ASTELLAS-2023US022840$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167031$24116703$1$I$20231016$20231016$20240722$20240722$PER$$US-ASTELLAS-2023US031160$ASTELLAS$$88$YR$$F$Y$$$20240722$$CN$US$US
241167041$24116704$1$I$20240401$20240426$20240722$20240722$PER$$US-ASTELLAS-2024US012773$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
241167051$24116705$1$I$20230101$20231011$20240722$20240722$PER$$US-ASTELLAS-2023US030722$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241167061$24116706$1$I$20230101$20231106$20240722$20240722$PER$$US-ASTELLAS-2023US026670$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167071$24116707$1$I$$20231012$20240722$20240722$PER$$US-ASTELLAS-2023US030809$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167081$24116708$1$I$$20230817$20240722$20240722$PER$$US-ASTELLAS-2023US024933$ASTELLAS$$7$DEC$$F$Y$$$20240722$$CN$US$US
241167091$24116709$1$I$$20230804$20240722$20240722$PER$$US-ASTELLAS-2023US023756$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167101$24116710$1$I$$20240530$20240722$20240722$PER$$US-ASTELLAS-2024US015864$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167111$24116711$1$I$$20240530$20240722$20240722$PER$$US-ASTELLAS-2024US015872$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167121$24116712$1$I$$20230908$20240722$20240722$PER$$US-ASTELLAS-2023US027639$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167131$24116713$1$I$20230101$20230824$20240722$20240722$PER$$US-ASTELLAS-2023US021497$ASTELLAS$$89$YR$$F$Y$$$20240722$$CN$US$US
241167141$24116714$1$I$20230801$20230822$20240722$20240722$PER$$US-ASTELLAS-2023US026431$ASTELLAS$$72$YR$$F$Y$$$20240722$$CN$US$US
241167151$24116715$1$I$$20230906$20240722$20240722$PER$$US-ASTELLAS-2023US026930$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
241167161$24116716$1$I$20240601$20240712$20240722$20240722$EXP$$US-UCBSA-2024035791$UCB$$42$YR$$F$Y$$$20240722$$HP$US$US
241167171$24116717$1$I$$20240711$20240722$20240722$EXP$$US-Jiangsu Hengrui Medicine Co., Ltd.-2159411$JIANGSU HENGRUI MEDICINE$20240711 64 H2024001203988 Docetaxel-induced pigmentary maculopathy INI$79$YR$$M$Y$$$20240722$$MD$US$US
241167182$24116718$2$F$$20230710$20240722$20240722$PER$$US-ASTELLAS-2023US020830$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167191$24116719$1$I$$20240507$20240722$20240722$PER$$US-ASTELLAS-2024US013520$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167201$24116720$1$I$$20240429$20240722$20240722$PER$$US-ASTELLAS-2024US012715$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167213$24116721$3$F$20240401$20240916$20240722$20240918$EXP$$US-ASTELLAS-2024US017140$ASTELLAS$$$$$M$Y$$$20240918$$CN$US$US
241167221$24116722$1$I$20240601$20240617$20240722$20240722$PER$$US-ASTELLAS-2024US017626$ASTELLAS$$81$YR$$F$Y$$$20240722$$CN$US$US
241167231$24116723$1$I$$20240520$20240722$20240722$PER$$US-ASTELLAS-2024US013435$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167241$24116724$1$I$$20230828$20240722$20240722$PER$$US-ASTELLAS-2023US026281$ASTELLAS$$$$$M$Y$107.48$KG$20240722$$CN$US$US
241167251$24116725$1$I$$20230927$20240722$20240722$PER$$US-ASTELLAS-2023US029207$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
241167261$24116726$1$I$$20230713$20240722$20240722$PER$$US-ASTELLAS-2023US021223$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167271$24116727$1$I$$20231024$20240722$20240722$PER$$US-ASTELLAS-2023US032227$ASTELLAS$$$$$M$Y$$$20240722$$MD$US$US
241167281$24116728$1$I$$20240521$20240722$20240722$PER$$US-ASTELLAS-2024US013371$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
241167291$24116729$1$I$20230801$20230926$20240722$20240722$PER$$US-ASTELLAS-2023US025922$ASTELLAS$$62$YR$$M$Y$$$20240722$$CN$US$US
241167301$24116730$1$I$$20230825$20240722$20240722$PER$$US-ASTELLAS-2023US025929$ASTELLAS$$91$YR$$M$Y$$$20240722$$CN$US$US
241167311$24116731$1$I$$20230828$20240722$20240722$PER$$US-ASTELLAS-2023US026065$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
241167321$24116732$1$I$$20240718$20240722$20240722$EXP$$NL-AUROBINDO-AUR-APL-2024-036040$AUROBINDO$$61$YR$$F$Y$125$KG$20240722$$CN$NL$NL
241167331$24116733$1$I$$20230804$20240722$20240722$PER$$US-ASTELLAS-2023US023760$ASTELLAS$$67$YR$$M$Y$$$20240722$$CN$US$US
241167341$24116734$1$I$20230528$20240129$20240722$20240722$PER$$US-ASTELLAS-2023US030171$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
241167351$24116735$1$I$$20230727$20240722$20240722$PER$$US-ASTELLAS-2023US022842$ASTELLAS$$69$YR$$F$Y$$$20240722$$CN$US$US
241167361$24116736$1$I$$20240508$20240722$20240722$PER$$US-ASTELLAS-2024US013518$ASTELLAS$$94$YR$$M$Y$$$20240722$$CN$US$US
241167371$24116737$1$I$$20240423$20240722$20240722$PER$$US-ASTELLAS-2024US012413$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167381$24116738$1$I$20240401$20240603$20240722$20240722$PER$$US-ASTELLAS-2024US016122$ASTELLAS$$63$YR$$M$Y$$$20240722$$CN$US$US
241167391$24116739$1$I$20230801$20230919$20240722$20240722$PER$$US-ASTELLAS-2023US025623$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
241167401$24116740$1$I$$20240624$20240722$20240722$PER$$US-ASTELLAS-2024US018162$ASTELLAS$$52$YR$$M$Y$$$20240722$$CN$US$US
241167411$24116741$1$I$$20231025$20240722$20240722$PER$$US-ASTELLAS-2023US032216$ASTELLAS$$$$E$F$Y$$$20240722$$CN$US$US
241167421$24116742$1$I$$20240625$20240722$20240722$PER$$US-ASTELLAS-2024US018254$ASTELLAS$$47$YR$$F$Y$$$20240722$$CN$US$US
241167431$24116743$1$I$$20230804$20240722$20240722$PER$$US-ASTELLAS-2023US024374$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167441$24116744$1$I$20240101$20240605$20240722$20240722$PER$$US-ASTELLAS-2024US016587$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167451$24116745$1$I$$20240621$20240722$20240722$PER$$US-ASTELLAS-2024US016573$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
241167461$24116746$1$I$20240502$20240521$20240722$20240722$PER$$US-ASTELLAS-2024US013443$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
241167471$24116747$1$I$$20240604$20240722$20240722$PER$$US-ASTELLAS-2024US016334$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167481$24116748$1$I$$20230810$20240722$20240722$PER$$US-ASTELLAS-2023US024383$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$US$US
241167494$24116749$4$F$20240711$20240816$20240722$20240826$EXP$$CA-CELLTRION INC.-2024CA017465$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
241167501$24116750$1$I$$20190722$20240722$20240722$EXP$$US-AstraZeneca-2019SF03095$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241167511$24116751$1$I$$20210927$20240722$20240722$EXP$$US-AstraZeneca-2021A749965$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241167521$24116752$1$I$$20230414$20240722$20240722$EXP$$US-AstraZeneca-2023A089211$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241167531$24116753$1$I$$20240516$20240722$20240722$PER$$US-ASTELLAS-2024US014344$ASTELLAS$$65$YR$$M$Y$$$20240722$$CN$US$US
241167541$24116754$1$I$$20221209$20240722$20240722$EXP$$US-AstraZeneca-2022A404494$ASTRAZENECA$$$$$M$Y$75.1$KG$20240722$$CN$US$
241167551$24116755$1$I$20240520$20240601$20240722$20240722$PER$$US-ASTELLAS-2024US014792$ASTELLAS$$42$YR$$F$Y$$$20240722$$CN$US$US
241167561$24116756$1$I$$20230818$20240722$20240722$PER$$US-ASTELLAS-2023US025203$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
241167571$24116757$1$I$20230801$20230829$20240722$20240722$PER$$US-ASTELLAS-2023US026210$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
241167581$24116758$1$I$$20231007$20240722$20240722$PER$$US-ASTELLAS-2023US030397$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$US$US
241167591$24116759$1$I$$20230913$20240722$20240722$PER$$US-ASTELLAS-2023US027715$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167601$24116760$1$I$20230801$20230929$20240722$20240722$PER$$US-ASTELLAS-2023US026666$ASTELLAS$$93$YR$$F$Y$$$20240722$$CN$US$US
241167611$24116761$1$I$$20240715$20240722$20240722$EXP$$CA-002147023-NVSC2023CA233954$Haleon PLC$$43$YR$$F$Y$$$20240722$$HP$CA$CA
241167621$24116762$1$I$$20231013$20240722$20240722$PER$$US-ASTELLAS-2023US031009$ASTELLAS$$76$YR$$M$Y$$$20240722$$CN$US$US
241167631$24116763$1$I$$20230718$20240722$20240722$PER$$US-ASTELLAS-2023US021859$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167641$24116764$1$I$$20231025$20240722$20240722$PER$$US-ASTELLAS-2023US028094$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167651$24116765$1$I$$20230803$20240722$20240722$PER$$US-ASTELLAS-2023US022856$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167661$24116766$1$I$$20230810$20240722$20240722$PER$$US-ASTELLAS-2023US024453$ASTELLAS$$83$YR$$F$Y$$$20240722$$CN$US$US
241167671$24116767$1$I$$20230801$20240722$20240722$PER$$US-ASTELLAS-2023US023415$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167681$24116768$1$I$$20231020$20240722$20240722$PER$$US-ASTELLAS-2023US028201$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167691$24116769$1$I$$20231006$20240722$20240722$PER$$US-ASTELLAS-2023US030457$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
241167701$24116770$1$I$$20231013$20240722$20240722$PER$$US-ASTELLAS-2023US031031$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
241167711$24116771$1$I$$20230901$20240722$20240722$PER$$US-ASTELLAS-2023US026680$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167721$24116772$1$I$$20240627$20240722$20240722$PER$$US-ASTELLAS-2024US018608$ASTELLAS$$77$YR$$F$Y$$$20240722$$CN$US$US
241167731$24116773$1$I$$20240509$20240722$20240722$PER$$US-ASTELLAS-2024US013875$ASTELLAS$$93$YR$$M$Y$$$20240722$$CN$US$US
241167741$24116774$1$I$$20231012$20240722$20240722$PER$$US-ASTELLAS-2023US030927$ASTELLAS$$92$YR$$F$Y$$$20240722$$CN$US$US
241167751$24116775$1$I$$20230915$20240722$20240722$PER$$US-ASTELLAS-2023US028097$ASTELLAS$$86$YR$$M$Y$$$20240722$$CN$US$US
241167761$24116776$1$I$$20240607$20240722$20240722$PER$$US-ASTELLAS-2024US016834$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167771$24116777$1$I$$20230721$20240722$20240722$PER$$US-ASTELLAS-2023US022346$ASTELLAS$$80$YR$$F$Y$$$20240722$$CN$US$US
241167781$24116778$1$I$$20240625$20240722$20240722$PER$$US-ASTELLAS-2024US018260$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167791$24116779$1$I$$20240627$20240722$20240722$PER$$US-ASTELLAS-2024US018614$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167801$24116780$1$I$$20240604$20240722$20240722$PER$$US-ASTELLAS-2024US016718$ASTELLAS$$79$YR$$F$Y$$$20240722$$CN$US$US
241167811$24116781$1$I$20240623$20240710$20240722$20240722$PER$$US-ASTELLAS-2024US018138$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
241167821$24116782$1$I$$20230922$20240722$20240722$PER$$US-ASTELLAS-2023US028795$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241167831$24116783$1$I$$20240627$20240722$20240722$PER$$US-ASTELLAS-2024US018606$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
241167841$24116784$1$I$$20210310$20240722$20240722$EXP$$US-AstraZeneca-2021A138884$ASTRAZENECA$$85$YR$$F$Y$$$20240722$$CN$US$
241167851$24116785$1$I$$20240624$20240722$20240722$PER$$US-ASTELLAS-2024US018135$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167861$24116786$1$I$$20240530$20240722$20240722$PER$$US-ASTELLAS-2024US014062$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167871$24116787$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114212$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$59.42$KG$20240722$$CN$US$US
241167882$24116788$2$F$$20240715$20240722$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112040$BRISTOL MYERS SQUIBB$Gault KS. The role of physical therapy within a multidisciplinary pancreatic cancer clinic to optimize care. Rehabilitation Oncology. 2024 Apr 01;42(2):119. doi:10.1097/01.REO.0000000000000365.$78$YR$E$F$Y$$$20240723$$MD$US$US
241167891$24116789$1$I$$20240710$20240722$20240722$EXP$CA-HPFB-001089008$CA-SERVIER-S24008879$SERVIER$$$$$$Y$$$20240722$$PH$CA$CA
241167901$24116790$1$I$20240712$20240715$20240722$20240722$PER$$US-ABBVIE-5844357$ABBVIE$$34$YR$$F$Y$$$20240722$$MD$US$US
241167911$24116791$1$I$20201029$20240711$20240722$20240722$EXP$IT-MLMSERVICE-20240708-PI126636-00306-1$IT-STRIDES ARCOLAB LIMITED-2024SP008827$STRIDES$Vittorio DM, Brigitta P, Alberto Z, Fabrizio Z, Paola T, Francesco B.. COVID-19 and lupus nephritis exacerbation in unvaccinated patients: a clinical case and literature review. Italian Journal of Nephrology. 2024;3$28$YR$$F$Y$$$20240722$$MD$IT$IT
241167923$24116792$3$F$20240101$20240830$20240722$20240909$EXP$$CA-CELLTRION INC.-2024CA017476$CELLTRION$$$$$$Y$$$20240909$$MD$CA$CA
241167931$24116793$1$I$$20230718$20240722$20240722$PER$$US-ASTELLAS-2023US021864$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
241167941$24116794$1$I$$20240503$20240722$20240722$PER$$US-ASTELLAS-2024US013179$ASTELLAS$$76$YR$$F$Y$$$20240722$$CN$US$US
241167951$24116795$1$I$20230828$20230828$20240722$20240722$PER$$US-ASTELLAS-2023US026074$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167961$24116796$1$I$20230901$20230925$20240722$20240722$PER$$US-ASTELLAS-2023US028937$ASTELLAS$$90$YR$$M$Y$$$20240722$$CN$US$US
241167971$24116797$1$I$$20230714$20240722$20240722$PER$$US-ASTELLAS-2023US021505$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241167981$24116798$1$I$$20230724$20240722$20240722$PER$$US-ASTELLAS-2023US022433$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241167991$24116799$1$I$$20230727$20240722$20240722$PER$$US-ASTELLAS-2023US022844$ASTELLAS$$55$YR$$F$Y$$$20240722$$CN$US$US
241168001$24116800$1$I$$20230714$20240722$20240722$PER$$US-ASTELLAS-2023US021520$ASTELLAS$$$$A$F$Y$$$20240722$$CN$US$US
241168011$24116801$1$I$$20230705$20240722$20240722$PER$$US-ASTELLAS-2023US020288$ASTELLAS$$95$YR$$F$Y$$$20240722$$CN$US$US
241168021$24116802$1$I$20230920$20230920$20240722$20240722$PER$$US-ASTELLAS-2023US028501$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
241168032$24116803$2$F$$20231211$20240722$20240722$PER$$US-ASTELLAS-2023US029814$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241168041$24116804$1$I$$20230803$20240722$20240722$PER$$US-ASTELLAS-2023US021218$ASTELLAS$$95$YR$$M$Y$$$20240722$$CN$US$US
241168051$24116805$1$I$$20231006$20240722$20240722$PER$$US-ASTELLAS-2023US030318$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241168061$24116806$1$I$20230801$20230829$20240722$20240722$PER$$US-ASTELLAS-2023US026212$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241168071$24116807$1$I$$20230720$20240722$20240722$PER$$US-ASTELLAS-2023US022328$ASTELLAS$$86$YR$$F$Y$$$20240722$$CN$US$US
241168081$24116808$1$I$$20230714$20240722$20240722$PER$$US-ASTELLAS-2023US021490$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
241168091$24116809$1$I$$20230718$20240722$20240722$PER$$US-ASTELLAS-2023US021849$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
241168101$24116810$1$I$20231016$20231016$20240722$20240722$PER$$US-ASTELLAS-2023US031153$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241168111$24116811$1$I$20230701$20230713$20240722$20240722$PER$$US-ASTELLAS-2023US020680$ASTELLAS$$52$YR$$M$Y$$$20240722$$HP$US$US
241168121$24116812$1$I$20231009$20240124$20240722$20240722$PER$$US-ASTELLAS-2023US031485$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
241168131$24116813$1$I$20240529$20240708$20240722$20240722$PER$$US-ASTELLAS-2024US015690$ASTELLAS$$77$YR$$M$Y$$$20240722$$CN$US$US
241168141$24116814$1$I$$20240615$20240722$20240722$PER$$US-ASTELLAS-2024US017505$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241168152$24116815$2$F$20240101$20240918$20240722$20240925$EXP$$US-ASTELLAS-2024US017397$ASTELLAS$$91$YR$E$M$Y$$$20240925$$CN$US$US
241168161$24116816$1$I$$20231003$20240722$20240722$PER$$US-ASTELLAS-2023US029831$ASTELLAS$$71$YR$$M$Y$$$20240722$$CN$US$US
241168171$24116817$1$I$20230719$20230720$20240722$20240722$PER$$US-ASTELLAS-2023US022323$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
241168181$24116818$1$I$$20230728$20240722$20240722$PER$$US-ASTELLAS-2023US023023$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241168191$24116819$1$I$$20240508$20240722$20240722$PER$$US-ASTELLAS-2024US013640$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
241168201$24116820$1$I$$20230707$20240722$20240722$PER$$US-ASTELLAS-2023US020547$ASTELLAS$$$$E$M$Y$$$20240722$$CN$US$US
241168211$24116821$1$I$$20230803$20240722$20240722$PER$$US-ASTELLAS-2023US022927$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
241168221$24116822$1$I$$20240510$20240722$20240722$PER$$US-ASTELLAS-2024US013684$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241168231$24116823$1$I$20240529$20240530$20240722$20240722$PER$$US-ASTELLAS-2024US015854$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
241168241$24116824$1$I$$20240521$20240722$20240722$PER$$US-ASTELLAS-2024US014783$ASTELLAS$$84$YR$$F$Y$$$20240722$$CN$US$US
241168251$24116825$1$I$$20240503$20240722$20240722$PER$$US-ASTELLAS-2024US013186$ASTELLAS$$65$YR$$M$Y$$$20240722$$CN$US$US
241168261$24116826$1$I$$20231009$20240722$20240722$PER$$US-ASTELLAS-2023US030403$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241168271$24116827$1$I$$20230916$20240722$20240722$PER$$US-ASTELLAS-2023US028031$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241168281$24116828$1$I$$20240503$20240722$20240722$PER$$US-ASTELLAS-2024US013190$ASTELLAS$$71$YR$$F$Y$$$20240722$$CN$US$US
241168291$24116829$1$I$$20230915$20240722$20240722$PER$$US-ASTELLAS-2023US028090$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241168301$24116830$1$I$$20230712$20240722$20240722$PER$$US-ASTELLAS-2023US021105$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241168311$24116831$1$I$20230801$20230807$20240722$20240722$PER$$US-ASTELLAS-2023US024000$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241168321$24116832$1$I$$20230906$20240722$20240722$PER$$US-ASTELLAS-2023US027275$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241168331$24116833$1$I$20230621$20231025$20240722$20240722$PER$$US-ASTELLAS-2023US029078$ASTELLAS$$80$YR$$M$Y$$$20240722$$CN$US$US
241168341$24116834$1$I$20230101$20230707$20240722$20240722$PER$$US-ASTELLAS-2023US020557$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241168351$24116835$1$I$$20230911$20240722$20240722$PER$$US-ASTELLAS-2023US027651$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241168361$24116836$1$I$$20240502$20240722$20240722$PER$$US-ASTELLAS-2024US013203$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241168371$24116837$1$I$20230101$20231010$20240722$20240722$PER$$US-ASTELLAS-2023US027212$ASTELLAS$$90$YR$$F$Y$$$20240722$$CN$US$US
241168381$24116838$1$I$20230801$20230906$20240722$20240722$PER$$US-ASTELLAS-2023US027221$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241168391$24116839$1$I$20230721$20230724$20240722$20240722$PER$$US-ASTELLAS-2023US022430$ASTELLAS$$78$YR$$M$Y$$$20240722$$CN$US$US
241168401$24116840$1$I$20230810$20230810$20240722$20240722$PER$$US-ASTELLAS-2023US024447$ASTELLAS$$78$YR$$F$Y$$$20240722$$CN$US$US
241168411$24116841$1$I$20240519$20240528$20240722$20240722$PER$$US-ASTELLAS-2024US015568$ASTELLAS$$77$YR$$F$Y$$$20240722$$MD$US$US
241168421$24116842$1$I$$20240521$20240722$20240722$PER$$US-ASTELLAS-2024US014788$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241168431$24116843$1$I$20240501$20240605$20240722$20240722$PER$$US-ASTELLAS-2024US016674$ASTELLAS$$90$YR$$M$Y$$$20240722$$CN$US$US
241168441$24116844$1$I$20230701$20230807$20240722$20240722$PER$$US-ASTELLAS-2023US022434$ASTELLAS$$$$A$M$Y$$$20240722$$CN$US$US
241168451$24116845$1$I$$20230906$20240722$20240722$PER$$US-ASTELLAS-2023US027004$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$US$US
241168461$24116846$1$I$$20240523$20240722$20240722$PER$$US-ASTELLAS-2024US015069$ASTELLAS$$$$$F$Y$$$20240722$$CN$US$US
241168471$24116847$1$I$$20230815$20240722$20240722$PER$$US-ASTELLAS-2023US023015$ASTELLAS$$92$YR$$F$Y$$$20240722$$CN$US$US
241168481$24116848$1$I$$20231003$20240722$20240722$PER$$US-ASTELLAS-2023US029802$ASTELLAS$$66$YR$$M$Y$$$20240722$$HP$US$US
241168491$24116849$1$I$$20230727$20240722$20240722$PER$$US-ASTELLAS-2023US022774$ASTELLAS$$69$YR$$F$Y$$$20240722$$CN$US$US
241168501$24116850$1$I$$20230815$20240722$20240722$PER$$US-ASTELLAS-2023US024860$ASTELLAS$$88$YR$$M$Y$$$20240722$$CN$US$US
241168511$24116851$1$I$20230908$20230908$20240722$20240722$PER$$US-ASTELLAS-2023US027542$ASTELLAS$$74$YR$$F$Y$$$20240722$$CN$US$US
241168521$24116852$1$I$$20240619$20240722$20240722$EXP$$CN-ROCHE-10000003197$ROCHE$$72$YR$E$M$Y$$$20240719$$CN$CN$CN
241168532$24116853$2$F$20240619$20240802$20240722$20240807$PER$$US-ROCHE-10000008621$ROCHE$$$$$$Y$$$20240807$$PH$US$US
241168542$24116854$2$F$20240612$20240718$20240722$20240729$EXP$$CN-ROCHE-10000030523$ROCHE$$88$YR$E$F$Y$55$KG$20240729$$HP$CN$CN
241168553$24116855$3$F$20240706$20240819$20240722$20240826$PER$$US-ROCHE-10000027281$ROCHE$$53$YR$A$F$Y$$$20240826$$CN$US$US
241168571$24116857$1$I$20240626$20240705$20240722$20240722$EXP$$TH-ROCHE-10000019187$ROCHE$$55$YR$A$M$Y$$$20240719$$CN$TH$TH
241168581$24116858$1$I$$20240711$20240722$20240722$PER$$US-ROCHE-10000028502$ROCHE$$11$YR$C$F$Y$$$20240719$$CN$US$US
241168591$24116859$1$I$$20240717$20240722$20240722$EXP$$CN-ROCHE-10000029707$ROCHE$$$$$M$Y$$$20240719$$MD$CN$CN
241168602$24116860$2$F$20240101$20240912$20240722$20240917$EXP$$FR-ROCHE-10000028499$ROCHE$$43$YR$A$F$Y$$$20240917$$MD$FR$FR
241168611$24116861$1$I$20240717$20240717$20240722$20240722$PER$$US-ROCHE-10000029964$ROCHE$$$$$$Y$$$20240719$$HP$US$US
241168621$24116862$1$I$$20240710$20240722$20240722$EXP$$IN-ROCHE-10000024246$ROCHE$$68$YR$E$M$Y$$$20240719$$CN$IN$IN
241168631$24116863$1$I$$20240715$20240722$20240722$PER$$US-ROCHE-10000028866$ROCHE$Waliany S, Hung Y, Rous F, Do A, Peterson J, Meservey C, et al. Atypical Lung Carcinoids with EML4-ALK Fusion and Responses to ALK Inhibitors (abstract number : PP01.69). Journal of Thoracic Oncology. 2024-Jul;19 (7): doi:10.1016/j.jtho.2024.05.304.$58$YR$A$F$Y$$$20240719$$HP$US$US
241168641$24116864$1$I$20240314$20240711$20240722$20240722$EXP$$BR-ROCHE-10000028579$ROCHE$$30$YR$A$F$Y$63$KG$20240719$$MD$BR$BR
241168651$24116865$1$I$$20240716$20240722$20240722$EXP$$CA-ROCHE-10000029191$ROCHE$$$$A$F$Y$$$20240719$$HP$CA$CA
241168661$24116866$1$I$$20240715$20240722$20240722$EXP$$JP-ROCHE-10000027488$ROCHE$Matsuoka A, Tate S, Nishikimi K, Otsuka S, Usui H, Tajima S, et al. Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series. Journal of Obstetrics and Gynaecology Research. 2024-Jul;50 (7):1148-54. doi:10.1111/jog.15954.$48$YR$A$F$Y$$$20240719$$HP$JP$JP
241168671$24116867$1$I$$20240715$20240722$20240722$EXP$$JP-ROCHE-10000030418$ROCHE$Matsuoka A, Tate S, Nishikimi K, Otsuka S, Usui H, Tajima S, et al. Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series. Journal of Obstetrics and Gynaecology Research. 2024-Jul;50 (7):1148-54. doi:10.1111/jog.15954.$65$YR$E$F$Y$$$20240719$$HP$JP$JP
241168691$24116869$1$I$$20240715$20240722$20240722$EXP$$JP-ROCHE-10000030421$ROCHE$Matsuoka A, Tate S, Nishikimi K, Otsuka S, Usui H, Tajima S, et al. Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series. Journal of Obstetrics and Gynaecology Research. 2024-Jul;50 (7):1148-54. doi:10.1111/jog.15954.$62$YR$A$F$Y$$$20240719$$HP$JP$JP
241168701$24116870$1$I$$20240705$20240722$20240722$EXP$$SG-ROCHE-10000019153$ROCHE$$$$$F$Y$$$20240719$$CN$SG$SG
241168711$24116871$1$I$$20240715$20240722$20240722$EXP$$JP-ROCHE-10000030424$ROCHE$Matsuoka A, Tate S, Nishikimi K, Otsuka S, Usui H, Tajima S, et al. Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series. Journal of Obstetrics and Gynaecology Research. 2024-Jul;50 (7):1148-54. doi:10.1111/jog.15954.$57$YR$A$F$Y$$$20240719$$HP$JP$JP
241168723$24116872$3$F$20231101$20240827$20240722$20240903$PER$$US-ROCHE-10000029053$ROCHE$$51$YR$A$M$Y$$$20240903$$CN$US$US
241168731$24116873$1$I$$20240713$20240722$20240722$PER$$US-ROCHE-10000026317$ROCHE$$66$YR$E$F$Y$$$20240719$$CN$US$US
241168741$24116874$1$I$$20240716$20240722$20240722$PER$$US-ROCHE-10000028788$ROCHE$$$$$$Y$$$20240719$$HP$US$US
241168751$24116875$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000029764$ROCHE$$$$$$Y$$$20240719$$HP$US$US
241168761$24116876$1$I$20240602$20240712$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035517$AUROBINDO$$76$YR$$M$Y$$$20240722$$HP$FR$FR
241168771$24116877$1$I$$20240715$20240722$20240722$EXP$$JP-ROCHE-10000030420$ROCHE$Matsuoka A, Tate S, Nishikimi K, Otsuka S, Usui H, Tajima S, et al. Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series. Journal of Obstetrics and Gynaecology Research. 2024-Jul;50 (7):1148-54. doi:10.1111/jog.15954.$64$YR$A$F$Y$$$20240719$$HP$JP$JP
241168791$24116879$1$I$20200101$20240717$20240722$20240722$PER$$US-ROCHE-10000030075$ROCHE$$25$YR$A$F$Y$72.57$KG$20240719$$CN$US$US
241168801$24116880$1$I$$20240712$20240722$20240722$EXP$$IN-ROCHE-10000024484$ROCHE$Siddini V, Khan M, Ravitej S, Babu K, Ballal S. Pediatric Transplant Experience from a Single Center in South India. Indian Journal of Transplantation. 2024-Jun-28;18 (2):127-31. doi:10.4103/ijot.ijot_83_23.$$$$$Y$$$20240719$$HP$IN$IN
241168811$24116881$1$I$$20240716$20240722$20240722$PER$$US-ROCHE-10000029519$ROCHE$$$$A$M$Y$$$20240719$$CN$US$US
241168821$24116882$1$I$20240711$20240716$20240722$20240722$EXP$$IN-ROCHE-10000029811$ROCHE$$58$YR$A$F$Y$$$20240719$$CN$IN$IN
241168831$24116883$1$I$$20240716$20240722$20240722$EXP$$US-ROCHE-10000029762$ROCHE$$51$YR$A$F$Y$60.33$KG$20240719$$MD$US$US
241168841$24116884$1$I$$20240716$20240722$20240722$PER$$US-ROCHE-10000027309$ROCHE$$63$YR$A$F$Y$$$20240719$$CN$US$US
241168851$24116885$1$I$$20240715$20240722$20240722$EXP$$CA-ROCHE-10000030789$ROCHE$$$$A$M$Y$$$20240719$$CN$CA$CA
241168861$24116886$1$I$$20240715$20240722$20240722$PER$$US-ROCHE-10000027371$ROCHE$$$$$$Y$$$20240719$$HP$US$US
241168872$24116887$2$F$$20240712$20240722$20240725$PER$$US-ROCHE-10000025450$ROCHE$$$$$$Y$$$20240725$$HP$US$US
241168882$24116888$2$F$20240706$20240808$20240722$20240813$EXP$$MX-ROCHE-10000028259$ROCHE$$43$YR$A$F$Y$71$KG$20240813$$CN$MX$MX
241168892$24116889$2$F$20240711$20240715$20240722$20240724$PER$$US-ROCHE-10000030294$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241168902$24116890$2$F$$20240723$20240722$20240724$EXP$$US-ROCHE-10000030331$ROCHE$$36$YR$A$M$Y$$$20240724$$CN$US$US
241168912$24116891$2$F$$20240718$20240722$20240723$PER$$US-ROCHE-10000030391$ROCHE$$55$YR$A$F$Y$$$20240723$$CN$US$US
241168921$24116892$1$I$20200627$20240712$20240722$20240722$EXP$GB-ROCHE-2640471$GB-ROCHE-10000026879$ROCHE$$39$YR$A$F$Y$$$20240719$$MD$GB$GB
241168931$24116893$1$I$$20240715$20240722$20240722$PER$$US-ROCHE-10000028130$ROCHE$$$$$$Y$$$20240719$$CN$US$US
241168941$24116894$1$I$20240501$20240717$20240722$20240722$EXP$$US-ROCHE-10000030333$ROCHE$$62$YR$A$F$Y$$$20240719$$CN$US$US
241168951$24116895$1$I$$20240711$20240722$20240722$EXP$$IN-ROCHE-10000029783$ROCHE$$$$$F$Y$$$20240719$$CN$IN$IN
241168961$24116896$1$I$20230901$20240716$20240722$20240722$PER$$US-ROCHE-3563633$ROCHE$$52$YR$A$F$Y$45.81$KG$20240719$$CN$US$US
241168971$24116897$1$I$$20240715$20240722$20240722$EXP$$US-ROCHE-10000027527$ROCHE$$66$YR$E$F$Y$$$20240719$$CN$US$US
241168981$24116898$1$I$$20240708$20240722$20240722$EXP$$CN-ROCHE-10000019564$ROCHE$$78$YR$E$F$Y$$$20240719$$CN$CN$CN
241168991$24116899$1$I$$20240704$20240722$20240722$EXP$$TH-ROCHE-10000029585$ROCHE$$56$YR$A$M$Y$$$20240719$$CN$TH$TH
241169011$24116901$1$I$$20240709$20240722$20240722$EXP$NL-SAMSUNG BIOEPIS-SB-2024-16897$NL-ROCHE-10000021679$ROCHE$Enders R, Kode V.. TRASTUZUMAB-ASSOCIATED CHOLESTATIC LIVER INJURY. Gastroenterology. doi:10.1016/S0016-5085%2824%2904367-1.$50$YR$A$F$Y$$$20240719$$HP$NL$NL
241169021$24116902$1$I$$20240621$20240722$20240722$PER$$US-ROCHE-10000009877$ROCHE$$$$$$Y$$$20240719$$HP$US$US
241169031$24116903$1$I$20240113$20240711$20240722$20240722$EXP$IT-MINISAL02-990949$IT-ROCHE-10000024193$ROCHE$$78$YR$E$M$Y$$$20240719$$MD$IT$IT
241169041$24116904$1$I$$20240717$20240722$20240722$EXP$$US-ROCHE-10000029802$ROCHE$$35$YR$A$M$Y$$$20240719$$CN$US$US
241169051$24116905$1$I$$20240711$20240722$20240722$EXP$$US-ROCHE-10000024703$ROCHE$$$$E$F$Y$$$20240719$$CN$US$US
241169061$24116906$1$I$$20240711$20240722$20240722$EXP$$TW-ROCHE-10000029712$ROCHE$Tsai C, Lin C, Chou Y, Jen H, Jain S. Clinical Applications of Comprehensive Genomic Profiling in Advanced Non-Small-Cell Lung Cancer-A Case Series. Doi: 10.3390/curroncol31060239. Current Oncology. 2024-Jun;31 (6):3161-76. doi:10.3390/curroncol31060239.$56$YR$A$M$Y$$$20240719$$HP$TW$TW
241169081$24116908$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000030394$ROCHE$$50$YR$A$M$Y$$$20240719$$CN$US$US
241169101$24116910$1$I$$20240716$20240722$20240722$EXP$$US-ROCHE-10000028750$ROCHE$$$$$$Y$$$20240719$$CN$US$US
241169112$24116911$2$F$$20240717$20240722$20240722$EXP$$US-ROCHE-10000028633$ROCHE$$33$YR$A$F$Y$$$20240722$$HP$US$US
241169121$24116912$1$I$$20240712$20240722$20240722$EXP$$IN-ROCHE-10000029784$ROCHE$$$$$M$Y$$$20240719$$CN$IN$IN
241169131$24116913$1$I$$20240712$20240722$20240722$EXP$$JP-ROCHE-10000029792$ROCHE$$7$DEC$E$M$Y$$$20240719$$MD$JP$JP
241169153$24116915$3$F$$20240722$20240722$20240723$PER$$US-ROCHE-10000022001$ROCHE$$$$A$F$Y$$$20240723$$HP$US$US
241169161$24116916$1$I$$20240709$20240722$20240722$EXP$$CA-ROCHE-10000026383$ROCHE$$$$E$F$Y$$$20240719$$CN$CA$CA
241169171$24116917$1$I$$20240712$20240722$20240722$EXP$$PK-ROCHE-3416770$ROCHE$$47$YR$A$M$Y$$$20240719$$CN$PK$PK
241169192$24116919$2$F$20231103$20240723$20240722$20240729$EXP$FR-AFSSAPS-MP2024001063$FR-ROCHE-10000028129$ROCHE$$70$YR$E$F$Y$$$20240729$$PH$FR$FR
241169201$24116920$1$I$20240711$20240712$20240722$20240722$EXP$$BR-ROCHE-10000025456$ROCHE$$50$YR$A$F$Y$67$KG$20240719$$PH$BR$BR
241169211$24116921$1$I$$20240716$20240722$20240722$PER$$US-ROCHE-10000029083$ROCHE$$$$A$F$Y$$$20240719$$CN$US$US
241169221$24116922$1$I$$20240708$20240722$20240722$EXP$$EG-ROCHE-10000021735$ROCHE$$$$A$M$Y$$$20240719$$MD$EG$EG
241169242$24116924$2$F$$20240828$20240722$20240906$PER$$US-ROCHE-10000028766$ROCHE$$$$A$F$Y$$$20240906$$CN$US$US
241169251$24116925$1$I$$20240709$20240722$20240722$EXP$$PH-ROCHE-10000030101$ROCHE$$$$$$Y$$$20240719$$MD$PH$PH
241169261$24116926$1$I$20240701$20240710$20240722$20240722$EXP$$JP-ROCHE-10000027353$ROCHE$$$$E$F$Y$$$20240719$$MD$JP$JP
241169272$24116927$2$F$$20240820$20240722$20240823$PER$$US-ROCHE-10000029754$ROCHE$$37$YR$A$F$Y$$$20240823$$MD$US$US
241169281$24116928$1$I$$20240718$20240722$20240722$EXP$$AU-ROCHE-10000030468$ROCHE$$$$$F$Y$$$20240719$$CN$AU$AU
241169292$24116929$2$F$20221018$20240716$20240722$20240723$EXP$$GB-ROCHE-3237177$ROCHE$$70$YR$E$M$Y$77.6$KG$20240723$$MD$GB$GB
241169301$24116930$1$I$$20240703$20240722$20240722$PER$$US-ROCHE-10000020343$ROCHE$$$$A$F$Y$$$20240719$$HP$US$US
241169311$24116931$1$I$20240601$20240713$20240722$20240722$EXP$$JP-ROCHE-10000030522$ROCHE$$8$DEC$E$$Y$$$20240719$$MD$JP$JP
241169322$24116932$2$F$20240716$20240823$20240722$20240826$PER$$US-ROCHE-10000029156$ROCHE$$22$YR$A$F$Y$58.97$KG$20240826$$CN$US$US
241169332$24116933$2$F$20240711$20240722$20240722$20240802$EXP$$CZ-ROCHE-10000029431$ROCHE$$77$YR$E$M$Y$$$20240802$$MD$CZ$CZ
241169342$24116934$2$F$20240130$20240902$20240722$20240913$EXP$$JP-ROCHE-10000025131$ROCHE$$70$YR$E$M$Y$$$20240913$$MD$JP$JP
241169351$24116935$1$I$$20240710$20240722$20240722$EXP$$US-ROCHE-10000023130$ROCHE$$65$YR$E$M$Y$$$20240719$$CN$US$US
241169361$24116936$1$I$$20240711$20240722$20240722$EXP$$JP-ROCHE-10000028577$ROCHE$$66$YR$E$F$Y$$$20240719$$MD$JP$JP
241169371$24116937$1$I$20240602$20240711$20240722$20240722$PER$$US-ROCHE-3576431$ROCHE$$$$$F$Y$$$20240719$$CN$US$US
241169381$24116938$1$I$$20240712$20240722$20240722$EXP$$IN-ROCHE-10000027941$ROCHE$Kulkarni A, Kumaraswamy P, Menon B, Sekaran A, Rambhatl A, Rambhatl S, et al. Downstaging with Atezolizumab-Bevacizumab: A Case Series. Journal of liver cancer. 2024-May-27;1-30. doi:10.17998/jlc.2024.05.12.$70$YR$E$M$Y$$$20240719$$MD$IN$IN
241169391$24116939$1$I$20240715$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024142187$AMGEN$$58$YR$A$F$Y$$$20240721$$CN$US$US
241169408$24116940$8$F$$20240731$20240722$20240810$PER$$US-ROCHE-10000026837$ROCHE$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy. Experimental and Clinical Transplantatio. 2024;22 (5):392-5. doi:10.6002/ect.2024.0029.$68$YR$E$F$Y$$$20240810$$MD$US$US
241169411$24116941$1$I$$20240716$20240722$20240722$EXP$$CA-ROCHE-10000029290$ROCHE$$$$A$F$Y$$$20240719$$CN$CA$CA
241169421$24116942$1$I$20240626$20240704$20240722$20240722$EXP$$CN-ROCHE-10000017385$ROCHE$$70$YR$E$M$Y$55$KG$20240719$$CN$CN$CN
241169431$24116943$1$I$$20240715$20240722$20240722$PER$$US-ROCHE-10000027434$ROCHE$$$$$$Y$$$20240719$$CN$US$US
241169443$24116944$3$F$20240430$20240913$20240722$20240921$PER$$US-ROCHE-10000027169$ROCHE$$$$A$M$Y$$$20240921$$MD$US$US
241169451$24116945$1$I$$20240717$20240722$20240722$EXP$$US-ROCHE-10000029981$ROCHE$$$$$$Y$$$20240719$$CN$US$US
241169462$24116946$2$F$$20240729$20240722$20240731$EXP$$CA-ROCHE-10000031006$ROCHE$$$$A$F$Y$$$20240731$$CN$CA$CA
241169471$24116947$1$I$$20240708$20240722$20240722$EXP$$CN-ROCHE-10000021467$ROCHE$Gao L, Wang X, Wu Y, Feng X, Rao W, Liu X, et al. Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphoma.. Leuk.Lymphoma. 2024;65 (6):746-757. doi:10.1080/10428194.2024.2329328.$$$$$Y$$$20240719$$HP$CN$CN
241169481$24116948$1$I$20240618$20240705$20240722$20240722$EXP$$TH-ROCHE-10000006800$ROCHE$$63$YR$A$F$Y$$$20240719$$CN$TH$TH
241169491$24116949$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000030279$ROCHE$$$$T$M$Y$$$20240719$$CN$US$US
241169501$24116950$1$I$20240531$20240606$20240722$20240722$EXP$$US-ROCHE-10000030122$ROCHE$$48$YR$A$M$Y$$$20240719$$HP$US$US
241169511$24116951$1$I$20230721$20240705$20240722$20240722$EXP$$TH-ROCHE-10000029613$ROCHE$$69$YR$E$M$Y$$$20240719$$CN$TH$TH
241169521$24116952$1$I$$20240716$20240722$20240722$PER$$US-ROCHE-10000029076$ROCHE$$$$A$F$Y$$$20240719$$CN$US$US
241169531$24116953$1$I$20240101$20240715$20240722$20240722$PER$$US-ROCHE-10000027537$ROCHE$$16$YR$T$F$Y$56.25$KG$20240719$$CN$US$US
241169544$24116954$4$F$20240708$20240902$20240722$20240910$PER$$US-ROCHE-10000026982$ROCHE$$71$YR$E$F$Y$53.52$KG$20240910$$CN$US$US
241169553$24116955$3$F$$20240902$20240722$20240906$PER$$US-ROCHE-10000021428$ROCHE$$$$$$Y$$$20240906$$HP$US$US
241169571$24116957$1$I$$20240712$20240722$20240722$EXP$$IN-ROCHE-3526682$ROCHE$$65$YR$E$F$Y$$$20240719$$MD$IN$IN
241169583$24116958$3$F$20190805$20240729$20240722$20240812$EXP$$CO-UCBSA-2023003817$UCB$$37$YR$$F$Y$62$KG$20240812$$CN$CO$CO
241169591$24116959$1$I$$20240716$20240722$20240722$EXP$$CO-UCBSA-2024036762$UCB$$$$$M$Y$$$20240722$$CN$CO$CO
241169603$24116960$3$F$$20240919$20240722$20240924$EXP$$TH-ROCHE-10000029275$ROCHE$$78$YR$E$M$Y$$$20240924$$CN$TH$TH
241169621$24116962$1$I$$20240716$20240722$20240722$PER$$US-ROCHE-10000028966$ROCHE$$$$A$F$Y$$$20240719$$CN$US$US
241169636$24116963$6$F$20240711$20240916$20240722$20240921$PER$$US-ROCHE-10000030480$ROCHE$$$$$M$Y$$$20240921$$HP$US$US
241169641$24116964$1$I$$20240719$20240722$20240722$PER$$NVSC2024US149531$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
241169651$24116965$1$I$$20240716$20240722$20240722$PER$$US-ROCHE-10000029397$ROCHE$$$$A$F$Y$$$20240719$$CN$US$US
241169671$24116967$1$I$20240619$20240708$20240722$20240722$EXP$$DE-ROCHE-10000008243$ROCHE$$81$YR$E$M$Y$100$KG$20240719$$MD$DE$DE
241169687$24116968$7$F$$20240903$20240722$20240909$PER$$US-ROCHE-10000027881$ROCHE$$72$YR$E$F$Y$$$20240909$$CN$US$US
241169692$24116969$2$F$20240707$20240813$20240722$20240821$PER$$US-ROCHE-10000027303$ROCHE$$30$YR$A$M$Y$$$20240821$$CN$US$US
241169702$24116970$2$F$20240523$20240716$20240722$20240723$PER$$US-ROCHE-10000028513$ROCHE$$23$YR$A$F$Y$$$20240723$$CN$US$US
241169711$24116971$1$I$$20240704$20240722$20240722$PER$$US-ROCHE-10000022359$ROCHE$$$$$$Y$$$20240719$$CN$US$US
241169721$24116972$1$I$20240625$20240705$20240722$20240722$EXP$$TH-ROCHE-3566242$ROCHE$$77$YR$E$M$Y$$$20240719$$CN$TH$TH
241169741$24116974$1$I$$20240705$20240722$20240722$PER$$US-ROCHE-RCA5211548$ROCHE$$$$$$Y$$$20240719$$CN$US$US
241169751$24116975$1$I$$20240716$20240722$20240722$EXP$$US-ROCHE-10000028526$ROCHE$$79$YR$E$F$Y$$$20240719$$CN$US$US
241169762$24116976$2$F$$20240821$20240722$20240827$PER$$US-ROCHE-10000028555$ROCHE$$61$YR$A$M$Y$$$20240827$$CN$US$US
241169771$24116977$1$I$20240630$20240709$20240722$20240722$EXP$$CN-ROCHE-10000021705$ROCHE$$58$YR$A$F$Y$53$KG$20240719$$HP$CN$CN
241169781$24116978$1$I$20240522$20240708$20240722$20240722$EXP$FR-AFSSAPS-AVTO2024000104$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109648$ZYDUS PHARM$$$$$$Y$$$20240722$$MD$FR$FR
241169792$24116979$2$F$20240610$20240729$20240722$20240809$EXP$FR-AFSSAPS-TS2024000763$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109603$ZYDUS PHARM$$$$$$Y$$$20240809$$MD$FR$FR
241169801$24116980$1$I$20240603$20240708$20240722$20240722$EXP$FR-AFSSAPS-AN2024000837$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109656$ZYDUS PHARM$$$$$$Y$$$20240722$$MD$FR$FR
241169811$24116981$1$I$20240308$20240708$20240722$20240722$EXP$FR-AFSSAPS-LL2024001220$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109725$ZYDUS PHARM$$$$$$Y$$$20240722$$MD$FR$FR
241169822$24116982$2$F$20230901$20240718$20240722$20240726$EXP$$US-GSK-US2024088623$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240726$$CN$US$US
241169831$24116983$1$I$$20240712$20240722$20240722$EXP$$DE-AUROBINDO-AUR-APL-2024-035650$AUROBINDO$$$$A$F$Y$64$KG$20240722$$MD$DE$DE
241169841$24116984$1$I$20240717$20240717$20240722$20240722$EXP$$US-ABBVIE-5845090$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241169851$24116985$1$I$$20240717$20240722$20240722$EXP$$CN-TAKEDA-2024TUS073237$TAKEDA$Gang W, Tianmei S, Andreas R, Jingdong M, Michael C. Effectiveness of vortioxetine in working patients with major depressive disorder in china: a subgroup analysis of the relieve china study. Neuropsychiatric Disease And Treatment. 2024;20:1211-1223$$$A$$Y$$$20240722$$MD$CN$CN
241169861$24116986$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5844835$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241169871$24116987$1$I$20230101$20240717$20240722$20240722$EXP$$CA-ABBVIE-5549460$ABBVIE$$$$$F$Y$$$20240722$$CN$CA$CA
241169881$24116988$1$I$$20240708$20240722$20240722$PER$$US-TEVA-VS-3218805$TEVA$$90$YR$$$Y$$$20240722$$CN$US$US
241169891$24116989$1$I$$20240708$20240722$20240722$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP008488$STRIDES$Kam I, Prentice D, Kho LK, Dharsono F.. Inflammatory epilepsy (FIRES) and haemophagocytic lymphohistiocytosis (HLH): an adult case.. BMJ-Case-Rep. 2023;16(1):1-4$4$DEC$$M$Y$$$20240722$$HP$AU$AU
241169901$24116990$1$I$20240415$20240712$20240722$20240722$EXP$$IT-AUROBINDO-AUR-APL-2024-035911$AUROBINDO$$67$YR$$F$Y$67$KG$20240722$$MD$IT$IT
241169921$24116992$1$I$$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115441$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240722$$HP$US$US
241169931$24116993$1$I$$20240709$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109670$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240722$$CN$US$US
241169941$24116994$1$I$20240716$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142761$AMGEN$$71$YR$E$F$Y$$$20240721$$HP$US$US
241169953$24116995$3$F$20221201$20240729$20240722$20240812$EXP$$CO-UCBSA-2024036009$UCB$$0$YR$$F$Y$1.66$KG$20240812$$CN$CO$CO
241169962$24116996$2$F$20240322$20240731$20240722$20240807$EXP$$CA-Orion Corporation ORION PHARMA-24_00030880$ORION$$66$YR$E$F$Y$$$20240807$$HP$CA$
241169972$24116997$2$F$$20240821$20240722$20240823$EXP$$CA-Orion Corporation ORION PHARMA-24_00030915$ORION$$25$YR$A$F$Y$99$KG$20240823$$HP$CA$
241169981$24116998$1$I$20230101$20240715$20240722$20240722$EXP$NL-EMA-DD-20240712-7482701-064706$NL-BIOCON BIOLOGICS LIMITED-BBL2024005241$BIOCON$$$$$$Y$$$20240722$$MD$NL$NL
241169991$24116999$1$I$$20240710$20240722$20240722$EXP$$GB-BEH-2024175648$CSL BEHRING$$$$A$F$Y$$$20240719$$CN$GB$GB
241170003$24117000$3$F$$20240801$20240722$20240806$EXP$$US-EXELIXIS-CABO-24079498$EXELIXIS$$$$$M$Y$$$20240806$$HP$US$US
241170012$24117001$2$F$$20240826$20240722$20240904$EXP$$FR-TEVA-VS-3220878$TEVA$De Waard A, Lefebvre L, Textoris J, Payen D. Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?. Front-Immunol 2023; 14.; De Waard A, Lefebvre L, Textoris J, Payen D. Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?. Front-Immunol 2023; 14.; De Waard A, Lefebvre L, Textoris J, Payen D. Case Report: Intercurrent infections in COVID-19-induced sustained...$60$YR$$M$Y$$$20240904$$HP$FR$FR
241170022$24117002$2$F$20240702$20240722$20240722$20240724$PER$$US-AMGEN-USASP2024144428$AMGEN$$50$YR$A$M$Y$$$20240724$$CN$US$US
241170031$24117003$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024142520$AMGEN$$$$$$Y$$$20240721$$CN$US$US
241170041$24117004$1$I$$20240715$20240722$20240722$EXP$$CA-Orion Corporation ORION PHARMA-24_00030876$ORION$$63$YR$A$F$Y$$$20240719$$HP$CA$
241170051$24117005$1$I$$20240712$20240722$20240722$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2023US000573$DECIPHERA PHARMACEUTICALS$$59$YR$A$M$Y$$$20240722$$CN$US$US
241170061$24117006$1$I$20240628$20240711$20240722$20240722$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2159412$JIANGSU HENGRUI MEDICINE$$66$YR$$$Y$72.5$KG$20240722$$MD$CN$CN
241170071$24117007$1$I$20240624$20240708$20240722$20240722$EXP$GB-MHRA-MED-202407071011142080-CVHZM$GB-GLENMARK PHARMACEUTICALS-2024GMK092267$GLENMARK$$$$$$Y$$$20240722$$CN$GB$GB
241170081$24117008$1$I$20240101$20240710$20240722$20240722$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000610$DECIPHERA PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
241170091$24117009$1$I$$20240717$20240722$20240722$EXP$CA-DRL-USA-SPO/CAN/24/0010562$CA-RDY-SPO/CAN/24/0010562$DR REDDYS$$$$$M$Y$$$20240722$$HP$CA$CA
241170101$24117010$1$I$20240715$20240717$20240722$20240722$EXP$$US-ABBVIE-5845256$ABBVIE$$49$YR$$F$Y$$$20240722$$CN$US$US
241170111$24117011$1$I$$20240719$20240722$20240722$PER$$US-AMGEN-USASP2024144076$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241170121$24117012$1$I$20230523$20240713$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-035180$AUROBINDO$$25$YR$$F$Y$72$KG$20240722$$CN$GB$GB
241170131$24117013$1$I$$20240713$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-035156$AUROBINDO$$$$$$Y$$$20240722$$CN$GB$GB
241170141$24117014$1$I$20240601$20240711$20240722$20240722$EXP$$US-CHIESI-2024CHF04228$CHIESI$$0$YR$$F$Y$$$20240719$$MD$US$US
241170155$24117015$5$F$20240101$20240919$20240722$20240928$EXP$$CA-CELLTRION INC.-2024CA017536$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
241170161$24117016$1$I$$20240710$20240722$20240722$EXP$$CA-APOTEX-2024AP008217$APOTEX$$59$YR$$M$Y$$$20240722$$PH$CA$CA
241170181$24117018$1$I$$20240713$20240722$20240722$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001415$BLUEPRINT MEDICINES$$$$$F$Y$$$20240722$$CN$US$US
241170191$24117019$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000028872$ROCHE$$$$A$M$Y$$$20240722$$CN$US$US
241170201$24117020$1$I$$20211012$20240722$20240722$EXP$$US-AstraZeneca-2021A773747$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241170211$24117021$1$I$20191001$20200218$20240722$20240722$EXP$$CO-AstraZeneca-2020SE25403$ASTRAZENECA$$18987$DY$$F$Y$$$20240722$$CN$CO$
241170221$24117022$1$I$$20191121$20240722$20240722$EXP$$ZA-AstraZeneca-2019SF67109$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$ZA$
241170231$24117023$1$I$$20240717$20240722$20240722$PER$$US-AstraZeneca-2024A163410$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241170241$24117024$1$I$$20231106$20240722$20240722$EXP$$US-AstraZeneca-2023A252814$ASTRAZENECA$$$$A$M$Y$103.9$KG$20240722$$CN$US$
241170251$24117025$1$I$20231228$20240716$20240722$20240722$EXP$$US-SERVIER-S24003262$SERVIER$$$$$$Y$$$20240719$$MD$US$US
241170262$24117026$2$F$20240101$20240828$20240722$20240905$EXP$$US-009507513-2407USA010884$MERCK$$$$$$Y$$$20240905$$MD$US$US
241170271$24117027$1$I$$20240718$20240722$20240722$EXP$$US-ROCHE-10000031516$ROCHE$$92$YR$E$F$Y$$$20240722$$CN$US$US
241170281$24117028$1$I$$20240710$20240722$20240722$EXP$CA-HPFB-001091274$CA-SERVIER-S24008890$SERVIER$$$$$$Y$$$20240722$$HP$CA$CA
241170292$24117029$2$F$20240607$20240903$20240722$20240909$EXP$$BG-SERVIER-S24006089$SERVIER$$$$$$Y$$$20240909$$MD$BG$BG
241170301$24117030$1$I$20231225$20240711$20240722$20240722$EXP$$FR-CELLTRION INC.-2024FR017164$CELLTRION$$$$$$Y$$$20240722$$MD$FR$FR
241170311$24117031$1$I$$20240711$20240722$20240722$EXP$$CA-APOTEX-2024AP008284$APOTEX$$78$YR$$F$Y$64$KG$20240722$$PH$CA$CA
241170322$24117032$2$F$$20240724$20240722$20240730$EXP$$JP-BEH-2024175577$CSL BEHRING$$$$N$M$Y$$$20240730$$HP$JP$JP
241170331$24117033$1$I$20240709$20240710$20240722$20240722$EXP$$US-BEH-2024175557$CSL BEHRING$$64$YR$A$F$Y$$$20240719$$HP$US$US
241170341$24117034$1$I$20240623$20240711$20240722$20240722$PER$$US-BEH-2024175769$CSL BEHRING$$32$YR$A$F$Y$$$20240719$$HP$US$US
241170351$24117035$1$I$$20240710$20240722$20240722$EXP$$US-STL-000213$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$38$WK$$F$Y$$$20240722$$MD$US$US
241170361$24117036$1$I$$20240710$20240722$20240722$EXP$$US-STL-000212$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$33$WK$$M$Y$$$20240722$$MD$US$US
241170371$24117037$1$I$$20240710$20240722$20240722$EXP$$US-STL-000211$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$38$WK$$F$Y$$$20240722$$MD$US$US
241170381$24117038$1$I$$20240710$20240722$20240722$EXP$$US-STL-000214$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$28$WK$$M$Y$$$20240722$$MD$US$US
241170391$24117039$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000030277$ROCHE$$8$YR$C$F$Y$$$20240722$$HP$US$US
241170401$24117040$1$I$$20240710$20240722$20240722$EXP$$US-STL-000216$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$39$WK$$F$Y$$$20240722$$MD$US$US
241170411$24117041$1$I$$20240710$20240722$20240722$EXP$$US-STL-000215$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$39$WK$$F$Y$$$20240722$$MD$US$US
241170421$24117042$1$I$$20240710$20240722$20240722$EXP$$US-STL-000217$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$36$WK$$F$Y$$$20240722$$MD$US$US
241170431$24117043$1$I$$20240710$20240722$20240722$EXP$$US-STL-000218$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$37$WK$$M$Y$$$20240722$$MD$US$US
241170441$24117044$1$I$$20240710$20240722$20240722$EXP$$US-STL-000219$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$35$WK$$F$Y$$$20240722$$MD$US$US
241170451$24117045$1$I$$20240710$20240722$20240722$EXP$$US-STL-000220$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$40$WK$$F$Y$$$20240722$$MD$US$US
241170461$24117046$1$I$$20240710$20240722$20240722$EXP$$US-STL-000222$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$31$WK$$M$Y$$$20240722$$MD$US$US
241170471$24117047$1$I$$20240710$20240722$20240722$EXP$$US-STL-000221$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$40$WK$$M$Y$$$20240722$$MD$US$US
241170481$24117048$1$I$$20240710$20240722$20240722$EXP$$US-BEH-2024175571$CSL BEHRING$$52$YR$A$F$Y$$$20240719$$HP$US$US
241170491$24117049$1$I$20240629$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024142377$AMGEN$$70$YR$E$F$Y$$$20240722$$CN$US$US
241170501$24117050$1$I$$20240709$20240722$20240722$EXP$$US-CLINIGEN-US-CLI-2024-010419$CLINIGEN$Hira A. Hasan, Lindsey S. Johnstone, Daniel J. Benedetti. A case of pancreatoblastoma in a child with Simpson-Golabi-Behmel syndrome: Highlighting the importance of alpha fetoprotein monitoring. Pediatric Blood + Cancer. 2024;71:8$$$I$F$Y$$$20240722$$MD$US$US
241170511$24117051$1$I$20240715$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142429$AMGEN$$$$$$Y$$$20240722$$PH$US$US
241170522$24117052$2$F$20240714$20240813$20240722$20240816$PER$$US-AMGEN-USASP2024142810$AMGEN$$86$YR$E$M$Y$$$20240816$$CN$US$US
241170531$24117053$1$I$$20240710$20240722$20240722$EXP$$US-STL-000224$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$33$WK$$F$Y$$$20240722$$MD$US$US
241170541$24117054$1$I$$20240710$20240722$20240722$EXP$$US-STL-000225$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$25$WK$$M$Y$$$20240722$$MD$US$US
241170551$24117055$1$I$$20240710$20240722$20240722$EXP$$US-STL-000223$Stallion Laboratories$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, et al. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatr Neurol. 2024 Jun 5;157:134-140. doi: 10.1016/j.pediatrneurol.2024.05.019.$39$WK$$F$Y$$$20240722$$MD$US$US
241170561$24117056$1$I$20240701$20240711$20240722$20240722$EXP$$US-BEH-2024175628$CSL BEHRING$$57$YR$A$F$Y$$$20240719$$HP$US$US
241170571$24117057$1$I$$20240715$20240722$20240722$EXP$$DE-BIOCON BIOLOGICS LIMITED-BBL2024005248$BIOCON$$$$$$Y$$$20240722$$MD$DE$DE
241170581$24117058$1$I$20240528$20240717$20240722$20240722$EXP$FR-AFSSAPS-ST2024001151$FR-GSK-FR2024089955$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$FR$FR
241170593$24117059$3$F$20240708$20240801$20240722$20240925$PER$$US-GSK-US2024AMR089173$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240925$$CN$US$US
241170601$24117060$1$I$$20240717$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114707$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240722$$MD$US$US
241170612$24117061$2$F$20240313$20240814$20240722$20240816$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-115104$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$65$KG$20240816$$MD$CZ$CZ
241170621$24117062$1$I$$20240710$20240722$20240722$EXP$$US-APOTEX-2024AP008304$APOTEX$Fenton GA, Dean EA.. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/ Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case Reports in Oncology. 2024;17 (1):75-81$64$YR$$F$Y$$$20240722$$HP$US$US
241170631$24117063$1$I$$20211027$20240722$20240722$EXP$$US-AstraZeneca-2021A790038$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241170641$24117064$1$I$$20240716$20240722$20240722$PER$$US-AstraZeneca-2024A164726$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241170651$24117065$1$I$$20210317$20240722$20240722$EXP$$AU-AstraZeneca-2021A177172$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$AU$
241170661$24117066$1$I$$20210426$20240722$20240722$EXP$$US-AstraZeneca-2021A377230$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241170671$24117067$1$I$$20200316$20240722$20240722$EXP$$US-AstraZeneca-2020SE41544$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241170681$24117068$1$I$$20240711$20240722$20240722$PER$$US-AstraZeneca-2024A159319$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241170691$24117069$1$I$$20200125$20240722$20240722$EXP$$RU-AstraZeneca-2020SE14354$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$RU$
241170701$24117070$1$I$$20210127$20240722$20240722$EXP$$US-AstraZeneca-2020SF40120$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241170711$24117071$1$I$20180831$20190717$20240722$20240722$EXP$$CO-AstraZeneca-2019SF04557$ASTRAZENECA$$19472$DY$$M$Y$$$20240722$$CN$CO$
241170721$24117072$1$I$20191128$20200115$20240722$20240722$EXP$$CO-AstraZeneca-2020SE08967$ASTRAZENECA$$18134$DY$$F$Y$$$20240722$$CN$CO$
241170731$24117073$1$I$20240101$20240715$20240722$20240722$EXP$$US-UCBSA-2024036094$UCB$$$$$F$Y$$$20240722$$HP$US$US
241170743$24117074$3$F$20200101$20240826$20240722$20240911$EXP$$DE-CELLTRION INC.-2024DE017336$CELLTRION$$$$$$Y$$$20240911$$MD$DE$DE
241170751$24117075$1$I$20240101$20240711$20240722$20240722$EXP$$US-ORPHANEU-2024004236$RECORDATI$$$$$$Y$$$20240722$$CN$US$US
241170761$24117076$1$I$$20240709$20240722$20240722$EXP$$GB-BEH-2024175306$CSL BEHRING$$$$$$Y$$$20240719$$HP$GB$GB
241170771$24117077$1$I$$20240712$20240722$20240722$EXP$$CA-CELLTRION INC.-2024CA017088$CELLTRION$$$$$$Y$$$20240722$$CN$CA$CA
241170781$24117078$1$I$20240712$20240715$20240722$20240722$PER$$US-ABBVIE-5841887$ABBVIE$$74$YR$$F$Y$97$KG$20240722$$CN$US$US
241170791$24117079$1$I$20240529$20240708$20240722$20240722$EXP$$US-UCBSA-2024027376$UCB$$56$YR$$F$Y$185$KG$20240722$$HP$US$US
241170802$24117080$2$F$20240101$20240710$20240722$20240723$EXP$$US-BEH-2024175455$CSL BEHRING$$33$YR$A$M$Y$$$20240723$$HP$US$US
241170814$24117081$4$F$20240623$20240911$20240722$20240915$EXP$$CA-ROCHE-10000031449$ROCHE$$53$YR$A$F$Y$$$20240915$$CN$CA$CA
241170821$24117082$1$I$$20240712$20240722$20240722$EXP$$CA-CELLTRION INC.-2024CA017532$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
241170842$24117084$2$F$20240701$20240719$20240722$20240725$EXP$$IE-ABBVIE-5846167$ABBVIE$$74$YR$$M$Y$$$20240725$$HP$IE$IE
241170852$24117085$2$F$$20240801$20240722$20240809$EXP$$JP-BEH-2024175574$CSL BEHRING$$$$$M$Y$$$20240809$$HP$JP$JP
241170861$24117086$1$I$$20240718$20240722$20240722$EXP$$ZA-ABBVIE-5845737$ABBVIE$$$$E$M$Y$$$20240722$$MD$ZA$ZA
241170871$24117087$1$I$20230122$20240124$20240722$20240722$EXP$FR-AFSSAPS-NC2023001442$FR-TEVA-VS-3151374$TEVA$$40$YR$$M$Y$$$20240722$$MD$FR$FR
241170891$24117089$1$I$20210908$20240716$20240722$20240722$EXP$$CO-UCBSA-2024036757$UCB$$27$YR$$M$Y$$$20240722$$CN$CO$CO
241170901$24117090$1$I$20221212$20240711$20240722$20240722$EXP$$FR-CELLTRION INC.-2024FR017188$CELLTRION$$$$$$Y$$$20240722$$PH$FR$FR
241170911$24117091$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5844537$ABBVIE$$$$$F$Y$$$20240722$$HP$US$US
241170922$24117092$2$F$$20240815$20240722$20240828$EXP$$US-BEH-2024175581$CSL BEHRING$$$$T$F$Y$$$20240828$$HP$US$US
241170932$24117093$2$F$20240601$20240715$20240722$20240730$EXP$$CN-BEH-2024175812$CSL BEHRING$$68$YR$E$F$Y$52$KG$20240730$$CN$CN$CN
241170943$24117094$3$F$20240101$20240909$20240722$20240917$EXP$$CA-CELLTRION INC.-2024CA017537$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
241170951$24117095$1$I$$20240712$20240722$20240722$EXP$$US-BEH-2024175730$CSL BEHRING$$62$YR$A$M$Y$108.84$KG$20240719$$HP$US$US
241170961$24117096$1$I$20230101$20240715$20240722$20240722$EXP$$EU-BAUSCHBL-2024BNL027969$BAUSCH AND LOMB$$$$A$F$Y$$$20240722$$MD$EU$EU
241170971$24117097$1$I$20240601$20240717$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114391$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240722$$CN$US$US
241170981$24117098$1$I$$20240709$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-110674$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240722$$PH$JP$JP
241170991$24117099$1$I$20240705$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024144586$AMGEN$$82$YR$E$M$Y$$$20240722$$CN$US$US
241171002$24117100$2$F$20240711$20240712$20240722$20240725$EXP$$ES-EMD Serono-2024038945$EMD SERONO INC$$8$YR$C$F$Y$$$20240725$$CN$ES$ES
241171011$24117101$1$I$$20240716$20240722$20240722$EXP$$NVSC2024US148965$NOVARTIS$$$$$M$Y$$$20240722$$CN$US$US
241171021$24117102$1$I$$20211123$20240722$20240722$EXP$$US-AstraZeneca-2021A827626$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241171033$24117103$3$F$$20240821$20240722$20240905$PER$$US-AstraZeneca-2024A162626$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
241171041$24117104$1$I$$20190710$20240722$20240722$EXP$$US-AstraZeneca-2019SF01309$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241171051$24117105$1$I$$20210324$20240722$20240722$EXP$$US-AstraZeneca-2021A224048$ASTRAZENECA$$54$YR$$F$Y$$$20240722$$CN$US$
241171062$24117106$2$F$$20240918$20240722$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU066306$SANDOZ$$$$$$Y$$$20240920$$HP$AU$AU
241171071$24117107$1$I$20240101$20240711$20240722$20240722$EXP$$US-ORPHANEU-2024005397$RECORDATI$$$$$$Y$$$20240722$$CN$US$US
241171081$24117108$1$I$$20210223$20240722$20240722$EXP$$US-AstraZeneca-2021A084629$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241171091$24117109$1$I$$20210325$20240722$20240722$EXP$$US-AstraZeneca-2021A230544$ASTRAZENECA$$67$YR$$F$Y$$$20240722$$CN$US$
241171101$24117110$1$I$20190704$20190930$20240722$20240722$EXP$$US-AstraZeneca-2019SF42086$ASTRAZENECA$$24890$DY$$F$Y$$$20240722$$CN$US$
241171111$24117111$1$I$$20240716$20240722$20240722$EXP$$SI-SANDOZ INC.-SDZ2024SI066260$SANDOZ$$48$YR$$F$Y$$$20240722$$MD$SI$SI
241171121$24117112$1$I$$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143081$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241171131$24117113$1$I$$20240712$20240722$20240722$EXP$$DE-EMD Serono-2024038138$EMD SERONO INC$$9$YR$C$M$Y$$$20240722$$CN$DE$DE
241171142$24117114$2$F$$20240828$20240722$20240902$EXP$$JP-TAKEDA-2024TJP010845$TAKEDA$$$$A$M$Y$$$20240902$$MD$JP$JP
241171151$24117115$1$I$$20240716$20240722$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA066017$SANDOZ$$$$$M$Y$$$20240722$$MD$CA$CA
241171161$24117116$1$I$$20240717$20240722$20240722$EXP$$CA-UCBSA-2024036683$UCB$$$$$F$Y$$$20240722$$MD$CA$CA
241171172$24117117$2$F$$20240719$20240722$20240723$EXP$$CA-SANDOZ INC.-SDZ2023CA050185$SANDOZ$$$$$F$Y$$$20240723$$HP$CA$CA
241171181$24117118$1$I$$20240708$20240722$20240722$EXP$$IN-IPCA LABORATORIES LIMITED-IPC-2024-IN-001796$IPCA$R.Meenakshi, K.Balamurali and G.Anbazhagan. A unique case of galactorrhea caused by tramadol dependency in a 32-year-old female- a case report. Indian Journal of Psychiatry. 2024;66 (1):S192$$$$$Y$$$20240722$$HP$IN$IN
241171202$24117120$2$F$$20240904$20240722$20240910$EXP$$US-TAKEDA-2024TUS025921$TAKEDA$$$$$M$Y$$$20240910$$CN$US$US
241171211$24117121$1$I$$20240717$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2024US066758$SANDOZ$$$$$$Y$$$20240722$$MD$US$US
241171222$24117122$2$F$20240913$20240918$20240722$20240927$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002046$Alvotech$$73$YR$$F$Y$$$20240927$$CN$CA$CA
241171231$24117123$1$I$$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142973$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241171242$24117124$2$F$20240713$20240722$20240722$20240724$PER$$US-AMGEN-USASP2024143897$AMGEN$$24$YR$A$F$Y$$$20240723$$CN$US$US
241171251$24117125$1$I$$20240712$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111864$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240722$$HP$US$US
241171261$24117126$1$I$$20240627$20240722$20240722$PER$$US-009507513-2406USA009753$MERCK$Zou H, Sutherland L, Geddie B. Pigmentary retinal dystrophy associated with peroxisome biogenesis disorder-Zellweger syndrome spectrum. Oxford Medical Case Reports. 2024;6:263-5$4$YR$$F$Y$$$20240722$$HP$US$US
241171272$24117127$2$F$$20240806$20240722$20240819$EXP$$TR-TWI PHARMACEUTICAL, INC-20240700022$TWI PHARMACEUTICALS$Kaya Akca U.; Sener S.; Batu E.D.; Balik Z.; Basaran O.; Bilginer Y. et al.. Drug-induced lupus erythematosus in childhood: Case-based review. Lupus. 2024;33:7:737-748$11$YR$$F$Y$$$20240816$$$TR$TR
241171282$24117128$2$F$20240101$20240917$20240722$20240923$EXP$$US-ABBVIE-5845146$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
241171291$24117129$1$I$$20240715$20240722$20240722$EXP$$CN-CHEPLA-2024009099$CHEPLAPHARM$Shi SM, Li ZH, Xu JR, Cai XX, Zhou XX, Zheng RC et al. An adult with hemorrhagic varicella co-infects with cytomegalovirus: a case report. BMC Infectious Diseases. 2024;24(1):1-6.https://doi.org/10.1186/s12879-024-09383-0.$25$YR$$M$Y$$$20240722$$HP$COUNTRY NOT SPECIFIED$CN
241171301$24117130$1$I$$20240716$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2024US066023$SANDOZ$$52$YR$$F$Y$$$20240722$$CN$US$US
241171311$24117131$1$I$20231215$20240711$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-034580$AUROBINDO$$83$YR$$F$Y$56$KG$20240722$$MD$FR$FR
241171322$24117132$2$F$20201115$20240723$20240722$20240727$EXP$$DE-SANDOZ INC.-SDZ2024DE066093$SANDOZ$$81$YR$$M$Y$70$KG$20240727$$PH$DE$DE
241171331$24117133$1$I$20240710$20240717$20240722$20240722$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040564$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$55$KG$20240722$$HP$CN$CN
241171341$24117134$1$I$$20240717$20240722$20240722$EXP$$AU-TGA-0000814260$SANDOZ$$$$$M$Y$$$20240722$$MD$AU$AU
241171351$24117135$1$I$20240630$20240708$20240722$20240722$EXP$$CN-OCTA-ALB11124$OCTAPHARMA$$$$A$M$Y$70$KG$20240722$$HP$CN$CN
241171361$24117136$1$I$$20240610$20240722$20240722$EXP$$CZ-ROCHE-3580420$ROCHE$Bartlova A,  Pyoderma gangrenosum in a pregnant patient-description of the case. Lecba ran. 2024-Feb;11 (2):6-11.$35$YR$A$F$Y$$$20240722$$MD$CZ$CZ
241171371$24117137$1$I$$20240716$20240722$20240722$EXP$$ES-SANDOZ INC.-SDZ2024ES066067$SANDOZ$$35$YR$$F$Y$$$20240722$$MD$ES$ES
241171381$24117138$1$I$20230822$20230828$20240722$20240722$EXP$$US-OCTA-GAM20323$OCTAPHARMA$$30$YR$A$F$Y$62$KG$20231025$$PH$US$US
241171403$24117140$3$F$$20240723$20240722$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA066486$SANDOZ$$$$$$Y$$$20240730$$HP$CA$CA
241171411$24117141$1$I$20230804$20230828$20240722$20240722$EXP$$US-OCTA-GAM20423$OCTAPHARMA$$26$YR$A$M$Y$123$KG$20231031$$PH$US$US
241171421$24117142$1$I$20230821$20230901$20240722$20240722$EXP$$US-OCTA-GAM21323$OCTAPHARMA$$64$YR$A$M$Y$84$KG$20231108$$PH$US$US
241171431$24117143$1$I$20211026$20240711$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-035102$AUROBINDO$$75$YR$$M$Y$92$KG$20240722$$PH$GB$GB
241171441$24117144$1$I$$20230731$20240722$20240722$EXP$$US-OCTA-NGAM02023$OCTAPHARMA$$$$$$Y$$$20230927$$MD$US$US
241171461$24117146$1$I$20240601$20240716$20240722$20240722$EXP$$US-ABBVIE-5844398$ABBVIE$$71$YR$$M$Y$$$20240722$$CN$US$US
241171471$24117147$1$I$$20210406$20240722$20240722$EXP$$US-AstraZeneca-2021A288529$ASTRAZENECA$$$$$F$Y$$$20240722$$HP$US$
241171482$24117148$2$F$20240701$20240911$20240722$20240920$30DAY$$US-GSK-US2024089566$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240920$$MD$US$US
241171491$24117149$1$I$20220606$20240717$20240722$20240722$EXP$$US-SANDOZ INC.-NVSC2022US136920$SANDOZ$$63$YR$$F$Y$53.968$KG$20240722$$CN$US$US
241171501$24117150$1$I$$20240715$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113818$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$PH$US$US
241171511$24117151$1$I$$20240717$20240722$20240722$EXP$$US-TAKEDA-2024TUS072684$TAKEDA$$$$$M$Y$$$20240722$$CN$US$US
241171521$24117152$1$I$$20190807$20240722$20240722$EXP$$US-AstraZeneca-2019SE85985$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241171531$24117153$1$I$20240328$20240716$20240722$20240722$EXP$$AU-TAKEDA-2024TUS031402$TAKEDA$$28$YR$$M$Y$$$20240722$$CN$AU$AU
241171541$24117154$1$I$$20240708$20240722$20240722$EXP$$US-UCBSA-2024034840$UCB$$12$YR$$F$Y$$$20240722$$CN$US$US
241171551$24117155$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114289$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240722$$CN$US$US
241171561$24117156$1$I$$20240701$20240722$20240722$PER$$AU-TOLMAR, INC.-24AU050678$TOLMAR$$$$$M$Y$$$20240722$$HP$AU$AU
241171571$24117157$1$I$$20240701$20240722$20240722$PER$$AU-TOLMAR, INC.-24AU050674$TOLMAR$$$$$M$Y$$$20240722$$CN$AU$AU
241171581$24117158$1$I$$20210428$20240722$20240722$EXP$$US-AstraZeneca-2021A373468$ASTRAZENECA$$$$$F$Y$58.5$KG$20240722$$CN$US$
241171591$24117159$1$I$20240119$20240701$20240722$20240722$PER$$BR-TOLMAR, INC.-24BR050731$TOLMAR$$9$YR$$F$Y$$$20240722$$CN$BR$BR
241171611$24117161$1$I$20230501$20230613$20240722$20240722$EXP$$US-AstraZeneca-2023A137691$ASTRAZENECA$$921$MON$$M$Y$$$20240722$$CN$US$
241171631$24117163$1$I$20240516$20240701$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA049811$TOLMAR$$69$YR$$M$Y$$$20240722$$HP$CA$CA
241171641$24117164$1$I$20240701$20240701$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050718$TOLMAR$$53$YR$$M$Y$$$20240722$$CN$CA$CA
241171651$24117165$1$I$20201018$20201117$20240722$20240722$EXP$$US-AstraZeneca-2020SF44179$ASTRAZENECA$$30821$DY$$F$Y$$$20240722$$CN$US$
241171661$24117166$1$I$20240611$20240701$20240722$20240722$PER$$DO-TOLMAR, INC.-24DO050401$TOLMAR$$68$YR$$M$Y$$$20240722$$CN$DO$DO
241171672$24117167$2$F$20240627$20240724$20240722$20240821$PER$$FR-TOLMAR, INC.-24FR050688$TOLMAR$$81$YR$$M$Y$$$20240821$$PH$FR$FR
241171681$24117168$1$I$20240701$20240701$20240722$20240722$PER$$FR-TOLMAR, INC.-24FR050693$TOLMAR$$82$YR$$M$Y$$$20240722$$HP$FR$FR
241171692$24117169$2$F$$20240716$20240722$20240722$EXP$$US-ABBVIE-5842819$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241171701$24117170$1$I$$20210209$20240722$20240722$EXP$$US-AstraZeneca-2021A057704$ASTRAZENECA$$$$$$Y$$$20240722$$CN$US$
241171711$24117171$1$I$$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142995$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241171721$24117172$1$I$20240713$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142903$AMGEN$$63$YR$A$F$Y$$$20240722$$CN$US$US
241171731$24117173$1$I$$20240717$20240722$20240722$EXP$$US-TAKEDA-2024TUS072652$TAKEDA$$$$$F$Y$$$20240722$$CN$US$US
241171741$24117174$1$I$20230101$20240711$20240722$20240722$EXP$$US-INTERCEPT-PM2023001533$INTERCEPT PHARMACEUTICALS$$$$$F$Y$62.132$KG$20240722$$CN$US$US
241171753$24117175$3$F$20231210$20240829$20240722$20240906$EXP$$US-INTERCEPT-PM2024001278$INTERCEPT PHARMACEUTICALS$$45$YR$$F$Y$92.063$KG$20240906$$CN$US$US
241171761$24117176$1$I$$20240710$20240722$20240722$PER$$US-TEVA-VS-3220776$TEVA$$$$E$M$Y$$$20240722$$HP$US$US
241171772$24117177$2$F$$20240725$20240722$20240729$EXP$$JP-TAKEDA-2024TJP010789$TAKEDA$$49$YR$$F$Y$$$20240729$$MD$JP$JP
241171781$24117178$1$I$20231013$20231130$20240722$20240722$EXP$FR-AFSSAPS-RN2023001193$FR-TEVA-VS-3146965$TEVA$$69$YR$$M$Y$85$KG$20240722$$MD$FR$FR
241171791$24117179$1$I$$20240710$20240722$20240722$EXP$$US-PADAGIS-2024PAD01165$PADAGIS$Ghalayni R, Al Kalaji B, Malik K. From Friend to Foe: A Case of Naloxone-Induced Pulmonary Edema. Hospital Pharmacy. 2024;59(4):407-410$$$$$Y$$$20240722$$HP$US$US
241171801$24117180$1$I$$20240711$20240722$20240722$EXP$$US-PADAGIS-2024PAD01172$PADAGIS$Obeng-Nyarko C.N., Puerta Durango K., Jackson S., Rodriguez O., Mollanazar N.K.. Dupilumab for the treatment of pityriasis lichenoides chronica. JAAD Case Reports. 2024;50:9-11$$$$$Y$$$20240722$$HP$US$US
241171811$24117181$1$I$20240701$20240715$20240722$20240722$EXP$$US-AMGEN-USASL2024140317$AMGEN$$71$YR$E$M$Y$$$20240722$$CN$US$US
241171821$24117182$1$I$20240423$20240711$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035465$AUROBINDO$$79$YR$$M$Y$69.9$KG$20240722$$MD$FR$FR
241171831$24117183$1$I$$20240711$20240722$20240722$EXP$$US-PADAGIS-2024PAD01175$PADAGIS$Ghalayni R., Al Kalaji B., Malik K.. Scrambler Therapy for the Treatment of Pain and Sensory Symptoms in Corticobasal Syndrome: A Case Series. Pain Medicine Case Reports. 2023;7(3):151-155$$$$$Y$$$20240722$$MD$US$US
241171843$24117184$3$F$20240708$20240807$20240722$20240820$PER$$US-APOTEX-2024AP008180$APOTEX$$$$$F$Y$$$20240820$$CN$US$US
241171851$24117185$1$I$$20240717$20240722$20240722$EXP$$JP-TAKEDA-2024TJP010829$TAKEDA$$5$DEC$$F$Y$$$20240722$$MD$JP$JP
241171861$24117186$1$I$20240417$20240715$20240722$20240722$PER$FR-AFSSAPS-ST2024001173$FR-Eisai-EC-2024-170148$EISAI$$82$YR$E$F$Y$57.5$KG$20240719$$HP$FR$FR
241171872$24117187$2$F$20240216$20240917$20240722$20240925$EXP$$NVSC2024US038405$NOVARTIS$$50$YR$$F$Y$$$20240925$$CN$US$US
241171881$24117188$1$I$$20240708$20240722$20240722$EXP$$GB-IBIGEN-2024-015551$ISTITUTO BICHIMICO ITALIANO GIOVANNI LORENZINI (IBIGEN)$$7$YR$$M$Y$24$KG$20240710$$PH$GB$GB
241171891$24117189$1$I$20240701$20240712$20240722$20240722$EXP$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000312$Tarsus Pharmaceuticals$$$$$$Y$$$20240722$$MD$US$US
241171901$24117190$1$I$20240101$20240717$20240722$20240722$PER$$US-ABBVIE-5845934$ABBVIE$$51$YR$$M$Y$158$KG$20240722$$MD$US$US
241171911$24117191$1$I$$20240710$20240722$20240722$EXP$$CA-APOTEX-2024AP008229$APOTEX$$84$YR$$F$Y$63.492$KG$20240722$$MD$CA$CA
241171922$24117192$2$F$20240104$20240808$20240722$20240816$EXP$$CA-CELLTRION INC.-2024CA000933$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
241171932$24117193$2$F$20240701$20240723$20240722$20240802$EXP$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000311$Tarsus Pharmaceuticals$$67$YR$$M$Y$$$20240802$$PH$US$US
241171941$24117194$1$I$20240522$20240708$20240722$20240722$EXP$$DE-ROCHE-10000021611$ROCHE$$84$YR$E$M$Y$55$KG$20240722$$MD$DE$DE
241171951$24117195$1$I$20240704$20240710$20240722$20240722$EXP$$CN-ROCHE-10000022928$ROCHE$$59$YR$A$F$Y$$$20240722$$HP$CN$CN
241171961$24117196$1$I$$20240709$20240722$20240722$EXP$$US-KOANAAP-SML-US-2024-00725$Unknown Manufacturer$Chan W, Park S, Shirkhoda L, Houshyar R, Connell RO. Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells. J-Med-Case-Rep. 2023;$54$YR$A$M$Y$$$20240719$$MD$US$US
241171972$24117197$2$F$$20240724$20240722$20240725$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-114780$BRISTOL MYERS SQUIBB$Darewicz M. Cabozantinib plus nivolumab as the first line treatment of metastatic renal cell carcinoma with rhabdoid differentiation-a case report.$63$YR$A$F$Y$$$20240725$$MD$PL$PL
241171992$24117199$2$F$20240101$20240802$20240722$20240806$PER$$US-AMGEN-USASP2024143028$AMGEN$$84$YR$E$M$Y$$$20240806$$CN$US$US
241172001$24117200$1$I$20240630$20240719$20240722$20240722$PER$$US-AMGEN-USASP2024143801$AMGEN$$$$$M$Y$$$20240722$$HP$US$US
241172014$24117201$4$F$20240101$20240808$20240722$20240920$EXP$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000307$Tarsus Pharmaceuticals$$74$YR$$F$Y$$$20240920$$CN$US$US
241172021$24117202$1$I$20240619$20240716$20240722$20240722$EXP$FR-AFSSAPS-GR2024000871$FR-ORGANON-O2407FRA001738$ORGANON$$60$YR$$F$Y$71$KG$20240722$$PH$FR$FR
241172032$24117203$2$F$20230701$20240909$20240722$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-011251$JAZZ$$56$YR$$F$Y$$$20240913$$CN$US$US
241172041$24117204$1$I$$20240708$20240722$20240722$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-21497$SAMSUNG BIOEPIS$$41$YR$A$F$Y$$$20240722$$CN$CA$CA
241172051$24117205$1$I$$20191010$20240722$20240722$EXP$$US-AstraZeneca-2019SF45239$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241172061$24117206$1$I$20230321$20230314$20240722$20240722$EXP$$CA-AstraZeneca-2023A063888$ASTRAZENECA$$27060$DY$$M$Y$$$20240722$$CN$CA$
241172071$24117207$1$I$$20230321$20240722$20240722$EXP$$US-AstraZeneca-2023A067875$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241172081$24117208$1$I$20210205$20210205$20240722$20240722$EXP$$RU-AstraZeneca-2021A035098$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$RU$
241172091$24117209$1$I$$20230503$20240722$20240722$EXP$$US-AstraZeneca-2023A103917$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241172101$24117210$1$I$$20240718$20240722$20240722$EXP$$AR-GSK-AR2024AMR090906$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$MD$AR$AR
241172111$24117211$1$I$20240709$20240715$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024088709$VIIV$$46$YR$$M$Y$$$20240722$$CN$US$US
241172121$24117212$1$I$$20240712$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR088924$VIIV$$$$$M$Y$91$KG$20240722$$CN$US$US
241172131$24117213$1$I$$20240718$20240722$20240722$EXP$$US-BAUSCHBL-2024BNL030351$BAUSCH AND LOMB$$89$YR$$F$Y$$$20240722$$CN$US$US
241172141$24117214$1$I$$20240718$20240722$20240722$PER$$US-GILEAD-2024-0681227$GILEAD$$$$$$Y$$$20240722$$HP$US$US
241172151$24117215$1$I$20190101$20240716$20240722$20240722$EXP$$DE-EMD Serono-2024039397$EMD SERONO INC$$57$YR$A$F$Y$$$20240722$$CN$DE$DE
241172161$24117216$1$I$$20240711$20240722$20240722$EXP$$US-GSK-US2024AMR090208$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$HP$US$US
241172172$24117217$2$F$$20240718$20240722$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114552$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240723$$CN$US$US
241172182$24117218$2$F$$20240720$20240722$20240731$EXP$$BE-AUROBINDO-AUR-APL-2024-034652$AUROBINDO$Saad M, Flament J.. Paracetamol overdose causing acute kidney injury without hepatotoxicity: a case report.. International journal of emergency medicine.. 2024;17(1):81$15$YR$$F$Y$57$KG$20240731$$MD$BE$BE
241172191$24117219$1$I$$20240710$20240722$20240722$EXP$$US-RDY-LIT/USA/24/0010465$DR REDDYS$Gravenmier C, Shahb B, Hussaini M, Zhang L. Chimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment. Leukemia and Lymphoma. 2024;65(5): 674-678. doi:10.1080/10428194.2023.2301038.$58$YR$A$M$Y$$$20240719$$HP$US$US
241172201$24117220$1$I$20240718$20240718$20240722$20240722$EXP$$GB-SANDOZ INC.-SDZ2024GB066525$SANDOZ$$50$YR$$F$Y$68$KG$20240722$$HP$GB$GB
241172211$24117221$1$I$20240711$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141534$AMGEN$$74$YR$E$F$Y$$$20240722$$CN$US$US
241172221$24117222$1$I$$20240715$20240722$20240722$PER$$US-AMGEN-USASP2024141566$AMGEN$$$$$$Y$$$20240722$$PH$US$US
241172232$24117223$2$F$$20240801$20240722$20240806$EXP$$CN-AMGEN-CHNSP2024144426$AMGEN$Wenyu Y.; Xiaolan L.; Beibei Z. et. al.. The safety and efficacy of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia in children. Natl Med J China. 2024;104 (27):2563-2567$$$$$Y$$$20240806$$HP$CN$CN
241172241$24117224$1$I$20240426$20240711$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035453$AUROBINDO$$51$YR$$F$Y$83$KG$20240722$$HP$FR$FR
241172251$24117225$1$I$$20240711$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-035062$AUROBINDO$$$$$F$Y$$$20240722$$MD$GB$GB
241172261$24117226$1$I$$20240717$20240722$20240722$EXP$CA-DRL-USA-SPO/CAN/24/0010542$CA-RDY-SPO/CAN/24/0010542$DR REDDYS$$81$YR$$F$Y$86$KG$20240722$$HP$CA$CA
241172271$24117227$1$I$20210306$20240709$20240722$20240722$EXP$$CO-UCBSA-2024035299$UCB$$84$YR$$F$Y$$$20240722$$CN$CO$CO
241172281$24117228$1$I$20210524$20211005$20240722$20240722$EXP$$CO-AstraZeneca-2021A765375$ASTRAZENECA$$25863$DY$$M$Y$65$KG$20240722$$CN$CO$
241172291$24117229$1$I$20240713$20240715$20240722$20240722$EXP$$CA-TAKEDA-2024TUS064691$TAKEDA$$72$YR$$M$Y$$$20240722$$CN$CA$CA
241172301$24117230$1$I$20230404$20240712$20240722$20240722$EXP$$CA-TAKEDA-2024TUS071845$TAKEDA$$50$YR$$M$Y$$$20240722$$MD$CA$CA
241172311$24117231$1$I$$20220819$20240722$20240722$EXP$$GB-AstraZeneca-2022A255817$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$GB$
241172321$24117232$1$I$$20211201$20240722$20240722$EXP$$US-AstraZeneca-2021A853460$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241172331$24117233$1$I$$20240717$20240722$20240722$EXP$$ZA-AstraZeneca-2024A163496$ASTRAZENECA$$92$YR$$F$Y$$$20240722$$CN$ZA$
241172341$24117234$1$I$$20230623$20240722$20240722$EXP$$US-AstraZeneca-2023A108582$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241172351$24117235$1$I$20230607$20230614$20240722$20240722$EXP$$IE-AstraZeneca-2023A116015$ASTRAZENECA$$25350$DY$$F$Y$$$20240722$$HP$IE$
241172361$24117236$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115405$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240722$$CN$US$US
241172371$24117237$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115421$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240722$$HP$US$US
241172381$24117238$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114632$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$69.3$KG$20240722$$HP$US$US
241172391$24117239$1$I$20240716$20240717$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-114995$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$MD$JP$JP
241172401$24117240$1$I$$20240712$20240722$20240722$EXP$$US-GSK-US2024AMR090203$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$HP$US$US
241172411$24117241$1$I$$20240716$20240722$20240722$EXP$$DE-ORGANON-O2407DEU001426$ORGANON$$$$$F$Y$$$20240722$$MD$DE$DE
241172421$24117242$1$I$20240712$20240715$20240722$20240722$EXP$$FR-EMD Serono-2024038520$EMD SERONO INC$$3$YR$C$M$Y$12$KG$20240722$$CN$FR$FR
241172431$24117243$1$I$20240101$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143700$AMGEN$$73$YR$E$M$Y$$$20240722$$CN$US$US
241172441$24117244$1$I$20240423$20240716$20240722$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006587$JAZZ$$50$YR$$F$Y$$$20240722$$CN$US$US
241172452$24117245$2$F$$20240920$20240722$20240925$EXP$$NVSC2024US147919$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
241172461$24117246$1$I$20240101$20240719$20240722$20240722$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040926$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240722$$HP$US$US
241172471$24117247$1$I$20240719$20240719$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040893$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240722$$CN$US$US
241172482$24117248$2$F$20240401$20240719$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040997$BOEHRINGER INGELHEIM$$50$YR$A$F$Y$$$20240722$$CN$US$US
241172491$24117249$1$I$20240719$20240719$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040901$BOEHRINGER INGELHEIM$$85$YR$E$F$Y$$$20240722$$CN$US$US
241172501$24117250$1$I$20240616$20240718$20240722$20240722$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040934$BOEHRINGER INGELHEIM$$92$YR$E$F$Y$$$20240722$$HP$CO$CO
241172511$24117251$1$I$20240101$20240719$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040941$BOEHRINGER INGELHEIM$$$$$$Y$$$20240722$$HP$US$US
241172521$24117252$1$I$20240719$20240719$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040978$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240722$$CN$US$US
241172531$24117253$1$I$$20240719$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040993$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240722$$CN$US$US
241172542$24117254$2$F$20240101$20240806$20240722$20240806$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040979$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240806$$CN$US$US
241172551$24117255$1$I$$20240719$20240722$20240722$EXP$NL-LRB-00986074$NL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040848$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$62$KG$20240722$$CN$NL$NL
241172561$24117256$1$I$$20240719$20240722$20240722$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040913$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240722$$CN$US$US
241172571$24117257$1$I$20240718$20240719$20240722$20240722$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040918$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240722$$CN$US$US
241172582$24117258$2$F$20240701$20240802$20240722$20240806$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040717$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240806$$MD$JP$JP
241172592$24117259$2$F$20240626$20240813$20240722$20240826$EXP$$GB-AUROBINDO-AUR-APL-2024-034841$AUROBINDO$$88$YR$$M$Y$66$KG$20240826$$MD$GB$GB
241172601$24117260$1$I$20240101$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114891$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240722$$HP$US$US
241172611$24117261$1$I$20230502$20240714$20240722$20240722$EXP$$JP-ROCHE-10000030514$ROCHE$$82$YR$E$$Y$$$20240722$$MD$JP$JP
241172621$24117262$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087738$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
241172632$24117263$2$F$$20240711$20240722$20240820$PER$$US-FDC-2024USSPO00464$FDC LIMITED$$$$$F$Y$$$20240820$$CN$US$US
241172641$24117264$1$I$$20240717$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040740$BOEHRINGER INGELHEIM$$$$$$Y$$$20240722$$MD$US$US
241172651$24117265$1$I$$20240708$20240722$20240722$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06672$HIKMA$$$$$F$Y$$$20240722$$HP$US$US
241172663$24117266$3$F$20240101$20240718$20240722$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040748$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240719$$CN$US$US
241172671$24117267$1$I$20240701$20240719$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041021$BOEHRINGER INGELHEIM$$$$$$Y$$$20240722$$PH$US$US
241172681$24117268$1$I$20240701$20240717$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040763$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$$$20240722$$CN$US$US
241172691$24117269$1$I$$20240719$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040984$BOEHRINGER INGELHEIM$$$$$$Y$$$20240722$$CN$US$US
241172701$24117270$1$I$$20240719$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041033$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240722$$MD$US$US
241172711$24117271$1$I$20240219$20240711$20240722$20240722$EXP$FR-AFSSAPS-AN2024000874$FR-ACS-20240250$ACS DOBFAR$$15$YR$T$M$Y$38.1$KG$20240711$$MD$FR$FR
241172721$24117272$1$I$$20240719$20240722$20240722$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040816$BOEHRINGER INGELHEIM$$$$$$Y$$$20240722$$MD$JP$JP
241172731$24117273$1$I$$20240719$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041036$BOEHRINGER INGELHEIM$$$$$$Y$$$20240722$$CN$US$US
241172741$24117274$1$I$20240717$20240719$20240722$20240722$EXP$GB-MHRA-MED-202407180848082900-WNFPB$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040834$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$$$20240722$$MD$GB$GB
241172751$24117275$1$I$$20220106$20240722$20240722$EXP$$US-AstraZeneca-2022A011185$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241172761$24117276$1$I$20220120$20220122$20240722$20240722$EXP$$SG-AstraZeneca-2022A041722$ASTRAZENECA$$25674$DY$$M$Y$$$20240722$$CN$SG$
241172771$24117277$1$I$$20230830$20240722$20240722$EXP$$US-AstraZeneca-2023A199008$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241172781$24117278$1$I$$20200617$20240722$20240722$EXP$$US-AstraZeneca-2020SE79382$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241172791$24117279$1$I$20240701$20240711$20240722$20240722$EXP$$CA-APOTEX-2024AP008345$APOTEX$$78$YR$E$F$Y$$$20240722$$CN$CA$CA
241172801$24117280$1$I$$20201009$20240722$20240722$EXP$$US-AstraZeneca-2020SF32392$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241172811$24117281$1$I$20240328$20240715$20240722$20240722$EXP$DK-DKMA-30734524$DK-CHEPLA-2024008947$CHEPLAPHARM$$52$YR$$F$Y$104$KG$20240722$$MD$COUNTRY NOT SPECIFIED$DK
241172824$24117282$4$F$20240711$20240808$20240722$20240927$EXP$$US-UCBSA-2024036516$UCB$$44$YR$$M$Y$$$20240927$$CN$US$US
241172832$24117283$2$F$$20240716$20240722$20240722$EXP$US-MLMSERVICE-20240613-PI099841-00232-1$US-ROCHE-10000016289$ROCHE$Rozenbaum Lerner G, Villamizar J, Pelaez A, Salgado J. Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis. American Journal of Respiratory and Critical Care Medicine. 2024;A3531:209. doi:10.1164/ajrccm-conference.2024.$68$YR$E$M$Y$84$KG$20240722$$MD$US$US
241172841$24117284$1$I$20240718$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143760$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241172851$24117285$1$I$$20240716$20240722$20240722$EXP$$US-AMGEN-USASP2024142504$AMGEN$$69$YR$E$F$Y$$$20240722$$MD$US$US
241172861$24117286$1$I$$20240711$20240722$20240722$EXP$$GB-862174955-ML2024-03994$Unknown Manufacturer$$$$$M$Y$$$20240722$$CN$GB$GB
241172871$24117287$1$I$$20240717$20240722$20240722$EXP$$US-UCBSA-2024036321$UCB$$$$$M$Y$$$20240722$$CN$US$US
241172891$24117289$1$I$$20240711$20240722$20240722$PER$$US-ROCHE-10000023545$ROCHE$Abers M, Vo P, Allg?uer M, Manion M, Butman J, Bishop R, et al. A multidisciplinary approach to mucormycosis. Journal of Infection. 2024;89 (2):1-2. doi:10.1016/j.jinf.2024.106214.$8$YR$C$F$Y$$$20240722$$HP$US$US
241172901$24117290$1$I$20240101$20240712$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112684$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240722$$CN$US$US
241172911$24117291$1$I$$20240716$20240722$20240722$EXP$$GR-BIOCON BIOLOGICS LIMITED-BBL2023002132$BIOCON$$$$$$Y$$$20240722$$MD$GR$GR
241172921$24117292$1$I$$20240712$20240722$20240722$EXP$$CA-CELLTRION INC.-2024CA017063$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
241172931$24117293$1$I$20240717$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024143003$AMGEN$$63$YR$A$M$Y$$$20240722$$CN$US$US
241172941$24117294$1$I$$20240712$20240722$20240722$EXP$$CA-CELLTRION INC.-2024CA017090$CELLTRION$$$$$$Y$$$20240722$$CN$CA$CA
241172961$24117296$1$I$$20240710$20240722$20240722$EXP$$IT-Oxford Pharmaceuticals, LLC-2159413$OXFORD PHARMACEUTICALS$Source document$72$YR$$M$Y$$$20240722$$$IT$IT
241172991$24117299$1$I$20240601$20240718$20240722$20240722$EXP$NL-LRB-00985806$NL-GSK-NL2024090860$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$PH$NL$NL
241173003$24117300$3$F$20240715$20240807$20240722$20240808$PER$$US-ALXN-202407USA001164US$ALEXION PHARMACEUTICALS$$65$YR$$F$Y$$$20240808$$CN$US$US
241173011$24117301$1$I$$20240718$20240722$20240722$PER$$NVSC2024US149064$NOVARTIS$$$$$M$Y$$$20240722$$MD$US$US
241173022$24117302$2$F$$20240719$20240722$20240801$PER$$US-FARMAPROD-202407-2525$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240801$$MD$US$US
241173031$24117303$1$I$$20240712$20240722$20240722$EXP$IT-MINISAL02-994828$IT-RDY-SPO/ITA/24/0010369$DR REDDYS$$72$YR$E$F$Y$$$20240719$$MD$IT$IT
241173041$24117304$1$I$$20240718$20240722$20240722$PER$$US-ROCHE-10000031387$ROCHE$$30$YR$A$F$Y$$$20240722$$HP$US$US
241173051$24117305$1$I$$20240709$20240722$20240722$EXP$$US-RDY-LIT/USA/24/0010455$DR REDDYS$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clinical Toxicology. 2024;62(5): 296-302. doi:10.1080/15563650.2024.2347514.$21$YR$A$F$Y$$$20240719$$HP$US$US
241173061$24117306$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141918$AMGEN$$$$$M$Y$$$20240722$$CN$US$US
241173073$24117307$3$F$20240101$20240909$20240722$20240919$EXP$$US-INSMED, INC.-2024-02457-US$INSMED$$$$$F$Y$$$20240919$$CN$US$US
241173081$24117308$1$I$$20220606$20240722$20240722$EXP$$US-AstraZeneca-2022A211567$ASTRAZENECA$$$$$M$Y$76.6$KG$20240722$$CN$US$
241173091$24117309$1$I$$20220610$20240722$20240722$EXP$$US-AstraZeneca-2022A219531$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241173101$24117310$1$I$$20210423$20240722$20240722$EXP$$US-AstraZeneca-2021A359934$ASTRAZENECA$$$$$M$Y$$$20240722$$HP$US$
241173111$24117311$1$I$20240101$20240712$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111913$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240722$$PH$US$US
241173121$24117312$1$I$$20240718$20240722$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114777$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$41$KG$20240722$$PH$CA$CA
241173131$24117313$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114709$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$77.56$KG$20240722$$CN$US$US
241173141$24117314$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115325$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$78.02$KG$20240722$$CN$US$US
241173151$24117315$1$I$$20240709$20240722$20240722$PER$$US-RDY-LIT/USA/24/0010375$DR REDDYS$Music S, Suvar T, Tan M, Amin S. Severe Bilateral Glossopharyngeal Neuralgia Managed With Nerve Blocks Following Plasmodium falciparum Malaria Infection Treated With Mefloquine. Pain Medicine Case Reports. 2024 Apr;8(3): 119-126.$38$YR$A$F$Y$$$20240719$$MD$US$US
241173161$24117316$1$I$$20240709$20240722$20240722$PER$$US-RDY-SPO/USA/24/0010224$DR REDDYS$$$$$F$Y$$$20240719$$CN$US$US
241173172$24117317$2$F$$20240822$20240722$20240829$EXP$$US-TEVA-VS-3220066$TEVA$Koga S, Pai E, Banihashemi A. Diffuse lymphocytic encephalomyelitis with stiffperson- like syndrome in multiple myeloma after Teclistamab treatment. J-Neuropathol-Exp-Neurol 2024; 83 (6): 457-458 abstr. 5.; Koga S, Pai E, Banihashemi A. Diffuse lymphocytic encephalomyelitis with stiffperson- like syndrome in multiple myeloma after Teclistamab treatment. J-Neuropathol-Exp-Neurol 2024; 83 (6): 457-458 abstr. 5.$45$YR$$M$Y$$$20240829$$HP$US$US
241173181$24117318$1$I$$20240719$20240722$20240722$PER$$NVSC2024US149556$NOVARTIS$$$$$$Y$$$20240722$$MD$US$US
241173191$24117319$1$I$$20240709$20240722$20240722$PER$$US-RDY-SPO/USA/24/0010330$DR REDDYS$$$$$F$Y$$$20240719$$PH$US$US
241173201$24117320$1$I$$20240715$20240722$20240722$EXP$$TW-AMGEN-TWNSP2024143652$AMGEN$$72$YR$E$M$Y$$$20240722$$HP$TW$TW
241173211$24117321$1$I$$20240709$20240722$20240722$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06664$HIKMA$$$$$F$Y$$$20240722$$CN$US$US
241173221$24117322$1$I$$20240717$20240722$20240722$EXP$$CA-UCBSA-2024036494$UCB$$$$$F$Y$$$20240722$$CN$CA$CA
241173231$24117323$1$I$$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143230$AMGEN$$$$$$Y$$$20240722$$PH$US$US
241173242$24117324$2$F$20240718$20240718$20240722$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040724$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240719$$CN$US$US
241173252$24117325$2$F$$20240806$20240722$20240812$EXP$DE-INDIVIOR EUROPE LIMITED-INDV-145808-2024$DE-RDY-SPO/DEU/24/0010381$DR REDDYS$$36$YR$A$F$Y$$$20240812$$MD$DE$DE
241173262$24117326$2$F$20240101$20240718$20240722$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040729$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240719$$CN$US$US
241173271$24117327$1$I$20240627$20240712$20240722$20240722$EXP$GB-MHRA-EMIS-659-7d8a1354-519f-4ff9-8b5e-0c23ea2cebb8$GB-RDY-SPO/GBR/24/0010390$DR REDDYS$$76$YR$E$M$Y$113$KG$20240719$$PH$GB$GB
241173282$24117328$2$F$20240329$20240814$20240722$20240821$PER$$US-RDY-SPO/USA/24/0010332$DR REDDYS$$36$YR$A$F$Y$81$KG$20240821$$MD$US$US
241173291$24117329$1$I$20230101$20240716$20240722$20240722$EXP$$MX-EMD Serono-2024039135$EMD SERONO INC$$10$YR$C$F$Y$$$20240722$$CN$MX$MX
241173301$24117330$1$I$20240708$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407122111069800-QDVHY$GB-TEVA-VS-3221175$TEVA$$28$YR$$M$Y$$$20240722$$CN$GB$GB
241173311$24117331$1$I$$20240713$20240722$20240722$EXP$GB-MHRA-MED-202407131625572030-BPNRG$GB-RDY-SPO/GBR/24/0010423$DR REDDYS$$$$$$Y$$$20240719$$CN$GB$GB
241173321$24117332$1$I$$20240710$20240722$20240722$PER$$US-RDY-SPO/USA/24/0010312$DR REDDYS$$13$YR$T$F$Y$$$20240722$$MD$US$US
241173331$24117333$1$I$$20240715$20240722$20240722$PER$$US-ALXN-202407USA000967US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
241173341$24117334$1$I$$20240709$20240722$20240722$PER$US-MLMSERVICE-20240702-PI119585-00102-1$US-RDY-SPO/USA/24/0010246$DR REDDYS$Jean FJ, Poulose M, An Unexpected Phenomenon: A Case of Citalopram-Induced Dyskinesia. Cureus. 2024;16(5):e61364. DOI: 10.7759/cureus.61364. DOI: 10.7759/cureus.61364$47$YR$A$M$Y$$$20240719$$MD$US$US
241173351$24117335$1$I$$20240708$20240722$20240722$PER$$US-RDY-SPO/USA/23/0187111$DR REDDYS$$22$YR$A$M$Y$$$20240719$$MD$US$US
241173361$24117336$1$I$20240717$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115143$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$95.25$KG$20240722$$CN$US$US
241173371$24117337$1$I$$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114578$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240722$$CN$US$US
241173381$24117338$1$I$$20240710$20240722$20240722$EXP$$US-RDY-LIT/USA/24/0010471$DR REDDYS$Fitzsimons J, Phelan K, Dhanarajan A. Hearing Loss in a Patient with Waldenstrom Macroglobulinemia Receiving Bortezomib. Case Reports in Oncology. 2024 Jun 18;17(1): 653-657. doi:10.1159/000539453.$67$YR$E$M$Y$$$20240719$$MD$US$US
241173391$24117339$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115226$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$90.26$KG$20240722$$CN$US$US
241173401$24117340$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089818$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241173412$24117341$2$F$20240101$20240923$20240722$20240926$EXP$$US-ABBVIE-5846210$ABBVIE$$$$$F$Y$63$KG$20240926$$CN$US$US
241173421$24117342$1$I$$20240711$20240722$20240722$EXP$$US-BEH-2024175634$CSL BEHRING$$$$E$M$Y$$$20240722$$HP$US$US
241173441$24117344$1$I$20240717$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142913$AMGEN$$$$$M$Y$$$20240722$$HP$US$US
241173451$24117345$1$I$20240716$20240718$20240722$20240722$EXP$GB-MHRA-MED-202407181214568440-TJQDG$GB-ORGANON-O2407GBR001872$ORGANON$$54$YR$$M$Y$82$KG$20240722$$CN$GB$GB
241173461$24117346$1$I$20240717$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024143468$AMGEN$$$$$F$Y$$$20240722$$HP$US$US
241173471$24117347$1$I$20220101$20240709$20240722$20240722$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-06665$HIKMA$Meller L, Jagadeesh V, Oca M, Wilson K, Zuraski C, Koretz ZA, et al. Meller L, Jagadeesh V, Oca M, Wilson K, Zuraski C, Koretz ZA, et al. Cytomegalovirus Retinitis in an Eye with Unilateral Retinoblastoma: A Case Report.. Case Reports in Ophthalmology. 2024;15(1):/$2$YR$$M$Y$$$20240722$$MD$US$US
241173482$24117348$2$F$$20240710$20240722$20240722$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003672$TERSERA THERAPEUTICS$$$$$$Y$$$20240722$$CN$AU$AU
241173491$24117349$1$I$20240326$20240708$20240722$20240722$EXP$ES-AEMPS-1544036$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109704$ZYDUS PHARM$$$$$$Y$$$20240722$$MD$ES$ES
241173501$24117350$1$I$20160901$20240712$20240722$20240722$EXP$$DE-CELLTRION INC.-2024DE017334$CELLTRION$$$$$$Y$$$20240722$$MD$DE$DE
241173511$24117351$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089221$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241173522$24117352$2$F$$20240723$20240722$20240725$EXP$$PT-ABBVIE-5844463$ABBVIE$Miguelote S. PO-0109-(12)-From Sevoflurane to Status Epilepticus. 30 th Congresso Nacional de Medicina Interna. National internal medicine congress. 2024;479.; Sofia Miguelote Dra.. PO-0109 - (12) - DO SEVOFLURANO AO MAL EPILETICO. 30 Congresso Nacional de Medicina Interna - Livro de resumos, May 2024, Congressos da Sociedade Portuguesa de Medicina Interna. 2024;479.$40$YR$$F$Y$$$20240725$$MD$PT$PT
241173531$24117353$1$I$20240628$20240710$20240722$20240722$PER$$US-RDY-SPO/USA/24/0010287$DR REDDYS$$28$YR$A$F$Y$$$20240719$$CN$US$US
241173541$24117354$1$I$$20240716$20240722$20240722$PER$$US-BIOVITRUM-2024-US-009946$BIOVITRUM$$67$YR$$F$Y$$$20240722$$CN$US$US
241173551$24117355$1$I$20240623$20240712$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035749$AUROBINDO$$83$YR$$F$Y$$$20240722$$MD$FR$FR
241173563$24117356$3$F$20240707$20240727$20240722$20240809$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092280$GLENMARK$$$$$$Y$$$20240809$$CN$US$US
241173572$24117357$2$F$20240124$20240717$20240722$20240725$EXP$NL-LRB-00985369$NL-NOVOPROD-1254979$NOVO NORDISK$$67$YR$$F$Y$98.1$KG$20240725$$MD$NL$NL
241173581$24117358$1$I$20240319$20240711$20240722$20240722$EXP$$CA-NOVOPROD-1255653$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$CA$CA
241173592$24117359$2$F$$20240722$20240722$20240731$EXP$NL-LRB-00983943$NL-NOVOPROD-1254904$NOVO NORDISK$$75$YR$$M$Y$88.7$KG$20240731$$MD$NL$NL
241173602$24117360$2$F$$20240716$20240722$20240725$EXP$$CN-NOVOPROD-1255301$NOVO NORDISK$$$$$M$Y$$$20240725$$CN$CN$CN
241173612$24117361$2$F$20240101$20240813$20240722$20240823$EXP$$SE-NOVOPROD-1255313$NOVO NORDISK$$75$YR$$F$Y$78$KG$20240823$$MD$SE$SE
241173631$24117363$1$I$20240101$20240711$20240722$20240722$EXP$$US-NOVOPROD-1255649$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$US$US
241173641$24117364$1$I$$20240710$20240722$20240722$EXP$$US-NOVOPROD-1256059$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$US$US
241173651$24117365$1$I$20240526$20240711$20240722$20240722$EXP$$CN-NOVOPROD-1244695$NOVO NORDISK$$36$YR$$F$Y$$$20240722$$PH$CN$CN
241173661$24117366$1$I$20200105$20240711$20240722$20240722$EXP$$CA-NOVOPROD-1249988$NOVO NORDISK$$$$$M$Y$$$20240722$$CN$CA$CA
241173681$24117368$1$I$$20240711$20240722$20240722$EXP$$JP-NOVOPROD-1254073$NOVO NORDISK$$44$YR$$$Y$$$20240722$$MD$JP$JP
241173691$24117369$1$I$20240101$20240711$20240722$20240722$EXP$$US-NOVOPROD-1255129$NOVO NORDISK$$52$YR$$F$Y$88$KG$20240722$$CN$US$US
241173701$24117370$1$I$20220801$20240710$20240722$20240722$EXP$$US-NOVOPROD-1256670$NOVO NORDISK$$49$YR$$M$Y$$$20240722$$MD$US$US
241173711$24117371$1$I$20240531$20240711$20240722$20240722$EXP$$GB-NOVOPROD-1255385$NOVO NORDISK$$39$YR$$F$Y$$$20240722$$CN$GB$GB
241173722$24117372$2$F$20240708$20240808$20240722$20240819$EXP$$IT-NOVOPROD-1254684$NOVO NORDISK$$71$YR$$M$Y$85$KG$20240819$$CN$IT$IT
241173731$24117373$1$I$20240315$20240711$20240722$20240722$EXP$GB-MHRA-MED-202406271853550440-WLCKT$GB-NOVOPROD-1247604$NOVO NORDISK$$$$$$Y$118$KG$20240722$$CN$GB$GB
241173741$24117374$1$I$$20240711$20240722$20240722$EXP$$US-NOVOPROD-1255969$NOVO NORDISK$$$$$M$Y$$$20240722$$CN$US$US
241173751$24117375$1$I$$20240711$20240722$20240722$EXP$NL-LRB-00985060$NL-NOVOPROD-1254975$NOVO NORDISK$$66$YR$$F$Y$70$KG$20240722$$MD$NL$NL
241173761$24117376$1$I$$20240711$20240722$20240722$EXP$$BR-NOVOPROD-1255708$NOVO NORDISK$$53$YR$$F$Y$82$KG$20240722$$MD$BR$BR
241173771$24117377$1$I$$20240716$20240722$20240722$PER$$US-BIOVITRUM-2024-US-009947$BIOVITRUM$$84$YR$$M$Y$$$20240722$$CN$US$US
241173781$24117378$1$I$20240101$20240502$20240722$20240722$PER$$US-AJANTA-2024AJA00089$AJANTA PHARMA$$81$YR$E$M$Y$180$KG$20240722$$CN$US$US
241173792$24117379$2$F$20240101$20240729$20240722$20240802$EXP$$US-PUMA BIOTECHNOLOGY, INC.-2024-PUM-US000806$PUMA$$$$$$Y$$$20240802$$HP$US$US
241173801$24117380$1$I$20240711$20240712$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-034848$AUROBINDO$$33$YR$$F$Y$$$20240722$$CN$GB$GB
241173811$24117381$1$I$20240308$20240713$20240722$20240722$EXP$$CN-BEIGENE-BGN-2024-010925$BEIGENE$$$$$$Y$$$20240722$$HP$CN$CN
241173821$24117382$1$I$20240430$20240712$20240722$20240722$EXP$FR-AFSSAPS-TO2024001230$FR-RDY-SPO/FRA/24/0010363$DR REDDYS$$75$YR$E$M$Y$$$20240719$$PH$FR$FR
241173841$24117384$1$I$$20240719$20240722$20240722$PER$$NVSC2024US149352$NOVARTIS$$$$$F$Y$$$20240722$$CN$US$US
241173851$24117385$1$I$20240701$20240716$20240722$20240722$PER$$US-ABBVIE-5846346$ABBVIE$$$$A$M$Y$$$20240722$$HP$US$US
241173861$24117386$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087733$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
241173871$24117387$1$I$$20240715$20240722$20240722$EXP$$MA-Tamarang, S.A.-2159414$TAMARANG PHARMACEUTICALS$Alj L, Tebaa A, Talibi I, Moubarik S, Benazzouz M, Soulaymani Bencheikh R. Lessons?learned from a cluster of immunization errors in newborns. Ther Adv Vaccines?Immunother. 2024 Jan 2;12:25151355231221009. doi:?10.1177/25151355231221009. PMID: 38178960; PMCID: PMC10762870. Article?found during weekly scientific literature research.$$$$$Y$$$20240722$$MD$MA$MA
241173881$24117388$1$I$20240531$20240711$20240722$20240722$EXP$CN-NMPA-6531271071084202400044$CN-NOVOPROD-1255616$NOVO NORDISK$$34$YR$$M$Y$116$KG$20240722$$HP$CN$CN
241173891$24117389$1$I$20200101$20240711$20240722$20240722$EXP$$US-NOVOPROD-1255990$NOVO NORDISK$$65$YR$$M$Y$$$20240722$$CN$US$US
241173901$24117390$1$I$$20200702$20240722$20240722$EXP$$US-AstraZeneca-2020SE84551$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241173912$24117391$2$F$20200601$20240722$20240722$20240729$EXP$GB-ROCHE-2642981$GB-RDY-GER/UKI/21/0132729$DR REDDYS$$39$YR$A$F$Y$$$20240729$$MD$GB$GB
241173925$24117392$5$F$20240715$20240910$20240722$20240923$EXP$$IE-UCBSA-2024036464$UCB$$66$YR$$M$Y$$$20240923$$HP$IE$IE
241173931$24117393$1$I$20210311$20210326$20240722$20240722$EXP$$US-AstraZeneca-2021A238417$ASTRAZENECA$$28549$DY$$M$Y$$$20240722$$CN$US$
241173941$24117394$1$I$20221128$20221128$20240722$20240722$EXP$$CO-AstraZeneca-2022A394019$ASTRAZENECA$$22156$DY$$F$Y$56$KG$20240722$$CN$CO$
241173951$24117395$1$I$$20220216$20240722$20240722$EXP$$US-AstraZeneca-2022A076764$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241173971$24117397$1$I$20240601$20240708$20240722$20240722$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-21429$SAMSUNG BIOEPIS$$29$YR$A$M$Y$$$20240722$$CN$CA$CA
241173981$24117398$1$I$20240702$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142267$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241174001$24117400$1$I$20240702$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142352$AMGEN$$63$YR$A$F$Y$$$20240722$$CN$US$US
241174011$24117401$1$I$20240716$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142911$AMGEN$$79$YR$E$M$Y$$$20240722$$CN$US$US
241174021$24117402$1$I$20240716$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143670$AMGEN$$79$YR$E$F$Y$$$20240722$$CN$US$US
241174032$24117403$2$F$20240711$20240722$20240722$20240724$PER$$US-AMGEN-USASP2024144296$AMGEN$$51$YR$A$F$Y$$$20240723$$CN$US$US
241174041$24117404$1$I$$20240708$20240722$20240722$PER$$US-RDY-SPO/USA/24/0010318$DR REDDYS$$$$E$F$Y$88$KG$20240719$$CN$US$US
241174051$24117405$1$I$$20240709$20240722$20240722$EXP$GB-MHRA-MED-202407091327046950-KHLJW$GB-Accord-435442$ACCORD$$10$YR$C$M$Y$$$20240719$$CN$GB$GB
241174061$24117406$1$I$20240625$20240710$20240722$20240722$EXP$GB-MHRA-MED-202407101240514010-VNRPB$GB-Accord-435677$ACCORD$$44$YR$A$M$Y$142$KG$20240719$$MD$GB$GB
241174071$24117407$1$I$$20240709$20240722$20240722$EXP$GB-MHRA-MED-202407091039521900-GMQNV$GB-Accord-435444$ACCORD$$34$YR$A$F$Y$$$20240719$$CN$GB$GB
241174081$24117408$1$I$$20240716$20240722$20240722$EXP$PT-EMA-2024711-AUTODUP-1720653654641$PT-Accord-436492$ACCORD$$58$YR$A$F$Y$$$20240719$$MD$PT$PT
241174101$24117410$1$I$$20240709$20240722$20240722$EXP$$CH-Accord-435124$ACCORD$Cancela Costa A, Kritikos A, Glampedakis E, Da Silva Pereira Clara J, Schaller F, Mercier T, et al. Antifungal drug penetration in soft tissue abscesses: a comparative analysis. The Journal of antimicrobial chemotherapy. 2024;79(7):1668-72. DOI: 10.1093/jac/dkae162.$61$YR$A$M$Y$$$20240719$$MD$CH$CH
241174111$24117411$1$I$20220101$20240709$20240722$20240722$EXP$$US-Accord-435132$ACCORD$Meller L, Jagadeesh V, Oca M, Wilson K, Zuraski C, Koretz ZA, et al. Cytomegalovirus Retinitis in an Eye with Unilateral Retinoblastoma: A Case Report. Case Reports in Ophthalmology. 2024;15(1):476-82. DOI:10.1159/000538738.$2$YR$C$M$Y$$$20240719$$MD$US$US
241174121$24117412$1$I$20230118$20240709$20240722$20240722$EXP$GB-ORGANON-O2403GBR001326$GB-Accord-435388$ACCORD$$82$YR$E$M$Y$72$KG$20240719$$MD$GB$GB
241174131$24117413$1$I$20240125$20240709$20240722$20240722$EXP$GB-MHRA-MED-202407081950377100-MCSQK$GB-Accord-435449$ACCORD$$4$YR$C$M$Y$16$KG$20240719$$CN$GB$GB
241174141$24117414$1$I$$20240710$20240722$20240722$EXP$CA-MHPD-E2B_07099642$CA-Accord-435339$ACCORD$$27$YR$A$M$Y$$$20240719$$HP$CA$CA
241174151$24117415$1$I$$20240710$20240722$20240722$EXP$CA-MHPD-E2B_07096627$CA-Accord-435492$ACCORD$$70$YR$E$F$Y$$$20240719$$HP$CA$CA
241174164$24117416$4$F$20230322$20240813$20240722$20240821$EXP$$IT-Accord-435879$ACCORD$Gunnellini M, Tornincasa A, Montedoro M, Caprodossi A, Prosperi E, Peverini M, et al. Neoadjuvant Treatment for a cT4cN+ HER2+ Breast Cancer: Case Report of a Therapeutic Success. Anticancer Research. 2024;44(6):2755-8.$35$YR$A$F$Y$81$KG$20240821$$MD$IT$IT
241174171$24117417$1$I$20231113$20240709$20240722$20240722$EXP$GB-MHRA-MED-202405091424109540-SRJVM$GB-Accord-435450$ACCORD$$62$YR$A$M$Y$$$20240719$$HP$GB$GB
241174181$24117418$1$I$$20240709$20240722$20240722$EXP$GB-MHRA-MED-202407081626102540-JWCDR$GB-Accord-435395$ACCORD$$$$$$Y$$$20240719$$HP$GB$GB
241174191$24117419$1$I$20240522$20240710$20240722$20240722$EXP$FR-AFSSAPS-TO2024001158$FR-Accord-435789$ACCORD$$64$YR$A$M$Y$88$KG$20240719$$PH$FR$FR
241174201$24117420$1$I$20220325$20240710$20240722$20240722$EXP$PL-URPL-DML-MLP.4401.1.759.2022$PL-Accord-435780$ACCORD$$70$YR$E$F$Y$40.5$KG$20240719$$MD$PL$PL
241174211$24117421$1$I$$20240710$20240722$20240722$EXP$CA-MHPD-E2B_07087264$CA-Accord-435555$ACCORD$$34$YR$A$F$Y$$$20240719$$HP$CA$CA
241174223$24117422$3$F$20240701$20240820$20240722$20240831$EXP$$US-Accord-435755$ACCORD$$57$YR$A$M$Y$$$20240831$$PH$US$US
241174231$24117423$1$I$$20240710$20240722$20240722$EXP$CA-MHPD-E2B_07091345$CA-Accord-435546$ACCORD$$78$YR$E$M$Y$$$20240719$$MD$CA$CA
241174241$24117424$1$I$20240622$20240708$20240722$20240722$EXP$$US-Accord-435222$ACCORD$$44$YR$A$F$Y$$$20240719$$HP$US$US
241174251$24117425$1$I$$20240710$20240722$20240722$EXP$CA-MHPD-E2B_07094462$CA-Accord-435341$ACCORD$$34$YR$A$F$Y$84$KG$20240719$$HP$CA$CA
241174262$24117426$2$F$20220131$20240717$20240722$20240722$EXP$FR-EMA-2024710-AUTODUP-1720648373714$FR-Accord-436724$ACCORD$$57$YR$A$F$Y$$$20240722$$PH$FR$FR
241174271$24117427$1$I$$20240716$20240722$20240722$EXP$HU-EMA-2024711-AUTODUP-1720653775022$HU-Accord-436482$ACCORD$$35$YR$A$F$Y$$$20240719$$MD$HU$HU
241174281$24117428$1$I$20240613$20240708$20240722$20240722$EXP$$US-Accord-435860$ACCORD$$22$YR$A$M$Y$$$20240719$$HP$US$US
241174291$24117429$1$I$20240615$20240709$20240722$20240722$EXP$GB-MHRA-MED-202407090231599110-SQRNK$GB-Accord-435443$ACCORD$$19$YR$A$M$Y$$$20240719$$CN$GB$GB
241174301$24117430$1$I$20240701$20240710$20240722$20240722$EXP$$US-Accord-435871$ACCORD$$43$YR$A$F$Y$$$20240719$$PH$US$US
241174312$24117431$2$F$$20240822$20240722$20240903$EXP$$IT-Accord-435032$ACCORD$Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports. Journal of pediatric hematology/oncology. 2024.$13$YR$T$M$Y$$$20240903$$MD$IT$IT
241174322$24117432$2$F$20240703$20240723$20240722$20240803$EXP$$US-Accord-435981$ACCORD$$39$YR$A$M$Y$$$20240803$$HP$US$US
241174331$24117433$1$I$$20240710$20240722$20240722$EXP$CA_MHPD-E2B_07099681$CA-Accord-435480$ACCORD$$63$YR$A$F$Y$$$20240719$$HP$CA$CA
241174341$24117434$1$I$20240707$20240709$20240722$20240722$EXP$$US-Accord-435413$ACCORD$$57$YR$A$M$Y$$$20240719$$PH$US$US
241174351$24117435$1$I$20231001$20240710$20240722$20240722$EXP$GB-MHRA-MED-202407101221271600-BQCKL$GB-Accord-435699$ACCORD$$75$YR$E$M$Y$90$KG$20240719$$CN$GB$GB
241174361$24117436$1$I$$20240710$20240722$20240722$EXP$CA-MHPD-E2B_07090649$CA-Accord-435542$ACCORD$$56$YR$A$F$Y$$$20240719$$MD$CA$CA
241174371$24117437$1$I$$20240708$20240722$20240722$EXP$CA-MHPD-E2B_07061672$CA-Accord-435154$ACCORD$$60$YR$A$F$Y$$$20240719$$HP$CA$CA
241174381$24117438$1$I$20240708$20240709$20240722$20240722$EXP$$US-Accord-435415$ACCORD$$31$YR$A$M$Y$$$20240719$$PH$US$US
241174391$24117439$1$I$20240611$20240709$20240722$20240722$EXP$$US-Accord-435225$ACCORD$$41$YR$A$M$Y$$$20240719$$HP$US$US
241174401$24117440$1$I$20240604$20240710$20240722$20240722$EXP$FR-AFSSAPS-AN2024000838$FR-Accord-435549$ACCORD$$81$YR$E$M$Y$57$KG$20240719$$PH$FR$FR
241174412$24117441$2$F$$20240715$20240722$20240724$EXP$$IN-Accord-434716$ACCORD$Mohan V, Jain S, Naithani R. Low-dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe-BIRD) in a child with relapsed/refractory B-cell acute lymphoblastic leukemia with TP53 mutation. Pediatr Blood Cancer. 2024 Jul 2:e31152.$11$YR$C$M$Y$$$20240724$$HP$IN$IN
241174421$24117442$1$I$$20240709$20240722$20240722$EXP$$US-Accord-435130$ACCORD$Lam L, Bansal V, Chai T, Driver LC. Recurrent Pain From Chemotherapy-Induced Peripheral Neuropathy After COVID-19 Infection -A Case Report. Pain Medicine Case Reports. 2023;7(8):357-9$59$YR$A$M$Y$$$20240719$$MD$US$US
241174431$24117443$1$I$$20240710$20240722$20240722$EXP$GB-MHRA-MED-202407101040248900-LGHCQ$GB-Accord-435680$ACCORD$$56$YR$A$M$Y$78$KG$20240719$$PH$GB$GB
241174443$24117444$3$F$20240626$20240724$20240722$20240803$EXP$$US-Accord-435878$ACCORD$$23$YR$A$M$Y$$$20240803$$HP$US$US
241174451$24117445$1$I$$20240710$20240722$20240722$EXP$$IE-Accord-435338$ACCORD$O^Reilly M, Krstic A, Iglesias-Martinez LF, Ryan EJ, Moran B, Winter D, et al. Genomic and Transcriptomic Analysis of a Patient with Early-Onset Colorectal Cancer and Therapy-Induced Focal Nodular Hyperplasia: A Case Report. Journal of Personalized Medicine. 2024;14(6):639$$$A$F$Y$$$20240719$$MD$IE$IE
241174462$24117446$2$F$$20240731$20240722$20240809$EXP$GB-MHRA-TPP32770833C2677317YC1720440010522$GB-Accord-435441$ACCORD$$10$YR$C$M$Y$28$KG$20240809$$HP$GB$GB
241174471$24117447$1$I$20240629$20240709$20240722$20240722$EXP$GB-MHRA-MED-202407092045395210-CQDTR$GB-Accord-435336$ACCORD$$52$YR$A$F$Y$105$KG$20240719$$CN$GB$GB
241174481$24117448$1$I$20240630$20240718$20240722$20240722$EXP$$US-TAKEDA-2024TUS073065$TAKEDA$$71$YR$$F$Y$$$20240722$$CN$US$US
241174501$24117450$1$I$$20240625$20240722$20240722$PER$$US-ALK-ABELLO A/S-2024AA002680$ALK-ABELLO$$$$$$Y$$$20240722$$HP$US$US
241174511$24117451$1$I$$20240710$20240722$20240722$PER$$US-RDY-CLI/USA/24/0010289$DR REDDYS$$25$YR$A$F$Y$66.68$KG$20240719$$CN$US$US
241174541$24117454$1$I$20240101$20240712$20240722$20240722$EXP$$CA-CELLTRION INC.-2024CA017484$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
241174551$24117455$1$I$$20240710$20240722$20240722$PER$US-MLMSERVICE-20240710-PI121376-00034-1$US-RDY-SPO/USA/24/0010317$DR REDDYS$Ghoussaini R, Saleh OA, Tabaja H. Graft versus histoplasma disease: A case of vascular graft infection. ID Cases. 2024;37: e02013. DOI:10.1016/j.idcr.2024.e02013$72$YR$E$M$Y$$$20240719$$MD$US$US
241174562$24117456$2$F$20230101$20240715$20240722$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040464$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240719$$CN$US$US
241174571$24117457$1$I$20240712$20240717$20240722$20240722$EXP$$US-TAKEDA-2024TUS072446$TAKEDA$$1$YR$$M$Y$$$20240722$$CN$US$US
241174581$24117458$1$I$$20240712$20240722$20240722$EXP$$CA-APOTEX-2020AP017126$APOTEX$$27$YR$$F$Y$$$20240722$$HP$CA$CA
241174601$24117460$1$I$20240708$20240709$20240722$20240722$PER$$US-ABBVIE-5841970$ABBVIE$$46$YR$$M$Y$$$20240722$$CN$US$US
241174611$24117461$1$I$20231115$20240712$20240722$20240722$EXP$$FR-CELLTRION INC.-2024FR017255$CELLTRION$$$$$$Y$$$20240722$$MD$FR$FR
241174621$24117462$1$I$20240628$20240711$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035403$AUROBINDO$$72$YR$$F$Y$96$KG$20240722$$PH$FR$FR
241174641$24117464$1$I$20190712$20240715$20240722$20240722$EXP$$CO-UCBSA-2024036728$UCB$$68$YR$$F$Y$$$20240722$$CN$CO$CO
241174652$24117465$2$F$$20240910$20240722$20240920$EXP$$CA-APOTEX-2024AP008258$APOTEX$$72$YR$$M$Y$$$20240920$$HP$CA$CA
241174661$24117466$1$I$$20240717$20240722$20240722$EXP$$US-AstraZeneca-2024A163727$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241174671$24117467$1$I$$20220302$20240722$20240722$EXP$$US-AstraZeneca-2022A097458$ASTRAZENECA$$$$$F$Y$117.9$KG$20240722$$CN$US$
241174681$24117468$1$I$$20240709$20240722$20240722$PER$$US-RDY-LIT/USA/24/0010458$DR REDDYS$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clinical Toxicology. 2024;62(5): 296-302. doi:10.1080/15563650.2024.2347514.$63$YR$A$M$Y$$$20240719$$HP$US$US
241174691$24117469$1$I$$20200625$20240722$20240722$EXP$$US-AstraZeneca-2020SE81762$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241174701$24117470$1$I$$20220825$20240722$20240722$EXP$$FR-AstraZeneca-2022A300662$ASTRAZENECA$$$$$$Y$$$20240722$$MD$FR$
241174711$24117471$1$I$$20230421$20240722$20240722$EXP$$US-AstraZeneca-2023A094364$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241174721$24117472$1$I$$20220324$20240722$20240722$EXP$$US-AstraZeneca-2022A126269$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241174731$24117473$1$I$$20240410$20240722$20240722$PER$$US-RDY-SPO/USA/24/0010506$DR REDDYS$$$$$F$Y$$$20240719$$CN$US$US
241174741$24117474$1$I$20220501$20240712$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-034936$AUROBINDO$$67$YR$$F$Y$$$20240722$$PH$GB$GB
241174752$24117475$2$F$20240704$20240719$20240722$20240724$EXP$IT-MINISAL02-995333$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-115265$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240724$$MD$IT$IT
241174761$24117476$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115412$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$HP$US$US
241174771$24117477$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115423$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$104.33$KG$20240722$$CN$US$US
241174781$24117478$1$I$$20240715$20240722$20240722$PER$$US-ALXN-202407USA000942US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
241174791$24117479$1$I$20240714$20240714$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-035196$AUROBINDO$$53$YR$$M$Y$78$KG$20240722$$CN$GB$GB
241174812$24117481$2$F$20130303$20240730$20240722$20240730$EXP$$CO-UCBSA-2024036772$UCB$$74$YR$$F$Y$$$20240730$$CN$CO$CO
241174822$24117482$2$F$$20240722$20240722$20240801$EXP$GB-MHRA-MED-202405151353006080-KDBHY$GB-MSNLABS-2024MSNSPO01579$MSN LABORATORIES$$$$$$Y$$$20240801$$MD$GB$GB
241174831$24117483$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089755$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241174841$24117484$1$I$20240702$20240712$20240722$20240722$EXP$$ES-AUROBINDO-AUR-APL-2024-035477$AUROBINDO$$69$YR$$F$Y$$$20240722$$HP$ES$ES
241174851$24117485$1$I$20240709$20240711$20240722$20240722$PER$$US-RDY-SPO/USA/24/0010309$DR REDDYS$$18$YR$A$F$Y$$$20240719$$CN$US$US
241174861$24117486$1$I$20240712$20240718$20240722$20240722$EXP$$US-UCBSA-2024036509$UCB$$28$YR$$F$Y$$$20240722$$CN$US$US
241174871$24117487$1$I$$20240715$20240722$20240722$EXP$$IT-UCBSA-2024036432$UCB$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$80$YR$$F$Y$$$20240722$$MD$IT$IT
241174881$24117488$1$I$20090101$20240716$20240722$20240722$EXP$$DE-ORGANON-O2407DEU001465$ORGANON$$39$YR$$F$Y$77$KG$20240722$$MD$DE$DE
241174891$24117489$1$I$$20240709$20240722$20240722$PER$$US-RDY-SPO/USA/24/0010298$DR REDDYS$$31$YR$A$F$Y$$$20240719$$MD$US$US
241174901$24117490$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA211269$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240722$$MD$US$US
241174911$24117491$1$I$20240101$20240711$20240722$20240722$PER$$US-SA-2024SA209465$SANOFI AVENTIS$$34$YR$A$F$Y$72$KG$20240722$$MD$US$US
241174921$24117492$1$I$20231101$20240715$20240722$20240722$PER$$US-SA-2024SA209308$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240722$$MD$US$US
241174931$24117493$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211001$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
241174941$24117494$1$I$20240716$20240716$20240722$20240722$PER$$US-SA-2024SA210597$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240722$$MD$US$US
241174951$24117495$1$I$20240501$20240715$20240722$20240722$PER$$US-SA-2024SA208533$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240722$$MD$US$US
241174961$24117496$1$I$20240101$20240717$20240722$20240722$PER$$US-SA-2024SA211884$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240722$$MD$US$US
241174971$24117497$1$I$20190412$20240712$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-034934$AUROBINDO$$66$YR$$F$Y$$$20240722$$PH$GB$GB
241174981$24117498$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA207011$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240722$$MD$US$US
241174991$24117499$1$I$20210804$20240712$20240722$20240722$EXP$$DE-AUROBINDO-AUR-APL-2024-035521$AUROBINDO$$$$E$F$Y$96$KG$20240722$$MD$DE$DE
241175001$24117500$1$I$20240101$20240715$20240722$20240722$EXP$$US-SA-2024SA210928$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240722$$MD$US$US
241175011$24117501$1$I$20231101$20240716$20240722$20240722$PER$$US-SA-2024SA211193$SANOFI AVENTIS$$51$YR$A$M$Y$71$KG$20240722$$MD$US$US
241175022$24117502$2$F$$20240910$20240722$20240916$PER$$US-SA-2024SA199496$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240916$$MD$US$US
241175031$24117503$1$I$20240711$20240715$20240722$20240722$PER$$US-SA-2024SA208447$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240722$$CN$US$US
241175051$24117505$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA209668$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240722$$MD$US$US
241175061$24117506$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209682$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$CN$US$US
241175071$24117507$1$I$20240427$20240715$20240722$20240722$PER$$US-SA-2024SA209256$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240722$$MD$US$US
241175082$24117508$2$F$20240715$20240813$20240722$20240822$PER$$US-SA-2024SA210130$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240822$$CN$US$US
241175091$24117509$1$I$$20240713$20240722$20240722$PER$$US-SA-2024SA209724$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240722$$MD$US$US
241175101$24117510$1$I$20240601$20240715$20240722$20240722$PER$$US-SA-2024SA210989$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240722$$MD$US$US
241175111$24117511$1$I$20240601$20240715$20240722$20240722$PER$$US-SA-2024SA210792$SANOFI AVENTIS$$62$YR$A$F$Y$98.8$KG$20240722$$MD$US$US
241175121$24117512$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210843$SANOFI AVENTIS$$$$C$M$Y$$$20240722$$MD$US$US
241175132$24117513$2$F$20230215$20240730$20240722$20240808$PER$$US-SA-2024SA211244$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240808$$MD$US$US
241175141$24117514$1$I$20231201$20240710$20240722$20240722$PER$$US-SA-2024SA209674$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240722$$MD$US$US
241175151$24117515$1$I$20240101$20240716$20240722$20240722$PER$$US-SA-2024SA210153$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$CN$US$US
241175162$24117516$2$F$$20240715$20240722$20240920$EXP$$US-SA-2024SA206736$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240920$$MD$US$US
241175171$24117517$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210647$SANOFI AVENTIS$$$$T$F$Y$$$20240722$$MD$US$US
241175182$24117518$2$F$20240101$20240813$20240722$20240826$PER$$US-SA-2024SA210699$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240826$$MD$US$US
241175191$24117519$1$I$20240712$20240715$20240722$20240722$PER$$US-SA-2024SA209487$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240722$$PH$US$US
241175201$24117520$1$I$20240501$20240711$20240722$20240722$PER$$US-SA-2024SA206987$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240722$$MD$US$US
241175211$24117521$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA209333$SANOFI AVENTIS$$9$YR$C$M$Y$34.2$KG$20240722$$MD$US$US
241175221$24117522$1$I$20240601$20240712$20240722$20240722$PER$$US-SA-2024SA210936$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240722$$MD$US$US
241175231$24117523$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210785$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240722$$MD$US$US
241175241$24117524$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210486$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240722$$MD$US$US
241175251$24117525$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210559$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240722$$MD$US$US
241175261$24117526$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210212$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240722$$MD$US$US
241175271$24117527$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210602$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240722$$MD$US$US
241175281$24117528$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA211132$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240722$$MD$US$US
241175291$24117529$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209978$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240722$$MD$US$US
241175301$24117530$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210040$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240722$$MD$US$US
241175311$24117531$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209746$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240722$$MD$US$US
241175324$24117532$4$F$20240716$20240815$20240722$20240827$PER$$US-SA-2024SA210111$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240827$$MD$US$US
241175332$24117533$2$F$20240713$20240726$20240722$20240805$PER$$US-SA-2024SA210391$SANOFI AVENTIS$$63$YR$A$F$Y$89.3$KG$20240805$$MD$US$US
241175341$24117534$1$I$20240101$20240710$20240722$20240722$PER$$US-SA-2024SA209694$SANOFI AVENTIS$$17$YR$T$F$Y$53$KG$20240722$$MD$US$US
241175351$24117535$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA207909$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240722$$MD$US$US
241175361$24117536$1$I$$20240715$20240722$20240722$EXP$$US-SA-2024SA210651$SANOFI AVENTIS$Saleh M, Barve M, Subbiah V, Papadopoulos K.. Open-label, dose-escalation FIGHT-101 study of pemigatinib combined with targeted therapy, chemotherapy, or immunotherapy in patients with advanced malignancies. ESMO Open.. 2024;9(7):1-11$$$$$Y$$$20240722$$HP$US$US
241175371$24117537$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA209591$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240722$$MD$US$US
241175381$24117538$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA208948$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240722$$MD$US$US
241175391$24117539$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA211260$SANOFI AVENTIS$$$$A$F$Y$88.813$KG$20240722$$MD$US$US
241175401$24117540$1$I$20240601$20240714$20240722$20240722$PER$$US-SA-2024SA210584$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240722$$MD$US$US
241175411$24117541$1$I$$20240709$20240722$20240722$PER$$US-RDY-SPO/USA/24/0010297$DR REDDYS$$15$YR$T$F$Y$$$20240719$$MD$US$US
241175421$24117542$1$I$20240704$20240712$20240722$20240722$PER$$US-SA-2024SA207910$SANOFI AVENTIS$$40$YR$A$M$Y$97.06$KG$20240722$$MD$US$US
241175432$24117543$2$F$$20240801$20240722$20240808$EXP$NL-LRB-00979005$NL-SA-2024SA209968$SANOFI AVENTIS$$65$YR$E$M$Y$102$KG$20240808$$HP$NL$NL
241175441$24117544$1$I$$20240715$20240722$20240722$EXP$$US-SA-2024SA209602$SANOFI AVENTIS$$$$E$M$Y$$$20240722$$CN$US$US
241175452$24117545$2$F$$20240801$20240722$20240808$EXP$NL-LRB-00978986$NL-SA-2024SA208293$SANOFI AVENTIS$$88$YR$E$M$Y$89$KG$20240808$$HP$NL$NL
241175461$24117546$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA211270$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240722$$MD$US$US
241175471$24117547$1$I$20240715$20240715$20240722$20240722$PER$$US-SA-2024SA210634$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240722$$HP$US$US
241175481$24117548$1$I$20240701$20240712$20240722$20240722$PER$$US-SA-2024SA202243$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240722$$MD$US$US
241175492$24117549$2$F$20240801$20240910$20240722$20240919$PER$$US-SA-2024SA210117$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240919$$MD$US$US
241175501$24117550$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210445$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240722$$CN$US$US
241175512$24117551$2$F$$20240911$20240722$20240919$PER$$US-SA-2024SA207215$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240919$$HP$US$US
241175522$24117552$2$F$20240101$20240826$20240722$20240910$PER$$US-SA-2024SA211038$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240910$$MD$US$US
241175532$24117553$2$F$$20240722$20240722$20240731$PER$$US-SA-2024SA210889$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240731$$MD$US$US
241175541$24117554$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA209160$SANOFI AVENTIS$$$$$$Y$$$20240722$$MD$US$US
241175551$24117555$1$I$20240601$20240715$20240722$20240722$PER$$US-SA-2024SA210504$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240722$$MD$US$US
241175561$24117556$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA208657$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240722$$MD$US$US
241175571$24117557$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA211149$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240722$$MD$US$US
241175581$24117558$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209592$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240722$$MD$US$US
241175591$24117559$1$I$20240701$20240715$20240722$20240722$PER$$US-SA-2024SA209141$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240722$$MD$US$US
241175601$24117560$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210658$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240722$$MD$US$US
241175611$24117561$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA210896$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240722$$MD$US$US
241175623$24117562$3$F$20240101$20240808$20240722$20240820$PER$$US-SA-2024SA210402$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240820$$MD$US$US
241175642$24117564$2$F$20240701$20240719$20240722$20240725$EXP$$BR-NOVOPROD-1256078$NOVO NORDISK$$$$$F$Y$$$20240725$$CN$BR$BR
241175651$24117565$1$I$20240628$20240711$20240722$20240722$EXP$$US-NOVOPROD-1256008$NOVO NORDISK$$60$YR$$F$Y$$$20240722$$CN$US$US
241175661$24117566$1$I$$20240709$20240722$20240722$EXP$$TR-NOVOPROD-1257840$NOVO NORDISK$$$$$M$Y$75$KG$20240722$$CN$TR$TR
241175671$24117567$1$I$20240707$20240711$20240722$20240722$EXP$$CA-NOVOPROD-1256050$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$CA$CA
241175681$24117568$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210216$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240722$$MD$US$US
241175691$24117569$1$I$$20240715$20240722$20240722$EXP$$US-SA-2024SA210966$SANOFI AVENTIS$$$$A$M$Y$97$KG$20240722$$MD$US$US
241175701$24117570$1$I$20240701$20240712$20240722$20240722$PER$$US-SA-2024SA209357$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240722$$MD$US$US
241175711$24117571$1$I$$20240715$20240722$20240722$EXP$NL-LRB-00979027$NL-SA-2024SA207669$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240722$$HP$NL$NL
241175721$24117572$1$I$20240423$20240714$20240722$20240722$EXP$$IL-EMD Serono-2024038332$EMD SERONO INC$$38$YR$A$F$Y$$$20240722$$CN$IL$IL
241175731$24117573$1$I$$20240709$20240722$20240722$PER$US-MLMSERVICE-20240703-PI119559-00165-1$US-RDY-SPO/USA/24/0010247$DR REDDYS$Baraban E, Thompson ED, Matoso A, Hruban RH, Argani P. Benign islet cells within peripancreatic lymph nodes: A potential diagnostic pitfall. American Journal of Surgical Pathology. 2024;48(7):834-8. DOI: 10.1097/PAS.0000000000002244.$8$DEC$E$M$Y$$$20240719$$MD$US$US
241175742$24117574$2$F$$20240821$20240722$20240827$PER$$US-PHARMING-PHAUS2024000604$PHARMING GROUP$$$$$$Y$$$20240827$$CN$US$US
241175752$24117575$2$F$$20240805$20240722$20240828$EXP$$US-PHARMING-PHAUS2024000608$PHARMING GROUP$$$$$$Y$$$20240807$$CN$US$US
241175762$24117576$2$F$$20240717$20240722$20240725$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00729$TARO$$$$$$Y$$$20240725$$CN$US$US
241175771$24117577$1$I$$20230629$20240722$20240722$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00744$TARO$$$$$$Y$$$20240719$$CN$US$US
241175782$24117578$2$F$$20240820$20240722$20240826$EXP$$JP-AMGEN-JPNSP2024142090$AMGEN$$$$$$Y$$$20240826$$PH$JP$JP
241175791$24117579$1$I$$20240718$20240722$20240722$EXP$$JP-ABBVIE-5818284$ABBVIE$$50$YR$$F$Y$$$20240722$$PH$JP$JP
241175801$24117580$1$I$20240601$20240711$20240722$20240722$EXP$$US-NOVOPROD-1257317$NOVO NORDISK$$$$A$M$Y$$$20240722$$CN$US$US
241175811$24117581$1$I$$20240711$20240722$20240722$EXP$$US-NOVOPROD-1257264$NOVO NORDISK$$$$A$F$Y$$$20240722$$CN$US$US
241175821$24117582$1$I$$20240711$20240722$20240722$EXP$$US-NOVOPROD-1256646$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$US$US
241175832$24117583$2$F$20240501$20240816$20240722$20240827$EXP$$US-NOVOPROD-1257287$NOVO NORDISK$$$$$F$Y$$$20240827$$CN$US$US
241175842$24117584$2$F$$20240903$20240722$20240916$EXP$$US-NOVOPROD-1256697$NOVO NORDISK$$82$YR$$F$Y$85.72$KG$20240916$$MD$US$US
241175851$24117585$1$I$$20240711$20240722$20240722$EXP$$US-NOVOPROD-1256663$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$US$US
241175862$24117586$2$F$$20240723$20240722$20240805$EXP$$IL-NOVOPROD-1257633$NOVO NORDISK$$70$YR$$M$Y$$$20240805$$MD$IL$IL
241175871$24117587$1$I$$20240711$20240722$20240722$EXP$$US-NOVOPROD-1256502$NOVO NORDISK$$$$$F$Y$$$20240722$$CN$US$US
241175882$24117588$2$F$20240501$20240722$20240722$20240724$EXP$$US-UCBSA-2024036570$UCB$$53$YR$$M$Y$$$20240724$$CN$US$US
241175891$24117589$1$I$$20240712$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024087745$VIIV$$$$$$Y$$$20240722$$PH$US$US
241175901$24117590$1$I$$20240716$20240722$20240722$EXP$$JP-SAKK-2024SA201630AA$SANOFI AVENTIS$$$$$M$Y$$$20240722$$PH$JP$JP
241175911$24117591$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA209740$SANOFI AVENTIS$$$$E$F$Y$$$20240722$$MD$US$US
241175921$24117592$1$I$20230101$20240711$20240722$20240722$PER$$US-SA-2024SA210314$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
241175931$24117593$1$I$20240101$20240711$20240722$20240722$PER$$US-SA-2024SA209796$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240722$$MD$US$US
241175941$24117594$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209577$SANOFI AVENTIS$$$$$$Y$$$20240722$$MD$US$US
241175951$24117595$1$I$20240711$20240712$20240722$20240722$PER$$US-SA-2024SA209585$SANOFI AVENTIS$$52$YR$A$F$Y$81.64$KG$20240722$$MD$US$US
241175961$24117596$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209498$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240722$$MD$US$US
241175971$24117597$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209473$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240722$$MD$US$US
241175981$24117598$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA207347$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240722$$MD$US$US
241175991$24117599$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA207175$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240722$$MD$US$US
241176001$24117600$1$I$20240101$20240711$20240722$20240722$PER$$US-SA-2024SA207471$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240722$$MD$US$US
241176012$24117601$2$F$20240101$20240820$20240722$20240830$PER$$US-SA-2024SA209516$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240830$$CN$US$US
241176021$24117602$1$I$20240301$20240711$20240722$20240722$PER$$US-SA-2024SA207902$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240722$$MD$US$US
241176031$24117603$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210616$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240721$$MD$US$US
241176041$24117604$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA207688$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240722$$MD$US$US
241176051$24117605$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA209662$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240721$$MD$US$US
241176061$24117606$1$I$20240701$20240712$20240722$20240722$PER$$US-SA-2024SA209483$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240721$$MD$US$US
241176071$24117607$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209795$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240721$$MD$US$US
241176081$24117608$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA210660$SANOFI AVENTIS$$$$C$F$Y$30.4$KG$20240721$$HP$US$US
241176091$24117609$1$I$$20240715$20240722$20240722$EXP$$US-SA-2024SA209127$SANOFI AVENTIS$Xia J, Ahmed R. Rapidly progressive locked-in syndrome secondary to atypical herpes simplex virus-1 rhombencephalitis in an immunocompromised individual. IDCases. 2024;37:e02027$61$YR$A$M$Y$$$20240721$$HP$US$US
241176101$24117610$1$I$20240101$20240711$20240722$20240722$PER$$US-SA-2024SA210061$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240721$$MD$US$US
241176111$24117611$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209656$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240721$$MD$US$US
241176125$24117612$5$F$20240101$20240904$20240722$20240913$EXP$$US-SA-2024SA207183$SANOFI AVENTIS$$59$YR$A$F$Y$58$KG$20240913$$CN$US$US
241176132$24117613$2$F$20240101$20240813$20240722$20240826$PER$$US-SA-2024SA210905$SANOFI AVENTIS$$52$YR$A$F$Y$104$KG$20240826$$MD$US$US
241176141$24117614$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA208825$SANOFI AVENTIS$$$$C$F$Y$$$20240721$$MD$US$US
241176152$24117615$2$F$$20240724$20240722$20240802$PER$$US-SA-2024SA208924$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240802$$MD$US$US
241176161$24117616$1$I$$20240715$20240722$20240722$EXP$$US-SA-2024SA208747$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240721$$HP$US$US
241176171$24117617$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA208537$SANOFI AVENTIS$$$$I$F$Y$$$20240721$$MD$US$US
241176181$24117618$1$I$20240712$20240712$20240722$20240722$PER$$US-SA-2024SA208879$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240721$$MD$US$US
241176191$24117619$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209421$SANOFI AVENTIS$$$$A$M$Y$76.65$KG$20240721$$MD$US$US
241176201$24117620$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA206833$SANOFI AVENTIS$$$$$F$Y$$$20240721$$CN$US$US
241176211$24117621$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209012$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240721$$MD$US$US
241176221$24117622$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA208621$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240721$$MD$US$US
241176231$24117623$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210543$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240721$$MD$US$US
241176241$24117624$1$I$20240101$20240711$20240722$20240722$PER$$US-SA-2024SA207216$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240721$$MD$US$US
241176252$24117625$2$F$20240101$20240827$20240722$20240909$PER$$US-SA-2024SA209413$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240909$$HP$US$US
241176261$24117626$1$I$20240101$20240716$20240722$20240722$PER$$US-SA-2024SA210528$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240721$$MD$US$US
241176271$24117627$1$I$20240715$20240715$20240722$20240722$PER$$US-SA-2024SA208519$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240721$$MD$US$US
241176281$24117628$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA209157$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240721$$MD$US$US
241176291$24117629$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA211858$SANOFI AVENTIS$$$$E$F$Y$65.7$KG$20240721$$MD$US$US
241176301$24117630$1$I$20240614$20240715$20240722$20240722$PER$$US-SA-2024SA210502$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240721$$MD$US$US
241176311$24117631$1$I$20240301$20240716$20240722$20240722$PER$$US-SA-2024SA211853$SANOFI AVENTIS$$43$YR$A$F$Y$81.64$KG$20240721$$MD$US$US
241176321$24117632$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210764$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240721$$CN$US$US
241176331$24117633$1$I$20240716$20240716$20240722$20240722$PER$$US-SA-2024SA211266$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240721$$MD$US$US
241176341$24117634$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210465$SANOFI AVENTIS$$$$A$M$Y$$$20240721$$MD$US$US
241176351$24117635$1$I$20240701$20240716$20240722$20240722$PER$$US-SA-2024SA211562$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240721$$MD$US$US
241176361$24117636$1$I$20240409$20240715$20240722$20240722$PER$$US-SA-2024SA211307$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240721$$MD$US$US
241176371$24117637$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211537$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240721$$CN$US$US
241176381$24117638$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA211238$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240721$$MD$US$US
241176391$24117639$1$I$$20240717$20240722$20240722$PER$$US-SA-2024SA210872$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240721$$MD$US$US
241176401$24117640$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA211217$SANOFI AVENTIS$$$$A$F$Y$163$KG$20240721$$MD$US$US
241176412$24117641$2$F$20240101$20240722$20240722$20240731$PER$$US-SA-2024SA211226$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240731$$MD$US$US
241176421$24117642$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211187$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240721$$MD$US$US
241176431$24117643$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210675$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240721$$MD$US$US
241176442$24117644$2$F$$20240722$20240722$20240729$PER$$US-SA-2024SA209936$SANOFI AVENTIS$$$$$$Y$$$20240729$$CN$US$US
241176451$24117645$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209485$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240721$$CN$US$US
241176461$24117646$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211110$SANOFI AVENTIS$$$$E$M$Y$$$20240721$$MD$US$US
241176471$24117647$1$I$$20240717$20240722$20240722$PER$$US-SA-2024SA211684$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240721$$HP$US$US
241176481$24117648$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209596$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240721$$MD$US$US
241176491$24117649$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210494$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240721$$MD$US$US
241176501$24117650$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211352$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240721$$CN$US$US
241176511$24117651$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209211$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240721$$HP$US$US
241176521$24117652$1$I$20240713$20240715$20240722$20240722$PER$$US-SA-2024SA210639$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240721$$MD$US$US
241176531$24117653$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA210640$SANOFI AVENTIS$$$$A$F$Y$163.2$KG$20240721$$MD$US$US
241176541$24117654$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210902$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240721$$MD$US$US
241176551$24117655$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210858$SANOFI AVENTIS$$$$E$M$Y$113.38$KG$20240721$$MD$US$US
241176561$24117656$1$I$20240101$20240711$20240722$20240722$PER$$US-SA-2024SA208987$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240721$$MD$US$US
241176571$24117657$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210305$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240721$$CN$US$US
241176581$24117658$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210209$SANOFI AVENTIS$$$$$F$Y$$$20240721$$MD$US$US
241176592$24117659$2$F$20240101$20240806$20240722$20240812$PER$$US-SA-2024SA211841$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240812$$CN$US$US
241176601$24117660$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211348$SANOFI AVENTIS$$$$$M$Y$$$20240721$$CN$US$US
241176611$24117661$1$I$20240101$20240716$20240722$20240722$PER$$US-SA-2024SA210844$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240721$$MD$US$US
241176622$24117662$2$F$20240220$20240917$20240722$20240926$EXP$$PT-CELLTRION INC.-2024PT017300$CELLTRION$$$$$$Y$$$20240926$$PH$PT$PT
241176631$24117663$1$I$$20240708$20240722$20240722$EXP$$CN-MSNLABS-2024MSNLIT01594$MSN LABORATORIES$Zhai W, Liu H, Li J, Xin H.Pregabalin-induced rhabdomyolysis: a case series and literature analysis.Journal of International Medical Research.2024;52(6):1-7$$$$$Y$$$20240722$$PH$CN$CN
241176641$24117664$1$I$$20240712$20240722$20240722$EXP$$GB-CELLTRION INC.-2024GB017470$CELLTRION$$$$$$Y$$$20240722$$HP$GB$GB
241176651$24117665$1$I$20240717$20240717$20240722$20240722$PER$$US-AMGEN-USASL2024142893$AMGEN$$$$$$Y$$$20240722$$PH$US$US
241176662$24117666$2$F$$20240923$20240722$20240925$EXP$$IT-UCBSA-2024036433$UCB$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;46(7):e26-30$88$YR$$M$Y$$$20240925$$MD$IT$IT
241176671$24117667$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024142529$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241176681$24117668$1$I$20230401$20240717$20240722$20240722$EXP$$PL-LEO Pharma-372089$LEO PHARM$$2$YR$$M$Y$$$20240722$$CN$PL$PL
241176691$24117669$1$I$$20240711$20240722$20240722$PER$$US-APOTEX-2024AP008344$APOTEX$Mahmoud A, Amir A, Bangash H, Ayaz S.. Pasteurella Multocida-induced Empyema in an Immunocompromised Patient - A Case Report. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2411$70$YR$$M$Y$$$20240722$$HP$US$US
241176701$24117670$1$I$$20240123$20240722$20240722$EXP$FR-AFSSAPS-AVMA2023000462$FR-TEVA-VS-3150971$TEVA$$25$YR$$M$Y$$$20240722$$MD$FR$FR
241176712$24117671$2$F$$20240822$20240722$20240829$EXP$$US-TEVA-VS-3220025$TEVA$Gullapalli D, Raza A, Khan A, Ganti SS, Pervaiz A. Battling the breath-stealers: Blastomyces and Pseudomonas triggering acute respiratory distress syndrome (ARDS). Med-Mycol-Case-Reports 2024; 45.; Gullapalli D, Raza A, Khan A, Ganti SS, Pervaiz A. Battling the breath-stealers: Blastomyces and Pseudomonas triggering acute respiratory distress syndrome (ARDS). Med-Mycol-Case-Reports 2024; 45.$46$YR$$M$Y$$$20240829$$HP$US$US
241176721$24117672$1$I$20240707$20240712$20240722$20240722$PER$$US-SA-2024SA209369$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240721$$MD$US$US
241176731$24117673$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210804$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240721$$MD$US$US
241176741$24117674$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA208379$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240721$$CN$US$US
241176752$24117675$2$F$20240701$20240823$20240722$20240919$PER$$US-SA-2024SA209705$SANOFI AVENTIS$$60$YR$A$F$Y$88$KG$20240919$$MD$US$US
241176761$24117676$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA207627$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240721$$MD$US$US
241176771$24117677$1$I$$20240710$20240722$20240722$PER$$US-SA-2024SA209658$SANOFI AVENTIS$$$$T$M$Y$81.64$KG$20240721$$MD$US$US
241176781$24117678$1$I$$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115387$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240722$$CN$US$US
241176791$24117679$1$I$$20240715$20240722$20240722$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-114468$BRISTOL MYERS SQUIBB$Cho W-H, Chiang W-Y. Case Report: Serial changes of ocular complications related to immune checkpoint inhibitors pembrolizumab and nivolumab. Frontiers in Ophthalmology. 2023 Jan 05;2:1-6. doi:10.3389/fopht.2022.1021574.$37$YR$A$F$Y$$$20240722$$HP$TW$TW
241176801$24117680$1$I$20240601$20240712$20240722$20240722$PER$$US-SA-2024SA209471$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240721$$MD$US$US
241176811$24117681$1$I$20240101$20240223$20240722$20240722$PER$$US-SA-2024SA211267$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240721$$MD$US$US
241176821$24117682$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210673$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240721$$MD$US$US
241176831$24117683$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210586$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240721$$CN$US$US
241176841$24117684$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209405$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240721$$MD$US$US
241176851$24117685$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210693$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240721$$MD$US$US
241176861$24117686$1$I$20240706$20240712$20240722$20240722$PER$$US-SA-2024SA210591$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240721$$MD$US$US
241176871$24117687$1$I$$20240711$20240722$20240722$PER$$US-SA-2023SA016416$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240721$$MD$US$US
241176881$24117688$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210697$SANOFI AVENTIS$$$$A$F$Y$136$KG$20240721$$MD$US$US
241176891$24117689$1$I$20240601$20240712$20240722$20240722$PER$$US-SA-2023SA135285$SANOFI AVENTIS$$$$A$F$Y$$$20240721$$MD$US$US
241176902$24117690$2$F$20240101$20240813$20240722$20240827$PER$$US-SA-2024SA206982$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240827$$MD$US$US
241176911$24117691$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210682$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240721$$MD$US$US
241176921$24117692$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210373$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240721$$HP$US$US
241176931$24117693$1$I$20240607$20240712$20240722$20240722$PER$$US-SA-2024SA209800$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240721$$MD$US$US
241176941$24117694$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210967$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240721$$MD$US$US
241176951$24117695$1$I$20240715$20240716$20240722$20240722$PER$$US-SA-2024SA210377$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240721$$CN$US$US
241176972$24117697$2$F$20240101$20240820$20240722$20240910$PER$$US-SA-2024SA210249$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240910$$MD$US$US
241176982$24117698$2$F$20140101$20240718$20240722$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040745$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240719$$CN$US$US
241176991$24117699$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209344$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240721$$MD$US$US
241177001$24117700$1$I$20240608$20240715$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040471$BOEHRINGER INGELHEIM$$90$YR$E$$Y$$$20240722$$CN$US$US
241177011$24117701$1$I$20240101$20240716$20240722$20240722$PER$$US-SA-2024SA210784$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240721$$HP$US$US
241177021$24117702$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210160$SANOFI AVENTIS$$$$$F$Y$$$20240721$$CN$US$US
241177031$24117703$1$I$20240601$20240713$20240722$20240722$PER$$US-SA-2024SA209722$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240721$$MD$US$US
241177041$24117704$1$I$20230801$20240712$20240722$20240722$PER$$US-SA-2024SA209459$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240721$$MD$US$US
241177051$24117705$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA211234$SANOFI AVENTIS$$$$A$F$Y$90.7$KG$20240720$$MD$US$US
241177061$24117706$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA211107$SANOFI AVENTIS$$$$A$F$Y$123.8$KG$20240720$$MD$US$US
241177072$24117707$2$F$20240712$20240718$20240722$20240729$PER$$US-SA-2024SA211000$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240729$$MD$US$US
241177082$24117708$2$F$20240101$20240726$20240722$20240805$PER$$US-SA-2024SA207499$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240805$$MD$US$US
241177091$24117709$1$I$20240701$20240711$20240722$20240722$PER$$US-SA-2024SA209758$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240720$$MD$US$US
241177101$24117710$1$I$20240713$20240715$20240722$20240722$PER$$US-SA-2024SA208610$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240720$$HP$US$US
241177111$24117711$1$I$20240701$20240716$20240722$20240722$PER$$US-SA-2024SA211399$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240720$$HP$US$US
241177121$24117712$1$I$20240703$20240711$20240722$20240722$PER$$US-SA-2024SA209558$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240720$$MD$US$US
241177131$24117713$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209237$SANOFI AVENTIS$$$$$M$Y$$$20240720$$CN$US$US
241177141$24117714$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA209403$SANOFI AVENTIS$$$$A$M$Y$72.57$KG$20240720$$MD$US$US
241177151$24117715$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA209404$SANOFI AVENTIS$$$$A$F$Y$131$KG$20240720$$MD$US$US
241177161$24117716$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210046$SANOFI AVENTIS$$11$YR$C$M$Y$52.6$KG$20240720$$MD$US$US
241177171$24117717$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211377$SANOFI AVENTIS$$$$A$F$Y$$$20240720$$CN$US$US
241177181$24117718$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA117083$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240720$$CN$US$US
241177191$24117719$1$I$$20240714$20240722$20240722$PER$$US-SA-2024SA210136$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240720$$MD$US$US
241177201$24117720$1$I$$20240717$20240722$20240722$PER$$US-SA-2024SA211720$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240720$$CN$US$US
241177211$24117721$1$I$20231101$20240716$20240722$20240722$PER$$US-SA-2024SA210093$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240720$$CN$US$US
241177221$24117722$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA209462$SANOFI AVENTIS$$$$$$Y$$$20240720$$MD$US$US
241177231$24117723$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA208972$SANOFI AVENTIS$$$$C$F$Y$$$20240720$$MD$US$US
241177241$24117724$1$I$20240714$20240715$20240722$20240722$PER$$US-SA-2024SA210036$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240720$$MD$US$US
241177251$24117725$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210286$SANOFI AVENTIS$$$$A$F$Y$$$20240720$$MD$US$US
241177262$24117726$2$F$$20240807$20240722$20240815$PER$$US-SA-2024SA209604$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240815$$CN$US$US
241177272$24117727$2$F$20240601$20240829$20240722$20240911$PER$$US-SA-2024SA209798$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240911$$MD$US$US
241177281$24117728$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA211018$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240720$$MD$US$US
241177291$24117729$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210395$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240720$$MD$US$US
241177301$24117730$1$I$$20240710$20240722$20240722$PER$$US-SA-2024SA207849$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240720$$MD$US$US
241177311$24117731$1$I$20240201$20240712$20240722$20240722$EXP$$NL-AUROBINDO-AUR-APL-2024-035659$AUROBINDO$$41$YR$$F$Y$$$20240722$$PH$NL$NL
241177322$24117732$2$F$20240711$20240829$20240722$20240905$EXP$$US-SA-2024SA209631$SANOFI AVENTIS$$71$YR$E$M$Y$165.8$KG$20240905$$HP$PR$US
241177331$24117733$1$I$$20240708$20240722$20240722$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092378$GLENMARK$Dogrul BN, Park C. Hydralazine Induced Visual and Auditory Hallucinations in a Kidney Transplant Patient: Case Report. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;1-3$$$$$Y$$$20240722$$MD$US$US
241177341$24117734$1$I$$20240715$20240722$20240722$EXP$$MA-Tamarang, S.A.-2159415$TAMARANG PHARMACEUTICALS$Alj L, Tebaa A, Talibi I, Moubarik S, Benazzouz M, Soulaymani Bencheikh R. Lessonslearned from a cluster of immunization errors in newborns. Ther Adv Vaccines Immunother. 2024 Jan 2;12:25151355231221009. doi:?10.1177/25151355231221009. PMID: 38178960; PMCID: PMC10762870. Article found during weekly scientific literature research.$$$$$Y$$$20240722$$MD$MA$MA
241177352$24117735$2$F$20240401$20240717$20240722$20240724$EXP$$NVSC2024PT148447$NOVARTIS$$$$$F$Y$$$20240724$$MD$PT$PT
241177362$24117736$2$F$20211101$20240716$20240722$20240729$EXP$FR-AFSSAPS-NY2024000796$FR-IQVIA JAPAN-O2407FRA001438$ORGANON$$46$YR$$F$Y$$$20240729$$MD$FR$FR
241177371$24117737$1$I$20240624$20240708$20240722$20240722$EXP$GB-MHRA-MED-202407071011142080-CVHZM$GB-MSNLABS-2024MSNSPO01576$MSN LABORATORIES$$$$$$Y$$$20240722$$CN$GB$GB
241177381$24117738$1$I$20240101$20240718$20240722$20240722$EXP$$CA-UCBSA-2024026020$UCB$$$$$F$Y$$$20240722$$CN$CA$CA
241177391$24117739$1$I$$20240712$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-034928$AUROBINDO$$$$$F$Y$$$20240722$$MD$GB$GB
241177401$24117740$1$I$$20240718$20240722$20240722$EXP$$US-TAKEDA-2024TUS044857$TAKEDA$$$$$M$Y$$$20240722$$MD$US$US
241177411$24117741$1$I$$20221024$20240722$20240722$EXP$$US-AstraZeneca-2022A355643$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241177421$24117742$1$I$$20220919$20240722$20240722$EXP$$US-AstraZeneca-2022A323683$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241177431$24117743$1$I$20230515$20230515$20240722$20240722$EXP$$US-AstraZeneca-2023A113387$ASTRAZENECA$$23467$DY$$F$Y$$$20240722$$CN$US$
241177441$24117744$1$I$$20220328$20240722$20240722$EXP$$US-AstraZeneca-2022A130571$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241177451$24117745$1$I$$20240715$20240722$20240722$EXP$AU-WT-2024-APC-085054$AU-WT-2024-APC-085054$Waylis$$79$YR$E$M$Y$$$20240722$$HP$AU$AU
241177461$24117746$1$I$20240624$20240709$20240722$20240722$EXP$$GB-MSNLABS-2024MSNSPO01578$MSN LABORATORIES$$$$$$Y$$$20240722$$MD$GB$GB
241177471$24117747$1$I$$20200811$20240722$20240722$EXP$$US-AstraZeneca-2020SF02003$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241177481$24117748$1$I$$20220413$20240722$20240722$EXP$$US-AstraZeneca-2022A151339$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241177491$24117749$1$I$$20200420$20240722$20240722$EXP$$US-AstraZeneca-2020SE53810$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241177502$24117750$2$F$20240712$20240830$20240722$20240917$PER$$US-SA-2024SA208769$SANOFI AVENTIS$$62$YR$A$F$Y$73.2$KG$20240918$$MD$US$US
241177511$24117751$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA211068$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240720$$MD$US$US
241177521$24117752$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA211026$SANOFI AVENTIS$$$$A$M$Y$106.59$KG$20240720$$MD$US$US
241177531$24117753$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA211116$SANOFI AVENTIS$$$$T$F$Y$$$20240720$$MD$US$US
241177542$24117754$2$F$$20240904$20240722$20240927$PER$$US-SA-2024SA210221$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240927$$MD$US$US
241177551$24117755$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210943$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240720$$MD$US$US
241177561$24117756$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210550$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240720$$MD$US$US
241177572$24117757$2$F$20240101$20240808$20240722$20240820$PER$$US-SA-2024SA211084$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240820$$CN$US$US
241177582$24117758$2$F$20240701$20240718$20240722$20240726$PER$$US-SA-2024SA208415$SANOFI AVENTIS$$$$$F$Y$$$20240726$$HP$US$US
241177591$24117759$1$I$20240301$20240715$20240722$20240722$PER$$US-SA-2024SA210241$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240720$$MD$US$US
241177602$24117760$2$F$20240712$20240718$20240722$20240727$PER$$US-SA-2024SA208169$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240727$$CN$US$US
241177611$24117761$1$I$$20240712$20240722$20240722$PER$$US-SA-2023SA265854$SANOFI AVENTIS$$$$A$F$Y$$$20240720$$MD$US$US
241177621$24117762$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210203$SANOFI AVENTIS$$$$A$F$Y$$$20240720$$MD$US$US
241177631$24117763$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA211143$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240720$$MD$US$US
241177641$24117764$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210180$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240720$$MD$US$US
241177651$24117765$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210523$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240720$$MD$US$US
241177661$24117766$1$I$20240714$20240715$20240722$20240722$PER$$US-SA-2024SA210133$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240720$$MD$US$US
241177671$24117767$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209263$SANOFI AVENTIS$$$$E$M$Y$64$KG$20240720$$MD$US$US
241177681$24117768$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209285$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240720$$MD$US$US
241177691$24117769$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210970$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240720$$MD$US$US
241177701$24117770$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210969$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240720$$MD$US$US
241177711$24117771$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210771$SANOFI AVENTIS$$$$E$M$Y$122$KG$20240720$$MD$US$US
241177721$24117772$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209184$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240720$$MD$US$US
241177731$24117773$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209257$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240720$$MD$US$US
241177741$24117774$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA210548$SANOFI AVENTIS$$$$A$M$Y$113$KG$20240720$$MD$US$US
241177751$24117775$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209242$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240720$$MD$US$US
241177761$24117776$1$I$20240701$20240712$20240722$20240722$PER$$US-SA-2024SA209174$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240720$$MD$US$US
241177771$24117777$1$I$$20240716$20240722$20240722$EXP$$US-SA-2024SA211691$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240720$$HP$US$US
241177781$24117778$1$I$20200101$20240716$20240722$20240722$EXP$$US-SA-2024SA210646$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240720$$MD$US$US
241177792$24117779$2$F$20240101$20240715$20240722$20240726$PER$$US-SA-2024SA209177$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240726$$MD$US$US
241177801$24117780$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA208979$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240720$$MD$US$US
241177811$24117781$1$I$$20240716$20240722$20240722$EXP$$US-SA-2024SA210982$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240720$$CN$US$US
241177821$24117782$1$I$$20240715$20240722$20240722$EXP$$US-SA-2024SA211626$SANOFI AVENTIS$$$$A$M$Y$64.8$KG$20240720$$MD$US$US
241177832$24117783$2$F$$20240716$20240722$20240723$EXP$$US-SA-2024SA211484$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241177843$24117784$3$F$20240801$20240830$20240722$20240927$PER$$US-SA-2024SA208810$SANOFI AVENTIS$$48$YR$A$F$Y$65.31$KG$20240927$$MD$US$US
241177851$24117785$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA208787$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240720$$MD$US$US
241177861$24117786$1$I$20240617$20240715$20240722$20240722$EXP$$US-UCBSA-2024035819$UCB$$60$YR$$M$Y$$$20240722$$CN$US$US
241177881$24117788$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210510$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240720$$MD$US$US
241177891$24117789$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA211185$SANOFI AVENTIS$$$$A$F$Y$$$20240720$$MD$US$US
241177901$24117790$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210755$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240720$$MD$US$US
241177911$24117791$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210716$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240720$$CN$US$US
241177921$24117792$1$I$20240625$20240715$20240722$20240722$PER$$US-SA-2024SA211235$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240720$$MD$US$US
241177931$24117793$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210700$SANOFI AVENTIS$$$$A$M$Y$$$20240720$$MD$US$US
241177941$24117794$1$I$20220308$20240717$20240722$20240722$EXP$PL-URPL-DML-MLP.4401.1.747.2022$PL-SA-2024SA211543$SANOFI AVENTIS$$65$YR$E$$Y$59$KG$20240720$$MD$PL$PL
241177953$24117795$3$F$20220121$20240722$20240722$20240731$PER$$US-SA-2024SA208376$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240731$$MD$US$US
241177961$24117796$1$I$20240703$20240715$20240722$20240722$PER$$US-SA-2024SA211194$SANOFI AVENTIS$$35$YR$A$F$Y$88.4$KG$20240720$$MD$US$US
241177971$24117797$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA208540$SANOFI AVENTIS$$$$A$M$Y$79.3$KG$20240720$$MD$US$US
241177981$24117798$1$I$20240701$20240712$20240722$20240722$PER$$US-SA-2024SA207203$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240720$$MD$US$US
241177991$24117799$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA207221$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240720$$MD$US$US
241178001$24117800$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA206951$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240720$$CN$US$US
241178011$24117801$1$I$20240701$20240712$20240722$20240722$PER$$US-SA-2024SA207129$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240720$$CN$US$US
241178021$24117802$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA206819$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240720$$MD$US$US
241178031$24117803$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA206845$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240720$$MD$US$US
241178041$24117804$1$I$$20240713$20240722$20240722$PER$$US-SA-2024SA210227$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240720$$MD$US$US
241178051$24117805$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA192178$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240720$$MD$US$US
241178061$24117806$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA208644$SANOFI AVENTIS$$$$A$M$Y$$$20240720$$MD$US$US
241178071$24117807$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA207888$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240719$$CN$US$US
241178081$24117808$1$I$20230101$20240715$20240722$20240722$PER$$US-SA-2024SA209710$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240720$$CN$US$US
241178091$24117809$1$I$$20240710$20240722$20240722$EXP$$JP-SA-2024SA211454$SANOFI AVENTIS$Akiyama H et al.. A case of severe irAE enteritis with difficult nutritional management.. The journal of Metabolism and Clinical Nutrition. 2024;27:unk$71$YR$E$F$Y$42.9$KG$20240719$$HP$JP$JP
241178101$24117810$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA209346$SANOFI AVENTIS$$$$A$M$Y$$$20240719$$HP$US$US
241178112$24117811$2$F$$20240719$20240722$20240727$PER$$US-SA-2024SA209684$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240727$$CN$US$US
241178122$24117812$2$F$$20240826$20240722$20240918$PER$$US-SA-2024SA210585$SANOFI AVENTIS$$$$E$F$Y$65.77$KG$20240918$$MD$US$US
241178131$24117813$1$I$$20240716$20240722$20240722$EXP$$JP-AMGEN-JPNSP2024141413$AMGEN$$$$$$Y$$$20240722$$PH$JP$JP
241178141$24117814$1$I$20240717$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142394$AMGEN$$74$YR$E$F$Y$$$20240722$$CN$US$US
241178162$24117816$2$F$$20240809$20240722$20240817$EXP$$JP-AMGEN-JPNSP2024140713$AMGEN$$$$$$Y$$$20240816$$PH$JP$JP
241178171$24117817$1$I$$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143229$AMGEN$$$$$F$Y$$$20240722$$PH$US$US
241178182$24117818$2$F$20240712$20240715$20240722$20240728$PER$$US-AMGEN-USASP2024141610$AMGEN$$95$YR$E$M$Y$$$20240727$$CN$US$US
241178192$24117819$2$F$$20240822$20240722$20240829$EXP$$US-TEVA-VS-3219809$TEVA$Fan J, Thanedar S, Ovechko V, Jana B. Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers. Case-Rep-Oncol 2024; 17 (1): 517-523.; Fan J, Thanedar S, Ovechko V, Jana B. Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers. Case-Rep-Oncol 2024; 17 (1): 517-523.$56$YR$$M$Y$$$20240829$$HP$US$US
241178202$24117820$2$F$$20240716$20240722$20240725$PER$$US-SA-2024SA209135$SANOFI AVENTIS$$83$YR$E$F$Y$63.5$KG$20240725$$MD$US$US
241178211$24117821$1$I$20220901$20240712$20240722$20240722$EXP$$ES-CELLTRION INC.-2024ES017316$CELLTRION$$$$$$Y$$$20240722$$MD$ES$ES
241178221$24117822$1$I$$20240708$20240722$20240722$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092409$GLENMARK$Marino-nunez D, Chadha A, Onajin O.. A Fatal Case of Cryptococcoid Vasculopathy. American Journal of Dermatopathology. 2024;46:7:S7$$$$$Y$$$20240722$$HP$US$US
241178231$24117823$1$I$$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024143762$AMGEN$$$$$$Y$$$20240722$$PH$US$US
241178242$24117824$2$F$$20240808$20240722$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-034663$AUROBINDO$LeBlanc FR, Grier DD, Myers KC, Shimamura A, Pommert L.. A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman?Diamond syndrome.. Pediatric Blood and Cancer. The American Society of Pediatric Hematology/Oncolog. 2024;71(8):e31137$27$YR$$M$Y$$$20240821$$MD$US$US
241178251$24117825$1$I$$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115491$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240722$$HP$US$US
241178261$24117826$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115071$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240722$$CN$US$US
241178271$24117827$1$I$$20240716$20240722$20240722$EXP$$US-GILEAD-2024-0681093$GILEAD$$$$A$F$Y$$$20240722$$CN$US$US
241178281$24117828$1$I$$20240711$20240722$20240722$EXP$$NL-AUROBINDO-AUR-APL-2024-034993$AUROBINDO$$68$YR$$F$Y$83$KG$20240722$$MD$NL$NL
241178291$24117829$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114873$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240722$$HP$US$US
241178301$24117830$1$I$$20240708$20240722$20240722$EXP$$DE-MELINTA THERAPEUTICS, LLC-DE-MLNT-24-00342$Unknown Manufacturer$$$$$$Y$$$20240722$$CN$DE$DE
241178311$24117831$1$I$20230701$20240714$20240722$20240722$EXP$$IL-EMD Serono-2024038461$EMD SERONO INC$$37$YR$A$F$Y$$$20240722$$CN$IL$IL
241178321$24117832$1$I$$20240718$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2024US066790$SANDOZ$$47$YR$$F$Y$$$20240722$$HP$US$US
241178332$24117833$2$F$$20240813$20240722$20240823$PER$$US-ABBVIE-5843791$ABBVIE$$$$$F$Y$$$20240823$$HP$US$US
241178341$24117834$1$I$$20240625$20240722$20240722$PER$$US-ROCHE-10000031501$ROCHE$$61$YR$A$F$Y$$$20240722$$CN$US$US
241178351$24117835$1$I$$20240717$20240722$20240722$EXP$$GB-ORGANON-O2407GBR001781$ORGANON$$69$YR$$F$Y$65$KG$20240722$$MD$GB$GB
241178361$24117836$1$I$$20240715$20240722$20240722$EXP$$MA-Tamarang, S.A.-2159416$TAMARANG PHARMACEUTICALS$Alj L, Tebaa A, Talibi I, Moubarik S, Benazzouz M, Soulaymani Bencheikh R. Lessonslearned from a cluster of immunization errors in newborns. Ther Adv Vaccines Immunother. 2024 Jan 2;12:25151355231221009. doi:?10.1177/25151355231221009. PMID: 38178960; PMCID: PMC10762870. Article found during weekly scientific literature research.$$$$$Y$$$20240722$$MD$MA$MA
241178381$24117838$1$I$20240508$20240712$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-034995$AUROBINDO$$29$YR$$F$Y$50$KG$20240722$$CN$FR$FR
241178391$24117839$1$I$20240101$20240715$20240722$20240722$EXP$$US-ABBVIE-5843187$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241178401$24117840$1$I$20240626$20240626$20240722$20240722$PER$$US-CSL-2024-006282$CSL Plasma$$42$YR$$F$Y$$$20240722$$HP$US$US
241178411$24117841$1$I$$20240716$20240722$20240722$EXP$$BR-TAKEDA-2024TUS073139$TAKEDA$$27$YR$$$Y$$$20240722$$CN$BR$BR
241178421$24117842$1$I$$20240716$20240722$20240722$EXP$$BR-TAKEDA-2024TUS073181$TAKEDA$$9$YR$$$Y$$$20240722$$CN$BR$BR
241178431$24117843$1$I$$20240708$20240722$20240722$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092397$GLENMARK$Yu EY, Ferrario C, Linch MD, Stoeckle M, Laguerre B, Arranz JA, et al.. Pembrolizumab plus abiraterone acetate and prednisone in patients with chemotherapy-na?ve metastatic castration-resistant prostate cancer: results from keynote-365 cohort D.. European Urology Oncology.. 2024$$$$$Y$$$20240722$$HP$US$US
241178441$24117844$1$I$20190903$20240716$20240722$20240722$EXP$$CA-TAKEDA-2019TUS050732$TAKEDA$$69$YR$$F$Y$$$20240722$$CN$CA$CA
241178452$24117845$2$F$20240710$20240816$20240722$20240823$EXP$$US-AMGEN-USASP2024140870$AMGEN$$11$MON$I$M$Y$$$20240823$$CN$US$US
241178461$24117846$1$I$20240701$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024142160$AMGEN$$67$YR$E$F$Y$$$20240722$$HP$US$US
241178472$24117847$2$F$20240718$20240730$20240722$20240802$PER$$US-AMGEN-USASP2024144600$AMGEN$$36$YR$A$F$Y$137.87$KG$20240802$$MD$US$US
241178481$24117848$1$I$20240101$20240715$20240722$20240722$EXP$$US-AMGEN-USASL2024135249$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241178491$24117849$1$I$20240101$20240711$20240722$20240722$PER$$CA-TOLMAR, INC.-24CA050977$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241178501$24117850$1$I$$20240712$20240722$20240722$EXP$$CA-TOLMAR, INC.-24CA050983$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241178511$24117851$1$I$$20240714$20240722$20240722$EXP$$CA-TOLMAR, INC.-24CA051023$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241178521$24117852$1$I$$20240713$20240722$20240722$EXP$$CA-TOLMAR, INC.-24CA051021$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241178531$24117853$1$I$$20240712$20240722$20240722$EXP$$CA-TOLMAR, INC.-24CA051025$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241178541$24117854$1$I$$20240713$20240722$20240722$EXP$$CA-TOLMAR, INC.-24CA051026$TOLMAR$$$$$M$Y$$$20240719$$CN$CA$CA
241178551$24117855$1$I$$20240711$20240722$20240722$EXP$$NL-TOLMAR, INC.-24NL050922$TOLMAR$$$$$M$Y$$$20240719$$CN$NL$NL
241178561$24117856$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089698$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241178571$24117857$1$I$20240601$20240712$20240722$20240722$EXP$$MX-ROCHE-10000028311$ROCHE$$35$YR$A$F$Y$59$KG$20240722$$CN$MX$MX
241178582$24117858$2$F$20240711$20240808$20240722$20240819$EXP$$GB-AUROBINDO-AUR-APL-2024-035133$AUROBINDO$$43$YR$$F$Y$$$20240819$$CN$GB$GB
241178591$24117859$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089832$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241178601$24117860$1$I$20240619$20240712$20240722$20240722$EXP$ES-AEMPS-1540420$ES-TEVA-VS-3220936$TEVA$$54$YR$$M$Y$100$KG$20240722$$MD$ES$ES
241178611$24117861$1$I$$20240711$20240722$20240722$EXP$$CA-APOTEX-2024AP008254$APOTEX$$68$YR$$F$Y$41$KG$20240722$$MD$CA$CA
241178621$24117862$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5695159$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241178631$24117863$1$I$$20240712$20240722$20240722$EXP$$NL-AUROBINDO-AUR-APL-2024-035638$AUROBINDO$$82$YR$$F$Y$56$KG$20240722$$PH$NL$NL
241178651$24117865$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS067184$TAKEDA$$$$$F$Y$$$20240722$$CN$US$US
241178661$24117866$1$I$$20240712$20240722$20240722$EXP$$JP-ROCHE-10000029841$ROCHE$$76$YR$E$M$Y$$$20240722$$PH$JP$JP
241178672$24117867$2$F$20240601$20240925$20240722$20240928$EXP$$CA-ABBVIE-5842737$ABBVIE$$43$YR$$M$Y$75$KG$20240928$$MD$CA$CA
241178681$24117868$1$I$$20230720$20240722$20240722$EXP$$US-AstraZeneca-2023A167076$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241178691$24117869$1$I$20220101$20220825$20240722$20240722$EXP$$CA-AstraZeneca-2022A288631$ASTRAZENECA$$59$YR$$F$Y$$$20240722$$MD$CA$
241178701$24117870$1$I$$20240716$20240722$20240722$EXP$$CA-AstraZeneca-2024A163996$ASTRAZENECA$$65$YR$$F$Y$$$20240722$$MD$CA$
241178711$24117871$1$I$20240301$20240717$20240722$20240722$EXP$$DK-AstraZeneca-2024A162922$ASTRAZENECA$$93$YR$$M$Y$$$20240722$$MD$DK$
241178721$24117872$1$I$$20230808$20240722$20240722$EXP$$US-AstraZeneca-2023A182109$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241178731$24117873$1$I$$20200427$20240722$20240722$EXP$$US-AstraZeneca-2020SE57662$ASTRAZENECA$$49$YR$$F$Y$$$20240722$$CN$US$
241178741$24117874$1$I$$20221005$20240722$20240722$EXP$$US-AstraZeneca-2022A340959$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241178751$24117875$1$I$$20221214$20240722$20240722$EXP$$US-AstraZeneca-2022A407279$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241178761$24117876$1$I$$20240714$20240722$20240722$EXP$$US-AstraZeneca-2024A161447$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241178771$24117877$1$I$$20240715$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115844$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240722$$CN$US$US
241178782$24117878$2$F$$20240924$20240722$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115478$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240930$$CN$US$US
241178791$24117879$1$I$$20240712$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113028$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240722$$CN$US$US
241178802$24117880$2$F$$20240715$20240722$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112244$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240812$$CN$US$US
241178812$24117881$2$F$20161109$20240912$20240722$20240924$EXP$$CN-ROCHE-2110072$ROCHE$$59$YR$A$F$Y$60$KG$20240924$$CN$CN$CN
241178821$24117882$1$I$$20240715$20240722$20240722$EXP$$CN-ROCHE-10000027827$ROCHE$Peng W, Tang N, Wang Q, Xiao Q, Tang X, Zhang H, et al. Allogeneic hematopoietic stem cell transplantation with low-dose bone marrow and PBSCs in 18 patients with severe aplastic anemia. Journal of Internal Intensive Medicine. 2024;30 (3):229-69. doi:10.11768/nkiwzzzz20240307.$$$$$Y$$$20240722$$HP$CN$CN
241178831$24117883$1$I$$20240610$20240722$20240722$PER$$BR-WT-2024-AMR-070331$Waylis$$$$$F$Y$$$20240722$$CN$BR$BR
241178841$24117884$1$I$20240619$20240712$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035696$AUROBINDO$$15$YR$$F$Y$46$KG$20240722$$MD$FR$FR
241178851$24117885$1$I$20240708$20240712$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035690$AUROBINDO$$86$YR$$F$Y$40$KG$20240722$$PH$FR$FR
241178861$24117886$1$I$20240701$20240715$20240722$20240722$PER$$US-ABBVIE-5846272$ABBVIE$$52$YR$$F$Y$$$20240722$$HP$US$US
241178871$24117887$1$I$$20240711$20240722$20240722$EXP$$JP-TAKEDA-2024TUS073159$TAKEDA$$69$YR$$M$Y$$$20240722$$MD$JP$JP
241178891$24117889$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5844194$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241178901$24117890$1$I$20240703$20240717$20240722$20240722$EXP$$US-ABBVIE-5844324$ABBVIE$$67$YR$$F$Y$$$20240722$$CN$US$US
241178911$24117891$1$I$$20240717$20240722$20240722$30DAY$$US-SANDOZ INC.-SDZ2024US066206$SANDOZ$$$$$F$Y$$$20240722$$HP$US$US
241178921$24117892$1$I$20240627$20240708$20240722$20240722$EXP$FR-AFSSAPS-BR2024000543$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109646$ZYDUS PHARM$$$$$$Y$$$20240722$$HP$FR$FR
241178931$24117893$1$I$$20240712$20240722$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-036010$AUROBINDO$CAVOLLI V, UKIMERAJ A, KRASNIQI S.. A RARE CASE OF A RESISTANT EXTRANODAL FOLLICULAR LYMPHOMA WITH PLASMACYTIC DIFFERENTIATION TRANSFORMED IN DIFFUSE LARGE B CELL LYMPHOMA TREATED SUCCESSFULLY WITH AUTOLOGOUS BONE MARROW TRANSPLANTATION.. hematol transfus cell ther.. 2024;46 (S3):13-28$48$YR$$F$Y$$$20240722$$HP$US$US
241178941$24117894$1$I$$20240717$20240722$20240722$EXP$FR-ALXN-202403EEA002029FR$FR-ROCHE-10000029666$ROCHE$$$$$F$Y$$$20240722$$MD$FR$FR
241178951$24117895$1$I$20240613$20240715$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2024US066038$SANDOZ$$24$YR$$F$Y$$$20240722$$HP$US$US
241178961$24117896$1$I$$20240712$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2024US066788$SANDOZ$$$$$$Y$$$20240722$$HP$US$US
241178981$24117898$1$I$$20240718$20240722$20240722$EXP$$US-UCBSA-2024036668$UCB$$$$$$Y$$$20240722$$CN$US$US
241178991$24117899$1$I$20240501$20240717$20240722$20240722$EXP$$US-UCBSA-2024029776$UCB$$38$YR$$M$Y$$$20240722$$CN$US$US
241179001$24117900$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087001$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
241179011$24117901$1$I$$20240709$20240722$20240722$EXP$$DE-ENDO USA, INC.-2024-002921$ENDO$Hans FP, Benning L, Pooth JS, Busch HJ.. A potentially lifesaving error: unintentional high-dose adrenaline administration in anaphylaxis-induced cardiac arrest; a case report. International Journal of Emergency Medicine. 2024;17(78):1-5$66$YR$$F$Y$$$20240722$$HP$DE$DE
241179021$24117902$1$I$$20240708$20240722$20240722$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-21353$SAMSUNG BIOEPIS$$$$$M$Y$$$20240722$$CN$CA$CA
241179031$24117903$1$I$$20240712$20240722$20240722$PER$$US-ABBVIE-5838703$ABBVIE$$78$YR$$F$Y$$$20240722$$HP$US$US
241179042$24117904$2$F$$20240730$20240722$20240813$EXP$$US-ENDO USA, INC.-2024-002947$ENDO$$$$$M$Y$$$20240813$$CN$US$US
241179051$24117905$1$I$20240624$20240715$20240722$20240722$EXP$$CN-ABBVIE-5844882$ABBVIE$$59$YR$$M$Y$60$KG$20240722$$HP$CN$CN
241179061$24117906$1$I$20240118$20240717$20240722$20240722$EXP$$CA-TAKEDA-2024TUS073169$TAKEDA$$83$YR$$F$Y$$$20240722$$CN$CA$CA
241179071$24117907$1$I$$20240708$20240722$20240722$EXP$$RU-Unichem Pharmaceuticals (USA) Inc-UCM202407-000880$UNICHEM$$$$$M$Y$$$20240722$$HP$RU$
241179081$24117908$1$I$$20240709$20240722$20240722$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202407-000879$UNICHEM$$41$YR$A$M$Y$$$20240722$$HP$US$
241179091$24117909$1$I$20230101$20240708$20240722$20240722$EXP$$US-CIPLA LTD.-2024US07477$CIPLA$$$$$$Y$$$20240722$$CN$US$US
241179101$24117910$1$I$$20231226$20240722$20240722$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425924$RANBAXY$$$$A$M$Y$$$20240722$$PH$US$US
241179111$24117911$1$I$$20230803$20240722$20240722$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404304$RANBAXY$$$$$$Y$$$20240722$$CN$US$US
241179121$24117912$1$I$$20230623$20240722$20240722$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397630$RANBAXY$$$$$F$Y$$$20240722$$CN$US$US
241179131$24117913$1$I$$20240405$20240722$20240722$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441890$RANBAXY$$$$$M$Y$$$20240722$$CN$US$US
241179142$24117914$2$F$$20240826$20240722$20240903$EXP$$US-TEVA-VS-3220952$TEVA$SHUKLA P, LUBRIN SI, SUBRAMANIAN R, JOSHI H. SEVERE ARDS AND IMMUNE RECONSTITUTION SYNDROME IN A RARE CASE OF MULTIDRUG-RESISTANT TUBERCULOSIS: A CASE REPORT AND REVIEW. Chest 2023; 164 (Suppl.) (4): A1514.; SHUKLA P, LUBRIN SI, SUBRAMANIAN R, JOSHI H. SEVERE ARDS AND IMMUNE RECONSTITUTION SYNDROME IN A RARE CASE OF MULTIDRUG-RESISTANT TUBERCULOSIS: A CASE REPORT AND REVIEW. Chest 2023; 164 (Suppl.) (4): A1514.$42$YR$$F$Y$$$20240903$$HP$US$US
241179151$24117915$1$I$$20240718$20240722$20240722$EXP$$US-TAKEDA-2024TUS073321$TAKEDA$$$$$M$Y$$$20240722$$CN$US$US
241179161$24117916$1$I$20230101$20240717$20240722$20240722$EXP$$US-ABBVIE-5844044$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241179171$24117917$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115359$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240722$$CN$US$US
241179183$24117918$3$F$20240711$20240731$20240722$20240802$PER$$US-AMGEN-USASP2024144007$AMGEN$$54$YR$A$$Y$$$20240802$$CN$US$US
241179191$24117919$1$I$20240712$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024142937$AMGEN$$$$$$Y$$$20240722$$HP$US$US
241179202$24117920$2$F$20240501$20240805$20240722$20240806$PER$$US-AMGEN-USASP2024143038$AMGEN$$45$YR$A$F$Y$$$20240806$$CN$US$US
241179211$24117921$1$I$$20240715$20240722$20240722$EXP$$NZ-AMGEN-NZLSL2024140562$AMGEN$$$$$F$Y$$$20240722$$CN$NZ$NZ
241179222$24117922$2$F$$20240711$20240722$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-035581$AUROBINDO$$63$YR$$F$Y$66$KG$20240719$$CN$NL$NL
241179231$24117923$1$I$$20240716$20240722$20240722$EXP$$CA-ABBVIE-5844722$ABBVIE$$$$A$M$Y$$$20240722$$CN$CA$CA
241179251$24117925$1$I$20240715$20240717$20240722$20240722$EXP$$US-ABBVIE-5844612$ABBVIE$$65$YR$$F$Y$$$20240722$$CN$US$US
241179262$24117926$2$F$$20240722$20240722$20240725$PER$$US-AMGEN-USASP2024142942$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241179271$24117927$1$I$20240701$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143098$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241179282$24117928$2$F$20240101$20240718$20240722$20240726$PER$$US-ABBVIE-5841235$ABBVIE$$$$$F$Y$$$20240726$$MD$US$US
241179291$24117929$1$I$$20240712$20240722$20240722$EXP$$GB-TEVA-VS-3221501$TEVA$$52$YR$$F$Y$$$20240722$$MD$GB$GB
241179301$24117930$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000030500$ROCHE$$$$$F$Y$$$20240722$$HP$US$US
241179321$24117932$1$I$$20240718$20240722$20240722$EXP$$CA-ABBVIE-5846919$ABBVIE$$$$A$F$Y$$$20240722$$HP$CA$CA
241179331$24117933$1$I$$20240718$20240722$20240722$EXP$$US-ABBVIE-5846433$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241179341$24117934$1$I$$20240716$20240722$20240722$PER$$US-ABBVIE-5846139$ABBVIE$$$$$$Y$$$20240722$$CN$US$US
241179351$24117935$1$I$$20240715$20240722$20240722$PER$$US-ALXN-202407USA000957US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
241179361$24117936$1$I$$20240717$20240722$20240722$EXP$$ES-UCBSA-2024030732$UCB$$3$YR$$F$Y$12$KG$20240722$$HP$ES$ES
241179373$24117937$3$F$20240601$20240830$20240722$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-035519$AUROBINDO$$$$E$F$Y$$$20240910$$MD$DE$DE
241179384$24117938$4$F$20240101$20240806$20240722$20240810$EXP$$CH-ABBVIE-5846227$ABBVIE$$$$$M$Y$$$20240810$$CN$CH$CH
241179391$24117939$1$I$20210224$20210324$20240722$20240722$EXP$$CO-AstraZeneca-2021A225015$ASTRAZENECA$$19153$DY$$F$Y$69$KG$20240722$$CN$CO$
241179401$24117940$1$I$$20220418$20240722$20240722$EXP$$US-AstraZeneca-2022A158478$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241179411$24117941$1$I$20200401$20200715$20240722$20240722$EXP$$CA-AstraZeneca-2020SE71589$ASTRAZENECA$$779$MON$$F$Y$$$20240722$$CN$CA$
241179421$24117942$1$I$$20200617$20240722$20240722$EXP$$US-AstraZeneca-2020SE78242$ASTRAZENECA$$72$YR$$F$Y$$$20240722$$CN$US$
241179431$24117943$1$I$$20240712$20240722$20240722$EXP$$CA-CELLTRION INC.-2024CA017479$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
241179441$24117944$1$I$$20200609$20240722$20240722$EXP$$US-AstraZeneca-2020SE75657$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241179451$24117945$1$I$20210511$20210602$20240722$20240722$EXP$$US-AstraZeneca-2021A500920$ASTRAZENECA$$23663$DY$$F$Y$$$20240722$$CN$US$
241179461$24117946$1$I$$20200721$20240722$20240722$EXP$$ZA-AstraZeneca-2020SE91704$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$ZA$
241179472$24117947$2$F$$20240718$20240722$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040728$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240719$$CN$US$US
241179482$24117948$2$F$$20240719$20240722$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040821$BOEHRINGER INGELHEIM$$$$$$Y$$$20240719$$CN$US$US
241179491$24117949$1$I$20220101$20240716$20240722$20240722$EXP$$TW-Orion Corporation ORION PHARMA-24_00030872$ORION$Hsieh C, Yu S. Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosedin a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Association.. Indian Journal of Dermatology. 2024;69(3):264-7.$66$YR$E$M$Y$$$20240722$$MD$TW$
241179502$24117950$2$F$20240101$20240909$20240722$20240917$EXP$$CA-CELLTRION INC.-2024CA013311$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
241179512$24117951$2$F$$20240718$20240722$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040689$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240719$$MD$US$US
241179524$24117952$4$F$$20240903$20240722$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113969$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$54.88$KG$20240906$$PH$US$US
241179531$24117953$1$I$$20240716$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115735$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$MD$JP$JP
241179541$24117954$1$I$20231018$20240717$20240722$20240722$EXP$FR-EMA-DD-20240710-7482677-061504$FR-Orion Corporation ORION PHARMA-24_00030894$ORION$$84$YR$E$F$Y$48.5$KG$20240722$$MD$FR$
241179551$24117955$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115626$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240722$$HP$US$US
241179561$24117956$1$I$$20240716$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115726$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$MD$JP$JP
241179572$24117957$2$F$$20240812$20240722$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113918$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240813$$CN$US$US
241179581$24117958$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115649$BRISTOL MYERS SQUIBB$$23$YR$A$F$Y$$$20240722$$HP$US$US
241179593$24117959$3$F$20240717$20240801$20240722$20240802$EXP$$VN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040536$BOEHRINGER INGELHEIM$$91$YR$E$M$Y$45$KG$20240802$$MD$VN$VN
241179603$24117960$3$F$$20240911$20240722$20240912$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-026380$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$72$KG$20240912$$MD$CA$CA
241179612$24117961$2$F$$20240717$20240722$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040401$BOEHRINGER INGELHEIM$$$$$$Y$$$20240719$$CN$US$US
241179621$24117962$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5845105$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241179632$24117963$2$F$20240304$20240719$20240722$20240723$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040773$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240719$$MD$JP$JP
241179644$24117964$4$F$$20240913$20240722$20240920$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-007774$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240920$$CN$US$US
241179651$24117965$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141572$AMGEN$Thorne J.E.; Liu T.; Mopuru R. et al.. Swept Source Optical Coherence Tomography Angiography Findings in Birdshot Chorioretinitis: A Cross Sectional Study of 21 Patients. Ocular Immunology and Inflammation. 2024;32 (5):616-620$$$$$Y$$$20240722$$MD$US$US
241179662$24117966$2$F$20200101$20240817$20240722$20240821$PER$$US-AMGEN-USASP2024143056$AMGEN$$54$YR$A$F$Y$$$20240821$$MD$US$US
241179671$24117967$1$I$20240716$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141407$AMGEN$$61$YR$A$F$Y$$$20240722$$CN$US$US
241179682$24117968$2$F$20240709$20240719$20240722$20240723$EXP$ES-AEMPS-1550061$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040789$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240719$$PH$ES$ES
241179696$24117969$6$F$20240717$20240920$20240722$20240925$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040778$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240925$$MD$CN$CN
241179702$24117970$2$F$$20240716$20240722$20240724$EXP$AU-ASPEN-AUS2024AU003908$AU-TGA-0000812171$SANDOZ$$3$MON$$$Y$$$20240724$$HP$AU$AU
241179712$24117971$2$F$20240101$20240719$20240722$20240723$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040767$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240719$$MD$SK$SK
241179721$24117972$1$I$$20240719$20240722$20240722$PER$$US-TAKEDA-2024TUS073337$TAKEDA$$$$$$Y$$$20240722$$CN$US$US
241179732$24117973$2$F$$20240711$20240722$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-225069$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240719$$CN$US$US
241179742$24117974$2$F$20240501$20240719$20240722$20240723$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040755$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$$$20240719$$MD$SK$SK
241179752$24117975$2$F$20240401$20240718$20240722$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040685$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240719$$CN$US$US
241179764$24117976$4$F$20240717$20240815$20240722$20240815$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040646$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240815$$PH$CA$CA
241179772$24117977$2$F$$20240717$20240722$20240723$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040511$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240719$$PH$JP$JP
241179781$24117978$1$I$$20240722$20240722$20240722$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041041$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240722$$MD$JP$JP
241179791$24117979$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089695$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241179811$24117981$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5844432$ABBVIE$$$$$F$Y$$$20240722$$HP$US$US
241179821$24117982$1$I$$20240709$20240722$20240722$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06607$HIKMA$$8$YR$$F$Y$28$KG$20240722$$PH$CA$CA
241179831$24117983$1$I$20240601$20240718$20240722$20240722$EXP$$AR-ABBVIE-5846281$ABBVIE$$55$YR$$M$Y$$$20240722$$CN$AR$AR
241179841$24117984$1$I$$20240619$20240722$20240722$PER$$BR-WT-2024-AMR-072415$Waylis$$$$E$F$Y$$$20240722$$CN$BR$BR
241179851$24117985$1$I$$20240708$20240722$20240722$EXP$$US-CIPLA LTD.-2024US07305$CIPLA$Li S, Halloran P, Siref A.. Concurrent neutrophilic eccrine hidradenitis and leukocytoclastic vasculitis. American Journal of Dermatopathology. 2024;46 (7):S20$$$$$Y$$$20240722$$MD$US$US
241179861$24117986$1$I$20240101$20240716$20240722$20240722$EXP$$CA-ABBVIE-5844569$ABBVIE$$$$A$F$Y$$$20240722$$CN$CA$CA
241179881$24117988$1$I$20240703$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407120834373590-RMKVP$GB-TEVA-VS-3221404$TEVA$$50$YR$$M$Y$$$20240722$$PH$GB$GB
241179891$24117989$1$I$20240601$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407121558575780-FMSJC$GB-TEVA-VS-3221438$TEVA$$$$$F$Y$$$20240722$$HP$GB$GB
241179901$24117990$1$I$$20240715$20240722$20240722$PER$$US-AMGEN-USASP2024143054$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241179912$24117991$2$F$20231101$20240819$20240722$20240824$EXP$$JP-ROCHE-3536410$ROCHE$$82$YR$E$F$Y$51$KG$20240824$$MD$JP$JP
241179921$24117992$1$I$20231006$20240712$20240722$20240722$EXP$$FR-Stemline Therapeutics, Inc.-2024ST004302$STEMLINE THERAPEUTICS$$52$YR$A$F$Y$74$KG$20240717$$PH$FR$FR
241179931$24117993$1$I$20240401$20240708$20240722$20240722$EXP$$FR-CIPLA LTD.-2024FR07433$CIPLA$$$$$$Y$$$20240722$$CN$FR$FR
241179941$24117994$1$I$20240711$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407120838256340-CQDNG$GB-TEVA-VS-3220973$TEVA$$24$YR$$F$Y$$$20240722$$HP$GB$GB
241179951$24117995$1$I$$20240712$20240722$20240722$EXP$$US-Stemline Therapeutics, Inc.-2024ST004297$STEMLINE THERAPEUTICS$$62$YR$A$F$Y$$$20240717$$CN$US$US
241179961$24117996$1$I$$20240715$20240722$20240722$PER$$US-ALXN-202407USA001016US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
241179971$24117997$1$I$20240511$20240715$20240722$20240722$EXP$$US-Stemline Therapeutics, Inc.-2024ST003170$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240717$$CN$US$US
241179981$24117998$1$I$20240101$20240712$20240722$20240722$EXP$$CA-CELLTRION INC.-2024CA014722$CELLTRION$$$$$$Y$$$20240722$$MD$CA$CA
241179991$24117999$1$I$$20240717$20240722$20240722$EXP$$JP-GSK-JP2024089921$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$JP$JP
241180001$24118000$1$I$20240101$20240716$20240722$20240722$PER$$US-ABBVIE-5843788$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241180011$24118001$1$I$$20240718$20240722$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA066640$SANDOZ$$41$YR$$M$Y$$$20240722$$CN$CA$CA
241180022$24118002$2$F$$20240809$20240722$20240823$EXP$$DK-TRIGEN LABORATORIES-2024ALO00327$Alora Pharma$Hansen SK, M?rk K, Tcacenco O, Vinter-Jensen L. Dissection of the coeliac trunk.. Ugeskr Laeger. 2024;186(2):V07230468$39$YR$$M$Y$$$20240823$$HP$DK$DK
241180031$24118003$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089613$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241180041$24118004$1$I$$20240715$20240722$20240722$EXP$$US-Stemline Therapeutics, Inc.-2024ST004322$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240717$$CN$US$US
241180053$24118005$3$F$20240715$20240902$20240722$20240902$EXP$$US-ALXN-202407USA000972US$ALEXION PHARMACEUTICALS$$71$YR$$M$Y$86.2$KG$20240902$$MD$US$US
241180061$24118006$1$I$$20240711$20240722$20240722$EXP$$US-Stemline Therapeutics, Inc.-2024ST004264$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240717$$CN$US$US
241180071$24118007$1$I$$20240718$20240722$20240722$EXP$$NVSC2024US148780$NOVARTIS$$$$$F$Y$$$20240722$$CN$US$US
241180081$24118008$1$I$$20240716$20240722$20240722$PER$$NVSC2024US149269$NOVARTIS$$$$$F$Y$49$KG$20240722$$HP$US$US
241180091$24118009$1$I$$20220511$20240722$20240722$EXP$$SG-AstraZeneca-2022A184284$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$SG$
241180101$24118010$1$I$$20210408$20240722$20240722$EXP$$RU-AstraZeneca-2021A284820$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$RU$
241180111$24118011$1$I$$20230621$20240722$20240722$EXP$$US-AstraZeneca-2023A146176$ASTRAZENECA$$$$$F$Y$$$20240722$$HP$US$
241180121$24118012$1$I$$20240708$20240722$20240722$EXP$$LB-NKFPHARMA-2024MPLIT00209$NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL$Zakar R, Saad N, El Tannoury M, El Tannoury B, Ismail MA, Riachy M, Karam L.Heparin-Induced Hemorrhagic Bullous Dermatosis: A Rare Complication of Unfractionated Heparin.cureus.JUL-2024;16 (7):1-10$82$YR$E$F$Y$$$20240722$$HP$LB$LB
241180131$24118013$1$I$20240514$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115479$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240722$$HP$US$US
241180141$24118014$1$I$$20240711$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111190$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240722$$CN$US$US
241180152$24118015$2$F$$20240724$20240722$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114809$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240726$$HP$US$US
241180161$24118016$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114256$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240722$$HP$US$US
241180171$24118017$1$I$$20200302$20240722$20240722$EXP$$CA-AstraZeneca-2020SE34144$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$CA$
241180181$24118018$1$I$20240710$20240711$20240722$20240722$EXP$$US-Stemline Therapeutics, Inc.-2024ST004253$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240717$$HP$US$US
241180191$24118019$1$I$$20210902$20240722$20240722$EXP$$US-AstraZeneca-2021A710820$ASTRAZENECA$$$$$$Y$$$20240722$$CN$US$
241180201$24118020$1$I$$20210924$20240722$20240722$EXP$$US-AstraZeneca-2021A747676$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241180211$24118021$1$I$20190930$20191003$20240722$20240722$EXP$$CO-AstraZeneca-2019SF42717$ASTRAZENECA$$30410$DY$$M$Y$$$20240722$$CN$CO$
241180221$24118022$1$I$$20230907$20240722$20240722$EXP$$CR-AstraZeneca-2023A206069$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$CR$
241180231$24118023$1$I$$20240714$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-035195$AUROBINDO$$$$$M$Y$$$20240722$$CN$GB$GB
241180241$24118024$1$I$$20211004$20240722$20240722$EXP$$US-AstraZeneca-2021A760214$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241180251$24118025$1$I$$20200811$20240722$20240722$EXP$$US-AstraZeneca-2020SF03355$ASTRAZENECA$$59$YR$$M$Y$$$20240722$$CN$US$
241180261$24118026$1$I$$20240712$20240722$20240722$EXP$$GB-TEVA-VS-3221407$TEVA$$62$YR$$M$Y$112$KG$20240722$$PH$GB$GB
241180272$24118027$2$F$20240601$20240729$20240722$20240731$EXP$$US-UCBSA-2024036702$UCB$$37$YR$$M$Y$$$20240731$$HP$US$US
241180282$24118028$2$F$20240214$20240809$20240722$20240812$PER$$US-BIOVITRUM-2024-US-009931$BIOVITRUM$$10$YR$$F$Y$$$20240812$$CN$US$US
241180291$24118029$1$I$$20240716$20240722$20240722$EXP$$CA-AMGEN-CANSP2024142554$AMGEN$$$$$$Y$$$20240722$$CN$CA$CA
241180302$24118030$2$F$$20240719$20240722$20240724$PER$$US-AMGEN-USASP2024144452$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241180311$24118031$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089813$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241180321$24118032$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089694$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241180333$24118033$3$F$$20240919$20240722$20240924$EXP$$JP-GSK-JP2024JPN090294$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$PH$JP$JP
241180341$24118034$1$I$$20240712$20240722$20240722$EXP$$US-Stemline Therapeutics, Inc.-2024ST004289$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240717$$CN$US$US
241180351$24118035$1$I$$20240715$20240722$20240722$EXP$$US-Stemline Therapeutics, Inc.-2024ST004307$STEMLINE THERAPEUTICS$$84$YR$E$F$Y$$$20240717$$CN$US$US
241180361$24118036$1$I$$20240712$20240722$20240722$EXP$$GB-TEVA-VS-3221521$TEVA$$44$YR$$M$Y$81$KG$20240722$$PH$GB$GB
241180371$24118037$1$I$$20240717$20240722$20240722$EXP$$AU-SANDOZ INC.-SDZ2024AU066384$SANDOZ$$$$$$Y$$$20240722$$HP$AU$AU
241180382$24118038$2$F$20220922$20240729$20240722$20240801$EXP$$JP-GSK-JP2023JPN103752$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$MD$JP$JP
241180394$24118039$4$F$20240101$20240905$20240722$20240919$EXP$$US-INSMED, INC.-2024-02816-US$INSMED$$$$$F$Y$$$20240919$$CN$US$US
241180402$24118040$2$F$20220328$20240724$20240722$20240803$EXP$$FR-AUROBINDO-AUR-APL-2024-035219$AUROBINDO$$50$YR$$F$Y$$$20240803$$HP$FR$FR
241180411$24118041$1$I$$20240620$20240722$20240722$PER$$JP-WT-2024-073007$Waylis$$91$YR$$M$Y$$$20240722$$PH$JP$JP
241180421$24118042$1$I$$20240715$20240722$20240722$EXP$$US-LEO Pharma-372026$LEO PHARM$$72$YR$$F$Y$$$20240722$$HP$US$US
241180431$24118043$1$I$20240712$20240712$20240722$20240722$EXP$$US-Stemline Therapeutics, Inc.-2024ST004300$STEMLINE THERAPEUTICS$$82$YR$E$F$Y$$$20240717$$CN$US$US
241180441$24118044$1$I$$20240708$20240722$20240722$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06655$HIKMA$Slaczka F, Slaczka M, Janjua E.. Slaczka F, Slaczka M, Janjua E. Refractory Crohn^s Disease Responsive to Dietary Therapy: A Case Report. Cureus. 2024;16(5):e61262:1-9$4$DEC$$M$Y$$$20240722$$MD$US$US
241180451$24118045$1$I$$20240715$20240722$20240722$EXP$$US-Stemline Therapeutics, Inc.-2024ST004325$STEMLINE THERAPEUTICS$$96$YR$E$F$Y$$$20240717$$CN$US$US
241180461$24118046$1$I$20240701$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143021$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241180472$24118047$2$F$$20240822$20240722$20240829$EXP$$US-TEVA-VS-3220027$TEVA$Contag CA, Studemeister L, Bogler Y, Cooper JD. Q fever presenting as splenic infarct without endocarditis. IDCases 2024; 37.; Contag CA, Studemeister L, Bogler Y, Cooper JD. Q fever presenting as splenic infarct without endocarditis. IDCases 2024; 37.$44$YR$$M$Y$$$20240829$$HP$US$US
241180481$24118048$1$I$$20240708$20240722$20240722$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06671$HIKMA$Fenton GA, Dean EA.. Fenton GA, Dean EA. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report.. Case Reports in Oncology. 2024;17(1):75-81$64$YR$$F$Y$$$20240722$$MD$US$US
241180491$24118049$1$I$$20240712$20240722$20240722$EXP$$US-Stemline Therapeutics, Inc.-2024ST004301$STEMLINE THERAPEUTICS$$88$YR$E$F$Y$$$20240716$$CN$US$US
241180504$24118050$4$F$20231101$20240719$20240722$20240801$PER$$US-ROCHE-10000027240$ROCHE$$77$YR$E$M$Y$98.88$KG$20240801$$CN$US$US
241180511$24118051$1$I$$20240709$20240722$20240722$PER$$US-ROCHE-10000028222$ROCHE$$$$$$Y$$$20240722$$MD$US$US
241180522$24118052$2$F$20240708$20240717$20240722$20240729$PER$$US-ROCHE-10000029433$ROCHE$$$$$$Y$$$20240729$$PH$US$US
241180531$24118053$1$I$20240101$20240717$20240722$20240722$EXP$$US-ABBVIE-5844436$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241180541$24118054$1$I$$20240708$20240722$20240722$PER$$US-ROCHE-10000026315$ROCHE$$$$E$F$Y$$$20240722$$CN$US$US
241180553$24118055$3$F$$20240718$20240722$20240725$PER$$US-ROCHE-10000022293$ROCHE$$$$$$Y$$$20240725$$HP$US$US
241180561$24118056$1$I$$20240202$20240722$20240722$EXP$GB-MHRA-MED-202402011207378440-QDGSB$GB-TEVA-VS-3152313$TEVA$$6$YR$$M$Y$$$20240722$$HP$GB$GB
241180571$24118057$1$I$20240601$20240710$20240722$20240722$EXP$$IT-ROCHE-10000025620$ROCHE$$46$YR$A$M$Y$$$20240722$$MD$IT$IT
241180581$24118058$1$I$$20240709$20240722$20240722$EXP$$US-862174955-ML2024-03981$Unknown Manufacturer$Qaiser S, Divanna M, Amir N, Luzuriaga A, Rodriguez C. Real-World Administration of Dantrolene: Harder Than a Board Exam. Am J Respir Crit Care Med. 2024;209: A3654.$65$YR$E$F$Y$$$20240722$$HP$US$US
241180592$24118059$2$F$20240614$20240731$20240722$20240812$EXP$GB-MHRA-MED-202407100125064420-GCWKP$GB-862174955-ML2024-04043$MICRO LABS$$37$YR$A$M$Y$72$KG$20240812$$CN$GB$GB
241180601$24118060$1$I$$20240709$20240722$20240722$EXP$$US-862174955-ML2024-03983$Unknown Manufacturer$Habib A, Butt K, Ibrahim R, Shaaban A, Lee HS. BRASH syndrome: A rare but reversible cause of sinus node dysfunction. Heart Rhythm Case Reports. 2024;10: 398-401. doi:10.1016/j.hrcr.2024.03.005.$57$YR$A$F$Y$$$20240722$$MD$US$US
241180611$24118061$1$I$$20240709$20240722$20240722$EXP$$US-GENEYORK-2024PPLIT00042$GENEYORK PHARMA$Deanda S, et al.Post-transplant Lymphoproliferative Disorder: A Nodular Area That Kept Growing.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209 (1):A5942$79$YR$E$F$Y$$$20240722$$HP$US$US
241180621$24118062$1$I$20220721$20220819$20240722$20240722$EXP$$CO-BIOVITRUM-2022CO09127$BIOVITRUM$$141$DY$$F$Y$5.8$KG$20240722$$CN$CO$CO
241180631$24118063$1$I$20240606$20240711$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-035027$AUROBINDO$$24$YR$$F$Y$55$KG$20240722$$CN$GB$GB
241180641$24118064$1$I$20230309$20240712$20240722$20240722$EXP$$CA-CELLTRION INC.-2023CA005689$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
241180651$24118065$1$I$$20240715$20240722$20240722$EXP$NL-LRB-00979004$NL-SA-2024SA208347$SANOFI AVENTIS$$53$YR$A$M$Y$88$KG$20240722$$HP$NL$NL
241180662$24118066$2$F$20240701$20240808$20240722$20240814$EXP$$US-SA-2024SA211849$SANOFI AVENTIS$$41$YR$A$F$Y$49.89$KG$20240814$$MD$US$US
241180671$24118067$1$I$20240704$20240714$20240722$20240722$EXP$$JP-ROCHE-10000030201$ROCHE$$77$YR$E$$Y$$$20240722$$MD$JP$JP
241180681$24118068$1$I$$20240711$20240722$20240722$EXP$$NL-AUROBINDO-AUR-APL-2024-035374$AUROBINDO$$76$YR$$F$Y$75$KG$20240722$$CN$NL$NL
241180691$24118069$1$I$$20240717$20240722$20240722$EXP$AU-TGA-0000781943$AU-SANDOZ INC.-SDZ2024AU050898$SANDOZ$$$$$$Y$$$20240722$$PH$AU$AU
241180721$24118072$1$I$$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113246$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240722$$HP$US$US
241180731$24118073$1$I$$20240712$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111580$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240722$$PH$US$US
241180741$24118074$1$I$20240701$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114064$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240722$$CN$US$US
241180752$24118075$2$F$$20240830$20240722$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114160$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240904$$HP$US$US
241180761$24118076$1$I$20240703$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115357$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240722$$CN$US$US
241180771$24118077$1$I$$20240712$20240722$20240722$EXP$$GB-ROCHE-10000026931$ROCHE$$$$A$F$Y$$$20240722$$HP$GB$GB
241180782$24118078$2$F$$20240723$20240722$20240802$EXP$$IT-AUROBINDO-AUR-APL-2024-034868$AUROBINDO$Lecis M, Stefanelli F, Montanari F, Biase AR, Lucaccioni L, Iughetti L.. Mesalamine-induced myopericarditis in children: a case report and a short revision of the literature.. Acta Biomedica. 2024;95(3):e2024035$14$YR$$M$Y$$$20240802$$MD$IT$IT
241180791$24118079$1$I$20240715$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142507$AMGEN$$82$YR$E$F$Y$$$20240722$$CN$US$US
241180801$24118080$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087728$GLAXOSMITHKLINE$$$$$M$Y$$$20240722$$CN$US$US
241180812$24118081$2$F$$20240719$20240722$20240724$EXP$$JP-GSK-JP2024JPN090803$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$PH$JP$JP
241180821$24118082$1$I$$20240718$20240722$20240722$30DAY$$US-GSK-US2024AMR091188$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$PH$US$US
241180831$24118083$1$I$20240101$20240718$20240722$20240722$EXP$$US-UCBSA-2024023349$UCB$$$$$M$Y$$$20240722$$CN$US$US
241180841$24118084$1$I$$20240708$20240722$20240722$PER$$US-ROCHE-10000019518$ROCHE$Wiersma R, Shaheen Z, Correll C, Hobday P. Case Report: Contiguous presentation of anti-MDA5 juvenile dermatomyositis and anti-AQP4 neuromyelitis optica spectrum disorder in an adolescent patient. Frontiers in Pediatrics. 2024-Jan;12:1-7. doi:10.3389/fped.2024.1376088.$17$YR$T$M$Y$$$20240722$$HP$US$US
241180852$24118085$2$F$20240101$20240716$20240722$20240723$EXP$$CA-CELLTRION INC.-2024CA017466$CELLTRION$$$$$$Y$$$20240723$$PH$CA$CA
241180871$24118087$1$I$$20240719$20240722$20240722$PER$$NVSC2024US149642$NOVARTIS$$73$YR$$F$Y$$$20240722$$MD$US$US
241180881$24118088$1$I$20240620$20240708$20240722$20240722$EXP$PT-INFARMED-R202406-548$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-06516$HIKMA$$$$$$Y$$$20240722$$PH$PT$PT
241180891$24118089$1$I$$20240709$20240722$20240722$PER$$US-AstraZeneca-2024A158262$ASTRAZENECA$$$$$$Y$$$20240722$$CN$US$
241180901$24118090$1$I$20160301$20210324$20240722$20240722$EXP$$CA-AstraZeneca-2020SF07850$ASTRAZENECA$$71$YR$$F$Y$89$KG$20240722$$MD$CA$
241180911$24118091$1$I$$20240720$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041025$BOEHRINGER INGELHEIM$$$$$$Y$$$20240722$$CN$US$US
241180921$24118092$1$I$$20220520$20240722$20240722$EXP$$US-AstraZeneca-2022A194433$ASTRAZENECA$$$$$$Y$$$20240722$$CN$US$
241180931$24118093$1$I$$20200501$20240722$20240722$EXP$$US-AstraZeneca-2020SE59978$ASTRAZENECA$$78$YR$$M$Y$$$20240722$$CN$US$
241180941$24118094$1$I$$20210624$20240722$20240722$EXP$$US-AstraZeneca-2021A564853$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241180951$24118095$1$I$20200910$20200910$20240722$20240722$EXP$$US-AstraZeneca-2020SF11375$ASTRAZENECA$$79$YR$$M$Y$$$20240722$$CN$US$
241180963$24118096$3$F$20240624$20240909$20240722$20240923$EXP$$JP-BRAINTREE LABORATORIES, INC.-2024BTE00430$BRAINTREE$$58$YR$$F$Y$48$KG$20240923$$CN$JP$JP
241180973$24118097$3$F$20240624$20240812$20240722$20240816$EXP$$BE-AstraZeneca-2024A162757$ASTRAZENECA$$85$YR$$M$Y$$$20240816$$MD$BE$
241180981$24118098$1$I$20200827$20200915$20240722$20240722$EXP$$US-AstraZeneca-2020SF12794$ASTRAZENECA$$28146$DY$$M$Y$$$20240722$$CN$US$
241180991$24118099$1$I$$20240711$20240722$20240722$EXP$$NL-AUROBINDO-AUR-APL-2024-035163$AUROBINDO$$92$YR$$F$Y$71$KG$20240722$$MD$NL$NL
241181001$24118100$1$I$20240626$20240716$20240722$20240722$EXP$$US-LEO Pharma-372061$LEO PHARM$$61$YR$$F$Y$$$20240722$$PH$US$US
241181012$24118101$2$F$20240701$20240716$20240722$20240725$PER$$US-AMGEN-USASP2024140726$AMGEN$$58$YR$A$F$Y$$$20240725$$CN$US$US
241181021$24118102$1$I$$20230831$20240722$20240722$EXP$$US-AstraZeneca-2023A199038$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241181031$24118103$1$I$$20230228$20240722$20240722$EXP$$GB-AstraZeneca-2023A010182$ASTRAZENECA$$$$$$Y$76$KG$20240722$$HP$GB$
241181041$24118104$1$I$20211119$20211119$20240722$20240722$EXP$$SG-AstraZeneca-2021A821223$ASTRAZENECA$$75$YR$$$Y$$$20240722$$CN$SG$
241181051$24118105$1$I$$20240715$20240722$20240722$EXP$$CA-ABBVIE-5847008$ABBVIE$$12$YR$$$Y$$$20240722$$MD$CA$CA
241181061$24118106$1$I$$20210309$20240722$20240722$EXP$$US-AstraZeneca-2020SF44990$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241181071$24118107$1$I$$20201021$20240722$20240722$EXP$$US-AstraZeneca-2020SF15250$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241181081$24118108$1$I$$20230209$20240722$20240722$EXP$$US-AstraZeneca-2023A035534$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241181091$24118109$1$I$$20240715$20240722$20240722$EXP$$BE-AMGEN-BELSP2024141758$AMGEN$Christelle L.. Activity of apremilast in a patient with severe pemphigus vulgaris: case report. Frontiers in Immunology. 2024;15:1-4$67$YR$E$F$Y$$$20240722$$HP$BE$BE
241181101$24118110$1$I$$20200918$20240722$20240722$EXP$$US-AstraZeneca-2020SF22288$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241181111$24118111$1$I$$20211027$20240722$20240722$EXP$$US-AstraZeneca-2021A789560$ASTRAZENECA$$$$$F$Y$74.8$KG$20240722$$CN$US$
241181124$24118112$4$F$$20240716$20240722$20240729$EXP$$US-ROCHE-10000027871$ROCHE$Chamseddine S, LaPelusa M, Carter K, Nguyen V, Mohamed Y, Sakr Y, et al. Severe febrile neutropenia and pancytopenia in a patient with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: a case report. Journal of Gastrointestinal Oncology. 2024-Jun;15 (3):1324-1330. doi:10.21037/jgo-24-290.$$$A$M$Y$$$20240729$$HP$US$US
241181131$24118113$1$I$$20240712$20240722$20240722$EXP$$CA-APOTEX-2024AP008330$APOTEX$$74$YR$$M$Y$108$KG$20240722$$PH$CA$CA
241181141$24118114$1$I$$20240712$20240722$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-036048$AUROBINDO$Burke B, El-Assaad I, Patel AR, Aziz PF. PO-05-078 NO ESCAPE? NO PROBLEM: FULMINANT MYOCARDITIS WITH COMPLETE AV BLOCK WITHOUT VENTRICULAR ESCAPE IN A PEDIATRIC PATIENT.. Heart-Rhythm. 2024;21 (Suppl.)(5):S607$6$YR$$F$Y$$$20240722$$HP$US$US
241181151$24118115$1$I$20040101$20240716$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2024US065938$SANDOZ$$$$$F$Y$$$20240722$$CN$US$US
241181171$24118117$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114864$BRISTOL MYERS SQUIBB$$25$YR$A$F$Y$$$20240722$$HP$US$US
241181182$24118118$2$F$$20240908$20240722$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115369$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$57.15$KG$20240910$$CN$US$US
241181191$24118119$1$I$20240714$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114047$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240722$$CN$US$US
241181201$24118120$1$I$$20240721$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115660$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$79.38$KG$20240722$$CN$US$US
241181211$24118121$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114319$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240722$$CN$US$US
241181222$24118122$2$F$$20240717$20240722$20240722$PER$$US-ROCHE-10000029789$ROCHE$$$$$$Y$$$20240722$$CN$US$US
241181232$24118123$2$F$20240601$20240724$20240722$20240808$EXP$$US-COOPERSURGICAL, INC.-2024CPS002137$COOPERSURGICAL$$25$YR$$F$Y$88.435$KG$20240807$$CN$US$US
241181241$24118124$1$I$20240605$20240712$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035667$AUROBINDO$$61$YR$$F$Y$$$20240722$$PH$FR$FR
241181251$24118125$1$I$$20240716$20240722$20240722$EXP$$US-LEO Pharma-372102$LEO PHARM$$56$YR$$F$Y$$$20240722$$CN$US$US
241181261$24118126$1$I$20231119$20240711$20240722$20240722$EXP$FR-AFSSAPS-LY2024001008$FR-TEVA-VS-3220655$TEVA$$62$YR$$M$Y$64$KG$20240722$$MD$FR$FR
241181283$24118128$3$F$20240712$20240815$20240722$20240827$PER$$US-AMGEN-USASP2024139738$AMGEN$$63$YR$A$M$Y$62.585$KG$20240826$$PH$US$US
241181291$24118129$1$I$20240313$20240716$20240722$20240722$EXP$FR-AFSSAPS-AN2024000668$FR-EMD Serono-2024038819$EMD SERONO INC$$64$YR$A$M$Y$$$20240722$$PH$FR$FR
241181301$24118130$1$I$$20240712$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2023-006245$AUROBINDO$$83$YR$$$Y$$$20240722$$MD$FR$FR
241181312$24118131$2$F$$20240417$20240722$20240722$PER$$US-ROCHE-10000020567$ROCHE$$75$YR$E$M$Y$$$20240722$$CN$US$US
241181321$24118132$1$I$$20240717$20240722$20240722$PER$$US-ABBVIE-5846815$ABBVIE$$$$$$Y$$$20240722$$HP$US$US
241181343$24118134$3$F$20240101$20240726$20240722$20240731$EXP$$DE-ROCHE-10000029793$ROCHE$$$$A$F$Y$$$20240731$$MD$DE$DE
241181352$24118135$2$F$20221001$20240828$20240722$20240906$EXP$$US-TEVA-VS-3219674$TEVA$Ouyang J, Sasidharan S, Jatoi T, Salifu M. How High Can Anion Gaps Be in Patients With Metabolic Acidosis? A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).; Ouyang J, Sasidharan S, Jatoi T, Salifu M. How High Can Anion Gaps Be in Patients With Metabolic Acidosis? A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$61$YR$$F$Y$$$20240906$$HP$US$US
241181361$24118136$1$I$$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024143757$AMGEN$$$$$$Y$$$20240722$$PH$US$US
241181372$24118137$2$F$20240601$20240820$20240722$20240826$EXP$$US-AMGEN-USASP2024141745$AMGEN$$$$$M$Y$$$20240826$$HP$US$US
241181382$24118138$2$F$$20240826$20240722$20240902$30DAY$$US-AMGEN-USASP2024142924$AMGEN$$$$$$Y$$$20240902$$HP$US$US
241181395$24118139$5$F$20240712$20240829$20240722$20240905$PER$$US-AMGEN-USASP2024140226$AMGEN$$41$YR$A$F$Y$142.9$KG$20240905$$PH$US$US
241181405$24118140$5$F$20240603$20240806$20240722$20240827$PER$$US-AMGEN-USASP2024142567$AMGEN$$61$YR$A$M$Y$128.8$KG$20240827$$HP$US$US
241181411$24118141$1$I$$20240712$20240722$20240722$EXP$$CO-AUROBINDO-AUR-APL-2024-034920$AUROBINDO$Tabares B, Sarmiento-Suarez AD, Gil O, Hernandez-Pabon JC, Firacative C.. Fatal co-infection by multiple pathogens in an indigenous woman with autoimmune hemolytic anemia and tuberculosis: a case report. BMC Infectious Diseases. 2024;24(1):645$28$YR$$F$Y$$$20240722$$MD$CO$CO
241181422$24118142$2$F$20240617$20240821$20240722$20240828$EXP$$US-AMGEN-USASP2024141799$AMGEN$$72$YR$E$F$Y$$$20240828$$HP$US$US
241181431$24118143$1$I$$20240712$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035257$AUROBINDO$$36$YR$$F$Y$$$20240722$$MD$FR$FR
241181441$24118144$1$I$$20240626$20240722$20240722$30DAY$$DE-UCBSA-2024033818$UCB$$$$$F$Y$$$20240722$$PH$DE$DE
241181451$24118145$1$I$$20240716$20240722$20240722$EXP$GR-SEATTLE GENETICS-2023SGN11095$GR-BIOCON BIOLOGICS LIMITED-BBL2023002131$BIOCON$$$$$$Y$$$20240722$$MD$GR$GR
241181461$24118146$1$I$20240101$20240708$20240722$20240722$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06549$HIKMA$$20$YR$$F$Y$$$20240722$$CN$US$US
241181473$24118147$3$F$20220621$20240722$20240722$20240724$EXP$$CA-ROCHE-3123583$ROCHE$$29$YR$A$F$Y$$$20240724$$CN$CA$CA
241181484$24118148$4$F$20240112$20240807$20240722$20240810$EXP$$JP-ABBVIE-5844111$ABBVIE$$65$YR$$M$Y$$$20240810$$MD$JP$JP
241181491$24118149$1$I$$20240709$20240722$20240722$PER$$US-FARMAPROD-202407-2562$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240722$$CN$US$US
241181501$24118150$1$I$$20240718$20240722$20240722$EXP$$US-TAKEDA-2024TUS072672$TAKEDA$$$$$F$Y$109.75$KG$20240722$$HP$US$US
241181511$24118151$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115046$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240722$$CN$US$US
241181521$24118152$1$I$$20240716$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115019$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$MD$JP$JP
241181532$24118153$2$F$20240601$20240729$20240722$20240803$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-02654$AMNEAL$$$$$$Y$$$20240803$$PH$JP$JP
241181541$24118154$1$I$$20201008$20240722$20240722$EXP$$GB-AstraZeneca-2020SF31735$ASTRAZENECA$$$$$M$Y$$$20240722$$HP$GB$
241181551$24118155$1$I$$20240710$20240722$20240722$EXP$$CA-TEVA-VS-3222618$TEVA$$67$YR$$F$Y$52$KG$20240722$$MD$CA$CA
241181561$24118156$1$I$$20230405$20240722$20240722$EXP$$CA-AstraZeneca-2023A082620$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$CA$
241181571$24118157$1$I$$20240716$20240722$20240722$PER$$US-ABBVIE-5845674$ABBVIE$$$$$$Y$$$20240722$$CN$US$US
241181581$24118158$1$I$$20240716$20240722$20240722$PER$$US-AstraZeneca-2024A162658$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241181591$24118159$1$I$$20200903$20240722$20240722$EXP$$US-AstraZeneca-2020SF14026$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241181601$24118160$1$I$$20240716$20240722$20240722$EXP$$US-UCBSA-2024036279$UCB$$$$$$Y$$$20240722$$CN$US$US
241181611$24118161$1$I$$20211021$20240722$20240722$EXP$$US-AstraZeneca-2021A782552$ASTRAZENECA$$$$$$Y$$$20240722$$CN$US$
241181621$24118162$1$I$20190101$20191219$20240722$20240722$EXP$$RU-AstraZeneca-2019SF86592$ASTRAZENECA$$56$YR$$F$Y$78$KG$20240722$$CN$RU$
241181631$24118163$1$I$$20220301$20240722$20240722$EXP$$US-AstraZeneca-2022A055307$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241181641$24118164$1$I$$20190910$20240722$20240722$EXP$$US-AstraZeneca-2019SF29933$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241181651$24118165$1$I$$20211202$20240722$20240722$EXP$$US-AstraZeneca-2021A853450$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241181661$24118166$1$I$$20201006$20240722$20240722$EXP$$US-AstraZeneca-2020SF31004$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241181671$24118167$1$I$$20221018$20240722$20240722$EXP$$US-AstraZeneca-2021A857263$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241181681$24118168$1$I$$20220603$20240722$20240722$EXP$$US-AstraZeneca-2022A214300$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241181691$24118169$1$I$20210101$20210421$20240722$20240722$EXP$$US-AstraZeneca-2021A351410$ASTRAZENECA$$79$YR$$F$Y$$$20240722$$CN$US$
241181701$24118170$1$I$$20201012$20240722$20240722$EXP$$US-AstraZeneca-2020SF31882$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241181711$24118171$1$I$20240704$20240716$20240722$20240722$PER$$US-PHARMING-PHAUS2024000607$PHARMING GROUP$$$$$$Y$$$20240722$$HP$US$US
241181722$24118172$2$F$$20240910$20240722$20240912$PER$$US-PHARMING-PHAUS2024000609$PHARMING GROUP$$$$$$Y$$$20240912$$CN$US$US
241181732$24118173$2$F$$20240910$20240722$20240912$PER$$US-PHARMING-PHAUS2024000605$PHARMING GROUP$$$$$$Y$$$20240912$$CN$US$US
241181741$24118174$1$I$20240712$20240713$20240722$20240722$PER$$US-PHARMING-PHAUS2024000600$PHARMING GROUP$$$$$$Y$$$20240722$$CN$US$US
241181751$24118175$1$I$$20201012$20240722$20240722$EXP$$US-AstraZeneca-2020SF35202$ASTRAZENECA$$$$$M$Y$$$20240722$$HP$US$
241181762$24118176$2$F$$20240821$20240722$20240823$PER$$US-PHARMING-PHAUS2024000606$PHARMING GROUP$$$$$$Y$$$20240823$$CN$US$US
241181771$24118177$1$I$$20220613$20240722$20240722$EXP$$US-AstraZeneca-2022A220603$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241181781$24118178$1$I$$20200616$20240722$20240722$EXP$$US-AstraZeneca-2020SE77899$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241181791$24118179$1$I$$20201111$20240722$20240722$EXP$$US-AstraZeneca-2020SF35254$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241181803$24118180$3$F$20240723$20240820$20240722$20240826$EXP$$AU-TAKEDA-2024TUS063144$TAKEDA$$74$YR$$F$Y$$$20240826$$CN$AU$AU
241181811$24118181$1$I$20240717$20240718$20240722$20240722$EXP$$US-UCBSA-2024036692$UCB$$29$YR$$F$Y$$$20240722$$HP$US$US
241181821$24118182$1$I$$20240716$20240722$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115453$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240722$$HP$CA$CA
241181832$24118183$2$F$20231106$20240826$20240722$20240902$EXP$$KR-ROCHE-10000027123$ROCHE$$48$YR$A$F$Y$49.8$KG$20240902$$MD$KR$KR
241181843$24118184$3$F$20240701$20240731$20240722$20240802$EXP$$US-ABBVIE-5844206$ABBVIE$$76$YR$$M$Y$$$20240802$$CN$US$US
241181851$24118185$1$I$$20240709$20240722$20240722$EXP$$CN-ROCHE-10000021988$ROCHE$$28$YR$A$M$Y$$$20240722$$CN$CN$CN
241181861$24118186$1$I$20240316$20240712$20240722$20240722$EXP$ES-AEMPS-1537426$ES-ROCHE-10000026058$ROCHE$$77$YR$E$F$Y$45.5$KG$20240722$$MD$ES$ES
241181872$24118187$2$F$20191015$20191030$20240722$20240822$EXP$$CO-TERSERA THERAPEUTICS LLC-2019TRS002529$TERSERA THERAPEUTICS$$$$$$Y$$$20240822$$CN$CO$CO
241181882$24118188$2$F$$20240828$20240722$20240906$EXP$$US-TEVA-VS-3219527$TEVA$Ozueh P, Agogbuo O, Walnofer A, Umezurike I, John L, Hammond TC, et al. Breathtaking Intrathoracic Rhabdoid Tumor. Am-J-Respir-Crit-Care-Med 2024; 209.; Ozueh P, Agogbuo O, Walnofer A, Umezurike I, John L, Hammond TC, et al. Breathtaking Intrathoracic Rhabdoid Tumor. Am-J-Respir-Crit-Care-Med 2024; 209.$63$YR$$M$Y$$$20240906$$HP$US$US
241181891$24118189$1$I$20220103$20240716$20240722$20240722$EXP$$DE-TAKEDA-2024TUS072966$TAKEDA$$8$DEC$$M$Y$70$KG$20240722$$MD$DE$DE
241181901$24118190$1$I$$20240712$20240722$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-035989$AUROBINDO$Das G, Ferris JC.. GENERALIZED CONVULSIONS IN APATIENT RECEIVING ULTRASHORT-ACTING BETA-BLOCKER INFUSION. DrugI ntelligence and Clinical Pharmacy. 1988;22:484-5$89$YR$$M$Y$$$20240722$$MD$US$US
241181911$24118191$1$I$20230911$20240718$20240722$20240722$EXP$$US-ABBVIE-5746923$ABBVIE$$88$YR$$M$Y$$$20240722$$CN$US$US
241181921$24118192$1$I$$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407121657258460-RTSLK$GB-TEVA-VS-3221228$TEVA$$$$$F$Y$$$20240722$$HP$GB$GB
241181931$24118193$1$I$20210101$20240711$20240722$20240722$EXP$$EC-ROCHE-10000025313$ROCHE$$72$YR$E$M$Y$$$20240722$$MD$EC$EC
241181941$24118194$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141835$AMGEN$Stilgenbauer, S;. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241181951$24118195$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141878$AMGEN$Stilgenbauer S;. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241181971$24118197$1$I$$20240712$20240722$20240722$EXP$$IN-ROCHE-10000026698$ROCHE$$$$A$F$Y$$$20240722$$MD$IN$IN
241181981$24118198$1$I$$20240712$20240722$20240722$EXP$$KR-ROCHE-3517567$ROCHE$$$$$$Y$$$20240722$$HP$KR$KR
241181991$24118199$1$I$20240101$20240709$20240722$20240722$EXP$$CO-CIPLA LTD.-2024CO07532$CIPLA$$$$$$Y$$$20240722$$CN$CO$CO
241182001$24118200$1$I$20231001$20231207$20240722$20240722$EXP$$DE-TEVA-VS-3136432$TEVA$$60$YR$$F$Y$$$20240722$$CN$DE$DE
241182012$24118201$2$F$$20240815$20240722$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114726$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$$$20240816$$CN$US$US
241182021$24118202$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114539$BRISTOL MYERS SQUIBB$$16$YR$T$F$Y$$$20240722$$MD$US$US
241182032$24118203$2$F$20240617$20240722$20240722$20240729$EXP$$JP-009507513-2407JPN002816J$MERCK$$78$YR$$M$Y$$$20240729$$MD$JP$JP
241182041$24118204$1$I$$20240717$20240722$20240722$PER$$NVSC2024US148436$NOVARTIS$$$$$F$Y$$$20240722$$HP$US$US
241182052$24118205$2$F$20240701$20240727$20240722$20240729$PER$$US-ABBVIE-5845648$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241182063$24118206$3$F$$20240710$20240722$20240913$EXP$$JP-UPSHER-SMITH LABORATORIES, LLC-20240700018$UPSHER SMITH LABORATORIES$Ide N.; Hosoya Y.; Yamamoto M.; Shigeno A.; Obayashi M.; Asada K, et al. Central Nervous System Adverse Reactions to Amantadine Intoxication: A Case Report and Analysis of JADER. in vivo. 2024;38:4:2090-2096$63$YR$$F$Y$36.7$KG$20240913$$$JP$JP
241182071$24118207$1$I$20230131$20240715$20240722$20240722$EXP$$CA-TAKEDA-2024TUS069027$TAKEDA$$46$YR$$F$Y$$$20240722$$CN$CA$CA
241182081$24118208$1$I$$20240717$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2024US066399$SANDOZ$$$$$$Y$$$20240722$$CN$US$US
241182091$24118209$1$I$$20240718$20240722$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA066605$SANDOZ$$30$YR$$F$Y$$$20240722$$CN$CA$CA
241182101$24118210$1$I$$20240716$20240722$20240722$PER$$US-ABBVIE-5845409$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241182111$24118211$1$I$$20240712$20240722$20240722$EXP$$RU-ROCHE-10000026703$ROCHE$$65$YR$E$F$Y$$$20240722$$MD$RU$RU
241182131$24118213$1$I$$20240708$20240722$20240722$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-21253$SAMSUNG BIOEPIS$$42$YR$A$M$Y$$$20240722$$CN$GB$GB
241182141$24118214$1$I$$20240709$20240722$20240722$EXP$$JP-ENDO USA, INC.-2024-002919$ENDO$Takei S, Kinoshita H, Jamal M, Yamashita T, Tanaka E, Kawahara S et al.. An autopsy case of intoxication caused by drug interaction with multiple psychotropic drugs, fluvoxamine, levomepromazine, and trihexyphenidyl. Legal Medicine. 2024;70:1-3$4$DEC$$F$Y$40$KG$20240722$$HP$JP$JP
241182161$24118216$1$I$$20240718$20240722$20240722$EXP$$US-UCBSA-2024036693$UCB$$$$$F$Y$$$20240722$$HP$US$US
241182171$24118217$1$I$$20240720$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041038$BOEHRINGER INGELHEIM$$$$$$Y$$$20240722$$CN$US$US
241182181$24118218$1$I$$20240718$20240722$20240722$PER$$US-TAKEDA-2024TUS073406$TAKEDA$$$$$M$Y$$$20240722$$MD$US$US
241182192$24118219$2$F$20240629$20240821$20240722$20240905$EXP$$US-PHATHOM PHARMACEUTICALS INC.-2024PHT00561$Phathom Pharmaceuticals$$47$YR$$F$Y$58.957$KG$20240905$$HP$US$US
241182201$24118220$1$I$$20240711$20240722$20240722$EXP$$CN-ROCHE-10000024791$ROCHE$$65$YR$E$F$Y$$$20240722$$CN$CN$CN
241182211$24118221$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089824$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241182222$24118222$2$F$20240101$20240722$20240722$20240731$EXP$$US-ABBVIE-5844604$ABBVIE$$$$$F$Y$57$KG$20240731$$CN$US$US
241182231$24118223$1$I$$20240708$20240722$20240722$PER$$US-TEVA-VS-3220565$TEVA$$8$YR$$F$Y$$$20240722$$CN$US$US
241182241$24118224$1$I$20240612$20240717$20240722$20240722$EXP$$CA-TAKEDA-2023TUS079932$TAKEDA$$28$YR$$F$Y$$$20240722$$MD$CA$CA
241182253$24118225$3$F$$20240808$20240722$20240813$EXP$$GB-MYLANLABS-2024M1066710$MYLAN$$$$$F$Y$$$20240813$$MD$GB$GB
241182261$24118226$1$I$20230228$20240712$20240722$20240722$EXP$$FR-CELLTRION INC.-2024FR017311$CELLTRION$$$$$$Y$$$20240722$$MD$FR$FR
241182271$24118227$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141842$AMGEN$Stilgenbauer, S.. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241182281$24118228$1$I$20240101$20240716$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2024US066602$SANDOZ$$$$$$Y$$$20240722$$CN$US$US
241182291$24118229$1$I$$20240719$20240722$20240722$EXP$$NVSC2024BE149241$NOVARTIS$$$$$$Y$$$20240722$$HP$BE$BE
241182301$24118230$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089615$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241182311$24118231$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089622$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241182321$24118232$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089222$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241182331$24118233$1$I$20240717$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142485$AMGEN$$70$YR$E$F$Y$$$20240722$$CN$US$US
241182341$24118234$1$I$$20240711$20240722$20240722$PER$$US-APOTEX-2024AP008357$APOTEX$Chan E, Liang L, Ling J, Horng GS.. Don^t Forget the Bug Spray: A Case of West Nile Virus Meningoencephalitis in a Kidney Transplant Patient. American Journal of Respiratory and Critical Care Medicine. 2024;209:1-4$36$YR$$M$Y$$$20240722$$HP$US$US
241182351$24118235$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141858$AMGEN$Stilgenbauer S;. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241182361$24118236$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024142870$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241182371$24118237$1$I$$20240716$20240722$20240722$PER$$US-ABBVIE-5843308$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241182381$24118238$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114120$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240722$$HP$US$US
241182391$24118239$1$I$$20240712$20240722$20240722$EXP$$BR-TAKEDA-2024TUS072715$TAKEDA$$$$$M$Y$$$20240722$$CN$BR$BR
241182402$24118240$2$F$20240703$20240910$20240722$20240917$EXP$$ZA-EMD Serono-2024038409$EMD SERONO INC$$38$YR$A$F$Y$$$20240917$$CN$ZA$ZA
241182411$24118241$1$I$$20240718$20240722$20240722$PER$$US-ROCHE-10000031956$ROCHE$$$$$$Y$$$20240722$$CN$US$US
241182422$24118242$2$F$20240711$20240730$20240722$20240803$PER$$US-AMGEN-USASP2024143718$AMGEN$$36$YR$A$M$Y$$$20240803$$HP$US$US
241182431$24118243$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141969$AMGEN$Stilgenbauer S. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241182441$24118244$1$I$$20240712$20240722$20240722$EXP$GR-GREOF-202400715$GR-TEVA-VS-3221058$TEVA$$64$YR$$F$Y$$$20240722$$MD$GR$GR
241182451$24118245$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089696$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241182461$24118246$1$I$$20240717$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024089980$VIIV$$$$$M$Y$$$20240722$$MD$US$US
241182471$24118247$1$I$$20240711$20240722$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-033192$JAZZ$$$$$F$Y$$$20240722$$CN$US$US
241182481$24118248$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089841$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241182511$24118251$1$I$$20230817$20240722$20240722$EXP$$RU-AstraZeneca-2023A190615$ASTRAZENECA$$$$$$Y$$$20240722$$MD$RU$
241182521$24118252$1$I$$20201207$20240722$20240722$EXP$$US-AstraZeneca-2020SF64956$ASTRAZENECA$$77$YR$$M$Y$$$20240722$$CN$US$
241182531$24118253$1$I$$20200901$20240722$20240722$EXP$$US-AstraZeneca-2020SF12672$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241182541$24118254$1$I$$20210731$20240722$20240722$EXP$$US-AstraZeneca-2021A659019$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241182551$24118255$1$I$$20240717$20240722$20240722$EXP$$GB-SANDOZ INC.-SDZ2024GB066474$SANDOZ$$$$$M$Y$$$20240722$$CN$GB$GB
241182561$24118256$1$I$$20230330$20240722$20240722$EXP$$US-AstraZeneca-2023A076056$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241182571$24118257$1$I$20221101$20221208$20240722$20240722$EXP$$US-AstraZeneca-2022A404440$ASTRAZENECA$$82$YR$$M$Y$$$20240722$$CN$US$
241182581$24118258$1$I$$20230505$20240722$20240722$EXP$$US-AstraZeneca-2023A106319$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241182601$24118260$1$I$$20240715$20240722$20240722$EXP$$CA-SA-2024SA210158$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240722$$MD$CA$CA
241182611$24118261$1$I$$20240716$20240722$20240722$PER$$US-AstraZeneca-2024A162543$ASTRAZENECA$$$$$$Y$$$20240722$$CN$US$
241182631$24118263$1$I$$20240715$20240722$20240722$EXP$$US-SA-2024SA207452$SANOFI AVENTIS$$$$$F$Y$$$20240722$$CN$US$US
241182641$24118264$1$I$$20240708$20240722$20240722$EXP$$JP-NOVOPROD-1257630$NOVO NORDISK$Takashi Uezono et al.,. Simultaneous analyses of hypoglycemic agents and C-peptide are essential in a homicide case with the combined dosing insulin and insulin-releasing drug. Legal Medicine. 2002;4:34?36$5$YR$$F$Y$19$KG$20240722$$HP$JP$JP
241182651$24118265$1$I$$20240716$20240722$20240722$EXP$ES-MALLINCKRODT-T201903048$ES-KOANAAP-SML-ES-2021-00947$Unknown Manufacturer$$56$YR$A$M$Y$$$20240722$$MD$ES$ES
241182662$24118266$2$F$$20240725$20240722$20240729$EXP$$FR-KOANAAP-SML-FR-2024-00757$SHILPA MEDICARE$Archer E, Bosdure L, Lejeune J, Faucheux L, Guery EA, Sillamy N et al. Hypofibrinogenemia induced by corticosteroids alone during treatment of acute lymphoblastic leukemia: a case report from Tours University Hospital. REVUE FRANCOPHONE O^HEMOSTASE ET THROMBOSE. 2024;6(2): 67-70.$14$YR$T$M$Y$$$20240729$$HP$FR$FR
241182672$24118267$2$F$20240101$20240805$20240722$20240813$EXP$$US-SA-2024SA210574$SANOFI AVENTIS$$$$A$F$Y$58$KG$20240813$$CN$US$US
241182681$24118268$1$I$$20240715$20240722$20240722$EXP$$IT-UCBSA-2024036431$UCB$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$83$YR$$F$Y$$$20240722$$MD$IT$IT
241182693$24118269$3$F$20240101$20240806$20240722$20240812$30DAY$$CO-AMGEN-COLSP2024141401$AMGEN$$$$$M$Y$$$20240812$$MD$CO$CO
241182701$24118270$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024140883$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241182711$24118271$1$I$20240712$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141705$AMGEN$$34$YR$A$F$Y$$$20240722$$CN$US$US
241182721$24118272$1$I$20240604$20240710$20240722$20240722$EXP$FR-AFSSAPS-GR2024000847$FR-009507513-2407FRA005771$MERCK$$67$YR$$M$Y$66$KG$20240719$$PH$FR$FR
241182733$24118273$3$F$$20240719$20240722$20240729$EXP$$JP-009507513-2407JPN002116J$MERCK$$$$$M$Y$$$20240729$$MD$JP$JP
241182742$24118274$2$F$$20240821$20240722$20240826$EXP$$NVSC2024EG138617$NOVARTIS$$$$$F$Y$$$20240826$$CN$EG$EG
241182751$24118275$1$I$$20240710$20240722$20240722$EXP$$JP-009507513-2407JPN002291J$MERCK$$33$YR$$F$Y$$$20240719$$MD$JP$JP
241182761$24118276$1$I$$20240717$20240722$20240722$EXP$$JP-009507513-2407JPN011084$MERCK$Matsumoto F, Matsuzawa Adachi M, Yoshida K, Yamashita T, Shiihara J, Fukuchi T, et al. Metastatic Pleomorphic Carcinoma of the Lung with Extensive Chromosomal Rearrangements: An Autopsy Case with a Literature Review. Internal medicine Advance Publication. 2024$47$YR$$M$Y$58$KG$20240719$$HP$JP$JP
241182771$24118277$1$I$20240101$20240626$20240722$20240722$PER$$US-009507513-2407USA001657$MERCK$$$$$F$Y$$$20240719$$CN$US$US
241182781$24118278$1$I$20240704$20240708$20240722$20240722$PER$$US-009507513-2407USA004163$MERCK$$75$YR$$M$Y$$$20240719$$CN$US$US
241182792$24118279$2$F$20240101$20240815$20240722$20240821$EXP$$US-009507513-2407USA009430$MERCK$$$$$M$Y$$$20240821$$CN$US$US
241182802$24118280$2$F$$20240731$20240722$20240805$EXP$$JP-009507513-2407JPN002907J$MERCK$$65$YR$$M$Y$$$20240805$$HP$JP$JP
241182811$24118281$1$I$$20240710$20240722$20240722$PER$$US-009507513-2407USA005304$MERCK$Ramirez-Velandia F, Enriquez Marulanda A, Filo J, Young M, Fodor Thomas B, Sconzo D, et al. Thromboembolic Events in the Posterior Circulation After Flow Diversion-A Closer Look at Coverage of the Posterior Cerebral Artery. World Neurosurgery. 2024;187 ()::e920-e928$$$E$$Y$$$20240719$$HP$US$US
241182821$24118282$1$I$20240621$20240710$20240722$20240722$EXP$$JP-009507513-2407JPN001857J$MERCK$$7$DEC$$M$Y$$$20240719$$MD$JP$JP
241182831$24118283$1$I$20240201$20240711$20240722$20240722$EXP$$JP-009507513-2407JPN000590J$MERCK$$8$DEC$$F$Y$$$20240719$$MD$JP$JP
241182841$24118284$1$I$20210501$20240714$20240722$20240722$EXP$$PT-009507513-2407PRT009712$MERCK$$41$YR$$M$Y$$$20240719$$MD$PT$PT
241182851$24118285$1$I$20240612$20240708$20240722$20240722$PER$$US-009507513-2407USA004199$MERCK$$72$YR$$M$Y$$$20240719$$CN$US$US
241182862$24118286$2$F$$20240713$20240722$20240722$EXP$$JP-009507513-2407JPN002277J$MERCK$$76$YR$$F$Y$$$20240722$$MD$JP$JP
241182873$24118287$3$F$$20240719$20240722$20240726$EXP$$JP-009507513-2407JPN002279J$MERCK$$47$YR$$M$Y$$$20240726$$MD$JP$JP
241182881$24118288$1$I$20230101$20240715$20240722$20240722$EXP$$AU-009507513-2407AUS010863$MERCK$$74$YR$$F$Y$$$20240719$$MD$AU$AU
241182891$24118289$1$I$$20240710$20240722$20240722$EXP$$JP-009507513-2407JPN002395J$MERCK$$77$YR$$M$Y$$$20240719$$MD$JP$JP
241182902$24118290$2$F$20240101$20240821$20240722$20240829$EXP$$JP-009507513-2407JPN002066J$MERCK$$70$YR$$M$Y$$$20240829$$MD$JP$JP
241182911$24118291$1$I$20240603$20240712$20240722$20240722$EXP$IT-MINISAL02-994227$IT-009507513-2407ITA008911$MERCK$$45$YR$$F$Y$50$KG$20240719$$MD$IT$IT
241182921$24118292$1$I$20240501$20240712$20240722$20240722$EXP$$US-009507513-2407USA009166$MERCK$$58$YR$$M$Y$$$20240719$$CN$US$US
241182931$24118293$1$I$20240604$20240715$20240722$20240722$EXP$FR-AFSSAPS-NT2024000826$FR-009507513-2407FRA009542$MERCK$$63$YR$$F$Y$85$KG$20240719$$MD$FR$FR
241182941$24118294$1$I$$20240621$20240722$20240722$PER$$US-009507513-2406USA009557$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$8$MON$$$Y$$$20240719$$HP$US$US
241182951$24118295$1$I$20240415$20240716$20240722$20240722$EXP$$HR-009507513-2407HRV010120$MERCK$$$$E$M$Y$$$20240719$$MD$HR$HR
241182961$24118296$1$I$$20240621$20240722$20240722$PER$$US-009507513-2406USA009555$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$16$YR$$$Y$$$20240719$$HP$US$US
241182971$24118297$1$I$$20240621$20240722$20240722$PER$$US-009507513-2406USA009556$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$16$YR$$$Y$$$20240719$$HP$US$US
241182981$24118298$1$I$20240711$20240717$20240722$20240722$EXP$GB-MHRA-MED-202407171335472920-JCNRY$GB-009507513-2407GBR010967$MERCK$$44$YR$$M$Y$124$KG$20240719$$MD$GB$GB
241182991$24118299$1$I$20240601$20240712$20240722$20240722$EXP$$US-009507513-2407USA008861$MERCK$$$$$F$Y$$$20240719$$CN$US$US
241183001$24118300$1$I$20240507$20240711$20240722$20240722$EXP$DE-CADRBFARM-2024329130$DE-009507513-2407DEU009563$MERCK$$69$YR$$M$Y$75$KG$20240719$$CN$DE$DE
241183012$24118301$2$F$20230612$20240710$20240722$20240722$EXP$$JP-009507513-2307JPN002576J$MERCK$Kanai O, Ito T, Takaori K, Saito Z, Imakita T, Oi I, et al.. O-1-4 A Case of EGFR-positive Non-small-cell Lung Cancer in which Nephritis Interstitial Developed After Successful Treatment with Pembrolizumab.. Joint academic conference of the 102nd Kinki Regional Meeting of the Japanese Re. 76$68$YR$$F$Y$$$20240722$$MD$JP$JP
241183021$24118302$1$I$20240307$20240716$20240722$20240722$EXP$$JP-009507513-2407JPN002930J$MERCK$$50$YR$$F$Y$$$20240719$$PH$JP$JP
241183031$24118303$1$I$$20240710$20240722$20240722$EXP$$JP-009507513-2407JPN002378J$MERCK$$77$YR$$M$Y$$$20240719$$MD$JP$JP
241183041$24118304$1$I$20240101$20240709$20240722$20240722$EXP$$JP-009507513-2407JPN000402J$MERCK$$76$YR$$M$Y$54$KG$20240719$$MD$JP$JP
241183054$24118305$4$F$20210101$20240710$20240722$20240725$EXP$$JP-009507513-2301JPN004104J$MERCK$Agata H, Takahashi T, Shigematsu K, Anko M, Yoshihama T, Senba H, et al.. A case of isolated ACTH deficiency associated with severe hyponatraemia after pembrolizumab treatment for recurrent endometrial carcinoma. Tokyo Journal of Obstetrics and Gynecology. 2024;73(1):134-40$57$YR$$F$Y$$$20240725$$MD$JP$JP
241183061$24118306$1$I$$20240718$20240722$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114698$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240722$$HP$CA$CA
241183071$24118307$1$I$$20240620$20240722$20240722$PER$$US-009507513-2406USA007407$MERCK$Mahmoud A, Amir A, Bangash H, Ayaz S. Pasteurella Multocida-induced Empyema in an Immunocompromised Patient - A Case Report. American Journal of Respiratory and Critical Care Medicine. 2024;209$70$YR$$M$Y$$$20240719$$HP$US$US
241183081$24118308$1$I$$20240710$20240722$20240722$EXP$$JP-009507513-2407JPN002318J$MERCK$$77$YR$$M$Y$$$20240719$$MD$JP$JP
241183091$24118309$1$I$$20240621$20240722$20240722$PER$$US-009507513-2406USA009554$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$13$YR$$$Y$$$20240719$$HP$US$US
241183101$24118310$1$I$20240606$20240710$20240722$20240722$PER$$US-009507513-2406USA009829$MERCK$$58$YR$$F$Y$$$20240719$$CN$US$US
241183111$24118311$1$I$$20240710$20240722$20240722$EXP$$CA-009507513-2407CAN005724$MERCK$Unknown. Unknown. Unknown$58$YR$$F$Y$$$20240719$$HP$CA$CA
241183121$24118312$1$I$$20240621$20240722$20240722$PER$$US-009507513-2406USA009553$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$10$YR$$$Y$$$20240719$$HP$US$US
241183131$24118313$1$I$$20240621$20240722$20240722$PER$$US-009507513-2406USA009552$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$6$YR$$$Y$$$20240719$$HP$US$US
241183141$24118314$1$I$20201125$20240709$20240722$20240722$EXP$$JP-009507513-2407JPN001830J$MERCK$$48$YR$$M$Y$$$20240719$$MD$JP$JP
241183151$24118315$1$I$$20240710$20240722$20240722$EXP$$JP-009507513-2407JPN002328J$MERCK$$84$YR$$M$Y$$$20240719$$MD$JP$JP
241183161$24118316$1$I$$20240710$20240722$20240722$EXP$$JP-009507513-2407JPN002325J$MERCK$$60$YR$$M$Y$$$20240719$$MD$JP$JP
241183171$24118317$1$I$$20240710$20240722$20240722$EXP$$JP-009507513-2407JPN002388J$MERCK$$69$YR$$M$Y$$$20240719$$MD$JP$JP
241183181$24118318$1$I$$20240715$20240722$20240722$EXP$$AU-009507513-2407AUS011550$MERCK$$$$$F$Y$$$20240719$$MD$AU$AU
241183191$24118319$1$I$20231101$20240716$20240722$20240722$PER$$US-009507513-2407USA011014$MERCK$$$$$M$Y$$$20240719$$CN$US$US
241183201$24118320$1$I$20180101$20240711$20240722$20240722$EXP$$JP-009507513-2407JPN008934$MERCK$$61$YR$$M$Y$$$20240719$$CN$JP$JP
241183211$24118321$1$I$20240601$20240625$20240722$20240722$PER$$US-009507513-2406USA008747$MERCK$$$$$F$Y$$$20240719$$CN$US$US
241183221$24118322$1$I$$20240621$20240722$20240722$PER$$US-009507513-2406USA009550$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$1$YR$$$Y$$$20240719$$HP$US$US
241183231$24118323$1$I$$20240711$20240722$20240722$PER$$US-009507513-2407USA005400$MERCK$$$$$$Y$$$20240719$$PH$US$US
241183241$24118324$1$I$$20240701$20240722$20240722$PER$$US-009507513-2407USA000657$MERCK$$$$C$$Y$$$20240719$$PH$US$US
241183251$24118325$1$I$$20240621$20240722$20240722$PER$$US-009507513-2406USA009551$MERCK$Samba SN, Daklallah Y, Brown SES, Colquhoun DA, Modi ZJ, Nause-Osthoff R.. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series. BMC anesthesiology. 2024;24:206$4$YR$$$Y$$$20240719$$HP$US$US
241183261$24118326$1$I$20220101$20240619$20240722$20240722$PER$$US-009507513-2407USA009443$MERCK$Bickenbach E, Pan J, King M. Emtricitabine/tenofovir alafenamide and doravirine in a virologically suppressed adult with HIV and on chronic ambulatory peritoneal dialysis: A case report. International Journal of STD and AIDS. 2024;0 (0):1-3$44$YR$$F$Y$$$20240719$$HP$US$US
241183272$24118327$2$F$$20240710$20240722$20240722$EXP$$JP-009507513-2407JPN002305J$MERCK$$74$YR$$M$Y$$$20240722$$MD$JP$JP
241183281$24118328$1$I$$20240710$20240722$20240722$EXP$$JP-009507513-2407JPN002405J$MERCK$$66$YR$$M$Y$$$20240719$$MD$JP$JP
241183291$24118329$1$I$20170428$20240710$20240722$20240722$EXP$$JP-009507513-1705JPN002384J$MERCK$$73$YR$$M$Y$57$KG$20240719$$MD$JP$JP
241183301$24118330$1$I$20220101$20240710$20240722$20240722$EXP$$JP-009507513-2204JPN002710J$MERCK$$83$YR$$F$Y$48$KG$20240719$$MD$JP$JP
241183311$24118331$1$I$$20240621$20240722$20240722$PER$$US-009507513-2406USA008111$MERCK$Melody M, Epperla N, Shouse G, Romancik J, Allen P, Moyo TK, et al.. Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.. Blood Advances.. 2024;8 (10):2327-31$63$YR$$M$Y$$$20240719$$HP$US$US
241183321$24118332$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115696$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240722$$HP$US$US
241183332$24118333$2$F$$20240909$20240722$20240916$EXP$$JP-009507513-2407JPN002113J$MERCK$Wanifuchi Y, Fujita T, Asano T, Mori M, Matsumoto N, Isogai A, et al.. SY2-7 Long-term clinical outcome of triple-negative breast cancer treatment and future challenges. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 9$$$$F$Y$$$20240916$$MD$JP$JP
241183341$24118334$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115638$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240722$$HP$US$US
241183351$24118335$1$I$$20240715$20240722$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-112999$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240722$$MD$CA$CA
241183366$24118336$6$F$$20240918$20240722$20240927$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005331$BIOCON$$$$$$Y$$$20240927$$CN$CA$CA
241183371$24118337$1$I$20240117$20240715$20240722$20240722$EXP$$DE-BIOCON BIOLOGICS LIMITED-BBL2024005255$BIOCON$$$$$$Y$$$20240719$$MD$DE$DE
241183381$24118338$1$I$$20240715$20240722$20240722$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005298$BIOCON$$$$$$Y$$$20240719$$CN$CA$CA
241183391$24118339$1$I$$20240715$20240722$20240722$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005291$BIOCON$$$$$$Y$$$20240719$$HP$CA$CA
241183401$24118340$1$I$$20240715$20240722$20240722$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005296$BIOCON$$$$$$Y$$$20240719$$MD$CA$CA
241183411$24118341$1$I$$20240715$20240722$20240722$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005297$BIOCON$$$$$$Y$$$20240719$$CN$CA$CA
241183421$24118342$1$I$20240124$20240715$20240722$20240722$EXP$$DE-BIOCON BIOLOGICS LIMITED-BBL2024005257$BIOCON$$$$$$Y$$$20240719$$MD$DE$DE
241183431$24118343$1$I$$20221017$20240722$20240722$EXP$$US-AstraZeneca-2022A349347$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241183442$24118344$2$F$$20240805$20240722$20240814$EXP$FR-AFSSAPS-PV2023000738$FR-BIOCON BIOLOGICS LIMITED-BBL2023002123$BIOCON$$$$$$Y$$$20240814$$MD$FR$FR
241183451$24118345$1$I$20230131$20240712$20240722$20240722$EXP$$FR-BIOCON BIOLOGICS LIMITED-BBL2023002116$BIOCON$$$$$$Y$$$20240719$$PH$FR$FR
241183461$24118346$1$I$$20230301$20240722$20240722$EXP$$US-AstraZeneca-2023A052042$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241183471$24118347$1$I$$20211116$20240722$20240722$EXP$$US-AstraZeneca-2021A809646$ASTRAZENECA$$$$$$Y$$$20240722$$CN$US$
241183481$24118348$1$I$20160101$20190903$20240722$20240722$EXP$$US-AstraZeneca-2019SF26515$ASTRAZENECA$$70$YR$$F$Y$73.5$KG$20240722$$CN$US$
241183492$24118349$2$F$$20240731$20240722$20240808$EXP$$TW-AstraZeneca-2023A040149$ASTRAZENECA$$50$YR$$M$Y$$$20240808$$CN$TW$
241183501$24118350$1$I$$20220217$20240722$20240722$EXP$$US-AstraZeneca-2022A077441$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241183511$24118351$1$I$$20200630$20240722$20240722$EXP$$US-AstraZeneca-2020SE83889$ASTRAZENECA$$59$YR$$F$Y$$$20240722$$CN$US$
241183522$24118352$2$F$20240618$20240805$20240722$20240827$PER$$US-TOLMAR, INC.-24US050360$TOLMAR$$68$YR$$M$Y$$$20240823$$PH$US$US
241183532$24118353$2$F$20240619$20240731$20240722$20240827$PER$$US-TOLMAR, INC.-24US050371$TOLMAR$$$$$M$Y$$$20240827$$PH$US$US
241183542$24118354$2$F$20240618$20240802$20240722$20240827$PER$$US-TOLMAR, INC.-24US050345$TOLMAR$$60$YR$$M$Y$$$20240827$$HP$US$US
241183551$24118355$1$I$$20220622$20240722$20240722$EXP$$DO-AstraZeneca-2022A233223$ASTRAZENECA$$$$$M$Y$$$20240722$$PH$DO$
241183562$24118356$2$F$$20240805$20240722$20240827$PER$$US-TOLMAR, INC.-24US050412$TOLMAR$$$$$$Y$$$20240823$$HP$US$US
241183572$24118357$2$F$20240621$20240805$20240722$20240827$PER$$US-TOLMAR, INC.-24US050408$TOLMAR$$82$YR$$M$Y$$$20240823$$HP$US$US
241183582$24118358$2$F$20240626$20240806$20240722$20240828$PER$$US-TOLMAR, INC.-24US050575$TOLMAR$$81$YR$$M$Y$$$20240827$$HP$US$US
241183591$24118359$1$I$$20221206$20240722$20240722$EXP$$US-AstraZeneca-2022A401111$ASTRAZENECA$$$$$M$Y$$$20240722$$MD$US$
241183601$24118360$1$I$20240628$20240628$20240722$20240722$PER$$US-TOLMAR, INC.-24US050680$TOLMAR$$65$YR$$M$Y$$$20240722$$HP$US$US
241183612$24118361$2$F$20240614$20240812$20240722$20240904$PER$$US-TOLMAR, INC.-24US050683$TOLMAR$$$$$$Y$$$20240904$$HP$US$US
241183621$24118362$1$I$$20220909$20240722$20240722$EXP$$US-AstraZeneca-2022A269437$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241183631$24118363$1$I$$20220725$20240722$20240722$EXP$$US-AstraZeneca-2022A221988$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241183641$24118364$1$I$20240628$20240628$20240722$20240722$PER$$US-TOLMAR, INC.-24US050682$TOLMAR$$89$YR$$M$Y$$$20240722$$HP$US$US
241183651$24118365$1$I$20220501$20220630$20240722$20240722$EXP$$ES-AstraZeneca-2022A243585$ASTRAZENECA$$764$MON$$F$Y$$$20240722$$CN$ES$
241183662$24118366$2$F$20240711$20240712$20240722$20240724$EXP$$JP-AMGEN-JPNSP2024143093$AMGEN$$91$YR$E$F$Y$$$20240724$$PH$JP$JP
241183671$24118367$1$I$20240611$20240712$20240722$20240722$EXP$$IN-ROCHE-10000018590$ROCHE$$69$YR$E$F$Y$$$20240722$$HP$IN$IN
241183682$24118368$2$F$$20240829$20240722$20240902$EXP$$JP-ROCHE-10000027208$ROCHE$Hatta T, Kojima K, Watanabe R, Okumura Y. Serial cardiac imaging reveals extensive myocardial calcifications and injury in septic cardiomyopathy-a case report. European Heart Journal Cardiovascular Imaging. 2024-Jul-01;25 (7):e185. doi:10.1093/ehjci/jeae032.$54$YR$A$M$Y$$$20240902$$HP$JP$JP
241183693$24118369$3$F$20240621$20240729$20240722$20240805$PER$$US-AMGEN-USASP2024140852$AMGEN$$49$YR$A$F$Y$93.878$KG$20240805$$HP$US$US
241183701$24118370$1$I$$20240716$20240722$20240722$PER$$US-ABBVIE-5843735$ABBVIE$$$$$$Y$$$20240720$$CN$US$US
241183711$24118371$1$I$20240712$20240712$20240722$20240722$30DAY$$US-GSK-US2024087787$GLAXOSMITHKLINE$$41$YR$$F$Y$$$20240722$$CN$US$US
241183721$24118372$1$I$$20240716$20240722$20240722$EXP$$CA-ROCHE-10000030276$ROCHE$$$$A$F$Y$$$20240722$$CN$CA$CA
241183731$24118373$1$I$$20240716$20240722$20240722$EXP$$CA-ROCHE-10000030637$ROCHE$$$$A$M$Y$$$20240722$$CN$CA$CA
241183741$24118374$1$I$20240524$20240712$20240722$20240722$EXP$FR-AFSSAPS-RE2024000619$FR-TEVA-VS-3220913$TEVA$$81$YR$$F$Y$93$KG$20240722$$MD$FR$FR
241183751$24118375$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00826$EPIC PHARM$R. Hoerle.A Last Resort: Lipid Emulsion Therapy in Lidocaine Anesthetic Systemic Toxicity (LAST).American Journal of Respiratory and Critical Care Medicine.2024;209:A5683$81$YR$E$F$Y$65$KG$20240722$$HP$US$US
241183761$24118376$1$I$$20240717$20240722$20240722$EXP$AU-TGA-0000811903$AU-SANDOZ INC.-SDZ2024AU066321$SANDOZ$$19$YR$$M$Y$$$20240722$$CN$AU$AU
241183772$24118377$2$F$$20240813$20240722$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114358$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$76.66$KG$20240819$$HP$US$US
241183781$24118378$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024142636$AMGEN$$$$$$Y$$$20240722$$PH$US$US
241183791$24118379$1$I$$20240708$20240722$20240722$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06668$HIKMA$Pham S, Heigle B, Gibbs C, Gebrehiwot WG, Pannu P. Pham S, Heigle B, Gibbs C, Gebrehiwot WG, Pannu P.  Complications of Infective Endocarditis: A Case Report of Intracerebral Hemorrhage Exacerbated by Enoxaparin.. Cureus. 2024;16(5):e61235$76$YR$$F$Y$$$20240722$$MD$US$US
241183801$24118380$1$I$$20240717$20240722$20240722$EXP$CA-DRL-USA-SPO/CAN/24/0010591$CA-RDY-SPO/CAN/24/0010591$DR REDDYS$$64$YR$A$M$Y$92$KG$20240722$$HP$CA$CA
241183811$24118381$1$I$$20240716$20240722$20240722$EXP$$CA-ABBVIE-5847018$ABBVIE$$12$YR$$F$Y$$$20240722$$MD$CA$CA
241183821$24118382$1$I$20230315$20240717$20240722$20240722$EXP$$GB-TAKEDA-2024TUS072368$TAKEDA$$5$YR$$F$Y$$$20240722$$HP$GB$GB
241183832$24118383$2$F$20240601$20240628$20240722$20240724$PER$$KR-WT-2024-APC-076035$Waylis$$81$YR$$M$Y$$$20240724$$CN$KR$KR
241183841$24118384$1$I$$20240712$20240722$20240722$EXP$$US-BEH-2024175821$CSL BEHRING$$$$E$F$Y$$$20240722$$HP$US$US
241183852$24118385$2$F$20240604$20240715$20240722$20240724$30DAY$$US-GSK-US2024088663$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240724$$CN$US$US
241183862$24118386$2$F$$20240827$20240722$20240905$EXP$$US-TEVA-VS-3220639$TEVA$Alexander J, Soney H, Lopez D, Naik D, Azimi A. RUSH TO DE-LIVER: A CASE OF HSV HEPATITIS IN PREGNANCY. J-Hosp-Med 2023; 18 S635-S636.; Alexander J, Soney H, Lopez D, Naik D, Azimi A. RUSH TO DE-LIVER: A CASE OF HSV HEPATITIS IN PREGNANCY. J-Hosp-Med 2023; 18 S635-S636.$24$YR$$F$Y$$$20240905$$HP$US$US
241183871$24118387$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087724$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
241183881$24118388$1$I$20240712$20240712$20240722$20240722$30DAY$$US-GSK-US2024087711$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
241183891$24118389$1$I$$20240719$20240722$20240722$PER$$US-ROCHE-10000031814$ROCHE$$33$YR$A$F$Y$$$20240722$$HP$US$US
241183901$24118390$1$I$20240601$20240710$20240722$20240722$EXP$$US-TEVA-VS-3220698$TEVA$$53$YR$$F$Y$$$20240722$$CN$US$US
241183912$24118391$2$F$$20240724$20240722$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113221$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240729$$HP$US$US
241183921$24118392$1$I$20240601$20240715$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112284$BRISTOL MYERS SQUIBB$$12$YR$T$F$Y$$$20240722$$HP$US$US
241183931$24118393$1$I$$20240718$20240722$20240722$EXP$$US-UCBSA-2024036717$UCB$$$$$F$Y$$$20240722$$HP$US$US
241183942$24118394$2$F$20240601$20240918$20240722$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112273$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240920$$HP$US$US
241183951$24118395$1$I$20240715$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024143158$AMGEN$$63$YR$A$M$Y$$$20240722$$CN$US$US
241183961$24118396$1$I$20200427$20240717$20240722$20240722$EXP$$AU-SANDOZ INC.-NVSC2020AU143499$SANDOZ$$80$YR$$F$Y$$$20240722$$MD$AU$AU
241183971$24118397$1$I$$20240708$20240722$20240722$EXP$$CN-EPICPHARMA-CN-2024EPCLIT00834$EPIC PHARM$Xiaoxue Xu.Reversible blindness after stellate ganglion block.Quantitative Imaging in Medicine and Surgery.24-APR-2024;14(5):3744-3750$53$YR$A$M$Y$65$KG$20240722$$MD$CN$CN
241183981$24118398$1$I$$20240716$20240722$20240722$PER$$NVSC2024US149595$NOVARTIS$$53$YR$$F$Y$$$20240722$$CN$US$US
241183991$24118399$1$I$$20240711$20240722$20240722$EXP$$CA-APOTEX-2024AP008287$APOTEX$$$$$M$Y$17$KG$20240722$$HP$CA$CA
241184002$24118400$2$F$$20240715$20240722$20240730$EXP$BE-ALKEM LABORATORIES LIMITED-BE-ALKEM-2024-15459$BE-ALKEM LABORATORIES LIMITED-BE-ALKEM-2024-15459$ALKEM$Meganck S, Raevens S, Ferdinande K, Verhelst X, Hoorens A, Degroote H, Geerts A, Van Vlierberghe H.. Recurrent rejections after liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient. Acta clinica Belgica. 2024;unk:1-8$32$YR$$F$Y$$$20240730$$MD$BE$BE
241184012$24118401$2$F$$20240715$20240722$20240730$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-15460$ALKEM$Lizondo Lopez T, Font I Barcelo A, Garcia Gutierrez C, Blasco M, Grafia I, Bastida C, Castro-Rebollo P, Soy-Muner D.. Clopidogrel-induced thrombotic microangiopathy: a case report. Eur J Hosp Pharm. 2024;0:1-4$75$YR$$M$Y$$$20240730$$HP$ES$ES
241184023$24118402$3$F$20240101$20240909$20240722$20240917$EXP$$US-TEVA-2023-US-2938722$TEVA$$38$YR$$M$Y$$$20240917$$CN$US$US
241184032$24118403$2$F$$20240719$20240722$20240802$EXP$IT-MLMSERVICE-20240628-PI115611-00275-1$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-15283$ALKEM$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et al.. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicology Reports. 2024;13:101683$15$YR$$F$Y$48$KG$20240802$$MD$IT$IT
241184051$24118405$1$I$$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024143128$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241184061$24118406$1$I$20240101$20240710$20240722$20240722$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01135$INTRA-CELLULAR THERAPIES$$$$$F$Y$94.785$KG$20240722$$CN$US$US
241184071$24118407$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141954$AMGEN$Stilgenbauer S. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241184082$24118408$2$F$$20240708$20240722$20240902$PER$$US-ASTELLAS-2024US019644$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241184091$24118409$1$I$20240501$20240606$20240722$20240722$PER$$US-AUROBINDO-AUR-APL-2024-029299$AUROBINDO$$69$YR$$F$Y$$$20240722$$CN$US$US
241184101$24118410$1$I$20240101$20240712$20240722$20240722$EXP$$US-TEVA-VS-3221555$TEVA$$$$$F$Y$$$20240722$$CN$US$US
241184111$24118411$1$I$20201015$20201015$20240722$20240722$EXP$$CO-AstraZeneca-2020SF35419$ASTRAZENECA$$13428$DY$$M$Y$$$20240722$$CN$CO$
241184121$24118412$1$I$$20230106$20240722$20240722$EXP$$US-AstraZeneca-2023A004850$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241184131$24118413$1$I$$20230522$20240722$20240722$EXP$$US-AstraZeneca-2023A078788$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241184141$24118414$1$I$20220827$20221024$20240722$20240722$EXP$$CO-AstraZeneca-2022A312805$ASTRAZENECA$$16119$DY$$M$Y$65$KG$20240722$$CN$CO$
241184151$24118415$1$I$$20200109$20240722$20240722$EXP$$CA-AstraZeneca-2020SE04954$ASTRAZENECA$$67$YR$$M$Y$$$20240722$$MD$CA$
241184161$24118416$1$I$20240711$20240717$20240722$20240722$EXP$$US-AstraZeneca-2024A163368$ASTRAZENECA$$30080$DY$$M$Y$$$20240722$$MD$US$
241184171$24118417$1$I$$20220128$20240722$20240722$EXP$$US-AstraZeneca-2022A052787$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241184181$24118418$1$I$$20220706$20240722$20240722$EXP$$US-AstraZeneca-2022A249474$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241184191$24118419$1$I$20220309$20220322$20240722$20240722$EXP$$US-AstraZeneca-2022A125181$ASTRAZENECA$$22975$DY$$F$Y$68.9$KG$20240722$$CN$US$
241184201$24118420$1$I$$20200508$20240722$20240722$EXP$$US-AstraZeneca-2020SE62071$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241184211$24118421$1$I$$20220705$20240722$20240722$EXP$$US-AstraZeneca-2022A248056$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241184221$24118422$1$I$20170101$20200831$20240722$20240722$EXP$$US-AstraZeneca-2020SF10765$ASTRAZENECA$$62$YR$$M$Y$108.9$KG$20240722$$CN$US$
241184231$24118423$1$I$$20240717$20240722$20240722$EXP$$US-TAKEDA-2024TUS072316$TAKEDA$$$$$M$Y$$$20240722$$CN$US$US
241184241$24118424$1$I$20240514$20240611$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090890$VIIV$$36$YR$$M$Y$$$20240722$$PH$US$US
241184251$24118425$1$I$20240514$20240611$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090856$VIIV$$59$YR$$F$Y$$$20240722$$PH$US$US
241184262$24118426$2$F$20210118$20240715$20240722$20240730$EXP$$GB-MDD US Operations-E2B_00006337$MDD OPERATIONS$$$$E$M$Y$$$20240729$$MD$GB$
241184271$24118427$1$I$20231014$20240716$20240722$20240722$EXP$$DE-SANDOZ INC.-SDZ2024DE066445$SANDOZ$$78$YR$$F$Y$$$20240722$$MD$DE$DE
241184282$24118428$2$F$20200415$20240917$20240722$20240927$EXP$$AT-CELLTRION INC.-2021AT006484$CELLTRION$$$$$$Y$$$20240927$$MD$AT$AT
241184292$24118429$2$F$$20240801$20240722$20240807$PER$$US-AMGEN-USASP2024141938$AMGEN$$$$$F$Y$$$20240807$$PH$US$US
241184302$24118430$2$F$20240710$20240729$20240722$20240730$PER$$US-AMGEN-USASP2024142142$AMGEN$$37$YR$A$M$Y$$$20240730$$HP$US$US
241184321$24118432$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087735$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
241184332$24118433$2$F$20240516$20240731$20240722$20240808$EXP$$CA-CELLTRION INC.-2024CA017472$CELLTRION$$$$$$Y$$$20240808$$HP$CA$CA
241184342$24118434$2$F$20240705$20240828$20240722$20240902$EXP$$CO-UCBSA-2024036729$UCB$$57$YR$$F$Y$$$20240902$$CN$CO$CO
241184361$24118436$1$I$20240704$20240709$20240722$20240722$EXP$$JP-ASTELLAS-2024US020305$ASTELLAS$$$$$M$Y$$$20240722$$CN$CH$JP
241184371$24118437$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00835$EPIC PHARM$Hua S.It^s Not Always the Liver: Rifampin-induced Lupus Pericarditis With Tamponade.American Journal of Respiratory and Critical Care Medicine .MAY-2024;209:A5679$63$YR$A$M$Y$$$20240722$$HP$US$US
241184382$24118438$2$F$$20240710$20240722$20240730$PER$$US-TEVA-VS-3221016$TEVA$$$$$F$Y$$$20240730$$CN$US$US
241184392$24118439$2$F$20240601$20240719$20240722$20240723$EXP$$US-UCBSA-2024036553$UCB$$60$YR$$F$Y$$$20240723$$CN$US$US
241184402$24118440$2$F$$20240723$20240722$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115544$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240724$$CN$US$US
241184411$24118441$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115633$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240722$$HP$US$US
241184421$24118442$1$I$$20240717$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114661$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240722$$CN$US$US
241184431$24118443$1$I$$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115028$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240722$$CN$US$US
241184441$24118444$1$I$20240101$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114414$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240722$$CN$US$US
241184451$24118445$1$I$$20240716$20240722$20240722$PER$$US-ABBVIE-5846415$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241184472$24118447$2$F$$20240719$20240722$20240730$EXP$$ID-ASTELLAS-2024US020269$ASTELLAS$Rohmah SN, Kuswadi I, Prasanto H, Puspitasari M, Wardhani Y. Clinical profile and outcome of tuberculosis in kidney transplant recipients: A case series in Dr. Sardjito general hospital, Indonesia. Nephrology. 2022;27 (Suppl 1):112$42$YR$$M$Y$$$20240730$$CN$NL$ID
241184481$24118448$1$I$$20240715$20240722$20240722$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005310$BIOCON$$$$$$Y$$$20240722$$HP$CA$CA
241184491$24118449$1$I$$20240707$20240722$20240722$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457413$RANBAXY$$$$$F$Y$73$KG$20240722$$CN$GB$GB
241184501$24118450$1$I$$20240707$20240722$20240722$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457876$RANBAXY$Candela-Canto S, Muchart J, Valera C, Jou C, Culebras D, Alamar M, et al. Completion of disconnective surgery for refractory epilepsy in pediatric patients using robot-assisted MRI-guided laser interstitial thermal therapy.. J Neurosurg Pediatr. 2023;31 (1):61-70$4$YR$$$Y$$$20240722$$MD$ES$ES
241184511$24118451$1$I$$20240707$20240722$20240722$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457840$RANBAXY$Candela-Canto S, Muchart J, Valera C, Jou C, Culebras D, Alamar M, et al. Completion of disconnective surgery for refractory epilepsy in pediatric patients using robot-assisted MRI-guided laser interstitial thermal therapy.. J Neurosurg Pediatr. 2023;31 (1):61-70$5$YR$$$Y$$$20240722$$MD$ES$ES
241184521$24118452$1$I$$20240707$20240722$20240722$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457870$RANBAXY$Candela-Canto S, Muchart J, Valera C, Jou C, Culebras D, Alamar M, et al. Completion of disconnective surgery for refractory epilepsy in pediatric patients using robot-assisted MRI-guided laser interstitial thermal therapy.. J Neurosurg Pediatr. 2023;31 (1):61-70$2$YR$$$Y$$$20240722$$MD$ES$ES
241184531$24118453$1$I$$20240707$20240722$20240722$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457826$RANBAXY$Candela-Canto S, Muchart J, Valera C, Jou C, Culebras D, Alamar M, et al. Completion of disconnective surgery for refractory epilepsy in pediatric patients using robot-assisted MRI-guided laser interstitial thermal therapy.. J Neurosurg Pediatr. 2023;31 (1):61-70$6$MON$$$Y$$$20240722$$MD$ES$ES
241184541$24118454$1$I$20240706$20240707$20240722$20240722$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457502$RANBAXY$$51$YR$$M$Y$90$KG$20240722$$CN$GB$GB
241184551$24118455$1$I$20240205$20240707$20240722$20240722$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457451$RANBAXY$$41$YR$$M$Y$56$KG$20240722$$CN$GB$GB
241184561$24118456$1$I$$20240707$20240722$20240722$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457432$RANBAXY$$58$YR$$M$Y$$$20240722$$CN$GB$GB
241184571$24118457$1$I$$20240707$20240722$20240722$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457843$RANBAXY$Candela-Canto S, Muchart J, Valera C, Jou C, Culebras D, Alamar M, et al. Completion of disconnective surgery for refractory epilepsy in pediatric patients using robot-assisted MRI-guided laser interstitial thermal therapy.. J Neurosurg Pediatr. 2023;31 (1):61-70$2$YR$$$Y$$$20240722$$MD$ES$ES
241184581$24118458$1$I$$20240707$20240722$20240722$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457858$RANBAXY$Candela-Canto S, Muchart J, Valera C, Jou C, Culebras D, Alamar M, et al. Completion of disconnective surgery for refractory epilepsy in pediatric patients using robot-assisted MRI-guided laser interstitial thermal therapy.. J Neurosurg Pediatr. 2023;31 (1):61-70$10$YR$$$Y$$$20240722$$MD$ES$ES
241184591$24118459$1$I$20240204$20240716$20240722$20240722$EXP$$JO-EMD Serono-2024038850$EMD SERONO INC$$28$YR$A$F$Y$$$20240722$$CN$JO$JO
241184601$24118460$1$I$$20240624$20240722$20240722$PER$$US-ROCHE-10000030300$ROCHE$$39$YR$A$F$Y$$$20240722$$CN$US$US
241184611$24118461$1$I$20231201$20240711$20240722$20240722$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001397$Alvotech$$76$YR$$F$Y$$$20240722$$CN$CA$CA
241184621$24118462$1$I$$20240709$20240722$20240722$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001938$Alvotech$$81$YR$$M$Y$$$20240722$$CN$CA$CA
241184632$24118463$2$F$20240612$20240805$20240722$20240815$EXP$FR-AFSSAPS-AN2024000835$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109616$ZYDUS PHARM$$$$$$Y$$$20240814$$MD$FR$FR
241184641$24118464$1$I$20231123$20240708$20240722$20240722$EXP$FR-AFSSAPS-RS2023000963$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109649$ZYDUS PHARM$$$$$$Y$$$20240722$$MD$FR$FR
241184651$24118465$1$I$$20240712$20240722$20240722$EXP$$CA-CELLTRION INC.-2024CA017477$CELLTRION$$$$$$Y$$$20240722$$HP$CA$CA
241184661$24118466$1$I$20240101$20240717$20240722$20240722$EXP$$NVSC2024IE147420$NOVARTIS$$$$A$F$Y$$$20240722$$HP$IE$IE
241184671$24118467$1$I$$20240718$20240722$20240722$PER$$NVSC2024US149637$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
241184681$24118468$1$I$20240326$20240712$20240722$20240722$EXP$ES-AEMPS-1544036$ES-TEVA-VS-3220949$TEVA$$88$YR$$M$Y$62.4$KG$20240722$$MD$ES$ES
241184691$24118469$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087737$GLAXOSMITHKLINE$$$$$M$Y$$$20240722$$CN$US$US
241184701$24118470$1$I$$20240715$20240722$20240722$EXP$$CH-ROCHE-10000027865$ROCHE$$$$$F$Y$$$20240722$$MD$CH$CH
241184711$24118471$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024142782$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240722$$MD$US$US
241184721$24118472$1$I$$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142753$AMGEN$$$$A$F$Y$$$20240722$$HP$US$US
241184731$24118473$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141866$AMGEN$Stilgenbauer, S.. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241184741$24118474$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141874$AMGEN$Stilgenbauer, S.. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241184751$24118475$1$I$$20240712$20240722$20240722$EXP$$CA-CELLTRION INC.-2024CA017480$CELLTRION$$$$$$Y$$$20240722$$MD$CA$CA
241184761$24118476$1$I$20240504$20240722$20240722$20240722$EXP$ES-AEMPS-1550564$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041084$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240722$$MD$ES$ES
241184771$24118477$1$I$20240705$20240713$20240722$20240722$EXP$$CN-Merck Healthcare KGaA-2024038556$MERCK KGAA$$92$YR$E$M$Y$50$KG$20240718$$HP$CN$CN
241184781$24118478$1$I$20240716$20240716$20240722$20240722$PER$$US-ABBVIE-5846578$ABBVIE$$54$YR$$F$Y$$$20240722$$MD$US$US
241184792$24118479$2$F$20240715$20240726$20240722$20240802$EXP$$CA-PUMA BIOTECHNOLOGY, INC.-2024-PUM-CA001005$PUMA$$$$$$Y$$$20240802$$MD$CA$CA
241184801$24118480$1$I$$20240711$20240722$20240722$EXP$$CA-APOTEX-2024AP008257$APOTEX$$71$YR$$M$Y$$$20240722$$HP$CA$CA
241184811$24118481$1$I$$20240717$20240722$20240722$PER$$US-ABBVIE-5846580$ABBVIE$$$$$$Y$$$20240722$$HP$US$US
241184821$24118482$1$I$20200512$20200630$20240722$20240722$EXP$$CA-AstraZeneca-2020SE63659$ASTRAZENECA$$20868$DY$$M$Y$$$20240722$$HP$CA$
241184832$24118483$2$F$$20240904$20240722$20240904$PER$$NVSC2024US148243$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
241184841$24118484$1$I$$20191129$20240722$20240722$EXP$$FR-AstraZeneca-2019SF74230$ASTRAZENECA$$$$$M$Y$$$20240722$$MD$FR$
241184851$24118485$1$I$$20240711$20240722$20240722$EXP$$US-STERISCIENCE B.V.-2024-ST-001065$Steriscience PTE$Gul MH, Taylor K, Bailey KL, Adickes E.. An Unexpected Cause of Acute Liver Failure.. Am-J-Respir-Crit-Care-Med. 2024;209$81$YR$$M$Y$$$20240722$$HP$US$US
241184861$24118486$1$I$20240717$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012464$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240722$$CN$US$US
241184871$24118487$1$I$$20210323$20240722$20240722$EXP$$US-AstraZeneca-2021A208899$ASTRAZENECA$$71$YR$$F$Y$$$20240722$$CN$US$
241184881$24118488$1$I$20240701$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011271$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240722$$CN$US$US
241184891$24118489$1$I$20240717$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012237$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240722$$CN$US$US
241184901$24118490$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012302$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240722$$CN$US$US
241184911$24118491$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013033$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240722$$CN$US$US
241184921$24118492$1$I$20240701$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011384$ELI LILLY AND CO$$86$YR$E$M$Y$$$20240722$$CN$US$US
241184931$24118493$1$I$20240711$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012349$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240722$$CN$US$US
241184941$24118494$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012914$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240722$$CN$US$US
241184951$24118495$1$I$20240701$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011917$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240722$$CN$US$US
241184962$24118496$2$F$$20240717$20240722$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011971$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240723$$CN$US$US
241184971$24118497$1$I$$20240715$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407010269$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240722$$CN$US$US
241184981$24118498$1$I$20240718$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012948$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240722$$CN$US$US
241184991$24118499$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012936$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240722$$CN$US$US
241185001$24118500$1$I$20240717$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012910$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240722$$CN$US$US
241185011$24118501$1$I$$20240711$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407008439$ELI LILLY AND CO$$87$YR$E$F$Y$$$20240722$$CN$US$US
241185021$24118502$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012080$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240722$$CN$US$US
241185032$24118503$2$F$$20240906$20240722$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202407012919$ELI LILLY AND CO$$$$$$Y$$$20240911$$CN$US$US
241185041$24118504$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012201$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240722$$CN$US$US
241185051$24118505$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012486$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240722$$CN$US$US
241185061$24118506$1$I$$20240715$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407009875$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240722$$CN$US$US
241185071$24118507$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011630$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240722$$CN$US$US
241185081$24118508$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012930$ELI LILLY AND CO$$$$$$Y$$$20240722$$CN$US$US
241185091$24118509$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012075$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240722$$CN$US$US
241185101$24118510$1$I$$20221020$20240722$20240722$EXP$$AU-AstraZeneca-2022A342528$ASTRAZENECA$$$$$M$Y$$$20240722$$MD$AU$
241185111$24118511$1$I$20201107$20201126$20240722$20240722$EXP$$PH-AstraZeneca-2020SF57446$ASTRAZENECA$$11268$DY$$F$Y$$$20240722$$CN$PH$
241185121$24118512$1$I$$20200325$20240722$20240722$EXP$$US-AstraZeneca-2020SE43361$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241185131$24118513$1$I$20230101$20240708$20240722$20240722$EXP$$GB-EPICPHARMA-GB-2024EPCLIT00832$EPIC PHARM$Nighat J. Nadeem.Case report: Diagnostic challenges in an adolescent case of autistic catatonia.Frontiers in Psychiatry.27-MAY-2024;15:01-07$15$YR$T$M$Y$$$20240722$$HP$GB$GB
241185141$24118514$1$I$$20200916$20240722$20240722$EXP$$CA-AstraZeneca-2020SF20627$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$CA$
241185151$24118515$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115641$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240722$$CN$US$US
241185161$24118516$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115509$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240722$$PH$US$US
241185171$24118517$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114888$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240722$$HP$US$US
241185181$24118518$1$I$20240715$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115932$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240722$$CN$US$US
241185191$24118519$1$I$$20240605$20240722$20240722$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-12682$ALKEM$Birck R, Keim V, Fiedler F, et al.. Pancreatitis after losartan. Lancet. 1998;351:1178$42$YR$$F$Y$$$20240722$$HP$DE$DE
241185201$24118520$1$I$$20240605$20240722$20240722$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-12692$ALKEM$Maringhini A, Termini A, Patti R, et al.. Enalapril-associated acute pancreatitis: recurrence after rechallenge. Am J Gastroenterol. 1997;92:166-167$65$YR$$F$Y$$$20240722$$HP$IT$IT
241185211$24118521$1$I$$20240605$20240722$20240722$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-12637$ALKEM$Carnovale A, Esposito P, Bassano P, et al.. Enalapril-induced acute recurrent pancreatitis. Dig Liver Dis. 2003;35:55-57$54$YR$$F$Y$$$20240722$$HP$IT$IT
241185221$24118522$1$I$20240522$20240712$20240722$20240722$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06302$VIFOR$$74$YR$$F$Y$$$20240722$$CN$ZA$ZA
241185231$24118523$1$I$$20240708$20240722$20240722$EXP$$US-PURACAP-US-2024EPCLIT00823$PURACAP$Patel D.A ^Tail^ of Caution: Pioglitazone Induced Recurrent Pleural Effusion.American Journal of Respiratory and Critical Care Medicine.19-MAY-2024;209$68$YR$E$F$Y$$$20240722$$HP$US$US
241185241$24118524$1$I$$20240507$20240722$20240722$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10111$ALKEM$Quilty F, Abel AAI, Clark AL.. Bilateral renal artery revascularisation in heart failure. BMJ Case Rep. 2024;17:e256323$7$DEC$$M$Y$65.3$KG$20240722$$HP$GB$GB
241185251$24118525$1$I$20230101$20240715$20240722$20240722$EXP$$GB-UCBSA-2024036614$UCB$Madenidou A-V, Kither H, Dyball S, Bruce IN, Tower C. Added IMPACT: The first successful natural birth using certolizumab in obstetric APS. Thrombosis research. 2024;241:1-3$$$N$F$Y$$$20240722$$HP$GB$GB
241185262$24118526$2$F$20201007$20240910$20240722$20240921$EXP$$DE-AUROBINDO-AUR-APL-2022-026617$AUROBINDO$$$$E$F$Y$87$KG$20240921$$MD$DE$DE
241185271$24118527$1$I$$20240712$20240722$20240722$EXP$$GB-VANTIVE-2024VAN018326$Vantive US Healthcare$$$$$F$Y$53.4$KG$20240722$$CN$GB$GB
241185281$24118528$1$I$$20240715$20240722$20240722$PER$$US-ABBVIE-5841167$ABBVIE$$$$$$Y$$$20240722$$CN$US$US
241185291$24118529$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087750$GLAXOSMITHKLINE$$$$$M$Y$$$20240722$$CN$US$US
241185301$24118530$1$I$20240203$20240719$20240722$20240722$EXP$GB-MHRA-MED-202407182050149140-BDJRG$GB-ASTELLAS-2024US020649$ASTELLAS$$73$YR$$M$Y$110$KG$20240722$$CN$GB$GB
241185314$24118531$4$F$20240621$20240814$20240722$20240820$EXP$$CA-BIOGEN-2024BI01270875$BIOGEN$$50$YR$$F$Y$$$20240820$$HP$CA$CA
241185322$24118532$2$F$20240520$20240813$20240722$20240821$EXP$IT-MINISAL02-988045$IT-ROCHE-3576101$ROCHE$$65$YR$E$M$Y$51$KG$20240821$$MD$IT$IT
241185331$24118533$1$I$$20240709$20240722$20240722$EXP$$US-MPL-000050$MLV PHARMA$$72$YR$E$M$Y$$$20240711$$MD$US$US
241185341$24118534$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115602$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240722$$MD$US$US
241185351$24118535$1$I$$20240708$20240722$20240722$EXP$$CA-ROCHE-10000024409$ROCHE$$65$YR$E$F$Y$$$20240722$$MD$CA$CA
241185362$24118536$2$F$$20240808$20240722$20240813$EXP$$US-ASTELLAS-2024US019227$ASTELLAS$$$$$M$Y$$$20240813$$CN$US$US
241185371$24118537$1$I$20230329$20240718$20240722$20240722$EXP$FR-AFSSAPS-PO2024000785$FR-ASTELLAS-2024EU007162$ASTELLAS$$33$YR$$F$Y$116$KG$20240722$$CN$FR$FR
241185381$24118538$1$I$$20240718$20240722$20240722$EXP$$CA-UCBSA-2024036713$UCB$$$$$F$Y$$$20240722$$HP$CA$CA
241185391$24118539$1$I$20240618$20240712$20240722$20240722$EXP$IT-MINISAL02-994407$IT-AMGEN-ITASP2024139102$AMGEN$$67$YR$E$M$Y$$$20240722$$MD$IT$IT
241185401$24118540$1$I$$20240709$20240722$20240722$EXP$$IT-ROCHE-10000020540$ROCHE$Donzella D, Bellis E, Crepaldi G, Data V, Gatto M, Lomater C. The Retention Rate and Safety of JAK Inhibitors in Rheumatoid Arthritis: Real Word Data from a Monocentric Cohort. Journal of Clinical Medicine. 2024-Jun;13 (12): doi:10.3390/jcm13123494.$$$$$Y$$$20240722$$HP$IT$IT
241185413$24118541$3$F$20240905$20240905$20240722$20240916$EXP$$US-ASTELLAS-2024US018288$ASTELLAS$$89$YR$E$M$Y$$$20240916$$CN$US$US
241185421$24118542$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024143126$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240722$$MD$US$US
241185431$24118543$1$I$$20240712$20240722$20240722$EXP$$BE-AUROBINDO-AUR-APL-2024-035775$AUROBINDO$$$$$F$Y$$$20240722$$MD$BE$BE
241185441$24118544$1$I$$20240708$20240722$20240722$EXP$$IT-EPICPHARMA-IT-2024EPCLIT00836$EPIC PHARM$Arianna Giorgetti.Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities.International Journal of Legal Medicine.03-JUN-2024$31$YR$A$M$Y$$$20240722$$HP$IT$IT
241185451$24118545$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00815$EPIC PHARM$U. D. Gupta.Severe Metabolic Acidosis Attributed to Metformin Overdose: Necessitating Urgent Dialysis and Critical Care.American Journal of Respiratory and Critical Care Medicine.2024;209:A3415$43$YR$A$F$Y$$$20240722$$HP$US$US
241185461$24118546$1$I$$20240712$20240722$20240722$EXP$$GB-MYLANLABS-2024M1066193$MYLAN$$$$$M$Y$$$20240722$$CN$GB$GB
241185471$24118547$1$I$20210512$20240717$20240722$20240722$EXP$$ES-AMGEN-ESPSP2024143272$AMGEN$$$$A$F$Y$$$20240722$$MD$ES$ES
241185481$24118548$1$I$$20240719$20240722$20240722$PER$$US-ROCHE-10000031930$ROCHE$$49$YR$A$F$Y$$$20240722$$MD$US$US
241185501$24118550$1$I$$20240718$20240722$20240722$PER$$US-ABBVIE-5847086$ABBVIE$$$$$F$Y$$$20240722$$MD$US$US
241185513$24118551$3$F$$20240731$20240722$20240812$EXP$$CA-AMGEN-CANSP2024139613$AMGEN$$40$YR$A$F$Y$96$KG$20240812$$HP$CA$CA
241185521$24118552$1$I$20211026$20240712$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-034931$AUROBINDO$$75$YR$$M$Y$$$20240722$$PH$GB$GB
241185531$24118553$1$I$$20240711$20240722$20240722$EXP$NL-LRB-00985143$NL-JUBILANT PHARMA LTD-2024NL001007$JUBILANT$$31$YR$$F$Y$78$KG$20240722$$CN$NL$NL
241185542$24118554$2$F$$20240731$20240722$20240808$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06304$VIFOR$$66$YR$$F$Y$$$20240808$$HP$ZA$ZA
241185551$24118555$1$I$$20240716$20240722$20240722$EXP$$US-BIOGEN-2024BI01273970$BIOGEN$$$$$F$Y$$$20240722$$MD$US$US
241185561$24118556$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06597$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241185571$24118557$1$I$$20240709$20240722$20240722$EXP$$PH-ROCHE-10000030072$ROCHE$$$$$$Y$$$20240722$$MD$PH$PH
241185583$24118558$3$F$20240101$20240729$20240722$20240805$EXP$$NVSC2024BR149087$NOVARTIS$$$$$F$Y$$$20240805$$CN$BR$BR
241185594$24118559$4$F$20220101$20240913$20240722$20240926$EXP$$RO-SA-2024SA206415$SANOFI AVENTIS$Popa CN, Bratu VD, Popa EC, Dinu DE, Iosif C, Chirita E, et al.. Neoadjuvant Chemotherapy: Friend or Foe.. Maedica - a Journal of Clinical Medicine.. 2024;19(2):417-22$71$YR$E$F$Y$$$20240926$$MD$RO$RO
241185601$24118560$1$I$$20240708$20240722$20240722$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-15664$ALKEM$Aftab M, Badyal DK, Bhatti N. Isoniazid induced pancreatitis: a case report. Int J Sci Res. 2018;7(7):17-8$15$YR$$F$Y$$$20240722$$HP$IN$IN
241185611$24118561$1$I$20210901$20240712$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-034930$AUROBINDO$$73$YR$$F$Y$$$20240722$$PH$GB$GB
241185621$24118562$1$I$$20240708$20240722$20240722$EXP$$IT-EPICPHARMA-IT-2024EPCLIT00833$EPIC PHARM$Arianna Giorgetti.Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities.International Journal of Legal Medicine.03-JUN-2024$31$YR$A$M$Y$$$20240722$$HP$IT$IT
241185631$24118563$1$I$20240717$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49849$$FDA-CTU$$74$YR$$M$N$$$20240717$N$HP$US$
241185641$24118564$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49839$$FDA-CTU$$$$$$N$$$20240717$N$CN$US$
241185651$24118565$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49838$$FDA-CTU$$$$$$N$$$20240717$N$CN$US$
241185661$24118566$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49854$$FDA-CTU$$$$$$N$$$20240717$N$CN$US$
241185671$24118567$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49899$$FDA-CTU$$78$YR$$F$N$$$20240718$N$$US$
241185681$24118568$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49842$$FDA-CTU$$$$$M$N$$$20240717$N$$US$
241185691$24118569$1$I$$20240712$20240722$20240722$EXP$$CO-AUROBINDO-AUR-APL-2024-034824$AUROBINDO$Tabares B, Sarmiento-Suarez AD, Gil O, Hernandez-Pabon JC, Firacative C. Fatal co-infection by multiple pathogens in an indigenous woman with autoimmune hemolytic anemia and tuberculosis: a case report. BMC Infectious Diseases. 2024;24(1):645$28$YR$$F$Y$$$20240722$$HP$CO$CO
241185701$24118570$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00830$EPIC PHARM$M. Renzetti.Salty, Sweet, and Severe: A Case of Linagliptin-induced Severe Hyponatremia.American Journal of Respiratory and Critical Care Medicin.2024;209:A7036$76$YR$E$F$Y$$$20240722$$HP$US$US
241185711$24118571$1$I$20240214$20240715$20240722$20240722$EXP$$US-SA-2024SA209589$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240722$$MD$US$US
241185721$24118572$1$I$$20240710$20240722$20240722$EXP$$CA-TEVA-VS-3222660$TEVA$$33$YR$$F$Y$71.668$KG$20240722$$HP$CA$CA
241185741$24118574$1$I$20240621$20240712$20240722$20240722$EXP$IT-MINISAL02-993265$IT-TEVA-VS-3221406$TEVA$$57$YR$$M$Y$$$20240722$$MD$IT$IT
241185751$24118575$1$I$$20240717$20240722$20240722$EXP$$NVSC2024MA149299$NOVARTIS$$$$$F$Y$$$20240722$$CN$MA$MA
241185762$24118576$2$F$$20240812$20240722$20240815$PER$$US-ROCHE-10000029858$ROCHE$$51$YR$A$M$Y$$$20240815$$CN$US$US
241185772$24118577$2$F$20240626$20240712$20240722$20240723$PER$$NVSC2024US146765$NOVARTIS$$74$YR$$M$Y$$$20240723$$CN$US$US
241185781$24118578$1$I$20240717$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49841$$FDA-CTU$$22$YR$$F$N$68.04$KG$20240717$N$MD$US$
241185791$24118579$1$I$$20240716$20240722$20240722$PER$$US-ROCHE-10000029395$ROCHE$$$$A$F$Y$$$20240722$$CN$US$US
241185801$24118580$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000031038$ROCHE$$19$YR$A$F$Y$$$20240722$$MD$US$US
241185811$24118581$1$I$$20240716$20240722$20240722$PER$$US-ROCHE-10000030335$ROCHE$$48$YR$A$F$Y$$$20240722$$CN$US$US
241185832$24118583$2$F$$20240726$20240722$20240729$EXP$$US-BAUSCH-BL-2024-011069$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240729$$CN$US$US
241185841$24118584$1$I$20240628$20240712$20240722$20240722$30DAY$$US-GSK-US2024087736$GLAXOSMITHKLINE$$92$YR$$F$Y$$$20240722$$CN$US$US
241185851$24118585$1$I$$20240717$20240717$20240717$DIR$FDA-CDER-CTU-2024-49851$$FDA-CTU$$$$$$N$$$20240717$$CN$US$
241185861$24118586$1$I$$20220315$20240722$20240722$EXP$$ZA-AstraZeneca-2022A116234$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$ZA$
241185871$24118587$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072753$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241185882$24118588$2$F$20240714$20240722$20240722$20240726$EXP$$CA-AstraZeneca-2024A164006$ASTRAZENECA$$31915$DY$$M$Y$$$20240726$$CN$CA$
241185891$24118589$1$I$$20240715$20240722$20240722$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005287$BIOCON$$$$$$Y$$$20240722$$MD$CA$CA
241185901$24118590$1$I$20240411$20240718$20240722$20240722$EXP$$US-UCBSA-2024036610$UCB$$74$YR$$F$Y$$$20240722$$CN$US$US
241185911$24118591$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024140924$AMGEN$$$$$$Y$$$20240722$$LW$US$US
241185921$24118592$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072752$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241185931$24118593$1$I$$20240712$20240722$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-029696$AUROBINDO$Jou K, Gujjula S, Ranjbar T, Butler K, Kaykaty V, Haney O, et al.. Unusual Incidence of Hyperammonemia After Roux-en-YGastric Bypass.. Surg-Obes-Relat-Dis. 2024;20 (Suppl.6):S59.$41$YR$$F$Y$$$20240722$$MD$US$US
241185951$24118595$1$I$$20240708$20240722$20240722$EXP$$MX-EPICPHARMA-MX-2024EPCLIT00846$EPIC PHARM$Manlio F. Marquez.A representative case of quinidine^s therapeutic effect on Brugada syndrome and the negative impact of the lack of availability in some countries, with a brief note on the lack of benefit of cilostazol.HeartRhythm Case Reports.APR-2024;10 (NO 4):259-262$45$YR$A$M$Y$$$20240722$$MD$MX$MX
241185961$24118596$1$I$20240117$20240717$20240722$20240722$EXP$FR-AFSSAPS-PC2024000572$FR-SA-2024SA209136$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240722$$HP$FR$FR
241185971$24118597$1$I$20230119$20240712$20240722$20240722$EXP$FR-AFSSAPS-NT2024000845$FR-PFIZER INC-202400217920$PFIZER$$81$YR$$M$Y$78.4$KG$20240722$$MD$FR$FR
241185981$24118598$1$I$$20240709$20240722$20240722$EXP$$IT-MYLANLABS-2024M1065856$MYLAN$Chiavarino F, Pruccoli J, Cecconi I, Vancini N, Cordelli DM, Parmeggiani A. Eating disorders in young patients with neurofibromatosis type 1. J-Paediatr-Child-Health 2023; 59 (5): 723-728.$15$YR$$F$Y$$$20240722$$HP$IT$IT
241186001$24118600$1$I$20240101$20240718$20240722$20240722$EXP$$GB-PFIZER INC-202400218127$PFIZER$$54$YR$$F$Y$50$KG$20240722$$MD$GB$GB
241186011$24118601$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400218633$PFIZER$$11$YR$$F$Y$$$20240722$$HP$CA$CA
241186021$24118602$1$I$$20240715$20240722$20240722$EXP$$CA-BAUSCH-BL-2019-009932$BAUSCH AND LOMB$$97$YR$$F$Y$81$KG$20240722$$CN$CA$CA
241186033$24118603$3$F$$20240905$20240722$20240909$EXP$$US-PFIZER INC-PV202400092980$PFIZER$$81$YR$$M$Y$$$20240909$$CN$US$US
241186042$24118604$2$F$20240619$20240722$20240722$20240725$EXP$$US-PFIZER INC-202400215416$PFIZER$$65$YR$$F$Y$$$20240725$$CN$US$US
241186053$24118605$3$F$20231228$20240919$20240722$20240923$EXP$$DE-PFIZER INC-202400218352$PFIZER$$$$E$M$Y$60$KG$20240923$$MD$DE$DE
241186071$24118607$1$I$$20240709$20240722$20240722$EXP$$IT-ROCHE-10000025659$ROCHE$$61$YR$A$M$Y$$$20240722$$MD$IT$IT
241186081$24118608$1$I$$20240718$20240722$20240722$PER$$US-ROCHE-10000031097$ROCHE$$64$YR$A$F$Y$$$20240722$$MD$US$US
241186091$24118609$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000031468$ROCHE$$16$YR$T$F$Y$$$20240722$$CN$US$US
241186101$24118610$1$I$20240319$20240713$20240722$20240722$EXP$$DE-BAUSCH-BL-2024-010727$BAUSCH AND LOMB$$84$YR$$F$Y$67$KG$20240722$$MD$DE$DE
241186111$24118611$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000031436$ROCHE$$63$YR$A$F$Y$$$20240722$$CN$US$US
241186122$24118612$2$F$20240429$20240730$20240722$20240801$EXP$$CO-TAKEDA-2024TUS073476$TAKEDA$$9$YR$$F$Y$$$20240801$$HP$CO$CO
241186141$24118614$1$I$20240101$20240715$20240722$20240722$EXP$$CN-ASTELLAS-2024US020520$ASTELLAS$$81$YR$$M$Y$$$20240722$$CN$CN$CN
241186151$24118615$1$I$$20240718$20240722$20240722$EXP$$US-TAKEDA-2024TUS047022$TAKEDA$$$$$M$Y$117.01$KG$20240722$$HP$US$US
241186161$24118616$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072740$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241186182$24118618$2$F$$20240828$20240722$20240906$EXP$$US-TEVA-VS-3219451$TEVA$Mcgee JD, Vyas H, Heyer M, Rahim M, Tang B, Kim B, et al. A Case of Tumoral Pulmonary Hypertension Resulting in Right Ventricular Failure. Am-J-Respir-Crit-Care-Med 2024; 209.; Mcgee JD, Vyas H, Heyer M, Rahim M, Tang B, Kim B, et al. A Case of Tumoral Pulmonary Hypertension Resulting in Right Ventricular Failure. Am-J-Respir-Crit-Care-Med 2024; 209.$44$YR$$F$Y$$$20240906$$HP$US$US
241186191$24118619$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024088772$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$HP$US$US
241186203$24118620$3$F$$20240924$20240722$20240927$30DAY$$US-PFIZER INC-202400213921$PFIZER$$9$YR$$M$Y$23.583$KG$20240927$$CN$US$US
241186211$24118621$1$I$$20240715$20240722$20240722$EXP$$CA-BAUSCH-BL-2024-010913$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240722$$CN$CA$CA
241186222$24118622$2$F$20240601$20240813$20240722$20240821$EXP$$CA-APOTEX-2024AP008449$APOTEX$$67$YR$E$M$Y$$$20240821$$PH$CA$CA
241186231$24118623$1$I$20240423$20240711$20240722$20240722$EXP$FR-AFSSAPS-RE2024000691$FR-Accord-435943$ACCORD$$79$YR$E$M$Y$69.9$KG$20240722$$MD$FR$FR
241186241$24118624$1$I$20230101$20240710$20240722$20240722$EXP$$IT-Accord-435340$ACCORD$Petrini I, Bruno R, Di Stefano I, Aprile V, Korasidis S, Pardini E, et al. A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers Harboring Different Somatic EGFR Mutations. Clinical Lung Cancer. 2024;25(5):e238-42.$48$YR$A$F$Y$$$20240722$$MD$IT$IT
241186251$24118625$1$I$$20240718$20240722$20240722$EXP$ES-EMA-2024713-AUTODUP-1720822028381$ES-Accord-436909$ACCORD$$$$$F$Y$$$20240722$$MD$ES$ES
241186261$24118626$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00827$EPIC PHARM$J. Ouyang.How High Can Anion Gaps Be in Patients With Metabolic Acidosis? A Case Report.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$61$YR$A$F$Y$$$20240722$$HP$US$US
241186271$24118627$1$I$20220222$20240711$20240722$20240722$EXP$PL-URPL-DML-MLP.4401.1.761.2022$PL-Accord-435947$ACCORD$$66$YR$E$F$Y$57$KG$20240722$$MD$PL$PL
241186281$24118628$1$I$20090101$20240711$20240722$20240722$EXP$DE-BFARM-24004867$DE-Accord-435937$ACCORD$$39$YR$A$F$Y$77$KG$20240722$$MD$DE$DE
241186291$24118629$1$I$20240702$20240716$20240722$20240722$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-113360$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240722$$HP$PR$PR
241186301$24118630$1$I$$20240716$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115647$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$MD$JP$JP
241186311$24118631$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115487$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$86.18$KG$20240722$$CN$US$US
241186321$24118632$1$I$$20240715$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112669$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$73$KG$20240722$$PH$US$US
241186331$24118633$1$I$$20240712$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113199$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240722$$CN$US$US
241186341$24118634$1$I$$20240709$20240722$20240722$EXP$$FR-ROCHE-10000025102$ROCHE$$68$YR$E$M$Y$$$20240722$$MD$FR$FR
241186351$24118635$1$I$20240703$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49888$$FDA-CTU$$69$YR$$F$N$$$20240718$Y$PH$US$
241186361$24118636$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072739$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241186371$24118637$1$I$20240708$20240711$20240722$20240722$EXP$$US-Accord-435995$ACCORD$$23$YR$A$M$Y$$$20240722$$PH$US$US
241186381$24118638$1$I$20220101$20240711$20240722$20240722$EXP$DE-BFARM-23009796$DE-Accord-401148$ACCORD$$35$YR$A$F$Y$$$20240722$$MD$DE$DE
241186393$24118639$3$F$20240628$20240812$20240722$20240823$EXP$$US-Accord-435964$ACCORD$$35$YR$A$F$Y$$$20240823$$PH$US$US
241186401$24118640$1$I$$20240711$20240722$20240722$EXP$$US-Accord-436796$ACCORD$$65$YR$E$M$Y$$$20240722$$CN$US$US
241186411$24118641$1$I$$20240710$20240722$20240722$EXP$$US-Accord-435862$ACCORD$$18$YR$A$M$Y$$$20240722$$PH$US$US
241186421$24118642$1$I$$20240708$20240722$20240722$EXP$$US-CIPLA LTD.-2024US07493$CIPLA$Hogan KO. Preventative plasmapheresis in a diabetic pregnant patient with hypertriglyceridemia and distal pancreatectomy.. Transfus-Med. 2023;33 (5):413 to 415$$$$$Y$$$20240722$$HP$US$US
241186431$24118643$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072751$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241186441$24118644$1$I$$20240717$20240722$20240722$EXP$$CA-TAKEDA-2024TUS072992$TAKEDA$$$$$M$Y$$$20240722$$HP$CA$CA
241186452$24118645$2$F$$20240916$20240722$20240930$EXP$CA-HPFB-001088867$CA-SERVIER-S24008871$SERVIER$$$$$$Y$$$20240930$$PH$CA$CA
241186461$24118646$1$I$$20240715$20240722$20240722$PER$$US-ROCHE-10000028721$ROCHE$$$$$F$Y$$$20240722$$PH$US$US
241186472$24118647$2$F$20240703$20240717$20240722$20240726$EXP$$JP-ROCHE-10000028937$ROCHE$$77$YR$E$M$Y$$$20240726$$MD$JP$JP
241186481$24118648$1$I$$20240718$20240722$20240722$PER$$US-ROCHE-10000031125$ROCHE$$$$$$Y$$$20240722$$PH$US$US
241186491$24118649$1$I$$20240710$20240722$20240722$EXP$$US-MYLANLABS-2024M1066216$MYLAN$Saigal K, Maleki A. Intravitreal Fluocinolone Acetonide 0.19 mg Implant in a Patient with Resistant Blau Syndrome: A Case Report. Case-Rep-Ophthal 2024; 15 (1): 63-70.$$$$F$Y$$$20240722$$HP$US$US
241186501$24118650$1$I$20240628$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50065$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241186512$24118651$2$F$$20240916$20240722$20240919$EXP$$AU-009507513-2407AUS011379$MERCK$$80$YR$$M$Y$$$20240919$$MD$AU$AU
241186521$24118652$1$I$$20240708$20240722$20240722$EXP$$US-PURACAP-US-2024EPCLIT00818$PURACAP$Kristin Wolf.A rare case of meloxicam-induced pseudoporphyria.Dermatology Online Journal.JAN-2024;30:1-3$55$YR$A$F$Y$$$20240722$$MD$US$US
241186533$24118653$3$F$20240703$20240717$20240722$20240905$PER$$US-ROCHE-10000028456$ROCHE$$$$$$Y$$$20240905$$HP$US$US
241186541$24118654$1$I$20231019$20240712$20240722$20240722$EXP$ES-AEMPS-1544766$ES-TEVA-VS-3221020$TEVA$$56$YR$$F$Y$60$KG$20240722$$MD$ES$ES
241186551$24118655$1$I$$20240710$20240722$20240722$EXP$CA-MHPD-E2B_07075185$CA-Accord-435552$ACCORD$$42$YR$A$F$Y$$$20240722$$HP$CA$CA
241186561$24118656$1$I$20240614$20240711$20240722$20240722$EXP$FR-AFSSAPS-AN2024000900$FR-Accord-436006$ACCORD$$72$YR$E$F$Y$52$KG$20240722$$MD$FR$FR
241186571$24118657$1$I$20240617$20240711$20240722$20240722$EXP$FR-AFSSAPS-MP2024001127$FR-Accord-436012$ACCORD$$86$YR$E$F$Y$65$KG$20240722$$MD$FR$FR
241186581$24118658$1$I$20240601$20240711$20240722$20240722$EXP$FR-AFSSAPS-AM2024000571$FR-Accord-435944$ACCORD$$82$YR$E$M$Y$71$KG$20240722$$MD$FR$FR
241186591$24118659$1$I$$20240715$20240722$20240722$EXP$$IN-HETERO-HET2024IN02386$HETERO$Tambe S, Jangid K, Shinde G, Jadhav S, Mahobia S, Lala M, et.al.. Drug-induced systemic lupus erythematosus in a child living with HIV. Indian Journal of Sexually Transmitted Diseases and AIDS.. 2024;45(1):59-61$12$YR$$M$Y$$$20240722$$HP$IN$IN
241186602$24118660$2$F$20240201$20240719$20240722$20240726$EXP$$NVSC2024MX025890$NOVARTIS$$0$YR$$M$Y$11$KG$20240726$$CN$MX$MX
241186612$24118661$2$F$$20240911$20240722$20240919$EXP$$RO-ROCHE-10000021272$ROCHE$$56$YR$A$F$Y$77$KG$20240919$$CN$RO$RO
241186621$24118662$1$I$$20240711$20240722$20240722$EXP$$JP-ROCHE-10000030089$ROCHE$Masuda S. Lecture slide. 2024.$1$MON$I$$Y$$$20240722$$HP$JP$JP
241186631$24118663$1$I$$20240711$20240722$20240722$EXP$$JP-VIATRISJAPAN-2024M1064846AA$MYLAN$Maruyama T, Kondo S, Nomura H, Hara H.. Haemodynamics of BRASH Syndrome in the Very Elderly Patients. The 47th Annual Meeting of The Japanese Society of Biorheology. 2024;29$97$YR$$F$Y$$$20240722$$MD$JP$JP
241186641$24118664$1$I$$20240711$20240722$20240722$EXP$$JP-MYE-2024M1066513AA$MYLAN$Yamada H, Toko M, Nakamori M, Ueno H, Aoki S, Sugimoto T, et al. Progressive multifocal leukoencephalopathy associated with systemic lupus erythematosus: longitudinal observation of lymphocytes, JC virus in cerebrospinal fluid, and brain magnetic resonance imaging. J-Neurovirol 2024;.. 2024$60$YR$$F$Y$$$20240722$$HP$JP$JP
241186652$24118665$2$F$$20240808$20240722$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114730$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240813$$CN$US$US
241186661$24118666$1$I$20240701$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114563$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240722$$CN$US$US
241186671$24118667$1$I$$20240711$20240722$20240722$EXP$$US-MYLANLABS-2024M1066575$MYLAN$Mak J, Gandhi R, Zaidan MF, Murthy V. Rituximab for Rapidly Progressive MDA5 Dermatomyositis-Associated Interstitial Lung Disease. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$41$YR$$F$Y$$$20240722$$HP$US$US
241186691$24118669$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087784$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$MD$US$US
241186701$24118670$1$I$$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113219$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240722$$HP$US$US
241186712$24118671$2$F$20240708$20240718$20240722$20240726$30DAY$$US-GSK-US2024087789$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240726$$CN$US$US
241186721$24118672$1$I$$20240710$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110563$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$75$KG$20240722$$CN$US$US
241186731$24118673$1$I$20231101$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115976$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240722$$CN$US$US
241186741$24118674$1$I$$20240710$20240722$20240722$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00605$Phathom Pharmaceuticals$$6$DEC$$M$Y$$$20240722$$MD$JP$JP
241186751$24118675$1$I$20240629$20240710$20240722$20240722$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00589$Phathom Pharmaceuticals$$7$DEC$$M$Y$$$20240722$$MD$JP$JP
241186761$24118676$1$I$$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003028$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241186782$24118678$2$F$20240711$20240717$20240722$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002179$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240809$$CN$US$US
241186791$24118679$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49855$$FDA-CTU$$$$$F$N$$$20240718$$CN$US$
241186801$24118680$1$I$20240301$20240712$20240722$20240722$EXP$$FR-BEH-2024175756$CSL BEHRING$$$$$M$Y$$$20240722$$CN$FR$FR
241186811$24118681$1$I$20240407$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003024$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240719$$CN$US$US
241186821$24118682$1$I$$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-003967$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
241186831$24118683$1$I$20240203$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-000647$ACADIA PHARMACEUTICALS$$56$YR$$M$Y$$$20240719$$CN$US$US
241186841$24118684$1$I$20240712$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-50057$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241186851$24118685$1$I$20240712$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49876$$FDA-CTU$$29$YR$$F$N$74.84$KG$20240718$N$CN$US$
241186871$24118687$1$I$$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003027$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241186881$24118688$1$I$$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003023$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$HP$US$US
241186891$24118689$1$I$$20240710$20240722$20240722$PER$$US-TAKEDA-2024TUS070938$TAKEDA$$$$$F$Y$$$20240722$$PH$US$US
241186901$24118690$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072829$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241186915$24118691$5$F$20240601$20240912$20240722$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002995$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240930$$CN$US$US
241186921$24118692$1$I$$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003016$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241186931$24118693$1$I$$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003013$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$HP$US$US
241186942$24118694$2$F$$20240625$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003001$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241186951$24118695$1$I$$20240718$20240722$20240722$EXP$$US-AstraZeneca-2024A164833$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241186961$24118696$1$I$$20211018$20240722$20240722$EXP$$CA-AstraZeneca-2021A733727$ASTRAZENECA$$$$$M$Y$$$20240722$$MD$CA$
241186971$24118697$1$I$20240616$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002996$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240719$$CN$US$US
241186982$24118698$2$F$20240612$20240718$20240722$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002999$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240812$$CN$US$US
241186991$24118699$1$I$$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002997$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
241187001$24118700$1$I$$20240719$20240722$20240722$PER$$US-ROCHE-10000031788$ROCHE$$68$YR$E$F$Y$$$20240722$$MD$US$US
241187012$24118701$2$F$$20240723$20240722$20240725$EXP$$KR-ROCHE-10000029934$ROCHE$Ohju K, Jieun C. Effective Prevention with Maintenance Treatment of Tocilizumab in Pediatric MOG-IgG Associated Disorder (MOGAD) Relapse. Annals of Child Neurology. 2024-Jul;32 (3):197-200. doi:10.26815/acn.2024.00514.$11$YR$C$F$Y$$$20240725$$MD$KR$KR
241187021$24118702$1$I$$20240711$20240722$20240722$EXP$$ZA-ROCHE-10000030382$ROCHE$$$$$F$Y$$$20240722$$MD$ZA$ZA
241187031$24118703$1$I$$20240716$20240722$20240722$PER$$US-ROCHE-10000029532$ROCHE$$75$YR$E$F$Y$$$20240722$$CN$US$US
241187041$24118704$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00843$EPIC PHARM$Epler KE.Serotonin- Like- Syndrome Resulting From Tranexamic Acid Applied to Airways During Flexible Bronchoscopy.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A5805$44$YR$A$M$Y$$$20240722$$HP$US$US
241187051$24118705$1$I$$20240625$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002988$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$HP$US$US
241187061$24118706$1$I$$20240625$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003000$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241187071$24118707$1$I$20240622$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003015$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240719$$CN$US$US
241187091$24118709$1$I$20240427$20240625$20240722$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001332$ACADIA PHARMACEUTICALS$$70$YR$$F$Y$$$20240719$$CN$US$US
241187101$24118710$1$I$$20240625$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003020$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241187111$24118711$1$I$$20240625$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003011$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
241187121$24118712$1$I$$20240625$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003014$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
241187131$24118713$1$I$$20240625$20240722$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002998$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241187141$24118714$1$I$20240620$20240625$20240722$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003019$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240719$$CN$US$US
241187151$24118715$1$I$$20240625$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003012$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241187161$24118716$1$I$$20240625$20240722$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001539$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240719$$HP$US$US
241187171$24118717$1$I$20231103$20240712$20240722$20240722$EXP$ES-AEMPS-1445862$ES-TEVA-VS-3221026$TEVA$$$$A$F$Y$$$20240722$$MD$ES$ES
241187191$24118719$1$I$20240625$20240625$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002991$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240719$$CN$US$US
241187201$24118720$1$I$$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002214$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241187211$24118721$1$I$$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003036$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241187221$24118722$1$I$$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003031$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241187233$24118723$3$F$$20240826$20240722$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002974$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
241187241$24118724$1$I$20240619$20240625$20240722$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002970$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240719$$CN$US$US
241187251$24118725$1$I$$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143740$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241187261$24118726$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072738$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241187271$24118727$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072785$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241187282$24118728$2$F$20240712$20240814$20240722$20240821$PER$$US-AMGEN-USASP2024143137$AMGEN$$71$YR$E$M$Y$$$20240820$$CN$US$US
241187294$24118729$4$F$20240522$20240805$20240722$20240810$EXP$$US-AMGEN-USASP2024141710$AMGEN$$59$YR$A$F$Y$$$20240810$$CN$US$US
241187301$24118730$1$I$20230101$20240715$20240722$20240722$EXP$$US-BIOGEN-2024BI01274079$BIOGEN$$$$$M$Y$$$20240722$$CN$US$US
241187311$24118731$1$I$20230101$20240715$20240722$20240722$PER$$US-BIOGEN-2023BI01241108$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
241187321$24118732$1$I$$20240719$20240722$20240722$PER$$US-HALEON-2188128$Haleon PLC$$$$$M$Y$$$20240722$$CN$US$US
241187333$24118733$3$F$$20240813$20240722$20240816$PER$$US-HALEON-2188086$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
241187341$24118734$1$I$$20240718$20240722$20240722$PER$$NVSC2024US149236$NOVARTIS$$$$$$Y$$$20240722$$CN$US$US
241187351$24118735$1$I$20240506$20240715$20240722$20240722$EXP$FR-SANDOZ-SDZ2024FR056597$FR-ROCHE-10000027211$ROCHE$$87$YR$E$M$Y$79$KG$20240722$$PH$FR$FR
241187361$24118736$1$I$20240717$20240717$20240722$20240722$PER$$US-ROCHE-10000029986$ROCHE$$$$$$Y$$$20240722$$PH$US$US
241187371$24118737$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072827$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241187381$24118738$1$I$20240526$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50086$$FDA-CTU$$69$YR$$F$N$$$20240718$Y$PH$US$
241187391$24118739$1$I$$20240716$20240722$20240722$EXP$CA-LEO Pharma-372071$CA-LEO Pharma-372071$LEO PHARM$$54$YR$$M$Y$$$20240722$$MD$CA$CA
241187401$24118740$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50073$$FDA-CTU$$48$YR$$F$N$$$20240718$N$$US$
241187411$24118741$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50093$$FDA-CTU$$69$YR$$F$N$$$20240718$N$$US$
241187421$24118742$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50085$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241187431$24118743$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50101$$FDA-CTU$$76$YR$$M$N$$$20240718$N$$US$
241187441$24118744$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50072$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241187451$24118745$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49886$$FDA-CTU$$88$YR$$M$N$$$20240718$N$$US$
241187471$24118747$1$I$$20240718$20240722$20240722$PER$$US-ROCHE-10000031007$ROCHE$$$$$F$Y$$$20240722$$CN$US$US
241187481$24118748$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000030792$ROCHE$$$$A$F$Y$$$20240722$$CN$US$US
241187491$24118749$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000030165$ROCHE$$$$A$F$Y$$$20240722$$CN$US$US
241187501$24118750$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000031448$ROCHE$$$$E$F$Y$$$20240722$$CN$US$US
241187511$24118751$1$I$$20240718$20240722$20240722$PER$$US-ROCHE-10000031008$ROCHE$$75$YR$E$$Y$$$20240722$$MD$US$US
241187522$24118752$2$F$$20240813$20240722$20240818$PER$$US-ROCHE-10000031911$ROCHE$$$$E$F$Y$$$20240819$$MD$US$US
241187531$24118753$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000031404$ROCHE$$$$A$F$Y$$$20240722$$CN$US$US
241187541$24118754$1$I$$20240626$20240722$20240722$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003021$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241187552$24118755$2$F$$20240812$20240722$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003029$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
241187562$24118756$2$F$20240712$20240719$20240722$20240724$EXP$$US-AMGEN-USASP2024142884$AMGEN$$48$YR$A$F$Y$$$20240724$$CN$US$US
241187577$24118757$7$F$20240211$20240903$20240722$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2021-US-008641$JAZZ$$41$YR$$M$Y$$$20240906$$PH$US$US
241187581$24118758$1$I$$20240719$20240722$20240722$PER$$US-ROCHE-10000032002$ROCHE$$$$A$$Y$$$20240722$$CN$US$US
241187591$24118759$1$I$$20240717$20240722$20240722$PER$$US-LEO Pharma-372087$LEO PHARM$$65$YR$$F$Y$$$20240722$$CN$US$US
241187601$24118760$1$I$20240608$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50060$$FDA-CTU$$57$YR$$M$N$$$20240718$N$HP$US$
241187611$24118761$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49885$$FDA-CTU$$58$YR$$F$N$$$20240718$N$CN$US$
241187621$24118762$1$I$20240523$20240712$20240722$20240722$EXP$$FR-MYLANLABS-2024M1066102$MYLAN$$$$$M$Y$$$20240722$$CN$FR$FR
241187651$24118765$1$I$20220901$20240712$20240722$20240722$EXP$$US-MYLANLABS-2024M1065983$MYLAN$$$$$F$Y$$$20240722$$CN$US$US
241187661$24118766$1$I$20231227$20240722$20240722$20240722$EXP$ES-AEMPS-1547807$NVSC2024ES149623$NOVARTIS$$64$YR$$F$Y$$$20240722$$MD$ES$ES
241187681$24118768$1$I$20240626$20240626$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003039$ACADIA PHARMACEUTICALS$$62$YR$$M$Y$$$20240719$$CN$US$US
241187701$24118770$1$I$20240701$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012568$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240722$$CN$US$US
241187711$24118771$1$I$20240717$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012155$ELI LILLY AND CO$$86$YR$E$M$Y$$$20240722$$CN$US$US
241187721$24118772$1$I$20240717$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012342$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240722$$CN$US$US
241187731$24118773$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012256$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240722$$CN$US$US
241187741$24118774$1$I$20240718$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012235$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240722$$CN$US$US
241187751$24118775$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012133$ELI LILLY AND CO$$65$YR$E$$Y$$$20240722$$CN$US$US
241187761$24118776$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407010490$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240722$$CN$US$US
241187771$24118777$1$I$$20240712$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011924$ELI LILLY AND CO$$$$$M$Y$$$20240722$$CN$US$US
241187782$24118778$2$F$20240701$20240718$20240722$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407011493$ELI LILLY AND CO$$92$YR$E$M$Y$$$20240724$$CN$US$US
241187791$24118779$1$I$20240703$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012204$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240722$$CN$US$US
241187801$24118780$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013041$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240722$$CN$US$US
241187811$24118781$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012408$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240722$$CN$US$US
241187821$24118782$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012250$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241187831$24118783$1$I$20240626$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011744$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240722$$CN$US$US
241187841$24118784$1$I$20240717$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012175$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240722$$CN$US$US
241187851$24118785$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013023$ELI LILLY AND CO$$30$YR$A$M$Y$$$20240722$$CN$US$US
241187861$24118786$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012937$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240722$$CN$US$US
241187871$24118787$1$I$20240708$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011170$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240722$$CN$US$US
241187881$24118788$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011299$ELI LILLY AND CO$$72$YR$E$$Y$$$20240722$$CN$US$US
241187892$24118789$2$F$$20240731$20240722$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407012274$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240806$$CN$US$US
241187901$24118790$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012770$ELI LILLY AND CO$$70$YR$E$$Y$$$20240722$$CN$US$US
241187911$24118791$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012103$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240722$$CN$US$US
241187921$24118792$1$I$$20240717$20240722$20240722$PER$$US-LEO Pharma-372097$LEO PHARM$$33$YR$$M$Y$$$20240722$$CN$US$US
241187931$24118793$1$I$20240123$20240124$20240722$20240722$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-103083$ZYDUS PHARM$$$$$$Y$$$20240722$$CN$US$US
241187941$24118794$1$I$20240414$20240417$20240722$20240722$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-106298$ZYDUS PHARM$$$$$$Y$$$20240722$$CN$US$US
241187951$24118795$1$I$20240627$20240712$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-034828$AUROBINDO$$76$YR$$M$Y$113$KG$20240722$$PH$GB$GB
241187961$24118796$1$I$20240524$20240715$20240722$20240722$EXP$$AR-BIOGEN-2024BI01274128$BIOGEN$$47$YR$$M$Y$$$20240722$$CN$AR$AR
241187972$24118797$2$F$$20240717$20240722$20240801$EXP$$US-BIOGEN-2024BI01274113$BIOGEN$$$$$F$Y$$$20240801$$HP$US$US
241187981$24118798$1$I$$20240716$20240722$20240722$EXP$$US-BIOGEN-2024BI01266060$BIOGEN$$$$$M$Y$$$20240722$$CN$US$US
241187992$24118799$2$F$$20240724$20240722$20240731$PER$$US-BIOGEN-2024BI01273807$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
241188001$24118800$1$I$$20240715$20240722$20240722$PER$$US-BIOGEN-2024BI01273908$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
241188021$24118802$1$I$20240712$20240712$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089132$VIIV$$44$YR$$M$Y$72.2$KG$20240722$$CN$US$US
241188031$24118803$1$I$20240707$20240715$20240722$20240722$EXP$$BR-BIOGEN-2024BI01274041$BIOGEN$$40$YR$$F$Y$79$KG$20240722$$CN$BR$BR
241188041$24118804$1$I$20240711$20240715$20240722$20240722$PER$$US-BIOGEN-2024BI01273837$BIOGEN$$29$YR$$F$Y$$$20240722$$CN$US$US
241188051$24118805$1$I$20240715$20240716$20240722$20240722$PER$$US-BIOGEN-2024BI01274248$BIOGEN$$24$YR$$F$Y$$$20240722$$CN$US$US
241188062$24118806$2$F$$20240823$20240722$20240829$PER$$US-BIOGEN-2024BI01273797$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
241188071$24118807$1$I$20240101$20240715$20240722$20240722$EXP$$CA-BIOGEN-2024BI01274026$BIOGEN$$$$$F$Y$$$20240722$$CN$CA$CA
241188081$24118808$1$I$20240701$20240718$20240722$20240722$EXP$$IL-ABBVIE-5845708$ABBVIE$$58$YR$$F$Y$$$20240722$$MD$IL$IL
241188091$24118809$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072779$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241188102$24118810$2$F$20240130$20240912$20240722$20240919$EXP$$JP-GENMAB-2024-00342$GENMAB$$62$YR$$F$Y$38.4$KG$20240919$$PH$JP$JP
241188111$24118811$1$I$20240104$20240711$20240722$20240722$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-06707$HIKMA$$62$YR$$M$Y$$$20240722$$MD$US$US
241188122$24118812$2$F$20240715$20240722$20240722$20240724$PER$$US-AMGEN-USASP2024141855$AMGEN$$53$YR$A$F$Y$$$20240723$$CN$US$US
241188132$24118813$2$F$$20240722$20240722$20240726$PER$$US-AMGEN-USASP2024144275$AMGEN$$75$YR$E$F$Y$$$20240725$$HP$US$US
241188141$24118814$1$I$$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142756$AMGEN$$$$A$$Y$$$20240722$$PH$US$US
241188161$24118816$1$I$20240716$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49866$$FDA-CTU$$64$YR$$F$N$$$20240718$N$PH$US$
241188171$24118817$1$I$20240711$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49890$$FDA-CTU$$56$YR$$M$N$$$20240718$N$PH$US$
241188181$24118818$1$I$$20240711$20240722$20240722$EXP$$US-BAYER-2024A100847$BAYER$$73$YR$E$F$Y$$$20240722$$CN$US$US
241188192$24118819$2$F$$20240723$20240722$20240729$PER$$US-LEO Pharma-372120$LEO PHARM$$46$YR$$F$Y$$$20240729$$CN$US$US
241188201$24118820$1$I$$20240606$20240722$20240722$EXP$$AU-JAZZ PHARMACEUTICALS-2024-AU-010990$JAZZ$$$$$M$Y$$$20240722$$MD$AU$AU
241188211$24118821$1$I$$20240715$20240722$20240722$EXP$$SK-PFIZER INC-PV202400092549$PFIZER$Sofrankova, L.. Varicella and its complications. Pediatria. 2024;(19) 2:64-69$6$YR$$F$Y$$$20240722$$MD$SK$SK
241188221$24118822$1$I$$20240713$20240722$20240722$EXP$$TW-PFIZER INC-PV202400092991$PFIZER$Jiang, Z.. Concomitant protothecosis and Corynespora cassiicola infection: A case report. Dermatologica Sinica. 2024;42(2):158-159$72$YR$$M$Y$$$20240722$$HP$TW$TW
241188241$24118824$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49869$$FDA-CTU$$$$$$N$$$20240718$N$PH$US$
241188251$24118825$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50079$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241188263$24118826$3$F$20220801$20240806$20240722$20240808$EXP$$US-PFIZER INC-202400218325$PFIZER$Krause, P.. Tafenoquine for Relapsing Babesiosis: A Case Series. Clinical infectious diseases. 2024;79(1):130-137$70$YR$$F$Y$$$20240808$$MD$US$US
241188271$24118827$1$I$20240213$20240712$20240722$20240722$EXP$$FR-CELLTRION INC.-2024FR017238$CELLTRION$$$$$$Y$$$20240722$$PH$FR$FR
241188281$24118828$1$I$20240101$20240716$20240722$20240722$EXP$$US-ABBVIE-5844617$ABBVIE$$$$$M$Y$$$20240720$$CN$US$US
241188291$24118829$1$I$$20240712$20240722$20240722$EXP$$JP-CHEPLA-2024009067$CHEPLAPHARM$$$$$$Y$$$20240722$$PH$COUNTRY NOT SPECIFIED$JP
241188301$24118830$1$I$$20240715$20240722$20240722$EXP$$CN-PFIZER INC-PV202400092902$PFIZER$Liu, L.. Co-infection with Nocardia asiatica and Pneumocystis jiroyecii: one case report and literature review. Chin J Infect Control. 2024;23(6):757-760$53$YR$$F$Y$$$20240722$$MD$CN$CN
241188312$24118831$2$F$$20240920$20240722$20240925$EXP$$US-CHEPLA-2024006409$CHEPLAPHARM$$$$A$M$Y$$$20240925$$CN$COUNTRY NOT SPECIFIED$US
241188321$24118832$1$I$$20240715$20240722$20240722$EXP$$IN-CHEPLA-2024009070$CHEPLAPHARM$Kakkar D, Singh A, Pillai RH, Panda T, Palatty RJ, Halder R, et al. A tertiary care centre experience with Elranatamab: A report of three cases. Leukemia Research Reports. 2024;21:100466. DOI: 10.1016/j.lrr.2024.100466.$4$DEC$$M$Y$$$20240722$$HP$COUNTRY NOT SPECIFIED$IN
241188331$24118833$1$I$$20240719$20240722$20240722$PER$$US-TAKEDA-2024TUS073503$TAKEDA$$$$$F$Y$$$20240722$$CN$US$US
241188341$24118834$1$I$20240101$20240716$20240722$20240722$EXP$$AU-BEH-2024175773$CSL BEHRING$$83$YR$E$M$Y$$$20240722$$HP$AU$AU
241188351$24118835$1$I$$20240717$20240722$20240722$PER$$US-LEO Pharma-372108$LEO PHARM$$19$YR$$F$Y$$$20240722$$CN$US$US
241188361$24118836$1$I$$20240710$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-034586$AUROBINDO$$78$YR$$F$Y$46$KG$20240722$$HP$GB$GB
241188371$24118837$1$I$$20240710$20240722$20240722$EXP$CA-HPFB-001089102$CA-SERVIER-S24008875$SERVIER$$$$$$Y$$$20240722$$PH$CA$CA
241188381$24118838$1$I$$20240712$20240722$20240722$EXP$$IT-MYLANLABS-2024M1067021$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$7$YR$$F$Y$$$20240722$$HP$IT$IT
241188391$24118839$1$I$$20240712$20240722$20240722$EXP$$IT-MYLANLABS-2024M1067032$MYLAN$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol 2024; 113 (1): 90-98.$8$YR$$F$Y$$$20240722$$HP$IT$IT
241188401$24118840$1$I$$20240712$20240722$20240722$EXP$$US-MYLANLABS-2024M1066754$MYLAN$Nichols MM, Pozdnyakova O. Snapper-Schneid bodies (coarse cytoplasmic granules) in a patient with multiply relapsed multiple myeloma. Blood 2024; 143 (24): 2559.$66$YR$$M$Y$$$20240722$$HP$US$US
241188411$24118841$1$I$$20240715$20240722$20240722$EXP$$US-CHEPLA-2024009097$CHEPLAPHARM$Joly L, Virgilio R, Yother C. Posttransplant Lymphoproliferative Disorder in a Patient With Alpha-1 Antitrypsin Deficiency: A Case Report. Cureus.2024;16(6): e62107  DOI: 10.7759/cureus.62107.$13$YR$$M$Y$$$20240722$$HP$COUNTRY NOT SPECIFIED$US
241188421$24118842$1$I$$20240712$20240722$20240722$EXP$$JP-MYLANLABS-2024M1066959$MYLAN$Muto T, Kyono H. A woman with schizophrenia who died due to Takotsubo cardiomyopathy occurring after electroconvulsive therapy. BMC-Psychiatry 2024; 24 139.. 2024;24:139$53$YR$$F$Y$$$20240722$$HP$JP$JP
241188431$24118843$1$I$$20240709$20240722$20240722$EXP$$US-MACLEODS PHARMA-MAC2024048318$MACLEODS$Mikhail ES, Jankowski M, Alexander D, Pandya D, Kunadi A..Survival and Vision Restoration Following Severe Metformin-associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature.Journal of Community Hospital Internal Medicine Perspectives.04-MAR-2024;14(2):96-99$$$$$Y$$$20240722$$MD$US$US
241188441$24118844$1$I$20240530$20240710$20240722$20240722$EXP$GB-MHRA-MED-202407101658218760-JDSFK$GB-MACLEODS PHARMA-MAC2024048321$MACLEODS$$$$$$Y$$$20240722$$CN$GB$GB
241188451$24118845$1$I$$20240710$20240722$20240722$EXP$$ZA-MACLEODS PHARMA-MAC2024048283$MACLEODS$$$$$$Y$$$20240722$$CN$ZA$ZA
241188461$24118846$1$I$$20240709$20240722$20240722$EXP$$GB-MACLEODS PHARMA-MAC2024048312$MACLEODS$$$$$$Y$$$20240722$$CN$GB$GB
241188471$24118847$1$I$$20240709$20240722$20240722$EXP$$IN-MACLEODS PHARMA-MAC2024048316$MACLEODS$Mukherjee B, Shivakumar T..A case of sensorineural deafness following ingestion of sildenafil.The Journal of Laryngology + Otology.APR-2007;121(4):395-7$$$$$Y$$$20240722$$HP$IN$IN
241188481$24118848$1$I$$20240709$20240722$20240722$EXP$GB-MHRA-MED-202407091658414790-GNZQR$GB-MACLEODS PHARMA-MAC2024048310$MACLEODS$$68$YR$E$M$Y$73$KG$20240722$$CN$GB$GB
241188491$24118849$1$I$20240517$20240712$20240722$20240722$EXP$$US-BAYER-2024A100952$BAYER$$$$$F$Y$$$20240722$$MD$US$US
241188501$24118850$1$I$$20240709$20240722$20240722$EXP$$OM-MACLEODS PHARMA-MAC2024048319$MACLEODS$Al-Amrani F, Al-Thihli K, Al-Ajmi E, Al-Futaisi A, Al-Murshedi F..Transient response to high-dose niacin therapy in a patient with NAXE deficiency.JIMD Reports.09-MAY-2024;65(4):212-225$$$$$Y$$$20240722$$HP$OM$OM
241188511$24118851$1$I$20090101$20240710$20240722$20240722$EXP$$DE-MACLEODS PHARMA-MAC2024048320$MACLEODS$$39$YR$A$F$Y$77$KG$20240722$$CN$DE$DE
241188522$24118852$2$F$$20240717$20240722$20240726$EXP$$US-MACLEODS PHARMA-MAC2024048300$MACLEODS$Nguyen C, Stanek JL..Sternomanubrial joint pain secondary to ulcerative colitis treated with ultrasound-guided injection..PM and R.2024;16(6):650-2$$$$$Y$$$20240726$$MD$US$US
241188532$24118853$2$F$$20240802$20240722$20240807$PER$$US-BIOGEN-2020BI00906278$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
241188541$24118854$1$I$$20240715$20240722$20240722$PER$$US-BIOGEN-2024BI01273840$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
241188551$24118855$1$I$20240101$20240715$20240722$20240722$PER$$US-BIOGEN-2024BI01273874$BIOGEN$$$$$F$Y$$$20240722$$HP$US$US
241188572$24118857$2$F$$20240813$20240722$20240816$PER$$US-BIOGEN-2024BI01273830$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
241188581$24118858$1$I$$20240715$20240722$20240722$PER$$US-BIOGEN-2024BI01273808$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
241188591$24118859$1$I$20240701$20240715$20240722$20240722$PER$$US-BIOGEN-2024BI01273856$BIOGEN$$29$YR$$F$Y$$$20240722$$CN$US$US
241188602$24118860$2$F$20240601$20240814$20240722$20240821$PER$$US-BIOGEN-2024BI01270755$BIOGEN$$42$YR$$F$Y$$$20240821$$CN$US$US
241188611$24118861$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06600$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241188621$24118862$1$I$20231204$20240715$20240722$20240722$PER$$US-BIOGEN-2023BI01239916$BIOGEN$$50$YR$$F$Y$$$20240722$$CN$US$US
241188631$24118863$1$I$$20240718$20240722$20240722$PER$$US-AstraZeneca-2024A164597$ASTRAZENECA$$$$$F$Y$$$20240722$$HP$US$
241188641$24118864$1$I$20221003$20221005$20240722$20240722$EXP$$AR-AstraZeneca-2022A342305$ASTRAZENECA$$19233$DY$$M$Y$$$20240722$$CN$AR$
241188651$24118865$1$I$$20240613$20240722$20240722$PER$$US-AstraZeneca-2024A139510$ASTRAZENECA$$$$$M$Y$$$20240722$$MD$US$
241188663$24118866$3$F$$20240718$20240722$20240814$PER$$US-AstraZeneca-2024A161617$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
241188671$24118867$1$I$$20211227$20240722$20240722$EXP$$US-AstraZeneca-2021A905128$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241188682$24118868$2$F$20240607$20240813$20240722$20240910$PER$$US-AstraZeneca-2024A162600$ASTRAZENECA$$24704$DY$$F$Y$$$20240910$$PH$US$
241188692$24118869$2$F$20230801$20240826$20240722$20240830$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-254370$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240830$$CN$JP$JP
241188701$24118870$1$I$$20240621$20240722$20240722$30DAY$$CA-UCBSA-2024032362$UCB$$$$$F$Y$$$20240722$$PH$CA$CA
241188711$24118871$1$I$$20240718$20240722$20240722$EXP$$US-UCBSA-2024036694$UCB$$$$$$Y$$$20240722$$CN$US$US
241188721$24118872$1$I$$20240712$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-034914$AUROBINDO$$45$YR$$F$Y$$$20240722$$CN$GB$GB
241188741$24118874$1$I$$20240709$20240722$20240722$EXP$$CA-ROCHE-10000028675$ROCHE$$49$YR$A$F$Y$96$KG$20240722$$CN$CA$CA
241188751$24118875$1$I$20240716$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49859$$FDA-CTU$$45$YR$$F$N$$$20240718$N$$US$
241188761$24118876$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS071941$TAKEDA$$$$E$F$Y$$$20240722$$CN$US$US
241188771$24118877$1$I$$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115224$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$111.58$KG$20240722$$CN$US$US
241188781$24118878$1$I$20230601$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115738$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240722$$HP$US$US
241188792$24118879$2$F$$20240903$20240722$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115708$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240910$$HP$US$US
241188801$24118880$1$I$20240706$20240712$20240722$20240722$EXP$$CN-BAYER-2024A101269$BAYER$$82$YR$E$F$Y$52.8$KG$20240722$$HP$CN$CN
241188811$24118881$1$I$$20240708$20240722$20240722$EXP$$PT-ROCHE-10000027232$ROCHE$Vasconcelos A, Silva L, Ferreira P, Ribeiro R, Monteiro M, Araujo R. Complications and relapse in a mantle cell lymphoma patient: a case report. Medicina Interna. 2024-Jun;31 (2):66-72. doi:10.24950/rspmi.2488.$73$YR$E$M$Y$$$20240722$$MD$PT$PT
241188832$24118883$2$F$20240618$20240827$20240722$20240905$EXP$$ES-AUROBINDO-AUR-APL-2024-036111$AUROBINDO$$66$YR$$F$Y$66$KG$20240905$$HP$ES$ES
241188851$24118885$1$I$$20240716$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024142902$AMGEN$$60$YR$A$F$Y$$$20240722$$MD$DE$DE
241188861$24118886$1$I$20240101$20240719$20240722$20240722$EXP$$US-UCBSA-2024036726$UCB$$$$$M$Y$$$20240722$$CN$US$US
241188872$24118887$2$F$20240502$20240805$20240722$20240808$EXP$$US-BEH-2024175565$CSL BEHRING$$5$YR$C$F$Y$$$20240808$$HP$US$US
241188881$24118888$1$I$$20240715$20240722$20240722$EXP$$US-MYLANLABS-2024M1017844$MYLAN$$$$$F$Y$$$20240722$$CN$US$US
241188891$24118889$1$I$20221110$20221201$20240722$20240722$EXP$GB-MHRA-ADR 27516553$GB-USV-001849$USV PRIVATE$$$$$F$Y$75$KG$20240722$$MD$GB$GB
241188901$24118890$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06595$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241188911$24118891$1$I$20240429$20240712$20240722$20240722$EXP$GR-GREOF-202400724$GR-TEVA-VS-3221063$TEVA$$70$YR$$F$Y$85$KG$20240722$$MD$GR$GR
241188921$24118892$1$I$20240613$20240711$20240722$20240722$EXP$FR-AFSSAPS-PC2024000557$FR-Accord-436029$ACCORD$$83$YR$E$F$Y$$$20240722$$MD$FR$FR
241188931$24118893$1$I$20240711$20240711$20240722$20240722$EXP$GB-MHRA-TPP14366369C7225055YC1720702054335$GB-Accord-436113$ACCORD$$54$YR$A$F$Y$$$20240722$$MD$GB$GB
241188941$24118894$1$I$20240628$20240711$20240722$20240722$EXP$FR-AFSSAPS-LY2024001046$FR-Accord-436026$ACCORD$$72$YR$E$F$Y$96$KG$20240722$$PH$FR$FR
241188951$24118895$1$I$20240604$20240711$20240722$20240722$EXP$$US-Accord-435989$ACCORD$$28$YR$A$$Y$$$20240722$$HP$US$US
241188961$24118896$1$I$20230806$20240717$20240722$20240722$EXP$BE-EMA-2024710-AUTODUP-1720639827751$BE-Accord-437323$ACCORD$$69$YR$E$F$Y$70.8$KG$20240722$$MD$BE$BE
241188971$24118897$1$I$20240705$20240711$20240722$20240722$EXP$IT-MINISAL02-994398$IT-Accord-435960$ACCORD$$55$YR$$F$Y$$$20240722$$MD$IT$IT
241188981$24118898$1$I$$20240711$20240722$20240722$EXP$$US-Accord-435976$ACCORD$$40$YR$A$M$Y$$$20240722$$HP$US$US
241188991$24118899$1$I$20240604$20240711$20240722$20240722$EXP$FR-AFSSAPS-PO2024000767$FR-Accord-435940$ACCORD$$76$YR$E$M$Y$76$KG$20240722$$MD$FR$FR
241189001$24118900$1$I$20240607$20240711$20240722$20240722$EXP$$US-Accord-435865$ACCORD$$45$YR$A$M$Y$$$20240722$$HP$US$US
241189011$24118901$1$I$20240601$20240711$20240722$20240722$EXP$FR-AFSSAPS-RE2024000687$FR-Accord-435803$ACCORD$$80$YR$E$M$Y$75$KG$20240722$$MD$FR$FR
241189021$24118902$1$I$$20240711$20240722$20240722$EXP$CA-MHPD-E2B_07087290$CA-Accord-435721$ACCORD$$51$YR$A$F$Y$$$20240722$$HP$CA$CA
241189031$24118903$1$I$$20240711$20240722$20240722$PER$$US-AMGEN-USASP2024141698$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241189041$24118904$1$I$20230525$20240718$20240722$20240722$EXP$DE-EMA-2024713-AUTODUP-1720822044989$DE-Accord-437177$ACCORD$$44$YR$A$F$Y$111$KG$20240722$$MD$DE$DE
241189051$24118905$1$I$20130101$20240710$20240722$20240722$EXP$$CZ-BAYER-2024A100715$BAYER$$48$YR$A$F$Y$$$20240722$$MD$CZ$CZ
241189062$24118906$2$F$$20240726$20240722$20240729$EXP$$IN-ASTELLAS-2024EU007073$ASTELLAS$Johri N, Choudhary A, Rawat U, Vengat M. Amphotericin-B-Induced Chronic Kidney Disease in a Post-COVID-19 Patient with Widespread Rhinocerebral Mucormycosis and Pneumonia: A Case Report. Current Drug Safety. 2024;19(4):474-7$67$YR$$M$Y$$$20240729$$HP$IN$IN
241189071$24118907$1$I$$20240711$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-035126$AUROBINDO$$47$YR$$F$Y$70$KG$20240722$$CN$GB$GB
241189081$24118908$1$I$20240124$20240708$20240722$20240722$EXP$FR-AFSSAPS-LL2024000232$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109635$ZYDUS PHARM$$$$$$Y$$$20240722$$MD$FR$FR
241189091$24118909$1$I$20240610$20240708$20240722$20240722$EXP$FR-AFSSAPS-GR2024000858$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109665$ZYDUS PHARM$$$$$$Y$$$20240722$$PH$FR$FR
241189101$24118910$1$I$$20240719$20240722$20240722$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041111$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240722$$MD$JP$JP
241189111$24118911$1$I$20240619$20240712$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035722$AUROBINDO$$22$YR$$M$Y$$$20240722$$MD$FR$FR
241189121$24118912$1$I$$20240424$20240722$20240722$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06061$HIKMA$Saleem T, Al-Jaghbeer MJ, Arrossi Valeria AV, Mehta AC.. Saleem T, Al-Jaghbeer MJ, Arrossi Valeria AV, Mehta AC. Panacinar emphysema complicating idiopathic pulmonary hemosiderosis: a case report. Oxford Medical Case Reports. 2023;2023(12):439-43$30$YR$$F$Y$$$20240722$$MD$US$US
241189131$24118913$1$I$$20240712$20240722$20240722$EXP$$ES-CELLTRION INC.-2024ES017239$CELLTRION$Cuenca-Barrales C, Espadafor-Lopez B, Ruiz-Carrascosa JC, Ruiz-Villaverdea R. Apremilast in the treatment of moderate-severepsoriasis in cancer patients. P I E L. 2019;34:375-384$$$$$Y$$$20240722$$HP$ES$ES
241189141$24118914$1$I$$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-50070$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241189151$24118915$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50080$$FDA-CTU$$72$YR$$M$N$58.97$KG$20240718$N$$US$
241189161$24118916$1$I$$20240715$20240722$20240722$EXP$$PT-009507513-2407PRT011647$MERCK$$52$YR$$M$Y$$$20240722$$MD$PT$PT
241189171$24118917$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072804$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241189181$24118918$1$I$20220801$20240712$20240722$20240722$EXP$$GB-AUROBINDO-AUR-APL-2024-035026$AUROBINDO$$61$YR$$F$Y$61$KG$20240722$$PH$GB$GB
241189191$24118919$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49887$$FDA-CTU$$69$YR$$M$N$$$20240718$N$$US$
241189201$24118920$1$I$$20240716$20240722$20240722$PER$$US-Millicent Holdings Ltd.-MILL20241039$MILLICENT HOLDINGS$$86$YR$E$F$Y$$$20240722$$CN$US$US
241189211$24118921$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50077$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241189231$24118923$1$I$20240601$20240712$20240722$20240722$EXP$DE-BFARM-24004754$DE-TEVA-VS-3221075$TEVA$$35$YR$$F$Y$47$KG$20240722$$MD$DE$DE
241189241$24118924$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072810$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241189251$24118925$1$I$20240601$20240715$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112267$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240722$$HP$US$US
241189261$24118926$1$I$$20240712$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-114046$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240722$$PH$JP$JP
241189271$24118927$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115202$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$87.54$KG$20240722$$HP$US$US
241189281$24118928$1$I$20240707$20240717$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114177$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$100.7$KG$20240722$$CN$US$US
241189291$24118929$1$I$$20240717$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114015$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240722$$HP$US$US
241189301$24118930$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114099$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240722$$HP$US$US
241189311$24118931$1$I$$20240715$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113798$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240722$$CN$US$US
241189321$24118932$1$I$$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407121503052230-GYWLN$GB-BEH-2024175694$CSL BEHRING$$77$YR$E$M$Y$$$20240722$$PH$GB$GB
241189331$24118933$1$I$20240101$20240712$20240722$20240722$EXP$$FR-AUROBINDO-AUR-APL-2024-035680$AUROBINDO$$33$YR$$F$Y$$$20240722$$MD$FR$FR
241189341$24118934$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089699$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241189351$24118935$1$I$20240626$20240710$20240722$20240722$EXP$GB-MHRA-MED-202407101249558670-TKDZM$GB-TEVA-VS-3220034$TEVA$$15$YR$$F$Y$$$20240722$$MD$GB$GB
241189361$24118936$1$I$$20210322$20240722$20240722$EXP$$US-AstraZeneca-2021A204264$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241189371$24118937$1$I$20240612$20240717$20240722$20240722$EXP$$US-AstraZeneca-2024A163235$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241189382$24118938$2$F$20240701$20240912$20240722$20240918$PER$$US-AstraZeneca-2024A162617$ASTRAZENECA$$678$MON$$M$Y$$$20240918$$CN$US$
241189391$24118939$1$I$20240710$20240711$20240722$20240722$EXP$$US-Accord-435998$ACCORD$$35$YR$A$M$Y$$$20240722$$HP$US$US
241189401$24118940$1$I$$20240711$20240722$20240722$EXP$GB-MHRA-MED-202407101715258340-SPQGB$GB-Accord-436085$ACCORD$$86$YR$E$M$Y$$$20240722$$PH$GB$GB
241189411$24118941$1$I$20240127$20240710$20240722$20240722$EXP$FR-AFSSAPS-ST2024001138$FR-Accord-436209$ACCORD$$56$YR$A$M$Y$77.2$KG$20240722$$HP$FR$FR
241189421$24118942$1$I$$20240711$20240722$20240722$EXP$NL-LRB-00982797$NL-Accord-436052$ACCORD$$64$YR$A$M$Y$58$KG$20240722$$MD$NL$NL
241189432$24118943$2$F$20240627$20240817$20240722$20240829$EXP$$BR-Accord-436228$ACCORD$$61$YR$A$F$Y$85.3$KG$20240829$$PH$BR$BR
241189442$24118944$2$F$20230801$20240718$20240722$20240730$EXP$$US-Accord-436234$ACCORD$$17$YR$T$M$Y$$$20240730$$HP$US$US
241189481$24118948$1$I$20230828$20240711$20240722$20240722$EXP$FR-AFSSAPS-AVCN2024000524$FR-Accord-435791$ACCORD$$37$YR$A$M$Y$$$20240722$$MD$FR$FR
241189491$24118949$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49895$$FDA-CTU$$65$YR$$F$N$$$20240718$N$$US$
241189501$24118950$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49891$$FDA-CTU$$51$YR$$M$N$$$20240718$N$$US$
241189511$24118951$1$I$20190101$20240710$20240722$20240722$EXP$$US-INSMED, INC.-2024-00183-US$INSMED$$$$$F$Y$$$20240722$$HP$US$US
241189521$24118952$1$I$20091228$20240716$20240722$20240722$EXP$$HK-ASTELLAS-2024EU007072$ASTELLAS$$74$YR$$M$Y$$$20240722$$HP$GB$HK
241189531$24118953$1$I$$20240715$20240722$20240722$EXP$$HU-CHEPLA-2024009016$CHEPLAPHARM$Irsai G, Tampu-Kiss T, Dezso B, Milt?nyi Z, Ill?s A, M?hes G. Sziszt?m?s cytomegalovirus-fertoz?s ?s sz?vodm?nyei ter?piarefrakter klasszikus Hodgkin-lymphom?ban [Complications of systemic cytomegalovirus infection in therapy-resistant Hodgkin^s lymphoma]. Orv Hetil. 2012 May 13;153(19):751-5. Hungarian. doi: 10.1556/OH.2012.29364. PMID: 22564287.$29$YR$$F$Y$$$20240722$$MD$COUNTRY NOT SPECIFIED$HU
241189541$24118954$1$I$20230213$20240712$20240722$20240722$EXP$$IT-AUROBINDO-AUR-APL-2024-035884$AUROBINDO$$61$YR$$F$Y$$$20240722$$MD$IT$IT
241189552$24118955$2$F$20240714$20240723$20240722$20240725$PER$$US-AMGEN-USASP2024141951$AMGEN$$71$YR$E$F$Y$$$20240725$$CN$US$US
241189561$24118956$1$I$$20240716$20240722$20240722$EXP$$US-AMGEN-USASL2024141551$AMGEN$$69$YR$E$F$Y$$$20240722$$CN$US$US
241189571$24118957$1$I$20240201$20240710$20240722$20240722$PER$$US-IGSA-BIG0029868$GRIFOLS$$65$YR$$F$Y$65.76$KG$20240719$$CN$US$US
241189581$24118958$1$I$20240713$20240715$20240722$20240722$PER$$US-AMGEN-USASP2024140763$AMGEN$$78$YR$E$M$Y$$$20240722$$CN$US$US
241189591$24118959$1$I$20240413$20240715$20240722$20240722$EXP$FR-AFSSAPS-LY2024001068$FR-JAZZ PHARMACEUTICALS-2024-FR-010812$JAZZ$$$$$$Y$$$20240722$$PH$FR$FR
241189601$24118960$1$I$20230101$20240712$20240722$20240722$EXP$$DE-CELLTRION INC.-2024DE017260$CELLTRION$$$$$$Y$$$20240722$$MD$DE$DE
241189611$24118961$1$I$$20240716$20240722$20240722$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003687$TERSERA THERAPEUTICS$$$$$$Y$$$20240722$$CN$AU$AU
241189621$24118962$1$I$$20240712$20240722$20240722$EXP$$DE-AUROBINDO-AUR-APL-2024-035657$AUROBINDO$$$$A$F$Y$$$20240722$$MD$DE$DE
241189632$24118963$2$F$$20240713$20240722$20240724$PER$$NVSC2024US145895$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
241189651$24118965$1$I$$20240712$20240722$20240722$EXP$$CA-APOTEX-2024AP008316$APOTEX$$60$YR$$M$Y$$$20240722$$PH$CA$CA
241189661$24118966$1$I$$20240628$20240722$20240722$EXP$$DE-ROCHE-10000030057$ROCHE$$84$YR$E$M$Y$$$20240722$$MD$DE$DE
241189671$24118967$1$I$20240708$20240711$20240722$20240722$EXP$$US-Accord-436794$ACCORD$$53$YR$A$M$Y$$$20240722$$HP$US$US
241189681$24118968$1$I$20240416$20240718$20240722$20240722$EXP$$ES-AUROBINDO-AUR-APL-2024-036030$AUROBINDO$$59$YR$$F$Y$$$20240722$$MD$ES$ES
241189692$24118969$2$F$20240305$20240711$20240722$20240724$EXP$GB-GLAXOSMITHKLINE-GB2024052443$GB-Accord-435814$ACCORD$$52$YR$A$M$Y$88$KG$20240724$$CN$GB$GB
241189701$24118970$1$I$$20240711$20240722$20240722$EXP$$US-Accord-435996$ACCORD$$44$YR$A$F$Y$$$20240722$$HP$US$US
241189712$24118971$2$F$20240618$20240711$20240722$20240723$EXP$$US-Accord-435973$ACCORD$$63$YR$A$M$Y$$$20240723$$HP$US$US
241189721$24118972$1$I$20231003$20240715$20240722$20240722$EXP$$CN-ASTELLAS-2024US020446$ASTELLAS$$13$YR$$M$Y$40$KG$20240722$$CN$CN$CN
241189741$24118974$1$I$20230803$20240717$20240722$20240722$EXP$BE-EMA-2024710-AUTODUP-1720639833391$BE-Accord-436903$ACCORD$$65$YR$E$F$Y$63$KG$20240722$$MD$BE$BE
241189751$24118975$1$I$$20240717$20240722$20240722$EXP$FR-EMA-2024710-AUTODUP-1720639772407$FR-Accord-436870$ACCORD$$$$$F$Y$$$20240722$$MD$FR$FR
241189761$24118976$1$I$$20240711$20240722$20240722$EXP$NL-LRB-00982611$NL-Accord-436037$ACCORD$$48$YR$A$F$Y$56$KG$20240722$$CN$NL$NL
241189771$24118977$1$I$$20240711$20240722$20240722$EXP$CA-MHPD-E2B_07095508$CA-Accord-435722$ACCORD$$55$YR$A$F$Y$$$20240722$$HP$CA$CA
241189781$24118978$1$I$20240709$20240711$20240722$20240722$EXP$$US-Accord-435970$ACCORD$$42$YR$A$M$Y$$$20240722$$PH$US$US
241189791$24118979$1$I$$20240711$20240722$20240722$EXP$$US-Accord-435993$ACCORD$$57$YR$A$M$Y$$$20240722$$PH$US$US
241189801$24118980$1$I$20240501$20240711$20240722$20240722$EXP$GB-MHRA-MED-202407111952215770-NZYMJ$GB-Accord-436078$ACCORD$$73$YR$E$M$Y$94$KG$20240722$$CN$GB$GB
241189812$24118981$2$F$20240724$20240802$20240722$20240814$EXP$$US-Accord-435863$ACCORD$$44$YR$A$F$Y$$$20240814$$PH$US$US
241189821$24118982$1$I$$20240711$20240722$20240722$EXP$$US-Accord-436237$ACCORD$Menke BA, Wagner W, Song H, Thomas W, Almeida NEC, Conrady CD, et. al. Case report: CMV retinitis following local and systemic immunosuppression. Front. Ophthalmol. 4:1354104 (2024).$71$YR$E$M$Y$$$20240722$$HP$US$US
241189831$24118983$1$I$$20240718$20240722$20240722$EXP$ES-EMA-2024713-AUTODUP-1720821932655$ES-Accord-436910$ACCORD$$$$$F$Y$$$20240722$$MD$ES$ES
241189841$24118984$1$I$$20240711$20240722$20240722$EXP$$EG-Accord-436153$ACCORD$Ali HT, Soliman ZA, Aborigiba F, Caprara ALF, Rissardo JP. Trazodone-induced parkinsonism in a middle-aged male: A case report. Afr Health Sci. 2024 Mar;24(1):206-212.$58$YR$A$M$Y$$$20240722$$HP$EG$EG
241189851$24118985$1$I$$20240711$20240722$20240722$EXP$FR-AFSSAPS-AN2024000668$FR-Accord-435961$ACCORD$$64$YR$A$M$Y$$$20240722$$PH$FR$FR
241189861$24118986$1$I$20240710$20240711$20240722$20240722$EXP$$US-Accord-435990$ACCORD$$51$YR$A$M$Y$$$20240722$$HP$US$US
241189871$24118987$1$I$$20240711$20240722$20240722$EXP$NL-LRB-00982744$NL-Accord-436053$ACCORD$$85$YR$E$F$Y$$$20240722$$MD$NL$NL
241189881$24118988$1$I$$20240711$20240722$20240722$EXP$NL-LRB-00981296$NL-Accord-435825$ACCORD$$70$YR$E$F$Y$65$KG$20240722$$MD$NL$NL
241189891$24118989$1$I$20240607$20240710$20240722$20240722$EXP$$BR-Accord-436221$ACCORD$$46$YR$A$F$Y$74.2$KG$20240722$$PH$BR$BR
241189901$24118990$1$I$$20240711$20240722$20240722$EXP$NL-LRB-00985780$NL-Accord-435967$ACCORD$$40$YR$A$M$Y$80$KG$20240722$$CN$NL$NL
241189911$24118991$1$I$20240419$20240711$20240722$20240722$EXP$FR-AFSSAPS-DJ2024000828$FR-Accord-435939$ACCORD$$55$YR$A$F$Y$$$20240722$$MD$FR$FR
241189921$24118992$1$I$20240708$20240710$20240722$20240722$EXP$$US-Accord-436932$ACCORD$$59$YR$A$M$Y$$$20240722$$MD$US$US
241189931$24118993$1$I$$20240711$20240722$20240722$EXP$$US-Accord-435886$ACCORD$LeBlanc FR, Grier DD, Myers KC, Shimamura A, Pommert L. A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome. Pediatric Blood and Cancer. 2024;71(8).$27$YR$A$M$Y$$$20240722$$MD$US$US
241189941$24118994$1$I$20240701$20240711$20240722$20240722$EXP$FR-AFSSAPS-AN2024000911$FR-Accord-435935$ACCORD$$51$YR$A$F$Y$$$20240722$$MD$FR$FR
241189951$24118995$1$I$20240501$20240711$20240722$20240722$EXP$ES-AEMPS-1547342$ES-Accord-435793$ACCORD$$52$YR$A$M$Y$$$20240722$$PH$ES$ES
241189961$24118996$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089217$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241189971$24118997$1$I$20240701$20240715$20240722$20240722$EXP$CN-NMPACDR-4307011003555202400544$CN-BAXTER-2024BAX021808$BAXTER$$48$YR$$F$Y$57.5$KG$20240722$$MD$CN$CN
241189981$24118998$1$I$20240101$20240717$20240722$20240722$EXP$$US-ABBVIE-5846124$ABBVIE$$$$$M$Y$$$20240722$$MD$US$US
241189991$24118999$1$I$$20240716$20240722$20240722$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14192$IPSEN$$$$$M$Y$$$20240722$$HP$US$US
241190001$24119000$1$I$20221101$20240712$20240722$20240722$EXP$$DE-CELLTRION INC.-2024DE017328$CELLTRION$$$$$$Y$$$20240722$$MD$DE$DE
241190012$24119001$2$F$$20240724$20240722$20240730$EXP$$CA-GSK-CA2024080301$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$CA$CA
241190021$24119002$1$I$$20240710$20240722$20240722$EXP$$US-BAXTER-2024BAX021466$BAXTER$$$$$$Y$$$20240722$$MD$US$US
241190032$24119003$2$F$20240630$20240722$20240722$20240801$EXP$$US-BAXTER-2024BAX021703$BAXTER$$67$YR$$$Y$65.5$KG$20240801$$PH$US$US
241190041$24119004$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141893$AMGEN$Stilgenbauer, S.. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241190051$24119005$1$I$$20240717$20240722$20240722$EXP$$CA-RDY-SPO/CAN/24/0010610$DR REDDYS$$86$YR$E$M$Y$$$20240722$$CN$CA$CA
241190061$24119006$1$I$$20240707$20240722$20240722$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457881$RANBAXY$Guseinova RM, Prosvirnina AA, Korchagina MO, Trukhin AA, Sheremeta MS. THYROTOXICOSIS IN A PATIENT WITH TURNER SYNDROME: RADIOACTIVE IODINE THERAPY. Probl Endokrinol (Mosk). 2022;68 (6):49-58$$$A$$Y$$$20240722$$HP$RU$RU
241190071$24119007$1$I$$20240712$20240722$20240722$EXP$$US-AUROBINDO-AUR-APL-2024-034876$AUROBINDO$Tallmadge M, MacBeth M, Palatnik A.. New Onset of Symptomatic Peptic Ulcer Disease Postpartum Secondary to Nonsteroidal Anti-Inflammatory Drug Use.. Case reports in obstetrics and gynecology.. 2024;6422824$27$YR$$F$Y$$$20240722$$MD$US$US
241190081$24119008$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457945$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445;1-12$27$YR$$M$Y$$$20240722$$HP$PL$PL
241190091$24119009$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457991$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445/1-12$42$YR$$F$Y$$$20240722$$HP$PL$PL
241190101$24119010$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458018$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445/1-12$38$YR$$F$Y$$$20240722$$HP$PL$PL
241190111$24119011$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457993$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445/1-12$45$YR$$F$Y$$$20240722$$HP$PL$PL
241190121$24119012$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457994$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445/1-12$40$YR$$M$Y$$$20240722$$HP$PL$PL
241190131$24119013$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458026$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445/1-12$28$YR$$M$Y$$$20240722$$HP$PL$PL
241190141$24119014$1$I$$20240707$20240722$20240722$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457969$RANBAXY$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int J Molecular Sc. 2023;24 (17):13562(1-17)$15$YR$$M$Y$$$20240722$$HP$ES$ES
241190151$24119015$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458012$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445;1-12$37$YR$$M$Y$$$20240722$$HP$PL$PL
241190161$24119016$1$I$$20240707$20240722$20240722$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457965$RANBAXY$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int J Molecular Sc. 2023;24 (17):13562(1-17)$3$YR$$F$Y$$$20240722$$HP$ES$ES
241190171$24119017$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458020$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445/1-12$36$YR$$F$Y$$$20240722$$HP$PL$PL
241190181$24119018$1$I$$20240707$20240722$20240722$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457939$RANBAXY$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int J Molecular Sc. 2023;24 (17):13562(1-17)$5$YR$$M$Y$$$20240722$$HP$ES$ES
241190191$24119019$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458027$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445/1-12$38$YR$$F$Y$$$20240722$$HP$PL$PL
241190201$24119020$1$I$$20240707$20240722$20240722$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457977$RANBAXY$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int J Molecular Sc. 2023;24 (17):13562(1-17)$36$MON$$F$Y$$$20240722$$HP$ES$ES
241190221$24119022$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457989$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445/1-12$42$YR$$M$Y$$$20240722$$HP$PL$PL
241190231$24119023$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458003$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445;1-12$29$YR$$M$Y$$$20240722$$HP$PL$PL
241190241$24119024$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457982$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445;1-12$27$YR$$M$Y$$$20240722$$HP$PL$PL
241190251$24119025$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50066$$FDA-CTU$$81$YR$$F$N$51.71$KG$20240718$N$$US$
241190261$24119026$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458015$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445;1-12$42$YR$$F$Y$$$20240722$$HP$PL$PL
241190271$24119027$1$I$$20240707$20240722$20240722$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457975$RANBAXY$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int J Molecular Sc. 2023;24 (17):13562(1-17)$36$MON$$F$Y$$$20240722$$HP$ES$ES
241190291$24119029$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457987$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445;1-12$40$YR$$M$Y$$$20240722$$HP$PL$PL
241190301$24119030$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457983$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445;1-12$23$YR$$M$Y$$$20240722$$HP$PL$PL
241190311$24119031$1$I$20190601$20240715$20240722$20240722$EXP$$HU-STRIDES ARCOLAB LIMITED-2024SP008774$STRIDES$Kurokawa T, Varga E.. Successful treatment of a challenging periprosthetic femoral fracture on a premenopausal patient with a long history of immunosuppression.. Case report.. Magyar Traumatologia Ortopedia, Kezsebeszet, Plasztikai Sebeszet.. 2024;67(1):47-57$39$YR$$F$Y$$$20240722$$MD$HU$HU
241190331$24119033$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50092$$FDA-CTU$$65$YR$$F$N$$$20240718$N$$US$
241190341$24119034$1$I$20240717$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50090$$FDA-CTU$$56$YR$$F$N$$$20240718$N$$US$
241190351$24119035$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49894$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241190361$24119036$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50084$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241190382$24119038$2$F$$20240827$20240722$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06424$LUPIN$$$$$$Y$$$20240918$$CN$US$US
241190391$24119039$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06584$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190401$24119040$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06516$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190411$24119041$1$I$$20240628$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06475$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190421$24119042$1$I$$20240628$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06456$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190431$24119043$1$I$20240718$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50097$$FDA-CTU$$67$YR$$F$N$$$20240718$Y$PH$US$
241190441$24119044$1$I$20240701$20240718$20240718$20240718$DIR$710692$$FDA-CTU$$44$YR$$F$N$67.5$KG$20240718$N$CN$US$
241190451$24119045$1$I$20240418$20240706$20240722$20240722$EXP$$GB-LUPIN PHARMACEUTICALS INC.-2024-06398$LUPIN$$$$$$Y$$$20240719$$CN$GB$GB
241190461$24119046$1$I$$20240705$20240722$20240722$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-06522$LUPIN$Vallabhaneni S, Mendonca TM, Nayak RR, Kamath G, Kamath A. Linezolid induced toxic optic neuropathy in drug resistant tuberculosis-A case series. Indian Journal of Tuberculosis. 2023;1-5$32$YR$$M$Y$$$20240719$$HP$IN$IN
241190481$24119048$1$I$$20240705$20240722$20240722$EXP$GB-MHRA-MED-202405101415057720-NPTCZ$GB-LUPIN PHARMACEUTICALS INC.-2024-06163$LUPIN$$$$$F$Y$70$KG$20240719$$HP$GB$GB
241190491$24119049$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06553$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190502$24119050$2$F$$20240814$20240722$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06559$LUPIN$$$$$$Y$$$20240830$$CN$US$US
241190511$24119051$1$I$$20240628$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06561$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190521$24119052$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06535$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190531$24119053$1$I$$20240705$20240722$20240722$EXP$GB-MHRA-MED-202405060908552160-VRYJP$GB-LUPIN PHARMACEUTICALS INC.-2024-06154$LUPIN$$$$$F$Y$56$KG$20240719$$MD$GB$GB
241190541$24119054$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06496$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190551$24119055$1$I$$20240706$20240722$20240722$EXP$GB-MHRA-MED-202407052254347130-HGPBD$GB-LUPIN PHARMACEUTICALS INC.-2024-06404$LUPIN$$23$YR$$F$Y$64$KG$20240719$$CN$GB$GB
241190561$24119056$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06517$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190572$24119057$2$F$$20240716$20240722$20240730$EXP$GB-MHRA-MED-202405101401069270-STKMW$GB-LUPIN PHARMACEUTICALS INC.-2024-06161$LUPIN$$$$$$Y$$$20240730$$MD$GB$GB
241190581$24119058$1$I$20240307$20240705$20240722$20240722$EXP$GB-MHRA-MED-202405162030425190-YNHGW$GB-LUPIN PHARMACEUTICALS INC.-2024-06395$LUPIN$$$$$$Y$$$20240719$$CN$GB$GB
241190591$24119059$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06545$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190601$24119060$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06568$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190611$24119061$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06495$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190621$24119062$1$I$20240513$20240705$20240722$20240722$EXP$GB-MHRA-MED-202405140626359200-LVCRM$GB-LUPIN PHARMACEUTICALS INC.-2024-06168$LUPIN$$$$$$Y$$$20240719$$CN$GB$GB
241190631$24119063$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06289$LUPIN$$$$$$Y$$$20240719$$MD$US$US
241190641$24119064$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06500$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190651$24119065$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06542$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190661$24119066$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06558$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190672$24119067$2$F$$20240709$20240722$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06566$LUPIN$$$$$$Y$$$20240808$$CN$US$US
241190681$24119068$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06540$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190692$24119069$2$F$$20240722$20240722$20240805$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06700$LUPIN$$$$$$Y$$$20240805$$PH$US$US
241190701$24119070$1$I$$20240703$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06814$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190712$24119071$2$F$20240311$20240813$20240722$20240826$EXP$GB-MHRA-MED-202405090912582800-FMHRG$GB-LUPIN PHARMACEUTICALS INC.-2024-06158$LUPIN$$$$$$Y$$$20240826$$PH$GB$GB
241190721$24119072$1$I$$20240628$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06503$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190731$24119073$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06544$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190741$24119074$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06614$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190751$24119075$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06536$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190761$24119076$1$I$20240514$20240705$20240722$20240722$EXP$GB-MHRA-MED-202405140824070430-GTNLS$GB-LUPIN PHARMACEUTICALS INC.-2024-06390$LUPIN$$$$$$Y$$$20240719$$MD$GB$GB
241190771$24119077$1$I$$20240628$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06477$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190783$24119078$3$F$$20240823$20240722$20240828$EXP$$US-AMGEN-USASP2024143637$AMGEN$$$$$M$Y$$$20240828$$MD$US$US
241190792$24119079$2$F$20240101$20240724$20240722$20240730$PER$$US-AMGEN-USASP2024144476$AMGEN$$$$$F$Y$$$20240729$$HP$US$US
241190801$24119080$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06531$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190811$24119081$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115565$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240722$$HP$US$US
241190821$24119082$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141903$AMGEN$Stilgenbauer, S.. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241190831$24119083$1$I$20240715$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116020$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240722$$CN$US$US
241190841$24119084$1$I$$20240708$20240722$20240722$EXP$GB-MHRA-MED-202407072116268200-GDLRZ$GB-LUPIN PHARMACEUTICALS INC.-2024-06405$LUPIN$$$$$$Y$$$20240719$$CN$GB$GB
241190851$24119085$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06515$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190861$24119086$1$I$$20240628$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06533$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190871$24119087$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06569$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190881$24119088$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06534$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190892$24119089$2$F$$20240814$20240722$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06485$LUPIN$$$$$$Y$$$20240901$$CN$US$US
241190902$24119090$2$F$$20240806$20240722$20240817$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-06910$LUPIN$$$$$$Y$$$20240817$$CN$IN$IN
241190911$24119091$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06518$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190922$24119092$2$F$$20240830$20240722$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06528$LUPIN$$$$$$Y$$$20240919$$CN$US$US
241190931$24119093$1$I$$20240711$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114611$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$82.33$KG$20240722$$PH$US$US
241190941$24119094$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06770$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190951$24119095$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06497$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190961$24119096$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06637$LUPIN$$$$$$Y$$$20240719$$CN$US$US
241190972$24119097$2$F$$20240813$20240722$20240826$EXP$$GB-LUPIN PHARMACEUTICALS INC.-2024-06152$LUPIN$$$$$$Y$$$20240826$$CN$GB$GB
241190981$24119098$1$I$$20240716$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115819$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$MD$JP$JP
241190991$24119099$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072757$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241191001$24119100$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072758$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241191021$24119102$1$I$$20240718$20240722$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115013$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240722$$MD$CA$CA
241191031$24119103$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072793$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241191041$24119104$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072763$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241191051$24119105$1$I$$20240716$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-114237$BRISTOL MYERS SQUIBB$Agena S, et al. Discussion on 3 cases of myelodysplastic syndrome after head and neck cancer treatment. The 48th Annual Meeting/Academic Congress of Japan Society for Head and Neck Cancer. 2024;50(2):P-039.$51$YR$A$M$Y$$$20240722$$HP$JP$JP
241191061$24119106$1$I$$20240712$20240722$20240722$EXP$$US-SA-2024SA206699$SANOFI AVENTIS$$$$$F$Y$$$20240722$$CN$US$US
241191071$24119107$1$I$20240601$20240708$20240722$20240722$EXP$$US-OCTA-GAM22324$OCTAPHARMA$$34$YR$A$F$Y$79$KG$20240722$$PH$US$US
241191081$24119108$1$I$$20240418$20240722$20240722$EXP$$US-TEVA-VS-3218067$TEVA$$80$YR$$M$Y$$$20240722$$CN$US$US
241191091$24119109$1$I$$20240715$20240722$20240722$EXP$$PT-ROCHE-10000029586$ROCHE$Sousa M, Braga A, Buchner G, Braga J. Rituximab as a treatment for refractory immune thrombocytopenia during pregnancy. Doi: 10.1097/MBC.0000000000001312. Blood coagulation + fibrinolysis : an international journal in haemostasis and thrombosis. 2024-Jul-01;35 (5):286-292. doi:10.1097/MBC.0000000000001312.$$$N$F$Y$1.6$KG$20240722$$HP$PT$PT
241191101$24119110$1$I$$20240712$20240722$20240722$EXP$PL-URPL-2-937-2019$PL-TEVA-VS-3221083$TEVA$$$$$F$Y$$$20240722$$CN$PL$PL
241191111$24119111$1$I$$20240707$20240722$20240722$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458011$RANBAXY$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain Sci. 2023;13 (3):445;1-12$35$YR$$F$Y$$$20240722$$HP$PL$PL
241191121$24119112$1$I$$20240711$20240722$20240722$EXP$$CA-TAKEDA-2024TUS071306$TAKEDA$$$$$M$Y$$$20240722$$CN$CA$CA
241191131$24119113$1$I$20240718$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50102$$FDA-CTU$$72$YR$$F$N$$$20240718$Y$HP$US$
241191141$24119114$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072822$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241191151$24119115$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072746$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241191161$24119116$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072742$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241191172$24119117$2$F$$20240821$20240722$20240827$EXP$$CA-TAKEDA-2024TUS072420$TAKEDA$$$$$M$Y$$$20240827$$CN$CA$CA
241191181$24119118$1$I$20240121$20240717$20240722$20240722$EXP$$NVSC2024GT149125$NOVARTIS$$43$YR$$M$Y$$$20240722$$CN$GT$GT
241191201$24119120$1$I$20240101$20240715$20240722$20240722$EXP$$US-SA-2024SA210608$SANOFI AVENTIS$$82$YR$E$M$Y$75.74$KG$20240722$$MD$US$US
241191211$24119121$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072744$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241191221$24119122$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06604$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241191231$24119123$1$I$$20240510$20240722$20240722$EXP$$US-LUPIN HEALTHCARE (UK) LIMITED-2024-06853$LUPIN$Armstrong AG, Kalia R, Troutman M. Lamotrigine drug interactions: Ignorance is not bliss. Kansas Journal of Medicine. 2022;15:109-111$82$YR$$F$Y$$$20240722$$MD$US$US
241191241$24119124$1$I$$20240718$20240722$20240722$PER$$US-009507513-2407USA011967$MERCK$$$$$F$Y$$$20240722$$MD$US$US
241191251$24119125$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06598$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241191261$24119126$1$I$20240531$20240719$20240722$20240722$EXP$$US-ORGANON-O2407USA001943$ORGANON$$20$YR$$F$Y$94.785$KG$20240722$$CN$US$US
241191271$24119127$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50055$$FDA-CTU$$73$YR$$F$N$$$20240718$N$$US$
241191282$24119128$2$F$$20240822$20240722$20240829$EXP$$US-TEVA-VS-3219760$TEVA$Devine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. J-Pediatr-Pharmacol-Ther 2023; 28 (2): 161-166; Devine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. J-Pediatr-Pharmacol-Ther 2023; 28 (2): 161-166.$29$DY$$$Y$$$20240829$$HP$US$US
241191292$24119129$2$F$$20240807$20240722$20240820$PER$$US-ROCHE-10000021807$ROCHE$$$$$$Y$$$20240820$$PH$US$US
241191302$24119130$2$F$20240630$20240807$20240722$20240813$EXP$IT-MINISAL02-994773$IT-TAKEDA-2024TUS072858$TAKEDA$$8$YR$$F$Y$20.5$KG$20240813$$HP$IT$IT
241191311$24119131$1$I$20240101$20240718$20240722$20240722$EXP$FR-AFSSAPS-PA2024001336$FR-TAKEDA-2024TUS072511$TAKEDA$$50$YR$$M$Y$87.7$KG$20240722$$HP$FR$FR
241191321$24119132$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072825$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241191331$24119133$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141246$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241191341$24119134$1$I$$20240711$20240722$20240722$EXP$$US-RDY-LIT/USA/24/0010461$DR REDDYS$Mahmoud A, Amir A, Bangash H, Ayaz S. Pasteurella Multocida-induced Empyema in an Immunocompromised Patient - A Case Report. American Journal of Respiratory and Critical Care Medicine. 2024 May;209(0): A2411. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2411.$70$YR$E$M$Y$$$20240722$$HP$US$US
241191353$24119135$3$F$20220101$20240828$20240722$20240905$EXP$$AT-ABBVIE-5842493$ABBVIE$$63$YR$$M$Y$$$20240905$$MD$AT$AT
241191361$24119136$1$I$$20240716$20240722$20240722$EXP$US-drreddys-SPO/USA/23/0180239$US-RDY-SPO/USA/23/0180239$DR REDDYS$Paige AMY, Mirza N, Rayad M, Miller RA. METFORMIN-INDUCED LACTIC ACIDOSIS COMPLICATED BY ACUTE LIVER FAILURE. Chest. 2023;164(4)Supplement:A1875. DOI: 10.1016/j.chest.2023.07.1294$63$YR$A$F$Y$$$20240722$$MD$US$US
241191372$24119137$2$F$$20240716$20240722$20240725$EXP$$AU-ABBVIE-5844927$ABBVIE$$52$YR$$F$Y$$$20240725$$MD$AU$AU
241191381$24119138$1$I$20220101$20240709$20240722$20240722$EXP$$DE-ABBVIE-5843941$ABBVIE$$19$YR$$M$Y$$$20240719$$MD$DE$DE
241191391$24119139$1$I$20240522$20240715$20240722$20240722$EXP$ES-AEMPS-1546377$ES-MYLANLABS-2024M1066139$MYLAN$$80$YR$$M$Y$$$20240722$$HP$ES$ES
241191401$24119140$1$I$20200804$20240715$20240722$20240722$EXP$$DE-MYLANLABS-2024M1066274$MYLAN$$$$A$F$Y$90$KG$20240722$$HP$DE$DE
241191411$24119141$1$I$20240209$20240715$20240722$20240722$EXP$FR-AFSSAPS-CN2024000684$FR-MYLANLABS-2024M1066030$MYLAN$$13$YR$$F$Y$57$KG$20240722$$PH$FR$FR
241191421$24119142$1$I$20221109$20240715$20240722$20240722$EXP$$GR-MYLANLABS-2023M1053823$MYLAN$$56$YR$$F$Y$84.6$KG$20240722$$HP$GR$GR
241191431$24119143$1$I$20240601$20240715$20240722$20240722$EXP$FR-AFSSAPS-RE2024000687$FR-MYLANLABS-2024M1066025$MYLAN$$80$YR$$M$Y$75$KG$20240722$$MD$FR$FR
241191441$24119144$1$I$$20240716$20240722$20240722$EXP$$US-SA-2024SA211719$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240722$$HP$US$US
241191453$24119145$3$F$20240625$20240802$20240722$20240807$EXP$$ES-MYLANLABS-2024M1066286$MYLAN$$8$YR$$F$Y$21$KG$20240807$$HP$ES$ES
241191461$24119146$1$I$20240101$20240709$20240722$20240722$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000145$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
241191471$24119147$1$I$$20240708$20240722$20240722$EXP$$US-VEROBIOTECH-2024USVEROSPO00147$VERO BIOTECH$$49$YR$A$M$Y$$$20240722$$HP$US$US
241191481$24119148$1$I$20240101$20240719$20240722$20240722$EXP$$US-UCBSA-2024036766$UCB$$$$$M$Y$$$20240722$$CN$US$US
241191491$24119149$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06620$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241191504$24119150$4$F$20240625$20240815$20240722$20240827$EXP$$MX-SERVIER-S24008887$SERVIER$$$$$$Y$$$20240827$$MD$MX$MX
241191511$24119151$1$I$20240712$20240715$20240722$20240722$EXP$$US-BAYER-2024A101816$BAYER$$71$YR$E$M$Y$$$20240722$$CN$US$US
241191522$24119152$2$F$20240702$20240802$20240722$20240808$EXP$$JP-GENMAB-2024-02553$GENMAB$$78$YR$$$Y$$$20240808$$HP$JP$JP
241191532$24119153$2$F$$20240805$20240722$20240810$EXP$$US-SA-2024SA211987$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$MD$US$US
241191541$24119154$1$I$20210308$20240717$20240722$20240722$EXP$$CN-SA-2024SA212712$SANOFI AVENTIS$$60$YR$A$M$Y$50$KG$20240722$$HP$CN$CN
241191551$24119155$1$I$$20240715$20240722$20240722$PER$$US-ALXN-202407USA000992US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
241191562$24119156$2$F$$20240806$20240722$20240812$EXP$$US-ALXN-202407USA001002US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241191571$24119157$1$I$$20240711$20240722$20240722$PER$$CA-PFM-2024-04017$PIERRE FABRE MEDICAMENT$Gourmel A, Kleiber N, Kokta V, Bergeron M, McCuaig C, Dor?-Bergeron M et al. Multimodal therapeutic approach for a severe case of kaposiform lymphangiomatosis from procedural interventions to targeted therapies. Pediatric Blood + Cancer. 2024;71:1-4$$$$$Y$$$20240722$$HP$CA$CA
241191581$24119158$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114956$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240722$$HP$US$US
241191591$24119159$1$I$$20240715$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113233$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240722$$CN$US$US
241191601$24119160$1$I$20240710$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115561$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$104.33$KG$20240722$$HP$US$US
241191612$24119161$2$F$$20240722$20240722$20240725$EXP$$US-ROCHE-10000031760$ROCHE$$85$YR$E$M$Y$$$20240725$$HP$US$US
241191621$24119162$1$I$20240701$20240717$20240722$20240722$EXP$$NVSC2024GB148464$NOVARTIS$$66$YR$$F$Y$$$20240722$$CN$GB$GB
241191631$24119163$1$I$20240527$20240716$20240722$20240722$EXP$$NVSC2024RU148643$NOVARTIS$$51$YR$$F$Y$54$KG$20240722$$MD$RU$RU
241191641$24119164$1$I$20240630$20240718$20240722$20240722$EXP$$NVSC2024US149150$NOVARTIS$$74$YR$$F$Y$$$20240722$$MD$US$US
241191651$24119165$1$I$$20240710$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407007821$ELI LILLY AND CO$$$$A$F$Y$$$20240722$$CN$US$US
241191661$24119166$1$I$$20240715$20240722$20240722$EXP$$NVSC2024CA146192$NOVARTIS$$$$$F$Y$$$20240722$$CN$CA$CA
241191671$24119167$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06616$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241191681$24119168$1$I$$20240719$20240722$20240722$PER$$US-HALEON-2188209$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
241191691$24119169$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141909$AMGEN$Stilgenbauer S. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II  Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241191701$24119170$1$I$20240501$20240715$20240722$20240722$EXP$ES-AEMPS-1547342$ES-STRIDES ARCOLAB LIMITED-2024SP008772$STRIDES$$52$YR$$M$Y$$$20240722$$PH$ES$ES
241191711$24119171$1$I$20210901$20240712$20240722$20240722$EXP$$DE-CELLTRION INC.-2024DE017246$CELLTRION$$$$$$Y$$$20240722$$MD$DE$DE
241191721$24119172$1$I$$20240719$20240722$20240722$PER$$US-TAKEDA-2024TUS073396$TAKEDA$$$$$F$Y$$$20240722$$CN$US$US
241191731$24119173$1$I$$20240716$20240722$20240722$EXP$$NVSC2024CA146997$NOVARTIS$$62$YR$$M$Y$$$20240722$$HP$CA$CA
241191751$24119175$1$I$$20240722$20240722$20240722$EXP$PL-URPL-1-3862-2020$NVSC2024PL149609$NOVARTIS$$40$YR$$M$Y$90$KG$20240722$$MD$PL$PL
241191761$24119176$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072816$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241191771$24119177$1$I$20180101$20240716$20240722$20240722$EXP$$CA-TAKEDA-2018TUS028978$TAKEDA$$$$$F$Y$$$20240722$$HP$CA$CA
241191791$24119179$1$I$$20240713$20240722$20240722$PER$$NVSC2024US149569$NOVARTIS$$$$$M$Y$$$20240722$$CN$US$US
241191801$24119180$1$I$$20201001$20240722$20240722$EXP$$US-AstraZeneca-2020SF27015$ASTRAZENECA$$55$YR$$M$Y$$$20240722$$HP$US$
241191811$24119181$1$I$$20201008$20240722$20240722$EXP$$US-AstraZeneca-2020SF32123$ASTRAZENECA$$54$YR$$F$Y$$$20240722$$CN$US$
241191821$24119182$1$I$20220902$20240712$20240722$20240722$EXP$FR-AFSSAPS-GR2024000854$FR-TEVA-VS-3221174$TEVA$$57$YR$$F$Y$$$20240722$$MD$FR$FR
241191831$24119183$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06623$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241191841$24119184$1$I$$20210531$20240722$20240722$EXP$$PT-AstraZeneca-2021A484099$ASTRAZENECA$$$$$$Y$$$20240722$$MD$PT$
241191851$24119185$1$I$20240705$20240715$20240722$20240722$EXP$LU-ALMPS-202404276$LU-BEH-2024175766$CSL BEHRING$$7$YR$C$M$Y$23$KG$20240722$$MD$LU$LU
241191862$24119186$2$F$$20240723$20240722$20240731$EXP$$GB-PERRIGO-24GB006506$PERRIGO$$96$YR$$F$Y$54$KG$20240731$$HP$GB$GB
241191872$24119187$2$F$20240701$20240805$20240722$20240808$EXP$$ES-ABBVIE-5842720$ABBVIE$$81$YR$$M$Y$$$20240808$$CN$ES$ES
241191881$24119188$1$I$20190101$20191002$20240722$20240722$EXP$$US-AstraZeneca-2018SF31367$ASTRAZENECA$$926$MON$$F$Y$$$20240722$$CN$US$
241191891$24119189$1$I$$20240718$20240722$20240722$EXP$$PT-AstraZeneca-2024A165613$ASTRAZENECA$$$$$$Y$$$20240722$$MD$PT$
241191901$24119190$1$I$$20210428$20240722$20240722$EXP$$US-AstraZeneca-2021A376547$ASTRAZENECA$$$$$M$Y$$$20240722$$MD$US$
241191911$24119191$1$I$$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-50056$$FDA-CTU$$$$$M$N$$$20240717$N$HP$US$
241191921$24119192$1$I$20240701$20240718$20240718$20240718$DIR$710711$$FDA-CTU$$55$YR$$F$N$63$KG$20240718$N$PH$US$
241191931$24119193$1$I$$20240715$20240718$20240718$DIR$FDA-CDER-CTU-2024-49902$$FDA-CTU$$$$$M$N$$$20240715$N$HP$US$
241191941$24119194$1$I$$20240718$20240718$20240718$DIR$710694$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241191951$24119195$1$I$20240714$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50089$$FDA-CTU$$3$YR$$M$N$$$20240718$N$HP$US$
241191961$24119196$1$I$20240718$20240718$20240718$20240718$DIR$710818$$FDA-CTU$$66$YR$$F$N$$$20240718$N$HP$US$
241191981$24119198$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072828$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241191991$24119199$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072745$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241192001$24119200$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072824$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241192013$24119201$3$F$20240610$20240815$20240722$20240823$EXP$$MX-SERVIER-S24008889$SERVIER$$$$$$Y$$$20240823$$MD$MX$MX
241192021$24119202$1$I$$20240716$20240722$20240722$EXP$$CA-Orion Corporation ORION PHARMA-24_00030916$ORION$$68$YR$E$F$Y$$$20240722$$HP$CA$
241192033$24119203$3$F$20240703$20240909$20240722$20240930$PER$$US-BELCHER PHARMACEUTICALS, LLC-2024US002290$PAREXEL$$$$$$Y$$$20240927$$PH$US$US
241192041$24119204$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06619$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241192051$24119205$1$I$$20240716$20240722$20240722$EXP$$NVSC2024US148764$NOVARTIS$$45$YR$$M$Y$$$20240722$$CN$US$US
241192061$24119206$1$I$$20240703$20240722$20240722$EXP$$HK-ROCHE-3572784$ROCHE$$$$$M$Y$$$20240722$$MD$HK$HK
241192071$24119207$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072765$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241192081$24119208$1$I$$20240715$20240722$20240722$EXP$$CA-BAYER-2024A101895$BAYER$$60$YR$A$F$Y$97$KG$20240722$$CN$CA$CA
241192091$24119209$1$I$$20240712$20240722$20240722$PER$$US-ABBVIE-5839576$ABBVIE$$51$YR$$M$Y$$$20240722$$MD$US$US
241192101$24119210$1$I$$20240717$20240722$20240722$EXP$CA-DRL-USA-SPO/CAN/24/0010594$CA-RDY-SPO/CAN/24/0010594$DR REDDYS$$73$YR$E$F$Y$$$20240722$$HP$CA$CA
241192111$24119211$1$I$$20240708$20240722$20240722$EXP$$CN-ROCHE-10000020523$ROCHE$$62$YR$A$F$Y$$$20240722$$CN$CN$CN
241192121$24119212$1$I$$20240717$20240722$20240722$EXP$$CA-Orion Corporation ORION PHARMA-24_00030934$ORION$$11$YR$C$F$Y$$$20240722$$HP$CA$
241192131$24119213$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141915$AMGEN$Stilgenbauer, S.. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241192151$24119215$1$I$$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142779$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241192162$24119216$2$F$20240101$20240723$20240722$20240730$PER$$US-AMGEN-USASP2024141672$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241192171$24119217$1$I$20220901$20240715$20240722$20240722$EXP$$PT-009507513-2407PRT011346$MERCK$$65$YR$$M$Y$$$20240722$$MD$PT$PT
241192181$24119218$1$I$$20240715$20240722$20240722$EXP$$IL-BAYER-2024A103278$BAYER$$$$$M$Y$$$20240722$$HP$IL$IL
241192191$24119219$1$I$20220930$20240712$20240722$20240722$EXP$$FR-CELLTRION INC.-2024FR017319$CELLTRION$$$$$$Y$$$20240722$$MD$FR$FR
241192202$24119220$2$F$$20240807$20240722$20240808$PER$$US-ALXN-202407USA000998US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241192211$24119221$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06624$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241192222$24119222$2$F$20240606$20240809$20240722$20240819$EXP$IT-MINISAL02-993711$IT-TEVA-VS-3220991$TEVA$$54$YR$$M$Y$$$20240819$$MD$IT$IT
241192231$24119223$1$I$$20240718$20240718$20240718$DIR$710783$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241192242$24119224$2$F$$20240709$20240722$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06567$LUPIN$$$$$$Y$$$20240808$$CN$US$US
241192261$24119226$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114587$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240722$$CN$US$US
241192271$24119227$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115704$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240722$$HP$US$US
241192281$24119228$1$I$20240716$20240716$20240722$20240722$EXP$$US-ASTELLAS-2024US020560$ASTELLAS$$66$YR$$M$Y$$$20240722$$CN$US$US
241192291$24119229$1$I$$20240718$20240722$20240722$PER$$US-TAKEDA-2024TUS072996$TAKEDA$$$$$$Y$$$20240722$$PH$US$US
241192301$24119230$1$I$$20240712$20240722$20240722$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06303$VIFOR$$$$E$M$Y$$$20240722$$HP$ZA$ZA
241192311$24119231$1$I$20240621$20240715$20240722$20240722$PER$$US-Vifor (International) Inc.-VIT-2024-06315$VIFOR$$62$YR$$F$Y$74$KG$20240722$$HP$US$US
241192321$24119232$1$I$$20240711$20240722$20240722$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008654$STRIDES$Khadraoui H, Herzog TJ, Jackson A, Billingsley C.. Acute pulmonary complications in the setting of high risk gestational trophoblastic neoplasia and induction of chemotherapy.. Gynecol-Oncol-Rep. 2023;48$33$YR$$F$Y$$$20240722$$HP$US$US
241192331$24119233$1$I$$20240718$20240722$20240722$PER$$US-GILEAD-2024-0681280$GILEAD$$$$$$Y$$$20240722$$CN$US$US
241192341$24119234$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141926$AMGEN$Stilgenbauer S. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241192351$24119235$1$I$20240514$20240717$20240722$20240722$EXP$$ES-AstraZeneca-2024A162823$ASTRAZENECA$$63$YR$$M$Y$$$20240722$$MD$ES$
241192362$24119236$2$F$$20240715$20240722$20240724$EXP$$NVSC2024AU131175$NOVARTIS$Krelle A, Price S, Law MM, Kranz S, Shamdasani P, Kane S et al.. The Challenges of Distinguishing Different Causes of TMA in a Pregnant Kidney Transplant Recipient. CASE REPORTS IN NEPHROLOGY. 2024;1-5$32$YR$$F$Y$$$20240724$$HP$AU$AU
241192381$24119238$1$I$20210319$20210322$20240722$20240722$EXP$$NL-AstraZeneca-2021A206392$ASTRAZENECA$$17768$DY$$F$Y$$$20240722$$HP$NL$
241192391$24119239$1$I$20201201$20210402$20240722$20240722$EXP$$US-AstraZeneca-2021A272850$ASTRAZENECA$$753$MON$$M$Y$161$KG$20240722$$CN$US$
241192401$24119240$1$I$$20220121$20240722$20240722$EXP$$RO-AstraZeneca-2022A016180$ASTRAZENECA$$$$$F$Y$$$20240722$$MD$RO$
241192411$24119241$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06626$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241192421$24119242$1$I$$20240711$20240722$20240722$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008820$STRIDES$Jackson DL, Coke L, Zhang SX, Steenbergen C, Khan G, Gorfu G, et al.. Myocarditis and brain abscess caused by disseminated Scedosporium boydii infection.. J-Natl-Med-Assoc. 2024;116 (3):238-246$52$YR$$M$Y$$$20240722$$HP$US$US
241192432$24119243$2$F$20240403$20240722$20240722$20240725$EXP$DE-BFARM-24002570$DE-TORRENT-00026994$TORRENT$$42$YR$A$M$Y$64$KG$20240725$$MD$DE$DE
241192441$24119244$1$I$20220101$20240715$20240722$20240722$EXP$DE-BFARM-23009796$DE-TORRENT-00026018$TORRENT$$35$YR$A$F$Y$$$20240719$$MD$DE$DE
241192451$24119245$1$I$$20240709$20240722$20240722$EXP$GB-MHRA-MED-202407090046268750-HCSGP$GB-TORRENT-00037195$TORRENT$$18$YR$A$M$Y$$$20240719$$CN$GB$GB
241192461$24119246$1$I$20090101$20240715$20240722$20240722$EXP$DE-DCGMA-24203575$DE-TORRENT-00027020$TORRENT$$39$YR$A$F$Y$77$KG$20240719$$MD$DE$DE
241192471$24119247$1$I$$20240709$20240722$20240722$EXP$GB-MHRA-MED-202407082013362770-TYVSG$GB-TORRENT-00037194$TORRENT$$26$YR$A$F$Y$$$20240719$$CN$GB$GB
241192481$24119248$1$I$20240125$20240709$20240722$20240722$EXP$GB-MHRA-MED-202407081950377100-MCSQK$GB-TORRENT-00037212$TORRENT$$4$YR$C$M$Y$16$KG$20240719$$CN$GB$GB
241192491$24119249$1$I$20240626$20240710$20240722$20240722$EXP$GB-MHRA-MED-202407101249558670-TKDZM$GB-TORRENT-00037219$TORRENT$$15$YR$T$F$Y$$$20240719$$MD$GB$GB
241192501$24119250$1$I$$20240710$20240722$20240722$EXP$GB-MHRA-MED-202407101209001950-WRHFP$GB-TORRENT-00037213$TORRENT$$25$YR$A$F$Y$60$KG$20240719$$CN$GB$GB
241192511$24119251$1$I$$20240711$20240722$20240722$EXP$GB-MHRA-MED-202407111638543220-JVWFM$GB-TORRENT-00037238$TORRENT$$$$$F$Y$$$20240719$$PH$GB$GB
241192521$24119252$1$I$$20240711$20240722$20240722$EXP$GB-002147023-NVSC2020GB046834$GB-TORRENT-00037243$TORRENT$$$$$M$Y$$$20240719$$MD$GB$GB
241192541$24119254$1$I$20240704$20240711$20240722$20240722$EXP$GB-MHRA-TPP17576274C5652396YC1720102731260$GB-TORRENT-00037240$TORRENT$$55$YR$A$F$Y$149$KG$20240719$$HP$GB$GB
241192551$24119255$1$I$$20240709$20240722$20240722$EXP$$US-TORRENT-00013675$TORRENT$$64$YR$A$F$Y$$$20240719$$CN$US$US
241192561$24119256$1$I$20210901$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407121200052970-HPVRW$GB-TORRENT-00037248$TORRENT$$73$YR$E$F$Y$$$20240719$$PH$GB$GB
241192573$24119257$3$F$20240701$20240802$20240722$20240808$EXP$$US-TORRENT-00013677$TORRENT$$41$YR$A$M$Y$86$KG$20240808$$PH$US$US
241192581$24119258$1$I$$20240711$20240722$20240722$EXP$$US-TORRENT-00013681$TORRENT$$65$YR$E$M$Y$$$20240719$$CN$US$US
241192592$24119259$2$F$$20240717$20240722$20240725$EXP$$US-TORRENT-00013673$TORRENT$$31$YR$A$M$Y$$$20240725$$MD$US$US
241192601$24119260$1$I$$20240708$20240722$20240722$EXP$$US-TORRENT-00013685$TORRENT$$78$YR$E$M$Y$$$20240719$$CN$US$US
241192612$24119261$2$F$20240501$20240820$20240722$20240822$30DAY$$US-UCBSA-2024032776$UCB$$63$YR$$F$Y$$$20240822$$CN$US$US
241192622$24119262$2$F$$20240717$20240722$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06564$LUPIN$$$$$$Y$$$20240808$$PH$US$US
241192631$24119263$1$I$$20240708$20240722$20240722$PER$$US-GLANDPHARMA-US-2024GLNSPO00467$GLAND PHARMA$$$$$$Y$$$20240722$$HP$US$US
241192641$24119264$1$I$20240712$20240715$20240722$20240722$EXP$$US-BAYER-2024A103306$BAYER$$84$YR$E$F$Y$$$20240722$$CN$US$US
241192652$24119265$2$F$20240627$20240913$20240722$20240923$EXP$GB-MHRA-MED-202407080000097570-ZLBHF$GB-Atnahs Limited-ATNAHS20240701982$Atnahs Healthcare$$47$YR$A$M$Y$72$KG$20240923$$CN$GB$GB
241192661$24119266$1$I$$20240710$20240722$20240722$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008959$STRIDES$Hata M, Mori T, Hirose Y, Nishida Y, Mandai S, Ando F, et al.. A case of unexpected diagnosis of fibronectin glomerulopathy with histological features of membranoproliferative glomerulonephritis.. BMC Nephrology. 2024;25:25$57$YR$$M$Y$$$20240722$$HP$JP$JP
241192671$24119267$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072585$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241192681$24119268$1$I$$20240718$20240718$20240718$DIR$710722$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241192691$24119269$1$I$$20240718$20240718$20240718$DIR$710756$$FDA-CTU$$$$$UNK$N$$$20240718$$CN$US$
241192701$24119270$1$I$$20240718$20240718$20240718$DIR$710702$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241192711$24119271$1$I$20240710$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50100$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241192721$24119272$1$I$$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-50061$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241192751$24119275$1$I$$20240710$20240722$20240722$EXP$$PK-ROCHE-10000030377$ROCHE$$28$YR$A$F$Y$$$20240722$$CN$PK$PK
241192761$24119276$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072750$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241192771$24119277$1$I$20240101$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024143249$AMGEN$$28$YR$A$F$Y$$$20240722$$CN$US$US
241192781$24119278$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141962$AMGEN$Stilgenbauer, S.. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241192791$24119279$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141930$AMGEN$Stilgenbauer, S.. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241192801$24119280$1$I$20240507$20240712$20240722$20240722$EXP$$US-TEVA-VS-3221691$TEVA$$21$YR$$F$Y$$$20240722$$MD$US$US
241192811$24119281$1$I$20240101$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141831$AMGEN$$34$YR$A$M$Y$$$20240722$$HP$US$US
241192821$24119282$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00816$EPIC PHARM$S. T. Bjork.Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A7429$74$YR$E$F$Y$$$20240722$$HP$US$US
241192831$24119283$1$I$$20240710$20240722$20240722$EXP$$US-MSNLABS-2024MSNLIT01593$MSN LABORATORIES$Al-Moussally F, Thompson BM, Masarweh OM, Shah N, Gaudi S, Restrepo J..Atorvastatin-Associated Eosinophilic Spongiosis: A Case Report and a Relevant Literature Review of Dermatological Manifestations.Cureus.2024;16 (5):e61071$$$$$Y$$$20240722$$MD$US$US
241192841$24119284$1$I$20240608$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50088$$FDA-CTU$$88$YR$$F$N$$$20240718$N$HP$US$
241192852$24119285$2$F$$20240712$20240722$20240724$PER$$US-TEVA-VS-3221600$TEVA$$$$A$F$Y$$$20240724$$CN$US$US
241192861$24119286$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072830$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241192871$24119287$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072747$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241192881$24119288$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072737$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241192901$24119290$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115807$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$81.9$KG$20240722$$CN$US$US
241192911$24119291$1$I$$20240715$20240722$20240722$EXP$PL-URPL-1-2628-2020$PL-ASTELLAS-2024EU007019$ASTELLAS$$79$YR$$F$Y$$$20240722$$HP$GB$PL
241192931$24119293$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012182$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240722$$CN$US$US
241192941$24119294$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013146$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240722$$CN$US$US
241192951$24119295$1$I$20240702$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407010405$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240722$$CN$US$US
241192961$24119296$1$I$20240629$20240701$20240722$20240722$EXP$$US-SUNBUM-2024-US-036459$SUN BUM$$26$YR$$F$Y$58.97$KG$20240722$$CN$US$US
241192971$24119297$1$I$20240718$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012968$ELI LILLY AND CO$$46$YR$A$$Y$$$20240722$$CN$US$US
241192981$24119298$1$I$20240418$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012311$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240722$$CN$US$US
241192991$24119299$1$I$$20240712$20240722$20240722$EXP$$PS-ANIPHARMA-2024-PS-000002$ANI$Maqboul I, Daraghmeh L, Eleiwi MR, et al.Atraumatic splenic rupture after administering aspirin, clopidogrel, and heparin to a patient with unstable angina: A case report..SAGE Open Medical Case Reports.2024;121-5.$49$YR$$M$Y$$$20240722$$HP$PS$PS
241193001$24119300$1$I$20240717$20240716$20240722$20240722$PER$$US-ABBVIE-5845718$ABBVIE$$31$YR$$F$Y$$$20240722$$CN$US$US
241193013$24119301$3$F$20240101$20240920$20240722$20240923$EXP$$US-KARYOPHARM-2024KPT001256$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240923$$CN$US$US
241193021$24119302$1$I$20230216$20240708$20240722$20240722$EXP$$DE-ROCHE-3339293$ROCHE$$32$YR$A$F$Y$$$20240722$$CN$DE$DE
241193031$24119303$1$I$$20240703$20240722$20240722$30DAY$$US-BECTON DICKINSON-US-BD-24-000448$BECTON DICKINSON$$$$$$Y$$$20240722$$CN$US$US
241193042$24119304$2$F$20240101$20240815$20240722$20240909$PER$$US-KARYOPHARM-2024KPT001257$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240909$$CN$US$US
241193061$24119306$1$I$$20240715$20240722$20240722$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005299$BIOCON$$$$$$Y$$$20240722$$CN$CA$CA
241193071$24119307$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00829$EPIC PHARM$M. Faris.A Life-threatening Bradyarrhythmia in the ICU: Beware of Phenytoin Loading!.American Journal of Respiratory and Critical Care Medicine.2024;209:A3646$75$YR$E$F$Y$$$20240722$$HP$US$US
241193083$24119308$3$F$20240601$20240917$20240722$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003017$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240927$$CN$US$US
241193091$24119309$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072815$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al.. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241193101$24119310$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072821$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241193111$24119311$1$I$$20240708$20240722$20240722$EXP$$TR-MSNLABS-2024MSNLIT01598$MSN LABORATORIES$Buhari G, Erkekol F, Pekel A, Yilmaz U, Keren M, Musabak U.Evaluation of the basophil activation in immediate type hypersensitivity reactions to chemotherapeutic agents.Alergologia Polska-Polish Journal of Allergology.2024;11 (1):48-55$$$$$Y$$$20240722$$HP$TR$TR
241193121$24119312$1$I$$20240715$20240722$20240722$EXP$$IL-ABBVIE-5845497$ABBVIE$$$$$F$Y$$$20240722$$MD$IL$IL
241193131$24119313$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072791$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241193142$24119314$2$F$20240315$20240723$20240722$20240802$EXP$$FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2024-019317$VALIDUS$$$$$$Y$$$20240802$$CN$FR$FR
241193161$24119316$1$I$$20240713$20240722$20240722$EXP$$JP-009507513-2407JPN002979J$MERCK$$$$$M$Y$$$20240722$$MD$JP$JP
241193171$24119317$1$I$$20240708$20240722$20240722$EXP$$CN-EPICPHARMA-CN-2024EPCLIT00842$EPIC PHARM$Jian Qu.Efficacy of omadacycline in the treatment of Legionella pneumonia: a case report.Frontiers in Cellular and Infection Microbiology.21-MAY-2024;14:1-5$44$YR$A$M$Y$$$20240722$$HP$CN$CN
241193181$24119318$1$I$20240531$20240711$20240722$20240722$EXP$FR-AFSSAPS-RN2024000741$FR-ALCON LABORATORIES-ALC2024FR003366$ALCON$$$$$$Y$$$20240722$$HP$FR$FR
241193191$24119319$1$I$$20240712$20240722$20240722$EXP$$JP-Orion Corporation ORION PHARMA-ENTC2024-0087$ORION$$$$E$$Y$$$20240722$$PH$JP$
241193202$24119320$2$F$$20240719$20240722$20240729$EXP$$GB-AMGEN-GBRSL2024140389$AMGEN$$52$YR$A$M$Y$$$20240729$$CN$GB$GB
241193211$24119321$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072759$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241193221$24119322$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072743$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241193231$24119323$1$I$$20240625$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002992$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
241193241$24119324$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072826$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241193251$24119325$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072766$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241193261$24119326$1$I$20240708$20240709$20240722$20240722$EXP$$US-RDY-CLI/USA/24/0010316$DR REDDYS$$25$YR$A$F$Y$$$20240722$$MD$US$US
241193271$24119327$1$I$$20240718$20240722$20240722$EXP$$US-GILEAD-2024-0681357$GILEAD$$$$A$M$Y$$$20240722$$CN$US$US
241193281$24119328$1$I$20230419$20240712$20240722$20240722$EXP$$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06769$HIKMA$$42$YR$$F$Y$77$KG$20240722$$MD$FR$FR
241193291$24119329$1$I$$20240719$20240722$20240722$EXP$$US-UCBSA-2024036723$UCB$$$$$M$Y$$$20240722$$CN$US$US
241193301$24119330$1$I$$20240717$20240722$20240722$EXP$CA-DRL-USA-SPO/CAN/24/0010595$CA-RDY-SPO/CAN/24/0010595$DR REDDYS$$73$YR$E$M$Y$$$20240722$$CN$CA$CA
241193311$24119331$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089617$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241193323$24119332$3$F$$20240824$20240722$20240826$30DAY$$US-PFIZER INC-202400215959$PFIZER$$15$YR$$M$Y$$$20240826$$HP$US$US
241193333$24119333$3$F$$20240903$20240722$20240904$30DAY$$US-PFIZER INC-202400215887$PFIZER$$16$YR$$M$Y$$$20240904$$CN$US$US
241193342$24119334$2$F$$20240821$20240722$20240821$30DAY$$PR-PFIZER INC-202400215945$PFIZER$$11$YR$$M$Y$$$20240821$$CN$PR$PR
241193355$24119335$5$F$$20240917$20240722$20240920$30DAY$$US-PFIZER INC-202400215996$PFIZER$$16$YR$$M$Y$$$20240920$$CN$US$US
241193361$24119336$1$I$$20201013$20240722$20240722$EXP$$US-AstraZeneca-2020SF34481$ASTRAZENECA$$$$$F$Y$$$20240722$$HP$US$
241193371$24119337$1$I$$20240709$20240722$20240722$PER$$US-AstraZeneca-2024A165413$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241193381$24119338$1$I$$20230524$20240722$20240722$EXP$$US-AstraZeneca-2023A121225$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241193391$24119339$1$I$$20200424$20240722$20240722$EXP$$US-AstraZeneca-2019SF76709$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241193401$24119340$1$I$20170914$20210225$20240722$20240722$EXP$FR-UCBSA-2018013909$FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2018-004446$VALIDUS$$$$$$Y$$$20240722$$PH$FR$FR
241193411$24119341$1$I$$20240712$20240722$20240722$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008850$STRIDES$Gupta A, Wojnowski K, Gurung P.. Mucormycosis - A Rare Etiology of Empyema Nessisitans.. Am-J-Respir-Crit-Care-Med. 2024;209(plusPoster)$$$$$Y$$$20240722$$HP$US$US
241193421$24119342$1$I$20200826$20201109$20240722$20240722$EXP$$US-AstraZeneca-2020SF14315$ASTRAZENECA$$27099$DY$$M$Y$$$20240722$$CN$US$
241193431$24119343$1$I$20240717$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50069$$FDA-CTU$$51$YR$$F$N$$$20240718$N$HP$US$
241193461$24119346$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089629$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241193471$24119347$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50083$$FDA-CTU$$65$YR$$F$N$$$20240718$N$$US$
241193481$24119348$1$I$20230922$20240716$20240722$20240722$EXP$$CH-GILEAD-2024-0681013$GILEAD$$$$A$$Y$$$20240722$$CN$CH$CH
241193491$24119349$1$I$$20240711$20240722$20240722$EXP$$US-INTERCEPT-PM2024000430$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240722$$HP$US$US
241193501$24119350$1$I$20240607$20240707$20240718$20240718$DIR$FDA-CDER-CTU-2024-50091$$FDA-CTU$$41$YR$$F$N$$$20240707$Y$PH$US$
241193511$24119351$1$I$$20240718$20240718$20240718$DIR$710712$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241193521$24119352$1$I$20240708$20240716$20240718$20240718$DIR$FDA-CDER-CTU-2024-50075$$FDA-CTU$$31$YR$$F$N$$$20240716$N$HP$US$
241193531$24119353$1$I$20240401$20240710$20240722$20240722$EXP$$US-INTERCEPT-PM2024001392$INTERCEPT PHARMACEUTICALS$$80$YR$$F$Y$$$20240722$$CN$US$US
241193541$24119354$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141976$AMGEN$Stilgenbauer, S.. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241193552$24119355$2$F$$20240813$20240722$20240823$EXP$$US-INTERCEPT-PM2024001407$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241193561$24119356$1$I$20240715$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143220$AMGEN$$79$YR$E$F$Y$$$20240722$$CN$US$US
241193571$24119357$1$I$20240509$20240712$20240722$20240722$EXP$$GB-AMGEN-GBRSP2024138997$AMGEN$$$$$M$Y$2$KG$20240722$$MD$GB$GB
241193581$24119358$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115788$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240722$$PH$US$US
241193591$24119359$1$I$20240101$20240710$20240722$20240722$EXP$$US-INTERCEPT-PM2024001400$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
241193601$24119360$1$I$$20240717$20240722$20240722$EXP$GB-MHRA-MED-202407121657258460-RTSLK$GB-STRIDES ARCOLAB LIMITED-2024SP008885$STRIDES$$$$$F$Y$$$20240722$$HP$GB$GB
241193611$24119361$1$I$20240101$20240718$20240722$20240722$EXP$$CA-UCBSA-2024036759$UCB$$$$$F$Y$$$20240722$$MD$CA$CA
241193622$24119362$2$F$20240101$20240731$20240722$20240828$PER$$US-009507513-2406USA008805$MERCK$$$$$M$Y$$$20240828$$HP$US$US
241193631$24119363$1$I$20240714$20240717$20240722$20240722$EXP$$CN-AMGEN-CHNSP2024142301$AMGEN$$13$YR$T$M$Y$$$20240722$$MD$CN$CN
241193641$24119364$1$I$$20240717$20240722$20240722$EXP$GB-MHRA-MED-202407121113269990-JSYKZ$GB-STRIDES ARCOLAB LIMITED-2024SP008861$STRIDES$$59$YR$$F$Y$57$KG$20240722$$CN$GB$GB
241193651$24119365$1$I$20240512$20240712$20240722$20240722$EXP$FR-AFSSAPS-TS2024000776$FR-STRIDES ARCOLAB LIMITED-2024SP008513$STRIDES$$50$YR$$M$Y$89$KG$20240722$$MD$FR$FR
241193662$24119366$2$F$$20240808$20240722$20240812$EXP$$EU-BAUSCHBL-2024BNL028264$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240812$$MD$EU$EU
241193671$24119367$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089697$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241193682$24119368$2$F$20240712$20240822$20240722$20240827$PER$$US-AMGEN-USASP2024142111$AMGEN$$75$YR$E$F$Y$$$20240826$$CN$US$US
241193691$24119369$1$I$$20240710$20240722$20240722$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02554$AMNEAL$$$$$$Y$$$20240722$$MD$US$US
241193701$24119370$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024143161$AMGEN$Schaenman J.; Lum E.; Bunnapradista S. et al.. Spectrum of Coronavirus Disease 2019 Outcomes in Kidney Transplant Recipients: A Single-Center Experience. Transplantation Proceedings. 2020;52 (9):2654-2658$$$$$Y$$$20240722$$HP$US$US
241193711$24119371$1$I$$20240717$20240722$20240722$PER$$US-ABBVIE-5845213$ABBVIE$$$$$F$Y$$$20240722$$MD$US$US
241193731$24119373$1$I$$20240708$20240722$20240722$EXP$$CN-EPICPHARMA-CN-2024EPCLIT00844$EPIC PHARM$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports.04-JUN-2024;18:1-10$19$YR$A$M$Y$$$20240722$$HP$CN$CN
241193742$24119374$2$F$$20240730$20240722$20240809$EXP$NL-LRB-00985036$NL-BAYER-2024A104123$BAYER$$76$YR$E$M$Y$75$KG$20240809$$CN$NL$NL
241193751$24119375$1$I$$20240718$20240722$20240722$PER$$US-GILEAD-2024-0681296$GILEAD$$$$$$Y$$$20240722$$CN$US$US
241193761$24119376$1$I$$20240710$20240722$20240722$PER$$US-TAKEDA-2024TUS070700$TAKEDA$$$$$$Y$$$20240722$$MD$US$US
241193771$24119377$1$I$20230531$20240718$20240722$20240722$EXP$$CA-TAKEDA-2024TUS073436$TAKEDA$$61$YR$$M$Y$$$20240722$$CN$CA$CA
241193784$24119378$4$F$$20240904$20240722$20240911$30DAY$$US-PFIZER INC-202400216589$PFIZER$$16$YR$$M$Y$$$20240911$$CN$US$US
241193791$24119379$1$I$20240702$20240715$20240722$20240722$EXP$$CA-APOTEX-2024AP008366$APOTEX$$82$YR$E$F$Y$$$20240722$$PH$CA$CA
241193801$24119380$1$I$$20240711$20240722$20240722$EXP$$CN-VANTIVE-2024VAN018329$Vantive US Healthcare$$62$YR$$M$Y$$$20240722$$CN$CN$CN
241193811$24119381$1$I$20240703$20240712$20240722$20240722$EXP$$CN-VANTIVE-2024VAN018365$Vantive US Healthcare$$58$YR$$F$Y$67$KG$20240722$$MD$CN$CN
241193821$24119382$1$I$$20240703$20240722$20240722$30DAY$$US-BECTON DICKINSON-US-BD-24-000449$BECTON DICKINSON$$$$$$Y$$$20240722$$CN$US$US
241193831$24119383$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00828$EPIC PHARM$Huang H.Traumatic lens subluxation from pickleball injury: a case series.Retinal Cases and Brief Reports.JAN-2024;18 (NO 1):15-17$76$YR$E$F$Y$$$20240722$$HP$US$US
241193841$24119384$1$I$$20240718$20240722$20240722$EXP$$GR-ROCHE-10000031358$ROCHE$$57$YR$A$M$Y$$$20240722$$MD$GR$GR
241193852$24119385$2$F$20240710$20240717$20240722$20240723$EXP$$CN-BAYER-2024A104407$BAYER$$50$YR$A$F$Y$64$KG$20240723$$HP$CN$CN
241193861$24119386$1$I$20240620$20240701$20240722$20240722$PER$$US-BAYER-2024A105440$BAYER$$32$YR$A$F$Y$$$20240722$$MD$US$US
241193871$24119387$1$I$$20240711$20240722$20240722$PER$US-MLMSERVICE-20240704-PI122803-00165-3$US-RDY-SPO/USA/24/0010370$DR REDDYS$Jackson JC, Sanchez D, Johns AC, Campbell MT, Aydin AM, Gokden N, et al. Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer. Journal of Clinical Medicine. 2024;13(12):3436. DOI:10.3390/jcm13123436.$86$YR$E$M$Y$$$20240722$$MD$US$US
241193882$24119388$2$F$20240702$20240815$20240722$20240910$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000441$BECTON DICKINSON$$$$$$Y$$$20240910$$CN$GB$GB
241193891$24119389$1$I$$20240717$20240722$20240722$PER$$US-ABBVIE-5847693$ABBVIE$$$$$F$Y$$$20240722$$MD$US$US
241193901$24119390$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087751$GLAXOSMITHKLINE$$$$$M$Y$$$20240722$$CN$US$US
241193911$24119391$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087776$GLAXOSMITHKLINE$$$$$M$Y$$$20240722$$CN$US$US
241193921$24119392$1$I$$20240718$20240722$20240722$EXP$$CA-PFIZER INC-202400218786$PFIZER$$81$YR$$F$Y$$$20240722$$HP$CA$CA
241193932$24119393$2$F$$20240821$20240722$20240821$30DAY$$US-PFIZER INC-202400215983$PFIZER$$34$YR$$M$Y$$$20240821$$HP$US$US
241193941$24119394$1$I$$20240718$20240722$20240722$EXP$$CA-PFIZER INC-202400218750$PFIZER$$60$YR$$M$Y$$$20240722$$HP$CA$CA
241193954$24119395$4$F$$20240918$20240722$20240924$30DAY$$US-PFIZER INC-202400215791$PFIZER$$8$YR$$M$Y$$$20240924$$HP$US$US
241193961$24119396$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400218702$PFIZER$$6$MON$$F$Y$$$20240722$$HP$CA$CA
241193971$24119397$1$I$$20240716$20240722$20240722$EXP$$CA-ABBVIE-5847013$ABBVIE$$71$YR$$M$Y$60$KG$20240722$$HP$CA$CA
241193983$24119398$3$F$$20240825$20240722$20240826$30DAY$$US-PFIZER INC-202400215389$PFIZER$$9$YR$$F$Y$$$20240826$$CN$US$US
241193992$24119399$2$F$20240702$20240815$20240722$20240910$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000442$BECTON DICKINSON$$$$$$Y$$$20240910$$CN$GB$GB
241194002$24119400$2$F$20240702$20240815$20240722$20240910$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000443$BECTON DICKINSON$$$$$$Y$$$20240910$$CN$GB$GB
241194012$24119401$2$F$20240702$20240815$20240722$20240910$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000444$BECTON DICKINSON$$$$$$Y$$$20240910$$CN$GB$GB
241194021$24119402$1$I$20240601$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50074$$FDA-CTU$$41$YR$$F$N$$$20240718$N$HP$US$
241194031$24119403$1$I$20240514$20240718$20240718$20240718$DIR$710801$$FDA-CTU$$10$YR$$M$N$37.8$KG$20240718$N$CN$US$
241194041$24119404$1$I$20240711$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50094$$FDA-CTU$$87$YR$$M$N$$$20240718$Y$PH$US$
241194052$24119405$2$F$$20240802$20240722$20240812$EXP$$US-MSNLABS-2024MSNSPO01568$MSN LABORATORIES$$$$$$Y$$$20240812$$CN$US$US
241194062$24119406$2$F$$20240722$20240722$20240725$EXP$DE-BFARM-24004918$DE-TORRENT-00027022$TORRENT$$$$A$F$Y$64$KG$20240725$$MD$DE$DE
241194073$24119407$3$F$20230618$20240722$20240722$20240729$EXP$DE-CADRBFARM-2024329184$DE-TORRENT-00027012$TORRENT$$57$YR$A$M$Y$85$KG$20240729$$CN$DE$DE
241194081$24119408$1$I$20211026$20240711$20240722$20240722$EXP$GB-GE HEALTHCARE-2024CSU007489$GB-TORRENT-00037246$TORRENT$$75$YR$E$M$Y$92$KG$20240722$$PH$GB$GB
241194091$24119409$1$I$20240709$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407111100441400-DSWBG$GB-TORRENT-00037250$TORRENT$$55$YR$A$M$Y$$$20240722$$MD$GB$GB
241194101$24119410$1$I$20190412$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407121113045010-HLCWN$GB-TORRENT-00037249$TORRENT$$66$YR$E$F$Y$$$20240722$$PH$GB$GB
241194112$24119411$2$F$20240626$20240813$20240722$20240821$EXP$GB-MHRA-MED-202407121035475230-VWCPD$GB-TORRENT-00037253$TORRENT$$88$YR$E$M$Y$66$KG$20240821$$MD$GB$GB
241194121$24119412$1$I$20240709$20240715$20240722$20240722$EXP$GB-MHRA-MED-202407151125228640-RKLZF$GB-TORRENT-00037274$TORRENT$$77$YR$E$F$Y$$$20240722$$PH$GB$GB
241194131$24119413$1$I$20211026$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407121137445660-DWTPJ$GB-TORRENT-00037257$TORRENT$$75$YR$E$M$Y$$$20240722$$PH$GB$GB
241194141$24119414$1$I$$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407121609474360-QJFYN$GB-TORRENT-00037254$TORRENT$$45$YR$A$F$Y$$$20240722$$CN$GB$GB
241194152$24119415$2$F$$20240715$20240722$20240730$EXP$$US-TORRENT-00013680$TORRENT$$65$YR$E$F$Y$$$20240730$$CN$US$US
241194161$24119416$1$I$20240627$20240712$20240722$20240722$EXP$GB-MHRA-EMIS-659-7d8a1354-519f-4ff9-8b5e-0c23ea2cebb8$GB-TORRENT-00037265$TORRENT$$76$YR$E$M$Y$113$KG$20240722$$PH$GB$GB
241194171$24119417$1$I$$20200618$20240722$20240722$EXP$$US-AstraZeneca-2020SE80030$ASTRAZENECA$$28$YR$$F$Y$$$20240722$$CN$US$
241194182$24119418$2$F$$20240718$20240722$20240725$EXP$$US-TORRENT-00013684$TORRENT$$33$YR$A$F$Y$$$20240725$$MD$US$US
241194191$24119419$1$I$$20191221$20240722$20240722$EXP$$RU-AstraZeneca-2019SF88147$ASTRAZENECA$$63$YR$$F$Y$84$KG$20240722$$CN$RU$
241194201$24119420$1$I$20240518$20240717$20240722$20240722$EXP$$US-BAYER-2024A104503$BAYER$$86$YR$E$M$Y$$$20240722$$HP$US$US
241194212$24119421$2$F$$20240821$20240722$20240821$30DAY$$US-PFIZER INC-202400216541$PFIZER$$12$YR$$M$Y$$$20240821$$CN$US$US
241194222$24119422$2$F$20240715$20240821$20240722$20240821$30DAY$$PR-PFIZER INC-202400216738$PFIZER$$13$YR$$M$Y$$$20240821$$CN$PR$PR
241194231$24119423$1$I$$20240708$20240722$20240722$EXP$$US-CIPLA LTD.-2024US07469$CIPLA$Ampomah K, Dean J, Patterson M.. Comprehensive review for the treatment of multilevel thoracic compression pain with a case report demonstrating use of peripheral stimulation.. Pain Medicine Case Reports.. 2024;8(3):95 to 101$$$$$Y$$$20240722$$MD$US$US
241194241$24119424$1$I$20240710$20240710$20240722$20240722$PER$$US-BRACCO-2024US04282$BRACCO$$46$YR$$F$Y$$$20240722$$CN$US$US
241194261$24119426$1$I$$20240709$20240722$20240722$EXP$$US-VIVUS, Inc.-2024V1000860$VIVUS$$$$A$F$Y$$$20240716$$CN$US$US
241194271$24119427$1$I$$20240711$20240722$20240722$EXP$$US-VIVUS, Inc.-2024V1000874$VIVUS$$$$A$F$Y$$$20240717$$CN$US$US
241194291$24119429$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089626$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241194301$24119430$1$I$$20240708$20240722$20240722$EXP$$GB-CIPLA LTD.-2024GB07010$CIPLA$$$$$$Y$$$20240722$$CN$GB$GB
241194312$24119431$2$F$$20240807$20240722$20240816$30DAY$$US-GSK-US2024AMR088848$GLAXOSMITHKLINE$$$$$M$Y$$$20240816$$CN$US$US
241194321$24119432$1$I$$20240505$20240722$20240722$PER$$US-GRAVITIPHARMA-GRA-2405-US-SPO-0149$GRAVITI PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
241194331$24119433$1$I$$20240402$20240722$20240722$PER$$US-GRAVITIPHARMA-GRA-2404-US-SPO-0081$GRAVITI PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
241194341$24119434$1$I$20220101$20240718$20240722$20240722$EXP$$US-UCBSA-2024036582$UCB$$$$$F$Y$$$20240722$$CN$US$US
241194351$24119435$1$I$20240101$20240719$20240722$20240722$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041051$BOEHRINGER INGELHEIM$$52$YR$A$M$Y$$$20240722$$CN$US$US
241194361$24119436$1$I$$20240712$20240722$20240722$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700551$MYOVANT SCIENCES$$$$$M$Y$$$20240722$$CN$US$US
241194371$24119437$1$I$20240531$20240714$20240722$20240722$EXP$$ES-ASTELLAS-2024US020821$ASTELLAS$$75$YR$$F$Y$$$20240722$$CN$ES$ES
241194381$24119438$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114800$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240722$$HP$US$US
241194391$24119439$1$I$20240306$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-50087$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241194401$24119440$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49896$$FDA-CTU$$71$YR$$M$N$$$20240718$N$$US$
241194411$24119441$1$I$20240420$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50071$$FDA-CTU$$91$YR$$M$N$$$20240718$N$$US$
241194421$24119442$1$I$$20240716$20240722$20240722$EXP$$AU-BEH-2024175770$CSL BEHRING$$47$YR$A$M$Y$51$KG$20240722$$HP$AU$AU
241194431$24119443$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00824$EPIC PHARM$S. T. Bjork.Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A7429$76$YR$E$F$Y$$$20240722$$HP$US$US
241194441$24119444$1$I$20240623$20240718$20240718$20240718$DIR$710790$$FDA-CTU$$44$YR$$M$N$83.25$KG$20240718$N$CN$US$
241194451$24119445$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50082$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241194461$24119446$1$I$$20240718$20240718$20240718$DIR$710732$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241194471$24119447$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50095$$FDA-CTU$$14$YR$$F$N$$$20240718$N$$US$
241194481$24119448$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072823$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241194491$24119449$1$I$$20240717$20240718$20240718$DIR$FDA-CDER-CTU-2024-50058$$FDA-CTU$$$$$F$N$$$20240717$N$HP$US$
241194501$24119450$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072818$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241194512$24119451$2$F$20230220$20231215$20240722$20240730$EXP$$JP-TEVA-2023-JP-2943021$TEVA$$39$YR$$F$Y$$$20240730$$MD$JP$JP
241194521$24119452$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00845$EPIC PHARM$C. Barrows.A Case of Acute Hypoxic Respiratory Failure After Administration of Rituximab.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A6326$61$YR$A$M$Y$$$20240722$$HP$US$US
241194531$24119453$1$I$$20240708$20240722$20240722$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-21129$SAMSUNG BIOEPIS$$81$YR$E$F$Y$$$20240722$$CN$GB$GB
241194541$24119454$1$I$20240715$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024142931$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241194551$24119455$1$I$20240607$20240712$20240722$20240722$EXP$ES-AEMPS-1538309$ES-TEVA-VS-3221015$TEVA$$59$YR$$F$Y$80$KG$20240722$$MD$ES$ES
241194561$24119456$1$I$$20240715$20240722$20240722$PER$$US-009507513-2407USA009676$MERCK$$8$DEC$$M$Y$$$20240722$$MD$US$US
241194571$24119457$1$I$20240716$20240717$20240722$20240722$PER$$PR-AMGEN-USASP2024142932$AMGEN$$41$YR$A$F$Y$$$20240722$$CN$PR$US
241194581$24119458$1$I$20210625$20240715$20240722$20240722$EXP$$US-TAKEDA-2021TUS052574$TAKEDA$$20$YR$$M$Y$70$KG$20240722$$CN$US$US
241194591$24119459$1$I$$20240715$20240722$20240722$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005300$BIOCON$$$$$$Y$$$20240722$$MD$CA$CA
241194601$24119460$1$I$$20240715$20240722$20240722$PER$$US-ALXN-202407USA001019US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
241194611$24119461$1$I$$20240712$20240722$20240722$EXP$$US-ASTELLAS-2024EU001778$ASTELLAS$$$$$M$Y$$$20240722$$CN$US$US
241194621$24119462$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089208$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241194631$24119463$1$I$$20240717$20240722$20240722$EXP$$FR-PFIZER INC-PV202400005017$PFIZER$$8$YR$$F$Y$18.3$KG$20240722$$MD$FR$FR
241194641$24119464$1$I$20240701$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141400$AMGEN$$62$YR$A$F$Y$$$20240722$$CN$US$US
241194651$24119465$1$I$20240530$20240722$20240722$20240722$EXP$FR-AFSSAPS-MA2024001215$NVSC2024FR149616$NOVARTIS$$67$YR$$M$Y$73$KG$20240722$$PH$FR$FR
241194661$24119466$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089628$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241194671$24119467$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00831$EPIC PHARM$S. Sasidharan.Myxedema Coma Triggering BRASH Syndrome.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$56$YR$A$F$Y$$$20240722$$HP$US$US
241194681$24119468$1$I$20200908$20240715$20240722$20240722$EXP$$US-009507513-2407USA009417$MERCK$$78$YR$$F$Y$64.399$KG$20240722$$MD$US$US
241194691$24119469$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115374$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240722$$CN$US$US
241194701$24119470$1$I$20240713$20240717$20240722$20240722$EXP$$US-BAYER-2024A105306$BAYER$$81$YR$E$F$Y$83.9$KG$20240722$$CN$US$US
241194711$24119471$1$I$$20240718$20240722$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114775$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$58$KG$20240722$$PH$CA$CA
241194733$24119473$3$F$20240701$20240911$20240722$20240913$30DAY$$CN-PFIZER INC-PV202400086041$PFIZER$$36$YR$$M$Y$$$20240913$$CN$CN$CN
241194742$24119474$2$F$20240714$20240717$20240722$20240725$EXP$$US-BAYER-2024A105366$BAYER$$72$YR$E$F$Y$90.703$KG$20240725$$CN$US$US
241194752$24119475$2$F$$20240823$20240722$20240827$30DAY$$CL-PFIZER INC-202400218654$PFIZER$$$$$$Y$$$20240827$$CN$CL$CL
241194773$24119477$3$F$$20240819$20240722$20240822$PER$$GB-PFIZER INC-PV202400090501$PFIZER$$71$YR$$M$Y$$$20240822$$CN$GB$GB
241194794$24119479$4$F$$20240904$20240722$20240910$30DAY$$GR-PFIZER INC-PV202400092424$PFIZER$$15$YR$$M$Y$50$KG$20240910$$CN$GR$GR
241194801$24119480$1$I$$20240709$20240722$20240722$EXP$$US-APOTEX-2024AP008308$APOTEX$Idowu D, Ezema K, Corcoran J, Farkas A.. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clinical Toxicology. 2024;62 (5):296-302$21$YR$$F$Y$$$20240722$$HP$US$US
241194811$24119481$1$I$$20240716$20240722$20240722$EXP$$CA-TAKEDA-2024TUS053208$TAKEDA$$$$$M$Y$$$20240722$$MD$CA$CA
241194821$24119482$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072741$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241194831$24119483$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072764$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241194841$24119484$1$I$$20240716$20240722$20240722$EXP$$CA-TAKEDA-2024TUS072598$TAKEDA$$$$$F$Y$$$20240722$$MD$CA$CA
241194851$24119485$1$I$$20240718$20240722$20240722$EXP$$CO-BAYER-2024A105437$BAYER$$61$YR$A$F$Y$$$20240722$$CN$CO$CO
241194862$24119486$2$F$20230701$20240815$20240722$20240816$EXP$$US-TAKEDA-US202000199$TAKEDA$$63$YR$$F$Y$$$20240816$$HP$US$US
241194871$24119487$1$I$$20240708$20240722$20240722$EXP$$CN-EPICPHARMA-CN-2024EPCLIT00821$EPIC PHARM$B Dai.Central Retinal Artery Occlusion after Peribulbar Injection of Triamcinolone Acetonide in Thyroid-associated Ophthalmopathy.Journal of Craniofacial Surgery.MAY-2024;1-2$38$YR$A$F$Y$$$20240722$$HP$CN$CN
241194881$24119488$1$I$20091002$20240716$20240722$20240722$EXP$$SG-ASTELLAS-2024US020342$ASTELLAS$$80$YR$$M$Y$58$KG$20240722$$HP$GB$SG
241194894$24119489$4$F$$20240922$20240722$20240926$30DAY$$US-PFIZER INC-202400209507$PFIZER$$10$YR$$F$Y$$$20240926$$CN$US$US
241194905$24119490$5$F$$20240919$20240722$20240923$30DAY$$US-PFIZER INC-PV202400092132$PFIZER$$$$$M$Y$$$20240923$$CN$US$US
241194912$24119491$2$F$20240712$20240724$20240722$20240805$EXP$$JP-PFIZER INC-PV202400092600$PFIZER$$$$$F$Y$$$20240805$$CN$JP$JP
241194931$24119493$1$I$20240708$20240716$20240722$20240722$EXP$$JP-009507513-2407JPN001385J$MERCK$$71$YR$$M$Y$$$20240722$$MD$JP$JP
241194941$24119494$1$I$$20240716$20240722$20240722$EXP$NL-LRB-00982460$NL-009507513-2407NLD010204$MERCK$$58$YR$$F$Y$55.8$KG$20240722$$MD$NL$NL
241194961$24119496$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50099$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241194971$24119497$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49898$$FDA-CTU$$40$YR$$F$N$$$20240718$N$$US$
241194981$24119498$1$I$20240717$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50098$$FDA-CTU$$62$YR$$M$N$78.3$KG$20240718$N$PH$US$
241194991$24119499$1$I$$20240718$20240718$20240718$DIR$710771$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241195001$24119500$1$I$20240712$20240718$20240718$20240718$DIR$710733$$FDA-CTU$$81$YR$$M$N$45$KG$20240718$N$PH$PR$
241195011$24119501$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087754$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
241195021$24119502$1$I$$20240712$20240722$20240722$EXP$$US-GSK-US2024AMR088850$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
241195033$24119503$3$F$$20240911$20240722$20240916$30DAY$$US-PFIZER INC-202400209735$PFIZER$$13$YR$$M$Y$$$20240916$$CN$US$US
241195042$24119504$2$F$$20240908$20240722$20240909$EXP$$US-PFIZER INC-202400216686$PFIZER$$12$YR$$M$Y$$$20240909$$CN$US$US
241195051$24119505$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072813$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241195061$24119506$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072820$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241195071$24119507$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072767$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241195081$24119508$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072755$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241195091$24119509$1$I$$20240718$20240718$20240718$DIR$710759$$FDA-CTU$$$$$UNK$N$$$20240718$$CN$US$
241195101$24119510$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49900$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241195111$24119511$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072754$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241195121$24119512$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072768$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241195131$24119513$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49901$$FDA-CTU$$60$YR$$F$N$77.56$KG$20240718$N$$US$
241195141$24119514$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089700$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241195161$24119516$1$I$20240513$20240710$20240722$20240722$EXP$$DE-MSNLABS-2024MSNSPO01588$MSN LABORATORIES$$$$$$Y$$$20240722$$MD$DE$DE
241195171$24119517$1$I$20240701$20240712$20240722$20240722$PER$$US-MYLANLABS-2024M1066014$MYLAN$$$$$F$Y$$$20240722$$CN$US$US
241195181$24119518$1$I$$20240715$20240722$20240722$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005301$BIOCON$$$$$$Y$$$20240722$$MD$CA$CA
241195191$24119519$1$I$20240719$20240719$20240722$20240722$PER$$US-AMGEN-USASP2024144012$AMGEN$$72$YR$E$$Y$$$20240722$$HP$US$US
241195201$24119520$1$I$20240719$20240719$20240722$20240722$PER$$US-AMGEN-USASP2024144025$AMGEN$$83$YR$E$F$Y$$$20240722$$HP$US$US
241195212$24119521$2$F$20240716$20240723$20240722$20240726$PER$$US-AMGEN-USASP2024143419$AMGEN$$72$YR$E$M$Y$$$20240726$$CN$US$US
241195221$24119522$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS073015$TAKEDA$$$$$F$Y$$$20240722$$CN$US$US
241195231$24119523$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072756$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241195241$24119524$1$I$$20240715$20240722$20240722$EXP$$FR-TAKEDA-2024TUS071454$TAKEDA$Walczak P, Fodil S, Vignal N, Cabannes-Hamy A, Boissel N, Raffoux E et al. Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1- positive acute lymphoblastic leukemia. Blood. 2021$49$YR$$M$Y$$$20240722$$MD$FR$FR
241195251$24119525$1$I$20240717$20240719$20240722$20240722$EXP$$US-UCBSA-2024036778$UCB$$72$YR$$M$Y$$$20240722$$CN$US$US
241195261$24119526$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072819$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241195272$24119527$2$F$20220526$20240819$20240722$20240825$EXP$$NVSC2022JP304828$NOVARTIS$$16$MON$$M$Y$11$KG$20240826$$MD$JP$JP
241195281$24119528$1$I$$20240705$20240722$20240722$30DAY$$GB-PFIZER INC-202400208651$PFIZER$$$$$M$Y$$$20240722$$CN$GB$GB
241195294$24119529$4$F$$20240916$20240722$20240920$30DAY$$US-PFIZER INC-202400205686$PFIZER$$61$YR$$$Y$$$20240920$$CN$US$US
241195301$24119530$1$I$$20200219$20240722$20240722$EXP$$MX-AstraZeneca-2020SE26719$ASTRAZENECA$$70$YR$$F$Y$55$KG$20240722$$CN$MX$
241195311$24119531$1$I$$20200303$20240722$20240722$EXP$$US-AstraZeneca-2020SE33914$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241195321$24119532$1$I$$20210326$20240722$20240722$EXP$$US-AstraZeneca-2021A238915$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241195331$24119533$1$I$$20240715$20240722$20240722$EXP$$FR-TAKEDA-2024TUS072666$TAKEDA$Walczak P, Fodil S, Vignal N, Cabannes-Hamy A, Boissel N, Raffoux E. et al.. Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1-positive acute lymphoblastic leukemia. Blood$53$YR$$F$Y$$$20240722$$MD$FR$FR
241195341$24119534$1$I$$20240703$20240722$20240722$PER$$US-TEVA-VS-3218773$TEVA$$64$YR$$F$Y$$$20240722$$PH$US$US
241195351$24119535$1$I$$20240710$20240722$20240722$EXP$$BR-TERSERA THERAPEUTICS LLC-2024TRS003671$TERSERA THERAPEUTICS$Vieira De Oliveira Filho, O; De Lima Medeiros, Y; Menezes De Araujo Oliveira, D; Galves Rodrigues, E; Antonio Lopes Pinto, C; Chagas Jaguar, G; Abreu Alves, F.. MUCOCUTANEOUS LICHENOID REACTION ASSOCIATED WITH PEMBRULIZUMAB IN A PATIENT WITH PROSTATE CANCER: A CASE REPORT. 50th Brazilian Congress of Stomatology and Oral Pathology (SOBEP). 2024$$$$$Y$$$20240722$$HP$BR$BR
241195362$24119536$2$F$$20240729$20240722$20240805$PER$$US-ABBVIE-5842139$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241195371$24119537$1$I$20210101$20220908$20240722$20240722$EXP$$US-RECORDATI-2021003303$RECORDATI$$$$$$Y$$$20240722$$CN$US$US
241195381$24119538$1$I$20240717$20240717$20240722$20240722$EXP$$US-BAYER-2024A105421$BAYER$$77$YR$E$F$Y$$$20240722$$CN$US$US
241195391$24119539$1$I$20230201$20240715$20240722$20240722$EXP$$PT-009507513-2407PRT011470$MERCK$$69$YR$$M$Y$$$20240722$$MD$PT$PT
241195401$24119540$1$I$$20240712$20240722$20240722$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001421$BLUEPRINT MEDICINES$$$$$F$Y$$$20240722$$CN$US$US
241195411$24119541$1$I$$20240711$20240722$20240722$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02581$AMNEAL$$$$$F$Y$$$20240722$$CN$US$US
241195423$24119542$3$F$20240101$20240911$20240722$20240918$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00371$XERIS PHARMACEUTICALS$$$$$F$Y$104$KG$20240916$$CN$US$US
241195432$24119543$2$F$20240708$20240906$20240722$20240910$30DAY$$US-PFIZER INC-202400210316$PFIZER$$13$YR$$M$Y$$$20240910$$CN$US$US
241195441$24119544$1$I$$20240715$20240722$20240722$EXP$$NVSC2024CA148301$NOVARTIS$$72$YR$$M$Y$$$20240722$$CN$CA$CA
241195453$24119545$3$F$$20240916$20240722$20240920$30DAY$$US-PFIZER INC-202400211249$PFIZER$$16$YR$$M$Y$$$20240920$$CN$US$US
241195462$24119546$2$F$$20240822$20240722$20240822$30DAY$$US-PFIZER INC-202400213270$PFIZER$$13$YR$$M$Y$$$20240822$$CN$US$US
241195471$24119547$1$I$20240718$20240718$20240722$20240722$PER$$US-BAYER-2024A105305$BAYER$$$$$F$Y$$$20240722$$MD$US$US
241195481$24119548$1$I$20230101$20240711$20240722$20240722$PER$$US-USAntibiotics-000324$USAntibiotics$$18$YR$A$M$Y$$$20240718$$CN$US$
241195501$24119550$1$I$20240624$20240715$20240722$20240722$30DAY$$US-GSK-US2024088608$GLAXOSMITHKLINE$$34$YR$$F$Y$$$20240722$$HP$US$US
241195511$24119551$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089624$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241195523$24119552$3$F$20240101$20240726$20240722$20240819$EXP$$US-SA-2024SA210248$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240819$$MD$US$US
241195531$24119553$1$I$20221101$20240715$20240722$20240722$EXP$$PT-009507513-2407PRT011639$MERCK$$64$YR$$F$Y$$$20240722$$MD$PT$PT
241195541$24119554$1$I$20240711$20240715$20240722$20240722$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700550$MYOVANT SCIENCES$$93$YR$$M$Y$$$20240722$$CN$US$US
241195551$24119555$1$I$20240710$20240718$20240722$20240722$EXP$$US-BAYER-2024A105455$BAYER$$71$YR$E$F$Y$66.213$KG$20240722$$CN$US$US
241195561$24119556$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00848$EPIC PHARM$Hirt PA.Cutaneous Mycobacterium avium-intracellulare infection masquerading as sarcoidosis.Pediatric Dermatology.may-2024;41:497-500$14$YR$T$M$Y$$$20240722$$HP$US$US
241195573$24119557$3$F$$20240916$20240722$20240918$30DAY$$CO-PFIZER INC-202400215004$PFIZER$$14$YR$$M$Y$$$20240918$$CN$CO$CO
241195581$24119558$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072769$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241195602$24119560$2$F$20240101$20240718$20240722$20240724$EXP$$US-PFIZER INC-PV202400094499$PFIZER$$60$YR$$M$Y$$$20240724$$CN$US$US
241195613$24119561$3$F$$20240906$20240722$20240910$30DAY$$CO-PFIZER INC-PV202400090503$PFIZER$$9$YR$$M$Y$$$20240910$$CN$CO$CO
241195621$24119562$1$I$20240611$20240709$20240722$20240722$EXP$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000460$Day One Biopharmaceuticals$$27$YR$$F$Y$60.2$KG$20240722$$HP$US$US
241195631$24119563$1$I$20240714$20240716$20240722$20240722$EXP$$CN-Merck Healthcare KGaA-2024039042$MERCK KGAA$$48$YR$A$F$Y$58$KG$20240719$$HP$CN$CN
241195653$24119565$3$F$$20240920$20240722$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114618$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240925$$HP$US$US
241195661$24119566$1$I$20240701$20240716$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115532$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240722$$MD$JP$JP
241195672$24119567$2$F$20240717$20240729$20240722$20240803$EXP$$NVSC2024ZA148700$NOVARTIS$$57$YR$$F$Y$$$20240803$$HP$ZA$ZA
241195681$24119568$1$I$20240703$20240710$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407008490$ELI LILLY AND CO$$$$$$Y$$$20240722$$CN$US$US
241195691$24119569$1$I$20240718$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012970$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240722$$CN$US$US
241195701$24119570$1$I$20240601$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012376$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241195711$24119571$1$I$$20240711$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407007998$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240722$$CN$US$US
241195721$24119572$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013415$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241195731$24119573$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012411$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240722$$CN$US$US
241195741$24119574$1$I$20240701$20240715$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407009989$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240722$$CN$US$US
241195751$24119575$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012539$ELI LILLY AND CO$$44$YR$A$$Y$$$20240722$$CN$US$US
241195762$24119576$2$F$$20240913$20240722$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202407005807$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
241195771$24119577$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012986$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240722$$CN$US$US
241195781$24119578$1$I$20240717$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012186$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240722$$CN$US$US
241195791$24119579$1$I$20240714$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012117$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240722$$CN$US$US
241195801$24119580$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012264$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240722$$CN$US$US
241195811$24119581$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012315$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241195821$24119582$1$I$20240717$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013036$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240722$$CN$US$US
241195832$24119583$2$F$20240712$20240723$20240722$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407012593$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240725$$CN$US$US
241195841$24119584$1$I$20240716$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011377$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240722$$CN$US$US
241195851$24119585$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407010552$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240722$$CN$US$US
241195861$24119586$1$I$20240712$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012446$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240722$$CN$US$US
241195871$24119587$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012245$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240722$$CN$US$US
241195881$24119588$1$I$20240712$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011583$ELI LILLY AND CO$$68$YR$E$$Y$$$20240722$$CN$US$US
241195891$24119589$1$I$20240101$20240717$20240722$20240722$EXP$$US-ABBVIE-5844079$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241195901$24119590$1$I$$20240717$20240722$20240722$EXP$$IT-SA-2024SA211802$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240722$$HP$IT$IT
241195911$24119591$1$I$$20240717$20240722$20240722$EXP$$IT-SA-2024SA211800$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240722$$HP$IT$IT
241195921$24119592$1$I$20220101$20240715$20240722$20240722$EXP$$PT-009507513-2407PRT011895$MERCK$$74$YR$$M$Y$$$20240722$$MD$PT$PT
241195931$24119593$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072814$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241195941$24119594$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00825$EPIC PHARM$C. Simone.Levetiracetam-associated Rhabdomyolysis.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209(1):A5704$20$YR$A$M$Y$$$20240722$$HP$US$US
241195961$24119596$1$I$20240515$20240712$20240722$20240722$EXP$FR-AFSSAPS-LY2024000884$FR-TEVA-VS-3221170$TEVA$$64$YR$$F$Y$$$20240722$$PH$FR$FR
241195971$24119597$1$I$$20240719$20240722$20240722$EXP$$NVSC2024GB119437$NOVARTIS$$23$YR$$M$Y$$$20240722$$CN$GB$GB
241195981$24119598$1$I$20240709$20240712$20240722$20240722$PER$$US-BAYER-2024A100592$BAYER$$28$YR$A$F$Y$$$20240722$$MD$US$US
241195992$24119599$2$F$20240101$20240717$20240722$20240801$EXP$$US-ABBVIE-5844110$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241196001$24119600$1$I$$20240712$20240722$20240722$EXP$$US-ABBVIE-5845002$ABBVIE$$$$$M$Y$$$20240722$$MD$US$US
241196011$24119601$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49897$$FDA-CTU$$16$YR$$F$N$68.04$KG$20240718$N$$US$
241196021$24119602$1$I$$20240718$20240718$20240718$DIR$710720$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241196031$24119603$1$I$20240718$20240718$20240718$20240718$DIR$710816$$FDA-CTU$$36$YR$$M$N$126$KG$20240718$N$CN$US$
241196041$24119604$1$I$20240425$20240718$20240718$20240718$DIR$710810$$FDA-CTU$$36$YR$$M$N$60$KG$20240718$N$CN$US$
241196051$24119605$1$I$20240602$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50096$$FDA-CTU$$69$YR$$F$N$$$20240718$N$$US$
241196072$24119607$2$F$20240401$20240826$20240722$20240904$EXP$$JP-AMGEN-JPNSP2024141983$AMGEN$$62$YR$A$F$Y$$$20240904$$MD$JP$JP
241196091$24119609$1$I$$20240714$20240722$20240722$PER$$US-BAYER-2024A102237$BAYER$$$$$F$Y$$$20240722$$CN$US$US
241196102$24119610$2$F$$20240821$20240722$20240827$EXP$$CA-Orion Corporation ORION PHARMA-24_00030939$ORION$$72$YR$E$F$Y$$$20240827$$HP$CA$
241196111$24119611$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141919$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241196121$24119612$1$I$$20240715$20240722$20240722$PER$$US-ALXN-202407USA000987US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
241196131$24119613$1$I$20240715$20240715$20240722$20240722$EXP$$NVSC2024US149422$NOVARTIS$$42$YR$$M$Y$$$20240722$$CN$US$US
241196142$24119614$2$F$$20240222$20240722$20240723$EXP$$NVSC2022DE244429$NOVARTIS$Shumilov E, Hasenkamp J, Maulhardt M, Mazzeo P, Schmidt N, Boyadzhiev H et al.. Outcomes of second allogeneic stem cell transplantation and anti-relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis. HEMATOLOGICAL ONCOLOGY. 2022;40:763-76$24$YR$$M$Y$$$20240723$$HP$DE$DE
241196152$24119615$2$F$20240129$20240729$20240722$20240805$EXP$$NVSC2024ZA148841$NOVARTIS$$66$YR$$F$Y$$$20240805$$CN$ZA$ZA
241196161$24119616$1$I$$20240715$20240722$20240722$EXP$NL-LRB-00980375$NL-MYLANLABS-2024M1067199$MYLAN$$74$YR$$M$Y$85$KG$20240722$$CN$NL$NL
241196171$24119617$1$I$20240619$20240715$20240722$20240722$EXP$FR-AFSSAPS-GR2024000871$FR-MYLANLABS-2024M1066056$MYLAN$$60$YR$$F$Y$71$KG$20240722$$PH$FR$FR
241196182$24119618$2$F$$20240723$20240722$20240725$EXP$$GB-MYLANLABS-2024M1066861$MYLAN$$$$$F$Y$$$20240725$$HP$GB$GB
241196191$24119619$1$I$20240621$20240715$20240722$20240722$EXP$HR-HALMED-300086110$HR-MYLANLABS-2024M1066437$MYLAN$$50$YR$$M$Y$$$20240722$$MD$HR$HR
241196201$24119620$1$I$$20240715$20240722$20240722$EXP$$FR-TAKEDA-2024TUS072596$TAKEDA$Walczak P, Fodil S, Vignal N, Cabannes-Hamy, A, Boissel N, Raffoux E, et al. Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1- positive acute lymphoblastic leukemia. Blood. 2021;1-9$81$YR$$M$Y$$$20240722$$MD$FR$FR
241196221$24119622$1$I$$20240708$20240722$20240722$EXP$$IN-COSETTE-CP2024IN000178$COSETTE PHARMACEUTICALS$$$$$$Y$$$20240722$$HP$IN$IN
241196232$24119623$2$F$$20240718$20240722$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001422$BLUEPRINT MEDICINES$$$$$F$Y$$$20240726$$CN$US$US
241196241$24119624$1$I$20240630$20240719$20240722$20240722$EXP$$US-BAYER-2024A105433$BAYER$$73$YR$E$M$Y$$$20240722$$CN$US$US
241196251$24119625$1$I$$20240708$20240722$20240722$EXP$$US-EPICPHARMA-US-2024EPCLIT00822$EPIC PHARM$Yousaf Z.Nystatin Induced Laryngeal Edema - First Reported Case.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$64$YR$A$F$Y$$$20240722$$HP$US$US
241196261$24119626$1$I$$20240718$20240722$20240722$EXP$$US-ABBVIE-5846292$ABBVIE$$$$$F$Y$$$20240722$$HP$US$US
241196271$24119627$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141198$AMGEN$$$$$M$Y$$$20240722$$CN$US$US
241196281$24119628$1$I$$20240709$20240722$20240722$EXP$$US-ROCHE-10000022497$ROCHE$$89$YR$E$M$Y$$$20240722$$CN$US$US
241196302$24119630$2$F$20240712$20240725$20240722$20240801$PER$$US-BAYER-2024A101500$BAYER$$16$YR$T$F$Y$92.5$KG$20240801$$HP$US$US
241196321$24119632$1$I$20240708$20240712$20240722$20240722$PER$$US-IGSA-BIG0029831$GRIFOLS$$63$YR$$M$Y$$$20240722$$HP$US$US
241196331$24119633$1$I$$20240715$20240722$20240722$EXP$$CA-MYLANLABS-2024M1066744$MYLAN$$64$YR$$F$Y$65.77$KG$20240722$$CN$CA$CA
241196341$24119634$1$I$20240711$20240718$20240718$20240718$DIR$710737$$FDA-CTU$$47$YR$$UNK$N$177$KG$20240718$N$CN$US$
241196351$24119635$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49884$$FDA-CTU$$54$YR$$F$N$$$20240718$N$HP$US$
241196361$24119636$1$I$$20240715$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112584$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240722$$HP$US$US
241196372$24119637$2$F$$20240722$20240722$20240725$EXP$$JP-PFIZER INC-202400217779$PFIZER$Yamane, K.. Successful curative treatment for a ruptured pancreatic acinar cell carcinoma by radical resection following modified FOLFIRINOX: a case report and literature review. International Cancer Conference Journal. 2024;13(3):281-288$48$YR$$M$Y$$$20240725$$MD$JP$JP
241196381$24119638$1$I$20090101$20240715$20240722$20240722$EXP$$HR-PFIZER INC-PV202400088450$PFIZER$Skugor, N.. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.. Collegium Antropologicum. 2010;34(1):241-5$36$YR$$F$Y$$$20240722$$HP$HR$HR
241196391$24119639$1$I$$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115447$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240722$$CN$US$US
241196401$24119640$1$I$$20240708$20240722$20240722$PER$$US-COSETTE-CP2024US000158$COSETTE PHARMACEUTICALS$$50$YR$A$F$Y$$$20240722$$PH$US$US
241196411$24119641$1$I$20240705$20240711$20240722$20240722$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS003696$TERSERA THERAPEUTICS$$$$$$Y$$$20240722$$MD$CN$CN
241196421$24119642$1$I$$20240711$20240722$20240722$PER$$US-ROCHE-10000025097$ROCHE$$6$YR$C$M$Y$$$20240722$$HP$US$US
241196441$24119644$1$I$20240715$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024144979$AMGEN$$85$YR$E$M$Y$$$20240722$$CN$US$US
241196451$24119645$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50062$$FDA-CTU$$54$YR$$F$N$$$20240718$N$$US$
241196461$24119646$1$I$$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-49889$$FDA-CTU$$82$YR$$M$N$$$20240718$N$$US$
241196471$24119647$1$I$20240716$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50059$$FDA-CTU$$87$YR$$M$N$$$20240718$N$$US$
241196481$24119648$1$I$$20240717$20240722$20240722$EXP$$AR-BEIGENE-BGN-2024-007258$BEIGENE$$$$$$Y$$$20240722$$MD$AR$AR
241196491$24119649$1$I$$20240717$20240722$20240722$EXP$$US-Stemline Therapeutics, Inc.-2024ST004377$STEMLINE THERAPEUTICS$$82$YR$E$F$Y$$$20240722$$CN$US$US
241196502$24119650$2$F$20240627$20240730$20240722$20240802$EXP$$US-UCBSA-2024036753$UCB$$39$YR$$M$Y$$$20240802$$CN$US$US
241196512$24119651$2$F$20240530$20240826$20240722$20240830$EXP$$NL-009507513-2407NLD011329$MERCK$$82$YR$$F$Y$$$20240830$$HP$NL$NL
241196521$24119652$1$I$20240625$20240718$20240718$20240718$DIR$710746$$FDA-CTU$$64$YR$$F$N$54$KG$20240718$N$CN$US$
241196531$24119653$1$I$20231002$20240709$20240722$20240722$EXP$$FR-CIPLA LTD.-2024FR07481$CIPLA$$$$$$Y$$$20240722$$MD$FR$FR
241196542$24119654$2$F$$20240725$20240722$20240731$EXP$$US-CIPLA LTD.-2024US07542$CIPLA$Nguyen C, Stanek JL. Sternomanubrial joint pain secondary to ulcerative colitis treated with ultrasound-guided injection. PM and R. 2024;16 (6):650 to 652$$$$$Y$$$20240731$$HP$US$US
241196555$24119655$5$F$20230101$20240913$20240722$20240921$PER$$US-ROCHE-10000027760$ROCHE$$14$YR$T$F$Y$44.91$KG$20240921$$CN$US$US
241196561$24119656$1$I$$20240715$20240722$20240722$EXP$$CA-ABBVIE-5847001$ABBVIE$$13$YR$$M$Y$$$20240722$$MD$CA$CA
241196571$24119657$1$I$$20201223$20240722$20240722$EXP$$US-AstraZeneca-2020SF74065$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241196581$24119658$1$I$$20191226$20240722$20240722$EXP$$US-AstraZeneca-2019SF91357$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241196591$24119659$1$I$$20201002$20240722$20240722$EXP$$AU-AstraZeneca-2020SF28464$ASTRAZENECA$$$$$F$Y$$$20240722$$MD$AU$
241196601$24119660$1$I$20240701$20240711$20240722$20240722$EXP$$KR-MALLINCKRODT-MNK202404593$MALLINCKRODT$$$$N$F$Y$3$KG$20240722$$HP$KR$KR
241196611$24119661$1$I$$20200904$20240722$20240722$EXP$$US-AstraZeneca-2020SF11703$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241196622$24119662$2$F$$20240924$20240722$20240926$EXP$$US-JNJFOC-20240743636$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$MD$US$US
241196631$24119663$1$I$$20240715$20240722$20240722$PER$$US-BAYER-2024A101503$BAYER$$39$YR$A$F$Y$$$20240722$$MD$US$US
241196642$24119664$2$F$20240618$20240905$20240722$20240911$EXP$$US-OTSUKA-2024_020016$OTSUKA$$87$YR$$F$Y$53.3$KG$20240911$$CN$US$US
241196651$24119665$1$I$$20240715$20240722$20240722$EXP$$AR-GSK-AR2024AMR089712$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$AR$AR
241196661$24119666$1$I$20230101$20230118$20240722$20240722$EXP$$KW-BIOVITRUM-2023KW01273$BIOVITRUM$$9$MON$$F$Y$$$20240722$$CN$KW$KW
241196671$24119667$1$I$$20240715$20240722$20240722$PER$$US-ALXN-202407USA000975US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
241196683$24119668$3$F$$20240826$20240722$20240830$EXP$$PT-MYLANLABS-2024M1067159$MYLAN$Pereira LM, Tinoco R, Mendes S, Amaro E, Fernandes N, Cruz D.. An unusual cause of syncope. Congresses of the Portuguese Society of Internal Medicine: 30th National Congres. 2024;1357$34$YR$$M$Y$$$20240830$$MD$PT$PT
241196691$24119669$1$I$20240601$20240716$20240722$20240722$PER$$US-ABBVIE-5846067$ABBVIE$$40$YR$$M$Y$90.718$KG$20240722$$CN$US$US
241196702$24119670$2$F$20240101$20240919$20240722$20240927$EXP$$US-ABBVIE-5839934$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
241196711$24119671$1$I$20240717$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142906$AMGEN$$23$YR$A$F$Y$$$20240722$$CN$US$US
241196721$24119672$1$I$$20240715$20240722$20240722$PER$$US-AMGEN-USASP2024142548$AMGEN$Mehra M.; Cossrow N.; Stellhorn R.A. et al.. Use of a Claims Database to Characterize and Estimate the Incidence of Castleman^s Disease. Blood. 2012;120 (21):4253$$$$$Y$$$20240722$$HP$US$US
241196731$24119673$1$I$20240120$20240718$20240718$20240718$DIR$710747$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241196741$24119674$1$I$$20240718$20240718$20240718$DIR$710766$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241196781$24119678$1$I$$20240718$20240722$20240722$PER$$US-BIOVITRUM-2024-US-010029$BIOVITRUM$$61$YR$$M$Y$$$20240722$$CN$US$US
241196792$24119679$2$F$$20240721$20240722$20240725$EXP$$AT-OTSUKA-2024_020290$OTSUKA$$92$YR$$F$Y$$$20240725$$MD$AT$AT
241196801$24119680$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089625$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241196812$24119681$2$F$20210101$20240829$20240722$20240906$EXP$$NL-CELLTRION INC.-2024NL017235$CELLTRION$$$$$$Y$$$20240906$$HP$NL$NL
241196821$24119682$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012898$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240722$$CN$US$US
241196831$24119683$1$I$20240112$20240710$20240722$20240722$EXP$FR-AFSSAPS-GR2024000808$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-06611$HIKMA$$78$YR$$F$Y$$$20240722$$PH$FR$FR
241196842$24119684$2$F$$20240719$20240722$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407011520$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240724$$CN$US$US
241196851$24119685$1$I$$20240712$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407008692$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240722$$CN$US$US
241196861$24119686$1$I$20240716$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011658$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240722$$CN$US$US
241196871$24119687$1$I$20240101$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013040$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240722$$CN$US$US
241196881$24119688$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013019$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240722$$CN$US$US
241196891$24119689$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012710$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241196911$24119691$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012292$ELI LILLY AND CO$$$$$F$Y$$$20240722$$HP$US$US
241196921$24119692$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012239$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240722$$CN$US$US
241196951$24119695$1$I$$20240718$20240718$20240718$DIR$710743$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241196961$24119696$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012109$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240722$$CN$US$US
241196971$24119697$1$I$20240606$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012195$ELI LILLY AND CO$$$$$$Y$$$20240722$$CN$US$US
241196981$24119698$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012231$ELI LILLY AND CO$$$$$$Y$$$20240722$$CN$US$US
241196991$24119699$1$I$$20240718$20240718$20240718$DIR$710780$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241197001$24119700$1$I$20240718$20240718$20240718$20240718$DIR$710758$$FDA-CTU$$70$YR$$UNK$N$$$20240718$Y$$US$
241197011$24119701$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011738$ELI LILLY AND CO$$$$$M$Y$$$20240722$$PH$US$US
241197021$24119702$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012966$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241197031$24119703$1$I$20240717$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012911$ELI LILLY AND CO$$68$YR$E$$Y$$$20240722$$CN$US$US
241197041$24119704$1$I$20240401$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012772$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240722$$CN$US$US
241197051$24119705$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012163$ELI LILLY AND CO$$$$$F$Y$$$20240722$$PH$US$US
241197061$24119706$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012217$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240722$$PH$US$US
241197071$24119707$1$I$$20240531$20240722$20240722$30DAY$$JP-UCBSA-2024028695$UCB$$$$$$Y$$$20240722$$PH$JP$JP
241197081$24119708$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011700$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240722$$CN$US$US
241197091$24119709$1$I$$20240715$20240722$20240722$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005307$BIOCON$$$$$$Y$$$20240722$$PH$CA$CA
241197102$24119710$2$F$$20240802$20240722$20240807$EXP$$JP-OTSUKA-2024_020176$OTSUKA$$60$YR$$F$Y$$$20240807$$MD$JP$JP
241197111$24119711$1$I$$20240718$20240722$20240722$PER$$US-ABBVIE-5847763$ABBVIE$$$$$F$Y$$$20240722$$HP$US$US
241197133$24119713$3$F$20090101$20240711$20240722$20240820$EXP$$BR-ABBVIE-5839389$ABBVIE$$$$$F$Y$$$20240820$$CN$BR$BR
241197141$24119714$1$I$$20240719$20240722$20240722$PER$$US-AMGEN-USASP2024143911$AMGEN$$$$$M$Y$$$20240722$$CN$US$US
241197151$24119715$1$I$20180101$20240711$20240722$20240722$EXP$$DE-CELLTRION INC.-2024DE017161$CELLTRION$$$$$$Y$$$20240722$$MD$DE$DE
241197162$24119716$2$F$20240111$20240712$20240722$20240724$EXP$$JP-ABBVIE-5592903$ABBVIE$$73$YR$$F$Y$$$20240724$$MD$JP$JP
241197171$24119717$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024142743$AMGEN$$$$$$Y$$$20240722$$HP$US$US
241197181$24119718$1$I$20220101$20240712$20240722$20240722$EXP$IE-HPRA-2024-114142$IE-TEVA-VS-3221062$TEVA$$77$YR$$M$Y$$$20240722$$PH$IE$IE
241197191$24119719$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024142919$AMGEN$Sharma S.; Ruiz J.; Desai A. et al.. Gender-based differences in COVID-19 outcomes following heart transplantation. ASAIO Journal. 2024;70 (SUPP_3):167$$$$F$Y$$$20240722$$HP$US$US
241197202$24119720$2$F$20240711$20240812$20240722$20240816$EXP$$US-BAYER-2024A105550$BAYER$$37$YR$A$M$Y$$$20240816$$CN$US$US
241197211$24119721$1$I$20240301$20240717$20240722$20240722$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2024-100149$REGENERON$$67$YR$$F$Y$$$20240722$$CN$CO$CO
241197221$24119722$1$I$20231201$20240715$20240722$20240722$EXP$$PT-009507513-2407PRT011255$MERCK$$65$YR$$M$Y$$$20240722$$MD$PT$PT
241197231$24119723$1$I$$20240715$20240722$20240722$EXP$NL-LRB-00976743$NL-MYLANLABS-2024M1066532$MYLAN$$55$YR$$M$Y$108$KG$20240722$$CN$NL$NL
241197241$24119724$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116099$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240722$$HP$US$US
241197251$24119725$1$I$20240606$20240712$20240722$20240722$EXP$$JP-ABBVIE-5838529$ABBVIE$$53$YR$$F$Y$$$20240719$$MD$JP$JP
241197261$24119726$1$I$$20200129$20240722$20240722$EXP$$US-AstraZeneca-2020SE15600$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241197271$24119727$1$I$$20221217$20240722$20240722$EXP$$US-AstraZeneca-2022A411394$ASTRAZENECA$$$$$F$Y$$$20240722$$HP$US$
241197281$24119728$1$I$$20240718$20240722$20240722$EXP$$SA-ARGENX-2024-ARGX-SA005708$ARGENX BVBA$$$$$$Y$$$20240722$$HP$SA$SA
241197291$24119729$1$I$$20240715$20240722$20240722$EXP$$US-ABBVIE-5842728$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241197311$24119731$1$I$20240718$20240719$20240722$20240722$EXP$$CN-BAYER-2024A105684$BAYER$$20$YR$A$F$Y$$$20240722$$HP$CN$CN
241197321$24119732$1$I$$20240710$20240722$20240722$EXP$$GB-TEVA-VS-3221365$TEVA$$71$YR$$F$Y$$$20240722$$CN$GB$GB
241197341$24119734$1$I$20240714$20240718$20240718$20240718$DIR$710729$$FDA-CTU$$81$YR$$M$N$66.15$KG$20240718$N$CN$US$
241197361$24119736$1$I$20240617$20240711$20240722$20240722$EXP$$ES-TEVA-VS-3213327$TEVA$$71$YR$$F$Y$$$20240722$$CN$ES$ES
241197371$24119737$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000031020$ROCHE$$54$YR$A$F$Y$$$20240722$$CN$US$US
241197381$24119738$1$I$$20240719$20240722$20240722$PER$$US-ROCHE-10000031777$ROCHE$$$$$$Y$$$20240722$$CN$US$US
241197391$24119739$1$I$$20240719$20240722$20240722$PER$$US-HALEON-2188088$Haleon PLC$$65$YR$$M$Y$$$20240722$$CN$US$US
241197401$24119740$1$I$20240430$20240709$20240722$20240722$EXP$$JP-APELLIS-2024-APL-0000488$APELLIS PHARMACEUTICALS$$$$$$Y$59$KG$20240718$$MD$JP$JP
241197413$24119741$3$F$20240718$20240830$20240722$20240903$PER$$US-AMGEN-USASP2024143713$AMGEN$$74$YR$E$F$Y$$$20240902$$HP$US$US
241197431$24119743$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024142938$AMGEN$Sharma S.; Ruiz J.; Desai A. et al.. Gender-based differences in COVID-19 outcomes following heart transplantation. ASAIO Journal. 2024;70 (SUPP_3):167$$$$F$Y$$$20240722$$HP$US$US
241197443$24119744$3$F$$20240822$20240722$20240822$30DAY$$US-PFIZER INC-202400217806$PFIZER$$15$YR$$M$Y$$$20240822$$HP$US$US
241197452$24119745$2$F$$20240722$20240722$20240730$30DAY$$US-PFIZER INC-202400218290$PFIZER$$11$YR$$M$Y$$$20240730$$CN$US$US
241197461$24119746$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024142962$AMGEN$Sharma S.; Ruiz J.; Desai A. et al.. Gender-based differences in COVID-19 outcomes following heart transplantation. ASAIO Journal. 2024;70 (SUPPL_3):167$$$$F$Y$$$20240722$$HP$US$US
241197472$24119747$2$F$$20240924$20240722$20240926$30DAY$$US-PFIZER INC-202400216528$PFIZER$$16$YR$$M$Y$$$20240926$$CN$US$US
241197482$24119748$2$F$20240601$20240822$20240722$20240822$30DAY$$US-PFIZER INC-202400217592$PFIZER$$10$YR$$F$Y$36.281$KG$20240822$$MD$US$US
241197492$24119749$2$F$20240701$20240917$20240722$20240920$30DAY$$US-PFIZER INC-202400217752$PFIZER$$15$YR$$M$Y$59.87$KG$20240920$$CN$US$US
241197502$24119750$2$F$$20240821$20240722$20240821$30DAY$$US-PFIZER INC-202400216300$PFIZER$$13$YR$$M$Y$$$20240821$$CN$US$US
241197511$24119751$1$I$$20240719$20240722$20240722$PER$$US-ROCHE-10000032031$ROCHE$$$$A$$Y$$$20240722$$CN$US$US
241197522$24119752$2$F$20240627$20240821$20240722$20240826$EXP$$JP-BAYER-2024A105757$BAYER$$74$YR$E$F$Y$48$KG$20240826$$HP$JP$JP
241197533$24119753$3$F$$20240722$20240722$20240724$PER$$US-HALEON-2188217$Haleon PLC$$$$$$Y$$$20240724$$CN$US$US
241197541$24119754$1$I$$20240715$20240722$20240722$EXP$$PL-MYLANLABS-2024M1050368$MYLAN$Skwarek-Dziekanowska A, Klaja B, Olajossy B, Miszczak M, Szewczuk A, Wojtowicz-Scislak G, Sobieszek. A stuck CSP lead: Should everyone have tools for TLE?. POLISH HEART JOURNAL. 2024;82(Suppl. I):55$54$YR$$M$Y$$$20240722$$MD$PL$PL
241197551$24119755$1$I$20240712$20240712$20240722$20240722$EXP$$US-JNJFOC-20240748009$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240722$$HP$US$US
241197562$24119756$2$F$$20240829$20240722$20240904$EXP$$JP-JNJFOC-20240756097$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240904$$MD$JP$JP
241197571$24119757$1$I$20240420$20240624$20240722$20240722$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00682$BIOCRYST PHARMACEUTICALS$$74$YR$$F$Y$$$20240722$$CN$US$US
241197582$24119758$2$F$20230711$20240916$20240722$20240923$EXP$$DE-ABBVIE-5842423$ABBVIE$$53$YR$$M$Y$$$20240923$$MD$DE$DE
241197591$24119759$1$I$20240301$20240716$20240722$20240722$PER$$US-BAYER-2024A103713$BAYER$$39$YR$A$F$Y$$$20240722$$MD$US$US
241197601$24119760$1$I$$20240712$20240722$20240722$PER$$US-BIOGEN-2024BI01273514$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
241197611$24119761$1$I$$20240711$20240722$20240722$PER$$US-BIOGEN-2024BI01273633$BIOGEN$$$$$F$Y$$$20240722$$MD$US$US
241197621$24119762$1$I$20240101$20240715$20240722$20240722$EXP$$IL-ABBVIE-5842804$ABBVIE$$$$$M$Y$$$20240719$$CN$IL$IL
241197632$24119763$2$F$$20240913$20240722$20240919$PER$$US-ROCHE-10000029941$ROCHE$$$$A$M$Y$$$20240919$$CN$US$US
241197641$24119764$1$I$$20240708$20240722$20240722$EXP$$CH-PURACAP-CH-2024EPCLIT00819$PURACAP$S. Jeltsch.How to differentiate erythema multiforme major from Stevens-Johnson syndrome?.Swiss Medical Weekly.2024;154 (276):112S-113S$41$YR$A$M$Y$$$20240722$$HP$CH$CH
241197651$24119765$1$I$$20240718$20240722$20240722$PER$$US-ROCHE-10000032030$ROCHE$$$$A$M$Y$$$20240722$$MD$US$US
241197661$24119766$1$I$$20240719$20240722$20240722$EXP$$US-ROCHE-10000031878$ROCHE$$58$YR$A$F$Y$$$20240722$$CN$US$US
241197671$24119767$1$I$$20240720$20240722$20240722$PER$$US-ROCHE-10000032381$ROCHE$$$$$$Y$$$20240722$$CN$US$US
241197682$24119768$2$F$20240101$20240719$20240722$20240724$EXP$$US-ROCHE-10000031801$ROCHE$$54$YR$A$F$Y$73.48$KG$20240724$$CN$US$US
241197701$24119770$1$I$$20240715$20240722$20240722$EXP$$US-ABBVIE-5841899$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241197711$24119771$1$I$20181009$20240716$20240722$20240722$EXP$$US-ABBVIE-5843493$ABBVIE$$49$YR$$M$Y$$$20240722$$CN$US$US
241197721$24119772$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024143077$AMGEN$Sharma S.; Ruiz J.; Desai A. et al.. Gender-based differences in COVID-19 outcomes following heart transplantation. ASAIO Journal. 2024;70 (SUPPL_3):167$$$$M$Y$$$20240722$$HP$US$US
241197741$24119774$1$I$$20240716$20240722$20240722$PER$$US-ROCHE-3573691$ROCHE$$86$YR$E$F$Y$$$20240722$$CN$US$US
241197751$24119775$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024143065$AMGEN$Sharma S.; Ruiz J.; Desai A. et al. Gender-based differences in COVID-19 outcomes following heart transplantation. ASAIO Journal. 2024;70 (SUPPL_3):167$$$$M$Y$$$20240722$$HP$US$US
241197761$24119776$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024143060$AMGEN$Sharma S.; Ruiz J.; Desai A. et al.. Gender-based differences in COVID-19 outcomes following heart transplantation. ASAIO Journal. 2024;70 (SUPPL_3):167$$$$M$Y$$$20240722$$HP$US$US
241197771$24119777$1$I$20200601$20220817$20240722$20240722$EXP$$US-RECORDATI-2021003922$RECORDATI$$$$$$Y$$$20240722$$CN$US$US
241197781$24119778$1$I$$20240714$20240722$20240722$EXP$$NVSC2024VN147077$NOVARTIS$$28$YR$$F$Y$$$20240722$$MD$VN$VN
241197791$24119779$1$I$$20240716$20240722$20240722$PER$$US-BAYER-2024A103866$BAYER$$$$$$Y$$$20240722$$CN$US$US
241197801$24119780$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024143069$AMGEN$Sharma. S.; Ruiz. J.; Desai. A. et.al. Gender-based differences in COVID-19 outcomes following heart transplantation. ASAIO Journal. 2024;70 (SUPPL_3):167$$$$M$Y$$$20240722$$HP$US$US
241197811$24119781$1$I$$20240715$20240722$20240722$EXP$$US-AMGEN-USASP2024143074$AMGEN$Sharma. S.; Ruiz. J.; Desai. A. et.al. Gender-based differences in COVID-19 outcomes following heart transplantation. ASAIO Journal. 2024;70 (SUPPL_3):167$$$$M$Y$$$20240722$$HP$US$US
241197821$24119782$1$I$20210101$20240715$20240722$20240722$EXP$$US-ABBVIE-5661747$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241197831$24119783$1$I$20240718$20240718$20240718$20240718$DIR$710727$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241197842$24119784$2$F$$20240719$20240722$20240729$PER$$US-JNJFOC-20240752313$JOHNSON AND JOHNSON$$5$YR$C$F$Y$$$20240729$$HP$US$US
241197851$24119785$1$I$20230101$20240719$20240722$20240722$PER$$US-ROCHE-10000031985$ROCHE$$37$YR$A$F$Y$46.72$KG$20240722$$CN$US$US
241197861$24119786$1$I$$20240718$20240722$20240722$PER$$US-ROCHE-10000031288$ROCHE$$52$YR$A$F$Y$$$20240722$$CN$US$US
241197871$24119787$1$I$20240715$20240718$20240718$20240718$DIR$710826$$FDA-CTU$$79$YR$$F$N$70.7$KG$20240718$N$PH$US$
241197881$24119788$1$I$$20240716$20240722$20240722$EXP$CN-MLMSERVICE-20240709-PI123186-00285-2$CN-CHEPLA-2024009101$CHEPLAPHARM$Keling P, Yuqian W, Li Z, Shushu L, Tao Z. Sinus arrest caused by amisulpride. Adverse Drug Reactions Journal. 2024;26(6):379-81. DOI: 10.3760/cma.j.cn114015-20230714-00525.$65$YR$$F$Y$$$20240722$$PH$COUNTRY NOT SPECIFIED$CN
241197891$24119789$1$I$20240628$20240718$20240722$20240722$PER$$US-ROCHE-10000031989$ROCHE$$$$A$F$Y$$$20240722$$CN$US$US
241197911$24119791$1$I$20220924$20240716$20240722$20240722$EXP$$KR-PFIZER INC-PV202400093581$PFIZER$$77$YR$$M$Y$54.8$KG$20240722$$MD$KR$KR
241197922$24119792$2$F$20240701$20240725$20240722$20240801$PER$$US-BAYER-2024A104752$BAYER$$33$YR$A$F$Y$$$20240801$$CN$US$US
241197931$24119793$1$I$20240614$20240712$20240722$20240722$EXP$FR-AFSSAPS-TS2024000769$FR-TEVA-VS-3221296$TEVA$$96$YR$$M$Y$54$KG$20240722$$MD$FR$FR
241197941$24119794$1$I$$20240715$20240722$20240722$EXP$$US-ABBVIE-5842634$ABBVIE$$$$$M$Y$$$20240719$$CN$US$US
241197961$24119796$1$I$20230718$20240715$20240722$20240722$EXP$$DE-TAKEDA-2024TUS072627$TAKEDA$$57$YR$$M$Y$85$KG$20240722$$HP$DE$DE
241197971$24119797$1$I$20231201$20240715$20240722$20240722$EXP$$US-ABBVIE-5623034$ABBVIE$$53$YR$$M$Y$$$20240719$$CN$US$US
241197982$24119798$2$F$20240820$20240821$20240722$20240828$PER$$US-BAYER-2024A104057$BAYER$$24$YR$A$M$Y$$$20240828$$CN$US$US
241197991$24119799$1$I$20230112$20240710$20240722$20240722$EXP$$JP-EXELIXIS-CABO-24079668$EXELIXIS$$66$YR$$M$Y$70.6$KG$20240722$$PH$JP$JP
241198001$24119800$1$I$$20240712$20240722$20240722$PER$$US-MYLANLABS-2024M1066386$MYLAN$$$$$$Y$$$20240722$$CN$US$US
241198022$24119802$2$F$20220930$20240902$20240722$20240910$EXP$$FR-CELLTRION INC.-2023FR007495$CELLTRION$de Marseille CRPV. Hypereosinophilia under Infliximab, regarding a case.. BULLETIN DE CRPV ET CEIP NO44 2023 - MARSEILLE-PROVENCE-CORSE ET NICE-ALPES-COTE. 2023;44 (2):1-6$$$$$Y$$$20240910$$HP$FR$FR
241198031$24119803$1$I$$20240718$20240722$20240722$PER$$US-ROCHE-10000031351$ROCHE$$$$T$M$Y$$$20240722$$CN$US$US
241198041$24119804$1$I$$20240716$20240722$20240722$PER$$US-ROCHE-10000031837$ROCHE$$$$$$Y$$$20240722$$CN$US$US
241198051$24119805$1$I$20240718$20240718$20240722$20240722$PER$$US-ROCHE-10000031014$ROCHE$$$$$M$Y$$$20240722$$CN$US$US
241198061$24119806$1$I$20240717$20240717$20240722$20240722$PER$$US-BAYER-2024A104776$BAYER$$24$YR$A$F$Y$$$20240722$$MD$US$US
241198071$24119807$1$I$20240703$20240718$20240722$20240722$PER$$US-ROCHE-10000031297$ROCHE$$38$YR$A$M$Y$$$20240722$$CN$US$US
241198081$24119808$1$I$$20240717$20240722$20240722$EXP$$US-ROCHE-10000020472$ROCHE$$61$YR$A$F$Y$$$20240722$$MD$US$US
241198094$24119809$4$F$$20240923$20240722$20240924$PER$$US-ROCHE-10000031749$ROCHE$$$$A$M$Y$113.4$KG$20240924$$CN$US$US
241198111$24119811$1$I$$20240718$20240722$20240722$PER$$US-ROCHE-10000031513$ROCHE$$$$A$$Y$$$20240722$$CN$US$US
241198121$24119812$1$I$$20240708$20240722$20240722$EXP$$SK-NORDICGR-056826$NORDIC PHARMA$$$$$M$Y$$$20240719$$MD$SK$SK
241198131$24119813$1$I$$20240717$20240722$20240722$EXP$$US-ROCHE-10000011761$ROCHE$$62$YR$A$F$Y$$$20240722$$CN$US$US
241198142$24119814$2$F$$20240722$20240722$20240801$EXP$$RO-NORDICGR-056814$NORDIC PHARMA$Rosu S, Tiba D, Ichim A, Balteanu M.. Combination with reserved prognosis: TB- rheumatoid arthritis.. Pneumologia.. 2022;71(4):150-3. doi:10.2478/pneum-2023-0039??Ro u S, Tiba D, Ichim A, B lteanu M. Asociere cu prognostic rezervat: TB-poliartrita reumatoida. Pneumologia. 2022;71:150-153.$54$YR$$F$Y$$$20240801$$HP$RO$RO
241198151$24119815$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000031400$ROCHE$$$$A$F$Y$$$20240722$$CN$US$US
241198161$24119816$1$I$$20240708$20240722$20240722$EXP$$SK-NORDICGR-056828$NORDIC PHARMA$Olearova A, Jureckova K.. Drug induced myelosupression- serious pharmacotherapy issue.. Farm Obzor.. 2014;LXXXIII:18; Olearova A, Jureckova K.. Metamizole-affected onset of action of filgrastim.. Klinicka Farmakologie a Farmacie. 2019;33(3):46-9$72$YR$$F$Y$70$KG$20240719$$MD$SK$SK
241198171$24119817$1$I$$20240708$20240722$20240722$EXP$$US-NORDICGR-056843$NORDIC PHARMA$Ayat P, Valdes Bracamontes MD, Khudyakov A, Al Ajam MR. Wherever You Go, Cryptococcus Is There: A Case Series. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6327. DOI:10.1164/ajrcc-conference.2024.209.1_MeetingAbstracts.A6327.$73$YR$$$Y$$$20240719$$MD$US$US
241198181$24119818$1$I$$20240708$20240722$20240722$EXP$$US-NORDICGR-056837$NORDIC PHARMA$Seidler N, Terlep O, Ramanujam V. Peripheral nerve blocks for through-knee amputation in a patient on extracorporeal membrane oxygenation. BMJ Case Reports. 2024;17(3):e259987. DOI: 10.1136/bcr-2024-259987.$5$DEC$$F$Y$$$20240719$$MD$US$US
241198191$24119819$1$I$$20240708$20240722$20240722$EXP$$GR-NORDICGR-056831$NORDIC PHARMA$Dimitroulas, T.. Pulmonary fibrosis from the perspective of the rheumatologist. 7th PANHELLENIC CONGRESS ON CHEST DISEASES, Presentations. 2024$65$YR$$M$Y$$$20240719$$MD$GR$GR
241198202$24119820$2$F$20230101$20240722$20240722$20240801$EXP$$NL-NORDICGR-055515$NORDIC PHARMA$$$$A$F$Y$$$20240801$$MD$NL$NL
241198211$24119821$1$I$$20240708$20240722$20240722$EXP$$RO-NORDICGR-056809$NORDIC PHARMA$CLAUDIA-IOANA DOGARU, MIRCEA TAMPA, CLARA MATEI, PETRONELA IONESCU, ANCA CRISTOCEA, BIANA DENISA STOIAN, GRIGORE CURCUBET, ANDREI BURLIBASA, SIMONA ROXANA GEORGESCU/BOWEN^S DISEASE: A VERY UNUSUAL LOCATION/ vol. 69, No. 1, 2024/25-29/$83$YR$$F$Y$$$20240718$$MD$RO$RO
241198221$24119822$1$I$$20240708$20240722$20240722$EXP$$IE-NORDICGR-056799$NORDIC PHARMA$$$$$F$Y$$$20240718$$MD$IE$IE
241198232$24119823$2$F$$20240807$20240722$20240819$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07044$LUPIN$$$$$$Y$$$20240819$$CN$US$US
241198241$24119824$1$I$20240601$20240708$20240722$20240722$EXP$FI-FIMEA-202402285$FI-NORDICGR-056818$NORDIC PHARMA$$71$YR$$F$Y$$$20240719$$MD$FI$FI
241198251$24119825$1$I$$20240715$20240722$20240722$EXP$$AR-GSK-AR2023AMR119078$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$AR$AR
241198261$24119826$1$I$20230701$20240717$20240722$20240722$EXP$$US-ABBVIE-5845231$ABBVIE$$30$YR$$F$Y$$$20240722$$CN$US$US
241198271$24119827$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000031928$ROCHE$$$$$F$Y$$$20240722$$CN$US$US
241198283$24119828$3$F$20240601$20240806$20240722$20240813$EXP$$TW-ABBVIE-5842456$ABBVIE$$67$YR$$M$Y$83$KG$20240813$$CN$TW$TW
241198291$24119829$1$I$$20240715$20240722$20240722$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001432$BLUEPRINT MEDICINES$$$$$M$Y$$$20240722$$CN$US$US
241198301$24119830$1$I$20221105$20240716$20240722$20240722$EXP$$US-ABBVIE-5844800$ABBVIE$$61$YR$$F$Y$$$20240722$$CN$US$US
241198311$24119831$1$I$20240701$20240715$20240722$20240722$EXP$$US-ABBVIE-5842263$ABBVIE$$86$YR$$M$Y$$$20240719$$CN$US$US
241198321$24119832$1$I$$20240715$20240722$20240722$EXP$$US-ABBVIE-5841393$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241198331$24119833$1$I$20240501$20240717$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114501$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240722$$HP$US$US
241198342$24119834$2$F$20200101$20240717$20240722$20240823$EXP$$US-ROCHE-10000030097$ROCHE$$48$YR$A$F$Y$$$20240823$$CN$US$US
241198353$24119835$3$F$20240718$20240730$20240722$20240802$PER$$US-PFIZER INC-202400219727$PFIZER$$85$YR$$M$Y$$$20240802$$CN$US$US
241198361$24119836$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400094215$PFIZER$$37$YR$$$Y$$$20240722$$CN$US$US
241198371$24119837$1$I$20240717$20240719$20240722$20240722$PER$$US-PFIZER INC-202400219957$PFIZER$$81$YR$$M$Y$$$20240722$$CN$US$US
241198381$24119838$1$I$20240710$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400094643$PFIZER$$80$YR$$M$Y$$$20240722$$CN$US$US
241198391$24119839$1$I$20240717$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218025$PFIZER$$22$YR$$F$Y$$$20240722$$CN$US$US
241198401$24119840$1$I$20240718$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218915$PFIZER$$37$YR$$M$Y$$$20240722$$CN$US$US
241198412$24119841$2$F$20240715$20240816$20240722$20240820$PER$$US-PFIZER INC-202400217958$PFIZER$$33$YR$$M$Y$$$20240820$$CN$US$US
241198421$24119842$1$I$20240713$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218016$PFIZER$$58$YR$$F$Y$$$20240722$$CN$US$US
241198431$24119843$1$I$20240719$20240719$20240722$20240722$PER$$US-PFIZER INC-202400219686$PFIZER$$65$YR$$F$Y$$$20240722$$HP$US$US
241198442$24119844$2$F$20240717$20240725$20240722$20240726$PER$$US-PFIZER INC-202400218250$PFIZER$$54$YR$$F$Y$$$20240726$$CN$US$US
241198451$24119845$1$I$20240718$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218795$PFIZER$$$$$M$Y$$$20240722$$CN$US$US
241198461$24119846$1$I$20240201$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400094568$PFIZER$$67$YR$$$Y$$$20240722$$CN$US$US
241198472$24119847$2$F$$20240723$20240722$20240729$EXP$$NVSC2024US148690$NOVARTIS$$$$$$Y$$$20240729$$CN$US$US
241198481$24119848$1$I$20240717$20240718$20240722$20240722$PER$$US-PFIZER INC-202400219199$PFIZER$$69$YR$$M$Y$$$20240722$$CN$US$US
241198491$24119849$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218952$PFIZER$$$$$$Y$$$20240722$$CN$US$US
241198501$24119850$1$I$20240717$20240719$20240722$20240722$PER$$US-PFIZER INC-202400219620$PFIZER$$25$YR$$F$Y$$$20240722$$CN$US$US
241198512$24119851$2$F$20240715$20240821$20240722$20240822$PER$$US-PFIZER INC-202400219655$PFIZER$$76$YR$$M$Y$$$20240822$$CN$US$US
241198522$24119852$2$F$$20240718$20240722$20240723$EXP$$US-PFIZER INC-202400218668$PFIZER$$63$YR$$F$Y$45.36$KG$20240723$$CN$US$US
241198532$24119853$2$F$20240717$20240725$20240722$20240730$PER$$US-PFIZER INC-202400219198$PFIZER$$64$YR$$F$Y$$$20240730$$CN$US$US
241198541$24119854$1$I$20240715$20240717$20240722$20240722$PER$$US-PFIZER INC-202400217654$PFIZER$$59$YR$$F$Y$89.81$KG$20240722$$CN$US$US
241198551$24119855$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400094584$PFIZER$$$$A$F$Y$$$20240722$$HP$US$US
241198561$24119856$1$I$$20240716$20240722$20240722$PER$$US-PFIZER INC-PV202400093502$PFIZER$$$$$$Y$$$20240722$$CN$US$US
241198571$24119857$1$I$20240716$20240717$20240722$20240722$PER$$US-PFIZER INC-202400217659$PFIZER$$78$YR$$F$Y$$$20240722$$CN$US$US
241198582$24119858$2$F$20240715$20240806$20240722$20240809$PER$$US-PFIZER INC-202400216522$PFIZER$$69$YR$$M$Y$90.703$KG$20240809$$MD$US$US
241198591$24119859$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400219778$PFIZER$$$$$M$Y$$$20240722$$CN$US$US
241198601$24119860$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400095032$PFIZER$$89$YR$$F$Y$$$20240722$$CN$US$US
241198611$24119861$1$I$20240712$20240716$20240722$20240722$PER$$US-PFIZER INC-202400216902$PFIZER$$43$YR$$F$Y$$$20240722$$CN$US$US
241198621$24119862$1$I$20240717$20240718$20240722$20240722$PER$$US-PFIZER INC-202400219651$PFIZER$$47$YR$$F$Y$$$20240722$$CN$US$US
241198631$24119863$1$I$20240719$20240719$20240722$20240722$PER$$US-PFIZER INC-202400219264$PFIZER$$66$YR$$M$Y$$$20240722$$CN$US$US
241198641$24119864$1$I$$20240718$20240718$20240718$DIR$710728$$FDA-CTU$$$$$UNK$N$$$20240718$$CN$US$
241198651$24119865$1$I$20240717$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218792$PFIZER$$65$YR$$M$Y$$$20240722$$CN$US$US
241198662$24119866$2$F$20240714$20240805$20240722$20240807$PER$$US-PFIZER INC-202400217798$PFIZER$$61$YR$$M$Y$108.84$KG$20240807$$CN$US$US
241198671$24119867$1$I$$20240718$20240718$20240718$DIR$710695$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241198681$24119868$1$I$20240713$20240718$20240718$20240718$DIR$710824$$FDA-CTU$$29$YR$$F$N$59$KG$20240718$N$PH$US$
241198691$24119869$1$I$20240716$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218084$PFIZER$$80$YR$$F$Y$$$20240722$$CN$US$US
241198701$24119870$1$I$20240719$20240720$20240722$20240722$PER$$US-PFIZER INC-202400219678$PFIZER$$36$YR$$F$Y$$$20240722$$CN$US$US
241198711$24119871$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400094514$PFIZER$$75$YR$$$Y$$$20240722$$CN$US$US
241198731$24119873$1$I$$20240718$20240718$20240718$DIR$710775$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241198741$24119874$1$I$20240717$20240718$20240718$20240718$DIR$710726$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241198751$24119875$1$I$20240717$20240717$20240722$20240722$PER$$US-PFIZER INC-202400217976$PFIZER$$39$YR$$M$Y$$$20240722$$CN$US$US
241198762$24119876$2$F$20240718$20240806$20240722$20240808$PER$$US-PFIZER INC-202400219623$PFIZER$$65$YR$$F$Y$58.957$KG$20240808$$CN$US$US
241198771$24119877$1$I$20240718$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218807$PFIZER$$84$YR$$M$Y$$$20240722$$HP$US$US
241198791$24119879$1$I$20240716$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218661$PFIZER$$58$YR$$F$Y$$$20240722$$CN$US$US
241198801$24119880$1$I$20240716$20240717$20240722$20240722$PER$$US-PFIZER INC-202400217956$PFIZER$$58$YR$$F$Y$$$20240722$$CN$US$US
241198811$24119881$1$I$20240717$20240721$20240722$20240722$PER$$US-PFIZER INC-202400220211$PFIZER$$28$YR$$F$Y$$$20240722$$CN$US$US
241198822$24119882$2$F$$20240725$20240722$20240726$PER$$US-PFIZER INC-202400219745$PFIZER$$45$YR$$M$Y$$$20240726$$CN$US$US
241198831$24119883$1$I$20240719$20240719$20240722$20240722$PER$$US-PFIZER INC-202400219619$PFIZER$$44$YR$$F$Y$$$20240722$$MD$US$US
241198842$24119884$2$F$20240717$20240822$20240722$20240823$PER$$US-PFIZER INC-202400218100$PFIZER$$32$YR$$F$Y$$$20240823$$CN$US$US
241198851$24119885$1$I$20240716$20240717$20240722$20240722$PER$$US-PFIZER INC-202400217936$PFIZER$$62$YR$$M$Y$$$20240722$$CN$US$US
241198861$24119886$1$I$20240717$20240718$20240722$20240722$PER$$US-PFIZER INC-202400219156$PFIZER$$63$YR$$F$Y$$$20240722$$CN$US$US
241198871$24119887$1$I$$20240716$20240722$20240722$PER$$KR-PFIZER INC-202400215965$PFIZER$$$$$$Y$$$20240722$$PH$KR$KR
241198881$24119888$1$I$20240716$20240718$20240722$20240722$PER$$US-PFIZER INC-202400219126$PFIZER$$34$YR$$F$Y$$$20240722$$CN$US$US
241198891$24119889$1$I$20240719$20240719$20240722$20240722$PER$$US-PFIZER INC-202400219639$PFIZER$$41$YR$$F$Y$$$20240722$$CN$US$US
241198902$24119890$2$F$20240701$20240722$20240722$20240725$PER$$US-PFIZER INC-202400216687$PFIZER$$74$YR$$F$Y$$$20240725$$CN$US$US
241198911$24119891$1$I$20240715$20240717$20240722$20240722$PER$$US-PFIZER INC-202400217993$PFIZER$$42$YR$$M$Y$$$20240722$$CN$US$US
241198922$24119892$2$F$20240716$20240806$20240722$20240809$PER$$US-PFIZER INC-202400217995$PFIZER$$52$YR$$F$Y$79.365$KG$20240809$$CN$US$US
241198932$24119893$2$F$20240702$20240725$20240722$20240730$PER$$US-PFIZER INC-202400219663$PFIZER$$67$YR$$F$Y$$$20240730$$CN$US$US
241198941$24119894$1$I$$20240716$20240722$20240722$PER$$US-PFIZER INC-202400217583$PFIZER$$$$$$Y$$$20240722$$CN$US$US
241198951$24119895$1$I$20240717$20240717$20240722$20240722$PER$$US-PFIZER INC-202400217985$PFIZER$$56$YR$$M$Y$$$20240722$$CN$US$US
241198961$24119896$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400094683$PFIZER$$11$YR$$$Y$$$20240722$$CN$US$US
241198971$24119897$1$I$20240718$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218676$PFIZER$$28$YR$$F$Y$$$20240722$$CN$US$US
241198982$24119898$2$F$$20240725$20240722$20240729$PER$$US-PFIZER INC-PV202400093917$PFIZER$$69$YR$$$Y$$$20240729$$CN$US$US
241198992$24119899$2$F$20240701$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218797$PFIZER$$69$YR$$M$Y$97.52$KG$20240722$$CN$US$US
241199001$24119900$1$I$20240716$20240719$20240722$20240722$PER$$US-PFIZER INC-202400219944$PFIZER$$$$A$F$Y$$$20240722$$CN$US$US
241199011$24119901$1$I$$20240719$20240722$20240722$PER$$US-PFIZER INC-PV202400095350$PFIZER$$38$YR$$M$Y$$$20240722$$CN$US$US
241199021$24119902$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400094525$PFIZER$$$$$$Y$$$20240722$$HP$US$US
241199033$24119903$3$F$20240318$20240805$20240722$20240816$EXP$$JP-UCBSA-2024017407$UCB$$53$YR$$F$Y$50.7$KG$20240816$$MD$JP$JP
241199041$24119904$1$I$$20240716$20240722$20240722$PER$$US-PFIZER INC-202400216561$PFIZER$$44$YR$$F$Y$$$20240722$$CN$US$US
241199052$24119905$2$F$20240701$20240828$20240722$20240904$PER$$US-PFIZER INC-202400218922$PFIZER$$77$YR$$F$Y$49.887$KG$20240904$$CN$US$US
241199061$24119906$1$I$20240718$20240721$20240722$20240722$PER$$US-PFIZER INC-202400220197$PFIZER$$67$YR$$F$Y$$$20240722$$CN$US$US
241199072$24119907$2$F$$20240821$20240722$20240828$PER$$US-BAYER-2024A104959$BAYER$$27$YR$A$F$Y$89.3$KG$20240828$$MD$US$US
241199081$24119908$1$I$$20240717$20240722$20240722$PER$$US-BAYER-2024A104524$BAYER$$22$YR$A$M$Y$$$20240722$$HP$US$US
241199091$24119909$1$I$20240512$20240717$20240722$20240722$EXP$FR-AFSSAPS-BX2024001376$FR-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2406FR05744$INSUD PHARMA$$37$YR$$F$Y$78$KG$20240722$$MD$FR$FR
241199101$24119910$1$I$20230925$20240717$20240722$20240722$EXP$SE-SEMPA-2024-005427$SE-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2407SE05739$INSUD PHARMA$$47$YR$$F$Y$51$KG$20240722$$CN$SE$SE
241199111$24119911$1$I$20240501$20240718$20240722$20240722$EXP$GB-MHRA-MED-202407182016564980-HSPGZ$GB-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2407GB05756$INSUD PHARMA$$54$YR$$F$Y$$$20240722$$CN$GB$GB
241199132$24119913$2$F$20240712$20240722$20240722$20240725$EXP$$ES-PFIZER INC-PV202400093538$PFIZER$$13$YR$$F$Y$33.2$KG$20240725$$MD$ES$ES
241199141$24119914$1$I$$20240715$20240722$20240722$EXP$$CA-ABBVIE-5842920$ABBVIE$$$$N$$Y$$$20240719$$CN$CA$CA
241199152$24119915$2$F$20240401$20240813$20240722$20240815$EXP$$US-ABBVIE-5844243$ABBVIE$$59$YR$$F$Y$$$20240815$$CN$US$US
241199181$24119918$1$I$20230227$20240708$20240722$20240722$EXP$FR-AFSSAPS-AM2024000479$FR-NORDICGR-056749$NORDIC PHARMA$$66$YR$$F$Y$$$20240717$$MD$FR$FR
241199194$24119919$4$F$$20240822$20240722$20240823$PER$$US-ROCHE-10000031033$ROCHE$$$$$$Y$$$20240823$$HP$US$US
241199201$24119920$1$I$20240524$20240716$20240722$20240722$PER$$US-ROCHE-3579756$ROCHE$$59$YR$A$F$Y$83.46$KG$20240722$$PH$US$US
241199212$24119921$2$F$$20240805$20240722$20240816$EXP$$PT-MYLANLABS-2024M1067197$MYLAN$Ferreira Da Costa RM, Lopes C, Ferreira Lopes D, Conde PV, Pereira JM, Mayor JS, et al.. Ferreira Da Costa RM, Lopes C, Ferreira Lopes D, Conde PV, Pereira JM, Mayor JS, Ferreira Da Costa M, Tribuna C. Eosinophilic pneumonitis secondary to amiodarone: a warning about pharmacological adverse effects. Congresses of the Portuguese Society of Internal Medicine. 2024;1270$78$YR$$F$Y$$$20240816$$MD$PT$PT
241199221$24119922$1$I$$20240715$20240722$20240722$EXP$$TW-MYLANLABS-2024M1067449$MYLAN$Wu W-L, Lee J-C, Su W-C, Wang S-Y, Wu C-J. A rare case of an endobronchial mass due to Neurospora intermedia. Int-J-Infect-Dis 2024; 146.$25$YR$$M$Y$$$20240722$$HP$TW$TW
241199231$24119923$1$I$$20240715$20240722$20240722$EXP$$BE-MYLANLABS-2024M1066664$MYLAN$Boland, L. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19.. Transplant International. 2024;37$$$A$$Y$$$20240722$$HP$BE$BE
241199242$24119924$2$F$$20240726$20240722$20240806$EXP$$GR-MYLANLABS-2024M1067077$MYLAN$Tsionis A, Irini Z, Anastasia A, Erifilli L, Vadim G, Fotini H.. ECTOPIC PREGNANCY AND METHOTREXATE: PRESENTATION OF 3 CASES  IN THE LAST YEAR WITH AN UNFAVORABLE OUTCOME. 16th PANHELLENIC CONGRESS ON OBSTETRICS AND GYNECOLOGY. 2024;466$$$$F$Y$$$20240806$$MD$GR$GR
241199253$24119925$3$F$$20240923$20240722$20240927$EXP$$PT-MYLANLABS-2024M1067213$MYLAN$Lage G, Fernandes L, Fernandes I, Clerigo V, Ferrao A. What hides behind the pink cloak. Congresses of the Portuguese Society of Internal Medicine. 2024;491$74$YR$$M$Y$$$20240927$$MD$PT$PT
241199263$24119926$3$F$$20240905$20240722$20240911$EXP$$PT-MYLANLABS-2024M1066729$MYLAN$Nogueira JV, Rodrigues L, Fernandes Neves C, Mesquita P, Vieira RM, Ribeiro Alves D, Coroado Ferreira F, Fonseca. et al.. HHV-6B pneumonia in an immunosuppressed patient. Doen?as infeciosas e parasit?rias/Caso cl?nico. 2024;273$83$YR$$M$Y$$$20240911$$MD$PT$PT
241199271$24119927$1$I$$20240715$20240722$20240722$EXP$$BE-MYLANLABS-2024M1066669$MYLAN$Boland, L. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19.. Transplant International.. 2024;37$$$A$$Y$$$20240722$$HP$BE$BE
241199281$24119928$1$I$$20240715$20240722$20240722$EXP$$BE-MYLANLABS-2024M1066427$MYLAN$Boland, L.. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19. Transplant International.. 2024;37$$$A$$Y$$$20240722$$HP$BE$BE
241199292$24119929$2$F$$20240726$20240722$20240806$EXP$$GR-MYLANLABS-2024M1066637$MYLAN$Tsionis A., Irini Z., Anastasia A., Erifilli L., Vadim G., Fotini H.. ECTOPIC PREGNANCY AND METHOTREXATE: PRESENTATION OF 3 CASES  IN THE LAST YEAR WITH AN UNFAVORABLE OUTCOME. 16th PANHELLENIC CONGRESS ON OBSTETRICS AND GYNECOLOGY. 2024;466$$$$F$Y$$$20240806$$MD$GR$GR
241199301$24119930$1$I$20240714$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142809$AMGEN$$71$YR$E$F$Y$$$20240722$$CN$US$US
241199311$24119931$1$I$$20240716$20240722$20240722$PER$$NVSC2024US147465$NOVARTIS$$$$$F$Y$$$20240722$$CN$US$US
241199322$24119932$2$F$$20240910$20240722$20240912$PER$$US-BIOGEN-2024BI01273892$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
241199331$24119933$1$I$20240411$20240711$20240722$20240722$EXP$FR-AFSSAPS-AVPA2024000623$FR-TEVA-VS-3220687$TEVA$$23$YR$$F$Y$$$20240722$$MD$FR$FR
241199341$24119934$1$I$20240625$20240716$20240722$20240722$EXP$$US-ABBVIE-5843476$ABBVIE$$76$YR$$M$Y$$$20240719$$CN$US$US
241199351$24119935$1$I$$20240719$20240722$20240722$PER$$US-BAYER-2024A105450$BAYER$$24$YR$A$F$Y$$$20240722$$HP$US$US
241199361$24119936$1$I$20240617$20240716$20240722$20240722$EXP$$CA-ABBVIE-5843985$ABBVIE$$60$YR$$F$Y$$$20240719$$CN$CA$CA
241199372$24119937$2$F$20240101$20240813$20240722$20240816$EXP$$US-ABBVIE-5843805$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
241199381$24119938$1$I$$20240718$20240718$20240718$DIR$710724$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241199391$24119939$1$I$20240718$20240718$20240718$20240718$DIR$710802$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241199401$24119940$1$I$$20240718$20240718$20240718$DIR$710789$$FDA-CTU$$$$$UNK$N$$$20240718$$CN$US$
241199411$24119941$1$I$$20240718$20240718$20240718$DIR$710767$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241199421$24119942$1$I$20200615$20240718$20240718$20240718$DIR$710700$$FDA-CTU$$8$YR$$M$N$49.5$KG$20240718$N$CN$US$
241199441$24119944$1$I$$20240717$20240722$20240722$EXP$$US-ABBVIE-5845323$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241199461$24119946$1$I$20240710$20240717$20240722$20240722$PER$$US-ABBVIE-5847372$ABBVIE$$67$YR$$$Y$127$KG$20240722$$CN$US$US
241199471$24119947$1$I$$20240717$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115178$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240722$$HP$US$US
241199481$24119948$1$I$20231201$20231221$20240722$20240722$EXP$GB-MHRA-MED-202312200854557870-NBMFG$GB-TEVA-VS-3139153$TEVA$$35$YR$$M$Y$65$KG$20240722$$CN$GB$GB
241199491$24119949$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06610$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241199502$24119950$2$F$$20240719$20240722$20240726$EXP$$US-ABBVIE-5843943$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241199513$24119951$3$F$20240101$20240822$20240722$20240829$EXP$$US-UCBSA-2024020295$UCB$$$$$F$Y$79.378$KG$20240829$$CN$US$US
241199522$24119952$2$F$20240101$20240822$20240722$20240903$PER$$US-ABBVIE-5841483$ABBVIE$$$$$F$Y$58.966$KG$20240903$$CN$US$US
241199534$24119953$4$F$20240101$20240916$20240722$20240918$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041162$BOEHRINGER INGELHEIM$$66$YR$E$F$Y$$$20240919$$CN$US$US
241199541$24119954$1$I$20240624$20240710$20240722$20240722$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000255$Unknown Manufacturer$$$$$$Y$$$20240722$$CN$US$US
241199551$24119955$1$I$$20240716$20240722$20240722$EXP$$CA-ABBVIE-5843804$ABBVIE$$$$E$M$Y$$$20240719$$CN$CA$CA
241199561$24119956$1$I$20240614$20240712$20240722$20240722$EXP$$CN-SA-2024SA209881$SANOFI AVENTIS$$81$YR$E$M$Y$60$KG$20240722$$HP$CN$CN
241199571$24119957$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072774$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241199581$24119958$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072736$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241199591$24119959$1$I$20180724$20240715$20240722$20240722$EXP$$CA-TAKEDA-2017TUS006561$TAKEDA$$64$YR$$M$Y$$$20240722$$CN$CA$CA
241199602$24119960$2$F$20240714$20240923$20240722$20240927$EXP$$US-TAKEDA-2023TUS125017$TAKEDA$$28$YR$$M$Y$$$20240927$$CN$US$US
241199611$24119961$1$I$20221201$20240715$20240722$20240722$EXP$$MT-BIOCON BIOLOGICS LIMITED-BBL2023002126$BIOCON$$$$$$Y$$$20240722$$MD$MT$MT
241199622$24119962$2$F$20240101$20240717$20240722$20240730$EXP$$US-ABBVIE-5845068$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241199631$24119963$1$I$$20240718$20240722$20240722$PER$$US-HALEON-2187983$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
241199641$24119964$1$I$20220101$20240715$20240722$20240722$EXP$$FR-SA-2024SA208925$SANOFI AVENTIS$F?rst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R, et al.. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease. Bone Marrow Transplantation.. 2024;59(7):918-27$30$YR$A$F$Y$$$20240722$$HP$FR$FR
241199651$24119965$1$I$$20240712$20240722$20240722$EXP$$CA-BAYER-2024A084934$BAYER$$80$YR$E$F$Y$$$20240722$$CN$CA$CA
241199663$24119966$3$F$$20240801$20240722$20240806$EXP$$AT-ABBVIE-5843819$ABBVIE$$44$YR$$M$Y$80$KG$20240806$$CN$AT$AT
241199671$24119967$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072770$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241199681$24119968$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072808$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241199691$24119969$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072807$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241199711$24119971$1$I$20240709$20240715$20240722$20240722$EXP$$CA-ROCHE-10000028133$ROCHE$$27$YR$A$M$Y$$$20240722$$CN$CA$CA
241199721$24119972$1$I$20240717$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024143141$AMGEN$$78$YR$E$F$Y$$$20240722$$CN$US$US
241199731$24119973$1$I$$20240717$20240722$20240722$EXP$$NVSC2024US148694$NOVARTIS$$$$$$Y$$$20240722$$CN$US$US
241199742$24119974$2$F$20240619$20240806$20240722$20240809$EXP$$GR-ABBVIE-5843842$ABBVIE$$60$YR$$F$Y$65$KG$20240809$$MD$GR$GR
241199752$24119975$2$F$$20240905$20240722$20240905$PER$$NVSC2024US149628$NOVARTIS$$$$$M$Y$$$20240905$$CN$US$US
241199761$24119976$1$I$$20240715$20240722$20240722$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005308$BIOCON$$$$$$Y$$$20240722$$HP$CA$CA
241199771$24119977$1$I$20181123$20240708$20240722$20240722$EXP$$ES-NORDICGR-056803$NORDIC PHARMA$$43$YR$$F$Y$$$20240718$$MD$ES$ES
241199781$24119978$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072771$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241199791$24119979$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072811$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241199801$24119980$1$I$20240605$20240711$20240722$20240722$PER$$US-BIOGEN-2024BI01273943$BIOGEN$$56$YR$$F$Y$$$20240722$$CN$US$US
241199811$24119981$1$I$$20240711$20240722$20240722$EXP$$GB-TEVA-VS-3221725$TEVA$$$$A$F$Y$$$20240722$$CN$GB$GB
241199821$24119982$1$I$$20240709$20240722$20240722$EXP$$KZ-FreseniusKabi-FK202410997$FRESENIUS KABI$$25$YR$A$M$Y$$$20240722$$MD$KZ$KZ
241199831$24119983$1$I$20240311$20240712$20240722$20240722$EXP$FR-AFSSAPS-BS2024000402$FR-BAUSCH-BL-2024-011103$BAUSCH AND LOMB$$63$YR$$M$Y$84$KG$20240722$$CN$FR$FR
241199843$24119984$3$F$$20240725$20240722$20240730$EXP$$MA-BAUSCH-BL-2024-011153$BAUSCH AND LOMB$Mourabiti H, Esayh G, Hoummani H, Hanchi S, Chaouche I, Achour S, Belahsen F. Paraparesie secondaire a la metformine: une situation rare a connaitre avec des images IRM caracteristiques. Toxicologie Analytique et Clinique.. 2024;1-6. doi:10.1016/j.toxac.2024.06.001$63$YR$$F$Y$$$20240730$$HP$MA$MA
241199851$24119985$1$I$20240718$20240718$20240718$20240718$DIR$710794$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241199861$24119986$1$I$20240415$20240718$20240722$20240722$EXP$FR-AFSSAPS-AN2024000807$FR-BAUSCH-BL-2024-011092$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240722$$PH$FR$FR
241199871$24119987$1$I$20240101$20240712$20240722$20240722$EXP$$US-TEVA-VS-3222076$TEVA$$15$YR$$M$Y$$$20240722$$MD$US$US
241199891$24119989$1$I$$20240718$20240718$20240718$DIR$710696$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241199902$24119990$2$F$20240620$20240719$20240722$20240918$EXP$FR-AFSSAPS-ST2024001142$FR-BAUSCH-BL-2024-011133$BAUSCH AND LOMB$$24$YR$$M$Y$85$KG$20240919$$MD$FR$FR
241199911$24119991$1$I$$20240718$20240718$20240718$DIR$710807$$FDA-CTU$$$$$F$N$$$20240718$N$PH$US$
241199921$24119992$1$I$20240226$20240717$20240722$20240722$EXP$$PL-SA-2024SA184923$SANOFI AVENTIS$$46$YR$A$M$Y$65$KG$20240722$$MD$PL$PL
241199931$24119993$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5843109$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241199941$24119994$1$I$20240718$20240722$20240722$20240722$EXP$DE-CADRBFARM-2024329432$NVSC2024DE149730$NOVARTIS$$63$YR$$F$Y$$$20240722$$MD$DE$DE
241199952$24119995$2$F$20240717$20240809$20240722$20240814$EXP$$US-SA-2024SA212747$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240814$$MD$US$US
241199961$24119996$1$I$$20240717$20240722$20240722$EXP$$DE-ABBVIE-5844923$ABBVIE$$$$$M$Y$$$20240719$$CN$DE$DE
241199982$24119998$2$F$$20240808$20240722$20240814$EXP$$US-ZENPEP LLC-2024AIMT01089$AIMMUNE$$$$$$Y$$$20240814$$HP$US$US
241199992$24119999$2$F$$20240801$20240722$20240806$EXP$$CN-AMGEN-CHNSP2024144276$AMGEN$Wenyu Y.; Xiaolan L.; Beibei Z. et al.. The safety and efficacy of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia in children. Natl Med J China. 2024;104 (27):2563-2567$$$$$Y$$$20240806$$HP$CN$CN
241200001$24120000$1$I$20220101$20240711$20240722$20240722$EXP$FR-AFSSAPS-GR2024000823$FR-TEVA-VS-3220923$TEVA$$44$YR$$F$Y$$$20240722$$PH$FR$FR
241200011$24120001$1$I$$20240715$20240722$20240722$EXP$$PT-ROCHE-10000026905$ROCHE$Sousa M, Braga A, Buchner G, Braga J. Rituximab as a treatment for refractory immune thrombocytopenia during pregnancy. Doi: 10.1097/MBC.0000000000001312. Blood coagulation + fibrinolysis : an international journal in haemostasis and thrombosis. 2024-Jul-01;35 (5):286-292. doi:10.1097/MBC.0000000000001312.$23$YR$A$F$Y$$$20240722$$HP$PT$PT
241200021$24120002$1$I$20240416$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114036$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$76.2$KG$20240722$$CN$US$US
241200051$24120005$1$I$$20240716$20240722$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-113433$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240722$$HP$CA$CA
241200061$24120006$1$I$$20240717$20240722$20240722$EXP$$US-LUNDBECK-DKLU4001926$LUNDBECK$$$$$$Y$$$20240722$$HP$US$US
241200071$24120007$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115748$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$88.9$KG$20240722$$CN$US$US
241200081$24120008$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012100$ELI LILLY AND CO$$$$A$M$Y$$$20240722$$CN$US$US
241200091$24120009$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013054$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241200101$24120010$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012775$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240722$$CN$US$US
241200112$24120011$2$F$$20240809$20240722$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202407012982$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240820$$MD$US$US
241200121$24120012$1$I$20240101$20240712$20240722$20240722$EXP$$AU-Eisai-EC-2024-170165$EISAI$Lee YC. Case presentation.$62$YR$A$F$Y$$$20240719$$MD$AU$AU
241200131$24120013$1$I$20240208$20240707$20240722$20240722$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202406001548$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240722$$CN$DE$DE
241200141$24120014$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012567$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240722$$MD$US$US
241200151$24120015$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012402$ELI LILLY AND CO$$15$YR$T$M$Y$$$20240722$$HP$US$US
241200161$24120016$1$I$20240717$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011475$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240722$$CN$US$US
241200171$24120017$1$I$20240716$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012249$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240722$$CN$US$US
241200181$24120018$1$I$20240702$20240707$20240722$20240722$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407007589$ELI LILLY AND CO$$30$YR$A$M$Y$63$KG$20240722$$CN$DE$CN
241200191$24120019$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012933$ELI LILLY AND CO$$$$A$M$Y$$$20240722$$CN$US$US
241200201$24120020$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012749$ELI LILLY AND CO$$$$A$F$Y$$$20240722$$CN$US$US
241200211$24120021$1$I$20240701$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012308$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240722$$CN$US$US
241200222$24120022$2$F$20240501$20240804$20240722$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202407012943$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240815$$MD$US$US
241200231$24120023$1$I$$20240718$20240722$20240722$EXP$$US-UCBSA-2024036649$UCB$$$$$M$Y$$$20240722$$CN$US$US
241200242$24120024$2$F$$20240807$20240722$20240812$EXP$$JP-BAUSCH-BL-2024-011099$BAUSCH AND LOMB$$25$YR$$F$Y$$$20240812$$MD$JP$JP
241200251$24120025$1$I$20240627$20240711$20240722$20240722$EXP$$US-BEH-2024175885$CSL BEHRING$$$$$M$Y$$$20240722$$CN$US$US
241200262$24120026$2$F$$20240712$20240722$20240723$EXP$$US-BAUSCH-BL-2024-011087$BAUSCH AND LOMB$$81$YR$$F$Y$$$20240723$$CN$US$US
241200271$24120027$1$I$20240711$20240715$20240722$20240722$EXP$$US-LEX-000398$LEXICON PHARMACEUTICALS$$98$YR$$F$Y$$$20240722$$CN$US$US
241200292$24120029$2$F$20240601$20240730$20240722$20240802$PER$$US-Eisai-EC-2024-168790$EISAI$$69$YR$E$F$Y$$$20240802$$CN$US$US
241200302$24120030$2$F$$20240731$20240722$20240807$EXP$$JP-JNJFOC-20240755777$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240807$$PH$JP$JP
241200311$24120031$1$I$20240601$20240717$20240722$20240722$EXP$$US-ABBVIE-5843917$ABBVIE$$56$YR$$M$Y$$$20240719$$CN$US$US
241200321$24120032$1$I$20240701$20240717$20240722$20240722$EXP$$US-ABBVIE-5844017$ABBVIE$$72$YR$$M$Y$$$20240719$$CN$US$US
241200331$24120033$1$I$20240717$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400219079$PFIZER$$30$YR$$F$Y$$$20240722$$HP$CA$CA
241200341$24120034$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400217668$PFIZER$$58$YR$$F$Y$76$KG$20240722$$CN$CA$CA
241200351$24120035$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400217673$PFIZER$$68$YR$$F$Y$69$KG$20240722$$CN$CA$CA
241200363$24120036$3$F$20240628$20240806$20240722$20240809$EXP$$ES-PFIZER INC-202400216920$PFIZER$$63$YR$$F$Y$53.6$KG$20240809$$MD$ES$ES
241200371$24120037$1$I$$20240718$20240722$20240722$EXP$$US-PFIZER INC-PV202400094332$PFIZER$Nanah, A.. Delayed Response to Glucocorticoids in Daptomycin Lung. American Journal of Therapeutics. 2024;31(4):e518-e521$75$YR$$M$Y$$$20240722$$MD$US$US
241200382$24120038$2$F$$20240815$20240722$20240820$EXP$$US-PFIZER INC-PV202400094232$PFIZER$$62$YR$$F$Y$$$20240820$$CN$US$US
241200391$24120039$1$I$$20240717$20240722$20240722$EXP$$JP-PFIZER INC-202400219123$PFIZER$$$$$M$Y$$$20240722$$MD$JP$JP
241200401$24120040$1$I$20230101$20240717$20240722$20240722$EXP$$US-PFIZER INC-2023SGN10808$PFIZER$$71$YR$$F$Y$66.21$KG$20240722$$CN$US$US
241200411$24120041$1$I$$20240717$20240722$20240722$EXP$$US-PFIZER INC-202400217543$PFIZER$$$$$F$Y$$$20240722$$MD$US$US
241200431$24120043$1$I$20240101$20240716$20240722$20240722$EXP$$AR-PFIZER INC-PV202400030180$PFIZER$$68$YR$$F$Y$$$20240722$$CN$AR$AR
241200441$24120044$1$I$20240701$20240717$20240722$20240722$EXP$$CN-PFIZER INC-PV202400093987$PFIZER$$61$YR$$F$Y$52.5$KG$20240722$$HP$CN$CN
241200451$24120045$1$I$20240526$20240716$20240722$20240722$EXP$FR-AFSSAPS-PB2024000790$FR-PFIZER INC-202400215941$PFIZER$$19$YR$$F$Y$$$20240722$$MD$FR$FR
241200461$24120046$1$I$20230110$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202201353303$PFIZER$$78$YR$$F$Y$63$KG$20240722$$MD$CA$CA
241200471$24120047$1$I$$20240716$20240722$20240722$EXP$$US-PFIZER INC-PV202400092273$PFIZER$Estrada Paz, O.. Paraneoplastic pemphigus with airway involvement. Respiratory Medicine Case Reports. 2024;51:10.1016/j.rmcr.2024.102085$55$YR$$F$Y$$$20240722$$HP$US$US
241200481$24120048$1$I$$20240717$20240722$20240722$EXP$$JP-PFIZER INC-PV202400094810$PFIZER$$78$YR$$F$Y$$$20240722$$HP$JP$JP
241200491$24120049$1$I$20240601$20240717$20240722$20240722$EXP$$CN-PFIZER INC-PV202400093990$PFIZER$$39$YR$$F$Y$50$KG$20240722$$HP$CN$CN
241200501$24120050$1$I$$20240716$20240722$20240722$EXP$$TW-PFIZER INC-202400216080$PFIZER$$80$YR$$F$Y$$$20240722$$CN$TW$TW
241200511$24120051$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400218625$PFIZER$$7$YR$$F$Y$33$KG$20240722$$HP$CA$CA
241200524$24120052$4$F$20240131$20240802$20240722$20240812$EXP$$PL-PFIZER INC-202400216892$PFIZER$$65$YR$$F$Y$65$KG$20240812$$MD$PL$PL
241200531$24120053$1$I$$20240717$20240722$20240722$EXP$$US-PFIZER INC-202400218734$PFIZER$$37$YR$$F$Y$$$20240722$$HP$US$US
241200541$24120054$1$I$$20240717$20240722$20240722$EXP$$US-PFIZER INC-202400217883$PFIZER$$88$YR$$M$Y$$$20240722$$CN$US$US
241200551$24120055$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400218858$PFIZER$$$$$F$Y$$$20240722$$MD$CA$CA
241200561$24120056$1$I$20240703$20240717$20240722$20240722$EXP$$CN-PFIZER INC-PV202400093981$PFIZER$$27$YR$$M$Y$74.6$KG$20240722$$HP$CN$CN
241200571$24120057$1$I$$20240715$20240722$20240722$EXP$$CA-PFIZER INC-202400110980$PFIZER$$83$YR$$F$Y$$$20240722$$MD$CA$CA
241200581$24120058$1$I$20240628$20240717$20240722$20240722$EXP$$CN-PFIZER INC-PV202400093988$PFIZER$$59$YR$$M$Y$55.5$KG$20240722$$HP$CN$CN
241200592$24120059$2$F$$20240723$20240722$20240729$EXP$$CA-PFIZER INC-202400218949$PFIZER$$65$YR$$M$Y$$$20240729$$HP$CA$CA
241200601$24120060$1$I$20240523$20240716$20240722$20240722$EXP$$IT-PFIZER INC-202400215872$PFIZER$$72$YR$$M$Y$70$KG$20240722$$MD$IT$IT
241200622$24120062$2$F$$20240723$20240722$20240726$EXP$$JP-PFIZER INC-202400216846$PFIZER$$65$YR$$M$Y$$$20240726$$PH$JP$JP
241200631$24120063$1$I$$20240717$20240722$20240722$EXP$$US-PFIZER INC-202400215529$PFIZER$$68$YR$$F$Y$$$20240722$$HP$US$US
241200642$24120064$2$F$20240101$20240719$20240722$20240723$EXP$$US-PFIZER INC-202400218777$PFIZER$$65$YR$$F$Y$$$20240723$$HP$US$US
241200651$24120065$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400217677$PFIZER$$$$$F$Y$87$KG$20240722$$MD$CA$CA
241200662$24120066$2$F$$20240731$20240722$20240806$EXP$$ES-PFIZER INC-PV202400093695$PFIZER$Anto, C.. USE OF ISAVUCONAZOLE IN CHILDREN WITH INVASIVE FUNGAL INFECTION: EXPERIENCE IN A PAEDIATRIC AND TERTIARY CARE CENTRE. 493$15$YR$$M$Y$60$KG$20240806$$MD$ES$ES
241200672$24120067$2$F$$20240723$20240722$20240724$EXP$$AU-PFIZER INC-202400219489$PFIZER$$60$YR$$F$Y$$$20240724$$HP$AU$AU
241200681$24120068$1$I$20220519$20240716$20240722$20240722$EXP$$GB-PFIZER INC-202400216290$PFIZER$$76$YR$$F$Y$65$KG$20240722$$MD$GB$GB
241200691$24120069$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400218962$PFIZER$$66$YR$$F$Y$$$20240722$$PH$CA$CA
241200701$24120070$1$I$$20240717$20240722$20240722$EXP$$US-PFIZER INC-202400218479$PFIZER$Story, S.. Successful desensitization to brentuximab vedotin after hypersensitivity reaction. Journal of Drugs in Dermatology. 2014;13(6):749-751$57$YR$$F$Y$$$20240722$$HP$US$US
241200712$24120071$2$F$$20240912$20240722$20240912$EXP$$CA-PFIZER INC-202300335706$PFIZER$$44$YR$$F$Y$$$20240912$$MD$CA$CA
241200721$24120072$1$I$$20240716$20240722$20240722$EXP$$CN-PFIZER INC-PV202400093446$PFIZER$$67$YR$$M$Y$$$20240722$$CN$CN$CN
241200731$24120073$1$I$20240717$20240717$20240722$20240722$EXP$$US-PFIZER INC-202400217629$PFIZER$$$$$M$Y$$$20240722$$MD$US$US
241200741$24120074$1$I$$20240717$20240722$20240722$EXP$$US-PFIZER INC-PV202400094039$PFIZER$$20$YR$$M$Y$$$20240722$$MD$US$US
241200751$24120075$1$I$20240701$20240717$20240722$20240722$EXP$$US-PFIZER INC-PV202400094352$PFIZER$$82$YR$$M$Y$$$20240722$$MD$US$US
241200761$24120076$1$I$20240430$20240717$20240722$20240722$EXP$FR-AFSSAPS-TO2024001230$FR-PFIZER INC-202400218293$PFIZER$$75$YR$$M$Y$$$20240722$$PH$FR$FR
241200772$24120077$2$F$$20240828$20240722$20240902$EXP$$US-PFIZER INC-PV202400094242$PFIZER$$36$YR$$F$Y$$$20240902$$MD$US$US
241200782$24120078$2$F$20230101$20240820$20240722$20240822$EXP$$CA-PFIZER INC-202400218665$PFIZER$$80$YR$$M$Y$$$20240822$$HP$CA$CA
241200793$24120079$3$F$$20240913$20240722$20240913$EXP$$CA-PFIZER INC-202300026489$PFIZER$$53$YR$$M$Y$$$20240913$$MD$CA$CA
241200801$24120080$1$I$$20240716$20240722$20240722$EXP$$JP-Eisai-EC-2024-170434$EISAI$Kishino Emi. Two cases of Drug-induced Lung disorder caused by Enhertu experienced at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society (Abstracts). 2024; -(-): EP-1131-.$81$YR$E$F$Y$$$20240719$$MD$JP$JP
241200811$24120081$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-PV202400094278$PFIZER$$58$YR$$F$Y$$$20240722$$CN$CA$CA
241200821$24120082$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400218607$PFIZER$$11$YR$$F$Y$$$20240722$$HP$CA$CA
241200833$24120083$3$F$20240613$20240726$20240722$20240730$EXP$$JP-PFIZER INC-202400219237$PFIZER$$57$YR$$M$Y$60$KG$20240730$$PH$JP$JP
241200841$24120084$1$I$$20240717$20240722$20240722$EXP$$US-ABBVIE-5843898$ABBVIE$$$$$$Y$$$20240719$$CN$US$US
241200851$24120085$1$I$$20240715$20240722$20240722$EXP$$PT-009507513-2407PRT011587$MERCK$$71$YR$$M$Y$$$20240722$$MD$PT$PT
241200861$24120086$1$I$$20240717$20240722$20240722$EXP$$US-PFIZER INC-202400218869$PFIZER$$66$YR$$F$Y$$$20240722$$HP$US$US
241200871$24120087$1$I$20230127$20240717$20240722$20240722$EXP$$FR-PFIZER INC-202400216941$PFIZER$$76$YR$$M$Y$60$KG$20240722$$MD$FR$FR
241200881$24120088$1$I$20240101$20240710$20240722$20240722$PER$$US-009507513-2407USA006362$MERCK$$$$$F$Y$59.9$KG$20240722$$CN$US$US
241200891$24120089$1$I$20240101$20240715$20240722$20240722$PER$$US-Eisai-EC-2024-170200$EISAI$$72$YR$E$M$Y$69.8$KG$20240719$$CN$US$US
241200901$24120090$1$I$$20240715$20240722$20240722$EXP$$DE-AMGEN-DEUSP2024141889$AMGEN$Stilgenbauer, S.. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240722$$MD$DE$DE
241200912$24120091$2$F$20240306$20240308$20240722$20240724$PER$$FR-Eisai-EC-2024-170535$EISAI$$74$YR$E$M$Y$80$KG$20240724$$MD$FR$FR
241200921$24120092$1$I$20230508$20240718$20240718$20240718$DIR$710752$$FDA-CTU$$68$YR$$F$N$103.5$KG$20240718$N$CN$US$
241200931$24120093$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5844371$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241200942$24120094$2$F$20240411$20240731$20240722$20240801$EXP$GB-MHRA-MED-202407181629003740-QVYCF$GB-JNJFOC-20240752922$JOHNSON AND JOHNSON$$59$YR$A$F$Y$60$KG$20240801$$MD$GB$GB
241200951$24120095$1$I$20240616$20240709$20240722$20240722$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00161$OPKO HEALTH$$76$YR$$F$Y$$$20240718$$PH$US$US
241200971$24120097$1$I$$20240709$20240722$20240722$EXP$$CL-SERVIER-S24008901$SERVIER$$$$$$Y$$$20240722$$PH$CL$CL
241200981$24120098$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072775$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241200993$24120099$3$F$$20240828$20240722$20240902$EXP$$GB-JNJFOC-20240751064$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240902$$CN$GB$GB
241201001$24120100$1$I$$20240717$20240722$20240722$EXP$$US-ABBVIE-5844058$ABBVIE$$$$$M$Y$$$20240719$$CN$US$US
241201011$24120101$1$I$$20200527$20240722$20240722$EXP$$US-AstraZeneca-2020SE70271$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241201021$24120102$1$I$20240101$20240717$20240722$20240722$EXP$$PL-ABBVIE-5843998$ABBVIE$$68$YR$$M$Y$$$20240719$$MD$PL$PL
241201031$24120103$1$I$$20240711$20240722$20240722$PER$$US-ROCHE-10000024406$ROCHE$$$$$$Y$$$20240722$$HP$US$US
241201041$24120104$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072809$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241201051$24120105$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024143125$AMGEN$$$$$M$Y$$$20240722$$CN$US$US
241201062$24120106$2$F$$20240807$20240722$20240812$PER$$US-AMGEN-USASP2024143235$AMGEN$$$$$$Y$$$20240811$$CN$US$US
241201071$24120107$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141678$AMGEN$$70$YR$E$F$Y$$$20240722$$HP$US$US
241201082$24120108$2$F$$20240719$20240722$20240730$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06301$LUPIN$$$$$$Y$$$20240730$$HP$US$US
241201092$24120109$2$F$20240713$20240730$20240722$20240805$EXP$$GB-MYLANLABS-2024M1067063$MYLAN$$$$$M$Y$$$20240805$$HP$GB$GB
241201102$24120110$2$F$20240627$20240716$20240722$20240725$EXP$FR-AFSSAPS-PO2024000769$FR-MYLANLABS-2024M1066403$MYLAN$$19$YR$$F$Y$$$20240725$$MD$FR$FR
241201112$24120111$2$F$$20240725$20240722$20240730$EXP$$NZ-MYLANLABS-2024M1067200$MYLAN$$$$$F$Y$$$20240730$$HP$NZ$NZ
241201121$24120112$1$I$20240613$20240716$20240722$20240722$EXP$FR-AFSSAPS-PC2024000557$FR-MYLANLABS-2024M1066334$MYLAN$$83$YR$$F$Y$$$20240722$$MD$FR$FR
241201131$24120113$1$I$20240101$20240710$20240722$20240722$PER$$US-009507513-2407USA005230$MERCK$$87$YR$$M$Y$$$20240722$$CN$US$US
241201141$24120114$1$I$$20240711$20240722$20240722$PER$$US-ROCHE-10000024716$ROCHE$$$$A$M$Y$$$20240722$$CN$US$US
241201151$24120115$1$I$20240501$20240715$20240722$20240722$EXP$FR-AFSSAPS-RN2024000770$FR-FreseniusKabi-FK202411256$FRESENIUS KABI$$80$YR$E$M$Y$$$20240722$$MD$FR$FR
241201161$24120116$1$I$20240529$20240710$20240722$20240722$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00166$OPKO HEALTH$$77$YR$$M$Y$$$20240718$$PH$US$US
241201172$24120117$2$F$20240601$20240723$20240722$20240725$EXP$$US-ABBVIE-5846810$ABBVIE$$70$YR$$F$Y$59$KG$20240725$$CN$US$US
241201181$24120118$1$I$$20240718$20240722$20240722$EXP$$JP-PFIZER INC-PV202400094383$PFIZER$$$$$$Y$$$20240722$$HP$JP$JP
241201191$24120119$1$I$$20240708$20240722$20240722$EXP$$NVSC2024TH149056$NOVARTIS$$78$YR$$M$Y$$$20240722$$MD$TH$TH
241201201$24120120$1$I$$20240718$20240722$20240722$EXP$$AR-PFIZER INC-202400212382$PFIZER$$74$YR$$F$Y$$$20240722$$CN$AR$AR
241201211$24120121$1$I$20240626$20240718$20240722$20240722$EXP$$GB-PFIZER INC-202400218140$PFIZER$$$$$$Y$$$20240722$$CN$GB$GB
241201221$24120122$1$I$20240705$20240718$20240722$20240722$EXP$$US-PFIZER INC-202400219230$PFIZER$$56$YR$$F$Y$$$20240722$$HP$US$US
241201233$24120123$3$F$20221101$20240806$20240722$20240809$EXP$$US-PFIZER INC-202400218968$PFIZER$Krause, P.. Tafenoquine for Relapsing Babesiosis: A Case Series. Clinical infectious diseases. 2024;79(1):130-137$52$YR$$M$Y$$$20240809$$MD$US$US
241201241$24120124$1$I$$20240716$20240722$20240722$EXP$$JP-PFIZER INC-PV202400093578$PFIZER$Kojima, M.. A case of a patient taking oral methotrexate sodium (MTX) presented with concurrent multiple Epstein-Barr virus-positive mucocutaneous ulcers in the oral cavity (The Japanese Society of Oral and Maxillofacial Surgeons). The 62nd Kitanihon Regional Meeting of the Japanese Stomatological Society. 2024;62nd:47$67$YR$$M$Y$$$20240722$$HP$JP$JP
241201251$24120125$1$I$20240701$20240718$20240722$20240722$EXP$$CN-PFIZER INC-PV202400094435$PFIZER$$72$YR$$F$Y$65$KG$20240722$$HP$CN$CN
241201262$24120126$2$F$20240617$20240812$20240722$20240815$EXP$FR-AFSSAPS-DJ2024000836$FR-PFIZER INC-202400218030$PFIZER$$75$YR$$F$Y$120$KG$20240815$$MD$FR$FR
241201272$24120127$2$F$20210101$20240813$20240722$20240821$EXP$$CA-APOTEX-2024AP008356$APOTEX$Wu H, Hill V.. Serotonin Syndrome and Catatonia in the Absence of a Serotonergic Agent Following Abrupt Withdrawal of Clozapine. Canadian Journal of Hospital Pharmacy. 2024;77(1):e3452.:1-3$47$YR$$M$Y$$$20240821$$MD$CA$CA
241201281$24120128$1$I$$20240722$20240722$20240722$EXP$$DE-GILEAD-2024-0681444$GILEAD$$72$YR$E$M$Y$$$20240722$$HP$DE$DE
241201291$24120129$1$I$$20231225$20240722$20240722$EXP$$GB-TEVA-VS-3141217$TEVA$Vakrinou A, Bellampalli R, Gulcebi MI, Martins Custodio H, Research Consortium GE, Balestrini S, et al. Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in clinical practice. J-Neurol-Neurosurg-Psychiatry 2023; 94 887-892.; Vakrinou A, Bellampalli R, Gulcebi MI, Martins Custodio H, Research Consortium GE, Balestrini S, et al. Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in...$$$$F$Y$$$20240722$$HP$GB$GB
241201301$24120130$1$I$$20240711$20240722$20240722$PER$$US-ABBVIE-5840160$ABBVIE$$$$A$$Y$$$20240719$$MD$US$US
241201311$24120131$1$I$20240526$20240711$20240722$20240722$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00167$OPKO HEALTH$$90$YR$$F$Y$$$20240718$$PH$US$US
241201322$24120132$2$F$$20240710$20240722$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458185$RANBAXY$Boris J, Al-Sudani H, Brophy A. Flecainide overdose-induced wide-complex tachyarrhythmia treated with sodium bicarbonate infusion. BMJ Case Rep. 2024;17 (6):e256391$5$DEC$$M$Y$$$20240725$$HP$US$US
241201331$24120133$1$I$20240712$20240712$20240722$20240722$PER$$US-ABBVIE-5843710$ABBVIE$$33$YR$$M$Y$$$20240719$$CN$US$US
241201341$24120134$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000030610$ROCHE$$$$E$F$Y$$$20240722$$CN$US$US
241201351$24120135$1$I$20240710$20240712$20240722$20240722$PER$$US-ABBVIE-5842201$ABBVIE$$33$YR$$M$Y$$$20240719$$CN$US$US
241201372$24120137$2$F$$20240716$20240722$20240725$PER$$JP-ROCHE-10000027642$ROCHE$Yokota H, Asahi R, Akamine Y, Kobayashi M, Wakabayashi H, Sakamoto S, et al. Case report of QT interval prolongation induced by anamorelin in an obese patient with non-small cell lung cancer. Journal of Pharmaceutical Health Care and Sciences. 2024-Jun-26;10 (1):33. doi:10.1186/s40780-024-00356-8.$6$DEC$A$F$Y$79$KG$20240725$$HP$JP$US
241201381$24120138$1$I$20240610$20240715$20240722$20240722$EXP$FR-AFSSAPS-PB2024000785$FR-Waylis Therapeutics LLC-ATNAHS20240702017$Waylis$$27$YR$A$M$Y$$$20240722$$MD$FR$FR
241201393$24120139$3$F$20240601$20240814$20240722$20240818$PER$$US-AMGEN-USASP2024143242$AMGEN$$61$YR$$F$Y$$$20240818$$HP$US$US
241201412$24120141$2$F$$20240712$20240722$20240722$PER$$US-ABBVIE-5841527$ABBVIE$$$$$$Y$$$20240719$$HP$US$US
241201421$24120142$1$I$$20240716$20240722$20240722$PER$$US-ABBVIE-5846799$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241201434$24120143$4$F$20231201$20240902$20240722$20240913$EXP$$US-UCBSA-2024036735$UCB$$59$YR$$F$Y$$$20240913$$CN$US$US
241201442$24120144$2$F$20240719$20240910$20240722$20240920$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00168$OPKO HEALTH$$76$YR$$M$Y$88$KG$20240918$$PH$US$US
241201452$24120145$2$F$20240601$20240806$20240722$20240807$PER$$US-AMGEN-USASP2024143871$AMGEN$$57$YR$A$F$Y$$$20240807$$CN$US$US
241201463$24120146$3$F$20240701$20240828$20240722$20240830$PER$$US-AMGEN-USASP2024143822$AMGEN$$75$YR$E$F$Y$$$20240830$$CN$US$US
241201471$24120147$1$I$$20230928$20240722$20240722$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2023AST000484$ASSERTIO THERAPEUTICS$$$$$$Y$$$20240722$$CN$US$US
241201481$24120148$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06611$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241201492$24120149$2$F$20240701$20240723$20240722$20240728$PER$$KR-Eisai-EC-2024-169885$EISAI$$73$YR$E$M$Y$$$20240728$$CN$KR$KR
241201501$24120150$1$I$20240501$20240528$20240722$20240722$PER$$US-LUNDBECK-DKLU3078655$LUNDBECK$$$$$$Y$$$20240722$$CN$US$US
241201511$24120151$1$I$$20220530$20240722$20240722$EXP$$US-AstraZeneca-2022A150904$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241201521$24120152$1$I$$20200414$20240722$20240722$EXP$$US-AstraZeneca-2020SE53115$ASTRAZENECA$$59$YR$$M$Y$$$20240722$$CN$US$
241201531$24120153$1$I$20240508$20240712$20240722$20240722$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00169$OPKO HEALTH$$74$YR$$F$Y$$$20240719$$PH$US$US
241201541$24120154$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06621$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241201551$24120155$1$I$$20240709$20240722$20240722$EXP$$JP-ROCHE-10000025108$ROCHE$$69$YR$E$M$Y$$$20240722$$PH$JP$JP
241201561$24120156$1$I$20040101$20240716$20240722$20240722$EXP$FR-AFSSAPS-AVLY2024000100$FR-Waylis Therapeutics LLC-ATNAHS20240702026$Waylis$$38$YR$A$M$Y$135$KG$20240722$$MD$FR$FR
241201571$24120157$1$I$20220101$20240712$20240722$20240722$PER$$US-ABBVIE-5840655$ABBVIE$$$$$M$Y$102$KG$20240719$$CN$US$US
241201581$24120158$1$I$20230721$20240714$20240722$20240722$EXP$$JP-ROCHE-10000031049$ROCHE$$74$YR$E$$Y$$$20240722$$MD$JP$JP
241201591$24120159$1$I$20240101$20240715$20240722$20240722$EXP$$US-JNJFOC-20240744616$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240722$$HP$US$US
241201601$24120160$1$I$$20240714$20240722$20240722$EXP$$IE-JNJFOC-20240738094$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$MD$IE$IE
241201611$24120161$1$I$$20240712$20240722$20240722$PER$$US-ABBVIE-5839683$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241201621$24120162$1$I$20240701$20240719$20240722$20240722$EXP$$JP-PFIZER INC-202400219326$PFIZER$$$$E$M$Y$$$20240722$$MD$JP$JP
241201631$24120163$1$I$20240718$20240719$20240722$20240722$EXP$GB-MHRA-MED-202407191459520230-ZCNRK$GB-PFIZER INC-202400219274$PFIZER$$64$YR$$M$Y$$$20240722$$HP$GB$GB
241201641$24120164$1$I$20240624$20240719$20240722$20240722$EXP$EG-EPVC-300263623$EG-PFIZER INC-PV202400094616$PFIZER$$74$YR$$M$Y$65$KG$20240722$$PH$EG$EG
241201651$24120165$1$I$20240422$20240718$20240722$20240722$EXP$FR-AFSSAPS-DJ2024000838$FR-PFIZER INC-202400218268$PFIZER$$86$YR$$F$Y$60$KG$20240722$$MD$FR$FR
241201662$24120166$2$F$20240413$20240723$20240722$20240723$EXP$FR-AFSSAPS-DJ2024000842$FR-PFIZER INC-202400218038$PFIZER$$46$YR$$M$Y$53$KG$20240723$$MD$FR$FR
241201671$24120167$1$I$20240718$20240719$20240722$20240722$EXP$$US-PFIZER INC-PV202400095273$PFIZER$$91$YR$$F$Y$$$20240722$$HP$US$US
241201681$24120168$1$I$$20240719$20240722$20240722$EXP$$IN-PFIZER INC-PV202400095094$PFIZER$$37$YR$$M$Y$$$20240722$$CN$IN$IN
241201691$24120169$1$I$$20240718$20240722$20240722$EXP$$US-PFIZER INC-PV202400094657$PFIZER$$61$YR$$M$Y$$$20240722$$CN$US$US
241201701$24120170$1$I$20240701$20240718$20240722$20240722$EXP$$CN-PFIZER INC-PV202400094189$PFIZER$$35$YR$$F$Y$51$KG$20240722$$HP$CN$CN
241201712$24120171$2$F$20240805$20240808$20240722$20240813$EXP$$CL-PFIZER INC-PV202400084768$PFIZER$$51$YR$$F$Y$$$20240813$$CN$CL$CL
241201723$24120172$3$F$20220701$20240909$20240722$20240910$EXP$$JP-PFIZER INC-PV202400094831$PFIZER$$77$YR$$F$Y$$$20240910$$MD$JP$JP
241201732$24120173$2$F$$20240722$20240722$20240724$EXP$$US-PFIZER INC-PV202300118540$PFIZER$$73$YR$$F$Y$$$20240724$$CN$US$US
241201741$24120174$1$I$20240712$20240718$20240722$20240722$EXP$$CN-PFIZER INC-PV202400094470$PFIZER$$7$YR$$M$Y$23.8$KG$20240722$$HP$CN$CN
241201751$24120175$1$I$20240625$20240718$20240722$20240722$EXP$$DE-PFIZER INC-202400218069$PFIZER$$$$$M$Y$79$KG$20240722$$MD$DE$DE
241201761$24120176$1$I$20240522$20240719$20240722$20240722$EXP$$US-PFIZER INC-202300429204$PFIZER$$86$YR$$F$Y$$$20240722$$CN$US$US
241201771$24120177$1$I$20210101$20240718$20240722$20240722$EXP$$ZA-PFIZER INC-PV202400094276$PFIZER$$26$YR$$F$Y$61$KG$20240722$$MD$ZA$ZA
241201781$24120178$1$I$20240627$20240719$20240722$20240722$EXP$$GB-PFIZER INC-202400219316$PFIZER$$28$YR$$F$Y$$$20240722$$CN$GB$GB
241201791$24120179$1$I$20240708$20240719$20240722$20240722$EXP$$EG-PFIZER INC-PV202400094610$PFIZER$$45$YR$$F$Y$85$KG$20240722$$PH$EG$EG
241201801$24120180$1$I$20240529$20240718$20240722$20240722$EXP$$FR-PFIZER INC-202400218269$PFIZER$$53$YR$$M$Y$90$KG$20240722$$MD$FR$FR
241201812$24120181$2$F$$20240719$20240722$20240724$EXP$$US-PFIZER INC-PV202400095250$PFIZER$$87$YR$$M$Y$$$20240724$$CN$US$US
241201821$24120182$1$I$20240706$20240718$20240722$20240722$EXP$$CN-PFIZER INC-PV202400094417$PFIZER$$67$YR$$M$Y$$$20240722$$HP$CN$CN
241201831$24120183$1$I$$20240718$20240722$20240722$EXP$$IN-PFIZER INC-2020337682$PFIZER$$48$YR$$F$Y$63$KG$20240722$$CN$IN$IN
241201841$24120184$1$I$20240101$20240718$20240722$20240722$EXP$$US-PFIZER INC-202400218805$PFIZER$$67$YR$$F$Y$$$20240722$$HP$US$US
241201851$24120185$1$I$$20240716$20240722$20240722$EXP$NL-LRB-00981518$NL-MYLANLABS-2024M1066332$MYLAN$$64$YR$$M$Y$87$KG$20240722$$PH$NL$NL
241201862$24120186$2$F$20210101$20240806$20240722$20240807$EXP$$IE-MYLANLABS-2024M1038512$MYLAN$$$$$M$Y$$$20240807$$MD$IE$IE
241201872$24120187$2$F$20240607$20240813$20240722$20240816$EXP$$GB-MYLANLABS-2024M1066713$MYLAN$$$$$M$Y$$$20240816$$MD$GB$GB
241201884$24120188$4$F$20240301$20240912$20240722$20240912$EXP$$CA-PFIZER INC-202400219207$PFIZER$$25$YR$$F$Y$$$20240912$$HP$CA$CA
241201891$24120189$1$I$$20240716$20240722$20240722$EXP$$BE-MYLANLABS-2024M1066877$MYLAN$$73$YR$$M$Y$$$20240722$$MD$BE$BE
241201901$24120190$1$I$20240610$20240716$20240722$20240722$EXP$GB-MHRA-MED-202407162119419410-SYKQR$GB-MYLANLABS-2024M1066689$MYLAN$$88$YR$$F$Y$51$KG$20240722$$CN$GB$GB
241201911$24120191$1$I$20240601$20240716$20240722$20240722$EXP$FR-AFSSAPS-AM2024000571$FR-MYLANLABS-2024M1066392$MYLAN$$82$YR$$M$Y$71$KG$20240722$$MD$FR$FR
241201921$24120192$1$I$20240621$20240715$20240722$20240722$PER$$US-ABBVIE-5841523$ABBVIE$$77$YR$$F$Y$63.5$KG$20240719$$CN$US$US
241201931$24120193$1$I$20240101$20240717$20240722$20240722$EXP$$US-ORGANON-O2407USA001788$ORGANON$$$$$F$Y$90.703$KG$20240722$$CN$US$US
241201941$24120194$1$I$$20240715$20240722$20240722$PER$$US-ABBVIE-5842266$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241201954$24120195$4$F$$20240815$20240722$20240816$PER$$NVSC2024US149805$NOVARTIS$$$$$F$Y$$$20240816$$PH$US$US
241201961$24120196$1$I$20240617$20240718$20240722$20240722$PER$$US-BAYER-2024A104922$BAYER$$24$YR$A$F$Y$$$20240722$$MD$US$US
241201971$24120197$1$I$$20240712$20240722$20240722$EXP$SE-SEMPA-2024-005345$SE-TEVA-VS-3221089$TEVA$$55$YR$$F$Y$$$20240722$$CN$SE$SE
241201981$24120198$1$I$20240117$20240715$20240722$20240722$EXP$FR-AFSSAPS-PC2024000572$FR-FreseniusKabi-FK202411257$FRESENIUS KABI$$75$YR$A$F$Y$$$20240722$$HP$FR$FR
241201991$24120199$1$I$$20240715$20240722$20240722$EXP$$DE-FreseniusKabi-FK202411103$FRESENIUS KABI$$$$A$F$Y$65$KG$20240722$$MD$DE$DE
241202001$24120200$1$I$$20240705$20240722$20240722$EXP$$US-CBFLEET-202407-US-002185$CB FLEET$$$$N$M$Y$$$20240722$$CN$US$US
241202012$24120201$2$F$20240603$20240729$20240722$20240805$EXP$$FR-FreseniusKabi-FK202411251$FRESENIUS KABI$$60$YR$A$M$Y$$$20240805$$MD$FR$FR
241202021$24120202$1$I$20201219$20240715$20240722$20240722$EXP$$BR-ORGANON-O2407BRA001414$ORGANON$$87$YR$$F$Y$156$KG$20240722$$CN$BR$BR
241202031$24120203$1$I$$20240716$20240722$20240722$PER$$US-ABBVIE-5845162$ABBVIE$$$$$F$Y$$$20240719$$CN$US$US
241202041$24120204$1$I$20240701$20240720$20240722$20240722$PER$$US-AMGEN-USASP2024144921$AMGEN$$54$YR$A$M$Y$$$20240722$$HP$US$US
241202051$24120205$1$I$$20240718$20240722$20240722$PER$$US-BAYER-2024A105584$BAYER$$$$$M$Y$$$20240722$$CN$US$US
241202061$24120206$1$I$20240101$20240712$20240722$20240722$PER$$US-ABBVIE-5839051$ABBVIE$$$$$$Y$$$20240722$$HP$US$US
241202071$24120207$1$I$$20240716$20240722$20240722$EXP$$US-MYLANLABS-2024M1067258$MYLAN$$$$$F$Y$$$20240722$$HP$US$US
241202081$24120208$1$I$$20240716$20240722$20240722$EXP$$US-MYLANLABS-2024M1067386$MYLAN$$$$$F$Y$$$20240722$$MD$US$US
241202091$24120209$1$I$$20240715$20240722$20240722$EXP$$BR-TAKEDA-2024TUS072591$TAKEDA$$$$$$Y$$$20240722$$CN$BR$BR
241202101$24120210$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115864$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$86.18$KG$20240722$$CN$US$US
241202111$24120211$1$I$$20240712$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-105792$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240722$$MD$JP$JP
241202121$24120212$1$I$20240716$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114207$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240722$$CN$US$US
241202131$24120213$1$I$20240718$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115061$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240722$$PH$US$US
241202151$24120215$1$I$20240702$20240711$20240722$20240722$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407010906$ELI LILLY AND CO$$72$YR$E$F$Y$60$KG$20240722$$CN$DE$CN
241202161$24120216$1$I$20240524$20240716$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010431$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240722$$CN$US$US
241202171$24120217$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012212$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240722$$CN$US$US
241202181$24120218$1$I$20240701$20240716$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010781$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241202191$24120219$1$I$$20240710$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006892$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240722$$CN$US$US
241202201$24120220$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012334$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240722$$HP$US$US
241202211$24120221$1$I$20220727$20240715$20240722$20240722$EXP$$RU-ELI_LILLY_AND_COMPANY-RU202407012592$ELI LILLY AND CO$$$$$M$Y$$$20240722$$MD$RU$RU
241202221$24120222$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013026$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240722$$CN$US$US
241202231$24120223$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407010765$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240722$$CN$US$US
241202242$24120224$2$F$20240101$20240820$20240722$20240823$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407000821AA$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240823$$CN$JP$JP
241202251$24120225$1$I$$20240709$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013057$ELI LILLY AND CO$$24$YR$A$M$Y$$$20240722$$CN$US$US
241202261$24120226$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013300$ELI LILLY AND CO$$9$YR$C$$Y$$$20240722$$CN$US$US
241202271$24120227$1$I$$20240711$20240722$20240722$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407009359$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240722$$CN$JP$JP
241202282$24120228$2$F$$20240815$20240722$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011151$ELI LILLY AND CO$$39$YR$A$F$Y$65$KG$20240828$$CN$US$US
241202301$24120230$1$I$20240613$20240711$20240722$20240722$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407012296$ELI LILLY AND CO$$68$YR$E$M$Y$64$KG$20240722$$CN$DE$CN
241202311$24120231$1$I$20240601$20240715$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010436$ELI LILLY AND CO$$$$$M$Y$$$20240722$$CN$US$US
241202321$24120232$1$I$20240715$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013128$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240722$$CN$US$US
241202331$24120233$1$I$$20240710$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006904$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241202341$24120234$1$I$20240601$20240710$20240722$20240722$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407008029$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$KR$KR
241202351$24120235$1$I$$20240708$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007344$ELI LILLY AND CO$$$$$$Y$$$20240722$$CN$US$US
241202361$24120236$1$I$20240708$20240716$20240722$20240722$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407012495$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240722$$CN$DE$CN
241202371$24120237$1$I$20220901$20240715$20240722$20240722$EXP$$RU-ELI_LILLY_AND_COMPANY-RU202407012432$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240722$$CN$RU$RU
241202381$24120238$1$I$20240201$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012359$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240722$$HP$US$US
241202391$24120239$1$I$$20240716$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010547$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240722$$HP$US$US
241202401$24120240$1$I$20180101$20240710$20240722$20240722$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202401007106$ELI LILLY AND CO$$72$YR$E$F$Y$60$KG$20240722$$CN$CN$CN
241202411$24120241$1$I$$20240708$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006402$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241202421$24120242$1$I$20240501$20240711$20240722$20240722$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407007136$ELI LILLY AND CO$$86$YR$E$F$Y$$$20240722$$CN$DE$DE
241202431$24120243$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013027$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241202441$24120244$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012083$ELI LILLY AND CO$$$$$$Y$$$20240722$$CN$US$US
241202454$24120245$4$F$20240503$20240801$20240722$20240806$EXP$$AU-PFIZER INC-PV202400094073$PFIZER$$75$YR$$F$Y$52$KG$20240806$$HP$AU$AU
241202463$24120246$3$F$20240716$20240827$20240722$20240827$PER$$US-AMGEN-USASP2024142768$AMGEN$$70$YR$E$F$Y$$$20240827$$MD$US$US
241202471$24120247$1$I$$20240709$20240722$20240722$PER$$US-JNJFOC-20240752813$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$PH$US$US
241202482$24120248$2$F$20240711$20240717$20240722$20240723$PER$$US-BAYER-2024A105854$BAYER$$21$YR$A$F$Y$$$20240723$$MD$US$US
241202491$24120249$1$I$$20240709$20240722$20240722$PER$$US-JNJFOC-20240752791$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
241202501$24120250$1$I$$20240716$20240722$20240722$EXP$$AU-MYLANLABS-2024M1067436$MYLAN$Mellor R, Girgis CM, Rodrigues A, Chen C, Cuan S, Gambhir P, et al. Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer. Curr-Oncol 2024; 31 (2): 828-838.$$$$M$Y$$$20240722$$HP$AU$AU
241202511$24120251$1$I$$20240715$20240722$20240722$PER$$US-ABBVIE-5841916$ABBVIE$$$$$$Y$$$20240722$$CN$US$US
241202521$24120252$1$I$20240704$20240715$20240722$20240722$PER$$US-Vifor (International) Inc.-VIT-2024-06319$VIFOR$$49$YR$$M$Y$64.5$KG$20240722$$HP$US$US
241202531$24120253$1$I$$20240721$20240722$20240722$EXP$$AU-GILEAD-2024-0681419$GILEAD$$$$E$M$Y$$$20240722$$HP$AU$AU
241202541$24120254$1$I$$20240716$20240722$20240722$EXP$$CA-ABBVIE-5847033$ABBVIE$$15$YR$$F$Y$$$20240722$$CN$CA$CA
241202551$24120255$1$I$20200930$20201023$20240722$20240722$EXP$$US-AstraZeneca-2020SF30606$ASTRAZENECA$$25476$DY$$F$Y$60.8$KG$20240722$$HP$US$
241202561$24120256$1$I$20200203$20200804$20240722$20240722$EXP$$CN-AstraZeneca-2020SF00550$ASTRAZENECA$$24268$DY$$M$Y$$$20240722$$CN$CN$
241202571$24120257$1$I$$20201105$20240722$20240722$EXP$$US-AstraZeneca-2020SF48594$ASTRAZENECA$$51$YR$$F$Y$$$20240722$$CN$US$
241202581$24120258$1$I$$20210324$20240722$20240722$EXP$$US-AstraZeneca-2021A230612$ASTRAZENECA$$$$$M$Y$68$KG$20240722$$CN$US$
241202591$24120259$1$I$$20200901$20240722$20240722$EXP$$US-AstraZeneca-2020SF12463$ASTRAZENECA$$68$YR$$M$Y$$$20240722$$CN$US$
241202601$24120260$1$I$$20240709$20240722$20240722$PER$$US-JNJFOC-20240752790$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$PH$US$US
241202611$24120261$1$I$$20240718$20240722$20240722$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-115499$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240722$$CN$DE$DE
241202621$24120262$1$I$$20240712$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111863$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$72.12$KG$20240722$$HP$US$US
241202631$24120263$1$I$20240101$20240708$20240722$20240722$EXP$$US-UCBSA-2024034992$UCB$$19$YR$$M$Y$$$20240722$$CN$US$US
241202641$24120264$1$I$20240627$20240715$20240722$20240722$EXP$FR-AFSSAPS-AM2024000555$FR-FreseniusKabi-FK202411249$FRESENIUS KABI$$35$YR$A$F$Y$80$KG$20240722$$MD$FR$FR
241202653$24120265$3$F$$20240822$20240722$20240830$PER$$US-VERTEX PHARMACEUTICALS-2024-011515$VERTEX$$$$$$Y$$$20240830$$CN$US$US
241202661$24120266$1$I$20240708$20240710$20240722$20240722$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011496$VERTEX$$$$A$M$Y$$$20240722$$CN$GB$GB
241202671$24120267$1$I$$20240710$20240722$20240722$EXP$$FR-VERTEX PHARMACEUTICALS-2024-011585$VERTEX$$$$$M$Y$$$20240722$$HP$FR$FR
241202681$24120268$1$I$$20240708$20240722$20240722$PER$$US-ROCHE-10000026765$ROCHE$$$$$F$Y$$$20240722$$MD$US$US
241202691$24120269$1$I$$20240712$20240722$20240722$EXP$$US-VERTEX PHARMACEUTICALS-2024-011740$VERTEX$$4$YR$$F$Y$$$20240722$$CN$US$DE
241202701$24120270$1$I$$20240712$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011723$VERTEX$$$$$M$Y$$$20240722$$CN$US$US
241202711$24120271$1$I$$20240712$20240722$20240722$EXP$$US-VERTEX PHARMACEUTICALS-2024-011751$VERTEX$$$$$F$Y$$$20240722$$CN$US$US
241202721$24120272$1$I$$20240710$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011513$VERTEX$$$$$$Y$$$20240722$$CN$US$US
241202731$24120273$1$I$$20240712$20240722$20240722$EXP$$US-VERTEX PHARMACEUTICALS-2024-011748$VERTEX$$$$T$F$Y$$$20240722$$CN$US$US
241202742$24120274$2$F$$20240715$20240722$20240725$PER$$US-MYLANLABS-2024M1066488$MYLAN$$$$$F$Y$$$20240725$$HP$US$US
241202752$24120275$2$F$20240701$20240718$20240722$20240725$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006292$AURINIA PHARMACEUTICALS$$52$YR$$F$Y$$$20240725$$CN$US$US
241202761$24120276$1$I$20230501$20240716$20240722$20240722$EXP$$MY-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035881$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240722$$PH$MY$MY
241202771$24120277$1$I$$20240711$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011636$VERTEX$$$$C$$Y$$$20240722$$HP$US$US
241202781$24120278$1$I$$20240712$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011726$VERTEX$$$$$M$Y$$$20240722$$CN$US$US
241202791$24120279$1$I$$20240710$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011628$VERTEX$$5$YR$$M$Y$$$20240722$$CN$US$US
241202801$24120280$1$I$$20240712$20240722$20240722$EXP$$US-VERTEX PHARMACEUTICALS-2024-011796$VERTEX$$$$$F$Y$$$20240722$$CN$US$US
241202821$24120282$1$I$$20240711$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011685$VERTEX$$$$C$$Y$$$20240722$$HP$US$US
241202831$24120283$1$I$$20240712$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011731$VERTEX$$$$$F$Y$$$20240722$$CN$US$US
241202841$24120284$1$I$$20240711$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011687$VERTEX$$$$C$$Y$$$20240722$$HP$US$US
241202851$24120285$1$I$$20240712$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011725$VERTEX$$2$YR$$$Y$$$20240722$$CN$US$US
241202861$24120286$1$I$$20240712$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011787$VERTEX$$$$T$M$Y$$$20240722$$CN$US$US
241202872$24120287$2$F$$20240809$20240722$20240814$PER$$US-VERTEX PHARMACEUTICALS-2024-000318$VERTEX$$$$$F$Y$$$20240814$$CN$US$US
241202881$24120288$1$I$$20240712$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011724$VERTEX$$2$YR$$$Y$$$20240722$$CN$US$US
241202891$24120289$1$I$$20240712$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011695$VERTEX$$$$$F$Y$$$20240722$$CN$US$US
241202901$24120290$1$I$$20240712$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011713$VERTEX$$$$$F$Y$$$20240722$$CN$US$US
241202912$24120291$2$F$$20240904$20240722$20240913$PER$$US-VERTEX PHARMACEUTICALS-2024-011789$VERTEX$$$$$$Y$$$20240913$$CN$GB$GB
241202921$24120292$1$I$$20240716$20240716$20240716$DIR$710352$$FDA-CTU$$$$$M$N$$$20240716$N$CN$US$
241202931$24120293$1$I$20240619$20240709$20240718$20240718$DIR$FDA-CDER-CTU-2024-50114$$FDA-CTU$$$$$$N$$$20240709$N$$US$
241202942$24120294$2$F$20240703$20240723$20240722$20240805$PER$$US-Calliditas-2024CAL01285$CALLIDITAS THERAPEUTICS$$71$YR$E$M$Y$143.9$KG$20240805$$CN$US$US
241202951$24120295$1$I$$20240718$20240722$20240722$EXP$GB-MHRA-MED-202407180940550910-ZYRGB$GB-ABBVIE-5848213$ABBVIE$$28$YR$$M$Y$$$20240722$$CN$GB$GB
241202961$24120296$1$I$20240715$20240718$20240722$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011053$JAZZ$$12$YR$$F$Y$$$20240722$$CN$US$US
241202971$24120297$1$I$$20240712$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011810$VERTEX$$44$YR$$M$Y$$$20240722$$CN$US$US
241202981$24120298$1$I$$20240715$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011821$VERTEX$$$$A$$Y$$$20240722$$CN$US$US
241202991$24120299$1$I$20240101$20240716$20240722$20240722$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011883$VERTEX$$$$A$M$Y$$$20240722$$CN$GB$GB
241203001$24120300$1$I$$20240716$20240722$20240722$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040004$BOEHRINGER INGELHEIM$Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case- series. Journal of the European Academy of Dermatology + Venereology. 2023;doi:10.1111/jdv.19678.$$$$$Y$$$20240722$$HP$IT$IT
241203011$24120301$1$I$$20240708$20240722$20240722$EXP$$PL-MEITHEAL-2024MPLIT00214$MEITHEAL PHARMACEUTICALS$Majowicz D, et al..Haemophagocytic lymphohistiocytosis: case series. Serum ferritin level as an indicator of treatment effectiveness.Hematology in Clinical Practice.2022;13 (3-4):130-7$31$YR$A$M$Y$$$20240719$$HP$PL$PL
241203021$24120302$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115869$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$47.63$KG$20240722$$CN$US$US
241203031$24120303$1$I$20240718$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115901$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240722$$CN$US$US
241203041$24120304$1$I$$20240708$20240722$20240722$EXP$$US-MEITHEAL-2024MPLIT00215$MEITHEAL PHARMACEUTICALS$Ravi S, et al.Acute Respiratory Compromise in the Context of COVID-19 and Gemcitabine.American Journal of Respiratory and Critical Care Medicine.may-2024;209$48$YR$A$F$Y$$$20240719$$HP$US$US
241203051$24120305$1$I$$20240708$20240722$20240722$EXP$$GB-MEITHEAL-2024MPLIT00217$MEITHEAL PHARMACEUTICALS$Gent DG, et al.Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights.Case Reports in Oncology.08-NOV-2022;15 (3):950-9$50$YR$A$M$Y$$$20240719$$HP$GB$GB
241203061$24120306$1$I$20240714$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024143007$AMGEN$$66$YR$E$F$Y$$$20240722$$CN$US$US
241203071$24120307$1$I$20240709$20240716$20240722$20240722$EXP$$NVSC2024CN148829$NOVARTIS$$80$YR$$M$Y$67$KG$20240722$$HP$CN$CN
241203081$24120308$1$I$$20240716$20240722$20240722$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-136667$DAIICHI$$40$YR$$F$Y$$$20240722$$HP$CA$CA
241203091$24120309$1$I$20180501$20240711$20240722$20240722$PER$$US-BIOGEN-2024BI01273501$BIOGEN$$19$YR$$F$Y$$$20240722$$CN$US$US
241203101$24120310$1$I$$20240708$20240722$20240722$EXP$$JP-MEITHEAL-2024MPLIT00216$MEITHEAL PHARMACEUTICALS$Ishibashi Y, et al..Pyothorax and Constrictive Pericarditis after Chemoradiotherapy for Esophageal Cancer.Internal Medicine.JAN-2024;63 (10):1387-93$75$YR$E$M$Y$59$KG$20240719$$MD$JP$JP
241203111$24120311$1$I$20240101$20240719$20240722$20240722$EXP$FR-AFSSAPS-RN2024000763$FR-JNJFOC-20240755457$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240722$$MD$FR$FR
241203123$24120312$3$F$$20240718$20240722$20240724$EXP$$US-LUNDBECK-DKLU4000346$LUNDBECK$$$$$$Y$$$20240724$$CN$US$US
241203131$24120313$1$I$$20240719$20240722$20240722$EXP$$GB-JNJFOC-20240752832$JOHNSON AND JOHNSON$$5$YR$C$M$Y$18$KG$20240722$$MD$GB$GB
241203141$24120314$1$I$$20240716$20240722$20240722$EXP$$US-JNJFOC-20240744766$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240722$$HP$US$US
241203151$24120315$1$I$$20240717$20240722$20240722$EXP$$US-JNJFOC-20240744932$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
241203161$24120316$1$I$$20240716$20240722$20240722$EXP$$US-JNJFOC-20240743731$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240722$$HP$US$US
241203171$24120317$1$I$20240101$20240716$20240722$20240722$EXP$$US-JNJFOC-20240744347$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240722$$HP$US$US
241203181$24120318$1$I$$20240717$20240722$20240722$EXP$$FR-JNJFOC-20240752872$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240722$$PH$FR$FR
241203191$24120319$1$I$20240301$20240709$20240722$20240722$PER$$US-JNJFOC-20240752814$JOHNSON AND JOHNSON$$$$$F$Y$$$20240721$$HP$US$US
241203201$24120320$1$I$20240101$20240716$20240722$20240722$EXP$$US-JNJFOC-20240744450$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240722$$HP$US$US
241203213$24120321$3$F$20240624$20240816$20240722$20240824$30DAY$$CH-JNJFOC-20240678494$JOHNSON AND JOHNSON$$$$$F$Y$$$20240824$$CN$CH$CH
241203221$24120322$1$I$$20240715$20240722$20240722$EXP$$US-JNJFOC-20240738852$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
241203232$24120323$2$F$20240601$20240729$20240722$20240803$EXP$$TW-JNJFOC-20240738342$JOHNSON AND JOHNSON$$40$YR$A$F$Y$65$KG$20240803$$CN$TW$TW
241203241$24120324$1$I$$20240718$20240722$20240722$PER$$US-JNJFOC-20240750841$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$HP$US$US
241203251$24120325$1$I$$20240709$20240722$20240722$PER$$US-JNJFOC-20240752795$JOHNSON AND JOHNSON$$$$$F$Y$$$20240721$$PH$US$US
241203261$24120326$1$I$20240531$20240703$20240718$20240718$DIR$FDA-CDER-CTU-2024-50118$$FDA-CTU$$63$YR$$F$N$180$LBS$20240703$N$CN$US$
241203271$24120327$1$I$20240601$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50117$$FDA-CTU$$$$$M$N$225$LBS$20240722$Y$CN$US$
241203281$24120328$1$I$$20240717$20240722$20240722$EXP$$MX-JNJFOC-20240749751$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$MD$MX$MX
241203293$24120329$3$F$20240625$20240731$20240722$20240806$30DAY$$US-JNJFOC-20240749265$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240806$$CN$US$US
241203301$24120330$1$I$20231223$20240715$20240722$20240722$EXP$$AR-JNJFOC-20240129562$JOHNSON AND JOHNSON$$54$YR$A$F$Y$78$KG$20240721$$CN$AR$AR
241203321$24120332$1$I$$20240705$20240722$20240722$PER$$US-JNJFOC-20240718115$JOHNSON AND JOHNSON$$$$$F$Y$$$20240721$$CN$US$US
241203331$24120333$1$I$$20240711$20240722$20240722$PER$$US-JNJFOC-20240752802$JOHNSON AND JOHNSON$$$$$$Y$$$20240721$$MD$US$US
241203341$24120334$1$I$$20240718$20240722$20240722$PER$$US-JNJFOC-20240749611$JOHNSON AND JOHNSON$$$$$F$Y$$$20240721$$CN$US$US
241203351$24120335$1$I$$20240718$20240722$20240722$PER$$US-JNJFOC-20240752170$JOHNSON AND JOHNSON$$$$$$Y$$$20240721$$HP$US$US
241203362$24120336$2$F$$20240710$20240722$20240723$EXP$$US-JNJFOC-20240749676$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$71.3$KG$20240723$$MD$US$US
241203382$24120338$2$F$$20240729$20240722$20240731$EXP$$US-JNJFOC-20240743107$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$HP$US$US
241203391$24120339$1$I$$20240711$20240722$20240722$PER$$US-JNJFOC-20240752796$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240721$$HP$US$US
241203401$24120340$1$I$20240101$20240719$20240722$20240722$PER$$US-JNJFOC-20240752711$JOHNSON AND JOHNSON$$$$$F$Y$$$20240721$$CN$US$US
241203413$24120341$3$F$$20240814$20240722$20240821$30DAY$$NL-JNJFOC-20240713929$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$PH$NL$NL
241203422$24120342$2$F$$20240730$20240722$20240821$30DAY$$AU-JNJFOC-20240710500$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$AU$AU
241203431$24120343$1$I$20230401$20240710$20240722$20240722$PER$$US-JNJFOC-20240728718$JOHNSON AND JOHNSON$$$$$$Y$$$20240721$$CN$US$US
241203441$24120344$1$I$20240301$20240710$20240722$20240722$PER$$US-JNJFOC-20240728513$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240721$$CN$US$US
241203451$24120345$1$I$$20240715$20240722$20240722$EXP$$CA-JNJFOC-20240748837$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240721$$CN$CA$CA
241203462$24120346$2$F$20240101$20240701$20240722$20240723$PER$$US-JNJFOC-20240703795$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240723$$CN$US$US
241203471$24120347$1$I$$20240718$20240722$20240722$PER$$US-JNJFOC-20240752090$JOHNSON AND JOHNSON$$$$$$Y$$$20240721$$HP$US$US
241203481$24120348$1$I$$20240718$20240722$20240722$PER$$US-JNJFOC-20240752188$JOHNSON AND JOHNSON$$$$$$Y$$$20240721$$MD$US$US
241203491$24120349$1$I$$20240718$20240722$20240722$PER$$US-JNJFOC-20240752111$JOHNSON AND JOHNSON$$$$$F$Y$$$20240721$$HP$US$US
241203501$24120350$1$I$20240510$20240715$20240722$20240722$EXP$$RU-JNJFOC-20240741713$JOHNSON AND JOHNSON$$10$YR$C$F$Y$$$20240721$$HP$RU$RU
241203511$24120351$1$I$$20240712$20240722$20240722$EXP$$US-JNJFOC-20240737310$JOHNSON AND JOHNSON$$$$$$Y$$$20240721$$CN$US$US
241203522$24120352$2$F$20240314$20240926$20240722$20240930$EXP$$CA-JNJFOC-20240625735$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240930$$HP$CA$CA
241203531$24120353$1$I$20240716$20240717$20240722$20240722$PER$$US-JNJFOC-20240746358$JOHNSON AND JOHNSON$$57$YR$A$$Y$$$20240721$$PH$US$US
241203545$24120354$5$F$20240715$20240823$20240722$20240829$30DAY$$US-JNJFOC-20240741796$JOHNSON AND JOHNSON$$49$YR$A$M$Y$94.432$KG$20240829$$CN$US$US
241203553$24120355$3$F$$20240904$20240722$20240916$EXP$$JP-JNJFOC-20240748982$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240916$$PH$JP$JP
241203561$24120356$1$I$$20240628$20240722$20240722$PER$$US-JNJFOC-20240700382$JOHNSON AND JOHNSON$$$$$$Y$$$20240721$$CN$US$US
241203572$24120357$2$F$20240717$20240827$20240722$20240902$PER$$US-JNJFOC-20240746542$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240902$$PH$US$US
241203581$24120358$1$I$$20240628$20240722$20240722$PER$$US-JNJFOC-20240700741$JOHNSON AND JOHNSON$$$$$$Y$$$20240721$$CN$US$US
241203592$24120359$2$F$$20240628$20240722$20240723$PER$$US-JNJFOC-20240703387$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$US$US
241203601$24120360$1$I$$20240708$20240722$20240722$EXP$$US-MEITHEAL-2024MPLIT00210$MEITHEAL PHARMACEUTICALS$Gualano FM, et al.Embryonal tumor with multilayered rosettes: Post-treatment maturation and implications for future therapy.Cancer Reports.MAY-2023;6(No. 5):1-7$5$MON$N$F$Y$$$20240722$$HP$US$US
241203612$24120361$2$F$$20240828$20240722$20240906$EXP$$GB-TEVA-VS-3141205$TEVA$Vakrinou A, Bellampalli R, Gulcebi MI, Martins Custodio H, Research Consortium GE, Balestrini S, et al. Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in clinical practice. J-Neurol-Neurosurg-Psychiatry 2023; 94 887-892.; Vakrinou A, Bellampalli R, Gulcebi MI, Martins Custodio H, Research Consortium GE, Balestrini S, et al. Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in...$$$$M$Y$$$20240906$$HP$GB$GB
241203631$24120363$1$I$20240323$20240712$20240722$20240722$EXP$FR-AFSSAPS-TO2024001222$FR-TEVA-VS-3221130$TEVA$$52$YR$$M$Y$84$KG$20240722$$PH$FR$FR
241203641$24120364$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089632$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241203651$24120365$1$I$20240711$20240711$20240722$20240722$EXP$$US-TEVA-VS-3221681$TEVA$$30$YR$$F$Y$$$20240722$$HP$US$US
241203661$24120366$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089614$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241203671$24120367$1$I$20240706$20240709$20240722$20240722$EXP$$US-RECORDATI RARE DISEASE INC.-2024005301$RECORDATI$$$$$$Y$$$20240722$$CN$US$US
241203681$24120368$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218888$PFIZER$$56$YR$$M$Y$$$20240722$$HP$US$US
241203691$24120369$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218909$PFIZER$$67$YR$$M$Y$$$20240722$$HP$US$US
241203701$24120370$1$I$20240707$20240716$20240722$20240722$EXP$$US-BAYER-2024A104056$BAYER$$37$YR$A$M$Y$$$20240722$$CN$US$US
241203711$24120371$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218935$PFIZER$$69$YR$$F$Y$$$20240722$$HP$US$US
241203721$24120372$1$I$20240611$20240715$20240722$20240722$EXP$$US-BIOGEN-2024BI01274038$BIOGEN$$59$YR$$F$Y$$$20240722$$CN$US$US
241203731$24120373$1$I$20240712$20240716$20240722$20240722$EXP$$US-BIOGEN-2024BI01274107$BIOGEN$$19$YR$$F$Y$$$20240722$$CN$US$US
241203742$24120374$2$F$$20240910$20240722$20240916$EXP$$CZ-BIOGEN-2024BI01274101$BIOGEN$$50$YR$$F$Y$$$20240916$$MD$CZ$CZ
241203751$24120375$1$I$$20240709$20240722$20240722$EXP$$JP-ORPHANEU-2024005400$RECORDATI$Case of acute-onset propionic acidaemia with rhabdomyolysis$$$$$Y$$$20240722$$MD$JP$JP
241203761$24120376$1$I$20181004$20240716$20240722$20240722$EXP$FR-AFSSAPS-AM2024000569$FR-ORGANON-O2407FRA001901$ORGANON$$67$YR$$F$Y$60$KG$20240722$$MD$FR$FR
241203771$24120377$1$I$20240527$20240715$20240722$20240722$EXP$ES-AEMPS-1547338$ES-FreseniusKabi-FK202411185$FRESENIUS KABI$$53$YR$A$F$Y$$$20240722$$MD$ES$ES
241203781$24120378$1$I$20240515$20240715$20240722$20240722$EXP$FR-AFSSAPS-MA2024000987$FR-FreseniusKabi-FK202411264$FRESENIUS KABI$$56$YR$A$M$Y$$$20240722$$MD$FR$FR
241203791$24120379$1$I$$20240711$20240722$20240722$EXP$$DE-RDY-LIT/DEU/24/0010378$DR REDDYS$Hans FP, Benning L, Pooth J, Busch H. A potentially lifesaving error: unintentional high-dose adrenaline administration in anaphylaxis-induced cardiac arrest; a case report. International Journal of Emergency Medicine. 17(1): doi:10.1186/s12245-024-00663-9.$66$YR$E$F$Y$$$20240722$$HP$DE$DE
241203802$24120380$2$F$$20240716$20240722$20240725$EXP$$NVSC2024RU145407$NOVARTIS$Teremov DD, Rumyantsev VA. Management strategy of a periodontist in treating a patient with bisphosphonate- related jaw osteonecrosis: a clinical case [??????? ????????????? ??? ??????? ???????? ? ????????????? ???????,  ????????? ?? ???? ?????? ?????????????: ??????????? ??????]. PARODONTOLOGIYA. 2024;29(2):163-9$48$YR$$F$Y$$$20240725$$HP$RU$RU
241203811$24120381$1$I$20240623$20240709$20240722$20240722$EXP$$US-THE RITEDOSE CORPORATION-2024RIT000092$THE RITEDOSE CORP$$$$$$Y$$$20240718$$CN$US$US
241203822$24120382$2$F$$20240823$20240722$20240902$EXP$$TR-TEVA-VS-3220090$TEVA$Kayabasi M, Ayhan Z, Lebe B, Ozkutuk AA, Soylev Bajin M, Nazli A, et al. Endogenous Endophthalmitis Caused by Aspergillus lentulus in an Immunocompromised Patient with Lung Cancer. Turk-J-Ophthalmol 2024; 54 (3): 175-179.; Kayabasi M, Ayhan Z, Lebe B, Ozkutuk AA, Soylev Bajin M, Nazli A, et al. Endogenous Endophthalmitis Caused by Aspergillus lentulus in an Immunocompromised Patient with Lung Cancer. Turk-J-Ophthalmol 2024; 54 (3): 175-179.; Kayabasi M, Ayhan Z, Lebe B, Ozkutuk AA, Soylev Baj...$78$YR$$M$Y$$$20240902$$HP$TR$TR
241203831$24120383$1$I$$20240715$20240722$20240722$EXP$NL-LRB-00981767$NL-UCBSA-2024035720$UCB$$26$YR$$F$Y$68$KG$20240722$$CN$NL$NL
241203841$24120384$1$I$$20200810$20240722$20240722$EXP$$US-AstraZeneca-2020SF03029$ASTRAZENECA$$$$$M$Y$$$20240722$$HP$US$
241203851$24120385$1$I$20200315$20200323$20240722$20240722$EXP$$CA-AstraZeneca-2020SE42913$ASTRAZENECA$$25315$DY$$F$Y$$$20240722$$CN$CA$
241203861$24120386$1$I$$20201012$20240722$20240722$EXP$$GB-AstraZeneca-2020SF33710$ASTRAZENECA$$$$$M$Y$$$20240722$$HP$GB$
241203871$24120387$1$I$$20191118$20240722$20240722$EXP$$US-AstraZeneca-2019SF66459$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241203881$24120388$1$I$$20201026$20240722$20240722$EXP$$US-AstraZeneca-2020SF42568$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241203891$24120389$1$I$$20210323$20240722$20240722$EXP$$US-AstraZeneca-2021A224698$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241203901$24120390$1$I$20190101$20201022$20240722$20240722$EXP$$US-AstraZeneca-2020SF39644$ASTRAZENECA$$47$YR$$M$Y$99.8$KG$20240722$$CN$US$
241203921$24120392$1$I$20201229$20210113$20240722$20240722$EXP$$US-AstraZeneca-2021A006341$ASTRAZENECA$$22375$DY$$M$Y$83.9$KG$20240722$$CN$US$
241203931$24120393$1$I$$20230622$20240722$20240722$EXP$$US-AstraZeneca-2023A145224$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241203941$24120394$1$I$$20201105$20240722$20240722$EXP$$US-AstraZeneca-2020SF47507$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241203951$24120395$1$I$$20240709$20240722$20240722$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202407008356$ELI LILLY AND CO$Maertens, Leonore; Pollet, Naomi; Clarysse, Marta; Vanderbeke, Lore; Verhaert, Nicolas; Desloovere, Christian; Loos, Elke.Severely complicated ear infection in a patient treated with ixekizumab: a case report.Eur Arch Otorhinolaryngol 2024;:.DOI:10.1007/s00405-024-08779-7$35$YR$A$M$Y$$$20240722$$HP$BE$BE
241203961$24120396$1$I$20240515$20240710$20240722$20240722$EXP$IT-MINISAL02-994395$IT-ELI_LILLY_AND_COMPANY-IT202407007541$ELI LILLY AND CO$$29$YR$A$M$Y$77$KG$20240722$$CN$IT$IT
241203971$24120397$1$I$20240704$20240712$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009320$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240722$$CN$US$US
241203981$24120398$1$I$$20240711$20240722$20240722$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407012434$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240722$$CN$DE$JP
241203991$24120399$1$I$$20240710$20240722$20240722$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202407008870$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$BE$BE
241204001$24120400$1$I$20240617$20240710$20240722$20240722$EXP$FR-AFSSAPS-MP2024001127$FR-ELI_LILLY_AND_COMPANY-FR202407008174$ELI LILLY AND CO$$86$YR$E$F$Y$65$KG$20240722$$CN$FR$FR
241204011$24120401$1$I$20190429$20240205$20240722$20240722$EXP$$GB-TEVA-201910_00008000$TEVA$$69$YR$$M$Y$69.85$KG$20240722$$CN$GB$GB
241204022$24120402$2$F$20240718$20240812$20240722$20240815$PER$$US-ABBVIE-5846076$ABBVIE$$59$YR$$F$Y$58$KG$20240815$$HP$US$US
241204031$24120403$1$I$20240101$20240716$20240722$20240722$PER$$US-PFIZER INC-202400216422$PFIZER$$61$YR$$F$Y$95.25$KG$20240722$$CN$US$US
241204041$24120404$1$I$20240601$20240716$20240722$20240722$PER$$US-PFIZER INC-202400217353$PFIZER$$20$YR$$M$Y$70.31$KG$20240722$$CN$US$US
241204051$24120405$1$I$$20240716$20240722$20240722$PER$$US-PFIZER INC-202400216226$PFIZER$$$$$F$Y$$$20240722$$CN$US$US
241204063$24120406$3$F$20240630$20240821$20240722$20240823$PER$$US-PFIZER INC-PV202400077748$PFIZER$$64$YR$$F$Y$89.161$KG$20240823$$HP$US$US
241204071$24120407$1$I$$20240716$20240722$20240722$PER$$US-PFIZER INC-PV202400093796$PFIZER$$71$YR$$M$Y$$$20240722$$CN$US$US
241204081$24120408$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400094283$PFIZER$$64$YR$$F$Y$$$20240722$$CN$US$US
241204091$24120409$1$I$$20240716$20240722$20240722$PER$$US-PFIZER INC-202400217735$PFIZER$$64$YR$$F$Y$$$20240722$$HP$US$US
241204101$24120410$1$I$$20240716$20240722$20240722$PER$$US-PFIZER INC-202400217921$PFIZER$$68$YR$$F$Y$$$20240722$$HP$US$US
241204112$24120411$2$F$$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400094128$PFIZER$$65$YR$$F$Y$$$20240722$$HP$US$US
241204122$24120412$2$F$$20240821$20240722$20240822$EXP$$CA-ORGANON-O2407CAN001544$ORGANON$$44$YR$$F$Y$70$KG$20240822$$HP$CA$CA
241204131$24120413$1$I$$20240718$20240722$20240722$EXP$$US-UCBSA-2024036631$UCB$$$$$F$Y$$$20240722$$CN$US$US
241204151$24120415$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024141921$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241204164$24120416$4$F$$20240913$20240722$20240919$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-005942$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
241204172$24120417$2$F$20240628$20240723$20240722$20240819$PER$$FR-TOLMAR, INC.-24FR050685$TOLMAR$$$$E$M$Y$$$20240819$$PH$FR$FR
241204183$24120418$3$F$20240627$20240814$20240722$20240909$PER$$FR-TOLMAR, INC.-24FR050652$TOLMAR$$85$YR$$M$Y$$$20240909$$PH$FR$FR
241204191$24120419$1$I$20220101$20240626$20240722$20240722$PER$$GT-TOLMAR, INC.-24GT050190$TOLMAR$$$$$M$Y$$$20240718$$CN$GT$GT
241204202$24120420$2$F$$20240723$20240722$20240819$PER$$IT-TOLMAR, INC.-24IT050556$TOLMAR$$$$$M$Y$$$20240819$$CN$IT$IT
241204212$24120421$2$F$20200101$20240731$20240722$20240826$PER$$GT-TOLMAR, INC.-24GT050608$TOLMAR$$$$$M$Y$$$20240826$$CN$GT$GT
241204221$24120422$1$I$20240529$20240628$20240722$20240722$PER$$NL-TOLMAR, INC.-24NL050662$TOLMAR$$81$YR$$M$Y$$$20240718$$CN$NL$NL
241204231$24120423$1$I$20240301$20240627$20240722$20240722$PER$$SV-TOLMAR, INC.-24SV050610$TOLMAR$$84$YR$$M$Y$$$20240718$$CN$SV$SV
241204242$24120424$2$F$$20240802$20240722$20240827$PER$$US-TOLMAR, INC.-24US050313$TOLMAR$$$$$M$Y$$$20240827$$PH$US$US
241204253$24120425$3$F$20240626$20240906$20240722$20240926$PER$$US-TOLMAR, INC.-24US050567$TOLMAR$$77$YR$$M$Y$$$20240926$$PH$US$US
241204262$24120426$2$F$20240116$20240815$20240722$20240906$PER$$US-TOLMAR, INC.-24US050668$TOLMAR$$$$$M$Y$$$20240906$$HP$US$US
241204272$24120427$2$F$20240528$20240814$20240722$20240906$PER$$US-TOLMAR, INC.-24US050670$TOLMAR$$67$YR$$M$Y$$$20240906$$HP$US$US
241204281$24120428$1$I$20240621$20240701$20240722$20240722$PER$$US-TOLMAR, INC.-24US050676$TOLMAR$$$$$M$Y$$$20240718$$HP$US$US
241204292$24120429$2$F$20240628$20240812$20240722$20240830$PER$$US-TOLMAR, INC.-24US050691$TOLMAR$$$$$M$Y$$$20240830$$HP$US$US
241204301$24120430$1$I$$20240712$20240722$20240722$PER$$US-ROCHE-10000025861$ROCHE$$$$$$Y$$$20240722$$PH$US$US
241204311$24120431$1$I$20240712$20240717$20240722$20240722$EXP$$NVSC2024CN148950$NOVARTIS$$64$YR$$F$Y$46$KG$20240722$$HP$CN$CN
241204321$24120432$1$I$$20240715$20240722$20240722$PER$$US-ABBVIE-5847561$ABBVIE$$$$$$Y$$$20240722$$HP$US$US
241204331$24120433$1$I$$20240623$20240722$20240722$30DAY$$US-VEROBIOTECH-2024USVEROSPO00148$VERO BIOTECH$$$$N$F$Y$$$20240722$$HP$US$US
241204341$24120434$1$I$20240717$20240719$20240722$20240722$EXP$$CN-BAYER-2024A105723$BAYER$$75$YR$E$F$Y$50$KG$20240722$$HP$CN$CN
241204351$24120435$1$I$$20240716$20240722$20240722$PER$$US-TAKEDA-2024TUS072557$TAKEDA$$$$$F$Y$67$KG$20240722$$MD$US$US
241204361$24120436$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116135$BRISTOL MYERS SQUIBB$$76$YR$E$$Y$$$20240722$$CN$US$US
241204371$24120437$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114617$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240722$$HP$US$US
241204381$24120438$1$I$$20240715$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113285$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240722$$CN$US$US
241204391$24120439$1$I$$20240712$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115616$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240722$$CN$US$US
241204401$24120440$1$I$$20240717$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159280$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241204411$24120441$1$I$$20240716$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159241$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241204421$24120442$1$I$$20240717$20240722$20240722$EXP$$US-BIOMARINAP-US-2024-159279$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241204431$24120443$1$I$$20240712$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159217$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241204441$24120444$1$I$20240701$20240718$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159284$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241204451$24120445$1$I$20240701$20240716$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159262$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241204464$24120446$4$F$20230404$20240807$20240722$20240808$30DAY$$US-UCBSA-2024018947$UCB$$59$YR$$F$Y$200$KG$20240808$$CN$US$US
241204471$24120447$1$I$$20240718$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159273$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241204481$24120448$1$I$20230101$20240708$20240722$20240722$PER$$US-ABBVIE-5847124$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241204492$24120449$2$F$20240101$20240820$20240722$20240822$PER$$US-AMGEN-USASP2024142949$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
241204501$24120450$1$I$$20240715$20240722$20240722$PER$$US-BIOGEN-2024BI01273737$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
241204511$24120451$1$I$$20240716$20240722$20240722$EXP$$FR-JNJFOC-20240744362$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240722$$PH$FR$FR
241204522$24120452$2$F$20240711$20240730$20240722$20240806$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-013381$JAZZ$$21$YR$$F$Y$$$20240806$$CN$US$US
241204532$24120453$2$F$$20240724$20240722$20240802$EXP$$CN-FreseniusKabi-FK202411099$FRESENIUS KABI$$$$$F$Y$$$20240802$$MD$CN$CN
241204541$24120454$1$I$20240524$20240702$20240718$20240718$DIR$FDA-CDER-CTU-2024-50115$$FDA-CTU$$67$YR$$F$N$81.65$KG$20240702$Y$CN$US$
241204551$24120455$1$I$$20240715$20240722$20240722$EXP$$CA-GENMAB-2024-02581$GENMAB$$73$YR$$M$Y$$$20240719$$PH$CA$CA
241204561$24120456$1$I$$20240715$20240722$20240722$EXP$$CA-GENMAB-2024-02585$GENMAB$$66$YR$$M$Y$$$20240719$$CN$CA$CA
241204571$24120457$1$I$$20240715$20240722$20240722$EXP$$CA-GENMAB-2024-02578$GENMAB$$$$$M$Y$$$20240719$$MD$CA$CA
241204581$24120458$1$I$$20240715$20240722$20240722$EXP$$CA-GENMAB-2024-02554$GENMAB$$56$YR$$F$Y$$$20240719$$MD$CA$CA
241204591$24120459$1$I$20210727$20240719$20240722$20240722$EXP$$DE-SANDOZ INC.-SDZ2024DE066807$SANDOZ$$68$YR$$F$Y$$$20240722$$MD$DE$DE
241204601$24120460$1$I$$20240716$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2024US066766$SANDOZ$$$$$$Y$$$20240722$$CN$US$US
241204612$24120461$2$F$$20240726$20240722$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA066434$SANDOZ$$35$YR$$F$Y$$$20240729$$HP$CA$CA
241204621$24120462$1$I$$20240716$20240722$20240722$EXP$$AU-SANDOZ INC.-SDZ2024AU066010$SANDOZ$$$$$$Y$$$20240722$$HP$AU$AU
241204631$24120463$1$I$$20240715$20240722$20240722$EXP$$AU-SANDOZ INC.-SDZ2024AU065422$SANDOZ$$85$YR$$M$Y$$$20240722$$HP$AU$AU
241204641$24120464$1$I$$20240719$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2024US066778$SANDOZ$$$$$F$Y$$$20240722$$HP$US$US
241204651$24120465$1$I$$20240717$20240722$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA066248$SANDOZ$$43$YR$$F$Y$44$KG$20240722$$HP$CA$CA
241204672$24120467$2$F$20240627$20240730$20240722$20240805$EXP$$US-SANDOZ INC.-NVSC2021US190586$SANDOZ$$10$YR$$F$Y$$$20240805$$CN$US$US
241204681$24120468$1$I$20240510$20240718$20240722$20240722$EXP$AU-TGA-0000813091$AU-SANDOZ INC.-SDZ2024AU066392$SANDOZ$$71$YR$$F$Y$$$20240722$$HP$AU$AU
241204701$24120470$1$I$$20240717$20240722$20240722$EXP$AU-TGA-0000812384$AU-SANDOZ INC.-SDZ2024AU066088$SANDOZ$$3$YR$$M$Y$$$20240722$$CN$AU$AU
241204711$24120471$1$I$$20240718$20240722$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA066603$SANDOZ$$72$YR$$M$Y$$$20240722$$PH$CA$CA
241204721$24120472$1$I$$20240716$20240722$20240722$EXP$$AU-SANDOZ INC.-SDZ2024AU065736$SANDOZ$$16$MON$$$Y$$$20240722$$HP$AU$AU
241204731$24120473$1$I$$20240716$20240722$20240722$EXP$$ES-SANDOZ INC.-SDZ2024ES066231$SANDOZ$$72$YR$$F$Y$$$20240722$$CN$ES$ES
241204741$24120474$1$I$$20240716$20240722$20240722$EXP$$AU-TGA-0000813115$SANDOZ$$13$YR$$M$Y$$$20240722$$HP$AU$AU
241204751$24120475$1$I$$20240717$20240722$20240722$EXP$AU-TGA-0000811876$AU-SANDOZ INC.-SDZ2024AU066204$SANDOZ$$$$$F$Y$$$20240722$$CN$AU$AU
241204761$24120476$1$I$20240201$20240719$20240722$20240722$EXP$DE-BFARM-24005015$DE-DSJP-DSE-2024-136623$DAIICHI$$75$YR$$F$Y$58$KG$20240722$$CN$DE$DE
241204772$24120477$2$F$$20240717$20240722$20240722$30DAY$$US-SANDOZ INC.-SDZ2024US066444$SANDOZ$$$$$M$Y$$$20240722$$CN$US$US
241204782$24120478$2$F$$20240723$20240722$20240726$EXP$$CA-SANDOZ INC.-NVSC2020CA087119$SANDOZ$$27$YR$$F$Y$$$20240726$$HP$CA$CA
241204792$24120479$2$F$$20240718$20240722$20240725$EXP$$US-PFIZER INC-202400216033$PFIZER$Rivera-Hernandez, V.. Pituitary Apoplexy: Pitfalls in Diagnosis. Journal of community hospital internal medicine perspectives. 2024;14(2):84-6$44$YR$$F$Y$$$20240725$$MD$US$US
241204802$24120480$2$F$$20240719$20240722$20240724$EXP$$US-PFIZER INC-PV202400094346$PFIZER$Hernandez, J.. Mycobacterium abscessus infection in left ventricular assist device (LVAD): a case series. Cureus. 2021;13(6):10.7759/cureus.15718$80$YR$$M$Y$$$20240724$$HP$US$US
241204811$24120481$1$I$20240601$20240715$20240722$20240722$EXP$AU-SA-SAC20240605001196$AU-SA-SAC20240605001196$SANDOZ$$84$YR$$M$Y$$$20240722$$HP$AU$AU
241204821$24120482$1$I$20240101$20240708$20240722$20240722$EXP$$CO-UCBSA-2024035166$UCB$$$$$M$Y$3.35$KG$20240722$$CN$CO$CO
241204831$24120483$1$I$20240702$20240708$20240722$20240722$PER$$US-ABBVIE-5848168$ABBVIE$$68$YR$$F$Y$94.347$KG$20240722$$CN$US$US
241204841$24120484$1$I$$20240711$20240722$20240722$PER$$US-ABBVIE-5846986$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241204852$24120485$2$F$20240101$20240910$20240722$20240913$EXP$$US-ABBVIE-5844446$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
241204861$24120486$1$I$20240712$20240619$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115957$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$102.06$KG$20240722$$CN$US$US
241204871$24120487$1$I$$20240716$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113746$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240722$$CN$US$US
241204882$24120488$2$F$20220101$20240809$20240722$20240816$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-114861$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240816$$MD$BR$BR
241204891$24120489$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072792$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241204901$24120490$1$I$20211001$20240716$20240722$20240722$EXP$$CA-OTSUKA-2024_020108$OTSUKA$$58$YR$$F$Y$$$20240722$$HP$CA$CA
241204911$24120491$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5844875$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241204922$24120492$2$F$$20240730$20240722$20240805$EXP$$US-ABBVIE-5844883$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241204932$24120493$2$F$$20240729$20240722$20240801$EXP$$US-SANDOZ INC.-NVSC2022US136598$SANDOZ$$$$$F$Y$102.95$KG$20240801$$CN$US$US
241204942$24120494$2$F$$20240730$20240722$20240802$EXP$GB-MHRA-MED-202407171329112380-FHGCW$GB-MYLANLABS-2024M1066883$MYLAN$$$$$F$Y$$$20240802$$HP$GB$GB
241204951$24120495$1$I$$20240717$20240722$20240722$EXP$GB-MHRA-MED-202407170959334590-PCSYF$GB-MYLANLABS-2024M1067025$MYLAN$$69$YR$$F$Y$$$20240722$$HP$GB$GB
241204961$24120496$1$I$20240101$20240717$20240722$20240722$EXP$$SG-MYLANLABS-2024M1066935$MYLAN$$75$YR$$F$Y$$$20240722$$HP$SG$SG
241204971$24120497$1$I$$20240717$20240722$20240722$EXP$$GB-MYLANLABS-2024M1066944$MYLAN$$69$YR$$F$Y$65$KG$20240722$$MD$GB$GB
241204981$24120498$1$I$20240704$20240708$20240722$20240722$EXP$$CO-BAYER-2024A099879$BAYER$$72$YR$E$M$Y$90$KG$20240722$$HP$CO$CO
241204992$24120499$2$F$20210701$20240909$20240722$20240911$EXP$$HR-SANDOZ INC.-SDZ2024HR066651$SANDOZ$$69$YR$$F$Y$$$20240911$$MD$HR$HR
241205012$24120501$2$F$$20240722$20240722$20240725$EXP$$PH-PFIZER INC-PV202400091925$PFIZER$Legaspi, L.. Rare Metastatic Primary Intra-Abdominal Follicular Dendritic Cell Sarcoma Poorly Responsive to Chemotherapy: A Case Report. Phillippine Journal of Internal Medicine. 2024;62(1):308-313$33$YR$$F$Y$$$20240725$$MD$PH$PH
241205021$24120502$1$I$$20240716$20240722$20240722$EXP$$JP-PFIZER INC-PV202400093468$PFIZER$Enomoto, Y.. A case of pituitary mass associated with MTX-associated lymphoproliferative disorder that spontaneously regressed with permanent discontinuation of MTX. The 244th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2024;244th$64$YR$$M$Y$$$20240722$$HP$JP$JP
241205032$24120503$2$F$$20240719$20240722$20240725$EXP$$US-PFIZER INC-202400218831$PFIZER$Hernandez, J.. Mycobacterium abscessus infection in left ventricular assist device (LVAD): a case series. Cureus. 2021;13(6):10.7759/cureus.15718$51$YR$$M$Y$$$20240725$$HP$US$US
241205043$24120504$3$F$$20240920$20240722$20240923$EXP$$AU-PFIZER INC-202400219049$PFIZER$Tan, A.. Systemic capillary leak syndrome in a patient treated with nivolumab/ipilimumab immunotherapy for metastatic melanoma with concurrent COVID-19 vaccination. BMJ Case Reports. 2024;17(7):10.1136/bcr-2024-259875$8$DEC$$F$Y$$$20240923$$HP$AU$AU
241205051$24120505$1$I$20240717$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142014$AMGEN$$79$YR$E$M$Y$$$20240722$$CN$US$US
241205061$24120506$1$I$20240709$20240719$20240722$20240722$EXP$GB-MHRA-TPP8791395C11687440YC1721293044825$GB-DSJP-DSE-2024-136634$DAIICHI$$47$YR$$M$Y$91$KG$20240722$$HP$GB$GB
241205071$24120507$1$I$$20240717$20240722$20240722$EXP$$NVSC2024US147836$NOVARTIS$$$$$M$Y$$$20240722$$CN$US$US
241205082$24120508$2$F$$20240806$20240722$20240812$EXP$$FR-OTSUKA-2024_020218$OTSUKA$$29$YR$$M$Y$$$20240812$$CN$FR$FR
241205093$24120509$3$F$$20240722$20240722$20240724$EXP$$CA-SANDOZ INC.-SDZ2024CA045247$SANDOZ$$$$$F$Y$$$20240724$$MD$CA$CA
241205101$24120510$1$I$$20240717$20240722$20240722$EXP$AU-MYLANLABS-2024M1054954$AU-SANDOZ INC.-SDZ2024AU066340$SANDOZ$$$$$$Y$$$20240722$$HP$AU$AU
241205111$24120511$1$I$20240611$20240717$20240722$20240722$EXP$$AU-SANDOZ INC.-SDZ2024AU066367$SANDOZ$$55$YR$$M$Y$95$KG$20240722$$MD$AU$AU
241205133$24120513$3$F$$20240910$20240722$20240912$EXP$$JP-PFIZER INC-202400214494$PFIZER$Honda, H.. Investigation of skin symptom and patient factor in cases treated with Enfortumab Vedotin at Nagasaki University Hospital.. The 73rd Annual Meeting of Central Section of Japanese Urological Association Pr. 2023;2023.10.12-14:177$73$YR$$M$Y$$$20240912$$MD$JP$JP
241205141$24120514$1$I$20240701$20240717$20240722$20240722$EXP$$US-SA-2024SA213048$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240722$$MD$US$US
241205151$24120515$1$I$20240701$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116125$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240722$$CN$US$US
241205161$24120516$1$I$20240718$20240719$20240722$20240722$EXP$$KR-DSJP-DSJ-2024-136600$DAIICHI$$62$YR$$F$Y$$$20240722$$CN$KR$KR
241205171$24120517$1$I$20240101$20240709$20240722$20240722$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000190$Unknown Manufacturer$$$$$$Y$$$20240722$$CN$US$US
241205181$24120518$1$I$$20240718$20240722$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA066581$SANDOZ$$61$YR$$M$Y$$$20240722$$CN$CA$CA
241205191$24120519$1$I$$20240717$20240722$20240722$EXP$$US-SA-2024SA081960$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240722$$MD$US$US
241205201$24120520$1$I$20240701$20240717$20240722$20240722$EXP$$US-SA-2024SA213190$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240722$$MD$US$US
241205221$24120522$1$I$$20240716$20240722$20240722$EXP$$CA-OTSUKA-2024_020110$OTSUKA$$$$$F$Y$$$20240722$$HP$CA$CA
241205231$24120523$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072776$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241205241$24120524$1$I$20230702$20240717$20240722$20240722$EXP$$US-SA-2024SA212767$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240722$$HP$US$US
241205251$24120525$1$I$$20240717$20240722$20240722$EXP$$US-SA-2024SA211949$SANOFI AVENTIS$$$$E$M$Y$63.5$KG$20240722$$MD$US$US
241205261$24120526$1$I$$20200304$20240722$20240722$EXP$$CA-AstraZeneca-2020SE34778$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$CA$
241205271$24120527$1$I$$20201127$20240722$20240722$EXP$$US-AstraZeneca-2020SF59651$ASTRAZENECA$$$$A$M$Y$$$20240722$$CN$US$
241205281$24120528$1$I$$20240717$20240722$20240722$PER$$US-ORGANON-O2407USA001838$ORGANON$$$$$F$Y$$$20240722$$CN$US$US
241205291$24120529$1$I$20240626$20240717$20240722$20240722$EXP$DE-DCGMA-24203616$DE-RDY-SPO/DEU/24/0010574$DR REDDYS$$91$YR$E$M$Y$79$KG$20240722$$MD$DE$DE
241205301$24120530$1$I$$20201120$20240722$20240722$EXP$$US-AstraZeneca-2020SF55979$ASTRAZENECA$$$$$M$Y$$$20240722$$HP$US$
241205311$24120531$1$I$20240709$20240716$20240722$20240722$EXP$$PL-DAIICHI SANKYO, INC.-DSJ-2024-136669$DAIICHI$$$$E$F$Y$$$20240722$$MD$PL$PL
241205321$24120532$1$I$$20201214$20240722$20240722$EXP$$US-AstraZeneca-2020SF68216$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241205334$24120533$4$F$$20240920$20240722$20240924$EXP$$US-TAKEDA-2024TUS024694$TAKEDA$$$$$M$Y$66.7$KG$20240924$$CN$US$US
241205341$24120534$1$I$$20240716$20240722$20240722$EXP$$AU-SANDOZ INC.-SDZ2024AU065899$SANDOZ$$$$$$Y$$$20240722$$HP$AU$AU
241205352$24120535$2$F$$20240822$20240722$20240829$EXP$$US-TEVA-VS-3220237$TEVA$Laughter MR, Tegla CA, Pawar S, Moshiri AS, Orlow SJ. Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C. JAAD-Case-Rep 2024; 49 28-31.; Laughter MR, Tegla CA, Pawar S, Moshiri AS, Orlow SJ. Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C. JAAD-Case-Rep 2024; 49 28-31.; Laughter MR, Tegla CA, Pawar S, Moshiri AS, Orlow SJ. Diffuse large B-cell lymphoma with cutaneous involvement in a p...$37$YR$$M$Y$$$20240829$$MD$US$US
241205371$24120537$1$I$$20240715$20240722$20240722$PER$$US-AGIOS-2407US03832$AGIOS PHARMACEUTICALS$$$$A$$Y$$$20240722$$CN$US$US
241205381$24120538$1$I$$20240625$20240722$20240722$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002994$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
241205392$24120539$2$F$20240101$20240820$20240722$20240822$EXP$DE-BESINS-2024-03592$DE-SANDOZ INC.-SDZ2024DE066456$SANDOZ$$71$YR$$F$Y$60$KG$20240822$$CN$DE$DE
241205401$24120540$1$I$20240528$20240712$20240722$20240722$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00170$OPKO HEALTH$$58$YR$$F$Y$$$20240719$$PH$US$US
241205412$24120541$2$F$20140101$20240909$20240722$20240913$EXP$$GB-SANDOZ INC.-SDZ2024GB065641$SANDOZ$$$$A$M$Y$73$KG$20240913$$MD$GB$GB
241205421$24120542$1$I$$20240718$20240722$20240722$EXP$$CA-SANDOZ INC.-SDZ2024CA066760$SANDOZ$$$$$F$Y$$$20240722$$CN$CA$CA
241205431$24120543$1$I$$20240703$20240722$20240722$PER$$US-BEH-2024175267$CSL BEHRING$$42$YR$A$F$Y$$$20240722$$HP$US$US
241205441$24120544$1$I$20240601$20240711$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111807$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240722$$HP$US$US
241205451$24120545$1$I$$20240620$20240722$20240722$PER$$US-STI Pharma LLC-2159284$STI PHARMA$$78$YR$$F$Y$$$20240722$$MD$US$US
241205461$24120546$1$I$$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115335$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240722$$CN$US$US
241205471$24120547$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115446$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240722$$CN$US$US
241205481$24120548$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115631$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240722$$PH$US$US
241205491$24120549$1$I$$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113775$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240722$$HP$US$US
241205501$24120550$1$I$$20240626$20240722$20240722$PER$$US-CSPC Ouyi Pharmaceutical Co., Ltd.-2159287$CSPC OUYI PHARMACEUTICAL$$$$$M$Y$$$20240722$$$US$US
241205512$24120551$2$F$20240625$20240807$20240722$20240816$EXP$PT-INFARMED-R202406-732$PT-TEVA-VS-3221193$TEVA$$37$YR$$M$Y$$$20240816$$PH$PT$PT
241205521$24120552$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012122$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240722$$CN$US$US
241205531$24120553$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012954$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240722$$HP$US$US
241205541$24120554$1$I$20240701$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012326$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241205551$24120555$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012947$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240722$$CN$US$US
241205561$24120556$1$I$20240701$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012200$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240722$$CN$US$US
241205571$24120557$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012145$ELI LILLY AND CO$$$$$$Y$$$20240722$$CN$US$US
241205581$24120558$1$I$20240621$20240718$20240718$20240718$DIR$710701$$FDA-CTU$$14$YR$$M$N$60.75$KG$20240718$N$CN$US$
241205591$24120559$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072805$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241205601$24120560$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072780$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241205631$24120563$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072787$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241205641$24120564$1$I$$20240704$20240722$20240722$EXP$$US-Nuvo Pharmaceuticals Inc-2159296$NUVO PHARMACEUTICALS$SD (Full text article).$49$YR$$F$Y$$$20240722$$$US$US
241205651$24120565$1$I$$20240715$20240722$20240722$EXP$$CA-TAKEDA-2024TUS072968$TAKEDA$$63$YR$$F$Y$$$20240722$$HP$CA$CA
241205661$24120566$1$I$$20240620$20240722$20240722$PER$$US-STI Pharma LLC-2159283$STI PHARMA$$80$YR$$M$Y$$$20240722$$MD$US$US
241205673$24120567$3$F$20240710$20240903$20240722$20240909$EXP$$HR-ABBVIE-5845657$ABBVIE$$70$YR$$F$Y$$$20240909$$HP$HR$HR
241205681$24120568$1$I$20240716$20240718$20240722$20240722$PER$$NVSC2024US148928$NOVARTIS$$68$YR$$M$Y$$$20240722$$CN$US$US
241205702$24120570$2$F$20240702$20240803$20240722$20240812$EXP$$TW-SERB S.A.S.-2159285$LABORATOIRES SERB$$34$YR$$F$Y$$$20240812$$PH$TW$TW
241205711$24120571$1$I$20240703$20240715$20240722$20240722$EXP$$NVSC2024CN148826$NOVARTIS$$86$YR$$F$Y$60$KG$20240722$$HP$CN$CN
241205721$24120572$1$I$$20240715$20240722$20240722$EXP$$NVSC2024US148846$NOVARTIS$Kirmaier A, Blackshear L, Lee MSL, Kirby JE. Cellulitis and bacteremia caused by the fish pathogen, Streptococcus iniae, in an immunocompromised patient: Case report and mini-review of zoonotic disease, lab identification, and antimicrobial susceptibility. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2024;108 (4):1-3$49$YR$$F$Y$$$20240722$$HP$US$US
241205731$24120573$1$I$$20240718$20240722$20240722$PER$$US-JNJFOC-20240749598$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$MD$US$US
241205741$24120574$1$I$$20240718$20240722$20240722$EXP$$DE-SANDOZ INC.-SDZ2024DE066607$SANDOZ$$$$$M$Y$$$20240722$$CN$DE$DE
241205751$24120575$1$I$20240715$20240717$20240722$20240722$EXP$$US-BAYER-2024A104340$BAYER$$9$YR$C$M$Y$$$20240722$$CN$US$US
241205771$24120577$1$I$20240701$20240703$20240722$20240722$PER$$US-BEH-2024175326$CSL BEHRING$$57$YR$A$M$Y$$$20240722$$CN$US$US
241205781$24120578$1$I$20240219$20240708$20240722$20240722$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000623$PAREXEL$$$$$$Y$$$20240722$$HP$CN$CN
241205791$24120579$1$I$$20240716$20240722$20240722$EXP$$AU-SANDOZ INC.-SDZ2024AU065804$SANDOZ$$$$$$Y$$$20240722$$HP$AU$AU
241205811$24120581$1$I$20230801$20240517$20240722$20240722$PER$$US-Lyne Laboratories Inc.-2159305$LYNE LABORATORIES$$23$MON$$M$Y$8.6364$KG$20240722$$$US$US
241205821$24120582$1$I$$20240705$20240722$20240722$EXP$$GB-B.Braun Medical Inc.-2159319$B BRAUN$$30$YR$$F$Y$46$KG$20240722$$$GB$GB
241205831$24120583$1$I$20230426$20240712$20240722$20240722$EXP$$ES-Hill Dermaceuticals, Inc.-2159288$HILL DERM$$67$YR$$M$Y$$$20240722$$MD$ES$ES
241205841$24120584$1$I$$20240715$20240722$20240722$EXP$$US-ANIPHARMA-2024-US-038719$ANI$$$$$F$Y$$$20240722$$HP$US$US
241205851$24120585$1$I$$20240613$20240722$20240722$PER$$US-STI Pharma LLC-2159282$STI PHARMA$$59$YR$$F$Y$$$20240722$$MD$US$US
241205861$24120586$1$I$20240708$20240716$20240722$20240722$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00172$OPKO HEALTH$$82$YR$$M$Y$$$20240719$$PH$US$US
241205871$24120587$1$I$20240611$20240717$20240722$20240722$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006285$AURINIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240722$$MD$US$US
241205881$24120588$1$I$$20240718$20240722$20240722$EXP$$IT-JNJFOC-20240756196$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$IT$IT
241205891$24120589$1$I$$20240710$20240722$20240722$EXP$$US-TPU-TPU-2024-00394$TEIKOKU$$$$$$Y$$$20240722$$CN$US$US
241205901$24120590$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072778$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241205911$24120591$1$I$20240101$20240716$20240722$20240722$EXP$$FR-ORGANON-O2407FRA001288$ORGANON$$$$$F$Y$85$KG$20240722$$CN$FR$FR
241205921$24120592$1$I$$20240716$20240722$20240722$EXP$$FR-SANDOZ INC.-SDZ2024FR066075$SANDOZ$$52$YR$$F$Y$$$20240722$$HP$FR$FR
241205931$24120593$1$I$$20240716$20240722$20240722$EXP$$AE-LUNDBECK-DKLU4001927$LUNDBECK$$$$$$Y$$$20240722$$CN$AE$AE
241205942$24120594$2$F$20240718$20240719$20240722$20240722$PER$$US-GILEAD-2024-0681424$GILEAD$$$$$M$Y$$$20240722$$CN$US$US
241205961$24120596$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072777$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241205971$24120597$1$I$$20240715$20240722$20240722$EXP$$CA-GSK-CA2023135067$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$CA$CA
241205981$24120598$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072790$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241205991$24120599$1$I$$20240714$20240722$20240722$EXP$$US-AMGEN-USASP2024141378$AMGEN$$$$E$M$Y$$$20240722$$HP$US$US
241206003$24120600$3$F$20240708$20240904$20240722$20240912$EXP$$GB-AMGEN-GBRNI2024141154$AMGEN$$74$YR$E$F$Y$$$20240912$$MD$GB$GB
241206011$24120601$1$I$$20240704$20240722$20240722$EXP$$US-Creekwood Pharmaceuticals LLC-2159290$CREEKWOOD PHARMACEUTICALS$Full text$49$YR$$M$Y$$$20240722$$$US$US
241206023$24120602$3$F$20240717$20240910$20240722$20240916$EXP$$US-OTSUKA-2024_020117$OTSUKA$$$$$M$Y$$$20240916$$HP$US$US
241206032$24120603$2$F$$20240806$20240722$20240813$EXP$$CA-GSK-CA2024089483$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$MD$CA$CA
241206041$24120604$1$I$20240101$20240715$20240722$20240722$PER$$US-ABBVIE-5844515$ABBVIE$$$$$$Y$$$20240722$$MD$US$US
241206051$24120605$1$I$$20240716$20240722$20240722$EXP$$JP-ROCHE-10000031123$ROCHE$$8$DEC$E$M$Y$$$20240722$$MD$JP$JP
241206061$24120606$1$I$$20240717$20240722$20240722$EXP$$GB-MYLANLABS-2024M1067029$MYLAN$$$$$M$Y$$$20240722$$PH$GB$GB
241206072$24120607$2$F$20240101$20240822$20240722$20240905$EXP$$US-UCBSA-2024014109$UCB$$$$$F$Y$$$20240905$$CN$US$US
241206081$24120608$1$I$$20240703$20240722$20240722$PER$$US-BEH-2024175320$CSL BEHRING$$$$E$M$Y$$$20240722$$CN$US$US
241206091$24120609$1$I$$20240710$20240722$20240722$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000624$PAREXEL$$$$$$Y$$$20240722$$HP$CN$CN
241206101$24120610$1$I$20240503$20240717$20240722$20240722$EXP$GB-MHRA-MED-202407171022017900-JTKWD$GB-MYLANLABS-2024M1067008$MYLAN$$50$YR$$M$Y$98$KG$20240722$$CN$GB$GB
241206111$24120611$1$I$20240717$20240718$20240718$20240718$DIR$710703$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241206122$24120612$2$F$$20240725$20240722$20240726$PER$$US-BAYER-2024A104965$BAYER$$$$$F$Y$$$20240726$$HP$US$US
241206131$24120613$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072806$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241206141$24120614$1$I$20240718$20240718$20240718$20240718$DIR$710680$$FDA-CTU$$23$YR$$F$N$94.5$KG$20240718$N$CN$US$
241206151$24120615$1$I$$20240720$20240720$20240720$DIR$FDA-CDER-CTU-2024-50104$$FDA-CTU$$55$YR$$M$N$$$20240720$N$$US$
241206161$24120616$1$I$20240715$20240718$20240718$20240718$DIR$710710$$FDA-CTU$$36$YR$$M$N$87.75$KG$20240718$N$CN$US$
241206172$24120617$2$F$$20240715$20240722$20240723$PER$$US-JNJFOC-20240743526$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$HP$US$US
241206181$24120618$1$I$$20240716$20240722$20240722$EXP$$IN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040116$BOEHRINGER INGELHEIM$$$$$$Y$$$20240722$$MD$IN$IN
241206191$24120619$1$I$20240625$20240704$20240722$20240722$EXP$$CN-Bio-Thera Solutions, Ltd.-2159286$BIO-THERA SOLUTIONS$$63$YR$$M$Y$60$KG$20240722$$$CN$CN
241206201$24120620$1$I$$20240719$20240722$20240722$EXP$$CA-ORGANON-O2407CAN001890$ORGANON$$71$YR$$M$Y$$$20240722$$HP$CA$CA
241206211$24120621$1$I$$20240123$20240722$20240722$PER$$US-SOCIETAL CDMO GAINESVILLE, LLC-SOC-2024-000003$RECRO PHARMA$$$$$M$Y$$$20240722$$CN$US$US
241206221$24120622$1$I$$20240103$20240722$20240722$PER$$US-SOCIETAL CDMO GAINESVILLE, LLC-SOC-2024-000001$RECRO PHARMA$$$$$$Y$$$20240722$$CN$US$US
241206231$24120623$1$I$20210101$20231027$20240722$20240722$PER$$US-SOCIETAL CDMO GAINESVILLE, LLC-SOC-2023-000036$RECRO PHARMA$$$$$F$Y$$$20240722$$CN$US$US
241206241$24120624$1$I$$20231011$20240722$20240722$PER$$US-SOCIETAL CDMO GAINESVILLE, LLC-SOC-2023-000035$RECRO PHARMA$$$$$$Y$$$20240722$$CN$US$US
241206251$24120625$1$I$$20230620$20240722$20240722$PER$$US-SOCIETAL CDMO GAINESVILLE, LLC-SOC-2023-000024$RECRO PHARMA$$$$$F$Y$$$20240722$$CN$US$US
241206271$24120627$1$I$20240610$20240719$20240720$20240720$DIR$FDA-CDER-CTU-2024-50105$$FDA-CTU$$287$DY$$M$N$7.03$KG$20240719$Y$PH$US$
241206281$24120628$1$I$20240719$20240719$20240720$20240720$DIR$FDA-CDER-CTU-2024-50106$$FDA-CTU$$46$YR$$M$N$68.49$KG$20240719$Y$PH$US$
241206293$24120629$3$F$$20240614$20240722$20240906$PER$$US-FARMAPROD-202406-2290$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
241206301$24120630$1$I$$20240717$20240722$20240722$EXP$$US-ABBVIE-5845154$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241206311$24120631$1$I$20240709$20240720$20240720$20240720$DIR$FDA-CDER-CTU-2024-50107$$FDA-CTU$$51$YR$$M$N$$$20240720$Y$PH$US$
241206321$24120632$1$I$20240714$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024141985$AMGEN$$75$YR$E$F$Y$$$20240722$$CN$US$US
241206331$24120633$1$I$$20240719$20240722$20240722$PER$$US-AMGEN-USASP2024145060$AMGEN$$$$$$Y$$$20240722$$HP$US$US
241206342$24120634$2$F$20240719$20240722$20240722$20240725$PER$$US-AMGEN-USASP2024144538$AMGEN$$87$YR$E$F$Y$$$20240725$$CN$US$US
241206351$24120635$1$I$20240618$20240716$20240722$20240722$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700655$MYOVANT SCIENCES$$80$YR$$M$Y$$$20240722$$CN$US$US
241206361$24120636$1$I$$20240712$20240722$20240722$EXP$$US-APOTEX-2024AP008440$APOTEX$Sanjeevi A, Clark BL, Aguirre A, Verghese BG. Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature. Clinical Immunology Communications. 2024;6:1-4$65$YR$$F$Y$$$20240722$$HP$US$US
241206373$24120637$3$F$20240627$20240718$20240722$20240729$30DAY$$US-ALKERMES INC.-ALK-2024-001784$ALKERMES$$$$$F$Y$$$20240729$$PH$US$US
241206381$24120638$1$I$$20240715$20240722$20240722$EXP$$CA-GSK-CA2024AMR089312$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$CA$CA
241206391$24120639$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115656$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240722$$CN$US$US
241206402$24120640$2$F$20240701$20240918$20240722$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115983$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$108.41$KG$20240919$$CN$US$US
241206411$24120641$1$I$$20240704$20240722$20240722$EXP$$US-Nuvo Pharmaceuticals Inc-2159298$NUVO PHARMACEUTICALS$Source document (Abstract)$49$YR$$M$Y$$$20240722$$$US$US
241206421$24120642$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115173$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240722$$CN$US$US
241206431$24120643$1$I$$20240112$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012979$ELI LILLY AND CO$$$$$$Y$$$20240722$$MD$US$US
241206442$24120644$2$F$20240101$20240724$20240722$20240807$EXP$$US-MYLANLABS-2024M1065686$MYLAN$$80$YR$$F$Y$$$20240807$$CN$US$US
241206452$24120645$2$F$20240715$20240920$20240722$20240925$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003921$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240925$$CN$US$US
241206461$24120646$1$I$$20240709$20240722$20240722$EXP$$JP-Breckenridge Pharmaceutical, Inc.-2159320$BRECKENRIDGE$$74$YR$$M$Y$$$20240722$$$JP$JP
241206471$24120647$1$I$$20240707$20240722$20240722$EXP$$GB-JUBILANT CADISTA PHARMACEUTICALS-2024JUB00057$JUBILANT$Gupta L, Semple T, Padley S, Bossley C.J.. Idiopathic pulmonary haemosiderosis. BMJ Case Reports. 2024;(17)6$$$C$M$Y$$$20240722$$MD$GB$GB
241206481$24120648$1$I$$20240707$20240722$20240722$EXP$$IN-JUBILANT CADISTA PHARMACEUTICALS-2024JUB00056$JUBILANT$Jose A, Kurian N, Nisha A. A boat in the stormy sea: A case report on systemic steroid induced Delirium and relapse of Psychosis in a patient with Pemphigus vulgaris. Indian J. Psychiatry.. 2024;(66):S183$61$YR$$M$Y$$$20240722$$HP$IN$IN
241206491$24120649$1$I$$20240712$20240722$20240722$EXP$$US-MYLANLABS-2024M1066759$MYLAN$Sanjeevi A, Clark BL, Aguirre A, Verghese BG. Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature. Clin-Immunol-Commun 2024; 6.$65$YR$$F$Y$$$20240722$$HP$US$US
241206501$24120650$1$I$$20240717$20240722$20240722$EXP$$GB-SANDOZ INC.-SDZ2024GB066458$SANDOZ$$$$$M$Y$$$20240722$$CN$GB$GB
241206511$24120651$1$I$$20240719$20240722$20240722$PER$$US-JNJFOC-20240754222$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
241206521$24120652$1$I$$20240715$20240722$20240722$EXP$$MA-Tamarang, S.A.-2159291$TAMARANG PHARMACEUTICALS$Alj L, Tebaa A, Talibi I, Moubarik S, Benazzouz M, Soulaymani Bencheikh R. Lessons learned from a cluster of immunization errors in newborns. Ther Adv Vaccines Immunother. 2024 Jan 2;12:25151355231221009. doi: 10.1177/25151355231221009. PMID: 38178960; PMCID: PMC10762870.?Article found during weekly scientific literature research.$1$DY$$$Y$$$20240722$$MD$MA$MA
241206531$24120653$1$I$$20240705$20240722$20240722$EXP$$GB-B.Braun Medical Inc.-2159317$B BRAUN$$30$YR$$F$Y$59$KG$20240722$$$GB$GB
241206543$24120654$3$F$20240101$20240819$20240722$20240901$EXP$$CA-UCBSA-2024033636$UCB$$$$$F$Y$54.875$KG$20240901$$CN$CA$CA
241206551$24120655$1$I$$20240704$20240722$20240722$EXP$$US-Nuvo Pharmaceuticals Inc-2159297$NUVO PHARMACEUTICALS$SD (Full text article).$80$YR$$M$Y$$$20240722$$$US$US
241206561$24120656$1$I$$20240704$20240722$20240722$EXP$$US-Nuvo Pharmaceuticals Inc-2159293$NUVO PHARMACEUTICALS$Source document$68$YR$$M$Y$$$20240722$$$US$US
241206571$24120657$1$I$20240601$20240710$20240722$20240722$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2024-001559$SK LIFE SCIENCE$$$$$$Y$$$20240722$$CN$US$US
241206581$24120658$1$I$20240101$20240627$20240722$20240722$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-001216$SK LIFE SCIENCE$$$$$$Y$$$20240722$$HP$CA$CA
241206591$24120659$1$I$20240501$20240710$20240722$20240722$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2024-001572$SK LIFE SCIENCE$$$$$$Y$$$20240722$$CN$US$US
241206603$24120660$3$F$$20240926$20240722$20240930$EXP$$IN-ROCHE-10000029268$ROCHE$$53$YR$A$F$Y$$$20240930$$CN$IN$IN
241206611$24120661$1$I$20240709$20240718$20240722$20240722$EXP$$NVSC2024CN149789$NOVARTIS$$73$YR$$M$Y$50$KG$20240722$$HP$CN$CN
241206621$24120662$1$I$$20240717$20240722$20240722$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003975$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240722$$MD$US$US
241206631$24120663$1$I$$20240717$20240722$20240722$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003965$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
241206641$24120664$1$I$$20240717$20240722$20240722$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003988$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240722$$CN$US$US
241206651$24120665$1$I$20240426$20240718$20240722$20240722$PER$$US-BAYER-2024A105296$BAYER$$38$YR$A$F$Y$$$20240722$$HP$US$US
241206661$24120666$1$I$20240501$20240717$20240722$20240722$EXP$$CA-ABBVIE-5803412$ABBVIE$$44$YR$$M$Y$$$20240722$$CN$CA$CA
241206671$24120667$1$I$$20240704$20240722$20240722$EXP$$DE-Ascend Therapeutics US, LLC-2159322$ASCEND$$48$YR$$F$Y$$$20240722$$$DE$DE
241206681$24120668$1$I$20240709$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407111401486780-PGRCW$GB-TEVA-VS-3220977$TEVA$$$$$M$Y$145$KG$20240722$$CN$GB$GB
241206691$24120669$1$I$$20240708$20240722$20240722$EXP$$US-B.Braun Medical Inc.-2159332$B BRAUN$Literature Article$38$YR$$F$Y$$$20240722$$$US$US
241206701$24120670$1$I$$20240705$20240722$20240722$EXP$$GB-B.Braun Medical Inc.-2159323$B BRAUN$$$$$F$Y$$$20240722$$$GB$GB
241206711$24120671$1$I$20240624$20240718$20240722$20240722$EXP$GB-MHRA-MED-202407181428507800-QYRGB$GB-GSK-GB2024090643$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$GB$GB
241206721$24120672$1$I$20240626$20240718$20240722$20240722$EXP$EE-SAM-1982407022$EE-GSK-EE2024090865$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$MD$EE$EE
241206732$24120673$2$F$20230801$20240719$20240722$20240725$PER$$US-BIOGEN-2023BI01224217$BIOGEN$$24$YR$$F$Y$$$20240725$$CN$US$US
241206741$24120674$1$I$20240711$20240712$20240722$20240722$PER$$US-BIOGEN-2024BI01273877$BIOGEN$$54$YR$$F$Y$$$20240722$$CN$US$US
241206751$24120675$1$I$20240418$20240418$20240722$20240722$PER$$US-Amphastar Pharmaceuticals, Inc.-2159340$AMPHASTAR$$$$$F$Y$$$20240722$$$US$US
241206761$24120676$1$I$20240101$20240717$20240722$20240722$EXP$$US-ABBVIE-5844130$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241206771$24120677$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06625$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241206781$24120678$1$I$$20240709$20240722$20240722$EXP$$FR-B.Braun Medical Inc.-2159337$B BRAUN$$49$YR$$M$Y$$$20240722$$$FR$FR
241206791$24120679$1$I$$20240708$20240722$20240722$EXP$$US-Vista Pharmaceuticals Inc.-2159421$VISTAPHARM$Full text$34$YR$$M$Y$$$20240722$$$US$US
241206801$24120680$1$I$$20240718$20240722$20240722$EXP$$US-UCBSA-2024036628$UCB$$$$$F$Y$$$20240722$$HP$US$US
241206811$24120681$1$I$$20240711$20240722$20240722$EXP$$CA-APOTEX-2024AP008261$APOTEX$$78$YR$$F$Y$$$20240722$$HP$CA$CA
241206821$24120682$1$I$$20240708$20240722$20240722$EXP$$US-Vista Pharmaceuticals Inc.-2159422$VISTAPHARM$Full text$26$YR$$F$Y$$$20240722$$$US$US
241206831$24120683$1$I$$20240705$20240722$20240722$EXP$$GB-B.Braun Medical Inc.-2159325$B BRAUN$$$$$F$Y$$$20240722$$$GB$GB
241206841$24120684$1$I$$20240716$20240722$20240722$EXP$$US-FreseniusKabi-FK202411443$FRESENIUS KABI$Talon A, Gao YA, Murray C, Deen S, Puebla Neira DA. Factitious Elevation of Plasma Free Hemoglobin in a Patient Undergoing VV-ECMO With Hypertriglyceridemia. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: doi:https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1700.$49$YR$A$M$Y$$$20240722$$HP$US$US
241206851$24120685$1$I$$20240715$20240722$20240722$EXP$$CA-FreseniusKabi-FK202411149$FRESENIUS KABI$$$$$M$Y$$$20240722$$MD$CA$CA
241206861$24120686$1$I$$20240311$20240722$20240722$PER$$US-Breckenridge Pharmaceutical, Inc.-2159334$BRECKENRIDGE$$41$YR$$M$Y$113.64$KG$20240722$$$US$US
241206871$24120687$1$I$$20240708$20240722$20240722$EXP$$US-Spectra Medical Devices, LLC-2159426$Spectra Medical Devices$Full text$81$YR$$F$Y$65$KG$20240722$$$US$US
241206881$24120688$1$I$20240613$20240719$20240722$20240722$EXP$$KR-DSJP-DSJ-2024-136606$DAIICHI$$70$YR$$M$Y$$$20240722$$CN$KR$KR
241206891$24120689$1$I$$20240705$20240722$20240722$EXP$$RU-B.Braun Medical Inc.-2159329$B BRAUN$$17$YR$$F$Y$58$KG$20240722$$$RU$RU
241206902$24120690$2$F$20240101$20240710$20240722$20240730$PER$$US-TEVA-VS-3220308$TEVA$$37$YR$$M$Y$$$20240730$$CN$US$US
241206911$24120691$1$I$$20240708$20240722$20240722$EXP$$IR-Spectra Medical Devices, LLC-2159427$Spectra Medical Devices$Full text$19$YR$$F$Y$$$20240722$$MD$IR$IR
241206921$24120692$1$I$$20240719$20240721$20240721$DIR$FDA-CDER-CTU-2024-50109$$FDA-CTU$$$$$F$N$$$20240719$N$HP$US$
241206931$24120693$1$I$$20240718$20240718$20240718$DIR$710716$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241206941$24120694$1$I$20240718$20240720$20240720$20240720$DIR$FDA-CDER-CTU-2024-50108$$FDA-CTU$$74$YR$$M$N$$$20240720$N$$US$
241206951$24120695$1$I$20240521$20240718$20240718$20240718$DIR$710709$$FDA-CTU$$10$YR$$M$N$40.5$KG$20240718$N$CN$US$
241206961$24120696$1$I$$20240721$20240721$20240721$DIR$FDA-CDER-CTU-2024-50110$$FDA-CTU$$52$YR$$F$N$$$20240721$N$$US$
241206971$24120697$1$I$20240715$20240718$20240718$20240718$DIR$710698$$FDA-CTU$$73$YR$$F$N$60.3$KG$20240718$N$CN$US$
241206981$24120698$1$I$$20240718$20240718$20240718$DIR$710714$$FDA-CTU$$63$YR$$F$N$61$KG$20240718$N$PH$US$
241206991$24120699$1$I$20240626$20240718$20240718$20240718$DIR$710719$$FDA-CTU$$4$YR$$F$N$18$KG$20240718$Y$MD$US$
241207001$24120700$1$I$20231201$20240717$20240722$20240722$EXP$$US-ABBVIE-5845456$ABBVIE$$60$YR$$F$Y$$$20240722$$CN$US$US
241207011$24120701$1$I$20240718$20240718$20240722$20240722$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-136473$DAIICHI$$41$YR$$F$Y$$$20240722$$CN$US$US
241207021$24120702$1$I$$20240716$20240722$20240722$EXP$$CA-ABBVIE-5847142$ABBVIE$$$$E$M$Y$$$20240722$$CN$CA$CA
241207031$24120703$1$I$$20240708$20240722$20240722$EXP$$GB-B.Braun Medical Inc.-2159333$B BRAUN$Literature Article$51$YR$$F$Y$$$20240722$$$GB$GB
241207041$24120704$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114351$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240722$$CN$US$US
241207051$24120705$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115422$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240722$$CN$US$US
241207084$24120708$4$F$$20240919$20240722$20240925$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003977$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240925$$CN$US$US
241207091$24120709$1$I$20240712$20240717$20240722$20240722$EXP$$US-ALXN-202407USA001220US$ALEXION PHARMACEUTICALS$$79$YR$$$Y$$$20240722$$MD$US$US
241207101$24120710$1$I$$20240708$20240722$20240722$EXP$$CN-B.Braun Medical Inc.-2159331$B BRAUN$$48$YR$$F$Y$55$KG$20240722$$$CN$CN
241207111$24120711$1$I$$20240710$20240722$20240722$EXP$$US-Oxford Pharmaceuticals, LLC-2159423$OXFORD PHARMACEUTICALS$Source document$71$YR$$F$Y$$$20240722$$MD$US$US
241207121$24120712$1$I$$20240708$20240722$20240722$EXP$$US-Omnivium Pharmaceuticals LLC-2159424$Omnivium Pharmaceuticals$Full text$40$YR$$M$Y$$$20240722$$$US$US
241207141$24120714$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06629$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241207161$24120716$1$I$$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115191$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240722$$CN$US$US
241207171$24120717$1$I$$20240708$20240722$20240722$EXP$$CN-Spectra Medical Devices, LLC-2159428$Spectra Medical Devices$Full text$53$YR$$M$Y$65$KG$20240722$$MD$CN$CN
241207181$24120718$1$I$20240620$20240708$20240722$20240722$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000626$PAREXEL$$$$$$Y$$$20240722$$HP$CN$CN
241207192$24120719$2$F$20240101$20240809$20240722$20240814$EXP$$JP-OTSUKA-2024_020067$OTSUKA$$$$E$F$Y$60$KG$20240814$$MD$JP$JP
241207202$24120720$2$F$20240101$20240724$20240722$20240730$EXP$$NVSC2024MX127457$NOVARTIS$$$$$M$Y$53$KG$20240730$$CN$MX$MX
241207221$24120722$1$I$$20240715$20240722$20240722$EXP$GB-VIIV HEALTHCARE ULC-GB2020EME125044$GB-RDY-SPO/GBR/24/0010442$DR REDDYS$$$$$M$Y$$$20240722$$CN$GB$GB
241207231$24120723$1$I$20240329$20240715$20240722$20240722$EXP$FR-AFSSAPS-LL2024001296$FR-RDY-SPO/FRA/24/0010440$DR REDDYS$$69$YR$E$F$Y$100$KG$20240722$$MD$FR$FR
241207241$24120724$1$I$20240201$20240715$20240722$20240722$EXP$$US-GSK-US2024088596$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241207251$24120725$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024088790$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241207261$24120726$1$I$$20240718$20240722$20240722$PER$$US-JNJFOC-20240748768$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$CN$US$US
241207271$24120727$1$I$20240701$20240717$20240722$20240722$PER$$US-JNJFOC-20240746355$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$HP$US$US
241207281$24120728$1$I$$20240701$20240722$20240722$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06632$LUPIN$$$$$$Y$$$20240722$$CN$US$US
241207291$24120729$1$I$$20240715$20240722$20240722$EXP$$IL-009507513-2407ISR011649$MERCK$$43$YR$$F$Y$$$20240722$$MD$IL$IL
241207302$24120730$2$F$$20240724$20240722$20240805$EXP$$US-FARMAPROD-202407-2570$DOMPE FARMACEUTICI$$54$YR$A$F$Y$$$20240805$$MD$US$US
241207311$24120731$1$I$20240518$20240710$20240722$20240722$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000631$PAREXEL$$$$$$Y$$$20240722$$HP$CN$CN
241207321$24120732$1$I$20240704$20240718$20240722$20240722$EXP$$US-JNJFOC-20240750511$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
241207331$24120733$1$I$$20240715$20240722$20240722$EXP$$ES-ROCHE-10000027032$ROCHE$Serna A, Navarro V, Iacoboni G, Lopez L, Sancho J, Gonzalez-Barca E, et al. Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes. Haematologica. 2024; doi:10.3324/haematol.2024.285219.$$$$$Y$$$20240722$$HP$ES$ES
241207342$24120734$2$F$20240326$20240722$20240722$20240726$EXP$$DE-BAXTER-2024BAX015951$BAXTER$$70$YR$$F$Y$$$20240726$$HP$DE$DE
241207352$24120735$2$F$20240623$20240805$20240722$20240814$EXP$FR-AFSSAPS-SE2024000546$FR-BAXTER-2024BAX021546$BAXTER$$70$YR$$F$Y$$$20240814$$MD$FR$FR
241207361$24120736$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012439$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240722$$HP$US$US
241207371$24120737$1$I$20240707$20240718$20240718$20240718$DIR$710717$$FDA-CTU$$60$YR$$F$N$$$20240718$Y$PH$US$
241207381$24120738$1$I$20240717$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012248$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240722$$CN$US$US
241207391$24120739$1$I$20240526$20240715$20240722$20240722$EXP$CN-NMPACDR-3412221002221202400121$CN-BAXTER-2024BAX021827$BAXTER$$55$YR$$F$Y$83$KG$20240722$$MD$CN$CN
241207401$24120740$1$I$20240620$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011939$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240722$$CN$US$US
241207411$24120741$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012504$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241207421$24120742$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011097$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240722$$CN$US$US
241207431$24120743$1$I$20240217$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012944$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240722$$CN$US$US
241207441$24120744$1$I$20240713$20240715$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012043$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240722$$CN$US$US
241207451$24120745$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012344$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240722$$CN$US$US
241207462$24120746$2$F$20240601$20240822$20240722$20240828$EXP$$US-ABBVIE-5845241$ABBVIE$$51$YR$$F$Y$$$20240828$$CN$US$US
241207471$24120747$1$I$20240628$20240715$20240722$20240722$EXP$$CN-ROCHE-10000027396$ROCHE$$44$YR$A$F$Y$62$KG$20240722$$HP$CN$CN
241207481$24120748$1$I$20240211$20240718$20240718$20240718$DIR$710699$$FDA-CTU$$61$YR$$M$N$99$KG$20240718$N$CN$US$
241207491$24120749$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5813873$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241207511$24120751$1$I$20240711$20240715$20240722$20240722$EXP$CN-NMPACDR-3704011509867202400653$CN-BAXTER-2024BAX021806$BAXTER$$55$YR$$F$Y$51$KG$20240722$$MD$CN$CN
241207521$24120752$1$I$$20240715$20240722$20240722$EXP$$IT-BAXTER-2024BAX021616$BAXTER$$59$YR$$M$Y$$$20240722$$CN$IT$IT
241207531$24120753$1$I$$20240717$20240722$20240722$EXP$GB-MHRA-MED-202407171056261430-WSPDC$GB-BAXTER-2024BAX021850$BAXTER$$59$YR$$F$Y$$$20240722$$PH$GB$GB
241207541$24120754$1$I$$20240716$20240722$20240722$EXP$$CA-BAXTER-2024BAX021772$BAXTER$$$$$$Y$$$20240722$$CN$CA$CA
241207551$24120755$1$I$20231201$20240715$20240722$20240722$EXP$$US-GSK-US2024088643$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241207561$24120756$1$I$20240701$20240715$20240722$20240722$EXP$$GB-GSK-GB2024EME065656$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$GB$GB
241207572$24120757$2$F$$20240508$20240722$20240927$PER$$US-ROCHE-3560793$ROCHE$$$$$F$Y$56.7$KG$20240927$$CN$US$US
241207581$24120758$1$I$$20240702$20240722$20240722$PER$$US-TEVA-VS-3154336$TEVA$$76$YR$$F$Y$79.38$KG$20240722$$HP$US$US
241207591$24120759$1$I$20240708$20240717$20240722$20240722$EXP$$CO-AstraZeneca-2024A165156$ASTRAZENECA$$28650$DY$$F$Y$$$20240722$$CN$CO$
241207601$24120760$1$I$20240325$20240711$20240722$20240722$EXP$FR-AFSSAPS-GR2024000811$FR-TEVA-VS-3220976$TEVA$$64$YR$$F$Y$$$20240722$$MD$FR$FR
241207612$24120761$2$F$$20240724$20240722$20240726$EXP$$JP-JNJFOC-20240752753$JOHNSON AND JOHNSON$Kayoko MINAKATA, et al.; Department of Forensics Medicine, Hamamatsu University School of Medicine. Analysis of RISPERIDONE metabolites in autopsy tissue and body fluids. Proceedings of the 43rd Annual Meeting of the Japanese Association of Forensic Toxicology;2024.6.29,30; Chiba-shi, Chiba:2024.p.65$4$DEC$A$M$Y$$$20240726$$$COUNTRY NOT SPECIFIED$JP
241207621$24120762$1$I$20230913$20240715$20240722$20240722$EXP$$AU-AstraZeneca-2024A165334$ASTRAZENECA$$43$YR$$F$Y$$$20240722$$MD$AU$
241207631$24120763$1$I$$20240717$20240722$20240722$EXP$$CA-ABBVIE-5845679$ABBVIE$$$$E$F$Y$$$20240722$$MD$CA$CA
241207641$24120764$1$I$20240715$20240718$20240718$20240718$DIR$710683$$FDA-CTU$$69$YR$$F$N$101.25$KG$20240718$N$CN$US$
241207652$24120765$2$F$20230101$20240724$20240722$20240730$EXP$$US-ABBVIE-5845164$ABBVIE$$$$$M$Y$93$KG$20240730$$CN$US$US
241207662$24120766$2$F$$20240731$20240722$20240806$EXP$$GB-JNJFOC-20240755586$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240806$$CN$GB$GB
241207671$24120767$1$I$20240101$20240625$20240722$20240722$PER$$US-TOLMAR, INC.-24US050137$TOLMAR$$24$YR$$M$Y$$$20240719$$CN$US$US
241207702$24120770$2$F$20240506$20240718$20240722$20240801$PER$$US-TOLMAR, INC.-24US050425$TOLMAR$$9$YR$$F$Y$31.746$KG$20240801$$CN$US$US
241207711$24120771$1$I$20240501$20240626$20240722$20240722$PER$$US-TOLMAR, INC.-24US050197$TOLMAR$$$$$M$Y$$$20240719$$MD$US$US
241207721$24120772$1$I$20240601$20240626$20240722$20240722$PER$$US-TOLMAR, INC.-24US050264$TOLMAR$$57$YR$$M$Y$$$20240719$$CN$US$US
241207731$24120773$1$I$$20240718$20240718$20240718$DIR$710745$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241207742$24120774$2$F$20240625$20240808$20240722$20240902$PER$$US-TOLMAR, INC.-24US050489$TOLMAR$$10$YR$$F$Y$$$20240902$$PH$US$US
241207751$24120775$1$I$$20240626$20240722$20240722$PER$$US-TOLMAR, INC.-24US050582$TOLMAR$$$$$$Y$$$20240722$$CN$US$US
241207761$24120776$1$I$20140101$20240718$20240718$20240718$DIR$710738$$FDA-CTU$$58$YR$$F$N$90$KG$20240718$N$CN$US$
241207772$24120777$2$F$20240626$20240808$20240722$20240902$PER$$US-TOLMAR, INC.-24US050578$TOLMAR$$8$YR$$F$Y$$$20240902$$HP$US$US
241207781$24120778$1$I$$20240712$20240722$20240722$PER$$US-TOLMAR, INC.-24US050701$TOLMAR$$$$$$Y$$$20240722$$CN$US$US
241207791$24120779$1$I$$20240701$20240722$20240722$PER$$US-TOLMAR, INC.-24US050734$TOLMAR$$$$$$Y$$$20240722$$CN$US$US
241207801$24120780$1$I$$20240709$20240722$20240722$PER$$US-TOLMAR, INC.-24US050705$TOLMAR$$$$$M$Y$$$20240722$$CN$US$US
241207811$24120781$1$I$$20240715$20240722$20240722$PER$$US-TOLMAR, INC.-24US050851$TOLMAR$$$$$M$Y$$$20240722$$CN$US$US
241207821$24120782$1$I$20240101$20240715$20240722$20240722$PER$$US-TOLMAR, INC.-24US050940$TOLMAR$$$$$M$Y$$$20240722$$CN$US$US
241207831$24120783$1$I$$20240717$20240722$20240722$EXP$NL-LRB-00990443$NL-ASTELLAS-2024EU007110$ASTELLAS$$82$YR$$F$Y$$$20240722$$CN$NL$NL
241207842$24120784$2$F$20240717$20240724$20240722$20240726$PER$$NVSC2024US148983$NOVARTIS$$$$$F$Y$$$20240726$$MD$US$US
241207851$24120785$1$I$$20240716$20240722$20240722$EXP$$ES-SANDOZ INC.-SDZ2024ES066178$SANDOZ$$71$YR$$M$Y$$$20240722$$HP$ES$ES
241207861$24120786$1$I$20230510$20240715$20240722$20240722$EXP$CH-SM-2024-12818$CH-MYLANLABS-2024M1067294$MYLAN$$$$N$M$Y$2.82$KG$20240722$$PH$CH$CH
241207871$24120787$1$I$20240410$20240715$20240722$20240722$EXP$FR-AFSSAPS-PP2024000785$FR-Eisai-EC-2024-170152$EISAI$$37$YR$A$M$Y$87$KG$20240722$$MD$FR$FR
241207881$24120788$1$I$$20240712$20240722$20240722$EXP$$US-APOTEX-2024AP008443$APOTEX$Noe G, Shah K, Cinderella M, Munjal S. Multiple Medication Use Resulting in Serotonin Syndrome with Deprescribing Resulting in Acute Dystonia. Journal of Clinical Psychopharmacology. 2024;44 (3):326-328$42$YR$$F$Y$$$20240722$$HP$US$US
241207891$24120789$1$I$$20240716$20240722$20240722$EXP$$JP-Eisai-EC-2024-170428$EISAI$$$$$$Y$$$20240722$$MD$JP$JP
241207901$24120790$1$I$20240401$20240716$20240722$20240722$EXP$$CA-ABBVIE-5844488$ABBVIE$$74$YR$$F$Y$$$20240722$$CN$CA$CA
241207911$24120791$1$I$$20240717$20240722$20240722$EXP$$FR-ORGANON-O2407FRA001924$ORGANON$$$$$F$Y$$$20240722$$MD$FR$FR
241207921$24120792$1$I$20201110$20210330$20240722$20240722$EXP$$US-BIOVITRUM-2020US8059$BIOVITRUM$$$$$M$Y$$$20240722$$MD$US$US
241207931$24120793$1$I$$20240717$20240722$20240722$PER$$US-JNJFOC-20240746065$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$HP$US$US
241207941$24120794$1$I$20220101$20240708$20240722$20240722$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK092359$GLENMARK$Sivagnanam H, Kumar PK, Velu KB, Viswanathan R.. Mucormycosis-Associated Colon Perforation in the Early Postrenal Transplant Period.. Indian Journal of Transplantation.. 2024;18(2):189-93$$$$$Y$$$20240722$$MD$IN$IN
241207951$24120795$1$I$20230101$20240716$20240722$20240722$EXP$$US-ABBVIE-5844759$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241207961$24120796$1$I$20200210$20200214$20240722$20240722$EXP$$US-BIOVITRUM-2020SE24803$BIOVITRUM$$193$DY$$M$Y$$$20240722$$CN$US$US
241207971$24120797$1$I$$20240716$20240722$20240722$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006276$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
241207981$24120798$1$I$$20240716$20240722$20240722$EXP$$AU-SANDOZ INC.-SDZ2024AU065762$SANDOZ$$$$$$Y$$$20240722$$HP$AU$AU
241207992$24120799$2$F$20240704$20240911$20240722$20240923$PER$$US-ABBVIE-5843568$ABBVIE$$76$YR$$F$Y$$$20240923$$HP$US$US
241208003$24120800$3$F$20240802$20240807$20240722$20240819$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-14209$IPSEN$$66$YR$E$M$Y$68.4$KG$20240819$$HP$US$US
241208011$24120801$1$I$$20240718$20240722$20240722$EXP$$JP-ABBVIE-5845526$ABBVIE$$$$$$Y$$$20240722$$MD$JP$JP
241208021$24120802$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089631$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241208031$24120803$1$I$$20240718$20240722$20240722$EXP$$US-GSK-US2024090773$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241208041$24120804$1$I$20240325$20240717$20240722$20240722$EXP$$JP-DSJP-DSJ-2024-136016$DAIICHI$$78$YR$$M$Y$58$KG$20240722$$HP$JP$JP
241208051$24120805$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072781$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241208072$24120807$2$F$20240101$20240718$20240722$20240727$EXP$$GB-TEVA-VS-3221400$TEVA$$61$YR$$F$Y$$$20240727$$MD$GB$GB
241208083$24120808$3$F$$20240822$20240722$20240831$EXP$$JP-TAKEDA-2024TUS072959$TAKEDA$$64$YR$$$Y$$$20240831$$MD$JP$JP
241208092$24120809$2$F$20240101$20240730$20240722$20240807$EXP$$US-ABBVIE-5846095$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241208101$24120810$1$I$$20240712$20240722$20240722$EXP$GB-MHRA-MED-202407121609474360-QJFYN$GB-TEVA-VS-3221312$TEVA$$45$YR$$F$Y$$$20240722$$CN$GB$GB
241208113$24120811$3$F$$20240904$20240722$20240916$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-04822$IPSEN$$86$YR$E$F$Y$89$KG$20240916$$CN$US$US
241208121$24120812$1$I$20240627$20240712$20240722$20240722$EXP$$GB-TEVA-VS-3221375$TEVA$$76$YR$$M$Y$113$KG$20240722$$PH$GB$GB
241208132$24120813$2$F$$20240819$20240722$20240924$PER$$US-ASCENT-2024ASSPO00006$ASCENT$$61$YR$A$M$Y$178$KG$20240924$$PH$US$US
241208141$24120814$1$I$$20240712$20240722$20240722$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00579$PARATEK PHARMACEUTICALS$$$$E$M$Y$$$20240722$$HP$US$US
241208151$24120815$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089620$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241208161$24120816$1$I$$20240717$20240722$20240722$EXP$$US-GSK-US2024AMR090947$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241208181$24120818$1$I$20060206$20240718$20240718$20240718$DIR$710734$$FDA-CTU$$$$$F$N$72.45$KG$20240718$N$CN$US$
241208191$24120819$1$I$20240717$20240718$20240718$20240718$DIR$710754$$FDA-CTU$$61$YR$$F$N$110.4$KG$20240718$N$PH$US$
241208201$24120820$1$I$20240714$20240718$20240718$20240718$DIR$710748$$FDA-CTU$$39$YR$$F$N$88.2$KG$20240718$N$CN$US$
241208211$24120821$1$I$20240707$20240718$20240718$20240718$DIR$710713$$FDA-CTU$$66$YR$$F$N$55.35$KG$20240718$N$PH$US$
241208221$24120822$1$I$$20240718$20240718$20240718$DIR$710751$$FDA-CTU$$$$$UNK$N$$$20240718$$CN$US$
241208231$24120823$1$I$20240715$20240718$20240718$20240718$DIR$710763$$FDA-CTU$$47$YR$$F$N$88.2$KG$20240718$N$$US$
241208241$24120824$1$I$$20240718$20240718$20240718$DIR$710764$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241208251$24120825$1$I$20230126$20240712$20240722$20240722$EXP$ES-AEMPS-1541337$ES-Ipsen Biopharmaceuticals, Inc.-2024-13911$IPSEN$$42$YR$A$F$Y$$$20240719$$MD$ES$ES
241208261$24120826$1$I$20230101$20240715$20240722$20240722$EXP$$US-ABBVIE-5844893$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241208271$24120827$1$I$20231208$20240716$20240722$20240722$EXP$$JP-DSJP-DSJ-2024-135854$DAIICHI$$87$YR$$F$Y$46$KG$20240722$$HP$JP$JP
241208281$24120828$1$I$20240717$20240718$20240718$20240718$DIR$710684$$FDA-CTU$$48$YR$$F$N$108$KG$20240718$Y$CN$US$
241208291$24120829$1$I$20240712$20240716$20240721$20240721$DIR$FDA-CDER-CTU-2024-50111$$FDA-CTU$$73$YR$$F$N$59.7$KG$20240716$N$PH$US$
241208301$24120830$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072788$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241208311$24120831$1$I$$20240718$20240718$20240718$DIR$710770$$FDA-CTU$$$$$UNK$N$$$20240718$N$CN$US$
241208322$24120832$2$F$20240709$20240919$20240722$20240925$EXP$$US-ABBVIE-5845144$ABBVIE$$47$YR$$F$Y$$$20240925$$CN$US$US
241208331$24120833$1$I$20240704$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50185$$FDA-CTU$$19$YR$$M$N$$$20240718$N$HP$US$
241208341$24120834$1$I$20240709$20240718$20240718$20240718$DIR$710772$$FDA-CTU$$60$YR$$M$N$122.7$KG$20240718$N$PH$US$
241208351$24120835$1$I$$20240716$20240722$20240722$EXP$$US-TAKEDA-2024TUS049197$TAKEDA$$$$$M$Y$75$KG$20240722$$HP$US$US
241208361$24120836$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50193$$FDA-CTU$$72$YR$$F$N$131.09$KG$20240719$Y$MD$US$
241208371$24120837$1$I$20240628$20240710$20240722$20240722$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14029$IPSEN$$4$YR$C$F$Y$21.7$KG$20240719$$CN$US$US
241208383$24120838$3$F$$20240826$20240722$20240904$EXP$$RO-TEVA-VS-3220943$TEVA$Ciurescu IA, Lencioni R, Stemmer SM, Farbstein M, Harpaz Z, Bareket-Samish A, et al. A long-term complete response to namodenoson in liver cancer with Child-Pugh B cirrhosis: A case report. Exper-Ther-Med 2024; 27 (6):.; Ciurescu IA, Lencioni R, Stemmer SM, Farbstein M, Harpaz Z, Bareket-Samish A, et al. A long-term complete response to namodenoson in liver cancer with Child-Pugh B cirrhosis: A case report. Exper-Ther-Med 2024; 27 (6):.; Ciurescu IA, Lencioni R, Stemmer SM, Farbstein M, Harpa...$$$A$F$Y$$$20240904$$HP$RO$IL
241208391$24120839$1$I$20240101$20240715$20240722$20240722$EXP$$US-SA-2024SA212723$SANOFI AVENTIS$$45$YR$A$F$Y$77$KG$20240722$$MD$US$US
241208401$24120840$1$I$$20240718$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159307$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241208411$24120841$1$I$20240627$20240717$20240722$20240722$EXP$DK-DKMA-30735433$DK-AMGEN-DNKSP2024142826$AMGEN$$75$YR$E$F$Y$87$KG$20240722$$MD$DK$DK
241208421$24120842$1$I$20240101$20240717$20240722$20240722$EXP$$FR-SA-2024SA211370$SANOFI AVENTIS$$7$YR$C$$Y$23$KG$20240722$$MD$FR$FR
241208431$24120843$1$I$$20240717$20240722$20240722$EXP$$GR-SA-2024SA212370$SANOFI AVENTIS$Nikol P, Natalia K, Xenophon A.. The effect of dupilumab in severe atopic dermatitis: the experience of the ^d. kalogeromitros^ allergy unit. 17th Panhellenic Congress of Allergology + Clinical Immunology. Unkn;Unknown:Unknown$$$$$Y$$$20240722$$MD$GR$GR
241208442$24120844$2$F$20240101$20240809$20240722$20240813$EXP$$US-ABBVIE-5846048$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
241208461$24120846$1$I$20240601$20240717$20240722$20240722$EXP$$US-SA-2023SA204667$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
241208471$24120847$1$I$20240101$20240717$20240722$20240722$EXP$$US-SA-2024SA213222$SANOFI AVENTIS$$64$YR$A$M$Y$99$KG$20240722$$MD$US$US
241208481$24120848$1$I$$20240717$20240722$20240722$EXP$$US-SA-2024SA213201$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
241208501$24120850$1$I$$20240716$20240722$20240722$EXP$NL-LRB-00982698$NL-MYLANLABS-2024M1066650$MYLAN$$68$YR$$M$Y$82$KG$20240722$$CN$NL$NL
241208511$24120851$1$I$$20240716$20240722$20240722$EXP$$CA-MYLANLABS-2024M1067231$MYLAN$$$$$M$Y$$$20240722$$PH$CA$CA
241208521$24120852$1$I$20240601$20240719$20240722$20240722$EXP$FR-AFSSAPS-TS2024000813$FR-SA-2024SA211959$SANOFI AVENTIS$$54$YR$A$M$Y$72$KG$20240722$$MD$FR$FR
241208531$24120853$1$I$20240507$20240716$20240722$20240722$EXP$FR-AFSSAPS-AN2024000913$FR-MYLANLABS-2024M1066679$MYLAN$$68$YR$$M$Y$105.6$KG$20240722$$PH$FR$FR
241208542$24120854$2$F$20240430$20240717$20240722$20240725$EXP$FR-AFSSAPS-TO2024001230$FR-SA-2024SA211984$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240725$$PH$FR$FR
241208551$24120855$1$I$20240101$20240709$20240722$20240722$PER$$US-KARYOPHARM-2024KPT001287$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240722$$CN$US$US
241208561$24120856$1$I$20240607$20240718$20240722$20240722$EXP$SE-SEMPA-2024-005117$SE-TAKEDA-2024TUS072586$TAKEDA$$30$YR$$F$Y$56$KG$20240722$$HP$SE$SE
241208571$24120857$1$I$$20240708$20240722$20240722$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092381$GLENMARK$Denton J, Ozgur H, Sazegar P, Galgiani J, Riaz T.. Musculoskeletal and CNS coccidiomycosis in an individual with multiple sclerosis on fingolimod -A case report. IDCases. 2024;37:e02021$$$$$Y$$$20240722$$MD$US$US
241208581$24120858$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072782$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241208591$24120859$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072786$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241208601$24120860$1$I$20240624$20240712$20240722$20240722$EXP$$CN-BAYER-2024A103852$BAYER$$$$$F$Y$$$20240722$$CN$CN$CN
241208611$24120861$1$I$20240701$20240709$20240722$20240722$PER$$US-KARYOPHARM-2024KPT001288$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240722$$CN$US$US
241208621$24120862$1$I$20240101$20240716$20240722$20240722$EXP$$US-ABBVIE-5844435$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241208631$24120863$1$I$20230124$20240710$20240722$20240722$EXP$$ES-ZAMBON SWITZERLAND LTD.-2024-ZAM-ES000040$PAREXEL$$$$$$Y$$$20240722$$MD$ES$ES
241208642$24120864$2$F$$20240722$20240722$20240725$EXP$$NVSC2024IT143597$NOVARTIS$Grimaudo MS, Laffi A, Gennaro N, Fazio R, D^Orazio F, Sama L et al.. Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule. FRONTIERS IN ONCOLOGY. 2023;13:1-7$50$YR$$M$Y$$$20240725$$HP$IT$IT
241208651$24120865$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115919$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$53.07$KG$20240722$$CN$US$US
241208662$24120866$2$F$$20240815$20240722$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115909$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$52.16$KG$20240819$$CN$US$US
241208671$24120867$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115413$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240722$$CN$US$US
241208682$24120868$2$F$20240701$20240727$20240722$20240731$EXP$$US-ABBVIE-5846185$ABBVIE$$66$YR$$F$Y$$$20240731$$CN$US$US
241208691$24120869$1$I$$20240717$20240722$20240722$PER$$US-GILEAD-2024-0681132$GILEAD$$64$YR$A$M$Y$$$20240722$$CN$US$US
241208701$24120870$1$I$20240701$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012450$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240722$$CN$US$US
241208711$24120871$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012547$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241208721$24120872$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012437$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240722$$CN$US$US
241208731$24120873$1$I$20240718$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012209$ELI LILLY AND CO$$50$YR$A$$Y$$$20240722$$CN$US$US
241208741$24120874$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012921$ELI LILLY AND CO$$$$$$Y$$$20240722$$CN$US$US
241208751$24120875$1$I$20240101$20240712$20240722$20240722$EXP$$CA-ABBVIE-5847140$ABBVIE$$43$YR$$F$Y$$$20240722$$CN$CA$CA
241208761$24120876$1$I$$20240716$20240722$20240722$EXP$$BR-TAKEDA-2024TUS073314$TAKEDA$$32$YR$$$Y$$$20240722$$CN$BR$BR
241208771$24120877$1$I$20240101$20240715$20240722$20240722$EXP$$US-PERRIGO-24US006751$PERRIGO$$$$$F$Y$$$20240722$$CN$US$US
241208782$24120878$2$F$$20240805$20240722$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407012927$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240809$$CN$US$US
241208791$24120879$1$I$$20240716$20240722$20240722$PER$$US-BAYER-2024A103909$BAYER$$$$$M$Y$$$20240722$$CN$US$US
241208801$24120880$1$I$$20240716$20240722$20240722$PER$$US-TAKEDA-2024TUS072563$TAKEDA$$$$$F$Y$$$20240722$$CN$US$US
241208811$24120881$1$I$$20240718$20240722$20240722$EXP$$AU-BAYER-2024A104757$BAYER$$73$YR$E$M$Y$$$20240722$$MD$AU$AU
241208821$24120882$1$I$20240701$20240712$20240722$20240722$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-022102$UNITED THERAPEUTICS$$35$YR$$F$Y$$$20240722$$$JP$JP
241208831$24120883$1$I$$20240715$20240722$20240722$EXP$$CA-ABBVIE-5847025$ABBVIE$$72$YR$$M$Y$171$KG$20240722$$HP$CA$CA
241208841$24120884$1$I$20240626$20240716$20240722$20240722$EXP$IE-HPRA-2024-114016$IE-MYLANLABS-2024M1066896$MYLAN$$54$YR$$F$Y$108.8$KG$20240722$$PH$IE$IE
241208851$24120885$1$I$20240325$20240716$20240722$20240722$EXP$$UA-MYLANLABS-2024M1067370$MYLAN$$47$YR$$M$Y$$$20240722$$HP$UA$UA
241208861$24120886$1$I$$20240716$20240722$20240722$EXP$NL-LRB-00985143$NL-MYLANLABS-2024M1066615$MYLAN$$31$YR$$F$Y$78$KG$20240722$$CN$NL$NL
241208871$24120887$1$I$20240601$20240717$20240722$20240722$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-14431$IPSEN$$82$YR$E$M$Y$$$20240722$$PH$JP$JP
241208881$24120888$1$I$20240101$20240716$20240722$20240722$EXP$$US-ABBVIE-5844378$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241208891$24120889$1$I$20240101$20240716$20240722$20240722$EXP$$GB-ABBVIE-5844203$ABBVIE$$64$YR$$F$Y$$$20240722$$CN$GB$GB
241208901$24120890$1$I$20240703$20240708$20240722$20240722$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000622$PAREXEL$$$$$$Y$$$20240722$$HP$CN$CN
241208911$24120891$1$I$$20240716$20240722$20240722$EXP$NL-LRB-00983934$NL-MYLANLABS-2024M1066793$MYLAN$$85$YR$$F$Y$84.6$KG$20240722$$MD$NL$NL
241208921$24120892$1$I$20240101$20240716$20240722$20240722$EXP$$GR-ABBVIE-5843586$ABBVIE$$$$$F$Y$85$KG$20240722$$CN$GR$GR
241208931$24120893$1$I$$20240718$20240718$20240718$DIR$710757$$FDA-CTU$$$$$UNK$N$$$20240718$$CN$US$
241208951$24120895$1$I$20240719$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50181$$FDA-CTU$$62$YR$$F$N$$$20240719$N$$US$
241208961$24120896$1$I$$20240720$20240722$20240722$DIR$FDA-CDER-CTU-2024-50144$$FDA-CTU$$$$$F$N$$$20240720$N$HP$US$
241208971$24120897$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50271$$FDA-CTU$$$$$F$N$$$20240719$N$HP$US$
241208991$24120899$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50217$$FDA-CTU$$$$$F$N$$$20240719$N$HP$US$
241209001$24120900$1$I$20230320$20240718$20240718$20240718$DIR$710688$$FDA-CTU$$32$YR$$F$N$90$KG$20240718$N$CN$US$
241209021$24120902$1$I$20240710$20240718$20240718$20240718$DIR$710778$$FDA-CTU$$67$YR$$F$N$93.3$KG$20240718$N$PH$US$
241209031$24120903$1$I$20240514$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50135$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241209041$24120904$1$I$20240716$20240718$20240718$20240718$DIR$710762$$FDA-CTU$$62$YR$$F$N$86.5$KG$20240718$N$PH$US$
241209051$24120905$1$I$20240702$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50131$$FDA-CTU$$54$YR$$M$N$$$20240718$N$HP$US$
241209061$24120906$1$I$20240717$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50130$$FDA-CTU$$36$YR$$F$N$$$20240718$N$HP$US$
241209081$24120908$1$I$20240101$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142755$AMGEN$$78$YR$E$M$Y$$$20240722$$CN$US$US
241209091$24120909$1$I$$20240719$20240722$20240722$PER$$US-AMGEN-USASP2024144810$AMGEN$$62$YR$A$M$Y$$$20240722$$CN$US$US
241209102$24120910$2$F$$20240722$20240722$20240727$PER$$US-ROCHE-10000030495$ROCHE$$$$$$Y$$$20240727$$HP$US$US
241209111$24120911$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5844417$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241209121$24120912$1$I$20240701$20240715$20240722$20240722$EXP$$US-CHIESI-2024CHF04410$CHIESI$$43$YR$$F$Y$$$20240722$$CN$US$US
241209131$24120913$1$I$20240710$20240716$20240722$20240722$EXP$$NVSC2024CN148824$NOVARTIS$$56$YR$$M$Y$93$KG$20240722$$HP$CN$CN
241209141$24120914$1$I$$20240715$20240722$20240722$EXP$$NVSC2024CA146281$NOVARTIS$$40$YR$$M$Y$140$KG$20240722$$CN$CA$CA
241209151$24120915$1$I$$20191224$20240722$20240722$EXP$$RU-AstraZeneca-2019SF88704$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$RU$
241209161$24120916$1$I$$20210727$20240722$20240722$EXP$$US-AstraZeneca-2021A650436$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241209171$24120917$1$I$$20240719$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041093$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240722$$HP$US$US
241209183$24120918$3$F$$20240719$20240722$20240726$EXP$$CA-AstraZeneca-2024A164961$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$CA$
241209191$24120919$1$I$$20240710$20240722$20240722$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007198$AEGERION$$$$$M$Y$102.49$KG$20240722$$CN$US$US
241209202$24120920$2$F$$20240822$20240722$20240829$EXP$$TR-TEVA-VS-3220406$TEVA$Mutlu C, Gunes S, Turan S, Camli SE. CLOZAPINE-INDUCED MYOCARDITIS: AN ADOLESCENT GIRL WITH VERY EARLY-ONSET SCHIZOPHRENIA. Psychiatr-Danub 2024; 36 (1): 123-125; Mutlu C, Gunes S, Turan S, Camli SE. CLOZAPINE-INDUCED MYOCARDITIS: AN ADOLESCENT GIRL WITH VERY EARLY-ONSET SCHIZOPHRENIA. Psychiatr-Danub 2024; 36 (1): 123-125.$13$YR$$F$Y$$$20240829$$HP$TR$TR
241209211$24120921$1$I$$20200413$20240722$20240722$EXP$$US-AstraZeneca-2020SE51670$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241209221$24120922$1$I$$20240711$20240722$20240722$EXP$$CA-APOTEX-2024AP008266$APOTEX$$$$$F$Y$$$20240722$$PH$CA$CA
241209231$24120923$1$I$$20220120$20240722$20240722$EXP$$US-AstraZeneca-2022A035775$ASTRAZENECA$$$$$$Y$$$20240722$$CN$US$
241209241$24120924$1$I$$20200723$20240722$20240722$EXP$$US-AstraZeneca-2020SE93594$ASTRAZENECA$$75$YR$$M$Y$$$20240722$$CN$US$
241209251$24120925$1$I$20240601$20240710$20240722$20240722$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007267$AEGERION$$$$$$Y$$$20240722$$MD$DE$DE
241209261$24120926$1$I$$20200424$20240722$20240722$EXP$$US-AstraZeneca-2020SE57137$ASTRAZENECA$$$$$F$Y$$$20240722$$HP$US$
241209272$24120927$2$F$20240717$20240823$20240722$20240829$PER$$US-JNJFOC-20240750101$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240829$$CN$US$US
241209281$24120928$1$I$$20240717$20240722$20240722$EXP$$CA-ORGANON-O2407CAN001667$ORGANON$$53$YR$$M$Y$$$20240722$$CN$CA$CA
241209291$24120929$1$I$20240715$20240715$20240722$20240722$PER$$US-ABBVIE-5844293$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241209301$24120930$1$I$19870101$20240716$20240722$20240722$EXP$FR-AFSSAPS-AVCN2024000518$FR-INDIVIOR UK LIMITED-INDV-146008-2024$RECKITT BENCKISER$$$$$$Y$$$20240722$$MD$FR$FR
241209311$24120931$1$I$$20240716$20240722$20240722$EXP$$CA-ABBVIE-5845854$ABBVIE$$$$$M$Y$$$20240722$$HP$CA$CA
241209321$24120932$1$I$20240703$20240718$20240722$20240722$EXP$$US-ABBVIE-5846450$ABBVIE$$54$YR$$F$Y$$$20240722$$CN$US$US
241209331$24120933$1$I$$20240716$20240722$20240722$EXP$NL-LRB-00981269$NL-MYLANLABS-2024M1066828$MYLAN$$62$YR$$F$Y$64$KG$20240722$$MD$NL$NL
241209341$24120934$1$I$$20240716$20240722$20240722$EXP$$CA-ABBVIE-5847039$ABBVIE$$63$YR$$F$Y$$$20240722$$CN$CA$CA
241209351$24120935$1$I$$20240716$20240722$20240722$EXP$NL-LRB-00981114$NL-MYLANLABS-2024M1066906$MYLAN$$75$YR$$F$Y$63$KG$20240722$$CN$NL$NL
241209361$24120936$1$I$20240601$20240712$20240722$20240722$EXP$SE-SEMPA-2024-004912$SE-GALDERMA-SE2024011346$GALDERMA$$$$$$Y$$$20240722$$HP$SE$SE
241209371$24120937$1$I$$20240716$20240722$20240722$EXP$$NL-ABBVIE-5846115$ABBVIE$$$$E$M$Y$$$20240722$$CN$NL$NL
241209381$24120938$1$I$20240701$20240715$20240722$20240722$PER$$US-KARYOPHARM-2024KPT001317$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240722$$CN$US$US
241209391$24120939$1$I$$20240716$20240722$20240722$EXP$$ZW-MYLANLABS-2024M1068078$MYLAN$Mandikiyana Chirimuta LA, Pascoe MJ, Lowe S. Emergent dolutegravir resistance in integrase-naive, treatment experienced patients from Zimbabwe. South-Afr-J-HIV-Med 2022; 23 (1): a1435.$29$YR$$F$Y$$$20240722$$HP$ZW$ZW
241209401$24120940$1$I$$20240710$20240722$20240722$EXP$$FR-MYLANLABS-2024M1065725$MYLAN$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6).$50$YR$$M$Y$$$20240722$$HP$FR$FR
241209413$24120941$3$F$20240709$20240813$20240722$20240820$EXP$$CA-GSK-CA2024046776$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$MD$CA$CA
241209421$24120942$1$I$$20240716$20240722$20240722$EXP$$ZA-MYLANLABS-2024M1068118$MYLAN$Frigati LJ, Rabie H. Third-Line Antiretroviral Therapy: What Do We Do When the Appropriate Formulations Are Not Available?. Children-(Basel) 2022; 9 (4): 1-6.$2$YR$$M$Y$$$20240722$$HP$ZA$ZA
241209431$24120943$1$I$20240711$20240716$20240722$20240722$EXP$$IT-ABBVIE-5845891$ABBVIE$$71$YR$$M$Y$$$20240722$$CN$IT$IT
241209451$24120945$1$I$20240713$20240715$20240722$20240722$EXP$$US-VANTIVE-2024VAN018349$Vantive US Healthcare$$32$YR$$F$Y$$$20240722$$HP$US$US
241209461$24120946$1$I$20240714$20240719$20240722$20240722$EXP$$SG-VANTIVE-2024VAN018453$Vantive US Healthcare$$66$YR$$F$Y$$$20240722$$CN$SG$SG
241209471$24120947$1$I$$20240718$20240722$20240722$EXP$$CN-VANTIVE-2024VAN018472$Vantive US Healthcare$$$$$M$Y$$$20240722$$CN$CN$CN
241209484$24120948$4$F$20240716$20240830$20240722$20240901$PER$$US-JNJFOC-20240743401$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240901$$CN$US$US
241209491$24120949$1$I$20240716$20240718$20240722$20240722$EXP$$US-ABBVIE-5846129$ABBVIE$$53$YR$$M$Y$$$20240722$$CN$US$US
241209501$24120950$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50289$$FDA-CTU$$85$YR$$M$N$88.9$KG$20240722$N$$US$
241209512$24120951$2$F$$20240730$20240722$20240805$EXP$$IN-VANTIVE-2024VAN016527$Vantive US Healthcare$$63$YR$$M$Y$$$20240805$$CN$IN$IN
241209521$24120952$1$I$$20240719$20240722$20240722$PER$$US-TAKEDA-2024TUS073275$TAKEDA$$$$$M$Y$64$KG$20240722$$HP$US$US
241209531$24120953$1$I$20240104$20240711$20240722$20240722$EXP$$US-UCBSA-2024001467$UCB$$35$YR$$F$Y$$$20240722$$CN$US$US
241209541$24120954$1$I$20240712$20240718$20240718$20240718$DIR$710773$$FDA-CTU$$82$YR$$F$N$64.4$KG$20240718$N$PH$US$
241209552$24120955$2$F$20240503$20240808$20240722$20240813$PER$$US-ABBVIE-5842270$ABBVIE$$29$YR$$F$Y$67$KG$20240813$$CN$US$US
241209561$24120956$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400217669$PFIZER$$$$$M$Y$$$20240722$$MD$US$US
241209571$24120957$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218711$PFIZER$$61$YR$$F$Y$$$20240722$$HP$US$US
241209581$24120958$1$I$20240101$20240716$20240722$20240722$PER$$US-PFIZER INC-PV202400093795$PFIZER$$57$YR$$F$Y$$$20240722$$HP$US$US
241209591$24120959$1$I$20240721$20240721$20240722$20240722$PER$$US-PFIZER INC-202400220625$PFIZER$$68$YR$$M$Y$$$20240722$$CN$US$US
241209621$24120962$1$I$20240326$20240718$20240718$20240718$DIR$710796$$FDA-CTU$$61$YR$$M$N$86$KG$20240718$N$PH$US$
241209631$24120963$1$I$20240415$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400094184$PFIZER$$76$YR$$M$Y$$$20240722$$CN$US$US
241209642$24120964$2$F$20240701$20240725$20240722$20240730$PER$$US-PFIZER INC-PV202400094485$PFIZER$$84$YR$$F$Y$$$20240730$$HP$US$US
241209651$24120965$1$I$$20240715$20240722$20240722$PER$$US-PFIZER INC-PV202300038588$PFIZER$$70$YR$$F$Y$$$20240722$$CN$US$US
241209661$24120966$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400094083$PFIZER$$$$$F$Y$$$20240722$$CN$US$US
241209671$24120967$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400094373$PFIZER$$37$YR$$M$Y$$$20240722$$CN$US$US
241209681$24120968$1$I$20240704$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50268$$FDA-CTU$$45$YR$$F$N$$$20240718$N$HP$US$
241209692$24120969$2$F$$20240718$20240722$20240729$PER$$US-PFIZER INC-PV202400094260$PFIZER$$80$YR$$M$Y$68.7$KG$20240729$$MD$US$US
241209711$24120971$1$I$20220201$20240718$20240718$20240718$DIR$710689$$FDA-CTU$$30$YR$$F$N$90$KG$20240718$N$CN$US$
241209722$24120972$2$F$20240915$20240919$20240722$20240925$PER$$US-PFIZER INC-202400216253$PFIZER$$58$YR$$F$Y$$$20240925$$HP$US$US
241209732$24120973$2$F$20240715$20240822$20240722$20240822$PER$$US-PFIZER INC-202400219428$PFIZER$$$$$F$Y$$$20240822$$HP$US$US
241209741$24120974$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218889$PFIZER$$31$YR$$F$Y$$$20240722$$HP$US$US
241209751$24120975$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218993$PFIZER$$$$$M$Y$$$20240722$$HP$US$US
241209761$24120976$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400084552$PFIZER$$71$YR$$F$Y$$$20240722$$MD$US$US
241209772$24120977$2$F$20230205$20240725$20240722$20240730$PER$$US-PFIZER INC-202400219706$PFIZER$$47$YR$$$Y$$$20240730$$CN$US$US
241209781$24120978$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218744$PFIZER$$89$YR$$F$Y$$$20240722$$CN$US$US
241209791$24120979$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218349$PFIZER$$48$YR$$F$Y$$$20240722$$HP$US$US
241209801$24120980$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400217817$PFIZER$$88$YR$$M$Y$$$20240722$$CN$US$US
241209811$24120981$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400094340$PFIZER$$60$YR$$F$Y$$$20240722$$MD$US$US
241209824$24120982$4$F$$20240822$20240722$20240827$PER$$US-PFIZER INC-202400215344$PFIZER$$44$YR$$F$Y$$$20240827$$CN$US$US
241209831$24120983$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400217940$PFIZER$$$$$M$Y$$$20240722$$HP$US$US
241209841$24120984$1$I$20240718$20240719$20240722$20240722$PER$$US-PFIZER INC-202400219701$PFIZER$$53$YR$$F$Y$$$20240722$$CN$US$US
241209851$24120985$1$I$$20240719$20240722$20240722$PER$$US-PFIZER INC-202400219294$PFIZER$$$$$M$Y$$$20240722$$HP$US$US
241209861$24120986$1$I$20240708$20240719$20240722$20240722$PER$$US-PFIZER INC-202400219369$PFIZER$$$$$M$Y$$$20240722$$HP$US$US
241209871$24120987$1$I$20240501$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218959$PFIZER$$56$YR$$F$Y$$$20240722$$HP$US$US
241209882$24120988$2$F$$20240719$20240722$20240723$PER$$US-PFIZER INC-PV202400095247$PFIZER$$61$YR$$F$Y$$$20240723$$HP$US$US
241209891$24120989$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218839$PFIZER$$48$YR$$F$Y$$$20240722$$HP$US$US
241209902$24120990$2$F$20240713$20240812$20240722$20240815$PER$$US-PFIZER INC-PV202400095121$PFIZER$$75$YR$$F$Y$68.481$KG$20240815$$CN$US$US
241209911$24120991$1$I$$20240716$20240722$20240722$EXP$$US-GILEAD-2024-0681087$GILEAD$$47$YR$A$F$Y$$$20240722$$CN$US$US
241209921$24120992$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400219652$PFIZER$$55$YR$$F$Y$$$20240722$$CN$US$US
241209931$24120993$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218669$PFIZER$$$$A$$Y$$$20240722$$HP$US$US
241209951$24120995$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218717$PFIZER$$43$YR$$F$Y$$$20240722$$HP$US$US
241209961$24120996$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218932$PFIZER$$$$$$Y$$$20240722$$HP$US$US
241209981$24120998$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400084682$PFIZER$$62$YR$$F$Y$$$20240722$$HP$US$US
241209991$24120999$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218895$PFIZER$$28$YR$$F$Y$$$20240722$$HP$US$US
241210001$24121000$1$I$20240601$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400094155$PFIZER$$38$YR$$F$Y$$$20240722$$HP$US$US
241210011$24121001$1$I$20120101$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400094157$PFIZER$$62$YR$$F$Y$$$20240722$$CN$US$US
241210021$24121002$1$I$$20240716$20240722$20240722$PER$$US-PFIZER INC-PV202400093310$PFIZER$$$$$$Y$$$20240722$$CN$US$US
241210031$24121003$1$I$20240601$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400094135$PFIZER$$68$YR$$F$Y$$$20240722$$HP$US$US
241210041$24121004$1$I$$20240719$20240722$20240722$PER$$US-PFIZER INC-PV202400095145$PFIZER$$71$YR$$M$Y$$$20240722$$HP$US$US
241210051$24121005$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400094249$PFIZER$$53$YR$$F$Y$$$20240722$$CN$US$US
241210061$24121006$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218937$PFIZER$$68$YR$$F$Y$$$20240722$$HP$US$US
241210072$24121007$2$F$$20240723$20240722$20240726$PER$$US-PFIZER INC-202400218883$PFIZER$$30$YR$$F$Y$$$20240726$$CN$US$US
241210081$24121008$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218713$PFIZER$$$$E$F$Y$$$20240722$$MD$US$US
241210091$24121009$1$I$20240702$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218940$PFIZER$$72$YR$$M$Y$$$20240722$$HP$US$US
241210101$24121010$1$I$$20240719$20240722$20240722$PER$$US-HALEON-2188132$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
241210111$24121011$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400219167$PFIZER$$13$YR$$F$Y$$$20240722$$HP$US$US
241210123$24121012$3$F$$20240817$20240722$20240821$PER$$US-PFIZER INC-PV202400089611$PFIZER$$$$$F$Y$$$20240821$$CN$US$US
241210132$24121013$2$F$$20240724$20240722$20240726$EXP$$US-PFIZER INC-202400217728$PFIZER$$80$YR$$F$Y$$$20240726$$CN$US$US
241210141$24121014$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400218811$PFIZER$$79$YR$$F$Y$$$20240722$$CN$US$US
241210151$24121015$1$I$20240612$20240716$20240722$20240722$EXP$FR-AFSSAPS-RS2024000689$FR-MYLANLABS-2024M1066667$MYLAN$$45$YR$$F$Y$65$KG$20240722$$HP$FR$FR
241210161$24121016$1$I$$20240716$20240722$20240722$EXP$NL-LRB-00981109$NL-MYLANLABS-2024M1066842$MYLAN$$89$YR$$F$Y$89$KG$20240722$$MD$NL$NL
241210172$24121017$2$F$$20240905$20240722$20240909$PER$$US-PFIZER INC-202400217969$PFIZER$$55$YR$$F$Y$$$20240909$$MD$US$US
241210181$24121018$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400218908$PFIZER$$$$$F$Y$$$20240722$$PH$US$US
241210191$24121019$1$I$20240719$20240720$20240722$20240722$PER$$US-PFIZER INC-202400220310$PFIZER$$56$YR$$M$Y$$$20240722$$CN$US$US
241210211$24121021$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400219764$PFIZER$$76$YR$$F$Y$$$20240722$$HP$US$US
241210221$24121022$1$I$20240701$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400094892$PFIZER$$68$YR$$F$Y$$$20240722$$HP$US$US
241210231$24121023$1$I$$20240709$20240722$20240722$EXP$$CA-AstraZeneca-2024A165335$ASTRAZENECA$$53$YR$$M$Y$$$20240722$$MD$CA$
241210241$24121024$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400217671$PFIZER$$$$A$M$Y$$$20240722$$MD$US$US
241210251$24121025$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400219695$PFIZER$$48$YR$$F$Y$$$20240722$$HP$US$US
241210261$24121026$1$I$20230201$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400094384$PFIZER$$62$YR$$F$Y$$$20240722$$HP$US$US
241210271$24121027$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400219768$PFIZER$$63$YR$$F$Y$$$20240722$$MD$US$US
241210281$24121028$1$I$$20240719$20240722$20240722$PER$$US-PFIZER INC-PV202400095165$PFIZER$$86$YR$$F$Y$$$20240722$$HP$US$US
241210291$24121029$1$I$20240627$20240718$20240718$20240718$DIR$710795$$FDA-CTU$$67$YR$$M$N$74.25$KG$20240718$N$CN$US$
241210301$24121030$1$I$$20191104$20240722$20240722$EXP$$PL-AstraZeneca-2019SF57176$ASTRAZENECA$$$$$F$Y$$$20240722$$MD$PL$
241210311$24121031$1$I$$20240716$20240722$20240722$PER$$US-ABBVIE-5845397$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241210321$24121032$1$I$$20201012$20240722$20240722$EXP$$US-AstraZeneca-2020SF32914$ASTRAZENECA$$64$YR$$F$Y$$$20240722$$CN$US$
241210351$24121035$1$I$20240701$20240718$20240718$20240718$DIR$710799$$FDA-CTU$$52$YR$$M$N$72$KG$20240718$N$CN$US$
241210361$24121036$1$I$$20201009$20240722$20240722$EXP$$US-AstraZeneca-2020SF33550$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241210371$24121037$1$I$$20240716$20240722$20240722$EXP$$US-AMGEN-USASP2024141944$AMGEN$Gondi K.T.; Hammer Y.; Yosef M. et al.. Longitudinal Change and Predictors of Myocardial Flow Reserve by Positron Emission Tomography for the Evaluation of Cardiac Allograft Vasculopathy Following Heart Transplantation. Journal of Cardiac Failure. 2024;30 (7):915-925$$$$$Y$$$20240722$$MD$US$US
241210382$24121038$2$F$$20240910$20240722$20240916$PER$$US-AstraZeneca-2024A162461$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
241210391$24121039$1$I$$20240712$20240722$20240722$EXP$$CA-BAYER-2024A101047$BAYER$$$$$$Y$$$20240722$$HP$CA$CA
241210401$24121040$1$I$20240101$20240715$20240722$20240722$EXP$$RO-AMGEN-ROUSP2024140423$AMGEN$$74$YR$E$M$Y$$$20240722$$MD$RO$RO
241210411$24121041$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50171$$FDA-CTU$$$$$F$N$$$20240719$N$HP$US$
241210431$24121043$1$I$$20210314$20240722$20240722$EXP$$CA-AstraZeneca-2021A152064$ASTRAZENECA$$41$YR$$F$Y$$$20240722$$MD$CA$
241210441$24121044$1$I$20201225$20201226$20240722$20240722$EXP$$US-AstraZeneca-2020SF74870$ASTRAZENECA$$26968$DY$$M$Y$72.6$KG$20240722$$PH$US$
241210461$24121046$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072789$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241210472$24121047$2$F$$20240821$20240722$20240821$PER$$US-PFIZER INC-PV202400094579$PFIZER$$50$YR$$F$Y$$$20240821$$CN$US$US
241210481$24121048$1$I$20200101$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400094372$PFIZER$$82$YR$$M$Y$$$20240722$$HP$US$US
241210491$24121049$1$I$$20240718$20240722$20240722$PER$$US-PFIZER INC-202400219176$PFIZER$$$$A$F$Y$$$20240722$$MD$US$US
241210502$24121050$2$F$$20240814$20240722$20240816$PER$$US-PFIZER INC-202400219128$PFIZER$$42$YR$$F$Y$$$20240816$$MD$US$US
241210511$24121051$1$I$20240703$20240718$20240722$20240722$PER$$US-PFIZER INC-PV202400094306$PFIZER$$59$YR$$M$Y$78.1$KG$20240722$$MD$US$US
241210523$24121052$3$F$$20240918$20240722$20240923$PER$$US-PFIZER INC-202400220011$PFIZER$$10$YR$$F$Y$$$20240923$$CN$US$US
241210531$24121053$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-202400217939$PFIZER$$27$YR$$F$Y$$$20240722$$HP$US$US
241210541$24121054$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400094063$PFIZER$$55$YR$$F$Y$$$20240722$$HP$US$US
241210551$24121055$1$I$20200620$20200626$20240722$20240722$EXP$$US-AstraZeneca-2020SE82743$ASTRAZENECA$$24099$DY$$M$Y$$$20240722$$PH$US$
241210561$24121056$1$I$$20220308$20240722$20240722$EXP$$US-AstraZeneca-2022A038410$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241210571$24121057$1$I$$20220505$20240722$20240722$EXP$$US-AstraZeneca-2022A176422$ASTRAZENECA$$$$$$Y$$$20240722$$CN$US$
241210582$24121058$2$F$20201001$20240722$20240722$20240726$EXP$$US-ABBVIE-5845161$ABBVIE$$69$YR$$M$Y$$$20240726$$CN$US$US
241210591$24121059$1$I$$20210326$20240722$20240722$EXP$$US-AstraZeneca-2021A247917$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241210601$24121060$1$I$$20240717$20240722$20240722$EXP$$ZA-AstraZeneca-2024A163592$ASTRAZENECA$$66$YR$$M$Y$$$20240722$$CN$ZA$
241210613$24121061$3$F$20240701$20240723$20240722$20240731$EXP$$CA-AstraZeneca-2024A162374$ASTRAZENECA$$843$MON$$F$Y$$$20240731$$CN$CA$
241210623$24121062$3$F$$20240723$20240722$20240807$EXP$$CA-AstraZeneca-2024A165311$ASTRAZENECA$$53$YR$$M$Y$$$20240808$$MD$CA$
241210702$24121070$2$F$20240116$20240801$20240722$20240807$EXP$FR-AFSSAPS-TO2024000498$FR-MYLANLABS-2024M1066698$MYLAN$$93$YR$$F$Y$54.8$KG$20240807$$PH$FR$FR
241210712$24121071$2$F$$20240801$20240722$20240807$EXP$$HU-MYLANLABS-2024M1002242$MYLAN$Koszoru K, Hidvegi B,Robert L, Czintner D, Blaga K, Hollo P. Combination therapy with etanercept in Lyells syndrome. Dermatological and venereological review. 2023;99(6):443$35$YR$$F$Y$$$20240807$$MD$HU$HU
241210731$24121073$1$I$$20240716$20240722$20240722$PER$$US-AMGEN-USASP2024142329$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241210742$24121074$2$F$$20240718$20240722$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116218$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240723$$CN$US$US
241210751$24121075$1$I$$20240627$20240722$20240722$PER$$US-LGM Pharma Solutions, LLC-2159346$LGM PHARMA$$$$$M$Y$$$20240722$$$US$US
241210761$24121076$1$I$$20240712$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115825$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240722$$CN$US$US
241210771$24121077$1$I$$20240624$20240722$20240722$PER$$US-STI Pharma LLC-2159349$STI PHARMA$$84$YR$$M$Y$$$20240722$$MD$US$US
241210781$24121078$1$I$$20240711$20240722$20240722$30DAY$$US-GSK-US2024AMR088570$GLAXOSMITHKLINE$$$$$M$Y$$$20240722$$CN$US$US
241210791$24121079$1$I$20240702$20240709$20240722$20240722$EXP$$GB-ANIPHARMA-2024-UK-000133$ANI$$55$YR$$F$Y$$$20240722$$CN$GB$GB
241210801$24121080$1$I$$20240621$20240722$20240722$PER$$US-STI Pharma LLC-2159345$STI PHARMA$$61$YR$$F$Y$$$20240722$$MD$US$US
241210811$24121081$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012940$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240722$$CN$US$US
241210821$24121082$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011442$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240722$$CN$US$US
241210832$24121083$2$F$$20240731$20240722$20240807$EXP$$ES-PFIZER INC-202400219173$PFIZER$Anto, C.. USE OF ISAVUCONAZOLE IN CHILDREN WITH INVASIVE FUNGAL INFECTION: EXPERIENCE IN A PAEDIATRIC AND TERTIARY CARE CENTRE. 493$14$YR$$M$Y$48$KG$20240807$$MD$ES$ES
241210841$24121084$1$I$20240718$20240719$20240722$20240722$PER$$US-PFIZER INC-202400219653$PFIZER$$55$YR$$F$Y$$$20240722$$CN$US$US
241210851$24121085$1$I$$20240719$20240722$20240722$PER$$US-PFIZER INC-PV202400095073$PFIZER$$$$$F$Y$$$20240722$$MD$US$US
241210861$24121086$1$I$20190114$20240716$20240722$20240722$EXP$FR-AFSSAPS-MP20190156$FR-PFIZER INC-2019SGN00954$PFIZER$$50$YR$$F$Y$72.5$KG$20240722$$MD$FR$FR
241210871$24121087$1$I$20240617$20240716$20240722$20240722$EXP$$CN-PFIZER INC-PV202400093389$PFIZER$$15$YR$$M$Y$90$KG$20240722$$HP$CN$CN
241210881$24121088$1$I$$20240621$20240722$20240722$PER$$US-STI Pharma LLC-2159342$STI PHARMA$Medical Assessment Form$74$YR$$F$Y$$$20240722$$MD$US$US
241210893$24121089$3$F$20190614$20240813$20240722$20240820$EXP$$JP-PFIZER INC-2021229645$PFIZER$$81$YR$$F$Y$39$KG$20240820$$MD$JP$JP
241210901$24121090$1$I$$20240715$20240722$20240722$EXP$$IL-009507513-2407ISR011528$MERCK$$29$YR$$M$Y$$$20240722$$MD$IL$IL
241210911$24121091$1$I$$20240701$20240722$20240722$PER$$US-STI Pharma LLC-2159351$STI PHARMA$$86$YR$$M$Y$$$20240722$$MD$US$US
241210921$24121092$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089616$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241210932$24121093$2$F$20240718$20240722$20240722$20240725$EXP$$GB-GSK-GB2022EME123365$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$HP$GB$GB
241210941$24121094$1$I$$20240715$20240722$20240722$EXP$$CH-VIIV HEALTHCARE LIMITED-CH2024EME089080$VIIV$$$$$$Y$$$20240722$$MD$CH$CH
241210951$24121095$1$I$20240716$20240716$20240722$20240722$EXP$$US-TAKEDA-2024TUS072295$TAKEDA$$54$YR$$M$Y$$$20240722$$CN$US$US
241210961$24121096$1$I$20240622$20240717$20240722$20240722$PER$$US-BIOVITRUM-2024-US-009892$BIOVITRUM$$74$YR$$F$Y$$$20240722$$MD$US$US
241210971$24121097$1$I$20191211$20240715$20240722$20240722$EXP$$CA-TAKEDA-2023TUS094059$TAKEDA$$63$YR$$F$Y$$$20240722$$CN$CA$CA
241210981$24121098$1$I$$20240708$20240722$20240722$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092418$GLENMARK$Abrahamowicz AA, Chow EJ, Child DD, Dao A, Morrison ED, Gill SK, et. al.. Disseminated Histoplasmosis in a Patient With Multiple Sclerosis Treated With Fingolimod.. Neurology: Neuroimmunology + Neuroinflammation.. 2021;8:3: e966:1-3$$$$$Y$$$20240722$$MD$US$US
241210991$24121099$1$I$$20240626$20240722$20240722$PER$$US-PFIZER INC-PV202400095031$PFIZER$$68$YR$$F$Y$$$20240722$$CN$US$US
241211001$24121100$1$I$$20240715$20240722$20240722$PER$$US-BIOGEN-2023BI01239656$BIOGEN$$$$$M$Y$$$20240722$$CN$US$US
241211011$24121101$1$I$20240601$20240712$20240722$20240722$EXP$SE-SEMPA-2024-005346$SE-TEVA-VS-3221082$TEVA$$71$YR$$M$Y$$$20240722$$MD$SE$SE
241211021$24121102$1$I$$20200507$20240722$20240722$EXP$$US-AstraZeneca-2020SE61855$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241211031$24121103$1$I$20201227$20201228$20240722$20240722$EXP$$US-AstraZeneca-2020SF75336$ASTRAZENECA$$24815$DY$$M$Y$$$20240722$$CN$US$
241211041$24121104$1$I$$20220620$20240722$20240722$EXP$$CA-AstraZeneca-2022A183489$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$CA$
241211051$24121105$1$I$$20200730$20240722$20240722$EXP$$US-AstraZeneca-2020SE97688$ASTRAZENECA$$$$$F$Y$$$20240722$$MD$US$
241211061$24121106$1$I$$20240718$20240722$20240722$EXP$$ZA-ABBVIE-5845633$ABBVIE$$2$YR$$M$Y$$$20240722$$MD$ZA$ZA
241211071$24121107$1$I$$20240717$20240722$20240722$EXP$$CA-MYLANLABS-2024M1066914$MYLAN$$$$$M$Y$$$20240722$$CN$CA$CA
241211081$24121108$1$I$$20200824$20240722$20240722$EXP$$US-AstraZeneca-2020SF08374$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241211091$24121109$1$I$$20240702$20240722$20240722$PER$$US-ABBVIE-5845698$ABBVIE$$$$$$Y$$$20240722$$HP$US$US
241211101$24121110$1$I$$20240719$20240722$20240722$PER$$US-TAKEDA-2024TUS073276$TAKEDA$$29$YR$$M$Y$68$KG$20240722$$MD$US$US
241211111$24121111$1$I$20240716$20240716$20240722$20240722$PER$$US-BAYER-2024A103612$BAYER$$$$$M$Y$$$20240722$$MD$US$US
241211121$24121112$1$I$20240524$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50292$$FDA-CTU$$68$YR$$F$N$$$20240722$N$$US$
241211131$24121113$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50302$$FDA-CTU$$52$YR$$F$N$$$20240722$N$$US$
241211141$24121114$1$I$$20240715$20240722$20240722$EXP$$PT-AMGEN-PRTSP2024141871$AMGEN$Salgueiro R R.; Tenreiro P.; Ventura P. et al.. POSA-072 - (2751) - DENOSUMAB: BETWEEN THE THERAPEUTIC PROMISE AND THE CHALLENGES OF HYPOCALCEMIA. 30th National Congress of Internal Medicine (CNMI). 1144$78$YR$E$F$Y$$$20240722$$HP$PT$PT
241211151$24121115$1$I$$20240715$20240722$20240722$DIR$FDA-CDER-CTU-2024-50126$$FDA-CTU$$$$$F$N$$$20240715$N$HP$US$
241211161$24121116$1$I$20230801$20240715$20240722$20240722$EXP$$PT-AMGEN-PRTSP2024141418$AMGEN$Henriques C.; Melo J.; Vasconcelos S et al. PO-0552 - (4842) - RESPIRATORY INFECTIONS: WHEN APPEARANCES ARE DECEPTIVE. 30th National Congress of Internal Medicine (CNMI). 905$60$YR$A$F$Y$$$20240722$$HP$PT$PT
241211171$24121117$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089627$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241211181$24121118$1$I$20240501$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50262$$FDA-CTU$$46$YR$$F$N$$$20240718$N$HP$US$
241211191$24121119$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50240$$FDA-CTU$$$$$M$N$$$20240719$N$HP$US$
241211201$24121120$1$I$20240716$20240717$20240722$20240722$EXP$$US-BAUSCH-BL-2024-010975$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240719$$CN$US$US
241211211$24121121$1$I$$20240715$20240722$20240722$EXP$$CA-BAUSCH-BL-2018-030104$BAUSCH AND LOMB$$34$YR$$F$Y$$$20240719$$CN$CA$CA
241211221$24121122$1$I$20240709$20240715$20240722$20240722$PER$$US-BAUSCH-BL-2024-010872$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240719$$CN$US$US
241211231$24121123$1$I$20240101$20240715$20240722$20240722$EXP$$US-BAUSCH-BL-2024-010851$BAUSCH AND LOMB$$83$YR$$M$Y$$$20240719$$CN$US$US
241211251$24121125$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50222$$FDA-CTU$$$$$M$N$$$20240719$N$HP$US$
241211261$24121126$1$I$20240708$20240717$20240722$20240722$EXP$$US-AMGEN-USASP2024142198$AMGEN$$40$YR$A$M$Y$$$20240722$$HP$US$US
241211272$24121127$2$F$$20240807$20240722$20240814$PER$$US-BIOGEN-2024BI01273187$BIOGEN$$$$$F$Y$$$20240814$$MD$US$US
241211282$24121128$2$F$$20240718$20240722$20240725$PER$$US-BIOGEN-2024BI01274489$BIOGEN$$$$$M$Y$$$20240725$$CN$US$US
241211291$24121129$1$I$$20240712$20240722$20240722$EXP$$US-BAUSCH-BL-2024-010993$BAUSCH AND LOMB$PRIVACY, Tsai H, Sabbagh M, Montesion M, Williams E, Arbini A, Boue D. Modern Pathology. Acute Promyelocytic Leukemia With Torque Teno Mini  Virus::RARA Fusion: An Approach to Screening and Diagnosis.. 2024;7:. doi:org/10.1016/j.modpat.2024.100509.$4$YR$$F$Y$$$20240719$$HP$US$US
241211301$24121130$1$I$$20240718$20240722$20240722$EXP$$CA-ABBVIE-5847093$ABBVIE$$64$YR$$M$Y$$$20240722$$MD$CA$CA
241211311$24121131$1$I$20240708$20240715$20240722$20240722$PER$$US-AMGEN-USASP2024140272$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241211323$24121132$3$F$20240101$20240822$20240722$20240830$EXP$$US-TEVA-VS-3222301$TEVA$$24$YR$$F$Y$$$20240830$$HP$US$US
241211331$24121133$1$I$20240708$20240712$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112073$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$82.1$KG$20240722$$HP$US$US
241211341$24121134$1$I$20240708$20240717$20240722$20240722$EXP$$CN-MYLANLABS-2024M1067420$MYLAN$$76$YR$$F$Y$50$KG$20240722$$HP$CN$CN
241211351$24121135$1$I$$20240718$20240722$20240722$EXP$$US-ABBVIE-5845810$ABBVIE$$$$$M$Y$$$20240722$$HP$US$US
241211362$24121136$2$F$20240719$20240725$20240722$20240728$EXP$$NVSC2024IN149968$NOVARTIS$$87$YR$$M$Y$$$20240729$$CN$IN$IN
241211371$24121137$1$I$$20240717$20240722$20240722$EXP$$NVSC2024CN148777$NOVARTIS$$65$YR$$M$Y$$$20240722$$CN$CN$CN
241211381$24121138$1$I$$20240718$20240722$20240722$EXP$$US-ABBVIE-5845900$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241211391$24121139$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089630$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241211401$24121140$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089619$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241211411$24121141$1$I$$20240711$20240722$20240722$EXP$$GB-009507513-2407GBR009137$MERCK$$$$$F$Y$$$20240722$$CN$GB$GB
241211422$24121142$2$F$$20240827$20240722$20240830$EXP$$JP-BAYER-2024A105028$BAYER$$$$$F$Y$$$20240830$$MD$JP$JP
241211431$24121143$1$I$$20240716$20240722$20240722$EXP$$FR-MYLANLABS-2024M1066548$MYLAN$$44$YR$$M$Y$$$20240722$$CN$FR$FR
241211442$24121144$2$F$20240217$20240730$20240722$20240801$EXP$$CA-AMERICAN REGENT INC-2024002728$AMERICAN REGENT$$46$YR$$F$Y$$$20240801$$HP$CA$CA
241211451$24121145$1$I$20240626$20240719$20240722$20240722$EXP$$DE-JNJFOC-20240755766$JOHNSON AND JOHNSON$$91$YR$E$M$Y$79$KG$20240722$$MD$DE$DE
241211461$24121146$1$I$$20240718$20240722$20240722$EXP$$BR-JNJFOC-20240753430$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240722$$MD$BR$BR
241211471$24121147$1$I$20240608$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50140$$FDA-CTU$$77$YR$$M$N$$$20240719$N$HP$US$
241211481$24121148$1$I$20200311$20240708$20240722$20240722$EXP$$ES-IOVANCE BIOTHERAPEUTICS INC.-IOV2020000001$IOVANCE BIOTHERAPEUTICS$$46$YR$$M$Y$$$20240717$$MD$ES$ES
241211491$24121149$1$I$20240626$20240712$20240722$20240722$EXP$FR-AFSSAPS-TS2024000768$FR-TEVA-VS-3221301$TEVA$$72$YR$$F$Y$52$KG$20240722$$MD$FR$FR
241211501$24121150$1$I$20240419$20240716$20240722$20240722$EXP$AU-TGA-0000814239$AU-SANDOZ INC.-SDZ2024AU066370$SANDOZ$$79$YR$$M$Y$$$20240722$$CN$AU$AU
241211511$24121151$1$I$$20240716$20240722$20240722$EXP$$AU-TGA-0000813111$SANDOZ$$13$YR$$$Y$$$20240722$$HP$AU$AU
241211522$24121152$2$F$$20240724$20240722$20240731$EXP$$CA-GSK-CA2024088649$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$MD$CA$CA
241211531$24121153$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089836$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241211541$24121154$1$I$$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50230$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241211551$24121155$1$I$$20240711$20240722$20240722$EXP$$US-RDY-LIT/USA/24/0010521$DR REDDYS$Allonce J, Patel V. New-onset Refractory Status Epilepticus Induced by Synthetic Marijuana: A Case Report. American Journal of Respiratory and Critical Care Medicine. 209: A2117. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2117.$26$YR$A$M$Y$$$20240722$$HP$US$US
241211561$24121156$1$I$$20240715$20240722$20240722$PER$$US-BIOGEN-2024BI01273911$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
241211571$24121157$1$I$20240101$20240712$20240722$20240722$EXP$$CZ-TEVA-VS-3221756$TEVA$$61$YR$$F$Y$$$20240722$$CN$CZ$CZ
241211581$24121158$1$I$$20240717$20240722$20240722$PER$$US-TAKEDA-2024TUS073075$TAKEDA$$$$$$Y$$$20240722$$CN$US$US
241211591$24121159$1$I$$20240715$20240722$20240722$EXP$$AU-SANDOZ INC.-SDZ2024AU065331$SANDOZ$$42$YR$$F$Y$$$20240722$$HP$AU$AU
241211611$24121161$1$I$$20240624$20240722$20240722$PER$$US-JNJFOC-20240711291$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$HP$US$US
241211621$24121162$1$I$20191201$20191223$20240722$20240722$EXP$$CO-AstraZeneca-2019SF89755$ASTRAZENECA$$21077$DY$$F$Y$$$20240722$$CN$CO$
241211631$24121163$1$I$20240716$20240718$20240722$20240722$EXP$$US-AstraZeneca-2024A164826$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241211641$24121164$1$I$20240423$20240717$20240722$20240722$EXP$$US-AstraZeneca-2024A163518$ASTRAZENECA$$$$$$Y$$$20240722$$CN$US$
241211651$24121165$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50309$$FDA-CTU$$76$YR$$F$N$$$20240722$N$$US$
241211661$24121166$1$I$$20201125$20240722$20240722$EXP$$US-AstraZeneca-2020SF58513$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241211672$24121167$2$F$$20240718$20240722$20240723$EXP$$IT-AstraZeneca-2024A161819$ASTRAZENECA$Rotundo S, Berardelli L, Gulli S, La Gamba V, Lionello R, Russo A, et al.. Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study.. BMC Infectious Diseases 2024;24(564):$$$A$$Y$$$20240723$$HP$IT$
241211681$24121168$1$I$$20200401$20240722$20240722$EXP$$US-AstraZeneca-2020SE47549$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241211691$24121169$1$I$$20240717$20240722$20240722$EXP$$GB-SANDOZ INC.-SDZ2024GB066453$SANDOZ$$$$$M$Y$$$20240722$$CN$GB$GB
241211711$24121171$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012094$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240722$$CN$US$US
241211721$24121172$1$I$20240701$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012991$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241211731$24121173$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012294$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240722$$CN$US$US
241211741$24121174$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407010813$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240722$$HP$US$US
241211751$24121175$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013409$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240722$$CN$US$US
241211761$24121176$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012266$ELI LILLY AND CO$$$$$$Y$$$20240722$$CN$US$US
241211772$24121177$2$F$20240714$20240723$20240722$20240726$PER$$US-AMGEN-USASP2024141713$AMGEN$$78$YR$E$F$Y$$$20240725$$HP$US$US
241211781$24121178$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087036$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
241211793$24121179$3$F$20240701$20240730$20240722$20240803$PER$$US-AMGEN-USASP2024143910$AMGEN$$77$YR$E$F$Y$$$20240802$$CN$US$US
241211801$24121180$1$I$20240501$20240718$20240722$20240722$EXP$GB-MHRA-TPP10772581C22275880YC1721237511184$GB-MYLANLABS-2024M1067721$MYLAN$$62$YR$$F$Y$82$KG$20240722$$MD$GB$GB
241211811$24121181$1$I$20240501$20240718$20240722$20240722$EXP$$SG-MYLANLABS-2024M1067428$MYLAN$$74$YR$$F$Y$$$20240722$$HP$SG$SG
241211821$24121182$1$I$$20240718$20240722$20240722$EXP$$GB-MYLANLABS-2024M1067730$MYLAN$$$$$M$Y$$$20240722$$CN$GB$GB
241211831$24121183$1$I$$20240717$20240722$20240722$PER$$US-PFIZER INC-PV202400094495$PFIZER$$52$YR$$F$Y$$$20240722$$CN$US$US
241211842$24121184$2$F$20240401$20240719$20240722$20240725$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006278$AURINIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240725$$MD$US$US
241211853$24121185$3$F$$20240822$20240722$20240828$EXP$$GB-BAYER-2024A103845$BAYER$$66$YR$E$M$Y$$$20240828$$HP$GB$GB
241211862$24121186$2$F$$20240726$20240722$20240730$EXP$$JP-ARGENX-2024-ARGX-JP005710$ARGENX BVBA$$$$$$Y$$$20240730$$MD$JP$JP
241211881$24121188$1$I$$20240716$20240722$20240722$EXP$$AU-SANDOZ INC.-SDZ2024AU065742$SANDOZ$$17$MON$$$Y$$$20240722$$HP$AU$AU
241211891$24121189$1$I$20220901$20240718$20240722$20240722$EXP$$CA-SANDOZ INC.-NVSC2022CA175416$SANDOZ$$58$YR$$M$Y$$$20240722$$CN$CA$CA
241211901$24121190$1$I$$20240716$20240722$20240722$EXP$$AU-SANDOZ INC.-SDZ2024AU065897$SANDOZ$$$$$$Y$$$20240722$$HP$AU$AU
241211911$24121191$1$I$20240609$20240710$20240722$20240722$EXP$$DE-ROCHE-10000030458$ROCHE$$34$YR$A$M$Y$$$20240722$$MD$DE$DE
241211921$24121192$1$I$$20240718$20240722$20240722$PER$$NVSC2024US150073$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
241211932$24121193$2$F$$20240805$20240722$20240904$30DAY$$JP-UCBSA-2024031254$UCB$$$$$$Y$$$20240904$$CN$JP$JP
241211941$24121194$1$I$$20240717$20240722$20240722$EXP$$AU-SANDOZ INC.-SDZ2024AU066167$SANDOZ$$1$MON$$F$Y$$$20240722$$CN$AU$AU
241211952$24121195$2$F$$20240805$20240722$20240806$PER$$US-ABBVIE-5845437$ABBVIE$$$$$$Y$$$20240806$$CN$US$US
241211961$24121196$1$I$$20240718$20240722$20240722$EXP$GB-MHRA-MED-202407180945033220-DTZNS$GB-MYLANLABS-2024M1067345$MYLAN$$$$$$Y$$$20240722$$CN$GB$GB
241211982$24121198$2$F$20240716$20240726$20240722$20240731$EXP$$NZ-MYLANLABS-2024M1067453$MYLAN$$71$YR$$F$Y$$$20240731$$HP$NZ$NZ
241211991$24121199$1$I$$20240712$20240722$20240722$EXP$$AT-TEVA-VS-3221828$TEVA$Literature Reference: Spanberger T., Therapeutic success in the relapse of multiple myeloma [Therapieerfolg im Rezidiv des Multiplen Myeloms]. Spectrum Onkologie; 2024 (Nr. 3): p. 99.$66$YR$$F$Y$$$20240722$$MD$AT$AT
241212001$24121200$1$I$20240722$20240722$20240722$20240722$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041175$BOEHRINGER INGELHEIM$$49$YR$A$F$Y$$$20240722$$CN$US$US
241212011$24121201$1$I$20240715$20240716$20240722$20240722$PER$$US-BIOGEN-2024BI01274053$BIOGEN$$42$YR$$F$Y$$$20240722$$CN$US$US
241212021$24121202$1$I$20231201$20240717$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2023US059040$SANDOZ$$58$YR$$F$Y$100.23$KG$20240722$$CN$US$US
241212031$24121203$1$I$20240601$20240722$20240722$20240722$EXP$FR-AFSSAPS-TS2024000813$FR-SANDOZ INC.-SDZ2024FR066848$SANDOZ$$54$YR$$M$Y$72$KG$20240722$$MD$FR$FR
241212051$24121205$1$I$$20240718$20240722$20240722$EXP$$US-MYLANLABS-2024M1068106$MYLAN$Applegarth J, Finn D, Tolkacz M, Iacco A. Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome. ASAIO-J 2024; 70 (Suppl. 3) 151 (plus Poster) abstr. P74.$18$YR$$F$Y$$$20240722$$HP$US$US
241212071$24121207$1$I$$20240719$20240722$20240722$PER$$US-HALEON-2188083$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
241212081$24121208$1$I$$20240718$20240722$20240722$EXP$$US-TAKEDA-2024TUS073172$TAKEDA$$$$$M$Y$$$20240722$$CN$US$US
241212091$24121209$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115931$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240722$$CN$US$US
241212101$24121210$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115903$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$60.78$KG$20240722$$CN$US$US
241212111$24121211$1$I$$20240720$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115867$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$78.47$KG$20240722$$CN$US$US
241212121$24121212$1$I$$20240715$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113326$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240722$$HP$US$US
241212131$24121213$1$I$$20240718$20240722$20240722$PER$$US-HALEON-2188167$Haleon PLC$$70$YR$$$Y$$$20240722$$CN$US$US
241212141$24121214$1$I$20240501$20240717$20240722$20240722$EXP$$US-ABBVIE-5845216$ABBVIE$$22$YR$$M$Y$$$20240722$$CN$US$US
241212151$24121215$1$I$20240101$20240717$20240722$20240722$EXP$$JP-ANIPHARMA-2024-JP-000191$ANI$$90$YR$$F$Y$$$20240722$$PH$JP$JP
241212162$24121216$2$F$20240718$20240726$20240722$20240730$EXP$$JP-ARGENX-2024-ARGX-JP005701$ARGENX BVBA$$$$$$Y$$$20240730$$MD$JP$JP
241212171$24121217$1$I$20240715$20240715$20240722$20240722$PER$$US-ABBVIE-5843973$ABBVIE$$67$YR$$F$Y$$$20240722$$CN$US$US
241212181$24121218$1$I$20240701$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142105$AMGEN$$$$$M$Y$$$20240722$$CN$US$US
241212192$24121219$2$F$$20240723$20240722$20240726$EXP$$US-AMGEN-USASP2024141716$AMGEN$$6$YR$C$M$Y$$$20240726$$CN$US$US
241212201$24121220$1$I$20240521$20240709$20240722$20240722$PER$$US-ALKERMES INC.-ALK-2024-001679$ALKERMES$$52$YR$$F$Y$57.642$KG$20240722$$HP$US$US
241212211$24121221$1$I$20230322$20240709$20240722$20240722$EXP$$GB-Ascend Therapeutics US, LLC-2159440$ASCEND$$51$YR$$F$Y$$$20240722$$$GB$GB
241212231$24121223$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50152$$FDA-CTU$$$$$M$N$$$20240722$N$HP$US$
241212241$24121224$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50311$$FDA-CTU$$33$YR$$F$N$$$20240722$N$$US$
241212251$24121225$1$I$20240718$20240718$20240718$20240718$DIR$710805$$FDA-CTU$$71$YR$$M$N$87.75$KG$20240718$N$PH$US$
241212261$24121226$1$I$20240715$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50266$$FDA-CTU$$81$YR$$M$N$$$20240718$N$HP$US$
241212271$24121227$1$I$20240718$20240718$20240718$20240718$DIR$710797$$FDA-CTU$$75$YR$$M$N$63$KG$20240718$N$PH$US$
241212281$24121228$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50227$$FDA-CTU$$$$$M$N$$$20240719$N$HP$US$
241212291$24121229$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50314$$FDA-CTU$$56$YR$$M$N$$$20240722$N$$US$
241212301$24121230$1$I$20240716$20240718$20240718$20240718$DIR$710812$$FDA-CTU$$64$YR$$F$N$$$20240718$Y$PH$US$
241212311$24121231$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50308$$FDA-CTU$$$$$M$N$$$20240719$N$HP$US$
241212321$24121232$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50295$$FDA-CTU$$31$YR$$F$N$$$20240722$N$$US$
241212331$24121233$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50214$$FDA-CTU$$$$$M$N$$$20240719$N$HP$US$
241212341$24121234$1$I$$20240718$20240718$20240718$DIR$710815$$FDA-CTU$$$$$F$N$54$KG$20240718$N$CN$US$
241212351$24121235$1$I$20240718$20240718$20240718$20240718$DIR$710804$$FDA-CTU$$26$YR$$F$N$85.5$KG$20240718$N$CN$US$
241212361$24121236$1$I$20240707$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50310$$FDA-CTU$$74$YR$$M$N$80$KG$20240719$N$PH$US$
241212371$24121237$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50286$$FDA-CTU$$$$$F$N$$$20240719$N$HP$US$
241212381$24121238$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50317$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241212401$24121240$1$I$20240525$20240718$20240718$20240718$DIR$710765$$FDA-CTU$$50$YR$$F$N$54.9$KG$20240718$N$CN$US$
241212421$24121242$1$I$20240708$20240710$20240722$20240722$EXP$$CN-ALCON LABORATORIES-ALC2024CN003374$ALCON$$74$YR$$M$Y$70$KG$20240722$$HP$CN$CN
241212432$24121243$2$F$$20240716$20240722$20240729$PER$$US-AMGEN-USASP2024142990$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241212441$24121244$1$I$$20240716$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159231$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241212451$24121245$1$I$$20240715$20240722$20240722$EXP$$SE-SA-2024SA208146$SANOFI AVENTIS$$$$$F$Y$$$20240722$$CN$SE$SE
241212461$24121246$1$I$20240627$20240715$20240722$20240722$EXP$$US-GSK-US2024088603$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241212471$24121247$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087706$GLAXOSMITHKLINE$$$$$M$Y$$$20240722$$CN$US$US
241212481$24121248$1$I$20240701$20240715$20240722$20240722$EXP$$US-VIIV HEALTHCARE LIMITED-US2024088743$VIIV$$$$$M$Y$$$20240722$$CN$US$US
241212491$24121249$1$I$20240716$20240716$20240722$20240722$30DAY$$US-PFIZER INC-202400216579$PFIZER$$8$YR$$F$Y$18.6$KG$20240722$$CN$US$US
241212511$24121251$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400218574$PFIZER$$7$YR$$F$Y$33$KG$20240722$$HP$CA$CA
241212521$24121252$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400218641$PFIZER$$57$YR$$F$Y$97$KG$20240722$$HP$CA$CA
241212534$24121253$4$F$20240719$20240912$20240722$20240913$30DAY$$US-PFIZER INC-202400216678$PFIZER$$7$YR$$F$Y$$$20240913$$HP$US$US
241212542$24121254$2$F$$20240821$20240722$20240821$30DAY$$US-PFIZER INC-202400217130$PFIZER$$12$YR$$M$Y$$$20240821$$CN$US$US
241212551$24121255$1$I$20240501$20240715$20240722$20240722$PER$$US-ABBVIE-5841869$ABBVIE$$64$YR$$F$Y$$$20240722$$CN$US$US
241212561$24121256$1$I$$20240718$20240722$20240722$EXP$$GB-SANDOZ INC.-SDZ2024GB066438$SANDOZ$$$$$M$Y$$$20240722$$HP$GB$GB
241212571$24121257$1$I$$20240719$20240722$20240722$EXP$$US-SANDOZ INC.-SDZ2024US067010$SANDOZ$$$$$F$Y$$$20240722$$CN$US$US
241212584$24121258$4$F$20240518$20240902$20240722$20240904$EXP$$AR-TAKEDA-2024TUS053108$TAKEDA$$31$YR$$F$Y$40$KG$20240904$$CN$AR$AR
241212591$24121259$1$I$20210428$20210429$20240722$20240722$EXP$$TW-AstraZeneca-2021A390577$ASTRAZENECA$$64$YR$$M$Y$$$20240722$$CN$TW$
241212601$24121260$1$I$$20201208$20240722$20240722$EXP$$US-AstraZeneca-2020SF66503$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241212611$24121261$1$I$$20200901$20240722$20240722$EXP$$US-AstraZeneca-2020SF14153$ASTRAZENECA$$$$$M$Y$64$KG$20240722$$CN$US$
241212621$24121262$1$I$20240614$20240614$20240722$20240722$30DAY$$NL-UCBSA-2024032336$UCB$$79$YR$$M$Y$$$20240722$$PH$NL$NL
241212631$24121263$1$I$$20201023$20240722$20240722$EXP$$US-AstraZeneca-2020SF40804$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241212642$24121264$2$F$20220315$20240716$20240722$20240726$EXP$PL-URPL-DML-MLP.4401.1.743.2022$PL-MYLANLABS-2024M1066545$MYLAN$$17$YR$$F$Y$53$KG$20240726$$MD$PL$PL
241212651$24121265$1$I$$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50133$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241212661$24121266$1$I$20240710$20240718$20240718$20240718$DIR$710823$$FDA-CTU$$$$$F$N$$$20240718$Y$$US$
241212671$24121267$1$I$$20200218$20240722$20240722$EXP$$ID-AstraZeneca-2020SE27108$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$ID$
241212681$24121268$1$I$$20210317$20240722$20240722$EXP$$US-AstraZeneca-2021A177626$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241212692$24121269$2$F$$20240722$20240722$20240725$EXP$$JP-AstraZeneca-2024A164634$ASTRAZENECA$Kawamura N, et al. 1 A case of combined immunotherapy with two immune checkpoint inhibitors for non-small cell lung cancer complicated by HIV infection. The 120th Kansai Branch Academic Meeting of the Japan Lung Cancer Society 2024;47-.$69$YR$$M$Y$$$20240725$$MD$JP$
241212711$24121271$1$I$20240612$20240718$20240718$20240718$DIR$710828$$FDA-CTU$$69$YR$$M$N$$$20240718$N$PH$US$
241212721$24121272$1$I$$20200428$20240722$20240722$EXP$$US-AstraZeneca-2020SE57892$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241212736$24121273$6$F$$20240910$20240722$20240913$30DAY$$US-PFIZER INC-PV202400091007$PFIZER$$11$YR$$M$Y$$$20240913$$CN$US$US
241212742$24121274$2$F$20240712$20240822$20240722$20240822$30DAY$$US-PFIZER INC-202400214432$PFIZER$$2$YR$$M$Y$$$20240822$$CN$US$US
241212751$24121275$1$I$$20240625$20240722$20240722$PER$$US-AstraZeneca-2024A148399$ASTRAZENECA$$$$$$Y$$$20240722$$CN$US$
241212761$24121276$1$I$$20210325$20240722$20240722$EXP$$US-AstraZeneca-2021A230387$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241212771$24121277$1$I$$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50244$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241212791$24121279$1$I$$20191203$20240722$20240722$EXP$$US-AstraZeneca-2019SF74540$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241212801$24121280$1$I$20240501$20240718$20240722$20240722$EXP$$GB-SANDOZ INC.-SDZ2024GB066566$SANDOZ$$62$YR$$F$Y$82$KG$20240722$$MD$GB$GB
241212812$24121281$2$F$$20240830$20240722$20240903$PER$$US-AMGEN-USASP2024144099$AMGEN$$$$$$Y$$$20240903$$CN$US$US
241212823$24121282$3$F$20240724$20240912$20240722$20240919$EXP$$CA-TAKEDA-2024TUS071987$TAKEDA$$64$YR$$F$Y$$$20240919$$CN$CA$CA
241212831$24121283$1$I$20220101$20240717$20240722$20240722$EXP$$US-ABBVIE-5845167$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241212841$24121284$1$I$20220613$20240709$20240722$20240722$EXP$FR-AFSSAPS-RN2024000744$FR-RDY-SPO/FRA/24/0010188$DR REDDYS$$74$YR$E$M$Y$$$20240722$$MD$FR$FR
241212854$24121285$4$F$$20240909$20240722$20240916$EXP$$CA-GSK-CA2024088713$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$CA$CA
241212861$24121286$1$I$$20240717$20240722$20240722$EXP$$US-ORGANON-O2407USA001861$ORGANON$$$$$F$Y$$$20240722$$CN$US$US
241212871$24121287$1$I$$20240708$20240722$20240722$PER$$US-Calliditas-2024CAL01284$CALLIDITAS THERAPEUTICS$$51$YR$A$M$Y$106$KG$20240722$$CN$US$US
241212881$24121288$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114879$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$102.51$KG$20240722$$CN$US$US
241212891$24121289$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116242$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$CN$US$US
241212901$24121290$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115824$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240722$$CN$US$US
241212913$24121291$3$F$$20240826$20240722$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115590$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240828$$HP$US$US
241212921$24121292$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115964$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$89.36$KG$20240722$$CN$US$US
241212941$24121294$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115953$BRISTOL MYERS SQUIBB$$99$YR$E$M$Y$$$20240722$$CN$US$US
241212951$24121295$1$I$20240101$20240717$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114139$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240722$$HP$US$US
241212962$24121296$2$F$$20240718$20240722$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407013007$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240725$$CN$US$US
241212971$24121297$1$I$20240716$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012111$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240722$$CN$US$US
241212981$24121298$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011786$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240722$$CN$US$US
241212991$24121299$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115990$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$85.5$KG$20240722$$CN$US$US
241213001$24121300$1$I$$20240710$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407007632$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240722$$CN$US$US
241213011$24121301$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012037$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241213022$24121302$2$F$20240223$20240730$20240722$20240802$EXP$$CA-AMERICAN REGENT INC-2024002730$AMERICAN REGENT$$20$YR$$F$Y$$$20240802$$HP$CA$CA
241213031$24121303$1$I$$20240719$20240722$20240722$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041073$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$84$KG$20240722$$HP$GB$GB
241213042$24121304$2$F$$20240718$20240722$20240725$PER$$US-ABBVIE-5847349$ABBVIE$$$$$F$Y$$$20240725$$HP$US$US
241213051$24121305$1$I$$20240717$20240722$20240722$EXP$$US-KYOWAKIRIN-2024KK017208$KYOWA$$$$$$Y$$$20240722$$HP$US$US
241213061$24121306$1$I$$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143485$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241213072$24121307$2$F$$20240816$20240722$20240826$30DAY$$US-GSK-US2024AMR087176$GLAXOSMITHKLINE$$$$$M$Y$$$20240826$$PH$US$US
241213081$24121308$1$I$$20240712$20240722$20240722$30DAY$$US-GSK-US2024087721$GLAXOSMITHKLINE$$$$$F$Y$$$20240722$$CN$US$US
241213091$24121309$1$I$$20240709$20240722$20240722$EXP$$US-GSK-US2024081163$GLAXOSMITHKLINE$$$$$M$Y$$$20240722$$CN$US$US
241213102$24121310$2$F$20240626$20240813$20240722$20240823$EXP$GB-MHRA-MED-202407121035475230-VWCPD$GB-TEVA-VS-3221378$TEVA$$88$YR$$M$Y$66$KG$20240823$$MD$GB$GB
241213111$24121311$1$I$20240404$20240717$20240722$20240722$EXP$$US-MYLANLABS-2024M1067636$MYLAN$$21$YR$$F$Y$$$20240722$$HP$US$US
241213121$24121312$1$I$20240701$20240716$20240722$20240722$EXP$$DE-MYLANLABS-2024M1066818$MYLAN$$$$A$F$Y$87$KG$20240722$$MD$DE$DE
241213132$24121313$2$F$$20240722$20240722$20240725$EXP$$CZ-MYLANLABS-2024M1066811$MYLAN$Bloomfield M, Klocperk A, Schneiderova H, Hlavackova E, Turnovec M, Tichy L et. al.. The expansion of national newborn screening marks an advancement in diagnosing patients with severe inborn errors of immunity. Cesko-slovenska pediatrie. 2024;79(3):136-41$7$WK$$M$Y$$$20240725$$HP$CZ$CZ
241213141$24121314$1$I$$20240716$20240722$20240722$EXP$NL-LRB-00981494$NL-MYLANLABS-2024M1066913$MYLAN$$65$YR$$F$Y$$$20240722$$MD$NL$NL
241213151$24121315$1$I$20210101$20240717$20240722$20240722$EXP$AU-ASPEN-AUS2024AU003585$AU-SANDOZ INC.-SDZ2024AU066371$SANDOZ$$10$YR$$F$Y$$$20240722$$HP$AU$AU
241213161$24121316$1$I$$20240718$20240722$20240722$EXP$$CA-TAKEDA-2024TUS073222$TAKEDA$$41$YR$$M$Y$$$20240722$$HP$CA$CA
241213171$24121317$1$I$20240507$20240718$20240718$20240718$DIR$710782$$FDA-CTU$$60$YR$$F$N$103.5$KG$20240718$Y$MD$US$
241213181$24121318$1$I$20240710$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50255$$FDA-CTU$$69$YR$$F$N$$$20240718$N$HP$US$
241213191$24121319$1$I$20240710$20240718$20240718$20240718$DIR$710829$$FDA-CTU$$41$YR$$F$N$$$20240718$Y$PH$US$
241213201$24121320$1$I$$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50224$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241213211$24121321$1$I$20240611$20240718$20240718$20240718$DIR$710833$$FDA-CTU$$24$YR$$F$N$$$20240718$N$CN$US$
241213221$24121322$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50138$$FDA-CTU$$$$$F$N$$$20240719$N$HP$US$
241213231$24121323$1$I$20240718$20240718$20240718$20240718$DIR$710809$$FDA-CTU$$34$YR$$F$N$85.5$KG$20240718$N$CN$US$
241213241$24121324$1$I$20240715$20240718$20240718$20240718$DIR$710806$$FDA-CTU$$48$YR$$F$N$78$KG$20240718$N$$US$
241213251$24121325$1$I$$20240719$20240722$20240722$PER$$NVSC2024US150071$NOVARTIS$$$$$F$Y$$$20240722$$PH$US$US
241213261$24121326$1$I$$20240715$20240722$20240722$EXP$$US-ABBVIE-5843240$ABBVIE$$$$$F$Y$$$20240722$$HP$US$US
241213274$24121327$4$F$$20240816$20240722$20240930$PER$$US-LUNDBECK-DKLU4001747$LUNDBECK$$$$$$Y$$$20241001$$CN$US$US
241213281$24121328$1$I$20240514$20240611$20240722$20240722$PER$$US-JNJFOC-20240756868$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240722$$PH$US$US
241213291$24121329$1$I$20240514$20240611$20240722$20240722$PER$$US-JNJFOC-20240756870$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240722$$PH$US$US
241213301$24121330$1$I$$20200813$20240722$20240722$EXP$$US-AstraZeneca-2020SF04231$ASTRAZENECA$$$$$F$Y$$$20240722$$CN$US$
241213314$24121331$4$F$20231101$20240819$20240722$20240822$EXP$$BR-AstraZeneca-2024A139182$ASTRAZENECA$$45$YR$$M$Y$83$KG$20240822$$CN$BR$
241213321$24121332$1$I$20240712$20240712$20240722$20240722$EXP$$CH-MYLANLABS-2024M1065531$MYLAN$$$$$F$Y$$$20240722$$CN$CH$CH
241213343$24121334$3$F$20240227$20240823$20240722$20240829$EXP$$US-AstraZeneca-2024A166184$ASTRAZENECA$$69$YR$$M$Y$68.7$KG$20240829$$HP$US$
241213351$24121335$1$I$20240627$20240718$20240718$20240718$DIR$710817$$FDA-CTU$$41$YR$$F$N$94.5$KG$20240718$Y$CN$US$
241213372$24121337$2$F$$20240718$20240722$20240815$EXP$$JP-AstraZeneca-2024A164968$ASTRAZENECA$$82$YR$$M$Y$$$20240815$$MD$JP$
241213383$24121338$3$F$20220617$20240917$20240722$20240918$EXP$$AT-MYLANLABS-2024M1064584$MYLAN$$29$YR$$M$Y$88.2$KG$20240918$$HP$AT$AT
241213391$24121339$1$I$$20240717$20240722$20240722$EXP$$JP-AstraZeneca-2024A164333$ASTRAZENECA$$$$$$Y$$$20240722$$MD$JP$
241213401$24121340$1$I$20240101$20240716$20240722$20240722$EXP$$US-ABBVIE-5844068$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241213422$24121342$2$F$20240101$20240723$20240722$20240726$EXP$$US-ABBVIE-5844801$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241213432$24121343$2$F$$20240918$20240722$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115933$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240924$$CN$US$US
241213441$24121344$1$I$$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115895$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240722$$CN$US$US
241213451$24121345$1$I$$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115593$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240722$$CN$US$US
241213461$24121346$1$I$20240722$20240722$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041189$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$$$20240722$$CN$US$US
241213471$24121347$1$I$20240319$20240716$20240722$20240722$EXP$$DE-MYLANLABS-2024M1067290$MYLAN$$84$YR$$F$Y$67$KG$20240722$$MD$DE$DE
241213481$24121348$1$I$20240705$20240715$20240722$20240722$PER$$US-ABBVIE-5843233$ABBVIE$$17$YR$$F$Y$$$20240722$$CN$US$US
241213491$24121349$1$I$$20240715$20240722$20240722$EXP$$AR-GSK-AR2024AMR090032$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$AR$AR
241213501$24121350$1$I$$20240711$20240722$20240722$PER$$US-JNJFOC-20240754114$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240722$$CN$US$US
241213511$24121351$1$I$$20240709$20240722$20240722$EXP$$JP-FERRINGPH-2024FE03866$FERRING$Sugita S, Ueno T, Takahashi K, Fukumoto W, Matsushita R, Yoshino H et. al. A case of metastatic prostate cancer with onset of aplasia pure red cell due to degarelix acetate. The 148th Academic Meeting of Kagoshima Division of the Japanese Urological Asso. 2024;6-7$$$$$Y$$$20240722$$MD$JP$JP
241213521$24121352$1$I$20240514$20240611$20240722$20240722$PER$$US-JNJFOC-20240756795$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240722$$PH$US$US
241213531$24121353$1$I$20240612$20240715$20240722$20240722$EXP$$CA-JNJFOC-20240744037$JOHNSON AND JOHNSON$$17$YR$T$M$Y$48$KG$20240722$$HP$CA$CA
241213541$24121354$1$I$$20240717$20240722$20240722$EXP$$JP-FERRINGPH-2024FE04012$FERRING$$$$$$Y$$$20240722$$HP$JP$JP
241213552$24121355$2$F$20220330$20240725$20240722$20240805$PER$$US-BAYER-2024A105573$BAYER$$45$YR$A$F$Y$$$20240805$$HP$US$US
241213561$24121356$1$I$20230201$20240710$20240722$20240722$EXP$$AU-Nova Laboratories Limited-2159441$NOVA LABORATORIES$Litereatrue referenced?Author: Title: Thiopurines and risk of lymphoproliferative disorders?Volume: 47 Year: 2024 Pages: 91   3$29$YR$$M$Y$$$20240722$$$AU$AU
241213572$24121357$2$F$20240707$20240822$20240722$20240829$30DAY$$US-GSK-US2024085117$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240829$$CN$US$US
241213581$24121358$1$I$20240101$20240718$20240722$20240722$EXP$FR-AFSSAPS-BR2024000585$FR-AMGEN-FRASP2024143407$AMGEN$$34$YR$A$M$Y$$$20240722$$MD$FR$FR
241213591$24121359$1$I$$20240718$20240722$20240722$EXP$$US-BAYER-2024A068292$BAYER$$61$YR$A$M$Y$$$20240722$$CN$US$US
241213611$24121361$1$I$$20240710$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116240$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$85.68$KG$20240722$$CN$US$US
241213631$24121363$1$I$$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116022$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240722$$CN$US$US
241213642$24121364$2$F$20220316$20240722$20240722$20240727$EXP$$KR-ABBVIE-5845639$ABBVIE$$61$YR$$F$Y$67$KG$20240727$$MD$KR$KR
241213651$24121365$1$I$20240618$20240715$20240722$20240722$EXP$FR-AFSSAPS-LL2024001298$FR-RDY-SPO/FRA/24/0010439$DR REDDYS$$59$YR$A$F$Y$50$KG$20240722$$MD$FR$FR
241213661$24121366$1$I$$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50248$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241213671$24121367$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50290$$FDA-CTU$$61$YR$$F$N$104.33$KG$20240722$N$$US$
241213681$24121368$1$I$20240605$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50319$$FDA-CTU$$65$YR$$M$N$$$20240722$Y$HP$US$
241213691$24121369$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50321$$FDA-CTU$$90$YR$$F$N$$$20240722$N$$US$
241213701$24121370$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50322$$FDA-CTU$$82$YR$$F$N$$$20240722$N$$US$
241213711$24121371$1$I$20240201$20240716$20240722$20240722$PER$$US-BIOGEN-2024BI01250422$BIOGEN$$37$YR$$F$Y$$$20240722$$CN$US$US
241213721$24121372$1$I$$20240717$20240722$20240722$PER$$US-BIOGEN-2024BI01274228$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
241213731$24121373$1$I$20210801$20240715$20240722$20240722$PER$$US-BIOGEN-2021BI01043945$BIOGEN$$58$YR$$M$Y$$$20240722$$CN$US$US
241213742$24121374$2$F$$20240718$20240722$20240802$EXP$$CA-HLS-202401784$HLS THERAPEUTICS$$$$A$M$Y$$$20240802$$HP$CA$CA
241213751$24121375$1$I$20240710$20240710$20240722$20240722$PER$$US-ABBVIE-5838695$ABBVIE$$63$YR$$F$Y$$$20240722$$CN$US$US
241213761$24121376$1$I$20240712$20240717$20240722$20240722$EXP$$NVSC2024CN148954$NOVARTIS$$62$YR$$M$Y$70$KG$20240722$$HP$CN$CN
241213771$24121377$1$I$20240423$20240716$20240722$20240722$EXP$FR-AFSSAPS-RE2024000691$FR-MYLANLABS-2024M1066643$MYLAN$$79$YR$$M$Y$69.9$KG$20240722$$MD$FR$FR
241213781$24121378$1$I$20240711$20240716$20240722$20240722$EXP$GB-MHRA-MED-202407161037593610-HRPYF$GB-009507513-2407GBR010345$MERCK$$53$YR$$M$Y$$$20240722$$HP$GB$GB
241213792$24121379$2$F$$20240724$20240722$20240805$PER$$US-JNJFOC-20240754115$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$HP$US$US
241213801$24121380$1$I$20240514$20240611$20240722$20240722$PER$$US-JNJFOC-20240756764$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240722$$PH$US$US
241213812$24121381$2$F$$20240829$20240722$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115904$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$61.69$KG$20240830$$CN$US$US
241213821$24121382$1$I$$20240717$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116152$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240722$$CN$US$US
241213831$24121383$1$I$20240425$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115474$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240722$$CN$US$US
241213843$24121384$3$F$20240701$20240814$20240722$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115027$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240815$$PH$US$US
241213851$24121385$1$I$$20240718$20240722$20240722$EXP$$US-PFIZER INC-202400219075$PFIZER$$14$YR$$M$Y$$$20240722$$HP$US$US
241213871$24121387$1$I$$20240719$20240722$20240722$EXP$$GB-PFIZER INC-PV202400095483$PFIZER$$83$YR$$M$Y$$$20240722$$CN$GB$GB
241213884$24121388$4$F$20240422$20240801$20240722$20240806$EXP$$DE-PFIZER INC-202400218028$PFIZER$$17$YR$$F$Y$65$KG$20240806$$MD$DE$DE
241213891$24121389$1$I$20240621$20240718$20240722$20240722$EXP$FR-AFSSAPS-ST2024001140$FR-PFIZER INC-202400218033$PFIZER$$62$YR$$F$Y$104$KG$20240722$$MD$FR$FR
241213901$24121390$1$I$$20240719$20240722$20240722$EXP$$GB-PFIZER INC-PV202400094602$PFIZER$$73$YR$$F$Y$$$20240722$$CN$GB$GB
241213911$24121391$1$I$$20240718$20240722$20240722$EXP$$CA-PFIZER INC-202300306845$PFIZER$$54$YR$$M$Y$$$20240722$$CN$CA$CA
241213921$24121392$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400218659$PFIZER$$52$YR$$F$Y$$$20240722$$HP$CA$CA
241213931$24121393$1$I$20230810$20240718$20240722$20240722$EXP$$US-PFIZER INC-202400218948$PFIZER$$$$$F$Y$$$20240722$$CN$US$US
241213941$24121394$1$I$20220525$20240718$20240722$20240722$EXP$FR-AFSSAPS-PC2024000565$FR-PFIZER INC-202400218262$PFIZER$$72$YR$$F$Y$80$KG$20240722$$MD$FR$FR
241213951$24121395$1$I$20180504$20240624$20240722$20240722$EXP$$CA-ANIPHARMA-2020-CA-001572$ANI$$57$YR$$F$Y$$$20240722$$MD$CA$CA
241213961$24121396$1$I$$20240717$20240722$20240722$EXP$NO-NOMAADVRE-PASRAPP-2024-Vdkdz5$NO-PURDUE-USA-2024-0310872$PURDUE$$63$YR$$M$Y$98$KG$20240722$$CN$NO$NO
241213971$24121397$1$I$20240628$20240716$20240722$20240722$EXP$$CN-PURDUE-USA-2024-0310862$PURDUE$$28$YR$$F$Y$$$20240722$$HP$CN$CN
241213981$24121398$1$I$20240621$20240716$20240722$20240722$EXP$$CN-PURDUE-USA-2024-0310881$PURDUE$$73$YR$$M$Y$48.9$KG$20240722$$HP$CN$CN
241213991$24121399$1$I$20230701$20240715$20240722$20240722$EXP$ES-AEMPS-1545540$ES-FreseniusKabi-FK202411176$FRESENIUS KABI$$42$YR$A$M$Y$$$20240719$$PH$ES$ES
241214011$24121401$1$I$20240315$20240718$20240722$20240722$EXP$$NVSC2024CN149921$NOVARTIS$$75$YR$$M$Y$75$KG$20240722$$HP$CN$CN
241214021$24121402$1$I$20240711$20240711$20240722$20240722$30DAY$$US-GSK-US2024086349$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240722$$CN$US$US
241214041$24121404$1$I$20240714$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50324$$FDA-CTU$$87$YR$$F$N$$$20240722$N$$US$
241214051$24121405$1$I$20240601$20240721$20240722$20240722$EXP$$EG-PFIZER INC-PV202400094770$PFIZER$$42$YR$$F$Y$60$KG$20240722$$PH$EG$EG
241214066$24121406$6$F$$20240813$20240722$20240815$EXP$$US-PFIZER INC-PV202300144207$PFIZER$$25$YR$$M$Y$$$20240815$$CN$US$US
241214071$24121407$1$I$20240620$20240715$20240722$20240722$EXP$FR-AFSSAPS-LL2024001308$FR-FreseniusKabi-FK202411260$FRESENIUS KABI$$76$YR$E$F$Y$$$20240719$$MD$FR$FR
241214081$24121408$1$I$$20240710$20240722$20240722$PER$$US-TEVA-VS-3220733$TEVA$$$$$F$Y$$$20240722$$PH$US$US
241214101$24121410$1$I$20180828$20240710$20240722$20240722$EXP$$BE-Nova Laboratories Limited-2159442$NOVA LABORATORIES$$37$YR$$M$Y$$$20240722$$$BE$BE
241214111$24121411$1$I$20231128$20240715$20240722$20240722$EXP$FR-AFSSAPS-ST2024001137$FR-FreseniusKabi-FK202411165$FRESENIUS KABI$$65$YR$E$F$Y$56.5$KG$20240719$$HP$FR$FR
241214121$24121412$1$I$20240709$20240715$20240722$20240722$PER$$US-JNJFOC-20240756162$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240722$$CN$US$US
241214132$24121413$2$F$20240624$20240718$20240722$20240725$PER$$US-FreseniusKabi-FK202411112$FRESENIUS KABI$$54$YR$A$F$Y$64.18$KG$20240725$$HP$US$US
241214141$24121414$1$I$20240418$20240715$20240722$20240722$EXP$FR-AFSSAPS-MP2024001149$FR-FreseniusKabi-FK202411262$FRESENIUS KABI$$1$YR$I$M$Y$11.5$KG$20240719$$MD$FR$FR
241214152$24121415$2$F$20240619$20240718$20240722$20240821$PER$$US-FreseniusKabi-FK202411114$FRESENIUS KABI$$57$YR$A$F$Y$57.15$KG$20240821$$HP$US$US
241214161$24121416$1$I$$20240717$20240722$20240722$EXP$$CA-SANDOZ INC.-SDZ2023CA004187$SANDOZ$$$$$F$Y$$$20240722$$CN$CA$CA
241214171$24121417$1$I$20240530$20240715$20240722$20240722$EXP$$FR-FreseniusKabi-FK202411159$FRESENIUS KABI$$67$YR$E$F$Y$52$KG$20240719$$PH$FR$FR
241214183$24121418$3$F$$20240821$20240722$20240822$EXP$$ES-Nova Laboratories Limited-2159443$NOVA LABORATORIES$$5$MON$$M$Y$$$20240822$$$ES$ES
241214193$24121419$3$F$$20240821$20240722$20240829$EXP$$AU-AstraZeneca-2024A163385$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$AU$
241214201$24121420$1$I$$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024143150$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241214213$24121421$3$F$$20240909$20240722$20240913$EXP$$JP-AstraZeneca-2024A164881$ASTRAZENECA$Misaka S.. P-256 A case of ovarian cancer with prolonged anaphylactic shock due to. Japanese Journal of Gynecological Oncology 2024;42(3):418.$57$YR$$F$Y$$$20240913$$MD$JP$
241214221$24121422$1$I$20240222$20240717$20240722$20240722$EXP$$FR-DSJP-DSE-2024-136619$DAIICHI$$$$E$F$Y$93$KG$20240722$$MD$FR$FR
241214231$24121423$1$I$20230317$20240715$20240722$20240722$EXP$PL-URPL-DML-MLP.4401.1.813.2023$PL-FreseniusKabi-FK202411135$FRESENIUS KABI$$$$$$Y$$$20240719$$PH$PL$PL
241214241$24121424$1$I$$20240715$20240722$20240722$EXP$$FR-FreseniusKabi-FK202411259$FRESENIUS KABI$$$$$F$Y$$$20240719$$MD$FR$FR
241214252$24121425$2$F$20240701$20240730$20240722$20240801$EXP$$GR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040883$BOEHRINGER INGELHEIM$$44$YR$A$M$Y$35$KG$20240801$$MD$GR$GR
241214261$24121426$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2019096520$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241214271$24121427$1$I$20240202$20240718$20240722$20240722$PER$$US-009507513-2407USA011778$MERCK$$56$YR$$F$Y$$$20240722$$CN$US$US
241214282$24121428$2$F$$20240821$20240722$20240822$EXP$$CA-PFIZER INC-202400218810$PFIZER$$76$YR$$F$Y$$$20240822$$MD$CA$CA
241214291$24121429$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400218680$PFIZER$$30$YR$$M$Y$$$20240722$$HP$CA$CA
241214301$24121430$1$I$$20240716$20240722$20240722$30DAY$$US-SANDOZ INC.-SDZ2024US066080$SANDOZ$$$$$F$Y$$$20240722$$CN$US$US
241214312$24121431$2$F$$20240826$20240722$20240904$EXP$$IT-TEVA-VS-3220845$TEVA$De Sanctis V, Soliman AT, Daar S, Tzoulis P, Di Maio S, Kattamis C. Longitudinal study of ICET-A on glucose tolerance, insulin sensitivity and beta-cell secretion in eleven beta-thalassemia major patients with mild iron overload. Acta-Biomed 2023; 94 (1): e2023011.; De Sanctis V, Soliman AT, Daar S, Tzoulis P, Di Maio S, Kattamis C. Longitudinal study of ICET-A on glucose tolerance, insulin sensitivity and beta-cell secretion in eleven beta-thalassemia major patients with mild iron overload. ...$$$$$Y$$$20240904$$MD$IT$IT
241214322$24121432$2$F$$20240820$20240722$20240822$EXP$$CA-PFIZER INC-202400218726$PFIZER$$76$YR$$F$Y$$$20240822$$CN$CA$CA
241214331$24121433$1$I$20240224$20240616$20240722$20240722$EXP$$CN-PFIZER INC-2024SGN02589$PFIZER$$53$YR$$M$Y$82$KG$20240722$$MD$CN$CN
241214342$24121434$2$F$$20240715$20240722$20240726$EXP$$US-GSK-US2024AMR089623$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241214351$24121435$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50327$$FDA-CTU$$50$YR$$F$N$$$20240722$N$$US$
241214361$24121436$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50326$$FDA-CTU$$77$YR$$F$N$108.86$KG$20240722$N$$US$
241214371$24121437$1$I$20240425$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50225$$FDA-CTU$$79$YR$$M$N$$$20240719$N$HP$US$
241214381$24121438$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50228$$FDA-CTU$$61$YR$$$N$88$KG$20240722$N$$US$
241214391$24121439$1$I$20240601$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50203$$FDA-CTU$$39$YR$$F$N$$$20240719$N$HP$US$
241214401$24121440$1$I$20240712$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50160$$FDA-CTU$$39$YR$$F$N$$$20240719$N$HP$US$
241214411$24121441$1$I$20240708$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50157$$FDA-CTU$$38$YR$$M$N$$$20240719$N$HP$US$
241214421$24121442$1$I$20240704$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50267$$FDA-CTU$$35$YR$$F$N$$$20240718$N$HP$US$
241214431$24121443$1$I$20240709$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50261$$FDA-CTU$$21$YR$$F$N$$$20240719$N$HP$US$
241214441$24121444$1$I$20240514$20240611$20240722$20240722$PER$$US-JNJFOC-20240756565$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240722$$PH$US$US
241214452$24121445$2$F$20240501$20240820$20240722$20240901$PER$$US-JNJFOC-20240756564$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240901$$PH$US$US
241214461$24121446$1$I$20240514$20240611$20240722$20240722$PER$$US-JNJFOC-20240756375$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240722$$PH$US$US
241214471$24121447$1$I$20240514$20240611$20240722$20240722$PER$$US-JNJFOC-20240756613$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240722$$PH$US$US
241214481$24121448$1$I$20240514$20240611$20240722$20240722$PER$$US-JNJFOC-20240756373$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240722$$PH$US$US
241214492$24121449$2$F$$20240722$20240722$20240723$PER$$US-JNJFOC-20240745431$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$MD$US$US
241214501$24121450$1$I$20240514$20240611$20240722$20240722$PER$$US-JNJFOC-20240756556$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240722$$PH$US$US
241214512$24121451$2$F$20240514$20240822$20240722$20240902$PER$$US-JNJFOC-20240756605$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240902$$PH$US$US
241214521$24121452$1$I$$20240719$20240722$20240722$PER$$US-BAYER-2024A106072$BAYER$$$$$$Y$$$20240722$$CN$US$US
241214531$24121453$1$I$20240707$20240719$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115732$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240722$$HP$US$US
241214541$24121454$1$I$20240617$20240712$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111693$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$88.9$KG$20240722$$MD$US$US
241214552$24121455$2$F$20240101$20240802$20240722$20240807$EXP$$US-ABBVIE-5844139$ABBVIE$$$$$F$Y$90$KG$20240807$$CN$US$US
241214561$24121456$1$I$20240708$20240721$20240722$20240722$DIR$FDA-CDER-CTU-2024-50307$$FDA-CTU$$9$YR$$M$N$$$20240721$N$HP$US$
241214571$24121457$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50275$$FDA-CTU$$58$YR$$M$N$$$20240719$N$PH$US$
241214581$24121458$1$I$$20240716$20240722$20240722$EXP$$US-ABBVIE-5613113$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241214591$24121459$1$I$20240722$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50313$$FDA-CTU$$79$YR$$F$N$$$20240722$N$PH$US$
241214601$24121460$1$I$$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50223$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241214611$24121461$1$I$20240101$20240715$20240722$20240722$EXP$$CA-JNJFOC-20240744343$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240722$$HP$CA$CA
241214621$24121462$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50285$$FDA-CTU$$52$YR$$F$N$83.91$KG$20240722$N$$US$
241214631$24121463$1$I$20240514$20240611$20240722$20240722$PER$$US-JNJFOC-20240757200$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240722$$PH$US$US
241214651$24121465$1$I$20240601$20240711$20240722$20240722$EXP$$MX-ROCHE-10000027024$ROCHE$$54$YR$A$F$Y$62$KG$20240722$$CN$MX$MX
241214661$24121466$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50329$$FDA-CTU$$68$YR$$F$N$$$20240722$N$$US$
241214671$24121467$1$I$$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50132$$FDA-CTU$$$$$M$N$$$20240718$N$HP$US$
241214684$24121468$4$F$20240612$20240912$20240722$20240916$PER$$US-PFIZER INC-202400218934$PFIZER$$80$YR$$M$Y$73.016$KG$20240916$$CN$US$US
241214691$24121469$1$I$20240717$20240719$20240722$20240722$PER$$US-HALEON-2188106$Haleon PLC$$67$YR$$F$Y$$$20240722$$CN$US$US
241214701$24121470$1$I$20240101$20240716$20240722$20240722$PER$$IN-Eisai-EC-2024-170354$EISAI$$73$YR$E$M$Y$$$20240722$$CN$IN$IN
241214711$24121471$1$I$20231030$20240711$20240722$20240722$EXP$IT-MINISAL02-993559$IT-TEVA-VS-3220521$TEVA$$67$YR$$F$Y$$$20240722$$MD$IT$IT
241214721$24121472$1$I$$20240712$20240722$20240722$EXP$$JP-009507513-2311JPN000750J$MERCK$$61$YR$$M$Y$$$20240722$$MD$JP$JP
241214731$24121473$1$I$20190501$20240715$20240722$20240722$EXP$$US-GSK-US2019162845$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241214741$24121474$1$I$$20240712$20240722$20240722$PER$$US-JNJFOC-20240756163$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
241214751$24121475$1$I$$20240717$20240722$20240722$PER$$US-BAYER-2024A106075$BAYER$$$$$$Y$$$20240722$$CN$US$US
241214761$24121476$1$I$20240619$20240716$20240722$20240722$PER$$NVSC2024US147280$NOVARTIS$$32$YR$$$Y$$$20240722$$HP$US$US
241214772$24121477$2$F$20240318$20240912$20240722$20240916$EXP$$JP-AstraZeneca-2024A077226$ASTRAZENECA$$72$YR$$M$Y$58$KG$20240916$$MD$JP$
241214781$24121478$1$I$$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50231$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241214791$24121479$1$I$20240717$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50263$$FDA-CTU$$26$YR$$F$N$$$20240718$N$HP$US$
241214801$24121480$1$I$20240429$20240719$20240719$20240719$DIR$710854$$FDA-CTU$$70$YR$$M$N$86.4$KG$20240719$Y$MD$US$
241214811$24121481$1$I$20240427$20240719$20240719$20240719$DIR$710865$$FDA-CTU$$39$YR$$F$N$107.55$KG$20240719$N$CN$US$
241214841$24121484$1$I$$20240719$20240719$20240719$DIR$710859$$FDA-CTU$$$$$F$N$$$20240719$N$HP$US$
241214851$24121485$1$I$$20240719$20240719$20240719$DIR$710860$$FDA-CTU$$$$$M$N$$$20240719$Y$HP$US$
241214863$24121486$3$F$20240101$20240801$20240722$20240807$EXP$$US-ABBVIE-5837230$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241214882$24121488$2$F$$20240722$20240722$20240724$EXP$$US-PFIZER INC-PV202400095025$PFIZER$$71$YR$$F$Y$49$KG$20240724$$HP$US$US
241214892$24121489$2$F$20210202$20240725$20240722$20240805$EXP$$PL-PFIZER INC-2021SGN01243$PFIZER$$71$YR$$F$Y$67$KG$20240805$$MD$PL$PL
241214901$24121490$1$I$$20240718$20240722$20240722$EXP$NL-LRB-00990425$NL-PFIZER INC-202400218199$PFIZER$$57$YR$$M$Y$80$KG$20240722$$MD$NL$NL
241214912$24121491$2$F$20240717$20240808$20240722$20240813$EXP$$DE-PFIZER INC-PV202400094615$PFIZER$$57$YR$$F$Y$$$20240813$$MD$DE$DE
241214921$24121492$1$I$$20240717$20240722$20240722$EXP$$CA-PFIZER INC-202400217681$PFIZER$$70$YR$$M$Y$$$20240722$$HP$CA$CA
241214933$24121493$3$F$20230428$20240814$20240722$20240820$EXP$$CN-PFIZER INC-2023SGN07907$PFIZER$$65$YR$$M$Y$70$KG$20240820$$MD$CN$CN
241214941$24121494$1$I$20200609$20240718$20240722$20240722$EXP$$IT-PFIZER INC-202400218108$PFIZER$$48$YR$$F$Y$$$20240722$$MD$IT$IT
241214951$24121495$1$I$$20240716$20240722$20240722$EXP$$US-PFIZER INC-PV202400093462$PFIZER$$85$YR$$M$Y$$$20240722$$HP$US$US
241214962$24121496$2$F$20240601$20240725$20240722$20240729$EXP$$GB-ABBVIE-5846006$ABBVIE$$61$YR$$M$Y$$$20240729$$CN$GB$GB
241214971$24121497$1$I$$20240712$20240722$20240722$EXP$$JP-009507513-2407JPN002352J$MERCK$$46$YR$$F$Y$$$20240722$$PH$JP$JP
241214982$24121498$2$F$$20240729$20240722$20240805$EXP$$US-ABBVIE-5844575$ABBVIE$$$$$M$Y$$$20240804$$CN$US$US
241214991$24121499$1$I$20230426$20240710$20240722$20240722$EXP$$CN-PFIZER INC-2023SGN04614$PFIZER$$22$YR$$M$Y$83$KG$20240722$$MD$CN$CN
241215002$24121500$2$F$$20240712$20240722$20240723$PER$$US-JNJFOC-20240756042$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$CN$US$US
241215011$24121501$1$I$$20240717$20240722$20240722$EXP$$US-ABBVIE-5844577$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241215021$24121502$1$I$20240701$20240710$20240722$20240722$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01097$AIMMUNE$$$$$$Y$$$20240722$$MD$US$US
241215032$24121503$2$F$$20240826$20240722$20240903$EXP$$IT-TEVA-VS-3220716$TEVA$Schiavello E, Spreafico F, Barretta F, Meraviglia G, Biassoni V, Terenziani M, et al. Ultra Short Course Chemotherapy for Early-Stage Non-Hodgkin^s Lymphoma in Children. Children-(Basel) 2022; 9 (9): 1-10.; Schiavello E, Spreafico F, Barretta F, Meraviglia G, Biassoni V, Terenziani M, et al. Ultra Short Course Chemotherapy for Early-Stage Non-Hodgkin^s Lymphoma in Children. Children-(Basel) 2022; 9 (9): 1-10.$$$C$$Y$$$20240903$$HP$IT$IT
241215041$24121504$1$I$20240710$20240719$20240722$20240722$30DAY$$US-SANDOZ INC.-SDZ2024US066918$SANDOZ$$58$YR$$F$Y$$$20240722$$HP$US$US
241215051$24121505$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115597$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240722$$HP$US$US
241215062$24121506$2$F$20240710$20240822$20240722$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114717$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$66.2$KG$20240828$$HP$US$US
241215072$24121507$2$F$20240707$20240723$20240722$20240726$PER$$SG-Eisai-EC-2024-169903$EISAI$$53$YR$A$F$Y$$$20240726$$MD$SG$SG
241215081$24121508$1$I$$20240715$20240722$20240722$EXP$DE-SEATTLE GENETICS-2024SGN00172$DE-RDY-SPO/DEU/24/0010436$DR REDDYS$$34$YR$A$F$Y$$$20240722$$MD$DE$DE
241215091$24121509$1$I$$20240718$20240722$20240722$PER$$US-TAKEDA-2024TUS073461$TAKEDA$$$$$M$Y$$$20240722$$CN$US$US
241215101$24121510$1$I$20240627$20240711$20240722$20240722$EXP$IT-MINISAL02-993511$IT-TEVA-VS-3220597$TEVA$$53$YR$$F$Y$73$KG$20240722$$PH$IT$IT
241215111$24121511$1$I$20230201$20240716$20240722$20240722$EXP$$US-SA-2024SA210691$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240722$$MD$US$US
241215121$24121512$1$I$20220801$20240712$20240722$20240722$EXP$$GB-TEVA-VS-3221523$TEVA$$61$YR$$F$Y$61$KG$20240722$$PH$GB$GB
241215131$24121513$1$I$20240705$20240712$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111860$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240722$$CN$US$US
241215151$24121515$1$I$$20240711$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111476$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240722$$HP$US$US
241215161$24121516$1$I$$20240718$20240722$20240722$EXP$$IT-AMERICAN REGENT INC-2024002796$AMERICAN REGENT$$44$YR$$F$Y$$$20240722$$HP$IT$IT
241215171$24121517$1$I$$20240718$20240722$20240722$PER$$US-BAYER-2024A104931$BAYER$$34$YR$A$F$Y$$$20240722$$HP$US$US
241215181$24121518$1$I$20231213$20240716$20240722$20240722$EXP$$CA-TAKEDA-2024TUS072589$TAKEDA$$77$YR$$M$Y$$$20240722$$CN$CA$CA
241215191$24121519$1$I$20230501$20240717$20240722$20240722$EXP$$IT-SA-2024SA211794$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240722$$HP$IT$IT
241215201$24121520$1$I$$20240717$20240722$20240722$EXP$$US-ABBVIE-5845266$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241215211$24121521$1$I$$20240717$20240722$20240722$EXP$$US-ABBVIE-5846175$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241215223$24121522$3$F$20240402$20240802$20240722$20240807$EXP$$US-ABBVIE-5846031$ABBVIE$$59$YR$$F$Y$145$KG$20240807$$CN$US$US
241215232$24121523$2$F$20240501$20240912$20240722$20240918$EXP$$JP-009507513-2405JPN003361J$MERCK$$7$DEC$$M$Y$$$20240918$$MD$JP$JP
241215241$24121524$1$I$20240718$20240719$20240719$20240719$DIR$710866$$FDA-CTU$$30$YR$$F$N$54$KG$20240719$N$CN$US$
241215261$24121526$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50167$$FDA-CTU$$67$YR$$F$N$$$20240722$N$$US$
241215291$24121529$1$I$20240702$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50127$$FDA-CTU$$54$YR$$M$N$$$20240718$N$HP$US$
241215321$24121532$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50316$$FDA-CTU$$69$YR$$M$N$$$20240722$N$HP$US$
241215331$24121533$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50328$$FDA-CTU$$79$YR$$F$N$$$20240722$N$$US$
241215341$24121534$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50320$$FDA-CTU$$41$YR$$M$N$$$20240722$N$PH$US$
241215351$24121535$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50265$$FDA-CTU$$40$YR$$F$N$42.18$KG$20240722$N$$US$
241215361$24121536$1$I$20240719$20240720$20240720$20240720$DIR$710840$$FDA-CTU$$84$YR$$F$N$$$20240720$N$HP$US$
241215381$24121538$1$I$20240703$20240720$20240720$20240720$DIR$710836$$FDA-CTU$$74$YR$$F$N$$$20240720$N$HP$US$
241215391$24121539$1$I$20240718$20240720$20240720$20240720$DIR$710879$$FDA-CTU$$14$YR$$F$N$58.5$KG$20240720$N$$US$
241215402$24121540$2$F$20240516$20240822$20240722$20240829$EXP$$US-ABBVIE-5770538$ABBVIE$$78$YR$$F$Y$43$KG$20240829$$CN$US$US
241215411$24121541$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115913$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$63.96$KG$20240722$$CN$US$US
241215423$24121542$3$F$$20240919$20240722$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116078$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240920$$CN$US$US
241215432$24121543$2$F$20200101$20240816$20240722$20240819$PER$$US-ALXN-A202000347$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240819$$CN$US$US
241215441$24121544$1$I$20240117$20240715$20240722$20240722$EXP$DE-SEATTLE GENETICS-2024SGN00827$DE-RDY-SPO/DEU/24/0010435$DR REDDYS$$67$YR$E$F$Y$61$KG$20240722$$MD$DE$DE
241215451$24121545$1$I$$20240711$20240722$20240722$30DAY$$US-GSK-US2024086602$GLAXOSMITHKLINE$$$$$M$Y$$$20240722$$CN$US$US
241215461$24121546$1$I$$20240718$20240722$20240722$EXP$$AU-Karo Pharma-2159445$Karo Pharma$$$$$M$Y$$$20240722$$$AU$AU
241215471$24121547$1$I$$20240718$20240722$20240722$EXP$$US-ABBVIE-5846665$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241215481$24121548$1$I$20240719$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115967$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240722$$MD$US$US
241215491$24121549$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115885$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240722$$CN$US$US
241215501$24121550$1$I$20240528$20240709$20240722$20240722$PER$$US-JNJFOC-20240752767$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240722$$PH$US$US
241215512$24121551$2$F$$20240718$20240722$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115714$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$CN$CA$CA
241215521$24121552$1$I$$20240719$20240722$20240722$30DAY$$US-SANDOZ INC.-SDZ2024US066900$SANDOZ$$54$YR$$F$Y$$$20240722$$HP$US$US
241215541$24121554$1$I$20190601$20240715$20240722$20240722$EXP$$NVSC2024RU142693$NOVARTIS$Dolgushina Yu V et al.. ??????????? ???? ?????????? ??????? ????????? IsaPD ? ??????? ???????????? ?????????????? ????????????? ??????? (????) [Clinical experience with IsaPD triplet therapy in the treatment of refractory relapsed multiple myeloma (RRMM)]. RUSSIAN JOURNAL OF HEMATOLOGY AND TRANSFUSIOLOGY. 2024;209$58$YR$$F$Y$$$20240722$$HP$RU$RU
241215551$24121555$1$I$$20240721$20240722$20240722$PER$$NVSC2024US149994$NOVARTIS$$$$$$Y$$$20240722$$CN$US$US
241215571$24121557$1$I$20240520$20240712$20240722$20240722$EXP$$US-RADIUS HEALTH, INC.-2024US003998$RADIUS PHARM$$80$YR$$F$Y$$$20240722$$CN$US$US
241215591$24121559$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50288$$FDA-CTU$$44$YR$$M$N$$$20240722$N$HP$US$
241215611$24121561$1$I$$20240716$20240722$20240722$DIR$FDA-CDER-CTU-2024-50246$$FDA-CTU$$$$$M$N$$$20240716$N$HP$US$
241215621$24121562$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50233$$FDA-CTU$$55$YR$$F$N$$$20240722$N$$US$
241215631$24121563$1$I$20240718$20240720$20240720$20240720$DIR$710835$$FDA-CTU$$6$MON$$F$N$2.79$KG$20240720$N$MD$US$
241215641$24121564$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50237$$FDA-CTU$$$$$M$N$$$20240719$N$HP$US$
241215671$24121567$1$I$$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50287$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241215681$24121568$1$I$20221108$20240720$20240720$20240720$DIR$710890$$FDA-CTU$$88$YR$$F$N$$$20240720$N$CN$US$
241215691$24121569$1$I$20240715$20240720$20240720$20240720$DIR$710873$$FDA-CTU$$81$YR$$F$N$50.4$KG$20240720$N$CN$US$
241215701$24121570$1$I$20240716$20240717$20240722$20240722$30DAY$$IT-SANDOZ INC.-SDZ2024IT066553$SANDOZ$$16$YR$$F$Y$48$KG$20240722$$CN$IT$IT
241215715$24121571$5$F$$20240916$20240722$20240920$30DAY$$US-PFIZER INC-202400212683$PFIZER$$14$YR$$M$Y$$$20240920$$CN$US$US
241215721$24121572$1$I$$20240707$20240722$20240722$EXP$$US-Marksans Pharma Limited-2159446$MARKSANS$$$$$$Y$$$20240722$$$US$US
241215732$24121573$2$F$$20240822$20240722$20240822$30DAY$$US-PFIZER INC-202400215388$PFIZER$$15$YR$$M$Y$$$20240822$$CN$US$US
241215741$24121574$1$I$$20240710$20240722$20240722$30DAY$$US-PFIZER INC-202400212118$PFIZER$$15$YR$$M$Y$$$20240722$$CN$US$US
241215761$24121576$1$I$$20240717$20240722$20240722$EXP$$US-ACIC Fine Chemicals Inc-2159447$ACIC FINE CHEMICALS$Literature article$53$YR$$F$Y$$$20240722$$MD$US$US
241215771$24121577$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116008$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$89.36$KG$20240722$$CN$US$US
241215781$24121578$1$I$$20240718$20240722$20240722$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-115785$BRISTOL MYERS SQUIBB$$30$YR$A$$Y$$$20240722$$PH$AU$AU
241215793$24121579$3$F$20240717$20240820$20240722$20240822$EXP$$AT-ABBVIE-5845693$ABBVIE$$74$YR$$M$Y$$$20240822$$CN$AT$AT
241215801$24121580$1$I$$20240718$20240722$20240722$EXP$$FR-DSJP-DSE-2024-136645$DAIICHI$$$$$F$Y$$$20240722$$MD$FR$FR
241215811$24121581$1$I$20240415$20240712$20240722$20240722$EXP$IT-MINISAL02-993739$IT-TEVA-VS-3221005$TEVA$$71$YR$$F$Y$$$20240722$$PH$IT$IT
241215821$24121582$1$I$20240719$20240720$20240720$20240720$DIR$710888$$FDA-CTU$$81$YR$$F$N$58.5$KG$20240720$N$CN$US$
241215831$24121583$1$I$$20240720$20240720$20240720$DIR$710837$$FDA-CTU$$7$YR$$F$N$$$20240720$N$$US$
241215841$24121584$1$I$20240703$20240720$20240720$20240720$DIR$710838$$FDA-CTU$$74$YR$$F$N$$$20240720$N$HP$US$
241215851$24121585$1$I$20240715$20240720$20240720$20240720$DIR$710883$$FDA-CTU$$52$YR$$F$N$$$20240720$N$MD$US$
241215861$24121586$1$I$20240707$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50283$$FDA-CTU$$58$YR$$F$N$$$20240719$N$$US$
241215871$24121587$1$I$$20240720$20240720$20240720$DIR$710874$$FDA-CTU$$$$$F$N$$$20240720$N$CN$US$
241215881$24121588$1$I$20240716$20240720$20240720$20240720$DIR$710881$$FDA-CTU$$47$YR$$F$N$67.5$KG$20240720$N$CN$US$
241215891$24121589$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50293$$FDA-CTU$$46$YR$$F$N$$$20240722$N$$US$
241215901$24121590$1$I$20240720$20240720$20240720$20240720$DIR$710893$$FDA-CTU$$32$YR$$F$N$$$20240720$N$CN$US$
241215911$24121591$1$I$$20240720$20240722$20240722$DIR$FDA-CDER-CTU-2024-50149$$FDA-CTU$$$$$F$N$$$20240720$N$$US$
241215931$24121593$1$I$$20240718$20240722$20240722$DIR$FDA-CDER-CTU-2024-50229$$FDA-CTU$$$$$F$N$$$20240718$N$$US$
241215941$24121594$1$I$20240628$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50280$$FDA-CTU$$77$YR$$F$N$$$20240719$N$HP$US$
241215971$24121597$1$I$20240101$20240712$20240722$20240722$EXP$$US-RADIUS HEALTH, INC.-2024US005392$RADIUS PHARM$$$$$F$Y$$$20240722$$CN$US$US
241215981$24121598$1$I$$20240715$20240722$20240722$EXP$$CA-BAUSCH-BL-2024-010862$BAUSCH AND LOMB$$80$YR$$M$Y$$$20240722$$CN$CA$CA
241215992$24121599$2$F$20240715$20240903$20240722$20240911$PER$$US-BAUSCH-BL-2024-010868$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240911$$CN$US$US
241216001$24121600$1$I$$20240716$20240722$20240722$EXP$$AU-BAUSCH-BL-2024-010899$BAUSCH AND LOMB$Lee E, Bosi I, Peacock K, Lau C, Ford L, Wong M, Hsu P. Novel infantile presentations of chronic granulomatous disease. Pediatric Allergy and Immunology. 2024;35:1-5. doi:10.1111/pai.14190$5$WK$$M$Y$$$20240722$$HP$AU$AU
241216011$24121601$1$I$20240101$20240718$20240722$20240722$EXP$$US-BAUSCH-BL-2024-011101$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240722$$CN$US$US
241216022$24121602$2$F$$20240905$20240722$20240905$PER$$NVSC2024US149351$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
241216031$24121603$1$I$$20240715$20240722$20240722$EXP$$FR-BAUSCH-BL-2024-011140$BAUSCH AND LOMB$$72$YR$$F$Y$53$KG$20240722$$CN$FR$FR
241216041$24121604$1$I$20240717$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012983$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240722$$CN$US$US
241216051$24121605$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407010470$ELI LILLY AND CO$$67$YR$E$$Y$$$20240722$$CN$US$US
241216061$24121606$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013065$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241216073$24121607$3$F$20240628$20240801$20240722$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-108422$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$PH$JP$JP
241216081$24121608$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012707$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240722$$CN$US$US
241216091$24121609$1$I$$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114911$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240722$$HP$US$US
241216101$24121610$1$I$$20240717$20240722$20240722$EXP$$US-ABBVIE-5845128$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241216114$24121611$4$F$$20240824$20240722$20240826$30DAY$$US-PFIZER INC-202400217968$PFIZER$$11$YR$$M$Y$30.39$KG$20240826$$CN$US$US
241216121$24121612$1$I$20240712$20240712$20240722$20240722$PER$$US-JNJFOC-20240756555$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240722$$CN$US$US
241216131$24121613$1$I$$20240719$20240722$20240722$PER$$NVSC2024US150105$NOVARTIS$$$$$$Y$$$20240722$$MD$US$US
241216141$24121614$1$I$20240101$20240708$20240722$20240722$PER$$US-ALKERMES INC.-ALK-2024-001888$ALKERMES$$$$$M$Y$$$20240722$$CN$US$US
241216171$24121617$1$I$20201102$20201104$20240722$20240722$EXP$$US-AstraZeneca-2020SF48024$ASTRAZENECA$$26260$DY$$M$Y$$$20240722$$CN$US$
241216181$24121618$1$I$$20240715$20240722$20240722$PER$$US-AstraZeneca-2024A165958$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241216192$24121619$2$F$20240101$20240723$20240722$20240809$PER$$US-KARYOPHARM-2024KPT001267$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240809$$CN$US$US
241216202$24121620$2$F$$20240826$20240722$20240905$EXP$$BE-TEVA-VS-3220772$TEVA$Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A, et al. PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer. Cold-Spring-Harb-Mol-Case-Stud 2023; 9 (2): 1-16.; Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A, et al. PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer. Cold-Spring-Harb-Mol-Case-Stud 2023; 9 (2): 1-16.; Amato O, Buisseret L, Gebhart G, Plou...$31$YR$$F$Y$$$20240905$$HP$BE$BE
241216211$24121621$1$I$$20240720$20240722$20240722$PER$$NVSC2024US150005$NOVARTIS$$$$$$Y$$$20240722$$CN$US$US
241216222$24121622$2$F$$20240712$20240722$20240724$EXP$$NVSC2024US145618$NOVARTIS$$$$A$F$Y$$$20240724$$CN$US$US
241216231$24121623$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116045$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$79.38$KG$20240722$$CN$US$US
241216241$24121624$1$I$20240101$20240716$20240722$20240722$EXP$$US-Eisai-EC-2024-169321$EISAI$$60$YR$A$M$Y$$$20240722$$CN$US$US
241216251$24121625$1$I$$20240717$20240722$20240722$EXP$AU-TGA-0000812477$AU-SANDOZ INC.-SDZ2024AU066381$SANDOZ$$$$$F$Y$$$20240722$$CN$AU$AU
241216261$24121626$1$I$20240101$20240708$20240722$20240722$PER$$US-ALKERMES INC.-ALK-2024-001855$ALKERMES$$$$$M$Y$$$20240722$$HP$US$US
241216272$24121627$2$F$$20240731$20240722$20240801$PER$$US-ABBVIE-5848122$ABBVIE$$$$$M$Y$$$20240801$$MD$US$US
241216281$24121628$1$I$20240427$20240712$20240722$20240722$EXP$FR-AFSSAPS-MA2024000768$FR-TEVA-VS-3221169$TEVA$$67$YR$$F$Y$$$20240722$$MD$FR$FR
241216291$24121629$1$I$20240710$20240710$20240722$20240722$PER$$US-ALKERMES INC.-ALK-2024-001871$ALKERMES$$29$YR$$F$Y$$$20240722$$PH$US$US
241216302$24121630$2$F$$20240718$20240722$20240802$EXP$$CA-HLS-202401771$HLS THERAPEUTICS$$$$A$F$Y$$$20240802$$HP$CA$CA
241216311$24121631$1$I$20240701$20240720$20240720$20240720$DIR$710886$$FDA-CTU$$49$YR$$F$N$78.75$KG$20240720$N$CN$US$
241216321$24121632$1$I$20230101$20240718$20240722$20240722$EXP$$US-ALXN-202407USA001395US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
241216331$24121633$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115908$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$69.4$KG$20240722$$CN$US$US
241216341$24121634$1$I$20240115$20240720$20240720$20240720$DIR$710875$$FDA-CTU$$77$YR$$M$N$71.55$KG$20240720$N$MD$US$
241216352$24121635$2$F$$20240831$20240722$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116015$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$79.83$KG$20240903$$CN$US$US
241216361$24121636$1$I$20240614$20240712$20240722$20240722$EXP$FR-AFSSAPS-LL2024001248$FR-TEVA-VS-3221135$TEVA$$93$YR$$M$Y$64.4$KG$20240722$$PH$FR$FR
241216371$24121637$1$I$$20240712$20240722$20240722$EXP$PL-URPL-1-1308-2020$PL-TEVA-VS-3220904$TEVA$$40$YR$$M$Y$80$KG$20240722$$MD$PL$PL
241216381$24121638$1$I$20240720$20240720$20240720$20240720$DIR$710882$$FDA-CTU$$55$YR$$M$N$92.25$KG$20240720$Y$CN$US$
241216391$24121639$1$I$20240601$20240708$20240722$20240722$PER$$US-ALKERMES INC.-ALK-2024-001848$ALKERMES$$$$$F$Y$$$20240722$$HP$US$US
241216411$24121641$1$I$$20240718$20240722$20240722$30DAY$$US-SANDOZ INC.-SDZ2024US066911$SANDOZ$$$$$F$Y$$$20240722$$HP$US$US
241216421$24121642$1$I$$20240710$20240722$20240722$EXP$$CA-TEVA-VS-3222706$TEVA$$49$YR$$F$Y$91$KG$20240722$$PH$CA$CA
241216431$24121643$1$I$20240628$20240718$20240722$20240722$EXP$$CN-WOODWARD-2024-CN-000285$WOODWARD PHARMA SERVICES$$31$YR$$F$Y$$$20240722$$HP$CN$CN
241216441$24121644$1$I$20240101$20240718$20240722$20240722$EXP$$US-ABBVIE-5845885$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241216451$24121645$1$I$$20201012$20240722$20240722$EXP$$US-AstraZeneca-2020SF33628$ASTRAZENECA$$$$$M$Y$$$20240722$$CN$US$
241216462$24121646$2$F$$20240802$20240722$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115207$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$82.55$KG$20240805$$CN$US$US
241216471$24121647$1$I$$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115140$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240722$$CN$US$US
241216481$24121648$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116041$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240722$$CN$US$US
241216492$24121649$2$F$$20240909$20240722$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115303$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$53.52$KG$20240912$$CN$US$US
241216501$24121650$1$I$20240701$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115168$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240722$$HP$US$US
241216512$24121651$2$F$20240701$20240814$20240722$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116185$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$111.58$KG$20240822$$MD$US$US
241216521$24121652$1$I$$20240719$20240722$20240722$PER$$US-JNJFOC-20240755425$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240722$$CN$US$US
241216541$24121654$1$I$20240501$20240720$20240720$20240720$DIR$710867$$FDA-CTU$$73$YR$$F$N$68.4$KG$20240720$N$CN$US$
241216551$24121655$1$I$20240620$20240720$20240720$20240720$DIR$710847$$FDA-CTU$$61$YR$$F$N$82.35$KG$20240720$N$CN$US$
241216571$24121657$1$I$20240718$20240720$20240720$20240720$DIR$710848$$FDA-CTU$$80$YR$$F$N$72$KG$20240720$N$CN$US$
241216581$24121658$1$I$20240601$20240712$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN007409$INCYTE$$$$$$Y$$$20240722$$CN$US$US
241216591$24121659$1$I$$20240708$20240722$20240722$PER$$US-TOLMAR, INC.-24US050898$TOLMAR$$$$$$Y$$$20240722$$CN$US$US
241216602$24121660$2$F$$20240806$20240722$20240811$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010730$JAZZ$$$$$M$Y$$$20240811$$HP$US$US
241216611$24121661$1$I$20240119$20240712$20240722$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002346$JAZZ$$59$YR$$F$Y$56.236$KG$20240722$$CN$US$US
241216621$24121662$1$I$$20240715$20240722$20240722$EXP$$US-BEH-2024175779$CSL BEHRING$$$$A$F$Y$$$20240722$$CN$US$US
241216631$24121663$1$I$20240701$20240715$20240722$20240722$PER$$US-KARYOPHARM-2024KPT001318$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240722$$CN$US$US
241216643$24121664$3$F$20240101$20240815$20240722$20240903$PER$$US-KARYOPHARM-2024KPT001277$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
241216651$24121665$1$I$$20240708$20240722$20240722$EXP$$IT-TEVA-VS-3220697$TEVA$Del Fabro V, Pennisi C, Leotta S, Petronaci A, Longo L, Elia F, et al. PRACTICAL CONSIDERATIONS ON MANAGEMENT OF INFECTION IN PATIENTS RECEIVING BISPECIFIC ANTIBODIES: A SINGLE CENTER EXPERIENCE. Haematologica 2024; 109 (Suppl.) 33.$$$$$Y$$$20240722$$HP$IT$IT
241216665$24121666$5$F$20240101$20240827$20240722$20240903$EXP$$US-KARYOPHARM-2024KPT001270$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
241216671$24121667$1$I$$20240712$20240722$20240722$EXP$$US-TEVA-VS-3221690$TEVA$$$$$F$Y$$$20240722$$HP$US$US
241216681$24121668$1$I$20240619$20240712$20240722$20240722$EXP$FR-AFSSAPS-GR2024000848$FR-TEVA-VS-3221146$TEVA$$56$YR$$F$Y$53$KG$20240722$$PH$FR$FR
241216693$24121669$3$F$20240626$20240926$20240722$20240928$EXP$$AT-Karo Pharma-2159448$Karo Pharma$$56$YR$$M$Y$$$20240928$$$AT$AT
241216702$24121670$2$F$20240627$20240727$20240722$20240806$PER$$US-RDY-SPO/USA/24/0010358$DR REDDYS$$54$YR$A$F$Y$$$20240806$$CN$US$US
241216711$24121671$1$I$20240718$20240720$20240720$20240720$DIR$710872$$FDA-CTU$$34$YR$$F$N$58.5$KG$20240720$N$CN$US$
241216721$24121672$1$I$20240401$20240720$20240720$20240720$DIR$710889$$FDA-CTU$$28$YR$$F$N$42$KG$20240720$N$CN$US$
241216731$24121673$1$I$20240220$20240720$20240720$20240720$DIR$710843$$FDA-CTU$$57$YR$$F$N$$$20240720$Y$CN$US$
241216771$24121677$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS071885$TAKEDA$$$$E$M$Y$$$20240722$$CN$US$US
241216781$24121678$1$I$$20240717$20240722$20240722$EXP$$US-SA-2024SA211486$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240722$$CN$US$US
241216791$24121679$1$I$$20240709$20240722$20240722$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2159449$BRECKENRIDGE$$$$$F$Y$$$20240722$$$ES$A1
241216811$24121681$1$I$$20240709$20240722$20240722$PER$$US-ALKERMES INC.-ALK-2024-001858$ALKERMES$$26$YR$$M$Y$$$20240722$$HP$US$US
241216822$24121682$2$F$20240710$20240829$20240722$20240906$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010950$JAZZ$$59$YR$$M$Y$$$20240906$$MD$JP$JP
241216831$24121683$1$I$$20240717$20240722$20240722$EXP$$JP-AstraZeneca-2024A164365$ASTRAZENECA$Komuta K, et al. 15 A case of TMB high extensive-stage small cell lung cancer in which complete response was maintained for more than 18 months by pembrolizumab monotherapy. The 120th Annual Meeting of the Kansai Branch of the Japan Lung Cancer Society 2024;50.$66$YR$$F$Y$$$20240722$$MD$JP$
241216841$24121684$1$I$$20240711$20240722$20240722$EXP$$GB-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2406GB05534$INSUD PHARMA$Darnborough S.. Darnborough S. Managing menopause in an irradiated pelvis ? uncharted territory.. Post Reproductive Health. 2024;30(2):127-34$5$DEC$$F$Y$$$20240722$$MD$GB$GB
241216851$24121685$1$I$$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113294$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240722$$HP$US$US
241216865$24121686$5$F$20240713$20240919$20240722$20240924$30DAY$$GR-PFIZER INC-202400215110$PFIZER$$13$YR$$F$Y$52$KG$20240924$$CN$GR$GR
241216871$24121687$1$I$$20240715$20240722$20240722$EXP$$MA-Tamarang, S.A.-2159417$TAMARANG PHARMACEUTICALS$Alj L, Tebaa A, Talibi I, Moubarik S, Benazzouz M, Soulaymani Bencheikh R.?Lessonslearned from a cluster of immunization errors in newborns. Ther Adv Vaccines Immunother. 2024 Jan 2;12:25151355231221009. doi:?10.1177/25151355231221009. PMID: 38178960; PMCID: PMC10762870. Article found during weekly scientific literature research.$$$$$Y$$$20240722$$MD$MA$MA
241216881$24121688$1$I$$20240715$20240722$20240722$EXP$$MA-Tamarang, S.A.-2159418$TAMARANG PHARMACEUTICALS$Alj L, Tebaa A, Talibi I, Moubarik S, Benazzouz M, Soulaymani Bencheikh R.?Lessonslearned from a cluster of immunization errors in newborns. Ther Adv Vaccines Immunother. 2024 Jan 2;12:25151355231221009. doi:?10.1177/25151355231221009. PMID: 38178960; PMCID: PMC10762870. Article found during weekly scientific literature research$$$$$Y$$$20240722$$MD$MA$MA
241216902$24121690$2$F$20240712$20240920$20240722$20240925$30DAY$$GR-PFIZER INC-202400215109$PFIZER$$12$YR$$F$Y$31$KG$20240925$$CN$GR$GR
241216911$24121691$1$I$20240715$20240715$20240722$20240722$30DAY$$GR-PFIZER INC-PV202400093177$PFIZER$$11$YR$$F$Y$30$KG$20240722$$CN$GR$GR
241216921$24121692$1$I$20240601$20240715$20240722$20240722$30DAY$$UY-PFIZER INC-202400216214$PFIZER$$11$YR$$M$Y$$$20240722$$CN$UY$UY
241216933$24121693$3$F$20240714$20240912$20240722$20240917$30DAY$$GR-PFIZER INC-PV202400093104$PFIZER$$14$YR$$M$Y$47$KG$20240917$$CN$GR$GR
241216941$24121694$1$I$$20240709$20240722$20240722$PER$$US-ALKERMES INC.-ALK-2024-001850$ALKERMES$$$$$M$Y$$$20240722$$HP$US$US
241216951$24121695$1$I$$20240715$20240722$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010805$JAZZ$$$$$F$Y$$$20240722$$HP$US$US
241216971$24121697$1$I$$20240720$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116027$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$55.34$KG$20240722$$CN$US$US
241216981$24121698$1$I$20240201$20240422$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011668$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240722$$CN$US$US
241216992$24121699$2$F$$20240816$20240722$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115055$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240821$$CN$US$US
241217002$24121700$2$F$$20240719$20240722$20240729$EXP$$US-EMERGENT BIOSOLUTIONS,-24000110$EMERGENT BIOSOLUTIONS$$42$YR$$F$Y$$$20240729$$CN$US$US
241217011$24121701$1$I$$20240716$20240722$20240722$EXP$$GB-AMGEN-GBRSL2024142539$AMGEN$$$$$F$Y$$$20240722$$CN$GB$GB
241217022$24121702$2$F$20240715$20240807$20240722$20240808$PER$$US-ALXN-202407USA001024US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241217031$24121703$1$I$$20240715$20240722$20240722$PER$$NVSC2024US146326$NOVARTIS$$$$$F$Y$$$20240722$$MD$US$US
241217041$24121704$1$I$20240204$20240712$20240722$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006190$JAZZ$$42$YR$$F$Y$$$20240722$$CN$US$US
241217052$24121705$2$F$20240718$20240816$20240722$20240820$PER$$US-AMGEN-USASP2024143832$AMGEN$$81$YR$E$M$Y$$$20240820$$CN$US$US
241217071$24121707$1$I$$20240704$20240722$20240722$PER$$US-JNJFOC-20240714542$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
241217083$24121708$3$F$20240803$20240822$20240722$20240827$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041050$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$67.13$KG$20240828$$CN$US$US
241217091$24121709$1$I$20240626$20240711$20240722$20240722$EXP$IT-MINISAL02-993487$IT-TEVA-VS-3220613$TEVA$$64$YR$$F$Y$86$KG$20240722$$PH$IT$IT
241217101$24121710$1$I$$20240710$20240722$20240722$PER$$US-EMD Serono-2024038568$EMD SERONO INC$$$$$F$Y$$$20240722$$MD$US$US
241217111$24121711$1$I$20230426$20240712$20240722$20240722$EXP$ES-AEMPS-1541314$ES-TEVA-VS-3220960$TEVA$$67$YR$$M$Y$$$20240722$$MD$ES$ES
241217121$24121712$1$I$$20240528$20240722$20240722$PER$$US-LUNDBECK-DKLU3078622$LUNDBECK$$$$$$Y$$$20240722$$CN$US$US
241217131$24121713$1$I$$20240713$20240722$20240722$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001418$BLUEPRINT MEDICINES$$68$YR$E$F$Y$$$20240722$$CN$US$US
241217141$24121714$1$I$$20240717$20240722$20240722$EXP$$ZA-AstraZeneca-2024A164170$ASTRAZENECA$$62$YR$$M$Y$$$20240722$$CN$ZA$
241217151$24121715$1$I$$20240719$20240722$20240722$PER$$US-PURDUE-USA-2024-0310843$PURDUE$$$$$F$Y$$$20240722$$PH$US$US
241217161$24121716$1$I$$20240715$20240722$20240722$PER$$US-MYLANLABS-2024M1066486$MYLAN$$$$$F$Y$$$20240722$$CN$US$US
241217171$24121717$1$I$$20240710$20240722$20240722$PER$$US-VERTEX PHARMACEUTICALS-2024-011516$VERTEX$$20$YR$$F$Y$$$20240722$$CN$US$US
241217181$24121718$1$I$$20240712$20240722$20240722$EXP$$US-VERTEX PHARMACEUTICALS-2024-011732$VERTEX$$$$$$Y$$$20240722$$CN$US$US
241217201$24121720$1$I$$20240715$20240722$20240722$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001435$BLUEPRINT MEDICINES$$$$$F$Y$$$20240722$$CN$US$US
241217211$24121721$1$I$20240619$20240711$20240722$20240722$EXP$IT-MINISAL02-992418$IT-TEVA-VS-3220608$TEVA$$73$YR$$M$Y$73$KG$20240722$$MD$IT$IT
241217222$24121722$2$F$20240713$20240717$20240722$20240801$EXP$$IE-PFIZER INC-PV202400093209$PFIZER$$9$YR$$M$Y$$$20240801$$CN$IE$IE
241217231$24121723$1$I$20231220$20240711$20240722$20240722$EXP$$CN-ROCHE-3570414$ROCHE$$70$YR$E$M$Y$$$20240722$$MD$CN$CN
241217242$24121724$2$F$$20240822$20240722$20240829$EXP$$US-TEVA-VS-3220450$TEVA$Razia D, Moin A, Arjuna A, Evans S. VASCULOPATHY AND DEMYELINATING COMPLICATIONS OF VARICELLA IN AN IMMUNOCOMPROMISED PATIENT. Crit-Care-Med 2024; 52 (Suppl.) (1): S228 abstr. 508.; Razia D, Moin A, Arjuna A, Evans S. VASCULOPATHY AND DEMYELINATING COMPLICATIONS OF VARICELLA IN AN IMMUNOCOMPROMISED PATIENT. Crit-Care-Med 2024; 52 (Suppl.) (1): S228 abstr. 508.$42$YR$$F$Y$$$20240829$$HP$US$US
241217253$24121725$3$F$20240714$20240912$20240722$20240917$30DAY$$GR-PFIZER INC-PV202400093743$PFIZER$$5$YR$$M$Y$14.3$KG$20240917$$CN$GR$GR
241217261$24121726$1$I$$20240718$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116095$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240722$$CN$US$US
241217271$24121727$1$I$20240701$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116106$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240722$$CN$US$US
241217281$24121728$1$I$20240705$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116002$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$48.08$KG$20240722$$HP$US$US
241217291$24121729$1$I$20240703$20240716$20240722$20240722$EXP$$US-KYOWAKIRIN-2024KK017320$KYOWA$$$$$$Y$$$20240722$$HP$US$US
241217301$24121730$1$I$20230803$20240717$20240722$20240722$EXP$$EU-BAUSCHBL-2024BNL029332$BAUSCH AND LOMB$$60$YR$$M$Y$$$20240722$$CN$EU$EU
241217311$24121731$1$I$20190101$20240715$20240722$20240722$EXP$$DE-JAZZ PHARMACEUTICALS-2024-DE-010802$JAZZ$$$$$$Y$$$20240722$$MD$DE$DE
241217321$24121732$1$I$$20240711$20240722$20240722$PER$$US-RDY-SPO/USA/24/0010357$DR REDDYS$$62$YR$E$$Y$$$20240722$$PH$US$US
241217331$24121733$1$I$$20240717$20240722$20240722$EXP$CA-DRL-USA-SPO/CAN/24/0010612$CA-RDY-SPO/CAN/24/0010612$DR REDDYS$$66$YR$E$F$Y$$$20240722$$HP$CA$CA
241217341$24121734$1$I$$20240712$20240722$20240722$EXP$$US-BAUSCH-BL-2024-011143$BAUSCH AND LOMB$$$$C$$Y$$$20240722$$$COUNTRY NOT SPECIFIED$US
241217351$24121735$1$I$$20240708$20240722$20240722$EXP$$US-EMERGENT BIOSOLUTIONS,-24000111$EMERGENT BIOSOLUTIONS$Skolnick P, Ellison M, Hutton E, Webster L. Reversal of Opioid?Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone. J Clin Pharmacol. 2024;64(7):828-39$$$A$$Y$$$20240722$$HP$US$US
241217362$24121736$2$F$$20240731$20240722$20240805$EXP$$ES-INCYTE CORPORATION-2024IN007526$INCYTE$$$$$$Y$$$20240805$$MD$ES$ES
241217371$24121737$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA207655$SANOFI AVENTIS$$$$C$M$Y$$$20240722$$MD$US$US
241217381$24121738$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA210098$SANOFI AVENTIS$$67$YR$E$F$Y$93.89$KG$20240722$$MD$US$US
241217392$24121739$2$F$20240101$20240918$20240722$20240927$PER$$US-SA-2024SA120701$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240927$$MD$US$US
241217401$24121740$1$I$20240711$20240711$20240722$20240722$PER$$US-SA-2024SA127555$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240722$$CN$US$US
241217411$24121741$1$I$20240701$20240711$20240722$20240722$PER$$US-SA-2024SA209488$SANOFI AVENTIS$$49$YR$A$F$Y$87.99$KG$20240722$$MD$US$US
241217421$24121742$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA209493$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
241217432$24121743$2$F$20240705$20240716$20240722$20240725$PER$$US-SA-2024SA204791$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240725$$MD$US$US
241217441$24121744$1$I$20240101$20240711$20240722$20240722$PER$$US-SA-2024SA209611$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240722$$MD$US$US
241217451$24121745$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA210882$SANOFI AVENTIS$$$$A$F$Y$68.4$KG$20240722$$MD$US$US
241217462$24121746$2$F$$20240805$20240722$20240813$PER$$US-SA-2024SA201641$SANOFI AVENTIS$$$$E$F$Y$90.703$KG$20240814$$MD$US$US
241217471$24121747$1$I$$20240711$20240722$20240722$PER$$US-SA-2023SA300331$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240722$$MD$US$US
241217481$24121748$1$I$20240601$20240711$20240722$20240722$PER$$US-SA-2024SA208877$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240722$$MD$US$US
241217491$24121749$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA207277$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240722$$MD$US$US
241217501$24121750$1$I$$20240711$20240722$20240722$PER$$US-SA-2024SA209737$SANOFI AVENTIS$$$$A$M$Y$$$20240722$$MD$US$US
241217511$24121751$1$I$20240101$20240711$20240722$20240722$PER$$US-SA-2024SA207906$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240722$$CN$US$US
241217521$24121752$1$I$20240701$20240711$20240722$20240722$PER$$US-SA-2024SA206291$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240722$$MD$US$US
241217532$24121753$2$F$$20240723$20240722$20240729$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-100575$REGENERON$$$$$$Y$$$20240729$$HP$DE$DE
241217541$24121754$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407010239$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241217551$24121755$1$I$20240718$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012400$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240722$$CN$US$US
241217561$24121756$1$I$$20240711$20240722$20240722$PER$$PT-SA-2024SA207396$SANOFI AVENTIS$$$$$$Y$$$20240722$$CN$US$PT
241217572$24121757$2$F$20240101$20240806$20240722$20240813$PER$$US-SA-2023SA302241$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240814$$MD$US$US
241217581$24121758$1$I$20240101$20240711$20240722$20240722$PER$$US-SA-2024SA209792$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240722$$MD$US$US
241217591$24121759$1$I$20240701$20240711$20240722$20240722$PER$$US-SA-2024SA143276$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240722$$MD$US$US
241217601$24121760$1$I$20240222$20240712$20240722$20240722$PER$$US-SA-2024SA208342$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240722$$MD$US$US
241217611$24121761$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209035$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240722$$MD$US$US
241217621$24121762$1$I$20240619$20240712$20240722$20240722$PER$$US-SA-2024SA208618$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240722$$MD$US$US
241217631$24121763$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA211183$SANOFI AVENTIS$$$$E$F$Y$61$KG$20240722$$MD$US$US
241217642$24121764$2$F$20240101$20240829$20240722$20240906$PER$$US-SA-2024SA209014$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240906$$MD$US$US
241217651$24121765$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA208259$SANOFI AVENTIS$$$$C$$Y$$$20240722$$MD$US$US
241217662$24121766$2$F$20240712$20240715$20240722$20240724$PER$$US-SA-2024SA209782$SANOFI AVENTIS$$76$YR$E$F$Y$74.84$KG$20240724$$CN$US$US
241217671$24121767$1$I$20240701$20240712$20240722$20240722$PER$$US-SA-2024SA209799$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240722$$MD$US$US
241217681$24121768$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209808$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240722$$MD$US$US
241217692$24121769$2$F$$20240826$20240722$20240918$PER$$US-SA-2024SA208735$SANOFI AVENTIS$$47$YR$A$F$Y$111$KG$20240918$$MD$US$US
241217701$24121770$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA208553$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240722$$MD$US$US
241217711$24121771$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA208917$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240722$$MD$US$US
241217721$24121772$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209215$SANOFI AVENTIS$$$$T$F$Y$$$20240722$$MD$US$US
241217731$24121773$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA210750$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240722$$MD$US$US
241217743$24121774$3$F$20240101$20240812$20240722$20240818$EXP$$US-SA-2024SA208377$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240818$$MD$US$US
241217751$24121775$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA209679$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240722$$MD$US$US
241217761$24121776$1$I$20240701$20240712$20240722$20240722$PER$$US-SA-2024SA210252$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240722$$MD$US$US
241217771$24121777$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA211243$SANOFI AVENTIS$$$$T$F$Y$68.03$KG$20240722$$MD$US$US
241217781$24121778$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA208816$SANOFI AVENTIS$$$$T$F$Y$45.986$KG$20240722$$MD$US$US
241217791$24121779$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA209803$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240722$$MD$US$US
241217801$24121780$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA210701$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
241217811$24121781$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA208601$SANOFI AVENTIS$$$$C$$Y$$$20240722$$CN$US$US
241217821$24121782$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA208544$SANOFI AVENTIS$$14$YR$T$F$Y$38.549$KG$20240722$$MD$US$US
241217832$24121783$2$F$20240101$20240814$20240722$20240828$PER$$US-SA-2024SA209807$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240828$$MD$US$US
241217841$24121784$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA208889$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240722$$MD$US$US
241217851$24121785$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA208685$SANOFI AVENTIS$$$$A$F$Y$88.45$KG$20240722$$MD$US$US
241217861$24121786$1$I$20240718$20240718$20240722$20240722$EXP$$CN-PFIZER INC-202400218287$PFIZER$$54$YR$$F$Y$$$20240722$$CN$CN$CN
241217881$24121788$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA211566$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240722$$MD$US$US
241217891$24121789$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA208876$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240722$$MD$US$US
241217901$24121790$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA211090$SANOFI AVENTIS$$$$A$F$Y$76.2$KG$20240722$$MD$US$US
241217911$24121791$1$I$20240101$20240712$20240722$20240722$PER$$US-SA-2024SA207912$SANOFI AVENTIS$$52$YR$A$F$Y$68$KG$20240722$$MD$US$US
241217921$24121792$1$I$20240706$20240716$20240722$20240722$EXP$$CA-ABBVIE-5844657$ABBVIE$$40$YR$$M$Y$$$20240722$$CN$CA$CA
241217931$24121793$1$I$20240601$20240712$20240722$20240722$PER$$US-SA-2024SA209686$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240722$$MD$US$US
241217941$24121794$1$I$20240101$20240713$20240722$20240722$PER$$US-SA-2024SA211198$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240722$$MD$US$US
241217961$24121796$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA208836$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240722$$MD$US$US
241217971$24121797$1$I$$20240712$20240722$20240722$PER$$US-SA-2024SA208596$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
241217982$24121798$2$F$20240101$20240903$20240722$20240912$PER$$US-SA-2024SA211248$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240912$$MD$US$US
241217992$24121799$2$F$$20240805$20240722$20240813$PER$$US-SA-2024SA211098$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240814$$MD$US$US
241218001$24121800$1$I$20240710$20240712$20240722$20240722$PER$$US-SA-2024SA210436$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240722$$MD$US$US
241218011$24121801$1$I$20240713$20240713$20240722$20240722$PER$$US-SA-2024SA211210$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240722$$MD$US$US
241218021$24121802$1$I$$20240713$20240722$20240722$PER$$US-SA-2024SA210629$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
241218031$24121803$1$I$20240701$20240712$20240722$20240722$PER$$US-SA-2024SA210376$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240722$$MD$US$US
241218042$24121804$2$F$20240501$20240725$20240722$20240805$PER$$US-SA-2024SA211118$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240804$$MD$US$US
241218051$24121805$1$I$20240701$20240714$20240722$20240722$PER$$US-SA-2024SA210270$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240722$$MD$US$US
241218061$24121806$1$I$20240712$20240715$20240722$20240722$PER$$US-SA-2024SA209478$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240722$$MD$US$US
241218071$24121807$1$I$20240101$20240717$20240722$20240722$PER$$US-SA-2024SA213232$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240722$$MD$US$US
241218083$24121808$3$F$20240101$20240731$20240722$20240813$PER$$US-SA-2024SA210141$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240814$$MD$US$US
241218091$24121809$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA121547$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240722$$MD$US$US
241218101$24121810$1$I$20240101$20240716$20240722$20240722$PER$$US-SA-2024SA210665$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240722$$MD$US$US
241218111$24121811$1$I$20240701$20240715$20240722$20240722$PER$$US-SA-2024SA211102$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240722$$MD$US$US
241218124$24121812$4$F$20240701$20240820$20240722$20240829$PER$$US-SA-2024SA208175$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240829$$HP$US$US
241218131$24121813$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210783$SANOFI AVENTIS$$$$E$M$Y$$$20240722$$MD$US$US
241218141$24121814$1$I$20240701$20240716$20240722$20240722$PER$$US-SA-2024SA211649$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240722$$MD$US$US
241218151$24121815$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA211268$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240722$$MD$US$US
241218161$24121816$1$I$$20240717$20240722$20240722$PER$$US-SA-2024SA210853$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240722$$MD$US$US
241218171$24121817$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209828$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240722$$MD$US$US
241218181$24121818$1$I$20240701$20240715$20240722$20240722$PER$$US-SA-2024SA209250$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240722$$CN$US$US
241218191$24121819$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210799$SANOFI AVENTIS$$$$A$M$Y$84.8$KG$20240722$$MD$US$US
241218201$24121820$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210663$SANOFI AVENTIS$$19$YR$A$M$Y$70$KG$20240722$$MD$US$US
241218212$24121821$2$F$20240701$20240809$20240722$20240826$PER$$US-SA-2024SA210447$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240826$$MD$US$US
241218221$24121822$1$I$20240701$20240715$20240722$20240722$PER$$US-SA-2024SA210250$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240722$$MD$US$US
241218231$24121823$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210226$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240722$$HP$US$US
241218242$24121824$2$F$20240717$20240718$20240722$20240730$PER$$US-SA-2024SA210612$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240730$$HP$US$US
241218251$24121825$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210729$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240722$$MD$US$US
241218264$24121826$4$F$20240620$20240918$20240722$20240920$EXP$$US-SA-2024SA210960$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240920$$MD$US$US
241218272$24121827$2$F$$20240909$20240722$20240917$PER$$US-SA-2024SA211451$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240918$$MD$US$US
241218281$24121828$1$I$20240701$20240716$20240722$20240722$PER$$US-SA-2024SA210366$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240722$$CN$US$US
241218291$24121829$1$I$20240708$20240715$20240722$20240722$PER$$US-SA-2024SA209178$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240722$$MD$US$US
241218301$24121830$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA208448$SANOFI AVENTIS$$$$$F$Y$$$20240722$$CN$US$US
241218311$24121831$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209219$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240722$$MD$US$US
241218321$24121832$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA208841$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240722$$MD$US$US
241218331$24121833$1$I$20240101$20240716$20240722$20240722$PER$$US-SA-2024SA210583$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240722$$MD$US$US
241218341$24121834$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210517$SANOFI AVENTIS$$$$C$M$Y$$$20240722$$MD$US$US
241218351$24121835$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA209683$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240722$$MD$US$US
241218362$24121836$2$F$20240207$20240828$20240722$20240923$PER$$US-SA-2024SA211191$SANOFI AVENTIS$$59$YR$A$F$Y$90$KG$20240923$$MD$US$US
241218371$24121837$1$I$20240701$20240715$20240722$20240722$PER$$US-SA-2024SA208583$SANOFI AVENTIS$$46$YR$A$F$Y$84.8$KG$20240722$$MD$US$US
241218381$24121838$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211818$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
241218391$24121839$1$I$20240701$20240715$20240722$20240722$PER$$US-SA-2024SA210664$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240722$$MD$US$US
241218401$24121840$1$I$$20240717$20240722$20240722$PER$$US-SA-2024SA211480$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240722$$CN$US$US
241218411$24121841$1$I$20240101$20240716$20240722$20240722$PER$$US-SA-2024SA210727$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240722$$MD$US$US
241218421$24121842$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210752$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
241218431$24121843$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA209305$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240722$$MD$US$US
241218441$24121844$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211043$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240722$$MD$US$US
241218451$24121845$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210388$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240722$$MD$US$US
241218463$24121846$3$F$20240101$20240826$20240722$20240919$PER$$US-SA-2024SA210818$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240919$$MD$US$US
241218471$24121847$1$I$20210701$20240716$20240722$20240722$PER$$US-SA-2024SA210805$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240722$$MD$US$US
241218482$24121848$2$F$20240101$20240807$20240722$20240816$PER$$US-SA-2024SA210935$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240816$$MD$US$US
241218491$24121849$1$I$20240712$20240715$20240722$20240722$PER$$US-SA-2024SA210932$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240722$$MD$US$US
241218501$24121850$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210823$SANOFI AVENTIS$$$$A$M$Y$$$20240722$$MD$US$US
241218511$24121851$1$I$20240715$20240716$20240722$20240722$PER$$US-SA-2024SA210369$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240722$$CN$US$US
241218521$24121852$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211552$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240722$$MD$US$US
241218531$24121853$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA209225$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240722$$MD$US$US
241218541$24121854$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210681$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240722$$MD$US$US
241218551$24121855$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210576$SANOFI AVENTIS$$$$A$F$Y$80.73$KG$20240722$$MD$US$US
241218561$24121856$1$I$$20240717$20240722$20240722$PER$$US-SA-2024SA212205$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240722$$CN$US$US
241218571$24121857$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210669$SANOFI AVENTIS$$$$A$F$Y$104$KG$20240722$$MD$US$US
241218581$24121858$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA208866$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240722$$MD$US$US
241218592$24121859$2$F$$20240722$20240722$20240729$PER$$US-SA-2024SA209911$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$CN$US$US
241218602$24121860$2$F$$20240719$20240722$20240730$PER$$US-SA-2024SA209222$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240730$$PH$US$US
241218612$24121861$2$F$20240101$20240723$20240722$20240801$PER$$US-SA-2024SA211504$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240801$$MD$US$US
241218621$24121862$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210813$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240722$$MD$US$US
241218631$24121863$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210105$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240722$$HP$US$US
241218641$24121864$1$I$20210401$20240716$20240722$20240722$PER$$US-SA-2024SA210418$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240722$$MD$US$US
241218651$24121865$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210394$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240722$$MD$US$US
241218661$24121866$1$I$20240701$20240717$20240722$20240722$PER$$US-SA-2024SA212065$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240722$$MD$US$US
241218671$24121867$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210934$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240722$$CN$US$US
241218681$24121868$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210387$SANOFI AVENTIS$$$$E$F$Y$$$20240722$$MD$US$US
241218691$24121869$1$I$20240101$20240718$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159294$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241218701$24121870$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210539$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240722$$MD$US$US
241218711$24121871$1$I$$20240717$20240722$20240722$PER$$US-SA-2024SA212206$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240722$$CN$US$US
241218721$24121872$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210770$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240722$$MD$US$US
241218731$24121873$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA209434$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240722$$HP$US$US
241218741$24121874$1$I$20240401$20240715$20240722$20240722$PER$$US-SA-2024SA209262$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240722$$CN$US$US
241218751$24121875$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210438$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240722$$MD$US$US
241218761$24121876$1$I$$20240717$20240722$20240722$PER$$US-SA-2024SA212292$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240722$$CN$US$US
241218771$24121877$1$I$20240708$20240715$20240722$20240722$PER$$US-SA-2024SA208727$SANOFI AVENTIS$$24$YR$A$F$Y$89.3$KG$20240722$$CN$US$US
241218781$24121878$1$I$20240701$20240716$20240722$20240722$PER$$US-SA-2024SA210855$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240722$$MD$US$US
241218791$24121879$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA211042$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240722$$MD$US$US
241218801$24121880$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA209298$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240722$$HP$US$US
241218811$24121881$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210593$SANOFI AVENTIS$$$$A$M$Y$$$20240722$$CN$US$US
241218822$24121882$2$F$$20240812$20240722$20240820$PER$$US-SA-2024SA210848$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240820$$MD$US$US
241218831$24121883$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211155$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240722$$CN$US$US
241218841$24121884$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA209688$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240722$$MD$US$US
241218851$24121885$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210592$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240722$$MD$US$US
241218861$24121886$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211115$SANOFI AVENTIS$$$$E$M$Y$63.5$KG$20240722$$MD$US$US
241218871$24121887$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA208669$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240722$$MD$US$US
241218881$24121888$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210955$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240722$$MD$US$US
241218891$24121889$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA210385$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240722$$CN$US$US
241218902$24121890$2$F$$20240822$20240722$20240904$PER$$US-SA-2024SA210885$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240904$$MD$US$US
241218911$24121891$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA208778$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240722$$MD$US$US
241218921$24121892$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211255$SANOFI AVENTIS$$$$E$F$Y$$$20240722$$CN$US$US
241218931$24121893$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210839$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240722$$MD$US$US
241218941$24121894$1$I$$20240528$20240722$20240722$PER$$US-LUNDBECK-DKLU3078654$LUNDBECK$$$$$$Y$$$20240722$$HP$US$US
241218951$24121895$1$I$20240701$20240715$20240722$20240722$PER$$US-SA-2024SA209712$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240722$$MD$US$US
241218961$24121896$1$I$20240701$20240715$20240722$20240722$PER$$US-SA-2024SA209373$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240722$$MD$US$US
241218971$24121897$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210871$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240722$$MD$US$US
241218981$24121898$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209224$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240722$$MD$US$US
241219001$24121900$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211048$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240722$$MD$US$US
241219021$24121902$1$I$20240701$20240715$20240722$20240722$PER$$US-SA-2024SA209856$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240722$$CN$US$US
241219033$24121903$3$F$20240701$20240821$20240722$20240904$PER$$US-SA-2024SA208043$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240904$$MD$US$US
241219041$24121904$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA211214$SANOFI AVENTIS$$$$A$M$Y$$$20240722$$MD$US$US
241219052$24121905$2$F$20240715$20240719$20240722$20240726$PER$$US-SA-2024SA210275$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240726$$CN$US$US
241219061$24121906$1$I$$20240717$20240722$20240722$PER$$US-SA-2024SA212210$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240722$$CN$US$US
241219071$24121907$1$I$20240601$20240715$20240722$20240722$PER$$US-SA-2024SA210961$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240722$$MD$US$US
241219081$24121908$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA209932$SANOFI AVENTIS$$$$$$Y$$$20240722$$CN$US$US
241219091$24121909$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA209235$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240722$$MD$US$US
241219102$24121910$2$F$20240101$20240722$20240722$20240730$PER$$US-SA-2024SA210409$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240731$$MD$US$US
241219111$24121911$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA211010$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240722$$MD$US$US
241219121$24121912$1$I$20230915$20240711$20240722$20240722$EXP$FR-AFSSAPS-GR2024000812$FR-TEVA-VS-3220974$TEVA$$44$YR$$M$Y$$$20240722$$MD$FR$FR
241219131$24121913$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA211203$SANOFI AVENTIS$$$$A$F$Y$$$20240722$$MD$US$US
241219141$24121914$1$I$$20240717$20240722$20240722$PER$$US-SA-2024SA211812$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240722$$MD$US$US
241219151$24121915$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210692$SANOFI AVENTIS$$54$YR$A$M$Y$99.7$KG$20240722$$MD$CA$US
241219161$24121916$1$I$20240712$20240715$20240722$20240722$PER$$US-SA-2024SA209693$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240722$$CN$US$US
241219171$24121917$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA209629$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240722$$CN$US$US
241219181$24121918$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA208934$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240722$$MD$US$US
241219191$24121919$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA211283$SANOFI AVENTIS$$$$E$F$Y$72.5$KG$20240722$$MD$US$US
241219201$24121920$1$I$20210501$20240715$20240722$20240722$PER$$US-SA-2024SA209541$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240722$$MD$US$US
241219211$24121921$1$I$20240101$20240715$20240722$20240722$PER$$US-SA-2024SA210972$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240722$$MD$US$US
241219221$24121922$1$I$20240714$20240715$20240722$20240722$PER$$US-SA-2024SA210900$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240722$$MD$US$US
241219242$24121924$2$F$20240717$20240722$20240722$20240730$EXP$$US-INCYTE CORPORATION-2024IN007618$INCYTE$$$$$$Y$$$20240730$$HP$US$US
241219251$24121925$1$I$$20240722$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041222$BOEHRINGER INGELHEIM$$$$$$Y$$$20240722$$CN$US$US
241219261$24121926$1$I$$20221229$20240722$20240722$EXP$$CA-DSJP-DSJ-2023-100206$DAIICHI$$$$$F$Y$$$20240722$$HP$CA$CA
241219271$24121927$1$I$$20210204$20240722$20240722$EXP$$FR-DSJP-DSJ-2021-104526$DAIICHI$$$$$F$Y$$$20240722$$MD$FR$FR
241219292$24121929$2$F$$20240826$20240722$20240903$EXP$$US-TEVA-VS-3220644$TEVA$Marino-Nunez D, Chadha A, Onajin O. A Fatal Case of Cryptococcoid Vasculopathy. Am-J-Dermatopathol 2024; 46 (7): S7.; Marino-Nunez D, Chadha A, Onajin O. A Fatal Case of Cryptococcoid Vasculopathy. Am-J-Dermatopathol 2024; 46 (7): S7.$$$$M$Y$$$20240903$$HP$US$US
241219301$24121930$1$I$20221001$20240715$20240722$20240722$EXP$$PT-009507513-2407PRT011859$MERCK$$54$YR$$M$Y$$$20240722$$MD$PT$PT
241219311$24121931$1$I$$20240717$20240722$20240722$EXP$$US-KYOWAKIRIN-2024KK017339$KYOWA$$$$$$Y$$$20240722$$MD$US$US
241219322$24121932$2$F$$20240625$20240722$20240801$EXP$$KR-GE HEALTHCARE-2024CSU008175$GE HEALTHCARE$$$$$$Y$$$20240801$$HP$KR$KR
241219332$24121933$2$F$$20240625$20240722$20240801$30DAY$$KR-GE HEALTHCARE-2024CSU007326$GE HEALTHCARE$$$$$F$Y$$$20240801$$HP$KR$KR
241219342$24121934$2$F$$20240819$20240722$20240821$PER$$US-PFIZER INC-202400218142$PFIZER$$16$YR$$F$Y$$$20240821$$MD$US$US
241219351$24121935$1$I$$20240717$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159271$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241219361$24121936$1$I$$20240717$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159269$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241219371$24121937$1$I$$20240718$20240722$20240722$EXP$$CA-009507513-2407CAN011877$MERCK$$84$YR$$F$Y$67$KG$20240722$$PH$CA$CA
241219381$24121938$1$I$$20240717$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159281$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241219393$24121939$3$F$$20240730$20240722$20240801$EXP$$US-KYOWAKIRIN-2024KK017340$KYOWA$$$$$$Y$$$20240801$$PH$US$US
241219401$24121940$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA212138$SANOFI AVENTIS$$$$$$Y$$$20240722$$LW$US$US
241219411$24121941$1$I$$20240710$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007144$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240722$$CN$US$US
241219421$24121942$1$I$20240701$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024142825$AMGEN$$63$YR$A$F$Y$$$20240722$$CN$US$US
241219441$24121944$1$I$20190101$20240710$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006853$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$US$US
241219451$24121945$1$I$$20240715$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010439$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240722$$CN$US$US
241219461$24121946$1$I$20240705$20240710$20240722$20240722$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407008021$ELI LILLY AND CO$$65$YR$E$M$Y$48$KG$20240722$$CN$CN$CN
241219471$24121947$1$I$20240622$20240710$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007679$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240722$$CN$US$US
241219481$24121948$1$I$$20240710$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007142$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240722$$CN$US$US
241219491$24121949$1$I$$20240710$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007655$ELI LILLY AND CO$$$$$$Y$$$20240722$$MD$US$US
241219502$24121950$2$F$20240715$20240911$20240722$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008728$ELI LILLY AND CO$$50$YR$A$F$Y$153.88$KG$20240923$$CN$US$US
241219511$24121951$1$I$$20240710$20240722$20240722$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407006543$ELI LILLY AND CO$$$$$M$Y$$$20240722$$CN$DE$DE
241219521$24121952$1$I$$20240710$20240722$20240722$EXP$GB-MHRA-MED-202407101203481950-JQLGF$GB-ELI_LILLY_AND_COMPANY-GB202407006726$ELI LILLY AND CO$$$$$F$Y$$$20240722$$CN$GB$GB
241219531$24121953$1$I$$20240710$20240722$20240722$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202407008927$ELI LILLY AND CO$$$$$M$Y$$$20240722$$MD$AE$AE
241219541$24121954$1$I$$20240710$20240722$20240722$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407007415$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240722$$HP$GB$GB
241219552$24121955$2$F$20200311$20240821$20240722$20240826$EXP$$US-JAZZ-2020-US-003715$JAZZ$$61$YR$$F$Y$$$20240825$$PH$US$US
241219561$24121956$1$I$$20240710$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006846$ELI LILLY AND CO$$73$YR$E$F$Y$88.4$KG$20240722$$CN$US$US
241219572$24121957$2$F$$20240826$20240722$20240903$EXP$$US-TEVA-VS-3220643$TEVA$Beck OG, Hardesty MM. Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion. Gynecol-Oncol-Rep 2023; 47.; Beck OG, Hardesty MM. Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion. Gynecol-Oncol-Rep 2023; 47.$51$YR$$F$Y$$$20240903$$HP$US$US
241219585$24121958$5$F$20240601$20240830$20240722$20240905$EXP$$JP-009507513-2407JPN003198J$MERCK$$45$YR$$F$Y$$$20240905$$MD$JP$JP
241219592$24121959$2$F$$20240801$20240722$20240802$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041151$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240802$$CN$US$US
241219601$24121960$1$I$$20240716$20240722$20240722$EXP$FR-AFSSAPS-AVNT2024000520$FR-MYLANLABS-2024M1066693$MYLAN$$26$YR$$M$Y$$$20240722$$HP$FR$FR
241219611$24121961$1$I$$20240716$20240722$20240722$EXP$NL-LRB-00982768$NL-MYLANLABS-2024M1066801$MYLAN$$47$YR$$F$Y$60$KG$20240722$$CN$NL$NL
241219621$24121962$1$I$20240424$20240712$20240722$20240722$PER$$RU-Eisai-EC-2024-170106$EISAI$$52$YR$A$M$Y$58$KG$20240722$$MD$RU$RU
241219631$24121963$1$I$$20240719$20240722$20240722$PER$$JP-Eisai-EC-2024-170608$EISAI$$71$YR$E$M$Y$$$20240722$$MD$JP$JP
241219642$24121964$2$F$20080101$20240215$20240722$20240725$PER$$US-IGSA-BIG0027752$GRIFOLS$$$$$M$Y$$$20240725$$HP$US$US
241219651$24121965$1$I$20240709$20240717$20240722$20240722$EXP$$CA-MYLANLABS-2024M1067582$MYLAN$$79$YR$$M$Y$$$20240722$$CN$CA$CA
241219665$24121966$5$F$$20240905$20240722$20240916$EXP$$DE-BAXTER-2024BAX021704$BAXTER$$51$YR$$M$Y$$$20240916$$MD$DE$DE
241219681$24121968$1$I$$20240717$20240722$20240722$EXP$$PT-PFIZER INC-202400217189$PFIZER$Ferreira Lopes, D. A HIPERTENSAO ARTERIAL COMO TRIGGER DA SINDROME DA ENCEFALOPATIA POSTERIOR REVERSIVEL: UMA ASSOCIACAO DE ELEVADO RISCO CLINICO. Revista Portuguesa de Hipertensao e Risco Cardiovascular. 2024;99 (Suppl):ID 54$40$YR$$F$Y$$$20240722$$MD$PT$PT
241219691$24121969$1$I$20231225$20240710$20240722$20240722$EXP$$CN-ROCHE-3573367$ROCHE$$81$YR$E$M$Y$$$20240722$$MD$CN$CN
241219701$24121970$1$I$20240716$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011056$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240722$$CN$US$US
241219711$24121971$1$I$20230101$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012985$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240722$$PH$US$US
241219721$24121972$1$I$20240715$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012425$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240722$$CN$US$US
241219731$24121973$1$I$20240714$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012066$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240722$$CN$US$US
241219741$24121974$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011055$ELI LILLY AND CO$$$$$$Y$$$20240722$$CN$US$US
241219751$24121975$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011900$ELI LILLY AND CO$$$$$M$Y$$$20240722$$PH$US$US
241219762$24121976$2$F$20240614$20240903$20240722$20240905$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010211$JAZZ$$22$YR$$M$Y$$$20240905$$CN$US$US
241219771$24121977$1$I$20240603$20240712$20240722$20240722$EXP$FR-AFSSAPS-AN2024000837$FR-TEVA-VS-3221188$TEVA$$66$YR$$M$Y$81$KG$20240722$$MD$FR$FR
241219781$24121978$1$I$$20240627$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN006898$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241219791$24121979$1$I$$20240709$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN007229$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241219801$24121980$1$I$20240424$20240717$20240722$20240722$EXP$$US-INCYTE CORPORATION-2024IN004785$INCYTE$$$$$$Y$$$20240719$$HP$US$US
241219811$24121981$1$I$$20240709$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN007235$INCYTE$$$$$$Y$$$20240719$$MD$US$US
241219821$24121982$1$I$$20240719$20240722$20240722$EXP$$US-OTSUKA-2024_020306$OTSUKA$$$$$M$Y$$$20240722$$CN$US$US
241219831$24121983$1$I$20230701$20240715$20240722$20240722$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010822$JAZZ$$46$YR$$F$Y$$$20240722$$CN$US$US
241219842$24121984$2$F$$20240830$20240722$20240911$PER$$US-INCYTE CORPORATION-2024IN007180$INCYTE$$$$$$Y$$$20240911$$CN$US$US
241219852$24121985$2$F$$20240708$20240722$20240805$PER$$US-INCYTE CORPORATION-2024IN007183$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241219861$24121986$1$I$$20240708$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN007185$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241219871$24121987$1$I$$20240625$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN006848$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241219881$24121988$1$I$$20240625$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN006847$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241219892$24121989$2$F$20240601$20240805$20240722$20240813$EXP$$JP-009507513-2407JPN000397J$MERCK$$72$YR$$F$Y$$$20240813$$MD$JP$JP
241219902$24121990$2$F$20240601$20240731$20240722$20240821$PER$$US-INCYTE CORPORATION-2024IN007057$INCYTE$$$$$$Y$$$20240821$$CN$US$US
241219911$24121991$1$I$20240629$20240703$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN007059$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241219921$24121992$1$I$$20240705$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN007135$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241219931$24121993$1$I$$20240705$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN007137$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241219941$24121994$1$I$$20240620$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN006648$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241219951$24121995$1$I$$20240702$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN007020$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241219961$24121996$1$I$$20240702$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN007021$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241219972$24121997$2$F$$20240702$20240722$20240925$PER$$US-INCYTE CORPORATION-2024IN007042$INCYTE$$$$$$Y$$$20240925$$CN$US$US
241219981$24121998$1$I$$20240702$20240722$20240722$PER$$US-INCYTE CORPORATION-2024IN007104$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241219991$24121999$1$I$$20240718$20240722$20240722$EXP$$US-INCYTE CORPORATION-2024IN007581$INCYTE$$$$$$Y$$$20240719$$CN$US$US
241220002$24122000$2$F$$20240716$20240722$20240725$EXP$$JP-Eisai-EC-2024-170429$EISAI$Nemoto Noriko et al.. Two cases of pseudocirrhosis caused by drug therapy for breast cancer liver metastases. The 32nd Annual Meeting of the Japanese Breast Cancer Society (abstracts). 2024; -(-): EP-1413(only 531)-EP-1413(only 531).$59$YR$A$F$Y$$$20240725$$MD$JP$JP
241220011$24122001$1$I$20231211$20240717$20240722$20240722$PER$$KR-Eisai-EC-2024-170326$EISAI$$35$YR$A$F$Y$57$KG$20240722$$CN$KR$KR
241220021$24122002$1$I$$20240719$20240722$20240722$EXP$GB-MHRA-MED-202407190926201320-QNYGS$GB-ABBVIE-5845511$ABBVIE$$$$$$Y$$$20240722$$HP$GB$GB
241220031$24122003$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116054$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240722$$CN$US$US
241220041$24122004$1$I$20240117$20240710$20240722$20240722$EXP$$CN-ROCHE-3573987$ROCHE$$71$YR$E$F$Y$$$20240722$$MD$CN$CN
241220061$24122006$1$I$$20240717$20240722$20240722$EXP$$US-INCYTE CORPORATION-2024IN007540$INCYTE$$$$$$Y$$$20240722$$CN$US$US
241220071$24122007$1$I$$20210205$20240722$20240722$EXP$$DE-DSJP-DSJ-2021-105222$DAIICHI$$$$E$F$Y$$$20240722$$MD$DE$DE
241220081$24122008$1$I$$20210130$20240722$20240722$EXP$$GB-DSJP-DSJ-2021-104523$DAIICHI$$$$$F$Y$$$20240722$$MD$GB$GB
241220093$24122009$3$F$$20240808$20240722$20240809$PER$$NVSC2024US150127$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241220101$24122010$1$I$$20240719$20240722$20240722$PER$$NVSC2024US150136$NOVARTIS$$$$$$Y$$$20240722$$HP$US$US
241220111$24122011$1$I$$20240708$20240722$20240722$EXP$$CA-HLS-202401696$HLS THERAPEUTICS$$$$E$F$Y$$$20240722$$PH$CA$CA
241220123$24122012$3$F$$20240923$20240722$20240926$EXP$$NVSC2024US149632$NOVARTIS$Rozenbaum Lerner G, Villamizar JP, Pelaez A, Salgado JC. Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis. AM J RESPIR CRIT CARE MED. 2024;209:A3531$68$YR$$M$Y$84$KG$20240926$$HP$US$US
241220131$24122013$1$I$$20240719$20240722$20240722$PER$$NVSC2024US149852$NOVARTIS$$$$$F$Y$$$20240722$$CN$US$US
241220141$24122014$1$I$20230301$20240719$20240722$20240722$EXP$$JP-Eisai-EC-2023-143667$EISAI$$$$E$F$Y$$$20240722$$MD$JP$JP
241220151$24122015$1$I$$20240715$20240722$20240722$EXP$GB-MHRA-MED-202407151547157910-PSZNR$GB-ABBVIE-5841069$ABBVIE$$$$$F$Y$73$KG$20240722$$PH$GB$GB
241220161$24122016$1$I$$20240708$20240722$20240722$EXP$$US-FMCRTG-FMC-2407-000820$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240722$$HP$US$US
241220171$24122017$1$I$$20240626$20240722$20240722$EXP$$US-MAYNE PHARMA-2024MYN000253$MAYNE$$$$$$Y$$$20240722$$CN$US$US
241220183$24122018$3$F$20240706$20240812$20240722$20240821$EXP$$US-BEH-2024175858$CSL BEHRING$$64$YR$A$M$Y$72$KG$20240821$$CN$US$US
241220191$24122019$1$I$$20240716$20240722$20240722$EXP$$EG-ELI_LILLY_AND_COMPANY-EG202407011694$ELI LILLY AND CO$$11$YR$C$F$Y$$$20240722$$CN$EG$EG
241220202$24122020$2$F$$20240717$20240722$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011032$ELI LILLY AND CO$$90$YR$E$M$Y$$$20240729$$CN$US$US
241220211$24122021$1$I$$20240710$20240722$20240722$EXP$$US-ELI_LILLY_AND_COMPANY-US202403003596$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240722$$CN$US$US
241220221$24122022$1$I$$20240710$20240722$20240722$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202311015479$ELI LILLY AND CO$$50$YR$A$F$Y$54$KG$20240722$$CN$CN$CN
241220241$24122024$1$I$$20240719$20240722$20240722$PER$$US-BIOMARINAP-US-2024-159301$BIOMARIN$$$$$$Y$$$20240722$$CN$US$US
241220251$24122025$1$I$$20240711$20240722$20240722$EXP$$JP-SMPA-2024SMP010718$SUNOVION$$$$$$Y$$$20240722$$CN$JP$JP
241220262$24122026$2$F$$20240801$20240722$20240812$EXP$$TW-SMPA-2024SMP010744$SUNOVION$$$$$$Y$$$20240812$$CN$TW$TW
241220271$24122027$1$I$$20240711$20240722$20240722$PER$$US-SMPA-2024SPA000135$SUNOVION$$$$$$Y$$$20240722$$CN$US$US
241220281$24122028$1$I$$20240718$20240722$20240722$PER$$NVSC2024US150049$NOVARTIS$$$$$M$Y$$$20240722$$CN$US$US
241220291$24122029$1$I$$20240719$20240722$20240722$EXP$$TR-ANIPHARMA-2024-TR-000074$ANI$Gul EE, Bektasoglu G, Dogan Z.Brugada phenocopy associated with multiple psychotic drugs..Journal of Electrocardiology.2023;81156-158.$17$YR$$F$Y$$$20240722$$MD$TR$TR
241220301$24122030$1$I$$20240717$20240722$20240722$EXP$CA-DRL-USA-SPO/CAN/24/0010571$CA-RDY-SPO/CAN/24/0010571$DR REDDYS$$75$YR$E$M$Y$$$20240722$$PH$CA$CA
241220311$24122031$1$I$$20240717$20240722$20240722$EXP$CA-GERMAN-SPO/CAN/24/0010588$CA-RDY-SPO/CAN/24/0010588$DR REDDYS$$76$YR$E$M$Y$$$20240722$$MD$CA$CA
241220321$24122032$1$I$20240622$20240705$20240722$20240722$EXP$$US-Standard Homeopathic-2159452$STANDARD HOMEOPATHIC$$55$YR$$F$Y$99$KG$20240722$$$US$US
241220331$24122033$1$I$$20240717$20240722$20240722$EXP$CA-DRL-USA-SPO/CAN/24/0010604$CA-RDY-SPO/CAN/24/0010604$DR REDDYS$$62$YR$A$M$Y$$$20240722$$HP$CA$CA
241220341$24122034$1$I$$20240717$20240722$20240722$EXP$CA-DRL-USA-SPO/CAN/24/0010587$CA-RDY-SPO/CAN/24/0010587$DR REDDYS$$88$YR$E$M$Y$$$20240722$$HP$CA$CA
241220351$24122035$1$I$20240711$20240711$20240722$20240722$EXP$$JP-ROCHE-10000030229$ROCHE$$7$DEC$E$F$Y$$$20240722$$MD$JP$JP
241220361$24122036$1$I$$20240710$20240722$20240722$EXP$$JP-ROCHE-10000027304$ROCHE$$79$YR$E$$Y$$$20240722$$MD$JP$JP
241220371$24122037$1$I$$20210204$20240722$20240722$EXP$$FR-DSJP-DSJ-2021-104527$DAIICHI$$$$$F$Y$$$20240722$$MD$FR$FR
241220381$24122038$1$I$20240701$20240715$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407010103$ELI LILLY AND CO$$78$YR$E$$Y$$$20240722$$CN$US$US
241220391$24122039$1$I$$20230113$20240722$20240722$EXP$$AU-DSJP-DSJ-2022-135791$DAIICHI$$$$$F$Y$$$20240722$$MD$AU$AU
241220401$24122040$1$I$$20240717$20240722$20240722$EXP$$DE-009507513-2407DEU012279$MERCK$$$$$F$Y$$$20240722$$MD$DE$DE
241220411$24122041$1$I$20240508$20240710$20240722$20240722$EXP$$JP-009507513-2407JPN002285J$MERCK$$39$YR$$F$Y$$$20240722$$MD$JP$JP
241220421$24122042$1$I$$20240709$20240722$20240722$PER$$US-009507513-2407USA005254$MERCK$$80$YR$$$Y$$$20240722$$CN$US$US
241220431$24122043$1$I$$20240719$20240722$20240722$PER$$NVSC2024US150141$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
241220442$24122044$2$F$20240717$20240719$20240722$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407012909$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240724$$HP$US$US
241220451$24122045$1$I$20240501$20240715$20240722$20240722$PER$$US-SA-2024SA210953$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240723$$MD$US$US
241220461$24122046$1$I$20240704$20240712$20240722$20240722$EXP$$CN-TAKEDA-2024TUS072620$TAKEDA$$61$YR$$F$Y$$$20240722$$HP$CN$CN
241220471$24122047$1$I$20240101$20240711$20240722$20240722$PER$$US-SA-2024SA206939$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240723$$MD$US$US
241220481$24122048$1$I$$20240710$20240722$20240722$PER$$US-SA-2024SA207346$SANOFI AVENTIS$$$$A$$Y$$$20240723$$CN$US$US
241220492$24122049$2$F$$20240715$20240722$20240726$EXP$$US-GSK-US2024GSK091457$GLAXOSMITHKLINE$Ahmed H, Ismayl M, Palicherla A, Selim M, Aboeata A. Bupropion-disguised chest pain presenting in a middle-aged male: a case report and review of literature. Annals of medicine and surgery. 2024;86 (7):4213-4216$$$$$Y$$$20240726$$MD$US$US
241220501$24122050$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024GSK091438$GLAXOSMITHKLINE$Stokes S, Zahler-Miller C, Dunn K.. Diagnosis and management of a herpes nipple infection that resulted in neonatal HSV encephalitis. BMJ case reports. 2024;17(7)$$$$$Y$$$20240722$$MD$US$US
241220511$24122051$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024GSK091571$GLAXOSMITHKLINE$Stokes S, Zahler-Miller C, Dunn K.. Diagnosis and management of a herpes nipple infection that resulted in neonatal HSV encephalitis. BMJ case reports. 2024;17(7)$$$$$Y$$$20240722$$MD$US$US
241220521$24122052$1$I$20240514$20240611$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090891$VIIV$$61$YR$$M$Y$$$20240722$$PH$US$US
241220531$24122053$1$I$20240514$20240611$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090892$VIIV$$74$YR$$F$Y$$$20240722$$PH$US$US
241220541$24122054$1$I$20240514$20240611$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089947$VIIV$$47$YR$$M$Y$$$20240722$$PH$US$US
241220551$24122055$1$I$20240514$20240611$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090982$VIIV$$34$YR$$M$Y$$$20240722$$PH$US$US
241220561$24122056$1$I$20240514$20240611$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090255$VIIV$$29$YR$$M$Y$$$20240722$$PH$US$US
241220571$24122057$1$I$20240514$20240611$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090894$VIIV$$57$YR$$F$Y$$$20240722$$PH$US$US
241220581$24122058$1$I$20240514$20240611$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090376$VIIV$$33$YR$$M$Y$$$20240722$$PH$US$US
241220592$24122059$2$F$20240501$20240820$20240722$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090375$VIIV$$44$YR$$M$Y$129$KG$20240830$$PH$US$US
241220602$24122060$2$F$20240514$20240822$20240722$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090378$VIIV$$41$YR$$M$Y$$$20240831$$PH$US$US
241220611$24122061$1$I$20240514$20240611$20240722$20240722$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090893$VIIV$$30$YR$$M$Y$$$20240722$$PH$US$US
241220631$24122063$1$I$$20240708$20240722$20240722$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06900$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240722$$HP$US$US
241220651$24122065$1$I$20240605$20240722$20240722$20240722$EXP$IT-MINISAL02-995588$IT-GILEAD-2024-0681503$GILEAD$$72$YR$E$M$Y$$$20240722$$MD$IT$IT
241220661$24122066$1$I$$20240719$20240722$20240722$EXP$$CN-TAKEDA-2024TUS073547$TAKEDA$$$$$M$Y$$$20240722$$CN$CN$CN
241220671$24122067$1$I$$20240708$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407006592$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240722$$CN$US$US
241220681$24122068$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011030$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240722$$CN$US$US
241220691$24122069$1$I$20240719$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013638$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240722$$HP$US$US
241220702$24122070$2$F$$20240830$20240722$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202407011348$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240903$$CN$US$US
241220711$24122071$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013044$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240722$$CN$US$US
241220721$24122072$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012134$ELI LILLY AND CO$$$$A$F$Y$$$20240722$$CN$US$US
241220732$24122073$2$F$20240621$20240801$20240722$20240805$EXP$$IT-TAKEDA-2024TUS073920$TAKEDA$$$$$M$Y$$$20240805$$CN$GB$IT
241220741$24122074$1$I$20240101$20240715$20240722$20240722$EXP$$CO-ASTELLAS-2024US020465$ASTELLAS$$37$YR$$M$Y$65$KG$20240722$$CN$CO$CO
241220752$24122075$2$F$20240501$20240920$20240722$20240926$EXP$$US-ASTELLAS-2024US018620$ASTELLAS$$63$YR$A$F$Y$$$20240926$$CN$US$US
241220761$24122076$1$I$$20240715$20240722$20240722$EXP$$US-TAKEDA-2024TUS072762$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240722$$MD$US$US
241220772$24122077$2$F$20240101$20240724$20240722$20240731$PER$$US-JAZZ PHARMACEUTICALS-2023-US-024986$JAZZ$$$$$M$Y$$$20240731$$HP$US$US
241220781$24122078$1$I$20240712$20240718$20240722$20240722$EXP$$US-MTPC-MTDA2024-0015105$Unknown Manufacturer$$74$YR$$M$Y$$$20240722$$CN$US$US
241220791$24122079$1$I$20240403$20240722$20240722$20240722$EXP$IT-MINISAL02-995578$IT-GILEAD-2024-0681495$GILEAD$$28$YR$A$F$Y$$$20240722$$MD$IT$IT
241220801$24122080$1$I$20240709$20240718$20240722$20240722$EXP$$CN-BEIGENE-BGN-2024-011220$BEIGENE$$$$$$Y$$$20240722$$HP$CN$CN
241220811$24122081$1$I$20230101$20240718$20240722$20240722$EXP$$CN-JNJFOC-20240756730$JOHNSON AND JOHNSON$Chen SY; Wang CH; Li YT; Huang C. Case report: Limb dysfunction, ventricular mass, and gangrene in a primary antiphospholipid syndrome patient. International Journal of Rheumatic Diseases. 2024;27(7)$32$YR$A$M$Y$$$20240722$$HP$CN$CN
241220821$24122082$1$I$20240601$20240705$20240722$20240722$PER$$US-JNJFOC-20240718332$JOHNSON AND JOHNSON$$96$YR$E$M$Y$$$20240722$$CN$US$US
241220831$24122083$1$I$20240520$20240719$20240722$20240722$EXP$FR-AFSSAPS-LL2024001312$FR-JNJFOC-20240756381$JOHNSON AND JOHNSON$$76$YR$E$M$Y$105$KG$20240722$$PH$FR$FR
241220841$24122084$1$I$$20240711$20240722$20240722$EXP$$CA-GILEAD-2024-0681235$GILEAD$$82$YR$E$F$Y$$$20240722$$CN$CA$CA
241220851$24122085$1$I$$20240710$20240722$20240722$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07025$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240722$$HP$US$US
241220861$24122086$1$I$20240313$20240722$20240722$20240722$EXP$IT-MINISAL02-995576$IT-GILEAD-2024-0681508$GILEAD$$60$YR$A$M$Y$$$20240722$$MD$IT$IT
241220871$24122087$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012616$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240722$$CN$US$US
241220882$24122088$2$F$20240717$20240719$20240722$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407012115$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240724$$CN$US$US
241220891$24122089$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012332$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240722$$CN$US$US
241220901$24122090$1$I$20230101$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011899$ELI LILLY AND CO$$$$$$Y$$$20240722$$HP$US$US
241220911$24122091$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012401$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240722$$CN$US$US
241220922$24122092$2$F$$20240812$20240722$20240812$PER$$US-ALXN-202407USA001001US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241220931$24122093$1$I$$20240715$20240722$20240722$PER$$US-ALXN-202407USA000979US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240722$$CN$US$US
241220941$24122094$1$I$20240701$20240708$20240722$20240722$EXP$$US-HLS-202400275$HLS THERAPEUTICS$$46$YR$A$M$Y$$$20240722$$PH$US$US
241220951$24122095$1$I$$20240718$20240722$20240722$30DAY$$US-SANDOZ INC.-SDZ2024US066804$SANDOZ$$$$$M$Y$$$20240722$$CN$US$US
241220961$24122096$1$I$20240504$20240715$20240722$20240722$EXP$$MX-AstraZeneca-2024A130465$ASTRAZENECA$$41$DY$$M$Y$4.6$KG$20240723$$CN$MX$
241221001$24122100$1$I$20240620$20240717$20240722$20240722$EXP$$NVSC2024US148129$NOVARTIS$$72$YR$$F$Y$79.365$KG$20240723$$CN$US$US
241221011$24122101$1$I$$20240708$20240722$20240722$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR01006$TARO$$$$$$Y$$$20240723$$HP$CA$CA
241221021$24122102$1$I$$20240716$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011074$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240722$$CN$US$US
241221031$24122103$1$I$20240710$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407011902$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240722$$CN$US$US
241221042$24122104$2$F$$20240729$20240722$20240802$PER$$US-ALXN-202407USA001026US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241221051$24122105$1$I$$20240716$20240722$20240722$PER$$US-ALXN-202407USA001041US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241221061$24122106$1$I$$20240711$20240722$20240722$EXP$$US-UCBSA-2024035632$UCB$$$$$M$Y$111.92$KG$20240723$$HP$US$US
241221071$24122107$1$I$$20240716$20240722$20240722$PER$$US-ALXN-202407USA001098US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241221082$24122108$2$F$20230201$20240906$20240722$20240912$PER$$US-AMGEN-USASP2024140339$AMGEN$$53$YR$A$F$Y$$$20240912$$CN$US$US
241221091$24122109$1$I$$20240715$20240722$20240722$EXP$$DE-JNJFOC-20240735564$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240723$$MD$DE$DE
241221102$24122110$2$F$$20240812$20240722$20240812$PER$$US-ALXN-202407USA001097US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241221112$24122111$2$F$$20240802$20240722$20240815$EXP$$US-UCBSA-2024035872$UCB$$$$A$F$Y$$$20240815$$CN$US$US
241221121$24122112$1$I$20240701$20240719$20240722$20240722$PER$$US-AMGEN-USASP2024144237$AMGEN$$62$YR$A$M$Y$$$20240722$$CN$US$US
241221131$24122113$1$I$$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012821$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240722$$CN$US$US
241221141$24122114$1$I$20240718$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012824$ELI LILLY AND CO$$$$$$Y$$$20240722$$CN$US$US
241221151$24122115$1$I$$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012823$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240722$$CN$US$US
241221161$24122116$1$I$20240702$20240717$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012822$ELI LILLY AND CO$$$$$M$Y$$$20240722$$CN$US$US
241221171$24122117$1$I$20240719$20240719$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407012785$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240722$$CN$US$US
241221181$24122118$1$I$$20240718$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407013721$ELI LILLY AND CO$$$$$M$Y$$$20240722$$CN$US$US
241221191$24122119$1$I$$20240716$20240722$20240722$PER$$US-ABBVIE-5845564$ABBVIE$$$$$M$Y$66$KG$20240722$$CN$US$US
241221201$24122120$1$I$20230801$20240517$20240722$20240722$EXP$$US-APELLIS-APL-2023-002817$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
241221212$24122121$2$F$20240716$20240808$20240722$20240815$EXP$$CA-ABBVIE-5846340$ABBVIE$$41$YR$$M$Y$$$20240815$$CN$CA$CA
241221221$24122122$1$I$20240501$20240710$20240722$20240722$EXP$$BR-UCBSA-2024035446$UCB$$70$YR$$F$Y$73$KG$20240723$$CN$BR$BR
241221232$24122123$2$F$20240101$20240711$20240722$20240809$PER$$US-009507513-2407USA001631$MERCK$$$$$F$Y$$$20240809$$CN$US$US
241221241$24122124$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA210709$SANOFI AVENTIS$$$$A$M$Y$74.843$KG$20240723$$MD$US$US
241221251$24122125$1$I$$20240719$20240722$20240722$EXP$$JP-JNJFOC-20240757671$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$MD$JP$JP
241221261$24122126$1$I$$20240719$20240722$20240722$EXP$NL-LRB-00990575$NL-JNJFOC-20240757719$JOHNSON AND JOHNSON$$71$YR$E$F$Y$78$KG$20240723$$CN$NL$NL
241221271$24122127$1$I$20240124$20240715$20240722$20240722$EXP$DE-SEATTLE GENETICS-2024SGN01516$DE-RDY-SPO/DEU/24/0010433$DR REDDYS$$$$$F$Y$$$20240723$$MD$DE$DE
241221282$24122128$2$F$$20240725$20240722$20240726$PER$$NVSC2024US150144$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241221291$24122129$1$I$20240131$20240715$20240722$20240722$EXP$$DE-SANDOZ INC.-SDZ2024DE059166$SANDOZ$$$$C$F$Y$15.5$KG$20240722$$HP$DE$DE
241221301$24122130$1$I$20240715$20240715$20240722$20240722$PER$$US-JNJFOC-20240739059$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240722$$HP$US$US
241221312$24122131$2$F$20170324$20240807$20240722$20240812$EXP$$JP-JNJFOC-20240369797$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240812$$MD$JP$JP
241221323$24122132$3$F$$20240719$20240722$20240726$EXP$$US-BIOGEN-2024BI01274105$BIOGEN$$$$$F$Y$$$20240726$$CN$US$US
241221331$24122133$1$I$$20240718$20240722$20240722$PER$$US-JNJFOC-20240752291$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$CN$US$US
241221341$24122134$1$I$20240701$20240715$20240722$20240722$EXP$$GB-JNJFOC-20240744212$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20240722$$CN$GB$GB
241221352$24122135$2$F$$20240725$20240722$20240801$EXP$$JP-JNJFOC-20240756118$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240801$$MD$JP$JP
241221361$24122136$1$I$$20240704$20240722$20240722$30DAY$$DE-JNJFOC-20240755818$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$DE$DE
241221371$24122137$1$I$20240601$20240716$20240722$20240722$EXP$$US-JNJFOC-20240744426$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240722$$CN$US$US
241221381$24122138$1$I$20240716$20240716$20240722$20240722$PER$$US-JNJFOC-20240745909$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240722$$HP$US$US
241221391$24122139$1$I$$20240717$20240722$20240722$EXP$$CA-ABBVIE-5847050$ABBVIE$$20$YR$$F$Y$50$KG$20240722$$CN$CA$CA
241221402$24122140$2$F$$20240716$20240722$20240723$PER$$US-JNJFOC-20240734315$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
241221414$24122141$4$F$20240717$20240816$20240722$20240817$PER$$US-JNJFOC-20240745367$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240817$$CN$US$US
241221442$24122144$2$F$$20240714$20240722$20240722$PER$$US-JNJFOC-20240741246$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
241221452$24122145$2$F$20240601$20240806$20240722$20240808$30DAY$$ES-JNJFOC-20240703919$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$PH$ES$ES
241221462$24122146$2$F$$20240718$20240722$20240724$PER$$US-JNJFOC-20240748285$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
241221474$24122147$4$F$20240101$20240918$20240722$20240922$EXP$$HR-JNJFOC-20240755725$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240923$$MD$HR$HR
241221482$24122148$2$F$20240625$20240809$20240722$20240813$30DAY$$TR-JNJFOC-20240704901$JOHNSON AND JOHNSON$$32$YR$A$F$Y$64$KG$20240813$$PH$TR$TR
241221491$24122149$1$I$20240313$20240715$20240722$20240722$EXP$FR-AFSSAPS-AN2024000668$FR-JNJFOC-20240741568$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240722$$PH$FR$FR
241221504$24122150$4$F$20240715$20240926$20240722$20240927$PER$$US-AMGEN-USASP2024142939$AMGEN$$76$YR$E$M$Y$$$20240927$$CN$US$US
241221512$24122151$2$F$20240101$20240728$20240722$20240801$EXP$$BR-JNJFOC-20240329817$JOHNSON AND JOHNSON$$35$YR$A$F$Y$66$KG$20240801$$CN$BR$BR
241221522$24122152$2$F$$20240814$20240722$20240820$PER$$US-JNJFOC-20240741797$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240820$$CN$US$US
241221532$24122153$2$F$$20240814$20240722$20240819$PER$$US-JNJFOC-20240737130$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$US$US
241221541$24122154$1$I$$20240716$20240722$20240722$PER$$US-JNJFOC-20240747569$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
241221551$24122155$1$I$$20240718$20240722$20240722$PER$$US-JNJFOC-20240755546$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$HP$US$US
241221561$24122156$1$I$$20240710$20240722$20240722$PER$$US-JNJFOC-20240727590$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$CN$US$US
241221573$24122157$3$F$20240101$20240827$20240722$20240903$EXP$$US-JNJFOC-20240738105$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240903$$CN$US$US
241221583$24122158$3$F$20240712$20240807$20240722$20240809$PER$$US-AMGEN-USASP2024141144$AMGEN$$47$YR$A$F$Y$57.596$KG$20240809$$HP$US$US
241221591$24122159$1$I$20240531$20240710$20240722$20240722$EXP$$CA-JNJFOC-20240728234$JOHNSON AND JOHNSON$$56$YR$A$M$Y$74$KG$20240722$$HP$CA$CA
241221601$24122160$1$I$$20240715$20240722$20240722$EXP$$US-GSK-US2024AMR089737$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$CN$US$US
241221611$24122161$1$I$20240415$20240722$20240722$20240722$EXP$FR-AFSSAPS-AN2024000807$FR-SANDOZ INC.-SDZ2024FR066925$SANDOZ$$76$YR$$M$Y$$$20240722$$PH$FR$FR
241221621$24122162$1$I$20240717$20240718$20240722$20240722$30DAY$$US-SANDOZ INC.-SDZ2024US066920$SANDOZ$$28$YR$$M$Y$$$20240722$$CN$US$US
241221631$24122163$1$I$20240301$20240715$20240722$20240722$EXP$$CA-JNJFOC-20240445739$JOHNSON AND JOHNSON$$53$YR$A$F$Y$68.4$KG$20240723$$HP$CA$CA
241221641$24122164$1$I$$20240720$20240722$20240722$PER$$NVSC2024US150145$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
241221652$24122165$2$F$$20240919$20240722$20240930$PER$$US-BAUSCHBL-2024BNL030123$BAUSCH AND LOMB$$$$$F$Y$63.5$KG$20240930$$CN$US$US
241221661$24122166$1$I$$20240718$20240722$20240722$PER$$US-BAUSCHBL-2024BNL030306$BAUSCH AND LOMB$$$$$F$Y$$$20240723$$MD$US$US
241221672$24122167$2$F$$20240715$20240722$20240723$PER$$US-BAUSCHBL-2024BNL030224$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240724$$CN$US$US
241221682$24122168$2$F$20240706$20240923$20240722$20240927$EXP$$CO-BIOGEN-2024BI01274335$BIOGEN$$$$$F$Y$$$20240927$$CN$CO$CO
241221691$24122169$1$I$20240701$20240716$20240722$20240722$PER$$US-ABBVIE-5846529$ABBVIE$$81$YR$$F$Y$$$20240722$$CN$US$US
241221711$24122171$1$I$20240101$20240716$20240722$20240722$EXP$$AU-BEH-2024175775$CSL BEHRING$$$$$M$Y$84$KG$20240722$$HP$AU$AU
241221721$24122172$1$I$20240601$20240711$20240722$20240722$EXP$$US-UCBSA-2024035616$UCB$$45$YR$$F$Y$$$20240723$$HP$US$US
241221732$24122173$2$F$20240101$20240731$20240722$20240808$PER$$US-SA-2024SA210812$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240808$$MD$US$US
241221741$24122174$1$I$20230104$20240722$20240722$20240722$EXP$FR-AFSSAPS-GR2024000915$FR-JNJFOC-20240756525$JOHNSON AND JOHNSON$$3$MON$I$F$Y$$$20240723$$PH$FR$FR
241221752$24122175$2$F$$20240808$20240722$20240812$PER$$US-ABBVIE-5845700$ABBVIE$$$$$F$Y$84$KG$20240812$$CN$US$US
241221761$24122176$1$I$$20240715$20240722$20240722$EXP$$IT-ESPERIONTHERAPEUTICS-2024ITA01103$ESPERION THERAPEUTICS$$$$$F$Y$$$20240723$$MD$IT$IT
241221771$24122177$1$I$$20240712$20240722$20240722$EXP$$US-BEH-2024175768$CSL BEHRING$$$$$F$Y$$$20240722$$HP$US$US
241221781$24122178$1$I$20240715$20240715$20240722$20240722$PER$$US-ABBVIE-5844138$ABBVIE$$81$YR$$F$Y$$$20240722$$CN$US$US
241221791$24122179$1$I$$20240717$20240722$20240722$EXP$$CA-ABBVIE-5845941$ABBVIE$$$$A$F$Y$$$20240722$$CN$CA$CA
241221801$24122180$1$I$$20240716$20240722$20240722$PER$$US-ABBVIE-5845505$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241221811$24122181$1$I$20240712$20240715$20240722$20240722$EXP$$CA-JNJFOC-20240741251$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240723$$HP$CA$CA
241221821$24122182$1$I$$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024143479$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241221831$24122183$1$I$20230101$20240716$20240722$20240722$EXP$$US-ABBVIE-5843558$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241221841$24122184$1$I$$20240719$20240722$20240722$EXP$$JP-TAKEDA-2024TJP010887$TAKEDA$$$$$F$Y$$$20240722$$MD$JP$JP
241221852$24122185$2$F$$20240812$20240722$20240820$30DAY$$GB-JNJFOC-20240721795$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240821$$CN$GB$GB
241221861$24122186$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA211126$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240723$$MD$US$US
241221871$24122187$1$I$$20240718$20240722$20240722$EXP$$US-ABBVIE-5845412$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241221883$24122188$3$F$20240101$20240725$20240722$20240730$EXP$$CA-JNJFOC-20240419701$JOHNSON AND JOHNSON$$36$YR$A$F$Y$54$KG$20240730$$HP$CA$CA
241221891$24122189$1$I$$20240718$20240722$20240722$EXP$$US-ABBVIE-5846148$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241221901$24122190$1$I$20240618$20240716$20240722$20240722$EXP$$US-ABBVIE-5844383$ABBVIE$$75$YR$$F$Y$$$20240722$$CN$US$US
241221911$24122191$1$I$20240101$20240716$20240722$20240722$EXP$$US-ABBVIE-5845190$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241221921$24122192$1$I$20230101$20240717$20240722$20240722$EXP$$CA-ABBVIE-5845671$ABBVIE$$54$YR$$F$Y$$$20240722$$CN$CA$CA
241221931$24122193$1$I$$20240709$20240722$20240722$EXP$$US-BEH-2024175492$CSL BEHRING$$$$A$F$Y$$$20240722$$CN$US$US
241221941$24122194$1$I$$20240717$20240722$20240722$EXP$$IN-Bion-013479$BIONPHARMA$$27$YR$A$M$Y$$$20240723$$HP$IN$IN
241221951$24122195$1$I$$20240717$20240722$20240722$EXP$$IN-Bion-013489$BIONPHARMA$$24$YR$A$M$Y$$$20240723$$HP$IN$IN
241221961$24122196$1$I$$20240717$20240722$20240722$EXP$$IN-Bion-013490$BIONPHARMA$$38$YR$A$F$Y$$$20240723$$HP$IN$IN
241221971$24122197$1$I$$20240717$20240722$20240722$EXP$$JP-Bion-013484$BIONPHARMA$$76$YR$E$F$Y$54$KG$20240723$$HP$JP$JP
241221981$24122198$1$I$$20240717$20240722$20240722$EXP$$US-Bion-013486$BIONPHARMA$$6$DEC$A$M$Y$$$20240723$$HP$US$US
241221993$24122199$3$F$20240717$20240816$20240722$20240822$EXP$$US-ABBVIE-5846228$ABBVIE$$71$YR$$M$Y$81.646$KG$20240822$$CN$US$US
241222001$24122200$1$I$20240709$20240715$20240722$20240722$EXP$$US-Bion-013499$BIONPHARMA$$78$YR$E$M$Y$$$20240723$$CN$US$US
241222011$24122201$1$I$$20240717$20240722$20240722$EXP$$RS-Bion-013480$BIONPHARMA$$32$YR$A$M$Y$$$20240723$$HP$RS$RS
241222021$24122202$1$I$$20240717$20240722$20240722$EXP$$US-Bion-013481$BIONPHARMA$$60$YR$A$M$Y$$$20240723$$HP$US$US
241222032$24122203$2$F$$20240813$20240722$20240821$EXP$$US-Bion-013500$BIONPHARMA$$80$YR$E$F$Y$$$20240821$$CN$US$US
241222041$24122204$1$I$$20240715$20240722$20240722$PER$$US-SA-2024SA077759$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240723$$MD$US$US
241222051$24122205$1$I$20240101$20240717$20240722$20240722$EXP$$US-ABBVIE-5844125$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241222061$24122206$1$I$20240701$20240717$20240722$20240722$EXP$$US-ABBVIE-5844774$ABBVIE$$75$YR$$F$Y$$$20240722$$CN$US$US
241222072$24122207$2$F$$20240809$20240722$20240813$30DAY$$GB-JNJFOC-20240740028$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$CN$GB$GB
241222081$24122208$1$I$$20240718$20240722$20240722$EXP$$US-ABBVIE-5846460$ABBVIE$$$$$M$Y$$$20240722$$HP$US$US
241222091$24122209$1$I$$20240717$20240722$20240722$PER$$US-SA-2024SA211459$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240723$$MD$US$US
241222101$24122210$1$I$20211101$20240718$20240722$20240722$EXP$$RU-ABBVIE-5846351$ABBVIE$$3$YR$$M$Y$$$20240722$$MD$RU$RU
241222113$24122211$3$F$20240706$20240913$20240722$20240920$EXP$$JP-ASTELLAS-2024JP005167$ASTELLAS$$72$YR$E$M$Y$$$20240920$$PH$JP$JP
241222121$24122212$1$I$$20240514$20240722$20240722$PER$$US-AMGEN-USASP2024144316$AMGEN$$56$YR$A$F$Y$$$20240722$$CN$US$US
241222131$24122213$1$I$$20240717$20240722$20240722$EXP$$JP-ASTELLAS-2024JP005066$ASTELLAS$$$$$M$Y$$$20240723$$PH$JP$JP
241222141$24122214$1$I$20240628$20240710$20240722$20240722$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2159454$JIANGSU HENGRUI MEDICINE$$62$YR$$M$Y$42$KG$20240722$$MD$CN$CN
241222152$24122215$2$F$$20240829$20240722$20240910$PER$$US-SA-2024SA210942$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240910$$MD$US$US
241222162$24122216$2$F$20240701$20240806$20240722$20240809$EXP$$BR-ASTELLAS-2024US020543$ASTELLAS$$$$$F$Y$$$20240809$$CN$BR$BR
241222171$24122217$1$I$20240421$20240717$20240722$20240722$EXP$$CH-ASTELLAS-2024US020580$ASTELLAS$$70$YR$$M$Y$50$KG$20240723$$CN$CH$CH
241222181$24122218$1$I$$20240722$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041215$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240722$$CN$US$US
241222191$24122219$1$I$$20240717$20240722$20240722$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041219$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240722$$CN$US$US
241222203$24122220$3$F$20240712$20240911$20240722$20240911$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041109$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$65$KG$20240911$$CN$DE$DE
241222211$24122221$1$I$20240601$20240722$20240722$20240722$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041241$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$$$20240722$$CN$US$US
241222221$24122222$1$I$$20240719$20240722$20240722$PER$$US-AMGEN-USASP2024143859$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241222231$24122223$1$I$$20240722$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041155$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240723$$CN$US$US
241222242$24122224$2$F$20240701$20240722$20240722$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041256$BOEHRINGER INGELHEIM$$88$YR$E$M$Y$$$20240723$$CN$US$US
241222251$24122225$1$I$$20240719$20240722$20240722$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041057$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240723$$CN$CA$CA
241222261$24122226$1$I$20240711$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143541$AMGEN$$71$YR$E$F$Y$$$20240722$$CN$US$US
241222271$24122227$1$I$20240717$20240717$20240722$20240722$PER$$US-AMGEN-USASP2024143716$AMGEN$$49$YR$A$F$Y$$$20240722$$CN$US$US
241222281$24122228$1$I$$20240722$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041278$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240723$$HP$US$US
241222291$24122229$1$I$20230901$20240719$20240722$20240722$EXP$$PT-JNJFOC-20240757446$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240723$$MD$PT$PT
241222301$24122230$1$I$20180101$20240716$20240722$20240722$EXP$$JP-GSK-JP2024JPN089084$GLAXOSMITHKLINE$$$$$$Y$$$20240722$$MD$JP$JP
241222311$24122231$1$I$20240718$20240718$20240722$20240722$PER$$US-JNJFOC-20240750628$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$MD$US$US
241222321$24122232$1$I$20230101$20240716$20240722$20240722$EXP$$US-ABBVIE-5843681$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241222331$24122233$1$I$$20240716$20240722$20240722$EXP$$BR-ABBVIE-5844202$ABBVIE$$$$$F$Y$$$20240722$$MD$BR$BR
241222341$24122234$1$I$20240719$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116166$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240722$$HP$US$US
241222351$24122235$1$I$$20240719$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116053$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240722$$CN$US$US
241222361$24122236$1$I$$20240715$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113031$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$96.16$KG$20240722$$PH$US$US
241222371$24122237$1$I$20240717$20240719$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115574$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240722$$HP$US$US
241222381$24122238$1$I$20240716$20240718$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115467$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$132.45$KG$20240722$$HP$US$US
241222391$24122239$1$I$$20240719$20240722$20240722$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041210$BOEHRINGER INGELHEIM$$$$$$Y$$$20240723$$HP$US$US
241222401$24122240$1$I$$20240715$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115778$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240722$$HP$US$US
241222411$24122241$1$I$$20240718$20240722$20240722$EXP$$US-ABBVIE-5845147$ABBVIE$Gupta NY, Al Diffalha S, Russ KB. An unusual case of colitis in a bone marrow transplant patient. Gastroenterology. 2024;167(3):e1-e4.$65$YR$$M$Y$$$20240722$$HP$US$US
241222431$24122243$1$I$20240422$20240709$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113114$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$53$KG$20240723$$PH$JP$JP
241222441$24122244$1$I$20240707$20240717$20240722$20240722$PER$$US-ABBVIE-5846656$ABBVIE$$55$YR$$M$Y$$$20240722$$CN$US$US
241222451$24122245$1$I$20230101$20240716$20240722$20240722$PER$$US-SA-2024SA211148$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240723$$MD$US$US
241222462$24122246$2$F$20240701$20240828$20240722$20240904$EXP$$NVSC2024MX149094$NOVARTIS$$57$YR$$M$Y$62$KG$20240904$$CN$MX$MX
241222471$24122247$1$I$$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114304$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$117.48$KG$20240723$$CN$US$US
241222482$24122248$2$F$$20240808$20240722$20240820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-114694$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$49$KG$20240820$$MD$JP$JP
241222491$24122249$1$I$$20240716$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113813$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240723$$CN$US$US
241222501$24122250$1$I$20240710$20240711$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113961$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240723$$MD$JP$JP
241222512$24122251$2$F$20240410$20240712$20240722$20240806$EXP$DK-DKMA-30729654$DK-BRISTOL-MYERS SQUIBB COMPANY-2024-111129$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240716$$MD$DK$DK
241222521$24122252$1$I$$20240715$20240722$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-112689$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$79$KG$20240723$$HP$CA$CA
241222531$24122253$1$I$$20240712$20240722$20240722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116246$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240723$$MD$JP$JP
241222541$24122254$1$I$$20240716$20240722$20240722$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114432$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240723$$PH$US$US
241222551$24122255$1$I$20240301$20240717$20240722$20240722$EXP$$US-ABBVIE-5845153$ABBVIE$$49$YR$$F$Y$$$20240722$$CN$US$US
241222561$24122256$1$I$$20240717$20240722$20240722$EXP$$US-ABBVIE-5845237$ABBVIE$$$$$M$Y$$$20240722$$CN$US$US
241222571$24122257$1$I$20240101$20240716$20240722$20240722$PER$$US-ABBVIE-5845447$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241222582$24122258$2$F$$20240801$20240722$20240805$EXP$$US-ABBVIE-5845702$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241222592$24122259$2$F$20201109$20240830$20240722$20240905$EXP$$JP-009507513-2405JPN000761J$MERCK$$19$YR$$F$Y$36$KG$20240905$$MD$JP$JP
241222601$24122260$1$I$$20240716$20240722$20240722$PER$$US-SA-2024SA212180$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240723$$MD$US$US
241222612$24122261$2$F$20240101$20240809$20240722$20240820$PER$$US-SA-2024SA212362$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240820$$CN$US$US
241222621$24122262$1$I$$20240716$20240722$20240722$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-116270$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240723$$HP$CA$CA
241222631$24122263$1$I$20240708$20240717$20240722$20240722$EXP$$CN-ABBVIE-5845947$ABBVIE$$61$YR$$F$Y$55$KG$20240722$$MD$CN$CN
241222652$24122265$2$F$20240715$20240809$20240722$20240812$PER$$US-AMGEN-USASP2024142999$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241222662$24122266$2$F$$20240917$20240722$20240920$EXP$$US-SANDOZ INC.-SDZ2024US067040$SANDOZ$$$$$F$Y$$$20240920$$CN$US$US
241222671$24122267$1$I$$20240717$20240722$20240722$PER$$US-ROCHE-10000030483$ROCHE$$44$YR$A$F$Y$$$20240723$$CN$US$US
241222681$24122268$1$I$20240101$20240718$20240722$20240722$EXP$$US-ABBVIE-5846158$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241222691$24122269$1$I$$20240718$20240722$20240722$PER$$US-ROCHE-10000031127$ROCHE$$56$YR$A$F$Y$$$20240723$$CN$US$US
241222701$24122270$1$I$$20240716$20240722$20240722$EXP$$DE-ABBVIE-5845355$ABBVIE$Holzle I, Volc S, Wehner Caroli J, Schaller M. Upadacitinib induced erythema, papules and pustules-Is it really acne or is it rosacea? J Deutsche Derma Gesell. 2024;15452.$27$YR$$F$Y$$$20240722$$HP$DE$DE
241222721$24122272$1$I$20240625$20240716$20240722$20240722$EXP$$NL-BIOGEN-2024BI01274366$BIOGEN$$65$YR$$M$Y$$$20240722$$CN$NL$NL
241222731$24122273$1$I$20211201$20240716$20240722$20240722$EXP$$BR-BIOGEN-2024BI01274111$BIOGEN$$28$YR$$F$Y$70$KG$20240722$$CN$BR$BR
241222743$24122274$3$F$$20240909$20240722$20240916$EXP$$CA-BIOGEN-2024BI01274308$BIOGEN$$$$$F$Y$$$20240916$$HP$CA$CA
241222752$24122275$2$F$20240701$20240806$20240722$20240810$EXP$$CA-ABBVIE-5845889$ABBVIE$$70$YR$$M$Y$$$20240810$$CN$CA$CA
241222771$24122277$1$I$20240101$20240717$20240722$20240722$EXP$$US-ABBVIE-5844501$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241222782$24122278$2$F$20240601$20240723$20240722$20240729$EXP$$US-BIOGEN-2024BI01274252$BIOGEN$$78$YR$$F$Y$$$20240729$$CN$US$US
241222791$24122279$1$I$$20240716$20240722$20240722$EXP$$US-BIOGEN-2024BI01274108$BIOGEN$$$$$M$Y$$$20240722$$CN$US$US
241222801$24122280$1$I$20240620$20240718$20240722$20240722$EXP$$US-ABBVIE-5846208$ABBVIE$$41$YR$$F$Y$$$20240722$$CN$US$US
241222811$24122281$1$I$20240101$20240717$20240722$20240722$EXP$$US-ABBVIE-5846445$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241222821$24122282$1$I$20240701$20240718$20240722$20240722$EXP$$US-ABBVIE-5846432$ABBVIE$$61$YR$$M$Y$$$20240722$$CN$US$US
241222831$24122283$1$I$$20240719$20240722$20240722$PER$$US-AMGEN-USASP2024144552$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241222842$24122284$2$F$20240701$20240718$20240722$20240727$EXP$$DE-ABBVIE-5846481$ABBVIE$$59$YR$$F$Y$$$20240727$$CN$DE$DE
241222851$24122285$1$I$20240101$20240718$20240722$20240722$EXP$$CA-ABBVIE-5846831$ABBVIE$$$$A$F$Y$$$20240722$$CN$CA$CA
241222861$24122286$1$I$20240101$20240709$20240722$20240722$EXP$$CA-ABBVIE-5847108$ABBVIE$$32$YR$$F$Y$$$20240722$$CN$CA$CA
241222871$24122287$1$I$20240701$20240717$20240722$20240722$EXP$$GB-ABBVIE-5845711$ABBVIE$$28$YR$$F$Y$$$20240722$$HP$GB$GB
241222881$24122288$1$I$$20240718$20240722$20240722$EXP$$CA-ABBVIE-5846961$ABBVIE$$$$A$M$Y$$$20240722$$CN$CA$CA
241222891$24122289$1$I$$20240717$20240722$20240722$EXP$$BG-ABBVIE-5845788$ABBVIE$$73$YR$$M$Y$$$20240722$$MD$BG$BG
241222903$24122290$3$F$20240101$20240905$20240722$20240912$EXP$$US-ABBVIE-5841452$ABBVIE$$$$$F$Y$65$KG$20240912$$CN$US$US
241222921$24122292$1$I$20200522$20240718$20240722$20240722$EXP$FR-AFSSAPS-PC2024000569$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-115993$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$48.8$KG$20240723$$PH$FR$FR
241222932$24122293$2$F$20240606$20240807$20240722$20240813$30DAY$$US-AMGEN-USASL2024139905$AMGEN$$70$YR$E$F$Y$$$20240813$$CN$US$US
241222941$24122294$1$I$$20240715$20240722$20240722$EXP$$US-NOVITIUMPHARMA-2024USNVP01315$NOVITIUM PHARMA$Stanley Bradshaw.Synchronous visceral Kaposi sarcoma and extracavitary primary effusion lymphoma in a patient with AIDS.BMJ Case reports.23-JAN-2023;15:e245306$$$$M$Y$$$20240723$$HP$US$US
241222952$24122295$2$F$20231101$20240823$20240722$20240827$EXP$$CA-SANDOZ INC.-SDZ2024CA066477$SANDOZ$$51$YR$$M$Y$$$20240827$$MD$CA$CA
241222962$24122296$2$F$20230101$20240725$20240722$20240731$EXP$$AR-BIOGEN-2024BI01245944$BIOGEN$$$$$F$Y$$$20240731$$CN$AR$AR
241222972$24122297$2$F$20240706$20240718$20240722$20240725$EXP$$US-BIOGEN-2024BI01274470$BIOGEN$$68$YR$$F$Y$$$20240725$$CN$US$US
241222981$24122298$1$I$20240603$20240717$20240722$20240722$EXP$$US-BIOGEN-2024BI01274474$BIOGEN$$46$YR$$F$Y$$$20240722$$CN$US$US
241222991$24122299$1$I$$20240708$20240722$20240722$EXP$$JP-AMGEN-JPNSP2024144075$AMGEN$$68$YR$E$F$Y$$$20240722$$MD$JP$JP
241223001$24122300$1$I$$20240722$20240722$20240722$EXP$$NVSC2024KE150117$NOVARTIS$$$$$M$Y$$$20240723$$MD$KE$KE
241223012$24122301$2$F$$20240806$20240722$20240808$EXP$$US-BIOGEN-2024BI01274535$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241223031$24122303$1$I$20240701$20240719$20240722$20240722$PER$$US-JNJFOC-20240754068$JOHNSON AND JOHNSON$$7$YR$C$M$Y$23.6$KG$20240723$$CN$US$US
241223041$24122304$1$I$$20240716$20240722$20240722$EXP$$US-BIOGEN-2024BI01274110$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
241223051$24122305$1$I$$20240716$20240722$20240722$EXP$$US-BIOGEN-2024BI01274368$BIOGEN$$$$$F$Y$$$20240722$$CN$US$US
241223062$24122306$2$F$$20240826$20240722$20240904$EXP$$IT-TEVA-VS-3220744$TEVA$Fabozzi F, Palumbo G, Di Pastena M, Zangari P, Bernardi S. Prolonged neutropenia in patients with lymphoma treated with antiretroviral therapy: Raltegravir too? A single-case report. Pediatr-Blood-Cancer 2023; 70 (4):.; Fabozzi F, Palumbo G, Di Pastena M, Zangari P, Bernardi S. Prolonged neutropenia in patients with lymphoma treated with antiretroviral therapy: Raltegravir too? A single-case report. Pediatr-Blood-Cancer 2023; 70 (4):.$6$YR$$F$Y$$$20240904$$HP$IT$IT
241223071$24122307$1$I$20240618$20240618$20240722$20240722$PER$$US-BEH-2024174517$CSL BEHRING$$35$YR$A$$Y$$$20240722$$PH$US$US
241223082$24122308$2$F$20240606$20240724$20240722$20240730$EXP$$US-BIOGEN-2024BI01274109$BIOGEN$$60$YR$$F$Y$$$20240730$$MD$US$US
241223091$24122309$1$I$$20240718$20240722$20240722$EXP$$US-ROCHE-10000031338$ROCHE$$$$A$F$Y$$$20240723$$CN$US$US
241223111$24122311$1$I$$20240719$20240722$20240722$PER$$US-HALEON-2188225$Haleon PLC$$$$$$Y$$$20240722$$CN$US$US
241223121$24122312$1$I$$20240717$20240722$20240722$EXP$$GB-JNJFOC-20240747499$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$HP$GB$GB
241223131$24122313$1$I$$20240716$20240722$20240722$PER$$US-JNJFOC-20240751950$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
241223141$24122314$1$I$20230723$20240718$20240722$20240722$EXP$$CN-ROCHE-10000030001$ROCHE$$53$YR$A$M$Y$$$20240723$$CN$CN$CN
241223151$24122315$1$I$20240605$20240718$20240722$20240722$EXP$$US-AstraZeneca-2024A164897$ASTRAZENECA$$26400$DY$$M$Y$$$20240723$$CN$US$
241223162$24122316$2$F$$20240916$20240722$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116264$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240924$$CN$US$US
241223171$24122317$1$I$20240606$20240722$20240722$20240722$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041252$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240723$$CN$US$US
241223181$24122318$1$I$$20240719$20240722$20240722$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-115894$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$68$KG$20240723$$HP$GB$GB
241223191$24122319$1$I$$20240715$20240722$20240722$PER$$US-ELI_LILLY_AND_COMPANY-US202407009901$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240722$$CN$US$US
241223201$24122320$1$I$20220301$20240717$20240722$20240722$EXP$$CA-ROCHE-10000031440$ROCHE$$85$YR$E$M$Y$$$20240723$$CN$CA$CA
241223211$24122321$1$I$20240606$20240715$20240722$20240722$PER$$US-ABBVIE-5842243$ABBVIE$$$$$F$Y$$$20240722$$CN$US$US
241223221$24122322$1$I$20240701$20240718$20240722$20240722$PER$$US-AMGEN-USASP2024143917$AMGEN$$45$YR$A$F$Y$$$20240722$$CN$US$US
241223232$24122323$2$F$20240101$20240919$20240722$20240930$PER$$US-SA-2024SA211088$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240930$$MD$US$US
241223241$24122324$1$I$20240701$20240710$20240722$20240722$PER$$US-SA-2024SA210613$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240723$$MD$US$US
241223251$24122325$1$I$20240626$20240704$20240722$20240722$PER$$US-BEH-2024175280$CSL BEHRING$$14$YR$T$F$Y$$$20240722$$HP$US$US
241223262$24122326$2$F$20230901$20240722$20240722$20240725$EXP$$US-ROCHE-10000031710$ROCHE$$44$YR$A$F$Y$$$20240725$$HP$US$US
241223271$24122327$1$I$20240629$20240717$20240722$20240722$EXP$$CN-ROCHE-10000029711$ROCHE$$51$YR$A$M$Y$$$20240723$$HP$CN$CN
241223281$24122328$1$I$$20240711$20240722$20240722$EXP$$IT-ROCHE-10000024709$ROCHE$Giordani E, Allegretti M, Sinibaldi A, Michelotti F, Ferretti G, Ricciardi E, et al. Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients. Journal of Experimental and Clinical Cancer Research. 2024-Dec;43 (182): doi:10.1186/s13046-024-03105-9.$$$$$Y$$$20240723$$HP$IT$IT
241223291$24122329$1$I$20240702$20240715$20240722$20240722$EXP$$FR-DENTSPLY-2024SCDP000211$DENTSPLY$$$$N$F$Y$$$20240723$$MD$FR$FR
241223302$24122330$2$F$$20240826$20240722$20240904$EXP$$IT-TEVA-VS-3220736$TEVA$Megna M, De Lucia M, Fornaro L, Tommasino N, Castiglione F, Cacciapuoti S, et al. Asymptomatic microscopic colitis induced by secukinumab. JAAD-Case-Rep 2024; 48 11-13.; Megna M, De Lucia M, Fornaro L, Tommasino N, Castiglione F, Cacciapuoti S, et al. Asymptomatic microscopic colitis induced by secukinumab. JAAD-Case-Rep 2024; 48 11-13.$58$YR$$M$Y$$$20240904$$MD$IT$IT
241223311$24122331$1$I$20240717$20240719$20240722$20240722$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115929$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$109.6$KG$20240723$$HP$US$US
241223321$24122332$1$I$$20240717$20240722$20240722$30DAY$$US-SANDOZ INC.-SDZ2024US067104$SANDOZ$$$$E$F$Y$$$20240722$$CN$US$US
241223331$24122333$1$I$$20240715$20240722$20240722$EXP$$BE-NOVITIUMPHARMA-2024BENVP01321$NOVITIUM PHARMA$Marine Georgery.Occurrence of Fatal Tubulopathy in an Old, Fit Patient Receiving Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report.Case Reports in Oncology.14-FEB-2024;17(1):239-246$82$YR$E$F$Y$$$20240723$$HP$BE$BE
241223341$24122334$1$I$20240713$20240715$20240722$20240722$PER$$US-ALXN-202407USA001092US$ALEXION PHARMACEUTICALS$$$$C$F$Y$$$20240723$$CN$US$US
241223371$24122337$1$I$$20240719$20240723$20240723$PER$$US-ROCHE-10000032158$ROCHE$$$$A$$Y$$$20240723$$CN$US$US
241223381$24122338$1$I$20240501$20240715$20240723$20240723$PER$$US-JNJFOC-20240739753$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$HP$US$US
241223391$24122339$1$I$$20240712$20240723$20240723$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-176991$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240723$$CN$CA$CA
241223401$24122340$1$I$20150201$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034870$AUROBINDO$Agusti A.. The importance of reporting suspected adverse reactions caused by new drugs.. Mult Scler.. 2015;21(11):1478-9$46$YR$$F$Y$85$KG$20240723$$MD$FR$FR
241223432$24122343$2$F$$20240731$20240723$20240803$EXP$$US-ABBVIE-5844062$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241223441$24122344$1$I$20240628$20240717$20240723$20240723$EXP$$CN-JNJFOC-20240748596$JOHNSON AND JOHNSON$$59$YR$A$F$Y$54$KG$20240723$$HP$CN$CN
241223451$24122345$1$I$$20240717$20240723$20240723$PER$$US-JNJFOC-20240747716$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$MD$US$US
241223462$24122346$2$F$$20240730$20240723$20240802$EXP$$CA-ABBVIE-5845677$ABBVIE$$$$A$F$Y$$$20240802$$CN$CA$CA
241223471$24122347$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5846674$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241223481$24122348$1$I$$20240619$20240723$20240723$EXP$$IT-CELLTRION INC.-2024IT017557$CELLTRION$Bixio, R.. Discontinuation of Infliximab leading to auditory loss in a patient with Cogan syndrome: a case report. Joint bone spine. 2024$$$$$Y$$$20240723$$HP$IT$IT
241223501$24122350$1$I$20240101$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114836$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240723$$HP$US$US
241223511$24122351$1$I$$20240716$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011880$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240722$$HP$US$US
241223521$24122352$1$I$20210915$20240711$20240723$20240723$EXP$$PL-AUROBINDO-AUR-APL-2024-035273$AUROBINDO$$73$YR$$M$Y$71$KG$20240723$$MD$PL$PL
241223531$24122353$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114542$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$88.45$KG$20240723$$HP$US$US
241223541$24122354$1$I$20240717$20240719$20240723$20240723$EXP$$US-TAKEDA-2024TUS071928$TAKEDA$$56$YR$$M$Y$46.8$KG$20240723$$HP$US$US
241223551$24122355$1$I$$20240715$20240723$20240723$PER$$US-ABBVIE-5846403$ABBVIE$$$$$$Y$$$20240723$$CN$US$US
241223561$24122356$1$I$$20240719$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116190$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240723$$CN$US$US
241223572$24122357$2$F$20240705$20240814$20240723$20240820$PER$$US-AMGEN-USASP2024140078$AMGEN$$33$YR$A$F$Y$70.385$KG$20240820$$PH$US$US
241223591$24122359$1$I$20240701$20240717$20240723$20240723$EXP$NL-LRB-00985611$NL-GSK-NL2024089961$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$NL$NL
241223602$24122360$2$F$$20240807$20240723$20240808$PER$$US-ALXN-202407USA001015US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241223611$24122361$1$I$20190306$20240716$20240723$20240723$EXP$$FR-GSK-FR2022GSK057859$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$FR$FR
241223621$24122362$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5846370$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241223631$24122363$1$I$$20240717$20240723$20240723$PER$$US-ABBVIE-5846689$ABBVIE$$$$$$Y$$$20240723$$HP$US$US
241223641$24122364$1$I$$20240715$20240723$20240723$EXP$$CA-JNJFOC-20240748917$JOHNSON AND JOHNSON$$25$YR$A$F$Y$64$KG$20240723$$HP$CA$CA
241223661$24122366$1$I$$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144822$AMGEN$$$$$$Y$$$20240722$$PH$US$US
241223671$24122367$1$I$20240709$20240712$20240723$20240723$PER$$US-ABBVIE-5846803$ABBVIE$$47$YR$$F$Y$$$20240723$$CN$US$US
241223681$24122368$1$I$$20240718$20240723$20240723$EXP$FR-AFSSAPS-GR2024000892$FR-GSK-FR2024090592$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$FR$FR
241223692$24122369$2$F$20240620$20240822$20240723$20240826$EXP$FR-AFSSAPS-BX2024001442$FR-GSK-FR2024090394$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$PH$FR$FR
241223702$24122370$2$F$$20240911$20240723$20240919$EXP$$DE-AUROBINDO-AUR-APL-2022-012586$AUROBINDO$Bonnet U, Kanti AK, Scherbaum N, Specka M. The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment - A Pilot Study. JOURNAL OF PSYCHOACTIVE DRUGS. 2022;1-10:55(1)$50$YR$$F$Y$$$20240919$$HP$DE$DE
241223712$24122371$2$F$$20240822$20240723$20240901$PER$$US-AstraZeneca-2024A163324$ASTRAZENECA$$$$$M$Y$$$20240901$$CN$US$
241223723$24122372$3$F$20240501$20240812$20240723$20240815$EXP$$US-ABBVIE-5842334$ABBVIE$$69$YR$$F$Y$49$KG$20240815$$CN$US$US
241223731$24122373$1$I$$20220930$20240723$20240723$EXP$$US-AstraZeneca-2022A335312$ASTRAZENECA$$$$$$Y$$$20240723$$MD$US$
241223742$24122374$2$F$20240701$20240724$20240723$20240729$EXP$$US-ABBVIE-5846144$ABBVIE$$67$YR$$F$Y$$$20240729$$CN$US$US
241223752$24122375$2$F$20240820$20240920$20240723$20240925$EXP$$GB-ABBVIE-5844734$ABBVIE$$72$YR$$M$Y$$$20240925$$CN$GB$GB
241223761$24122376$1$I$$20240718$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115784$BRISTOL MYERS SQUIBB$Article cannot be requested due to no citation$$$$$Y$$$20240723$$HP$CA$CA
241223772$24122377$2$F$$20240725$20240723$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116153$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240729$$CN$US$US
241223781$24122378$1$I$20240615$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144894$AMGEN$$59$YR$A$M$Y$$$20240722$$HP$US$US
241223791$24122379$1$I$20240701$20240722$20240723$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041292$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240723$$CN$US$US
241223801$24122380$1$I$20240101$20240718$20240723$20240723$EXP$$US-ABBVIE-5846537$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241223811$24122381$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024142018$AMGEN$$$$$M$Y$$$20240722$$CN$US$US
241223823$24122382$3$F$20240601$20240813$20240723$20240821$PER$$US-AMGEN-USASP2024142859$AMGEN$$41$YR$A$F$Y$$$20240821$$HP$US$US
241223831$24122383$1$I$20240513$20240716$20240723$20240723$EXP$FR-AFSSAPS-PB2024000711$FR-ROCHE-10000028194$ROCHE$$56$YR$A$F$Y$92$KG$20240723$$PH$FR$FR
241223841$24122384$1$I$20240715$20240718$20240723$20240723$EXP$$US-ABBVIE-5846816$ABBVIE$$41$YR$$F$Y$$$20240723$$CN$US$US
241223852$24122385$2$F$20240716$20240822$20240723$20240830$EXP$$IT-ABBVIE-5847120$ABBVIE$$84$YR$$F$Y$68$KG$20240830$$MD$IT$IT
241223861$24122386$1$I$$20240711$20240723$20240723$EXP$$JP-MALLINCKRODT-MNK202404546$MALLINCKRODT$$$$$F$Y$$$20240723$$PH$JP$JP
241223871$24122387$1$I$$20240710$20240723$20240723$EXP$$JP-MALLINCKRODT-MNK202403457$MALLINCKRODT$$$$E$$Y$$$20240723$$HP$JP$JP
241223881$24122388$1$I$20240701$20240708$20240723$20240723$EXP$JP-MALLINCKRODT-MNK202404526$JP-MALLINCKRODT-MNK202404526$MALLINCKRODT$$2$WK$$M$Y$1$KG$20240723$$CN$JP$JP
241223891$24122389$1$I$$20240717$20240723$20240723$EXP$$US-TAKEDA-2024TUS072327$TAKEDA$$$$$M$Y$$$20240723$$HP$US$US
241223901$24122390$1$I$$20240719$20240723$20240723$EXP$$US-AVEO PHARMACEUTICALS, INC.-2024-AVEO-US000550$PAREXEL$$$$$$Y$$$20240723$$CN$US$US
241223911$24122391$1$I$$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A164319$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241223921$24122392$1$I$20240101$20240717$20240723$20240723$EXP$$US-ABBVIE-5845298$ABBVIE$$$$$F$Y$$$20240723$$HP$US$US
241223931$24122393$1$I$20240101$20240718$20240723$20240723$EXP$$US-ABBVIE-5845856$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241223941$24122394$1$I$20230101$20240718$20240723$20240723$EXP$$PR-ABBVIE-5649158$ABBVIE$$$$$F$Y$82$KG$20240723$$CN$PR$PR
241223951$24122395$1$I$$20240710$20240723$20240723$EXP$$US-LAURUS LABS LIMITED-2024LAU000055$LAURUS LABS LIMITED$Mikhail ES, Jankowski M, Alexander D, Pandya D, Kunadi A.. Survival and Vision Restoration Following Severe Metformin-associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature. J Community Hosp Intern Med Perspect.. J Community Hosp Intern Med Perspect. 2024;14(2)$72$YR$$F$Y$$$20240723$$HP$US$US
241223961$24122396$1$I$$20240710$20240723$20240723$EXP$$US-LAURUS LABS LIMITED-2024LAU000056$LAURUS LABS LIMITED$Sendil S, Yarlagadda K, Lawal H, Nookala V, Shingala H. Metformin Associated Lactic Acidosis in the Intensive Care Unit: A Rare Condition Mimicking Sepsis. Cureus. 2020;12(7)$63$YR$$M$Y$$$20240723$$HP$US$US
241223991$24122399$1$I$$20240717$20240723$20240723$EXP$$JP-CHATTEMPRD-2024OHG024511$CHATTEM$$66$YR$E$F$Y$$$20240723$$HP$JP$JP
241224001$24122400$1$I$$20240716$20240723$20240723$EXP$$NL-ABBVIE-5801005$ABBVIE$$$$E$M$Y$$$20240723$$CN$NL$NL
241224011$24122401$1$I$20240703$20240712$20240723$20240723$EXP$$CN-TAKEDA-2024TUS072899$TAKEDA$$71$YR$$M$Y$62$KG$20240723$$HP$CN$CN
241224021$24122402$1$I$20240701$20240717$20240723$20240723$EXP$$FR-ABBVIE-5845790$ABBVIE$$75$YR$$M$Y$$$20240723$$CN$FR$FR
241224031$24122403$1$I$$20240716$20240723$20240723$EXP$$US-ABBVIE-5845099$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241224041$24122404$1$I$20240714$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112781$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240716$$CN$US$US
241224051$24122405$1$I$20240714$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112811$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240716$$CN$US$US
241224062$24122406$2$F$$20240905$20240723$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112683$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240906$$CN$US$US
241224071$24122407$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210991$SANOFI AVENTIS$$$$T$F$Y$$$20240723$$MD$US$US
241224081$24122408$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA210125$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240723$$CN$US$US
241224091$24122409$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210773$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240723$$MD$US$US
241224101$24122410$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA211548$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240723$$CN$US$US
241224111$24122411$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211097$SANOFI AVENTIS$$$$$F$Y$$$20240723$$PH$US$US
241224121$24122412$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5845864$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241224131$24122413$1$I$20240101$20240718$20240723$20240723$EXP$$GB-ABBVIE-5846265$ABBVIE$$25$YR$$F$Y$$$20240723$$CN$GB$GB
241224141$24122414$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5846410$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241224152$24122415$2$F$20240715$20240816$20240723$20240819$PER$$US-JNJFOC-20240743176$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$US$US
241224161$24122416$1$I$$20240605$20240723$20240723$PER$$US-TRAVERE-2024TVT00575$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240716$$MD$US$US
241224171$24122417$1$I$$20240717$20240723$20240723$PER$$US-JNJFOC-20240747708$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$MD$US$US
241224181$24122418$1$I$20240717$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024144126$AMGEN$$49$YR$A$F$Y$$$20240722$$CN$US$US
241224191$24122419$1$I$20240101$20240718$20240723$20240723$EXP$$CA-ABBVIE-5846654$ABBVIE$$76$YR$$F$Y$$$20240723$$MD$CA$CA
241224201$24122420$1$I$$20240715$20240723$20240723$EXP$$US-ABBVIE-5842038$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241224211$24122421$1$I$20240609$20240718$20240723$20240723$EXP$$US-ABBVIE-5848263$ABBVIE$$59$YR$$F$Y$$$20240723$$HP$US$US
241224221$24122422$1$I$$20240716$20240723$20240723$EXP$$US-ABBVIE-5843532$ABBVIE$$$$$F$Y$$$20240723$$HP$US$US
241224231$24122423$1$I$20231127$20240715$20240723$20240723$PER$$US-009507513-2407USA010385$MERCK$$68$YR$$F$Y$$$20240723$$CN$US$US
241224241$24122424$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5847046$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241224251$24122425$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115192$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240723$$CN$US$US
241224261$24122426$1$I$$20240319$20240723$20240723$EXP$$CA-HALEON-2177716$Haleon PLC$$40$YR$$F$Y$$$20240722$$HP$CA$CA
241224272$24122427$2$F$$20240807$20240723$20240814$EXP$US-MLMSERVICE-20240710-PI120627-00177-1$US-STRIDES ARCOLAB LIMITED-2024SP008786$STRIDES$Martin CE, Kuhn AK, Leopold KN, Creo AL, Schoettler PJ, Allen-Rhoades WA.. Exogenous steroid replacement in a pediatric patient with adrenocortical carcinoma receiving mitotane. Pediatric Blood and Cancer. 2024;71(8):e31072$$$$$Y$$$20240814$$PH$US$US
241224281$24122428$1$I$20240708$20240717$20240723$20240723$EXP$$US-TAKEDA-2023TUS013073$TAKEDA$$65$YR$$F$Y$111$KG$20240723$$CN$US$US
241224291$24122429$1$I$$20240715$20240723$20240723$EXP$$ES-NOVITIUMPHARMA-2024ESNVP01331$NOVITIUM PHARMA$Francisco Andujar-Vera.Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM.International Journal of Molecular Sciences.01-SEP-2023;24(17):13562$14$YR$T$F$Y$$$20240723$$HP$ES$ES
241224301$24122430$1$I$20240613$20240718$20240723$20240723$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-100571$REGENERON$$$$$F$Y$$$20240723$$CN$CA$CA
241224311$24122431$1$I$20240501$20240527$20240723$20240723$EXP$$CA-HALEON-2178254$Haleon PLC$$$$$$Y$$$20240722$$CN$CA$CA
241224322$24122432$2$F$20240701$20240731$20240723$20240803$EXP$$US-ABBVIE-5845079$ABBVIE$$72$YR$$F$Y$$$20240803$$CN$US$US
241224331$24122433$1$I$20240712$20240712$20240723$20240723$EXP$$CA-JNJFOC-20240736687$JOHNSON AND JOHNSON$$14$YR$T$F$Y$62$KG$20240723$$HP$CA$CA
241224342$24122434$2$F$$20240715$20240723$20240723$EXP$NL-LRB-00981114$NL-STRIDES ARCOLAB LIMITED-2024SP008832$STRIDES$$75$YR$$F$Y$63$KG$20240723$$CN$NL$NL
241224351$24122435$1$I$$20230306$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115865$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$51.701$KG$20240723$$CN$US$US
241224362$24122436$2$F$$20240909$20240723$20240913$EXP$$US-CHATTEMPRD-2024OHG024367$CHATTEM$$70$YR$E$F$Y$$$20240913$$CN$US$US
241224371$24122437$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024145064$AMGEN$$$$A$F$Y$$$20240722$$MD$US$US
241224381$24122438$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5848435$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241224393$24122439$3$F$$20240826$20240723$20240827$PER$$US-JNJFOC-20240750135$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$CN$US$US
241224403$24122440$3$F$20240101$20240813$20240723$20240819$EXP$$CA-ABBVIE-5846588$ABBVIE$$62$YR$$M$Y$$$20240819$$CN$CA$CA
241224411$24122441$1$I$$20240716$20240723$20240723$EXP$$US-JNJFOC-20240744317$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
241224421$24122442$1$I$$20240712$20240723$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-034838$AUROBINDO$$44$YR$$M$Y$81$KG$20240723$$PH$GB$GB
241224431$24122443$1$I$$20240715$20240723$20240723$EXP$$US-ABBVIE-5841949$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241224441$24122444$1$I$$20240716$20240723$20240723$EXP$$US-CHATTEMPRD-2024OHG024481$CHATTEM$$$$$F$Y$$$20240723$$CN$US$US
241224451$24122445$1$I$20240601$20240717$20240723$20240723$EXP$$DE-ABBVIE-5844247$ABBVIE$$45$YR$$M$Y$84$KG$20240723$$MD$DE$DE
241224461$24122446$1$I$20240601$20240717$20240723$20240723$EXP$$US-JNJFOC-20240745984$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240722$$HP$US$US
241224471$24122447$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5846221$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241224481$24122448$1$I$20240601$20240712$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-035703$AUROBINDO$$42$YR$$M$Y$$$20240723$$PH$FR$FR
241224491$24122449$1$I$20240606$20240718$20240723$20240723$EXP$HR-HALMED-300086062$HR-GSK-HR2024090862$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$HR$HR
241224511$24122451$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115834$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$JP$JP
241224521$24122452$1$I$20161201$20240719$20240723$20240723$EXP$FR-TAKEDA-2017MPI001626$FR-GSK-FR2024091021$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$FR$FR
241224532$24122453$2$F$20240713$20240816$20240723$20240817$PER$$US-JNJFOC-20240742507$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240817$$CN$US$US
241224541$24122454$1$I$20240626$20240719$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116283$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240723$$CN$US$US
241224553$24122455$3$F$$20240731$20240723$20240803$EXP$$JP-ABBVIE-5847728$ABBVIE$Harima E, Shiokawa M, Hiura M, Nakanishi N, Takeda H, Takai A. et al. 34: A case of liver disorder with high uptake throughout the liver on PET. The 244th Kinki Regional Meeting of the Japanese Society of Internal Medicine (2024).; Harima E, Shiokawa M, Hiura M, Nakanishi N, Takeda H, Takai A. et al. 34: A case of liver disorder with high uptake throughout the liver on PET. The 244th Kinki Regional Meeting of the Japanese Society of Internal Medicine (2024).$67$YR$$F$Y$$$20240803$$MD$JP$JP
241224561$24122456$1$I$20240112$20240530$20240723$20240723$EXP$FR-AFSSAPS-SE2024000398$FR-HALEON-2179306$Haleon PLC$$60$YR$$F$Y$50.4$KG$20240722$$MD$FR$FR
241224571$24122457$1$I$$20240708$20240723$20240723$EXP$$US-Axsome Therapeutics, Inc.-AXS202407-000975$AXSOME THERAPEUTICS$$67$YR$E$M$Y$$$20240723$$CN$US$
241224581$24122458$1$I$$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024144394$AMGEN$$$$$$Y$$$20240722$$PH$US$US
241224591$24122459$1$I$$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A164794$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241224601$24122460$1$I$20240101$20240718$20240723$20240723$EXP$$CA-UCBSA-2024036755$UCB$$$$$F$Y$$$20240723$$CN$CA$CA
241224621$24122462$1$I$$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024143480$AMGEN$$$$A$$Y$$$20240722$$PH$US$US
241224632$24122463$2$F$20240101$20240807$20240723$20240809$EXP$$CA-UCBSA-2024003015$UCB$$$$$F$Y$$$20240809$$CN$CA$CA
241224641$24122464$1$I$$20240624$20240723$20240723$PER$$US-009507513-2406USA008647$MERCK$$$$A$M$Y$$$20240723$$HP$US$US
241224651$24122465$1$I$$20240717$20240723$20240723$EXP$$NL-ELI_LILLY_AND_COMPANY-NL202407011996$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240723$$CN$NL$NL
241224663$24122466$3$F$20230101$20240911$20240723$20240917$EXP$$JP-009507513-2302JPN000241J$MERCK$$73$YR$$M$Y$$$20240917$$MD$JP$JP
241224671$24122467$1$I$20240621$20240710$20240723$20240723$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407007230$ELI LILLY AND CO$$45$YR$A$F$Y$57$KG$20240723$$CN$CN$CN
241224681$24122468$1$I$$20240710$20240723$20240723$EXP$$SG-ELI_LILLY_AND_COMPANY-SG202407006552$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240723$$CN$SG$SG
241224691$24122469$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115829$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$JP$JP
241224701$24122470$1$I$20240626$20240718$20240723$20240723$EXP$FR-AFSSAPS-GR2024000914$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-116090$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$61$KG$20240723$$PH$FR$FR
241224711$24122471$1$I$20231119$20240715$20240723$20240723$EXP$$RU-ABBVIE-5845853$ABBVIE$$52$YR$$F$Y$78$KG$20240723$$HP$RU$RU
241224721$24122472$1$I$20240702$20240710$20240723$20240723$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407011968$ELI LILLY AND CO$$55$YR$A$M$Y$70$KG$20240723$$CN$DE$CN
241224731$24122473$1$I$20240701$20240718$20240723$20240723$EXP$$US-VANTIVE-2024VAN018498$Vantive US Healthcare$$79$YR$$F$Y$$$20240723$$CN$US$US
241224742$24122474$2$F$20240601$20240724$20240723$20240726$PER$$US-JNJFOC-20240746117$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$CN$US$US
241224751$24122475$1$I$20240711$20240716$20240723$20240723$EXP$$CN-BEIGENE-BGN-2024-011075$BEIGENE$$$$$$Y$$$20240723$$HP$CN$CN
241224761$24122476$1$I$20240704$20240716$20240723$20240723$EXP$$JP-VANTIVE-2024VAN018236$Vantive US Healthcare$$55$YR$$M$Y$$$20240723$$MD$JP$JP
241224771$24122477$1$I$20240701$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024142713$AMGEN$$$$$$Y$$$20240722$$PH$US$US
241224781$24122478$1$I$20120101$20240717$20240723$20240723$EXP$$US-JNJFOC-20240752232$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240723$$CN$US$US
241224812$24122481$2$F$20220901$20240724$20240723$20240725$EXP$$NL-ROCHE-10000032175$ROCHE$$52$YR$A$F$Y$$$20240725$$HP$NL$NL
241224821$24122482$1$I$20240714$20240715$20240723$20240723$EXP$$US-VIIV HEALTHCARE LIMITED-US2024088734$VIIV$$75$YR$$F$Y$$$20240723$$CN$US$US
241224831$24122483$1$I$20240110$20240626$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-036298$AUROBINDO$$$$A$M$Y$$$20240723$$PH$FR$FR
241224841$24122484$1$I$20230118$20240530$20240723$20240723$EXP$ES-AEMPS-1521571$ES-HALEON-2179264$Haleon PLC$$51$YR$$M$Y$$$20240723$$PH$ES$ES
241224851$24122485$1$I$$20240716$20240723$20240723$EXP$$PE-NOVITIUMPHARMA-2024PENVP01337$NOVITIUM PHARMA$Julio Alejandro Cerna-Lopez.Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review.The Colombian Journal of Rheumatology.14-JUL-2023;30(3):277-282$47$YR$A$M$Y$$$20240723$$HP$PE$PE
241224861$24122486$1$I$$20240715$20240723$20240723$EXP$$DE-JNJFOC-20240743434$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240723$$HP$DE$DE
241224871$24122487$1$I$$20240629$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050709$TOLMAR$$$$$M$Y$$$20240723$$CN$CA$CA
241224881$24122488$1$I$$20240629$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050710$TOLMAR$$$$$M$Y$$$20240723$$CN$CA$CA
241224891$24122489$1$I$20240630$20240630$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050716$TOLMAR$$80$YR$$M$Y$$$20240723$$CN$CA$CA
241224901$24122490$1$I$20240629$20240629$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050719$TOLMAR$$67$YR$$M$Y$$$20240723$$CN$CA$CA
241224911$24122491$1$I$$20240630$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050748$TOLMAR$$$$$M$Y$$$20240723$$CN$CA$CA
241224921$24122492$1$I$$20240629$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050749$TOLMAR$$$$$M$Y$$$20240723$$CN$CA$CA
241224932$24122493$2$F$20240627$20240808$20240723$20240903$PER$$US-TOLMAR, INC.-24US050690$TOLMAR$$80$YR$$M$Y$$$20240903$$PH$US$US
241224941$24122494$1$I$20240601$20240716$20240723$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040213$BOEHRINGER INGELHEIM$$59$YR$A$F$Y$$$20240723$$CN$US$US
241224951$24122495$1$I$20240101$20240716$20240723$20240723$PER$$US-BAUSCHBL-2024BNL030226$BAUSCH AND LOMB$$$$E$F$Y$$$20240723$$MD$US$US
241224961$24122496$1$I$$20240709$20240723$20240723$EXP$$US-CIPLA LTD.-2024US07749$CIPLA$Makunts T,  Abagyan R. Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA adverse event reporting system. Frontiers in Psychiatry. 2024;15:1414622$$$$$Y$$$20240723$$HP$US$US
241224971$24122497$1$I$20240626$20240713$20240723$20240723$EXP$GB-MHRA-MED-202407131000570760-VFCNS$GB-TEVA-VS-3221563$TEVA$$25$YR$$F$Y$$$20240723$$CN$GB$GB
241224981$24122498$1$I$20240101$20240709$20240723$20240723$EXP$$EG-CIPLA LTD.-2024EG07730$CIPLA$$$$$$Y$$$20240723$$CN$EG$EG
241224991$24122499$1$I$$20240712$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008877$STRIDES$Wireko FW, Ryu JH.. Successful Pregnancies in a Patient With Severe Antisynthetase Syndrome- Related Interstitial Lung Disease (AS-ILD).. Am-J-Respir-Crit-Care-Med. 2024;209$$$$$Y$$$20240723$$HP$US$US
241225001$24122500$1$I$$20240719$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116245$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240723$$CN$US$US
241225011$24122501$1$I$$20240719$20240723$20240723$EXP$$SK-ABBVIE-5846392$ABBVIE$$64$YR$$M$Y$$$20240723$$CN$SK$SK
241225021$24122502$1$I$$20220228$20240723$20240723$EXP$$US-AstraZeneca-2022A093018$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241225031$24122503$1$I$20240628$20240716$20240723$20240723$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037954$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240723$$MD$JP$JP
241225043$24122504$3$F$$20240717$20240723$20240725$PER$$US-AMGEN-USASP2024143767$AMGEN$$38$YR$A$M$Y$$$20240725$$CN$US$US
241225051$24122505$1$I$$20240712$20240723$20240723$PER$$US-AMGEN-USASP2024141072$AMGEN$Ohls, R.. Recombinant erythropoietin as Treatment for the Late Hyporegenerative Anemia of Rh Hemolytic Disease. Pediatrics. 1992;90 (No. 5):678-80$82$DY$I$M$Y$1.85$KG$20240722$$HP$US$US
241225061$24122506$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024142695$AMGEN$$$$$$Y$$$20240722$$PH$US$US
241225071$24122507$1$I$$20240715$20240723$20240723$EXP$$CA-TOLMAR, INC.-24CA050717$TOLMAR$$$$$M$Y$$$20240723$$CN$CA$CA
241225081$24122508$1$I$20240716$20240716$20240723$20240723$PER$$US-AMGEN-USASL2024142709$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241225092$24122509$2$F$20190101$20240711$20240723$20240827$EXP$$CA-TOLMAR, INC.-24CA051058$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
241225101$24122510$1$I$20240714$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144913$AMGEN$$6$YR$C$M$Y$$$20240722$$CN$US$US
241225111$24122511$1$I$$20240712$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008878$STRIDES$Wireko FW, Ryu JH.. Successful Pregnancies in a Patient With Severe Antisynthetase Syndrome- Related Interstitial Lung Disease (AS-ILD).. Am-J-Respir-Crit-Care-Med. 2024;209$$$$$Y$$$20240723$$HP$US$US
241225122$24122512$2$F$$20240709$20240723$20240723$EXP$$US-KOANAAP-SML-US-2024-00726$Unknown Manufacturer$Sharp JA, Jones D, Rotow JK, Fidias PM, Bertino E, Dwight H. D. Response to Dabrafenib PlusTrametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non-Small CellLung Cancer.. J-Natl-Compr-Canc-Netw.. 2024;22: 1-5. doi:10.6004/jnccn.2024.7009.$79$YR$E$F$Y$$$20240719$$MD$US$US
241225141$24122514$1$I$20240624$20240716$20240723$20240723$EXP$$CN-BEIGENE-BGN-2024-011088$BEIGENE$$$$$$Y$$$20240723$$HP$CN$CN
241225161$24122516$1$I$$20240715$20240723$20240723$EXP$$CA-002147023-NVSC2023CA193057$Haleon PLC$$40$YR$$F$Y$96$KG$20240722$$HP$CA$CA
241225172$24122517$2$F$$20240715$20240723$20240805$EXP$$CA-HALEON-2187463$Haleon PLC$$44$YR$$F$Y$$$20240804$$HP$CA$CA
241225181$24122518$1$I$$20240716$20240723$20240723$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000625$DECIPHERA PHARMACEUTICALS$$75$YR$E$F$Y$$$20240723$$HP$US$US
241225191$24122519$1$I$$20240710$20240723$20240723$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008918$STRIDES$Nakajima T, Iba Y, Shibata T, Ohkawa A, Kawaharada N.. Mitral Valve Infective Endocarditis Associated With Prednisolone-Induced Immunosuppression: A Case Report.. Cureus. 2023;15(11):e48474$74$YR$$M$Y$$$20240723$$HP$JP$JP
241225201$24122520$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA210808$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240723$$MD$US$US
241225212$24122521$2$F$20240430$20240521$20240723$20240730$EXP$$AU-SA-2024SA210568$SANOFI AVENTIS$$2$YR$C$$Y$11.5$KG$20240730$$MD$AU$AU
241225221$24122522$1$I$$20240718$20240723$20240723$PER$$US-SA-2024SA212821$SANOFI AVENTIS$$$$$M$Y$$$20240723$$CN$US$US
241225231$24122523$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115262$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240723$$CN$US$US
241225241$24122524$1$I$$20240715$20240723$20240723$PER$$US-GILEAD-2024-0680819$GILEAD$$$$$F$Y$$$20240722$$CN$US$US
241225251$24122525$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012746$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240723$$CN$US$US
241225264$24122526$4$F$20211211$20240821$20240723$20240828$EXP$$CA-CELLTRION INC.-2021CA017488$CELLTRION$$$$$$Y$$$20240828$$CN$CA$CA
241225271$24122527$1$I$$20240713$20240723$20240723$EXP$GB-MHRA-MED-202407131026080490-MKHLY$GB-TEVA-VS-3221452$TEVA$$$$$F$Y$$$20240723$$CN$GB$GB
241225281$24122528$1$I$$20240715$20240723$20240723$PER$$US-APOTEX-2024AP008522$APOTEX$Bhimineni C, Mushlin N. SHIFT WORKERS ACTING OUT? A CASE OF SHIFT WORK SLEEP DISORDER CAUSING REM BEHAVIOR DISORDER. Sleep. 2024;47 (Suppl.1):A523$67$YR$$M$Y$$$20240723$$HP$US$US
241225291$24122529$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142814$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240722$$MD$US$US
241225301$24122530$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142833$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240722$$MD$US$US
241225311$24122531$1$I$$20240717$20240723$20240723$EXP$$US-SA-2024SA211706$SANOFI AVENTIS$$$$A$M$Y$$$20240723$$CN$US$US
241225321$24122532$1$I$$20240711$20240723$20240723$PER$$US-JNJFOC-20240730539$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$US$US
241225332$24122533$2$F$20240714$20240722$20240723$20240725$PER$$US-AMGEN-USASP2024144905$AMGEN$$31$YR$A$F$Y$$$20240724$$CN$US$US
241225341$24122534$1$I$$20240712$20240723$20240723$PER$$US-BAUSCHBL-2024BNL030110$BAUSCH AND LOMB$$$$$F$Y$$$20240722$$CN$US$US
241225351$24122535$1$I$$20240710$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008917$STRIDES$Wan L, Thomas J, Yan A, Mann J, Szema A. A Case Report of Steroid-Induced Angioedema and Urticaria. Cureus. 2023;15(10):e46515$$$$$Y$$$20240723$$HP$US$US
241225361$24122536$1$I$$20230120$20240723$20240723$EXP$$IN-AstraZeneca-2023A017720$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$IN$
241225371$24122537$1$I$20190501$20190724$20240723$20240723$EXP$$MX-AstraZeneca-2019SF08959$ASTRAZENECA$$776$MON$$F$Y$60$KG$20240723$$CN$MX$
241225382$24122538$2$F$$20240808$20240723$20240818$PER$$US-BAUSCHBL-2024BNL029937$BAUSCH AND LOMB$$$$$F$Y$$$20240819$$CN$US$US
241225391$24122539$1$I$20240716$20240717$20240723$20240723$EXP$$CA-JNJFOC-20240748262$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240723$$HP$CA$CA
241225404$24122540$4$F$$20240906$20240723$20240911$PER$$NVSC2024US146438$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
241225411$24122541$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024142725$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241225421$24122542$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142851$AMGEN$Dean R. M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240722$$MD$US$US
241225431$24122543$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142958$AMGEN$Dean R. M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240722$$MD$US$US
241225441$24122544$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142865$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240722$$MD$US$US
241225451$24122545$1$I$20240701$20240717$20240723$20240723$PER$$US-BAUSCHBL-2024BNL030263$BAUSCH AND LOMB$$$$$F$Y$$$20240722$$CN$US$US
241225461$24122546$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211246$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241225471$24122547$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212437$SANOFI AVENTIS$$$$A$M$Y$$$20240723$$MD$US$US
241225482$24122548$2$F$$20240810$20240723$20240819$PER$$US-SA-2024SA210983$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240819$$CN$US$US
241225491$24122549$1$I$20230101$20240715$20240723$20240723$PER$$US-SA-2024SA210424$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240723$$MD$US$US
241225501$24122550$1$I$20240319$20240711$20240723$20240723$EXP$$DE-AUROBINDO-AUR-APL-2024-035558$AUROBINDO$$84$YR$$F$Y$67$KG$20240723$$MD$DE$DE
241225511$24122551$1$I$$20240716$20240723$20240723$EXP$$PE-NOVITIUMPHARMA-2024PENVP01350$NOVITIUM PHARMA$Julio Alejandro Cerna-Lopez.Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review.The Colombian Journal of Rheumatology.14-JUL-2023;30(3):277-282$61$YR$A$F$Y$$$20240723$$HP$PE$PE
241225522$24122552$2$F$20240712$20240809$20240723$20240815$PER$$US-AMGEN-USASP2024140871$AMGEN$$65$YR$E$M$Y$78.7$KG$20240815$$PH$US$US
241225531$24122553$1$I$$20240710$20240723$20240723$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008920$STRIDES$Tanaka M, Oshikata C, Yamashita Y, Ishono R, Nakadegawa R, Masumitsu Y, et al.,. Eosinophilic granulomatosis with polyangiitis and severe cardiac involvement in a patient surviving for 34 years. J Asthma. 2023;60(12):2233-224$$$$F$Y$$$20240723$$HP$JP$JP
241225551$24122555$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA208864$SANOFI AVENTIS$$$$$$Y$$$20240723$$CN$US$US
241225562$24122556$2$F$20240101$20240829$20240723$20240911$PER$$US-SA-2024SA210687$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240911$$MD$US$US
241225571$24122557$1$I$$20240628$20240723$20240723$PER$$US-GLK-002357$GLAUKOS$$$$$$Y$$$20240723$$MD$US$US
241225581$24122558$1$I$$20240712$20240723$20240723$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000615$DECIPHERA PHARMACEUTICALS$$70$YR$E$F$Y$$$20240723$$CN$US$US
241225591$24122559$1$I$20240101$20240718$20240723$20240723$EXP$$BG-ABBVIE-5846499$ABBVIE$$58$YR$$F$Y$$$20240723$$CN$BG$BG
241225601$24122560$1$I$$20240716$20240723$20240723$PER$$US-BIOVITRUM-2024-US-009989$BIOVITRUM$$67$YR$$F$Y$$$20240719$$CN$US$US
241225611$24122561$1$I$$20240709$20240723$20240723$EXP$$US-SPECGX-T202401519$SPECGX$Naumann J, Naumann T. Acute precipitated opioid withdrawal with akathisia, delirium, and lactic acidosis from low-dose naltrexone for chronic pain: Case report. Pain Medicine Case Reports. 2023;7(8):353-6$66$YR$$M$Y$$$20240723$$HP$US$US
241225621$24122562$1$I$20240610$20240719$20240723$20240723$EXP$$JP-TAKEDA-2024TJP007646$TAKEDA$$7$DEC$$M$Y$$$20240723$$MD$JP$JP
241225632$24122563$2$F$20240603$20240814$20240723$20240906$PER$$US-GLK-002358$GLAUKOS$$39$YR$$F$Y$$$20240906$$HP$US$US
241225644$24122564$4$F$20240502$20240808$20240723$20240819$EXP$$GB-AUROBINDO-AUR-APL-2024-035901$AUROBINDO$$74$YR$$F$Y$$$20240819$$MD$GB$GB
241225651$24122565$1$I$$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024142901$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241225661$24122566$1$I$$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024144570$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241225671$24122567$1$I$$20240714$20240723$20240723$EXP$$US-HETERO-HET2024US02364$HETERO$Edwards C, Gerpen SV, Anand V.. New-Onset Seizures in an Adolescent Following Use of LSD  while on Low-Dose Lithium Therapy: A Case Study. South Dakota Medicine. 2024;77 (1):31$15$YR$$F$Y$$$20240723$$MD$US$US
241225681$24122568$1$I$20240708$20240715$20240723$20240723$PER$$US-SA-2024SA211213$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240723$$MD$US$US
241225691$24122569$1$I$$20240715$20240723$20240723$EXP$$GB-EMD Serono-2024038643$EMD SERONO INC$$$$$F$Y$$$20240723$$CN$GB$GB
241225701$24122570$1$I$$20240712$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008946$STRIDES$Vu KT, Wolfe RM, Lambird JE, Maracaja DLV.. A case of VEXAS syndrome presenting with unusual bone marrow granulomas: a diagnostic dilemma.. BMC Rheumatol. 2023;7(1):18$7$DEC$$M$Y$$$20240723$$HP$US$US
241225711$24122571$1$I$$20210330$20240723$20240723$EXP$$US-BIOVITRUM-2021US0621$BIOVITRUM$$$$C$M$Y$$$20240719$$CN$US$US
241225722$24122572$2$F$20240716$20240812$20240723$20240819$30DAY$$US-AMGEN-USASL2024142798$AMGEN$$60$YR$A$F$Y$$$20240819$$PH$US$US
241225731$24122573$1$I$$20240717$20240723$20240723$PER$$US-AMGEN-USASL2024143619$AMGEN$$$$$$Y$$$20240722$$CN$US$US
241225743$24122574$3$F$20240701$20240809$20240723$20240816$30DAY$$NL-JNJFOC-20240713508$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240816$$CN$NL$NL
241225751$24122575$1$I$$20240711$20240723$20240723$EXP$$EU-BAUSCHBL-2024BNL030020$BAUSCH AND LOMB$Howley F, Abukhodair S, Barra E, O^Connell K, McNally C. Misidentification of Brucella melitensis as Ochrobactrum species: Potential pitfalls in the diagnosis of brucellosis. BMJ Case Reports. 2024;17:E260072:1-4. doi:10.1136/bcr-2024- 260072$3$DEC$$M$Y$$$20240722$$MD$EU$EU
241225761$24122576$1$I$20210101$20240715$20240723$20240723$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP008956$STRIDES$Almeida AS, Yonamine FK, Soares AD, Penido NO, Cruz OLM.. Cochlear implant for profound hearing loss post COVID-19 complications.. Brazi-J-Otorhinolaryngol. 2023;89 (6)$55$YR$$M$Y$$$20240723$$HP$BR$BR
241225771$24122577$1$I$$20240715$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008909$STRIDES$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series.. Clin-Transl-Gastroenterol. 2024;15 (3)$55$YR$$F$Y$$$20240723$$MD$US$US
241225781$24122578$1$I$20240101$20240715$20240723$20240723$EXP$$US-ABBVIE-5842822$ABBVIE$$40$YR$$F$Y$$$20240723$$CN$US$US
241225791$24122579$1$I$$20240715$20240723$20240723$PER$$US-ABBVIE-5842277$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241225801$24122580$1$I$$20240709$20240723$20240723$EXP$$US-SPECGX-T202401520$SPECGX$Ricci C, Noord BV, Burch A, Tibbs M. A case of an autoimmune blistering disease: Pemphigus vulgaris. Cureus. 2024;16(6):1-7$82$YR$$M$Y$$$20240723$$HP$US$US
241225821$24122582$1$I$20230413$20230420$20240723$20240723$EXP$$ZA-BIOVITRUM-2023-ZA-010088$BIOVITRUM$$169$DY$$M$Y$3.4$KG$20240719$$CN$ZA$ZA
241225831$24122583$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA212254$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240723$$MD$US$US
241225841$24122584$1$I$$20240715$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008910$STRIDES$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series.. Clin-Transl-Gastroenterol. 2024;15 (3)$74$YR$$F$Y$$$20240723$$MD$US$US
241225851$24122585$1$I$$20240719$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116294$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240723$$CN$US$US
241225861$24122586$1$I$20240701$20240711$20240723$20240723$EXP$$BR-BIOVITRUM-2024-BR-010008$BIOVITRUM$$120$DY$$F$Y$2.7$KG$20240719$$HP$BR$BR
241225871$24122587$1$I$$20240718$20240723$20240723$PER$$US-AstraZeneca-2024A164318$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241225881$24122588$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209569$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240723$$MD$US$US
241225891$24122589$1$I$$20211014$20240723$20240723$EXP$$US-AstraZeneca-2021A775617$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241225901$24122590$1$I$20211001$20211228$20240723$20240723$EXP$$US-AstraZeneca-2021A909652$ASTRAZENECA$$577$MON$$F$Y$$$20240723$$CN$US$
241225911$24122591$1$I$20210528$20210827$20240723$20240723$EXP$$FR-AstraZeneca-2021A698515$ASTRAZENECA$$24093$DY$$F$Y$$$20240723$$HP$FR$
241225921$24122592$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013694$ELI LILLY AND CO$$28$YR$A$M$Y$$$20240723$$HP$US$US
241225931$24122593$1$I$20240628$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012441$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240723$$CN$US$US
241225941$24122594$1$I$20240601$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013215$ELI LILLY AND CO$$29$YR$A$M$Y$$$20240723$$CN$US$US
241225951$24122595$1$I$$20200317$20240723$20240723$EXP$$US-BIOVITRUM-2020SE41200$BIOVITRUM$$$$I$M$Y$$$20240719$$HP$US$US
241225961$24122596$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024142910$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241225971$24122597$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024144770$AMGEN$$$$$F$Y$$$20240722$$PH$US$US
241225982$24122598$2$F$20240704$20240725$20240723$20240802$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-21486$SAMSUNG BIOEPIS$$76$YR$E$M$Y$93$KG$20240802$$MD$DE$DE
241225992$24122599$2$F$$20240807$20240723$20240813$EXP$$US-CELLTRION INC.-2024US017620$CELLTRION$$$$$$Y$$$20240813$$HP$US$US
241226001$24122600$1$I$20220406$20220411$20240723$20240723$EXP$$CO-BIOVITRUM-2022CO05278$BIOVITRUM$$61$DY$$F$Y$2.3$KG$20240719$$CN$CO$CO
241226012$24122601$2$F$$20240808$20240723$20240812$EXP$$CA-JNJFOC-20240744958$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240812$$PH$CA$CA
241226021$24122602$1$I$20220424$20220425$20240723$20240723$EXP$$ZA-BIOVITRUM-2022ZA05831$BIOVITRUM$$199$DY$$F$Y$6$KG$20240719$$CN$ZA$ZA
241226031$24122603$1$I$20230331$20230421$20240723$20240723$EXP$$ZA-BIOVITRUM-2023-ZA-009872$BIOVITRUM$$65$DY$$F$Y$$$20240719$$CN$ZA$ZA
241226041$24122604$1$I$20230516$20230704$20240723$20240723$EXP$$CO-BIOVITRUM-2023-CO-011133$BIOVITRUM$$101$DY$$F$Y$4.8$KG$20240719$$CN$CO$CO
241226051$24122605$1$I$20140101$20240718$20240723$20240723$EXP$GB-ELI_LILLY_AND_COMPANY-GB202407005819$GB-STRIDES ARCOLAB LIMITED-2024SP008990$STRIDES$$$$A$M$Y$73$KG$20240723$$MD$GB$GB
241226061$24122606$1$I$$20190918$20240723$20240723$EXP$$US-BIOVITRUM-2019SF35001$BIOVITRUM$$$$I$F$Y$$$20240719$$CN$US$US
241226071$24122607$1$I$20240705$20240705$20240723$20240723$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-21165$SAMSUNG BIOEPIS$$13$YR$T$F$Y$39$KG$20240719$$CN$CA$CA
241226081$24122608$1$I$20240101$20240710$20240723$20240723$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109768$ZYDUS PHARM$$$$$$Y$$$20240723$$HP$US$US
241226091$24122609$1$I$20240701$20240711$20240723$20240723$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109805$ZYDUS PHARM$$$$$$Y$$$20240723$$HP$US$US
241226101$24122610$1$I$20220101$20240715$20240723$20240723$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109804$ZYDUS PHARM$$$$$$Y$$$20240723$$CN$US$US
241226111$24122611$1$I$20240507$20240708$20240723$20240723$EXP$FR-AFSSAPS-TS2024000771$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109671$ZYDUS PHARM$$$$$$Y$$$20240723$$CN$FR$FR
241226121$24122612$1$I$$20240711$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110739$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240719$$HP$CA$CA
241226131$24122613$1$I$$20240709$20240723$20240723$EXP$$JP-UCBSA-2024035456$UCB$$$$$$Y$$$20240723$$MD$JP$JP
241226141$24122614$1$I$$20240718$20240723$20240723$PER$$US-SA-2024SA212824$SANOFI AVENTIS$$13$YR$T$$Y$$$20240723$$MD$US$US
241226151$24122615$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209835$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240723$$MD$US$US
241226162$24122616$2$F$$20240724$20240723$20240807$EXP$$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109713$ZYDUS PHARM$Marc R R, Santiago C A, Jordi C P and Maria L O S. Visceral coloration due to the blue of postmortem methylene Postmortem visceral staining due to methylene blue. Magazine Spanish Legal Medicine. Page no 3$$$$$Y$$$20240807$$MD$ES$ES
241226171$24122617$1$I$20230905$20240710$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04521$AMNEAL$$$$$$Y$$$20240723$$CN$US$US
241226183$24122618$3$F$20240327$20240806$20240723$20240809$30DAY$$US-AMGEN-USASP2024142584$AMGEN$$68$YR$E$F$Y$$$20240809$$HP$US$US
241226191$24122619$1$I$20240514$20240710$20240723$20240723$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-21747$SAMSUNG BIOEPIS$$53$YR$A$F$Y$$$20240719$$MD$DE$DE
241226201$24122620$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115252$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240719$$CN$US$US
241226211$24122621$1$I$20220901$20240712$20240723$20240723$EXP$$FR-CELLTRION INC.-2024FR017304$CELLTRION$$$$$$Y$$$20240723$$MD$FR$FR
241226221$24122622$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115386$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240719$$CN$US$US
241226233$24122623$3$F$20240401$20240514$20240723$20240802$PER$$TR-MEN-2024-096065$MENARINI$$70$YR$$M$Y$$$20240801$$MD$TR$TR
241226242$24122624$2$F$20240619$20240711$20240723$20240725$EXP$$KR-SAMSUNG BIOEPIS-SB-2024-21913$SAMSUNG BIOEPIS$$18$YR$A$M$Y$$$20240725$$CN$KR$KR
241226262$24122626$2$F$$20240813$20240723$20240816$PER$$US-BIOGEN-2024BI01273873$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
241226281$24122628$1$I$20240711$20240715$20240723$20240723$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000630$PAREXEL$$$$$$Y$$$20240723$$HP$CN$CN
241226292$24122629$2$F$$20240813$20240723$20240816$PER$$US-BIOGEN-2024BI01273871$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
241226301$24122630$1$I$$20240712$20240723$20240723$EXP$$CA-APOTEX-2024AP008313$APOTEX$$38$YR$$M$Y$78.005$KG$20240723$$CN$CA$CA
241226313$24122631$3$F$20240704$20240814$20240723$20240816$EXP$$DE-GSK-DE2024090140$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$DE$DE
241226321$24122632$1$I$$20240711$20240723$20240723$EXP$NL-LRB-00982797$NL-KOANAAP-SML-NL-2024-00739$Unknown Manufacturer$$64$YR$A$M$Y$58$KG$20240719$$MD$NL$NL
241226331$24122633$1$I$20240710$20240716$20240723$20240723$PER$$US-JNJFOC-20240742759$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240723$$CN$US$US
241226341$24122634$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000031263$ROCHE$$$$$F$Y$$$20240723$$CN$US$US
241226351$24122635$1$I$$20240717$20240723$20240723$PER$$US-JNJFOC-20240746574$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
241226361$24122636$1$I$$20240715$20240723$20240723$PER$$US-JNJFOC-20240738244$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$HP$US$US
241226371$24122637$1$I$$20240709$20240723$20240723$EXP$$US-KOANAAP-SML-US-2024-00730$Unknown Manufacturer$W L, Syed Q, Jae L, H.Shu D, Ralph H, Daniel A L. transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma-two case reports. Annals of Pancreatic Cancer. 2022 Jun 21;doi:10.21037/apc-22-1.$67$YR$E$M$Y$$$20240719$$MD$US$US
241226381$24122638$1$I$$20240709$20240723$20240723$EXP$$US-KOANAAP-SML-US-2024-00734$Unknown Manufacturer$Ozueh P, Agogbuo O, Walnofer A, Umezurike I, John L, Hammond TC. Breathtaking Intrathoracic Rhabdoid Tumor. Am-J-Respir-Crit-Care-Med. 2024;$63$YR$A$M$Y$$$20240719$$MD$US$US
241226401$24122640$1$I$$20240709$20240723$20240723$EXP$$US-KOANAAP-SML-US-2024-00728$Unknown Manufacturer$Beck OG, Hardesty MM. Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion. Gynecologic Oncology Reports. 2023 Apr 14;47: doi:10.1016/j.gore.2023.101187.$51$YR$A$F$Y$$$20240719$$MD$US$US
241226412$24122641$2$F$$20240709$20240723$20240723$EXP$$ES-KOANAAP-SML-ES-2024-00727$Unknown Manufacturer$Ramirez SE, Mateo MC, Egea SE, Cepero ML, Mugarza PG, Sanz SB. Spontaneous remission of a pulmonary sclerosing epithelioid fibrosarcoma. Translational Cancer Research. 2024 May 21;13(5): 2564-2570. doi:10.21037/tcr-23-2276.$58$YR$A$F$Y$$$20240723$$MD$ES$ES
241226421$24122642$1$I$$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A164293$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241226432$24122643$2$F$$20240809$20240723$20240819$EXP$$IT-TEVA-VS-3220838$TEVA$Chighizola CB, Suardi I, Marino A, Gattinara M, Costi S, Cattaneo A, et al. Belimumab-induced periungual pyogenic granulomas: A case report. Lupus 2024; 1-5.; Chighizola CB, Suardi I, Marino A, Gattinara M, Costi S, Cattaneo A, et al. Belimumab-induced periungual pyogenic granulomas: A case report. Lupus 2024; 1-5.$21$YR$$F$Y$$$20240819$$HP$IT$IT
241226441$24122644$1$I$$20220831$20240723$20240723$EXP$$AE-AstraZeneca-2022A304563$ASTRAZENECA$$$$$$Y$$$20240723$$CN$AE$
241226451$24122645$1$I$$20230627$20240723$20240723$EXP$$US-AstraZeneca-2023A114574$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241226461$24122646$1$I$$20211018$20240723$20240723$EXP$$US-AstraZeneca-2021A779520$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241226472$24122647$2$F$$20240819$20240723$20240903$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-21270$SAMSUNG BIOEPIS$$67$YR$E$F$Y$66.3$KG$20240903$$HP$CA$CA
241226482$24122648$2$F$$20240802$20240723$20240809$EXP$$JP-GSK-JP2024JPN088838$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$PH$JP$JP
241226491$24122649$1$I$$20240715$20240723$20240723$EXP$$US-GSK-US2024AMR089830$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
241226502$24122650$2$F$$20240724$20240723$20240726$EXP$$JP-JNJFOC-20240752754$JOHNSON AND JOHNSON$Kayoko MINAKATA, et al.; Department of Forensics Medicine, Hamamatsu University School of Medicine. Analysis of RISPERIDONE metabolites in autopsy tissue and body fluids. Proceedings of the 43rd Annual Meeting of the Japanese Association of Forensic Toxicology;2024.6.29,30; Chiba-shi, Chiba:2024.p.65$6$DEC$A$M$Y$$$20240726$$$COUNTRY NOT SPECIFIED$JP
241226513$24122651$3$F$20240607$20240828$20240723$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003034$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240920$$CN$US$US
241226521$24122652$1$I$$20240626$20240723$20240723$PER$$US-BEIGENE-BGN-2024-009989$BEIGENE$$$$$$Y$$$20240723$$HP$US$US
241226543$24122654$3$F$$20240821$20240723$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003035$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
241226552$24122655$2$F$$20240716$20240723$20240801$EXP$$JP-009507513-2407JPN003393J$MERCK$Kanasugi Y, Ohzeki K, Nishiyama H, Honda T. P-038 A Case of Intestinal mural pneumatosis Progressing after Administration of Lenvatinib. Gynecologic Oncology. 2024;42(3):364$53$YR$$F$Y$$$20240801$$MD$JP$JP
241226561$24122656$1$I$$20240722$20240723$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041300$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240723$$CN$US$US
241226571$24122657$1$I$$20240627$20240723$20240723$PER$$US-BEIGENE-BGN-2024-010060$BEIGENE$$$$$$Y$$$20240723$$CN$US$US
241226582$24122658$2$F$$20240811$20240723$20240821$PER$$US-BAUSCHBL-2024BNL030071$BAUSCH AND LOMB$$$$$F$Y$$$20240821$$CN$US$US
241226602$24122660$2$F$20240401$20240819$20240723$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115035$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240827$$CN$US$US
241226611$24122661$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115653$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$JP$JP
241226621$24122662$1$I$20240413$20240718$20240723$20240723$EXP$$ES-AUROBINDO-AUR-APL-2024-036025$AUROBINDO$$57$YR$$M$Y$$$20240723$$MD$ES$ES
241226631$24122663$1$I$20240715$20240719$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116323$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240723$$CN$US$US
241226641$24122664$1$I$20230525$20240718$20240723$20240723$EXP$$IT-AMNEAL PHARMACEUTICALS-2023-AMRX-04734$AMNEAL$$$$$$Y$$$20240723$$HP$IT$IT
241226651$24122665$1$I$20240101$20240712$20240723$20240723$EXP$$US-MALLINCKRODT-MNK202404147$MALLINCKRODT$$56$YR$A$M$Y$$$20240723$$CN$US$US
241226661$24122666$1$I$20240708$20240708$20240723$20240723$EXP$$US-MALLINCKRODT-MNK202404454$MALLINCKRODT$$68$YR$$M$Y$$$20240723$$CN$US$US
241226671$24122667$1$I$$20240710$20240723$20240723$EXP$$US-MALLINCKRODT-MNK202404598$MALLINCKRODT$$$$$F$Y$$$20240723$$HP$US$US
241226681$24122668$1$I$$20240716$20240723$20240723$EXP$$CO-JNJFOC-20240746161$JOHNSON AND JOHNSON$$61$YR$A$F$Y$68$KG$20240723$$HP$CO$CO
241226691$24122669$1$I$$20240715$20240723$20240723$EXP$$US-MALLINCKRODT-MNK202404616$MALLINCKRODT$$$$A$F$Y$$$20240723$$HP$US$US
241226703$24122670$3$F$20240705$20240910$20240723$20240919$EXP$$DE-JNJFOC-20240745649$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240919$$HP$DE$DE
241226713$24122671$3$F$20240703$20240910$20240723$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06981$LUPIN$$$$$$Y$$$20240925$$CN$US$US
241226722$24122672$2$F$$20240906$20240723$20240906$PER$$NVSC2024US150347$NOVARTIS$$$$$F$Y$$$20240906$$HP$US$US
241226731$24122673$1$I$$20240716$20240723$20240723$EXP$$JP-GSK-JP2024089183$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$PH$JP$JP
241226741$24122674$1$I$20240101$20240708$20240723$20240723$EXP$$US-MALLINCKRODT-MNK202404467$MALLINCKRODT$$71$YR$E$F$Y$$$20240723$$HP$US$US
241226751$24122675$1$I$$20240715$20240723$20240723$EXP$$US-MALLINCKRODT-MNK202404613$MALLINCKRODT$$$$$F$Y$195$KG$20240723$$HP$US$US
241226763$24122676$3$F$$20240919$20240723$20240930$PER$$US-TRAVERE-2024TVT00582$TRAVERE THERAPEUTICS$$45$YR$A$F$Y$$$20240930$$CN$US$US
241226771$24122677$1$I$$20240426$20240723$20240723$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445184$RANBAXY$$$$$$Y$$$20240723$$CN$US$US
241226781$24122678$1$I$20200101$20240713$20240723$20240723$EXP$GB-MHRA-MED-202407130716135200-DMRVF$GB-TEVA-VS-3221448$TEVA$$59$YR$$F$Y$81$KG$20240723$$CN$GB$GB
241226791$24122679$1$I$$20240607$20240723$20240723$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451705$RANBAXY$$$$$M$Y$$$20240723$$CN$US$US
241226801$24122680$1$I$20240321$20240409$20240723$20240723$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442515$RANBAXY$$$$$F$Y$$$20240723$$CN$US$US
241226815$24122681$5$F$20240101$20240913$20240723$20240920$EXP$$JP-GENMAB-2024-02190AA$GENMAB$$46$YR$$M$Y$76$KG$20240920$$MD$JP$JP
241226821$24122682$1$I$$20240629$20240723$20240723$PER$$US-JNJFOC-20240703436$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$US$US
241226832$24122683$2$F$20240715$20240716$20240723$20240731$PER$$US-CHATTEMPRD-2024OHG024423$CHATTEM$$$$$F$Y$$$20240731$$CN$US$US
241226841$24122684$1$I$$20240716$20240723$20240723$PER$$US-CHATTEMPRD-2024OHG024506$CHATTEM$$$$$F$Y$$$20240723$$CN$US$US
241226851$24122685$1$I$$20240712$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-036023$AUROBINDO$$25$YR$$M$Y$$$20240723$$PH$US$US
241226861$24122686$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA210413$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240723$$CN$US$US
241226871$24122687$1$I$20240701$20240715$20240723$20240723$PER$$US-SA-2024SA211942$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240723$$MD$US$US
241226881$24122688$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA210030$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240723$$MD$US$US
241226891$24122689$1$I$20230101$20240711$20240723$20240723$EXP$$CH-EMD Serono-2024034599$EMD SERONO INC$$62$YR$A$F$Y$$$20240719$$CN$CH$CH
241226901$24122690$1$I$$20240712$20240723$20240723$PER$$US-EMD Serono-2024038474$EMD SERONO INC$$33$YR$A$F$Y$$$20240719$$CN$US$US
241226911$24122691$1$I$$20240715$20240723$20240723$EXP$$US-AMAROX PHARMA-HET2024US02357$HETERO$Oomrigar SC, Fernandez J, Ortiz CR, Rajen H, Toll A, Colome EP et al.. The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death.. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5653$$$$F$Y$$$20240723$$HP$US$US
241226923$24122692$3$F$$20240731$20240723$20240902$PER$$US-CHATTEMPRD-2024OHG024420$CHATTEM$$84$YR$E$F$Y$$$20240902$$CN$US$US
241226931$24122693$1$I$$20210317$20240723$20240723$EXP$$US-AstraZeneca-2021A174369$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241226941$24122694$1$I$$20200710$20240723$20240723$EXP$$US-AstraZeneca-2020SE88925$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241226951$24122695$1$I$$20221201$20240723$20240723$EXP$$US-AstraZeneca-2022A395912$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241226961$24122696$1$I$$20210922$20240723$20240723$EXP$$GB-AstraZeneca-2021A746512$ASTRAZENECA$$$$$F$Y$$$20240723$$HP$GB$
241226971$24122697$1$I$$20220519$20240723$20240723$EXP$$US-AstraZeneca-2022A192559$ASTRAZENECA$$$$$F$Y$68$KG$20240723$$CN$US$
241226981$24122698$1$I$$20240710$20240723$20240723$EXP$$US-EMD Serono-2024037643$EMD SERONO INC$Balasundaram P, Sakr M. Chromosomal Integration of HHV-6 in a Preterm Neonate: A Rare Case of Hyperleukocytosis and Clinical Implications. Pediatric Reports. 2024;16(2): 432-437. doi:https://doi.org/10.3390/ pediatric16020037.$36$YR$A$F$Y$$$20240719$$HP$US$US
241226991$24122699$1$I$$20240710$20240723$20240723$EXP$$US-EMD Serono-2024038415$EMD SERONO INC$Balasundaram P, Sakr M. Chromosomal Integration of HHV-6 in a Preterm Neonate: A Rare Case of Hyperleukocytosis and Clinical Implications. Pediatric Reports. 2024 Jun 01;16(2): 432-437. doi:https://doi.org/10.3390/ pediatric16020037.$$$N$M$Y$$$20240719$$HP$US$US
241227001$24122700$1$I$$20240716$20240723$20240723$EXP$$US-ARGENX-2024-ARGX-US005604$ARGENX BVBA$$$$$$Y$$$20240723$$CN$US$US
241227012$24122701$2$F$$20240723$20240723$20240805$PER$$US-EMD Serono-2024038470$EMD SERONO INC$$64$YR$A$F$Y$$$20240805$$CN$US$US
241227021$24122702$1$I$$20240715$20240723$20240723$EXP$$NL-JNJFOC-20240741693$JOHNSON AND JOHNSON$$67$YR$E$M$Y$80$KG$20240723$$CN$NL$NL
241227031$24122703$1$I$20220101$20240715$20240723$20240723$EXP$$BR-SA-2024SA197640$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240723$$CN$BR$BR
241227041$24122704$1$I$$20240708$20240723$20240723$PER$$US-EMD Serono-2024037556$EMD SERONO INC$$55$YR$A$F$Y$$$20240719$$MD$US$US
241227051$24122705$1$I$$20240718$20240723$20240723$EXP$$US-TAKEDA-2018TUS004119$TAKEDA$$$$$M$Y$$$20240723$$HP$US$US
241227062$24122706$2$F$20210101$20240809$20240723$20240819$EXP$$PT-TEVA-VS-3220737$TEVA$Paulo N, Goncalves PL, Cerqueira A, Araujo J, Sampaio S, Vasconcelos MP. Recurrent parvovirus B19 infection-associated pure red cell aplasia in kidney transplantation. Nephrol-Dial-Transplant 2024; 39 (Suppl. 1) i2698 abstr. 1572.; Paulo N, Goncalves PL, Cerqueira A, Araujo J, Sampaio S, Vasconcelos MP. Recurrent parvovirus B19 infection-associated pure red cell aplasia in kidney transplantation. Nephrol-Dial-Transplant 2024; 39 (Suppl. 1) i2698 abstr. 1572.$42$YR$$M$Y$$$20240819$$HP$PT$PT
241227072$24122707$2$F$20240718$20240805$20240723$20240807$PER$$US-JNJFOC-20240750579$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240807$$CN$US$US
241227081$24122708$1$I$$20240717$20240723$20240723$EXP$$JP-Harman-000063$HARMAN FINOCHEM$Takahashi Y, Nakano H, Motoki M, Wakimoto Y, Ikechi D, Koyama Y, Hashimoto H. Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review. Acute Med Surg. 2024 Jul 15;11(1):e981. doi: 10.1002/ams2.981.$45$YR$$F$Y$$$20240722$$MD$JP$
241227091$24122709$1$I$$20240716$20240723$20240723$EXP$$GB-JNJFOC-20240744196$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240722$$HP$GB$GB
241227101$24122710$1$I$20170703$20240715$20240723$20240723$EXP$$AU-TAKEDA-2024TUS072921$TAKEDA$$64$YR$$F$Y$$$20240723$$MD$AU$AU
241227112$24122711$2$F$20240708$20240723$20240723$20240725$PER$$US-AMGEN-USASP2024143973$AMGEN$$77$YR$E$F$Y$$$20240725$$CN$US$US
241227122$24122712$2$F$20240502$20240807$20240723$20240810$PER$$US-AMGEN-USASP2024144114$AMGEN$$77$YR$E$F$Y$$$20240810$$CN$US$US
241227131$24122713$1$I$$20240709$20240723$20240723$EXP$$US-NOVOPROD-1257673$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241227142$24122714$2$F$20240601$20240717$20240723$20240727$EXP$FR-AFSSAPS-RE2024000687$FR-TEVA-VS-3221041$TEVA$$80$YR$$M$Y$75$KG$20240727$$MD$FR$FR
241227152$24122715$2$F$20240101$20240719$20240723$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-022014$UNITED THERAPEUTICS$$$$$F$Y$96.145$KG$20240727$$$US$US
241227161$24122716$1$I$$20240711$20240723$20240723$EXP$$US-EMD Serono-2024038117$EMD SERONO INC$$$$A$F$Y$94$KG$20240719$$MD$US$US
241227171$24122717$1$I$$20240712$20240723$20240723$PER$$US-EMD Serono-2024038223$EMD SERONO INC$$46$YR$A$F$Y$$$20240719$$PH$US$US
241227181$24122718$1$I$$20240711$20240723$20240723$EXP$$CA-Orion Corporation ORION PHARMA-24_00030945$ORION$$40$YR$A$F$Y$$$20240723$$HP$CA$
241227191$24122719$1$I$20231001$20240716$20240723$20240723$EXP$$BR-EMD Serono-2024038857$EMD SERONO INC$$53$YR$A$M$Y$$$20240719$$CN$BR$BR
241227202$24122720$2$F$20240626$20240730$20240723$20240809$30DAY$$US-JNJFOC-20240678142$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240809$$CN$US$US
241227211$24122721$1$I$20230301$20240709$20240723$20240723$EXP$$FR-EMD Serono-2024039138$EMD SERONO INC$$$$$F$Y$$$20240719$$CN$FR$FR
241227221$24122722$1$I$$20240710$20240723$20240723$EXP$$US-EMD Serono-2024028426$EMD SERONO INC$$$$A$M$Y$$$20240719$$CN$US$US
241227231$24122723$1$I$$20240709$20240723$20240723$EXP$$US-EMD Serono-2024037710$EMD SERONO INC$Farouji A, Haddad AW, Kloub M, Paige A, Miller R. A Case of Metformin-Associated Lactic Acidosis Complicated by Acute Liver Failure, Acute Renal Failure, and Shock. Cureus, part of springer nature. 2024 Jul 06;16(6): e61911. doi:10.7759/cureus.61911.$63$YR$A$F$Y$$$20240719$$HP$US$US
241227241$24122724$1$I$20231201$20240710$20240723$20240723$EXP$$DE-EMD Serono-2024023334$EMD SERONO INC$$81$YR$E$F$Y$$$20240719$$CN$DE$DE
241227251$24122725$1$I$$20240719$20240723$20240723$EXP$$ES-AUROBINDO-AUR-APL-2024-036359$AUROBINDO$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. International Journal of Molecular Sciences. 2023;24(17):13562$1$YR$$F$Y$$$20240723$$HP$ES$ES
241227261$24122726$1$I$20230718$20240718$20240723$20240723$EXP$$CA-TAKEDA-2024TUS073579$TAKEDA$$31$YR$$F$Y$$$20240723$$CN$CA$CA
241227271$24122727$1$I$$20240712$20240723$20240723$PER$$US-EMD Serono-2024038244$EMD SERONO INC$$41$YR$A$F$Y$$$20240719$$MD$US$US
241227281$24122728$1$I$$20240709$20240723$20240723$EXP$$FR-EMD Serono-2024037474$EMD SERONO INC$$$$$F$Y$$$20240719$$CN$FR$FR
241227292$24122729$2$F$$20240816$20240723$20240826$EXP$$US-EMD Serono-2024038114$EMD SERONO INC$$42$YR$A$F$Y$94$KG$20240826$$CN$US$US
241227301$24122730$1$I$$20240711$20240723$20240723$EXP$$US-NOVOPROD-1256413$NOVO NORDISK$$$$$F$Y$$$20240723$$MD$US$US
241227312$24122731$2$F$20240501$20240822$20240723$20240830$EXP$$UA-NOVOPROD-1255543$NOVO NORDISK$$672$MON$$F$Y$$$20240830$$CN$UA$UA
241227322$24122732$2$F$20240501$20240819$20240723$20240828$EXP$FI-FIMEA-202402561$FI-NOVOPROD-1256040$NOVO NORDISK$$51$YR$$M$Y$$$20240828$$CN$FI$FI
241227331$24122733$1$I$$20240712$20240723$20240723$EXP$NO-NOMAADVRE-PASRAPP-2024-V8bg7p$NO-NOVOPROD-1256033$NOVO NORDISK$$55$YR$$M$Y$140$KG$20240723$$CN$NO$NO
241227341$24122734$1$I$$20240711$20240723$20240723$EXP$$US-NOVOPROD-1256415$NOVO NORDISK$$$$$M$Y$$$20240723$$HP$US$US
241227351$24122735$1$I$$20240710$20240723$20240723$EXP$$JP-NOVOPROD-1244733$NOVO NORDISK$H. Narusawa et al.,. A girl with type I diabetes mellitus who?s subcutaneous insulin resistance was treated effectively with faster-acting insulin aspart mixed with heparin. The 97th Annual Congress of the Japan Endocrine Society. 2024;100:No.1 p O1-7-1$14$YR$$F$Y$$$20240723$$MD$JP$JP
241227361$24122736$1$I$20240201$20240712$20240723$20240723$EXP$$CN-NOVOPROD-1256090$NOVO NORDISK$$71$YR$$M$Y$$$20240723$$HP$CN$CN
241227371$24122737$1$I$$20240711$20240723$20240723$EXP$$US-NOVOPROD-1258164$NOVO NORDISK$$61$YR$$M$Y$$$20240723$$PH$US$US
241227381$24122738$1$I$$20240711$20240723$20240723$EXP$$US-NOVOPROD-1258167$NOVO NORDISK$$$$A$F$Y$$$20240723$$MD$US$US
241227391$24122739$1$I$20240705$20240711$20240723$20240723$EXP$$US-NOVOPROD-1256384$NOVO NORDISK$$35$YR$$F$Y$$$20240723$$CN$US$US
241227401$24122740$1$I$$20240710$20240723$20240723$EXP$$TR-NOVOPROD-1258796$NOVO NORDISK$$$$$$Y$$$20240723$$CN$TR$TR
241227413$24122741$3$F$20231012$20240905$20240723$20240918$EXP$$CN-NOVOPROD-1254949$NOVO NORDISK$Liu Zuodong et al.. Type 2 diabetes patient with poorly controlled blood glucose after subcutaneous injection of premixed human insulin converted to treatment with insulin degludec and insulin aspart: a case report. Chin J Diabetes Mellitus. 2024;16(1):61$65$YR$$F$Y$56$KG$20240918$$HP$CN$CN
241227421$24122742$1$I$20240101$20240712$20240723$20240723$EXP$DK-DKMA-30729590$DK-NOVOPROD-1256036$NOVO NORDISK$$66$YR$$F$Y$65$KG$20240723$$CN$DK$DK
241227431$24122743$1$I$$20240712$20240723$20240723$EXP$$ES-NOVOPROD-1256245$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$ES$ES
241227441$24122744$1$I$20150101$20240711$20240723$20240723$EXP$$US-NOVOPROD-1256529$NOVO NORDISK$$51$YR$$M$Y$$$20240723$$CN$US$US
241227452$24122745$2$F$$20240806$20240723$20240816$EXP$$DE-EMD Serono-2024038763$EMD SERONO INC$$61$YR$A$M$Y$71$KG$20240816$$CN$DE$DE
241227461$24122746$1$I$$20240625$20240723$20240723$EXP$$IL-EMD Serono-2024038953$EMD SERONO INC$$$$$F$Y$$$20240719$$MD$IL$IL
241227471$24122747$1$I$20240722$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116322$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240723$$CN$US$US
241227481$24122748$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115342$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240723$$MD$US$US
241227491$24122749$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115747$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$JP$JP
241227501$24122750$1$I$20240610$20240716$20240723$20240723$EXP$FR-AFSSAPS-LL2024001275$FR-EMD Serono-2024038732$EMD SERONO INC$$62$YR$A$F$Y$$$20240719$$PH$FR$FR
241227511$24122751$1$I$$20240711$20240723$20240723$EXP$$CL-EMD Serono-2024038186$EMD SERONO INC$$$$A$F$Y$$$20240719$$CN$CL$CL
241227521$24122752$1$I$$20240712$20240723$20240723$EXP$$DE-EMD Serono-2024038336$EMD SERONO INC$$$$E$F$Y$$$20240719$$CN$DE$DE
241227531$24122753$1$I$20240706$20240716$20240723$20240723$EXP$$CO-JNJFOC-20240749414$JOHNSON AND JOHNSON$$58$YR$A$F$Y$62$KG$20240723$$HP$CO$CO
241227541$24122754$1$I$$20240718$20240723$20240723$EXP$$CA-TAKEDA-2024TUS073883$TAKEDA$$$$$M$Y$$$20240723$$CN$CA$CA
241227552$24122755$2$F$20240101$20240725$20240723$20240809$EXP$$US-NOVOPROD-1256980$NOVO NORDISK$$73$YR$$F$Y$$$20240809$$CN$US$US
241227561$24122756$1$I$20240701$20240712$20240723$20240723$EXP$CN-NMPA-3505211028530202400207$CN-NOVOPROD-1256367$NOVO NORDISK$$61$YR$$F$Y$$$20240723$$HP$CN$CN
241227571$24122757$1$I$20240101$20240712$20240723$20240723$EXP$$US-NOVOPROD-1256641$NOVO NORDISK$$73$YR$$F$Y$$$20240723$$CN$US$US
241227581$24122758$1$I$$20240708$20240723$20240723$EXP$$IT-IPCA LABORATORIES LIMITED-IPC-2024-IT-001813$IPCA$M Marano, BM Goffredo, S Faraci et al. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicology Reports. 2024;13(101683):1-4$$$$$Y$$$20240723$$HP$IT$IT
241227591$24122759$1$I$$20240712$20240723$20240723$EXP$$US-NOVOPROD-1257623$NOVO NORDISK$$28$YR$$F$Y$$$20240723$$HP$US$US
241227601$24122760$1$I$$20240712$20240723$20240723$EXP$$US-NOVOPROD-1256992$NOVO NORDISK$$$$$F$Y$$$20240723$$HP$US$US
241227611$24122761$1$I$$20240712$20240723$20240723$EXP$$CN-NOVOPROD-1256286$NOVO NORDISK$$$$$F$Y$$$20240723$$MD$CN$CN
241227621$24122762$1$I$20230501$20240712$20240723$20240723$EXP$$US-NOVOPROD-1256666$NOVO NORDISK$$76$YR$$M$Y$$$20240723$$CN$US$US
241227631$24122763$1$I$20240708$20240712$20240723$20240723$EXP$$US-NOVOPROD-1257036$NOVO NORDISK$$80$YR$$F$Y$$$20240723$$CN$US$US
241227641$24122764$1$I$20220101$20240712$20240723$20240723$EXP$$US-NOVOPROD-1256994$NOVO NORDISK$$79$YR$$F$Y$$$20240723$$CN$US$US
241227651$24122765$1$I$20240618$20240712$20240723$20240723$EXP$$US-NOVOPROD-1256517$NOVO NORDISK$$71$YR$$F$Y$$$20240723$$CN$US$US
241227661$24122766$1$I$20240516$20240712$20240723$20240723$EXP$$US-NOVOPROD-1256644$NOVO NORDISK$$80$YR$$F$Y$$$20240723$$CN$US$US
241227671$24122767$1$I$$20240712$20240723$20240723$EXP$$US-NOVOPROD-1256673$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241227682$24122768$2$F$20231023$20240801$20240723$20240809$EXP$$US-NOVOPROD-1257329$NOVO NORDISK$$80$YR$$F$Y$$$20240809$$CN$US$US
241227691$24122769$1$I$$20240712$20240723$20240723$EXP$$JP-NOVOPROD-1256768$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$JP$JP
241227701$24122770$1$I$$20240712$20240723$20240723$EXP$$US-NOVOPROD-1257173$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241227711$24122771$1$I$$20240712$20240723$20240723$EXP$$US-NOVOPROD-1256640$NOVO NORDISK$$$$$F$Y$$$20240723$$HP$US$US
241227721$24122772$1$I$$20240712$20240723$20240723$EXP$$US-NOVOPROD-1257012$NOVO NORDISK$$81$YR$$M$Y$$$20240723$$MD$US$US
241227731$24122773$1$I$$20240712$20240723$20240723$EXP$$JP-NOVOPROD-1257974$NOVO NORDISK$$7$DEC$$M$Y$$$20240723$$PH$JP$JP
241227741$24122774$1$I$20240715$20240716$20240723$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-021982$UNITED THERAPEUTICS$$73$YR$$F$Y$63.039$KG$20240723$$$US$US
241227751$24122775$1$I$$20240712$20240723$20240723$EXP$$US-NOVOPROD-1257636$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241227761$24122776$1$I$20240717$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143743$AMGEN$$69$YR$E$$Y$$$20240722$$CN$US$US
241227771$24122777$1$I$$20240712$20240723$20240723$EXP$$US-NOVOPROD-1257860$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241227781$24122778$1$I$20230101$20240713$20240723$20240723$EXP$$CN-NOVOPROD-1257984$NOVO NORDISK$$75$YR$$M$Y$67$KG$20240723$$CN$CN$CN
241227791$24122779$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209708$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240723$$CN$US$US
241227802$24122780$2$F$20240710$20240801$20240723$20240809$PER$$US-SA-2024SA209771$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240809$$CN$US$US
241227813$24122781$3$F$20240101$20240731$20240723$20240809$PER$$US-SA-2024SA209651$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240809$$MD$US$US
241227821$24122782$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209826$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240723$$MD$US$US
241227831$24122783$1$I$$20240719$20240723$20240723$PER$$NVSC2024US150381$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
241227841$24122784$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072783$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241227851$24122785$1$I$20230520$20230725$20240723$20240723$EXP$$US-AstraZeneca-2023A129261$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241227861$24122786$1$I$$20200114$20240723$20240723$EXP$$US-AstraZeneca-2020SE07309$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241227871$24122787$1$I$20200430$20210309$20240723$20240723$EXP$$CO-AstraZeneca-2021A130809$ASTRAZENECA$$23708$DY$$M$Y$$$20240723$$CN$CO$
241227882$24122788$2$F$$20240823$20240723$20240901$PER$$US-AstraZeneca-2024A157371$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
241227891$24122789$1$I$$20210802$20240723$20240723$EXP$$US-AstraZeneca-2021A660699$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241227901$24122790$1$I$20240701$20240715$20240723$20240723$EXP$$US-NOVOPROD-1256503$NOVO NORDISK$$67$YR$$F$Y$$$20240723$$CN$US$US
241227911$24122791$1$I$$20210201$20240723$20240723$EXP$$GB-AstraZeneca-2021A030276$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$GB$
241227922$24122792$2$F$$20240822$20240723$20240827$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-100534$REGENERON$$96$YR$$M$Y$$$20240827$$CN$CH$CH
241227932$24122793$2$F$20240701$20240718$20240723$20240723$EXP$$US-ROCHE-10000031287$ROCHE$$84$YR$E$M$Y$$$20240723$$CN$US$US
241227941$24122794$1$I$20240718$20240719$20240723$20240723$EXP$$JP-TAKEDA-2024TJP010885$TAKEDA$$6$DEC$$M$Y$$$20240723$$MD$JP$JP
241227951$24122795$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072796$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241227961$24122796$1$I$$20231111$20240723$20240723$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419069$RANBAXY$$$$$F$Y$$$20240723$$CN$US$US
241227971$24122797$1$I$$20240510$20240723$20240723$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447199$RANBAXY$$$$$F$Y$$$20240723$$CN$US$US
241227981$24122798$1$I$20231030$20231030$20240723$20240723$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-416874$RANBAXY$$75$YR$E$F$Y$$$20240723$$CN$US$US
241227991$24122799$1$I$20240401$20240405$20240723$20240723$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441841$RANBAXY$$$$$F$Y$$$20240723$$CN$US$US
241228001$24122800$1$I$$20230612$20240723$20240723$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395742$RANBAXY$$$$E$F$Y$$$20240723$$CN$US$US
241228012$24122801$2$F$$20240801$20240723$20240808$EXP$$JP-AMGEN-JPNSP2024144387$AMGEN$$$$$$Y$$$20240807$$PH$JP$JP
241228021$24122802$1$I$20240706$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024143482$AMGEN$$$$$F$Y$$$20240722$$PH$US$US
241228031$24122803$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072797$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241228041$24122804$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072795$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241228051$24122805$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072799$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241228061$24122806$1$I$$20240718$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115617$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240723$$HP$CA$CA
241228071$24122807$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115679$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240723$$CN$US$US
241228082$24122808$2$F$$20240829$20240723$20240910$PER$$US-SA-2024SA210442$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240910$$HP$US$US
241228091$24122809$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212334$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240723$$CN$US$US
241228101$24122810$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209829$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240723$$MD$US$US
241228111$24122811$1$I$20240707$20240715$20240723$20240723$PER$$US-SA-2024SA211477$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240723$$MD$US$US
241228121$24122812$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209830$SANOFI AVENTIS$$$$E$F$Y$$$20240723$$MD$US$US
241228131$24122813$1$I$20240101$20240715$20240723$20240723$PER$$US-SA-2024SA210631$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240723$$CN$US$US
241228141$24122814$1$I$20240701$20240715$20240723$20240723$PER$$US-SA-2024SA211383$SANOFI AVENTIS$$31$YR$A$$Y$$$20240723$$CN$US$US
241228163$24122816$3$F$20240101$20240827$20240723$20240918$PER$$US-SA-2024SA210590$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240918$$MD$US$US
241228171$24122817$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA210138$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240723$$MD$US$US
241228182$24122818$2$F$20240101$20240730$20240723$20240808$PER$$US-SA-2024SA210587$SANOFI AVENTIS$$71$YR$E$F$Y$94.3$KG$20240809$$MD$US$US
241228191$24122819$1$I$20210121$20240715$20240723$20240723$PER$$US-SA-2024SA210475$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240723$$MD$US$US
241228201$24122820$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA210684$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240723$$MD$US$US
241228211$24122821$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209825$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240723$$MD$US$US
241228221$24122822$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072800$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241228231$24122823$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072798$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241228241$24122824$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072794$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241228251$24122825$1$I$20240119$20240722$20240723$20240723$EXP$FR-AFSSAPS-TO2024001320$NVSC2024FR149724$NOVARTIS$$55$YR$$M$Y$69$KG$20240723$$MD$FR$FR
241228261$24122826$1$I$20230801$20240711$20240723$20240723$PER$$US-SA-2024SA207016$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240723$$MD$US$US
241228272$24122827$2$F$20240101$20240904$20240723$20240919$PER$$US-SA-2024SA212834$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240919$$CN$US$US
241228282$24122828$2$F$20240101$20240827$20240723$20240904$EXP$$US-SA-2024SA061216$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240904$$MD$US$US
241228291$24122829$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA210705$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240723$$MD$US$US
241228301$24122830$1$I$20240601$20240715$20240723$20240723$PER$$US-SA-2024SA210698$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240723$$MD$US$US
241228313$24122831$3$F$20240101$20240725$20240723$20240807$PER$$US-SA-2024SA207307$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240807$$MD$US$US
241228321$24122832$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072803$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241228331$24122833$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072802$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241228341$24122834$1$I$20240101$20240719$20240723$20240723$EXP$$JP-GENMAB-2024-00336AA$GENMAB$$78$YR$$M$Y$$$20240723$$MD$JP$JP
241228352$24122835$2$F$20240601$20240722$20240723$20240731$PER$$US-SA-2024SA210743$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240731$$MD$US$US
241228361$24122836$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072812$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241228371$24122837$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072817$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/ refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241228381$24122838$1$I$$20240715$20240723$20240723$EXP$$US-TAKEDA-2024TUS072801$TAKEDA$Bumma N, Richter J, Jagannath S, Lee CH, Hoffman EJ, Suvannasankha A, et al. Linvoseltamab for treatment of relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2024$$$$$Y$$$20240723$$MD$US$US
241228391$24122839$1$I$20240712$20240715$20240723$20240723$PER$$US-ROCHE-10000027777$ROCHE$$34$YR$A$F$Y$$$20240723$$CN$US$US
241228401$24122840$1$I$$20240716$20240723$20240723$EXP$$US-GSK-US2024089389$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$CN$US$US
241228411$24122841$1$I$$20240719$20240723$20240723$PER$$NVSC2024US150345$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
241228421$24122842$1$I$$20240715$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02638$AMNEAL$$$$$F$Y$73.16$KG$20240723$$MD$US$US
241228431$24122843$1$I$$20240717$20240723$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-022171$UNITED THERAPEUTICS$$$$$F$Y$69.841$KG$20240723$$$US$US
241228441$24122844$1$I$$20240714$20240723$20240723$EXP$$IL-TAKEDA-2024TUS072957$TAKEDA$$75$YR$$M$Y$$$20240723$$HP$IL$IL
241228452$24122845$2$F$$20240809$20240723$20240819$EXP$$JP-TEVA-VS-3220037$TEVA$Ishikawa K, Hasegawa R, Shibutani K, Mikami Y, Kawai F, Matsuo T, et al. Probiotic-related Clostridium butyricum bacteremia: A case report and literature review. Anaerobe 2023; 83 1-5.; Ishikawa K, Hasegawa R, Shibutani K, Mikami Y, Kawai F, Matsuo T, et al. Probiotic-related Clostridium butyricum bacteremia: A case report and literature review. Anaerobe 2023; 83 1-5.$62$YR$$F$Y$$$20240819$$HP$JP$JP
241228465$24122846$5$F$20240101$20240819$20240723$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022060$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240828$$$US$US
241228471$24122847$1$I$20240101$20240717$20240723$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-022191$UNITED THERAPEUTICS$$$$$F$Y$55.329$KG$20240723$$$US$US
241228481$24122848$1$I$20240708$20240715$20240723$20240723$EXP$$CO-BIOVITRUM-2024-CO-010108$BIOVITRUM$$76$DY$$M$Y$3.2$KG$20240723$$CN$CO$CO
241228491$24122849$1$I$$20240708$20240723$20240723$PER$$US-AMGEN-USASP2024145090$AMGEN$$$$$F$Y$$$20240722$$CN$US$US
241228501$24122850$1$I$$20240712$20240723$20240723$PER$$US-SA-2024SA208406$SANOFI AVENTIS$$67$YR$E$F$Y$63$KG$20240723$$MD$US$US
241228511$24122851$1$I$20240515$20240717$20240723$20240723$EXP$$RU-AMGEN-RUSSP2024142684$AMGEN$$43$YR$A$F$Y$82$KG$20240722$$HP$RU$RU
241228521$24122852$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209027$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240722$$MD$US$US
241228531$24122853$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA208496$SANOFI AVENTIS$$$$A$M$Y$$$20240722$$MD$US$US
241228541$24122854$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA210790$SANOFI AVENTIS$$$$T$M$Y$$$20240722$$MD$US$US
241228551$24122855$1$I$20240101$20240712$20240723$20240723$PER$$US-SA-2024SA209729$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240722$$MD$US$US
241228561$24122856$1$I$$20240717$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02627$AMNEAL$$$$$F$Y$$$20240723$$CN$US$US
241228571$24122857$1$I$$20240715$20240723$20240723$EXP$$US-JNJFOC-20240738711$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
241228582$24122858$2$F$20240717$20240718$20240723$20240828$PER$$US-AMGEN-USASP2024143748$AMGEN$$76$YR$E$M$Y$$$20240828$$CN$US$US
241228591$24122859$1$I$20240705$20240722$20240723$20240723$EXP$PL-URPL-DML-MLP.4401.1.156.2024$PL-JNJFOC-20240756954$JOHNSON AND JOHNSON$$50$YR$A$F$Y$58$KG$20240723$$MD$PL$PL
241228601$24122860$1$I$20240702$20240716$20240723$20240723$EXP$$CN-BEIGENE-BGN-2024-011072$BEIGENE$$$$$$Y$$$20240723$$HP$CN$CN
241228611$24122861$1$I$$20211223$20240723$20240723$EXP$$US-AstraZeneca-2021A900336$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241228626$24122862$6$F$20240101$20240917$20240723$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-021623$UNITED THERAPEUTICS$$$$$M$Y$148.3$KG$20240921$$$US$US
241228632$24122863$2$F$$20240906$20240723$20240906$PER$$NVSC2024US147075$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
241228641$24122864$1$I$20220724$20220726$20240723$20240723$EXP$$US-AstraZeneca-2022A268309$ASTRAZENECA$$81$YR$$M$Y$95.3$KG$20240723$$CN$US$
241228651$24122865$1$I$20210601$20220311$20240723$20240723$EXP$$US-AstraZeneca-2022A111314$ASTRAZENECA$$926$MON$$F$Y$$$20240723$$CN$US$
241228661$24122866$1$I$$20221114$20240723$20240723$EXP$$US-AstraZeneca-2022A377240$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241228671$24122867$1$I$$20210520$20240723$20240723$EXP$$US-AstraZeneca-2021A462135$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241228681$24122868$1$I$$20220811$20240723$20240723$EXP$$US-AstraZeneca-2022A285788$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241228691$24122869$1$I$$20240709$20240723$20240723$EXP$GB-MHRA-MED-202406281141054980-NZHDV$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14666$ALKEM$$$$$$Y$$$20240723$$CN$GB$GB
241228701$24122870$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210392$SANOFI AVENTIS$$$$$M$Y$$$20240723$$CN$US$US
241228711$24122871$1$I$20240624$20240709$20240723$20240723$EXP$GB-MHRA-MED-202407071011142080-CVHZM$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15418$ALKEM$$$$$$Y$$$20240723$$CN$GB$GB
241228722$24122872$2$F$$20240719$20240723$20240802$EXP$JP-MLMSERVICE-20240701-PI118292-00059-1$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-15440$ALKEM$Tsukui D, Haga T, Abe K.. Discordance Between Mucosal Appearances and Pathologic Findings in Intestinal Mycobacterial Infection in an Immunocompromised Patient.. Mayo Clinic Proceedings. 2024;99(7):1112-1113$6$DEC$$M$Y$$$20240802$$MD$JP$JP
241228731$24122873$1$I$20230101$20240715$20240723$20240723$EXP$$GB-UCBSA-2024035758$UCB$Madenidou A-V, Kither H, Dyball S, Bruce IN, Tower C. Added IMPACT: The first successful natural birth using certolizumab in obstetric APS. Thrombosis research. 2024;241:1-3$30$YR$$F$Y$$$20240723$$HP$GB$GB
241228741$24122874$1$I$$20240709$20240723$20240723$EXP$GB-MHRA-TPP235478C10176111YC1720174692746$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15420$ALKEM$$57$YR$$M$Y$137$KG$20240723$$MD$GB$GB
241228751$24122875$1$I$$20240717$20240723$20240723$EXP$$US-TAKEDA-2024TUS072592$TAKEDA$$$$$$Y$$$20240723$$CN$US$US
241228761$24122876$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA211651$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240723$$MD$US$US
241228771$24122877$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211638$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240723$$CN$US$US
241228781$24122878$1$I$$20240718$20240723$20240723$PER$$PR-JNJFOC-20240752172$JOHNSON AND JOHNSON$$68$YR$E$M$Y$62.14$KG$20240723$$HP$PR$PR
241228791$24122879$1$I$20230113$20240716$20240723$20240723$EXP$$JP-GSK-JP2023JPN053586$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$JP$JP
241228801$24122880$1$I$$20240716$20240723$20240723$PER$$NVSC2024US147382$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
241228812$24122881$2$F$$20240808$20240723$20240808$PER$$NVSC2024US150406$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241228821$24122882$1$I$20230101$20240717$20240723$20240723$EXP$$CA-ABBVIE-5845691$ABBVIE$$$$E$F$Y$$$20240723$$CN$CA$CA
241228831$24122883$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211586$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240723$$MD$US$US
241228842$24122884$2$F$$20240907$20240723$20240916$EXP$$CA-CELLTRION INC.-2024CA017581$CELLTRION$$$$$$Y$$$20240916$$PH$CA$CA
241228851$24122885$1$I$20240101$20240716$20240723$20240723$EXP$$US-SA-2024SA210541$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240723$$MD$US$US
241228861$24122886$1$I$$20240718$20240723$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-022328$UNITED THERAPEUTICS$$$$$F$Y$104.31$KG$20240723$$$US$US
241228871$24122887$1$I$20240501$20240716$20240723$20240723$EXP$$US-JNJFOC-20240742835$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
241228881$24122888$1$I$$20240718$20240723$20240723$EXP$$GB-JNJFOC-20240755104$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$HP$GB$GB
241228892$24122889$2$F$20240101$20240731$20240723$20240807$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00714$CATALYST PHARMA$$$$$M$Y$72.562$KG$20240807$$CN$US$US
241228902$24122890$2$F$20240716$20240813$20240723$20240814$PER$$US-AMGEN-USASP2024143015$AMGEN$$76$YR$E$M$Y$$$20240814$$CN$US$US
241228911$24122891$1$I$20240709$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143735$AMGEN$$92$YR$E$F$Y$$$20240722$$CN$US$US
241228923$24122892$3$F$20231107$20240913$20240723$20240924$EXP$$US-UCBSA-2023055484$UCB$$39$YR$$F$Y$$$20240924$$CN$US$US
241228932$24122893$2$F$$20240925$20240723$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115910$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240926$$HP$US$US
241228942$24122894$2$F$$20240912$20240723$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115519$BRISTOL MYERS SQUIBB$$5$DEC$A$F$Y$$$20240917$$MD$JP$JP
241228961$24122896$1$I$$20240717$20240723$20240723$EXP$$CA-PFIZER INC-202400217680$PFIZER$$50$YR$$F$Y$64$KG$20240723$$PH$CA$CA
241228981$24122898$1$I$$20240717$20240723$20240723$EXP$$CA-PFIZER INC-202400217667$PFIZER$$83$YR$$F$Y$75$KG$20240723$$MD$CA$CA
241228991$24122899$1$I$20240101$20240716$20240723$20240723$EXP$$US-SA-2024SA212049$SANOFI AVENTIS$$92$YR$E$M$Y$$$20240723$$MD$US$US
241229001$24122900$1$I$$20240206$20240723$20240723$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-01911$ALKEM$$$$$F$Y$$$20240723$$CN$US$US
241229011$24122901$1$I$$20230531$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2023-06543$ALKEM$$$$A$M$Y$$$20240723$$MD$FR$FR
241229021$24122902$1$I$$20230629$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2023-07796$ALKEM$$$$$F$Y$$$20240723$$MD$FR$FR
241229031$24122903$1$I$20230712$20230920$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2023-10810$ALKEM$$$$$M$Y$$$20240723$$HP$FR$FR
241229041$24122904$1$I$$20240318$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-06517$ALKEM$$$$A$F$Y$$$20240723$$MD$FR$FR
241229051$24122905$1$I$$20240419$20240723$20240723$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-09456$ALKEM$$$$$M$Y$$$20240723$$CN$US$US
241229061$24122906$1$I$20221201$20240524$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-09957$ALKEM$$$$A$F$Y$$$20240723$$MD$FR$FR
241229071$24122907$1$I$$20231013$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2023-08425$ALKEM$$43$YR$$F$Y$$$20240723$$MD$FR$FR
241229081$24122908$1$I$20230327$20230622$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2023-07577$ALKEM$$58$YR$$F$Y$$$20240723$$MD$FR$FR
241229091$24122909$1$I$$20240429$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2023-14236$ALKEM$$$$A$M$Y$$$20240723$$MD$FR$FR
241229101$24122910$1$I$$20230824$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2023-10183$ALKEM$$$$$M$Y$$$20240723$$MD$FR$FR
241229111$24122911$1$I$$20240123$20240723$20240723$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-01733$ALKEM$$75$YR$$M$Y$$$20240723$$CN$US$US
241229121$24122912$1$I$$20230905$20240723$20240723$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-10486$ALKEM$$$$$F$Y$$$20240723$$CN$US$US
241229131$24122913$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115220$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$105.69$KG$20240719$$CN$US$US
241229141$24122914$1$I$$20231214$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2023-16231$ALKEM$$52$YR$$F$Y$$$20240723$$PH$FR$FR
241229151$24122915$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211171$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240723$$MD$US$US
241229161$24122916$1$I$20220101$20230803$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2022-15449$ALKEM$$84$YR$$F$Y$$$20240723$$MD$FR$FR
241229171$24122917$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211489$SANOFI AVENTIS$$$$A$F$Y$88.45$KG$20240723$$MD$US$US
241229181$24122918$1$I$20201004$20240709$20240723$20240723$EXP$$CN-RISINGPHARMA-CN-2024RISLIT00248$RISING PHARMACEUTICALS$Yunpeng Jin.Zolpidem-triggered atrial fibrillation in a  patient with cardiomyopathy: a case report..BMC Cardiovascular Disorders.2024;24:1-7$40$YR$A$M$Y$$$20240723$$HP$CN$CN
241229191$24122919$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115295$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240719$$CN$US$US
241229201$24122920$1$I$$20240709$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109502$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240719$$MD$US$US
241229211$24122921$1$I$$20240516$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2022-15456$ALKEM$$$$A$M$Y$$$20240723$$MD$FR$FR
241229221$24122922$1$I$20231110$20231128$20240723$20240723$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2023-14237$ALKEM$$$$A$M$Y$$$20240723$$MD$FR$FR
241229231$24122923$1$I$$20240717$20240723$20240723$PER$$US-JNJFOC-20240749560$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$HP$US$US
241229241$24122924$1$I$20240716$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113926$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240719$$CN$US$US
241229251$24122925$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115307$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240719$$HP$US$US
241229261$24122926$1$I$20240701$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114947$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240719$$HP$US$US
241229271$24122927$1$I$$20240711$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111408$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240719$$CN$US$US
241229281$24122928$1$I$20240709$20240715$20240723$20240723$PER$$US-ROCHE-10000032044$ROCHE$$$$$F$Y$66$KG$20240723$$CN$US$US
241229291$24122929$1$I$$20240709$20240723$20240723$EXP$$US-UCBSA-2024021015$UCB$$$$$F$Y$$$20240723$$HP$US$US
241229301$24122930$1$I$20240711$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114801$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240719$$HP$US$US
241229311$24122931$1$I$$20240712$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112180$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240719$$CN$US$US
241229322$24122932$2$F$$20240719$20240723$20240726$PER$$US-AMGEN-USASP2024145270$AMGEN$$21$YR$A$F$Y$$$20240726$$HP$US$US
241229331$24122933$1$I$$20240715$20240723$20240723$EXP$$EG-AMGEN-EGYSP2024119886$AMGEN$$$$$F$Y$$$20240723$$CN$EG$EG
241229341$24122934$1$I$$20240717$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115170$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240719$$CN$US$US
241229351$24122935$1$I$$20240719$20240723$20240723$PER$$US-JNJFOC-20240753342$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
241229361$24122936$1$I$20240424$20240717$20240723$20240723$EXP$$PL-JNJFOC-20240749528$JOHNSON AND JOHNSON$$$$E$M$Y$70$KG$20240723$$MD$PL$PL
241229372$24122937$2$F$20240513$20240805$20240723$20240809$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-076097$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$71.2$KG$20240809$$MD$DE$DE
241229381$24122938$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114433$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$65.77$KG$20240719$$CN$US$US
241229393$24122939$3$F$20240605$20240821$20240723$20240830$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-110657$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240830$$MD$PL$PL
241229401$24122940$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114397$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240719$$CN$US$US
241229411$24122941$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115149$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$68.95$KG$20240719$$PH$US$US
241229421$24122942$1$I$20240701$20240710$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110086$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240719$$PH$US$US
241229431$24122943$1$I$20240219$20240719$20240723$20240723$EXP$FR-AFSSAPS-AN2024000874$FR-ROCHE-10000031349$ROCHE$$15$YR$T$M$Y$38.1$KG$20240723$$MD$FR$FR
241229441$24122944$1$I$20210605$20240605$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210901157$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$63.6$KG$20240719$$MD$US$US
241229451$24122945$1$I$20240711$20240714$20240723$20240723$EXP$GB-MHRA-MED-202407140146142130-SRJMH$GB-TEVA-VS-3221456$TEVA$$36$YR$$M$Y$117$KG$20240723$$CN$GB$GB
241229464$24122946$4$F$20240101$20240905$20240723$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021703$UNITED THERAPEUTICS$$$$$F$Y$97.052$KG$20240914$$$US$US
241229472$24122947$2$F$$20240717$20240723$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-034323$AUROBINDO$Nguyen C, Stanek JL. Sternomanubrial joint pain secondary to ulcerative colitis treated with ultrasound-guided injection.. PM and R. 2024;16(6):650-2$31$YR$$M$Y$$$20240726$$MD$US$US
241229481$24122948$1$I$$20240709$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034248$AUROBINDO$$57$YR$$F$Y$80$KG$20240719$$PH$FR$FR
241229491$24122949$1$I$$20240708$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-035419$AUROBINDO$Saleh A, D^Amico A, Hasnie A, Clarkson S, Heindl B.. Atrial arrhythmias and acute pericarditis triggered by bleach ingestion-associated oesophageal perforation: a case report.. Eur-Heart-J-Case-Rep. 2024;8(2):2-4$36$YR$$M$Y$$$20240719$$HP$US$US
241229501$24122950$1$I$20240704$20240709$20240723$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-034319$AUROBINDO$$71$YR$$M$Y$$$20240719$$PH$GB$GB
241229511$24122951$1$I$20221003$20231019$20240723$20240723$PER$$US-AUROBINDO-AUR-APL-2023-065642$AUROBINDO$$5$YR$$M$Y$$$20240719$$CN$US$US
241229521$24122952$1$I$$20240708$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-034684$AUROBINDO$Khattar G, Sanayeh EB, Makram M, Rabah H, Baker SA, Khan S, et al.. THE CONCOMITANT OCCURRENCE OF HIDRADENITIS SUPPURATIVA AND FOURNIER^S GANGRENE. European Journal of Case Reports in Internal Medicine. 2024;11:1 to 6$42$YR$$F$Y$$$20240719$$HP$US$US
241229531$24122953$1$I$$20240708$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-034835$AUROBINDO$Torrado C, Baysal MA, Chakraborty A, Norris BL, Khawaja F, Tsimberidou AM. Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy. Front-Immunol. 2024;15:1366271$$$A$M$Y$$$20240719$$HP$US$US
241229541$24122954$1$I$$20200604$20240723$20240723$EXP$$TH-AstraZeneca-2020SE73027$ASTRAZENECA$$65$YR$$F$Y$$$20240723$$MD$TH$
241229551$24122955$1$I$20200101$20201229$20240723$20240723$EXP$$US-AstraZeneca-2020SF12905$ASTRAZENECA$$50$YR$$F$Y$$$20240723$$CN$US$
241229562$24122956$2$F$$20240722$20240723$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-034354$AUROBINDO$$93$YR$$M$Y$$$20240801$$MD$GB$GB
241229572$24122957$2$F$$20240826$20240723$20240905$PER$$US-AstraZeneca-2024A165485$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
241229581$24122958$1$I$$20220419$20240723$20240723$EXP$$US-AstraZeneca-2022A156913$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241229591$24122959$1$I$$20240716$20240723$20240723$PER$$US-ABBVIE-5843647$ABBVIE$$$$$$Y$$$20240723$$HP$US$US
241229603$24122960$3$F$20230327$20240826$20240723$20240901$EXP$$FR-AUROBINDO-AUR-APL-2024-035609$AUROBINDO$$39$YR$$F$Y$110$KG$20240901$$MD$FR$FR
241229611$24122961$1$I$20240508$20240716$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-035607$AUROBINDO$$58$YR$$M$Y$$$20240719$$MD$FR$FR
241229621$24122962$1$I$$20240716$20240723$20240723$EXP$$ES-AUROBINDO-AUR-APL-2024-035619$AUROBINDO$Lopez E, Villarino M, Luna E, Gimenez E, Franco C, De Quintana A.. Alpha coma without bad prognosis: regarding a case.. XLVII Annual Meeting of the Society of Clinical Neurophysiology of the Communiti$39$YR$$M$Y$$$20240719$$HP$ES$ES
241229632$24122963$2$F$$20240808$20240723$20240814$EXP$$PT-AUROBINDO-AUR-APL-2024-035614$AUROBINDO$Pic?o de Carvalho C, Carmo F, Martins R, Matos E, Torres E, Rebelo M. Pic?o de Carvalho C, Carmo F, Martins R, Matos E, Torres E, Rebelo M.. When vitamin supplementation would make all the difference. Birth and Growth Medical Journal. 2024;33(2):127-132$6$MON$$F$Y$$$20240814$$MD$PT$PT
241229643$24122964$3$F$$20240725$20240723$20240812$PER$$US-AstraZeneca-2024A158257$ASTRAZENECA$$$$$F$Y$$$20240812$$MD$US$
241229652$24122965$2$F$$20240809$20240723$20240830$30DAY$$DE-JNJFOC-20240720619$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$DE$DE
241229661$24122966$1$I$$20221122$20240723$20240723$EXP$$TW-AstraZeneca-2022A385702$ASTRAZENECA$$58$YR$$F$Y$$$20240723$$CN$TW$
241229671$24122967$1$I$20240718$20240718$20240723$20240723$EXP$$US-JNJFOC-20240757123$JOHNSON AND JOHNSON$$79$YR$$M$Y$$$20240723$$CN$US$US
241229681$24122968$1$I$$20230215$20240723$20240723$EXP$$US-AstraZeneca-2023A040998$ASTRAZENECA$$$$$M$Y$60.8$KG$20240723$$CN$US$
241229691$24122969$1$I$$20221223$20240723$20240723$EXP$$US-AstraZeneca-2022A416536$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241229701$24122970$1$I$20240507$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034685$AUROBINDO$$67$YR$$M$Y$86$KG$20240719$$PH$FR$FR
241229712$24122971$2$F$$20240724$20240723$20240727$PER$$US-ABBVIE-5847088$ABBVIE$$$$A$F$Y$$$20240727$$CN$US$US
241229722$24122972$2$F$20240703$20240926$20240723$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114580$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$66.68$KG$20240930$$CN$US$US
241229731$24122973$1$I$$20240722$20240723$20240723$EXP$NL-LRB-00993082$NVSC2024NL149985$NOVARTIS$$71$YR$$F$Y$75$KG$20240723$$HP$NL$NL
241229741$24122974$1$I$$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034847$AUROBINDO$Chappuy M, Merah I, Ragonnet D, Ternay J-D and Rolland B. The Lyon resource center for drug addictions (CERLAM). Courrier des addictions. 2024;XXVI (2):24-27$47$YR$$M$Y$$$20240719$$MD$FR$FR
241229751$24122975$1$I$$20240711$20240723$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-035254$AUROBINDO$$89$YR$$F$Y$89$KG$20240719$$MD$NL$NL
241229761$24122976$1$I$20240411$20240709$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034361$AUROBINDO$$96$YR$$M$Y$$$20240719$$PH$FR$FR
241229772$24122977$2$F$20180814$20230731$20240723$20240912$EXP$$JP-GSK-JP2018JPN154567$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$JP$JP
241229781$24122978$1$I$20240701$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034603$AUROBINDO$$51$YR$$F$Y$$$20240719$$MD$FR$FR
241229791$24122979$1$I$$20240710$20240723$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-034676$AUROBINDO$$89$YR$$M$Y$75$KG$20240719$$MD$NL$NL
241229801$24122980$1$I$20240604$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034751$AUROBINDO$$81$YR$$M$Y$57$KG$20240719$$PH$FR$FR
241229811$24122981$1$I$$20240708$20240723$20240723$EXP$$CZ-AUROBINDO-AUR-APL-2024-035132$AUROBINDO$Kvapil M.. Glycohaemoglobin  reduction from 88 to 45 by  changing the diagnosis as  confirmation of the Sapir-Whorf  hypothesis (Glykovan? hemoglobin z 88 na 45 zm?nou diagn?zy coby potvrzen? Sapirovy?Whorfovy hypot?zy). KAZUISTIKY V DIABETOLOGII. 2024;22(2):12-15$$$E$M$Y$82$KG$20240719$$HP$CZ$CZ
241229821$24122982$1$I$$20240711$20240723$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-035331$AUROBINDO$$65$YR$$F$Y$$$20240719$$MD$NL$NL
241229832$24122983$2$F$$20240902$20240723$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-034982$AUROBINDO$Gullapalli D, Raza A, Khan A, Ganti SS, Pervaiz A.. Battling the breath-stealers: Blastomyces and Pseudomonas triggering acute respiratory distress syndrome (ARDS). Med-Mycol-Case-Reports. 2024$46$YR$$M$Y$$$20240912$$HP$US$US
241229841$24122984$1$I$20240313$20240711$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-035467$AUROBINDO$$64$YR$$M$Y$$$20240719$$PH$FR$FR
241229851$24122985$1$I$$20240711$20240723$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-035250$AUROBINDO$$20$YR$$F$Y$63$KG$20240719$$CN$NL$NL
241229861$24122986$1$I$20130301$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034791$AUROBINDO$Reynaud Q, Dupont D, Nove-Josserand R, Durupt S, Persat F, Ader F et al.. Rare and unusual presentation of Cladophialophora infection in a pulmonary transplant cystic fibrosis patient.. Transplant Infectious Disease.. 2017;19(6):Article Number e12789.$35$YR$$F$Y$$$20240719$$MD$FR$FR
241229871$24122987$1$I$20240601$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034704$AUROBINDO$$44$YR$$F$Y$$$20240719$$PH$FR$FR
241229881$24122988$1$I$20240629$20240711$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-035424$AUROBINDO$$42$YR$$M$Y$$$20240719$$PH$FR$FR
241229891$24122989$1$I$20231001$20240710$20240723$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-034598$AUROBINDO$$75$YR$$M$Y$90$KG$20240719$$CN$GB$GB
241229901$24122990$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115199$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240719$$CN$US$US
241229911$24122991$1$I$20230828$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034650$AUROBINDO$$37$YR$$M$Y$$$20240719$$MD$FR$FR
241229922$24122992$2$F$$20240730$20240723$20240812$EXP$$CZ-AUROBINDO-AUR-APL-2024-033697$AUROBINDO$Gregov?  M.. Bimekizumab napric spektrem axialnich spondylarthritid (Bimekizumab across the axial spondyloarthritis spectrum).. Farmakoterapeutick? revue. 2024;9(3):245-250$27$YR$$M$Y$$$20240812$$MD$CZ$CZ
241229931$24122993$1$I$20220505$20240710$20240723$20240723$EXP$$IT-AUROBINDO-AUR-APL-2024-034726$AUROBINDO$$60$YR$$M$Y$$$20240719$$MD$IT$IT
241229941$24122994$1$I$20240619$20240710$20240723$20240723$EXP$$PT-AUROBINDO-AUR-APL-2024-034417$AUROBINDO$$69$YR$$M$Y$$$20240719$$PH$PT$PT
241229951$24122995$1$I$$20240709$20240723$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-034376$AUROBINDO$$18$YR$$M$Y$$$20240719$$CN$GB$GB
241229961$24122996$1$I$20200101$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034703$AUROBINDO$$21$YR$$M$Y$$$20240719$$MD$FR$FR
241229971$24122997$1$I$20221201$20240710$20240723$20240723$EXP$$ES-AUROBINDO-AUR-APL-2024-034570$AUROBINDO$D?az-Alberola I, Espuch-Oliver A, Fern?ndez-Segovia F, L?pez-Nevot M?. Possible Role of Cytomegalovirus in Gastric Cancer Development and Recurrent Macrolide-Resistant Campylobacter jejuni Infection in Common Variable Immunodeficiency: A Case Report and Literature Discussion. Microorganisms. 2024;12(6):1078$46$YR$$M$Y$$$20240719$$HP$ES$ES
241229981$24122998$1$I$$20240710$20240723$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-034748$AUROBINDO$$55$YR$$M$Y$108$KG$20240719$$CN$NL$NL
241229991$24122999$1$I$20230618$20240709$20240723$20240723$EXP$$DE-AUROBINDO-AUR-APL-2024-034463$AUROBINDO$$57$YR$$M$Y$85$KG$20240719$$CN$DE$DE
241230001$24123000$1$I$$20240709$20240723$20240723$EXP$$IT-AUROBINDO-AUR-APL-2016-13684$AUROBINDO$Esposito S, Pinzani R, Raffaeli G, Lucchi T, Agostoni C, Principi N.. A young infant with transient severe hypertriglyceridemia temporarily associated with meropenem administration: A case report and review of the literature.. Medicine (United States). 2016;95(38):Article Number e4872$75$DY$$F$Y$$$20240719$$MD$IT$IT
241230011$24123001$1$I$$20240709$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-035267$AUROBINDO$Rehman A, Olayiwola A, Vu CA, Bhatt P, Joseph J-A, Ayoade F.. Nocardia brasiliensis Pyomyositis in an Immunocompetent Patient Following Gardening Activity.. J-Investig-Med-High-Impact-Case-Rep. 2024;12:1?4$48$YR$$M$Y$$$20240719$$MD$US$US
241230021$24123002$1$I$20240421$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034857$AUROBINDO$$35$YR$$M$Y$$$20240719$$MD$FR$FR
241230031$24123003$1$I$$20240716$20240723$20240723$PER$$US-ROCHE-10000029325$ROCHE$$$$E$M$Y$$$20240723$$CN$US$US
241230041$24123004$1$I$$20240709$20240723$20240723$EXP$$IT-AUROBINDO-AUR-APL-2024-034906$AUROBINDO$Morena A, Gravinese C, Frea S, Angelini F, Boretto P, Gallone G, et al. PERCUTANEOUS LEFT STELLATE GANGLION BLOCK TO INCREASE VENTRICULAR FIBRILLATION THRESHOLD AND DEFIBRILLATION SUCCESS RATE IN ACUTE FULMINANT MYOCARDITIS WITH ELECTRICAL STORM.. Eur-Heart-J-Suppl. 2024;26 (Suppl.):ii4$57$YR$$M$Y$$$20240719$$HP$IT$IT
241230051$24123005$1$I$$20240709$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-034892$AUROBINDO$Bengio M, Goodwin G, Roka A, Marin M. Pediatric headache patient with cerebral abscesses: a brief review of the literature and case report. J-Int-Med-Res. 2023;51(11):1?11$12$YR$$M$Y$$$20240719$$HP$US$US
241230061$24123006$1$I$20240313$20240709$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034680$AUROBINDO$$72$YR$$M$Y$55$KG$20240719$$MD$FR$FR
241230071$24123007$1$I$$20240709$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-035284$AUROBINDO$Chajkowski A, Rodriguez CA. Antibacterials/micafungin/norepinephrine: Lack of efficacy: case report. Am-J-Respir-Crit-Care-Med. 2024;209:A1660$71$YR$$M$Y$$$20240719$$HP$US$US
241230081$24123008$1$I$$20240711$20240723$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-035380$AUROBINDO$$39$YR$$F$Y$74$KG$20240719$$CN$NL$NL
241230091$24123009$1$I$$20240711$20240723$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-035008$AUROBINDO$$48$YR$$F$Y$$$20240719$$MD$NL$NL
241230101$24123010$1$I$$20240711$20240723$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-035394$AUROBINDO$$21$YR$$F$Y$70$KG$20240719$$CN$NL$NL
241230111$24123011$1$I$20240523$20240711$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-035472$AUROBINDO$$73$YR$$F$Y$$$20240719$$PH$FR$FR
241230121$24123012$1$I$20200503$20240711$20240723$20240723$EXP$$PL-AUROBINDO-AUR-APL-2024-035537$AUROBINDO$$39$YR$$M$Y$75$KG$20240719$$MD$PL$PL
241230131$24123013$1$I$$20240709$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-035500$AUROBINDO$Devine MN, Gordon SE, Press CA. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. J-PediatrPharmacol-Ther. 2023;28(2):161-166$52$DY$$$Y$$$20240719$$HP$US$US
241230141$24123014$1$I$$20240708$20240723$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-034550$AUROBINDO$$44$YR$$F$Y$$$20240719$$CN$GB$GB
241230151$24123015$1$I$20240614$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034690$AUROBINDO$$34$YR$$F$Y$75$KG$20240719$$PH$FR$FR
241230161$24123016$1$I$$20240710$20240723$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-034753$AUROBINDO$$56$YR$$F$Y$84$KG$20240719$$HP$NL$NL
241230171$24123017$1$I$$20240710$20240723$20240723$EXP$$PL-AUROBINDO-AUR-APL-2024-034700$AUROBINDO$$$$$M$Y$$$20240719$$CN$PL$PL
241230181$24123018$1$I$$20240711$20240723$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-035388$AUROBINDO$$52$YR$$M$Y$84$KG$20240719$$MD$NL$NL
241230191$24123019$1$I$20230826$20240709$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034402$AUROBINDO$$91$YR$$F$Y$$$20240719$$PH$FR$FR
241230201$24123020$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114158$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240719$$HP$US$US
241230211$24123021$1$I$$20240711$20240723$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-034985$AUROBINDO$$56$YR$$F$Y$98$KG$20240719$$MD$NL$NL
241230221$24123022$1$I$$20240711$20240723$20240723$EXP$$NL-AUROBINDO-AUR-APL-2024-035115$AUROBINDO$$37$YR$$F$Y$95$KG$20240719$$CN$NL$NL
241230231$24123023$1$I$20240209$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034702$AUROBINDO$$13$YR$$F$Y$57$KG$20240719$$PH$FR$FR
241230241$24123024$1$I$$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034792$AUROBINDO$Garaix F, Hery G, Tsimaratos M, Colson P, Tamalet C.. Human papillomavirus type 7-associated anal condyloma after renal transplantation in a child.. Pediatric Transplantation. e13470$11$YR$$M$Y$$$20240719$$MD$FR$FR
241230251$24123025$1$I$20240604$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034640$AUROBINDO$$76$YR$$M$Y$76$KG$20240719$$MD$FR$FR
241230261$24123026$1$I$$20240709$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-035081$AUROBINDO$Van Arnam J, Blessing M, Mohila C.. Diffuse Spinal Cord Necrosis and Peripheral Neuropathy Due To Neuroleukemiosis in the Setting of Menin Inhibitor Treatment. J-Neuropathol-Exp-Neurol. 2024;83(6):527 abstr. 174$15$YR$$M$Y$$$20240719$$HP$US$US
241230271$24123027$1$I$$20240710$20240723$20240723$EXP$$PT-AUROBINDO-AUR-APL-2024-034830$AUROBINDO$$48$YR$$F$Y$$$20240719$$MD$PT$PT
241230281$24123028$1$I$20240515$20240709$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034240$AUROBINDO$$65$YR$$F$Y$121$KG$20240719$$MD$FR$FR
241230292$24123029$2$F$$20240726$20240723$20240807$EXP$$US-AUROBINDO-AUR-APL-2024-034805$AUROBINDO$Memon R, Mehreen R, Mack MA, Okoyeze K, Shaikh A, Shan Ul Abedin M, et al. Biopsy of Thoracic Lymph Node Diagnosing Mystery of Distributive Shock Caused by Idiopathic Multicenteric Castleman Disease With TAFRO Syndrome.. Am-J-Respir-Crit-Care-Med. 2023;207:A5893$36$YR$$M$Y$$$20240807$$HP$US$US
241230301$24123030$1$I$20240619$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034631$AUROBINDO$$60$YR$$F$Y$71$KG$20240719$$PH$FR$FR
241230312$24123031$2$F$20240701$20240715$20240723$20240724$EXP$$IT-AUROBINDO-AUR-APL-2024-034293$AUROBINDO$$71$YR$$M$Y$$$20240724$$PH$IT$IT
241230321$24123032$1$I$20230401$20240710$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034699$AUROBINDO$$45$YR$$F$Y$$$20240719$$MD$FR$FR
241230331$24123033$1$I$20240627$20240709$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034247$AUROBINDO$$86$YR$$M$Y$87.6$KG$20240719$$MD$FR$FR
241230342$24123034$2$F$$20240708$20240723$20240806$EXP$$US-AUROBINDO-AUR-APL-2024-035813$AUROBINDO$Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donorspecific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant. 2011;11 (3):500-510$41$YR$$F$Y$$$20240806$$HP$US$US
241230351$24123035$1$I$$20240708$20240723$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-034673$AUROBINDO$Mittal A, Navaratnarajah M , Harden S, Velissaris T , and Roberts PR. Staged hybrid ablation in left atrial appendage aneurysm a rare cause of refractory atrial tachyarrhythmia-a case report.. European Heart Journal - Case Reports. 2024;8:ytae298$28$YR$$M$Y$$$20240719$$HP$GB$GB
241230361$24123036$1$I$$20240708$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-034621$AUROBINDO$Hammond TC, Emeruwa I, Swain SR, Larson SM, Castells MC. Life-threatening Mast Cell Activation and Anaphylaxis in Mast Cell Leukemia and the Role of Omalizumab. Am-J-Respir-CritCare-Med. 2024;209:A5294$31$YR$$M$Y$$$20240719$$HP$US$US
241230371$24123037$1$I$20180703$20240710$20240723$20240723$EXP$$IT-AUROBINDO-AUR-APL-2024-031895$AUROBINDO$$65$YR$$$Y$$$20240719$$MD$IT$IT
241230381$24123038$1$I$20240512$20240709$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034375$AUROBINDO$$50$YR$$M$Y$89$KG$20240719$$MD$FR$FR
241230391$24123039$1$I$20240703$20240709$20240723$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-034476$AUROBINDO$$61$YR$$F$Y$71$KG$20240719$$PH$GB$GB
241230402$24123040$2$F$$20240715$20240723$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-034859$AUROBINDO$$$$$F$Y$$$20240724$$CN$FR$FR
241230411$24123041$1$I$$20240709$20240723$20240723$EXP$$CN-AUROBINDO-AUR-APL-2024-034921$AUROBINDO$Fu J, Chen L, Su T, Xu S, Liu Y. phosphoglycerate dehydrogenase deficiency by a novel mutation. Int-J-Dev-Neurosci. 2023;83(1):44-52$14$YR$$M$Y$$$20240719$$HP$CN$CN
241230421$24123042$1$I$$20240709$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-034536$AUROBINDO$Chappuy M, Merah I, Ragonnet D, DeTernay J, Rolland B.. Lyon resource center for prescription drug use disorder  (CERLAM).. Courrier des addictions.. 2024;XXVI (2):24-27$33$YR$$F$Y$$$20240719$$MD$FR$FR
241230431$24123043$1$I$$20240710$20240723$20240723$EXP$$PL-AUROBINDO-AUR-APL-2024-034819$AUROBINDO$$42$YR$$M$Y$150$KG$20240719$$MD$PL$PL
241230442$24123044$2$F$20240702$20240731$20240723$20240811$EXP$$GB-AUROBINDO-AUR-APL-2024-034350$AUROBINDO$$10$YR$$M$Y$28$KG$20240812$$HP$GB$GB
241230451$24123045$1$I$$20240625$20240723$20240723$PER$$US-OTSUKA-2024_012297$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241230462$24123046$2$F$20240617$20240627$20240723$20240905$EXP$$US-OTSUKA-2024_017459$OTSUKA$$46$YR$$F$Y$113.38$KG$20240905$$HP$US$US
241230471$24123047$1$I$$20240708$20240723$20240723$PER$$US-OTSUKA-2024_019402$OTSUKA$$43$YR$$F$Y$$$20240723$$HP$US$US
241230481$24123048$1$I$$20240708$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-035546$AUROBINDO$Shriya Sharma, Smruti Desai, Juan Leoni, Smit Paghdar, Jose Ruiz and Rohan Goswami. Case report: eosinophilic myocarditis in hypereosinophilic syndrome: a journey to heart transplantation. Front-Immuno. 2024;15:1418665$51$YR$$F$Y$$$20240719$$MD$US$US
241230491$24123049$1$I$20230401$20240618$20240723$20240723$PER$$US-OTSUKA-2024_017652$OTSUKA$$32$YR$$F$Y$$$20240723$$HP$US$US
241230501$24123050$1$I$$20240708$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2023-031217$AUROBINDO$Pien I, Mudgal CS.. Osteonecrosis of Trapezium Occurring in Patient with History of Recurrent Carpometacarpal Corticosteroid Injection.. Journal of Hand Surgery (Asian-Pacific Volume). 2023;28(1):129-33$$$$F$Y$$$20240719$$MD$US$US
241230511$24123051$1$I$20240401$20240619$20240723$20240723$PER$$US-OTSUKA-2024_017586$OTSUKA$$18$YR$$M$Y$$$20240723$$PH$US$US
241230522$24123052$2$F$20180101$20240716$20240723$20240808$PER$$US-OTSUKA-2024_013963$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241230531$24123053$1$I$$20240703$20240723$20240723$EXP$$US-OTSUKA-2024_018941$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241230541$24123054$1$I$$20240709$20240723$20240723$PER$$US-OTSUKA-2024_019473$OTSUKA$$74$YR$$F$Y$$$20240723$$MD$US$US
241230551$24123055$1$I$$20240701$20240723$20240723$PER$$US-OTSUKA-2024_013365$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241230561$24123056$1$I$$20240715$20240723$20240723$PER$$US-OTSUKA-2024_017177$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241230571$24123057$1$I$$20240709$20240723$20240723$PER$$US-OTSUKA-2024_019374$OTSUKA$$72$YR$$M$Y$$$20240723$$HP$US$US
241230581$24123058$1$I$20240101$20240702$20240723$20240723$EXP$$US-OTSUKA-2024_018874$OTSUKA$$$$$F$Y$$$20240723$$PH$US$US
241230591$24123059$1$I$20240301$20240621$20240723$20240723$PER$$US-OTSUKA-2024_017787$OTSUKA$$24$YR$$F$Y$99.79$KG$20240723$$CN$US$US
241230601$24123060$1$I$$20240620$20240723$20240723$PER$$US-OTSUKA-2024_017709$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241230611$24123061$1$I$20230414$20240619$20240723$20240723$PER$$US-OTSUKA-2024_016577$OTSUKA$$4$DEC$$F$Y$$$20240723$$HP$US$US
241230621$24123062$1$I$20240613$20240618$20240723$20240723$PER$$US-OTSUKA-2024_017449$OTSUKA$$81$YR$$F$Y$63.96$KG$20240723$$CN$US$US
241230631$24123063$1$I$$20240708$20240723$20240723$PER$$US-OTSUKA-2024_019315$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241230641$24123064$1$I$$20240625$20240723$20240723$PER$$US-OTSUKA-2024_012249$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241230651$24123065$1$I$$20240627$20240723$20240723$PER$$US-OTSUKA-2024_018417$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241230661$24123066$1$I$$20240123$20240723$20240723$PER$$US-OTSUKA-2024_002193$OTSUKA$$17$YR$$F$Y$$$20240723$$HP$US$US
241230671$24123067$1$I$20240408$20240621$20240723$20240723$PER$$US-OTSUKA-2024_015565$OTSUKA$$61$YR$$F$Y$$$20240723$$HP$US$US
241230681$24123068$1$I$$20240708$20240723$20240723$PER$$US-OTSUKA-2024_019311$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241230691$24123069$1$I$20240101$20240702$20240723$20240723$PER$$US-OTSUKA-2024_018814$OTSUKA$$87$YR$$F$Y$58.97$KG$20240723$$HP$US$US
241230702$24123070$2$F$20240618$20240725$20240723$20240808$PER$$US-OTSUKA-2024_017537$OTSUKA$$60$YR$$F$Y$$$20240808$$MD$US$US
241230711$24123071$1$I$$20240426$20240723$20240723$PER$$US-OTSUKA-2024_012306$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241230721$24123072$1$I$$20240708$20240723$20240723$PER$$US-OTSUKA-2024_019425$OTSUKA$$73$YR$$M$Y$$$20240723$$HP$US$US
241230731$24123073$1$I$$20240716$20240723$20240723$PER$$NVSC2024US147554$NOVARTIS$$$$$$Y$$$20240723$$PH$US$US
241230741$24123074$1$I$$20240719$20240723$20240723$PER$$US-ROCHE-10000032420$ROCHE$$65$YR$E$F$Y$$$20240723$$CN$US$US
241230752$24123075$2$F$$20240918$20240723$20240925$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-21366$SAMSUNG BIOEPIS$$68$YR$E$M$Y$$$20240925$$CN$GB$GB
241230761$24123076$1$I$$20240717$20240723$20240723$PER$$US-ROCHE-10000030729$ROCHE$$$$E$F$Y$$$20240723$$CN$US$US
241230771$24123077$1$I$20240713$20240716$20240723$20240723$EXP$$CN-BEIGENE-BGN-2024-011080$BEIGENE$$$$$$Y$$$20240723$$HP$CN$CN
241230781$24123078$1$I$$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113898$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240719$$CN$US$US
241230791$24123079$1$I$20240516$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114395$BRISTOL MYERS SQUIBB$$80$YR$E$$Y$$$20240719$$MD$US$US
241230801$24123080$1$I$20231120$20240710$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110510$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240719$$PH$US$US
241230811$24123081$1$I$$20240712$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113051$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240719$$HP$US$US
241230821$24123082$1$I$20240101$20240716$20240723$20240723$30DAY$$US-GSK-US2024089553$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240723$$CN$US$US
241230831$24123083$1$I$20240711$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114326$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$114.12$KG$20240719$$CN$US$US
241230841$24123084$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024143151$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241230861$24123086$1$I$20240601$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114221$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240719$$HP$US$US
241230871$24123087$1$I$$20240716$20240723$20240723$PER$$US-ABBVIE-5847072$ABBVIE$$$$$$Y$$$20240723$$CN$US$US
241230881$24123088$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115385$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240719$$CN$US$US
241230891$24123089$1$I$$20240717$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115116$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$$$20240719$$CN$US$US
241230901$24123090$1$I$$20240716$20240723$20240723$PER$US-MLMSERVICE-20240709-PI127981-00128-1$US-RDY-SPO/USA/24/0010580$DR REDDYS$Estrada Paz OA, Young TJ. Paraneoplastic pemphigus with airway involvement. Respiratory Medicine Case Reports. 2024:51. DOI: 10.1016/j.rmcr.2024.102085.$55$YR$A$F$Y$$$20240723$$MD$US$US
241230911$24123091$1$I$$20240716$20240723$20240723$EXP$US-MLMSERVICE-20240709-PI127491-00311-1$US-RDY-SPO/USA/24/0010582$DR REDDYS$Shah D. Diagnostic Challenges of Psoriasis: A Multifaceted Case of Triple-Drug Interaction and Literature Review. Consultant. 2024;64(6):e3. Doi: 10.25270/con.2024.06.000002.$37$YR$A$F$Y$$$20240723$$MD$US$US
241230921$24123092$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115120$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$83.01$KG$20240719$$CN$US$US
241230931$24123093$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211482$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240723$$HP$US$US
241230941$24123094$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212520$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240723$$CN$US$US
241230951$24123095$1$I$$20240718$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115108$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240719$$CN$CA$CA
241230963$24123096$3$F$20240514$20240919$20240723$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR090948$VIIV$$42$YR$$M$Y$$$20240929$$PH$US$US
241230971$24123097$1$I$20240514$20240611$20240723$20240723$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091171$VIIV$$30$YR$$M$Y$$$20240723$$PH$US$US
241230981$24123098$1$I$20240514$20240611$20240723$20240723$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091170$VIIV$$43$YR$$F$Y$$$20240723$$PH$US$US
241230992$24123099$2$F$20240501$20240812$20240723$20240819$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090432$VIIV$$57$YR$$M$Y$63$KG$20240819$$PH$US$US
241231001$24123100$1$I$20240514$20240611$20240723$20240723$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091033$VIIV$$55$YR$$M$Y$$$20240723$$PH$US$US
241231011$24123101$1$I$20240514$20240611$20240723$20240723$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091035$VIIV$$39$YR$$M$Y$$$20240723$$PH$US$US
241231023$24123102$3$F$20240501$20240919$20240723$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR090434$VIIV$$27$YR$$M$Y$$$20240926$$PH$US$US
241231031$24123103$1$I$20240514$20240611$20240723$20240723$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091037$VIIV$$68$YR$$M$Y$$$20240723$$PH$US$US
241231041$24123104$1$I$20240514$20240611$20240723$20240723$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090994$VIIV$$50$YR$$F$Y$$$20240723$$PH$US$US
241231051$24123105$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115067$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240719$$CN$US$US
241231061$24123106$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114227$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240719$$HP$US$US
241231071$24123107$1$I$20240708$20240712$20240723$20240723$PER$$US-ROCHE-10000026212$ROCHE$$74$YR$E$F$Y$$$20240723$$CN$US$US
241231082$24123108$2$F$20240516$20240913$20240723$20240923$PER$$US-ROCHE-10000024559$ROCHE$$$$E$M$Y$$$20240923$$MD$US$US
241231091$24123109$1$I$$20240711$20240723$20240723$PER$$US-ROCHE-10000024463$ROCHE$$$$$F$Y$$$20240723$$CN$US$US
241231101$24123110$1$I$$20240712$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111950$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$78.3$KG$20240723$$CN$US$US
241231111$24123111$1$I$20211002$20211005$20240723$20240723$EXP$$US-AstraZeneca-2021A761745$ASTRAZENECA$$92$YR$$M$Y$$$20240723$$CN$US$
241231121$24123112$1$I$$20240719$20240723$20240723$PER$$US-AstraZeneca-2024A165930$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241231131$24123113$1$I$$20240712$20240723$20240723$EXP$$CA-APOTEX-2024AP008338$APOTEX$$7$YR$$M$Y$18$KG$20240723$$HP$CA$CA
241231141$24123114$1$I$$20230413$20240723$20240723$EXP$$US-AstraZeneca-2023A087805$ASTRAZENECA$$$$$F$Y$$$20240723$$MD$US$
241231151$24123115$1$I$$20231031$20240723$20240723$EXP$$US-AstraZeneca-2023A248004$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241231161$24123116$1$I$$20200916$20240723$20240723$EXP$$US-AstraZeneca-2020SF20278$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241231172$24123117$2$F$20240718$20240904$20240723$20240909$PER$$US-AstraZeneca-2024A164545$ASTRAZENECA$$74$YR$$F$Y$$$20240909$$CN$US$
241231181$24123118$1$I$$20220124$20240723$20240723$EXP$$US-AstraZeneca-2022A043123$ASTRAZENECA$$$$$$Y$77.1$KG$20240723$$CN$US$
241231191$24123119$1$I$$20220407$20240723$20240723$EXP$$AU-AstraZeneca-2022A147262$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$AU$
241231201$24123120$1$I$$20240719$20240723$20240723$EXP$$NVSC2024US149881$NOVARTIS$$$$$M$Y$$$20240723$$CN$US$US
241231211$24123121$1$I$$20240714$20240723$20240723$EXP$GB-MHRA-MED-202407141650513870-WRJLM$GB-TEVA-VS-3221467$TEVA$$$$$M$Y$$$20240723$$CN$GB$GB
241231221$24123122$1$I$20240507$20240716$20240723$20240723$EXP$FR-AFSSAPS-AN2024000913$FR-EMD Serono-2024038739$EMD SERONO INC$$68$YR$E$M$Y$106$KG$20240723$$PH$FR$FR
241231231$24123123$1$I$20230101$20240708$20240723$20240723$EXP$$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109714$ZYDUS PHARM$$$$$$Y$$$20240723$$CN$ES$ES
241231241$24123124$1$I$20220801$20240709$20240723$20240723$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092300$GLENMARK$Morgans CW, Mosavi-Hecht R, Yang P, Heyer B, Rosenberg CR, White E, et al. Case Report: Longitudinal Evaluation and Treatment of a Melanoma-Associated Retinopathy Patient. Research square. 2024;rs.3.:rs-4595829$$$$$Y$$$20240723$$HP$US$US
241231251$24123125$1$I$$20240716$20240723$20240723$EXP$$GB-AMGEN-GBRSP2024142703$AMGEN$$$$$M$Y$$$20240723$$HP$GB$GB
241231261$24123126$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143682$AMGEN$$$$A$F$Y$$$20240723$$CN$US$US
241231271$24123127$1$I$$20230711$20240723$20240723$EXP$$US-OTSUKA-2023_018724$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241231281$24123128$1$I$$20230712$20240723$20240723$PER$$US-OTSUKA-2023_018989$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241231291$24123129$1$I$$20230719$20240723$20240723$PER$$US-OTSUKA-2023_019437$OTSUKA$$54$YR$$M$Y$$$20240723$$PH$US$US
241231301$24123130$1$I$$20230711$20240723$20240723$PER$$US-OTSUKA-2023_018723$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241231311$24123131$1$I$$20230725$20240723$20240723$EXP$$US-OTSUKA-2023_019944$OTSUKA$$65$YR$$F$Y$$$20240723$$MD$US$US
241231321$24123132$1$I$$20230807$20240723$20240723$PER$$US-OTSUKA-2023_021278$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241231331$24123133$1$I$20220601$20230807$20240723$20240723$PER$$US-OTSUKA-2023_021127$OTSUKA$$26$YR$$F$Y$$$20240723$$CN$US$US
241231341$24123134$1$I$$20230801$20240723$20240723$PER$$US-OTSUKA-2023_020546$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241231351$24123135$1$I$$20230802$20240723$20240723$PER$$US-OTSUKA-2023_020702$OTSUKA$$97$YR$$F$Y$$$20240723$$MD$US$US
241231361$24123136$1$I$$20230725$20240723$20240723$EXP$$US-OTSUKA-2023_019948$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241231371$24123137$1$I$20230301$20230717$20240723$20240723$PER$$US-OTSUKA-2023_019217$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241231382$24123138$2$F$$20230724$20240723$20240808$PER$$US-OTSUKA-2023_019859$OTSUKA$$7$DEC$$M$Y$$$20240808$$MD$US$US
241231391$24123139$1$I$$20230801$20240723$20240723$PER$$US-OTSUKA-2023_020608$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241231401$24123140$1$I$$20230724$20240723$20240723$PER$$US-OTSUKA-2023_019871$OTSUKA$$$$$F$Y$$$20240723$$PH$US$US
241231411$24123141$1$I$$20230727$20240723$20240723$PER$$US-OTSUKA-2023_020179$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241231421$24123142$1$I$$20230710$20240723$20240723$PER$$US-OTSUKA-2023_018562$OTSUKA$$$$$M$Y$70.31$KG$20240723$$CN$US$US
241231431$24123143$1$I$$20230802$20240723$20240723$PER$$US-OTSUKA-2023_020747$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241231441$24123144$1$I$$20230803$20240723$20240723$PER$$US-OTSUKA-2023_021002$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241231451$24123145$1$I$$20230727$20240723$20240723$PER$$US-OTSUKA-2023_020124$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
241231461$24123146$1$I$$20230728$20240723$20240723$PER$$US-OTSUKA-2023_020318$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241231471$24123147$1$I$$20230714$20240723$20240723$EXP$$US-OTSUKA-2023_019118$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241231481$24123148$1$I$$20230712$20240723$20240723$PER$$US-OTSUKA-2023_018804$OTSUKA$$$$$M$Y$72.57$KG$20240723$$CN$US$US
241231491$24123149$1$I$20230601$20230717$20240723$20240723$PER$$US-OTSUKA-2023_019246$OTSUKA$$$$$F$Y$48.53$KG$20240723$$HP$US$US
241231501$24123150$1$I$$20230804$20240723$20240723$PER$$US-OTSUKA-2023_021036$OTSUKA$$4$DEC$$F$Y$$$20240723$$MD$US$US
241231511$24123151$1$I$$20230804$20240723$20240723$PER$$US-OTSUKA-2023_021074$OTSUKA$$11$YR$$$Y$$$20240723$$MD$US$US
241231521$24123152$1$I$$20230726$20240723$20240723$PER$$US-OTSUKA-2023_020040$OTSUKA$$26$YR$$F$Y$$$20240723$$MD$US$US
241231531$24123153$1$I$$20230802$20240723$20240723$PER$$US-OTSUKA-2023_020689$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241231541$24123154$1$I$$20230714$20240723$20240723$PER$$US-OTSUKA-2023_019120$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241231551$24123155$1$I$$20230808$20240723$20240723$PER$$US-OTSUKA-2023_021286$OTSUKA$$50$YR$$M$Y$$$20240723$$HP$US$US
241231562$24123156$2$F$$20230728$20240723$20240808$PER$$US-OTSUKA-2023_020317$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241231571$24123157$1$I$$20230807$20240723$20240723$PER$$US-OTSUKA-2023_021146$OTSUKA$$5$DEC$$F$Y$$$20240723$$HP$US$US
241231581$24123158$1$I$20221101$20230801$20240723$20240723$PER$$US-OTSUKA-2023_020598$OTSUKA$$69$YR$$F$Y$$$20240723$$CN$US$US
241231591$24123159$1$I$20230701$20230801$20240723$20240723$PER$$US-OTSUKA-2023_020582$OTSUKA$$64$YR$$M$Y$$$20240723$$CN$US$US
241231601$24123160$1$I$$20230711$20240723$20240723$EXP$$US-OTSUKA-2023_018730$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241231611$24123161$1$I$$20230802$20240723$20240723$PER$$US-OTSUKA-2023_020768$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241231621$24123162$1$I$20230804$20230804$20240723$20240723$PER$$US-OTSUKA-2023_021014$OTSUKA$$34$YR$$F$Y$86.18$KG$20240723$$CN$US$US
241231631$24123163$1$I$20230101$20230728$20240723$20240723$PER$$US-OTSUKA-2023_020320$OTSUKA$$4$DEC$$F$Y$$$20240723$$HP$US$US
241231641$24123164$1$I$$20230712$20240723$20240723$PER$$US-OTSUKA-2023_019008$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241231651$24123165$1$I$$20230726$20240723$20240723$PER$$US-OTSUKA-2023_020069$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241231661$24123166$1$I$$20230714$20240723$20240723$PER$$US-OTSUKA-2023_019258$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
241231671$24123167$1$I$$20230807$20240723$20240723$PER$$US-OTSUKA-2023_021175$OTSUKA$$3$DEC$$F$Y$$$20240723$$HP$US$US
241231681$24123168$1$I$$20230727$20240723$20240723$PER$$US-OTSUKA-2023_020173$OTSUKA$$88$YR$$$Y$$$20240723$$HP$US$US
241231691$24123169$1$I$$20230726$20240723$20240723$PER$$US-OTSUKA-2023_020092$OTSUKA$$$$E$F$Y$$$20240723$$MD$US$US
241231701$24123170$1$I$$20230714$20240723$20240723$PER$$US-OTSUKA-2023_019117$OTSUKA$$91$YR$$M$Y$$$20240723$$MD$US$US
241231711$24123171$1$I$20230501$20230727$20240723$20240723$PER$$US-OTSUKA-2023_020192$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241231721$24123172$1$I$$20230719$20240723$20240723$PER$$US-OTSUKA-2023_019491$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241231731$24123173$1$I$20230721$20230721$20240723$20240723$PER$$US-OTSUKA-2023_019752$OTSUKA$$18$YR$$M$Y$$$20240723$$CN$US$US
241231741$24123174$1$I$20230101$20230726$20240723$20240723$PER$$US-OTSUKA-2023_020087$OTSUKA$$20$YR$$F$Y$$$20240723$$MD$US$US
241231751$24123175$1$I$$20230726$20240723$20240723$EXP$$US-OTSUKA-2023_020136$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241231761$24123176$1$I$$20230809$20240723$20240723$PER$$US-OTSUKA-2023_021520$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241231771$24123177$1$I$$20230731$20240723$20240723$PER$$US-OTSUKA-2023_020498$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241231782$24123178$2$F$$20230807$20240723$20240808$PER$$US-OTSUKA-2023_021176$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241231791$24123179$1$I$20230101$20230714$20240723$20240723$PER$$US-OTSUKA-2023_019116$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241231801$24123180$1$I$20240101$20240717$20240723$20240723$EXP$$CA-JNJFOC-20240530366$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240723$$CN$CA$CA
241231811$24123181$1$I$20240401$20240716$20240723$20240723$EXP$$US-SA-2024SA212071$SANOFI AVENTIS$$65$YR$E$F$Y$45.26$KG$20240723$$HP$US$US
241231821$24123182$1$I$20240405$20240716$20240723$20240723$EXP$$US-SA-2024SA212719$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240723$$MD$US$US
241231831$24123183$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115125$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240719$$CN$US$US
241231841$24123184$1$I$$20230911$20240723$20240723$PER$$US-OTSUKA-2023_022026$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241231851$24123185$1$I$20230612$20230911$20240723$20240723$PER$$US-OTSUKA-2023_018749$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241231861$24123186$1$I$$20230815$20240723$20240723$PER$$US-OTSUKA-2023_021907$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241231871$24123187$1$I$20230801$20230825$20240723$20240723$PER$$US-OTSUKA-2023_022765$OTSUKA$$73$YR$$F$Y$87.54$KG$20240723$$CN$US$US
241231881$24123188$1$I$$20230811$20240723$20240723$PER$$US-OTSUKA-2023_021621$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241231891$24123189$1$I$$20230906$20240723$20240723$PER$$US-OTSUKA-2023_023743$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241231901$24123190$1$I$$20230825$20240723$20240723$PER$$US-OTSUKA-2023_022745$OTSUKA$$5$DEC$$F$Y$$$20240723$$CN$US$US
241231911$24123191$1$I$$20230818$20240723$20240723$PER$$US-OTSUKA-2023_022157$OTSUKA$$19$YR$$M$Y$$$20240723$$HP$US$US
241231921$24123192$1$I$$20230906$20240723$20240723$PER$$US-OTSUKA-2023_023764$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241231931$24123193$1$I$$20230914$20240723$20240723$PER$$US-OTSUKA-2023_024461$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241231941$24123194$1$I$$20230908$20240723$20240723$PER$$US-OTSUKA-2023_023971$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241231951$24123195$1$I$20230101$20230822$20240723$20240723$PER$$US-OTSUKA-2023_022176$OTSUKA$$21$YR$$F$Y$$$20240723$$HP$US$US
241231961$24123196$1$I$$20230810$20240723$20240723$PER$$US-OTSUKA-2023_021545$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241231971$24123197$1$I$$20230823$20240723$20240723$PER$$US-OTSUKA-2023_022517$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241231981$24123198$1$I$$20230823$20240723$20240723$PER$$US-OTSUKA-2023_022508$OTSUKA$$80$YR$$M$Y$$$20240723$$HP$US$US
241231992$24123199$2$F$$20230915$20240723$20240808$EXP$$US-OTSUKA-2023_024557$OTSUKA$$30$YR$$M$Y$$$20240808$$HP$US$US
241232001$24123200$1$I$$20230824$20240723$20240723$PER$$US-OTSUKA-2023_022779$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232011$24123201$1$I$$20230823$20240723$20240723$PER$$US-OTSUKA-2023_022544$OTSUKA$$70$YR$$$Y$$$20240723$$HP$US$US
241232021$24123202$1$I$$20230810$20240723$20240723$PER$$US-OTSUKA-2023_021465$OTSUKA$$37$YR$$M$Y$$$20240723$$MD$US$US
241232031$24123203$1$I$$20230809$20240723$20240723$PER$$US-OTSUKA-2023_021475$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241232041$24123204$1$I$20230814$20230911$20240723$20240723$PER$$US-OTSUKA-2023_021751$OTSUKA$$79$YR$$F$Y$59.86$KG$20240723$$HP$US$US
241232051$24123205$1$I$$20230822$20240723$20240723$PER$$US-OTSUKA-2023_022421$OTSUKA$$5$DEC$$M$Y$$$20240723$$HP$US$US
241232061$24123206$1$I$$20230830$20240723$20240723$PER$$US-OTSUKA-2023_023265$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241232071$24123207$1$I$$20230919$20240723$20240723$EXP$$US-OTSUKA-2023_024768$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241232081$24123208$1$I$$20230910$20240723$20240723$PER$$US-OTSUKA-2023_018513$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241232091$24123209$1$I$$20230830$20240723$20240723$PER$$US-OTSUKA-2023_023297$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241232101$24123210$1$I$$20230823$20240723$20240723$PER$$US-OTSUKA-2023_022507$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241232111$24123211$1$I$$20230913$20240723$20240723$PER$$US-OTSUKA-2023_024316$OTSUKA$$53$YR$$M$Y$$$20240723$$HP$US$US
241232121$24123212$1$I$$20230809$20240723$20240723$PER$$US-OTSUKA-2023_021488$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241232131$24123213$1$I$$20230811$20240723$20240723$PER$$US-OTSUKA-2023_021648$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241232141$24123214$1$I$20230710$20230910$20240723$20240723$PER$$US-OTSUKA-2023_018500$OTSUKA$$67$YR$$F$Y$63.5$KG$20240723$$CN$US$US
241232151$24123215$1$I$$20230914$20240723$20240723$PER$$US-OTSUKA-2023_024418$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232161$24123216$1$I$$20230909$20240723$20240723$PER$$US-OTSUKA-2023_024043$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
241232171$24123217$1$I$$20230809$20240723$20240723$PER$$US-OTSUKA-2023_021376$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241232181$24123218$1$I$$20230919$20240723$20240723$EXP$$US-OTSUKA-2023_024783$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241232191$24123219$1$I$$20230810$20240723$20240723$PER$$US-OTSUKA-2023_021527$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241232201$24123220$1$I$$20230810$20240723$20240723$PER$$US-OTSUKA-2023_021503$OTSUKA$$70$YR$$F$Y$$$20240723$$HP$US$US
241232211$24123221$1$I$$20230817$20240723$20240723$PER$$US-OTSUKA-2023_022050$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241232221$24123222$1$I$$20230907$20240723$20240723$PER$$US-OTSUKA-2023_023845$OTSUKA$$80$YR$$M$Y$$$20240723$$HP$US$US
241232231$24123223$1$I$$20230914$20240723$20240723$PER$$US-OTSUKA-2023_024429$OTSUKA$$15$YR$$M$Y$$$20240723$$HP$US$US
241232241$24123224$1$I$$20230810$20240723$20240723$PER$$US-OTSUKA-2023_021511$OTSUKA$$$$$M$Y$74.84$KG$20240723$$MD$US$US
241232251$24123225$1$I$$20230829$20240723$20240723$PER$$US-OTSUKA-2023_023274$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232261$24123226$1$I$$20230823$20240723$20240723$PER$$US-OTSUKA-2023_022557$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232271$24123227$1$I$$20230810$20240723$20240723$PER$$US-OTSUKA-2023_021521$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241232281$24123228$1$I$20230726$20230918$20240723$20240723$EXP$$US-OTSUKA-2023_020706$OTSUKA$$31$YR$$F$Y$66.67$KG$20240723$$HP$US$US
241232291$24123229$1$I$$20230823$20240723$20240723$PER$$US-OTSUKA-2023_022552$OTSUKA$$$$A$M$Y$$$20240723$$HP$US$US
241232301$24123230$1$I$$20230911$20240723$20240723$PER$$US-OTSUKA-2023_024125$OTSUKA$$92$YR$$M$Y$$$20240723$$MD$US$US
241232311$24123231$1$I$$20230824$20240723$20240723$PER$$US-OTSUKA-2023_022646$OTSUKA$$2$DEC$$F$Y$$$20240723$$MD$US$US
241232321$24123232$1$I$20230817$20230817$20240723$20240723$PER$$US-OTSUKA-2023_022046$OTSUKA$$15$YR$$F$Y$$$20240723$$CN$US$US
241232331$24123233$1$I$$20230908$20240723$20240723$EXP$$US-OTSUKA-2023_023959$OTSUKA$$2$DEC$$M$Y$$$20240723$$MD$US$US
241232341$24123234$1$I$$20230814$20240723$20240723$PER$$US-OTSUKA-2023_021766$OTSUKA$$80$YR$$F$Y$$$20240723$$MD$US$US
241232351$24123235$1$I$$20230918$20240723$20240723$PER$$US-OTSUKA-2023_024729$OTSUKA$$14$YR$$F$Y$$$20240723$$MD$US$US
241232361$24123236$1$I$20230301$20230828$20240723$20240723$EXP$$US-OTSUKA-2023_018683$OTSUKA$$71$YR$$F$Y$67.12$KG$20240723$$HP$US$US
241232371$24123237$1$I$$20230907$20240723$20240723$PER$$US-OTSUKA-2023_023910$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241232381$24123238$1$I$$20230817$20240723$20240723$EXP$$US-OTSUKA-2023_022055$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232391$24123239$1$I$20230801$20230829$20240723$20240723$PER$$US-OTSUKA-2023_023063$OTSUKA$$24$YR$$F$Y$99.79$KG$20240723$$CN$US$US
241232401$24123240$1$I$$20230825$20240723$20240723$PER$$US-OTSUKA-2023_022764$OTSUKA$$$$$F$Y$52.16$KG$20240723$$CN$US$US
241232411$24123241$1$I$$20240716$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-113540$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240719$$HP$CA$CA
241232421$24123242$1$I$20230101$20230810$20240723$20240723$PER$$US-OTSUKA-2023_021519$OTSUKA$$$$$M$Y$120.2$KG$20240723$$CN$US$US
241232431$24123243$1$I$$20230910$20240723$20240723$PER$$US-OTSUKA-2023_018736$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241232441$24123244$1$I$20230914$20230914$20240723$20240723$PER$$US-OTSUKA-2023_024448$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241232451$24123245$1$I$$20230809$20240723$20240723$PER$$US-OTSUKA-2023_021420$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232461$24123246$1$I$20230101$20230822$20240723$20240723$PER$$US-OTSUKA-2023_022411$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232471$24123247$1$I$$20230831$20240723$20240723$PER$$US-OTSUKA-2023_023279$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241232481$24123248$1$I$$20230908$20240723$20240723$PER$$US-OTSUKA-2023_024033$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241232491$24123249$1$I$$20230822$20240723$20240723$PER$$US-OTSUKA-2023_022425$OTSUKA$$19$YR$$M$Y$$$20240723$$HP$US$US
241232501$24123250$1$I$$20230913$20240723$20240723$PER$$US-OTSUKA-2023_024333$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232511$24123251$1$I$20230221$20230815$20240723$20240723$PER$$US-OTSUKA-2023_021829$OTSUKA$$73$YR$$M$Y$82$KG$20240723$$PH$US$US
241232521$24123252$1$I$$20230810$20240723$20240723$PER$$US-OTSUKA-2023_021477$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241232531$24123253$1$I$$20230823$20240723$20240723$PER$$US-OTSUKA-2023_022492$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241232541$24123254$1$I$$20230831$20240723$20240723$PER$$US-OTSUKA-2023_023186$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241232551$24123255$1$I$$20230912$20240723$20240723$PER$$US-OTSUKA-2023_024208$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241232561$24123256$1$I$$20230918$20240723$20240723$PER$$US-OTSUKA-2023_024732$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241232571$24123257$1$I$$20230830$20240723$20240723$PER$$US-OTSUKA-2023_023119$OTSUKA$$11$YR$$M$Y$$$20240723$$CN$US$US
241232581$24123258$1$I$$20230814$20240723$20240723$PER$$US-OTSUKA-2023_021740$OTSUKA$$73$YR$$M$Y$$$20240723$$HP$US$US
241232591$24123259$1$I$$20230811$20240723$20240723$PER$$US-OTSUKA-2023_021649$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241232601$24123260$1$I$$20230810$20240723$20240723$PER$$US-OTSUKA-2023_021471$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232611$24123261$1$I$$20230824$20240723$20240723$PER$$US-OTSUKA-2023_022623$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232621$24123262$1$I$$20230823$20240723$20240723$PER$$US-OTSUKA-2023_022548$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241232631$24123263$1$I$$20230830$20240723$20240723$PER$$US-OTSUKA-2023_023301$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232641$24123264$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06687$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241232651$24123265$1$I$$20231011$20240723$20240723$PER$$US-OTSUKA-2023_026678$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232661$24123266$1$I$20230927$20231004$20240723$20240723$PER$$US-OTSUKA-2023_026074$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241232671$24123267$1$I$20230802$20230928$20240723$20240723$PER$$US-OTSUKA-2023_021166$OTSUKA$$3$DEC$$F$Y$$$20240723$$HP$US$US
241232681$24123268$1$I$$20231004$20240723$20240723$PER$$US-OTSUKA-2023_026051$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241232691$24123269$1$I$$20231012$20240723$20240723$PER$$US-OTSUKA-2023_026843$OTSUKA$$22$YR$$M$Y$$$20240723$$HP$US$US
241232701$24123270$1$I$$20230919$20240723$20240723$EXP$$US-OTSUKA-2023_024782$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241232711$24123271$1$I$$20231004$20240723$20240723$EXP$$US-OTSUKA-2023_026096$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241232722$24123272$2$F$$20231003$20240723$20240808$PER$$US-OTSUKA-2023_025973$OTSUKA$$4$DEC$$F$Y$$$20240808$$MD$US$US
241232731$24123273$1$I$$20231102$20240723$20240723$PER$$US-OTSUKA-2023_029121$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232741$24123274$1$I$20230101$20231011$20240723$20240723$PER$$US-OTSUKA-2023_026683$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241232751$24123275$1$I$$20231024$20240723$20240723$PER$$US-OTSUKA-2023_027928$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241232761$24123276$1$I$20230910$20230921$20240723$20240723$EXP$$US-OTSUKA-2023_024996$OTSUKA$$65$YR$$F$Y$$$20240723$$MD$US$US
241232772$24123277$2$F$$20231004$20240723$20240808$EXP$$US-OTSUKA-2023_026076$OTSUKA$$$$E$F$Y$$$20240808$$MD$US$US
241232781$24123278$1$I$$20230929$20240723$20240723$PER$$US-OTSUKA-2023_025716$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241232791$24123279$1$I$$20231004$20240723$20240723$EXP$$US-OTSUKA-2023_026090$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241232801$24123280$1$I$$20231004$20240723$20240723$EXP$$US-OTSUKA-2023_026089$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241232811$24123281$1$I$$20230920$20240723$20240723$PER$$US-OTSUKA-2023_024891$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232821$24123282$1$I$$20230929$20240723$20240723$PER$$US-OTSUKA-2023_025746$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241232831$24123283$1$I$$20231009$20240723$20240723$PER$$US-OTSUKA-2023_026592$OTSUKA$$$$E$M$Y$$$20240723$$MD$US$US
241232841$24123284$1$I$$20231003$20240723$20240723$PER$$US-OTSUKA-2023_025967$OTSUKA$$$$$F$Y$95.25$KG$20240723$$CN$US$US
241232851$24123285$1$I$$20230928$20240723$20240723$PER$$US-OTSUKA-2023_025710$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232861$24123286$1$I$$20231102$20240723$20240723$PER$$US-OTSUKA-2023_025633$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232871$24123287$1$I$20230801$20231031$20240723$20240723$PER$$US-OTSUKA-2023_023269$OTSUKA$$42$YR$$M$Y$72.57$KG$20240723$$CN$US$US
241232881$24123288$1$I$$20231005$20240723$20240723$EXP$$US-OTSUKA-2023_026182$OTSUKA$$8$DEC$$F$Y$$$20240723$$MD$US$US
241232891$24123289$1$I$$20231020$20240723$20240723$PER$$US-OTSUKA-2023_027614$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241232901$24123290$1$I$$20231020$20240723$20240723$PER$$US-OTSUKA-2023_027651$OTSUKA$$$$E$F$Y$$$20240723$$CN$US$US
241232911$24123291$1$I$$20230919$20240723$20240723$PER$$US-OTSUKA-2023_024778$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241232921$24123292$1$I$20240701$20240718$20240723$20240723$EXP$$AU-ROCHE-3389812$ROCHE$$61$YR$A$F$Y$$$20240723$$CN$AU$AU
241232931$24123293$1$I$$20230920$20240723$20240723$PER$$US-OTSUKA-2023_024915$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241232941$24123294$1$I$$20230920$20240723$20240723$PER$$US-OTSUKA-2023_024907$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241232951$24123295$1$I$20230101$20231012$20240723$20240723$PER$$US-OTSUKA-2023_026832$OTSUKA$$62$YR$$F$Y$$$20240723$$HP$US$US
241232961$24123296$1$I$$20230929$20240723$20240723$PER$$US-OTSUKA-2023_023846$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241232971$24123297$1$I$$20230922$20240723$20240723$PER$$US-OTSUKA-2023_025135$OTSUKA$$$$E$M$Y$$$20240723$$MD$US$US
241232981$24123298$1$I$20220601$20231012$20240723$20240723$PER$$US-OTSUKA-2023_026827$OTSUKA$$46$YR$$F$Y$$$20240723$$HP$US$US
241232991$24123299$1$I$$20231016$20240723$20240723$PER$$US-OTSUKA-2023_027127$OTSUKA$$68$YR$$F$Y$$$20240723$$MD$US$US
241233001$24123300$1$I$$20231023$20240723$20240723$EXP$$US-OTSUKA-2023_027786$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233011$24123301$1$I$$20231012$20240723$20240723$PER$$US-OTSUKA-2023_026852$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233021$24123302$1$I$$20230928$20240723$20240723$PER$$US-OTSUKA-2023_025677$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233031$24123303$1$I$$20231010$20240723$20240723$EXP$$US-OTSUKA-2023_026543$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233041$24123304$1$I$$20231009$20240723$20240723$EXP$$US-OTSUKA-2023_026478$OTSUKA$$78$YR$$F$Y$$$20240723$$HP$US$US
241233051$24123305$1$I$$20231017$20240723$20240723$EXP$$US-OTSUKA-2023_027244$OTSUKA$$$$E$F$Y$$$20240723$$HP$US$US
241233061$24123306$1$I$$20231010$20240723$20240723$EXP$$US-OTSUKA-2023_026613$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233071$24123307$1$I$$20231024$20240723$20240723$PER$$US-OTSUKA-2023_027921$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241233081$24123308$1$I$$20230921$20240723$20240723$PER$$US-OTSUKA-2023_025129$OTSUKA$$$$A$F$Y$$$20240723$$MD$US$US
241233091$24123309$1$I$$20231019$20240723$20240723$PER$$US-OTSUKA-2023_027464$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241233102$24123310$2$F$$20231006$20240723$20240808$PER$$US-OTSUKA-2023_026330$OTSUKA$$5$DEC$$F$Y$$$20240808$$HP$US$US
241233111$24123311$1$I$$20230926$20240723$20240723$EXP$$US-OTSUKA-2023_026212$OTSUKA$$8$DEC$$F$Y$$$20240723$$HP$US$US
241233121$24123312$1$I$$20231009$20240723$20240723$PER$$US-OTSUKA-2023_026426$OTSUKA$$30$YR$$F$Y$$$20240723$$HP$US$US
241233131$24123313$1$I$$20231026$20240723$20240723$PER$$US-OTSUKA-2023_030035$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241233141$24123314$1$I$$20231011$20240723$20240723$PER$$US-OTSUKA-2023_026692$OTSUKA$$48$YR$$F$Y$$$20240723$$HP$US$US
241233151$24123315$1$I$$20231009$20240723$20240723$PER$$US-OTSUKA-2023_026425$OTSUKA$$52$YR$$F$Y$$$20240723$$MD$US$US
241233162$24123316$2$F$$20230926$20240723$20240808$EXP$$US-OTSUKA-2023_024799$OTSUKA$$80$YR$$M$Y$$$20240808$$HP$US$US
241233171$24123317$1$I$$20231020$20240723$20240723$EXP$$US-OTSUKA-2023_027607$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233181$24123318$1$I$20230101$20231009$20240723$20240723$PER$$US-OTSUKA-2023_026480$OTSUKA$$5$DEC$$F$Y$$$20240723$$MD$US$US
241233191$24123319$1$I$20230901$20231024$20240723$20240723$PER$$US-OTSUKA-2023_027896$OTSUKA$$33$YR$$F$Y$$$20240723$$CN$US$US
241233201$24123320$1$I$$20230919$20240723$20240723$PER$$US-OTSUKA-2023_024774$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233211$24123321$1$I$$20231004$20240723$20240723$PER$$US-OTSUKA-2023_026142$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241233221$24123322$1$I$$20230925$20240723$20240723$PER$$US-OTSUKA-2023_025226$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241233231$24123323$1$I$$20231009$20240723$20240723$PER$$US-OTSUKA-2023_026578$OTSUKA$$$$E$F$Y$$$20240723$$MD$US$US
241233241$24123324$1$I$$20230920$20240723$20240723$PER$$US-OTSUKA-2023_024899$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233251$24123325$1$I$$20231012$20240723$20240723$PER$$US-OTSUKA-2023_026824$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
241233261$24123326$1$I$$20231025$20240723$20240723$PER$$US-OTSUKA-2023_028000$OTSUKA$$95$YR$$F$Y$$$20240723$$MD$US$US
241233271$24123327$1$I$20231011$20231016$20240723$20240723$PER$$US-OTSUKA-2023_027120$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241233281$24123328$1$I$20230101$20230928$20240723$20240723$PER$$US-OTSUKA-2023_025599$OTSUKA$$84$YR$$M$Y$$$20240723$$HP$US$US
241233291$24123329$1$I$$20231016$20240723$20240723$PER$$US-OTSUKA-2023_027070$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241233301$24123330$1$I$$20231014$20240723$20240723$EXP$$US-OTSUKA-2023_021414$OTSUKA$$72$YR$$F$Y$$$20240723$$MD$US$US
241233311$24123331$1$I$$20231019$20240723$20240723$EXP$$US-OTSUKA-2023_027463$OTSUKA$$5$DEC$$F$Y$$$20240723$$MD$US$US
241233321$24123332$1$I$$20231023$20240723$20240723$EXP$$US-OTSUKA-2023_027768$OTSUKA$$52$YR$$M$Y$$$20240723$$HP$US$US
241233331$24123333$1$I$$20231102$20240723$20240723$PER$$US-OTSUKA-2023_028946$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241233341$24123334$1$I$20230808$20231012$20240723$20240723$EXP$$US-OTSUKA-2023_023833$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
241233351$24123335$1$I$$20230921$20240723$20240723$PER$$US-OTSUKA-2023_025038$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241233361$24123336$1$I$$20231031$20240723$20240723$PER$$US-OTSUKA-2023_022330$OTSUKA$$35$YR$$F$Y$$$20240723$$HP$US$US
241233371$24123337$1$I$$20230920$20240723$20240723$PER$$US-OTSUKA-2023_024919$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241233381$24123338$1$I$20230802$20231002$20240723$20240723$PER$$US-OTSUKA-2023_027372$OTSUKA$$30$YR$$F$Y$$$20240723$$HP$US$US
241233391$24123339$1$I$$20231017$20240723$20240723$PER$$US-OTSUKA-2023_027195$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241233401$24123340$1$I$$20230930$20240723$20240723$PER$$US-OTSUKA-2023_020496$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241233411$24123341$1$I$$20231012$20240723$20240723$EXP$$US-OTSUKA-2023_026875$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233421$24123342$1$I$20231006$20231006$20240723$20240723$PER$$US-OTSUKA-2023_026325$OTSUKA$$44$YR$$M$Y$102.51$KG$20240723$$CN$US$US
241233432$24123343$2$F$20230924$20230928$20240723$20240808$PER$$US-OTSUKA-2023_025607$OTSUKA$$42$YR$$F$Y$58.97$KG$20240808$$CN$US$US
241233441$24123344$1$I$$20231005$20240723$20240723$PER$$US-OTSUKA-2023_024492$OTSUKA$$7$DEC$$F$Y$$$20240723$$HP$US$US
241233451$24123345$1$I$$20230929$20240723$20240723$PER$$US-OTSUKA-2023_025704$OTSUKA$$82$YR$$F$Y$$$20240723$$MD$US$US
241233461$24123346$1$I$$20230920$20240723$20240723$PER$$US-OTSUKA-2023_024908$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233471$24123347$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115166$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240719$$CN$US$US
241233481$24123348$1$I$$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112389$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240719$$HP$US$US
241233491$24123349$1$I$$20240712$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111787$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240719$$CN$US$US
241233501$24123350$1$I$20240708$20240710$20240723$20240723$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2159456$JIANGSU HENGRUI MEDICINE$$70$YR$$F$Y$61$KG$20240723$$MD$CN$CN
241233511$24123351$1$I$$20240716$20240723$20240723$PER$$NVSC2024US147089$NOVARTIS$$52$YR$$F$Y$$$20240723$$MD$US$US
241233521$24123352$1$I$$20240131$20240723$20240723$EXP$$US-OTSUKA-2024_002722$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233531$24123353$1$I$20240101$20240124$20240723$20240723$PER$$US-OTSUKA-2024_002110$OTSUKA$$73$YR$$M$Y$$$20240723$$HP$US$US
241233541$24123354$1$I$$20231114$20240723$20240723$PER$$US-OTSUKA-2023_024577$OTSUKA$$24$YR$$F$Y$$$20240723$$HP$US$US
241233551$24123355$1$I$$20230925$20240723$20240723$EXP$$US-OTSUKA-2023_025347$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233561$24123356$1$I$$20231201$20240723$20240723$PER$$US-OTSUKA-2023_025970$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241233571$24123357$1$I$$20231201$20240723$20240723$PER$$US-OTSUKA-2023_025708$OTSUKA$$6$DEC$$F$Y$$$20240723$$MD$US$US
241233581$24123358$1$I$$20240124$20240723$20240723$PER$$US-OTSUKA-2024_002204$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241233591$24123359$1$I$$20231108$20240723$20240723$PER$$US-OTSUKA-2023_029345$OTSUKA$$70$YR$$F$Y$$$20240723$$MD$US$US
241233601$24123360$1$I$20230924$20231109$20240723$20240723$PER$$US-OTSUKA-2023_024097$OTSUKA$$8$DEC$$F$Y$$$20240723$$MD$US$US
241233611$24123361$1$I$$20231108$20240723$20240723$PER$$US-OTSUKA-2023_029302$OTSUKA$$30$YR$$F$Y$$$20240723$$HP$US$US
241233621$24123362$1$I$$20230717$20240723$20240723$PER$$US-OTSUKA-2023_019221$OTSUKA$$$$$F$Y$46.72$KG$20240723$$CN$US$US
241233631$24123363$1$I$$20240129$20240723$20240723$EXP$$US-OTSUKA-2024_002600$OTSUKA$$8$DEC$$$Y$$$20240723$$MD$US$US
241233641$24123364$1$I$20230101$20231106$20240723$20240723$PER$$US-OTSUKA-2023_029065$OTSUKA$$$$$M$Y$136.08$KG$20240723$$CN$US$US
241233651$24123365$1$I$$20231201$20240723$20240723$PER$$US-OTSUKA-2023_026050$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241233661$24123366$1$I$$20230925$20240723$20240723$PER$$US-OTSUKA-2023_025246$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241233671$24123367$1$I$$20231114$20240723$20240723$PER$$US-OTSUKA-2023_029885$OTSUKA$$91$YR$$M$Y$$$20240723$$MD$US$US
241233681$24123368$1$I$$20231106$20240723$20240723$PER$$US-OTSUKA-2023_025865$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241233691$24123369$1$I$20230901$20240117$20240723$20240723$EXP$$US-OTSUKA-2024_001530$OTSUKA$$68$YR$$F$Y$$$20240723$$HP$US$US
241233701$24123370$1$I$$20231201$20240723$20240723$PER$$US-OTSUKA-2023_026021$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241233711$24123371$1$I$$20231114$20240723$20240723$EXP$$US-OTSUKA-2023_029836$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241233722$24123372$2$F$$20231116$20240723$20240808$PER$$US-OTSUKA-2023_024776$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241233731$24123373$1$I$$20231120$20240723$20240723$PER$$US-OTSUKA-2023_030346$OTSUKA$$9$DEC$$F$Y$$$20240723$$MD$US$US
241233741$24123374$1$I$$20240130$20240723$20240723$PER$$US-OTSUKA-2024_002662$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241233751$24123375$1$I$20230803$20231211$20240723$20240723$PER$$US-OTSUKA-2023_027920$OTSUKA$$70$YR$$F$Y$81.63$KG$20240723$$HP$US$US
241233761$24123376$1$I$20230801$20240528$20240723$20240723$PER$$US-OTSUKA-2023_027072$OTSUKA$$59$YR$$F$Y$70.31$KG$20240723$$CN$US$US
241233771$24123377$1$I$$20231201$20240723$20240723$PER$$US-OTSUKA-2023_025799$OTSUKA$$83$YR$$F$Y$$$20240723$$MD$US$US
241233781$24123378$1$I$$20230927$20240723$20240723$PER$$US-OTSUKA-2023_025518$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241233791$24123379$1$I$$20230925$20240723$20240723$PER$$US-OTSUKA-2023_025270$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241233801$24123380$1$I$$20240129$20240723$20240723$EXP$$US-OTSUKA-2024_002473$OTSUKA$$8$DEC$$$Y$$$20240723$$MD$US$US
241233811$24123381$1$I$$20231108$20240723$20240723$EXP$$US-OTSUKA-2023_029298$OTSUKA$$59$YR$$F$Y$$$20240723$$MD$US$US
241233821$24123382$1$I$$20240408$20240723$20240723$EXP$$US-OTSUKA-2024_002706$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241233831$24123383$1$I$$20231110$20240723$20240723$PER$$US-OTSUKA-2023_029574$OTSUKA$$$$$M$Y$85.28$KG$20240723$$CN$US$US
241233841$24123384$1$I$$20231117$20240723$20240723$PER$$US-OTSUKA-2023_024769$OTSUKA$$$$E$F$Y$$$20240723$$HP$US$US
241233851$24123385$1$I$$20231213$20240723$20240723$PER$$US-OTSUKA-2023_026855$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241233861$24123386$1$I$$20240103$20240723$20240723$PER$$US-OTSUKA-2024_000237$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241233871$24123387$1$I$20230801$20231020$20240723$20240723$PER$$US-OTSUKA-2023_028320$OTSUKA$$52$YR$$F$Y$$$20240723$$CN$US$US
241233881$24123388$1$I$20230901$20231117$20240723$20240723$PER$$US-OTSUKA-2023_030250$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241233891$24123389$1$I$$20230719$20240723$20240723$PER$$US-OTSUKA-2023_019425$OTSUKA$$32$YR$$F$Y$$$20240723$$HP$US$US
241233901$24123390$1$I$$20240131$20240723$20240723$PER$$US-OTSUKA-2024_002774$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
241233911$24123391$1$I$$20231110$20240723$20240723$PER$$US-OTSUKA-2023_027919$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241233921$24123392$1$I$$20230718$20240723$20240723$PER$$US-OTSUKA-2023_019369$OTSUKA$$50$YR$$F$Y$$$20240723$$HP$US$US
241233932$24123393$2$F$20220801$20231129$20240723$20240808$EXP$$US-OTSUKA-2023_027275$OTSUKA$$75$YR$$F$Y$$$20240808$$MD$US$US
241233941$24123394$1$I$$20230718$20240723$20240723$PER$$US-OTSUKA-2023_019350$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
241233951$24123395$1$I$20230901$20240124$20240723$20240723$PER$$US-OTSUKA-2024_002159$OTSUKA$$13$YR$$F$Y$54.43$KG$20240723$$CN$US$US
241233961$24123396$1$I$$20231109$20240723$20240723$PER$$US-OTSUKA-2023_029464$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241233971$24123397$1$I$$20240201$20240723$20240723$PER$$US-OTSUKA-2024_002868$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241233981$24123398$1$I$$20230912$20240723$20240723$EXP$$US-OTSUKA-2023_024393$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241233991$24123399$1$I$20231101$20240123$20240723$20240723$PER$$US-OTSUKA-2023_030500$OTSUKA$$88$YR$$F$Y$67.13$KG$20240723$$CN$US$US
241234002$24123400$2$F$$20231115$20240723$20240808$PER$$US-OTSUKA-2023_024426$OTSUKA$$19$YR$$F$Y$$$20240808$$HP$US$US
241234011$24123401$1$I$$20231114$20240723$20240723$PER$$US-OTSUKA-2023_029805$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234021$24123402$1$I$$20230718$20240723$20240723$PER$$US-OTSUKA-2023_019306$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241234031$24123403$1$I$$20240201$20240723$20240723$PER$$US-OTSUKA-2024_002893$OTSUKA$$70$YR$$M$Y$$$20240723$$MD$US$US
241234041$24123404$1$I$$20240111$20240723$20240723$PER$$US-OTSUKA-2024_001042$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241234051$24123405$1$I$$20230927$20240723$20240723$PER$$US-OTSUKA-2023_025530$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241234061$24123406$1$I$$20240125$20240723$20240723$PER$$US-OTSUKA-2024_002241$OTSUKA$$7$DEC$$F$Y$$$20240723$$HP$US$US
241234071$24123407$1$I$20230405$20231130$20240723$20240723$PER$$US-OTSUKA-2023_027469$OTSUKA$$45$YR$$M$Y$$$20240723$$CN$US$US
241234081$24123408$1$I$$20240131$20240723$20240723$PER$$US-OTSUKA-2024_002772$OTSUKA$$59$YR$$M$Y$$$20240723$$HP$US$US
241234091$24123409$1$I$$20230925$20240723$20240723$PER$$US-OTSUKA-2023_025340$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241234101$24123410$1$I$$20231109$20240723$20240723$PER$$US-OTSUKA-2023_029676$OTSUKA$$38$YR$$F$Y$$$20240723$$HP$US$US
241234111$24123411$1$I$$20231103$20240723$20240723$EXP$$US-OTSUKA-2023_028965$OTSUKA$$21$YR$$F$Y$43.09$KG$20240723$$HP$US$US
241234121$24123412$1$I$20240101$20240206$20240723$20240723$EXP$$US-OTSUKA-2024_002770$OTSUKA$$30$YR$$F$Y$$$20240723$$HP$US$US
241234131$24123413$1$I$$20231024$20240723$20240723$PER$$US-OTSUKA-2023_028312$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241234141$24123414$1$I$$20230927$20240723$20240723$PER$$US-OTSUKA-2023_025506$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241234151$24123415$1$I$20231115$20231116$20240723$20240723$PER$$US-OTSUKA-2023_030092$OTSUKA$$45$YR$$M$Y$$$20240723$$PH$US$US
241234161$24123416$1$I$$20231117$20240723$20240723$PER$$US-OTSUKA-2023_030199$OTSUKA$$3$DEC$$F$Y$$$20240723$$HP$US$US
241234172$24123417$2$F$20230601$20231201$20240723$20240808$EXP$$US-OTSUKA-2023_026833$OTSUKA$$45$YR$$M$Y$$$20240808$$HP$US$US
241234181$24123418$1$I$$20231121$20240723$20240723$PER$$US-OTSUKA-2023_030632$OTSUKA$$5$DEC$$F$Y$$$20240723$$HP$US$US
241234191$24123419$1$I$$20230926$20240723$20240723$PER$$US-OTSUKA-2023_025401$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241234201$24123420$1$I$$20231114$20240723$20240723$PER$$US-OTSUKA-2023_029824$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
241234211$24123421$1$I$20230101$20231107$20240723$20240723$PER$$US-OTSUKA-2023_029210$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234221$24123422$1$I$$20240201$20240723$20240723$PER$$US-OTSUKA-2024_002874$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241234231$24123423$1$I$20240530$20240715$20240723$20240723$EXP$$CN-BEIGENE-BGN-2024-011030$BEIGENE$$$$$$Y$$$20240723$$HP$CN$CN
241234241$24123424$1$I$20231116$20231206$20240723$20240723$PER$$US-OTSUKA-2023_030492$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234251$24123425$1$I$$20231212$20240723$20240723$PER$$US-OTSUKA-2023_032486$OTSUKA$$39$YR$$F$Y$$$20240723$$HP$US$US
241234261$24123426$1$I$20221228$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031396$OTSUKA$$48$YR$$M$Y$$$20240723$$CN$US$US
241234271$24123427$1$I$$20231117$20240723$20240723$PER$$US-OTSUKA-2023_030291$OTSUKA$$5$DEC$$F$Y$$$20240723$$HP$US$US
241234281$24123428$1$I$20220701$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031404$OTSUKA$$1$YR$$M$Y$$$20240723$$CN$US$US
241234291$24123429$1$I$$20231027$20240723$20240723$PER$$US-OTSUKA-2023_028345$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241234301$24123430$1$I$$20231206$20240723$20240723$PER$$US-OTSUKA-2023_031821$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241234311$24123431$1$I$$20240104$20240723$20240723$PER$$US-OTSUKA-2023_028968$OTSUKA$$$$$M$Y$77.11$KG$20240723$$CN$US$US
241234321$24123432$1$I$$20231214$20240723$20240723$PER$$US-OTSUKA-2023_032751$OTSUKA$$38$YR$$M$Y$$$20240723$$CN$US$US
241234331$24123433$1$I$$20231207$20240723$20240723$PER$$US-OTSUKA-2023_031961$OTSUKA$$65$YR$$F$Y$$$20240723$$HP$US$US
241234341$24123434$1$I$$20231101$20240723$20240723$EXP$$US-OTSUKA-2023_028834$OTSUKA$$60$YR$$F$Y$$$20240723$$MD$US$US
241234351$24123435$1$I$$20231102$20240723$20240723$EXP$$US-OTSUKA-2023_028789$OTSUKA$$$$$F$Y$72.57$KG$20240723$$CN$US$US
241234361$24123436$1$I$$20240105$20240723$20240723$PER$$US-OTSUKA-2024_000525$OTSUKA$$$$$F$Y$77.11$KG$20240723$$CN$US$US
241234371$24123437$1$I$$20240104$20240723$20240723$PER$$US-OTSUKA-2024_000418$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241234381$24123438$1$I$$20231206$20240723$20240723$EXP$$US-OTSUKA-2023_032035$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241234391$24123439$1$I$$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031300$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241234401$24123440$1$I$$20231116$20240723$20240723$PER$$US-OTSUKA-2023_030119$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234411$24123441$1$I$$20240108$20240723$20240723$PER$$US-OTSUKA-2024_000646$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241234421$24123442$1$I$$20240105$20240723$20240723$PER$$US-OTSUKA-2024_000524$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241234431$24123443$1$I$$20240105$20240723$20240723$PER$$US-OTSUKA-2024_000582$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241234441$24123444$1$I$$20231129$20240723$20240723$PER$$US-OTSUKA-2023_031227$OTSUKA$$$$$$Y$$$20240723$$PH$US$US
241234451$24123445$1$I$$20231221$20240723$20240723$PER$$US-OTSUKA-2023_033514$OTSUKA$$$$$F$Y$86.18$KG$20240723$$CN$US$US
241234461$24123446$1$I$20220406$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031400$OTSUKA$$41$YR$$F$Y$$$20240723$$CN$US$US
241234471$24123447$1$I$20210922$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031397$OTSUKA$$66$YR$$F$Y$$$20240723$$CN$US$US
241234481$24123448$1$I$20230901$20231219$20240723$20240723$PER$$US-OTSUKA-2023_028720$OTSUKA$$56$YR$$F$Y$90.7$KG$20240723$$HP$US$US
241234491$24123449$1$I$$20240104$20240723$20240723$EXP$$US-OTSUKA-2024_000434$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234501$24123450$1$I$20221008$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031408$OTSUKA$$39$YR$$M$Y$$$20240723$$CN$US$US
241234511$24123451$1$I$$20231206$20240723$20240723$PER$$US-OTSUKA-2023_032110$OTSUKA$$84$YR$$M$Y$$$20240723$$MD$US$US
241234521$24123452$1$I$$20231213$20240723$20240723$PER$$US-OTSUKA-2023_032594$OTSUKA$$$$E$$Y$$$20240723$$PH$US$US
241234531$24123453$1$I$20211129$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031395$OTSUKA$$56$YR$$M$Y$$$20240723$$CN$US$US
241234541$24123454$1$I$$20231027$20240723$20240723$PER$$US-OTSUKA-2023_028315$OTSUKA$$$$$F$Y$54.43$KG$20240723$$CN$US$US
241234551$24123455$1$I$$20231212$20240723$20240723$PER$$US-OTSUKA-2023_032483$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234561$24123456$1$I$20231201$20231212$20240723$20240723$PER$$US-OTSUKA-2023_032515$OTSUKA$$52$YR$$F$Y$45.36$KG$20240723$$CN$US$US
241234571$24123457$1$I$20220814$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031412$OTSUKA$$31$YR$$F$Y$$$20240723$$CN$US$US
241234581$24123458$1$I$$20231208$20240723$20240723$PER$$US-OTSUKA-2023_032144$OTSUKA$$9$DEC$$M$Y$$$20240723$$HP$US$US
241234591$24123459$1$I$20220801$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031411$OTSUKA$$26$YR$$F$Y$$$20240723$$CN$US$US
241234601$24123460$1$I$$20231218$20240723$20240723$EXP$$US-OTSUKA-2023_033002$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234611$24123461$1$I$$20231101$20240723$20240723$PER$$US-OTSUKA-2023_028847$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241234621$24123462$1$I$20231001$20231102$20240723$20240723$PER$$US-OTSUKA-2023_028809$OTSUKA$$40$YR$$F$Y$$$20240723$$HP$US$US
241234631$24123463$1$I$20231006$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031401$OTSUKA$$68$YR$$F$Y$$$20240723$$CN$US$US
241234641$24123464$1$I$$20231218$20240723$20240723$PER$$US-OTSUKA-2023_033061$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241234651$24123465$1$I$$20240104$20240723$20240723$PER$$US-OTSUKA-2024_000448$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241234661$24123466$1$I$$20231212$20240723$20240723$EXP$$US-OTSUKA-2023_032514$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234671$24123467$1$I$$20231108$20240723$20240723$PER$$US-OTSUKA-2023_029453$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234681$24123468$1$I$$20231205$20240723$20240723$PER$$US-OTSUKA-2023_031817$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234691$24123469$1$I$$20231102$20240723$20240723$PER$$US-OTSUKA-2023_028853$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241234701$24123470$1$I$$20231129$20240723$20240723$PER$$US-OTSUKA-2023_031165$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
241234711$24123471$1$I$$20231026$20240723$20240723$PER$$US-OTSUKA-2023_028177$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241234721$24123472$1$I$20231001$20231102$20240723$20240723$PER$$US-OTSUKA-2023_028849$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241234731$24123473$1$I$20230303$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031394$OTSUKA$$61$YR$$M$Y$$$20240723$$CN$US$US
241234741$24123474$1$I$$20240104$20240723$20240723$PER$$US-OTSUKA-2024_000417$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241234751$24123475$1$I$$20231102$20240723$20240723$PER$$US-OTSUKA-2023_028857$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241234761$24123476$1$I$20230614$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031413$OTSUKA$$58$YR$$F$Y$$$20240723$$CN$US$US
241234771$24123477$1$I$$20231128$20240723$20240723$PER$$US-OTSUKA-2023_031081$OTSUKA$$$$$F$Y$85.73$KG$20240723$$CN$US$US
241234781$24123478$1$I$20220821$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031402$OTSUKA$$59$YR$$F$Y$$$20240723$$CN$US$US
241234791$24123479$1$I$$20231117$20240723$20240723$PER$$US-OTSUKA-2023_030221$OTSUKA$$$$E$M$Y$$$20240723$$HP$US$US
241234801$24123480$1$I$$20231213$20240723$20240723$PER$$US-OTSUKA-2023_032644$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241234811$24123481$1$I$$20231128$20240723$20240723$PER$$US-OTSUKA-2023_030621$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234821$24123482$1$I$20210831$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031398$OTSUKA$$49$YR$$F$Y$$$20240723$$CN$US$US
241234831$24123483$1$I$20231127$20231127$20240723$20240723$PER$$US-OTSUKA-2023_031024$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241234841$24123484$1$I$20220525$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031410$OTSUKA$$24$YR$$F$Y$$$20240723$$CN$US$US
241234851$24123485$1$I$20230302$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031406$OTSUKA$$39$YR$$F$Y$$$20240723$$CN$US$US
241234861$24123486$1$I$20231114$20231207$20240723$20240723$EXP$$US-OTSUKA-2023_031026$OTSUKA$$19$YR$$F$Y$$$20240723$$HP$US$US
241234871$24123487$1$I$$20231027$20240723$20240723$PER$$US-OTSUKA-2023_028306$OTSUKA$$47$YR$$F$Y$$$20240723$$HP$US$US
241234881$24123488$1$I$$20231212$20240723$20240723$PER$$US-OTSUKA-2023_032460$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234891$24123489$1$I$$20231107$20240723$20240723$PER$$US-OTSUKA-2023_029221$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234901$24123490$1$I$$20231116$20240723$20240723$PER$$US-OTSUKA-2023_030062$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234911$24123491$1$I$$20231025$20240723$20240723$PER$$US-OTSUKA-2023_028050$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241234921$24123492$1$I$$20231115$20240723$20240723$PER$$US-OTSUKA-2023_029918$OTSUKA$$72$YR$$F$Y$$$20240723$$MD$US$US
241234931$24123493$1$I$$20231114$20240723$20240723$PER$$US-OTSUKA-2023_029810$OTSUKA$$9$DEC$$F$Y$$$20240723$$MD$US$US
241234941$24123494$1$I$$20231102$20240723$20240723$PER$$US-OTSUKA-2023_028829$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241234951$24123495$1$I$$20231206$20240723$20240723$PER$$US-OTSUKA-2023_031862$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241234961$24123496$1$I$$20231107$20240723$20240723$PER$$US-OTSUKA-2023_029177$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241234971$24123497$1$I$$20231128$20240723$20240723$PER$$US-OTSUKA-2023_025341$OTSUKA$$90$YR$$F$Y$$$20240723$$MD$US$US
241234981$24123498$1$I$$20240103$20240723$20240723$PER$$US-OTSUKA-2024_000259$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241234991$24123499$1$I$20220615$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031409$OTSUKA$$40$YR$$F$Y$$$20240723$$CN$US$US
241235001$24123500$1$I$$20231114$20240723$20240723$PER$$US-OTSUKA-2023_029841$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241235011$24123501$1$I$20230412$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031417$OTSUKA$$43$YR$$F$Y$$$20240723$$CN$US$US
241235021$24123502$1$I$$20231218$20240723$20240723$PER$$US-OTSUKA-2023_032999$OTSUKA$$14$YR$$M$Y$$$20240723$$CN$US$US
241235031$24123503$1$I$$20231129$20240723$20240723$PER$$US-OTSUKA-2023_031149$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241235041$24123504$1$I$$20231211$20240723$20240723$PER$$US-OTSUKA-2023_032356$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241235051$24123505$1$I$$20231025$20240723$20240723$PER$$US-OTSUKA-2023_028044$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241235061$24123506$1$I$$20231129$20240723$20240723$EXP$$US-OTSUKA-2023_031159$OTSUKA$$$$$F$Y$72.57$KG$20240723$$CN$US$US
241235071$24123507$1$I$$20231219$20240723$20240723$PER$$US-OTSUKA-2023_032294$OTSUKA$$$$$F$Y$80.74$KG$20240723$$CN$US$US
241235081$24123508$1$I$$20240105$20240723$20240723$PER$$US-OTSUKA-2024_000518$OTSUKA$$$$$F$Y$67.13$KG$20240723$$CN$US$US
241235091$24123509$1$I$20230801$20231106$20240723$20240723$PER$$US-OTSUKA-2023_029087$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241235101$24123510$1$I$$20231025$20240723$20240723$PER$$US-OTSUKA-2023_028034$OTSUKA$$5$DEC$$F$Y$$$20240723$$HP$US$US
241235111$24123511$1$I$$20231128$20240723$20240723$PER$$US-OTSUKA-2023_031090$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241235121$24123512$1$I$20230405$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031399$OTSUKA$$46$YR$$F$Y$$$20240723$$CN$US$US
241235131$24123513$1$I$$20231103$20240723$20240723$PER$$US-OTSUKA-2023_028953$OTSUKA$$18$YR$$F$Y$$$20240723$$HP$US$US
241235141$24123514$1$I$20220704$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031407$OTSUKA$$28$YR$$F$Y$$$20240723$$CN$US$US
241235151$24123515$1$I$$20231113$20240723$20240723$PER$$US-OTSUKA-2023_029833$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241235161$24123516$1$I$20231201$20231220$20240723$20240723$PER$$US-OTSUKA-2023_033234$OTSUKA$$89$YR$$F$Y$44$KG$20240723$$CN$US$US
241235171$24123517$1$I$$20231109$20240723$20240723$PER$$US-OTSUKA-2023_029479$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241235181$24123518$1$I$$20231218$20240723$20240723$EXP$$US-OTSUKA-2023_032978$OTSUKA$$10$DEC$$F$Y$$$20240723$$HP$US$US
241235191$24123519$1$I$$20231102$20240723$20240723$PER$$US-OTSUKA-2023_028822$OTSUKA$$$$$F$Y$$$20240723$$PH$US$US
241235201$24123520$1$I$$20231108$20240723$20240723$PER$$US-OTSUKA-2023_029322$OTSUKA$$61$YR$$F$Y$$$20240723$$HP$US$US
241235211$24123521$1$I$$20240212$20240723$20240723$PER$$US-OTSUKA-2024_004160$OTSUKA$$$$A$M$Y$$$20240723$$MD$US$US
241235221$24123522$1$I$$20240210$20240723$20240723$PER$$US-OTSUKA-2024_003826$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241235231$24123523$1$I$$20240229$20240723$20240723$PER$$US-OTSUKA-2024_005609$OTSUKA$$7$DEC$$F$Y$$$20240723$$HP$US$US
241235241$24123524$1$I$20240201$20240229$20240723$20240723$PER$$US-OTSUKA-2024_005728$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241235251$24123525$1$I$$20240207$20240723$20240723$PER$$US-OTSUKA-2024_003632$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241235261$24123526$1$I$$20240219$20240723$20240723$PER$$US-OTSUKA-2024_004476$OTSUKA$$67$YR$$F$Y$63.5$KG$20240723$$CN$US$US
241235271$24123527$1$I$20231201$20240208$20240723$20240723$PER$$US-OTSUKA-2024_003769$OTSUKA$$17$YR$$F$Y$$$20240723$$MD$US$US
241235281$24123528$1$I$$20240206$20240723$20240723$EXP$$US-OTSUKA-2024_003261$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241235291$24123529$1$I$$20240228$20240723$20240723$PER$$US-OTSUKA-2024_005439$OTSUKA$$7$DEC$$F$Y$$$20240723$$MD$US$US
241235301$24123530$1$I$$20240227$20240723$20240723$EXP$$US-OTSUKA-2024_005509$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241235311$24123531$1$I$$20240110$20240723$20240723$PER$$US-OTSUKA-2024_001020$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241235321$24123532$1$I$$20240222$20240723$20240723$PER$$US-OTSUKA-2024_004923$OTSUKA$$8$DEC$$F$Y$$$20240723$$HP$US$US
241235331$24123533$1$I$20231201$20240110$20240723$20240723$PER$$US-OTSUKA-2024_000897$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241235341$24123534$1$I$$20240229$20240723$20240723$EXP$$US-OTSUKA-2024_005593$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241235351$24123535$1$I$$20240222$20240723$20240723$PER$$US-OTSUKA-2024_004903$OTSUKA$$8$DEC$$F$Y$$$20240723$$HP$US$US
241235361$24123536$1$I$$20240223$20240723$20240723$PER$$US-OTSUKA-2024_005021$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241235371$24123537$1$I$20240201$20240212$20240723$20240723$PER$$US-OTSUKA-2024_003906$OTSUKA$$25$YR$$M$Y$95.25$KG$20240723$$CN$US$US
241235381$24123538$1$I$$20240228$20240723$20240723$EXP$$US-OTSUKA-2024_005487$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241235391$24123539$1$I$$20240302$20240723$20240723$PER$$US-OTSUKA-2024_006095$OTSUKA$$6$DEC$$M$Y$$$20240723$$HP$US$US
241235401$24123540$1$I$$20240215$20240723$20240723$PER$$US-OTSUKA-2024_004254$OTSUKA$$45$YR$$F$Y$$$20240723$$HP$US$US
241235411$24123541$1$I$20240201$20240226$20240723$20240723$PER$$US-OTSUKA-2024_005195$OTSUKA$$71$YR$$M$Y$92.53$KG$20240723$$CN$US$US
241235421$24123542$1$I$20220401$20240301$20240723$20240723$PER$$US-OTSUKA-2024_005753$OTSUKA$$67$YR$$M$Y$89.36$KG$20240723$$CN$US$US
241235431$24123543$1$I$20230801$20240219$20240723$20240723$PER$$US-OTSUKA-2024_004538$OTSUKA$$53$YR$$F$Y$79.38$KG$20240723$$CN$US$US
241235441$24123544$1$I$$20240206$20240723$20240723$PER$$US-OTSUKA-2024_003260$OTSUKA$$$$$F$Y$102.51$KG$20240723$$HP$US$US
241235451$24123545$1$I$20240201$20240215$20240723$20240723$PER$$US-OTSUKA-2024_004250$OTSUKA$$73$YR$$F$Y$81.65$KG$20240723$$CN$US$US
241235461$24123546$1$I$$20240109$20240723$20240723$PER$$US-OTSUKA-2024_000874$OTSUKA$$$$$$Y$$$20240723$$PH$US$US
241235472$24123547$2$F$20230101$20240227$20240723$20240808$PER$$US-OTSUKA-2024_005367$OTSUKA$$67$YR$$F$Y$95.25$KG$20240808$$CN$US$US
241235481$24123548$1$I$$20240221$20240723$20240723$PER$$US-OTSUKA-2024_004852$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241235491$24123549$1$I$$20240205$20240723$20240723$PER$$US-OTSUKA-2024_003179$OTSUKA$$90$YR$$M$Y$$$20240723$$MD$US$US
241235501$24123550$1$I$$20240208$20240723$20240723$PER$$US-OTSUKA-2024_003529$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241235511$24123551$1$I$$20240201$20240723$20240723$PER$$US-OTSUKA-2024_002983$OTSUKA$$$$E$F$Y$$$20240723$$MD$US$US
241235531$24123553$1$I$$20240202$20240723$20240723$PER$$US-OTSUKA-2024_003004$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241235541$24123554$1$I$$20240207$20240723$20240723$PER$$US-OTSUKA-2024_003327$OTSUKA$$$$$F$Y$70.31$KG$20240723$$CN$US$US
241235551$24123555$1$I$$20240214$20240723$20240723$PER$$US-OTSUKA-2024_004245$OTSUKA$$43$YR$$M$Y$$$20240723$$HP$US$US
241235561$24123556$1$I$$20240228$20240723$20240723$PER$$US-OTSUKA-2024_005456$OTSUKA$$$$E$$Y$$$20240723$$MD$US$US
241235571$24123557$1$I$$20240220$20240723$20240723$PER$$US-OTSUKA-2024_004693$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241235581$24123558$1$I$$20240205$20240723$20240723$EXP$$US-OTSUKA-2024_000519$OTSUKA$$$$$F$Y$47.62$KG$20240723$$MD$US$US
241235591$24123559$1$I$20240201$20240221$20240723$20240723$PER$$US-OTSUKA-2024_004950$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241235601$24123560$1$I$$20240228$20240723$20240723$EXP$$US-OTSUKA-2024_005760$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241235611$24123561$1$I$20240109$20240110$20240723$20240723$PER$$US-OTSUKA-2024_000902$OTSUKA$$79$YR$$M$Y$$$20240723$$CN$US$US
241235621$24123562$1$I$$20240208$20240723$20240723$PER$$US-OTSUKA-2024_003531$OTSUKA$$27$YR$$F$Y$$$20240723$$HP$US$US
241235631$24123563$1$I$$20240220$20240723$20240723$EXP$$US-OTSUKA-2024_004691$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241235641$24123564$1$I$$20240212$20240723$20240723$PER$$US-OTSUKA-2024_003819$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241235651$24123565$1$I$$20240222$20240723$20240723$PER$$US-OTSUKA-2024_004966$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241235661$24123566$1$I$$20240214$20240723$20240723$PER$$US-OTSUKA-2023_032304$OTSUKA$$$$$M$Y$81.65$KG$20240723$$CN$US$US
241235671$24123567$1$I$$20240126$20240723$20240723$PER$$US-OTSUKA-2023_031072$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241235681$24123568$1$I$$20240205$20240723$20240723$PER$$US-OTSUKA-2023_032657$OTSUKA$$$$$F$Y$77.11$KG$20240723$$CN$US$US
241235691$24123569$1$I$$20240221$20240723$20240723$PER$$US-OTSUKA-2024_004953$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241235701$24123570$1$I$$20240207$20240723$20240723$PER$$US-OTSUKA-2024_003436$OTSUKA$$$$$M$Y$77.11$KG$20240723$$CN$US$US
241235711$24123571$1$I$$20240228$20240723$20240723$PER$$US-OTSUKA-2024_005488$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241235721$24123572$1$I$20240221$20240301$20240723$20240723$PER$$US-OTSUKA-2024_005715$OTSUKA$$48$YR$$F$Y$$$20240723$$CN$US$US
241235741$24123574$1$I$$20240212$20240723$20240723$PER$$US-OTSUKA-2024_004710$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241235751$24123575$1$I$20240201$20240226$20240723$20240723$PER$$US-OTSUKA-2024_005218$OTSUKA$$64$YR$$F$Y$76.2$KG$20240723$$CN$US$US
241235761$24123576$1$I$$20240222$20240723$20240723$PER$$US-OTSUKA-2024_005033$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241235771$24123577$1$I$$20240229$20240723$20240723$PER$$US-OTSUKA-2024_005582$OTSUKA$$55$YR$$M$Y$$$20240723$$MD$US$US
241235782$24123578$2$F$$20240229$20240723$20240808$PER$$US-OTSUKA-2024_005621$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241235791$24123579$1$I$$20240304$20240723$20240723$EXP$$US-OTSUKA-2024_006042$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
241235801$24123580$1$I$$20240215$20240723$20240723$PER$$US-OTSUKA-2024_004357$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241235811$24123581$1$I$$20240228$20240723$20240723$PER$$US-OTSUKA-2024_005592$OTSUKA$$62$YR$$F$Y$$$20240723$$MD$US$US
241235821$24123582$1$I$$20240212$20240723$20240723$PER$$US-OTSUKA-2024_004709$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241235831$24123583$1$I$$20240206$20240723$20240723$EXP$$US-OTSUKA-2024_003253$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241235841$24123584$1$I$20240213$20240214$20240723$20240723$PER$$US-OTSUKA-2024_004129$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241235851$24123585$1$I$$20240229$20240723$20240723$PER$$US-OTSUKA-2024_005624$OTSUKA$$$$E$F$Y$$$20240723$$HP$US$US
241235861$24123586$1$I$$20240216$20240723$20240723$PER$$US-OTSUKA-2024_004325$OTSUKA$$98$YR$$F$Y$$$20240723$$HP$US$US
241235871$24123587$1$I$$20240214$20240723$20240723$PER$$US-OTSUKA-2024_004127$OTSUKA$$$$E$F$Y$$$20240723$$MD$US$US
241235881$24123588$1$I$20240229$20240229$20240723$20240723$EXP$$US-OTSUKA-2024_005596$OTSUKA$$18$YR$$F$Y$$$20240723$$HP$US$US
241235891$24123589$1$I$20240201$20240301$20240723$20240723$PER$$US-OTSUKA-2024_005945$OTSUKA$$60$YR$$F$Y$$$20240723$$HP$US$US
241235901$24123590$1$I$$20240108$20240723$20240723$PER$$US-OTSUKA-2024_000675$OTSUKA$$7$DEC$$F$Y$$$20240723$$HP$US$US
241235911$24123591$1$I$$20240109$20240723$20240723$EXP$$US-OTSUKA-2024_000946$OTSUKA$$$$E$F$Y$$$20240723$$HP$US$US
241235921$24123592$1$I$$20240222$20240723$20240723$PER$$US-OTSUKA-2024_004949$OTSUKA$$$$$F$Y$80.74$KG$20240723$$PH$US$US
241235931$24123593$1$I$20240201$20240221$20240723$20240723$EXP$$US-OTSUKA-2024_004853$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241235941$24123594$1$I$$20240124$20240723$20240723$PER$$US-OTSUKA-2023_030840$OTSUKA$$$$$F$Y$72.57$KG$20240723$$CN$US$US
241235951$24123595$1$I$$20240112$20240723$20240723$PER$$US-OTSUKA-2024_001082$OTSUKA$$7$DEC$$F$Y$$$20240723$$MD$US$US
241235961$24123596$1$I$$20240304$20240723$20240723$PER$$US-OTSUKA-2024_005964$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241235971$24123597$1$I$$20240229$20240723$20240723$PER$$US-OTSUKA-2024_005628$OTSUKA$$25$YR$$M$Y$$$20240723$$HP$US$US
241235981$24123598$1$I$$20240126$20240723$20240723$PER$$US-OTSUKA-2023_031054$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241235991$24123599$1$I$20240104$20240225$20240723$20240723$EXP$$US-OTSUKA-2024_004188$OTSUKA$$19$YR$$F$Y$$$20240723$$HP$US$US
241236001$24123600$1$I$$20240213$20240723$20240723$PER$$US-OTSUKA-2024_003969$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241236011$24123601$1$I$$20240205$20240723$20240723$EXP$$US-OTSUKA-2023_031837$OTSUKA$$44$YR$$F$Y$$$20240723$$HP$US$US
241236021$24123602$1$I$$20240205$20240723$20240723$PER$$US-OTSUKA-2024_003160$OTSUKA$$$$$F$Y$29.48$KG$20240723$$MD$US$US
241236031$24123603$1$I$$20240206$20240723$20240723$PER$$US-OTSUKA-2024_003519$OTSUKA$$$$E$F$Y$$$20240723$$HP$US$US
241236041$24123604$1$I$$20240108$20240723$20240723$PER$$US-OTSUKA-2024_000906$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236051$24123605$1$I$$20240207$20240723$20240723$PER$$US-OTSUKA-2024_003611$OTSUKA$$95$YR$$F$Y$$$20240723$$HP$US$US
241236061$24123606$1$I$$20240219$20240723$20240723$PER$$US-OTSUKA-2024_004738$OTSUKA$$75$YR$$M$Y$$$20240723$$HP$US$US
241236071$24123607$1$I$$20240202$20240723$20240723$PER$$US-OTSUKA-2024_003046$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241236081$24123608$1$I$$20240212$20240723$20240723$PER$$US-OTSUKA-2024_003816$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241236091$24123609$1$I$$20240109$20240723$20240723$PER$$US-OTSUKA-2024_000759$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241236101$24123610$1$I$20230101$20240111$20240723$20240723$PER$$US-OTSUKA-2024_001010$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241236111$24123611$1$I$$20240216$20240723$20240723$PER$$US-OTSUKA-2024_004374$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241236121$24123612$1$I$$20240226$20240723$20240723$EXP$$US-OTSUKA-2024_005174$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
241236131$24123613$1$I$$20240226$20240723$20240723$PER$$US-OTSUKA-2024_005205$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241236141$24123614$1$I$$20240111$20240723$20240723$PER$$US-OTSUKA-2024_000951$OTSUKA$$37$YR$$F$Y$$$20240723$$MD$US$US
241236151$24123615$1$I$$20240221$20240723$20240723$PER$$US-OTSUKA-2024_004919$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
241236161$24123616$1$I$$20240222$20240723$20240723$PER$$US-OTSUKA-2024_004952$OTSUKA$$9$DEC$$M$Y$$$20240723$$HP$US$US
241236171$24123617$1$I$$20240227$20240723$20240723$PER$$US-OTSUKA-2024_005343$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236182$24123618$2$F$20240218$20240219$20240723$20240808$PER$$US-OTSUKA-2024_004527$OTSUKA$$81$YR$$M$Y$77.11$KG$20240808$$CN$US$US
241236192$24123619$2$F$20240627$20240726$20240723$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115985$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240731$$CN$US$US
241236201$24123620$1$I$$20240715$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407009802$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240723$$CN$US$US
241236211$24123621$1$I$20240713$20240715$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407009768$ELI LILLY AND CO$$64$YR$E$M$Y$$$20240723$$CN$US$US
241236221$24123622$1$I$20240101$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013043$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240723$$CN$US$US
241236231$24123623$1$I$$20240716$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011825$ELI LILLY AND CO$$$$$$Y$$$20240723$$HP$US$US
241236241$24123624$1$I$$20240715$20240723$20240723$EXP$$IT-AMGEN-ITASP2024144608$AMGEN$Maccora I.; Accardo V.; Cattalini M. et al.. Uveitis as predictor of disease flare after the first anti-TNF withdrawal in oligoarticular and polyarticular juvenile idiopathic arthritis: a multicentric Italian experience. Clinical and Experimental Rheumatology. 2023$$$$$Y$$$20240723$$HP$IT$IT
241236251$24123625$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024143110$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240723$$MD$US$US
241236261$24123626$1$I$20231201$20240205$20240723$20240723$PER$$US-AMGEN-USASP2024143686$AMGEN$$66$YR$E$M$Y$$$20240723$$CN$US$US
241236271$24123627$1$I$$20240314$20240723$20240723$PER$$US-OTSUKA-2024_007097$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236281$24123628$1$I$$20240427$20240723$20240723$PER$$US-OTSUKA-2024_004901$OTSUKA$$96$YR$$F$Y$$$20240723$$HP$US$US
241236291$24123629$1$I$$20240403$20240723$20240723$PER$$US-OTSUKA-2024_009193$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241236301$24123630$1$I$20240101$20240329$20240723$20240723$PER$$US-OTSUKA-2024_008696$OTSUKA$$47$YR$$F$Y$$$20240723$$HP$US$US
241236311$24123631$1$I$$20240409$20240723$20240723$PER$$US-OTSUKA-2024_010441$OTSUKA$$60$YR$$F$Y$$$20240723$$HP$US$US
241236321$24123632$1$I$$20240320$20240723$20240723$PER$$US-OTSUKA-2024_007611$OTSUKA$$$$E$F$Y$$$20240723$$MD$US$US
241236331$24123633$1$I$$20240405$20240723$20240723$PER$$US-OTSUKA-2024_009546$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
241236341$24123634$1$I$$20240328$20240723$20240723$EXP$$US-OTSUKA-2024_008658$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241236351$24123635$1$I$$20240408$20240723$20240723$PER$$US-OTSUKA-2024_003326$OTSUKA$$54$YR$$F$Y$$$20240723$$HP$US$US
241236361$24123636$1$I$$20240402$20240723$20240723$PER$$US-OTSUKA-2024_009056$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241236371$24123637$1$I$$20240327$20240723$20240723$PER$$US-OTSUKA-2024_008396$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241236381$24123638$1$I$$20240404$20240723$20240723$PER$$US-OTSUKA-2024_009356$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241236391$24123639$1$I$$20240313$20240723$20240723$PER$$US-OTSUKA-2024_006920$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241236401$24123640$1$I$$20240328$20240723$20240723$PER$$US-OTSUKA-2024_008558$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241236411$24123641$1$I$$20240328$20240723$20240723$PER$$US-OTSUKA-2024_008517$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236421$24123642$1$I$$20240410$20240723$20240723$PER$$US-OTSUKA-2024_006834$OTSUKA$$38$YR$$F$Y$73.92$KG$20240723$$MD$US$US
241236432$24123643$2$F$$20240319$20240723$20240808$EXP$$US-OTSUKA-2024_007485$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241236441$24123644$1$I$$20240326$20240723$20240723$PER$$US-OTSUKA-2024_008296$OTSUKA$$4$DEC$$F$Y$$$20240723$$MD$US$US
241236451$24123645$1$I$$20240314$20240723$20240723$PER$$US-OTSUKA-2024_007217$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241236461$24123646$1$I$$20240325$20240723$20240723$PER$$US-OTSUKA-2024_008138$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241236471$24123647$1$I$20231201$20240329$20240723$20240723$PER$$US-OTSUKA-2024_008695$OTSUKA$$50$YR$$F$Y$$$20240723$$HP$US$US
241236481$24123648$1$I$$20240716$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-113628$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240723$$HP$CA$CA
241236492$24123649$2$F$$20240311$20240723$20240808$PER$$US-OTSUKA-2024_006545$OTSUKA$$38$YR$$F$Y$$$20240808$$MD$US$US
241236501$24123650$1$I$$20240505$20240723$20240723$PER$$US-OTSUKA-2024_006217$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236511$24123651$1$I$$20240308$20240723$20240723$PER$$US-OTSUKA-2024_006421$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241236521$24123652$1$I$20240301$20240402$20240723$20240723$PER$$US-OTSUKA-2024_009029$OTSUKA$$$$E$F$Y$$$20240723$$MD$US$US
241236531$24123653$1$I$$20240312$20240723$20240723$PER$$US-OTSUKA-2024_006657$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236541$24123654$1$I$$20240408$20240723$20240723$EXP$$US-OTSUKA-2024_010289$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241236551$24123655$1$I$$20240327$20240723$20240723$PER$$US-OTSUKA-2024_008393$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241236561$24123656$1$I$$20240330$20240723$20240723$PER$$US-OTSUKA-2024_008697$OTSUKA$$40$YR$$F$Y$$$20240723$$CN$US$US
241236571$24123657$1$I$$20240327$20240723$20240723$PER$$US-OTSUKA-2024_008445$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241236582$24123658$2$F$20231201$20240403$20240723$20240808$PER$$US-OTSUKA-2024_009147$OTSUKA$$68$YR$$F$Y$$$20240808$$CN$US$US
241236591$24123659$1$I$$20240320$20240723$20240723$PER$$US-OTSUKA-2024_007606$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241236601$24123660$1$I$$20240328$20240723$20240723$PER$$US-OTSUKA-2024_008650$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241236611$24123661$1$I$$20240308$20240723$20240723$PER$$US-OTSUKA-2024_000664$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241236621$24123662$1$I$$20240312$20240723$20240723$PER$$US-OTSUKA-2024_006832$OTSUKA$$13$YR$$$Y$$$20240723$$MD$US$US
241236631$24123663$1$I$$20240327$20240723$20240723$PER$$US-OTSUKA-2024_007687$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236641$24123664$1$I$$20240326$20240723$20240723$PER$$US-OTSUKA-2024_008603$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241236651$24123665$1$I$$20240326$20240723$20240723$PER$$US-OTSUKA-2024_008419$OTSUKA$$40$YR$$F$Y$$$20240723$$MD$US$US
241236661$24123666$1$I$$20240409$20240723$20240723$PER$$US-OTSUKA-2024_010549$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241236671$24123667$1$I$$20240405$20240723$20240723$PER$$US-OTSUKA-2024_010206$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
241236681$24123668$1$I$$20240329$20240723$20240723$PER$$US-OTSUKA-2024_008675$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
241236691$24123669$1$I$20240313$20240313$20240723$20240723$PER$$US-OTSUKA-2024_006902$OTSUKA$$83$YR$$F$Y$74.84$KG$20240723$$CN$US$US
241236701$24123670$1$I$$20240308$20240723$20240723$PER$$US-OTSUKA-2024_006440$OTSUKA$$9$DEC$$F$Y$$$20240723$$MD$US$US
241236711$24123671$1$I$20240314$20240419$20240723$20240723$PER$$US-OTSUKA-2024_007605$OTSUKA$$72$YR$$F$Y$$$20240723$$HP$US$US
241236721$24123672$1$I$$20240308$20240723$20240723$PER$$US-OTSUKA-2024_006445$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236731$24123673$1$I$$20240328$20240723$20240723$PER$$US-OTSUKA-2024_008676$OTSUKA$$$$E$M$Y$$$20240723$$HP$US$US
241236741$24123674$1$I$$20240306$20240723$20240723$PER$$US-OTSUKA-2024_006435$OTSUKA$$21$YR$$M$Y$$$20240723$$CN$US$US
241236751$24123675$1$I$$20240408$20240723$20240723$PER$$US-OTSUKA-2024_011189$OTSUKA$$90$YR$$F$Y$$$20240723$$HP$US$US
241236761$24123676$1$I$$20240401$20240723$20240723$PER$$US-OTSUKA-2024_008748$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
241236771$24123677$1$I$$20240327$20240723$20240723$PER$$US-OTSUKA-2024_008537$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236781$24123678$1$I$$20240314$20240723$20240723$EXP$$US-OTSUKA-2024_007043$OTSUKA$$82$YR$$F$Y$$$20240723$$CN$US$US
241236791$24123679$1$I$$20240314$20240723$20240723$PER$$US-OTSUKA-2024_007046$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241236801$24123680$1$I$20240101$20240307$20240723$20240723$PER$$US-OTSUKA-2024_003783$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241236811$24123681$1$I$$20240321$20240723$20240723$EXP$$US-OTSUKA-2024_007738$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241236821$24123682$1$I$20240405$20240408$20240723$20240723$PER$$US-OTSUKA-2024_010188$OTSUKA$$74$YR$$F$Y$78.02$KG$20240723$$CN$US$US
241236831$24123683$1$I$$20240312$20240723$20240723$PER$$US-OTSUKA-2024_004244$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241236841$24123684$1$I$$20240328$20240723$20240723$EXP$$US-OTSUKA-2024_008666$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236851$24123685$1$I$$20240312$20240723$20240723$PER$$US-OTSUKA-2024_006760$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241236861$24123686$1$I$20231201$20240308$20240723$20240723$PER$$US-OTSUKA-2024_000270$OTSUKA$$70$YR$$F$Y$63.49$KG$20240723$$MD$US$US
241236871$24123687$1$I$$20240318$20240723$20240723$PER$$US-OTSUKA-2024_007447$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236881$24123688$1$I$$20240329$20240723$20240723$PER$$US-OTSUKA-2024_008681$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241236891$24123689$1$I$20231223$20240322$20240723$20240723$PER$$US-OTSUKA-2024_007906$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241236901$24123690$1$I$$20240409$20240723$20240723$PER$$US-OTSUKA-2024_010615$OTSUKA$$75$YR$$M$Y$$$20240723$$CN$US$US
241236911$24123691$1$I$$20240318$20240723$20240723$PER$$US-OTSUKA-2024_007279$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241236921$24123692$1$I$$20240505$20240723$20240723$PER$$US-OTSUKA-2024_006197$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236931$24123693$1$I$$20240319$20240723$20240723$PER$$US-OTSUKA-2024_007490$OTSUKA$$79$YR$$M$Y$$$20240723$$HP$US$US
241236941$24123694$1$I$20240201$20240313$20240723$20240723$PER$$US-OTSUKA-2024_006905$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241236951$24123695$1$I$$20240304$20240723$20240723$PER$$US-OTSUKA-2024_005960$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241236961$24123696$1$I$$20240321$20240723$20240723$PER$$US-OTSUKA-2024_008142$OTSUKA$$$$C$$Y$$$20240723$$CN$US$US
241236971$24123697$1$I$$20240305$20240723$20240723$EXP$$US-OTSUKA-2024_006231$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241236981$24123698$1$I$$20240405$20240723$20240723$PER$$US-OTSUKA-2024_007045$OTSUKA$$$$$F$Y$91.17$KG$20240723$$CN$US$US
241236991$24123699$1$I$$20240403$20240723$20240723$PER$$US-OTSUKA-2024_009198$OTSUKA$$17$YR$$F$Y$$$20240723$$HP$US$US
241237001$24123700$1$I$$20240313$20240723$20240723$PER$$US-OTSUKA-2024_006915$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241237011$24123701$1$I$$20240318$20240723$20240723$PER$$US-OTSUKA-2024_007288$OTSUKA$$62$YR$$M$Y$$$20240723$$CN$US$US
241237021$24123702$1$I$20240308$20240314$20240723$20240723$PER$$US-OTSUKA-2024_007054$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241237031$24123703$1$I$$20240327$20240723$20240723$PER$$US-OTSUKA-2024_008453$OTSUKA$$$$$F$Y$$$20240723$$PH$US$US
241237042$24123704$2$F$$20240318$20240723$20240808$PER$$US-OTSUKA-2024_007313$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241237051$24123705$1$I$$20240313$20240723$20240723$PER$$US-OTSUKA-2024_006939$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241237061$24123706$1$I$$20240419$20240723$20240723$PER$$US-OTSUKA-2024_005057$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241237071$24123707$1$I$$20240506$20240723$20240723$PER$$US-OTSUKA-2024_013363$OTSUKA$$$$$$Y$$$20240723$$PH$US$US
241237081$24123708$1$I$$20240322$20240723$20240723$PER$$US-OTSUKA-2024_007903$OTSUKA$$64$YR$$M$Y$$$20240723$$HP$US$US
241237091$24123709$1$I$$20240305$20240723$20240723$PER$$US-OTSUKA-2024_006219$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241237101$24123710$1$I$$20240408$20240723$20240723$PER$$US-OTSUKA-2024_011188$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241237111$24123711$1$I$$20240321$20240723$20240723$PER$$US-OTSUKA-2024_007785$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241237121$24123712$1$I$$20240505$20240723$20240723$PER$$US-OTSUKA-2024_006283$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241237131$24123713$1$I$20231201$20240321$20240723$20240723$PER$$US-OTSUKA-2024_007692$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241237141$24123714$1$I$$20240319$20240723$20240723$PER$$US-OTSUKA-2024_007591$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
241237151$24123715$1$I$20240304$20240304$20240723$20240723$PER$$US-OTSUKA-2024_005864$OTSUKA$$38$YR$$F$Y$111.11$KG$20240723$$CN$US$US
241237161$24123716$1$I$$20240306$20240723$20240723$PER$$US-OTSUKA-2024_006179$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241237171$24123717$1$I$$20240505$20240723$20240723$PER$$US-OTSUKA-2024_006174$OTSUKA$$90$YR$$F$Y$$$20240723$$MD$US$US
241237182$24123718$2$F$$20240319$20240723$20240808$EXP$$US-OTSUKA-2024_007486$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241237191$24123719$1$I$$20240327$20240723$20240723$PER$$US-OTSUKA-2024_008457$OTSUKA$$5$DEC$$M$Y$$$20240723$$HP$US$US
241237201$24123720$1$I$$20240321$20240723$20240723$PER$$US-OTSUKA-2024_007740$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241237211$24123721$1$I$$20240322$20240723$20240723$EXP$$US-OTSUKA-2024_007862$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241237221$24123722$1$I$$20240321$20240723$20240723$PER$$US-OTSUKA-2024_007778$OTSUKA$$48$YR$$F$Y$$$20240723$$MD$US$US
241237231$24123723$1$I$$20240321$20240723$20240723$EXP$$US-OTSUKA-2024_007685$OTSUKA$$64$YR$$F$Y$$$20240723$$MD$US$US
241237241$24123724$1$I$$20240307$20240723$20240723$PER$$US-OTSUKA-2024_006299$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241237251$24123725$1$I$$20240320$20240723$20240723$PER$$US-OTSUKA-2024_003995$OTSUKA$$3$DEC$$M$Y$$$20240723$$HP$US$US
241237261$24123726$1$I$$20240314$20240723$20240723$PER$$US-OTSUKA-2024_007074$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241237271$24123727$1$I$$20240711$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111661$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240719$$CN$US$US
241237282$24123728$2$F$$20240314$20240723$20240808$PER$$US-OTSUKA-2024_007145$OTSUKA$Kim J, Tsygankova V, Le K, Keshishyan A, Perna J, Hermida AP.. Consideration of ECT Electrode Placement in a Patient with Post-stroke Encephalomalacia and Heart Transplant. American Journal of Geriatric Psychiatry. 2024;32(4):S98$63$YR$$F$Y$$$20240808$$HP$US$US
241237291$24123729$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024144958$AMGEN$$6$YR$C$F$Y$$$20240723$$CN$US$US
241237301$24123730$1$I$20240101$20240718$20240723$20240723$EXP$$US-UCBSA-2024016936$UCB$$$$$F$Y$$$20240723$$CN$US$US
241237311$24123731$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114001$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240719$$CN$US$US
241237321$24123732$1$I$$20240318$20240723$20240723$PER$$US-OTSUKA-2024_007448$OTSUKA$$71$YR$$F$Y$$$20240723$$PH$US$US
241237331$24123733$1$I$$20240509$20240723$20240723$PER$$US-OTSUKA-2024_013450$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241237341$24123734$1$I$$20240510$20240723$20240723$PER$$US-OTSUKA-2024_006826$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241237351$24123735$1$I$$20240325$20240723$20240723$PER$$US-OTSUKA-2024_008276$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241237361$24123736$1$I$$20240509$20240723$20240723$PER$$US-OTSUKA-2024_013460$OTSUKA$$3$DEC$$F$Y$$$20240723$$HP$US$US
241237371$24123737$1$I$$20240510$20240723$20240723$PER$$US-OTSUKA-2024_013608$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241237381$24123738$1$I$$20240514$20240723$20240723$PER$$US-OTSUKA-2024_013946$OTSUKA$$$$E$$Y$$$20240723$$MD$US$US
241237391$24123739$1$I$$20240509$20240723$20240723$PER$$US-OTSUKA-2024_013463$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241237401$24123740$1$I$$20240318$20240723$20240723$PER$$US-OTSUKA-2024_007272$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241237411$24123741$1$I$20231122$20240514$20240723$20240723$PER$$US-OTSUKA-2024_014050$OTSUKA$$86$YR$$M$Y$$$20240723$$HP$US$US
241237421$24123742$1$I$$20240507$20240723$20240723$PER$$US-OTSUKA-2024_013366$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241237432$24123743$2$F$$20240516$20240723$20240808$PER$$US-OTSUKA-2024_014176$OTSUKA$$86$YR$$F$Y$$$20240808$$HP$US$US
241237441$24123744$1$I$$20240510$20240723$20240723$EXP$$US-OTSUKA-2024_013597$OTSUKA$$7$DEC$$F$Y$$$20240723$$HP$US$US
241237451$24123745$1$I$$20240513$20240723$20240723$PER$$US-OTSUKA-2024_013736$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241237461$24123746$1$I$$20240527$20240723$20240723$PER$$US-OTSUKA-2024_013613$OTSUKA$$79$YR$$M$Y$$$20240723$$CN$US$US
241237471$24123747$1$I$$20240514$20240723$20240723$PER$$US-OTSUKA-2024_013941$OTSUKA$$38$YR$$F$Y$$$20240723$$MD$US$US
241237481$24123748$1$I$$20240516$20240723$20240723$PER$$US-OTSUKA-2024_014187$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241237491$24123749$1$I$20240530$20240603$20240723$20240723$PER$$US-OTSUKA-2024_015896$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241237501$24123750$1$I$$20240517$20240723$20240723$PER$$US-OTSUKA-2024_014311$OTSUKA$$$$$F$Y$54.43$KG$20240723$$CN$US$US
241237511$24123751$1$I$$20240516$20240723$20240723$EXP$$US-OTSUKA-2024_014164$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241237521$24123752$1$I$$20240514$20240723$20240723$PER$$US-OTSUKA-2024_014048$OTSUKA$$75$YR$$F$Y$$$20240723$$HP$US$US
241237531$24123753$1$I$$20240514$20240723$20240723$PER$$US-OTSUKA-2024_013925$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
241237541$24123754$1$I$20230611$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031422$OTSUKA$$55$YR$$F$Y$$$20240723$$CN$US$US
241237551$24123755$1$I$$20240314$20240723$20240723$PER$$US-OTSUKA-2024_007047$OTSUKA$$45$YR$$F$Y$$$20240723$$MD$US$US
241237561$24123756$1$I$$20240513$20240723$20240723$PER$$US-OTSUKA-2024_013751$OTSUKA$$72$YR$$M$Y$$$20240723$$CN$US$US
241237571$24123757$1$I$$20240510$20240723$20240723$PER$$US-OTSUKA-2024_013578$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241237581$24123758$1$I$$20240603$20240723$20240723$PER$$US-OTSUKA-2024_015901$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241237591$24123759$1$I$$20240510$20240723$20240723$PER$$US-OTSUKA-2024_013577$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241237601$24123760$1$I$$20240516$20240723$20240723$PER$$US-OTSUKA-2024_014227$OTSUKA$$4$DEC$$F$Y$$$20240723$$MD$US$US
241237611$24123761$1$I$20231030$20231030$20240723$20240723$EXP$$US-OTSUKA-2023_028511$OTSUKA$$62$YR$$F$Y$69.85$KG$20240723$$CN$US$US
241237621$24123762$1$I$$20231030$20240723$20240723$PER$$US-OTSUKA-2023_028610$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241237631$24123763$1$I$$20240514$20240723$20240723$PER$$US-OTSUKA-2024_013948$OTSUKA$$$$E$F$Y$$$20240723$$HP$US$US
241237641$24123764$1$I$$20240510$20240723$20240723$PER$$US-OTSUKA-2024_007048$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241237651$24123765$1$I$$20240517$20240723$20240723$PER$$US-OTSUKA-2024_014291$OTSUKA$$49$YR$$F$Y$$$20240723$$HP$US$US
241237661$24123766$1$I$$20240603$20240723$20240723$PER$$US-OTSUKA-2024_015904$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241237671$24123767$1$I$$20240502$20240723$20240723$PER$$US-OTSUKA-2024_005037$OTSUKA$$8$DEC$$M$Y$$$20240723$$MD$US$US
241237681$24123768$1$I$$20240514$20240723$20240723$PER$$US-OTSUKA-2024_013897$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241237691$24123769$1$I$20230101$20231101$20240723$20240723$PER$$US-OTSUKA-2023_028707$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241237701$24123770$1$I$20230113$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031420$OTSUKA$$33$YR$$M$Y$$$20240723$$CN$US$US
241237711$24123771$1$I$20231220$20240514$20240723$20240723$PER$$US-OTSUKA-2024_014085$OTSUKA$$9$DEC$$F$Y$$$20240723$$HP$US$US
241237721$24123772$1$I$$20240522$20240723$20240723$PER$$US-OTSUKA-2024_014737$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241237731$24123773$1$I$$20240520$20240723$20240723$PER$$US-OTSUKA-2024_007274$OTSUKA$$$$$F$Y$63.49$KG$20240723$$HP$US$US
241237741$24123774$1$I$$20240617$20240723$20240723$PER$$US-OTSUKA-2024_007216$OTSUKA$$3$DEC$$F$Y$$$20240723$$MD$US$US
241237751$24123775$1$I$$20231101$20240723$20240723$PER$$US-OTSUKA-2023_028714$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241237761$24123776$1$I$$20240514$20240723$20240723$EXP$$US-OTSUKA-2024_014094$OTSUKA$$3$DEC$$F$Y$$$20240723$$HP$US$US
241237771$24123777$1$I$20230528$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031421$OTSUKA$$30$YR$$M$Y$$$20240723$$CN$US$US
241237781$24123778$1$I$$20240517$20240723$20240723$PER$$US-OTSUKA-2024_007646$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241237791$24123779$1$I$$20231101$20240723$20240723$PER$$US-OTSUKA-2023_028691$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241237801$24123780$1$I$$20231101$20240723$20240723$PER$$US-OTSUKA-2023_028687$OTSUKA$$85$YR$$F$Y$$$20240723$$MD$US$US
241237811$24123781$1$I$20221012$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031414$OTSUKA$$37$YR$$M$Y$$$20240723$$CN$US$US
241237821$24123782$1$I$20231001$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031423$OTSUKA$$44$YR$$F$Y$$$20240723$$CN$US$US
241237831$24123783$1$I$$20240603$20240723$20240723$PER$$US-OTSUKA-2024_015843$OTSUKA$$95$YR$$F$Y$$$20240723$$MD$US$US
241237841$24123784$1$I$20230926$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031424$OTSUKA$$43$YR$$M$Y$$$20240723$$CN$US$US
241237851$24123785$1$I$20221014$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031415$OTSUKA$$50$YR$$F$Y$$$20240723$$CN$US$US
241237861$24123786$1$I$$20240603$20240723$20240723$PER$$US-OTSUKA-2024_015973$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241237871$24123787$1$I$$20231101$20240723$20240723$PER$$US-OTSUKA-2023_028690$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241237881$24123788$1$I$20230203$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031418$OTSUKA$$52$YR$$F$Y$$$20240723$$CN$US$US
241237891$24123789$1$I$$20231201$20240723$20240723$PER$$US-OTSUKA-2023_031457$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241237901$24123790$1$I$$20231201$20240723$20240723$PER$$US-OTSUKA-2023_031460$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
241237911$24123791$1$I$20230321$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031416$OTSUKA$$31$YR$$F$Y$$$20240723$$CN$US$US
241237921$24123792$1$I$20230226$20231130$20240723$20240723$PER$$US-OTSUKA-2023_031419$OTSUKA$$29$YR$$F$Y$$$20240723$$CN$US$US
241237931$24123793$1$I$20230717$20240710$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110527$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240719$$PH$US$US
241237941$24123794$1$I$20240101$20240712$20240723$20240723$EXP$$US-ABBVIE-5848448$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241237951$24123795$1$I$20201201$20240711$20240723$20240723$PER$$US-ROCHE-3574034$ROCHE$Liguori N, Longo M and Safran H. Abdominal aortitis with immune checkpoint inhibition. DOI:100092Z10NL2021. J Case Rep Images in Oncology 2021;7:-.$43$YR$A$M$Y$$$20240723$$HP$US$US
241237961$24123796$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113755$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$89.81$KG$20240719$$CN$US$US
241237971$24123797$1$I$$20240103$20240723$20240723$EXP$$US-OTSUKA-2024_000207$OTSUKA$$65$YR$$M$Y$$$20240723$$HP$US$US
241237981$24123798$1$I$$20240416$20240723$20240723$PER$$US-OTSUKA-2024_012161$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241237991$24123799$1$I$20230101$20231205$20240723$20240723$PER$$US-OTSUKA-2023_031723$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241238002$24123800$2$F$$20240220$20240723$20240808$PER$$US-OTSUKA-2024_004701$OTSUKA$$39$YR$$M$Y$$$20240808$$MD$US$US
241238011$24123801$1$I$$20240102$20240723$20240723$PER$$US-OTSUKA-2024_000118$OTSUKA$$4$DEC$$F$Y$$$20240723$$MD$US$US
241238021$24123802$1$I$$20240422$20240723$20240723$PER$$US-OTSUKA-2024_011763$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241238031$24123803$1$I$$20240221$20240723$20240723$PER$$US-OTSUKA-2024_004823$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241238041$24123804$1$I$$20240425$20240723$20240723$PER$$US-OTSUKA-2024_009220$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241238051$24123805$1$I$$20231205$20240723$20240723$PER$$US-OTSUKA-2023_031717$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241238061$24123806$1$I$20230101$20240205$20240723$20240723$PER$$US-OTSUKA-2023_031461$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241238071$24123807$1$I$$20231205$20240723$20240723$PER$$US-OTSUKA-2023_031715$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241238081$24123808$1$I$$20240415$20240723$20240723$PER$$US-OTSUKA-2024_010937$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241238091$24123809$1$I$$20240102$20240723$20240723$PER$$US-OTSUKA-2024_000115$OTSUKA$$9$DEC$$F$Y$$$20240723$$MD$US$US
241238101$24123810$1$I$$20240417$20240723$20240723$PER$$US-OTSUKA-2024_011249$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241238111$24123811$1$I$$20240418$20240723$20240723$PER$$US-OTSUKA-2024_011521$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241238121$24123812$1$I$$20240425$20240723$20240723$PER$$US-OTSUKA-2024_012171$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241238131$24123813$1$I$$20240409$20240723$20240723$PER$$US-OTSUKA-2024_010438$OTSUKA$$4$DEC$$F$Y$$$20240723$$HP$US$US
241238141$24123814$1$I$$20240424$20240723$20240723$EXP$$US-OTSUKA-2024_012042$OTSUKA$$72$YR$$F$Y$$$20240723$$MD$US$US
241238151$24123815$1$I$$20240417$20240723$20240723$PER$$US-OTSUKA-2024_011326$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241238161$24123816$1$I$$20240131$20240723$20240723$EXP$$US-OTSUKA-2024_002724$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
241238171$24123817$1$I$$20240119$20240723$20240723$PER$$US-OTSUKA-2024_001747$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241238181$24123818$1$I$$20240124$20240723$20240723$EXP$$US-OTSUKA-2024_002156$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241238191$24123819$1$I$$20240221$20240723$20240723$EXP$$US-OTSUKA-2024_004804$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241238202$24123820$2$F$$20240416$20240723$20240808$PER$$US-OTSUKA-2024_011302$OTSUKA$$$$E$F$Y$$$20240808$$HP$US$US
241238211$24123821$1$I$$20240416$20240723$20240723$PER$$US-OTSUKA-2024_011232$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241238221$24123822$1$I$$20240221$20240723$20240723$PER$$US-OTSUKA-2024_004838$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241238231$24123823$1$I$$20231226$20240723$20240723$PER$$US-OTSUKA-2023_033848$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241238241$24123824$1$I$$20240122$20240723$20240723$PER$$US-OTSUKA-2024_002010$OTSUKA$$72$YR$$M$Y$$$20240723$$MD$US$US
241238251$24123825$1$I$$20240221$20240723$20240723$EXP$$US-OTSUKA-2024_004799$OTSUKA$$78$YR$$F$Y$$$20240723$$MD$US$US
241238262$24123826$2$F$20230101$20231228$20240723$20240808$EXP$$US-OTSUKA-2023_034027$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241238271$24123827$1$I$$20240118$20240723$20240723$EXP$$US-OTSUKA-2024_001652$OTSUKA$$7$DEC$$F$Y$$$20240723$$HP$US$US
241238281$24123828$1$I$$20240415$20240723$20240723$PER$$US-OTSUKA-2024_011082$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241238291$24123829$1$I$20240401$20240426$20240723$20240723$PER$$US-OTSUKA-2024_012544$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241238301$24123830$1$I$$20231221$20240723$20240723$PER$$US-OTSUKA-2023_033723$OTSUKA$$29$YR$$F$Y$$$20240723$$CN$US$US
241238311$24123831$1$I$$20240423$20240723$20240723$PER$$US-OTSUKA-2024_011921$OTSUKA$$43$YR$$F$Y$$$20240723$$CN$US$US
241238321$24123832$1$I$$20240122$20240723$20240723$PER$$US-OTSUKA-2024_001856$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241238331$24123833$1$I$$20240124$20240723$20240723$PER$$US-OTSUKA-2024_002165$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241238341$24123834$1$I$20240409$20240411$20240723$20240723$PER$$US-OTSUKA-2024_010849$OTSUKA$$38$YR$$F$Y$$$20240723$$HP$US$US
241238351$24123835$1$I$$20240417$20240723$20240723$PER$$US-OTSUKA-2024_011358$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241238361$24123836$1$I$$20240425$20240723$20240723$PER$$US-OTSUKA-2024_012294$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241238371$24123837$1$I$$20240410$20240723$20240723$PER$$US-OTSUKA-2024_010716$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241238381$24123838$1$I$$20240423$20240723$20240723$PER$$US-OTSUKA-2024_011833$OTSUKA$$$$A$M$Y$$$20240723$$MD$US$US
241238391$24123839$1$I$$20240131$20240723$20240723$PER$$US-OTSUKA-2024_002713$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
241238401$24123840$1$I$$20240416$20240723$20240723$PER$$US-OTSUKA-2024_011502$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241238411$24123841$1$I$$20240415$20240723$20240723$PER$$US-OTSUKA-2024_010946$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241238421$24123842$1$I$20240401$20240423$20240723$20240723$PER$$US-OTSUKA-2024_011994$OTSUKA$$$$E$F$Y$$$20240723$$HP$US$US
241238431$24123843$1$I$$20240418$20240723$20240723$EXP$$US-OTSUKA-2024_011464$OTSUKA$$85$YR$$M$Y$$$20240723$$HP$US$US
241238441$24123844$1$I$$20240119$20240723$20240723$PER$$US-OTSUKA-2024_001702$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241238451$24123845$1$I$$20240410$20240723$20240723$PER$$US-OTSUKA-2024_010748$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
241238461$24123846$1$I$$20240415$20240723$20240723$PER$$US-OTSUKA-2024_011014$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241238471$24123847$1$I$$20240426$20240723$20240723$PER$$US-OTSUKA-2024_012264$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241238481$24123848$1$I$20240319$20240411$20240723$20240723$PER$$US-OTSUKA-2024_008090$OTSUKA$$4$DEC$$M$Y$$$20240723$$HP$US$US
241238491$24123849$1$I$$20240117$20240723$20240723$EXP$$US-OTSUKA-2024_001468$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241238501$24123850$1$I$$20240220$20240723$20240723$PER$$US-OTSUKA-2024_004833$OTSUKA$$71$YR$$F$Y$$$20240723$$HP$US$US
241238511$24123851$1$I$$20240411$20240723$20240723$PER$$US-OTSUKA-2024_010826$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241238521$24123852$1$I$20240119$20240122$20240723$20240723$PER$$US-OTSUKA-2024_002058$OTSUKA$$41$YR$$F$Y$$$20240723$$CN$US$US
241238531$24123853$1$I$$20240116$20240723$20240723$PER$$US-OTSUKA-2024_001326$OTSUKA$$5$DEC$$F$Y$$$20240723$$MD$US$US
241238541$24123854$1$I$$20240422$20240723$20240723$PER$$US-OTSUKA-2024_011760$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241238551$24123855$1$I$20231201$20240423$20240723$20240723$PER$$US-OTSUKA-2024_011961$OTSUKA$$85$YR$$F$Y$68.49$KG$20240723$$CN$US$US
241238561$24123856$1$I$$20240125$20240723$20240723$PER$$US-OTSUKA-2024_002281$OTSUKA$$92$YR$$F$Y$$$20240723$$CN$US$US
241238571$24123857$1$I$$20240129$20240723$20240723$EXP$$US-OTSUKA-2024_002601$OTSUKA$$8$DEC$$$Y$$$20240723$$MD$US$US
241238581$24123858$1$I$$20240424$20240723$20240723$PER$$US-OTSUKA-2024_012147$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241238591$24123859$1$I$20240101$20240117$20240723$20240723$PER$$US-OTSUKA-2024_001541$OTSUKA$$43$YR$$F$Y$$$20240723$$HP$US$US
241238601$24123860$1$I$$20240130$20240723$20240723$PER$$US-OTSUKA-2024_002692$OTSUKA$$$$A$F$Y$$$20240723$$HP$US$US
241238611$24123861$1$I$$20240411$20240723$20240723$PER$$US-OTSUKA-2024_010841$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241238622$24123862$2$F$$20240419$20240723$20240808$PER$$US-OTSUKA-2024_011526$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241238631$24123863$1$I$$20240122$20240723$20240723$PER$$US-OTSUKA-2024_001845$OTSUKA$$$$$F$Y$72.57$KG$20240723$$CN$US$US
241238641$24123864$1$I$$20240220$20240723$20240723$EXP$$US-OTSUKA-2024_004650$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241238651$24123865$1$I$$20240119$20240723$20240723$PER$$US-OTSUKA-2024_001771$OTSUKA$$6$DEC$$F$Y$$$20240723$$MD$US$US
241238661$24123866$1$I$$20240423$20240723$20240723$PER$$US-OTSUKA-2024_011957$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241238671$24123867$1$I$$20231201$20240723$20240723$PER$$US-OTSUKA-2023_031462$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
241238681$24123868$1$I$$20240123$20240723$20240723$PER$$US-OTSUKA-2024_002014$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241238691$24123869$1$I$$20240411$20240723$20240723$PER$$US-OTSUKA-2024_010835$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241238701$24123870$1$I$$20240125$20240723$20240723$PER$$US-OTSUKA-2024_002238$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241238712$24123871$2$F$$20231222$20240723$20240808$PER$$US-OTSUKA-2023_033728$OTSUKA$$$$$M$Y$117.93$KG$20240808$$CN$US$US
241238721$24123872$1$I$$20240417$20240723$20240723$PER$$US-OTSUKA-2024_011437$OTSUKA$$76$YR$$F$Y$$$20240723$$MD$US$US
241238731$24123873$1$I$$20240424$20240723$20240723$PER$$US-OTSUKA-2024_012040$OTSUKA$$74$YR$$F$Y$$$20240723$$CN$US$US
241238741$24123874$1$I$$20240424$20240723$20240723$PER$$US-OTSUKA-2024_012058$OTSUKA$$9$DEC$$F$Y$$$20240723$$HP$US$US
241238751$24123875$1$I$$20240419$20240723$20240723$PER$$US-OTSUKA-2024_011541$OTSUKA$$$$$F$Y$$$20240723$$PH$US$US
241238761$24123876$1$I$$20240416$20240723$20240723$PER$$US-OTSUKA-2024_011168$OTSUKA$$$$$M$Y$$$20240723$$MD$US$US
241238771$24123877$1$I$$20240111$20240723$20240723$PER$$US-OTSUKA-2024_001140$OTSUKA$$8$DEC$$M$Y$$$20240723$$MD$US$US
241238781$24123878$1$I$$20240415$20240723$20240723$PER$$US-OTSUKA-2024_010994$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241238791$24123879$1$I$20240129$20240418$20240723$20240723$PER$$US-OTSUKA-2024_011426$OTSUKA$$60$YR$$M$Y$144.7$KG$20240723$$HP$US$US
241238801$24123880$1$I$$20240220$20240723$20240723$PER$$US-OTSUKA-2024_004652$OTSUKA$$20$YR$$F$Y$$$20240723$$HP$US$US
241238811$24123881$1$I$$20240129$20240723$20240723$PER$$US-OTSUKA-2024_002535$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
241238821$24123882$1$I$20231001$20240221$20240723$20240723$PER$$US-OTSUKA-2024_004813$OTSUKA$$7$DEC$$F$Y$$$20240723$$HP$US$US
241238831$24123883$1$I$20240422$20240423$20240723$20240723$PER$$US-OTSUKA-2024_011848$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241238842$24123884$2$F$$20240116$20240723$20240808$PER$$US-OTSUKA-2024_001390$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241238851$24123885$1$I$$20240122$20240723$20240723$PER$$US-OTSUKA-2024_001861$OTSUKA$$$$E$M$Y$$$20240723$$HP$US$US
241238862$24123886$2$F$$20240416$20240723$20240808$PER$$US-OTSUKA-2024_011285$OTSUKA$$$$E$F$Y$$$20240808$$HP$US$US
241238871$24123887$1$I$$20240425$20240723$20240723$PER$$US-OTSUKA-2024_012157$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241238881$24123888$1$I$$20240417$20240723$20240723$PER$$US-OTSUKA-2024_011275$OTSUKA$$$$E$M$Y$$$20240723$$HP$US$US
241238891$24123889$1$I$$20240410$20240723$20240723$PER$$US-OTSUKA-2024_010571$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241238901$24123890$1$I$$20240716$20240723$20240723$PER$$US-ABBVIE-5843856$ABBVIE$$$$$$Y$$$20240723$$HP$US$US
241238911$24123891$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113369$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240719$$HP$US$US
241238921$24123892$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115086$BRISTOL MYERS SQUIBB$$21$YR$A$F$Y$53.98$KG$20240719$$CN$US$US
241238931$24123893$1$I$$20240715$20240723$20240723$EXP$GB-MHRA-TPP44986497C949673YC1720799610125$GB-ESPERIONTHERAPEUTICS-2024GBR01132$ESPERION THERAPEUTICS$$60$YR$$M$Y$93$KG$20240723$$MD$GB$GB
241238941$24123894$1$I$20230429$20240712$20240723$20240723$PER$$US-ROCHE-10000026459$ROCHE$$69$YR$E$F$Y$$$20240723$$HP$US$US
241238952$24123895$2$F$$20240715$20240723$20240803$EXP$$US-AMGEN-USASP2024143157$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240803$$MD$US$US
241238961$24123896$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024143145$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240723$$MD$US$US
241238971$24123897$1$I$20220101$20240712$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113863$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$79.38$KG$20240719$$CN$US$US
241238981$24123898$1$I$$20240603$20240723$20240723$EXP$$US-OTSUKA-2024_015868$OTSUKA$$6$DEC$$F$Y$$$20240723$$HP$US$US
241238991$24123899$1$I$$20240501$20240723$20240723$EXP$$US-OTSUKA-2024_012834$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241239001$24123900$1$I$$20240604$20240723$20240723$PER$$US-OTSUKA-2024_016085$OTSUKA$$27$YR$$F$Y$82.36$KG$20240723$$CN$US$US
241239011$24123901$1$I$$20240522$20240723$20240723$PER$$US-OTSUKA-2024_014765$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241239021$24123902$1$I$$20240612$20240723$20240723$PER$$US-OTSUKA-2024_016947$OTSUKA$$60$YR$$F$Y$$$20240723$$MD$US$US
241239031$24123903$1$I$$20240603$20240723$20240723$PER$$US-OTSUKA-2024_009145$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241239042$24123904$2$F$$20240725$20240723$20240808$PER$$US-OTSUKA-2024_016940$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241239051$24123905$1$I$$20240502$20240723$20240723$EXP$$US-OTSUKA-2024_012796$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241239061$24123906$1$I$$20240430$20240723$20240723$PER$$US-OTSUKA-2024_012588$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239071$24123907$1$I$$20240604$20240723$20240723$PER$$US-OTSUKA-2024_016343$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241239081$24123908$1$I$$20240506$20240723$20240723$PER$$US-OTSUKA-2024_013028$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241239091$24123909$1$I$$20240604$20240723$20240723$PER$$US-OTSUKA-2024_016213$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241239101$24123910$1$I$20150101$20240506$20240723$20240723$EXP$$US-OTSUKA-2024_013095$OTSUKA$$$$A$F$Y$31.75$KG$20240723$$MD$US$US
241239111$24123911$1$I$20231218$20240606$20240723$20240723$PER$$US-OTSUKA-2024_011430$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239121$24123912$1$I$20240403$20240506$20240723$20240723$EXP$$US-OTSUKA-2024_013029$OTSUKA$$23$YR$$F$Y$50.8$KG$20240723$$HP$US$US
241239131$24123913$1$I$$20240611$20240723$20240723$PER$$US-OTSUKA-2024_016832$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241239141$24123914$1$I$$20240523$20240723$20240723$PER$$US-OTSUKA-2024_015005$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239151$24123915$1$I$$20240612$20240723$20240723$PER$$US-OTSUKA-2024_016922$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241239161$24123916$1$I$$20240502$20240723$20240723$PER$$US-OTSUKA-2024_012850$OTSUKA$$5$DEC$$F$Y$$$20240723$$CN$US$US
241239171$24123917$1$I$$20240501$20240723$20240723$EXP$$US-OTSUKA-2024_012813$OTSUKA$$$$E$F$Y$$$20240723$$MD$US$US
241239181$24123918$1$I$$20240612$20240723$20240723$PER$$US-OTSUKA-2024_016930$OTSUKA$$$$E$M$Y$$$20240723$$MD$US$US
241239191$24123919$1$I$20230101$20240612$20240723$20240723$PER$$US-OTSUKA-2024_016928$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239201$24123920$1$I$$20240613$20240723$20240723$PER$$US-OTSUKA-2024_017109$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241239211$24123921$1$I$$20240506$20240723$20240723$PER$$US-OTSUKA-2024_012993$OTSUKA$$4$DEC$$F$Y$$$20240723$$MD$US$US
241239221$24123922$1$I$$20240521$20240723$20240723$PER$$US-OTSUKA-2024_014624$OTSUKA$$$$E$F$Y$$$20240723$$MD$US$US
241239231$24123923$1$I$$20240523$20240723$20240723$PER$$US-OTSUKA-2024_014911$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239241$24123924$1$I$$20240501$20240723$20240723$EXP$$US-OTSUKA-2024_012835$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241239251$24123925$1$I$$20240614$20240723$20240723$PER$$US-OTSUKA-2024_017162$OTSUKA$$$$E$F$Y$$$20240723$$MD$US$US
241239261$24123926$1$I$$20240516$20240723$20240723$PER$$US-OTSUKA-2024_009552$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239271$24123927$1$I$$20240611$20240723$20240723$PER$$US-OTSUKA-2024_016831$OTSUKA$$101$YR$$M$Y$$$20240723$$MD$US$US
241239281$24123928$1$I$$20240522$20240723$20240723$PER$$US-OTSUKA-2024_014746$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
241239291$24123929$1$I$20240410$20240516$20240723$20240723$EXP$$US-OTSUKA-2024_012005$OTSUKA$$41$YR$$M$Y$92.52$KG$20240723$$HP$US$US
241239301$24123930$1$I$$20240502$20240723$20240723$PER$$US-OTSUKA-2024_012817$OTSUKA$$65$YR$$F$Y$$$20240723$$HP$US$US
241239312$24123931$2$F$20240223$20240513$20240723$20240808$EXP$$US-OTSUKA-2024_010477$OTSUKA$$68$YR$$F$Y$76.7$KG$20240808$$HP$US$US
241239321$24123932$1$I$$20240522$20240723$20240723$PER$$US-OTSUKA-2024_014841$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241239331$24123933$1$I$$20240610$20240723$20240723$PER$$US-OTSUKA-2024_016836$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241239341$24123934$1$I$$20240611$20240723$20240723$PER$$US-OTSUKA-2024_016850$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241239351$24123935$1$I$$20240605$20240723$20240723$PER$$US-OTSUKA-2024_011248$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241239361$24123936$1$I$$20240604$20240723$20240723$EXP$$US-OTSUKA-2024_016047$OTSUKA$$52$YR$$M$Y$$$20240723$$HP$US$US
241239371$24123937$1$I$$20240517$20240723$20240723$PER$$US-OTSUKA-2024_007835$OTSUKA$$$$E$F$Y$$$20240723$$PH$US$US
241239381$24123938$1$I$$20240529$20240723$20240723$PER$$US-OTSUKA-2024_015698$OTSUKA$$30$YR$$M$Y$$$20240723$$HP$US$US
241239391$24123939$1$I$$20240426$20240723$20240723$PER$$US-OTSUKA-2024_012291$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241239401$24123940$1$I$$20240530$20240723$20240723$PER$$US-OTSUKA-2024_015543$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241239411$24123941$1$I$$20240603$20240723$20240723$EXP$$US-OTSUKA-2024_016012$OTSUKA$$$$$$Y$$$20240723$$CN$US$US
241239421$24123942$1$I$$20240603$20240723$20240723$PER$$US-OTSUKA-2024_015839$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241239431$24123943$1$I$$20240429$20240723$20240723$EXP$$US-OTSUKA-2024_012451$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241239441$24123944$1$I$$20240520$20240723$20240723$PER$$US-OTSUKA-2024_014498$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239452$24123945$2$F$$20240607$20240723$20240808$PER$$US-OTSUKA-2024_016504$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241239461$24123946$1$I$20240101$20240430$20240723$20240723$PER$$US-OTSUKA-2024_012644$OTSUKA$$50$YR$$F$Y$$$20240723$$CN$US$US
241239471$24123947$1$I$$20240606$20240723$20240723$PER$$US-OTSUKA-2024_016345$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241239481$24123948$1$I$$20240531$20240723$20240723$PER$$US-OTSUKA-2024_015689$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241239491$24123949$1$I$$20240530$20240723$20240723$PER$$US-OTSUKA-2024_015525$OTSUKA$$52$YR$$F$Y$52.61$KG$20240723$$HP$US$US
241239501$24123950$1$I$$20240521$20240723$20240723$PER$$US-OTSUKA-2024_014603$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239511$24123951$1$I$20240503$20240520$20240723$20240723$PER$$US-OTSUKA-2024_014415$OTSUKA$$71$YR$$F$Y$113.4$KG$20240723$$CN$US$US
241239521$24123952$1$I$20240501$20240529$20240723$20240723$PER$$US-OTSUKA-2024_015437$OTSUKA$$74$YR$$F$Y$$$20240723$$PH$US$US
241239531$24123953$1$I$$20240523$20240723$20240723$EXP$$US-OTSUKA-2024_014943$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239541$24123954$1$I$$20240529$20240723$20240723$PER$$US-OTSUKA-2024_015533$OTSUKA$$73$YR$$F$Y$$$20240723$$HP$US$US
241239551$24123955$1$I$$20240607$20240723$20240723$EXP$$US-OTSUKA-2024_016607$OTSUKA$$8$DEC$$F$Y$$$20240723$$MD$US$US
241239561$24123956$1$I$20240518$20240605$20240723$20240723$EXP$$US-OTSUKA-2024_014586$OTSUKA$$48$YR$$F$Y$92$KG$20240723$$HP$US$US
241239571$24123957$1$I$$20240430$20240723$20240723$PER$$US-OTSUKA-2024_012710$OTSUKA$$70$YR$$M$Y$$$20240723$$MD$US$US
241239581$24123958$1$I$$20240514$20240723$20240723$PER$$US-OTSUKA-2024_011167$OTSUKA$$$$$F$Y$91.17$KG$20240723$$CN$US$US
241239591$24123959$1$I$20240501$20240606$20240723$20240723$PER$$US-OTSUKA-2024_016330$OTSUKA$$72$YR$$F$Y$68.04$KG$20240723$$CN$US$US
241239601$24123960$1$I$20240301$20240426$20240723$20240723$PER$$US-OTSUKA-2024_012302$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239611$24123961$1$I$20240610$20240610$20240723$20240723$PER$$US-OTSUKA-2024_016585$OTSUKA$$$$$M$Y$$$20240723$$PH$US$US
241239621$24123962$1$I$$20240606$20240723$20240723$PER$$US-OTSUKA-2024_016578$OTSUKA$$4$DEC$$F$Y$$$20240723$$HP$US$US
241239631$24123963$1$I$$20240430$20240723$20240723$PER$$US-OTSUKA-2024_012607$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241239641$24123964$1$I$$20240613$20240723$20240723$PER$$US-OTSUKA-2024_017059$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239651$24123965$1$I$$20240603$20240723$20240723$PER$$US-OTSUKA-2024_015829$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241239662$24123966$2$F$$20240801$20240723$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114219$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240807$$CN$US$US
241239671$24123967$1$I$$20240605$20240723$20240723$PER$$US-OTSUKA-2024_016360$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241239681$24123968$1$I$$20240520$20240723$20240723$PER$$US-OTSUKA-2024_014418$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241239691$24123969$1$I$$20240524$20240723$20240723$PER$$US-OTSUKA-2024_015233$OTSUKA$$55$YR$$F$Y$$$20240723$$HP$US$US
241239701$24123970$1$I$$20240520$20240723$20240723$PER$$US-OTSUKA-2024_014419$OTSUKA$$73$YR$$F$Y$$$20240723$$HP$US$US
241239711$24123971$1$I$$20240521$20240723$20240723$PER$$US-OTSUKA-2024_008520$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241239721$24123972$1$I$$20240520$20240723$20240723$PER$$US-OTSUKA-2024_014571$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239731$24123973$1$I$20240612$20240612$20240723$20240723$PER$$US-OTSUKA-2024_016943$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241239741$24123974$1$I$$20240613$20240723$20240723$PER$$US-OTSUKA-2024_017058$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239751$24123975$1$I$$20240506$20240723$20240723$PER$$US-OTSUKA-2024_013115$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241239761$24123976$1$I$$20240523$20240723$20240723$PER$$US-OTSUKA-2024_014905$OTSUKA$$$$$M$Y$106.59$KG$20240723$$CN$US$US
241239771$24123977$1$I$$20240605$20240723$20240723$EXP$$US-OTSUKA-2024_016265$OTSUKA$$30$YR$$F$Y$$$20240723$$HP$US$US
241239781$24123978$1$I$$20240503$20240723$20240723$PER$$US-OTSUKA-2024_012963$OTSUKA$$84$YR$$F$Y$$$20240723$$MD$US$US
241239791$24123979$1$I$$20240501$20240723$20240723$PER$$US-OTSUKA-2024_012787$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241239801$24123980$1$I$$20240605$20240723$20240723$PER$$US-OTSUKA-2024_016180$OTSUKA$$49$YR$$F$Y$$$20240723$$HP$US$US
241239811$24123981$1$I$$20240522$20240723$20240723$PER$$US-OTSUKA-2024_014744$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241239821$24123982$1$I$$20240717$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114523$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240719$$CN$US$US
241239831$24123983$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114259$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240719$$CN$US$US
241239841$24123984$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115148$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240719$$HP$US$US
241239851$24123985$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06682$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241239861$24123986$1$I$$20240719$20240723$20240723$PER$$NVSC2024US150395$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
241239871$24123987$1$I$20240101$20240716$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114244$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240719$$MD$US$US
241239881$24123988$1$I$$20240711$20240723$20240723$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06743$HIKMA$, Kuhn AK, Leopold KN, Creo AL, Schoettler PJ, Allen-Rhoades WA. Martin CE, Kuhn AK, Leopold KN, Creo AL, Schoettler PJ, Allen-Rhoades WA. Exogenous steroid replacement in a pediatric patient with adrenocortical carcinoma receiving mitotane.. Pediatric Blood and Cancer. 2024;71(8):e31072$16$YR$$F$Y$$$20240723$$PH$US$US
241239891$24123989$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024142653$AMGEN$$$$$$Y$$$20240723$$PH$US$US
241239901$24123990$1$I$20240712$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024143519$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241239911$24123991$1$I$20240708$20240722$20240723$20240723$EXP$BG-BDA-27886$BG-JNJFOC-20240756422$JOHNSON AND JOHNSON$$14$YR$T$F$Y$$$20240723$$MD$BG$BG
241239921$24123992$1$I$$20240508$20240723$20240723$PER$$US-OTSUKA-2024_013350$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241239931$24123993$1$I$$20240626$20240723$20240723$PER$$US-OTSUKA-2024_018316$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241239941$24123994$1$I$20240601$20240619$20240723$20240723$PER$$US-OTSUKA-2024_017572$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241239951$24123995$1$I$$20240620$20240723$20240723$PER$$US-OTSUKA-2024_017777$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241239961$24123996$1$I$$20240703$20240723$20240723$PER$$US-OTSUKA-2024_018952$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241239971$24123997$1$I$$20240626$20240723$20240723$PER$$US-OTSUKA-2024_018286$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241239981$24123998$1$I$20240101$20240625$20240723$20240723$PER$$US-OTSUKA-2024_018173$OTSUKA$$$$$F$Y$58.51$KG$20240723$$CN$US$US
241239991$24123999$1$I$$20240705$20240723$20240723$PER$$US-OTSUKA-2024_019159$OTSUKA$$$$$F$Y$$$20240723$$PH$US$US
241240001$24124000$1$I$$20240507$20240723$20240723$PER$$US-OTSUKA-2024_013214$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241240011$24124001$1$I$$20240506$20240723$20240723$PER$$US-OTSUKA-2024_013224$OTSUKA$$$$$F$Y$$$20240723$$MD$US$US
241240021$24124002$1$I$$20240626$20240723$20240723$PER$$US-OTSUKA-2024_018348$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241240031$24124003$1$I$$20240701$20240723$20240723$PER$$US-OTSUKA-2024_012684$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241240041$24124004$1$I$$20240709$20240723$20240723$PER$$US-OTSUKA-2024_019455$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241240051$24124005$1$I$$20240507$20240723$20240723$EXP$$US-OTSUKA-2024_013232$OTSUKA$$48$YR$$F$Y$$$20240723$$HP$US$US
241240061$24124006$1$I$$20240708$20240723$20240723$PER$$US-OTSUKA-2024_019442$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241240071$24124007$1$I$20240627$20240627$20240723$20240723$PER$$US-OTSUKA-2024_018834$OTSUKA$$63$YR$$M$Y$$$20240723$$PH$US$US
241240081$24124008$1$I$$20240507$20240723$20240723$PER$$US-OTSUKA-2024_013202$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241240091$24124009$1$I$$20240507$20240723$20240723$PER$$US-OTSUKA-2024_013199$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241240101$24124010$1$I$20240601$20240627$20240723$20240723$EXP$$US-OTSUKA-2024_018456$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241240111$24124011$1$I$$20240514$20240723$20240723$PER$$US-OTSUKA-2024_014954$OTSUKA$$$$$$Y$$$20240723$$MD$US$US
241240121$24124012$1$I$20240501$20240701$20240723$20240723$PER$$US-OTSUKA-2024_012949$OTSUKA$$35$YR$$F$Y$99.79$KG$20240723$$CN$US$US
241240131$24124013$1$I$$20240507$20240723$20240723$PER$$US-OTSUKA-2024_013307$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241240141$24124014$1$I$$20240506$20240723$20240723$PER$$US-OTSUKA-2024_013220$OTSUKA$$$$$F$Y$$$20240723$$HP$US$US
241240151$24124015$1$I$$20240620$20240723$20240723$PER$$US-OTSUKA-2024_017774$OTSUKA$$$$$$Y$$$20240723$$HP$US$US
241240161$24124016$1$I$20240328$20240618$20240723$20240723$EXP$$US-OTSUKA-2024_016348$OTSUKA$$35$YR$$M$Y$$$20240723$$HP$US$US
241240171$24124017$1$I$$20240621$20240723$20240723$PER$$US-OTSUKA-2024_017772$OTSUKA$$2$YR$$F$Y$$$20240723$$CN$US$US
241240181$24124018$1$I$$20240627$20240723$20240723$PER$$US-OTSUKA-2024_018412$OTSUKA$$61$YR$$F$Y$$$20240723$$CN$US$US
241240192$24124019$2$F$$20240718$20240723$20240725$EXP$$CA-AstraZeneca-2024A166048$ASTRAZENECA$$$$$F$Y$$$20240725$$HP$CA$
241240201$24124020$1$I$$20230424$20240723$20240723$EXP$$US-AstraZeneca-2023A096224$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241240211$24124021$1$I$20191121$20191203$20240723$20240723$EXP$$CO-AstraZeneca-2019SF75758$ASTRAZENECA$$25248$DY$$M$Y$$$20240723$$CN$CO$
241240221$24124022$1$I$$20220701$20240723$20240723$EXP$$US-AstraZeneca-2022A243510$ASTRAZENECA$$$$$$Y$$$20240723$$HP$US$
241240231$24124023$1$I$$20220302$20240723$20240723$EXP$$US-AstraZeneca-2022A096787$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241240241$24124024$1$I$$20211216$20240723$20240723$EXP$$US-AstraZeneca-2021A886261$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241240251$24124025$1$I$$20220406$20240723$20240723$EXP$$US-AstraZeneca-2022A142717$ASTRAZENECA$$$$$$Y$$$20240723$$HP$US$
241240261$24124026$1$I$20230417$20240709$20240723$20240723$EXP$$GB-INTERCEPT-PM2023000975$INTERCEPT PHARMACEUTICALS$$$$E$F$Y$$$20240723$$CN$GB$GB
241240271$24124027$1$I$$20220722$20240723$20240723$EXP$$US-AstraZeneca-2022A234870$ASTRAZENECA$$84$YR$$M$Y$$$20240723$$CN$US$
241240281$24124028$1$I$$20200529$20240723$20240723$EXP$$DO-AstraZeneca-2020SE71867$ASTRAZENECA$$39$YR$$F$Y$$$20240723$$CN$DO$
241240291$24124029$1$I$$20220628$20240723$20240723$EXP$$US-AstraZeneca-2022A240190$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241240302$24124030$2$F$$20240722$20240723$20240924$PER$$US-FDC-2024USSPO00529$FDC LIMITED$$$$$F$Y$$$20240924$$CN$US$US
241240312$24124031$2$F$$20240826$20240723$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-114773$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240830$$MD$JP$JP
241240331$24124033$1$I$$20230119$20240723$20240723$EXP$$CA-AstraZeneca-2022A385687$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$CA$
241240341$24124034$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114413$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240719$$CN$US$US
241240351$24124035$1$I$$20240715$20240723$20240723$EXP$$PL-CHEPLA-2024009160$CHEPLAPHARM$Chrobak J, Rodek P, Kucia K. Multiple-Monitored Electroconvulsive Therapy (MMECT) - does it really just belong in psychiatry^s past? A case report. Psychiatr Pol. 2024;58(2):343-349. doi: 10.12740/PP/OnlineFirst/156320.$49$YR$$F$Y$$$20240722$$HP$COUNTRY NOT SPECIFIED$PL
241240361$24124036$1$I$$20240717$20240723$20240723$EXP$$US-UCBSA-2024036470$UCB$$$$$M$Y$$$20240723$$HP$US$US
241240371$24124037$1$I$20240101$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114818$BRISTOL MYERS SQUIBB$$19$YR$A$F$Y$$$20240719$$HP$US$US
241240381$24124038$1$I$20240127$20240722$20240723$20240723$EXP$$NL-ABBVIE-5848426$ABBVIE$$79$YR$$M$Y$$$20240723$$HP$NL$NL
241240391$24124039$1$I$20240215$20240717$20240723$20240723$EXP$FR-AFSSAPS-AN2024000874$FR-CHEPLA-2024009058$CHEPLAPHARM$$15$YR$$M$Y$38.099$KG$20240723$$MD$COUNTRY NOT SPECIFIED$FR
241240401$24124040$1$I$20240601$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114535$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240719$$HP$US$US
241240411$24124041$1$I$20240127$20240716$20240723$20240723$EXP$$US-UCBSA-2024036863$UCB$$0$YR$$F$Y$2.45$KG$20240723$$HP$US$US
241240421$24124042$1$I$$20240717$20240723$20240723$PER$$NVSC2024US147974$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
241240432$24124043$2$F$20240531$20240806$20240723$20240808$EXP$$NVSJ2024JP008566$NOVARTIS$$76$YR$$M$Y$$$20240809$$MD$JP$JP
241240441$24124044$1$I$$20240716$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114275$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240719$$CN$US$US
241240451$24124045$1$I$20240620$20240718$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115361$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240723$$CN$US$US
241240461$24124046$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115365$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$62.6$KG$20240719$$CN$US$US
241240471$24124047$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114417$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240719$$CN$US$US
241240481$24124048$1$I$20240701$20240718$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115181$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240719$$CN$US$US
241240491$24124049$1$I$$20240717$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114693$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240719$$MD$US$US
241240501$24124050$1$I$$20240710$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111360$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240719$$HP$US$US
241240511$24124051$1$I$20240614$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024143025$AMGEN$$67$YR$E$F$Y$$$20240723$$CN$US$US
241240522$24124052$2$F$20240601$20240919$20240723$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114689$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240920$$HP$US$US
241240531$24124053$1$I$20240715$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114745$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$58.5$KG$20240719$$PH$US$US
241240541$24124054$1$I$20240101$20240717$20240723$20240723$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017605$UNITED THERAPEUTICS$$$$$F$Y$$$20240723$$$US$US
241240551$24124055$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114705$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$105.23$KG$20240719$$CN$US$US
241240561$24124056$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114677$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240719$$MD$US$US
241240571$24124057$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115062$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240719$$CN$US$US
241240581$24124058$1$I$$20240715$20240723$20240723$PER$$US-ALXN-202407USA000980US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241240591$24124059$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113331$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240719$$CN$US$US
241240601$24124060$1$I$$20240715$20240723$20240723$PER$$US-ABBVIE-5841944$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241240613$24124061$3$F$20240601$20240730$20240723$20240812$EXP$$US-UCBSA-2024035874$UCB$$29$YR$$F$Y$$$20240812$$HP$US$US
241240621$24124062$1$I$$20240718$20240723$20240723$PER$$US-GILEAD-2024-0681251$GILEAD$$60$YR$A$$Y$$$20240723$$PH$US$US
241240631$24124063$1$I$20240628$20240715$20240723$20240723$EXP$$CA-APOTEX-2024AP008425$APOTEX$$74$YR$E$M$Y$$$20240723$$PH$CA$CA
241240641$24124064$1$I$20240520$20240717$20240723$20240723$EXP$$CA-JNJFOC-20240585405$JOHNSON AND JOHNSON$$41$YR$A$M$Y$87.1$KG$20240723$$HP$CA$CA
241240652$24124065$2$F$$20240712$20240723$20240726$EXP$$US-ALXN-202407USA000837US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240726$$MD$US$US
241240662$24124066$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3220111$TEVA$Habib A, Butt K, Ibrahim R, Shaaban A, Lee HS. BRASH syndrome: A rare but reversible cause of sinus node dysfunction. HeartRhythm-Case-Rep 2024; 10 (6): 398-401.; Habib A, Butt K, Ibrahim R, Shaaban A, Lee HS. BRASH syndrome: A rare but reversible cause of sinus node dysfunction. HeartRhythm-Case-Rep 2024; 10 (6): 398-401.$57$YR$$F$Y$$$20240819$$MD$US$US
241240671$24124067$1$I$$20240605$20240723$20240723$30DAY$$CL-UCBSA-2024029457$UCB$$$$$$Y$$$20240723$$CN$CL$CL
241240681$24124068$1$I$$20240715$20240723$20240723$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-113723$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240719$$PH$FR$FR
241240691$24124069$1$I$$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112472$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$43.09$KG$20240723$$CN$US$US
241240705$24124070$5$F$20240610$20240906$20240723$20240912$EXP$$JP-SANDOZ INC.-SDZ2024JP065449$SANDOZ$$69$YR$$M$Y$56$KG$20240912$$MD$JP$JP
241240711$24124071$1$I$20240701$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116364$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240723$$HP$US$US
241240721$24124072$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116410$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$JP$JP
241240731$24124073$1$I$20240608$20240716$20240723$20240723$EXP$$IL-ALXN-202407EEA000965IL$ALEXION PHARMACEUTICALS$$92$YR$$M$Y$$$20240719$$MD$IL$IL
241240742$24124074$2$F$$20240819$20240723$20240827$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-113324$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240827$$MD$ES$ES
241240751$24124075$1$I$20170601$20220422$20240723$20240723$EXP$$CO-AstraZeneca-2022A163567$ASTRAZENECA$$21041$DY$$F$Y$62$KG$20240723$$CN$CO$
241240761$24124076$1$I$20230316$20230316$20240723$20240723$EXP$$ZA-AstraZeneca-2023A063971$ASTRAZENECA$$23046$DY$$M$Y$$$20240723$$CN$ZA$
241240771$24124077$1$I$$20221017$20240723$20240723$EXP$$US-AstraZeneca-2022A350299$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241240781$24124078$1$I$$20240718$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114822$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240719$$HP$CA$CA
241240791$24124079$1$I$$20240711$20240723$20240723$EXP$$US-ALXN-202407USA000815US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$CN$US$US
241240801$24124080$1$I$$20240715$20240723$20240723$EXP$$RO-AstraZeneca-2024A160676$ASTRAZENECA$$54$YR$$F$Y$$$20240723$$MD$RO$
241240811$24124081$1$I$$20230501$20240723$20240723$EXP$$US-AstraZeneca-2023A101940$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241240821$24124082$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013010$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240723$$CN$US$US
241240831$24124083$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013399$ELI LILLY AND CO$$$$A$$Y$$$20240723$$CN$US$US
241240841$24124084$1$I$$20240713$20240723$20240723$PER$$NVSC2024US146162$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
241240851$24124085$1$I$20240701$20240715$20240723$20240723$PER$$US-ABBVIE-5842181$ABBVIE$$$$$$Y$$$20240723$$CN$US$US
241240861$24124086$1$I$20240712$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013208$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240723$$CN$US$US
241240871$24124087$1$I$20240701$20240712$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112405$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$114.76$KG$20240719$$PH$US$US
241240884$24124088$4$F$$20240820$20240723$20240825$EXP$$FR-ALXN-202407EEA000784FR$ALEXION PHARMACEUTICALS$$$$A$F$Y$89$KG$20240825$$MD$FR$FR
241240891$24124089$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114643$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240719$$CN$US$US
241240901$24124090$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113350$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240719$$CN$US$US
241240912$24124091$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3220109$TEVA$Van Arnam J, Blessing M, Mohila C. Diffuse Spinal Cord Necrosis and Peripheral Neuropathy Due To Neuroleukemiosis in the Setting of Menin Inhibitor Treatment. J-Neuropathol-Exp-Neurol 2024; 83 (6): 527 abstr. 174.; Van Arnam J, Blessing M, Mohila C. Diffuse Spinal Cord Necrosis and Peripheral Neuropathy Due To Neuroleukemiosis in the Setting of Menin Inhibitor Treatment. J-Neuropathol-Exp-Neurol 2024; 83 (6): 527 abstr. 174.$15$YR$$M$Y$$$20240819$$HP$US$US
241240921$24124092$1$I$$20240716$20240723$20240723$PER$$US-ABBVIE-5845592$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241240932$24124093$2$F$20240710$20240917$20240723$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112827$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240920$$CN$US$US
241240941$24124094$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113333$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240719$$CN$US$US
241240963$24124096$3$F$20240715$20240916$20240723$20240919$30DAY$$FR-SANDOZ INC.-SDZ2024FR065687$SANDOZ$$5$YR$$F$Y$$$20240919$$CN$FR$FR
241240972$24124097$2$F$20240904$20240904$20240723$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003041$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240926$$CN$US$US
241240981$24124098$1$I$20221101$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114628$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$77.11$KG$20240719$$CN$US$US
241240991$24124099$1$I$20240101$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115099$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240719$$CN$US$US
241241001$24124100$1$I$$20240717$20240723$20240723$30DAY$$US-SANDOZ INC.-SDZ2024US066828$SANDOZ$$$$$M$Y$$$20240723$$CN$US$US
241241011$24124101$1$I$20240403$20240715$20240723$20240723$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-115038$BRISTOL MYERS SQUIBB$$10$YR$C$F$Y$30$KG$20240719$$MD$CZ$CZ
241241033$24124103$3$F$$20240828$20240723$20240830$30DAY$$US-SANDOZ INC.-SDZ2024US066865$SANDOZ$$$$A$F$Y$63.492$KG$20240830$$CN$US$US
241241042$24124104$2$F$$20240723$20240723$20240729$EXP$$US-TAKEDA-2022TUS040155$TAKEDA$$$$$F$Y$$$20240729$$HP$US$US
241241051$24124105$1$I$$20240719$20240723$20240723$PER$$US-HALEON-2188316$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241241062$24124106$2$F$20240701$20240717$20240723$20240826$PER$$US-BAUSCH-BL-2024-011075$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240826$$CN$US$US
241241071$24124107$1$I$$20240715$20240723$20240723$PER$$US-BAUSCH-BL-2024-010807$BAUSCH AND LOMB$$$$$M$Y$$$20240723$$CN$US$US
241241081$24124108$1$I$20240715$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024142063$AMGEN$$69$YR$E$F$Y$$$20240723$$CN$US$US
241241091$24124109$1$I$20240101$20240715$20240723$20240723$EXP$$CA-CELLTRION INC.-2024CA008313$CELLTRION$$$$$$Y$$$20240723$$HP$CA$CA
241241101$24124110$1$I$$20240722$20240723$20240723$EXP$$FR-SANDOZ INC.-SDZ2024FR066922$SANDOZ$$$$$M$Y$$$20240723$$MD$FR$FR
241241111$24124111$1$I$$20240715$20240723$20240723$EXP$$NL-AMGEN-NLDSP2024143052$AMGEN$$55$YR$A$F$Y$68$KG$20240723$$CN$NL$NL
241241122$24124112$2$F$$20240722$20240723$20240725$PER$$US-HALEON-2188244$Haleon PLC$$59$YR$$F$Y$$$20240725$$CN$US$US
241241133$24124113$3$F$20231029$20240819$20240723$20240820$EXP$FR-AFSSAPS-TS2024000829$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041080$BOEHRINGER INGELHEIM$$$$$F$Y$2.7$KG$20240820$$MD$FR$FR
241241144$24124114$4$F$$20240918$20240723$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US066541$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
241241151$24124115$1$I$20240602$20240722$20240723$20240723$EXP$GB-MHRA-MED-202407221141275750-GLRKS$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041149$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$88$KG$20240723$$PH$GB$GB
241241161$24124116$1$I$20240719$20240719$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US067009$SANDOZ$$39$YR$$F$Y$$$20240723$$HP$US$US
241241172$24124117$2$F$20240514$20240731$20240723$20240805$EXP$$IT-BAUSCH-BL-2024-011145$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240805$$MD$IT$IT
241241181$24124118$1$I$$20240720$20240723$20240723$EXP$$AT-BAUSCH-BL-2024-011159$BAUSCH AND LOMB$$85$YR$$F$Y$$$20240723$$MD$AT$AT
241241191$24124119$1$I$$20240716$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114987$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240719$$HP$CA$CA
241241201$24124120$1$I$20231201$20240721$20240723$20240723$EXP$FR-AFSSAPS-AN2024000916$FR-BAUSCH-BL-2024-011198$BAUSCH AND LOMB$$74$YR$$$Y$$$20240723$$MD$FR$FR
241241211$24124121$1$I$20240501$20240721$20240723$20240723$EXP$FR-AFSSAPS-AN2024000917$FR-BAUSCH-BL-2024-011197$BAUSCH AND LOMB$$63$YR$$$Y$$$20240723$$MD$FR$FR
241241222$24124122$2$F$$20240722$20240723$20240725$PER$$US-AMGEN-USASP2024142592$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241241231$24124123$1$I$$20240715$20240723$20240723$EXP$$GB-TEVA-VS-3221909$TEVA$$$$$M$Y$$$20240723$$HP$GB$GB
241241243$24124124$3$F$20240629$20240715$20240723$20240826$PER$$US-ROCHE-10000026176$ROCHE$$22$YR$A$F$Y$$$20240826$$CN$US$US
241241251$24124125$1$I$20240615$20240720$20240723$20240723$EXP$FR-AFSSAPS-NC2024000837$FR-BAUSCH-BL-2024-011160$BAUSCH AND LOMB$$89$YR$$F$Y$$$20240723$$MD$FR$FR
241241261$24124126$1$I$20231121$20240721$20240723$20240723$EXP$FR-AFSSAPS-AM2024000561$FR-BAUSCH-BL-2024-011173$BAUSCH AND LOMB$$78$YR$$M$Y$100$KG$20240723$$MD$FR$FR
241241271$24124127$1$I$$20240711$20240723$20240723$EXP$$PT-ROCHE-10000031409$ROCHE$$$$$M$Y$$$20240723$$MD$PT$PT
241241281$24124128$1$I$20240523$20240527$20240723$20240723$30DAY$$JP-UCBSA-2024028700$UCB$$$$$$Y$$$20240723$$PH$JP$JP
241241291$24124129$1$I$$20240718$20240723$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA066609$SANDOZ$$45$YR$$F$Y$$$20240723$$CN$CA$CA
241241301$24124130$1$I$20240319$20240716$20240723$20240723$EXP$$DE-SANDOZ INC.-SDZ2024DE066183$SANDOZ$$84$YR$$F$Y$67$KG$20240723$$MD$DE$DE
241241311$24124131$1$I$20240421$20240717$20240723$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA043036$SANDOZ$$76$YR$$M$Y$$$20240723$$MD$CA$CA
241241322$24124132$2$F$20240420$20240806$20240723$20240811$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114810$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240812$$CN$US$US
241241331$24124133$1$I$$20240710$20240723$20240723$EXP$$CA-APOTEX-2024AP008238$APOTEX$$$$$F$Y$$$20240723$$HP$CA$CA
241241352$24124135$2$F$20240501$20240812$20240723$20240820$PER$$US-JNJFOC-20240759104$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240821$$PH$US$US
241241381$24124138$1$I$$20240718$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114839$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240719$$PH$CA$CA
241241391$24124139$1$I$20240101$20240715$20240723$20240723$EXP$$HR-BRISTOL-MYERS SQUIBB COMPANY-2024-114051$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240719$$MD$HR$HR
241241401$24124140$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115154$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240719$$CN$US$US
241241411$24124141$1$I$$20191009$20240723$20240723$EXP$$AU-AstraZeneca-2019SF45756$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$AU$
241241421$24124142$1$I$20210411$20210511$20240723$20240723$EXP$$CO-AstraZeneca-2021A424318$ASTRAZENECA$$25967$DY$$M$Y$$$20240723$$CN$CO$
241241431$24124143$1$I$$20210521$20240723$20240723$EXP$$US-AstraZeneca-2021A467974$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241241441$24124144$1$I$$20240718$20240723$20240723$EXP$$NVSC2024US148960$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
241241451$24124145$1$I$$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113894$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240719$$HP$US$US
241241461$24124146$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114634$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240719$$CN$US$US
241241471$24124147$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114802$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240719$$HP$US$US
241241481$24124148$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115296$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240719$$HP$US$US
241241491$24124149$1$I$$20240716$20240723$20240723$EXP$NL-LRB-00985417$NL-ORGANON-O2407NLD001448$ORGANON$$63$YR$$F$Y$80$KG$20240723$$CN$NL$NL
241241501$24124150$1$I$20240717$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114962$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240719$$CN$US$US
241241513$24124151$3$F$$20240801$20240723$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106416$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240805$$CN$US$US
241241531$24124153$1$I$$20240722$20240723$20240723$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041107$BOEHRINGER INGELHEIM$$69$YR$E$F$Y$$$20240723$$MD$IT$IT
241241541$24124154$1$I$$20240717$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114659$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240719$$CN$US$US
241241551$24124155$1$I$$20240722$20240723$20240723$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041088$BOEHRINGER INGELHEIM$$$$$$Y$$$20240723$$MD$JP$JP
241241562$24124156$2$F$$20240805$20240723$20240806$EXP$$US-UCBSA-2024036210$UCB$$$$$M$Y$69$KG$20240806$$MD$US$US
241241571$24124157$1$I$20240710$20240717$20240723$20240723$EXP$$US-VIIV HEALTHCARE LIMITED-US2024090061$VIIV$$53$YR$$F$Y$$$20240723$$CN$US$US
241241582$24124158$2$F$$20240816$20240723$20240819$PER$$US-ALXN-202407USA001107US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241241591$24124159$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142945$AMGEN$Sharma. S.; Ruiz. J.; Desai. A. et.al. Gender-based differences in COVID-19 outcomes following heart transplantation. ASAIO Journal. 2024;70 (SUPPL_3):167$$$$F$Y$$$20240723$$HP$US$US
241241601$24124160$1$I$$20240718$20240723$20240723$EXP$$US-UCBSA-2024024793$UCB$$$$$F$Y$63.5$KG$20240723$$CN$US$US
241241611$24124161$1$I$20240714$20240714$20240723$20240723$EXP$GB-MHRA-MED-202407141136241030-SLPZT$GB-TEVA-VS-3221464$TEVA$$53$YR$$M$Y$78$KG$20240723$$CN$GB$GB
241241621$24124162$1$I$$20240717$20240723$20240723$EXP$$US-AMGEN-USASP2024142346$AMGEN$Coates M.D.; Glickman D.; Dalessio S. et al.. The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study. Inflammatory Bowel Diseases. 2024;30 (7):1055-1061$$$$$Y$$$20240723$$MD$US$US
241241631$24124163$1$I$$20240716$20240723$20240723$EXP$$US-TAKEDA-2024TUS049925$TAKEDA$$$$$M$Y$$$20240723$$CN$US$US
241241641$24124164$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115756$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$JP$JP
241241651$24124165$1$I$$20240715$20240723$20240723$EXP$$NL-SANDOZ INC.-NVSC2021NL057368$SANDOZ$Lokin ASHJ, Van de Kieft MJ, Kemperman PMJH. Delusional infestation, a crystal-clear conviction. DUTCH JOURNAL OF DERMATOLOGY AND VENEREOLOGY. 2020;30(8):37-9$40$YR$$F$Y$$$20240723$$MD$NL$NL
241241661$24124166$1$I$20240101$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115213$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240719$$HP$US$US
241241671$24124167$1$I$20240717$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114776$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240723$$HP$US$US
241241682$24124168$2$F$$20240717$20240723$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407011195$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240724$$CN$US$US
241241691$24124169$1$I$20240711$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012520$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240723$$CN$US$US
241241702$24124170$2$F$$20240723$20240723$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407013164$ELI LILLY AND CO$$$$$M$Y$$$20240725$$CN$US$US
241241711$24124171$1$I$20231101$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012252$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240723$$CN$US$US
241241722$24124172$2$F$20240718$20240807$20240723$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407013310$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240808$$CN$US$US
241241732$24124173$2$F$20240601$20240809$20240723$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114145$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240821$$HP$US$US
241241741$24124174$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142970$AMGEN$Sharma. S.; Ruiz. J.; Desai. A. et.al. Gender-based differences in COVID-19 outcomes following heart transplantation. ASAIO Journal. 2024;70 (SUPPL_3):167$$$$M$Y$$$20240723$$HP$US$US
241241751$24124175$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113929$BRISTOL MYERS SQUIBB$Tokura T.A case of salmonella colitis developing during maintenance therapy for multiple myeloma followed by rapid development of septic cardiomyopathy requiring interdisciplinary treatment. The 98th Annual Meeting of the Japanese Association for Infectious Diseases and the 72nd Annual Meeting of the Japanese Society of Chemotherapy (Joint Meeting; Programs and Abstracts) . 2024;P-240$50$YR$A$F$Y$$$20240719$$MD$JP$JP
241241761$24124176$1$I$$20240716$20240723$20240723$EXP$$CA-Bion-013464$BIONPHARMA$$47$YR$A$M$Y$$$20240723$$HP$CA$CA
241241772$24124177$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3220454$TEVA$Johnson DJ, Baadh P, Mudrakola HV. Eosinophilic Pleural Effusion and Eosinophilic Pneumonia Following Prolonged Daptomycin Administration. Am-J-Respir-Crit-Care-Med 2024; 209.; Johnson DJ, Baadh P, Mudrakola HV. Eosinophilic Pleural Effusion and Eosinophilic Pneumonia Following Prolonged Daptomycin Administration. Am-J-Respir-Crit-Care-Med 2024; 209.$76$YR$$M$Y$$$20240819$$HP$US$US
241241781$24124178$1$I$$20240715$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-112454$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240719$$HP$CA$CA
241241793$24124179$3$F$20220809$20240808$20240723$20240815$EXP$$CO-UCBSA-2024036935$UCB$$55$YR$$F$Y$$$20240815$$CN$CO$CO
241241801$24124180$1$I$20230101$20240708$20240723$20240723$EXP$$FR-INSMED, INC.-2023-01545-FR$INSMED$$$$$F$Y$42$KG$20240723$$CN$FR$FR
241241812$24124181$2$F$20240101$20240814$20240723$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111070$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240820$$HP$US$US
241241821$24124182$1$I$20231101$20240717$20240723$20240723$EXP$$CO-SANDOZ INC.-SDZ2024CO066668$SANDOZ$$43$YR$$$Y$$$20240723$$CN$CO$CO
241241831$24124183$1$I$$20240715$20240723$20240723$EXP$$US-ROCHE-10000024315$ROCHE$$$$A$F$Y$$$20240723$$CN$US$US
241241841$24124184$1$I$$20240627$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003043$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241241851$24124185$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113336$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240719$$CN$US$US
241241861$24124186$1$I$$20240712$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113009$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240719$$CN$US$US
241241881$24124188$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113991$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240719$$HP$US$US
241241891$24124189$1$I$$20240711$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114610$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$82.33$KG$20240719$$PH$US$US
241241901$24124190$1$I$$20240716$20240723$20240723$PER$$US-JNJFOC-20240747709$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240723$$HP$US$US
241241911$24124191$1$I$20240305$20240705$20240723$20240723$EXP$GB-MHRA-MED-202406260926267920-QLDBR$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-06498$HIKMA$$$$$$Y$$$20240723$$CN$GB$GB
241241921$24124192$1$I$20220521$20240718$20240723$20240723$EXP$$CA-SANDOZ INC.-NVSC2022CA105265$SANDOZ$$51$YR$$F$Y$$$20240723$$CN$CA$CA
241241931$24124193$1$I$20240101$20240705$20240723$20240723$PER$$US-JNJFOC-20240721728$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240723$$CN$US$US
241241941$24124194$1$I$20240605$20240711$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111017$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240719$$CN$US$US
241241951$24124195$1$I$$20240721$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US066901$SANDOZ$$$$$$Y$$$20240723$$CN$US$US
241241961$24124196$1$I$20240709$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114844$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$90.72$KG$20240719$$HP$US$US
241241973$24124197$3$F$20240601$20240814$20240723$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115233$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240821$$CN$US$US
241241981$24124198$1$I$20240618$20240711$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110759$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$82.33$KG$20240719$$PH$US$US
241241991$24124199$1$I$$20240712$20240723$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA065374$SANDOZ$$72$YR$$M$Y$$$20240723$$HP$CA$CA
241242001$24124200$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115235$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240719$$CN$US$US
241242011$24124201$1$I$20220301$20230224$20240723$20240723$EXP$$US-RECORDATI-2022001119$RECORDATI$$$$$$Y$$$20240723$$CN$US$US
241242021$24124202$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114856$BRISTOL MYERS SQUIBB$$76$YR$$F$Y$$$20240719$$CN$US$US
241242031$24124203$1$I$$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112980$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240719$$CN$US$US
241242041$24124204$1$I$20240101$20240708$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111240$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240719$$CN$US$US
241242051$24124205$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114653$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240719$$CN$US$US
241242063$24124206$3$F$$20240919$20240723$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114429$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240920$$CN$US$US
241242073$24124207$3$F$$20240913$20240723$20240919$EXP$$US-SANDOZ INC.-SDZ2024US066919$SANDOZ$$$$$F$Y$$$20240919$$HP$US$US
241242081$24124208$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114162$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240719$$HP$US$US
241242093$24124209$3$F$20240101$20240809$20240723$20240812$PER$$US-AMGEN-USASP2024143610$AMGEN$$$$$$Y$$$20240812$$PH$US$US
241242101$24124210$1$I$$20240714$20240723$20240723$EXP$$KR-JNJFOC-20240739272$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$KR$DE
241242121$24124212$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114647$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$84.3$KG$20240719$$CN$US$US
241242131$24124213$1$I$20240401$20240718$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US066940$SANDOZ$$76$YR$$M$Y$$$20240723$$CN$US$US
241242141$24124214$1$I$20240109$20240717$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114313$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240719$$CN$US$US
241242151$24124215$1$I$$20240715$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112933$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$81.19$KG$20240719$$CN$US$US
241242161$24124216$1$I$$20230320$20240723$20240723$EXP$$US-AstraZeneca-2023A067773$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241242171$24124217$1$I$$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116312$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240723$$CN$US$US
241242181$24124218$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115790$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$JP$JP
241242191$24124219$1$I$$20240704$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110247$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$CN$US$US
241242201$24124220$1$I$20230101$20240716$20240723$20240723$EXP$$US-SA-2024SA212731$SANOFI AVENTIS$$32$YR$A$F$Y$48.7$KG$20240723$$MD$US$US
241242211$24124221$1$I$20240714$20240716$20240723$20240723$EXP$$US-SA-2024SA212745$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240723$$MD$US$US
241242221$24124222$1$I$$20240718$20240723$20240723$PER$$US-JNJFOC-20240752245$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$CN$US$US
241242231$24124223$1$I$$20240715$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US067136$SANDOZ$$$$$$Y$$$20240723$$PH$US$US
241242251$24124225$1$I$$20240719$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US067073$SANDOZ$$$$$F$Y$$$20240723$$CN$US$US
241242261$24124226$1$I$20240720$20240720$20240723$20240723$PER$$NVSC2024US150428$NOVARTIS$$$$$F$Y$$$20240723$$HP$US$US
241242271$24124227$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06680$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241242281$24124228$1$I$$20240717$20240723$20240723$PER$$US-HALEON-2187724$Haleon PLC$$$$$M$Y$$$20240723$$CN$US$US
241242291$24124229$1$I$$20240719$20240723$20240723$EXP$$BE-JNJFOC-20240755764$JOHNSON AND JOHNSON$$32$YR$A$$Y$$$20240723$$MD$BE$BE
241242302$24124230$2$F$20240313$20240816$20240723$20240819$EXP$$CZ-JNJFOC-20240756082$JOHNSON AND JOHNSON$$75$YR$E$M$Y$65$KG$20240820$$MD$CZ$CZ
241242311$24124231$1$I$20231114$20240719$20240723$20240723$EXP$$NVSC2024US150029$NOVARTIS$$56$YR$$M$Y$$$20240723$$CN$US$US
241242321$24124232$1$I$$20240715$20240723$20240723$EXP$$GB-TAKEDA-2024TUS073560$TAKEDA$$$$$F$Y$$$20240723$$MD$GB$GB
241242332$24124233$2$F$$20240816$20240723$20240827$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06711$HIKMA$$$$$F$Y$454.4$KG$20240827$$CN$US$US
241242341$24124234$1$I$20200201$20240712$20240723$20240723$EXP$$IN-ROCHE-10000024578$ROCHE$Sivagnanam H, Kumar P, Palaniselvam S, Viswanathan R. Two-Year Follow-up of Necrotic Herpetic Retinopathy in a Renal Transplant Recipient. Indian Journal of Transplantation. 2024;18 (2):184-8. doi:10.4103/ijot.ijot_113_23.$32$YR$A$M$Y$$$20240723$$HP$IN$IN
241242351$24124235$1$I$$20240708$20240723$20240723$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06571$LUPIN$Siler C, Fuller W, Whaley D, Keating J. Polypharmacy in older adults: A case study. South Dakota Medicine. 2023;76(3):124-127$64$YR$$F$Y$$$20240723$$MD$US$US
241242364$24124236$4$F$20240705$20240801$20240723$20240910$PER$$US-BEH-2024175515$CSL BEHRING$$$$$F$Y$$$20240910$$PH$US$US
241242372$24124237$2$F$20231101$20240730$20240723$20240805$EXP$$JP-AMGEN-JPNSP2024039841$AMGEN$$$$A$F$Y$$$20240805$$MD$JP$JP
241242382$24124238$2$F$20240717$20240808$20240723$20240813$PER$$US-AMGEN-USASP2024143037$AMGEN$$66$YR$E$M$Y$82.132$KG$20240812$$HP$US$US
241242392$24124239$2$F$$20240722$20240723$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407013933$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240726$$CN$US$US
241242401$24124240$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012973$ELI LILLY AND CO$$$$$M$Y$$$20240723$$CN$US$US
241242411$24124241$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012304$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$US$US
241242421$24124242$1$I$20240716$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013577$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240723$$CN$US$US
241242431$24124243$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013221$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240723$$CN$US$US
241242441$24124244$1$I$20240719$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013137$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240723$$CN$US$US
241242451$24124245$1$I$$20240715$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011753$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$US$US
241242461$24124246$1$I$$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011659$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240723$$CN$US$US
241242471$24124247$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012978$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240723$$CN$US$US
241242481$24124248$1$I$20240710$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013182$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240723$$CN$US$US
241242491$24124249$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013159$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240723$$CN$US$US
241242501$24124250$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013170$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240723$$CN$US$US
241242511$24124251$1$I$20240524$20240708$20240723$20240723$EXP$$US-UCBSA-2024034549$UCB$$53$YR$$F$Y$$$20240723$$CN$US$US
241242522$24124252$2$F$$20240812$20240723$20240813$EXP$$US-ALXN-202407USA001102US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$PH$US$US
241242531$24124253$1$I$20221101$20240202$20240723$20240723$EXP$$CA-CELLTRION INC.-2021CA019546$CELLTRION$$$$$$Y$$$20240723$$MD$CA$CA
241242542$24124254$2$F$$20240813$20240723$20240819$30DAY$$US-AMGEN-USASP2024142964$AMGEN$$$$$$Y$$$20240819$$HP$US$US
241242551$24124255$1$I$$20240717$20240723$20240723$EXP$$JP-GSK-JP2023103639$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$JP$JP
241242561$24124256$1$I$$20240718$20240723$20240723$EXP$$CN-AMGEN-CHNSP2024143640$AMGEN$Chen S.; Shen L.; Cao W. et al.. Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation. Blood cancer journal. 2024;14 (1)$14$YR$T$M$Y$$$20240723$$HP$CN$CN
241242571$24124257$1$I$$20240715$20240723$20240723$EXP$$US-BEH-2024175838$CSL BEHRING$$$$A$M$Y$$$20240723$$HP$US$US
241242581$24124258$1$I$$20240715$20240723$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA066885$SANDOZ$$54$YR$$F$Y$$$20240723$$HP$CA$CA
241242591$24124259$1$I$$20240719$20240723$20240723$EXP$$NVSC2024US150099$NOVARTIS$$$$$$Y$$$20240723$$MD$US$US
241242603$24124260$3$F$20240718$20240719$20240723$20240726$EXP$$US-AMGEN-USASP2024143705$AMGEN$$73$YR$E$F$Y$$$20240726$$CN$US$US
241242611$24124261$1$I$20230101$20240718$20240723$20240723$EXP$$US-009507513-2407USA011504$MERCK$$$$$M$Y$$$20240723$$CN$US$US
241242621$24124262$1$I$20240716$20240716$20240723$20240723$PER$$US-JNJFOC-20240749030$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
241242633$24124263$3$F$20240711$20240905$20240723$20240909$PER$$US-AMGEN-USASP2024140861$AMGEN$$79$YR$E$M$Y$87.5$KG$20240909$$PH$US$US
241242641$24124264$1$I$$20221202$20240723$20240723$EXP$$US-AstraZeneca-2022A398657$ASTRAZENECA$$$$$F$Y$70.8$KG$20240723$$CN$US$
241242652$24124265$2$F$$20240805$20240723$20240806$EXP$$US-UCBSA-2024036908$UCB$$$$$M$Y$$$20240806$$CN$US$US
241242661$24124266$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06633$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241242681$24124268$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06730$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241242692$24124269$2$F$$20240725$20240723$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003047$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
241242701$24124270$1$I$$20240717$20240723$20240723$30DAY$$US-SANDOZ INC.-SDZ2024US067019$SANDOZ$$$$$F$Y$$$20240723$$CN$US$US
241242711$24124271$1$I$$20240717$20240723$20240723$EXP$$US-GSK-US2024AMR090532$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
241242721$24124272$1$I$20240410$20240709$20240723$20240723$EXP$IE-HPRA-2024-112345$IE-SAMSUNG BIOEPIS-SB-2024-21286$SAMSUNG BIOEPIS$$59$YR$A$M$Y$$$20240723$$HP$IE$IE
241242731$24124273$1$I$20231109$20240715$20240723$20240723$EXP$$CN-BEIGENE-BGN-2024-011009$BEIGENE$$$$$$Y$$$20240723$$HP$CN$CN
241242741$24124274$1$I$$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112411$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240723$$HP$US$US
241242751$24124275$1$I$20240205$20240717$20240723$20240723$EXP$$CA-ABBVIE-5845721$ABBVIE$$$$E$M$Y$$$20240723$$MD$CA$CA
241242761$24124276$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06755$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241242771$24124277$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06689$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241242781$24124278$1$I$20220518$20240712$20240723$20240723$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00717$CATALYST PHARMA$$63$YR$$M$Y$$$20240723$$CN$US$US
241242792$24124279$2$F$$20240717$20240723$20240924$PER$$US-ABBVIE-5848296$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
241242801$24124280$1$I$20240718$20240718$20240723$20240723$EXP$$US-ABBVIE-5845888$ABBVIE$$47$YR$$F$Y$$$20240723$$CN$US$US
241242811$24124281$1$I$$20240713$20240723$20240723$30DAY$$US-GSK-US2024AMR091436$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$HP$US$US
241242821$24124282$1$I$$20240710$20240723$20240723$EXP$$US-APOTEX-2024AP008307$APOTEX$Fitzsimons J, Phelan K, Dhanarajan A. Hearing Loss in a Patient with WaldenstromMacroglobulinemia Receiving Bortezomib. Case Reports in Oncology. 2024;17 (1):653-657$67$YR$$M$Y$$$20240723$$HP$US$US
241242832$24124283$2$F$$20240821$20240723$20240823$PER$$US-AMGEN-USASP2024144691$AMGEN$$69$YR$E$F$Y$$$20240823$$MD$US$US
241242841$24124284$1$I$20240701$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144047$AMGEN$$72$YR$E$M$Y$$$20240723$$CN$US$US
241242851$24124285$1$I$20240715$20240716$20240723$20240723$PER$$US-ALXN-202407USA001127US$ALEXION PHARMACEUTICALS$$40$YR$$F$Y$$$20240723$$CN$US$US
241242871$24124287$1$I$20240402$20240404$20240723$20240723$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-105562$ZYDUS PHARM$$$$$$Y$$$20240723$$CN$US$US
241242881$24124288$1$I$20240715$20240719$20240723$20240723$EXP$$CN-BEIGENE-BGN-2024-011270$BEIGENE$$$$$$Y$$$20240723$$HP$CN$CN
241242891$24124289$1$I$20240101$20240717$20240723$20240723$EXP$$CA-ABBVIE-5845942$ABBVIE$$46$YR$$F$Y$$$20240723$$CN$CA$CA
241242901$24124290$1$I$20240701$20240702$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050751$TOLMAR$$66$YR$$M$Y$$$20240723$$CN$CA$CA
241242911$24124291$1$I$$20240716$20240723$20240723$EXP$$NVSC2024CA146987$NOVARTIS$$30$YR$$M$Y$99$KG$20240723$$HP$CA$CA
241242921$24124292$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06767$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241242932$24124293$2$F$20240617$20240729$20240723$20240821$PER$$CA-TOLMAR, INC.-24CA050324$TOLMAR$$79$YR$$M$Y$$$20240821$$HP$CA$CA
241242941$24124294$1$I$20240617$20240702$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050278$TOLMAR$$87$YR$$M$Y$$$20240723$$HP$CA$CA
241242951$24124295$1$I$$20240702$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050753$TOLMAR$$$$$M$Y$$$20240723$$CN$CA$CA
241242961$24124296$1$I$20240101$20240702$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050752$TOLMAR$$$$$M$Y$$$20240723$$CN$CA$CA
241242971$24124297$1$I$$20240702$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050754$TOLMAR$$$$$M$Y$$$20240723$$CN$CA$CA
241242981$24124298$1$I$20240101$20240702$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050756$TOLMAR$$$$$M$Y$$$20240723$$CN$CA$CA
241242991$24124299$1$I$20240201$20240716$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050798$TOLMAR$$80$YR$$M$Y$$$20240723$$CN$CA$CA
241243002$24124300$2$F$$20240731$20240723$20240826$PER$$CA-TOLMAR, INC.-24CA050786$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
241243011$24124301$1$I$20240702$20240702$20240723$20240723$PER$$FR-TOLMAR, INC.-24FR050766$TOLMAR$$75$YR$$M$Y$$$20240723$$PH$FR$FR
241243021$24124302$1$I$$20240702$20240723$20240723$PER$$CA-TOLMAR, INC.-24CA050805$TOLMAR$$$$$M$Y$$$20240723$$CN$CA$CA
241243032$24124303$2$F$20240701$20240815$20240723$20240821$EXP$$US-ABBVIE-5844868$ABBVIE$$75$YR$$F$Y$$$20240821$$CN$US$US
241243041$24124304$1$I$20240703$20240717$20240723$20240723$EXP$$JP-JNJFOC-20240758374$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240723$$MD$JP$JP
241243051$24124305$1$I$20240626$20240628$20240723$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003052$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240723$$CN$US$US
241243061$24124306$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06684$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241243071$24124307$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116256$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240723$$CN$US$US
241243081$24124308$1$I$20240717$20240719$20240723$20240723$EXP$$CA-ABBVIE-5847099$ABBVIE$$89$YR$$M$Y$$$20240723$$CN$CA$CA
241243092$24124309$2$F$20230601$20240708$20240723$20240723$EXP$$CN-AZURITY PHARMACEUTICALS, INC.-AZR202407-000061$AZURITY PHARMACEUTICALS$Ouyang H, Zhang S, Xu F, Lin W, Liu Z, Guo H.. Spinal dural arteriovenous fistula with low back pain as the only symptom at onset: A case report. American journal of case report. 2024;25:e943947 (1-6)$71$YR$$M$Y$$$20240723$$HP$CN$CN
241243101$24124310$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06784$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241243111$24124311$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06729$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241243122$24124312$2$F$$20240912$20240723$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003053$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
241243132$24124313$2$F$20240101$20240905$20240723$20240907$EXP$$US-TAKEDA-2024TUS072645$TAKEDA$$$$$F$Y$$$20240907$$CN$US$US
241243144$24124314$4$F$20240619$20240906$20240723$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115398$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$77.3$KG$20240909$$HP$US$US
241243151$24124315$1$I$20210316$20210511$20240723$20240723$EXP$$US-AstraZeneca-2021A421169$ASTRAZENECA$$23827$DY$$M$Y$145.2$KG$20240723$$CN$US$
241243162$24124316$2$F$$20200625$20240723$20240815$EXP$$US-AstraZeneca-2020SE82532$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
241243171$24124317$1$I$$20240715$20240723$20240723$EXP$GB-MHRA-MED-202407121113269990-JSYKZ$GB-TEVA-VS-3221736$TEVA$$59$YR$$F$Y$57$KG$20240723$$CN$GB$GB
241243181$24124318$1$I$$20220923$20240723$20240723$EXP$$US-AstraZeneca-2022A329855$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241243191$24124319$1$I$$20210825$20240723$20240723$EXP$$US-AstraZeneca-2021A699884$ASTRAZENECA$$$$$M$Y$95.3$KG$20240723$$CN$US$
241243201$24124320$1$I$$20201229$20240723$20240723$EXP$$US-AstraZeneca-2020SF75894$ASTRAZENECA$$76$YR$$F$Y$$$20240723$$CN$US$
241243211$24124321$1$I$20220101$20220224$20240723$20240723$EXP$$US-AstraZeneca-2022A025846$ASTRAZENECA$$818$MON$$M$Y$65.8$KG$20240723$$CN$US$
241243221$24124322$1$I$20220122$20220622$20240723$20240723$EXP$$BR-AstraZeneca-2022A230127$ASTRAZENECA$$$$$F$Y$57$KG$20240723$$HP$BR$
241243231$24124323$1$I$$20240711$20240723$20240723$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06733$HIKMA$LeBlanc FR, Grier DD, Myers KC, Shimamura A, Pommert L.. LeBlanc FR, Grier DD, Myers KC, Shimamura A, Pommert L. A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome.. Pediatric Blood and Cancer.. 2024;71(8):e31137$$$$$Y$$$20240719$$MD$US$US
241243241$24124324$1$I$$20230307$20240723$20240723$EXP$$US-AstraZeneca-2023A056759$ASTRAZENECA$$$$$M$Y$$$20240723$$HP$US$
241243251$24124325$1$I$20220721$20220920$20240723$20240723$EXP$$US-AstraZeneca-2022A280519$ASTRAZENECA$$74$YR$$M$Y$$$20240723$$CN$US$
241243261$24124326$1$I$$20230516$20240723$20240723$EXP$$US-AstraZeneca-2023A114150$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241243271$24124327$1$I$20240721$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014026$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240723$$CN$US$US
241243281$24124328$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06841$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241243291$24124329$1$I$20240626$20240722$20240723$20240723$EXP$ES-AEMPS-1551890$ES-ABBVIE-5848204$ABBVIE$$53$YR$$M$Y$$$20240723$$MD$ES$ES
241243301$24124330$1$I$$20240513$20240723$20240723$PER$$US-AUROBINDO-AUR-APL-2024-025573$AUROBINDO$$$$$M$Y$$$20240719$$PH$US$US
241243311$24124331$1$I$$20240520$20240723$20240723$PER$$US-AUROBINDO-AUR-APL-2024-026132$AUROBINDO$$16$YR$$M$Y$$$20240719$$HP$US$US
241243321$24124332$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06769$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241243331$24124333$1$I$$20240118$20240723$20240723$PER$$US-AUROBINDO-AUR-APL-2024-003704$AUROBINDO$$56$YR$$F$Y$65$KG$20240719$$CN$US$US
241243341$24124334$1$I$$20240715$20240723$20240723$EXP$$CO-ROCHE-10000027219$ROCHE$$52$YR$A$F$Y$$$20240723$$CN$CO$CO
241243352$24124335$2$F$20240704$20240731$20240723$20240805$EXP$$JP-GILEAD-2024-0679642$GILEAD$$87$YR$E$M$Y$$$20240805$$PH$JP$JP
241243362$24124336$2$F$$20240812$20240723$20240812$PER$$US-ALXN-202407USA001124US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241243371$24124337$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06772$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241243381$24124338$1$I$$20240716$20240723$20240723$PER$$US-ABBVIE-5846426$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241243391$24124339$1$I$$20240716$20240723$20240723$EXP$$CN-CHEPLA-2024009048$CHEPLAPHARM$Cui HM, Shu XP, Wei ZQ, Wu XY. The ^appearing^ and ^disappearing^ ascites in the treatment of colorectal cancer: a case report. Frontiers in Oncology. 2024;14:1372812. doi: 10.3389/fonc.2024.1372812.$65$YR$$M$Y$$$20240723$$HP$COUNTRY NOT SPECIFIED$CN
241243401$24124340$1$I$20240717$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024143113$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241243412$24124341$2$F$$20240730$20240723$20240806$EXP$$US-ABBVIE-5845058$ABBVIE$$54$YR$$M$Y$$$20240806$$CN$US$US
241243421$24124342$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06761$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241243432$24124343$2$F$20240713$20240731$20240723$20240807$30DAY$$US-AMGEN-USASP2024140348$AMGEN$$66$YR$E$M$Y$$$20240807$$HP$US$US
241243441$24124344$1$I$$20240716$20240723$20240723$EXP$$US-ABBVIE-5846767$ABBVIE$$$$$M$Y$$$20240723$$HP$US$US
241243453$24124345$3$F$20240720$20240726$20240723$20240729$EXP$$IT-BIOVITRUM-2024-IT-010105$BIOVITRUM$$47$YR$$M$Y$85$KG$20240729$$MD$IT$IT
241243461$24124346$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06701$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241243471$24124347$1$I$$20240717$20240723$20240723$EXP$CA-DRL-USA-SPO/CAN/24/0010583$CA-RDY-SPO/CAN/24/0010583$DR REDDYS$$84$YR$E$F$Y$29.03$KG$20240723$$HP$CA$CA
241243491$24124349$1$I$$20240716$20240723$20240723$PER$$US-ABBVIE-5846107$ABBVIE$$$$$$Y$$$20240723$$CN$US$US
241243501$24124350$1$I$20200226$20240715$20240723$20240723$EXP$$CA-CELLTRION INC.-2019CA027737$CELLTRION$$$$$$Y$$$20240723$$MD$CA$CA
241243511$24124351$1$I$20220201$20220823$20240723$20240723$EXP$$US-RECORDATI-2022000738$RECORDATI$$$$$$Y$$$20240723$$CN$US$US
241243521$24124352$1$I$20240711$20240714$20240723$20240723$EXP$$CN-BEIGENE-BGN-2024-010926$BEIGENE$$$$$$Y$$$20240723$$HP$CN$CN
241243532$24124353$2$F$20160101$20240802$20240723$20240815$EXP$$US-UCBSA-2024036879$UCB$$$$$F$Y$$$20240815$$CN$US$US
241243541$24124354$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024140473$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241243551$24124355$1$I$$20240715$20240723$20240723$EXP$$NVSC2024US147334$NOVARTIS$$40$YR$$F$Y$$$20240723$$HP$US$US
241243561$24124356$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06712$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241243583$24124358$3$F$20240101$20240823$20240723$20240831$PER$$US-AMGEN-USASP2024143450$AMGEN$$62$YR$A$F$Y$$$20240831$$CN$US$US
241243593$24124359$3$F$20240811$20240812$20240723$20240814$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-021323$UNITED THERAPEUTICS$$61$YR$$M$Y$$$20240814$$$CA$CA
241243602$24124360$2$F$20240719$20240719$20240723$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116334$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240801$$MD$US$US
241243611$24124361$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116006$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240723$$CN$US$US
241243631$24124363$1$I$$20240625$20240723$20240723$PER$$US-BEIGENE-BGN-2024-009699$BEIGENE$$$$$$Y$$$20240723$$PH$US$US
241243641$24124364$1$I$$20240715$20240723$20240723$EXP$$CA-JNJFOC-20240748910$JOHNSON AND JOHNSON$$74$YR$E$M$Y$64$KG$20240723$$HP$CA$CA
241243651$24124365$1$I$$20240711$20240723$20240723$EXP$$CA-APOTEX-2024AP008296$APOTEX$$$$$$Y$$$20240723$$MD$CA$CA
241243661$24124366$1$I$20240125$20240709$20240723$20240723$EXP$GB-MHRA-MED-202407081950377100-MCSQK$GB-GLENMARK PHARMACEUTICALS-2024GMK092321$GLENMARK$$$$$$Y$$$20240723$$CN$GB$GB
241243671$24124367$1$I$20240712$20240715$20240723$20240723$EXP$$US-VANTIVE-2024VAN018350$Vantive US Healthcare$$58$YR$$F$Y$$$20240723$$HP$US$US
241243681$24124368$1$I$20240601$20240716$20240723$20240723$EXP$FR-AFSSAPS-AM2024000571$FR-EMD Serono-2024038604$EMD SERONO INC$$82$YR$E$M$Y$71$KG$20240723$$MD$FR$FR
241243691$24124369$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024141862$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241243701$24124370$1$I$20230901$20240716$20240723$20240723$EXP$$US-ARGENX-2024-ARGX-US005605$ARGENX BVBA$$$$$$Y$$$20240723$$CN$US$US
241243711$24124371$1$I$20240614$20240711$20240723$20240723$EXP$$CA-ROCHE-10000031120$ROCHE$$30$YR$A$F$Y$$$20240723$$CN$CA$CA
241243721$24124372$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06681$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241243735$24124373$5$F$$20240923$20240723$20240930$EXP$$IT-ALXN-202407EEA001200IT$ALEXION PHARMACEUTICALS$$$$A$$Y$59$KG$20240930$$MD$IT$IT
241243741$24124374$1$I$$20240718$20240723$20240723$EXP$$GB-JNJFOC-20240754358$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$HP$GB$GB
241243751$24124375$1$I$20240601$20240715$20240723$20240723$PER$$US-ABBVIE-5843266$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241243761$24124376$1$I$$20240721$20240723$20240723$PER$$US-HALEON-2188243$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241243771$24124377$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5845859$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241243781$24124378$1$I$20240101$20240717$20240723$20240723$EXP$$US-ABBVIE-5846090$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241243792$24124379$2$F$$20240809$20240723$20240819$EXP$$PL-TEVA-VS-3220843$TEVA$Majowicz D, Kostrzewa K, Gromek T, Sokolowska B, Hus M. Haemophagocytic lymphohistiocytosis: case series. Serum ferritin level as an indicator of treatment effectiveness. Hematol-Clinic-Pract 2022; 13 130-137.; Majowicz D, Kostrzewa K, Gromek T, Sokolowska B, Hus M. Haemophagocytic lymphohistiocytosis: case series. Serum ferritin level as an indicator of treatment effectiveness. Hematol-Clinic-Pract 2022; 13 130-137.; Majowicz D, Kostrzewa K, Gromek T, Sokolowska B, Hus M. Haemophagocytic lym...$31$YR$$M$Y$$$20240819$$HP$PL$PL
241243812$24124381$2$F$20240716$20240725$20240723$20240731$PER$$US-AMGEN-USASP2024142010$AMGEN$$$$$M$Y$$$20240731$$CN$US$US
241243823$24124382$3$F$20240716$20240826$20240723$20240827$PER$$US-AMGEN-USASP2024143442$AMGEN$$85$YR$E$F$Y$$$20240827$$CN$US$US
241243833$24124383$3$F$20240712$20240910$20240723$20240916$PER$$US-AMGEN-USASP2024141172$AMGEN$$$$$F$Y$$$20240916$$PH$US$US
241243841$24124384$1$I$$20240717$20240723$20240723$EXP$$US-ABBVIE-5844399$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241243851$24124385$1$I$20240701$20240717$20240723$20240723$EXP$$US-ABBVIE-5844750$ABBVIE$$75$YR$$F$Y$$$20240723$$CN$US$US
241243862$24124386$2$F$20240101$20240723$20240723$20240729$EXP$$PR-ABBVIE-5843617$ABBVIE$$$$$F$Y$68$KG$20240729$$CN$PR$PR
241243872$24124387$2$F$20240627$20240830$20240723$20240903$EXP$$CA-ABBVIE-5845716$ABBVIE$$29$YR$$F$Y$$$20240903$$CN$CA$CA
241243881$24124388$1$I$$20240712$20240723$20240723$PER$$US-ABBVIE-5847058$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241243891$24124389$1$I$20240721$20240722$20240723$20240723$EXP$$CH-ABBVIE-5848442$ABBVIE$$74$YR$$M$Y$100$KG$20240723$$HP$CH$CH
241243902$24124390$2$F$20240101$20240731$20240723$20240805$EXP$$US-SA-2024SA211791$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240805$$MD$US$US
241243911$24124391$1$I$$20240719$20240723$20240723$EXP$$CA-ABBVIE-5846776$ABBVIE$$$$E$M$Y$$$20240723$$CN$CA$CA
241243921$24124392$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5848344$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241243931$24124393$1$I$$20240719$20240723$20240723$PER$$US-ROCHE-10000032345$ROCHE$$53$YR$A$F$Y$$$20240723$$HP$US$US
241243941$24124394$1$I$20240430$20240717$20240723$20240723$EXP$FR-AFSSAPS-TO2024001230$FR-EMD Serono-2024039018$EMD SERONO INC$$75$YR$E$M$Y$$$20240723$$PH$FR$FR
241243951$24124395$1$I$20240716$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024142726$AMGEN$$85$YR$E$M$Y$$$20240723$$CN$US$US
241243961$24124396$1$I$$20210112$20240723$20240723$EXP$$GB-AstraZeneca-2021A007799$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$GB$
241243971$24124397$1$I$$20230403$20240723$20240723$EXP$$GB-AstraZeneca-2023A077797$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$GB$
241243981$24124398$1$I$20211220$20220329$20240723$20240723$EXP$$US-AstraZeneca-2022A072504$ASTRAZENECA$$22791$DY$$F$Y$$$20240723$$CN$US$
241243991$24124399$1$I$$20220210$20240723$20240723$EXP$$US-AstraZeneca-2022A068629$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241244001$24124400$1$I$$20230213$20240723$20240723$EXP$$US-AstraZeneca-2022A420441$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241244011$24124401$1$I$$20210607$20240723$20240723$EXP$$US-AstraZeneca-2021A507275$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241244021$24124402$1$I$$20230130$20240723$20240723$EXP$$US-AstraZeneca-2023A025530$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241244031$24124403$1$I$$20230214$20240723$20240723$EXP$$US-AstraZeneca-2023A038458$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241244041$24124404$1$I$$20201211$20240723$20240723$EXP$$TT-AstraZeneca-2020SF67255$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$TT$
241244051$24124405$1$I$20220124$20220124$20240723$20240723$EXP$$US-AstraZeneca-2022A046777$ASTRAZENECA$$12523$DY$$F$Y$$$20240723$$CN$US$
241244071$24124407$1$I$$20240627$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003054$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241244081$24124408$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115905$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240723$$MD$US$US
241244092$24124409$2$F$$20240916$20240723$20240926$EXP$$IT-AUROBINDO-AUR-APL-2024-035658$AUROBINDO$Pozzi A, Bonfanti P, Bartesaghi G, Refugjati T, Marini A, Corrado G.. NON-RESPONSE TO INCLISIRAN THERAPY IN THREE PATIENTS WITH STATIN INTOLERANCE: A CASE SERIES.. Eur-Heart-J-Suppl. 2024;26 (Suppl. 2):ii78 abstr. suae036.182.$79$YR$$F$Y$$$20240926$$HP$IT$IT
241244101$24124410$1$I$20240619$20240712$20240723$20240723$EXP$FR-AFSSAPS-RN2024000735$FR-ROCHE-10000030512$ROCHE$$49$YR$A$M$Y$$$20240723$$MD$FR$FR
241244113$24124411$3$F$$20240812$20240723$20240812$PER$$US-ALXN-202407USA001106US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241244121$24124412$1$I$$20240709$20240723$20240723$EXP$$PL-ROCHE-10000025403$ROCHE$$84$YR$E$M$Y$$$20240723$$MD$PL$PL
241244132$24124413$2$F$$20240715$20240723$20240729$EXP$$US-LEO Pharma-372070$LEO PHARM$$36$YR$$F$Y$$$20240729$$CN$US$US
241244141$24124414$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143623$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241244151$24124415$1$I$$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144108$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241244161$24124416$1$I$$20240717$20240723$20240723$EXP$$JP-GSK-JP2024091494$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$JP$JP
241244171$24124417$1$I$20240618$20240627$20240723$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002941$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240723$$CN$US$US
241244181$24124418$1$I$20240620$20240626$20240723$20240723$EXP$$US-NEBO-662767$PHARMACOSMOS$$80$YR$$F$Y$$$20240723$$CN$US$US
241244191$24124419$1$I$$20211216$20240723$20240723$EXP$$US-AstraZeneca-2021A882631$ASTRAZENECA$$32$YR$$F$Y$90.7$KG$20240723$$CN$US$
241244201$24124420$1$I$$20230313$20240723$20240723$EXP$$US-AstraZeneca-2023A050550$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241244211$24124421$1$I$$20230526$20240723$20240723$EXP$$US-AstraZeneca-2023A123947$ASTRAZENECA$$$$$F$Y$62.7$KG$20240723$$CN$US$
241244221$24124422$1$I$$20230502$20240723$20240723$EXP$$IN-AstraZeneca-2023A126510$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$IN$
241244231$24124423$1$I$$20230118$20240723$20240723$EXP$$US-AstraZeneca-2023A015583$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241244241$24124424$1$I$20240626$20240626$20240723$20240723$30DAY$$GR-UCBSA-2024033758$UCB$$$$$M$Y$$$20240723$$PH$GR$GR
241244261$24124426$1$I$$20221227$20240723$20240723$EXP$$US-AstraZeneca-2022A419694$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241244271$24124427$1$I$20221011$20240606$20240723$20240723$EXP$$TH-AstraZeneca-2022A347817$ASTRAZENECA$$3265$WK$$F$Y$$$20240723$$CN$TH$
241244281$24124428$1$I$$20201006$20240723$20240723$EXP$$US-AstraZeneca-2020SF32016$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241244291$24124429$1$I$$20210428$20240723$20240723$EXP$$ZA-AstraZeneca-2021A386235$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$ZA$
241244302$24124430$2$F$20230901$20240819$20240723$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003032$ACADIA PHARMACEUTICALS$$1$YR$$F$Y$$$20240912$$CN$US$US
241244311$24124431$1$I$$20230421$20240723$20240723$EXP$$US-AstraZeneca-2023A095746$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241244321$24124432$1$I$$20220502$20240723$20240723$EXP$$US-AstraZeneca-2022A171575$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241244331$24124433$1$I$$20220323$20240723$20240723$EXP$$US-AstraZeneca-2022A126176$ASTRAZENECA$$$$$F$Y$$$20240723$$HP$US$
241244351$24124435$1$I$$20240718$20240723$20240723$EXP$$GB-CELLTRION INC.-2024GB010930$CELLTRION$$$$$$Y$$$20240723$$CN$GB$GB
241244361$24124436$1$I$20240706$20240715$20240723$20240723$EXP$$PK-ROCHE-10000027846$ROCHE$$69$YR$E$M$Y$$$20240723$$CN$PK$PK
241244371$24124437$1$I$$20240627$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003046$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241244382$24124438$2$F$20240301$20240812$20240723$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003057$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240830$$CN$US$US
241244392$24124439$2$F$$20240723$20240723$20240730$PER$$US-LEO Pharma-372139$LEO PHARM$$56$YR$$M$Y$$$20240730$$CN$US$US
241244402$24124440$2$F$$20240729$20240723$20240806$EXP$$CN-ROCHE-10000024687$ROCHE$Li J, Wu Q, Guo X, Rong L, Fang Y. Salvage treatment of ruxolitinib for refractory adenovirus-associated hemophagocytic syndrome post-haploidentical allogeneic stem cell transplantation: a case report. Translational Pediatrics. 2024-Jun;13 (6):994-1000. doi:10.21037/tp-24-27.$11$YR$C$M$Y$$$20240806$$HP$CN$CN
241244413$24124441$3$F$$20240906$20240723$20240913$EXP$$PL-AUROBINDO-AUR-APL-2024-035826$AUROBINDO$Zakrzewski D, Zawadzka M, Mazurkiewicz-Beldziiska M.. Chtopiec z cieikimi lekoopornymi napadami padaczkowymi o poczatku w wieku 6 miesiecy i op?inieniem rozwoju psychoruchowego.. Medycyna Praktyczna. 2024;57-60$6$MON$$M$Y$$$20240913$$MD$PL$PL
241244422$24124442$2$F$$20240723$20240723$20240726$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-100585$REGENERON$$$$$$Y$$$20240726$$HP$DE$DE
241244432$24124443$2$F$20240101$20240919$20240723$20240926$EXP$$US-ABBVIE-5752093$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
241244442$24124444$2$F$$20240828$20240723$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003044$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
241244451$24124445$1$I$20240617$20240628$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003042$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240723$$CN$US$US
241244461$24124446$1$I$20230814$20240628$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003045$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240723$$CN$US$US
241244471$24124447$1$I$$20240715$20240723$20240723$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001005$ALEMBIC$Sorabekka R.A, Gray W.H, Dabak R.J, Padikka K.A, Hocl L, Ckarl M.G.et.al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70 (7):e92-e96$$$$$Y$$$20240723$$HP$US$US
241244481$24124448$1$I$$20240711$20240723$20240723$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001022$ALEMBIC$Nguyen D.G, Morris S.A,  Hamilton A, Kwange S.O, Steuerwald N, Symanowski J. et.al.. Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (DPYD) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Center. JCO Precision Oncology. 2024;8 (e2300623):1-13$$$$$Y$$$20240723$$PH$US$US
241244491$24124449$1$I$$20240711$20240723$20240723$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001023$ALEMBIC$Nguyen D.G, Morris S.A,  Hamilton A, Kwange S.O, Steuerwald N, Symanowski J. et.al.. Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (DPYD) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Center. JCO Precision Oncology. 2024;8 (e2300623):1-13$$$$$Y$$$20240723$$PH$US$US
241244504$24124450$4$F$$20240828$20240723$20240904$EXP$$TH-ROCHE-10000030533$ROCHE$$68$YR$E$M$Y$$$20240904$$CN$TH$TH
241244511$24124451$1$I$$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144123$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241244521$24124452$1$I$20240701$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143195$AMGEN$$67$YR$E$F$Y$$$20240723$$CN$US$US
241244532$24124453$2$F$20240624$20240808$20240723$20240813$EXP$$JP-GSK-JP2024091468$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$MD$JP$JP
241244541$24124454$1$I$20240123$20240709$20240723$20240723$EXP$$TH-ROCHE-10000031108$ROCHE$$91$YR$E$F$Y$$$20240723$$HP$TH$TH
241244552$24124455$2$F$$20240809$20240723$20240812$PER$$US-JNJFOC-20240756602$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
241244561$24124456$1$I$$20240708$20240723$20240723$EXP$$CN-Owlpharma Consulting, Lda.-2159457$OWLPHARMA CONSULTING$Scientific Article from weekly Literature search$37$YR$$F$Y$$$20240723$$$CN$CN
241244571$24124457$1$I$$20240709$20240723$20240723$EXP$GB-MHRA-MED-202407091327046950-KHLJW$GB-GLENMARK PHARMACEUTICALS-2024GMK092323$GLENMARK$$$$$$Y$$$20240723$$CN$GB$GB
241244581$24124458$1$I$$20240716$20240723$20240723$EXP$$JP-GILEAD-2024-0681077$GILEAD$Yamane S, Sumikawa T, Nishigami M, Matsushita M, Ueda Y, Hasegawa Y, et al.. KT-14 ?A case of COVID-19 complicated with infective endocarditis. The 70th Chugoku-Shikoku Regional Meeting of the Japanese Respiratory Society. 2024;UNK:80$51$YR$A$F$Y$$$20240723$$MD$JP$JP
241244594$24124459$4$F$20240826$20240905$20240723$20240914$EXP$$CA-CELLTRION INC.-2024CA017376$CELLTRION$$$$$$Y$$$20240914$$MD$CA$CA
241244601$24124460$1$I$$20240716$20240723$20240723$PER$$US-PCCINC-2024-PPL-000538$PIRAMAL$$$$$$Y$$$20240723$$HP$US$US
241244622$24124462$2$F$20170101$20240717$20240723$20240723$PER$$US-ABBVIE-5848267$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241244632$24124463$2$F$20221101$20240723$20240723$20240801$EXP$$DE-ROCHE-3258449$ROCHE$$35$YR$A$F$Y$51$KG$20240801$$MD$DE$DE
241244641$24124464$1$I$20230706$20240715$20240723$20240723$EXP$$KR-009507513-2407KOR008804$MERCK$$$$E$M$Y$70$KG$20240723$$HP$KR$KR
241244651$24124465$1$I$20240513$20240718$20240723$20240723$EXP$$CA-TAKEDA-2024TUS054982$TAKEDA$$33$YR$$F$Y$$$20240723$$MD$CA$CA
241244662$24124466$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3220455$TEVA$Hanif IH, Abdelrahim S, Al Shaarani M, Lu H, Ahmad R, Goswami S, et al. Immune Checkpoint Therapy-Induced Lupus Nephritis. Kidney-Int-Rep 2024; 9 (5): 1534-1537.; Hanif IH, Abdelrahim S, Al Shaarani M, Lu H, Ahmad R, Goswami S, et al. Immune Checkpoint Therapy-Induced Lupus Nephritis. Kidney-Int-Rep 2024; 9 (5): 1534-1537.; Hanif IH, Abdelrahim S, Al Shaarani M, Lu H, Ahmad R, Goswami S, et al. Immune Checkpoint Therapy-Induced Lupus Nephritis. Kidney-Int-Rep 2024; 9 (5): 1534-1537.$$$E$M$Y$$$20240819$$HP$US$US
241244671$24124467$1$I$$20220317$20240723$20240723$EXP$$US-AstraZeneca-2022A118059$ASTRAZENECA$$48$YR$$F$Y$79.8$KG$20240723$$CN$US$
241244681$24124468$1$I$$20200916$20240723$20240723$EXP$$US-AstraZeneca-2020SF13675$ASTRAZENECA$$76$YR$$F$Y$$$20240723$$CN$US$
241244691$24124469$1$I$20210703$20210812$20240723$20240723$EXP$$US-AstraZeneca-2021A682936$ASTRAZENECA$$60$YR$$M$Y$$$20240723$$CN$US$
241244701$24124470$1$I$$20230411$20240723$20240723$EXP$$US-AstraZeneca-2023A080150$ASTRAZENECA$$68$YR$$F$Y$$$20240723$$CN$US$
241244711$24124471$1$I$$20230524$20240723$20240723$EXP$$US-AstraZeneca-2023A121267$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241244721$24124472$1$I$$20230616$20240723$20240723$EXP$$AU-AstraZeneca-2023A109439$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$AU$
241244731$24124473$1$I$$20220630$20240723$20240723$EXP$$US-AstraZeneca-2022A243675$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241244741$24124474$1$I$$20201130$20240723$20240723$EXP$$US-AstraZeneca-2020SF54986$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241244751$24124475$1$I$$20210426$20240723$20240723$EXP$$US-AstraZeneca-2021A362643$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241244761$24124476$1$I$$20200130$20240723$20240723$EXP$$RU-AstraZeneca-2020SE16870$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$RU$
241244771$24124477$1$I$$20230802$20240723$20240723$EXP$$US-AstraZeneca-2023A177030$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241244782$24124478$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3220452$TEVA$Wong C, Ang G, Malik M, Iqbal S. From Tongue Swelling to Skin Sloughing: Azithromycin-induced SJS/TEN. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A5659.; Wong C, Ang G, Malik M, Iqbal S. From Tongue Swelling to Skin Sloughing: Azithromycin-induced SJS/TEN. Am-J-Respir-Crit-Care-Med 2024; 209 (0): A5659.$71$YR$$F$Y$$$20240819$$HP$US$US
241244791$24124479$1$I$$20240712$20240723$20240723$EXP$$CN-ROCHE-10000031062$ROCHE$Gu Y, Chu X, Zhao L, Hong B, Luo Z, Lin Z. Thrombolysis with low?dose and standard?dose intravenous recombinant tissue plasminogen activator in elderly patients with acute ischemic stroke?a stratified analysis. The Journal of Practical Medicine. 2024;11(40): 1568-1573.$$$E$$Y$$$20240723$$MD$CN$CN
241244801$24124480$1$I$$20240628$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003050$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241244811$24124481$1$I$20240101$20240717$20240723$20240723$EXP$$US-ABBVIE-5845074$ABBVIE$$67$YR$$F$Y$$$20240723$$CN$US$US
241244821$24124482$1$I$$20240715$20240723$20240723$EXP$$FR-TAKEDA-2024TUS072699$TAKEDA$Walczak P, Fodil S, Vignal N, Cabannes-Hamy A, Boissel N, Raffoux E, et al.. Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1- positive acute lymphoblastic leukemia. Blood. 2021$31$YR$$M$Y$$$20240723$$MD$FR$FR
241244832$24124483$2$F$20240601$20240806$20240723$20240819$EXP$$JP-UCBSA-2024035756$UCB$$8$DEC$$F$Y$$$20240819$$PH$JP$JP
241244841$24124484$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000031063$ROCHE$$89$YR$E$F$Y$$$20240723$$MD$US$US
241244861$24124486$1$I$$20240716$20240723$20240723$PER$$US-ABBVIE-5847622$ABBVIE$$$$$$Y$$$20240723$$CN$US$US
241244873$24124487$3$F$20240614$20240809$20240723$20240819$PER$$US-TRIS PHARMA, INC.-24US011574$TRIS PHARM$$$$$$Y$$$20240819$$HP$US$US
241244881$24124488$1$I$$20240618$20240723$20240723$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108915$ZYDUS PHARM$$$$$$Y$$$20240723$$HP$US$US
241244891$24124489$1$I$$20240715$20240723$20240723$EXP$$US-CHEPLA-2024009059$CHEPLAPHARM$Amusina O, Mehta S, Nelson ME. Brugada phenocopy secondary to hyperkalemia and hyponatremia in primary adrenal insufficiency. J Am Coll Emerg Physicians Open. 2022;10;3(4):e12800.DOI: 10.1002/emp2.12800.$26$YR$$M$Y$$$20240723$$HP$COUNTRY NOT SPECIFIED$US
241244902$24124490$2$F$20240622$20240903$20240723$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003004$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240913$$CN$US$US
241244911$24124491$1$I$20080801$20240716$20240723$20240723$EXP$$HK-CHEPLA-2024008991$CHEPLAPHARM$$66$YR$$M$Y$$$20240723$$CN$COUNTRY NOT SPECIFIED$HK
241244922$24124492$2$F$20240628$20240906$20240723$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003055$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240927$$CN$US$US
241244931$24124493$1$I$$20240709$20240723$20240723$EXP$$IT-AUROBINDO-AUR-APL-2024-035371$AUROBINDO$Tansella D, Pittorru R, Perazzolo Marra M.. VENTRICULAR ARRHYTHMIAS IN A UNEXPECTED CARDIAC MAGNETIC RESONANCE. Eur-Heart-J-Suppl. 2024;26 (Suppl.):ii52-ii53$59$YR$$M$Y$$$20240723$$HP$IT$IT
241244953$24124495$3$F$20240828$20240829$20240723$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116257$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240830$$CN$US$US
241244961$24124496$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116479$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240723$$HP$US$US
241244971$24124497$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116301$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240723$$CN$US$US
241244982$24124498$2$F$$20240805$20240723$20240808$EXP$$JP-GILEAD-2024-0681074$GILEAD$Kohara H. K-19 A review of treatment of a patient with postoperative liver metastasis of pancreatic head cancer who tested positive for COVID-19 antigen test and was hospitalised for accompanying severe pneumonia. The 70th Chugoku-Shikoku Regional Meeting of the Japanese Respiratory Society. unk;unk:67$8$DEC$E$M$Y$$$20240808$$MD$JP$JP
241244992$24124499$2$F$$20240724$20240723$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003056$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
241245001$24124500$1$I$20240408$20240628$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001858$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240723$$CN$US$US
241245012$24124501$2$F$$20240913$20240723$20240919$PER$$NVSC2024US146463$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
241245021$24124502$1$I$$20240709$20240723$20240723$EXP$GB-MHRA-MED-202407092212033490-KTPGJ$GB-GLENMARK PHARMACEUTICALS-2024GMK092328$GLENMARK$$$$$$Y$$$20240723$$CN$GB$GB
241245031$24124503$1$I$20240605$20240629$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003058$ACADIA PHARMACEUTICALS$$90$YR$$M$Y$$$20240723$$CN$US$US
241245041$24124504$1$I$$20240711$20240723$20240723$EXP$$US-HBP-2024US030947$HELSINN HEALTHCARE$$$$$M$Y$$$20240723$$CN$US$US
241245051$24124505$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024144472$AMGEN$$$$$$Y$$$20240723$$MD$US$US
241245064$24124506$4$F$20240101$20240906$20240723$20240916$EXP$$CA-CELLTRION INC.-2024CA011618$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
241245071$24124507$1$I$$20240708$20240723$20240723$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-06574$LUPIN$Abdullah, Behera MR, Kaul A, Agarwal V, Prasad P, Prasad N, et al. The unusual adverse effects of antituberculosis therapy in kidney patients. International Journal of Mycobacteriology. 2024;13 (2):183-190$16$YR$$M$Y$$$20240723$$HP$IN$IN
241245081$24124508$1$I$$20240716$20240723$20240723$PER$$US-ABBVIE-5845417$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241245091$24124509$1$I$$20240708$20240723$20240723$EXP$$IN-IPCA LABORATORIES LIMITED-IPC-2024-IN-001799$IPCA$Sarthak Parmar, Pooja Shatadal and Ritambhara Mehta. Diagnostic dilemma: Systemic lupus erythematosus (SLE) induced psychosis vs steroid-induced psychosis- A case report. Indian Journal of Psychiatry. 2024;S167$$$$$Y$$$20240723$$MD$IN$IN
241245102$24124510$2$F$$20240726$20240723$20240731$EXP$$US-ABBVIE-5846127$ABBVIE$$$$$F$Y$117$KG$20240731$$CN$US$US
241245111$24124511$1$I$$20240717$20240723$20240723$EXP$$CA-ABBVIE-5845943$ABBVIE$$42$YR$$M$Y$$$20240723$$CN$CA$CA
241245121$24124512$1$I$$20240714$20240723$20240723$EXP$$US-JNJFOC-20240743194$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240723$$MD$US$US
241245131$24124513$1$I$20230101$20240717$20240723$20240723$EXP$$US-ABBVIE-5845910$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241245141$24124514$1$I$$20240712$20240723$20240723$EXP$$JP-ROCHE-3579533$ROCHE$Uryu H, Kawashima R, Ishiguro M, Tanizawa M, Kanazawa Y, et al. Case of Primary Adrenal Insufficiency Triggered by Cytomegalovirus Infection after Obinutuzumab plus Bendamustine Therapy for Follicular Lymphoma. Internal Medicine. 2024;1-6. doi:10.2169/internalmedicine.3334-23.$69$YR$E$M$Y$$$20240723$$HP$JP$JP
241245151$24124515$1$I$$20240717$20240723$20240723$PER$$US-ABBVIE-5845450$ABBVIE$$$$$$Y$$$20240723$$HP$US$US
241245161$24124516$1$I$20230803$20220721$20240723$20240723$EXP$$CA-CELLTRION INC.-2022CA022417$CELLTRION$$$$$$Y$$$20240723$$MD$CA$CA
241245171$24124517$1$I$$20240716$20240723$20240723$EXP$$NVSC2024US146663$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
241245182$24124518$2$F$$20240807$20240723$20240808$PER$$US-ALXN-202407USA001109US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241245191$24124519$1$I$$20230301$20240723$20240723$EXP$$US-AstraZeneca-2023A055910$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241245201$24124520$1$I$$20240716$20240723$20240723$EXP$$CA-TAKEDA-2024TUS072427$TAKEDA$$$$$F$Y$$$20240723$$CN$CA$CA
241245211$24124521$1$I$$20210528$20240723$20240723$EXP$$CA-AstraZeneca-2021A484313$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$CA$
241245222$24124522$2$F$20240701$20240722$20240723$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-114719$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240729$$MD$JP$JP
241245231$24124523$1$I$20240701$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161959$ASTRAZENECA$$61$YR$$F$Y$70.3$KG$20240723$$HP$US$
241245242$24124524$2$F$20240518$20240722$20240723$20240729$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02634$AMNEAL$$56$YR$$M$Y$117.91$KG$20240729$$CN$US$US
241245251$24124525$1$I$20240716$20240716$20240723$20240723$PER$$US-AstraZeneca-2024A162602$ASTRAZENECA$$26224$DY$$M$Y$$$20240723$$CN$US$
241245261$24124526$1$I$20220418$20220801$20240723$20240723$EXP$$US-AstraZeneca-2022A225202$ASTRAZENECA$$48$YR$$F$Y$$$20240723$$CN$US$
241245271$24124527$1$I$$20200217$20240723$20240723$EXP$$US-AstraZeneca-2020SE25291$ASTRAZENECA$$$$$F$Y$$$20240723$$HP$US$
241245281$24124528$1$I$20210424$20210524$20240723$20240723$EXP$$CO-AstraZeneca-2021A466158$ASTRAZENECA$$28338$DY$$F$Y$50$KG$20240723$$CN$CO$
241245291$24124529$1$I$$20211227$20240723$20240723$EXP$$US-AstraZeneca-2021A905020$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241245301$24124530$1$I$$20240718$20240723$20240723$EXP$$ZA-AstraZeneca-2024A164324$ASTRAZENECA$$66$YR$$M$Y$$$20240723$$CN$ZA$
241245311$24124531$1$I$$20221116$20240723$20240723$EXP$$US-AstraZeneca-2022A382709$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241245321$24124532$1$I$$20210521$20240723$20240723$EXP$$ZA-AstraZeneca-2021A461961$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$ZA$
241245332$24124533$2$F$$20240805$20240723$20240901$PER$$US-AstraZeneca-2024A161547$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
241245341$24124534$1$I$$20230714$20240723$20240723$EXP$$CA-AstraZeneca-2023A144418$ASTRAZENECA$$$$$M$Y$102$KG$20240723$$CN$CA$
241245351$24124535$1$I$$20201207$20240723$20240723$EXP$$US-AstraZeneca-2020SF65927$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241245361$24124536$1$I$$20240708$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407006775$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240723$$CN$US$US
241245371$24124537$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012817$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240723$$CN$US$US
241245381$24124538$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013133$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240723$$CN$US$US
241245391$24124539$1$I$20240719$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013166$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240723$$CN$US$US
241245402$24124540$2$F$$20240717$20240723$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202407011399$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240828$$CN$US$US
241245411$24124541$1$I$20240719$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013214$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240723$$CN$US$US
241245421$24124542$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013280$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240723$$CN$US$US
241245431$24124543$1$I$20240717$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012904$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240723$$CN$US$US
241245441$24124544$1$I$20240716$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011587$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240723$$CN$US$US
241245451$24124545$1$I$20240714$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012651$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240723$$CN$US$US
241245461$24124546$1$I$$20240715$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407009538$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240723$$CN$US$US
241245471$24124547$1$I$20240718$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012633$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$US$US
241245481$24124548$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012598$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240723$$CN$US$US
241245491$24124549$1$I$20240501$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011372$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240723$$CN$US$US
241245501$24124550$1$I$20240101$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013297$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$US$US
241245511$24124551$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013689$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240723$$CN$US$US
241245521$24124552$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013160$ELI LILLY AND CO$$$$$M$Y$$$20240723$$CN$US$US
241245531$24124553$1$I$20240716$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013267$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240723$$CN$US$US
241245541$24124554$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013269$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240723$$CN$US$US
241245551$24124555$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012980$ELI LILLY AND CO$$$$A$$Y$$$20240723$$CN$US$US
241245561$24124556$1$I$20240718$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012459$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$US$US
241245572$24124557$2$F$$20240712$20240723$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407009548$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240726$$HP$US$US
241245581$24124558$1$I$20240715$20240716$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011049$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240723$$CN$US$US
241245591$24124559$1$I$20240701$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013636$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240723$$CN$US$US
241245601$24124560$1$I$20240717$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011416$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240723$$HP$US$US
241245611$24124561$1$I$$20240710$20240723$20240723$EXP$$CA-TEVA-VS-3222678$TEVA$$69$YR$$F$Y$111$KG$20240723$$MD$CA$CA
241245621$24124562$1$I$$20240429$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002741$STEMLINE THERAPEUTICS$$45$YR$A$F$Y$$$20240718$$HP$US$US
241245631$24124563$1$I$$20240429$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002745$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$CN$US$US
241245641$24124564$1$I$$20240429$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002749$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241245651$24124565$1$I$$20240429$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002750$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$MD$US$US
241245661$24124566$1$I$$20240430$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002758$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241245671$24124567$1$I$$20240430$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002764$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241245681$24124568$1$I$$20240501$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002782$STEMLINE THERAPEUTICS$$48$YR$A$F$Y$$$20240718$$CN$US$US
241245691$24124569$1$I$$20240501$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002790$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241245701$24124570$1$I$$20240501$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002791$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241245711$24124571$1$I$$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002795$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241245721$24124572$1$I$$20240429$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002733$STEMLINE THERAPEUTICS$$48$YR$A$F$Y$$$20240718$$CN$US$US
241245731$24124573$1$I$$20240430$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002770$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241245741$24124574$1$I$$20240430$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002774$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$CN$US$US
241245751$24124575$1$I$$20240502$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002804$STEMLINE THERAPEUTICS$$89$YR$E$F$Y$$$20240718$$CN$US$US
241245761$24124576$1$I$$20240502$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002812$STEMLINE THERAPEUTICS$$68$YR$A$F$Y$$$20240718$$CN$US$US
241245771$24124577$1$I$20240101$20240614$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002814$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241245781$24124578$1$I$$20240502$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002819$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241245791$24124579$1$I$$20240502$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002834$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241245801$24124580$1$I$$20240503$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002844$STEMLINE THERAPEUTICS$$51$YR$A$F$Y$$$20240718$$CN$US$US
241245811$24124581$1$I$$20240503$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002848$STEMLINE THERAPEUTICS$$62$YR$A$F$Y$$$20240718$$CN$US$US
241245821$24124582$1$I$20240101$20240503$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002850$STEMLINE THERAPEUTICS$$47$YR$A$F$Y$$$20240718$$CN$US$US
241245832$24124583$2$F$20240126$20240920$20240723$20240926$EXP$$JP-GILEAD-2024-0681073$GILEAD$Nitta H, Suzuki H, Matsubara H, Naito T, Yamada M, Yamamoto H, et al.. 24  A case of steroid-induced pancreatitis during treatment of drug-induced liver injury caused by remdesivir. The 253rd Tokai Regional Meeting of the Japanese Society of Internal Medicine. 2024;unk:unk$83$YR$E$F$Y$40$KG$20240926$$MD$JP$JP
241245841$24124584$1$I$20240401$20240717$20240723$20240723$EXP$$AR-JNJFOC-20240750030$JOHNSON AND JOHNSON$$62$YR$A$F$Y$70$KG$20240723$$CN$AR$AR
241245853$24124585$3$F$20240715$20240814$20240723$20240820$PER$$US-AMGEN-USASP2024140827$AMGEN$$68$YR$E$M$Y$87$KG$20240820$$PH$US$US
241245861$24124586$1$I$20240714$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024142926$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241245871$24124587$1$I$$20240502$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002817$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240718$$CN$US$US
241245881$24124588$1$I$$20240502$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002820$STEMLINE THERAPEUTICS$$34$YR$A$F$Y$$$20240718$$CN$US$US
241245891$24124589$1$I$$20240716$20240723$20240723$PER$$US-ABBVIE-5843128$ABBVIE$$$$$$Y$$$20240723$$CN$US$US
241245901$24124590$1$I$$20240718$20240723$20240723$EXP$$US-GILEAD-2024-0681304$GILEAD$$$$E$M$Y$$$20240723$$CN$US$US
241245911$24124591$1$I$20240101$20240720$20240723$20240723$EXP$$ZA-ABBVIE-5848439$ABBVIE$$72$YR$$M$Y$$$20240723$$HP$ZA$ZA
241245921$24124592$1$I$$20240716$20240723$20240723$EXP$$GR-ROCHE-10000028075$ROCHE$Koutsianas C, Tsalapaki C, Mavrea E, Dimopoulou N, Vassilopoulos D. Simultaneous use of rituximab and mepolizumab in relapsing anca negative eosinophilic granulomatosis with polyangiitis [Abstract Number: 1253]. Annals of the Rheumatic Diseases. 2024-Jun;83 (Sup: 1):1967-8. doi:10.1136/annrheumdis-2024-eular.3759.$$$$$Y$$$20240723$$HP$GR$GR
241245931$24124593$1$I$20240430$20240501$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002798$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241245941$24124594$1$I$$20240502$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002811$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
241245951$24124595$1$I$$20240516$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002793$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241245961$24124596$1$I$$20240429$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002738$STEMLINE THERAPEUTICS$$41$YR$A$F$Y$$$20240718$$CN$US$US
241245971$24124597$1$I$$20240501$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002799$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241245982$24124598$2$F$20240718$20240731$20240723$20240805$30DAY$$US-AMGEN-USASP2024143169$AMGEN$$68$YR$E$$Y$50.93$KG$20240805$$PH$US$US
241245991$24124599$1$I$20240710$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024144454$AMGEN$$$$$$Y$$$20240723$$PH$US$US
241246001$24124600$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002769$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241246011$24124601$1$I$20240714$20240716$20240723$20240723$EXP$$US-VIIV HEALTHCARE LIMITED-US2024089517$VIIV$$70$YR$$M$Y$$$20240723$$HP$US$US
241246021$24124602$1$I$$20240717$20240723$20240723$EXP$$JP-GSK-JP2024089932$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$PH$JP$JP
241246031$24124603$1$I$$20240607$20240723$20240723$EXP$$US-UCBSA-2024029460$UCB$$$$$F$Y$108.57$KG$20240723$$HP$US$US
241246041$24124604$1$I$$20230118$20240723$20240723$EXP$$CA-CELLTRION INC.-2021CA019549$CELLTRION$$$$$$Y$$$20240723$$MD$CA$CA
241246051$24124605$1$I$20240715$20240717$20240723$20240723$PER$$US-ABBVIE-5844841$ABBVIE$$37$YR$$F$Y$110.67$KG$20240723$$CN$US$US
241246061$24124606$1$I$20240713$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143248$AMGEN$$74$YR$E$F$Y$$$20240723$$CN$US$US
241246081$24124608$1$I$$20240719$20240723$20240723$PER$$US-JNJFOC-20240753376$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$CN$US$US
241246092$24124609$2$F$$20240809$20240723$20240819$EXP$$IT-TEVA-VS-3220900$TEVA$Perriello VM, Falini L, Ruggeri L, Innocente A, Ballanti S, Costa C, et al. CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma. Am-J-Hematol 2023; 98 212-219.; Perriello VM, Falini L, Ruggeri L, Innocente A, Ballanti S, Costa C, et al. CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma. Am-J-Hematol 2023; 98 212-219.; Perriello...$63$YR$$M$Y$$$20240819$$HP$IT$IT
241246101$24124610$1$I$$20240715$20240723$20240723$EXP$$US-GSK-US2024088710$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$MD$US$US
241246111$24124611$1$I$$20240717$20240723$20240723$EXP$$US-GILEAD-2024-0681284$GILEAD$$$$A$M$Y$$$20240723$$HP$US$US
241246121$24124612$1$I$20240710$20240718$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114842$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$69$KG$20240723$$CN$US$US
241246131$24124613$1$I$$20240712$20240723$20240723$EXP$$US-NOVAST LABORATORIES INC.-2024NOV000275$NOVAST$Mikhail ES, Jankowski M, Alexander D, Pandya D, Kunadi A.. Survival and vision restoration following severe metformin associated metabolic acidosis with transient blindness: A Case Report and review of the literature. JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES. 2024;14:96-99$72$YR$$F$Y$$$20240723$$HP$US$US
241246141$24124614$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115275$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240723$$CN$US$US
241246151$24124615$1$I$20230511$20240716$20240723$20240723$EXP$$AT-SANDOZ INC.-SDZ2023AT020156$SANDOZ$$35$YR$$F$Y$62$KG$20240723$$MD$AT$AT
241246161$24124616$1$I$20240601$20240719$20240723$20240723$EXP$$US-UCBSA-2024036926$UCB$$33$YR$$F$Y$$$20240723$$HP$US$US
241246171$24124617$1$I$$20240711$20240723$20240723$PER$$US-TEVA-VS-3221178$TEVA$$$$E$F$Y$$$20240723$$CN$US$US
241246181$24124618$1$I$$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024142296$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241246191$24124619$1$I$$20240714$20240723$20240723$EXP$$CA-JNJFOC-20240742315$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240723$$MD$CA$CA
241246201$24124620$1$I$$20240712$20240723$20240723$EXP$$DE-NOVAST LABORATORIES INC.-2024NOV000276$NOVAST$Heinz P, Wolf B, Schuldes S.. Locked-in Syndrome After Pontine Hemorrhage in an Amphetamine Abuser. Dtsch Arztebl Int.. 2024;121:323-30$37$YR$$F$Y$$$20240723$$MD$DE$DE
241246211$24124621$1$I$$20240722$20240723$20240723$PER$$US-JNJFOC-20240757397$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$CN$US$US
241246221$24124622$1$I$$20240718$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US066850$SANDOZ$$17$YR$$F$Y$$$20240723$$MD$US$US
241246232$24124623$2$F$$20240726$20240723$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA066896$SANDOZ$$84$YR$$F$Y$29.025$KG$20240729$$HP$CA$CA
241246242$24124624$2$F$20240217$20240711$20240723$20240726$EXP$$DE-SA-2024SA198258$SANOFI AVENTIS$$44$YR$A$F$Y$87$KG$20240726$$MD$DE$DE
241246253$24124625$3$F$20240131$20240805$20240723$20240809$EXP$$PL-SANDOZ INC.-SDZ2024PL066631$SANDOZ$$65$YR$$F$Y$65$KG$20240809$$MD$PL$PL
241246261$24124626$1$I$$20240708$20240723$20240723$PER$$US-ABBVIE-5848768$ABBVIE$$$$$$Y$$$20240723$$CN$US$US
241246271$24124627$1$I$$20240718$20240723$20240723$EXP$$DE-SANDOZ INC.-SDZ2024DE064686$SANDOZ$$90$YR$$F$Y$$$20240723$$PH$DE$DE
241246281$24124628$1$I$$20240718$20240723$20240723$EXP$$US-HALEON-2187964$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241246291$24124629$1$I$$20240716$20240723$20240723$EXP$$GB-TAKEDA-2024TUS037898$TAKEDA$$$$$F$Y$$$20240723$$CN$GB$GB
241246301$24124630$1$I$20240715$20240715$20240723$20240723$PER$$US-ABBVIE-5843948$ABBVIE$$23$YR$$M$Y$$$20240723$$CN$US$US
241246311$24124631$1$I$$20240722$20240723$20240723$EXP$$CA-SANDOZ INC.-NVSC2023CA035891$SANDOZ$$38$YR$$M$Y$$$20240723$$HP$CA$CA
241246321$24124632$1$I$20240709$20240715$20240723$20240723$EXP$$PK-ROCHE-10000027826$ROCHE$$27$YR$A$M$Y$$$20240723$$CN$PK$PK
241246331$24124633$1$I$$20240711$20240723$20240723$EXP$$CA-TEVA-VS-3222761$TEVA$$25$YR$$F$Y$64$KG$20240723$$HP$CA$CA
241246341$24124634$1$I$$20230501$20240723$20240723$EXP$$US-AstraZeneca-2023A102199$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241246352$24124635$2$F$$20210324$20240723$20240814$EXP$$US-AstraZeneca-2021A211610$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
241246361$24124636$1$I$$20210204$20240723$20240723$EXP$$US-AstraZeneca-2021A035493$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241246371$24124637$1$I$$20240401$20240723$20240723$PER$$US-CELLTRION INC.-2024US008154$CELLTRION$Lambert LH, Tompkins BL, Uber IC, Kapoor KG, Ramsey DJ.. Retinal injury from a laser skin resurfacing device during medical tourism: a public health concern. BMC Ophthalmology. 2024;24:134$$$$$Y$$$20240723$$HP$US$US
241246381$24124638$1$I$20221201$20230406$20240723$20240723$EXP$$US-AstraZeneca-2023A083822$ASTRAZENECA$$20210$DY$$F$Y$$$20240723$$CN$US$
241246391$24124639$1$I$$20230405$20240723$20240723$EXP$$ZA-AstraZeneca-2023A081053$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$ZA$
241246401$24124640$1$I$$20230508$20240723$20240723$EXP$$US-AstraZeneca-2023A107544$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241246411$24124641$1$I$$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A164477$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241246421$24124642$1$I$$20221220$20240723$20240723$EXP$$US-AstraZeneca-2022A414120$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241246431$24124643$1$I$$20220701$20240723$20240723$EXP$$US-AstraZeneca-2022A245382$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241246441$24124644$1$I$$20230705$20240723$20240723$EXP$$US-AstraZeneca-2023A154889$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241246451$24124645$1$I$20240101$20240719$20240723$20240723$EXP$$US-UCBSA-2024027964$UCB$$$$$F$Y$$$20240723$$HP$US$US
241246461$24124646$1$I$20221201$20230106$20240723$20240723$EXP$$US-AstraZeneca-2023A005228$ASTRAZENECA$$26658$DY$$M$Y$$$20240723$$CN$US$
241246471$24124647$1$I$$20210615$20240723$20240723$EXP$$US-AstraZeneca-2021A532758$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241246481$24124648$1$I$$20240715$20240723$20240723$EXP$$ZA-AstraZeneca-2024A162337$ASTRAZENECA$$53$YR$$F$Y$$$20240723$$CN$ZA$
241246491$24124649$1$I$20230416$20230602$20240723$20240723$EXP$$US-AstraZeneca-2023A092142$ASTRAZENECA$$75$YR$$F$Y$$$20240723$$CN$US$
241246501$24124650$1$I$20210101$20210427$20240723$20240723$EXP$$TH-AstraZeneca-2021A367076$ASTRAZENECA$$725$MON$$F$Y$$$20240723$$CN$TH$
241246511$24124651$1$I$20240617$20240718$20240723$20240723$EXP$$US-AMGEN-USASP2024143198$AMGEN$$50$YR$A$M$Y$$$20240723$$CN$US$US
241246521$24124652$1$I$$20240714$20240723$20240723$EXP$$SE-JNJFOC-20240740935$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240723$$HP$FI$SE
241246532$24124653$2$F$$20240806$20240723$20240814$EXP$$JP-TAKEDA-2024TUS072960$TAKEDA$$55$YR$$$Y$$$20240814$$MD$JP$JP
241246541$24124654$1$I$$20240424$20240723$20240723$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06148$HIKMA$Verga S, Burkart L, Holt J, Nandavaram S.. Verga S, Burkart L, Holt J, Nandavaram S. Disseminated Mycobacterium Tuberculosis Post Lung Transplantation.. Journal of Heart and Lung Transplantation. 2024;43(4):484$$$$$Y$$$20240723$$MD$US$US
241246551$24124655$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5846926$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241246561$24124656$1$I$$20240716$20240723$20240723$EXP$$US-GILEAD-2024-0675425$GILEAD$$$$A$F$Y$$$20240723$$CN$US$US
241246571$24124657$1$I$$20240717$20240723$20240723$PER$$US-LEO Pharma-372131$LEO PHARM$$70$YR$$M$Y$$$20240723$$PH$US$US
241246581$24124658$1$I$$20240720$20240723$20240723$EXP$GB-MHRA-TPP49423561C11562390YC1721321484481$GB-ORGANON-O2407GBR001957$ORGANON$$5$YR$$M$Y$17$KG$20240723$$MD$GB$GB
241246591$24124659$1$I$$20240712$20240723$20240723$EXP$$RO-AUROBINDO-AUR-APL-2024-031286$AUROBINDO$Mih?il? Z-A, Branea O-E, Branea, I-A, Laz?r A.. ACUTE MUSCLE TOXICITY FOLLOWING AN OLANZAPINE OVERDOSE: A CASE REPORT.. ACTA MEDICA MARISIENSIS.. 2024;70(Supplement 2:42$31$YR$$F$Y$$$20240723$$HP$RO$RO
241246602$24124660$2$F$20240606$20240814$20240723$20240819$PER$$US-AMGEN-USASP2024143418$AMGEN$$73$YR$E$F$Y$$$20240818$$HP$US$US
241246611$24124661$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115843$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$73.94$KG$20240723$$CN$US$US
241246621$24124662$1$I$$20240717$20240723$20240723$EXP$$GR-BIOCON BIOLOGICS LIMITED-BBL2023002135$BIOCON$$$$$$Y$$$20240723$$MD$GR$GR
241246631$24124663$1$I$20240629$20240718$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115762$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240723$$PH$US$US
241246641$24124664$1$I$20240101$20240716$20240723$20240723$EXP$$CA-ABBVIE-5844627$ABBVIE$$63$YR$$F$Y$$$20240723$$CN$CA$CA
241246651$24124665$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116540$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$JP$JP
241246661$24124666$1$I$20240708$20240716$20240723$20240723$EXP$$US-ABBVIE-5844433$ABBVIE$$65$YR$$M$Y$$$20240723$$CN$US$US
241246671$24124667$1$I$20240712$20240715$20240723$20240723$30DAY$$US-AMGEN-USASP2024140620$AMGEN$$$$$$Y$$$20240723$$PH$US$US
241246691$24124669$1$I$$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012126$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$US$US
241246711$24124671$1$I$$20240712$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-029902$AUROBINDO$Krishna V, Mindel J, Sammartino F, Block C, Dwivedi AK, VanGompel JJ, et al.. A phase 1 open-label trial evaluating focused ultrasound unilateral anterior thalamotomy for focal onset epilepsy. Epilepsia. 2023;64:831-842$39$YR$$M$Y$$$20240723$$HP$US$US
241246721$24124672$1$I$$20240628$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003059$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241246731$24124673$1$I$$20240422$20240723$20240723$PER$$US-CELLTRION INC.-2024US009792$CELLTRION$Glynn SM, Gaillard S, Stone RL, Fader AN, Beavis AL.. Pembrolizumab with bevacizumab and cyclophosphamide for the treatment of recurrent ovarian clear cell carcinoma: A case series. Gynecologic Oncology Reports. 2024;53$$$$$Y$$$20240723$$HP$US$US
241246742$24124674$2$F$20240101$20240808$20240723$20240814$EXP$$JP-SA-2024SA210135$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240814$$MD$JP$JP
241246751$24124675$1$I$$20240712$20240723$20240723$EXP$$US-JNJFOC-20240737474$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
241246761$24124676$1$I$20240401$20240712$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-035694$AUROBINDO$$20$YR$$M$Y$$$20240723$$MD$FR$FR
241246771$24124677$1$I$$20240715$20240723$20240723$EXP$$CA-TAKEDA-2024TUS072090$TAKEDA$$$$$F$Y$$$20240723$$CN$CA$CA
241246781$24124678$1$I$$20240712$20240723$20240723$EXP$$DE-AUROBINDO-AUR-APL-2024-035741$AUROBINDO$$$$A$F$Y$65$KG$20240723$$MD$DE$DE
241246792$24124679$2$F$20230401$20240910$20240723$20240918$EXP$$JP-009507513-2305JPN000881J$MERCK$$72$YR$$M$Y$$$20240918$$MD$JP$JP
241246801$24124680$1$I$20240619$20240717$20240723$20240723$EXP$PT-INFARMED-R202406-538$PT-HALEON-2187771$Haleon PLC$$30$YR$$F$Y$$$20240723$$PH$PT$PT
241246811$24124681$1$I$20230817$20240717$20240723$20240723$EXP$$CA-TAKEDA-2024TUS072896$TAKEDA$$23$YR$$F$Y$$$20240723$$MD$CA$CA
241246821$24124682$1$I$20200601$20210325$20240723$20240723$EXP$$NL-TERSERA THERAPEUTICS LLC-2021TRS001504$TERSERA THERAPEUTICS$$$$$$Y$$$20240723$$HP$NL$NL
241246831$24124683$1$I$$20240422$20240723$20240723$PER$$US-CELLTRION INC.-2024US009794$CELLTRION$Glynn SM, Gaillard S, Stone RL, Fader AN, Beavis AL. Pembrolizumab with bevacizumab and cyclophosphamide for the treatment of recurrent ovarian clear cell carcinoma: A case series. Gynecologic Oncology Reports. 2024;53:101374$$$$$Y$$$20240723$$HP$US$US
241246842$24124684$2$F$$20240730$20240723$20240802$EXP$$CA-ROCHE-3567944$ROCHE$$$$A$F$Y$$$20240803$$CN$CA$CA
241246851$24124685$1$I$20240626$20240628$20240723$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003061$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240723$$CN$US$US
241246861$24124686$1$I$20180901$20191031$20240723$20240723$EXP$$IN-ABBVIE-19K-078-3166547-00$ABBVIE$Mirgh SP, Ahmed R, Agrawal N, Bothra S, Mohan B, Garg A, et al. Knowing the flip side of the coin: ibrutinib associated cystoid macular edema. Indian J Hematol Blood Transfus. 2020;36(1):208-210.$62$YR$$M$Y$$$20240723$$HP$IN$IN
241246873$24124687$3$F$$20240805$20240723$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-036106$AUROBINDO$$$$$M$Y$0.456$KG$20240820$$MD$FR$FR
241246881$24124688$1$I$$20240712$20240723$20240723$EXP$$DE-AUROBINDO-AUR-APL-2024-035716$AUROBINDO$$$$E$M$Y$$$20240723$$MD$DE$DE
241246891$24124689$1$I$$20240506$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01607$AMNEAL$$$$$$Y$$$20240723$$CN$US$US
241246901$24124690$1$I$20240228$20240301$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00779$AMNEAL$$$$$F$Y$58.957$KG$20240723$$MD$US$US
241246911$24124691$1$I$20240422$20240423$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01414$AMNEAL$$51$YR$$M$Y$$$20240723$$CN$US$US
241246921$24124692$1$I$20231214$20240125$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04395$AMNEAL$$62$YR$$M$Y$92.971$KG$20240723$$CN$US$US
241246931$24124693$1$I$$20231106$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03926$AMNEAL$$$$$F$Y$$$20240723$$CN$US$US
241246941$24124694$1$I$$20240416$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01348$AMNEAL$$$$$M$Y$$$20240723$$CN$US$US
241246951$24124695$1$I$$20240507$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01849$AMNEAL$$$$$$Y$$$20240723$$CN$US$US
241246961$24124696$1$I$20240204$20240209$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00472$AMNEAL$$62$YR$$M$Y$99.773$KG$20240723$$CN$US$US
241246971$24124697$1$I$$20231117$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04168$AMNEAL$$$$$M$Y$$$20240723$$CN$US$US
241246981$24124698$1$I$$20240326$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01169$AMNEAL$$$$$$Y$$$20240723$$CN$US$US
241247001$24124700$1$I$$20240402$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01101$AMNEAL$$$$$F$Y$102.04$KG$20240723$$CN$US$US
241247011$24124701$1$I$$20240718$20240723$20240723$EXP$$US-AMGEN-USASP2024143618$AMGEN$$$$$M$Y$$$20240723$$HP$US$US
241247021$24124702$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143300$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241247033$24124703$3$F$20240721$20240807$20240723$20240812$PER$$US-AMGEN-USASP2024145503$AMGEN$$39$YR$A$M$Y$$$20240812$$CN$US$US
241247042$24124704$2$F$20240701$20240809$20240723$20240815$PER$$US-AMGEN-USASP2024141616$AMGEN$$$$$$Y$$$20240814$$PH$US$US
241247051$24124705$1$I$20240101$20240718$20240723$20240723$EXP$$US-ABBVIE-5847653$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241247062$24124706$2$F$20240526$20240718$20240723$20240729$PER$$NVSC2024US149104$NOVARTIS$$$$$$Y$$$20240729$$CN$US$US
241247072$24124707$2$F$$20240712$20240723$20240723$EXP$$US-JNJFOC-20240737147$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$CN$US$US
241247082$24124708$2$F$$20240830$20240723$20240911$EXP$$US-UCBSA-2024035431$UCB$$$$$M$Y$$$20240911$$HP$US$US
241247092$24124709$2$F$20240717$20240730$20240723$20240805$EXP$$BE-ABBVIE-5845325$ABBVIE$$53$YR$$M$Y$66$KG$20240805$$MD$BE$BE
241247111$24124711$1$I$20240624$20240624$20240723$20240723$PER$$US-009507513-2406USA008674$MERCK$$1$YR$$$Y$$$20240723$$HP$US$US
241247122$24124712$2$F$20240612$20240812$20240723$20240816$EXP$$CA-ABBVIE-5844228$ABBVIE$$42$YR$$M$Y$87.9$KG$20240816$$MD$CA$CA
241247131$24124713$1$I$$20240718$20240723$20240723$EXP$$US-TAKEDA-2024TUS073265$TAKEDA$$$$$F$Y$$$20240723$$CN$US$US
241247142$24124714$2$F$$20240801$20240723$20240807$EXP$$JP-GSK-JP2024JPN090192$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$JP$JP
241247151$24124715$1$I$$20240719$20240723$20240723$EXP$$AR-GSK-AR2024AMR091416$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$AR$AR
241247172$24124717$2$F$$20240731$20240723$20240806$EXP$$CA-GSK-CA2024090018$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$MD$CA$CA
241247181$24124718$1$I$20230601$20240720$20240723$20240723$EXP$$GB-SANDOZ INC.-SDZ2023EG005886$SANDOZ$$41$YR$$M$Y$102$KG$20240723$$CN$GB$EG
241247191$24124719$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5845883$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241247202$24124720$2$F$20231031$20240724$20240723$20240731$EXP$$CA-AMGEN-CANNI2024144550$AMGEN$$$$$F$Y$$$20240730$$CN$CA$CA
241247211$24124721$1$I$$20221031$20240723$20240723$EXP$$US-AstraZeneca-2022A361824$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241247222$24124722$2$F$20240909$20240909$20240723$20240914$EXP$$CA-TAKEDA-2024TUS072398$TAKEDA$$70$YR$$F$Y$$$20240914$$CN$CA$CA
241247231$24124723$1$I$20240523$20240717$20240723$20240723$EXP$$JP-HALEON-2178823$Haleon PLC$$7$DEC$$M$Y$$$20240723$$CN$JP$JP
241247241$24124724$1$I$$20240711$20240723$20240723$EXP$$US-TEVA-VS-3221272$TEVA$$70$YR$$M$Y$$$20240723$$MD$US$US
241247252$24124725$2$F$$20240719$20240723$20240816$PER$$US-AstraZeneca-2024A165407$ASTRAZENECA$$$$$$Y$$$20240816$$CN$US$
241247261$24124726$1$I$20240601$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116178$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240723$$HP$US$US
241247271$24124727$1$I$$20220728$20240723$20240723$EXP$$GB-AstraZeneca-2022A252894$ASTRAZENECA$$$$$F$Y$80$KG$20240723$$MD$GB$
241247281$24124728$1$I$20210107$20210125$20240723$20240723$EXP$$US-AstraZeneca-2020SF71213$ASTRAZENECA$$27119$DY$$F$Y$68$KG$20240723$$CN$US$
241247291$24124729$1$I$20240101$20240719$20240723$20240723$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-116277$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240723$$CN$PR$PR
241247301$24124730$1$I$$20211019$20240723$20240723$EXP$$US-AstraZeneca-2021A780491$ASTRAZENECA$$$$$F$Y$$$20240723$$MD$US$
241247311$24124731$1$I$20210124$20210125$20240723$20240723$EXP$$US-AstraZeneca-2021A016333$ASTRAZENECA$$19853$DY$$F$Y$$$20240723$$CN$US$
241247321$24124732$1$I$$20240710$20240723$20240723$PER$$US-TEVA-VS-3220657$TEVA$$$$E$M$Y$$$20240723$$CN$US$US
241247331$24124733$1$I$$20221121$20240723$20240723$EXP$$US-AstraZeneca-2022A386406$ASTRAZENECA$$$$$F$Y$139.6$KG$20240723$$CN$US$
241247341$24124734$1$I$$20191205$20240723$20240723$EXP$$US-AstraZeneca-2019SF77420$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241247351$24124735$1$I$$20230104$20240723$20240723$EXP$$US-AstraZeneca-2023A003671$ASTRAZENECA$$$$$M$Y$90.7$KG$20240723$$CN$US$
241247361$24124736$1$I$$20240718$20240723$20240723$EXP$$ZA-AstraZeneca-2024A164326$ASTRAZENECA$$71$YR$$M$Y$$$20240723$$CN$ZA$
241247371$24124737$1$I$20240619$20240712$20240723$20240723$EXP$$DE-AUROBINDO-AUR-APL-2024-035670$AUROBINDO$$81$YR$$M$Y$100$KG$20240723$$MD$DE$DE
241247381$24124738$1$I$$20240715$20240723$20240723$EXP$$BG-AstraZeneca-2024A164538$ASTRAZENECA$$$$$M$Y$$$20240723$$MD$BG$
241247391$24124739$1$I$$20230117$20240723$20240723$EXP$$US-AstraZeneca-2023A014096$ASTRAZENECA$$$$$F$Y$64$KG$20240723$$MD$US$
241247401$24124740$1$I$$20210607$20240723$20240723$EXP$$US-AstraZeneca-2021A511588$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241247411$24124741$1$I$20240626$20240715$20240723$20240723$EXP$$FR-AstraZeneca-2024A160678$ASTRAZENECA$$69$YR$$F$Y$71$KG$20240723$$MD$FR$
241247421$24124742$1$I$20240706$20240718$20240723$20240723$EXP$$ZA-AstraZeneca-2024A164340$ASTRAZENECA$$84$YR$$M$Y$$$20240723$$CN$ZA$
241247431$24124743$1$I$$20240711$20240723$20240723$EXP$$CA-TEVA-VS-3222632$TEVA$$69$YR$$M$Y$65$KG$20240723$$PH$CA$CA
241247441$24124744$1$I$$20240719$20240723$20240723$PER$$US-TAKEDA-2024TUS073921$TAKEDA$$$$$F$Y$$$20240723$$CN$US$US
241247451$24124745$1$I$20240613$20240715$20240723$20240723$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000535$PAREXEL$$$$$$Y$$$20240723$$HP$US$US
241247461$24124746$1$I$20240101$20240717$20240723$20240723$PER$DE-BFARM-24004819$DE-IDORSIA-008164-2024-DE$IDORSIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240723$$CN$DE$DE
241247471$24124747$1$I$$20240708$20240723$20240723$EXP$$US-IBSA PHARMA INC.-2024IBS000314$IBSA INSTITUT BIOCHIMIQUE$$$$$$Y$$$20240723$$CN$US$US
241247482$24124748$2$F$20240703$20240703$20240723$20240725$PER$$US-JNJFOC-20240712079$JOHNSON AND JOHNSON$$29$MON$C$F$Y$$$20240725$$CN$US$US
241247494$24124749$4$F$20240713$20240719$20240723$20240801$30DAY$$US-JNJFOC-20240752437$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$PH$US$US
241247501$24124750$1$I$$20240716$20240723$20240723$EXP$$US-BIOGEN-2024BI01274177$BIOGEN$$$$$$Y$$$20240723$$MD$US$US
241247511$24124751$1$I$20240627$20240719$20240723$20240723$EXP$$US-VIIV HEALTHCARE LIMITED-US2024091144$VIIV$$$$$$Y$$$20240723$$CN$US$US
241247521$24124752$1$I$$20240716$20240723$20240723$EXP$$RO-CHEPLA-2024009060$CHEPLAPHARM$Cana Ruiu D, Maria DT, Popa R, Moraru S, Micu EG, Vaduva C, et al. A 68-Year-Old Man with Depression and Acute Renal Failure Due to Rhabdomyolysis Associated with Alcohol Intoxication While Taking Low-Dose Escitalopram: A Case Report. The American journal of case reports. 2024;25:e943422. DOI: 10.12659/AJCR.943422.$68$YR$$M$Y$$$20240723$$MD$COUNTRY NOT SPECIFIED$RO
241247531$24124753$1$I$$20240722$20240723$20240723$PER$$NVSC2024US150173$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
241247541$24124754$1$I$$20240520$20240723$20240723$PER$$US-CELLTRION INC.-2024US012198$CELLTRION$Majeed A, Alaparthi S, Halegoua-DeMarzio D, Eberle-Singh J, Jiang W, Anne PR, et, al.. Complete Pathologic Response to Gemcitabine and Oxaliplatin Chemotherapy After Prior Therapies in a Patient With Hepatocellular Carcinoma and Peritoneal Metastases Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. World J Oncol. 2024;15(3):511-520.$$$$$Y$$$20240723$$HP$US$US
241247551$24124755$1$I$20240101$20240716$20240723$20240723$EXP$$US-ABBVIE-5844864$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241247563$24124756$3$F$20240717$20240828$20240723$20240829$PER$$US-AMGEN-USASP2024143304$AMGEN$$61$YR$A$M$Y$$$20240829$$PH$US$US
241247571$24124757$1$I$20240716$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024143119$AMGEN$$81$YR$E$F$Y$$$20240723$$CN$US$US
241247581$24124758$1$I$20240101$20240718$20240723$20240723$PER$$US-ROCHE-10000032004$ROCHE$$50$YR$A$F$Y$$$20240723$$CN$US$US
241247591$24124759$1$I$20220913$20240712$20240723$20240723$EXP$$PL-AUROBINDO-AUR-APL-2024-035504$AUROBINDO$$74$YR$$M$Y$81$KG$20240723$$MD$PL$PL
241247601$24124760$1$I$$20240722$20240723$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041318$BOEHRINGER INGELHEIM$$$$$$Y$$$20240723$$HP$US$US
241247612$24124761$2$F$$20240721$20240723$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-020083$UNITED THERAPEUTICS$$$$$F$Y$43.991$KG$20240724$$$US$US
241247622$24124762$2$F$$20240828$20240723$20240910$EXP$$JP-AMGEN-JPNSP2024144067$AMGEN$$76$YR$E$F$Y$$$20240910$$MD$JP$JP
241247631$24124763$1$I$$20240722$20240723$20240723$PER$$US-TAKEDA-2024TUS074014$TAKEDA$$$$$$Y$$$20240723$$CN$US$US
241247641$24124764$1$I$20240612$20240717$20240723$20240723$EXP$$IN-ROCHE-3572249$ROCHE$$59$YR$A$M$Y$$$20240723$$CN$IN$IN
241247651$24124765$1$I$20230101$20240717$20240723$20240723$EXP$$AU-ABBVIE-5847054$ABBVIE$$57$YR$$M$Y$$$20240723$$MD$AU$AU
241247661$24124766$1$I$20240328$20240712$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-035697$AUROBINDO$$75$YR$$M$Y$85$KG$20240723$$MD$FR$FR
241247671$24124767$1$I$$20240720$20240723$20240723$PER$$US-ROCHE-10000033248$ROCHE$$$$$$Y$$$20240723$$CN$US$US
241247681$24124768$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115951$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$66.68$KG$20240723$$CN$US$US
241247693$24124769$3$F$20240717$20240802$20240723$20240806$PER$$US-AMGEN-USASP2024144475$AMGEN$$73$YR$E$F$Y$$$20240806$$CN$US$US
241247701$24124770$1$I$20240329$20240716$20240723$20240723$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009880$UNITED THERAPEUTICS$$68$YR$$F$Y$58.957$KG$20240723$$$US$US
241247711$24124771$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024141583$AMGEN$$$$$$Y$$$20240723$$MD$US$US
241247721$24124772$1$I$$20240718$20240723$20240723$PER$$US-LEO Pharma-372176$LEO PHARM$$$$$F$Y$$$20240723$$HP$US$US
241247731$24124773$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013196$ELI LILLY AND CO$$53$YR$A$$Y$$$20240723$$CN$US$US
241247741$24124774$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013309$ELI LILLY AND CO$$$$$M$Y$$$20240723$$CN$US$US
241247751$24124775$1$I$20240701$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011699$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240723$$CN$US$US
241247761$24124776$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012258$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240723$$CN$US$US
241247771$24124777$1$I$$20240712$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-035939$AUROBINDO$Leung GJ, Bye KN, Leloux MR, Markota M, Allen ND.. Making Clozapine Therapeutic Drug Monitoring Essential for Optimal Patient Care: Letter to the Editor. Ther Drug Monit. 2024;00:1-2$30$YR$$M$Y$$$20240723$$MD$US$US
241247782$24124778$2$F$$20240730$20240723$20240807$30DAY$$CA-JNJFOC-20240712803$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$PH$CA$CA
241247791$24124779$1$I$20240701$20240711$20240723$20240723$PER$$US-JNJFOC-20240737048$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240723$$CN$US$US
241247811$24124781$1$I$20240101$20240712$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-035671$AUROBINDO$$73$YR$$M$Y$$$20240723$$PH$FR$FR
241247822$24124782$2$F$20240716$20240805$20240723$20240813$EXP$$GB-VANTIVE-2024VAN018363$Vantive US Healthcare$$74$YR$$M$Y$$$20240813$$HP$GB$GB
241247831$24124783$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000030953$ROCHE$$$$$$Y$$$20240723$$CN$US$US
241247842$24124784$2$F$$20240905$20240723$20240906$PER$$US-ROCHE-10000031426$ROCHE$$$$A$M$Y$$$20240906$$CN$US$US
241247852$24124785$2$F$20240717$20240729$20240723$20240801$EXP$$ES-ABBVIE-5846358$ABBVIE$$71$YR$$M$Y$$$20240731$$MD$ES$ES
241247861$24124786$1$I$20211120$20220503$20240723$20240723$EXP$$US-AstraZeneca-2021A854077$ASTRAZENECA$$20828$DY$$F$Y$$$20240723$$CN$US$
241247871$24124787$1$I$20200301$20200514$20240723$20240723$EXP$$CN-AstraZeneca-2020SE63494$ASTRAZENECA$$592$MON$$M$Y$62$KG$20240723$$CN$CN$
241247881$24124788$1$I$$20240430$20240723$20240723$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01528$AMNEAL$$$$$F$Y$$$20240723$$CN$US$US
241247891$24124789$1$I$20231130$20240715$20240723$20240723$EXP$$PT-AstraZeneca-2024A160833$ASTRAZENECA$$67$YR$$M$Y$$$20240723$$MD$PT$
241247901$24124790$1$I$$20221215$20240723$20240723$EXP$$RU-AstraZeneca-2022A410471$ASTRAZENECA$$$$$F$Y$$$20240723$$MD$RU$
241247911$24124791$1$I$20220731$20220823$20240723$20240723$EXP$$CO-AstraZeneca-2022A298491$ASTRAZENECA$$24121$DY$$F$Y$58$KG$20240723$$CN$CO$
241247922$24124792$2$F$$20240805$20240723$20240813$EXP$$US-AstraZeneca-2024A161592$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
241247931$24124793$1$I$20210625$20210629$20240723$20240723$EXP$$RU-AstraZeneca-2021A580651$ASTRAZENECA$$30716$DY$$F$Y$60$KG$20240723$$CN$RU$
241247941$24124794$1$I$$20230616$20240723$20240723$EXP$$US-AstraZeneca-2023A141398$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241247951$24124795$1$I$$20210121$20240723$20240723$EXP$$US-AstraZeneca-2021A012143$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241247961$24124796$1$I$$20240718$20240723$20240723$EXP$$AR-AstraZeneca-2024A164915$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$AR$
241247971$24124797$1$I$$20230105$20240723$20240723$EXP$$US-AstraZeneca-2023A004521$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241247981$24124798$1$I$$20210426$20240723$20240723$EXP$$US-AstraZeneca-2021A365800$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241247992$24124799$2$F$20240712$20240819$20240723$20240828$EXP$$US-ARDELYX-2024ARDX005308$ARDELYX$$40$YR$$F$Y$$$20240828$$HP$US$US
241248001$24124800$1$I$20240708$20240712$20240723$20240723$EXP$$JP-ARDELYX-2024ARDX005457$ARDELYX$$9$DEC$$M$Y$$$20240723$$MD$JP$JP
241248011$24124801$1$I$$20240715$20240723$20240723$PER$$US-ROCHE-10000031903$ROCHE$$$$$$Y$$$20240723$$CN$US$US
241248021$24124802$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000032604$ROCHE$$$$$$Y$$$20240723$$CN$US$US
241248032$24124803$2$F$20240726$20240819$20240723$20240822$PER$$US-ROCHE-10000031138$ROCHE$$51$YR$A$F$Y$117.93$KG$20240822$$CN$US$US
241248041$24124804$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000031192$ROCHE$$$$A$F$Y$$$20240723$$HP$US$US
241248051$24124805$1$I$20240617$20240712$20240723$20240723$EXP$$US-ARDELYX-2024ARDX005381$ARDELYX$$38$YR$$M$Y$$$20240723$$MD$US$US
241248061$24124806$1$I$20220221$20240717$20240723$20240723$EXP$$CO-UCBSA-2024036967$UCB$$66$YR$$F$Y$$$20240723$$CN$CO$CO
241248072$24124807$2$F$$20240809$20240723$20240819$EXP$$GB-TEVA-VS-3220844$TEVA$Reid I, Sharma A, Gogbashian A, Kaur B, Fotopoulou C. Germ cell cancer in pregnancy - Successfully treated with chemotherapy and surgery. Gynecol-Oncol-Rep 2023; 47 1-4; Reid I, Sharma A, Gogbashian A, Kaur B, Fotopoulou C. Germ cell cancer in pregnancy - Successfully treated with chemotherapy and surgery. Gynecol-Oncol-Rep 2023; 47 1-4.$31$YR$$F$Y$$$20240819$$HP$GB$GB
241248081$24124808$1$I$$20240704$20240723$20240723$PER$$US-JNJFOC-20240717917$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$US$US
241248091$24124809$1$I$20240514$20240718$20240723$20240723$EXP$$US-JNJFOC-20240751395$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240723$$MD$US$US
241248103$24124810$3$F$20240624$20240913$20240723$20240919$EXP$$JP-JNJFOC-20240759687$JOHNSON AND JOHNSON$$61$YR$A$M$Y$55.6$KG$20240919$$MD$JP$JP
241248111$24124811$1$I$$20240715$20240723$20240723$EXP$$AU-JNJFOC-20240738167$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240723$$MD$AU$AU
241248121$24124812$1$I$20240519$20240712$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-035691$AUROBINDO$$79$YR$$M$Y$58$KG$20240723$$MD$FR$FR
241248131$24124813$1$I$$20240503$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002856$STEMLINE THERAPEUTICS$$52$YR$A$F$Y$$$20240718$$CN$US$US
241248141$24124814$1$I$$20240503$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002868$STEMLINE THERAPEUTICS$$43$YR$A$F$Y$$$20240718$$CN$US$US
241248151$24124815$1$I$$20240506$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002876$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
241248161$24124816$1$I$$20240506$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002893$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
241248171$24124817$1$I$$20240506$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002894$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240718$$CN$US$US
241248181$24124818$1$I$$20240506$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002880$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241248191$24124819$1$I$$20240527$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002882$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241248201$24124820$1$I$$20240507$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002918$STEMLINE THERAPEUTICS$$43$YR$A$F$Y$$$20240718$$CN$US$US
241248211$24124821$1$I$$20240503$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002854$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241248221$24124822$1$I$$20240507$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002936$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$CN$US$US
241248231$24124823$1$I$$20240507$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002945$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240718$$CN$US$US
241248241$24124824$1$I$$20240504$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002861$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241248251$24124825$1$I$$20240520$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002864$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241248261$24124826$1$I$$20240607$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002899$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241248271$24124827$1$I$$20240418$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002957$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241248281$24124828$1$I$$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002965$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241248291$24124829$1$I$$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002969$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240718$$CN$US$US
241248301$24124830$1$I$$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002970$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241248311$24124831$1$I$$20240507$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002933$STEMLINE THERAPEUTICS$$42$YR$A$F$Y$$$20240718$$CN$US$US
241248321$24124832$1$I$$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002982$STEMLINE THERAPEUTICS$$45$YR$A$F$Y$$$20240718$$HP$US$US
241248331$24124833$1$I$$20240507$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002939$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241248341$24124834$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002954$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241248351$24124835$1$I$$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002980$STEMLINE THERAPEUTICS$$33$YR$A$F$Y$$$20240718$$CN$US$US
241248361$24124836$1$I$$20240509$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002985$STEMLINE THERAPEUTICS$$52$YR$A$F$Y$$$20240718$$CN$US$US
241248371$24124837$1$I$$20240509$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002989$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$MD$US$US
241248381$24124838$1$I$$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002972$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
241248391$24124839$1$I$$20240509$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002994$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$PH$US$US
241248401$24124840$1$I$$20240509$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002997$STEMLINE THERAPEUTICS$$82$YR$E$F$Y$$$20240718$$CN$US$US
241248411$24124841$1$I$$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003019$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240718$$CN$US$US
241248421$24124842$1$I$20240424$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003021$STEMLINE THERAPEUTICS$$83$YR$E$F$Y$$$20240718$$HP$US$US
241248431$24124843$1$I$20240504$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003030$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241248441$24124844$1$I$$20240507$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002932$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
241248451$24124845$1$I$$20240507$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002944$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241248461$24124846$1$I$$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003037$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240718$$CN$US$US
241248471$24124847$1$I$$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003038$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241248481$24124848$1$I$$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003041$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240718$$CN$US$US
241248491$24124849$1$I$20240501$20240523$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002961$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241248501$24124850$1$I$$20240506$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002884$STEMLINE THERAPEUTICS$$84$YR$E$F$Y$$$20240718$$CN$US$US
241248511$24124851$1$I$$20240509$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002987$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$HP$US$US
241248531$24124853$1$I$$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002962$STEMLINE THERAPEUTICS$$45$YR$A$F$Y$$$20240718$$CN$US$US
241248541$24124854$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003054$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241248552$24124855$2$F$20190101$20240809$20240723$20240819$EXP$$IT-TEVA-VS-3140393$TEVA$Trovato E, Capalbo E, Cartocci A, Buggiani G. Apremilast in Patients Difficult to Treat: A Multicentric Real-Life Long-Term Experience. Dermatol Ther. 2023:1-7.; Trovato E, Capalbo E, Cartocci A, Buggiani G. Apremilast in Patients Difficult to Treat: A Multicentric Real-Life Long-Term Experience. Dermatol Ther. 2023:1-7.$71$YR$$M$Y$$$20240819$$HP$IT$IT
241248561$24124856$1$I$20240407$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002964$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241248571$24124857$1$I$$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003040$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241248581$24124858$1$I$$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003043$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240718$$CN$US$US
241248591$24124859$1$I$20240513$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003056$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241248601$24124860$1$I$$20240719$20240723$20240723$PER$$US-ROCHE-10000033109$ROCHE$$77$YR$E$F$Y$$$20240723$$CN$US$US
241248611$24124861$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000032993$ROCHE$$$$$$Y$$$20240723$$HP$US$US
241248621$24124862$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003051$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240718$$CN$US$US
241248631$24124863$1$I$$20240719$20240723$20240723$PER$$US-ROCHE-10000031787$ROCHE$$38$YR$A$F$Y$$$20240723$$CN$US$US
241248641$24124864$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000032692$ROCHE$$66$YR$E$M$Y$$$20240723$$CN$US$US
241248651$24124865$1$I$$20240712$20240723$20240723$EXP$$BO-ROCHE-10000026978$ROCHE$$$$$F$Y$$$20240723$$MD$BO$BO
241248671$24124867$1$I$20240625$20240723$20240723$20240723$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041319$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$$$20240723$$HP$SG$SG
241248681$24124868$1$I$$20240722$20240723$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041320$BOEHRINGER INGELHEIM$$$$$$Y$$$20240723$$HP$US$US
241248691$24124869$1$I$20240508$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003028$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241248701$24124870$1$I$$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003032$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240718$$CN$US$US
241248711$24124871$1$I$$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002974$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$CN$US$US
241248721$24124872$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003053$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240718$$CN$US$US
241248731$24124873$1$I$$20240708$20240723$20240723$EXP$$JP-AMGEN-JPNSP2024144073$AMGEN$$78$YR$E$F$Y$$$20240723$$MD$JP$JP
241248741$24124874$1$I$$20240710$20240723$20240723$EXP$$JP-UCBSA-2024035443$UCB$$$$$$Y$$$20240723$$PH$JP$JP
241248751$24124875$1$I$20240601$20240722$20240723$20240723$EXP$FR-AFSSAPS-LL2024001360$NVSC2024FR149998$NOVARTIS$$61$YR$$F$Y$$$20240723$$MD$FR$FR
241248761$24124876$1$I$$20240719$20240723$20240723$EXP$$TR-ABBVIE-5846631$ABBVIE$$$$A$F$Y$$$20240723$$MD$TR$TR
241248771$24124877$1$I$$20240715$20240723$20240723$EXP$$US-HALEON-2187826$Haleon PLC$Alsabbagh Alchirazi K, Bhavsar-Burke I, Syed H, Alkhayyat M, Bass S, Kapoor A. et.al. Molecular Adsorbent Recirculating System in Acute Liver Failure. ACG case reports journal. 2024;11(7):e01389$44$YR$$M$Y$$$20240722$$HP$US$US
241248782$24124878$2$F$$20240725$20240723$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116339$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240726$$HP$US$US
241248791$24124879$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115859$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240723$$CN$US$US
241248801$24124880$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115891$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240723$$CN$US$US
241248811$24124881$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115912$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240723$$CN$US$US
241248821$24124882$1$I$$20240715$20240723$20240723$30DAY$$US-GSK-US2024088721$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$CN$US$US
241248831$24124883$1$I$20240401$20240715$20240723$20240723$30DAY$$US-GSK-US2024088591$GLAXOSMITHKLINE$$43$YR$$F$Y$$$20240723$$CN$US$US
241248841$24124884$1$I$$20240710$20240723$20240723$PER$$US-MSNLABS-2024MSNSPO01575$MSN LABORATORIES$$$$$$Y$$$20240723$$CN$US$US
241248852$24124885$2$F$20240301$20240724$20240723$20240731$EXP$$ZA-AMGEN-ZAFSP2024142984$AMGEN$$73$YR$E$F$Y$52$KG$20240731$$MD$ZA$ZA
241248862$24124886$2$F$20240131$20240802$20240723$20240807$EXP$$PL-AMGEN-POLSP2024143217$AMGEN$$65$YR$E$F$Y$65$KG$20240807$$MD$PL$PL
241248871$24124887$1$I$$20240712$20240723$20240723$EXP$$US-JNJFOC-20240734719$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$HP$US$US
241248881$24124888$1$I$20240101$20240715$20240723$20240723$PER$$US-JNJFOC-20240739010$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
241248891$24124889$1$I$$20240629$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003068$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241248901$24124890$1$I$20240701$20240716$20240723$20240723$EXP$$US-ABBVIE-5848338$ABBVIE$$49$YR$$M$Y$$$20240723$$CN$US$US
241248911$24124891$1$I$20240124$20240716$20240723$20240723$EXP$$US-ABBVIE-5731677$ABBVIE$$73$YR$$F$Y$59$KG$20240723$$CN$US$US
241248921$24124892$1$I$$20240610$20240723$20240723$PER$$US-CELLTRION INC.-2024US014377$CELLTRION$Kuhn TM, Ahmad S, Recio FO, Awada A, McKenzie ND, Kendrick JE, et al.. Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer. Int J Gynecol Cancer. 2024;1-8$$$$$Y$$$20240723$$MD$US$US
241248931$24124893$1$I$20240101$20240719$20240723$20240723$EXP$$BG-ABBVIE-5848139$ABBVIE$$39$YR$$F$Y$$$20240723$$CN$BG$BG
241248941$24124894$1$I$20240705$20240718$20240723$20240723$EXP$IT-MINISAL02-995112$IT-GILEAD-2024-0681242$GILEAD$$57$YR$A$F$Y$$$20240723$$MD$IT$IT
241248951$24124895$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5295477$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241248962$24124896$2$F$20230801$20240820$20240723$20240826$EXP$$US-ROCHE-10000026369$ROCHE$$70$YR$E$F$Y$72.57$KG$20240826$$CN$US$US
241248971$24124897$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115888$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240723$$CN$US$US
241248981$24124898$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143212$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241248991$24124899$1$I$20240101$20240719$20240723$20240723$PER$$US-ABBVIE-5847020$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241249001$24124900$1$I$20240201$20240716$20240723$20240723$PER$$US-ALXN-202407USA001215US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$MD$US$US
241249011$24124901$1$I$20201221$20240715$20240723$20240723$EXP$DE-ROCHE-2793793$DE-ROCHE-2793793$ROCHE$$54$YR$A$F$Y$91$KG$20240723$$MD$DE$DE
241249022$24124902$2$F$20240403$20240729$20240723$20240803$EXP$$JP-ROCHE-10000031570$ROCHE$$78$YR$E$M$Y$$$20240803$$PH$JP$JP
241249031$24124903$1$I$$20240711$20240723$20240723$EXP$$NO-ROCHE-10000024114$ROCHE$Fagerang B, Fagerang B, Cyranka L, Schjalm C, McAdam K, Larsen C, et al. The function of the complement system remains fully intact throughout the course of  allogeneic stem cell transplantation. Frontiers in Immunology. 2024;15:1-13. doi:10.3389/fimmu.2024.1422370.$$$$$Y$$$20240723$$HP$NO$NO
241249041$24124904$1$I$$20240711$20240723$20240723$EXP$GB-MHRA-MED-202407101715258340-SPQGB$GB-MSNLABS-2024MSNSPO01601$MSN LABORATORIES$$$$$$Y$$$20240723$$PH$GB$GB
241249052$24124905$2$F$$20240717$20240723$20240725$EXP$$IR-ROCHE-10000028758$ROCHE$Najafi A, Jafarzade F, Ojaghi H. Prevalence of Endophthalmitis after Intravitreal Injection of Avastin (Bevacizumab) in Patients Wearing Masks. Journal of Babol University of Medical Sciences. 2024;26:1-7.$$$$$Y$$$20240725$$MD$IR$IR
241249061$24124906$1$I$$20240716$20240723$20240723$EXP$$AR-JNJFOC-20240746233$JOHNSON AND JOHNSON$$64$YR$A$F$Y$85$KG$20240723$$MD$AR$AR
241249072$24124907$2$F$$20240729$20240723$20240731$PER$$US-JNJFOC-20240707617$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240731$$CN$US$US
241249082$24124908$2$F$$20240718$20240723$20240724$EXP$$JP-JNJFOC-20240754305$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240724$$MD$JP$JP
241249094$24124909$4$F$20230101$20240715$20240723$20240731$EXP$$NVSC2023BR206343$NOVARTIS$$$$$F$Y$$$20240731$$CN$BR$BR
241249101$24124910$1$I$$20240718$20240723$20240723$PER$$US-JNJFOC-20240752325$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
241249111$24124911$1$I$$20240716$20240723$20240723$PER$$US-JNJFOC-20240742653$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$MD$US$US
241249121$24124912$1$I$$20240713$20240723$20240723$EXP$GB-MHRA-MED-202407131026080490-MKHLY$GB-862174955-ML2024-04015$Unknown Manufacturer$$$$$F$Y$$$20240723$$CN$GB$GB
241249131$24124913$1$I$20240709$20240715$20240723$20240723$EXP$GB-MHRA-MED-202407151125228640-RKLZF$GB-862174955-ML2024-04027$Unknown Manufacturer$$77$YR$E$F$Y$$$20240723$$PH$GB$GB
241249141$24124914$1$I$$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024143263$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241249151$24124915$1$I$20090101$20240715$20240723$20240723$EXP$$DE-862174955-ML2024-03998$Unknown Manufacturer$$39$YR$A$F$Y$77$KG$20240723$$MD$DE$DE
241249161$24124916$1$I$20230101$20240213$20240723$20240723$EXP$$CA-CELLTRION INC.-2022CA022569$CELLTRION$$$$$$Y$$$20240723$$CN$CA$CA
241249171$24124917$1$I$$20240715$20240723$20240723$EXP$$ZA-AstraZeneca-2024A162359$ASTRAZENECA$$89$YR$$M$Y$$$20240723$$CN$ZA$
241249181$24124918$1$I$20240701$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A164801$ASTRAZENECA$$31993$DY$$M$Y$$$20240723$$CN$US$
241249191$24124919$1$I$20230907$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161398$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241249201$24124920$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116068$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240723$$CN$US$US
241249212$24124921$2$F$$20240808$20240723$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116450$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240812$$CN$US$US
241249221$24124922$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115815$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240723$$CN$US$US
241249231$24124923$1$I$20240625$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116413$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240723$$HP$US$US
241249241$24124924$1$I$20210419$20210427$20240723$20240723$EXP$$US-AstraZeneca-2021A365237$ASTRAZENECA$$20375$DY$$M$Y$$$20240723$$CN$US$
241249251$24124925$1$I$$20240709$20240723$20240723$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-07083$LUPIN$$65$YR$$F$Y$97$KG$20240723$$HP$CA$CA
241249261$24124926$1$I$$20210419$20240723$20240723$EXP$$US-AstraZeneca-2021A335887$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241249271$24124927$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161759$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241249281$24124928$1$I$$20220818$20240723$20240723$EXP$$CA-AstraZeneca-2022A264815$ASTRAZENECA$$$$$M$Y$$$20240723$$MD$CA$
241249291$24124929$1$I$$20240715$20240723$20240723$EXP$$CA-APOTEX-2024AP008387$APOTEX$$$$$$Y$$$20240723$$CN$CA$CA
241249302$24124930$2$F$20240430$20240718$20240723$20240729$EXP$$US-AstraZeneca-2024A164893$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241249311$24124931$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161557$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241249321$24124932$1$I$20240601$20240711$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407008635$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240723$$CN$US$US
241249331$24124933$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407008191$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$US$US
241249341$24124934$1$I$$20240709$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407006079$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240723$$CN$US$US
241249351$24124935$1$I$20240401$20240716$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407010834$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240723$$CN$US$US
241249361$24124936$1$I$20240719$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013225$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240723$$CN$US$US
241249371$24124937$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013227$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240723$$CN$US$US
241249381$24124938$1$I$20240702$20240716$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011162$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240723$$MD$US$US
241249391$24124939$1$I$20240719$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012916$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240723$$CN$US$US
241249401$24124940$1$I$$20231225$20240723$20240723$EXP$$GB-TEVA-VS-3141221$TEVA$Vakrinou A, Bellampalli R, Gulcebi MI, Martins Custodio H, Research Consortium GE, Balestrini S, et al. Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in clinical practice. J-Neurol-Neurosurg-Psychiatry 2023; 94 887-892.; Vakrinou A, Bellampalli R, Gulcebi MI, Martins Custodio H, Research Consortium GE, Balestrini S, et al. Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in...$$$$F$Y$$$20240723$$HP$GB$GB
241249411$24124941$1$I$$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011325$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240723$$CN$US$US
241249421$24124942$1$I$20240614$20240715$20240723$20240723$EXP$IT-MINISAL02-991964$IT-ROCHE-10000026438$ROCHE$$66$YR$E$M$Y$60$KG$20240723$$MD$IT$IT
241249432$24124943$2$F$$20240722$20240723$20240802$EXP$$IT-MSNLABS-2024MSNLIT01596$MSN LABORATORIES$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, Nardo M.Di.Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars..Toxicology Reports.2024;13:101683$$$$$Y$$$20240802$$MD$IT$IT
241249441$24124944$1$I$20240619$20240626$20240723$20240723$PER$$US-009507513-2406USA009388$MERCK$$$$$F$Y$$$20240723$$HP$US$US
241249451$24124945$1$I$$20240715$20240723$20240723$EXP$$DE-AMGEN-DEUSP2024141940$AMGEN$Stilgenbauer S. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240723$$MD$DE$DE
241249461$24124946$1$I$$20240610$20240723$20240723$PER$$US-CELLTRION INC.-2024US014419$CELLTRION$Kuhn TM, Ahmad S, Recio FO, Awada A, McKenzie ND, Kendrick JE, et al.. Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer. Int J Gynecol Cancer. 2024;0:1-8$$$$$Y$$$20240723$$MD$US$US
241249471$24124947$1$I$$20240626$20240723$20240723$PER$$US-JNJFOC-20240673781$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
241249481$24124948$1$I$20221001$20240715$20240723$20240723$EXP$$FR-JNJFOC-20240737092$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240723$$HP$FR$FR
241249501$24124950$1$I$$20240711$20240723$20240723$EXP$NL-LRB-00979384$NL-JUBILANT PHARMA LTD-2024NL000991$JUBILANT$$46$YR$$F$Y$74$KG$20240723$$CN$NL$NL
241249511$24124951$1$I$20210101$20240715$20240723$20240723$EXP$IN-MLMSERVICE-20240709-PI123243-00285-1$IN-JUBILANT CADISTA PHARMACEUTICALS-2024IN001028$JUBILANT$Chauhan A, Agrawal M, Yadav P, Chauhan VS. Rapid cycling in late-onset bipolar affective disorder predominantly mania.. Medical Journal Armed Forces India.. 2024$70$YR$$F$Y$$$20240723$$MD$IN$IN
241249521$24124952$1$I$$20231204$20240723$20240723$EXP$$CA-TEVA-VS-3141418$TEVA$$18$YR$$F$Y$$$20240723$$PH$CA$CA
241249532$24124953$2$F$$20240902$20240723$20240909$EXP$$PL-MSNLABS-2024MSNLIT01597$MSN LABORATORIES$Stawarz K, Galazka A, Gorzelnik A, Durzynska M, Bienkowska-Pluta K, Zwolinski J.Case report: An uncommon presentation of extramedullary plasmacytoma without a concurrent diagnosis of multiple myeloma..Frontiers in Oncology.2024;14:1353943$$$$$Y$$$20240909$$MD$PL$PL
241249541$24124954$1$I$$20240722$20240723$20240723$PER$$US-GILEAD-2024-0681567$GILEAD$$57$YR$A$M$Y$$$20240723$$HP$US$US
241249551$24124955$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003068$STEMLINE THERAPEUTICS$$85$YR$E$F$Y$$$20240718$$CN$US$US
241249561$24124956$1$I$$20240514$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003092$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240718$$CN$US$US
241249571$24124957$1$I$$20240515$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003117$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240718$$HP$US$US
241249581$24124958$1$I$20240515$20240515$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003127$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240718$$CN$US$US
241249591$24124959$1$I$$20240515$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003128$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240718$$CN$US$US
241249601$24124960$1$I$$20240611$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003147$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241249611$24124961$1$I$$20240610$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003142$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241249621$24124962$1$I$$20240610$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003059$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241249631$24124963$1$I$20240515$20240604$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003122$STEMLINE THERAPEUTICS$$49$YR$A$F$Y$$$20240718$$CN$US$US
241249641$24124964$1$I$$20240516$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003153$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240718$$CN$US$US
241249651$24124965$1$I$$20240516$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003158$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240718$$CN$US$US
241249661$24124966$1$I$$20240517$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003168$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241249671$24124967$1$I$$20240517$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003182$STEMLINE THERAPEUTICS$$45$YR$A$F$Y$$$20240718$$CN$US$US
241249681$24124968$1$I$$20240518$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003191$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
241249691$24124969$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003072$STEMLINE THERAPEUTICS$$82$YR$E$F$Y$$$20240718$$CN$US$US
241249701$24124970$1$I$$20240520$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003210$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240718$$CN$US$US
241249711$24124971$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003058$STEMLINE THERAPEUTICS$$82$YR$E$F$Y$$$20240718$$CN$US$US
241249721$24124972$1$I$20240511$20240515$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003137$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241249731$24124973$1$I$$20240520$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003219$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241249741$24124974$1$I$20240101$20240514$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003086$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241249751$24124975$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003228$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241249761$24124976$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003230$STEMLINE THERAPEUTICS$$49$YR$A$F$Y$$$20240718$$HP$US$US
241249771$24124977$1$I$$20240514$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003099$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240718$$HP$US$US
241249781$24124978$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003240$STEMLINE THERAPEUTICS$$62$YR$A$F$Y$$$20240718$$CN$US$US
241249791$24124979$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003245$STEMLINE THERAPEUTICS$$62$YR$A$F$Y$$$20240718$$HP$US$US
241249801$24124980$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003062$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241249811$24124981$1$I$$20240514$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003077$STEMLINE THERAPEUTICS$$61$YR$E$F$Y$$$20240718$$CN$US$US
241249821$24124982$1$I$20240101$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003250$STEMLINE THERAPEUTICS$$45$YR$A$F$Y$$$20240718$$CN$US$US
241249831$24124983$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003257$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240718$$HP$US$US
241249841$24124984$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003060$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241249851$24124985$1$I$$20240522$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003275$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240718$$CN$US$US
241249861$24124986$1$I$$20240516$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003148$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
241249871$24124987$1$I$$20240522$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003269$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$HP$US$US
241249881$24124988$1$I$$20240522$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003278$STEMLINE THERAPEUTICS$$43$YR$A$F$Y$$$20240718$$CN$US$US
241249891$24124989$1$I$$20240522$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003289$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241249901$24124990$1$I$$20240530$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003292$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
241249921$24124992$1$I$$20240517$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003163$STEMLINE THERAPEUTICS$$46$YR$A$F$Y$$$20240718$$CN$US$US
241249931$24124993$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003263$STEMLINE THERAPEUTICS$$62$YR$A$F$Y$$$20240718$$CN$US$US
241249941$24124994$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003264$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241249952$24124995$2$F$20240706$20240903$20240723$20240909$EXP$$CO-UCBSA-2024036763$UCB$$75$YR$$M$Y$$$20240909$$CN$CO$CO
241249961$24124996$1$I$$20240523$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003328$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241249971$24124997$1$I$$20240716$20240723$20240723$PER$$US-BIOGEN-2024BI01274075$BIOGEN$$$$$F$Y$$$20240723$$CN$US$US
241249981$24124998$1$I$$20240516$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003154$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$CN$US$US
241249991$24124999$1$I$$20240607$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003231$STEMLINE THERAPEUTICS$$39$YR$A$F$Y$$$20240718$$CN$US$US
241250004$24125000$4$F$$20240917$20240723$20240923$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-019479$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240923$$CN$CA$CA
241250011$24125001$1$I$$20240722$20240723$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041327$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240723$$CN$US$US
241250021$24125002$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003232$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$CN$US$US
241250031$24125003$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003235$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
241250041$24125004$1$I$$20240523$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003311$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$CN$US$US
241250051$24125005$1$I$20240101$20240717$20240723$20240723$PER$$US-ORGANON-O2407USA001902$ORGANON$$23$YR$$F$Y$$$20240723$$CN$US$US
241250061$24125006$1$I$$20240617$20240723$20240723$PER$$US-CELLTRION INC.-2024US015072$CELLTRION$Mohd Mari AA, Sidhu A, Matos M, Kinaan M. A Rare Case of Insulin-Like Growth Factor (IGF-2) Induced Hypoglycemia Associated With Metastatic Colon Cancer. Cureus. 2024;16(5)$$$$$Y$$$20240723$$HP$US$US
241250071$24125007$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003070$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240718$$CN$US$US
241250081$24125008$1$I$20240501$20240606$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003205$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241250091$24125009$1$I$$20240522$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003297$STEMLINE THERAPEUTICS$$78$YR$E$F$Y$$$20240718$$CN$US$US
241250101$24125010$1$I$$20240514$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003095$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$CN$US$US
241250112$24125011$2$F$$20240925$20240723$20240926$EXP$$NVSC2024GR149086$NOVARTIS$$$$$F$Y$$$20240926$$MD$GR$GR
241250122$24125012$2$F$$20240731$20240723$20240803$PER$$US-ABBVIE-5846554$ABBVIE$$$$$F$Y$$$20240803$$MD$US$US
241250132$24125013$2$F$20240601$20240906$20240723$20240921$PER$$US-RISINGPHARMA-US-2024RISSPO00247$RISING PHARMACEUTICALS$$60$YR$A$M$Y$270$KG$20240921$$PH$US$US
241250141$24125014$1$I$$20240606$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003254$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240718$$CN$US$US
241250151$24125015$1$I$20240701$20240717$20240723$20240723$EXP$$US-ABBVIE-5845491$ABBVIE$$48$YR$$F$Y$$$20240723$$CN$US$US
241250171$24125017$1$I$$20240715$20240723$20240723$30DAY$$US-GSK-US2024088763$GLAXOSMITHKLINE$$$$$M$Y$$$20240723$$CN$US$US
241250181$24125018$1$I$20240717$20240717$20240723$20240723$EXP$$US-VIIV HEALTHCARE LIMITED-US2024090019$VIIV$$34$YR$$F$Y$$$20240723$$HP$US$US
241250191$24125019$1$I$$20230830$20240723$20240723$PER$$US-AUROBINDO-AUR-APL-2023-051728$AUROBINDO$$$$$$Y$$$20240723$$CN$US$US
241250201$24125020$1$I$20240701$20240716$20240723$20240723$EXP$$US-ABBVIE-5844041$ABBVIE$$64$YR$$M$Y$$$20240723$$CN$US$US
241250212$24125021$2$F$20240708$20240808$20240723$20240817$EXP$$CN-SA-2024SA210485$SANOFI AVENTIS$$59$YR$A$F$Y$63$KG$20240817$$HP$CN$CN
241250222$24125022$2$F$$20240808$20240723$20240817$EXP$$US-ROCHE-10000027380$ROCHE$$31$YR$A$F$Y$154.22$KG$20240817$$CN$US$US
241250231$24125023$1$I$$20240614$20240723$20240723$PER$$US-AUROBINDO-AUR-APL-2024-018742$AUROBINDO$$$$$$Y$$$20240723$$CN$US$US
241250242$24125024$2$F$20210101$20240809$20240723$20240819$EXP$$DE-TEVA-VS-3220709$TEVA$Bruns L, Volker L, Klamroth R, Kuhlmann MK, Jabs WJ. Concomitant presentation of thrombotic thrombocytopenic purpura, immune thrombocytopenia, and autoimmune hemolytic anemia in a patient with newly diagnosed systemic lupus erythematosus. Clin-Nephrol-Case-Stud 2023; 11 (1): 147-153.; Bruns L, Volker L, Klamroth R, Kuhlmann MK, Jabs WJ. Concomitant presentation of thrombotic thrombocytopenic purpura, immune thrombocytopenia, and autoimmune hemolytic anemia in a patient with newly diagnosed sy...$29$YR$$F$Y$$$20240819$$HP$DE$DE
241250251$24125025$1$I$$20231009$20240723$20240723$PER$$US-AUROBINDO-AUR-APL-2023-063583$AUROBINDO$$$$E$F$Y$$$20240723$$CN$US$US
241250261$24125026$1$I$20230629$20230808$20240723$20240723$PER$$US-AUROBINDO-AUR-APL-2023-054003$AUROBINDO$$80$YR$$F$Y$50$KG$20240723$$PH$US$US
241250271$24125027$1$I$20240201$20240718$20240723$20240723$EXP$FR-AFSSAPS-PA2024001347$FR-TAKEDA-2024TUS072848$TAKEDA$$35$YR$$M$Y$68$KG$20240723$$HP$FR$FR
241250281$24125028$1$I$$20240702$20240723$20240723$PER$$US-JNJFOC-20240711728$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240723$$CN$US$US
241250291$24125029$1$I$$20240705$20240723$20240723$PER$$US-AUROBINDO-AUR-APL-2024-026154$AUROBINDO$$$$$$Y$$$20240723$$CN$US$US
241250302$24125030$2$F$20240718$20240718$20240723$20240728$PER$$US-AMGEN-USASP2024143727$AMGEN$$89$YR$E$$Y$$$20240728$$CN$US$US
241250312$24125031$2$F$20240716$20240822$20240723$20240828$30DAY$$US-AMGEN-USASL2024142281$AMGEN$$$$$$Y$$$20240827$$HP$US$US
241250321$24125032$1$I$$20240715$20240723$20240723$EXP$$DE-AMGEN-DEUSP2024141896$AMGEN$Stilgenbauer S. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results from a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240723$$MD$DE$DE
241250331$24125033$1$I$$20240717$20240723$20240723$PER$$US-ROCHE-10000032574$ROCHE$$$$A$F$Y$$$20240723$$CN$US$US
241250341$24125034$1$I$$20240716$20240723$20240723$EXP$$CA-ROCHE-3470398$ROCHE$$$$A$F$Y$$$20240723$$CN$CA$CA
241250351$24125035$1$I$$20240719$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US067077$SANDOZ$$$$$F$Y$$$20240723$$CN$US$US
241250362$24125036$2$F$20230701$20240723$20240723$20240729$EXP$$AR-SANDOZ INC.-SDZ2024AR067140$SANDOZ$$8$YR$$M$Y$38$KG$20240729$$CN$AR$AR
241250371$24125037$1$I$$20240710$20240723$20240723$EXP$$US-MSNLABS-2024MSNLIT01595$MSN LABORATORIES$Fink NS, Abubshait L, Deshisky A.Anti-HMGCR (Hydroxy-3-Methylglutaryl-CoA Reductase) Myopathy: A Rare Cause of Proximal Muscle Weakness..Cureus.2024;16(5):e61094$$$$$Y$$$20240723$$MD$US$US
241250382$24125038$2$F$$20240801$20240723$20240809$EXP$$US-LEO Pharma-372121$LEO PHARM$$68$YR$$M$Y$$$20240809$$CN$US$US
241250391$24125039$1$I$$20240713$20240723$20240723$EXP$$TR-NOVITIUMPHARMA-2024TRNVP01379$NOVITIUM PHARMA$Cemre Istanbullu.A case of Pitt-Hopkins syndrome: psychopharmacological approach for anxiety, insomnia, and agitation.Neurocase.03-MAY-2024;29:117-120$$$$F$Y$$$20240723$$HP$TR$TR
241250401$24125040$1$I$$20240716$20240723$20240723$EXP$$CA-ROCHE-10000032462$ROCHE$$$$A$M$Y$$$20240723$$CN$CA$CA
241250411$24125041$1$I$$20240715$20240723$20240723$EXP$$CA-HALEON-2187372$Haleon PLC$$6$DEC$$F$Y$$$20240722$$HP$CA$CA
241250423$24125042$3$F$$20240821$20240723$20240902$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07096$LUPIN$$$$$$Y$$$20240902$$HP$US$US
241250431$24125043$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115644$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240723$$HP$US$US
241250441$24125044$1$I$$20240709$20240723$20240723$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK092320$GLENMARK$$$$$$Y$$$20240723$$HP$GB$GB
241250451$24125045$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116461$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240723$$HP$US$US
241250461$24125046$1$I$20240703$20240715$20240723$20240723$EXP$IT-MINISAL02-994409$IT-SA-2024SA208301$SANOFI AVENTIS$$57$YR$A$M$Y$70$KG$20240723$$MD$IT$IT
241250471$24125047$1$I$20240606$20240712$20240723$20240723$EXP$SE-SEMPA-2024-004951$SE-JUBILANT CADISTA PHARMACEUTICALS-2024SE001023$JUBILANT$$89$YR$$F$Y$$$20240723$$MD$SE$SE
241250481$24125048$1$I$$20240716$20240723$20240723$EXP$US-MLMSERVICE-20240712-PI125158-00285-2$US-JUBILANT CADISTA PHARMACEUTICALS-2024US001047$JUBILANT$Homiack DR, Yan LE, Petry LG, Lloyd JR, Najjar F, Cook EH. Successful Electroconvulsive Therapy in a Patient With Catatonia and Maternal Duplication 15q11-13 Syndrome. The journal of ECT. 2024$24$YR$$M$Y$$$20240723$$MD$US$US
241250491$24125049$1$I$20200101$20240710$20240723$20240723$EXP$$TR-JUBILANT CADISTA PHARMACEUTICALS-2024TR001015$JUBILANT$Alp A, Rollas T, Eroglu EO, Yildiz MI, Yagcioglu AEA, Ulug BD. Catatonia Due to Lithium Neurotoxicity: A Case Report.. Turkish journal of psychiatry. 2024;35(2):150-5$60$YR$$F$Y$$$20240723$$MD$TR$TR
241250501$24125050$1$I$20240717$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024143148$AMGEN$$57$YR$A$F$Y$$$20240723$$CN$US$US
241250512$24125051$2$F$20240701$20240719$20240723$20240724$PER$$NVSC2024US149631$NOVARTIS$$62$YR$$F$Y$$$20240724$$CN$US$US
241250521$24125052$1$I$20200101$20240717$20240723$20240723$EXP$$US-ROCHE-10000030810$ROCHE$$48$YR$A$M$Y$88.45$KG$20240723$$CN$US$US
241250531$24125053$1$I$20240718$20240718$20240723$20240723$EXP$$US-ABBVIE-5846308$ABBVIE$$66$YR$$M$Y$$$20240723$$CN$US$US
241250541$24125054$1$I$20231128$20240103$20240723$20240723$EXP$$CN-TEVA-VS-3142404$TEVA$$68$YR$$M$Y$87$KG$20240723$$CN$CN$CN
241250551$24125055$1$I$20200803$20211022$20240723$20240723$EXP$$CA-CELLTRION INC.-2020CA035362$CELLTRION$$62$YR$$M$Y$$$20240723$$MD$CA$CA
241250562$24125056$2$F$$20240806$20240723$20240814$EXP$$JP-TAKEDA-2024TUS072965$TAKEDA$$68$YR$$$Y$$$20240814$$MD$JP$JP
241250571$24125057$1$I$$20240717$20240723$20240723$PER$$US-HALEON-2188421$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241250581$24125058$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115755$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240723$$CN$US$US
241250601$24125060$1$I$$20240719$20240723$20240723$PER$$US-ROCHE-10000032800$ROCHE$$47$YR$A$M$Y$$$20240723$$CN$US$US
241250611$24125061$1$I$$20240717$20240723$20240723$PER$$US-ROCHE-10000031087$ROCHE$$$$$F$Y$$$20240723$$HP$US$US
241250621$24125062$1$I$20210613$20240717$20240723$20240723$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-115655$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$53.4$KG$20240723$$MD$KR$KR
241250631$24125063$1$I$$20240722$20240723$20240723$PER$$US-HALEON-2188424$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241250641$24125064$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000033094$ROCHE$$$$$$Y$$$20240723$$HP$US$US
241250651$24125065$1$I$$20240718$20240723$20240723$EXP$$ZA-AstraZeneca-2024A164325$ASTRAZENECA$$27028$DY$$F$Y$$$20240723$$CN$ZA$
241250661$24125066$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161811$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241250671$24125067$1$I$$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A164817$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241250681$24125068$1$I$$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A164457$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241250691$24125069$1$I$$20230713$20240723$20240723$EXP$$US-AstraZeneca-2023A161582$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241250701$24125070$1$I$$20240716$20240723$20240723$EXP$$US-PCCINC-2024-PPL-000539$PIRAMAL$$$$$$Y$$$20240723$$HP$US$US
241250711$24125071$1$I$$20240715$20240723$20240723$EXP$$US-ROCHE-10000030164$ROCHE$McKinley B, Pai T, Wolf E, Li S, Correia G, Zhao Y, et al. Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis. Frontiers in Oncology. 2024-Jun-21;14:1-11. doi:10.3389/fonc.2024.1417175.$$$$$Y$$$20240723$$HP$US$US
241250721$24125072$1$I$$20240701$20240723$20240723$PER$$US-JNJFOC-20240704045$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
241250731$24125073$1$I$$20240715$20240723$20240723$EXP$$DE-AMGEN-DEUSP2024141810$AMGEN$Stilgenbauer, S.. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240723$$MD$DE$DE
241250742$24125074$2$F$20240612$20240917$20240723$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022118$UNITED THERAPEUTICS$$61$YR$$F$Y$62.585$KG$20240925$$$US$US
241250751$24125075$1$I$$20240708$20240723$20240723$EXP$$US-CorePharma LLC-2159458$COREPHARMA$Source document (FTA).$27$YR$$F$Y$$$20240723$$$US$US
241250761$24125076$1$I$$20240716$20240723$20240723$EXP$$GB-TAKEDA-2024TUS073288$TAKEDA$$$$$$Y$$$20240723$$CN$GB$GB
241250792$24125079$2$F$20240101$20240809$20240723$20240816$PER$$FR-ALK-ABELLO A/S-2024AA002912$ALK-ABELLO$$$$$$Y$$$20240816$$PH$FR$FR
241250801$24125080$1$I$$20240628$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003070$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241250811$24125081$1$I$20240611$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115225$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$54.88$KG$20240723$$CN$US$US
241250821$24125082$1$I$$20240624$20240723$20240723$PER$$US-SCIEGENP-2024SCSPO00322$SCIEGEN$$$$$$Y$$$20240723$$CN$US$US
241250831$24125083$1$I$20240705$20240722$20240723$20240723$EXP$$SG-VANTIVE-2024VAN018461$Vantive US Healthcare$$71$YR$$F$Y$$$20240723$$HP$SG$SG
241250841$24125084$1$I$$20240718$20240723$20240723$EXP$$US-TAKEDA-2024TUS073433$TAKEDA$$$$$F$Y$$$20240723$$CN$US$US
241250852$24125085$2$F$$20240826$20240723$20240829$EXP$$JP-BEH-2024175870$CSL BEHRING$$80$YR$E$M$Y$$$20240829$$MD$JP$JP
241250861$24125086$1$I$$20240719$20240723$20240723$EXP$$DE-ABBVIE-5848423$ABBVIE$$$$$F$Y$$$20240723$$CN$DE$DE
241250872$24125087$2$F$$20240731$20240723$20240807$PER$$US-ALXN-202407USA000963US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241250881$24125088$1$I$$20240716$20240723$20240723$EXP$$US-JNJFOC-20240741940$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240723$$CN$US$US
241250891$24125089$1$I$$20210520$20240723$20240723$EXP$$US-AstraZeneca-2021A459488$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241250903$24125090$3$F$20240101$20240827$20240723$20240830$EXP$$TH-AstraZeneca-2024A165387$ASTRAZENECA$$26519$DY$$F$Y$$$20240830$$MD$TH$
241250911$24125091$1$I$$20210430$20240723$20240723$EXP$$US-AstraZeneca-2021A394283$ASTRAZENECA$$$$$F$Y$108$KG$20240723$$CN$US$
241250921$24125092$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A162414$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241250931$24125093$1$I$20240312$20240715$20240723$20240723$EXP$$GB-AstraZeneca-2024A160815$ASTRAZENECA$$61$YR$$F$Y$40$KG$20240723$$MD$GB$
241250941$24125094$1$I$$20230921$20240723$20240723$EXP$$US-AstraZeneca-2023A217259$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241250951$24125095$1$I$20240618$20240716$20240723$20240723$EXP$$NVSC2024US147344$NOVARTIS$$77$YR$$F$Y$45$KG$20240723$$CN$US$US
241250961$24125096$1$I$20240628$20240722$20240723$20240723$PER$$US-ROCHE-10000033081$ROCHE$$68$YR$E$F$Y$$$20240723$$CN$US$US
241250971$24125097$1$I$$20240722$20240723$20240723$EXP$$US-ROCHE-10000033177$ROCHE$$55$YR$A$F$Y$$$20240723$$CN$US$US
241250981$24125098$1$I$20240717$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143462$AMGEN$$77$YR$E$M$Y$$$20240723$$CN$US$US
241250991$24125099$1$I$20240716$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024144098$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241251002$24125100$2$F$$20240723$20240723$20240726$PER$$US-ROCHE-10000033523$ROCHE$Usman S, Cheema M, Ghuman Z, Mustafa S, Iftikhar A. Ocrelizumab-induced organizing pneumonia in multiple sclerosis: case report and literature review. Archive of clinical cases. 2024-Jul-16;11 (2):69-73. doi:10.22551/2024.43.1102.10291.$42$YR$A$M$Y$$$20240726$$HP$US$US
241251012$24125101$2$F$20240719$20240812$20240723$20240813$PER$$US-ROCHE-10000033170$ROCHE$$$$$$Y$$$20240813$$HP$US$US
241251021$24125102$1$I$$20240711$20240723$20240723$EXP$$JP-ROCHE-10000027988$ROCHE$Nakai T, Seki H, Makino A, Kadota Y, Kaburagi T. Development of neuro-Behcet^s disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy: A case report. Breast disease. 2024-Jan;43 (1):223-229. doi:10.3233/BD-230026.$40$YR$A$F$Y$$$20240723$$HP$JP$JP
241251031$24125103$1$I$$20240611$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003658$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240718$$HP$US$US
241251041$24125104$1$I$$20240611$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003659$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241251051$24125105$1$I$$20240611$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003666$STEMLINE THERAPEUTICS$$51$YR$A$F$Y$$$20240718$$CN$US$US
241251061$24125106$1$I$$20240611$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003670$STEMLINE THERAPEUTICS$$43$YR$A$F$Y$$$20240718$$HP$US$US
241251071$24125107$1$I$$20240611$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003671$STEMLINE THERAPEUTICS$$49$YR$A$F$Y$$$20240718$$CN$US$US
241251081$24125108$1$I$$20240611$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003676$STEMLINE THERAPEUTICS$$44$YR$A$F$Y$$$20240718$$CN$US$US
241251091$24125109$1$I$$20240611$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003677$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241251101$24125110$1$I$20240601$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003683$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240718$$CN$US$US
241251111$24125111$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003685$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241251121$24125112$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003689$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241251131$24125113$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003696$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240718$$CN$US$US
241251141$24125114$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003698$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241251151$24125115$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003699$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
241251161$24125116$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003701$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241251171$24125117$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003704$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240718$$HP$US$US
241251181$24125118$1$I$$20240613$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003710$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240718$$CN$US$US
241251191$24125119$1$I$20240608$20240613$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003718$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240718$$CN$US$US
241251201$24125120$1$I$$20240613$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003725$STEMLINE THERAPEUTICS$$89$YR$E$M$Y$$$20240718$$CN$US$US
241251211$24125121$1$I$$20240613$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003728$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241251221$24125122$1$I$20240613$20240613$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003732$STEMLINE THERAPEUTICS$$51$YR$A$F$Y$$$20240718$$CN$US$US
241251231$24125123$1$I$$20240613$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003735$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241251241$24125124$1$I$$20240614$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003744$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241251251$24125125$1$I$20240101$20240614$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003745$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241251261$24125126$1$I$$20240614$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003746$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241251271$24125127$1$I$$20240614$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003747$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241251281$24125128$1$I$$20240614$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003749$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240718$$CN$US$US
241251291$24125129$1$I$$20240614$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003756$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$HP$US$US
241251301$24125130$1$I$20240101$20240614$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003757$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240718$$CN$US$US
241251311$24125131$1$I$$20240614$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003761$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$HP$US$US
241251321$24125132$1$I$$20240615$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003763$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241251331$24125133$1$I$$20240615$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003765$STEMLINE THERAPEUTICS$$46$YR$A$M$Y$$$20240718$$CN$US$US
241251341$24125134$1$I$$20240615$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003766$STEMLINE THERAPEUTICS$$50$YR$A$F$Y$$$20240718$$CN$US$US
241251351$24125135$1$I$$20240615$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003769$STEMLINE THERAPEUTICS$$46$YR$A$M$Y$$$20240718$$CN$US$US
241251361$24125136$1$I$$20240614$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003771$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241251371$24125137$1$I$$20240721$20240723$20240723$PER$$US-ROCHE-10000032787$ROCHE$$9$YR$C$M$Y$$$20240723$$HP$US$US
241251382$24125138$2$F$$20240806$20240723$20240809$EXP$$CA-JNJFOC-20240756190$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240809$$HP$CA$CA
241251391$24125139$1$I$$20240715$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-036034$AUROBINDO$Sallee L, Souchet L, Boutolleau D, Nguyen S. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports. International Journal of Antimicrobial Agents. 2024;63(6):107169$54$YR$$F$Y$$$20240723$$MD$FR$FR
241251401$24125140$1$I$$20240719$20240723$20240723$PER$$NVSC2024US150629$NOVARTIS$$$$$$Y$$$20240723$$MD$US$US
241251411$24125141$1$I$$20240624$20240723$20240723$PER$$US-SCIEGENP-2024SCSPO00323$SCIEGEN$$$$$$Y$$$20240723$$CN$US$US
241251421$24125142$1$I$$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114022$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240723$$HP$US$US
241251431$24125143$1$I$$20240611$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003672$STEMLINE THERAPEUTICS$$46$YR$A$F$Y$$$20240718$$CN$US$US
241251441$24125144$1$I$$20240614$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003755$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241251451$24125145$1$I$$20240715$20240723$20240723$EXP$$DE-AMGEN-DEUSP2024141946$AMGEN$Stilgenbauer, S.. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240723$$MD$DE$DE
241251461$24125146$1$I$$20240717$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115030$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240723$$HP$US$US
241251471$24125147$1$I$$20240710$20240723$20240723$EXP$$US-CIPLA LTD.-2024US07466$CIPLA$$$$$$Y$$$20240723$$CN$US$US
241251482$24125148$2$F$$20240802$20240723$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003072$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
241251491$24125149$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115517$BRISTOL MYERS SQUIBB$$8$YR$C$F$Y$34$KG$20240723$$PH$US$US
241251501$24125150$1$I$20240622$20240715$20240723$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-035279$AUROBINDO$$28$YR$$F$Y$88$KG$20240723$$PH$GB$GB
241251511$24125151$1$I$20240417$20240711$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-061785$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240723$$PH$JP$JP
241251521$24125152$1$I$$20240715$20240723$20240723$PER$$US-ABBVIE-5846233$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241251536$24125153$6$F$$20240711$20240723$20240830$PER$$US-ROCHE-10000026214$ROCHE$$$$E$F$Y$$$20240830$$CN$US$US
241251541$24125154$1$I$$20240715$20240723$20240723$EXP$$DE-AMGEN-DEUSP2024141981$AMGEN$Stilgenbauer S. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240723$$MD$DE$DE
241251551$24125155$1$I$20231109$20240102$20240723$20240723$EXP$GB-MHRA-MED-202312291946033760-JGHKT$GB-TEVA-VS-3143280$TEVA$$39$YR$$M$Y$$$20240723$$MD$GB$GB
241251561$24125156$1$I$20240708$20240717$20240723$20240723$EXP$$CO-UCBSA-2024036970$UCB$$88$YR$$M$Y$$$20240723$$CN$CO$CO
241251571$24125157$1$I$20210101$20240722$20240723$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041367$BOEHRINGER INGELHEIM$$61$YR$A$F$Y$$$20240723$$CN$US$US
241251581$24125158$1$I$$20240717$20240723$20240723$EXP$$US-ROCHE-10000029909$ROCHE$$$$E$M$Y$$$20240723$$CN$US$US
241251592$24125159$2$F$20240710$20240719$20240723$20240726$EXP$$NVSC2024CN150299$NOVARTIS$$72$YR$$F$Y$45$KG$20240726$$HP$CN$CN
241251601$24125160$1$I$20240331$20240718$20240723$20240723$EXP$$TN-ABBVIE-5846056$ABBVIE$$61$YR$$F$Y$$$20240723$$CN$TN$TN
241251611$24125161$1$I$$20240711$20240723$20240723$EXP$$DE-JNJFOC-20240732476$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$MD$DE$DE
241251622$24125162$2$F$20240101$20240722$20240723$20240725$EXP$$ES-ABBVIE-5846209$ABBVIE$$$$$F$Y$$$20240725$$HP$ES$ES
241251632$24125163$2$F$$20240812$20240723$20240812$PER$$US-ALXN-202407USA001114US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241251641$24125164$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116345$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240723$$HP$US$US
241251651$24125165$1$I$$20240710$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112118$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$109$KG$20240723$$MD$US$US
241251662$24125166$2$F$$20240809$20240723$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111667$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$72.57$KG$20240814$$CN$US$US
241251671$24125167$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116402$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240723$$HP$US$US
241251681$24125168$1$I$20210918$20240717$20240723$20240723$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-116253$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$57.4$KG$20240723$$MD$KR$KR
241251691$24125169$1$I$20240601$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116354$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240723$$HP$US$US
241251701$24125170$1$I$$20240715$20240723$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-035397$AUROBINDO$$74$YR$$F$Y$$$20240723$$MD$GB$GB
241251711$24125171$1$I$20240712$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013250$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240723$$CN$US$US
241251721$24125172$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013400$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$US$US
241251731$24125173$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013283$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240723$$CN$US$US
241251741$24125174$1$I$20240101$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012471$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240723$$CN$US$US
241251751$24125175$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013318$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240723$$CN$US$US
241251761$24125176$1$I$20240705$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012123$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240723$$CN$US$US
241251771$24125177$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06645$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241251781$24125178$1$I$$20240718$20240723$20240723$PER$$US-GILEAD-2024-0681283$GILEAD$$$$$$Y$$$20240723$$CN$US$US
241251791$24125179$1$I$$20240715$20240723$20240723$EXP$$DE-AMGEN-DEUSP2024141986$AMGEN$Stilgenbauer S. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240723$$MD$DE$DE
241251802$24125180$2$F$$20240718$20240723$20240724$EXP$$US-ROCHE-10000029588$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241251811$24125181$1$I$$20240709$20240723$20240723$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06667$HIKMA$$$$$F$Y$$$20240723$$CN$US$US
241251821$24125182$1$I$20240627$20240627$20240723$20240723$PER$$US-JNJFOC-20240676008$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
241251831$24125183$1$I$$20240717$20240723$20240723$EXP$$CA-JNJFOC-20240753837$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$90$KG$20240723$$HP$CA$CA
241251841$24125184$1$I$20240529$20240715$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-035907$AUROBINDO$$$DY$$M$Y$4.135$KG$20240723$$HP$FR$FR
241251852$24125185$2$F$$20240817$20240723$20240820$EXP$$IT-ROCHE-10000025687$ROCHE$$$$$M$Y$$$20240820$$MD$IT$IT
241251861$24125186$1$I$$20240702$20240723$20240723$PER$$US-JNJFOC-20240712782$JOHNSON AND JOHNSON$$31$YR$A$$Y$$$20240723$$CN$US$US
241251871$24125187$1$I$20240712$20240716$20240723$20240723$PER$$US-ROCHE-10000029549$ROCHE$$71$YR$E$F$Y$$$20240723$$CN$US$US
241251881$24125188$1$I$$20240708$20240723$20240723$EXP$$IN-CorePharma LLC-2159459$COREPHARMA$Source document (Abstract).$$$$M$Y$$$20240723$$$IN$IN
241251895$24125189$5$F$20240101$20240824$20240723$20240829$PER$$US-ROCHE-10000030761$ROCHE$$69$YR$E$F$Y$79.83$KG$20240829$$HP$US$US
241251901$24125190$1$I$20240101$20240719$20240723$20240723$EXP$$US-ABBVIE-5848056$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241251912$24125191$2$F$$20240906$20240723$20240910$PER$$US-AstraZeneca-2024A164624$ASTRAZENECA$$$$$$Y$$$20240910$$MD$US$
241251921$24125192$1$I$$20210314$20240723$20240723$EXP$$CA-AstraZeneca-2021A152247$ASTRAZENECA$$$$$M$Y$$$20240723$$MD$CA$
241251931$24125193$1$I$20190801$20191021$20240723$20240723$EXP$$CO-TERSERA THERAPEUTICS LLC-2019TRS002436$TERSERA THERAPEUTICS$$$$$$Y$$$20240723$$CN$CO$CO
241251941$24125194$1$I$$20210115$20240723$20240723$EXP$$US-AstraZeneca-2021A009248$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241251951$24125195$1$I$20240520$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A162527$ASTRAZENECA$$17508$DY$$F$Y$$$20240723$$CN$US$
241251961$24125196$1$I$$20240715$20240723$20240723$EXP$$GB-AstraZeneca-2024A161779$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$GB$
241251971$24125197$1$I$$20240718$20240723$20240723$EXP$$CA-Orion Corporation ORION PHARMA-24_00030942$ORION$$$$$M$Y$$$20240723$$HP$CA$
241251981$24125198$1$I$$20211123$20240723$20240723$EXP$$US-AstraZeneca-2021A825857$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241251991$24125199$1$I$$20230518$20240723$20240723$EXP$$US-AstraZeneca-2023A116257$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241252001$24125200$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024143013$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241252011$24125201$1$I$$20221111$20240723$20240723$EXP$$US-AstraZeneca-2022A376234$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241252021$24125202$1$I$$20230526$20240723$20240723$EXP$$US-AstraZeneca-2023A124100$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241252032$24125203$2$F$$20240821$20240723$20240823$EXP$$FR-TAKEDA-2024TUS073937$TAKEDA$$$$E$F$Y$$$20240823$$MD$FR$FR
241252042$24125204$2$F$20240101$20240822$20240723$20240828$EXP$$JP-009507513-2407JPN003202J$MERCK$$8$DEC$$M$Y$$$20240828$$MD$JP$JP
241252052$24125205$2$F$20240518$20240809$20240723$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003074$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240830$$CN$US$US
241252063$24125206$3$F$20240719$20240806$20240723$20240808$EXP$$DE-ABBVIE-5848444$ABBVIE$$88$YR$$M$Y$$$20240808$$MD$DE$DE
241252071$24125207$1$I$20240430$20240722$20240723$20240723$EXP$FR-AFSSAPS-TO2024001230$FR-UCBSA-2024036898$UCB$$75$YR$$M$Y$$$20240723$$PH$FR$FR
241252081$24125208$1$I$20240718$20240718$20240723$20240723$EXP$$PT-ABBVIE-5848441$ABBVIE$$79$YR$$F$Y$$$20240723$$CN$PT$PT
241252091$24125209$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06696$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241252102$24125210$2$F$20240601$20240903$20240723$20240909$EXP$$US-BEH-2024175875$CSL BEHRING$$24$YR$A$F$Y$$$20240909$$HP$US$US
241252111$24125211$1$I$20240510$20230203$20240723$20240723$EXP$$CA-CELLTRION INC.-2023CA025505$CELLTRION$$$$$$Y$$$20240723$$MD$CA$CA
241252121$24125212$1$I$20240709$20240715$20240723$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-035413$AUROBINDO$$77$YR$$F$Y$$$20240723$$PH$GB$GB
241252141$24125214$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000031030$ROCHE$$$$$$Y$$$20240723$$CN$US$US
241252151$24125215$1$I$20140101$20240715$20240723$20240723$EXP$$CA-BIOGEN-2024BI01273735$BIOGEN$$$$$F$Y$$$20240723$$CN$CA$CA
241252161$24125216$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5847092$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241252171$24125217$1$I$$20240613$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002530$STEMLINE THERAPEUTICS$$84$YR$E$F$Y$$$20240718$$CN$US$US
241252181$24125218$1$I$$20240429$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002740$STEMLINE THERAPEUTICS$$46$YR$A$F$Y$$$20240718$$CN$US$US
241252191$24125219$1$I$$20240429$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002747$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
241252201$24125220$1$I$$20240429$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002746$STEMLINE THERAPEUTICS$$52$YR$A$F$Y$$$20240718$$HP$US$US
241252211$24125221$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002756$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241252221$24125222$1$I$$20240430$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002761$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241252231$24125223$1$I$$20240428$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002722$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240718$$CN$US$US
241252241$24125224$1$I$$20240430$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002766$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
241252251$24125225$1$I$$20240524$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002771$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241252261$24125226$1$I$$20240430$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002772$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241252271$24125227$1$I$$20240430$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002773$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241252281$24125228$1$I$$20240501$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002786$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241252291$24125229$1$I$$20240501$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002787$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241252301$24125230$1$I$$20240501$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002788$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240718$$CN$US$US
241252311$24125231$1$I$$20240604$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002789$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240718$$CN$US$US
241252321$24125232$1$I$$20240529$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002792$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240718$$CN$US$US
241252331$24125233$1$I$$20240430$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002754$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240718$$CN$US$US
241252341$24125234$1$I$$20240430$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002755$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241252351$24125235$1$I$$20240620$20240723$20240723$EXP$$AU-Avondale Pharmaceuticals, LLC-2159460$AVONDALE PHARMACEUTICALS$Initial$$$$$Y$$$20240723$$$AU$AU
241252361$24125236$1$I$20240424$20240430$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002775$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241252371$24125237$1$I$$20240520$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002794$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$CN$US$US
241252381$24125238$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-3527169$ROCHE$$$$A$F$Y$$$20240723$$MD$US$US
241252391$24125239$1$I$$20240430$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002768$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241252411$24125241$1$I$20230101$20240716$20240723$20240723$EXP$$US-ABBVIE-5843395$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241252421$24125242$1$I$20240716$20240716$20240723$20240723$PER$$US-BAUSCH-BL-2024-010935$BAUSCH AND LOMB$$$$$F$Y$$$20240723$$CN$US$US
241252441$24125244$1$I$$20240722$20240723$20240723$PER$$US-ROCHE-10000033676$ROCHE$$82$YR$E$F$Y$$$20240723$$CN$US$US
241252452$24125245$2$F$$20240718$20240723$20240729$EXP$$IT-TAKEDA-2024TUS073453$TAKEDA$$$$$$Y$$$20240729$$HP$IT$IT
241252461$24125246$1$I$$20240718$20240723$20240723$EXP$$BG-ABBVIE-5846360$ABBVIE$$55$YR$$M$Y$$$20240723$$CN$BG$BG
241252473$24125247$3$F$20170201$20240918$20240723$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-007854$JAZZ$$56$YR$$M$Y$$$20240923$$MD$US$US
241252482$24125248$2$F$$20240820$20240723$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115926$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240827$$CN$US$US
241252491$24125249$1$I$20240601$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116451$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240723$$HP$US$US
241252501$24125250$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116417$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240723$$HP$US$US
241252511$24125251$1$I$$20240717$20240723$20240723$PER$$US-ROCHE-10000032051$ROCHE$$52$YR$A$M$Y$$$20240723$$CN$US$US
241252531$24125253$1$I$$20240715$20240723$20240723$PER$$US-BAUSCH-BL-2024-010958$BAUSCH AND LOMB$$$$$F$Y$$$20240723$$CN$US$US
241252541$24125254$1$I$$20240719$20240723$20240723$EXP$$EU-BAUSCHBL-2024BNL029325$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240723$$MD$EU$EU
241252552$24125255$2$F$$20240812$20240723$20240812$PER$$US-ALXN-202407USA001101US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241252561$24125256$1$I$$20240717$20240723$20240723$EXP$$TR-SANDOZ INC.-SDZ2024TR067056$SANDOZ$$$$E$M$Y$$$20240723$$CN$TR$TR
241252571$24125257$1$I$$20240719$20240723$20240723$PER$$US-ROCHE-10000032874$ROCHE$$$$$F$Y$$$20240723$$CN$US$US
241252581$24125258$1$I$$20240722$20240723$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA067113$SANDOZ$$16$YR$$F$Y$$$20240723$$CN$CA$CA
241252591$24125259$1$I$20240718$20240718$20240723$20240723$PER$$US-ROCHE-10000031304$ROCHE$$$$$F$Y$$$20240723$$CN$US$US
241252601$24125260$1$I$20240514$20240611$20240723$20240723$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090377$VIIV$$43$YR$$M$Y$$$20240723$$PH$US$US
241252613$24125261$3$F$20240501$20240919$20240723$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR090479$VIIV$$33$YR$$M$Y$$$20240927$$PH$US$US
241252621$24125262$1$I$20240514$20240611$20240723$20240723$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091173$VIIV$$57$YR$$F$Y$$$20240723$$PH$US$US
241252651$24125265$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143237$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241252662$24125266$2$F$$20240724$20240723$20240729$PER$$US-AMGEN-USASP2024142055$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241252671$24125267$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000032521$ROCHE$$43$YR$A$F$Y$$$20240723$$CN$US$US
241252681$24125268$1$I$20240705$20240717$20240723$20240723$EXP$$NVSC2024CN148967$NOVARTIS$$34$YR$$F$Y$62.8$KG$20240723$$HP$CN$CN
241252691$24125269$1$I$$20240715$20240723$20240723$EXP$$NL-AMGEN-NLDSP2024140074$AMGEN$Sonneveld, P.. Carfilzomib Combined with Thalidomide and Dexamethasone (CTD) Is an Highly Effective Induction and Consolidation Treatment in Newly Diagnosed Patients with  Multiple Myeloma (NM) Who Are Transplant Candidate. Blood. 2012;120 (21):333$$$$$Y$$$20240723$$MD$NL$NL
241252701$24125270$1$I$$20240718$20240723$20240723$EXP$GB-MHRA-MED-202407180945033220-DTZNS$GB-ABBVIE-5848145$ABBVIE$$$$$$Y$$$20240723$$CN$GB$GB
241252711$24125271$1$I$20240713$20240716$20240723$20240723$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS003721$TERSERA THERAPEUTICS$$$$$$Y$$$20240723$$CN$NL$NL
241252721$24125272$1$I$$20240628$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003075$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241252731$24125273$1$I$$20240708$20240723$20240723$EXP$$ES-CorePharma LLC-2159461$COREPHARMA$Source document (Abstract)$54$YR$$F$Y$$$20240723$$$ES$ES
241252741$24125274$1$I$20240719$20240719$20240723$20240723$PER$$US-JNJFOC-20240753729$JOHNSON AND JOHNSON$$59$YR$A$$Y$$$20240723$$PH$US$US
241252751$24125275$1$I$20240715$20240715$20240723$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-035328$AUROBINDO$$63$YR$$M$Y$81$KG$20240723$$CN$GB$GB
241252761$24125276$1$I$20231019$20240709$20240723$20240723$EXP$$JP-ROCHE-10000031924$ROCHE$$45$YR$A$F$Y$54$KG$20240723$$MD$JP$JP
241252771$24125277$1$I$20240702$20240709$20240723$20240723$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK092330$GLENMARK$$$$$$Y$$$20240723$$MD$GB$GB
241252791$24125279$1$I$20240101$20240715$20240723$20240723$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021531$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240723$$MD$US$US
241252802$24125280$2$F$$20240805$20240723$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116356$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240806$$HP$US$US
241252811$24125281$1$I$$20240715$20240723$20240723$EXP$$US-ROCHE-10000027016$ROCHE$Storandt M, Zemla T, Patell K, Naleid N, Gile J, Tran N, et al. Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort study. The oncologist. 2024-Jul-09;1-11. doi:10.1093/oncolo/oyae142.$$$$$Y$$$20240723$$MD$US$US
241252821$24125282$1$I$$20240712$20240723$20240723$EXP$$US-ROCHE-3574962$ROCHE$$$$E$F$Y$$$20240723$$MD$US$US
241252831$24125283$1$I$$20240715$20240723$20240723$PER$$US-ROCHE-10000028953$ROCHE$Rashid S, Meshkin R, Cakir B, Hoyek S, Rossin E, Eliott D, et al. Concurrent Central Retinal Vein Occlusion and Rhegmatogenous Retinal Detachment in Two Young Healthy Patients. Retinal Cases and Brief Reports. 2024; doi:10.1097/ICB.0000000000001622.$28$YR$A$M$Y$$$20240723$$HP$US$US
241252841$24125284$1$I$20240522$20240715$20240723$20240723$EXP$FR-AFSSAPS-GR2024000856$FR-TEVA-VS-3221515$TEVA$$88$YR$$F$Y$$$20240723$$PH$FR$FR
241252851$24125285$1$I$20240627$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116365$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$76.2$KG$20240723$$PH$US$US
241252861$24125286$1$I$$20240720$20240723$20240723$EXP$$NVSC2024US149997$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
241252872$24125287$2$F$$20240827$20240723$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003076$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$CN$US$US
241252881$24125288$1$I$20240101$20240711$20240723$20240723$EXP$$US-TEVA-VS-3221597$TEVA$$15$YR$$F$Y$$$20240723$$HP$US$US
241252891$24125289$1$I$$20240711$20240723$20240723$EXP$$US-RDY-LIT/USA/24/0010518$DR REDDYS$Rodriguez H, Tan J, Reddy S. A Missed Mass: An Exceedingly Rare Round Cell Sarcoma Leading to Respiratory Failure in a 19-year-old. American Journal of Respiratory and Critical Care Medicine. 209(0): doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6532.$19$YR$A$F$Y$$$20240723$$HP$US$US
241252901$24125290$1$I$$20240710$20240723$20240723$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06674$HIKMA$Ghoussaini R, Saleh OA, Tabaja H.. Ghoussaini R, Saleh OA, Tabaja H. Graft versus histoplasma disease: A case of vascular graft infection.. IDCases. 2024;/:/$72$YR$$M$Y$$$20240723$$MD$US$US
241252911$24125291$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06702$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241252921$24125292$1$I$20240105$20240716$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-036125$AUROBINDO$$75$YR$$F$Y$60$KG$20240723$$MD$FR$FR
241252931$24125293$1$I$20240101$20240716$20240723$20240723$EXP$$AU-BEH-2024172108$CSL BEHRING$$77$YR$E$M$Y$80$KG$20240723$$CN$AU$AU
241252944$24125294$4$F$$20240725$20240723$20240801$EXP$$NVSC2024CA146394$NOVARTIS$$$$$F$Y$$$20240801$$HP$CA$CA
241252952$24125295$2$F$$20240711$20240723$20240725$EXP$$NVSC2024CA146135$NOVARTIS$$56$YR$$F$Y$$$20240725$$HP$CA$CA
241252961$24125296$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024144101$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241252972$24125297$2$F$$20240830$20240723$20240905$PER$$US-AstraZeneca-2024A162586$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
241252982$24125298$2$F$$20240822$20240723$20240830$EXP$$US-AstraZeneca-2024A162605$ASTRAZENECA$$77$YR$$F$Y$69.7$KG$20240830$$MD$US$
241252991$24125299$1$I$20240618$20240715$20240723$20240723$EXP$$ES-AstraZeneca-2024A162365$ASTRAZENECA$$43$YR$$F$Y$$$20240723$$CN$ES$
241253001$24125300$1$I$20240708$20240716$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-036181$AUROBINDO$$70$YR$$M$Y$$$20240723$$MD$FR$FR
241253011$24125301$1$I$$20240715$20240723$20240723$EXP$$RU-AstraZeneca-2024A165653$ASTRAZENECA$$81$YR$$M$Y$$$20240723$$MD$RU$
241253021$24125302$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116435$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$53.07$KG$20240723$$HP$US$US
241253031$24125303$1$I$20240720$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116449$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$105.23$KG$20240723$$CN$US$US
241253042$24125304$2$F$$20240923$20240723$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116587$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240925$$CN$US$US
241253051$24125305$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116621$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$JP$JP
241253061$24125306$1$I$$20240522$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002312$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240722$$CN$US$US
241253071$24125307$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116266$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$PH$US$US
241253081$24125308$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116416$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240723$$HP$US$US
241253091$24125309$1$I$20240601$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116518$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240723$$HP$US$US
241253102$24125310$2$F$$20240814$20240723$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116703$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$43.9$KG$20240821$$CN$US$US
241253111$24125311$1$I$$20240711$20240723$20240723$EXP$$CA-TEVA-VS-3222909$TEVA$$78$YR$$F$Y$70$KG$20240723$$MD$CA$CA
241253121$24125312$1$I$$20240716$20240723$20240723$EXP$$CA-ORGANON-O2407CAN001454$ORGANON$$44$YR$$F$Y$$$20240723$$MD$CA$CA
241253132$24125313$2$F$$20240718$20240723$20240729$EXP$$CN-AMGEN-CHNSP2024143592$AMGEN$Chen S.; Shen L.; Cao W. et al.. Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation. Blood cancer journal. 2024;14 (1)$60$YR$A$M$Y$$$20240729$$HP$CN$CN
241253141$24125314$1$I$$20240710$20240723$20240723$EXP$$DK-MACLEODS PHARMA-MAC2024048329$MACLEODS$Skouvig Pedersen O, Barkholt TO, Horskaer Madsen S, Rudolf F.Tuberculosis immune reconstitution syndrome (TB-IRIS) followed by recurring lymphadenitis up to 8 years post-antituberculous treatment..BMJ Case Reports.2024;17(6):e259211$$$$$Y$$$20240723$$MD$DK$DK
241253151$24125315$1$I$20200101$20240710$20240723$20240723$EXP$$TR-MACLEODS PHARMA-MAC2024048331$MACLEODS$Alp A, Rollas T, Eroglu EO, Yildiz MI, Yagcioglu AEA, Ulug BD..Catatonia Due to Lithium Neurotoxicity: A Case Report.Turkish journal of psychiatry.2024;35(2):150-5$$$$$Y$$$20240723$$MD$TR$TR
241253161$24125316$1$I$$20240710$20240723$20240723$EXP$$US-MACLEODS PHARMA-MAC2024048348$MACLEODS$Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D^Agati VD, Markowitz GS..Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.Kidney international..01-DEC-2010;78(11):1171-7$$$$$Y$$$20240723$$HP$US$US
241253171$24125317$1$I$$20240710$20240723$20240723$EXP$$US-MACLEODS PHARMA-MAC2024048349$MACLEODS$Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D Agati VD, Markowitz GS.Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.Kidney international.2010;78(11):1171-7$63$YR$A$M$Y$$$20240723$$HP$US$US
241253182$24125318$2$F$20220601$20240722$20240723$20240731$EXP$$CN-MACLEODS PHARMA-MAC2024048332$MACLEODS$Cao L, Wang F, Liu JY, Chang YY.Renal injury caused by tenofovir disoproxil fumarate in a patient with liver cancer complicated with HBV infection: a case report and literature analysis..China Pharmacy-Zhongguo Yaofang.2024;357:866-71$$$$$Y$$$20240731$$PH$CN$CN
241253191$24125319$1$I$$20240710$20240723$20240723$EXP$$IN-MACLEODS PHARMA-MAC2024048333$MACLEODS$Athish KK, Rao SN, Marimuthu VH, Krishna V, Arun A..Tenofovir-Associated Kidney Dysfunction and Bone Fracture: A Case Report and Literature Review.Cureus.03-JUN-2024;16(6);e61562:1-5$$$$$Y$$$20240723$$HP$IN$IN
241253201$24125320$1$I$$20240710$20240723$20240723$EXP$$US-MACLEODS PHARMA-MAC2024048350$MACLEODS$Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D^Agati VD, Markowitz GS.Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.Kidney international.2010;78(11):1171-7$$$$$Y$$$20240723$$HP$US$US
241253211$24125321$1$I$$20240710$20240723$20240723$EXP$$US-MACLEODS PHARMA-MAC2024048354$MACLEODS$Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D^Agati VD, Markowitz GS.Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.Kidney international.2010;78(11):1171-7$$$$$Y$$$20240723$$HP$US$US
241253221$24125322$1$I$$20240710$20240723$20240723$EXP$$US-MACLEODS PHARMA-MAC2024048359$MACLEODS$Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.Kidney Int$$$$$Y$$$20240723$$HP$US$US
241253231$24125323$1$I$20240621$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50492$$FDA-CTU$$68$YR$$F$N$$$20240722$N$HP$US$
241253241$24125324$1$I$$20240710$20240723$20240723$EXP$$US-MACLEODS PHARMA-MAC2024048352$MACLEODS$Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D^Agati VD, Markowitz GS.Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.Kidney international.01-DEC-2010;78(11):1171-7$$$$$Y$$$20240723$$HP$US$US
241253251$24125325$1$I$$20240710$20240723$20240723$EXP$$US-MACLEODS PHARMA-MAC2024048351$MACLEODS$Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D Agati VD, Markowitz GS.Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.Kidney International.DEC-2010;78(11):1171-1177$$$$$Y$$$20240723$$HP$US$US
241253261$24125326$1$I$$20240715$20240723$20240723$EXP$$GB-TEVA-VS-3221765$TEVA$$$$$F$Y$$$20240723$$HP$GB$GB
241253272$24125327$2$F$$20240716$20240723$20240723$PER$$US-ABBVIE-2134051US$ABBVIE$$$$$$Y$$$20240723$$MD$US$US
241253281$24125328$1$I$20240703$20240718$20240723$20240723$EXP$$CN-ROCHE-10000031303$ROCHE$$34$YR$A$F$Y$50$KG$20240723$$HP$CN$CN
241253291$24125329$1$I$$20240718$20240723$20240723$EXP$GB-MHRA-MED-202407180956233390-PZWYM$GB-ABBVIE-5848146$ABBVIE$$$$$$Y$$$20240723$$CN$GB$GB
241253302$24125330$2$F$20240101$20240715$20240723$20240725$PER$$US-ABBVIE-5843575$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241253311$24125331$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06711$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241253321$24125332$1$I$20240328$20240719$20240723$20240723$EXP$$AR-JNJFOC-20240757788$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240723$$CN$AR$AR
241253331$24125333$1$I$$20240715$20240723$20240723$EXP$$GB-AMGEN-GBRSP2024143046$AMGEN$$73$YR$E$F$Y$$$20240723$$CN$GB$GB
241253341$24125334$1$I$$20240716$20240723$20240723$EXP$$US-JNJFOC-20240744677$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
241253351$24125335$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06699$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241253361$24125336$1$I$20240611$20240717$20240723$20240723$EXP$$US-BEH-2024175892$CSL BEHRING$$72$YR$E$F$Y$$$20240723$$HP$US$US
241253371$24125337$1$I$20240626$20240711$20240723$20240723$EXP$ES-AEMPS-1543557$ES-TEVA-VS-3220514$TEVA$$43$YR$$M$Y$$$20240723$$PH$ES$ES
241253381$24125338$1$I$20240711$20240718$20240723$20240723$EXP$$CN-ROCHE-10000030995$ROCHE$$73$YR$E$F$Y$45$KG$20240723$$HP$CN$CN
241253391$24125339$1$I$20231110$20240715$20240723$20240723$EXP$FR-AFSSAPS-NC2024000650$FR-TAKEDA-2024TUS073431$TAKEDA$$37$YR$$F$Y$$$20240723$$HP$FR$FR
241253401$24125340$1$I$$20240712$20240723$20240723$EXP$$JP-ROCHE-10000024618$ROCHE$Yoshino R, Nakatsubo M, Ujiie N. Breast cancer with biomarker reversal during the course of treatment: a case report. Journal of Surgical Case Reports. 2024-Jun-01;2024 (6):1-4. doi:10.1093/jscr/rjae432.$59$YR$A$F$Y$$$20240723$$HP$JP$JP
241253411$24125341$1$I$$20240718$20240723$20240723$EXP$$CA-TAKEDA-2024TUS072497$TAKEDA$$$$$M$Y$$$20240723$$MD$CA$CA
241253421$24125342$1$I$20210101$20240718$20240723$20240723$EXP$$US-UCBSA-2024036626$UCB$$$$$F$Y$$$20240723$$CN$US$US
241253431$24125343$1$I$20230901$20240712$20240723$20240723$EXP$IT-MINISAL02-993937$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06770$HIKMA$$75$YR$$M$Y$$$20240723$$MD$IT$IT
241253441$24125344$1$I$20240709$20240715$20240723$20240723$EXP$$US-BEH-2024175957$CSL BEHRING$$67$YR$E$M$Y$79.365$KG$20240723$$CN$US$US
241253451$24125345$1$I$$20240719$20240723$20240723$PER$$US-ROCHE-10000033413$ROCHE$$45$YR$A$F$Y$$$20240723$$CN$US$US
241253461$24125346$1$I$$20240722$20240723$20240723$PER$$US-HALEON-2188373$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241253471$24125347$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06756$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241253481$24125348$1$I$$20240708$20240723$20240723$EXP$$SG-ROCHE-10000029957$ROCHE$$76$YR$E$F$Y$$$20240723$$CN$SG$SG
241253491$24125349$1$I$20211028$20240716$20240723$20240723$EXP$$CA-TAKEDA-2021TUS067993$TAKEDA$$71$YR$$M$Y$$$20240723$$MD$CA$CA
241253501$24125350$1$I$$20240722$20240723$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041208$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240723$$CN$US$US
241253511$24125351$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06754$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241253521$24125352$1$I$$20240722$20240723$20240723$EXP$GB-MHRA-MED-202407221205181460-SBKML$GB-UCBSA-2024036903$UCB$$$$$$Y$$$20240723$$MD$GB$GB
241253531$24125353$1$I$20240719$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50541$$FDA-CTU$$60$YR$$F$N$$$20240722$Y$PH$US$
241253541$24125354$1$I$20240712$20240718$20240718$20240718$DIR$FDA-CDER-CTU-2024-50332$$FDA-CTU$$55$YR$$M$N$$$20240718$N$PH$US$
241253551$24125355$1$I$20230224$20230224$20240722$20240722$DIR$FDA-CDER-CTU-2024-50519$$FDA-CTU$$56$YR$$F$N$86.8$KG$20230224$N$HP$US$
241253561$24125356$1$I$$20240628$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003078$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241253571$24125357$1$I$20240702$20240715$20240723$20240723$EXP$$CN-JNJFOC-20240740999$JOHNSON AND JOHNSON$$54$YR$A$M$Y$61$KG$20240723$$HP$CN$CN
241253581$24125358$1$I$$20240716$20240723$20240723$EXP$$US-JNJFOC-20240744689$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
241253591$24125359$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116012$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240723$$MD$US$US
241253602$24125360$2$F$$20240718$20240723$20240729$EXP$$CN-AMGEN-CHNSP2024143649$AMGEN$Chen S.; Shen L.; Cao W. et al.. Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation. Blood cancer journal. 2024;14 (1)$29$YR$A$F$Y$$$20240729$$HP$CN$CN
241253611$24125361$1$I$20240702$20240717$20240723$20240723$EXP$$CN-ROCHE-10000030219$ROCHE$$37$YR$A$F$Y$47$KG$20240723$$HP$CN$CN
241253621$24125362$1$I$$20240710$20240723$20240723$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06700$HIKMA$Guy DR, DeVore S, Kirtani V, Duffy N.. Guy DR, DeVore S, Kirtani V, Duffy N. Generalized pustular psoriasis successfully treated with spesolimab in the setting of metastatic colon cancer.. JAAD Case Reports. 2024;/:/$76$YR$$M$Y$$$20240723$$MD$US$US
241253632$24125363$2$F$20240625$20240820$20240723$20240829$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001128$AKEBIA THERAPEUTICS$$86$YR$$M$Y$$$20240829$$PH$JP$JP
241253641$24125364$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06820$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241253651$24125365$1$I$$20240717$20240723$20240723$EXP$$CA-ABBVIE-5845660$ABBVIE$$$$A$F$Y$$$20240723$$MD$CA$CA
241253661$24125366$1$I$20240101$20240718$20240723$20240723$EXP$$US-ABBVIE-5846069$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241253671$24125367$1$I$$20240712$20240723$20240723$EXP$$US-AUROBINDO-AUR-APL-2024-035863$AUROBINDO$Ami C, Krishna S. CDK4/6 inhibitor-induced Interstitial Lung Disease (ILD) - A Case Series. Cancer Research. 2024;84 (9_Supple):PO1-05-04$61$YR$$F$Y$$$20240723$$HP$US$US
241253681$24125368$1$I$20210606$20240708$20240723$20240723$EXP$$FR-SERVIER-S24008898$SERVIER$$$$$$Y$$$20240723$$MD$FR$FR
241253691$24125369$1$I$$20240719$20240723$20240723$EXP$$CA-TAKEDA-2024TUS074124$TAKEDA$$$$$M$Y$$$20240723$$HP$CA$CA
241253701$24125370$1$I$$20240701$20240723$20240723$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06765$LUPIN$$$$$$Y$$$20240723$$CN$US$US
241253712$24125371$2$F$$20240726$20240723$20240803$EXP$$US-ABBVIE-5845274$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241253724$24125372$4$F$20240101$20240814$20240723$20240821$EXP$$US-ABBVIE-5845280$ABBVIE$$$$$F$Y$74$KG$20240821$$CN$US$US
241253731$24125373$1$I$20240101$20240722$20240723$20240723$EXP$GB-MHRA-MED-202407221004094690-NFMRB$GB-ABBVIE-5848440$ABBVIE$$$$$F$Y$$$20240723$$PH$GB$GB
241253742$24125374$2$F$$20240819$20240723$20240823$EXP$$NVSC2024VE150115$NOVARTIS$$$$A$F$Y$$$20240823$$CN$VE$VE
241253753$24125375$3$F$$20240924$20240723$20240930$EXP$$US-TAKEDA-2024TUS072707$TAKEDA$$$$$F$Y$48$KG$20240930$$HP$US$US
241253761$24125376$1$I$20240614$20240628$20240723$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003080$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240723$$CN$US$US
241253771$24125377$1$I$20240601$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024144648$AMGEN$$46$YR$A$M$Y$$$20240723$$HP$US$US
241253781$24125378$1$I$20240611$20240715$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-036047$AUROBINDO$$45$YR$$F$Y$54$KG$20240723$$MD$FR$FR
241253791$24125379$1$I$$20240709$20240723$20240723$PER$$US-AMGEN-USASP2024145832$AMGEN$$$$A$M$Y$$$20240723$$CN$US$US
241253802$24125380$2$F$20240713$20240730$20240723$20240802$PER$$US-LEO Pharma-372184$LEO PHARM$$64$YR$$F$Y$$$20240802$$PH$US$US
241253811$24125381$1$I$20240612$20240718$20240723$20240723$EXP$$AT-AstraZeneca-2024A166513$ASTRAZENECA$$61$YR$$M$Y$64$KG$20240723$$MD$AT$
241253821$24125382$1$I$$20211201$20240723$20240723$EXP$$US-AstraZeneca-2021A854119$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241253831$24125383$1$I$$20240717$20240723$20240723$EXP$$US-ROCHE-10000030203$ROCHE$$74$YR$E$F$Y$$$20240723$$CN$US$US
241253841$24125384$1$I$$20220707$20240723$20240723$EXP$$US-AstraZeneca-2022A249784$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241253851$24125385$1$I$$20240722$20240723$20240723$EXP$$US-UCBSA-2024036995$UCB$$$$$M$Y$$$20240723$$CN$US$US
241253861$24125386$1$I$$20220603$20240723$20240723$EXP$$ZA-AstraZeneca-2022A214404$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$ZA$
241253871$24125387$1$I$20191014$20191206$20240723$20240723$EXP$$CO-AstraZeneca-2019SF79352$ASTRAZENECA$$29768$DY$$M$Y$$$20240723$$CN$CO$
241253881$24125388$1$I$$20210419$20240723$20240723$EXP$$US-AstraZeneca-2021A335385$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241253891$24125389$1$I$$20240710$20240723$20240723$EXP$$TH-ROCHE-10000031889$ROCHE$$58$YR$A$F$Y$$$20240723$$CN$TH$TH
241253901$24125390$1$I$20240716$20240718$20240723$20240723$EXP$$CO-ABBVIE-5846092$ABBVIE$$77$YR$$M$Y$$$20240723$$MD$CO$CO
241253912$24125391$2$F$20220101$20240723$20240723$20240726$EXP$$US-ABBVIE-5846250$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241253921$24125392$1$I$20240101$20240715$20240723$20240723$EXP$$JP-Vifor (International) Inc.-VIT-2024-06313$VIFOR$$88$YR$$F$Y$$$20240723$$HP$JP$JP
241253931$24125393$1$I$$20240717$20240723$20240723$EXP$$CA-Orion Corporation ORION PHARMA-24_00030938$ORION$$14$YR$T$F$Y$$$20240723$$MD$CA$
241253942$24125394$2$F$$20240723$20240723$20240730$PER$$US-BIOGEN-2024BI01272807$BIOGEN$$$$$F$Y$$$20240730$$CN$US$US
241253952$24125395$2$F$20240101$20240725$20240723$20240731$PER$$US-BIOGEN-2024BI01273815$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
241253961$24125396$1$I$20240619$20240709$20240723$20240723$EXP$FR-AFSSAPS-RE2024000650$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06568$HIKMA$$24$YR$$M$Y$133$KG$20240723$$MD$FR$FR
241253972$24125397$2$F$$20240722$20240723$20240729$EXP$$US-GSK-US2024089412$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241253982$24125398$2$F$$20240821$20240723$20240823$EXP$$CA-Orion Corporation ORION PHARMA-24_00030951$ORION$$76$YR$E$F$Y$$$20240823$$MD$CA$
241253991$24125399$1$I$$20240710$20240723$20240723$EXP$$UA-STRIDES ARCOLAB LIMITED-2024SP008943$STRIDES$Smiyan S, Koshak B, Komorovsky R, Slaba U, Bilukha A.. Diagnostic challenge of tuberculosis in systemic lupus erythematosus: a case report and literature review.. Rheumatol Int.. 2023;43(11):2131-2139$5$DEC$$F$Y$$$20240723$$HP$UA$UA
241254001$24125400$1$I$$20240717$20240723$20240723$EXP$$US-ROCHE-10000032029$ROCHE$$$$$$Y$$$20240723$$CN$US$US
241254011$24125401$1$I$$20240712$20240723$20240723$EXP$AU-TGA-808187$AU-Accord-435425$ACCORD$$27$YR$A$F$Y$$$20240723$$HP$AU$AU
241254021$24125402$1$I$$20240710$20240723$20240723$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008929$STRIDES$Okano H, Takagi M, Mukai K, Nishimura A, Asakawa K, Baba Y et al.. The Possibility of Acute Drug-Induced Liver Injury Associated With Prednisolone. Cureus. 2024;16(2):e54227$38$YR$$F$Y$$$20240723$$HP$JP$JP
241254031$24125403$1$I$$20240712$20240723$20240723$EXP$AU-TGA-805017$AU-Accord-435531$ACCORD$$3$YR$C$F$Y$$$20240723$$HP$AU$AU
241254041$24125404$1$I$20231010$20240711$20240723$20240723$EXP$AT-EMA-DD-20240709-7482661-092040$AT-Accord-436172$ACCORD$$60$YR$A$F$Y$80$KG$20240723$$MD$AT$AT
241254051$24125405$1$I$$20240628$20240723$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003089$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241254061$24125406$1$I$$20240710$20240723$20240723$EXP$$US-Accord-436036$ACCORD$$$$$F$Y$$$20240723$$HP$US$US
241254071$24125407$1$I$$20240712$20240723$20240723$EXP$CA-MHPD-E2B_001083688$CA-Accord-436107$ACCORD$$74$YR$E$M$Y$$$20240723$$HP$CA$CA
241254081$24125408$1$I$20240703$20240711$20240723$20240723$EXP$$US-Accord-435955$ACCORD$$50$YR$A$F$Y$$$20240723$$HP$US$US
241254095$24125409$5$F$20240627$20240827$20240723$20240906$EXP$$US-Accord-436284$ACCORD$$52$YR$A$M$Y$$$20240906$$HP$US$US
241254101$24125410$1$I$$20240715$20240723$20240723$EXP$$CA-APOTEX-2024AP008385$APOTEX$$73$YR$$F$Y$$$20240723$$CN$CA$CA
241254111$24125411$1$I$$20240712$20240723$20240723$EXP$CA-MHPD-E2B_07106150$CA-Accord-436051$ACCORD$$$$$F$Y$$$20240723$$CN$CA$CA
241254121$24125412$1$I$$20240713$20240723$20240723$EXP$AU-TGA-809309$AU-Accord-435602$ACCORD$$47$YR$A$M$Y$$$20240723$$HP$AU$
241254131$24125413$1$I$20240625$20240718$20240723$20240723$EXP$$US-BEH-2024175970$CSL BEHRING$$18$YR$A$F$Y$$$20240723$$CN$US$US
241254141$24125414$1$I$20201029$20240711$20240723$20240723$EXP$$IT-Accord-435876$ACCORD$Vittorio DM, Brigitta P, Alberto Z, Fabrizio Z, Paola T, Francesco B. COVID-19 and lupus nephritis exacerbation in unvaccinated patients: a clinical case and literature review. Italian Journal of Nephrology. 2024;3. DOI: 10.69097/41-03-2024-07.$28$YR$A$F$Y$$$20240723$$MD$IT$IT
241254151$24125415$1$I$20220101$20240712$20240723$20240723$EXP$$IN-Accord-435983$ACCORD$Sivagnanam H, Kumar PK, Velu KB, Viswanathan R. Mucormycosis-Associated Colon Perforation in the Early Postrenal Transplant Period. Indian Journal of Transplantation. 2024;18(2): 189-93.$32$YR$A$M$Y$$$20240723$$MD$IN$IN
241254161$24125416$1$I$$20240711$20240723$20240723$EXP$$US-Accord-436927$ACCORD$Lathiya MK, Errabelli P, Roy S, Mareedu N. Severe acute kidney injury due to oxalate crystal induced severe interstitial nephritis: A case report. World J Nephrol. 2024 Jun 25;13(2):93976. doi: 10.5527/wjn.v13.i2.93976.$71$YR$E$F$Y$76$KG$20240723$$MD$US$US
241254173$24125417$3$F$$20240910$20240723$20240919$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-17220$SAMSUNG BIOEPIS$$40$YR$A$F$Y$$$20240919$$CN$CA$CA
241254181$24125418$1$I$$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013008$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240723$$CN$US$US
241254191$24125419$1$I$$20240716$20240723$20240723$EXP$$IT-AMGEN-ITASP2024141843$AMGEN$Musolino A.; Casartelli C.; Tommasi C. et al.. Functional HRD by RAD51 identifies BRCAl VUS associated with loss of gene function and response to DNA-damaging agents. ESMO Open. 2024;9 (7):103629$66$YR$E$F$Y$$$20240723$$HP$IT$IT
241254201$24125420$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012479$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240723$$CN$US$US
241254211$24125421$1$I$20230901$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011643$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240723$$CN$US$US
241254221$24125422$1$I$20240719$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013205$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240723$$CN$US$US
241254231$24125423$1$I$20240719$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014266$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240723$$CN$US$US
241254241$24125424$1$I$$20240716$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202403006138$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240723$$PH$US$US
241254253$24125425$3$F$20190414$20240826$20240723$20240910$EXP$$CA-CELLTRION INC.-2023CA019883$CELLTRION$$$$$$Y$$$20240910$$CN$CA$CA
241254261$24125426$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013186$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240723$$CN$US$US
241254271$24125427$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013207$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240723$$CN$US$US
241254281$24125428$1$I$20240719$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013224$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240723$$CN$US$US
241254291$24125429$1$I$20240701$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013188$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240723$$CN$US$US
241254302$24125430$2$F$$20240724$20240723$20240727$PER$$US-AMGEN-USASP2024143867$AMGEN$$$$$F$Y$$$20240727$$CN$US$US
241254311$24125431$1$I$20240718$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143737$AMGEN$$80$YR$E$M$Y$$$20240723$$CN$US$US
241254321$24125432$1$I$$20240717$20240723$20240723$EXP$$US-AMGEN-USASP2024142373$AMGEN$$78$YR$E$M$Y$90$KG$20240723$$PH$US$US
241254331$24125433$1$I$$20240717$20240723$20240723$PER$$NVSC2024US147939$NOVARTIS$$$$$M$Y$$$20240723$$CN$US$US
241254341$24125434$1$I$$20240719$20240723$20240723$EXP$$NVSC2024AT150134$NOVARTIS$$$$$F$Y$$$20240723$$MD$AT$AT
241254351$24125435$1$I$20240101$20240715$20240723$20240723$EXP$$US-SA-2024SA142165$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240723$$CN$US$US
241254361$24125436$1$I$$20240713$20240723$20240723$EXP$$FR-TEVA-VS-3221578$TEVA$$$$$F$Y$$$20240723$$CN$FR$FR
241254371$24125437$1$I$20240716$20240719$20240723$20240723$EXP$$CN-ROCHE-10000031717$ROCHE$$51$YR$A$F$Y$58$KG$20240723$$HP$CN$CN
241254381$24125438$1$I$$20240718$20240723$20240723$30DAY$$US-GSK-US2024090786$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$CN$US$US
241254391$24125439$1$I$20240603$20240716$20240723$20240723$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003920$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
241254401$24125440$1$I$20220111$20240721$20240721$20240721$DIR$FDA-CDER-CTU-2024-50345$$FDA-CTU$$31$YR$$F$N$47$KG$20240721$N$CN$AU$
241254411$24125441$1$I$$20240715$20240723$20240723$EXP$NL-LRB-00981305$NL-NAARI PTE LIMITED-2024NP000070$NAARI PHARMA$$37$YR$$F$Y$95$KG$20240723$$CN$NL$NL
241254422$24125442$2$F$$20240807$20240723$20240814$EXP$NL-LRB-00981120$NL-SA-2024SA209946$SANOFI AVENTIS$$48$YR$A$M$Y$106$KG$20240814$$HP$NL$NL
241254432$24125443$2$F$$20240724$20240723$20240731$EXP$$US-SA-2024SA211861$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240731$$MD$US$US
241254441$24125444$1$I$20240621$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024141079$AMGEN$$62$YR$A$F$Y$$$20240723$$CN$US$US
241254451$24125445$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143262$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241254461$24125446$1$I$$20240715$20240723$20240723$EXP$$CA-AMGEN-CANNI2024144800$AMGEN$$$$$F$Y$$$20240723$$CN$CA$CA
241254471$24125447$1$I$$20240712$20240723$20240723$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008982$STRIDES$Liu H, Liu Y, Cao H, Liu Y.. An adult progressive Langerhans cell histiocytosis with central nervous system involvement for 10 years: A case report.. eNeurologicalSci.. 2023;32:1000471$35$YR$$F$Y$$$20240723$$HP$CN$CN
241254481$24125448$1$I$20240704$20240628$20240723$20240723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003082$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240723$$CN$US$US
241254501$24125450$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50403$$FDA-CTU$$63$YR$$F$N$$$20240722$N$$US$
241254511$24125451$1$I$20240717$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50419$$FDA-CTU$$54$YR$$F$N$$$20240722$N$HP$US$
241254521$24125452$1$I$$20240718$20240723$20240723$EXP$$US-JNJFOC-20240751142$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240723$$HP$US$US
241254531$24125453$1$I$20240719$20240722$20240723$20240723$EXP$$US-ROCHE-10000033598$ROCHE$$85$YR$E$F$Y$$$20240723$$CN$US$US
241254542$24125454$2$F$$20240724$20240723$20240830$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003946$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240830$$CN$US$US
241254551$24125455$1$I$$20240717$20240723$20240723$PER$$US-BAUSCHBL-2024BNL030264$BAUSCH AND LOMB$$$$$F$Y$$$20240723$$CN$US$US
241254561$24125456$1$I$$20240712$20240723$20240723$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008935$STRIDES$Kaneko Y, Hayashi S, Igawa K.. A case of hypocomplementemic urticarial vasculitis syndrome complicated by eosinophilic pneumonia: a case report and review of the literature. Journal of International Medical Research. 2023;51(7):1-5$8$DEC$$M$Y$$$20240723$$MD$JP$JP
241254571$24125457$1$I$20240629$20240711$20240723$20240723$EXP$IT-MINISAL02-993580$IT-TEVA-VS-3220519$TEVA$$25$YR$$F$Y$$$20240723$$MD$IT$IT
241254581$24125458$1$I$20240112$20240112$20240723$20240723$EXP$$CN-TEVA-VS-3147705$TEVA$$$$$$Y$$$20240723$$MD$CN$CN
241254591$24125459$1$I$$20240712$20240723$20240723$EXP$$CN-ROCHE-10000024958$ROCHE$$$$$F$Y$$$20240723$$MD$CN$CN
241254602$24125460$2$F$$20240828$20240723$20240919$EXP$$US-SA-2024SA213034$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240919$$MD$US$US
241254611$24125461$1$I$$20240501$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002796$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240718$$CN$US$US
241254621$24125462$1$I$$20240502$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002803$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241254631$24125463$1$I$20240101$20240613$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002813$STEMLINE THERAPEUTICS$$93$YR$E$F$Y$$$20240718$$CN$US$US
241254641$24125464$1$I$$20240502$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002826$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241254651$24125465$1$I$$20240502$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002833$STEMLINE THERAPEUTICS$$44$YR$A$F$Y$$$20240718$$CN$US$US
241254661$24125466$1$I$$20240503$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002847$STEMLINE THERAPEUTICS$$86$YR$E$F$Y$$$20240718$$CN$US$US
241254671$24125467$1$I$20240101$20240503$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002866$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$CN$US$US
241254681$24125468$1$I$$20240502$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002830$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240718$$CN$US$US
241254691$24125469$1$I$$20240614$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002831$STEMLINE THERAPEUTICS$$82$YR$E$F$Y$$$20240718$$CN$US$US
241254701$24125470$1$I$20240401$20240516$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002832$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241254711$24125471$1$I$$20240503$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002851$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241254721$24125472$1$I$$20240503$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002853$STEMLINE THERAPEUTICS$$84$YR$E$F$Y$$$20240718$$CN$US$US
241254731$24125473$1$I$$20240503$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002867$STEMLINE THERAPEUTICS$$87$YR$E$F$Y$$$20240718$$CN$US$US
241254741$24125474$1$I$$20240506$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002875$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241254751$24125475$1$I$$20240506$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002883$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241254761$24125476$1$I$$20240506$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002888$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241254771$24125477$1$I$$20240506$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002890$STEMLINE THERAPEUTICS$$38$YR$A$F$Y$$$20240718$$CN$US$US
241254781$24125478$1$I$$20240506$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002885$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241254791$24125479$1$I$$20240605$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002895$STEMLINE THERAPEUTICS$$30$YR$A$F$Y$$$20240718$$CN$US$US
241254801$24125480$1$I$20240101$20240515$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002897$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240718$$CN$US$US
241254811$24125481$1$I$$20240507$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002920$STEMLINE THERAPEUTICS$$89$YR$E$F$Y$$$20240718$$CN$US$US
241254821$24125482$1$I$$20240610$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002921$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240718$$CN$US$US
241254831$24125483$1$I$$20240507$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002927$STEMLINE THERAPEUTICS$$$$$F$Y$$$20240718$$CN$US$US
241254841$24125484$1$I$$20240613$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002929$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241254851$24125485$1$I$$20240517$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002940$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241254861$24125486$1$I$$20240520$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002950$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241254871$24125487$1$I$$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002959$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
241254881$24125488$1$I$$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002973$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240718$$CN$US$US
241254892$24125489$2$F$$20240726$20240723$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST002975$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240801$$CN$US$US
241254901$24125490$1$I$$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002976$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241254911$24125491$1$I$20240101$20240607$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002977$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
241254921$24125492$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002818$STEMLINE THERAPEUTICS$$78$YR$E$F$Y$$$20240718$$CN$US$US
241254931$24125493$1$I$$20240605$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002881$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$CN$US$US
241254941$24125494$1$I$$20240508$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002979$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241254951$24125495$1$I$20240101$20240613$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002991$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241254961$24125496$1$I$$20240610$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002988$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241254971$24125497$1$I$$20240603$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002996$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241254981$24125498$1$I$$20240507$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002943$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240718$$CN$US$US
241254991$24125499$1$I$$20240509$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002999$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240718$$CN$US$US
241255001$24125500$1$I$$20240509$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003000$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241255011$24125501$1$I$$20240613$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002998$STEMLINE THERAPEUTICS$$97$YR$E$F$Y$$$20240718$$CN$US$US
241255021$24125502$1$I$20240710$20240711$20240723$20240723$EXP$$US-Accord-435997$ACCORD$$72$YR$E$M$Y$$$20240723$$HP$US$US
241255031$24125503$1$I$$20240502$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002802$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241255041$24125504$1$I$$20240712$20240723$20240723$EXP$AU-TGA-805974$AU-Accord-435544$ACCORD$$$$$M$Y$$$20240723$$HP$AU$AU
241255051$24125505$1$I$20240522$20240711$20240723$20240723$EXP$ES-AEMPS-1546377$ES-Accord-436005$ACCORD$$80$YR$E$M$Y$$$20240723$$HP$ES$ES
241255061$24125506$1$I$$20240712$20240723$20240723$EXP$AU-TGA-806025$AU-Accord-435535$ACCORD$$59$YR$A$F$Y$$$20240723$$HP$AU$AU
241255071$24125507$1$I$$20240506$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002892$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241255081$24125508$1$I$$20240713$20240723$20240723$EXP$AU-TGA-809558$AU-Accord-435664$ACCORD$$42$YR$A$F$Y$$$20240723$$HP$AU$AU
241255091$24125509$1$I$20240709$20240712$20240723$20240723$EXP$GB-MHRA-MED-202407111401486780-PGRCW$GB-Accord-436091$ACCORD$$$$$M$Y$145$KG$20240723$$CN$GB$GB
241255101$24125510$1$I$$20240507$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002938$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240718$$CN$US$US
241255111$24125511$1$I$$20240509$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002993$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$CN$US$US
241255121$24125512$1$I$$20240504$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002863$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241255131$24125513$1$I$$20240520$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002869$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241255141$24125514$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50514$$FDA-CTU$$60$YR$$F$N$$$20240722$N$$US$
241255151$24125515$1$I$$20240713$20240723$20240723$EXP$AU-TGA-809429$AU-Accord-435605$ACCORD$$$$$$Y$$$20240723$$HP$AU$AU
241255161$24125516$1$I$20240707$20240712$20240723$20240723$EXP$$US-Accord-436338$ACCORD$$56$YR$A$F$Y$$$20240723$$HP$US$US
241255171$24125517$1$I$20240329$20240711$20240723$20240723$EXP$$CN-Accord-435852$ACCORD$$72$YR$E$M$Y$47$KG$20240723$$HP$CN$CN
241255192$24125519$2$F$$20240801$20240723$20240813$EXP$CA-MHPD-E2B_07101500$CA-Accord-436093$ACCORD$$50$YR$A$M$Y$$$20240813$$CN$CA$CA
241255201$24125520$1$I$$20240514$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003018$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240718$$CN$US$US
241255211$24125521$1$I$$20240604$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002990$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241255221$24125522$1$I$$20240607$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST002941$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241255231$24125523$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50422$$FDA-CTU$$39$YR$$M$N$$$20240722$N$$US$
241255241$24125524$1$I$20220615$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50378$$FDA-CTU$$55$YR$$F$N$284$LBS$20240722$N$$US$
241255254$24125525$4$F$20240717$20240830$20240723$20240902$PER$$US-JNJFOC-20240753194$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240902$$PH$US$US
241255261$24125526$1$I$20240601$20240718$20240723$20240723$EXP$$CN-SA-2024SA212726$SANOFI AVENTIS$$2$YR$C$F$Y$15$KG$20240723$$CN$CN$CN
241255271$24125527$1$I$20240722$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50377$$FDA-CTU$$29$YR$$F$N$77.5$KG$20240722$N$PH$US$
241255281$24125528$1$I$20240703$20240718$20240723$20240723$EXP$IT-MINISAL02-994992$IT-SA-2024SA211965$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240723$$MD$IT$IT
241255291$24125529$1$I$$20240715$20240723$20240723$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008968$STRIDES$Zhao Y, Ma HH, Wang D, Lian HY, Wang TY, Zhang R.. [Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis]. [Chinese].. Zhonghua-Er-Ke-Za-Zhi. 2024;62:60-65$0$YR$$M$Y$$$20240723$$HP$CN$CN
241255311$24125531$1$I$$20230710$20240723$20240723$EXP$$US-AstraZeneca-2023A158080$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241255321$24125532$1$I$$20230727$20240723$20240723$EXP$$US-AstraZeneca-2023A171834$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241255331$24125533$1$I$$20240521$20240723$20240723$30DAY$$DE-UCBSA-2024028138$UCB$$73$YR$$M$Y$$$20240723$$CN$DE$DE
241255341$24125534$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A165944$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241255351$24125535$1$I$$20240715$20240723$20240723$EXP$$HN-AstraZeneca-2024A160151$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$HN$
241255361$24125536$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161761$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241255371$24125537$1$I$$20210602$20240723$20240723$EXP$$ZA-AstraZeneca-2021A500466$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$ZA$
241255381$24125538$1$I$$20240718$20240723$20240723$EXP$$US-SA-2024SA213479$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240723$$CN$US$US
241255391$24125539$1$I$$20240715$20240723$20240723$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008970$STRIDES$Zhao Y, Ma HH, Wang D, Lian HY, Wang TY, Zhang R. [Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis]. [Chinese].. Zhonghua-Er-Ke-Za-Zhi. 2024;62:60-65$1$YR$$M$Y$$$20240723$$HP$CN$CN
241255401$24125540$1$I$20220301$20240124$20240723$20240723$EXP$FR-AFSSAPS-RS2023000952$FR-TEVA-VS-3151210$TEVA$$68$YR$$F$Y$66$KG$20240723$$MD$FR$FR
241255411$24125541$1$I$$20240719$20240723$20240723$EXP$$NVSC2024US150103$NOVARTIS$$62$YR$$F$Y$$$20240723$$HP$US$US
241255422$24125542$2$F$$20240904$20240723$20240913$EXP$$US-ASTELLAS-2024US020509$ASTELLAS$$53$YR$A$M$Y$$$20240913$$CN$US$US
241255431$24125543$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143488$AMGEN$$$$A$F$Y$$$20240723$$CN$US$US
241255441$24125544$1$I$$20240720$20240723$20240723$EXP$$EU-BAUSCHBL-2024BNL030361$BAUSCH AND LOMB$$85$YR$$F$Y$$$20240723$$MD$EU$EU
241255452$24125545$2$F$$20240814$20240723$20240825$EXP$$US-BAUSCHBL-2024BNL030165$BAUSCH AND LOMB$$$$$F$Y$$$20240826$$CN$US$US
241255461$24125546$1$I$$20240715$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008895$STRIDES$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series.. Clin-Transl-Gastroenterol. 2024;15 (3)$63$YR$$M$Y$$$20240723$$MD$US$US
241255471$24125547$1$I$$20240712$20240723$20240723$EXP$$IL-ROCHE-10000027699$ROCHE$$$$A$F$Y$$$20240723$$HP$IL$IL
241255481$24125548$1$I$$20240715$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008896$STRIDES$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series.. Clin-Transl-Gastroenterol. 2024;15 (3)$42$YR$$F$Y$$$20240723$$MD$US$US
241255492$24125549$2$F$$20240718$20240723$20240726$PER$$US-ABBVIE-5847085$ABBVIE$$25$YR$$F$Y$$$20240726$$HP$US$US
241255501$24125550$1$I$$20240712$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008936$STRIDES$Stellern JJ, Plaisted J, Welles C.. Disseminated nocardiosis with persistent neurological disease. BMJ Case Reports. 2024;17:e257935$$$$$Y$$$20240723$$HP$US$US
241255512$24125551$2$F$20231214$20240715$20240723$20240819$EXP$$GB-EXELIXIS-CABO-24074168$EXELIXIS$$55$YR$$F$Y$110$KG$20240818$$MD$GB$GB
241255522$24125552$2$F$20240711$20240812$20240723$20240812$PER$$US-ALXN-202407USA001108US$ALEXION PHARMACEUTICALS$$43$YR$$M$Y$$$20240812$$CN$US$US
241255531$24125553$1$I$$20240715$20240723$20240723$EXP$$IN-STERISCIENCE B.V.-2024-ST-001075$Steriscience PTE$Mehta RY, Rathod J, Chavda SD, Basiya DV. Maternal and Perinatal Outcome in Eclampsia: An Experience from Tertiary Care Teaching Hospital, a Prospective Observational Study.. Res-J-Med-Sci. 2024;18 (5):203-208$$$$F$Y$$$20240723$$HP$IN$IN
241255541$24125554$1$I$20240617$20240625$20240723$20240723$PER$$US-JNJFOC-20240674242$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$HP$US$US
241255553$24125555$3$F$20240101$20240905$20240723$20240910$EXP$$JP-JNJFOC-20240467503$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240910$$HP$JP$JP
241255561$24125556$1$I$20240719$20240722$20240723$20240723$PER$$US-HALEON-2188380$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241255575$24125557$5$F$20240711$20240906$20240723$20240911$EXP$$US-ROCHE-10000031048$ROCHE$$68$YR$E$M$Y$85$KG$20240911$$MD$US$US
241255581$24125558$1$I$20240601$20240722$20240723$20240723$PER$$US-AMGEN-USASP2024145595$AMGEN$$$$$F$Y$$$20240723$$HP$US$US
241255591$24125559$1$I$$20240713$20240723$20240723$EXP$$US-EMD Serono-2024038781$EMD SERONO INC$$$$A$F$Y$$$20240723$$MD$US$US
241255601$24125560$1$I$20240702$20240715$20240723$20240723$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159464$JIANGSU HANSOH PHARMACEUTICAL$$40$YR$$M$Y$65$KG$20240723$$MD$CN$CN
241255611$24125561$1$I$$20240708$20240723$20240723$EXP$$DE-CorePharma LLC-2159468$COREPHARMA$Full text article.$64$YR$$M$Y$$$20240723$$$DE$DE
241255621$24125562$1$I$$20240619$20240723$20240723$EXP$$KR-Appco Pharma LLC-2159465$APPCO PHARMA$Initial$77$YR$$F$Y$$$20240723$$$KR$KR
241255631$24125563$1$I$20240623$20240624$20240723$20240723$PER$$US-Oxford Pharmaceuticals, LLC-2159467$OXFORD PHARMACEUTICALS$$64$YR$$F$Y$$$20240723$$$US$US
241255641$24125564$1$I$20240702$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50350$$FDA-CTU$$41$YR$$F$N$147$LBS$20240722$Y$CN$US$
241255651$24125565$1$I$20240722$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50351$$FDA-CTU$$38$YR$$$N$$$20240722$N$PH$US$
241255661$24125566$1$I$20240722$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50372$$FDA-CTU$$81$YR$$F$N$$$20240722$N$HP$US$
241255671$24125567$1$I$$20240628$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003092$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241255681$24125568$1$I$$20240710$20240723$20240723$EXP$$PT-MSNLABS-2024MSNLIT01592$MSN LABORATORIES$Lobato CT, Castelo Branco S, Camoes J, Molinos E.Rhabdomyolysis secondary to a weight-loss prescription.BMJ Case Reports.2024;17(6):e258208$$$$$Y$$$20240723$$MD$PT$PT
241255691$24125569$1$I$$20240718$20240723$20240723$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010986$JAZZ$$$$$F$Y$$$20240723$$CN$US$US
241255701$24125570$1$I$$20240708$20240723$20240723$EXP$$IN-LUPIN LIMITED-2024-07004$LUPIN$$$$$$Y$$$20240723$$MD$IN$IN
241255711$24125571$1$I$20240709$20240715$20240723$20240723$EXP$$US-LEO Pharma-372053$LEO PHARM$$81$YR$$M$Y$$$20240723$$PH$US$US
241255722$24125572$2$F$20240712$20240808$20240723$20240814$EXP$$DE-EXELIXIS-XL18424079618$EXELIXIS$$$$$$Y$$$20240814$$MD$DE$DE
241255731$24125573$1$I$20220101$20240717$20240723$20240723$EXP$$DE-TAKEDA-2024TUS072188$TAKEDA$$48$YR$$M$Y$$$20240723$$HP$DE$DE
241255741$24125574$1$I$20210204$20240715$20240723$20240723$EXP$$CA-CELLTRION INC.-2023CA009612$CELLTRION$$$$$$Y$$$20240723$$CN$CA$CA
241255751$24125575$1$I$$20240711$20240723$20240723$PER$$US-TEVA-VS-3221209$TEVA$$$$A$F$Y$$$20240723$$PH$US$US
241255771$24125577$1$I$$20240709$20240723$20240723$EXP$$TH-ROCHE-10000032486$ROCHE$$73$YR$E$M$Y$$$20240723$$CN$TH$TH
241255781$24125578$1$I$$20240718$20240723$20240723$EXP$$US-AMGEN-USASP2024143234$AMGEN$$91$YR$E$F$Y$$$20240723$$CN$US$US
241255801$24125580$1$I$$20240717$20240723$20240723$EXP$$NVSC2024US148281$NOVARTIS$$64$YR$$F$Y$78.912$KG$20240723$$PH$US$US
241255811$24125581$1$I$20240718$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024143835$AMGEN$$53$YR$A$F$Y$$$20240723$$CN$US$US
241255821$24125582$1$I$20240417$20240718$20240723$20240723$EXP$$CA-JNJFOC-20240373342$JOHNSON AND JOHNSON$$53$YR$$F$Y$$$20240723$$HP$CA$CA
241255831$24125583$1$I$20240708$20240712$20240723$20240723$PER$$US-JNJFOC-20240737103$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240723$$CN$US$US
241255841$24125584$1$I$$20240719$20240723$20240723$EXP$$US-JNJFOC-20240752355$JOHNSON AND JOHNSON$$96$YR$E$F$Y$$$20240723$$CN$US$US
241255851$24125585$1$I$20240717$20240717$20240723$20240723$EXP$$US-JNJFOC-20240745870$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240723$$HP$US$US
241255861$24125586$1$I$$20240714$20240723$20240723$EXP$$CN-JNJFOC-20240752193$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240723$$HP$CN$CN
241255871$24125587$1$I$20240101$20240712$20240723$20240723$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14087$IPSEN$$68$YR$E$F$Y$$$20240723$$HP$US$US
241255882$24125588$2$F$$20240809$20240723$20240814$PER$$US-PFIZER INC-PV202400095062$PFIZER$$60$YR$$F$Y$$$20240814$$CN$US$US
241255891$24125589$1$I$$20240627$20240723$20240723$PER$$US-PFIZER INC-PV202400095043$PFIZER$$32$YR$$F$Y$$$20240723$$CN$US$US
241255902$24125590$2$F$20240405$20240822$20240723$20240822$PER$$US-PFIZER INC-PV202400094262$PFIZER$$16$YR$$M$Y$68.039$KG$20240822$$MD$US$US
241255911$24125591$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-202400219975$PFIZER$$63$YR$$F$Y$$$20240723$$CN$US$US
241255921$24125592$1$I$$20240718$20240723$20240723$EXP$$US-PFIZER INC-202400219644$PFIZER$$52$YR$$F$Y$$$20240723$$HP$US$US
241255931$24125593$1$I$20240705$20240715$20240723$20240723$EXP$BE-FAMHP-DHH-N2024-122384$BE-PFIZER INC-202400214805$PFIZER$$62$YR$$F$Y$$$20240723$$PH$BE$BE
241255941$24125594$1$I$20240701$20240718$20240723$20240723$EXP$$CA-PFIZER INC-202400219244$PFIZER$$94$YR$$M$Y$$$20240723$$PH$CA$CA
241255951$24125595$1$I$20240625$20240716$20240723$20240723$EXP$FR-AFSSAPS-CN2024000685$FR-PFIZER INC-202400218640$PFIZER$$74$YR$$M$Y$123$KG$20240723$$MD$FR$FR
241255961$24125596$1$I$$20240715$20240723$20240723$PER$$US-PFIZER INC-PV202400095008$PFIZER$$51$YR$$F$Y$$$20240723$$CN$US$US
241255971$24125597$1$I$$20240717$20240723$20240723$EXP$$CA-PFIZER INC-202400218652$PFIZER$$16$YR$$F$Y$52$KG$20240723$$HP$CA$CA
241255981$24125598$1$I$$20240717$20240723$20240723$EXP$$IN-PFIZER INC-PV202400075728$PFIZER$$49$YR$$M$Y$$$20240723$$CN$IN$IN
241255994$24125599$4$F$20240601$20240904$20240723$20240906$EXP$$US-ROCHE-10000028803$ROCHE$$65$YR$E$M$Y$131.54$KG$20240906$$CN$US$US
241256002$24125600$2$F$$20240802$20240723$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407010661$ELI LILLY AND CO$$$$$M$Y$$$20240809$$CN$JP$JP
241256011$24125601$1$I$$20240717$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407012070$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$US$US
241256023$24125602$3$F$$20240729$20240723$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009785$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240802$$CN$US$US
241256031$24125603$1$I$$20240719$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013641$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240723$$HP$US$US
241256041$24125604$1$I$20240101$20240717$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011303$ELI LILLY AND CO$$$$$M$Y$$$20240723$$CN$US$US
241256051$24125605$1$I$$20240717$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011327$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240723$$CN$US$US
241256061$24125606$1$I$20230815$20240710$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007161$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240723$$CN$US$US
241256072$24125607$2$F$$20240710$20240723$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407007470$ELI LILLY AND CO$$50$YR$A$$Y$$$20240724$$CN$US$US
241256081$24125608$1$I$$20240711$20240723$20240723$EXP$GB-MHRA-MED-202407111401592480-WVQST$GB-ELI_LILLY_AND_COMPANY-GB202407008263$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$GB$GB
241256101$24125610$1$I$$20240711$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008421$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240723$$CN$US$US
241256111$24125611$1$I$$20240710$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407006818$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$US$US
241256121$24125612$1$I$$20240710$20240723$20240723$EXP$GB-MHRA-MED-202407100737401910-PWYDJ$GB-ELI_LILLY_AND_COMPANY-GB202407007362$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240723$$CN$GB$GB
241256131$24125613$1$I$$20240710$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008324$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240723$$CN$US$US
241256151$24125615$1$I$$20240710$20240723$20240723$EXP$GB-MHRA-MED-202407101015201630-HVZTQ$GB-ELI_LILLY_AND_COMPANY-GB202407007373$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$GB$GB
241256162$24125616$2$F$20240603$20240806$20240723$20240813$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406005219$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240813$$CN$JP$JP
241256171$24125617$1$I$$20240710$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007101$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240723$$CN$US$US
241256181$24125618$1$I$20240709$20240710$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007124$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240723$$CN$US$US
241256191$24125619$1$I$$20240712$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008996$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240723$$CN$US$US
241256201$24125620$1$I$$20240710$20240723$20240723$PER$$US-MSNLABS-2024MSNSPO01574$MSN LABORATORIES$$$$$$Y$$$20240723$$CN$US$US
241256211$24125621$1$I$$20240628$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003093$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241256221$24125622$1$I$20231101$20240717$20240723$20240723$EXP$FR-AFSSAPS-TS2024000765$FR-CHEPLA-2024009170$CHEPLAPHARM$$78$YR$$F$Y$$$20240723$$MD$COUNTRY NOT SPECIFIED$FR
241256231$24125623$1$I$20231214$20240708$20240723$20240723$EXP$DE-SA-2024SA192552$DE-SERVIER-S24009022$SERVIER$$$$$$Y$$$20240723$$MD$DE$DE
241256251$24125625$1$I$$20240715$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008913$STRIDES$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series.. Clin-Transl-Gastroenterol. 2024;15 (3)$78$YR$$F$Y$$$20240723$$MD$US$US
241256261$24125626$1$I$$20240715$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008953$STRIDES$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series.. Clin-Transl-Gastroenterol. 2024;15(3)$55$YR$$M$Y$$$20240723$$MD$US$US
241256271$24125627$1$I$20240705$20240711$20240723$20240723$EXP$$US-Accord-435985$ACCORD$$42$YR$A$M$Y$$$20240723$$HP$US$US
241256281$24125628$1$I$$20240711$20240723$20240723$EXP$NL-LRB-00981024$NL-Accord-435946$ACCORD$$61$YR$A$F$Y$63$KG$20240723$$MD$NL$NL
241256291$24125629$1$I$$20240712$20240723$20240723$EXP$CA-MHPD-001085657$CA-Accord-436109$ACCORD$$75$YR$E$F$Y$$$20240723$$HP$CA$CA
241256301$24125630$1$I$$20240714$20240723$20240723$EXP$GB-MHRA-MED-202407141650513870-WRJLM$GB-Accord-436386$ACCORD$$$$$M$Y$$$20240723$$CN$GB$GB
241256311$24125631$1$I$$20240712$20240723$20240723$EXP$CA-MHPD-E2B_07106200$CA-Accord-436045$ACCORD$$70$YR$E$F$Y$$$20240723$$HP$CA$CA
241256321$24125632$1$I$$20240712$20240723$20240723$EXP$CA-MHPD-001085955$CA-Accord-436309$ACCORD$$71$YR$E$M$Y$$$20240723$$PH$CA$CA
241256331$24125633$1$I$$20240715$20240723$20240723$EXP$$JP-Accord-436121$ACCORD$Nakai T, Seki H, Makino A, Kadota Y, Kaburagi T, Okumura T, et al. Development of neuro-Behcet^s disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy: A case report. Breast disease. 2024;43(1):223-9. DOI: 10.3233/BD-230026.$40$YR$A$F$Y$$$20240723$$MD$JP$JP
241256341$24125634$1$I$$20240718$20240723$20240723$EXP$ES-EMA-2024713-AUTODUP-1720821861410$ES-Accord-436893$ACCORD$$$$$F$Y$$$20240723$$HP$ES$ES
241256351$24125635$1$I$$20240710$20240723$20240723$PER$$US-TEVA-VS-3221118$TEVA$$$$A$F$Y$$$20240723$$CN$US$US
241256361$24125636$1$I$$20240719$20240723$20240723$PER$$US-AstraZeneca-2024A165688$ASTRAZENECA$$$$$M$Y$$$20240723$$MD$US$
241256371$24125637$1$I$$20240713$20240723$20240723$EXP$GB-MHRA-MED-202407130706431500-HGQCM$GB-Accord-436366$ACCORD$$$$$$Y$$$20240723$$CN$GB$GB
241256381$24125638$1$I$$20240715$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008954$STRIDES$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series.. Clin-Transl-Gastroenterol. 2024;15(3)$69$YR$$F$Y$$$20240723$$MD$US$US
241256391$24125639$1$I$$20230126$20240723$20240723$PER$$US-BAYER-2024A105978$BAYER$$$$$F$Y$$$20240723$$HP$US$US
241256401$24125640$1$I$20230318$20230407$20240723$20240723$EXP$$US-AstraZeneca-2023A082871$ASTRAZENECA$$28971$DY$$M$Y$$$20240723$$CN$US$
241256411$24125641$1$I$20240712$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A165629$ASTRAZENECA$$22749$DY$$F$Y$$$20240723$$CN$US$
241256421$24125642$1$I$$20240713$20240723$20240723$EXP$AU-TGA-810199$AU-Accord-435659$ACCORD$$$$$$Y$$$20240723$$HP$AU$AU
241256431$24125643$1$I$$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A164703$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241256441$24125644$1$I$$20240715$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008949$STRIDES$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series.. Clin-Transl-Gastroenterol. 2024;15(3)$52$YR$$F$Y$$$20240723$$MD$US$US
241256452$24125645$2$F$$20240912$20240723$20240913$PER$$US-ALXN-202407USA001313US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
241256462$24125646$2$F$$20240801$20240723$20240807$EXP$$CN-AMGEN-CHNSP2024144409$AMGEN$Wenyu Y.; Xiaolan L.; Beibei Z. et al.. The safety and efficacy of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia in children. Natl Med J China. 2024;104 (27):2563-2567$$$$$Y$$$20240807$$HP$CN$CN
241256471$24125647$1$I$$20240715$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008951$STRIDES$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series.. Clin-Transl-Gastroenterol. 2024;15(3)$32$YR$$F$Y$$$20240723$$MD$US$US
241256483$24125648$3$F$20240702$20240911$20240723$20240913$EXP$$JP-PFIZER INC-202400219615$PFIZER$$77$YR$$M$Y$$$20240913$$HP$JP$JP
241256492$24125649$2$F$20240701$20240730$20240723$20240802$EXP$$KR-PFIZER INC-202400218288$PFIZER$$71$YR$$F$Y$70$KG$20240802$$CN$KR$KR
241256501$24125650$1$I$20200501$20240718$20240723$20240723$EXP$$US-PFIZER INC-PV202400095014$PFIZER$$59$YR$$F$Y$$$20240723$$HP$US$US
241256513$24125651$3$F$$20240914$20240723$20240916$EXP$$CA-PFIZER INC-202400213601$PFIZER$$70$YR$$M$Y$$$20240916$$HP$CA$CA
241256521$24125652$1$I$20240704$20240718$20240723$20240723$EXP$$CN-PFIZER INC-PV202400094446$PFIZER$$64$YR$$M$Y$$$20240723$$HP$CN$CN
241256531$24125653$1$I$$20240628$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003119$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241256541$24125654$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50532$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241256551$24125655$1$I$20240511$20240718$20240723$20240723$EXP$$GB-PFIZER INC-202400218547$PFIZER$$64$YR$$M$Y$78.2$KG$20240723$$MD$GB$GB
241256561$24125656$1$I$$20240718$20240723$20240723$EXP$$CA-PFIZER INC-202400219236$PFIZER$$99$YR$$M$Y$$$20240723$$PH$CA$CA
241256571$24125657$1$I$20240717$20240718$20240723$20240723$EXP$$CN-PFIZER INC-PV202400094476$PFIZER$$29$YR$$F$Y$56$KG$20240723$$HP$CN$CN
241256581$24125658$1$I$20240718$20240718$20240723$20240723$EXP$$CA-PFIZER INC-202200457462$PFIZER$$54$YR$$F$Y$52.2$KG$20240723$$MD$CA$CA
241256591$24125659$1$I$$20240718$20240723$20240723$EXP$$JP-PFIZER INC-202400219795$PFIZER$$89$YR$$F$Y$$$20240723$$MD$JP$JP
241256601$24125660$1$I$20240625$20240715$20240723$20240723$EXP$$FR-SHIONOGI, INC-2024001615$SHIONOGI$$$$$$Y$$$20240723$$MD$FR$FR
241256611$24125661$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50418$$FDA-CTU$$67$YR$$F$N$$$20240722$N$$US$
241256621$24125662$1$I$20220525$20240718$20240723$20240723$EXP$FR-AFSSAPS-PC2024000564$FR-PFIZER INC-202400218258$PFIZER$$40$YR$$F$Y$70$KG$20240723$$MD$FR$FR
241256631$24125663$1$I$20230526$20240718$20240723$20240723$EXP$$GB-PFIZER INC-202400218588$PFIZER$$73$YR$$F$Y$61$KG$20240723$$HP$GB$GB
241256641$24125664$1$I$$20240712$20240723$20240723$EXP$$DK-AUROBINDO-AUR-APL-2024-035672$AUROBINDO$Pedersen OS, Barkholt TO, Madsen SH, Rudolf F.. Tuberculosis immune reconstitution syndrome (TB-IRIS) followed by recurring lymphadenitis up to 8 years post-antituberculous treatment.. BMJ Case Reports.. 2024;17 (6)$$$A$F$Y$$$20240723$$HP$DK$DK
241256661$24125666$1$I$20230601$20240712$20240723$20240723$EXP$$SG-ROCHE-10000032930$ROCHE$$71$YR$E$M$Y$$$20240723$$CN$SG$SG
241256671$24125667$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000033353$ROCHE$$$$E$M$Y$$$20240723$$CN$US$US
241256681$24125668$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50388$$FDA-CTU$$39$YR$$$N$$$20240722$N$$US$
241256691$24125669$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50463$$FDA-CTU$$52$YR$$F$N$$$20240722$N$$US$
241256701$24125670$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50540$$FDA-CTU$$$$$F$N$$$20240719$N$HP$US$
241256711$24125671$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50409$$FDA-CTU$$69$YR$$F$N$$$20240722$N$$US$
241256721$24125672$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50387$$FDA-CTU$$77$YR$$F$N$219$LBS$20240722$N$$US$
241256731$24125673$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50516$$FDA-CTU$$69$YR$$F$N$$$20240722$N$$US$
241256741$24125674$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50416$$FDA-CTU$$69$YR$$F$N$$$20240722$N$$US$
241256751$24125675$1$I$$20240717$20240723$20240723$EXP$$US-GSK-US2024AMR090944$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
241256761$24125676$1$I$20240605$20240709$20240723$20240723$EXP$ES-AEMPS-1543196$ES-HIKMA PHARMACEUTICALS USA INC.-ES-H14001-24-06566$HIKMA$$52$YR$$F$Y$$$20240723$$MD$ES$ES
241256771$24125677$1$I$$20240715$20240723$20240723$EXP$$GB-AUROBINDO-AUR-APL-2024-035432$AUROBINDO$$$$$M$Y$$$20240723$$HP$GB$GB
241256781$24125678$1$I$20240501$20240712$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-035698$AUROBINDO$$80$YR$$M$Y$$$20240723$$MD$FR$FR
241256791$24125679$1$I$$20240715$20240723$20240723$EXP$$US-KEDRION-009537$KEDRION$Selmek K., Harding M. Kawasaki Disease. Pediatr Rev. 2024 Jul 1;45(7):425-427. doi: 10.1542/pir.2023-006051.$18$MON$$$Y$$$20240723$$MD$US$US
241256801$24125680$1$I$20240710$20240712$20240723$20240723$EXP$$TW-AMGEN-TWNSP2024142730$AMGEN$$$$E$F$Y$$$20240723$$HP$TW$TW
241256811$24125681$1$I$$20240711$20240723$20240723$PER$$US-TAKEDA-2024TUS073849$TAKEDA$$$$$$Y$$$20240723$$CN$US$US
241256822$24125682$2$F$$20240708$20240723$20240821$PER$$US-ROCHE-10000026464$ROCHE$$$$T$M$Y$52.16$KG$20240821$$CN$US$US
241256831$24125683$1$I$20240719$20240719$20240723$20240723$PER$$NVSC2024US150620$NOVARTIS$$81$YR$$F$Y$$$20240723$$MD$US$US
241256841$24125684$1$I$20240712$20240716$20240723$20240723$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700653$MYOVANT SCIENCES$$76$YR$$M$Y$$$20240723$$CN$US$US
241256851$24125685$1$I$$20240712$20240723$20240723$EXP$CA-MHPD-E2B_001084932$CA-Accord-436102$ACCORD$$58$YR$A$M$Y$$$20240723$$HP$CA$CA
241256861$24125686$1$I$20240710$20240711$20240723$20240723$EXP$$US-Accord-435999$ACCORD$$67$YR$E$M$Y$$$20240723$$PH$US$US
241256874$24125687$4$F$20240627$20240815$20240723$20240827$EXP$$US-Accord-436281$ACCORD$$58$YR$A$F$Y$$$20240827$$MD$US$US
241256881$24125688$1$I$20240101$20240711$20240723$20240723$EXP$CN-HENLIUS-24CN015861$CN-Accord-437525$ACCORD$$61$YR$A$F$Y$69$KG$20240723$$MD$CN$CN
241256891$24125689$1$I$$20240713$20240723$20240723$EXP$AU-TGA-805933$AU-Accord-435618$ACCORD$$61$YR$A$M$Y$$$20240723$$HP$AU$AU
241256901$24125690$1$I$$20240712$20240723$20240723$EXP$AU-TGA-804418$AU-Accord-435541$ACCORD$$80$YR$E$M$Y$$$20240723$$HP$AU$AU
241256912$24125691$2$F$20240709$20240820$20240723$20240831$EXP$$US-Accord-435968$ACCORD$$53$YR$A$M$Y$$$20240831$$HP$US$US
241256921$24125692$1$I$$20240711$20240723$20240723$EXP$$US-Accord-435888$ACCORD$Jackson JC, Sanchez D, Johns AC, Campbell MT, Aydin AM, Gokden N, et al. Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer. Journal of Clinical Medicine. 2024;13(12):3436.$28$YR$A$M$Y$$$20240723$$MD$US$US
241256931$24125693$1$I$$20240712$20240723$20240723$EXP$$IR-Accord-435984$ACCORD$Rahbar M, Latifi M, Pourhosein E, Mahmoudi E, Seyhoun I, Dehghani S. Long-term graft survival in a kidney transplant recipient with glioblastoma: Case report. Transplantation Reports. 2024;9(3):100158. DOI: 10.1016/j.tpr.2024.100158.$51$YR$A$F$Y$$$20240723$$MD$IR$IR
241256941$24125694$1$I$$20240712$20240723$20240723$EXP$AU-TGA-807368$AU-Accord-435517$ACCORD$$$$$M$Y$$$20240723$$HP$AU$AU
241256952$24125695$2$F$$20240723$20240723$20240729$PER$$US-HALEON-2188392$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241256961$24125696$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000033255$ROCHE$$$$T$F$Y$$$20240723$$CN$US$US
241256971$24125697$1$I$$20240716$20240723$20240723$EXP$$CA-APOTEX-2024AP008453$APOTEX$$41$YR$$F$Y$54$KG$20240723$$PH$CA$CA
241256981$24125698$1$I$$20240716$20240723$20240723$EXP$$JP-ARGENX-2024-ARGX-JP005585AA$ARGENX BVBA$$$$$$Y$$$20240723$$MD$JP$JP
241256991$24125699$1$I$20240101$20240717$20240723$20240723$EXP$IT-MINISAL02-995889$IT-009507513-2407ITA011566$MERCK$$39$YR$$F$Y$$$20240723$$MD$IT$IT
241257001$24125700$1$I$$20240711$20240723$20240723$EXP$$US-MYLANLABS-2024M1066587$MYLAN$Guck D, Mullholand J. Rescue Awake Venovenous Extracorporeal Membrane Oxygenation With Right Ventricular Support in Secondary to COVID-19, A Case Series. Am-J-Respir-Crit-Care-Med 2024; 209 A5562 (plus Poster).$55$YR$$F$Y$$$20240723$$HP$US$US
241257011$24125701$1$I$$20240712$20240723$20240723$EXP$$US-ORPHANEU-2024005410$RECORDATI$$$$$$Y$$$20240723$$CN$US$US
241257021$24125702$1$I$$20240710$20240723$20240723$EXP$$NL-MYLANLABS-2024M1066133$MYLAN$Ten Brinck MFM, Verheijen IWH, van de Wardt J, van Dijk GW, Nijhuis FAP, Verrips A. Dilated fixed pupils and respiratory failure: a rare clinical course of Lambert-Eaton myasthenic syndrome. BMJ-Neurol-Open 2023; 5 (2): 1-4.$62$YR$$F$Y$$$20240723$$HP$NL$NL
241257031$24125703$1$I$$20240712$20240723$20240723$EXP$$IT-MYLANLABS-2024M1066767$MYLAN$Mannini E, Misirocchi F, Lazzari S, Balella G, Bottignole D, Frapporti M, et al. Off-label use of cannabidiol in genetic epileptic and developmental encephalopathies: A case report. Epilepsy-Behav-Rep 2024; 27.$$$$F$Y$$$20240723$$HP$IT$IT
241257041$24125704$1$I$$20240711$20240723$20240723$EXP$$US-MYLANLABS-2024M1066213$MYLAN$Mahmoud A, Amir A, Bangash H, Ayaz S. Pasteurella Multocida-induced Empyema in an Immunocompromised Patient - A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$70$YR$$M$Y$$$20240723$$HP$US$US
241257051$24125705$1$I$$20240711$20240723$20240723$EXP$$US-MYLANLABS-2024M1066551$MYLAN$Acharya R, Clapp W, Upadhyay K. Safety and Efficacy of Very Early Conversion to Belatacept in Pediatric Kidney Transplantation with Transplant-Associated Thrombotic Microangiopathy: Case Study and Review of Literature. Clinics-Practice 2024; 14 (3): 882-891.$17$YR$$M$Y$$$20240723$$HP$US$US
241257061$24125706$1$I$$20240710$20240723$20240723$EXP$$IT-MYLANLABS-2024M1066600$MYLAN$Carta A, Cavassa V, Puci MV, Averna R, Sotgiu G, Valeri G, et al. Treatment of Aggressive Behavior and Agitation in an 11-Year-Old Boy with Co-Occurring Autism and ADHD: A Case Report and Literature Review on the Use of Intravenous Valproate in Emergency Psychiatry. J-Clin-Med 2024; 13 (12): 1-22.$11$YR$$M$Y$$$20240723$$HP$IT$IT
241257071$24125707$1$I$$20240715$20240723$20240723$30DAY$$US-GSK-US2024088642$GLAXOSMITHKLINE$$$$$M$Y$$$20240723$$CN$US$US
241257081$24125708$1$I$$20240711$20240723$20240723$EXP$$US-MYLANLABS-2024M1066550$MYLAN$Bhanot N, Sokos GG, Benza RL, Murali S. Concomitant cat scratch disease and squamous cell carcinoma in a cardiac transplant. Infect-Dis-Rep 2012; 4 3-5.$65$YR$$M$Y$$$20240723$$HP$US$US
241257091$24125709$1$I$20240615$20240715$20240723$20240723$30DAY$$US-GSK-US2024088652$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240723$$CN$US$US
241257101$24125710$1$I$$20240712$20240723$20240723$EXP$$IT-AUROBINDO-AUR-APL-2024-035506$AUROBINDO$Tondulli, L. A RARE CASE OF PULMONARY VASCULITIS DUE TO NEW ANTIANGIOGENIC DRUGS.. Annals of Oncology.. 2009;20 (Suppl 5)$67$YR$$F$Y$$$20240723$$HP$IT$IT
241257121$24125712$1$I$20240701$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50498$$FDA-CTU$$39$YR$$$N$$$20240722$N$$US$
241257131$24125713$1$I$20231201$20240715$20240723$20240723$EXP$$FR-AUROBINDO-AUR-APL-2024-035782$AUROBINDO$$7$YR$$M$Y$$$20240723$$MD$FR$FR
241257141$24125714$1$I$$20240716$20240723$20240723$EXP$$US-BEH-2024175861$CSL BEHRING$$$$$F$Y$$$20240723$$CN$US$US
241257151$24125715$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50515$$FDA-CTU$$64$YR$$F$N$$$20240722$N$$US$
241257161$24125716$1$I$20240201$20240716$20240723$20240723$EXP$$CA-Orion Corporation ORION PHARMA-24_00030354$ORION$$59$YR$A$F$Y$$$20240723$$MD$CA$
241257171$24125717$1$I$20240714$20240719$20240723$20240723$PER$$NVSC2024US149858$NOVARTIS$$42$YR$$M$Y$$$20240723$$CN$US$US
241257181$24125718$1$I$20240604$20240711$20240723$20240723$EXP$$US-Accord-435987$ACCORD$$8$YR$C$$Y$$$20240723$$HP$US$US
241257191$24125719$1$I$20240613$20240712$20240723$20240723$EXP$$US-Accord-435853$ACCORD$$54$YR$A$M$Y$$$20240723$$HP$US$US
241257201$24125720$1$I$$20240712$20240723$20240723$EXP$GB-MHRA-MED-202407121609474360-QJFYN$GB-Accord-436071$ACCORD$$45$YR$A$F$Y$$$20240723$$CN$GB$GB
241257211$24125721$1$I$$20240712$20240723$20240723$EXP$CA-MHPD-001084539$CA-Accord-436110$ACCORD$$79$YR$E$F$Y$$$20240723$$HP$CA$CA
241257221$24125722$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50382$$FDA-CTU$$64$YR$$F$N$$$20240722$N$$US$
241257231$24125723$1$I$$20240712$20240723$20240723$EXP$AU-TGA-805259$AU-Accord-435519$ACCORD$$59$YR$A$M$Y$$$20240723$$HP$AU$AU
241257241$24125724$1$I$$20240712$20240723$20240723$EXP$CA-MHPD-E2B_07106363$CA-Accord-436100$ACCORD$$67$YR$E$M$Y$$$20240723$$MD$CA$CA
241257251$24125725$1$I$20240708$20240712$20240723$20240723$EXP$$US-Accord-436306$ACCORD$$32$YR$A$M$Y$$$20240723$$PH$US$US
241257261$24125726$1$I$$20240712$20240723$20240723$EXP$AU-TGA-805021$AU-Accord-435529$ACCORD$$12$YR$T$M$Y$$$20240723$$HP$AU$AU
241257271$24125727$1$I$$20240712$20240723$20240723$EXP$CA-MHPD-E2B_07106159$CA-Accord-436041$ACCORD$$53$YR$A$M$Y$70$KG$20240723$$CN$CA$CA
241257281$24125728$1$I$$20240712$20240723$20240723$EXP$CA-MHPD-001084159$CA-Accord-436103$ACCORD$$62$YR$A$M$Y$130$KG$20240723$$HP$CA$CA
241257291$24125729$1$I$$20240712$20240723$20240723$EXP$AU-TGA-804464$AU-Accord-435540$ACCORD$$75$YR$E$F$Y$$$20240723$$HP$AU$AU
241257301$24125730$1$I$$20240712$20240723$20240723$EXP$AU-TGA-808005$AU-Accord-435435$ACCORD$$$$$F$Y$$$20240723$$HP$AU$AU
241257312$24125731$2$F$$20240727$20240723$20240807$EXP$CA-APOTEX-2024AP008259$CA-Accord-437380$ACCORD$$55$YR$A$M$Y$$$20240807$$HP$CA$CA
241257321$24125732$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116584$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$JP$JP
241257331$24125733$1$I$20240529$20240718$20240723$20240723$EXP$FR-AFSSAPS-MA2024000993$FR-PFIZER INC-202400219483$PFIZER$$56$YR$$F$Y$$$20240723$$MD$FR$FR
241257341$24125734$1$I$20240717$20240719$20240723$20240723$EXP$$CN-PFIZER INC-PV202400094910$PFIZER$$34$YR$$F$Y$64.5$KG$20240723$$HP$CN$CN
241257351$24125735$1$I$$20240719$20240723$20240723$EXP$$US-PFIZER INC-PV202400094886$PFIZER$$6$MON$$F$Y$$$20240723$$HP$US$US
241257363$24125736$3$F$20240709$20240805$20240723$20240806$EXP$$TW-PFIZER INC-PV202400095326$PFIZER$$$$A$F$Y$$$20240806$$HP$TW$TW
241257371$24125737$1$I$20240718$20240719$20240723$20240723$EXP$$CO-PFIZER INC-PV202400095501$PFIZER$$88$YR$$F$Y$$$20240723$$CN$CO$CO
241257382$24125738$2$F$20230627$20240820$20240723$20240822$EXP$$JP-PFIZER INC-PV202400095114$PFIZER$$66$YR$$F$Y$$$20240822$$MD$JP$JP
241257393$24125739$3$F$20240101$20240819$20240723$20240821$EXP$$US-PFIZER INC-202400219779$PFIZER$$60$YR$$F$Y$56.7$KG$20240821$$CN$US$US
241257401$24125740$1$I$$20240712$20240723$20240723$EXP$AU-TGA-807803$AU-Accord-435558$ACCORD$$45$YR$A$M$Y$$$20240723$$HP$AU$AU
241257411$24125741$1$I$20240101$20240717$20240723$20240723$EXP$$US-ABBVIE-5845871$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241257421$24125742$1$I$20240719$20240719$20240723$20240723$EXP$GB-MHRA-MED-202407191507001060-NWJBD$GB-PFIZER INC-202400219278$PFIZER$$24$YR$$F$Y$$$20240723$$HP$GB$GB
241257431$24125743$1$I$20240713$20240719$20240723$20240723$EXP$$CN-PFIZER INC-PV202400094979$PFIZER$$92$YR$$M$Y$$$20240723$$HP$CN$CN
241257441$24125744$1$I$20240616$20240719$20240723$20240723$EXP$$CN-PFIZER INC-PV202400094946$PFIZER$$37$YR$$F$Y$45$KG$20240723$$HP$CN$CN
241257451$24125745$1$I$$20240709$20240723$20240723$EXP$$SG-ROCHE-10000032012$ROCHE$$60$YR$A$F$Y$$$20240723$$CN$SG$SG
241257461$24125746$1$I$20240501$20240717$20240723$20240723$EXP$$CN-ABBVIE-5845940$ABBVIE$$61$YR$$M$Y$73$KG$20240723$$MD$CN$CN
241257481$24125748$1$I$20240601$20240716$20240723$20240723$PER$$US-ABBVIE-5847326$ABBVIE$$42$YR$$F$Y$$$20240723$$CN$US$US
241257491$24125749$1$I$20240606$20240722$20240723$20240723$EXP$GB-MHRA-31205853$GB-ABBVIE-5848655$ABBVIE$$48$YR$$M$Y$86$KG$20240723$$CN$GB$GB
241257504$24125750$4$F$20240330$20240808$20240723$20240810$EXP$$CA-ABBVIE-5845329$ABBVIE$$38$YR$$M$Y$105.4$KG$20240810$$MD$CA$CA
241257521$24125752$1$I$20240201$20240628$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003087$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240723$$CN$US$US
241257531$24125753$1$I$$20240710$20240723$20240723$EXP$$CA-TEVA-VS-3222849$TEVA$$19$YR$$M$Y$98$KG$20240723$$HP$CA$CA
241257541$24125754$1$I$20200503$20240718$20240723$20240723$EXP$PL-URPL-1-3709-2020$PL-CHEPLA-2024009129$CHEPLAPHARM$$26$YR$A$F$Y$53$KG$20240723$$MD$COUNTRY NOT SPECIFIED$PL
241257551$24125755$1$I$20230301$20240717$20240723$20240723$EXP$$BR-BIOGEN-2024BI01274682$BIOGEN$$46$YR$$F$Y$85$KG$20240723$$CN$BR$BR
241257571$24125757$1$I$$20221024$20240723$20240723$EXP$$NVSC2022CL304829$NOVARTIS$$$$$F$Y$$$20240723$$MD$CL$CL
241257581$24125758$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024142618$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241257591$24125759$1$I$$20240612$20240723$20240723$EXP$$CA-AMGEN-CANNI2024047269$AMGEN$$20$YR$A$F$Y$$$20240723$$CN$CA$CA
241257602$24125760$2$F$$20240814$20240723$20240821$EXP$$FR-TAKEDA-2024TUS069557$TAKEDA$$$$E$F$Y$$$20240821$$CN$FR$FR
241257611$24125761$1$I$20240510$20240613$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003026$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241257621$24125762$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003029$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240718$$CN$US$US
241257631$24125763$1$I$$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003033$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241257641$24125764$1$I$$20240510$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003042$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240718$$CN$US$US
241257651$24125765$1$I$$20240607$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003050$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241257661$24125766$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003065$STEMLINE THERAPEUTICS$$90$YR$E$F$Y$$$20240718$$CN$US$US
241257671$24125767$1$I$20240101$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003066$STEMLINE THERAPEUTICS$$48$YR$A$F$Y$$$20240718$$CN$US$US
241257681$24125768$1$I$$20240514$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003076$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241257691$24125769$1$I$$20240514$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003096$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241257701$24125770$1$I$$20240514$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003097$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241257711$24125771$1$I$$20240514$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003082$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241257721$24125772$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003093$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241257731$24125773$1$I$$20240514$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003101$STEMLINE THERAPEUTICS$$51$YR$A$M$Y$$$20240718$$CN$US$US
241257741$24125774$1$I$20240501$20240611$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003126$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240718$$CN$US$US
241257761$24125776$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003074$STEMLINE THERAPEUTICS$$78$YR$E$F$Y$$$20240718$$CN$US$US
241257771$24125777$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003120$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241257781$24125778$1$I$$20240516$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003145$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241257791$24125779$1$I$20240101$20240516$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003155$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241257801$24125780$1$I$20240501$20240516$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003160$STEMLINE THERAPEUTICS$$44$YR$A$F$Y$$$20240718$$CN$US$US
241257811$24125781$1$I$$20240517$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003164$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241257821$24125782$1$I$$20240516$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003144$STEMLINE THERAPEUTICS$$34$YR$A$F$Y$$$20240718$$CN$US$US
241257831$24125783$1$I$20240101$20240517$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003181$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241257841$24125784$1$I$$20240518$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003188$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240718$$CN$US$US
241257851$24125785$1$I$$20240518$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003189$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241257861$24125786$1$I$$20240520$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003201$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241257871$24125787$1$I$$20240514$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003113$STEMLINE THERAPEUTICS$$52$YR$A$F$Y$$$20240718$$CN$US$US
241257881$24125788$1$I$$20240520$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003212$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241257891$24125789$1$I$$20240520$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003220$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
241257901$24125790$1$I$20240513$20240515$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003139$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241257911$24125791$1$I$$20240615$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003242$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241257921$24125792$1$I$$20240515$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003138$STEMLINE THERAPEUTICS$$51$YR$A$F$Y$$$20240718$$CN$US$US
241257931$24125793$1$I$20240501$20240603$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003243$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241257941$24125794$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003237$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241257951$24125795$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003247$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241257961$24125796$1$I$$20240522$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003239$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241257971$24125797$1$I$$20240610$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003046$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240718$$CN$US$US
241257981$24125798$1$I$20240510$20240609$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003157$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
241257991$24125799$1$I$20240527$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003255$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240718$$CN$US$US
241258001$24125800$1$I$20210619$20240708$20240723$20240723$EXP$$FR-SERVIER-S21007374$SERVIER$$$$$$Y$$$20240723$$MD$FR$FR
241258011$24125801$1$I$$20240515$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003132$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240718$$CN$US$US
241258021$24125802$1$I$20231201$20240719$20240723$20240723$EXP$$CA-UCBSA-2024002798$UCB$$53$YR$$F$Y$$$20240723$$CN$CA$CA
241258031$24125803$1$I$$20240520$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003204$STEMLINE THERAPEUTICS$$29$YR$A$F$Y$$$20240718$$CN$US$US
241258041$24125804$1$I$$20240520$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003215$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241258051$24125805$1$I$$20240715$20240723$20240723$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008907$STRIDES$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series.. Clin-Transl-Gastroenterol. 2024;15(3)$27$YR$$M$Y$$$20240723$$MD$US$US
241258061$24125806$1$I$20220101$20240722$20240723$20240723$EXP$SE-SEMPA-2024-005587$SE-UCBSA-2024036904$UCB$$30$YR$$F$Y$63$KG$20240723$$MD$SE$SE
241258071$24125807$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003246$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240718$$CN$US$US
241258081$24125808$1$I$20240330$20240711$20240723$20240723$EXP$GB-MHRA-MED-202407111234376400-YVZLN$GB-TEVA-VS-3220386$TEVA$$$$$F$Y$$$20240723$$CN$GB$GB
241258091$24125809$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161486$ASTRAZENECA$$$$$M$Y$$$20240723$$HP$US$
241258101$24125810$1$I$$20240517$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003165$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240718$$CN$US$US
241258111$24125811$1$I$$20240521$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003248$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241258131$24125813$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003061$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241258141$24125814$1$I$20231030$20240710$20240723$20240723$EXP$IT-MINISAL02-993559$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06621$HIKMA$$67$YR$$F$Y$$$20240723$$MD$IT$IT
241258151$24125815$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116009$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240723$$CN$US$US
241258161$24125816$1$I$20240717$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116337$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240723$$CN$US$US
241258171$24125817$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116877$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240723$$CN$US$US
241258181$24125818$1$I$$20240513$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003067$STEMLINE THERAPEUTICS$$88$YR$E$F$Y$$$20240718$$CN$US$US
241258191$24125819$1$I$$20240520$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003209$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241258201$24125820$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003234$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$CN$US$US
241258211$24125821$1$I$$20240722$20240723$20240723$EXP$$US-PFIZER INC-202400220897$PFIZER$$$$$F$Y$$$20240723$$MD$US$US
241258222$24125822$2$F$20240601$20240812$20240723$20240813$EXP$$AR-PFIZER INC-202400201514$PFIZER$$64$YR$$F$Y$$$20240813$$CN$AR$AR
241258231$24125823$1$I$$20240710$20240723$20240723$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008923$STRIDES$Meng Y, Duan X, Liu J.. Immunoglobulin G4-Related Disease Complicating Ruptured Isolated Iliac Artery Aneurysm: A Complex Management Dilemma.. American Journal of Case Reports. 2024;25:e942727$63$YR$$F$Y$$$20240723$$HP$CN$CN
241258241$24125824$1$I$20240325$20240722$20240723$20240723$EXP$ES-AEMPS-1550309$ES-PFIZER INC-202400220441$PFIZER$$51$YR$$F$Y$$$20240723$$HP$ES$ES
241258251$24125825$1$I$$20240611$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003207$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241258261$24125826$1$I$20240701$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116324$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$79$KG$20240723$$PH$US$US
241258271$24125827$1$I$$20240719$20240723$20240723$EXP$$ZA-PFIZER INC-202400219309$PFIZER$$34$YR$$F$Y$$$20240723$$MD$ZA$ZA
241258282$24125828$2$F$20240701$20240806$20240723$20240808$EXP$$US-PFIZER INC-PV202300174655$PFIZER$$61$YR$$F$Y$61.235$KG$20240808$$HP$US$US
241258291$24125829$1$I$$20240719$20240723$20240723$EXP$$US-PFIZER INC-202300316641$PFIZER$$77$YR$$M$Y$$$20240723$$MD$US$US
241258301$24125830$1$I$$20240712$20240723$20240723$EXP$$US-ORPHANEU-2024005439$RECORDATI$$$$$$Y$$$20240723$$CN$US$US
241258311$24125831$1$I$$20240719$20240723$20240723$EXP$$CO-PFIZER INC-PV202400095462$PFIZER$$$$$M$Y$$$20240723$$MD$CO$CO
241258331$24125833$1$I$$20240710$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014048$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240723$$CN$US$US
241258341$24125834$1$I$20240706$20240719$20240723$20240723$EXP$$ES-PFIZER INC-202400220451$PFIZER$$64$YR$$F$Y$$$20240723$$PH$ES$ES
241258352$24125835$2$F$20240718$20240719$20240723$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407013198$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240725$$CN$US$US
241258361$24125836$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014315$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240723$$CN$US$US
241258371$24125837$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014162$ELI LILLY AND CO$$74$YR$E$$Y$$$20240723$$CN$US$US
241258381$24125838$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50543$$FDA-CTU$$63$YR$$F$N$$$20240722$N$$US$
241258391$24125839$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50384$$FDA-CTU$$34$YR$$F$N$350$LBS$20240722$N$$US$
241258401$24125840$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013223$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240723$$CN$US$US
241258411$24125841$1$I$20191001$20240710$20240723$20240723$EXP$$HU-ELI_LILLY_AND_COMPANY-HU202407009194$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240723$$CN$HU$HU
241258421$24125842$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50385$$FDA-CTU$$77$YR$$F$N$230$LBS$20240722$N$$US$
241258431$24125843$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50414$$FDA-CTU$$68$YR$$M$N$$$20240722$N$$US$
241258441$24125844$1$I$$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012262$ELI LILLY AND CO$$18$YR$A$F$Y$$$20240723$$CN$US$US
241258451$24125845$1$I$20240716$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011686$ELI LILLY AND CO$$$$$M$Y$$$20240723$$CN$US$US
241258461$24125846$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013001$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240723$$CN$US$US
241258471$24125847$1$I$$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011976$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240723$$CN$US$US
241258482$24125848$2$F$$20240719$20240723$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407013339$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240726$$CN$US$US
241258511$24125851$1$I$$20240716$20240723$20240723$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407011450$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240723$$CN$NL$JP
241258521$24125852$1$I$$20240629$20240723$20240723$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003170$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241258531$24125853$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024141631$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241258541$24125854$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013314$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240723$$CN$US$US
241258551$24125855$1$I$$20240627$20240723$20240723$PER$$US-AMGEN-USASP2024145290$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241258562$24125856$2$F$20240101$20240813$20240723$20240828$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01045$AVADEL CNS PHARMA$$$$$F$Y$75.9$KG$20240828$$CN$US$US
241258571$24125857$1$I$20240701$20240717$20240723$20240723$EXP$$US-ABBVIE-5845866$ABBVIE$$59$YR$$F$Y$$$20240723$$CN$US$US
241258582$24125858$2$F$$20240829$20240723$20240910$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06710$HIKMA$$$$$M$Y$$$20240906$$MD$US$US
241258602$24125860$2$F$20240705$20240902$20240723$20240903$EXP$$NL-ABBVIE-5848427$ABBVIE$$62$YR$$F$Y$$$20240903$$CN$NL$NL
241258611$24125861$1$I$$20240715$20240723$20240723$EXP$$TR-MYLANLABS-2024M1067542$MYLAN$Visneci EF, Aydin T, Tekin FC, Acar D. A Case of Pulmonary Embolism after Receiving a Dose of Sildenafil. Akad-Acil-Tip-Olgu-Sunum-Dergisi 2024; 15 (2): 53-55.$81$YR$$M$Y$$$20240723$$HP$TR$TR
241258621$24125862$1$I$$20240710$20240723$20240723$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP008976$STRIDES$Nadaf Z, Upadhya P, A J, et al.. Cocaine-Induced Steroid Resistant Organising Pneumonia in a Young Male: The Lows of Getting High.. Cureus. 2023;15(10):e46923$21$YR$$M$Y$$$20240723$$HP$IN$IN
241258631$24125863$1$I$20240717$20240719$20240723$20240723$EXP$$US-GILEAD-2024-0681525$GILEAD$$83$YR$E$F$Y$$$20240723$$CN$US$US
241258642$24125864$2$F$20240501$20240820$20240723$20240904$PER$$US-GRANULES-US-2024GRASPO00279$GRANULES INDIA$$57$YR$A$M$Y$195$KG$20240904$$CN$US$US
241258651$24125865$1$I$$20240714$20240723$20240723$EXP$$EG-ROCHE-10000026836$ROCHE$$24$YR$A$F$Y$65$KG$20240723$$CN$EG$EG
241258661$24125866$1$I$20240710$20240717$20240723$20240723$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090059$VIIV$$56$YR$$M$Y$$$20240723$$HP$US$US
241258671$24125867$1$I$$20240717$20240723$20240723$EXP$$US-INCYTE CORPORATION-2024IN007564$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241258681$24125868$1$I$$20240717$20240723$20240723$EXP$$US-GILEAD-2024-0681245$GILEAD$$$$E$M$Y$$$20240723$$CN$US$US
241258691$24125869$1$I$$20240710$20240723$20240723$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008900$STRIDES$Ogasawara Y, Ito N, Kogiso T, Yoshizawa S, Nagashima Y, Tokushige K. A case of neuroendocrine carcinoma with massive invasion to the liver and multiorgan causing acute liver failure.. Clin J Gastroenterol. 2023;16(4):580-587.$56$YR$$M$Y$$$20240723$$HP$JP$JP
241258701$24125870$1$I$20240703$20240708$20240723$20240723$EXP$$US-ALKERMES INC.-ALK-2024-001874$ALKERMES$$62$YR$$M$Y$$$20240723$$CN$US$US
241258713$24125871$3$F$$20240829$20240723$20240904$EXP$$DE-MYLANLABS-2024M1066718$MYLAN$Brueckner I, Welter-Luedeke J ,Zangl A, Graw M, Paul LD et,al.. Alpha-Pyrrolidinohexanophenone Alpha-PHP) vs.Alpha-pyrrolidinoisohexanophenone (Alpha-iHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology.. 2024;48:299-313$36$YR$$F$Y$$$20240904$$HP$DE$DE
241258721$24125872$1$I$$20240717$20240723$20240723$EXP$$US-INCYTE CORPORATION-2024IN007536$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241258731$24125873$1$I$$20240711$20240723$20240723$EXP$$SG-ROCHE-10000030269$ROCHE$$49$YR$A$F$Y$$$20240723$$CN$SG$SG
241258741$24125874$1$I$$20240722$20240723$20240723$PER$$NVSC2024US150480$NOVARTIS$$$$$F$Y$$$20240723$$HP$US$US
241258761$24125876$1$I$$20240717$20240723$20240723$EXP$$CA-TAKEDA-2024TUS072884$TAKEDA$$$$$F$Y$$$20240723$$CN$CA$CA
241258771$24125877$1$I$$20240716$20240723$20240723$EXP$$US-TAKEDA-2024TUS072662$TAKEDA$$$$$$Y$$$20240723$$CN$US$US
241258781$24125878$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-PV202400095186$PFIZER$$72$YR$$F$Y$$$20240723$$CN$US$US
241258791$24125879$1$I$20240603$20240719$20240723$20240723$PER$$US-PFIZER INC-202400198078$PFIZER$$79$YR$$M$Y$$$20240723$$MD$US$US
241258802$24125880$2$F$20240715$20240918$20240723$20240919$PER$$US-PFIZER INC-202400217858$PFIZER$$60$YR$$M$Y$115.65$KG$20240919$$CN$US$US
241258811$24125881$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-202400221058$PFIZER$$50$YR$$M$Y$$$20240723$$HP$US$US
241258821$24125882$1$I$$20240717$20240723$20240723$PER$$US-PFIZER INC-202400218931$PFIZER$$51$YR$$F$Y$$$20240723$$HP$US$US
241258841$24125884$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-PV202400095270$PFIZER$$$$E$F$Y$$$20240723$$CN$US$US
241258851$24125885$1$I$$20240717$20240723$20240723$PER$$US-PFIZER INC-202400217725$PFIZER$$37$YR$$M$Y$104.33$KG$20240723$$PH$US$US
241258861$24125886$1$I$20240717$20240718$20240723$20240723$PER$$US-PFIZER INC-202400208937$PFIZER$$69$YR$$M$Y$$$20240723$$HP$US$US
241258871$24125887$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-202400219853$PFIZER$$15$YR$$F$Y$$$20240723$$HP$US$US
241258881$24125888$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-PV202400095210$PFIZER$$36$YR$$M$Y$$$20240723$$HP$US$US
241258895$24125889$5$F$$20240919$20240723$20240920$PER$$US-PFIZER INC-PV202400095440$PFIZER$$99$YR$$F$Y$$$20240920$$HP$US$US
241258901$24125890$1$I$$20240715$20240723$20240723$PER$$US-PFIZER INC-202400218367$PFIZER$$$$$M$Y$$$20240723$$CN$US$US
241258911$24125891$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-202400220004$PFIZER$$68$YR$$M$Y$$$20240723$$HP$US$US
241258922$24125892$2$F$$20240820$20240723$20240823$PER$$US-PFIZER INC-PV202400095187$PFIZER$$71$YR$$M$Y$$$20240823$$HP$US$US
241258931$24125893$1$I$20240708$20240719$20240723$20240723$PER$$US-PFIZER INC-202400219865$PFIZER$$63$YR$$M$Y$$$20240723$$CN$US$US
241258942$24125894$2$F$$20240723$20240723$20240726$PER$$US-PFIZER INC-PV202400095202$PFIZER$$44$YR$$F$Y$$$20240726$$MD$US$US
241258951$24125895$1$I$20240709$20240717$20240723$20240723$PER$$US-PFIZER INC-202400217860$PFIZER$$42$YR$$F$Y$$$20240723$$CN$US$US
241258961$24125896$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-202400220262$PFIZER$$51$YR$$F$Y$$$20240723$$MD$US$US
241258971$24125897$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-202400219399$PFIZER$$$$A$M$Y$$$20240723$$HP$US$US
241258982$24125898$2$F$$20240731$20240723$20240805$PER$$US-PFIZER INC-PV202400095101$PFIZER$$60$YR$$$Y$$$20240805$$CN$US$US
241258991$24125899$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-202400220257$PFIZER$$$$$F$Y$$$20240723$$CN$US$US
241259002$24125900$2$F$$20240723$20240723$20240724$PER$$US-PFIZER INC-202400218707$PFIZER$$62$YR$$F$Y$$$20240724$$HP$US$US
241259012$24125901$2$F$$20240813$20240723$20240816$PER$$US-PFIZER INC-202400219872$PFIZER$$62$YR$$F$Y$$$20240816$$CN$US$US
241259021$24125902$1$I$$20240711$20240723$20240723$EXP$GB-MHRA-MED-202407110823316370-YMRDP$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-06731$HIKMA$$$$$$Y$$$20240723$$CN$GB$GB
241259032$24125903$2$F$$20240906$20240723$20240909$PER$$US-PFIZER INC-PV202400095509$PFIZER$$76$YR$$M$Y$$$20240909$$HP$US$US
241259041$24125904$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-202400219881$PFIZER$$66$YR$$F$Y$$$20240723$$CN$US$US
241259051$24125905$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-202400219844$PFIZER$$$$$M$Y$$$20240723$$CN$US$US
241259061$24125906$1$I$20240717$20240718$20240723$20240723$PER$$US-PFIZER INC-202400219077$PFIZER$$49$YR$$M$Y$$$20240723$$MD$US$US
241259071$24125907$1$I$20180101$20240717$20240723$20240723$PER$$US-PFIZER INC-202400218699$PFIZER$$50$YR$$M$Y$$$20240723$$HP$US$US
241259081$24125908$1$I$$20240716$20240723$20240723$EXP$$GB-JNJFOC-20240751100$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240723$$CN$GB$GB
241259091$24125909$1$I$20221009$20240419$20240723$20240723$EXP$GB-TEVA-VS-3220244$GB-TEVA-VS-3220244$TEVA$$2$MON$$F$Y$60$KG$20240723$$CN$GB$GB
241259101$24125910$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50426$$FDA-CTU$$55$YR$$F$N$214$LBS$20240722$N$$US$
241259111$24125911$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50510$$FDA-CTU$$$$$M$N$$$20240722$N$HP$US$
241259121$24125912$1$I$20240717$20240711$20240723$20240723$EXP$$AU-TAKEDA-2024TUS074051$TAKEDA$$20$YR$$F$Y$$$20240723$$CN$AU$AU
241259141$24125914$1$I$20230801$20240716$20240723$20240723$EXP$$JP-AMGEN-JPNSP2023141492$AMGEN$$$$E$$Y$$$20240723$$MD$JP$JP
241259161$24125916$1$I$20220811$20240712$20240723$20240723$EXP$$US-ORPHANEU-2024005384$RECORDATI$$$$$$Y$$$20240723$$CN$US$US
241259171$24125917$1$I$20240421$20240712$20240723$20240723$EXP$$US-TAKEDA-2024TUS073927$TAKEDA$$73$YR$$F$Y$47$KG$20240723$$MD$US$US
241259181$24125918$1$I$$20240524$20240723$20240723$PER$$US-HALEON-2178476$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241259191$24125919$1$I$$20240712$20240723$20240723$EXP$$US-VIVUS, Inc.-2024V1000883$VIVUS$$$$A$F$Y$$$20240718$$CN$US$US
241259203$24125920$3$F$$20240731$20240723$20240809$EXP$$ES-MSNLABS-2024MSNLIT01637$MSN LABORATORIES$Lizondo Lopez T, Font I Barcelo A, Garcia Gutierrez C, Blasco M, Grafia I, Bastida C, Castro-Rebollo P, Soy-Muner D.Clopidogrel-induced thrombotic microangiopathy: a case report.European Journal of Hospital Pharmacy.2024;0:1-4$$$$$Y$$$20240809$$PH$ES$ES
241259211$24125921$1$I$$20240718$20240723$20240723$EXP$NL-LRB-00985143$NL-CHEPLA-2024009229$CHEPLAPHARM$$31$YR$$F$Y$78$KG$20240723$$CN$COUNTRY NOT SPECIFIED$NL
241259231$24125923$1$I$20240622$20240719$20240723$20240723$EXP$$US-GSK-US2024AMR092087$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
241259241$24125924$1$I$$20240708$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110729$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240723$$CN$US$US
241259251$24125925$1$I$$20240719$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116145$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240723$$HP$US$US
241259261$24125926$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50488$$FDA-CTU$$58$YR$$M$N$$$20240722$N$$US$
241259272$24125927$2$F$$20240812$20240723$20240814$EXP$$US-GILEAD-2024-0678306$GILEAD$$61$YR$A$F$Y$$$20240814$$HP$US$US
241259281$24125928$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50411$$FDA-CTU$$53$YR$$F$N$$$20240722$N$$US$
241259291$24125929$1$I$20240721$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50542$$FDA-CTU$$61$YR$$M$N$$$20240722$Y$PH$US$
241259301$24125930$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116330$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$122.47$KG$20240723$$CN$US$US
241259311$24125931$1$I$$20240717$20240723$20240723$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-114588$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240723$$PH$FR$FR
241259321$24125932$1$I$20240630$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50449$$FDA-CTU$$64$YR$$F$N$$$20240722$Y$PH$US$
241259331$24125933$1$I$$20240722$20240723$20240723$EXP$$JP-EXELIXIS-CABO-24079718$EXELIXIS$$$$E$$Y$$$20240723$$MD$JP$JP
241259351$24125935$1$I$$20240719$20240723$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041097$BOEHRINGER INGELHEIM$$$$$$Y$$$20240723$$MD$US$US
241259371$24125937$1$I$$20240711$20240723$20240723$EXP$$US-PROCTER+GAMBLE-PH24005848$PROCTER AND GAMBLE$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clinical Toxicology. 2024;62 (5):296-302$21$YR$$F$Y$$$20240723$$HP$US$US
241259383$24125938$3$F$20240101$20240920$20240723$20240925$EXP$$US-SA-2024SA213037$SANOFI AVENTIS$$42$YR$A$F$Y$74$KG$20240925$$MD$US$US
241259391$24125939$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240759580$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240723$$PH$US$US
241259401$24125940$1$I$20240301$20240718$20240723$20240723$EXP$$US-JNJFOC-20240753361$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240723$$HP$US$US
241259411$24125941$1$I$$20240711$20240723$20240723$EXP$$US-TEVA-VS-3221382$TEVA$$28$YR$$M$Y$$$20240723$$CN$US$US
241259421$24125942$1$I$$20240708$20240723$20240723$EXP$$GB-NORDICGR-056790$NORDIC PHARMA$$$$$F$Y$$$20240722$$PH$GB$GB
241259431$24125943$1$I$20240429$20240708$20240723$20240723$EXP$GB-MHRA-MED-202405301137143310-SQHNL$GB-NORDICGR-056797$NORDIC PHARMA$$74$YR$$M$Y$$$20240722$$PH$GB$GB
241259441$24125944$1$I$20240604$20240708$20240723$20240723$EXP$GB-MHRA-MED-202406091756198760-PZSFT$GB-NORDICGR-056793$NORDIC PHARMA$$49$YR$$F$Y$$$20240722$$MD$GB$GB
241259451$24125945$1$I$$20240708$20240723$20240723$EXP$GB-MHRA-MED-202406191429425310-ZVBKC$GB-NORDICGR-056789$NORDIC PHARMA$$$$$F$Y$$$20240722$$PH$GB$
241259463$24125946$3$F$20240620$20240915$20240723$20240919$EXP$$CA-BAUSCH-BL-2024-010981$BAUSCH AND LOMB$$43$YR$$F$Y$$$20240919$$PH$CA$CA
241259471$24125947$1$I$20240623$20240716$20240723$20240723$PER$$US-ROCHE-10000028969$ROCHE$$32$YR$A$M$Y$$$20240723$$CN$US$US
241259481$24125948$1$I$20240712$20240715$20240723$20240723$30DAY$$US-GSK-US2024088624$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240723$$CN$US$US
241259491$24125949$1$I$20240704$20240711$20240723$20240723$EXP$$US-GSK-US2024AMR089611$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$CN$US$US
241259501$24125950$1$I$20231014$20240708$20240723$20240723$EXP$GB-MHRA-MED-202406211105419530-SVCRT$GB-NORDICGR-056791$NORDIC PHARMA$$10$YR$$F$Y$46$KG$20240722$$HP$GB$GB
241259511$24125951$1$I$$20240708$20240723$20240723$PER$$US-GRANULES-US-2024GRASPO00282$GRANULES INDIA$$56$YR$A$F$Y$$$20240723$$CN$US$US
241259521$24125952$1$I$$20240619$20240723$20240723$EXP$$KR-Appco Pharma LLC-2159469$APPCO PHARMA$Initial$40$YR$$F$Y$$$20240723$$$KR$KR
241259531$24125953$1$I$$20240719$20240723$20240723$PER$$US-ROCHE-10000032654$ROCHE$$$$A$M$Y$$$20240723$$CN$US$US
241259541$24125954$1$I$$20240716$20240723$20240723$PER$$US-ROCHE-10000032948$ROCHE$$$$C$M$Y$$$20240723$$CN$US$US
241259551$24125955$1$I$$20240716$20240723$20240723$PER$$US-ROCHE-10000032959$ROCHE$$2$YR$C$M$Y$$$20240723$$CN$US$US
241259561$24125956$1$I$$20240716$20240723$20240723$PER$$US-ROCHE-10000032953$ROCHE$$$$$M$Y$$$20240723$$CN$US$US
241259571$24125957$1$I$20240701$20240717$20240723$20240723$PER$$US-ROCHE-10000030634$ROCHE$$30$YR$A$M$Y$$$20240723$$CN$US$US
241259581$24125958$1$I$20240715$20240719$20240723$20240723$PER$$US-ROCHE-10000031756$ROCHE$$63$YR$A$F$Y$$$20240723$$CN$US$US
241259591$24125959$1$I$20240711$20240719$20240723$20240723$PER$$US-ROCHE-10000032706$ROCHE$$31$YR$A$M$Y$$$20240723$$CN$US$US
241259601$24125960$1$I$$20240716$20240723$20240723$EXP$$NVSC2024CA148259$NOVARTIS$$$$A$F$Y$$$20240723$$MD$CA$CA
241259612$24125961$2$F$20240716$20240819$20240723$20240821$PER$$US-AMGEN-USASP2024142776$AMGEN$$77$YR$E$M$Y$$$20240821$$CN$US$US
241259621$24125962$1$I$$20240618$20240723$20240723$PER$$US-Stallergenes SAS-2157035$STALLERGENES$$34$YR$$F$Y$$$20240723$$$US$US
241259631$24125963$1$I$20240702$20240716$20240723$20240723$EXP$$US-SA-2024SA212010$SANOFI AVENTIS$$19$YR$A$M$Y$112$KG$20240723$$MD$US$US
241259643$24125964$3$F$$20240809$20240723$20240902$EXP$$US-TEVA-VS-3219453$TEVA$Woodard VV, Ragland MF. A Rare Case of Necrotizing Pneumonia in an Immunocompromised Patient. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A2444.; Woodard VV, Ragland MF. A Rare Case of Necrotizing Pneumonia in an Immunocompromised Patient. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A2444.$67$YR$$M$Y$$$20240902$$HP$US$US
241259651$24125965$1$I$$20240718$20240723$20240723$EXP$$CA-TAKEDA-2024TUS073535$TAKEDA$$$$$M$Y$$$20240723$$CN$CA$CA
241259661$24125966$1$I$$20240716$20240723$20240723$EXP$$CA-SA-2024SA213534$SANOFI AVENTIS$$$$$$Y$$$20240723$$MD$CA$CA
241259681$24125968$1$I$20240718$20240719$20240723$20240723$PER$$NVSC2024US149830$NOVARTIS$$27$YR$$F$Y$$$20240723$$CN$US$US
241259691$24125969$1$I$$20240709$20240723$20240723$EXP$$US-GLANDPHARMA-US-2024GLNLIT00496$GLAND PHARMA$S. T. Bjork.Nephrotoxicity as a complication of inhaled tobramycin for pseudomonas pneumonia: a case series.American journal of respiratory and critical care medicine.MAY-2024;209$74$YR$E$F$Y$$$20240723$$HP$US$US
241259711$24125971$1$I$20240101$20240718$20240723$20240723$EXP$$US-SA-2024SA212693$SANOFI AVENTIS$$10$YR$C$F$Y$34$KG$20240723$$MD$US$US
241259721$24125972$1$I$$20240719$20240723$20240723$PER$$US-TAKEDA-2024TUS074007$TAKEDA$$$$$M$Y$$$20240723$$CN$US$US
241259731$24125973$1$I$$20240709$20240723$20240723$EXP$$US-BELUSA-2024BELLIT0077$BIOLOGICAL E.$Johnson DJ, Baadh P, Mudrakola HV.Eosinophilic Pleural Effusion and Eosinophilic Pneumonia Following Prolonged Daptomycin Administration.American Journal of Respiratory and Critical Care Medicine.2024;209:A1947$$$$$Y$$$20240723$$HP$US$US
241259741$24125974$1$I$20240601$20240718$20240723$20240723$EXP$$US-SA-2024SA213262$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240723$$MD$US$US
241259751$24125975$1$I$$20240529$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003398$STEMLINE THERAPEUTICS$$$$$F$Y$$$20240718$$PH$US$US
241259761$24125976$1$I$$20240524$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003337$STEMLINE THERAPEUTICS$$38$YR$A$F$Y$$$20240718$$CN$US$US
241259771$24125977$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003392$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$CN$US$US
241259781$24125978$1$I$$20240529$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003401$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241259791$24125979$1$I$$20240530$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003428$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241259801$24125980$1$I$$20240531$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003446$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240718$$CN$US$US
241259811$24125981$1$I$$20240601$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003451$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240718$$CN$US$US
241259821$24125982$1$I$$20240529$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003388$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241259831$24125983$1$I$$20240603$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003457$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240718$$CN$US$US
241259841$24125984$1$I$$20240603$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003463$STEMLINE THERAPEUTICS$$85$YR$E$F$Y$$$20240718$$CN$US$US
241259851$24125985$1$I$$20240603$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003466$STEMLINE THERAPEUTICS$$$$$$Y$$$20240718$$CN$US$US
241259861$24125986$1$I$$20240603$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003470$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241259871$24125987$1$I$$20240529$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003389$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241259881$24125988$1$I$$20240528$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003367$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240718$$HP$US$US
241259891$24125989$1$I$20240501$20240603$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003472$STEMLINE THERAPEUTICS$$63$YR$A$F$Y$$$20240718$$CN$US$US
241259901$24125990$1$I$$20240603$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003479$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
241259911$24125991$1$I$$20240608$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003377$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240718$$CN$US$US
241259921$24125992$1$I$$20240603$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003480$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240718$$CN$US$US
241259931$24125993$1$I$20240604$20240604$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003491$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240718$$HP$US$US
241259941$24125994$1$I$$20240604$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003493$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$CN$US$US
241259951$24125995$1$I$$20240604$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003495$STEMLINE THERAPEUTICS$$48$YR$A$F$Y$$$20240718$$CN$US$US
241259961$24125996$1$I$$20240604$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003496$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
241259971$24125997$1$I$20240401$20240605$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003508$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241259981$24125998$1$I$$20240605$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003511$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240718$$CN$US$US
241259991$24125999$1$I$$20240603$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003477$STEMLINE THERAPEUTICS$$62$YR$A$F$Y$$$20240718$$CN$US$US
241260001$24126000$1$I$$20240605$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003516$STEMLINE THERAPEUTICS$$52$YR$A$F$Y$$$20240718$$CN$US$US
241260011$24126001$1$I$$20240528$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003350$STEMLINE THERAPEUTICS$$46$YR$A$F$Y$$$20240718$$CN$US$US
241260021$24126002$1$I$20240501$20240529$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003391$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241260031$24126003$1$I$$20240604$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003488$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$HP$US$US
241260041$24126004$1$I$$20240605$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003512$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241260051$24126005$1$I$20240531$20240605$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003517$STEMLINE THERAPEUTICS$$46$YR$A$F$Y$$$20240718$$CN$US$US
241260061$24126006$1$I$$20240604$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003348$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241260071$24126007$1$I$$20240604$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003497$STEMLINE THERAPEUTICS$$50$YR$A$F$Y$$$20240718$$CN$US$US
241260081$24126008$1$I$$20240605$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003521$STEMLINE THERAPEUTICS$$41$YR$A$F$Y$$$20240718$$CN$US$US
241260091$24126009$1$I$$20240606$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003524$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241260101$24126010$1$I$$20240607$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003539$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241260111$24126011$1$I$$20240607$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003554$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$HP$US$US
241260121$24126012$1$I$$20240607$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003561$STEMLINE THERAPEUTICS$$62$YR$A$F$Y$$$20240718$$CN$US$US
241260131$24126013$1$I$$20240610$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003610$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241260141$24126014$1$I$$20240530$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003416$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241260151$24126015$1$I$20240401$20240603$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003471$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241260161$24126016$1$I$$20240610$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003623$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$HP$US$US
241260171$24126017$1$I$$20240610$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003633$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240718$$HP$US$US
241260181$24126018$1$I$$20240612$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003637$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$HP$US$US
241260191$24126019$1$I$$20240610$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003649$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241260211$24126021$1$I$$20240610$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003406$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241260221$24126022$1$I$20240529$20240531$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003434$STEMLINE THERAPEUTICS$$$$$F$Y$$$20240718$$CN$US$US
241260231$24126023$1$I$$20240710$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003450$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241260241$24126024$1$I$20240712$20240715$20240723$20240723$EXP$$GB-MYLANLABS-2024M1066697$MYLAN$$$$$M$Y$$$20240723$$CN$GB$GB
241260251$24126025$1$I$$20240709$20240723$20240723$PER$$US-APOTEX-2024AP008139$APOTEX$$$$$$Y$$$20240723$$HP$US$US
241260261$24126026$1$I$$20240530$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003426$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241260271$24126027$1$I$$20240717$20240723$20240723$PER$$US-ROCHE-10000031984$ROCHE$$$$E$M$Y$$$20240723$$CN$US$US
241260283$24126028$3$F$$20240805$20240723$20240808$PER$$US-PFIZER INC-PV202300181029$PFIZER$$61$YR$$F$Y$51.3$KG$20240808$$MD$US$US
241260291$24126029$1$I$$20240718$20240723$20240723$PER$$US-PFIZER INC-PV202400095208$PFIZER$$72$YR$$F$Y$54.422$KG$20240723$$CN$US$US
241260301$24126030$1$I$20240719$20240719$20240723$20240723$PER$$US-PFIZER INC-202400219747$PFIZER$$$$$$Y$$$20240723$$CN$US$US
241260312$24126031$2$F$20240701$20240723$20240723$20240725$PER$$US-PFIZER INC-202400220259$PFIZER$$62$YR$$M$Y$90.703$KG$20240725$$CN$US$US
241260321$24126032$1$I$20240721$20240722$20240723$20240723$PER$$US-PFIZER INC-202400220906$PFIZER$$53$YR$$M$Y$$$20240723$$CN$US$US
241260331$24126033$1$I$20240720$20240720$20240723$20240723$PER$$US-PFIZER INC-202400220224$PFIZER$$67$YR$$M$Y$$$20240723$$CN$US$US
241260342$24126034$2$F$$20240724$20240723$20240725$PER$$US-PFIZER INC-202400220657$PFIZER$$$$$$Y$$$20240725$$CN$US$US
241260351$24126035$1$I$20230101$20240720$20240723$20240723$PER$$US-PFIZER INC-202400220459$PFIZER$$$$A$F$Y$$$20240723$$CN$US$US
241260361$24126036$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-202400221030$PFIZER$$6$YR$$F$Y$$$20240723$$CN$US$US
241260371$24126037$1$I$$20240722$20240723$20240723$PER$$US-PFIZER INC-202400220857$PFIZER$$61$YR$$F$Y$$$20240723$$CN$US$US
241260382$24126038$2$F$$20240809$20240723$20240813$PER$$US-PFIZER INC-202400220988$PFIZER$$70$YR$$F$Y$$$20240813$$HP$US$US
241260391$24126039$1$I$$20240528$20240723$20240723$PER$$US-Stemline Therapeutics, Inc.-2024ST003354$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$CN$US$US
241260401$24126040$1$I$$20240715$20240723$20240723$PER$$US-ALXN-202407USA001081US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241260411$24126041$1$I$20240101$20240719$20240723$20240723$PER$$US-PFIZER INC-PV202400095395$PFIZER$$38$YR$$F$Y$$$20240723$$CN$US$US
241260422$24126042$2$F$20240721$20240813$20240723$20240816$PER$$US-PFIZER INC-202400220611$PFIZER$$68$YR$$F$Y$109.76$KG$20240816$$CN$US$US
241260432$24126043$2$F$$20240724$20240723$20240725$PER$$US-PFIZER INC-PV202400095194$PFIZER$$$$$M$Y$$$20240725$$CN$US$US
241260441$24126044$1$I$20240720$20240720$20240723$20240723$PER$$US-PFIZER INC-202400220206$PFIZER$$70$YR$$F$Y$$$20240723$$CN$US$US
241260451$24126045$1$I$20240720$20240721$20240723$20240723$PER$$US-PFIZER INC-202400220626$PFIZER$$55$YR$$F$Y$$$20240723$$CN$US$US
241260461$24126046$1$I$20231002$20240721$20240721$20240721$DIR$710896$$FDA-CTU$$55$YR$$F$N$93.6$KG$20240721$N$CN$US$
241260471$24126047$1$I$$20240720$20240723$20240723$PER$$US-PFIZER INC-PV202400095098$PFIZER$$61$YR$$$Y$$$20240723$$CN$US$US
241260481$24126048$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-PV202400095150$PFIZER$$$$$F$Y$$$20240723$$CN$US$US
241260491$24126049$1$I$$20240718$20240723$20240723$PER$$US-PFIZER INC-202400219162$PFIZER$$$$E$M$Y$$$20240723$$MD$US$US
241260501$24126050$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013163$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240723$$CN$US$US
241260511$24126051$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012139$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$US$US
241260531$24126053$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013062$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$US$US
241260541$24126054$1$I$20240718$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013034$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240723$$CN$US$US
241260551$24126055$1$I$$20240712$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407008771$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240723$$CN$US$US
241260562$24126056$2$F$$20240909$20240723$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202407013184$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240911$$CN$US$US
241260571$24126057$1$I$20240716$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012677$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240723$$HP$US$US
241260583$24126058$3$F$$20240904$20240723$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202407013158$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240927$$CN$US$US
241260591$24126059$1$I$20240718$20240720$20240723$20240723$PER$$US-PFIZER INC-202400220252$PFIZER$$69$YR$$M$Y$$$20240723$$CN$US$US
241260601$24126060$1$I$$20240720$20240723$20240723$PER$$US-PFIZER INC-202400219908$PFIZER$$80$YR$$M$Y$$$20240723$$CN$US$US
241260611$24126061$1$I$20240701$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013397$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240723$$CN$US$US
241260621$24126062$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-PV202400095280$PFIZER$$49$YR$$M$Y$$$20240723$$CN$US$US
241260631$24126063$1$I$$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013063$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240723$$CN$US$US
241260643$24126064$3$F$20240720$20240723$20240723$20240726$PER$$US-PFIZER INC-202400220661$PFIZER$$95$YR$$F$Y$$$20240726$$CN$US$US
241260651$24126065$1$I$20240720$20240720$20240723$20240723$PER$$US-PFIZER INC-202400220282$PFIZER$$44$YR$$F$Y$$$20240723$$CN$US$US
241260661$24126066$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013457$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240723$$CN$US$US
241260671$24126067$1$I$20240601$20240720$20240723$20240723$PER$$US-PFIZER INC-202400220723$PFIZER$$57$YR$$M$Y$$$20240723$$CN$US$US
241260681$24126068$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-PV202400095402$PFIZER$$53$YR$$F$Y$$$20240723$$HP$US$US
241260701$24126070$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-PV202400095269$PFIZER$$37$YR$$M$Y$$$20240723$$HP$US$US
241260711$24126071$1$I$20240721$20240721$20240723$20240723$PER$$US-PFIZER INC-202400220632$PFIZER$$56$YR$$F$Y$$$20240723$$CN$US$US
241260721$24126072$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-202400220689$PFIZER$$68$YR$$F$Y$$$20240723$$CN$US$US
241260731$24126073$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-PV202400095272$PFIZER$$53$YR$$F$Y$$$20240723$$CN$US$US
241260741$24126074$1$I$20240720$20240720$20240723$20240723$PER$$US-PFIZER INC-202400220279$PFIZER$$68$YR$$M$Y$$$20240723$$CN$US$US
241260751$24126075$1$I$$20240720$20240723$20240723$PER$$US-PFIZER INC-PV202400095344$PFIZER$$38$YR$$$Y$$$20240723$$CN$US$US
241260761$24126076$1$I$20240701$20240720$20240723$20240723$PER$$US-PFIZER INC-202400220234$PFIZER$$66$YR$$F$Y$$$20240723$$CN$US$US
241260772$24126077$2$F$$20240814$20240723$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003678$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
241260781$24126078$1$I$$20240709$20240723$20240723$EXP$$US-GLANDPHARMA-US-2024GLNLIT00506$GLAND PHARMA$S. T. Bjork.Nephrotoxicity as a Complication of Inhaled Tobramycin for Pseudomonas Pneumonia: A Case Series.American Journal of Respiratory and Critical Care Medicine.2024;209:A7429$76$YR$E$F$Y$$$20240723$$HP$US$US
241260791$24126079$1$I$20240601$20240702$20240723$20240723$PER$$US-009507513-2407USA001400$MERCK$$51$YR$$F$Y$$$20240723$$CN$US$US
241260811$24126081$1$I$$20240718$20240723$20240723$EXP$$CL-JNJFOC-20240753230$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240723$$CN$CL$CL
241260821$24126082$1$I$$20240717$20240723$20240723$EXP$$US-JNJFOC-20240746478$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240723$$HP$US$US
241260831$24126083$1$I$20230627$20240716$20240723$20240723$EXP$$CA-ABBVIE-5844533$ABBVIE$$$$E$F$Y$$$20240723$$CN$CA$CA
241260851$24126085$1$I$20240713$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144466$AMGEN$$62$YR$A$$Y$$$20240723$$CN$US$US
241260861$24126086$1$I$$20240718$20240723$20240723$PER$$US-GILEAD-2024-0681254$GILEAD$$$$$$Y$$$20240723$$CN$US$US
241260871$24126087$1$I$20240101$20240709$20240723$20240723$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01149$INTRA-CELLULAR THERAPIES$$$$$F$Y$62.585$KG$20240723$$HP$US$US
241260881$24126088$1$I$$20240606$20240723$20240723$PER$$US-Stallergenes SAS-2159471$STALLERGENES$$61$YR$$F$Y$$$20240723$$$US$US
241260891$24126089$1$I$$20240716$20240723$20240723$EXP$$DE-009507513-2407DEU010163$MERCK$$$$A$F$Y$65$KG$20240723$$MD$DE$DE
241260901$24126090$1$I$$20240709$20240723$20240723$EXP$$US-BELUSA-2024BELLIT0078$BIOLOGICAL E.$Hossain S, Patten E, Anigbogu J.Daptomycin-induced Lung Injury.Am-J-Respir-Crit-Care-Med.2024;209:A2004$$$$$Y$$$20240723$$HP$US$US
241260912$24126091$2$F$$20240711$20240723$20240725$EXP$$VE-ROCHE-10000027258$ROCHE$$86$YR$E$M$Y$$$20240725$$MD$VE$VE
241260922$24126092$2$F$$20240806$20240723$20240806$PER$$NVSC2024US149755$NOVARTIS$$$$$M$Y$$$20240807$$HP$US$US
241260931$24126093$1$I$$20240708$20240723$20240723$EXP$$IT-CorePharma LLC-2159472$COREPHARMA$Source document (Abstract).$66$YR$$F$Y$$$20240723$$$IT$IT
241260943$24126094$3$F$20210701$20240812$20240723$20240813$EXP$$NVSC2024PT146783$NOVARTIS$Oliveira C, Queiroz L, Almeida M, Fernandes R, Caeiro C. Hepatoxicidade grave com ribociclib, a proposito de um caso desafiante [Challenging case of severe hepatotoxicity with ribociclib]. REVISTA PORTUGUESA DE ONCOLOGIA. 2024;7 (N1-2):46-8$45$YR$$F$Y$$$20240813$$HP$PT$PT
241260951$24126095$1$I$20240702$20240721$20240721$20240721$DIR$710898$$FDA-CTU$$29$YR$$F$N$79.2$KG$20240721$N$CN$US$
241260961$24126096$1$I$20240716$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50420$$FDA-CTU$$78$YR$$F$N$90$KG$20240719$N$$US$
241260971$24126097$1$I$20240402$20240721$20240721$20240721$DIR$710906$$FDA-CTU$$67$YR$$F$N$88.2$KG$20240721$Y$CN$US$
241260981$24126098$1$I$20240721$20240721$20240721$20240721$DIR$710913$$FDA-CTU$$30$YR$$F$N$58.5$KG$20240721$N$CN$US$
241261001$24126100$1$I$20231101$20240718$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116208$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$43.54$KG$20240723$$CN$US$US
241261011$24126101$1$I$20240101$20240715$20240723$20240723$EXP$$CA-JNJFOC-20240609943$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240723$$HP$CA$CA
241261021$24126102$1$I$$20240709$20240723$20240723$EXP$$US-GLANDPHARMA-US-2024GLNLIT00509$GLAND PHARMA$ZA Qazi.A Rare Cause of Acute Hypoxic Respiratory Failure After ST-Elevation Myocardial Infarction.American Journal of Respiratory and Critical Care Medicine.209:A3650$77$YR$E$F$Y$$$20240723$$HP$US$US
241261031$24126103$1$I$$20240709$20240723$20240723$EXP$$US-BELUSA-2024BELLIT0079$BIOLOGICAL E.$Mcgee JD, Vyas H, Heyer M, Rahim M, Tang B, Kim B,Subbaiah TB.A Case of Tumoral Pulmonary Hypertension Resulting in Right Ventricular Failure.Am J Respir Crit Care Med.2024;209:A2232$$$$$Y$$$20240723$$HP$US$US
241261041$24126104$1$I$20240608$20240712$20240723$20240723$EXP$$US-Vifor (International) Inc.-VIT-2024-06279$VIFOR$$31$YR$$M$Y$103.5$KG$20240723$$HP$US$US
241261051$24126105$1$I$20200831$20240709$20240723$20240723$EXP$$KR-009507513-2407KOR005191$MERCK$$$$$M$Y$$$20240723$$HP$KR$KR
241261071$24126107$1$I$$20240716$20240723$20240723$EXP$$NVSC2024CA146976$NOVARTIS$$9$YR$$M$Y$$$20240723$$HP$CA$CA
241261082$24126108$2$F$20230620$20240717$20240723$20240801$EXP$$JP-INCYTE CORPORATION-2023IN010251$INCYTE$$$$$$Y$$$20240801$$MD$JP$JP
241261091$24126109$1$I$$20240710$20240723$20240723$EXP$$CA-TEVA-VS-3222787$TEVA$$6$YR$$M$Y$35$KG$20240723$$CN$CA$CA
241261101$24126110$1$I$20240708$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50528$$FDA-CTU$$19$YR$$F$N$$$20240722$N$HP$US$
241261111$24126111$1$I$$20240710$20240723$20240723$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000146$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240723$$HP$US$US
241261131$24126113$1$I$$20240721$20240721$20240721$DIR$710900$$FDA-CTU$$19$YR$$F$N$81$KG$20240721$N$CN$US$
241261141$24126114$1$I$20240716$20240717$20240723$20240723$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700691$MYOVANT SCIENCES$$84$YR$$M$Y$$$20240723$$CN$US$US
241261151$24126115$1$I$20240710$20240721$20240721$20240721$DIR$710920$$FDA-CTU$$79$YR$$M$N$90.9$KG$20240721$N$CN$US$
241261161$24126116$1$I$$20240715$20240723$20240723$EXP$$CA-MYLANLABS-2024M1066053$MYLAN$$68$YR$$F$Y$$$20240723$$CN$CA$CA
241261171$24126117$1$I$20240625$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50415$$FDA-CTU$$75$YR$$F$N$$$20240719$N$PH$US$
241261191$24126119$1$I$20240618$20240709$20240723$20240723$EXP$$DE-RICHTER-2024-GR-007202$MYOVANT SCIENCES$$47$YR$$F$Y$$$20240723$$MD$DE$DE
241261201$24126120$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50389$$FDA-CTU$$$$$M$N$$$20240722$N$HP$US$
241261211$24126121$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115177$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240723$$CN$US$US
241261221$24126122$1$I$$20240715$20240723$20240723$PER$$US-ALXN-202407USA000999US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241261231$24126123$1$I$$20240717$20240723$20240723$EXP$$US-GILEAD-2024-0681250$GILEAD$$$$A$F$Y$$$20240723$$CN$US$US
241261241$24126124$1$I$$20240709$20240723$20240723$EXP$$IT-BELUSA-2024BELLIT0080$BIOLOGICAL E.$Valenti G, Monello A, Rusticali G, Losi L, Bolognesi G, Aschieri D..ACUTE PULMONARY EMBOLISM: NEW HORIZONS IN CAT LAB.European Heart Journal Supplements.2024;26 (2):ii110$$$$$Y$$$20240723$$HP$IT$IT
241261251$24126125$1$I$$20240709$20240723$20240723$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00502$GLAND PHARMA$Fan C.Warfarin-related nephropathy due to excessive anticoagulation induced by combination of warfarin and amiodarone.Adverse drug reactions journal.MAY-2024;26 (No 5):318-320$49$YR$A$M$Y$$$20240723$$HP$CN$CN
241261261$24126126$1$I$20240709$20240715$20240723$20240723$EXP$GB-MHRA-MED-202407151125228640-RKLZF$GB-TEVA-VS-3221928$TEVA$$77$YR$$F$Y$$$20240723$$PH$GB$GB
241261272$24126127$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3219669$TEVA$Saunders AE, Shanahan KM, Downs JW. A Case of Multidrug-Resistant Tuberculosis in an Active Duty Military Health Care Worker. Mil-Med 2024; 00.; Saunders AE, Shanahan KM, Downs JW. A Case of Multidrug-Resistant Tuberculosis in an Active Duty Military Health Care Worker. Mil-Med 2024; 00.$30$YR$$M$Y$$$20240819$$HP$US$US
241261281$24126128$1$I$$20240619$20240723$20240723$EXP$$US-Appco Pharma LLC-2159473$APPCO PHARMA$Initial$42$YR$$F$Y$$$20240723$$MD$US$US
241261291$24126129$1$I$$20240717$20240723$20240723$PER$$NVSC2024US149110$NOVARTIS$$$$$M$Y$94$KG$20240723$$CN$US$US
241261301$24126130$1$I$$20240716$20240723$20240723$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700633$MYOVANT SCIENCES$$$$$M$Y$$$20240723$$CN$US$US
241261311$24126131$1$I$20240109$20240718$20240723$20240723$EXP$$CA-ROCHE-3502540$ROCHE$$40$YR$A$M$Y$$$20240723$$CN$CA$CA
241261321$24126132$1$I$20240701$20240715$20240723$20240723$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-14208$IPSEN$$82$YR$E$M$Y$66.2$KG$20240723$$HP$US$US
241261332$24126133$2$F$20240704$20240827$20240723$20240917$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000445$BECTON DICKINSON$$$$$$Y$$$20240917$$CN$GB$GB
241261342$24126134$2$F$$20240718$20240723$20240812$EXP$$US-BEH-2024175944$CSL BEHRING$$57$YR$A$$Y$$$20240812$$CN$US$US
241261352$24126135$2$F$20240704$20240827$20240723$20240917$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000446$BECTON DICKINSON$$$$$$Y$$$20240917$$CN$GB$GB
241261362$24126136$2$F$20240704$20240827$20240723$20240917$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000447$BECTON DICKINSON$$$$$$Y$$$20240917$$CN$GB$GB
241261373$24126137$3$F$$20240807$20240723$20240819$EXP$$US-UCBSA-2024036719$UCB$$$$$F$Y$174$KG$20240819$$HP$US$US
241261392$24126139$2$F$$20240723$20240723$20240726$EXP$$NVSJ2024JP008792$NOVARTIS$$$$$$Y$$$20240726$$PH$JP$JP
241261402$24126140$2$F$$20240902$20240723$20240906$EXP$$NVSC2024DE149917$NOVARTIS$Toskov V, Cseh A, Claviez A, Drexler B, Rotari N, Schwarz-Furlan S et. al.. Variable clinical courses of varicella zoster virus infection-related or vaccination-related bone marrow failure.. J PEDIATR HEMATOL ONCOL. 2024;46:e354-9$4$YR$$F$Y$$$20240906$$HP$DE$DE
241261413$24126141$3$F$20231214$20240821$20240723$20240826$EXP$$NVSJ2024JP008762$NOVARTIS$$$$E$F$Y$$$20240826$$MD$JP$JP
241261422$24126142$2$F$20240703$20240816$20240723$20240910$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000451$BECTON DICKINSON$$$$$$Y$$$20240910$$CN$GB$GB
241261431$24126143$1$I$20240717$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144474$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241261441$24126144$1$I$$20240715$20240723$20240723$EXP$$GR-AMGEN-GRCSP2024140968$AMGEN$$63$YR$A$F$Y$$$20240723$$MD$GR$GR
241261451$24126145$1$I$$20240715$20240723$20240723$EXP$$DE-AMGEN-DEUSP2024141868$AMGEN$Stilgenbauer S;. Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase 11 Study of the Gcllsg and fcgcll/MW. Blood. 2012;120 (21):716$$$$$Y$$$20240723$$MD$DE$DE
241261461$24126146$1$I$$20240718$20240723$20240723$EXP$$NVSC2024CN149914$NOVARTIS$$$$$$Y$$$20240723$$HP$CN$CN
241261481$24126148$1$I$20221201$20240721$20240721$20240721$DIR$710936$$FDA-CTU$$46$YR$$F$N$63$KG$20240721$N$CN$US$
241261491$24126149$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50471$$FDA-CTU$$$$$M$N$$$20240722$N$HP$US$
241261501$24126150$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50523$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241261511$24126151$1$I$$20240721$20240723$20240723$EXP$$NVSC2024US150046$NOVARTIS$$$$$F$Y$$$20240723$$MD$US$US
241261522$24126152$2$F$20240601$20240818$20240723$20240822$EXP$$NVSC2024KW148353$NOVARTIS$$56$YR$$F$Y$$$20240822$$CN$KW$KW
241261532$24126153$2$F$$20240819$20240723$20240823$EXP$$NVSJ2024JP008771$NOVARTIS$$83$YR$$F$Y$$$20240823$$MD$JP$JP
241261542$24126154$2$F$20240703$20240911$20240723$20240930$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000452$BECTON DICKINSON$$$$$$Y$$$20240930$$CN$GB$GB
241261552$24126155$2$F$20240703$20240911$20240723$20240926$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000453$BECTON DICKINSON$$$$$$Y$$$20240926$$CN$GB$GB
241261571$24126157$1$I$$20240716$20240723$20240723$EXP$$AT-REGENERON PHARMACEUTICALS, INC.-2024-100955$REGENERON$$76$YR$$F$Y$$$20240723$$CN$AT$AT
241261581$24126158$1$I$$20240711$20240723$20240723$PER$$US-RDY-SPO/USA/24/0010422$DR REDDYS$$75$YR$E$M$Y$$$20240723$$CN$US$US
241261591$24126159$1$I$$20240715$20240723$20240723$EXP$$US-MYLANLABS-2024M1068038$MYLAN$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J-Ophthalmic-Inflamm-Infect 2024; 14.$76$YR$$F$Y$$$20240723$$HP$US$US
241261601$24126160$1$I$$20240715$20240723$20240723$EXP$$US-MYLANLABS-2024M1068064$MYLAN$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J-Ophthalmic-Inflamm-Infect 2024; 14.$70$YR$$M$Y$$$20240723$$HP$US$US
241261611$24126161$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50487$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241261621$24126162$1$I$20240706$20240721$20240721$20240721$DIR$710933$$FDA-CTU$$36$YR$$F$N$89.1$KG$20240721$N$CN$US$
241261631$24126163$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50391$$FDA-CTU$$79$YR$$F$N$62.14$KG$20240722$N$$US$
241261642$24126164$2$F$$20240726$20240723$20240802$EXP$$GR-MYLANLABS-2024M1067080$MYLAN$Tsionis A., Irini Z., Anastasia A., Erifilli L., Vadim G., Fotini H.. ECTOPIC PREGNANCY AND METHOTREXATE: PRESENTATION OF 3 CASES  IN THE LAST YEAR WITH AN UNFAVORABLE OUTCOME. 16th PANHELLENIC CONGRESS ON OBSTETRICS AND GYNECOLOGY. 2024;466$$$$F$Y$$$20240802$$MD$GR$GR
241261651$24126165$1$I$20240721$20240721$20240721$20240721$DIR$710904$$FDA-CTU$$$$$F$N$$$20240721$N$MD$US$
241261661$24126166$1$I$$20240715$20240723$20240723$EXP$$US-MYLANLABS-2024M1067551$MYLAN$Ozer S, Farabi B, Kann R, Atak MF, Shulman K, Marmon S. Refractory antimelanoma differentiation-associated gene 5 antibody negative ulcerative dermatomyositis responsive to mycophenolate mofetil. JAAD-Case-Rep 2024; 50 1-3.$52$YR$$F$Y$$$20240723$$MD$US$US
241261671$24126167$1$I$20240717$20240717$20240723$20240723$EXP$$US-RIGEL-20240700074$RIGEL PHARMACEUTICALS$$94$YR$$M$Y$65.771$KG$20240723$$CN$US$US
241261682$24126168$2$F$$20240809$20240723$20240819$EXP$$FR-TEVA-VS-3220834$TEVA$Sallee L, Souchet L, Boutolleau D, Nguyen S. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports. Int-J-Antimicrob-Agents 2024; 63 (6): 1-2.; Sallee L, Souchet L, Boutolleau D, Nguyen S. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports. Int-J-Antimicrob-...$60$YR$$F$Y$$$20240819$$HP$FR$FR
241261701$24126170$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116221$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240723$$CN$US$US
241261711$24126171$1$I$20240701$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116459$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$53.52$KG$20240723$$CN$US$US
241261721$24126172$1$I$$20240720$20240723$20240723$PER$$NVSC2024US150052$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
241261731$24126173$1$I$$20240709$20240723$20240723$EXP$$US-GLANDPHARMA-US-2024GLNLIT00486$GLAND PHARMA$Goswami S.Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series.Pediatric Nephrology.JAN-2024$6$YR$C$F$Y$$$20240723$$HP$US$US
241261741$24126174$1$I$$20240715$20240723$20240723$EXP$$NVSC2023IN274427$NOVARTIS$$$$$M$Y$$$20240723$$CN$IN$IN
241261761$24126176$1$I$$20240715$20240723$20240723$EXP$$NVSC2024US146630$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
241261781$24126178$1$I$20240619$20240717$20240723$20240723$EXP$$US-JAZZ-2022-US-003836$JAZZ$$55$YR$$F$Y$$$20240723$$CN$US$US
241261791$24126179$1$I$20240719$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013150$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240723$$CN$US$US
241261802$24126180$2$F$20240101$20240727$20240723$20240805$PER$$US-ABBVIE-5845304$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241261811$24126181$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013599$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$US$US
241261821$24126182$1$I$20240714$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011270$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240723$$CN$US$US
241261831$24126183$1$I$20200503$20240718$20240723$20240723$EXP$PL-URPL-1-3712-2020$PL-CHEPLA-2024009083$CHEPLAPHARM$$39$YR$A$M$Y$75$KG$20240723$$MD$COUNTRY NOT SPECIFIED$PL
241261842$24126184$2$F$$20240731$20240723$20240807$EXP$$CA-BEH-2024175710$CSL BEHRING$$18$YR$A$M$Y$57$KG$20240807$$CN$CA$CA
241261851$24126185$1$I$$20240718$20240723$20240723$PER$$US-GILEAD-2024-0681294$GILEAD$$$$$$Y$$$20240723$$CN$US$US
241261861$24126186$1$I$$20240709$20240723$20240723$EXP$$US-BELUSA-2024BELLIT0082$BIOLOGICAL E.$Qaiser S, Divanna M, Amir N, Luzuriaga A, Rodriguez C.Real-World Administration of Dantrolene: Harder Than a Board Exam.Am-J-Respir-Crit-Care-Med.2024;209:A3654$$$$$Y$$$20240723$$HP$US$US
241261873$24126187$3$F$20240628$20240807$20240723$20240818$30DAY$$CA-JNJFOC-20240707145$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240819$$PH$CA$CA
241261882$24126188$2$F$$20240812$20240723$20240827$EXP$IT-STADA-01262616$IT-SERVIER-S24009023$SERVIER$Celardo G, Scaffei E, Buchignani B, Donatelli G, Costagli M, Cristofani P, et al.. Case report: Exploring chemoradiotherapy-induced leukoencephalopathy with 7T imaging and quantitative susceptibility mapping.. Front Neurol. 2024;15:1-6$$$$$Y$$$20240827$$HP$IT$IT
241261891$24126189$1$I$$20240708$20240723$20240723$EXP$$US-CorePharma LLC-2159474$COREPHARMA$Source document (FTA).$65$YR$$F$Y$$$20240723$$$US$US
241261901$24126190$1$I$$20240708$20240723$20240723$EXP$GB-MHRA-MED-202405301002557780-MHRQS$GB-NORDICGR-056796$NORDIC PHARMA$$$$$F$Y$$$20240722$$PH$GB$GB
241261911$24126191$1$I$$20240711$20240723$20240723$EXP$$US-INSMED, INC.-2024-02893-US$INSMED$$75$YR$$F$Y$$$20240723$$MD$US$US
241261921$24126192$1$I$$20240624$20240723$20240723$30DAY$$US-VEROBIOTECH-2024USVEROSPO00149$VERO BIOTECH$$$$$$Y$$$20240723$$HP$US$US
241261931$24126193$1$I$20240603$20240717$20240723$20240723$EXP$$RU-AMGEN-RUSSP2024142600$AMGEN$$67$YR$E$F$Y$84$KG$20240723$$HP$RU$RU
241261941$24126194$1$I$$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024144065$AMGEN$$$$$$Y$$$20240723$$PH$US$US
241261951$24126195$1$I$20240716$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143800$AMGEN$$79$YR$E$M$Y$$$20240723$$CN$US$US
241261962$24126196$2$F$20240101$20240905$20240723$20240912$EXP$$US-AMGEN-USASP2024143322$AMGEN$$72$YR$E$M$Y$$$20240911$$HP$US$US
241261972$24126197$2$F$20240401$20240719$20240723$20240725$EXP$$PL-009507513-2407POL011955$MERCK$$66$YR$$F$Y$83$KG$20240725$$MD$PL$PL
241261982$24126198$2$F$$20240909$20240723$20240924$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00591$Phathom Pharmaceuticals$$$$$$Y$$$20240924$$PH$JP$JP
241261991$24126199$1$I$20240624$20240709$20240723$20240723$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00580$Phathom Pharmaceuticals$$6$DEC$$F$Y$$$20240723$$MD$JP$JP
241262001$24126200$1$I$$20240716$20240723$20240723$EXP$$CA-009507513-2407CAN011600$MERCK$Unknown. Unknown. Unknown$52$YR$$M$Y$$$20240723$$HP$CA$CA
241262011$24126201$1$I$$20240624$20240723$20240723$30DAY$$US-VEROBIOTECH-2024USVEROSPO00150$VERO BIOTECH$$$$$$Y$$$20240723$$HP$US$US
241262022$24126202$2$F$$20240819$20240723$20240827$EXP$$US-AstraZeneca-2024A161471$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
241262031$24126203$1$I$$20200506$20240723$20240723$EXP$$CA-AstraZeneca-2020SE60832$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$CA$
241262041$24126204$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A163049$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241262051$24126205$1$I$$20240709$20240723$20240723$EXP$$US-BELUSA-2024BELLIT0083$BIOLOGICAL E.$Sompalli S, Foray N, Sreedhar R..A Rare Case of Non-traumatic Splenic Rupture Following Portal Vein Thrombosis..Am-J-Respir-Crit-Care-Med.2024;209:A1727$$$$$Y$$$20240723$$HP$US$US
241262062$24126206$2$F$$20240820$20240723$20240827$EXP$$US-AstraZeneca-2024A161641$ASTRAZENECA$$$$$F$Y$$$20240827$$MD$US$
241262071$24126207$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161435$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241262091$24126209$1$I$20240623$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A165567$ASTRAZENECA$$31241$DY$$F$Y$$$20240723$$CN$US$
241262101$24126210$1$I$20240624$20240709$20240723$20240723$EXP$$TH-ROCHE-10000032531$ROCHE$$58$YR$A$M$Y$$$20240723$$CN$TH$TH
241262111$24126211$1$I$$20240628$20240723$20240723$EXP$$US-PADAGIS-2024PAD01218$PADAGIS$$$$$$Y$$$20240723$$CN$US$US
241262121$24126212$1$I$$20211229$20240723$20240723$EXP$$US-AstraZeneca-2021A788106$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241262131$24126213$1$I$$20240711$20240723$20240723$PER$$US-TEVA-VS-3221364$TEVA$$$$$M$Y$$$20240723$$MD$US$US
241262142$24126214$2$F$$20240727$20240723$20240806$PER$$US-RDY-SPO/USA/24/0010311$DR REDDYS$$$$$F$Y$$$20240806$$PH$US$US
241262151$24126215$1$I$$20240718$20240723$20240723$EXP$$CN-AMGEN-CHNSP2024145043$AMGEN$Huiying Q.; Yan P.; Xiangyue Z. et al.. Clinical efficacy and safety of blinatumomab bridging CAR- T cell therapy in the treatment of patients with adult acute B-cell lymphoblastic leukemia. Chin J Hematol. 2024;45 (4):339-343$$$$$Y$$$20240723$$HP$CN$CN
241262172$24126217$2$F$20210521$20240719$20240723$20240802$EXP$GB-MHRA-MED-202407091817023340-TMGQY$GB-ALIMERA SCIENCES INC.-GB-A16013-24-000464$ALIMERA$$54$YR$$F$Y$50$KG$20240802$$CN$GB$GB
241262182$24126218$2$F$$20240729$20240723$20240813$PER$$US-EPICPHARMA-US-2024EPCSPO00847$EPIC PHARM$$36$YR$A$F$Y$90.71$KG$20240813$$CN$US$US
241262191$24126219$1$I$$20240528$20240723$20240723$30DAY$$SE-UCBSA-2024029009$UCB$$$$$$Y$$$20240723$$PH$SE$SE
241262201$24126220$1$I$$20240710$20240723$20240723$EXP$$CA-TEVA-VS-3222754$TEVA$$6$YR$$M$Y$35$KG$20240723$$CN$CA$CA
241262211$24126221$1$I$$20240708$20240723$20240723$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000265$ASSERTIO THERAPEUTICS$$40$YR$$F$Y$$$20240723$$HP$CA$CA
241262222$24126222$2$F$$20240820$20240723$20240823$EXP$$CA-Orion Corporation ORION PHARMA-24_00030936$ORION$$76$YR$E$F$Y$$$20240823$$HP$CA$
241262231$24126223$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50454$$FDA-CTU$$50$YR$$M$N$190$LBS$20240722$N$$US$
241262241$24126224$1$I$20231231$20240721$20240721$20240721$DIR$710935$$FDA-CTU$$33$YR$$F$N$53.1$KG$20240721$N$CN$US$
241262251$24126225$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50413$$FDA-CTU$$81$YR$$M$N$$$20240722$N$$US$
241262271$24126227$1$I$20240516$20240721$20240721$20240721$DIR$710939$$FDA-CTU$$73$YR$$F$N$55.8$KG$20240721$N$CN$US$
241262291$24126229$1$I$$20240716$20240723$20240723$EXP$$US-GSK-US2024089490$GLAXOSMITHKLINE$$$$$F$Y$$$20240723$$MD$US$US
241262301$24126230$1$I$$20240709$20240723$20240723$EXP$$US-GLANDPHARMA-US-2024GLNLIT00524$GLAND PHARMA$C. Puri.A Case of Emphysematous Gastritis With Septic Shock and Clostridioides Difficile.American Journal of Respiratory and Critical Care Medicine.2024;209:A1630$72$YR$E$F$Y$$$20240723$$HP$US$US
241262311$24126231$1$I$20240601$20240718$20240723$20240723$PER$$US-ABBVIE-5849149$ABBVIE$$$$$F$Y$$$20240723$$HP$US$US
241262321$24126232$1$I$20080911$20240709$20240723$20240723$PER$$US-009507513-2407USA008323$MERCK$Charles AJ, Smith VL, Goodwin CR, Johnson MO. An adult with recurrent atypical teratoid rhabdoid tumor of the spine. CNS Oncology. 2024;13 (1)$42$YR$$M$Y$$$20240723$$HP$US$US
241262331$24126233$1$I$20240101$20240710$20240723$20240723$EXP$$JP-INSMED, INC.-2024-02835-JP$INSMED$$73$YR$$F$Y$$$20240723$$PH$JP$JP
241262342$24126234$2$F$20230707$20240905$20240723$20240911$EXP$$JP-009507513-2309JPN001103J$MERCK$$31$YR$$F$Y$$$20240911$$MD$JP$JP
241262351$24126235$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116244$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240723$$CN$US$US
241262362$24126236$2$F$$20240913$20240723$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116497$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240916$$HP$US$US
241262371$24126237$1$I$20240401$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116372$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240723$$HP$US$US
241262381$24126238$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116407$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240723$$HP$US$US
241262391$24126239$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116231$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240723$$CN$US$US
241262401$24126240$1$I$$20240713$20240723$20240723$EXP$$US-ROCHE-10000026995$ROCHE$$$$$$Y$$$20240723$$CN$US$US
241262411$24126241$1$I$$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024143856$AMGEN$$$$$F$Y$$$20240723$$HP$US$US
241262421$24126242$1$I$$20240718$20240723$20240723$PER$$US-ROCHE-10000031722$ROCHE$$$$$F$Y$$$20240723$$CN$US$US
241262431$24126243$1$I$$20240709$20240723$20240723$EXP$$US-BELUSA-2024BELLIT0084$BIOLOGICAL E.$Bhatt G, Meyer C, Shalit B, Butcher BW.Collision of Clots: When Catastrophic Antiphospholipid Syndrome Meets Heparin-induced Thrombocytopenia.Am-J-Respir-Crit-Care-Med.2024;A3544:209$$$$$Y$$$20240723$$HP$US$US
241262441$24126244$1$I$$20240722$20240723$20240723$PER$$US-HALEON-2188393$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241262451$24126245$1$I$$20240716$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007513$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241262462$24126246$2$F$20240801$20240808$20240723$20240812$EXP$$CA-JNJFOC-20240752475$JOHNSON AND JOHNSON$$33$YR$A$M$Y$108$KG$20240812$$HP$CA$CA
241262491$24126249$1$I$$20240715$20240723$20240723$EXP$$US-MYLANLABS-2024M1067894$MYLAN$Grable S, Houchard G, Rossfeld Z. Alpha Alert: Utilization of Transdermal Clonidine for Refractory Agitation. J-Pain-Pall-Care-Pharmacother 2024; 38 (2): 149-152.$79$YR$$M$Y$$$20240723$$PH$US$US
241262501$24126250$1$I$20240718$20240721$20240721$20240721$DIR$710942$$FDA-CTU$$23$YR$$F$N$126.45$KG$20240721$N$CN$US$
241262511$24126251$1$I$20240721$20240721$20240721$20240721$DIR$710930$$FDA-CTU$$38$YR$$F$N$76.05$KG$20240721$N$CN$US$
241262521$24126252$1$I$20240720$20240721$20240721$20240721$DIR$710929$$FDA-CTU$$71$YR$$M$N$96.75$KG$20240721$N$CN$US$
241262531$24126253$1$I$$20240715$20240723$20240723$EXP$$US-MYLANLABS-2024M1067456$MYLAN$Senchyna F, Murugesan K, Rotunno W, Nadimpalli SS, Deresinski S, Banaei N. Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-beta-lactamase-Producing Escherichia coli Causing Fatal Bloodstream Infection. Clin-Infect-Dis 2024; 78 (6): 1425-1428.$12$YR$$M$Y$$$20240723$$HP$US$US
241262541$24126254$1$I$$20240715$20240723$20240723$EXP$$NZ-MYLANLABS-2024M1067443$MYLAN$Ferguson L, Hooper S. Lidocaine Infusion: An Analgesic Option for Checkpoint Inhibitor Arthritis: A Case Report. J-Pain-Pall-Care-Pharmacother 2024; 38 (2): 153-156.$49$YR$$M$Y$$$20240723$$MD$NZ$NZ
241262551$24126255$1$I$$20240715$20240723$20240723$EXP$$US-MYLANLABS-2024M1067451$MYLAN$Acosta C, Zhang C, Deutsch G, Graw-Panzer K. A Case of Persistent Tachypnea in a Two-month-old Infant. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A2330.$2$MON$$M$Y$$$20240723$$HP$US$US
241262561$24126256$1$I$20240629$20240709$20240723$20240723$PER$$US-EPICPHARMA-US-2024EPCSPO00856$EPIC PHARM$$36$YR$A$F$Y$269$KG$20240723$$CN$US$US
241262571$24126257$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116643$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240723$$HP$US$US
241262581$24126258$1$I$$20240709$20240723$20240723$EXP$$US-GLANDPHARMA-US-2024GLNLIT00479$GLAND PHARMA$$77$YR$E$F$Y$$$20240723$$MD$US$US
241262591$24126259$1$I$$20240718$20240723$20240723$EXP$$CN-AMGEN-CHNSP2024145080$AMGEN$Huiying Q.; Yan P.; Xiangvue Z. et al.. Clinical efficacy and safety of blinatumomab bridging CAR- T cell therapy in the treatment of patients with adult acute B-cell lymphoblastic leukemia. Chin J Hematol. 2024;45 (4):339-343$$$$$Y$$$20240723$$HP$CN$CN
241262603$24126260$3$F$$20240801$20240723$20240807$EXP$$CN-AMGEN-CHNSP2024144418$AMGEN$Wenyu Y.; Xiaolan L.; Beibei Z. et al.. The safety and efficacy of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia in children. Natl Med J China. 2024;104 (27):2563-2567$$$$$Y$$$20240807$$HP$CN$CN
241262614$24126261$4$F$20240717$20240731$20240723$20240815$PER$$US-AMGEN-USASP2024142929$AMGEN$$78$YR$E$F$Y$81$KG$20240814$$PH$US$US
241262622$24126262$2$F$$20240801$20240723$20240807$EXP$$CN-AMGEN-CHNSP2024144392$AMGEN$Wenyu Y.; Xiaolan L.; Beibei Z. et al.. The safety and efficacy of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia in children. Natl Med J China. 2024;104 (27):2563-2567$$$$$Y$$$20240807$$HP$CN$CN
241262631$24126263$1$I$$20240715$20240723$20240723$EXP$$PT-AMGEN-PRTSP2024142287$AMGEN$Costa A.; Faustino C.; Correia F. et al.. PO-0184 - (2479) - HEMOPHAGOCYTIC SYNDROME - WHEN SHOULD THIS ENTITY BE CONSIDERED? ABOUT A CLINICAL CASE. 30th National Congress of Internal Medicine (CNMI). 552$50$YR$A$F$Y$$$20240723$$HP$PT$PT
241262641$24126264$1$I$$20240709$20240723$20240723$EXP$$GR-BELUSA-2024BELLIT0085$BIOLOGICAL E.$$$$$$Y$$$20240723$$HP$GR$GR
241262651$24126265$1$I$$20240715$20240723$20240723$EXP$$IT-MYLANLABS-2024M1067545$MYLAN$Scala M, Martinez Trapote P, Rodriguez-Jimenez R, Pecorino B, Serretti A. Managing a Treatment-Resistant Schizophrenia Spectrum Disorder with a Hormonal Twist in a Female Patient: A Case Report of a Progestin-Only Pill. J-Clin-Psychopharmacol 2024; 44 (3): 323-326.$$$A$F$Y$$$20240723$$HP$IT$IT
241262661$24126266$1$I$$20240715$20240723$20240723$EXP$$CH-JNJFOC-20240757448$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$MD$CH$CH
241262672$24126267$2$F$$20240918$20240723$20240925$EXP$$US-INCYTE CORPORATION-2024IN007588$INCYTE$$$$$$Y$$$20240925$$HP$US$US
241262681$24126268$1$I$$20240708$20240723$20240723$EXP$$FR-TEVA-VS-3220847$TEVA$Sallee L, Souchet L, Boutolleau D, Nguyen S. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports. Int-J-Antimicrob-Agents 2024; 63 (6): 1-2.$54$YR$$F$Y$$$20240723$$HP$FR$FR
241262693$24126269$3$F$$20240906$20240723$20240912$EXP$$JP-JNJFOC-20240756068$JOHNSON AND JOHNSON$$2$DEC$A$M$Y$$$20240912$$MD$JP$JP
241262701$24126270$1$I$20230824$20240715$20240723$20240723$EXP$$AU-009507513-2407AUS012159$MERCK$$73$YR$$F$Y$$$20240723$$MD$AU$AU
241262721$24126272$1$I$$20240708$20240723$20240723$EXP$$IN-LUPIN LIMITED-2024-06576$LUPIN$Abdullah, Behera MR, Kaul A, Agarwal V, Prasad P, Prasad N, et al. The unusual adverse effects of antituberculosis therapy in kidney patients. International Journal of Mycobacteriology. 2024;13 (2):183-190$56$YR$$M$Y$$$20240723$$HP$IN$IN
241262731$24126273$1$I$$20240715$20240723$20240723$EXP$$CA-JNJFOC-20240748843$JOHNSON AND JOHNSON$$67$YR$E$F$Y$59$KG$20240723$$HP$CA$CA
241262741$24126274$1$I$$20240709$20240723$20240723$EXP$$US-GLANDPHARMA-US-2024GLNLIT00482$GLAND PHARMA$S Sasidharan.Myxedema Coma Triggering BRASH Syndrome.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$56$YR$A$F$Y$$$20240723$$HP$US$US
241262751$24126275$1$I$$20240719$20240723$20240723$EXP$$US-INCYTE CORPORATION-2024IN007615$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241262761$24126276$1$I$$20240711$20240723$20240723$EXP$$US-RDY-LIT/USA/24/0010519$DR REDDYS$Betts C, Maxwell M, Floyd M, Pawlowski J. Neoadjuvant Cemiplimab Followed by Radiation for Locally Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: A Case Report. Advances in Radiation Oncology. 9(8): doi:10.1016/j.adro.2024.101529.$60$YR$A$F$Y$$$20240723$$HP$US$US
241262772$24126277$2$F$20240912$20240913$20240723$20240924$EXP$$US-BEH-2024175878$CSL BEHRING$$52$YR$A$F$Y$85$KG$20240924$$MD$US$US
241262781$24126278$1$I$$20240709$20240723$20240723$EXP$$US-BELUSA-2024BELLIT0086$BIOLOGICAL E.$$$$$$Y$$$20240723$$HP$US$US
241262791$24126279$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116464$BRISTOL MYERS SQUIBB$$21$YR$A$F$Y$$$20240723$$HP$US$US
241262802$24126280$2$F$20230701$20240725$20240723$20240806$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-23-00439$CATALYST PHARMA$$53$YR$$F$Y$77.551$KG$20240806$$CN$US$US
241262811$24126281$1$I$$20240715$20240723$20240723$PER$$US-ROCHE-10000030027$ROCHE$$24$YR$A$F$Y$$$20240723$$HP$US$US
241262821$24126282$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113937$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240723$$CN$US$US
241262832$24126283$2$F$$20240923$20240723$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110455$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240925$$CN$US$US
241262841$24126284$1$I$$20240718$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114790$BRISTOL MYERS SQUIBB$$97$YR$E$F$Y$$$20240723$$HP$CA$CA
241262851$24126285$1$I$20230727$20240718$20240723$20240723$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407012271$ELI LILLY AND CO$$17$DY$$F$Y$$$20240723$$CN$JP$JP
241262861$24126286$1$I$$20240709$20240723$20240723$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06660$HIKMA$Kwon D, Seu M, Barnes S.. Kwon D, Seu M, Barnes S. Mind the Anion Gap: 5-Oxoproline-Induced High Anion Gap Metabolic Acidosis in End-Stage Renal Disease.. Cureus. 2024;16(5):e61328.:1-5$74$YR$$F$Y$$$20240723$$MD$US$US
241262871$24126287$1$I$$20240708$20240723$20240723$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000270$ASSERTIO THERAPEUTICS$$40$YR$$F$Y$$$20240723$$HP$CA$CA
241262881$24126288$1$I$20240514$20240721$20240721$20240721$DIR$710908$$FDA-CTU$$70$YR$$F$N$78.75$KG$20240721$N$CN$US$
241262891$24126289$1$I$20240719$20240721$20240721$20240721$DIR$710918$$FDA-CTU$$50$YR$$F$N$67.5$KG$20240721$N$CN$US$
241262901$24126290$1$I$20220423$20240721$20240721$20240721$DIR$710922$$FDA-CTU$$$$$UNK$N$$$20240721$N$CN$US$
241262911$24126291$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A166119$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241262921$24126292$1$I$20240716$20240716$20240723$20240723$EXP$$US-MYLANLABS-2024M1067293$MYLAN$$32$YR$$F$Y$$$20240723$$MD$US$US
241262931$24126293$1$I$$20240716$20240723$20240723$EXP$$US-MYLANLABS-2024M1067888$MYLAN$Torelli VA, Ernest Jean R, Tran E. Acute Hypoxic Respiratory Failure Secondary to Daptomycin-induced Eosinophilic Pneumonia. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A2019.$86$YR$$F$Y$$$20240723$$HP$US$US
241262941$24126294$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50451$$FDA-CTU$$57$YR$$F$N$$$20240722$N$$US$
241262961$24126296$1$I$$20240716$20240723$20240723$EXP$$AU-MYLANLABS-2024M1067437$MYLAN$Mellor R, Girgis CM, Rodrigues A, Chen C, Cuan S, Gambhir P, et al. Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer. Curr-Oncol 2024; 31 (2): 828-838.$$$$M$Y$$$20240723$$HP$AU$AU
241262971$24126297$1$I$$20240716$20240723$20240723$EXP$$NL-MYLANLABS-2024M1067243$MYLAN$$26$YR$$M$Y$$$20240723$$HP$NL$NL
241262984$24126298$4$F$$20240909$20240723$20240913$EXP$$GR-MYLANLABS-2024M1067033$MYLAN$Giannias R, Alexandrou S, Ntoumou E, Adamidou S, Skafida E, Tzortzi M. A case of serotoninergic syndrome. Archives of Hellenic Medicine. 2024;41(4):555-557$82$YR$$F$Y$$$20240913$$HP$GR$GR
241262991$24126299$1$I$$20240716$20240723$20240723$EXP$$US-MYLANLABS-2024M1067858$MYLAN$Anderson M, Brozzi N, Rosenthal R, Hernandez-Montfort J, Reddy R, Gopalan R. Panel Discussion: Non-cardiac Surgery Interventions on Patients Receiving Impella Support. Interven-Cardiol-(London) 2024; 19 (Suppl.) 31-34.$66$YR$$F$Y$$$20240723$$MD$US$US
241263001$24126300$1$I$$20240716$20240723$20240723$EXP$$US-MYLANLABS-2024M1067585$MYLAN$Weigle DP, Nielsen A, Braunecker S. Uncommon and Unfavorable: Heparin-Induced Hyperkalemia. J-Cardiothorac-Vasc-Anesth 2024; 1-4.$56$YR$$M$Y$$$20240723$$MD$US$US
241263011$24126301$1$I$20240619$20240716$20240723$20240723$EXP$$NL-MYLANLABS-2024M1066851$MYLAN$$67$YR$$F$Y$82$KG$20240723$$HP$NL$NL
241263021$24126302$1$I$$20240716$20240723$20240723$EXP$NL-LRB-00981305$NL-MYLANLABS-2024M1066838$MYLAN$$37$YR$$F$Y$95$KG$20240723$$CN$NL$NL
241263031$24126303$1$I$20230407$20240716$20240723$20240723$EXP$FR-AFSSAPS-TO2024001283$FR-MYLANLABS-2024M1067265$MYLAN$$82$YR$$M$Y$75$KG$20240723$$PH$FR$FR
241263041$24126304$1$I$20240610$20240716$20240723$20240723$EXP$FR-AFSSAPS-LL2024001275$FR-MYLANLABS-2024M1067090$MYLAN$$62$YR$$F$Y$$$20240723$$PH$FR$FR
241263051$24126305$1$I$$20240716$20240723$20240723$EXP$$US-MYLANLABS-2024M1068062$MYLAN$Kuczmarski TM, Lynch RC. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma. Br-J-Haematol 2024; 205 (1): 100-108.$58$YR$$M$Y$$$20240723$$HP$US$US
241263061$24126306$1$I$$20240718$20240723$20240723$EXP$$CA-ROCHE-3338008$ROCHE$$$$A$F$Y$$$20240723$$CN$CA$CA
241263073$24126307$3$F$$20240820$20240723$20240824$EXP$$FR-AstraZeneca-2024A166654$ASTRAZENECA$$$$$F$Y$$$20240823$$HP$FR$
241263081$24126308$1$I$$20240709$20240723$20240723$PER$$US-EPICPHARMA-US-2024EPCSPO00817$EPIC PHARM$$$$$$Y$$$20240723$$CN$US$US
241263091$24126309$1$I$$20240718$20240723$20240723$EXP$$AR-JNJFOC-20240752552$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240723$$CN$AR$AR
241263101$24126310$1$I$20240620$20240716$20240723$20240723$EXP$$CO-AMGEN-COLSP2024137329$AMGEN$$48$YR$A$M$Y$$$20240723$$MD$CO$CO
241263111$24126311$1$I$20220215$20220303$20240723$20240723$EXP$$US-AstraZeneca-2022A099879$ASTRAZENECA$$21855$DY$$F$Y$$$20240723$$CN$US$
241263122$24126312$2$F$20240720$20240723$20240723$20240724$PER$$US-AMGEN-USASP2024145566$AMGEN$$49$YR$A$F$Y$$$20240724$$CN$US$US
241263131$24126313$1$I$$20240716$20240723$20240723$30DAY$$US-GSK-US2024089562$GLAXOSMITHKLINE$$$$$M$Y$$$20240723$$CN$US$US
241263141$24126314$1$I$$20240709$20240723$20240723$EXP$$PE-GLANDPHARMA-PE-2024GLNLIT00504$GLAND PHARMA$$34$YR$A$F$Y$$$20240723$$HP$PE$PE
241263151$24126315$1$I$20231225$20240715$20240723$20240723$EXP$$CA-CELLTRION INC.-2023CA025337$CELLTRION$$$$$$Y$$$20240723$$CN$CA$CA
241263161$24126316$1$I$$20240716$20240723$20240723$EXP$$JP-PFIZER INC-202400220474$PFIZER$Tokoyoda, S.. Three cases of osteosarcoma in which delayed elimination of methotrexate resulted from third spacing following high-dose methotrexate sodium therapy. The Journal of the Japanese Orthopaedic Association. 2024;98(6)$13$YR$$M$Y$$$20240723$$HP$JP$JP
241263171$24126317$1$I$$20240719$20240723$20240723$EXP$$CA-PFIZER INC-202400220680$PFIZER$$$$$$Y$$$20240723$$HP$CA$CA
241263181$24126318$1$I$$20240719$20240723$20240723$EXP$$CA-PFIZER INC-202400220674$PFIZER$$$$$$Y$$$20240723$$HP$CA$CA
241263191$24126319$1$I$$20240718$20240723$20240723$EXP$$US-PFIZER INC-202400219225$PFIZER$$64$YR$$M$Y$$$20240723$$CN$US$US
241263202$24126320$2$F$20240601$20240806$20240723$20240809$EXP$$US-PFIZER INC-202400218798$PFIZER$$70$YR$$F$Y$$$20240809$$CN$US$US
241263212$24126321$2$F$20231201$20240719$20240723$20240724$EXP$$CN-PFIZER INC-202400218866$PFIZER$Li, J.. Systemic Lupus Erythematosus Complicated with Mycobacterium Leprae Infection: a Rare Case Report. Clinical laboratory. 2024;70(7):1388-1391$42$YR$$F$Y$$$20240724$$MD$CN$CN
241263222$24126322$2$F$$20240801$20240723$20240805$EXP$$CN-PFIZER INC-PV202400095035$PFIZER$Chen, Z.. Therapeutic effect of haploidentical hematopoietic stem cell transplantation for treatment of infant acute leukemia harboring KMT2A - r gene rearrangements. Journal of China Pediatric Blood and Cancer. 2024;29(3):186-193$$$C$M$Y$$$20240805$$HP$CN$CN
241263231$24126323$1$I$$20240719$20240723$20240723$EXP$$CA-PFIZER INC-202400220635$PFIZER$$$$$$Y$$$20240723$$HP$CA$CA
241263241$24126324$1$I$$20240719$20240723$20240723$EXP$$CA-PFIZER INC-202400220724$PFIZER$$$$$$Y$$$20240723$$HP$CA$CA
241263253$24126325$3$F$$20240905$20240723$20240906$PER$$NVSC2024US149870$NOVARTIS$$$$$M$Y$$$20240906$$CN$US$US
241263261$24126326$1$I$$20240709$20240723$20240723$PER$$US-EPICPHARMA-US-2024EPCSPO00857$EPIC PHARM$$$$$$Y$$$20240723$$CN$US$US
241263272$24126327$2$F$$20240905$20240723$20240910$EXP$$JP-OTSUKA-2024_020185$OTSUKA$$20$YR$$M$Y$$$20240910$$MD$JP$JP
241263281$24126328$1$I$$20240712$20240723$20240723$EXP$$CN-ROCHE-10000031043$ROCHE$Gu Y, Chu X Z. Thrombolysis with low-dose and standard-dose intravenous recombinant tissue plasminogen activator in elderly patients with acute ischemic stroke: a stratified analysis.. The Journal of Practical Medicine. 2024;40 (11):1568-73.$$$E$$Y$$$20240723$$MD$CN$CN
241263292$24126329$2$F$20231218$20240723$20240723$20240730$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700033$UPSHER SMITH LABORATORIES$$0$YR$$F$Y$8.6$KG$20240730$$$US$US
241263302$24126330$2$F$20240101$20240820$20240723$20240823$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-100489$REGENERON$$$$$F$Y$$$20240823$$CN$US$US
241263311$24126331$1$I$$20240710$20240723$20240723$EXP$$PT-SCIEGENP-2024SCLIT00340$SCIEGEN$Sousa BSGC, et al.Decoding the enigma: Valproate encephalopathy in a bipolar  affective disorder without hyperammonemia.Bipolar Disorders.JUN-2024;1 (1):1-3$63$YR$A$F$Y$$$20240723$$HP$PT$PT
241263321$24126332$1$I$$20240716$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007510$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241263331$24126333$1$I$$20240717$20240723$20240723$EXP$$CA-Orion Corporation ORION PHARMA-24_00030943$ORION$$$$$F$Y$$$20240723$$MD$CA$
241263342$24126334$2$F$20240101$20240709$20240723$20240726$PER$$US-TEVA-VS-3221153$TEVA$$71$YR$$F$Y$64.41$KG$20240726$$PH$US$US
241263351$24126335$1$I$$20240709$20240723$20240723$EXP$$US-GLANDPHARMA-US-2024GLNLIT00485$GLAND PHARMA$M Shakir.Spontaneous Pulmonary Hematoma on Heparin Infusion With Rapid Progression.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$66$YR$E$M$Y$$$20240723$$HP$US$US
241263361$24126336$1$I$$20240717$20240723$20240723$PER$$US-GILEAD-2024-0681256$GILEAD$$$$$M$Y$$$20240723$$HP$US$US
241263375$24126337$5$F$20220101$20240910$20240723$20240917$EXP$$NVSC2024MX131934$NOVARTIS$$$$$F$Y$86$KG$20240917$$CN$MX$MX
241263382$24126338$2$F$$20240724$20240723$20240731$EXP$$NVSC2024CA146446$NOVARTIS$$40$YR$$F$Y$$$20240731$$HP$CA$CA
241263391$24126339$1$I$$20240717$20240723$20240723$EXP$$NVSC2024US148399$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
241263401$24126340$1$I$$20240715$20240723$20240723$PER$$US-AMGEN-USASP2024141794$AMGEN$Shantha J. G.; Choo C. H.; Acharya N. R.. Common practice patterns in the diagnosis and management of Vogt-Koyanagi-Harada syndrome: a survey study of uveitis specialists. Frontiers in ophthalmology Publication. 2023;3:1-6$$$$$Y$$$20240723$$HP$US$US
241263411$24126341$1$I$$20240718$20240723$20240723$EXP$$US-ORGANON-O2407USA001898$ORGANON$$$$$F$Y$$$20240723$$CN$US$US
241263421$24126342$1$I$$20240716$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007508$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241263432$24126343$2$F$20240710$20240813$20240723$20240824$EXP$$US-Accord-435861$ACCORD$$34$YR$A$M$Y$$$20240824$$HP$US$US
241263441$24126344$1$I$$20240712$20240723$20240723$EXP$CA-MHPD-E2B_001084463$CA-Accord-436104$ACCORD$$69$YR$E$M$Y$65$KG$20240723$$PH$CA$CA
241263452$24126345$2$F$20240627$20240718$20240723$20240726$EXP$$US-AMGEN-USASP2024142850$AMGEN$$29$YR$A$M$Y$$$20240726$$HP$US$US
241263461$24126346$1$I$$20240718$20240723$20240723$EXP$$CA-Orion Corporation ORION PHARMA-24_00030949$ORION$$60$YR$A$M$Y$$$20240723$$HP$CA$
241263471$24126347$1$I$20240101$20240715$20240723$20240723$EXP$$IN-AMGEN-USASL2024141388$AMGEN$$36$YR$A$F$Y$$$20240723$$CN$IN$US
241263481$24126348$1$I$$20240711$20240723$20240723$EXP$$US-Accord-436432$ACCORD$$$$$F$Y$90.72$KG$20240723$$CN$US$US
241263491$24126349$1$I$20200201$20240716$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007507$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241263501$24126350$1$I$20240618$20240715$20240723$20240723$EXP$$CN-BEIGENE-BGN-2024-011012$BEIGENE$$$$$$Y$$$20240723$$HP$CN$CN
241263511$24126351$1$I$20240429$20240716$20240723$20240723$EXP$CH-SM-2024-12957$CH-UCBSA-2024035942$UCB$$54$YR$$F$Y$$$20240723$$MD$CH$CH
241263521$24126352$1$I$$20240716$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007500$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241263531$24126353$1$I$$20240716$20240723$20240723$EXP$$US-VIVUS LLC-2024V1000905$VIVUS$$$$A$F$Y$$$20240723$$CN$US$US
241263541$24126354$1$I$$20240716$20240723$20240723$EXP$$US-VIVUS LLC-2024V1000903$VIVUS$$$$A$F$Y$$$20240723$$CN$US$US
241263551$24126355$1$I$$20240709$20240723$20240723$EXP$$US-GLANDPHARMA-US-2024GLNLIT00483$GLAND PHARMA$S Sompalli.A Rare Case of Non-traumatic Splenic Rupture Following Portal Vein Thrombosis.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$53$YR$A$F$Y$$$20240723$$HP$US$US
241263561$24126356$1$I$$20240717$20240723$20240723$EXP$$CA-Orion Corporation ORION PHARMA-24_00030957$ORION$$7$YR$C$F$Y$33$KG$20240723$$HP$CA$
241263571$24126357$1$I$20240718$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50518$$FDA-CTU$$61$YR$$M$N$$$20240719$N$HP$US$
241263591$24126359$1$I$20240521$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50503$$FDA-CTU$$83$YR$$M$N$72.58$KG$20240719$N$PH$US$
241263601$24126360$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50531$$FDA-CTU$$58$YR$$M$N$$$20240719$N$HP$US$
241263611$24126361$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50447$$FDA-CTU$$57$YR$$F$N$$$20240722$N$$US$
241263631$24126363$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50393$$FDA-CTU$$77$YR$$F$N$$$20240722$N$$US$
241263641$24126364$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50526$$FDA-CTU$$$$$F$N$$$20240722$Y$HP$US$
241263651$24126365$1$I$20240629$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50539$$FDA-CTU$$91$YR$$M$N$$$20240722$Y$PH$US$
241263661$24126366$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50425$$FDA-CTU$$20$YR$$M$N$$$20240722$N$$US$
241263671$24126367$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50400$$FDA-CTU$$42$YR$$F$N$119.29$KG$20240722$N$$US$
241263681$24126368$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50482$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241263713$24126371$3$F$20160101$20240909$20240723$20240922$EXP$$US-UCBSA-2024036141$UCB$$$$$M$Y$$$20240922$$HP$US$US
241263721$24126372$1$I$$20240715$20240723$20240723$30DAY$$US-GSK-US2024088738$GLAXOSMITHKLINE$$$$$M$Y$$$20240723$$CN$US$US
241263732$24126373$2$F$20240717$20240724$20240723$20240729$PER$$US-AMGEN-USASP2024143621$AMGEN$$44$YR$A$M$Y$$$20240729$$CN$US$US
241263741$24126374$1$I$20240717$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024143749$AMGEN$$55$YR$A$F$Y$$$20240723$$CN$US$US
241263751$24126375$1$I$$20240718$20240723$20240723$EXP$$CA-TAKEDA-2024TUS073418$TAKEDA$$$$$M$Y$$$20240723$$CN$CA$CA
241263761$24126376$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116247$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240723$$PH$US$US
241263771$24126377$1$I$20240613$20240715$20240723$20240723$EXP$$CN-BEIGENE-BGN-2024-011013$BEIGENE$$$$$$Y$$$20240723$$HP$CN$CN
241263781$24126378$1$I$$20240710$20240723$20240723$EXP$$GB-BEH-2024175650$CSL BEHRING$$$$$F$Y$$$20240723$$CN$GB$GB
241263793$24126379$3$F$$20240801$20240723$20240807$EXP$$CA-TAKEDA-2024TUS072507$TAKEDA$$$$$F$Y$$$20240807$$CN$CA$CA
241263801$24126380$1$I$$20240715$20240723$20240723$EXP$$CA-TAKEDA-2024TUS069124$TAKEDA$$$$$F$Y$$$20240723$$CN$CA$CA
241263811$24126381$1$I$20240719$20240719$20240723$20240723$EXP$$MY-PFIZER INC-202400219649$PFIZER$$34$YR$$M$Y$$$20240723$$MD$MY$MY
241263821$24126382$1$I$$20240716$20240723$20240723$EXP$$JP-PFIZER INC-PV202400093550$PFIZER$Tokoyoda, S.. Three cases of osteosarcoma in which delayed elimination of methotrexate resulted from third spacing following high-dose methotrexate sodium therapy. The Journal of the Japanese Orthopaedic Association. 2024;98(6)$15$YR$$M$Y$$$20240723$$HP$JP$JP
241263831$24126383$1$I$$20240722$20240723$20240723$EXP$$FR-PFIZER INC-202400220539$PFIZER$Archer E.. Hypofibrinogenemia induced by corticoids alone during the treatment of acute lymphoblastic leukemia: about a clinical case at the CHU de Tours. REVUE FRANCOPHONE D HEMOSTASE ET THROMBOSE. 2024;6(2):67-70$14$YR$$M$Y$$$20240723$$HP$FR$FR
241263841$24126384$1$I$$20240716$20240723$20240723$EXP$$JP-PFIZER INC-202400220475$PFIZER$Tokoyoda, S.. Three cases of osteosarcoma in which delayed elimination of methotrexate resulted from third spacing following high-dose methotrexate sodium therapy. The Journal of the Japanese Orthopaedic Association. 2024;98(6)$12$YR$$M$Y$$$20240723$$HP$JP$JP
241263851$24126385$1$I$20240719$20240719$20240723$20240723$EXP$GB-MHRA-MED-202407191629259490-VPTKM$GB-PFIZER INC-202400219314$PFIZER$$54$YR$$F$Y$78$KG$20240723$$HP$GB$GB
241263861$24126386$1$I$$20240715$20240723$20240723$EXP$$US-PFIZER INC-PV202400093787$PFIZER$Hill, B.. Complete remission of CD30-positive difuse large B-cell lymphoma in a patient with post-transplant lymphoproliferative disorder and end-stage renal disease treated with single-agent brentuximab vedotin. Leukemia + Lymphoma. 2015;56 (5):1552-1553$62$YR$$F$Y$$$20240723$$MD$US$US
241263872$24126387$2$F$20240628$20240719$20240723$20240725$EXP$$US-PFIZER INC-202400219780$PFIZER$$12$YR$$M$Y$29.4$KG$20240725$$MD$US$US
241263881$24126388$1$I$$20240722$20240723$20240723$EXP$$MA-PFIZER INC-PV202400096025$PFIZER$$$$$F$Y$$$20240723$$CN$MA$MA
241263891$24126389$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50478$$FDA-CTU$$65$YR$$F$N$$$20240722$N$$US$
241263901$24126390$1$I$20240101$20240722$20240723$20240723$EXP$$JP-PFIZER INC-PV202400095261$PFIZER$$9$DEC$$M$Y$$$20240723$$PH$JP$JP
241263921$24126392$1$I$20240401$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50593$$FDA-CTU$$55$YR$$F$N$79.11$KG$20240722$N$HP$US$
241263951$24126395$1$I$$20240717$20240723$20240723$EXP$$CA-MYLANLABS-2024M1066909$MYLAN$$94$YR$$F$Y$$$20240723$$PH$CA$CA
241263962$24126396$2$F$$20240718$20240723$20240730$PER$$US-AMGEN-USASP2024145549$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241263972$24126397$2$F$20240101$20240724$20240723$20240730$EXP$$US-JNJFOC-20240752235$JOHNSON AND JOHNSON$$$$$M$Y$$$20240731$$HP$US$US
241263981$24126398$1$I$$20240718$20240723$20240723$PER$$US-JNJFOC-20240753712$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$MD$US$US
241263991$24126399$1$I$20240718$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024145162$AMGEN$$$$$$Y$$$20240723$$HP$US$US
241264011$24126401$1$I$20240709$20240715$20240723$20240723$EXP$$CN-SA-2024SA211368$SANOFI AVENTIS$$70$YR$E$F$Y$60$KG$20240723$$HP$CN$CN
241264021$24126402$1$I$20240612$20240712$20240723$20240723$EXP$$CO-HBP-2024CO030998$HELSINN HEALTHCARE$$$$A$F$Y$$$20240723$$MD$CO$CO
241264031$24126403$1$I$$20240715$20240723$20240723$EXP$$AU-TAKEDA-2024TUS072855$TAKEDA$$$$$F$Y$$$20240723$$HP$AU$AU
241264051$24126405$1$I$20240709$20240711$20240723$20240723$EXP$$US-Accord-436791$ACCORD$$38$YR$A$M$Y$$$20240723$$PH$US$US
241264061$24126406$1$I$20240620$20240716$20240723$20240723$EXP$$US-Vifor (International) Inc.-VIT-2024-06361$VIFOR$$43$YR$$M$Y$102$KG$20240723$$HP$US$US
241264072$24126407$2$F$$20240808$20240723$20240819$PER$$US-INCYTE CORPORATION-2024IN007493$INCYTE$$$$$$Y$$$20240819$$CN$US$US
241264081$24126408$1$I$$20240716$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007490$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241264091$24126409$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115961$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240723$$CN$US$US
241264101$24126410$1$I$$20240718$20240723$20240723$EXP$$CN-AMGEN-CHNSP2024145154$AMGEN$Huiying Q.; Yan P.; Xiangyue Z. et al.. Clinical efficacy and safety of blinatumomab bridging CAR- T cell therapy in the treatment of patients with adult acute B-cell lymphoblastic leukemia. Chin J Hematol. 2024;45 (4):339-343$$$$$Y$$$20240723$$HP$CN$CN
241264111$24126411$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115849$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240723$$CN$US$US
241264121$24126412$1$I$$20240718$20240723$20240723$PER$$US-GILEAD-2024-0681303$GILEAD$$$$$$Y$$$20240723$$CN$US$US
241264131$24126413$1$I$20230101$20240717$20240723$20240723$EXP$$NVSC2022AR279045$NOVARTIS$$23$YR$$M$Y$$$20240723$$CN$AR$AR
241264141$24126414$1$I$$20240722$20240723$20240723$PER$$US-HALEON-2188386$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241264152$24126415$2$F$20240101$20240725$20240723$20240726$EXP$$US-ABBVIE-5847705$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241264161$24126416$1$I$$20240718$20240723$20240723$EXP$$BR-JNJFOC-20240753293$JOHNSON AND JOHNSON$$35$YR$A$M$Y$62$KG$20240723$$CN$BR$BR
241264171$24126417$1$I$20240401$20240717$20240723$20240723$EXP$$US-ABBVIE-5844894$ABBVIE$$56$YR$$F$Y$$$20240723$$CN$US$US
241264182$24126418$2$F$20240701$20240730$20240723$20240805$EXP$$CO-JNJFOC-20240749886$JOHNSON AND JOHNSON$$79$YR$E$F$Y$46$KG$20240804$$HP$CO$CO
241264191$24126419$1$I$20240717$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143413$AMGEN$$66$YR$E$M$Y$$$20240723$$CN$US$US
241264201$24126420$1$I$$20240717$20240723$20240723$PER$$NVSC2024US148298$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
241264211$24126421$1$I$20240719$20240719$20240723$20240723$PER$$NVSC2024US149960$NOVARTIS$$79$YR$$F$Y$$$20240723$$CN$US$US
241264221$24126422$1$I$$20240710$20240723$20240723$EXP$$CA-TEVA-VS-3222683$TEVA$$13$YR$$M$Y$33$KG$20240723$$HP$CA$CA
241264231$24126423$1$I$$20240528$20240723$20240723$PER$$US-LUNDBECK-DKLU3078652$LUNDBECK$$$$$$Y$$$20240723$$HP$US$US
241264241$24126424$1$I$$20240719$20240723$20240723$EXP$$US-GILEAD-2024-0681453$GILEAD$$$$E$F$Y$$$20240723$$CN$US$US
241264251$24126425$1$I$$20240529$20240723$20240723$PER$$US-LUNDBECK-DKLU4000055$LUNDBECK$$$$$$Y$$$20240723$$CN$US$US
241264261$24126426$1$I$$20240709$20240723$20240723$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06632$HIKMA$Weigle DP, Nielsen A, Braunecker S.. Weigle DP, Nielsen A, Braunecker S. Uncommon and Unfavorable: Heparin-Induced Hyperkalemia.. J Cardiothorac Vasc Anesth.. 2024;1-4:1-4 pgs$56$YR$$M$Y$$$20240723$$MD$US$US
241264271$24126427$1$I$$20240711$20240723$20240723$EXP$$US-ABBVIE-5847098$ABBVIE$$$$$M$Y$$$20240723$$MD$US$US
241264281$24126428$1$I$$20240708$20240723$20240723$EXP$$JP-SANDOZ INC.-SDZ2024JP064416$SANDOZ$Horisawa S, Kim K, Murakami M, Nishitani M, Kawamata T, Taira T. Efficacy and safety of zolpidem for musician^s dystonia. Journal of movement disorders$62$YR$$$Y$$$20240723$$MD$JP$JP
241264302$24126430$2$F$$20240910$20240723$20240923$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000268$ASSERTIO THERAPEUTICS$$43$YR$$F$Y$$$20240923$$HP$CA$CA
241264311$24126431$1$I$$20240718$20240723$20240723$EXP$$US-SA-2024SA213303$SANOFI AVENTIS$$$$E$M$Y$$$20240723$$MD$US$US
241264331$24126433$1$I$$20240715$20240723$20240723$EXP$$AR-GSK-AR2024AMR089828$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$AR$AR
241264341$24126434$1$I$$20240716$20240723$20240723$PER$$US-GILEAD-2024-0681000$GILEAD$$$$$M$Y$$$20240723$$CN$US$US
241264351$24126435$1$I$$20240529$20240723$20240723$PER$$US-LUNDBECK-DKLU3078699$LUNDBECK$$$$$$Y$$$20240723$$CN$US$US
241264362$24126436$2$F$$20240723$20240723$20240729$EXP$$US-PFIZER INC-202400217537$PFIZER$Stewart, M.. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecologic Oncology Reports. 2024;54:10.1016/j.gore.2024.101452$33$YR$$F$Y$$$20240729$$HP$US$US
241264372$24126437$2$F$20220801$20240722$20240723$20240725$EXP$$TW-PFIZER INC-202400219433$PFIZER$Peng, T.. Gemcitabine-Associated Hyperammonemia in a Patient With Cholangiocarcinoma. American journal of therapeutics. 2024;31(4):e439-e440$57$YR$$F$Y$$$20240725$$HP$TW$TW
241264381$24126438$1$I$$20240722$20240723$20240723$EXP$$FR-PFIZER INC-2021SGN00340$PFIZER$$72$YR$$F$Y$$$20240723$$HP$FR$FR
241264431$24126443$1$I$20240607$20240708$20240723$20240723$EXP$FR-AFSSAPS-GR2024000832$FR-SERVIER-S24009020$SERVIER$$$$$$Y$$$20240723$$PH$FR$FR
241264441$24126444$1$I$20220301$20221024$20240723$20240723$EXP$$CA-AstraZeneca-2022A357522$ASTRAZENECA$$957$MON$$M$Y$$$20240723$$CN$CA$
241264451$24126445$1$I$$20230502$20240723$20240723$EXP$$US-AstraZeneca-2023A103866$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241264461$24126446$1$I$$20240709$20240723$20240723$EXP$$TH-ASTELLAS-2024US020492$ASTELLAS$$60$YR$$F$Y$$$20240723$$CN$CH$TH
241264471$24126447$1$I$20240626$20240717$20240723$20240723$PER$$US-Eisai-EC-2024-170453$EISAI$$64$YR$A$M$Y$$$20240723$$CN$US$US
241264481$24126448$1$I$$20240722$20240723$20240723$PER$$US-HALEON-2188420$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241264491$24126449$1$I$20230101$20240717$20240723$20240723$EXP$$US-ABBVIE-5846789$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241264502$24126450$2$F$$20240722$20240723$20240723$EXP$$US-ROCHE-10000032348$ROCHE$Barnajian M, Gioia W, Iordache F, Bergamasch, R. Mucormycosis-Induced Colon Perforationafter Renal Transplantation. SURGICAL INFECTIONS. 2014;15 (5):1-2. doi:10.1089/sur.2013.131.$66$YR$E$M$Y$$$20240723$$HP$US$US
241264511$24126451$1$I$$20240717$20240723$20240723$EXP$$PT-009507513-2407PRT011569$MERCK$$71$YR$$F$Y$$$20240723$$MD$PT$PT
241264521$24126452$1$I$$20240721$20240723$20240723$PER$$NVSC2024US150198$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
241264531$24126453$1$I$20240101$20240722$20240723$20240723$PER$$US-AMGEN-USASP2024145449$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241264541$24126454$1$I$$20240716$20240723$20240723$EXP$$FR-Waylis Therapeutics LLC-ATNAHS20240702027$Waylis$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N, Pelletier R and al.. a national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxicologie Analytique + Clinique. 2023;35:376-394. doi:DOI.org/10.1016/j.toxac.2023.09.008$27$YR$A$M$Y$$$20240723$$MD$FR$FR
241264551$24126455$1$I$20240714$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144049$AMGEN$$75$YR$E$F$Y$$$20240723$$CN$US$US
241264561$24126456$1$I$$20240717$20240723$20240723$EXP$$JP-ABBVIE-5848173$ABBVIE$$$$$M$Y$$$20240723$$MD$JP$JP
241264571$24126457$1$I$$20240716$20240723$20240723$EXP$$CA-GSK-CA2023140508$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$HP$CA$CA
241264581$24126458$1$I$$20240717$20240723$20240723$EXP$$US-GSK-US2024AMR091351$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
241264591$24126459$1$I$$20240717$20240723$20240723$EXP$$US-GSK-US2024AMR090456$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
241264601$24126460$1$I$$20240711$20240723$20240723$EXP$$CA-TEVA-VS-3221966$TEVA$$30$YR$$F$Y$$$20240723$$HP$CA$CA
241264612$24126461$2$F$$20240719$20240723$20240724$EXP$$LB-Merz Pharmaceuticals GmbH-2024070000035$MERZ$$$$$$Y$$$20240724$$MD$LB$LB
241264621$24126462$1$I$$20240709$20240723$20240723$EXP$$JP-GALDERMA-JP2024011090$GALDERMA$$$$$$Y$$$20240723$$PH$JP$JP
241264631$24126463$1$I$$20240718$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115796$BRISTOL MYERS SQUIBB$Article cannot be requested due to no citation$$$$$Y$$$20240723$$HP$CA$CA
241264641$24126464$1$I$20210622$20240717$20240723$20240723$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-116454$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$65$KG$20240723$$MD$KR$KR
241264661$24126466$1$I$20210101$20240716$20240723$20240723$PER$$US-ABBVIE-2128650US$ABBVIE$$36$YR$$F$Y$161$KG$20240723$$HP$US$US
241264673$24126467$3$F$$20240722$20240723$20240726$PER$$NVSC2024US150899$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241264681$24126468$1$I$$20240715$20240723$20240723$PER$$US-ABBVIE-5843587$ABBVIE$$$$A$F$Y$$$20240723$$HP$US$US
241264691$24126469$1$I$$20240718$20240723$20240723$EXP$$FR-JNJFOC-20240748701$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240723$$PH$FR$FR
241264702$24126470$2$F$20240201$20240722$20240723$20240724$EXP$FR-AFSSAPS-LM2024000399$FR-GILEAD-2024-0681499$GILEAD$$77$YR$E$M$Y$58$KG$20240724$$MD$FR$FR
241264712$24126471$2$F$$20240724$20240723$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07097$LUPIN$$$$$$Y$$$20240818$$CN$US$US
241264721$24126472$1$I$20240429$20240706$20240723$20240723$PER$$US-BEH-2024172012$CSL BEHRING$$28$YR$A$F$Y$$$20240723$$HP$US$US
241264731$24126473$1$I$$20240717$20240723$20240723$EXP$$US-GSK-US2024AMR090531$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
241264741$24126474$1$I$$20240716$20240723$20240723$EXP$$CN-AMGEN-CHNSP2024141963$AMGEN$Mao X.; Chen Y.; Wang J. et al.. Pituitary-adrenal axis dysfunction induced by tislelizumab immunotherapy for non-small cell lung cancer: a case series and literature review. BMC Pulmonary Medicine. 2024;24 (1):1-8$74$YR$E$M$Y$$$20240723$$HP$CN$CN
241264751$24126475$1$I$$20240716$20240723$20240723$PER$$US-ABBVIE-5843742$ABBVIE$$$$A$$Y$$$20240723$$CN$US$US
241264761$24126476$1$I$$20240717$20240723$20240723$EXP$$US-GSK-US2024AMR090448$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
241264771$24126477$1$I$$20240722$20240722$20240722$DIR$710975$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241264782$24126478$2$F$$20240809$20240723$20240819$EXP$$PL-TEVA-VS-3220934$TEVA$Skowronski M, Halicki P, Halicka A. Disseminated BCGitis after intravesical Bacillus Calmette-Guerin therapy in a patient with bladder cancer. Pol-Arch-Med-Wewn 2024; 134 (5):.; Skowronski M, Halicki P, Halicka A. Disseminated BCGitis after intravesical Bacillus Calmette-Guerin therapy in a patient with bladder cancer. Pol-Arch-Med-Wewn 2024; 134 (5):.$58$YR$$M$Y$$$20240819$$MD$PL$PL
241264791$24126479$1$I$$20240720$20240723$20240723$PER$$US-PFIZER INC-PV202400095093$PFIZER$$65$YR$$$Y$$$20240723$$CN$US$US
241264802$24126480$2$F$$20240822$20240723$20240822$30DAY$$US-PFIZER INC-202400213348$PFIZER$$58$YR$$M$Y$$$20240822$$HP$US$US
241264811$24126481$1$I$$20240722$20240723$20240723$PER$$US-PFIZER INC-PV202400095626$PFIZER$$51$YR$$F$Y$$$20240723$$HP$US$US
241264821$24126482$1$I$$20240717$20240723$20240723$PER$$JP-PFIZER INC-202400216650$PFIZER$$$$$$Y$$$20240723$$PH$JP$JP
241264831$24126483$1$I$$20240722$20240723$20240723$PER$$US-PFIZER INC-PV202400095625$PFIZER$$55$YR$$F$Y$$$20240723$$HP$US$US
241264842$24126484$2$F$20240717$20240806$20240723$20240808$PER$$US-PFIZER INC-202400221517$PFIZER$$49$YR$$F$Y$56.236$KG$20240808$$HP$US$US
241264854$24126485$4$F$20240701$20240822$20240723$20240822$30DAY$$US-PFIZER INC-202400214143$PFIZER$$15$YR$$M$Y$$$20240822$$CN$US$US
241264861$24126486$1$I$20220801$20240722$20240723$20240723$PER$$US-PFIZER INC-PV202400095683$PFIZER$$21$YR$$F$Y$$$20240723$$CN$US$US
241264871$24126487$1$I$20240601$20240722$20240723$20240723$PER$$US-PFIZER INC-202400220790$PFIZER$$$$$F$Y$$$20240723$$MD$US$US
241264881$24126488$1$I$20240701$20240722$20240723$20240723$PER$$US-PFIZER INC-202400220900$PFIZER$$61$YR$$F$Y$$$20240723$$CN$US$US
241264901$24126490$1$I$$20240722$20240723$20240723$PER$$US-PFIZER INC-PV202400095961$PFIZER$$61$YR$$M$Y$$$20240723$$CN$US$US
241264912$24126491$2$F$20240706$20240724$20240723$20240726$PER$$US-PFIZER INC-202400219917$PFIZER$$46$YR$$F$Y$$$20240726$$HP$US$US
241264921$24126492$1$I$20240701$20240722$20240723$20240723$PER$$US-PFIZER INC-PV202400095861$PFIZER$$78$YR$$$Y$$$20240723$$CN$US$US
241264931$24126493$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-PV202400095576$PFIZER$$69$YR$$F$Y$$$20240723$$CN$US$US
241264941$24126494$1$I$$20240722$20240723$20240723$PER$$US-PFIZER INC-PV202400095818$PFIZER$$61$YR$$F$Y$$$20240723$$HP$US$US
241264952$24126495$2$F$20240720$20240722$20240723$20240725$PER$$US-PFIZER INC-202400220798$PFIZER$$74$YR$$M$Y$102.05$KG$20240725$$CN$US$US
241264961$24126496$1$I$20240719$20240722$20240723$20240723$PER$$US-PFIZER INC-202400221478$PFIZER$$48$YR$$F$Y$$$20240723$$HP$US$US
241264972$24126497$2$F$$20240723$20240723$20240725$PER$$US-PFIZER INC-202400220994$PFIZER$$28$YR$$M$Y$$$20240725$$MD$US$US
241264981$24126498$1$I$$20240720$20240723$20240723$PER$$US-PFIZER INC-PV202400095340$PFIZER$$63$YR$$F$Y$$$20240723$$CN$US$US
241264991$24126499$1$I$20240721$20240722$20240723$20240723$PER$$US-PFIZER INC-202400221597$PFIZER$$79$YR$$F$Y$$$20240723$$MD$US$US
241265002$24126500$2$F$$20240724$20240723$20240724$PER$$US-PFIZER INC-202400221091$PFIZER$$60$YR$$$Y$$$20240724$$CN$US$US
241265012$24126501$2$F$20240712$20240806$20240723$20240812$PER$$US-PFIZER INC-202400220911$PFIZER$$70$YR$$M$Y$77.111$KG$20240812$$CN$US$US
241265021$24126502$1$I$$20240722$20240723$20240723$PER$$US-PFIZER INC-202400220743$PFIZER$$$$$F$Y$$$20240723$$CN$US$US
241265031$24126503$1$I$$20240722$20240723$20240723$PER$$US-PFIZER INC-202400220757$PFIZER$$$$$M$Y$$$20240723$$CN$US$US
241265041$24126504$1$I$$20240722$20240723$20240723$PER$$US-PFIZER INC-PV202400095687$PFIZER$$54$YR$$F$Y$$$20240723$$CN$US$US
241265052$24126505$2$F$$20240729$20240723$20240730$PER$$US-PFIZER INC-202400219731$PFIZER$$$$$$Y$$$20240730$$PH$US$US
241265061$24126506$1$I$20240721$20240722$20240723$20240723$PER$$US-PFIZER INC-202400220773$PFIZER$$48$YR$$F$Y$$$20240723$$CN$US$US
241265071$24126507$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50484$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241265092$24126509$2$F$$20240722$20240723$20240801$EXP$$RU-ROCHE-10000032781$ROCHE$$29$YR$A$F$Y$$$20240801$$MD$RU$RU
241265101$24126510$1$I$20240706$20240709$20240723$20240723$PER$$US-ROCHE-10000027223$ROCHE$$36$YR$A$M$Y$90.72$KG$20240723$$CN$US$US
241265112$24126511$2$F$$20240823$20240723$20240823$PER$$US-PFIZER INC-202400217982$PFIZER$$4$YR$$M$Y$$$20240823$$CN$US$US
241265121$24126512$1$I$20240620$20240716$20240723$20240723$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00726$CATALYST PHARMA$$72$YR$$M$Y$81.188$KG$20240723$$CN$US$US
241265132$24126513$2$F$$20240719$20240723$20240724$PER$$US-JNJFOC-20240750974$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240724$$CN$US$US
241265142$24126514$2$F$$20240823$20240723$20240829$EXP$$US-OTSUKA-2024_020244$OTSUKA$$$$$F$Y$$$20240829$$CN$US$US
241265157$24126515$7$F$20240701$20240920$20240723$20240927$EXP$$US-BEH-2024175923$CSL BEHRING$$35$YR$A$F$Y$102.04$KG$20240927$$HP$US$US
241265161$24126516$1$I$$20240717$20240723$20240723$EXP$$DE-AMGEN-DEUSP2024142587$AMGEN$Bitterer F.; Zhou J.Y.; Eder D. et.al.. Case report: Predictability of clinical response and rejection risk after immune checkpoint inhibition in liver transplantation. Frontiers in transplantation. 2023;2:1-9$62$YR$A$M$Y$$$20240723$$HP$DE$DE
241265181$24126518$1$I$$20240715$20240723$20240723$EXP$$IN-AMGEN-INDSP2024143102$AMGEN$Waghmare,C.. Apremilast in Erythema Nodosum Leprosum: A Case Series. Journal of Dermatology + Dermatology Surgery. 2024;28 (1):42-45$42$YR$A$M$Y$68$KG$20240723$$HP$IN$IN
241265191$24126519$1$I$$20240711$20240723$20240723$PER$$US-TEVA-VS-3220688$TEVA$$71$YR$$F$Y$$$20240723$$CN$US$US
241265201$24126520$1$I$20240101$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112278$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240723$$HP$US$US
241265211$24126521$1$I$$20240719$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116046$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240723$$CN$US$US
241265221$24126522$1$I$$20230815$20240723$20240723$EXP$$US-AstraZeneca-2023A187010$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241265231$24126523$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161552$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241265241$24126524$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161551$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241265251$24126525$1$I$$20210210$20240723$20240723$EXP$$US-AstraZeneca-2021A051256$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241265261$24126526$1$I$$20240718$20240723$20240723$EXP$$ZA-AstraZeneca-2024A164300$ASTRAZENECA$$40$YR$$M$Y$$$20240723$$CN$ZA$
241265271$24126527$1$I$$20240717$20240723$20240723$EXP$$US-GSK-US2024AMR090527$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
241265281$24126528$1$I$20220701$20240711$20240723$20240723$EXP$FR-AFSSAPS-GR2024000817$FR-TEVA-VS-3220869$TEVA$$75$YR$$F$Y$$$20240723$$PH$FR$FR
241265291$24126529$1$I$20210101$20240718$20240723$20240723$EXP$$US-PFIZER INC-PV202400094642$PFIZER$$55$YR$$F$Y$$$20240723$$HP$US$US
241265301$24126530$1$I$$20240722$20240723$20240723$EXP$$CA-PFIZER INC-202300442597$PFIZER$$61$YR$$M$Y$$$20240723$$HP$CA$CA
241265311$24126531$1$I$$20240719$20240723$20240723$EXP$$US-PFIZER INC-PV202400095227$PFIZER$$81$YR$$F$Y$$$20240723$$HP$US$US
241265324$24126532$4$F$20240813$20240819$20240723$20240821$EXP$$US-PFIZER INC-202400219665$PFIZER$$55$YR$$F$Y$68.038$KG$20240821$$HP$US$US
241265331$24126533$1$I$20240701$20240718$20240723$20240723$EXP$$US-PFIZER INC-PV202400094631$PFIZER$$83$YR$$F$Y$$$20240723$$PH$US$US
241265351$24126535$1$I$$20240130$20240723$20240723$EXP$$BE-TEVA-VS-3152504$TEVA$$$$$F$Y$$$20240723$$MD$BE$BE
241265361$24126536$1$I$20240701$20240720$20240722$20240722$DIR$FDA-CDER-CTU-2024-50458$$FDA-CTU$$56$YR$$F$N$$$20240720$N$HP$US$
241265372$24126537$2$F$$20240720$20240723$20240926$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-123847$DAIICHI$$$$$M$Y$$$20240926$$CN$US$US
241265381$24126538$1$I$20240429$20240708$20240723$20240723$EXP$GB-MHRA-ADR 28737293$GB-NORDICGR-056784$NORDIC PHARMA$$40$YR$$M$Y$$$20240723$$PH$GB$GB
241265391$24126539$1$I$20230101$20240715$20240723$20240723$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019318$VALIDUS$$$$$$Y$$$20240723$$CN$US$US
241265401$24126540$1$I$$20240717$20240723$20240723$EXP$$US-ABBVIE-5844384$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241265411$24126541$1$I$20220101$20240718$20240723$20240723$EXP$$NVSC2024CN139684$NOVARTIS$$41$YR$$M$Y$$$20240723$$CN$CN$CN
241265421$24126542$1$I$20240701$20240717$20240723$20240723$EXP$$US-ABBVIE-5844464$ABBVIE$$43$YR$$M$Y$$$20240723$$CN$US$US
241265431$24126543$1$I$20240101$20240717$20240723$20240723$EXP$$US-ABBVIE-5844475$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241265441$24126544$1$I$20240718$20240718$20240723$20240723$PER$$US-AMGEN-USASL2024145188$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241265452$24126545$2$F$20240601$20240718$20240723$20240726$EXP$$US-AstraZeneca-2024A162771$ASTRAZENECA$$832$MON$$M$Y$$$20240726$$CN$US$
241265461$24126546$1$I$$20240719$20240723$20240723$PER$$US-AstraZeneca-2024A165862$ASTRAZENECA$$$$$$Y$$$20240723$$HP$US$
241265471$24126547$1$I$$20230214$20240723$20240723$EXP$$ZA-AstraZeneca-2023A038283$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$ZA$
241265481$24126548$1$I$$20240717$20240723$20240723$EXP$$CA-GILEAD-2024-0681300$GILEAD$$$$E$F$Y$$$20240723$$CN$CA$CA
241265491$24126549$1$I$20240701$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50522$$FDA-CTU$$26$YR$$F$N$$$20240722$N$HP$US$
241265511$24126551$1$I$20231201$20240715$20240723$20240723$EXP$$BR-AstraZeneca-2024A165389$ASTRAZENECA$$57$YR$$F$Y$$$20240723$$CN$BR$
241265521$24126552$1$I$$20240712$20240723$20240723$EXP$$CN-ROCHE-10000024670$ROCHE$Lan Y, Zhao J, Zhao F, Li J, Li X. Partial response to trastuzumab deruxtecan (DS8201) following progression in HER2-amplified breast cancer with pulmonary metastases managed with disitamab vedotin (RC48): a comprehensive case report and literature review. Frontiers in Oncology. 2024-Jun-17;14:1-9. doi:10.3389/fonc.2024.1338661.$42$YR$A$F$Y$$$20240723$$HP$CN$CN
241265531$24126553$1$I$$20240719$20240723$20240723$EXP$$TN-PFIZER INC-PV202400094693$PFIZER$$73$YR$$F$Y$$$20240723$$MD$TN$TN
241265553$24126555$3$F$20240716$20240912$20240723$20240918$30DAY$$US-PFIZER INC-202400217582$PFIZER$$10$YR$$F$Y$36.281$KG$20240918$$MD$US$US
241265561$24126556$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50508$$FDA-CTU$$$$$M$N$$$20240722$N$HP$US$
241265571$24126557$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50417$$FDA-CTU$$34$YR$$F$N$$$20240722$N$$US$
241265581$24126558$1$I$$20240722$20240722$20240722$DIR$710991$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241265592$24126559$2$F$$20240722$20240723$20240724$EXP$$US-PFIZER INC-PV202400095292$PFIZER$$79$YR$$$Y$$$20240724$$CN$US$US
241265603$24126560$3$F$$20240904$20240723$20240904$30DAY$$US-PFIZER INC-202400217163$PFIZER$$13$YR$$M$Y$$$20240904$$CN$US$US
241265611$24126561$1$I$$20240529$20240723$20240723$PER$$US-LUNDBECK-DKLU4000066$LUNDBECK$$$$$$Y$$$20240723$$CN$US$US
241265621$24126562$1$I$$20240722$20240723$20240723$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136880$DAIICHI$$$$$F$Y$$$20240723$$CN$US$US
241265631$24126563$1$I$$20240228$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0201080$MYOVANT SCIENCES$$24$YR$$F$Y$$$20240723$$HP$US$US
241265641$24126564$1$I$$20240319$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300689$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241265651$24126565$1$I$20240201$20240304$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300100$MYOVANT SCIENCES$$19$YR$$F$Y$$$20240723$$HP$US$US
241265661$24126566$1$I$$20240304$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300094$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241265671$24126567$1$I$$20240301$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300034$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241265681$24126568$1$I$$20240307$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300263$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241265691$24126569$1$I$20240201$20240301$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300070$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241265701$24126570$1$I$20240311$20240312$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300404$MYOVANT SCIENCES$$31$YR$$F$Y$$$20240723$$CN$US$US
241265711$24126571$1$I$$20240311$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300338$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241265731$24126573$1$I$20240315$20240321$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300567$MYOVANT SCIENCES$$22$YR$$F$Y$$$20240723$$CN$US$US
241265741$24126574$1$I$$20240321$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300772$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$HP$US$US
241265751$24126575$1$I$$20240329$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300742$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241265761$24126576$1$I$20240305$20240306$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300262$MYOVANT SCIENCES$$44$YR$$F$Y$$$20240723$$CN$US$US
241265771$24126577$1$I$$20240228$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0201053$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241265781$24126578$1$I$20240201$20240227$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0201029$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$MD$US$US
241265791$24126579$1$I$$20240301$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300032$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241265801$24126580$1$I$$20240229$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0201123$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241265811$24126581$1$I$$20240301$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300001$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241265821$24126582$1$I$$20240720$20240723$20240723$PER$$NVSC2024US150047$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
241265831$24126583$1$I$20240701$20240718$20240723$20240723$EXP$$US-JNJFOC-20240757133$JOHNSON AND JOHNSON$$72$YR$E$F$Y$90.9$KG$20240723$$HP$US$US
241265842$24126584$2$F$$20240821$20240723$20240823$EXP$$US-JNJFOC-20240744333$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240823$$HP$US$US
241265851$24126585$1$I$20240718$20240722$20240723$20240723$EXP$$CN-BAYER-2024A106364$BAYER$$20$YR$A$F$Y$45$KG$20240723$$HP$CN$CN
241265861$24126586$1$I$$20240717$20240723$20240723$PER$$US-BAYER-2024A106476$BAYER$$28$YR$A$F$Y$$$20240723$$CN$US$US
241265871$24126587$1$I$$20240714$20240723$20240723$EXP$$GB-ROCHE-10000027182$ROCHE$$56$YR$A$M$Y$$$20240723$$HP$GB$GB
241265881$24126588$1$I$20240702$20240712$20240723$20240723$PER$$US-BAYER-2024A100997$BAYER$$29$YR$A$F$Y$$$20240723$$HP$US$US
241265891$24126589$1$I$$20240308$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0301143$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$MD$US$US
241265901$24126590$1$I$$20240322$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300849$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241265911$24126591$1$I$20240101$20240329$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0301095$MYOVANT SCIENCES$$22$YR$$F$Y$$$20240723$$CN$US$US
241265921$24126592$1$I$20240320$20240321$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0300801$MYOVANT SCIENCES$$44$YR$$F$Y$$$20240723$$CN$US$US
241265931$24126593$1$I$$20240716$20240723$20240723$PER$$US-ALXN-202407USA001222US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241265941$24126594$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50474$$FDA-CTU$$28$YR$$F$N$$$20240722$N$$US$
241265951$24126595$1$I$$20240722$20240722$20240722$DIR$711018$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241265961$24126596$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50386$$FDA-CTU$$68$YR$$M$N$$$20240722$N$$US$
241265971$24126597$1$I$$20240722$20240722$20240722$DIR$710995$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241265991$24126599$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50481$$FDA-CTU$$75$YR$$F$N$$$20240722$N$$US$
241266001$24126600$1$I$$20240722$20240722$20240722$DIR$710971$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241266011$24126601$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50512$$FDA-CTU$$53$YR$$M$N$$$20240722$N$$US$
241266021$24126602$1$I$$20240718$20240723$20240723$PER$$US-GILEAD-2024-0681288$GILEAD$$$$$$Y$$$20240723$$CN$US$US
241266031$24126603$1$I$20240412$20240717$20240723$20240723$EXP$FR-AFSSAPS-AVPA2024000641$FR-MYLANLABS-2024M1066996$MYLAN$$15$YR$$F$Y$$$20240723$$MD$FR$FR
241266041$24126604$1$I$$20240717$20240723$20240723$EXP$$JP-MYE-2024M1066654AA$MYLAN$$$$$F$Y$$$20240723$$PH$JP$JP
241266051$24126605$1$I$20240608$20240711$20240723$20240723$EXP$$PK-ROCHE-10000016271$ROCHE$$57$YR$A$M$Y$$$20240723$$CN$PK$PK
241266062$24126606$2$F$20240601$20240905$20240723$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114862$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240909$$HP$US$US
241266071$24126607$1$I$$20240529$20240723$20240723$PER$$US-LUNDBECK-DKLU3078714$LUNDBECK$$$$$$Y$$$20240723$$HP$US$US
241266081$24126608$1$I$20240711$20240718$20240723$20240723$EXP$$US-BEH-2024175939$CSL BEHRING$$66$YR$E$M$Y$94.2$KG$20240723$$HP$US$US
241266101$24126610$1$I$$20240715$20240723$20240723$PER$$US-BAYER-2024A101443$BAYER$$64$YR$A$M$Y$$$20240723$$CN$US$US
241266111$24126611$1$I$20240701$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144485$AMGEN$$86$YR$E$$Y$$$20240723$$PH$US$US
241266121$24126612$1$I$$20240529$20240723$20240723$PER$$US-LUNDBECK-DKLU3078671$LUNDBECK$$$$$$Y$$$20240723$$CN$US$US
241266131$24126613$1$I$$20240715$20240723$20240723$EXP$$CA-Orion Corporation ORION PHARMA-TREX2024-0195$ORION$Beckett M, Dhir A. Suspected drug-induced Sweet^s syndrome in a patient receiving allopurinol and hydralazine. Allergy, Asthma and Clinical Immunology. 2024;20 (SUPPL 1): 60:23.$81$YR$E$F$Y$$$20240723$$MD$CA$
241266141$24126614$1$I$20230501$20240718$20240723$20240723$EXP$$US-GILEAD-2024-0681292$GILEAD$$59$YR$A$F$Y$$$20240723$$CN$US$US
241266151$24126615$1$I$$20240712$20240723$20240723$EXP$$CN-ROCHE-10000031189$ROCHE$Gu Y, Chu X Z. Thrombolysis with low?dose and standard?dose intravenous recombinant tissue plasminogen activator in elderly patients with acute ischemic stroke: a stratified analysis. The Journal of Practical Medicine. 2024;40 (11):1568-73.$$$E$$Y$$$20240723$$MD$CN$CN
241266171$24126617$1$I$$20240717$20240723$20240723$EXP$$NVSC2024AU149814$NOVARTIS$$76$YR$$M$Y$$$20240723$$HP$AU$AU
241266181$24126618$1$I$$20240716$20240723$20240723$PER$$US-ABBVIE-5846091$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241266191$24126619$1$I$20240406$20240408$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400277$MYOVANT SCIENCES$$32$YR$$F$Y$$$20240723$$CN$US$US
241266201$24126620$1$I$$20240411$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400404$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266211$24126621$1$I$$20240409$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400303$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266221$24126622$1$I$$20240417$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400688$MYOVANT SCIENCES$$20$YR$$F$Y$$$20240723$$MD$US$US
241266231$24126623$1$I$$20240423$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400897$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$MD$US$US
241266241$24126624$1$I$20240419$20240422$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400812$MYOVANT SCIENCES$$36$YR$$F$Y$$$20240723$$CN$US$US
241266251$24126625$1$I$$20240423$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400898$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$MD$US$US
241266261$24126626$1$I$$20240411$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400088$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266271$24126627$1$I$$20240403$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400219$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266281$24126628$1$I$20240401$20240404$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400187$MYOVANT SCIENCES$$46$YR$$F$Y$$$20240723$$CN$US$US
241266291$24126629$1$I$$20240409$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400314$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266301$24126630$1$I$20240424$20240424$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400932$MYOVANT SCIENCES$$44$YR$$F$Y$$$20240723$$CN$US$US
241266311$24126631$1$I$$20240401$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400341$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$MD$US$US
241266321$24126632$1$I$20240422$20240423$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400889$MYOVANT SCIENCES$$43$YR$$F$Y$$$20240723$$CN$US$US
241266331$24126633$1$I$20240402$20240404$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400179$MYOVANT SCIENCES$$25$YR$$F$Y$74.83$KG$20240723$$CN$US$US
241266342$24126634$2$F$$20240822$20240723$20240925$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400630$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
241266351$24126635$1$I$$20240416$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400598$MYOVANT SCIENCES$$$$$F$Y$92.517$KG$20240723$$CN$US$US
241266361$24126636$1$I$$20240422$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400805$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266371$24126637$1$I$20240415$20240415$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0400542$MYOVANT SCIENCES$$25$YR$$F$Y$$$20240723$$CN$US$US
241266381$24126638$1$I$$20240718$20240723$20240723$PER$$US-GILEAD-2024-0681275$GILEAD$$$$$$Y$$$20240723$$CN$US$US
241266391$24126639$1$I$20240530$20240717$20240723$20240723$EXP$FR-AFSSAPS-RE2024000697$FR-MYLANLABS-2024M1067423$MYLAN$$23$YR$$F$Y$56.1$KG$20240723$$MD$FR$FR
241266401$24126640$1$I$$20240708$20240723$20240723$EXP$EU-AFSSAPS-AVMA2024000286$EU-ETHYPHARM-2024001848$ETHYPHARM$$$$$$Y$$$20240723$$PH$EU$
241266411$24126641$1$I$$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024143769$AMGEN$$$$$$Y$$$20240723$$PH$US$US
241266421$24126642$1$I$20240101$20240717$20240723$20240723$EXP$FR-AFSSAPS-MP2024001146$FR-MYLANLABS-2024M1067383$MYLAN$$33$YR$$F$Y$$$20240723$$MD$FR$FR
241266431$24126643$1$I$$20240715$20240723$20240723$EXP$$JP-ROCHE-10000030416$ROCHE$Matsuoka A, Tate S, Nishikimi K, Otsuka S, Usui H, Tajima S, et al. Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series. Journal of Obstetrics and Gynaecology Research. 2024-Jul;50 (7):1148-54. doi:10.1111/jog.15954.$65$YR$E$F$Y$$$20240723$$HP$JP$JP
241266441$24126644$1$I$20240401$20240718$20240723$20240723$EXP$$US-ABBVIE-5845875$ABBVIE$$80$YR$$M$Y$$$20240723$$CN$US$US
241266451$24126645$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024143105$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241266462$24126646$2$F$20240717$20240723$20240723$20240726$PER$$US-AMGEN-USASP2024143852$AMGEN$$77$YR$E$F$Y$$$20240726$$CN$US$US
241266471$24126647$1$I$$20240429$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0401139$MYOVANT SCIENCES$$49$YR$$F$Y$58.957$KG$20240723$$CN$US$US
241266482$24126648$2$F$20240711$20240729$20240723$20240731$EXP$$GB-MYLANLABS-2024M1067800$MYLAN$$55$YR$$F$Y$$$20240731$$MD$GB$GB
241266491$24126649$1$I$$20240426$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0401100$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266501$24126650$1$I$20240423$20240425$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0401080$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266511$24126651$1$I$$20240425$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0401007$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266521$24126652$1$I$20230401$20240502$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500065$MYOVANT SCIENCES$$26$YR$$F$Y$77.098$KG$20240723$$CN$US$US
241266531$24126653$1$I$20240428$20240429$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0401120$MYOVANT SCIENCES$$34$YR$$F$Y$$$20240723$$CN$US$US
241266541$24126654$1$I$$20240502$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500066$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266551$24126655$1$I$$20240417$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0401295$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266561$24126656$1$I$$20240424$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0401001$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$MD$US$US
241266571$24126657$1$I$$20240424$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0401298$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266581$24126658$1$I$$20240425$20240723$20240723$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0401052$MYOVANT SCIENCES$$46$YR$$F$Y$$$20240723$$MD$US$US
241266601$24126660$1$I$$20240711$20240723$20240723$PER$$US-RDY-SPO/USA/24/0010319$DR REDDYS$$67$YR$E$M$Y$$$20240723$$PH$US$US
241266611$24126661$1$I$20240704$20240715$20240723$20240723$EXP$RO-NMA-2024-SP0463$RO-FreseniusKabi-FK202411098$FRESENIUS KABI$$47$YR$A$F$Y$77$KG$20240723$$MD$RO$RO
241266621$24126662$1$I$$20240717$20240723$20240723$EXP$NL-LRB-00981024$NL-FreseniusKabi-FK202411274$FRESENIUS KABI$$61$YR$A$F$Y$63$KG$20240723$$MD$NL$NL
241266631$24126663$1$I$20240712$20240716$20240723$20240723$EXP$$CN-FreseniusKabi-FK202411329$FRESENIUS KABI$$61$YR$A$F$Y$50$KG$20240723$$HP$CN$CN
241266641$24126664$1$I$$20240718$20240723$20240723$EXP$$US-JNJFOC-20240752142$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$CN$US$US
241266652$24126665$2$F$20240719$20240729$20240723$20240802$EXP$$JP-JNJFOC-20240759837$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240802$$PH$JP$JP
241266661$24126666$1$I$$20240705$20240723$20240723$PER$$US-MYLANLABS-2024M1064367$MYLAN$$$$$$Y$$$20240723$$CN$US$US
241266671$24126667$1$I$20240702$20240716$20240723$20240723$EXP$$GR-MYLANLABS-2024M1063611$MYLAN$$66$YR$$F$Y$$$20240723$$CN$GR$GR
241266681$24126668$1$I$$20240716$20240723$20240723$EXP$NL-LRB-00979384$NL-MYLANLABS-2024M1066837$MYLAN$$46$YR$$F$Y$74$KG$20240723$$CN$NL$NL
241266691$24126669$1$I$20240523$20240716$20240723$20240723$EXP$FR-AFSSAPS-LL2024001276$FR-MYLANLABS-2024M1066658$MYLAN$$73$YR$$F$Y$$$20240723$$PH$FR$FR
241266701$24126670$1$I$20230403$20240716$20240723$20240723$EXP$FR-AFSSAPS-MA2024000808$FR-MYLANLABS-2024M1066690$MYLAN$$39$YR$$M$Y$$$20240723$$MD$FR$FR
241266711$24126671$1$I$$20240716$20240723$20240723$EXP$NL-LRB-00982744$NL-MYLANLABS-2024M1066602$MYLAN$$85$YR$$F$Y$$$20240723$$MD$NL$NL
241266721$24126672$1$I$$20240502$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500079$MYOVANT SCIENCES$$$$$F$Y$69.388$KG$20240723$$CN$US$US
241266731$24126673$1$I$$20240503$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500143$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266741$24126674$1$I$$20240719$20240723$20240723$EXP$$AU-GILEAD-2024-0681336$GILEAD$$$$$F$Y$$$20240723$$PH$AU$AU
241266761$24126676$1$I$$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116232$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$57.61$KG$20240723$$CN$US$US
241266771$24126677$1$I$20240205$20240515$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500083$MYOVANT SCIENCES$$44$YR$$F$Y$58.503$KG$20240723$$HP$US$US
241266781$24126678$1$I$$20240503$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500125$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241266791$24126679$1$I$$20201120$20240723$20240723$EXP$$US-AstraZeneca-2020SF55618$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241266802$24126680$2$F$$20240701$20240723$20240801$EXP$$KR-GE HEALTHCARE-2024CSU007666$GE HEALTHCARE$$$$$$Y$$$20240801$$HP$KR$KR
241266811$24126681$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A162211$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241266821$24126682$1$I$$20240709$20240723$20240723$EXP$$PS-BELUSA-2024BELLIT0081$BIOLOGICAL E.$$$$$$Y$$$20240723$$HP$PS$PS
241266841$24126684$1$I$20220505$20220526$20240723$20240723$EXP$$US-AstraZeneca-2022A201776$ASTRAZENECA$$25413$DY$$F$Y$$$20240723$$CN$US$
241266851$24126685$1$I$20240622$20240712$20240723$20240723$EXP$$US-Vifor (International) Inc.-VIT-2024-06298$VIFOR$$35$YR$$M$Y$123$KG$20240723$$HP$US$US
241266861$24126686$1$I$$20240722$20240722$20240722$DIR$710959$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241266883$24126688$3$F$$20240819$20240723$20240902$PER$$US-AstraZeneca-2024A164585$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$US$
241266892$24126689$2$F$20231203$20240806$20240723$20240814$EXP$$KW-Vifor (International) Inc.-VIT-2024-06268$VIFOR$$52$YR$$M$Y$74$KG$20240814$$MD$KW$KW
241266901$24126690$1$I$$20240711$20240723$20240723$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06216$VIFOR$$$$A$M$Y$$$20240723$$CN$ZA$ZA
241266911$24126691$1$I$20240712$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161608$ASTRAZENECA$$28542$DY$$M$Y$110.2$KG$20240723$$CN$US$
241266921$24126692$1$I$$20201021$20240723$20240723$EXP$$US-AstraZeneca-2020SF39537$ASTRAZENECA$$54$YR$$F$Y$86.2$KG$20240723$$CN$US$
241266941$24126694$1$I$20220901$20230206$20240723$20240723$EXP$$US-AstraZeneca-2023A031751$ASTRAZENECA$$915$MON$$F$Y$$$20240723$$CN$US$
241266951$24126695$1$I$$20240719$20240723$20240723$PER$$US-AstraZeneca-2024A166969$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241266961$24126696$1$I$$20200122$20240723$20240723$EXP$$US-AstraZeneca-2020SE04433$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241266971$24126697$1$I$20240718$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013939$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240723$$CN$US$US
241266981$24126698$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013496$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$US$US
241266991$24126699$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013255$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240723$$CN$US$US
241267002$24126700$2$F$$20240723$20240723$20240806$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-001632$SK LIFE SCIENCE$$$$$$Y$$$20240806$$HP$CA$CA
241267011$24126701$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013265$ELI LILLY AND CO$$$$$F$Y$$$20240723$$HP$US$US
241267022$24126702$2$F$$20240731$20240723$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407012902$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240805$$CN$US$US
241267041$24126704$1$I$$20240715$20240723$20240723$PER$$US-BAYER-2024A101505$BAYER$$32$YR$A$F$Y$$$20240723$$MD$US$US
241267051$24126705$1$I$20210901$20240708$20240723$20240723$EXP$$PT-NORDICGR-056816$NORDIC PHARMA$$61$YR$$F$Y$$$20240723$$HP$PT$PT
241267061$24126706$1$I$20240401$20240410$20240723$20240723$PER$$US-UCBSA-2024017975$UCB$$$$$M$Y$$$20240723$$CN$US$US
241267071$24126707$1$I$$20240411$20240723$20240723$PER$$US-UCBSA-2024018148$UCB$$$$$$Y$$$20240723$$MD$US$US
241267081$24126708$1$I$$20240412$20240723$20240723$PER$$US-UCBSA-2024018381$UCB$$$$A$$Y$$$20240723$$HP$US$US
241267091$24126709$1$I$$20240411$20240723$20240723$PER$$US-UCBSA-2024018460$UCB$$$$$$Y$$$20240723$$HP$US$US
241267101$24126710$1$I$$20240404$20240723$20240723$PER$$US-UCBSA-2024016794$UCB$$$$$F$Y$64$KG$20240723$$HP$US$US
241267111$24126711$1$I$$20240509$20240723$20240723$PER$$US-UCBSA-2024023945$UCB$$$$$M$Y$$$20240723$$HP$US$US
241267122$24126712$2$F$20240712$20240725$20240723$20240729$PER$$US-AMGEN-USASP2024144139$AMGEN$$75$YR$E$M$Y$$$20240729$$CN$US$US
241267132$24126713$2$F$20240101$20240912$20240723$20240923$EXP$$US-UCBSA-2024031138$UCB$$$$$F$Y$104.3$KG$20240923$$HP$US$US
241267141$24126714$1$I$20240501$20240514$20240723$20240723$PER$$US-UCBSA-2024024788$UCB$$74$YR$$M$Y$98$KG$20240723$$CN$US$US
241267151$24126715$1$I$20240101$20240702$20240723$20240723$PER$$US-UCBSA-2024015717$UCB$$$$$M$Y$162$KG$20240723$$CN$US$US
241267161$24126716$1$I$20240101$20240607$20240723$20240723$PER$$US-UCBSA-2024029684$UCB$$$$$F$Y$109.68$KG$20240723$$PH$US$US
241267171$24126717$1$I$$20240709$20240723$20240723$PER$$US-BEH-2024175621$CSL BEHRING$$$$$$Y$$$20240723$$CN$US$US
241267182$24126718$2$F$20240701$20240722$20240723$20240730$EXP$FR-AFSSAPS-AN2024000928$FR-TAKEDA-2024TUS073532$TAKEDA$$86$YR$$M$Y$$$20240730$$HP$FR$FR
241267191$24126719$1$I$$20240711$20240723$20240723$PER$$US-MYLANLABS-2024M1066751$MYLAN$$$$$M$Y$$$20240723$$CN$US$US
241267201$24126720$1$I$$20240714$20240723$20240723$EXP$$US-Calliditas-2024CAL01316$CALLIDITAS THERAPEUTICS$$$$E$M$Y$$$20240723$$MD$US$US
241267211$24126721$1$I$$20240716$20240723$20240723$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003978$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
241267221$24126722$1$I$$20240722$20240723$20240723$EXP$$GB-UCBSA-2024036930$UCB$$$$$F$Y$$$20240723$$CN$GB$GB
241267231$24126723$1$I$$20240722$20240722$20240722$DIR$711007$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241267241$24126724$1$I$$20240722$20240722$20240722$DIR$710967$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241267252$24126725$2$F$$20240722$20240723$20240726$EXP$$US-PFIZER INC-PV202400095386$PFIZER$Raman, V.. Eosinophilic pneumonia: a case of daptomycin induced lung injury. Journal of Community Hospital Internal Medicine Perspectives. 2021;11(2):280-285$71$YR$$M$Y$$$20240726$$HP$US$US
241267261$24126726$1$I$$20240715$20240723$20240723$EXP$$CN-PFIZER INC-PV202400092906$PFIZER$Bingdi ZHI. SARS-CoV-2 infection combined with L isteria meningitis: A case report and literature review. Clinical Focus. 2024;39:347-353$77$YR$$F$Y$$$20240723$$MD$CN$CN
241267271$24126727$1$I$$20240715$20240723$20240723$PER$$CZ-Blueprint Medicines Corporation-SP-CZ-2024-001444$BLUEPRINT MEDICINES$$$$$F$Y$$$20240723$$MD$CZ$CZ
241267282$24126728$2$F$$20240723$20240723$20240729$EXP$$AE-PFIZER INC-202400219418$PFIZER$Agarwal, A.. Cytomegalovirus-Associated Non-Necrotizing Retinopathy, Occlusive Retinal Vasculitis, and Neovascularization. Ocular Immunology and Inflammation. 2024;32(5):529-533$41$YR$$F$Y$$$20240729$$MD$AE$AE
241267291$24126729$1$I$$20240715$20240723$20240723$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001429$BLUEPRINT MEDICINES$$$$$F$Y$$$20240723$$CN$US$US
241267301$24126730$1$I$$20240719$20240723$20240723$EXP$$JP-Eisai-EC-2024-170610$EISAI$$75$YR$E$M$Y$$$20240723$$MD$JP$JP
241267311$24126731$1$I$$20240715$20240723$20240723$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001434$BLUEPRINT MEDICINES$$$$$M$Y$$$20240723$$CN$US$US
241267321$24126732$1$I$20240426$20240715$20240723$20240723$EXP$$FR-FreseniusKabi-FK202411250$FRESENIUS KABI$$51$YR$A$F$Y$83$KG$20240723$$HP$FR$FR
241267332$24126733$2$F$$20240726$20240723$20240802$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001438$BLUEPRINT MEDICINES$$$$$F$Y$$$20240802$$CN$US$US
241267341$24126734$1$I$20240702$20240713$20240723$20240723$EXP$$UA-RDY-SPO/UKR/24/0010513$DR REDDYS$$19$YR$A$F$Y$$$20240723$$MD$UA$UA
241267351$24126735$1$I$$20240715$20240723$20240723$EXP$$IN-FreseniusKabi-FK202411444$FRESENIUS KABI$Shyma Z, Adiga A, D^Souza MJ, V. AV. Chemotherapy-induced zosteriform lichen planus following mastectomy: A rare case report. International Journal of Surgery Case Reports. 2024 Jan;114: 1-4. doi:https://doi.org/10.1016/j.ijscr.2023.109177.$62$YR$A$F$Y$$$20240723$$HP$IN$IN
241267361$24126736$1$I$$20240715$20240723$20240723$EXP$$PT-FreseniusKabi-FK202411366$FRESENIUS KABI$Monteiro ID, Silva MA, Silva SA, Silv?rio BA, Lopes AR, Miranda OL. MI-120 -(4030) -DRSIFE -An atypical reaction to antibiotic therapy. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. 2024 May;1403.$88$YR$E$F$Y$$$20240723$$MD$PT$PT
241267371$24126737$1$I$20240604$20240715$20240723$20240723$EXP$FR-AFSSAPS-PO2024000767$FR-FreseniusKabi-FK202411196$FRESENIUS KABI$$76$YR$E$M$Y$76$KG$20240723$$MD$FR$FR
241267381$24126738$1$I$20230317$20240715$20240723$20240723$EXP$PL-URPL-DML-MLP.4401.1.812.2023$PL-FreseniusKabi-FK202411137$FRESENIUS KABI$$32$YR$A$F$Y$73$KG$20240723$$PH$PL$PL
241267391$24126739$1$I$$20240716$20240723$20240723$PER$$US-MYLANLABS-2024M1067500$MYLAN$$$$$F$Y$$$20240723$$HP$US$US
241267404$24126740$4$F$20240621$20240817$20240723$20240821$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004029$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240821$$HP$IT$IT
241267412$24126741$2$F$$20240802$20240723$20240808$EXP$$JP-JNJFOC-20240759800$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240808$$PH$JP$JP
241267423$24126742$3$F$20240822$20240924$20240723$20240930$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001450$BLUEPRINT MEDICINES$$66$YR$E$F$Y$$$20240930$$CN$US$US
241267431$24126743$1$I$$20240715$20240723$20240723$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001439$BLUEPRINT MEDICINES$$$$$F$Y$$$20240723$$CN$US$US
241267441$24126744$1$I$$20240711$20240723$20240723$PER$$US-TEVA-VS-3221186$TEVA$$$$A$F$Y$$$20240723$$CN$US$US
241267452$24126745$2$F$20240712$20240805$20240723$20240808$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001452$BLUEPRINT MEDICINES$$63$YR$A$F$Y$$$20240808$$MD$US$US
241267461$24126746$1$I$$20240715$20240723$20240723$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001453$BLUEPRINT MEDICINES$$$$$F$Y$$$20240723$$CN$US$US
241267471$24126747$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116799$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240723$$HP$US$US
241267481$24126748$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50521$$FDA-CTU$$$$$F$N$$$20240719$N$CN$US$
241267501$24126750$1$I$20240719$20240720$20240722$20240722$DIR$FDA-CDER-CTU-2024-50443$$FDA-CTU$$66$YR$$M$N$$$20240720$N$HP$US$
241267511$24126751$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50476$$FDA-CTU$$64$YR$$F$N$$$20240722$N$$US$
241267521$24126752$1$I$20240718$20240722$20240722$20240722$DIR$710990$$FDA-CTU$$47$YR$$F$N$74.8$KG$20240722$N$PH$US$
241267531$24126753$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50506$$FDA-CTU$$51$YR$$M$N$$$20240722$N$$US$
241267541$24126754$1$I$20240531$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50520$$FDA-CTU$$66$YR$$F$N$$$20240719$N$HP$US$
241267551$24126755$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50398$$FDA-CTU$$79$YR$$M$N$$$20240722$N$$US$
241267561$24126756$1$I$20240720$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50501$$FDA-CTU$$62$YR$$F$N$$$20240722$N$$US$
241267571$24126757$1$I$20231026$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50461$$FDA-CTU$$88$YR$$M$N$$$20240722$N$$US$
241267581$24126758$1$I$$20240722$20240723$20240723$PER$$US-HALEON-2188467$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241267591$24126759$1$I$$20240716$20240723$20240723$PER$$US-MYLANLABS-2024M1066447$MYLAN$$$$$F$Y$$$20240723$$CN$US$US
241267602$24126760$2$F$20230726$20240731$20240723$20240806$EXP$$FR-ORGANON-O2407FRA001939$ORGANON$$33$YR$$F$Y$$$20240806$$CN$FR$FR
241267612$24126761$2$F$20240709$20240816$20240723$20240826$EXP$$JP-ROCHE-10000028833$ROCHE$$9$DEC$E$M$Y$$$20240826$$MD$JP$JP
241267622$24126762$2$F$20240719$20240814$20240723$20240816$EXP$$CN-BAYER-2024A106546$BAYER$$45$YR$A$M$Y$$$20240816$$MD$CN$CN
241267631$24126763$1$I$$20240716$20240723$20240723$PER$$US-BAYER-2024A106076$BAYER$$$$$$Y$$$20240723$$CN$US$US
241267641$24126764$1$I$$20240719$20240723$20240723$EXP$$US-BAYER-2024A106201$BAYER$$67$YR$E$F$Y$$$20240723$$CN$US$US
241267651$24126765$1$I$20240717$20240719$20240723$20240723$EXP$$CN-BAYER-2024A106265$BAYER$$48$YR$A$M$Y$85$KG$20240723$$HP$CN$CN
241267661$24126766$1$I$20240703$20240710$20240723$20240723$EXP$RU-RZN-2444024$RU-BAYER-2024A100079$BAYER$$3$YR$C$M$Y$$$20240723$$HP$RU$RU
241267671$24126767$1$I$20240702$20240719$20240723$20240723$EXP$$CN-BAYER-2024A106371$BAYER$$79$YR$E$F$Y$$$20240723$$HP$CN$CN
241267681$24126768$1$I$20240711$20240719$20240723$20240723$EXP$$CO-BAYER-2024A101321$BAYER$$71$YR$E$F$Y$$$20240723$$CN$CO$CO
241267691$24126769$1$I$20240711$20240717$20240723$20240723$PER$$US-BAYER-2024A104498$BAYER$$38$YR$A$F$Y$$$20240723$$HP$US$US
241267702$24126770$2$F$20240408$20240830$20240723$20240903$EXP$$US-BAYER-2024A100501$BAYER$$23$YR$A$F$Y$$$20240903$$CN$US$US
241267712$24126771$2$F$20240101$20240829$20240723$20240906$EXP$$US-BAYER-2024A104534$BAYER$$53$YR$A$F$Y$$$20240906$$CN$US$US
241267721$24126772$1$I$20240101$20240719$20240723$20240723$EXP$$CO-BAYER-2024A083433$BAYER$$46$YR$A$F$Y$$$20240723$$CN$CO$CO
241267731$24126773$1$I$$20240717$20240723$20240723$EXP$NL-LRB-00982487$NL-BAYER-2024A104219$BAYER$$36$YR$A$F$Y$62$KG$20240723$$CN$NL$NL
241267752$24126775$2$F$$20240809$20240723$20240816$PER$$US-BAYER-2024A104538$BAYER$$36$YR$A$F$Y$73.469$KG$20240816$$MD$US$US
241267761$24126776$1$I$20240601$20240718$20240723$20240723$EXP$$US-TAKEDA-2024TUS073045$TAKEDA$$57$YR$$F$Y$$$20240723$$CN$US$US
241267771$24126777$1$I$$20240717$20240723$20240723$PER$$US-BAYER-2024A104514$BAYER$$35$YR$A$F$Y$$$20240723$$MD$US$US
241267781$24126778$1$I$$20240718$20240723$20240723$PER$$US-BAYER-2024A105987$BAYER$$$$$$Y$$$20240723$$CN$US$US
241267791$24126779$1$I$20240715$20240715$20240723$20240723$EXP$$US-JNJFOC-20240739747$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$HP$US$US
241267801$24126780$1$I$$20240722$20240722$20240722$DIR$711039$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241267811$24126781$1$I$$20240721$20240723$20240723$PER$$NVSC2024US150801$NOVARTIS$$$$$M$Y$$$20240723$$CN$US$US
241267821$24126782$1$I$$20240716$20240723$20240723$EXP$$US-SA-2024SA212991$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240723$$MD$US$US
241267832$24126783$2$F$$20240904$20240723$20240924$EXP$$US-SA-2024SA212982$SANOFI AVENTIS$$$$A$F$Y$80.7$KG$20240924$$MD$US$US
241267841$24126784$1$I$$20240716$20240723$20240723$EXP$$US-SA-2020SA144973$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240723$$MD$US$US
241267851$24126785$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50524$$FDA-CTU$$52$YR$$M$N$$$20240722$N$$US$
241267861$24126786$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50407$$FDA-CTU$$69$YR$$F$N$$$20240722$N$$US$
241267871$24126787$1$I$$20240722$20240722$20240722$DIR$711031$$FDA-CTU$$27$YR$$M$N$82.8$KG$20240722$N$HP$US$
241267881$24126788$1$I$$20240715$20240723$20240723$PER$$US-MYLANLABS-2024M1066380$MYLAN$$$$$F$Y$$$20240723$$HP$US$US
241267891$24126789$1$I$$20240717$20240723$20240723$PER$$US-BAYER-2024A104528$BAYER$$$$$F$Y$$$20240723$$HP$US$US
241267901$24126790$1$I$$20240716$20240723$20240723$PER$$US-BAYER-2024A103494$BAYER$$$$$$Y$$$20240723$$CN$US$US
241267911$24126791$1$I$$20240620$20240723$20240723$PER$$US-MYLANLABS-2024M1017054$MYLAN$$$$$M$Y$$$20240723$$CN$US$US
241267921$24126792$1$I$20210927$20240717$20240723$20240723$EXP$NL-LRB-00976556$NL-FreseniusKabi-FK202408857$FRESENIUS KABI$$56$YR$A$F$Y$72$KG$20240723$$PH$NL$NL
241267931$24126793$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50467$$FDA-CTU$$92$YR$$M$N$$$20240722$N$$US$
241267941$24126794$1$I$$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50456$$FDA-CTU$$82$YR$$F$N$$$20240719$N$$US$
241267951$24126795$1$I$20240417$20240715$20240723$20240723$EXP$FR-AFSSAPS-TS2024000789$FR-FreseniusKabi-FK202411195$FRESENIUS KABI$$46$YR$A$F$Y$$$20240723$$MD$FR$FR
241267961$24126796$1$I$20240701$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50392$$FDA-CTU$$74$YR$$F$N$$$20240719$Y$PH$US$
241267971$24126797$1$I$20220101$20240719$20240723$20240723$PER$$US-009507513-2407USA012177$MERCK$Nicaise EH., Yildirim A, Sheth S, Richter E, Daneshmand MA., Maithel SK, et al. Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma. CA Cancer Journal for Clinicians. 2024;74(4):323-38$41$YR$$M$Y$$$20240723$$MD$US$US
241267981$24126798$1$I$$20240702$20240723$20240723$PER$$US-009507513-2407USA001603$MERCK$$$$$M$Y$$$20240723$$CN$US$US
241267991$24126799$1$I$$20240623$20240723$20240723$PER$$US-009507513-2406USA007923$MERCK$Sayah DM, Schwartz BS, Kukreja J, Singer JP, Golden JA, Leard LE. Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis. Transpl Infect Dis. 2013;15(2):E70-4$70$YR$$F$Y$$$20240723$$HP$US$US
241268002$24126800$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3219460$TEVA$Suthar PP, Hughes K, Mafraji M, Akyuz M, Jhaveri M, Dua SG. Case 324: CHANTER Syndrome. Radiology 2024; 311 (1): 1-4.; Suthar PP, Hughes K, Mafraji M, Akyuz M, Jhaveri M, Dua SG. Case 324: CHANTER Syndrome. Radiology 2024; 311 (1): 1-4.; Suthar PP, Hughes K, Mafraji M, Akyuz M, Jhaveri M, Dua SG. Case 324: CHANTER Syndrome. Radiology 2024; 311 (1): 1-4.$69$YR$$M$Y$$$20240819$$MD$US$US
241268011$24126801$1$I$$20240718$20240723$20240723$PER$$NVSC2024US149390$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
241268021$24126802$1$I$$20240513$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500523$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268031$24126803$1$I$$20240506$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500225$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268041$24126804$1$I$$20240509$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500364$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$MD$US$US
241268051$24126805$1$I$$20240510$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500402$MYOVANT SCIENCES$$39$YR$$F$Y$99.773$KG$20240723$$CN$US$US
241268061$24126806$1$I$20240301$20240506$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500210$MYOVANT SCIENCES$$36$YR$$F$Y$$$20240723$$CN$US$US
241268071$24126807$1$I$$20240506$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500199$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268081$24126808$1$I$$20240510$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500472$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268091$24126809$1$I$$20240509$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500363$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268101$24126810$1$I$$20240514$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500550$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268111$24126811$1$I$$20240509$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500373$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$MD$US$US
241268121$24126812$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013387$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240723$$CN$US$US
241268131$24126813$1$I$$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113159$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$43.09$KG$20240723$$HP$US$US
241268141$24126814$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116362$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240723$$HP$US$US
241268151$24126815$1$I$$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012372$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240723$$PH$US$US
241268161$24126816$1$I$$20240709$20240723$20240723$EXP$$US-GLANDPHARMA-US-2024GLNLIT00511$GLAND PHARMA$S. Sasidharan.Triple whammy of Amlodipine, Carvedilol and Diphenhydramine overdose.American journal of respiratory and critical care medicine.MAY-2024;209$27$YR$A$F$Y$$$20240723$$HP$US$US
241268171$24126817$1$I$20240701$20240711$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407008806$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$US$US
241268181$24126818$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013857$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240723$$CN$US$US
241268191$24126819$1$I$20240709$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014232$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240723$$CN$US$US
241268201$24126820$1$I$20240101$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457940$RANBAXY$$23$YR$$F$Y$$$20240723$$MD$FR$FR
241268211$24126821$1$I$20220808$20240708$20240723$20240723$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457968$RANBAXY$$57$YR$$M$Y$$$20240723$$PH$ES$ES
241268221$24126822$1$I$20240410$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457932$RANBAXY$$28$YR$$F$Y$$$20240723$$MD$FR$FR
241268232$24126823$2$F$$20240822$20240723$20240906$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457959$RANBAXY$Habraszka D, Gaweda S, Spalek A, Helbig G. Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia with accompanying hereditary hemorrhagic telangiectasia. Acta Haematol Polon. 2024;52 (2):123-125$42$YR$$F$Y$$$20240906$$HP$PL$PL
241268241$24126824$1$I$$20240722$20240723$20240723$PER$$NVSC2024US150934$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
241268251$24126825$1$I$20240601$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024144244$AMGEN$$56$YR$$M$Y$$$20240723$$HP$US$US
241268262$24126826$2$F$20220415$20240723$20240723$20240725$EXP$FR-AFSSAPS-PP2024000812$NVSC2024FR149746$NOVARTIS$$60$YR$$F$Y$75$KG$20240725$$MD$FR$FR
241268271$24126827$1$I$$20240718$20240723$20240723$EXP$$NVSC2024US149533$NOVARTIS$$$$$$Y$$$20240723$$MD$US$US
241268282$24126828$2$F$20240601$20240924$20240723$20240926$EXP$$US-JNJFOC-20240750318$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240926$$HP$US$US
241268291$24126829$1$I$$20240710$20240723$20240723$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-13958$IPSEN$$$$$F$Y$$$20240723$$CN$US$US
241268301$24126830$1$I$$20240710$20240723$20240723$PER$$US-JNJFOC-20240752310$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
241268311$24126831$1$I$$20240714$20240723$20240723$EXP$$SE-JNJFOC-20240756786$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240723$$HP$FI$SE
241268323$24126832$3$F$$20240813$20240723$20240821$PER$$US-ALXN-202406USA001607US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
241268332$24126833$2$F$20230101$20240725$20240723$20240731$PER$$US-ABBVIE-5847070$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241268341$24126834$1$I$20221209$20230117$20240723$20240723$EXP$$US-AstraZeneca-2023A014110$ASTRAZENECA$$30191$DY$$M$Y$$$20240723$$CN$US$
241268351$24126835$1$I$$20230612$20240723$20240723$EXP$$US-AstraZeneca-2023A136826$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241268361$24126836$1$I$$20240709$20240723$20240723$EXP$$DE-GLANDPHARMA-DE-2024GLNLIT00528$GLAND PHARMA$Daniel Karczewski.Serratia marcescens prosthetic joint infection:  two case reports and a review of the literature.Journal of Medical Case Reports.2023;17:01-12$72$YR$E$F$Y$$$20240723$$HP$DE$DE
241268371$24126837$1$I$20240701$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144182$AMGEN$$66$YR$E$$Y$$$20240723$$CN$US$US
241268381$24126838$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116393$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240723$$HP$US$US
241268391$24126839$1$I$$20240715$20240723$20240723$30DAY$$AU-SA-2024SA210695$SANOFI AVENTIS$$$$A$$Y$$$20240723$$CN$AU$AU
241268401$24126840$1$I$$20240520$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500808$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268411$24126841$1$I$$20240523$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500978$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268421$24126842$1$I$$20240520$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500769$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268431$24126843$1$I$$20240522$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500944$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268441$24126844$1$I$$20240521$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500818$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$HP$US$US
241268451$24126845$1$I$$20240514$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500706$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268461$24126846$1$I$$20240523$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500993$MYOVANT SCIENCES$$$$$F$Y$72.562$KG$20240723$$CN$US$US
241268471$24126847$1$I$$20240604$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500816$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268481$24126848$1$I$$20240515$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500607$MYOVANT SCIENCES$$$$$F$Y$90.7$KG$20240723$$CN$US$US
241268491$24126849$1$I$$20240520$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500787$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268501$24126850$1$I$$20240516$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500700$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$MD$US$US
241268511$24126851$1$I$$20240514$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0500561$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241268521$24126852$1$I$20240501$20240531$20240723$20240723$PER$$US-MYOVANT SCIENCES GMBH-2024MYSCI0501180$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$MD$US$US
241268531$24126853$1$I$20240715$20240719$20240722$20240722$DIR$FDA-CDER-CTU-2024-50383$$FDA-CTU$$64$YR$$F$N$$$20240719$N$$US$
241268541$24126854$1$I$$20240722$20240722$20240722$DIR$711068$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241268551$24126855$1$I$$20240722$20240722$20240722$DIR$FDA-CDER-CTU-2024-50469$$FDA-CTU$$77$YR$$F$N$$$20240722$N$$US$
241268581$24126858$1$I$$20240717$20240723$20240723$PER$$US-BAYER-2024A104542$BAYER$$38$YR$A$F$Y$$$20240723$$HP$US$US
241268601$24126860$1$I$20240627$20240627$20240723$20240723$30DAY$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00334$XERIS PHARMACEUTICALS$$$$$M$Y$$$20240722$$CN$US$US
241268611$24126861$1$I$20240722$20240722$20240722$20240722$DIR$711094$$FDA-CTU$$77$YR$$UNK$N$$$20240722$N$$US$
241268621$24126862$1$I$$20240722$20240722$20240722$DIR$710972$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241268631$24126863$1$I$20240501$20240530$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007306$VANDA PHARMACEUTICALS$$48$YR$$F$Y$$$20240723$$CN$US$US
241268641$24126864$1$I$$20240603$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007309$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241268651$24126865$1$I$$20240530$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007305$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241268661$24126866$1$I$$20240530$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007304$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241268671$24126867$1$I$$20240530$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007273$VANDA PHARMACEUTICALS$$$$$M$Y$58.05$KG$20240723$$CN$US$US
241268681$24126868$1$I$$20240703$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007345$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241268691$24126869$1$I$$20240603$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007307$VANDA PHARMACEUTICALS$$$$$F$Y$52.608$KG$20240723$$CN$US$US
241268702$24126870$2$F$$20240725$20240723$20240731$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-14494$IPSEN$$$$$M$Y$$$20240731$$PH$JP$JP
241268712$24126871$2$F$20240701$20240814$20240723$20240906$PER$$US-TOLMAR, INC.-24US050695$TOLMAR$$77$YR$$M$Y$$$20240906$$PH$US$US
241268722$24126872$2$F$$20240814$20240723$20240906$PER$$US-TOLMAR, INC.-24US050692$TOLMAR$$$$$M$Y$$$20240906$$HP$US$US
241268732$24126873$2$F$20240701$20240815$20240723$20240906$PER$$US-TOLMAR, INC.-24US050721$TOLMAR$$78$YR$$M$Y$$$20240906$$HP$US$US
241268741$24126874$1$I$20240701$20240701$20240723$20240723$PER$$US-TOLMAR, INC.-24US050699$TOLMAR$$81$YR$$M$Y$$$20240722$$PH$US$US
241268752$24126875$2$F$20240101$20240722$20240723$20240812$PER$$US-TOLMAR, INC.-24US050744$TOLMAR$$80$YR$$M$Y$$$20240812$$CN$US$US
241268762$24126876$2$F$20240625$20240815$20240723$20240909$PER$$US-TOLMAR, INC.-24US050768$TOLMAR$$82$YR$$M$Y$$$20240909$$HP$US$US
241268771$24126877$1$I$$20240702$20240723$20240723$PER$$US-TOLMAR, INC.-24US050781$TOLMAR$$$$$M$Y$$$20240722$$CN$US$US
241268791$24126879$1$I$20240417$20240708$20240723$20240723$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457901$RANBAXY$$$$$F$Y$60$KG$20240723$$HP$IT$IT
241268801$24126880$1$I$$20240708$20240723$20240723$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457857$RANBAXY$Wach A, Kosalka-Wegiel J, Korkosz M. Double trouble: a case of DRESS syndrome induced by lamotrigine and subsequent skin reaction to levetiracetam. Pol Arch Med Wewn. 2024;134(6):1-2$21$YR$$F$Y$$$20240723$$MD$PL$PL
241268812$24126881$2$F$20240418$20240717$20240723$20240801$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458128$RANBAXY$$53$YR$$F$Y$$$20240801$$PH$ES$ES
241268821$24126882$1$I$20240325$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457478$RANBAXY$$85$YR$$M$Y$56$KG$20240723$$PH$FR$FR
241268831$24126883$1$I$20240229$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458041$RANBAXY$$77$YR$$F$Y$81$KG$20240723$$MD$FR$FR
241268841$24126884$1$I$20231015$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458280$RANBAXY$$35$YR$$F$Y$76$KG$20240723$$MD$FR$FR
241268851$24126885$1$I$$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458278$RANBAXY$$22$YR$$F$Y$$$20240723$$PH$FR$FR
241268861$24126886$1$I$$20240708$20240723$20240723$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458016$RANBAXY$$$$$F$Y$$$20240723$$HP$GB$GB
241268871$24126887$1$I$20231225$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458121$RANBAXY$$29$YR$$M$Y$$$20240723$$PH$FR$FR
241268881$24126888$1$I$20231006$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458033$RANBAXY$$59$YR$$F$Y$157$KG$20240723$$MD$FR$FR
241268891$24126889$1$I$$20240708$20240723$20240723$EXP$$LK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458336$RANBAXY$Ishanya Abeyagunawardena , Chirath Madurapperuma, Poobalasingham Thuvarakan, Zeenath Thowfeek, Nagaratnam Sujeewa, Gaya Katulanda, et al.. Uncommon triggers of insulin autoimmune syndrome: a case report. Journal of Medical Case Reports. 2024;18 (1):292$67$YR$$M$Y$$$20240723$$HP$LK$LK
241268901$24126890$1$I$20240418$20240708$20240723$20240723$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457562$RANBAXY$$34$YR$$M$Y$$$20240723$$MD$IT$IT
241268911$24126891$1$I$$20240708$20240723$20240723$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458074$RANBAXY$$51$YR$$M$Y$80$KG$20240723$$CN$NL$NL
241268921$24126892$1$I$$20240708$20240723$20240723$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458188$RANBAXY$Raveglia F, Libretti L, Cioffi U, Guttadauro A, Petrella F. Minimally invasive surgical management of chronic cough-induced rib fracture non-union: a case report. Am J Case Rep. 2024;25:e943222$54$YR$$M$Y$$$20240723$$HP$IT$IT
241268931$24126893$1$I$20240316$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458249$RANBAXY$$89$YR$$M$Y$77$KG$20240723$$HP$FR$FR
241268942$24126894$2$F$20240418$20240717$20240723$20240801$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457686$RANBAXY$$26$YR$$F$Y$$$20240801$$PH$ES$ES
241268951$24126895$1$I$20201013$20240708$20240723$20240723$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458284$RANBAXY$$17$YR$$F$Y$62.2$KG$20240723$$MD$PL$PL
241268961$24126896$1$I$20240327$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458246$RANBAXY$$33$YR$$M$Y$84$KG$20240723$$MD$FR$FR
241268971$24126897$1$I$$20240708$20240723$20240723$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458099$RANBAXY$$57$YR$$M$Y$137$KG$20240723$$MD$GB$GB
241268981$24126898$1$I$20231224$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458245$RANBAXY$$79$YR$$M$Y$60$KG$20240723$$MD$FR$FR
241268991$24126899$1$I$20220530$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458289$RANBAXY$$41$YR$$F$Y$$$20240723$$PH$FR$FR
241269001$24126900$1$I$$20240708$20240723$20240723$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458383$RANBAXY$Takei S, Kinoshita H, Jamal M, Yamashita T, Tanaka E, Kawahara S, et al.. An autopsy case of intoxication caused by drug interaction with multiple psychotropic drugs, fluvoxamine, levomepromazine, and trihexyphenidyl. Leg Med Tokyo. 2024;70 (0):1-2$3$DEC$$F$Y$40$KG$20240723$$HP$JP$JP
241269011$24126901$1$I$20240417$20240708$20240723$20240723$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457564$RANBAXY$$17$YR$$M$Y$75$KG$20240723$$MD$IT$IT
241269021$24126902$1$I$20240403$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458127$RANBAXY$$22$YR$$F$Y$$$20240723$$MD$FR$FR
241269031$24126903$1$I$20210401$20240708$20240723$20240723$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458017$RANBAXY$$29$YR$$M$Y$98$KG$20240723$$CN$GB$GB
241269041$24126904$1$I$20240130$20240708$20240723$20240723$EXP$FR-AFSSAPS-PV2024000398$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458111$RANBAXY$$53$YR$$F$Y$$$20240723$$PH$FR$FR
241269051$24126905$1$I$20230101$20240708$20240723$20240723$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457992$RANBAXY$$59$YR$$M$Y$$$20240723$$MD$RO$RO
241269061$24126906$1$I$20240409$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457585$RANBAXY$$79$YR$$F$Y$43$KG$20240723$$MD$FR$FR
241269071$24126907$1$I$20240101$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457912$RANBAXY$$65$YR$$F$Y$$$20240723$$PH$FR$FR
241269081$24126908$1$I$20240419$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457747$RANBAXY$$51$YR$$M$Y$$$20240723$$MD$FR$FR
241269091$24126909$1$I$20240101$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457925$RANBAXY$$39$YR$$M$Y$$$20240723$$PH$FR$FR
241269101$24126910$1$I$20230412$20240722$20240723$20240723$EXP$FR-AFSSAPS-PC2024000565$FR-FreseniusKabi-FK202411477$FRESENIUS KABI$$72$YR$E$F$Y$80$KG$20240723$$MD$FR$FR
241269111$24126911$1$I$$20240125$20240723$20240723$EXP$$GB-TEVA-VS-3150045$TEVA$$45$YR$$F$Y$$$20240723$$HP$GB$GB
241269121$24126912$1$I$$20240722$20240722$20240722$DIR$710973$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241269131$24126913$1$I$20240216$20240708$20240723$20240723$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457841$RANBAXY$$67$YR$$F$Y$$$20240723$$PH$NL$NL
241269141$24126914$1$I$$20240718$20240723$20240723$EXP$$CN-FreseniusKabi-FK202411402$FRESENIUS KABI$$$$$$Y$$$20240723$$PH$CN$CN
241269151$24126915$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458218$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17 (6):771-778$$$$$Y$$$20240723$$MD$US$US
241269161$24126916$1$I$$20240722$20240722$20240722$DIR$710977$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241269181$24126918$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458205$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17No. 6:771-778$$$$$Y$$$20240723$$MD$US$US
241269191$24126919$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458198$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17No. 6:771-778$$$$$Y$$$20240723$$MD$US$US
241269201$24126920$1$I$20240719$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50527$$FDA-CTU$$64$YR$$F$N$69.9$KG$20240722$N$$US$
241269211$24126921$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458212$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17 (6):771-778$$$$$Y$$$20240723$$MD$US$US
241269221$24126922$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458160$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$68$YR$$M$Y$$$20240723$$HP$TW$TW
241269232$24126923$2$F$$20240725$20240723$20240729$EXP$$CA-TAKEDA-2024TUS074009$TAKEDA$$$$$F$Y$$$20240729$$CN$CA$CA
241269251$24126925$1$I$$20240717$20240723$20240723$PER$$US-BAYER-2024A104547$BAYER$$38$YR$A$F$Y$$$20240723$$MD$US$US
241269261$24126926$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458156$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$68$YR$$F$Y$$$20240723$$HP$TW$TW
241269271$24126927$1$I$20230904$20240708$20240723$20240723$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457453$RANBAXY$$67$YR$$M$Y$60$KG$20240723$$PH$FR$FR
241269281$24126928$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458201$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17No. 6:771-778$$$$$Y$$$20240723$$MD$US$US
241269291$24126929$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458200$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17; 6:771-778$$$$$Y$$$20240723$$MD$US$US
241269301$24126930$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458193$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17No. 6:771-778$$$$$Y$$$20240723$$MD$US$US
241269311$24126931$1$I$$20240708$20240723$20240723$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457850$RANBAXY$Kim J, Lee J, Lee S, Kim K. Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report. Medicina. 2024;60:992$79$YR$$M$Y$$$20240723$$HP$KR$KR
241269321$24126932$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457598$RANBAXY$Sablaban IM, Gautam M. Kratom + Stimulant Co-Addiction: A Case Series and Brief Review. J Addict Dis. 2023;41(2):181-184$34$YR$$M$Y$$$20240723$$MD$US$US
241269331$24126933$1$I$$20240708$20240723$20240723$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458036$RANBAXY$Zhang Y, Huang Z. Ripretinib in combination with tyrosine kinase inhibitor as a late-line treatment option for refractory gastrointestinal stromal tumors: two case reports and literature review. Front Pharmacol. 2023;14:1122885(1-8)$73$YR$$F$Y$$$20240723$$HP$CN$CN
241269341$24126934$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458204$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17No. 6:771-778$$$$$Y$$$20240723$$MD$US$US
241269351$24126935$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458149$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$71$YR$$F$Y$$$20240723$$HP$TW$TW
241269361$24126936$1$I$$20240708$20240723$20240723$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457981$RANBAXY$Knudsen GHo, Kermanian N, Kock-Jensen CH, Antulov R. Opioid-Induced Leukoencephalopathies: A Report of Two Cases. Case Rep Neurol. 2022;14 (1):25-30$30$YR$$M$Y$$$20240723$$HP$DK$DK
241269371$24126937$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458150$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$56$YR$$F$Y$$$20240723$$HP$TW$TW
241269381$24126938$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458146$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$35$YR$$M$Y$$$20240723$$HP$TW$TW
241269391$24126939$1$I$$20240708$20240723$20240723$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457677$RANBAXY$Cabalova P. Recurrent impetigo facies. Dermatol Pract. 2024;Mar;18(2):112-114$80$YR$$M$Y$$$20240723$$MD$CZ$CZ
241269401$24126940$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458159$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$68$YR$$F$Y$$$20240723$$HP$TW$TW
241269411$24126941$1$I$$20240708$20240723$20240723$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457884$RANBAXY$Lu H, Yuan J, Wu Z, Wang L, Wu S, Chen Q, et al. Distribution of drug-resistant genes in alveolar lavage fluid from patients with psittacosis and traceability analysis of causative organisms. Front Microbiol. 2023;14:1-12$73$YR$$M$Y$$$20240723$$HP$CN$CN
241269422$24126942$2$F$$20240716$20240723$20240731$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458172$RANBAXY$Gul EE, Bektasoglu G, Dogan Z. Brugada phenocopy associated with multiple psychotic drugs. J Electrocardiol. 2023;81:156-158$17$YR$$F$Y$$$20240731$$MD$TR$TR
241269431$24126943$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457600$RANBAXY$Sablaban IM, Gautam M. Kratom + Stimulant Co-Addiction: A Case Series and Brief Review. J Addict Dis. 2023;41(2):181-184$44$YR$$M$Y$$$20240723$$MD$US$US
241269441$24126944$1$I$$20240708$20240723$20240723$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458114$RANBAXY$Ozek G, Aksoylar S, Ucar SK, Canda E, Akcan M, Carti O, et al. Hematopoietic stem cell transplantationwith reduced toxicity conditioning regimen in mitochondrial neurogastrointestinal encephalopathy syndrome. Pediatr Blood Cancer. 2023;70 (7):e30334(1-7)$$$$F$Y$$$20240723$$HP$TR$TR
241269451$24126945$1$I$$20240708$20240723$20240723$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458115$RANBAXY$Ozek G, Aksoylar S, Ucar SK, Canda E, Akcan M, Carti O, et al. Hematopoietic stem cell transplantationwith reduced toxicity conditioning regimen in mitochondrial neurogastrointestinal encephalopathy syndrome. Pediatr Blood Cancer. 2023;70 (7):e30334(1-7)$$$$M$Y$$$20240723$$HP$TR$TR
241269461$24126946$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458065$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17No. 6:771-778$$$$$Y$$$20240723$$MD$US$US
241269471$24126947$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458147$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$37$YR$$F$Y$$$20240723$$HP$TW$TW
241269481$24126948$1$I$$20240708$20240723$20240723$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458100$RANBAXY$Chu Z, Lin H, Zhan Q, Liu T, Wang Y. A retrospective analysis of first-line PD-1 monoclonal antibodies treatment in patients with leptomeningeal metastasis from solid tumors. J Oncol Pharm Pract. 2023;29 (3):582-589$$$$$Y$$$20240723$$HP$CN$CN
241269492$24126949$2$F$$20240802$20240723$20240816$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457316$RANBAXY$Lopez T, Barcelo A, Gutierrez C, Blasco M, Grafia I, Bastida C, et al. Clopidogrel-induced thrombotic microangiopathy: a case report. Eur J Hosp Pharm. 2024;Jul 4:1-5$75$YR$$M$Y$$$20240816$$CN$ES$ES
241269501$24126950$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458196$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17No. 6:771-778$$$$$Y$$$20240723$$MD$US$US
241269511$24126951$1$I$$20240708$20240723$20240723$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458009$RANBAXY$Zhang Y, Huang Z. Ripretinib in combination with tyrosine kinase inhibitor as a late-line treatment option for refractory gastrointestinal stromal tumors: two case reports and literature review. Front Pharmacol. 2023;14:1122885(1-8)$57$YR$$F$Y$$$20240723$$HP$CN$CN
241269521$24126952$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458191$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17No. 6:771-778$$$$$Y$$$20240723$$MD$US$US
241269531$24126953$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457664$RANBAXY$Gondek S, Ogledzinski M, Lin W, Milejczyk K, Juengel B, Potter L, et al. Persistence of long-term  insulin independence after islet transplantation and two subsequent pregnancies. Eur J Transl Clin Med. 2023;6(1):9-13$29$YR$$F$Y$66$KG$20240723$$HP$US$US
241269541$24126954$1$I$$20240708$20240723$20240723$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458061$RANBAXY$Herrington J, Batthish M, Takrouri H, Yarascavitch B, Gross A. Asymptomatic intraspinal epidermoid cyst in a 7-year-old male with juvenile idiopathic arthritis identified by an advanced physiotherapist practitioner: a case report. J Man Manip Ther. 2024;32 (3):343-351$7$YR$$M$Y$$$20240723$$HP$CA$CA
241269551$24126955$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458148$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$52$YR$$F$Y$$$20240723$$HP$TW$TW
241269561$24126956$1$I$$20240708$20240723$20240723$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445511$RANBAXY$Yu D, Luo Y, Sun L. Nontyphoidal salmonella septic arthritis in A patient with systemic lupus erythematosus:A case report. Diagn Microbiol Infect Dis. 2024;Apr 27,109(3):116332,PMID: 38692203$43$YR$$F$Y$$$20240723$$HP$CN$CN
241269571$24126957$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458155$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$62$YR$$F$Y$$$20240723$$HP$TW$TW
241269581$24126958$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458192$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17No. 6:771-778$$$$$Y$$$20240723$$MD$US$US
241269591$24126959$1$I$20240630$20240701$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007342$VANDA PHARMACEUTICALS$$24$YR$$F$Y$67.574$KG$20240723$$CN$US$US
241269601$24126960$1$I$$20240405$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007247$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241269611$24126961$1$I$$20240708$20240723$20240723$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458070$RANBAXY$Zhang W, Cao W, Tao W, Wang Y, Tangzhu C, Shen Q, et al. Anti-NMDAR encephalitis in a child with long impaired consciousness and persistent antibodies: a case report and mini review. Front Immunol. 2024;15:1402523$8$YR$$F$Y$$$20240723$$HP$CN$CN
241269621$24126962$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457680$RANBAXY$Young KZ, Guan LL, Friedman BJ, Rambhatla PV. Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil. Int J Womens Dermatol. 2022;8 (3):1-2$47$YR$$F$Y$$$20240723$$MD$US$US
241269631$24126963$1$I$$20240516$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007285$VANDA PHARMACEUTICALS$$$$$M$Y$113.83$KG$20240723$$CN$US$US
241269641$24126964$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458576$RANBAXY$Siler C, Fuller W, Whaley D, Keating J. Polypharmacy in Older Adults: A Case Study. S D Med. 2023;Mar; 76 (3):124-127$64$YR$$F$Y$$$20240723$$MD$US$US
241269651$24126965$1$I$$20240423$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007265$VANDA PHARMACEUTICALS$$$$$F$Y$72.562$KG$20240723$$CN$US$US
241269661$24126966$1$I$$20240614$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007323$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241269671$24126967$1$I$$20240702$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007344$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241269681$24126968$1$I$20200701$20240719$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007301$VANDA PHARMACEUTICALS$$49$YR$$F$Y$74.376$KG$20240723$$CN$US$US
241269691$24126969$1$I$$20240408$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007250$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241269701$24126970$1$I$20240601$20240625$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007334$VANDA PHARMACEUTICALS$$51$YR$$F$Y$$$20240723$$CN$US$US
241269711$24126971$1$I$$20240709$20240723$20240723$EXP$$US-GLANDPHARMA-US-2024GLNLIT00490$GLAND PHARMA$E. K. Hourigan.The right side of cardiogenic shock: a case of beta-blocker induced cardiogenic shock in a female with suspected pulmonary hypertension.American journal of respiratory and critical care medicine .MAY-2024;209$41$YR$A$F$Y$$$20240723$$HP$US$US
241269721$24126972$1$I$$20240717$20240723$20240723$PER$$US-ROCHE-10000031133$ROCHE$$26$YR$A$F$Y$$$20240723$$CN$US$US
241269734$24126973$4$F$20240330$20240731$20240723$20240805$EXP$$US-MYLANLABS-2024M1067275$MYLAN$$0$YR$$F$Y$0.64$KG$20240805$$CN$US$US
241269741$24126974$1$I$$20240513$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007263$VANDA PHARMACEUTICALS$$$$$F$Y$141.04$KG$20240723$$CN$US$US
241269751$24126975$1$I$$20240716$20240723$20240723$EXP$$CA-TAKEDA-2024TUS072299$TAKEDA$$$$$M$Y$$$20240723$$CN$CA$CA
241269761$24126976$1$I$20240701$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116456$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240723$$HP$US$US
241269771$24126977$1$I$20240717$20240718$20240723$20240723$PER$$US-BAYER-2024A105340$BAYER$$44$YR$A$F$Y$$$20240723$$CN$US$US
241269781$24126978$1$I$$20240718$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115798$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240723$$CN$CA$CA
241269791$24126979$1$I$$20240626$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007337$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241269801$24126980$1$I$$20240612$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007256$VANDA PHARMACEUTICALS$$$$$M$Y$90.703$KG$20240723$$CN$US$US
241269811$24126981$1$I$$20240516$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007248$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241269821$24126982$1$I$$20240522$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007295$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241269831$24126983$1$I$$20240415$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007255$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241269841$24126984$1$I$$20210524$20240723$20240723$EXP$$US-AstraZeneca-2021A470642$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241269851$24126985$1$I$20240501$20240514$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007281$VANDA PHARMACEUTICALS$$44$YR$$M$Y$$$20240723$$CN$US$US
241269861$24126986$1$I$20240512$20240604$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007282$VANDA PHARMACEUTICALS$$56$YR$$F$Y$73.469$KG$20240723$$CN$US$US
241269871$24126987$1$I$$20240617$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007325$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241269881$24126988$1$I$$20240423$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007266$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241269891$24126989$1$I$$20240717$20240723$20240723$EXP$NL-LRB-00985374$NL-MYLANLABS-2024M1067194$MYLAN$$21$YR$$F$Y$70$KG$20240723$$CN$NL$NL
241269901$24126990$1$I$20240502$20240719$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007275$VANDA PHARMACEUTICALS$$37$YR$$M$Y$$$20240723$$CN$US$US
241269911$24126991$1$I$20240622$20240717$20240723$20240723$EXP$HR-HALMED-300086113$HR-MYLANLABS-2024M1067108$MYLAN$$32$YR$$F$Y$$$20240723$$MD$HR$HR
241269922$24126992$2$F$20240717$20240724$20240723$20240726$PER$$US-BAYER-2024A105394$BAYER$$20$YR$A$F$Y$$$20240726$$HP$US$US
241269931$24126993$1$I$20240720$20240720$20240723$20240723$EXP$$CA-TAKEDA-2024TUS074006$TAKEDA$$24$YR$$F$Y$$$20240723$$CN$CA$CA
241269942$24126994$2$F$$20240716$20240723$20240812$30DAY$$US-UCBSA-2024035185$UCB$$$$A$M$Y$$$20240812$$CN$US$US
241269953$24126995$3$F$$20240820$20240723$20240829$EXP$$JP-TAKEDA-2024TUS072922$TAKEDA$Kato D. A case of recurrent refractory AL amyloidosis treated with D-BCD therapy$52$YR$$M$Y$90.2$KG$20240829$$MD$JP$JP
241269961$24126996$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458136$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$57$YR$$F$Y$$$20240723$$HP$TW$TW
241269971$24126997$1$I$$20240708$20240723$20240723$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457933$RANBAXY$Li X, Jin Y. Zolpidem-triggered atrial fibrillation in a patient with cardiomyopathy: a case report. BMC Cardiovasc Disord. 2024;24(1):339$40$YR$$M$Y$$$20240723$$HP$CN$CN
241269981$24126998$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458157$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$55$YR$$F$Y$$$20240723$$HP$TW$TW
241270001$24127000$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457667$RANBAXY$Gondek S, Ogledzinski M, Lin W, Milejczyk K, Juengel B, Potter L, et al. Persistence of long-term  insulin independence after islet transplantation and two subsequent pregnancies. Eur J Transl Clin Med. 2023;6(1):9-13$$$N$$Y$$$20240723$$HP$US$US
241270011$24127001$1$I$$20240708$20240723$20240723$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457986$RANBAXY$Knudsen GHo, Kermanian N, Kock-Jensen CH, Antulov R. Opioid-Induced Leukoencephalopathies: A Report of Two Cases. Case Rep Neurol. 2022;14 (1):25-30$24$YR$$M$Y$$$20240723$$HP$DK$DK
241270021$24127002$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458152$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$58$YR$$F$Y$$$20240723$$HP$TW$TW
241270031$24127003$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458154$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$49$YR$$F$Y$$$20240723$$HP$TW$TW
241270041$24127004$1$I$$20240708$20240723$20240723$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458119$RANBAXY$Ozek G, Aksoylar S, Ucar SK, Canda E, Akcan M, Carti O, et al. Hematopoietic stem cell transplantationwith reduced toxicity conditioning regimen in mitochondrial neurogastrointestinal encephalopathy syndrome. Pediatr Blood Cancer. 2023;70 (7):e30334(1-7)$$$$$Y$$$20240723$$HP$TR$TR
241270071$24127007$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458158$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$65$YR$$F$Y$$$20240723$$HP$TW$TW
241270081$24127008$1$I$$20240708$20240723$20240723$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458161$RANBAXY$Lan T-Y, Lin Y-C, Tseng T-C, Yang H-C, Kao J-H, Cheng C-F et al. Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas. Gut Liver. 2023;Mar; 17(2):288-298$75$YR$$M$Y$$$20240723$$HP$TW$TW
241270092$24127009$2$F$$20240712$20240723$20240726$EXP$$AR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457825$RANBAXY$Cervantes JG, Gasque RA, Lenz ME, Barbero M, Navarro L, Roca I, et al. Liver transplantation as treatment for acetaminophen poisoning. Medicina B Aires. 2024;84:588-591$28$YR$$F$Y$$$20240726$$HP$AR$AR
241270101$24127010$1$I$$20240722$20240722$20240722$DIR$711117$$FDA-CTU$$$$$M$N$$$20240722$N$CN$US$
241270111$24127011$1$I$$20240708$20240723$20240723$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457887$RANBAXY$Lu H, Yuan J, Wu Z, Wang L, Wu S, Chen Q, et al. Distribution of drug-resistant genes in alveolar lavage fluid from patients with psittacosis and traceability analysis of causative organisms. Front Microbiol. 2023;14:1-12$64$YR$$F$Y$$$20240723$$HP$CN$CN
241270121$24127012$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458217$RANBAXY$Lindsay SE, Gehling H, Ryu WHA, Yoo J, Philipp T. Posterior Fixation Without Debridement for Vertebral Body Osteomyelitis and Discitis: A 10-Year Retrospective Review. Int J Spine Surg. 2023;17 (6):771-778$$$$$Y$$$20240723$$MD$US$US
241270131$24127013$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457353$RANBAXY$$$$E$M$Y$$$20240723$$CN$US$US
241270141$24127014$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457602$RANBAXY$Sablaban IM, Gautam M. Kratom + Stimulant Co-Addiction: A Case Series and Brief Review. J Addict Dis. 2023;41(2):181-184$21$YR$$M$Y$$$20240723$$MD$US$US
241270151$24127015$1$I$$20240604$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007312$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241270161$24127016$1$I$$20240708$20240723$20240723$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457996$RANBAXY$Liu HHW, Ho TW, Tsang NSK, Lam JTW, Hui YT. Doxycycline-induced gastric injury. Hong Kong Med J. 2024;30(3):248/e1-2$28$YR$$M$Y$$$20240723$$HP$CN$CN
241270171$24127017$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50581$$FDA-CTU$$$$$M$N$$$20240723$N$HP$US$
241270181$24127018$1$I$20240221$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50547$$FDA-CTU$$65$YR$$F$N$53.5$KG$20240722$N$$US$
241270191$24127019$1$I$20240704$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50585$$FDA-CTU$$19$YR$$M$N$$$20240719$N$HP$US$
241270201$24127020$1$I$20240716$20240722$20240722$20240722$DIR$711061$$FDA-CTU$$$$$UNK$N$$$20240722$N$HP$US$
241270211$24127021$1$I$$20240502$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007274$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270221$24127022$1$I$$20240604$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007311$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270231$24127023$1$I$$20240516$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007284$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270241$24127024$1$I$$20240507$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007243$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241270251$24127025$1$I$$20240412$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007253$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270261$24127026$1$I$$20240514$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007283$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270271$24127027$1$I$$20240528$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007302$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270281$24127028$1$I$20240719$20240722$20240722$20240722$DIR$711025$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241270291$24127029$1$I$20240719$20240722$20240722$20240722$DIR$711015$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241270301$24127030$1$I$$20240607$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007316$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270311$24127031$1$I$$20240418$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007261$VANDA PHARMACEUTICALS$$$$$F$Y$89.388$KG$20240723$$CN$US$US
241270321$24127032$1$I$$20240719$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007249$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270331$24127033$1$I$$20240708$20240723$20240723$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457313$RANBAXY$Ballotari M, Truver MT, Dhoble LR, Kinsey AM, Hoyer JL, Chronister CW et al. A Postmortem Case Report involving Fentanyl, Desalkylgidazepam and Bromazolam. J Anal Toxicol. 2024;Jul 5:bkae059/ Online ahead of print$24$YR$$M$Y$$$20240723$$HP$US$US
241270341$24127034$1$I$20240614$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50610$$FDA-CTU$$35$YR$$M$N$$$20240723$N$HP$US$
241270361$24127036$1$I$20240603$20240611$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007320$VANDA PHARMACEUTICALS$$58$YR$$F$Y$$$20240723$$CN$US$US
241270371$24127037$1$I$$20240709$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007321$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241270381$24127038$1$I$$20240718$20240723$20240723$EXP$$US-JNJFOC-20240751458$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240723$$HP$US$US
241270391$24127039$1$I$$20240718$20240723$20240723$EXP$$CA-JNJFOC-20240754152$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$HP$CA$CA
241270401$24127040$1$I$$20240718$20240723$20240723$PER$$US-BAYER-2024A105726$BAYER$$$$$F$Y$$$20240723$$HP$US$US
241270411$24127041$1$I$$20240722$20240723$20240723$EXP$$IT-PFIZER INC-PV202400095353$PFIZER$$17$YR$$F$Y$$$20240723$$CN$IT$IT
241270431$24127043$1$I$$20240711$20240723$20240723$EXP$$AU-TEVA-VS-3221313$TEVA$$$$$F$Y$$$20240723$$HP$AU$AU
241270441$24127044$1$I$$20240619$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007326$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270451$24127045$1$I$$20240429$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007269$VANDA PHARMACEUTICALS$$$$$M$Y$95.254$KG$20240723$$CN$US$US
241270461$24127046$1$I$$20240716$20240723$20240723$EXP$$JP-PFIZER INC-PV202400093328$PFIZER$Hakamada, C.. A case of acute kidney injury due to the combination use of nirmatrelvir/ritonavir and tacrolimus. The 253rd Tokai Regional Meeting of The Japanese Society of Internal Medicine. 2024;253rd$60$YR$$M$Y$$$20240723$$HP$JP$JP
241270471$24127047$1$I$20230101$20240718$20240723$20240723$EXP$$CA-PFIZER INC-202400219352$PFIZER$$73$YR$$F$Y$$$20240723$$HP$CA$CA
241270501$24127050$1$I$20160101$20240719$20240723$20240723$EXP$$US-PFIZER INC-PV202400095335$PFIZER$$57$YR$$F$Y$$$20240723$$HP$US$US
241270511$24127051$1$I$20210301$20240722$20240723$20240723$EXP$$FR-PFIZER INC-2021SGN01258$PFIZER$$58$YR$$M$Y$$$20240723$$HP$FR$FR
241270521$24127052$1$I$$20240603$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007310$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241270531$24127053$1$I$$20240607$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007318$VANDA PHARMACEUTICALS$$$$$M$Y$70.295$KG$20240723$$CN$US$US
241270541$24127054$1$I$20240701$20240715$20240723$20240723$PER$$US-UNITED THERAPEUTICS-UNT-2024-021834$UNITED THERAPEUTICS$$41$YR$$F$Y$92.971$KG$20240723$$$US$US
241270551$24127055$1$I$$20240719$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007343$VANDA PHARMACEUTICALS$$$$$F$Y$106.57$KG$20240723$$CN$US$US
241270561$24127056$1$I$$20240621$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007331$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241270571$24127057$1$I$$20240408$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007251$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241270582$24127058$2$F$20230125$20240829$20240723$20240907$EXP$$IT-AMGEN-ITASP2024144132$AMGEN$$82$YR$E$F$Y$$$20240907$$PH$IT$IT
241270592$24127059$2$F$20240101$20240722$20240723$20240729$EXP$$US-AMGEN-USASP2024144272$AMGEN$$70$YR$E$F$Y$$$20240729$$HP$US$US
241270601$24127060$1$I$$20240719$20240723$20240723$PER$$US-BAYER-2024A106082$BAYER$$91$YR$E$F$Y$$$20240723$$CN$US$US
241270611$24127061$1$I$$20240610$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007272$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270621$24127062$1$I$$20240621$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007332$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270631$24127063$1$I$20240119$20240131$20240723$20240723$EXP$GB-MHRA-MED-202401301621550490-MBRWS$GB-TEVA-VS-3151735$TEVA$$83$YR$$$Y$$$20240723$$PH$GB$GB
241270641$24127064$1$I$$20240607$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007317$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241270651$24127065$1$I$20240614$20240614$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007324$VANDA PHARMACEUTICALS$$61$YR$$F$Y$$$20240723$$CN$US$US
241270661$24127066$1$I$$20240522$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007294$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270671$24127067$1$I$$20240502$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007258$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241270681$24127068$1$I$$20240625$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007335$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241270691$24127069$1$I$$20240412$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007254$VANDA PHARMACEUTICALS$$$$$M$Y$79.365$KG$20240723$$CN$US$US
241270701$24127070$1$I$$20240510$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007279$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241270711$24127071$1$I$$20240517$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007288$VANDA PHARMACEUTICALS$$$$$F$Y$85.714$KG$20240723$$CN$US$US
241270721$24127072$1$I$20240101$20240711$20240723$20240723$EXP$$US-TEVA-VS-3212446$TEVA$$81$YR$$F$Y$$$20240723$$MD$US$US
241270732$24127073$2$F$$20240726$20240723$20240730$EXP$$GB-TAKEDA-2024TUS074091$TAKEDA$$$$$M$Y$$$20240730$$CN$GB$GB
241270751$24127075$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50570$$FDA-CTU$$$$$F$N$$$20240719$N$HP$US$
241270761$24127076$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50615$$FDA-CTU$$$$$M$N$$$20240722$N$HP$US$
241270781$24127078$1$I$$20240722$20240722$20240722$DIR$711141$$FDA-CTU$$44$YR$$F$N$$$20240722$N$PH$US$
241270791$24127079$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50568$$FDA-CTU$$74$YR$$M$N$166$LBS$20240719$N$$US$
241270801$24127080$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50566$$FDA-CTU$$74$YR$$M$N$166$LBS$20240719$N$$US$
241270811$24127081$1$I$20240713$20240715$20240723$20240723$DIR$FDA-CDER-CTU-2024-50533$$FDA-CTU$$4$YR$$F$N$18.8$KG$20240715$N$$US$
241270831$24127083$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50612$$FDA-CTU$$$$$M$N$$$20240722$N$HP$US$
241270841$24127084$1$I$20240531$20240712$20240723$20240723$DIR$FDA-CDER-CTU-2024-50545$$FDA-CTU$$83$YR$$M$N$85.1$KG$20240712$N$$US$
241270871$24127087$1$I$20240322$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50546$$FDA-CTU$$78$YR$$M$N$75.8$KG$20240722$N$$US$
241270881$24127088$1$I$$20240722$20240722$20240722$DIR$710952$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241270891$24127089$1$I$20230103$20240708$20240723$20240723$EXP$$DE-NORDICGR-056881$NORDIC PHARMA$$4$DEC$$M$Y$$$20240719$$MD$DE$DE
241270901$24127090$1$I$20211015$20240708$20240723$20240723$EXP$$DE-NORDICGR-2022000725$NORDIC PHARMA$$$$A$M$Y$$$20240723$$MD$DE$DE
241270911$24127091$1$I$20230804$20240708$20240723$20240723$EXP$$DE-NORDICGR-055889$NORDIC PHARMA$$$$E$M$Y$$$20240723$$HP$DE$DE
241270921$24127092$1$I$20240201$20240708$20240723$20240723$EXP$$DE-NORDICGR-056884$NORDIC PHARMA$$83$YR$$F$Y$$$20240719$$HP$DE$DE
241270931$24127093$1$I$20220301$20240708$20240723$20240723$EXP$$DE-NORDICGR-2023002813$NORDIC PHARMA$$72$YR$$F$Y$$$20240723$$MD$DE$
241270941$24127094$1$I$20191120$20240708$20240723$20240723$EXP$$DE-NORDICGR-2021000287$NORDIC PHARMA$$54$YR$$F$Y$$$20240719$$HP$DE$
241270951$24127095$1$I$20240312$20240708$20240723$20240723$EXP$DE-EMA-DD-20240606-7482827-161245$DE-NORDICGR-056895$NORDIC PHARMA$$$$A$F$Y$$$20240719$$MD$DE$DE
241270961$24127096$1$I$20240429$20240708$20240723$20240723$EXP$$DE-NORDICGR-056891$NORDIC PHARMA$$61$YR$$F$Y$57$KG$20240719$$MD$DE$DE
241270971$24127097$1$I$20210605$20240708$20240723$20240723$EXP$$DE-NORDICGR-2022000566$NORDIC PHARMA$$$$A$F$Y$$$20240723$$MD$DE$DE
241270981$24127098$1$I$20230116$20240708$20240723$20240723$EXP$$DE-NORDICGR-056890$NORDIC PHARMA$$$$A$M$Y$$$20240723$$MD$DE$DE
241271001$24127100$1$I$$20240509$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007277$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271022$24127102$2$F$20240807$20240808$20240723$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-022266$UNITED THERAPEUTICS$$67$YR$$F$Y$70.295$KG$20240816$$$US$US
241271031$24127103$1$I$$20240226$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007195$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271041$24127104$1$I$$20240605$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007315$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271051$24127105$1$I$20240517$20240521$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007297$VANDA PHARMACEUTICALS$$61$YR$$F$Y$$$20240723$$CN$US$US
241271061$24127106$1$I$$20240130$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007157$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271071$24127107$1$I$$20240628$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007339$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271081$24127108$1$I$$20240312$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007222$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271091$24127109$1$I$$20240709$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007293$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271101$24127110$1$I$20240426$20240430$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007270$VANDA PHARMACEUTICALS$$55$YR$$F$Y$$$20240723$$CN$US$US
241271121$24127112$1$I$$20240719$20240723$20240723$PER$$US-BAYER-2024A106178$BAYER$$$$$M$Y$$$20240723$$CN$US$US
241271131$24127113$1$I$$20240718$20240723$20240723$PER$$US-BIOVITRUM-2024-US-010065$BIOVITRUM$$81$YR$$F$Y$$$20240723$$CN$US$US
241271141$24127114$1$I$$20240716$20240723$20240723$EXP$$CA-TAKEDA-2024TUS072413$TAKEDA$$$$$M$Y$62$KG$20240723$$CN$CA$CA
241271151$24127115$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116112$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240723$$HP$US$US
241271161$24127116$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116306$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240723$$HP$US$US
241271172$24127117$2$F$20240607$20240829$20240723$20240903$EXP$$IT-AMGEN-ITASP2024144143$AMGEN$$76$YR$E$F$Y$$$20240903$$PH$IT$IT
241271181$24127118$1$I$20240719$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116891$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240723$$MD$US$US
241271192$24127119$2$F$$20240822$20240723$20240822$30DAY$$US-PFIZER INC-202400219106$PFIZER$$14$YR$$M$Y$$$20240822$$CN$US$US
241271201$24127120$1$I$20240709$20240710$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007054$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240723$$CN$US$US
241271212$24127121$2$F$$20240825$20240723$20240826$30DAY$$AU-PFIZER INC-202400217733$PFIZER$$$$$$Y$$$20240826$$CN$AU$AU
241271224$24127122$4$F$$20240824$20240723$20240826$30DAY$$US-PFIZER INC-202400216581$PFIZER$$9$YR$$M$Y$$$20240826$$CN$US$US
241271231$24127123$1$I$$20240718$20240723$20240723$30DAY$$BE-PFIZER INC-202400218589$PFIZER$$$$$F$Y$$$20240723$$CN$BE$BR
241271242$24127124$2$F$$20240828$20240723$20240828$30DAY$$HR-PFIZER INC-PV202400094229$PFIZER$$10$YR$$M$Y$$$20240828$$MD$HR$HR
241271253$24127125$3$F$$20240825$20240723$20240826$30DAY$$US-PFIZER INC-202400218088$PFIZER$$5$YR$$M$Y$$$20240826$$CN$US$US
241271273$24127127$3$F$20220201$20240828$20240723$20240905$30DAY$$US-PFIZER INC-202400218846$PFIZER$$10$YR$$M$Y$49.887$KG$20240905$$CN$US$US
241271281$24127128$1$I$$20240718$20240723$20240723$30DAY$$US-PFIZER INC-PV202400044377$PFIZER$$$$$$Y$$$20240723$$CN$US$US
241271292$24127129$2$F$20240717$20240828$20240723$20240828$30DAY$$CO-PFIZER INC-PV202400094248$PFIZER$$9$YR$$F$Y$$$20240828$$CN$CO$CO
241271302$24127130$2$F$$20240822$20240723$20240822$30DAY$$US-PFIZER INC-202400217890$PFIZER$$7$YR$$F$Y$$$20240822$$CN$US$US
241271312$24127131$2$F$$20240825$20240723$20240826$30DAY$$US-PFIZER INC-202400216868$PFIZER$$8$YR$$F$Y$$$20240826$$CN$US$US
241271322$24127132$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3220067$TEVA$Puri C, Khan AA, Sher N. A Case of Emphysematous Gastritis with Septic Shock and Clostridioides Difficile. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Puri C, Khan AA, Sher N. A Case of Emphysematous Gastritis With Septic Shock and Clostridioides Difficile. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$72$YR$$F$Y$$$20240819$$HP$US$US
241271331$24127133$1$I$$20240709$20240723$20240723$EXP$$US-LEADINGPHARMA-US-2024LEALIT00296$LEADING PHARMA$Donato Mignone.A RUDE AWAKENING: A CASE OF SUGAMMADEX CAUSING TRANSIENT CARDIOMYOPATHY MIMICKING STEMI.Journal of the American College of Cardiology.apr-2024;83 (Suppl.) No.13:3618$43$YR$A$M$Y$$$20240723$$HP$US$US
241271341$24127134$1$I$20220101$20240719$20240723$20240723$EXP$AU-TGA-0000813074$AU-ORGANON-O2407AUS002035$ORGANON$$$$$M$Y$$$20240723$$CN$AU$AU
241271351$24127135$1$I$$20240722$20240723$20240723$PER$$US-HALEON-2188384$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241271361$24127136$1$I$$20240124$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007140$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271371$24127137$1$I$$20240319$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007231$VANDA PHARMACEUTICALS$$$$$F$Y$87.528$KG$20240723$$CN$US$US
241271381$24127138$1$I$$20240124$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007142$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271391$24127139$1$I$$20240111$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007123$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271401$24127140$1$I$$20240308$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007199$VANDA PHARMACEUTICALS$$$$$F$Y$101.59$KG$20240723$$CN$US$US
241271411$24127141$1$I$$20240321$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007233$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271421$24127142$1$I$$20240712$20240723$20240723$PER$$US-TEVA-VS-3222058$TEVA$$$$$F$Y$$$20240723$$CN$US$US
241271431$24127143$1$I$20240401$20240410$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007230$VANDA PHARMACEUTICALS$$80$YR$$M$Y$86.168$KG$20240723$$CN$US$US
241271441$24127144$1$I$20230924$20240220$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007130$VANDA PHARMACEUTICALS$$73$YR$$F$Y$60.771$KG$20240723$$CN$US$US
241271451$24127145$1$I$20240722$20240722$20240722$20240722$DIR$711021$$FDA-CTU$$75$YR$$F$N$65.25$KG$20240722$Y$CN$US$
241271461$24127146$1$I$20240619$20240718$20240723$20240723$EXP$$AU-BEH-2024176013$CSL BEHRING$$64$YR$A$F$Y$$$20240723$$HP$AU$AU
241271471$24127147$1$I$20240417$20240417$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007191$VANDA PHARMACEUTICALS$$66$YR$$F$Y$$$20240723$$CN$US$US
241271491$24127149$1$I$$20240722$20240723$20240723$PER$$US-BAYER-2024A106156$BAYER$$80$YR$E$$Y$$$20240723$$CN$US$US
241271501$24127150$1$I$20240719$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50530$$FDA-CTU$$77$YR$$F$N$89$KG$20240722$N$$US$
241271511$24127151$1$I$20240712$20240716$20240723$20240723$DIR$FDA-CDER-CTU-2024-50535$$FDA-CTU$$58$YR$$F$N$83.6$KG$20240716$N$$US$
241271521$24127152$1$I$$20240226$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007197$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271531$24127153$1$I$$20240223$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007193$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271541$24127154$1$I$$20240124$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007141$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271551$24127155$1$I$20240301$20240722$20240722$20240722$DIR$711065$$FDA-CTU$$30$YR$$M$N$81$KG$20240722$N$CN$US$
241271561$24127156$1$I$20240719$20240722$20240722$20240722$DIR$711005$$FDA-CTU$$76$YR$$F$N$110$KG$20240722$N$HP$US$
241271571$24127157$1$I$$20240130$20240723$20240723$EXP$$US-TEVA-VS-3152897$TEVA$$63$YR$$F$Y$$$20240723$$CN$US$US
241271581$24127158$1$I$$20240312$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007210$VANDA PHARMACEUTICALS$$$$$F$Y$79.365$KG$20240723$$CN$US$US
241271591$24127159$1$I$$20240327$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007237$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$HP$US$US
241271601$24127160$1$I$$20240326$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007174$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271611$24127161$1$I$20240704$20240715$20240723$20240723$EXP$$CA-INCYTE CORPORATION-2024IN007054$INCYTE$$$$$$Y$$$20240723$$HP$CA$CA
241271623$24127162$3$F$20240701$20240802$20240723$20240808$PER$$US-UNITED THERAPEUTICS-UNT-2024-022072$UNITED THERAPEUTICS$$69$YR$$F$Y$85.261$KG$20240808$$$US$US
241271631$24127163$1$I$$20240226$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007202$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271641$24127164$1$I$$20240122$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007138$VANDA PHARMACEUTICALS$$$$$M$Y$87.664$KG$20240723$$CN$US$US
241271652$24127165$2$F$20240101$20240723$20240723$20240730$PER$$US-UNITED THERAPEUTICS-UNT-2024-022416$UNITED THERAPEUTICS$$$$$F$Y$61.224$KG$20240730$$$US$US
241271661$24127166$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116827$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240723$$CN$US$US
241271671$24127167$1$I$20240710$20240722$20240723$20240723$PER$$US-BAYER-2024A106244$BAYER$$$$$F$Y$$$20240723$$HP$US$US
241271691$24127169$1$I$$20240109$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007118$VANDA PHARMACEUTICALS$$$$$M$Y$123.81$KG$20240723$$CN$US$US
241271701$24127170$1$I$$20240716$20240723$20240723$EXP$$NVSC2024CO006390$NOVARTIS$$$$$F$Y$56$KG$20240723$$CN$CO$CO
241271712$24127171$2$F$$20240822$20240723$20240822$30DAY$$US-PFIZER INC-202400219229$PFIZER$$58$YR$$F$Y$$$20240822$$CN$US$US
241271721$24127172$1$I$$20240220$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007186$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271731$24127173$1$I$$20240213$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007177$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271741$24127174$1$I$$20240124$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007143$VANDA PHARMACEUTICALS$$$$$F$Y$89.388$KG$20240723$$CN$US$US
241271751$24127175$1$I$$20240123$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007144$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271761$24127176$1$I$$20240129$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007149$VANDA PHARMACEUTICALS$$$$$F$Y$90.703$KG$20240723$$CN$US$US
241271771$24127177$1$I$$20240126$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007122$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271781$24127178$1$I$$20240119$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007132$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271791$24127179$1$I$$20240129$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007150$VANDA PHARMACEUTICALS$$$$$M$Y$126.55$KG$20240723$$CN$US$US
241271801$24127180$1$I$$20240319$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007201$VANDA PHARMACEUTICALS$$$$$M$Y$78.912$KG$20240723$$CN$US$US
241271811$24127181$1$I$$20240124$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007121$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271821$24127182$1$I$$20240627$20240723$20240723$PER$$JP-MYOVANT SCIENCES GMBH-2024MYSCI0501280$MYOVANT SCIENCES$$$$$F$Y$$$20240723$$HP$JP$JP
241271831$24127183$1$I$$20240213$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007179$VANDA PHARMACEUTICALS$$$$$M$Y$57.596$KG$20240723$$CN$US$US
241271841$24127184$1$I$20220201$20240610$20240723$20240723$PER$$JP-MYOVANT SCIENCES GMBH-2024MYSCI0501281$MYOVANT SCIENCES$$3$DEC$$F$Y$$$20240723$$HP$JP$JP
241271851$24127185$1$I$$20240226$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007196$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271861$24127186$1$I$$20240713$20240723$20240723$EXP$$GB-TEVA-VS-3222634$TEVA$$$$$$Y$$$20240723$$CN$GB$GB
241271871$24127187$1$I$$20240717$20240723$20240723$EXP$$DE-MYLANLABS-2024M1067425$MYLAN$$$$A$F$Y$$$20240723$$MD$DE$DE
241271881$24127188$1$I$$20240326$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007235$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271891$24127189$1$I$$20240213$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007175$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271901$24127190$1$I$$20240305$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007211$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241271911$24127191$1$I$$20240123$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007137$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271921$24127192$1$I$$20240201$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007158$VANDA PHARMACEUTICALS$$$$$F$Y$129.25$KG$20240723$$CN$US$US
241271931$24127193$1$I$$20240129$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007151$VANDA PHARMACEUTICALS$$$$$M$Y$78.866$KG$20240723$$CN$US$US
241271941$24127194$1$I$20190101$20240628$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007145$VANDA PHARMACEUTICALS$$$$$F$Y$83.9$KG$20240723$$CN$US$US
241271951$24127195$1$I$$20240325$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007236$VANDA PHARMACEUTICALS$$$$$F$Y$54.785$KG$20240723$$CN$US$US
241271961$24127196$1$I$$20240305$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007212$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241271971$24127197$1$I$20240401$20240528$20240723$20240723$PER$$JP-MYOVANT SCIENCES GMBH-2024MYSCI0501282$MYOVANT SCIENCES$$43$YR$$F$Y$$$20240723$$HP$JP$JP
241271981$24127198$1$I$20240419$20240715$20240723$20240723$EXP$FR-AFSSAPS-DJ2024000828$FR-FreseniusKabi-FK202411203$FRESENIUS KABI$$55$YR$A$F$Y$$$20240723$$MD$FR$FR
241271991$24127199$1$I$$20240710$20240723$20240723$PER$$US-USAntibiotics-000326$USAntibiotics$$$$$F$Y$$$20240722$$CN$US$
241272001$24127200$1$I$20221212$20230123$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2022TASUS006347$VANDA PHARMACEUTICALS$$5$YR$$M$Y$15.42$KG$20240723$$CN$US$US
241272011$24127201$1$I$$20240709$20240723$20240723$EXP$$US-LEADINGPHARMA-US-2024LEALIT00303$LEADING PHARMA$R. Hoerle.A Last Resort: Lipid Emulsion Therapy in Lidocaine Anesthetic Systemic Toxicity (LAST).American Journal of Respiratory and Critical Care Medicine.2024;209:A5683$81$YR$E$F$Y$65$KG$20240723$$HP$US$US
241272021$24127202$1$I$$20230118$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006446$VANDA PHARMACEUTICALS$$$$$F$Y$38.458$KG$20240723$$CN$US$US
241272031$24127203$1$I$$20240714$20240723$20240723$EXP$$CN-JNJFOC-20240752332$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240723$$HP$CN$CN
241272041$24127204$1$I$$20240716$20240723$20240723$EXP$$US-JNJFOC-20240746168$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$HP$US$US
241272051$24127205$1$I$20240301$20240716$20240723$20240723$EXP$$US-JNJFOC-20240746257$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240723$$MD$US$US
241272061$24127206$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116511$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240723$$CN$US$US
241272071$24127207$1$I$20240611$20240715$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103602$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240723$$CN$US$US
241272081$24127208$1$I$$20240718$20240723$20240723$EXP$$US-JNJFOC-20240752162$JOHNSON AND JOHNSON$$91$YR$E$F$Y$$$20240723$$HP$US$US
241272091$24127209$1$I$$20240718$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115264$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240723$$CN$US$US
241272101$24127210$1$I$$20240715$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113968$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240723$$CN$US$US
241272112$24127211$2$F$$20240827$20240723$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115070$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240829$$CN$US$US
241272121$24127212$1$I$$20240716$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007488$INCYTE$$$$$$Y$$$20240723$$PH$US$US
241272131$24127213$1$I$$20240715$20240723$20240723$EXP$$US-MYLANLABS-2024M1066299$MYLAN$$75$YR$$F$Y$47.17$KG$20240723$$CN$US$US
241272141$24127214$1$I$20221201$20240717$20240723$20240723$PER$$US-BAYER-2024A104256$BAYER$$32$YR$A$F$Y$$$20240723$$MD$US$US
241272151$24127215$1$I$20240701$20240717$20240723$20240723$EXP$$CA-OTSUKA-2024_020171$OTSUKA$$62$YR$$M$Y$$$20240723$$PH$CA$CA
241272161$24127216$1$I$$20230501$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006450$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241272172$24127217$2$F$20000101$20240723$20240723$20240730$EXP$$US-ABBVIE-5845507$ABBVIE$$$$$F$Y$49$KG$20240730$$CN$US$US
241272181$24127218$1$I$$20230208$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006522$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241272191$24127219$1$I$$20230320$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006612$VANDA PHARMACEUTICALS$$$$$F$Y$41.678$KG$20240723$$CN$US$US
241272201$24127220$1$I$$20230424$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006690$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$PH$US$US
241272211$24127221$1$I$$20230201$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006492$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241272221$24127222$1$I$$20230614$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006806$VANDA PHARMACEUTICALS$$$$$F$Y$33.224$KG$20240723$$HP$US$US
241272231$24127223$1$I$$20230621$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006818$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241272241$24127224$1$I$$20240722$20240723$20240723$EXP$$FR-PFIZER INC-2021SGN04755$PFIZER$$$$$F$Y$$$20240723$$HP$FR$FR
241272261$24127226$1$I$20230621$20240716$20240723$20240723$EXP$$US-ABBVIE-5846005$ABBVIE$$22$YR$$F$Y$$$20240723$$MD$US$US
241272271$24127227$1$I$$20230705$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006837$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241272281$24127228$1$I$$20230622$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006453$VANDA PHARMACEUTICALS$$$$$M$Y$74.195$KG$20240723$$CN$US$US
241272301$24127230$1$I$$20240717$20240723$20240723$EXP$$US-GSK-US2024AMR090450$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
241272311$24127231$1$I$$20230705$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006840$VANDA PHARMACEUTICALS$$$$$M$Y$81.633$KG$20240723$$CN$US$US
241272321$24127232$1$I$$20240715$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007487$INCYTE$$$$$$Y$$$20240723$$HP$US$US
241272331$24127233$1$I$20230101$20230710$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006849$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241272341$24127234$1$I$$20230711$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006853$VANDA PHARMACEUTICALS$$$$$F$Y$61.224$KG$20240723$$CN$US$US
241272351$24127235$1$I$$20230707$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006846$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241272361$24127236$1$I$$20230711$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006852$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241272371$24127237$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50622$$FDA-CTU$$73$YR$$M$N$225$LBS$20240723$N$$US$
241272381$24127238$1$I$$20230705$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006839$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241272391$24127239$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50571$$FDA-CTU$$53$YR$$F$N$$$20240719$N$$US$
241272401$24127240$1$I$20230601$20230707$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006845$VANDA PHARMACEUTICALS$$59$YR$$F$Y$79.365$KG$20240723$$CN$US$US
241272421$24127242$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50639$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241272431$24127243$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50557$$FDA-CTU$$71$YR$$F$N$$$20240719$N$$US$
241272441$24127244$1$I$20240430$20240717$20240723$20240723$EXP$FR-AFSSAPS-TO2024001230$FR-MYLANLABS-2024M1067374$MYLAN$$75$YR$$M$Y$$$20240723$$PH$FR$FR
241272451$24127245$1$I$$20240717$20240723$20240723$PER$$US-BAYER-2024A106144$BAYER$$86$YR$E$F$Y$$$20240723$$CN$US$US
241272461$24127246$1$I$$20240514$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007208$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241272471$24127247$1$I$$20240219$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007183$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241272481$24127248$1$I$$20240420$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007161$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241272491$24127249$1$I$$20240117$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007129$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241272501$24127250$1$I$$20240206$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007169$VANDA PHARMACEUTICALS$$$$$F$Y$63.039$KG$20240723$$CN$US$US
241272511$24127251$1$I$$20240326$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007205$VANDA PHARMACEUTICALS$$$$$F$Y$141.04$KG$20240723$$CN$US$US
241272521$24127252$1$I$$20240403$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007134$VANDA PHARMACEUTICALS$$$$$F$Y$76.19$KG$20240723$$CN$US$US
241272531$24127253$1$I$$20240113$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007124$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241272542$24127254$2$F$20240630$20240802$20240723$20240806$EXP$$TW-ABBVIE-5848432$ABBVIE$$79$YR$$M$Y$$$20240806$$CN$TW$TW
241272551$24127255$1$I$20240306$20240709$20240723$20240723$EXP$$IT-HQ SPECIALTY-IT-2024INT000071$INTERCHEM$$18$DY$$M$Y$1$KG$20240723$$MD$IT$IT
241272561$24127256$1$I$$20240709$20240723$20240723$EXP$$CN-LEADINGPHARMA-CN-2024LEALIT00306$LEADING PHARMA$Xiaoxue Xu.Reversible blindness after stellate ganglion block.Quantitative Imaging in Medicine and Surgery.26-APR-2024;14:3744-3750$53$YR$A$M$Y$65$KG$20240723$$MD$CN$CN
241272571$24127257$1$I$$20240206$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007167$VANDA PHARMACEUTICALS$$$$$M$Y$80.726$KG$20240723$$CN$US$US
241272581$24127258$1$I$$20240410$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007226$VANDA PHARMACEUTICALS$$$$$F$Y$96.78$KG$20240723$$CN$US$US
241272591$24127259$1$I$$20240718$20240723$20240723$EXP$$CA-ORGANON-O2407CAN001812$ORGANON$$43$YR$$F$Y$96$KG$20240723$$HP$CA$CA
241272611$24127261$1$I$$20240716$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007485$INCYTE$$$$$$Y$$$20240723$$HP$US$US
241272621$24127262$1$I$20240717$20240719$20240723$20240723$PER$$US-BAYER-2024A106202$BAYER$$68$YR$E$F$Y$$$20240723$$CN$US$US
241272632$24127263$2$F$$20240912$20240723$20240917$EXP$$JP-OTSUKA-2024_020173$OTSUKA$$60$YR$$M$Y$$$20240917$$MD$JP$JP
241272641$24127264$1$I$$20240318$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007228$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241272651$24127265$1$I$$20240208$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007171$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241272661$24127266$1$I$$20240131$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007154$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241272671$24127267$1$I$$20240228$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007204$VANDA PHARMACEUTICALS$$$$$F$Y$68.027$KG$20240723$$CN$US$US
241272681$24127268$1$I$20231120$20240312$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007188$VANDA PHARMACEUTICALS$$61$YR$$M$Y$99.773$KG$20240723$$CN$US$US
241272691$24127269$1$I$$20240220$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007189$VANDA PHARMACEUTICALS$$$$$M$Y$91.61$KG$20240723$$CN$US$US
241272701$24127270$1$I$$20240520$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007241$VANDA PHARMACEUTICALS$$$$$F$Y$85.261$KG$20240723$$CN$US$US
241272711$24127271$1$I$$20240307$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007216$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241272721$24127272$1$I$$20240227$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007220$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241272731$24127273$1$I$20240619$20240711$20240723$20240723$EXP$FR-AFSSAPS-LM2024000377$FR-TEVA-VS-3220715$TEVA$$14$YR$$M$Y$55.3$KG$20240723$$MD$FR$FR
241272741$24127274$1$I$$20240124$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007139$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241272751$24127275$1$I$$20240716$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007447$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241272761$24127276$1$I$$20240720$20240723$20240723$PER$$US-BAYER-2024A106097$BAYER$$$$$$Y$$$20240723$$CN$US$US
241272774$24127277$4$F$$20240829$20240723$20240911$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115942$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$96$KG$20240912$$HP$CA$CA
241272781$24127278$1$I$20230714$20230714$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006861$VANDA PHARMACEUTICALS$$42$YR$$M$Y$84.082$KG$20240723$$CN$US$US
241272791$24127279$1$I$$20230713$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006863$VANDA PHARMACEUTICALS$$$$$F$Y$52.154$KG$20240723$$CN$US$US
241272801$24127280$1$I$20220101$20230713$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006868$VANDA PHARMACEUTICALS$$$$$F$Y$71.202$KG$20240723$$CN$US$US
241272811$24127281$1$I$$20230713$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006860$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241272821$24127282$1$I$20230709$20230717$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006869$VANDA PHARMACEUTICALS$$21$YR$$M$Y$68.027$KG$20240723$$CN$US$US
241272831$24127283$1$I$$20230719$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006872$VANDA PHARMACEUTICALS$$$$$F$Y$58.05$KG$20240723$$CN$US$US
241272841$24127284$1$I$$20230719$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006871$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241272851$24127285$1$I$$20240715$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007443$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241272861$24127286$1$I$$20240715$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007437$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241272871$24127287$1$I$$20240718$20240723$20240723$EXP$$US-GSK-US2024091751$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$HP$US$US
241272883$24127288$3$F$$20240920$20240723$20240924$EXP$$CA-JNJFOC-20240752327$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$HP$CA$CA
241272892$24127289$2$F$20240601$20240816$20240723$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116737$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240821$$CN$US$US
241272901$24127290$1$I$$20230727$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006883$VANDA PHARMACEUTICALS$$$$$F$Y$49.887$KG$20240723$$CN$US$US
241272911$24127291$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50613$$FDA-CTU$$70$YR$$F$N$$$20240723$N$$US$
241272921$24127292$1$I$$20240722$20240723$20240723$EXP$GB-MHRA-TPP19250208C9433810YC1721401337492$GB-ORGANON-O2407GBR002067$ORGANON$$69$YR$$M$Y$64$KG$20240723$$MD$GB$GB
241272931$24127293$1$I$20230728$20230728$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006888$VANDA PHARMACEUTICALS$$39$YR$$F$Y$82.676$KG$20240723$$CN$US$US
241272941$24127294$1$I$$20230720$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006874$VANDA PHARMACEUTICALS$$$$$F$Y$133.97$KG$20240723$$CN$US$US
241272951$24127295$1$I$$20230720$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006567$VANDA PHARMACEUTICALS$$$$$F$Y$30.839$KG$20240723$$CN$US$US
241272961$24127296$1$I$$20230726$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006882$VANDA PHARMACEUTICALS$$$$$M$Y$76.19$KG$20240723$$CN$US$US
241272971$24127297$1$I$$20230726$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006876$VANDA PHARMACEUTICALS$$$$$M$Y$111.57$KG$20240723$$CN$US$US
241272982$24127298$2$F$20240425$20240717$20240723$20240726$EXP$$CN-AMGEN-CHNSP2024142705$AMGEN$$55$YR$A$F$Y$$$20240726$$HP$CN$CN
241272992$24127299$2$F$20240718$20240726$20240723$20240730$PER$$US-AMGEN-USASP2024144636$AMGEN$$76$YR$E$F$Y$$$20240730$$CN$US$US
241273001$24127300$1$I$20240710$20240717$20240723$20240723$EXP$$US-OTSUKA-2024_020226$OTSUKA$$$$$F$Y$$$20240723$$CN$US$US
241273031$24127303$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014174$ELI LILLY AND CO$$47$YR$A$$Y$$$20240723$$CN$US$US
241273041$24127304$1$I$$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011594$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240723$$CN$US$US
241273051$24127305$1$I$$20240711$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407007756$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240723$$CN$US$US
241273061$24127306$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013980$ELI LILLY AND CO$$$$A$F$Y$$$20240723$$CN$US$US
241273071$24127307$1$I$20240601$20240710$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012396$ELI LILLY AND CO$$60$YR$A$M$Y$77.098$KG$20240723$$CN$US$US
241273081$24127308$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013319$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240723$$CN$US$US
241273091$24127309$1$I$20240708$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013035$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$US$US
241273101$24127310$1$I$20240717$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012739$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240723$$CN$US$US
241273111$24127311$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50623$$FDA-CTU$$84$YR$$M$N$276$LBS$20240723$N$$US$
241273121$24127312$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013869$ELI LILLY AND CO$$$$$M$Y$$$20240723$$CN$US$US
241273131$24127313$1$I$20240712$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013274$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240723$$CN$US$US
241273141$24127314$1$I$20240601$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013238$ELI LILLY AND CO$$51$YR$A$$Y$$$20240723$$CN$US$US
241273161$24127316$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50584$$FDA-CTU$$23$YR$$F$N$$$20240719$N$$US$
241273171$24127317$1$I$$20240409$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007182$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273181$24127318$1$I$$20240308$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007164$VANDA PHARMACEUTICALS$$$$$F$Y$72.562$KG$20240723$$CN$US$US
241273191$24127319$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50565$$FDA-CTU$$42$YR$$F$N$$$20240719$N$$US$
241273212$24127321$2$F$$20240712$20240723$20240805$EXP$$FR-ROCHE-10000027157$ROCHE$Chausson N, Olindo S, Laborne F, Aghasaryan M, Renou P, Soumah D. Second-dose intravenous thrombolysis  with tenecteplase in alteplase-resistant medium-vessel-occlusion strokes: A retrospective and comparative study. European Stroke Journal. 2024;1-9. doi:10.1177/23969873241254936.$$$$$Y$$$20240805$$HP$FR$FR
241273221$24127322$1$I$$20240220$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007185$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273231$24127323$1$I$$20240125$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007146$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273241$24127324$1$I$$20240419$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007242$VANDA PHARMACEUTICALS$$67$YR$$M$Y$$$20240723$$CN$US$US
241273251$24127325$1$I$$20240709$20240723$20240723$EXP$$IT-LEADINGPHARMA-IT-2024LEALIT00311$LEADING PHARMA$$70$YR$E$M$Y$$$20240723$$HP$IT$IT
241273261$24127326$1$I$$20240418$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007180$VANDA PHARMACEUTICALS$$$$$F$Y$43.084$KG$20240723$$CN$US$US
241273271$24127327$1$I$20230101$20240111$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007120$VANDA PHARMACEUTICALS$$$$$F$Y$89.796$KG$20240723$$CN$US$US
241273281$24127328$1$I$$20240307$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007215$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241273291$24127329$1$I$$20240228$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007203$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241273301$24127330$1$I$$20240207$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007168$VANDA PHARMACEUTICALS$$$$$F$Y$67.12$KG$20240723$$CN$US$US
241273312$24127331$2$F$20240707$20240910$20240723$20240923$EXP$$KR-SAMSUNG BIOEPIS-SB-2024-21757$SAMSUNG BIOEPIS$$78$YR$E$F$Y$34$KG$20240923$$MD$KR$KR
241273321$24127332$1$I$20230601$20230731$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006890$VANDA PHARMACEUTICALS$$16$YR$$F$Y$81.633$KG$20240723$$CN$US$US
241273332$24127333$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3220162$TEVA$Yeung SJ, Qdaisat A, Bischof JJ, Caterino JM, Kyriacou DN, Coyne Md C. A case series of adrenal insufficiency (likely due to hypophysitis) in cancer patients treated with immune checkpoint inhibitors. Am-J-Emerg-Med 2024; 80 (0): 227.e1-227.e5.; Yeung SJ, Qdaisat A, Bischof JJ, Caterino JM, Kyriacou DN, Coyne Md C. A case series of adrenal insufficiency (likely due to hypophysitis) in cancer patients treated with immune checkpoint inhibitors. Am-J-Emerg-Med 2024; 80 (0): 227.e1-227.e5.$37$YR$$F$Y$$$20240819$$MD$US$US
241273342$24127334$2$F$20230406$20240802$20240723$20240808$EXP$$DE-SANDOZ INC.-SDZ2024DE065208$SANDOZ$$$$E$F$Y$58$KG$20240808$$CN$DE$DE
241273351$24127335$1$I$20240201$20240721$20240723$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA067228$SANDOZ$$87$YR$$M$Y$$$20240723$$MD$CA$CA
241273363$24127336$3$F$20240708$20240801$20240723$20240805$EXP$$BE-SANDOZ INC.-SDZ2024BE067007$SANDOZ$$60$YR$$F$Y$61$KG$20240805$$MD$BE$BE
241273371$24127337$1$I$$20230731$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006889$VANDA PHARMACEUTICALS$$$$$F$Y$104.76$KG$20240723$$CN$US$US
241273382$24127338$2$F$20220829$20240730$20240723$20240807$EXP$$CO-UCBSA-2024036973$UCB$$24$YR$$M$Y$$$20240807$$CN$CO$CO
241273391$24127339$1$I$$20230802$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006894$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273401$24127340$1$I$$20240715$20240723$20240723$EXP$$NVSC2024US146543$NOVARTIS$$42$YR$$M$Y$$$20240723$$CN$US$US
241273411$24127341$1$I$$20230803$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006897$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241273421$24127342$1$I$$20230804$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006898$VANDA PHARMACEUTICALS$$$$$M$Y$122$KG$20240723$$CN$US$US
241273431$24127343$1$I$$20230803$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006895$VANDA PHARMACEUTICALS$$$$$M$Y$129.25$KG$20240723$$CN$US$US
241273441$24127344$1$I$$20230804$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006899$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273452$24127345$2$F$20240703$20240827$20240723$20240903$EXP$$GB-MYLANLABS-2024M1063531$MYLAN$$$$$M$Y$$$20240903$$MD$GB$GB
241273461$24127346$1$I$20240710$20240719$20240723$20240723$EXP$$AU-MYLANLABS-2024M1001613$MYLAN$$48$YR$$F$Y$$$20240723$$HP$AU$AU
241273472$24127347$2$F$20170515$20240727$20240723$20240731$EXP$$AR-MYLANLABS-2024M1047961$MYLAN$$15$YR$$M$Y$$$20240731$$HP$AR$AR
241273481$24127348$1$I$$20240722$20240723$20240723$PER$$US-HALEON-2188475$Haleon PLC$$62$YR$$F$Y$$$20240723$$CN$US$US
241273491$24127349$1$I$$20240308$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007131$VANDA PHARMACEUTICALS$$$$$F$Y$72.562$KG$20240723$$CN$US$US
241273501$24127350$1$I$20240301$20240319$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007232$VANDA PHARMACEUTICALS$$75$YR$$F$Y$$$20240723$$CN$US$US
241273511$24127351$1$I$$20240515$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007153$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273521$24127352$1$I$$20240308$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007218$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273531$24127353$1$I$$20240126$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007147$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241273541$24127354$1$I$$20231012$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006984$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273551$24127355$1$I$20240222$20240222$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007190$VANDA PHARMACEUTICALS$$49$YR$$F$Y$$$20240723$$HP$US$US
241273561$24127356$1$I$$20240306$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007213$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273571$24127357$1$I$$20240226$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007200$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273583$24127358$3$F$20240101$20240907$20240723$20240913$PER$$US-Eisai-EC-2024-170486$EISAI$$77$YR$E$F$Y$59$KG$20240913$$CN$US$US
241273591$24127359$1$I$$20240209$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007163$VANDA PHARMACEUTICALS$$$$$M$Y$90.703$KG$20240723$$CN$US$US
241273601$24127360$1$I$$20240712$20240723$20240723$EXP$$AU-TEVA-VS-3221906$TEVA$$$$$F$Y$$$20240723$$HP$AU$AU
241273612$24127361$2$F$20240713$20240719$20240723$20240726$PER$$AT-Eisai-EC-2024-170556$EISAI$$65$YR$E$M$Y$$$20240726$$MD$AT$AT
241273621$24127362$1$I$$20230818$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006915$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$HP$US$US
241273631$24127363$1$I$20240711$20240711$20240723$20240723$PER$$US-RDY-SPO/USA/24/0010334$DR REDDYS$$76$YR$E$F$Y$64$KG$20240723$$CN$US$US
241273641$24127364$1$I$$20230817$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006917$VANDA PHARMACEUTICALS$$$$$M$Y$77.551$KG$20240723$$CN$US$US
241273651$24127365$1$I$$20230810$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006906$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273661$24127366$1$I$$20230814$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006911$VANDA PHARMACEUTICALS$$$$$F$Y$72.562$KG$20240723$$CN$US$US
241273671$24127367$1$I$$20230807$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006901$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273681$24127368$1$I$$20230808$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006875$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241273691$24127369$1$I$$20230809$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006907$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273701$24127370$1$I$20200330$20230808$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006721$VANDA PHARMACEUTICALS$$2$YR$$F$Y$17.324$KG$20240723$$CN$US$US
241273711$24127371$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116196$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240723$$CN$US$US
241273721$24127372$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115671$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240723$$HP$US$US
241273741$24127374$1$I$$20240717$20240723$20240723$EXP$$IN-BRISTOL-MYERS SQUIBB COMPANY-2024-113632$BRISTOL MYERS SQUIBB$Oli A, Bhatia A. Unusual clinical features and histopathological findings in a case of pseudo-endophthalmitis in neovascular glaucoma. Romanian Journal of Ophthalmology. 2024 Apr 01;68(2):182-6. doi:10.22336/rjo.2024.34.$56$YR$A$M$Y$$$20240723$$MD$IN$IN
241273751$24127375$1$I$20240101$20240715$20240723$20240723$EXP$$US-SA-2024SA211407$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240723$$CN$US$US
241273761$24127376$1$I$$20231221$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007094$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273771$24127377$1$I$20231001$20231122$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007020$VANDA PHARMACEUTICALS$$55$YR$$M$Y$$$20240723$$CN$US$US
241273781$24127378$1$I$$20231214$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007077$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273791$24127379$1$I$$20231026$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007007$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241273811$24127381$1$I$$20231130$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007051$VANDA PHARMACEUTICALS$$$$$F$Y$54.422$KG$20240723$$CN$US$US
241273821$24127382$1$I$$20231207$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007068$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241273831$24127383$1$I$$20231214$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007080$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273841$24127384$1$I$20231101$20231116$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007019$VANDA PHARMACEUTICALS$$32$YR$$M$Y$$$20240723$$CN$US$US
241273852$24127385$2$F$20240601$20240730$20240723$20240802$EXP$$CN-PFIZER INC-PV202400094176$PFIZER$$17$YR$$M$Y$$$20240802$$CN$CN$CN
241273861$24127386$1$I$$20231208$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007065$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241273871$24127387$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50621$$FDA-CTU$$96$YR$$F$N$$$20240723$N$$US$
241273881$24127388$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50561$$FDA-CTU$$45$YR$$F$N$$$20240719$N$$US$
241273891$24127389$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50558$$FDA-CTU$$57$YR$$F$N$$$20240719$N$$US$
241273902$24127390$2$F$$20240913$20240723$20240913$EXP$$CA-PFIZER INC-202400219246$PFIZER$$60$YR$$F$Y$$$20240913$$CN$CA$CA
241273912$24127391$2$F$20240101$20240724$20240723$20240729$PER$$TR-PFIZER INC-PV202400079973$PFIZER$$5$YR$$F$Y$15.5$KG$20240729$$MD$TR$TR
241273921$24127392$1$I$20230101$20240719$20240723$20240723$EXP$GB-MHRA-MED-202407192028491290-CHBYL$GB-PFIZER INC-202400219417$PFIZER$$30$YR$$F$Y$51$KG$20240723$$CN$GB$GB
241273932$24127393$2$F$20240701$20240914$20240723$20240916$EXP$$CA-PFIZER INC-202400220448$PFIZER$$35$YR$$M$Y$$$20240916$$HP$CA$CA
241273941$24127394$1$I$20240704$20240718$20240723$20240723$EXP$$SA-SANDOZ INC.-SDZ2024SA066630$SANDOZ$$69$YR$$F$Y$$$20240723$$CN$SA$SA
241273951$24127395$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50653$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241273961$24127396$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50578$$FDA-CTU$$30$YR$$F$N$68.04$KG$20240719$N$HP$US$
241273971$24127397$1$I$$20231121$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007033$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241273983$24127398$3$F$$20240723$20240723$20240729$30DAY$$FR-SANDOZ INC.-SDZ2024FR062325$SANDOZ$$6$YR$$F$Y$$$20240729$$CN$FR$FR
241274001$24127400$1$I$$20240719$20240723$20240723$EXP$$AU-MYLANLABS-2024M1068075$MYLAN$$$$$F$Y$$$20240723$$HP$AU$AU
241274012$24127401$2$F$$20240820$20240723$20240826$EXP$$GB-MYLANLABS-2024M1068138$MYLAN$$$$$M$Y$$$20240826$$HP$GB$GB
241274021$24127402$1$I$$20240719$20240723$20240723$EXP$$AU-MYLANLABS-2024M1067935$MYLAN$$$$$F$Y$$$20240723$$PH$AU$AU
241274033$24127403$3$F$$20240826$20240723$20240830$EXP$$US-ABBVIE-5845140$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
241274045$24127404$5$F$20240101$20240914$20240723$20240916$EXP$$CA-PFIZER INC-202300141017$PFIZER$$32$YR$$M$Y$$$20240916$$HP$CA$CA
241274051$24127405$1$I$$20240715$20240723$20240723$EXP$$CA-SANDOZ INC.-NVSC2021CA008197$SANDOZ$$44$YR$$M$Y$$$20240723$$CN$CA$CA
241274061$24127406$1$I$20240719$20240719$20240723$20240723$EXP$$GB-MYLANLABS-2024M1067802$MYLAN$$71$YR$$F$Y$63$KG$20240723$$MD$GB$GB
241274071$24127407$1$I$20240101$20240717$20240723$20240723$EXP$$CA-ABBVIE-5845817$ABBVIE$$$$A$F$Y$$$20240723$$CN$CA$CA
241274101$24127410$1$I$$20240718$20240723$20240723$30DAY$$US-SANDOZ INC.-SDZ2024US067066$SANDOZ$$$$$F$Y$$$20240723$$CN$US$US
241274111$24127411$1$I$20240625$20240719$20240723$20240723$EXP$$GB-SANDOZ INC.-NVSC2020GB004522$SANDOZ$$66$YR$$M$Y$$$20240723$$PH$GB$GB
241274121$24127412$1$I$$20240716$20240723$20240723$EXP$$AU-SANDOZ INC.-SDZ2024AU066950$SANDOZ$$$$N$M$Y$$$20240723$$HP$AU$AU
241274131$24127413$1$I$20240101$20240717$20240723$20240723$EXP$$US-ABBVIE-5845906$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241274141$24127414$1$I$$20240722$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US067207$SANDOZ$$$$$F$Y$$$20240723$$CN$US$US
241274151$24127415$1$I$$20240716$20240723$20240723$EXP$$JP-009507513-2407JPN003234J$MERCK$$70$YR$$F$Y$$$20240723$$MD$JP$JP
241274161$24127416$1$I$20240701$20240717$20240723$20240723$EXP$$CN-PURDUE-USA-2024-0310897$PURDUE$$58$YR$$F$Y$64$KG$20240723$$HP$CN$CN
241274171$24127417$1$I$20240710$20240718$20240723$20240723$EXP$$CN-PURDUE-USA-2024-0310891$PURDUE$$81$YR$$F$Y$29$KG$20240723$$HP$CN$CN
241274181$24127418$1$I$$20240716$20240723$20240723$EXP$$US-SA-2024SA214636$SANOFI AVENTIS$$$$A$F$Y$58.513$KG$20240723$$MD$US$US
241274191$24127419$1$I$$20230829$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006925$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241274201$24127420$1$I$20230616$20230830$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006802$VANDA PHARMACEUTICALS$$72$YR$$M$Y$$$20240723$$CN$US$US
241274211$24127421$1$I$$20230818$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006919$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241274221$24127422$1$I$$20230831$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006856$VANDA PHARMACEUTICALS$$$$$M$Y$102.04$KG$20240723$$CN$US$US
241274231$24127423$1$I$20230715$20230822$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006873$VANDA PHARMACEUTICALS$$32$YR$$M$Y$94.785$KG$20240723$$CN$US$US
241274251$24127425$1$I$$20230824$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006922$VANDA PHARMACEUTICALS$$$$$F$Y$71.202$KG$20240723$$CN$US$US
241274263$24127426$3$F$20221201$20240814$20240723$20240821$PER$$US-SA-2024SA214277$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240821$$MD$US$US
241274271$24127427$1$I$$20240723$20240723$20240723$EXP$$AU-MYLANLABS-2024M1068386$MYLAN$$$$$M$Y$$$20240723$$HP$AU$AU
241274281$24127428$1$I$20240716$20240719$20240723$20240723$EXP$GB-MHRA-MED-202407191119188980-VBRWP$GB-MYLANLABS-2024M1067759$MYLAN$$84$YR$$F$Y$$$20240723$$PH$GB$GB
241274298$24127429$8$F$20240101$20240917$20240723$20240920$EXP$$US-SA-2024SA213259$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240920$$MD$US$US
241274312$24127431$2$F$20240101$20240802$20240723$20240807$EXP$$US-SA-2024SA211851$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240807$$MD$US$US
241274321$24127432$1$I$$20240716$20240723$20240723$EXP$AU-GENERIC HEALTH PTY. LTD.-2024-04594$AU-SANDOZ INC.-SDZ2024AU067177$SANDOZ$$$$$$Y$$$20240723$$HP$AU$AU
241274331$24127433$1$I$20240701$20240718$20240723$20240723$EXP$$US-SA-2024SA214678$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240723$$MD$US$US
241274341$24127434$1$I$20240709$20240718$20240723$20240723$EXP$IT-MINISAL02-995192$IT-SA-2024SA214345$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240723$$PH$IT$IT
241274351$24127435$1$I$$20240718$20240723$20240723$EXP$$US-SA-2024SA213315$SANOFI AVENTIS$$$$E$F$Y$$$20240723$$MD$US$US
241274361$24127436$1$I$$20230905$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006931$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241274371$24127437$1$I$$20230907$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006932$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241274381$24127438$1$I$$20230911$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006942$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241274391$24127439$1$I$$20230901$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006927$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241274401$24127440$1$I$$20240715$20240723$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA066902$SANDOZ$$53$YR$$M$Y$$$20240723$$CN$CA$CA
241274411$24127441$1$I$$20230907$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006934$VANDA PHARMACEUTICALS$$$$$F$Y$115.28$KG$20240723$$CN$US$US
241274421$24127442$1$I$$20230906$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006879$VANDA PHARMACEUTICALS$$$$$M$Y$14.1$KG$20240723$$HP$US$US
241274431$24127443$1$I$20221116$20230908$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006937$VANDA PHARMACEUTICALS$$21$YR$$M$Y$$$20240723$$HP$US$US
241274441$24127444$1$I$$20230905$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006859$VANDA PHARMACEUTICALS$$$$$F$Y$64.399$KG$20240723$$CN$US$US
241274451$24127445$1$I$$20230907$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006444$VANDA PHARMACEUTICALS$$$$$F$Y$89.342$KG$20240723$$CN$US$US
241274461$24127446$1$I$$20230906$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006933$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241274471$24127447$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024144556$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241274482$24127448$2$F$20240516$20240809$20240723$20240814$EXP$ES-AEMPS-1545283$ES-SA-2024SA213220$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240814$$MD$ES$ES
241274491$24127449$1$I$$20240716$20240723$20240723$EXP$$GB-JNJFOC-20240744788$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240722$$MD$GB$GB
241274502$24127450$2$F$$20240823$20240723$20240826$30DAY$$CL-PFIZER INC-202400217544$PFIZER$$$$$$Y$$$20240826$$CN$CL$CL
241274513$24127451$3$F$$20240809$20240723$20240822$30DAY$$FR-JNJFOC-20240722637$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240822$$PH$FR$FR
241274521$24127452$1$I$20231101$20240718$20240723$20240723$EXP$$US-SA-2024SA213195$SANOFI AVENTIS$$57$YR$A$$Y$$$20240723$$HP$US$US
241274542$24127454$2$F$$20240913$20240723$20240913$EXP$$CA-PFIZER INC-202400219810$PFIZER$$58$YR$$M$Y$$$20240913$$MD$CA$CA
241274551$24127455$1$I$20210101$20240719$20240723$20240723$EXP$GB-MHRA-31250496$GB-PFIZER INC-202400219260$PFIZER$$71$YR$$F$Y$61$KG$20240723$$CN$GB$GB
241274561$24127456$1$I$$20240717$20240723$20240723$EXP$$US-ABBVIE-5845462$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241274572$24127457$2$F$$20240923$20240723$20240930$EXP$$CA-TAKEDA-2024TUS074108$TAKEDA$$$$$M$Y$$$20240930$$CN$CA$CA
241274581$24127458$1$I$20240630$20240722$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US067085$SANDOZ$$$$$M$Y$$$20240723$$CN$US$US
241274591$24127459$1$I$20240629$20240716$20240723$20240723$EXP$$US-JNJFOC-20240742841$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240722$$CN$US$US
241274601$24127460$1$I$20240501$20240716$20240723$20240723$EXP$FR-AFSSAPS-RN2024000770$FR-009507513-2407FRA010076$MERCK$$80$YR$$M$Y$$$20240723$$MD$FR$FR
241274611$24127461$1$I$20240701$20240712$20240723$20240723$PER$$US-SA-2024SA211236$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240723$$CN$US$US
241274621$24127462$1$I$$20240711$20240723$20240723$PER$$US-SA-2024SA207026$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240723$$CN$US$US
241274631$24127463$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50651$$FDA-CTU$$70$YR$$F$N$$$20240723$N$PH$US$
241274642$24127464$2$F$20240601$20240820$20240723$20240916$PER$$US-SA-2024SA208663$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240916$$MD$US$US
241274651$24127465$1$I$20240201$20240711$20240723$20240723$PER$$US-SA-2024SA208994$SANOFI AVENTIS$$46$YR$A$F$Y$113$KG$20240723$$MD$US$US
241274661$24127466$1$I$20240708$20240709$20240723$20240723$PER$$US-SA-2024SA206217$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240723$$MD$US$US
241274671$24127467$1$I$$20240712$20240723$20240723$PER$$US-SA-2024SA212297$SANOFI AVENTIS$$20$YR$A$F$Y$61.2$KG$20240723$$MD$US$US
241274681$24127468$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50573$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241274691$24127469$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50624$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241274702$24127470$2$F$$20240716$20240723$20240725$PER$$US-SA-2024SA209268$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240725$$MD$US$US
241274711$24127471$1$I$20240101$20240712$20240723$20240723$PER$$US-SA-2024SA211902$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240723$$CN$US$US
241274721$24127472$1$I$20230101$20240711$20240723$20240723$PER$$US-SA-2024SA209539$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240723$$MD$US$US
241274733$24127473$3$F$20240710$20240710$20240723$20240826$PER$$US-SA-2024SA206352$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240826$$HP$US$US
241274742$24127474$2$F$20240701$20240814$20240723$20240828$PER$$US-SA-2024SA195711$SANOFI AVENTIS$$82$YR$E$F$Y$62.132$KG$20240828$$MD$US$US
241274751$24127475$1$I$20240701$20240711$20240723$20240723$PER$$US-SA-2024SA209480$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240723$$MD$US$US
241274762$24127476$2$F$$20240722$20240723$20240725$PER$$US-JNJFOC-20240755996$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
241274771$24127477$1$I$$20240714$20240723$20240723$EXP$$US-JNJFOC-20240741125$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$HP$US$US
241274781$24127478$1$I$20240701$20240717$20240723$20240723$EXP$$CA-Eisai-EC-2024-170625$EISAI$$62$YR$A$M$Y$$$20240723$$CN$CA$CA
241274793$24127479$3$F$$20240826$20240723$20240917$PER$$US-SA-2024SA210888$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240918$$CN$US$US
241274801$24127480$1$I$$20240712$20240723$20240723$PER$$US-SA-2024SA209806$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240723$$MD$US$US
241274812$24127481$2$F$20240101$20240712$20240723$20240726$PER$$US-SA-2024SA209024$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240726$$MD$US$US
241274821$24127482$1$I$20240701$20240712$20240723$20240723$PER$$US-SA-2024SA208923$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240723$$MD$US$US
241274831$24127483$1$I$$20240712$20240723$20240723$PER$$US-SA-2024SA211231$SANOFI AVENTIS$$$$C$F$Y$25.855$KG$20240723$$MD$US$US
241274841$24127484$1$I$$20240712$20240723$20240723$PER$$US-SA-2024SA209259$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240723$$MD$US$US
241274851$24127485$1$I$20230101$20240712$20240723$20240723$PER$$US-SA-2024SA208320$SANOFI AVENTIS$$$$I$$Y$$$20240723$$CN$US$US
241274862$24127486$2$F$20240101$20240910$20240723$20240918$PER$$US-SA-2024SA211896$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240918$$MD$US$US
241274871$24127487$1$I$$20240712$20240723$20240723$PER$$US-SA-2024SA208205$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240723$$MD$US$US
241274881$24127488$1$I$20240101$20240712$20240723$20240723$PER$$US-SA-2024SA208945$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240723$$MD$US$US
241274891$24127489$1$I$20240704$20240717$20240723$20240723$EXP$$CL-BIOMARINAP-CL-2024-159134$BIOMARIN$$$$$$Y$$$20240723$$CN$CL$CL
241274901$24127490$1$I$$20231207$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007061$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241274911$24127491$1$I$$20240102$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007107$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241274921$24127492$1$I$$20240206$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007088$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241274931$24127493$1$I$$20231226$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007003$VANDA PHARMACEUTICALS$$$$$F$Y$68.027$KG$20240723$$CN$US$US
241274941$24127494$1$I$$20240102$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007103$VANDA PHARMACEUTICALS$$$$$M$Y$92.971$KG$20240723$$CN$US$US
241274951$24127495$1$I$$20240102$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007104$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241274961$24127496$1$I$$20240222$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007038$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241274971$24127497$1$I$$20231130$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007046$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241274981$24127498$1$I$20240105$20240711$20240723$20240723$EXP$$SE-JNJFOC-20240258549$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240722$$HP$SE$SE
241274991$24127499$1$I$$20231129$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007045$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241275001$24127500$1$I$20230801$20240105$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007099$VANDA PHARMACEUTICALS$$54$YR$$F$Y$$$20240723$$CN$US$US
241275011$24127501$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211813$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240723$$HP$US$US
241275021$24127502$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209230$SANOFI AVENTIS$$$$T$F$Y$$$20240723$$MD$US$US
241275031$24127503$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA059392$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240723$$CN$US$US
241275041$24127504$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211843$SANOFI AVENTIS$$$$A$M$Y$97$KG$20240723$$MD$US$US
241275052$24127505$2$F$20240517$20240806$20240723$20240813$PER$$US-SA-2024SA208982$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240814$$MD$US$US
241275061$24127506$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA171156$SANOFI AVENTIS$$$$E$M$Y$68.03$KG$20240723$$MD$US$US
241275071$24127507$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211112$SANOFI AVENTIS$$$$E$M$Y$$$20240723$$MD$US$US
241275081$24127508$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA210282$SANOFI AVENTIS$$$$A$F$Y$65.77$KG$20240723$$MD$US$US
241275091$24127509$1$I$20210501$20240713$20240723$20240723$PER$$US-SA-2024SA209661$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241275101$24127510$1$I$20240601$20240714$20240723$20240723$PER$$US-SA-2024SA208093$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240723$$MD$US$US
241275111$24127511$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211188$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241275121$24127512$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA210787$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240723$$MD$US$US
241275132$24127513$2$F$$20240729$20240723$20240807$PER$$US-SA-2024SA212402$SANOFI AVENTIS$$$$C$$Y$$$20240807$$HP$US$US
241275142$24127514$2$F$20231201$20240829$20240723$20240910$PER$$US-SA-2024SA211045$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240910$$MD$US$US
241275151$24127515$1$I$$20240715$20240723$20240723$PER$$US-SA-2022SA498076$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241275161$24127516$1$I$20240717$20240717$20240723$20240723$PER$$US-SA-2024SA212142$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240723$$CN$US$US
241275171$24127517$1$I$20240101$20240714$20240723$20240723$PER$$US-SA-2024SA209779$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240723$$MD$US$US
241275182$24127518$2$F$$20240812$20240723$20240814$30DAY$$TR-JNJFOC-20240737312$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$TR$TR
241275191$24127519$1$I$$20240722$20240723$20240723$PER$$US-HALEON-2188452$Haleon PLC$$$$$M$Y$$$20240723$$CN$US$US
241275201$24127520$1$I$$20240722$20240723$20240723$EXP$$GB-SANDOZ INC.-SDZ2024GB067257$SANDOZ$$60$YR$$F$Y$118$KG$20240723$$PH$GB$GB
241275211$24127521$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA210551$SANOFI AVENTIS$$$$C$M$Y$$$20240723$$HP$US$US
241275221$24127522$1$I$20231211$20240715$20240723$20240723$PER$$US-SA-2024SA211857$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240723$$MD$US$US
241275231$24127523$1$I$20240701$20240715$20240723$20240723$PER$$US-SA-2024SA210976$SANOFI AVENTIS$$32$YR$A$F$Y$52.1$KG$20240723$$MD$US$US
241275241$24127524$1$I$20240601$20240715$20240723$20240723$PER$$US-SA-2024SA211520$SANOFI AVENTIS$$47$YR$A$F$Y$86.182$KG$20240723$$MD$US$US
241275251$24127525$1$I$20240701$20240716$20240723$20240723$PER$$US-SA-2024SA210642$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240723$$MD$US$US
241275261$24127526$1$I$20240312$20240722$20240722$20240722$DIR$711092$$FDA-CTU$$76$YR$$M$N$61.2$KG$20240722$$CN$US$
241275271$24127527$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50559$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241275281$24127528$1$I$20240501$20240717$20240723$20240723$PER$$US-SA-2024SA211655$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240723$$MD$US$US
241275291$24127529$1$I$$20240722$20240722$20240722$DIR$710966$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241275301$24127530$1$I$20240722$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50640$$FDA-CTU$$79$YR$$M$N$$$20240723$Y$PH$US$
241275311$24127531$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211047$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240723$$MD$US$US
241275321$24127532$1$I$20240417$20240722$20240722$20240722$DIR$711146$$FDA-CTU$$9$YR$$M$N$27$KG$20240722$N$CN$US$
241275331$24127533$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50638$$FDA-CTU$$66$YR$$M$N$$$20240723$N$$US$
241275341$24127534$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211664$SANOFI AVENTIS$$$$A$F$Y$123$KG$20240723$$MD$US$US
241275351$24127535$1$I$$20240722$20240722$20240722$DIR$711038$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241275371$24127537$1$I$20240714$20240715$20240723$20240723$PER$$US-SA-2024SA209660$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240723$$CN$US$US
241275381$24127538$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50552$$FDA-CTU$$47$YR$$M$N$$$20240723$N$HP$US$
241275391$24127539$1$I$20240719$20240722$20240722$20240722$DIR$711028$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241275401$24127540$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210439$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240723$$MD$US$US
241275411$24127541$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA210566$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240723$$CN$US$US
241275421$24127542$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211257$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241275431$24127543$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211180$SANOFI AVENTIS$$$$A$M$Y$$$20240723$$MD$US$US
241275441$24127544$1$I$20240701$20240716$20240723$20240723$PER$$US-SA-2024SA210965$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240723$$MD$US$US
241275451$24127545$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211125$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240723$$MD$US$US
241275461$24127546$1$I$20240701$20240717$20240723$20240723$PER$$US-SA-2024SA212359$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240723$$MD$US$US
241275471$24127547$1$I$$20231121$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007032$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241275481$24127548$1$I$20240704$20240716$20240723$20240723$PER$$US-SA-2024SA212512$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240723$$MD$US$US
241275491$24127549$1$I$$20231103$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007018$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241275501$24127550$1$I$$20231030$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007011$VANDA PHARMACEUTICALS$$$$$F$Y$62.132$KG$20240723$$CN$US$US
241275511$24127551$1$I$$20231026$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007006$VANDA PHARMACEUTICALS$$$$$F$Y$90.703$KG$20240723$$CN$US$US
241275521$24127552$1$I$$20231012$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006987$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241275532$24127553$2$F$$20240828$20240723$20240831$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010924$JAZZ$$$$$M$Y$14.6$KG$20240831$$CN$US$US
241275544$24127554$4$F$20240705$20240920$20240723$20240927$EXP$$US-BEH-2024168864$CSL BEHRING$$73$YR$E$F$Y$83$KG$20240927$$CN$US$US
241275552$24127555$2$F$$20240911$20240723$20240926$PER$$US-SA-2024SA212124$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240926$$MD$US$US
241275561$24127556$1$I$20220101$20240715$20240723$20240723$PER$$US-SA-2024SA208843$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240723$$CN$US$US
241275571$24127557$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210435$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240723$$PH$US$US
241275582$24127558$2$F$20240101$20240819$20240723$20240830$PER$$US-SA-2024SA210457$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240830$$MD$US$US
241275591$24127559$1$I$20240101$20240717$20240723$20240723$PER$$US-SA-2024SA196467$SANOFI AVENTIS$$76$YR$E$F$Y$72.5$KG$20240723$$MD$US$US
241275601$24127560$1$I$20240712$20240715$20240723$20240723$PER$$US-SA-2024SA210407$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240723$$MD$US$US
241275611$24127561$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211249$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240723$$MD$US$US
241275621$24127562$1$I$20240401$20240715$20240723$20240723$PER$$US-SA-2024SA211083$SANOFI AVENTIS$$25$YR$A$F$Y$80.7$KG$20240723$$MD$US$US
241275631$24127563$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211662$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240723$$MD$US$US
241275641$24127564$1$I$20240713$20240715$20240723$20240723$PER$$US-SA-2024SA212283$SANOFI AVENTIS$$72$YR$E$M$Y$78.02$KG$20240723$$MD$US$US
241275652$24127565$2$F$20240101$20240819$20240723$20240829$PER$$US-SA-2024SA212172$SANOFI AVENTIS$$52$YR$A$F$Y$73.482$KG$20240829$$MD$US$US
241275661$24127566$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212884$SANOFI AVENTIS$$$$E$F$Y$$$20240723$$MD$US$US
241275671$24127567$1$I$20220901$20240715$20240723$20240723$PER$$US-SA-2024SA185729$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240723$$MD$US$US
241275681$24127568$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212223$SANOFI AVENTIS$$$$C$F$Y$$$20240723$$MD$US$US
241275693$24127569$3$F$$20240815$20240723$20240827$PER$$US-SA-2024SA212190$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240827$$CN$US$US
241275702$24127570$2$F$20240101$20240916$20240723$20240920$PER$$US-SA-2024SA212532$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240920$$MD$US$US
241275711$24127571$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212533$SANOFI AVENTIS$$$$$M$Y$$$20240723$$CN$US$US
241275721$24127572$1$I$20200101$20240716$20240723$20240723$PER$$US-SA-2024SA208953$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240723$$MD$US$US
241275731$24127573$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA213183$SANOFI AVENTIS$$52$YR$A$F$Y$92.986$KG$20240723$$MD$US$US
241275745$24127574$5$F$20240705$20240808$20240723$20240813$30DAY$$IE-JNJFOC-20240719177$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$HP$IE$IE
241275751$24127575$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA210671$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240723$$MD$US$US
241275761$24127576$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50635$$FDA-CTU$$23$YR$$M$N$$$20240723$N$$US$
241275771$24127577$1$I$$20240718$20240723$20240723$EXP$$US-JNJFOC-20240749252$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
241275781$24127578$1$I$$20240722$20240723$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA067139$SANDOZ$$$$$F$Y$$$20240723$$CN$CA$CA
241275791$24127579$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212186$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240723$$MD$US$US
241275801$24127580$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA212184$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240723$$MD$US$US
241275811$24127581$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211208$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241275821$24127582$1$I$20240705$20240717$20240723$20240723$PER$$US-SA-2024SA212185$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240723$$MD$US$US
241275831$24127583$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA212135$SANOFI AVENTIS$$$$E$F$Y$$$20240723$$CN$US$US
241275842$24127584$2$F$20240101$20240731$20240723$20240809$PER$$US-SA-2024SA212211$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240809$$MD$US$US
241275851$24127585$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA210434$SANOFI AVENTIS$$$$T$M$Y$56$KG$20240723$$MD$US$US
241275861$24127586$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA212139$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240723$$CN$US$US
241275871$24127587$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211568$SANOFI AVENTIS$$$$A$M$Y$90.703$KG$20240723$$MD$US$US
241275881$24127588$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211281$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240723$$MD$US$US
241275891$24127589$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA211205$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241275901$24127590$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA211930$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240723$$MD$US$US
241275911$24127591$1$I$20230101$20240716$20240723$20240723$PER$$US-SA-2024SA211262$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240723$$MD$US$US
241275921$24127592$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA212353$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240723$$MD$US$US
241275931$24127593$1$I$20240713$20240715$20240723$20240723$PER$$US-SA-2024SA211176$SANOFI AVENTIS$$77$YR$E$F$Y$57.6$KG$20240723$$MD$US$US
241275941$24127594$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210164$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240723$$CN$US$US
241275951$24127595$1$I$20240701$20240716$20240723$20240723$PER$$US-SA-2024SA211636$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240723$$MD$US$US
241275961$24127596$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA210119$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240723$$MD$US$US
241275971$24127597$1$I$$20231109$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007027$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241275981$24127598$1$I$$20231103$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007016$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241275991$24127599$1$I$20231201$20231204$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007055$VANDA PHARMACEUTICALS$$31$YR$$F$Y$$$20240723$$CN$US$US
241276001$24127600$1$I$20231001$20231026$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007004$VANDA PHARMACEUTICALS$$70$YR$$F$Y$$$20240723$$CN$US$US
241276011$24127601$1$I$$20231106$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007022$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241276021$24127602$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA210531$SANOFI AVENTIS$$42$YR$A$$Y$$$20240723$$CN$US$US
241276031$24127603$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212160$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240723$$MD$US$US
241276041$24127604$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209279$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240723$$MD$US$US
241276051$24127605$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211764$SANOFI AVENTIS$$$$E$M$Y$$$20240723$$MD$US$US
241276061$24127606$1$I$20240706$20240717$20240723$20240723$PER$$US-SA-2024SA212357$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240723$$MD$US$US
241276071$24127607$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209526$SANOFI AVENTIS$$$$$F$Y$$$20240723$$CN$US$US
241276081$24127608$1$I$20240621$20240717$20240723$20240723$PER$$US-SA-2024SA212153$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240723$$MD$US$US
241276091$24127609$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212251$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240723$$MD$US$US
241276101$24127610$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211500$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240723$$MD$US$US
241276111$24127611$1$I$20240701$20240716$20240723$20240723$PER$$US-SA-2024SA211645$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240723$$MD$US$US
241276121$24127612$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA212158$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240723$$MD$US$US
241276131$24127613$1$I$20240507$20240716$20240723$20240723$PER$$US-SA-2024SA212349$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240723$$MD$US$US
241276141$24127614$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212456$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240723$$MD$US$US
241276151$24127615$1$I$20240715$20240715$20240723$20240723$PER$$US-SA-2024SA211556$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240723$$MD$US$US
241276161$24127616$1$I$20240101$20240717$20240723$20240723$PER$$US-SA-2024SA212188$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240723$$MD$US$US
241276171$24127617$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211022$SANOFI AVENTIS$$$$A$F$Y$66.67$KG$20240723$$MD$US$US
241276181$24127618$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210247$SANOFI AVENTIS$$$$$F$Y$$$20240723$$HP$US$US
241276192$24127619$2$F$20240101$20240802$20240723$20240816$PER$$US-SA-2024SA212247$SANOFI AVENTIS$$66$YR$E$F$Y$54.4$KG$20240816$$MD$US$US
241276201$24127620$1$I$20240701$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115236$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240723$$CN$US$US
241276211$24127621$1$I$20240627$20240719$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116333$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240723$$CN$US$US
241276222$24127622$2$F$20240101$20240718$20240723$20240731$EXP$$JP-JNJFOC-20240755844$JOHNSON AND JOHNSON$$9$DEC$E$M$Y$$$20240801$$MD$JP$JP
241276231$24127623$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116812$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240723$$HP$US$US
241276241$24127624$1$I$$20230914$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006913$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241276251$24127625$1$I$$20230913$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006946$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241276261$24127626$1$I$20230412$20230912$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006847$VANDA PHARMACEUTICALS$$48$YR$$F$Y$$$20240723$$CN$US$US
241276271$24127627$1$I$$20230915$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006947$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241276281$24127628$1$I$$20230912$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006943$VANDA PHARMACEUTICALS$$$$$M$Y$75.283$KG$20240723$$CN$US$US
241276291$24127629$1$I$$20230911$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006941$VANDA PHARMACEUTICALS$$$$$F$Y$113.38$KG$20240723$$CN$US$US
241276301$24127630$1$I$$20230918$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006951$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241276311$24127631$1$I$$20230913$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006916$VANDA PHARMACEUTICALS$$$$$F$Y$59.002$KG$20240723$$CN$US$US
241276321$24127632$1$I$$20240716$20240723$20240723$PER$$US-SA-2023SA022597$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240723$$MD$US$US
241276331$24127633$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA208566$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240723$$MD$US$US
241276342$24127634$2$F$$20240730$20240723$20240808$PER$$US-SA-2024SA211784$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240808$$MD$US$US
241276351$24127635$1$I$20240101$20240715$20240723$20240723$PER$$US-SA-2024SA212530$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240723$$MD$US$US
241276361$24127636$1$I$20240501$20240716$20240723$20240723$PER$$US-SA-2024SA211962$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240723$$MD$US$US
241276371$24127637$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212173$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240723$$MD$US$US
241276381$24127638$1$I$20240101$20240717$20240723$20240723$PER$$US-SA-2023SA394868$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240723$$MD$US$US
241276391$24127639$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA213538$SANOFI AVENTIS$$$$E$F$Y$$$20240723$$MD$US$US
241276401$24127640$1$I$20240711$20240715$20240723$20240723$PER$$US-SA-2024SA208803$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240723$$CN$US$US
241276411$24127641$1$I$20240601$20240715$20240723$20240723$PER$$US-SA-2024SA211447$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240723$$MD$US$US
241276421$24127642$1$I$20240601$20240716$20240723$20240723$PER$$US-SA-2024SA212025$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240723$$MD$US$US
241276431$24127643$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212844$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241276441$24127644$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212182$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240723$$MD$US$US
241276451$24127645$1$I$20240701$20240716$20240723$20240723$PER$$US-SA-2024SA213069$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240723$$MD$US$US
241276464$24127646$4$F$20240101$20240731$20240723$20240808$PER$$US-SA-2024SA210809$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240808$$MD$US$US
241276471$24127647$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211278$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241276481$24127648$1$I$20240701$20240715$20240723$20240723$PER$$US-SA-2024SA210768$SANOFI AVENTIS$$47$YR$A$M$Y$163.2$KG$20240723$$MD$US$US
241276491$24127649$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211275$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240723$$MD$US$US
241276501$24127650$1$I$20240717$20240717$20240723$20240723$PER$$US-SA-2024SA212151$SANOFI AVENTIS$$$$$F$Y$$$20240723$$CN$US$US
241276511$24127651$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210386$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240723$$MD$US$US
241276521$24127652$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA212529$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240723$$MD$US$US
241276531$24127653$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210929$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240723$$MD$US$US
241276541$24127654$1$I$20240701$20240715$20240723$20240723$PER$$US-SA-2024SA212155$SANOFI AVENTIS$$16$YR$T$F$Y$47$KG$20240723$$MD$US$US
241276551$24127655$1$I$20240701$20240716$20240723$20240723$PER$$US-SA-2024SA210973$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240723$$MD$US$US
241276561$24127656$1$I$20230101$20240717$20240723$20240723$PER$$US-SA-2024SA212808$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240723$$MD$US$US
241276572$24127657$2$F$20240101$20240903$20240723$20240911$PER$$US-SA-2024SA210775$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240911$$MD$US$US
241276581$24127658$1$I$20240101$20240715$20240723$20240723$PER$$US-SA-2024SA212738$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240723$$MD$US$US
241276591$24127659$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA209657$SANOFI AVENTIS$$$$$$Y$$$20240723$$MD$US$US
241276601$24127660$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50554$$FDA-CTU$$$$$M$N$$$20240722$N$HP$US$
241276611$24127661$1$I$20240712$20240715$20240723$20240723$PER$$US-SA-2024SA211153$SANOFI AVENTIS$$50$YR$A$F$Y$72.575$KG$20240723$$MD$US$US
241276621$24127662$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50567$$FDA-CTU$$$$$M$N$$$20240722$N$HP$US$
241276631$24127663$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50620$$FDA-CTU$$37$YR$$F$N$$$20240723$N$HP$US$
241276641$24127664$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA211531$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240723$$MD$US$US
241276661$24127666$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212416$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240723$$HP$US$US
241276671$24127667$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50551$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241276681$24127668$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211240$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240723$$MD$US$US
241276692$24127669$2$F$20240101$20240911$20240723$20240917$PER$$US-SA-2024SA212662$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240918$$MD$US$US
241276702$24127670$2$F$$20240816$20240723$20240829$PER$$US-SA-2024SA213681$SANOFI AVENTIS$$$$A$F$Y$79$KG$20240829$$MD$US$US
241276711$24127671$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211437$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240723$$MD$US$US
241276721$24127672$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211023$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240723$$MD$US$US
241276731$24127673$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211174$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240723$$MD$US$US
241276741$24127674$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212380$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240723$$CN$US$US
241276751$24127675$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA212983$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240723$$MD$US$US
241276761$24127676$1$I$$20240714$20240723$20240723$EXP$$US-JNJFOC-20240747214$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
241276772$24127677$2$F$$20240924$20240723$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA067087$SANDOZ$$$$$F$Y$$$20240925$$MD$CA$CA
241276784$24127678$4$F$$20240910$20240723$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA039249$SANDOZ$$$$$F$Y$$$20240916$$MD$CA$CA
241276791$24127679$1$I$$20240722$20240723$20240723$PER$$NVSC2024US150941$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
241276811$24127681$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA211469$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240723$$MD$US$US
241276821$24127682$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211199$SANOFI AVENTIS$$$$T$F$Y$$$20240723$$MD$US$US
241276831$24127683$1$I$20240712$20240717$20240723$20240723$PER$$US-SA-2024SA212556$SANOFI AVENTIS$$60$YR$A$M$Y$58$KG$20240723$$MD$US$US
241276841$24127684$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA212730$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240723$$MD$US$US
241276851$24127685$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA212404$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240723$$MD$US$US
241276861$24127686$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA212234$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240723$$MD$US$US
241276871$24127687$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA211211$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240723$$MD$US$US
241276881$24127688$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212854$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240723$$MD$US$US
241276891$24127689$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA213661$SANOFI AVENTIS$$59$YR$A$M$Y$102$KG$20240723$$MD$US$US
241276901$24127690$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211265$SANOFI AVENTIS$$$$A$M$Y$104$KG$20240723$$MD$US$US
241276911$24127691$1$I$20240601$20240716$20240723$20240723$PER$$US-SA-2024SA212352$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240723$$MD$US$US
241276921$24127692$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA210865$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240723$$MD$US$US
241276931$24127693$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA207286$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240723$$MD$US$US
241276941$24127694$1$I$20240101$20240717$20240723$20240723$PER$$US-SA-2024SA212753$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240723$$MD$US$US
241276951$24127695$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA208576$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240723$$MD$US$US
241276961$24127696$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212891$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241276971$24127697$1$I$20240101$20240715$20240723$20240723$PER$$US-SA-2024SA211051$SANOFI AVENTIS$$48$YR$A$F$Y$63.5$KG$20240723$$MD$US$US
241276981$24127698$1$I$20240201$20240715$20240723$20240723$PER$$US-SA-2024SA212310$SANOFI AVENTIS$$45$YR$A$F$Y$77.1$KG$20240723$$MD$US$US
241276991$24127699$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA212315$SANOFI AVENTIS$$$$A$F$Y$97.06$KG$20240723$$MD$US$US
241277001$24127700$1$I$20221001$20240715$20240723$20240723$PER$$US-SA-2024SA211443$SANOFI AVENTIS$$$$A$M$Y$$$20240723$$MD$US$US
241277011$24127701$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212191$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240723$$MD$US$US
241277021$24127702$1$I$20240501$20240715$20240723$20240723$PER$$US-SA-2024SA206271$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240723$$CN$US$US
241277032$24127703$2$F$$20240821$20240723$20240828$30DAY$$FR-JNJFOC-20240718820$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240828$$PH$FR$FR
241277051$24127705$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA210246$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240723$$MD$US$US
241277061$24127706$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212463$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240723$$MD$US$US
241277071$24127707$1$I$20230701$20240715$20240723$20240723$PER$$US-SA-2024SA210836$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240723$$MD$US$US
241277081$24127708$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211441$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240723$$MD$US$US
241277091$24127709$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA213625$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241277101$24127710$1$I$20200101$20240715$20240723$20240723$PER$$US-SA-2024SA208654$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240723$$HP$US$US
241277111$24127711$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211532$SANOFI AVENTIS$$$$A$M$Y$100$KG$20240723$$MD$US$US
241277121$24127712$1$I$$20240717$20240723$20240723$EXP$$FR-AMGEN-FRASP2024142822$AMGEN$$$$$F$Y$$$20240723$$MD$FR$FR
241277131$24127713$1$I$$20240717$20240723$20240723$EXP$$JP-JNJFOC-20240756043$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240722$$PH$JP$JP
241277142$24127714$2$F$20240716$20240731$20240723$20240807$PER$$US-SA-2024SA212534$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240807$$CN$US$US
241277151$24127715$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211694$SANOFI AVENTIS$$$$E$F$Y$$$20240723$$MD$US$US
241277161$24127716$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211386$SANOFI AVENTIS$$72$YR$E$F$Y$39$KG$20240723$$MD$US$US
241277171$24127717$1$I$$20240715$20240723$20240723$EXP$$CA-JNJFOC-20240741129$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240722$$HP$CA$CA
241277181$24127718$1$I$20220101$20240716$20240723$20240723$PER$$US-SA-2024SA213229$SANOFI AVENTIS$$60$YR$A$F$Y$97$KG$20240723$$MD$US$US
241277191$24127719$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211277$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241277201$24127720$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA212878$SANOFI AVENTIS$$64$YR$A$M$Y$78$KG$20240723$$MD$US$US
241277211$24127721$1$I$$20231106$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007023$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241277221$24127722$1$I$$20231211$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007069$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241277231$24127723$1$I$$20231214$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007078$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241277241$24127724$1$I$$20240304$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006994$VANDA PHARMACEUTICALS$$$$$M$Y$49.887$KG$20240723$$CN$US$US
241277251$24127725$1$I$$20231011$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006983$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241277261$24127726$1$I$20231214$20231214$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007079$VANDA PHARMACEUTICALS$$55$YR$$F$Y$$$20240723$$CN$US$US
241277271$24127727$1$I$$20231212$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007075$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241277281$24127728$1$I$$20231024$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007002$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241277291$24127729$1$I$20231205$20231218$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007058$VANDA PHARMACEUTICALS$$55$YR$$F$Y$$$20240723$$CN$US$US
241277301$24127730$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50660$$FDA-CTU$$51$YR$$F$N$$$20240723$N$$US$
241277311$24127731$1$I$20230101$20240126$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007005$VANDA PHARMACEUTICALS$$$$$F$Y$50.703$KG$20240723$$CN$US$US
241277324$24127732$4$F$20240101$20240909$20240723$20240925$PER$$US-SA-2024SA211215$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240925$$MD$US$US
241277332$24127733$2$F$20240715$20240718$20240723$20240728$PER$$US-SA-2024SA212157$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240728$$MD$US$US
241277341$24127734$1$I$20240717$20240718$20240723$20240723$PER$$US-SA-2024SA212887$SANOFI AVENTIS$$$$$F$Y$$$20240723$$HP$US$US
241277351$24127735$1$I$$20240718$20240723$20240723$PER$$US-SA-2024SA212964$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240723$$CN$US$US
241277362$24127736$2$F$20240101$20240816$20240723$20240829$PER$$US-SA-2024SA212306$SANOFI AVENTIS$$52$YR$A$F$Y$53.5$KG$20240829$$MD$US$US
241277371$24127737$1$I$20240101$20240718$20240723$20240723$PER$$US-SA-2024SA213783$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240723$$CN$US$US
241277381$24127738$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA212429$SANOFI AVENTIS$$$$E$F$Y$72.5$KG$20240723$$MD$US$US
241277391$24127739$1$I$$20240718$20240723$20240723$PER$$US-SA-2024SA213314$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240723$$MD$US$US
241277401$24127740$1$I$$20240718$20240723$20240723$PER$$US-SA-2024SA212177$SANOFI AVENTIS$$$$E$F$Y$$$20240723$$MD$US$US
241277411$24127741$1$I$20230301$20240715$20240723$20240723$PER$$US-SA-2024SA212023$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240723$$MD$US$US
241277421$24127742$1$I$$20240718$20240723$20240723$PER$$US-SA-2024SA212490$SANOFI AVENTIS$$$$E$M$Y$$$20240723$$CN$US$US
241277431$24127743$1$I$20240101$20240715$20240723$20240723$PER$$US-SA-2024SA210433$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240723$$MD$US$US
241277441$24127744$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211219$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240723$$MD$US$US
241277451$24127745$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211184$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240723$$MD$US$US
241277461$24127746$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211007$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240723$$MD$US$US
241277471$24127747$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA210441$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241277481$24127748$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA210678$SANOFI AVENTIS$$$$E$F$Y$$$20240723$$MD$US$US
241277491$24127749$1$I$20240101$20240718$20240723$20240723$PER$$US-SA-2024SA212839$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240723$$MD$US$US
241277501$24127750$1$I$$20240718$20240723$20240723$PER$$US-SA-2024SA212947$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240723$$HP$US$US
241277512$24127751$2$F$$20240717$20240723$20240724$PER$$US-SA-2024SA212217$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240724$$MD$US$US
241277521$24127752$1$I$$20240718$20240723$20240723$PER$$US-SA-2024SA211614$SANOFI AVENTIS$$$$A$$Y$$$20240723$$MD$US$US
241277531$24127753$1$I$20240701$20240718$20240723$20240723$PER$$US-SA-2024SA212605$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240723$$CN$US$US
241277541$24127754$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210979$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240723$$MD$US$US
241277552$24127755$2$F$$20240722$20240723$20240729$PER$$US-SA-2024SA213107$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240729$$CN$US$US
241277561$24127756$1$I$20240101$20240717$20240723$20240723$PER$$US-SA-2024SA212164$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240723$$MD$US$US
241277571$24127757$1$I$20240713$20240717$20240723$20240723$PER$$US-SA-2024SA212374$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240723$$CN$US$US
241277581$24127758$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50658$$FDA-CTU$$66$YR$$F$N$103.87$KG$20240723$N$$US$
241277591$24127759$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA211577$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240723$$MD$US$US
241277601$24127760$1$I$20240718$20240718$20240723$20240723$PER$$US-SA-2024SA213064$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240723$$CN$US$US
241277611$24127761$1$I$20240101$20240715$20240723$20240723$PER$$US-SA-2024SA210645$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240723$$MD$US$US
241277621$24127762$1$I$$20240718$20240723$20240723$PER$$US-SA-2024SA213029$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240723$$CN$US$US
241277631$24127763$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA212020$SANOFI AVENTIS$$$$A$F$Y$77$KG$20240723$$HP$US$US
241277641$24127764$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209777$SANOFI AVENTIS$$$$$F$Y$$$20240723$$CN$US$US
241277651$24127765$1$I$20240701$20240716$20240723$20240723$PER$$US-SA-2024SA211284$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240723$$MD$US$US
241277662$24127766$2$F$$20240719$20240723$20240726$EXP$$IN-VANTIVE-2024VAN018481$Vantive US Healthcare$$66$YR$$M$Y$$$20240726$$CN$IN$IN
241277671$24127767$1$I$$20240716$20240723$20240723$EXP$$CN-VANTIVE-2024VAN018398$Vantive US Healthcare$$$$$F$Y$$$20240723$$CN$CN$CN
241277681$24127768$1$I$20240514$20240715$20240723$20240723$EXP$$SG-VANTIVE-2024VAN018334$Vantive US Healthcare$$80$YR$$F$Y$$$20240723$$CN$SG$SG
241277691$24127769$1$I$$20240716$20240723$20240723$EXP$$US-VANTIVE-2024VAN018390$Vantive US Healthcare$$$$$$Y$$$20240723$$HP$US$US
241277701$24127770$1$I$$20240712$20240723$20240723$EXP$$CN-ROCHE-10000031106$ROCHE$Gu Y, Chu X, Zhao L, Hong B, Luo Z, Lin Z. P24-05067: Thrombolysis with low-dose and standard-dose intravenous recombinant tissue plasminogen activator in elderly patients with acute ischemic strokea stratified analysis. The Journal of Practical Medicine. 2024;11 (40):1568-73.$$$E$$Y$$$20240723$$MD$CN$CN
241277714$24127771$4$F$$20240829$20240723$20240830$PER$$US-ROCHE-10000033196$ROCHE$$$$A$F$Y$$$20240830$$CN$US$US
241277721$24127772$1$I$20221031$20240722$20240723$20240723$PER$$US-ROCHE-10000033378$ROCHE$$64$YR$A$F$Y$78.92$KG$20240723$$MD$US$US
241277731$24127773$1$I$$20240722$20240723$20240723$PER$$US-ROCHE-10000033259$ROCHE$$$$$M$Y$$$20240723$$HP$US$US
241277741$24127774$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50577$$FDA-CTU$$97$YR$$F$N$88.9$KG$20240719$N$$US$
241277751$24127775$1$I$$20240718$20240723$20240723$PER$$US-SA-2024SA212643$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240723$$CN$US$US
241277761$24127776$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50562$$FDA-CTU$$71$YR$$F$N$$$20240719$N$$US$
241277771$24127777$1$I$20240712$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50544$$FDA-CTU$$67$YR$$F$N$119.8$KG$20240722$N$$US$
241277781$24127778$1$I$20240717$20240718$20240723$20240723$PER$$US-SA-2024SA213395$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240723$$MD$US$US
241277791$24127779$1$I$$20240715$20240723$20240723$EXP$$SK-TAKEDA-2024TUS073446$TAKEDA$$65$YR$$M$Y$$$20240723$$MD$SK$SK
241277801$24127780$1$I$$20240715$20240723$20240723$EXP$$IN-AMGEN-INDSP2024143080$AMGEN$Waghmare:S.. Apremilast in Erythema Nodosum Leprosum: A Case Series. Journal of Dermatology + Dermatology Surgery. 2024;28 (1):42-45$36$YR$A$F$Y$59$KG$20240723$$MD$IN$IN
241277811$24127781$1$I$$20240719$20240723$20240723$PER$$US-JNJFOC-20240752965$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$HP$US$US
241277821$24127782$1$I$20240429$20240715$20240723$20240723$EXP$$US-JNJFOC-20240739320$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
241277831$24127783$1$I$$20240712$20240723$20240723$PER$$US-SA-2024SA210471$SANOFI AVENTIS$$$$T$F$Y$49.8$KG$20240723$$HP$US$US
241277841$24127784$1$I$$20240715$20240723$20240723$EXP$$CA-SANDOZ INC.-PHHY2019CA054482$SANDOZ$$39$YR$$M$Y$130$KG$20240723$$MD$CA$CA
241277851$24127785$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA210738$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240723$$HP$US$US
241277861$24127786$1$I$20240101$20240715$20240723$20240723$PER$$US-SA-2024SA211397$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241277871$24127787$1$I$20240622$20240712$20240723$20240723$EXP$$JP-ROCHE-10000031703$ROCHE$$30$YR$A$$Y$$$20240723$$MD$JP$JP
241277881$24127788$1$I$$20240715$20240723$20240723$EXP$$US-JNJFOC-20240748787$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
241277891$24127789$1$I$$20240717$20240723$20240723$EXP$$US-OTSUKA-2024_020242$OTSUKA$$$$$M$Y$$$20240723$$HP$US$US
241277901$24127790$1$I$$20240711$20240723$20240723$EXP$$US-JNJFOC-20240736809$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$CN$US$US
241277921$24127792$1$I$$20240719$20240723$20240723$EXP$$US-ABBVIE-5848311$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241277931$24127793$1$I$$20240712$20240723$20240723$PER$$US-JNJFOC-20240755441$JOHNSON AND JOHNSON$$$$$F$Y$94.1$KG$20240722$$MD$US$US
241277941$24127794$1$I$$20240718$20240723$20240723$PER$$US-BIOMARINAP-US-2024-159302$BIOMARIN$$$$$$Y$$$20240723$$CN$US$US
241277951$24127795$1$I$20231130$20231130$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007052$VANDA PHARMACEUTICALS$$70$YR$$M$Y$$$20240723$$CN$US$US
241277961$24127796$1$I$$20231206$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007062$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241277971$24127797$1$I$$20231226$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007098$VANDA PHARMACEUTICALS$$$$$M$Y$104.31$KG$20240723$$CN$US$US
241277981$24127798$1$I$$20231024$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006998$VANDA PHARMACEUTICALS$$$$$M$Y$88.435$KG$20240723$$CN$US$US
241277991$24127799$1$I$$20231030$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007009$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$HP$US$US
241278001$24127800$1$I$$20231221$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007095$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241278011$24127801$1$I$$20240104$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007111$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241278031$24127803$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50560$$FDA-CTU$$47$YR$$F$N$63.5$KG$20240719$N$$US$
241278041$24127804$1$I$20231201$20231215$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007082$VANDA PHARMACEUTICALS$$29$YR$$F$Y$$$20240723$$CN$US$US
241278051$24127805$1$I$$20231030$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007008$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278061$24127806$1$I$$20231220$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007092$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278071$24127807$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50574$$FDA-CTU$$66$YR$$F$N$$$20240719$N$$US$
241278081$24127808$1$I$20240722$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50656$$FDA-CTU$$72$YR$$F$N$$$20240723$Y$PH$US$
241278091$24127809$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50580$$FDA-CTU$$55$YR$$F$N$$$20240719$N$$US$
241278101$24127810$1$I$$20240718$20240723$20240723$EXP$$DE-MYLANLABS-2024M1068047$MYLAN$Austein T, Sommer MM, Morche M, Finck A. Uncommon diagnosis of malignant Melanoma by bone marrow smear. Oncol-Res-Treat 2023; 46 (Suppl. 5) 175 abstr. P327.$62$YR$$M$Y$$$20240723$$HP$DE$DE
241278121$24127812$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50661$$FDA-CTU$$59$YR$$M$N$$$20240723$N$$US$
241278131$24127813$1$I$20240718$20240718$20240723$20240723$EXP$$IE-MYLANLABS-2024M1067838$MYLAN$$$$$M$Y$$$20240723$$CN$IE$IE
241278141$24127814$1$I$$20240718$20240723$20240723$EXP$GB-MHRA-MED-202407180956233390-PZWYM$GB-MYLANLABS-2024M1067339$MYLAN$$$$$$Y$$$20240723$$CN$GB$GB
241278151$24127815$1$I$$20240718$20240723$20240723$EXP$$IN-MYLANLABS-2024M1068040$MYLAN$Nazeer FA, Bhaskaramenon SC, George S, Nazeer MM, Sumitra SN. Docetaxel-induced bullous eruption. J Skin Sex  Transm Dis. 2024;6:103-4$45$YR$$F$Y$$$20240723$$HP$IN$IN
241278161$24127816$1$I$$20240718$20240723$20240723$EXP$$US-MYLANLABS-2024M1068068$MYLAN$Hamill G, Burchard T, Khan EK. Gazing into the Crystal Ball: Correlating ATP-binding Cassette Protein A3 (ABCA3) Pathogenic Variant Genotypes and Phenotypes. Am-J-Respir-Crit-Care-Med 2024; 209 A2326.$3$WK$$F$Y$$$20240723$$HP$US$US
241278171$24127817$1$I$20240619$20240718$20240723$20240723$EXP$IT-MINISAL02-994625$IT-MYLANLABS-2024M1067498$MYLAN$$48$YR$$F$Y$$$20240723$$MD$IT$IT
241278181$24127818$1$I$20240707$20240718$20240723$20240723$EXP$GB-MHRA-MED-202407181820541080-BLPYH$GB-MYLANLABS-2024M1067708$MYLAN$$61$YR$$M$Y$85$KG$20240723$$CN$GB$GB
241278191$24127819$1$I$$20240718$20240723$20240723$EXP$$AU-MYLANLABS-2024M1067461$MYLAN$$$$$F$Y$$$20240723$$PH$AU$AU
241278201$24127820$1$I$20240618$20240718$20240723$20240723$EXP$$SG-MYLANLABS-2024M1067429$MYLAN$$72$YR$$F$Y$$$20240723$$HP$SG$SG
241278211$24127821$1$I$20240717$20240718$20240723$20240723$EXP$GB-MHRA-TPP29324321C8579691YC1721221023804$GB-MYLANLABS-2024M1067735$MYLAN$$94$YR$$F$Y$53$KG$20240723$$MD$GB$GB
241278221$24127822$1$I$20240714$20240718$20240723$20240723$EXP$GB-MHRA-MED-202407181502206810-HFZWP$GB-MYLANLABS-2024M1067599$MYLAN$$$$$M$Y$$$20240723$$MD$GB$GB
241278231$24127823$1$I$20240702$20240718$20240723$20240723$EXP$$SG-MYLANLABS-2024M1067083$MYLAN$$74$YR$$M$Y$$$20240723$$HP$SG$SG
241278241$24127824$1$I$$20240715$20240723$20240723$EXP$$IN-AMGEN-INDSP2024143016$AMGEN$Waghmare:S.. Apremilast in Erythema Nodosum Leprosum: A Case Series. Journal of Dermatology + Dermatology Surgery. 2024;28 (1):42-45$26$YR$A$F$Y$50$KG$20240723$$MD$IN$IN
241278251$24127825$1$I$$20240722$20240723$20240723$PER$$NVSC2024US150977$NOVARTIS$$$$$M$Y$$$20240723$$MD$US$US
241278261$24127826$1$I$20240212$20240719$20240723$20240723$EXP$FR-AFSSAPS-LL2024001326$FR-JNJFOC-20240756051$JOHNSON AND JOHNSON$$57$YR$A$M$Y$70$KG$20240722$$PH$FR$FR
241278271$24127827$1$I$$20240715$20240723$20240723$EXP$$CA-JNJFOC-20240748919$JOHNSON AND JOHNSON$$42$YR$A$F$Y$51$KG$20240722$$HP$CA$CA
241278282$24127828$2$F$20240708$20240722$20240723$20240731$PER$$US-Eisai-EC-2024-170090$EISAI$$60$YR$A$F$Y$$$20240731$$MD$US$US
241278291$24127829$1$I$20230329$20240722$20240723$20240723$EXP$FR-AFSSAPS-PO2024000785$FR-SANDOZ INC.-SDZ2024FR066876$SANDOZ$$33$YR$$F$Y$116$KG$20240723$$MD$FR$FR
241278301$24127830$1$I$$20240717$20240723$20240723$EXP$$ZA-JNJFOC-20240748577$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$MD$ZA$ZA
241278311$24127831$1$I$$20240722$20240723$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA067114$SANDOZ$$62$YR$$M$Y$$$20240723$$CN$CA$CA
241278321$24127832$1$I$20230701$20240126$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007100$VANDA PHARMACEUTICALS$$23$YR$$M$Y$90.703$KG$20240723$$CN$US$US
241278331$24127833$1$I$$20240105$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007113$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241278341$24127834$1$I$$20240209$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007112$VANDA PHARMACEUTICALS$$$$$F$Y$112.47$KG$20240723$$CN$US$US
241278351$24127835$1$I$20200101$20240104$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007114$VANDA PHARMACEUTICALS$$$$$M$Y$115.19$KG$20240723$$CN$US$US
241278361$24127836$1$I$$20231107$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007024$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278371$24127837$1$I$$20231208$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007031$VANDA PHARMACEUTICALS$$$$$F$Y$95.238$KG$20240723$$CN$US$US
241278381$24127838$1$I$$20240104$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007110$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278391$24127839$1$I$$20231129$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007039$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241278401$24127840$1$I$$20240719$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007028$VANDA PHARMACEUTICALS$$$$$F$Y$61.224$KG$20240723$$CN$US$US
241278411$24127841$1$I$$20240125$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007116$VANDA PHARMACEUTICALS$$$$$F$Y$68.027$KG$20240723$$CN$US$US
241278421$24127842$1$I$$20240717$20240723$20240723$EXP$CA-DRL-USA-SPO/CAN/24/0010572$CA-RDY-SPO/CAN/24/0010572$DR REDDYS$$58$YR$A$F$Y$58.51$KG$20240723$$HP$CA$CA
241278431$24127843$1$I$$20240711$20240723$20240723$PER$$US-RDY-SPO/USA/24/0010333$DR REDDYS$$$$$F$Y$$$20240723$$CN$US$US
241278441$24127844$1$I$$20240717$20240723$20240723$EXP$CA-DRL-USA-SPO/CAN/24/0010576$CA-RDY-SPO/CAN/24/0010576$DR REDDYS$$73$YR$E$F$Y$47$KG$20240723$$HP$CA$CA
241278451$24127845$1$I$$20240715$20240723$20240723$EXP$$US-ARGENX-2024-ARGX-US005555$ARGENX BVBA$$$$$$Y$$$20240723$$CN$US$US
241278465$24127846$5$F$20240715$20240903$20240723$20240906$30DAY$$US-JNJFOC-20240739379$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240906$$CN$US$US
241278471$24127847$1$I$20240202$20240718$20240723$20240723$EXP$$DE-ABBVIE-5848630$ABBVIE$$41$YR$$M$Y$140$KG$20240723$$MD$DE$DE
241278481$24127848$1$I$20240201$20240718$20240723$20240723$EXP$$AU-ABBVIE-5848627$ABBVIE$$46$YR$$M$Y$$$20240723$$CN$AU$AU
241278493$24127849$3$F$$20240819$20240723$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010922$JAZZ$$$$$M$Y$$$20240823$$CN$US$US
241278501$24127850$1$I$$20240719$20240723$20240723$EXP$$US-JNJFOC-20240754351$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
241278511$24127851$1$I$$20240717$20240723$20240723$EXP$$US-ABBVIE-5847183$ABBVIE$$$$$F$Y$$$20240723$$HP$US$US
241278521$24127852$1$I$$20240722$20240723$20240723$PER$$US-GILEAD-2024-0681542$GILEAD$$61$YR$A$M$Y$$$20240723$$CN$US$US
241278531$24127853$1$I$20240710$20240723$20240723$20240723$EXP$CZ-CZSUKL-24002068$CZ-SANDOZ INC.-SDZ2024CZ067255$SANDOZ$$54$YR$$F$Y$$$20240723$$PH$CZ$CZ
241278541$24127854$1$I$$20240719$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US067376$SANDOZ$$$$$F$Y$$$20240723$$MD$US$US
241278552$24127855$2$F$20240701$20240726$20240723$20240730$EXP$$FR-JNJFOC-20240756071$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240730$$PH$FR$FR
241278561$24127856$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50569$$FDA-CTU$$64$YR$$F$N$$$20240723$N$$US$
241278571$24127857$1$I$20240604$20240717$20240723$20240723$EXP$$AU-SANDOZ INC.-SDZ2024AU066166$SANDOZ$$56$YR$$F$Y$69.6$KG$20240723$$MD$AU$AU
241278582$24127858$2$F$$20240701$20240723$20240801$EXP$$KR-GE HEALTHCARE-2024CSU008287$GE HEALTHCARE$$$$$$Y$$$20240801$$HP$KR$KR
241278592$24127859$2$F$$20240701$20240723$20240801$EXP$$KR-GE HEALTHCARE-2024CSU008286$GE HEALTHCARE$$$$$$Y$$$20240801$$HP$KR$KR
241278601$24127860$1$I$$20230926$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006963$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278611$24127861$1$I$$20230925$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006962$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278621$24127862$1$I$20240710$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50662$$FDA-CTU$$71$YR$$F$N$73.3$KG$20240723$N$PH$US$
241278631$24127863$1$I$$20230920$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006954$VANDA PHARMACEUTICALS$$$$$F$Y$55.51$KG$20240723$$CN$US$US
241278641$24127864$1$I$20230802$20230920$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006409$VANDA PHARMACEUTICALS$$43$YR$$F$Y$146.05$KG$20240723$$HP$US$US
241278651$24127865$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50564$$FDA-CTU$$60$YR$$M$N$109.32$KG$20240719$N$$US$
241278661$24127866$1$I$$20230922$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006958$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278671$24127867$1$I$$20230927$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006964$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278681$24127868$1$I$$20230918$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006950$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278691$24127869$1$I$$20230921$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006956$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241278701$24127870$1$I$$20240715$20240723$20240723$EXP$$IE-JNJFOC-20240740818$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240722$$MD$IE$IE
241278712$24127871$2$F$20240705$20240729$20240723$20240731$EXP$$US-JNJFOC-20240751900$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240801$$CN$US$US
241278722$24127872$2$F$20210101$20240712$20240723$20240726$EXP$$HK-ROCHE-10000031981$ROCHE$$53$YR$A$M$Y$$$20240726$$CN$HK$HK
241278731$24127873$1$I$$20230927$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006968$VANDA PHARMACEUTICALS$$$$$F$Y$78.005$KG$20240723$$CN$US$US
241278741$24127874$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116268$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240723$$CN$US$US
241278752$24127875$2$F$20240101$20240730$20240723$20240802$EXP$$JP-JNJFOC-20240726814$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240802$$PH$JP$JP
241278761$24127876$1$I$$20240714$20240723$20240723$EXP$$CN-JNJFOC-20240752204$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240723$$HP$CN$CN
241278771$24127877$1$I$$20231211$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007070$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241278781$24127878$1$I$$20231215$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007081$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278791$24127879$1$I$$20231018$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006991$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278801$24127880$1$I$20240102$20240109$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007097$VANDA PHARMACEUTICALS$$31$YR$$M$Y$$$20240723$$CN$US$US
241278811$24127881$1$I$$20231204$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007017$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278821$24127882$1$I$20231208$20231208$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007071$VANDA PHARMACEUTICALS$$40$YR$$F$Y$$$20240723$$PH$US$US
241278831$24127883$1$I$$20231024$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007001$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278861$24127886$1$I$$20231019$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006995$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241278871$24127887$1$I$$20231127$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007034$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241278881$24127888$1$I$20231201$20231219$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007090$VANDA PHARMACEUTICALS$$25$YR$$F$Y$64.082$KG$20240723$$CN$US$US
241278891$24127889$1$I$$20240711$20240723$20240723$PER$$US-TEVA-VS-3221389$TEVA$$31$YR$$F$Y$$$20240723$$CN$US$US
241278901$24127890$1$I$$20230928$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006967$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278911$24127891$1$I$$20230929$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006970$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241278921$24127892$1$I$$20231002$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006971$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278931$24127893$1$I$$20231002$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006972$VANDA PHARMACEUTICALS$$$$$F$Y$58.095$KG$20240723$$CN$US$US
241278941$24127894$1$I$$20230929$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006926$VANDA PHARMACEUTICALS$$$$$F$Y$72.574$KG$20240723$$CN$US$US
241278951$24127895$1$I$$20230928$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006966$VANDA PHARMACEUTICALS$$$$$M$Y$98.413$KG$20240723$$CN$US$US
241278961$24127896$1$I$$20231002$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006980$VANDA PHARMACEUTICALS$$$$$M$Y$110.2$KG$20240723$$CN$US$US
241278971$24127897$1$I$$20230928$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006969$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241278983$24127898$3$F$20220101$20240715$20240723$20240820$EXP$DE-ROCHE-3316504$DE-TORRENT-00027026$TORRENT$$51$YR$A$M$Y$$$20240820$$MD$DE$DE
241278991$24127899$1$I$20220801$20240712$20240723$20240723$EXP$GB-GE HEALTHCARE-2024CSU007334$GB-TORRENT-00037251$TORRENT$$61$YR$A$F$Y$61$KG$20240723$$PH$GB$GB
241279001$24127900$1$I$20210101$20240715$20240723$20240723$EXP$$IN-TORRENT-00003606$TORRENT$$70$YR$E$F$Y$$$20240723$$MD$IN$IN
241279011$24127901$1$I$20240714$20240714$20240723$20240723$EXP$GB-MHRA-MED-202407141136241030-SLPZT$GB-TORRENT-00037273$TORRENT$$53$YR$A$M$Y$78$KG$20240723$$CN$GB$GB
241279021$24127902$1$I$$20240712$20240723$20240723$EXP$$US-TORRENT-00013682$TORRENT$$$$A$M$Y$90$KG$20240723$$CN$US$US
241279032$24127903$2$F$20231101$20240725$20240723$20240731$EXP$$US-ABBVIE-5846256$ABBVIE$$91$YR$$M$Y$77$KG$20240731$$CN$US$US
241279041$24127904$1$I$20240523$20240717$20240723$20240723$EXP$$IT-AMGEN-ITASP2024142480$AMGEN$$72$YR$E$M$Y$70$KG$20240723$$MD$IT$IT
241279051$24127905$1$I$20240625$20240718$20240723$20240723$EXP$$DE-AMGEN-DEUSP2024143162$AMGEN$$$$$M$Y$79$KG$20240723$$MD$DE$DE
241279061$24127906$1$I$20240718$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024144627$AMGEN$$72$YR$E$F$Y$$$20240723$$CN$US$US
241279071$24127907$1$I$20240708$20240716$20240723$20240723$EXP$$CN-AMGEN-CHNSP2024141458$AMGEN$$50$YR$A$F$Y$57.5$KG$20240723$$HP$CN$CN
241279081$24127908$1$I$$20240716$20240723$20240723$PER$$US-MYLANLABS-2024M1067351$MYLAN$$$$$M$Y$$$20240723$$MD$US$US
241279101$24127910$1$I$$20231003$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006974$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241279111$24127911$1$I$$20231004$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006976$VANDA PHARMACEUTICALS$$$$$F$Y$48.98$KG$20240723$$CN$US$US
241279121$24127912$1$I$20230818$20231011$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006918$VANDA PHARMACEUTICALS$$26$YR$$M$Y$$$20240723$$CN$US$US
241279131$24127913$1$I$$20231003$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006973$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241279141$24127914$1$I$$20231004$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006978$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241279151$24127915$1$I$$20231004$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006979$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241279161$24127916$1$I$20230310$20231005$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006596$VANDA PHARMACEUTICALS$$11$YR$$F$Y$83.9$KG$20240723$$CN$US$US
241279171$24127917$1$I$$20231003$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006977$VANDA PHARMACEUTICALS$$$$$F$Y$57.596$KG$20240723$$CN$US$US
241279182$24127918$2$F$20231001$20240724$20240723$20240801$EXP$$US-Calliditas-2024CAL01253$CALLIDITAS THERAPEUTICS$$60$YR$A$M$Y$$$20240801$$CN$US$US
241279191$24127919$1$I$20240716$20240718$20240723$20240723$PER$$US-PFIZER INC-202400219170$PFIZER$$46$YR$$F$Y$$$20240723$$HP$US$US
241279202$24127920$2$F$20240726$20240726$20240723$20240730$PER$$US-PFIZER INC-202400221453$PFIZER$$23$YR$$M$Y$$$20240730$$CN$US$US
241279212$24127921$2$F$$20240912$20240723$20240916$PER$$US-PFIZER INC-202400219859$PFIZER$$58$YR$$F$Y$$$20240916$$MD$US$US
241279221$24127922$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50563$$FDA-CTU$$54$YR$$F$N$90.26$KG$20240719$N$$US$
241279231$24127923$1$I$$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50556$$FDA-CTU$$49$YR$$M$N$$$20240719$N$$US$
241279241$24127924$1$I$20240301$20240710$20240723$20240723$PER$$US-ALKERMES INC.-ALK-2024-001862$ALKERMES$$39$YR$$M$Y$$$20240723$$HP$US$US
241279251$24127925$1$I$20240701$20240716$20240723$20240723$PER$$US-PFIZER INC-202400217647$PFIZER$$37$YR$$M$Y$79.83$KG$20240723$$CN$US$US
241279261$24127926$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50606$$FDA-CTU$$43$YR$$F$N$$$20240723$N$$US$
241279281$24127928$1$I$$20240722$20240722$20240722$DIR$711037$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241279291$24127929$1$I$$20240711$20240723$20240723$EXP$$US-AVEVA-000704$AVEVA$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Med Pathol. 2024. doi: 10.1097/PAF.0000000000000943. PMID: 38833356.$17$YR$T$M$Y$$$20240723$$MD$US$US
241279301$24127930$1$I$$20240711$20240723$20240723$EXP$$US-AVEVA-000705$AVEVA$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Med Pathol. 2024. doi: 10.1097/PAF.0000000000000943. PMID: 38833356.$17$YR$T$M$Y$$$20240723$$MD$US$US
241279311$24127931$1$I$$20240711$20240723$20240723$EXP$$US-AVEVA-000700$AVEVA$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Med Pathol. 2024. doi: 10.1097/PAF.0000000000000943. PMID: 38833356.$13$YR$T$F$Y$$$20240723$$MD$US$US
241279321$24127932$1$I$$20240711$20240723$20240723$EXP$$US-AVEVA-000701$AVEVA$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Med Pathol. 2024. doi: 10.1097/PAF.0000000000000943. PMID: 38833356.$15$YR$T$M$Y$$$20240723$$MD$US$US
241279331$24127933$1$I$$20240711$20240723$20240723$EXP$$US-AVEVA-000698$AVEVA$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Med Pathol. 2024. doi: 10.1097/PAF.0000000000000943. PMID: 38833356.$11$MON$I$M$Y$$$20240723$$MD$US$US
241279341$24127934$1$I$$20240711$20240723$20240723$EXP$$US-AVEVA-000699$AVEVA$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Med Pathol. 2024. doi: 10.1097/PAF.0000000000000943. PMID: 38833356.$2$YR$C$F$Y$$$20240723$$MD$US$US
241279351$24127935$1$I$$20240711$20240723$20240723$EXP$$US-AVEVA-000703$AVEVA$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Med Pathol. 2024. doi: 10.1097/PAF.0000000000000943. PMID: 38833356.$4$YR$C$M$Y$$$20240723$$MD$US$US
241279361$24127936$1$I$$20240711$20240723$20240723$EXP$$US-AVEVA-000706$AVEVA$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Med Pathol. 2024. doi: 10.1097/PAF.0000000000000943. PMID: 38833356.$17$YR$T$M$Y$$$20240723$$MD$US$US
241279371$24127937$1$I$$20240711$20240723$20240723$EXP$$US-AVEVA-000702$AVEVA$Monday K, Shattuck B, Barba K, Revercomb CH. Fentanyl Deaths in Infants and Children: A Case Series and Literature Review. Am J Forensic Med Pathol. 2024. doi: 10.1097/PAF.0000000000000943. PMID: 38833356.$17$YR$T$F$Y$$$20240723$$MD$US$US
241279381$24127938$1$I$20240720$20240720$20240723$20240723$PER$$US-PFIZER INC-202400220294$PFIZER$$43$YR$$M$Y$$$20240723$$CN$US$US
241279391$24127939$1$I$20240719$20240720$20240723$20240723$PER$$US-PFIZER INC-202400219700$PFIZER$$41$YR$$F$Y$$$20240723$$HP$US$US
241279401$24127940$1$I$$20240722$20240723$20240723$EXP$$CA-PFIZER INC-202400220878$PFIZER$$72$YR$$M$Y$$$20240723$$HP$CA$CA
241279412$24127941$2$F$$20240718$20240723$20240725$PER$$US-PFIZER INC-202400218834$PFIZER$$$$$F$Y$$$20240725$$CN$US$US
241279421$24127942$1$I$20240721$20240722$20240723$20240723$PER$$US-PFIZER INC-202400221402$PFIZER$$59$YR$$M$Y$$$20240723$$CN$US$US
241279431$24127943$1$I$20240711$20240716$20240723$20240723$PER$$US-ABBVIE-5846969$ABBVIE$$35$YR$$F$Y$$$20240723$$MD$US$US
241279441$24127944$1$I$$20240715$20240723$20240723$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06312$VIFOR$$$$E$F$Y$$$20240723$$CN$ZA$ZA
241279451$24127945$1$I$$20231212$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007073$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241279461$24127946$1$I$$20231207$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007076$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241279471$24127947$1$I$$20231114$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007029$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241279481$24127948$1$I$$20240501$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007101$VANDA PHARMACEUTICALS$$$$$F$Y$114.29$KG$20240723$$CN$US$US
241279491$24127949$1$I$$20231013$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006988$VANDA PHARMACEUTICALS$$$$$F$Y$146.03$KG$20240723$$CN$US$US
241279501$24127950$1$I$$20231107$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007026$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241279511$24127951$1$I$$20231220$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007093$VANDA PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
241279521$24127952$1$I$$20231211$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007072$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241279531$24127953$1$I$$20240712$20240723$20240723$PER$$US-MYLANLABS-2024M1066456$MYLAN$$$$$F$Y$$$20240723$$CN$US$US
241279541$24127954$1$I$$20231012$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006986$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241279551$24127955$1$I$$20231127$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007035$VANDA PHARMACEUTICALS$$$$$F$Y$89.342$KG$20240723$$CN$US$US
241279561$24127956$1$I$$20240715$20240723$20240723$PER$$US-BAYER-2024A101502$BAYER$$$$A$F$Y$$$20240723$$HP$US$US
241279571$24127957$1$I$20240601$20240718$20240723$20240723$PER$$US-ABBVIE-5848697$ABBVIE$$$$$F$Y$$$20240723$$MD$US$US
241279581$24127958$1$I$$20240716$20240723$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA066989$SANDOZ$$84$YR$$F$Y$$$20240723$$PH$CA$CA
241279591$24127959$1$I$$20240717$20240723$20240723$PER$$US-BAYER-2024A104519$BAYER$$$$$F$Y$$$20240723$$HP$US$US
241279611$24127961$1$I$$20231128$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007042$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241279621$24127962$1$I$20230401$20231012$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006959$VANDA PHARMACEUTICALS$$20$YR$$F$Y$$$20240723$$CN$US$US
241279631$24127963$1$I$20231101$20240201$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007105$VANDA PHARMACEUTICALS$$51$YR$$F$Y$$$20240723$$CN$US$US
241279641$24127964$1$I$$20240312$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007102$VANDA PHARMACEUTICALS$$$$$F$Y$38.549$KG$20240723$$CN$US$US
241279651$24127965$1$I$20230903$20240304$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006930$VANDA PHARMACEUTICALS$$92$YR$$M$Y$80.726$KG$20240723$$CN$US$US
241279661$24127966$1$I$$20240103$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007106$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241279671$24127967$1$I$$20231128$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007041$VANDA PHARMACEUTICALS$$$$$F$Y$78.231$KG$20240723$$CN$US$US
241279681$24127968$1$I$$20231220$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006965$VANDA PHARMACEUTICALS$$$$$F$Y$103.86$KG$20240723$$CN$US$US
241279691$24127969$1$I$$20231106$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006936$VANDA PHARMACEUTICALS$$$$$M$Y$58.957$KG$20240723$$HP$US$US
241279703$24127970$3$F$$20240906$20240723$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116650$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240910$$CN$US$US
241279711$24127971$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117040$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$79.38$KG$20240723$$CN$US$US
241279721$24127972$1$I$20240701$20240722$20240723$20240723$PER$$US-JNJFOC-20240757478$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240723$$MD$US$US
241279731$24127973$1$I$20240624$20240711$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008434$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$US$US
241279741$24127974$1$I$$20240711$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008065$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240723$$HP$US$US
241279752$24127975$2$F$20240717$20240718$20240723$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407012565$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240731$$CN$US$US
241279761$24127976$1$I$20240624$20240711$20240723$20240723$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407008014$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240723$$HP$GB$GB
241279771$24127977$1$I$$20240711$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008960$ELI LILLY AND CO$$$$$M$Y$$$20240723$$CN$US$US
241279781$24127978$1$I$$20231017$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006870$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241279791$24127979$1$I$20240630$20240711$20240723$20240723$EXP$GB-MHRA-MED-202407111241438180-FWNRJ$GB-ELI_LILLY_AND_COMPANY-GB202407008367$ELI LILLY AND CO$$72$YR$E$M$Y$100$KG$20240723$$CN$GB$GB
241279801$24127980$1$I$$20240711$20240723$20240723$PER$$US-ALKERMES INC.-ALK-2024-001825$ALKERMES$$$$$F$Y$113.38$KG$20240723$$HP$US$US
241279811$24127981$1$I$20240501$20240711$20240723$20240723$PER$$US-ALKERMES INC.-ALK-2024-001875$ALKERMES$$40$YR$$F$Y$$$20240723$$HP$US$US
241279821$24127982$1$I$$20240715$20240723$20240723$EXP$GB-MHRA-MED-202407151354095780-MGYVC$GB-TEVA-VS-3221605$TEVA$$74$YR$$F$Y$$$20240723$$MD$GB$GB
241279831$24127983$1$I$$20231102$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006982$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241279841$24127984$1$I$$20231013$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006957$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241279851$24127985$1$I$$20231101$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007014$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$HP$US$US
241279871$24127987$1$I$$20231029$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007010$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241279882$24127988$2$F$$20240716$20240723$20240726$PER$$US-IGSA-BIG0029950$GRIFOLS$$$$$M$Y$$$20240726$$CN$US$US
241279891$24127989$1$I$20240510$20240717$20240723$20240723$EXP$$BR-ORGANON-O2407BRA001942$ORGANON$$38$YR$$F$Y$63$KG$20240723$$HP$BR$BR
241279901$24127990$1$I$$20240715$20240723$20240723$PER$$US-JNJFOC-20240743137$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
241279911$24127991$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210779$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241279921$24127992$1$I$$20231026$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006892$VANDA PHARMACEUTICALS$$$$$F$Y$52.608$KG$20240723$$CN$US$US
241279931$24127993$1$I$20230711$20231017$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006866$VANDA PHARMACEUTICALS$$67$YR$$F$Y$65.306$KG$20240723$$CN$US$US
241279942$24127994$2$F$20240101$20240812$20240723$20240826$PER$$US-SA-2024SA209832$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240826$$MD$US$US
241279953$24127995$3$F$$20240808$20240723$20240820$PER$$US-SA-2024SA210449$SANOFI AVENTIS$$1$YR$I$F$Y$12.7$KG$20240820$$MD$US$US
241279961$24127996$1$I$20240711$20240711$20240723$20240723$PER$$US-ALKERMES INC.-ALK-2024-001889$ALKERMES$$25$YR$$F$Y$$$20240723$$HP$US$US
241279971$24127997$1$I$20240601$20240712$20240723$20240723$EXP$$US-UCBSA-2024035809$UCB$$41$YR$$F$Y$$$20240723$$HP$US$US
241279981$24127998$1$I$20240711$20240711$20240723$20240723$PER$$US-ALKERMES INC.-ALK-2024-001877$ALKERMES$$38$YR$$M$Y$72.562$KG$20240723$$PH$US$US
241279991$24127999$1$I$$20231130$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006939$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241280001$24128000$1$I$20240716$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024142763$AMGEN$$69$YR$E$F$Y$$$20240723$$CN$US$US
241280011$24128001$1$I$$20231129$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006893$VANDA PHARMACEUTICALS$$$$$M$Y$26.077$KG$20240723$$CN$US$US
241280021$24128002$1$I$$20231114$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007030$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241280031$24128003$1$I$$20231107$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007025$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241280041$24128004$1$I$20231001$20231113$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007015$VANDA PHARMACEUTICALS$$10$YR$$F$Y$18.594$KG$20240723$$CN$US$US
241280051$24128005$1$I$20240718$20240718$20240723$20240723$PER$$US-JNJFOC-20240749372$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240722$$CN$US$US
241280061$24128006$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50611$$FDA-CTU$$62$YR$$M$N$$$20240723$N$$US$
241280071$24128007$1$I$20230615$20231115$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006841$VANDA PHARMACEUTICALS$$71$YR$$F$Y$58.957$KG$20240723$$CN$US$US
241280081$24128008$1$I$$20231206$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007060$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241280091$24128009$1$I$$20231207$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006878$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241280101$24128010$1$I$$20231204$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007056$VANDA PHARMACEUTICALS$$$$$M$Y$39.909$KG$20240723$$CN$US$US
241280111$24128011$1$I$20231215$20231219$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007087$VANDA PHARMACEUTICALS$$8$YR$$F$Y$32.29$KG$20240723$$CN$US$US
241280121$24128012$1$I$$20240715$20240723$20240723$EXP$$US-JNJFOC-20240738262$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$HP$US$US
241280131$24128013$1$I$$20240718$20240723$20240723$PER$$US-JNJFOC-20240751932$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$HP$US$US
241280141$24128014$1$I$$20240108$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007117$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241280152$24128015$2$F$$20240723$20240723$20240724$PER$$US-ROCHE-10000023022$ROCHE$$$$$$Y$$$20240724$$HP$US$US
241280161$24128016$1$I$20240619$20240722$20240722$20240722$DIR$711145$$FDA-CTU$$84$YR$$F$N$$$20240722$Y$MD$US$
241280172$24128017$2$F$20240630$20240724$20240723$20240725$EXP$$NZ-MYLANLABS-2024M1068419$MYLAN$$67$YR$$M$Y$$$20240725$$PH$NZ$NZ
241280181$24128018$1$I$$20240719$20240723$20240723$PER$$US-ROCHE-10000031757$ROCHE$$$$A$F$Y$$$20240723$$CN$US$US
241280193$24128019$3$F$$20240904$20240723$20240904$EXP$$NZ-MYLANLABS-2024M1068390$MYLAN$$$$$F$Y$$$20240904$$HP$NZ$NZ
241280201$24128020$1$I$20240719$20240722$20240723$20240723$EXP$$NZ-MYLANLABS-2024M1068380$MYLAN$$54$YR$$M$Y$$$20240723$$HP$NZ$NZ
241280212$24128021$2$F$20240709$20240725$20240723$20240801$EXP$$CA-GSK-CA2024089991$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$CA$CA
241280221$24128022$1$I$$20240718$20240723$20240723$EXP$$GB-JNJFOC-20240752144$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$HP$GB$GB
241280231$24128023$1$I$$20240712$20240723$20240723$EXP$$CA-GILEAD-2024-0676158$GILEAD$$35$YR$A$F$Y$$$20240723$$CN$CA$CA
241280251$24128025$1$I$$20240411$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006912$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241280261$24128026$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50608$$FDA-CTU$$33$YR$$F$N$47.63$KG$20240723$N$$US$
241280271$24128027$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50607$$FDA-CTU$$60$YR$$F$N$97.52$KG$20240723$N$$US$
241280281$24128028$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50663$$FDA-CTU$$82$YR$$F$N$$$20240723$N$$US$
241280291$24128029$1$I$$20240717$20240723$20240723$EXP$CA-DRL-USA-SPO/CAN/24/0010578$CA-RDY-SPO/CAN/24/0010578$DR REDDYS$$84$YR$E$F$Y$$$20240723$$PH$CA$CA
241280301$24128030$1$I$$20240720$20240723$20240723$PER$$US-ROCHE-10000033041$ROCHE$$15$YR$T$M$Y$$$20240723$$CN$US$US
241280312$24128031$2$F$20240603$20240722$20240723$20240725$EXP$$US-JNJFOC-20240738403$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240725$$HP$US$US
241280321$24128032$1$I$$20240419$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007260$VANDA PHARMACEUTICALS$$$$$F$Y$116.55$KG$20240723$$CN$US$US
241280331$24128033$1$I$$20240712$20240723$20240723$PER$$US-ALKERMES INC.-ALK-2024-001881$ALKERMES$$$$$M$Y$$$20240723$$CN$US$US
241280341$24128034$1$I$20240714$20240716$20240723$20240723$EXP$$PL-BAYER-2024A104280$BAYER$$$$$F$Y$$$20240723$$MD$PL$PL
241280351$24128035$1$I$$20240416$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007257$VANDA PHARMACEUTICALS$$$$$F$Y$18.957$KG$20240723$$CN$US$US
241280361$24128036$1$I$$20240516$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007286$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241280371$24128037$1$I$$20240403$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007246$VANDA PHARMACEUTICALS$$$$$F$Y$52.608$KG$20240723$$CN$US$US
241280381$24128038$1$I$$20240131$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007155$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241280391$24128039$1$I$20240711$20240716$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007308$VANDA PHARMACEUTICALS$$7$YR$$F$Y$$$20240723$$HP$US$US
241280401$24128040$1$I$$20240511$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007278$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$HP$US$US
241280411$24128041$1$I$$20240506$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007276$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241280421$24128042$1$I$$20240419$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007262$VANDA PHARMACEUTICALS$$$$$F$Y$53.107$KG$20240723$$CN$US$US
241280431$24128043$1$I$$20240510$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007268$VANDA PHARMACEUTICALS$$$$$M$Y$20$KG$20240723$$CN$US$US
241280442$24128044$2$F$20230102$20240813$20240723$20240826$PER$$US-ALKERMES INC.-ALK-2024-001884$ALKERMES$$42$YR$$M$Y$$$20240826$$HP$US$US
241280461$24128046$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116809$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240723$$HP$US$US
241280471$24128047$1$I$20240306$20240720$20240723$20240723$EXP$$CN-BAYER-2024A106661$BAYER$$56$YR$A$F$Y$70$KG$20240723$$HP$CN$CN
241280481$24128048$1$I$$20240628$20240723$20240723$PER$$US-JNJFOC-20240703579$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
241280491$24128049$1$I$20230418$20240720$20240723$20240723$EXP$GB-MHRA-MED-202407200142335290-WZPRM$GB-ORGANON-O2407GBR001962$ORGANON$$29$YR$$M$Y$$$20240723$$CN$GB$GB
241280502$24128050$2$F$$20240814$20240723$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114059$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$80.7$KG$20240829$$PH$US$US
241280511$24128051$1$I$20240623$20240722$20240723$20240723$EXP$GB-MHRA-MED-202407211526198410-SRDLP$GB-ORGANON-O2407GBR002053$ORGANON$$62$YR$$F$Y$56$KG$20240723$$CN$GB$GB
241280521$24128052$1$I$$20240723$20240723$20240723$EXP$$TW-BAYER-2024A106668$BAYER$$$$$M$Y$$$20240723$$HP$TW$TW
241280532$24128053$2$F$20240601$20240718$20240723$20240731$EXP$$JP-JNJFOC-20240755028$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240731$$MD$JP$JP
241280541$24128054$1$I$$20240719$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006924$VANDA PHARMACEUTICALS$$$$$M$Y$107.94$KG$20240723$$CN$US$US
241280551$24128055$1$I$$20240521$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007291$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241280561$24128056$1$I$$20240119$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007133$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$HP$US$US
241280571$24128057$1$I$$20240603$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007178$VANDA PHARMACEUTICALS$$$$$F$Y$21.995$KG$20240723$$CN$US$US
241280581$24128058$1$I$$20240115$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007096$VANDA PHARMACEUTICALS$$$$$F$Y$52.154$KG$20240723$$CN$US$US
241280591$24128059$1$I$$20240621$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS006877$VANDA PHARMACEUTICALS$$$$$F$Y$56.372$KG$20240723$$CN$US$US
241280601$24128060$1$I$$20240229$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007206$VANDA PHARMACEUTICALS$$$$$M$Y$30.839$KG$20240723$$CN$US$US
241280611$24128061$1$I$$20240213$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007176$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241280621$24128062$1$I$$20240315$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007227$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241280631$24128063$1$I$$20240702$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2023TASUS007021$VANDA PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241280641$24128064$1$I$$20240719$20240723$20240723$EXP$$FR-JNJFOC-20240752221$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240722$$PH$FR$FR
241280652$24128065$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3220642$TEVA$Hammond TC, Emeruwa I, Swain SR, Larson SM, Castells MC. Life-threatening Mast Cell Activation and Anaphylaxis in Mast Cell Leukemia and the Role of Omalizumab. Am-J-Respir-Crit-Care-Med 2024; 209.; Hammond TC, Emeruwa I, Swain SR, Larson SM, Castells MC. Life-threatening Mast Cell Activation and Anaphylaxis in Mast Cell Leukemia and the Role of Omalizumab. Am-J-Respir-Crit-Care-Med 2024; 209.$31$YR$$M$Y$$$20240819$$HP$US$US
241280661$24128066$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA212524$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240723$$MD$US$US
241280671$24128067$1$I$20240221$20240403$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007192$VANDA PHARMACEUTICALS$$52$YR$$M$Y$99.773$KG$20240723$$HP$US$US
241280683$24128068$3$F$20220701$20240826$20240723$20240830$EXP$$CA-JNJFOC-20220820769$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240830$$HP$CA$CA
241280691$24128069$1$I$20240621$20240719$20240723$20240723$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700786$MYOVANT SCIENCES$$72$YR$$M$Y$$$20240723$$CN$US$US
241280701$24128070$1$I$$20240715$20240723$20240723$PER$$US-JNJFOC-20240742649$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$HP$US$US
241280713$24128071$3$F$20240717$20240718$20240723$20240729$PER$$US-JNJFOC-20240748904$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240730$$CN$US$US
241280721$24128072$1$I$$20240627$20240723$20240723$PER$$US-JNJFOC-20240700546$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$CN$US$US
241280732$24128073$2$F$20240715$20240814$20240723$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116767$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240821$$HP$US$US
241280741$24128074$1$I$$20240328$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007136$VANDA PHARMACEUTICALS$$$$$M$Y$49.433$KG$20240723$$CN$US$US
241280751$24128075$1$I$20180101$20240716$20240723$20240723$EXP$$CA-JNJFOC-20211149471$JOHNSON AND JOHNSON$$44$YR$A$M$Y$114$KG$20240722$$HP$CA$CA
241280761$24128076$1$I$$20240714$20240723$20240723$EXP$$CN-JNJFOC-20240752145$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240723$$HP$CN$CN
241280771$24128077$1$I$20240719$20240722$20240723$20240723$PER$$US-AMGEN-USASP2024145459$AMGEN$$56$YR$A$F$Y$$$20240723$$CN$US$US
241280781$24128078$1$I$$20240708$20240723$20240723$PER$$US-TEVA-VS-3219713$TEVA$$23$YR$$F$Y$$$20240723$$CN$US$US
241280791$24128079$1$I$20240101$20240716$20240723$20240723$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018966$UNITED THERAPEUTICS$$$$$F$Y$113.38$KG$20240723$$PH$US$US
241280801$24128080$1$I$$20240716$20240723$20240723$EXP$$JP-EXELIXIS-CABO-24079624$EXELIXIS$$6$DEC$$$Y$$$20240723$$MD$JP$JP
241280811$24128081$1$I$$20240709$20240723$20240723$PER$$US-MYLANLABS-2024M1065687$MYLAN$$$$$M$Y$$$20240723$$CN$US$US
241280821$24128082$1$I$20240101$20240717$20240723$20240723$EXP$$US-JNJFOC-20240747767$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$HP$US$US
241280832$24128083$2$F$20240531$20240806$20240723$20240806$EXP$$DE-SANDOZ INC.-SDZ2024DE066355$SANDOZ$$17$YR$$F$Y$63.9$KG$20240806$$MD$DE$DE
241280841$24128084$1$I$$20240717$20240723$20240723$EXP$$US-JNJFOC-20240748191$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240722$$HP$US$US
241280851$24128085$1$I$$20240627$20240723$20240723$PER$$US-JNJFOC-20240700650$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
241280861$24128086$1$I$$20240715$20240723$20240723$EXP$$SA-Amarin Pharma, Inc-2024AMR000354$AMARIN$$49$YR$A$M$Y$$$20240723$$MD$SA$SA
241280871$24128087$1$I$$20240719$20240723$20240723$EXP$$US-JNJFOC-20240752374$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
241280881$24128088$1$I$20240419$20240718$20240723$20240723$EXP$$CA-TAKEDA-2024TUS036014$TAKEDA$$60$YR$$M$Y$$$20240723$$CN$CA$CA
241280893$24128089$3$F$20240721$20240913$20240723$20240923$EXP$$US-JNJFOC-20240747768$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240924$$HP$US$US
241280902$24128090$2$F$$20240820$20240723$20240827$EXP$CA-DRL-USA-SPO/CAN/24/0010586$CA-RDY-SPO/CAN/24/0010586$DR REDDYS$$70$YR$E$F$Y$65$KG$20240827$$MD$CA$CA
241280911$24128091$1$I$$20240717$20240723$20240723$EXP$$US-TAKEDA-2023TUS090836$TAKEDA$$$$$M$Y$35.102$KG$20240723$$HP$US$US
241280921$24128092$1$I$$20240715$20240723$20240723$EXP$$DE-TAKEDA-2024TUS064087$TAKEDA$$33$YR$$F$Y$$$20240723$$HP$DE$DE
241280931$24128093$1$I$20240512$20240716$20240723$20240723$EXP$$BR-JNJFOC-20240755834$JOHNSON AND JOHNSON$$52$YR$A$F$Y$64$KG$20240722$$HP$BR$BR
241280943$24128094$3$F$20240101$20240918$20240723$20240926$EXP$$CA-JNJFOC-20240732572$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$HP$CA$CA
241280953$24128095$3$F$20240101$20240807$20240723$20240809$30DAY$$FI-JNJFOC-20240725657$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240809$$PH$FI$FI
241280961$24128096$1$I$$20240719$20240723$20240723$EXP$$US-ABBVIE-5847680$ABBVIE$$$$$$Y$$$20240723$$CN$US$US
241280971$24128097$1$I$$20240717$20240723$20240723$EXP$$US-JNJFOC-20240747877$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240722$$MD$US$US
241280981$24128098$1$I$$20240711$20240723$20240723$PER$$US-MYLANLABS-2024M1066066$MYLAN$$$$$M$Y$$$20240723$$CN$US$US
241280991$24128099$1$I$$20240712$20240723$20240723$PER$$US-VERTEX PHARMACEUTICALS-2024-011727$VERTEX$$$$$$Y$$$20240723$$CN$US$US
241281001$24128100$1$I$$20240712$20240723$20240723$PER$$US-VERTEX PHARMACEUTICALS-2024-011800$VERTEX$$$$$$Y$$$20240723$$CN$US$US
241281011$24128101$1$I$$20240712$20240723$20240723$PER$$US-VERTEX PHARMACEUTICALS-2024-011752$VERTEX$$$$$$Y$$$20240723$$CN$US$US
241281021$24128102$1$I$$20240711$20240723$20240723$PER$$US-VERTEX PHARMACEUTICALS-2024-007045$VERTEX$$$$A$$Y$$$20240723$$CN$US$US
241281031$24128103$1$I$$20240712$20240723$20240723$PER$$US-VERTEX PHARMACEUTICALS-2024-011678$VERTEX$$$$$$Y$$$20240723$$CN$US$US
241281041$24128104$1$I$$20240722$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US066996$SANDOZ$$81$YR$$M$Y$71.09$KG$20240723$$CN$US$US
241281051$24128105$1$I$$20240712$20240723$20240723$PER$$US-VERTEX PHARMACEUTICALS-2024-011666$VERTEX$$20$YR$$F$Y$$$20240723$$CN$US$US
241281061$24128106$1$I$$20240711$20240723$20240723$PER$$US-VERTEX PHARMACEUTICALS-2024-011686$VERTEX$$$$C$$Y$$$20240723$$HP$US$US
241281071$24128107$1$I$$20240712$20240723$20240723$PER$$US-VERTEX PHARMACEUTICALS-2024-011729$VERTEX$$$$$$Y$$$20240723$$CN$US$US
241281081$24128108$1$I$$20240717$20240723$20240723$EXP$$AU-VERTEX PHARMACEUTICALS-2024-011987$VERTEX$$$$T$F$Y$$$20240723$$HP$AU$AU
241281091$24128109$1$I$$20240712$20240723$20240723$PER$$US-VERTEX PHARMACEUTICALS-2018-005864$VERTEX$$$$$F$Y$$$20240723$$CN$US$US
241281101$24128110$1$I$$20240717$20240723$20240723$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011929$VERTEX$$$$A$M$Y$$$20240723$$CN$GB$GB
241281112$24128111$2$F$$20240902$20240723$20240906$EXP$$RU-VERTEX PHARMACEUTICALS-2024-011808$VERTEX$$11$YR$$F$Y$38$KG$20240906$$MD$RU$RU
241281121$24128112$1$I$$20240718$20240723$20240723$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012033$VERTEX$$$$$F$Y$$$20240723$$CN$GB$GB
241281132$24128113$2$F$$20240723$20240723$20240730$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-102417$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240730$$PH$DE$DE
241281141$24128114$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116726$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240723$$CN$US$US
241281161$24128116$1$I$$20211027$20240723$20240723$EXP$$US-AstraZeneca-2021A790005$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241281171$24128117$1$I$$20230227$20240723$20240723$EXP$$US-AstraZeneca-2023A048761$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241281181$24128118$1$I$20240701$20240716$20240723$20240723$EXP$$CA-JNJFOC-20240732249$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240722$$CN$CA$CA
241281191$24128119$1$I$20240101$20240716$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113568$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$97$KG$20240723$$PH$US$US
241281201$24128120$1$I$$20221206$20240723$20240723$EXP$$US-AstraZeneca-2022A400486$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241281211$24128121$1$I$$20210415$20240723$20240723$EXP$$ZA-AstraZeneca-2021A322364$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$ZA$
241281221$24128122$1$I$20221101$20230523$20240723$20240723$EXP$$US-AstraZeneca-2023A120235$ASTRAZENECA$$798$MON$$F$Y$$$20240723$$CN$US$
241281231$24128123$1$I$20240521$20240703$20240723$20240723$PER$$US-AstraZeneca-2024A162180$ASTRAZENECA$$68$YR$$F$Y$$$20240723$$CN$US$
241281242$24128124$2$F$$20240730$20240723$20240801$EXP$$US-JNJFOC-20240747887$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240801$$HP$US$US
241281251$24128125$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407009827$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240723$$HP$US$US
241281261$24128126$1$I$20240430$20240716$20240723$20240723$EXP$FR-AFSSAPS-TO2024001230$FR-ORGANON-O2407FRA001404$ORGANON$$75$YR$$M$Y$$$20240723$$PH$FR$FR
241281271$24128127$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013272$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240723$$CN$US$US
241281281$24128128$1$I$20240719$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013539$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240723$$CN$US$US
241281291$24128129$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013382$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240723$$CN$US$US
241281301$24128130$1$I$20240721$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014326$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240723$$CN$US$US
241281311$24128131$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013924$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$US$US
241281322$24128132$2$F$20240802$20240820$20240723$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202407012905$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240822$$CN$US$US
241281331$24128133$1$I$20240721$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014246$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240723$$CN$US$US
241281341$24128134$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014638$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240723$$CN$US$US
241281361$24128136$1$I$20240601$20240703$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407002694$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240723$$CN$US$US
241281372$24128137$2$F$20240627$20240926$20240723$20240930$PER$$US-JNJFOC-20240731945$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240930$$CN$US$US
241281381$24128138$1$I$20240613$20240718$20240723$20240723$EXP$$NZ-MYLANLABS-2024M1058364$MYLAN$$41$YR$$F$Y$127.9$KG$20240723$$HP$NZ$NZ
241281391$24128139$1$I$20240101$20240718$20240723$20240723$EXP$$GB-MYLANLABS-2024M1057751$MYLAN$$$$$M$Y$$$20240723$$HP$GB$GB
241281401$24128140$1$I$$20240719$20240723$20240723$EXP$$BE-JNJFOC-20240755722$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240722$$MD$BE$BE
241281411$24128141$1$I$$20240717$20240723$20240723$PER$$US-JNJFOC-20240744846$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$MD$US$US
241281431$24128143$1$I$20240101$20240628$20240723$20240723$PER$$US-JNJFOC-20240700381$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$CN$US$US
241281441$24128144$1$I$20240607$20240702$20240723$20240723$EXP$$DE-ROCHE-10000032805$ROCHE$$55$YR$A$M$Y$84$KG$20240723$$MD$DE$DE
241281451$24128145$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA209232$SANOFI AVENTIS$$$$A$F$Y$78$KG$20240723$$MD$US$US
241281472$24128147$2$F$20210801$20240725$20240723$20240731$EXP$$IN-SA-2024SA212822$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240731$$MD$IN$IN
241281481$24128148$1$I$20240601$20240716$20240723$20240723$PER$$US-SA-2024SA211981$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240723$$MD$US$US
241281491$24128149$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211356$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240723$$MD$US$US
241281501$24128150$1$I$20240701$20240719$20240723$20240723$PER$$US-JNJFOC-20240753683$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$CN$US$US
241281521$24128152$1$I$20240721$20240722$20240722$20240722$DIR$711133$$FDA-CTU$$73$MON$$M$N$67.5$KG$20240722$N$CN$US$
241281531$24128153$1$I$$20240718$20240723$20240723$PER$$US-JNJFOC-20240750308$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$MD$US$US
241281541$24128154$1$I$$20240717$20240723$20240723$EXP$$US-JNJFOC-20240748983$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$HP$US$US
241281551$24128155$1$I$20240722$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50626$$FDA-CTU$$71$YR$$M$N$$$20240723$Y$PH$US$
241281561$24128156$1$I$$20240722$20240722$20240722$DIR$711142$$FDA-CTU$$73$YR$$M$N$$$20240722$Y$PH$US$
241281571$24128157$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50667$$FDA-CTU$$88$YR$$F$N$$$20240723$N$$US$
241281581$24128158$1$I$$20240717$20240723$20240723$EXP$$US-JNJFOC-20240747698$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240722$$HP$US$US
241281591$24128159$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50582$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241281601$24128160$1$I$20240701$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50637$$FDA-CTU$$5$YR$$M$N$$$20240723$N$PH$US$
241281621$24128162$1$I$20230101$20240717$20240723$20240723$EXP$$US-009507513-2407USA011039$MERCK$Luong B, Koch G, Trivedi K, Ramachandran K.. Immune-Mediated Diabetes Mellitus, Diabetic Ketoacidosis, Enteritis, and Thrombotic Thrombocytopenic Purpura Presenting as Adverse Effects of Pembrolizumab Therapy. American journal of therapeutics. 2024;31 (4):e474-e475$73$YR$$F$Y$$$20240723$$HP$US$US
241281631$24128163$1$I$$20240711$20240723$20240723$PER$$US-JNJFOC-20240732258$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
241281641$24128164$1$I$$20240717$20240723$20240723$EXP$$US-ABBVIE-5844829$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241281652$24128165$2$F$20240605$20240724$20240723$20240727$EXP$$JP-JNJFOC-20240752740$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240727$$MD$JP$JP
241281662$24128166$2$F$20240201$20240801$20240723$20240809$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007261$AEGERION$$66$YR$$F$Y$$$20240809$$CN$US$US
241281671$24128167$1$I$$20240717$20240723$20240723$EXP$$US-OTSUKA-2024_020249$OTSUKA$$$$$M$Y$$$20240723$$CN$US$US
241281681$24128168$1$I$20240620$20240716$20240723$20240723$EXP$$US-ABBVIE-5817564$ABBVIE$$76$YR$$M$Y$107$KG$20240723$$CN$US$US
241281692$24128169$2$F$20240711$20240807$20240723$20240813$PER$$US-FreseniusKabi-FK202411307$FRESENIUS KABI$$$$$$Y$$$20240813$$MD$US$US
241281701$24128170$1$I$$20240715$20240723$20240723$EXP$$CA-JNJFOC-20240746009$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240722$$HP$CA$CA
241281731$24128173$1$I$$20240722$20240722$20240722$DIR$710953$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241281741$24128174$1$I$$20240709$20240723$20240723$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06674$LUPIN$Van Noord B, Samaan C, Flamm A. A case of delayed and immediate hypersensitivity reactions induced by corticosteroids. Dermatitis. 2024;35(2):191-192$71$YR$$M$Y$$$20240723$$MD$US$US
241281761$24128176$1$I$$20240718$20240723$20240723$PER$$US-JNJFOC-20240750550$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$HP$US$US
241281772$24128177$2$F$20240603$20240730$20240723$20240802$EXP$$FR-AMGEN-FRASP2024142108$AMGEN$$60$YR$A$M$Y$$$20240802$$MD$FR$FR
241281781$24128178$1$I$20240101$20240716$20240723$20240723$EXP$$US-JNJFOC-20240747943$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240722$$HP$US$US
241281791$24128179$1$I$20240716$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024142794$AMGEN$$70$YR$E$M$Y$$$20240723$$CN$US$US
241281802$24128180$2$F$$20240716$20240723$20240731$EXP$$US-009507513-2407USA011353$MERCK$Kuczmarski TM, Lynch RC.. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma. British Journal of Haematology. 2024;205(1):100-8$49$YR$$F$Y$$$20240731$$HP$US$US
241281811$24128181$1$I$$20240718$20240723$20240723$EXP$$US-009507513-2407USA012337$MERCK$Montag L, Piver R, Vidalin A, Johnson M, Rungruang B, Higgins R. Pembrolizumab-induced myasthenia gravis: Two patients^ experiences. Gynecologic Oncology Reports. 2024;54:1-4$85$YR$$F$Y$$$20240723$$HP$US$US
241281821$24128182$1$I$$20240718$20240723$20240723$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700758$MYOVANT SCIENCES$$$$$M$Y$$$20240723$$HP$US$US
241281831$24128183$1$I$$20240716$20240723$20240723$EXP$$JP-009507513-2407JPN003239J$MERCK$$59$YR$$F$Y$$$20240723$$MD$JP$JP
241281842$24128184$2$F$$20240821$20240723$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115823$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$113.4$KG$20240823$$CN$US$US
241281851$24128185$1$I$20240720$20240722$20240723$20240723$EXP$$CO-BAYER-2024A106725$BAYER$$53$YR$A$F$Y$$$20240723$$CN$CO$CO
241281862$24128186$2$F$$20240910$20240723$20240912$EXP$$CA-ROCHE-10000033012$ROCHE$$$$A$F$Y$$$20240912$$CN$CA$CA
241281871$24128187$1$I$20240706$20240722$20240723$20240723$EXP$FR-AFSSAPS-RS2024000728$NVSC2024FR149995$NOVARTIS$$53$YR$$M$Y$75.6$KG$20240723$$MD$FR$FR
241281881$24128188$1$I$20180401$20240708$20240723$20240723$EXP$$US-BRAINTREE LABORATORIES, INC.-2024BTE00422$BRAINTREE$$29$YR$$M$Y$63.503$KG$20240723$$CN$US$US
241281891$24128189$1$I$20240101$20240717$20240723$20240723$EXP$$US-ABBVIE-5845719$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241281902$24128190$2$F$20240715$20240805$20240723$20240812$PER$$US-SA-2024SA210780$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240812$$MD$US$US
241281911$24128191$1$I$$20240715$20240723$20240723$PER$$US-AMGEN-USASP2024141856$AMGEN$Korde N.. Phase II Clinical and Correlative Study of Carfilzomib, Lenalidomide, and Dexamethasone (CRd) in Newly Diagnosed Multiple Myeloma (MM) Patients. Blood. 2012;120 (21):732$$$$$Y$$$20240723$$MD$US$US
241281931$24128193$1$I$20240601$20240717$20240723$20240723$EXP$$CA-ABBVIE-5845672$ABBVIE$$$$A$F$Y$$$20240723$$CN$CA$CA
241281941$24128194$1$I$$20240702$20240723$20240723$PER$$US-009507513-2407USA009668$MERCK$Jamshidi F, Lozano L, Tucker B, Andorf J, Sohn E, Stone E, et al.. Belzutifan in Individuals with von Hippel-Lindau Retinal Hemangioblastomas: Institutional Experience and Review of the Literature. Ocular Oncology and Pathology. 2024;1-8$$$A$$Y$$$20240723$$HP$US$US
241281962$24128196$2$F$20240701$20240722$20240723$20240725$EXP$$BE-ABBVIE-5845890$ABBVIE$$$$E$M$Y$75$KG$20240725$$HP$BE$BE
241281971$24128197$1$I$$20240716$20240723$20240723$EXP$$US-ALXN-202407USA001126US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240723$$MD$US$US
241281981$24128198$1$I$20210101$20240715$20240723$20240723$EXP$$ES-JNJFOC-20240752966$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240722$$CN$ES$ES
241281992$24128199$2$F$20240621$20240722$20240723$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116819$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240809$$CN$US$US
241282001$24128200$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114764$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240723$$HP$US$US
241282011$24128201$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116825$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240723$$CN$US$US
241282021$24128202$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116286$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240723$$CN$US$US
241282031$24128203$1$I$$20240719$20240723$20240723$EXP$$US-GILEAD-2024-0681371$GILEAD$$$$E$M$Y$$$20240723$$HP$US$US
241282041$24128204$1$I$20240101$20240628$20240723$20240723$PER$$US-JNJFOC-20240700446$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240722$$CN$US$US
241282054$24128205$4$F$20240714$20240812$20240723$20240819$30DAY$$US-JNJFOC-20240738671$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240820$$CN$US$US
241282062$24128206$2$F$$20240920$20240723$20240923$EXP$$NVSC2024US149333$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
241282072$24128207$2$F$$20240821$20240723$20240823$30DAY$$DE-JNJFOC-20240747920$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$PH$DE$DE
241282081$24128208$1$I$$20240717$20240723$20240723$EXP$$AU-SANDOZ INC.-SDZ2024AU066860$SANDOZ$$73$YR$$M$Y$$$20240723$$MD$AU$AU
241282091$24128209$1$I$20240101$20240718$20240723$20240723$EXP$$US-ABBVIE-5846679$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241282102$24128210$2$F$$20240718$20240723$20240726$EXP$$IT-JNJFOC-20240755705$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$HP$IT$IT
241282112$24128211$2$F$20090101$20240823$20240723$20240828$EXP$$US-ABBVIE-5847029$ABBVIE$$$$$M$Y$108.86$KG$20240828$$CN$US$US
241282121$24128212$1$I$20240101$20240716$20240723$20240723$EXP$$US-JNJFOC-20240744484$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240722$$HP$US$US
241282132$24128213$2$F$20240715$20240723$20240723$20240726$PER$$US-JNJFOC-20240738260$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240726$$CN$US$US
241282141$24128214$1$I$$20240717$20240723$20240723$PER$$US-Taiho Oncology Inc-2024-007022$TAIHO ONCOLOGY INC$$62$YR$A$F$Y$77.11$KG$20240723$$CN$US$US
241282152$24128215$2$F$$20240731$20240723$20240802$PER$$US-Taiho Oncology Inc-2024-007056$TAIHO ONCOLOGY INC$$80$YR$E$M$Y$$$20240802$$CN$US$US
241282161$24128216$1$I$$20240711$20240723$20240723$EXP$$US-JNJFOC-20240754535$JOHNSON AND JOHNSON$$61$YR$A$M$Y$74.2$KG$20240722$$CN$US$US
241282171$24128217$1$I$$20240715$20240723$20240723$PER$$US-JNJFOC-20240738132$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$CN$US$US
241282182$24128218$2$F$20240101$20240904$20240723$20240916$PER$$US-SA-2024SA211431$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240916$$MD$US$US
241282191$24128219$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210798$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241282202$24128220$2$F$$20240730$20240723$20240802$30DAY$$GB-JNJFOC-20240748213$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$GB$GB
241282211$24128221$1$I$20240501$20240722$20240723$20240723$EXP$$US-JNJFOC-20240757556$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240723$$CN$US$US
241282221$24128222$1$I$$20240709$20240723$20240723$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092294$GLENMARK$Dilibe A, Subramanian L, Poyser TA, Oriaifo O, Brady R, Srikanth S. Tacrolimus-induced posterior reversible encephalopathy syndrome following liver transplantation. World journal of transplantation.. 2024;14 (2):91146$$$$$Y$$$20240723$$MD$US$US
241282231$24128223$1$I$$20240722$20240722$20240722$DIR$711088$$FDA-CTU$$$$$F$N$$$20240722$N$$US$
241282241$24128224$1$I$20240626$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50668$$FDA-CTU$$66$YR$$F$N$$$20240723$N$HP$US$
241282251$24128225$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50670$$FDA-CTU$$73$YR$$F$N$$$20240723$N$$US$
241282262$24128226$2$F$$20240801$20240723$20240806$EXP$$CA-MYLANLABS-2024M1068300$MYLAN$$$$$$Y$$$20240806$$CN$CA$CA
241282272$24128227$2$F$20240722$20240819$20240723$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116872$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240822$$CN$US$US
241282281$24128228$1$I$20240716$20240716$20240723$20240723$PER$$US-JNJFOC-20240744391$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$PH$US$US
241282291$24128229$1$I$$20240716$20240723$20240723$EXP$$LB-ROCHE-10000028716$ROCHE$$$$A$M$Y$$$20240723$$MD$LB$LB
241282302$24128230$2$F$20210801$20240724$20240723$20240731$EXP$$BR-TAKEDA-2023TUS075501$TAKEDA$$57$YR$$M$Y$62$KG$20240731$$CN$BR$BR
241282311$24128231$1$I$$20240719$20240723$20240723$EXP$GB-MHRA-MED-202407181431113190-NHRFC$GB-JNJFOC-20240752808$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240722$$HP$GB$GB
241282322$24128232$2$F$$20240730$20240723$20240805$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-116700$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240805$$MD$IL$IL
241282341$24128234$1$I$$20240722$20240722$20240722$DIR$710963$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241282351$24128235$1$I$$20240722$20240722$20240722$DIR$710997$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241282361$24128236$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50673$$FDA-CTU$$68$YR$$F$N$$$20240723$N$HP$US$
241282371$24128237$1$I$20240716$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024141973$AMGEN$$72$YR$E$$Y$$$20240723$$CN$US$US
241282381$24128238$1$I$$20240717$20240723$20240723$PER$$US-JNJFOC-20240746012$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$HP$US$US
241282401$24128240$1$I$$20240717$20240723$20240723$EXP$$US-JNJFOC-20240746467$JOHNSON AND JOHNSON$$$$$F$Y$$$20240722$$HP$US$US
241282411$24128241$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142828$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240723$$MD$US$US
241282421$24128242$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142619$AMGEN$Dean R.M;. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240723$$MD$US$US
241282431$24128243$1$I$$20240715$20240723$20240723$EXP$$NL-JNJFOC-20240747311$JOHNSON AND JOHNSON$$67$YR$E$F$Y$82$KG$20240723$$HP$NL$NL
241282441$24128244$1$I$20220708$20240716$20240723$20240723$EXP$$JP-JNJFOC-20240752880$JOHNSON AND JOHNSON$$89$YR$E$F$Y$45.2$KG$20240722$$MD$JP$JP
241282452$24128245$2$F$20240618$20240701$20240723$20240808$EXP$GB-MHRA-TPP61840023C11097060YC1719228836778$GB-ORGANON-O2407GBR002087$ORGANON$$86$YR$$F$Y$$$20240808$$MD$GB$GB
241282462$24128246$2$F$$20240829$20240723$20240829$30DAY$$CL-PFIZER INC-202400220836$PFIZER$$10$YR$$$Y$$$20240829$$CN$CL$CL
241282491$24128249$1$I$20140101$20240717$20240723$20240723$PER$$US-JNJFOC-20240750892$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240722$$HP$US$US
241282501$24128250$1$I$$20240715$20240723$20240723$EXP$$SK-JNJFOC-20240741132$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240722$$MD$SK$SK
241282511$24128251$1$I$20210120$20240715$20240723$20240723$EXP$$FR-AMGEN-FRANI2024140501$AMGEN$$51$YR$A$F$Y$$$20240723$$HP$FR$FR
241282521$24128252$1$I$$20210209$20240723$20240723$EXP$$US-AstraZeneca-2021A049125$ASTRAZENECA$$45$YR$$F$Y$$$20240723$$CN$US$
241282531$24128253$1$I$$20220621$20240723$20240723$EXP$$US-AstraZeneca-2022A229619$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241282542$24128254$2$F$20240701$20240823$20240723$20240904$PER$$US-AstraZeneca-2024A163582$ASTRAZENECA$$811$MON$$F$Y$$$20240904$$CN$US$
241282551$24128255$1$I$$20230105$20240723$20240723$EXP$$US-AstraZeneca-2023A004277$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241282561$24128256$1$I$20190114$20240715$20240723$20240723$EXP$FR-AFSSAPS-MP20190156$FR-BAXTER-2024BAX021651$BAXTER$$50$YR$$F$Y$72.5$KG$20240723$$MD$FR$FR
241282571$24128257$1$I$20240418$20240715$20240723$20240723$EXP$$GR-BAXTER-2024BAX021698$BAXTER$$68$YR$$M$Y$74.3$KG$20240723$$MD$GR$GR
241282581$24128258$1$I$$20240715$20240723$20240723$EXP$$BE-BAXTER-2024BAX021710$BAXTER$$$$$M$Y$$$20240723$$CN$BE$BE
241282591$24128259$1$I$20240111$20240715$20240723$20240723$EXP$ES-AEMPS-1547832$ES-BAXTER-2024BAX021629$BAXTER$$77$YR$$F$Y$45.5$KG$20240723$$MD$ES$ES
241282601$24128260$1$I$$20220610$20240723$20240723$EXP$$US-AstraZeneca-2022A176719$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241282611$24128261$1$I$$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A165749$ASTRAZENECA$$$$$$Y$$$20240723$$MD$US$
241282621$24128262$1$I$$20210529$20240723$20240723$EXP$$US-AstraZeneca-2021A488680$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241282631$24128263$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A162555$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241282641$24128264$1$I$$20220811$20240723$20240723$EXP$$US-AstraZeneca-2022A285044$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241282651$24128265$1$I$$20210426$20240723$20240723$EXP$$CA-AstraZeneca-2021A366823$ASTRAZENECA$$49$YR$$M$Y$$$20240723$$MD$CA$
241282661$24128266$1$I$20240501$20240719$20240723$20240723$PER$$US-AstraZeneca-2024A165735$ASTRAZENECA$$41$YR$$F$Y$$$20240723$$HP$US$
241282671$24128267$1$I$$20230815$20240723$20240723$EXP$$US-AstraZeneca-2023A186623$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241282691$24128269$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50672$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241282711$24128271$1$I$$20240722$20240722$20240722$DIR$710979$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241282731$24128273$1$I$$20240722$20240722$20240722$DIR$710970$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241282741$24128274$1$I$$20240722$20240722$20240722$DIR$711008$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241282751$24128275$1$I$$20240722$20240722$20240722$DIR$710965$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241282761$24128276$1$I$$20230613$20240723$20240723$EXP$$US-AstraZeneca-2023A137483$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241282771$24128277$1$I$20240418$20240716$20240723$20240723$EXP$FR-AFSSAPS-MP2024001149$FR-BAXTER-2024BAX021688$BAXTER$$1$YR$$M$Y$11.5$KG$20240723$$MD$FR$FR
241282781$24128278$1$I$$20240716$20240723$20240723$EXP$$CA-BAXTER-2024BAX021771$BAXTER$$40$YR$$M$Y$$$20240723$$HP$CA$CA
241282791$24128279$1$I$20240601$20240722$20240723$20240723$EXP$GB-MHRA-31183311$GB-ABBVIE-5848673$ABBVIE$$57$YR$$M$Y$$$20240723$$PH$GB$GB
241282801$24128280$1$I$$20240716$20240723$20240723$PER$$US-ABBVIE-5849227$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241282811$24128281$1$I$$20210419$20240723$20240723$EXP$$US-AstraZeneca-2021A343817$ASTRAZENECA$$$$$M$Y$75.3$KG$20240723$$CN$US$
241282821$24128282$1$I$$20240715$20240723$20240723$EXP$$PL-AMGEN-POLSP2024140753$AMGEN$$63$YR$A$F$Y$$$20240723$$MD$PL$PL
241282831$24128283$1$I$$20240716$20240723$20240723$EXP$$CA-BAXTER-2024BAX021773$BAXTER$$65$YR$$F$Y$34$KG$20240723$$HP$CA$CA
241282841$24128284$1$I$$20221018$20240723$20240723$EXP$$US-AstraZeneca-2022A350690$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241282852$24128285$2$F$$20240802$20240723$20240807$EXP$$CA-JNJFOC-20240749260$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240807$$HP$CA$CA
241282862$24128286$2$F$20240716$20240819$20240723$20240822$PER$$US-JNJFOC-20240745385$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240822$$PH$US$US
241282871$24128287$1$I$20240101$20240708$20240723$20240723$PER$$US-JNJFOC-20240751452$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240723$$PH$US$US
241282881$24128288$1$I$$20240718$20240723$20240723$PER$$US-JNJFOC-20240750194$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
241282891$24128289$1$I$$20240715$20240723$20240723$EXP$$ZA-AstraZeneca-2024A161245$ASTRAZENECA$$84$YR$$F$Y$$$20240723$$CN$ZA$
241282901$24128290$1$I$$20240710$20240723$20240723$EXP$$US-MYLANLABS-2024M1066219$MYLAN$Heard S, Lin J. Systemic Allergic Reaction to a Spinal Cord Stimulator Trial: A Case Report. Pain-Med-Case-Rep 2023; 7 (3): 121-124.$52$YR$$F$Y$$$20240723$$HP$US$US
241282911$24128291$1$I$$20240718$20240723$20240723$EXP$$CA-AstraZeneca-2024A165769$ASTRAZENECA$$$$$$Y$$$20240723$$MD$CA$
241282931$24128293$1$I$$20240716$20240723$20240723$EXP$$US-BAXTER-2024BAX021776$BAXTER$$29$YR$$F$Y$$$20240723$$HP$US$US
241282941$24128294$1$I$20240101$20240718$20240723$20240723$EXP$$JP-AstraZeneca-2024A165998$ASTRAZENECA$$80$YR$$M$Y$$$20240723$$MD$JP$
241282951$24128295$1$I$$20240715$20240723$20240723$EXP$$CA-AstraZeneca-2024A162435$ASTRAZENECA$$$$$$Y$$$20240723$$MD$CA$
241282961$24128296$1$I$20231108$20240715$20240723$20240723$EXP$$US-BAXTER-2024BAX021621$BAXTER$$62$YR$$M$Y$93$KG$20240723$$HP$US$US
241282971$24128297$1$I$20240709$20240717$20240723$20240723$EXP$$US-GILEAD-2024-0681293$GILEAD$$5$YR$C$M$Y$$$20240723$$CN$US$US
241282981$24128298$1$I$20240713$20240718$20240723$20240723$EXP$$CO-AstraZeneca-2024A165313$ASTRAZENECA$$22999$DY$$F$Y$$$20240723$$CN$CO$
241282991$24128299$1$I$20240508$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A164662$ASTRAZENECA$$$$$$Y$$$20240723$$CN$US$
241283001$24128300$1$I$$20240716$20240723$20240723$EXP$$US-ABBVIE-5845084$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241283011$24128301$1$I$20240101$20240715$20240723$20240723$EXP$$DE-AstraZeneca-2024A086738$ASTRAZENECA$$29018$DY$$M$Y$75$KG$20240723$$MD$DE$
241283021$24128302$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161390$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241283031$24128303$1$I$20240615$20240719$20240723$20240723$EXP$$TR-GSK-TR2024TRK091567$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$TR$TR
241283041$24128304$1$I$20240619$20240715$20240723$20240723$PER$$US-SA-2024SA210679$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240723$$CN$US$US
241283051$24128305$1$I$$20240709$20240723$20240723$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092295$GLENMARK$Nguyen C, Stanek JL. Sternomanubrial joint pain secondary to ulcerative colitis treated with ultrasound-guided injection.. PM and R.. 2024;16 (6):650-2$$$$$Y$$$20240723$$MD$US$US
241283061$24128306$1$I$20240601$20240712$20240723$20240723$PER$$US-SA-2024SA206058$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240723$$MD$US$US
241283071$24128307$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA212872$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240723$$CN$US$US
241283082$24128308$2$F$20240101$20240727$20240723$20240730$PER$$US-ABBVIE-5848241$ABBVIE$$$$$F$Y$61$KG$20240730$$CN$US$US
241283091$24128309$1$I$$20240722$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US067381$SANDOZ$$$$$F$Y$$$20240723$$CN$US$US
241283101$24128310$1$I$20200503$20240715$20240723$20240723$EXP$PL-URPL-1-3709-2020$PL-JNJFOC-20240740230$JOHNSON AND JOHNSON$$26$YR$A$F$Y$53$KG$20240723$$MD$PL$PL
241283111$24128311$1$I$20240723$20240723$20240723$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041450$BOEHRINGER INGELHEIM$$81$YR$E$$Y$$$20240723$$CN$US$US
241283121$24128312$1$I$20240720$20240722$20240723$20240723$PER$$US-BAYER-2024A106157$BAYER$$87$YR$E$M$Y$$$20240723$$CN$US$US
241283131$24128313$1$I$$20240711$20240723$20240723$EXP$$US-MYLANLABS-2024M1066549$MYLAN$Admane S, Clark M, Bruera E, Reddy A. Caught in the Name Game: Navigating the Data Linkage Conundrum. J-Pain-Symptom-Manage 2024; 68 (1): e79-e81.$55$YR$$F$Y$$$20240723$$MD$US$US
241283141$24128314$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115380$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240723$$CN$US$US
241283151$24128315$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116800$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240723$$CN$US$US
241283161$24128316$1$I$$20240715$20240723$20240723$EXP$$ZA-AstraZeneca-2024A161693$ASTRAZENECA$$63$YR$$F$Y$$$20240723$$CN$ZA$
241283171$24128317$1$I$$20210421$20240723$20240723$EXP$$GB-AstraZeneca-2021A351641$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$GB$
241283181$24128318$1$I$$20240718$20240723$20240723$EXP$$US-AstraZeneca-2024A165855$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241283191$24128319$1$I$20211216$20211216$20240723$20240723$EXP$$US-AstraZeneca-2021A882840$ASTRAZENECA$$83$YR$$M$Y$62.4$KG$20240723$$CN$US$
241283201$24128320$1$I$$20240718$20240723$20240723$PER$$US-GILEAD-2024-0681313$GILEAD$$50$YR$A$M$Y$$$20240723$$MD$US$US
241283211$24128321$1$I$20240501$20240716$20240723$20240723$PER$$US-TAKEDA-2024TUS072425$TAKEDA$$33$YR$$F$Y$66$KG$20240723$$MD$US$US
241283221$24128322$1$I$$20240715$20240723$20240723$EXP$$CA-AstraZeneca-2024A166512$ASTRAZENECA$$65$YR$$F$Y$34$KG$20240723$$MD$CA$
241283231$24128323$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142840$AMGEN$Dean R. M.;. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240723$$MD$US$US
241283241$24128324$1$I$20240101$20240716$20240723$20240723$EXP$$RU-009507513-2407RUS011466$MERCK$$76$YR$$F$Y$$$20240723$$HP$RU$RU
241283251$24128325$1$I$20240701$20240716$20240723$20240723$EXP$$US-VIIV HEALTHCARE LIMITED-US2024089528$VIIV$$$$$$Y$$$20240723$$CN$US$US
241283263$24128326$3$F$$20240829$20240723$20240905$30DAY$$BR-JNJFOC-20240713276$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$PH$BR$BR
241283271$24128327$1$I$$20240628$20240723$20240723$PER$$US-JNJFOC-20240748972$JOHNSON AND JOHNSON$$$$$M$Y$$$20240722$$CN$US$US
241283282$24128328$2$F$$20240822$20240723$20240829$EXP$$BE-TEVA-VS-3220740$TEVA$Struys I, Velazquez C, Ubels J, Van Leeuwen A, Ghosh M, Geurts J, et al. CHEMOTHERAPY during PREGNANCY IS ASSOCIATED with INCREASED GENOTOXICITY and MUTATIONAL LOAD in the FETAL HEMATOPOIETIC COMPARTMENT. Int-J-Gynecol-Cancer 2023; 33 (Suppl.) A210-A211 abstr. 506.; Struys I, Velazquez C, Ubels J, Van Leeuwen A, Ghosh M, Geurts J, et al. CHEMOTHERAPY during PREGNANCY IS ASSOCIATED with INCREASED GENOTOXICITY and MUTATIONAL LOAD in the FETAL HEMATOPOIETIC COMPARTMENT. Int-J-Gynecol-Cancer 2023...$$$$$Y$$$20240829$$HP$BE$BE
241283291$24128329$1$I$$20240720$20240723$20240723$PER$$US-TAKEDA-2024TUS073863$TAKEDA$$$$$$Y$$$20240723$$CN$US$US
241283301$24128330$1$I$$20240722$20240723$20240723$PER$$US-BAYER-2024A106159$BAYER$$$$$F$Y$$$20240723$$CN$US$US
241283313$24128331$3$F$20240717$20240719$20240723$20240904$PER$$NVSC2024US149093$NOVARTIS$$11$YR$$M$Y$$$20240904$$CN$US$US
241283321$24128332$1$I$20240601$20240716$20240723$20240723$EXP$$CO-JNJFOC-20240745866$JOHNSON AND JOHNSON$$67$YR$E$F$Y$92$KG$20240722$$HP$CO$CO
241283331$24128333$1$I$$20240716$20240723$20240723$EXP$$NVSC2024MX149652$NOVARTIS$$$$$M$Y$70$KG$20240723$$CN$MX$MX
241283341$24128334$1$I$$20240722$20240723$20240723$PER$$NVSC2024US150874$NOVARTIS$$$$$M$Y$$$20240723$$CN$US$US
241283351$24128335$1$I$$20240717$20240723$20240723$PER$$US-AMGEN-USASP2024144185$AMGEN$$$$$$Y$$$20240723$$MD$US$US
241283361$24128336$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115360$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240723$$CN$US$US
241283371$24128337$1$I$20240701$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116772$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240723$$CN$US$US
241283381$24128338$1$I$$20240714$20240723$20240723$EXP$$CN-JNJFOC-20240739974$JOHNSON AND JOHNSON$$$$$$Y$$$20240722$$HP$CN$CN
241283391$24128339$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142818$AMGEN$Dean R. M.;. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240723$$MD$US$US
241283401$24128340$1$I$20240701$20240718$20240723$20240723$PER$$US-JNJFOC-20240750996$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240723$$HP$US$US
241283412$24128341$2$F$20240201$20240801$20240723$20240808$PER$$US-BAYER-2024A104078$BAYER$$28$YR$A$F$Y$$$20240808$$HP$US$US
241283431$24128343$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142845$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240723$$MD$US$US
241283441$24128344$1$I$20140101$20240715$20240723$20240723$EXP$$CN-009507513-2407CHN011564$MERCK$$$$A$M$Y$74$KG$20240723$$HP$CN$CN
241283451$24128345$1$I$20240619$20240717$20240723$20240723$EXP$$JP-GSK-JP2024091427$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$JP$JP
241283461$24128346$1$I$20240701$20240719$20240723$20240723$EXP$$AU-VIIV HEALTHCARE LIMITED-AU2024APC091520$VIIV$$$$$$Y$$$20240723$$PH$AU$AU
241283471$24128347$1$I$20240711$20240716$20240723$20240723$PER$$US-ABBVIE-5843888$ABBVIE$$27$YR$$F$Y$$$20240723$$CN$US$US
241283481$24128348$1$I$$20240710$20240723$20240723$EXP$$MX-BIOMARINAP-MX-2024-159313$BIOMARIN$$$$$$Y$$$20240723$$CN$US$MX
241283491$24128349$1$I$$20240722$20240723$20240723$EXP$$US-BAUSCH-BL-2024-011221$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240723$$CN$US$US
241283501$24128350$1$I$$20240716$20240723$20240723$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR090345$VIIV$$$$$$Y$$$20240723$$MD$US$US
241283511$24128351$1$I$20240718$20240718$20240723$20240723$PER$$US-JNJFOC-20240749481$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240723$$PH$US$US
241283521$24128352$1$I$20240701$20240717$20240723$20240723$EXP$$CA-JNJFOC-20240748814$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240723$$HP$CA$CA
241283531$24128353$1$I$$20240702$20240723$20240723$PER$$US-JNJFOC-20240710899$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240723$$CN$US$US
241283541$24128354$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116126$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240723$$CN$US$US
241283551$24128355$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116774$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240723$$CN$US$US
241283561$24128356$1$I$$20240722$20240723$20240723$PER$$NVSC2024US151001$NOVARTIS$$$$$$Y$37.642$KG$20240723$$CN$US$US
241283581$24128358$1$I$20240721$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116924$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240723$$CN$US$US
241283591$24128359$1$I$$20240715$20240723$20240723$PER$$US-ROCHE-10000030711$ROCHE$Deshpande A,  Delayed-onset serum sickness due to rituximab in pemphigus vulgaris. Indian J Drugs in Dermatol. 2019;5 (1):54.$17$YR$T$M$Y$$$20240723$$HP$US$US
241283612$24128361$2$F$$20240805$20240723$20240807$PER$$US-PFIZER INC-PV202400095543$PFIZER$$74$YR$$M$Y$$$20240807$$HP$US$US
241283622$24128362$2$F$$20240828$20240723$20240904$PER$$US-PFIZER INC-PV202400086516$PFIZER$$64$YR$$M$Y$$$20240904$$CN$US$US
241283631$24128363$1$I$$20240715$20240723$20240723$EXP$$CA-BAUSCH-BL-2024-010790$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240723$$HP$CA$CA
241283651$24128365$1$I$20240701$20240719$20240723$20240723$PER$$US-PFIZER INC-PV202400095264$PFIZER$$69$YR$$F$Y$$$20240723$$HP$US$US
241283681$24128368$1$I$$20240722$20240722$20240722$DIR$711010$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241283691$24128369$1$I$$20240718$20240723$20240723$EXP$$US-GILEAD-2024-0681346$GILEAD$$$$E$M$Y$$$20240723$$CN$US$US
241283701$24128370$1$I$20240715$20240722$20240722$20240722$DIR$711110$$FDA-CTU$$54$YR$$M$N$69.75$KG$20240722$N$CN$US$
241283711$24128371$1$I$$20240711$20240723$20240723$PER$$US-SA-2022SA456209$SANOFI AVENTIS$$$$A$M$Y$$$20240723$$MD$US$US
241283721$24128372$1$I$$20240718$20240723$20240723$EXP$$NZ-TAKEDA-2024TUS072971$TAKEDA$$$$$$Y$$$20240723$$MD$NZ$NZ
241283731$24128373$1$I$$20240716$20240723$20240723$EXP$$US-ABBVIE-5849535$ABBVIE$$$$E$$Y$$$20240723$$CN$US$US
241283742$24128374$2$F$$20240724$20240723$20240801$EXP$$NL-AstraZeneca-2024A160742$ASTRAZENECA$$75$YR$$M$Y$88.7$KG$20240801$$MD$NL$
241283752$24128375$2$F$$20240830$20240723$20240904$EXP$$JP-PFIZER INC-202400220428$PFIZER$$$$$$Y$$$20240904$$PH$JP$JP
241283762$24128376$2$F$20240718$20240726$20240723$20240729$EXP$$TW-PFIZER INC-202400219821$PFIZER$$40$YR$$F$Y$$$20240729$$PH$TW$TW
241283772$24128377$2$F$$20240723$20240723$20240724$EXP$$US-PFIZER INC-PV202400096022$PFIZER$$61$YR$$M$Y$$$20240724$$CN$US$US
241283781$24128378$1$I$20240710$20240718$20240723$20240723$EXP$$FR-AstraZeneca-2024A163853$ASTRAZENECA$$$$A$F$Y$$$20240723$$MD$FR$
241283791$24128379$1$I$20240101$20240715$20240723$20240723$PER$$US-SA-2024SA210919$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240723$$MD$US$US
241283801$24128380$1$I$$20240719$20240723$20240723$EXP$$TN-PFIZER INC-202400220548$PFIZER$$$$$$Y$$$20240723$$MD$TN$TN
241283811$24128381$1$I$$20240722$20240723$20240723$EXP$$JP-PFIZER INC-202400220471$PFIZER$$$$E$$Y$$$20240723$$MD$JP$JP
241283822$24128382$2$F$20240707$20240731$20240723$20240805$EXP$$ES-PFIZER INC-202400220377$PFIZER$$68$YR$$M$Y$$$20240805$$PH$ES$ES
241283832$24128383$2$F$20240702$20240819$20240723$20240826$30DAY$$DE-PFIZER INC-202400218613$PFIZER$$$$$M$Y$$$20240826$$PH$DE$DE
241283841$24128384$1$I$20240714$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A162775$ASTRAZENECA$$21817$DY$$F$Y$$$20240723$$CN$US$
241283851$24128385$1$I$20240708$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A162609$ASTRAZENECA$$30628$DY$$F$Y$$$20240723$$CN$US$
241283861$24128386$1$I$$20240715$20240723$20240723$EXP$$RU-AstraZeneca-2024A166093$ASTRAZENECA$Ignatova GL, Antonov VN. Fixed combination of glycopyrronium bromide / indacaterol / mometasone in patients with severe uncontrolled asthma. RMJ 2024;6:16-20.$$$$F$Y$78$KG$20240723$$HP$RU$
241283871$24128387$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A161362$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241283881$24128388$1$I$$20240715$20240723$20240723$EXP$$AT-AstraZeneca-2024A161709$ASTRAZENECA$Scherr S., Ksiazek S.H., Schwarz C., S?emann M.D.. SGLT2 Inhibitor Use for Treatment of Hypocitraturia in a Distal Renal Tubular Acidosis. Kidney Medicine 2024;6(7):$50$YR$$M$Y$$$20240723$$MD$AT$
241283891$24128389$1$I$20240101$20240715$20240723$20240723$EXP$$TH-AstraZeneca-2024A165294$ASTRAZENECA$$21393$DY$$M$Y$$$20240723$$CN$TH$
241283901$24128390$1$I$$20240715$20240723$20240723$EXP$$US-AMGEN-USASP2024142855$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240723$$MD$US$US
241283911$24128391$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A143873$ASTRAZENECA$$$$$F$Y$64.4$KG$20240723$$MD$US$
241283921$24128392$1$I$$20240719$20240723$20240723$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-12478$IPSEN$$$$$M$Y$$$20240723$$CN$GB$GB
241283932$24128393$2$F$20240723$20240919$20240723$20240920$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041471$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240920$$CN$US$US
241283941$24128394$1$I$$20240722$20240723$20240723$EXP$$CN-VANTIVE-2024VAN018537$Vantive US Healthcare$$$$$M$Y$$$20240723$$CN$CN$CN
241283951$24128395$1$I$$20240718$20240723$20240723$EXP$$AU-GE HEALTHCARE-2024CSU008170$GE HEALTHCARE$$39$YR$$F$Y$$$20240723$$HP$AU$AU
241283961$24128396$1$I$20240706$20240715$20240723$20240723$EXP$$CN-AstraZeneca-2024A163874$ASTRAZENECA$$27144$DY$$M$Y$76$KG$20240723$$MD$CN$
241283972$24128397$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3220247$TEVA$Torrado C, Baysal MA, Chakraborty A, Norris BL, Khawaja F, Tsimberidou AM. Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy. Front-Immunol 2024; 15.; Torrado C, Baysal MA, Chakraborty A, Norris BL, Khawaja F, Tsimberidou AM. Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy. Front-Immunol 2024; 15.; Torrado C, Baysal MA, Chakraborty A, No...$$$A$M$Y$$$20240819$$HP$US$US
241283981$24128398$1$I$$20240722$20240723$20240723$EXP$$US-BAUSCH-BL-2024-011237$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240723$$HP$US$US
241283991$24128399$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA210822$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240723$$MD$US$US
241284001$24128400$1$I$$20240228$20240723$20240723$PER$$US-VANDA PHARMACEUTICALS, INC-2024TASUS007152$VANDA PHARMACEUTICALS$$$$$M$Y$145.6$KG$20240723$$CN$US$US
241284011$24128401$1$I$20240722$20240722$20240722$20240722$DIR$711113$$FDA-CTU$$67$YR$$F$N$104.85$KG$20240722$N$PH$US$
241284021$24128402$1$I$20240720$20240722$20240722$20240722$DIR$711062$$FDA-CTU$$77$YR$$M$N$78$KG$20240722$N$$US$
241284031$24128403$1$I$$20240722$20240722$20240722$DIR$710996$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241284041$24128404$1$I$20240601$20240722$20240722$20240722$DIR$711029$$FDA-CTU$$53$YR$$F$N$55.35$KG$20240722$N$CN$US$
241284051$24128405$1$I$$20240722$20240722$20240722$DIR$711006$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241284061$24128406$1$I$20231001$20240722$20240722$20240722$DIR$711116$$FDA-CTU$$54$YR$$F$N$$$20240722$N$CN$US$
241284071$24128407$1$I$$20240722$20240722$20240722$DIR$710969$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241284081$24128408$1$I$20240722$20240722$20240722$20240722$DIR$711052$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241284091$24128409$1$I$20240701$20240716$20240723$20240723$EXP$$US-ARGENX-2024-ARGX-US005649$ARGENX BVBA$$$$$$Y$$$20240723$$PH$US$US
241284101$24128410$1$I$20240701$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116871$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240723$$CN$US$US
241284121$24128412$1$I$20240708$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116576$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240723$$HP$US$US
241284131$24128413$1$I$$20240719$20240723$20240723$EXP$$LB-BRISTOL-MYERS SQUIBB COMPANY-2024-115827$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$LB$LB
241284151$24128415$1$I$$20240716$20240723$20240723$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003873$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
241284161$24128416$1$I$20240605$20240717$20240723$20240723$EXP$$CN-JNJFOC-20240748267$JOHNSON AND JOHNSON$$6$MON$I$F$Y$6.35$KG$20240723$$HP$CN$CN
241284171$24128417$1$I$20240708$20240717$20240723$20240723$EXP$$AE-JNJFOC-20240745387$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240723$$MD$AE$AE
241284181$24128418$1$I$$20240719$20240723$20240723$PER$$NVSC2024US150607$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
241284191$24128419$1$I$20240605$20240719$20240723$20240723$EXP$$US-OTSUKA-2024_020329$OTSUKA$$87$YR$$F$Y$$$20240723$$CN$US$US
241284201$24128420$1$I$20240701$20240715$20240723$20240723$PER$$US-MYLANLABS-2024M1066482$MYLAN$$58$YR$$F$Y$$$20240723$$CN$US$US
241284211$24128421$1$I$20240718$20240718$20240723$20240723$EXP$$CO-ABBVIE-5849714$ABBVIE$$77$YR$$M$Y$61$KG$20240723$$HP$CO$CO
241284221$24128422$1$I$20240613$20240715$20240723$20240723$EXP$FR-AFSSAPS-GR2024000860$FR-TEVA-VS-3221881$TEVA$$32$YR$$M$Y$76$KG$20240723$$PH$FR$FR
241284231$24128423$1$I$$20240719$20240723$20240723$EXP$$BG-ABBVIE-5847095$ABBVIE$$76$YR$$M$Y$$$20240723$$HP$BG$BG
241284241$24128424$1$I$$20240723$20240723$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041464$BOEHRINGER INGELHEIM$$$$$$Y$$$20240723$$CN$US$US
241284251$24128425$1$I$$20240722$20240723$20240723$PER$$US-HALEON-2188406$Haleon PLC$$$$$F$Y$$$20240723$$CN$US$US
241284261$24128426$1$I$$20240711$20240723$20240723$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06924$NEUROCRINE BIOSCIENCES$$19$YR$$F$Y$$$20240723$$MD$US$US
241284271$24128427$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240759609$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240723$$PH$US$US
241284281$24128428$1$I$20240201$20240718$20240723$20240723$PER$$US-PFIZER INC-202400219691$PFIZER$$9$YR$$F$Y$$$20240723$$CN$US$US
241284291$24128429$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114215$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240719$$CN$US$US
241284301$24128430$1$I$$20240722$20240722$20240722$DIR$711063$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241284311$24128431$1$I$$20240716$20240723$20240723$EXP$$US-GSK-US2024089565$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
241284321$24128432$1$I$$20240722$20240722$20240722$DIR$711001$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241284331$24128433$1$I$$20240722$20240722$20240722$DIR$710974$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241284342$24128434$2$F$20240718$20240829$20240723$20240903$EXP$$US-OTSUKA-2024_020337$OTSUKA$$73$YR$$M$Y$$$20240903$$PH$US$US
241284352$24128435$2$F$20210101$20240809$20240723$20240819$EXP$$US-TEVA-VS-3219742$TEVA$Schumaier NP, Heidemann DG, Gupta C. Durvalumab-associated limbal stem cell deficiency and secondary corneal perforation. Am-J-Ophthalmol-Case-Rep 2024; 35.; Schumaier NP, Heidemann DG, Gupta C. Durvalumab-associated limbal stem cell deficiency and secondary corneal perforation. Am-J-Ophthalmol-Case-Rep 2024; 35.$65$YR$$M$Y$$$20240819$$HP$US$US
241284371$24128437$1$I$$20240717$20240723$20240723$EXP$$US-MYLANLABS-2024M1067341$MYLAN$$82$YR$$F$Y$$$20240723$$CN$US$US
241284381$24128438$1$I$$20240712$20240723$20240723$EXP$$CN-JNJFOC-20240744664$JOHNSON AND JOHNSON$$$$$$Y$$$20240719$$HP$CN$CN
241284391$24128439$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114955$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240719$$CN$US$US
241284402$24128440$2$F$$20240817$20240723$20240827$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007265$AEGERION$$$$$F$Y$73.016$KG$20240827$$CN$US$US
241284411$24128441$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114025$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240719$$HP$US$US
241284421$24128442$1$I$$20240718$20240723$20240723$EXP$$US-009507513-2407USA012660$MERCK$Montag L, Piver R, Vidalin A, Johnson M, Rungruang B, Higgins R. Pembrolizumab-induced myasthenia gravis: Two patients^ experiences. Gynecologic Oncology Reports. 2024;54:1-4$80$YR$$F$Y$$$20240723$$HP$US$US
241284431$24128443$1$I$$20240702$20240723$20240723$PER$$US-009507513-2407USA009669$MERCK$Jamshidi F, Lozano L, Tucker B, Andorf J, Sohn E, Stone E, et al.. Belzutifan in Individuals with von Hippel-Lindau Retinal Hemangioblastomas: Institutional Experience and Review of the Literature. Ocular Oncology and Pathology. 2024;1-8$$$A$$Y$$$20240723$$HP$US$US
241284441$24128444$1$I$$20240710$20240723$20240723$EXP$$AU-AstraZeneca-2024A159433$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$AU$
241284451$24128445$1$I$$20220809$20240723$20240723$EXP$$US-AstraZeneca-2022A283974$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241284462$24128446$2$F$20240709$20240827$20240723$20240903$EXP$$US-AstraZeneca-2024A161737$ASTRAZENECA$$20035$DY$$F$Y$$$20240903$$MD$US$
241284471$24128447$1$I$$20240716$20240723$20240723$EXP$$US-PERRIGO-24US006792$PERRIGO$$$$A$$Y$$$20240723$$CN$US$US
241284481$24128448$1$I$20240605$20240716$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113660$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240719$$HP$US$US
241284491$24128449$1$I$$20240711$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407007810$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$US$US
241284502$24128450$2$F$20240722$20240723$20240723$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407013938$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240726$$CN$US$US
241284511$24128451$1$I$20240722$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014678$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240723$$CN$US$US
241284521$24128452$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013461$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240723$$CN$US$US
241284531$24128453$1$I$20240711$20240711$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008052$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240723$$CN$US$US
241284541$24128454$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014649$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240723$$CN$US$US
241284551$24128455$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013147$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240723$$CN$US$US
241284561$24128456$1$I$20240619$20240715$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407009971$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240723$$CN$US$US
241284571$24128457$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014072$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240723$$PH$US$US
241284593$24128459$3$F$20240101$20240813$20240723$20240814$EXP$$MX-JNJFOC-20240753332$JOHNSON AND JOHNSON$$25$YR$A$F$Y$75$KG$20240814$$CN$MX$MX
241284611$24128461$1$I$$20240716$20240723$20240723$EXP$$NVSC2024IT131316$NOVARTIS$$$$A$F$Y$$$20240723$$MD$IT$IT
241284621$24128462$1$I$20240508$20240716$20240723$20240723$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-114813$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240719$$PH$GB$GB
241284631$24128463$1$I$20240618$20240718$20240723$20240723$EXP$$IT-AMERICAN REGENT INC-2024002791$AMERICAN REGENT$$44$YR$$F$Y$$$20240723$$MD$IT$IT
241284642$24128464$2$F$20230617$20240830$20240723$20240908$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113319$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$38$KG$20240909$$MD$JP$JP
241284651$24128465$1$I$20240612$20240717$20240723$20240723$EXP$$US-ABBVIE-5845224$ABBVIE$$61$YR$$F$Y$$$20240723$$CN$US$US
241284661$24128466$1$I$$20240716$20240723$20240723$EXP$$GB-JNJFOC-20240751070$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240719$$CN$GB$GB
241284673$24128467$3$F$20240611$20240913$20240723$20240919$EXP$$US-ABBVIE-5845880$ABBVIE$$67$YR$$F$Y$$$20240919$$CN$US$US
241284681$24128468$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114488$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$113.4$KG$20240719$$CN$US$US
241284691$24128469$1$I$20240601$20240718$20240723$20240723$EXP$$US-ABBVIE-5846163$ABBVIE$$53$YR$$F$Y$$$20240723$$CN$US$US
241284701$24128470$1$I$20240719$20240722$20240722$20240722$DIR$711040$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241284711$24128471$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114526$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240719$$HP$US$US
241284721$24128472$1$I$20240702$20240718$20240723$20240723$PER$$US-BAYER-2024A105324$BAYER$$29$YR$A$F$Y$$$20240723$$MD$US$US
241284731$24128473$1$I$$20240722$20240723$20240723$PER$$US-BAYER-2024A106171$BAYER$$$$$$Y$$$20240723$$CN$US$US
241284751$24128475$1$I$20240101$20240717$20240723$20240723$PER$$US-SA-2024SA212604$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240723$$MD$US$US
241284761$24128476$1$I$20240701$20240711$20240723$20240723$PER$$US-SA-2024SA211005$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240723$$MD$US$US
241284772$24128477$2$F$20240101$20240726$20240723$20240806$30DAY$$US-ALKERMES INC.-ALK-2024-001868$ALKERMES$$$$$$Y$$$20240806$$HP$US$US
241284792$24128479$2$F$$20240815$20240723$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114469$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240821$$CN$US$US
241284801$24128480$1$I$$20240717$20240723$20240723$PER$$US-BAYER-2024A104586$BAYER$$56$YR$A$M$Y$$$20240723$$CN$US$US
241284833$24128483$3$F$$20240905$20240723$20240911$EXP$$PT-MYLANLABS-2024M1067161$MYLAN$Valente CT, Tenreiro P, Figueiredo RS, et al. A case of toxidermia to imatinib. Congresses of the Portuguese Society of Internal Medicine. 2024;1470$76$YR$$F$Y$$$20240911$$MD$PT$PT
241284842$24128484$2$F$$20240823$20240723$20240828$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-100525$REGENERON$$86$YR$$F$Y$$$20240828$$HP$CH$CH
241284851$24128485$1$I$$20240715$20240723$20240723$EXP$$US-MYLANLABS-2024M1067203$MYLAN$O^Meara KT, Fansiwala K, Kathuria-Prakash N, El-Masry M, Oh S. Acute hypoxic respiratory failure due to Lenalidomide-induced interstitial pneumonitis in a patient with multiple myeloma. BMC-Pulm-Med 2024; 24 (1): 321.$80$YR$$M$Y$$$20240723$$HP$US$US
241284862$24128486$2$F$$20240802$20240723$20240808$EXP$$FR-MYLANLABS-2024M1061585$MYLAN$Sztejkowski C., Sibilia J., Danion F., Mertz P., Elodie F., Kassegne L. et al. Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event. Rheumatology. 2024;63(6):e185-e187$52$YR$$F$Y$$$20240808$$HP$FR$FR
241284871$24128487$1$I$20240611$20240718$20240723$20240723$EXP$$FR-PFIZER INC-202400218261$PFIZER$$58$YR$$F$Y$$$20240723$$MD$FR$FR
241284882$24128488$2$F$20240101$20240815$20240723$20240819$EXP$$US-PFIZER INC-PV202400094898$PFIZER$$71$YR$$F$Y$$$20240819$$HP$US$US
241284892$24128489$2$F$$20240723$20240723$20240726$EXP$$US-PFIZER INC-202400220405$PFIZER$Vrionis, A.. Images in Anesthesiology: Carotid Sinus Reflex From Neck Mass and Opioids. Cureus. 2024;16(6):e62048$74$YR$$M$Y$$$20240726$$HP$US$US
241284904$24128490$4$F$20240701$20240905$20240723$20240909$EXP$$US-PFIZER INC-PV202400095119$PFIZER$$62$YR$$F$Y$$$20240909$$HP$US$US
241284921$24128492$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115017$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240719$$HP$US$US
241284941$24128494$1$I$$20240717$20240723$20240723$EXP$$US-ABBVIE-5845288$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241284951$24128495$1$I$$20240221$20240723$20240723$PER$$US-NOVOPROD-1164557$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241284961$24128496$1$I$$20231205$20240723$20240723$PER$$US-NOVOPROD-1153167$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241284971$24128497$1$I$20231217$20231220$20240723$20240723$PER$$US-NOVOPROD-1156501$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241284981$24128498$1$I$$20240111$20240723$20240723$PER$$US-NOVOPROD-1164109$NOVO NORDISK$$$$$M$Y$$$20240723$$MD$US$US
241284991$24128499$1$I$$20240126$20240723$20240723$PER$$US-NOVOPROD-1169817$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241285001$24128500$1$I$$20231212$20240723$20240723$PER$$US-NOVOPROD-1152411$NOVO NORDISK$$$$$M$Y$$$20240723$$HP$US$US
241285011$24128501$1$I$20220101$20240122$20240723$20240723$PER$$US-NOVOPROD-1159710$NOVO NORDISK$$83$YR$$F$Y$$$20240723$$CN$US$US
241285021$24128502$1$I$20230901$20231213$20240723$20240723$PER$$US-NOVOPROD-1152565$NOVO NORDISK$$70$YR$$F$Y$$$20240723$$CN$US$US
241285031$24128503$1$I$20240115$20240125$20240723$20240723$PER$$US-NOVOPROD-1169027$NOVO NORDISK$$68$YR$$F$Y$$$20240723$$CN$US$US
241285041$24128504$1$I$$20240221$20240723$20240723$PER$$US-NOVOPROD-1151212$NOVO NORDISK$$60$YR$$M$Y$$$20240723$$MD$US$US
241285051$24128505$1$I$$20231220$20240723$20240723$PER$$US-NOVOPROD-1154755$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241285061$24128506$1$I$20230524$20240102$20240723$20240723$PER$$US-NOVOPROD-1150803$NOVO NORDISK$$59$YR$$M$Y$$$20240723$$HP$US$US
241285082$24128508$2$F$20230401$20240515$20240723$20240723$PER$$US-NOVOPROD-1087610$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241285091$24128509$1$I$$20240401$20240723$20240723$PER$$US-NOVOPROD-1159304$NOVO NORDISK$$66$YR$$F$Y$$$20240723$$MD$US$US
241285101$24128510$1$I$20231001$20240328$20240723$20240723$PER$$US-NOVOPROD-1150837$NOVO NORDISK$$76$YR$$F$Y$$$20240723$$CN$US$US
241285111$24128511$1$I$$20240103$20240723$20240723$PER$$US-NOVOPROD-1160531$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241285121$24128512$1$I$20230701$20230713$20240723$20240723$PER$$US-NOVOPROD-1094745$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241285131$24128513$1$I$20240106$20240112$20240723$20240723$PER$$US-NOVOPROD-1164939$NOVO NORDISK$$68$YR$$M$Y$$$20240723$$CN$US$US
241285141$24128514$1$I$$20240110$20240723$20240723$PER$$US-NOVOPROD-1162546$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241285151$24128515$1$I$$20231204$20240723$20240723$PER$$US-NOVOPROD-1149678$NOVO NORDISK$$77$YR$$F$Y$$$20240723$$CN$US$US
241285161$24128516$1$I$20230901$20240109$20240723$20240723$PER$$US-NOVOPROD-1153967$NOVO NORDISK$$69$YR$$F$Y$$$20240723$$CN$US$US
241285171$24128517$1$I$20231101$20240607$20240723$20240723$PER$$US-NOVOPROD-1152457$NOVO NORDISK$$69$YR$$F$Y$$$20240723$$CN$US$US
241285181$24128518$1$I$$20240716$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114446$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240719$$CN$US$US
241285191$24128519$1$I$20231223$20231228$20240723$20240723$PER$$US-NOVOPROD-1158829$NOVO NORDISK$$60$YR$$F$Y$$$20240723$$CN$US$US
241285201$24128520$1$I$$20240112$20240723$20240723$PER$$US-NOVOPROD-1163800$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241285211$24128521$1$I$$20240112$20240723$20240723$PER$$US-NOVOPROD-1163801$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241285221$24128522$1$I$20231127$20240301$20240723$20240723$PER$$US-NOVOPROD-1169138$NOVO NORDISK$$76$YR$$F$Y$$$20240723$$CN$US$US
241285231$24128523$1$I$20220101$20240223$20240723$20240723$PER$$US-NOVOPROD-1159041$NOVO NORDISK$$70$YR$$F$Y$$$20240723$$CN$US$US
241285241$24128524$1$I$20220601$20240129$20240723$20240723$PER$$US-NOVOPROD-1152335$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241285251$24128525$1$I$20231101$20240223$20240723$20240723$PER$$US-NOVOPROD-1165572$NOVO NORDISK$$63$YR$$$Y$$$20240723$$HP$US$US
241285262$24128526$2$F$20230601$20231209$20240723$20240723$PER$$US-NOVOPROD-1169472$NOVO NORDISK$$77$YR$$M$Y$$$20240723$$CN$US$US
241285271$24128527$1$I$20231021$20240126$20240723$20240723$PER$$US-NOVOPROD-1168906$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241285281$24128528$1$I$$20230601$20240723$20240723$PER$$US-NOVOPROD-1168354$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241285291$24128529$1$I$$20240102$20240723$20240723$PER$$US-NOVOPROD-1159686$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241285301$24128530$1$I$$20240530$20240723$20240723$PER$$US-NOVOPROD-1169517$NOVO NORDISK$$$$$$Y$$$20240723$$HP$US$US
241285311$24128531$1$I$20231201$20240228$20240723$20240723$PER$$US-NOVOPROD-1163459$NOVO NORDISK$$$$$F$Y$$$20240723$$HP$US$US
241285321$24128532$1$I$$20240509$20240723$20240723$PER$$US-NOVOPROD-1085300$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241285332$24128533$2$F$20240106$20240506$20240723$20240723$PER$$US-NOVOPROD-1162383$NOVO NORDISK$$69$YR$$F$Y$$$20240723$$CN$US$US
241285341$24128534$1$I$20231001$20240703$20240723$20240723$PER$$US-NOVOPROD-1161374$NOVO NORDISK$$68$YR$$F$Y$$$20240723$$CN$US$US
241285351$24128535$1$I$$20240108$20240723$20240723$PER$$US-NOVOPROD-1162197$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241285362$24128536$2$F$$20230915$20240723$20240723$PER$$US-NOVOPROD-1120130$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241285371$24128537$1$I$20230601$20240112$20240723$20240723$PER$$US-NOVOPROD-1154402$NOVO NORDISK$$71$YR$$M$Y$$$20240723$$CN$US$US
241285381$24128538$1$I$20240101$20240118$20240723$20240723$PER$$US-NOVOPROD-1167641$NOVO NORDISK$$65$YR$$F$Y$$$20240723$$CN$US$US
241285391$24128539$1$I$$20231205$20240723$20240723$PER$$US-NOVOPROD-1149422$NOVO NORDISK$$$$$M$Y$$$20240723$$MD$US$US
241285401$24128540$1$I$20240501$20240718$20240723$20240723$EXP$$SA-AMERICAN REGENT INC-2024002787$AMERICAN REGENT$$49$YR$$F$Y$62$KG$20240723$$MD$SA$SA
241285411$24128541$1$I$$20240530$20240723$20240723$PER$$US-NOVOPROD-1168513$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241285421$24128542$1$I$$20240112$20240723$20240723$PER$$US-NOVOPROD-1165020$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241285431$24128543$1$I$$20240125$20240723$20240723$PER$$US-NOVOPROD-1168861$NOVO NORDISK$$$$A$$Y$$$20240723$$CN$US$US
241285441$24128544$1$I$20240120$20240304$20240723$20240723$PER$$US-NOVOPROD-1169427$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241285451$24128545$1$I$20240116$20240229$20240723$20240723$PER$$US-NOVOPROD-1169627$NOVO NORDISK$$71$YR$$M$Y$111$KG$20240723$$MD$US$US
241285461$24128546$1$I$20231212$20240205$20240723$20240723$PER$$US-NOVOPROD-1156442$NOVO NORDISK$$40$YR$$M$Y$$$20240723$$CN$US$US
241285471$24128547$1$I$$20240102$20240723$20240723$PER$$US-NOVOPROD-1160284$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241285481$24128548$1$I$$20240530$20240723$20240723$PER$$US-NOVOPROD-1169516$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241285491$24128549$1$I$$20240205$20240723$20240723$PER$$US-NOVOPROD-1153481$NOVO NORDISK$$69$YR$$M$Y$$$20240723$$CN$US$US
241285501$24128550$1$I$20230501$20230629$20240723$20240723$PER$$US-NOVOPROD-1165592$NOVO NORDISK$$84$YR$$$Y$$$20240723$$CN$US$US
241285511$24128551$1$I$$20231206$20240723$20240723$PER$$US-NOVOPROD-1150873$NOVO NORDISK$$50$YR$$M$Y$$$20240723$$MD$US$US
241285521$24128552$1$I$$20240719$20240723$20240723$PER$$US-JNJFOC-20240757392$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
241285533$24128553$3$F$20180101$20240801$20240723$20240808$EXP$$US-SA-2024SA213009$SANOFI AVENTIS$$41$YR$A$F$Y$11.3$KG$20240808$$MD$US$US
241285541$24128554$1$I$$20240717$20240723$20240723$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-113986$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240719$$HP$PR$PR
241285561$24128556$1$I$$20240722$20240723$20240723$EXP$$CN-TAKEDA-2024TUS074264$TAKEDA$$$$$F$Y$$$20240723$$CN$CN$CN
241285571$24128557$1$I$$20240715$20240723$20240723$EXP$$GB-TEVA-VS-3221731$TEVA$$60$YR$$M$Y$93$KG$20240723$$MD$GB$GB
241285582$24128558$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3219757$TEVA$Kobayashi T, Ford B, Diekema DJ, Sekar P. Disseminated Mycobacterium chimaera infection successfully treated with a clofazimine-containing regimen and long-term follow-up after discontinuing treatment. IDCases 2024; 36 1-4.; Kobayashi T, Ford B, Diekema DJ, Sekar P. Disseminated Mycobacterium chimaera infection successfully treated with a clofazimine-containing regimen and long-term follow-up after discontinuing treatment. IDCases 2024; 36 1-4.$67$YR$$M$Y$$$20240819$$HP$US$US
241285591$24128559$1$I$20240720$20240722$20240722$20240722$DIR$711027$$FDA-CTU$$28$YR$$F$N$72$KG$20240722$N$CN$US$
241285601$24128560$1$I$$20240722$20240722$20240722$DIR$710964$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241285611$24128561$1$I$20240720$20240722$20240722$20240722$DIR$711072$$FDA-CTU$$73$YR$$M$N$72$KG$20240722$N$CN$US$
241285621$24128562$1$I$20240705$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50689$$FDA-CTU$$77$YR$$F$N$$$20240723$Y$HP$US$
241285631$24128563$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50690$$FDA-CTU$$49$YR$$F$N$87.09$KG$20240723$N$$US$
241285641$24128564$1$I$20240722$20240722$20240722$20240722$DIR$711135$$FDA-CTU$$60$YR$$F$N$111.15$KG$20240722$N$CN$US$
241285651$24128565$1$I$$20240722$20240722$20240722$DIR$711004$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241285671$24128567$1$I$20240717$20240722$20240722$20240722$DIR$711081$$FDA-CTU$$62$YR$$F$N$95.4$KG$20240722$N$CN$US$
241285681$24128568$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50691$$FDA-CTU$$49$YR$$F$N$$$20240723$N$$US$
241285701$24128570$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50676$$FDA-CTU$$62$YR$$F$N$$$20240723$N$$US$
241285721$24128572$1$I$20240629$20240719$20240723$20240723$EXP$$JP-BAYER-2024A106309$BAYER$$65$YR$E$F$Y$$$20240723$$HP$JP$JP
241285731$24128573$1$I$$20240506$20240723$20240723$PER$$US-NOVOPROD-1229345$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241285741$24128574$1$I$$20240414$20240723$20240723$PER$$US-NOVOPROD-1212134$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241285751$24128575$1$I$20240217$20240301$20240723$20240723$PER$$US-NOVOPROD-1186334$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241285761$24128576$1$I$20240404$20240520$20240723$20240723$PER$$US-NOVOPROD-1216542$NOVO NORDISK$$90$YR$$F$Y$$$20240723$$CN$US$US
241285771$24128577$1$I$20240219$20240319$20240723$20240723$PER$$US-NOVOPROD-1194891$NOVO NORDISK$$64$YR$$F$Y$$$20240723$$CN$US$US
241285782$24128578$2$F$20240422$20240507$20240723$20240723$PER$$US-NOVOPROD-1214425$NOVO NORDISK$$$$$F$Y$$$20240723$$PH$US$US
241285791$24128579$1$I$$20240226$20240723$20240723$PER$$US-NOVOPROD-1184448$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241285801$24128580$1$I$20240419$20240425$20240723$20240723$PER$$US-NOVOPROD-1216432$NOVO NORDISK$$59$YR$$M$Y$$$20240723$$CN$US$US
241285811$24128581$1$I$$20240228$20240723$20240723$PER$$US-NOVOPROD-1184790$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241285821$24128582$1$I$$20240428$20240723$20240723$PER$$US-NOVOPROD-1214725$NOVO NORDISK$$$$A$M$Y$$$20240723$$CN$US$US
241285831$24128583$1$I$$20240422$20240723$20240723$PER$$US-NOVOPROD-1176433$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241285841$24128584$1$I$20240206$20240226$20240723$20240723$PER$$US-NOVOPROD-1184566$NOVO NORDISK$$55$YR$$F$Y$$$20240723$$CN$US$US
241285851$24128585$1$I$$20240207$20240723$20240723$PER$$US-NOVOPROD-1175391$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241285861$24128586$1$I$20240101$20240521$20240723$20240723$PER$$US-NOVOPROD-1226846$NOVO NORDISK$$$$$F$Y$$$20240723$$MD$US$US
241285871$24128587$1$I$$20240509$20240723$20240723$PER$$US-NOVOPROD-1224782$NOVO NORDISK$$$$$M$Y$$$20240723$$HP$US$US
241285883$24128588$3$F$20231223$20240524$20240723$20240723$PER$$US-NOVOPROD-1171018$NOVO NORDISK$$74$YR$$M$Y$$$20240723$$CN$US$US
241285892$24128589$2$F$$20240520$20240723$20240723$PER$$US-NOVOPROD-1229269$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241285901$24128590$1$I$20240222$20240324$20240723$20240723$PER$$US-NOVOPROD-1196597$NOVO NORDISK$$81$YR$$M$Y$$$20240723$$CN$US$US
241285911$24128591$1$I$20220101$20240222$20240723$20240723$PER$$US-NOVOPROD-1182843$NOVO NORDISK$$70$YR$$F$Y$$$20240723$$CN$US$US
241285921$24128592$1$I$$20240213$20240723$20240723$PER$$US-NOVOPROD-1178233$NOVO NORDISK$$$$A$M$Y$$$20240723$$CN$US$US
241285931$24128593$1$I$$20230815$20240723$20240723$PER$$US-NOVOPROD-1225366$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241285941$24128594$1$I$$20240312$20240723$20240723$PER$$US-NOVOPROD-1193053$NOVO NORDISK$$$$A$M$Y$$$20240723$$CN$US$US
241285951$24128595$1$I$$20230905$20240723$20240723$PER$$US-NOVOPROD-1223548$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241285961$24128596$1$I$20220101$20240502$20240723$20240723$PER$$US-NOVOPROD-1220312$NOVO NORDISK$$67$YR$$F$Y$$$20240723$$CN$US$US
241285971$24128597$1$I$$20240523$20240723$20240723$PER$$US-NOVOPROD-1231649$NOVO NORDISK$$$$A$M$Y$$$20240723$$CN$US$US
241285981$24128598$1$I$$20240513$20240723$20240723$PER$$US-NOVOPROD-1224542$NOVO NORDISK$$45$YR$$F$Y$$$20240723$$HP$US$US
241285991$24128599$1$I$$20240319$20240723$20240723$PER$$US-NOVOPROD-1173534$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286001$24128600$1$I$$20230921$20240723$20240723$PER$$US-NOVOPROD-1228720$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241286011$24128601$1$I$$20240530$20240723$20240723$PER$$US-NOVOPROD-1223772$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241286021$24128602$1$I$20240708$20240710$20240723$20240723$DIR$FDA-CDER-CTU-2024-50692$$FDA-CTU$$65$YR$$M$N$117.93$KG$20240710$Y$HP$US$
241286031$24128603$1$I$$20240306$20240723$20240723$PER$$US-NOVOPROD-1188809$NOVO NORDISK$$$$A$F$Y$$$20240723$$HP$US$US
241286041$24128604$1$I$$20240517$20240723$20240723$PER$$US-NOVOPROD-1246665$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286051$24128605$1$I$$20240530$20240723$20240723$PER$$US-NOVOPROD-1235864$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286061$24128606$1$I$20240417$20240418$20240723$20240723$PER$$US-NOVOPROD-1213684$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241286071$24128607$1$I$20240201$20240227$20240723$20240723$PER$$US-NOVOPROD-1184190$NOVO NORDISK$$70$YR$$M$Y$$$20240723$$HP$US$US
241286082$24128608$2$F$$20240418$20240723$20240723$PER$$US-NOVOPROD-1215219$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241286092$24128609$2$F$20230101$20240528$20240723$20240723$PER$$US-NOVOPROD-1233666$NOVO NORDISK$$49$YR$$F$Y$$$20240723$$CN$US$US
241286101$24128610$1$I$$20240301$20240723$20240723$PER$$US-NOVOPROD-1188802$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286111$24128611$1$I$$20240212$20240723$20240723$PER$$US-NOVOPROD-1207516$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241286121$24128612$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50677$$FDA-CTU$$70$YR$$F$N$$$20240723$N$$US$
241286131$24128613$1$I$20231029$20240321$20240723$20240723$PER$$US-NOVOPROD-1171054$NOVO NORDISK$$58$YR$$M$Y$92.517$KG$20240723$$PH$US$US
241286141$24128614$1$I$$20240528$20240723$20240723$PER$$US-NOVOPROD-1236653$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241286152$24128615$2$F$$20230714$20240723$20240723$PER$$US-NOVOPROD-1205670$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241286161$24128616$1$I$20240512$20240514$20240723$20240723$PER$$US-NOVOPROD-1227252$NOVO NORDISK$$72$YR$$F$Y$$$20240723$$CN$US$US
241286171$24128617$1$I$$20240209$20240723$20240723$PER$$US-NOVOPROD-1176770$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286181$24128618$1$I$$20240508$20240723$20240723$PER$$US-NOVOPROD-1190669$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286191$24128619$1$I$$20240228$20240723$20240723$PER$$US-NOVOPROD-1184809$NOVO NORDISK$$$$$F$Y$$$20240723$$PH$US$US
241286201$24128620$1$I$20240204$20240209$20240723$20240723$PER$$US-NOVOPROD-1176324$NOVO NORDISK$$69$YR$$M$Y$$$20240723$$CN$US$US
241286211$24128621$1$I$$20240408$20240723$20240723$PER$$US-NOVOPROD-1181088$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286221$24128622$1$I$$20240315$20240723$20240723$PER$$US-NOVOPROD-1243371$NOVO NORDISK$$$$$M$Y$$$20240723$$MD$US$US
241286231$24128623$1$I$$20240515$20240723$20240723$PER$$US-NOVOPROD-1227133$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286241$24128624$1$I$$20240326$20240723$20240723$PER$$US-NOVOPROD-1198592$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241286253$24128625$3$F$20231214$20240304$20240723$20240723$PER$$US-NOVOPROD-1176068$NOVO NORDISK$$78$YR$$F$Y$$$20240723$$CN$US$US
241286261$24128626$1$I$20231003$20240506$20240723$20240723$PER$$US-NOVOPROD-1185484$NOVO NORDISK$$72$YR$$F$Y$$$20240723$$CN$US$US
241286271$24128627$1$I$$20240312$20240723$20240723$PER$$US-NOVOPROD-1190566$NOVO NORDISK$$$$$F$Y$$$20240723$$MD$US$US
241286281$24128628$1$I$20240405$20240527$20240723$20240723$PER$$US-NOVOPROD-1222789$NOVO NORDISK$$70$YR$$F$Y$$$20240723$$CN$US$US
241286291$24128629$1$I$$20240410$20240723$20240723$PER$$US-NOVOPROD-1209053$NOVO NORDISK$$$$$M$Y$$$20240723$$HP$US$US
241286301$24128630$1$I$$20240327$20240723$20240723$PER$$US-NOVOPROD-1198676$NOVO NORDISK$$56$YR$$M$Y$$$20240723$$PH$US$US
241286311$24128631$1$I$20240313$20240430$20240723$20240723$PER$$US-NOVOPROD-1188810$NOVO NORDISK$$70$YR$$F$Y$$$20240723$$MD$US$US
241286321$24128632$1$I$20240503$20240529$20240723$20240723$PER$$US-NOVOPROD-1234356$NOVO NORDISK$$63$YR$$F$Y$$$20240723$$CN$US$US
241286331$24128633$1$I$$20240307$20240723$20240723$PER$$US-NOVOPROD-1189982$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286341$24128634$1$I$$20230720$20240723$20240723$PER$$US-NOVOPROD-1208771$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241286351$24128635$1$I$20220101$20240409$20240723$20240723$PER$$US-NOVOPROD-1208760$NOVO NORDISK$$49$YR$$F$Y$$$20240723$$CN$US$US
241286361$24128636$1$I$20240422$20240503$20240723$20240723$PER$$US-NOVOPROD-1220902$NOVO NORDISK$$69$YR$$F$Y$$$20240723$$CN$US$US
241286371$24128637$1$I$$20240419$20240723$20240723$PER$$US-NOVOPROD-1215471$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286381$24128638$1$I$$20230801$20240723$20240723$PER$$US-NOVOPROD-1227491$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286391$24128639$1$I$$20240227$20240723$20240723$PER$$US-NOVOPROD-1185559$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241286401$24128640$1$I$20240310$20240507$20240723$20240723$PER$$US-NOVOPROD-1204802$NOVO NORDISK$$61$YR$$$Y$63.95$KG$20240723$$MD$US$US
241286411$24128641$1$I$20240101$20240404$20240723$20240723$PER$$US-NOVOPROD-1204858$NOVO NORDISK$$55$YR$$F$Y$$$20240723$$CN$US$US
241286421$24128642$1$I$$20240420$20240723$20240723$PER$$US-NOVOPROD-1210328$NOVO NORDISK$$58$YR$$F$Y$$$20240723$$MD$US$US
241286431$24128643$1$I$$20240215$20240723$20240723$PER$$US-NOVOPROD-1179841$NOVO NORDISK$$$$E$$Y$$$20240723$$CN$US$US
241286441$24128644$1$I$20230601$20240408$20240723$20240723$PER$$US-NOVOPROD-1172012$NOVO NORDISK$$75$YR$$M$Y$$$20240723$$CN$US$US
241286451$24128645$1$I$20240205$20240212$20240723$20240723$PER$$US-NOVOPROD-1177094$NOVO NORDISK$$64$YR$$M$Y$$$20240723$$CN$US$US
241286461$24128646$1$I$$20240306$20240723$20240723$PER$$US-NOVOPROD-1188555$NOVO NORDISK$$76$YR$$M$Y$$$20240723$$CN$US$US
241286471$24128647$1$I$$20240528$20240723$20240723$PER$$US-NOVOPROD-1234487$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286481$24128648$1$I$$20240311$20240723$20240723$PER$$US-NOVOPROD-1190302$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286491$24128649$1$I$$20240312$20240723$20240723$PER$$US-NOVOPROD-1190477$NOVO NORDISK$$$$$M$Y$$$20240723$$MD$US$US
241286501$24128650$1$I$20210101$20240308$20240723$20240723$PER$$US-NOVOPROD-1188472$NOVO NORDISK$$64$YR$$F$Y$$$20240723$$CN$US$US
241286511$24128651$1$I$20240423$20240513$20240723$20240723$PER$$US-NOVOPROD-1226154$NOVO NORDISK$$77$YR$$M$Y$$$20240723$$CN$US$US
241286521$24128652$1$I$$20240529$20240723$20240723$PER$$US-NOVOPROD-1235205$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286531$24128653$1$I$20240328$20240516$20240723$20240723$PER$$US-NOVOPROD-1220557$NOVO NORDISK$$68$YR$$M$Y$$$20240723$$CN$US$US
241286541$24128654$1$I$$20230808$20240723$20240723$PER$$US-NOVOPROD-1219886$NOVO NORDISK$$70$YR$$F$Y$$$20240723$$CN$US$US
241286551$24128655$1$I$20240327$20240420$20240723$20240723$PER$$US-NOVOPROD-1214355$NOVO NORDISK$$72$YR$$F$Y$$$20240723$$CN$US$US
241286561$24128656$1$I$$20240429$20240723$20240723$PER$$US-NOVOPROD-1216609$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241286571$24128657$1$I$$20240201$20240723$20240723$PER$$US-NOVOPROD-1171922$NOVO NORDISK$$$$$M$Y$$$20240723$$MD$US$US
241286581$24128658$1$I$$20240419$20240723$20240723$PER$$US-NOVOPROD-1210206$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241286591$24128659$1$I$$20240426$20240723$20240723$PER$$US-NOVOPROD-1214888$NOVO NORDISK$$$$A$M$Y$$$20240723$$CN$US$US
241286601$24128660$1$I$$20240206$20240723$20240723$PER$$US-NOVOPROD-1176528$NOVO NORDISK$$$$A$M$Y$$$20240723$$MD$US$US
241286611$24128661$1$I$20240301$20240322$20240723$20240723$PER$$US-NOVOPROD-1197929$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241286621$24128662$1$I$20240501$20240522$20240723$20240723$PER$$US-NOVOPROD-1231070$NOVO NORDISK$$$$A$M$Y$$$20240723$$CN$US$US
241286631$24128663$1$I$$20240716$20240723$20240723$PER$$US-009507513-2407USA011354$MERCK$Kuczmarski Thomas M., Lynch Ryan C.,. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma. British Journal of Haematology. 2024;205(1):100-8$24$YR$$M$Y$$$20240723$$HP$US$US
241286642$24128664$2$F$$20240423$20240723$20240906$PER$$US-FARMAPROD-202404-1568$DOMPE FARMACEUTICI$$$$E$M$Y$63.5$KG$20240904$$CN$US$
241286651$24128665$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116305$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240723$$CN$US$US
241286662$24128666$2$F$$20240813$20240723$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116878$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$119.75$KG$20240816$$CN$US$US
241286671$24128667$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115012$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240723$$HP$US$US
241286682$24128668$2$F$20240609$20240623$20240723$20240906$PER$$US-FARMAPROD-202406-2213$DOMPE FARMACEUTICI$$57$YR$A$M$Y$$$20240904$$CN$US$US
241286692$24128669$2$F$$20240812$20240723$20240813$PER$$NVSC2024US150988$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
241286701$24128670$1$I$$20240403$20240723$20240723$PER$$US-NOVOPROD-1206228$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286711$24128671$1$I$$20240404$20240723$20240723$PER$$US-NOVOPROD-1204191$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241286722$24128672$2$F$20240503$20240322$20240723$20240723$PER$$US-NOVOPROD-1174337$NOVO NORDISK$$66$YR$$M$Y$$$20240723$$CN$US$US
241286732$24128673$2$F$$20230628$20240723$20240723$PER$$US-NOVOPROD-1173015$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286741$24128674$1$I$$20240117$20240723$20240723$PER$$US-NOVOPROD-1172473$NOVO NORDISK$$$$A$$Y$$$20240723$$CN$US$US
241286751$24128675$1$I$$20240304$20240723$20240723$PER$$US-NOVOPROD-1171049$NOVO NORDISK$$47$YR$$M$Y$104.31$KG$20240723$$HP$US$US
241286761$24128676$1$I$20231215$20240306$20240723$20240723$PER$$US-NOVOPROD-1181606$NOVO NORDISK$$73$YR$$F$Y$$$20240723$$CN$US$US
241286771$24128677$1$I$$20240227$20240723$20240723$PER$$US-NOVOPROD-1175252$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286781$24128678$1$I$$20240208$20240723$20240723$PER$$US-NOVOPROD-1175849$NOVO NORDISK$$50$YR$$F$Y$$$20240723$$HP$US$US
241286791$24128679$1$I$$20240411$20240723$20240723$PER$$US-NOVOPROD-1206864$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286801$24128680$1$I$$20240209$20240723$20240723$PER$$US-NOVOPROD-1177030$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286811$24128681$1$I$$20240206$20240723$20240723$PER$$US-NOVOPROD-1174636$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241286821$24128682$1$I$$20240208$20240723$20240723$PER$$US-NOVOPROD-1175800$NOVO NORDISK$$$$$F$Y$$$20240723$$MD$US$US
241286831$24128683$1$I$$20240212$20240723$20240723$PER$$US-NOVOPROD-1177275$NOVO NORDISK$$$$$F$Y$$$20240723$$MD$US$US
241286841$24128684$1$I$20240124$20240206$20240723$20240723$PER$$US-NOVOPROD-1176536$NOVO NORDISK$$78$YR$$F$Y$$$20240723$$CN$US$US
241286851$24128685$1$I$$20240208$20240723$20240723$PER$$US-NOVOPROD-1176354$NOVO NORDISK$$$$$M$Y$$$20240723$$HP$US$US
241286861$24128686$1$I$20240201$20240402$20240723$20240723$PER$$US-NOVOPROD-1181275$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241286871$24128687$1$I$20240105$20240313$20240723$20240723$PER$$US-NOVOPROD-1180454$NOVO NORDISK$$85$YR$$M$Y$$$20240723$$CN$US$US
241286881$24128688$1$I$$20240526$20240723$20240723$PER$$US-NOVOPROD-1247621$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241286891$24128689$1$I$20240201$20240412$20240723$20240723$PER$$US-NOVOPROD-1176238$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286901$24128690$1$I$$20240314$20240723$20240723$PER$$US-NOVOPROD-1193201$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241286911$24128691$1$I$$20240308$20240723$20240723$PER$$US-NOVOPROD-1189719$NOVO NORDISK$$$$$F$Y$$$20240723$$MD$US$US
241286921$24128692$1$I$$20240301$20240723$20240723$PER$$US-NOVOPROD-1189277$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286931$24128693$1$I$20240301$20240321$20240723$20240723$PER$$US-NOVOPROD-1196769$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286941$24128694$1$I$$20240425$20240723$20240723$PER$$US-NOVOPROD-1212911$NOVO NORDISK$$$$A$F$Y$$$20240723$$MD$US$US
241286951$24128695$1$I$$20240228$20240723$20240723$PER$$US-NOVOPROD-1184668$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241286961$24128696$1$I$$20240221$20240723$20240723$PER$$US-NOVOPROD-1181810$NOVO NORDISK$$60$YR$$M$Y$$$20240723$$MD$US$US
241286971$24128697$1$I$20240301$20240502$20240723$20240723$PER$$US-NOVOPROD-1220244$NOVO NORDISK$$75$YR$$F$Y$$$20240723$$CN$US$US
241286981$24128698$1$I$$20240322$20240723$20240723$PER$$US-NOVOPROD-1186421$NOVO NORDISK$$$$$M$Y$$$20240723$$HP$US$US
241286991$24128699$1$I$20240224$20240302$20240723$20240723$PER$$US-NOVOPROD-1187591$NOVO NORDISK$$62$YR$$F$Y$$$20240723$$HP$US$US
241287001$24128700$1$I$$20240226$20240723$20240723$PER$$US-NOVOPROD-1183609$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241287011$24128701$1$I$$20240402$20240723$20240723$PER$$US-NOVOPROD-1203479$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241287021$24128702$1$I$$20240429$20240723$20240723$PER$$US-NOVOPROD-1182226$NOVO NORDISK$$$$$F$Y$$$20240723$$MD$US$US
241287031$24128703$1$I$$20240422$20240723$20240723$PER$$US-NOVOPROD-1214365$NOVO NORDISK$$$$$F$Y$$$20240723$$MD$US$US
241287041$24128704$1$I$20240302$20240327$20240723$20240723$PER$$US-NOVOPROD-1199218$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241287051$24128705$1$I$$20230605$20240723$20240723$PER$$US-NOVOPROD-1249186$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241287061$24128706$1$I$$20240227$20240723$20240723$PER$$US-NOVOPROD-1186031$NOVO NORDISK$$$$$M$Y$$$20240723$$HP$US$US
241287071$24128707$1$I$20240402$20240417$20240723$20240723$PER$$US-NOVOPROD-1213911$NOVO NORDISK$$54$YR$$F$Y$$$20240723$$CN$US$US
241287081$24128708$1$I$$20230706$20240723$20240723$PER$$US-NOVOPROD-1228232$NOVO NORDISK$$80$YR$$F$Y$$$20240723$$CN$US$US
241287091$24128709$1$I$20230101$20240501$20240723$20240723$PER$$US-NOVOPROD-1219770$NOVO NORDISK$$58$YR$$M$Y$$$20240723$$MD$US$US
241287101$24128710$1$I$$20230814$20240723$20240723$PER$$US-NOVOPROD-1222838$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241287111$24128711$1$I$$20240228$20240723$20240723$PER$$US-NOVOPROD-1184462$NOVO NORDISK$$$$A$M$Y$$$20240723$$MD$US$US
241287121$24128712$1$I$20240717$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50698$$FDA-CTU$$63$YR$$M$N$$$20240723$Y$HP$US$
241287131$24128713$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50685$$FDA-CTU$$81$YR$$F$N$73.48$KG$20240723$N$HP$US$
241287141$24128714$1$I$$20240403$20240723$20240723$PER$$US-NOVOPROD-1203164$NOVO NORDISK$$45$YR$$F$Y$$$20240723$$MD$US$US
241287151$24128715$1$I$$20240313$20240723$20240723$PER$$US-NOVOPROD-1246678$NOVO NORDISK$$$$A$$Y$$$20240723$$CN$US$US
241287161$24128716$1$I$20240101$20240312$20240723$20240723$PER$$US-NOVOPROD-1190575$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241287171$24128717$1$I$$20240426$20240723$20240723$PER$$US-NOVOPROD-1216281$NOVO NORDISK$$$$E$F$Y$$$20240723$$CN$US$US
241287181$24128718$1$I$20230101$20240305$20240723$20240723$PER$$US-NOVOPROD-1187246$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241287191$24128719$1$I$$20240501$20240723$20240723$PER$$US-NOVOPROD-1218130$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241287201$24128720$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50688$$FDA-CTU$$60$YR$$F$N$157.4$KG$20240723$N$$US$
241287211$24128721$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50683$$FDA-CTU$$65$YR$$M$N$73.48$KG$20240723$N$HP$US$
241287221$24128722$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50682$$FDA-CTU$$51$YR$$F$N$76.2$KG$20240723$N$$US$
241287231$24128723$1$I$$20240422$20240723$20240723$PER$$US-NOVOPROD-1196304$NOVO NORDISK$$82$YR$$M$Y$$$20240723$$CN$US$US
241287241$24128724$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50686$$FDA-CTU$$46$YR$$F$N$$$20240723$N$$US$
241287251$24128725$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50684$$FDA-CTU$$50$YR$$F$N$$$20240723$N$$US$
241287261$24128726$1$I$20240412$20240415$20240723$20240723$PER$$US-NOVOPROD-1211829$NOVO NORDISK$$72$YR$$F$Y$$$20240723$$CN$US$US
241287271$24128727$1$I$$20240328$20240723$20240723$PER$$US-NOVOPROD-1200844$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241287281$24128728$1$I$$20240528$20240723$20240723$PER$$US-NOVOPROD-1231114$NOVO NORDISK$$$$E$$Y$$$20240723$$CN$US$US
241287291$24128729$1$I$$20240409$20240723$20240723$PER$$US-NOVOPROD-1198023$NOVO NORDISK$$88$YR$$M$Y$$$20240723$$CN$US$US
241287301$24128730$1$I$$20240418$20240723$20240723$PER$$US-NOVOPROD-1215724$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241287311$24128731$1$I$$20240514$20240723$20240723$PER$$US-NOVOPROD-1226323$NOVO NORDISK$$$$$F$Y$$$20240723$$PH$US$US
241287321$24128732$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50680$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241287331$24128733$1$I$20240418$20240507$20240723$20240723$PER$$US-NOVOPROD-1222776$NOVO NORDISK$$54$YR$$F$Y$$$20240723$$CN$US$US
241287341$24128734$1$I$$20240228$20240723$20240723$PER$$US-NOVOPROD-1184850$NOVO NORDISK$$$$A$F$Y$$$20240723$$HP$US$US
241287352$24128735$2$F$20240301$20240507$20240723$20240723$PER$$US-NOVOPROD-1228652$NOVO NORDISK$$75$YR$$M$Y$$$20240723$$CN$US$US
241287361$24128736$1$I$$20230811$20240723$20240723$PER$$US-NOVOPROD-1222876$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241287371$24128737$1$I$$20240423$20240723$20240723$PER$$US-NOVOPROD-1216222$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241287381$24128738$1$I$$20240530$20240723$20240723$PER$$US-NOVOPROD-1235844$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241287391$24128739$1$I$$20240527$20240723$20240723$PER$$US-NOVOPROD-1233413$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241287401$24128740$1$I$$20240506$20240723$20240723$PER$$US-NOVOPROD-1221664$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241287411$24128741$1$I$$20240228$20240723$20240723$PER$$US-NOVOPROD-1184919$NOVO NORDISK$$$$$F$Y$$$20240723$$HP$US$US
241287421$24128742$1$I$20231031$20240424$20240723$20240723$PER$$US-NOVOPROD-1215523$NOVO NORDISK$$72$YR$$F$Y$$$20240723$$CN$US$US
241287431$24128743$1$I$$20230905$20240723$20240723$PER$$US-NOVOPROD-1222892$NOVO NORDISK$$$$$M$Y$$$20240723$$CN$US$US
241287441$24128744$1$I$$20240222$20240723$20240723$PER$$US-NOVOPROD-1182455$NOVO NORDISK$$40$YR$$M$Y$99.773$KG$20240723$$MD$US$US
241287451$24128745$1$I$$20240529$20240723$20240723$PER$$US-NOVOPROD-1234710$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241287461$24128746$1$I$$20240315$20240723$20240723$PER$$US-NOVOPROD-1192682$NOVO NORDISK$$46$YR$$M$Y$$$20240723$$CN$US$US
241287471$24128747$1$I$$20240305$20240723$20240723$PER$$US-NOVOPROD-1189817$NOVO NORDISK$$$$A$M$Y$$$20240723$$CN$US$US
241287481$24128748$1$I$$20240509$20240723$20240723$PER$$US-NOVOPROD-1223906$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241287491$24128749$1$I$$20240425$20240723$20240723$PER$$US-NOVOPROD-1217266$NOVO NORDISK$$$$A$F$Y$$$20240723$$CN$US$US
241287501$24128750$1$I$$20240502$20240723$20240723$PER$$US-NOVOPROD-1221004$NOVO NORDISK$$$$$F$Y$$$20240723$$HP$US$US
241287511$24128751$1$I$$20240329$20240723$20240723$PER$$US-NOVOPROD-1201014$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241287521$24128752$1$I$$20240305$20240723$20240723$PER$$US-NOVOPROD-1189294$NOVO NORDISK$$$$$F$Y$$$20240723$$CN$US$US
241287531$24128753$1$I$$20240402$20240723$20240723$PER$$US-NOVOPROD-1203364$NOVO NORDISK$$$$$F$Y$$$20240723$$MD$US$US
241287541$24128754$1$I$20231101$20240522$20240723$20240723$PER$$US-NOVOPROD-1219323$NOVO NORDISK$$79$YR$$F$Y$$$20240723$$CN$US$US
241287551$24128755$1$I$$20240521$20240723$20240723$PER$$US-NOVOPROD-1230107$NOVO NORDISK$$$$$$Y$$$20240723$$CN$US$US
241287561$24128756$1$I$$20240718$20240723$20240723$EXP$$CA-JNJFOC-20240754545$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240723$$PH$CA$CA
241287572$24128757$2$F$20240716$20240826$20240723$20240828$PER$$US-JNJFOC-20240745988$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240829$$CN$US$US
241287581$24128758$1$I$$20240722$20240723$20240723$EXP$$ES-JAZZ PHARMACEUTICALS-2024-ES-011086$JAZZ$$$$$$Y$$$20240723$$MD$ES$ES
241287591$24128759$1$I$$20240529$20240723$20240723$PER$$US-NOVOPROD-1246833$NOVO NORDISK$$$$E$F$Y$$$20240723$$CN$US$US
241287601$24128760$1$I$20240719$20240719$20240723$20240723$EXP$$US-JNJFOC-20240756419$JOHNSON AND JOHNSON$$91$YR$E$M$Y$$$20240723$$HP$US$US
241287611$24128761$1$I$$20240717$20240723$20240723$EXP$$AU-SANDOZ INC.-SDZ2024AU054758$SANDOZ$$73$YR$$M$Y$$$20240723$$HP$AU$AU
241287622$24128762$2$F$$20240717$20240723$20240801$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457197$RANBAXY$Zhiryakova AS, Denisenko NP, Kryukov AV, Akmalova K.A, Tuchkova SN, Mirzaev K.B, Sychev DA. Patients^ pharmacogenetic characteristics and the risk of adverse reactions to non-steroidal anti-inflammatory drugs: case reports. Safety and Risk of Pharmacotherapy. 2024;12(2):1-14$57$YR$$F$Y$$$20240801$$HP$RU$RU
241287631$24128763$1$I$$20240719$20240723$20240723$EXP$$US-ABBVIE-5848290$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241287641$24128764$1$I$20240501$20240718$20240723$20240723$EXP$$US-ABBVIE-5846600$ABBVIE$$73$YR$$F$Y$$$20240723$$CN$US$US
241287651$24128765$1$I$20240220$20240715$20240723$20240723$EXP$$US-BAXTER-2024BAX021604$BAXTER$$59$YR$$M$Y$60.1$KG$20240723$$HP$US$US
241287662$24128766$2$F$$20240716$20240723$20240731$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456993$RANBAXY$Levlev EN, Bekhtereva DR, Khuzina ZR, Chalgubaev EK, Chekmareva IN. Clinical case of mechanical and non-mechanical rhabdomyolysis complicated by acute kidney injury. Case report. Consilium Medicum. 2024;26(1):45-47$36$YR$$M$Y$$$20240731$$HP$RU$RU
241287671$24128767$1$I$20240717$20240718$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US067068$SANDOZ$$5$YR$$M$Y$$$20240723$$CN$US$US
241287681$24128768$1$I$$20240716$20240723$20240723$EXP$CA-MMM-IBKG1FDC$CA-GSK-CA2023108508$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$HP$CA$CA
241287691$24128769$1$I$20240711$20240718$20240723$20240723$EXP$$CN-MYLANLABS-2024M1067611$MYLAN$$67$YR$$M$Y$67.5$KG$20240723$$HP$CN$CN
241287701$24128770$1$I$20240621$20240717$20240723$20240723$EXP$FR-AFSSAPS-LL2024001281$FR-MYLANLABS-2024M1067369$MYLAN$$69$YR$$M$Y$$$20240723$$MD$FR$FR
241287711$24128771$1$I$20240610$20240716$20240723$20240723$EXP$CN-NMPACDR-5301811058739202400025$CN-BAXTER-2024BAX021872$BAXTER$$43$YR$$F$Y$53$KG$20240723$$MD$CN$CN
241287729$24128772$9$F$20240101$20240927$20240723$20240930$EXP$$GB-MYLANLABS-2024M1058209$MYLAN$$$$$M$Y$$$20240930$$CN$GB$GB
241287731$24128773$1$I$20240328$20240717$20240723$20240723$EXP$FR-AFSSAPS-BS2024000421$FR-MYLANLABS-2024M1067253$MYLAN$$75$YR$$M$Y$85$KG$20240723$$MD$FR$FR
241287741$24128774$1$I$$20240716$20240723$20240723$EXP$$US-SA-2024SA211935$SANOFI AVENTIS$$$$E$F$Y$$$20240723$$MD$US$US
241287751$24128775$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212261$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240723$$MD$US$US
241287761$24128776$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211052$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240723$$MD$US$US
241287771$24128777$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211442$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240723$$CN$US$US
241287781$24128778$1$I$$20240717$20240723$20240723$EXP$$BE-MYLANLABS-2024M1067255$MYLAN$$$$E$F$Y$71.6$KG$20240723$$MD$BE$BE
241287791$24128779$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA212595$SANOFI AVENTIS$$$$$F$Y$$$20240723$$CN$US$US
241287802$24128780$2$F$$20240724$20240723$20240727$EXP$$US-ABBVIE-5844812$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241287811$24128781$1$I$20240715$20240715$20240723$20240723$EXP$$BG-AstraZeneca-2024A164308$ASTRAZENECA$$$$$F$Y$$$20240723$$MD$BG$
241287822$24128782$2$F$20240628$20240826$20240723$20240827$EXP$$DE-SANDOZ INC.-SDZ2024DE067343$SANDOZ$$75$YR$$M$Y$76$KG$20240827$$MD$DE$DE
241287831$24128783$1$I$20240711$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A165846$ASTRAZENECA$$29310$DY$$F$Y$$$20240723$$CN$US$
241287841$24128784$1$I$$20240715$20240723$20240723$EXP$$US-AstraZeneca-2024A165841$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241287852$24128785$2$F$$20240722$20240723$20240730$EXP$$US-AstraZeneca-2024A166662$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241287861$24128786$1$I$20240710$20240718$20240723$20240723$EXP$$CN-AstraZeneca-2024A167364$ASTRAZENECA$$19571$DY$$F$Y$58.5$KG$20240723$$MD$CN$
241287871$24128787$1$I$$20240715$20240723$20240723$EXP$$ZA-AstraZeneca-2024A161067$ASTRAZENECA$$48$YR$$F$Y$$$20240723$$CN$ZA$
241287881$24128788$1$I$$20240719$20240723$20240723$PER$$US-JNJFOC-20240756616$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$HP$US$US
241287891$24128789$1$I$20211101$20240716$20240723$20240723$EXP$$US-ABBVIE-5844330$ABBVIE$$62$YR$$M$Y$$$20240723$$CN$US$US
241287901$24128790$1$I$$20240716$20240723$20240723$EXP$$US-ABBVIE-5844826$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241287911$24128791$1$I$$20240716$20240723$20240723$EXP$$AU-SANDOZ INC.-SDZ2024AU065997$SANDOZ$$70$YR$$M$Y$$$20240723$$MD$AU$AU
241287922$24128792$2$F$$20240729$20240723$20240731$EXP$$HU-SANDOZ INC.-SDZ2024HU067181$SANDOZ$$$$$$Y$$$20240731$$CN$HU$HU
241287931$24128793$1$I$20200406$20240716$20240723$20240723$EXP$$KR-OTSUKA-2024_020029$OTSUKA$$34$YR$$M$Y$$$20240723$$MD$KR$KR
241287941$24128794$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211079$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240723$$MD$US$US
241287952$24128795$2$F$$20240718$20240723$20240802$PER$$US-SA-2024SA212466$SANOFI AVENTIS$$$$A$$Y$$$20240802$$CN$US$US
241287961$24128796$1$I$20240716$20240717$20240723$20240723$PER$$US-SA-2024SA212361$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$CN$US$US
241287971$24128797$1$I$20240101$20240715$20240723$20240723$PER$$US-SA-2024SA212478$SANOFI AVENTIS$$$$A$F$Y$70$KG$20240723$$MD$US$US
241287981$24128798$1$I$20240704$20240717$20240723$20240723$EXP$$US-ABBVIE-5845904$ABBVIE$$76$YR$$M$Y$$$20240723$$CN$US$US
241287991$24128799$1$I$$20240717$20240723$20240723$EXP$$FI-MYLANLABS-2024M1067426$MYLAN$$$$$F$Y$$$20240723$$HP$FI$FI
241288001$24128800$1$I$$20240717$20240723$20240723$EXP$$FI-MYLANLABS-2024M1067605$MYLAN$$60$YR$$M$Y$$$20240723$$HP$FI$FI
241288012$24128801$2$F$$20240729$20240723$20240805$EXP$$FI-MYLANLABS-2024M1067564$MYLAN$$7$DEC$$F$Y$$$20240805$$HP$FI$FI
241288021$24128802$1$I$20231229$20240717$20240723$20240723$EXP$FR-AFSSAPS-TO2024001240$FR-MYLANLABS-2024M1067371$MYLAN$$91$YR$$M$Y$$$20240723$$PH$FR$FR
241288031$24128803$1$I$20240619$20240717$20240723$20240723$EXP$FR-AFSSAPS-TS2024000801$FR-MYLANLABS-2024M1067457$MYLAN$$15$YR$$F$Y$46$KG$20240723$$MD$FR$FR
241288041$24128804$1$I$20240501$20240717$20240723$20240723$EXP$FR-AFSSAPS-RN2024000770$FR-MYLANLABS-2024M1067399$MYLAN$$80$YR$$M$Y$$$20240723$$MD$FR$FR
241288051$24128805$1$I$20240101$20240717$20240723$20240723$EXP$$CA-ABBVIE-5845948$ABBVIE$$49$YR$$F$Y$$$20240723$$CN$CA$CA
241288061$24128806$1$I$$20240718$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116377$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240723$$MD$JP$JP
241288071$24128807$1$I$$20240715$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113848$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$80.29$KG$20240723$$HP$US$US
241288082$24128808$2$F$$20240919$20240723$20240927$EXP$$JP-OTSUKA-2024_020126$OTSUKA$$5$DEC$$F$Y$$$20240927$$MD$JP$JP
241288091$24128809$1$I$$20211222$20240723$20240723$EXP$$NL-BIOVITRUM-2021NL12929$BIOVITRUM$$$$I$M$Y$3.1$KG$20240723$$CN$NL$NL
241288101$24128810$1$I$20240715$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024143855$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241288111$24128811$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240759734$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240723$$PH$US$US
241288121$24128812$1$I$$20220718$20240723$20240723$EXP$$BR-BIOVITRUM-2022BR08996$BIOVITRUM$$$$I$M$Y$3.8$KG$20240723$$CN$BR$BR
241288131$24128813$1$I$20220806$20220927$20240723$20240723$EXP$$CO-BIOVITRUM-2022CO09792$BIOVITRUM$$71$DY$$F$Y$$$20240723$$CN$CO$CO
241288141$24128814$1$I$$20240717$20240723$20240723$EXP$$IT-MYLANLABS-2024M1067103$MYLAN$$54$YR$$M$Y$$$20240723$$CN$IT$IT
241288151$24128815$1$I$$20240717$20240723$20240723$EXP$$HU-MYLANLABS-2024M1067464$MYLAN$Bartha NS, Szerafin L, Ilonczai P, Varju L, Rejto L.. Pneumonitis as a rare side effect of brentuximab-vedotin.. Hematology-Transfusiology. 2024;57(1):59-60$72$YR$$F$Y$$$20240723$$MD$HU$HU
241288161$24128816$1$I$20240703$20240717$20240723$20240723$EXP$IT-MINISAL02-994823$IT-MYLANLABS-2024M1067176$MYLAN$$76$YR$$F$Y$$$20240723$$PH$IT$IT
241288172$24128817$2$F$20240603$20240802$20240723$20240807$EXP$$FR-MYLANLABS-2024M1067162$MYLAN$$60$YR$$M$Y$$$20240807$$MD$FR$FR
241288181$24128818$1$I$20240620$20240715$20240723$20240723$EXP$$US-BAYER-2024A091379$BAYER$$54$YR$A$M$Y$$$20240723$$CN$US$US
241288192$24128819$2$F$20240618$20240723$20240723$20240731$EXP$$NVSC2024BE150644$NOVARTIS$$45$YR$$M$Y$132$KG$20240731$$MD$BE$BE
241288201$24128820$1$I$20211120$20211227$20240723$20240723$EXP$$ES-BIOVITRUM-2022ES00011$BIOVITRUM$$9$DY$$M$Y$$$20240723$$CN$ES$ES
241288211$24128821$1$I$$20240717$20240723$20240723$EXP$$US-SA-2024SA212044$SANOFI AVENTIS$$$$E$M$Y$$$20240723$$MD$US$US
241288221$24128822$1$I$20221203$20221207$20240723$20240723$EXP$$ES-BIOVITRUM-2022ES14945$BIOVITRUM$$18$WK$$M$Y$$$20240723$$CN$ES$ES
241288231$24128823$1$I$$20240715$20240723$20240723$PER$$US-APOTEX-2024AP008526$APOTEX$O^Meara KT, Fansiwala K, Kathuria-Prakash N, El-Masry M, Oh S. Acute hypoxic respiratory failure due to Lenalidomide-induced interstitial pneumonitis in a patient with multiple myeloma. BMC Pulmonary Medicine. 2024;24:321:1-5$80$YR$$M$Y$$$20240723$$HP$US$US
241288242$24128824$2$F$20240101$20240911$20240723$20240917$EXP$$US-ABBVIE-5846264$ABBVIE$$$$$F$Y$75$KG$20240917$$CN$US$US
241288251$24128825$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5846461$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241288262$24128826$2$F$$20240722$20240723$20240726$EXP$$US-BAUSCH-BL-2024-011247$BAUSCH AND LOMB$Ahmed H, Ismayl M, Palicherla A, Selim M, Aboeata A. Bupropion-disguised chest pain presenting in a middle-aged male: A case report and review of literature. Annals of medicine and surgery. 2024 MAY 28;86:4213-4216. doi:10.1097/MS9.0000000000002175$47$YR$$M$Y$$$20240726$$MD$US$US
241288272$24128827$2$F$$20240809$20240723$20240819$EXP$$CH-TEVA-VS-3220734$TEVA$Sofia P, Fortesa M. Plasmapheresis in a Pediatric Case of Multiorgan failure with Suspected DRESS or TSS. Swiss-Med-Wkly 2024; 154 (Suppl.) 19S.; Sofia P, Fortesa M. Plasmapheresis in a Pediatric Case of Multiorgan failure with Suspected DRESS or TSS. Swiss-Med-Wkly 2024; 154 (Suppl.) 19S.$7$YR$$F$Y$$$20240819$$HP$CH$CH
241288281$24128828$1$I$$20240716$20240723$20240723$EXP$$US-BAYER-2024A104852$BAYER$Mingyue Luo,Lu Sun,Rongping Dai,Youxin Chen,+Chan Wu.. Central retinal vein occlusion in patients with metastatic solid tumors on tyrosine kinase inhibitors: a report of case series and literature review. Frontiers in Medicine. 2024$66$YR$E$M$Y$$$20240723$$HP$US$US
241288302$24128830$2$F$$20221124$20240723$20240903$EXP$$NL-BIOVITRUM-2022NL14132$BIOVITRUM$$$$I$F$Y$3.3$KG$20240903$$HP$NL$NL
241288311$24128831$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5846241$ABBVIE$$$$$M$Y$$$20240723$$HP$US$US
241288321$24128832$1$I$20210201$20240715$20240723$20240723$EXP$$NVSC2024US148257$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
241288331$24128833$1$I$20240615$20240721$20240723$20240723$EXP$HR-HALMED-300086092$HR-BAUSCH-BL-2024-011192$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240723$$MD$HR$HR
241288341$24128834$1$I$20240716$20240719$20240723$20240723$EXP$$US-BAUSCH-BL-2024-002059$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240723$$CN$US$US
241288351$24128835$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240759732$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240723$$PH$US$US
241288361$24128836$1$I$$20240712$20240723$20240723$EXP$$AT-JNJFOC-20240744840$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$MD$AT$AT
241288372$24128837$2$F$20240514$20240718$20240723$20240725$PER$$US-SA-2024SA212053$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240725$$MD$US$US
241288381$24128838$1$I$20240101$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117104$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240723$$CN$US$US
241288401$24128840$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240760436$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240723$$PH$US$US
241288411$24128841$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240760437$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240723$$PH$US$US
241288421$24128842$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240760435$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240723$$PH$US$US
241288431$24128843$1$I$$20240715$20240723$20240723$EXP$$AU-JNJFOC-20240740592$JOHNSON AND JOHNSON$Drug survival of biologics in psoriasis: An Australian multicentre retrospective study.. Australas J Dermatol.$$$$$Y$$$20240723$$MD$AU$AU
241288442$24128844$2$F$$20240812$20240723$20240820$EXP$$CA-AstraZeneca-2024A164089$ASTRAZENECA$$52$YR$$F$Y$113$KG$20240820$$MD$CA$
241288452$24128845$2$F$20240316$20240730$20240723$20240808$EXP$$CA-AMERICAN REGENT INC-2024002736$AMERICAN REGENT$$35$YR$$F$Y$$$20240808$$HP$CA$CA
241288462$24128846$2$F$$20240823$20240723$20240826$EXP$$BR-AstraZeneca-2024A166992$ASTRAZENECA$$$$$F$Y$$$20240826$$CN$BR$
241288471$24128847$1$I$20240718$20240719$20240723$20240723$EXP$GB-MHRA-MED-202407191459520230-ZCNRK$GB-MYLANLABS-2024M1067803$MYLAN$$64$YR$$M$Y$$$20240723$$HP$GB$GB
241288481$24128848$1$I$$20240722$20240723$20240723$PER$$US-BAYER-2024A106254$BAYER$$$$$F$Y$$$20240723$$HP$US$US
241288492$24128849$2$F$$20240812$20240723$20240812$PER$$US-ALXN-202407USA001018US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241288514$24128851$4$F$20231201$20240830$20240723$20240908$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-114094$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240909$$MD$JP$JP
241288521$24128852$1$I$$20240715$20240723$20240723$PER$$US-JNJFOC-20240748185$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$CN$US$US
241288531$24128853$1$I$20240710$20240717$20240723$20240723$PER$$US-JNJFOC-20240760421$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240723$$HP$US$US
241288541$24128854$1$I$$20240717$20240723$20240723$EXP$$GB-JNJFOC-20240752510$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240723$$MD$GB$GB
241288551$24128855$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240760434$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240723$$PH$US$US
241288562$24128856$2$F$20240618$20240726$20240723$20240729$EXP$IT-MINISAL02-995959$IT-GILEAD-2024-0681648$GILEAD$$52$YR$A$M$Y$$$20240729$$MD$IT$IT
241288571$24128857$1$I$20110101$20240716$20240723$20240723$EXP$$US-TAKEDA-ALL1-2011-05118$TAKEDA$$$$$M$Y$$$20240723$$CN$US$US
241288582$24128858$2$F$$20240718$20240723$20240729$EXP$$CA-TAKEDA-2024TUS073444$TAKEDA$$$$$$Y$$$20240729$$HP$CA$CA
241288601$24128860$1$I$20240717$20240717$20240723$20240723$EXP$$JP-009507513-2407JPN003217J$MERCK$$19$YR$$M$Y$$$20240723$$PH$JP$JP
241288611$24128861$1$I$$20240722$20240723$20240723$PER$$NVSC2024US151010$NOVARTIS$$$$$M$Y$$$20240723$$CN$US$US
241288621$24128862$1$I$20240720$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116946$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240723$$CN$US$US
241288631$24128863$1$I$20240201$20240711$20240723$20240723$EXP$FR-AFSSAPS-LM2024000374$FR-TEVA-VS-3220722$TEVA$$68$YR$$F$Y$63$KG$20240723$$MD$FR$FR
241288641$24128864$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117134$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240723$$HP$US$US
241288651$24128865$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117119$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240723$$HP$US$US
241288663$24128866$3$F$20240701$20240925$20240723$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116729$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240927$$CN$US$US
241288672$24128867$2$F$$20240807$20240723$20240812$EXP$$GB-MYLANLABS-2024M1068045$MYLAN$$$$A$F$Y$$$20240812$$PH$GB$GB
241288681$24128868$1$I$20231101$20240719$20240723$20240723$PER$$US-JNJFOC-20240756009$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240723$$CN$US$US
241288691$24128869$1$I$$20240722$20240722$20240722$DIR$711036$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241288702$24128870$2$F$20230221$20240729$20240723$20240730$EXP$$IT-GSK-IT2023GSK095780$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$MD$IT$IT
241288711$24128871$1$I$20230101$20240717$20240723$20240723$EXP$$JP-009507513-2309JPN000551J$MERCK$$73$YR$$F$Y$$$20240723$$MD$JP$JP
241288721$24128872$1$I$20240715$20240722$20240722$20240722$DIR$711046$$FDA-CTU$$76$YR$$F$N$51.3$KG$20240722$N$CN$US$
241288731$24128873$1$I$20230908$20240722$20240722$20240722$DIR$711098$$FDA-CTU$$70$YR$$F$N$63$KG$20240722$N$HP$US$
241288741$24128874$1$I$$20240722$20240722$20240722$DIR$710993$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241288751$24128875$1$I$$20240711$20240723$20240723$EXP$$US-TEVA-VS-3222179$TEVA$$71$YR$$M$Y$$$20240723$$CN$US$US
241288771$24128877$1$I$20240715$20240717$20240723$20240723$PER$$US-ABBVIE-5846602$ABBVIE$$$$$F$Y$$$20240723$$HP$US$US
241288781$24128878$1$I$$20240712$20240723$20240723$EXP$$CN-ROCHE-10000031572$ROCHE$Gu Y, Chu X Z. Thrombolysis with low-dose and standard-dose intravenous recombinant tissue plasminogen activator in elderly patients with acute ischemic stroke: a stratified analysis. The Journal of Practical Medicine. 2024;40 (11):1568-73.$$$E$$Y$$$20240723$$MD$CN$CN
241288791$24128879$1$I$$20240719$20240723$20240723$EXP$$DE-JNJFOC-20240759860$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240723$$CN$DE$DE
241288801$24128880$1$I$$20240717$20240723$20240723$PER$$US-JNJFOC-20240745723$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$HP$US$US
241288811$24128881$1$I$20240517$20240716$20240723$20240723$EXP$$US-OTSUKA-2024_014310$OTSUKA$$41$YR$$F$Y$88$KG$20240723$$MD$US$US
241288821$24128882$1$I$$20240722$20240722$20240722$DIR$710976$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241288831$24128883$1$I$$20240722$20240722$20240722$DIR$710956$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241288841$24128884$1$I$$20240722$20240722$20240722$DIR$710992$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241288851$24128885$1$I$20240719$20240722$20240722$20240722$DIR$711045$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241288871$24128887$1$I$20240719$20240722$20240722$20240722$DIR$711035$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241288881$24128888$1$I$20240510$20240711$20240723$20240723$EXP$FR-AFSSAPS-SE2024000541$FR-TEVA-VS-3220711$TEVA$$14$YR$$M$Y$70$KG$20240723$$MD$FR$FR
241288891$24128889$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116476$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240723$$CN$US$US
241288904$24128890$4$F$20240502$20240826$20240723$20240903$EXP$$CL-BIOMARINAP-CL-2024-158116$BIOMARIN$$$$$$Y$$$20240903$$CN$CL$CL
241288911$24128891$1$I$$20240717$20240723$20240723$PER$$US-JNJFOC-20240746497$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
241288922$24128892$2$F$$20240809$20240723$20240819$EXP$$CH-TEVA-VS-3220786$TEVA$Bours B, Barcena C, Cairoli A, De Leval L, Schaefer N, Segot A. Primary bone marrow lymphoma (PBML): a rare cause of chronic inflammation with diffuse bone marrow hypermetabolism. Swiss-Med-Wkly 2023; 153 (Suppl. 274) 69S-70S abstr. 279.; Bours B, Barcena C, Cairoli A, De Leval L, Schaefer N, Segot A. Primary bone marrow lymphoma (PBML): a rare cause of chronic inflammation with diffuse bone marrow hypermetabolism. Swiss-Med-Wkly 2023; 153 (Suppl. 274) 69S-70S abstr. 279.$81$YR$$F$Y$$$20240819$$HP$CH$CH
241288934$24128893$4$F$20240416$20240819$20240723$20240827$EXP$$GB-DSJP-DSE-2024-124567$DAIICHI$$52$YR$$F$Y$$$20240827$$HP$GB$GB
241288942$24128894$2$F$20240708$20240722$20240723$20240730$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001448$BLUEPRINT MEDICINES$$68$YR$E$F$Y$$$20240730$$CN$US$US
241288954$24128895$4$F$20240101$20240923$20240723$20240927$EXP$$US-AMGEN-USASP2024143668$AMGEN$$$$$$Y$$$20240927$$MD$US$US
241288961$24128896$1$I$20240101$20240709$20240723$20240723$PER$$US-KARYOPHARM-2024KPT001289$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240723$$CN$US$US
241288971$24128897$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211197$SANOFI AVENTIS$$$$A$F$Y$68.94$KG$20240723$$MD$US$US
241288981$24128898$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA211160$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241288992$24128899$2$F$20240709$20240722$20240723$20240729$PER$$US-SA-2024SA211349$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240729$$CN$US$US
241289001$24128900$1$I$$20240711$20240723$20240723$PER$$US-SA-2024SA207218$SANOFI AVENTIS$$$$$F$Y$$$20240723$$HP$US$US
241289011$24128901$1$I$20240722$20240722$20240722$20240722$DIR$710987$$FDA-CTU$$76$YR$$F$N$108.4$KG$20240722$N$HP$US$
241289031$24128903$1$I$$20240722$20240723$20240723$PER$$NVSC2024US150997$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
241289041$24128904$1$I$20240716$20240722$20240722$20240722$DIR$711080$$FDA-CTU$$48$YR$$F$N$90.45$KG$20240722$N$CN$US$
241289051$24128905$1$I$20240721$20240721$20240723$20240723$EXP$$US-BIOMARINAP-US-2024-159319$BIOMARIN$$$$$$Y$$$20240723$$CN$US$US
241289062$24128906$2$F$$20240717$20240723$20240827$EXP$$PL-APELLIS-2024-APL-0000514$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240827$$MD$PL$PL
241289071$24128907$1$I$$20240709$20240723$20240723$EXP$$US-BEH-2024176030$CSL BEHRING$$70$YR$E$F$Y$$$20240723$$CN$US$US
241289082$24128908$2$F$20240627$20240906$20240723$20240909$PER$$NVSC2024US150609$NOVARTIS$$53$YR$$$Y$$$20240909$$CN$US$US
241289092$24128909$2$F$$20240906$20240723$20240906$PER$$NVSC2024US149843$NOVARTIS$$79$YR$$F$Y$$$20240906$$CN$US$US
241289101$24128910$1$I$$20230605$20240723$20240723$EXP$$EC-NALPROPION PHARMACEUTICALS INC.-EC-2024CUR003445$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$EC$EC
241289111$24128911$1$I$$20240715$20240723$20240723$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003460$CURRAX PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$CA$CA
241289122$24128912$2$F$20240101$20240801$20240723$20240807$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR002820$CURRAX PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$CA$CA
241289131$24128913$1$I$$20240718$20240723$20240723$30DAY$$US-SANDOZ INC.-SDZ2024US066991$SANDOZ$$$$$M$Y$$$20240723$$CN$US$US
241289141$24128914$1$I$20240101$20240710$20240723$20240723$PER$$US-SA-2024SA209560$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240723$$MD$US$US
241289151$24128915$1$I$20240601$20240715$20240723$20240723$PER$$US-SA-2024SA211641$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240723$$MD$US$US
241289161$24128916$1$I$$20240715$20240723$20240723$EXP$$ZA-AstraZeneca-2024A161114$ASTRAZENECA$$70$YR$$F$Y$$$20240723$$CN$ZA$
241289171$24128917$1$I$$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115044$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240723$$HP$US$US
241289182$24128918$2$F$$20240815$20240723$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116834$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240818$$CN$US$US
241289191$24128919$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013564$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240723$$CN$US$US
241289201$24128920$1$I$20240701$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116813$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240723$$CN$US$US
241289251$24128925$1$I$20240719$20240722$20240722$20240722$DIR$711023$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241289261$24128926$1$I$$20240722$20240722$20240722$DIR$711050$$FDA-CTU$$76$YR$$F$N$$$20240722$N$PH$US$
241289271$24128927$1$I$20240722$20240722$20240722$20240722$DIR$711128$$FDA-CTU$$60$YR$$F$N$76.95$KG$20240722$N$HP$US$
241289281$24128928$1$I$$20240723$20240723$20240723$PER$$US-HALEON-2188500$Haleon PLC$$$$$$Y$$$20240723$$CN$US$US
241289291$24128929$1$I$$20240722$20240723$20240723$PER$$US-BIOMARINAP-US-2024-159334$BIOMARIN$$$$$$Y$$$20240723$$CN$US$US
241289301$24128930$1$I$$20240722$20240723$20240723$PER$$US-JNJFOC-20240758193$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$US$US
241289311$24128931$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA211212$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240723$$MD$US$US
241289321$24128932$1$I$20240621$20240722$20240723$20240723$EXP$FR-AFSSAPS-BX2024001477$NVSC2024FR149999$NOVARTIS$$59$YR$$F$Y$$$20240723$$MD$FR$FR
241289332$24128933$2$F$$20240809$20240723$20240819$EXP$$US-TEVA-VS-3219661$TEVA$Arnouk S, Huynh Q, Saric M, Papadopoulos J. A Case Report of Cardiac Arrest After Intravenous Administration of Sulfur Hexafluoride (Lumason R) Ultrasound Enhancing Agent. J-Pharm-Pract 2024; 37 (2): 509-512.; Arnouk S, Huynh Q, Saric M, Papadopoulos J. A Case Report of Cardiac Arrest After Intravenous Administration of Sulfur Hexafluoride (Lumason R) Ultrasound Enhancing Agent. J-Pharm-Pract 2024; 37 (2): 509-512.$35$YR$$M$Y$$$20240819$$PH$US$US
241289351$24128935$1$I$$20240717$20240723$20240723$PER$$US-009507513-2407USA011225$MERCK$$75$YR$$F$Y$$$20240723$$CN$US$US
241289361$24128936$1$I$$20240718$20240723$20240723$PER$$NVSC2024US149074$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
241289371$24128937$1$I$$20240722$20240723$20240723$PER$$US-BIOMARINAP-US-2024-159331$BIOMARIN$$$$$$Y$$$20240723$$CN$US$US
241289381$24128938$1$I$$20240722$20240723$20240723$PER$$US-BIOMARINAP-US-2024-159327$BIOMARIN$$$$$$Y$$$20240723$$CN$US$US
241289391$24128939$1$I$$20240717$20240723$20240723$EXP$$US-TAKEDA-2024TUS073208$TAKEDA$$$$$M$Y$$$20240723$$CN$US$US
241289401$24128940$1$I$$20240719$20240723$20240723$PER$$US-BIOMARINAP-US-2024-159328$BIOMARIN$$$$$$Y$$$20240723$$CN$US$US
241289411$24128941$1$I$$20240708$20240723$20240723$EXP$$US-CMP PHARMA-2024CMP00041$CMP PHARMA$Li S, Halloran P.Siref A.. Concurrent Neutrophilic Eccrine Hidradenitis and Leukocytoclastic Vasculitis. Am. J. Dermatopathol. 2024;46(7):S20$58$YR$$F$Y$$$20240723$$HP$US$US
241289422$24128942$2$F$20240712$20240819$20240723$20240827$EXP$$US-GENMAB-2024-02614$GENMAB$$79$YR$$F$Y$60$KG$20240827$$PH$US$US
241289431$24128943$1$I$$20240708$20240723$20240723$EXP$$IN-CMP PHARMA-2024CMP00040$CMP PHARMA$Abdullah. The Unusual Adverse Effects of Antituberculosis Therapy in Kidney Patients. Int. J. Mycobacteriology.. 2024;13(2):183-190$55$YR$$F$Y$$$20240723$$HP$IN$IN
241289442$24128944$2$F$$20240913$20240723$20240917$EXP$$CA-TAKEDA-2024TUS074272$TAKEDA$$$$$F$Y$$$20240917$$CN$CA$CA
241289451$24128945$1$I$$20240716$20240723$20240723$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-099355$REGENERON$Makiko Hino, Megumi Hachisuka, Hideki Nagai, Tadanori Kanazawa, Aoi Nemoto et al.. P-012 A Case of Destructive Thyroiditis during Cemiplimab Therapy for Recurrent Cervical Cancer.. Japanese journal of Gynecologic Oncology.. 2024;42(3):357$79$YR$$F$Y$$$20240723$$MD$JP$JP
241289461$24128946$1$I$$20240722$20240722$20240722$DIR$711115$$FDA-CTU$$$$$M$N$$$20240722$N$CN$US$
241289471$24128947$1$I$$20240718$20240723$20240723$PER$$US-ABBVIE-5848610$ABBVIE$$$$$$Y$$$20240723$$CN$US$US
241289481$24128948$1$I$$20240722$20240722$20240722$DIR$711096$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241289501$24128950$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116263$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240723$$CN$US$US
241289511$24128951$1$I$20220910$20240718$20240723$20240723$EXP$FR-AFSSAPS-MP20223439$FR-BRISTOL-MYERS SQUIBB COMPANY-2023-031756$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$66$KG$20240723$$CN$FR$FR
241289521$24128952$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116604$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240723$$CN$US$US
241289531$24128953$1$I$20240101$20240710$20240723$20240723$PER$$US-MYLANLABS-2024M1064818$MYLAN$$$$$M$Y$92.21$KG$20240723$$CN$US$US
241289541$24128954$1$I$20200101$20240716$20240723$20240723$EXP$$US-TAKEDA-2024TUS072607$TAKEDA$$$$$M$Y$$$20240723$$CN$US$US
241289551$24128955$1$I$$20240711$20240723$20240723$PER$$US-TEVA-VS-3221957$TEVA$$$$A$F$Y$$$20240723$$CN$US$US
241289561$24128956$1$I$$20240722$20240722$20240722$DIR$711012$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241289575$24128957$5$F$20240916$20240916$20240723$20240923$EXP$$CA-TAKEDA-2024TUS069889$TAKEDA$$37$YR$$F$Y$$$20240923$$CN$CA$CA
241289581$24128958$1$I$20240718$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024145032$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241289592$24128959$2$F$$20240803$20240723$20240809$PER$$US-AMGEN-USASP2024143283$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241289611$24128961$1$I$$20240722$20240722$20240722$DIR$710961$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241289621$24128962$1$I$20240722$20240722$20240722$20240722$DIR$711084$$FDA-CTU$$60$YR$$M$N$$$20240722$N$$US$
241289631$24128963$1$I$$20240722$20240722$20240722$DIR$710962$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241289641$24128964$1$I$20240718$20240722$20240722$20240722$DIR$710957$$FDA-CTU$$64$YR$$F$N$$$20240722$N$$US$
241289651$24128965$1$I$20240704$20240722$20240722$20240722$DIR$710954$$FDA-CTU$$61$YR$$M$N$$$20240722$N$$US$
241289661$24128966$1$I$$20240722$20240722$20240722$DIR$710958$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241289671$24128967$1$I$20240721$20240722$20240722$20240722$DIR$711055$$FDA-CTU$$11$YR$$M$N$67.4$KG$20240722$Y$HP$US$
241289681$24128968$1$I$20240722$20240722$20240722$20240722$DIR$711033$$FDA-CTU$$4$MON$$F$N$$$20240722$N$$US$
241289691$24128969$1$I$20240722$20240722$20240722$20240722$DIR$711032$$FDA-CTU$$62$YR$$F$N$$$20240722$N$$US$
241289701$24128970$1$I$20240719$20240722$20240722$20240722$DIR$710951$$FDA-CTU$$79$YR$$M$N$$$20240722$N$$US$
241289711$24128971$1$I$$20240722$20240722$20240722$DIR$710999$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241289721$24128972$1$I$20240719$20240722$20240722$20240722$DIR$710950$$FDA-CTU$$60$YR$$F$N$$$20240722$N$$US$
241289731$24128973$1$I$20240601$20240718$20240723$20240723$EXP$GB-MHRA-MED-202407162134022710-WZYVQ$GB-ABBVIE-5848266$ABBVIE$$$$$F$Y$$$20240723$$HP$GB$GB
241289741$24128974$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211228$SANOFI AVENTIS$$$$A$M$Y$$$20240723$$MD$US$US
241289751$24128975$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA213665$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240723$$MD$US$US
241289761$24128976$1$I$$20240718$20240723$20240723$PER$$US-TAKEDA-2024TUS073030$TAKEDA$$$$$M$Y$104$KG$20240723$$MD$US$US
241289771$24128977$1$I$$20240709$20240723$20240723$PER$$US-MYLANLABS-2024M1064800$MYLAN$$82$YR$$F$Y$85.28$KG$20240723$$HP$US$US
241289781$24128978$1$I$20240101$20240715$20240723$20240723$PER$$US-SA-2024SA211251$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240723$$MD$US$US
241289791$24128979$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211282$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240723$$MD$US$US
241289801$24128980$1$I$$20240716$20240723$20240723$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-099923$REGENERON$Keiko Ebisawa, Junsuke Muraoka, Mizue Itoi, Takako Kusanishi, Miwa Ijiri, Kiyomi Suzuka, and Naotake Tanaka. OS-198 Experience with Cemiplimab in Our Hospital.. Japanese journal of Gynecologic Oncology. 2024;42(3):307$$$$F$Y$$$20240723$$MD$JP$JP
241289821$24128982$1$I$$20240723$20240723$20240723$PER$$NVSC2024US151029$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
241289831$24128983$1$I$$20240722$20240723$20240723$PER$$NVSC2024US150888$NOVARTIS$$$$$M$Y$$$20240723$$CN$US$US
241289841$24128984$1$I$20240722$20240722$20240723$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041153$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240723$$CN$US$US
241289851$24128985$1$I$$20240702$20240723$20240723$PER$$US-JNJFOC-20240707156$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
241289861$24128986$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240759425$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240723$$PH$US$US
241289892$24128989$2$F$20240730$20240730$20240723$20240805$EXP$$CA-TAKEDA-2023TUS109995$TAKEDA$$58$YR$$F$Y$$$20240805$$CN$CA$CA
241289901$24128990$1$I$$20240715$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407010600$ELI LILLY AND CO$$$$$M$Y$$$20240723$$CN$US$US
241289911$24128991$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013927$ELI LILLY AND CO$$$$A$M$Y$$$20240723$$CN$US$US
241289921$24128992$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014784$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240723$$CN$US$US
241289931$24128993$1$I$$20240219$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014561$ELI LILLY AND CO$$$$$F$Y$$$20240723$$MD$US$US
241289941$24128994$1$I$20240708$20240715$20240723$20240723$PER$$US-ABBVIE-5844557$ABBVIE$$29$YR$$F$Y$$$20240723$$CN$US$US
241289951$24128995$1$I$20080101$20240708$20240723$20240723$EXP$GB-MHRA-MED-202407081345488890-FKBGM$GB-PHARMAAND GMBH-2024PHR00419$pharmaAND$$41$YR$$M$Y$$$20240723$$CN$GB$GB
241289961$24128996$1$I$$20240708$20240723$20240723$EXP$$US-PARI RESPIRATORY EQUIPMENT, INC.-2024PAR00053$PARI RESPIRATORY EQUIPMENT$$$$$M$Y$46.485$KG$20240723$$HP$US$US
241289971$24128997$1$I$$20240718$20240723$20240723$EXP$$MY-AstraZeneca-2024A164135$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$MY$
241289991$24128999$1$I$20240112$20240711$20240723$20240723$EXP$FR-AFSSAPS-GR2024000808$FR-TEVA-VS-3220946$TEVA$$78$YR$$F$Y$$$20240723$$PH$FR$FR
241290011$24129001$1$I$20240717$20240722$20240722$20240722$DIR$711064$$FDA-CTU$$32$YR$$F$N$93.6$KG$20240722$N$CN$US$
241290021$24129002$1$I$20240621$20240722$20240722$20240722$DIR$711051$$FDA-CTU$$75$YR$$M$N$90$KG$20240722$Y$CN$US$
241290031$24129003$1$I$$20240722$20240722$20240722$DIR$710986$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241290041$24129004$1$I$$20240722$20240722$20240722$DIR$711003$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241290061$24129006$1$I$20240706$20240722$20240722$20240722$DIR$711030$$FDA-CTU$$45$YR$$F$N$118.8$KG$20240722$Y$CN$US$
241290082$24129008$2$F$$20240722$20240723$20240731$30DAY$$US-GSK-US2024090642$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$MD$US$US
241290091$24129009$1$I$$20240715$20240723$20240723$PER$$US-JNJFOC-20240748542$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$US$US
241290121$24129012$1$I$$20240722$20240722$20240722$DIR$711002$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241290133$24129013$3$F$$20240725$20240723$20240801$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR091183$VIIV$$$$$$Y$$$20240801$$MD$US$US
241290141$24129014$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116468$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240723$$HP$US$US
241290151$24129015$1$I$$20240722$20240722$20240722$DIR$711013$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241290161$24129016$1$I$20240527$20240722$20240722$20240722$DIR$711020$$FDA-CTU$$63$YR$$F$N$$$20240722$N$PH$US$
241290171$24129017$1$I$$20240715$20240723$20240723$EXP$$KR-AstraZeneca-2024A161192$ASTRAZENECA$$$$A$M$Y$$$20240723$$CN$KR$
241290201$24129020$1$I$20240325$20240718$20240723$20240723$EXP$$ZA-AstraZeneca-2024A164171$ASTRAZENECA$$47$YR$$M$Y$$$20240723$$CN$ZA$
241290211$24129021$1$I$$20240722$20240722$20240722$DIR$710982$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241290222$24129022$2$F$$20240816$20240723$20240820$PER$$US-PFIZER INC-202400213160$PFIZER$$$$$$Y$$$20240820$$HP$US$US
241290231$24129023$1$I$20240629$20240708$20240723$20240723$30DAY$$FR-PFIZER INC-202400209495$PFIZER$$5$MON$$F$Y$$$20240723$$MD$FR$FR
241290271$24129027$1$I$$20240718$20240723$20240723$EXP$$GB-AstraZeneca-2024A164190$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$GB$
241290282$24129028$2$F$$20240809$20240723$20240812$30DAY$$ZA-PFIZER INC-202400216073$PFIZER$$$$$F$Y$$$20240812$$CN$ZA$ZA
241290291$24129029$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA211232$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240723$$MD$US$US
241290301$24129030$1$I$20240101$20240715$20240723$20240723$PER$$US-SA-2024SA211515$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240723$$MD$US$US
241290311$24129031$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211144$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240723$$MD$US$US
241290321$24129032$1$I$$20240717$20240723$20240723$EXP$$US-GSK-US2024AMR091394$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$CN$US$US
241290331$24129033$1$I$$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116336$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240723$$CN$US$US
241290341$24129034$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116155$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240723$$HP$US$US
241290351$24129035$1$I$$20240722$20240722$20240722$DIR$710955$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241290361$24129036$1$I$20240715$20240722$20240722$20240722$DIR$711076$$FDA-CTU$$76$YR$$M$N$92.25$KG$20240722$N$CN$US$
241290371$24129037$1$I$$20240722$20240722$20240722$DIR$711009$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241290381$24129038$1$I$$20240722$20240722$20240722$DIR$710983$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241290391$24129039$1$I$$20240722$20240722$20240722$DIR$710985$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241290401$24129040$1$I$$20240716$20240723$20240723$EXP$$CO-ASTELLAS-2024US020585$ASTELLAS$$74$YR$$M$Y$$$20240723$$CN$CO$CO
241290411$24129041$1$I$$20240702$20240723$20240723$PER$$US-009507513-2407USA009670$MERCK$Jamshidi F, Lozano L, Tucker B, Andorf J, Sohn E, Stone E, et al.. Belzutifan in Individuals with von Hippel-Lindau Retinal Hemangioblastomas: Institutional Experience and Review of the Literature. Ocular Oncology and Pathology. 2024;1-8$$$A$$Y$$$20240723$$HP$US$US
241290421$24129042$1$I$20240101$20240717$20240723$20240723$EXP$$US-ABBVIE-5844578$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241290431$24129043$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116717$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240723$$CN$US$US
241290442$24129044$2$F$20240101$20240912$20240723$20240916$EXP$$UY-BRISTOL-MYERS SQUIBB COMPANY-2024-116329$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240916$$HP$UY$UY
241290451$24129045$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116672$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$63.96$KG$20240723$$CN$US$US
241290461$24129046$1$I$20240719$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116466$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$64.86$KG$20240723$$HP$US$US
241290471$24129047$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114286$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240723$$CN$US$US
241290481$24129048$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117005$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240723$$HP$US$US
241290491$24129049$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115872$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240723$$CN$US$US
241290501$24129050$1$I$20240718$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012431$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240723$$CN$US$US
241290511$24129051$1$I$$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114494$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240723$$CN$US$US
241290521$24129052$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014742$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240723$$CN$US$US
241290531$24129053$1$I$$20240719$20240723$20240723$EXP$GB-MHRA-TPP49423561C11562390YC1721321484481$GB-MYLANLABS-2024M1067813$MYLAN$$5$YR$$M$Y$17$KG$20240723$$MD$GB$GB
241290541$24129054$1$I$20240601$20240711$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407007844$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240723$$CN$US$US
241290551$24129055$1$I$$20240723$20240723$20240723$PER$$US-PURDUE PHARMA-USA-2024-0310907$PURDUE$$$$$$Y$$$20240723$$CN$US$US
241290561$24129056$1$I$$20240722$20240723$20240723$PER$$US-PURDUE-USA-2024-0310885$PURDUE$$$$$F$Y$$$20240723$$CN$US$US
241290571$24129057$1$I$$20240722$20240723$20240723$PER$$US-PURDUE-USA-2024-0310831$PURDUE$$$$$F$Y$$$20240723$$PH$US$US
241290581$24129058$1$I$$20240722$20240723$20240723$PER$$US-PURDUE-USA-2024-0310886$PURDUE$$$$$F$Y$$$20240723$$PH$US$US
241290601$24129060$1$I$$20240716$20240723$20240723$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-099915$REGENERON$Masahiro Taguchi, Yoshifumi Takahashi, Kohei Tamura, Miki Shinohara, Takahiro Koyanagi, Suzuyo Takahashi, Akiyo Taneichi, Shizuo Machida, Yasushi Saga, Yuji Takei, Hiroyuki Fujiwara. et.al. Experience with cemiplimab therapy for advanced or recurrent cervical cancer.. Japanese Journal of Gynecologic Oncology. 2024;42 (3):306$$$$F$Y$$$20240723$$MD$JP$JP
241290612$24129061$2$F$$20240729$20240723$20240802$EXP$$CA-LUNDBECK-DKLU4001978$LUNDBECK$$$$$$Y$$$20240802$$HP$CA$CA
241290621$24129062$1$I$$20240718$20240723$20240723$EXP$$GB-MYLANLABS-2024M1067914$MYLAN$$$$$M$Y$$$20240723$$HP$GB$GB
241290631$24129063$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA212168$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240723$$MD$US$US
241290641$24129064$1$I$20240709$20240715$20240723$20240723$PER$$US-SA-2024SA210940$SANOFI AVENTIS$$58$YR$A$F$Y$63.039$KG$20240723$$MD$US$US
241290652$24129065$2$F$20240719$20240730$20240723$20240803$PER$$US-AMGEN-USASP2024145443$AMGEN$$75$YR$E$F$Y$$$20240803$$PH$US$US
241290671$24129067$1$I$$20240718$20240723$20240723$PER$$NVSC2024US150025$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
241290681$24129068$1$I$20240713$20240718$20240723$20240723$EXP$$ZA-AstraZeneca-2024A164278$ASTRAZENECA$$61$YR$$F$Y$$$20240723$$CN$ZA$
241290691$24129069$1$I$20240709$20240715$20240723$20240723$EXP$$CN-AstraZeneca-2024A163173$ASTRAZENECA$$25597$DY$$M$Y$66$KG$20240723$$MD$CN$
241290701$24129070$1$I$$20240720$20240723$20240723$EXP$$FR-PFIZER INC-PV202400095451$PFIZER$$$$$$Y$$$20240723$$MD$FR$FR
241290712$24129071$2$F$$20240813$20240723$20240815$PER$$US-PFIZER INC-PV202400094573$PFIZER$$$$$F$Y$$$20240815$$CN$US$US
241290721$24129072$1$I$$20240722$20240723$20240723$EXP$$TW-PFIZER INC-PV202400095956$PFIZER$$$$A$F$Y$$$20240723$$HP$TW$TW
241290731$24129073$1$I$20240401$20240716$20240723$20240723$EXP$$FR-AMERICAN REGENT INC-2024002737$AMERICAN REGENT$$80$YR$$M$Y$69$KG$20240723$$PH$FR$FR
241290741$24129074$1$I$$20240719$20240723$20240723$PER$$US-PFIZER INC-PV202400095131$PFIZER$$52$YR$$F$Y$$$20240723$$HP$US$US
241290751$24129075$1$I$20240719$20240720$20240723$20240723$EXP$GB-MHRA-MED-202407201015508670-FTQJN$GB-PFIZER INC-202400219477$PFIZER$$48$YR$$M$Y$77$KG$20240723$$HP$GB$GB
241290761$24129076$1$I$20240711$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024144535$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241290772$24129077$2$F$$20240801$20240723$20240806$EXP$$US-SANDOZ INC.-NVSC2022US085004$SANDOZ$$$$$F$Y$49.887$KG$20240806$$CN$US$US
241290781$24129078$1$I$$20240711$20240723$20240723$EXP$$IN-ROCHE-10000027945$ROCHE$$65$YR$E$F$Y$$$20240723$$MD$IN$IN
241290792$24129079$2$F$$20240722$20240723$20240724$PER$$NVSC2024US150853$NOVARTIS$$$$$M$Y$$$20240724$$CN$US$US
241290801$24129080$1$I$$20240720$20240723$20240723$PER$$NVSC2024US150240$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
241290811$24129081$1$I$$20240711$20240723$20240723$EXP$$US-RDY-LIT/USA/24/0010520$DR REDDYS$Bhanot N, Sokos GG, Benza RL, Murali S. Concomitant cat scratch disease and squamous cell carcinoma in a cardiac transplant. Infectious Disease Reports. 2012;4: 3-5. doi:10.4081/idr.2012.e02.$65$YR$E$M$Y$$$20240723$$HP$US$US
241290831$24129083$1$I$20240711$20240722$20240722$20240722$DIR$711121$$FDA-CTU$$70$YR$$M$N$61.1$KG$20240722$N$PH$US$
241290841$24129084$1$I$20240715$20240722$20240722$20240722$DIR$710984$$FDA-CTU$$75$YR$$M$N$76$KG$20240722$N$PH$US$
241290851$24129085$1$I$$20240722$20240722$20240722$DIR$710980$$FDA-CTU$$$$$UNK$N$$$20240722$$CN$US$
241290871$24129087$1$I$20240715$20240722$20240722$20240722$DIR$711125$$FDA-CTU$$83$YR$$F$N$$$20240722$N$HP$US$
241290884$24129088$4$F$$20240716$20240723$20240910$PER$$US-BEH-2024175847$CSL BEHRING$$$$E$F$Y$$$20240910$$PH$US$US
241290892$24129089$2$F$$20240823$20240723$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116380$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240830$$HP$US$US
241290901$24129090$1$I$20240710$20240712$20240723$20240723$EXP$$FR-JNJFOC-20240728365$JOHNSON AND JOHNSON$$62$YR$A$M$Y$77$KG$20240723$$PH$FR$FR
241290911$24129091$1$I$20240401$20240718$20240723$20240723$EXP$$US-JNJFOC-20240751055$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240723$$HP$US$US
241290921$24129092$1$I$20240622$20240722$20240723$20240723$EXP$$US-BAYER-2024A106394$BAYER$$71$YR$E$M$Y$$$20240723$$HP$US$US
241290932$24129093$2$F$20240712$20240813$20240723$20240816$PER$$US-ABBVIE-5847904$ABBVIE$$$$$$Y$$$20240816$$HP$US$US
241290941$24129094$1$I$20230913$20240531$20240723$20240723$EXP$$CA-LUNDBECK-DKLU3067719$LUNDBECK$$$$$$Y$$$20240723$$HP$CA$CA
241290951$24129095$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116629$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240723$$HP$US$US
241290962$24129096$2$F$20240501$20240911$20240723$20240919$EXP$FR-AFSSAPS-AN2024000917$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-116313$BRISTOL MYERS SQUIBB$$63$YR$A$$Y$$$20240919$$MD$FR$FR
241290972$24129097$2$F$$20240821$20240723$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116943$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240825$$CN$US$US
241290981$24129098$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116554$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240723$$HP$US$US
241290991$24129099$1$I$20240708$20240708$20240723$20240723$PER$$US-MYLANLABS-2024M1064392$MYLAN$$60$YR$$M$Y$$$20240723$$CN$US$US
241291001$24129100$1$I$$20240717$20240723$20240723$EXP$CA-DRL-USA-SPO/CAN/24/0010622$CA-RDY-SPO/CAN/24/0010622$DR REDDYS$$64$YR$A$F$Y$$$20240723$$HP$CA$CA
241291011$24129101$1$I$20240711$20240716$20240723$20240723$PER$$US-BIOGEN-2024BI01274297$BIOGEN$$50$YR$$F$Y$$$20240723$$HP$US$US
241291022$24129102$2$F$$20240816$20240723$20240822$PER$$US-BIOGEN-2024BI01274045$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
241291031$24129103$1$I$$20240716$20240723$20240723$PER$$US-BIOGEN-2024BI01273949$BIOGEN$$$$$F$Y$$$20240723$$MD$US$US
241291041$24129104$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA211109$SANOFI AVENTIS$$$$A$F$Y$$$20240723$$MD$US$US
241291053$24129105$3$F$$20240805$20240723$20240809$PER$$US-BIOGEN-2024BI01272539$BIOGEN$$$$$F$Y$$$20240809$$CN$US$US
241291061$24129106$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA211499$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240723$$MD$US$US
241291071$24129107$1$I$20240601$20240716$20240723$20240723$PER$$US-BIOGEN-2024BI01270591$BIOGEN$$52$YR$$F$Y$$$20240723$$CN$US$US
241291094$24129109$4$F$$20240814$20240723$20240821$PER$$US-BIOGEN-2022BI01155871$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
241291102$24129110$2$F$20240720$20240724$20240723$20240727$EXP$$UY-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041493$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240727$$MD$UY$UY
241291111$24129111$1$I$$20240703$20240723$20240723$PER$$US-BIOGEN-2024BI01274741$BIOGEN$$$$$F$Y$$$20240723$$HP$US$US
241291121$24129112$1$I$$20240717$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007574$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241291132$24129113$2$F$$20240905$20240723$20240905$PER$$NVSC2024US149740$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
241291141$24129114$1$I$$20240709$20240723$20240723$EXP$$TR-DEXPHARM-2024-2410$DEXCEL$?etin ?. Minor/Major Congenital Malformations and Neurodevelopmental Outcomes in Children Prenatally Exposed to Levetiracetam, Lamotrigine, and Carbamazepine Monotherapy. Clinical Neuropharmacology. :10?1097.$$$C$$Y$$$20240723$$HP$TR$TR
241291151$24129115$1$I$20240515$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116424$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240723$$HP$US$US
241291162$24129116$2$F$$20240717$20240723$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407011075$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240725$$CN$US$US
241291172$24129117$2$F$$20240919$20240723$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116258$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$49.44$KG$20240928$$PH$US$US
241291181$24129118$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014628$ELI LILLY AND CO$$52$YR$A$$Y$$$20240723$$CN$US$US
241291192$24129119$2$F$20240601$20240808$20240723$20240812$EXP$$CA-LUNDBECK-DKLU4001989$LUNDBECK$$$$$$Y$$$20240812$$CN$CA$CA
241291201$24129120$1$I$$20240718$20240723$20240723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210203338$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240723$$HP$CA$CA
241291211$24129121$1$I$$20240717$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007565$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241291222$24129122$2$F$$20240724$20240723$20240730$EXP$$US-BAUSCH-BL-2024-011258$BAUSCH AND LOMB$Van Noord B, Samaan C, Flamm A. A Case of Delayed and Immediate Hypersensitivity Reactions Induced by Corticosteroids. Dermatitis.. 2024;35(2):191-192. doi:10.1089/derm.2023.0146$$$$M$Y$$$20240730$$HP$US$US
241291231$24129123$1$I$$20240722$20240723$20240723$PER$$US-BAUSCH-BL-2024-011263$BAUSCH AND LOMB$$40$YR$$F$Y$$$20240723$$MD$US$US
241291241$24129124$1$I$$20240717$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007556$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241291251$24129125$1$I$$20240722$20240723$20240723$EXP$$CA-BAUSCH-BL-2024-011215$BAUSCH AND LOMB$$78$YR$$F$Y$$$20240723$$HP$CA$CA
241291261$24129126$1$I$20160811$20240718$20240723$20240723$EXP$$FR-BAUSCH-BL-2024-011096$BAUSCH AND LOMB$$41$YR$$M$Y$83$KG$20240723$$MD$FR$FR
241291271$24129127$1$I$20240607$20240717$20240723$20240723$EXP$HR-HALMED-300086066$HR-MYLANLABS-2024M1067105$MYLAN$$26$YR$$M$Y$$$20240723$$MD$HR$HR
241291281$24129128$1$I$20240625$20240717$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007555$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241291291$24129129$1$I$$20240717$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007553$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241291301$24129130$1$I$$20240719$20240723$20240723$PER$$US-ROCHE-10000031623$ROCHE$$47$YR$A$F$Y$$$20240723$$HP$US$US
241291311$24129131$1$I$20240101$20240717$20240723$20240723$PER$$US-SA-2024SA211647$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240723$$MD$US$US
241291321$24129132$1$I$$20240715$20240723$20240723$PER$$US-MYLANLABS-2024M1066802$MYLAN$$$$$F$Y$$$20240723$$CN$US$US
241291331$24129133$1$I$$20240717$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007552$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241291341$24129134$1$I$$20240717$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007543$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241291351$24129135$1$I$20240721$20240721$20240723$20240723$PER$$US-JNJFOC-20240755765$JOHNSON AND JOHNSON$$$$$F$Y$$$20240723$$CN$US$US
241291361$24129136$1$I$$20240717$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007538$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241291371$24129137$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116089$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240723$$CN$US$US
241291381$24129138$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116742$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240723$$CN$US$US
241291391$24129139$1$I$20240101$20240718$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114834$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240723$$HP$US$US
241291401$24129140$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-034738$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240723$$CN$US$US
241291412$24129141$2$F$$20240722$20240723$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041503$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240723$$CN$US$US
241291432$24129143$2$F$20240510$20240717$20240723$20240726$EXP$$CA-MYLANLABS-2024M1045389$MYLAN$$78$YR$$M$Y$$$20240726$$CN$CA$CA
241291441$24129144$1$I$$20240712$20240723$20240723$EXP$$GB-GSK-GB2024050011$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$HP$GB$GB
241291451$24129145$1$I$20240410$20240711$20240723$20240723$EXP$FR-AFSSAPS-AVPA2024000619$FR-TEVA-VS-3220704$TEVA$$27$YR$$M$Y$$$20240723$$MD$FR$FR
241291463$24129146$3$F$20240101$20240808$20240723$20240816$EXP$$US-BAYER-2024A087948$BAYER$$64$YR$A$F$Y$141.95$KG$20240816$$CN$US$US
241291471$24129147$1$I$$20240711$20240723$20240723$EXP$GB-MHRA-TPP60650852C1407829YC1720607951968$GB-PERRIGO-24GB006540$PERRIGO$$38$YR$$M$Y$80$KG$20240723$$MD$GB$GB
241291481$24129148$1$I$$20240719$20240723$20240723$EXP$$GB-MYLANLABS-2024M1068223$MYLAN$$$$$F$Y$$$20240723$$PH$GB$GB
241291491$24129149$1$I$$20240723$20240723$20240723$PER$$NVSC2024US151060$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
241291501$24129150$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240759528$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240723$$PH$US$US
241291512$24129151$2$F$20240524$20240722$20240723$20240724$EXP$$GB-ABBVIE-5848812$ABBVIE$$$$$M$Y$64$KG$20240724$$CN$GB$GB
241291521$24129152$1$I$$20240722$20240723$20240723$EXP$$US-ABBVIE-5849632$ABBVIE$$$$$$Y$$$20240723$$MD$US$US
241291531$24129153$1$I$$20240717$20240723$20240723$EXP$$US-AMGEN-USASP2024142181$AMGEN$$$$A$F$Y$$$20240723$$CN$US$US
241291542$24129154$2$F$$20240919$20240723$20240920$EXP$$NVSC2024US025934$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
241291551$24129155$1$I$$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116634$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$93.44$KG$20240723$$CN$US$US
241291571$24129157$1$I$$20240715$20240723$20240723$EXP$$AU-MYLANLABS-2024M1067218$MYLAN$Cook AM, Patuzzi RB. One mechanism of sudden sensorineural hearing loss after sildenafil and sexual activity. Int-J-Audiol 2024; 1-4.$4$DEC$$M$Y$$$20240723$$HP$AU$AU
241291581$24129158$1$I$$20240717$20240723$20240723$EXP$$US-MYLANLABS-2024M1068378$MYLAN$Gault KS. The role of physical therapy within a multidisciplinary pancreatic cancer clinic to optimize care. Rehabil-Oncol 2024; 42 (2): 119.$78$YR$$F$Y$$$20240723$$HP$US$US
241291591$24129159$1$I$$20240716$20240723$20240723$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-135990$DAIICHI$$89$YR$$M$Y$$$20240723$$MD$JP$JP
241291601$24129160$1$I$$20240716$20240723$20240723$EXP$$US-ABBVIE-5751049$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241291612$24129161$2$F$20240618$20240726$20240723$20240801$EXP$FR-AFSSAPS-LL2024001298$FR-009507513-2407FRA011469$MERCK$$59$YR$$F$Y$50$KG$20240801$$MD$FR$FR
241291621$24129162$1$I$20240101$20240712$20240723$20240723$EXP$FR-AFSSAPS-NT2024000825$FR-TEVA-VS-3221157$TEVA$$67$YR$$F$Y$54$KG$20240723$$MD$FR$FR
241291641$24129164$1$I$$20240722$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116743$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240723$$CN$US$US
241291651$24129165$1$I$$20240716$20240723$20240723$PER$$US-MYLANLABS-2024M1067653$MYLAN$$$$$F$Y$$$20240723$$CN$US$US
241291662$24129166$2$F$20240101$20240906$20240723$20240913$PER$$US-Eisai-EC-2024-170558$EISAI$$73$YR$E$F$Y$$$20240913$$CN$US$US
241291671$24129167$1$I$20240624$20240718$20240723$20240723$PER$$US-Eisai-EC-2024-168830$EISAI$$61$YR$A$M$Y$$$20240723$$CN$US$US
241291692$24129169$2$F$20240701$20240910$20240723$20240916$EXP$$CH-AstraZeneca-2024A165146$ASTRAZENECA$$68$YR$$F$Y$$$20240916$$HP$CH$
241291701$24129170$1$I$$20240717$20240723$20240723$EXP$$US-MYLANLABS-2024M1068179$MYLAN$Bollam RR, Reddy VK. Persistent Pseudomonas Aeruginosa Pneumonia Due to Antimicrobial Resistance Development Requiring Lobectomy. Am-J-Respir-Crit-Care-Med 2024; 209 (0): (plus Poster).$56$YR$$F$Y$$$20240723$$HP$US$US
241291711$24129171$1$I$$20240716$20240723$20240723$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-099908$REGENERON$Masahiro Taguchi, Yoshifumi Takahashi, Kohei Tamura, Miki Shinohara, Takahiro Koyanagi, Suzuyo Takahashi, Akiyo Taneichi.. 0S-195 Experience with cemiplimab therapy for advanced or recurrent cervical cancer.. Japanese Journal of Gynecologic Oncology.. 2024;42(3):306$$$$F$Y$$$20240723$$MD$JP$JP
241291721$24129172$1$I$20240719$20240722$20240723$20240723$PER$$NVSC2024US151013$NOVARTIS$$79$YR$$F$Y$$$20240723$$CN$US$US
241291741$24129174$1$I$20240101$20240718$20240723$20240723$EXP$$FR-MYLANLABS-2024M1067881$MYLAN$$83$YR$$M$Y$$$20240723$$CN$FR$FR
241291751$24129175$1$I$$20240717$20240723$20240723$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07044$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240723$$HP$US$US
241291762$24129176$2$F$20230818$20240918$20240723$20240923$EXP$$FR-009507513-2407FRA011130$MERCK$$$$E$F$Y$$$20240923$$HP$FR$FR
241291771$24129177$1$I$20240701$20240718$20240723$20240723$EXP$$US-BAUSCH-BL-2024-011118$BAUSCH AND LOMB$$$$$M$Y$$$20240723$$MD$US$US
241291781$24129178$1$I$$20240705$20240723$20240723$PER$$US-JNJFOC-20240718168$JOHNSON AND JOHNSON$$$$$$Y$$$20240723$$CN$US$US
241291792$24129179$2$F$$20240909$20240723$20240923$PER$$US-SA-2024SA210937$SANOFI AVENTIS$$$$E$M$Y$$$20240923$$MD$US$US
241291801$24129180$1$I$20231201$20240717$20240723$20240723$PER$$US-SA-2024SA211527$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240723$$MD$US$US
241291811$24129181$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210907$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240723$$MD$US$US
241291833$24129183$3$F$$20240808$20240723$20240809$EXP$$ES-PFIZER INC-202400219174$PFIZER$Anto, C.. USE OF ISAVUCONAZOLE IN CHILDREN WITH INVASIVE FUNGAL INFECTION: EXPERIENCE IN A PAEDIATRIC AND TERTIARY CARE CENTRE. 493$16$YR$$F$Y$52$KG$20240809$$MD$ES$ES
241291841$24129184$1$I$20240701$20240717$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011203$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240723$$CN$US$US
241291852$24129185$2$F$$20240711$20240723$20240726$EXP$$US-OTTER-US-2024AST000263$UNKNOWN$$$$$F$Y$$$20240726$$CN$US$US
241291861$24129186$1$I$$20240722$20240723$20240723$EXP$$US-GILEAD-2024-0681558$GILEAD$$68$YR$E$M$Y$$$20240723$$CN$US$US
241291871$24129187$1$I$$20240719$20240723$20240723$EXP$$NVSC2024AU149923$NOVARTIS$$58$YR$$M$Y$$$20240723$$HP$AU$AU
241291881$24129188$1$I$$20240722$20240723$20240723$PER$$NVSC2024US151072$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
241291891$24129189$1$I$20230301$20240711$20240723$20240723$EXP$FR-AFSSAPS-GR2024000833$FR-TEVA-VS-3220910$TEVA$$46$YR$$F$Y$$$20240723$$PH$FR$FR
241291901$24129190$1$I$$20240719$20240723$20240723$EXP$$US-PFIZER INC-202400221111$PFIZER$$38$YR$$F$Y$$$20240723$$CN$US$US
241291913$24129191$3$F$$20240730$20240723$20240806$EXP$$IL-PFIZER INC-PV202400094265$PFIZER$$87$YR$$M$Y$$$20240806$$MD$IL$IL
241291922$24129192$2$F$20240101$20240806$20240723$20240808$EXP$$CA-PFIZER INC-202400032286$PFIZER$$68$YR$$M$Y$$$20240808$$PH$CA$CA
241291931$24129193$1$I$20240523$20240722$20240723$20240723$EXP$ES-AEMPS-1550304$ES-PFIZER INC-202400220461$PFIZER$$53$YR$$F$Y$$$20240723$$MD$ES$ES
241291944$24129194$4$F$20240711$20240825$20240723$20240829$EXP$$US-GILEAD-2024-0681268$GILEAD$$59$YR$A$F$Y$120.64$KG$20240829$$HP$US$US
241291962$24129196$2$F$$20240910$20240723$20240918$EXP$$NVSC2024BR148851$NOVARTIS$$$$$F$Y$$$20240918$$CN$BR$BR
241291971$24129197$1$I$$20240722$20240723$20240723$EXP$$CA-HLS-202401823$HLS THERAPEUTICS$$$$$M$Y$$$20240723$$HP$CA$CA
241291981$24129198$1$I$20240711$20240712$20240723$20240723$PER$$US-SMPA-2024SPA000142$SUNOVION$$$$$$Y$$$20240723$$CN$US$US
241291991$24129199$1$I$$20240717$20240723$20240723$PER$$US-SA-2024SA129601$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240723$$MD$US$US
241292001$24129200$1$I$20240101$20240715$20240723$20240723$PER$$US-SA-2024SA211677$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240723$$MD$US$US
241292011$24129201$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210895$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240723$$MD$US$US
241292021$24129202$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210868$SANOFI AVENTIS$$$$A$M$Y$77.56$KG$20240723$$MD$US$US
241292031$24129203$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA210866$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240723$$MD$US$US
241292041$24129204$1$I$20240101$20240716$20240723$20240723$PER$$US-SA-2024SA210859$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240723$$MD$US$US
241292051$24129205$1$I$$20240722$20240723$20240723$PER$$NVSC2024US150621$NOVARTIS$$$$$$Y$$$20240723$$CN$US$US
241292061$24129206$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210860$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240723$$MD$US$US
241292071$24129207$1$I$$20240722$20240723$20240723$PER$$NVSC2024US151074$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
241292081$24129208$1$I$$20240722$20240723$20240723$PER$$NVSC2024US150976$NOVARTIS$$$$$$Y$$$20240723$$HP$US$US
241292092$24129209$2$F$20240606$20240808$20240723$20240814$EXP$$IE-MYLANLABS-2024M1067332$MYLAN$$79$YR$$M$Y$$$20240814$$HP$IE$IE
241292101$24129210$1$I$20240619$20240717$20240723$20240723$EXP$FR-AFSSAPS-AVCN2024000517$FR-MYLANLABS-2024M1067239$MYLAN$$22$YR$$M$Y$$$20240723$$MD$FR$FR
241292111$24129211$1$I$$20240715$20240723$20240723$EXP$$ID-AstraZeneca-2024A163184$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$ID$
241292121$24129212$1$I$$20240718$20240723$20240723$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-116644$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240723$$MD$FR$FR
241292131$24129213$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013609$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240723$$CN$US$US
241292141$24129214$1$I$$20240717$20240723$20240723$EXP$IT-MINISAL02-994741$IT-MYLANLABS-2024M1067174$MYLAN$$34$YR$$M$Y$$$20240723$$MD$IT$IT
241292151$24129215$1$I$$20240722$20240723$20240723$PER$$NVSC2024US151059$NOVARTIS$$$$$F$Y$$$20240723$$CN$US$US
241292161$24129216$1$I$$20240722$20240723$20240723$PER$$CA-HLS-202401826$HLS THERAPEUTICS$$$$$F$Y$$$20240723$$HP$CA$CA
241292171$24129217$1$I$$20240709$20240723$20240723$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR01020$TARO$$$$$$Y$$$20240724$$HP$CA$CA
241292182$24129218$2$F$20240105$20240819$20240723$20240827$EXP$$US-APELLIS-APL-2024-003579$APELLIS PHARMACEUTICALS$Minaker, S., Mansour, H., Regillo, C., Pieramici, D., Brown, D., Pearlman, J., Saperstein, D., Wykoff, C., Miller, M.C., Escalona-Benz, E., Holcomb, D., Ham, D., Cone, C., Quinn, K., MacCumber, M.. Real-World practice patterns and adverse events of pegcetacoplan injection for Geographic Atrophy.$$$$$Y$$$20240827$$MD$US$US
241292191$24129219$1$I$$20240722$20240723$20240723$EXP$$CA-HLS-202401828$HLS THERAPEUTICS$$51$YR$A$M$Y$$$20240723$$HP$CA$CA
241292201$24129220$1$I$$20240717$20240723$20240723$PER$$JP-Eisai-EC-2024-170670$EISAI$$$$E$M$Y$$$20240723$$MD$JP$JP
241292213$24129221$3$F$20240712$20240806$20240723$20240813$EXP$$US-BAYER-2024A104061$BAYER$$35$YR$A$M$Y$$$20240813$$CN$US$US
241292224$24129222$4$F$20240601$20240911$20240723$20240919$PER$$JP-Eisai-EC-2024-170511$EISAI$$$$E$F$Y$$$20240919$$MD$JP$JP
241292231$24129223$1$I$$20240709$20240723$20240723$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR01022$TARO$$$$$$Y$$$20240724$$HP$CA$CA
241292241$24129224$1$I$20240304$20240717$20240723$20240723$EXP$$NVSC2024ES117482$NOVARTIS$$76$YR$$F$Y$70.5$KG$20240723$$MD$ES$ES
241292261$24129226$1$I$$20240716$20240723$20240723$EXP$$CA-MYLANLABS-2024M1068093$MYLAN$Lundby C, Farrell B, Wilson A. Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects. Br-J-Clin-Pharmacol 2024; 90 (7).$76$YR$$F$Y$$$20240723$$HP$CA$CA
241292271$24129227$1$I$$20240716$20240723$20240723$EXP$$RO-MYLANLABS-2024M1068077$MYLAN$Dolfi A, Tudose C. Obsessive-compulsive disorder in a woman with high-functioning autism. Dusunen-Adam 2024; 37 114-116.$24$YR$$F$Y$$$20240723$$HP$RO$RO
241292302$24129230$2$F$$20240914$20240723$20240920$EXP$$IN-INCYTE CORPORATION-2024IN007680$INCYTE$$$$$$Y$$$20240920$$CN$IN$IN
241292321$24129232$1$I$20240601$20240717$20240723$20240723$PER$$US-Eisai-EC-2024-170385$EISAI$$59$YR$A$F$Y$83.5$KG$20240723$$CN$US$US
241292331$24129233$1$I$20230801$20240716$20240723$20240723$PER$$US-SA-2024SA212150$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240723$$MD$US$US
241292341$24129234$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA212132$SANOFI AVENTIS$$$$A$M$Y$$$20240723$$MD$US$US
241292351$24129235$1$I$$20240717$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007535$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241292361$24129236$1$I$$20210428$20240723$20240723$EXP$$BR-AstraZeneca-2021A379482$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$BR$
241292371$24129237$1$I$20240604$20240715$20240723$20240723$EXP$$CN-AstraZeneca-2024A163104$ASTRAZENECA$$68$YR$$F$Y$51$KG$20240723$$MD$CN$
241292391$24129239$1$I$$20240718$20240723$20240723$EXP$$ZA-AstraZeneca-2024A164251$ASTRAZENECA$$84$YR$$F$Y$$$20240723$$CN$ZA$
241292401$24129240$1$I$$20210520$20240723$20240723$EXP$$US-AstraZeneca-2021A462752$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241292411$24129241$1$I$$20240709$20240723$20240723$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR01023$TARO$$$$$$Y$$$20240724$$PH$CA$CA
241292421$24129242$1$I$$20240718$20240723$20240723$EXP$$CA-ORGANON-O2407CAN002061$ORGANON$$48$YR$$F$Y$68$KG$20240723$$HP$CA$CA
241292441$24129244$1$I$$20231220$20240723$20240723$PER$$US-SOMERSET-2023-US-001666$ODIN PHARMACEUTICALS$$74$YR$$F$Y$$$20240723$$CN$US$US
241292462$24129246$2$F$$20240717$20240723$20240730$30DAY$$US-NOVOPROD-1246563$NOVO NORDISK$$$$$F$Y$$$20240730$$CN$US$US
241292471$24129247$1$I$20240618$20240709$20240723$20240723$PER$$US-009507513-2407USA004354$MERCK$$64$YR$$M$Y$$$20240723$$CN$US$US
241292481$24129248$1$I$$20221121$20240723$20240723$EXP$$US-AstraZeneca-2022A389563$ASTRAZENECA$$$$$M$Y$$$20240723$$CN$US$
241292491$24129249$1$I$$20221222$20240723$20240723$EXP$$US-AstraZeneca-2022A416010$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241292501$24129250$1$I$$20200618$20240723$20240723$EXP$$US-AstraZeneca-2020SE79981$ASTRAZENECA$$$$$F$Y$$$20240723$$CN$US$
241292512$24129251$2$F$20240601$20240719$20240723$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116064$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240724$$CN$US$US
241292521$24129252$1$I$$20240708$20240723$20240723$EXP$$CA-MEDEXUS PHARMA, INC.-2024MED00326$MEDEXUS PHARMA$Bethany FW; Onofre M; Marina P; Yuka A. Drug-induced interstitial lung disease associated with dupilumab for the tr. JAAD CASE REPORTS. 2024;50:12-15$73$YR$$F$Y$$$20240723$$HP$CA$CA
241292531$24129253$1$I$20240601$20240712$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007394$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241292542$24129254$2$F$20210108$20240724$20240723$20240802$PER$$US-INCYTE CORPORATION-2024IN007549$INCYTE$$$$$$Y$$$20240802$$CN$US$US
241292551$24129255$1$I$$20240717$20240723$20240723$PER$$US-INCYTE CORPORATION-2024IN007567$INCYTE$$$$$$Y$$$20240723$$CN$US$US
241292561$24129256$1$I$$20240702$20240723$20240723$PER$$US-JNJFOC-20240708285$JOHNSON AND JOHNSON$$$$$M$Y$$$20240723$$CN$US$US
241292571$24129257$1$I$$20240718$20240723$20240723$EXP$$US-UROVANT SCIENCES GMBH-202407-URV-001086$UROVANT SCIENCES$$$$$F$Y$$$20240723$$HP$US$US
241292581$24129258$1$I$$20240718$20240723$20240723$EXP$$JP-UROVANT SCIENCES GMBH-202407-URV-001085$UROVANT SCIENCES$$90$YR$$F$Y$$$20240723$$HP$JP$US
241292591$24129259$1$I$$20240716$20240723$20240723$EXP$$US-UROVANT SCIENCES GMBH-202407-URV-001075$UROVANT SCIENCES$$$$$F$Y$$$20240723$$CN$US$US
241292601$24129260$1$I$$20240719$20240723$20240723$EXP$$US-UROVANT SCIENCES GMBH-202407-URV-001096$UROVANT SCIENCES$$$$$F$Y$80.272$KG$20240723$$CN$US$US
241292611$24129261$1$I$20240210$20240711$20240723$20240723$EXP$$US-APELLIS-APL-2024-004004$APELLIS PHARMACEUTICALS$Minaker, S., Mansour, H., Regillo, C., Pieramici, D., Brown, D., Pearlman, J., Saperstein, D., Wykoff, C., Miller, M.C., Escalona-Benz, E., Holcomb, D., Ham, D., Cone, C., Quinn, K., MacCumber, M.. Real-World practice patterns and adverse events of pegcetacoplan injection for Geographic Atrophy.$$$$$Y$$$20240723$$MD$US$US
241292621$24129262$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012893$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240723$$CN$US$US
241292631$24129263$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013253$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240723$$CN$US$US
241292641$24129264$1$I$$20240723$20240723$20240723$EXP$$JP-ANIPHARMA-2024-JP-000192$ANI$Takei S, Kinoshita H, Jamal M, et al.An autopsy case of intoxication caused by drug interaction with multiple psychotropic drugs, fluvoxamine, levomepromazine, and trihexyphenidyl..Legal Medicine.2024;70.$3$DEC$$F$Y$40$KG$20240723$$HP$JP$JP
241292652$24129265$2$F$20240627$20240718$20240723$20240725$EXP$$CN-009507513-2407CHN012199$MERCK$$77$YR$$F$Y$60$KG$20240725$$HP$CN$CN
241292661$24129266$1$I$$20240716$20240723$20240723$EXP$$JP-Eisai-EC-2024-170425$EISAI$Imanari Shun. Initial experience with lenvatinib + pembrolizumab therapy for renal cell carcinoma at our hospital. Abstracts of the 95th Gunma Regional Meeting of the Japanese Urological Association. 2024; -(-): 8-.$$$$$Y$$$20240723$$MD$JP$JP
241292671$24129267$1$I$$20240720$20240723$20240723$PER$$NVSC2024US150085$NOVARTIS$$$$$M$Y$$$20240723$$CN$US$US
241292682$24129268$2$F$$20240715$20240723$20240724$EXP$$NVSC2024CN149053$NOVARTIS$Zhang H, Peng Q, Zhao X, He Y, Liu J. Clofazimine enteropathy: a case of pigmentation of the whole small intestine caused by clofazimine. ENDOSCOPY. 2024;56:E578?579$32$YR$$M$Y$$$20240724$$HP$CN$CN
241292691$24129269$1$I$$20240715$20240723$20240723$EXP$$CA-ALXN-202407CAN000758CA$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240723$$HP$CA$CA
241292701$24129270$1$I$$20230503$20240723$20240723$PER$$US-SOMERSET-2023-US-000396$ODIN PHARMACEUTICALS$$84$YR$$M$Y$$$20240723$$CN$US$US
241292711$24129271$1$I$$20240711$20240723$20240723$PER$$US-APELLIS-2024-APL-0000468$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
241292721$24129272$1$I$$20240717$20240723$20240723$EXP$$US-GILEAD-2024-0681112$GILEAD$$$$A$M$Y$$$20240723$$CN$US$US
241292742$24129274$2$F$$20240731$20240723$20240809$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010961$JAZZ$$$$$M$Y$$$20240809$$MD$US$US
241292752$24129275$2$F$20240709$20240815$20240723$20240820$EXP$$US-ABBVIE-5846801$ABBVIE$$59$YR$$F$Y$71$KG$20240820$$MD$US$US
241292762$24129276$2$F$20240701$20240729$20240723$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041542$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240730$$CN$US$US
241292771$24129277$1$I$$20240722$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116997$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240723$$HP$US$US
241292781$24129278$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240760409$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240723$$PH$US$US
241292791$24129279$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240760181$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240723$$PH$US$US
241292802$24129280$2$F$$20240719$20240723$20240726$EXP$$NVSC2024TR150021$NOVARTIS$Kaplan MM, Cinel G, Celikel E. Lung Disease: A Rare but Devastating Complication of Systemic Juvenile Idiopathic Arthritis and the Use of Tofacitinib as a Treatment. ARCHIVOS DE BRONCONEUMOLOGIA. 2024;60:374-5$2$YR$$M$Y$$$20240726$$HP$TR$TR
241292811$24129281$1$I$20240601$20240717$20240723$20240723$PER$$JP-Eisai-EC-2024-170508$EISAI$$$$E$F$Y$$$20240723$$MD$JP$JP
241292821$24129282$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240760381$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240723$$PH$US$US
241292831$24129283$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240760383$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240723$$PH$US$US
241292842$24129284$2$F$20240716$20240814$20240723$20240822$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011151$JAZZ$$59$YR$$M$Y$$$20240822$$MD$JP$JP
241292861$24129286$1$I$$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024143909$AMGEN$$60$YR$A$F$Y$$$20240723$$CN$US$US
241292873$24129287$3$F$$20240905$20240723$20240906$PER$$NVSC2024US150805$NOVARTIS$$$$$M$Y$$$20240906$$CN$US$US
241292881$24129288$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014824$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240723$$CN$US$US
241292891$24129289$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012888$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240723$$CN$US$US
241292901$24129290$1$I$$20240708$20240723$20240723$EXP$$US-HLS-202400268$HLS THERAPEUTICS$$38$YR$A$M$Y$$$20240723$$MD$JP$US
241292911$24129291$1$I$20240718$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012891$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$US$US
241292931$24129293$1$I$$20230425$20240723$20240723$PER$$US-SOMERSET-2023-US-000352$ODIN PHARMACEUTICALS$$75$YR$$F$Y$$$20240723$$CN$US$US
241292941$24129294$1$I$20240101$20240716$20240723$20240723$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011149$JAZZ$$50$YR$$F$Y$$$20240723$$MD$JP$JP
241292951$24129295$1$I$$20240719$20240723$20240723$EXP$$CA-009507513-2407CAN012373$MERCK$$72$YR$$$Y$57$KG$20240723$$CN$CA$CA
241292961$24129296$1$I$$20240722$20240723$20240723$EXP$$BE-GILEAD-2024-0681209$GILEAD$$$$$M$Y$$$20240723$$PH$BE$BE
241292971$24129297$1$I$20240721$20240721$20240723$20240723$DIR$FDA-CDER-CTU-2024-50699$$FDA-CTU$$32$YR$$F$N$71.21$KG$20240721$N$$US$
241292982$24129298$2$F$$20240813$20240723$20240813$PER$$US-ALXN-202407USA001207US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241292993$24129299$3$F$20240624$20240801$20240723$20240816$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0614$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240816$$MD$US$US
241293001$24129300$1$I$$20240719$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116163$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240723$$CN$US$US
241293011$24129301$1$I$$20240711$20240723$20240723$EXP$$BE-APELLIS-APL-2024-003830$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240723$$HP$BE$BE
241293021$24129302$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013725$ELI LILLY AND CO$$$$$$Y$$$20240723$$MD$US$US
241293031$24129303$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014312$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240723$$CN$US$US
241293041$24129304$1$I$$20230516$20240723$20240723$PER$$US-SOMERSET-2023-US-000452$ODIN PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241293051$24129305$1$I$$20240718$20240723$20240723$EXP$$CA-TAKEDA-2024TUS073234$TAKEDA$$66$YR$$F$Y$$$20240723$$HP$CA$CA
241293063$24129306$3$F$20240709$20240827$20240723$20240903$30DAY$$MX-AMGEN-MEXSP2024139733$AMGEN$$$$$M$Y$$$20240903$$PH$MX$MX
241293071$24129307$1$I$$20240723$20240723$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041497$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240723$$CN$US$US
241293081$24129308$1$I$$20240717$20240723$20240723$EXP$$CA-TAKEDA-2024TUS072991$TAKEDA$$$$$F$Y$$$20240723$$HP$CA$CA
241293101$24129310$1$I$20171223$20240718$20240723$20240723$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010982$JAZZ$$55$YR$$M$Y$$$20240723$$HP$US$US
241293111$24129311$1$I$$20230731$20240723$20240723$PER$$US-SOMERSET-2023-US-001126$ODIN PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241293121$24129312$1$I$$20240709$20240723$20240723$PER$$US-TEVA-VS-3220755$TEVA$$$$$F$Y$$$20240723$$$US$US
241293131$24129313$1$I$$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014040$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240723$$CN$US$US
241293142$24129314$2$F$20240706$20240723$20240723$20240730$PER$$US-ALXN-202407USA001147US$ALEXION PHARMACEUTICALS$$61$YR$$M$Y$$$20240730$$CN$US$US
241293151$24129315$1$I$20240719$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012889$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240723$$HP$US$US
241293163$24129316$3$F$20230401$20240905$20240723$20240906$PER$$NVSC2024US150006$NOVARTIS$$91$YR$$M$Y$180$KG$20240906$$CN$US$US
241293172$24129317$2$F$20240327$20240724$20240723$20240726$EXP$IT-MINISAL02-995585$IT-GILEAD-2024-0681511$GILEAD$$54$YR$A$M$Y$$$20240726$$MD$IT$IT
241293181$24129318$1$I$20240413$20240722$20240723$20240723$EXP$IT-MINISAL02-995587$IT-GILEAD-2024-0681523$GILEAD$$58$YR$A$M$Y$$$20240723$$MD$IT$IT
241293191$24129319$1$I$$20240716$20240723$20240723$PER$$US-ALXN-202407USA001074US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240723$$CN$US$US
241293201$24129320$1$I$$20240708$20240723$20240723$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06853$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240723$$PH$US$US
241293211$24129321$1$I$$20240708$20240723$20240723$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06850$NEUROCRINE BIOSCIENCES$$$$E$F$Y$$$20240723$$HP$US$US
241293221$24129322$1$I$20240707$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012890$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240723$$CN$US$US
241293231$24129323$1$I$$20240716$20240723$20240723$PER$$US-ALXN-202407USA001055US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240723$$HP$US$US
241293242$24129324$2$F$20240101$20240819$20240723$20240903$PER$$US-009507513-2407USA000958$MERCK$$$$$F$Y$88.435$KG$20240903$$HP$US$US
241293252$24129325$2$F$20240618$20240722$20240723$20240723$PER$$US-GILEAD-2024-0681537$GILEAD$$75$YR$E$M$Y$$$20240723$$HP$US$US
241293261$24129326$1$I$20240413$20240709$20240723$20240723$EXP$$CA-HLS-202401711$HLS THERAPEUTICS$$66$YR$E$M$Y$$$20240723$$PH$CA$CA
241293271$24129327$1$I$20220121$20220203$20240723$20240723$PER$$US-SOMERSET-2022-US-000077$ODIN PHARMACEUTICALS$$70$YR$E$F$Y$$$20240723$$CN$US$US
241293281$24129328$1$I$$20230818$20240723$20240723$PER$$US-SOMERSET-2023-US-001227$ODIN PHARMACEUTICALS$$75$YR$$F$Y$$$20240723$$CN$US$US
241293291$24129329$1$I$$20240709$20240723$20240723$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07013$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240723$$MD$US$US
241293302$24129330$2$F$20240613$20240819$20240723$20240830$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07017$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240831$$HP$US$US
241293321$24129332$1$I$20240124$20240717$20240723$20240723$EXP$$PT-009507513-2406PRT006887$MERCK$$75$YR$$M$Y$$$20240723$$PH$PT$PT
241293331$24129333$1$I$20240501$20240529$20240723$20240723$PER$$US-LUNDBECK-DKLU3078711$LUNDBECK$$$$$$Y$$$20240723$$HP$US$US
241293343$24129334$3$F$$20240719$20240723$20240903$PER$$US-LUNDBECK-DKLU4000288$LUNDBECK$$$$$$Y$$$20240903$$CN$US$US
241293351$24129335$1$I$20240601$20240709$20240723$20240723$EXP$$US-HLS-202400305$HLS THERAPEUTICS$$34$YR$A$$Y$$$20240723$$MD$US$US
241293361$24129336$1$I$$20240722$20240723$20240723$EXP$$AU-GILEAD-2024-0681553$GILEAD$$$$E$M$Y$$$20240723$$CN$AU$AU
241293371$24129337$1$I$20240722$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014080$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240723$$CN$US$US
241293381$24129338$1$I$20240401$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407014838$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240723$$CN$US$US
241293391$24129339$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013722$ELI LILLY AND CO$$$$A$F$Y$$$20240723$$CN$US$US
241293401$24129340$1$I$20240721$20240722$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013907$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240723$$CN$US$US
241293411$24129341$1$I$20240716$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013707$ELI LILLY AND CO$$$$$F$Y$$$20240723$$CN$US$US
241293421$24129342$1$I$$20240719$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407013710$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$US$US
241293431$24129343$1$I$$20240722$20240723$20240723$EXP$$AU-GILEAD-2024-0681554$GILEAD$$$$A$M$Y$$$20240723$$CN$AU$AU
241293442$24129344$2$F$$20240807$20240723$20240808$PER$$US-ALXN-202407USA001205US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
241293451$24129345$1$I$$20240722$20240723$20240723$EXP$$AU-GILEAD-2024-0681555$GILEAD$$$$A$M$Y$$$20240723$$CN$AU$AU
241293462$24129346$2$F$$20240730$20240723$20240812$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI07203$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240812$$PH$JP$JP
241293471$24129347$1$I$$20240722$20240723$20240723$EXP$$AU-GILEAD-2024-0681556$GILEAD$$$$A$F$Y$$$20240723$$CN$AU$AU
241293481$24129348$1$I$20240514$20240611$20240723$20240723$PER$$US-JNJFOC-20240759193$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240723$$PH$US$US
241293491$24129349$1$I$$20240510$20240723$20240723$PER$$US-AMGEN-USASP2024133527$AMGEN$$$$$$Y$$$20240706$$CN$US$US
241293501$24129350$1$I$$20240709$20240723$20240723$EXP$$US-HLS-202400297$HLS THERAPEUTICS$$$$E$$Y$$$20240723$$PH$US$US
241293513$24129351$3$F$$20240822$20240723$20240828$PER$$US-ALXN-202407USA001177US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
241293522$24129352$2$F$20240717$20240726$20240723$20240801$EXP$$GB-JNJFOC-20240759790$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240801$$CN$GB$GB
241293531$24129353$1$I$$20240709$20240723$20240723$EXP$$US-HLS-202400303$HLS THERAPEUTICS$$$$A$$Y$$$20240723$$MD$US$US
241293541$24129354$1$I$$20240722$20240723$20240723$EXP$$GB-GILEAD-2024-0681605$GILEAD$$$$$F$Y$$$20240723$$HP$GB$GB
241293551$24129355$1$I$$20240719$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116763$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240723$$CN$US$US
241293561$24129356$1$I$$20230323$20240723$20240723$PER$$US-SOMERSET-2023-US-000231$ODIN PHARMACEUTICALS$$$$$F$Y$$$20240723$$CN$US$US
241293571$24129357$1$I$$20240717$20240723$20240723$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407011780$ELI LILLY AND CO$$$$$M$Y$$$20240723$$MD$GB$GB
241293581$24129358$1$I$$20240712$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011923$ELI LILLY AND CO$Guo W.,Lozeau D.,Tonnesen M.,Schuval S.,de Jesus A.,Miller D, et. al..A case of mother and child with CANDLE syndrome: Diagnosis and subsequent treatment with baricitinib..Pediatric Dermatology. 2024;:1-4.DOI:10.1111/pde.15667$2$YR$I$M$Y$$$20240723$$MD$US$US
241293591$24129359$1$I$$20240716$20240723$20240723$PER$$US-SA-2024SA210627$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$MD$US$US
241293601$24129360$1$I$20240709$20240711$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007662$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240723$$CN$US$US
241293611$24129361$1$I$$20240718$20240723$20240723$EXP$$US-LUNDBECK-DKLU4001977$LUNDBECK$$$$$$Y$$$20240724$$CN$US$US
241293621$24129362$1$I$$20240710$20240723$20240723$EXP$GB-MHRA-MED-202407102006561080-TBQPH$GB-ELI_LILLY_AND_COMPANY-GB202407007462$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240723$$CN$GB$GB
241293631$24129363$1$I$20231215$20240719$20240723$20240723$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013717$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240723$$CN$US$US
241293641$24129364$1$I$$20240723$20240723$20240723$PER$$US-GILEAD-2024-0681625$GILEAD$$$$$$Y$$$20240723$$PH$US$US
241293651$24129365$1$I$20201201$20240718$20240723$20240723$EXP$$FR-LUNDBECK-DKLU4002027$LUNDBECK$$$$$$Y$$$20240724$$CN$FR$FR
241293661$24129366$1$I$20240101$20240718$20240723$20240723$EXP$$US-009507513-2407USA011788$MERCK$$73$YR$$F$Y$97.959$KG$20240723$$CN$US$US
241293671$24129367$1$I$$20240718$20240723$20240723$EXP$$NVSJ2024JP007537$NOVARTIS$$$$$M$Y$$$20240724$$PH$JP$JP
241293682$24129368$2$F$20240101$20240725$20240723$20240731$EXP$$US-JNJFOC-20240747881$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240731$$CN$US$US
241293691$24129369$1$I$$20240716$20240723$20240723$EXP$$TR-ELI_LILLY_AND_COMPANY-TR202407010896$ELI LILLY AND CO$Acar U, Kucuk B, Agin A, Koc M, Sobaci G..Case report of tadalafil-induced central serous chorioretinopath.J Clin Exp Ophthalmol 2024;5 (357):1-3.DOI:10.4172/2155-9570.1000357$47$YR$A$M$Y$$$20240723$$MD$TR$TR
241293703$24129370$3$F$20240715$20240810$20240723$20240815$EXP$$NVSC2024CO149310$NOVARTIS$$51$YR$$F$Y$64$KG$20240815$$CN$CO$CO
241293711$24129371$1$I$20240622$20240719$20240723$20240723$EXP$FR-AFSSAPS-LL2024001319$FR-SANDOZ INC.-SDZ2024FR067004$SANDOZ$$60$YR$$M$Y$107$KG$20240723$$PH$FR$FR
241293721$24129372$1$I$$20240722$20240723$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA067075$SANDOZ$$14$YR$$F$Y$$$20240723$$MD$CA$CA
241293731$24129373$1$I$$20240719$20240723$20240723$EXP$$CA-SANDOZ INC.-SDZ2024CA066934$SANDOZ$$$$$M$Y$$$20240723$$MD$CA$CA
241293741$24129374$1$I$20240301$20240624$20240723$20240723$PER$$US-009507513-2406USA008600$MERCK$$86$YR$$F$Y$$$20240723$$CN$US$US
241293751$24129375$1$I$$20240723$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117061$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240724$$HP$US$US
241293761$24129376$1$I$$20240716$20240723$20240723$EXP$$US-JNJFOC-20240744588$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240724$$MD$US$US
241293771$24129377$1$I$$20240717$20240723$20240723$EXP$$JP-009507513-2407JPN003323J$MERCK$$7$DEC$$M$Y$$$20240723$$MD$JP$JP
241293781$24129378$1$I$$20240723$20240723$20240723$EXP$$NVSC2024UZ150964$NOVARTIS$$$$A$F$Y$$$20240724$$MD$UZ$UZ
241293791$24129379$1$I$$20240718$20240723$20240723$EXP$$NVSJ2024JP008799$NOVARTIS$$$$$$Y$$$20240724$$MD$JP$JP
241293802$24129380$2$F$20240717$20240816$20240723$20240821$PER$$US-AMGEN-USASP2024143425$AMGEN$$70$YR$E$M$Y$$$20240820$$CN$US$US
241293811$24129381$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143495$AMGEN$Michalowski M.; Wilk S.; Michalowski W. et al.. Provision and evaluation of explanations within an automated planning-based approach to solving the multimorbidity problem. Journal of Biomedical Informatics. 2024;156:1-25$70$YR$E$M$Y$$$20240723$$HP$US$US
241293821$24129382$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-114913$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$MD$JP$JP
241293831$24129383$1$I$$20240712$20240723$20240723$EXP$$US-BIOGEN-2024BI01273789$BIOGEN$$$$$F$Y$$$20240723$$CN$US$US
241293842$24129384$2$F$20240702$20240823$20240723$20240827$EXP$$NVSJ2024JP007881$NOVARTIS$$74$YR$$M$Y$$$20240828$$PH$JP$JP
241293852$24129385$2$F$$20240812$20240723$20240813$EXP$$US-ALXN-202407USA001028US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240813$$MD$US$US
241293862$24129386$2$F$20240101$20240807$20240723$20240812$EXP$$JP-SAKK-2024SA210368AA$SANOFI AVENTIS$$$$$$Y$$$20240813$$MD$JP$JP
241293871$24129387$1$I$20240711$20240718$20240723$20240723$EXP$$US-ABBVIE-5845822$ABBVIE$$69$YR$$M$Y$$$20240723$$CN$US$US
241293881$24129388$1$I$20240719$20240722$20240723$20240723$EXP$$US-ABBVIE-5849639$ABBVIE$$$$$$Y$$$20240723$$CN$US$US
241293891$24129389$1$I$20240708$20240713$20240723$20240723$EXP$$US-BIOGEN-2024BI01273813$BIOGEN$$$$$F$Y$$$20240723$$HP$US$US
241293901$24129390$1$I$20240429$20240716$20240723$20240723$EXP$FR-AFSSAPS-PC2024000578$FR-BIOGEN-2024BI01274125$BIOGEN$$65$YR$$M$Y$62$KG$20240723$$MD$FR$FR
241293912$24129391$2$F$20240501$20240918$20240723$20240919$EXP$FR-AFSSAPS-AN2024000917$FR-JNJFOC-20240760694$JOHNSON AND JOHNSON$$63$YR$A$$Y$$$20240919$$MD$FR$FR
241293921$24129392$1$I$$20240723$20240723$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041499$BOEHRINGER INGELHEIM$$$$$$Y$$$20240724$$CN$US$US
241293931$24129393$1$I$20240710$20240719$20240723$20240723$EXP$HR-HALMED-300086197$HR-BRISTOL-MYERS SQUIBB COMPANY-2024-116028$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$85$KG$20240724$$MD$HR$HR
241293941$24129394$1$I$20240720$20240723$20240723$20240723$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041526$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240724$$CN$US$US
241293951$24129395$1$I$$20240717$20240723$20240723$EXP$$CA-ABBVIE-5846170$ABBVIE$$$$A$F$Y$$$20240723$$CN$CA$CA
241293961$24129396$1$I$$20240719$20240723$20240723$PER$$US-JNJFOC-20240752511$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$HP$US$US
241293971$24129397$1$I$$20240722$20240723$20240723$PER$$NVSC2024US151078$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241293981$24129398$1$I$20240101$20240711$20240723$20240723$EXP$$US-ABBVIE-5667403$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241293991$24129399$1$I$20240511$20240722$20240723$20240723$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041393$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240724$$CN$BR$BR
241294001$24129400$1$I$20240101$20240717$20240723$20240723$EXP$$CA-ABBVIE-5832427$ABBVIE$$62$YR$$M$Y$$$20240723$$CN$CA$CA
241294021$24129402$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5847100$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241294031$24129403$1$I$$20240716$20240723$20240723$PER$$US-ALXN-202407USA001257US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
241294043$24129404$3$F$$20240923$20240723$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116510$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240925$$HP$US$US
241294051$24129405$1$I$20240716$20240716$20240723$20240723$EXP$$US-JNJFOC-20240745726$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240724$$MD$US$US
241294061$24129406$1$I$20230101$20240701$20240723$20240723$PER$$US-009507513-2407USA000928$MERCK$$$$$M$Y$$$20240723$$CN$US$US
241294071$24129407$1$I$20240723$20240723$20240723$20240723$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041545$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240724$$CN$US$US
241294082$24129408$2$F$$20240912$20240723$20240923$EXP$$CA-TAKEDA-2024TUS073023$TAKEDA$$$$$F$Y$$$20240923$$CN$CA$CA
241294091$24129409$1$I$20240704$20240708$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407006728$ELI LILLY AND CO$$18$YR$A$F$Y$49.887$KG$20240723$$CN$US$US
241294102$24129410$2$F$$20240730$20240723$20240801$PER$$NVSC2024US151081$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241294111$24129411$1$I$$20240716$20240723$20240723$EXP$$US-JNJFOC-20240742775$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
241294122$24129412$2$F$20240529$20240910$20240723$20240917$EXP$$CA-ABBVIE-5845812$ABBVIE$$68$YR$$F$Y$$$20240917$$CN$CA$CA
241294131$24129413$1$I$20240101$20240719$20240723$20240723$EXP$$GB-ABBVIE-5847017$ABBVIE$$53$YR$$F$Y$$$20240723$$CN$GB$GB
241294141$24129414$1$I$$20240719$20240723$20240723$EXP$$US-ABBVIE-5847621$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241294151$24129415$1$I$20240717$20240718$20240723$20240723$30DAY$$US-SANDOZ INC.-SDZ2024US066894$SANDOZ$$5$YR$$M$Y$$$20240723$$CN$US$US
241294161$24129416$1$I$$20240718$20240723$20240723$30DAY$$US-SANDOZ INC.-SDZ2024US067017$SANDOZ$$$$$M$Y$$$20240723$$CN$US$US
241294171$24129417$1$I$$20240718$20240723$20240723$EXP$$US-JNJFOC-20240756472$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240724$$MD$US$US
241294181$24129418$1$I$$20240716$20240723$20240723$EXP$$CA-JNJFOC-20240744856$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240724$$HP$CA$CA
241294191$24129419$1$I$$20240722$20240723$20240723$PER$$NVSC2024US150843$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241294201$24129420$1$I$20240716$20240719$20240723$20240723$EXP$$US-ABBVIE-5848584$ABBVIE$$65$YR$$M$Y$$$20240723$$CN$US$US
241294211$24129421$1$I$$20240716$20240723$20240723$EXP$$US-JNJFOC-20240747886$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240724$$HP$US$US
241294221$24129422$1$I$20240710$20240716$20240723$20240723$EXP$$DE-JNJFOC-20240732885$JOHNSON AND JOHNSON$$$$E$M$Y$71.4$KG$20240724$$MD$DE$DE
241294231$24129423$1$I$20240101$20240717$20240723$20240723$EXP$$US-ABBVIE-5844631$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241294241$24129424$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5846153$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241294251$24129425$1$I$20231027$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144910$AMGEN$$59$YR$A$F$Y$$$20240723$$HP$US$US
241294261$24129426$1$I$20240702$20240715$20240723$20240723$PER$$US-ABBVIE-5843722$ABBVIE$$58$YR$$F$Y$88$KG$20240723$$CN$US$US
241294271$24129427$1$I$20240101$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024142722$AMGEN$$32$YR$A$F$Y$$$20240723$$CN$US$US
241294281$24129428$1$I$20230724$20240714$20240723$20240723$PER$$US-JNJFOC-20240740397$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240724$$HP$US$US
241294293$24129429$3$F$$20240731$20240723$20240809$EXP$$CA-HALEON-2187790$Haleon PLC$$44$YR$$F$Y$$$20240809$$HP$CA$CA
241294302$24129430$2$F$20240601$20240821$20240723$20240828$EXP$$CO-BIOGEN-2024BI01274361$BIOGEN$$54$YR$$F$Y$57.5$KG$20240828$$CN$CO$CO
241294311$24129431$1$I$20240101$20240718$20240723$20240723$EXP$$US-ABBVIE-5848032$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241294321$24129432$1$I$$20240719$20240723$20240723$EXP$$US-ABBVIE-5848726$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241294331$24129433$1$I$20240512$20240718$20240723$20240723$EXP$$US-ABBVIE-5846627$ABBVIE$$48$YR$$M$Y$$$20240723$$CN$US$US
241294343$24129434$3$F$20240723$20240811$20240723$20240814$EXP$$US-ABBVIE-5844713$ABBVIE$$82$YR$$F$Y$51.255$KG$20240814$$CN$US$US
241294352$24129435$2$F$20240701$20240809$20240723$20240814$EXP$$CA-ABBVIE-5848814$ABBVIE$$39$YR$$M$Y$$$20240814$$CN$CA$CA
241294361$24129436$1$I$20240717$20240715$20240723$20240723$PER$$US-ALXN-202407USA001244US$ALEXION PHARMACEUTICALS$$77$YR$$M$Y$$$20240724$$CN$US$US
241294371$24129437$1$I$$20240716$20240723$20240723$PER$$US-BAUSCHBL-2024BNL030190$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240724$$HP$US$US
241294381$24129438$1$I$$20240715$20240723$20240723$PER$$US-BAUSCHBL-2024BNL030384$BAUSCH AND LOMB$$$$$F$Y$$$20240724$$CN$US$US
241294392$24129439$2$F$$20240719$20240723$20240805$EXP$$NL-JNJFOC-20240713742$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$PH$NL$NL
241294401$24129440$1$I$20240209$20240716$20240723$20240723$EXP$$BR-JNJFOC-20240750000$JOHNSON AND JOHNSON$$53$YR$A$F$Y$71$KG$20240724$$CN$BR$BR
241294411$24129441$1$I$$20240716$20240723$20240723$EXP$$JP-JNJFOC-20240759889$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240724$$MD$JP$JP
241294421$24129442$1$I$20231201$20240723$20240723$20240723$EXP$FR-AFSSAPS-AN2024000916$FR-JNJFOC-20240760904$JOHNSON AND JOHNSON$$74$YR$E$$Y$$$20240724$$MD$FR$FR
241294432$24129443$2$F$$20240730$20240723$20240731$EXP$$NVSJ2024JP008941$NOVARTIS$$$$$$Y$$$20240801$$PH$JP$JP
241294441$24129444$1$I$20240701$20240716$20240723$20240723$PER$$US-BAUSCHBL-2024BNL030249$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240724$$CN$US$US
241294451$24129445$1$I$$20240722$20240723$20240723$EXP$$CA-HALEON-2188099$Haleon PLC$$52$YR$$M$Y$$$20240723$$HP$CA$CA
241294461$24129446$1$I$$20240717$20240723$20240723$PER$$US-LEO Pharma-372173$LEO PHARM$$77$YR$$F$Y$$$20240724$$PH$US$US
241294471$24129447$1$I$20220101$20240716$20240723$20240723$EXP$$US-ABBVIE-5689021$ABBVIE$$$$$M$Y$87$KG$20240723$$CN$US$US
241294481$24129448$1$I$$20240716$20240723$20240723$PER$$US-BAUSCHBL-2024BNL030252$BAUSCH AND LOMB$$53$YR$$F$Y$$$20240724$$CN$US$US
241294492$24129449$2$F$20240702$20240717$20240723$20240828$EXP$$CN-HALEON-2187779$Haleon PLC$$73$YR$$F$Y$41$KG$20240828$$HP$CN$CN
241294511$24129451$1$I$$20240708$20240723$20240723$PER$$US-TEVA-VS-3219636$TEVA$$$$$$Y$$$20240723$$CN$US$US
241294521$24129452$1$I$20230601$20240717$20240723$20240723$EXP$$US-ABBVIE-5845728$ABBVIE$$54$YR$$M$Y$$$20240723$$CN$US$US
241294531$24129453$1$I$$20240716$20240723$20240723$EXP$$US-JNJFOC-20240748964$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$MD$US$US
241294542$24129454$2$F$20240701$20240723$20240723$20240729$EXP$$GB-ABBVIE-5846659$ABBVIE$$58$YR$$M$Y$$$20240729$$CN$GB$GB
241294551$24129455$1$I$20240714$20240715$20240723$20240723$EXP$$CA-ABBVIE-5846870$ABBVIE$$$$A$M$Y$124$KG$20240723$$CN$CA$CA
241294561$24129456$1$I$20240101$20240719$20240723$20240723$EXP$$US-ABBVIE-5848557$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241294571$24129457$1$I$$20240718$20240723$20240723$EXP$$US-ABBVIE-5847733$ABBVIE$$$$$M$Y$$$20240723$$MD$US$US
241294581$24129458$1$I$20240101$20240716$20240723$20240723$EXP$$US-ABBVIE-5826525$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241294591$24129459$1$I$20240717$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024143918$AMGEN$$83$YR$E$F$Y$$$20240723$$CN$US$US
241294601$24129460$1$I$$20240705$20240723$20240723$PER$$US-ABBVIE-5846119$ABBVIE$$$$$$Y$$$20240723$$CN$US$US
241294612$24129461$2$F$20240301$20240725$20240723$20240806$EXP$$GB-CELLTRION INC.-2024GB017439$CELLTRION$$$$$$Y$$$20240806$$CN$GB$GB
241294621$24129462$1$I$$20240717$20240723$20240723$EXP$$US-ABBVIE-5845707$ABBVIE$$$$$M$Y$$$20240723$$CN$US$US
241294641$24129464$1$I$20240101$20240719$20240723$20240723$EXP$$US-ABBVIE-5848685$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241294651$24129465$1$I$$20240718$20240723$20240723$EXP$$CA-ABBVIE-5846872$ABBVIE$$$$A$M$Y$$$20240723$$CN$CA$CA
241294661$24129466$1$I$$20240715$20240723$20240723$EXP$$CA-HALEON-2188013$Haleon PLC$$$$$F$Y$$$20240723$$HP$CA$CA
241294671$24129467$1$I$$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012323$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240723$$CN$US$US
241294681$24129468$1$I$$20240722$20240723$20240723$EXP$$NL-ABBVIE-5848162$ABBVIE$$71$YR$$F$Y$$$20240723$$HP$NL$NL
241294691$24129469$1$I$20240712$20240718$20240723$20240723$EXP$$JP-ASTELLAS-2024JP005179$ASTELLAS$$9$DEC$$M$Y$$$20240724$$MD$JP$JP
241294702$24129470$2$F$20240710$20240802$20240723$20240807$EXP$$JP-ASTELLAS-2024JP005105$ASTELLAS$$83$YR$$M$Y$$$20240807$$PH$JP$JP
241294711$24129471$1$I$$20240719$20240723$20240723$EXP$$US-ABBVIE-5848525$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241294721$24129472$1$I$20240609$20240718$20240723$20240723$EXP$$BE-ABBVIE-5846436$ABBVIE$$65$YR$$F$Y$$$20240723$$CN$BE$BE
241294731$24129473$1$I$$20240715$20240723$20240723$EXP$$CA-HALEON-2187731$Haleon PLC$$43$YR$$F$Y$$$20240722$$MD$CA$CA
241294741$24129474$1$I$20210806$20240716$20240723$20240723$PER$$US-ABBVIE-2129169US$ABBVIE$$27$YR$$F$Y$$$20240723$$HP$US$US
241294751$24129475$1$I$$20240716$20240723$20240723$EXP$$US-ASTELLAS-2024EU007135$ASTELLAS$$$$$M$Y$$$20240724$$CN$US$US
241294761$24129476$1$I$20240601$20240716$20240723$20240723$EXP$$US-ABBVIE-5845501$ABBVIE$$45$YR$$M$Y$$$20240723$$CN$US$US
241294771$24129477$1$I$20240701$20240718$20240723$20240723$EXP$$CN-ABBVIE-5844996$ABBVIE$$60$YR$$F$Y$45$KG$20240723$$MD$CN$CN
241294781$24129478$1$I$20240101$20240718$20240723$20240723$EXP$$US-ABBVIE-5848301$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241294791$24129479$1$I$$20240719$20240723$20240723$EXP$$US-ABBVIE-5847572$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241294801$24129480$1$I$20240715$20240718$20240723$20240723$EXP$$US-ABBVIE-5847626$ABBVIE$$74$YR$$F$Y$$$20240723$$CN$US$US
241294811$24129481$1$I$$20240708$20240723$20240723$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202407-000058$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240723$$CN$US$US
241294822$24129482$2$F$20240601$20240719$20240723$20240723$EXP$$JP-SA-2024SA211419$SANOFI AVENTIS$$$$E$F$Y$$$20240724$$CN$JP$JP
241294831$24129483$1$I$$20240718$20240723$20240723$PER$$US-ABBVIE-5848498$ABBVIE$$$$$F$Y$54$KG$20240723$$CN$US$US
241294842$24129484$2$F$20240701$20240810$20240723$20240815$30DAY$$US-AMGEN-USASP2024139737$AMGEN$$30$YR$A$M$Y$$$20240815$$HP$US$US
241294851$24129485$1$I$$20240718$20240723$20240723$PER$$US-LEO Pharma-372171$LEO PHARM$$67$YR$$M$Y$$$20240724$$CN$US$US
241294861$24129486$1$I$$20240722$20240723$20240723$EXP$$NVSC2024US150926$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241294871$24129487$1$I$$20240715$20240723$20240723$EXP$$CA-002147023-NVSC2024CA031624$Haleon PLC$$44$YR$$F$Y$$$20240722$$HP$CA$CA
241294881$24129488$1$I$20240717$20240717$20240723$20240723$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113959$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240724$$HP$US$US
241294893$24129489$3$F$20240617$20240730$20240723$20240803$EXP$$BR-CELLTRION INC.-2024BR017649$CELLTRION$$$$$$Y$$$20240803$$CN$BR$BR
241294901$24129490$1$I$20240501$20240716$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407011157$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240723$$CN$US$US
241294913$24129491$3$F$20240712$20240807$20240723$20240815$PER$$US-AMGEN-USASP2024140609$AMGEN$$54$YR$A$F$Y$116.5$KG$20240815$$PH$US$US
241294922$24129492$2$F$20230101$20240918$20240723$20240923$EXP$$GB-AMGEN-GBRSP2024145066$AMGEN$$45$YR$A$F$Y$$$20240923$$CN$GB$GB
241294941$24129494$1$I$$20240715$20240723$20240723$EXP$$CA-HALEON-2188150$Haleon PLC$$53$YR$$M$Y$$$20240723$$CN$CA$CA
241294951$24129495$1$I$20240718$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024143146$AMGEN$$60$YR$A$F$Y$$$20240723$$CN$US$US
241294961$24129496$1$I$$20240715$20240723$20240723$EXP$$AU-JNJFOC-20240741423$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240724$$HP$AU$AU
241294972$24129497$2$F$$20240730$20240723$20240801$EXP$$JP-GSK-JP2024JPN089666$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$PH$JP$JP
241294982$24129498$2$F$$20240802$20240723$20240807$EXP$$JP-GSK-JP2024090462$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$PH$JP$JP
241294991$24129499$1$I$20200519$20240717$20240723$20240723$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-116176$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$53$KG$20240724$$MD$KR$KR
241295002$24129500$2$F$$20240813$20240723$20240813$PER$$US-ALXN-202407USA001196US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241295012$24129501$2$F$$20240724$20240723$20240729$EXP$$FR-JNJFOC-20240757432$JOHNSON AND JOHNSON$$76$YR$E$F$Y$70$KG$20240729$$MD$FR$FR
241295021$24129502$1$I$$20240718$20240723$20240723$PER$$US-JNJFOC-20230165005$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$HP$US$US
241295031$24129503$1$I$$20240719$20240723$20240723$EXP$$US-JNJFOC-20240755854$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$HP$US$US
241295041$24129504$1$I$20240101$20240716$20240723$20240723$PER$$US-ABBVIE-5846295$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241295051$24129505$1$I$$20240709$20240723$20240723$EXP$$CA-HALEON-2188174$Haleon PLC$$43$YR$$$Y$$$20240723$$HP$CA$CA
241295061$24129506$1$I$$20240711$20240723$20240723$EXP$$CA-002147023-NVSC2020CA193186$Haleon PLC$$69$YR$$F$Y$$$20240723$$CN$CA$CA
241295071$24129507$1$I$$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024144490$AMGEN$$$$$F$Y$$$20240723$$MD$US$US
241295081$24129508$1$I$$20240722$20240723$20240723$EXP$$US-JNJFOC-20240757180$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$HP$US$US
241295092$24129509$2$F$$20240723$20240723$20240726$PER$$US-JNJFOC-20240758226$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$HP$US$US
241295103$24129510$3$F$20230701$20240729$20240723$20240807$EXP$FR-AFSSAPS-LL2024001394$FR-ABBVIE-5847919$ABBVIE$$65$YR$$F$Y$$$20240807$$MD$FR$FR
241295112$24129511$2$F$$20240918$20240723$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU066433$SANDOZ$$$$$$Y$$$20240920$$HP$AU$AU
241295121$24129512$1$I$$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144520$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241295131$24129513$1$I$20240718$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024144122$AMGEN$$81$YR$E$F$Y$$$20240723$$CN$US$US
241295141$24129514$1$I$$20240719$20240723$20240723$EXP$$US-ABBVIE-5847388$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241295151$24129515$1$I$$20240719$20240723$20240723$EXP$$US-ABBVIE-5848210$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241295161$24129516$1$I$$20240716$20240723$20240723$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115782$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$MD$JP$JP
241295172$24129517$2$F$$20240717$20240723$20240726$EXP$$GB-EMD Serono-2024039084$EMD SERONO INC$$57$YR$A$F$Y$$$20240726$$HP$GB$GB
241295181$24129518$1$I$20240101$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024142817$AMGEN$$54$YR$A$F$Y$$$20240723$$CN$US$US
241295192$24129519$2$F$20240713$20240723$20240723$20240726$PER$$US-AMGEN-USASP2024144078$AMGEN$$75$YR$E$F$Y$$$20240726$$CN$US$US
241295202$24129520$2$F$$20240722$20240723$20240726$PER$$NVSC2024US150962$NOVARTIS$$19$YR$$F$Y$$$20240726$$CN$US$US
241295212$24129521$2$F$20240716$20240725$20240723$20240805$EXP$$US-JNJFOC-20240756233$JOHNSON AND JOHNSON$$38$YR$A$F$Y$109.82$KG$20240805$$HP$US$US
241295222$24129522$2$F$$20240722$20240723$20240731$PER$$NVSC2024US150065$NOVARTIS$$$$$F$Y$$$20240731$$CN$US$US
241295232$24129523$2$F$$20240722$20240723$20240816$PER$$US-ROCHE-10000033492$ROCHE$$$$E$F$Y$$$20240816$$CN$US$US
241295241$24129524$1$I$$20240715$20240723$20240723$PER$$US-SA-2024SA208507$SANOFI AVENTIS$$$$$$Y$$$20240724$$HP$US$US
241295252$24129525$2$F$20240601$20240827$20240723$20240829$EXP$$NVSC2024DE142708$NOVARTIS$$$$E$F$Y$$$20240829$$MD$DE$DE
241295261$24129526$1$I$$20240718$20240723$20240723$EXP$$CA-ABBVIE-5846287$ABBVIE$$$$A$F$Y$$$20240723$$MD$CA$CA
241295271$24129527$1$I$$20240716$20240723$20240723$PER$$US-AMGEN-USASP2024145044$AMGEN$$$$A$M$Y$$$20240723$$HP$US$US
241295281$24129528$1$I$$20240715$20240723$20240723$EXP$$EG-AMGEN-EGYSP2024144659$AMGEN$$$$$F$Y$$$20240723$$CN$EG$EG
241295291$24129529$1$I$20240708$20240718$20240723$20240723$PER$$US-ELI_LILLY_AND_COMPANY-US202407012358$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240723$$PH$US$US
241295301$24129530$1$I$$20240717$20240723$20240723$EXP$$US-AMGEN-USASP2024142748$AMGEN$Tun H. W.; Wolf E. B.; Imperial R. et al. Clinical and Genomic Profile of Primary Cranial Neurolymphomatosis. Journal of Blood Medicine. 2024;15:291-303$57$YR$A$M$Y$$$20240723$$HP$US$US
241295312$24129531$2$F$$20240904$20240723$20240906$PER$$US-ROCHE-10000033347$ROCHE$$$$$F$Y$$$20240906$$PH$US$US
241295321$24129532$1$I$20240622$20240709$20240723$20240723$EXP$$CA-HLS-202401716$HLS THERAPEUTICS$$56$YR$A$F$Y$$$20240723$$CN$CA$CA
241295332$24129533$2$F$20240401$20240729$20240723$20240806$EXP$$GR-EMD Serono-2024039192$EMD SERONO INC$$67$YR$E$F$Y$$$20240806$$MD$GR$GR
241295341$24129534$1$I$$20240719$20240723$20240723$PER$$US-ROCHE-10000032775$ROCHE$$$$E$M$Y$$$20240724$$CN$US$US
241295361$24129536$1$I$$20240718$20240723$20240723$EXP$JP-MMM-Y8U6BTZ9$JP-GSK-JP2024090822$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$JP$JP
241295371$24129537$1$I$20240718$20240718$20240723$20240723$PER$$US-ABBVIE-5847585$ABBVIE$$53$YR$$F$Y$$$20240723$$CN$US$US
241295381$24129538$1$I$20190914$20240717$20240723$20240723$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117068$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$53$KG$20240724$$MD$KR$KR
241295393$24129539$3$F$20240514$20240730$20240723$20240802$EXP$$NVSC2024FR147452$NOVARTIS$$67$YR$$M$Y$73$KG$20240802$$MD$FR$FR
241295401$24129540$1$I$$20240709$20240723$20240723$PER$$US-RDY-SPO/USA/24/0010302$DR REDDYS$$$$$$Y$$$20240724$$CN$US$US
241295411$24129541$1$I$20240717$20240718$20240723$20240723$PER$$US-AMGEN-USASP2024144524$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241295421$24129542$1$I$$20240719$20240723$20240723$PER$$US-AMGEN-USASP2024144117$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241295431$24129543$1$I$$20240718$20240723$20240723$EXP$$US-SANDOZ INC.-SDZ2024US066719$SANDOZ$$$$$F$Y$$$20240723$$CN$US$US
241295441$24129544$1$I$$20240711$20240723$20240723$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111413$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240724$$CN$US$US
241295462$24129546$2$F$20240710$20240904$20240723$20240905$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041530$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$$$20240905$$CN$US$US
241295481$24129548$1$I$$20240716$20240723$20240723$PER$$US-PCCINC-2024-PPL-000540$PIRAMAL$$$$$$Y$$$20240724$$HP$US$US
241295491$24129549$1$I$$20240719$20240723$20240723$EXP$$US-ABBVIE-5847750$ABBVIE$$$$$F$Y$$$20240723$$CN$US$US
241295502$24129550$2$F$20240701$20240710$20240724$20240726$EXP$$US-009507513-2407USA005356$MERCK$$47$YR$$F$Y$$$20240726$$HP$US$US
241295511$24129551$1$I$20240610$20240722$20240724$20240724$EXP$ES-AEMPS-1550297$ES-GSK-ES2024091635$GLAXOSMITHKLINE$$$$$$Y$$$20240723$$MD$ES$ES
241295521$24129552$1$I$$20240716$20240724$20240724$EXP$$CA-009507513-2407CAN011157$MERCK$$67$YR$$M$Y$56$KG$20240723$$HP$CA$CA
241295532$24129553$2$F$20240101$20240816$20240724$20240822$EXP$$CA-ABBVIE-5847339$ABBVIE$$22$YR$$M$Y$$$20240822$$CN$CA$CA
241295541$24129554$1$I$$20240710$20240724$20240724$PER$$US-RDY-SPO/USA/24/0010304$DR REDDYS$$80$YR$E$M$Y$$$20240724$$CN$US$US
241295552$24129555$2$F$20240717$20240826$20240724$20240827$PER$$US-JNJFOC-20240746239$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240827$$CN$US$US
241295561$24129556$1$I$$20240716$20240724$20240724$PER$$US-PCCINC-2024-PPL-000542$PIRAMAL$$$$$$Y$$$20240724$$HP$US$US
241295572$24129557$2$F$20240101$20240912$20240724$20240917$PER$$US-AMGEN-USASP2024142146$AMGEN$$71$YR$E$F$Y$$$20240917$$PH$US$US
241295581$24129558$1$I$$20240709$20240724$20240724$EXP$$CN-AMGEN-CHNNI2024144720$AMGEN$LING F., ZHAO Y.. Effect of nicorandil combined with ivabradine on angina symptoms and endothelial function in patients with coronary microcirculation disorders.. China Medical Engineering. 2024;32(6)$$$$$Y$$$20240723$$MD$CN$CN
241295592$24129559$2$F$$20240722$20240724$20240725$EXP$$CH-ELI_LILLY_AND_COMPANY-CH202407013408$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240725$$MD$CH$CH
241295601$24129560$1$I$$20240717$20240724$20240724$EXP$$RS-ELI_LILLY_AND_COMPANY-RS202407011588$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240724$$CN$RS$RS
241295611$24129561$1$I$$20240716$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011931$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240723$$HP$US$US
241295621$24129562$1$I$$20240711$20240724$20240724$EXP$$CH-ELI_LILLY_AND_COMPANY-CH202407008093$ELI LILLY AND CO$$$$$M$Y$$$20240723$$CN$CH$CH
241295632$24129563$2$F$$20240730$20240724$20240809$EXP$NL-LRB-00983890$NL-ELI_LILLY_AND_COMPANY-NL202407008276$ELI LILLY AND CO$$64$YR$A$M$Y$75$KG$20240809$$CN$NL$NL
241295642$24129564$2$F$20230106$20240725$20240724$20240730$EXP$$CH-ELI_LILLY_AND_COMPANY-CH202407013551$ELI LILLY AND CO$$68$YR$E$M$Y$62.5$KG$20240730$$MD$CH$CH
241295651$24129565$1$I$20240416$20240717$20240724$20240724$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406007191$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240723$$CN$JP$JP
241295662$24129566$2$F$20220101$20240730$20240724$20240809$EXP$$RO-ELI_LILLY_AND_COMPANY-RO202402002813$ELI LILLY AND CO$$65$YR$E$F$Y$41$KG$20240809$$CN$RO$RO
241295674$24129567$4$F$20240722$20240909$20240724$20240911$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407014226$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240911$$CN$JP$JP
241295681$24129568$1$I$20240629$20240711$20240724$20240724$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407011975$ELI LILLY AND CO$$16$YR$T$M$Y$60$KG$20240723$$CN$DE$CN
241295691$24129569$1$I$$20240716$20240724$20240724$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407011122$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$JP$JP
241295701$24129570$1$I$$20240717$20240724$20240724$EXP$$AR-ELI_LILLY_AND_COMPANY-AR202407012848$ELI LILLY AND CO$$$$$M$Y$$$20240723$$CN$AR$AR
241295711$24129571$1$I$$20240710$20240724$20240724$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407007468$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240723$$CN$DE$DE
241295721$24129572$1$I$$20240711$20240724$20240724$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407007654$ELI LILLY AND CO$$75$YR$E$$Y$$$20240723$$CN$JP$JP
241295731$24129573$1$I$20240709$20240711$20240724$20240724$EXP$$NL-ELI_LILLY_AND_COMPANY-NL202407008061$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240723$$MD$NL$NL
241295741$24129574$1$I$$20240716$20240724$20240724$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407011484$ELI LILLY AND CO$$$$$$Y$$$20240723$$CN$JP$JP
241295751$24129575$1$I$20201017$20240717$20240724$20240724$EXP$$CH-ELI_LILLY_AND_COMPANY-CH202407013796$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240723$$CN$CH$CH
241295762$24129576$2$F$20230101$20240726$20240724$20240807$EXP$$NL-ELI_LILLY_AND_COMPANY-NL202407008368$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240807$$CN$NL$NL
241295771$24129577$1$I$$20240711$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009259$ELI LILLY AND CO$$89$YR$E$M$Y$$$20240723$$CN$US$US
241295781$24129578$1$I$20231222$20240711$20240724$20240724$EXP$$ID-ELI_LILLY_AND_COMPANY-ID202407008889$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240723$$CN$ID$ID
241295791$24129579$1$I$$20240718$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013104$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240723$$CN$US$US
241295801$24129580$1$I$$20240711$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407007795$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240723$$CN$US$US
241295811$24129581$1$I$20240101$20240718$20240724$20240724$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407013839$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240723$$CN$JP$JP
241295821$24129582$1$I$20210928$20240711$20240724$20240724$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407008448$ELI LILLY AND CO$$68$YR$E$F$Y$64$KG$20240723$$CN$CN$CN
241295831$24129583$1$I$$20240711$20240724$20240724$EXP$NL-LRB-00985609$NL-ELI_LILLY_AND_COMPANY-NL202407008280$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240723$$CN$NL$NL
241295841$24129584$1$I$$20240715$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010373$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240723$$CN$US$US
241295851$24129585$1$I$20240101$20240716$20240724$20240724$EXP$$US-ABBVIE-5844355$ABBVIE$$47$YR$$M$Y$$$20240724$$CN$US$US
241295861$24129586$1$I$$20240718$20240724$20240724$PER$$US-JNJFOC-20240756596$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$MD$US$US
241295871$24129587$1$I$20230101$20240710$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008427$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240723$$CN$US$US
241295881$24129588$1$I$20230901$20240716$20240724$20240724$EXP$$US-ABBVIE-5844540$ABBVIE$$56$YR$$M$Y$$$20240724$$CN$US$US
241295892$24129589$2$F$20240628$20240729$20240724$20240806$EXP$$ZA-CELLTRION INC.-2024ZA016532$CELLTRION$$$$$$Y$$$20240806$$CN$ZA$ZA
241295901$24129590$1$I$20240416$20240719$20240724$20240724$EXP$NL-LRB-00990706$NL-GSK-NL2024091067$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$NL$NL
241295911$24129591$1$I$$20240717$20240724$20240724$EXP$$US-ABBVIE-5845176$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241295921$24129592$1$I$$20240710$20240724$20240724$PER$$US-BEH-2024175688$CSL BEHRING$$$$$F$Y$$$20240724$$CN$US$US
241295931$24129593$1$I$20240711$20240716$20240724$20240724$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000184$DENDREON$$$$$$Y$$$20240723$$HP$US$US
241295951$24129595$1$I$20240601$20240719$20240724$20240724$EXP$$US-ABBVIE-5810627$ABBVIE$$54$YR$$F$Y$108.86$KG$20240724$$CN$US$US
241295962$24129596$2$F$$20240807$20240724$20240807$PER$$NVSC2024US151213$NOVARTIS$$$$$F$Y$$$20240807$$HP$US$US
241295971$24129597$1$I$20240601$20240717$20240724$20240724$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-114473$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$117.03$KG$20240724$$CN$PR$PR
241295981$24129598$1$I$$20240702$20240724$20240724$EXP$$US-ABBVIE-5848622$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241295992$24129599$2$F$$20240723$20240724$20240724$PER$$NVSC2024US150937$NOVARTIS$$$$$M$Y$$$20240724$$CN$US$US
241296001$24129600$1$I$20240101$20240712$20240724$20240724$EXP$$US-Emmaus Medical, Inc.-EMM202407-000353$EMMAUS LIFE SCIENCES$$22$YR$A$M$Y$127$KG$20240724$$CN$US$
241296011$24129601$1$I$$20240716$20240724$20240724$EXP$$CA-ABBVIE-5849796$ABBVIE$$$$$F$Y$$$20240724$$PH$CA$CA
241296031$24129603$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146181$AMGEN$$$$$$Y$$$20240723$$MD$US$US
241296041$24129604$1$I$$20240718$20240724$20240724$EXP$$US-GSK-US2024090576$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241296052$24129605$2$F$$20240809$20240724$20240813$PER$$US-BEH-2024175443$CSL BEHRING$$$$A$F$Y$$$20240813$$CN$US$US
241296061$24129606$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024144222$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241296072$24129607$2$F$$20240729$20240724$20240730$EXP$$US-ABBVIE-5847438$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241296082$24129608$2$F$20240716$20240731$20240724$20240806$EXP$$CO-ABBVIE-5850021$ABBVIE$$62$YR$$M$Y$73$KG$20240806$$HP$CO$CO
241296093$24129609$3$F$20240716$20240731$20240724$20240808$EXP$$US-ABBVIE-5845422$ABBVIE$$31$YR$$F$Y$$$20240808$$CN$US$US
241296101$24129610$1$I$$20240715$20240724$20240724$PER$$US-JNJFOC-20240755037$JOHNSON AND JOHNSON$$$$$M$Y$75.6$KG$20240724$$MD$US$US
241296111$24129611$1$I$20170101$20240717$20240724$20240724$EXP$$AT-ABBVIE-5845726$ABBVIE$$21$YR$$M$Y$$$20240724$$CN$AT$AT
241296121$24129612$1$I$$20240715$20240724$20240724$EXP$$CA-002147023-NVSC2024CA009440$Haleon PLC$$43$YR$$F$Y$96$KG$20240723$$HP$CA$CA
241296131$24129613$1$I$$20240719$20240724$20240724$EXP$$US-ABBVIE-5848220$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241296141$24129614$1$I$$20240723$20240724$20240724$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041370$BOEHRINGER INGELHEIM$Shimizu H. A case in which the cause of prolongation of metabolic acidosis after drug overdose was Jardiance. Journal of Japanese Society for Emergency Medicine. 2024;27(3): 321.$4$DEC$A$F$Y$$$20240724$$MD$JP$JP
241296151$24129615$1$I$$20240717$20240724$20240724$30DAY$$US-GSK-US2024AMR091691$GLAXOSMITHKLINE$$34$YR$$F$Y$$$20240724$$CN$US$US
241296161$24129616$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR091393$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241296171$24129617$1$I$$20240716$20240724$20240724$EXP$$US-ABBVIE-5844886$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241296181$24129618$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR091397$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241296191$24129619$1$I$$20240722$20240724$20240724$EXP$$ZA-ABBVIE-5848413$ABBVIE$$$$E$M$Y$$$20240724$$CN$ZA$ZA
241296201$24129620$1$I$$20240719$20240724$20240724$EXP$$US-ABBVIE-5849808$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241296211$24129621$1$I$$20240716$20240724$20240724$PER$$US-ABBVIE-2132364US$ABBVIE$$32$YR$$F$Y$156$KG$20240724$$HP$US$US
241296222$24129622$2$F$20240101$20240725$20240724$20240805$PER$$US-SA-2024SA214239$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240805$$MD$US$US
241296232$24129623$2$F$$20240807$20240724$20240812$EXP$$US-HLS-202400286$HLS THERAPEUTICS$$$$A$$Y$$$20240812$$HP$US$US
241296241$24129624$1$I$20240705$20240718$20240724$20240724$EXP$$CO-ABBVIE-5850220$ABBVIE$$75$YR$$M$Y$68$KG$20240724$$HP$CO$CO
241296251$24129625$1$I$$20240722$20240724$20240724$EXP$$US-TAKEDA-2024TUS074076$TAKEDA$$$$$F$Y$$$20240724$$HP$US$US
241296261$24129626$1$I$20231220$20240722$20240724$20240724$EXP$$JP-TAKEDA-2024TJP011004$TAKEDA$$13$YR$$M$Y$$$20240724$$MD$JP$JP
241296272$24129627$2$F$20240715$20240723$20240724$20240724$PER$$US-AMGEN-USASP2024146028$AMGEN$$$$$$Y$$$20240724$$HP$US$US
241296283$24129628$3$F$20240720$20240808$20240724$20240809$PER$$US-AMGEN-USASP2024145335$AMGEN$$71$YR$E$F$Y$$$20240808$$PH$US$US
241296291$24129629$1$I$20240301$20240718$20240724$20240724$EXP$$US-ABBVIE-5848671$ABBVIE$$57$YR$$M$Y$$$20240724$$CN$US$US
241296301$24129630$1$I$$20240708$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR084778$VIIV$$$$A$M$Y$$$20240724$$CN$US$US
241296311$24129631$1$I$$20240722$20240724$20240724$EXP$$US-ROCHE-10000033418$ROCHE$$77$YR$E$F$Y$$$20240724$$CN$US$US
241296322$24129632$2$F$20240111$20240819$20240724$20240820$EXP$$JP-TAKEDA-2024TJP010948$TAKEDA$$33$YR$$F$Y$50$KG$20240820$$MD$JP$JP
241296331$24129633$1$I$$20240716$20240724$20240724$EXP$$US-CIPLA LTD.-2024US07766$CIPLA$Shah D. Diagnostic challenges of psoriasis: A multifaceted case of triple-drug interaction and literature review. Consultant. 2024;64 (6):e3$$$$$Y$$$20240724$$MD$US$US
241296341$24129634$1$I$20240601$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116259$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240724$$HP$US$US
241296364$24129636$4$F$$20240821$20240724$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115683$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240826$$PH$JP$JP
241296371$24129637$1$I$$20240712$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112317$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240724$$HP$US$US
241296383$24129638$3$F$20240701$20240918$20240724$20240922$EXP$$US-ABBVIE-5846790$ABBVIE$$49$YR$$F$Y$$$20240922$$CN$US$US
241296397$24129639$7$F$20240101$20240823$20240724$20240828$EXP$$ES-ABBVIE-5846487$ABBVIE$$$$$M$Y$$$20240828$$CN$ES$ES
241296401$24129640$1$I$20240630$20240718$20240724$20240724$EXP$$FR-ABBVIE-5848637$ABBVIE$$63$YR$$M$Y$$$20240724$$HP$FR$FR
241296431$24129643$1$I$20240701$20240715$20240724$20240724$PER$$US-JNJFOC-20240738977$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$CN$US$US
241296452$24129645$2$F$20240101$20240802$20240724$20240813$EXP$$JP-ABBVIE-5824067$ABBVIE$$68$YR$$M$Y$58$KG$20240813$$MD$JP$JP
241296461$24129646$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA214232$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240724$$MD$US$US
241296471$24129647$1$I$$20240720$20240724$20240724$PER$$US-SA-2024SA214244$SANOFI AVENTIS$$$$$$Y$$$20240724$$HP$US$US
241296481$24129648$1$I$20240626$20240718$20240724$20240724$EXP$$US-ABBVIE-5846606$ABBVIE$$29$YR$$M$Y$$$20240724$$CN$US$US
241296491$24129649$1$I$20231228$20240716$20240724$20240724$EXP$FR-AFSSAPS-NY2024000792$FR-STRIDES ARCOLAB LIMITED-2024SP008894$STRIDES$$41$YR$$F$Y$80$KG$20240724$$MD$FR$FR
241296501$24129650$1$I$$20240715$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-021816$UNITED THERAPEUTICS$$$$$M$Y$77.098$KG$20240724$$$US$US
241296511$24129651$1$I$20240101$20240719$20240724$20240724$EXP$$US-ABBVIE-5847311$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241296521$24129652$1$I$$20240722$20240724$20240724$PER$$NVSC2024US151215$NOVARTIS$$$$$M$Y$$$20240724$$CN$US$US
241296532$24129653$2$F$20240601$20240719$20240724$20240724$EXP$$US-ABBVIE-5839819$ABBVIE$$66$YR$$M$Y$107$KG$20240724$$CN$US$US
241296541$24129654$1$I$20230101$20240709$20240724$20240724$EXP$$JP-ADAMAS Pharma-ADM202407-002489$ADAMAS PHARMA$$$$$M$Y$$$20240723$$MD$JP$
241296552$24129655$2$F$20240711$20240729$20240724$20240806$PER$$US-AstraZeneca-2024A159033$ASTRAZENECA$$26435$DY$$F$Y$$$20240806$$HP$US$
241296561$24129656$1$I$20240701$20240722$20240724$20240724$EXP$$US-AstraZeneca-2024A166892$ASTRAZENECA$$$$$M$Y$$$20240724$$HP$US$
241296571$24129657$1$I$$20240719$20240724$20240724$EXP$$US-ABBVIE-5848107$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241296581$24129658$1$I$$20240718$20240724$20240724$EXP$$CA-TAKEDA-2024TUS073851$TAKEDA$$$$$M$Y$$$20240724$$CN$CA$CA
241296593$24129659$3$F$20240701$20240807$20240724$20240813$PER$$US-AMGEN-USASP2024140447$AMGEN$$68$YR$E$F$Y$69.3$KG$20240813$$HP$US$US
241296601$24129660$1$I$20240501$20240718$20240724$20240724$EXP$SE-SEMPA-2024-004671$SE-ABBVIE-5845524$ABBVIE$$$$$$Y$$$20240724$$HP$SE$SE
241296611$24129661$1$I$$20240711$20240724$20240724$EXP$NL-LRB-00981718$NL-JUBILANT PHARMA LTD-2024NL000999$JUBILANT$$$$N$M$Y$4$KG$20240724$$MD$NL$NL
241296622$24129662$2$F$$20240905$20240724$20240905$PER$$NVSC2024US148966$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
241296631$24129663$1$I$$20240716$20240724$20240724$EXP$$BE-NOVITIUMPHARMA-2024BENVP01349$NOVITIUM PHARMA$Beatrijs Mertens.Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review.Antibiotics.21-JUN-2023;12:1-19$52$YR$A$F$Y$$$20240724$$HP$BE$BE
241296641$24129664$1$I$20240721$20240721$20240724$20240724$EXP$GB-MHRA-MED-202407211006196690-CFHYB$GB-ABBVIE-5848165$ABBVIE$$56$YR$$M$Y$$$20240724$$CN$GB$GB
241296651$24129665$1$I$$20240718$20240724$20240724$PER$$US-ABBVIE-5848323$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241296661$24129666$1$I$$20240719$20240724$20240724$EXP$$BR-ABBVIE-5846762$ABBVIE$$$$$F$Y$$$20240724$$MD$BR$BR
241296671$24129667$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090522$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241296682$24129668$2$F$$20240906$20240724$20240909$PER$$NVSC2024US150933$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
241296691$24129669$1$I$$20240715$20240724$20240724$EXP$GB-MHRA-MED-202407151320228720-VFYJD$GB-ABBVIE-5847402$ABBVIE$$$$$$Y$$$20240724$$CN$GB$GB
241296711$24129671$1$I$20240718$20240722$20240724$20240724$EXP$$ZA-ABBVIE-5848411$ABBVIE$$38$YR$$M$Y$$$20240724$$PH$ZA$ZA
241296721$24129672$1$I$$20240717$20240724$20240724$EXP$$CA-ABBVIE-5845715$ABBVIE$$$$A$F$Y$$$20240724$$CN$CA$CA
241296732$24129673$2$F$20240101$20240820$20240724$20240825$EXP$$CA-ABBVIE-5846501$ABBVIE$$48$YR$$F$Y$$$20240825$$MD$CA$CA
241296742$24129674$2$F$20240716$20240812$20240724$20240812$PER$$US-ALXN-202407USA001144US$ALEXION PHARMACEUTICALS$$69$YR$$M$Y$$$20240812$$CN$US$US
241296751$24129675$1$I$$20240719$20240724$20240724$EXP$$CA-ABBVIE-5846856$ABBVIE$$$$A$F$Y$$$20240724$$HP$CA$CA
241296761$24129676$1$I$20240101$20240717$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-016160$UNITED THERAPEUTICS$$$$$F$Y$58.503$KG$20240724$$$US$US
241296771$24129677$1$I$20240718$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024144666$AMGEN$$64$YR$A$M$Y$$$20240723$$CN$US$US
241296781$24129678$1$I$20240601$20240715$20240724$20240724$PER$$US-ABBVIE-5841861$ABBVIE$$66$YR$$F$Y$49.895$KG$20240724$$CN$US$US
241296792$24129679$2$F$20240101$20240904$20240724$20240908$EXP$$CA-JNJFOC-20240744553$JOHNSON AND JOHNSON$$6$YR$C$F$Y$$$20240909$$HP$CA$CA
241296805$24129680$5$F$20240101$20240827$20240724$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-022325$UNITED THERAPEUTICS$$$$$F$Y$70.295$KG$20240905$$$US$US
241296811$24129681$1$I$20240716$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144477$AMGEN$$73$YR$E$M$Y$$$20240723$$CN$US$US
241296821$24129682$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA214276$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240724$$MD$US$US
241296841$24129684$1$I$20240720$20240720$20240724$20240724$EXP$GB-MHRA-MED-202407201021288140-GCDFH$GB-ABBVIE-5848621$ABBVIE$$65$YR$$M$Y$$$20240724$$MD$GB$GB
241296851$24129685$1$I$$20240718$20240724$20240724$EXP$$GR-ABBVIE-5850216$ABBVIE$$$$$F$Y$$$20240724$$MD$GR$GR
241296862$24129686$2$F$$20240906$20240724$20240912$EXP$JP-MMM-E0Y4NSJZ$JP-VIIV HEALTHCARE LIMITED-JP2024090496$VIIV$$$$$$Y$$$20240912$$MD$JP$JP
241296871$24129687$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090526$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241296881$24129688$1$I$20220926$20240716$20240724$20240724$EXP$ES-AEMPS-1543623$ES-TAKEDA-2024TUS071869$TAKEDA$$50$YR$$F$Y$$$20240724$$HP$ES$ES
241296892$24129689$2$F$$20240726$20240724$20240730$EXP$$US-ABBVIE-5845133$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241296901$24129690$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090453$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241296911$24129691$1$I$$20240715$20240724$20240724$EXP$$IN-STERISCIENCE B.V.-2024-ST-001072$Steriscience PTE$Mehta RY, Rathod J, Chavda SD, Basiya DV. Maternal and Perinatal Outcome in Eclampsia: An Experience from Tertiary Care Teaching Hospital, a Prospective Observational Study. Res-J-Med-Sci. 2024;18 (5):203-208$$$$F$Y$$$20240724$$HP$IN$IN
241296921$24129692$1$I$$20240715$20240724$20240724$EXP$$IN-STERISCIENCE B.V.-2024-ST-001074$Steriscience PTE$Mehta RY, Rathod J, Chavda SD, Basiya DV.. Maternal and Perinatal Outcome in Eclampsia: An Experience from Tertiary Care Teaching Hospital, a Prospective Observational Study.. Res-J-Med-Sci. 2024;18(5):203-208$$$$F$Y$$$20240724$$HP$IN$IN
241296931$24129693$1$I$$20240711$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407008440$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240724$$CN$US$US
241296941$24129694$1$I$$20240716$20240724$20240724$PER$$US-ALXN-202407USA001152US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
241296951$24129695$1$I$$20240624$20240724$20240724$PER$$US-AstraZeneca-2024A167358$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241296961$24129696$1$I$$20240709$20240724$20240724$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0253$GRAVITI PHARMACEUTICALS$Hammond TC, Emeruwa I, Swain SR, Larson SM, Castells MC.Life-threatening Mast Cell Activation and Anaphylaxis in Mast Cell Leukemia and the Role of Omalizumab.Am-J-Respir-Crit- Care-Med.2024;209:A5294$31$YR$A$M$Y$$$20240724$$HP$US$US
241296971$24129697$1$I$$20240709$20240724$20240724$EXP$$GB-MDD US Operations-E2B_00006371$MDD OPERATIONS$$81$YR$$F$Y$$$20240723$$MD$GB$GB
241296981$24129698$1$I$$20240707$20240724$20240724$PER$$US-APOTEX-2024AP008188$APOTEX$Jaspersen SL, Bruns DA, Candee MS, Battaglia A, Carey JC, Fishler KP.. Seizures in trisomy 18: Prevalence, description, and treatment. American Journal of Medical Genetics Part A. 2023;191A (4):1026-1037$$$$$Y$$$20240724$$MD$US$US
241296991$24129699$1$I$$20240715$20240724$20240724$EXP$$CN-HALEON-2187810$Haleon PLC$Hu Dan; Zhang Wenwen; Shao Yan; Gu Lijun. Nursing care of a patient with epidermolysis bullosa necrotizing drug eruption caused by anti-tumor drugs. Electronic Journal of Surgery. #PY#;11(01):72-76. .; Hu Dan; Zhang Wenwen; Shao Yan; Gu Lijun. Nursing care of a patient with epidermolysis bullosa necrotizing drug eruption caused by anti-tumor drugs. Electronic Journal of Surgery. #PY#;11(01):72-76. .; Hu D, Zhang W, Shao Y, Gu L. Nursing care of a patient with epidermolysis bullosa necrotizing...$57$YR$$M$Y$$$20240723$$HP$CN$CN
241297001$24129700$1$I$$20240712$20240724$20240724$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002056$Alvotech$$$$$F$Y$$$20240724$$CN$CA$CA
241297011$24129701$1$I$$20240711$20240724$20240724$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002052$Alvotech$$36$YR$$M$Y$$$20240724$$CN$CA$CA
241297021$24129702$1$I$$20240719$20240724$20240724$PER$$US-ROCHE-10000032774$ROCHE$$3$YR$C$M$Y$$$20240724$$HP$US$US
241297032$24129703$2$F$$20240908$20240724$20240916$EXP$$CA-CELLTRION INC.-2024CA017582$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
241297041$24129704$1$I$$20240715$20240724$20240724$EXP$$CA-STRIDES ARCOLAB LIMITED-2024SP009071$STRIDES$Joyce S, Lea S, Woolner M, Leddy A.. Treatment of Gamma Hydroxybutyrate Withdrawal in a Pregnant Female: A Case Report.. J-Addict-Med. 2024;18 (3):342-344$32$YR$$F$Y$$$20240724$$MD$CA$CA
241297061$24129706$1$I$$20240707$20240724$20240724$PER$$US-APOTEX-2024AP008189$APOTEX$Jaspersen SL, Bruns DA, Candee MS, Battaglia A, Carey JC, Fishler KP.. Seizures in trisomy 18: Prevalence, description, and treatment. American Journal of Medical Genetics Part A. 2023;191A (4):1026-1037$$$$$Y$$$20240724$$MD$US$US
241297071$24129707$1$I$$20240718$20240724$20240724$EXP$$US-GSK-US2024090587$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$US$US
241297081$24129708$1$I$$20240718$20240724$20240724$EXP$$US-GSK-US2024090634$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$US$US
241297091$24129709$1$I$$20240712$20240724$20240724$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP008902$STRIDES$van den Beukel BAW, Poot A, Beuk R.. Fatal Course of Cutaneous Cholesterol Embolization Syndrome: A Case Report.. Int J Low Extrem Wounds.. 2023;22(4):753-758$$$$$Y$$$20240724$$HP$NL$NL
241297101$24129710$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090940$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241297111$24129711$1$I$$20240715$20240724$20240724$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009065$STRIDES$Liu H, Xue F, Zhou R, Tian H, Mao J, Wu T.. Chidamide in combination with azacitidine for an elderly patient with peripheral T cell lymphoma-not otherwise specified: A case report.. Oncol-Lett. 2024;28 (2):1-6$71$YR$$M$Y$$$20240724$$MD$CN$CN
241297121$24129712$1$I$$20240715$20240724$20240724$EXP$IN-MLMSERVICE-20240708-PI125022-00270-1$IN-STRIDES ARCOLAB LIMITED-2024SP009001$STRIDES$Kamtalwar S, Mirgh S, More A, Sharma P, Patkar N, Rajpal S, et al. Recurrent Cytokine Storm in SARS-CoV-2 Infected Patients with Hematolymphoid Malignancy: A New Perspective.. South Asian Journal of Cancer. 2024;13(2):157-62$72$YR$$M$Y$$$20240724$$MD$IN$IN
241297132$24129713$2$F$$20240719$20240724$20240730$PER$$US-SA-2024SA213151$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240730$$CN$US$US
241297141$24129714$1$I$$20240715$20240724$20240724$PER$$US-SA-2024SA211139$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240724$$MD$US$US
241297151$24129715$1$I$20240714$20240715$20240724$20240724$EXP$GB-MHRA-MED-202407151513480410-VQNSB$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039932$BOEHRINGER INGELHEIM$$44$YR$A$M$Y$109$KG$20240724$$PH$GB$GB
241297161$24129716$1$I$20231001$20240715$20240724$20240724$PER$$US-SA-2024SA211015$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240724$$MD$US$US
241297171$24129717$1$I$$20240712$20240724$20240724$PER$$US-SA-2024SA212249$SANOFI AVENTIS$$$$E$M$Y$$$20240724$$MD$US$US
241297181$24129718$1$I$$20240715$20240724$20240724$EXP$$TW-STRIDES ARCOLAB LIMITED-2024SP008965$STRIDES$Wu W-L, Lee J-C, Su W-C, Wang S-Y, Wu C-J.. A rare case of an endobronchial mass due to Neurospora intermedia.. Int-J-Infect-Dis. 2024;146$25$YR$$M$Y$$$20240724$$HP$TW$TW
241297191$24129719$1$I$$20240712$20240724$20240724$PER$$US-SA-2024SA211905$SANOFI AVENTIS$$62$YR$A$F$Y$99.7$KG$20240724$$MD$US$US
241297201$24129720$1$I$$20240722$20240724$20240724$EXP$$US-AstraZeneca-2024A166807$ASTRAZENECA$$$$$$Y$$$20240724$$MD$US$
241297211$24129721$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR091390$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241297221$24129722$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A162409$ASTRAZENECA$$$$$F$Y$$$20240724$$MD$US$
241297231$24129723$1$I$$20240709$20240724$20240724$PER$$US-TEVA-VS-3220142$TEVA$$$$A$F$Y$$$20240724$$HP$US$US
241297241$24129724$1$I$$20240717$20240724$20240724$PER$$US-AMGEN-USASP2024143420$AMGEN$$67$YR$E$F$Y$$$20240723$$MD$US$US
241297251$24129725$1$I$20240718$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024144498$AMGEN$$65$YR$E$F$Y$$$20240723$$CN$US$US
241297261$24129726$1$I$$20240716$20240724$20240724$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009057$STRIDES$Wang Y, An Y, Hou X, Xu Y, Li Z, Liu X, et al.. Cushing^s Syndrome in Pregnancy Secondary to Adrenocortical Adenoma: A Case Series and Review.. Endocrinol-Diabetes-Metab. 2024;7 (2)$39$YR$$F$Y$$$20240724$$HP$CN$CN
241297272$24129727$2$F$20240701$20240830$20240724$20240905$EXP$$JP-GSK-JP2024JPN089720$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$PH$JP$JP
241297282$24129728$2$F$20240722$20240801$20240724$20240930$PER$$US-AMGEN-USASP2024146086$AMGEN$$75$YR$E$M$Y$$$20240930$$CN$US$US
241297291$24129729$1$I$$20240715$20240724$20240724$EXP$AT-SANDOZ-SDZ2024AT058437$AT-ROCHE-10000027832$ROCHE$$$$E$M$Y$$$20240724$$MD$AT$AT
241297301$24129730$1$I$$20240716$20240724$20240724$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009058$STRIDES$Wang Y, An Y, Hou X, Xu Y, Li Z, Liu X, et al.. Cushing^s Syndrome in Pregnancy Secondary to Adrenocortical Adenoma: A Case Series and Review.. Endocrinol-Diabetes-Metab. 2024;7 (2)$$$$$Y$$$20240724$$HP$CN$CN
241297312$24129731$2$F$20210101$20240826$20240724$20240903$EXP$$DE-CELLTRION INC.-2024DE016955$CELLTRION$Ettl J, Wurstlein R, Luck H et al.. Enhertu (trastuzumab deruxtecan) Treatment experience in patients with HER2-positivem and HER2-low advanced breast cancer. Senology, Oncology World and Tumor Diagnostics + Therapy enclosed. 2023;1-12$$$$$Y$$$20240903$$MD$DE$DE
241297321$24129732$1$I$20240718$20240718$20240724$20240724$PER$$US-JNJFOC-20240749994$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$PH$US$US
241297331$24129733$1$I$$20240715$20240724$20240724$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP008969$STRIDES$Ide N, Hosoya Y, Yamamoto M, Shigeno A, Obayashi M, Asada K, et al.. Central Nervous System Adverse Reactions to Amantadine Intoxication: A Case Report and Analysis of JADER.. In-Vivo. 2024;38 (4):2090-2096$63$YR$$F$Y$$$20240724$$HP$JP$JP
241297341$24129734$1$I$$20240715$20240724$20240724$EXP$$GB-AUROBINDO-AUR-APL-2024-035255$AUROBINDO$$25$YR$$F$Y$$$20240724$$CN$GB$GB
241297351$24129735$1$I$20220901$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035962$AUROBINDO$$36$YR$$F$Y$$$20240724$$PH$FR$FR
241297361$24129736$1$I$$20240713$20240724$20240724$EXP$$US-HALEON-2187469$Haleon PLC$$44$YR$$M$Y$$$20240723$$MD$US$US
241297371$24129737$1$I$$20240716$20240724$20240724$EXP$$TW-STRIDES ARCOLAB LIMITED-2024SP009083$STRIDES$Chen R-L, Ip PP, Shaw J-J, Wang Y-H, Fan L-H, Shen Y-L, et al.. Anti-Thymocyte Globulin (ATG)-Free Nonmyeloablative Haploidentical PBSCT Plus Post-Transplantation Cyclophosphamide Is a Safe and Efficient Treatment Approach for Pediatric Acquired Aplastic Anemia.. Int-J-Molecular-Sci. 2022;23 (23)$7$YR$$M$Y$$$20240724$$HP$TW$TW
241297391$24129739$1$I$20220101$20240717$20240724$20240724$EXP$$US-GSK-US2024090046$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241297402$24129740$2$F$$20240719$20240724$20240731$EXP$IN-STRIDES ARCOLAB LIMITED-2024SP009026$IN-STRIDES ARCOLAB LIMITED-2024SP009026$STRIDES$Kaur B, Kundu K, Singh P, Saini LK, Gupta R.. Positive airway pressure (PAP) as a remedy for treatment-resistant migraine - A case report.. Lung-India. 2024;41 (4):322-324$33$YR$$F$Y$$$20240731$$MD$IN$IN
241297411$24129741$1$I$$20240715$20240724$20240724$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008971$STRIDES$Zhao Y, Ma HH, Wang D, Lian HY, Wang TY, Zhang R. [Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis]. [Chinese]. Zhonghua-Er-Ke-Za-Zhi. 2024;62:60-65$3$YR$$M$Y$$$20240724$$HP$CN$CN
241297421$24129742$1$I$$20240715$20240724$20240724$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008914$STRIDES$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series.. Clin-Transl-Gastroenterol. 2024;15 (3)$81$YR$$M$Y$$$20240724$$MD$US$US
241297431$24129743$1$I$20240101$20240702$20240724$20240724$PER$$US-TEVA-VS-3223204$TEVA$$57$YR$$F$Y$$$20240724$$PH$US$US
241297441$24129744$1$I$20240717$20240717$20240724$20240724$EXP$$US-JNJFOC-20240746875$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240724$$HP$US$US
241297451$24129745$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA214241$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240724$$MD$US$US
241297461$24129746$1$I$$20240720$20240724$20240724$PER$$US-SA-2024SA214290$SANOFI AVENTIS$$70$YR$E$$Y$$$20240724$$CN$US$US
241297471$24129747$1$I$20240101$20240716$20240724$20240724$PER$$US-SA-2024SA027933$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240724$$MD$US$US
241297482$24129748$2$F$20240708$20240828$20240724$20240910$EXP$$GB-UCBSA-2024036661$UCB$$77$YR$$F$Y$$$20240910$$CN$GB$GB
241297491$24129749$1$I$20240601$20240719$20240724$20240724$EXP$FR-AFSSAPS-DJ2024000852$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-116865$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$78$KG$20240724$$MD$FR$FR
241297501$24129750$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014522$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240724$$CN$US$US
241297511$24129751$1$I$20240701$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145234$AMGEN$$65$YR$E$M$Y$$$20240723$$PH$US$US
241297521$24129752$1$I$$20240716$20240724$20240724$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022230$UNITED THERAPEUTICS$$$$$F$Y$$$20240724$$$US$US
241297532$24129753$2$F$20240101$20240725$20240724$20240729$PER$$US-AMGEN-USASP2024144444$AMGEN$$72$YR$E$M$Y$$$20240729$$CN$US$US
241297541$24129754$1$I$$20240715$20240724$20240724$EXP$$ZA-STRIDES ARCOLAB LIMITED-2024SP008952$STRIDES$Nkoane MA, Adefolalu AO.. Rapid-onset diarrhoea in HIV patient: The importance of suspecting cholera in non-endemic areas.. S-Afr-J-Infect-Dis. 2024;39 (1)$48$YR$$M$Y$$$20240724$$HP$ZA$ZA
241297551$24129755$1$I$$20240717$20240724$20240724$EXP$$BR-JNJFOC-20240750336$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$MD$BR$BR
241297561$24129756$1$I$20240101$20240715$20240724$20240724$EXP$$US-JNJFOC-20240562388$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240724$$HP$US$US
241297571$24129757$1$I$$20240712$20240724$20240724$PER$$US-SA-2024SA210047$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240724$$MD$US$US
241297581$24129758$1$I$20240101$20240715$20240724$20240724$PER$$US-SA-2024SA209216$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240724$$MD$US$US
241297591$24129759$1$I$20240708$20240712$20240724$20240724$EXP$$US-NOVOPROD-1257048$NOVO NORDISK$$$$A$F$Y$$$20240724$$CN$US$US
241297601$24129760$1$I$20240101$20240712$20240724$20240724$EXP$$US-NOVOPROD-1256520$NOVO NORDISK$$67$YR$$F$Y$$$20240724$$CN$US$US
241297611$24129761$1$I$$20240712$20240724$20240724$EXP$$US-NOVOPROD-1256410$NOVO NORDISK$$$$$M$Y$$$20240724$$MD$US$US
241297621$24129762$1$I$$20240719$20240724$20240724$PER$$NVSC2024US150004$NOVARTIS$$$$$M$Y$$$20240724$$CN$US$US
241297632$24129763$2$F$20240101$20240725$20240724$20240726$PER$$US-AMGEN-USASP2024145852$AMGEN$$63$YR$A$F$Y$$$20240726$$CN$US$US
241297641$24129764$1$I$$20240712$20240724$20240724$EXP$$US-NOVOPROD-1257610$NOVO NORDISK$$$$$F$Y$$$20240724$$CN$US$US
241297651$24129765$1$I$20240701$20240712$20240724$20240724$EXP$GB-MHRA-MED-202407121127404280-SFLRK$GB-NOVOPROD-1255253$NOVO NORDISK$$$$$$Y$$$20240724$$PH$GB$GB
241297661$24129766$1$I$20230708$20240713$20240724$20240724$EXP$$EG-NOVOPROD-1256330$NOVO NORDISK$$909$MON$$M$Y$80$KG$20240724$$CN$EG$EG
241297671$24129767$1$I$20190101$20240715$20240724$20240724$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP008911$STRIDES$Luo J, Wu X, Xue G, Li J, Rong C.. Red man syndrome caused by oral vancomycin.. Advers-Drug-React-J. 2021;23 (4):221-223$55$YR$$M$Y$$$20240724$$HP$CN$CN
241297681$24129768$1$I$20200101$20240712$20240724$20240724$EXP$$US-NOVOPROD-1231374$NOVO NORDISK$$$$$F$Y$$$20240724$$CN$US$US
241297691$24129769$1$I$$20240715$20240724$20240724$EXP$$CA-002147023-NVSC2024CA055248$Haleon PLC$$35$YR$$F$Y$$$20240723$$MD$CA$CA
241297713$24129771$3$F$20240622$20240813$20240724$20240829$EXP$$MX-NOVOPROD-1256148$NOVO NORDISK$$70$YR$$M$Y$60$KG$20240829$$CN$MX$MX
241297721$24129772$1$I$$20240711$20240724$20240724$EXP$$TR-NOVOPROD-1259183$NOVO NORDISK$$$$$M$Y$70$KG$20240724$$CN$TR$TR
241297733$24129773$3$F$20231129$20240831$20240724$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-035762$AUROBINDO$$$$E$F$Y$89$KG$20240910$$MD$DE$DE
241297741$24129774$1$I$20220702$20240710$20240724$20240724$EXP$FI-EMA-DD-20240709-7483181-070759$FI-NOVOPROD-1253603$NOVO NORDISK$$80$YR$$F$Y$86$KG$20240724$$HP$FI$FI
241297751$24129775$1$I$$20240715$20240724$20240724$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009040$STRIDES$Kirmaier A, Blackshear L, Lee MSL, Kirby JE.. Cellulitis and bacteremia caused by the fish pathogen, Streptococcus iniae, in an immunocompromised patient: Case report and mini-review of zoonotic disease, lab identification, and antimicrobial susceptibility.. Diagn-Microbiol-Infect-Dis. 2024;108 (4)$49$YR$$F$Y$$$20240724$$HP$US$US
241297764$24129776$4$F$$20240802$20240724$20240808$PER$$NVSC2024US150078$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241297771$24129777$1$I$$20240716$20240724$20240724$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01341$NOVITIUM PHARMA$Jin-Mei Yao.A Case of Adult Acute B-Cell Lymphoblastic Leukemia with Hypercalcemia and Osteolytic Bone Lesions.Clinical Laboratory.01-JUL-2023;69:1534-1536$53$YR$A$M$Y$$$20240724$$HP$CN$CN
241297781$24129778$1$I$$20240716$20240724$20240724$EXP$$CA-BEH-2024175912$CSL BEHRING$$9$YR$C$F$Y$17$KG$20240724$$CN$CA$CA
241297792$24129779$2$F$$20240805$20240724$20240813$EXP$$US-CHATTEMPRD-2024OHG024683$CHATTEM$$89$YR$E$F$Y$$$20240813$$CN$US$US
241297801$24129780$1$I$$20240716$20240724$20240724$EXP$US-MLMSERVICE-20240712-PI125158-00285-2$US-RDY-SPO/USA/24/0010590$DR REDDYS$Homiack DR, Yan LE, Petry LG, Lloyd JR, Najjar F, Cook EH. Successful Electroconvulsive Therapy in a Patient With Catatonia and Maternal Duplication 15q11-13 Syndrome. The journal of ECT. 2024. DOI:10.1097/YCT.0000000000001054.$24$YR$A$M$Y$$$20240724$$MD$US$US
241297811$24129781$1$I$$20240711$20240724$20240724$EXP$$TR-NOVOPROD-1259270$NOVO NORDISK$$$$$F$Y$$$20240724$$CN$TR$TR
241297821$24129782$1$I$$20240715$20240724$20240724$EXP$$US-NOVOPROD-1257913$NOVO NORDISK$$$$$F$Y$$$20240724$$CN$US$US
241297831$24129783$1$I$$20240715$20240724$20240724$EXP$$NL-AUROBINDO-AUR-APL-2024-035891$AUROBINDO$$82$YR$$F$Y$70$KG$20240724$$CN$NL$NL
241297842$24129784$2$F$20240714$20240716$20240724$20240725$PER$$US-JNJFOC-20240738316$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240726$$PH$US$US
241297852$24129785$2$F$20240709$20240725$20240724$20240807$EXP$$JP-AMGEN-JPNSP2024144722$AMGEN$$$$$$Y$$$20240806$$PH$JP$JP
241297862$24129786$2$F$$20240723$20240724$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117125$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$77$KG$20240729$$PH$US$US
241297871$24129787$1$I$20220105$20240717$20240724$20240724$EXP$$IT-AMGEN-ITANI2024144673$AMGEN$$45$YR$A$F$Y$58$KG$20240723$$MD$IT$IT
241297883$24129788$3$F$20230101$20240814$20240724$20240822$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040285$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$56$KG$20240822$$CN$BR$BR
241297891$24129789$1$I$$20240716$20240724$20240724$EXP$$US-NOVOPROD-1257911$NOVO NORDISK$$$$$F$Y$$$20240724$$HP$US$US
241297902$24129790$2$F$$20240920$20240724$20240924$EXP$$NVSC2024US150222$NOVARTIS$$$$$M$Y$$$20240924$$CN$US$US
241297911$24129791$1$I$20240502$20240712$20240724$20240724$PER$$US-SA-2024SA209810$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240724$$MD$US$US
241297921$24129792$1$I$20240701$20240712$20240724$20240724$PER$$US-SA-2024SA209811$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240724$$MD$US$US
241297933$24129793$3$F$20240101$20240813$20240724$20240826$PER$$US-SA-2024SA214300$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240826$$MD$US$US
241297941$24129794$1$I$20240707$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035897$AUROBINDO$$79$YR$$F$Y$$$20240724$$PH$FR$FR
241297951$24129795$1$I$$20240713$20240724$20240724$EXP$$US-HALEON-2187202$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
241297961$24129796$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117114$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240724$$CN$US$US
241297971$24129797$1$I$$20240717$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114452$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240724$$CN$US$US
241297991$24129799$1$I$20240417$20240717$20240724$20240724$EXP$$GB-ROCHE-10000029556$ROCHE$$27$YR$A$M$Y$$$20240724$$HP$GB$GB
241298011$24129801$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA109930$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240724$$MD$US$US
241298021$24129802$1$I$20240601$20240715$20240724$20240724$PER$$US-SA-2024SA212314$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240724$$MD$US$US
241298031$24129803$1$I$20230913$20240717$20240724$20240724$EXP$$HU-SA-2023SA284619$SANOFI AVENTIS$$46$YR$A$M$Y$80$KG$20240724$$MD$HU$HU
241298041$24129804$1$I$20240225$20240708$20240724$20240724$PER$$US-JNJFOC-20240721567$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240724$$CN$US$US
241298051$24129805$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117170$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240724$$CN$US$US
241298071$24129807$1$I$20240201$20240719$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117136$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240724$$CN$US$US
241298081$24129808$1$I$20240404$20240722$20240724$20240724$EXP$FR-AFSSAPS-RE2024000741$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-116823$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$70$KG$20240724$$MD$FR$FR
241298091$24129809$1$I$$20240721$20240724$20240724$PER$$US-AMGEN-USASP2024146213$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241298101$24129810$1$I$20240701$20240719$20240724$20240724$EXP$$CN-PFIZER INC-PV202400094929$PFIZER$$37$YR$$F$Y$61$KG$20240724$$HP$CN$CN
241298111$24129811$1$I$20240620$20240719$20240724$20240724$EXP$$CN-PFIZER INC-PV202400094908$PFIZER$$4$YR$$F$Y$18$KG$20240724$$HP$CN$CN
241298123$24129812$3$F$20240701$20240920$20240724$20240926$EXP$$JP-PFIZER INC-202400221219$PFIZER$$8$DEC$$F$Y$$$20240926$$MD$JP$JP
241298132$24129813$2$F$20240101$20240916$20240724$20240919$EXP$$CA-PFIZER INC-202400196920$PFIZER$$64$YR$$F$Y$$$20240919$$MD$CA$CA
241298141$24129814$1$I$20240611$20240719$20240724$20240724$EXP$$CN-PFIZER INC-PV202400094956$PFIZER$$32$YR$$F$Y$74$KG$20240724$$HP$CN$CN
241298152$24129815$2$F$20231101$20240725$20240724$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407013403$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240729$$CN$US$US
241298161$24129816$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014550$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240724$$HP$US$US
241298171$24129817$1$I$$20240702$20240724$20240724$PER$$AU-TOLMAR, INC.-24AU050762$TOLMAR$$$$$M$Y$$$20240724$$CN$AU$AU
241298181$24129818$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013889$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240724$$CN$US$US
241298192$24129819$2$F$20240618$20240813$20240724$20240903$PER$$AU-TOLMAR, INC.-24AU050783$TOLMAR$$$$$$Y$$$20240903$$PH$AU$AU
241298201$24129820$1$I$$20240702$20240724$20240724$PER$$AU-TOLMAR, INC.-24AU050733$TOLMAR$$$$$M$Y$$$20240724$$CN$AU$AU
241298211$24129821$1$I$$20240702$20240724$20240724$PER$$AU-TOLMAR, INC.-24AU050769$TOLMAR$$$$$M$Y$$$20240724$$CN$AU$AU
241298222$24129822$2$F$20240625$20240813$20240724$20240903$PER$$AU-TOLMAR, INC.-24AU050784$TOLMAR$$$$$$Y$$$20240903$$PH$AU$AU
241298232$24129823$2$F$20240514$20240813$20240724$20240903$PER$$AU-TOLMAR, INC.-24AU050782$TOLMAR$$$$$$Y$$$20240903$$PH$AU$AU
241298241$24129824$1$I$$20240715$20240724$20240724$EXP$$GB-CELLTRION INC.-2024GB017528$CELLTRION$$$$$$Y$$$20240724$$CN$GB$GB
241298251$24129825$1$I$$20240715$20240724$20240724$EXP$$IT-AUROBINDO-AUR-APL-2024-035639$AUROBINDO$Pedio E, Tauro S, Perfetti S, Zaccaro S, Greco G, Mandunzio D, et al.. RENAL INFARCTION: AN ACUTE COMPLICATION OF APICAL THROMBOSIS IN A PATIENT WITH STEMI. Eur-Heart-J-Suppl. 2024;26 (Suppl. 2):ii199-ii200$50$YR$$M$Y$$$20240724$$HP$IT$IT
241298261$24129826$1$I$$20240611$20240724$20240724$EXP$GB-MHRA-MED-202406111211085470-CTLHS$GB-DEXPHARM-2024-2412$DEXCEL$$$$$$Y$$$20240724$$CN$GB$GB
241298271$24129827$1$I$20230130$20240715$20240724$20240724$EXP$$FR-CELLTRION INC.-2024FR017481$CELLTRION$$$$$$Y$$$20240724$$MD$FR$FR
241298281$24129828$1$I$$20240715$20240724$20240724$EXP$$DE-JNJFOC-20240749091$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240724$$HP$DE$DE
241298293$24129829$3$F$20240712$20240819$20240724$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003427$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240830$$CN$US$US
241298301$24129830$1$I$$20240626$20240724$20240724$PER$$BR-WT-2024-AMR-077081$Waylis$$40$YR$$F$Y$$$20240724$$CN$BR$BR
241298311$24129831$1$I$20240701$20240722$20240724$20240724$EXP$$US-ABBVIE-5849620$ABBVIE$$59$YR$$M$Y$$$20240724$$CN$US$US
241298321$24129832$1$I$20180302$20240715$20240724$20240724$EXP$$ES-CELLTRION INC.-2024ES017462$CELLTRION$$$$$$Y$$$20240724$$MD$ES$ES
241298332$24129833$2$F$$20240917$20240724$20240926$EXP$$CA-CELLTRION INC.-2024CA017583$CELLTRION$$$$$$Y$$$20240926$$CN$CA$CA
241298341$24129834$1$I$20240620$20240716$20240724$20240724$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019020$UNITED THERAPEUTICS$$69$YR$$F$Y$41.27$KG$20240724$$$US$US
241298351$24129835$1$I$$20240717$20240724$20240724$EXP$$CH-ABBVIE-5844285$ABBVIE$Oberholzer J, Fayolle D, Vandenbulcke A, Gaudet JG. Cardiac arrest during deep brain stimulation: A case report. Clinical Case Reports. 2024;12(7):e9147.$54$YR$$M$Y$$$20240724$$HP$CH$CH
241298361$24129836$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA213963$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240724$$MD$US$US
241298371$24129837$1$I$$20240719$20240724$20240724$EXP$$US-SA-2024SA213441$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240724$$MD$US$US
241298382$24129838$2$F$20240201$20240715$20240724$20240726$PER$$US-SA-2024SA210469$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240726$$MD$US$US
241298391$24129839$1$I$$20240715$20240724$20240724$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003413$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241298402$24129840$2$F$20240715$20240920$20240724$20240920$EXP$$NVSC2024US148642$NOVARTIS$$56$YR$$F$Y$$$20240920$$CN$US$US
241298412$24129841$2$F$20240721$20240723$20240724$20240725$PER$$US-AMGEN-USASP2024145837$AMGEN$$83$YR$E$F$Y$$$20240725$$CN$US$US
241298421$24129842$1$I$$20240702$20240724$20240724$EXP$$DE-ROCHE-10000026413$ROCHE$$$$A$F$Y$$$20240724$$MD$DE$DE
241298431$24129843$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR091389$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241298441$24129844$1$I$$20240718$20240724$20240724$PER$$US-ABBVIE-5850020$ABBVIE$$$$A$F$Y$$$20240724$$CN$US$US
241298451$24129845$1$I$$20240718$20240724$20240724$EXP$$US-HALEON-2188105$Haleon PLC$$$$$F$Y$$$20240723$$CN$US$US
241298462$24129846$2$F$20240703$20240724$20240724$20240730$EXP$$CA-ROCHE-10000023232$ROCHE$$41$YR$A$F$Y$$$20240730$$CN$CA$CA
241298471$24129847$1$I$20240721$20240722$20240724$20240724$EXP$$US-AstraZeneca-2024A166623$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241298481$24129848$1$I$$20230322$20240724$20240724$EXP$$US-AstraZeneca-2023A070016$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241298491$24129849$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117004$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$HP$US$US
241298501$24129850$1$I$$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115630$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240724$$HP$US$US
241298512$24129851$2$F$$20240830$20240724$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117011$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240904$$CN$US$US
241298521$24129852$1$I$$20240718$20240724$20240724$EXP$$US-GSK-US2024AMR091500$GLAXOSMITHKLINE$$$$$F$Y$$$20240724$$CN$US$US
241298531$24129853$1$I$20240702$20240717$20240724$20240724$EXP$$JP-GENMAB-2024-02556$GENMAB$$$$$$Y$$$20240724$$MD$JP$JP
241298541$24129854$1$I$$20240718$20240724$20240724$PER$$US-ROCHE-10000033481$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241298551$24129855$1$I$20240101$20240718$20240724$20240724$EXP$$US-ABBVIE-5846862$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241298561$24129856$1$I$$20240712$20240724$20240724$EXP$$US-RDY-LIT/USA/24/0010606$DR REDDYS$Nichols MM, Pozdnyakova O. Snapper-Schneid bodies (coarse cytoplasmic granules) in a patient with multiply relapsed multiple myeloma. Blood. 2024 Jun;143(24): doi:10.1182/blood.2024024221.$66$YR$E$M$Y$$$20240724$$HP$US$US
241298572$24129857$2$F$$20240820$20240724$20240828$EXP$$CH-JNJFOC-20240755292$JOHNSON AND JOHNSON$$56$YR$A$M$Y$82$KG$20240828$$MD$CH$CH
241298581$24129858$1$I$$20240719$20240724$20240724$EXP$$US-ABBVIE-5847014$ABBVIE$$$$$M$Y$$$20240724$$HP$US$US
241298591$24129859$1$I$20230419$20240718$20240724$20240724$EXP$$US-ABBVIE-5846846$ABBVIE$$74$YR$$F$Y$$$20240724$$CN$US$US
241298602$24129860$2$F$20240712$20240712$20240724$20240726$PER$$US-CHATTEMPRD-2024OHG024174$CHATTEM$$$$$F$Y$$$20240719$$CN$US$US
241298612$24129861$2$F$$20240806$20240724$20240816$EXP$$US-BAXTER-2024BAX021915$BAXTER$$$$$F$Y$$$20240816$$HP$US$US
241298621$24129862$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117132$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240724$$CN$US$US
241298631$24129863$1$I$$20240715$20240724$20240724$EXP$$CA-APOTEX-2024AP008401$APOTEX$$36$YR$$F$Y$$$20240724$$HP$CA$CA
241298641$24129864$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014410$ELI LILLY AND CO$$64$YR$A$$Y$$$20240724$$CN$US$US
241298651$24129865$1$I$20240701$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014270$ELI LILLY AND CO$$25$YR$A$M$Y$$$20240724$$CN$US$US
241298661$24129866$1$I$20240719$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013248$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240724$$CN$US$US
241298671$24129867$1$I$20240717$20240717$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407011433$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240724$$CN$US$US
241298681$24129868$1$I$20240201$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407012996$ELI LILLY AND CO$$$$$F$Y$$$20240724$$CN$US$US
241298691$24129869$1$I$20240501$20240715$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407010583$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240724$$CN$US$US
241298701$24129870$1$I$$20240721$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014023$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240724$$CN$US$US
241298711$24129871$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014524$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240724$$CN$US$US
241298721$24129872$1$I$20240722$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014091$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240724$$CN$US$US
241298731$24129873$1$I$20231001$20240718$20240724$20240724$EXP$$CA-BIOGEN-2024BI01274674$BIOGEN$$61$YR$$M$Y$$$20240724$$CN$CA$CA
241298741$24129874$1$I$20231001$20240705$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407004747$ELI LILLY AND CO$$$$$F$Y$$$20240724$$CN$US$US
241298751$24129875$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014165$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240724$$CN$US$US
241298762$24129876$2$F$$20240722$20240724$20240726$EXP$$GB-BIOGEN-2024BI01274536$BIOGEN$$$$$$Y$$$20240726$$HP$GB$GB
241298771$24129877$1$I$$20240717$20240724$20240724$EXP$$CA-ROCHE-10000031412$ROCHE$$$$A$F$Y$$$20240724$$CN$CA$CA
241298783$24129878$3$F$20240712$20240829$20240724$20240909$EXP$$DE-ROCHE-10000032301$ROCHE$$61$YR$A$F$Y$$$20240909$$MD$DE$DE
241298801$24129880$1$I$$20240719$20240724$20240724$EXP$$US-JNJFOC-20240757051$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240724$$HP$US$US
241298811$24129881$1$I$$20240709$20240724$20240724$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458379$RANBAXY$Geusens D, Dierickx D, Carton S, Van Cutsem E, Dekervel J. Immunotherapy Rechallenge After Checkpoint Inhibitor Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review. Clin Colorectal Cancer. 2024;23(2):194-197$48$YR$$M$Y$$$20240724$$MD$BE$BE
241298821$24129882$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090942$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241298831$24129883$1$I$20231123$20240718$20240724$20240724$EXP$$NVSC2024MX150363$NOVARTIS$$75$YR$$F$Y$50$KG$20240724$$MD$MX$MX
241298841$24129884$1$I$20240710$20240715$20240724$20240724$30DAY$$US-GSK-US2024088741$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240724$$CN$US$US
241298852$24129885$2$F$$20240923$20240724$20240924$PER$$US-ROCHE-10000033465$ROCHE$$$$$$Y$$$20240924$$CN$US$US
241298861$24129886$1$I$$20240716$20240724$20240724$EXP$$US-NOVITIUMPHARMA-2024USNVP01332$NOVITIUM PHARMA$Hyun Jun Kim.OCCLUSIVE CYTOMEGALOVIRUS PANUVEITIS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT.Retinal Cases and Brief Reports.01-JUL-2024;18:442-445$60$YR$A$M$Y$$$20240724$$HP$US$US
241298871$24129887$1$I$20240301$20240408$20240724$20240724$PER$$US-AJANTA-2024AJA00077$AJANTA PHARMA$$39$YR$A$F$Y$170$KG$20240724$$CN$US$US
241298881$24129888$1$I$$20240718$20240724$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011060$JAZZ$$$$$M$Y$$$20240723$$CN$US$US
241298893$24129889$3$F$$20240902$20240724$20240902$PER$$US-ALXN-202407USA001209US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240902$$CN$US$US
241298901$24129890$1$I$$20240715$20240724$20240724$EXP$NL-LRB-00990413$NL-ALK-ABELLO A/S-2024AA002907$ALK-ABELLO$$$$$$Y$$$20240724$$MD$NL$NL
241298911$24129891$1$I$$20230815$20240724$20240724$EXP$$CA-AstraZeneca-2023A187518$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$CA$
241298921$24129892$1$I$$20230502$20240724$20240724$EXP$$US-AstraZeneca-2023A103501$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241298931$24129893$1$I$$20240719$20240724$20240724$EXP$$ES-UCBSA-2024037169$UCB$$$$$$Y$$$20240724$$MD$ES$ES
241298941$24129894$1$I$20240614$20240722$20240724$20240724$EXP$$US-AstraZeneca-2024A166604$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241298951$24129895$1$I$20240720$20240722$20240724$20240724$EXP$$US-AstraZeneca-2024A167004$ASTRAZENECA$$$$$M$Y$$$20240724$$MD$US$
241298962$24129896$2$F$20240720$20240906$20240724$20240910$EXP$$US-AstraZeneca-2024A166775$ASTRAZENECA$$31035$DY$$M$Y$$$20240910$$CN$US$
241298971$24129897$1$I$$20240715$20240724$20240724$EXP$$CA-APOTEX-2024AP008393$APOTEX$$34$YR$$M$Y$$$20240724$$MD$CA$CA
241298982$24129898$2$F$20240715$20240723$20240724$20240725$PER$$US-ROCHE-10000033348$ROCHE$$$$$M$Y$$$20240725$$CN$US$US
241298991$24129899$1$I$$20240722$20240724$20240724$PER$$NVSC2024US151306$NOVARTIS$$$$$$Y$$$20240724$$MD$US$US
241299001$24129900$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-10000033467$ROCHE$$$$$F$Y$$$20240724$$HP$US$US
241299012$24129901$2$F$$20240722$20240724$20240724$EXP$$US-ROCHE-10000033167$ROCHE$$$$E$M$Y$$$20240724$$MD$US$US
241299021$24129902$1$I$$20240626$20240724$20240724$PER$$KR-WT-2024-APC-075239$Waylis$$$$$$Y$$$20240724$$CN$KR$KR
241299031$24129903$1$I$20240722$20240722$20240724$20240724$PER$$NVSC2024US151037$NOVARTIS$$76$YR$$F$Y$108.4$KG$20240724$$PH$US$US
241299041$24129904$1$I$$20240719$20240724$20240724$PER$$US-ABBVIE-5849599$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241299051$24129905$1$I$$20240715$20240724$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010866$JAZZ$$$$$F$Y$$$20240723$$CN$US$US
241299062$24129906$2$F$$20240724$20240724$20240729$EXP$$DZ-ROCHE-10000033318$ROCHE$$$$A$F$Y$$$20240729$$MD$DZ$DZ
241299071$24129907$1$I$$20240723$20240724$20240724$EXP$$AU-ROCHE-10000033120$ROCHE$$$$A$F$Y$$$20240724$$HP$AU$AU
241299082$24129908$2$F$$20240719$20240724$20240725$PER$$NVSC2024US150602$NOVARTIS$$$$$F$Y$165$KG$20240725$$HP$US$US
241299091$24129909$1$I$20240719$20240719$20240724$20240724$EXP$$PR-JNJFOC-20240757132$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240724$$HP$PR$PR
241299102$24129910$2$F$20240701$20240724$20240724$20240802$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022449$UNITED THERAPEUTICS$$71$YR$$M$Y$65.306$KG$20240802$$$US$US
241299112$24129911$2$F$20240704$20240814$20240724$20240821$EXP$$JP-GENMAB-2024-02579$GENMAB$$8$DEC$$M$Y$$$20240821$$MD$JP$JP
241299122$24129912$2$F$$20240719$20240724$20240724$EXP$$US-ROCHE-10000032122$ROCHE$$$$I$M$Y$$$20240724$$CN$US$US
241299131$24129913$1$I$$20240715$20240724$20240724$EXP$$CA-CELLTRION INC.-2024CA017676$CELLTRION$$$$$$Y$$$20240724$$PH$CA$CA
241299141$24129914$1$I$$20240627$20240724$20240724$PER$$CA-WT-2024-075111$Waylis$$75$YR$$M$Y$$$20240724$$PH$CA$CA
241299151$24129915$1$I$20240606$20240717$20240724$20240724$EXP$FR-AFSSAPS-TS2024000829$FR-ABBVIE-5842868$ABBVIE$$$$$F$Y$2.7$KG$20240724$$MD$FR$FR
241299161$24129916$1$I$$20240716$20240724$20240724$PER$$US-BEIGENE-BGN-2024-011178$BEIGENE$$$$$$Y$$$20240724$$PH$US$US
241299171$24129917$1$I$20240101$20240715$20240724$20240724$PER$$US-SA-2024SA212424$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240724$$MD$US$US
241299182$24129918$2$F$20240101$20240814$20240724$20240828$PER$$US-SA-2024SA209395$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240828$$MD$US$US
241299191$24129919$1$I$20230820$20240718$20240724$20240724$EXP$FR-AFSSAPS-PA2023001743$FR-ROCHE-10000030673$ROCHE$$57$YR$A$F$Y$43$KG$20240724$$MD$FR$FR
241299201$24129920$1$I$$20240717$20240724$20240724$EXP$$US-JNJFOC-20240746530$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$HP$US$US
241299211$24129921$1$I$20240718$20240718$20240724$20240724$EXP$$US-JNJFOC-20240756586$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240724$$MD$US$US
241299221$24129922$1$I$$20210610$20240724$20240724$EXP$$US-AstraZeneca-2021A525490$ASTRAZENECA$$$$$$Y$$$20240724$$CN$US$
241299231$24129923$1$I$$20221101$20240724$20240724$EXP$$US-AstraZeneca-2022A362984$ASTRAZENECA$$$$$M$Y$$$20240724$$HP$US$
241299241$24129924$1$I$20240101$20240722$20240724$20240724$EXP$$US-UCBSA-2024037121$UCB$$$$$F$Y$$$20240724$$CN$US$US
241299251$24129925$1$I$20240101$20240718$20240724$20240724$EXP$$US-EMD Serono-2024039303$EMD SERONO INC$$$$$F$Y$$$20240724$$MD$US$US
241299261$24129926$1$I$20240715$20240715$20240724$20240724$30DAY$$US-GSK-US2024088751$GLAXOSMITHKLINE$$40$YR$$F$Y$$$20240724$$CN$US$US
241299271$24129927$1$I$$20240717$20240724$20240724$PER$$US-AMGEN-USASP2024144081$AMGEN$$$$$F$Y$$$20240723$$CN$US$US
241299281$24129928$1$I$$20240715$20240724$20240724$EXP$$PT-AMGEN-PRTSP2024142687$AMGEN$Reymao F.M.; Czajkowska A.; Gornes A.R. et al.. HIDRADENITIS SUPPURATIVA - PAIN CONTROL IN PATIENTS WITH REFRACTORY INJURIES. Doencas autoimunes, reumatologicas e vasculites. 2024;1481$51$YR$A$M$Y$$$20240723$$HP$PT$PT
241299291$24129929$1$I$20240719$20240722$20240724$20240724$EXP$$US-UCBSA-2024037071$UCB$$31$YR$$F$Y$$$20240724$$CN$US$US
241299301$24129930$1$I$20240704$20240722$20240724$20240724$EXP$ES-AEMPS-1548350$ES-UCBSA-2024036910$UCB$$75$YR$$F$Y$$$20240724$$MD$ES$ES
241299311$24129931$1$I$$20240717$20240724$20240724$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02648$AMNEAL$$$$$M$Y$73.016$KG$20240724$$CN$US$US
241299322$24129932$2$F$$20240822$20240724$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116495$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240827$$PH$JP$JP
241299331$24129933$1$I$20240705$20240717$20240724$20240724$EXP$$US-BEH-2024175895$CSL BEHRING$$32$YR$A$M$Y$$$20240724$$HP$US$US
241299342$24129934$2$F$20240714$20240716$20240724$20240730$EXP$$US-ALXN-202407USA001239US$ALEXION PHARMACEUTICALS$$61$YR$$F$Y$79.378$KG$20240730$$PH$US$US
241299351$24129935$1$I$$20240717$20240724$20240724$EXP$$CN-ALVOTECHPMS-2024-ALVOTECHPMS-002054$Alvotech$Maitiyaer M, Liu Y, Keyimu N, Wen Y, Liu Z, Huang W, Yu S. A novel approach with tofacitinib for the management of keratoderma blennorrhagicum in reactive arthritis: a case report. Front Immunol. 2024 Jul 2;15:1399249. doi: 10.3389/fimmu.2024.1399249. PMID: 39015574; PMCID: PMC11249543.$42$YR$$F$Y$$$20240724$$HP$CN$
241299363$24129936$3$F$20240729$20240815$20240724$20240821$PER$$US-AMGEN-USASP2024143797$AMGEN$$80$YR$E$M$Y$$$20240821$$HP$US$US
241299371$24129937$1$I$20240718$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024143875$AMGEN$$74$YR$E$F$Y$$$20240723$$MD$US$US
241299382$24129938$2$F$20240721$20240725$20240724$20240728$PER$$US-AMGEN-USASP2024145493$AMGEN$$35$YR$A$F$Y$$$20240728$$HP$US$US
241299391$24129939$1$I$$20240628$20240724$20240724$PER$$BR-WT-2024-AMR-077178$Waylis$$$$$F$Y$$$20240724$$CN$BR$BR
241299402$24129940$2$F$$20240912$20240724$20240920$EXP$$CA-CELLTRION INC.-2024CA017684$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
241299412$24129941$2$F$$20240731$20240724$20240801$PER$$US-HALEON-2187302$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241299421$24129942$1$I$20240711$20240715$20240724$20240724$30DAY$$US-GSK-US2024088575$GLAXOSMITHKLINE$$63$YR$$M$Y$$$20240724$$CN$US$US
241299431$24129943$1$I$20240721$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145460$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241299441$24129944$1$I$20240101$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024143247$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241299451$24129945$1$I$20240628$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035780$AUROBINDO$$72$YR$$M$Y$83$KG$20240724$$PH$FR$FR
241299463$24129946$3$F$$20240730$20240724$20240809$EXP$GB-002147023-NVSC2023GB012168$GB-TEVA-VS-3220011$TEVA$Lazenbury A, De Chellis A, Singh J, Illingworth MA. A Case Report of Suspected Omeprazole-Induced Psychosis in a 6-Year-Old Girl with Acute Disseminated Encephalomyelitis. Developmental Medicine and Child Neurology 2023;65(Supplement 1):23.; Lazenbury A, De Chellis A, Singh J, Illingworth MA. A case report of suspected omeprazole-induced psychosis in a 6-year-old girl with acute disseminated encephalomyelitis. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY. 2023;65_23. doi_10.1111_dmcn.15477; Eaz...$6$YR$$F$Y$$$20240809$$MD$GB$GB
241299471$24129947$1$I$20181122$20240718$20240724$20240724$EXP$$CA-SHIRE-CA201900669AA$TAKEDA$$26$YR$$F$Y$43$KG$20240724$$HP$CA$CA
241299481$24129948$1$I$$20240716$20240724$20240724$EXP$$CA-APOTEX-2024AP008483$APOTEX$$$$$M$Y$$$20240724$$CN$CA$CA
241299492$24129949$2$F$20240722$20240820$20240724$20240822$EXP$$NVSC2024DE150939$NOVARTIS$$67$YR$$F$Y$83$KG$20240822$$MD$DE$DE
241299501$24129950$1$I$$20240722$20240724$20240724$EXP$$DE-AstraZeneca-2024A166852$ASTRAZENECA$$$$$F$Y$$$20240724$$MD$DE$
241299511$24129951$1$I$$20210525$20240724$20240724$EXP$$US-AstraZeneca-2021A480863$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241299521$24129952$1$I$20220822$20240715$20240724$20240724$EXP$$FR-CELLTRION INC.-2024FR017430$CELLTRION$$$$$$Y$$$20240724$$MD$FR$FR
241299531$24129953$1$I$20210421$20210520$20240724$20240724$EXP$$US-AstraZeneca-2021A461932$ASTRAZENECA$$29794$DY$$M$Y$$$20240724$$CN$US$
241299541$24129954$1$I$20231201$20240719$20240724$20240724$EXP$FR-AFSSAPS-AN2024000916$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-117133$BRISTOL MYERS SQUIBB$$74$YR$E$$Y$$$20240724$$MD$FR$FR
241299551$24129955$1$I$20240720$20240720$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013890$ELI LILLY AND CO$$$$$$Y$$$20240724$$CN$US$US
241299561$24129956$1$I$20240720$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014207$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240724$$CN$US$US
241299571$24129957$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014801$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240724$$HP$US$US
241299581$24129958$1$I$20240701$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013988$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240724$$CN$US$US
241299591$24129959$1$I$$20220617$20240724$20240724$EXP$$US-AstraZeneca-2022A227011$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241299601$24129960$1$I$20240711$20240719$20240724$20240724$EXP$$US-TAKEDA-2024TUS074168$TAKEDA$$80$YR$$M$Y$$$20240724$$CN$US$US
241299611$24129961$1$I$20240101$20240716$20240724$20240724$PER$$US-UCBSA-2024026322$UCB$$$$$M$Y$65.77$KG$20240724$$HP$US$US
241299621$24129962$1$I$20240717$20240717$20240724$20240724$PER$$US-AMGEN-USASP2024144470$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241299631$24129963$1$I$$20240719$20240724$20240724$EXP$$NVSC2024US150459$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241299641$24129964$1$I$$20240722$20240724$20240724$PER$$NVSC2024US151337$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241299652$24129965$2$F$$20240725$20240724$20240731$EXP$$NVSC2024BR150660$NOVARTIS$$$$$M$Y$$$20240801$$CN$BR$BR
241299661$24129966$1$I$$20240722$20240724$20240724$EXP$$TH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041364$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240724$$MD$TH$TH
241299671$24129967$1$I$$20240718$20240724$20240724$EXP$$CA-APOTEX-2024AP008605$APOTEX$$$$$F$Y$$$20240724$$MD$CA$CA
241299681$24129968$1$I$20240430$20240712$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035677$AUROBINDO$$75$YR$$M$Y$$$20240724$$PH$FR$FR
241299691$24129969$1$I$$20240430$20240724$20240724$EXP$$US-OTSUKA-2024_012610$OTSUKA$$$$$$Y$$$20240724$$HP$US$US
241299701$24129970$1$I$$20240312$20240724$20240724$EXP$$US-OTSUKA-2024_006773$OTSUKA$$$$$F$Y$$$20240724$$MD$US$US
241299711$24129971$1$I$20240201$20240318$20240724$20240724$PER$$US-OTSUKA-2024_007318$OTSUKA$$67$YR$$F$Y$$$20240724$$PH$US$US
241299721$24129972$1$I$$20240326$20240724$20240724$PER$$US-OTSUKA-2024_008278$OTSUKA$$$$$F$Y$$$20240724$$HP$US$US
241299731$24129973$1$I$20240722$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145851$AMGEN$$51$YR$A$F$Y$$$20240723$$HP$US$US
241299741$24129974$1$I$$20240717$20240724$20240724$PER$$US-AMGEN-USASP2024143155$AMGEN$$$$$M$Y$$$20240723$$MD$US$US
241299751$24129975$1$I$20240716$20240716$20240724$20240724$EXP$$TW-AMGEN-TWNSP2024144688$AMGEN$$80$YR$E$F$Y$$$20240723$$HP$TW$TW
241299762$24129976$2$F$$20240720$20240724$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003383$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241299771$24129977$1$I$20240101$20240716$20240724$20240724$EXP$$US-AMGEN-USASP2024141195$AMGEN$$$$$M$Y$$$20240723$$CN$US$US
241299781$24129978$1$I$20240715$20240716$20240724$20240724$EXP$$US-ABBVIE-5846062$ABBVIE$$40$YR$$M$Y$$$20240724$$MD$US$US
241299791$24129979$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151328$NOVARTIS$$$$$M$Y$126.1$KG$20240724$$CN$US$US
241299801$24129980$1$I$20240601$20240718$20240724$20240724$EXP$FR-AFSSAPS-TS2024000813$FR-AMGEN-FRASP2024144771$AMGEN$$54$YR$A$M$Y$72$KG$20240723$$MD$FR$FR
241299811$24129981$1$I$$20240715$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113824$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240724$$CN$US$US
241299821$24129982$1$I$$20240718$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115089$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$67.13$KG$20240724$$CN$US$US
241299831$24129983$1$I$$20240709$20240724$20240724$EXP$$US-SUPERNUS Pharmaceuticals, Inc.-SUP202407-002470$SUPERNUS$$17$YR$$M$Y$$$20240723$$MD$US$
241299841$24129984$1$I$20240101$20240718$20240724$20240724$EXP$$US-JNJFOC-20240752252$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240724$$HP$US$US
241299851$24129985$1$I$$20240721$20240724$20240724$PER$$US-AMGEN-USASP2024145384$AMGEN$$$$$$Y$$$20240723$$CN$US$US
241299861$24129986$1$I$20240611$20240716$20240724$20240724$EXP$FR-AFSSAPS-PV2024000619$FR-BIOGEN-2024BI01274093$BIOGEN$$$$N$M$Y$3.04$KG$20240724$$MD$FR$FR
241299873$24129987$3$F$20240101$20240806$20240724$20240815$EXP$$US-INTERCEPT-PM2024001418$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240815$$CN$US$US
241299881$24129988$1$I$20240508$20240710$20240724$20240724$EXP$$CA-INTERCEPT-PM2024001459$INTERCEPT PHARMACEUTICALS$$63$YR$$F$Y$63.5$KG$20240724$$MD$CA$CA
241299891$24129989$1$I$$20240718$20240724$20240724$EXP$$US-GSK-US2024090613$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241299901$24129990$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024090111$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241299911$24129991$1$I$20240706$20240717$20240724$20240724$EXP$$CN-SA-2024SA212969$SANOFI AVENTIS$$69$YR$E$F$Y$63$KG$20240724$$HP$CN$CN
241299921$24129992$1$I$$20240715$20240724$20240724$EXP$$US-INTERCEPT-PM2024001431$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241299931$24129993$1$I$$20201020$20240724$20240724$EXP$$US-AstraZeneca-2020SF20115$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241299941$24129994$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A163025$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241299951$24129995$1$I$20240519$20240722$20240724$20240724$EXP$$US-AstraZeneca-2024A166748$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241299962$24129996$2$F$20240401$20240723$20240724$20240801$EXP$$DE-AUROBINDO-AUR-APL-2024-035894$AUROBINDO$$67$YR$$F$Y$85$KG$20240801$$MD$DE$DE
241299971$24129997$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024144478$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241299982$24129998$2$F$20240715$20240718$20240724$20240724$EXP$$US-AMGEN-USASP2024143664$AMGEN$$$$$F$Y$$$20240724$$PH$US$US
241299991$24129999$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144812$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
241300002$24130000$2$F$20240721$20240723$20240724$20240726$PER$$US-AMGEN-USASP2024145887$AMGEN$$63$YR$A$M$Y$$$20240726$$CN$US$US
241300013$24130001$3$F$20240627$20240730$20240724$20240807$PER$$US-AMGEN-USASP2024139810$AMGEN$$33$YR$A$F$Y$89.3$KG$20240807$$HP$US$US
241300021$24130002$1$I$$20240722$20240724$20240724$EXP$$US-ROCHE-10000033908$ROCHE$$$$A$F$Y$$$20240724$$CN$US$US
241300031$24130003$1$I$20240719$20240719$20240724$20240724$PER$$US-LEO Pharma-372197$LEO PHARM$$59$YR$$F$Y$$$20240724$$CN$US$US
241300041$24130004$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024090138$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241300051$24130005$1$I$$20240715$20240724$20240724$PER$$US-ROCHE-10000033847$ROCHE$Rashid S, Meshkin R, Cakir B, Hoyek S, Rossin E, Eliott D, et al. Concurrent Central Retinal Vein Occlusion and Rhegmatogenous Retinal Detachment in Two Young Healthy Patients. Retinal Cases and Brief Reports. 2024; doi:10.1097/ICB.0000000000001622.$19$YR$A$M$Y$$$20240724$$HP$US$US
241300061$24130006$1$I$20240720$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014147$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240724$$CN$US$US
241300071$24130007$1$I$$20240721$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014238$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240724$$CN$US$US
241300081$24130008$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014386$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240724$$CN$US$US
241300091$24130009$1$I$20240719$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014394$ELI LILLY AND CO$$$$A$$Y$$$20240724$$CN$US$US
241300101$24130010$1$I$$20240717$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014027$ELI LILLY AND CO$$77$YR$E$$Y$$$20240724$$PH$US$US
241300111$24130011$1$I$20240722$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014169$ELI LILLY AND CO$$$$$M$Y$$$20240724$$CN$US$US
241300122$24130012$2$F$$20240722$20240724$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202407014338$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240815$$HP$US$US
241300131$24130013$1$I$$20240710$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202308015395$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240724$$CN$US$US
241300141$24130014$1$I$$20240717$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407011197$ELI LILLY AND CO$$34$YR$A$F$Y$64.8$KG$20240724$$CN$US$US
241300152$24130015$2$F$$20240726$20240724$20240807$EXP$$US-AUROBINDO-AUR-APL-2024-036186$AUROBINDO$Kim HJ, Brill D, Giuliari GP. OCCLUSIVE CYTOMEGALOVIRUS PANUVEITIS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT.. Retin-Cases-Brief-Rep. 2024;18(4):442-445$60$YR$$M$Y$$$20240807$$MD$US$US
241300161$24130016$1$I$$20240719$20240724$20240724$PER$$US-LEO Pharma-372189$LEO PHARM$$78$YR$$F$Y$$$20240724$$PH$US$US
241300171$24130017$1$I$20240101$20240718$20240724$20240724$EXP$$CA-JNJFOC-20240181052$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240724$$HP$CA$CA
241300181$24130018$1$I$$20240709$20240724$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456253$RANBAXY$Bisht K, Mohan B, Jatteppanavar B, Sony HT, Handu S, Dhar M. An observational study of root-cause analysis of medication errors in elderly with methotrexate toxicity. Expert Opin Drug Saf. 2024;23 (5):593-597$$$E$F$Y$$$20240724$$HP$IN$IN
241300191$24130019$1$I$20240301$20240719$20240724$20240724$EXP$$NVSC2024GR138435$NOVARTIS$$65$YR$$F$Y$$$20240724$$MD$GR$GR
241300202$24130020$2$F$20240301$20240813$20240724$20240813$PER$$US-ALXN-202407USA001213US$ALEXION PHARMACEUTICALS$$74$YR$$F$Y$$$20240813$$CN$US$US
241300221$24130022$1$I$$20240717$20240724$20240724$EXP$$PH-JNJFOC-20240751029$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$PH$PH
241300231$24130023$1$I$$20240715$20240724$20240724$EXP$$CA-APOTEX-2024AP008384$APOTEX$$22$YR$$F$Y$$$20240724$$HP$CA$CA
241300241$24130024$1$I$20240101$20240719$20240724$20240724$EXP$$US-TAKEDA-2024TUS074303$TAKEDA$$26$YR$$M$Y$$$20240724$$MD$US$US
241300251$24130025$1$I$$20240723$20240724$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041608$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240724$$MD$US$US
241300261$24130026$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024144494$AMGEN$$$$A$$Y$$$20240724$$MD$US$US
241300271$24130027$1$I$20240603$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035773$AUROBINDO$$75$YR$$M$Y$$$20240724$$MD$FR$FR
241300282$24130028$2$F$20240708$20240723$20240724$20240725$PER$$US-AMGEN-USASP2024144828$AMGEN$$78$YR$E$M$Y$$$20240725$$CN$US$US
241300291$24130029$1$I$$20240718$20240724$20240724$EXP$$GB-TAKEDA-2024TUS074324$TAKEDA$$$$$M$Y$$$20240724$$CN$GB$GB
241300304$24130030$4$F$20240711$20240809$20240724$20240820$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-112769$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240820$$CN$PR$PR
241300311$24130031$1$I$$20220303$20240724$20240724$EXP$$AU-AstraZeneca-2022A102384$ASTRAZENECA$$$$$$Y$$$20240724$$MD$AU$
241300321$24130032$1$I$$20240628$20240724$20240724$PER$$BR-WT-2024-AMR-077079$Waylis$$$$$F$Y$$$20240724$$CN$BR$BR
241300331$24130033$1$I$$20240710$20240724$20240724$PER$$US-APOTEX-2024AP008290$APOTEX$Lee B, George J, Novello B, Bhullar R.. Botulinum Toxicity Managed With Pyridostigmine Following Botulinum Toxin Injections for Bilateral Neurogenic Thoracic Outlet Syndrome: A Case Report. Pain Medicine Case Reports. 2023;7(1):15-19$$$A$F$Y$$$20240724$$HP$US$US
241300341$24130034$1$I$$20240716$20240724$20240724$PER$$US-ABBVIE-5846080$ABBVIE$$$$A$F$Y$$$20240724$$MD$US$US
241300351$24130035$1$I$$20240718$20240724$20240724$PER$$US-ROCHE-10000033773$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241300362$24130036$2$F$20240720$20240913$20240724$20240916$PER$$US-ROCHE-10000033064$ROCHE$$35$YR$A$M$Y$97.98$KG$20240916$$CN$US$US
241300371$24130037$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-10000033947$ROCHE$$16$YR$T$M$Y$$$20240724$$CN$US$US
241300381$24130038$1$I$$20240630$20240724$20240724$PER$$BR-WT-2024-AMR-078310$Waylis$$$$A$F$Y$$$20240724$$CN$BR$BR
241300391$24130039$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-10000033954$ROCHE$$9$YR$C$M$Y$$$20240724$$CN$US$US
241300401$24130040$1$I$$20240723$20240724$20240724$EXP$$IL-ROCHE-10000033693$ROCHE$$$$A$F$Y$$$20240724$$CN$IL$IL
241300411$24130041$1$I$$20240715$20240724$20240724$EXP$$US-UCBSA-2024036909$UCB$Berger JA, Simpao AF, Dubow SR, McClung HA, Liu GW, Waldman AT, et al.. A retrospective observational cohort study of the anesthetic management and outcomes of pediatric patients with Alexander disease undergoing lumbar puncture or magnetic resonance imaging. Paediatric Anaesthesia. 2024;34(8):810-17$$$$$Y$$$20240724$$HP$US$US
241300421$24130042$1$I$20240712$20240719$20240724$20240724$PER$$US-ROCHE-10000032522$ROCHE$$7$YR$C$M$Y$$$20240724$$CN$US$US
241300432$24130043$2$F$$20240716$20240724$20240828$PER$$US-ROCHE-10000032971$ROCHE$$$$$M$Y$$$20240828$$CN$US$US
241300441$24130044$1$I$$20240719$20240724$20240724$PER$$US-ROCHE-10000033190$ROCHE$$$$$$Y$$$20240724$$PH$US$US
241300451$24130045$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-10000033493$ROCHE$$$$A$F$Y$$$20240724$$CN$US$US
241300461$24130046$1$I$$20240719$20240724$20240724$PER$$US-ROCHE-10000032668$ROCHE$$$$A$M$Y$$$20240724$$CN$US$US
241300471$24130047$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-10000033237$ROCHE$$$$A$M$Y$$$20240724$$CN$US$US
241300481$24130048$1$I$20240301$20240722$20240724$20240724$PER$$US-ROCHE-10000033337$ROCHE$$6$YR$C$M$Y$$$20240724$$CN$US$US
241300491$24130049$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-10000033226$ROCHE$$$$A$M$Y$$$20240724$$CN$US$US
241300501$24130050$1$I$$20240717$20240724$20240724$EXP$$US-ABBVIE-5845641$ABBVIE$$$$$$Y$$$20240722$$MD$US$US
241300512$24130051$2$F$20240301$20240813$20240724$20240813$PER$$US-ALXN-202407USA001214US$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240813$$CN$US$US
241300521$24130052$1$I$20240701$20240722$20240724$20240724$EXP$$PT-ABBVIE-5850404$ABBVIE$$$$$$Y$$$20240724$$PH$PT$PT
241300531$24130053$1$I$$20240425$20240724$20240724$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06186$HIKMA$Alshawa L, Leahy B, Rueckert J, Maskey A, Anstead M, Keshavamurthy S. Alshawa L, Leahy B, Rueckert J, Maskey A, Anstead M, Keshavamurthy S, et al. Hemophagocytic Lymphohistiocytosis: A Rare Diagnosis in the Immediate Aftermath of Lung Transplantation.. Journal of Heart and Lung Transplantation. 2024;43(4):S484-S485.$63$YR$$M$Y$$$20240724$$MD$US$US
241300541$24130054$1$I$$20240719$20240724$20240724$PER$$US-BIOGEN-2024BI01274029$BIOGEN$$$$$F$Y$$$20240724$$CN$US$US
241300551$24130055$1$I$20240312$20240718$20240724$20240724$PER$$US-ROCHE-3576053$ROCHE$$52$YR$A$F$Y$72.57$KG$20240724$$CN$US$US
241300561$24130056$1$I$20240101$20240717$20240724$20240724$EXP$$PL-JNJFOC-20240755824$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240724$$MD$PL$PL
241300574$24130057$4$F$$20240816$20240724$20240826$30DAY$$US-JNJFOC-20240729862$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$CN$US$US
241300581$24130058$1$I$20230101$20240718$20240724$20240724$EXP$$NVSC2023MX052816$NOVARTIS$$$$$F$Y$58$KG$20240724$$CN$MX$MX
241300591$24130059$1$I$$20240719$20240724$20240724$PER$$US-ROCHE-10000032229$ROCHE$$$$$$Y$$$20240724$$PH$US$US
241300601$24130060$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090536$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241300612$24130061$2$F$20240708$20240916$20240724$20240918$EXP$$CA-ROCHE-10000031958$ROCHE$$57$YR$A$F$Y$$$20240918$$CN$CA$CA
241300621$24130062$1$I$20240101$20240709$20240724$20240724$EXP$$US-ENDO USA, INC.-2024-002911$ENDO$$$$$F$Y$$$20240724$$CN$US$US
241300632$24130063$2$F$20240423$20240718$20240724$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-117218$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240802$$MD$JP$JP
241300641$24130064$1$I$20240718$20240719$20240724$20240724$PER$$NVSC2024US149886$NOVARTIS$$60$YR$$M$Y$$$20240724$$CN$US$US
241300651$24130065$1$I$$20240723$20240724$20240724$PER$$US-ROCHE-10000033616$ROCHE$$40$YR$A$F$Y$$$20240724$$CN$US$US
241300661$24130066$1$I$$20240723$20240724$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041565$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240724$$CN$US$US
241300672$24130067$2$F$$20240823$20240724$20240827$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-100899$REGENERON$$91$YR$$M$Y$$$20240827$$HP$CH$CH
241300681$24130068$1$I$20240701$20240716$20240724$20240724$PER$$US-AMGEN-USASP2024142604$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241300691$24130069$1$I$20240717$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145022$AMGEN$$57$YR$A$F$Y$$$20240724$$CN$US$US
241300702$24130070$2$F$20240715$20240808$20240724$20240809$PER$$NVSC2024US149273$NOVARTIS$$63$YR$$M$Y$81$KG$20240809$$PH$US$US
241300711$24130071$1$I$20240718$20240719$20240724$20240724$EXP$$CA-JNJFOC-20240757208$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240724$$HP$CA$CA
241300722$24130072$2$F$20240716$20240830$20240724$20240911$PER$$US-JNJFOC-20240753746$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240911$$CN$US$US
241300731$24130073$1$I$$20240716$20240724$20240724$PER$$US-ALXN-202407USA001117US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241300742$24130074$2$F$20240626$20240813$20240724$20240826$EXP$GB-MHRA-MED-202407121035475230-VWCPD$GB-LUPIN PHARMACEUTICALS INC.-2024-06788$LUPIN$$$$$$Y$$$20240826$$MD$GB$GB
241300751$24130075$1$I$20240101$20240718$20240724$20240724$EXP$$CH-ABBVIE-5845840$ABBVIE$$77$YR$$M$Y$$$20240724$$MD$CH$CH
241300761$24130076$1$I$20240510$20240712$20240724$20240724$EXP$$US-GSK-US2024AMR088537$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241300772$24130077$2$F$$20240926$20240724$20240930$EXP$$FR-BIOGEN-2024BI01274459$BIOGEN$$$$A$F$Y$$$20240930$$MD$FR$FR
241300781$24130078$1$I$$20240717$20240724$20240724$EXP$$CA-BIOGEN-2024BI01274318$BIOGEN$$$$$F$Y$$$20240724$$CN$CA$CA
241300791$24130079$1$I$20240501$20240717$20240724$20240724$EXP$$US-BIOGEN-2024BI01274447$BIOGEN$$69$YR$$M$Y$$$20240724$$MD$US$US
241300801$24130080$1$I$20211026$20240717$20240724$20240724$EXP$$US-BIOGEN-2024BI01274315$BIOGEN$$55$YR$$F$Y$$$20240724$$CN$US$US
241300811$24130081$1$I$$20240711$20240724$20240724$EXP$$TW-ROCHE-10000023411$ROCHE$$$$A$M$Y$$$20240724$$MD$TW$TW
241300831$24130083$1$I$$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116896$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240724$$HP$US$US
241300841$24130084$1$I$20240101$20240715$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112560$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240724$$HP$US$US
241300852$24130085$2$F$20240705$20240729$20240724$20240731$30DAY$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-105049$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240731$$CN$GB$GB
241300861$24130086$1$I$20240101$20240717$20240724$20240724$EXP$$SE-UCBSA-2024037131$UCB$$77$YR$$F$Y$$$20240724$$MD$SE$SE
241300872$24130087$2$F$$20240806$20240724$20240809$EXP$$US-BIOGEN-2024BI01274677$BIOGEN$$$$$F$Y$53.118$KG$20240809$$MD$US$US
241300881$24130088$1$I$$20240716$20240724$20240724$EXP$$US-GSK-US2024089405$GLAXOSMITHKLINE$$$$$M$Y$$$20240724$$MD$US$US
241300891$24130089$1$I$$20240719$20240724$20240724$EXP$$NVSC2024US151076$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241300901$24130090$1$I$$20240716$20240724$20240724$PER$$NVSC2024US147671$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
241300911$24130091$1$I$20240713$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024144484$AMGEN$$62$YR$A$F$Y$$$20240724$$CN$US$US
241300921$24130092$1$I$20240127$20240715$20240724$20240724$EXP$$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06784$HIKMA$$56$YR$$M$Y$77.2$KG$20240724$$HP$FR$FR
241300931$24130093$1$I$20240101$20240717$20240724$20240724$EXP$$US-ORG100016242-2024000433$PACIRA$$57$YR$A$F$Y$76$KG$20240724$$MD$US$US
241300941$24130094$1$I$$20240718$20240724$20240724$EXP$$US-EXELIXIS-CABO-24078387$EXELIXIS$$$$$F$Y$$$20240724$$MD$US$US
241300951$24130095$1$I$$20240607$20240724$20240724$30DAY$$US-GSK-US2024AMR091167$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241300961$24130096$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090435$VIIV$$56$YR$$F$Y$$$20240724$$PH$US$US
241300971$24130097$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090609$VIIV$$25$YR$$M$Y$$$20240724$$PH$US$US
241300982$24130098$2$F$$20240717$20240724$20240725$PER$$NVSC2024US147561$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
241300991$24130099$1$I$$20240723$20240724$20240724$EXP$$GB-JNJFOC-20240761465$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240724$$PH$GB$GB
241301002$24130100$2$F$$20240813$20240724$20240813$PER$$US-ALXN-202407USA001245US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
241301011$24130101$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090433$VIIV$$31$YR$$M$Y$$$20240724$$PH$US$US
241301021$24130102$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090426$VIIV$$60$YR$$M$Y$$$20240724$$PH$US$US
241301031$24130103$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090460$VIIV$$43$YR$$M$Y$$$20240724$$PH$US$US
241301041$24130104$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091177$VIIV$$51$YR$$F$Y$$$20240724$$PH$US$US
241301051$24130105$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090488$VIIV$$34$YR$$M$Y$$$20240724$$PH$US$US
241301061$24130106$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090521$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241301071$24130107$1$I$20240322$20240716$20240724$20240724$EXP$GB-MHRA-MED-202407161345500870-CKDTL$GB-TEVA-VS-3222113$TEVA$$112$YR$$F$Y$64$KG$20240724$$MD$GB$GB
241301081$24130108$1$I$$20210415$20240724$20240724$EXP$$AU-AstraZeneca-2021A317425$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$AU$
241301091$24130109$1$I$$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116641$BRISTOL MYERS SQUIBB$$33$YR$A$M$Y$$$20240724$$CN$US$US
241301101$24130110$1$I$$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115555$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240724$$HP$US$US
241301111$24130111$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116682$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240724$$CN$US$US
241301121$24130112$1$I$20240701$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014337$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240724$$CN$US$US
241301131$24130113$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014462$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240724$$CN$US$US
241301141$24130114$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014388$ELI LILLY AND CO$$28$YR$A$$Y$$$20240724$$CN$US$US
241301151$24130115$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014593$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240724$$HP$US$US
241301161$24130116$1$I$20240722$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014875$ELI LILLY AND CO$$$$$$Y$$$20240724$$CN$US$US
241301171$24130117$1$I$$20240717$20240724$20240724$PER$$US-JNJFOC-20240745850$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$MD$US$US
241301181$24130118$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090539$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241301193$24130119$3$F$$20240907$20240724$20240917$PER$$NVSC2024US151007$NOVARTIS$$$$$$Y$$$20240917$$CN$US$US
241301201$24130120$1$I$20240601$20240722$20240724$20240724$EXP$$US-TERSERA THERAPEUTICS LLC-2024TRS003166$TERSERA THERAPEUTICS$$$$$$Y$$$20240724$$CN$US$US
241301211$24130121$1$I$20240629$20240711$20240724$20240724$PER$$US-IGSA-BIG0029826$GRIFOLS$$36$YR$$M$Y$63.5$KG$20240724$$HP$US$US
241301221$24130122$1$I$20240201$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145941$AMGEN$$69$YR$E$F$Y$$$20240724$$CN$US$US
241301231$24130123$1$I$20230516$20240718$20240724$20240724$EXP$$CO-UCBSA-2024037128$UCB$$46$YR$$M$Y$$$20240724$$CN$CO$CO
241301255$24130125$5$F$20240710$20240815$20240724$20240816$EXP$$BR-JNJFOC-20240758188$JOHNSON AND JOHNSON$$51$YR$A$F$Y$83$KG$20240816$$HP$BR$BR
241301263$24130126$3$F$20240424$20240918$20240724$20240926$EXP$$CA-JNJFOC-20240562797$JOHNSON AND JOHNSON$$54$YR$A$F$Y$66$KG$20240926$$HP$CA$CA
241301273$24130127$3$F$20231130$20240909$20240724$20240916$EXP$$JP-009507513-2407JPN003477J$MERCK$Kobara H, Ando H, Fujioka M, Uchiyama N, Shinagawa M, Takeuchi H, et al.. P-203 Three cases of recurrent uterine body carcinosarcoma treated with lenvatinib + pembrolizumab combination therapy. The journal of the Japan Society of Gynecologic Oncology  The 66th Annual Meetin. 2024;42(3?:405$54$YR$$F$Y$$$20240916$$MD$JP$JP
241301281$24130128$1$I$$20240717$20240724$20240724$EXP$$GB-GSK-GB2024EME090352$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$GB$GB
241301291$24130129$1$I$20240718$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024143636$AMGEN$$35$YR$A$F$Y$$$20240724$$CN$US$US
241301301$24130130$1$I$$20240717$20240724$20240724$PER$$US-ALXN-202407USA001221US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241301312$24130131$2$F$$20240726$20240724$20240812$PER$$NVSC2024US151173$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
241301321$24130132$1$I$$20240715$20240724$20240724$EXP$$IT-AUROBINDO-AUR-APL-2024-035641$AUROBINDO$Vecchio C, Zuffada F, Bianchi M, Nassiacos D.. DISCOVERING PALPITATIONS. Eur-Heart-JSuppl. 2024;26:(Suppl.)ii47$51$YR$$M$Y$$$20240724$$HP$IT$IT
241301331$24130133$1$I$20240715$20240718$20240724$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011029$JAZZ$$3$YR$$M$Y$$$20240724$$CN$US$US
241301341$24130134$1$I$20240603$20240716$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113806$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240724$$CN$US$US
241301351$24130135$1$I$$20240703$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107081$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240724$$CN$US$US
241301361$24130136$1$I$$20240718$20240724$20240724$EXP$ES-JNJFOC-20240727877$ES-GSK-ES2024090593$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$ES$ES
241301371$24130137$1$I$$20240722$20240724$20240724$EXP$$US-SANDOZ INC.-SDZ2024US067264$SANDOZ$$$$$$Y$$$20240724$$CN$US$US
241301384$24130138$4$F$$20240906$20240724$20240913$EXP$CZ-GLPHARMA-24.0826$CZ-GSK-CZ2024090060$GLAXOSMITHKLINE$Grombirikova H , Bily V, Sedlacek P, Litzman J, Freiberger T, Sediva A. Neonatal screening of severe combined immunodeficiency (SCID) in the Czech Republic. Allergy. 2024;26(2):85-9$$$$$Y$$$20240913$$MD$CZ$CZ
241301391$24130139$1$I$20240101$20240722$20240724$20240724$EXP$$US-UCBSA-2024037125$UCB$$$$$F$Y$$$20240724$$HP$US$US
241301401$24130140$1$I$$20240719$20240724$20240724$EXP$$GB-JNJFOC-20240759973$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240724$$CN$GB$GB
241301411$24130141$1$I$$20240716$20240724$20240724$EXP$$US-SANDOZ INC.-SDZ2024US067524$SANDOZ$$$$$$Y$$$20240724$$CN$US$US
241301421$24130142$1$I$20240101$20240716$20240724$20240724$EXP$$DE-SA-2024SA211713$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240724$$CN$DE$DE
241301431$24130143$1$I$$20240722$20240724$20240724$EXP$$DE-ADIENNEP-2024AD000607$ADIENNE PHARMA + BIOTECH$Vinci L, Strahm B, Speckmann C, Erlacher M. The different faces of GATA2 deficiency: implications for therapy and surveillance. Front Oncol. 2024;14:1423856. DOI: ?10.3389/fonc.2024.1423856$$$T$F$Y$$$20240722$$MD$DE$
241301441$24130144$1$I$$20240715$20240724$20240724$EXP$$IT-AUROBINDO-AUR-APL-2023-042408$AUROBINDO$Chiavarino F, Pruccoli J, Cecconi I, Vancini N, Cordelli DM, Parmeggiani A. Eating disorders in young patients with neurofibromatosis type 1. Journal of Paediatrics and Child Health. 2023;59(5):723-8$14$YR$$F$Y$38.4$KG$20240724$$MD$IT$IT
241301451$24130145$1$I$$20240722$20240724$20240724$EXP$$DE-ADIENNEP-2024AD000609$ADIENNE PHARMA + BIOTECH$Vinci L, Strahm B, Speckmann C, Erlacher M. The different faces of GATA2 deficiency: implications for therapy and surveillance. Front Oncol. 2024;14:1423856. DOI: ?10.3389/fonc.2024.1423856$$$C$M$Y$$$20240722$$MD$DE$
241301461$24130146$1$I$$20240718$20240724$20240724$PER$$US-ROCHE-10000033416$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241301471$24130147$1$I$$20240717$20240724$20240724$EXP$$US-SA-2024SA213548$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240724$$CN$US$US
241301481$24130148$1$I$20240712$20240715$20240724$20240724$EXP$$BR-CELLTRION INC.-2024BR017586$CELLTRION$$$$$$Y$$$20240724$$CN$BR$BR
241301491$24130149$1$I$20240701$20240711$20240724$20240724$EXP$$CN-OCTA-ALB11224$OCTAPHARMA$$81$YR$E$M$Y$75$KG$20240723$$HP$CN$CN
241301511$24130151$1$I$20240718$20240722$20240724$20240724$PER$$US-HALEON-2188522$Haleon PLC$$86$YR$$F$Y$$$20240724$$CN$US$US
241301521$24130152$1$I$$20240717$20240724$20240724$EXP$$US-SA-2024SA212144$SANOFI AVENTIS$$$$E$F$Y$$$20240724$$MD$US$US
241301531$24130153$1$I$$20240716$20240724$20240724$EXP$$US-NOVITIUMPHARMA-2024USNVP01347$NOVITIUM PHARMA$Sanchez A.Legionella pneumophila and Staphylococcus aureus co-infections in a patient with SARS-CoV-2.BMJ Case Reports.01-MAR-2022;15:1-3$$$$M$Y$$$20240724$$HP$US$US
241301542$24130154$2$F$20240101$20240907$20240724$20240916$EXP$$CA-CELLTRION INC.-2024CA016097$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
241301551$24130155$1$I$20240621$20240722$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US067212$SANDOZ$$16$YR$$F$Y$$$20240724$$CN$US$US
241301561$24130156$1$I$$20240717$20240724$20240724$EXP$$US-CHEPLA-1400037116$CHEPLAPHARM$$$$E$F$Y$$$20240724$$CN$COUNTRY NOT SPECIFIED$US
241301571$24130157$1$I$20220901$20240719$20240724$20240724$EXP$FR-AFSSAPS-RS2024000698$FR-SA-2024SA213370$SANOFI AVENTIS$$69$YR$E$M$Y$93$KG$20240724$$PH$FR$FR
241301581$24130158$1$I$20240630$20240718$20240724$20240724$EXP$HR-HALMED-300086130$HR-CHEPLA-2024009105$CHEPLAPHARM$$$$T$F$Y$$$20240724$$MD$COUNTRY NOT SPECIFIED$HR
241301591$24130159$1$I$20240424$20240718$20240724$20240724$EXP$$CN-CHEPLA-2024009204$CHEPLAPHARM$$65$YR$$M$Y$$$20240724$$HP$COUNTRY NOT SPECIFIED$CN
241301601$24130160$1$I$20240501$20240722$20240724$20240724$EXP$$NVSC2024DE149739$NOVARTIS$$86$YR$$F$Y$50$KG$20240724$$MD$DE$DE
241301611$24130161$1$I$20240505$20240715$20240724$20240724$EXP$GB-MHRA-MED-202407150925440130-WTZRN$GB-TEVA-VS-3221565$TEVA$$$$$F$Y$$$20240724$$PH$GB$GB
241301621$24130162$1$I$$20240719$20240724$20240724$EXP$$DE-TAKEDA-2024TUS074308$TAKEDA$$9$DEC$$F$Y$$$20240724$$MD$DE$DE
241301631$24130163$1$I$$20240719$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116668$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240724$$HP$US$US
241301641$24130164$1$I$20230101$20240717$20240724$20240724$PER$$US-ALXN-202407USA001241US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241301651$24130165$1$I$20240720$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014168$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240724$$CN$US$US
241301661$24130166$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013950$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240724$$CN$US$US
241301671$24130167$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014243$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240724$$CN$US$US
241301682$24130168$2$F$$20240723$20240724$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015079$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240725$$CN$US$US
241301691$24130169$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014101$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240724$$CN$US$US
241301701$24130170$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014766$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240724$$CN$US$US
241301711$24130171$1$I$20240720$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013926$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240724$$CN$US$US
241301721$24130172$1$I$20240719$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014202$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240724$$CN$US$US
241301731$24130173$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014116$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240724$$HP$US$US
241301741$24130174$1$I$20240723$20240723$20240724$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041555$BOEHRINGER INGELHEIM$$50$YR$A$F$Y$$$20240724$$CN$US$US
241301751$24130175$1$I$20240626$20240715$20240724$20240724$EXP$IT-MINISAL02-993857$IT-TEVA-VS-3221689$TEVA$$50$YR$$F$Y$$$20240724$$MD$IT$IT
241301761$24130176$1$I$20240718$20240718$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US066921$SANDOZ$$12$YR$$M$Y$$$20240724$$CN$US$US
241301772$24130177$2$F$$20240822$20240724$20240829$EXP$$JP-TAKEDA-2024TUS074054$TAKEDA$$72$YR$$$Y$$$20240829$$MD$JP$JP
241301781$24130178$1$I$20240528$20240723$20240724$20240724$EXP$$DE-SANDOZ INC.-SDZ2024DE067416$SANDOZ$$69$YR$$M$Y$120$KG$20240724$$MD$DE$DE
241301791$24130179$1$I$$20240722$20240724$20240724$EXP$$ES-SANDOZ INC.-SDZ2024ES067179$SANDOZ$$39$YR$$M$Y$$$20240724$$HP$ES$ES
241301811$24130181$1$I$20240706$20240710$20240724$20240724$EXP$$US-MDD US Operations-MDD202407-002498$MDD OPERATIONS$$81$YR$$M$Y$$$20240724$$HP$US$
241301821$24130182$1$I$$20240722$20240724$20240724$EXP$$TW-SANDOZ INC.-SDZ2024TW066884$SANDOZ$$$$$F$Y$$$20240724$$CN$TW$TW
241301832$24130183$2$F$$20240722$20240724$20240726$EXP$$US-SANDOZ INC.-SDZ2024US067389$SANDOZ$$$$$F$Y$$$20240726$$CN$US$US
241301842$24130184$2$F$20240605$20240826$20240724$20240829$PER$$US-ABBVIE-5845212$ABBVIE$$24$YR$$F$Y$64.863$KG$20240829$$MD$US$US
241301851$24130185$1$I$$20240718$20240724$20240724$EXP$$IL-SANDOZ INC.-SDZ2024IL067457$SANDOZ$$$$E$M$Y$$$20240724$$CN$IL$IL
241301861$24130186$1$I$20240708$20240723$20240724$20240724$EXP$IT-MINISAL02-995798$IT-SANDOZ INC.-SDZ2024IT067282$SANDOZ$$48$YR$$F$Y$$$20240724$$MD$IT$IT
241301871$24130187$1$I$$20240716$20240724$20240724$30DAY$$EG-SANDOZ INC.-SDZ2024EG000826$SANDOZ$$$$$M$Y$22$KG$20240724$$CN$EG$EG
241301881$24130188$1$I$$20240715$20240724$20240724$PER$$US-RDY-LIT/USA/24/0010725$DR REDDYS$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15(3): doi:10.14309/ctg.0000000000000679.$63$YR$A$M$Y$$$20240724$$MD$US$US
241301891$24130189$1$I$$20240715$20240724$20240724$EXP$$CA-CELLTRION INC.-2024CA017712$CELLTRION$$$$$$Y$$$20240724$$HP$CA$CA
241301901$24130190$1$I$20240712$20240716$20240724$20240724$EXP$$US-RDY-CLI/USA/24/0010541$DR REDDYS$$25$YR$A$F$Y$$$20240724$$MD$US$US
241301911$24130191$1$I$$20240722$20240724$20240724$PER$$NVSC2024US150535$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241301921$24130192$1$I$$20230810$20240724$20240724$EXP$$GB-SANDOZ INC.-NVSC2020GB319407$SANDOZ$$$$$M$Y$$$20240724$$CN$GB$GB
241301931$24130193$1$I$$20240723$20240724$20240724$EXP$$FR-SANDOZ INC.-SDZ2024FR067269$SANDOZ$$67$YR$$M$Y$$$20240724$$HP$FR$FR
241301941$24130194$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06780$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241301952$24130195$2$F$20230309$20240822$20240724$20240823$EXP$$DE-SANDOZ INC.-SDZ2024DE067411$SANDOZ$$$$E$M$Y$$$20240823$$MD$DE$DE
241301963$24130196$3$F$20240716$20240906$20240724$20240910$PER$$US-AMGEN-USASP2024144508$AMGEN$$55$YR$A$F$Y$$$20240909$$CN$US$US
241301971$24130197$1$I$$20240723$20240724$20240724$EXP$$FR-SANDOZ INC.-SDZ2024FR067270$SANDOZ$$$$A$$Y$$$20240724$$MD$FR$FR
241301981$24130198$1$I$$20240718$20240724$20240724$EXP$$CA-JNJFOC-20240754142$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240724$$HP$CA$CA
241301992$24130199$2$F$$20240813$20240724$20240813$PER$$US-ALXN-202407USA001237US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241302001$24130200$1$I$20231128$20240715$20240724$20240724$EXP$$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06786$HIKMA$$65$YR$$F$Y$56.5$KG$20240724$$HP$FR$FR
241302011$24130201$1$I$20240601$20240614$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003268$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241302021$24130202$1$I$$20240522$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003287$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241302031$24130203$1$I$$20240611$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003283$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$HP$US$US
241302041$24130204$1$I$$20240522$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003294$STEMLINE THERAPEUTICS$$$$$F$Y$$$20240718$$HP$US$US
241302051$24130205$1$I$$20240523$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003310$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241302061$24130206$1$I$$20240524$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003323$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241302071$24130207$1$I$$20240524$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003331$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241302081$24130208$1$I$$20240524$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003338$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241302091$24130209$1$I$$20240524$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003340$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240718$$CN$US$US
241302101$24130210$1$I$$20240524$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003346$STEMLINE THERAPEUTICS$$78$YR$E$F$Y$$$20240718$$CN$US$US
241302111$24130211$1$I$$20240524$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003347$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241302121$24130212$1$I$$20240522$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003286$STEMLINE THERAPEUTICS$$38$YR$A$F$Y$$$20240718$$CN$US$US
241302131$24130213$1$I$$20240528$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003359$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241302141$24130214$1$I$$20240528$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003366$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240718$$CN$US$US
241302151$24130215$1$I$$20240521$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003265$STEMLINE THERAPEUTICS$$89$YR$E$F$Y$$$20240718$$CN$US$US
241302161$24130216$1$I$$20240611$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003379$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241302171$24130217$1$I$20240510$20240522$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003290$STEMLINE THERAPEUTICS$$89$YR$E$F$Y$$$20240718$$CN$US$US
241302181$24130218$1$I$$20240530$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003410$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241302191$24130219$1$I$$20240530$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003411$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241302201$24130220$1$I$$20240529$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003396$STEMLINE THERAPEUTICS$$49$YR$A$F$Y$$$20240718$$CN$US$US
241302211$24130221$1$I$$20240610$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003430$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241302221$24130222$1$I$$20240612$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003431$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241302231$24130223$1$I$$20240530$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003432$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$CN$US$US
241302241$24130224$1$I$$20240613$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003433$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241302251$24130225$1$I$$20240531$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003447$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240718$$CN$US$US
241302261$24130226$1$I$$20240602$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003452$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240718$$CN$US$US
241302271$24130227$1$I$20240518$20240522$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003293$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240718$$CN$US$US
241302281$24130228$1$I$$20240603$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003460$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240718$$CN$US$US
241302291$24130229$1$I$$20240521$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003261$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241302301$24130230$1$I$$20240522$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003282$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240718$$CN$US$US
241302311$24130231$1$I$$20240529$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003405$STEMLINE THERAPEUTICS$$86$YR$E$F$Y$$$20240718$$CN$US$US
241302321$24130232$1$I$$20240522$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003267$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241302331$24130233$1$I$20240601$20240604$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003490$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240718$$CN$US$US
241302341$24130234$1$I$$20240604$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003494$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241302351$24130235$1$I$$20240604$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003498$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240718$$CN$US$US
241302361$24130236$1$I$20240601$20240605$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003510$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240718$$CN$US$US
241302371$24130237$1$I$20240601$20240605$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003522$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241302381$24130238$1$I$20240501$20240522$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003288$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240718$$CN$US$US
241302391$24130239$1$I$$20240603$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003481$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
241302401$24130240$1$I$$20240605$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003509$STEMLINE THERAPEUTICS$$81$YR$E$M$Y$$$20240718$$CN$US$US
241302411$24130241$1$I$20240605$20240606$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003525$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241302422$24130242$2$F$20230710$20240829$20240724$20240902$EXP$$JP-TAKEDA-2023TJP011574$TAKEDA$$25$YR$$F$Y$79.3$KG$20240902$$MD$JP$JP
241302431$24130243$1$I$$20240530$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003412$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240718$$CN$US$US
241302441$24130244$1$I$20240501$20240603$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003473$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240718$$CN$US$US
241302451$24130245$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06707$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241302471$24130247$1$I$$20240628$20240724$20240724$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003067$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241302481$24130248$1$I$$20240604$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003332$STEMLINE THERAPEUTICS$$90$YR$E$F$Y$$$20240718$$CN$US$US
241302491$24130249$1$I$$20240603$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003459$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240718$$CN$US$US
241302501$24130250$1$I$20240524$20240711$20240724$20240724$EXP$$US-UCBSA-2024035628$UCB$$8$YR$$M$Y$$$20240724$$CN$US$US
241302511$24130251$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06757$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241302521$24130252$1$I$$20240521$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003256$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241302531$24130253$1$I$20240703$20240716$20240724$20240724$EXP$$CN-ROCHE-10000028813$ROCHE$$57$YR$A$M$Y$$$20240724$$HP$CN$CN
241302541$24130254$1$I$$20240522$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003271$STEMLINE THERAPEUTICS$$86$YR$E$F$Y$$$20240718$$CN$US$US
241302551$24130255$1$I$20240516$20240522$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003273$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241302561$24130256$1$I$$20240529$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003386$STEMLINE THERAPEUTICS$$52$YR$A$F$Y$$$20240718$$CN$US$US
241302571$24130257$1$I$$20240531$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003443$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240718$$CN$US$US
241302591$24130259$1$I$$20240719$20240724$20240724$PER$$NVSC2024US150648$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
241302601$24130260$1$I$$20240715$20240724$20240724$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001431$BLUEPRINT MEDICINES$$$$$M$Y$$$20240724$$CN$US$US
241302614$24130261$4$F$20240501$20240731$20240724$20240807$EXP$$GB-ABBVIE-5844483$ABBVIE$$82$YR$$F$Y$$$20240807$$CN$GB$GB
241302621$24130262$1$I$$20240716$20240724$20240724$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001446$BLUEPRINT MEDICINES$$$$$M$Y$$$20240724$$CN$US$US
241302631$24130263$1$I$20240712$20240715$20240724$20240724$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001419$BLUEPRINT MEDICINES$$$$$$Y$$$20240724$$CN$US$US
241302641$24130264$1$I$$20240716$20240724$20240724$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001457$BLUEPRINT MEDICINES$$$$$M$Y$$$20240724$$CN$US$US
241302651$24130265$1$I$$20240717$20240724$20240724$EXP$$CH-Bion-013487$BIONPHARMA$$64$YR$A$F$Y$$$20240724$$HP$CH$CH
241302661$24130266$1$I$$20240718$20240724$20240724$EXP$$IT-Bion-013496$BIONPHARMA$$0$YR$N$F$Y$$$20240724$$HP$IT$IT
241302672$24130267$2$F$20240101$20240809$20240724$20240816$EXP$$CA-CELLTRION INC.-2024CA017721$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
241302681$24130268$1$I$$20240715$20240724$20240724$EXP$$US-Bion-013497$BIONPHARMA$$57$YR$A$F$Y$$$20240724$$CN$US$US
241302691$24130269$1$I$20240715$20240717$20240724$20240724$EXP$$US-Bion-013498$BIONPHARMA$$64$YR$A$M$Y$$$20240724$$CN$US$US
241302701$24130270$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06735$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241302721$24130272$1$I$$20240711$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015177$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240724$$CN$US$US
241302731$24130273$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014476$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240724$$CN$US$US
241302741$24130274$1$I$20240616$20240712$20240724$20240724$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-115508$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240724$$CN$PR$PR
241302751$24130275$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014493$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240724$$CN$US$US
241302761$24130276$1$I$20240718$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014066$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240724$$CN$US$US
241302771$24130277$1$I$20240718$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144865$AMGEN$$51$YR$A$M$Y$$$20240724$$CN$US$US
241302781$24130278$1$I$$20240718$20240724$20240724$EXP$$VN-Bion-013492$BIONPHARMA$$$$C$F$Y$$$20240724$$HP$VN$VN
241302792$24130279$2$F$20240601$20240820$20240724$20240828$EXP$$JP-UCBSA-2024035943$UCB$$59$YR$$M$Y$$$20240829$$MD$JP$JP
241302801$24130280$1$I$$20240722$20240724$20240724$PER$$US-HALEON-2188314$Haleon PLC$$$$$$Y$$$20240724$$CN$US$US
241302811$24130281$1$I$$20240718$20240724$20240724$EXP$$US-TAKEDA-2024TUS073940$TAKEDA$$$$$M$Y$$$20240724$$CN$US$US
241302821$24130282$1$I$$20240528$20240724$20240724$EXP$$US-ENDO USA, INC.-2024-002451$ENDO$$$$$$Y$$$20240724$$CN$US$US
241302831$24130283$1$I$$20240717$20240724$20240724$EXP$$US-JNJFOC-20240748650$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$CN$US$US
241302841$24130284$1$I$20240718$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144005$AMGEN$$$$$M$Y$$$20240724$$HP$US$US
241302851$24130285$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024146224$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241302861$24130286$1$I$20240501$20240722$20240724$20240724$EXP$$US-SANDOZ INC.-SDZ2024US067368$SANDOZ$$81$YR$$F$Y$$$20240724$$HP$US$US
241302871$24130287$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06643$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241302881$24130288$1$I$$20240715$20240724$20240724$PER$$US-RDY-LIT/USA/24/0010726$DR REDDYS$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15(3): doi:10.14309/ctg.0000000000000679.$42$YR$A$F$Y$$$20240724$$MD$US$US
241302891$24130289$1$I$$20240715$20240724$20240724$PER$$US-ROCHE-10000021113$ROCHE$$$$$$Y$$$20240724$$MD$US$US
241302901$24130290$1$I$20190915$20240718$20240724$20240724$EXP$$CO-UCBSA-2024037130$UCB$$52$YR$$F$Y$$$20240724$$CN$CO$CO
241302911$24130291$1$I$$20240709$20240724$20240724$EXP$$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001783$IPCA$$$$$$Y$$$20240724$$HP$GB$GB
241302931$24130293$1$I$$20240723$20240724$20240724$EXP$$BE-SANDOZ INC.-SDZ2024BE067480$SANDOZ$$55$YR$$M$Y$$$20240724$$HP$BE$BE
241302941$24130294$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151481$NOVARTIS$$$$$F$Y$$$20240724$$HP$US$US
241302951$24130295$1$I$20231210$20240717$20240724$20240724$EXP$NL-LRB-00980839$NL-EMD Serono-2024039017$EMD SERONO INC$$$$N$M$Y$3$KG$20240724$$MD$NL$NL
241302962$24130296$2$F$20240625$20240911$20240724$20240917$EXP$$JP-ABBVIE-5849657$ABBVIE$$64$YR$$F$Y$90$KG$20240917$$MD$JP$JP
241302971$24130297$1$I$$20240721$20240724$20240724$PER$$US-AMGEN-USASP2024145394$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241302981$24130298$1$I$20240101$20240715$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-019551$UNITED THERAPEUTICS$$$$$F$Y$80.726$KG$20240724$$$US$US
241302991$24130299$1$I$$20240626$20240724$20240724$PER$$US-009507513-2406USA009744$MERCK$$$$$F$Y$$$20240724$$HP$US$US
241303001$24130300$1$I$$20240723$20240724$20240724$EXP$$CA-ORGANON-O2407CAN002160$ORGANON$$40$YR$$F$Y$$$20240724$$HP$CA$CA
241303012$24130301$2$F$$20240916$20240724$20240918$EXP$$NVSC2024US149394$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
241303021$24130302$1$I$20230401$20230425$20240724$20240724$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-091478$ZYDUS PHARM$$$$$$Y$$$20240724$$CN$US$US
241303031$24130303$1$I$20230101$20230213$20240724$20240724$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-088480$ZYDUS PHARM$$$$$$Y$$$20240724$$CN$US$US
241303041$24130304$1$I$$20230123$20240724$20240724$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-087581$ZYDUS PHARM$$$$$$Y$$$20240724$$MD$US$US
241303051$24130305$1$I$20240501$20240625$20240724$20240724$30DAY$$AE-UCBSA-2024032526$UCB$$86$YR$$F$Y$$$20240724$$MD$AE$AE
241303061$24130306$1$I$20240201$20240402$20240724$20240724$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-105585$ZYDUS PHARM$$$$$$Y$$$20240724$$CN$US$US
241303071$24130307$1$I$20230101$20231017$20240724$20240724$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-099393$ZYDUS PHARM$$$$$$Y$$$20240724$$CN$US$US
241303081$24130308$1$I$$20240204$20240724$20240724$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-103333$ZYDUS PHARM$$$$$$Y$$$20240724$$CN$US$US
241303101$24130310$1$I$$20240717$20240724$20240724$EXP$$US-JNJFOC-20240748473$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$MD$US$US
241303111$24130311$1$I$$20240715$20240724$20240724$EXP$$BR-JNJFOC-20240749082$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240724$$PH$BR$BR
241303121$24130312$1$I$20240715$20240717$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-022253$UNITED THERAPEUTICS$$57$YR$$F$Y$98.866$KG$20240724$$$US$US
241303131$24130313$1$I$$20240717$20240724$20240724$PER$$US-ALXN-202407USA001173US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241303141$24130314$1$I$$20240716$20240724$20240724$PER$$US-ALXN-202407USA001157US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240724$$HP$US$US
241303151$24130315$1$I$20210101$20240720$20240724$20240724$PER$$US-AMGEN-USASP2024144712$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
241303162$24130316$2$F$20240713$20240812$20240724$20240814$30DAY$$US-AMGEN-USASP2024142923$AMGEN$$78$YR$E$M$Y$95$KG$20240814$$PH$US$US
241303173$24130317$3$F$20240718$20240813$20240724$20240814$PER$$US-AMGEN-USASP2024144446$AMGEN$$80$YR$E$F$Y$$$20240814$$CN$US$US
241303182$24130318$2$F$20240717$20240911$20240724$20240919$EXP$$NVSC2024DE149108$NOVARTIS$$$$A$M$Y$82$KG$20240919$$MD$DE$DE
241303191$24130319$1$I$$20240722$20240724$20240724$EXP$$CA-SANDOZ INC.-SDZ2024CA067118$SANDOZ$$64$YR$$F$Y$$$20240724$$CN$CA$CA
241303201$24130320$1$I$20240622$20240718$20240724$20240724$EXP$$US-BIOGEN-2024BI01274699$BIOGEN$$20$YR$$F$Y$$$20240724$$CN$US$US
241303221$24130322$1$I$$20240723$20240724$20240724$EXP$GB-MHRA-MIDB-8225be0e-d7a1-4a04-8e40-6b311ad5997e$GB-TEVA-VS-3224096$TEVA$$83$YR$$$Y$$$20240724$$PH$GB$GB
241303232$24130323$2$F$$20240826$20240724$20240902$EXP$$US-BIOGEN-2024BI01274479$BIOGEN$$$$$$Y$$$20240902$$CN$US$US
241303243$24130324$3$F$20240226$20240819$20240724$20240820$EXP$$US-UCBSA-2024010492$UCB$$78$YR$$M$Y$$$20240820$$CN$US$US
241303253$24130325$3$F$20240701$20240731$20240724$20240806$PER$$US-ABBVIE-5848410$ABBVIE$$90$YR$$M$Y$$$20240806$$CN$US$US
241303261$24130326$1$I$$20240716$20240724$20240724$EXP$$VN-AstraZeneca-2024A163631$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$VN$
241303271$24130327$1$I$$20240715$20240724$20240724$PER$$US-AstraZeneca-2024A165703$ASTRAZENECA$$57$YR$$F$Y$$$20240724$$CN$US$
241303286$24130328$6$F$20240101$20240813$20240724$20240820$EXP$$CA-CELLTRION INC.-2024CA017273$CELLTRION$$$$$$Y$$$20240820$$CN$CA$CA
241303291$24130329$1$I$$20240715$20240724$20240724$EXP$$US-PBT-009535$PANACEA BIOTEC$Zouridis S, Oo YH, Syn WK. Role of Sirolimus and Rituximab in the Treatment of Autoimmune Hepatitis. ACG Case Rep J. 2024 Jul 11;11(7):e01414. doi: 10.14309/crj.0000000000001414.$23$YR$A$F$Y$$$20240724$$MD$US$US
241303301$24130330$1$I$20220101$20240716$20240724$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-061515$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240724$$MD$JP$JP
241303311$24130331$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015110$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240724$$CN$US$US
241303321$24130332$1$I$$20240723$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015137$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240724$$CN$US$US
241303331$24130333$1$I$20240708$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014290$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240724$$CN$US$US
241303341$24130334$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014015$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240724$$CN$US$US
241303351$24130335$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013943$ELI LILLY AND CO$$61$YR$A$$Y$$$20240724$$CN$US$US
241303362$24130336$2$F$20240710$20240715$20240724$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021871$UNITED THERAPEUTICS$$51$YR$$F$Y$97.052$KG$20240725$$$US$US
241303371$24130337$1$I$$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014468$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240724$$CN$US$US
241303381$24130338$1$I$20210419$20210421$20240724$20240724$EXP$$NL-TERSERA THERAPEUTICS LLC-2021TRS001992$TERSERA THERAPEUTICS$$$$$$Y$$$20240724$$CN$NL$NL
241303391$24130339$1$I$20200606$20200609$20240724$20240724$EXP$$CO-TERSERA THERAPEUTICS LLC-2020TRS001654$TERSERA THERAPEUTICS$$$$$$Y$$$20240724$$CN$CO$CO
241303401$24130340$1$I$20230101$20231120$20240724$20240724$EXP$$CA-TEVA-VS-3134867$TEVA$$64$YR$$F$Y$$$20240724$$PH$CA$CA
241303411$24130341$1$I$20240708$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144866$AMGEN$$58$YR$A$F$Y$$$20240724$$CN$US$US
241303421$24130342$1$I$$20240718$20240724$20240724$EXP$$JP-GSK-JP2024JPN090279$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$JP$JP
241303431$24130343$1$I$$20240710$20240724$20240724$EXP$$TH-ROCHE-10000030000$ROCHE$$$$$M$Y$$$20240724$$MD$TH$TH
241303441$24130344$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151466$NOVARTIS$$$$$$Y$$$20240724$$MD$US$US
241303451$24130345$1$I$20240715$20240716$20240724$20240724$PER$$US-AMGEN-USASP2024140983$AMGEN$$47$YR$A$$Y$$$20240724$$CN$US$US
241303461$24130346$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024143702$AMGEN$$$$A$M$Y$$$20240724$$CN$US$US
241303471$24130347$1$I$$20240710$20240724$20240724$EXP$$JP-AMGEN-JPNSP2024144944$AMGEN$$$$$M$Y$$$20240724$$CN$JP$JP
241303491$24130349$1$I$$20240715$20240724$20240724$EXP$$US-RDY-LIT/USA/24/0010727$DR REDDYS$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15(3): doi:10.14309/ctg.0000000000000679.$78$YR$E$F$Y$$$20240724$$MD$US$US
241303502$24130350$2$F$20231116$20240809$20240724$20240821$EXP$$US-INSMED-2023-04698-USAA$INSMED$$69$YR$$F$Y$$$20240821$$CN$US$US
241303522$24130352$2$F$$20240722$20240724$20240726$PER$$NVSC2024US151110$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
241303531$24130353$1$I$$20240723$20240724$20240724$PER$$US-HALEON-2188598$Haleon PLC$$$$$$Y$$$20240724$$CN$US$US
241303541$24130354$1$I$$20240606$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003535$STEMLINE THERAPEUTICS$$82$YR$E$F$Y$$$20240718$$CN$US$US
241303551$24130355$1$I$$20240607$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003551$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241303561$24130356$1$I$$20240607$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003558$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241303571$24130357$1$I$$20240607$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003559$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
241303581$24130358$1$I$$20240607$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003557$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240718$$CN$US$US
241303591$24130359$1$I$$20240607$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003560$STEMLINE THERAPEUTICS$$78$YR$E$F$Y$$$20240718$$HP$US$US
241303601$24130360$1$I$$20240607$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003563$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
241303611$24130361$1$I$20240418$20240610$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003614$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240718$$CN$US$US
241303621$24130362$1$I$$20240610$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003620$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240718$$CN$US$US
241303631$24130363$1$I$$20240610$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003636$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240718$$CN$US$US
241303641$24130364$1$I$$20240610$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003639$STEMLINE THERAPEUTICS$$44$YR$A$F$Y$$$20240718$$CN$US$US
241303651$24130365$1$I$$20240610$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003640$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240718$$CN$US$US
241303661$24130366$1$I$$20240610$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003645$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241303671$24130367$1$I$20240601$20240610$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003646$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241303681$24130368$1$I$$20240611$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003660$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240718$$CN$US$US
241303691$24130369$1$I$$20240611$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003662$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$CN$US$US
241303701$24130370$1$I$$20240611$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003663$STEMLINE THERAPEUTICS$$62$YR$A$F$Y$$$20240718$$CN$US$US
241303711$24130371$1$I$$20240611$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003674$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240718$$CN$US$US
241303721$24130372$1$I$$20240612$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003679$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240718$$CN$US$US
241303731$24130373$1$I$$20240612$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003694$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241303741$24130374$1$I$$20240612$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003702$STEMLINE THERAPEUTICS$$51$YR$A$F$Y$$$20240718$$CN$US$US
241303751$24130375$1$I$$20240612$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003705$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241303761$24130376$1$I$$20240613$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003712$STEMLINE THERAPEUTICS$$$$A$F$Y$$$20240718$$MD$US$US
241303771$24130377$1$I$$20240613$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003719$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240718$$CN$US$US
241303781$24130378$1$I$$20240613$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003721$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240718$$CN$US$US
241303791$24130379$1$I$$20240613$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003722$STEMLINE THERAPEUTICS$$37$YR$A$F$Y$$$20240718$$CN$US$US
241303801$24130380$1$I$20240101$20240613$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003726$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240718$$CN$US$US
241303811$24130381$1$I$$20240613$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003729$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$CN$US$US
241303821$24130382$1$I$$20240613$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003730$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240718$$CN$US$US
241303831$24130383$1$I$20240101$20240614$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003762$STEMLINE THERAPEUTICS$$70$YR$E$F$Y$$$20240718$$CN$US$US
241303841$24130384$1$I$$20240615$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003764$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240718$$CN$US$US
241303851$24130385$1$I$$20240615$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003767$STEMLINE THERAPEUTICS$$49$YR$A$F$Y$$$20240718$$CN$US$US
241303861$24130386$1$I$$20240612$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003695$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240718$$CN$US$US
241303872$24130387$2$F$$20240905$20240724$20240911$EXP$$JP-GSK-JP2024JPN090800$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$MD$JP$JP
241303881$24130388$1$I$20240622$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035784$AUROBINDO$$50$YR$$F$Y$$$20240724$$MD$FR$FR
241303891$24130389$1$I$$20240607$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003555$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241303901$24130390$1$I$$20240610$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003616$STEMLINE THERAPEUTICS$$78$YR$E$F$Y$$$20240718$$CN$US$US
241303911$24130391$1$I$$20240612$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003707$STEMLINE THERAPEUTICS$$40$YR$A$F$Y$$$20240718$$CN$US$US
241303921$24130392$1$I$$20240614$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003748$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240718$$CN$US$US
241303931$24130393$1$I$$20240610$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003641$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240718$$CN$US$US
241303941$24130394$1$I$$20240611$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003656$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240718$$CN$US$US
241303951$24130395$1$I$$20240613$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003731$STEMLINE THERAPEUTICS$$74$YR$E$F$Y$$$20240718$$CN$US$US
241303961$24130396$1$I$20240717$20240717$20240724$20240724$EXP$$US-JNJFOC-20240745684$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$CN$US$US
241303972$24130397$2$F$$20240723$20240724$20240728$EXP$$US-ABBVIE-5846074$ABBVIE$$$$$M$Y$$$20240728$$CN$US$US
241303981$24130398$1$I$$20240709$20240724$20240724$EXP$$US-HLS-202400301$HLS THERAPEUTICS$$42$YR$A$M$Y$$$20240724$$HP$US$US
241303992$24130399$2$F$20240716$20240813$20240724$20240813$PER$$US-ALXN-202407USA001250US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241304001$24130400$1$I$20240708$20240715$20240724$20240724$EXP$$CN-ROCHE-10000027305$ROCHE$$68$YR$E$M$Y$55$KG$20240724$$HP$CN$CN
241304022$24130402$2$F$$20240731$20240724$20240805$PER$$US-AMGEN-USASP2024143823$AMGEN$$$$$M$Y$$$20240804$$CN$US$US
241304031$24130403$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145151$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241304041$24130404$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146245$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241304051$24130405$1$I$20240719$20240722$20240724$20240724$EXP$GB-MHRA-MED-202407222214251530-LHRDY$GB-SANDOZ INC.-SDZ2024GB067619$SANDOZ$$70$YR$$F$Y$52$KG$20240724$$CN$GB$GB
241304062$24130406$2$F$$20240626$20240724$20240731$PER$$US-TRAVERE-2024TVT00585$TRAVERE THERAPEUTICS$$26$YR$A$F$Y$$$20240731$$CN$US$US
241304071$24130407$1$I$$20240706$20240724$20240724$PER$$US-JNJFOC-20240721123$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
241304081$24130408$1$I$20240101$20240719$20240724$20240724$EXP$$CA-ABBVIE-5847195$ABBVIE$$$$E$F$Y$$$20240724$$CN$CA$CA
241304091$24130409$1$I$$20240709$20240724$20240724$EXP$$US-PHARMAAND GMBH-2024PHR00420$pharmaAND$$$$$F$Y$$$20240724$$CN$US$US
241304101$24130410$1$I$20231201$20240709$20240724$20240724$EXP$$FR-PHARMAAND GMBH-2024PHR00422$pharmaAND$$60$YR$$F$Y$81$KG$20240724$$MD$FR$FR
241304111$24130411$1$I$20240518$20240709$20240724$20240724$EXP$$US-PHARMAAND GMBH-2024PHR00309$pharmaAND$$67$YR$$F$Y$$$20240724$$CN$US$US
241304121$24130412$1$I$20230101$20240709$20240724$20240724$EXP$$FR-PHARMAAND GMBH-2024PHR00421$pharmaAND$$63$YR$$M$Y$70$KG$20240724$$MD$FR$FR
241304131$24130413$1$I$20240401$20240719$20240724$20240724$EXP$$US-ABBVIE-5848390$ABBVIE$$59$YR$$F$Y$$$20240724$$CN$US$US
241304142$24130414$2$F$20240523$20240715$20240724$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036041$AUROBINDO$$79$YR$$F$Y$$$20240725$$MD$FR$FR
241304154$24130415$4$F$20240628$20240813$20240724$20240827$EXP$$US-ABBVIE-5847196$ABBVIE$$53$YR$$F$Y$$$20240827$$CN$US$US
241304161$24130416$1$I$$20240717$20240724$20240724$PER$$US-ABBVIE-5843935$ABBVIE$$$$$$Y$$$20240724$$CN$US$US
241304171$24130417$1$I$20240101$20240716$20240724$20240724$EXP$$GB-ROCHE-10000029636$ROCHE$$61$YR$A$F$Y$$$20240724$$HP$GB$GB
241304182$24130418$2$F$$20240820$20240724$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115096$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$62.14$KG$20240822$$CN$US$US
241304191$24130419$1$I$20040101$20240719$20240724$20240724$EXP$$US-ABBVIE-5847094$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241304201$24130420$1$I$$20240715$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113268$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$71.21$KG$20240724$$CN$US$US
241304211$24130421$1$I$20240701$20240719$20240724$20240724$PER$$US-ABBVIE-5849890$ABBVIE$$42$YR$$F$Y$$$20240724$$HP$US$US
241304221$24130422$1$I$20240717$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014009$ELI LILLY AND CO$$$$$M$Y$$$20240724$$CN$US$US
241304231$24130423$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014263$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240724$$CN$US$US
241304242$24130424$2$F$$20240722$20240724$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407014143$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240730$$CN$US$US
241304251$24130425$1$I$20240101$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036020$AUROBINDO$$50$YR$$M$Y$87.7$KG$20240724$$PH$FR$FR
241304261$24130426$1$I$20240712$20240715$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013846$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240724$$CN$US$US
241304271$24130427$1$I$20240712$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014660$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240724$$CN$US$US
241304281$24130428$1$I$20240601$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014451$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240724$$CN$US$US
241304291$24130429$1$I$$20240710$20240724$20240724$EXP$GB-MYLANLABS-2024M1063102$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15547$ALKEM$$$$$M$Y$$$20240724$$CN$GB$GB
241304301$24130430$1$I$$20240710$20240724$20240724$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-15541$ALKEM$$29$YR$$F$Y$$$20240724$$HP$AU$AU
241304311$24130431$1$I$$20240710$20240724$20240724$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-15548$ALKEM$$65$YR$$M$Y$$$20240724$$HP$AU$AU
241304321$24130432$1$I$20240702$20240710$20240724$20240724$EXP$GB-MHRA-EMIS-5223-d79dbae5-58ca-435d-8ee1-ae1cf7c6fb64$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15532$ALKEM$$65$YR$$M$Y$70$KG$20240724$$MD$GB$GB
241304331$24130433$1$I$$20240710$20240724$20240724$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-15556$ALKEM$$80$YR$$F$Y$$$20240724$$HP$AU$AU
241304341$24130434$1$I$20240701$20240719$20240724$20240724$EXP$$CL-ABBVIE-5850156$ABBVIE$$32$YR$$F$Y$$$20240724$$CN$CL$CL
241304351$24130435$1$I$$20240710$20240724$20240724$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-15543$ALKEM$$21$YR$$M$Y$$$20240724$$HP$AU$AU
241304361$24130436$1$I$$20240710$20240724$20240724$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-15544$ALKEM$$30$YR$$M$Y$$$20240724$$HP$AU$AU
241304371$24130437$1$I$$20240710$20240724$20240724$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2024-15733$ALKEM$Ruiz-Manriquez J, Kauffman-Ortega E, Gamboa-Dominguez A, Rios-Valencia J, Ramirez-Quesada W, Flores-Garcia NC.. Sinusoidal obstruction syndrome after liver transplantation: an interplay between thrombotic and immunological factors. A case report.. Journal of Liver Transplantation. 2021;2:1-4$37$YR$$M$Y$$$20240724$$HP$MX$MX
241304381$24130438$1$I$$20240710$20240724$20240724$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-15753$ALKEM$Zhang XY, Gong JY, Wang JS, Feng JY, Chen L, Xie XB, Lu Y.. Efficacy of rituximab-containing regimens used as first-line and rescue therapy for giant cell hepatitis with autoimmune hemolytic anemia a retrospective study. Clinics and Research in Hepatology and Gastroenterology. 2024;48:102392$8$MON$$$Y$$$20240724$$HP$CN$CN
241304391$24130439$1$I$20240701$20240722$20240724$20240724$EXP$$US-ABBVIE-5849917$ABBVIE$$74$YR$$F$Y$$$20240724$$CN$US$US
241304401$24130440$1$I$$20240710$20240724$20240724$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-15173$ALKEM$Zhang XY, Gong JY, Wang JS, Feng JY, Chen L, Xie XB, Lu Y. Efficacy of rituximab-containing regimens used as first-line and rescue therapy for giant cell hepatitis with autoimmune hemolytic anemia a retrospective study. Clinics and Research in Hepatology and Gastroenterology. 2024;48:102392$14$MON$$$Y$$$20240724$$HP$CN$CN
241304411$24130441$1$I$$20240716$20240724$20240724$EXP$$VN-AstraZeneca-2024A165917$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$VN$
241304421$24130442$1$I$$20240710$20240724$20240724$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-15754$ALKEM$Zhang XY, Gong JY, Wang JS, Feng JY, Chen L, Xie XB, Lu Y.. Efficacy of rituximab-containing regimens used as first-line and rescue therapy for giant cell hepatitis with autoimmune hemolytic anemia a retrospective study. Clinics and Research in Hepatology and Gastroenterology. 2024;48:102392$6$MON$$$Y$$$20240724$$HP$CN$CN
241304431$24130443$1$I$$20240715$20240724$20240724$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS003282$TERSERA THERAPEUTICS$$$$$$Y$$$20240724$$MD$CN$CN
241304451$24130445$1$I$20240625$20240712$20240724$20240724$EXP$$MK-ROCHE-10000026828$ROCHE$$40$YR$A$F$Y$$$20240724$$MD$MK$MK
241304462$24130446$2$F$$20240723$20240724$20240806$EXP$US-MLMSERVICE-20240702-PI120109-00306-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15531$ALKEM$Dilibe A, Subramanian L, Poyser TA, Oriaifo O, Brady R, Srikanth S, et al.. Tacrolimus-induced posterior reversible encephalopathy syndrome following liver transplantation. World journal of transplantation. 2024;14(2):91146$66$YR$$M$Y$$$20240806$$MD$US$US
241304472$24130447$2$F$20240713$20240807$20240724$20240816$EXP$$IN-VANTIVE-2024VAN018408$Vantive US Healthcare$$56$YR$$F$Y$$$20240816$$CN$IN$IN
241304481$24130448$1$I$$20240722$20240724$20240724$EXP$$US-ABBVIE-5850085$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241304491$24130449$1$I$20231002$20240709$20240724$20240724$EXP$IT-MINISAL02-985170$IT-SAMSUNG BIOEPIS-SB-2024-21236$SAMSUNG BIOEPIS$$63$YR$A$M$Y$$$20240724$$PH$IT$IT
241304501$24130450$1$I$$20240710$20240724$20240724$EXP$GB-MHRA-MED-202407092212033490-KTPGJ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15535$ALKEM$$$$$F$Y$$$20240724$$CN$GB$GB
241304511$24130451$1$I$20230118$20240710$20240724$20240724$EXP$GB-MHRA-ADR 28616851$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15540$ALKEM$$82$YR$$M$Y$72$KG$20240724$$MD$GB$GB
241304521$24130452$1$I$$20240710$20240724$20240724$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-15562$ALKEM$$$$$M$Y$$$20240724$$HP$AU$AU
241304532$24130453$2$F$$20240821$20240724$20240823$EXP$$NVSC2024AU150987$NOVARTIS$$45$YR$$F$Y$$$20240823$$MD$AU$AU
241304541$24130454$1$I$$20240723$20240724$20240724$EXP$$NVSC2024US151023$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241304552$24130455$2$F$20240606$20240809$20240724$20240812$EXP$$US-UCBSA-2024028877$UCB$$24$YR$$F$Y$$$20240812$$CN$US$US
241304561$24130456$1$I$20090101$20240710$20240724$20240724$EXP$DE-DCGMA-24203575$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-15549$ALKEM$$39$YR$$F$Y$77$KG$20240724$$MD$DE$DE
241304571$24130457$1$I$$20240716$20240724$20240724$EXP$$US-GSK-US2024089508$GLAXOSMITHKLINE$$$$$F$Y$$$20240724$$CN$US$US
241304581$24130458$1$I$$20240710$20240724$20240724$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-15555$ALKEM$$75$YR$$M$Y$$$20240724$$HP$AU$AU
241304591$24130459$1$I$20240601$20240722$20240724$20240724$EXP$$US-UCBSA-2024037151$UCB$$37$YR$$F$Y$$$20240724$$HP$US$US
241304601$24130460$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06615$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241304611$24130461$1$I$$20240718$20240724$20240724$PER$$US-ALXN-202407USA001291US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241304622$24130462$2$F$20240716$20240813$20240724$20240813$PER$$US-ALXN-202407USA001249US$ALEXION PHARMACEUTICALS$$23$YR$$F$Y$$$20240813$$CN$US$US
241304631$24130463$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145267$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241304641$24130464$1$I$$20240722$20240724$20240724$PER$$US-JNJFOC-20240758695$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240724$$CN$US$US
241304651$24130465$1$I$$20240718$20240724$20240724$EXP$$US-JNJFOC-20240749805$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$HP$US$US
241304661$24130466$1$I$$20240718$20240724$20240724$EXP$$US-TERSERA THERAPEUTICS LLC-2024TRS003659$TERSERA THERAPEUTICS$$$$$$Y$$$20240724$$CN$US$US
241304671$24130467$1$I$$20240718$20240724$20240724$EXP$$FR-JNJFOC-20240748638$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240724$$PH$FR$FR
241304681$24130468$1$I$$20240715$20240724$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-035117$AUROBINDO$Rivera-Hernandez V, Zareva E, Silparshetty S.. Pituitary Apoplexy: Pitfalls in Diagnosis.  ;14(2):84-6. DOI:10.55729/2000-9666.1316.. Journal of community hospital internal medicine perspectives. 2024;14(2):84-6$44$YR$$F$Y$$$20240724$$MD$US$US
241304692$24130469$2$F$$20240807$20240724$20240808$PER$$NVSC2024US151420$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241304701$24130470$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A162579$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241304711$24130471$1$I$$20240716$20240724$20240724$EXP$$JP-ROCHE-10000031650$ROCHE$Nishioka A, Aoe K, Yoshimoto E, Nakamura K, Mashimo S, Kishino D. 10 A case of pulmonary alveolar haemorrhage which developed during treatment of hepatocellular carcinoma with atezolizumab + bevacizumab. The 244th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2024$78$YR$E$F$Y$$$20240724$$MD$JP$JP
241304721$24130472$1$I$20240722$20240722$20240724$20240724$EXP$$CA-UCBSA-2024037159$UCB$$50$YR$$F$Y$$$20240724$$CN$CA$CA
241304732$24130473$2$F$20240101$20240917$20240724$20240920$EXP$$IT-ABBVIE-5845847$ABBVIE$$35$YR$$M$Y$$$20240920$$CN$IT$IT
241304751$24130475$1$I$20230501$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035915$AUROBINDO$$47$YR$$M$Y$$$20240724$$MD$FR$FR
241304762$24130476$2$F$20160401$20240731$20240724$20240807$EXP$$JP-EMD Serono-2024039542$EMD SERONO INC$$82$YR$E$M$Y$66$KG$20240807$$MD$JP$JP
241304771$24130477$1$I$20200101$20240719$20240724$20240724$EXP$$US-ABBVIE-5847810$ABBVIE$$66$YR$$F$Y$$$20240724$$CN$US$US
241304781$24130478$1$I$$20240502$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST002829$STEMLINE THERAPEUTICS$$47$YR$A$F$Y$$$20240718$$CN$US$US
241304791$24130479$1$I$$20240506$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST002874$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240718$$CN$US$US
241304801$24130480$1$I$20240401$20240507$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST002924$STEMLINE THERAPEUTICS$$50$YR$A$F$Y$$$20240718$$CN$US$US
241304811$24130481$1$I$$20240508$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST002960$STEMLINE THERAPEUTICS$$42$YR$A$F$Y$$$20240718$$CN$US$US
241304821$24130482$1$I$$20240524$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003329$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240718$$CN$US$US
241304831$24130483$1$I$$20240529$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003407$STEMLINE THERAPEUTICS$$46$YR$A$F$Y$$$20240718$$CN$US$US
241304841$24130484$1$I$$20240614$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003750$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240718$$CN$US$US
241304851$24130485$1$I$$20240610$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003634$STEMLINE THERAPEUTICS$$55$YR$A$F$Y$$$20240718$$CN$US$US
241304861$24130486$1$I$20240101$20240606$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003071$STEMLINE THERAPEUTICS$$82$YR$E$F$Y$$$20240718$$CN$US$US
241304871$24130487$1$I$$20240716$20240724$20240724$EXP$$US-GSK-US2024089520$GLAXOSMITHKLINE$$$$$F$Y$$$20240724$$MD$US$US
241304881$24130488$1$I$$20240715$20240724$20240724$EXP$$US-GSK-US2024AMR090365$GLAXOSMITHKLINE$$$$$F$Y$$$20240724$$CN$US$US
241304891$24130489$1$I$20240418$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035850$AUROBINDO$$1$YR$$M$Y$11.5$KG$20240724$$MD$FR$FR
241304901$24130490$1$I$$20240612$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003687$STEMLINE THERAPEUTICS$$89$YR$E$F$Y$$$20240718$$CN$US$US
241304911$24130491$1$I$$20240613$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003266$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240718$$CN$US$US
241304921$24130492$1$I$20240101$20240722$20240724$20240724$EXP$$DE-ABBVIE-5850342$ABBVIE$$$$$F$Y$$$20240724$$CN$DE$DE
241304931$24130493$1$I$20240101$20240719$20240724$20240724$EXP$$US-ABBVIE-5847933$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241304941$24130494$1$I$$20240531$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003449$STEMLINE THERAPEUTICS$$85$YR$E$F$Y$$$20240718$$CN$US$US
241304951$24130495$1$I$20240101$20240722$20240724$20240724$EXP$$US-ABBVIE-5850204$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241304961$24130496$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151488$NOVARTIS$$$$A$F$Y$$$20240724$$HP$US$US
241304971$24130497$1$I$20240620$20240722$20240724$20240724$EXP$$US-UCBSA-2024037175$UCB$$43$YR$$F$Y$$$20240724$$CN$US$US
241304981$24130498$1$I$$20240715$20240724$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-036370$AUROBINDO$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN.. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatr-BloodCancer. 2024;71(7):e31004$22$YR$$F$Y$$$20240724$$HP$US$US
241304991$24130499$1$I$20230101$20240711$20240724$20240724$PER$$US-BEH-2024173418$CSL BEHRING$$72$YR$E$F$Y$$$20240724$$CN$US$US
241305001$24130500$1$I$20240317$20240627$20240724$20240724$EXP$$VN-ROCHE-3500383$ROCHE$$39$YR$A$F$Y$$$20240724$$MD$VN$VN
241305012$24130501$2$F$20240719$20240731$20240724$20240806$EXP$$JP-JNJFOC-20240763085$JOHNSON AND JOHNSON$$$$A$$Y$$$20240806$$PH$JP$JP
241305021$24130502$1$I$$20240722$20240724$20240724$EXP$$US-JNJFOC-20240756543$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
241305031$24130503$1$I$20230429$20240717$20240724$20240724$PER$$US-ALXN-202407USA001174US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241305041$24130504$1$I$$20240722$20240724$20240724$EXP$$JP-ABBVIE-5849654$ABBVIE$$60$YR$$M$Y$$$20240724$$MD$JP$JP
241305051$24130505$1$I$20240101$20240102$20240724$20240724$PER$$US-AMGEN-USASP2024146191$AMGEN$$60$YR$A$F$Y$$$20240724$$CN$US$US
241305061$24130506$1$I$20240501$20240720$20240724$20240724$PER$$US-AMGEN-USASP2024145148$AMGEN$$69$YR$E$F$Y$$$20240724$$CN$US$US
241305071$24130507$1$I$$20240721$20240724$20240724$PER$$US-AMGEN-USASP2024145387$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241305081$24130508$1$I$20240719$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144662$AMGEN$$73$YR$E$F$Y$$$20240724$$HP$US$US
241305093$24130509$3$F$$20240823$20240724$20240830$EXP$$JP-GSK-JP2024JPN089634$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$PH$JP$JP
241305111$24130511$1$I$20240501$20240717$20240724$20240724$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-115528$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240724$$PH$DE$DE
241305121$24130512$1$I$20240605$20240722$20240724$20240724$EXP$FR-AFSSAPS-AN2024000920$FR-GSK-FR2024092016$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$FR$FR
241305131$24130513$1$I$20240201$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117006$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240724$$CN$US$US
241305141$24130514$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013969$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240724$$CN$US$US
241305161$24130516$1$I$20240722$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014287$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240724$$CN$US$US
241305171$24130517$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013930$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240724$$CN$US$US
241305181$24130518$1$I$$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014029$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240724$$CN$US$US
241305191$24130519$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014789$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240724$$CN$US$US
241305201$24130520$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014273$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240724$$CN$US$US
241305211$24130521$1$I$20240701$20240715$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407010154$ELI LILLY AND CO$$68$YR$E$$Y$$$20240724$$CN$US$US
241305221$24130522$1$I$$20240715$20240724$20240724$EXP$$GB-AUROBINDO-AUR-APL-2024-035386$AUROBINDO$$$$$$Y$73$KG$20240724$$PH$GB$GB
241305241$24130524$1$I$20240101$20240718$20240724$20240724$EXP$$US-ABBVIE-5848095$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241305251$24130525$1$I$20240101$20240709$20240724$20240724$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01176$AVADEL CNS PHARMA$$$$$F$Y$$$20240724$$CN$US$US
241305261$24130526$1$I$20231228$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035861$AUROBINDO$$41$YR$$F$Y$80$KG$20240724$$MD$FR$FR
241305271$24130527$1$I$20240201$20240715$20240724$20240724$EXP$$CA-LEO Pharma-371920$LEO PHARM$$49$YR$$M$Y$$$20240724$$CN$CA$CA
241305281$24130528$1$I$20240717$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145888$AMGEN$$59$YR$A$F$Y$$$20240724$$CN$US$US
241305291$24130529$1$I$20240712$20240718$20240724$20240724$EXP$$CA-TAKEDA-2024TUS073408$TAKEDA$$31$YR$$M$Y$$$20240724$$CN$CA$CA
241305311$24130531$1$I$$20240715$20240724$20240724$EXP$$GB-AUROBINDO-AUR-APL-2024-035409$AUROBINDO$$59$YR$$F$Y$57$KG$20240724$$CN$GB$GB
241305322$24130532$2$F$20240101$20240807$20240724$20240808$EXP$$US-UCBSA-2024037177$UCB$$$$$F$Y$$$20240808$$CN$US$US
241305331$24130533$1$I$20240627$20240719$20240724$20240724$EXP$$CN-JNJFOC-20240751881$JOHNSON AND JOHNSON$$82$YR$E$M$Y$57.5$KG$20240724$$HP$CN$CN
241305341$24130534$1$I$$20240722$20240724$20240724$EXP$$US-JNJFOC-20240757931$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$CN$US$US
241305351$24130535$1$I$20240701$20240710$20240724$20240724$PER$$US-BEH-2024175664$CSL BEHRING$$61$YR$A$F$Y$$$20240724$$HP$US$US
241305362$24130536$2$F$$20240809$20240724$20240815$PER$$US-BEH-2024175665$CSL BEHRING$$6$YR$C$F$Y$$$20240815$$HP$US$US
241305371$24130537$1$I$$20240716$20240724$20240724$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000254$EMCURE$Alsabbagh Alchirazi K, Bhavsar-Burke I, Syed H, Alkhayyat M, Bass S, Kapoor A, et al.. Molecular Adsorbent Recirculating System in Acute Liver Failure. ACG CASE REPORTS JOURNAL. 2024;11(7):e01389$44$YR$$M$Y$$$20240724$$MD$US$US
241305381$24130538$1$I$$20240716$20240724$20240724$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000249$EMCURE$Sood N, Vadnerkar A, Kodali M, Hamacher LK.. Cutaneous Pneumocystis Jirovecii Infection in an Allogeneic Stem Cell Transplant Recipient. European Journal of Case reports in internal medicine. 2024;11(7):004615$67$YR$$M$Y$$$20240724$$HP$US$US
241305391$24130539$1$I$$20240716$20240724$20240724$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000255$EMCURE$Dalton LM, Kauffman CA, Miceli MH. Oral Lipid Nanocrystal Amphotericin B (MAT2203) for the Treatment of Invasive Fungal Infections. Open Forum Infect Dis. 2024;11(7):1-4$44$YR$$M$Y$$$20240724$$HP$US$US
241305401$24130540$1$I$$20240716$20240724$20240724$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000257$EMCURE$Contag CA, Studemeister L, Bogler Y, Cooper JD. Q fever presenting as splenic infarct without endocarditis. IDCases. 2024;37:e02012$44$YR$$M$Y$$$20240724$$HP$US$US
241305411$24130541$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A162576$ASTRAZENECA$$$$$F$Y$102.5$KG$20240724$$CN$US$
241305421$24130542$1$I$$20240715$20240724$20240724$PER$$US-AstraZeneca-2024A161631$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241305431$24130543$1$I$$20240715$20240724$20240724$PER$$US-EMD Serono-2024039763$EMD SERONO INC$$$$E$F$Y$$$20240724$$MD$US$US
241305441$24130544$1$I$20240101$20240718$20240724$20240724$PER$$US-ABBVIE-5849611$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241305451$24130545$1$I$$20240718$20240724$20240724$PER$$US-ABBVIE-5849806$ABBVIE$$$$$F$Y$$$20240724$$MD$US$US
241305462$24130546$2$F$20240605$20240726$20240724$20240808$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01196$AVADEL CNS PHARMA$$31$YR$$F$Y$68.345$KG$20240808$$CN$US$US
241305481$24130548$1$I$20240101$20240719$20240724$20240724$EXP$$US-ABBVIE-5847589$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241305491$24130549$1$I$$20240715$20240724$20240724$EXP$$ES-AUROBINDO-AUR-APL-2024-035983$AUROBINDO$Anadon Ruiz L, Mart?n Lahuerta M. Anadon Ruiz L, Martin Lahuerta M.. Nursing care plan for a patient diagnosed with a childhood-onset psychotic disorder who takes medication. Health Research Magazine. 2024;V (6)$18$YR$$M$Y$$$20240724$$HP$ES$ES
241305501$24130550$1$I$$20240716$20240724$20240724$EXP$$JP-BAUSCH-BL-2024-011201$BAUSCH AND LOMB$$23$YR$$M$Y$$$20240724$$MD$JP$JP
241305512$24130551$2$F$$20240826$20240724$20240829$EXP$$CA-BAUSCH-BL-2024-011233$BAUSCH AND LOMB$$38$YR$$M$Y$$$20240829$$HP$CA$CA
241305521$24130552$1$I$20190101$20240719$20240724$20240724$EXP$$US-ABBVIE-5834117$ABBVIE$$$$$M$Y$64.41$KG$20240724$$CN$US$US
241305531$24130553$1$I$$20240717$20240724$20240724$EXP$$IN-BAUSCH-BL-2024-011194$BAUSCH AND LOMB$Ancilla L, Sundaram B, Pathak N, Raj A. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. Journal of Nephropharmacology. 2024 JUN 29;13(2):1-5. doi:10.34172/npj.2024.11681$58$YR$$M$Y$$$20240724$$HP$IN$IN
241305541$24130554$1$I$$20240717$20240724$20240724$EXP$$IN-BAUSCH-BL-2024-011005$BAUSCH AND LOMB$Ancilla L, Sundaram B, Pathak N, Raj A. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. Journal of Nephropharmacology. 2024 JUN 29;13(2):1-5. doi:10.34172/npj.2024.11681$55$YR$$M$Y$$$20240724$$HP$IN$IN
241305552$24130555$2$F$20240715$20240814$20240724$20240814$PER$$US-AMGEN-USASP2024144935$AMGEN$$69$YR$E$M$Y$$$20240814$$CN$US$US
241305561$24130556$1$I$$20240715$20240724$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-036161$AUROBINDO$$71$YR$$F$Y$$$20240724$$PH$US$US
241305571$24130557$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117159$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240724$$CN$US$US
241305581$24130558$1$I$20240717$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117097$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$63.5$KG$20240724$$CN$US$US
241305591$24130559$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116816$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240724$$HP$US$US
241305601$24130560$1$I$$20240717$20240724$20240724$PER$$US-JNJFOC-20240745664$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$CN$US$US
241305611$24130561$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144411$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241305622$24130562$2$F$20240717$20240816$20240724$20240823$30DAY$$US-AMGEN-USASP2024143076$AMGEN$$56$YR$A$F$Y$151.93$KG$20240823$$CN$US$US
241305633$24130563$3$F$20240715$20240723$20240724$20240801$PER$$US-AMGEN-USASP2024142848$AMGEN$$81$YR$E$M$Y$$$20240731$$CN$US$US
241305641$24130564$1$I$20240124$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035937$AUROBINDO$$74$YR$$M$Y$67$KG$20240724$$MD$FR$FR
241305651$24130565$1$I$$20240716$20240724$20240724$EXP$$JP-TAKEDA-2024TUS072956$TAKEDA$$73$YR$$F$Y$48$KG$20240724$$MD$JP$JP
241305661$24130566$1$I$$20240723$20240724$20240724$EXP$$ES-ADIENNEP-2024AD000541$ADIENNE PHARMA + BIOTECH$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection? Transpl Infect Dis. 2024;26(3):e14276. DOI: 10.1111/tid.14276$$$C$F$Y$$$20240723$$MD$ES$
241305671$24130567$1$I$$20240717$20240724$20240724$EXP$$US-CHIESI-2024CHF04402$CHIESI$$$$$M$Y$90$KG$20240724$$CN$US$US
241305681$24130568$1$I$20240714$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144916$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
241305691$24130569$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145101$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241305701$24130570$1$I$$20240715$20240724$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-036201$AUROBINDO$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series.. JAAD-Case-Rep. 2023;40:14-18$$$A$F$Y$$$20240724$$HP$US$US
241305711$24130571$1$I$$20240715$20240724$20240724$EXP$$DE-AUROBINDO-AUR-APL-2024-036003$AUROBINDO$Christoph H, Nicolaus K, Pfeffer LK, Fehse B, Berger SC, Reinhardt S, et al.. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med-(NY). 2024;5(6):550-558$47$YR$$F$Y$$$20240724$$HP$DE$DE
241305721$24130572$1$I$$20240715$20240724$20240724$EXP$$CA-002147023-PHHY2019CA054482$Haleon PLC$$40$YR$$M$Y$130$KG$20240724$$MD$CA$CA
241305731$24130573$1$I$20210601$20240717$20240724$20240724$EXP$$US-GSK-US2021263785$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241305741$24130574$1$I$20240622$20240715$20240724$20240724$EXP$$CA-APOTEX-2024AP008491$APOTEX$$46$YR$A$F$Y$$$20240724$$PH$CA$CA
241305751$24130575$1$I$$20240711$20240724$20240724$PER$$US-BEH-2024175716$CSL BEHRING$$$$$M$Y$$$20240724$$CN$US$US
241305762$24130576$2$F$$20240726$20240724$20240731$PER$$US-LEO Pharma-372218$LEO PHARM$$65$YR$$M$Y$$$20240731$$PH$US$US
241305772$24130577$2$F$$20240812$20240724$20240821$EXP$$JP-UCBSA-2024036658$UCB$Horiguchi S. Case of SCN2A-related Epileptic Encephalopathy for which Global Genetic Analysis was Useful in Making Early Decision of Therapeutic Strategy. Journal of Japan Society of Perinatal and Neonatal Medicine. 2024;60(S1):P23-2$15$DY$$F$Y$$$20240821$$MD$JP$JP
241305781$24130578$1$I$$20240715$20240724$20240724$EXP$$ES-AUROBINDO-AUR-APL-2024-036218$AUROBINDO$Alfonso C, Lopez De Las Heras M, Martinez SC, Prieto-Perez L, Alvarez Alvarez B, Waleed AlHayani A, et al.. Characteristics and rates of infection by HIV in people receiving non-occupational post-exposure prophylaxis (nPEP) against HIV. Sex-Transmit-Infect. 2024;100(4):231-235$$$A$$Y$$$20240724$$HP$ES$ES
241305791$24130579$1$I$20240618$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035851$AUROBINDO$$83$YR$$F$Y$51$KG$20240724$$PH$FR$FR
241305801$24130580$1$I$$20240715$20240724$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-036369$AUROBINDO$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatr-Blood-Cancer. 2024;71 (7):e31004$31$YR$$M$Y$$$20240724$$HP$US$US
241305811$24130581$1$I$$20240723$20240724$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041553$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240724$$CN$US$US
241305821$24130582$1$I$$20220908$20240724$20240724$EXP$$US-AstraZeneca-2022A313581$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241305831$24130583$1$I$$20210605$20240724$20240724$EXP$$US-AstraZeneca-2021A506891$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241305841$24130584$1$I$$20210428$20240724$20240724$EXP$$US-AstraZeneca-2021A372490$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241305851$24130585$1$I$$20231108$20240724$20240724$EXP$$US-AstraZeneca-2023A256462$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241305861$24130586$1$I$20221201$20230113$20240724$20240724$EXP$$CA-AstraZeneca-2022A416398$ASTRAZENECA$$679$MON$$M$Y$$$20240724$$CN$CA$
241305871$24130587$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116920$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240724$$HP$US$US
241305881$24130588$1$I$$20210611$20240724$20240724$EXP$$US-AstraZeneca-2021A526637$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241305892$24130589$2$F$$20240731$20240724$20240807$EXP$$CA-HALEON-2188202$Haleon PLC$$44$YR$$F$Y$$$20240806$$HP$CA$CA
241305901$24130590$1$I$$20240717$20240724$20240724$PER$$US-JNJFOC-20240746087$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$PH$US$US
241305911$24130591$1$I$20240718$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014480$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240724$$CN$US$US
241305921$24130592$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013947$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240724$$HP$US$US
241305933$24130593$3$F$$20240903$20240724$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202407013896$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240905$$CN$US$US
241305941$24130594$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014122$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240724$$CN$US$US
241305951$24130595$1$I$$20240510$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003039$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240718$$HP$US$US
241305961$24130596$1$I$20240501$20240516$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003161$STEMLINE THERAPEUTICS$$45$YR$A$F$Y$$$20240718$$CN$US$US
241305971$24130597$1$I$$20240603$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003456$STEMLINE THERAPEUTICS$$68$YR$E$F$Y$$$20240718$$HP$US$US
241305981$24130598$1$I$$20240606$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003529$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240718$$CN$US$US
241305991$24130599$1$I$$20240612$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003686$STEMLINE THERAPEUTICS$$48$YR$A$F$Y$$$20240718$$CN$US$US
241306001$24130600$1$I$$20240514$20240724$20240724$PER$$US-Stemline Therapeutics, Inc.-2024ST003108$STEMLINE THERAPEUTICS$$59$YR$A$F$Y$$$20240718$$HP$US$US
241306013$24130601$3$F$$20240731$20240724$20240812$EXP$$CA-AMGEN-CANSP2024144631$AMGEN$$40$YR$A$F$Y$96$KG$20240812$$HP$CA$CA
241306021$24130602$1$I$20190101$20240715$20240724$20240724$EXP$$DE-AUROBINDO-AUR-APL-2024-035969$AUROBINDO$$$$A$F$Y$$$20240724$$MD$DE$DE
241306031$24130603$1$I$20240320$20240715$20240724$20240724$EXP$$ES-AUROBINDO-AUR-APL-2024-035972$AUROBINDO$$81$YR$$F$Y$$$20240724$$MD$ES$ES
241306043$24130604$3$F$20240301$20240823$20240724$20240830$EXP$$IT-ROCHE-10000026735$ROCHE$$52$YR$A$M$Y$$$20240830$$MD$IT$IT
241306051$24130605$1$I$20240601$20240716$20240724$20240724$EXP$SE-SEMPA-2024-005381$SE-TEVA-VS-3222336$TEVA$$53$YR$$M$Y$$$20240724$$MD$SE$SE
241306061$24130606$1$I$20180718$20240717$20240724$20240724$PER$$US-ORGANON-1807USA009674$ORGANON$$77$YR$$F$Y$$$20240724$$CN$US$US
241306071$24130607$1$I$$20240715$20240724$20240724$EXP$GB-MHRA-MED-202407151547157910-PSZNR$GB-ASPEN-GLO2024GB004891$ASPEN$$$$$$Y$$$20240724$$PH$GB$GB
241306081$24130608$1$I$$20240715$20240724$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-036202$AUROBINDO$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep. 2023;40:14-18$$$A$F$Y$$$20240724$$HP$US$US
241306091$24130609$1$I$20240505$20240715$20240724$20240724$EXP$$GB-AUROBINDO-AUR-APL-2024-035330$AUROBINDO$$$$$F$Y$$$20240724$$PH$GB$GB
241306103$24130610$3$F$$20240820$20240724$20240828$PER$$US-ABBVIE-5842949$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
241306111$24130611$1$I$20240522$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035779$AUROBINDO$$3$MON$$F$Y$3.58$KG$20240724$$MD$FR$FR
241306121$24130612$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145933$AMGEN$$$$A$F$Y$$$20240724$$HP$US$US
241306131$24130613$1$I$20231201$20240718$20240724$20240724$30DAY$$US-GSK-US2024090678$GLAXOSMITHKLINE$$$$$F$Y$$$20240724$$CN$US$US
241306141$24130614$1$I$$20240718$20240724$20240724$EXP$$JP-GSK-JP2024JPN090290$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$PH$JP$JP
241306151$24130615$1$I$$20240711$20240724$20240724$PER$$US-BEH-2024175745$CSL BEHRING$$$$C$F$Y$$$20240724$$HP$US$US
241306161$24130616$1$I$20230630$20240712$20240724$20240724$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240700082$RIGEL PHARMACEUTICALS$$74$YR$$F$Y$64$KG$20240724$$MD$JP$JP
241306171$24130617$1$I$$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036029$AUROBINDO$Lemonnier N, Payen M, Curado J.. Trauma-Induced Clostridium cadaveris Septic Arthritis of the Knee in an Immunocompetent Young Patient: A Case Report.. Am-J-Case-Rep. 2024;25e943084$11$YR$$M$Y$$$20240724$$HP$FR$FR
241306181$24130618$1$I$20240718$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145006$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241306191$24130619$1$I$20240523$20240715$20240724$20240724$EXP$$IT-AUROBINDO-AUR-APL-2024-035355$AUROBINDO$$72$YR$$M$Y$70$KG$20240724$$MD$IT$IT
241306211$24130621$1$I$20240701$20240711$20240724$20240724$PER$$US-BEH-2024175740$CSL BEHRING$$22$YR$A$M$Y$$$20240724$$HP$US$US
241306222$24130622$2$F$20240401$20240919$20240724$20240923$EXP$$NVSC2024US088569$NOVARTIS$$58$YR$$F$Y$$$20240923$$CN$US$US
241306232$24130623$2$F$20240330$20240717$20240724$20240918$EXP$$US-CHIESI-2024CHF04392$CHIESI$$51$YR$$F$Y$$$20240918$$MD$US$US
241306241$24130624$1$I$20230110$20240709$20240724$20240724$EXP$$PE-UCBSA-2023055979$UCB$$28$YR$$M$Y$83$KG$20240724$$CN$PE$PE
241306251$24130625$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116550$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240724$$HP$US$US
241306261$24130626$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117179$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240724$$CN$US$US
241306271$24130627$1$I$$20240627$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116071$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$PH$US$US
241306281$24130628$1$I$$20240715$20240724$20240724$30DAY$$US-GSK-US2024AMR089444$GLAXOSMITHKLINE$$$$$F$Y$$$20240724$$CN$US$US
241306291$24130629$1$I$$20240709$20240724$20240724$PER$$US-JNJFOC-20240729016$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
241306302$24130630$2$F$$20240726$20240724$20240801$EXP$$CH-JNJFOC-20240747999$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240801$$HP$CH$CH
241306321$24130632$1$I$$20240717$20240724$20240724$EXP$$GB-TAKEDA-2024TUS068192$TAKEDA$$$$$M$Y$$$20240724$$CN$GB$GB
241306331$24130633$1$I$$20240716$20240724$20240724$EXP$$NVSC2024US147448$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241306341$24130634$1$I$$20240716$20240724$20240724$EXP$$US-SA-2024SA210555$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240724$$MD$US$US
241306351$24130635$1$I$$20240718$20240724$20240724$PER$$US-BIOGEN-2024BI01274350$BIOGEN$$$$$F$Y$$$20240724$$CN$US$US
241306362$24130636$2$F$20200421$20240906$20240724$20240911$EXP$$CA-TAKEDA-2020TUS038524$TAKEDA$$37$YR$$F$Y$$$20240911$$HP$CA$CA
241306372$24130637$2$F$20240101$20240924$20240724$20240930$EXP$$CA-ABBVIE-5845644$ABBVIE$$$$E$F$Y$$$20240929$$CN$CA$CA
241306381$24130638$1$I$20230101$20240717$20240724$20240724$EXP$$PR-ABBVIE-5845772$ABBVIE$$$$$F$Y$54$KG$20240724$$CN$PR$PR
241306391$24130639$1$I$20240717$20240717$20240724$20240724$PER$$US-AMGEN-USASP2024143796$AMGEN$$82$YR$E$$Y$$$20240724$$CN$US$US
241306402$24130640$2$F$20240718$20240812$20240724$20240813$PER$$US-AMGEN-USASP2024145254$AMGEN$$73$YR$E$M$Y$$$20240813$$CN$US$US
241306411$24130641$1$I$$20240709$20240724$20240724$PER$$US-JNJFOC-20240725243$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
241306421$24130642$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A163645$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241306431$24130643$1$I$20240701$20240719$20240724$20240724$EXP$$PE-AstraZeneca-2024A165671$ASTRAZENECA$$23072$DY$$F$Y$$$20240724$$CN$PE$
241306441$24130644$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A162619$ASTRAZENECA$$$$$M$Y$62$KG$20240724$$CN$US$
241306451$24130645$1$I$$20240717$20240724$20240724$EXP$$US-CHIESI-2024CHF04415$CHIESI$$$$$F$Y$$$20240724$$MD$US$US
241306462$24130646$2$F$$20240729$20240724$20240806$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024003625$BIOCON$$$$$$Y$$$20240806$$CN$CA$CA
241306471$24130647$1$I$$20230831$20240724$20240724$EXP$$US-AstraZeneca-2023A199993$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241306481$24130648$1$I$$20240719$20240724$20240724$EXP$$US-AstraZeneca-2024A165865$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241306491$24130649$1$I$$20240716$20240724$20240724$EXP$$CA-AstraZeneca-2024A163751$ASTRAZENECA$$71$YR$$M$Y$$$20240724$$MD$CA$
241306501$24130650$1$I$$20240716$20240724$20240724$EXP$$AU-TOLMAR, INC.-24AU051018$TOLMAR$$$$$M$Y$$$20240724$$CN$AU$AU
241306511$24130651$1$I$$20240716$20240724$20240724$EXP$$CA-TOLMAR, INC.-24CA051053$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
241306521$24130652$1$I$$20240715$20240724$20240724$PER$$NVSC2024US147392$NOVARTIS$$$$$M$Y$$$20240724$$CN$US$US
241306532$24130653$2$F$$20240722$20240724$20240730$EXP$$US-TOLMAR, INC.-24US051069$TOLMAR$$$$$M$Y$71.655$KG$20240730$$CN$US$US
241306541$24130654$1$I$$20240720$20240724$20240724$PER$$NVSC2024US150196$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
241306551$24130655$1$I$20240701$20240717$20240724$20240724$EXP$$US-SA-2024SA214661$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240724$$MD$US$US
241306562$24130656$2$F$20230509$20240723$20240724$20240730$EXP$$KR-TAKEDA-2024TUS072406$TAKEDA$$$$E$F$Y$$$20240730$$MD$KR$KR
241306571$24130657$1$I$$20240715$20240724$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-035629$AUROBINDO$Wilkinson AJ, Yang A, Chen GH. Stellate ganglion block to mitigate thalamic pain syndrome of an oncological origin. Pain-Pract. 2024;24(1):231-234$44$YR$$F$Y$$$20240724$$HP$US$US
241306581$24130658$1$I$$20240722$20240724$20240724$EXP$$CA-SANDOZ INC.-SDZ2024CA067055$SANDOZ$$44$YR$$F$Y$$$20240724$$HP$CA$CA
241306592$24130659$2$F$$20240903$20240724$20240923$EXP$$US-SA-2024SA213005$SANOFI AVENTIS$$$$E$F$Y$$$20240923$$MD$US$US
241306603$24130660$3$F$$20240819$20240724$20240822$EXP$$US-TAKEDA-2024TUS073356$TAKEDA$$$$$M$Y$$$20240822$$CN$US$US
241306611$24130661$1$I$20240625$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035852$AUROBINDO$$81$YR$$F$Y$87.8$KG$20240724$$PH$FR$FR
241306621$24130662$1$I$20220101$20240718$20240724$20240724$EXP$$US-ABBVIE-5839486$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241306631$24130663$1$I$$20240719$20240724$20240724$EXP$$CA-TAKEDA-2024TUS074036$TAKEDA$$$$$F$Y$$$20240724$$CN$CA$CA
241306642$24130664$2$F$$20240828$20240724$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-117326$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240903$$MD$JP$JP
241306653$24130665$3$F$20240622$20240909$20240724$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202407013935$ELI LILLY AND CO$$69$YR$E$F$Y$83.9$KG$20240918$$MD$US$US
241306661$24130666$1$I$20240719$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014709$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240724$$CN$US$US
241306671$24130667$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014371$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240724$$CN$US$US
241306681$24130668$1$I$$20240722$20240724$20240724$EXP$$US-GILEAD-2024-0681707$GILEAD$$$$E$F$Y$$$20240724$$CN$US$US
241306691$24130669$1$I$20230704$20240715$20240724$20240724$EXP$ES-AEMPS-1545406$ES-Orion Corporation ORION PHARMA-24_00030811$ORION$$42$YR$A$M$Y$95$KG$20240724$$PH$ES$
241306701$24130670$1$I$20231121$20240715$20240724$20240724$EXP$SE-SEMPA-2024-004298$SE-TEVA-VS-3221819$TEVA$$23$YR$$M$Y$$$20240724$$MD$SE$SE
241306711$24130671$1$I$20240101$20240723$20240724$20240724$EXP$$US-UCBSA-2024037173$UCB$$$$$F$Y$$$20240724$$CN$US$US
241306721$24130672$1$I$$20240716$20240724$20240724$EXP$$CA-APOTEX-2024AP008469$APOTEX$$34$YR$$F$Y$71$KG$20240724$$HP$CA$CA
241306742$24130674$2$F$$20240715$20240724$20240812$EXP$$PT-TEVA-VS-3222153$TEVA$Sousa CC, Olim C, Moniz ME, Ferreira MV, Neto CT, Faria T. - A state of hyponatremic illness - a rare case. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts[CNMI]. 2024 May; 224. CO-0123 - (4334)$$$$F$Y$$$20240812$$MD$PT$PT
241306757$24130675$7$F$20240815$20240917$20240724$20240919$EXP$$CA-TAKEDA-2024TUS073978$TAKEDA$$34$YR$$F$Y$$$20240919$$CN$CA$CA
241306762$24130676$2$F$20240101$20240722$20240724$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-021981$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240731$$$US$US
241306781$24130678$1$I$$20240717$20240724$20240724$EXP$$US-JNJFOC-20240746894$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240724$$HP$US$US
241306791$24130679$1$I$$20240718$20240724$20240724$EXP$$US-ABBVIE-5846836$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241306802$24130680$2$F$$20240916$20240724$20240923$EXP$$US-AMGEN-USASP2024142780$AMGEN$Mahipal A.; Storandt M.H.; Zemla T.Y. et al.. Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort study. Oncologist. 2024;1-11$$$$$Y$$$20240923$$MD$US$US
241306811$24130681$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024143719$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
241306821$24130682$1$I$20240709$20240715$20240724$20240724$EXP$$IT-AUROBINDO-AUR-APL-2024-036037$AUROBINDO$$86$YR$$F$Y$$$20240724$$PH$IT$IT
241306831$24130683$1$I$20240723$20240723$20240724$20240724$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041557$BOEHRINGER INGELHEIM$$87$YR$E$M$Y$$$20240724$$CN$US$US
241306841$24130684$1$I$$20240711$20240724$20240724$EXP$HU-INCYTE CORPORATION-2024IN006240$HU-ROCHE-10000024541$ROCHE$A. Jona, E. Kiss, A. Kenyeres, L. Gergely, Z. Simon, A. Illes. Our experience with Mosunetuzumab. Hematology-Transfusiology. 2024;76$64$YR$A$M$Y$$$20240724$$MD$HU$HU
241306851$24130685$1$I$20240101$20240719$20240724$20240724$EXP$$CA-ABBVIE-5847821$ABBVIE$$65$YR$$M$Y$$$20240724$$CN$CA$CA
241306861$24130686$1$I$20240618$20240716$20240724$20240724$PER$$US-RDY-SPO/USA/24/0010547$DR REDDYS$$40$YR$A$F$Y$$$20240724$$HP$US$US
241306871$24130687$1$I$20240101$20240702$20240724$20240724$PER$$AU-TOLMAR, INC.-24AU050723$TOLMAR$$$$$M$Y$$$20240724$$CN$AU$AU
241306881$24130688$1$I$20240305$20240702$20240724$20240724$PER$$AU-TOLMAR, INC.-24AU050725$TOLMAR$$80$YR$$M$Y$$$20240724$$CN$AU$AU
241306891$24130689$1$I$$20240702$20240724$20240724$PER$$AU-TOLMAR, INC.-24AU050727$TOLMAR$$$$$M$Y$$$20240724$$CN$AU$AU
241306902$24130690$2$F$20240716$20240726$20240724$20240801$PER$$US-AMGEN-USASP2024142897$AMGEN$$56$YR$A$F$Y$65.3$KG$20240801$$PH$US$US
241306911$24130691$1$I$20240702$20240715$20240724$20240724$EXP$FR-AFSSAPS-MP2024001145$FR-ROCHE-10000027433$ROCHE$$78$YR$E$M$Y$$$20240724$$MD$FR$FR
241306921$24130692$1$I$$20240722$20240724$20240724$EXP$$US-ABBVIE-5850119$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241306931$24130693$1$I$$20240717$20240724$20240724$EXP$$US-AMGEN-USASP2024144573$AMGEN$Tilley M.S.; Edwards S.W.; Brown M.L. et al.. Assessment of Posttransplant Bacteremia Caused by Extended-Spectrum Beta- Lactamase-Producing Gram-Negative Bacteria Among Kidney Transplant Recipients. Clinical Transplantation. 2024;38 (7):1-6$$$$$Y$$$20240724$$HP$US$US
241306941$24130694$1$I$$20240719$20240724$20240724$PER$$NVSC2024US151235$NOVARTIS$$$$$$Y$$$20240724$$MD$US$US
241306951$24130695$1$I$$20240719$20240724$20240724$EXP$$GB-ABBVIE-5850145$ABBVIE$$$$A$F$Y$$$20240724$$CN$GB$GB
241306961$24130696$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024144585$AMGEN$Patel N. A.; Rashid S.; Meshkin R. S. et al.. Concurrent Central Retinal Vein Occlusion and Rhegmatogenous Retinal Detachment in Two Young Healthy Patients. Retinal Cases + Brief Reports. 2024;1-17$19$YR$A$M$Y$$$20240724$$MD$US$US
241306972$24130697$2$F$20240101$20240718$20240724$20240725$EXP$$CA-ABBVIE-5811619$ABBVIE$$35$YR$$F$Y$$$20240725$$HP$CA$CA
241306983$24130698$3$F$$20240730$20240724$20240809$EXP$$US-GSK-US2024AMR089889$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241306991$24130699$1$I$20240714$20240719$20240724$20240724$EXP$$CH-ABBVIE-5849786$ABBVIE$$87$YR$$M$Y$$$20240724$$CN$CH$CH
241307001$24130700$1$I$20210125$20210205$20240724$20240724$EXP$$BE-AstraZeneca-2021A043802$ASTRAZENECA$$26705$DY$$M$Y$$$20240724$$CN$BE$
241307011$24130701$1$I$$20240715$20240724$20240724$EXP$GB-MHRA-MED-202407131312322270-SDVLH$GB-TEVA-VS-3221635$TEVA$$50$YR$$F$Y$78$KG$20240724$$CN$GB$GB
241307021$24130702$1$I$$20240719$20240724$20240724$EXP$$US-AstraZeneca-2024A165786$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241307031$24130703$1$I$$20200717$20240724$20240724$EXP$$GB-AstraZeneca-2020SE91236$ASTRAZENECA$$$$$F$Y$$$20240724$$HP$GB$
241307041$24130704$1$I$$20240719$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116893$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240724$$CN$US$US
241307051$24130705$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117194$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$120.2$KG$20240724$$CN$US$US
241307061$24130706$1$I$20240710$20240715$20240724$20240724$EXP$GB-MHRA-MED-202407151147209780-NGTWM$GB-TEVA-VS-3221709$TEVA$$62$YR$$M$Y$$$20240724$$MD$GB$GB
241307071$24130707$1$I$$20240716$20240724$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-117420$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$MD$JP$JP
241307082$24130708$2$F$$20240716$20240724$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113317$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240719$$HP$US$US
241307092$24130709$2$F$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116326$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240724$$CN$US$US
241307101$24130710$1$I$$20240718$20240724$20240724$EXP$$US-SA-2024SA214566$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$MD$US$US
241307111$24130711$1$I$$20240718$20240724$20240724$EXP$$US-GILEAD-2024-0672527$GILEAD$$$$A$M$Y$$$20240724$$CN$US$US
241307133$24130713$3$F$$20240828$20240724$20240829$EXP$$JP-BEH-2024175927$CSL BEHRING$$$$$M$Y$$$20240829$$MD$JP$JP
241307141$24130714$1$I$20240101$20240719$20240724$20240724$EXP$$JP-JNJFOC-20240762167$JOHNSON AND JOHNSON$$9$DEC$E$M$Y$$$20240724$$MD$JP$JP
241307152$24130715$2$F$$20240711$20240724$20240725$EXP$$JP-UCBSA-2024036435$UCB$$92$YR$$F$Y$$$20240725$$PH$JP$JP
241307161$24130716$1$I$$20240715$20240724$20240724$PER$$NVSC2024US146510$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
241307171$24130717$1$I$20240501$20240716$20240724$20240724$EXP$$JP-009507513-2407JPN003195J$MERCK$$8$DEC$$M$Y$$$20240724$$MD$JP$JP
241307182$24130718$2$F$20240215$20240718$20240724$20240730$EXP$GB-MHRA-MED-202407081343185320-QFNHG$GB-LUPIN PHARMACEUTICALS INC.-2024-06426$LUPIN$$$$$$Y$$$20240730$$CN$GB$GB
241307191$24130719$1$I$20240722$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145875$AMGEN$$66$YR$E$F$Y$$$20240724$$HP$US$US
241307201$24130720$1$I$$20240716$20240724$20240724$EXP$$JP-TAKEDA-2024TUS074354$TAKEDA$$81$YR$$F$Y$$$20240724$$PH$JP$JP
241307211$24130721$1$I$20240101$20240718$20240724$20240724$EXP$$US-ABBVIE-5785278$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241307222$24130722$2$F$$20240918$20240724$20240924$EXP$$US-TAKEDA-2024TUS060649$TAKEDA$$$$$F$Y$$$20240924$$CN$US$US
241307231$24130723$1$I$20240702$20240702$20240724$20240724$PER$$US-JNJFOC-20240710869$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$CN$US$US
241307243$24130724$3$F$$20240812$20240724$20240812$PER$$US-ALXN-202407USA001111US$ALEXION PHARMACEUTICALS$$$$$F$Y$58.231$KG$20240812$$CN$US$US
241307251$24130725$1$I$20240701$20240718$20240724$20240724$PER$$US-ALXN-202407USA001290US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
241307261$24130726$1$I$20240113$20240710$20240724$20240724$EXP$$JP-MRZWEB-24-01825$MERZ$$75$YR$$M$Y$$$20240724$$MD$JP$JP
241307272$24130727$2$F$20220101$20240729$20240724$20240807$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001483$BLUEPRINT MEDICINES$$18$YR$A$M$Y$$$20240807$$MD$CN$CN
241307281$24130728$1$I$$20240719$20240724$20240724$PER$$US-ROCHE-10000032036$ROCHE$$41$YR$A$M$Y$$$20240724$$CN$US$US
241307292$24130729$2$F$20230426$20240729$20240724$20240807$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001484$BLUEPRINT MEDICINES$$57$YR$A$F$Y$$$20240807$$MD$CN$CN
241307301$24130730$1$I$20240101$20240719$20240724$20240724$EXP$$US-ABBVIE-5847554$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241307311$24130731$1$I$20240719$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144823$AMGEN$$85$YR$E$M$Y$$$20240724$$MD$US$US
241307321$24130732$1$I$$20240717$20240724$20240724$EXP$$ES-AMGEN-ESPSP2024142605$AMGEN$$$$A$$Y$$$20240724$$PH$ES$ES
241307332$24130733$2$F$20240201$20240911$20240724$20240914$EXP$$US-ABBVIE-5847638$ABBVIE$$58$YR$$F$Y$$$20240914$$CN$US$US
241307341$24130734$1$I$20240601$20240627$20240724$20240724$EXP$$US-NEBO-662877$PHARMACOSMOS$$$$$F$Y$$$20240724$$CN$US$US
241307351$24130735$1$I$20240507$20240715$20240724$20240724$EXP$ES-AEMPS-1544929$ES-TEVA-VS-3221665$TEVA$$66$YR$$M$Y$$$20240724$$HP$ES$ES
241307362$24130736$2$F$20210101$20240828$20240724$20240905$EXP$$US-AMGEN-USASP2024142935$AMGEN$$48$YR$A$F$Y$$$20240905$$LW$US$US
241307381$24130738$1$I$$20240709$20240724$20240724$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-07139$LUPIN$$30$YR$$M$Y$$$20240724$$HP$CA$CA
241307391$24130739$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116797$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240724$$CN$US$US
241307401$24130740$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116795$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240724$$CN$US$US
241307412$24130741$2$F$20240601$20240715$20240724$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112902$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$65.77$KG$20240802$$CN$US$US
241307422$24130742$2$F$$20240809$20240724$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116830$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240819$$CN$US$US
241307431$24130743$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014177$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240724$$CN$US$US
241307441$24130744$1$I$$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014304$ELI LILLY AND CO$$$$A$F$Y$$$20240724$$CN$US$US
241307451$24130745$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014349$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240724$$CN$US$US
241307461$24130746$1$I$20240701$20240717$20240724$20240724$PER$$US-AMGEN-USASP2024142773$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241307472$24130747$2$F$20240710$20240807$20240724$20240812$EXP$$CA-ABBVIE-5849394$ABBVIE$$77$YR$$M$Y$$$20240812$$HP$CA$CA
241307481$24130748$1$I$$20240718$20240724$20240724$PER$$NVSC2024US148854$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241307491$24130749$1$I$20240716$20240723$20240724$20240724$PER$$NVSC2024US151562$NOVARTIS$$42$YR$$F$Y$$$20240724$$CN$US$US
241307501$24130750$1$I$20240701$20240722$20240724$20240724$EXP$$US-ABBVIE-5850139$ABBVIE$$25$YR$$F$Y$$$20240724$$CN$US$US
241307511$24130751$1$I$$20240715$20240724$20240724$EXP$$PK-ROCHE-10000027510$ROCHE$$60$YR$A$F$Y$$$20240724$$CN$PK$PK
241307531$24130753$1$I$$20240719$20240724$20240724$EXP$$US-JNJFOC-20240756626$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240724$$HP$US$US
241307541$24130754$1$I$20240101$20240722$20240724$20240724$EXP$$US-ABBVIE-5850112$ABBVIE$$$$$M$Y$$$20240724$$HP$US$US
241307552$24130755$2$F$$20240716$20240724$20240805$EXP$$JP-009507513-2407JPN003506J$MERCK$Fujii T, Fujisawa R, Nagasaki N, Okumura M, Hiraoka Y, Inoue S, et al.. 14 A case of metastatic right ureteric cancer with hyperprogressive disease after administration of pembrolizumab. The 339th Okayama Regional Meeting of the Japanese Urological Association. 11$74$YR$$M$Y$$$20240805$$HP$JP$JP
241307561$24130756$1$I$$20240716$20240724$20240724$EXP$$ZA-AstraZeneca-2024A163425$ASTRAZENECA$$53$YR$$M$Y$$$20240724$$CN$ZA$
241307571$24130757$1$I$$20240723$20240724$20240724$EXP$IT-UCBSA-2024036005$IT-SANDOZ INC.-SDZ2024IT067491$SANDOZ$$49$YR$$M$Y$$$20240724$$MD$IT$IT
241307581$24130758$1$I$$20200409$20240724$20240724$EXP$$GB-AstraZeneca-2020SE49216$ASTRAZENECA$$$$$F$Y$$$20240724$$HP$GB$
241307601$24130760$1$I$20220912$20240719$20240724$20240724$EXP$IT-MINISAL02-995352$IT-ABBVIE-5850086$ABBVIE$$57$YR$$M$Y$61$KG$20240724$$MD$IT$IT
241307611$24130761$1$I$$20240716$20240724$20240724$EXP$$GB-AstraZeneca-2024A162971$ASTRAZENECA$$60$YR$$F$Y$$$20240724$$HP$GB$
241307622$24130762$2$F$20240706$20240906$20240724$20240910$EXP$$US-AstraZeneca-2024A165909$ASTRAZENECA$$22228$DY$$F$Y$$$20240910$$CN$US$
241307631$24130763$1$I$20240411$20240715$20240724$20240724$EXP$$US-KERYX BIOPHARMACEUTICALS INC.-US-AKEB-24-001105$AKEBIA THERAPEUTICS$$66$YR$$M$Y$$$20240724$$HP$US$US
241307641$24130764$1$I$20240711$20240722$20240724$20240724$EXP$$US-ABBVIE-5850239$ABBVIE$$77$YR$$M$Y$$$20240724$$CN$US$US
241307661$24130766$1$I$$20240715$20240724$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-036371$AUROBINDO$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatr-BloodCancer. 2024;71(7):e31004$6$YR$$F$Y$$$20240724$$HP$US$US
241307671$24130767$1$I$20240430$20240718$20240724$20240724$EXP$$US-ABBVIE-5846050$ABBVIE$$19$YR$$M$Y$79$KG$20240724$$CN$US$US
241307682$24130768$2$F$20240717$20240730$20240724$20240801$PER$$US-AMGEN-USASP2024144496$AMGEN$$68$YR$E$F$Y$75.8$KG$20240801$$HP$US$US
241307691$24130769$1$I$20240520$20240712$20240724$20240724$EXP$$ES-AMNEAL PHARMACEUTICALS-2024-AMRX-02671$AMNEAL$$$$$$Y$$$20240724$$MD$ES$ES
241307701$24130770$1$I$$20240717$20240724$20240724$EXP$$US-AMGEN-USASP2024144980$AMGEN$$$$E$F$Y$$$20240724$$MD$US$US
241307712$24130771$2$F$20240703$20240719$20240724$20240726$EXP$$IN-VANTIVE-2024VAN018465$Vantive US Healthcare$$24$YR$$F$Y$$$20240726$$CN$IN$IN
241307722$24130772$2$F$20140101$20240802$20240724$20240808$EXP$$US-AMGEN-USASP2024144000$AMGEN$$$$$F$Y$$$20240808$$HP$US$US
241307732$24130773$2$F$$20240725$20240724$20240729$EXP$$US-TAKEDA-2024TUS074343$TAKEDA$$$$$M$Y$$$20240729$$CN$US$US
241307752$24130775$2$F$20240101$20240913$20240724$20240917$EXP$$SE-Orion Corporation ORION PHARMA-TREX2024-0194$ORION$$81$YR$E$F$Y$$$20240917$$CN$SE$
241307762$24130776$2$F$20240711$20240730$20240724$20240807$EXP$$JP-ROCHE-10000032562$ROCHE$$84$YR$E$F$Y$$$20240807$$PH$JP$JP
241307772$24130777$2$F$$20240723$20240724$20240724$PER$$US-JNJFOC-20240757401$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$HP$US$US
241307781$24130778$1$I$$20240722$20240724$20240724$PER$$US-JNJFOC-20240760348$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$HP$US$US
241307791$24130779$1$I$$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116117$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240724$$CN$US$US
241307801$24130780$1$I$20240526$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035333$AUROBINDO$$19$YR$$F$Y$$$20240724$$MD$FR$FR
241307811$24130781$1$I$$20240720$20240724$20240724$PER$$US-ROCHE-10000033635$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241307821$24130782$1$I$20230601$20240715$20240724$20240724$EXP$GB-MHRA-MED-202407151938578880-RWFNV$GB-TEVA-VS-3221693$TEVA$$$$$F$Y$$$20240724$$CN$GB$GB
241307831$24130783$1$I$$20240719$20240724$20240724$PER$$US-ABBVIE-5847302$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241307841$24130784$1$I$$20240721$20240724$20240724$PER$$US-AMGEN-USASP2024145317$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241307851$24130785$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146100$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241307861$24130786$1$I$$20240718$20240724$20240724$EXP$$NVSC2024KR149675$NOVARTIS$$7$YR$$F$Y$$$20240724$$MD$KR$KR
241307871$24130787$1$I$20240101$20240624$20240724$20240724$EXP$$US-UCBSA-2024032453$UCB$$$$A$F$Y$$$20240724$$CN$US$US
241307882$24130788$2$F$$20240718$20240724$20240822$EXP$$JP-TEVA-VS-3223666$TEVA$$48$YR$$M$Y$$$20240822$$HP$JP$JP
241307901$24130790$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145242$AMGEN$$$$$M$Y$$$20240724$$HP$US$US
241307921$24130792$1$I$$20240715$20240724$20240724$EXP$$PL-AUROBINDO-AUR-APL-2024-036432$AUROBINDO$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain-Sci. 2023;13No. 3:445$36$YR$$F$Y$$$20240724$$HP$PL$PL
241307932$24130793$2$F$$20240731$20240724$20240802$EXP$$HK-ROCHE-10000032318$ROCHE$$64$YR$A$F$Y$$$20240802$$CN$HK$HK
241307941$24130794$1$I$$20240710$20240724$20240724$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001116$AKEBIA THERAPEUTICS$$9$DEC$$F$Y$$$20240724$$PH$JP$JP
241307951$24130795$1$I$20190906$20240718$20240724$20240724$EXP$$CA-TAKEDA-2021TUS062615$TAKEDA$$62$YR$$M$Y$$$20240724$$CN$CA$CA
241307961$24130796$1$I$$20240717$20240724$20240724$EXP$$US-ROCHE-10000029809$ROCHE$$92$YR$E$F$Y$$$20240724$$CN$US$US
241307971$24130797$1$I$$20240715$20240724$20240724$EXP$$IT-AUROBINDO-AUR-APL-2024-036114$AUROBINDO$Lamaida N, Cerciello A.. CARDIAC CONTRACTILITY MODULATION: AN OPTION FOR CHRONIC HEART FAILURE; A CASE REPORT.. Eur-Heart-J-suppl. 2024;26(Suppl2)ii134:338$72$YR$$$Y$$$20240724$$HP$IT$IT
241307984$24130798$4$F$20240624$20240923$20240724$20240927$EXP$$DE-TAKEDA-2024TUS073017$TAKEDA$$27$YR$$F$Y$82$KG$20240927$$MD$DE$DE
241307994$24130799$4$F$20240502$20240830$20240724$20240909$EXP$$DE-ROCHE-10000028743$ROCHE$$44$YR$A$F$Y$$$20240909$$MD$DE$DE
241308001$24130800$1$I$20180921$20240722$20240724$20240724$EXP$$CA-TAKEDA-2018TUS015857$TAKEDA$$51$YR$$F$Y$$$20240724$$MD$CA$CA
241308011$24130801$1$I$$20240715$20240724$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-036451$AUROBINDO$Hawkins AN,  Breton JM, Bhatnagar A, Paudel N, Voyadzis JM. Spinal extramedullary hematopoiesis mimicking an epidural tumor in a patient with high-risk polycythemia vera: illustrative case. JOURNAL OF NEUROSURGERY. 2024;8 (2):1-4$43$YR$$M$Y$$$20240724$$MD$US$US
241308021$24130802$1$I$20240101$20240718$20240724$20240724$EXP$$US-BIOGEN-2024BI01270866$BIOGEN$$50$YR$$M$Y$$$20240724$$CN$US$US
241308032$24130803$2$F$$20240726$20240724$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-036380$AUROBINDO$Zhang S, Sueblinvong V, Varga P. Atrial Arrhythmia and Bradycardia as a Presentation of Congenital Long QT Syndrome. Pediatric Cardiology. 2024$$$N$$Y$$$20240807$$HP$GB$US
241308041$24130804$1$I$$20240716$20240724$20240724$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP009022$STRIDES$Batra CM, Jain S, Kumar KP, Goyal M, Kachroo V, Takkar S, et al.. Spontaneous Hypoglycaemia due to Insulin Autoimmune Syndrome in Six Cases, Response to Steroid Therapy and Rituximab.. Indian-J-Endocrinol-Metab. 2024;28 (3):295-301$60$YR$$F$Y$$$20240724$$MD$IN$IN
241308051$24130805$1$I$20240322$20240627$20240724$20240724$PER$$BR-TOLMAR, INC.-24BR050068$TOLMAR$$8$YR$$F$Y$$$20240724$$CN$BR$BR
241308061$24130806$1$I$20240626$20240626$20240724$20240724$PER$$TR-TOLMAR, INC.-24TR050533$TOLMAR$$63$YR$$M$Y$$$20240724$$MD$TR$TR
241308071$24130807$1$I$20240627$20240627$20240724$20240724$PER$$TR-TOLMAR, INC.-24TR050580$TOLMAR$$75$YR$$M$Y$$$20240724$$HP$TR$TR
241308081$24130808$1$I$20240628$20240628$20240724$20240724$PER$$TR-TOLMAR, INC.-24TR050653$TOLMAR$$71$YR$$M$Y$$$20240724$$HP$TR$TR
241308091$24130809$1$I$20240626$20240627$20240724$20240724$PER$$TR-TOLMAR, INC.-24TR050656$TOLMAR$$68$YR$$M$Y$$$20240724$$HP$TR$TR
241308101$24130810$1$I$20240627$20240627$20240724$20240724$PER$$TR-TOLMAR, INC.-24TR050687$TOLMAR$$69$YR$$M$Y$$$20240724$$HP$TR$TR
241308111$24130811$1$I$20240628$20240628$20240724$20240724$PER$$TR-TOLMAR, INC.-24TR050689$TOLMAR$$87$YR$$M$Y$$$20240724$$PH$TR$TR
241308122$24130812$2$F$20240611$20240729$20240724$20240820$PER$$US-TOLMAR, INC.-24US050202$TOLMAR$$$$$$Y$$$20240820$$HP$US$US
241308132$24130813$2$F$20240101$20240904$20240724$20240909$EXP$$US-KYOWAKIRIN-2024KK017291$KYOWA$$$$$$Y$$$20240909$$HP$US$US
241308142$24130814$2$F$20240618$20240731$20240724$20240827$PER$$US-TOLMAR, INC.-24US050327$TOLMAR$$$$$$Y$$$20240827$$PH$US$US
241308152$24130815$2$F$20240620$20240802$20240724$20240827$PER$$US-TOLMAR, INC.-24US050337$TOLMAR$$90$YR$$M$Y$$$20240827$$HP$US$US
241308161$24130816$1$I$$20240624$20240724$20240724$PER$$US-AstraZeneca-2024A146047$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241308172$24130817$2$F$20220506$20240816$20240724$20240822$EXP$$CA-TAKEDA-2022TUS029295$TAKEDA$$37$YR$$M$Y$$$20240822$$HP$CA$CA
241308182$24130818$2$F$20240101$20240719$20240724$20240726$EXP$$JP-AstraZeneca-2024A164970$ASTRAZENECA$$$$$$Y$$$20240726$$MD$JP$
241308191$24130819$1$I$20200312$20200312$20240724$20240724$EXP$$US-AstraZeneca-2020SE39767$ASTRAZENECA$$26104$DY$$M$Y$$$20240724$$CN$US$
241308201$24130820$1$I$20240601$20240716$20240724$20240724$EXP$$US-JNJFOC-20240743388$JOHNSON AND JOHNSON$$68$YR$E$$Y$$$20240724$$CN$US$US
241308211$24130821$1$I$$20240719$20240724$20240724$PER$$US-JNJFOC-20240756604$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$CN$US$US
241308221$24130822$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117220$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240724$$HP$US$US
241308231$24130823$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117000$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$89.36$KG$20240724$$CN$US$US
241308241$24130824$1$I$$20240715$20240724$20240724$EXP$$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-114007$BRISTOL MYERS SQUIBB$Hamida O, Karlsson F, Lundqvist A, Gerling M, Liu LL. Cytokine release syndrome after treatment with immune checkpoint inhibitors: an observational cohort study of 2672 patients from karolinska university hospital in sweden. OncoImmunology. 2024 Jul 03;13(1):1-7. doi:10.1080/2162402X.2024.2372875.$6$DEC$A$M$Y$$$20240724$$HP$SE$SE
241308251$24130825$1$I$$20240716$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407010865$ELI LILLY AND CO$$64$YR$A$$Y$$$20240724$$CN$US$US
241308261$24130826$1$I$20240301$20240716$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407010728$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240724$$CN$US$US
241308271$24130827$1$I$$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013923$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240724$$CN$US$US
241308281$24130828$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013956$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240724$$CN$US$US
241308291$24130829$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014534$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240724$$CN$US$US
241308301$24130830$1$I$$20240715$20240724$20240724$EXP$$CA-APOTEX-2024AP008374$APOTEX$$77$YR$$F$Y$60$KG$20240724$$PH$CA$CA
241308312$24130831$2$F$$20240822$20240724$20240826$PER$$US-AMGEN-USASP2024146026$AMGEN$$56$YR$A$F$Y$$$20240826$$HP$US$US
241308321$24130832$1$I$20190101$20240718$20240724$20240724$EXP$$US-ABBVIE-5846068$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241308331$24130833$1$I$$20240715$20240724$20240724$EXP$$AU-AUROBINDO-AUR-APL-2024-036686$AUROBINDO$Tan XN, Yew CY, Ragg SJ, Harrup RA, Johnston AM. Outpatient autologous stem cell transplantation in Royal Hobart Hospital, Tasmania: a single-centre, retrospective review in the Australian setting.. intern-Med-J. 2022;52(7):1242-1250$$$$$Y$$$20240724$$HP$AU$AU
241308342$24130834$2$F$20240101$20240718$20240724$20240726$PER$$US-ABBVIE-5849580$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241308361$24130836$1$I$20060101$20240722$20240724$20240724$EXP$$US-ABBVIE-5843369$ABBVIE$$$$$F$Y$70$KG$20240724$$CN$US$US
241308372$24130837$2$F$20240721$20240731$20240724$20240801$PER$$US-AMGEN-USASP2024145675$AMGEN$$56$YR$A$F$Y$$$20240801$$CN$US$US
241308381$24130838$1$I$$20240715$20240724$20240724$EXP$$BE-AUROBINDO-AUR-APL-2024-036445$AUROBINDO$Mertens B, Elkayal O, Dreesen E, Wauters J, Meersseman P, Debaveye Y, et al. Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review. Antibiotics-(Basel). 2023;12(7):1-19$52$YR$$F$Y$67$KG$20240724$$HP$BE$BE
241308391$24130839$1$I$$20240723$20240724$20240724$EXP$$US-UCBSA-2024037270$UCB$$$$$M$Y$$$20240724$$CN$US$US
241308401$24130840$1$I$$20240717$20240724$20240724$EXP$$CN-JNJFOC-20240757693$JOHNSON AND JOHNSON$$$$A$$Y$$$20240724$$MD$CN$CN
241308411$24130841$1$I$$20240722$20240724$20240724$EXP$$KR-JNJFOC-20240759685$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$HP$KR$KR
241308421$24130842$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151116$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241308431$24130843$1$I$20240714$20240715$20240724$20240724$30DAY$$US-GSK-US2024088777$GLAXOSMITHKLINE$$88$YR$$F$Y$$$20240724$$CN$US$US
241308441$24130844$1$I$$20240715$20240724$20240724$EXP$$GB-AUROBINDO-AUR-APL-2024-035436$AUROBINDO$$53$YR$$M$Y$$$20240724$$HP$GB$GB
241308454$24130845$4$F$20240719$20240724$20240724$20240725$PER$$US-ROCHE-10000032513$ROCHE$$45$YR$A$M$Y$68.49$KG$20240725$$CN$US$US
241308462$24130846$2$F$$20240718$20240724$20240726$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009107$STRIDES$Liang J, Xu X, Chen Z, Yu J, Tang Y.. Combined Use of Emapalumab With Ruxolitinib and Dexamethasone as an Effective Treatment for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Complicated With Multiorgan Damage and Severe Infection.. J-Pediatr-Hematol-Oncol. 2024;46 (5):e360-e362$8$YR$$F$Y$$$20240726$$MD$CN$CN
241308471$24130847$1$I$$20240716$20240724$20240724$PER$$US-ALXN-202407USA001076US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241308482$24130848$2$F$$20240725$20240724$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116925$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240808$$CN$US$US
241308491$24130849$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116699$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240724$$HP$US$US
241308503$24130850$3$F$$20240813$20240724$20240820$EXP$$US-ROCHE-RCA5208841$ROCHE$$62$YR$A$F$Y$63.5$KG$20240820$$MD$US$US
241308514$24130851$4$F$$20240723$20240724$20240731$EXP$$US-ROCHE-10000033335$ROCHE$$$$$M$Y$61.69$KG$20240731$$CN$US$US
241308521$24130852$1$I$20181004$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035945$AUROBINDO$$67$YR$$F$Y$60$KG$20240724$$MD$FR$FR
241308531$24130853$1$I$20240628$20240719$20240724$20240724$EXP$$NVSC2024RU150064$NOVARTIS$$44$YR$$F$Y$64$KG$20240724$$HP$RU$RU
241308542$24130854$2$F$20201004$20240711$20240724$20240801$EXP$$CN-SA-2024SA205040$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240719$$HP$CN$CN
241308551$24130855$1$I$20240426$20240716$20240724$20240724$EXP$$GT-SA-2024SA210625$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240724$$CN$GT$GT
241308561$24130856$1$I$20240712$20240716$20240724$20240724$EXP$$CN-ALCON LABORATORIES-ALC2024CN003448$ALCON$$46$YR$$F$Y$50$KG$20240724$$HP$CN$CN
241308571$24130857$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06630$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241308581$24130858$1$I$20220101$20240715$20240724$20240724$EXP$$CA-RIGEL PHARMACEUTICALS, INC.-2022FOS000239$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240724$$MD$CA$CA
241308592$24130859$2$F$20240716$20240830$20240724$20240903$PER$$US-AMGEN-USASP2024144421$AMGEN$$72$YR$E$M$Y$$$20240903$$CN$US$US
241308602$24130860$2$F$$20240913$20240724$20240920$EXP$$JP-AMGEN-JPNSP2024144625$AMGEN$$$$$$Y$$$20240920$$PH$JP$JP
241308611$24130861$1$I$$20240715$20240724$20240724$EXP$$IT-AUROBINDO-AUR-APL-2024-036381$AUROBINDO$Chiavarino F, Pruccoli J, Cecconi I, Vancini N, Cordelli DM, Parmeggiani A. Eating disorders in young patients with neurofibromatosis type 1. Journal of Paediatrics and Child Health. 2023;59:723-728$15$YR$$F$Y$$$20240724$$HP$IT$IT
241308631$24130863$1$I$$20240718$20240724$20240724$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009025$STRIDES$Applegarth J, Finn D, Tolkacz M, Iacco A.. Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome.  ;  .. ASAIO-J. 2024;70 (Suppl. 3):151 (plus Poster) abstr. P74$18$YR$$F$Y$$$20240724$$HP$US$US
241308651$24130865$1$I$20240215$20240717$20240724$20240724$EXP$GB-MHRA-MED-202407171730228890-BCZNF$GB-SA-2024SA210861$SANOFI AVENTIS$$23$YR$A$M$Y$72$KG$20240724$$CN$GB$GB
241308662$24130866$2$F$20240705$20240723$20240724$20240725$EXP$$US-ROCHE-10000034409$ROCHE$$89$YR$E$$Y$$$20240725$$CN$US$US
241308671$24130867$1$I$20240709$20240716$20240724$20240724$EXP$$US-AMGEN-USASL2024143374$AMGEN$$86$YR$E$F$Y$$$20240724$$CN$US$US
241308681$24130868$1$I$20240527$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035848$AUROBINDO$$55$YR$$F$Y$88$KG$20240724$$PH$FR$FR
241308691$24130869$1$I$$20240711$20240724$20240724$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06686$HIKMA$$$$$$Y$$$20240724$$CN$US$US
241308701$24130870$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06759$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241308711$24130871$1$I$$20240717$20240724$20240724$30DAY$$US-GSK-US2024090752$GLAXOSMITHKLINE$$$$A$F$Y$$$20240724$$MD$US$US
241308721$24130872$1$I$20230410$20240715$20240724$20240724$EXP$$US-UNITED THERAPEUTICS-UNT-2023-011100$UNITED THERAPEUTICS$$62$YR$$F$Y$45.805$KG$20240724$$$US$US
241308732$24130873$2$F$$20240719$20240724$20240726$EXP$$DE-SA-2024SA215538$SANOFI AVENTIS$$$$$M$Y$$$20240726$$MD$DE$DE
241308741$24130874$1$I$$20240718$20240724$20240724$EXP$$US-SA-2024SA213357$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240724$$MD$US$US
241308751$24130875$1$I$20240626$20240718$20240724$20240724$EXP$$US-SA-2024SA213205$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240724$$MD$US$US
241308761$24130876$1$I$20240401$20240717$20240724$20240724$EXP$$BR-TAKEDA-2024TUS073403$TAKEDA$$39$YR$$M$Y$$$20240724$$CN$BR$BR
241308772$24130877$2$F$$20240814$20240724$20240819$PER$$NVSC2024US150643$NOVARTIS$$$$$F$Y$114$KG$20240819$$CN$US$US
241308792$24130879$2$F$$20240819$20240724$20240827$PER$$US-ABBVIE-5847126$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
241308801$24130880$1$I$$20240719$20240724$20240724$EXP$$DE-TAKEDA-2024TUS074233$TAKEDA$$$$$F$Y$$$20240724$$CN$DE$DE
241308811$24130881$1$I$20240219$20240709$20240724$20240724$EXP$$CZ-MIRUM PHARMACEUTICALS INTERNATIONAL B.V.-CZ-MIR-24-00560$Unknown Manufacturer$$$$$$Y$$$20240724$$MD$CZ$CZ
241308821$24130882$1$I$20231025$20240715$20240724$20240724$EXP$AT-BASGAGES-2024-005011$AT-TEVA-VS-3221715$TEVA$$75$YR$$M$Y$90$KG$20240724$$MD$AT$AT
241308832$24130883$2$F$$20240813$20240724$20240813$PER$$US-ALXN-202407USA001182US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
241308841$24130884$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06782$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241308851$24130885$1$I$20240710$20240716$20240724$20240724$EXP$$JP-ROCHE-10000031115$ROCHE$$69$YR$E$M$Y$$$20240724$$MD$JP$JP
241308861$24130886$1$I$20240101$20240709$20240724$20240724$PER$$US-JNJFOC-20240728704$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$CN$US$US
241308871$24130887$1$I$20240601$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116400$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240724$$HP$US$US
241308885$24130888$5$F$20240717$20240814$20240724$20240819$30DAY$$US-JNJFOC-20240756940$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240819$$CN$US$US
241308892$24130889$2$F$20240725$20240725$20240724$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117560$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240726$$CN$US$US
241308901$24130890$1$I$$20240722$20240724$20240724$PER$$US-JNJFOC-20240757017$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240724$$HP$US$US
241308921$24130892$1$I$$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116804$BRISTOL MYERS SQUIBB$$26$YR$A$M$Y$$$20240724$$PH$US$US
241308931$24130893$1$I$$20240720$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013921$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240724$$CN$US$US
241308941$24130894$1$I$$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014013$ELI LILLY AND CO$$$$$$Y$$$20240724$$CN$US$US
241308951$24130895$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014107$ELI LILLY AND CO$$$$$$Y$$$20240724$$CN$US$US
241308961$24130896$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015173$ELI LILLY AND CO$$$$$M$Y$$$20240724$$CN$US$US
241308971$24130897$1$I$$20240718$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014599$ELI LILLY AND CO$$$$$F$Y$$$20240724$$CN$US$US
241308981$24130898$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013993$ELI LILLY AND CO$$$$$F$Y$$$20240724$$CN$US$US
241308991$24130899$1$I$$20240718$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013039$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240724$$CN$US$US
241309001$24130900$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014863$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240724$$CN$US$US
241309011$24130901$1$I$20240613$20240716$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036193$AUROBINDO$$29$YR$$F$Y$$$20240724$$PH$FR$FR
241309021$24130902$1$I$20231201$20240716$20240724$20240724$EXP$$RO-TAKEDA-2024TUS073559$TAKEDA$$73$YR$$F$Y$$$20240724$$CN$RO$RO
241309031$24130903$1$I$20240712$20240716$20240724$20240724$EXP$$LT-ARGENX-2024-ARGX-LT005622$ARGENX BVBA$$$$$$Y$$$20240724$$MD$LT$LT
241309042$24130904$2$F$$20240828$20240724$20240903$EXP$$BE-BEH-2024175947$CSL BEHRING$$$$A$F$Y$$$20240903$$MD$BE$BE
241309052$24130905$2$F$20231201$20240725$20240724$20240801$EXP$$DE-ROCHE-3510301$ROCHE$$35$YR$A$F$Y$$$20240801$$CN$DE$DE
241309062$24130906$2$F$20240710$20240719$20240724$20240727$PER$$US-AMGEN-USASP2024144933$AMGEN$$83$YR$E$M$Y$$$20240727$$HP$US$US
241309071$24130907$1$I$20240715$20240716$20240724$20240724$EXP$$GB-AUROBINDO-AUR-APL-2024-035550$AUROBINDO$$51$YR$$F$Y$$$20240724$$HP$GB$GB
241309081$24130908$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A162513$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241309091$24130909$1$I$$20240710$20240724$20240724$EXP$$CA-APOTEX-2024AP008195$APOTEX$$4$YR$$M$Y$14$KG$20240724$$HP$CA$CA
241309101$24130910$1$I$$20190926$20240724$20240724$EXP$$US-AstraZeneca-2019SF34278$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241309111$24130911$1$I$$20240614$20240724$20240724$EXP$$FR-AstraZeneca-2024A141933$ASTRAZENECA$$$$$$Y$$$20240724$$MD$FR$
241309131$24130913$1$I$20240523$20240716$20240724$20240724$EXP$$FR-AstraZeneca-2024A161826$ASTRAZENECA$$86$YR$$F$Y$56$KG$20240724$$MD$FR$
241309141$24130914$1$I$20230606$20240716$20240724$20240724$EXP$$JP-AstraZeneca-2024A120973$ASTRAZENECA$$77$YR$$M$Y$72$KG$20240724$$MD$JP$
241309151$24130915$1$I$20240714$20240719$20240724$20240724$EXP$$CN-TAKEDA-2024TUS073870$TAKEDA$$82$YR$$M$Y$63$KG$20240724$$HP$CN$CN
241309161$24130916$1$I$$20240722$20240724$20240724$EXP$$CA-TAKEDA-2024TUS074442$TAKEDA$$$$$F$Y$$$20240724$$CN$CA$CA
241309171$24130917$1$I$$20191220$20240724$20240724$EXP$$RU-AstraZeneca-2019SF87662$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$RU$
241309181$24130918$1$I$$20230526$20240724$20240724$EXP$$US-AstraZeneca-2023A126044$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241309191$24130919$1$I$$20240716$20240724$20240724$EXP$$CA-AstraZeneca-2024A164026$ASTRAZENECA$$71$YR$$M$Y$$$20240724$$MD$CA$
241309201$24130920$1$I$$20240719$20240724$20240724$PER$$US-AstraZeneca-2024A165459$ASTRAZENECA$$$$$$Y$$$20240724$$CN$US$
241309212$24130921$2$F$20230606$20240806$20240724$20240807$PER$$NVSC2024US132496$NOVARTIS$$$$$F$Y$$$20240808$$HP$US$US
241309222$24130922$2$F$20240701$20240906$20240724$20240911$EXP$$US-AstraZeneca-2024A165807$ASTRAZENECA$$$$$M$Y$$$20240911$$HP$US$
241309231$24130923$1$I$$20240718$20240724$20240724$PER$$US-GILEAD-2024-0681301$GILEAD$$$$$$Y$$$20240724$$CN$US$US
241309241$24130924$1$I$$20240718$20240724$20240724$EXP$$JP-JNJFOC-20240759453$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$CN$JP$JP
241309251$24130925$1$I$$20240717$20240724$20240724$EXP$$CN-JNJFOC-20240761457$JOHNSON AND JOHNSON$$$$A$$Y$$$20240724$$MD$CN$CN
241309261$24130926$1$I$$20240716$20240724$20240724$EXP$$US-GSK-US2024089559$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$US$US
241309272$24130927$2$F$20240711$20240821$20240724$20240903$30DAY$$US-AMGEN-USASP2024140373$AMGEN$$58$YR$A$F$Y$73.35$KG$20240903$$HP$US$US
241309281$24130928$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024145039$AMGEN$$$$$$Y$$$20240724$$HP$US$US
241309292$24130929$2$F$$20240721$20240724$20240728$PER$$US-AMGEN-USASP2024145211$AMGEN$$$$A$$Y$$$20240728$$CN$US$US
241309301$24130930$1$I$20240701$20240716$20240724$20240724$PER$$US-AMGEN-USASP2024141718$AMGEN$$70$YR$E$F$Y$81$KG$20240724$$HP$US$US
241309311$24130931$1$I$20210101$20240717$20240724$20240724$EXP$$ES-AMGEN-ESPSP2024142682$AMGEN$Salido-vallejo, R.. Improvement in quality of life in patients with Hailey-Hailey disease treated with ablative CO2 laser. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024;22:996-998$57$YR$A$F$Y$$$20240724$$MD$ES$ES
241309321$24130932$1$I$20230101$20240716$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036194$AUROBINDO$$34$YR$$M$Y$$$20240724$$MD$FR$FR
241309331$24130933$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06760$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241309341$24130934$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024143742$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
241309351$24130935$1$I$$20210519$20240724$20240724$EXP$$US-AstraZeneca-2021A451584$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241309361$24130936$1$I$20220101$20240716$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036191$AUROBINDO$$76$YR$$F$Y$45$KG$20240724$$PH$FR$FR
241309371$24130937$1$I$20240101$20240715$20240724$20240724$EXP$IT-MINISAL02-993996$IT-TEVA-VS-3221764$TEVA$$74$YR$$M$Y$86$KG$20240724$$MD$IT$IT
241309382$24130938$2$F$20240713$20240822$20240724$20240826$EXP$$BR-TAKEDA-2024TUS072534$TAKEDA$$34$YR$$F$Y$105$KG$20240826$$CN$BR$BR
241309391$24130939$1$I$$20240718$20240724$20240724$EXP$NL-LRB-00981656$NL-CHEPLA-2024009100$CHEPLAPHARM$$42$YR$$F$Y$90$KG$20240724$$CN$COUNTRY NOT SPECIFIED$NL
241309401$24130940$1$I$$20210513$20240724$20240724$EXP$$US-AstraZeneca-2021A434248$ASTRAZENECA$$$$$F$Y$37.2$KG$20240724$$CN$US$
241309411$24130941$1$I$20240510$20240716$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036157$AUROBINDO$$79$YR$$F$Y$52$KG$20240724$$MD$FR$FR
241309421$24130942$1$I$20230301$20240718$20240724$20240724$EXP$GB-MHRA-MED-202407170659011650-LWPQN$GB-CHEPLA-2024009102$CHEPLAPHARM$$25$YR$$M$Y$65$KG$20240724$$CN$COUNTRY NOT SPECIFIED$GB
241309431$24130943$1$I$$20240715$20240724$20240724$EXP$$PT-CHEPLA-2024009224$CHEPLAPHARM$Ferreira T, Rebelo SD, Tornada A. PO-0269 - (4254) - An unusual cause of fever. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. 2024:634.$58$YR$$F$Y$$$20240724$$HP$COUNTRY NOT SPECIFIED$PT
241309441$24130944$1$I$$20240718$20240724$20240724$EXP$NL-LRB-00984085$NL-CHEPLA-2024009117$CHEPLAPHARM$$53$YR$$F$Y$60$KG$20240724$$CN$COUNTRY NOT SPECIFIED$NL
241309451$24130945$1$I$20240111$20240718$20240724$20240724$EXP$FR-AFSSAPS-TO2024000498$FR-CHEPLA-2024009230$CHEPLAPHARM$$93$YR$$F$Y$54.799$KG$20240724$$PH$COUNTRY NOT SPECIFIED$FR
241309463$24130946$3$F$$20240920$20240724$20240926$EXP$$JP-009507513-2407JPN003496J$MERCK$Ogimoto K, Matsui K, Ichida K, Aratake J, Narita M, Hamasaki K, et al.. OS-250 Report of 5 cases of suspected irAE myocarditis at our hospital -Actual status of screening and treatment for irAE myocarditis. The journal of the Japan Society of Gynecologic Oncology The 66th Annual Meeting. 2024;42(3):320$$$$F$Y$$$20240926$$MD$JP$JP
241309491$24130949$1$I$20240709$20240717$20240724$20240724$EXP$IT-MINISAL02-994691$IT-TAKEDA-2024TUS072181$TAKEDA$$19$YR$$F$Y$$$20240724$$HP$IT$IT
241309501$24130950$1$I$20240704$20240715$20240724$20240724$EXP$$GB-BAXTER-2024BAX021522$BAXTER$$48$YR$$F$Y$$$20240724$$CN$GB$GB
241309511$24130951$1$I$20210424$20210427$20240724$20240724$EXP$$US-AstraZeneca-2021A364954$ASTRAZENECA$$27598$DY$$M$Y$89.8$KG$20240724$$CN$US$
241309521$24130952$1$I$20240614$20240715$20240724$20240724$EXP$FR-AFSSAPS-GR2024000875$FR-BAXTER-2024BAX021627$BAXTER$$4$YR$$M$Y$13.7$KG$20240724$$PH$FR$FR
241309531$24130953$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116636$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$102.51$KG$20240724$$CN$US$US
241309551$24130955$1$I$$20210517$20240724$20240724$EXP$$US-AstraZeneca-2021A132588$ASTRAZENECA$$20028$DY$$F$Y$59$KG$20240724$$CN$US$
241309561$24130956$1$I$20240709$20240716$20240724$20240724$EXP$$CN-AstraZeneca-2024A165372$ASTRAZENECA$$40$YR$$M$Y$60$KG$20240724$$MD$CN$
241309573$24130957$3$F$20240715$20240903$20240724$20240910$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021629$UNITED THERAPEUTICS$$35$YR$$F$Y$$$20240910$$$US$US
241309581$24130958$1$I$$20240719$20240724$20240724$PER$$US-ABBVIE-5849377$ABBVIE$$$$$M$Y$$$20240724$$HP$US$US
241309591$24130959$1$I$$20240723$20240724$20240724$EXP$$NVSC2024US151133$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241309603$24130960$3$F$$20240724$20240724$20240729$EXP$$NVSC2024US151381$NOVARTIS$$$$$F$Y$$$20240729$$CN$US$US
241309611$24130961$1$I$$20240722$20240724$20240724$PER$$NVSC2024US151134$NOVARTIS$$$$$M$Y$$$20240724$$CN$US$US
241309621$24130962$1$I$$20240719$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US067064$SANDOZ$$$$$$Y$$$20240724$$CN$US$US
241309631$24130963$1$I$20240422$20240716$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036123$AUROBINDO$$86$YR$$F$Y$60$KG$20240724$$MD$FR$FR
241309643$24130964$3$F$20240708$20240813$20240724$20240814$EXP$$US-TAKEDA-2024TUS073296$TAKEDA$$50$YR$$M$Y$$$20240814$$MD$US$US
241309651$24130965$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06762$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241309675$24130967$5$F$20240325$20240816$20240724$20240826$PER$$US-AMGEN-USASP2024142466$AMGEN$$50$YR$A$F$Y$117.9$KG$20240826$$HP$US$US
241309684$24130968$4$F$20240415$20240808$20240724$20240812$PER$$US-AMGEN-USASP2024142463$AMGEN$$71$YR$E$M$Y$123.81$KG$20240812$$HP$US$US
241309692$24130969$2$F$20240524$20240724$20240724$20240730$30DAY$$US-AMGEN-USASP2024142545$AMGEN$$66$YR$E$M$Y$81.8$KG$20240730$$HP$US$US
241309702$24130970$2$F$20240628$20240723$20240724$20240725$EXP$$US-ABBVIE-5850237$ABBVIE$$82$YR$$M$Y$$$20240725$$CN$US$US
241309711$24130971$1$I$$20240715$20240724$20240724$EXP$$CA-APOTEX-2024AP008410$APOTEX$$41$YR$$M$Y$130$KG$20240724$$HP$CA$CA
241309721$24130972$1$I$20201209$20240704$20240724$20240724$EXP$$CA-CELLTRION INC.-2024CA006350$CELLTRION$$$$$$Y$$$20240724$$CN$CA$CA
241309731$24130973$1$I$$20240717$20240724$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010929$JAZZ$$$$$F$Y$$$20240724$$CN$US$US
241309741$24130974$1$I$20240601$20240717$20240724$20240724$EXP$$CN-GSK-CN2024APC090335$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$CN$CN
241309751$24130975$1$I$20240701$20240717$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-021739$UNITED THERAPEUTICS$$38$YR$$F$Y$50.34$KG$20240724$$$US$US
241309761$24130976$1$I$$20240716$20240724$20240724$PER$$US-RDY-SPO/USA/24/0010539$DR REDDYS$$28$YR$A$F$Y$$$20240724$$CN$US$US
241309771$24130977$1$I$20240719$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144811$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241309781$24130978$1$I$20210901$20240717$20240724$20240724$EXP$$PT-AMGEN-PRTSP2024143258$AMGEN$$59$YR$A$F$Y$85$KG$20240724$$HP$PT$PT
241309791$24130979$1$I$$20240715$20240724$20240724$EXP$$US-TEVA-VS-3222024$TEVA$$74$YR$$F$Y$$$20240724$$CN$US$US
241309801$24130980$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06562$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241309812$24130981$2$F$20240721$20240826$20240724$20240909$EXP$$US-UCBSA-2024037166$UCB$$10$YR$$M$Y$$$20240909$$CN$US$US
241309821$24130982$1$I$$20240716$20240724$20240724$PER$$US-EMD Serono-2024039366$EMD SERONO INC$$$$$F$Y$$$20240724$$CN$US$US
241309831$24130983$1$I$$20240705$20240724$20240724$PER$$US-TEVA-VS-3220428$TEVA$$$$$$Y$$$20240724$$PH$US$US
241309842$24130984$2$F$20240713$20240723$20240724$20240726$EXP$$IN-VANTIVE-2024VAN018497$Vantive US Healthcare$$67$YR$$F$Y$$$20240726$$CN$IN$IN
241309851$24130985$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145118$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241309861$24130986$1$I$$20240723$20240724$20240724$EXP$$NVSC2024US151126$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241309881$24130988$1$I$20210201$20240716$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036156$AUROBINDO$$32$YR$$M$Y$$$20240724$$MD$FR$FR
241309891$24130989$1$I$$20240716$20240724$20240724$EXP$$NVSC2024MX149580$NOVARTIS$$$$$M$Y$$$20240724$$CN$MX$MX
241309901$24130990$1$I$$20240701$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06779$LUPIN$$$$$$Y$$$20240724$$PH$US$US
241309912$24130991$2$F$$20240903$20240724$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117215$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240906$$HP$US$US
241309922$24130992$2$F$$20240814$20240724$20240820$EXP$$US-TAKEDA-2024TUS069803$TAKEDA$$$$$F$Y$$$20240820$$CN$US$US
241309932$24130993$2$F$20240708$20240816$20240724$20240821$EXP$$GB-JNJFOC-20240748965$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240821$$CN$GB$GB
241309941$24130994$1$I$$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014236$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240724$$CN$US$US
241309951$24130995$1$I$$20240723$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015417$ELI LILLY AND CO$$$$$F$Y$$$20240724$$CN$US$US
241309961$24130996$1$I$$20240723$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015413$ELI LILLY AND CO$$$$$F$Y$$$20240724$$CN$US$US
241309972$24130997$2$F$20240101$20240808$20240724$20240809$PER$$US-JNJFOC-20240672878$JOHNSON AND JOHNSON$$84$YR$E$F$Y$55.3$KG$20240809$$CN$US$US
241309991$24130999$1$I$20240101$20240715$20240724$20240724$EXP$DK-DKMA-30729507$DK-TEVA-VS-3221468$TEVA$$68$YR$$F$Y$$$20240724$$MD$DK$DK
241310001$24131000$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024143808$AMGEN$$$$$F$Y$$$20240724$$PH$US$US
241310011$24131001$1$I$20240627$20240715$20240724$20240724$EXP$$CN-ROCHE-10000027280$ROCHE$$75$YR$E$M$Y$60$KG$20240724$$HP$CN$CN
241310021$24131002$1$I$20240410$20240716$20240724$20240724$EXP$$GB-AUROBINDO-AUR-APL-2024-035554$AUROBINDO$$$$$M$Y$$$20240724$$CN$GB$GB
241310034$24131003$4$F$$20240729$20240724$20240731$EXP$$US-ROCHE-3390322$ROCHE$$62$YR$A$F$Y$$$20240731$$PH$US$US
241310041$24131004$1$I$20240101$20240718$20240724$20240724$EXP$$GB-ABBVIE-5839647$ABBVIE$$37$YR$$F$Y$$$20240724$$CN$GB$GB
241310051$24131005$1$I$20240707$20240712$20240724$20240724$EXP$GB-MHRA-MED-202407112158541270-CKJVM$GB-MSNLABS-2024MSNSPO01605$MSN LABORATORIES$$$$$$Y$$$20240724$$CN$GB$GB
241310061$24131006$1$I$$20240719$20240724$20240724$EXP$$US-AMGEN-USASP2024144501$AMGEN$Kernan N.A.; Klein E.; Mauguen A. et al.. Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult Patients. Transplantation and Cellular Therapy. 2024;30 (7):692.e1-692.e12$$$$$Y$$$20240724$$MD$US$US
241310071$24131007$1$I$$20240716$20240724$20240724$EXP$$CA-AstraZeneca-2024A163617$ASTRAZENECA$$41$YR$$M$Y$$$20240724$$MD$CA$
241310081$24131008$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A163487$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241310091$24131009$1$I$20240101$20240716$20240724$20240724$EXP$$JP-AstraZeneca-2024A164292$ASTRAZENECA$$62$YR$$M$Y$$$20240724$$MD$JP$
241310101$24131010$1$I$20240109$20240723$20240724$20240724$EXP$FR-AFSSAPS-NY2024000843$FR-SANDOZ INC.-SDZ2024FR067534$SANDOZ$$41$YR$$M$Y$92$KG$20240724$$PH$FR$FR
241310111$24131011$1$I$$20240607$20240724$20240724$PER$$US-AstraZeneca-2024A167744$ASTRAZENECA$$$$$$Y$$$20240724$$MD$US$
241310121$24131012$1$I$20231220$20240716$20240724$20240724$EXP$$GB-AstraZeneca-2024A162050$ASTRAZENECA$$84$YR$$F$Y$67$KG$20240724$$MD$GB$
241310131$24131013$1$I$$20240712$20240724$20240724$EXP$$US-MYLANLABS-2024M1066231$MYLAN$Ghalayni R, Al Kalaji B, Malik K. From Friend to Foe: A Case of Naloxone-Induced Pulmonary Edema. Hosp-Pharm 2024; 59 (4): 407-410.$66$YR$$F$Y$$$20240724$$HP$US$US
241310142$24131014$2$F$$20240715$20240724$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-036109$AUROBINDO$Moga T, Robillard K, Prabhu A, Jamot S, Bain A.. HSV Esophagitis With Hematemesis and Recalcitrant Food Bolus.. Am-J-Gastroenterol. 2022;117(10):S1570 abstr. S2332$58$YR$$F$Y$$$20240725$$MD$US$US
241310151$24131015$1$I$$20240719$20240724$20240724$PER$$US-AstraZeneca-2024A165948$ASTRAZENECA$$$$$$Y$$$20240724$$CN$US$
241310161$24131016$1$I$20240713$20240716$20240724$20240724$EXP$$GB-AUROBINDO-AUR-APL-2024-035727$AUROBINDO$$26$YR$$F$Y$$$20240724$$CN$GB$GB
241310171$24131017$1$I$20240523$20240722$20240724$20240724$EXP$$KR-AstraZeneca-2024A147674$ASTRAZENECA$$854$MON$$M$Y$$$20240724$$MD$KR$
241310181$24131018$1$I$$20240712$20240724$20240724$EXP$$US-MYLANLABS-2024M1067009$MYLAN$Brenneman E, Keil E, Advani SD, Campbell KB, Wrenn R. A Turtle Disaster: Salmonella enteritidis Cardiovascular Implantable Electronic Device Infection. Open-Forum-Infect-Dis 2022; 9 (12):.$60$YR$$M$Y$$$20240724$$PH$US$US
241310191$24131019$1$I$$20240711$20240724$20240724$EXP$$US-MYLANLABS-2024M1066546$MYLAN$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.$$$A$$Y$$$20240724$$PH$US$US
241310201$24131020$1$I$$20240711$20240724$20240724$EXP$$US-MYLANLABS-2024M1066586$MYLAN$Maurya A, Sivanandham R, Bagheri S, Moshtahedian K. Immune-mediated Myositis With Bulbar Involvement Leading to Respiratory Failure: A Rare Adverse Effect of Pembrolizumab. Am-J-Respir-Crit-Care-Med 2024; 209.$72$YR$$M$Y$$$20240724$$HP$US$US
241310212$24131021$2$F$20240601$20240812$20240724$20240814$PER$$US-JNJFOC-20240673317$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240814$$MD$US$US
241310221$24131022$1$I$20240626$20240722$20240724$20240724$PER$$US-TAKEDA-2024TUS073992$TAKEDA$$35$YR$$M$Y$82$KG$20240724$$MD$US$US
241310231$24131023$1$I$$20240717$20240724$20240724$30DAY$$US-GSK-US2024090181$GLAXOSMITHKLINE$$$$$F$Y$$$20240724$$CN$US$US
241310244$24131024$4$F$20240101$20240904$20240724$20240909$EXP$$US-PUMA BIOTECHNOLOGY, INC.-2024-PUM-US000978$PUMA$$$$$$Y$$$20240909$$CN$US$US
241310252$24131025$2$F$20240501$20240808$20240724$20240813$PER$$US-ABBVIE-5849776$ABBVIE$$75$YR$$F$Y$65.77$KG$20240813$$CN$US$US
241310261$24131026$1$I$20240101$20240624$20240724$20240724$PER$$US-009507513-2406USA008999$MERCK$$$$$F$Y$$$20240724$$MD$US$US
241310271$24131027$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-10000033742$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241310281$24131028$1$I$20240701$20240716$20240724$20240724$PER$$US-ABBVIE-5846047$ABBVIE$$$$A$M$Y$$$20240724$$MD$US$US
241310293$24131029$3$F$20240719$20240827$20240724$20240830$PER$$US-AMGEN-USASP2024145423$AMGEN$$80$YR$E$F$Y$$$20240830$$CN$US$US
241310301$24131030$1$I$$20240715$20240724$20240724$EXP$$PL-AUROBINDO-AUR-APL-2024-035986$AUROBINDO$Kuc A, Stachura A, Jazdzyk P, Grzelinska J, Swiecicki L.. Adjunctive electroconvulsive therapy in the treatment of a patient with comorbid major depressive disorder, posttraumatic stress disorder, and anorexia nervosa - a case report. Postepy-Psychiatrii-i-Neurologii. 2024;33(1):43-48$28$YR$$F$Y$$$20240724$$HP$PL$PL
241310311$24131031$1$I$20221206$20240716$20240724$20240724$EXP$$CA-CELLTRION INC.-2022CA021210$CELLTRION$$$$$$Y$$$20240724$$HP$CA$CA
241310321$24131032$1$I$20240101$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145670$AMGEN$$91$YR$E$F$Y$$$20240724$$CN$US$US
241310331$24131033$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024143092$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241310341$24131034$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024144597$AMGEN$Sood N.; Kushnir M.; Jayavelu B.. Acute Renal Thrombotic Microangiopathy Caused by Eltrombopag and Romiplostim in a Patient with Myelodysplastic Syndromes (MDS) and Underlying Antiphospholipid Syndrome. European Journal of Case Reports in Intemal Medicine. 2024;11 (7)$80$YR$E$M$Y$$$20240724$$HP$US$US
241310371$24131037$1$I$20230101$20240716$20240724$20240724$PER$$US-ABBVIE-5846749$ABBVIE$$$$A$F$Y$$$20240724$$MD$US$US
241310382$24131038$2$F$$20240812$20240724$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06842$LUPIN$$$$$$Y$$$20240901$$CN$US$US
241310391$24131039$1$I$20240101$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116142$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$50.8$KG$20240724$$CN$US$US
241310401$24131040$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117241$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240724$$HP$US$US
241310411$24131041$1$I$20240601$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117336$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240724$$HP$US$US
241310422$24131042$2$F$$20240814$20240724$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117158$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240819$$CN$US$US
241310432$24131043$2$F$$20240726$20240724$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117243$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240729$$HP$US$US
241310441$24131044$1$I$$20240717$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114131$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240724$$HP$US$US
241310451$24131045$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117231$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240724$$HP$US$US
241310461$24131046$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117216$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240724$$CN$US$US
241310471$24131047$1$I$$20240715$20240724$20240724$PER$$US-TEVA-VS-3222401$TEVA$Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN. Relationship between Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular-Immunol-Inflamm 2023; 31 (5): 900-904.; Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN. Relationship between Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular-Immunol-Inflamm 2023; 31 (5): 9...$$$$$Y$$$20240724$$HP$US$US
241310483$24131048$3$F$20240325$20240826$20240724$20240830$30DAY$$US-AMGEN-USASP2024142601$AMGEN$$82$YR$E$M$Y$86.229$KG$20240830$$HP$US$US
241310491$24131049$1$I$20240626$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024144898$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241310501$24131050$1$I$20240720$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145314$AMGEN$$69$YR$E$F$Y$$$20240724$$CN$US$US
241310511$24131051$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024143123$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241310522$24131052$2$F$20200824$20240819$20240724$20240820$EXP$$DE-SANDOZ INC.-SDZ2024DE067339$SANDOZ$$51$YR$$M$Y$$$20240820$$HP$DE$DE
241310531$24131053$1$I$$20240716$20240724$20240724$EXP$$IN-KOANAAP-SML-IN-2024-00749$Unknown Manufacturer$Bhattacharjee U, Jandial A, Singh C, Lekshmon K, Mishra K, Sandal R. Pregnancy and long-term outcomes of female patients with chronic myeloid leukemia on tyrosine kinase inhibitors who experienced unplanned pregnancies. Leukemia Research. 2023 Aug 02;133(107367): 1-6. doi:10.1016/j.leukres.2023.107367.$$$A$F$Y$$$20240724$$MD$IN$IN
241310541$24131054$1$I$20240626$20240715$20240724$20240724$EXP$ES-AEMPS-1549106$ES-AMAROX PHARMA-AMR2024ES02309$HETERO$$83$YR$$M$Y$$$20240724$$PH$ES$ES
241310551$24131055$1$I$20240630$20240701$20240724$20240724$PER$$US-JNJFOC-20240703740$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$CN$US$US
241310562$24131056$2$F$$20240809$20240724$20240819$EXP$$US-TEVA-VS-3222399$TEVA$Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN. Relationship between Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular-Immunol-Inflamm 2023; 31 (5): 900-904.; Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN. Relationship between Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Ocular-Immunol-Inflamm 2023; 31 (5): 9...$$$$$Y$$$20240819$$HP$US$US
241310572$24131057$2$F$20190101$20240829$20240724$20240903$EXP$$CA-JNJFOC-20220640932$JOHNSON AND JOHNSON$$37$YR$A$F$Y$46$KG$20240903$$HP$CA$CA
241310582$24131058$2$F$$20240903$20240724$20240903$EXP$$AU-ALXN-202407OCE000935AU$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$MD$AU$AU
241310591$24131059$1$I$19950101$20240716$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036165$AUROBINDO$$44$YR$$M$Y$80$KG$20240724$$MD$FR$FR
241310601$24131060$1$I$$20240720$20240724$20240724$EXP$GB-MHRA-MED-202407201634330970-JDYGN$GB-MYLANLABS-2024M1068079$MYLAN$$60$YR$$F$Y$89$KG$20240724$$CN$GB$GB
241310611$24131061$1$I$$20240716$20240724$20240724$EXP$$US-KOANAAP-SML-US-2024-00751$Unknown Manufacturer$Kuraitis D, Bogner P, Gopalakrishnan D, Pei S. Relapse or recall Docetaxel-associated re-emergence of paraneoplastic dermatomyositis. JAAD-Case-Rep. 2024;50: 33-36. doi:10.1016/j.jdcr.2024.05.012.$68$YR$E$M$Y$$$20240724$$MD$US$US
241310621$24131062$1$I$$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2017-09811$AUROBINDO$Guerry M-J, Lemyze M.. Acute skin failure.. British Medical Journal.. 2012;00:1-5$54$YR$$M$Y$$$20240724$$MD$FR$FR
241310631$24131063$1$I$20240624$20240721$20240724$20240724$EXP$GB-MHRA-MED-202407211256251510-KJGCY$GB-MYLANLABS-2024M1068054$MYLAN$$64$YR$$M$Y$74$KG$20240724$$CN$GB$GB
241310641$24131064$1$I$20230805$20240714$20240724$20240724$EXP$$JP-ROCHE-10000031046$ROCHE$$68$YR$E$$Y$$$20240724$$MD$JP$JP
241310651$24131065$1$I$$20240723$20240724$20240724$PER$$US-HALEON-2188625$Haleon PLC$$$$$F$Y$$$20240724$$CN$US$US
241310661$24131066$1$I$$20240716$20240724$20240724$EXP$$CA-APOTEX-2024AP008496$APOTEX$$53$YR$$F$Y$98$KG$20240724$$HP$CA$CA
241310671$24131067$1$I$$20240722$20240724$20240724$EXP$$NVSC2024US151068$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241310681$24131068$1$I$20240614$20240716$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-035578$AUROBINDO$$60$YR$$M$Y$$$20240724$$MD$FR$FR
241310692$24131069$2$F$$20240820$20240724$20240827$EXP$$IN-VANTIVE-2024VAN018485$Vantive US Healthcare$$44$YR$$M$Y$$$20240827$$CN$IN$IN
241310701$24131070$1$I$$20240714$20240724$20240724$EXP$$KW-IHL-000591$INVENTIA HEALTHCARE$$16$YR$T$M$Y$$$20240720$$MD$KW$KW
241310713$24131071$3$F$$20240820$20240724$20240822$EXP$$US-ROCHE-10000031653$ROCHE$$49$YR$A$F$Y$$$20240822$$CN$US$US
241310721$24131072$1$I$$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036512$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:1-6$43$YR$$F$Y$$$20240724$$HP$FR$FR
241310734$24131073$4$F$$20240826$20240724$20240904$30DAY$$US-JNJFOC-20240745857$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$MD$US$US
241310741$24131074$1$I$$20240624$20240724$20240724$PER$$US-JNJFOC-20240665941$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$CN$US$US
241310751$24131075$1$I$$20240718$20240724$20240724$EXP$$US-JNJFOC-20240749590$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$MD$US$US
241310761$24131076$1$I$$20240715$20240724$20240724$PER$$US-RDY-SPO/USA/24/0010553$DR REDDYS$$$$$F$Y$$$20240724$$MD$US$US
241310771$24131077$1$I$$20240715$20240724$20240724$PER$$US-RDY-SPO/USA/24/0010554$DR REDDYS$$17$YR$T$M$Y$$$20240724$$HP$US$US
241310781$24131078$1$I$$20240709$20240724$20240724$PER$$US-RDY-LIT/USA/24/0010379$DR REDDYS$Kiskaddon AL, Wilsey M, Gonzalez-Gomez I, Laks J, Miles A, Carapellucci J. Basiliximab therapy for immune-mediated bowel disease in a pediatric heart transplant patient. Pediatric Transplantation. 27(2): e14443. doi:10.1111/petr.14443.$9$YR$C$F$Y$$$20240724$$HP$US$US
241310791$24131079$1$I$$20240715$20240724$20240724$EXP$$ZA-RDY-LIT/ZAF/24/0010697$DR REDDYS$Nkoane MA, Adefolalu AO. Rapid-onset diarrhoea in HIV patient: The importance of suspecting cholera in non-endemic areas. Southern African Journal of Infectious Diseases. 2024;39(1): doi:10.4102/sajid.v39i1.619.$48$YR$A$M$Y$$$20240724$$HP$ZA$ZA
241310801$24131080$1$I$20240201$20240722$20240724$20240724$EXP$FR-AFSSAPS-LM2024000413$FR-ABBVIE-5848367$ABBVIE$$52$YR$$F$Y$65$KG$20240724$$MD$FR$FR
241310811$24131081$1$I$20240626$20240715$20240724$20240724$EXP$FR-AFSSAPS-MP2024001119$FR-TEVA-VS-3221865$TEVA$$40$YR$$M$Y$$$20240724$$MD$FR$FR
241310823$24131082$3$F$20240711$20240805$20240724$20240809$30DAY$$US-AMGEN-USASP2024144124$AMGEN$$54$YR$A$M$Y$103.95$KG$20240809$$PH$US$US
241310831$24131083$1$I$20240718$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145281$AMGEN$$78$YR$E$$Y$$$20240724$$CN$US$US
241310841$24131084$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145990$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
241310861$24131086$1$I$20230101$20240719$20240724$20240724$EXP$GB-MHRA-MED-202407091817328230-QGMRC$GB-CHEPLA-2024009175$CHEPLAPHARM$$33$YR$$F$Y$125$KG$20240724$$CN$COUNTRY NOT SPECIFIED$GB
241310871$24131087$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117077$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240724$$CN$US$US
241310881$24131088$1$I$20230428$20240719$20240724$20240724$EXP$IT-MINISAL02-990532$IT-CHEPLA-2024007957$CHEPLAPHARM$$68$YR$$M$Y$$$20240724$$MD$COUNTRY NOT SPECIFIED$IT
241310891$24131089$1$I$20240620$20240716$20240724$20240724$EXP$ES-AEMPS-1539728$ES-ROCHE-10000028418$ROCHE$$81$YR$E$F$Y$50$KG$20240724$$PH$ES$ES
241310901$24131090$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A163239$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241310921$24131092$1$I$20240714$20240716$20240724$20240724$EXP$$CL-VANTIVE-2024VAN018372$Vantive US Healthcare$$68$YR$$F$Y$76$KG$20240724$$HP$CL$CL
241310931$24131093$1$I$20240101$20240716$20240724$20240724$EXP$$JP-AstraZeneca-2024A163274$ASTRAZENECA$$$$$$Y$$$20240724$$MD$JP$
241310941$24131094$1$I$$20240719$20240724$20240724$PER$$US-AstraZeneca-2024A165565$ASTRAZENECA$$$$$F$Y$53$KG$20240724$$CN$US$
241310953$24131095$3$F$20240101$20240819$20240724$20240902$EXP$$US-UCBSA-2024036319$UCB$$$$$F$Y$$$20240902$$HP$US$US
241310971$24131097$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116299$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240724$$CN$US$US
241310981$24131098$1$I$20230616$20240711$20240724$20240724$EXP$$TH-ROCHE-10000023665$ROCHE$$64$YR$A$$Y$$$20240724$$CN$TH$TH
241310991$24131099$1$I$20240701$20240717$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407011952$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240724$$CN$US$US
241311001$24131100$1$I$20240723$20240723$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015418$ELI LILLY AND CO$$$$$F$Y$$$20240724$$CN$US$US
241311011$24131101$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014408$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240724$$CN$US$US
241311021$24131102$1$I$20240720$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014443$ELI LILLY AND CO$$$$A$M$Y$$$20240724$$CN$US$US
241311031$24131103$1$I$20240716$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014099$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240724$$CN$US$US
241311041$24131104$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014682$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240724$$CN$US$US
241311051$24131105$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014160$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240724$$CN$US$US
241311061$24131106$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014064$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240724$$CN$US$US
241311071$24131107$1$I$20240601$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014588$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240724$$CN$US$US
241311081$24131108$1$I$20150801$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036514$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:1-6$50$YR$$M$Y$$$20240724$$HP$FR$FR
241311091$24131109$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145306$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241311101$24131110$1$I$20240601$20240717$20240724$20240724$EXP$$GB-JNJFOC-20240747142$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240724$$MD$GB$GB
241311111$24131111$1$I$$20240716$20240724$20240724$EXP$$PT-JNJFOC-20240747613$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240724$$MD$PT$PT
241311121$24131112$1$I$20240716$20240717$20240724$20240724$EXP$$ES-ABBVIE-5845762$ABBVIE$$73$YR$$F$Y$$$20240724$$CN$ES$ES
241311141$24131114$1$I$20240301$20240715$20240724$20240724$EXP$$US-ROCHE-10000027308$ROCHE$$70$YR$E$M$Y$$$20240724$$CN$US$US
241311151$24131115$1$I$$20240715$20240724$20240724$EXP$$NL-AUROBINDO-AUR-APL-2024-036177$AUROBINDO$Wichers R, Heller HM, van Veen S. Deciding on life-saving treatment after a violent suicide attempt: an ethical case report. General Psychiatry. 2024;37:e101409$39$YR$$M$Y$$$20240724$$HP$NL$NL
241311162$24131116$2$F$$20240715$20240724$20240812$EXP$$PT-TEVA-VS-3222163$TEVA$Marques J et al. Case of PJ.Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts.2024 May: 1220. POSA-144 - (4518).$79$YR$$F$Y$$$20240812$$MD$PT$PT
241311171$24131117$1$I$$20240715$20240724$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-036213$AUROBINDO$Sanchez A, Elliott EI, Wang P, Spichler-Moffarah A. Legionella pneumophila and Staphylococcus aureus co-infections in a patient with SARS-CoV-2. BMJ-Case-Rep. 2022;15No. 3$$$A$M$Y$$$20240724$$HP$US$US
241311181$24131118$1$I$20180101$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036510$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:1-6$27$YR$$M$Y$$$20240724$$HP$FR$FR
241311191$24131119$1$I$$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036502$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol Drug Saf. 2024;33:1-6$6$YR$$M$Y$$$20240724$$HP$FR$FR
241311202$24131120$2$F$20240123$20240909$20240724$20240917$EXP$$CA-CELLTRION INC.-2024CA003644$CELLTRION$$$$$$Y$$$20240917$$CN$CA$CA
241311211$24131121$1$I$20240723$20240723$20240724$20240724$EXP$$US-ROCHE-10000034357$ROCHE$$86$YR$E$M$Y$$$20240724$$CN$US$US
241311221$24131122$1$I$$20240715$20240724$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-035990$AUROBINDO$Oomrigar SC, Fernandez J, Rivera Ortiz C, Rajen H, Toll A, Perez Colome E, et al.. The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death.. Am-J-Respir-Crit-Care-Med. 2024$$$$F$Y$$$20240724$$HP$US$US
241311231$24131123$1$I$$20240716$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036207$AUROBINDO$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N, Pelletier R and al... A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).. Toxicologie Analytique + Clinique. 2023;35:376-394.$52$YR$$M$Y$$$20240724$$MD$FR$FR
241311241$24131124$1$I$$20240714$20240724$20240724$EXP$$LK-MPL-000052$MLV PHARMA$$56$YR$A$F$Y$$$20240716$$MD$LK$LK
241311251$24131125$1$I$$20240715$20240724$20240724$PER$$US-RDY-SPO/USA/24/0010551$DR REDDYS$$27$YR$A$F$Y$$$20240724$$HP$US$US
241311261$24131126$1$I$$20240714$20240724$20240724$EXP$$CN-VKT-000571$VKT PHARMA PRIVATE LIMITED$$50$YR$A$M$Y$$$20240717$$MD$CN$CN
241311271$24131127$1$I$$20240715$20240724$20240724$EXP$$US-TAKEDA-2024TUS071847$TAKEDA$$74$YR$$F$Y$$$20240724$$MD$US$US
241311281$24131128$1$I$$20240713$20240724$20240724$EXP$$CN-ROCHE-3577093$ROCHE$Wang R, Tan G, Lei D, Li Y, Gong J, Tang Y, et al. Risk of HBV reactivation in HCC patients undergoing combination therapy of PD-1 inhibitors and angiogenesis inhibitors in the antiviral era. Journal of Cancer Research and Clinical Oncology. 2024;150 (3):1-12. doi:10.1007/s00432-024-05677-7.$$$$$Y$$$20240724$$HP$CN$CN
241311291$24131129$1$I$20240401$20240717$20240724$20240724$EXP$NL-LRB-00981544$NL-GSK-NL2024090266$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$NL$NL
241311303$24131130$3$F$20240719$20240810$20240724$20240814$EXP$$US-ABBVIE-5846866$ABBVIE$$82$YR$$M$Y$91.171$KG$20240814$$CN$US$US
241311314$24131131$4$F$$20240819$20240724$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA067145$SANDOZ$$43$YR$$F$Y$96$KG$20240829$$HP$CA$CA
241311321$24131132$1$I$$20240717$20240724$20240724$EXP$$US-TAKEDA-2024TUS031904$TAKEDA$$$$$F$Y$$$20240724$$CN$US$US
241311331$24131133$1$I$$20240611$20240724$20240724$EXP$$IN-SA-2024SA207283$SANOFI AVENTIS$$$$$F$Y$$$20240724$$CN$IN$IN
241311341$24131134$1$I$20210101$20240110$20240724$20240724$EXP$$AT-SA-2024SA214576$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$HP$AT$AT
241311351$24131135$1$I$$20240712$20240724$20240724$EXP$$US-TEVA-VS-3221720$TEVA$$$$$F$Y$$$20240724$$MD$US$US
241311361$24131136$1$I$$20240719$20240724$20240724$EXP$$CO-TAKEDA-2024TUS074144$TAKEDA$$$$$F$Y$$$20240724$$HP$CO$CO
241311381$24131138$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116753$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$80.29$KG$20240724$$CN$US$US
241311392$24131139$2$F$$20240819$20240724$20240828$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-113895$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240828$$MD$ES$ES
241311404$24131140$4$F$20240910$20240916$20240724$20240925$EXP$$VN-ROCHE-10000031933$ROCHE$$64$YR$A$F$Y$$$20240925$$MD$VN$VN
241311411$24131141$1$I$$20240722$20240724$20240724$EXP$$CA-UCBSA-2024037210$UCB$$$$$F$Y$$$20240724$$CN$CA$CA
241311421$24131142$1$I$$20240711$20240724$20240724$EXP$$FR-TEVA-VS-3222077$TEVA$$$$$F$Y$$$20240724$$CN$FR$FR
241311431$24131143$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458526$RANBAXY$Supron AD, Bergmark RW, Roditi RE, Buchheit KM. Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth. Ann Allergy Asthma Immunol. 2023;131 (3):384-386$26$YR$$F$Y$$$20240724$$MD$US$US
241311442$24131144$2$F$$20240913$20240724$20240927$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458320$RANBAXY$Krzystanek M, Martyniak E, Palasz A, Skalacka K, Chwalba A, Wierzbinski P. Amantadine in Treatment of Dysthymia-The Pilot Case Series Study. Pharmaceuticals. 2023;16(6):no pagination$34$YR$$M$Y$$$20240927$$HP$PL$PL
241311451$24131145$1$I$$20240709$20240724$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458256$RANBAXY$Bisht K, Mohan B, Jatteppanavar B, Sony HT, Handu S, Dhar M. An observational study of root-cause analysis of medication errors in elderly with methotrexate toxicity. Expert Opin Drug Saf. 2024;23(5):593-597$$$E$F$Y$$$20240724$$HP$IN$IN
241311471$24131147$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458410$RANBAXY$Clancy CJ, Chen L, Shields RK, Zhao Y, Cheng S, Chavda KD, et al. Epidemiology and Molecular Characterization of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae in Transplant Recipients. Am J Transplant. 2013;13(10):2619-2633$42$YR$$F$Y$$$20240724$$HP$US$US
241311481$24131148$1$I$$20240709$20240724$20240724$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457944$RANBAXY$Wojtowicz A, Undas A, Huras H, Musial J, Rytlewski K, Reron A, et al. Aspirin resistance may be associated with adverse pregnancy outcomes. Neuro Endocrinol Lett. 2011;32(3):334-339$$$A$F$Y$$$20240724$$HP$PL$PL
241311491$24131149$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457763$RANBAXY$Supron AD, Bergmark RW, Roditi RE, Buchheit KM. Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth. Ann Allergy Asthma Immunol. 2023;131 (3):384-386$59$YR$$F$Y$$$20240724$$MD$US$US
241311501$24131150$1$I$$20240709$20240724$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458253$RANBAXY$Bisht K, Mohan B, Jatteppanavar B, Sony HT, Handu S, Dhar M. An observational study of root-cause analysis of medication errors in elderly with methotrexate toxicity. Expert Opin Drug Saf. 2024;23(5):593-597$$$E$M$Y$$$20240724$$HP$IN$IN
241311511$24131151$1$I$$20240709$20240724$20240724$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457729$RANBAXY$Rossignon P, Nguyen LDK, Boegner P, Ku J, Herpain A. Refractory insulin resistance and hemophagocytic lymphohistiocytosis following enfortumab vedotin treatment A case report. Molecular and Clinical Oncology. 2024;20 (44):1-7$56$YR$$M$Y$$$20240724$$HP$BE$BE
241311521$24131152$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458474$RANBAXY$Bradshaw S, Oertling E, Rezigh A. Synchronous visceral Kaposi sarcoma and extracavitary primary effusion lymphoma in a patient with AIDS. BMJ Case Rep. 2022;15:e245306$3$DEC$$M$Y$$$20240724$$HP$US$US
241311532$24131153$2$F$$20240813$20240724$20240828$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458391$RANBAXY$$$$$M$Y$$$20240828$$PH$GB$GB
241311541$24131154$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458521$RANBAXY$Supron AD, Bergmark RW, Roditi RE, Buchheit KM. Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth. Ann Allergy Asthma Immunol. 2023;131 (3):384-386$34$YR$$M$Y$$$20240724$$MD$US$US
241311551$24131155$1$I$$20240709$20240724$20240724$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458479$RANBAXY$Endo Y, Inoue K, Katsuta T, Tachibana S, Kondo H, Nakamura J, et al. Two Cases of EGFR-mutated Non-small-cell Lung Cancer Treated with Erlotinib+Ramucirumab After Osimertinib-induced Lung Injury. Haigan. 2024;64 (3):186-192$77$YR$$F$Y$$$20240724$$HP$JP$JP
241311561$24131156$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458522$RANBAXY$Supron AD, Bergmark RW, Roditi RE, Buchheit KM. Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth. Ann Allergy Asthma Immunol. 2023;131 (3):384-386$16$YR$$F$Y$$$20240724$$MD$US$US
241311572$24131157$2$F$$20240724$20240724$20240808$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458482$RANBAXY$Oakman G, Ong C. Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Overlap IgA Nephropathy: A Case Report. Case Rep Nephrol Dialysis. 2024;14:36-41$26$YR$$F$Y$$$20240808$$HP$AU$AU
241311581$24131158$1$I$$20240709$20240724$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458238$RANBAXY$Bisht K, Mohan B, Jatteppanavar B, Sony HT, Handu S, Dhar M. An observational study of root-cause analysis of medication errors in elderly with methotrexate toxicity. Expert Opin Drug Saf. 2024;23(5):593-597$$$E$F$Y$$$20240724$$HP$IN$IN
241311591$24131159$1$I$$20240709$20240724$20240724$EXP$$QA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458344$RANBAXY$Abdulgayoom M, Soliman D, Helmy A, Haroon A, Telfah H, Ghasoub R, et al. Relapsed IgA Multiple Myeloma as Testicular Plasmacytoma after Quadrable Novel Therapy and Autologous Stem Cell Transplant: A Rare Case Report and Literature Review. Case Rep Oncol. 2024;17(1):291-297$39$YR$$M$Y$$$20240724$$HP$QA$QA
241311601$24131160$1$I$20200101$20240722$20240724$20240724$EXP$$JP-ASTELLAS-2024JP003502$ASTELLAS$$86$YR$$M$Y$$$20240724$$MD$JP$JP
241311611$24131161$1$I$$20240709$20240724$20240724$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457976$RANBAXY$Yamagishi H, Sekiguchi N, Hirano A, Oshima A, Imai T. Metformin associated Lactic Acidosis Induced by Excessive Alcohol Consumption. The Japanese Society of Internal Medicine. 2024;63 (12):1745-1749$65$YR$$M$Y$50$KG$20240724$$HP$JP$JP
241311621$24131162$1$I$$20240709$20240724$20240724$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457943$RANBAXY$Wojtowicz A, Undas A, Huras H, Musial J, Rytlewski K, Reron A, et al. Aspirin resistance may be associated with adverse pregnancy outcomes. Neuro Endocrinol Lett. 2011;32(3):334-339$$$A$F$Y$$$20240724$$HP$PL$PL
241311631$24131163$1$I$$20240709$20240724$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458251$RANBAXY$Bisht K, Mohan B, Jatteppanavar B, Sony HT, Handu S, Dhar M. An observational study of root-cause analysis of medication errors in elderly with methotrexate toxicity. Expert Opin Drug Saf. 2024;23(5):593-597$$$E$M$Y$$$20240724$$HP$IN$IN
241311641$24131164$1$I$$20240709$20240724$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457849$RANBAXY$PC A, Nambiar PN, KM N, Aslam S, NC K, Pillai DP, Sureshbabu S. New Onset Encephalopathy with Toxic Triphasic Waves. Int J Ep. 2022;8:77-80$69$YR$$F$Y$$$20240724$$HP$IN$IN
241311651$24131165$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458523$RANBAXY$Supron AD, Bergmark RW, Roditi RE, Buchheit KM. Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth. Ann Allergy Asthma Immunol. 2023;131 (3):384-386$59$YR$$F$Y$$$20240724$$MD$US$US
241311661$24131166$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458365$RANBAXY$Raza HS, Love JS, Mikolajczyk AE. Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding. ACG Case Rep J. 2024;11 (6):e01378$38$YR$$M$Y$$$20240724$$MD$US$US
241311671$24131167$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458349$RANBAXY$Cardona Quinones RA, Salem Hernandez SA, Sekimitsu S, Antongiorgi Torres J, Yerstein O, Safar LT.. neuropsychiatric case of delayed post-hypoxic leukoencephalopathy from opioid intoxication resulting in Anton-Babinski syndrome and quadriplegia. NEUROCASE. 2023;29 (5):160-166$26$YR$$M$Y$$$20240724$$HP$US$US
241311681$24131168$1$I$$20240709$20240724$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458255$RANBAXY$Bisht K, Mohan B, Jatteppanavar B, Sony HT, Handu S, Dhar M. An observational study of root-cause analysis of medication errors in elderly with methotrexate toxicity. Expert Opin Drug Saf. 2024;23(5):593-597$$$E$M$Y$$$20240724$$HP$IN$IN
241311692$24131169$2$F$$20240716$20240724$20240731$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457821$RANBAXY$Bhattacharjee U, Jandial A, Singh C, Lekshmon KS, Mishra K, Sandal R, et al. Pregnancy and long-term outcomes of female patients with chronic myeloid leukemia on tyrosine kinase inhibitors who experienced unplanned pregnancies. Leuk Res. 2023;OCT; 133:107367/1-7$$$$F$Y$$$20240731$$HP$IN$IN
241311701$24131170$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458340$RANBAXY$Herzberg SD, Bosso AM, Sangal NR, Bosso JV. Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2023;131 (4):528-530$$$$F$Y$$$20240724$$HP$US$US
241311711$24131171$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458525$RANBAXY$Supron AD, Bergmark RW, Roditi RE, Buchheit KM. Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth. Ann Allergy Asthma Immunol. 2023;131 (3):384-386$56$YR$$M$Y$$$20240724$$MD$US$US
241311721$24131172$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458341$RANBAXY$Herzberg SD, Bosso AM, Sangal NR, Bosso JV. Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2023;131 (4):528-530$13$YR$$F$Y$$$20240724$$HP$US$US
241311731$24131173$1$I$$20240709$20240724$20240724$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458064$RANBAXY$Dias e SilvaD, Borba GB, Beal JR, Botrus G, Osawa A, Araujo SEA, et al. Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report. Int J Molecular Sci. 2023;24 (4):4209(1-9)$60$YR$$M$Y$$$20240724$$HP$BR$BR
241311741$24131174$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458413$RANBAXY$Clancy CJ, Chen L, Shields RK, Zhao Y, Cheng S, Chavda KD, et al. Epidemiology and Molecular Characterization of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae in Transplant Recipients. Am J Transplant. 2013;13(10):2619-2633$64$YR$$M$Y$$$20240724$$HP$US$US
241311751$24131175$1$I$$20240709$20240724$20240724$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457521$RANBAXY$Kim MY, Jung SY, Hong S, Oh SW, Jin KN, Kim JE, et al. Establishment and characterization of BMCPDC-019: a novel patient-derived cell line of EGFR-mutant pulmonary adenocarcinoma transformed into small-cell lung cancer. Hum Cell. 2023;36:2179-2186$58$YR$$F$Y$$$20240724$$HP$KR$KR
241311761$24131176$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458567$RANBAXY$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clin Toxicol (Phila). 2024;62 (5):296-302$21$YR$$F$Y$$$20240724$$HP$US$US
241311771$24131177$1$I$$20240709$20240724$20240724$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458436$RANBAXY$Barrault C, Alqallaf S, Lison H, Lamote-Chaouche I, Bourcier V, Laugier J, et al. Baclofen Combined With Psychosocial Care is Useful and Safe in Alcohol-Related Cirrhosis Patients: A Real-Life Multicenter Study. Alcohol and Alcoholism. 2023;58 (2):117-124$$$$$Y$$$20240724$$HP$FR$FR
241311781$24131178$1$I$$20240709$20240724$20240724$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458004$RANBAXY$Georgery M, Ram A, Van Meerhaeghe T, Drowart A, Clause A-L, Lago LD, et al. Occurrence of Fatal Tubulopathy in an Old, Fit Patient Receiving Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report. Case Rep Oncol. 2024;17 (1):239-246$79$YR$$F$Y$$$20240724$$HP$BE$BE
241311791$24131179$1$I$20240624$20240709$20240724$20240724$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458428$RANBAXY$$76$YR$$F$Y$67$KG$20240724$$MD$GB$GB
241311801$24131180$1$I$$20240709$20240724$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458250$RANBAXY$Bisht K, Mohan B, Jatteppanavar B, Sony HT, Handu S, Dhar M. An observational study of root-cause analysis of medication errors in elderly with methotrexate toxicity. Expert Opin Drug Saf. 2024;23(5):593-597$$$E$F$Y$$$20240724$$HP$IN$IN
241311811$24131181$1$I$$20240709$20240724$20240724$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458107$RANBAXY$Mruzek H, Hubska J, Roslon M, Ambroziak U. A 21-year-old woman with suspected adrenal insufficiency. Med Prak. 2024;6:87-91$21$YR$$F$Y$$$20240724$$HP$PL$PL
241311821$24131182$1$I$$20240709$20240724$20240724$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458332$RANBAXY$Li XF, Zhang YP, Wei LL, Wang ZJ, Yang MQ. SMARCA4?deficient uterine adnexal tumor with ascites: A case report and literature review. Oncol Lett. 2024;28:357; 1-8$64$YR$$F$Y$$$20240724$$HP$CN$CN
241311832$24131183$2$F$$20240718$20240724$20240802$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458270$RANBAXY$Skoropad VY, Mironova DY, Kolobaev IV, Ivanov SA, Kaprin AD.. Toxicity analysis during neoadjuvant induction chemotherapy and subsequent chemoradiotherapy in patients with locally advanced gastric cancer. Onkol Zhur Imen Gerc. 2024;13 (2):15-20$$$$$Y$$$20240802$$HP$RU$RU
241311841$24131184$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457741$RANBAXY$Herzberg SD, Bosso AM, Sangal NR, Bosso JV. Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2023;131 (4):528-530$$$$F$Y$$$20240724$$HP$US$US
241311851$24131185$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458493$RANBAXY$Hoang S, Pujar T, Bellorin-Font E, Edwards JC, Miyata KN. A case of ifosfamide induced acute kidney injury, Fanconi syndrome, and nephrogenic diabetes insipidus. CEN Case Rep. 2024;13 (3):194-198$54$YR$$M$Y$$$20240724$$HP$US$US
241311861$24131186$1$I$$20240709$20240724$20240724$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457942$RANBAXY$Wojtowicz A, Undas A, Huras H, Musial J, Rytlewski K, Reron A, et al. Aspirin resistance may be associated with adverse pregnancy outcomes. Neuro Endocrinol Lett. 2011;32(3):334-339$$$A$F$Y$$$20240724$$HP$PL$PL
241311871$24131187$1$I$$20240709$20240724$20240724$EXP$$JO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458361$RANBAXY$Qusai AlJarrah, Saleh A. Ba-shammakh, Mohammed Z. Allouh, Mohammed W. Afaneh. Blue Toe Syndrome in Behcet?s Disease: A Case Report. Am J Case Rep. 2024;25 (0):no pagination$51$YR$$M$Y$$$20240724$$HP$JO$JO
241311881$24131188$1$I$$20240709$20240724$20240724$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458442$RANBAXY$Chiavarino F, Pruccoli J, Cecconi I, Vancini N, Cordelli DM, Parmeggiani A. Eating disorders in young patients with neurofibromatosis type 1. J Paediatr Child Health. 2023;59 (5):723-728$15$YR$$F$Y$$$20240724$$HP$IT$IT
241311891$24131189$1$I$$20240711$20240724$20240724$EXP$$JP-TEVA-VS-3224113$TEVA$$$$$$Y$$$20240724$$PH$JP$JP
241311901$24131190$1$I$$20240709$20240724$20240724$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457931$RANBAXY$Wojtowicz A, Undas A, Huras H, Musial J, Rytlewski K, Reron A, et al. Aspirin resistance may be associated with adverse pregnancy outcomes. Neuro Endocrinol Lett. 2011;32(3):334-339$$$A$F$Y$$$20240724$$HP$PL$PL
241311911$24131191$1$I$$20240709$20240724$20240724$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457941$RANBAXY$Wojtowicz A, Undas A, Huras H, Musial J, Rytlewski K, Reron A, et al. Aspirin resistance may be associated with adverse pregnancy outcomes. Neuro Endocrinol Lett. 2011;32(3):334-339$$$A$F$Y$$$20240724$$HP$PL$PL
241311921$24131192$1$I$20230826$20240717$20240724$20240724$EXP$$CA-GSK-CA2023119082$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$CA$CA
241311942$24131194$2$F$20240215$20240718$20240724$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458008$RANBAXY$$58$YR$$M$Y$64$KG$20240802$$CN$GB$GB
241311951$24131195$1$I$$20240719$20240724$20240724$EXP$$US-ORGANON-O2407USA002111$ORGANON$$$$$F$Y$$$20240724$$CN$US$US
241311961$24131196$1$I$$20240715$20240724$20240724$EXP$$US-GSK-US2024088697$GLAXOSMITHKLINE$$$$$F$Y$$$20240724$$HP$US$US
241311971$24131197$1$I$20240712$20240715$20240724$20240724$EXP$$US-GSK-US2024088733$GLAXOSMITHKLINE$$24$YR$$F$Y$$$20240724$$CN$US$US
241311981$24131198$1$I$$20240709$20240724$20240724$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458389$RANBAXY$$93$YR$$M$Y$$$20240724$$MD$GB$GB
241311991$24131199$1$I$$20240722$20240724$20240724$EXP$$CA-Orion Corporation ORION PHARMA-24_00031001$ORION$$72$YR$E$M$Y$$$20240724$$HP$CA$
241312001$24131200$1$I$$20240710$20240724$20240724$EXP$$ZA-ROCHE-10000026795$ROCHE$$$$A$F$Y$$$20240724$$CN$ZA$ZA
241312011$24131201$1$I$20240721$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145690$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241312032$24131203$2$F$20240719$20240813$20240724$20240816$PER$$US-AMGEN-USASP2024144438$AMGEN$$67$YR$E$M$Y$$$20240816$$CN$US$US
241312042$24131204$2$F$20240718$20240726$20240724$20240731$PER$$US-AMGEN-USASP2024143314$AMGEN$$29$YR$A$F$Y$$$20240730$$PH$US$US
241312053$24131205$3$F$20240528$20240902$20240724$20240913$EXP$$GR-Accord-436524$ACCORD$$66$YR$E$F$Y$68$KG$20240913$$HP$GR$GR
241312061$24131206$1$I$$20240716$20240724$20240724$EXP$CA-MHPD-E2B_07114432$CA-Accord-436755$ACCORD$$67$YR$E$M$Y$$$20240724$$HP$CA$CA
241312071$24131207$1$I$$20240712$20240724$20240724$EXP$AU-TGA-805025$AU-Accord-435526$ACCORD$$4$YR$C$F$Y$$$20240724$$HP$AU$AU
241312091$24131209$1$I$20240117$20240718$20240724$20240724$EXP$DE-EMA-2024713-AUTODUP-1720821902358$DE-Accord-437657$ACCORD$$67$YR$E$F$Y$61$KG$20240724$$MD$DE$DE
241312101$24131210$1$I$$20240716$20240724$20240724$EXP$CA-MHPD-E2B_07109130$CA-Accord-436753$ACCORD$$67$YR$E$M$Y$$$20240724$$MD$CA$CA
241312111$24131211$1$I$$20240713$20240724$20240724$EXP$AU-TGA-809426$AU-Accord-435668$ACCORD$$48$YR$A$F$Y$$$20240724$$HP$AU$AU
241312121$24131212$1$I$20230101$20240719$20240724$20240724$EXP$$CA-Orion Corporation ORION PHARMA-24_00030985$ORION$$73$YR$E$F$Y$$$20240724$$HP$CA$
241312131$24131213$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50795$$FDA-CTU$$$$$M$N$$$20240723$N$HP$US$
241312142$24131214$2$F$20230101$20240828$20240724$20240906$EXP$$CA-CELLTRION INC.-2023CA019886$CELLTRION$$$$$$Y$$$20240906$$MD$CA$CA
241312151$24131215$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50780$$FDA-CTU$$71$YR$$F$N$$$20240723$N$$US$
241312161$24131216$1$I$$20240719$20240724$20240724$EXP$$ZA-AstraZeneca-2024A165664$ASTRAZENECA$$96$YR$$M$Y$$$20240724$$CN$ZA$
241312171$24131217$1$I$$20240719$20240724$20240724$EXP$$ZA-AstraZeneca-2024A165644$ASTRAZENECA$$88$YR$$F$Y$$$20240724$$CN$ZA$
241312182$24131218$2$F$$20240716$20240724$20240816$EXP$$RO-AstraZeneca-2024A165697$ASTRAZENECA$$$$$M$Y$$$20240816$$MD$RO$
241312192$24131219$2$F$$20240823$20240724$20240823$PER$$US-ALXN-202407USA001280US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241312201$24131220$1$I$$20240719$20240724$20240724$EXP$$IN-ASTELLAS-2024US021022$ASTELLAS$$$$$M$Y$$$20240724$$CN$IN$IN
241312211$24131221$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A163461$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241312231$24131223$1$I$20240610$20240719$20240724$20240724$EXP$$JP-ABBVIE-5836643$ABBVIE$$70$YR$$F$Y$$$20240724$$MD$JP$JP
241312242$24131224$2$F$20240704$20240820$20240724$20240827$PER$$US-ALXN-202407USA001271US$ALEXION PHARMACEUTICALS$$78$YR$$M$Y$$$20240827$$CN$US$US
241312261$24131226$1$I$$20240717$20240724$20240724$EXP$$IN-ROCHE-10000031619$ROCHE$$66$YR$E$F$Y$$$20240724$$CN$IN$IN
241312271$24131227$1$I$$20240714$20240724$20240724$EXP$$US-JNJFOC-20240749495$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$HP$US$US
241312281$24131228$1$I$20211101$20240718$20240724$20240724$EXP$$CN-ASTELLAS-2024US020832$ASTELLAS$$49$YR$$M$Y$$$20240724$$HP$CN$CN
241312294$24131229$4$F$$20240926$20240724$20240930$EXP$$NVSC2024US150213$NOVARTIS$$$$$F$Y$$$20241001$$CN$US$US
241312301$24131230$1$I$$20240709$20240724$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458252$RANBAXY$Bisht K, Mohan B, Jatteppanavar B, Sony HT, Handu S, Dhar M. An observational study of root-cause analysis of medication errors in elderly with methotrexate toxicity. Expert Opin Drug Saf. 2024;23(5):593-597$$$E$F$Y$$$20240724$$HP$IN$IN
241312311$24131231$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458553$RANBAXY$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clin Toxicol (Phila). 2024;62 (5):296-302$44$YR$$F$Y$$$20240724$$HP$US$US
241312321$24131232$1$I$20240703$20240709$20240724$20240724$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458398$RANBAXY$$48$YR$$M$Y$$$20240724$$HP$GB$GB
241312331$24131233$1$I$$20240709$20240724$20240724$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458446$RANBAXY$Chiavarino F, Pruccoli J, Cecconi I, Vancini N, Cordelli DM, Parmeggiani A. Eating disorders in young patients with neurofibromatosis type 1. J Paediatr Child Health. 2023;59 (5):723-728$14$YR$$F$Y$48$KG$20240724$$HP$IT$IT
241312341$24131234$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458524$RANBAXY$Supron AD, Bergmark RW, Roditi RE, Buchheit KM. Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth. Ann Allergy Asthma Immunol. 2023;131 (3):384-386$55$YR$$F$Y$$$20240724$$MD$US$US
241312351$24131235$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458514$RANBAXY$Supron AD, Bergmark RW, Roditi RE, Buchheit KM. Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth. Ann Allergy Asthma Immunol. 2023;131 (3):384-386$51$YR$$M$Y$$$20240724$$MD$US$US
241312361$24131236$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458418$RANBAXY$Obeng-Nyarko CN, Puerta Durango K, Jackson S, Rodriguez O, Mollanazar NK. Dupilumab for the treatment of pityriasis lichenoides chronica. JAAD Case Rep. 2024;50 (0):9-11$56$YR$$F$Y$$$20240724$$MD$US$US
241312371$24131237$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458570$RANBAXY$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clin Toxicol (Phila). 2024;62 (5):296-302$25$YR$$F$Y$$$20240724$$HP$US$US
241312381$24131238$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458505$RANBAXY$Kuraitis D, Bogner P, Gopalakrishnan D, Pei S. Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis. JAAD Case Rep. 2024;Aug; 50 (0):33-36$68$YR$$M$Y$$$20240724$$MD$US$US
241312391$24131239$1$I$$20240709$20240724$20240724$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457915$RANBAXY$Burgener A-V, Seth-Smith HMB,Kern-Baumann S, Durovic A,Blaich A, Menter T, et al.. A Case Study of Zoonotic Chlamydia abortus Infection: Diagnostic Challenges From Clinical and Microbiological Perspectives. Open Forum Infect Dis. 2022;9(10):ofac524(1-5)$33$YR$$F$Y$$$20240724$$MD$CH$CH
241312401$24131240$1$I$$20240709$20240724$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458258$RANBAXY$Nair SM, Sahu A, Prasad A, George AM, Goel A, Gupta T. Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report. Indian J Radiol Imag. 2024;34 (2):351-355$46$YR$$M$Y$$$20240724$$HP$IN$IN
241312411$24131241$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458510$RANBAXY$Nagi T, Barnes S, Weiss A. Rare Case of Endoscopically Diagnosed Ischemic Colitis Secondary to Chronic Phentermine Use. ACG Case Rep J. 2024;11 (6):e01363$48$YR$$F$Y$$$20240724$$MD$US$US
241312422$24131242$2$F$$20240822$20240724$20240906$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458449$RANBAXY$Endo Y, Inoue K, Katsuta T, Tachibana S, Kondo H, Nakamura J, et al. Two Cases of EGFR-mutated Non-small-cell Lung Cancer Treated with Erlotinib+Ramucirumab After Osimertinib-induced Lung Injury. Haigan. 2024;64 (3):186-192$63$YR$$M$Y$$$20240906$$HP$JP$JP
241312432$24131243$2$F$20230405$20240826$20240724$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457852$RANBAXY$Dai B, Jiang Y, Dai Y. Central Retinal Artery Occlusion after Peribulbar Injection of Triamcinolone Acetonide in Thyroid-associated Ophthalmopathy. J Craniofac Surg. 2024;Jul/Aug; 35(5):e482-e484$38$YR$$F$Y$$$20240909$$MD$CN$CN
241312441$24131244$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458571$RANBAXY$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clin Toxicol (Phila). 2024;62 (5):296-302$63$YR$$M$Y$$$20240724$$HP$US$US
241312451$24131245$1$I$$20240709$20240724$20240724$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458254$RANBAXY$Bisht K, Mohan B, Jatteppanavar B, Sony HT, Handu S, Dhar M. An observational study of root-cause analysis of medication errors in elderly with methotrexate toxicity. Expert Opin Drug Saf. 2024;23(5):593-597$$$E$F$Y$$$20240724$$HP$IN$IN
241312461$24131246$1$I$$20240709$20240724$20240724$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458572$RANBAXY$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clin Toxicol (Phila). 2024;62 (5):296-302$18$YR$$F$Y$$$20240724$$HP$US$US
241312471$24131247$1$I$$20240709$20240724$20240724$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458447$RANBAXY$Miyachi M, Sugimoto Y, Sugitatsu Y, Tomida A, Yoshida H, Tsuchiya K, et al. Entrectinib treatment induces a durable response against ARHGEF11::NTRK1 fusion gene-positive spinal cord diffuse pediatric-type high-grade glioma. Pediatr Blood Cancer. 2023;70 (10):1-3$5$YR$$M$Y$$$20240724$$HP$JP$JP
241312482$24131248$2$F$$20240904$20240724$20240923$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000454$BECTON DICKINSON$$$$$$Y$$$20240923$$CN$GB$GB
241312491$24131249$1$I$$20240715$20240724$20240724$30DAY$$US-GSK-US2024088755$GLAXOSMITHKLINE$$$$$F$Y$$$20240724$$CN$US$US
241312501$24131250$1$I$$20240718$20240724$20240724$EXP$$JP-ASTELLAS-2024JP005166$ASTELLAS$$83$YR$$M$Y$$$20240724$$PH$JP$JP
241312521$24131252$1$I$$20240717$20240724$20240724$EXP$$US-SA-2024SA215012$SANOFI AVENTIS$$$$E$M$Y$83$KG$20240724$$MD$US$US
241312531$24131253$1$I$$20240717$20240724$20240724$EXP$$CA-GSK-CA2024AMR090821$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$CA$CA
241312541$24131254$1$I$$20240718$20240724$20240724$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115498$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240724$$HP$CA$CA
241312551$24131255$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117608$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240724$$CN$US$US
241312561$24131256$1$I$$20240711$20240724$20240724$EXP$$IN-CIPLA LTD.-2024IN07681$CIPLA$$$$$$Y$$$20240724$$CN$IN$IN
241312571$24131257$1$I$$20240628$20240724$20240724$PER$$JP-WT-2024-079562$Waylis$$$$$M$Y$$$20240724$$CN$JP$JP
241312581$24131258$1$I$$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014025$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240724$$CN$US$US
241312591$24131259$1$I$$20240718$20240724$20240724$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407012667$ELI LILLY AND CO$Junge M, Tsokos M, Puschel K..Suicide by insulin injection in combination with B-blocker application..Forensic Science International 2000;113:457-460.DOI:doi.org/10.1016/j.forsciint.2024.112126$68$YR$E$M$Y$$$20240724$$MD$DE$DE
241312601$24131260$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015367$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240724$$CN$US$US
241312611$24131261$1$I$$20240718$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407012352$ELI LILLY AND CO$$41$YR$A$$Y$$$20240724$$LW$US$US
241312621$24131262$1$I$$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013359$ELI LILLY AND CO$$62$YR$A$$Y$$$20240724$$CN$US$US
241312631$24131263$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014276$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240724$$CN$US$US
241312641$24131264$1$I$20230601$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014557$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240724$$CN$US$US
241312651$24131265$1$I$20240720$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015305$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240724$$CN$US$US
241312661$24131266$1$I$20240101$20240719$20240724$20240724$EXP$$US-SA-2024SA206906$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240724$$MD$US$US
241312673$24131267$3$F$20240415$20240729$20240724$20240805$EXP$FR-AFSSAPS-AN2024000807$FR-SA-2024SA213300$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240805$$PH$FR$FR
241312681$24131268$1$I$20240521$20240718$20240724$20240724$EXP$FR-AFSSAPS-MA2024000982$FR-SA-2024SA211618$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240724$$MD$FR$FR
241312691$24131269$1$I$$20240716$20240724$20240724$EXP$CA-MHPD-E2B_07108378$CA-Accord-436757$ACCORD$$69$YR$E$M$Y$$$20240724$$HP$CA$CA
241312701$24131270$1$I$$20240713$20240724$20240724$EXP$AU-TGA-809282$AU-Accord-435603$ACCORD$$53$YR$A$M$Y$$$20240724$$HP$AU$AU
241312711$24131271$1$I$$20240716$20240724$20240724$EXP$CA-MHPD-E2B_07114422$CA-Accord-436767$ACCORD$$69$YR$E$F$Y$$$20240724$$HP$CA$CA
241312721$24131272$1$I$$20240713$20240724$20240724$EXP$AU-TGA-805027$AU-Accord-435596$ACCORD$$80$YR$E$F$Y$$$20240724$$HP$AU$AU
241312732$24131273$2$F$20240621$20240731$20240724$20240806$30DAY$$FR-JNJFOC-20240676974$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240806$$PH$FR$FR
241312751$24131275$1$I$20240710$20240712$20240724$20240724$EXP$$US-Accord-436247$ACCORD$$53$YR$A$F$Y$$$20240724$$HP$US$US
241312761$24131276$1$I$20240708$20240712$20240724$20240724$EXP$$US-Accord-436418$ACCORD$$54$YR$A$M$Y$$$20240724$$HP$US$US
241312771$24131277$1$I$20240709$20240713$20240724$20240724$EXP$$US-Accord-436291$ACCORD$$63$YR$A$F$Y$$$20240724$$HP$US$US
241312782$24131278$2$F$20240710$20240722$20240724$20240801$EXP$$US-Accord-436299$ACCORD$$19$YR$A$F$Y$$$20240801$$HP$US$US
241312791$24131279$1$I$20240624$20240716$20240724$20240724$EXP$GB-MHRA-MED-202407161310431130-BFNHC$GB-Accord-436639$ACCORD$$51$YR$A$F$Y$56$KG$20240724$$HP$GB$GB
241312802$24131280$2$F$20211001$20240718$20240724$20240727$EXP$ES-EMA-2024711-AUTODUP-1720726854969$ES-Accord-437665$ACCORD$$$$A$F$Y$$$20240726$$MD$ES$ES
241312811$24131281$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50801$$FDA-CTU$$78$YR$$M$N$$$20240723$N$$US$
241312822$24131282$2$F$$20240812$20240724$20240823$EXP$$JP-Accord-436125$ACCORD$Maruyama T, Kondo S, Nomura H. Case series of bradycardia, renal failure, atrioventricular nodal blockers, shock and hyperkalemia syndrome in patients with dementia. Geriatrics and Gerontology International. 2024;24(7):737-8.$94$YR$E$M$Y$47$KG$20240823$$MD$JP$JP
241312831$24131283$1$I$20201218$20240720$20240724$20240724$EXP$$NVSC2021AT036366$NOVARTIS$$$$A$F$Y$$$20240724$$MD$AT$AT
241312841$24131284$1$I$$20240718$20240724$20240724$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700789$MYOVANT SCIENCES$$$$$M$Y$$$20240724$$CN$US$US
241312852$24131285$2$F$20210101$20240722$20240724$20240731$EXP$$CN-Accord-436736$ACCORD$Cui HM, Shu XP, Wei ZQ, Wu XY. The ^appearing^ and ^disappearing^ ascites in the treatment of colorectal cancer: a case report. Front Oncol. 2024 Jun 27;14:1372812. doi: 10.3389/fonc.2024.1372812.$65$YR$E$M$Y$$$20240731$$HP$CN$CN
241312861$24131286$1$I$$20240716$20240724$20240724$EXP$$US-VIIV HEALTHCARE LIMITED-US2024089455$VIIV$$$$$M$Y$$$20240724$$HP$US$US
241312871$24131287$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090524$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241312881$24131288$1$I$$20240715$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089845$VIIV$$$$$M$Y$$$20240724$$HP$US$US
241312891$24131289$1$I$20240701$20240716$20240724$20240724$PER$$US-ROCHE-10000029260$ROCHE$$51$YR$A$M$Y$$$20240724$$CN$US$US
241312901$24131290$1$I$20240610$20240715$20240724$20240724$EXP$FR-AFSSAPS-GR2024000858$FR-TEVA-VS-3221885$TEVA$$42$YR$$F$Y$62$KG$20240724$$PH$FR$FR
241312912$24131291$2$F$20240618$20240719$20240724$20240730$EXP$$US-ROCHE-10000031728$ROCHE$$67$YR$E$M$Y$$$20240730$$MD$US$US
241312921$24131292$1$I$$20240719$20240724$20240724$EXP$$US-TAKEDA-2024TUS073570$TAKEDA$$$$$F$Y$$$20240724$$CN$US$US
241312941$24131294$1$I$$20240711$20240724$20240724$PER$$US-ALXN-202407USA000808US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
241312951$24131295$1$I$$20240719$20240724$20240724$EXP$$US-BEH-2024176017$CSL BEHRING$$68$YR$E$F$Y$138$KG$20240724$$CN$US$US
241312961$24131296$1$I$$20240709$20240724$20240724$EXP$$US-SHIELD THERAPEUTICS-US-STX-24-00168$IRON THERAPEUTICS$$71$YR$$M$Y$$$20240724$$CN$US$US
241312971$24131297$1$I$$20240715$20240724$20240724$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP008908$STRIDES$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B.. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series.. Clin-Transl-Gastroenterol. 2024;15(3)$54$YR$$F$Y$$$20240724$$MD$US$US
241312981$24131298$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR091352$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241312991$24131299$1$I$20240101$20240718$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114967$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240724$$HP$US$US
241313001$24131300$1$I$$20240718$20240724$20240724$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021667$UNITED THERAPEUTICS$$$$$F$Y$83.9$KG$20240724$$$US$US
241313011$24131301$1$I$$20240718$20240724$20240724$PER$$US-ABBVIE-5848223$ABBVIE$$$$$$Y$$$20240724$$CN$US$US
241313031$24131303$1$I$20240626$20240718$20240724$20240724$EXP$$JP-ABBVIE-5817514$ABBVIE$$30$YR$$M$Y$$$20240724$$PH$JP$JP
241313041$24131304$1$I$$20240618$20240724$20240724$EXP$$ZA-ROCHE-3064648$ROCHE$$$$A$F$Y$$$20240724$$CN$ZA$ZA
241313061$24131306$1$I$$20240711$20240724$20240724$EXP$$OM-MAIA Pharmaceuticals, Inc.-MAI202407-000023$MAIA PHARMACEUTICALS$$73$YR$E$F$Y$$$20240724$$HP$OM$
241313071$24131307$1$I$$20240711$20240724$20240724$EXP$$US-MAIA Pharmaceuticals, Inc.-MAI202407-000022$MAIA PHARMACEUTICALS$$$$C$$Y$$$20240724$$HP$US$
241313082$24131308$2$F$20240719$20240808$20240724$20240814$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-101334$REGENERON$$91$YR$$M$Y$$$20240814$$MD$JP$JP
241313091$24131309$1$I$20230528$20240713$20240724$20240724$EXP$$TH-ROCHE-10000033361$ROCHE$$$$$M$Y$$$20240724$$CN$TH$TH
241313101$24131310$1$I$$20240715$20240724$20240724$EXP$$CA-STRIDES ARCOLAB LIMITED-2024SP009073$STRIDES$Joyce S, Lea S, Woolner M, Leddy A.. Treatment of Gamma Hydroxybutyrate Withdrawal in a Pregnant Female: A Case Report.. J-Addict-Med. 2024;18 (3):342-344$$$I$M$Y$$$20240724$$MD$CA$CA
241313111$24131311$1$I$20220101$20240715$20240724$20240724$EXP$CN-MLMSERVICE-20240708-PI125005-00232-1$CN-STRIDES ARCOLAB LIMITED-2024SP009000$STRIDES$Li J, Wu Q, Guo X, Rong L, Fang Y.. Salvage treatment of ruxolitinib for refractory adenovirus-associated hemophagocytic syndrome post-haploidentical allogeneic stem cell transplantation: a case report.. Transl Pediatr. 2024;13(6):994-1000$11$YR$$M$Y$$$20240724$$MD$CN$CN
241313122$24131312$2$F$20240613$20240814$20240724$20240821$30DAY$$FR-JNJFOC-20240729118$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240821$$CN$FR$FR
241313131$24131313$1$I$20240717$20240717$20240724$20240724$EXP$$CA-JNJFOC-20240748277$JOHNSON AND JOHNSON$$54$YR$A$M$Y$89$KG$20240724$$CN$CA$CA
241313144$24131314$4$F$20240114$20240807$20240724$20240813$30DAY$$PL-JNJFOC-20240713499$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$PL$PL
241313151$24131315$1$I$$20240717$20240724$20240724$EXP$$US-MYLANLABS-2024M1068293$MYLAN$Sohal A, Kowdley KV. Complete Biochemical Remission with Oral Vancomycin in a Patient with Primary Sclerosing Cholangitis and High Serum Immunoglobulin G4 Levels. ACG-Case-Rep-J 2024; 11 (1): E01256.$20$YR$$M$Y$$$20240724$$MD$US$US
241313161$24131316$1$I$$20240717$20240724$20240724$EXP$$US-MYLANLABS-2024M1068225$MYLAN$Haynes TM, Kukuc L, Proute M, Fishberg R. A PCSK9 and APOB Double Heterozygote Presenting Phenotypically Similar to Homozygous Familial Hypercholesterolemia. Circulation 2023; 148 (Suppl.).$73$YR$$F$Y$$$20240724$$HP$US$US
241313171$24131317$1$I$$20240717$20240724$20240724$EXP$$IN-MYLANLABS-2024M1068394$MYLAN$Maheshwari MU, Shanmugasundaram N, Sankar K, Sekar M, Wong LS, Sabarathinam S, et al. Haloperidol-induced painless legs and moving toe syndrome in a schizophrenia patient: a case report. Future-Sci-OA 2024; 10 (1):.$45$YR$$F$Y$$$20240724$$HP$IN$IN
241313181$24131318$1$I$$20240719$20240724$20240724$PER$$US-TAKEDA-2024TUS073374$TAKEDA$$$$A$F$Y$$$20240724$$MD$US$US
241313191$24131319$1$I$$20240722$20240724$20240724$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136859$DAIICHI$$$$$F$Y$$$20240724$$CN$US$US
241313201$24131320$1$I$$20240722$20240724$20240724$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136869$DAIICHI$$$$$F$Y$$$20240724$$CN$US$US
241313211$24131321$1$I$$20240723$20240724$20240724$PER$$US-ROCHE-10000034308$ROCHE$$63$YR$A$F$Y$$$20240724$$HP$US$US
241313221$24131322$1$I$20240706$20240712$20240724$20240724$EXP$$TH-ROCHE-10000033289$ROCHE$$76$YR$E$M$Y$$$20240724$$CN$TH$TH
241313232$24131323$2$F$20240721$20240801$20240724$20240801$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041633$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240801$$PH$DE$DE
241313241$24131324$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50763$$FDA-CTU$$7$YR$$M$N$$$20240723$N$$US$
241313251$24131325$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50785$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241313261$24131326$1$I$$20240716$20240724$20240724$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP009091$STRIDES$Walle N, Dorr AA, Potente S, Schmidt PH, Schafer N.. The last resort-Suicide by taking pentobarbital. [German].. Rechtsmedizin. 2023;33(4):301-306$53$YR$$F$Y$$$20240724$$HP$DE$DE
241313271$24131327$1$I$20240618$20240715$20240724$20240724$EXP$FR-AFSSAPS-NC2024000815$FR-TEVA-VS-3221897$TEVA$$57$YR$$F$Y$$$20240724$$MD$FR$FR
241313281$24131328$1$I$$20240717$20240724$20240724$PER$$US-TAKEDA-2024TUS072844$TAKEDA$$$$A$F$Y$75$KG$20240724$$CN$US$US
241313291$24131329$1$I$$20240717$20240724$20240724$PER$$US-TAKEDA-2024TUS072638$TAKEDA$$37$YR$$M$Y$$$20240724$$MD$US$US
241313301$24131330$1$I$$20240716$20240724$20240724$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP009108$STRIDES$Dunn A, Wu N, Cordaro F.. Management of loperamide-related opioid use disorder with buprenorphine within an Australian context: A case report.. Drug-Alcohol-Rev. 2024;1-4$28$YR$$M$Y$$$20240724$$HP$AU$AU
241313321$24131332$1$I$$20240710$20240724$20240724$EXP$$US-ROCHE-10000028333$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241313331$24131333$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50737$$FDA-CTU$$45$YR$$F$N$$$20240723$N$$US$
241313341$24131334$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50700$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241313381$24131338$1$I$20240712$20240713$20240724$20240724$EXP$$US-Accord-436272$ACCORD$$45$YR$A$M$Y$$$20240724$$HP$US$US
241313391$24131339$1$I$20240704$20240712$20240724$20240724$EXP$$US-Accord-436263$ACCORD$$42$YR$A$M$Y$$$20240724$$HP$US$US
241313402$24131340$2$F$$20240722$20240724$20240801$EXP$$TR-Accord-436761$ACCORD$Gurbuz AF, Eryilmaz MK, Yildiz O, Kilinc F, Araz M, Artac M. Rare case of myelodysplastic syndrome with excess blasts 2 developing after adjuvant chemoradiotherapy for triple-negative breast cancer in a patient with Bloom syndrome. Strahlenther Onkol. 2024 Jul 12.$30$YR$A$F$Y$$$20240801$$MD$TR$TR
241313412$24131341$2$F$$20240718$20240724$20240730$EXP$$IR-Accord-436117$ACCORD$Sasani E, Khodavaisy S, Salehi M, Bagheri-Josheghani S, Abdorahimi M, Manshadi SAD, et al. Concomitant tuberculosis and aspergillosis in patients with COVID-19: a case report. Iranian Journal of Microbiology. 2024;16(3):428-33. DOI:10.18502/ijm.v16i3.15800.$51$YR$A$F$Y$$$20240730$$MD$IR$IR
241313422$24131342$2$F$$20240812$20240724$20240823$EXP$$JP-Accord-436124$ACCORD$Maruyama T, Kondo S, Nomura H. Case series of bradycardia, renal failure, atrioventricular nodal blockers, shock and hyperkalemia syndrome in patients with dementia. Geriatrics and Gerontology International. 2024;24(7):737-8$96$YR$E$F$Y$35$KG$20240823$$MD$JP$JP
241313431$24131343$1$I$$20240716$20240724$20240724$EXP$CA-MHPD-E2B_07108339$CA-Accord-436770$ACCORD$$71$YR$E$F$Y$$$20240724$$MD$CA$CA
241313452$24131345$2$F$20240710$20240722$20240724$20240801$EXP$$US-Accord-435798$ACCORD$$14$YR$T$M$Y$$$20240801$$HP$US$US
241313461$24131346$1$I$20240621$20240718$20240724$20240724$EXP$$FR-AMERICAN REGENT INC-2024002788$AMERICAN REGENT$$36$YR$$F$Y$98$KG$20240724$$MD$FR$FR
241313471$24131347$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151495$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241313483$24131348$3$F$$20240905$20240724$20240909$PER$$NVSC2024US151664$NOVARTIS$$$$$$Y$$$20240909$$MD$US$US
241313491$24131349$1$I$20240713$20240717$20240724$20240724$EXP$$NVSC2024US148389$NOVARTIS$$18$YR$$F$Y$$$20240724$$PH$US$US
241313503$24131350$3$F$$20240723$20240724$20240726$PER$$NVSC2024US151667$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241313511$24131351$1$I$$20240510$20240724$20240724$PER$$US-Breckenridge Pharmaceutical, Inc.-2159493$BRECKENRIDGE$$6$DEC$$M$Y$$$20240724$$$US$US
241313522$24131352$2$F$20240601$20240808$20240724$20240812$EXP$$US-ABBVIE-5847633$ABBVIE$$85$YR$$M$Y$$$20240812$$CN$US$US
241313531$24131353$1$I$$20240709$20240724$20240724$EXP$$US-Vitruvias Therapeutics-2159501$VITRUVIAS THERAPEUTICS$$$$$F$Y$$$20240724$$$US$US
241313541$24131354$1$I$$20240719$20240724$20240724$PER$$US-Mission Pharmacal Company-2159483$MISSION$$53$YR$$M$Y$$$20240724$$$US$US
241313551$24131355$1$I$20240601$20240720$20240724$20240724$EXP$$GR-ABBVIE-5848434$ABBVIE$$68$YR$$M$Y$59$KG$20240724$$CN$GR$GR
241313561$24131356$1$I$$20240709$20240724$20240724$EXP$$US-AptaPharma Inc.-2159508$APTAPHARMA$Abstract$61$YR$$M$Y$$$20240724$$$US$US
241313571$24131357$1$I$$20240717$20240724$20240724$EXP$$FR-MYLANLABS-2024M1067187$MYLAN$$83$YR$$$Y$$$20240724$$MD$FR$FR
241313581$24131358$1$I$20240523$20240717$20240724$20240724$EXP$FR-AFSSAPS-NT2024000800$FR-Accord-437075$ACCORD$$79$YR$E$F$Y$$$20240724$$MD$FR$FR
241313591$24131359$1$I$20240709$20240713$20240724$20240724$EXP$$US-Accord-436287$ACCORD$$31$YR$A$M$Y$$$20240724$$PH$US$US
241313611$24131361$1$I$$20240716$20240724$20240724$EXP$CA-MHPD-E2B_07114735$CA-Accord-436776$ACCORD$$71$YR$E$M$Y$$$20240724$$HP$CA$CA
241313621$24131362$1$I$20240711$20240713$20240724$20240724$EXP$$US-Accord-437004$ACCORD$$69$YR$E$M$Y$$$20240724$$PH$US$US
241313631$24131363$1$I$20240703$20240715$20240724$20240724$EXP$CN-HENLIUS-24CN015899$CN-Accord-437018$ACCORD$$68$YR$E$F$Y$53$KG$20240724$$MD$CN$CN
241313641$24131364$1$I$$20240716$20240724$20240724$EXP$$GR-AMGEN-GRCSP2024141003$AMGEN$$60$YR$A$F$Y$$$20240724$$MD$GR$GR
241313661$24131366$1$I$20240721$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50799$$FDA-CTU$$71$YR$$M$N$$$20240722$N$PH$US$
241313671$24131367$1$I$$20240713$20240724$20240724$EXP$AU-TGA-810101$AU-Accord-435604$ACCORD$$$$$F$Y$$$20240724$$HP$AU$AU
241313681$24131368$1$I$$20240626$20240724$20240724$PER$$US-Vitruvias Therapeutics-2159496$VITRUVIAS THERAPEUTICS$$$$$F$Y$$$20240724$$$US$US
241313691$24131369$1$I$$20240716$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114041$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240724$$CN$US$US
241313701$24131370$1$I$$20240716$20240724$20240724$PER$$US-Mission Pharmacal Company-2159486$MISSION$$30$YR$$F$Y$$$20240724$$$US$US
241313711$24131371$1$I$20240101$20240716$20240724$20240724$EXP$$JP-TEVA-VS-3223208$TEVA$$$$$M$Y$$$20240724$$CN$JP$JP
241313721$24131372$1$I$20240615$20240719$20240724$20240724$EXP$$AT-ABBVIE-5848466$ABBVIE$$78$YR$$M$Y$$$20240724$$CN$AT$AT
241313732$24131373$2$F$20240601$20240923$20240724$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114910$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240930$$PH$US$US
241313741$24131374$1$I$20240313$20240719$20240724$20240724$EXP$$NVSC2024US059130$NOVARTIS$$34$YR$$F$Y$$$20240724$$CN$US$US
241313751$24131375$1$I$$20240717$20240724$20240724$EXP$$BR-ABBVIE-5850274$ABBVIE$$56$YR$$F$Y$$$20240724$$MD$BR$BR
241313771$24131377$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014830$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240724$$CN$US$US
241313781$24131378$1$I$20240720$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013991$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240724$$CN$US$US
241313792$24131379$2$F$20240601$20240725$20240724$20240730$EXP$$FR-MYLANLABS-2024M1067192$MYLAN$$91$YR$$F$Y$56$KG$20240730$$MD$FR$FR
241313801$24131380$1$I$$20240715$20240724$20240724$EXP$$US-MYLANLABS-2024M1068121$MYLAN$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J-Ophthalmic-Inflamm-Infect 2024; 14.$50$YR$$M$Y$$$20240724$$HP$US$US
241313811$24131381$1$I$$20240715$20240724$20240724$EXP$$UG-MYLANLABS-2024M1068084$MYLAN$Nambuya M, Mayanja-Kizza H. A case report: recurrent anemia related to long term acyclovir use in a pregnant HIV infected Ugandan. Afr-Health-Sci 2024; 24 (1): 91-93.$19$YR$$F$Y$$$20240724$$HP$UG$UG
241313821$24131382$1$I$$20240715$20240724$20240724$EXP$$DE-MYLANLABS-2024M1067439$MYLAN$Rupprecht H. Accidental intoxication by fentanyl patch. MMW-Fortschr-Med 2023; 165 (4): 50-51.$80$YR$$F$Y$$$20240724$$MD$DE$DE
241313831$24131383$1$I$20240608$20240618$20240724$20240724$EXP$$US-The Mentholatum Company-2159503$MENTHOLATUM$$65$YR$$M$Y$$$20240724$$$US$US
241313841$24131384$1$I$$20240715$20240724$20240724$EXP$$AU-MYLANLABS-2024M1067831$MYLAN$Shah K, Wong J, Mac K, Lau NS, Wong VM, Makris A. Adrenal insufficiency in hemodialysis patients-An under-recognized problem: A case series. Hemodial-Int 2024; 28 (2): 229-232.$17$YR$$F$Y$$$20240724$$HP$AU$AU
241313851$24131385$1$I$$20240715$20240724$20240724$EXP$$US-MYLANLABS-2024M1068065$MYLAN$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J-Ophthalmic-Inflamm-Infect 2024; 14.$65$YR$$F$Y$$$20240724$$HP$US$US
241313861$24131386$1$I$$20240715$20240724$20240724$EXP$$US-MYLANLABS-2024M1068102$MYLAN$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J-Ophthalmic-Inflamm-Infect 2024; 14.$65$YR$$M$Y$$$20240724$$HP$US$US
241313871$24131387$1$I$$20240715$20240724$20240724$EXP$$US-MYLANLABS-2024M1068095$MYLAN$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J-Ophthalmic-Inflamm-Infect 2024; 14.$43$YR$$M$Y$$$20240724$$HP$US$US
241313881$24131388$1$I$$20240715$20240724$20240724$EXP$$AR-TAKEDA-2024TUS072693$TAKEDA$Rivero R, Strusberg I, Rousseau M, Yori S, Herrero CB, Joekes S, et al. Off label use of intravenous immunoglobulin g in a highly complex pediatric hospital in argentina a prospective observational study. Journal Of The School Of Medical Sciences Of Cordoba. 2024;81(2):254-69$$$$$Y$$$20240724$$HP$AR$AR
241313891$24131389$1$I$$20240715$20240724$20240724$EXP$$AR-TAKEDA-2024TUS072676$TAKEDA$Rivero R, Strusberg I, Rousseau M, Yori S, Herrero CB, Joekes S, et al. Off label use of intravenous immunoglobulin g in a highly complex pediatric hospital in argentina a prospective observational study. Journal Of The School Of Medical Sciences Of Cordoba. 2024;81(2):254-69$$$$F$Y$$$20240724$$HP$AR$AR
241313901$24131390$1$I$20240621$20240715$20240724$20240724$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159502$JIANGSU HANSOH PHARMACEUTICAL$$69$YR$$M$Y$50$KG$20240724$$MD$CN$CN
241313911$24131391$1$I$20240617$20240723$20240724$20240724$EXP$$DE-JNJFOC-20240762854$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240724$$MD$DE$DE
241313921$24131392$1$I$20240607$20240715$20240724$20240724$EXP$$MX-BIOVITRUM-2024-MX-010121$BIOVITRUM$$75$DY$$M$Y$4.6$KG$20240724$$CN$MX$MX
241313931$24131393$1$I$20221224$20240709$20240724$20240724$EXP$$US-Vitruvias Therapeutics-2159500$VITRUVIAS THERAPEUTICS$$32$YR$$F$Y$101.82$KG$20240724$$$US$US
241313941$24131394$1$I$20230322$20240709$20240724$20240724$EXP$$GB-Ascend Therapeutics US, LLC-2159478$ASCEND$$51$YR$$F$Y$$$20240724$$$GB$GB
241313951$24131395$1$I$$20240716$20240724$20240724$EXP$$CA-ROCHE-10000032027$ROCHE$$76$YR$E$F$Y$$$20240724$$CN$CA$CA
241313971$24131397$1$I$$20240715$20240724$20240724$PER$$US-Mission Pharmacal Company-2159484$MISSION$$54$YR$$F$Y$$$20240724$$$US$US
241313991$24131399$1$I$20231216$20240715$20240724$20240724$EXP$SE-SEMPA-2024-005369$SE-TEVA-VS-3221837$TEVA$$78$YR$$M$Y$$$20240724$$MD$SE$SE
241314011$24131401$1$I$$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116934$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240724$$HP$US$US
241314021$24131402$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117106$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240724$$CN$US$US
241314031$24131403$1$I$$20240715$20240724$20240724$30DAY$$US-GSK-US2024AMR088855$GLAXOSMITHKLINE$$$$$M$Y$$$20240724$$CN$US$US
241314041$24131404$1$I$20240523$20240717$20240724$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116379$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$56.9$KG$20240724$$PH$JP$JP
241314051$24131405$1$I$$20240709$20240724$20240724$EXP$$US-Zhejiang Jingxin Pharmaceutical Co., Ltd-2159512$ZHEJIANG JINGXIN PHARMACEUTICAL$Full text$20$YR$$M$Y$$$20240724$$$US$US
241314061$24131406$1$I$$20240717$20240724$20240724$EXP$$US-BAYER-2024A104585$BAYER$$$$$$Y$$$20240724$$HP$US$US
241314071$24131407$1$I$$20240528$20240724$20240724$PER$$US-Breckenridge Pharmaceutical, Inc.-2159498$BRECKENRIDGE$$$$$F$Y$$$20240724$$$US$US
241314081$24131408$1$I$20240312$20240312$20240724$20240724$PER$$US-Armstrong Pharmaceuticals, Inc.-2159492$ARMSTRONG$$$$$M$Y$$$20240724$$$US$US
241314092$24131409$2$F$20240701$20240724$20240724$20240802$PER$$US-AMGEN-USASP2024143839$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241314101$24131410$1$I$$20240714$20240724$20240724$EXP$$US-BEH-2024175774$CSL BEHRING$$$$A$F$Y$$$20240724$$CN$US$US
241314112$24131411$2$F$20240503$20240717$20240724$20240726$EXP$$GB-AUROBINDO-AUR-APL-2024-035783$AUROBINDO$$36$YR$$F$Y$62$KG$20240726$$CN$GB$GB
241314121$24131412$1$I$20240715$20240718$20240724$20240724$EXP$$CO-VANTIVE-2024VAN018409$Vantive US Healthcare$$38$YR$$M$Y$52$KG$20240724$$HP$CO$CO
241314131$24131413$1$I$20240625$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024143974$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241314142$24131414$2$F$20240718$20240815$20240724$20240817$PER$$US-AMGEN-USASP2024144871$AMGEN$$63$YR$A$M$Y$$$20240817$$CN$US$US
241314151$24131415$1$I$$20240722$20240724$20240724$EXP$$NVSJ2024JP008978$NOVARTIS$$$$E$F$Y$$$20240724$$MD$JP$JP
241314161$24131416$1$I$$20240717$20240724$20240724$EXP$$NVSC2024IR150448$NOVARTIS$Rahbar M, Latifi M, Pourhosein E, Mahmoudi E, Seyhoun I, Dehghani S.. Long-term graft survival in a kidney transplant recipient with glioblastoma:  Case report. TRANSPLANTATION REPORTS. 2024;9(3):1-3$61$YR$$F$Y$$$20240724$$HP$IR$IR
241314171$24131417$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145273$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241314191$24131419$1$I$20240620$20240717$20240724$20240724$EXP$$NVSJ2024JP007481$NOVARTIS$$56$YR$$F$Y$69.2$KG$20240724$$MD$JP$JP
241314201$24131420$1$I$$20240722$20240724$20240724$EXP$$NVSC2024US151128$NOVARTIS$$$$$F$Y$$$20240724$$HP$US$US
241314221$24131422$1$I$$20240723$20240724$20240724$EXP$$DZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041666$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240724$$PH$DZ$DZ
241314234$24131423$4$F$20240101$20240830$20240724$20240903$EXP$$US-JNJFOC-20240740947$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
241314241$24131424$1$I$20240716$20240717$20240724$20240724$EXP$$US-JNJFOC-20240745939$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240724$$CN$US$US
241314251$24131425$1$I$20240714$20240715$20240724$20240724$EXP$GB-MHRA-MED-202407151946562730-KMYRD$GB-TEVA-VS-3221755$TEVA$$45$YR$$M$Y$98$KG$20240724$$CN$GB$GB
241314261$24131426$1$I$$20240715$20240724$20240724$PER$$US-Mission Pharmacal Company-2159485$MISSION$$76$YR$$M$Y$$$20240724$$$US$US
241314271$24131427$1$I$20240704$20240715$20240724$20240724$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159515$JIANGSU HANSOH PHARMACEUTICAL$$43$YR$$F$Y$59.5$KG$20240724$$MD$CN$CN
241314281$24131428$1$I$$20240619$20240724$20240724$EXP$$US-Appco Pharma LLC-2159516$APPCO PHARMA$Initial$16$YR$$F$Y$$$20240724$$$US$US
241314295$24131429$5$F$20240101$20240912$20240724$20240918$EXP$$US-PUMA BIOTECHNOLOGY, LTD.-2024-PUM-US000712$PUMA$$$$$$Y$$$20240918$$HP$US$US
241314301$24131430$1$I$$20240709$20240724$20240724$EXP$$CH-AptaPharma Inc.-2159510$APTAPHARMA$Full text$41$YR$$M$Y$$$20240724$$$CH$CH
241314311$24131431$1$I$20240614$20240716$20240724$20240724$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159518$JIANGSU HANSOH PHARMACEUTICAL$$62$YR$$M$Y$57$KG$20240724$$MD$CN$CN
241314321$24131432$1$I$$20240619$20240724$20240724$EXP$$SE-Appco Pharma LLC-2159517$APPCO PHARMA$Initial$73$YR$$F$Y$$$20240724$$$SE$SE
241314331$24131433$1$I$$20240709$20240724$20240724$EXP$$TN-AptaPharma Inc.-2159509$APTAPHARMA$Abstract$57$YR$$F$Y$$$20240724$$$TN$TN
241314341$24131434$1$I$20240703$20240717$20240724$20240724$EXP$FR-AFSSAPS-MP2024001140$FR-MYLANLABS-2024M1067389$MYLAN$$21$YR$$F$Y$60$KG$20240724$$PH$FR$FR
241314351$24131435$1$I$$20240709$20240724$20240724$EXP$$CH-Guardian Drug Company-2159511$GUARDIAN PHARMACEUTICALS$Full text$41$YR$$M$Y$$$20240724$$$CH$CH
241314361$24131436$1$I$$20240709$20240724$20240724$EXP$$IT-WES Pharma Inc-2159514$WES PHARMA$Full text$70$YR$$M$Y$$$20240724$$$IT$IT
241314381$24131438$1$I$20240719$20240723$20240723$20240723$DIR$711154$$FDA-CTU$$66$YR$$M$N$76.5$KG$20240723$N$CN$US$
241314391$24131439$1$I$$20240723$20240723$20240723$DIR$711164$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241314401$24131440$1$I$$20240723$20240723$20240723$DIR$711165$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241314411$24131441$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50788$$FDA-CTU$$85$YR$$M$N$$$20240723$N$$US$
241314421$24131442$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50742$$FDA-CTU$$22$YR$$F$N$$$20240723$N$$US$
241314431$24131443$1$I$$20240619$20240724$20240724$EXP$$AU-Appco Pharma LLC-2159519$APPCO PHARMA$Initial$$$$$Y$$$20240724$$$AU$AU
241314441$24131444$1$I$20240719$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50755$$FDA-CTU$$54$YR$$M$N$$$20240723$N$$US$
241314481$24131448$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50707$$FDA-CTU$$58$YR$$F$N$80.29$KG$20240723$N$$US$
241314491$24131449$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50732$$FDA-CTU$$62$YR$$F$N$78.47$KG$20240723$N$$US$
241314501$24131450$1$I$$20240718$20240724$20240724$EXP$$NVSJ2024JP008847$NOVARTIS$$$$$$Y$$$20240724$$PH$JP$JP
241314511$24131451$1$I$20230101$20240718$20240724$20240724$EXP$$US-ABBVIE-5847677$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241314521$24131452$1$I$20240701$20240717$20240724$20240724$EXP$$JP-ARDELYX-2024ARDX005489$ARDELYX$$6$DEC$$M$Y$$$20240724$$PH$JP$JP
241314531$24131453$1$I$20240101$20240717$20240724$20240724$EXP$$JP-ARDELYX-2024ARDX005565$ARDELYX$$6$DEC$$M$Y$$$20240724$$MD$JP$JP
241314543$24131454$3$F$20220101$20240826$20240724$20240828$EXP$$NO-BAYER-2024A103916$BAYER$$30$YR$A$F$Y$$$20240828$$CN$NO$NO
241314553$24131455$3$F$$20240805$20240724$20240805$EXP$$UA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041672$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$100$KG$20240805$$HP$UA$UA
241314561$24131456$1$I$$20240716$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091182$VIIV$$$$$F$Y$$$20240724$$MD$US$US
241314572$24131457$2$F$20240605$20240917$20240724$20240930$EXP$$JP-ARDELYX-2024ARDX005567$ARDELYX$$52$YR$$M$Y$$$20240929$$HP$JP$JP
241314581$24131458$1$I$$20240718$20240724$20240724$EXP$$BR-TAKEDA-2024TUS073922$TAKEDA$$$$$M$Y$$$20240724$$CN$BR$BR
241314591$24131459$1$I$$20240722$20240724$20240724$PER$$US-JNJFOC-20240760891$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$CN$US$US
241314611$24131461$1$I$20240701$20240723$20240724$20240724$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034374$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240724$$CN$US$US
241314621$24131462$1$I$20240401$20240715$20240724$20240724$EXP$ES-AEMPS-1541457$ES-TEVA-VS-3221679$TEVA$$76$YR$$F$Y$$$20240724$$MD$ES$ES
241314631$24131463$1$I$$20240709$20240724$20240724$EXP$$IN-LEADINGPHARMA-IN-2024LEALIT00297$LEADING PHARMA$U. Gottam.Hydroxyurea Induced Interstitial Pneumonia: A Rare Clinical Entity.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A2018$63$YR$E$M$Y$$$20240724$$HP$IN$IN
241314641$24131464$1$I$$20240718$20240724$20240724$EXP$$BR-AMGEN-BRASP2024144208$AMGEN$$85$YR$E$F$Y$$$20240724$$PH$BR$BR
241314651$24131465$1$I$20240713$20240715$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-021764$UNITED THERAPEUTICS$$69$YR$$F$Y$$$20240724$$$US$US
241314671$24131467$1$I$$20240709$20240724$20240724$EXP$$CZ-TEVA-VS-3220951$TEVA$Hyanek J et al. MATERNALNI HYPERCHOLESTEROLEMIE: KASUISTIKA DOPLNENA AKTUALNI PERIKONCEPCNI PROBLEMATIKOU FAMILIARNI HYPERCHOLESTEROLEMIE. Ateroskleroza 2024; XXVIII (1-2): 2003?Hyanek J et al. MATERNAL HYPERCHOLESTEROLEMIA: A CASE REPORT ADDED WITH THE CURRENT PERICONCEPTION PROBLEMS OF FAMILIAL HYPERCHOLESTEROLEMIA. Ateroskleroza 2024; XXVIII (1-2): 2003; Hyanek J et al. MATERNALNI HYPERCHOLESTEROLEMIE: KASUISTIKA DOPLNENA AKTUALNI PERIKONCEPCNI PROBLEMATIKOU FAMILIARNI HYPERCHOLESTEROLEMIE...$32$YR$$F$Y$$$20240724$$MD$CZ$CZ
241314681$24131468$1$I$$20240703$20240724$20240724$EXP$$PL-UCBSA-2024018997$UCB$$$$$F$Y$$$20240724$$CN$PL$PL
241314691$24131469$1$I$20240710$20240717$20240724$20240724$EXP$$AR-BIOGEN-2024BI01274323$BIOGEN$$13$YR$$M$Y$$$20240724$$CN$AR$AR
241314701$24131470$1$I$$20240719$20240724$20240724$EXP$$GB-MYLANLABS-2024M1067767$MYLAN$$86$YR$$F$Y$68$KG$20240724$$HP$GB$GB
241314711$24131471$1$I$20240101$20240722$20240724$20240724$EXP$$US-ABBVIE-5850136$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241314721$24131472$1$I$$20240715$20240724$20240724$EXP$$BE-AUROBINDO-AUR-APL-2024-036446$AUROBINDO$Mertens B, Elkayal O, Dreesen E, Wauters J, Meersseman P, Debaveye Y, et al.. Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review. Antibiotics-(Basel). 2023;12(7)$61$YR$$M$Y$81.3$KG$20240724$$HP$BE$BE
241314741$24131474$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116967$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240724$$CN$US$US
241314752$24131475$2$F$20240705$20240816$20240724$20240822$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-114663$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240822$$MD$DE$DE
241314761$24131476$1$I$20240714$20240719$20240724$20240724$EXP$$NVSC2024US149641$NOVARTIS$$38$YR$$F$Y$$$20240724$$CN$US$US
241314771$24131477$1$I$20240410$20240716$20240724$20240724$EXP$GB-MHRA-MED-202407161256551910-ZSFGY$GB-TEVA-VS-3221953$TEVA$$$$$M$Y$$$20240724$$CN$GB$GB
241314782$24131478$2$F$$20240806$20240724$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-022208$UNITED THERAPEUTICS$$$$$F$Y$58.141$KG$20240810$$$US$US
241314801$24131480$1$I$20240711$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50711$$FDA-CTU$$73$YR$$M$N$$$20240723$N$HP$US$
241314811$24131481$1$I$$20240723$20240723$20240723$DIR$711166$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241314821$24131482$1$I$$20240718$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-022309$UNITED THERAPEUTICS$$$$$F$Y$103.4$KG$20240724$$$US$US
241314831$24131483$1$I$20240722$20240723$20240724$20240724$PER$$US-ROCHE-10000034574$ROCHE$$$$$F$Y$$$20240724$$CN$US$US
241314841$24131484$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014148$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240724$$CN$US$US
241314851$24131485$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014153$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240724$$CN$US$US
241314861$24131486$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014351$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240724$$CN$US$US
241314871$24131487$1$I$$20240709$20240724$20240724$EXP$$CN-LEADINGPHARMA-CN-2024LEALIT00309$LEADING PHARMA$$19$YR$A$M$Y$$$20240724$$HP$CN$CN
241314881$24131488$1$I$$20240714$20240724$20240724$EXP$NL-LRB-00982527$NL-Accord-436301$ACCORD$$48$YR$A$F$Y$$$20240724$$MD$NL$NL
241314892$24131489$2$F$20180718$20240722$20240724$20240802$EXP$AU-TGA-811490$AU-Accord-435608$ACCORD$$56$YR$A$F$Y$$$20240802$$HP$AU$AU
241314901$24131490$1$I$$20240712$20240724$20240724$EXP$AU-TGA-807054$AU-Accord-435518$ACCORD$$63$YR$A$F$Y$$$20240724$$HP$AU$AU
241314912$24131491$2$F$20180718$20240722$20240724$20240801$EXP$AU-TGA-810881$AU-Accord-435611$ACCORD$$56$YR$A$F$Y$$$20240801$$HP$AU$AU
241314921$24131492$1$I$20221201$20240718$20240724$20240724$EXP$MT-EMA-2024711-AUTODUP-1720726450335$MT-Accord-437661$ACCORD$$3$DEC$A$F$Y$$$20240724$$MD$MT$MT
241314931$24131493$1$I$$20240716$20240724$20240724$EXP$CA-MHPD-E2B_07108780$CA-Accord-436734$ACCORD$$59$YR$A$M$Y$$$20240724$$MD$CA$CA
241314941$24131494$1$I$$20240112$20240724$20240724$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67919$HIKMA$$$$$$Y$$$20240723$$PH$US$US
241314951$24131495$1$I$$20240603$20240724$20240724$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03719$HIKMA$$$$$$Y$$$20240723$$HP$US$US
241314962$24131496$2$F$20240701$20240718$20240724$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-022048$UNITED THERAPEUTICS$$73$YR$$F$Y$$$20240727$$$US$US
241314971$24131497$1$I$$20240713$20240724$20240724$EXP$AU-TGA-809154$AU-Accord-435615$ACCORD$$$$$M$Y$$$20240724$$HP$AU$AU
241314981$24131498$1$I$$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036001$AUROBINDO$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N and al... Chemsex in France: a national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).. Toxicologie Analytique + Clinique.. 2023;35:376-394$62$YR$$M$Y$$$20240724$$MD$FR$FR
241314991$24131499$1$I$$20240723$20240723$20240723$DIR$711167$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241315001$24131500$1$I$20240711$20240723$20240723$20240723$DIR$711162$$FDA-CTU$$69$YR$$F$N$70$KG$20240723$N$HP$US$
241315011$24131501$1$I$$20240715$20240724$20240724$PER$$US-IDORSIA-008260-2024-US$IDORSIA PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241315021$24131502$1$I$$20240709$20240724$20240724$PER$$US-IDORSIA-008239-2024-US$IDORSIA PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
241315031$24131503$1$I$$20240709$20240724$20240724$PER$$US-IDORSIA-008240-2024-US$IDORSIA PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
241315041$24131504$1$I$20240722$20240723$20240723$20240723$DIR$711163$$FDA-CTU$$52$YR$$F$N$72$KG$20240723$N$HP$US$
241315051$24131505$1$I$20240718$20240723$20240723$20240723$DIR$711171$$FDA-CTU$$73$YR$$M$N$$$20240723$Y$HP$US$
241315061$24131506$1$I$20240722$20240723$20240723$20240723$DIR$711173$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241315071$24131507$1$I$$20240719$20240724$20240724$EXP$$GB-MYLANLABS-2024M1068425$MYLAN$Rossi NP, Sathyanarayanan G, Mahmood M, Shakespeare D. Toxic leukoencephalopathy versus delayed post-hypoxic leukoencephalopathy after oral morphine sulphate overdose. BMJ-Case-Rep 2023; 16.$5$DEC$$M$Y$$$20240724$$HP$GB$GB
241315081$24131508$1$I$20240702$20240702$20240724$20240724$PER$$US-P+L Developments of Newyork Corporation-2159520$PL DEVELOPMENTS$$$$$$Y$$$20240724$$$US$US
241315091$24131509$1$I$20100921$20240722$20240724$20240724$EXP$$FR-ASTELLAS-2024US020879$ASTELLAS$$75$YR$$M$Y$53$KG$20240724$$HP$GB$FR
241315101$24131510$1$I$20240708$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144864$AMGEN$$58$YR$A$M$Y$$$20240724$$CN$US$US
241315111$24131511$1$I$20240412$20240723$20240723$20240723$DIR$711168$$FDA-CTU$$37$YR$$F$N$180.45$KG$20240723$N$MD$US$
241315121$24131512$1$I$$20240717$20240724$20240724$PER$$US-AMGEN-USASP2024146366$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241315131$24131513$1$I$20240718$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024143603$AMGEN$$21$YR$A$M$Y$$$20240724$$CN$US$US
241315141$24131514$1$I$20240504$20240719$20240724$20240724$EXP$$US-GSK-US2024091111$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241315151$24131515$1$I$$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036505$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:1-6$11$YR$$M$Y$$$20240724$$HP$FR$FR
241315161$24131516$1$I$20240707$20240715$20240724$20240724$EXP$$BR-CELLTRION INC.-2024BR017456$CELLTRION$$$$$$Y$$$20240724$$CN$BR$BR
241315172$24131517$2$F$$20240808$20240724$20240820$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090155$VIIV$$$$$F$Y$$$20240820$$PH$US$US
241315181$24131518$1$I$$20240715$20240724$20240724$EXP$$IN-ROCHE-10000024696$ROCHE$$74$YR$E$M$Y$$$20240724$$CN$IN$IN
241315191$24131519$1$I$20240613$20240722$20240724$20240724$EXP$$FR-GSK-FR2024GSK092067$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$FR$FR
241315201$24131520$1$I$20221201$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036516$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;2024:1-6$57$YR$$M$Y$$$20240724$$HP$FR$FR
241315212$24131521$2$F$$20240709$20240724$20240831$EXP$$GB-LEADINGPHARMA-GB-2024LEALIT00313$LEADING PHARMA$Nighat J. Nadeem.Case report: Diagnostic challenges in an adolescent case of autistic catatonia.Frontiers in Psychiatry.JAN-2024;12:1-7$15$YR$T$M$Y$$$20240831$$HP$GB$GB
241315221$24131522$1$I$20240710$20240712$20240724$20240724$EXP$$US-Accord-435858$ACCORD$$76$YR$E$M$Y$$$20240724$$HP$US$US
241315231$24131523$1$I$20240708$20240713$20240724$20240724$EXP$CN-HENLIUS-24CN015893$CN-Accord-437774$ACCORD$$48$YR$A$F$Y$69$KG$20240724$$MD$CN$CN
241315241$24131524$1$I$$20240713$20240724$20240724$EXP$GB-MHRA-MED-202407131625572030-BPNRG$GB-Accord-436373$ACCORD$$$$$$Y$$$20240724$$CN$GB$GB
241315251$24131525$1$I$20240714$20240714$20240724$20240724$EXP$GB-MHRA-MED-202407141136241030-SLPZT$GB-Accord-436380$ACCORD$$53$YR$A$M$Y$78$KG$20240724$$CN$GB$GB
241315262$24131526$2$F$$20240805$20240724$20240816$EXP$$US-Accord-436442$ACCORD$$$$$F$Y$66.68$KG$20240816$$MD$US$US
241315271$24131527$1$I$$20240714$20240724$20240724$EXP$NL-LRB-00984293$NL-Accord-436316$ACCORD$$92$YR$E$F$Y$71$KG$20240724$$MD$NL$NL
241315282$24131528$2$F$$20240723$20240724$20240801$EXP$$JP-ROCHE-10000032445$ROCHE$$$$C$F$Y$$$20240801$$PH$JP$JP
241315291$24131529$1$I$$20240719$20240724$20240724$EXP$$US-TAKEDA-2023TUS100098$TAKEDA$$$$$F$Y$$$20240724$$CN$US$US
241315301$24131530$1$I$20230101$20240718$20240724$20240724$EXP$$US-BAUSCH-BL-2023-014434$BAUSCH AND LOMB$$60$YR$$M$Y$$$20240724$$CN$US$US
241315321$24131532$1$I$$20240723$20240724$20240724$PER$$US-ROCHE-10000034330$ROCHE$$46$YR$A$F$Y$$$20240724$$CN$US$US
241315331$24131533$1$I$20240701$20240715$20240724$20240724$EXP$$DE-BAUSCH-BL-2024-011204$BAUSCH AND LOMB$$84$YR$$M$Y$$$20240724$$CN$DE$DE
241315341$24131534$1$I$20240701$20240722$20240724$20240724$EXP$$US-BAUSCH-BL-2024-011276$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240724$$CN$US$US
241315351$24131535$1$I$20240723$20240723$20240724$20240724$EXP$GB-MHRA-MED-202407231630088740-RQMLN$GB-JNJFOC-20240762008$JOHNSON AND JOHNSON$$41$YR$A$F$Y$72$KG$20240724$$PH$GB$GB
241315361$24131536$1$I$20240625$20240722$20240724$20240724$EXP$FR-AFSSAPS-GR2024000926$FR-BAUSCH-BL-2024-011272$BAUSCH AND LOMB$$74$YR$$F$Y$$$20240724$$PH$FR$FR
241315371$24131537$1$I$$20240719$20240724$20240724$EXP$$US-LEO Pharma-372185$LEO PHARM$$72$YR$$F$Y$$$20240724$$MD$US$US
241315381$24131538$1$I$$20240719$20240724$20240724$EXP$$US-ABBVIE-5849968$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241315392$24131539$2$F$$20240822$20240724$20240903$30DAY$$IL-JNJFOC-20240759807$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$IL$IL
241315401$24131540$1$I$20240722$20240723$20240723$20240723$DIR$711174$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241315411$24131541$1$I$20240722$20240723$20240723$20240723$DIR$711175$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241315421$24131542$1$I$20240722$20240723$20240723$20240723$DIR$711181$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241315431$24131543$1$I$20240722$20240723$20240723$20240723$DIR$711183$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241315441$24131544$1$I$$20240723$20240723$20240723$DIR$711184$$FDA-CTU$$$$$UNK$N$$$20240723$$CN$US$
241315461$24131546$1$I$$20240723$20240723$20240723$DIR$711180$$FDA-CTU$$$$$UNK$N$$$20240723$$CN$US$
241315471$24131547$1$I$$20240723$20240723$20240723$DIR$711187$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241315481$24131548$1$I$$20240723$20240723$20240723$DIR$711178$$FDA-CTU$$$$$UNK$N$$$20240723$$CN$US$
241315521$24131552$1$I$20240708$20240723$20240723$20240723$DIR$711152$$FDA-CTU$$51$YR$$M$N$90$KG$20240723$N$CN$US$
241315531$24131553$1$I$$20240723$20240723$20240723$DIR$711196$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241315551$24131555$1$I$20240609$20240723$20240723$20240723$DIR$711192$$FDA-CTU$$76$YR$$F$N$$$20240723$N$HP$US$
241315561$24131556$1$I$$20240709$20240724$20240724$EXP$$CN-LEADINGPHARMA-CN-2024LEALIT00310$LEADING PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused  by vancomycin.Journal of Medical Case Reports.04-JUN-2024;18:01-10$40$YR$A$M$Y$$$20240724$$HP$CN$CN
241315571$24131557$1$I$20240714$20240718$20240724$20240724$EXP$$CN-ABBVIE-5848451$ABBVIE$$60$YR$$F$Y$$$20240724$$HP$CN$CN
241315581$24131558$1$I$20211221$20230330$20240724$20240724$EXP$$US-SA-2021SA435669$SANOFI AVENTIS$$$$E$F$Y$$$20240724$$MD$US$US
241315602$24131560$2$F$$20240720$20240724$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036508$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:1-6$18$YR$$F$Y$$$20240731$$HP$FR$FR
241315611$24131561$1$I$$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036506$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:1-6$14$YR$$$Y$$$20240724$$MD$FR$FR
241315621$24131562$1$I$$20240716$20240724$20240724$EXP$$US-MYLANLABS-2024M1068063$MYLAN$Kuczmarski TM, Lynch RC. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma. Br-J-Haematol 2024; 205 (1): 100-108.$24$YR$$M$Y$$$20240724$$HP$US$US
241315631$24131563$1$I$20240720$20240723$20240723$20240723$DIR$711156$$FDA-CTU$$57$YR$$F$N$$$20240723$N$CN$US$
241315641$24131564$1$I$$20240716$20240724$20240724$EXP$$ZW-MYLANLABS-2024M1068111$MYLAN$Mandikiyana Chirimuta LA, Pascoe MJ, Lowe S. Emergent dolutegravir resistance in integrase-naive, treatment experienced patients from Zimbabwe. South-Afr-J-HIV-Med 2022; 23 (1): a1435.$7$YR$$M$Y$$$20240724$$HP$ZW$ZW
241315651$24131565$1$I$$20240716$20240724$20240724$EXP$$JP-MYE-2024M1068025AA$MYLAN$Yamamoto A, Nishimori H, Shirai T, Takano K, Komura A, Kambara Y, et al. Recurrent Cerebral Hemorrhaging with Platelet Dysfunction Accompanied by Anti-glycoprotein VI Autoantibodies in a Patient with TAFRO Syndrome. Intern-Med 2024; 63 (13): 1917-1922.. 2024;63 (13):1917-1922$55$YR$$M$Y$$$20240724$$HP$JP$JP
241315661$24131566$1$I$$20240716$20240724$20240724$EXP$$US-MYLANLABS-2024M1067528$MYLAN$Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.$59$YR$$F$Y$$$20240724$$HP$US$US
241315671$24131567$1$I$$20240718$20240724$20240724$PER$$US-BAUSCH-BL-2024-011196$BAUSCH AND LOMB$$$$$F$Y$$$20240724$$CN$US$US
241315681$24131568$1$I$20240101$20240709$20240724$20240724$PER$$US-TEVA-VS-3224411$TEVA$$77$YR$$F$Y$88.45$KG$20240724$$CN$US$US
241315691$24131569$1$I$$20240716$20240724$20240724$EXP$$NZ-MYLANLABS-2024M1068183$MYLAN$Lee HK, Reiche L. Lamotrigine-induced generalised pustular psoriasis. N-Z-Med-J 2023; 136 99-101.$23$YR$$F$Y$$$20240724$$HP$NZ$NZ
241315702$24131570$2$F$$20240802$20240724$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116524$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240805$$HP$US$US
241315711$24131571$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116798$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240724$$CN$US$US
241315721$24131572$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116853$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240724$$CN$US$US
241315731$24131573$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116367$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240724$$HP$US$US
241315742$24131574$2$F$20230315$20240731$20240724$20240808$EXP$$US-TAKEDA-2024TUS073332$TAKEDA$$37$YR$$M$Y$$$20240808$$CN$US$US
241315751$24131575$1$I$20240718$20240723$20240724$20240724$PER$$US-ROCHE-10000034635$ROCHE$$21$YR$A$F$Y$$$20240724$$CN$US$US
241315761$24131576$1$I$20240701$20240718$20240724$20240724$PER$$US-ABBVIE-5848746$ABBVIE$$60$YR$$F$Y$$$20240724$$HP$US$US
241315771$24131577$1$I$$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036531$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:1-6$23$YR$$M$Y$$$20240724$$HP$FR$FR
241315781$24131578$1$I$20240709$20240711$20240724$20240724$EXP$$IT-NEBO-664033$PHARMACOSMOS$$36$YR$$F$Y$$$20240719$$HP$IT$IT
241315791$24131579$1$I$$20240715$20240724$20240724$EXP$NL-LRB-00981114$NL-PERRIGO-24NL006607$PERRIGO$$75$YR$$F$Y$63$KG$20240724$$CN$NL$NL
241315802$24131580$2$F$20240622$20240725$20240724$20240805$EXP$GB-MHRA-MED-202407151537133990-CHZTP$GB-PERRIGO-24GB006660$PERRIGO$$28$YR$$F$Y$88$KG$20240805$$PH$GB$GB
241315811$24131581$1$I$$20240709$20240724$20240724$EXP$$US-LEADINGPHARMA-US-2024LEALIT00315$LEADING PHARMA$Z Yousaf.Nystatin Induced Laryngeal Edema - First Reported Case.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$64$YR$E$F$Y$$$20240724$$HP$US$US
241315821$24131582$1$I$$20240715$20240724$20240724$EXP$$GB-PERRIGO-24GB006840$PERRIGO$Manti M, Kamperidis N, Toskas A, Martin H, Misra R. Acute severe ulcerative colitis flare complicated by myopericarditis and infliximab-induced hepatitis. European Journal of Case Reports in Internal Medicine. 2024:11(4). DOI:10.12890/2024_004383.$25$YR$$M$Y$$$20240724$$MD$GB$GB
241315832$24131583$2$F$20240512$20240813$20240724$20240826$EXP$$US-UCBSA-2024037152$UCB$$63$YR$$F$Y$63.946$KG$20240826$$HP$US$US
241315841$24131584$1$I$$20240719$20240724$20240724$EXP$$US-GILEAD-2024-0681412$GILEAD$$25$YR$A$M$Y$$$20240724$$CN$US$US
241315852$24131585$2$F$20240101$20240718$20240724$20240801$EXP$$GB-ADVANZ PHARMA-202407005985$ADVANZ PHARMA$$$$$$Y$$$20240801$$MD$GB$GB
241315861$24131586$1$I$20240718$20240718$20240724$20240724$EXP$$US-ABBVIE-5845723$ABBVIE$$31$YR$$F$Y$$$20240724$$CN$US$US
241315871$24131587$1$I$20240101$20240719$20240724$20240724$EXP$$US-JNJFOC-20240756578$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240724$$HP$US$US
241315881$24131588$1$I$20240714$20240718$20240724$20240724$EXP$$US-BAYER-2024A106061$BAYER$$64$YR$A$F$Y$103.4$KG$20240724$$CN$US$US
241315892$24131589$2$F$20240616$20240829$20240724$20240902$PER$$US-AMGEN-USASP2024145610$AMGEN$$83$YR$E$F$Y$$$20240902$$CN$US$US
241315901$24131590$1$I$$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036507$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:1-6$17$YR$$M$Y$$$20240724$$HP$FR$FR
241315911$24131591$1$I$$20240716$20240724$20240724$PER$$US-ABBVIE-5843895$ABBVIE$$42$YR$$F$Y$83$KG$20240724$$CN$US$US
241315921$24131592$1$I$$20240719$20240724$20240724$PER$$US-HALEON-2187982$Haleon PLC$$$$$$Y$$$20240724$$CN$US$US
241315932$24131593$2$F$$20240715$20240724$20240812$EXP$$PT-TEVA-VS-3222261$TEVA$Campos S., Conceicao V., Vieira N., Arez L. LYELL SYNDROME - A MATERIAL ADVERSE EFFECT. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. 2024 May: 637. PO-0272 - (4498)$20$YR$$M$Y$$$20240812$$MD$PT$PT
241315942$24131594$2$F$$20240917$20240724$20240919$PER$$US-PFIZER INC-202400219808$PFIZER$$58$YR$$F$Y$$$20240919$$CN$US$US
241315961$24131596$1$I$20141201$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036513$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:1-6$43$YR$$M$Y$$$20240724$$HP$FR$FR
241315973$24131597$3$F$$20240809$20240724$20240813$PER$$US-PFIZER INC-PV202400095653$PFIZER$$51$YR$$F$Y$$$20240813$$HP$US$US
241315981$24131598$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400220977$PFIZER$$70$YR$$F$Y$83.46$KG$20240724$$HP$US$US
241315993$24131599$3$F$20231012$20240809$20240724$20240813$EXP$$US-PFIZER INC-PV202400095715$PFIZER$$83$YR$$F$Y$$$20240813$$HP$US$US
241316001$24131600$1$I$20240501$20240716$20240724$20240724$EXP$IE-HPRA-2024-114186$IE-PERRIGO-24IE006664$PERRIGO$$51$YR$$F$Y$$$20240724$$PH$IE$IE
241316011$24131601$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-PV202400096062$PFIZER$$83$YR$$F$Y$$$20240724$$CN$US$US
241316032$24131603$2$F$$20240725$20240724$20240726$EXP$$US-PFIZER INC-202400221032$PFIZER$$70$YR$$F$Y$$$20240726$$HP$US$US
241316041$24131604$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-PV202300002273$PFIZER$$76$YR$$F$Y$$$20240724$$MD$US$US
241316052$24131605$2$F$20240709$20240717$20240724$20240730$EXP$$AU-PERRIGO-24AU006709$PERRIGO$$30$YR$$F$Y$55$KG$20240730$$CN$AU$AU
241316062$24131606$2$F$$20240729$20240724$20240730$PER$$US-PFIZER INC-202400220759$PFIZER$$79$YR$$F$Y$$$20240730$$CN$US$US
241316071$24131607$1$I$20240101$20240722$20240724$20240724$EXP$$GB-UCBSA-2024037260$UCB$$$$A$F$Y$$$20240724$$CN$GB$GB
241316081$24131608$1$I$$20240719$20240724$20240724$EXP$$US-PFIZER INC-PV202400094529$PFIZER$$39$YR$$F$Y$$$20240724$$HP$US$US
241316094$24131609$4$F$$20240909$20240724$20240911$PER$$US-PFIZER INC-PV202400059451$PFIZER$$64$YR$$F$Y$$$20240911$$HP$US$US
241316101$24131610$1$I$$20240719$20240724$20240724$PER$$US-PFIZER INC-PV202400095408$PFIZER$$87$YR$$F$Y$$$20240724$$HP$US$US
241316111$24131611$1$I$20240715$20240717$20240724$20240724$EXP$$GB-PERRIGO-24GB006746$PERRIGO$$80$YR$$F$Y$77$KG$20240724$$HP$GB$GB
241316121$24131612$1$I$$20240719$20240724$20240724$EXP$$CN-PFIZER INC-PV202400094788$PFIZER$Yan, M.. Treatment exploration of patients with refractory advanced KIT exon 9 mutant gastrointestinal stromal tumors: combination targeted therapy and cytoreductive surgery. Journal of Digestive Oncology (ElectronicVersion). 2024;16 (2):250-255$44$YR$$F$Y$$$20240724$$HP$CN$CN
241316142$24131614$2$F$$20240729$20240724$20240730$PER$$US-PFIZER INC-PV202400096470$PFIZER$$72$YR$$F$Y$$$20240730$$HP$US$US
241316151$24131615$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400222054$PFIZER$$85$YR$$F$Y$$$20240724$$HP$US$US
241316161$24131616$1$I$$20240722$20240724$20240724$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041643$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240724$$CN$US$US
241316174$24131617$4$F$20230614$20240807$20240724$20240812$PER$$US-BAYER-2024A104393$BAYER$$20$YR$A$F$Y$$$20240812$$MD$US$US
241316183$24131618$3$F$20240701$20240719$20240724$20240802$EXP$$US-SA-2024SA213366$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240802$$CN$US$US
241316191$24131619$1$I$$20240715$20240724$20240724$EXP$$IT-AUROBINDO-AUR-APL-2024-036138$AUROBINDO$Morena A, Matta M, Ferraris F, Frea S, Anselmino M, Berruquier P, et al.. CONTINUOUS LEFT STELLATE GANGLION BLOCK DURING VT ABLATION TO SLOW VT AND IMPROVE ABLATION OUTCOME. Eur-Heart-J-Suppl. 2024;26 (Suppl. 2):ii146$71$YR$$M$Y$$$20240724$$HP$IT$IT
241316201$24131620$1$I$$20240717$20240724$20240724$EXP$$US-MYLANLABS-2024M1068069$MYLAN$Chhabra K, Gudipati S, Bloomingdale R. Opioid Withdrawal Causing a Broken Heart!. Circulation 2023; 148 (Suppl.).$26$YR$$M$Y$$$20240724$$HP$US$US
241316211$24131621$1$I$$20240723$20240723$20240723$DIR$711199$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241316221$24131622$1$I$$20240717$20240724$20240724$EXP$$US-MYLANLABS-2024M1068181$MYLAN$Pokharel G, Alkhatatneh H, Fleischer J, Janosky M, Terner S. An unusual elevation in international normalized ratio in the setting of apixaban use. J-Invest-Med 2023; 71 135-136.$67$YR$$M$Y$$$20240724$$HP$US$US
241316231$24131623$1$I$20240322$20240717$20240724$20240724$EXP$$CN-SA-2024SA214843$SANOFI AVENTIS$$59$YR$A$M$Y$82$KG$20240724$$HP$CN$CN
241316241$24131624$1$I$$20240717$20240724$20240724$EXP$$JP-MYE-2024M1068029AA$MYLAN$Tsukui D, Haga T, Abe K. Discordance Between Mucosal Appearances and Pathologic Findings in Intestinal Mycobacterial Infection in an Immunocompromised Patient. Mayo-Clin-Proc 2024; 99 (7): 1112-1113.. 2024;99 (7):1112-1113$6$DEC$$M$Y$$$20240724$$MD$JP$JP
241316251$24131625$1$I$$20240717$20240724$20240724$EXP$$DK-MYLANLABS-2024M1067358$MYLAN$Pedersen OS, Barkholt TO, Madsen SH, Rudolf F.. Tuberculosis immune reconstitution syndrome (TB-IRIS) followed by recurring lymphadenitis up to 8 years post-antituberculous treatment.. BMJ Case Reports.. 2024;17 (6)$$$A$F$Y$$$20240724$$HP$DK$DK
241316261$24131626$1$I$$20240723$20240723$20240723$DIR$711194$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241316271$24131627$1$I$20240708$20240723$20240723$20240723$DIR$711153$$FDA-CTU$$45$YR$$F$N$63.9$KG$20240723$N$CN$US$
241316281$24131628$1$I$20240716$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50697$$FDA-CTU$$66$YR$$M$N$$$20240723$Y$HP$US$
241316292$24131629$2$F$20170101$20240822$20240724$20240829$EXP$$IT-MYLANLABS-2024M1067338$MYLAN$Perencin B, Zacchi A, Zanconati F, Tomietto P, Bianco F, Di Maso V.. COVID-19 and lupus nephritis flare in unvaccinated patients: a case report and literature review.. Italian Journal of Nephrology. 2024;3$28$YR$$F$Y$$$20240829$$HP$IT$IT
241316302$24131630$2$F$20240201$20240723$20240724$20240815$PER$$US-009507513-2406USA008571$MERCK$$72$YR$$F$Y$$$20240815$$MD$US$US
241316312$24131631$2$F$$20240802$20240724$20240812$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090162$VIIV$$$$$M$Y$$$20240812$$PH$US$US
241316321$24131632$1$I$$20240716$20240724$20240724$PER$$US-ALXN-202407USA001135US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241316331$24131633$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50792$$FDA-CTU$$80$YR$$F$N$$$20240723$N$$US$
241316341$24131634$1$I$20240520$20240718$20240724$20240724$EXP$IT-MINISAL02-993278$IT-ROCHE-10000030356$ROCHE$$60$YR$A$M$Y$$$20240724$$MD$IT$IT
241316351$24131635$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014172$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240724$$CN$US$US
241316361$24131636$1$I$20230101$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014192$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240724$$CN$US$US
241316371$24131637$1$I$20240722$20240723$20240723$20240723$DIR$711212$$FDA-CTU$$75$YR$$F$N$$$20240723$N$HP$US$
241316381$24131638$1$I$$20240715$20240724$20240724$EXP$FR-AFSSAPS-AVNT2024000511$FR-TEVA-VS-3221918$TEVA$$24$YR$$F$Y$$$20240724$$HP$FR$FR
241316391$24131639$1$I$20240722$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014595$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240724$$CN$US$US
241316401$24131640$1$I$20240717$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024143472$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241316411$24131641$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014757$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240724$$CN$US$US
241316421$24131642$1$I$$20240715$20240724$20240724$EXP$$US-TEVA-VS-3222268$TEVA$$51$YR$$F$Y$$$20240724$$CN$US$US
241316431$24131643$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50722$$FDA-CTU$$82$YR$$M$N$$$20240723$N$$US$
241316441$24131644$1$I$20240526$20240719$20240724$20240724$EXP$$US-AstraZeneca-2024A165573$ASTRAZENECA$$$$$$Y$$$20240724$$HP$US$
241316451$24131645$1$I$$20240719$20240724$20240724$EXP$$ES-MYLANLABS-2024M1068604$MYLAN$Lizondo Lopez T, Font I Barcelo A, Garcia Gutierrez C, Blasco M, Grafia I, Bastida C, et al. Clopidogrel-induced thrombotic microangiopathy: A case report. Eur-J-Hosp-Pharm 2024; 0 (0).$75$YR$$M$Y$$$20240724$$HP$ES$ES
241316461$24131646$1$I$20240722$20240723$20240723$20240723$DIR$711213$$FDA-CTU$$34$YR$$F$N$57.6$KG$20240723$N$PH$US$
241316471$24131647$1$I$$20220627$20240724$20240724$EXP$$US-AstraZeneca-2022A237552$ASTRAZENECA$$$$$F$Y$$$20240724$$MD$US$
241316481$24131648$1$I$20210601$20240716$20240724$20240724$EXP$$ES-AstraZeneca-2024A161900$ASTRAZENECA$$64$YR$$M$Y$69$KG$20240724$$MD$ES$
241316491$24131649$1$I$20240605$20240716$20240724$20240724$EXP$$FR-AstraZeneca-2024A161940$ASTRAZENECA$$76$YR$$M$Y$$$20240724$$MD$FR$
241316501$24131650$1$I$$20240716$20240724$20240724$EXP$$US-ABBVIE-2307587US$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241316511$24131651$1$I$20231229$20240719$20240724$20240724$EXP$$US-AstraZeneca-2024A165316$ASTRAZENECA$$$$$M$Y$$$20240724$$HP$US$
241316521$24131652$1$I$20240401$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50706$$FDA-CTU$$84$YR$$M$N$$$20240723$N$HP$US$
241316531$24131653$1$I$$20240719$20240724$20240724$PER$$US-AstraZeneca-2024A165514$ASTRAZENECA$$$$$$Y$$$20240724$$CN$US$
241316541$24131654$1$I$20240515$20240719$20240724$20240724$EXP$$US-AstraZeneca-2024A165905$ASTRAZENECA$$$$$F$Y$$$20240724$$HP$US$
241316551$24131655$1$I$$20220105$20240724$20240724$EXP$$US-AstraZeneca-2022A008801$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241316561$24131656$1$I$$20220224$20240724$20240724$EXP$$US-AstraZeneca-2022A089438$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241316571$24131657$1$I$20200505$20210505$20240724$20240724$EXP$$AU-AstraZeneca-2021A403749$ASTRAZENECA$$25819$DY$$F$Y$$$20240724$$CN$AU$
241316582$24131658$2$F$$20240906$20240724$20240913$EXP$$BG-AstraZeneca-2024A164565$ASTRAZENECA$$$$$F$Y$$$20240913$$MD$BG$
241316592$24131659$2$F$$20240722$20240724$20240726$PER$$US-JNJFOC-20240756666$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$CN$US$US
241316601$24131660$1$I$$20220223$20240724$20240724$EXP$$US-AstraZeneca-2022A085542$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241316612$24131661$2$F$20240619$20240820$20240724$20240829$EXP$$JP-NEBO-664687$PHARMACOSMOS$$29$YR$$F$Y$$$20240829$$MD$JP$JP
241316621$24131662$1$I$20240524$20240718$20240724$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-018591$JAZZ$$25$YR$$F$Y$$$20240724$$CN$US$US
241316631$24131663$1$I$$20240712$20240724$20240724$EXP$FR-AFSSAPS-NT2024000788$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06741$HIKMA$$62$YR$$F$Y$$$20240724$$MD$FR$FR
241316642$24131664$2$F$$20240722$20240724$20240724$EXP$$CA-HLS-202401824$HLS THERAPEUTICS$$$$$F$Y$$$20240724$$HP$CA$CA
241316651$24131665$1$I$$20240722$20240724$20240724$EXP$$US-ABBVIE-5850201$ABBVIE$$$$$F$Y$$$20240724$$HP$US$US
241316681$24131668$1$I$20240301$20240723$20240723$20240723$DIR$711189$$FDA-CTU$$42$YR$$F$N$81$KG$20240723$N$CN$US$
241316712$24131671$2$F$20240627$20240731$20240724$20240806$PER$$US-BAYER-2024A104758$BAYER$$30$YR$A$F$Y$73.9$KG$20240806$$HP$US$US
241316731$24131673$1$I$$20240717$20240724$20240724$EXP$$DE-AMGEN-DEUSP2024142904$AMGEN$$$$A$M$Y$$$20240724$$MD$DE$DE
241316741$24131674$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142511$AMGEN$Kaseb A. O.; Chamseddine S.; Lapelusa M. et al.. Severe febrile neutropenia and pancytopenia in a patient with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: a case report. Journal of gastrointestinal oncology (online). 2024;15 (3):1324-1330$$$A$M$Y$$$20240724$$MD$US$US
241316751$24131675$1$I$20240628$20240718$20240724$20240724$EXP$$US-RIGEL-20240700001$RIGEL PHARMACEUTICALS$$68$YR$$F$Y$86.183$KG$20240724$$CN$US$US
241316762$24131676$2$F$20240720$20240815$20240724$20240823$EXP$$US-BEH-2024175974$CSL BEHRING$$36$YR$A$F$Y$$$20240823$$HP$US$US
241316771$24131677$1$I$20240701$20240715$20240724$20240724$EXP$$CN-BEIGENE-BGN-2024-011004$BEIGENE$$$$$$Y$$$20240724$$HP$CN$CN
241316781$24131678$1$I$$20240709$20240724$20240724$EXP$$US-LEADINGPHARMA-US-2024LEALIT00317$LEADING PHARMA$K. Holbert.Multiorgan failure from heat stroke in a person taking glycopyrrolate.American journal of respiratory and critical care medicine.JAN-2024;209$24$YR$A$M$Y$$$20240724$$HP$US$US
241316791$24131679$1$I$20230324$20240722$20240724$20240724$EXP$$US-UCBSA-2023015888$UCB$$27$YR$$M$Y$$$20240724$$CN$US$US
241316802$24131680$2$F$20240617$20240730$20240724$20240805$PER$$US-BAYER-2024A105113$BAYER$$35$YR$A$F$Y$60$KG$20240805$$MD$US$US
241316811$24131681$1$I$$20240722$20240724$20240724$PER$$US-HALEON-2188526$Haleon PLC$$76$YR$$M$Y$$$20240724$$CN$US$US
241316822$24131682$2$F$$20240722$20240724$20240729$PER$$US-BIOGEN-2017BI00491138$BIOGEN$$$$$M$Y$$$20240729$$CN$US$US
241316832$24131683$2$F$$20240812$20240724$20240813$PER$$US-ALXN-202407USA001170US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
241316842$24131684$2$F$20240415$20240813$20240724$20240816$EXP$$NVSC2024US091275$NOVARTIS$$51$YR$$M$Y$$$20240816$$CN$US$US
241316851$24131685$1$I$$20240710$20240724$20240724$PER$$US-JNJFOC-20240727627$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$CN$US$US
241316863$24131686$3$F$20240712$20240922$20240724$20240925$EXP$$NVSC2024IR148044$NOVARTIS$$54$YR$$M$Y$$$20240925$$CN$IR$IR
241316872$24131687$2$F$20240705$20240724$20240724$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112985$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240726$$CN$US$US
241316881$24131688$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116956$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240724$$CN$US$US
241316891$24131689$1$I$20240705$20240717$20240724$20240724$EXP$FR-AFSSAPS-MP2024001152$FR-REGENERON PHARMACEUTICALS, INC.-2024-099206$REGENERON$$77$YR$$M$Y$$$20240724$$PH$FR$FR
241316901$24131690$1$I$20190601$20210512$20240724$20240724$EXP$$MX-AstraZeneca-2019SF53307$ASTRAZENECA$$781$MON$$M$Y$80$KG$20240724$$CN$MX$
241316911$24131691$1$I$20240710$20240719$20240724$20240724$EXP$$US-AstraZeneca-2024A165814$ASTRAZENECA$$23551$DY$$M$Y$$$20240724$$CN$US$
241316922$24131692$2$F$20240219$20240724$20240724$20240801$EXP$$JP-AstraZeneca-2024A164855$ASTRAZENECA$$83$YR$$F$Y$$$20240801$$MD$JP$
241316931$24131693$1$I$$20240717$20240724$20240724$EXP$$CA-TAKEDA-2023TUS006691$TAKEDA$$$$$F$Y$118$KG$20240724$$HP$CA$CA
241316951$24131695$1$I$20240717$20240717$20240724$20240724$EXP$$US-TAKEDA-2024TUS072397$TAKEDA$$$$$F$Y$$$20240724$$CN$US$US
241316961$24131696$1$I$$20240624$20240724$20240724$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000136$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241316971$24131697$1$I$20240701$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50704$$FDA-CTU$$70$YR$$F$N$$$20240723$N$HP$US$
241316981$24131698$1$I$20230901$20240723$20240723$20240723$DIR$711155$$FDA-CTU$$35$YR$$M$N$70$KG$20240723$N$CN$AE$
241316991$24131699$1$I$20240701$20240719$20240724$20240724$EXP$$MY-JNJFOC-20240757238$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$MD$MY$MY
241317001$24131700$1$I$20240715$20240723$20240724$20240724$PER$$US-ROCHE-10000034420$ROCHE$$$$$M$Y$$$20240724$$CN$US$US
241317011$24131701$1$I$$20240718$20240724$20240724$PER$$US-ROCHE-10000031330$ROCHE$$44$YR$A$M$Y$$$20240724$$CN$US$US
241317021$24131702$1$I$$20240709$20240724$20240724$EXP$$US-GLANDPHARMA-US-2024GLNLIT00499$GLAND PHARMA$S. Vallabhajosyula.Fighting the Recovering Heart While Drowning in Volume: Role of VA-V ECMO Configuration in Migrating Mixing Cloud Effect.American Journal of Respiratory and Critical Care Medicine.JAN-2024;209:A5582$43$YR$A$F$Y$$$20240724$$HP$US$US
241317031$24131703$1$I$$20240717$20240724$20240724$EXP$$CA-TAKEDA-2024TUS073008$TAKEDA$$$$$F$Y$$$20240724$$CN$CA$CA
241317043$24131704$3$F$20240610$20240725$20240724$20240730$PER$$US-ROCHE-10000032760$ROCHE$$41$YR$A$F$Y$58.06$KG$20240730$$CN$US$US
241317051$24131705$1$I$$20240715$20240724$20240724$EXP$$US-AUROBINDO-AUR-APL-2024-035999$AUROBINDO$Mosher AM, Hartman E, Keusch D, Papadakis JE, Buxton K, Northam WT, et al.. Spinal catheter revision in pediatric intrathecal baclofen pumps: risk factors and postoperative outcomes. NeurosurgFocus. 2024;56No. 6:1-8$$$$$Y$$$20240724$$MD$US$US
241317061$24131706$1$I$20240601$20240709$20240724$20240724$PER$$US-TEVA-VS-3221121$TEVA$$77$YR$$F$Y$88.45$KG$20240724$$CN$US$US
241317072$24131707$2$F$20240701$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024145091$AMGEN$$$$$$Y$$$20240724$$MD$US$US
241317081$24131708$1$I$20240711$20240715$20240724$20240724$PER$$US-AMGEN-USASP2024144945$AMGEN$$45$YR$A$F$Y$$$20240724$$CN$US$US
241317101$24131710$1$I$20240714$20240715$20240724$20240724$PER$$US-AMGEN-USASP2024141140$AMGEN$$63$YR$A$F$Y$$$20240724$$CN$US$US
241317111$24131711$1$I$20170501$20240715$20240724$20240724$EXP$$FR-AUROBINDO-AUR-APL-2024-036504$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:1-6$9$YR$$F$Y$$$20240724$$HP$FR$FR
241317131$24131713$1$I$20240214$20240719$20240724$20240724$EXP$$CA-TAKEDA-2024TUS074215$TAKEDA$$17$YR$$F$Y$$$20240724$$MD$CA$CA
241317151$24131715$1$I$20240716$20240723$20240723$20240723$DIR$711224$$FDA-CTU$$61$YR$$M$N$92.3$KG$20240723$N$HP$US$
241317161$24131716$1$I$$20240723$20240723$20240723$DIR$711223$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241317171$24131717$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50721$$FDA-CTU$$47$YR$$F$N$$$20240723$N$$US$
241317191$24131719$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50797$$FDA-CTU$$46$YR$$F$N$$$20240723$N$$US$
241317201$24131720$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50702$$FDA-CTU$$68$YR$$F$N$63.5$KG$20240723$N$$US$
241317221$24131722$1$I$20240715$20240723$20240723$20240723$DIR$711225$$FDA-CTU$$81$YR$$M$N$49.86$KG$20240723$N$HP$US$
241317231$24131723$1$I$20240723$20240723$20240723$20240723$DIR$711160$$FDA-CTU$$74$YR$$F$N$69.4$KG$20240723$N$MD$US$
241317241$24131724$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50796$$FDA-CTU$$$$$M$N$$$20240723$N$HP$US$
241317252$24131725$2$F$20240101$20240828$20240724$20240830$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-013058$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240829$$CN$JP$JP
241317261$24131726$1$I$20240701$20240723$20240724$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041612$BOEHRINGER INGELHEIM$$89$YR$E$M$Y$$$20240724$$HP$US$US
241317272$24131727$2$F$$20240905$20240724$20240906$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038016$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240906$$CN$JP$JP
241317281$24131728$1$I$$20240716$20240724$20240724$EXP$$SD-HIKMA PHARMACEUTICALS USA INC.-SD-H14001-24-06798$HIKMA$Saad AH, Omar SM, Elgilli AA, Omer IAA, Jalaleldeen MH.. Saad AH, Omar SM, Elgilli AA, Omer IAA, Jalaleldeen MH. An Atypical Seizure Onset and Re-Emergence in a Refugee with an Undiagnosed Sturge-Weber Syndrome: A Case Report from a Limited Setting. International Medical Case Reports Journal. 2024;17:615-620$39$YR$$F$Y$$$20240724$$MD$SD$SD
241317293$24131729$3$F$$20240731$20240724$20240807$EXP$$US-ASTELLAS-2024US020519$ASTELLAS$Wu, S.. Cutaneous toxicity associated with enfortumab vedotin treatment of metastatic urothelial carcinoma.. Dermatol Online J.. 2019;25(2):UNk$8$DEC$$M$Y$$$20240807$$MD$US$US
241317306$24131730$6$F$20240625$20240819$20240724$20240828$EXP$$CA-BEH-2024174902$CSL BEHRING$$75$YR$E$F$Y$52.5$KG$20240828$$HP$CA$CA
241317311$24131731$1$I$$20240717$20240724$20240724$EXP$$NVSC2024US148277$NOVARTIS$$$$$M$Y$$$20240724$$CN$US$US
241317321$24131732$1$I$$20240716$20240724$20240724$EXP$$CA-APOTEX-2024AP008492$APOTEX$$57$YR$$F$Y$67$KG$20240724$$HP$CA$CA
241317332$24131733$2$F$20140319$20240808$20240724$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-035392$AUROBINDO$$64$YR$$M$Y$89$KG$20240820$$MD$GB$GB
241317341$24131734$1$I$20240701$20240717$20240724$20240724$PER$$US-ALXN-202407USA001179US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241317351$24131735$1$I$$20240717$20240724$20240724$EXP$$GB-TEVA-VS-3222107$TEVA$$69$YR$$F$Y$65$KG$20240724$$MD$GB$GB
241317361$24131736$1$I$$20240718$20240724$20240724$EXP$NL-LRB-00985279$NL-MYLANLABS-2024M1067496$MYLAN$$43$YR$$F$Y$85$KG$20240724$$CN$NL$NL
241317371$24131737$1$I$$20240717$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-022164$UNITED THERAPEUTICS$$$$$F$Y$65.76$KG$20240724$$$US$US
241317381$24131738$1$I$$20240718$20240724$20240724$EXP$$SE-MYLANLABS-2024M1067706$MYLAN$$$$E$M$Y$$$20240724$$CN$SE$SE
241317391$24131739$1$I$$20240718$20240724$20240724$EXP$$US-MYLANLABS-2024M1068050$MYLAN$Singanallur P, Schrader K, Chiravuri S, Abdulfattah O. Multifactorial Shock: Managing a Patient With Septic Shock and Left Ventricular Outflow Tract Obstruction. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$80$YR$$F$Y$$$20240724$$HP$US$US
241317401$24131740$1$I$$20240718$20240724$20240724$EXP$NL-LRB-00981603$NL-MYLANLABS-2024M1067493$MYLAN$$43$YR$$F$Y$72$KG$20240724$$CN$NL$NL
241317411$24131741$1$I$$20240718$20240724$20240724$EXP$NL-LRB-00981723$NL-MYLANLABS-2024M1067640$MYLAN$$56$YR$$F$Y$98$KG$20240724$$MD$NL$NL
241317421$24131742$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50709$$FDA-CTU$$25$YR$$M$N$102.06$KG$20240723$N$$US$
241317431$24131743$1$I$20240626$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50774$$FDA-CTU$$59$YR$$M$N$$$20240723$N$HP$US$
241317451$24131745$1$I$20240718$20240718$20240724$20240724$EXP$$US-JNJFOC-20240756455$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240724$$HP$US$US
241317471$24131747$1$I$20240713$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50770$$FDA-CTU$$44$YR$$F$N$179$KG$20240723$N$PH$US$
241317481$24131748$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50798$$FDA-CTU$$43$YR$$F$N$$$20240723$N$$US$
241317491$24131749$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00508$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$51$YR$A$F$Y$$$20240724$$HP$CN$CN
241317501$24131750$1$I$20240528$20240709$20240724$20240724$PER$$US-SERVIER-S24008714$SERVIER$$$$$$Y$$$20240724$$HP$US$US
241317512$24131751$2$F$20220201$20240813$20240724$20240819$EXP$$US-UCBSA-2024037202$UCB$$83$YR$$F$Y$113$KG$20240819$$CN$US$US
241317521$24131752$1$I$$20240715$20240724$20240724$EXP$$PL-AUROBINDO-AUR-APL-2024-036437$AUROBINDO$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D.. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain-Sci. 2023;13:3$38$YR$$F$Y$$$20240724$$HP$PL$PL
241317531$24131753$1$I$$20240718$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-022303$UNITED THERAPEUTICS$$$$$F$Y$62.585$KG$20240724$$$US$US
241317541$24131754$1$I$$20240722$20240724$20240724$PER$$US-JNJFOC-20240756897$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$CN$US$US
241317551$24131755$1$I$20230522$20240722$20240724$20240724$EXP$$KR-009507513-2407KOR012038$MERCK$$$$E$M$Y$$$20240724$$HP$KR$KR
241317561$24131756$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00512$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$37$YR$A$F$Y$$$20240724$$HP$CN$CN
241317571$24131757$1$I$$20240716$20240724$20240724$EXP$$CA-TAKEDA-2024TUS071174$TAKEDA$$$$$F$Y$$$20240724$$CN$CA$CA
241317581$24131758$1$I$$20240716$20240724$20240724$EXP$$JP-AstraZeneca-2024A164711$ASTRAZENECA$$31$YR$$F$Y$$$20240724$$MD$JP$
241317591$24131759$1$I$20240501$20240722$20240724$20240724$EXP$$US-UCBSA-2024031623$UCB$$62$YR$$M$Y$72.1$KG$20240724$$CN$US$US
241317602$24131760$2$F$20240719$20240926$20240724$20240927$EXP$$NVSC2024US150051$NOVARTIS$$63$YR$$F$Y$$$20240927$$CN$US$US
241317612$24131761$2$F$20230622$20240731$20240724$20240801$EXP$$NVSC2024GB150646$NOVARTIS$$$$N$M$Y$$$20240801$$CN$GB$GB
241317621$24131762$1$I$20240101$20240718$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-020442$UNITED THERAPEUTICS$$$$$F$Y$56.236$KG$20240724$$$US$US
241317641$24131764$1$I$$20240717$20240724$20240724$PER$$US-EMD Serono-2024039154$EMD SERONO INC$$$$$F$Y$$$20240724$$HP$US$US
241317652$24131765$2$F$$20240722$20240724$20240730$EXP$$US-GILEAD-2024-0681366$GILEAD$$$$T$F$Y$$$20240730$$CN$US$US
241317661$24131766$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00516$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$40$YR$A$M$Y$$$20240724$$HP$CN$CN
241317671$24131767$1$I$$20240717$20240724$20240724$EXP$$CA-GSK-CA2024AMR090364$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$CA$CA
241317681$24131768$1$I$$20240718$20240724$20240724$PER$$US-ABBVIE-5849590$ABBVIE$$$$$$Y$$$20240724$$HP$US$US
241317701$24131770$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50752$$FDA-CTU$$33$YR$$M$N$$$20240723$N$HP$US$
241317711$24131771$1$I$20240501$20240719$20240723$20240723$DIR$FDA-CDER-CTU-2024-50745$$FDA-CTU$$77$YR$$F$N$$$20240719$N$HP$US$
241317721$24131772$1$I$20240501$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50800$$FDA-CTU$$61$YR$$F$N$$$20240723$N$HP$US$
241317731$24131773$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50777$$FDA-CTU$$63$YR$$F$N$160$LBS$20240723$N$$US$
241317741$24131774$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116274$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240724$$CN$US$US
241317752$24131775$2$F$20220201$20240802$20240724$20240808$EXP$$NVSC2024ZA150721$NOVARTIS$$49$YR$$F$Y$$$20240809$$CN$ZA$ZA
241317761$24131776$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00517$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$38$YR$A$M$Y$$$20240724$$HP$CN$CN
241317772$24131777$2$F$$20240731$20240724$20240806$EXP$$ES-PFIZER INC-202400219172$PFIZER$Anto, C.. USE OF ISAVUCONAZOLE IN CHILDREN WITH INVASIVE FUNGAL INFECTION: EXPERIENCE IN A PAEDIATRIC AND TERTIARY CARE CENTRE. 493$7$YR$$M$Y$24$KG$20240806$$MD$ES$ES
241317781$24131778$1$I$20201202$20240722$20240724$20240724$EXP$$FR-PFIZER INC-2021SGN02126$PFIZER$$67$YR$$F$Y$50$KG$20240724$$MD$FR$FR
241317791$24131779$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090943$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241317811$24131781$1$I$$20230611$20240724$20240724$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395748$RANBAXY$$$$A$M$Y$$$20240724$$CN$US$US
241317821$24131782$1$I$$20231229$20240724$20240724$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-427053$RANBAXY$$$$$F$Y$$$20240724$$CN$US$US
241317831$24131783$1$I$$20240722$20240724$20240724$EXP$$CA-HLS-202401822$HLS THERAPEUTICS$$$$$M$Y$$$20240724$$HP$CA$CA
241317841$24131784$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00530$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$48$YR$A$M$Y$$$20240724$$HP$CN$CN
241317851$24131785$1$I$$20240718$20240724$20240724$PER$$US-BAYER-2024A104769$BAYER$$44$YR$A$F$Y$$$20240724$$CN$US$US
241317861$24131786$1$I$$20240718$20240724$20240724$EXP$$JP-ASTELLAS-2024JP005210$ASTELLAS$$8$DEC$$$Y$$$20240724$$MD$JP$JP
241317871$24131787$1$I$$20240715$20240724$20240724$EXP$$ES-TEVA-VS-3223939$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$59$YR$$F$Y$$$20240724$$HP$ES$ES
241317881$24131788$1$I$20240601$20240719$20240724$20240724$EXP$$CN-JNJFOC-20240762898$JOHNSON AND JOHNSON$$87$YR$E$M$Y$74$KG$20240724$$HP$CN$CN
241317891$24131789$1$I$$20240709$20240724$20240724$EXP$$CL-SERVIER-S24008912$SERVIER$$$$$$Y$$$20240724$$PH$CL$CL
241317902$24131790$2$F$$20240809$20240724$20240819$EXP$$ES-TEVA-VS-3223696$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.; Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening c...$64$YR$$F$Y$$$20240819$$HP$ES$ES
241317912$24131791$2$F$20240717$20240729$20240724$20240731$PER$$NVSC2024US149059$NOVARTIS$$7$MON$$F$Y$$$20240731$$MD$US$US
241317923$24131792$3$F$20240101$20240725$20240724$20240809$EXP$$CH-UCBSA-2024036629$UCB$$$$$F$Y$55$KG$20240809$$MD$CH$CH
241317931$24131793$1$I$$20240710$20240724$20240724$PER$$US-Covis Pharma GmbH-2024COV00837$COVIS PHARMA$$$$$F$Y$$$20240724$$CN$US$US
241317941$24131794$1$I$20240708$20240715$20240724$20240724$EXP$$US-Covis Pharma GmbH-2024COV00876$COVIS PHARMA$$86$YR$E$F$Y$$$20240724$$PH$US$US
241317951$24131795$1$I$$20240715$20240724$20240724$EXP$$CA-APOTEX-2024AP008359$APOTEX$$72$YR$$M$Y$86$KG$20240724$$PH$CA$CA
241317961$24131796$1$I$$20240718$20240724$20240724$EXP$$US-ABBVIE-5847091$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241317971$24131797$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00532$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$56$YR$A$F$Y$$$20240724$$HP$CN$CN
241317981$24131798$1$I$20240721$20240721$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-022475$UNITED THERAPEUTICS$$75$YR$$F$Y$75.737$KG$20240724$$$US$US
241317991$24131799$1$I$$20240721$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-022469$UNITED THERAPEUTICS$$$$$F$Y$65.306$KG$20240724$$$US$US
241318002$24131800$2$F$20240101$20240724$20240724$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-020959$UNITED THERAPEUTICS$$$$$F$Y$76.19$KG$20240731$$$US$US
241318011$24131801$1$I$20240708$20240715$20240724$20240724$EXP$$CN-BEIGENE-BGN-2024-011007$BEIGENE$$$$$$Y$$$20240724$$HP$CN$CN
241318021$24131802$1$I$$20240718$20240724$20240724$EXP$$US-ABBVIE-5842523$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241318031$24131803$1$I$$20240717$20240724$20240724$PER$$US-ALXN-202407USA001169US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241318041$24131804$1$I$$20240722$20240724$20240724$PER$$NVSC2024US150922$NOVARTIS$$$$$F$Y$$$20240724$$MD$US$US
241318051$24131805$1$I$$20240716$20240724$20240724$PER$$US-TAKEDA-2024TUS073083$TAKEDA$$32$YR$$F$Y$$$20240724$$CN$US$US
241318062$24131806$2$F$$20240718$20240724$20240820$EXP$$US-BIOGEN-2024BI01274715$BIOGEN$$$$A$M$Y$$$20240820$$MD$US$US
241318071$24131807$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00533$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$84$YR$E$M$Y$$$20240724$$HP$CN$CN
241318082$24131808$2$F$20240717$20240717$20240724$20240726$EXP$$US-CSL-2024-006813$CSL Plasma$$53$YR$$F$Y$$$20240726$$HP$US$US
241318091$24131809$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117261$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240724$$HP$US$US
241318101$24131810$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117412$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240724$$CN$US$US
241318117$24131811$7$F$20240101$20240830$20240724$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021339$UNITED THERAPEUTICS$$$$$M$Y$88.435$KG$20240906$$$US$US
241318121$24131812$1$I$20240701$20240721$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-022533$UNITED THERAPEUTICS$$42$YR$$F$Y$89.342$KG$20240724$$$US$US
241318131$24131813$1$I$20240716$20240716$20240724$20240724$PER$$DE-BRACCO-2024DE04398$BRACCO$$$$$M$Y$$$20240724$$MD$DE$DE
241318142$24131814$2$F$20210727$20240918$20240724$20240926$EXP$$GB-TEVA-VS-3222154$TEVA$$52$YR$$F$Y$101$KG$20240926$$MD$GB$GB
241318151$24131815$1$I$20240101$20240719$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-022539$UNITED THERAPEUTICS$$$$$F$Y$76.19$KG$20240724$$$US$US
241318164$24131816$4$F$20240101$20240917$20240724$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-006877$UNITED THERAPEUTICS$$$$$F$Y$81.633$KG$20240921$$$US$US
241318171$24131817$1$I$20240719$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116076$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240724$$HP$US$US
241318191$24131819$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014024$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240724$$CN$US$US
241318201$24131820$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015180$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240724$$CN$US$US
241318211$24131821$1$I$$20240701$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015261$ELI LILLY AND CO$$$$$$Y$$$20240724$$CN$US$US
241318221$24131822$1$I$$20240718$20240724$20240724$EXP$$JP-BAYER-2024A105770$BAYER$$$$$F$Y$$$20240724$$MD$JP$JP
241318231$24131823$1$I$$20240718$20240724$20240724$EXP$$US-GILEAD-2024-0681391$GILEAD$$$$T$M$Y$$$20240724$$CN$US$US
241318241$24131824$1$I$$20240718$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-021911$UNITED THERAPEUTICS$$$$$F$Y$87.528$KG$20240724$$$US$US
241318251$24131825$1$I$$20240717$20240724$20240724$PER$$NVSC2024US147602$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
241318263$24131826$3$F$$20240911$20240724$20240913$PER$$NVSC2024US151211$NOVARTIS$$$$$M$Y$$$20240913$$HP$US$US
241318272$24131827$2$F$$20240906$20240724$20240909$PER$$NVSC2024US151330$NOVARTIS$$$$$F$Y$$$20240909$$MD$US$US
241318281$24131828$1$I$20240720$20240723$20240723$20240723$DIR$711208$$FDA-CTU$$66$YR$$UNK$N$87.3$KG$20240723$N$CN$US$
241318291$24131829$1$I$20240301$20240723$20240724$20240724$EXP$$US-INCYTE CORPORATION-2024IN007718$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241318301$24131830$1$I$20240429$20240722$20240724$20240724$EXP$IT-MINISAL02-994915$IT-UCBSA-2024036907$UCB$$78$YR$$M$Y$$$20240724$$MD$IT$IT
241318311$24131831$1$I$20240501$20240712$20240724$20240724$EXP$FR-AFSSAPS-AM2024000551$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06745$HIKMA$$66$YR$$M$Y$79$KG$20240724$$MD$FR$FR
241318321$24131832$1$I$$20240711$20240724$20240724$EXP$$CA-B.Braun Medical Inc.-2159522$B BRAUN$$63$YR$$F$Y$72$KG$20240724$$$CA$CA
241318331$24131833$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00534$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$72$YR$E$M$Y$$$20240724$$HP$CN$CN
241318341$24131834$1$I$$20240719$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-022567$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240724$$$US$US
241318353$24131835$3$F$20190401$20240808$20240724$20240816$EXP$$CA-APOTEX-2024AP008447$APOTEX$$42$YR$A$F$Y$58.7$KG$20240816$$HP$CA$CA
241318362$24131836$2$F$20240618$20240719$20240724$20240802$PER$$US-SERVIER-S24008715$SERVIER$$$$$$Y$$$20240802$$HP$US$US
241318371$24131837$1$I$20240716$20240722$20240724$20240724$EXP$$CO-BAYER-2024A107176$BAYER$$44$YR$A$M$Y$$$20240724$$CN$CO$CO
241318382$24131838$2$F$$20240722$20240724$20240725$EXP$$US-ROCHE-10000031711$ROCHE$$71$YR$E$F$Y$100$KG$20240725$$HP$US$US
241318391$24131839$1$I$20240718$20240718$20240724$20240724$EXP$$US-GILEAD-2024-0681386$GILEAD$$37$YR$A$F$Y$$$20240724$$CN$US$US
241318401$24131840$1$I$$20240709$20240724$20240724$EXP$$CH-GLANDPHARMA-CH-2024GLNLIT00535$GLAND PHARMA$Gut L.Hypercalcemia due to severe Amiodarone-induced Thyrotoxicosis - A case report.Swiss Medical Weekly.MAY-2024;154 (Suppl.):113S abstr. P144$60$YR$A$M$Y$$$20240724$$HP$CH$CH
241318412$24131841$2$F$20220101$20240809$20240724$20240819$EXP$$CN-TEVA-VS-3222691$TEVA$Tang M, Zhang Z, Wang L, Qian H, Wu W, Liu Z, et al. Coronary artery ectasia associated with IgG4-related disease: a case report and literature review. BMC-Cardiovasc-Disord 2023; 23 (1):.; Tang M, Zhang Z, Wang L, Qian H, Wu W, Liu Z, et al. Coronary artery ectasia associated with IgG4-related disease: a case report and literature review. BMC-Cardiovasc-Disord 2023; 23 (1):.; Tang M, Zhang Z, Wang L, Qian H, Wu W, Liu Z, et al. Coronary artery ectasia associated with IgG4-related disease: a ...$77$YR$$M$Y$$$20240819$$HP$CN$CN
241318421$24131842$1$I$$20240715$20240724$20240724$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001437$BLUEPRINT MEDICINES$$$$$$Y$$$20240724$$MD$US$US
241318431$24131843$1$I$$20240722$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-012912$UNITED THERAPEUTICS$$$$$F$Y$51.247$KG$20240724$$$US$US
241318441$24131844$1$I$$20240711$20240724$20240724$PER$$US-TEVA-VS-3221200$TEVA$$$$E$M$Y$$$20240724$$CN$US$US
241318454$24131845$4$F$$20240830$20240724$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-022566$UNITED THERAPEUTICS$$$$$F$Y$85.261$KG$20240906$$$US$US
241318461$24131846$1$I$$20240715$20240724$20240724$PER$US-MLMSERVICE-20240708-PI125136-00150-2$US-RDY-SPO/USA/24/0010463$DR REDDYS$Denton J, Ozgur H, Sazegar P, Galgiani J, Riaz T. Musculoskeletal and CNS coccidiomycosis in an individual with multiple sclerosis on fingolimod - A case report. ID Cases. 2024;37: e0202.$56$YR$A$F$Y$$$20240724$$MD$US$US
241318471$24131847$1$I$$20240722$20240724$20240724$EXP$$CA-HLS-202401821$HLS THERAPEUTICS$$$$$M$Y$$$20240724$$HP$CA$CA
241318481$24131848$1$I$$20240721$20240724$20240724$PER$$US-UNITED THERAPEUTICS-UNT-2024-021875$UNITED THERAPEUTICS$$$$$F$Y$92.517$KG$20240724$$$US$US
241318491$24131849$1$I$$20240717$20240724$20240724$EXP$$CA-Orion Corporation ORION PHARMA-24_00030954$ORION$$52$YR$A$F$Y$$$20240724$$HP$CA$
241318501$24131850$1$I$$20240715$20240724$20240724$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001436$BLUEPRINT MEDICINES$$$$A$$Y$$$20240724$$MD$US$US
241318511$24131851$1$I$20240701$20240718$20240724$20240724$EXP$$US-ABBVIE-5846514$ABBVIE$$67$YR$$F$Y$$$20240724$$CN$US$US
241318532$24131853$2$F$$20240722$20240724$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117691$BRISTOL MYERS SQUIBB$$37$YR$A$M$Y$$$20240729$$CN$US$US
241318541$24131854$1$I$$20240709$20240724$20240724$EXP$$US-GLANDPHARMA-US-2024GLNLIT00503$GLAND PHARMA$A. Geller.An Exudative Enigma: Recurrent Pleural Effusions Following Drug-Eluting Bead Transarterial Chemoembolization With Percutaneous Ethanol Injection for Palliative Treatment of Hepatocellular Carcinoma.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$64$YR$A$M$Y$$$20240724$$HP$US$US
241318551$24131855$1$I$20240321$20240722$20240724$20240724$EXP$$ES-JNJFOC-20240761258$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$MD$ES$ES
241318562$24131856$2$F$20240609$20240829$20240724$20240830$EXP$$US-TAKEDA-2024TUS061375$TAKEDA$$42$YR$$$Y$$$20240830$$MD$US$US
241318571$24131857$1$I$$20240717$20240724$20240724$EXP$$US-TAKEDA-2024TUS026741$TAKEDA$$$$$F$Y$$$20240724$$CN$US$US
241318581$24131858$1$I$20210223$20240722$20240724$20240724$EXP$$FR-PFIZER INC-2021SGN01457$PFIZER$$57$YR$$F$Y$$$20240724$$MD$FR$FR
241318591$24131859$1$I$20240626$20240723$20240724$20240724$EXP$$US-PFIZER INC-202400222218$PFIZER$$75$YR$$F$Y$$$20240724$$HP$US$US
241318601$24131860$1$I$20210316$20240722$20240724$20240724$EXP$$FR-PFIZER INC-2021SGN01903$PFIZER$$82$YR$$F$Y$$$20240724$$MD$FR$FR
241318611$24131861$1$I$20220228$20240715$20240724$20240724$EXP$$CN-PFIZER INC-2022SGN04517$PFIZER$$38$YR$$F$Y$68$KG$20240724$$MD$CN$CN
241318621$24131862$1$I$20240717$20240717$20240724$20240724$EXP$$CA-PFIZER INC-202400198781$PFIZER$$58$YR$$F$Y$$$20240724$$MD$CA$CA
241318631$24131863$1$I$$20240722$20240724$20240724$EXP$$US-PFIZER INC-PV202400095964$PFIZER$$70$YR$$M$Y$$$20240724$$HP$US$US
241318642$24131864$2$F$20240101$20240813$20240724$20240815$EXP$$US-PFIZER INC-202400219093$PFIZER$$35$YR$$F$Y$$$20240815$$CN$US$US
241318651$24131865$1$I$$20240723$20240724$20240724$EXP$$CA-PFIZER INC-202400222166$PFIZER$$$$$F$Y$$$20240724$$HP$CA$CA
241318662$24131866$2$F$20210201$20240829$20240724$20240829$EXP$$FR-PFIZER INC-2021SGN01485$PFIZER$$50$YR$$F$Y$80$KG$20240829$$MD$FR$FR
241318671$24131867$1$I$$20240716$20240724$20240724$EXP$$SG-PFIZER INC-202400222035$PFIZER$$$$$$Y$$$20240724$$MD$SG$SG
241318691$24131869$1$I$$20240719$20240724$20240724$EXP$$US-PFIZER INC-202400220400$PFIZER$Sorabella, R.. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children.. ASAIO Journal. 2024;70(7):e92-6$17$YR$$M$Y$85$KG$20240724$$MD$US$US
241318701$24131870$1$I$$20240719$20240724$20240724$EXP$$CA-ANIPHARMA-2024-CA-003315$ANI$$91$YR$$M$Y$$$20240724$$MD$CA$CA
241318711$24131871$1$I$$20240722$20240724$20240724$PER$$US-BAYER-2024A106483$BAYER$$$$$F$Y$$$20240724$$CN$US$US
241318721$24131872$1$I$20240721$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50802$$FDA-CTU$$69$YR$$M$N$81.2$KG$20240723$N$$US$
241318732$24131873$2$F$20210129$20240828$20240724$20240828$EXP$$FR-PFIZER INC-2021SGN01560$PFIZER$$77$YR$$F$Y$55$KG$20240828$$MD$FR$FR
241318741$24131874$1$I$$20240722$20240724$20240724$EXP$$CA-HLS-202401820$HLS THERAPEUTICS$$73$YR$E$M$Y$$$20240724$$HP$CA$CA
241318751$24131875$1$I$20240101$20240723$20240724$20240724$EXP$BG-BDA-27893$BG-BAYER-2024A106566$BAYER$$78$YR$E$F$Y$$$20240724$$CN$BG$BG
241318761$24131876$1$I$$20240719$20240724$20240724$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700793$MYOVANT SCIENCES$$$$$M$Y$$$20240724$$CN$US$US
241318771$24131877$1$I$20240607$20240628$20240724$20240724$PER$$US-009507513-2407USA000481$MERCK$$$$$F$Y$$$20240724$$CN$US$US
241318781$24131878$1$I$$20240720$20240724$20240724$EXP$$CN-GILEAD-2024-0681445$GILEAD$$67$YR$E$F$Y$$$20240724$$HP$CN$CN
241318791$24131879$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145611$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241318801$24131880$1$I$$20240720$20240724$20240724$EXP$$US-INCYTE CORPORATION-2024IN007629$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241318821$24131882$1$I$20240712$20240715$20240724$20240724$DIR$FDA-CDER-CTU-2024-50804$$FDA-CTU$$57$YR$$M$N$84.8$KG$20240715$N$$US$
241318831$24131883$1$I$$20240723$20240723$20240723$DIR$711182$$FDA-CTU$$$$$UNK$N$$$20240723$$CN$US$
241318841$24131884$1$I$20240716$20240722$20240724$20240724$DIR$FDA-CDER-CTU-2024-50803$$FDA-CTU$$82$YR$$M$N$81.3$KG$20240722$N$$US$
241318851$24131885$1$I$$20240723$20240723$20240723$DIR$711185$$FDA-CTU$$$$$UNK$N$$$20240723$$CN$US$
241318861$24131886$1$I$20240713$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50805$$FDA-CTU$$46$YR$$M$N$$$20240723$N$HP$US$
241318871$24131887$1$I$$20240722$20240724$20240724$DIR$FDA-CDER-CTU-2024-50806$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241318883$24131888$3$F$$20240909$20240724$20240913$EXP$$US-TAKEDA-2024TUS073093$TAKEDA$$$$$M$Y$$$20240913$$CN$US$US
241318891$24131889$1$I$20240723$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50807$$FDA-CTU$$60$YR$$M$N$$$20240723$N$HP$US$
241318901$24131890$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50810$$FDA-CTU$$70$YR$$F$N$$$20240724$N$$US$
241318911$24131891$1$I$$20240719$20240724$20240724$EXP$$US-INCYTE CORPORATION-2024IN007628$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241318921$24131892$1$I$20240101$20240723$20240724$20240724$EXP$$DE-BAYER-2024A106874$BAYER$$71$YR$E$M$Y$$$20240724$$CN$DE$DE
241318931$24131893$1$I$$20240715$20240724$20240724$EXP$$US-APOTEX-2024AP008530$APOTEX$Kirmaier A, Blackshear L, Lee MSL, Kirby JE.. Cellulitis and bacteremia caused by the fish pathogen, Streptococcus iniae, in an immunocompromised patient: Case report and mini-review of zoonotic disease, lab identification, and antimicrobial susceptibility.. Diagnostic Microbiology + Infectious Disease. 2024;108:1-3$49$YR$$F$Y$$$20240724$$HP$US$US
241318941$24131894$1$I$$20240723$20240723$20240723$DIR$711202$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241318951$24131895$1$I$$20240718$20240724$20240724$DIR$FDA-CDER-CTU-2024-50814$$FDA-CTU$$$$$F$N$$$20240718$N$HP$US$
241318961$24131896$1$I$$20240723$20240723$20240723$DIR$711236$$FDA-CTU$$$$$UNK$N$$$20240723$$CN$US$
241318971$24131897$1$I$$20240716$20240724$20240724$EXP$$US-BAYER-2024A103929$BAYER$$$$$M$Y$$$20240724$$MD$US$US
241318981$24131898$1$I$$20240709$20240724$20240724$EXP$$US-GLANDPHARMA-US-2024GLNLIT00501$GLAND PHARMA$$51$YR$A$F$Y$$$20240724$$HP$US$US
241318992$24131899$2$F$20240719$20240830$20240724$20240909$PER$$US-LEO Pharma-372183$LEO PHARM$$18$YR$$M$Y$$$20240909$$CN$US$US
241319001$24131900$1$I$$20240722$20240724$20240724$EXP$$US-PFIZER INC-PV202400095595$PFIZER$Venkatraman, S.. A Rare Neurotoxicity Syndrome Following Opioid Intoxication. Annals of Neurology. 2024;96(2):412-415$55$YR$$F$Y$$$20240724$$HP$US$US
241319012$24131901$2$F$$20240823$20240724$20240902$PER$$US-AstraZeneca-2024A167187$ASTRAZENECA$$$$$F$Y$$$20240902$$HP$US$
241319021$24131902$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A163929$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241319031$24131903$1$I$$20240715$20240724$20240724$EXP$$ES-TEVA-VS-3223944$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$62$YR$$F$Y$$$20240724$$HP$ES$ES
241319051$24131905$1$I$20240603$20240717$20240724$20240724$PER$$US-ALXN-202407USA001176US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240724$$HP$US$US
241319061$24131906$1$I$$20240722$20240724$20240724$PER$$CA-HLS-202401819$HLS THERAPEUTICS$$$$$F$Y$$$20240724$$HP$CA$CA
241319071$24131907$1$I$20240501$20240716$20240724$20240724$PER$$US-INCYTE CORPORATION-2024IN007519$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241319081$24131908$1$I$20230810$20240717$20240724$20240724$EXP$$IT-SA-2024SA214976$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240724$$MD$IT$IT
241319091$24131909$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00513$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$63$YR$A$M$Y$$$20240724$$HP$CN$CN
241319103$24131910$3$F$$20240917$20240724$20240920$30DAY$$US-PFIZER INC-202400216632$PFIZER$$13$YR$$F$Y$$$20240920$$CN$US$US
241319123$24131912$3$F$$20240831$20240724$20240903$30DAY$$US-PFIZER INC-202400218960$PFIZER$$11$YR$$M$Y$33.57$KG$20240903$$HP$US$US
241319134$24131913$4$F$$20240912$20240724$20240916$30DAY$$US-PFIZER INC-202400215748$PFIZER$$14$YR$$M$Y$$$20240916$$CN$US$US
241319141$24131914$1$I$$20240715$20240724$20240724$30DAY$$US-PFIZER INC-202400215783$PFIZER$$12$YR$$F$Y$$$20240724$$CN$US$US
241319153$24131915$3$F$$20240918$20240724$20240923$30DAY$$US-PFIZER INC-202400211209$PFIZER$$8$YR$$F$Y$$$20240923$$MD$US$US
241319163$24131916$3$F$$20240831$20240724$20240903$30DAY$$PR-PFIZER INC-202400219839$PFIZER$$14$YR$$F$Y$31.75$KG$20240903$$HP$PR$PR
241319173$24131917$3$F$$20240801$20240724$20240807$30DAY$$US-PFIZER INC-202400219724$PFIZER$$8$YR$$M$Y$$$20240807$$CN$US$US
241319182$24131918$2$F$$20240824$20240724$20240826$30DAY$$US-PFIZER INC-202400215976$PFIZER$$13$YR$$M$Y$41.73$KG$20240826$$CN$US$US
241319193$24131919$3$F$$20240830$20240724$20240830$30DAY$$US-PFIZER INC-202400216748$PFIZER$$14$YR$$M$Y$54.43$KG$20240830$$CN$US$US
241319201$24131920$1$I$20240627$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024144621$AMGEN$$71$YR$E$F$Y$$$20240724$$CN$US$US
241319211$24131921$1$I$$20240709$20240724$20240724$EXP$$US-GLANDPHARMA-US-2024GLNLIT00510$GLAND PHARMA$Donato Mignone.A RUDE AWAKENING: A CASE OF SUGAMMADEX CAUSING TRANSIENT CARDIOMYOPATHY  MIMICKING STEMI.Journal of the American College of Cardiology.02-apr-2024;83(13)$43$YR$A$M$Y$$$20240724$$HP$US$US
241319221$24131922$1$I$20231006$20240719$20240724$20240724$EXP$$CA-TAKEDA-2024TUS073975$TAKEDA$$65$YR$$M$Y$$$20240724$$CN$CA$CA
241319231$24131923$1$I$$20240717$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090156$VIIV$$$$$$Y$$$20240724$$MD$US$US
241319241$24131924$1$I$$20240717$20240724$20240724$EXP$$CA-Orion Corporation ORION PHARMA-24_00030961$ORION$$30$YR$A$M$Y$$$20240724$$HP$CA$
241319253$24131925$3$F$$20240717$20240724$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114262$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$94.8$KG$20240719$$CN$US$US
241319261$24131926$1$I$$20240719$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116021$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240724$$CN$US$US
241319271$24131927$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116694$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240724$$CN$US$US
241319281$24131928$1$I$$20240604$20240724$20240724$PER$$US-ROCHE-10000028906$ROCHE$$$$$F$Y$$$20240724$$HP$US$US
241319292$24131929$2$F$20240113$20240723$20240724$20240807$EXP$$JP-JOURNEY MEDICAL CORPORATION-2024JNY00072$JOURNEY MEDICAL CORPORATION$$29$YR$$F$Y$$$20240807$$PH$JP$JP
241319302$24131930$2$F$$20240715$20240724$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112440$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240719$$CN$US$US
241319311$24131931$1$I$$20240722$20240724$20240724$PER$$US-JNJFOC-20240760340$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$MD$US$US
241319321$24131932$1$I$$20240717$20240724$20240724$EXP$$GB-TEVA-VS-3222123$TEVA$$$$$F$Y$$$20240724$$CN$GB$GB
241319331$24131933$1$I$20240723$20240723$20240724$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041615$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240724$$CN$US$US
241319342$24131934$2$F$$20240824$20240724$20240826$30DAY$$US-PFIZER INC-202400214511$PFIZER$$11$YR$$M$Y$$$20240826$$CN$US$US
241319352$24131935$2$F$$20240824$20240724$20240826$30DAY$$US-PFIZER INC-202400217799$PFIZER$$14$YR$$M$Y$$$20240826$$CN$US$US
241319363$24131936$3$F$$20240828$20240724$20240828$30DAY$$US-PFIZER INC-202400217795$PFIZER$$12$YR$$F$Y$$$20240828$$CN$US$US
241319382$24131938$2$F$$20240823$20240724$20240823$30DAY$$US-PFIZER INC-202400218943$PFIZER$$13$YR$$M$Y$$$20240823$$HP$US$US
241319391$24131939$1$I$20240101$20240712$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009789$ELI LILLY AND CO$$$$$$Y$$$20240724$$CN$US$US
241319401$24131940$1$I$20230607$20240711$20240724$20240724$EXP$GB-MHRA-MED-202407111434262140-YCZTG$GB-ELI_LILLY_AND_COMPANY-GB202407008242$ELI LILLY AND CO$$33$YR$A$F$Y$84$KG$20240724$$CN$GB$GB
241319411$24131941$1$I$$20240711$20240724$20240724$EXP$GB-MHRA-MED-202407120227134240-ZRBYF$GB-ELI_LILLY_AND_COMPANY-GB202407008240$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240724$$CN$GB$GB
241319421$24131942$1$I$$20240711$20240724$20240724$EXP$GB-MHRA-MED-202407111156506570-DLBSF$GB-ELI_LILLY_AND_COMPANY-GB202407009015$ELI LILLY AND CO$$$$$F$Y$$$20240724$$CN$GB$GB
241319431$24131943$1$I$20240701$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013940$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240724$$CN$US$US
241319442$24131944$2$F$20230101$20240729$20240724$20240805$EXP$$PT-ELI_LILLY_AND_COMPANY-PT202407008869$ELI LILLY AND CO$$61$YR$A$M$Y$100$KG$20240805$$CN$PT$PT
241319451$24131945$1$I$$20240712$20240724$20240724$EXP$GB-MHRA-MED-202407121714307050-CVBHS$GB-ELI_LILLY_AND_COMPANY-GB202407009060$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240724$$CN$GB$GB
241319461$24131946$1$I$$20240711$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008060$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240724$$CN$US$US
241319471$24131947$1$I$20240705$20240712$20240724$20240724$EXP$GB-MHRA-MED-202407121225018050-SMKPB$GB-ELI_LILLY_AND_COMPANY-GB202407009057$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240724$$CN$GB$GB
241319481$24131948$1$I$20240707$20240712$20240724$20240724$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407008342$ELI LILLY AND CO$$46$YR$A$F$Y$114$KG$20240724$$CN$GB$GB
241319491$24131949$1$I$$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50813$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241319501$24131950$1$I$$20240712$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008780$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240724$$CN$US$US
241319511$24131951$1$I$20240624$20240715$20240724$20240724$EXP$ES-AEMPS-1546657$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039708$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$98.3$KG$20240724$$MD$ES$ES
241319521$24131952$1$I$20240530$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50815$$FDA-CTU$$45$YR$$F$N$$$20240724$Y$HP$US$
241319531$24131953$1$I$$20240718$20240724$20240724$EXP$$US-SA-2024SA213529$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$CN$US$US
241319541$24131954$1$I$$20240717$20240724$20240724$EXP$$CA-Orion Corporation ORION PHARMA-24_00030952$ORION$$11$YR$C$F$Y$$$20240724$$HP$CA$
241319561$24131956$1$I$$20240722$20240724$20240724$PER$$CA-HLS-202401817$HLS THERAPEUTICS$$$$$F$Y$$$20240724$$HP$CA$CA
241319571$24131957$1$I$$20240723$20240724$20240724$PER$$US-ROCHE-10000034976$ROCHE$$51$YR$A$F$Y$49.9$KG$20240724$$HP$US$US
241319581$24131958$1$I$20240713$20240715$20240724$20240724$EXP$$PK-ROCHE-10000008282$ROCHE$$60$YR$A$F$Y$$$20240724$$CN$PK$PK
241319592$24131959$2$F$20240630$20240829$20240724$20240909$EXP$$US-SA-2024SA214294$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240909$$MD$US$US
241319601$24131960$1$I$$20240717$20240724$20240724$PER$$NVSC2024US149010$NOVARTIS$$$$$F$Y$$$20240724$$MD$US$US
241319611$24131961$1$I$20240719$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144826$AMGEN$$74$YR$E$F$Y$$$20240724$$CN$US$US
241319621$24131962$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145446$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241319631$24131963$1$I$$20240713$20240724$20240724$PER$$NL-PFM-2024-04094$PIERRE FABRE MEDICAMENT$Leenders EK, Kleimeier LE, Weeke LC, Coppens CH, Klein WM, Draaisma JM et al. Trametinib restores the central conducting lymphatic flow in a premature infant with Noonan syndrome. Clinical case reports. 2024;12:1-5$$$$$Y$$$20240724$$HP$NL$NL
241319641$24131964$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400220842$PFIZER$$59$YR$$M$Y$$$20240724$$CN$US$US
241319651$24131965$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-PV202400096123$PFIZER$$65$YR$$M$Y$$$20240724$$HP$US$US
241319661$24131966$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400221115$PFIZER$$56$YR$$F$Y$$$20240724$$PH$US$US
241319671$24131967$1$I$$20240723$20240724$20240724$PER$$US-PFIZER INC-PV202400096368$PFIZER$$47$YR$$F$Y$$$20240724$$HP$US$US
241319681$24131968$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400220832$PFIZER$$28$YR$$F$Y$$$20240724$$MD$US$US
241319691$24131969$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-PV202200071180$PFIZER$$38$YR$$F$Y$$$20240724$$CN$US$US
241319702$24131970$2$F$$20240910$20240724$20240912$PER$$US-PFIZER INC-202400221093$PFIZER$$74$YR$$F$Y$92.971$KG$20240912$$CN$US$US
241319712$24131971$2$F$20230101$20240916$20240724$20240919$PER$$US-PFIZER INC-202400220952$PFIZER$$68$YR$$F$Y$$$20240919$$HP$US$US
241319721$24131972$1$I$$20240719$20240724$20240724$PER$$US-PFIZER INC-202400221023$PFIZER$$66$YR$$F$Y$$$20240724$$HP$US$US
241319731$24131973$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-PV202400095939$PFIZER$$81$YR$$F$Y$$$20240724$$HP$US$US
241319741$24131974$1$I$$20240719$20240724$20240724$PER$$US-PFIZER INC-202400220972$PFIZER$$54$YR$$F$Y$$$20240724$$HP$US$US
241319761$24131976$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400221064$PFIZER$$43$YR$$F$Y$$$20240724$$HP$US$US
241319771$24131977$1$I$$20240720$20240724$20240724$PER$$US-PFIZER INC-202400221161$PFIZER$$77$YR$$F$Y$$$20240724$$MD$US$US
241319781$24131978$1$I$20240101$20240722$20240724$20240724$PER$$US-PFIZER INC-PV202400095934$PFIZER$$61$YR$$F$Y$$$20240724$$HP$US$US
241319792$24131979$2$F$20240701$20240724$20240724$20240729$PER$$US-PFIZER INC-PV202400095965$PFIZER$$81$YR$$M$Y$$$20240729$$HP$US$US
241319801$24131980$1$I$$20240717$20240724$20240724$EXP$$DE-TAKEDA-2024TUS059861$TAKEDA$$33$YR$$F$Y$$$20240724$$CN$DE$DE
241319811$24131981$1$I$$20240712$20240724$20240724$EXP$$GB-AMGEN-GBRSP2024146096$AMGEN$$$$$F$Y$$$20240724$$MD$GB$GB
241319822$24131982$2$F$$20240810$20240724$20240814$EXP$$US-SA-2024SA214663$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240814$$MD$US$US
241319831$24131983$1$I$$20240710$20240724$20240724$30DAY$$US-JNJFOC-20240755890$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
241319841$24131984$1$I$20231001$20240718$20240724$20240724$EXP$$BR-BIOGEN-2024BI01274752$BIOGEN$$49$YR$$F$Y$76$KG$20240724$$CN$BR$BR
241319851$24131985$1$I$$20240719$20240724$20240724$PER$$US-BEH-2024175972$CSL BEHRING$$$$A$M$Y$$$20240724$$HP$US$US
241319861$24131986$1$I$$20240711$20240724$20240724$EXP$$IN-B.Braun Medical Inc.-2159524$B BRAUN$Literature Article$4$YR$$F$Y$$$20240724$$$IN$IN
241319871$24131987$1$I$20220801$20240710$20240724$20240724$EXP$$JP-UPSHER-SMITH LABORATORIES, LLC-20240700016$UPSHER SMITH LABORATORIES$Kusudo K.; Uchida H.; Okada Y.; Yoshida K.. Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine: A Case Report. J. Clin. Pharmacol. 2024;44:4:424-425$$$A$M$Y$$$20240724$$MD$JP$JP
241319881$24131988$1$I$$20240722$20240724$20240724$EXP$$CA-HLS-202401816$HLS THERAPEUTICS$$$$$M$Y$$$20240724$$HP$CA$CA
241319891$24131989$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00515$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$17$YR$T$M$Y$$$20240724$$HP$CN$CN
241319911$24131991$1$I$$20240717$20240724$20240724$PER$$US-ALXN-202407USA001248US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
241319921$24131992$1$I$$20240719$20240724$20240724$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700794$MYOVANT SCIENCES$$$$$M$Y$$$20240724$$MD$US$US
241319931$24131993$1$I$$20240712$20240724$20240724$PER$$US-UPSHER-SMITH LABORATORIES, LLC-20240700027$UPSHER SMITH LABORATORIES$$$$$$Y$$$20240724$$MD$US$US
241319952$24131995$2$F$$20240920$20240724$20240923$EXP$$NVSC2024US150949$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
241319961$24131996$1$I$20240330$20240718$20240724$20240724$EXP$FR-AFSSAPS-PP2024000782$FR-PFIZER INC-202400218058$PFIZER$$68$YR$$F$Y$66.5$KG$20240724$$MD$FR$FR
241319971$24131997$1$I$$20240722$20240724$20240724$PER$$US-TAKEDA-2022TUS001900$TAKEDA$$$$$M$Y$$$20240724$$CN$US$US
241319981$24131998$1$I$$20240711$20240724$20240724$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700024$UPSHER SMITH LABORATORIES$$$$$F$Y$88.435$KG$20240724$$CN$US$US
241319991$24131999$1$I$20240718$20240719$20240724$20240724$EXP$$US-PFIZER INC-PV202400095579$PFIZER$$81$YR$$F$Y$$$20240724$$CN$US$US
241320001$24132000$1$I$20240507$20240722$20240724$20240724$EXP$SK-SUKLSK-20240452$SK-PFIZER INC-202400220155$PFIZER$$43$YR$$$Y$$$20240724$$MD$SK$SK
241320021$24132002$1$I$$20240720$20240724$20240724$EXP$$EG-PFIZER INC-PV202400094768$PFIZER$$65$YR$$F$Y$57$KG$20240724$$PH$EG$EG
241320032$24132003$2$F$20020301$20240725$20240724$20240726$EXP$$US-PFIZER INC-2002055810$PFIZER$Mathis, A.. Probable case of torsades de pointes induced by fluconazole. Pharmacotherapy. 2002;22(12 I):1632-1637$25$YR$$F$Y$$$20240726$$PH$US$US
241320052$24132005$2$F$20240619$20240813$20240724$20240819$EXP$$ES-PFIZER INC-202400220445$PFIZER$$77$YR$$M$Y$$$20240819$$MD$ES$ES
241320061$24132006$1$I$20240629$20240722$20240724$20240724$EXP$$CA-PFIZER INC-202400222147$PFIZER$$78$YR$$F$Y$$$20240724$$HP$CA$CA
241320071$24132007$1$I$20240627$20240722$20240724$20240724$EXP$$PR-PFIZER INC-202400221822$PFIZER$$61$YR$$M$Y$$$20240724$$HP$PR$PR
241320092$24132009$2$F$20240721$20240730$20240724$20240802$EXP$$US-PFIZER INC-202400221532$PFIZER$$86$YR$$$Y$$$20240802$$CN$US$US
241320101$24132010$1$I$20240717$20240718$20240724$20240724$EXP$$CO-PFIZER INC-PV202400095467$PFIZER$$80$YR$$F$Y$$$20240724$$CN$CO$CO
241320111$24132011$1$I$$20240722$20240724$20240724$EXP$$US-PFIZER INC-202400220795$PFIZER$$$$$F$Y$$$20240724$$MD$US$US
241320122$24132012$2$F$$20240725$20240724$20240730$EXP$$KR-PFIZER INC-PV202400095684$PFIZER$Lee, N.. Methotrexate-Induced Stroke-Like Leukoencephalopathy. Annals of Child Neurology. 2024;32(3):193-196$18$YR$$M$Y$$$20240730$$MD$KR$KR
241320131$24132013$1$I$$20240722$20240724$20240724$EXP$$JP-PFIZER INC-PV202400095657$PFIZER$$50$YR$$M$Y$$$20240724$$MD$JP$JP
241320151$24132015$1$I$20240718$20240719$20240724$20240724$EXP$GB-MHRA-MED-202407191509250810-ZFNTB$GB-PFIZER INC-202400219273$PFIZER$$66$YR$$M$Y$$$20240724$$HP$GB$GB
241320164$24132016$4$F$$20240823$20240724$20240828$EXP$$CA-PFIZER INC-202400220867$PFIZER$$73$YR$$M$Y$$$20240828$$CN$CA$CA
241320173$24132017$3$F$$20240903$20240724$20240906$EXP$$US-PFIZER INC-202400220760$PFIZER$$66$YR$$M$Y$$$20240906$$CN$US$US
241320182$24132018$2$F$20240101$20240913$20240724$20240913$EXP$$CA-PFIZER INC-202400113143$PFIZER$$56$YR$$F$Y$$$20240913$$CN$CA$CA
241320191$24132019$1$I$20240707$20240722$20240724$20240724$EXP$$CN-PFIZER INC-PV202400095732$PFIZER$$53$YR$$F$Y$$$20240724$$HP$CN$CN
241320201$24132020$1$I$20240722$20240722$20240724$20240724$EXP$$GB-PFIZER INC-202400220725$PFIZER$$77$YR$$M$Y$71$KG$20240724$$HP$GB$GB
241320222$24132022$2$F$20231201$20240719$20240724$20240726$EXP$FR-AFSSAPS-AN2024000916$FR-PFIZER INC-202400220288$PFIZER$$74$YR$$$Y$$$20240726$$MD$FR$FR
241320232$24132023$2$F$$20240801$20240724$20240805$EXP$$US-PFIZER INC-202400220747$PFIZER$$79$YR$$F$Y$63.492$KG$20240805$$CN$US$US
241320241$24132024$1$I$20220601$20240722$20240724$20240724$EXP$FR-AFSSAPS-BR2024000589$FR-PFIZER INC-202400220313$PFIZER$$60$YR$$F$Y$58$KG$20240724$$MD$FR$FR
241320261$24132026$1$I$20240102$20240722$20240724$20240724$EXP$FR-AFSSAPS-NT2024000852$FR-PFIZER INC-202400220089$PFIZER$$12$YR$$M$Y$$$20240724$$MD$FR$FR
241320273$24132027$3$F$20240529$20240806$20240724$20240808$EXP$$DE-PFIZER INC-202400220240$PFIZER$$17$YR$$F$Y$63.9$KG$20240808$$HP$DE$DE
241320281$24132028$1$I$20240703$20240719$20240724$20240724$EXP$$ES-PFIZER INC-PV202400089841$PFIZER$$61$YR$$M$Y$$$20240724$$PH$ES$ES
241320291$24132029$1$I$20240502$20240719$20240724$20240724$EXP$$CN-PFIZER INC-PV202400094974$PFIZER$$8$YR$$M$Y$25$KG$20240724$$HP$CN$CN
241320301$24132030$1$I$20240229$20240718$20240724$20240724$EXP$$FR-PFIZER INC-202400218274$PFIZER$$82$YR$$M$Y$58$KG$20240724$$MD$FR$FR
241320314$24132031$4$F$$20240826$20240724$20240904$EXP$$US-PFIZER INC-PV202400095878$PFIZER$$80$YR$$F$Y$$$20240904$$CN$US$US
241320331$24132033$1$I$20240715$20240722$20240724$20240724$EXP$$CN-PFIZER INC-PV202400095754$PFIZER$$91$YR$$F$Y$58$KG$20240724$$HP$CN$CN
241320342$24132034$2$F$$20240915$20240724$20240916$EXP$$CA-PFIZER INC-202400220770$PFIZER$$27$YR$$M$Y$$$20240916$$CN$CA$CA
241320351$24132035$1$I$20240701$20240719$20240724$20240724$EXP$$US-PFIZER INC-202300453042$PFIZER$$56$YR$$M$Y$$$20240724$$CN$US$US
241320361$24132036$1$I$$20240722$20240724$20240724$PER$$US-HALEON-2188540$Haleon PLC$$59$YR$$$Y$$$20240724$$CN$US$US
241320371$24132037$1$I$$20240723$20240724$20240724$PER$$US-TAKEDA-2024TUS074552$TAKEDA$$$$$M$Y$$$20240724$$HP$US$US
241320381$24132038$1$I$20240101$20240717$20240724$20240724$EXP$GB-MHRA-MED-202407121426166340-RWFMK$GB-TEVA-VS-3222109$TEVA$$34$YR$$F$Y$59$KG$20240724$$CN$GB$GB
241320392$24132039$2$F$$20240723$20240724$20240725$PER$$US-AMGEN-USASP2024145407$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241320401$24132040$1$I$20230125$20240722$20240724$20240724$EXP$$CA-PFIZER INC-202201337224$PFIZER$$65$YR$$M$Y$$$20240724$$MD$CA$CA
241320411$24132041$1$I$20240701$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024144063$AMGEN$$72$YR$E$F$Y$$$20240724$$CN$US$US
241320421$24132042$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117384$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240724$$HP$US$US
241320431$24132043$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024143175$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241320441$24132044$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024143164$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241320451$24132045$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142595$AMGEN$Gupta S.; Gowda N.; Gogineni K. et al.. An unusual presentation and delayed diagnosis of multifocal lung adenocarcinoma. Journal of Thoracic Oncology. 2024;19 (7):e31-e32$61$YR$A$F$Y$$$20240724$$MD$US$US
241320461$24132046$1$I$$20240718$20240724$20240724$EXP$$CN-AMGEN-CHNSP2024145100$AMGEN$Huiying Q.; Yan P.; Xiangyue Z. et al.. Clinical efficacy and safety of blinatumomab bridging CAR- T cell therapy in the treatment of patients with adult acute B-cell lymphoblastic leukemia. Chin J Hematol. 2024;45 (4):339-343$$$$$Y$$$20240724$$HP$CN$CN
241320471$24132047$1$I$$20240716$20240724$20240724$EXP$$US-AMGEN-USASP2024142623$AMGEN$Sharma R ; Gonzalez M.; Chaudhary V. et al.. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy. Experimental and Clinical Transplantation. 2024;22 (5):392-395$68$YR$E$F$Y$$$20240724$$HP$US$US
241320481$24132048$1$I$$20240718$20240724$20240724$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700784$MYOVANT SCIENCES$$$$$M$Y$$$20240724$$CN$US$US
241320491$24132049$1$I$$20240718$20240724$20240724$EXP$NL-LRB-00985458$NL-MYLANLABS-2024M1067465$MYLAN$$52$YR$$F$Y$$$20240724$$PH$NL$NL
241320501$24132050$1$I$20240707$20240717$20240724$20240724$EXP$IT-MINISAL02-994768$IT-MYLANLABS-2024M1067202$MYLAN$$$$$F$Y$$$20240724$$MD$IT$IT
241320511$24132051$1$I$20240716$20240717$20240724$20240724$EXP$$AR-MYLANLABS-2024M1066982$MYLAN$$45$YR$$F$Y$$$20240724$$CN$AR$AR
241320521$24132052$1$I$$20240718$20240724$20240724$EXP$NL-LRB-00982514$NL-MYLANLABS-2024M1067762$MYLAN$$71$YR$$M$Y$67$KG$20240724$$CN$NL$NL
241320531$24132053$1$I$20230516$20240717$20240724$20240724$EXP$$JP-009507513-2406JPN005918$MERCK$$79$YR$$F$Y$33$KG$20240724$$MD$JP$JP
241320541$24132054$1$I$$20240722$20240724$20240724$EXP$$CA-HLS-202401815$HLS THERAPEUTICS$$$$$M$Y$$$20240724$$HP$CA$CA
241320551$24132055$1$I$20240101$20240718$20240724$20240724$EXP$FR-AFSSAPS-MP2024001146$FR-CHEPLA-2024009200$CHEPLAPHARM$$33$YR$$F$Y$$$20240724$$MD$COUNTRY NOT SPECIFIED$FR
241320561$24132056$1$I$20210801$20240719$20240724$20240724$EXP$$US-CHEPLA-1400048116$CHEPLAPHARM$$75$YR$E$M$Y$$$20240724$$CN$COUNTRY NOT SPECIFIED$US
241320571$24132057$1$I$$20240718$20240724$20240724$EXP$$US-CHEPLA-2024009249$CHEPLAPHARM$$$$$M$Y$$$20240724$$MD$COUNTRY NOT SPECIFIED$US
241320582$24132058$2$F$20240101$20240812$20240724$20240814$EXP$$US-UCBSA-2024037277$UCB$$$$$M$Y$$$20240814$$CN$US$US
241320601$24132060$1$I$$20240721$20240724$20240724$EXP$$NVSC2024US149988$NOVARTIS$$31$YR$$F$Y$$$20240724$$CN$US$US
241320611$24132061$1$I$20240711$20240719$20240724$20240724$EXP$$AU-BEH-2024175995$CSL BEHRING$$4$YR$C$M$Y$$$20240724$$MD$AU$AU
241320622$24132062$2$F$$20240814$20240724$20240821$30DAY$$GR-JNJFOC-20240753785$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$GR$GR
241320631$24132063$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142954$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241320641$24132064$1$I$$20240709$20240724$20240724$EXP$$IT-LEADINGPHARMA-IT-2024LEALIT00318$LEADING PHARMA$Massimo Carollo.Not only Van Gogh: a case of BRASH syndrome with concomitant digoxin toxicity.Journal of medical case reports.JUN-2024;18$66$YR$E$F$Y$$$20240724$$HP$IT$IT
241320651$24132065$1$I$20240715$20240718$20240724$20240724$EXP$$CN-JNJFOC-20240752230$JOHNSON AND JOHNSON$$13$YR$T$F$Y$27$KG$20240724$$HP$CN$CN
241320661$24132066$1$I$$20240722$20240724$20240724$EXP$$CA-Orion Corporation ORION PHARMA-24_00030964$ORION$$88$YR$E$F$Y$$$20240724$$HP$CA$
241320671$24132067$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00519$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$22$YR$A$M$Y$$$20240724$$HP$CN$CN
241320681$24132068$1$I$$20240718$20240724$20240724$EXP$$CA-Orion Corporation ORION PHARMA-24_00030965$ORION$$81$YR$E$F$Y$$$20240724$$HP$CA$
241320693$24132069$3$F$$20240801$20240724$20240805$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-077006$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240806$$PH$CH$CH
241320701$24132070$1$I$$20240719$20240724$20240724$EXP$CA-HPFB-001074239$CA-SERVIER-S24005587$SERVIER$$$$$$Y$$$20240724$$PH$CA$CA
241320711$24132071$1$I$20240626$20240723$20240724$20240724$EXP$DK-DKMA-30735086$DK-ABBVIE-5849787$ABBVIE$$65$YR$$F$Y$$$20240724$$MD$DK$DK
241320721$24132072$1$I$20240628$20240628$20240724$20240724$PER$$US-CSL-2024-006245$CSL Plasma$$57$YR$$F$Y$$$20240724$$HP$US$US
241320734$24132073$4$F$20240727$20240731$20240724$20240807$EXP$$US-GSK-US2024086600$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
241320741$24132074$1$I$20240101$20240722$20240724$20240724$EXP$$US-PFIZER INC-202400221198$PFIZER$$80$YR$$F$Y$45.36$KG$20240724$$CN$US$US
241320751$24132075$1$I$$20240722$20240724$20240724$EXP$$US-PFIZER INC-202400221798$PFIZER$$62$YR$$F$Y$$$20240724$$CN$US$US
241320761$24132076$1$I$20070101$20240722$20240724$20240724$EXP$PT-INFARMED-T202407-332$PT-PFIZER INC-202400220334$PFIZER$$47$YR$$M$Y$$$20240724$$MD$PT$PT
241320771$24132077$1$I$$20240722$20240724$20240724$EXP$$KR-PFIZER INC-PV202400095118$PFIZER$$87$YR$$F$Y$$$20240724$$CN$KR$KR
241320781$24132078$1$I$$20240722$20240724$20240724$EXP$$IT-PFIZER INC-202400220395$PFIZER$$31$YR$$M$Y$$$20240724$$CN$IT$IT
241320791$24132079$1$I$20240713$20240722$20240724$20240724$EXP$$GB-PFIZER INC-202400220708$PFIZER$$55$YR$$F$Y$94$KG$20240724$$CN$GB$GB
241320801$24132080$1$I$20240717$20240722$20240724$20240724$EXP$$CN-PFIZER INC-PV202400095740$PFIZER$$55$YR$$M$Y$45$KG$20240724$$HP$CN$CN
241320811$24132081$1$I$20240111$20240722$20240724$20240724$EXP$FR-AFSSAPS-ST2024001188$FR-PFIZER INC-202400220228$PFIZER$$59$YR$$M$Y$$$20240724$$HP$FR$FR
241320821$24132082$1$I$$20240722$20240724$20240724$EXP$$GT-PFIZER INC-PV202400096144$PFIZER$$26$YR$$M$Y$$$20240724$$CN$GT$GT
241320831$24132083$1$I$20240706$20240722$20240724$20240724$EXP$$CN-PFIZER INC-PV202400095801$PFIZER$$49$YR$$M$Y$60$KG$20240724$$HP$CN$CN
241320841$24132084$1$I$20240515$20240722$20240724$20240724$EXP$$GB-PFIZER INC-PV202400077134$PFIZER$$80$YR$$F$Y$$$20240724$$CN$GB$GB
241320874$24132087$4$F$20240712$20240802$20240724$20240808$EXP$$CO-AKCEA THERAPEUTICS, INC.-2024IS005988$AKCEA THERAPEUTICS$$$$$$Y$$$20240808$$CN$CO$CO
241320881$24132088$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142975$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241320891$24132089$1$I$$20240627$20240724$20240724$30DAY$$US-Kaleo, Inc.-2024KL000018$KALEO$$15$YR$T$M$Y$$$20240723$$CN$US$US
241320911$24132091$1$I$$20240711$20240724$20240724$EXP$$CA-B.Braun Medical Inc.-2159525$B BRAUN$$59$YR$$M$Y$92$KG$20240724$$$CA$CA
241320921$24132092$1$I$$20240709$20240724$20240724$EXP$$CN-LEADINGPHARMA-CN-2024LEALIT00319$LEADING PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin.Journal of Medical Case Reports .04-JUN-2024;18:1-10$72$YR$E$M$Y$$$20240724$$HP$CN$CN
241320931$24132093$1$I$20240319$20240710$20240724$20240724$EXP$$CN-ROCHE-3570527$ROCHE$$84$YR$E$M$Y$$$20240724$$MD$CN$CN
241320941$24132094$1$I$$20240715$20240724$20240724$EXP$$ES-TEVA-VS-3223956$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$65$YR$$M$Y$$$20240724$$HP$ES$ES
241320951$24132095$1$I$$20240716$20240724$20240724$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001458$BLUEPRINT MEDICINES$$$$$F$Y$$$20240724$$CN$US$US
241320961$24132096$1$I$$20240722$20240724$20240724$EXP$$JP-ABBVIE-5849655$ABBVIE$$50$YR$$M$Y$$$20240724$$MD$JP$JP
241320972$24132097$2$F$$20240719$20240724$20240729$EXP$$BR-UCBSA-2024037164$UCB$$$$$$Y$$$20240729$$MD$BR$BR
241320982$24132098$2$F$20240101$20240725$20240724$20240731$EXP$$US-BIOGEN-2024BI01270487$BIOGEN$$$$$F$Y$85.352$KG$20240731$$CN$US$US
241320991$24132099$1$I$$20240711$20240724$20240724$30DAY$$US-GSK-US2024086627$GLAXOSMITHKLINE$$$$$M$Y$$$20240724$$CN$US$US
241321002$24132100$2$F$20231201$20240816$20240724$20240823$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-091923$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240823$$MD$DE$DE
241321011$24132101$1$I$20240101$20240717$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114743$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$67.13$KG$20240724$$HP$US$US
241321021$24132102$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00518$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$19$YR$A$M$Y$$$20240724$$HP$CN$CN
241321032$24132103$2$F$$20240819$20240724$20240826$30DAY$$TR-JNJFOC-20240750646$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$TR$TR
241321042$24132104$2$F$$20240726$20240724$20240730$EXP$$CA-ANIPHARMA-2024-CA-003333$ANI$$76$YR$$F$Y$73$KG$20240730$$MD$CA$CA
241321051$24132105$1$I$$20240723$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015503$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240724$$CN$US$US
241321061$24132106$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142977$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241321071$24132107$1$I$20240722$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014316$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240724$$CN$US$US
241321081$24132108$1$I$$20240712$20240724$20240724$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407009046$ELI LILLY AND CO$$$$$F$Y$$$20240724$$PH$GB$GB
241321091$24132109$1$I$$20240712$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202402013816$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240724$$CN$US$US
241321101$24132110$1$I$20240708$20240712$20240724$20240724$EXP$FR-AFSSAPS-CN2024000687$FR-ELI_LILLY_AND_COMPANY-FR202407009085$ELI LILLY AND CO$$86$YR$E$F$Y$40$KG$20240724$$CN$FR$FR
241321111$24132111$1$I$20240603$20240712$20240724$20240724$EXP$ES-AEMPS-1545208$ES-ELI_LILLY_AND_COMPANY-ES202407009081$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240724$$CN$ES$ES
241321121$24132112$1$I$$20240717$20240724$20240724$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202407011898$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240724$$CN$TW$TW
241321131$24132113$1$I$$20240719$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013294$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240724$$CN$US$US
241321142$24132114$2$F$$20240729$20240724$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407014302$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240801$$CN$US$US
241321151$24132115$1$I$20240701$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014118$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240724$$CN$US$US
241321161$24132116$1$I$20240721$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202304009100$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240724$$CN$US$US
241321171$24132117$1$I$20240711$20240718$20240724$20240724$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407014518$ELI LILLY AND CO$$25$YR$A$F$Y$33$KG$20240724$$CN$DE$CN
241321181$24132118$1$I$20240621$20240712$20240724$20240724$EXP$FR-AFSSAPS-LL2024001281$FR-ELI_LILLY_AND_COMPANY-FR202407009087$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240724$$CN$FR$FR
241321191$24132119$1$I$$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013390$ELI LILLY AND CO$$66$YR$E$$Y$$$20240724$$CN$US$US
241321201$24132120$1$I$$20240717$20240724$20240724$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202407011912$ELI LILLY AND CO$$88$YR$E$M$Y$$$20240724$$CN$TW$TW
241321211$24132121$1$I$20240621$20240712$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008983$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240724$$CN$US$US
241321232$24132123$2$F$$20240715$20240724$20240726$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407009089$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240726$$CN$DE$DE
241321241$24132124$1$I$$20240712$20240724$20240724$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008618$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240724$$CN$US$US
241321251$24132125$1$I$$20240717$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407012478$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240724$$CN$US$US
241321261$24132126$1$I$20240707$20240723$20240724$20240724$EXP$$CN-BAYER-2024A107321$BAYER$$58$YR$A$M$Y$75$KG$20240724$$HP$CN$CN
241321271$24132127$1$I$$20240722$20240724$20240724$EXP$$US-UCBSA-2024037156$UCB$$$$$M$Y$$$20240724$$HP$US$US
241321281$24132128$1$I$$20240723$20240724$20240724$PER$$US-HALEON-2188669$Haleon PLC$$$$$$Y$$$20240724$$CN$US$US
241321292$24132129$2$F$20240620$20240718$20240724$20240801$EXP$IT-MINISAL02-994287$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06790$HIKMA$$23$YR$$F$Y$$$20240801$$MD$IT$IT
241321301$24132130$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024143085$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241321311$24132131$1$I$20240718$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024143888$AMGEN$$68$YR$E$M$Y$$$20240724$$CN$US$US
241321321$24132132$1$I$$20240715$20240724$20240724$EXP$$PT-TEVA-VS-3222627$TEVA$Ambr?sio AR, Nunes FDO, Fernandes S, Tavares R, Rodrigues P. IMI-152 - (4246) - AVIUM COMPLEX. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional de Medicina Interna - Livro de resumos. 2024 May: 1435$81$YR$$F$Y$$$20240724$$MD$PT$PT
241321331$24132133$1$I$20240712$20240721$20240724$20240724$EXP$$ID-AstraZeneca-2024A167733$ASTRAZENECA$$26939$DY$$M$Y$$$20240724$$CN$ID$
241321341$24132134$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A162710$ASTRAZENECA$$$$$M$Y$74.4$KG$20240724$$CN$US$
241321351$24132135$1$I$20240708$20240718$20240724$20240724$EXP$GB-MHRA-MED-202407182009487710-VRMJW$GB-MYLANLABS-2024M1068797$MYLAN$$57$YR$$M$Y$$$20240724$$CN$GB$GB
241321361$24132136$1$I$20240701$20240716$20240724$20240724$EXP$FR-AFSSAPS-RS2024000678$FR-MYLANLABS-2024M1066676$MYLAN$$80$YR$$M$Y$60$KG$20240724$$MD$FR$FR
241321371$24132137$1$I$$20240718$20240724$20240724$EXP$NL-LRB-00984293$NL-MYLANLABS-2024M1067628$MYLAN$$92$YR$$F$Y$71$KG$20240724$$MD$NL$NL
241321381$24132138$1$I$20231001$20240718$20240724$20240724$EXP$CH-SM-2024-13329$CH-MYLANLABS-2024M1068375$MYLAN$$$$N$F$Y$2.22$KG$20240724$$PH$CH$CH
241321392$24132139$2$F$20240101$20240725$20240724$20240806$PER$$US-BAYER-2024A102992$BAYER$$39$YR$A$F$Y$122.45$KG$20240806$$MD$US$US
241321401$24132140$1$I$20240628$20240723$20240724$20240724$EXP$$US-BAYER-2024A107159$BAYER$$70$YR$E$M$Y$$$20240724$$CN$US$US
241321412$24132141$2$F$$20240715$20240724$20240812$EXP$$PT-TEVA-VS-3222157$TEVA$Chumbo C, Figueiredo F, Sarmento M, Valido T, Cruz T. PO-0253 - (2707) - The Disguised Guilty. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. 2024 May; 618. .$88$YR$$F$Y$$$20240812$$MD$PT$PT
241321421$24132142$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00520$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$62$YR$A$M$Y$$$20240724$$HP$CN$CN
241321431$24132143$1$I$$20240702$20240724$20240724$PER$$US-009507513-2407USA003259$MERCK$Singh A, Nguyen L, Everest S, Vinogradov M. Metastatic Porocarcinoma Effectively Managed by Pembrolizumab. Cureus. 2021;13 (11):e20004$79$YR$$M$Y$$$20240724$$HP$US$US
241321441$24132144$1$I$$20240718$20240724$20240724$PER$$US-BAYER-2024A105989$BAYER$$$$$$Y$$$20240724$$CN$US$US
241321451$24132145$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400222511$PFIZER$$$$A$F$Y$$$20240724$$MD$US$US
241321462$24132146$2$F$$20240724$20240724$20240724$PER$$US-PFIZER INC-202400222359$PFIZER$$$$$$Y$$$20240724$$CN$US$US
241321471$24132147$1$I$20240101$20240719$20240724$20240724$PER$$US-PFIZER INC-PV202400095283$PFIZER$$51$YR$$F$Y$$$20240724$$HP$US$US
241321481$24132148$1$I$$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222203$PFIZER$$$$$M$Y$$$20240724$$MD$US$US
241321491$24132149$1$I$$20240719$20240724$20240724$PER$$US-PFIZER INC-PV202400095434$PFIZER$$68$YR$$F$Y$$$20240724$$HP$US$US
241321501$24132150$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400221831$PFIZER$$77$YR$$M$Y$$$20240724$$PH$US$US
241321511$24132151$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142988$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241321521$24132152$1$I$$20240709$20240724$20240724$EXP$$JP-AMGEN-JPNSP2024144721$AMGEN$Tamura A, Higashiyama R, Yoshida T, Satozono Y, Ohe Y. Response to dabrafenib plus trametinib on a rare BRAF mutation (V600_W604 deletion-insertion R) in an advanced non-small cell lung cancer patient.. Thoracic Cancer. 2024;15:1454-6$70$YR$E$F$Y$$$20240724$$MD$JP$JP
241321531$24132153$1$I$20240706$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222267$PFIZER$$82$YR$$F$Y$$$20240724$$HP$US$US
241321551$24132155$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50817$$FDA-CTU$$28$YR$$F$N$99.79$KG$20240724$N$$US$
241321571$24132157$1$I$20240716$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50822$$FDA-CTU$$29$YR$$F$N$$$20240723$N$HP$US$
241321591$24132159$1$I$$20240719$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116725$BRISTOL MYERS SQUIBB$$27$YR$A$M$Y$$$20240724$$HP$US$US
241321601$24132160$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117051$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240724$$HP$US$US
241321612$24132161$2$F$$20240826$20240724$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117195$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$69.85$KG$20240828$$CN$US$US
241321621$24132162$1$I$$20240717$20240724$20240724$PER$$US-ABBVIE-5848616$ABBVIE$$$$$$Y$$$20240724$$MD$US$US
241321632$24132163$2$F$$20240716$20240724$20240805$EXP$$JP-009507513-2407JPN003516J$MERCK$Hase N, Yoneoka Y, Amano T, Takahashi A, Nishimura H, Deguchi M, et al.. P-180 irAEs caused by pembrolizumab use and their management at our hospital. The journal of the Japan Society of Gynecologic Oncology The 66th Annual Meeting. 2024;42(3):399$$$$F$Y$$$20240805$$MD$JP$JP
241321641$24132164$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00522$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$19$YR$A$M$Y$$$20240724$$HP$CN$CN
241321652$24132165$2$F$20240501$20240813$20240724$20240820$EXP$$CA-GSK-CA2024073199$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$MD$CA$CA
241321662$24132166$2$F$$20240725$20240724$20240802$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001454$BLUEPRINT MEDICINES$$64$YR$A$F$Y$$$20240802$$MD$CN$CN
241321671$24132167$1$I$20160906$20240722$20240724$20240724$EXP$$CA-TAKEDA-2024TUS074594$TAKEDA$$61$YR$$M$Y$$$20240724$$CN$CA$CA
241321681$24132168$1$I$$20240715$20240724$20240724$PER$$US-BAYER-2024A103552$BAYER$$$$$F$Y$$$20240724$$CN$US$US
241321691$24132169$1$I$$20240722$20240724$20240724$PER$$US-HALEON-2188702$Haleon PLC$$$$$$Y$$$20240724$$CN$US$US
241321702$24132170$2$F$$20240711$20240724$20240725$EXP$$US-TEVA-VS-3222023$TEVA$$32$YR$$F$Y$$$20240725$$PH$US$US
241321711$24132171$1$I$20240529$20240715$20240724$20240724$EXP$FI-FIMEA-202402205$FI-BAXTER-2024BAX020073$BAXTER$$42$YR$$M$Y$$$20240724$$MD$FI$FI
241321721$24132172$1$I$20240717$20240718$20240724$20240724$PER$$US-BAYER-2024A106149$BAYER$$85$YR$E$F$Y$$$20240724$$CN$US$US
241321733$24132173$3$F$$20240816$20240724$20240821$EXP$$GB-MYLANLABS-2024M1068126$MYLAN$$$$$M$Y$$$20240821$$MD$GB$GB
241321741$24132174$1$I$$20240718$20240724$20240724$EXP$$US-BEH-2024175992$CSL BEHRING$$$$A$M$Y$$$20240724$$HP$US$US
241321761$24132176$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145612$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241321771$24132177$1$I$20230920$20240717$20240724$20240724$EXP$$CA-GSK-CA2023146545$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$CA$CA
241321781$24132178$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00527$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$39$YR$A$M$Y$$$20240724$$HP$CN$CN
241321791$24132179$1$I$$20240715$20240724$20240724$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001427$BLUEPRINT MEDICINES$$$$$F$Y$$$20240724$$CN$US$US
241321801$24132180$1$I$20240722$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145616$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
241321811$24132181$1$I$20240721$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145820$AMGEN$$62$YR$A$M$Y$$$20240724$$CN$US$US
241321821$24132182$1$I$20240617$20240722$20240724$20240724$EXP$$NVSC2024IN151098$NOVARTIS$$61$YR$$M$Y$$$20240724$$CN$IN$IN
241321832$24132183$2$F$20240617$20240717$20240724$20240731$EXP$$US-BEH-2024175841$CSL BEHRING$$32$YR$A$M$Y$$$20240731$$CN$US$US
241321841$24132184$1$I$20240713$20240716$20240724$20240724$EXP$GB-MHRA-MED-202407160144527060-FLSYZ$GB-TEVA-VS-3221861$TEVA$$26$YR$$F$Y$$$20240724$$CN$GB$GB
241321851$24132185$1$I$$20240718$20240724$20240724$EXP$$CA-SHIRE-CA201911166AA$TAKEDA$$$$$M$Y$$$20240724$$CN$CA$CA
241321861$24132186$1$I$20240709$20240712$20240724$20240724$PER$$US-TEVA-VS-3221554$TEVA$$63$YR$$M$Y$$$20240724$$CN$US$US
241321871$24132187$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116279$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240724$$CN$US$US
241321881$24132188$1$I$$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115906$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240724$$CN$US$US
241321892$24132189$2$F$$20240904$20240724$20240905$PER$$US-AstraZeneca-2024A165440$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
241321901$24132190$1$I$$20240715$20240724$20240724$EXP$$ES-TEVA-VS-3223958$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$53$YR$$M$Y$$$20240724$$HP$ES$ES
241321911$24132191$1$I$20240701$20240716$20240724$20240724$EXP$$JP-AstraZeneca-2024A163973$ASTRAZENECA$$63$YR$$M$Y$$$20240724$$MD$JP$
241321921$24132192$1$I$$20240711$20240724$20240724$EXP$$IN-B.Braun Medical Inc.-2159526$B BRAUN$Literature Article$22$YR$$M$Y$$$20240724$$$IN$IN
241321932$24132193$2$F$20231109$20240807$20240724$20240823$PER$$US-BAYER-2024A106895$BAYER$$3$YR$C$F$Y$$$20240823$$CN$US$US
241321942$24132194$2$F$$20240823$20240724$20240830$30DAY$$BR-JNJFOC-20240746963$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$PH$BR$BR
241321954$24132195$4$F$20240719$20240828$20240724$20240903$30DAY$$US-JNJFOC-20240753155$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$CN$US$US
241321961$24132196$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00529$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$71$YR$E$F$Y$$$20240724$$HP$CN$CN
241321971$24132197$1$I$$20240717$20240724$20240724$EXP$GB-MHRA-MED-202407171056261430-WSPDC$GB-TEVA-VS-3223062$TEVA$$59$YR$$F$Y$$$20240724$$PH$GB$GB
241321981$24132198$1$I$20240611$20240717$20240724$20240724$PER$$US-Vifor (International) Inc.-VIT-2024-06418$VIFOR$$61$YR$$F$Y$130.7$KG$20240724$$HP$US$US
241321991$24132199$1$I$$20240703$20240724$20240724$EXP$$US-Vifor (International) Inc.-VIT-2024-06015$VIFOR$$$$$M$Y$$$20240724$$HP$US$US
241322001$24132200$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50824$$FDA-CTU$$$$$F$N$$$20240724$N$HP$US$
241322011$24132201$1$I$20240615$20240717$20240724$20240724$PER$$US-Vifor (International) Inc.-VIT-2024-06415$VIFOR$$51$YR$$F$Y$46.8$KG$20240724$$HP$US$US
241322021$24132202$1$I$20240603$20240717$20240724$20240724$PER$$US-Vifor (International) Inc.-VIT-2024-06416$VIFOR$$51$YR$$M$Y$95$KG$20240724$$HP$US$US
241322033$24132203$3$F$$20240829$20240724$20240830$PER$$US-ROCHE-10000031105$ROCHE$$$$E$F$Y$64$KG$20240830$$PH$US$US
241322041$24132204$1$I$$20240723$20240724$20240724$PER$$US-BAYER-2024A106952$BAYER$$$$$F$Y$$$20240724$$CN$US$US
241322051$24132205$1$I$$20240711$20240724$20240724$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03399$HIKMA$$85$YR$$F$Y$$$20240724$$CN$US$US
241322061$24132206$1$I$$20240716$20240724$20240724$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06363$VIFOR$$62$YR$$M$Y$$$20240724$$HP$ZA$ZA
241322071$24132207$1$I$$20240723$20240724$20240724$PER$$US-ROCHE-10000034453$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241322081$24132208$1$I$$20240717$20240724$20240724$EXP$$CA-ABBVIE-5850421$ABBVIE$$$$E$M$Y$$$20240724$$HP$CA$CA
241322091$24132209$1$I$$20240716$20240724$20240724$PER$$US-ALXN-202407USA001122US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
241322101$24132210$1$I$$20240723$20240724$20240724$PER$$US-ROCHE-10000034523$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241322112$24132211$2$F$20240628$20240827$20240724$20240910$EXP$$JP-ALXN-202407JPN000442JPAA$ALEXION PHARMACEUTICALS$$6$DEC$$F$Y$$$20240910$$MD$JP$JP
241322121$24132212$1$I$$20240723$20240724$20240724$PER$$US-ROCHE-10000034421$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241322132$24132213$2$F$$20240815$20240724$20240819$30DAY$$JP-JNJFOC-20240743415$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$JP$JP
241322141$24132214$1$I$20240101$20240716$20240724$20240724$EXP$$US-ABBVIE-5846106$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241322151$24132215$1$I$$20240719$20240724$20240724$PER$$US-BAYER-2024A105510$BAYER$$18$YR$A$F$Y$$$20240724$$MD$US$US
241322161$24132216$1$I$20240722$20240723$20240724$20240724$PER$$US-BAYER-2024A107045$BAYER$$79$YR$E$F$Y$$$20240724$$CN$US$US
241322171$24132217$1$I$$20240604$20240724$20240724$PER$$US-ALVOGEN-2024094823$ALVOGEN$$58$YR$$M$Y$$$20240724$$CN$US$US
241322181$24132218$1$I$$20240719$20240724$20240724$EXP$$US-JNJFOC-20240710279$JOHNSON AND JOHNSON$$81$YR$E$F$Y$58.2$KG$20240724$$HP$US$US
241322191$24132219$1$I$$20240711$20240724$20240724$EXP$$CA-MACLEODS PHARMA-MAC2020027794$MACLEODS$Cowley E, Omar MA.Suspected Drug-Induced Rhabdomyolysis From the Combination of Atorvastatin, Amiodarone, and Ciprofloxacin.Annals of Pharmacotherapy.2020;1-2$$$$$Y$$$20240724$$PH$CA$CA
241322201$24132220$1$I$$20240711$20240724$20240724$EXP$$DE-MACLEODS PHARMA-MAC2014001280$MACLEODS$Paparoupa M, Pietrzak S, Gillissen A..Acute rhabdomyolysis associated with coadministration of levofloxacin and simvastatin in a patient with normal renal function.Case Rep Med..2014;2014:562929$$$$$Y$$$20240724$$HP$DE$DE
241322211$24132221$1$I$$20240711$20240724$20240724$EXP$US-MACLEODS PHARMA UK LTD-MAC2019022714$US-MACLEODS PHARMA UK LTD-MAC2019022714$MACLEODS$$$$$$Y$$$20240724$$PH$US$US
241322222$24132222$2$F$$20240724$20240724$20240803$EXP$$PE-MACLEODS PHARMA-MAC2024048378$MACLEODS$$$$$$Y$$$20240803$$CN$PE$PE
241322231$24132223$1$I$$20240711$20240724$20240724$EXP$$IL-MACLEODS PHARMA-MAC2024048342$MACLEODS$Gazit I, Wussuki-Lior O, Tauber T, Morad Y.Systemic Treatment With Cyclosporine A in Children With Severe Vernal Keratoconjunctivitis.Cornea.2024;00:1-4$$$$$Y$$$20240724$$MD$IL$IL
241322241$24132224$1$I$$20240711$20240724$20240724$EXP$$SA-MACLEODS PHARMA-MAC2024048364$MACLEODS$Irfan F, Karim SI.Co-prescription of ciprofloxacin and statins; a dangerous combination: Case Report.JPMA. The Journal of the Pakistan Medical Association.01-JUL-2020;70(7):1272-4$65$YR$A$F$Y$$$20240724$$HP$SA$SA
241322251$24132225$1$I$$20240711$20240724$20240724$EXP$$TR-MACLEODS PHARMA-MAC2024048341$MACLEODS$Visneci EF, Aydin T, Tekin FC, Acar D.A Case of Pulmonary Embolism after Receiving a Dose of Sildenafil..Akademik Acil Tip Olgu Sunumlari Dergisi.2024;15(2):53-5$$$$$Y$$$20240724$$MD$TR$TR
241322261$24132226$1$I$$20240711$20240724$20240724$EXP$$CN-MACLEODS PHARMA-MAC2024048361$MACLEODS$Zhang W, Liu X, Wang X, Ma H, Zhang P..Case report: Propylthiouracil-induced serious side effect: Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis or IgA vasculitis.Medicine (Baltimore).05-JUL-2024;103(27):e38790:1-6$$$$$Y$$$20240724$$MD$CN$CN
241322272$24132227$2$F$$20240711$20240724$20240726$EXP$$US-MACLEODS PHARMA-MAC2024048360$MACLEODS$Kumar T, White AM, White A..Diagnosis of Graves^ Disease and Methimazole-Induced Lupus Erythematosus in an Adolescent Male During the COVID-19 Era: A Case Report.Cureus.09-JUN-2024;16(6):e62023$$$$$Y$$$20240726$$HP$US$US
241322281$24132228$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090946$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241322291$24132229$1$I$$20240711$20240724$20240724$EXP$$BE-MACLEODS PHARMA-MAC2024048369$MACLEODS$De Schryver N, Wittebole X, Van den Bergh P, Haufroid V, Goffin E, Hantson P..Severe rhabdomyolysis associated with simvastatin and role of ciprofloxacin and amlodipine coadministration..Case reports in nephrology.2015;2015(1):761393$$$$$Y$$$20240724$$HP$BE$BE
241322301$24132230$1$I$$20240717$20240724$20240724$PER$$US-AMGEN-USASP2024144471$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241322311$24132231$1$I$$20240711$20240724$20240724$EXP$$IL-MACLEODS PHARMA-MAC2024048363$MACLEODS$Korzets A, Gafter U, Dicker D, Herman M, Ori Y..Levofloxacin and rhabdomyolysis in a renal transplant patient.Nephrology Dialysis Transplantation.2006;21(11):3304-5$$$$$Y$$$20240724$$HP$IL$IL
241322322$24132232$2$F$20240701$20240726$20240724$20240731$PER$$US-AMGEN-USASP2024144250$AMGEN$$31$YR$A$F$Y$71.1$KG$20240731$$PH$US$US
241322331$24132233$1$I$$20240627$20240724$20240724$PER$$CA-TOLMAR, INC.-24CA050594$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
241322341$24132234$1$I$$20240628$20240724$20240724$PER$$CA-TOLMAR, INC.-24CA050595$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
241322351$24132235$1$I$$20240716$20240724$20240724$PER$$CA-TOLMAR, INC.-24CA050603$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
241322361$24132236$1$I$20220101$20240711$20240724$20240724$EXP$DE-EMA-DD-20240710-7482647-081633$DE-MACLEODS PHARMA-MAC2024048336$MACLEODS$$$$$$Y$$$20240724$$MD$DE$DE
241322371$24132237$1$I$20240627$20240627$20240724$20240724$PER$$CA-TOLMAR, INC.-24CA050696$TOLMAR$$83$YR$$M$Y$$$20240724$$CN$CA$CA
241322381$24132238$1$I$$20240628$20240724$20240724$PER$$CA-TOLMAR, INC.-24CA050708$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
241322391$24132239$1$I$$20240716$20240724$20240724$PER$$CA-TOLMAR, INC.-24CA050698$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
241322401$24132240$1$I$20240101$20240628$20240724$20240724$PER$$CA-TOLMAR, INC.-24CA050712$TOLMAR$$$$$M$Y$$$20240724$$CN$CA$CA
241322411$24132241$1$I$20240628$20240628$20240724$20240724$PER$$CA-TOLMAR, INC.-24CA050745$TOLMAR$$77$YR$$M$Y$$$20240724$$CN$CA$CA
241322421$24132242$1$I$$20240626$20240724$20240724$PER$$DO-TOLMAR, INC.-24DO050537$TOLMAR$$$$$M$Y$$$20240724$$CN$DO$DO
241322431$24132243$1$I$20240717$20240718$20240724$20240724$EXP$$US-ABBVIE-5846593$ABBVIE$$91$YR$$F$Y$$$20240724$$CN$US$US
241322441$24132244$1$I$$20240719$20240724$20240724$PER$$US-ROCHE-10000032551$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241322451$24132245$1$I$$20240502$20240724$20240724$PER$$US-ALVOGEN-2024094593$ALVOGEN$$$$$M$Y$$$20240724$$CN$US$US
241322463$24132246$3$F$20240301$20240823$20240724$20240828$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-261900$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$92.98$KG$20240828$$CN$CA$CA
241322472$24132247$2$F$$20240625$20240724$20240802$PER$$US-FMCRTG-FMC-2407-000771$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240719$$CN$US$US
241322482$24132248$2$F$20240628$20240627$20240724$20240802$PER$$US-FMCRTG-FMC-2407-000787$FRESENIUS MEDICAL CARE$$61$YR$A$F$Y$98.6$KG$20240719$$HP$US$US
241322491$24132249$1$I$20240412$20240624$20240724$20240724$PER$$US-FMCRTG-FMC-2406-000757$FRESENIUS MEDICAL CARE$$60$YR$A$M$Y$110$KG$20240724$$HP$US$US
241322502$24132250$2$F$20240606$20240607$20240724$20240802$PER$$US-FMCRTG-FMC-2406-000705$FRESENIUS MEDICAL CARE$$36$YR$A$F$Y$71$KG$20240719$$HP$US$US
241322512$24132251$2$F$$20240626$20240724$20240802$PER$$US-FMCRTG-FMC-2407-000782$FRESENIUS MEDICAL CARE$$62$YR$A$F$Y$132$KG$20240719$$CN$US$US
241322521$24132252$1$I$$20240715$20240724$20240724$EXP$$ES-TEVA-VS-3223965$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$66$YR$$M$Y$$$20240724$$HP$ES$ES
241322532$24132253$2$F$$20240627$20240724$20240802$PER$$US-FMCRTG-FMC-2407-000774$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240719$$HP$US$US
241322542$24132254$2$F$$20240702$20240724$20240802$PER$$US-FMCRTG-FMC-2407-000805$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240719$$CN$US$US
241322551$24132255$1$I$$20240626$20240724$20240724$PER$$US-FMCRTG-FMC-2407-000781$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240724$$HP$US$US
241322562$24132256$2$F$$20240729$20240724$20240805$EXP$$US-TAKEDA-2024TUS073494$TAKEDA$$$$$M$Y$$$20240805$$PH$US$US
241322572$24132257$2$F$$20240715$20240724$20240812$EXP$$PT-TEVA-VS-3222206$TEVA$Lopes B, Furtado D, Freitas J, Azevedo S,  Caley L, Pedro F,  Matos AL, Martins I. CO-0247 - (4553) - Olmesartan enteropathy - a rare cause of chronic diarrhea. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts [CNMI]. 2024 May; 340).$72$YR$$F$Y$$$20240812$$MD$PT$PT
241322582$24132258$2$F$20210101$20240718$20240724$20240826$PER$$US-ROCHE-3477163$ROCHE$$66$YR$E$F$Y$86.18$KG$20240826$$CN$US$US
241322592$24132259$2$F$20240719$20240729$20240724$20240730$PER$$US-PFIZER INC-202400222297$PFIZER$$64$YR$$F$Y$$$20240730$$HP$US$US
241322601$24132260$1$I$$20240719$20240724$20240724$PER$$US-PFIZER INC-PV202400095385$PFIZER$$56$YR$$M$Y$$$20240724$$HP$US$US
241322612$24132261$2$F$$20240912$20240724$20240916$EXP$$JP-PFIZER INC-PV202400095829$PFIZER$$38$YR$$M$Y$$$20240916$$PH$JP$JP
241322621$24132262$1$I$$20240723$20240724$20240724$EXP$$AU-PFIZER INC-PV202400095944$PFIZER$$73$YR$$M$Y$$$20240724$$MD$AU$AU
241322631$24132263$1$I$$20240723$20240724$20240724$EXP$$US-PFIZER INC-202400222229$PFIZER$$75$YR$$F$Y$$$20240724$$CN$US$US
241322641$24132264$1$I$20240723$20240723$20240724$20240724$EXP$$US-PFIZER INC-PV202400096266$PFIZER$$86$YR$$M$Y$$$20240724$$CN$US$US
241322652$24132265$2$F$$20240723$20240724$20240726$PER$$US-PFIZER INC-PV202400095407$PFIZER$$69$YR$$F$Y$$$20240726$$HP$US$US
241322661$24132266$1$I$20240101$20240723$20240724$20240724$EXP$ES-AEMPS-1546938$ES-PFIZER INC-202400221599$PFIZER$$71$YR$$M$Y$60$KG$20240724$$MD$ES$ES
241322671$24132267$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400222165$PFIZER$$$$$$Y$$$20240724$$MD$US$US
241322681$24132268$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50825$$FDA-CTU$$27$YR$$F$N$$$20240724$N$$US$
241322691$24132269$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400222148$PFIZER$$46$YR$$F$Y$$$20240724$$CN$US$US
241322701$24132270$1$I$$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222347$PFIZER$$$$$$Y$$$20240724$$CN$US$US
241322711$24132271$1$I$$20240723$20240724$20240724$PER$$US-PFIZER INC-PV202400096257$PFIZER$$$$$M$Y$$$20240724$$CN$US$US
241322721$24132272$1$I$20240402$20240717$20240724$20240724$EXP$$GB-009507513-2407GBR000596$MERCK$$35$YR$$M$Y$110$KG$20240724$$MD$GB$GB
241322743$24132274$3$F$20240701$20240718$20240724$20240730$EXP$$CA-TEVA-VS-3223470$TEVA$$76$YR$$F$Y$$$20240730$$HP$CA$CA
241322751$24132275$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50828$$FDA-CTU$$47$YR$$F$N$$$20240724$N$$US$
241322761$24132276$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00531$GLAND PHARMA$Yulu Zhou.Case analysis of hepatotoxicity caused by vancomycin..Journal of Medical Case Reports.04-JUN-2024;18:1-10$34$YR$A$F$Y$$$20240724$$HP$CN$CN
241322771$24132277$1$I$$20240723$20240724$20240724$EXP$$CA-PFIZER INC-202400222164$PFIZER$$62$YR$$M$Y$$$20240724$$CN$CA$CA
241322781$24132278$1$I$20240722$20240723$20240723$20240723$DIR$711258$$FDA-CTU$$35$YR$$F$N$82.35$KG$20240723$Y$CN$US$
241322791$24132279$1$I$20240407$20240723$20240723$20240723$DIR$711229$$FDA-CTU$$56$YR$$F$N$100$KG$20240723$N$CN$AU$
241322801$24132280$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117620$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240724$$CN$US$US
241322811$24132281$1$I$$20240722$20240724$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-117275$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240724$$MD$JP$JP
241322821$24132282$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145214$AMGEN$$$$$F$Y$$$20240724$$HP$US$US
241322831$24132283$1$I$$20240717$20240724$20240724$EXP$GB-MHRA-MED-202407171042467250-HLSVN$GB-TEVA-VS-3222928$TEVA$$60$YR$$F$Y$$$20240724$$PH$GB$GB
241322841$24132284$1$I$20240719$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145452$AMGEN$$$$$F$Y$$$20240724$$HP$US$US
241322851$24132285$1$I$20240718$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145619$AMGEN$$75$YR$E$F$Y$$$20240724$$CN$US$US
241322871$24132287$1$I$20240708$20240709$20240724$20240724$30DAY$$CL-PFIZER INC-202400213552$PFIZER$$10$YR$$M$Y$$$20240724$$CN$CL$CL
241322881$24132288$1$I$$20240711$20240724$20240724$30DAY$$GB-PFIZER INC-PV202400091700$PFIZER$$12$YR$$M$Y$$$20240724$$CN$GB$GB
241322891$24132289$1$I$20240501$20240723$20240723$20240723$DIR$711245$$FDA-CTU$$52$YR$$F$N$105.75$KG$20240723$N$MD$US$
241322903$24132290$3$F$20240101$20240915$20240724$20240916$EXP$$CA-PFIZER INC-202400219196$PFIZER$$36$YR$$M$Y$$$20240916$$HP$CA$CA
241322913$24132291$3$F$$20240912$20240724$20240916$30DAY$$CL-PFIZER INC-202400221900$PFIZER$$$$$$Y$$$20240916$$CN$CL$CL
241322921$24132292$1$I$$20240719$20240724$20240724$EXP$$AR-PFIZER INC-202400220829$PFIZER$$10$YR$$M$Y$$$20240724$$CN$AR$AR
241322932$24132293$2$F$$20240722$20240724$20240729$30DAY$$GB-PFIZER INC-PV202400095519$PFIZER$$87$YR$$M$Y$$$20240729$$CN$GB$GB
241322944$24132294$4$F$$20240916$20240724$20240918$30DAY$$CL-PFIZER INC-202400220663$PFIZER$$15$YR$$$Y$$$20240918$$CN$CL$CL
241322951$24132295$1$I$20240618$20240721$20240724$20240724$EXP$$NVSC2024CN151581$NOVARTIS$$55$YR$$F$Y$68$KG$20240724$$HP$CN$CN
241322961$24132296$1$I$20230401$20240717$20240724$20240724$EXP$$GR-BIOCON BIOLOGICS LIMITED-BBL2023002134$BIOCON$$$$$$Y$$$20240724$$MD$GR$GR
241322972$24132297$2$F$20240622$20240724$20240724$20240731$EXP$$AU-TAKEDA-2024TUS064053$TAKEDA$$48$YR$$F$Y$$$20240731$$HP$AU$AU
241322981$24132298$1$I$$20240723$20240724$20240724$PER$$US-ROCHE-10000034694$ROCHE$$$$A$M$Y$$$20240724$$CN$US$US
241322992$24132299$2$F$$20240910$20240724$20240915$PER$$US-BEH-2024175800$CSL BEHRING$$$$E$M$Y$$$20240915$$HP$US$US
241323001$24132300$1$I$$20240715$20240724$20240724$PER$$US-ABBVIE-5848232$ABBVIE$$$$$$Y$$$20240724$$MD$US$US
241323011$24132301$1$I$$20240720$20240724$20240724$PER$$US-AMGEN-USASP2024145609$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241323021$24132302$1$I$20240506$20240715$20240724$20240724$EXP$ES-AEMPS-1545204$ES-TEVA-VS-3221700$TEVA$$73$YR$$M$Y$$$20240724$$HP$ES$ES
241323031$24132303$1$I$$20240719$20240724$20240724$EXP$$US-ABBVIE-5848556$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241323041$24132304$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151811$NOVARTIS$$$$$M$Y$$$20240724$$HP$US$US
241323051$24132305$1$I$$20240709$20240724$20240724$EXP$$US-GLANDPHARMA-US-2024GLNLIT00472$GLAND PHARMA$M Ghose.Vancomycin Induced Anaphylaxis Presenting With Cardiac Arrest: Judicious Use of Antibiotic in Low Risk Procedures.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$74$YR$E$F$Y$$$20240724$$HP$US$US
241323063$24132306$3$F$20240712$20240819$20240724$20240828$30DAY$$GB-JNJFOC-20240738141$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240828$$HP$GB$GB
241323071$24132307$1$I$$20240716$20240724$20240724$PER$$US-BIOGEN-2024BI01274194$BIOGEN$$$$$F$Y$$$20240724$$CN$US$US
241323091$24132309$1$I$20240711$20240717$20240724$20240724$EXP$$CN-SA-2024SA214473$SANOFI AVENTIS$$57$YR$A$M$Y$59$KG$20240724$$HP$CN$CN
241323111$24132311$1$I$20240626$20240716$20240724$20240724$EXP$$AR-TAKEDA-2024TUS073349$TAKEDA$$31$YR$$F$Y$$$20240724$$CN$AR$AR
241323121$24132312$1$I$$20240717$20240724$20240724$EXP$CA-SA-SAC20240712001060$CA-SA-2024SA205784$SANOFI AVENTIS$$76$YR$E$M$Y$54$KG$20240724$$MD$CA$CA
241323131$24132313$1$I$20240703$20240717$20240724$20240724$EXP$$CN-SA-2024SA214263$SANOFI AVENTIS$$55$YR$A$M$Y$60$KG$20240724$$HP$CN$CN
241323142$24132314$2$F$$20240722$20240724$20240726$PER$$US-ROCHE-10000026139$ROCHE$$$$$$Y$$$20240726$$MD$US$US
241323151$24132315$1$I$20240101$20240718$20240724$20240724$EXP$$ES-SA-2024SA173107$SANOFI AVENTIS$$74$YR$E$F$Y$66$KG$20240724$$MD$ES$ES
241323161$24132316$1$I$20240101$20240719$20240724$20240724$EXP$$US-SA-2024SA216184$SANOFI AVENTIS$$90$YR$E$F$Y$$$20240724$$MD$US$US
241323171$24132317$1$I$$20240719$20240724$20240724$EXP$$US-SA-2024SA216271$SANOFI AVENTIS$$$$A$F$Y$61.23$KG$20240724$$MD$US$US
241323183$24132318$3$F$$20240905$20240724$20240910$30DAY$$JP-PFIZER INC-PV202400093482$PFIZER$$8$YR$$M$Y$$$20240910$$MD$JP$JP
241323191$24132319$1$I$20240101$20240625$20240724$20240724$30DAY$$CA-PFIZER INC-202400201746$PFIZER$$10$YR$$F$Y$$$20240724$$HP$CA$CA
241323212$24132321$2$F$20240626$20240805$20240724$20240807$EXP$$GB-PFIZER INC-PV202400094614$PFIZER$$10$YR$$F$Y$28$KG$20240807$$CN$GB$GB
241323221$24132322$1$I$20240701$20240719$20240724$20240724$EXP$$US-SA-2024SA215954$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240724$$MD$US$US
241323231$24132323$1$I$$20240718$20240724$20240724$EXP$$US-ABBVIE-5847022$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241323241$24132324$1$I$20240101$20240718$20240724$20240724$EXP$$CA-ABBVIE-5846334$ABBVIE$$$$$F$Y$$$20240724$$HP$CA$CA
241323251$24132325$1$I$$20240719$20240724$20240724$EXP$$GB-ABBVIE-5848657$ABBVIE$$$$A$F$Y$$$20240724$$CN$GB$GB
241323261$24132326$1$I$$20240715$20240724$20240724$EXP$$US-RDY-LIT/USA/24/0010699$DR REDDYS$O^Meara KT, Fansiwala K, Kathuria-Prakash N, El-Masry M, Oh S. Acute hypoxic respiratory failure due to Lenalidomide-induced interstitial pneumonitis in a patient with multiple myeloma. BMC Pulmonary Medicine. 2024;321(1): doi:10.1186/s12890-024-03129-z.$80$YR$E$M$Y$$$20240724$$HP$US$US
241323271$24132327$1$I$20240707$20240722$20240724$20240724$PER$$US-ROCHE-10000033806$ROCHE$$19$YR$A$M$Y$$$20240724$$CN$US$US
241323282$24132328$2$F$$20240807$20240724$20240813$PER$$US-ROCHE-10000033753$ROCHE$$1$YR$I$M$Y$$$20240813$$CN$US$US
241323291$24132329$1$I$$20240716$20240724$20240724$PER$$US-ROCHE-10000032966$ROCHE$$$$$M$Y$$$20240724$$CN$US$US
241323302$24132330$2$F$$20240723$20240724$20240729$EXP$$US-TAKEDA-2024TUS018953$TAKEDA$$$$$F$Y$$$20240729$$CN$US$US
241323311$24132331$1$I$20230101$20240717$20240724$20240724$EXP$IT-MINISAL02-989898$IT-BAYER-2024A087905$BAYER$$67$YR$E$F$Y$54$KG$20240724$$MD$IT$IT
241323321$24132332$1$I$$20240715$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112494$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240724$$HP$US$US
241323331$24132333$1$I$$20240716$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114607$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240724$$CN$US$US
241323341$24132334$1$I$20240628$20240717$20240724$20240724$PER$$US-Vifor (International) Inc.-VIT-2024-06417$VIFOR$$35$YR$$F$Y$64$KG$20240724$$HP$US$US
241323352$24132335$2$F$$20240814$20240724$20240821$PER$$US-BIOGEN-2024BI01274255$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
241323363$24132336$3$F$20240718$20240918$20240724$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116897$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240923$$CN$US$US
241323381$24132338$1$I$20230630$20240718$20240724$20240724$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407001334$ELI LILLY AND CO$$2$WK$$F$Y$$$20240724$$CN$JP$JP
241323391$24132339$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-10000034059$ROCHE$$17$YR$T$M$Y$$$20240724$$CN$US$US
241323402$24132340$2$F$$20240724$20240724$20240730$EXP$$CA-JNJFOC-20240753006$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240730$$HP$CA$CA
241323412$24132341$2$F$20240624$20240805$20240724$20240812$EXP$$AR-TAKEDA-2024TUS067605$TAKEDA$$10$YR$$M$Y$$$20240812$$CN$AR$AR
241323421$24132342$1$I$20240723$20240723$20240723$20240723$DIR$711250$$FDA-CTU$$30$YR$$F$N$$$20240723$N$PH$US$
241323431$24132343$1$I$20240416$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014794$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240724$$CN$US$US
241323441$24132344$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-10000033228$ROCHE$$81$YR$E$M$Y$$$20240724$$CN$US$US
241323451$24132345$1$I$$20240716$20240724$20240724$PER$$US-ROCHE-10000029655$ROCHE$$$$A$F$Y$$$20240724$$CN$US$US
241323462$24132346$2$F$$20240801$20240724$20240802$PER$$US-ROCHE-10000033188$ROCHE$$79$YR$E$F$Y$$$20240802$$CN$US$US
241323472$24132347$2$F$$20240723$20240724$20240725$PER$$US-ROCHE-10000032864$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241323481$24132348$1$I$$20240718$20240724$20240724$EXP$$US-GSK-US2024AMR092032$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241323491$24132349$1$I$$20240709$20240724$20240724$EXP$$US-GLANDPHARMA-US-2024GLNLIT00468$GLAND PHARMA$S Venkat Ramanan.Thyroid Tempest: Unravelling a Rare Case of Amiodarone-Induced Thyroid Storm.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A3400$74$YR$E$F$Y$$$20240724$$HP$US$US
241323501$24132350$1$I$20240710$20240723$20240723$20240723$DIR$711237$$FDA-CTU$$68$YR$$F$N$70.2$KG$20240723$N$HP$US$
241323511$24132351$1$I$$20240715$20240724$20240724$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001451$BLUEPRINT MEDICINES$$$$$F$Y$$$20240724$$CN$US$US
241323521$24132352$1$I$$20240715$20240724$20240724$EXP$$CO-VANTIVE-2024VAN018314$Vantive US Healthcare$$$$$M$Y$$$20240724$$HP$CO$CO
241323531$24132353$1$I$$20240718$20240724$20240724$EXP$$JP-AstraZeneca-2024A166519$ASTRAZENECA$$$$$$Y$$$20240724$$MD$JP$
241323541$24132354$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145886$AMGEN$$$$$F$Y$$$20240724$$PH$US$US
241323551$24132355$1$I$$20240716$20240724$20240724$EXP$$US-AMGEN-USASP2024144271$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241323572$24132357$2$F$20240716$20240723$20240724$20240731$EXP$$IN-VANTIVE-2024VAN018502$Vantive US Healthcare$$8$YR$$M$Y$$$20240731$$CN$IN$IN
241323581$24132358$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-10000033427$ROCHE$$10$YR$C$M$Y$$$20240724$$CN$US$US
241323592$24132359$2$F$$20240726$20240724$20240730$EXP$$JP-BEH-2024175949$CSL BEHRING$$7$DY$N$M$Y$2.598$KG$20240730$$MD$JP$JP
241323602$24132360$2$F$$20240906$20240724$20240906$PER$$NVSC2024US151380$NOVARTIS$$$$$F$Y$$$20240906$$HP$US$US
241323612$24132361$2$F$20240719$20240730$20240724$20240805$EXP$$CA-JNJFOC-20240754717$JOHNSON AND JOHNSON$$25$YR$A$M$Y$101$KG$20240804$$HP$CA$CA
241323622$24132362$2$F$$20240723$20240724$20240725$EXP$$US-ROCHE-10000033787$ROCHE$$$$A$F$Y$$$20240725$$CN$US$US
241323631$24132363$1$I$20240701$20240719$20240724$20240724$EXP$$US-ABBVIE-5848362$ABBVIE$$87$YR$$M$Y$$$20240724$$CN$US$US
241323641$24132364$1$I$$20240709$20240724$20240724$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06484$LUPIN$Naumann J, Naumann T. Acute precipitated opioid withdrawal with akathisia, delirium, and lactic acidosis from low-dose naltrexone for chronic pain: case report. Pain Medicine Case Reports. 2023;7(8):353-356$$$A$M$Y$$$20240724$$MD$US$US
241323651$24132365$1$I$$20240722$20240724$20240724$EXP$$GR-PFIZER INC-2024SGN00446$PFIZER$$$$$F$Y$$$20240724$$MD$GR$GR
241323661$24132366$1$I$$20240719$20240724$20240724$EXP$$US-PFIZER INC-202400221989$PFIZER$Hernandez, J.. Mycobacterium abscessus infection in left ventricular assist device (LVAD): a case series. Cureus. 2021;13(6):10.7759/cureus.15718$51$YR$$M$Y$$$20240724$$HP$US$US
241323671$24132367$1$I$20240709$20240718$20240724$20240724$EXP$$CN-PFIZER INC-PV202400094443$PFIZER$$16$YR$$F$Y$$$20240724$$HP$CN$CN
241323682$24132368$2$F$$20240722$20240724$20240731$EXP$$US-PFIZER INC-PV202400095378$PFIZER$Neyra, K.. Acute eosinophilic pneumonia due to exposure to daptomycin leading to ventilator-dependent respiratory failure. Chest. 2015;148(4):0286-0287$73$YR$$M$Y$$$20240731$$MD$US$US
241323692$24132369$2$F$20231110$20240725$20240724$20240730$EXP$FR-AFSSAPS-NC2024000650$FR-PFIZER INC-202400221888$PFIZER$$37$YR$$F$Y$$$20240730$$MD$FR$FR
241323701$24132370$1$I$$20240722$20240724$20240724$EXP$$GR-PFIZER INC-2024SGN00521$PFIZER$$$$$F$Y$$$20240724$$MD$GR$GR
241323711$24132371$1$I$$20240722$20240724$20240724$EXP$$GR-PFIZER INC-2024SGN01514$PFIZER$$$$$F$Y$$$20240724$$MD$GR$GR
241323722$24132372$2$F$20210801$20240723$20240724$20240726$EXP$$IN-PFIZER INC-202400220662$PFIZER$Sahay, M.. A Rare Malignancy Postrenal Transplantation-The Dark Side of Success. Indian Journal of Transplantation. 2024;18(2):171-73$32$YR$$M$Y$$$20240726$$MD$IN$IN
241323731$24132373$1$I$$20240717$20240724$20240724$PER$$US-BAYER-2024A104573$BAYER$$35$YR$A$F$Y$$$20240724$$CN$US$US
241323741$24132374$1$I$20240601$20240624$20240724$20240724$PER$$US-LEX-000356$LEXICON PHARMACEUTICALS$$85$YR$$M$Y$$$20240724$$CN$US$US
241323751$24132375$1$I$$20240719$20240724$20240724$PER$$US-ROCHE-10000032347$ROCHE$$52$YR$A$F$Y$$$20240724$$HP$US$US
241323761$24132376$1$I$$20240709$20240724$20240724$EXP$$US-GLANDPHARMA-US-2024GLNLIT00469$GLAND PHARMA$S Goswami.Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series.Pediatric Nephrology .JAN-2024$15$YR$T$M$Y$$$20240724$$HP$US$US
241323771$24132377$1$I$20230101$20240718$20240724$20240724$EXP$$US-INCYTE CORPORATION-2024IN007675$INCYTE$$$$$$Y$$$20240724$$MD$US$US
241323782$24132378$2$F$20220501$20240819$20240724$20240823$EXP$$US-UCBSA-2024035019$UCB$$86$YR$$F$Y$$$20240823$$CN$US$US
241323791$24132379$1$I$20240701$20240722$20240724$20240724$EXP$$US-UCBSA-2024037136$UCB$$31$YR$$F$Y$$$20240724$$HP$US$US
241323802$24132380$2$F$$20240730$20240724$20240802$EXP$$US-INCYTE CORPORATION-2024IN007691$INCYTE$$$$$$Y$$$20240802$$CN$US$US
241323811$24132381$1$I$$20240713$20240724$20240724$PER$$US-JNJFOC-20240737328$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
241323822$24132382$2$F$$20240820$20240724$20240827$30DAY$$US-GSK-US2024088658$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$HP$US$US
241323831$24132383$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142408$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241323842$24132384$2$F$20240717$20240924$20240724$20240930$EXP$$US-INCYTE CORPORATION-2024IN007678$INCYTE$$$$$$Y$$$20240930$$CN$US$US
241323851$24132385$1$I$20240101$20240722$20240724$20240724$EXP$$US-INCYTE CORPORATION-2024IN007682$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241323861$24132386$1$I$$20240709$20240724$20240724$EXP$$IT-GLANDPHARMA-IT-2024GLNLIT00493$GLAND PHARMA$$66$YR$E$F$Y$$$20240724$$HP$IT$IT
241323871$24132387$1$I$$20240722$20240724$20240724$EXP$$CA-HLS-202401827$HLS THERAPEUTICS$$40$YR$A$F$Y$$$20240724$$HP$CA$CA
241323881$24132388$1$I$20230226$20240715$20240724$20240724$EXP$PL-URPL-DML-MLP.4401.1.810.2023$PL-TEVA-VS-3221919$TEVA$$47$YR$$$Y$110$KG$20240724$$MD$PL$PL
241323891$24132389$1$I$20240718$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145946$AMGEN$$53$YR$A$F$Y$$$20240724$$CN$US$US
241323902$24132390$2$F$20240716$20240729$20240724$20240803$PER$$US-AMGEN-USASP2024141727$AMGEN$$66$YR$E$F$Y$73.5$KG$20240803$$PH$US$US
241323911$24132391$1$I$$20240718$20240724$20240724$EXP$$CO-ABBVIE-5850067$ABBVIE$$$$$M$Y$75$KG$20240724$$HP$CO$CO
241323921$24132392$1$I$$20240709$20240724$20240724$EXP$$US-GLANDPHARMA-US-2024GLNLIT00500$GLAND PHARMA$C Simone.Levetiracetam-associated Rhabdomyolysis. American Journal of Respiratory and Critical Care Medicine.MAY-2024;209(1)$20$YR$A$M$Y$$$20240724$$HP$US$US
241323931$24132393$1$I$$20240624$20240724$20240724$PER$$US-LEX-000357$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241323943$24132394$3$F$20240710$20240807$20240724$20240822$30DAY$$US-JNJFOC-20240733680$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240822$$CN$US$US
241323951$24132395$1$I$$20240722$20240724$20240724$EXP$$CA-HLS-202401829$HLS THERAPEUTICS$$65$YR$E$M$Y$$$20240724$$HP$CA$CA
241323961$24132396$1$I$20240530$20240625$20240724$20240724$EXP$$CN-GE HEALTHCARE-2024CSU007237$GE HEALTHCARE$$72$YR$$M$Y$60$KG$20240724$$HP$CN$CN
241323971$24132397$1$I$20240430$20240502$20240724$20240724$PER$$US-GE HEALTHCARE-2024CSU004765$GE HEALTHCARE$$62$YR$$$Y$$$20240724$$HP$US$US
241323981$24132398$1$I$20240717$20240718$20240724$20240724$EXP$GB-MHRA-MED-202407180920120750-BWGSC$GB-GE HEALTHCARE-2024CSU008159$GE HEALTHCARE$$43$YR$$M$Y$$$20240724$$HP$GB$GB
241323992$24132399$2$F$$20240709$20240724$20240906$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06941$NEUROCRINE BIOSCIENCES$$70$YR$$F$Y$$$20240906$$CN$US$US
241324001$24132400$1$I$20240220$20240715$20240724$20240724$EXP$$US-FreseniusKabi-FK202411144$FRESENIUS KABI$$59$YR$A$M$Y$60.1$KG$20240724$$HP$US$US
241324011$24132401$1$I$20240526$20240715$20240724$20240724$EXP$FR-AFSSAPS-PB2024000790$FR-FreseniusKabi-FK202411268$FRESENIUS KABI$$19$YR$A$F$Y$$$20240724$$MD$FR$FR
241324021$24132402$1$I$$20240715$20240724$20240724$EXP$$US-RDY-LIT/USA/24/0010724$DR REDDYS$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15(3): doi:10.14309/ctg.0000000000000679.$74$YR$E$F$Y$$$20240724$$MD$US$US
241324031$24132403$1$I$20240625$20240715$20240724$20240724$EXP$$ES-FreseniusKabi-FK202411188$FRESENIUS KABI$$8$YR$C$F$Y$$$20240724$$HP$ES$ES
241324051$24132405$1$I$$20240715$20240724$20240724$EXP$$PT-TEVA-VS-3223053$TEVA$Carolina Coelho; In?s Fiuza Rua; Angela Ghiletchi; In?s Ferreira; S?rgio Caba?o; Rita Bernardino et.al. TRIMETHOPRIM/ SULFAMETHOXAZOLE AND KIDNEY DISEASE - A RELATIONSHIP OF TUBULAR ACIDOSIS. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional de Medicina Interna - Livro de resumos. May 2024: 655.$80$YR$$M$Y$$$20240724$$MD$PT$PT
241324061$24132406$1$I$20230623$20240722$20240724$20240724$EXP$$KR-009507513-2407KOR012030$MERCK$$$$$F$Y$$$20240724$$HP$KR$KR
241324071$24132407$1$I$20240716$20240717$20240724$20240724$EXP$$US-BIOGEN-2024BI01274226$BIOGEN$$29$YR$$F$Y$$$20240724$$MD$US$US
241324081$24132408$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117768$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240724$$CN$US$US
241324091$24132409$1$I$$20240722$20240724$20240724$EXP$$CA-HLS-202401830$HLS THERAPEUTICS$$28$YR$A$M$Y$$$20240724$$HP$CA$CA
241324101$24132410$1$I$20240101$20240719$20240724$20240724$EXP$GB-MHRA-MED-202407190921373920-WPLBN$GB-ABBVIE-5845506$ABBVIE$$77$YR$$M$Y$$$20240724$$MD$GB$GB
241324111$24132411$1$I$20240718$20240719$20240724$20240724$PER$$US-JNJFOC-20240752479$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240724$$PH$US$US
241324121$24132412$1$I$$20240723$20240723$20240723$DIR$711251$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241324131$24132413$1$I$20240723$20240723$20240723$20240723$DIR$711260$$FDA-CTU$$80$YR$$M$N$$$20240723$N$HP$US$
241324141$24132414$1$I$$20240723$20240723$20240723$DIR$711256$$FDA-CTU$$$$$UNK$N$$$20240723$N$CN$US$
241324151$24132415$1$I$20240707$20240723$20240723$20240723$DIR$711263$$FDA-CTU$$73$YR$$F$N$90$KG$20240723$N$CN$US$
241324161$24132416$1$I$20240206$20240715$20240724$20240724$EXP$$CN-PFIZER INC-202400220824$PFIZER$$30$YR$$M$Y$80$KG$20240724$$MD$CN$CN
241324172$24132417$2$F$20240625$20240726$20240724$20240731$EXP$$CN-PFIZER INC-202400220666$PFIZER$$24$YR$$F$Y$$$20240731$$HP$CN$CN
241324181$24132418$1$I$20240511$20240723$20240724$20240724$EXP$SE-SEMPA-2024-005592$SE-PFIZER INC-202400221708$PFIZER$$50$YR$$F$Y$85$KG$20240724$$MD$SE$SE
241324191$24132419$1$I$20240701$20240723$20240724$20240724$EXP$FR-AFSSAPS-PB2024000804$FR-PFIZER INC-202400221704$PFIZER$$105$YR$$F$Y$65.4$KG$20240724$$MD$FR$FR
241324202$24132420$2$F$20240101$20240723$20240724$20240802$EXP$FR-AFSSAPS-BS2024000451$FR-PFIZER INC-202400221495$PFIZER$$45$YR$$F$Y$60$KG$20240802$$MD$FR$FR
241324211$24132421$1$I$20240607$20240722$20240724$20240724$EXP$FR-AFSSAPS-TS2024000828$FR-PFIZER INC-202400220096$PFIZER$$49$YR$$F$Y$80$KG$20240724$$CN$FR$FR
241324221$24132422$1$I$20240715$20240723$20240724$20240724$EXP$$CN-PFIZER INC-PV202400096276$PFIZER$$31$YR$$F$Y$68$KG$20240724$$HP$CN$CN
241324231$24132423$1$I$$20240711$20240724$20240724$EXP$$US-PFIZER INC-PV202400091190$PFIZER$$86$YR$$F$Y$62.6$KG$20240724$$MD$US$US
241324242$24132424$2$F$20240401$20240826$20240724$20240828$EXP$IT-MINISAL02-995977$IT-PFIZER INC-202400221508$PFIZER$$61$YR$$M$Y$90$KG$20240828$$MD$IT$IT
241324253$24132425$3$F$$20240807$20240724$20240815$EXP$$ES-PFIZER INC-202400217999$PFIZER$Anto, C.. Use of isavuconazole in children with invasive fungal infection: Experience in a paediatric and tertiary care centre. 69 Congreso de la AEP, celebrado en Granada del 1 al 3 de junio de 2023. 2023;493$5$YR$$M$Y$17$KG$20240815$$MD$ES$ES
241324261$24132426$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A165615$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241324271$24132427$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146464$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241324281$24132428$1$I$$20240717$20240724$20240724$EXP$$US-AMGEN-USASP2024145225$AMGEN$$65$YR$E$M$Y$$$20240724$$MD$US$US
241324291$24132429$1$I$20240601$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144377$AMGEN$$57$YR$A$F$Y$$$20240724$$HP$US$US
241324301$24132430$1$I$20240611$20240716$20240724$20240724$EXP$NL-LRB-00985652$NL-MYLANLABS-2024M1066398$MYLAN$$$$I$$Y$$$20240724$$MD$NL$NL
241324314$24132431$4$F$$20240918$20240724$20240920$EXP$$GB-MYLANLABS-2024M1067990$MYLAN$$$$$M$Y$$$20240920$$PH$GB$GB
241324321$24132432$1$I$$20240716$20240724$20240724$EXP$NL-LRB-00981718$NL-MYLANLABS-2024M1066742$MYLAN$$$$N$M$Y$4$KG$20240724$$MD$NL$NL
241324331$24132433$1$I$20121101$20240715$20240724$20240724$EXP$$ES-MYLANLABS-2023M1123136$MYLAN$Casado E, Costa E, Mezquita-Raya P, Andujar-Espinosa R, Neyro JL.. Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases.. Drugs Context.. 2023;12:1-13$73$YR$$M$Y$$$20240724$$HP$ES$ES
241324341$24132434$1$I$$20240715$20240724$20240724$EXP$$PL-Covis Pharma GmbH-2024COV00905$COVIS PHARMA$$$$$M$Y$$$20240724$$CN$PL$PL
241324361$24132436$1$I$$20240723$20240724$20240724$EXP$$CA-ORGANON-O2407CAN002163$ORGANON$$60$YR$$F$Y$$$20240724$$HP$CA$CA
241324371$24132437$1$I$$20240709$20240724$20240724$EXP$$PL-GLANDPHARMA-PL-2024GLNLIT00484$GLAND PHARMA$Aneta Klotzka.Anthracycline-Induced Microcirculation disorders: AIM PILOT Study.KARDIOLOGIA POLSKA.13-MAY-2023;81:766-768$57$YR$A$F$Y$$$20240724$$MD$PL$PL
241324382$24132438$2$F$$20240901$20240724$20240910$EXP$$US-BAYER-2024A106466$BAYER$$$$$F$Y$$$20240910$$CN$US$US
241324391$24132439$1$I$$20240708$20240724$20240724$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06950$NEUROCRINE BIOSCIENCES$$6$DEC$$M$Y$$$20240724$$HP$US$US
241324401$24132440$1$I$20230626$20240722$20240724$20240724$EXP$$KR-009507513-2407KOR012033$MERCK$$$$$M$Y$$$20240724$$HP$KR$KR
241324411$24132441$1$I$$20240717$20240724$20240724$PER$$US-ABBVIE-5847665$ABBVIE$$$$$$Y$$$20240724$$CN$US$US
241324421$24132442$1$I$20240723$20240723$20240723$20240723$DIR$711262$$FDA-CTU$$79$YR$$F$N$$$20240723$N$HP$US$
241324441$24132444$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50833$$FDA-CTU$$68$YR$$F$N$230$LBS$20240723$N$$US$
241324451$24132445$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50849$$FDA-CTU$$74$YR$$F$N$$$20240723$N$$US$
241324461$24132446$1$I$$20240717$20240724$20240724$EXP$$GR-BIOGEN-2024BI01274539$BIOGEN$$$$$M$Y$$$20240724$$MD$GR$GR
241324471$24132447$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116663$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240724$$CN$US$US
241324481$24132448$1$I$20240713$20240723$20240724$20240724$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-117553$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240724$$MD$DE$DE
241324492$24132449$2$F$20240701$20240927$20240724$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117229$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240930$$HP$US$US
241324501$24132450$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117227$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240724$$HP$US$US
241324511$24132451$1$I$$20240715$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116944$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$HP$US$MX
241324521$24132452$1$I$20240628$20240722$20240724$20240724$EXP$$CN-BAYER-2024A106383$BAYER$$57$YR$A$F$Y$72$KG$20240724$$HP$CN$CN
241324532$24132453$2$F$$20240806$20240724$20240812$PER$$US-BAYER-2024A105541$BAYER$$33$YR$A$F$Y$$$20240812$$MD$US$US
241324542$24132454$2$F$20240222$20240718$20240724$20240726$EXP$FR-AFSSAPS-BX2024001440$FR-009507513-2407FRA011596$MERCK$$48$YR$$F$Y$65$KG$20240726$$PH$FR$FR
241324551$24132455$1$I$20240716$20240716$20240724$20240724$PER$$US-ALXN-202407USA001064US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241324561$24132456$1$I$$20240715$20240724$20240724$EXP$$US-Calliditas-2024CAL01329$CALLIDITAS THERAPEUTICS$$66$YR$E$M$Y$77.7$KG$20240724$$CN$US$US
241324581$24132458$1$I$$20240709$20240724$20240724$EXP$$US-GLANDPHARMA-US-2024GLNLIT00474$GLAND PHARMA$K.E. Epler.Serotonin-Like-Syndrome Resulting From Tranexamic Acid Applied to Airways During Flexible Bronchoscopy.American Journal of Respiratory and Critical Care Medicine.2024;209:A5805$44$YR$A$M$Y$$$20240724$$HP$US$US
241324591$24132459$1$I$$20240719$20240724$20240724$EXP$$US-KYOWAKIRIN-2024KK017514$KYOWA$$$$$$Y$$$20240724$$HP$US$US
241324601$24132460$1$I$20240719$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145655$AMGEN$$66$YR$E$M$Y$$$20240724$$CN$US$US
241324611$24132461$1$I$20221115$20240717$20240724$20240724$EXP$$RU-009507513-2407RUS012158$MERCK$$$$$F$Y$$$20240724$$MD$RU$RU
241324621$24132462$1$I$20240704$20240715$20240724$20240724$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000647$PAREXEL$$$$$$Y$$$20240724$$HP$CN$CN
241324631$24132463$1$I$$20240711$20240724$20240724$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000642$PAREXEL$$$$$$Y$$$20240724$$HP$CN$CN
241324641$24132464$1$I$20130725$20171204$20240724$20240724$EXP$$FR-OTSUKA-2016_026664$OTSUKA$$29$YR$$F$Y$$$20240724$$HP$FR$FR
241324651$24132465$1$I$20240101$20240718$20240724$20240724$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012015$VERTEX$$$$A$M$Y$$$20240724$$CN$GB$GB
241324661$24132466$1$I$$20240722$20240724$20240724$PER$$NVSC2024US151020$NOVARTIS$$$$$M$Y$$$20240724$$HP$US$US
241324673$24132467$3$F$$20240912$20240724$20240917$EXP$$NVSC2024US151323$NOVARTIS$$$$$M$Y$$$20240917$$HP$US$US
241324681$24132468$1$I$20240619$20240717$20240724$20240724$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011936$VERTEX$$28$YR$$M$Y$$$20240724$$CN$GB$GB
241324691$24132469$1$I$$20240717$20240724$20240724$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011934$VERTEX$$$$$F$Y$$$20240724$$CN$GB$GB
241324701$24132470$1$I$$20240719$20240724$20240724$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012075$VERTEX$$$$A$F$Y$$$20240724$$CN$GB$GB
241324711$24132471$1$I$$20240716$20240724$20240724$PER$$US-VERTEX PHARMACEUTICALS-2024-011909$VERTEX$$3$YR$$$Y$$$20240724$$PH$US$US
241324722$24132472$2$F$$20240726$20240724$20240731$EXP$$US-VERTEX PHARMACEUTICALS-2024-011804$VERTEX$$$$T$F$Y$$$20240731$$CN$US$US
241324731$24132473$1$I$$20240717$20240724$20240724$EXP$$AU-VERTEX PHARMACEUTICALS-2024-011988$VERTEX$$17$YR$$M$Y$$$20240724$$MD$AU$AU
241324741$24132474$1$I$$20240717$20240724$20240724$EXP$$CA-VERTEX PHARMACEUTICALS-2024-011960$VERTEX$$11$YR$$F$Y$$$20240724$$PH$CA$CA
241324751$24132475$1$I$20231101$20240717$20240724$20240724$EXP$RU-RZN-2466653$RU-VERTEX PHARMACEUTICALS-2024-012046$VERTEX$$$$C$M$Y$47$KG$20240724$$MD$RU$RU
241324761$24132476$1$I$20240722$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222379$PFIZER$$52$YR$$F$Y$$$20240724$$CN$US$US
241324771$24132477$1$I$20240723$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222090$PFIZER$$36$YR$$F$Y$$$20240724$$CN$US$US
241324781$24132478$1$I$$20240719$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116052$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$71$KG$20240724$$PH$US$US
241324791$24132479$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-PV202400096008$PFIZER$$45$YR$$F$Y$$$20240724$$CN$US$US
241324801$24132480$1$I$20240722$20240722$20240724$20240724$PER$$US-PFIZER INC-202400221596$PFIZER$$53$YR$$F$Y$$$20240724$$CN$US$US
241324811$24132481$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-PV202400095967$PFIZER$$$$A$M$Y$$$20240724$$CN$US$US
241324841$24132484$1$I$20240722$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222302$PFIZER$$58$YR$$F$Y$$$20240724$$CN$US$US
241324851$24132485$1$I$$20240720$20240724$20240724$PER$$US-PFIZER INC-202400219902$PFIZER$$61$YR$$$Y$$$20240724$$CN$US$US
241324861$24132486$1$I$$20240722$20240724$20240724$PER$$JP-PFIZER INC-202400220090$PFIZER$$$$$$Y$$$20240724$$PH$JP$JP
241324873$24132487$3$F$20240701$20240826$20240724$20240829$PER$$US-PFIZER INC-202400221673$PFIZER$$74$YR$$F$Y$61.23$KG$20240829$$CN$US$US
241324881$24132488$1$I$20240721$20240724$20240724$20240724$PER$$US-PFIZER INC-202400222687$PFIZER$$37$YR$$F$Y$$$20240724$$CN$US$US
241324891$24132489$1$I$20240722$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222330$PFIZER$$51$YR$$M$Y$$$20240724$$CN$US$US
241324901$24132490$1$I$$20240719$20240724$20240724$PER$$JP-PFIZER INC-202400219956$PFIZER$$$$A$M$Y$$$20240724$$CN$JP$JP
241324921$24132492$1$I$20240723$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222346$PFIZER$$59$YR$$F$Y$$$20240724$$HP$US$US
241324932$24132493$2$F$20240701$20240722$20240724$20240725$PER$$US-PFIZER INC-202400219978$PFIZER$$72$YR$$F$Y$$$20240725$$CN$US$US
241324941$24132494$1$I$20240723$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222358$PFIZER$$70$YR$$F$Y$$$20240724$$CN$US$US
241324951$24132495$1$I$$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222349$PFIZER$$36$YR$$F$Y$$$20240724$$CN$US$US
241324963$24132496$3$F$20240719$20240903$20240724$20240905$PER$$US-PFIZER INC-PV202400096169$PFIZER$$29$YR$$M$Y$102$KG$20240905$$CN$US$US
241324971$24132497$1$I$$20240722$20240724$20240724$PER$$JP-PFIZER INC-202400220342$PFIZER$$$$$$Y$$$20240724$$PH$JP$JP
241324981$24132498$1$I$20240722$20240722$20240724$20240724$PER$$US-PFIZER INC-202400221407$PFIZER$$33$YR$$F$Y$$$20240724$$CN$US$US
241324991$24132499$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400221053$PFIZER$$35$YR$$F$Y$$$20240724$$CN$US$US
241325001$24132500$1$I$$20240722$20240724$20240724$PER$$JP-PFIZER INC-202400219974$PFIZER$$$$$$Y$$$20240724$$PH$JP$JP
241325011$24132501$1$I$20240722$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50885$$FDA-CTU$$43$YR$$M$N$$$20240723$Y$PH$US$
241325034$24132503$4$F$20240718$20240829$20240724$20240904$PER$$US-PFIZER INC-202400219909$PFIZER$$75$YR$$F$Y$65.32$KG$20240904$$CN$US$US
241325041$24132504$1$I$$20240719$20240724$20240724$PER$$US-PFIZER INC-202400220038$PFIZER$$$$$F$Y$$$20240724$$CN$US$US
241325052$24132505$2$F$20240721$20240809$20240724$20240813$PER$$US-PFIZER INC-202400221603$PFIZER$$41$YR$$F$Y$63.492$KG$20240813$$CN$US$US
241325071$24132507$1$I$20240720$20240723$20240723$20240723$DIR$711271$$FDA-CTU$$66$YR$$F$N$53.4$KG$20240723$Y$HP$US$
241325081$24132508$1$I$20240612$20240723$20240723$20240723$DIR$711276$$FDA-CTU$$59$YR$$M$N$90.9$KG$20240723$N$HP$US$
241325091$24132509$1$I$$20240722$20240724$20240724$PER$$JP-PFIZER INC-202400219968$PFIZER$$$$$$Y$$$20240724$$PH$JP$JP
241325101$24132510$1$I$20240723$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222542$PFIZER$$66$YR$$M$Y$$$20240724$$CN$US$US
241325111$24132511$1$I$20240722$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222301$PFIZER$$54$YR$$F$Y$$$20240724$$CN$US$US
241325122$24132512$2$F$20240722$20240812$20240724$20240814$PER$$US-PFIZER INC-202400222376$PFIZER$$71$YR$$M$Y$92.98$KG$20240814$$CN$US$US
241325131$24132513$1$I$20240721$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222544$PFIZER$$50$YR$$F$Y$$$20240724$$CN$US$US
241325142$24132514$2$F$$20240728$20240724$20240730$PER$$US-PFIZER INC-202400221611$PFIZER$$38$YR$$M$Y$$$20240730$$CN$US$US
241325151$24132515$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50868$$FDA-CTU$$63$YR$$$N$$$20240723$N$CN$US$
241325161$24132516$1$I$20240722$20240723$20240723$20240723$DIR$711273$$FDA-CTU$$37$YR$$F$N$68.94$KG$20240723$Y$HP$US$
241325171$24132517$1$I$20240301$20240723$20240723$20240723$DIR$711277$$FDA-CTU$$62$YR$$M$N$110.25$KG$20240723$N$CN$US$
241325181$24132518$1$I$20240723$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222280$PFIZER$$63$YR$$F$Y$$$20240724$$CN$US$US
241325191$24132519$1$I$20220101$20240722$20240724$20240724$PER$$US-PFIZER INC-202400221435$PFIZER$$$$$F$Y$$$20240724$$CN$US$US
241325202$24132520$2$F$$20240731$20240724$20240801$PER$$US-PFIZER INC-PV202400096360$PFIZER$$$$$F$Y$$$20240801$$CN$US$US
241325211$24132521$1$I$20230917$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222319$PFIZER$$65$YR$$M$Y$$$20240724$$CN$US$US
241325231$24132523$1$I$20240701$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222577$PFIZER$$39$YR$$F$Y$$$20240724$$PH$US$US
241325241$24132524$1$I$20240714$20240723$20240724$20240724$PER$$US-PFIZER INC-202400221982$PFIZER$$36$YR$$M$Y$$$20240724$$CN$US$US
241325251$24132525$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400220903$PFIZER$$76$YR$$F$Y$$$20240724$$PH$US$US
241325261$24132526$1$I$$20240719$20240724$20240724$PER$$US-PFIZER INC-PV202400096171$PFIZER$$$$$$Y$$$20240724$$CN$US$US
241325271$24132527$1$I$$20240718$20240724$20240724$PER$$US-PFIZER INC-202400218944$PFIZER$$73$YR$$F$Y$$$20240724$$MD$US$US
241325283$24132528$3$F$$20240926$20240724$20240930$PER$$US-PFIZER INC-202400222432$PFIZER$$71$YR$$F$Y$$$20240930$$MD$US$US
241325294$24132529$4$F$20240719$20240822$20240724$20240826$PER$$US-PFIZER INC-202400220266$PFIZER$$70$YR$$F$Y$56.236$KG$20240826$$HP$US$US
241325301$24132530$1$I$20240716$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222348$PFIZER$$55$YR$$F$Y$$$20240724$$CN$US$US
241325311$24132531$1$I$20240629$20240722$20240724$20240724$PER$$US-PFIZER INC-202400204250$PFIZER$$82$YR$$M$Y$72.562$KG$20240724$$CN$US$US
241325322$24132532$2$F$20240701$20240729$20240724$20240731$PER$$CN-PFIZER INC-202400222328$PFIZER$$$$$F$Y$$$20240731$$CN$CN$CN
241325331$24132533$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146225$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241325341$24132534$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145149$AMGEN$$$$$F$Y$$$20240724$$HP$US$US
241325351$24132535$1$I$20240711$20240724$20240724$20240724$EXP$CZ-CZSUKL-24002044$CZ-BAYER-2024A107444$BAYER$$70$YR$E$$Y$$$20240724$$MD$CZ$CZ
241325371$24132537$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR091396$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241325381$24132538$1$I$$20240624$20240724$20240724$PER$$US-LEX-000358$LEXICON PHARMACEUTICALS$$58$YR$$F$Y$$$20240724$$CN$US$US
241325403$24132540$3$F$20191002$20240924$20240724$20240928$EXP$$JP-ABBVIE-20K-087-3449346-00$ABBVIE$$62$YR$$M$Y$59$KG$20240928$$CN$JP$JP
241325411$24132541$1$I$20220530$20240722$20240724$20240724$EXP$FR-AFSSAPS-PC2024000564$FR-FreseniusKabi-FK202411478$FRESENIUS KABI$$40$YR$A$F$Y$70$KG$20240724$$MD$FR$FR
241325421$24132542$1$I$20240523$20240717$20240724$20240724$EXP$$IT-FreseniusKabi-FK202411355$FRESENIUS KABI$$72$YR$E$M$Y$70$KG$20240724$$MD$IT$IT
241325431$24132543$1$I$$20240709$20240724$20240724$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00492$GLAND PHARMA$Yao Wang.Efficacy of omadacycline in the treatment of Legionella pneumonia: a case report.Frontiers in cellular and infection microbiology.21-MAY-2024;14:01-05$44$YR$A$M$Y$$$20240724$$HP$CN$CN
241325441$24132544$1$I$$20240719$20240724$20240724$EXP$$US-ABBVIE-5850749$ABBVIE$$$$$$Y$$$20240724$$MD$US$US
241325451$24132545$1$I$20240418$20240715$20240724$20240724$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000649$PAREXEL$$$$$$Y$$$20240724$$HP$CN$CN
241325463$24132546$3$F$$20240715$20240724$20240805$EXP$$CN-INCYTE CORPORATION-2024IN007619$INCYTE$Zhao Y, Ma HH, Wang D, Lian HY, Wang TY, Zhang R.. Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis. ZHONGHUA-ER-KE-ZA-ZHI. 2024;62:60-5$$$$$Y$$$20240805$$HP$CN$CN
241325474$24132547$4$F$20240706$20240819$20240724$20240925$PER$$US-ROCHE-10000025705$ROCHE$$71$YR$E$F$Y$102.05$KG$20240925$$CN$US$US
241325483$24132548$3$F$20240606$20240918$20240724$20240923$PER$$US-ROCHE-10000009196$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
241325492$24132549$2$F$20240611$20240722$20240724$20240812$PER$$US-TOLMAR, INC.-24US050162$TOLMAR$$88$YR$$M$Y$$$20240812$$HP$US$US
241325502$24132550$2$F$20240612$20240723$20240724$20240819$PER$$US-TOLMAR, INC.-24US050192$TOLMAR$$$$$M$Y$$$20240819$$HP$US$US
241325511$24132551$1$I$20240621$20240625$20240724$20240724$PER$$US-TOLMAR, INC.-24US050414$TOLMAR$$37$YR$$M$Y$$$20240724$$HP$US$US
241325521$24132552$1$I$20200701$20240718$20240724$20240724$PER$$US-INCYTE CORPORATION-2024IN007609$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241325532$24132553$2$F$20240618$20240809$20240724$20240903$PER$$US-TOLMAR, INC.-24US050491$TOLMAR$$$$$M$Y$$$20240903$$HP$US$US
241325541$24132554$1$I$$20240625$20240724$20240724$PER$$US-TOLMAR, INC.-24US050431$TOLMAR$$$$$M$Y$$$20240724$$HP$US$US
241325552$24132555$2$F$20240624$20240808$20240724$20240903$PER$$US-TOLMAR, INC.-24US050458$TOLMAR$$76$YR$$M$Y$$$20240903$$HP$US$US
241325561$24132556$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-10000034586$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241325571$24132557$1$I$20240710$20240719$20240724$20240724$EXP$$US-AstraZeneca-2024A165787$ASTRAZENECA$$23551$DY$$$Y$$$20240724$$CN$US$
241325581$24132558$1$I$$20240715$20240724$20240724$EXP$$CA-APOTEX-2024AP008390$APOTEX$$69$YR$$F$Y$60$KG$20240724$$MD$CA$CA
241325591$24132559$1$I$20240101$20240718$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114821$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240724$$HP$US$US
241325601$24132560$1$I$$20230925$20240724$20240724$EXP$$US-AstraZeneca-2023A219180$ASTRAZENECA$$$$$$Y$$$20240724$$CN$US$
241325611$24132561$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024143837$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
241325622$24132562$2$F$$20240722$20240724$20240729$PER$$US-AMGEN-USASP2024145789$AMGEN$$$$$F$Y$129$KG$20240729$$CN$US$US
241325631$24132563$1$I$$20240723$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015190$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240724$$CN$US$US
241325641$24132564$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142572$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241325651$24132565$1$I$$20240712$20240724$20240724$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407009114$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240724$$CN$GB$GB
241325662$24132566$2$F$$20240712$20240724$20240724$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202407013567$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240724$$CN$DE$MX
241325671$24132567$1$I$20240710$20240712$20240724$20240724$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202407013505$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240724$$CN$DE$MX
241325681$24132568$1$I$$20240715$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407009492$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240724$$CN$US$US
241325691$24132569$1$I$20240720$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014021$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240724$$CN$US$US
241325701$24132570$1$I$$20240723$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015090$ELI LILLY AND CO$$$$$$Y$$$20240724$$PH$US$US
241325711$24132571$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014264$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240724$$CN$US$US
241325721$24132572$1$I$20240722$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014189$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240724$$CN$US$US
241325731$24132573$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014672$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240724$$CN$US$US
241325741$24132574$1$I$$20240718$20240724$20240724$PER$$US-INCYTE CORPORATION-2024IN007608$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241325751$24132575$1$I$$20240716$20240724$20240724$EXP$$US-SERB S.A.S.-2159532$LABORATOIRES SERB$$$$$F$Y$$$20240724$$PH$US$US
241325761$24132576$1$I$$20240709$20240724$20240724$EXP$$PL-GLANDPHARMA-PL-2024GLNLIT00505$GLAND PHARMA$Aneta Klotzka.Anthracycline-induced microcirculation disorders: aim pilot study.Kardiologia Polska.03-FEB-2023;81:766-768$61$YR$A$F$Y$$$20240724$$HP$PL$PL
241325791$24132579$1$I$20240723$20240723$20240723$20240723$DIR$711235$$FDA-CTU$$31$MON$$M$N$14.85$KG$20240723$Y$CN$US$
241325811$24132581$1$I$20040614$20240723$20240723$20240723$DIR$711231$$FDA-CTU$$87$YR$$M$N$81$KG$20240723$Y$CN$US$
241325822$24132582$2$F$20231101$20240809$20240724$20240818$EXP$FR-AFSSAPS-TS2024000765$FR-ROCHE-10000032690$ROCHE$$78$YR$E$F$Y$$$20240819$$MD$FR$FR
241325831$24132583$1$I$$20240721$20240724$20240724$PER$$US-ABBVIE-5851053$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241325841$24132584$1$I$$20240710$20240724$20240724$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-21574$SAMSUNG BIOEPIS$$$$$M$Y$74$KG$20240724$$PH$AU$AU
241325861$24132586$1$I$20210712$20240722$20240724$20240724$EXP$$NVSC2024KR150762$NOVARTIS$$76$YR$$M$Y$$$20240724$$HP$KR$KR
241325871$24132587$1$I$$20240716$20240724$20240724$EXP$$NVSC2024CR150960$NOVARTIS$$$$$$Y$$$20240724$$MD$CR$CR
241325887$24132588$7$F$20230209$20240904$20240724$20240909$EXP$$NVSC2024BR077235$NOVARTIS$$67$YR$$M$Y$53$KG$20240909$$MD$BR$BR
241325891$24132589$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151201$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
241325901$24132590$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-3548590$ROCHE$$65$YR$E$F$Y$$$20240724$$CN$US$US
241325911$24132591$1$I$$20240719$20240724$20240724$PER$$US-ROCHE-10000033752$ROCHE$$$$A$M$Y$$$20240724$$HP$US$US
241325921$24132592$1$I$$20240716$20240724$20240724$EXP$$JP-ROCHE-10000033093$ROCHE$$$$$F$Y$$$20240724$$PH$JP$JP
241325931$24132593$1$I$20240716$20240722$20240724$20240724$EXP$GB-MHRA-31250470$NVSC2024GB151409$NOVARTIS$$$$$M$Y$$$20240724$$HP$GB$GB
241325941$24132594$1$I$20240619$20240715$20240724$20240724$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000646$PAREXEL$$$$$$Y$$$20240724$$HP$CN$CN
241325951$24132595$1$I$20240608$20240712$20240724$20240724$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000643$PAREXEL$$$$$$Y$$$20240724$$HP$CN$CN
241325961$24132596$1$I$20200506$20240715$20240724$20240724$EXP$PL-URPL-1-3691-2020$PL-TEVA-VS-3221923$TEVA$$40$YR$$M$Y$80$KG$20240724$$MD$PL$PL
241325981$24132598$1$I$$20240718$20240724$20240724$PER$$US-INCYTE CORPORATION-2024IN007606$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241325991$24132599$1$I$20240117$20240723$20240724$20240724$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041650$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$50$KG$20240724$$MD$DE$DE
241326001$24132600$1$I$$20240716$20240724$20240724$EXP$$US-ROCHE-10000028396$ROCHE$$94$YR$E$F$Y$$$20240724$$CN$US$US
241326011$24132601$1$I$20230501$20240718$20240724$20240724$PER$$US-INCYTE CORPORATION-2024IN007605$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241326021$24132602$1$I$$20240709$20240724$20240724$EXP$$PL-GLANDPHARMA-PL-2024GLNLIT00507$GLAND PHARMA$Aneta Klotzka.Anthracycline-Induced Microcirculation disorders: AIM PILOT Study.Kardiologia Polska.13-MAY-2023;81:766-768$59$YR$A$F$Y$$$20240724$$MD$PL$PL
241326032$24132603$2$F$20230301$20240903$20240724$20240910$EXP$$US-OTSUKA-2024_020328$OTSUKA$$56$YR$$M$Y$95.25$KG$20240910$$MD$US$US
241326041$24132604$1$I$20240601$20240718$20240724$20240724$PER$$US-ABBVIE-5848040$ABBVIE$$61$YR$$M$Y$$$20240724$$CN$US$US
241326051$24132605$1$I$$20240723$20240724$20240724$PER$$US-ROCHE-10000034509$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241326061$24132606$1$I$20240322$20240719$20240724$20240724$EXP$$NVSC2024RU150252$NOVARTIS$$27$YR$$F$Y$58$KG$20240724$$HP$RU$RU
241326072$24132607$2$F$$20240716$20240724$20240724$PER$$US-ROCHE-10000028517$ROCHE$$31$YR$A$F$Y$$$20240724$$CN$US$US
241326081$24132608$1$I$$20240709$20240724$20240724$EXP$$US-GLANDPHARMA-US-2024GLNLIT00481$GLAND PHARMA$Aaron. Gans.A case of drug-induced stevens-Johnson syndrome with primarily visceral involvement.American journal of respiratory and critical care medicine.MAY-2024;209$76$YR$E$F$Y$$$20240724$$HP$US$US
241326091$24132609$1$I$$20240724$20240724$20240724$EXP$GB-MHRA-MED-202407241057230650-KMPBN$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041699$BOEHRINGER INGELHEIM$$58$YR$A$M$Y$80$KG$20240724$$CN$GB$GB
241326103$24132610$3$F$20240608$20240731$20240724$20240806$PER$$US-FreseniusKabi-FK202411306$FRESENIUS KABI$$45$YR$A$M$Y$86.5$KG$20240806$$PH$US$US
241326111$24132611$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142594$AMGEN$Dean R.M;. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241326123$24132612$3$F$20240612$20240731$20240724$20240807$PER$$US-FreseniusKabi-FK202411305$FRESENIUS KABI$$57$YR$A$M$Y$68.1$KG$20240807$$PH$US$US
241326131$24132613$1$I$20240301$20240722$20240724$20240724$EXP$FR-AFSSAPS-BX2024001457$FR-FreseniusKabi-FK202411479$FRESENIUS KABI$$65$YR$E$M$Y$$$20240724$$MD$FR$FR
241326141$24132614$1$I$$20240715$20240724$20240724$EXP$$PT-TEVA-VS-3222475$TEVA$Farinha D, Couto M, Barroso J, Gomes C, Reis M. CO-0133 - (4713) - Statin-induced necrotizing myopathy is a rare, immune-mediated adverse effect. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional de Medicina Interna - Livro de resumos. 2024 May: 234.$69$YR$$M$Y$$$20240724$$MD$PT$PT
241326153$24132615$3$F$20240101$20240826$20240724$20240828$EXP$$US-ABBVIE-5848508$ABBVIE$$$$$M$Y$111$KG$20240828$$CN$US$US
241326162$24132616$2$F$$20240726$20240724$20240730$PER$$US-PFIZER INC-PV202400096207$PFIZER$$53$YR$$F$Y$$$20240730$$CN$US$US
241326171$24132617$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400221047$PFIZER$$$$$M$Y$$$20240724$$HP$US$US
241326181$24132618$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-202400222308$PFIZER$$66$YR$$M$Y$$$20240724$$CN$US$US
241326191$24132619$1$I$$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222651$PFIZER$$54$YR$$F$Y$$$20240724$$CN$US$US
241326202$24132620$2$F$20240528$20240816$20240724$20240820$PER$$US-PFIZER INC-202400221964$PFIZER$$61$YR$$F$Y$63.5$KG$20240820$$HP$US$US
241326211$24132621$1$I$$20240719$20240724$20240724$PER$$US-PFIZER INC-PV202400095558$PFIZER$$70$YR$$F$Y$$$20240724$$CN$US$US
241326221$24132622$1$I$$20240722$20240724$20240724$PER$$US-PFIZER INC-PV202400096206$PFIZER$$53$YR$$F$Y$$$20240724$$HP$US$US
241326231$24132623$1$I$$20240720$20240724$20240724$PER$$US-PFIZER INC-202400220843$PFIZER$$$$$$Y$$$20240724$$HP$US$US
241326242$24132624$2$F$20240101$20240808$20240724$20240813$EXP$$US-ABBVIE-5847736$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
241326251$24132625$1$I$20240601$20240718$20240724$20240724$PER$$US-INCYTE CORPORATION-2024IN007600$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241326261$24132626$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151659$NOVARTIS$$39$YR$$F$Y$$$20240724$$CN$US$US
241326271$24132627$1$I$$20240718$20240724$20240724$PER$$US-INCYTE CORPORATION-2024IN007584$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241326281$24132628$1$I$$20240709$20240724$20240724$EXP$$PL-GLANDPHARMA-PL-2024GLNLIT00488$GLAND PHARMA$Aneta Klotzka.Anthracycline-Induced Microcirculation disorders: AIM PILOT Study.Kardiologia Polska.13-MAY-2023;81:766-768$54$YR$A$F$Y$$$20240724$$MD$PL$PL
241326291$24132629$1$I$20240501$20240625$20240724$20240724$PER$$US-LEX-000361$LEXICON PHARMACEUTICALS$$91$YR$$$Y$$$20240724$$CN$US$US
241326302$24132630$2$F$$20240730$20240724$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115715$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$79.83$KG$20240806$$PH$US$US
241326311$24132631$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142742$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241326324$24132632$4$F$20240715$20240924$20240724$20240926$PER$$US-AMGEN-USASP2024147067$AMGEN$$80$YR$E$F$Y$$$20240926$$CN$US$US
241326343$24132634$3$F$20240715$20240730$20240724$20240805$EXP$$NVSC2024CN150616$NOVARTIS$$$$$F$Y$$$20240803$$CN$CN$CN
241326351$24132635$1$I$$20240716$20240724$20240724$EXP$NL-LRB-00981516$NL-SA-2024SA210304$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240724$$PH$NL$NL
241326362$24132636$2$F$20240626$20240808$20240724$20240814$EXP$$SK-JNJFOC-20240754500$JOHNSON AND JOHNSON$$$$E$$Y$$$20240814$$MD$SK$SK
241326371$24132637$1$I$20240722$20240723$20240723$20240723$DIR$711296$$FDA-CTU$$25$YR$$F$N$95.85$KG$20240723$N$CN$US$
241326381$24132638$1$I$20240722$20240723$20240723$20240723$DIR$711287$$FDA-CTU$$57$YR$$F$N$53.1$KG$20240723$Y$CN$US$
241326391$24132639$1$I$$20240723$20240723$20240723$DIR$711275$$FDA-CTU$$$$$F$N$81$KG$20240723$Y$CN$US$
241326401$24132640$1$I$20240426$20240723$20240723$20240723$DIR$711215$$FDA-CTU$$58$YR$$F$N$65.25$KG$20240723$N$CN$US$
241326411$24132641$1$I$20240701$20240723$20240723$20240723$DIR$711294$$FDA-CTU$$81$YR$$F$N$51.3$KG$20240723$N$CN$US$
241326421$24132642$1$I$20190824$20240723$20240723$20240723$DIR$711289$$FDA-CTU$$34$YR$$M$N$81$KG$20240723$N$CN$US$
241326431$24132643$1$I$20240721$20240723$20240723$20240723$DIR$711259$$FDA-CTU$$77$YR$$M$N$74.4$KG$20240723$N$HP$US$
241326451$24132645$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50892$$FDA-CTU$$50$YR$$F$N$$$20240723$N$$US$
241326471$24132647$1$I$20240712$20240723$20240723$20240723$DIR$711292$$FDA-CTU$$68$YR$$M$N$65.25$KG$20240723$N$CN$US$
241326481$24132648$1$I$$20240719$20240724$20240724$EXP$$US-SA-2024SA216170$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240724$$MD$US$US
241326491$24132649$1$I$$20240710$20240724$20240724$PER$$US-SA-2024SA212386$SANOFI AVENTIS$$$$$F$Y$$$20240724$$CN$US$US
241326502$24132650$2$F$$20240711$20240724$20240801$PER$$US-SA-2024SA207800$SANOFI AVENTIS$$$$A$F$Y$$$20240719$$MD$US$US
241326513$24132651$3$F$20240701$20240801$20240724$20240809$PER$$US-SA-2024SA205453$SANOFI AVENTIS$$69$YR$E$F$Y$51.7$KG$20240809$$MD$US$US
241326522$24132652$2$F$20240710$20240711$20240724$20240801$PER$$US-SA-2024SA206383$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240719$$CN$US$US
241326532$24132653$2$F$$20240716$20240724$20240729$PER$$US-SA-2024SA208275$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240729$$MD$US$US
241326541$24132654$1$I$20230201$20240722$20240724$20240724$EXP$$FR-ABBVIE-5847715$ABBVIE$$58$YR$$F$Y$$$20240724$$MD$FR$FR
241326555$24132655$5$F$20240101$20240822$20240724$20240826$PER$$US-ROCHE-10000026597$ROCHE$$69$YR$E$M$Y$107.95$KG$20240826$$CN$US$US
241326561$24132656$1$I$$20240712$20240724$20240724$EXP$$HR-THE J. MOLNER COMPANY-202407000017$The J.Molner Company$Luka Svitek. Syndrome of inappropriate antidiuretic hormone secretion as an adverse reaction of ciprofloxacin: a case report and literature review. Biochem Med (Zagreb). 2024;34(1):010803$$$$$Y$$$20240724$$HP$HR$HR
241326571$24132657$1$I$$20240712$20240724$20240724$EXP$$US-THE J. MOLNER COMPANY-202407000012$The J.Molner Company$Unknown. Ciprofloxacin. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2024$$$$$Y$$$20240724$$HP$US$US
241326581$24132658$1$I$$20240712$20240724$20240724$EXP$$US-THE J. MOLNER COMPANY-202407000018$The J.Molner Company$Unknown. Ciprofloxacin. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2024$80$YR$$F$Y$$$20240724$$HP$US$US
241326591$24132659$1$I$$20240712$20240724$20240724$EXP$$US-THE J. MOLNER COMPANY-202407000014$The J.Molner Company$Aditya Sharma. Aplastic anaemia following antibiotic use for urinary tract infection. BMJ Case Rep .. 2024;17(2):e254547$$$$$Y$$$20240724$$HP$US$US
241326601$24132660$1$I$$20240712$20240724$20240724$PER$$US-SA-2024SA207111$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240724$$CN$US$US
241326611$24132661$1$I$$20240712$20240724$20240724$PER$$US-SA-2024SA209797$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240724$$MD$US$US
241326621$24132662$1$I$$20240712$20240724$20240724$PER$$US-SA-2024SA215281$SANOFI AVENTIS$$$$A$F$Y$49.44$KG$20240724$$MD$US$US
241326631$24132663$1$I$$20240712$20240724$20240724$PER$$US-SA-2024SA129761$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240724$$MD$US$US
241326644$24132664$4$F$$20240805$20240724$20240807$PER$$NVSC2024US151812$NOVARTIS$$$$$M$Y$$$20240807$$CN$US$US
241326651$24132665$1$I$$20240717$20240724$20240724$PER$$US-BIOGEN-2024BI01274956$BIOGEN$$$$$$Y$$$20240724$$MD$US$US
241326662$24132666$2$F$$20240809$20240724$20240819$EXP$$DE-TEVA-VS-3223711$TEVA$Cremer A, Enssle JC, Pfaff S, Kouidri K, Lang F, Brandts C, et al. Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML. Ann-Hematol 2023; 102 2903-2908.; Cremer A, Enssle JC, Pfaff S, Kouidri K, Lang F, Brandts C, et al. Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased r...$$$$$Y$$$20240819$$HP$DE$DE
241326671$24132667$1$I$20231201$20240716$20240724$20240724$PER$$US-SA-2024SA212116$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240724$$MD$US$US
241326681$24132668$1$I$20240501$20240716$20240724$20240724$PER$$US-SA-2024SA212432$SANOFI AVENTIS$$61$YR$A$M$Y$90$KG$20240724$$MD$US$US
241326691$24132669$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA212830$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240724$$MD$US$US
241326701$24132670$1$I$$20240715$20240724$20240724$PER$$US-SA-2024SA212267$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$MD$US$US
241326711$24132671$1$I$$20240715$20240724$20240724$PER$$US-SA-2024SA211581$SANOFI AVENTIS$$$$A$F$Y$77.11$KG$20240724$$HP$US$US
241326721$24132672$1$I$20240711$20240716$20240724$20240724$PER$$US-SA-2024SA212240$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240724$$MD$US$US
241326731$24132673$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212345$SANOFI AVENTIS$$$$$M$Y$$$20240724$$MD$US$US
241326741$24132674$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212253$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$MD$US$US
241326751$24132675$1$I$20240721$20240723$20240723$20240723$DIR$711233$$FDA-CTU$$48$YR$$F$N$86.4$KG$20240723$N$CN$US$
241326761$24132676$1$I$20240401$20240715$20240724$20240724$PER$$US-SA-2024SA212528$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$MD$US$US
241326771$24132677$1$I$20240101$20240716$20240724$20240724$PER$$US-SA-2024SA212219$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240724$$MD$US$US
241326781$24132678$1$I$20240501$20240715$20240724$20240724$PER$$US-SA-2024SA212531$SANOFI AVENTIS$$42$YR$A$F$Y$120.66$KG$20240724$$MD$US$US
241326791$24132679$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA213596$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$MD$US$US
241326801$24132680$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50886$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241326811$24132681$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50883$$FDA-CTU$$87$YR$$F$N$181$LBS$20240723$N$$US$
241326821$24132682$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50838$$FDA-CTU$$45$YR$$F$N$$$20240723$N$$US$
241326831$24132683$1$I$20240101$20240715$20240724$20240724$PER$$US-SA-2024SA212526$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240724$$MD$US$US
241326841$24132684$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA212438$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240724$$MD$US$US
241326852$24132685$2$F$20240610$20240804$20240724$20240812$PER$$US-SA-2024SA212230$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240812$$MD$US$US
241326861$24132686$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA211866$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$MD$US$US
241326871$24132687$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA212488$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240724$$MD$US$US
241326881$24132688$1$I$20240701$20240717$20240724$20240724$PER$$US-SA-2024SA214399$SANOFI AVENTIS$$14$YR$T$M$Y$98$KG$20240724$$MD$US$US
241326891$24132689$1$I$$20240715$20240724$20240724$PER$$US-SA-2024SA213707$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$MD$US$US
241326901$24132690$1$I$$20240718$20240724$20240724$EXP$$US-TAKEDA-2023TUS071076$TAKEDA$$$$$M$Y$$$20240724$$MD$US$US
241326913$24132691$3$F$20231201$20240823$20240724$20240830$EXP$$JP-AstraZeneca-2024A164952$ASTRAZENECA$$90$YR$$M$Y$$$20240830$$HP$JP$
241326921$24132692$1$I$$20221024$20240724$20240724$EXP$$US-AstraZeneca-2022A356839$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241326931$24132693$1$I$$20220727$20240724$20240724$EXP$$US-AstraZeneca-2022A270774$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241326941$24132694$1$I$$20200727$20240724$20240724$EXP$$US-AstraZeneca-2020SE96650$ASTRAZENECA$$$$$M$Y$81.6$KG$20240724$$CN$US$
241326951$24132695$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212348$SANOFI AVENTIS$$$$A$F$Y$61$KG$20240724$$MD$US$US
241326961$24132696$1$I$20240101$20240716$20240724$20240724$PER$$US-SA-2024SA210357$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240724$$CN$US$US
241326971$24132697$1$I$20240701$20240716$20240724$20240724$PER$$US-SA-2024SA210614$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240724$$MD$US$US
241326981$24132698$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA207180$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240724$$MD$US$US
241326992$24132699$2$F$20240706$20240809$20240724$20240819$PER$$US-SA-2024SA211523$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240819$$MD$US$US
241327002$24132700$2$F$$20240711$20240724$20240801$PER$$US-SA-2024SA207397$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240719$$CN$US$US
241327011$24132701$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA210824$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$MD$US$US
241327021$24132702$1$I$$20201102$20240724$20240724$EXP$$US-AstraZeneca-2020SF34480$ASTRAZENECA$$55$YR$$F$Y$$$20240724$$CN$US$
241327031$24132703$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA214164$SANOFI AVENTIS$$62$YR$A$M$Y$129.2$KG$20240724$$MD$US$US
241327041$24132704$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212757$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240724$$MD$US$US
241327051$24132705$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212258$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$MD$US$US
241327062$24132706$2$F$$20240715$20240724$20240801$PER$$US-SA-2024SA209903$SANOFI AVENTIS$$$$$F$Y$$$20240719$$CN$US$US
241327072$24132707$2$F$$20240812$20240724$20240819$PER$$US-SA-2024SA213358$SANOFI AVENTIS$$$$A$F$Y$$$20240819$$MD$US$US
241327081$24132708$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212458$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240724$$MD$US$US
241327091$24132709$1$I$20240101$20240716$20240724$20240724$PER$$US-SA-2024SA212156$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240724$$MD$US$US
241327101$24132710$1$I$$20240715$20240724$20240724$PER$$US-SA-2024SA129945$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240724$$MD$US$US
241327111$24132711$1$I$20240701$20240716$20240724$20240724$PER$$US-SA-2024SA212162$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240724$$MD$US$US
241327121$24132712$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212411$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240724$$MD$US$US
241327131$24132713$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA085620$SANOFI AVENTIS$$31$YR$A$F$Y$45$KG$20240724$$MD$US$US
241327141$24132714$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212106$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240724$$MD$US$US
241327152$24132715$2$F$20240101$20240827$20240724$20240905$PER$$US-SA-2024SA214338$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240905$$MD$US$US
241327161$24132716$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA214198$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240724$$MD$US$US
241327171$24132717$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212804$SANOFI AVENTIS$$$$A$$Y$$$20240724$$HP$US$US
241327181$24132718$1$I$20240701$20240715$20240724$20240724$PER$$US-SA-2024SA211516$SANOFI AVENTIS$$40$YR$A$F$Y$58$KG$20240724$$MD$US$US
241327191$24132719$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA213392$SANOFI AVENTIS$$$$A$F$Y$52$KG$20240724$$MD$US$US
241327205$24132720$5$F$$20240913$20240724$20240923$PER$$US-SA-2024SA214899$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240923$$CN$US$US
241327211$24132721$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA214190$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240724$$MD$US$US
241327221$24132722$1$I$20240101$20240716$20240724$20240724$PER$$US-SA-2024SA212522$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240724$$MD$US$US
241327231$24132723$1$I$20240628$20240715$20240724$20240724$PER$$US-SA-2024SA213511$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240724$$MD$US$US
241327241$24132724$1$I$20240715$20240715$20240724$20240724$PER$$US-SA-2024SA212696$SANOFI AVENTIS$$8$YR$C$F$Y$49$KG$20240724$$MD$US$US
241327251$24132725$1$I$20240701$20240715$20240724$20240724$PER$$US-SA-2024SA211776$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240724$$MD$US$US
241327261$24132726$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212067$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$MD$US$US
241327271$24132727$1$I$$20240715$20240724$20240724$PER$$US-SA-2024SA212527$SANOFI AVENTIS$$$$A$F$Y$90.7$KG$20240724$$MD$US$US
241327281$24132728$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212777$SANOFI AVENTIS$$$$$F$Y$$$20240724$$HP$US$US
241327291$24132729$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA212446$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$MD$US$US
241327301$24132730$1$I$20240701$20240716$20240724$20240724$PER$$US-SA-2024SA211745$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240724$$MD$US$US
241327311$24132731$1$I$$20240715$20240724$20240724$PER$$US-SA-2024SA212208$SANOFI AVENTIS$$$$E$F$Y$$$20240724$$MD$US$US
241327321$24132732$1$I$20240601$20240716$20240724$20240724$PER$$US-SA-2024SA212259$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240724$$MD$US$US
241327331$24132733$1$I$20240101$20240723$20240724$20240724$EXP$$FR-SANDOZ INC.-SDZ2024FR067652$SANDOZ$$55$YR$$M$Y$$$20240724$$PH$FR$FR
241327341$24132734$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA213353$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240724$$MD$US$US
241327351$24132735$1$I$20240101$20240716$20240724$20240724$PER$$US-SA-2024SA211514$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240724$$MD$US$US
241327371$24132737$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212105$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240724$$MD$US$US
241327381$24132738$1$I$20240501$20240717$20240724$20240724$PER$$US-SA-2024SA212825$SANOFI AVENTIS$$37$YR$A$F$Y$58.5$KG$20240724$$MD$US$US
241327391$24132739$1$I$20240101$20240715$20240724$20240724$PER$$US-SA-2024SA212119$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240724$$MD$US$US
241327401$24132740$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA213544$SANOFI AVENTIS$$18$YR$A$M$Y$127$KG$20240724$$MD$US$US
241327411$24132741$1$I$20240701$20240715$20240724$20240724$PER$$US-SA-2024SA211622$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240724$$MD$US$US
241327422$24132742$2$F$$20240820$20240724$20240829$PER$$US-SA-2024SA212525$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240829$$MD$US$US
241327431$24132743$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA211264$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240724$$MD$US$US
241327441$24132744$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA213786$SANOFI AVENTIS$$$$A$F$Y$83$KG$20240724$$MD$US$US
241327451$24132745$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212128$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240724$$MD$US$US
241327461$24132746$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50879$$FDA-CTU$$59$YR$$M$N$$$20240723$N$$US$
241327471$24132747$1$I$$20240628$20240724$20240724$PER$$US-JNJFOC-20240700792$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$CN$US$US
241327481$24132748$1$I$20240101$20240719$20240724$20240724$EXP$$US-ABBVIE-5848472$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241327491$24132749$1$I$20240101$20240626$20240724$20240724$PER$$US-Eisai-EC-2024-168991$EISAI$$36$YR$A$F$Y$$$20240724$$CN$US$US
241327502$24132750$2$F$20230427$20240814$20240724$20240820$EXP$$CA-TAKEDA-2023TUS043585$TAKEDA$$74$YR$$M$Y$$$20240820$$CN$CA$CA
241327511$24132751$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50867$$FDA-CTU$$43$YR$$F$N$$$20240723$N$$US$
241327531$24132753$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50843$$FDA-CTU$$79$YR$$M$N$$$20240723$N$$US$
241327541$24132754$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142864$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241327551$24132755$1$I$20240723$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50893$$FDA-CTU$$82$YR$$M$N$70.31$KG$20240723$N$HP$US$
241327561$24132756$1$I$$20240715$20240724$20240724$PER$$US-GILEAD-2024-0680817$GILEAD$$62$YR$A$M$Y$$$20240724$$PH$US$US
241327571$24132757$1$I$20240101$20240716$20240724$20240724$PER$$US-SA-2024SA212351$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240724$$MD$US$US
241327581$24132758$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA210987$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240724$$MD$US$US
241327591$24132759$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212243$SANOFI AVENTIS$$$$E$F$Y$65.3$KG$20240724$$MD$US$US
241327602$24132760$2$F$20240101$20240812$20240724$20240820$PER$$US-SA-2024SA214265$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240820$$MD$US$US
241327611$24132761$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA214160$SANOFI AVENTIS$$$$E$M$Y$$$20240724$$MD$US$US
241327621$24132762$1$I$20240629$20240715$20240724$20240724$PER$$US-SA-2024SA214132$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240724$$MD$US$US
241327633$24132763$3$F$20240701$20240918$20240724$20240925$PER$$US-SA-2024SA209280$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240925$$MD$US$US
241327641$24132764$1$I$20231001$20240716$20240724$20240724$PER$$US-SA-2024SA211033$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240724$$CN$US$US
241327651$24132765$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA213784$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240724$$MD$US$US
241327661$24132766$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212406$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240724$$MD$US$US
241327671$24132767$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA213689$SANOFI AVENTIS$$$$A$M$Y$113$KG$20240724$$MD$US$US
241327681$24132768$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA213774$SANOFI AVENTIS$$$$A$F$Y$72.57$KG$20240724$$MD$US$US
241327691$24132769$1$I$$20240715$20240724$20240724$PER$$US-SA-2024SA212449$SANOFI AVENTIS$$$$A$F$Y$204$KG$20240724$$MD$US$US
241327701$24132770$1$I$20240309$20240722$20240724$20240724$EXP$$NVSC2024US150852$NOVARTIS$$39$YR$$F$Y$$$20240724$$HP$US$US
241327711$24132771$1$I$20240701$20240723$20240724$20240724$EXP$GB-MHRA-MED-202407231032484840-LBVNT$GB-ABBVIE-5850450$ABBVIE$$18$YR$$F$Y$65$KG$20240724$$CN$GB$GB
241327721$24132772$1$I$$20240722$20240724$20240724$PER$$US-ROCHE-10000033290$ROCHE$$74$YR$E$F$Y$$$20240724$$CN$US$US
241327732$24132773$2$F$20231118$20240914$20240724$20240916$EXP$$CA-PFIZER INC-202300350460$PFIZER$$72$YR$$M$Y$$$20240916$$PH$CA$CA
241327741$24132774$1$I$20240101$20240715$20240724$20240724$PER$$US-SA-2024SA212413$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240724$$MD$US$US
241327751$24132775$1$I$20240629$20240715$20240724$20240724$PER$$US-SA-2024SA211046$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240724$$MD$US$US
241327761$24132776$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA213482$SANOFI AVENTIS$$10$YR$C$F$Y$31.796$KG$20240724$$MD$US$US
241327771$24132777$1$I$20240516$20240716$20240724$20240724$PER$$US-SA-2024SA213760$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240724$$PH$US$US
241327781$24132778$1$I$$20240715$20240724$20240724$PER$$US-SA-2024SA211462$SANOFI AVENTIS$$$$T$M$Y$$$20240724$$MD$US$US
241327791$24132779$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA213593$SANOFI AVENTIS$$60$YR$A$M$Y$94.3$KG$20240724$$MD$US$US
241327801$24132780$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA211693$SANOFI AVENTIS$$$$E$F$Y$$$20240724$$MD$US$US
241327811$24132781$1$I$$20240715$20240724$20240724$PER$$US-SA-2024SA212122$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240724$$MD$US$US
241327821$24132782$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA211617$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240724$$MD$US$US
241327831$24132783$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212847$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240724$$MD$US$US
241327841$24132784$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA211455$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240724$$MD$US$US
241327851$24132785$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212879$SANOFI AVENTIS$$$$T$F$Y$$$20240724$$MD$US$US
241327871$24132787$1$I$20200701$20240716$20240724$20240724$PER$$US-SA-2024SA213401$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240724$$MD$US$US
241327881$24132788$1$I$20231221$20240710$20240724$20240724$EXP$$CA-CHIESI-2023CHF06936$CHIESI$$72$YR$$F$Y$107$KG$20240724$$CN$CA$CA
241327891$24132789$1$I$$20240718$20240724$20240724$EXP$NL-LRB-00981108$NL-MYLANLABS-2024M1068186$MYLAN$$68$YR$$F$Y$47$KG$20240724$$CN$NL$NL
241327902$24132790$2$F$$20240801$20240724$20240812$EXP$$US-MYLANLABS-2024M1068382$MYLAN$Sharayah S, Agner SC, Shinawi M, Rudnick D, Mar S. Neurological Improvement in a Patient with Cerebroretinal Microangiopathy with Calcifications and Cysts-1 Treated with Bevacizumab. Ann-Child-Neurol 2023; 31 (1): 52-55.. Annals of Child Neurology. 2023;31(1):52-55$16$YR$$M$Y$$$20240812$$MD$US$US
241327911$24132791$1$I$20240628$20240722$20240724$20240724$EXP$FR-AFSSAPS-GR2024000885$FR-MYLANLABS-2024M1068221$MYLAN$$72$YR$$M$Y$83$KG$20240724$$PH$FR$FR
241327922$24132792$2$F$20240330$20240731$20240724$20240802$EXP$$US-MYLANLABS-2024M1067404$MYLAN$$35$YR$$F$Y$$$20240802$$CN$US$US
241327931$24132793$1$I$20240101$20240716$20240724$20240724$PER$$US-SA-2024SA167954$SANOFI AVENTIS$$$$T$F$Y$90.7$KG$20240724$$MD$US$US
241327941$24132794$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA213656$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240724$$MD$US$US
241327951$24132795$1$I$20240101$20240716$20240724$20240724$PER$$US-SA-2024SA213431$SANOFI AVENTIS$$50$YR$A$M$Y$86.18$KG$20240724$$MD$US$US
241327961$24132796$1$I$20240708$20240715$20240724$20240724$PER$$US-SA-2024SA212041$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240724$$MD$US$US
241327971$24132797$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA213777$SANOFI AVENTIS$$63$YR$A$M$Y$68$KG$20240724$$MD$US$US
241327981$24132798$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA213517$SANOFI AVENTIS$$$$E$M$Y$$$20240724$$MD$US$US
241327991$24132799$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212716$SANOFI AVENTIS$$$$A$M$Y$88.435$KG$20240724$$MD$US$US
241328012$24132801$2$F$20240714$20240716$20240724$20240725$PER$$US-SA-2024SA212350$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240725$$MD$US$US
241328021$24132802$1$I$20240629$20240717$20240724$20240724$PER$$US-SA-2024SA214171$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240724$$MD$US$US
241328041$24132804$1$I$20240701$20240717$20240724$20240724$PER$$US-SA-2024SA214068$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240724$$MD$US$US
241328051$24132805$1$I$20240715$20240716$20240724$20240724$PER$$US-SA-2024SA211360$SANOFI AVENTIS$$93$YR$E$M$Y$$$20240724$$MD$US$US
241328061$24132806$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA214048$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240724$$MD$US$US
241328071$24132807$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA211346$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240724$$CN$US$US
241328081$24132808$1$I$20240601$20240716$20240724$20240724$PER$$US-SA-2024SA213312$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240724$$MD$US$US
241328091$24132809$1$I$$20240719$20240724$20240724$30DAY$$EG-SANDOZ INC.-SDZ2023EG021577$SANDOZ$$$$$F$Y$26$KG$20240724$$CN$EG$EG
241328101$24132810$1$I$20230620$20240715$20240724$20240724$PER$$US-SA-2024SA213330$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240724$$MD$US$US
241328111$24132811$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50872$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241328121$24132812$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA210776$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240724$$MD$US$US
241328131$24132813$1$I$20240710$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50881$$FDA-CTU$$85$YR$$M$N$$$20240722$N$HP$US$
241328141$24132814$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50845$$FDA-CTU$$$$$M$N$$$20240723$N$HP$US$
241328152$24132815$2$F$20240601$20240812$20240724$20240821$PER$$US-SA-2024SA212339$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240821$$MD$US$US
241328171$24132817$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA212459$SANOFI AVENTIS$$$$E$F$Y$$$20240724$$MD$US$US
241328181$24132818$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA210712$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$MD$US$US
241328194$24132819$4$F$20240501$20240909$20240724$20240920$PER$$US-SA-2024SA214057$SANOFI AVENTIS$$82$YR$E$M$Y$82.6$KG$20240920$$MD$US$US
241328201$24132820$1$I$$20240718$20240724$20240724$PER$$US-BAUSCH-BL-2024-011105$BAUSCH AND LOMB$$34$YR$$F$Y$$$20240724$$CN$US$US
241328212$24132821$2$F$$20240813$20240724$20240816$PER$$US-BAUSCH-BL-2024-011109$BAUSCH AND LOMB$$44$YR$$M$Y$$$20240816$$MD$US$US
241328221$24132822$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA213485$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240724$$MD$US$US
241328231$24132823$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA213140$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240724$$MD$US$US
241328241$24132824$1$I$20240716$20240718$20240724$20240724$PER$$US-SA-2024SA214038$SANOFI AVENTIS$$$$$F$Y$$$20240724$$CN$US$US
241328251$24132825$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA214358$SANOFI AVENTIS$$$$A$M$Y$$$20240724$$MD$US$US
241328261$24132826$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA213782$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240724$$MD$US$US
241328271$24132827$1$I$20240601$20240718$20240724$20240724$PER$$US-SA-2024SA214227$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240724$$MD$US$US
241328281$24132828$1$I$20230101$20240718$20240724$20240724$PER$$US-SA-2024SA213683$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240724$$CN$US$US
241328291$24132829$1$I$20240701$20240718$20240724$20240724$PER$$US-SA-2024SA213337$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240724$$MD$US$US
241328301$24132830$1$I$20240101$20240718$20240724$20240724$PER$$US-SA-2024SA213769$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240724$$MD$US$US
241328311$24132831$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA214282$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240724$$MD$US$US
241328321$24132832$1$I$20231101$20240718$20240724$20240724$PER$$US-SA-2024SA211827$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240724$$PH$US$US
241328331$24132833$1$I$20240718$20240718$20240724$20240724$PER$$US-SA-2024SA214568$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240724$$MD$US$US
241328341$24132834$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA213572$SANOFI AVENTIS$$$$T$F$Y$$$20240724$$HP$US$US
241328351$24132835$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212159$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240724$$MD$US$US
241328362$24132836$2$F$20240101$20240816$20240724$20240830$PER$$US-SA-2024SA214404$SANOFI AVENTIS$$57$YR$A$F$Y$71$KG$20240830$$MD$US$US
241328374$24132837$4$F$20240101$20240905$20240724$20240914$PER$$US-SA-2024SA214310$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240914$$MD$US$US
241328381$24132838$1$I$20240101$20240718$20240724$20240724$PER$$US-SA-2024SA213512$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240724$$MD$US$US
241328391$24132839$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA212781$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240724$$CN$US$US
241328403$24132840$3$F$20240711$20240719$20240724$20240801$PER$$US-SA-2024SA212409$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240801$$MD$US$US
241328411$24132841$1$I$20240717$20240718$20240724$20240724$PER$$US-SA-2024SA214610$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240724$$CN$US$US
241328422$24132842$2$F$$20240906$20240724$20240916$PER$$US-SA-2024SA214311$SANOFI AVENTIS$$7$YR$C$F$Y$24.5$KG$20240916$$MD$US$US
241328431$24132843$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA212796$SANOFI AVENTIS$$$$$F$Y$$$20240724$$MD$US$US
241328441$24132844$1$I$20240101$20240716$20240724$20240724$PER$$US-SA-2024SA212222$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240724$$MD$US$US
241328451$24132845$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA214958$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240724$$MD$US$US
241328461$24132846$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA213590$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240724$$MD$US$US
241328471$24132847$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA212154$SANOFI AVENTIS$$$$E$M$Y$$$20240724$$MD$US$US
241328481$24132848$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA213546$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$HP$US$US
241328492$24132849$2$F$$20240723$20240724$20240725$EXP$$US-ROCHE-10000034457$ROCHE$$92$YR$E$F$Y$$$20240725$$MD$US$US
241328501$24132850$1$I$20240701$20240718$20240724$20240724$PER$$US-SA-2024SA213773$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240724$$MD$US$US
241328512$24132851$2$F$20240701$20240719$20240724$20240730$PER$$US-SA-2024SA214600$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240730$$MD$US$US
241328521$24132852$1$I$20240615$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116357$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240724$$HP$US$US
241328531$24132853$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA214010$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240724$$CN$US$US
241328541$24132854$1$I$20240101$20240718$20240724$20240724$PER$$US-SA-2024SA214560$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240724$$MD$US$US
241328551$24132855$1$I$20240625$20240718$20240724$20240724$PER$$US-SA-2024SA214327$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240724$$MD$US$US
241328561$24132856$1$I$20240601$20240718$20240724$20240724$PER$$US-SA-2024SA214304$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240724$$MD$US$US
241328571$24132857$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA214434$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240724$$MD$US$US
241328581$24132858$1$I$20240701$20240718$20240724$20240724$PER$$US-SA-2024SA213506$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240724$$MD$US$US
241328592$24132859$2$F$20210101$20240718$20240724$20240730$PER$$US-SA-2024SA214668$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240730$$CN$US$US
241328601$24132860$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA213922$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240724$$MD$US$US
241328611$24132861$1$I$20240708$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50853$$FDA-CTU$$50$YR$$F$N$$$20240723$N$HP$US$
241328622$24132862$2$F$20240718$20240729$20240724$20240805$PER$$US-SA-2024SA214168$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240805$$CN$US$US
241328632$24132863$2$F$20240719$20240722$20240724$20240731$PER$$US-SA-2024SA212869$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240731$$CN$US$US
241328651$24132865$1$I$$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50865$$FDA-CTU$$$$$F$N$$$20240722$N$HP$US$
241328661$24132866$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA214349$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240724$$MD$US$US
241328671$24132867$1$I$$20240719$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116706$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240724$$CN$US$US
241328691$24132869$1$I$$20240716$20240724$20240724$EXP$NL-LRB-00981122$NL-SA-2024SA209966$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240724$$HP$NL$NL
241328701$24132870$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014082$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240724$$CN$US$US
241328711$24132871$1$I$20240717$20240719$20240724$20240724$PER$$US-SA-2024SA213635$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240724$$MD$US$US
241328721$24132872$1$I$20240718$20240719$20240724$20240724$PER$$US-SA-2024SA214341$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240724$$MD$US$US
241328731$24132873$1$I$$20240719$20240724$20240724$PER$$US-SA-2024SA215863$SANOFI AVENTIS$$$$$M$Y$$$20240724$$MD$US$US
241328741$24132874$1$I$20240101$20240719$20240724$20240724$PER$$US-SA-2024SA214887$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240724$$MD$US$US
241328751$24132875$1$I$$20240719$20240724$20240724$PER$$US-SA-2024SA214491$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240724$$CN$US$US
241328761$24132876$1$I$20240101$20240721$20240724$20240724$PER$$US-SA-2024SA214321$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240724$$CN$US$US
241328772$24132877$2$F$$20240722$20240724$20240729$PER$$US-SA-2024SA213994$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240729$$HP$US$US
241328781$24132878$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151505$NOVARTIS$$$$A$M$Y$$$20240724$$CN$US$US
241328791$24132879$1$I$$20240717$20240724$20240724$EXP$$AU-JNJFOC-20240748669$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240724$$CN$AU$AU
241328801$24132880$1$I$20240318$20240716$20240724$20240724$EXP$$US-JNJFOC-20240744416$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240724$$CN$US$US
241328811$24132881$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144544$AMGEN$$$$$F$Y$$$20240724$$HP$US$US
241328831$24132883$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024143153$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241328841$24132884$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142966$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241328851$24132885$1$I$20240709$20240715$20240724$20240724$EXP$$US-Calliditas-2024CAL01331$CALLIDITAS THERAPEUTICS$$70$YR$E$M$Y$85.9$KG$20240724$$CN$US$US
241328862$24132886$2$F$20240625$20240806$20240724$20240808$EXP$$US-TAKEDA-2024TUS074559$TAKEDA$$70$YR$$F$Y$$$20240808$$CN$US$US
241328871$24132887$1$I$$20240722$20240724$20240724$EXP$$US-SANDOZ INC.-SDZ2024US067392$SANDOZ$$$$$F$Y$$$20240724$$HP$US$US
241328881$24132888$1$I$$20240722$20240724$20240724$EXP$$NVSC2024PH150539$NOVARTIS$$$$$$Y$$$20240724$$MD$PH$PH
241328892$24132889$2$F$$20240906$20240724$20240906$PER$$NVSC2024US151482$NOVARTIS$$$$$F$Y$$$20240906$$HP$US$US
241328901$24132890$1$I$$20240709$20240724$20240724$EXP$$US-GLANDPHARMA-US-2024GLNLIT00497$GLAND PHARMA$J Ouyang.How High Can Anion Gaps Be in Patients With Metabolic Acidosis? A Case Report.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$61$YR$A$F$Y$$$20240724$$HP$US$US
241328911$24132891$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50847$$FDA-CTU$$63$YR$$F$N$120$LBS$20240723$N$$US$
241328921$24132892$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50848$$FDA-CTU$$63$YR$$F$N$130$LBS$20240723$N$$US$
241328931$24132893$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50852$$FDA-CTU$$64$YR$$F$N$58.06$KG$20240723$N$$US$
241328941$24132894$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50844$$FDA-CTU$$80$YR$$F$N$72.57$KG$20240723$N$$US$
241328961$24132896$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50857$$FDA-CTU$$$$$M$N$$$20240723$N$$US$
241328975$24132897$5$F$$20240805$20240724$20240816$EXP$$BR-SANDOZ INC.-SDZ2024BR067171$SANDOZ$$84$YR$$M$Y$$$20240816$$CN$BR$BR
241328981$24132898$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA213510$SANOFI AVENTIS$$$$E$F$Y$52$KG$20240724$$MD$US$US
241328991$24132899$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA214442$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240724$$MD$US$US
241329001$24132900$1$I$$20240716$20240724$20240724$EXP$$US-ABBVIE-5849704$ABBVIE$$80$YR$$M$Y$$$20240724$$MD$US$US
241329011$24132901$1$I$20240627$20240715$20240724$20240724$PER$$US-SA-2024SA212427$SANOFI AVENTIS$$62$YR$A$F$Y$76.2$KG$20240724$$MD$US$US
241329021$24132902$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212415$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240724$$MD$US$US
241329032$24132903$2$F$20240510$20240815$20240724$20240820$EXP$$US-KYOWAKIRIN-2024KK017485$KYOWA$$$$$$Y$$$20240820$$CN$US$US
241329042$24132904$2$F$$20240809$20240724$20240819$EXP$$US-TEVA-VS-3222857$TEVA$McMullan P, Brown R, Bibb L, Ferenczi K. Cutaneous CD30 positive anaplastic large cell lymphoma mimicking breast carcinoma en cuirasse. JAAD-Case-Rep 2023; 40 37-40.; McMullan P, Brown R, Bibb L, Ferenczi K. Cutaneous CD30 positive anaplastic large cell lymphoma mimicking breast carcinoma en cuirasse. JAAD-Case-Rep 2023; 40 37-40.; McMullan P, Brown R, Bibb L, Ferenczi K. Cutaneous CD30 positive anaplastic large cell lymphoma mimicking breast carcinoma en cuirasse. JAAD-Case-Rep 2023; 40 37-40.$80$YR$$F$Y$$$20240819$$HP$US$US
241329051$24132905$1$I$20240522$20240723$20240724$20240724$EXP$$ES-SANDOZ INC.-SDZ2024ES067505$SANDOZ$$87$YR$$M$Y$70$KG$20240724$$HP$ES$ES
241329066$24132906$6$F$20240628$20240815$20240724$20240819$PER$$DE-Eisai-EC-2024-170645$EISAI$$72$YR$E$M$Y$71$KG$20240819$$MD$DE$DE
241329071$24132907$1$I$$20230317$20240724$20240724$EXP$$NL-BIOVITRUM-2023-NL-007768$BIOVITRUM$$$$I$F$Y$4.6$KG$20240724$$HP$NL$NL
241329081$24132908$1$I$20240101$20240716$20240724$20240724$EXP$$US-Eisai-EC-2024-169204$EISAI$$74$YR$E$M$Y$98.88$KG$20240724$$CN$US$US
241329091$24132909$1$I$20231024$20240722$20240724$20240724$EXP$FI-FIMEA-202402602$FI-FreseniusKabi-FK202411539$FRESENIUS KABI$$54$YR$A$F$Y$$$20240724$$PH$FI$FI
241329101$24132910$1$I$20240511$20240718$20240724$20240724$EXP$CH-SM-2024-13371$CH-MYLANLABS-2024M1068277$MYLAN$$68$YR$$F$Y$$$20240724$$MD$CH$CH
241329111$24132911$1$I$$20240717$20240724$20240724$PER$$US-ROCHE-10000030740$ROCHE$$$$$$Y$$$20240724$$CN$US$US
241329122$24132912$2$F$$20240809$20240724$20240819$EXP$$US-TEVA-VS-3222866$TEVA$: Mueller SW, Molina KC, Blass B, Gibson C, Kohler AD, Krsak M, et al. Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa. J-Burn-Care-Res 2024; 45 (3): 808-810.; Mueller SW, Molina KC, Blass B, Gibson C, Kohler AD, Krsak M, et al. Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa. J-Burn-Care-Res 2024; 45 (3): 808-810.$48$YR$$M$Y$$$20240819$$HP$US$US
241329131$24132913$1$I$20240715$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145487$AMGEN$$68$YR$E$F$Y$$$20240724$$CN$US$US
241329142$24132914$2$F$20240720$20240726$20240724$20240730$30DAY$$US-SANDOZ INC.-SDZ2024US067237$SANDOZ$$29$YR$$F$Y$$$20240730$$CN$US$US
241329152$24132915$2$F$$20240716$20240724$20240809$EXP$$IN-AMGEN-INDSP2024141595$AMGEN$Wali, S.. Cyclophosphamide Toxicity in Pediatric Nephrotic Syndrome Patient: A Case Report and Literature Review. Current Drug Safety. 2024;19:489-496$5$YR$C$M$Y$$$20240809$$HP$IN$IN
241329162$24132916$2$F$$20240809$20240724$20240819$EXP$$US-TEVA-VS-3222396$TEVA$Henry PJ, Wen JH, Feldman EB, Vargas J. Minocycline Induced Parenchymal Lung Disease with Peripheral Eosinophilia. Am-J-Respir-Crit-Care-Med 2024; 209.; Henry PJ, Wen JH, Feldman EB, Vargas J. Minocycline Induced Parenchymal Lung Disease with Peripheral Eosinophilia. Am-J-Respir-Crit-Care-Med 2024; 209.$70$YR$$M$Y$$$20240819$$HP$US$US
241329171$24132917$1$I$$20240723$20240724$20240724$EXP$$SK-ABBVIE-5849835$ABBVIE$$65$YR$$M$Y$$$20240724$$MD$SK$SK
241329181$24132918$1$I$20230524$20230621$20240724$20240724$EXP$$BR-BIOVITRUM-2023-BR-012371$BIOVITRUM$$576$DY$$M$Y$$$20240724$$CN$BR$BR
241329191$24132919$1$I$20240708$20240722$20240724$20240724$EXP$$CA-ABBVIE-5850345$ABBVIE$$$$$$Y$$$20240724$$MD$CA$CA
241329201$24132920$1$I$$20230616$20240724$20240724$EXP$$US-AstraZeneca-2023A101710$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241329211$24132921$1$I$$20200508$20240724$20240724$EXP$$US-AstraZeneca-2020SE62553$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241329221$24132922$1$I$$20240313$20240724$20240724$EXP$$NVSC2024US151115$NOVARTIS$$$$$F$Y$$$20240724$$MD$US$US
241329231$24132923$1$I$$20240719$20240724$20240724$EXP$$NL-AstraZeneca-2024A164867$ASTRAZENECA$$66$YR$$M$Y$95$KG$20240724$$MD$NL$
241329241$24132924$1$I$20191101$20210407$20240724$20240724$EXP$$US-AstraZeneca-2021A292323$ASTRAZENECA$$769$MON$$F$Y$74.8$KG$20240724$$CN$US$
241329251$24132925$1$I$$20230921$20240724$20240724$EXP$$US-AstraZeneca-2023A217972$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241329261$24132926$1$I$$20230522$20240724$20240724$EXP$$US-AstraZeneca-2023A119130$ASTRAZENECA$$$$$$Y$$$20240724$$CN$US$
241329272$24132927$2$F$$20240807$20240724$20240814$EXP$NL-LRB-00981118$NL-SA-2024SA211611$SANOFI AVENTIS$$92$YR$E$F$Y$69.7$KG$20240814$$HP$NL$NL
241329281$24132928$1$I$20240624$20240716$20240724$20240724$EXP$$CO-BIOVITRUM-2024-CO-010147$BIOVITRUM$$111$DY$$F$Y$4$KG$20240724$$CN$CO$CO
241329301$24132930$1$I$$20220706$20240724$20240724$EXP$$CA-AstraZeneca-2022A248265$ASTRAZENECA$$71$YR$$F$Y$$$20240724$$MD$CA$
241329311$24132931$1$I$$20240723$20240724$20240724$EXP$$GB-SANDOZ INC.-SDZ2024GB067601$SANDOZ$$$$A$M$Y$$$20240724$$CN$GB$GB
241329321$24132932$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA213088$SANOFI AVENTIS$$$$A$$Y$$$20240724$$CN$US$US
241329331$24132933$1$I$$20240723$20240724$20240724$PER$$US-JNJFOC-20240761224$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$PH$US$US
241329343$24132934$3$F$$20240812$20240724$20240819$PER$$US-SA-2024SA213642$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240819$$CN$US$US
241329351$24132935$1$I$20240101$20240716$20240724$20240724$PER$$US-SA-2024SA212852$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240724$$MD$US$US
241329361$24132936$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212841$SANOFI AVENTIS$$$$A$F$Y$82.55$KG$20240724$$MD$US$US
241329371$24132937$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024146744$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241329381$24132938$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024143315$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
241329391$24132939$1$I$$20240722$20240724$20240724$EXP$GB-MHRA-TPP19250208C9433810YC1721401337492$GB-SANDOZ INC.-SDZ2024GB067501$SANDOZ$$69$YR$$M$Y$64$KG$20240724$$MD$GB$GB
241329402$24132940$2$F$20240620$20240822$20240724$20240830$EXP$$US-BAYER-2024A104804$BAYER$$41$YR$A$F$Y$$$20240830$$PH$US$US
241329411$24132941$1$I$20240101$20240404$20240724$20240724$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00097$Unknown Manufacturer$$$$$F$Y$$$20240724$$CN$US$US
241329421$24132942$1$I$20240101$20240517$20240724$20240724$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00222$Unknown Manufacturer$$$$$F$Y$$$20240724$$CN$US$US
241329431$24132943$1$I$20240627$20240717$20240724$20240724$EXP$$US-GSK-US2024090165$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241329441$24132944$1$I$$20240516$20240724$20240724$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00077$Unknown Manufacturer$$$$$F$Y$63.492$KG$20240724$$HP$US$US
241329451$24132945$1$I$$20240426$20240724$20240724$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00171$Unknown Manufacturer$$$$$F$Y$$$20240724$$CN$US$US
241329461$24132946$1$I$$20240709$20240724$20240724$EXP$$US-GLANDPHARMA-US-2024GLNLIT00491$GLAND PHARMA$S Ravi.Acute Respiratory Compromise in the Context of COVID-19 and Gemcitabine.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A5539$48$YR$A$F$Y$$$20240724$$HP$US$US
241329471$24132947$1$I$20240615$20240722$20240724$20240724$EXP$$US-ROCHE-10000033923$ROCHE$$82$YR$E$M$Y$$$20240724$$CN$US$US
241329482$24132948$2$F$$20240725$20240724$20240729$EXP$$US-ABBVIE-5849983$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241329491$24132949$1$I$$20240722$20240724$20240724$30DAY$$FR-SANDOZ INC.-SDZ2024FR067462$SANDOZ$$11$YR$$M$Y$$$20240724$$CN$FR$FR
241329501$24132950$1$I$$20240723$20240724$20240724$EXP$$US-SANDOZ INC.-SDZ2024US067793$SANDOZ$$$$$F$Y$$$20240724$$CN$US$US
241329512$24132951$2$F$$20240722$20240724$20240726$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041283$BOEHRINGER INGELHEIM$$5$DEC$A$M$Y$$$20240726$$MD$JP$JP
241329521$24132952$1$I$20240720$20240722$20240724$20240724$EXP$$US-ROCHE-10000033728$ROCHE$$88$YR$E$M$Y$$$20240724$$CN$US$US
241329532$24132953$2$F$20231106$20240725$20240724$20240731$EXP$$TW-BIOGEN-2024BI01262550$BIOGEN$$33$YR$$F$Y$54$KG$20240731$$HP$TW$TW
241329541$24132954$1$I$20240622$20240624$20240724$20240724$PER$$US-LEX-000355$LEXICON PHARMACEUTICALS$$82$YR$$F$Y$$$20240724$$CN$US$US
241329551$24132955$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50860$$FDA-CTU$$86$YR$$F$N$70.76$KG$20240723$N$$US$
241329561$24132956$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50856$$FDA-CTU$$60$YR$$F$N$108.86$KG$20240723$N$$US$
241329571$24132957$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146214$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241329581$24132958$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50866$$FDA-CTU$$64$YR$$F$N$$$20240723$N$$US$
241329591$24132959$1$I$$20240722$20240724$20240724$EXP$$CA-SANDOZ INC.-NVSC2023CA147359$SANDOZ$$56$YR$$M$Y$$$20240724$$CN$CA$CA
241329601$24132960$1$I$$20240715$20240724$20240724$EXP$$CA-FreseniusKabi-FK202411277$FRESENIUS KABI$$25$YR$A$F$Y$64$KG$20240724$$HP$CA$CA
241329611$24132961$1$I$20030101$20240722$20240724$20240724$EXP$$FR-GILEAD-2024-0681498$GILEAD$$58$YR$A$F$Y$71$KG$20240724$$MD$FR$FR
241329622$24132962$2$F$$20240821$20240724$20240826$EXP$$US-BAYER-2024A106422$BAYER$$$$$$Y$$$20240826$$CN$US$US
241329631$24132963$1$I$20090101$20240710$20240724$20240724$EXP$$DE-AUROBINDO-AUR-APL-2024-034584$AUROBINDO$$39$YR$$F$Y$77$KG$20240724$$MD$DE$DE
241329641$24132964$1$I$20230801$20240711$20240724$20240724$EXP$$PL-SK LIFE SCIENCE, INC-SKPVG-2024-001447$SK LIFE SCIENCE$$$$$$Y$$$20240724$$HP$PL$PL
241329661$24132966$1$I$20240606$20240722$20240724$20240724$EXP$GB-MHRA-31205853$GB-SANDOZ INC.-SDZ2024GB067263$SANDOZ$$48$YR$$M$Y$86$KG$20240724$$CN$GB$GB
241329671$24132967$1$I$$20240710$20240724$20240724$EXP$$ES-AUROBINDO-AUR-APL-2024-036055$AUROBINDO$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol. 2024;35 (Suppl. 1):S60-S61 abstr. 130P$59$YR$$F$Y$$$20240724$$HP$ES$ES
241329681$24132968$1$I$20240419$20240718$20240724$20240724$EXP$$FR-DSJP-DSE-2024-123823$DAIICHI$$$$E$F$Y$$$20240724$$MD$FR$FR
241329691$24132969$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117137$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$68.95$KG$20240724$$CN$US$US
241329701$24132970$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117338$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240724$$HP$US$US
241329711$24132971$1$I$$20240718$20240724$20240724$PER$$US-BAYER-2024A106374$BAYER$$$$$$Y$$$20240724$$MD$US$US
241329721$24132972$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014857$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240724$$CN$US$US
241329731$24132973$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014440$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240724$$CN$US$US
241329741$24132974$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014470$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240724$$CN$US$US
241329752$24132975$2$F$20240719$20240729$20240724$20240730$30DAY$$FR-SANDOZ INC.-SDZ2024FR067438$SANDOZ$$16$YR$$$Y$$$20240730$$CN$FR$FR
241329762$24132976$2$F$$20240722$20240724$20240729$EXP$$IE-SANDOZ INC.-PHHY2019IE154317$SANDOZ$$$$$F$Y$$$20240729$$MD$IE$IE
241329771$24132977$1$I$20240713$20240719$20240724$20240724$EXP$NO-NOMAADVRE-RELISM-2024-Vbkp3d$NO-NALPROPION PHARMACEUTICALS INC.-NO-2024CUR003429$CURRAX PHARMACEUTICALS$$52$YR$$M$Y$$$20240724$$MD$NO$NO
241329781$24132978$1$I$$20240710$20240724$20240724$EXP$$ES-AUROBINDO-AUR-APL-2024-035914$AUROBINDO$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol. 2024;35 (Suppl. 1):S60-S61 abstr. 130P$64$YR$$F$Y$$$20240724$$HP$ES$ES
241329793$24132979$3$F$$20240827$20240724$20240904$EXP$$US-ROCHE-10000029658$ROCHE$$35$YR$A$F$Y$$$20240904$$MD$US$US
241329802$24132980$2$F$20240110$20240724$20240724$20240802$EXP$NO-NOMAADVRE-PASRAPP-2024-V9za5j$NO-NALPROPION PHARMACEUTICALS INC.-NO-2024CUR003346$CURRAX PHARMACEUTICALS$$31$YR$$F$Y$79$KG$20240802$$CN$NO$NO
241329811$24132981$1$I$$20240716$20240724$20240724$EXP$$BE-BAXTER-2024BAX021693$BAXTER$$54$YR$$F$Y$$$20240724$$CN$BE$BE
241329831$24132983$1$I$$20240716$20240724$20240724$PER$$US-ABBVIE-5845611$ABBVIE$$$$$$Y$$$20240724$$CN$US$US
241329841$24132984$1$I$20231201$20240710$20240724$20240724$EXP$GB-MHRA-MED-202407101040248900-LGHCQ$GB-GLENMARK PHARMACEUTICALS-2024GMK092309$GLENMARK$$$$$$Y$$$20240724$$PH$GB$GB
241329852$24132985$2$F$$20240809$20240724$20240819$EXP$$DE-TEVA-VS-3223216$TEVA$Barba L, Carrubba C, Spindler K, Weise CM, Sachs T, Foschi M, et al. Posterior reversible encephalopathy syndrome associated with antibiotic therapy: a case report and systematic review. Neurol-Sci 2024;.; Barba L, Carrubba C, Spindler K, Weise CM, Sachs T, Foschi M, et al. Posterior reversible encephalopathy syndrome associated with antibiotic therapy: a case report and systematic review. Neurol-Sci 2024;.; Barba L, Carrubba C, Spindler K, Weise CM, Sachs T, Foschi M, et al. Posterior revers...$55$YR$$F$Y$$$20240819$$HP$DE$DE
241329864$24132986$4$F$20240701$20240925$20240724$20240930$EXP$$US-KYOWAKIRIN-2024KK017494$KYOWA$$$$$$Y$$$20240930$$CN$US$US
241329871$24132987$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151483$NOVARTIS$$$$$M$Y$$$20240724$$MD$US$US
241329882$24132988$2$F$20230427$20240807$20240724$20240816$EXP$FR-AFSSAPS-AN2024000896$FR-TEVA-VS-3221927$TEVA$$88$YR$$F$Y$78$KG$20240816$$PH$FR$FR
241329891$24132989$1$I$$20240717$20240724$20240724$EXP$$NVSC2024PL149771$NOVARTIS$Kubeczko M, Gabrys D, Gawkowska M, Polakiewicz-Gilowska A, Cortez AJ, Krzywon A et al.. Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer. CANCERS. 2023;15(3):1-17$$$$F$Y$$$20240724$$HP$PL$PL
241329901$24132990$1$I$$20240716$20240724$20240724$EXP$$JP-AstraZeneca-2024A164713$ASTRAZENECA$$$$$F$Y$$$20240724$$HP$JP$
241329911$24132991$1$I$$20240716$20240724$20240724$EXP$$IN-AstraZeneca-2024A162545$ASTRAZENECA$$56$YR$$M$Y$$$20240724$$CN$IN$
241329921$24132992$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A162662$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241329932$24132993$2$F$$20240914$20240724$20240916$EXP$$CA-PFIZER INC-202400221733$PFIZER$$60$YR$$F$Y$$$20240916$$HP$CA$CA
241329941$24132994$1$I$$20210806$20240724$20240724$EXP$$CA-AstraZeneca-2021A672198$ASTRAZENECA$$$$$F$Y$$$20240724$$HP$CA$
241329965$24132996$5$F$20240801$20240913$20240724$20240913$EXP$$CA-PFIZER INC-202400221732$PFIZER$$75$YR$$M$Y$$$20240913$$MD$CA$CA
241329971$24132997$1$I$$20240719$20240724$20240724$30DAY$$US-GSK-US2024090798$GLAXOSMITHKLINE$$81$YR$$M$Y$$$20240724$$CN$US$US
241329982$24132998$2$F$20240101$20240814$20240724$20240816$EXP$$US-UCBSA-2024037154$UCB$$$$$F$Y$$$20240816$$CN$US$US
241330001$24133000$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A165821$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241330011$24133001$1$I$20240722$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146036$AMGEN$$75$YR$E$F$Y$$$20240724$$CN$US$US
241330021$24133002$1$I$20240718$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145686$AMGEN$$81$YR$E$F$Y$$$20240724$$CN$US$US
241330031$24133003$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146948$AMGEN$$$$$$Y$$$20240724$$HP$US$US
241330041$24133004$1$I$$20240524$20240724$20240724$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00431$UPSHER-SMITH$$$$$M$Y$$$20240724$$CN$US$US
241330051$24133005$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50874$$FDA-CTU$$66$YR$$F$N$$$20240723$N$$US$
241330061$24133006$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50887$$FDA-CTU$$65$YR$$M$N$73.48$KG$20240723$N$$US$
241330071$24133007$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50855$$FDA-CTU$$60$YR$$F$N$108.86$KG$20240723$N$$US$
241330081$24133008$1$I$$20240723$20240724$20240724$EXP$PL-ORESUND-24OPAJY0378P$PL-SANDOZ INC.-SDZ2024PL067492$SANDOZ$$27$YR$$M$Y$$$20240724$$MD$PL$PL
241330091$24133009$1$I$$20240722$20240724$20240724$EXP$GB-MHRA-MED-202407222219382160-HYBLF$GB-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2407GB05827$INSUD PHARMA$$$$$F$Y$$$20240724$$CN$GB$GB
241330102$24133010$2$F$$20240819$20240724$20240822$PER$$US-BIOVITRUM-2024-US-010107$BIOVITRUM$$82$YR$$F$Y$$$20240822$$CN$US$US
241330111$24133011$1$I$20240418$20240716$20240724$20240724$EXP$FR-AFSSAPS-PB2024000707$FR-ROCHE-10000028239$ROCHE$$34$YR$A$F$Y$$$20240724$$MD$FR$FR
241330121$24133012$1$I$$20240723$20240724$20240724$PER$$US-BAYER-2024A107000$BAYER$$$$$$Y$$$20240724$$MD$US$US
241330131$24133013$1$I$20231101$20240717$20240724$20240724$EXP$FR-AFSSAPS-PO2024000763$FR-BAYER-2024A104051$BAYER$$47$YR$A$F$Y$92$KG$20240724$$CN$FR$FR
241330141$24133014$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA212178$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240724$$CN$US$US
241330151$24133015$1$I$20220101$20240719$20240724$20240724$EXP$FR-AFSSAPS-RS2024000699$FR-SA-2024SA213304$SANOFI AVENTIS$$76$YR$E$F$Y$45$KG$20240724$$PH$FR$FR
241330161$24133016$1$I$20240601$20240709$20240724$20240724$EXP$$US-TEVA-VS-3212281$TEVA$$31$YR$$F$Y$$$20240724$$CN$US$US
241330171$24133017$1$I$$20240717$20240724$20240724$PER$$US-JNJFOC-20240746850$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$HP$US$US
241330182$24133018$2$F$20240101$20240827$20240724$20240902$EXP$$US-AMGEN-USASP2024141876$AMGEN$$67$YR$E$F$Y$$$20240902$$CN$US$US
241330191$24133019$1$I$$20240718$20240724$20240724$EXP$$US-AMGEN-USASP2024143753$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241330203$24133020$3$F$20240719$20240805$20240724$20240808$EXP$$US-ORGANON-O2407USA002108$ORGANON$$29$YR$$F$Y$$$20240808$$MD$US$US
241330211$24133021$1$I$20220105$20240717$20240724$20240724$EXP$$CN-SA-2024SA214400$SANOFI AVENTIS$$66$YR$E$F$Y$56$KG$20240724$$HP$CN$CN
241330222$24133022$2$F$20240101$20240820$20240724$20240902$EXP$$US-SA-2024SA215958$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240902$$MD$US$US
241330232$24133023$2$F$$20240815$20240724$20240819$EXP$$BR-TAKEDA-2024TUS073231$TAKEDA$$$$$M$Y$130$KG$20240819$$CN$CO$BR
241330241$24133024$1$I$$20240709$20240724$20240724$EXP$$HR-GLANDPHARMA-HR-2024GLNLIT00498$GLAND PHARMA$Sonja Skiljic.Point-of-care diagnostic approach in a critically ill patient with severe bleeding from urinary tract.Acta clin croat.2023;62:138-142$73$YR$E$M$Y$$$20240724$$HP$HR$HR
241330252$24133025$2$F$$20240809$20240724$20240819$EXP$$US-TEVA-VS-3222801$TEVA$Miller MJ, Lee P, Lee BG, Flegel WA, West-Mitchell K, Conry-Cantilena K, et al. Consideration for alpha-gal syndrome in two critically ill persons with group O blood who received group B plasma. Transfusion 2024; 64 (5): 949-951.; Miller MJ, Lee P, Lee BG, Flegel WA, West-Mitchell K, Conry-Cantilena K, et al. Consideration for alpha-gal syndrome in two critically ill persons with group O blood who received group B plasma. Transfusion 2024; 64 (5): 949-951.$64$YR$$M$Y$$$20240819$$MD$US$US
241330283$24133028$3$F$20240701$20240819$20240724$20240822$EXP$$US-Eisai-EC-2024-170743$EISAI$$74$YR$E$M$Y$$$20240822$$CN$US$US
241330291$24133029$1$I$$20240718$20240724$20240724$EXP$$CA-ABBVIE-5846166$ABBVIE$$$$E$F$Y$$$20240724$$MD$CA$CA
241330303$24133030$3$F$20240719$20240823$20240724$20240829$PER$$US-AMGEN-USASP2024145497$AMGEN$$86$YR$E$F$Y$$$20240829$$CN$US$US
241330311$24133031$1$I$20240502$20240718$20240724$20240724$EXP$FR-AFSSAPS-PB2024000792$FR-009507513-2407FRA011584$MERCK$$40$YR$$F$Y$100$KG$20240724$$CN$FR$FR
241330321$24133032$1$I$$20240714$20240724$20240724$EXP$$JP-JNJFOC-20240739895$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$HP$JP$JP
241330331$24133033$1$I$$20240716$20240724$20240724$EXP$$US-PERRIGO-24US006890$PERRIGO$Gaur D, Michalopulos MG, Drake KA, Gattineni J. Acetaminophen induced high anion gap metabolic acidosis: a potentially under-recognized consequence from a common medication. Pediatric Nephrology. 2024. DOI: 10.1007/s00467-024-06396-4.$12$YR$$F$Y$$$20240724$$MD$US$US
241330341$24133034$1$I$$20240716$20240724$20240724$EXP$$AU-TEVA-VS-3222951$TEVA$$25$YR$$F$Y$$$20240724$$HP$AU$AU
241330352$24133035$2$F$20240401$20240902$20240724$20240910$EXP$$MX-ROCHE-10000034081$ROCHE$$56$YR$A$F$Y$50$KG$20240910$$CN$MX$MX
241330361$24133036$1$I$$20240716$20240724$20240724$EXP$$AU-TEVA-VS-3222753$TEVA$$$$$F$Y$$$20240724$$HP$AU$AU
241330371$24133037$1$I$20240703$20240718$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US054925$SANDOZ$$9$YR$$F$Y$$$20240724$$HP$US$US
241330381$24133038$1$I$$20240719$20240724$20240724$EXP$$US-AstraZeneca-2024A165904$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241330391$24133039$1$I$$20240716$20240724$20240724$EXP$$ES-AstraZeneca-2024A163762$ASTRAZENECA$$74$YR$$F$Y$$$20240724$$CN$ES$
241330401$24133040$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A162406$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241330412$24133041$2$F$$20240724$20240724$20240729$PER$$NVSC2024US147937$NOVARTIS$$$$$F$Y$$$20240729$$CN$US$US
241330421$24133042$1$I$$20240716$20240724$20240724$EXP$$CN-AstraZeneca-2024A163134$ASTRAZENECA$$$$A$M$Y$64$KG$20240724$$MD$CN$
241330431$24133043$1$I$20240705$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A162193$ASTRAZENECA$$26366$DY$$F$Y$92.5$KG$20240724$$CN$US$
241330441$24133044$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A163011$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241330451$24133045$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A162441$ASTRAZENECA$$$$A$M$Y$$$20240724$$CN$US$
241330461$24133046$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50889$$FDA-CTU$$68$YR$$F$N$63.5$KG$20240723$N$$US$
241330471$24133047$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50842$$FDA-CTU$$79$YR$$M$N$$$20240723$N$$US$
241330481$24133048$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A162698$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241330491$24133049$1$I$20231117$20240719$20240724$20240724$EXP$$JP-AstraZeneca-2023A293699$ASTRAZENECA$$16$YR$$F$Y$$$20240724$$MD$JP$
241330501$24133050$1$I$20240701$20240716$20240724$20240724$PER$$US-SA-2024SA212787$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240724$$MD$US$US
241330511$24133051$1$I$$20240719$20240724$20240724$EXP$GB-MHRA-MED-202407191143595730-YFPRV$GB-SA-2024SA213576$SANOFI AVENTIS$$$$$F$Y$$$20240724$$HP$GB$GB
241330522$24133052$2$F$20240721$20240831$20240724$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US067199$SANDOZ$$62$YR$$F$Y$$$20240903$$CN$US$US
241330531$24133053$1$I$20240224$20240723$20240724$20240724$EXP$FR-AFSSAPS-NT2024000849$FR-SANDOZ INC.-SDZ2024FR067579$SANDOZ$$15$YR$$M$Y$57$KG$20240724$$PH$FR$FR
241330551$24133055$1$I$20240522$20240723$20240724$20240724$EXP$$US-SANDOZ INC.-SDZ2024US067705$SANDOZ$$73$YR$$M$Y$$$20240724$$HP$US$US
241330561$24133056$1$I$$20240710$20240724$20240724$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07035$LUPIN$$$$$$Y$$$20240724$$CN$US$US
241330571$24133057$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024090134$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241330581$24133058$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090939$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241330591$24133059$1$I$$20240723$20240724$20240724$PER$$US-BAYER-2024A106939$BAYER$$31$YR$A$F$Y$$$20240724$$MD$US$US
241330601$24133060$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50846$$FDA-CTU$$45$YR$$F$N$$$20240723$N$$US$
241330611$24133061$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50851$$FDA-CTU$$20$YR$$F$N$48.08$KG$20240723$N$$US$
241330621$24133062$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50858$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241330631$24133063$1$I$$20240717$20240724$20240724$EXP$$US-ABBVIE-5845562$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241330642$24133064$2$F$$20240911$20240724$20240919$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011204$JAZZ$$$$$M$Y$$$20240919$$MD$JP$JP
241330651$24133065$1$I$$20240709$20240724$20240724$PER$$US-COSETTE-CP2024US000161$COSETTE PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
241330661$24133066$1$I$20240601$20240718$20240724$20240724$EXP$$JP-AMGEN-JPNSP2024140675$AMGEN$$$$A$F$Y$$$20240724$$MD$JP$JP
241330681$24133068$1$I$20240718$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024145003$AMGEN$$41$YR$A$F$Y$$$20240724$$CN$US$US
241330691$24133069$1$I$20230522$20230529$20240724$20240724$EXP$$ZA-BIOVITRUM-2023-ZA-011366$BIOVITRUM$$132$DY$$F$Y$4$KG$20240724$$CN$ZA$ZA
241330701$24133070$1$I$$20240718$20240724$20240724$EXP$$US-SA-2024SA213524$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240724$$MD$US$US
241330711$24133071$1$I$$20240719$20240724$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011119$JAZZ$$$$$M$Y$$$20240724$$CN$US$US
241330721$24133072$1$I$$20240719$20240724$20240724$PER$$US-TAKEDA-2024TUS073947$TAKEDA$$$$$F$Y$$$20240724$$CN$US$US
241330731$24133073$1$I$$20240723$20240724$20240724$EXP$$CA-ORGANON-O2407CAN002169$ORGANON$$38$YR$$M$Y$$$20240724$$HP$CA$CA
241330741$24133074$1$I$$20240719$20240724$20240724$EXP$$JP-GSK-JP2024092013$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$MD$JP$JP
241330751$24133075$1$I$$20240701$20240724$20240724$PER$$US-JNJFOC-20240708106$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240724$$CN$US$US
241330761$24133076$1$I$20190901$20240716$20240724$20240724$EXP$$AT-SANDOZ INC.-NVSC2020AT165011$SANDOZ$$63$YR$$F$Y$58$KG$20240724$$MD$AT$AT
241330771$24133077$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024143844$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241330781$24133078$1$I$$20240717$20240724$20240724$PER$$US-AGIOS-2407US03839$AGIOS PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241330791$24133079$1$I$$20240717$20240724$20240724$EXP$$BE-ABBVIE-5848623$ABBVIE$$$$E$F$Y$49$KG$20240724$$HP$BE$BE
241330801$24133080$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151377$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
241330811$24133081$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR091360$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241330821$24133082$1$I$20240709$20240719$20240724$20240724$EXP$$US-JNJFOC-20240756587$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240724$$HP$US$US
241330831$24133083$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50836$$FDA-CTU$$70$YR$$M$N$$$20240723$N$$US$
241330841$24133084$1$I$20240501$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50859$$FDA-CTU$$16$YR$$F$N$$$20240723$N$PH$US$
241330851$24133085$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50854$$FDA-CTU$$33$YR$$M$N$$$20240723$N$HP$US$
241330861$24133086$1$I$20240322$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50841$$FDA-CTU$$69$YR$$F$N$$$20240723$N$$US$
241330871$24133087$1$I$20240717$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50876$$FDA-CTU$$78$YR$$F$N$$$20240723$Y$PH$US$
241330881$24133088$1$I$20240719$20240722$20240723$20240723$DIR$FDA-CDER-CTU-2024-50850$$FDA-CTU$$23$YR$$F$N$$$20240722$N$HP$US$
241330891$24133089$1$I$20240723$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50890$$FDA-CTU$$58$YR$$F$N$$$20240723$N$PH$US$
241330901$24133090$1$I$20240722$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-50871$$FDA-CTU$$56$YR$$F$N$122.47$KG$20240723$N$$US$
241330911$24133091$1$I$20240711$20240718$20240724$20240724$EXP$$CN-009507513-2407CHN012161$MERCK$$54$YR$$F$Y$57$KG$20240724$$HP$CN$CN
241330922$24133092$2$F$$20240902$20240724$20240913$PER$$US-APELLIS-2024-APL-0000505$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240913$$MD$US$US
241330931$24133093$1$I$$20240711$20240724$20240724$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092346$GLENMARK$Martin CE, Kuhn AK, Leopold KN, Creo AL, Schoettler PJ, Allen-Rhoades WA.. Exogenous steroid replacement in a pediatric patient with adrenocortical carcinoma receiving mitotane. Pediatric Blood and Cancer. 2024;71(8):e31072$$$$$Y$$$20240724$$PH$US$US
241330941$24133094$1$I$$20240716$20240724$20240724$EXP$$CA-ABBVIE-5849829$ABBVIE$$$$$M$Y$$$20240724$$PH$CA$CA
241330951$24133095$1$I$20240721$20240722$20240724$20240724$PER$$US-ROCHE-10000033613$ROCHE$$68$YR$E$F$Y$$$20240724$$CN$US$US
241330961$24133096$1$I$20240708$20240722$20240724$20240724$EXP$$DE-ABBVIE-5847741$ABBVIE$$79$YR$$M$Y$$$20240724$$MD$DE$DE
241330971$24133097$1$I$$20240717$20240724$20240724$EXP$$KR-AMGEN-KORSP2024142349$AMGEN$Kim K. Real-world outcome of patients with extensively pretreated multiple myeloma who were treated with selinexor and dexamethasone: a Korean multicenter retrospective analysis. Annals of Hematology. 2024;103 (7):2365-2372$$$$$Y$$$20240724$$HP$KR$KR
241330981$24133098$1$I$$20240712$20240724$20240724$EXP$$US-GILEAD-2024-0677552$GILEAD$$$$A$F$Y$$$20240724$$CN$US$US
241330991$24133099$1$I$20210504$20240722$20240724$20240724$EXP$$NVSC2024KR150661$NOVARTIS$$75$YR$$M$Y$67.65$KG$20240724$$HP$KR$KR
241331001$24133100$1$I$20231211$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117822$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240724$$MD$US$US
241331011$24133101$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117470$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$73.48$KG$20240724$$CN$US$US
241331021$24133102$1$I$$20240723$20240724$20240724$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-117417$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240724$$HP$PR$PR
241331031$24133103$1$I$$20240718$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115681$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$56.25$KG$20240724$$HP$US$US
241331041$24133104$1$I$20240614$20240711$20240724$20240724$EXP$$CN-G1 THERAPEUTICS-2024G1CN0000095$G1 THERAPEUTICS$$$$$$Y$$$20240724$$MD$CN$CN
241331051$24133105$1$I$20240101$20240716$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014912$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240724$$CN$US$US
241331061$24133106$1$I$20240720$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014383$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240724$$CN$US$US
241331071$24133107$1$I$20231014$20240715$20240724$20240724$EXP$FR-AFSSAPS-PA2024000835$FR-TEVA-VS-3221932$TEVA$$50$YR$$F$Y$93$KG$20240724$$MD$FR$FR
241331081$24133108$1$I$20240503$20240717$20240724$20240724$EXP$GB-MHRA-MED-202407171022017900-JTKWD$GB-BAYER-2024A104091$BAYER$$50$YR$A$M$Y$98$KG$20240724$$CN$GB$GB
241331091$24133109$1$I$$20240722$20240724$20240724$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137152$DAIICHI$$$$$F$Y$$$20240724$$HP$US$US
241331102$24133110$2$F$20240718$20240731$20240724$20240803$PER$$US-ABBVIE-5850327$ABBVIE$$82$YR$$F$Y$$$20240803$$CN$US$US
241331111$24133111$1$I$20240101$20240717$20240724$20240724$EXP$$DE-AMGEN-DEUSP2024073082$AMGEN$$82$YR$E$F$Y$$$20240724$$CN$DE$DE
241331131$24133113$1$I$$20240723$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US067830$SANDOZ$$$$$F$Y$$$20240724$$CN$US$US
241331141$24133114$1$I$$20240710$20240724$20240724$PER$$US-SA-2024SA206805$SANOFI AVENTIS$$$$A$F$Y$$$20240724$$CN$US$US
241331151$24133115$1$I$20240101$20240718$20240724$20240724$PER$$US-SA-2024SA212864$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240724$$MD$US$US
241331162$24133116$2$F$20240701$20240718$20240724$20240729$PER$$US-SA-2024SA212428$SANOFI AVENTIS$$64$YR$A$F$Y$81.6$KG$20240729$$MD$US$US
241331171$24133117$1$I$20240601$20240715$20240724$20240724$PER$$US-SA-2024SA211487$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240724$$MD$US$US
241331181$24133118$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212535$SANOFI AVENTIS$$$$$$Y$$$20240724$$MD$US$US
241331191$24133119$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA212840$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240724$$MD$US$US
241331201$24133120$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212523$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240724$$MD$US$US
241331211$24133121$1$I$20240101$20240715$20240724$20240724$PER$$US-SA-2024SA132541$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240724$$MD$US$US
241331222$24133122$2$F$20240701$20240919$20240724$20240926$EXP$$GB-GSK-GB2024EME090239$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$GB$GB
241331231$24133123$1$I$20240101$20240627$20240724$20240724$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000137$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241331241$24133124$1$I$20220601$20240722$20240724$20240724$EXP$DE-CADRBFARM-2024328566$DE-ABBVIE-5850060$ABBVIE$$$$$$Y$$$20240724$$CN$DE$DE
241331251$24133125$1$I$$20240716$20240724$20240724$EXP$$CA-AstraZeneca-2024A163885$ASTRAZENECA$$$$$F$Y$$$20240724$$MD$CA$
241331264$24133126$4$F$$20240716$20240724$20240731$EXP$$US-ROCHE-10000029596$ROCHE$$62$YR$A$M$Y$81.19$KG$20240731$$HP$US$US
241331271$24133127$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50920$$FDA-CTU$$60$YR$$F$N$86.18$KG$20240724$N$$US$
241331281$24133128$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50916$$FDA-CTU$$72$YR$$F$N$$$20240724$N$$US$
241331291$24133129$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50922$$FDA-CTU$$63$YR$$F$N$$$20240724$N$$US$
241331301$24133130$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50951$$FDA-CTU$$84$YR$$M$N$$$20240724$N$$US$
241331311$24133131$1$I$$20240724$20240724$20240724$EXP$$US-BAYER-2024A107530$BAYER$$77$YR$E$F$Y$$$20240724$$HP$US$US
241331321$24133132$1$I$$20240717$20240724$20240724$PER$$US-ABBVIE-5844221$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241331332$24133133$2$F$20230531$20240727$20240724$20240805$EXP$$AE-AstraZeneca-2023A171496$ASTRAZENECA$$53$YR$$F$Y$62$KG$20240805$$MD$AE$
241331341$24133134$1$I$$20240716$20240724$20240724$EXP$$CA-AstraZeneca-2024A164883$ASTRAZENECA$$$$$F$Y$$$20240724$$MD$CA$
241331351$24133135$1$I$20240701$20240715$20240724$20240724$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-117597$BRISTOL MYERS SQUIBB$$20$YR$A$F$Y$$$20240724$$HP$BR$BR
241331361$24133136$1$I$20240717$20240719$20240724$20240724$EXP$$US-AstraZeneca-2024A165815$ASTRAZENECA$$28111$DY$$F$Y$$$20240724$$CN$US$
241331381$24133138$1$I$20240207$20240717$20240724$20240724$EXP$$US-GSK-US2024090028$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241331392$24133139$2$F$20240719$20240723$20240724$20240727$EXP$$NVSC2023CA149809$NOVARTIS$$31$YR$$F$Y$$$20240727$$CN$CA$CA
241331411$24133141$1$I$20240701$20240719$20240724$20240724$PER$$US-PFIZER INC-PV202400095276$PFIZER$$64$YR$$F$Y$$$20240724$$CN$US$US
241331422$24133142$2$F$20240718$20240724$20240724$20240726$PER$$AU-PFIZER INC-202400220947$PFIZER$$$$$$Y$$$20240726$$PH$AU$AU
241331431$24133143$1$I$20240718$20240719$20240724$20240724$PER$$US-PFIZER INC-202400219868$PFIZER$$$$$F$Y$$$20240724$$CN$US$US
241331441$24133144$1$I$$20240723$20240724$20240724$PER$$PR-PFIZER INC-PV202400096505$PFIZER$$54$YR$$F$Y$$$20240724$$CN$PR$PR
241331451$24133145$1$I$20240402$20240724$20240724$20240724$EXP$FR-AFSSAPS-RS2024000713$FR-BAYER-2024A107429$BAYER$$69$YR$E$M$Y$69$KG$20240724$$MD$FR$FR
241331462$24133146$2$F$$20240920$20240724$20240925$EXP$$JP-009507513-2407JPN003495J$MERCK$Ogimoto K, Matsui K, Ichida K, Aratake J, Narita M, Hamasaki K, et al.. OS-250 Report of 5 cases of suspected irAE myocarditis at our hospital -Actual status of screening and treatment for irAE myocarditis. The journal of the Japan Society of Gynecologic Oncology The 66th Annual Meeting. 2024;42(3):320$$$$F$Y$$$20240925$$MD$JP$JP
241331471$24133147$1$I$20240719$20240722$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US067459$SANDOZ$$12$YR$$F$Y$$$20240724$$CN$US$US
241331481$24133148$1$I$$20240723$20240724$20240724$EXP$$ES-SANDOZ INC.-SDZ2024ES067353$SANDOZ$$64$YR$$M$Y$$$20240724$$HP$ES$ES
241331491$24133149$1$I$$20240719$20240724$20240724$EXP$$TW-AMGEN-TWNSP2024145108$AMGEN$$$$$$Y$$$20240724$$HP$TW$TW
241331501$24133150$1$I$$20240719$20240724$20240724$EXP$$TW-AMGEN-TWNSP2024145093$AMGEN$$$$$$Y$$$20240724$$HP$TW$TW
241331511$24133151$1$I$20220701$20240715$20240724$20240724$EXP$FR-AFSSAPS-GR2024000839$FR-TEVA-VS-3221894$TEVA$$53$YR$$F$Y$$$20240724$$PH$FR$FR
241331521$24133152$1$I$$20240709$20240724$20240724$EXP$$US-HLS-202400300$HLS THERAPEUTICS$$65$YR$E$F$Y$$$20240724$$MD$US$US
241331531$24133153$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117518$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240724$$CN$US$US
241331541$24133154$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117501$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240724$$CN$US$US
241331552$24133155$2$F$$20240724$20240724$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116876$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240729$$HP$US$US
241331563$24133156$3$F$20210113$20240827$20240724$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-011635$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$67$KG$20240904$$MD$JP$JP
241331571$24133157$1$I$$20200217$20240724$20240724$EXP$$US-AstraZeneca-2020SE25335$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241331582$24133158$2$F$$20240913$20240724$20240913$PER$$US-PFIZER INC-202400220917$PFIZER$$45$YR$$M$Y$$$20240913$$HP$US$US
241331591$24133159$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A165978$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241331601$24133160$1$I$20240503$20240716$20240724$20240724$EXP$$FR-AstraZeneca-2024A161792$ASTRAZENECA$$86$YR$$F$Y$67$KG$20240724$$MD$FR$
241331612$24133161$2$F$$20240716$20240724$20240818$EXP$$GB-AstraZeneca-2024A148362$ASTRAZENECA$$67$YR$$F$Y$90$KG$20240819$$MD$GB$
241331621$24133162$1$I$$20200325$20240724$20240724$EXP$$US-AstraZeneca-2020SE43829$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241331631$24133163$1$I$20240101$20240716$20240724$20240724$EXP$$FR-AstraZeneca-2024A164165$ASTRAZENECA$$$$A$F$Y$$$20240724$$MD$FR$
241331641$24133164$1$I$$20230717$20240724$20240724$EXP$$US-AstraZeneca-2023A164256$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241331652$24133165$2$F$$20240905$20240724$20240909$EXP$$US-AstraZeneca-2024A162554$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
241331661$24133166$1$I$$20240712$20240724$20240724$EXP$$US-GILEAD-2024-0678015$GILEAD$$42$YR$A$F$Y$$$20240724$$CN$US$US
241331671$24133167$1$I$20240625$20240719$20240724$20240724$30DAY$$US-GSK-US2024091113$GLAXOSMITHKLINE$$79$YR$$F$Y$82.1$KG$20240724$$CN$US$US
241331681$24133168$1$I$20240711$20240716$20240724$20240724$EXP$$US-GILEAD-2024-0681066$GILEAD$$74$YR$E$F$Y$$$20240724$$CN$US$US
241331693$24133169$3$F$20240717$20240815$20240724$20240823$EXP$$JP-EMD Serono-2024039034$EMD SERONO INC$$76$YR$E$F$Y$61$KG$20240823$$PH$JP$JP
241331702$24133170$2$F$20240101$20240717$20240724$20240801$EXP$$CN-009507513-2407CHN012089$MERCK$$50$YR$$M$Y$65$KG$20240801$$HP$CN$CN
241331711$24133171$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117539$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$91.81$KG$20240724$$PH$US$US
241331721$24133172$1$I$20240714$20240716$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114014$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240724$$PH$US$US
241331731$24133173$1$I$20240401$20240715$20240724$20240724$EXP$FR-AFSSAPS-NT2024000769$FR-TEVA-VS-3221937$TEVA$$75$YR$$M$Y$64.5$KG$20240724$$MD$FR$FR
241331742$24133174$2$F$$20240905$20240724$20240909$PER$$US-PFIZER INC-202400222607$PFIZER$$72$YR$$M$Y$$$20240909$$CN$US$US
241331751$24133175$1$I$$20240717$20240724$20240724$PER$$US-MYLANLABS-2024M1067623$MYLAN$$$$$F$Y$$$20240724$$CN$US$US
241331761$24133176$1$I$20240712$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50894$$FDA-CTU$$70$YR$$M$N$89.8$KG$20240723$N$$US$
241331771$24133177$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50927$$FDA-CTU$$46$YR$$F$N$$$20240724$N$$US$
241331781$24133178$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50955$$FDA-CTU$$55$YR$$F$N$76.2$KG$20240724$N$$US$
241331792$24133179$2$F$$20240822$20240724$20240829$EXP$$US-TEVA-VS-3222813$TEVA$Xu E, Thomas S, Habibi B. Intrathecal Methotrexate-Induced Lumbosacral Polyradiculopathy: A Case Report. Pain-Med-Case-Rep 2024; 8 (1): 31-35.; Xu E, Thomas S, Habibi B. Intrathecal Methotrexate-Induced Lumbosacral Polyradiculopathy: A Case Report. Pain-Med-Case-Rep 2024; 8 (1): 31-35.$68$YR$$F$Y$$$20240829$$HP$US$US
241331801$24133180$1$I$$20240722$20240724$20240724$EXP$$US-OTSUKA-2024_020486$OTSUKA$$$$$F$Y$$$20240724$$HP$US$US
241331812$24133181$2$F$20240710$20240905$20240724$20240909$EXP$$US-JAZZ-2022-US-032925$JAZZ$$42$YR$$F$Y$$$20240909$$HP$US$US
241331821$24133182$1$I$$20240710$20240724$20240724$EXP$$US-ALVOGEN-2024095048$ALVOGEN$Golparvar A, Nafeh O, Alzamani M, Singh V, Jennings M. The Development of Disinhibited Social Engagement Disorder: A Case Report on the Psychiatric Implications of Prenatal Fentanyl Use. Cureus. 2024 May 25;16(5):e61078. doi:https://dx.doi.org/10.7759/cureus.61078$$$$F$Y$$$20240724$$HP$US$US
241331831$24133183$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50948$$FDA-CTU$$35$YR$$F$N$146.51$KG$20240724$N$$US$
241331842$24133184$2$F$20231228$20240828$20240724$20240903$EXP$$BE-BEH-2024167207$CSL BEHRING$$59$YR$A$F$Y$93$KG$20240903$$MD$BE$BE
241331851$24133185$1$I$20240710$20240723$20240724$20240724$EXP$$US-INCYTE CORPORATION-2024IN007696$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241331865$24133186$5$F$$20240923$20240724$20240930$EXP$$CA-GSK-CA2024076506$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$PH$CA$CA
241331871$24133187$1$I$$20240716$20240724$20240724$EXP$$US-GILEAD-2024-0680967$GILEAD$$$$E$F$Y$$$20240724$$CN$US$US
241331881$24133188$1$I$20240622$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50925$$FDA-CTU$$74$YR$$F$N$$$20240724$N$PH$US$
241331892$24133189$2$F$$20240723$20240724$20240724$PER$$NVSC2024US150938$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
241331901$24133190$1$I$20231025$20240422$20240724$20240724$EXP$$GB-SA-2023SA355084$SANOFI AVENTIS$$65$YR$E$M$Y$76.5$KG$20240724$$HP$GB$GB
241331912$24133191$2$F$20240718$20240718$20240724$20240726$EXP$$NZ-BAXTER-2024BAX021787$BAXTER$$63$YR$$M$Y$$$20240726$$HP$NZ$NZ
241331921$24133192$1$I$$20240719$20240724$20240724$PER$$US-ABBVIE-5850339$ABBVIE$$69$YR$$F$Y$$$20240724$$MD$US$US
241331931$24133193$1$I$20240512$20240715$20240724$20240724$EXP$FR-AFSSAPS-PB2024000758$FR-TEVA-VS-3221939$TEVA$$18$YR$$F$Y$59.5$KG$20240724$$MD$FR$FR
241331961$24133196$1$I$20240703$20240719$20240724$20240724$EXP$GB-MHRA-MED-202407191827362400-DZKQG$GB-Ipsen Biopharmaceuticals, Inc.-2024-14481$IPSEN$$29$YR$A$F$Y$58$KG$20240724$$CN$GB$GB
241331971$24133197$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50949$$FDA-CTU$$65$YR$$M$N$$$20240724$N$$US$
241331982$24133198$2$F$$20240807$20240724$20240812$PER$$US-JNJFOC-20240748823$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$HP$US$US
241331991$24133199$1$I$20231014$20240716$20240724$20240724$EXP$$TH-ROCHE-10000032560$ROCHE$$72$YR$E$M$Y$$$20240724$$CN$TH$TH
241332001$24133200$1$I$20240708$20240721$20240724$20240724$EXP$$CN-AstraZeneca-2024A166366$ASTRAZENECA$$25407$DY$$M$Y$62$KG$20240724$$MD$CN$
241332011$24133201$1$I$$20220418$20240724$20240724$EXP$$US-AstraZeneca-2022A157884$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241332022$24133202$2$F$$20240717$20240724$20240725$PER$$US-ALXN-A202111119$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240725$$MD$US$US
241332031$24133203$1$I$20240411$20240716$20240724$20240724$EXP$$IT-AstraZeneca-2024A162033$ASTRAZENECA$$51$YR$$F$Y$$$20240724$$MD$IT$
241332041$24133204$1$I$20240703$20240716$20240724$20240724$EXP$PT-INFARMED-J202407-205$PT-BAXTER-2024BAX021699$BAXTER$$45$YR$$F$Y$100$KG$20240724$$PH$PT$PT
241332051$24133205$1$I$$20210430$20240724$20240724$EXP$$US-AstraZeneca-2021A382666$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241332061$24133206$1$I$20240626$20240712$20240724$20240724$EXP$EU-LRB-00985193$EU-SEPTODONT-2024018801$SEPTODONT$$$$A$$Y$43$KG$20240724$$HP$EU$EU
241332071$24133207$1$I$$20240718$20240724$20240724$EXP$$US-APELLIS-2024-APL-0000519$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240724$$MD$US$US
241332081$24133208$1$I$20240613$20240715$20240724$20240724$EXP$$US-GILEAD-2024-0680921$GILEAD$$70$YR$E$M$Y$$$20240724$$CN$US$US
241332091$24133209$1$I$$20240724$20240724$20240724$PER$$US-HALEON-2188724$Haleon PLC$$$$$F$Y$$$20240724$$CN$US$US
241332101$24133210$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA213114$SANOFI AVENTIS$$$$$F$Y$$$20240724$$CN$US$US
241332111$24133211$1$I$$20240715$20240724$20240724$EXP$$FR-SA-2024SA208929$SANOFI AVENTIS$F?rst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R, et al.. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease. Bone Marrow Transplantation.. 2024;59(7):918-27$30$YR$A$M$Y$$$20240724$$HP$FR$FR
241332122$24133212$2$F$$20240809$20240724$20240819$EXP$$US-TEVA-VS-3222650$TEVA$Li A, Manak CK. (029) Management of Agitation Secondary to Immune Cell-Effector Associated Neurotoxicity Syndrome (ICANS) in a Pediatric Patient. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S14-S15.; Li A, Manak CK. (029) Management of Agitation Secondary to Immune Cell-Effector Associated Neurotoxicity Syndrome (ICANS) in a Pediatric Patient. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S14-S15.$18$YR$$F$Y$$$20240819$$HP$US$US
241332141$24133214$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50944$$FDA-CTU$$58$YR$$M$N$$$20240724$N$$US$
241332151$24133215$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50947$$FDA-CTU$$75$YR$$F$N$$$20240724$N$$US$
241332181$24133218$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50900$$FDA-CTU$$55$YR$$F$N$127.01$KG$20240724$N$$US$
241332191$24133219$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50962$$FDA-CTU$$60$YR$$F$N$244$LBS$20240724$N$$US$
241332201$24133220$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50915$$FDA-CTU$$35$YR$$F$N$136$LBS$20240724$N$$US$
241332211$24133221$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50953$$FDA-CTU$$63$YR$$F$N$$$20240724$N$$US$
241332221$24133222$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50896$$FDA-CTU$$57$YR$$F$N$131$KG$20240724$N$$US$
241332231$24133223$1$I$$20240715$20240724$20240724$EXP$$US-GILEAD-2024-0680916$GILEAD$$26$YR$A$F$Y$$$20240724$$CN$US$US
241332241$24133224$1$I$$20240714$20240724$20240724$EXP$$SE-JNJFOC-20240756790$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240724$$HP$FI$SE
241332251$24133225$1$I$$20240722$20240724$20240724$PER$$NVSC2024US151046$NOVARTIS$$34$YR$$F$Y$$$20240724$$CN$US$US
241332271$24133227$1$I$$20240722$20240724$20240724$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-136870$DAIICHI$$$$$F$Y$$$20240724$$HP$US$US
241332281$24133228$1$I$$20240719$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115722$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240724$$HP$US$US
241332291$24133229$1$I$$20240724$20240724$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041737$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240724$$MD$US$US
241332301$24133230$1$I$20180611$20180820$20240724$20240724$EXP$$JP-TAKEDA-SH201812057$TAKEDA$$10$YR$$F$Y$$$20240724$$MD$JP$JP
241332311$24133231$1$I$$20240719$20240724$20240724$EXP$$US-OTSUKA-2024_020361$OTSUKA$$$$$M$Y$$$20240724$$MD$US$US
241332321$24133232$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144836$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241332331$24133233$1$I$$20240717$20240724$20240724$PER$$US-ABBVIE-5849887$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241332341$24133234$1$I$20240601$20240716$20240724$20240724$PER$$US-SA-2024SA213243$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240724$$MD$US$US
241332352$24133235$2$F$20210101$20240723$20240724$20240730$EXP$NO-NOMAADVRE-PASRAPP-2024-Vp37ne$NO-OTSUKA-2024_020274$OTSUKA$$38$YR$$F$Y$$$20240730$$CN$NO$NO
241332361$24133236$1$I$20240501$20240716$20240724$20240724$PER$$US-SA-2024SA213694$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240724$$MD$US$US
241332371$24133237$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212998$SANOFI AVENTIS$$$$$F$Y$$$20240724$$MD$US$US
241332381$24133238$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212420$SANOFI AVENTIS$$$$A$M$Y$83$KG$20240724$$MD$US$US
241332391$24133239$1$I$20240201$20240717$20240724$20240724$EXP$NL-LRB-00990354$NL-SA-2024SA210708$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240724$$PH$NL$NL
241332411$24133241$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA213027$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240724$$MD$US$US
241332422$24133242$2$F$$20240711$20240724$20240830$PER$$US-SA-2024SA097396$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240830$$MD$US$US
241332432$24133243$2$F$20240201$20240923$20240724$20240927$EXP$$CA-OTSUKA-2024_002931$OTSUKA$$63$YR$$M$Y$$$20240927$$CN$CA$CA
241332441$24133244$1$I$20240701$20240718$20240724$20240724$PER$$US-SA-2024SA212827$SANOFI AVENTIS$$54$YR$A$M$Y$78.005$KG$20240724$$MD$US$US
241332451$24133245$1$I$20220101$20240719$20240724$20240724$PER$$US-SA-2024SA213940$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240724$$PH$US$US
241332462$24133246$2$F$$20240730$20240724$20240807$PER$$US-SA-2024SA213684$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240807$$CN$US$US
241332471$24133247$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA212779$SANOFI AVENTIS$$$$$M$Y$$$20240724$$MD$US$US
241332491$24133249$1$I$$20240715$20240724$20240724$EXP$$US-GILEAD-2024-0680882$GILEAD$Chiu C, Brumble L, Vikram H, Watt K, Beam E. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clinical Transplantation. 2024;38(7):Unk. doi:10.1111/ctr.15389$39$YR$A$F$Y$$$20240724$$MD$US$US
241332501$24133250$1$I$$20240621$20240724$20240724$PER$$US-JNJFOC-20240744572$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240724$$CN$US$US
241332511$24133251$1$I$20180101$20240711$20240724$20240724$EXP$$BR-TEVA-VS-3221440$TEVA$$46$YR$$M$Y$$$20240724$$CN$BR$BR
241332521$24133252$1$I$$20240718$20240724$20240724$EXP$$FR-AMERICAN REGENT INC-2024002789$AMERICAN REGENT$$$$$M$Y$$$20240724$$PH$FR$FR
241332531$24133253$1$I$20230601$20240717$20240724$20240724$EXP$$AU-VIIV HEALTHCARE LIMITED-AU2024090110$VIIV$$$$$$Y$$$20240724$$CN$AU$AU
241332542$24133254$2$F$20240411$20240722$20240724$20240729$EXP$NL-LRB-00981350$NL-MYLANLABS-2024M1066895$MYLAN$$13$YR$$M$Y$47$KG$20240729$$PH$NL$NL
241332551$24133255$1$I$$20240721$20240724$20240724$PER$$US-AMGEN-USASP2024145257$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241332561$24133256$1$I$$20240717$20240724$20240724$EXP$$NL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041710$BOEHRINGER INGELHEIM$$35$YR$A$M$Y$88$KG$20240724$$MD$NL$NL
241332571$24133257$1$I$20240101$20240716$20240724$20240724$PER$$US-SA-2024SA211671$SANOFI AVENTIS$$64$YR$A$M$Y$94.8$KG$20240724$$MD$US$US
241332581$24133258$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142371$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241332591$24133259$1$I$$20240604$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-031677$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332601$24133260$1$I$20240516$20240604$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-031729$FOUNDATION CONSUMER HEALTHCARE$$23$YR$$F$Y$58.06$KG$20240724$$CN$US$US
241332611$24133261$1$I$20240401$20240605$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-031941$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332621$24133262$1$I$20240603$20240605$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-031947$FOUNDATION CONSUMER HEALTHCARE$$16$YR$$F$Y$69.85$KG$20240724$$CN$US$US
241332631$24133263$1$I$20240604$20240605$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-032011$FOUNDATION CONSUMER HEALTHCARE$$19$YR$$F$Y$78.02$KG$20240724$$CN$US$US
241332641$24133264$1$I$20240501$20240606$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-032109$FOUNDATION CONSUMER HEALTHCARE$$31$YR$$F$Y$48.99$KG$20240724$$CN$US$US
241332651$24133265$1$I$20240607$20240610$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-032611$FOUNDATION CONSUMER HEALTHCARE$$28$YR$$F$Y$72.58$KG$20240724$$CN$US$US
241332661$24133266$1$I$20240607$20240610$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-032649$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332671$24133267$1$I$20240608$20240610$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-032660$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332681$24133268$1$I$20240601$20240610$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-032758$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332691$24133269$1$I$20240607$20240610$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-032704$FOUNDATION CONSUMER HEALTHCARE$$24$YR$$F$Y$58.97$KG$20240724$$CN$US$US
241332701$24133270$1$I$20240528$20240611$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-032877$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332711$24133271$1$I$20240328$20240611$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-032956$FOUNDATION CONSUMER HEALTHCARE$$39$YR$$F$Y$86.18$KG$20240724$$CN$US$US
241332721$24133272$1$I$20230919$20240611$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-032988$FOUNDATION CONSUMER HEALTHCARE$$36$YR$$F$Y$$$20240724$$CN$US$US
241332731$24133273$1$I$20240611$20240611$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-033018$FOUNDATION CONSUMER HEALTHCARE$$43$YR$$F$Y$61.24$KG$20240724$$CN$US$US
241332741$24133274$1$I$$20240611$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-033034$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332751$24133275$1$I$20240610$20240611$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-033053$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332761$24133276$1$I$20240201$20240613$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-033419$FOUNDATION CONSUMER HEALTHCARE$$28$YR$$F$Y$56.7$KG$20240724$$CN$US$US
241332771$24133277$1$I$20240613$20240613$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-033586$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332781$24133278$1$I$$20240614$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-033783$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332791$24133279$1$I$20240601$20240617$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-033943$FOUNDATION CONSUMER HEALTHCARE$$22$YR$$F$Y$83.46$KG$20240724$$CN$US$US
241332801$24133280$1$I$20240613$20240617$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-033971$FOUNDATION CONSUMER HEALTHCARE$$33$YR$$F$Y$70$KG$20240724$$CN$US$US
241332811$24133281$1$I$20240604$20240617$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-034017$FOUNDATION CONSUMER HEALTHCARE$$23$YR$$F$Y$68.04$KG$20240724$$CN$US$US
241332821$24133282$1$I$20240606$20240618$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-034267$FOUNDATION CONSUMER HEALTHCARE$$24$YR$$F$Y$73.94$KG$20240724$$CN$US$US
241332831$24133283$1$I$20240601$20240621$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-034760$FOUNDATION CONSUMER HEALTHCARE$$18$YR$$F$Y$68.04$KG$20240724$$CN$US$US
241332841$24133284$1$I$$20240620$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-034768$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332851$24133285$1$I$$20240621$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-034881$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332861$24133286$1$I$$20240621$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-034886$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332871$24133287$1$I$20240619$20240621$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-034908$FOUNDATION CONSUMER HEALTHCARE$$18$YR$$F$Y$50.8$KG$20240724$$CN$US$US
241332881$24133288$1$I$$20240624$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-035058$FOUNDATION CONSUMER HEALTHCARE$$30$YR$$F$Y$58.97$KG$20240724$$CN$US$US
241332891$24133289$1$I$$20240624$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-035084$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332901$24133290$1$I$20240501$20240624$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-035149$FOUNDATION CONSUMER HEALTHCARE$$37$YR$$F$Y$$$20240724$$CN$US$US
241332911$24133291$1$I$20240601$20240625$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-035469$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332921$24133292$1$I$20240622$20240625$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-035474$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332931$24133293$1$I$20240605$20240626$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-035645$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332941$24133294$1$I$$20240626$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-035655$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332951$24133295$1$I$20230101$20240627$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-035801$FOUNDATION CONSUMER HEALTHCARE$$44$YR$$F$Y$75.75$KG$20240724$$CN$US$US
241332961$24133296$1$I$20240622$20240627$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-035828$FOUNDATION CONSUMER HEALTHCARE$$42$YR$$F$Y$48.99$KG$20240724$$CN$US$US
241332971$24133297$1$I$20240628$20240628$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-036030$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332981$24133298$1$I$20240625$20240628$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-036049$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241332991$24133299$1$I$20240627$20240628$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-036083$FOUNDATION CONSUMER HEALTHCARE$$17$YR$$F$Y$$$20240724$$CN$US$US
241333001$24133300$1$I$$20240628$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-036097$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240724$$CN$US$US
241333011$24133301$1$I$20240525$20240620$20240724$20240724$PER$$US-FOUNDATIONCONSUMERHC-2024-US-037055$FOUNDATION CONSUMER HEALTHCARE$$35$YR$$F$Y$77.11$KG$20240724$$CN$US$US
241333031$24133303$1$I$$20240714$20240724$20240724$PER$$US-TEVA-VS-3222091$TEVA$$$$E$F$Y$$$20240724$$CN$US$US
241333041$24133304$1$I$$20240712$20240724$20240724$PER$$US-MYLANLABS-2024M1066060$MYLAN$$$$$F$Y$$$20240724$$CN$US$US
241333052$24133305$2$F$$20240812$20240724$20240814$EXP$$US-GILEAD-2024-0680853$GILEAD$$$$E$F$Y$$$20240814$$CN$US$US
241333061$24133306$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151674$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241333072$24133307$2$F$$20240717$20240724$20240725$EXP$$CA-AstraZeneca-2024A163662$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$CA$
241333081$24133308$1$I$$20240716$20240724$20240724$EXP$$ZA-AstraZeneca-2024A162333$ASTRAZENECA$$78$YR$$F$Y$$$20240724$$CN$ZA$
241333092$24133309$2$F$20210101$20240919$20240724$20240925$EXP$$NVSC2024BR150336$NOVARTIS$$$$$F$Y$$$20240925$$CN$BR$BR
241333101$24133310$1$I$20231001$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014609$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240724$$CN$US$US
241333111$24133311$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013963$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240724$$CN$US$US
241333121$24133312$1$I$20240701$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014134$ELI LILLY AND CO$$$$$F$Y$$$20240724$$CN$US$US
241333131$24133313$1$I$20240717$20240717$20240724$20240724$EXP$$US-VIIV HEALTHCARE LIMITED-US2024090102$VIIV$$66$YR$$M$Y$$$20240724$$CN$US$US
241333142$24133314$2$F$$20240723$20240724$20240729$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004043$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
241333151$24133315$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212934$SANOFI AVENTIS$$$$C$M$Y$9.7$KG$20240724$$MD$US$US
241333161$24133316$1$I$20240429$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A165819$ASTRAZENECA$$63$YR$$F$Y$68$KG$20240724$$CN$US$
241333181$24133318$1$I$20240101$20240719$20240724$20240724$EXP$$MX-AMERICAN REGENT INC-2024002639$AMERICAN REGENT$$$$$F$Y$62$KG$20240724$$CN$MX$MX
241333191$24133319$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212868$SANOFI AVENTIS$$$$A$F$Y$145.14$KG$20240724$$MD$US$US
241333201$24133320$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50931$$FDA-CTU$$55$YR$$F$N$200$LBS$20240724$N$$US$
241333211$24133321$1$I$20240719$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144657$AMGEN$$84$YR$E$M$Y$$$20240724$$CN$US$US
241333221$24133322$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146265$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241333231$24133323$1$I$$20240717$20240724$20240724$EXP$$JP-009507513-2407JPN003213J$MERCK$$$$E$$Y$$$20240724$$PH$JP$JP
241333242$24133324$2$F$20230101$20240808$20240724$20240816$EXP$$US-BAYER-2024A104052$BAYER$$43$YR$A$F$Y$$$20240816$$CN$US$US
241333251$24133325$1$I$20231001$20240715$20240724$20240724$EXP$$US-GILEAD-2024-0680798$GILEAD$$26$YR$A$F$Y$$$20240724$$HP$US$US
241333271$24133327$1$I$20240708$20240717$20240724$20240724$EXP$$AT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004046$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240724$$HP$AT$AT
241333282$24133328$2$F$$20240816$20240724$20240819$EXP$$BG-ALXN-202407EEA001481BG$ALEXION PHARMACEUTICALS$$$$C$F$Y$$$20240819$$HP$BG$BG
241333291$24133329$1$I$20240627$20240712$20240724$20240724$EXP$$US-GILEAD-2024-0680778$GILEAD$$79$YR$E$F$Y$$$20240724$$CN$US$US
241333301$24133330$1$I$$20240722$20240724$20240724$PER$$US-ABBVIE-5850706$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241333311$24133331$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151884$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241333322$24133332$2$F$20231102$20240906$20240724$20240912$EXP$$JP-ROCHE-10000030235$ROCHE$$74$YR$E$M$Y$43.9$KG$20240912$$MD$JP$JP
241333331$24133333$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146502$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241333341$24133334$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142546$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241333351$24133335$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142531$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241333361$24133336$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142585$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241333371$24133337$1$I$20240717$20240718$20240724$20240724$EXP$$US-ABBVIE-5846984$ABBVIE$$70$YR$$M$Y$$$20240724$$CN$US$US
241333381$24133338$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50945$$FDA-CTU$$80$YR$$F$N$$$20240724$N$$US$
241333391$24133339$1$I$20240624$20240717$20240724$20240724$EXP$$CN-SA-2024SA215396$SANOFI AVENTIS$$63$YR$A$F$Y$52.3$KG$20240724$$HP$CN$CN
241333401$24133340$1$I$20240101$20240719$20240724$20240724$EXP$$US-ABBVIE-5848512$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241333411$24133341$1$I$$20240712$20240724$20240724$EXP$$US-GILEAD-2024-0680776$GILEAD$$$$E$F$Y$$$20240724$$CN$US$US
241333421$24133342$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50954$$FDA-CTU$$49$YR$$M$N$$$20240724$N$$US$
241333432$24133343$2$F$$20240731$20240724$20240801$PER$$US-ROCHE-10000033430$ROCHE$$74$YR$E$F$Y$$$20240801$$MD$US$US
241333441$24133344$1$I$20240709$20240712$20240724$20240724$EXP$GB-MHRA-MED-202407111401486780-PGRCW$GB-GLENMARK PHARMACEUTICALS-2024GMK092390$GLENMARK$$$$$$Y$$$20240724$$CN$GB$GB
241333451$24133345$1$I$20230701$20240722$20240724$20240724$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041339$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240724$$CN$US$US
241333461$24133346$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50957$$FDA-CTU$$31$YR$$F$N$$$20240724$N$$US$
241333471$24133347$1$I$20240516$20240716$20240724$20240724$EXP$$US-ABBVIE-5780764$ABBVIE$$74$YR$$F$Y$57$KG$20240724$$CN$US$US
241333481$24133348$1$I$20240601$20240717$20240724$20240724$EXP$$US-GSK-US2024090126$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241333493$24133349$3$F$$20240813$20240724$20240819$EXP$$US-GILEAD-2024-0680725$GILEAD$$56$YR$A$M$Y$$$20240819$$CN$US$US
241333501$24133350$1$I$20201201$20240312$20240724$20240724$EXP$IT-MINISAL02-973086$IT-TEVA-VS-3171100$TEVA$$69$YR$$M$Y$$$20240724$$MD$IT$IT
241333511$24133351$1$I$20240724$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50956$$FDA-CTU$$66$YR$$M$N$$$20240724$Y$HP$US$
241333521$24133352$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50911$$FDA-CTU$$82$YR$$F$N$$$20240724$N$$US$
241333531$24133353$1$I$$20240724$20240724$20240724$DIR$711304$$FDA-CTU$$$$$UNK$N$$$20240724$N$CN$US$
241333541$24133354$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50917$$FDA-CTU$$51$YR$$F$N$171$LBS$20240724$N$$US$
241333551$24133355$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142632$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241333561$24133356$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142606$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241333571$24133357$1$I$20210304$20240723$20240724$20240724$EXP$FR-AFSSAPS-MA2024001135$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-117700$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240724$$MD$FR$FR
241333581$24133358$1$I$$20240716$20240724$20240724$EXP$$IT-INCYTE CORPORATION-2024IN007611$INCYTE$$$$$$Y$$$20240724$$MD$IT$IT
241333593$24133359$3$F$20240101$20240924$20240724$20240927$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003951$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$JP$JP
241333601$24133360$1$I$20240615$20240724$20240724$20240724$DIR$711310$$FDA-CTU$$37$YR$$M$N$61.6$KG$20240724$N$HP$US$
241333621$24133362$1$I$$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50946$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241333631$24133363$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50933$$FDA-CTU$$72$YR$$F$N$200$LBS$20240724$N$HP$US$
241333641$24133364$1$I$$20240724$20240724$20240724$DIR$711305$$FDA-CTU$$$$$UNK$N$$$20240724$N$CN$US$
241333651$24133365$1$I$$20240724$20240724$20240724$DIR$711313$$FDA-CTU$$$$$UNK$N$$$20240724$$CN$US$
241333661$24133366$1$I$20240723$20240724$20240724$20240724$DIR$711308$$FDA-CTU$$40$YR$$M$N$102$KG$20240724$N$HP$US$
241333671$24133367$1$I$$20240724$20240724$20240724$DIR$711315$$FDA-CTU$$$$$UNK$N$$$20240724$N$CN$US$
241333681$24133368$1$I$20230802$20240724$20240724$20240724$DIR$711317$$FDA-CTU$$14$YR$$M$N$$$20240724$N$CN$US$
241333691$24133369$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50939$$FDA-CTU$$50$YR$$M$N$170$LBS$20240724$N$$US$
241333701$24133370$1$I$20240616$20240724$20240724$20240724$DIR$711320$$FDA-CTU$$37$YR$$M$N$61.8$KG$20240724$N$HP$US$
241333711$24133371$1$I$$20240724$20240724$20240724$DIR$711316$$FDA-CTU$$$$$UNK$N$$$20240724$$CN$US$
241333721$24133372$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50935$$FDA-CTU$$74$YR$$F$N$127$LBS$20240724$N$$US$
241333741$24133374$1$I$$20240720$20240724$20240724$PER$$US-ABBVIE-5851208$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241333753$24133375$3$F$$20240904$20240724$20240913$EXP$$JP-ALXN-202406JPN000903JP$ALEXION PHARMACEUTICALS$$6$DEC$$M$Y$60$KG$20240913$$MD$JP$JP
241333762$24133376$2$F$20240708$20240722$20240724$20240806$EXP$$US-ABBVIE-5848676$ABBVIE$$25$YR$$M$Y$$$20240806$$HP$US$US
241333771$24133377$1$I$$20240718$20240724$20240724$EXP$$US-JNJFOC-20240750554$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240724$$HP$US$US
241333781$24133378$1$I$$20240717$20240724$20240724$EXP$$CA-JNJFOC-20240754577$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240724$$HP$CA$CA
241333792$24133379$2$F$20230701$20240717$20240724$20240724$EXP$$CO-GSK-CO2023AMR131005$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$CO$CO
241333801$24133380$1$I$$20240719$20240724$20240724$PER$$US-BAUSCH-BL-2024-011147$BAUSCH AND LOMB$$83$YR$$F$Y$$$20240724$$CN$US$US
241333813$24133381$3$F$20240723$20240724$20240724$20240814$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2021-32193$IPSEN$$84$YR$E$M$Y$$$20240814$$CN$GB$GB
241333821$24133382$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117867$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240724$$CN$US$US
241333831$24133383$1$I$$20240607$20240724$20240724$30DAY$$DE-UCBSA-2024029642$UCB$$$$$M$Y$$$20240724$$PH$DE$DE
241333842$24133384$2$F$$20240826$20240724$20240902$EXP$$CA-GSK-CA2024AMR090328$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$CA$CA
241333851$24133385$1$I$20240601$20240626$20240724$20240724$PER$$US-LEX-000365$LEXICON PHARMACEUTICALS$$64$YR$$M$Y$$$20240724$$CN$US$US
241333861$24133386$1$I$20240715$20240716$20240724$20240724$EXP$$US-ZENPEP LLC-2024AIMT01105$AIMMUNE$$$$$$Y$$$20240724$$CN$US$US
241333881$24133388$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A163237$ASTRAZENECA$$$$$F$Y$55.8$KG$20240724$$CN$US$
241333891$24133389$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A165580$ASTRAZENECA$$$$$M$Y$$$20240724$$CN$US$
241333901$24133390$1$I$$20210415$20240724$20240724$EXP$$US-AstraZeneca-2021A324309$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241333911$24133391$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A162967$ASTRAZENECA$$$$$F$Y$93.7$KG$20240724$$CN$US$
241333921$24133392$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024144684$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241333931$24133393$1$I$20190101$20240716$20240724$20240724$EXP$$JO-AstraZeneca-2024A166360$ASTRAZENECA$Alshari O, Jadallah RK, Al Sharie AH, Alzghoul SM, Al-Karaki JM, Bani Amer MS. Palbociclib and Fulvestrant Combined Regimen Induced Prolonged Bone Metastasis Control of Stage IV HR+/HER2- Breast Cancer: A Case Report. Radiology Case Reports 2024;19(9):4049-4054.$60$YR$$F$Y$$$20240724$$HP$JO$
241333941$24133394$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA212859$SANOFI AVENTIS$$$$C$M$Y$32.6$KG$20240724$$MD$US$US
241333952$24133395$2$F$20240713$20240718$20240724$20240731$PER$$US-SA-2024SA212287$SANOFI AVENTIS$$63$YR$A$F$Y$97$KG$20240731$$MD$US$US
241333961$24133396$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142754$AMGEN$Dean R. M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241333971$24133397$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142729$AMGEN$Dean R. M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241333981$24133398$1$I$$20240722$20240724$20240724$PER$$US-ABBVIE-5850951$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241333991$24133399$1$I$20240601$20240722$20240724$20240724$EXP$$US-Taiho Oncology Inc-2024-007129$TAIHO ONCOLOGY INC$$46$YR$A$F$Y$102.51$KG$20240724$$CN$US$US
241334001$24133400$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024090130$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241334014$24133401$4$F$20240101$20240802$20240724$20240808$EXP$$CO-BIOMARINAP-CO-2024-159376$BIOMARIN$$$$$$Y$$$20240808$$CN$CO$CO
241334021$24133402$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142764$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241334032$24133403$2$F$20240704$20240827$20240724$20240903$30DAY$$US-GSK-US2024090150$GLAXOSMITHKLINE$$70$YR$$M$Y$$$20240903$$CN$US$US
241334041$24133404$1$I$$20240717$20240724$20240724$EXP$$CA-GSK-CA2023165374$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$CA$CA
241334051$24133405$1$I$20240506$20240717$20240724$20240724$EXP$$CO-Ipsen Biopharmaceuticals, Inc.-2024-10033$IPSEN$$80$YR$E$F$Y$68$KG$20240724$$MD$CO$CO
241334061$24133406$1$I$20240701$20240719$20240724$20240724$EXP$$TR-AMERICAN REGENT INC-2024002807$AMERICAN REGENT$$29$YR$$F$Y$$$20240724$$HP$TR$TR
241334071$24133407$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142991$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241334081$24133408$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142796$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241334091$24133409$1$I$$20240717$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407012213$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240724$$CN$US$US
241334101$24133410$1$I$$20240718$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116119$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240724$$HP$US$US
241334111$24133411$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014323$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240724$$CN$US$US
241334121$24133412$1$I$20240627$20240718$20240724$20240724$EXP$$US-ABBVIE-5846570$ABBVIE$$72$YR$$F$Y$$$20240724$$CN$US$US
241334131$24133413$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014420$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240724$$CN$US$US
241334141$24133414$1$I$$20240723$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015249$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240724$$CN$US$US
241334151$24133415$1$I$$20240712$20240724$20240724$EXP$$US-GILEAD-2024-0680674$GILEAD$$$$A$F$Y$$$20240724$$CN$US$US
241334161$24133416$1$I$$20240524$20240724$20240724$PER$$US-LUNDBECK-DKLU3078590$LUNDBECK$$$$$$Y$$$20240724$$CN$US$US
241334171$24133417$1$I$20240709$20240724$20240724$20240724$DIR$711318$$FDA-CTU$$77$YR$$F$N$96.75$KG$20240724$N$$US$
241334181$24133418$1$I$$20240722$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US067218$SANDOZ$$$$$F$Y$$$20240724$$CN$US$US
241334191$24133419$1$I$20240625$20240724$20240724$20240724$DIR$711323$$FDA-CTU$$75$YR$$M$N$$$20240724$N$$US$
241334201$24133420$1$I$20240625$20240722$20240724$20240724$EXP$$DE-SANDOZ INC.-SDZ2024DE067210$SANDOZ$$$$$M$Y$79$KG$20240724$$MD$DE$DE
241334211$24133421$1$I$$20240719$20240724$20240724$EXP$$US-ABBVIE-5848470$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241334222$24133422$2$F$20240710$20240807$20240724$20240821$PER$$US-Calliditas-2024CAL01300$CALLIDITAS THERAPEUTICS$$31$YR$A$F$Y$67.9$KG$20240821$$CN$US$US
241334252$24133425$2$F$20240730$20240724$20240724$20240730$EXP$$US-GILEAD-2024-0680694$GILEAD$$62$YR$A$M$Y$$$20240730$$CN$US$US
241334271$24133427$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50919$$FDA-CTU$$80$YR$$F$N$$$20240724$N$$US$
241334291$24133429$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50909$$FDA-CTU$$59$YR$$M$N$$$20240724$N$HP$US$
241334302$24133430$2$F$20240101$20240729$20240724$20240731$EXP$$AT-SANDOZ INC.-SDZ2024AT067551$SANDOZ$$34$YR$$$Y$$$20240731$$CN$AT$AT
241334311$24133431$1$I$$20240723$20240724$20240724$EXP$$US-SANDOZ INC.-SDZ2024US067712$SANDOZ$$$$$F$Y$$$20240724$$HP$US$US
241334321$24133432$1$I$20240709$20240724$20240724$20240724$DIR$711324$$FDA-CTU$$83$YR$$F$N$$$20240724$Y$HP$US$
241334341$24133434$1$I$$20240723$20240724$20240724$EXP$$IT-SANDOZ INC.-SDZ2024IT067653$SANDOZ$$$$$$Y$75$KG$20240724$$MD$IT$IT
241334351$24133435$1$I$20240503$20240723$20240724$20240724$EXP$FR-AFSSAPS-LL2024001380$FR-SANDOZ INC.-SDZ2024FR067429$SANDOZ$$54$YR$$F$Y$71$KG$20240724$$MD$FR$FR
241334381$24133438$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50952$$FDA-CTU$$76$YR$$M$N$$$20240724$N$$US$
241334391$24133439$1$I$20240624$20240724$20240724$20240724$DIR$711326$$FDA-CTU$$68$YR$$M$N$92.4$KG$20240724$N$HP$US$
241334401$24133440$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50902$$FDA-CTU$$37$YR$$F$N$$$20240724$N$$US$
241334451$24133445$1$I$$20240724$20240724$20240724$DIR$711327$$FDA-CTU$$$$$UNK$N$$$20240724$N$CN$US$
241334461$24133446$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50918$$FDA-CTU$$75$YR$$M$N$236$LBS$20240724$N$$US$
241334471$24133447$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50950$$FDA-CTU$$76$YR$$F$N$152$LBS$20240724$N$$US$
241334481$24133448$1$I$$20240724$20240724$20240724$DIR$711330$$FDA-CTU$$$$$UNK$N$$$20240724$N$CN$US$
241334492$24133449$2$F$20240101$20240803$20240724$20240806$PER$$US-ABBVIE-5850230$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241334501$24133450$1$I$$20240724$20240724$20240724$DIR$711332$$FDA-CTU$$$$$UNK$N$$$20240724$N$CN$US$
241334511$24133451$1$I$20240720$20240724$20240724$20240724$DIR$711333$$FDA-CTU$$74$YR$$F$N$68.85$KG$20240724$N$CN$US$
241334521$24133452$1$I$20240723$20240724$20240724$20240724$DIR$711325$$FDA-CTU$$$$$F$N$$$20240724$N$HP$US$
241334531$24133453$1$I$$20240719$20240724$20240724$EXP$$US-OTSUKA-2024_020358$OTSUKA$$$$$F$Y$$$20240724$$MD$US$US
241334542$24133454$2$F$20240815$20240903$20240724$20240910$EXP$$CO-GSK-CO2024AMR090903$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$CO$CO
241334561$24133456$1$I$20240709$20240724$20240724$20240724$DIR$711335$$FDA-CTU$$51$YR$$M$N$94.05$KG$20240724$N$CN$US$
241334571$24133457$1$I$20240617$20240724$20240724$20240724$DIR$711331$$FDA-CTU$$73$YR$$F$N$$$20240724$N$$US$
241334581$24133458$1$I$20240624$20240710$20240724$20240724$DIR$FDA-CDER-CTU-2024-50895$$FDA-CTU$$67$YR$$M$N$87.4$KG$20240710$N$$US$
241334601$24133460$1$I$$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50921$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241334612$24133461$2$F$$20240716$20240724$20240830$EXP$$PL-GILEAD-2024-0680545$GILEAD$$$$A$F$Y$$$20240830$$MD$PL$PL
241334621$24133462$1$I$$20240628$20240724$20240724$PER$$US-LEX-000367$LEXICON PHARMACEUTICALS$$67$YR$$M$Y$$$20240724$$CN$US$US
241334631$24133463$1$I$20240711$20240724$20240724$20240724$DIR$711341$$FDA-CTU$$55$YR$$M$N$$$20240724$Y$HP$US$
241334641$24133464$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50923$$FDA-CTU$$81$YR$$M$N$$$20240724$N$$US$
241334651$24133465$1$I$$20240722$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US067340$SANDOZ$$$$$$Y$$$20240724$$CN$US$US
241334663$24133466$3$F$$20240924$20240724$20240927$30DAY$$CA-PFIZER INC-202400218966$PFIZER$$39$YR$$M$Y$$$20240927$$CN$CA$CA
241334671$24133467$1$I$20240628$20240719$20240724$20240724$EXP$$SG-AMERICAN REGENT INC-2024002811$AMERICAN REGENT$$33$YR$$F$Y$$$20240724$$HP$SG$SG
241334681$24133468$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145372$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241334691$24133469$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142824$AMGEN$Dean R. M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241334711$24133471$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142860$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241334723$24133472$3$F$$20240917$20240724$20240919$30DAY$$CH-PFIZER INC-202400220722$PFIZER$$$$$$Y$$$20240919$$HP$CH$CH
241334731$24133473$1$I$$20240722$20240724$20240724$EXP$GB-MHRA-31136924$GB-PFIZER INC-202400220692$PFIZER$$42$YR$$F$Y$$$20240724$$CN$GB$GB
241334742$24133474$2$F$20240701$20240915$20240724$20240916$EXP$$CA-PFIZER INC-202400221676$PFIZER$$75$YR$$M$Y$$$20240916$$CN$CA$CA
241334752$24133475$2$F$20240101$20240915$20240724$20240916$EXP$$CA-PFIZER INC-PV202400085443$PFIZER$$63$YR$$F$Y$77.8$KG$20240916$$MD$CA$CA
241334762$24133476$2$F$20230701$20240827$20240724$20240830$EXP$$GB-PFIZER INC-202400221569$PFIZER$$23$YR$$F$Y$74$KG$20240830$$CN$GB$GB
241334777$24133477$7$F$$20240905$20240724$20240905$30DAY$$US-PFIZER INC-202400218946$PFIZER$$16$YR$$M$Y$$$20240905$$HP$US$US
241334781$24133478$1$I$20200901$20240723$20240724$20240724$EXP$$PT-SANDOZ INC.-SDZ2024PT067413$SANDOZ$$72$YR$$M$Y$$$20240724$$MD$PT$PT
241334791$24133479$1$I$$20240718$20240724$20240724$EXP$$GB-TAKEDA-2024TUS073917$TAKEDA$$$$$F$Y$$$20240724$$CN$GB$GB
241334801$24133480$1$I$$20240722$20240724$20240724$EXP$$US-SANDOZ INC.-SDZ2024US067525$SANDOZ$$$$$$Y$$$20240724$$CN$US$US
241334811$24133481$1$I$20240401$20240720$20240724$20240724$EXP$$IT-ABBVIE-5849261$ABBVIE$$77$YR$$F$Y$$$20240724$$CN$IT$IT
241334821$24133482$1$I$$20240718$20240724$20240724$EXP$$NVSC2024CA150151$NOVARTIS$$$$A$F$Y$$$20240724$$MD$CA$CA
241334831$24133483$1$I$$20240723$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US038902$SANDOZ$$$$$M$Y$$$20240724$$CN$US$US
241334841$24133484$1$I$$20240723$20240724$20240724$EXP$$US-SANDOZ INC.-SDZ2024US067779$SANDOZ$$$$$F$Y$$$20240724$$CN$US$US
241334851$24133485$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117073$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240724$$CN$US$US
241334861$24133486$1$I$$20240718$20240724$20240724$EXP$NL-LRB-00982760$NL-MYLANLABS-2024M1067942$MYLAN$$31$YR$$F$Y$69$KG$20240724$$MD$NL$NL
241334871$24133487$1$I$$20240719$20240724$20240724$EXP$$GB-MYLANLABS-2024M1068094$MYLAN$$$$$M$Y$$$20240724$$HP$GB$GB
241334881$24133488$1$I$$20240718$20240724$20240724$EXP$NL-LRB-00985419$NL-MYLANLABS-2024M1067859$MYLAN$$57$YR$$M$Y$72$KG$20240724$$CN$NL$NL
241334892$24133489$2$F$$20240802$20240724$20240802$PER$$US-AstraZeneca-2024A149341$ASTRAZENECA$$$$$F$Y$$$20240802$$MD$US$
241334903$24133490$3$F$$20240917$20240724$20240923$30DAY$$AR-PFIZER INC-PV202400093268$PFIZER$$9$YR$$M$Y$$$20240923$$CN$AR$AR
241334921$24133492$1$I$$20240716$20240724$20240724$EXP$$US-AstraZeneca-2024A135578$ASTRAZENECA$$$$$F$Y$$$20240724$$MD$US$
241334932$24133493$2$F$20240716$20240722$20240724$20240726$EXP$$CA-AstraZeneca-2024A167125$ASTRAZENECA$$29272$DY$$M$Y$$$20240726$$CN$CA$
241334941$24133494$1$I$20240101$20240719$20240724$20240724$EXP$$BR-ABBVIE-5849244$ABBVIE$$$$$F$Y$$$20240724$$CN$BR$BR
241334951$24133495$1$I$20240717$20240717$20240724$20240724$PER$$US-ABBVIE-5848320$ABBVIE$$73$YR$$F$Y$$$20240724$$CN$US$US
241334961$24133496$1$I$20240716$20240722$20240724$20240724$EXP$$MX-SANDOZ INC.-SDZ2024MX067598$SANDOZ$$8$YR$$M$Y$$$20240724$$HP$MX$MX
241334971$24133497$1$I$$20240513$20240724$20240724$EXP$$ZA-AstraZeneca-2024A168173$ASTRAZENECA$$$$$F$Y$$$20240724$$HP$ZA$
241334981$24133498$1$I$$20240711$20240724$20240724$EXP$$US-CIPLA LTD.-2024US07668$CIPLA$$$$$$Y$$$20240724$$HP$US$US
241334991$24133499$1$I$20230101$20240723$20240724$20240724$EXP$$US-ROCHE-10000034400$ROCHE$$63$YR$A$$Y$$$20240724$$HP$US$US
241335002$24133500$2$F$20240101$20240812$20240724$20240812$PER$$US-ALXN-202407USA001116US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241335012$24133501$2$F$$20240802$20240724$20240806$EXP$$CA-AMERICAN REGENT INC-2024002816$AMERICAN REGENT$$$$$F$Y$$$20240806$$CN$CA$CA
241335022$24133502$2$F$$20240718$20240724$20240731$EXP$$US-CIPLA LTD.-2024US07765$CIPLA$Applegarth J, Finn D, Tolkacz M, lacco A. Calcium channel blocker overdose and ECMO: A unique presentation of Harlequin syndrome. ASAIO Journal. 2024;70 (Supp 3):151$$$$$Y$$$20240731$$MD$US$US
241335031$24133503$1$I$20240620$20240716$20240724$20240724$EXP$CN-NMPACDR-4301011002666202400391$CN-BAXTER-2024BAX021875$BAXTER$$74$YR$$F$Y$58$KG$20240724$$MD$CN$CN
241335041$24133504$1$I$20210215$20240722$20240724$20240724$EXP$$FR-PFIZER INC-2021SGN02103$PFIZER$$51$YR$$F$Y$52$KG$20240724$$MD$FR$FR
241335051$24133505$1$I$$20240716$20240724$20240724$EXP$$CA-AstraZeneca-2024A164849$ASTRAZENECA$$72$YR$$M$Y$$$20240724$$MD$CA$
241335061$24133506$1$I$20240701$20240722$20240724$20240724$EXP$$CN-PFIZER INC-PV202400095729$PFIZER$$52$YR$$F$Y$$$20240724$$HP$CN$CN
241335076$24133507$6$F$20240601$20240805$20240724$20240808$EXP$$CA-PFIZER INC-202400201384$PFIZER$$66$YR$$F$Y$$$20240808$$HP$CA$CA
241335081$24133508$1$I$20240423$20240722$20240724$20240724$EXP$SE-SEMPA-2024-005586$SE-PFIZER INC-202400220178$PFIZER$$38$YR$$F$Y$58$KG$20240724$$CN$SE$SE
241335092$24133509$2$F$20240701$20240807$20240724$20240813$30DAY$$GR-PFIZER INC-202400216725$PFIZER$$51$YR$$F$Y$$$20240813$$CN$GR$GR
241335101$24133510$1$I$$20240720$20240724$20240724$EXP$NL-LRB-00985419$NL-PFIZER INC-202400221145$PFIZER$$57$YR$$M$Y$72$KG$20240724$$CN$NL$NL
241335111$24133511$1$I$$20240719$20240724$20240724$EXP$GB-MHRA-MED-202407160951268160-QPBKC$GB-PFIZER INC-202400219313$PFIZER$$$$$F$Y$$$20240724$$HP$GB$GB
241335121$24133512$1$I$20240715$20240717$20240724$20240724$30DAY$$AR-PFIZER INC-202400218645$PFIZER$$11$YR$$M$Y$$$20240724$$HP$AR$AR
241335131$24133513$1$I$20240709$20240723$20240724$20240724$EXP$$CN-PFIZER INC-PV202400096317$PFIZER$$53$YR$$F$Y$52$KG$20240724$$HP$CN$CN
241335141$24133514$1$I$20240621$20240722$20240724$20240724$EXP$$CN-PFIZER INC-PV202400095728$PFIZER$$56$YR$$F$Y$$$20240724$$HP$CN$CN
241335152$24133515$2$F$20231101$20240913$20240724$20240913$EXP$$US-PFIZER INC-PV202400095537$PFIZER$$14$YR$$M$Y$37.4$KG$20240913$$MD$US$US
241335161$24133516$1$I$20240705$20240722$20240724$20240724$EXP$FR-AFSSAPS-LL2024001333$FR-PFIZER INC-202400220293$PFIZER$$68$YR$$F$Y$98$KG$20240724$$PH$FR$FR
241335181$24133518$1$I$20240705$20240722$20240724$20240724$EXP$SE-SEMPA-2024-005562$SE-PFIZER INC-202400220367$PFIZER$$75$YR$$M$Y$$$20240724$$MD$SE$SE
241335191$24133519$1$I$$20240711$20240724$20240724$EXP$$US-CIPLA LTD.-2024US07667$CIPLA$LeBlanc FR, Pommert L, Grier DD, Myers KC, Shimamura A.. A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman?Diamond syndrome.. Pediatric Blood and Cancer.. 2024;71 (8); e31137$$$$$Y$$$20240724$$HP$US$US
241335203$24133520$3$F$$20240809$20240724$20240813$EXP$$US-SANDOZ INC.-SDZ2024US066855$SANDOZ$$$$$M$Y$$$20240813$$MD$US$US
241335211$24133521$1$I$$20240713$20240724$20240724$EXP$$GB-CIPLA LTD.-2024GB07698$CIPLA$$$$$$Y$$$20240724$$CN$GB$GB
241335221$24133522$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR091353$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241335231$24133523$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090511$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241335241$24133524$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090458$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241335251$24133525$1$I$$20240716$20240724$20240724$PER$$US-TAKEDA-2024TUS072294$TAKEDA$$$$$F$Y$$$20240724$$MD$US$US
241335262$24133526$2$F$$20240812$20240724$20240815$EXP$$RO-SANDOZ INC.-SDZ2024RO067390$SANDOZ$$37$YR$$F$Y$$$20240815$$HP$RO$RO
241335273$24133527$3$F$20240422$20240812$20240724$20240812$EXP$$DE-PFIZER INC-202400216914$PFIZER$$17$YR$$F$Y$63.9$KG$20240812$$MD$DE$DE
241335281$24133528$1$I$$20240723$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US067784$SANDOZ$$$$$F$Y$$$20240724$$CN$US$US
241335291$24133529$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090533$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241335301$24133530$1$I$$20240716$20240724$20240724$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-113814$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$MD$DE$DE
241335311$24133531$1$I$20230101$20240716$20240724$20240724$EXP$$US-SA-2024SA212202$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240724$$MD$US$US
241335325$24133532$5$F$$20240923$20240724$20240927$PER$$NVSC2024US151300$NOVARTIS$$$$$$Y$$$20240927$$CN$US$US
241335332$24133533$2$F$$20240723$20240724$20240724$PER$$US-ROCHE-10000034564$ROCHE$$70$YR$E$F$Y$$$20240724$$MD$US$US
241335341$24133534$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212129$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240724$$CN$US$US
241335351$24133535$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212232$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240724$$MD$US$US
241335361$24133536$1$I$20240521$20240724$20240724$20240724$DIR$711336$$FDA-CTU$$61$YR$$M$N$85.5$KG$20240724$N$CN$US$
241335371$24133537$1$I$20240724$20240724$20240724$20240724$DIR$711339$$FDA-CTU$$42$YR$$M$N$81$KG$20240724$N$CN$US$
241335391$24133539$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212228$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240724$$MD$US$US
241335401$24133540$1$I$20230725$20240724$20240724$20240724$DIR$711340$$FDA-CTU$$67$YR$$F$N$48.6$KG$20240724$N$MD$US$
241335412$24133541$2$F$20240513$20240725$20240724$20240726$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00920$AIMMUNE$$$$$$Y$$$20240726$$HP$US$US
241335421$24133542$1$I$20240715$20240724$20240724$20240724$DIR$711306$$FDA-CTU$$73$YR$$F$N$91.2$KG$20240724$Y$PH$US$
241335431$24133543$1$I$20240722$20240724$20240724$20240724$DIR$711348$$FDA-CTU$$66$YR$$M$N$$$20240724$N$PH$US$
241335441$24133544$1$I$$20240724$20240724$20240724$DIR$711344$$FDA-CTU$$$$$UNK$N$$$20240724$N$CN$US$
241335461$24133546$1$I$$20240724$20240724$20240724$DIR$711351$$FDA-CTU$$$$$UNK$N$$$20240724$N$CN$US$
241335471$24133547$1$I$$20240724$20240724$20240724$DIR$711312$$FDA-CTU$$$$$UNK$N$$$20240724$$CN$US$
241335481$24133548$1$I$20240718$20240724$20240724$20240724$DIR$711314$$FDA-CTU$$31$YR$$M$N$81$KG$20240724$N$HP$US$
241335491$24133549$1$I$20240713$20240724$20240724$20240724$DIR$711319$$FDA-CTU$$21$YR$$F$N$65.25$KG$20240724$N$CN$US$
241335501$24133550$1$I$20240712$20240715$20240724$20240724$EXP$$CN-GE HEALTHCARE-2024CSU008104$GE HEALTHCARE$$80$YR$$M$Y$60$KG$20240724$$HP$CN$CN
241335511$24133551$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146075$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241335521$24133552$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142960$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241335541$24133554$1$I$$20240717$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114306$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$72.12$KG$20240724$$CN$US$US
241335551$24133555$1$I$20240601$20240717$20240724$20240724$PER$$US-SA-2024SA212161$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240724$$MD$US$US
241335561$24133556$1$I$20231201$20240717$20240724$20240724$PER$$US-SA-2024SA212163$SANOFI AVENTIS$$16$YR$T$$Y$$$20240724$$MD$US$US
241335571$24133557$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA212181$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240724$$MD$US$US
241335581$24133558$1$I$20240101$20240719$20240724$20240724$PER$$US-KARYOPHARM-2024KPT001342$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240724$$HP$US$US
241335591$24133559$1$I$20231001$20240717$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407011671$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240724$$CN$US$US
241335601$24133560$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR090519$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241335611$24133561$1$I$20240609$20240722$20240724$20240724$EXP$FR-AFSSAPS-LL2024001332$FR-DSJP-DSE-2024-136826$DAIICHI$$63$YR$$F$Y$85$KG$20240724$$MD$FR$FR
241335621$24133562$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142971$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241335641$24133564$1$I$$20240717$20240724$20240724$EXP$$US-BAYER-2024A104383$BAYER$$$$$F$Y$$$20240724$$HP$US$US
241335651$24133565$1$I$$20240722$20240724$20240724$EXP$$GB-ABBVIE-5849792$ABBVIE$$$$A$F$Y$$$20240724$$CN$GB$GB
241335661$24133566$1$I$20240101$20240722$20240724$20240724$EXP$$US-PFIZER INC-PV202400031017$PFIZER$$51$YR$$F$Y$$$20240724$$HP$US$US
241335671$24133567$1$I$$20240719$20240724$20240724$EXP$$PL-GILEAD-2024-0681330$GILEAD$$35$YR$A$F$Y$$$20240724$$MD$PL$PL
241335682$24133568$2$F$20240501$20240722$20240724$20240726$PER$$US-ABBVIE-5850473$ABBVIE$$66$YR$$F$Y$$$20240726$$CN$US$US
241335692$24133569$2$F$$20240726$20240724$20240730$EXP$$US-PFIZER INC-202400222092$PFIZER$$70$YR$$M$Y$77.098$KG$20240730$$HP$US$US
241335701$24133570$1$I$20240712$20240719$20240724$20240724$PER$$US-JNJFOC-20240753883$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240724$$CN$US$US
241335721$24133572$1$I$$20240716$20240724$20240724$EXP$$FR-AstraZeneca-2024A165166$ASTRAZENECA$$57$YR$$F$Y$$$20240724$$PH$FR$
241335731$24133573$1$I$20200716$20201104$20240724$20240724$EXP$$MX-AstraZeneca-2020SE90845$ASTRAZENECA$$57$YR$$M$Y$60$KG$20240724$$CN$MX$
241335742$24133574$2$F$20240330$20240812$20240724$20240814$EXP$IT-MINISAL02-995968$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-117201$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240814$$MD$IT$IT
241335751$24133575$1$I$$20240303$20240724$20240724$EXP$$ZA-AstraZeneca-2024A168011$ASTRAZENECA$$$$$$Y$$$20240724$$HP$ZA$
241335761$24133576$1$I$$20240715$20240724$20240724$EXP$$CA-AstraZeneca-2024A167625$ASTRAZENECA$$53$YR$$M$Y$$$20240724$$MD$CA$
241335771$24133577$1$I$$20240424$20240724$20240724$EXP$$US-AstraZeneca-2024A098662$ASTRAZENECA$$$$$F$Y$$$20240724$$CN$US$
241335781$24133578$1$I$$20240724$20240724$20240724$DIR$711352$$FDA-CTU$$$$$UNK$N$$$20240724$N$CN$US$
241335791$24133579$1$I$20240724$20240724$20240724$20240724$DIR$711349$$FDA-CTU$$45$YR$$UNK$N$$$20240724$N$$US$
241335803$24133580$3$F$$20240812$20240724$20240813$EXP$$FR-AstraZeneca-2024A164231$ASTRAZENECA$$35$YR$$F$Y$$$20240813$$MD$FR$
241335811$24133581$1$I$$20240718$20240724$20240724$PER$$US-BAYER-2024A106037$BAYER$$$$$$Y$$$20240724$$CN$US$US
241335821$24133582$1$I$$20240715$20240724$20240724$EXP$$US-RDY-LIT/USA/24/0010729$DR REDDYS$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15(3): doi:10.14309/ctg.0000000000000679.$81$YR$E$M$Y$$$20240724$$MD$US$US
241335831$24133583$1$I$$20240715$20240724$20240724$EXP$$US-RDY-LIT/USA/24/0010719$DR REDDYS$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15(3): doi:10.14309/ctg.0000000000000679.$52$YR$A$F$Y$$$20240724$$MD$US$US
241335851$24133585$1$I$20240609$20240724$20240724$20240724$DIR$711354$$FDA-CTU$$88$YR$$F$N$51.75$KG$20240724$N$CN$US$
241335861$24133586$1$I$$20240715$20240724$20240724$EXP$$US-RDY-LIT/USA/24/0010720$DR REDDYS$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15(3): doi:10.14309/ctg.0000000000000679.$32$YR$A$F$Y$$$20240724$$MD$US$US
241335871$24133587$1$I$$20240715$20240724$20240724$EXP$$US-RDY-LIT/USA/24/0010718$DR REDDYS$Todd J, Saboori S, Zeidan J, Ahrens W, Moshiree B, Jacobs C. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15(3): doi:10.14309/ctg.0000000000000679.$69$YR$E$F$Y$$$20240724$$MD$US$US
241335881$24133588$1$I$$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222176$PFIZER$$$$$M$Y$$$20240724$$CN$US$US
241335892$24133589$2$F$$20240801$20240724$20240807$PER$$US-PFIZER INC-202400221977$PFIZER$$$$$F$Y$$$20240807$$CN$US$US
241335901$24133590$1$I$20240713$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024147046$AMGEN$$75$YR$E$M$Y$$$20240724$$CN$US$US
241335911$24133591$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142854$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241335921$24133592$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142804$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241335931$24133593$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142863$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241335941$24133594$1$I$$20240716$20240724$20240724$EXP$$CA-AstraZeneca-2024A165997$ASTRAZENECA$$65$YR$$F$Y$34$KG$20240724$$MD$CA$
241335951$24133595$1$I$$20240718$20240724$20240724$EXP$$US-AMGEN-USASP2024143008$AMGEN$$$$A$F$Y$$$20240724$$CN$US$US
241335974$24133597$4$F$20240718$20240805$20240724$20240808$PER$$US-AMGEN-USASP2024143829$AMGEN$$69$YR$E$F$Y$50$KG$20240808$$PH$US$US
241335981$24133598$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142844$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241336021$24133602$1$I$20240722$20240724$20240724$20240724$DIR$711353$$FDA-CTU$$42$YR$$M$N$121.95$KG$20240724$N$$US$
241336031$24133603$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212140$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240724$$HP$US$US
241336041$24133604$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212029$SANOFI AVENTIS$$$$$$Y$$$20240724$$HP$US$US
241336051$24133605$1$I$$20240628$20240724$20240724$PER$$US-PFIZER INC-PV202400095070$PFIZER$$53$YR$$F$Y$$$20240724$$CN$US$US
241336062$24133606$2$F$$20240729$20240724$20240729$PER$$US-PFIZER INC-202400219672$PFIZER$$$$$$Y$$$20240729$$HP$US$US
241336081$24133608$1$I$$20240711$20240724$20240724$PER$$US-PFIZER INC-PV202400095069$PFIZER$$49$YR$$F$Y$$$20240724$$CN$US$US
241336092$24133609$2$F$$20240912$20240724$20240912$PER$$US-PFIZER INC-202400219060$PFIZER$$18$YR$$M$Y$$$20240912$$MD$US$US
241336102$24133610$2$F$$20240823$20240724$20240823$PER$$US-PFIZER INC-202400220203$PFIZER$$5$YR$$M$Y$$$20240823$$CN$US$US
241336111$24133611$1$I$20221201$20240723$20240724$20240724$EXP$$US-DSJP-DSU-2022-145886$DAIICHI$$79$YR$$F$Y$46.7$KG$20240724$$CN$US$US
241336121$24133612$1$I$20240101$20240719$20240724$20240724$EXP$$US-ABBVIE-5840513$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241336131$24133613$1$I$20240507$20240715$20240724$20240724$EXP$FR-AFSSAPS-TS2024000771$FR-TEVA-VS-3221903$TEVA$$49$YR$$F$Y$51$KG$20240724$$CN$FR$FR
241336161$24133616$1$I$20240101$20240718$20240724$20240724$EXP$$US-ABBVIE-5846875$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241336171$24133617$1$I$20240601$20240719$20240724$20240724$EXP$$US-ABBVIE-5849748$ABBVIE$$88$YR$$F$Y$$$20240724$$CN$US$US
241336181$24133618$1$I$20240624$20240722$20240724$20240724$EXP$GB-MHRA-MED-202407121616451930-ZGPLV$GB-DSJP-DSE-2024-136844$DAIICHI$$65$YR$$F$Y$59$KG$20240724$$PH$GB$GB
241336191$24133619$1$I$$20240722$20240724$20240724$PER$$NVSC2024US151878$NOVARTIS$$$$$F$Y$$$20240724$$HP$US$US
241336202$24133620$2$F$20240523$20240724$20240724$20240730$EXP$$IT-MYLANLABS-2024M1068251$MYLAN$$72$YR$$M$Y$70$KG$20240730$$MD$IT$IT
241336211$24133621$1$I$$20240715$20240724$20240724$EXP$$US-TEVA-VS-3222707$TEVA$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatr-Blood-Cancer 2024; 71 (7): e31004.$6$YR$$F$Y$$$20240724$$HP$US$US
241336221$24133622$1$I$$20240723$20240724$20240724$EXP$GB-MHRA-MED-202407232209444480-NGZPL$GB-MYLANLABS-2024M1068823$MYLAN$$32$YR$$F$Y$$$20240724$$MD$GB$GB
241336231$24133623$1$I$20240703$20240723$20240724$20240724$EXP$$CA-MYLANLABS-2024M1067088$MYLAN$$85$YR$$F$Y$$$20240724$$HP$CA$CA
241336241$24133624$1$I$20240623$20240722$20240724$20240724$EXP$FR-AFSSAPS-TO2024001298$FR-MYLANLABS-2024M1068313$MYLAN$$83$YR$$F$Y$$$20240724$$MD$FR$FR
241336251$24133625$1$I$20240418$20240722$20240724$20240724$EXP$FR-AFSSAPS-MP2024001149$FR-MYLANLABS-2024M1068167$MYLAN$$1$YR$$M$Y$11.5$KG$20240724$$MD$FR$FR
241336261$24133626$1$I$20240718$20240719$20240724$20240724$EXP$$CA-ABBVIE-5850218$ABBVIE$$90$YR$$M$Y$$$20240724$$HP$CA$CA
241336271$24133627$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024142891$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241336282$24133628$2$F$20240514$20240824$20240724$20240826$PER$$US-PFIZER INC-PV202400095606$PFIZER$$50$YR$$M$Y$170.1$KG$20240826$$MD$US$US
241336291$24133629$1$I$$20240711$20240724$20240724$PER$$US-TEVA-VS-3221354$TEVA$$65$YR$$F$Y$$$20240724$$PH$US$US
241336312$24133631$2$F$20240614$20240805$20240724$20240813$EXP$$JP-GENMAB-2024-02101AA$GENMAB$$78$YR$$M$Y$$$20240813$$MD$JP$JP
241336332$24133633$2$F$20240101$20240806$20240724$20240809$EXP$$ES-ABBVIE-5838510$ABBVIE$$$$$F$Y$$$20240809$$HP$ES$ES
241336341$24133634$1$I$20230901$20240722$20240724$20240724$EXP$$PT-FreseniusKabi-FK202411553$FRESENIUS KABI$$45$YR$A$F$Y$$$20240724$$MD$PT$PT
241336351$24133635$1$I$$20240715$20240724$20240724$PER$US-MLMSERVICE-20240708-PI124994-00123-1$US-RDY-SPO/USA/24/0010479$DR REDDYS$Warner Robinson, Beth N. McLellan. Utilization of scalp cooling to prevent chemotherapy-induced alopecia in woman of skin of color with type 3 hair. JAAD Case Reports. 2024;50:65-8. DOI:10.1016/j.jdcr.2023.10.018.$58$YR$A$F$Y$$$20240724$$MD$US$US
241336361$24133636$1$I$$20240722$20240724$20240724$EXP$$US-ABBVIE-5850217$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241336371$24133637$1$I$$20240722$20240724$20240724$EXP$$US-ABBVIE-5850195$ABBVIE$$$$$M$Y$$$20240724$$HP$US$US
241336381$24133638$1$I$20240720$20240722$20240724$20240724$EXP$$CO-ABBVIE-5850444$ABBVIE$$72$YR$$M$Y$$$20240724$$CN$CO$CO
241336391$24133639$1$I$20230323$20240718$20240724$20240724$EXP$$JP-DSJP-DSJ-2023-111614$DAIICHI$$76$YR$$F$Y$$$20240724$$HP$JP$JP
241336411$24133641$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117657$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$75.75$KG$20240724$$CN$US$US
241336431$24133643$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014259$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240724$$CN$US$US
241336441$24133644$1$I$$20240723$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015239$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240724$$CN$US$US
241336451$24133645$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014208$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240724$$CN$US$US
241336461$24133646$1$I$$20240716$20240724$20240724$EXP$NL-LRB-00981128$NL-SA-2024SA210240$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240724$$HP$NL$NL
241336471$24133647$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014129$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240724$$CN$US$US
241336481$24133648$1$I$20240708$20240718$20240724$20240724$EXP$$CN-SA-2024SA214395$SANOFI AVENTIS$$50$YR$A$M$Y$70$KG$20240724$$HP$CN$CN
241336491$24133649$1$I$$20240709$20240724$20240724$EXP$$US-HLS-202400304$HLS THERAPEUTICS$$$$A$$Y$$$20240724$$HP$US$US
241336501$24133650$1$I$$20240719$20240724$20240724$EXP$$US-PERRIGO-24US006877$PERRIGO$Alsabbagh Alchirazi K, Bhavsar-Burke I, Syed H, Alkhayyat M, Bass S, Kapoor A, et al. Molecular Adsorbent Recirculating System in Acute Liver Failure. ACG case reports journal. 2024;11(7):e01389. DOI: 10.14309/crj.0000000000001389.$44$YR$$M$Y$$$20240724$$MD$US$US
241336511$24133651$1$I$$20240712$20240724$20240724$EXP$$CH-TEVA-VS-3222640$TEVA$$$$$M$Y$$$20240724$$HP$CH$CH
241336521$24133652$1$I$$20240723$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US067777$SANDOZ$$$$$M$Y$$$20240724$$HP$US$US
241336531$24133653$1$I$20240701$20240722$20240724$20240724$EXP$$US-ABBVIE-5850576$ABBVIE$$65$YR$$M$Y$$$20240724$$HP$US$US
241336541$24133654$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151908$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241336551$24133655$1$I$$20240723$20240724$20240724$EXP$$HN-BAYER-2024A107567$BAYER$$42$YR$A$M$Y$$$20240724$$CN$HN$HN
241336563$24133656$3$F$20240101$20240821$20240724$20240828$EXP$$US-ABBVIE-5844678$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
241336571$24133657$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117730$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240724$$CN$US$US
241336581$24133658$1$I$$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117087$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240724$$CN$US$US
241336592$24133659$2$F$20240601$20240719$20240724$20240729$EXP$$FR-ABBVIE-5847378$ABBVIE$$65$YR$$M$Y$$$20240729$$MD$FR$FR
241336601$24133660$1$I$$20240717$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114364$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$72$KG$20240724$$PH$US$US
241336611$24133661$1$I$$20240719$20240724$20240724$PER$$NVSC2024US150622$NOVARTIS$$27$YR$$F$Y$$$20240724$$CN$US$US
241336622$24133662$2$F$$20240911$20240724$20240912$PER$$NVSC2024US151905$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
241336632$24133663$2$F$20231128$20240723$20240724$20240727$EXP$$US-ABBVIE-5844519$ABBVIE$$70$YR$$F$Y$66$KG$20240727$$MD$US$US
241336641$24133664$1$I$$20240719$20240724$20240724$EXP$$US-JNJFOC-20240755855$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240724$$MD$US$US
241336651$24133665$1$I$20230101$20240715$20240724$20240724$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2023XER02272$XERIS PHARMACEUTICALS$$$$$F$Y$64.399$KG$20240724$$CN$US$US
241336661$24133666$1$I$$20240717$20240724$20240724$EXP$AU-TGA-0000811876$NVSC2024AU150096$NOVARTIS$$$$$F$Y$$$20240724$$CN$AU$AU
241336673$24133667$3$F$20240101$20240920$20240724$20240925$PER$$US-PFIZER INC-202400222318$PFIZER$$10$YR$$F$Y$$$20240925$$CN$US$US
241336691$24133669$1$I$$20240718$20240724$20240724$EXP$$SG-MYLANLABS-2024M1067782$MYLAN$$$$$F$Y$$$20240724$$HP$SG$SG
241336701$24133670$1$I$20240101$20240717$20240724$20240724$EXP$$US-ABBVIE-5845783$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241336711$24133671$1$I$$20240722$20240724$20240724$EXP$GB-MHRA-MED-202407221836467660-FLBWV$GB-MYLANLABS-2024M1068632$MYLAN$$34$YR$$M$Y$83$KG$20240724$$CN$GB$GB
241336722$24133672$2$F$20240718$20240814$20240724$20240820$EXP$$GB-MYLANLABS-2024M1068128$MYLAN$$$$$M$Y$$$20240820$$PH$GB$GB
241336731$24133673$1$I$$20240719$20240724$20240724$30DAY$$CO-PFIZER INC-PV202400095458$PFIZER$$8$YR$$M$Y$$$20240724$$CN$CO$CO
241336742$24133674$2$F$20231101$20240909$20240724$20240918$PER$$US-ABBVIE-5844922$ABBVIE$$67$YR$$M$Y$87.089$KG$20240918$$CN$US$US
241336752$24133675$2$F$$20240829$20240724$20240829$30DAY$$CO-PFIZER INC-PV202400095506$PFIZER$$$$$M$Y$$$20240829$$MD$CO$CO
241336761$24133676$1$I$$20240722$20240724$20240724$EXP$$US-SANDOZ INC.-SDZ2024US067464$SANDOZ$$$$$F$Y$$$20240724$$CN$US$US
241336771$24133677$1$I$$20240717$20240724$20240724$PER$$US-TAKEDA-2024TUS072517$TAKEDA$$$$$$Y$$$20240724$$CN$US$US
241336782$24133678$2$F$$20240828$20240724$20240903$EXP$$AU-MYLANLABS-2024M1068073$MYLAN$$$$$M$Y$$$20240903$$PH$AU$AU
241336791$24133679$1$I$$20240711$20240724$20240724$EXP$$FR-TEVA-VS-3221643$TEVA$$25$YR$$$Y$52$KG$20240724$$CN$FR$FR
241336801$24133680$1$I$$20240708$20240724$20240724$PER$$US-JNJFOC-20240762719$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240724$$CN$US$US
241336811$24133681$1$I$20240514$20240611$20240724$20240724$PER$$US-JNJFOC-20240763425$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240724$$PH$US$US
241336821$24133682$1$I$20240514$20240611$20240724$20240724$PER$$US-JNJFOC-20240763896$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240724$$PH$US$US
241336831$24133683$1$I$20240514$20240611$20240724$20240724$PER$$US-JNJFOC-20240763438$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240724$$PH$US$US
241336842$24133684$2$F$20240501$20240808$20240724$20240822$PER$$US-JNJFOC-20240763395$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240822$$PH$US$US
241336852$24133685$2$F$20240710$20240730$20240724$20240805$EXP$$BR-TAKEDA-2024TUS073255$TAKEDA$$43$YR$$M$Y$68$KG$20240805$$CN$BR$BR
241336861$24133686$1$I$$20240718$20240724$20240724$PER$$US-BAYER-2024A105395$BAYER$$80$YR$E$F$Y$$$20240724$$CN$US$US
241336891$24133689$1$I$20240702$20240716$20240724$20240724$EXP$IT-MINISAL02-994240$IT-TEVA-VS-3222334$TEVA$$80$YR$$M$Y$$$20240724$$PH$IT$IT
241336911$24133691$1$I$$20240720$20240724$20240724$PER$$US-ROCHE-10000034046$ROCHE$$15$YR$T$M$Y$$$20240724$$CN$US$US
241336921$24133692$1$I$20240610$20240716$20240724$20240724$EXP$FR-AFSSAPS-MP2024001134$FR-009507513-2407FRA010217$MERCK$$95$YR$$F$Y$57.4$KG$20240724$$PH$FR$FR
241336931$24133693$1$I$20240713$20240723$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US067795$SANDOZ$$70$YR$$F$Y$$$20240724$$PH$US$US
241336943$24133694$3$F$20240703$20240822$20240724$20240826$EXP$$JP-PFIZER INC-PV202400087598$PFIZER$$77$YR$$$Y$40.9$KG$20240826$$MD$JP$JP
241336952$24133695$2$F$$20240805$20240724$20240808$EXP$$IN-PFIZER INC-2024SGN05911$PFIZER$$68$YR$$F$Y$$$20240808$$CN$IN$IN
241336961$24133696$1$I$$20240722$20240724$20240724$EXP$$FR-PFIZER INC-PV202400095574$PFIZER$Samalin, E.. Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients. Digestive and Liver Disease. 2024;56(8):1375-1381$$$A$$Y$$$20240724$$HP$FR$FR
241336971$24133697$1$I$$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116462$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240724$$CN$US$US
241336981$24133698$1$I$20240720$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117155$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240724$$HP$US$US
241336991$24133699$1$I$20240212$20240723$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117623$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240724$$CN$US$US
241337001$24133700$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117488$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$68.49$KG$20240724$$CN$US$US
241337011$24133701$1$I$20220101$20240719$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116331$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$86.82$KG$20240724$$HP$US$US
241337021$24133702$1$I$20240622$20240715$20240724$20240724$EXP$FR-AFSSAPS-NT2024000789$FR-TEVA-VS-3221933$TEVA$$51$YR$$M$Y$83$KG$20240724$$MD$FR$FR
241337034$24133703$4$F$$20240809$20240724$20240816$EXP$$NVSC2024US151906$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
241337041$24133704$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151678$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241337061$24133706$1$I$20240514$20240611$20240724$20240724$PER$$US-JNJFOC-20240764091$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240724$$PH$US$US
241337071$24133707$1$I$20240514$20240611$20240724$20240724$PER$$US-JNJFOC-20240764123$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240724$$PH$US$US
241337091$24133709$1$I$20240514$20240611$20240724$20240724$PER$$US-JNJFOC-20240764089$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240724$$PH$US$US
241337102$24133710$2$F$20240501$20240827$20240724$20240903$PER$$US-JNJFOC-20240764249$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240903$$PH$US$US
241337111$24133711$1$I$20240101$20240719$20240724$20240724$EXP$$US-ABBVIE-5847637$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241337121$24133712$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146262$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241337131$24133713$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024146206$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241337141$24133714$1$I$$20240720$20240724$20240724$PER$$US-AMGEN-USASP2024145650$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241337151$24133715$1$I$20240710$20240716$20240724$20240724$EXP$$JP-Eisai-EC-2024-170304$EISAI$$$$$$Y$$$20240724$$MD$JP$JP
241337161$24133716$1$I$$20240701$20240724$20240724$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041715$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240724$$HP$BR$BR
241337171$24133717$1$I$$20240716$20240724$20240724$PER$$CA-Eisai-EC-2024-170272$EISAI$$$$$F$Y$$$20240724$$HP$CA$CA
241337181$24133718$1$I$$20240716$20240724$20240724$EXP$$US-FreseniusKabi-FK202411453$FRESENIUS KABI$Weigle DP, Nielsen A, Braunecker S. Uncommon and Unfavorable: Heparin-Induced Hyperkalemia. Journal of Cardiothoracic and Vascular Anesthesia. 2024;1-4. doi:https://dx.doi.org/10.1053/j.jvca.2024.04.045.$56$YR$A$M$Y$$$20240724$$MD$US$US
241337191$24133719$1$I$$20240716$20240724$20240724$EXP$$US-BEH-2024175930$CSL BEHRING$$$$E$M$Y$$$20240724$$HP$US$US
241337201$24133720$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151191$NOVARTIS$$$$$$Y$$$20240724$$CN$US$US
241337211$24133721$1$I$$20240723$20240724$20240724$EXP$$CA-TAKEDA-2024TUS074565$TAKEDA$$$$$M$Y$$$20240724$$CN$CA$CA
241337221$24133722$1$I$$20240717$20240724$20240724$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14332$IPSEN$$$$$F$Y$$$20240724$$HP$US$US
241337231$24133723$1$I$$20240703$20240724$20240724$PER$$US-ALXN-202407USA001284US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241337241$24133724$1$I$$20240720$20240724$20240724$EXP$$US-ABBVIE-5847613$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241337251$24133725$1$I$$20240719$20240724$20240724$PER$$US-BIOMARINAP-US-2024-159339$BIOMARIN$$$$$$Y$$$20240724$$CN$US$US
241337261$24133726$1$I$20240514$20240611$20240724$20240724$PER$$US-JNJFOC-20240764419$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240724$$PH$US$US
241337271$24133727$1$I$$20240717$20240724$20240724$EXP$$US-JNJFOC-20240751670$JOHNSON AND JOHNSON$$$$$M$Y$113.6$KG$20240724$$CN$US$US
241337281$24133728$1$I$$20240717$20240724$20240724$EXP$$US-GILEAD-2024-0681222$GILEAD$$$$$M$Y$$$20240724$$CN$US$US
241337291$24133729$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117435$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240724$$CN$US$US
241337301$24133730$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117740$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240724$$HP$US$US
241337314$24133731$4$F$$20240805$20240724$20240809$EXP$$BE-PFIZER INC-202400221195$PFIZER$Ghysen, K.. Immunotherapy-induced diabetes mellitus: A case study. Tijdschrift voor Geneeskunde en Gezondheidszorg. 2024;80(7):585-93$73$YR$$M$Y$$$20240809$$MD$BE$BE
241337323$24133732$3$F$20230201$20240730$20240724$20240805$EXP$$ID-PFIZER INC-202400221150$PFIZER$Rohmah, S.. Diagnostic and therapeutic challenges of tuberculosis in kidney transplant recipients; a case series study. Journal of Nephropharmacology. 2024;13(2):e11679$60$YR$$M$Y$$$20240805$$MD$ID$ID
241337333$24133733$3$F$20240601$20240827$20240724$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117410$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$76.2$KG$20240905$$CN$US$US
241337341$24133734$1$I$20220101$20240719$20240724$20240724$EXP$$JP-PFIZER INC-202400220402$PFIZER$Hirano, S.. A case of pulmonary tuberculosis that developed during nivolumab and ipilimumab treatment for pulmonary adenocarcinoma that recurred two months after completion of anti-tuberculous treatment. Chinese Clinical Oncology. 2024;13(3):43$7$DEC$$M$Y$$$20240724$$MD$JP$JP
241337352$24133735$2$F$$20240722$20240724$20240725$EXP$$US-PFIZER INC-PV202400095532$PFIZER$Laches, R.. Omission of etoposide in the treatment of haemophagocytic lymphohistiocytosis secondary to primary central nervous system lymphoma with satisfactory response. BMJ Case Reports. 2024;17 (7):10.1136/bcr-2023-258559$7$DEC$$F$Y$$$20240725$$HP$US$US
241337361$24133736$1$I$20210327$20240722$20240724$20240724$EXP$FR-AFSSAPS-MA2024001076$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-116957$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240724$$PH$FR$FR
241337371$24133737$1$I$$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013753$ELI LILLY AND CO$$$$$$Y$$$20240724$$CN$US$US
241337381$24133738$1$I$20240712$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014152$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240724$$CN$US$US
241337392$24133739$2$F$$20240717$20240724$20240730$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202407014657$ELI LILLY AND CO$Luan J, Afolabi B..New-Onset Seizures and Psychosis in an Elderly Patient With No Seizure History in the Context of Low-Dose Diazepam Withdrawal..Primary Care Companion for CNS Disorder 2024;26 (2):e1-e2.DOI:doi.org/10.4088/PCC.23cr03654$65$YR$E$F$Y$$$20240730$$MD$CA$CA
241337402$24133740$2$F$20240101$20240724$20240724$20240729$EXP$$CA-AstraZeneca-2024A165383$ASTRAZENECA$$595$MON$$F$Y$$$20240729$$MD$CA$
241337414$24133741$4$F$$20240911$20240724$20240911$30DAY$$CO-PFIZER INC-PV202400094261$PFIZER$$$$$M$Y$$$20240911$$CN$CO$CO
241337421$24133742$1$I$$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144277$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241337432$24133743$2$F$20240101$20240817$20240724$20240902$PER$$US-SA-2024SA212086$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240902$$CN$US$US
241337441$24133744$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA212262$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240724$$MD$US$US
241337452$24133745$2$F$20240214$20240730$20240724$20240802$EXP$$CA-TAKEDA-2024TUS072890$TAKEDA$$73$YR$$M$Y$$$20240802$$CN$CA$CA
241337462$24133746$2$F$$20240729$20240724$20240731$EXP$$US-KYOWAKIRIN-2024KK017519$KYOWA$$$$$$Y$$$20240731$$CN$US$US
241337471$24133747$1$I$$20240717$20240724$20240724$30DAY$$US-PFIZER INC-PV202400094068$PFIZER$$$$$$Y$$$20240724$$HP$US$US
241337482$24133748$2$F$20240701$20240911$20240724$20240918$PER$$US-ABBVIE-5845879$ABBVIE$$53$YR$$F$Y$168$KG$20240918$$CN$US$US
241337491$24133749$1$I$$20240723$20240724$20240724$EXP$$TH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041659$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240724$$HP$TH$TH
241337501$24133750$1$I$20240501$20240722$20240724$20240724$EXP$$DE-ABBVIE-5850435$ABBVIE$$25$YR$$F$Y$$$20240724$$CN$DE$DE
241337511$24133751$1$I$$20240722$20240724$20240724$EXP$$KR-TAKEDA-2024TUS074604$TAKEDA$$$$$$Y$$$20240724$$HP$KR$KR
241337522$24133752$2$F$$20240923$20240724$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117406$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240925$$HP$US$US
241337531$24133753$1$I$$20240717$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115392$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240724$$CN$US$US
241337541$24133754$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117766$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240724$$CN$US$US
241337551$24133755$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117628$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240724$$CN$US$US
241337561$24133756$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117659$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240724$$CN$US$US
241337571$24133757$1$I$20240704$20240722$20240724$20240724$EXP$GB-MHRA-MED-202407220835527400-JWVKZ$GB-GSK-GB2024091675$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$GB$GB
241337581$24133758$1$I$$20240717$20240724$20240724$EXP$$JP-TAKEDA-2024TUS074359$TAKEDA$$$$$$Y$$$20240724$$MD$JP$JP
241337591$24133759$1$I$$20240722$20240724$20240724$EXP$$GB-GSK-GB2024091680$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$GB$GB
241337601$24133760$1$I$$20240722$20240724$20240724$PER$$US-AMGEN-USASP2024145890$AMGEN$$70$YR$E$M$Y$$$20240724$$CN$US$US
241337611$24133761$1$I$$20240709$20240724$20240724$EXP$$CA-HLS-202401706$HLS THERAPEUTICS$$$$E$M$Y$$$20240724$$HP$CA$CA
241337622$24133762$2$F$$20240809$20240724$20240819$EXP$$US-TEVA-VS-3222679$TEVA$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatr-Blood-Cancer 2024; 71 (7): e31004; Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatr-Blood-Cancer 2024; 71 (7): e31004.$28$YR$$M$Y$$$20240819$$HP$US$US
241337641$24133764$1$I$$20240722$20240724$20240724$PER$$US-BAYER-2024A106736$BAYER$$$$$M$Y$$$20240724$$CN$US$US
241337651$24133765$1$I$20211022$20240715$20240724$20240724$EXP$FR-AFSSAPS-AM2024000546$FR-TEVA-VS-3221917$TEVA$$91$YR$$F$Y$45.4$KG$20240724$$MD$FR$FR
241337661$24133766$1$I$$20240722$20240724$20240724$EXP$GB-MHRA-MED-202407221543388240-QNLMC$GB-GSK-GB2024091688$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$GB$GB
241337671$24133767$1$I$20240714$20240716$20240724$20240724$PER$$US-APELLIS-APL-2023-003346$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241337681$24133768$1$I$$20240718$20240724$20240724$EXP$$US-JNJFOC-20240752736$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$CN$US$US
241337702$24133770$2$F$$20240724$20240724$20240725$PER$$US-PURDUE-USA-2024-0310908$PURDUE$$$$$F$Y$$$20240725$$CN$US$US
241337711$24133771$1$I$$20240723$20240724$20240724$PER$$US-PURDUE-USA-2020-0187296$PURDUE$$40$YR$$M$Y$$$20240724$$CN$US$US
241337721$24133772$1$I$$20240710$20240724$20240724$PER$$US-MYLANLABS-2024M1065440$MYLAN$$$$$F$Y$64.86$KG$20240724$$CN$US$US
241337731$24133773$1$I$20240716$20240717$20240724$20240724$PER$$US-MYLANLABS-2024M1067286$MYLAN$$61$YR$$M$Y$$$20240724$$CN$US$US
241337741$24133774$1$I$20171128$20240718$20240724$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010981$JAZZ$$56$YR$$F$Y$$$20240724$$MD$US$US
241337753$24133775$3$F$20240201$20240807$20240724$20240812$EXP$$NVSC2024AR149326$NOVARTIS$$76$YR$$F$Y$$$20240812$$CN$AR$AR
241337761$24133776$1$I$$20240715$20240724$20240724$EXP$$US-TAKEDA-2024TUS072133$TAKEDA$$$$$F$Y$$$20240724$$CN$US$US
241337772$24133777$2$F$20240804$20240805$20240724$20240822$PER$$US-TRAVERE-2024TVT00586$TRAVERE THERAPEUTICS$$61$YR$A$M$Y$$$20240822$$CN$US$US
241337784$24133778$4$F$20240701$20240807$20240724$20240809$PER$$US-BAUSCH-BL-2024-010904$BAUSCH AND LOMB$$43$YR$$M$Y$$$20240809$$CN$US$US
241337791$24133779$1$I$$20240716$20240724$20240724$PER$$US-BAUSCH-BL-2024-011006$BAUSCH AND LOMB$$$$$M$Y$$$20240724$$HP$US$US
241337801$24133780$1$I$$20240715$20240724$20240724$EXP$$PT-FreseniusKabi-FK202411370$FRESENIUS KABI$Henriques C, Melo J, Vasconcelos S, Ramos R, Costa MM. PO-0552 -(4842) -Respiratory infections: when looks can be deceiving. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional de Medicina Interna - Livro de resumos. 2024 May;905-905.$60$YR$A$F$Y$$$20240724$$HP$PT$PT
241337822$24133782$2$F$20240101$20240721$20240724$20240725$EXP$$CN-ABBVIE-5848452$ABBVIE$$$$$M$Y$60$KG$20240725$$MD$CN$CN
241337831$24133783$1$I$$20240721$20240724$20240724$EXP$$GR-BAUSCH-BL-2024-011188$BAUSCH AND LOMB$Nalmpanti A. MONITORING OF PREGNANCY WITH MYASTHENIA GRAVIS, HISTORY OF INTERSTITIAL PREGNANCY AND RECURRENT MISCARRIAGES. PANHELLENIC CONGRESS ON OBSTETRICS AND  GYNECOLOGY. 2024;116:.$30$YR$$F$Y$$$20240724$$MD$GR$GR
241337841$24133784$1$I$20240322$20240718$20240724$20240724$EXP$$CA-ABBVIE-5846261$ABBVIE$$67$YR$$F$Y$$$20240724$$CN$CA$CA
241337851$24133785$1$I$20230101$20240716$20240724$20240724$EXP$$JP-DSJP-DSJ-2023-139517$DAIICHI$$52$YR$$F$Y$57.7$KG$20240724$$MD$JP$JP
241337862$24133786$2$F$20200824$20240816$20240724$20240819$EXP$$DE-BAUSCH-BL-2024-011162$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240819$$HP$DE$DE
241337871$24133787$1$I$20240201$20240717$20240724$20240724$EXP$$JP-DSJP-DSJ-2024-136321$DAIICHI$Sugiyama H, Katano Y, Hashimoto S, Kobayashi T, Yamamoto S, Mutou H, et al. 40 A Case of Genotype A Acute Hepatitis B in an Elderly Patient. The 253rd Japanese Society of Internal Medicine Tokai Regional Meeting. 2024$85$YR$$M$Y$$$20240724$$MD$JP$JP
241337881$24133788$1$I$20240622$20240718$20240724$20240724$EXP$$FR-DSJP-DSE-2024-136446$DAIICHI$$$$A$F$Y$$$20240724$$MD$FR$FR
241337891$24133789$1$I$$20240723$20240724$20240724$EXP$$CA-ORGANON-O2407CAN002143$ORGANON$$50$YR$$F$Y$68$KG$20240724$$HP$CA$CA
241337911$24133791$1$I$$20240723$20240724$20240724$EXP$$US-ABBVIE-5851839$ABBVIE$$$$A$M$Y$$$20240724$$CN$US$US
241337921$24133792$1$I$20240606$20240718$20240724$20240724$EXP$$HR-BAUSCH-BL-2024-011289$BAUSCH AND LOMB$$$$$F$Y$$$20240724$$MD$HR$HR
241337931$24133793$1$I$$20240719$20240724$20240724$EXP$$NVSC2024US150409$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241337942$24133794$2$F$$20240723$20240724$20240725$PER$$NVSC2024US151494$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
241337951$24133795$1$I$$20240716$20240724$20240724$EXP$$US-LUNDBECK-DKLU4001848$LUNDBECK$$$$$$Y$$$20240724$$HP$US$US
241337962$24133796$2$F$20230101$20240725$20240724$20240730$EXP$$US-ABBVIE-5851082$ABBVIE$$$$$F$Y$44$KG$20240730$$CN$US$US
241337971$24133797$1$I$$20240524$20240724$20240724$PER$$US-LUNDBECK-DKLU3078587$LUNDBECK$$$$$$Y$$$20240724$$CN$US$US
241337982$24133798$2$F$$20240716$20240724$20240815$PER$$US-TRAVERE-2024TVT00587$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$CN$US$US
241337991$24133799$1$I$20240626$20240723$20240724$20240724$EXP$GB-MHRA-MED-202407231007152710-FRSYZ$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041636$BOEHRINGER INGELHEIM$$87$YR$E$F$Y$66$KG$20240724$$HP$GB$GB
241338001$24133800$1$I$$20240712$20240724$20240724$EXP$$US-FARMAPROD-202407-2591$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240724$$CN$US$US
241338011$24133801$1$I$$20240721$20240724$20240724$EXP$$SA-SANDOZ INC.-SDZ2024SA067331$SANDOZ$$$$$F$Y$$$20240724$$CN$SA$SA
241338021$24133802$1$I$$20240709$20240724$20240724$EXP$$US-HLS-202400280$HLS THERAPEUTICS$$$$A$$Y$$$20240724$$MD$US$US
241338032$24133803$2$F$$20240812$20240724$20240812$PER$$US-ALXN-202407USA001208US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241338041$24133804$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117909$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240724$$CN$US$US
241338052$24133805$2$F$$20240806$20240724$20240812$EXP$$DE-BIOMARINAP-DE-2024-159342$BIOMARIN$$$$$$Y$$$20240812$$HP$DE$DE
241338061$24133806$1$I$$20240722$20240724$20240724$PER$$NVSC2024US150884$NOVARTIS$$$$$F$Y$$$20240724$$HP$US$US
241338071$24133807$1$I$$20240709$20240724$20240724$EXP$$US-HLS-202400284$HLS THERAPEUTICS$$$$A$M$Y$$$20240724$$HP$US$US
241338081$24133808$1$I$20240722$20240723$20240724$20240724$PER$$NVSC2024US151932$NOVARTIS$$$$$$Y$$$20240724$$PH$US$US
241338094$24133809$4$F$20240701$20240730$20240724$20240806$EXP$$US-AMGEN-USASP2024143776$AMGEN$$$$A$F$Y$$$20240806$$MD$US$US
241338101$24133810$1$I$$20240715$20240724$20240724$PER$$US-MYLANLABS-2024M1066463$MYLAN$$$$$F$Y$$$20240724$$CN$US$US
241338111$24133811$1$I$20240606$20240723$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US067757$SANDOZ$$76$YR$$F$Y$$$20240724$$HP$US$US
241338121$24133812$1$I$20240706$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117712$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240724$$CN$US$US
241338131$24133813$1$I$20240612$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117369$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240724$$HP$US$US
241338141$24133814$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117433$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240724$$CN$US$US
241338151$24133815$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117450$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240724$$CN$US$US
241338161$24133816$1$I$20240623$20240628$20240724$20240724$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00705$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241338181$24133818$1$I$$20240722$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US038055$SANDOZ$$$$$M$Y$$$20240724$$CN$US$US
241338191$24133819$1$I$$20240722$20240724$20240724$PER$$US-BIOMARINAP-US-2024-159367$BIOMARIN$$$$$$Y$$$20240724$$CN$US$US
241338202$24133820$2$F$20240723$20240809$20240724$20240820$PER$$US-BIOMARINAP-US-2024-159357$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
241338211$24133821$1$I$$20240723$20240724$20240724$PER$$US-BIOMARINAP-US-2024-159348$BIOMARIN$$$$$$Y$$$20240724$$CN$US$US
241338221$24133822$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116821$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240724$$CN$US$US
241338231$24133823$1$I$$20240719$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115809$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240724$$HP$US$US
241338241$24133824$1$I$20240417$20240722$20240724$20240724$EXP$IT-MINISAL02-995417$IT-GILEAD-2024-0681482$GILEAD$$76$YR$E$F$Y$$$20240724$$MD$IT$IT
241338252$24133825$2$F$$20240805$20240724$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117483$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240807$$CN$US$US
241338261$24133826$1$I$20240627$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117703$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240724$$PH$US$US
241338271$24133827$1$I$20240701$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117596$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$81.65$KG$20240724$$CN$US$US
241338281$24133828$1$I$$20240719$20240724$20240724$EXP$$NVSC2024US149898$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241338291$24133829$1$I$$20240723$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015346$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240724$$CN$US$US
241338303$24133830$3$F$$20240807$20240724$20240814$EXP$$NVSC2024US151150$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
241338311$24133831$1$I$20240101$20240524$20240724$20240724$PER$$US-LUNDBECK-DKLU3078640$LUNDBECK$$$$$$Y$$$20240724$$CN$US$US
241338321$24133832$1$I$$20240709$20240724$20240724$EXP$$US-HLS-202400282$HLS THERAPEUTICS$$$$A$F$Y$$$20240724$$CN$US$US
241338341$24133834$1$I$$20240719$20240724$20240724$PER$$US-BAUSCH-BL-2024-011210$BAUSCH AND LOMB$$$$$F$Y$$$20240724$$CN$US$US
241338352$24133835$2$F$$20240724$20240724$20240726$PER$$NVSC2024US151675$NOVARTIS$$$$$M$Y$$$20240726$$PH$US$US
241338362$24133836$2$F$$20240921$20240724$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117604$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240924$$HP$US$US
241338372$24133837$2$F$20240701$20240820$20240724$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117629$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240823$$CN$US$US
241338395$24133839$5$F$$20240904$20240724$20240906$30DAY$$US-PFIZER INC-202400218872$PFIZER$$63$YR$$F$Y$$$20240906$$CN$US$US
241338404$24133840$4$F$$20240824$20240724$20240826$30DAY$$US-PFIZER INC-202400218235$PFIZER$$8$YR$$M$Y$$$20240826$$CN$US$US
241338411$24133841$1$I$20240401$20240716$20240724$20240724$PER$$US-SA-2024SA213472$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240724$$MD$US$US
241338421$24133842$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA213518$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240724$$MD$US$US
241338431$24133843$1$I$20240401$20240717$20240724$20240724$PER$$US-SA-2024SA212569$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240724$$MD$US$US
241338443$24133844$3$F$20210804$20240827$20240724$20240903$EXP$$US-TAKEDA-2024TUS074211$TAKEDA$$12$YR$$F$Y$$$20240903$$PH$US$US
241338451$24133845$1$I$20240501$20240715$20240724$20240724$EXP$FR-AFSSAPS-AM2024000551$FR-TEVA-VS-3221942$TEVA$$66$YR$$M$Y$79$KG$20240724$$MD$FR$FR
241338461$24133846$1$I$20240702$20240715$20240724$20240724$PER$$US-RDY-SPO/USA/24/0010564$DR REDDYS$$15$YR$T$$Y$$$20240724$$CN$US$US
241338471$24133847$1$I$$20240722$20240724$20240724$EXP$$US-ABBVIE-5850772$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241338481$24133848$1$I$$20240715$20240724$20240724$PER$$US-RDY-SPO/USA/24/0010549$DR REDDYS$$17$YR$T$$Y$$$20240724$$MD$US$US
241338493$24133849$3$F$$20240911$20240724$20240916$30DAY$$US-PFIZER INC-202400217891$PFIZER$$35$YR$$F$Y$$$20240916$$CN$US$US
241338501$24133850$1$I$$20240722$20240724$20240724$EXP$$US-KYOWAKIRIN-2024KK017603$KYOWA$$$$$$Y$$$20240724$$HP$US$US
241338511$24133851$1$I$$20240719$20240724$20240724$PER$$US-JNJFOC-20240753930$JOHNSON AND JOHNSON$$$$$F$Y$$$20240724$$CN$US$US
241338525$24133852$5$F$20240723$20240902$20240724$20240903$PER$$US-JNJFOC-20240761412$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240903$$PH$US$US
241338531$24133853$1$I$$20240716$20240724$20240724$PER$$US-MYLANLABS-2024M1067382$MYLAN$$$$$F$Y$60.78$KG$20240724$$CN$US$US
241338541$24133854$1$I$$20240716$20240724$20240724$EXP$$GB-TEVA-VS-3146514$TEVA$$55$YR$$M$Y$$$20240724$$MD$GB$GB
241338551$24133855$1$I$$20240709$20240724$20240724$EXP$$US-HLS-202400281$HLS THERAPEUTICS$$$$A$M$Y$$$20240724$$$COUNTRY NOT SPECIFIED$US
241338562$24133856$2$F$20240701$20240722$20240724$20240726$EXP$$IE-ABBVIE-5850558$ABBVIE$$76$YR$$M$Y$$$20240726$$CN$IE$IE
241338591$24133859$1$I$$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222175$PFIZER$$78$YR$$M$Y$$$20240724$$CN$US$US
241338601$24133860$1$I$20240101$20240723$20240724$20240724$PER$$US-PFIZER INC-202400222340$PFIZER$$59$YR$$F$Y$$$20240724$$CN$US$US
241338611$24133861$1$I$20240101$20240723$20240724$20240724$30DAY$$US-SANDOZ INC.-SDZ2024US067820$SANDOZ$$$$$$Y$$$20240724$$CN$US$US
241338621$24133862$1$I$$20240722$20240724$20240724$PER$$NVSC2024US151938$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241338632$24133863$2$F$20240606$20240827$20240724$20240905$EXP$$JP-AMERICAN REGENT INC-2024002813$AMERICAN REGENT$$21$YR$$F$Y$$$20240905$$MD$JP$JP
241338644$24133864$4$F$20240718$20240909$20240724$20240920$PER$$JP-Eisai-EC-2024-170604$EISAI$$69$YR$E$F$Y$$$20240920$$MD$JP$JP
241338651$24133865$1$I$$20240723$20240724$20240724$PER$$US-JNJFOC-20240761943$JOHNSON AND JOHNSON$$$$$M$Y$$$20240724$$PH$US$US
241338661$24133866$1$I$$20240716$20240724$20240724$EXP$$US-AMGEN-USASP2024142649$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241338671$24133867$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024144578$AMGEN$$$$$F$Y$$$20240724$$MD$US$US
241338681$24133868$1$I$20240716$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116887$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240724$$CN$US$US
241338691$24133869$1$I$$20240712$20240724$20240724$EXP$$TR-ELI_LILLY_AND_COMPANY-TR202407012782$ELI LILLY AND CO$$$$$M$Y$$$20240724$$CN$DE$TR
241338701$24133870$1$I$$20240712$20240724$20240724$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407012470$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240724$$CN$FR$FR
241338711$24133871$1$I$$20240723$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015213$ELI LILLY AND CO$$$$$M$Y$$$20240724$$CN$US$US
241338722$24133872$2$F$20221224$20240725$20240724$20240725$EXP$$US-DEXPHARM-2024-2425$DEXCEL$$32$YR$A$F$Y$101.6$KG$20240725$$CN$US$US
241338731$24133873$1$I$20200503$20240718$20240724$20240724$EXP$$PL-ELI_LILLY_AND_COMPANY-PL202407014860$ELI LILLY AND CO$$39$YR$A$M$Y$75$KG$20240724$$CN$PL$PL
241338741$24133874$1$I$$20240723$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407015209$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240724$$CN$US$US
241338751$24133875$1$I$20240613$20240712$20240724$20240724$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407009788$ELI LILLY AND CO$$61$YR$A$F$Y$49$KG$20240724$$CN$CN$CN
241338762$24133876$2$F$20240712$20240903$20240724$20240913$EXP$$GR-ELI_LILLY_AND_COMPANY-GR202407012283$ELI LILLY AND CO$$$$A$F$Y$62$KG$20240913$$CN$GR$GR
241338771$24133877$1$I$20240620$20240723$20240724$20240724$EXP$$US-UROVANT SCIENCES GMBH-202407-URV-001103$UROVANT SCIENCES$$86$YR$$M$Y$$$20240724$$HP$US$US
241338781$24133878$1$I$$20240701$20240724$20240724$PER$$US-LEX-000368$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240724$$CN$US$US
241338795$24133879$5$F$20240719$20240828$20240724$20240905$30DAY$$US-JNJFOC-20240752951$JOHNSON AND JOHNSON$$60$YR$A$F$Y$67.646$KG$20240905$$HP$US$US
241338801$24133880$1$I$$20240718$20240724$20240724$PER$$US-MYLANLABS-2024M1067923$MYLAN$$$$$$Y$$$20240724$$CN$US$US
241338821$24133882$1$I$20240423$20240719$20240724$20240724$EXP$$FR-AMERICAN REGENT INC-2024002800$AMERICAN REGENT$$60$YR$$M$Y$72$KG$20240724$$MD$FR$FR
241338841$24133884$1$I$20240601$20240723$20240724$20240724$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700941$MYOVANT SCIENCES$$70$YR$$M$Y$$$20240724$$CN$US$US
241338852$24133885$2$F$20221221$20240723$20240724$20240802$EXP$$BR-SANDOZ INC.-NVSC2022BR290343$SANDOZ$$55$YR$$F$Y$$$20240802$$HP$BR$BR
241338902$24133890$2$F$20240712$20240725$20240724$20240801$EXP$$BR-JNJFOC-20240753111$JOHNSON AND JOHNSON$$75$YR$E$M$Y$61$KG$20240801$$MD$BR$BR
241338911$24133891$1$I$20240710$20240722$20240724$20240724$PER$$US-JNJFOC-20240757396$JOHNSON AND JOHNSON$$$$$$Y$$$20240724$$HP$US$US
241338921$24133892$1$I$20240720$20240720$20240724$20240724$PER$$US-PFIZER INC-202400219709$PFIZER$$41$YR$$M$Y$73.016$KG$20240724$$CN$US$US
241338931$24133893$1$I$$20240716$20240724$20240724$EXP$$US-ALXN-202407USA001031US$ALEXION PHARMACEUTICALS$$$$I$F$Y$4.082$KG$20240724$$PH$US$US
241338942$24133894$2$F$20240119$20240719$20240724$20240909$EXP$$TH-BAYER-2024A106865$BAYER$$$$$M$Y$$$20240909$$CN$TH$TH
241338951$24133895$1$I$20240617$20240715$20240724$20240724$EXP$FR-FreseniusKabi-FK202409719$FR-FreseniusKabi-FK202409719$FRESENIUS KABI$$72$YR$E$F$Y$$$20240724$$PH$FR$FR
241338961$24133896$1$I$$20240715$20240724$20240724$EXP$$US-TEVA-VS-3221092$TEVA$$$$$M$Y$$$20240724$$HP$US$US
241338971$24133897$1$I$$20240723$20240724$20240724$EXP$$NO-PURDUE-USA-2024-0310925$PURDUE$Dalaker VM, Furuhaugen H, Brekke M, Bj?rnaas MA, Krpo M, ?iestad EL, Vallersnes OM.. Drugs in blood and urine samples from victims of suspected exposure to drink spiking:  A prospective observational study from Oslo, Norway. PLoS ONE. 2024;19(7):e0306191$26$YR$$M$Y$$$20240724$$HP$NO$NO
241338982$24133898$2$F$20240301$20240729$20240724$20240731$EXP$DK-DKMA-30729423$DK-PURDUE-USA-2024-0310909$PURDUE$$81$YR$$F$Y$48$KG$20240731$$MD$DK$DK
241339001$24133900$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116654$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240724$$CN$US$US
241339011$24133901$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116591$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240724$$CN$US$US
241339021$24133902$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116300$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240724$$CN$US$US
241339031$24133903$1$I$$20240723$20240724$20240724$EXP$$CA-PURDUE-USA-2024-0310917$PURDUE$$55$YR$$M$Y$$$20240724$$CN$CA$CA
241339041$24133904$1$I$20240715$20240723$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117309$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$83.91$KG$20240724$$PH$US$US
241339051$24133905$1$I$20240701$20240719$20240724$20240724$EXP$$TR-AMERICAN REGENT INC-2024002801$AMERICAN REGENT$$65$YR$$F$Y$70$KG$20240724$$HP$TR$TR
241339061$24133906$1$I$20231124$20240522$20240724$20240724$EXP$$BE-APELLIS-APL-2024-004379$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240724$$MD$BE$BE
241339071$24133907$1$I$$20240723$20240724$20240724$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-117605$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240724$$MD$CH$CH
241339081$24133908$1$I$20240301$20240718$20240724$20240724$PER$$US-ABBVIE-5847090$ABBVIE$$56$YR$$M$Y$65.77$KG$20240724$$CN$US$US
241339093$24133909$3$F$20240101$20240805$20240724$20240808$PER$$US-AMGEN-USASP2024145744$AMGEN$$47$YR$A$F$Y$$$20240808$$CN$US$US
241339101$24133910$1$I$$20240717$20240724$20240724$PER$$US-EMD Serono-2024039118$EMD SERONO INC$$$$A$F$Y$$$20240724$$CN$US$US
241339122$24133912$2$F$20240714$20240717$20240724$20240729$PER$$CN-Eisai-EC-2024-170504$EISAI$$64$YR$A$M$Y$$$20240729$$HP$CN$CN
241339132$24133913$2$F$20240605$20240722$20240724$20240729$EXP$FR-FreseniusKabi-FK202409691$FR-FreseniusKabi-FK202409691$FRESENIUS KABI$$67$YR$E$F$Y$$$20240729$$PH$FR$FR
241339141$24133914$1$I$20240528$20240715$20240724$20240724$EXP$FR-FreseniusKabi-FK202409716$FR-FreseniusKabi-FK202409716$FRESENIUS KABI$$45$YR$A$F$Y$$$20240724$$HP$FR$FR
241339151$24133915$1$I$20240530$20240715$20240724$20240724$PER$$US-RDY-SPO/USA/24/0010561$DR REDDYS$$15$YR$T$$Y$$$20240724$$MD$US$US
241339161$24133916$1$I$$20240711$20240724$20240724$EXP$$US-BRAINTREE LABORATORIES, INC.-2024BTE00444$BRAINTREE$$$$$F$Y$$$20240724$$MD$US$US
241339181$24133918$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151939$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241339191$24133919$1$I$20240712$20240717$20240724$20240724$EXP$$DO-ELI_LILLY_AND_COMPANY-DO202407015639$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240724$$CN$DE$DO
241339203$24133920$3$F$20040101$20240730$20240724$20240730$EXP$$US-ANIPHARMA-2024-US-039799$ANI$$82$YR$$F$Y$$$20240730$$HP$US$US
241339211$24133921$1$I$$20240717$20240724$20240724$EXP$$US-GSK-US2024AMR091395$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$CN$US$US
241339221$24133922$1$I$$20240718$20240724$20240724$EXP$$JP-009507513-2407JPN003719J$MERCK$$6$DEC$$F$Y$$$20240724$$MD$JP$JP
241339233$24133923$3$F$$20240908$20240724$20240911$30DAY$$US-PFIZER INC-202400219183$PFIZER$$10$YR$$F$Y$29.03$KG$20240911$$CN$US$US
241339243$24133924$3$F$$20240904$20240724$20240904$30DAY$$US-PFIZER INC-202400220015$PFIZER$$7$YR$$M$Y$$$20240904$$CN$US$US
241339251$24133925$1$I$$20240719$20240724$20240724$30DAY$$GB-PFIZER INC-PV202400094681$PFIZER$$10$YR$$M$Y$$$20240724$$CN$GB$GB
241339261$24133926$1$I$20240101$20240724$20240724$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041778$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240724$$CN$US$US
241339271$24133927$1$I$20240615$20240718$20240724$20240724$EXP$$US-GILEAD-2024-0681397$GILEAD$$81$YR$E$F$Y$$$20240724$$CN$US$US
241339285$24133928$5$F$20240715$20240819$20240724$20240828$PER$$US-SA-2024SA211258$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240828$$CN$US$US
241339291$24133929$1$I$$20240718$20240724$20240724$EXP$$CA-EMD Serono-2024033969$EMD SERONO INC$$$$C$M$Y$$$20240724$$CN$CA$CA
241339302$24133930$2$F$20240101$20240815$20240724$20240828$PER$$US-SA-2024SA212179$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240828$$CN$US$US
241339311$24133931$1$I$$20240719$20240724$20240724$PER$$JP-Eisai-EC-2024-170605$EISAI$$79$YR$E$F$Y$$$20240724$$MD$JP$JP
241339321$24133932$1$I$20240516$20240722$20240724$20240724$EXP$FR-AFSSAPS-LY2024001100$FR-Eisai-EC-2024-170632$EISAI$$54$YR$A$M$Y$81$KG$20240724$$PH$FR$FR
241339332$24133933$2$F$20240601$20240918$20240724$20240925$PER$$JP-Eisai-EC-2024-170669$EISAI$$$$E$F$Y$$$20240925$$MD$JP$JP
241339352$24133935$2$F$$20240912$20240724$20240918$EXP$$FR-INCYTE CORPORATION-2024IN007709$INCYTE$$$$$$Y$$$20240918$$MD$FR$FR
241339371$24133937$1$I$$20240718$20240724$20240724$PER$$US-AMGEN-USASL2024144224$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241339381$24133938$1$I$$20240719$20240724$20240724$EXP$$NVSC2024US071442$NOVARTIS$$$$$F$Y$$$20240724$$CN$US$US
241339401$24133940$1$I$$20240724$20240724$20240724$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041769$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$$$20240724$$CN$US$US
241339411$24133941$1$I$$20240718$20240724$20240724$EXP$$US-BAUSCH-BL-2024-011086$BAUSCH AND LOMB$$$$$F$Y$$$20240724$$CN$US$US
241339421$24133942$1$I$20170524$20240712$20240724$20240724$EXP$$US-COOPERSURGICAL, INC.-2024CPS002187$COOPERSURGICAL$$$$$F$Y$$$20240724$$LW$US$US
241339431$24133943$1$I$20220711$20240712$20240724$20240724$EXP$$US-COOPERSURGICAL, INC.-2024CPS002188$COOPERSURGICAL$$$$$F$Y$$$20240724$$LW$US$US
241339442$24133944$2$F$20240114$20240904$20240724$20240919$EXP$$US-COOPERSURGICAL, INC.-2024CPS002191$COOPERSURGICAL$$31$YR$$F$Y$105.22$KG$20240919$$CN$US$US
241339453$24133945$3$F$20240702$20240812$20240724$20240816$PER$$US-BAUSCH-BL-2024-011120$BAUSCH AND LOMB$$79$YR$$F$Y$$$20240816$$CN$US$US
241339481$24133948$1$I$$20240724$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117810$BRISTOL MYERS SQUIBB$$84$YR$E$$Y$78.02$KG$20240724$$CN$US$US
241339491$24133949$1$I$20240719$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014511$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240724$$CN$US$US
241339501$24133950$1$I$$20240718$20240724$20240724$PER$$US-INCYTE CORPORATION-2024IN007596$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241339511$24133951$1$I$20240701$20240717$20240724$20240724$EXP$$CN-009507513-2407CHN012049$MERCK$$77$YR$$F$Y$51$KG$20240724$$HP$CN$CN
241339521$24133952$1$I$20240701$20240717$20240724$20240724$EXP$$AR-MYLANLABS-2024M1067723$MYLAN$$15$YR$$F$Y$$$20240724$$HP$AR$AR
241339532$24133953$2$F$$20240809$20240724$20240819$PER$$US-INCYTE CORPORATION-2024IN007604$INCYTE$$$$$$Y$$$20240819$$CN$US$US
241339541$24133954$1$I$$20240504$20240724$20240724$PER$$US-APELLIS-APL-2024-003673$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241339551$24133955$1$I$20240715$20240717$20240724$20240724$EXP$$US-Eisai-EC-2024-170457$EISAI$$70$YR$E$M$Y$84.37$KG$20240724$$MD$US$US
241339561$24133956$1$I$20240706$20240716$20240724$20240724$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00594$PARATEK PHARMACEUTICALS$$31$YR$$F$Y$$$20240724$$MD$CN$CN
241339571$24133957$1$I$$20240722$20240724$20240724$EXP$$AU-MYLANLABS-2024M1068582$MYLAN$$$$$F$Y$$$20240724$$HP$AU$AU
241339582$24133958$2$F$20240407$20240724$20240724$20240724$PER$$US-GILEAD-2024-0681815$GILEAD$$53$YR$A$M$Y$$$20240724$$MD$US$US
241339592$24133959$2$F$20240610$20240919$20240724$20240924$EXP$$IL-CARA THERAPEUTICS, INC.-2024-00060-IL$CARA THERAPEUTICS$$$$$F$Y$85$KG$20240924$$MD$IL$IL
241339603$24133960$3$F$$20240827$20240724$20240830$PER$$US-ALXN-202407USA001120US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
241339611$24133961$1$I$20240717$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024143641$AMGEN$$41$YR$A$F$Y$$$20240724$$CN$US$US
241339621$24133962$1$I$20240510$20240716$20240724$20240724$PER$$US-Eisai-EC-2024-170333$EISAI$$69$YR$E$F$Y$$$20240724$$CN$US$US
241339633$24133963$3$F$$20240730$20240724$20240823$PER$$US-BEH-2024174643$CSL BEHRING$$$$$M$Y$$$20240823$$HP$US$US
241339642$24133964$2$F$$20240722$20240724$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407012683$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240730$$CN$US$US
241339651$24133965$1$I$$20240720$20240724$20240724$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-101428$REGENERON$$$$$F$Y$$$20240724$$MD$JP$JP
241339661$24133966$1$I$$20240718$20240724$20240724$EXP$$ZA-AstraZeneca-2024A164162$ASTRAZENECA$$77$YR$$F$Y$$$20240724$$CN$ZA$
241339671$24133967$1$I$$20240710$20240724$20240724$30DAY$$FR-PFIZER INC-202400186483$PFIZER$$62$YR$$F$Y$$$20240724$$PH$FR$FR
241339681$24133968$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090489$VIIV$$69$YR$$F$Y$$$20240724$$PH$US$US
241339691$24133969$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091297$VIIV$$52$YR$$M$Y$$$20240724$$PH$US$US
241339701$24133970$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090999$VIIV$$60$YR$$M$Y$$$20240724$$PH$US$US
241339711$24133971$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090487$VIIV$$50$YR$$F$Y$$$20240724$$PH$US$US
241339722$24133972$2$F$20240501$20240808$20240724$20240820$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090641$VIIV$$45$YR$$M$Y$$$20240820$$PH$US$US
241339732$24133973$2$F$20240501$20240827$20240724$20240902$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091294$VIIV$$56$YR$$F$Y$49$KG$20240902$$PH$US$US
241339742$24133974$2$F$20240501$20240920$20240724$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR091034$VIIV$$52$YR$$F$Y$$$20240930$$MD$US$US
241339751$24133975$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091176$VIIV$$56$YR$$F$Y$$$20240724$$PH$US$US
241339761$24133976$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091036$VIIV$$40$YR$$M$Y$$$20240724$$PH$US$US
241339772$24133977$2$F$20240501$20240823$20240724$20240902$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091178$VIIV$$59$YR$$M$Y$81.179$KG$20240902$$PH$US$US
241339781$24133978$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090652$VIIV$$31$YR$$F$Y$$$20240724$$PH$US$US
241339792$24133979$2$F$20240501$20240828$20240724$20240903$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090930$VIIV$$56$YR$$F$Y$52$KG$20240903$$PH$US$US
241339801$24133980$1$I$20240514$20240611$20240724$20240724$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091175$VIIV$$59$YR$$M$Y$$$20240724$$PH$US$US
241339811$24133981$1$I$$20240721$20240724$20240724$EXP$$US-GILEAD-2024-0681481$GILEAD$$$$A$F$Y$$$20240724$$PH$US$US
241339821$24133982$1$I$$20240715$20240724$20240724$EXP$$US-VERTEX PHARMACEUTICALS-2024-011992$VERTEX$Caza TN, Walker PD.. Clinicopathologic Features of Kidney Disease in Patients With Cystic Fibrosis. Kidney Int Rep. 2024;9:2286-9$23$YR$$M$Y$$$20240724$$HP$US$US
241339831$24133983$1$I$$20240715$20240724$20240724$EXP$$US-VERTEX PHARMACEUTICALS-2024-011828$VERTEX$Caza TN, Walker PD.. Clinicopathologic Features of Kidney Disease in Patients With Cystic Fibrosis. Kidney Int Rep. 2024;9:2286-9$21$YR$$M$Y$$$20240724$$HP$US$US
241339841$24133984$1$I$$20240715$20240724$20240724$EXP$$US-VERTEX PHARMACEUTICALS-2024-011991$VERTEX$Caza TN, Walker PD. Clinicopathologic features of kidney disease in patients with Cystic fibrosis. Kidney Int Rep. 2024;9:2286-9$18$YR$$M$Y$$$20240724$$HP$US$US
241339851$24133985$1$I$20230101$20240722$20240724$20240724$EXP$$US-INCYTE CORPORATION-2024IN007697$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241339861$24133986$1$I$$20240716$20240724$20240724$PER$$US-APELLIS-2024-APL-0000504$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240724$$MD$US$US
241339871$24133987$1$I$20240712$20240722$20240724$20240724$EXP$GB-MHRA-MED-202407221448493150-SPNRD$GB-LUNDBECK-DKLU4001982$LUNDBECK$$$$$$Y$$$20240724$$HP$GB$GB
241339881$24133988$1$I$20240718$20240718$20240724$20240724$EXP$$GB-GSK-GB2024EME091366$GLAXOSMITHKLINE$$$$$$Y$$$20240724$$HP$GB$GB
241339891$24133989$1$I$$20240719$20240724$20240724$PER$$MX-Eisai-EC-2024-170622$EISAI$$60$YR$A$M$Y$$$20240724$$MD$MX$MX
241339903$24133990$3$F$20240704$20240909$20240724$20240920$EXP$$JP-Eisai-EC-2024-170514$EISAI$$67$YR$E$F$Y$$$20240920$$MD$JP$JP
241339911$24133991$1$I$$20240719$20240724$20240724$PER$$JP-Eisai-EC-2024-170607$EISAI$$80$YR$E$M$Y$$$20240724$$MD$JP$JP
241339921$24133992$1$I$$20240722$20240724$20240724$PER$$NVSC2024US151944$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241339931$24133993$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151946$NOVARTIS$$$$$$Y$$$20240724$$HP$US$US
241339942$24133994$2$F$$20240813$20240724$20240813$EXP$$US-ALXN-202407USA001325US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240813$$HP$US$US
241339951$24133995$1$I$$20240723$20240724$20240724$EXP$$US-ABBVIE-5851972$ABBVIE$$$$A$M$Y$$$20240724$$HP$US$US
241339961$24133996$1$I$$20240722$20240724$20240724$EXP$$GR-GILEAD-2024-0681686$GILEAD$Manolaka Ch. et al. ACUTE LIVER INJURY AFTER REMDESEVIR ADMINISTRATION IN A PATIENT WITH COVID- 19 INFECTION - AN INTERESTING CASE. 50th ANNUAL PANHELLENIC MEDICAL CONGRESS, 25-27 APRIL 2024_ABSTRACTS. 2024;unk:unk$56$YR$A$F$Y$$$20240724$$HP$GR$GR
241339971$24133997$1$I$$20240719$20240724$20240724$EXP$$US-GILEAD-2024-0681468$GILEAD$$$$A$F$Y$$$20240724$$CN$US$US
241339991$24133999$1$I$$20240717$20240724$20240724$EXP$$IT-INCYTE CORPORATION-2024IN007677$INCYTE$$$$$$Y$$$20240724$$MD$IT$IT
241340001$24134000$1$I$$20240612$20240724$20240724$PER$$US-FMCRTG-FMC-2406-000716$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240724$$CN$US$US
241340011$24134001$1$I$$20240712$20240724$20240724$EXP$$US-FMCRTG-FMC-2407-000839$FRESENIUS MEDICAL CARE$$71$YR$E$F$Y$$$20240724$$HP$US$US
241340022$24134002$2$F$$20240802$20240724$20240811$PER$$US-RDY-CLI/USA/24/0010649$DR REDDYS$$$$A$F$Y$$$20240811$$HP$US$US
241340032$24134003$2$F$$20240802$20240724$20240811$PER$$US-RDY-CLI/USA/24/0010743$DR REDDYS$$17$YR$T$F$Y$$$20240811$$MD$US$US
241340042$24134004$2$F$$20240801$20240724$20240812$EXP$$US-RDY-CLI/USA/24/0010650$DR REDDYS$$25$YR$A$F$Y$$$20240812$$MD$US$US
241340051$24134005$1$I$$20240715$20240724$20240724$EXP$$US-RDY-LIT/USA/24/0010717$DR REDDYS$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15(3): doi:10.14309/ctg.0000000000000679.$55$YR$A$M$Y$$$20240724$$MD$US$US
241340061$24134006$1$I$$20240720$20240724$20240724$PER$$US-INCYTE CORPORATION-2024IN007624$INCYTE$$$$$$Y$$$20240724$$MD$US$US
241340071$24134007$1$I$$20240722$20240724$20240724$EXP$$US-INCYTE CORPORATION-2024IN007676$INCYTE$$$$$$Y$$$20240724$$CN$US$US
241340082$24134008$2$F$20240711$20240718$20240724$20240826$PER$$US-IMP-2024000508$Harrow Health$$71$YR$E$F$Y$$$20240826$$CN$US$US
241340091$24134009$1$I$20240722$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117767$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$65.86$KG$20240724$$HP$US$US
241340101$24134010$1$I$$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116831$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240724$$CN$US$US
241340112$24134011$2$F$$20240724$20240724$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117818$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240726$$CN$US$US
241340121$24134012$1$I$$20240721$20240724$20240724$EXP$$US-GILEAD-2024-0681478$GILEAD$$$$T$M$Y$$$20240724$$PH$US$US
241340143$24134014$3$F$$20240906$20240724$20240906$PER$$US-ALXN-202407USA001172US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
241340152$24134015$2$F$20240101$20240723$20240724$20240821$PER$$US-IMP-2024000484$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
241340161$24134016$1$I$$20240719$20240724$20240724$EXP$$US-LIGAND-2024-US-039821$LIGAND$Zardoost P,  Buckman Z, Weaver J, Elton S, Prouty A, Stuart R, et al..Continuous renal replacement therapy for lithium toxicity: A worthy treatment to avoid intradialytic hypotension and vasopressors.Clinical Case Reports.2024;12(4):.$54$YR$$F$Y$$$20240724$$HP$US$US
241340171$24134017$1$I$$20240715$20240724$20240724$EXP$$US-RDY-LIT/USA/24/0010721$DR REDDYS$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15(3): doi:10.14309/ctg.0000000000000679.$27$YR$A$M$Y$$$20240724$$MD$US$US
241340181$24134018$1$I$$20240724$20240724$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041791$BOEHRINGER INGELHEIM$$$$$$Y$$$20240724$$CN$US$US
241340191$24134019$1$I$20230530$20240711$20240724$20240724$EXP$$US-APELLIS-APL-2023-002836$APELLIS PHARMACEUTICALS$Andre J. Witkin, MD, FASRS1 , Glenn J. Jaffe, MD2, Sunil K. Srivastava, MD3,  Janet L. Davis, MD4, Judy E. Kim, MD, FARVO, FASRS5,  and the ReST Committee. Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee.Journal of VitreoRetinal Diseases . 2023;$$$$$Y$$$20240724$$MD$US$US
241340202$24134020$2$F$20240507$20240726$20240724$20240729$EXP$FR-AFSSAPS-NC2024000851$FR-GILEAD-2024-0681667$GILEAD$$61$YR$A$F$Y$$$20240729$$HP$FR$FR
241340211$24134021$1$I$$20240716$20240724$20240724$EXP$$CA-GILEAD-2024-0680975$GILEAD$$$$$F$Y$$$20240724$$MD$CA$CA
241340221$24134022$1$I$$20240722$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407014272$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240724$$CN$US$US
241340231$24134023$1$I$$20240719$20240724$20240724$PER$$US-ELI_LILLY_AND_COMPANY-US202407013787$ELI LILLY AND CO$$73$YR$E$$Y$$$20240724$$CN$US$US
241340242$24134024$2$F$$20240801$20240724$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407014221$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240806$$CN$US$US
241340253$24134025$3$F$20160901$20240724$20240724$20240903$PER$$US-BIOMARINAP-US-2023-159315$BIOMARIN$$$$$$Y$$$20240903$$PH$US$US
241340262$24134026$2$F$20240101$20240805$20240724$20240812$EXP$$US-009507513-2407USA012795$MERCK$$$$$F$Y$$$20240812$$MD$US$US
241340271$24134027$1$I$$20240719$20240724$20240724$EXP$$US-ABBVIE-5848588$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241340281$24134028$1$I$$20240720$20240724$20240724$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-101727$REGENERON$$8$DEC$$F$Y$$$20240724$$MD$JP$JP
241340291$24134029$1$I$$20240719$20240724$20240724$EXP$$US-ABBVIE-5847771$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241340302$24134030$2$F$20240501$20240823$20240724$20240903$PER$$US-JNJFOC-20240763805$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240903$$PH$US$US
241340311$24134031$1$I$20240122$20240718$20240724$20240724$EXP$$US-GILEAD-2024-0681370$GILEAD$$30$YR$A$$Y$$$20240724$$CN$US$US
241340321$24134032$1$I$20240101$20240719$20240724$20240724$EXP$$US-ABBVIE-5751832$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241340331$24134033$1$I$20230101$20240722$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116975$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240724$$HP$US$US
241340341$24134034$1$I$$20240701$20240724$20240724$PER$$US-LEX-000369$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240724$$CN$US$US
241340354$24134035$4$F$20240501$20240819$20240724$20240827$EXP$$JP-RADIUS HEALTH, INC.-2024JP005471$RADIUS PHARM$$80$YR$$M$Y$$$20240827$$MD$JP$JP
241340362$24134036$2$F$20240718$20240820$20240724$20240822$EXP$$IL-ABBVIE-5849301$ABBVIE$$27$YR$$F$Y$58$KG$20240822$$MD$IL$IL
241340371$24134037$1$I$20240601$20240716$20240724$20240724$PER$$US-SA-2024SA212131$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240725$$CN$US$US
241340382$24134038$2$F$20240630$20240823$20240724$20240828$EXP$FR-AFSSAPS-TO2024001272$FR-GILEAD-2024-0681361$GILEAD$$69$YR$E$F$Y$62$KG$20240828$$MD$FR$FR
241340401$24134040$1$I$$20240719$20240724$20240724$PER$$US-ABBVIE-5850140$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241340413$24134041$3$F$20240501$20240912$20240724$20240924$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06951$NEUROCRINE BIOSCIENCES$$52$YR$$F$Y$$$20240924$$HP$US$US
241340421$24134042$1$I$$20240723$20240724$20240724$EXP$$US-ROCHE-10000035069$ROCHE$$$$$$Y$$$20240724$$MD$US$US
241340432$24134043$2$F$20240715$20240726$20240724$20240801$EXP$$US-APELLIS-2024-APL-0000481$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
241340441$24134044$1$I$20240701$20240718$20240724$20240724$EXP$$JP-009507513-2407JPN003721J$MERCK$$7$DEC$$F$Y$$$20240724$$MD$JP$JP
241340452$24134045$2$F$20240517$20240730$20240724$20240809$EXP$$AU-BEH-2024173162$CSL BEHRING$$80$YR$E$F$Y$$$20240809$$HP$AU$AU
241340461$24134046$1$I$20240712$20240716$20240724$20240724$PER$$US-RDY-SPO/USA/24/0010537$DR REDDYS$$27$YR$A$F$Y$$$20240724$$CN$US$US
241340471$24134047$1$I$20240701$20240723$20240724$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041678$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240724$$CN$US$US
241340481$24134048$1$I$20210101$20240717$20240724$20240724$EXP$$US-RDY-SPO/USA/24/0010680$DR REDDYS$$32$YR$A$F$Y$$$20240724$$CN$US$US
241340491$24134049$1$I$$20240717$20240724$20240724$EXP$$US-RDY-SPO/USA/24/0010738$DR REDDYS$$$$$F$Y$$$20240724$$MD$US$US
241340501$24134050$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151945$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241340511$24134051$1$I$$20240718$20240724$20240724$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-009707$JAZZ$$$$$F$Y$$$20240724$$CN$US$US
241340521$24134052$1$I$$20240723$20240724$20240724$PER$$US-JNJFOC-20240763682$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240724$$HP$US$US
241340531$24134053$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA214318$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240725$$MD$US$US
241340541$24134054$1$I$20240205$20240722$20240724$20240724$EXP$FR-AFSSAPS-TS2024000825$FR-GILEAD-2024-0681492$GILEAD$$35$YR$A$F$Y$59$KG$20240724$$MD$FR$FR
241340551$24134055$1$I$$20240722$20240724$20240724$EXP$$CA-JNJFOC-20240765809$JOHNSON AND JOHNSON$$$$$F$Y$94$KG$20240724$$CN$CA$CA
241340563$24134056$3$F$$20240820$20240724$20240829$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI07204$NEUROCRINE BIOSCIENCES$$77$YR$$F$Y$$$20240829$$MD$JP$JP
241340591$24134059$1$I$$20240708$20240724$20240724$PER$$US-TPU-TPU-2024-00380$TEIKOKU$$$$$F$Y$$$20240724$$CN$US$US
241340602$24134060$2$F$20240101$20240829$20240724$20240905$EXP$$US-ABBVIE-5850695$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
241340611$24134061$1$I$20240717$20240719$20240724$20240724$EXP$$US-BIOMARINAP-US-2024-159306$BIOMARIN$$$$$$Y$$$20240724$$CN$US$US
241340621$24134062$1$I$$20240723$20240724$20240724$EXP$$US-BIOMARINAP-US-2024-159351$BIOMARIN$$$$$$Y$$$20240724$$CN$US$US
241340631$24134063$1$I$$20240419$20240724$20240724$PER$$US-APELLIS-APL-2024-004286$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241340641$24134064$1$I$20240101$20240722$20240724$20240724$EXP$$US-ABBVIE-5850506$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241340651$24134065$1$I$20240715$20240722$20240724$20240724$EXP$$CN-ROCHE-10000034315$ROCHE$$52$YR$A$F$Y$63$KG$20240725$$HP$CN$CN
241340671$24134067$1$I$20240301$20240723$20240724$20240724$PER$$US-ROCHE-10000034455$ROCHE$$32$YR$A$$Y$$$20240725$$CN$US$US
241340681$24134068$1$I$$20240717$20240724$20240724$EXP$$US-JNJFOC-20240752231$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240725$$HP$US$US
241340691$24134069$1$I$$20240718$20240724$20240724$EXP$$BR-JNJFOC-20240753616$JOHNSON AND JOHNSON$$$$$F$Y$62$KG$20240725$$CN$BR$BR
241340701$24134070$1$I$20240424$20240722$20240724$20240724$EXP$SK-SUKLSK-20240449$SK-ROCHE-10000033394$ROCHE$$67$YR$E$F$Y$85$KG$20240725$$HP$SK$SK
241340712$24134071$2$F$$20240716$20240724$20240807$EXP$$JP-009507513-2407JPN003400J$MERCK$Kagawa A, Wakabayashi Y, Muta T, Izumi Y, Matsumoto N, Taniwaki M, et al.. KT-25 A Case of Transient Aggravation of Adult T-cell Leukaemia Triggered by an Immune Checkpoint Inhibitor during Treatment for Lung Cancer. The 70th Chugoku-Shikoku Regional Meeting of the Japanese Respiratory Society. 86$84$YR$$F$Y$$$20240807$$MD$JP$JP
241340721$24134072$1$I$$20240719$20240724$20240724$PER$$US-ROCHE-10000034660$ROCHE$$$$$$Y$$$20240725$$PH$US$US
241340741$24134074$1$I$20240702$20240719$20240724$20240724$EXP$$CN-ROCHE-10000031673$ROCHE$$70$YR$E$M$Y$85$KG$20240725$$HP$CN$CN
241340751$24134075$1$I$20240627$20240718$20240724$20240724$EXP$$CN-ROCHE-10000033122$ROCHE$$72$YR$E$F$Y$$$20240725$$HP$CN$CN
241340762$24134076$2$F$$20240910$20240724$20240918$EXP$$NVSJ2024JP008759$NOVARTIS$Takaya S,  Misugi T, Kitada K, Kurihara Y, Tahara M, Hamuro T, et al.. A Case of Bicervical Bicornuate Uterus with Placenta Attached to the Septum in Diamniotic Dichorionic Twins. Journal of Japan Society of Perinatal and Neonatal Medicine/The 60th Annual Cong. 2024;60:P50-5$$$N$M$Y$2.075$KG$20240918$$HP$JP$JP
241340772$24134077$2$F$$20240808$20240724$20240819$30DAY$$CH-JNJFOC-20240755778$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$PH$CH$CH
241340782$24134078$2$F$20230614$20240905$20240724$20240913$EXP$$US-SANDOZ INC.-NVSC2023US149364$SANDOZ$$34$YR$$M$Y$90.703$KG$20240913$$CN$US$US
241340801$24134080$1$I$20230625$20240720$20240724$20240724$EXP$$NVSJ2023JP010348$NOVARTIS$$$$$M$Y$$$20240725$$CN$JP$JP
241340811$24134081$1$I$$20240717$20240724$20240724$EXP$$JP-SMPA-2024SMP011022$SUNOVION$$$$$$Y$$$20240724$$CN$JP$JP
241340822$24134082$2$F$$20240731$20240724$20240807$EXP$$JP-MTPC-MTPC2024-0015081$MITSUBISHI TANABE PHARMA$$7$DEC$$M$Y$$$20240807$$PH$JP$JP
241340831$24134083$1$I$$20240718$20240724$20240724$EXP$$US-MTPC-MTDA2024-0015201$Unknown Manufacturer$$$$E$M$Y$$$20240724$$CN$US$US
241340841$24134084$1$I$20240717$20240719$20240724$20240724$PER$$US-AMGEN-USASP2024144819$AMGEN$$64$YR$A$F$Y$$$20240724$$CN$US$US
241340851$24134085$1$I$$20240718$20240724$20240724$EXP$$US-MTPC-MTDA2024-0015093$Unknown Manufacturer$$$$E$$Y$$$20240724$$HP$US$US
241340871$24134087$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151934$NOVARTIS$$$$$$Y$$$20240725$$MD$US$US
241340881$24134088$1$I$$20240718$20240724$20240724$EXP$$US-JNJFOC-20240750445$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$HP$US$US
241340891$24134089$1$I$$20240715$20240724$20240724$PER$$US-RDY-SPO/USA/24/0010498$DR REDDYS$$82$YR$E$F$Y$$$20240725$$CN$US$US
241340901$24134090$1$I$$20240723$20240724$20240724$EXP$GB-MHRA-31183392$GB-SANDOZ INC.-SDZ2024GB067632$SANDOZ$$$$$F$Y$$$20240724$$PH$GB$GB
241340911$24134091$1$I$$20240716$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113803$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240725$$HP$US$US
241340925$24134092$5$F$$20240927$20240724$20240930$EXP$$NVSC2024SV151859$NOVARTIS$$$$$F$Y$$$20240930$$CN$SV$SV
241340931$24134093$1$I$$20240718$20240724$20240724$EXP$$NVSJ2024JP008798$NOVARTIS$$$$$$Y$$$20240725$$MD$JP$JP
241340952$24134095$2$F$20240101$20240808$20240724$20240814$EXP$$CA-ABBVIE-5848816$ABBVIE$$78$YR$$F$Y$$$20240814$$CN$CA$CA
241340962$24134096$2$F$20240403$20240911$20240724$20240919$EXP$$CA-JNJFOC-20240419279$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240919$$HP$CA$CA
241340971$24134097$1$I$20240501$20240719$20240724$20240724$EXP$$US-SANDOZ INC.-SDZ2024US067893$SANDOZ$$54$YR$$F$Y$$$20240724$$CN$US$US
241340981$24134098$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151951$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241340991$24134099$1$I$$20240718$20240724$20240724$EXP$$US-ABBVIE-5845894$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241341001$24134100$1$I$$20240722$20240724$20240724$EXP$$US-ABBVIE-5850151$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241341011$24134101$1$I$$20240715$20240724$20240724$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-114945$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240725$$MD$JP$JP
241341021$24134102$1$I$$20240718$20240724$20240724$EXP$$ZA-AMGEN-ZAFSP2024145553$AMGEN$$$$$$Y$$$20240724$$HP$ZA$ZA
241341041$24134104$1$I$$20240719$20240724$20240724$EXP$$US-BIOGEN-2024BI01274698$BIOGEN$$$$$F$Y$$$20240724$$CN$US$US
241341051$24134105$1$I$$20240716$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113473$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240725$$HP$US$US
241341062$24134106$2$F$20221201$20240912$20240724$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-025167$JAZZ$$19$YR$$F$Y$$$20240918$$CN$US$US
241341071$24134107$1$I$20240701$20240716$20240724$20240724$EXP$$US-BIOGEN-2024BI01274150$BIOGEN$$69$YR$$F$Y$$$20240724$$CN$US$US
241341081$24134108$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151965$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241341091$24134109$1$I$20240615$20240717$20240724$20240724$EXP$$US-ABBVIE-5848428$ABBVIE$$97$YR$$$Y$$$20240724$$CN$US$US
241341101$24134110$1$I$20240201$20240717$20240724$20240724$EXP$$US-ABBVIE-5666013$ABBVIE$$69$YR$$M$Y$$$20240724$$CN$US$US
241341111$24134111$1$I$$20240717$20240724$20240724$EXP$$US-ABBVIE-5846983$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241341121$24134112$1$I$20240101$20240718$20240724$20240724$EXP$$US-ABBVIE-5846658$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241341131$24134113$1$I$20230127$20240722$20240724$20240724$EXP$$CA-ABBVIE-5850417$ABBVIE$$75$YR$$M$Y$$$20240724$$MD$CA$CA
241341141$24134114$1$I$20240101$20240719$20240724$20240724$EXP$$US-JNJFOC-20240678978$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240725$$CN$US$US
241341152$24134115$2$F$$20240729$20240724$20240730$EXP$$NVSJ2024JP008936$NOVARTIS$$95$YR$$F$Y$$$20240731$$PH$JP$JP
241341161$24134116$1$I$20240101$20240722$20240724$20240724$EXP$$GR-ABBVIE-5850343$ABBVIE$$86$YR$$M$Y$$$20240724$$CN$GR$GR
241341172$24134117$2$F$$20240828$20240724$20240904$30DAY$$GB-JNJFOC-20240746805$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$GB$GB
241341182$24134118$2$F$20240501$20240828$20240724$20240903$PER$$US-JNJFOC-20240765185$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240903$$PH$US$US
241341191$24134119$1$I$$20240718$20240724$20240724$EXP$$US-JNJFOC-20240751859$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240725$$HP$US$US
241341202$24134120$2$F$20230201$20240725$20240724$20240730$EXP$$US-ABBVIE-5846618$ABBVIE$$67$YR$$F$Y$76.203$KG$20240730$$CN$US$US
241341211$24134121$1$I$20240101$20240722$20240724$20240724$EXP$$US-ABBVIE-5850765$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241341222$24134122$2$F$$20240910$20240724$20240923$EXP$$JP-AMGEN-JPNSP2024146587$AMGEN$$$$$$Y$$$20240922$$MD$JP$JP
241341231$24134123$1$I$20240501$20240718$20240724$20240724$EXP$FR-AFSSAPS-LY2024000936$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-115442$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$86$KG$20240725$$PH$FR$FR
241341241$24134124$1$I$20240101$20240722$20240724$20240724$EXP$$US-ABBVIE-5850699$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241341252$24134125$2$F$20240708$20240726$20240724$20240730$PER$$US-AMGEN-USASP2024145909$AMGEN$$65$YR$E$F$Y$$$20240730$$CN$US$US
241341261$24134126$1$I$20230101$20240722$20240724$20240724$EXP$$US-ABBVIE-5850396$ABBVIE$$$$$F$Y$$$20240724$$HP$US$US
241341271$24134127$1$I$$20240724$20240724$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041821$BOEHRINGER INGELHEIM$$$$$$Y$$$20240725$$CN$US$US
241341282$24134128$2$F$20240101$20240722$20240724$20240726$EXP$$US-SANDOZ INC.-SDZ2024US067765$SANDOZ$$$$$F$Y$$$20240726$$CN$US$US
241341291$24134129$1$I$20240401$20240714$20240724$20240724$EXP$$PT-JNJFOC-20240752272$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240725$$MD$PT$PT
241341301$24134130$1$I$$20240718$20240724$20240724$EXP$$US-ABBVIE-5845895$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241341312$24134131$2$F$20230701$20240822$20240724$20240828$EXP$$DE-ABBVIE-5848639$ABBVIE$$59$YR$$M$Y$$$20240828$$MD$DE$DE
241341321$24134132$1$I$20240101$20240719$20240724$20240724$EXP$$US-ABBVIE-5847564$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241341331$24134133$1$I$20240101$20240722$20240724$20240724$EXP$$US-ABBVIE-5849927$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241341341$24134134$1$I$$20240723$20240724$20240724$EXP$$US-ABBVIE-5851595$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241341351$24134135$1$I$20240722$20240722$20240724$20240724$EXP$$FR-ABBVIE-5850623$ABBVIE$$77$YR$$F$Y$$$20240724$$HP$FR$FR
241341361$24134136$1$I$$20240723$20240724$20240724$EXP$$PH-HALEON-2188482$Haleon PLC$$$$$$Y$$$20240724$$CN$PH$PH
241341372$24134137$2$F$20240601$20240726$20240724$20240729$EXP$$NVSJ2024JP008976$NOVARTIS$$82$YR$$M$Y$$$20240730$$MD$JP$JP
241341381$24134138$1$I$$20240719$20240724$20240724$PER$$US-SA-2024SA214165$SANOFI AVENTIS$$$$$M$Y$$$20240725$$CN$US$US
241341391$24134139$1$I$$20240720$20240724$20240724$PER$$US-JNJFOC-20240755618$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$MD$US$US
241341401$24134140$1$I$$20240717$20240724$20240724$EXP$$JP-JNJFOC-20240763373$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240725$$MD$JP$JP
241341411$24134141$1$I$$20240723$20240724$20240724$PER$$NVSC2024US151991$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241341421$24134142$1$I$20240719$20240720$20240724$20240724$EXP$$CN-HALEON-2188111$Haleon PLC$$22$YR$$F$Y$62$KG$20240724$$HP$CN$CN
241341432$24134143$2$F$$20240821$20240724$20240903$30DAY$$US-JNJFOC-20240748233$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
241341442$24134144$2$F$20240616$20240729$20240724$20240809$EXP$$JP-AMGEN-JPNSP2024130728$AMGEN$$85$YR$E$F$Y$$$20240809$$PH$JP$JP
241341452$24134145$2$F$$20240725$20240724$20240805$EXP$$JP-AMGEN-JPNSP2024144730$AMGEN$$82$YR$E$M$Y$$$20240805$$PH$JP$JP
241341461$24134146$1$I$$20240719$20240724$20240724$EXP$$AU-HALEON-2188581$Haleon PLC$$80$YR$$F$Y$$$20240724$$HP$AU$AU
241341471$24134147$1$I$$20240717$20240724$20240724$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-117682$BRISTOL MYERS SQUIBB$Ricard L, Cervera P, Stocker N, Corre E, Van de Wyngaert Z, Banet A, et al. A combination of 5-azacytidine and nivolumab is a potentially effective rescue therapy in relapsed/refractory AITL. Frontiers In Immunology. 2024 Jun 25;15:1-7.doi:10.3389/fimmu.2024.1410638.$56$YR$A$M$Y$$$20240725$$HP$FR$FR
241341481$24134148$1$I$$20240717$20240724$20240724$PER$$US-BIOGEN-2024BI01274480$BIOGEN$$$$$M$Y$$$20240724$$CN$US$US
241341502$24134150$2$F$$20240722$20240724$20240726$PER$$NVSC2024US151926$NOVARTIS$$$$$M$Y$$$20240726$$HP$US$US
241341511$24134151$1$I$$20240712$20240724$20240724$EXP$$US-RDY-LIT/USA/24/0010631$DR REDDYS$Noe G, Shah K, Cinderella M, Munjal S. Multiple Medication Use Resulting in Serotonin Syndrome with Deprescribing Resulting in Acute Dystonia. Journal of Clinical Psychopharmacology. 2024;44(3): 326-328. doi:10.1097/JCP.0000000000001831.$42$YR$A$F$Y$$$20240725$$HP$US$US
241341521$24134152$1$I$$20240718$20240724$20240724$EXP$BE-FAMHP-DHH-N2024-122325$BE-HALEON-2188519$Haleon PLC$$$$$F$Y$$$20240724$$PH$BE$BE
241341531$24134153$1$I$$20240712$20240724$20240724$EXP$$US-RDY-LIT/USA/24/0010633$DR REDDYS$Sanjeevi A, Clark BL, Aguirre A, Verghes BG. Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature. Clinical Immunology Communications. 2024;6: 1-4. doi:10.1016/j.clicom.2024.06.002.$65$YR$E$F$Y$$$20240725$$HP$US$US
241341541$24134154$1$I$$20240723$20240724$20240724$EXP$$BE-SANDOZ INC.-SDZ2024BE067582$SANDOZ$$15$YR$$F$Y$57$KG$20240724$$HP$BE$BE
241341551$24134155$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117290$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240725$$HP$US$US
241341562$24134156$2$F$$20240730$20240724$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117299$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240731$$HP$US$US
241341571$24134157$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117171$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240725$$CN$US$US
241341581$24134158$1$I$$20240723$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117357$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240725$$CN$US$US
241341591$24134159$1$I$20240701$20240717$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114195$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240725$$PH$US$US
241341601$24134160$1$I$$20240722$20240724$20240724$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117877$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240725$$CN$US$US
241341611$24134161$1$I$$20240711$20240724$20240724$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202407-000893$UNICHEM$$18$YR$A$F$Y$$$20240725$$HP$US$
241341621$24134162$1$I$$20240715$20240724$20240724$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202407-000907$UNICHEM$$12$YR$T$F$Y$63$KG$20240725$$$COUNTRY NOT SPECIFIED$
241341631$24134163$1$I$$20240712$20240724$20240724$EXP$$EG-Unichem Pharmaceuticals (USA) Inc-UCM202407-000895$UNICHEM$$58$YR$A$M$Y$$$20240725$$HP$EG$
241341651$24134165$1$I$$20240715$20240724$20240724$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202407-000908$UNICHEM$$14$YR$T$F$Y$129$KG$20240725$$$COUNTRY NOT SPECIFIED$
241341661$24134166$1$I$$20240715$20240724$20240724$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202407-000909$UNICHEM$$15$YR$T$F$Y$49$KG$20240725$$$COUNTRY NOT SPECIFIED$
241341671$24134167$1$I$20201030$20240718$20240724$20240724$EXP$$PL-HALEON-2185791$Haleon PLC$$96$YR$$F$Y$45$KG$20240724$$MD$PL$PL
241341681$24134168$1$I$$20240722$20240724$20240724$EXP$$AU-PFIZER INC-202400221615$PFIZER$$65$YR$$M$Y$$$20240724$$MD$AU$AU
241341691$24134169$1$I$$20240717$20240724$20240724$EXP$$US-BIOGEN-2024BI01274477$BIOGEN$$$$$F$Y$$$20240724$$HP$US$US
241341711$24134171$1$I$20220810$20240718$20240724$20240724$EXP$$GB-BIOGEN-2024BI01274684$BIOGEN$$$$$F$Y$$$20240724$$CN$GB$GB
241341722$24134172$2$F$$20240906$20240724$20240909$EXP$$JP-TAKEDA-2024TJP010975$TAKEDA$$3$DEC$$F$Y$$$20240909$$MD$JP$JP
241341732$24134173$2$F$20240701$20240724$20240724$20240729$EXP$$US-ABBVIE-5842186$ABBVIE$$78$YR$$M$Y$66$KG$20240729$$CN$US$US
241341741$24134174$1$I$20240707$20240718$20240724$20240724$EXP$$US-ASTELLAS-2024US019571$ASTELLAS$$86$YR$$F$Y$$$20240725$$CN$US$US
241341751$24134175$1$I$$20240717$20240724$20240724$EXP$$CO-ASTELLAS-2024US020804$ASTELLAS$$$$$M$Y$$$20240725$$CN$CO$CO
241341762$24134176$2$F$20230101$20240915$20240724$20240916$EXP$$CA-PFIZER INC-202300269168$PFIZER$$55$YR$$M$Y$$$20240916$$HP$CA$CA
241341772$24134177$2$F$$20240902$20240724$20240904$EXP$$JP-TAKEDA-2024TJP011003$TAKEDA$$40$YR$$M$Y$$$20240904$$MD$JP$JP
241341781$24134178$1$I$$20240717$20240724$20240724$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-117687$BRISTOL MYERS SQUIBB$Ricard L, Cervera P, Stocker N, Corre E, Van de Wyngaert Z, Banet A, et al. A combination of 5-azacytidine and nivolumab is a potentially effective rescue therapy in relapsed/refractory AITL. Frontiers In Immunology. 2024 Jun 25;15:1-7.doi:10.3389/fimmu.2024.1410638.$52$YR$A$M$Y$$$20240725$$HP$FR$FR
241341791$24134179$1$I$$20240716$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113220$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240725$$HP$US$US
241341801$24134180$1$I$$20240717$20240724$20240724$EXP$$JP-ASTELLAS-2024JP005213$ASTELLAS$Seki M, Sato N, Ohnuki T, Kobayashi M, Kuwahara A,Yoshimori E,et al.. A case of Ph-positive ALL who developed chronic inflammatory demyelinating polyradiculoneuropathy 9 months after allogeneic transplant. The 46th Annual Meeting of the Japanese Society for Transplantation and Cellular. 2024;O52-4$64$YR$$M$Y$$$20240725$$MD$JP$JP
241341813$24134181$3$F$20240701$20240802$20240724$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117317$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240807$$CN$US$US
241341831$24134183$1$I$$20240716$20240724$20240724$PER$$US-SA-2023SA006683$SANOFI AVENTIS$$86$YR$E$M$Y$78.4$KG$20240725$$MD$US$US
241341841$24134184$1$I$20240101$20240716$20240724$20240724$EXP$$US-ABBVIE-5845802$ABBVIE$$$$$M$Y$82$KG$20240724$$CN$US$US
241341851$24134185$1$I$$20240715$20240724$20240724$EXP$$CA-HALEON-2187960$Haleon PLC$$43$YR$$F$Y$96$KG$20240724$$HP$CA$CA
241341861$24134186$1$I$$20240724$20240724$20240724$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041800$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240725$$HP$US$US
241341872$24134187$2$F$20240503$20240729$20240724$20240806$30DAY$$US-AMGEN-USASP2024143412$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241341884$24134188$4$F$$20240906$20240724$20240911$PER$$NVSC2024US151016$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
241341891$24134189$1$I$$20240723$20240724$20240724$PER$$US-TAKEDA-2024TUS074419$TAKEDA$$$$$M$Y$86$KG$20240724$$MD$US$US
241341901$24134190$1$I$20240701$20240718$20240724$20240724$EXP$$CH-ABBVIE-5847827$ABBVIE$$73$YR$$F$Y$$$20240724$$MD$CH$CH
241341911$24134191$1$I$20240626$20240722$20240724$20240724$EXP$FR-AFSSAPS-GR2024000914$FR-ABBVIE-5849628$ABBVIE$$71$YR$$M$Y$61$KG$20240724$$PH$FR$FR
241341921$24134192$1$I$20240101$20240722$20240724$20240724$EXP$$DE-ABBVIE-5850437$ABBVIE$$$$$M$Y$$$20240724$$CN$DE$DE
241341931$24134193$1$I$20240715$20240722$20240724$20240724$EXP$$US-ABBVIE-5850590$ABBVIE$$25$YR$$M$Y$$$20240724$$CN$US$US
241341941$24134194$1$I$$20240723$20240724$20240724$EXP$$CA-ABBVIE-5851614$ABBVIE$$$$E$M$Y$$$20240724$$CN$CA$CA
241341951$24134195$1$I$$20240514$20240724$20240724$EXP$$CA-HALEON-2176008$Haleon PLC$$69$YR$$M$Y$$$20240724$$HP$CA$CA
241341961$24134196$1$I$$20240718$20240724$20240724$EXP$$US-TAKEDA-2024TUS074276$TAKEDA$$$$$M$Y$$$20240724$$CN$US$US
241341971$24134197$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA211938$SANOFI AVENTIS$$$$$F$Y$$$20240725$$MD$US$US
241341981$24134198$1$I$20240101$20240717$20240724$20240724$PER$$US-SA-2024SA212137$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240725$$MD$US$US
241341992$24134199$2$F$$20240822$20240724$20240828$EXP$$JP-GSK-JP2024JPN090875$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$PH$JP$JP
241342001$24134200$1$I$$20240717$20240724$20240724$PER$$US-ABBVIE-5846821$ABBVIE$$$$$$Y$$$20240724$$MD$US$US
241342011$24134201$1$I$$20240717$20240724$20240724$PER$$US-ABBVIE-5844236$ABBVIE$$$$$$Y$$$20240724$$CN$US$US
241342021$24134202$1$I$20240701$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024145079$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241342031$24134203$1$I$$20240715$20240724$20240724$PER$$JP-Eisai-EC-2024-170389$EISAI$$63$YR$A$F$Y$$$20240725$$MD$JP$JP
241342042$24134204$2$F$20240712$20240813$20240724$20240813$EXP$$US-ALXN-202407USA001247US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
241342051$24134205$1$I$20240101$20240719$20240724$20240724$EXP$$US-ABBVIE-5848842$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241342062$24134206$2$F$20240101$20240722$20240724$20240729$EXP$$CA-ABBVIE-5847635$ABBVIE$$54$YR$$M$Y$$$20240729$$CN$CA$CA
241342071$24134207$1$I$20190101$20240719$20240724$20240724$EXP$$US-ABBVIE-5847902$ABBVIE$$63$YR$$F$Y$$$20240724$$CN$US$US
241342082$24134208$2$F$20201003$20240822$20240724$20240828$EXP$$JP-GSK-JP2024JPN010906$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$JP$JP
241342091$24134209$1$I$$20240719$20240724$20240724$EXP$$US-ABBVIE-5849720$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241342101$24134210$1$I$20240101$20240723$20240724$20240724$EXP$$US-ABBVIE-5851353$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241342111$24134211$1$I$$20240722$20240724$20240724$EXP$$US-ABBVIE-5850381$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241342124$24134212$4$F$20240101$20240912$20240724$20240918$PER$$US-AMGEN-USASP2024144366$AMGEN$$64$YR$A$M$Y$$$20240918$$HP$US$US
241342131$24134213$1$I$20240101$20240719$20240724$20240724$EXP$$US-JNJFOC-20240669783$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240725$$CN$US$US
241342141$24134214$1$I$20060815$20240702$20240724$20240724$EXP$$ES-HALEON-PHBS2006ES15606$Haleon PLC$$34$YR$$M$Y$70$KG$20240724$$HP$ES$ES
241342162$24134216$2$F$20190308$20240815$20240724$20240820$EXP$$CA-TAKEDA-2019TUS033916$TAKEDA$$68$YR$$F$Y$$$20240820$$CN$CA$CA
241342171$24134217$1$I$20240610$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115973$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$48.08$KG$20240725$$CN$US$US
241342182$24134218$2$F$20240715$20240816$20240724$20240821$EXP$$TR-ABBVIE-5846266$ABBVIE$$78$YR$$F$Y$70$KG$20240821$$CN$TR$TR
241342191$24134219$1$I$$20240724$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117898$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240725$$CN$US$US
241342203$24134220$3$F$20240701$20240920$20240724$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115317$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240924$$CN$US$US
241342211$24134221$1$I$20240101$20240719$20240724$20240724$EXP$$CA-ABBVIE-5850511$ABBVIE$$75$YR$$M$Y$$$20240724$$HP$CA$CA
241342221$24134222$1$I$$20240717$20240724$20240724$PER$$US-ALXN-202407USA001297US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241342231$24134223$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA212482$SANOFI AVENTIS$$$$$$Y$$$20240725$$MD$US$US
241342241$24134224$1$I$$20240716$20240724$20240724$PER$$US-SA-2024SA213393$SANOFI AVENTIS$$$$A$F$Y$90.71$KG$20240725$$MD$US$US
241342251$24134225$1$I$20240101$20240718$20240724$20240724$PER$$US-AMGEN-USASP2024144483$AMGEN$$37$YR$A$F$Y$$$20240724$$HP$US$US
241342261$24134226$1$I$20240101$20240718$20240724$20240724$EXP$$US-ABBVIE-5846037$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241342271$24134227$1$I$20240101$20240711$20240724$20240724$EXP$$US-ABBVIE-5838950$ABBVIE$$$$$M$Y$$$20240724$$CN$US$US
241342285$24134228$5$F$20240101$20240905$20240724$20240918$EXP$$US-ABBVIE-5658877$ABBVIE$$$$$F$Y$58.966$KG$20240918$$CN$US$US
241342291$24134229$1$I$$20240718$20240724$20240724$EXP$BE-FAMHP-DHH-N2024-122326$BE-HALEON-2188521$Haleon PLC$$$$$M$Y$$$20240724$$PH$BE$BE
241342301$24134230$1$I$20240624$20240717$20240724$20240724$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040432$BOEHRINGER INGELHEIM$$16$YR$T$F$Y$50$KG$20240725$$HP$FR$FR
241342311$24134231$1$I$20240722$20240723$20240724$20240724$EXP$$CH-ABBVIE-5851804$ABBVIE$$85$YR$$M$Y$$$20240724$$CN$CH$CH
241342322$24134232$2$F$20230101$20240821$20240724$20240828$EXP$$JP-009507513-2305JPN000869J$MERCK$$52$YR$$F$Y$$$20240828$$MD$JP$JP
241342331$24134233$1$I$$20240718$20240724$20240724$EXP$$ES-ABBVIE-5846258$ABBVIE$$$$$F$Y$$$20240724$$HP$ES$ES
241342341$24134234$1$I$20240101$20240722$20240724$20240724$PER$$US-ABBVIE-5851976$ABBVIE$$$$T$M$Y$$$20240724$$CN$US$US
241342351$24134235$1$I$20240719$20240719$20240724$20240724$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115709$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$68.9$KG$20240725$$PH$US$US
241342372$24134237$2$F$20190101$20240730$20240724$20240807$EXP$$US-ABBVIE-5848519$ABBVIE$$$$$F$Y$80.286$KG$20240807$$CN$US$US
241342382$24134238$2$F$$20240812$20240724$20240813$PER$$NVSC2024US152048$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
241342391$24134239$1$I$20230601$20240717$20240724$20240724$EXP$$US-ABBVIE-5845713$ABBVIE$$51$YR$$F$Y$$$20240724$$CN$US$US
241342402$24134240$2$F$$20240802$20240724$20240807$PER$$NVSC2024US150880$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
241342411$24134241$1$I$$20240715$20240724$20240724$EXP$$US-AMGEN-USASP2024141780$AMGEN$Avery R. A. Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor. Cancer. 1996;78(1):128-132$24$YR$A$M$Y$$$20240724$$MD$US$US
241342421$24134242$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA213785$SANOFI AVENTIS$$74$YR$E$F$Y$90.71$KG$20240725$$MD$US$US
241342431$24134243$1$I$20230101$20240719$20240724$20240724$EXP$$GR-ABBVIE-5849305$ABBVIE$$$$$M$Y$85$KG$20240724$$CN$GR$GR
241342451$24134245$1$I$$20240718$20240724$20240724$PER$$US-SA-2024SA214450$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240725$$MD$US$US
241342461$24134246$1$I$20240719$20240722$20240724$20240724$EXP$$US-ABBVIE-5851349$ABBVIE$$79$YR$$F$Y$$$20240724$$CN$US$US
241342471$24134247$1$I$20240101$20240716$20240724$20240724$EXP$$US-ABBVIE-5845262$ABBVIE$$$$$F$Y$$$20240724$$CN$US$US
241342491$24134249$1$I$$20240717$20240724$20240724$PER$$US-SA-2024SA214020$SANOFI AVENTIS$$$$A$M$Y$$$20240725$$MD$US$US
241342501$24134250$1$I$20240701$20240716$20240724$20240724$PER$$US-SA-2024SA213653$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240725$$MD$US$US
241342512$24134251$2$F$20200101$20240725$20240724$20240730$EXP$$US-ABBVIE-5850631$ABBVIE$$$$$F$Y$79.379$KG$20240730$$CN$US$US
241342521$24134252$1$I$20240118$20240723$20240724$20240724$EXP$FR-AFSSAPS-DJ2024000846$FR-SANDOZ INC.-SDZ2024FR067656$SANDOZ$$44$YR$$F$Y$63$KG$20240724$$MD$FR$FR
241342532$24134253$2$F$$20240820$20240724$20240823$EXP$$DE-ABBVIE-5850566$ABBVIE$$$$$F$Y$$$20240823$$PH$DE$DE
241342542$24134254$2$F$20240521$20240802$20240724$20240807$EXP$$US-009507513-2407USA011981$MERCK$$78$YR$$M$Y$$$20240807$$HP$US$US
241342553$24134255$3$F$20240709$20240716$20240724$20240913$EXP$$DE-BEH-2024175931$CSL BEHRING$$85$YR$E$M$Y$68$KG$20240913$$HP$DE$DE
241342562$24134256$2$F$20240701$20240724$20240724$20240728$EXP$$GR-ABBVIE-5845638$ABBVIE$$84$YR$$F$Y$$$20240728$$CN$GR$GR
241342572$24134257$2$F$20240501$20240815$20240724$20240820$EXP$$US-ABBVIE-5813658$ABBVIE$$65$YR$$F$Y$77.11$KG$20240820$$CN$US$US
241342581$24134258$1$I$20240101$20240711$20240724$20240724$EXP$$US-ETON PHARMACEUTICALS, INC-2024ETO000157$ETON PHARMACEUTICALS$$$$$$Y$$$20240724$$CN$US$US
241342591$24134259$1$I$20240701$20240717$20240724$20240724$EXP$$US-ABBVIE-5846476$ABBVIE$$51$YR$$F$Y$$$20240724$$CN$US$US
241342602$24134260$2$F$$20240813$20240725$20240813$PER$$US-ALXN-202407USA001285US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241342612$24134261$2$F$20240715$20240725$20240725$20240801$PER$$US-ALXN-202407USA001274US$ALEXION PHARMACEUTICALS$$41$YR$$F$Y$$$20240801$$CN$US$US
241342621$24134262$1$I$$20240715$20240725$20240725$EXP$$CA-NOVITIUMPHARMA-2024CANVP01319$NOVITIUM PHARMA$Julie Herrington.Asymptomatic intraspinal epidermoid cyst in a 7-year-old male with juvenile idiopathic arthritis identified by an advanced physiotherapist practitioner: a case report.Journal of Manual + Manipulative Therapy .02-APR-2024;32(3):343-351$7$YR$C$M$Y$$$20240725$$HP$CA$CA
241342631$24134263$1$I$$20240718$20240725$20240725$EXP$$BR-AstraZeneca-2024A166839$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$BR$
241342641$24134264$1$I$20240713$20240719$20240725$20240725$EXP$$US-ABBVIE-5847189$ABBVIE$$74$YR$$F$Y$$$20240725$$CN$US$US
241342651$24134265$1$I$$20240723$20240725$20240725$EXP$$US-ABBVIE-5851400$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241342661$24134266$1$I$$20240719$20240725$20240725$PER$$US-ABBVIE-5847258$ABBVIE$$76$YR$$F$Y$$$20240725$$CN$US$US
241342672$24134267$2$F$$20240715$20240725$20240729$PER$$US-AMGEN-USASP2024145456$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241342681$24134268$1$I$20240402$20240723$20240725$20240725$EXP$$US-ABBVIE-5851744$ABBVIE$$64$YR$$F$Y$$$20240725$$CN$US$US
241342691$24134269$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5850598$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241342701$24134270$1$I$$20240722$20240725$20240725$EXP$$NVSC2024FR151871$NOVARTIS$$62$YR$$F$Y$$$20240725$$MD$FR$FR
241342711$24134271$1$I$$20240718$20240725$20240725$EXP$$US-ABBVIE-5847883$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241342723$24134272$3$F$20240701$20240815$20240725$20240822$EXP$$FR-AMGEN-FRASP2024144089$AMGEN$$86$YR$E$M$Y$$$20240822$$MD$FR$FR
241342733$24134273$3$F$20240705$20240920$20240725$20240928$EXP$$PT-AMGEN-PRTSP2024142603$AMGEN$$72$YR$E$F$Y$38.6$KG$20240928$$PH$PT$PT
241342741$24134274$1$I$$20240716$20240725$20240725$EXP$$US-SANDOZ INC.-SDZ2024US067930$SANDOZ$$74$YR$$F$Y$$$20240725$$CN$US$US
241342751$24134275$1$I$$20240717$20240725$20240725$PER$$US-ABBVIE-5844887$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241342761$24134276$1$I$20220622$20240718$20240725$20240725$EXP$$CA-TAKEDA-2022TUS045869$TAKEDA$$35$YR$$M$Y$$$20240725$$CN$CA$CA
241342771$24134277$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5341762$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241342783$24134278$3$F$$20240828$20240725$20240903$PER$$US-ALXN-202407USA001259US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
241342791$24134279$1$I$$20240715$20240725$20240725$EXP$$ES-TEVA-VS-3223969$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$64$YR$$M$Y$$$20240725$$HP$ES$ES
241342811$24134281$1$I$$20240716$20240725$20240725$EXP$$CA-APOTEX-2024AP008513$APOTEX$$73$YR$$F$Y$45$KG$20240725$$MD$CA$CA
241342821$24134282$1$I$$20240718$20240725$20240725$PER$$US-JNJFOC-20240750302$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240725$$CN$US$US
241342833$24134283$3$F$$20240925$20240725$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-117693$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240926$$PH$JP$JP
241342841$24134284$1$I$20240715$20240717$20240725$20240725$PER$$US-AMGEN-USASP2024145896$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
241342852$24134285$2$F$20240718$20240917$20240725$20240919$EXP$$JP-TAKEDA-2024TJP011081$TAKEDA$$3$YR$$F$Y$$$20240919$$MD$JP$JP
241342862$24134286$2$F$$20240808$20240725$20240812$EXP$$US-ABBVIE-5802759$ABBVIE$$$$$F$Y$66$KG$20240812$$CN$US$US
241342872$24134287$2$F$$20240718$20240725$20240726$PER$$US-ALXN-202407USA001180US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240726$$HP$US$US
241342881$24134288$1$I$20240201$20240719$20240725$20240725$EXP$$US-ABBVIE-5847754$ABBVIE$$58$YR$$M$Y$$$20240725$$CN$US$US
241342892$24134289$2$F$20240716$20240813$20240725$20240813$PER$$US-ALXN-202407USA001184US$ALEXION PHARMACEUTICALS$$48$YR$$F$Y$$$20240813$$CN$US$US
241342901$24134290$1$I$$20240718$20240725$20240725$EXP$$CA-AMGEN-CANSL2024144145$AMGEN$$71$YR$E$F$Y$$$20240724$$CN$CA$CA
241342911$24134291$1$I$$20240723$20240725$20240725$EXP$$US-ABBVIE-5851291$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241342933$24134293$3$F$20240711$20240805$20240725$20240809$30DAY$$US-AMGEN-USASP2024144410$AMGEN$$66$YR$E$M$Y$87$KG$20240809$$PH$US$US
241342942$24134294$2$F$20240714$20240822$20240725$20240824$EXP$$CA-ABBVIE-5851615$ABBVIE$$69$YR$$F$Y$$$20240824$$CN$CA$CA
241342954$24134295$4$F$20240713$20240919$20240725$20240925$PER$$US-JNJFOC-20240753470$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240925$$CN$US$US
241342963$24134296$3$F$20240526$20240818$20240725$20240823$EXP$$US-JNJFOC-20240751564$JOHNSON AND JOHNSON$$49$YR$A$F$Y$93.978$KG$20240823$$HP$US$US
241342971$24134297$1$I$$20240717$20240725$20240725$PER$$US-TAKEDA-2024TUS072603$TAKEDA$$$$$F$Y$46.712$KG$20240725$$CN$US$US
241342981$24134298$1$I$20240720$20240723$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117753$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240725$$CN$US$US
241342991$24134299$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117352$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240725$$HP$US$US
241343001$24134300$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116782$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240725$$CN$US$US
241343011$24134301$1$I$20240406$20240718$20240725$20240725$EXP$$GB-CHATTEMPRD-2024OHG024656$CHATTEM$$67$YR$E$F$Y$68$KG$20240725$$MD$GB$GB
241343022$24134302$2$F$20231201$20240724$20240725$20240802$PER$$US-SA-2024SA213770$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240802$$MD$US$US
241343031$24134303$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA213011$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240725$$MD$US$US
241343041$24134304$1$I$$20240719$20240725$20240725$PER$$US-SA-2024SA214488$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240725$$CN$US$US
241343051$24134305$1$I$$20240718$20240725$20240725$EXP$$US-ABBVIE-5841222$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241343061$24134306$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015634$ELI LILLY AND CO$$50$YR$A$$Y$$$20240725$$CN$US$US
241343071$24134307$1$I$20240722$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145900$AMGEN$$60$YR$A$F$Y$$$20240724$$PH$US$US
241343081$24134308$1$I$$20240717$20240725$20240725$EXP$$US-TAKEDA-2024TUS073301$TAKEDA$$$$$F$Y$$$20240725$$CN$US$US
241343091$24134309$1$I$20240601$20240716$20240725$20240725$EXP$$CA-APOTEX-2024AP008584$APOTEX$$74$YR$E$M$Y$$$20240725$$HP$CA$CA
241343101$24134310$1$I$$20240721$20240725$20240725$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011129$JAZZ$$$$$F$Y$$$20240724$$CN$US$US
241343111$24134311$1$I$$20240719$20240725$20240725$PER$$US-ABBVIE-5849216$ABBVIE$$$$$$Y$$$20240725$$MD$US$US
241343121$24134312$1$I$$20240722$20240725$20240725$EXP$$AR-BEIGENE-BGN-2024-011481$BEIGENE$$$$$$Y$$$20240725$$MD$AR$AR
241343132$24134313$2$F$$20240815$20240725$20240821$PER$$US-ABBVIE-5848943$ABBVIE$$$$$F$Y$$$20240821$$MD$US$US
241343142$24134314$2$F$$20240722$20240725$20240729$PER$$US-ALXN-202407USA001171US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240729$$HP$US$US
241343153$24134315$3$F$$20240821$20240725$20240822$PER$$NVSC2024US152123$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
241343161$24134316$1$I$$20240710$20240725$20240725$EXP$$US-IBSA PHARMA INC.-2024IBS000319$IBSA INSTITUT BIOCHIMIQUE$$$$$$Y$$$20240724$$CN$US$US
241343171$24134317$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116586$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$56.7$KG$20240725$$CN$US$US
241343181$24134318$1$I$$20240723$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117330$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$88$KG$20240725$$CN$US$US
241343191$24134319$1$I$20240717$20240717$20240725$20240725$PER$$US-SA-2024SA212503$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240725$$MD$US$US
241343202$24134320$2$F$$20240808$20240725$20240812$EXP$$NVSJ2024JP008990$NOVARTIS$$$$A$F$Y$$$20240813$$MD$JP$JP
241343211$24134321$1$I$20240601$20240720$20240725$20240725$EXP$$US-ABBVIE-5850440$ABBVIE$$65$YR$$F$Y$$$20240725$$CN$US$US
241343221$24134322$1$I$20240101$20240718$20240725$20240725$EXP$$US-ABBVIE-5845873$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241343233$24134323$3$F$$20240905$20240725$20240911$EXP$$US-TAKEDA-2024TUS074120$TAKEDA$$$$$M$Y$65$KG$20240911$$CN$US$US
241343241$24134324$1$I$20230101$20240717$20240725$20240725$EXP$$US-ABBVIE-4769850$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241343251$24134325$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152111$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241343261$24134326$1$I$20231201$20240717$20240725$20240725$EXP$$US-ABBVIE-5781315$ABBVIE$$52$YR$$F$Y$$$20240725$$CN$US$US
241343271$24134327$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA214487$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240725$$MD$US$US
241343282$24134328$2$F$20240401$20240717$20240725$20240802$30DAY$$US-JNJFOC-20240750513$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240802$$CN$US$US
241343291$24134329$1$I$20240101$20240719$20240725$20240725$EXP$$US-JNJFOC-20240756630$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240725$$HP$US$US
241343301$24134330$1$I$20240710$20240711$20240725$20240725$30DAY$$US-JNJFOC-20240731157$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$HP$US$US
241343311$24134331$1$I$20240101$20240718$20240725$20240725$EXP$$US-ABBVIE-5847577$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241343321$24134332$1$I$20240627$20240716$20240725$20240725$EXP$$IE-ABBVIE-5849492$ABBVIE$$76$YR$$M$Y$$$20240725$$HP$IE$IE
241343332$24134333$2$F$$20240717$20240725$20240727$EXP$$CA-CELLTRION INC.-2024CA017745$CELLTRION$$$$$$Y$$$20240727$$HP$CA$CA
241343341$24134334$1$I$$20240722$20240725$20240725$EXP$$SE-ABBVIE-5850351$ABBVIE$$$$$M$Y$$$20240725$$CN$SE$SE
241343351$24134335$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152135$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241343361$24134336$1$I$19660101$20240719$20240725$20240725$EXP$$US-CHATTEMPRD-2024OHG024817$CHATTEM$$$$A$F$Y$$$20240725$$LW$US$US
241343372$24134337$2$F$20240701$20240801$20240725$20240806$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011115$JAZZ$$8$YR$$F$Y$$$20240806$$HP$US$US
241343391$24134339$1$I$$20240716$20240725$20240725$PER$$US-APOTEX-2024AP008627$APOTEX$Frankel ES, Hajduczok AG, Rajapreyar IN, Brailovsky Y.. Recurrent giant cell myocarditis after heart transplant: a case report. European Heart Journal - Case Reports. 2022;6 (9):1-5$33$YR$$M$Y$$$20240725$$MD$US$US
241343401$24134340$1$I$20240626$20240723$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117522$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240725$$CN$US$US
241343412$24134341$2$F$20231201$20240724$20240725$20240805$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-116385$BRISTOL MYERS SQUIBB$Zhou D, Tang S, Li J. Systemic lupus erythematosus complicated with mycobacterium leprae infection: a rare case report. Clinical Laboratory. 2024;70(7):1388-91. doi:10.7754/Clin.Lab.2024.240149.$42$YR$A$F$Y$$$20240805$$HP$CN$CN
241343422$24134342$2$F$$20240823$20240725$20240903$PER$$US-AstraZeneca-2024A166704$ASTRAZENECA$$$$$F$Y$$$20240903$$HP$US$
241343431$24134343$1$I$$20200213$20240725$20240725$EXP$$MX-AstraZeneca-2020SE23500$ASTRAZENECA$$73$YR$$M$Y$85$KG$20240725$$CN$MX$
241343441$24134344$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024142992$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241343452$24134345$2$F$20240701$20240723$20240725$20240801$PER$$US-AMGEN-USASP2024145884$AMGEN$$36$YR$A$F$Y$$$20240801$$HP$US$US
241343461$24134346$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214512$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240725$$MD$US$US
241343471$24134347$1$I$20240715$20240719$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407012957$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240725$$CN$US$US
241343481$24134348$1$I$20240701$20240722$20240725$20240725$EXP$$US-ABBVIE-5850484$ABBVIE$$58$YR$$F$Y$$$20240725$$CN$US$US
241343492$24134349$2$F$20240705$20240801$20240725$20240808$EXP$$TW-ABBVIE-5848461$ABBVIE$$59$YR$$F$Y$71$KG$20240808$$CN$TW$TW
241343501$24134350$1$I$$20230712$20240725$20240725$EXP$$US-CHATTEMPRD-2023OHG002828$CHATTEM$$$$$$Y$$$20240725$$CN$US$US
241343511$24134351$1$I$20240101$20240719$20240725$20240725$EXP$$US-ABBVIE-5848004$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241343521$24134352$1$I$$20240716$20240725$20240725$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009059$STRIDES$Wang Y, An Y, Hou X, Xu Y, Li Z, Liu X, et al.. Cushing^s Syndrome in Pregnancy Secondary to Adrenocortical Adenoma: A Case Series and Review.  ;. Endocrinol-Diabetes-Metab. 2024;7 (2):.$27$YR$$F$Y$$$20240725$$HP$CN$CN
241343531$24134353$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152128$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241343541$24134354$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024142993$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241343552$24134355$2$F$20240723$20240724$20240725$20240729$PER$$NVSC2024US151824$NOVARTIS$$63$YR$$F$Y$$$20240729$$CN$US$US
241343572$24134357$2$F$$20240821$20240725$20240830$30DAY$$US-GSK-US2024AMR089126$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
241343581$24134358$1$I$$20240716$20240725$20240725$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009060$STRIDES$Wang Y, An Y, Hou X, Xu Y, Li Z, Liu X, et al.. Cushing^s Syndrome in Pregnancy Secondary to Adrenocortical Adenoma: A Case Series and Review. ;. Endocrinol-Diabetes-Metab. 2024;7 (2):.$$$$$Y$$$20240725$$HP$CN$CN
241343592$24134359$2$F$20240719$20240726$20240725$20240731$EXP$$US-JNJFOC-20240760949$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240731$$HP$US$US
241343601$24134360$1$I$$20240715$20240725$20240725$EXP$$PT-TEVA-VS-3222026$TEVA$Literature Reference:  Veiga C, Anjo C, Albergaria I, Nunes A, Atan?sio G, Nascimento E. DERMATOMYOSITIS SAE1- A CASE REPORT.Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 990.$62$YR$$F$Y$$$20240725$$MD$PT$PT
241343611$24134361$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143001$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241343622$24134362$2$F$20240719$20240807$20240725$20240809$30DAY$$US-AMGEN-USASP2024143920$AMGEN$$56$YR$A$F$Y$138$KG$20240809$$PH$US$US
241343632$24134363$2$F$$20240717$20240725$20240730$PER$$US-ABBVIE-5846179$ABBVIE$$$$$F$Y$$$20240730$$HP$US$US
241343642$24134364$2$F$20240101$20240911$20240725$20240918$EXP$$US-ABBVIE-4719125$ABBVIE$$$$$F$Y$63$KG$20240918$$CN$US$US
241343651$24134365$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152080$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241343661$24134366$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146271$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241343671$24134367$1$I$$20240717$20240725$20240725$PER$$US-AMGEN-USASP2024144180$AMGEN$$$$$$Y$$$20240724$$MD$US$US
241343681$24134368$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143000$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241343691$24134369$1$I$20240701$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024145466$AMGEN$$76$YR$E$F$Y$$$20240724$$CN$US$US
241343703$24134370$3$F$20240717$20240730$20240725$20240813$30DAY$$US-AMGEN-USASP2024143799$AMGEN$$58$YR$A$F$Y$114.2$KG$20240812$$HP$US$US
241343711$24134371$1$I$20220201$20240715$20240725$20240725$EXP$$US-GSK-US2024088786$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240725$$CN$US$US
241343721$24134372$1$I$20180730$20240723$20240725$20240725$EXP$$FR-SANDOZ INC.-PHHY2018FR149268$SANDOZ$$67$YR$$M$Y$98$KG$20240725$$MD$FR$FR
241343731$24134373$1$I$20240705$20240712$20240725$20240725$PER$$US-ABBVIE-5846547$ABBVIE$$$$$F$Y$$$20240725$$MD$US$US
241343741$24134374$1$I$$20240719$20240725$20240725$EXP$$US-ABBVIE-5849683$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241343751$24134375$1$I$$20240717$20240725$20240725$PER$$US-ABBVIE-5845418$ABBVIE$$$$$$Y$$$20240725$$CN$US$US
241343761$24134376$1$I$20230201$20240715$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036515$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:1-6$55$YR$$M$Y$$$20240725$$HP$FR$FR
241343771$24134377$1$I$$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024145009$AMGEN$$$$$M$Y$$$20240724$$PH$US$US
241343781$24134378$1$I$20240101$20240723$20240725$20240725$EXP$$US-ABBVIE-5851282$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241343791$24134379$1$I$$20240715$20240725$20240725$EXP$$PL-AUROBINDO-AUR-APL-2024-036436$AUROBINDO$Siwek M, Chrobak AA, Gorostowicz A, Krol P, Dudek D. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain-Sci. 2023;13:No. 3$27$YR$$M$Y$$$20240725$$HP$PL$PL
241343801$24134380$1$I$$20240717$20240725$20240725$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP009135$STRIDES$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B.. Statins and immune-mediated necrotizing myopathy: Variability in the risk.. Therapie. 2024;79(3):365-370$81$YR$$M$Y$$$20240725$$HP$FR$FR
241343811$24134381$1$I$$20240715$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036147$AUROBINDO$Rodrigues M, Eberst L, Follana P, Gauthier L, Jacquemin V, Tessier C, et al. Real-world dostarlimab use in advanced/recurrent endometrial cancer in France. Bulletin Cancer. 2023;110(10):1041-1050$$$$F$Y$$$20240725$$HP$FR$FR
241343821$24134382$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024AMR091983$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241343832$24134383$2$F$20240720$20240813$20240725$20240817$PER$$US-AMGEN-USASP2024145462$AMGEN$$82$YR$E$F$Y$$$20240817$$CN$US$US
241343851$24134385$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024147035$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241343861$24134386$1$I$20240721$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145840$AMGEN$$53$YR$A$F$Y$$$20240724$$CN$US$US
241343871$24134387$1$I$20240719$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145677$AMGEN$$71$YR$E$$Y$$$20240724$$CN$US$US
241343891$24134389$1$I$$20240717$20240725$20240725$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP009140$STRIDES$Maheshwari MU, Shanmugasundaram N, Sankar K, Sekar M, Wong LS, Sabarathinam S, et al.. Haloperidol-induced painless legs and moving toe syndrome in a schizophrenia patient: a case report.. Future-Sci-OA. 2024;10 (1)$45$YR$$F$Y$$$20240725$$HP$IN$IN
241343902$24134390$2$F$$20240710$20240725$20240726$30DAY$$US-JNJFOC-20240754258$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$CN$US$US
241343911$24134391$1$I$$20240715$20240725$20240725$EXP$$ES-TEVA-VS-3223948$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$51$YR$$M$Y$$$20240725$$HP$ES$ES
241343923$24134392$3$F$$20240908$20240725$20240916$EXP$$CA-CELLTRION INC.-2024CA017725$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
241343931$24134393$1$I$20240718$20240718$20240725$20240725$EXP$$US-ABBVIE-5846222$ABBVIE$$84$YR$$M$Y$$$20240725$$CN$US$US
241343941$24134394$1$I$$20240520$20240725$20240725$PER$$US-Accord-421916$ACCORD$$$$$F$Y$$$20240725$$CN$US$US
241343951$24134395$1$I$20240716$20240717$20240725$20240725$PER$$US-HETERO-HET2024US02394$HETERO$$57$YR$$F$Y$81.6$KG$20240725$$CN$US$US
241343961$24134396$1$I$20240716$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145512$AMGEN$$76$YR$E$F$Y$$$20240724$$PH$US$US
241343971$24134397$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143005$AMGEN$Dean R. M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AUPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241343981$24134398$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143011$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241343991$24134399$1$I$20240522$20240722$20240725$20240725$EXP$$US-ABBVIE-5850665$ABBVIE$$59$YR$$M$Y$$$20240725$$CN$US$US
241344001$24134400$1$I$20240717$20240723$20240725$20240725$EXP$$GB-UCBSA-2024037327$UCB$$55$YR$$F$Y$$$20240725$$CN$GB$GB
241344011$24134401$1$I$20231101$20240718$20240725$20240725$EXP$$CA-ABBVIE-5846255$ABBVIE$$49$YR$$F$Y$$$20240725$$CN$CA$CA
241344031$24134403$1$I$$20240715$20240725$20240725$EXP$$CA-ROCHE-10000031667$ROCHE$$69$YR$E$M$Y$$$20240725$$MD$CA$CA
241344042$24134404$2$F$20240718$20240802$20240725$20240805$PER$$US-AMGEN-USASP2024144583$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
241344051$24134405$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143184$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241344062$24134406$2$F$$20240715$20240725$20240807$EXP$$US-AMGEN-USASP2024143019$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240807$$MD$US$US
241344071$24134407$1$I$$20240718$20240725$20240725$EXP$$NVSC2024US150080$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
241344081$24134408$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143139$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241344091$24134409$1$I$$20240716$20240725$20240725$EXP$$IN-ROCHE-10000034099$ROCHE$$$$$M$Y$$$20240725$$CN$IN$IN
241344101$24134410$1$I$20230817$20230922$20240725$20240725$EXP$$US-AstraZeneca-2023A217860$ASTRAZENECA$$17828$DY$$F$Y$$$20240725$$CN$US$
241344121$24134412$1$I$20240710$20240715$20240725$20240725$PER$$US-SA-2024SA212431$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240725$$MD$US$US
241344131$24134413$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA212136$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240725$$MD$US$US
241344142$24134414$2$F$20240711$20240731$20240725$20240809$PER$$US-ABBVIE-5846849$ABBVIE$$61$YR$$M$Y$116$KG$20240809$$CN$US$US
241344151$24134415$1$I$20240301$20240718$20240725$20240725$EXP$$ES-ABBVIE-5846482$ABBVIE$$79$YR$$M$Y$$$20240725$$CN$ES$ES
241344162$24134416$2$F$20240701$20240722$20240725$20240805$EXP$$US-ABBVIE-5850393$ABBVIE$$54$YR$$F$Y$$$20240805$$CN$US$US
241344181$24134418$1$I$$20240715$20240725$20240725$EXP$$ES-TEVA-VS-3223994$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$68$YR$$M$Y$$$20240725$$HP$ES$ES
241344202$24134420$2$F$20240717$20240826$20240725$20240827$PER$$US-JNJFOC-20240750171$JOHNSON AND JOHNSON$$28$YR$A$$Y$$$20240827$$CN$US$US
241344213$24134421$3$F$20240630$20240718$20240725$20240807$EXP$$TR-JNJFOC-20240713524$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$PH$TR$TR
241344221$24134422$1$I$20240101$20240717$20240725$20240725$EXP$$BR-JNJFOC-20240749803$JOHNSON AND JOHNSON$$33$YR$A$M$Y$73$KG$20240725$$CN$BR$BR
241344232$24134423$2$F$20090506$20240910$20240725$20240915$PER$$US-JNJFOC-20240755540$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240916$$HP$US$US
241344241$24134424$1$I$$20240723$20240725$20240725$EXP$$US-JNJFOC-20240760812$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20240725$$CN$US$US
241344251$24134425$1$I$20240723$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024147178$AMGEN$$39$YR$A$F$Y$$$20240724$$CN$US$US
241344262$24134426$2$F$20240716$20240724$20240725$20240726$PER$$US-AMGEN-USASP2024145315$AMGEN$$62$YR$A$F$Y$$$20240726$$CN$US$US
241344271$24134427$1$I$$20240718$20240725$20240725$PER$$US-ABBVIE-5847475$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241344282$24134428$2$F$20240603$20240828$20240725$20240830$EXP$$VN-ROCHE-10000027186$ROCHE$$73$YR$E$F$Y$$$20240830$$MD$VN$VN
241344301$24134430$1$I$20240712$20240717$20240725$20240725$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000252$EMCURE$$$$$$Y$$$20240725$$CN$US$US
241344311$24134431$1$I$$20240716$20240725$20240725$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000259$EMCURE$Edwards C, Van Gerpen S, Anand V.. New-Onset Seizures in an Adolescent Following Use of LSD while on Low-Dose Lithium Therapy: A Case Study. South Dakota Medicine: the journal of the south dakota state medical association. 2024;77(1):31-35$15$YR$$F$Y$$$20240725$$MD$US$US
241344322$24134432$2$F$20240601$20240731$20240725$20240802$PER$$US-AMGEN-USASP2024145953$AMGEN$$80$YR$E$F$Y$$$20240802$$CN$US$US
241344332$24134433$2$F$$20240721$20240725$20240729$PER$$US-AMGEN-USASP2024145737$AMGEN$$$$A$F$Y$$$20240729$$CN$US$US
241344341$24134434$1$I$20240330$20240409$20240725$20240725$PER$$US-CIPLA LTD.-2024US03703$CIPLA$$$$$$Y$$$20240725$$CN$US$US
241344351$24134435$1$I$20240101$20240425$20240725$20240725$PER$$US-CIPLA LTD.-2024US03911$CIPLA$$$$$$Y$$$20240725$$CN$US$US
241344361$24134436$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143192$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241344372$24134437$2$F$$20240723$20240725$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015497$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240726$$CN$US$US
241344381$24134438$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015443$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240725$$CN$US$US
241344391$24134439$1$I$$20240715$20240725$20240725$EXP$$ES-TEVA-VS-3224003$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$65$YR$$M$Y$$$20240725$$HP$ES$ES
241344401$24134440$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA213417$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240725$$MD$US$US
241344411$24134441$1$I$20240515$20240717$20240725$20240725$EXP$$CZ-CELLTRION INC.-2024CZ017771$CELLTRION$$$$$$Y$$$20240725$$MD$CZ$CZ
241344421$24134442$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143203$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241344431$24134443$1$I$$20240714$20240725$20240725$EXP$$US-CBL-002705$CONCORD BIOTECH$Hakobyan K, Acob T, Aleksanyan M, Jumaah O, Prabhakaran S. Upper Gastrointestinal (GI) Manifestations of Inflammatory Myositis: A Tale of Two Patients. Cureus. 2024 Jun 11;16(6):e62153. doi: 10.7759/cureus.62153.$32$YR$A$F$Y$$$20240725$$HP$US$US
241344442$24134444$2$F$20240101$20240725$20240725$20240729$PER$$US-AMGEN-USASP2024145866$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241344461$24134446$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143197$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241344471$24134447$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143205$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241344481$24134448$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143196$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241344491$24134449$1$I$20231127$20240723$20240725$20240725$EXP$FR-AFSSAPS-TS2024000835$FR-GSK-FR2024092187$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$FR$FR
241344501$24134450$1$I$$20240717$20240725$20240725$30DAY$$US-GSK-US2024090069$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
241344511$24134451$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143218$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241344522$24134452$2$F$$20240820$20240725$20240829$EXP$$CH-TAKEDA-2024TUS074478$TAKEDA$$56$YR$$M$Y$82$KG$20240829$$MD$CH$CH
241344531$24134453$1$I$20240620$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146056$AMGEN$$61$YR$A$F$Y$$$20240724$$CN$US$US
241344542$24134454$2$F$20240610$20240725$20240725$20240729$PER$$US-AMGEN-USASP2024146095$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241344551$24134455$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024143223$AMGEN$Dean R. M.. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240724$$MD$US$US
241344561$24134456$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146852$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241344572$24134457$2$F$20240716$20240723$20240725$20240802$PER$$US-AMGEN-USASP2024146378$AMGEN$$$$$F$Y$$$20240802$$CN$US$US
241344582$24134458$2$F$20240701$20240815$20240725$20240816$EXP$$BG-ABBVIE-5850401$ABBVIE$$76$YR$$M$Y$$$20240816$$CN$BG$BG
241344592$24134459$2$F$20240706$20240806$20240725$20240812$30DAY$$US-JNJFOC-20240722898$JOHNSON AND JOHNSON$$33$YR$A$M$Y$78.996$KG$20240812$$CN$US$US
241344602$24134460$2$F$$20240722$20240725$20240730$EXP$$JP-JNJFOC-20240760880$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$MD$JP$JP
241344612$24134461$2$F$20240625$20240823$20240725$20240827$EXP$$CA-JNJFOC-20240640578$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240828$$HP$CA$CA
241344621$24134462$1$I$20240712$20240724$20240725$20240725$EXP$ES-AEMPS-1550840$ES-JNJFOC-20240765147$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240725$$MD$ES$ES
241344641$24134464$1$I$20240701$20240722$20240725$20240725$EXP$$IT-ABBVIE-5850352$ABBVIE$$76$YR$$M$Y$$$20240725$$CN$IT$IT
241344651$24134465$1$I$$20240722$20240725$20240725$EXP$$DE-ABBVIE-5850657$ABBVIE$$$$$M$Y$$$20240725$$CN$DE$DE
241344661$24134466$1$I$20240701$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145376$AMGEN$$60$YR$A$F$Y$$$20240724$$CN$US$US
241344671$24134467$1$I$20240710$20240715$20240725$20240725$PER$$US-AMGEN-USASP2024140781$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241344681$24134468$1$I$$20240722$20240725$20240725$PER$$US-BIOVITRUM-2024-US-010139$BIOVITRUM$$18$YR$$M$Y$$$20240725$$CN$US$US
241344693$24134469$3$F$$20240919$20240725$20240927$EXP$$JP-009507513-2407JPN004063J$MERCK$Hirose D, Eiraku M, Kurihara M, Mori C, Nakajima Y, Maeda A, et al.. [O4-4 A Case of TEN Suspected to be Caused by COVID-19 infection]. Journal of Japanese Society for Emergency Medicine/The 27th General Meeting and. 2024;27(3):322$8$DEC$$F$Y$$$20240927$$MD$JP$JP
241344701$24134470$1$I$20240701$20240701$20240725$20240725$PER$$FR-TOLMAR, INC.-24FR050732$TOLMAR$$72$YR$$M$Y$$$20240725$$PH$FR$FR
241344711$24134471$1$I$$20240625$20240725$20240725$PER$$AU-TOLMAR, INC.-24AU050522$TOLMAR$$$$$M$Y$$$20240725$$CN$AU$AU
241344721$24134472$1$I$20240621$20240621$20240725$20240725$PER$$PH-TOLMAR, INC.-24PH051184$TOLMAR$$$$$M$Y$$$20240725$$MD$PH$PH
241344731$24134473$1$I$20240619$20240624$20240725$20240725$PER$$TR-TOLMAR, INC.-24TR050445$TOLMAR$$71$YR$$M$Y$$$20240725$$PH$TR$TR
241344741$24134474$1$I$20240624$20240624$20240725$20240725$PER$$TR-TOLMAR, INC.-24TR050476$TOLMAR$$67$YR$$M$Y$$$20240725$$MD$TR$TR
241344751$24134475$1$I$20240614$20240624$20240725$20240725$PER$$TR-TOLMAR, INC.-24TR050483$TOLMAR$$80$YR$$M$Y$$$20240725$$HP$TR$TR
241344762$24134476$2$F$20240614$20240726$20240725$20240816$PER$$US-TOLMAR, INC.-24US050279$TOLMAR$$68$YR$$M$Y$$$20240816$$HP$US$US
241344772$24134477$2$F$20240530$20240807$20240725$20240903$PER$$US-TOLMAR, INC.-24US050426$TOLMAR$$42$YR$$M$Y$$$20240903$$PH$US$US
241344782$24134478$2$F$20240624$20240807$20240725$20240903$PER$$US-TOLMAR, INC.-24US050442$TOLMAR$$80$YR$$M$Y$$$20240903$$PH$US$US
241344791$24134479$1$I$20240531$20240716$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011078$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241344802$24134480$2$F$$20240918$20240725$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117102$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240920$$CN$US$US
241344811$24134481$1$I$20240703$20240716$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011074$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241344821$24134482$1$I$20240621$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145895$AMGEN$$65$YR$E$F$Y$$$20240724$$CN$US$US
241344831$24134483$1$I$20240101$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024145412$AMGEN$$86$YR$E$F$Y$$$20240724$$CN$US$US
241344841$24134484$1$I$$20240719$20240725$20240725$EXP$$NVSJ2024JP008949$NOVARTIS$$$$A$M$Y$$$20240725$$MD$JP$JP
241344851$24134485$1$I$$20240722$20240725$20240725$EXP$$NVSC2024CA151799$NOVARTIS$$$$$$Y$$$20240725$$MD$CA$CA
241344861$24134486$1$I$20240709$20240710$20240725$20240725$PER$$US-JNJFOC-20240727671$JOHNSON AND JOHNSON$$92$YR$E$F$Y$$$20240725$$CN$US$US
241344871$24134487$1$I$$20240723$20240725$20240725$EXP$$JP-JNJFOC-20240766753$JOHNSON AND JOHNSON$$7$DEC$E$F$Y$$$20240725$$PH$JP$JP
241344881$24134488$1$I$20240423$20240722$20240725$20240725$EXP$FR-AFSSAPS-DJ2024000847$FR-GSK-FR2024092045$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$FR$FR
241344891$24134489$1$I$$20240717$20240725$20240725$PER$$US-ROCHE-10000033384$ROCHE$$$$$$Y$$$20240725$$MD$US$US
241344901$24134490$1$I$20240717$20240717$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011172$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241344911$24134491$1$I$$20240717$20240725$20240725$PER$$US-TAKEDA-2024TUS072573$TAKEDA$$$$$M$Y$$$20240725$$MD$US$US
241344922$24134492$2$F$20240722$20240724$20240725$20240727$PER$$US-AMGEN-USASP2024145494$AMGEN$$73$YR$E$F$Y$$$20240727$$CN$US$US
241344931$24134493$1$I$20240515$20240716$20240725$20240725$EXP$$CA-CELLTRION INC.-2024CA017804$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
241344952$24134495$2$F$20240719$20240815$20240725$20240819$PER$$US-ROCHE-10000033395$ROCHE$$$$$$Y$$$20240819$$PH$US$US
241344961$24134496$1$I$$20240722$20240725$20240725$PER$$US-ROCHE-10000034258$ROCHE$$$$$F$Y$$$20240725$$CN$US$US
241344971$24134497$1$I$$20240710$20240725$20240725$30DAY$$US-JNJFOC-20240727486$JOHNSON AND JOHNSON$$$$$M$Y$$$20240725$$CN$US$US
241344982$24134498$2$F$$20240729$20240725$20240806$EXP$$US-TEVA-VS-3222777$TEVA$Kuraitis D, Bogner P, Gopalakrishnan D, Pei S. Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis. JAAD-Case-Rep 2024; 50 33-36.; Kuraitis D, Bogner P, Gopalakrishnan D, Pei S. Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis. JAAD-Case-Rep 2024; 50 33-36.$68$YR$$M$Y$$$20240806$$HP$US$US
241344991$24134499$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152193$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241345001$24134500$1$I$20240628$20240716$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011077$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241345012$24134501$2$F$$20240731$20240725$20240809$EXP$$JP-ROCHE-10000031211$ROCHE$Kawamura K, Ishikura K, Minai K, Tamura T, Yoshida Y, Ishii A. A case of drug-induced thrombosis abdominal aorta in which a pharmacist considered drug interactions and supported warfarin treatment  [Abstract number: P-070]. The 13th Annual Meeting of the Japanese Society of Hospital Pharmacists in Tohok. 2024;191.$54$YR$A$F$Y$$$20240809$$PH$JP$JP
241345022$24134502$2$F$20240701$20240731$20240725$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114143$BRISTOL MYERS SQUIBB$$13$YR$T$M$Y$$$20240806$$HP$US$US
241345031$24134503$1$I$$20240718$20240725$20240725$PER$$NVSC2024US148486$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
241345042$24134504$2$F$$20240807$20240725$20240812$PER$$US-TAKEDA-2024TUS072526$TAKEDA$$23$YR$$F$Y$$$20240812$$CN$US$US
241345051$24134505$1$I$$20240722$20240725$20240725$EXP$$US-JNJFOC-20240760501$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240725$$CN$US$US
241345062$24134506$2$F$$20240812$20240725$20240822$EXP$$NL-AUROBINDO-AUR-APL-2024-036214$AUROBINDO$$72$YR$$F$Y$$$20240822$$MD$NL$NL
241345071$24134507$1$I$$20240716$20240725$20240725$EXP$$US-LUOXIN-LUX-2024-US-LIT-00038$LUOXIN AUROVITAS PHARMA(CHENGDU)$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN.Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series..Pediatr-Blood-Cancer.2024;71(7):e31004$31$YR$A$M$Y$$$20240725$$HP$US$US
241345081$24134508$1$I$$20240701$20240725$20240725$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000578$PAREXEL$$$$$$Y$$$20240725$$PH$US$US
241345091$24134509$1$I$$20220816$20240725$20240725$EXP$$DE-AstraZeneca-2022A290431$ASTRAZENECA$$$$A$M$Y$$$20240725$$HP$DE$
241345101$24134510$1$I$20240625$20240716$20240725$20240725$EXP$$DE-AUROBINDO-AUR-APL-2024-036168$AUROBINDO$$$$$M$Y$79$KG$20240725$$MD$DE$DE
241345111$24134511$1$I$$20240718$20240725$20240725$EXP$$NVSC2024US150658$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
241345121$24134512$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152224$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241345131$24134513$1$I$$20240717$20240725$20240725$EXP$$GB-CELLTRION INC.-2024GB017794$CELLTRION$$$$$$Y$$$20240725$$CN$GB$GB
241345141$24134514$1$I$$20240716$20240725$20240725$EXP$$US-LUOXIN-LUX-2024-US-LIT-00039$LUOXIN AUROVITAS PHARMA(CHENGDU)$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN.Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series..Pediatr-Blood-Cancer.2024;71(7):e31004$22$YR$A$F$Y$$$20240725$$HP$US$US
241345151$24134515$1$I$20240626$20240702$20240725$20240725$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000576$PAREXEL$$$$$$Y$$$20240725$$PH$US$US
241345161$24134516$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117246$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240725$$HP$US$US
241345181$24134518$1$I$20240622$20240717$20240725$20240725$EXP$$JP-VANTIVE-2024VAN017902$Vantive US Healthcare$$7$DEC$$M$Y$$$20240725$$MD$JP$JP
241345191$24134519$1$I$$20240716$20240725$20240725$EXP$$BR-TAKEDA-2024TUS072660$TAKEDA$$$$$M$Y$$$20240725$$CN$BR$BR
241345201$24134520$1$I$20240711$20240717$20240725$20240725$PER$$US-AMGEN-USASP2024142978$AMGEN$$20$YR$A$F$Y$$$20240724$$CN$US$US
241345212$24134521$2$F$20240101$20240819$20240725$20240827$EXP$$BR-AMGEN-BRASP2024144100$AMGEN$$$$$F$Y$$$20240827$$PH$BR$BR
241345222$24134522$2$F$20240403$20240916$20240725$20240925$EXP$$IT-AUROBINDO-AUR-APL-2024-036266$AUROBINDO$$29$YR$$F$Y$$$20240925$$MD$IT$IT
241345232$24134523$2$F$20240712$20240820$20240725$20240827$30DAY$$US-AMGEN-USASP2024141750$AMGEN$$83$YR$E$M$Y$87.2$KG$20240826$$HP$US$US
241345241$24134524$1$I$20220101$20240714$20240725$20240725$EXP$$US-CBL-002707$CONCORD BIOTECH$Zieneldien T, Kim J, Greene J. Breakthrough Pneumocystis jirovecii Pneumonia in an Allogeneic Hematopoietic Stem Cell Transplant Recipient. Cureus. 2024 Jun 7;16(6):e61890. doi: 10.7759/cureus.61890.$50$YR$A$F$Y$$$20240725$$HP$US$US
241345251$24134525$1$I$$20240714$20240725$20240725$EXP$$US-CBL-002710$CONCORD BIOTECH$Shirini K, Kamberi S, Drachenberg C, Haririan A, Saharia K, Meier RPH. Renal transplantation using kidneys from a donor with high grade cytomegalovirus viraemia: case report and literature review. Lancet Infect Dis. 2024 Jul 8:S1473-3099(24)00359-1. doi: 10.1016/S1473-3099(24)00359-1.$61$YR$A$M$Y$$$20240725$$MD$US$US
241345262$24134526$2$F$$20240817$20240725$20240831$EXP$$US-CBL-002703$CONCORD BIOTECH$$13$YR$T$M$Y$$$20240831$$HP$US$US
241345271$24134527$1$I$20240701$20240701$20240725$20240725$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000577$PAREXEL$$$$$$Y$$$20240725$$CN$US$US
241345284$24134528$4$F$$20240729$20240725$20240801$EXP$$US-ROCHE-10000034082$ROCHE$$79$YR$E$M$Y$$$20240801$$HP$US$US
241345291$24134529$1$I$20240305$20240717$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036303$AUROBINDO$$9$YR$$M$Y$$$20240725$$CN$FR$FR
241345301$24134530$1$I$$20240710$20240725$20240725$PER$$US-TEVA-VS-3220778$TEVA$$44$YR$$M$Y$$$20240725$$HP$US$US
241345312$24134531$2$F$20240716$20240725$20240725$20240730$PER$$US-AMGEN-USASP2024142672$AMGEN$$64$YR$A$F$Y$52.6$KG$20240730$$PH$US$US
241345321$24134532$1$I$$20240716$20240725$20240725$EXP$$JP-AMGEN-JPNSP2024146112$AMGEN$$$$$$Y$$$20240724$$MD$JP$JP
241345331$24134533$1$I$$20240718$20240725$20240725$EXP$$CN-AMGEN-CHNSP2024143602$AMGEN$Chen S.; Shen L.; Cao W. et al.. Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation. Blood cancer journal. 2024;14 (1)$48$YR$A$F$Y$$$20240724$$HP$CN$CN
241345341$24134534$1$I$$20240715$20240725$20240725$EXP$$DE-CEROVENE INC.-2024CER000004$CEROVENE USA$Heinz P, Wolf B, Schuldes S.. Locked-in Syndrome After Pontine Hemorrhage in an Amphetamine Abuser. Dtsch Arztebl Int.. 2024;121:330$37$YR$$F$Y$$$20240725$$MD$DE$DE
241345355$24134535$5$F$20240716$20240830$20240725$20240909$EXP$$KR-CELLTRION INC.-2024KR017691$CELLTRION$$$$$$Y$$$20240909$$MD$KR$KR
241345361$24134536$1$I$$20240722$20240725$20240725$EXP$$NVSC2024US065572$NOVARTIS$$$$$F$Y$$$20240725$$MD$US$US
241345372$24134537$2$F$20240612$20240729$20240725$20240731$EXP$$NVSC2024DE137983$NOVARTIS$$$$E$M$Y$$$20240731$$CN$DE$DE
241345382$24134538$2$F$20240723$20240819$20240725$20240820$PER$$NVSC2024US152042$NOVARTIS$$76$YR$$M$Y$88.9$KG$20240820$$CN$US$US
241345391$24134539$1$I$$20240713$20240725$20240725$EXP$$IN-ROCHE-10000027769$ROCHE$$65$YR$E$F$Y$84.7$KG$20240725$$MD$IN$IN
241345401$24134540$1$I$20240701$20240717$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114217$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240725$$CN$US$US
241345411$24134541$1$I$$20230523$20240725$20240725$EXP$$US-AstraZeneca-2023A121011$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$US$
241345421$24134542$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165599$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241345431$24134543$1$I$$20240715$20240725$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-112426$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240725$$MD$CA$CA
241345441$24134544$1$I$$20240718$20240725$20240725$EXP$$US-AMGEN-USASP2024146045$AMGEN$$$$$$Y$$$20240724$$CN$US$US
241345451$24134545$1$I$20240710$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146061$AMGEN$$75$YR$E$F$Y$$$20240724$$CN$US$US
241345462$24134546$2$F$20240718$20240812$20240725$20240820$EXP$$US-HETERO-HET2024US02401$HETERO$$79$YR$$F$Y$90.7$KG$20240820$$CN$US$US
241345471$24134547$1$I$20240709$20240717$20240725$20240725$EXP$GB-MHRA-MED-202407111100441400-DSWBG$GB-AMAROX PHARMA-AMR2024GB02336$HETERO$$55$YR$$M$Y$$$20240725$$MD$GB$GB
241345482$24134548$2$F$20230616$20230728$20240725$20240725$PER$$US-IGSA-BIG0025013$GRIFOLS$$69$YR$$M$Y$124.72$KG$20240725$$HP$US$US
241345492$24134549$2$F$$20230728$20240725$20240725$PER$$US-IGSA-BIG0025014$GRIFOLS$$$$$F$Y$94.785$KG$20240725$$HP$US$US
241345501$24134550$1$I$20240716$20240716$20240725$20240725$EXP$$GB-AUROBINDO-AUR-APL-2024-035475$AUROBINDO$$40$YR$$F$Y$97$KG$20240725$$CN$GB$GB
241345511$24134551$1$I$$20240716$20240725$20240725$EXP$$CA-ROCHE-10000031661$ROCHE$$40$YR$A$F$Y$$$20240725$$HP$CA$CA
241345521$24134552$1$I$$20240722$20240725$20240725$EXP$$NVSC2024NG151867$NOVARTIS$$$$$F$Y$$$20240725$$MD$NG$NG
241345531$24134553$1$I$20230101$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146527$AMGEN$$$$$F$Y$$$20240724$$CN$US$US
241345542$24134554$2$F$20240625$20240813$20240725$20240819$30DAY$$US-AMGEN-USASP2024143370$AMGEN$$$$$$Y$$$20240819$$PH$US$US
241345551$24134555$1$I$$20240716$20240725$20240725$EXP$$NL-AUROBINDO-AUR-APL-2024-036215$AUROBINDO$$85$YR$$F$Y$$$20240725$$MD$NL$NL
241345563$24134556$3$F$20240516$20240802$20240725$20240807$EXP$$US-GSK-US2024090190$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$US$US
241345571$24134557$1$I$$20240722$20240725$20240725$EXP$$US-UCBSA-2024037279$UCB$$$$$F$Y$$$20240725$$HP$US$US
241345581$24134558$1$I$20240718$20240723$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117465$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$97.52$KG$20240725$$CN$US$US
241345591$24134559$1$I$$20240715$20240725$20240725$EXP$$IN-STERISCIENCE B.V.-2024-ST-001073$Steriscience PTE$Mehta RY, Rathod J, Chavda SD, Basiya DV.. Maternal and Perinatal Outcome in Eclampsia: An Experience from Tertiary Care Teaching Hospital, a Prospective Observational Study.. Res-J-Med-Sci. 2024;18 (5):203-208$$$$F$Y$$$20240725$$HP$IN$IN
241345601$24134560$1$I$$20240717$20240725$20240725$PER$$US-ALXN-202407USA001187US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241345611$24134561$1$I$20240722$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014997$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240725$$CN$US$US
241345621$24134562$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015319$ELI LILLY AND CO$$$$$$Y$$$20240725$$CN$US$US
241345633$24134563$3$F$20230701$20240918$20240725$20240924$EXP$$GB-AMGEN-GBRSP2024145078$AMGEN$$73$YR$E$F$Y$$$20240924$$CN$GB$GB
241345641$24134564$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145965$AMGEN$$$$$M$Y$$$20240724$$CN$US$US
241345652$24134565$2$F$$20240909$20240725$20240911$PER$$US-BIOVITRUM-2024-US-010133$BIOVITRUM$$61$YR$$M$Y$$$20240911$$CN$US$US
241345662$24134566$2$F$20240702$20240812$20240725$20240903$30DAY$$CN-JNJFOC-20240714927$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$MD$CN$CN
241345671$24134567$1$I$20240101$20240719$20240725$20240725$PER$$US-ABBVIE-5849755$ABBVIE$$$$$$Y$$$20240725$$CN$US$US
241345691$24134569$1$I$$20240715$20240725$20240725$EXP$$IN-STERISCIENCE B.V.-2024-ST-001076$Steriscience PTE$Mehta RY, Rathod J, Chavda SD, Basiya DV.. Maternal and Perinatal Outcome in Eclampsia: An Experience from Tertiary Care Teaching Hospital, a Prospective Observational Study.. Res-J-Med-Sci. 2024;18 (5):203-208$$$$F$Y$$$20240725$$HP$IN$IN
241345702$24134570$2$F$20240630$20240731$20240725$20240801$PER$$US-BIOVITRUM-2024-US-010168$BIOVITRUM$$62$YR$$M$Y$$$20240801$$CN$US$US
241345711$24134571$1$I$$20240723$20240725$20240725$PER$$US-BIOVITRUM-2024-US-010178$BIOVITRUM$$82$YR$$F$Y$$$20240725$$CN$US$US
241345721$24134572$1$I$$20220914$20240725$20240725$EXP$$US-AstraZeneca-2022A318795$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241345731$24134573$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165526$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241345741$24134574$1$I$$20200409$20240725$20240725$EXP$$CA-AstraZeneca-2019SE95832$ASTRAZENECA$$$$$F$Y$$$20240725$$HP$CA$
241345753$24134575$3$F$20220628$20240806$20240725$20240813$EXP$$CA-CELLTRION INC.-2022CA022471$CELLTRION$$$$$$Y$$$20240813$$MD$CA$CA
241345761$24134576$1$I$$20240714$20240725$20240725$EXP$GB-MHRA-MED-202407141536029070-BLNZQ$GB-NOVOPROD-1255481$NOVO NORDISK$$69$YR$$F$Y$$$20240725$$PH$GB$GB
241345771$24134577$1$I$$20240715$20240725$20240725$EXP$$CN-STERISCIENCE B.V.-2024-ST-001080$Steriscience PTE$Zhao Y, Ma HH, Wang D, Lian HY, Wang TY, Zhang R.. [Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis]. [Chinese].. Zhonghua-Er-Ke-Za-Zhi. 2024;62:60-65.$3$YR$$M$Y$$$20240725$$HP$CN$CN
241345782$24134578$2$F$$20240823$20240725$20240827$PER$$US-BIOVITRUM-2024-US-010174$BIOVITRUM$$51$YR$$M$Y$$$20240827$$CN$US$US
241345791$24134579$1$I$$20240715$20240725$20240725$EXP$$CN-STERISCIENCE B.V.-2024-ST-001079$Steriscience PTE$Zhao Y, Ma HH, Wang D, Lian HY, Wang TY, Zhang R.. [Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis]. [Chinese].. Zhonghua-Er-Ke-Za-Zhi. 2024;62:60-65$0$YR$$M$Y$$$20240725$$HP$CN$CN
241345801$24134580$1$I$$20240717$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092573$VIIV$$$$$$Y$$$20240725$$HP$US$US
241345812$24134581$2$F$$20240724$20240725$20240725$EXP$$US-BIOVITRUM-2024-US-010189$BIOVITRUM$$$$$M$Y$$$20240725$$PH$US$US
241345821$24134582$1$I$20240201$20240724$20240725$20240725$EXP$FR-AFSSAPS-LM2024000413$FR-JNJFOC-20240766548$JOHNSON AND JOHNSON$$52$YR$A$F$Y$65$KG$20240725$$MD$FR$FR
241345833$24134583$3$F$20240307$20240802$20240725$20240815$EXP$$RO-AUROBINDO-AUR-APL-2024-036212$AUROBINDO$Desiderio G, Maria FD, Alkojok A, Galizia V, Arena G, Macarie I et al. PROGRESSES AND CHALLENGES IN THE MANAGEMENT OF MULTIPLE MYELOMA: NAVIGATING THROUGH A RELAPSING-REMITTING COURSE. Acta Medica Marisiensis. 2024;70, Suppl.3:194$58$YR$$M$Y$$$20240815$$MD$RO$RO
241345841$24134584$1$I$20240704$20240714$20240725$20240725$EXP$CN-NMPA-4403061004846202400130$CN-NOVOPROD-1256308$NOVO NORDISK$$55$YR$$F$Y$51$KG$20240725$$HP$CN$CN
241345853$24134585$3$F$$20240916$20240725$20240918$EXP$$NVSC2024US147998$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
241345861$24134586$1$I$$20230621$20240725$20240725$PER$$US-STRIDES ARCOLAB LIMITED-2023SP010300$STRIDES$Elgwairi E, Thomas D, Khan A, Verma S, Sabapathy R.. SUPRAVENTRICULAR TACHYCARDIA IN THE SETTING OF CATECHOLAMINE CRISES IN A PATIENT WITH UNTREATABLE METASTATIC PARAGANGLIOMA: A MANAGEMENT CHALLENGE.. J-Am-Coll-Cardiol.. 2023;81 (8):2790$64$YR$$M$Y$$$20240725$$HP$US$US
241345871$24134587$1$I$$20240715$20240725$20240725$EXP$$ES-TEVA-VS-3223981$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$63$YR$$F$Y$$$20240725$$HP$ES$ES
241345881$24134588$1$I$20240721$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146041$AMGEN$$56$YR$A$F$Y$$$20240724$$CN$US$US
241345891$24134589$1$I$20240101$20240717$20240725$20240725$EXP$$DE-AMGEN-DEUNI2024142591$AMGEN$$43$YR$A$F$Y$$$20240724$$MD$DE$DE
241345901$24134590$1$I$20240516$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146059$AMGEN$$70$YR$E$F$Y$$$20240724$$CN$US$US
241345911$24134591$1$I$$20240715$20240725$20240725$EXP$GB-MHRA-MED-202407151303551630-QJWSC$GB-NOVOPROD-1256359$NOVO NORDISK$$$$$M$Y$$$20240725$$HP$GB$GB
241345922$24134592$2$F$$20240723$20240725$20240731$PER$$US-AMGEN-USASP2024146479$AMGEN$$$$$M$Y$$$20240731$$CN$US$US
241345931$24134593$1$I$20220601$20240715$20240725$20240725$EXP$SE-SEMPA-2024-005499$SE-NOVOPROD-1256680$NOVO NORDISK$$41$YR$$F$Y$96$KG$20240725$$CN$SE$SE
241345941$24134594$1$I$20240714$20240715$20240725$20240725$EXP$$TH-NOVOPROD-1256202$NOVO NORDISK$$59$YR$$M$Y$$$20240725$$MD$TH$TH
241345951$24134595$1$I$20240510$20240715$20240725$20240725$EXP$$DE-NOVOPROD-1256686$NOVO NORDISK$$57$YR$$M$Y$$$20240725$$MD$DE$DE
241345961$24134596$1$I$20240201$20240715$20240725$20240725$EXP$FI-FIMEA-202402581$FI-NOVOPROD-1256691$NOVO NORDISK$$49$YR$$M$Y$$$20240725$$CN$FI$FI
241345971$24134597$1$I$20220711$20240715$20240725$20240725$EXP$DK-DKMA-30735468$DK-NOVOPROD-1256684$NOVO NORDISK$$40$YR$$M$Y$126.3$KG$20240725$$MD$DK$DK
241345981$24134598$1$I$20240511$20240715$20240725$20240725$EXP$$PL-NOVOPROD-1256890$NOVO NORDISK$$36$YR$$M$Y$115$KG$20240725$$CN$PL$PL
241345991$24134599$1$I$20230604$20240715$20240725$20240725$EXP$GB-MHRA-MED-202407151750096320-KLCZG$GB-NOVOPROD-1256390$NOVO NORDISK$$60$YR$$F$Y$75$KG$20240725$$CN$GB$GB
241346001$24134600$1$I$20240614$20240715$20240725$20240725$EXP$$CO-NOVOPROD-1256717$NOVO NORDISK$$53$YR$$F$Y$75$KG$20240725$$CN$CO$CO
241346012$24134601$2$F$$20240730$20240725$20240809$EXP$NL-LRB-00985881$NL-NOVOPROD-1256689$NOVO NORDISK$$54$YR$$F$Y$103$KG$20240809$$CN$NL$NL
241346021$24134602$1$I$20240303$20240715$20240725$20240725$EXP$DK-DKMA-30735414$DK-NOVOPROD-1256676$NOVO NORDISK$$45$YR$$M$Y$$$20240725$$MD$DK$DK
241346031$24134603$1$I$20200101$20240715$20240725$20240725$EXP$NO-NOMAADVRE-PASRAPP-2024-Vdkg94$NO-NOVOPROD-1256687$NOVO NORDISK$$51$YR$$F$Y$56$KG$20240725$$CN$NO$NO
241346042$24134604$2$F$20240101$20240801$20240725$20240807$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000634$DECIPHERA PHARMACEUTICALS$$74$YR$E$M$Y$162.6$KG$20240807$$CN$US$US
241346052$24134605$2$F$$20240813$20240725$20240813$PER$$US-ALXN-202407USA001288US$ALEXION PHARMACEUTICALS$$$$$M$Y$3.628$KG$20240813$$MD$US$US
241346061$24134606$1$I$20240101$20240715$20240725$20240725$EXP$CN-NMPA-3701021009161202400450$CN-NOVOPROD-1256875$NOVO NORDISK$$58$YR$$F$Y$49$KG$20240725$$HP$CN$CN
241346072$24134607$2$F$20240401$20240902$20240725$20240910$EXP$$AE-EMD Serono-2024038845$EMD SERONO INC$$$$$M$Y$$$20240910$$MD$AE$AE
241346081$24134608$1$I$20240623$20240715$20240725$20240725$EXP$$CN-NOVOPROD-1256930$NOVO NORDISK$$28$YR$$F$Y$74$KG$20240725$$CN$CN$CN
241346091$24134609$1$I$20240623$20240627$20240725$20240725$PER$$US-009507513-2407USA000211$MERCK$$$$$M$Y$$$20240725$$CN$US$US
241346101$24134610$1$I$$20240717$20240725$20240725$EXP$$US-ABBVIE-5845200$ABBVIE$Hodson EL, Kranyak A, Salem I, Buckey JC. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases. Journal of Tissue Viability. 2024;33(3):449-451.$54$YR$$F$Y$$$20240725$$HP$US$US
241346111$24134611$1$I$$20240117$20240725$20240725$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000881$STRIDES$Sarmiento-Ramon JC, Sosa-Pagan M, Dendy J.. Pheochromocytoma During Pregnancy: A Ticking Time Bomb.. J-Endocr-Soc. 2020;4(Suppl. 1):A77 abstr. SAT-194$25$YR$$F$Y$$$20240725$$MD$US$US
241346121$24134612$1$I$20240717$20240718$20240725$20240725$EXP$$US-ESPERIONTHERAPEUTICS-2024USA01138$ESPERION THERAPEUTICS$$68$YR$$F$Y$$$20240725$$CN$US$US
241346131$24134613$1$I$$20240712$20240725$20240725$PER$$US-CHATTEMPRD-2024OHG024241$CHATTEM$$$$A$$Y$$$20240725$$CN$US$US
241346141$24134614$1$I$20240604$20240717$20240725$20240725$EXP$$IN-ROCHE-3557042$ROCHE$$72$YR$E$M$Y$$$20240725$$CN$IN$IN
241346153$24134615$3$F$$20240812$20240725$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06676$LUPIN$$$$$$Y$$$20240827$$CN$US$US
241346162$24134616$2$F$20240717$20240806$20240725$20240812$PER$$US-AMGEN-USASP2024145171$AMGEN$$75$YR$E$F$Y$$$20240812$$CN$US$US
241346172$24134617$2$F$20240717$20240801$20240725$20240807$EXP$$JP-AMGEN-JPNSP2024146157$AMGEN$$6$DEC$A$F$Y$$$20240806$$PH$JP$JP
241346181$24134618$1$I$$20240717$20240725$20240725$PER$$US-CHATTEMPRD-2024OHG024754$CHATTEM$$$$$M$Y$$$20240725$$CN$US$US
241346191$24134619$1$I$20240101$20240723$20240725$20240725$EXP$$US-ABBVIE-5851246$ABBVIE$$$$$M$Y$$$20240725$$HP$US$US
241346201$24134620$1$I$$20240718$20240725$20240725$EXP$GB-MHRA-MED-202407180956233390-PZWYM$GB-AMAROX PHARMA-AMR2024GB02369$HETERO$$$$$$Y$$$20240725$$CN$GB$GB
241346211$24134621$1$I$$20240723$20240725$20240725$EXP$$US-TAKEDA-2024TUS074621$TAKEDA$$$$$M$Y$$$20240725$$CN$US$US
241346222$24134622$2$F$$20240724$20240725$20240730$30DAY$$US-JNJFOC-20240705076$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240730$$PH$US$US
241346231$24134623$1$I$$20240723$20240725$20240725$EXP$$US-TAKEDA-2024TUS074671$TAKEDA$$$$$F$Y$$$20240725$$CN$US$US
241346241$24134624$1$I$$20210609$20240725$20240725$EXP$$US-AstraZeneca-2021A517749$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$US$
241346251$24134625$1$I$20210614$20210614$20240725$20240725$EXP$$ZA-AstraZeneca-2021A532344$ASTRAZENECA$$31782$DY$$M$Y$$$20240725$$CN$ZA$
241346261$24134626$1$I$$20220221$20240725$20240725$EXP$$US-AstraZeneca-2022A082091$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241346271$24134627$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165696$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241346282$24134628$2$F$$20240805$20240725$20240810$EXP$$DE-ROCHE-10000031071$ROCHE$$$$$M$Y$$$20240810$$MD$DE$DE
241346291$24134629$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015265$ELI LILLY AND CO$$89$YR$E$F$Y$$$20240725$$CN$US$US
241346301$24134630$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015053$ELI LILLY AND CO$$$$$F$Y$$$20240725$$CN$US$US
241346332$24134633$2$F$20240701$20240819$20240725$20240826$EXP$$BR-AMGEN-BRASP2024143780$AMGEN$$$$$M$Y$$$20240826$$PH$BR$BR
241346342$24134634$2$F$$20240729$20240725$20240802$EXP$$CA-TEVA-VS-3224672$TEVA$$76$YR$$F$Y$73$KG$20240802$$MD$CA$CA
241346351$24134635$1$I$$20240229$20240725$20240725$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002626$STRIDES$Crosby J, Hansen C, Findlay J, Zamora-Martinez AC, Abdalla A.. COVID-19 Induced Pheochromocytoma Multisystem Crisis.. Am-J-Respir-Crit-Care-Med. 2023;207$43$YR$$M$Y$$$20240725$$HP$US$US
241346362$24134636$2$F$$20240718$20240725$20240730$PER$$US-CHATTEMPRD-2024OHG024531$CHATTEM$$$$$F$Y$$$20240730$$CN$US$US
241346372$24134637$2$F$$20240726$20240725$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06781$LUPIN$$$$$$Y$$$20240818$$CN$US$US
241346381$24134638$1$I$$20240314$20240725$20240725$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003270$STRIDES$Heyman TD, Jayaram A, Eisenberg Y, Crivellaro S, Mohammed A, Briller JE.. Pheochromocytoma: Secondary Hypertension in Pregnancy. JACC-Case-Rep. 2024;29 (4)$29$YR$$F$Y$$$20240725$$MD$US$US
241346391$24134639$1$I$$20240717$20240725$20240725$EXP$$US-TAKEDA-2024TUS056999$TAKEDA$$$$$M$Y$$$20240725$$CN$US$US
241346401$24134640$1$I$$20240718$20240725$20240725$PER$$US-HETERO-HET2024US02396$HETERO$$$$$M$Y$$$20240725$$CN$US$US
241346411$24134641$1$I$20240723$20240723$20240725$20240725$PER$$NVSC2024US152028$NOVARTIS$$$$$M$Y$$$20240725$$CN$US$US
241346421$24134642$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152082$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241346431$24134643$1$I$20240708$20240723$20240725$20240725$PER$$NVSC2024US152043$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
241346442$24134644$2$F$$20240730$20240725$20240805$EXP$$DE-AMGEN-DEUSP2024146994$AMGEN$$28$YR$A$F$Y$65$KG$20240805$$CN$DE$DE
241346463$24134646$3$F$20240722$20240924$20240725$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117711$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240929$$CN$US$US
241346471$24134647$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117896$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240725$$CN$US$US
241346481$24134648$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117632$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240725$$CN$US$US
241346491$24134649$1$I$$20240718$20240725$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-117360$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240725$$HP$CA$CA
241346501$24134650$1$I$20240101$20240719$20240725$20240725$EXP$$UY-ABBVIE-5850069$ABBVIE$$$$$M$Y$$$20240725$$CN$UY$UY
241346512$24134651$2$F$$20240806$20240725$20240812$EXP$$AU-AMGEN-AUSSP2024142563$AMGEN$$71$YR$E$F$Y$$$20240812$$MD$AU$AU
241346521$24134652$1$I$$20240712$20240725$20240725$EXP$$FR-SA-2024SA214495$SANOFI AVENTIS$$77$YR$E$$Y$$$20240725$$PH$FR$FR
241346531$24134653$1$I$$20240715$20240725$20240725$EXP$$ES-TEVA-VS-3223988$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$73$YR$$M$Y$$$20240725$$HP$ES$ES
241346541$24134654$1$I$$20240717$20240725$20240725$PER$$US-AMGEN-USASP2024146116$AMGEN$$$$$$Y$$$20240724$$MD$US$US
241346551$24134655$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146018$AMGEN$$$$$$Y$$$20240724$$PH$US$US
241346561$24134656$1$I$$20240717$20240725$20240725$EXP$GB-MHRA-MED-202407171329112380-FHGCW$GB-AMAROX PHARMA-AMR2024GB02339$HETERO$$$$$F$Y$$$20240725$$HP$GB$GB
241346572$24134657$2$F$$20240910$20240725$20240920$EXP$$CA-APOTEX-2024AP008610$APOTEX$$$$$F$Y$$$20240920$$MD$CA$CA
241346581$24134658$1$I$$20240719$20240725$20240725$EXP$$US-AMGEN-USASP2024145072$AMGEN$$$$$M$Y$$$20240725$$HP$US$US
241346591$24134659$1$I$$20240719$20240725$20240725$PER$$NVSC2024US149790$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
241346602$24134660$2$F$20240717$20240723$20240725$20240731$PER$$US-AMGEN-USASP2024143739$AMGEN$$$$$$Y$$$20240731$$PH$US$US
241346611$24134661$1$I$$20240719$20240725$20240725$PER$$US-TRIS PHARMA, INC.-24US011576$TRIS PHARM$$$$$$Y$$$20240725$$CN$US$US
241346632$24134663$2$F$20240625$20240813$20240725$20240816$EXP$$CA-JNJFOC-20240754117$JOHNSON AND JOHNSON$$61$YR$A$F$Y$73$KG$20240816$$HP$CA$CA
241346641$24134664$1$I$$20240723$20240725$20240725$PER$$US-JNJFOC-20240761502$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
241346651$24134665$1$I$20240708$20240718$20240725$20240725$EXP$GB-MHRA-MED-202407182009487710-VRMJW$GB-RDY-SPO/GBR/24/0010731$DR REDDYS$$57$YR$A$M$Y$$$20240725$$CN$GB$GB
241346663$24134666$3$F$$20240918$20240725$20240926$EXP$$US-HETERO-HET2024US02429$HETERO$$$$$$Y$$$20240926$$PH$US$US
241346671$24134667$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152289$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241346681$24134668$1$I$20221214$20240719$20240725$20240725$EXP$$US-UCBSA-2024037187$UCB$$30$YR$$F$Y$54$KG$20240725$$HP$US$US
241346691$24134669$1$I$20240401$20240716$20240725$20240725$EXP$$BR-CELLTRION INC.-2024BR017603$CELLTRION$$$$$$Y$$$20240725$$CN$BR$BR
241346701$24134670$1$I$$20240718$20240725$20240725$EXP$$US-AMGEN-USASP2024144095$AMGEN$$$$$F$Y$$$20240725$$HP$US$US
241346711$24134671$1$I$$20240717$20240725$20240725$EXP$$US-SA-2024SA212038$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240725$$CN$US$US
241346721$24134672$1$I$20240610$20240716$20240725$20240725$EXP$$GB-AUROBINDO-AUR-APL-2024-035522$AUROBINDO$$88$YR$$F$Y$51$KG$20240725$$CN$GB$GB
241346731$24134673$1$I$$20240701$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06708$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241346742$24134674$2$F$20240721$20240726$20240725$20240730$PER$$US-AMGEN-USASP2024146032$AMGEN$$81$YR$E$F$Y$$$20240730$$CN$US$US
241346751$24134675$1$I$20240721$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015121$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240725$$CN$US$US
241346761$24134676$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015608$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240725$$CN$US$US
241346771$24134677$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015225$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240725$$CN$US$US
241346781$24134678$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015176$ELI LILLY AND CO$$$$$M$Y$$$20240725$$CN$US$US
241346791$24134679$1$I$20240715$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015451$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240725$$CN$US$US
241346801$24134680$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015372$ELI LILLY AND CO$$76$YR$E$$Y$$$20240725$$CN$US$US
241346811$24134681$1$I$$20240723$20240725$20240725$EXP$GB-MHRA-MIDB-ad1944d5-2d80-46a0-ae96-8daea506b59e$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-117421$BRISTOL MYERS SQUIBB$$66$YR$E$$Y$$$20240725$$PH$GB$GB
241346821$24134682$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014989$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240725$$CN$US$US
241346831$24134683$1$I$$20240719$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407013156$ELI LILLY AND CO$$60$YR$A$F$Y$95.238$KG$20240725$$CN$US$US
241346841$24134684$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015254$ELI LILLY AND CO$$$$$M$Y$$$20240725$$CN$US$US
241346851$24134685$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015080$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240725$$CN$US$US
241346862$24134686$2$F$20240721$20240829$20240725$20240901$PER$$US-ELI_LILLY_AND_COMPANY-US202407014729$ELI LILLY AND CO$$90$YR$E$M$Y$$$20240901$$CN$US$US
241346871$24134687$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015221$ELI LILLY AND CO$$$$$F$Y$$$20240725$$CN$US$US
241346881$24134688$1$I$$20240722$20240725$20240725$EXP$$US-AstraZeneca-2024A166567$ASTRAZENECA$$$$$F$Y$$$20240725$$HP$US$
241346891$24134689$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165739$ASTRAZENECA$$69$YR$$$Y$$$20240725$$CN$US$
241346901$24134690$1$I$20240722$20240722$20240725$20240725$30DAY$$US-SANDOZ INC.-SDZ2024US067213$SANDOZ$$30$YR$$$Y$$$20240725$$CN$US$US
241346911$24134691$1$I$20230703$20240716$20240725$20240725$EXP$$BR-TAKEDA-2023TUS069242$TAKEDA$$49$YR$$F$Y$$$20240725$$CN$BR$BR
241346921$24134692$1$I$$20240715$20240725$20240725$EXP$$ES-TEVA-VS-3224008$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$68$YR$$M$Y$$$20240725$$HP$ES$ES
241346931$24134693$1$I$20230501$20240722$20240725$20240725$EXP$$SG-JNJFOC-20240759368$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240725$$HP$SG$SG
241346942$24134694$2$F$$20240826$20240725$20240902$EXP$$US-CELLTRION INC.-2024US017592$CELLTRION$$$$$$Y$$$20240902$$CN$US$US
241346952$24134695$2$F$20240701$20240820$20240725$20240822$PER$$US-AMGEN-USASP2024145966$AMGEN$$75$YR$E$F$Y$$$20240822$$HP$US$US
241346962$24134696$2$F$20240101$20240809$20240725$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-020932$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240817$$$US$US
241346973$24134697$3$F$20240717$20240807$20240725$20240814$PER$$US-HETERO-HET2024US02398$HETERO$$11$YR$$F$Y$$$20240814$$CN$US$US
241346981$24134698$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146845$AMGEN$$$$$F$Y$$$20240725$$PH$US$US
241346991$24134699$1$I$$20240717$20240725$20240725$PER$$US-AMGEN-USASP2024144996$AMGEN$Chiu C.; Beam E.; Brumble L.M.et. al. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clinical Transplantation. 2024;38 (7):1-9$$$$$Y$$$20240725$$HP$US$US
241347003$24134700$3$F$20240401$20240906$20240725$20240918$EXP$$JP-EMD Serono-2024039611$EMD SERONO INC$$78$YR$E$M$Y$51$KG$20240918$$MD$JP$JP
241347013$24134701$3$F$20230101$20240919$20240725$20240924$EXP$$US-ABBVIE-5850794$ABBVIE$$$$$M$Y$57$KG$20240924$$CN$US$US
241347021$24134702$1$I$20240626$20240719$20240725$20240725$EXP$$US-ABBVIE-5849707$ABBVIE$$84$YR$$F$Y$$$20240725$$CN$US$US
241347032$24134703$2$F$$20240730$20240725$20240801$EXP$$US-ABBVIE-5850031$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241347041$24134704$1$I$$20240717$20240725$20240725$PER$$US-AMGEN-USASP2024145061$AMGEN$Chiu C.; Beam E.; Brumble L.M.et. al. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clinical Transplantation. 2024;38 (7):1-9$$$$$Y$$$20240725$$HP$US$US
241347051$24134705$1$I$$20240710$20240725$20240725$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-13092$SAMSUNG BIOEPIS$$76$YR$E$F$Y$$$20240725$$CN$GB$GB
241347062$24134706$2$F$20240717$20240718$20240725$20240726$EXP$$US-JNJFOC-20240751918$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240726$$CN$US$US
241347071$24134707$1$I$$20240718$20240725$20240725$EXP$$BG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040826$BOEHRINGER INGELHEIM$Kraevsky P. PELLEGRINI-STIEDA FOLLOWING ACL AND MCL SURGERY: CASE REPORT. Military Medicine. 2024 Jul 08;issue 2: 26-28.$57$YR$A$M$Y$$$20240725$$MD$BG$BG
241347081$24134708$1$I$$20240723$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117710$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240725$$CN$US$US
241347091$24134709$1$I$$20240716$20240725$20240725$EXP$$CA-APOTEX-2024AP008473$APOTEX$$$$$F$Y$$$20240725$$HP$CA$CA
241347101$24134710$1$I$$20240717$20240725$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-022190$UNITED THERAPEUTICS$$$$$F$Y$98.866$KG$20240725$$$US$US
241347111$24134711$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152304$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241347122$24134712$2$F$$20240729$20240725$20240808$EXP$$US-TEVA-VS-3222765$TEVA$Van Noord B, Samaan C, Flamm A. A Case of Delayed and Immediate Hypersensitivity Reactions Induced by Corticosteroids. Dermatitis 2024; 35 (2): 191-192.; Van Noord B, Samaan C, Flamm A. A Case of Delayed and Immediate Hypersensitivity Reactions Induced by Corticosteroids. Dermatitis 2024; 35 (2): 191-192.; Van Noord B, Samaan C, Flamm A. A Case of Delayed and Immediate Hypersensitivity Reactions Induced by Corticosteroids. Dermatitis 2024; 35 (2): 191-192.$71$YR$$M$Y$$$20240808$$MD$US$US
241347131$24134713$1$I$20240616$20240718$20240725$20240725$EXP$FR-AFSSAPS-GR2024000848$FR-CHEPLA-2024009214$CHEPLAPHARM$$56$YR$$F$Y$53$KG$20240725$$PH$COUNTRY NOT SPECIFIED$FR
241347141$24134714$1$I$$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003088$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241347152$24134715$2$F$20240721$20240725$20240725$20240809$PER$$US-AMGEN-USASP2024145882$AMGEN$$76$YR$E$F$Y$$$20240809$$CN$US$US
241347161$24134716$1$I$20240721$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146031$AMGEN$$76$YR$E$M$Y$$$20240725$$CN$US$US
241347171$24134717$1$I$$20240717$20240725$20240725$PER$$US-AMGEN-USASP2024145011$AMGEN$Chiu C.; Beam E.; Brumble L.M.et. al. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clinical Transplantation. 2024;38 (7):1-9$$$$$Y$$$20240725$$HP$US$US
241347181$24134718$1$I$20240201$20240217$20240725$20240725$PER$$US-CIPLA LTD.-2024US02138$CIPLA$$$$$$Y$$$20240725$$CN$US$US
241347191$24134719$1$I$20240713$20240718$20240725$20240725$PER$$US-AMGEN-USASP2024147033$AMGEN$$$$$M$Y$$$20240725$$CN$US$US
241347201$24134720$1$I$20240201$20240308$20240725$20240725$PER$$US-CIPLA LTD.-2024US02539$CIPLA$$$$$$Y$$$20240725$$CN$US$US
241347211$24134721$1$I$20240601$20240717$20240725$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018079$UNITED THERAPEUTICS$$68$YR$$F$Y$57.596$KG$20240725$$$US$US
241347221$24134722$1$I$20230809$20240722$20240725$20240725$PER$$US-IGSA-BIG0025581$GRIFOLS$$75$YR$$M$Y$$$20240725$$CN$US$US
241347231$24134723$1$I$$20240718$20240725$20240725$EXP$$CN-ROCHE-10000030972$ROCHE$$64$YR$A$M$Y$$$20240725$$CN$CN$CN
241347241$24134724$1$I$20240701$20240718$20240725$20240725$EXP$$AU-JNJFOC-20240754188$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240725$$CN$AU$AU
241347251$24134725$1$I$20240722$20240722$20240725$20240725$PER$$US-JNJFOC-20240758946$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240725$$CN$US$US
241347271$24134727$1$I$20230101$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036085$AUROBINDO$$68$YR$$M$Y$$$20240725$$MD$FR$FR
241347281$24134728$1$I$20240601$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146389$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241347292$24134729$2$F$$20240808$20240725$20240813$EXP$$IT-AMGEN-ITASP2024144479$AMGEN$La Torre F.; Coppola C.; Anelli M.G. et al.. Disease activity assessment for juvenile idiopathic arthritis in transitional care. Reumatismo. 2024;76 (2):115-120$$$$$Y$$$20240813$$HP$IT$IT
241347303$24134730$3$F$20240703$20240729$20240725$20240805$30DAY$$US-AMGEN-USASP2024144433$AMGEN$$$$$F$Y$$$20240805$$HP$US$US
241347311$24134731$1$I$20240621$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003090$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240725$$CN$US$US
241347322$24134732$2$F$20240501$20240724$20240725$20240801$EXP$$BR-CELLTRION INC.-2024BR017643$CELLTRION$$$$$$Y$$$20240801$$HP$BR$BR
241347331$24134733$1$I$$20240715$20240725$20240725$30DAY$$US-GSK-US2024088789$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
241347341$24134734$1$I$$20240715$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092224$VIIV$$$$$$Y$$$20240725$$HP$US$US
241347351$24134735$1$I$20231108$20240715$20240725$20240725$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-06732$HIKMA$$$$$$Y$$$20240725$$HP$US$US
241347361$24134736$1$I$20240722$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117814$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240725$$CN$US$US
241347371$24134737$1$I$$20240714$20240725$20240725$PER$$US-JNJFOC-20240740640$JOHNSON AND JOHNSON$$$$$M$Y$$$20240725$$CN$US$US
241347381$24134738$1$I$20240602$20240722$20240725$20240725$EXP$$US-AstraZeneca-2024A166480$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241347391$24134739$1$I$$20240721$20240725$20240725$EXP$$TR-DEXPHARM-2024-2411$DEXCEL$Boyaci, F.; Arslan, U. Causation or Coincidence? A Case of Coexisting Spontaneous Coronary Artery Dissection and Coronary Thrombosis in a Patient with Kounis Syndrome. International Journal of the Cardiovascular Academy 2023, V9, P48-51.$39$YR$A$M$Y$$$20240725$$HP$TR$TR
241347401$24134740$1$I$$20240701$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06631$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241347411$24134741$1$I$20240701$20240716$20240725$20240725$EXP$$KR-CELLTRION INC.-2024KR017604$CELLTRION$$$$$$Y$$$20240725$$MD$KR$KR
241347421$24134742$1$I$$20240718$20240725$20240725$EXP$$CA-APOTEX-2024AP008594$APOTEX$$16$YR$$F$Y$110$KG$20240725$$CN$CA$CA
241347442$24134744$2$F$20240718$20240821$20240725$20240823$PER$$US-AMGEN-USASP2024144849$AMGEN$$79$YR$E$M$Y$$$20240823$$CN$US$US
241347451$24134745$1$I$20240101$20240717$20240725$20240725$PER$$US-AMGEN-USASP2024143349$AMGEN$$$$$M$Y$$$20240725$$MD$US$US
241347471$24134747$1$I$$20240718$20240725$20240725$EXP$$NVSJ2024JP008846$NOVARTIS$$$$$$Y$$$20240725$$PH$JP$JP
241347481$24134748$1$I$$20240723$20240725$20240725$PER$$NVSC2024US151391$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
241347491$24134749$1$I$$20240723$20240725$20240725$EXP$$GB-ABBVIE-5850296$ABBVIE$$54$YR$$M$Y$$$20240725$$PH$GB$GB
241347501$24134750$1$I$$20240722$20240725$20240725$PER$$NVSC2024US152298$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241347511$24134751$1$I$20240602$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003109$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240725$$CN$US$US
241347521$24134752$1$I$20240101$20240717$20240725$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-022157$UNITED THERAPEUTICS$$$$$M$Y$63.492$KG$20240725$$$US$US
241347541$24134754$1$I$$20240722$20240725$20240725$PER$$US-JNJFOC-20240760343$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$HP$US$US
241347551$24134755$1$I$20240305$20240716$20240725$20240725$EXP$$US-BAXTER-2024BAX021718$BAXTER$$55$YR$$M$Y$159.6$KG$20240725$$MD$US$US
241347561$24134756$1$I$20240701$20240718$20240725$20240725$PER$$US-AMGEN-USASP2024144514$AMGEN$$64$YR$A$F$Y$$$20240725$$CN$US$US
241347572$24134757$2$F$20240710$20240726$20240725$20240730$PER$$US-AMGEN-USASP2024146538$AMGEN$$71$YR$E$F$Y$$$20240730$$CN$US$US
241347581$24134758$1$I$$20240715$20240725$20240725$30DAY$$US-GSK-US2024088736$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$HP$US$US
241347591$24134759$1$I$$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003110$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241347601$24134760$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06352$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241347612$24134761$2$F$20240708$20240723$20240725$20240726$PER$$US-ROCHE-10000033140$ROCHE$$$$$$Y$$$20240726$$MD$US$US
241347621$24134762$1$I$$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024145393$AMGEN$$$$$$Y$$$20240725$$PH$US$US
241347633$24134763$3$F$20240702$20240911$20240725$20240919$EXP$$CA-CELLTRION INC.-2024CA017724$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
241347641$24134764$1$I$$20240701$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06704$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241347651$24134765$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06375$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241347661$24134766$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152297$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241347671$24134767$1$I$20240122$20240715$20240725$20240725$EXP$FR-AFSSAPS-TO2024000936$FR-TEVA-VS-3207768$TEVA$$70$YR$$F$Y$55$KG$20240725$$PH$FR$FR
241347682$24134768$2$F$$20240830$20240725$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003112$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
241347691$24134769$1$I$$20240718$20240725$20240725$PER$$US-ABBVIE-5848339$ABBVIE$$35$YR$$F$Y$$$20240725$$CN$US$US
241347701$24134770$1$I$$20240717$20240725$20240725$EXP$$CA-APOTEX-2024AP008547$APOTEX$$84$YR$$F$Y$$$20240725$$HP$CA$CA
241347711$24134771$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06368$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241347721$24134772$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06334$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241347731$24134773$1$I$20230117$20240717$20240725$20240725$EXP$$RU-ABBVIE-5852166$ABBVIE$$68$YR$$F$Y$88$KG$20240725$$MD$RU$RU
241347741$24134774$1$I$$20240716$20240725$20240725$EXP$$OM-ENDO USA, INC.-2024-002967$ENDO$Ellouze NF, Hazra D, Abri SA.. Baclofen-induced neurotoxicity in a dialysis patient managed with continuous venovenous hemodialysis: A case report and literature review. Turkish Journal of Emergency Medicine. 2024;24 (3):176-179$73$YR$$F$Y$$$20240725$$MD$OM$OM
241347751$24134775$1$I$$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003116$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
241347761$24134776$1$I$$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003117$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241347772$24134777$2$F$$20240917$20240725$20240925$EXP$$GR-ROCHE-10000035092$ROCHE$$$$$M$Y$$$20240925$$MD$GR$GR
241347781$24134778$1$I$$20240718$20240725$20240725$PER$$US-JNJFOC-20240750126$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$MD$US$US
241347792$24134779$2$F$20240719$20240807$20240725$20240811$PER$$US-AMGEN-USASP2024144831$AMGEN$$$$$$Y$$$20240811$$PH$US$US
241347801$24134780$1$I$$20240717$20240725$20240725$EXP$$ZA-AstraZeneca-2024A163773$ASTRAZENECA$$77$YR$$F$Y$$$20240725$$CN$ZA$
241347812$24134781$2$F$20240701$20240813$20240725$20240819$PER$$US-AMGEN-USASP2024144431$AMGEN$$69$YR$E$M$Y$$$20240819$$PH$US$US
241347821$24134782$1$I$$20240716$20240725$20240725$EXP$$US-APOTEX-2024AP008628$APOTEX$Ogundare T, Ologun OA. Feeling blue to seeing red: A case of escitalopram-induced epistaxis. Clinical Case Reports. 2024;12 (7): e9128:1-4$33$YR$$F$Y$$$20240725$$HP$US$US
241347831$24134783$1$I$20240721$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015227$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240725$$CN$US$US
241347841$24134784$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015508$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240725$$CN$US$US
241347851$24134785$1$I$$20240711$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407008749$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240725$$CN$US$US
241347861$24134786$1$I$20240723$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015327$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240725$$CN$US$US
241347871$24134787$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016031$ELI LILLY AND CO$$$$$M$Y$$$20240725$$CN$US$US
241347881$24134788$1$I$20230901$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202310000426$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240725$$CN$US$US
241347891$24134789$1$I$$20240717$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407012483$ELI LILLY AND CO$$$$$M$Y$$$20240725$$CN$US$US
241347902$24134790$2$F$20240701$20240723$20240725$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407015151$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240731$$CN$US$US
241347911$24134791$1$I$20240722$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014167$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240725$$CN$US$US
241347921$24134792$1$I$$20240717$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015365$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240725$$CN$US$US
241347931$24134793$1$I$20240720$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014674$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240725$$CN$US$US
241347942$24134794$2$F$$20240725$20240725$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407015338$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240805$$CN$US$US
241347951$24134795$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06376$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241347961$24134796$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06353$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241347971$24134797$1$I$20240501$20240725$20240725$20240725$EXP$FR-AFSSAPS-NC2024000877$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041881$BOEHRINGER INGELHEIM$$7$DY$N$F$Y$2.392$KG$20240725$$MD$FR$FR
241347982$24134798$2$F$$20240807$20240725$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003118$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
241347991$24134799$1$I$20240603$20240717$20240725$20240725$30DAY$$US-GSK-US2024073325$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240725$$MD$US$US
241348011$24134801$1$I$20240709$20240717$20240725$20240725$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-101058$REGENERON$$85$YR$$M$Y$$$20240725$$HP$CO$CO
241348021$24134802$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06807$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241348032$24134803$2$F$20240101$20240807$20240725$20240816$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-18527$SAMSUNG BIOEPIS$$49$YR$A$F$Y$$$20240816$$CN$CA$CA
241348041$24134804$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152330$NOVARTIS$$$$$$Y$$$20240725$$MD$US$US
241348052$24134805$2$F$$20240828$20240725$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003120$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
241348061$24134806$1$I$$20240723$20240725$20240725$PER$$US-GILEAD-2024-0681701$GILEAD$$$$A$M$Y$$$20240725$$CN$US$US
241348071$24134807$1$I$$20240719$20240725$20240725$EXP$$US-KYOWAKIRIN-2024KK017541$KYOWA$$$$$$Y$$$20240725$$HP$US$US
241348081$24134808$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06365$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241348091$24134809$1$I$$20240721$20240725$20240725$PER$$US-LEO Pharma-372225$LEO PHARM$$36$YR$$M$Y$$$20240725$$PH$US$US
241348104$24134810$4$F$20240611$20240905$20240725$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003121$ACADIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240916$$CN$US$US
241348111$24134811$1$I$$20240717$20240725$20240725$PER$$US-TAKEDA-2024TUS072581$TAKEDA$$$$$$Y$$$20240725$$CN$US$US
241348123$24134812$3$F$20240401$20240821$20240725$20240821$PER$$US-ALXN-202407USA001322US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240821$$MD$US$US
241348132$24134813$2$F$$20240808$20240725$20240813$30DAY$$AR-JNJFOC-20240722834$JOHNSON AND JOHNSON$$60$YR$A$F$Y$90$KG$20240813$$CN$AR$AR
241348141$24134814$1$I$$20240718$20240725$20240725$EXP$$AR-AMGEN-ARGSP2024145583$AMGEN$$75$YR$E$F$Y$$$20240725$$CN$AR$AR
241348151$24134815$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146411$AMGEN$$$$$$Y$$$20240725$$MD$US$US
241348161$24134816$1$I$$20240713$20240725$20240725$EXP$$JP-AMGEN-JPNSP2024146020$AMGEN$$$$A$F$Y$$$20240725$$MD$JP$JP
241348181$24134818$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06329$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241348191$24134819$1$I$20240701$20240722$20240725$20240725$EXP$$US-ABBVIE-5850075$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241348202$24134820$2$F$20240501$20240725$20240725$20240727$EXP$$US-ABBVIE-5845187$ABBVIE$$58$YR$$F$Y$$$20240727$$CN$US$US
241348212$24134821$2$F$20240101$20240830$20240725$20240909$EXP$$CA-CELLTRION INC.-2024CA016137$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
241348221$24134822$1$I$20240601$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003133$ACADIA PHARMACEUTICALS$$58$YR$$F$Y$$$20240725$$CN$US$US
241348231$24134823$1$I$20240625$20240718$20240725$20240725$PER$$US-AMGEN-USASP2024144493$AMGEN$$53$YR$A$F$Y$$$20240725$$CN$US$US
241348241$24134824$1$I$20240705$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024143896$AMGEN$$67$YR$E$F$Y$$$20240725$$CN$US$US
241348251$24134825$1$I$20240719$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145712$AMGEN$$62$YR$A$F$Y$$$20240725$$CN$US$US
241348261$24134826$1$I$20240701$20240724$20240725$20240725$EXP$$GR-ABBVIE-5852099$ABBVIE$$64$YR$$F$Y$$$20240725$$CN$GR$GR
241348271$24134827$1$I$20240508$20240722$20240725$20240725$EXP$$US-ABBVIE-5851596$ABBVIE$$47$YR$$M$Y$$$20240725$$CN$US$US
241348282$24134828$2$F$$20240726$20240725$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003150$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
241348291$24134829$1$I$20220101$20220219$20240725$20240725$EXP$$US-AstraZeneca-2022A083039$ASTRAZENECA$$540$MON$$F$Y$$$20240725$$CN$US$
241348301$24134830$1$I$$20230518$20240725$20240725$EXP$$US-AstraZeneca-2023A111903$ASTRAZENECA$$3778$WK$$M$Y$$$20240725$$CN$US$
241348311$24134831$1$I$$20231013$20240725$20240725$EXP$$US-AstraZeneca-2023A235292$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241348321$24134832$1$I$$20220209$20240725$20240725$EXP$$BR-AstraZeneca-2022A071503$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$BR$
241348331$24134833$1$I$$20240717$20240725$20240725$PER$$US-ROCHE-10000030496$ROCHE$$$$$M$Y$$$20240725$$CN$US$US
241348343$24134834$3$F$20240301$20240717$20240725$20240805$EXP$$US-ROCHE-10000030145$ROCHE$$$$$F$Y$3.08$KG$20240805$$CN$US$US
241348351$24134835$1$I$20240101$20240712$20240725$20240725$PER$$US-TEVA-VS-3222032$TEVA$$71$YR$$F$Y$77.11$KG$20240725$$CN$US$US
241348361$24134836$1$I$20020101$20240707$20240725$20240725$PER$$US-TEVA-VS-3219719$TEVA$$31$YR$$F$Y$$$20240725$$CN$US$US
241348371$24134837$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152025$NOVARTIS$$$$$M$Y$$$20240725$$CN$US$US
241348381$24134838$1$I$20240709$20240715$20240725$20240725$30DAY$$US-GSK-US2024088720$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240725$$HP$US$US
241348392$24134839$2$F$20230101$20240710$20240725$20240726$PER$$US-TEVA-2023-US-2920902$TEVA$$66$YR$$M$Y$$$20240726$$CN$US$US
241348403$24134840$3$F$$20240904$20240725$20240904$PER$$US-JNJFOC-20240762832$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$CN$US$US
241348411$24134841$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117745$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240725$$CN$US$US
241348422$24134842$2$F$$20240816$20240725$20240819$EXP$$US-ALXN-202407USA001441US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241348431$24134843$1$I$$20240719$20240725$20240725$PER$$NVSC2024US152334$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
241348442$24134844$2$F$$20240815$20240725$20240819$PER$$US-ALXN-202407USA001403US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241348451$24134845$1$I$20240719$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015109$ELI LILLY AND CO$$52$YR$A$$Y$$$20240725$$CN$US$US
241348461$24134846$1$I$20240601$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014228$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240725$$HP$US$US
241348471$24134847$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015118$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240725$$CN$US$US
241348482$24134848$2$F$20240723$20240723$20240725$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015193$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240726$$CN$US$US
241348491$24134849$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015181$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240725$$CN$US$US
241348501$24134850$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016042$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240725$$CN$US$US
241348511$24134851$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015196$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240725$$CN$US$US
241348521$24134852$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016035$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240725$$CN$US$US
241348531$24134853$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015251$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240725$$CN$US$US
241348541$24134854$1$I$20240720$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015481$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240725$$CN$US$US
241348551$24134855$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015496$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240725$$CN$US$US
241348561$24134856$1$I$20240721$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014136$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240725$$CN$US$US
241348572$24134857$2$F$20240701$20240805$20240725$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003151$ACADIA PHARMACEUTICALS$$29$YR$$F$Y$$$20240828$$CN$US$US
241348581$24134858$1$I$20240722$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146500$AMGEN$$$$$M$Y$$$20240725$$CN$US$US
241348591$24134859$1$I$$20240705$20240725$20240725$PER$$CA-TOLMAR, INC.-24CA050860$TOLMAR$$$$$M$Y$$$20240725$$CN$CA$CA
241348601$24134860$1$I$20240625$20240704$20240725$20240725$PER$$CA-TOLMAR, INC.-24CA050857$TOLMAR$$79$YR$$M$Y$$$20240725$$CN$CA$CA
241348641$24134864$1$I$$20240705$20240725$20240725$PER$$CA-TOLMAR, INC.-24CA050889$TOLMAR$$$$$M$Y$$$20240725$$CN$CA$CA
241348651$24134865$1$I$20240630$20240701$20240725$20240725$PER$$FR-TOLMAR, INC.-24FR050735$TOLMAR$$66$YR$$M$Y$$$20240725$$PH$FR$FR
241348661$24134866$1$I$20240702$20240702$20240725$20240725$PER$$FR-TOLMAR, INC.-24FR050778$TOLMAR$$74$YR$$M$Y$$$20240725$$PH$FR$FR
241348671$24134867$1$I$20240601$20240703$20240725$20240725$PER$$CO-TOLMAR, INC.-24CO050760$TOLMAR$$72$YR$$M$Y$$$20240725$$CN$CO$CO
241348681$24134868$1$I$20240702$20240702$20240725$20240725$PER$$FR-TOLMAR, INC.-24FR050776$TOLMAR$$74$YR$$M$Y$$$20240725$$PH$FR$FR
241348691$24134869$1$I$20240608$20240701$20240725$20240725$PER$$HK-TOLMAR, INC.-24HK050405$TOLMAR$$11$YR$$F$Y$$$20240725$$MD$HK$HK
241348701$24134870$1$I$$20240716$20240725$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-116472$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$73$KG$20240725$$MD$CA$CA
241348711$24134871$1$I$20240101$20240701$20240725$20240725$PER$$GT-TOLMAR, INC.-24GT050738$TOLMAR$$$$$M$Y$$$20240725$$CN$GT$GT
241348722$24134872$2$F$$20240731$20240725$20240829$PER$$HN-TOLMAR, INC.-24HN050330$TOLMAR$$$$$F$Y$$$20240829$$CN$HN$HN
241348731$24134873$1$I$20240429$20240701$20240725$20240725$PER$$IT-TOLMAR, INC.-24IT050664$TOLMAR$$$$$$Y$$$20240725$$MD$IT$IT
241348741$24134874$1$I$20240628$20240701$20240725$20240725$PER$$TR-TOLMAR, INC.-24TR050661$TOLMAR$$76$YR$$M$Y$$$20240725$$MD$TR$TR
241348755$24134875$5$F$20240101$20240911$20240725$20240919$EXP$$CA-CELLTRION INC.-2024CA016726$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
241348761$24134876$1$I$20240718$20240722$20240725$20240725$EXP$$US-ABBVIE-5653722$ABBVIE$$79$YR$$F$Y$$$20240725$$CN$US$US
241348771$24134877$1$I$$20240718$20240725$20240725$EXP$$JP-ABBVIE-5524340$ABBVIE$Hosomi S, Nishida Y, Fujiwara Y. Efficacy of upadacitinib as a second-line jak inhibitor in ulcerative colitis: a case series. Intern Med. 2024;63(13):1882-5.; Hosomi S, Nishida Y, Fujiwara Y. Efficacy of upadacitinib as a second-line JAK inhibitor in ulcerative colitis: a case series. Intern Med. 2023:1-4.$47$YR$$M$Y$$$20240725$$MD$JP$JP
241348781$24134878$1$I$20240717$20240719$20240725$20240725$30DAY$$IT-SANDOZ INC.-SDZ2024IT067562$SANDOZ$$10$YR$$$Y$28$KG$20240725$$CN$IT$IT
241348791$24134879$1$I$$20240709$20240725$20240725$PER$$US-Norvium Bioscience LLC-000001$Norvium Bioscience$$62$YR$A$F$Y$$$20240725$$CN$US$US
241348801$24134880$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06742$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241348811$24134881$1$I$20240701$20240721$20240725$20240725$EXP$$CA-JNJFOC-20240756473$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240725$$HP$CA$CA
241348821$24134882$1$I$20240701$20240716$20240725$20240725$EXP$$US-GSK-US2024AMR090630$GLAXOSMITHKLINE$$93$YR$$F$Y$60$KG$20240725$$CN$US$US
241348832$24134883$2$F$20240101$20240910$20240725$20240913$EXP$$US-ABBVIE-5849823$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
241348842$24134884$2$F$$20240808$20240725$20240810$PER$$NVSC2024US152335$NOVARTIS$$$$$F$Y$$$20240810$$CN$US$US
241348853$24134885$3$F$$20240905$20240725$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003169$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241348863$24134886$3$F$$20240822$20240725$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003173$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
241348872$24134887$2$F$$20240726$20240725$20240731$PER$$US-LEO Pharma-372252$LEO PHARM$$50$YR$$F$Y$$$20240731$$CN$US$US
241348881$24134888$1$I$$20240718$20240725$20240725$PER$US-MLMSERVICE-20240711-PI128860-00165-1$US-RDY-SPO/USA/24/0010751$DR REDDYS$Gault KS. THE ROLE OF PHYSICAL THERAPY WITHIN A MULTIDISCIPLINARY PANCREATIC CANCER CLINIC TO OPTIMIZE CARE. Rehabilitation Oncology. 2024;42(2):119. DOI:10.1097/01.REO.0000000000000365.$78$YR$E$F$Y$$$20240725$$MD$US$US
241348892$24134889$2$F$$20240816$20240725$20240828$EXP$$CZ-SA-2024SA213170$SANOFI AVENTIS$$$$E$F$Y$$$20240828$$MD$CZ$CZ
241348911$24134891$1$I$20240113$20240722$20240725$20240725$EXP$$ES-PCCINC-2024-PPL-000549$PIRAMAL$$$$$$Y$$$20240725$$MD$ES$ES
241348921$24134892$1$I$20240702$20240718$20240725$20240725$EXP$$IT-AUROBINDO-AUR-APL-2024-036347$AUROBINDO$$80$YR$$M$Y$$$20240725$$PH$IT$IT
241348932$24134893$2$F$$20240729$20240725$20240812$EXP$$US-ARDELYX-2024ARDX005438$ARDELYX$$57$YR$$M$Y$$$20240812$$HP$US$US
241348943$24134894$3$F$20240724$20240903$20240725$20240904$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-102116$REGENERON$$77$YR$$M$Y$$$20240904$$MD$JP$JP
241348953$24134895$3$F$$20240829$20240725$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003095$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
241348961$24134896$1$I$20240701$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003172$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240725$$CN$US$US
241348981$24134898$1$I$$20240724$20240725$20240725$30DAY$$US-SANDOZ INC.-SDZ2024US067912$SANDOZ$$$$$F$Y$$$20240725$$HP$US$US
241348991$24134899$1$I$$20240718$20240725$20240725$EXP$$GB-AUROBINDO-AUR-APL-2024-035918$AUROBINDO$$$$$$Y$$$20240725$$CN$GB$GB
241349001$24134900$1$I$$20240723$20240725$20240725$EXP$$CA-ORGANON-O2407CAN002142$ORGANON$$44$YR$$F$Y$$$20240725$$HP$CA$CA
241349011$24134901$1$I$20230101$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A141805$ASTRAZENECA$$79$YR$$F$Y$$$20240725$$MD$JP$
241349021$24134902$1$I$20240101$20240723$20240725$20240725$EXP$SE-SEMPA-2024-005602$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-117811$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240725$$MD$SE$SE
241349031$24134903$1$I$$20240716$20240725$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-117479$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$MD$JP$JP
241349041$24134904$1$I$$20240716$20240725$20240725$PER$$US-JNJFOC-20240743124$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
241349051$24134905$1$I$$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024143887$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241349061$24134906$1$I$20240708$20240711$20240725$20240725$PER$$US-TEVA-VS-3222162$TEVA$$44$YR$$M$Y$90.72$KG$20240725$$CN$US$US
241349073$24134907$3$F$$20240906$20240725$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003176$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241349081$24134908$1$I$20240623$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003096$ACADIA PHARMACEUTICALS$$91$YR$$M$Y$$$20240725$$CN$US$US
241349104$24134910$4$F$20231216$20240925$20240725$20240927$EXP$$DE-SANDOZ INC.-SDZ2024DE066428$SANDOZ$$58$YR$$F$Y$$$20240927$$MD$DE$DE
241349111$24134911$1$I$20240707$20240718$20240725$20240725$EXP$$CN-ROCHE-10000030979$ROCHE$$56$YR$A$F$Y$67$KG$20240725$$HP$CN$CN
241349121$24134912$1$I$$20240718$20240725$20240725$EXP$$CZ-AUROBINDO-AUR-APL-2024-036415$AUROBINDO$Sitina M, Sramek V.. Euglykemicka ketoacidoza asociovana se SGLT2 inhibitory a DPP4 inhibitory ? rozbor kazuistik. Anesteziologie a intenzivni medicina. 2024;35(2):116-21$59$YR$$F$Y$$$20240725$$MD$CZ$CZ
241349131$24134913$1$I$20240701$20240715$20240725$20240725$PER$$US-GAMIDA CELL LTD.-GC-24US000012$GAMIDA CELL$$$$$M$Y$$$20240724$$HP$US$US
241349142$24134914$2$F$$20240730$20240725$20240814$EXP$$DE-INSMED, INC.-2024-02852-DE$INSMED$$45$YR$$M$Y$$$20240814$$CN$DE$DE
241349151$24134915$1$I$$20240711$20240725$20240725$EXP$$US-INSMED, INC.-2024-02875-US$INSMED$$$$$F$Y$$$20240725$$CN$US$US
241349161$24134916$1$I$20240415$20240715$20240725$20240725$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS003743$TERSERA THERAPEUTICS$$$$$$Y$$$20240725$$CN$NL$NL
241349171$24134917$1$I$20240315$20240625$20240725$20240725$PER$$US-GAMIDA CELL LTD.-GC-24US000011$GAMIDA CELL$$21$YR$$M$Y$70$KG$20240724$$MD$US$US
241349181$24134918$1$I$20240618$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003099$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240725$$CN$US$US
241349191$24134919$1$I$$20240716$20240725$20240725$PER$$US-AMGEN-USASP2024143666$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241349201$24134920$1$I$20240101$20240724$20240725$20240725$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041840$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240725$$CN$US$US
241349212$24134921$2$F$20240725$20240730$20240725$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003177$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240822$$CN$US$US
241349221$24134922$1$I$20240609$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003098$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240725$$CN$US$US
241349231$24134923$1$I$20240614$20240723$20240725$20240725$EXP$FR-AFSSAPS-AVCN2024000554$FR-SANDOZ INC.-SDZ2024FR067541$SANDOZ$$21$YR$$M$Y$$$20240725$$MD$FR$FR
241349241$24134924$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06340$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241349251$24134925$1$I$$20240723$20240725$20240725$EXP$$GB-SANDOZ INC.-SDZ2024GB067707$SANDOZ$$65$YR$$F$Y$$$20240725$$PH$GB$GB
241349263$24134926$3$F$20231012$20240726$20240725$20240726$EXP$$JP-Merz Pharmaceuticals GmbH-24-02049$MERZ$$87$YR$$M$Y$51.3$KG$20240726$$MD$JP$JP
241349271$24134927$1$I$20240508$20240716$20240725$20240725$EXP$IT-MINISAL02-993159$IT-SANDOZ INC.-SDZ2024IT067886$SANDOZ$$62$YR$$F$Y$$$20240725$$MD$IT$IT
241349281$24134928$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117890$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240725$$CN$US$US
241349292$24134929$2$F$20160101$20240729$20240725$20240731$EXP$$FR-SANDOZ INC.-PHHY2016FR186004$SANDOZ$$85$YR$$F$Y$60$KG$20240731$$MD$FR$FR
241349303$24134930$3$F$$20240819$20240725$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002867$ACADIA PHARMACEUTICALS$$$$$M$Y$75$KG$20240830$$CN$US$US
241349311$24134931$1$I$$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003178$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241349321$24134932$1$I$20240601$20240717$20240725$20240725$EXP$$US-SANDOZ INC.-SDZ2024US067772$SANDOZ$$55$YR$$F$Y$52.6$KG$20240725$$CN$US$US
241349331$24134933$1$I$20240601$20240722$20240725$20240725$EXP$$CA-ABBVIE-5851713$ABBVIE$$61$YR$$F$Y$$$20240725$$CN$CA$CA
241349341$24134934$1$I$20240722$20240723$20240725$20240725$EXP$$FR-ABBVIE-5852089$ABBVIE$$74$YR$$M$Y$$$20240725$$CN$FR$FR
241349352$24134935$2$F$$20240813$20240725$20240813$PER$$US-ALXN-202407USA001307US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240813$$CN$US$US
241349362$24134936$2$F$$20240731$20240725$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003065$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241349371$24134937$1$I$20240601$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003063$ACADIA PHARMACEUTICALS$$84$YR$$F$Y$$$20240725$$CN$US$US
241349381$24134938$1$I$20240621$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003060$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240725$$CN$US$US
241349392$24134939$2$F$20240701$20240819$20240725$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003066$ACADIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240912$$CN$US$US
241349401$24134940$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06748$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241349412$24134941$2$F$$20240724$20240725$20240730$EXP$$GB-SANDOZ INC.-SDZ2024GB064729$SANDOZ$$38$YR$$F$Y$$$20240730$$MD$GB$GB
241349421$24134942$1$I$$20240720$20240725$20240725$EXP$$US-JNJFOC-20240755688$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$MD$US$US
241349432$24134943$2$F$20240723$20240729$20240725$20240805$EXP$$JP-JNJFOC-20240767092$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240805$$CN$JP$JP
241349441$24134944$1$I$20240601$20240716$20240725$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019570$UNITED THERAPEUTICS$$40$YR$$F$Y$89.342$KG$20240725$$$US$US
241349451$24134945$1$I$20240101$20240723$20240725$20240725$EXP$$GB-UCBSA-2024037144$UCB$$$$$F$Y$$$20240725$$CN$GB$GB
241349462$24134946$2$F$20240611$20240725$20240725$20240729$EXP$$IN-ROCHE-10000027672$ROCHE$$69$YR$E$F$Y$49$KG$20240729$$HP$IN$IN
241349471$24134947$1$I$20240614$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003069$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240725$$CN$US$US
241349483$24134948$3$F$$20240926$20240725$20240927$EXP$$NVSC2024US151087$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
241349491$24134949$1$I$20240619$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003077$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240725$$CN$US$US
241349501$24134950$1$I$$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003071$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241349511$24134951$1$I$20200817$20240718$20240725$20240725$EXP$PL-URPL-1-1937-2020$PL-AMGEN-POLSP2024146290$AMGEN$$21$YR$A$F$Y$49$KG$20240725$$MD$PL$PL
241349531$24134953$1$I$$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003086$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241349541$24134954$1$I$$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003079$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241349551$24134955$1$I$20240701$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003085$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240725$$CN$US$US
241349561$24134956$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146686$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241349572$24134957$2$F$20240714$20240820$20240725$20240824$PER$$US-AMGEN-USASP2024145297$AMGEN$$76$YR$E$M$Y$$$20240824$$CN$US$US
241349581$24134958$1$I$20240112$20240620$20240725$20240725$EXP$$CA-CELLTRION INC.-2022CA022615$CELLTRION$$$$$$Y$$$20240725$$MD$CA$CA
241349591$24134959$1$I$20240101$20240717$20240725$20240725$EXP$$CA-CELLTRION INC.-2024CA017824$CELLTRION$$$$$$Y$$$20240725$$HP$CA$CA
241349601$24134960$1$I$20230101$20240722$20240725$20240725$EXP$$US-ABBVIE-5829667$ABBVIE$$$$$F$Y$90$KG$20240725$$CN$US$US
241349611$24134961$1$I$20240628$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003101$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240725$$CN$US$US
241349621$24134962$1$I$20240626$20240724$20240725$20240725$EXP$IT-MINISAL02-993575$IT-SANDOZ INC.-SDZ2024IT067879$SANDOZ$$74$YR$$F$Y$$$20240725$$PH$IT$IT
241349631$24134963$1$I$20240711$20240717$20240725$20240725$EXP$$CA-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00759$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$CA$CA
241349641$24134964$1$I$$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003100$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241349652$24134965$2$F$20240718$20240819$20240725$20240822$PER$$US-AMGEN-USASP2024144349$AMGEN$$81$YR$E$M$Y$$$20240822$$CN$US$US
241349662$24134966$2$F$$20240823$20240725$20240828$30DAY$$US-ROCHE-10000029716$ROCHE$$$$$$Y$$$20240828$$HP$US$US
241349681$24134968$1$I$$20240722$20240725$20240725$EXP$$US-JNJFOC-20240760640$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240725$$HP$US$US
241349692$24134969$2$F$20240627$20240719$20240725$20240728$EXP$$US-JNJFOC-20240750474$JOHNSON AND JOHNSON$$69$YR$$F$Y$$$20240729$$CN$US$US
241349701$24134970$1$I$20220101$20240723$20240725$20240725$EXP$$DE-SANDOZ INC.-SDZ2024DE067253$SANDOZ$$19$YR$$M$Y$$$20240725$$MD$DE$DE
241349711$24134971$1$I$20240101$20240717$20240725$20240725$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-008232$UNITED THERAPEUTICS$$11$YR$$M$Y$$$20240725$$MD$JP$JP
241349721$24134972$1$I$20240101$20240710$20240725$20240725$EXP$$US-INSMED, INC.-2024-01926-US$INSMED$$$$$M$Y$$$20240725$$CN$US$US
241349731$24134973$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06839$LUPIN$$$$$$Y$$$20240725$$PH$US$US
241349745$24134974$5$F$$20240801$20240725$20240805$EXP$$US-SANDOZ INC.-SDZ2024US067092$SANDOZ$$$$$F$Y$$$20240805$$HP$US$US
241349761$24134976$1$I$20240609$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003103$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240725$$CN$US$US
241349771$24134977$1$I$$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002642$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
241349781$24134978$1$I$$20240715$20240725$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-022216$UNITED THERAPEUTICS$$$$C$F$Y$$$20240725$$$US$US
241349791$24134979$1$I$$20240715$20240725$20240725$EXP$$US-NOVOPROD-1258980$NOVO NORDISK$LeSage, Brian et al.,. Massive Pulmonary Embolism with Venoarterial Extracorporeal Membrane Oxygenation Rescue In A Patient Recently Started On Semaglutide: A Case Report. ASAIO Journal. 2024$45$YR$$F$Y$$$20240725$$HP$US$US
241349801$24134980$1$I$20240711$20240716$20240725$20240725$EXP$CN-NMPA-5133211029850202400113$CN-NOVOPROD-1257544$NOVO NORDISK$$41$YR$$M$Y$85.4$KG$20240725$$HP$CN$CN
241349811$24134981$1$I$20240703$20240715$20240725$20240725$EXP$$US-NOVOPROD-1257626$NOVO NORDISK$$64$YR$$F$Y$$$20240725$$MD$US$US
241349821$24134982$1$I$19980101$20240715$20240725$20240725$EXP$NZ-Medsafe-149179$NZ-NOVOPROD-1258558$NOVO NORDISK$$22$YR$$M$Y$$$20240725$$CN$NZ$NZ
241349834$24134983$4$F$20240101$20240913$20240725$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-021647$UNITED THERAPEUTICS$$$$$M$Y$135.15$KG$20240921$$$US$US
241349841$24134984$1$I$20240402$20240715$20240725$20240725$EXP$NZ-Medsafe-155832$NZ-NOVOPROD-1258600$NOVO NORDISK$$76$YR$$M$Y$$$20240725$$PH$NZ$NZ
241349851$24134985$1$I$$20240716$20240725$20240725$EXP$$US-NOVOPROD-1258247$NOVO NORDISK$$$$$F$Y$$$20240725$$CN$US$US
241349861$24134986$1$I$20240701$20240715$20240725$20240725$EXP$$US-NOVOPROD-1257029$NOVO NORDISK$$66$YR$$M$Y$$$20240725$$CN$US$US
241349871$24134987$1$I$20240303$20240715$20240725$20240725$EXP$$US-NOVOPROD-1258150$NOVO NORDISK$$79$YR$$F$Y$$$20240725$$CN$US$US
241349882$24134988$2$F$20240109$20240916$20240725$20240926$EXP$$NL-NOVOPROD-1257408$NOVO NORDISK$$83$YR$$F$Y$75$KG$20240926$$HP$NL$NL
241349892$24134989$2$F$$20240822$20240725$20240904$EXP$$US-NOVOPROD-1258183$NOVO NORDISK$$$$$F$Y$$$20240904$$MD$US$US
241349901$24134990$1$I$$20240715$20240725$20240725$EXP$$US-NOVOPROD-1258066$NOVO NORDISK$$$$$M$Y$$$20240725$$CN$US$US
241349911$24134991$1$I$20230101$20240715$20240725$20240725$EXP$$US-NOVOPROD-1257418$NOVO NORDISK$$50$YR$$F$Y$$$20240725$$CN$US$US
241349931$24134993$1$I$20240301$20240715$20240725$20240725$EXP$$US-NOVOPROD-1257000$NOVO NORDISK$$69$YR$$F$Y$$$20240725$$CN$US$US
241349943$24134994$3$F$20240608$20240905$20240725$20240916$EXP$$US-NOVOPROD-1258951$NOVO NORDISK$$48$YR$$F$Y$$$20240916$$MD$US$US
241349951$24134995$1$I$20231001$20240715$20240725$20240725$EXP$$BR-CELLTRION INC.-2024BR010554$CELLTRION$$$$$$Y$$$20240725$$CN$BR$BR
241349961$24134996$1$I$20240409$20240712$20240725$20240725$EXP$GB-MHRA-MED-202407121230391680-TWMFS$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001806$IPCA$$$$$$Y$$$20240725$$CN$GB$GB
241349972$24134997$2$F$$20240725$20240725$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003102$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
241349986$24134998$6$F$20240713$20240816$20240725$20240823$EXP$$KR-CELLTRION INC.-2024KR017568$CELLTRION$$$$$$Y$$$20240823$$MD$KR$KR
241349991$24134999$1$I$$20240721$20240725$20240725$EXP$$US-JNJFOC-20240759611$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240725$$HP$US$US
241350001$24135000$1$I$20240717$20240717$20240725$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022184$UNITED THERAPEUTICS$$43$YR$$F$Y$52.154$KG$20240725$$PH$US$US
241350012$24135001$2$F$20240627$20240812$20240725$20240814$30DAY$$US-JNJFOC-20240759304$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240814$$HP$US$US
241350021$24135002$1$I$$20240723$20240725$20240725$EXP$$CA-ORGANON-O2407CAN002176$ORGANON$$43$YR$$F$Y$$$20240725$$MD$CA$CA
241350031$24135003$1$I$20240701$20240716$20240725$20240725$EXP$$GB-NOVOPROD-1256712$NOVO NORDISK$$45$YR$$F$Y$92$KG$20240725$$PH$GB$GB
241350041$24135004$1$I$$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003104$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241350051$24135005$1$I$20240419$20240716$20240725$20240725$EXP$SE-SEMPA-2024-005524$SE-NOVOPROD-1257341$NOVO NORDISK$$44$YR$$M$Y$$$20240725$$MD$SE$SE
241350061$24135006$1$I$20240301$20240718$20240725$20240725$EXP$DK-DKMA-30735573$DK-NOVOPROD-1259145$NOVO NORDISK$$82$YR$$F$Y$92$KG$20240725$$MD$DK$DK
241350071$24135007$1$I$$20240718$20240725$20240725$EXP$$JP-NOVOPROD-1259368$NOVO NORDISK$$79$YR$$F$Y$$$20240725$$PH$JP$JP
241350081$24135008$1$I$$20240716$20240725$20240725$EXP$GB-MHRA-MED-202407161232045940-VNCGB$GB-NOVOPROD-1256723$NOVO NORDISK$$31$YR$$F$Y$$$20240725$$CN$GB$GB
241350091$24135009$1$I$20240716$20240716$20240725$20240725$EXP$$MX-NOVOPROD-1201251$NOVO NORDISK$$58$YR$$F$Y$76$KG$20240725$$CN$MX$MX
241350101$24135010$1$I$$20240717$20240725$20240725$EXP$$TR-NOVOPROD-1259789$NOVO NORDISK$$$$$M$Y$$$20240725$$CN$TR$TR
241350111$24135011$1$I$$20240717$20240725$20240725$EXP$$GB-NOVOPROD-1257675$NOVO NORDISK$$$$$$Y$$$20240725$$HP$GB$GB
241350121$24135012$1$I$20240713$20240716$20240725$20240725$EXP$$AU-NOVOPROD-1253589$NOVO NORDISK$$$$$M$Y$$$20240725$$CN$AU$AU
241350131$24135013$1$I$20231222$20240716$20240725$20240725$EXP$GB-MHRA-MED-202407161456297610-RWGHY$GB-NOVOPROD-1256752$NOVO NORDISK$$42$YR$$F$Y$$$20240725$$MD$GB$GB
241350141$24135014$1$I$20240715$20240716$20240725$20240725$EXP$GB-MHRA-MED-202407160955424540-ZWJMC$GB-NOVOPROD-1256709$NOVO NORDISK$$$$$$Y$85$KG$20240725$$PH$GB$GB
241350151$24135015$1$I$20220101$20240716$20240725$20240725$EXP$SE-SEMPA-2024-005517$SE-NOVOPROD-1257340$NOVO NORDISK$$60$YR$$M$Y$$$20240725$$MD$SE$SE
241350161$24135016$1$I$20240516$20240716$20240725$20240725$EXP$$US-NOVOPROD-1226610$NOVO NORDISK$$78$YR$$F$Y$97.7$KG$20240725$$MD$US$US
241350171$24135017$1$I$20240101$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146342$AMGEN$$31$YR$A$F$Y$$$20240725$$HP$US$US
241350181$24135018$1$I$$20240716$20240725$20240725$EXP$$AU-INFO-20240210$INFORLIFE$Stone C, Bertolotti A, Davey L, Murrell DF. Atypical fixed drug eruption in confetti due to paracetamol. Dermatologica Sinica. 2024;42(2):160-1. DOI: 10.4103/ds.DS-D-23-00161$$$$F$Y$$$20240717$$MD$AU$
241350191$24135019$1$I$20240720$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145480$AMGEN$$80$YR$E$$Y$$$20240725$$CN$US$US
241350201$24135020$1$I$$20240716$20240725$20240725$EXP$$US-INFO-20240211$INFORLIFE$Gaur D, Michalopulos MG, Drake KA, Gattineni J. Acetaminophen induced high anion gap metabolic acidosis: a potentially under-recognized consequence from a common medication. Pediatric Nephrology. 2024. DOI: 10.1007/s00467-024-06396-4.$12$YR$C$F$Y$$$20240717$$MD$US$
241350211$24135021$1$I$$20240716$20240725$20240725$EXP$$AU-INFO-20240209$INFORLIFE$Stone C, Bertolotti A, Davey L, Murrell DF. Atypical fixed drug eruption in confetti due to paracetamol. Dermatologica Sinica. 2024;42(2):160-1. DOI: 10.4103/ds.DS-D-23-00161$45$YR$A$F$Y$$$20240717$$MD$AU$
241350221$24135022$1$I$20240719$20240719$20240725$20240725$PER$$US-JNJFOC-20240755977$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240725$$HP$US$US
241350231$24135023$1$I$$20240722$20240725$20240725$EXP$$US-JNJFOC-20240757531$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
241350241$24135024$1$I$$20240714$20240725$20240725$EXP$$TN-INFO-20240214$INFORLIFE$Dridi B, Agrebi M, Sahnoun D, Ben Salem C. Metronidazole-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome With Parvovirus B19 Reactivation: A Pediatric Case. Cureus. 2024 Jun 11;16(6):e62125. doi: 10.7759/cureus.62125. PMID: 38993456; PMCID: PMC11238016.$10$YR$C$F$Y$$$20240717$$MD$TN$
241350251$24135025$1$I$$20240719$20240725$20240725$EXP$$US-AstraZeneca-2024A166079$ASTRAZENECA$$59$YR$$M$Y$$$20240725$$CN$US$
241350261$24135026$1$I$20240601$20240716$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113641$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240725$$HP$US$US
241350271$24135027$1$I$20240101$20240722$20240725$20240725$EXP$$US-JNJFOC-20240760827$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240725$$HP$US$US
241350281$24135028$1$I$20240701$20240719$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116447$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$82.1$KG$20240725$$PH$US$US
241350291$24135029$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117660$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240725$$CN$US$US
241350301$24135030$1$I$$20240719$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115609$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240725$$HP$US$US
241350311$24135031$1$I$$20240710$20240725$20240725$EXP$$US-BRAINTREE LABORATORIES, INC.-2024BTE00446$BRAINTREE$Zaher EA, Ebrahim MA, Patel P, Adhikari B. Cardiac Arrest Following GoLytely Consumption: A Potential Trigger for Hypovolemic Shock. Cureus. 16(6):e61486$71$YR$$M$Y$$$20240725$$HP$US$US
241350321$24135032$1$I$$20210722$20240725$20240725$EXP$$NL-TERSERA THERAPEUTICS LLC-2021TRS003612$TERSERA THERAPEUTICS$$$$$$Y$$$20240725$$MD$NL$NL
241350331$24135033$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015198$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240725$$CN$US$US
241350341$24135034$1$I$20240723$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015538$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240725$$CN$US$US
241350351$24135035$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015336$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240725$$CN$US$US
241350361$24135036$1$I$20240723$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015322$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240725$$CN$US$US
241350371$24135037$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015411$ELI LILLY AND CO$$$$A$F$Y$$$20240725$$CN$US$US
241350381$24135038$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015240$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240725$$CN$US$US
241350391$24135039$1$I$$20240719$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407013537$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240725$$CN$US$US
241350402$24135040$2$F$$20240911$20240725$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202407014988$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240916$$CN$US$US
241350411$24135041$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015963$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240725$$CN$US$US
241350421$24135042$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015220$ELI LILLY AND CO$$$$$F$Y$$$20240725$$CN$US$US
241350432$24135043$2$F$$20240723$20240725$20240806$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-15825$ALKEM$Li Y, Liu Y, Sun X, Wang Y, She D, Zhang Z.. Insulin autoimmune syndrome caused by esomeprazole in a Chinese patient. Endokrynologia Polska. 2022;73(6):994-995$58$YR$$M$Y$70$KG$20240806$$HP$CN$CN
241350441$24135044$1$I$20230501$20240722$20240725$20240725$EXP$$FR-GILEAD-2024-0681496$GILEAD$$49$YR$A$F$Y$$$20240725$$PH$FR$FR
241350451$24135045$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06845$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241350461$24135046$1$I$$20240711$20240725$20240725$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-15772$ALKEM$Talarico G, Tosto G, Pietracupa S, Piacentini E, Canevelli M, Lenzi GL, Bruno G.. Serotonin toxicity: a short review of the literature and two case reports involving citalopram. Neurol Sci. 2011;32:507-509$65$YR$$F$Y$$$20240725$$HP$IT$IT
241350471$24135047$1$I$$20240719$20240725$20240725$EXP$$GB-AUROBINDO-AUR-APL-2024-036391$AUROBINDO$$93$YR$$F$Y$$$20240725$$MD$GB$GB
241350481$24135048$1$I$$20240723$20240725$20240725$PER$$US-HALEON-2188700$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241350491$24135049$1$I$$20240715$20240725$20240725$EXP$$CN-ROCHE-10000030124$ROCHE$Wang Y, Xu Y, Liu X, Li C, Wang J, Zhang X, et al. The efficacy and safety of trastuzumab and albumin-bound paclitaxel with or without pyrotinib as neoadjuvant therapy for HER2-positive breast cancer: a prospective observational cohort study. Gland surgery. 2024-May-30;13 (5):654-62. doi:10.21037/gs-24-81.$$$$F$Y$$$20240725$$HP$CN$CN
241350502$24135050$2$F$$20240729$20240725$20240806$EXP$$JP-TEVA-VS-3222605$TEVA$Inada M, Ando N, Mizushima D, Kikuchi Y, Gatanaga H, Oka S. Effect of unintended short-term 3.0 g/day amoxicillin and probenecid treatment for early syphilis on patients with HIV-1 infection. Ther-Adv-Infect-Dis 2023; 10 1-6; Inada M, Ando N, Mizushima D, Kikuchi Y, Gatanaga H, Oka S. Effect of unintended short-term 3.0 g/day amoxicillin and probenecid treatment for early syphilis on patients with HIV-1 infection. Ther-Adv-Infect-Dis 2023; 10 1-6.; Inada M, Ando N, Mizushima D, Kikuchi Y, Gat...$40$YR$$M$Y$$$20240806$$HP$JP$JP
241350521$24135052$1$I$$20240709$20240725$20240725$PER$$US-JNJFOC-20240752449$JOHNSON AND JOHNSON$$$$$M$Y$$$20240725$$MD$US$US
241350531$24135053$1$I$20240723$20240723$20240725$20240725$EXP$GB-MHRA-MED-202407230647463120-ZYNKC$GB-ABBVIE-5851747$ABBVIE$$$$$$Y$$$20240725$$CN$GB$GB
241350541$24135054$1$I$20221115$20240715$20240725$20240725$PER$FR-AFSSAPS-AM2024000565$FR-IGSA-BIG0029851$GRIFOLS$$36$YR$$F$Y$90$KG$20240725$$MD$FR$FR
241350551$24135055$1$I$20240718$20240719$20240725$20240725$EXP$$US-NEBO-664792$PHARMACOSMOS$$$$A$F$Y$$$20240725$$HP$US$US
241350561$24135056$1$I$20240422$20240716$20240725$20240725$EXP$$US-ACORDA-ACO_177365_2024$ACORDA$$66$YR$$M$Y$$$20240725$$CN$US$US
241350571$24135057$1$I$$20240716$20240725$20240725$EXP$IE-MLMSERVICE-20240709-PI127203-00185-1$IE-JUBILANT CADISTA PHARMACEUTICALS-2024IE001045$JUBILANT$Babiker S, Hajalamin M. An atypical encounter: Mounir-Kuhn syndrome and aspergilloma coexistence: A case report. Radiology Case Reports. 2024;19(9):3962-5.$69$YR$$M$Y$39$KG$20240725$$MD$IE$IE
241350581$24135058$1$I$$20240718$20240725$20240725$EXP$$CA-GSK-CA2024091040$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$CA$CA
241350603$24135060$3$F$$20240830$20240725$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117506$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$93.44$KG$20240903$$CN$US$US
241350611$24135061$1$I$$20240723$20240725$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-117334$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240725$$MD$CA$CA
241350631$24135063$1$I$20200501$20240716$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116938$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$51.701$KG$20240725$$CN$US$US
241350641$24135064$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117380$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240725$$HP$US$US
241350651$24135065$1$I$$20240716$20240725$20240725$EXP$$US-JNJFOC-20240748557$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
241350662$24135066$2$F$20240101$20240819$20240725$20240826$EXP$$JP-AMGEN-JPNSP2024145952$AMGEN$$82$YR$E$F$Y$$$20240826$$MD$JP$JP
241350671$24135067$1$I$$20240716$20240725$20240725$EXP$$CA-APOTEX-2024AP008461$APOTEX$$80$YR$$M$Y$72$KG$20240725$$HP$CA$CA
241350681$24135068$1$I$$20240710$20240725$20240725$EXP$$US-PHARMAAND GMBH-2024PHR00425$pharmaAND$$$$$F$Y$$$20240725$$HP$US$US
241350691$24135069$1$I$$20240716$20240725$20240725$EXP$$NL-SA-2024SA212031$SANOFI AVENTIS$$$$$M$Y$$$20240725$$HP$NL$NL
241350701$24135070$1$I$20240414$20240716$20240725$20240725$EXP$ES-AEMPS-1542796$ES-TEVA-VS-3222027$TEVA$$14$YR$$M$Y$$$20240725$$MD$ES$ES
241350711$24135071$1$I$$20240710$20240725$20240725$EXP$$US-PHARMAAND GMBH-2024PHR00423$pharmaAND$$$$$F$Y$34.5$KG$20240725$$CN$US$US
241350721$24135072$1$I$$20240718$20240725$20240725$EXP$$JP-AMGEN-JPNSP2024146310$AMGEN$$$$$$Y$$$20240725$$PH$JP$JP
241350731$24135073$1$I$20240722$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146639$AMGEN$$62$YR$A$F$Y$$$20240725$$CN$US$US
241350741$24135074$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146588$AMGEN$$$$$$Y$$$20240725$$HP$US$US
241350751$24135075$1$I$20240722$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145914$AMGEN$$68$YR$E$M$Y$$$20240725$$CN$US$US
241350761$24135076$1$I$20230927$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145910$AMGEN$$53$YR$A$F$Y$$$20240725$$HP$US$US
241350772$24135077$2$F$$20240729$20240725$20240805$EXP$$NL-EMD Serono-2024038933$EMD SERONO INC$$46$YR$A$F$Y$70$KG$20240805$$HP$NL$NL
241350781$24135078$1$I$20240101$20240717$20240725$20240725$EXP$$CN-SA-2024SA214286$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240725$$CN$CN$CN
241350791$24135079$1$I$$20240711$20240725$20240725$EXP$$PE-ROCHE-10000025464$ROCHE$$57$YR$A$F$Y$$$20240725$$CN$PE$PE
241350801$24135080$1$I$$20240415$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2024-016717$AUROBINDO$$$$$M$Y$$$20240725$$HP$US$US
241350811$24135081$1$I$20240101$20240722$20240725$20240725$EXP$$US-ORGANON-O2407USA002122$ORGANON$$$$$F$Y$59.864$KG$20240725$$CN$US$US
241350821$24135082$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146855$AMGEN$$12$YR$T$M$Y$$$20240725$$CN$US$US
241350831$24135083$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146672$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241350841$24135084$1$I$20240720$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145938$AMGEN$$65$YR$E$M$Y$$$20240725$$PH$US$US
241350851$24135085$1$I$20240723$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024147188$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241350871$24135087$1$I$20240101$20240723$20240725$20240725$EXP$$US-UCBSA-2024037354$UCB$$$$$M$Y$$$20240725$$HP$US$US
241350881$24135088$1$I$$20240417$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2024-016728$AUROBINDO$$$$$M$Y$$$20240725$$HP$US$US
241350901$24135090$1$I$$20240718$20240725$20240725$EXP$US-MLMSERVICE-20240711-PI128830-00050-1$US-RDY-SPO/USA/24/0010750$DR REDDYS$Applegarth J, Finn D, Tolkacz M, Iacco A. Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome. ASAIO Journal. 2024;70(Supplement 3):151.$18$YR$A$F$Y$$$20240725$$MD$US$US
241350921$24135092$1$I$20240627$20240718$20240725$20240725$EXP$$US-SA-2024SA214786$SANOFI AVENTIS$$61$YR$A$M$Y$90$KG$20240725$$MD$US$US
241350931$24135093$1$I$$20240522$20240725$20240725$PER$$US-CPL-004238$CADILA$$57$YR$A$F$Y$$$20240725$$CN$US$US
241350941$24135094$1$I$$20240629$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2024-024291$AUROBINDO$$$$$M$Y$$$20240725$$CN$US$US
241350951$24135095$1$I$20240627$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003183$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240725$$CN$US$US
241350961$24135096$1$I$20240516$20240718$20240725$20240725$EXP$DE-AMK-276855$DE-ROCHE-10000030758$ROCHE$$63$YR$A$F$Y$76$KG$20240725$$CN$DE$DE
241350971$24135097$1$I$$20240715$20240725$20240725$EXP$$CN-ROCHE-10000026613$ROCHE$Ji X, Liu Z, Ye Y, Li Q, Liu X, Zhou M, et al. Advanced Lung Adenocarcinoma with EGFR 19-del Mutation Transformed into SCC after EGFR-tyrosine Kinase inhibitors Treatment: A Case report. World Journal of Clinical Cases. 2024-Jul-16;12 (20):4405-11. doi:10.12998/wjcc.v12.i20.4405.$67$YR$E$F$Y$$$20240725$$HP$CN$CN
241350981$24135098$1$I$$20240717$20240725$20240725$EXP$$FR-KOANAAP-SML-FR-2024-00756$Unknown Manufacturer$Furst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R, et al. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLAimmunized adults with sickle cell disease. Bone Marrow Transplantation. 2024-Jul;59 (7):918-27. doi:10.1038/s41409-024-02257-8.$22$YR$A$M$Y$$$20240725$$MD$FR$FR
241350991$24135099$1$I$$20240715$20240725$20240725$EXP$$US-GSK-US2024AMR089843$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
241351001$24135100$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024AMR091495$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
241351011$24135101$1$I$$20240716$20240725$20240725$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01334$NOVITIUM PHARMA$Dongjie Yu.Nontyphoidal salmonella septic arthritis in A patient with systemic lupus erythematosus: A case report.Diagnostic Microbiology and Infectious Disease.30-APR-2024;109:1-3$43$YR$A$F$Y$$$20240725$$HP$CN$CN
241351021$24135102$1$I$20240717$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117618$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240725$$PH$US$US
241351031$24135103$1$I$$20240618$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2024-028714$AUROBINDO$$$$$M$Y$$$20240725$$CN$US$US
241351041$24135104$1$I$20240708$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145672$AMGEN$$82$YR$E$F$Y$$$20240725$$CN$US$US
241351051$24135105$1$I$20240710$20240717$20240725$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022166$UNITED THERAPEUTICS$$75$YR$$M$Y$72.109$KG$20240725$$$US$US
241351071$24135107$1$I$$20240717$20240725$20240725$EXP$$CA-AstraZeneca-2024A164795$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$CA$
241351081$24135108$1$I$20240713$20240723$20240725$20240725$EXP$$US-AstraZeneca-2024A167984$ASTRAZENECA$$$$$M$Y$$$20240725$$MD$US$
241351091$24135109$1$I$$20230524$20240725$20240725$EXP$$US-AstraZeneca-2023A128895$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241351101$24135110$1$I$$20221007$20240725$20240725$EXP$$US-AstraZeneca-2022A342351$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241351111$24135111$1$I$$20221017$20240725$20240725$EXP$$US-AstraZeneca-2022A349587$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241351121$24135112$1$I$$20240723$20240725$20240725$EXP$$NVSC2024US151982$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241351132$24135113$2$F$20240630$20240806$20240725$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003111$ACADIA PHARMACEUTICALS$$90$YR$$F$Y$$$20240829$$CN$US$US
241351142$24135114$2$F$$20240730$20240725$20240802$EXP$$US-JNJFOC-20240760675$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240802$$HP$US$US
241351151$24135115$1$I$$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003184$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
241351161$24135116$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146700$AMGEN$$$$$$Y$$$20240725$$PH$US$US
241351171$24135117$1$I$$20240716$20240725$20240725$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001024$ALEMBIC$Fenner E.G, Simpson C.E.. An adult patient with pulmonary arterial hypertension, a NOTCH3 mutation, and leflunomide exposure. Pulmonary Circulation. 2024;14(3) e12411:1-4$$$$$Y$$$20240725$$HP$US$US
241351181$24135118$1$I$$20240712$20240725$20240725$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00359$Unknown Manufacturer$$$$$$Y$$$20240725$$CN$BR$BR
241351191$24135119$1$I$$20240718$20240725$20240725$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001026$ALEMBIC$$$$$$Y$$$20240725$$CN$US$US
241351201$24135120$1$I$$20240715$20240725$20240725$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001003$ALEMBIC$$$$$$Y$$$20240725$$CN$US$US
241351222$24135122$2$F$$20240715$20240725$20240725$EXP$$US-ROCHE-10000027152$ROCHE$Li X, Fung B, Kumar R. Successful Treatment of Rituximab-Induced Crohn^s Disease With Ustekinumab. ACG case reports journal. 2024;11 (7):1-3. doi:10.14309/crj.0000000000001403.$51$YR$A$M$Y$$$20240725$$MD$US$US
241351231$24135123$1$I$20240101$20240718$20240725$20240725$EXP$$US-JNJFOC-20240750987$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240725$$CN$US$US
241351241$24135124$1$I$$20240716$20240725$20240725$EXP$$US-JNJFOC-20240743622$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$MD$US$US
241351251$24135125$1$I$$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003190$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
241351262$24135126$2$F$$20240723$20240725$20240806$EXP$AU-MLMSERVICE-20240710-PI122722-00177-1$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-15735$ALKEM$Goradia S, Holper S, Lim YZ, Brady SRE. Anti-melanoma differentiation-associated gene 5 (anti-MDA5) positive dermatomyositis: early detection is crucial.. BMJ Case Reports. 2024;17(6):e259338$7$DEC$$F$Y$50$KG$20240806$$MD$AU$AU
241351271$24135127$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117445$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$PH$US$US
241351281$24135128$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116712$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240725$$CN$US$US
241351293$24135129$3$F$20201029$20240805$20240725$20240820$EXP$IT-MLMSERVICE-20240708-PI126636-00306-1$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-15746$ALKEM$Perencin B, Zacchi A, Zanconati F, Tomietto P, Bianco F, Di Maso V. COVID-19 and lupus nephritis exacerbation in unvaccinated patients: a clinical case and literature review. Italian Journal of Nephrology. 2024;3:71-83$28$YR$$F$Y$$$20240820$$MD$IT$IT
241351301$24135130$1$I$$20240717$20240725$20240725$EXP$$ZA-AstraZeneca-2024A163511$ASTRAZENECA$$57$YR$$M$Y$$$20240725$$CN$ZA$
241351313$24135131$3$F$20240709$20240820$20240725$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115773$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240822$$MD$JP$JP
241351321$24135132$1$I$20220921$20220923$20240725$20240725$EXP$$US-AstraZeneca-2022A330910$ASTRAZENECA$$73$YR$$$Y$$$20240725$$CN$US$
241351331$24135133$1$I$$20221109$20240725$20240725$EXP$$US-AstraZeneca-2022A373124$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241351341$24135134$1$I$$20240716$20240725$20240725$EXP$$CA-APOTEX-2024AP008505$APOTEX$$57$YR$$F$Y$$$20240725$$HP$CA$CA
241351351$24135135$1$I$20240122$20240717$20240725$20240725$EXP$$FR-AstraZeneca-2024A162761$ASTRAZENECA$$76$YR$$M$Y$$$20240725$$MD$FR$
241351361$24135136$1$I$20240118$20240718$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036606$AUROBINDO$$44$YR$$F$Y$63$KG$20240725$$MD$FR$FR
241351371$24135137$1$I$20240618$20240720$20240725$20240725$EXP$$ES-AUROBINDO-AUR-APL-2024-036497$AUROBINDO$$53$YR$$F$Y$$$20240725$$PH$ES$ES
241351381$24135138$1$I$20240711$20240718$20240725$20240725$EXP$$TH-ROCHE-10000034141$ROCHE$$62$YR$A$F$Y$$$20240725$$CN$TH$MY
241351391$24135139$1$I$20240721$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145907$AMGEN$$53$YR$A$M$Y$$$20240725$$HP$US$US
241351401$24135140$1$I$20240628$20240718$20240725$20240725$EXP$$GB-AUROBINDO-AUR-APL-2024-035966$AUROBINDO$$91$YR$$M$Y$$$20240725$$MD$GB$GB
241351411$24135141$1$I$$20240718$20240725$20240725$PER$$US-ROCHE-10000030987$ROCHE$$$$C$M$Y$$$20240725$$MD$US$US
241351421$24135142$1$I$$20240718$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036587$AUROBINDO$$14$YR$$F$Y$$$20240725$$MD$FR$FR
241351432$24135143$2$F$$20240820$20240725$20240827$EXP$$US-GSK-US2024090655$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
241351441$24135144$1$I$20240601$20240628$20240725$20240725$PER$$US-JNJFOC-20240707485$JOHNSON AND JOHNSON$$66$YR$E$M$Y$74.002$KG$20240725$$CN$US$US
241351451$24135145$1$I$20240707$20240718$20240725$20240725$EXP$SE-SEMPA-2024-005516$SE-JNJFOC-20240752453$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240725$$MD$SE$SE
241351462$24135146$2$F$$20240712$20240725$20240805$EXP$$CA-HALEON-2187533$Haleon PLC$$53$YR$$M$Y$$$20240805$$CN$CA$CA
241351471$24135147$1$I$$20240723$20240725$20240725$EXP$$CA-ORGANON-O2407CAN002180$ORGANON$$72$YR$$M$Y$$$20240725$$HP$CA$CA
241351481$24135148$1$I$20240710$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145660$AMGEN$$80$YR$E$F$Y$$$20240725$$CN$US$US
241351491$24135149$1$I$20240101$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024144149$AMGEN$$52$YR$A$F$Y$$$20240725$$HP$US$US
241351501$24135150$1$I$20230807$20240718$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036538$AUROBINDO$$83$YR$$F$Y$$$20240725$$PH$FR$FR
241351513$24135151$3$F$$20240823$20240725$20240903$EXP$$CA-ROCHE-10000031584$ROCHE$$$$A$F$Y$$$20240903$$CN$CA$CA
241351521$24135152$1$I$$20240716$20240725$20240725$EXP$$CA-APOTEX-2023AP015341$APOTEX$$77$YR$$M$Y$$$20240725$$HP$CA$CA
241351531$24135153$1$I$20240612$20240713$20240725$20240725$EXP$$US-Accord-436256$ACCORD$$34$YR$A$F$Y$$$20240725$$HP$US$US
241351542$24135154$2$F$$20240510$20240725$20240802$PER$$US-Accord-424915$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
241351551$24135155$1$I$20201001$20240717$20240725$20240725$EXP$$CA-TOLMAR, INC.-23CA039581$TOLMAR$I. Janes, B.Ogunyemi, M. Andrews. Case-Leuprolide acetate-induced necrotic skin ulceration. Canadian Urological Association Jopurnal, Residents? room. 2023;17:3:e92-e^94$63$YR$$M$Y$$$20240725$$MD$CA$CA
241351561$24135156$1$I$$20240717$20240725$20240725$EXP$$CA-TOLMAR, INC.-24CA051125$TOLMAR$$$$$M$Y$$$20240725$$CN$CA$CA
241351571$24135157$1$I$$20240717$20240725$20240725$EXP$$NL-TOLMAR, INC.-24NL050883$TOLMAR$$$$$M$Y$$$20240725$$CN$NL$NL
241351581$24135158$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014694$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240725$$CN$US$US
241351591$24135159$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015014$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240725$$CN$US$US
241351601$24135160$1$I$20240723$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015312$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240725$$CN$US$US
241351612$24135161$2$F$20240716$20240905$20240725$20240913$EXP$$US-ALK-ABELLO A/S-2024AA002929$ALK-ABELLO$$$$$$Y$$$20240913$$MD$US$US
241351621$24135162$1$I$$20240720$20240725$20240725$EXP$$AR-JNJFOC-20240758002$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$CN$AR$AR
241351632$24135163$2$F$$20240806$20240725$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117893$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240809$$CN$US$US
241351641$24135164$1$I$20240601$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015226$ELI LILLY AND CO$$$$$M$Y$$$20240725$$CN$US$US
241351651$24135165$1$I$20240701$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116653$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240725$$HP$US$US
241351661$24135166$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116868$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240725$$PH$US$US
241351671$24135167$1$I$20240718$20240719$20240725$20240725$EXP$$GB-AUROBINDO-AUR-APL-2024-036442$AUROBINDO$$64$YR$$M$Y$$$20240725$$HP$GB$GB
241351681$24135168$1$I$$20220928$20240725$20240725$EXP$$BR-AstraZeneca-2022A335159$Unknown Manufacturer$$$$$$Y$$$20240725$$CN$BR$BR
241351691$24135169$1$I$20181221$20240722$20240725$20240725$PER$$US-GILEAD-2024-0681557$GILEAD$$66$YR$E$M$Y$$$20240725$$CN$US$US
241351701$24135170$1$I$$20240717$20240725$20240725$EXP$$US-ABBVIE-5657567$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241351711$24135171$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146689$AMGEN$$$$$$Y$$$20240725$$PH$US$US
241351732$24135173$2$F$$20240724$20240725$20240726$PER$$US-JNJFOC-20240764819$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$CN$US$US
241351742$24135174$2$F$20240601$20240913$20240725$20240920$EXP$$CA-JNJFOC-20240756357$JOHNSON AND JOHNSON$$40$YR$A$M$Y$115$KG$20240920$$HP$CA$CA
241351751$24135175$1$I$20240721$20240721$20240725$20240725$EXP$$US-JNJFOC-20240757542$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
241351761$24135176$1$I$20240723$20240723$20240725$20240725$PER$$US-JNJFOC-20240763695$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240725$$CN$US$US
241351771$24135177$1$I$$20240719$20240725$20240725$EXP$$JP-GSK-JP2024JPN091362$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$JP$JP
241351781$24135178$1$I$$20240719$20240725$20240725$EXP$$JP-GSK-JP2024JPN091361$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$JP$JP
241351792$24135179$2$F$20240718$20240813$20240725$20240820$30DAY$$US-AMGEN-USASP2024144341$AMGEN$$38$YR$A$F$Y$146.51$KG$20240820$$HP$US$US
241351811$24135181$1$I$$20240716$20240725$20240725$EXP$$DE-NOVITIUMPHARMA-2024DENVP01339$NOVITIUM PHARMA$Felix Patricius Hans.A potentially lifesaving error: unintentional high-dose adrenaline administration in anaphylaxis-induced cardiac arrest; a case report.International Journal of Emergency Medicine.28-JUN-2024;17:1$66$YR$A$F$Y$$$20240725$$HP$DE$DE
241351821$24135182$1$I$20240515$20240724$20240725$20240725$PER$$NVSC2024US152437$NOVARTIS$$82$YR$$F$Y$$$20240725$$HP$US$US
241351831$24135183$1$I$20230101$20240718$20240725$20240725$EXP$$ES-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00381$VELOXIS PHARMACEUTICALS$$2$YR$$M$Y$$$20240725$$PH$ES$ES
241351841$24135184$1$I$$20240712$20240725$20240725$PER$$US-HALEON-2187151$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
241351851$24135185$1$I$20240701$20240709$20240725$20240725$PER$$US-JNJFOC-20240727823$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240725$$HP$US$US
241351861$24135186$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117789$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$HP$US$US
241351871$24135187$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116617$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$67.59$KG$20240725$$CN$US$US
241351881$24135188$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116875$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240725$$CN$US$US
241351891$24135189$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117173$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240725$$PH$US$US
241351901$24135190$1$I$20240511$20240722$20240725$20240725$EXP$FR-AFSSAPS-AM2024000586$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-116889$BRISTOL MYERS SQUIBB$$67$YR$A$F$Y$74$KG$20240725$$PH$FR$FR
241351912$24135191$2$F$$20240813$20240725$20240816$PER$$US-BIOGEN-2024BI01274450$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
241351921$24135192$1$I$20220519$20240716$20240725$20240725$EXP$$GB-TEVA-VS-3222218$TEVA$$76$YR$$F$Y$65$KG$20240725$$MD$GB$GB
241351931$24135193$1$I$$20240718$20240725$20240725$EXP$$NVSC2024US117112$NOVARTIS$$$$$M$Y$$$20240725$$CN$US$US
241351941$24135194$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5850614$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241351951$24135195$1$I$20240709$20240715$20240725$20240725$PER$$US-HALEON-2187271$Haleon PLC$$72$YR$$$Y$$$20240719$$CN$US$US
241351961$24135196$1$I$$20240717$20240725$20240725$PER$$US-HALEON-2187922$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
241351971$24135197$1$I$$20240716$20240725$20240725$EXP$GB-MHRA-MED-202407161425300610-ZNYCK$GB-TEVA-VS-3222273$TEVA$$41$YR$$F$Y$$$20240725$$PH$GB$GB
241351981$24135198$1$I$20240610$20240716$20240725$20240725$EXP$GB-MHRA-MED-202407162119419410-SYKQR$GB-TEVA-VS-3222283$TEVA$$88$YR$$F$Y$51$KG$20240725$$CN$GB$GB
241351991$24135199$1$I$$20240717$20240725$20240725$PER$$US-HALEON-2187719$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
241352003$24135200$3$F$20230101$20240815$20240725$20240822$PER$$US-AMGEN-USASP2024145514$AMGEN$$73$YR$E$F$Y$$$20240822$$CN$US$US
241352011$24135201$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146743$AMGEN$$$$$$Y$$$20240725$$MD$US$US
241352021$24135202$1$I$20240710$20240717$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090048$VIIV$$56$YR$$F$Y$$$20240725$$PH$US$US
241352031$24135203$1$I$$20240722$20240725$20240725$EXP$GB-MHRA-31137098$GB-ORGANON-O2407GBR002069$ORGANON$$$$$M$Y$$$20240725$$CN$GB$GB
241352051$24135205$1$I$$20240715$20240725$20240725$EXP$$CN-ROCHE-10000029638$ROCHE$Lin Y, Han Q, Chen L, Wang Y, Ren P, Liu G, et al. Obinutuzumab in Refractory Membranous Nephropathy: A Case Series. Kidney Medicine. 2024-Aug;6 (8):1-9. doi:10.1016/j.xkme.2024.100853.$$$$$Y$$$20240725$$HP$CN$CN
241352061$24135206$1$I$20240701$20240717$20240725$20240725$PER$$US-BIOGEN-2024BI01274265$BIOGEN$$21$YR$$F$Y$$$20240725$$CN$US$US
241352071$24135207$1$I$20240101$20240718$20240725$20240725$PER$$US-BIOGEN-2024BI01274672$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
241352081$24135208$1$I$20230101$20240718$20240725$20240725$PER$$US-BIOGEN-2023BI01220507$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
241352092$24135209$2$F$20240701$20240722$20240725$20240729$PER$$US-BIOGEN-2024BI01274855$BIOGEN$$71$YR$$F$Y$$$20240729$$CN$US$US
241352103$24135210$3$F$$20240911$20240725$20240913$PER$$US-BIOGEN-2024BI01274426$BIOGEN$$$$$F$Y$$$20240913$$MD$US$US
241352111$24135211$1$I$$20240717$20240725$20240725$PER$$US-BIOGEN-2024BI01274275$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
241352121$24135212$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5850308$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241352131$24135213$1$I$$20240717$20240725$20240725$PER$$US-HALEON-2187788$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
241352141$24135214$1$I$20240401$20240716$20240725$20240725$EXP$$CA-APOTEX-2024AP008602$APOTEX$$80$YR$E$F$Y$$$20240725$$PH$CA$CA
241352151$24135215$1$I$$20200620$20240725$20240725$EXP$$CA-AstraZeneca-2020SE12349$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$CA$
241352161$24135216$1$I$$20240717$20240725$20240725$EXP$$ZA-AstraZeneca-2024A163685$ASTRAZENECA$$68$YR$$F$Y$$$20240725$$CN$ZA$
241352171$24135217$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165545$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241352181$24135218$1$I$20240628$20240717$20240725$20240725$EXP$$FR-AstraZeneca-2024A162956$ASTRAZENECA$$26$YR$$F$Y$100$KG$20240725$$MD$FR$
241352191$24135219$1$I$20240709$20240713$20240725$20240725$EXP$GB-MHRA-MED-202407111401486780-PGRCW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15882$ALKEM$$$$$M$Y$145$KG$20240725$$CN$GB$GB
241352201$24135220$1$I$20240626$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003107$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240725$$HP$US$US
241352212$24135221$2$F$$20240904$20240725$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-117244$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240911$$PH$JP$JP
241352221$24135222$1$I$20240722$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015415$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240725$$CN$US$US
241352232$24135223$2$F$$20240822$20240725$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114175$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240830$$CN$US$US
241352241$24135224$1$I$$20240717$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407011548$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240725$$CN$US$US
241352251$24135225$1$I$20240205$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015055$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240725$$CN$US$US
241352261$24135226$1$I$20240101$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014582$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240725$$CN$US$US
241352271$24135227$1$I$$20240718$20240725$20240725$PER$$US-HALEON-2187887$Haleon PLC$$$$$F$Y$$$20240719$$CN$US$US
241352281$24135228$1$I$20240701$20240718$20240725$20240725$PER$$US-BIOGEN-2024BI01274468$BIOGEN$$27$YR$$F$Y$$$20240725$$CN$US$US
241352291$24135229$1$I$20240721$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145683$AMGEN$$84$YR$E$M$Y$$$20240725$$MD$US$US
241352301$24135230$1$I$$20240719$20240725$20240725$EXP$$US-JNJFOC-20240753202$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$MD$US$US
241352311$24135231$1$I$$20240617$20240725$20240725$PER$$US-ROCHE-10000006146$ROCHE$$$$$$Y$$$20240725$$MD$US$US
241352322$24135232$2$F$$20240801$20240725$20240809$EXP$$CN-ARGENX-2024-ARGX-CN005557$ARGENX BVBA$Ge L, Li Y, Sun Y, Chen W, Ni X, Wei F, Mu Z et al.. Efgartigimod-Associated Kaposi^s Varicelliform Eruption and Herpetic Conjunctivitis in a Patient with seropositive Ocular Myasthenia Gravis: case report and review. Front. Immunol.. 2024;15:01-05$$$$$Y$$$20240809$$HP$CN$CN
241352334$24135233$4$F$20240101$20240902$20240725$20240911$EXP$$CA-CELLTRION INC.-2024CA008248$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
241352341$24135234$1$I$20200201$20240722$20240725$20240725$EXP$$US-GILEAD-2024-0681464$GILEAD$$61$YR$A$M$Y$$$20240725$$CN$US$US
241352351$24135235$1$I$20240711$20240711$20240725$20240725$PER$$US-ROCHE-10000028312$ROCHE$$$$$F$Y$$$20240725$$CN$US$US
241352361$24135236$1$I$$20240707$20240725$20240725$PER$$US-JNJFOC-20240721955$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
241352375$24135237$5$F$20240624$20240917$20240725$20240924$EXP$$JP-AMGEN-JPNSP2024144413$AMGEN$$90$YR$E$F$Y$$$20240924$$HP$JP$JP
241352382$24135238$2$F$$20240909$20240725$20240919$PER$$US-ABBVIE-5842514$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
241352392$24135239$2$F$$20240729$20240725$20240808$EXP$$IT-TEVA-VS-3223215$TEVA$Morena A, Gravinese C, Frea S, Angelini F, Boretto P, Gallone G, et al. PERCUTANEOUS LEFT STELLATE GANGLION BLOCK TO INCREASE VENTRICULAR FIBRILLATION THRESHOLD AND DEFIBRILLATION SUCCESS RATE IN ACUTE FULMINANT MYOCARDITIS WITH ELECTRICAL STORM. Eur-Heart-J-Suppl 2024; 26 (Suppl.) ii4.; Morena A, Gravinese C, Frea S, Angelini F, Boretto P, Gallone G, et al. PERCUTANEOUS LEFT STELLATE GANGLION BLOCK TO INCREASE VENTRICULAR FIBRILLATION THRESHOLD AND DEFIBRILLATION SUCCESS RATE IN ACUTE FULMIN...$57$YR$$M$Y$$$20240808$$HP$IT$IT
241352401$24135240$1$I$20240720$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145659$AMGEN$$67$YR$E$M$Y$$$20240725$$CN$US$US
241352411$24135241$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024147094$AMGEN$$58$YR$A$F$Y$$$20240725$$CN$US$US
241352422$24135242$2$F$20220501$20240715$20240725$20240906$PER$$US-ABBVIE-2219526US$ABBVIE$$58$YR$$M$Y$99.79$KG$20240906$$CN$US$US
241352431$24135243$1$I$$20240723$20240725$20240725$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041850$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240725$$MD$US$US
241352441$24135244$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152424$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241352451$24135245$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118092$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$71.21$KG$20240725$$CN$US$US
241352461$24135246$1$I$$20240717$20240725$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109852$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$PH$JP$JP
241352471$24135247$1$I$$20240722$20240725$20240725$PER$$US-LEO Pharma-372231$LEO PHARM$$68$YR$$F$Y$$$20240725$$CN$US$US
241352482$24135248$2$F$$20240724$20240725$20240726$EXP$$US-ROCHE-10000035652$ROCHE$$68$YR$E$M$Y$69.4$KG$20240726$$PH$US$US
241352501$24135250$1$I$$20240722$20240725$20240725$EXP$$US-BIOGEN-2024BI01275206$BIOGEN$$$$$M$Y$$$20240725$$CN$US$US
241352512$24135251$2$F$$20240815$20240725$20240823$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011123$JAZZ$$$$$F$Y$$$20240823$$HP$US$US
241352522$24135252$2$F$$20240814$20240725$20240820$EXP$$CA-TAKEDA-2024TUS040970$TAKEDA$$$$$F$Y$$$20240820$$MD$CA$CA
241352531$24135253$1$I$$20240720$20240725$20240725$EXP$$US-GILEAD-2024-0681520$GILEAD$$$$T$F$Y$$$20240725$$CN$US$US
241352541$24135254$1$I$$20240719$20240725$20240725$EXP$$US-EXELIXIS-CABO-24077499$EXELIXIS$$$$$M$Y$$$20240725$$CN$US$US
241352551$24135255$1$I$20240613$20240724$20240725$20240725$EXP$HR-HALMED-300086162$HR-TAKEDA-2024TUS074751$TAKEDA$$38$YR$$F$Y$$$20240725$$HP$HR$HR
241352562$24135256$2$F$20240708$20240910$20240725$20240924$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000459$BECTON DICKINSON$$$$$$Y$$$20240924$$CN$GB$GB
241352571$24135257$1$I$$20240708$20240725$20240725$30DAY$$FR-BECTON DICKINSON-FR-BD-24-000460$BECTON DICKINSON$$$$$$Y$$$20240725$$CN$FR$FR
241352581$24135258$1$I$20240710$20240722$20240725$20240725$EXP$$US-AstraZeneca-2024A168016$ASTRAZENECA$$28306$DY$$M$Y$$$20240725$$MD$US$
241352601$24135260$1$I$20240703$20240724$20240725$20240725$EXP$HR-HALMED-300086201$HR-TAKEDA-2024TUS074753$TAKEDA$$36$YR$$M$Y$$$20240725$$HP$HR$HR
241352611$24135261$1$I$20240101$20240718$20240725$20240725$EXP$$US-ABBVIE-5846841$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241352621$24135262$1$I$$20240723$20240725$20240725$EXP$$CA-TAKEDA-2024TUS074556$TAKEDA$$$$$F$Y$$$20240725$$CN$CA$CA
241352631$24135263$1$I$20240601$20240722$20240725$20240725$EXP$$US-ABBVIE-5850226$ABBVIE$$71$YR$$F$Y$$$20240725$$CN$US$US
241352641$24135264$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5850516$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241352651$24135265$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5850512$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241352671$24135267$1$I$$20240715$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090957$VIIV$$34$YR$$M$Y$$$20240725$$HP$US$US
241352682$24135268$2$F$20240401$20240812$20240725$20240814$EXP$$US-ABBVIE-5850524$ABBVIE$$72$YR$$M$Y$96$KG$20240814$$CN$US$US
241352691$24135269$1$I$$20240716$20240725$20240725$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01335$NOVITIUM PHARMA$Yoshinari Obata. Immune checkpoint inhibitor-related type 1 diabetes mellitus which develops long after treatment discontinuation: a case report and review of literature.Diabetology International .18-APR-2024;NA:1-12$76$YR$E$F$Y$54$KG$20240725$$HP$JP$JP
241352701$24135270$1$I$20240701$20240722$20240725$20240725$EXP$$US-ABBVIE-5850673$ABBVIE$$68$YR$$F$Y$$$20240725$$CN$US$US
241352711$24135271$1$I$$20240716$20240725$20240725$EXP$$CA-APOTEX-2024AP008472$APOTEX$$41$YR$$M$Y$$$20240725$$CN$CA$CA
241352731$24135273$1$I$20240111$20240725$20240725$20240725$EXP$FR-AFSSAPS-TO2024001377$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041880$BOEHRINGER INGELHEIM$$90$YR$E$F$Y$$$20240725$$PH$FR$FR
241352744$24135274$4$F$20240701$20240806$20240725$20240808$PER$$US-AMGEN-USASP2024146510$AMGEN$$70$YR$E$F$Y$$$20240808$$HP$US$US
241352751$24135275$1$I$$20240102$20240725$20240725$EXP$$US-TEVA-VS-3222941$TEVA$$76$YR$$F$Y$$$20240725$$CN$US$US
241352761$24135276$1$I$$20240715$20240725$20240725$PER$$US-EMD Serono-2024038557$EMD SERONO INC$$53$YR$A$M$Y$$$20240725$$CN$US$US
241352772$24135277$2$F$20240101$20240807$20240725$20240815$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-14638$IPSEN$$72$YR$E$M$Y$$$20240815$$MD$JP$JP
241352781$24135278$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015035$ELI LILLY AND CO$$$$A$F$Y$$$20240725$$CN$US$US
241352791$24135279$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146694$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241352801$24135280$1$I$20240619$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024144451$AMGEN$$71$YR$E$M$Y$$$20240725$$CN$US$US
241352811$24135281$1$I$20240718$20240718$20240725$20240725$PER$$US-AMGEN-USASP2024147091$AMGEN$$$$$$Y$$$20240725$$HP$US$US
241352821$24135282$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015064$ELI LILLY AND CO$$$$$M$Y$$$20240725$$HP$US$US
241352831$24135283$1$I$20240719$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016070$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240725$$CN$US$US
241352841$24135284$1$I$20240101$20240719$20240725$20240725$EXP$$US-ABBVIE-5848674$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241352851$24135285$1$I$20240701$20240719$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407013277$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240725$$CN$US$US
241352862$24135286$2$F$20240723$20240723$20240725$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407015299$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240730$$HP$US$US
241352871$24135287$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015469$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240725$$CN$US$US
241352882$24135288$2$F$20240701$20240830$20240725$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-022482$UNITED THERAPEUTICS$$68$YR$$F$Y$68.027$KG$20240905$$$US$US
241352891$24135289$1$I$20221121$20240717$20240725$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2023-034370$UNITED THERAPEUTICS$$21$YR$$F$Y$51.701$KG$20240725$$$US$US
241352902$24135290$2$F$$20240809$20240725$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117645$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$81.19$KG$20240813$$CN$US$US
241352911$24135291$1$I$20240101$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117879$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240725$$CN$US$US
241352921$24135292$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117905$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240725$$CN$US$US
241352931$24135293$1$I$$20240716$20240725$20240725$EXP$$CN-STERISCIENCE B.V.-2024-ST-001083$Steriscience PTE$Wang Y, An Y, Hou X, Xu Y, Li Z, Liu X, et al.. Cushing^s Syndrome in Pregnancy Secondary to Adrenocortical Adenoma: A Case Series and Review.. Endocrinol-Diabetes-Metab. 2024;7(2)$35$YR$$F$Y$$$20240725$$HP$CN$CN
241352941$24135294$1$I$20240712$20240715$20240725$20240725$EXP$$DE-ALVOGEN-2024095165$ALVOGEN$$75$YR$$F$Y$$$20240725$$PH$DE$DE
241352952$24135295$2$F$$20240723$20240725$20240729$PER$$US-JNJFOC-20240762321$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$HP$US$US
241352962$24135296$2$F$$20240816$20240725$20240822$30DAY$$US-JNJFOC-20240755791$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
241352972$24135297$2$F$20240718$20240724$20240725$20240727$EXP$$TR-ABBVIE-5850822$ABBVIE$$66$YR$$M$Y$65$KG$20240727$$CN$TR$TR
241352981$24135298$1$I$20191112$20240716$20240725$20240725$EXP$$BE-ASPEN-GLO2019BE014285$ASPEN$$$$$$Y$$$20240725$$MD$BE$BE
241352991$24135299$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146054$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241353001$24135300$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145392$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241353013$24135301$3$F$20240619$20240912$20240725$20240921$EXP$$JP-AMGEN-JPNSP2024144217$AMGEN$$77$YR$E$F$Y$$$20240921$$MD$JP$JP
241353021$24135302$1$I$$20240704$20240725$20240725$PER$$US-JNJFOC-20240718125$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
241353031$24135303$1$I$$20240722$20240725$20240725$EXP$$US-SA-2024SA215548$SANOFI AVENTIS$$$$$$Y$$$20240725$$HP$US$US
241353041$24135304$1$I$$20240722$20240725$20240725$PER$$US-TAKEDA-2024TUS074084$TAKEDA$$7$YR$$F$Y$$$20240725$$MD$US$US
241353054$24135305$4$F$20220101$20240829$20240725$20240902$EXP$$US-ORGANON-O2407USA002219$ORGANON$$$$$F$Y$65.76$KG$20240902$$MD$US$US
241353062$24135306$2$F$20240101$20240729$20240725$20240801$EXP$$US-SA-2024SA199112$SANOFI AVENTIS$$82$YR$E$M$Y$74$KG$20240801$$MD$US$US
241353072$24135307$2$F$20240101$20240805$20240725$20240812$EXP$$KZ-ORGANON-O2407KAZ001461$ORGANON$$45$YR$$F$Y$$$20240812$$CN$KZ$KZ
241353081$24135308$1$I$20240701$20240722$20240725$20240725$EXP$$BR-EMD Serono-2024039798$EMD SERONO INC$$$$$F$Y$$$20240725$$MD$BR$BR
241353092$24135309$2$F$$20240823$20240725$20240830$EXP$$IT-CELLTRION INC.-2024IT017803$CELLTRION$Musone D, Nicosia V, D^Alessandro R, Andrietti M, Steri PF, Ruosi C, et. al.. Therapeutic plasmapheresis in idiopathic membranous nephropathy anti-PLA2Rrelated: A case series. J Clin Apher. 2024;39(3):e22134$$$$$Y$$$20240830$$HP$IT$IT
241353101$24135310$1$I$20220801$20240722$20240725$20240725$EXP$$CR-BIOGEN-2024BI01274993$BIOGEN$$26$YR$$F$Y$52$KG$20240725$$CN$CR$CR
241353113$24135311$3$F$20180627$20240819$20240725$20240822$EXP$$CA-ABBVIE-18P-028-2408650-00$ABBVIE$$27$YR$$M$Y$$$20240822$$MD$CA$CA
241353121$24135312$1$I$20240712$20240715$20240725$20240725$EXP$GB-MHRA-MED-202407151659469150-MKBWS$GB-ROCHE-10000027656$ROCHE$$36$YR$A$F$Y$$$20240725$$PH$GB$GB
241353131$24135313$1$I$$20240719$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116004$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240725$$CN$US$US
241353141$24135314$1$I$$20240718$20240725$20240725$PER$$US-HALEON-2188230$Haleon PLC$$34$YR$$F$Y$$$20240725$$HP$US$US
241353151$24135315$1$I$20240720$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117637$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240725$$CN$US$US
241353161$24135316$1$I$$20240718$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115093$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240725$$CN$US$US
241353171$24135317$1$I$20240626$20240719$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116346$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$66.23$KG$20240725$$PH$US$US
241353181$24135318$1$I$$20240717$20240725$20240725$EXP$$US-AstraZeneca-2024A166206$ASTRAZENECA$$23655$DY$$F$Y$$$20240725$$CN$US$
241353192$24135319$2$F$20240701$20240801$20240725$20240802$EXP$$IE-AstraZeneca-2024A166191$ASTRAZENECA$$77$YR$$M$Y$$$20240802$$MD$IE$
241353201$24135320$1$I$$20240715$20240725$20240725$EXP$$GB-AUROBINDO-AUR-APL-2023-044074$AUROBINDO$Koksa K, Acres R, Studley M, Briggs J.. Disseminated Mucormycosis in a patient on long term immunosuppression: Severe fungal infections as multi-system disorders. J-Intens-Care-Soc. 2023;24 (1):43-44$5$DEC$$F$Y$$$20240725$$HP$GB$GB
241353211$24135321$1$I$20220601$20240722$20240725$20240725$EXP$$US-ABBVIE-5565880$ABBVIE$$46$YR$$F$Y$90$KG$20240725$$CN$US$US
241353221$24135322$1$I$$20240716$20240725$20240725$PER$$US-ABBVIE-5848067$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241353231$24135323$1$I$$20240715$20240725$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-036367$AUROBINDO$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy. A case series.. Pediatr-Blood-Cancer. 2024;71(7):e31004$28$YR$$M$Y$$$20240725$$HP$US$US
241353242$24135324$2$F$$20240725$20240725$20240730$EXP$$US-ABBVIE-5850600$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241353251$24135325$1$I$$20230726$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-042369$AUROBINDO$$$$A$M$Y$61.235$KG$20240725$$CN$US$US
241353261$24135326$1$I$$20240719$20240725$20240725$PER$$US-BEH-2024176213$CSL BEHRING$$$$A$F$Y$$$20240725$$HP$US$US
241353271$24135327$1$I$$20230706$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-047134$AUROBINDO$$$$$M$Y$$$20240725$$CN$US$US
241353281$24135328$1$I$20230101$20240718$20240725$20240725$EXP$$BR-BIOGEN-2024BI01274754$BIOGEN$$$$$F$Y$76$KG$20240725$$CN$BR$BR
241353291$24135329$1$I$20240716$20240719$20240725$20240725$EXP$$US-UCBSA-2024037350$UCB$$21$YR$$F$Y$49$KG$20240725$$MD$US$US
241353301$24135330$1$I$20240501$20240717$20240725$20240725$EXP$$US-BIOGEN-2024BI01269358$BIOGEN$$21$YR$$F$Y$$$20240725$$HP$US$US
241353311$24135331$1$I$$20230913$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-055433$AUROBINDO$$$$$$Y$$$20240725$$CN$US$US
241353321$24135332$1$I$$20230810$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-054208$AUROBINDO$$$$$$Y$$$20240725$$CN$US$US
241353331$24135333$1$I$$20240715$20240725$20240725$EXP$$CZ-AUROBINDO-AUR-APL-2024-035893$AUROBINDO$Klocperk A, Bloomfield AM, Schneiderova H, Hlavackova E, Turnovec M, Tichy L et al.. Novorozenecky screening tezke kombinovane imunodeficience (SCID) v Ceske republice [Neonatal screening of severe combined immunodeficiency (SCID) in the Czech Republic].. Alergie. 2024;26(2):85-9$$$I$$Y$$$20240725$$MD$CZ$CZ
241353341$24135334$1$I$$20240719$20240725$20240725$PER$$US-ABBVIE-5849219$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241353351$24135335$1$I$20230308$20240717$20240725$20240725$EXP$$US-JNJFOC-20240751904$JOHNSON AND JOHNSON$$0$YR$$F$Y$$$20240725$$MD$US$US
241353361$24135336$1$I$$20240722$20240725$20240725$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011185$JAZZ$$$$$M$Y$$$20240725$$CN$US$US
241353371$24135337$1$I$20240427$20240719$20240725$20240725$EXP$$IN-SANDOZ INC.-SDZ2024IN052830$SANDOZ$$50$YR$$M$Y$$$20240725$$CN$IN$IN
241353381$24135338$1$I$$20240209$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-057066$AUROBINDO$$68$YR$$F$Y$57.152$KG$20240725$$CN$US$US
241353391$24135339$1$I$$20231020$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-065682$AUROBINDO$$$$$$Y$$$20240725$$CN$US$US
241353401$24135340$1$I$$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036112$AUROBINDO$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N, Pelletier R et al. A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxicologie Analytique + Clinique. 2023;35:376-394$$$$M$Y$$$20240725$$MD$FR$FR
241353411$24135341$1$I$$20240717$20240725$20240725$PER$$US-TAKEDA-2024TUS073175$TAKEDA$$$$$F$Y$99.773$KG$20240725$$CN$US$US
241353421$24135342$1$I$20230127$20240715$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-035998$AUROBINDO$$76$YR$$M$Y$60$KG$20240725$$MD$FR$FR
241353431$24135343$1$I$$20231011$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-059011$AUROBINDO$$$$$$Y$$$20240725$$CN$US$US
241353442$24135344$2$F$$20240919$20240725$20240926$EXP$$TR-ROCHE-10000031699$ROCHE$$$$$M$Y$$$20240926$$CN$TR$TR
241353452$24135345$2$F$20240701$20240724$20240725$20240802$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020767$UNITED THERAPEUTICS$$40$YR$$F$Y$$$20240802$$PH$US$US
241353461$24135346$1$I$$20240219$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2024-002748$AUROBINDO$$$$$M$Y$$$20240725$$MD$US$US
241353471$24135347$1$I$$20240724$20240725$20240725$PER$$US-HALEON-2188825$Haleon PLC$$80$YR$$M$Y$$$20240725$$CN$US$US
241353481$24135348$1$I$$20240724$20240725$20240725$30DAY$$US-SANDOZ INC.-SDZ2024US068048$SANDOZ$$$$$F$Y$$$20240725$$HP$US$US
241353501$24135350$1$I$$20231201$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-077588$AUROBINDO$$39$YR$$F$Y$$$20240725$$HP$US$US
241353511$24135351$1$I$20230412$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036192$AUROBINDO$$72$YR$$F$Y$80$KG$20240725$$MD$FR$FR
241353521$24135352$1$I$$20240111$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-077572$AUROBINDO$$64$YR$$M$Y$$$20240725$$CN$US$US
241353531$24135353$1$I$20240611$20240715$20240725$20240725$EXP$$IT-AUROBINDO-AUR-APL-2024-035876$AUROBINDO$$61$YR$$M$Y$63$KG$20240725$$MD$IT$IT
241353541$24135354$1$I$$20240604$20240725$20240725$PER$$JP-WT-2024-02717$Waylis$Yoshizawa K. One case of pityriasis lichenoides-like skin eruption caused by eszopiclone. The 123rd Annual Meeting of the Japan Dermatological Association from 2024-Jun-06 to 2024-Jun-09; P-56$48$YR$$M$Y$$$20240725$$MD$JP$JP
241353551$24135355$1$I$$20240716$20240725$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-036590$AUROBINDO$Rashid AM, Cheung TP, Paracha R, Vitale GC, Vyce SD. Minocycline-Induced Black Bone Disease in Foot and Ankle Surgery: A Case Report.. J-Am-Podiatr-Med-Assoc. 2024;114(2):no pagination$51$YR$$M$Y$$$20240725$$HP$US$US
241353561$24135356$1$I$$20240412$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2024-016803$AUROBINDO$$$$$$Y$$$20240725$$HP$US$US
241353571$24135357$1$I$$20240402$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2024-008101$AUROBINDO$$$$$F$Y$$$20240725$$CN$US$US
241353581$24135358$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5850796$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241353591$24135359$1$I$20240401$20240722$20240725$20240725$PER$$PR-ABBVIE-5851342$ABBVIE$$70$YR$$F$Y$$$20240725$$CN$PR$US
241353601$24135360$1$I$$20240126$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2024-003233$AUROBINDO$$$$$$Y$$$20240725$$CN$US$US
241353614$24135361$4$F$20240719$20240920$20240725$20240926$EXP$$CA-ABBVIE-5850697$ABBVIE$$78$YR$$F$Y$$$20240926$$MD$CA$CA
241353623$24135362$3$F$20240701$20240812$20240725$20240814$EXP$$PT-ABBVIE-5850407$ABBVIE$$32$YR$$F$Y$$$20240814$$CN$PT$PT
241353631$24135363$1$I$$20240715$20240725$20240725$EXP$$US-GSK-US2024AMR090344$GLAXOSMITHKLINE$$$$$M$Y$$$20240725$$CN$US$US
241353641$24135364$1$I$$20240516$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2024-017087$AUROBINDO$$$$$M$Y$$$20240725$$CN$US$US
241353651$24135365$1$I$$20240630$20240725$20240725$PER$$US-JNJFOC-20240703441$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$CN$US$US
241353662$24135366$2$F$$20240809$20240725$20240819$30DAY$$TW-JNJFOC-20240754726$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$PH$TW$TW
241353671$24135367$1$I$$20240524$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2024-018294$AUROBINDO$$$$$F$Y$$$20240725$$CN$US$US
241353681$24135368$1$I$$20240715$20240725$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-035622$AUROBINDO$Siler C, Fuller W, Whaley D, Keating J. Polypharmacy in Older Adults: A Case Study. S-D-Med. 2023;76(3):124-127$64$YR$$F$Y$$$20240725$$HP$US$US
241353693$24135369$3$F$$20240830$20240725$20240906$EXP$$US-ROCHE-10000035391$ROCHE$$86$YR$E$M$Y$$$20240906$$CN$US$US
241353701$24135370$1$I$$20230822$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-049406$AUROBINDO$$$$$$Y$$$20240725$$CN$US$US
241353711$24135371$1$I$$20231103$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-062323$AUROBINDO$$$$$$Y$$$20240725$$CN$US$US
241353721$24135372$1$I$$20230825$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-049409$AUROBINDO$$$$$$Y$$$20240725$$CN$US$US
241353731$24135373$1$I$$20231011$20240725$20240725$PER$$US-AUROBINDO-AUR-APL-2023-059169$AUROBINDO$$$$$$Y$$$20240725$$CN$US$US
241353741$24135374$1$I$20240415$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036190$AUROBINDO$$76$YR$$M$Y$$$20240725$$PH$FR$FR
241353751$24135375$1$I$$20240724$20240725$20240725$PER$$US-HALEON-2188794$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241353761$24135376$1$I$$20240610$20240725$20240725$PER$$JP-WT-2024-02869$Waylis$$$$$M$Y$$$20240725$$CN$JP$JP
241353771$24135377$1$I$20220530$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036172$AUROBINDO$$40$YR$$F$Y$70$KG$20240725$$MD$FR$FR
241353782$24135378$2$F$$20240716$20240725$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115302$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240809$$CN$US$US
241353791$24135379$1$I$20240708$20240716$20240725$20240725$EXP$$GB-AUROBINDO-AUR-APL-2024-035569$AUROBINDO$$48$YR$$F$Y$$$20240725$$PH$GB$GB
241353801$24135380$1$I$$20240718$20240725$20240725$PER$$US-HALEON-2187885$Haleon PLC$$83$YR$$M$Y$$$20240719$$CN$US$US
241353811$24135381$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015962$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240725$$CN$US$US
241353821$24135382$1$I$20240721$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014450$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240725$$CN$US$US
241353831$24135383$1$I$20240721$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015241$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240725$$CN$US$US
241353841$24135384$1$I$20240701$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014146$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240725$$CN$US$US
241353852$24135385$2$F$$20240723$20240725$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407015169$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240731$$CN$US$US
241353862$24135386$2$F$20230901$20240718$20240725$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407012507$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240729$$HP$US$US
241353871$24135387$1$I$20240501$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015492$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240725$$CN$US$US
241353881$24135388$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015269$ELI LILLY AND CO$$$$$F$Y$$$20240725$$CN$US$US
241353891$24135389$1$I$20240709$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015475$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240725$$CN$US$US
241353901$24135390$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016238$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240725$$CN$US$US
241353911$24135391$1$I$20240713$20240716$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407010686$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240725$$CN$US$US
241353921$24135392$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015320$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240725$$CN$US$US
241353931$24135393$1$I$$20240718$20240725$20240725$EXP$$IN-ROCHE-10000033695$ROCHE$$65$YR$E$F$Y$$$20240725$$CN$IN$IN
241353941$24135394$1$I$20240501$20240715$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117565$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240725$$CN$US$US
241353953$24135395$3$F$$20240821$20240725$20240828$EXP$$CA-CELLTRION INC.-2024CA017634$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
241353961$24135396$1$I$$20240719$20240725$20240725$30DAY$$US-GSK-US2024091216$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
241353973$24135397$3$F$20240712$20240723$20240725$20240925$PER$$US-GSK-US2024AMR089946$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240925$$CN$US$US
241353981$24135398$1$I$20240709$20240717$20240725$20240725$PER$$US-Vifor (International) Inc.-VIT-2024-06406$VIFOR$$72$YR$$F$Y$57$KG$20240725$$HP$US$US
241353991$24135399$1$I$$20240716$20240725$20240725$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14310$IPSEN$$$$$F$Y$$$20240725$$HP$US$US
241354001$24135400$1$I$20180730$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036224$AUROBINDO$$67$YR$$M$Y$104$KG$20240725$$MD$FR$FR
241354011$24135401$1$I$20240712$20240716$20240725$20240725$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001449$BLUEPRINT MEDICINES$$75$YR$E$M$Y$$$20240725$$CN$US$US
241354021$24135402$1$I$$20240717$20240725$20240725$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001464$BLUEPRINT MEDICINES$$$$$M$Y$$$20240725$$CN$US$US
241354032$24135403$2$F$$20240814$20240725$20240821$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001466$BLUEPRINT MEDICINES$$$$$F$Y$$$20240821$$CN$US$US
241354041$24135404$1$I$$20240716$20240725$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-036294$AUROBINDO$Menon A, Enunwa CA, Read WL, James KP. Rare Delayed Ifosfamide Encephalopathy: A Case Report of Chemotherapeutic Neurotoxicity. Case reports in Oncology. 2024;17 (1):202-207$25$YR$$F$Y$$$20240725$$HP$US$US
241354051$24135405$1$I$$20240716$20240725$20240725$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001445$BLUEPRINT MEDICINES$$$$$M$Y$$$20240725$$CN$US$US
241354061$24135406$1$I$$20240716$20240725$20240725$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001440$BLUEPRINT MEDICINES$$$$$F$Y$$$20240725$$CN$US$US
241354071$24135407$1$I$$20240710$20240725$20240725$30DAY$$US-JNJFOC-20240754666$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
241354081$24135408$1$I$$20240628$20240725$20240725$PER$$US-JNJFOC-20240703350$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240725$$CN$US$US
241354091$24135409$1$I$$20211209$20240725$20240725$EXP$$US-AstraZeneca-2021A869544$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241354102$24135410$2$F$$20240716$20240725$20240805$EXP$$PT-BEH-2024176145$CSL BEHRING$$$$$F$Y$$$20240805$$HP$PT$PT
241354111$24135411$1$I$$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A164851$ASTRAZENECA$Yamamoto K, et al. Two cases of non-small cell lung cancer, in which tocilizumab was effective against cytokine release syndrome (CRS) refractory to steroid pulse therapy induced by chemotherapy + anti-PD-L1 antibody + anti-CTLA-4 antibody.. The 120th Kansai Branch Academic Meeting of the Japan Lung Cancer Society 2024;49.$57$YR$$M$Y$$$20240725$$MD$JP$
241354121$24135412$1$I$$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A163050$ASTRAZENECA$Miyamoto K.;  Ogino H.;  Kakimoto T.;  Matsumura Y.;  Haji K.;  Mitsuhashi A.;  Morita Y.;  Tsukazaki Y.;  Yabuki Y.;  Ozaki R.;  Yoneda H.;  Sato S.;  Hanibuchi M.;  Bando Y.; Nokihara H.;  Nishioka Y. Transformation of epidermal growth factor receptor mutated lung adenocarcinoma to small-cell carcinoma long after the cessation of tyrosine kinase inhibitor treatment: A case series and literature review. Respiratory Medicine Case Reports 2024;51:102076.$67$YR$$M$Y$$$20240725$$HP$JP$
241354132$24135413$2$F$20240301$20240828$20240725$20240905$EXP$$JP-AstraZeneca-2024A164632$ASTRAZENECA$Riku S, et al. 5 An elderly male case of delirium due to dehydration associated with SGLT2 inhibitors in the depressive phase of bipolar disorder. Psychiatria et Neurologia Japonica 2024;126(6):408.$80$YR$$M$Y$$$20240905$$MD$JP$
241354141$24135414$1$I$$20240717$20240725$20240725$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001460$BLUEPRINT MEDICINES$$$$$F$Y$$$20240725$$CN$US$US
241354152$24135415$2$F$20240715$20240717$20240725$20240803$PER$$US-ROCHE-10000033765$ROCHE$$$$$$Y$$$20240803$$CN$US$US
241354161$24135416$1$I$$20240717$20240725$20240725$PER$$US-ABBVIE-5848624$ABBVIE$$$$$$Y$$$20240725$$CN$US$US
241354171$24135417$1$I$$20240712$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010510$DR REDDYS$$14$YR$T$F$Y$$$20240725$$HP$US$US
241354181$24135418$1$I$$20240712$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010457$DR REDDYS$$18$YR$T$$Y$$$20240725$$MD$US$US
241354192$24135419$2$F$$20240726$20240725$20240731$PER$$US-JNJFOC-20240672812$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241354201$24135420$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034687$ROCHE$$$$$$Y$$$20240725$$HP$US$US
241354211$24135421$1$I$20231101$20240717$20240725$20240725$EXP$$FR-AstraZeneca-2024A167799$ASTRAZENECA$$78$YR$$F$Y$$$20240725$$MD$FR$
241354221$24135422$1$I$20240713$20240723$20240725$20240725$EXP$$AU-ROCHE-10000035131$ROCHE$$59$YR$A$F$Y$$$20240725$$CN$AU$AU
241354231$24135423$1$I$$20240719$20240725$20240725$EXP$$US-AMGEN-USASP2024144839$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241354241$24135424$1$I$$20240710$20240725$20240725$EXP$$US-SAMSUNG BIOEPIS-SB-2024-21812$SAMSUNG BIOEPIS$Miller M, Pasternak B. Rescue therapy with upadacitinib in medically refractory pediatric ulcerative colitis. Journal of Pediatric Gastroenterology and Nutrition. 2024 APR 01;5(2):197-199. doi:10.1002/jpr3.12067$13$YR$T$F$Y$$$20240725$$HP$US$US
241354252$24135425$2$F$20240711$20240816$20240725$20240819$EXP$$US-ALXN-202407USA001025US$ALEXION PHARMACEUTICALS$$47$YR$$$Y$$$20240819$$PH$US$US
241354261$24135426$1$I$$20240710$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111433$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240725$$HP$US$US
241354271$24135427$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117911$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240725$$CN$US$US
241354281$24135428$1$I$20240629$20240722$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117919$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240725$$PH$US$US
241354291$24135429$1$I$$20240718$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115221$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240725$$CN$US$US
241354301$24135430$1$I$$20240717$20240725$20240725$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-101822$REGENERON$$85$YR$$F$Y$$$20240725$$HP$CO$CO
241354312$24135431$2$F$20240701$20240807$20240725$20240816$EXP$$ZA-TEVA-VS-3221871$TEVA$$48$YR$$F$Y$$$20240816$$CN$ZA$ZA
241354321$24135432$1$I$$20240613$20240725$20240725$PER$$JP-WT-2024-03218$Waylis$$$$$F$Y$$$20240725$$CN$JP$JP
241354331$24135433$1$I$20231101$20240710$20240725$20240725$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-21330$SAMSUNG BIOEPIS$$1$DY$N$M$Y$2.69$KG$20240725$$MD$DE$DE
241354341$24135434$1$I$$20240701$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06709$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241354351$24135435$1$I$20200501$20240715$20240725$20240725$EXP$$GB-TEVA-VS-3221938$TEVA$$45$YR$$F$Y$$$20240725$$MD$GB$GB
241354361$24135436$1$I$$20240722$20240725$20240725$EXP$$GB-ROCHE-10000006469$ROCHE$$$$$$Y$$$20240725$$CN$GB$GB
241354371$24135437$1$I$$20240718$20240725$20240725$30DAY$$US-GSK-US2024090749$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
241354381$24135438$1$I$$20240716$20240725$20240725$EXP$$US-GSK-US2024AMR092936$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$HP$US$US
241354392$24135439$2$F$20240716$20240731$20240725$20240807$EXP$$US-AMGEN-USASP2024145155$AMGEN$$67$YR$E$F$Y$87$KG$20240807$$HP$US$US
241354401$24135440$1$I$20240501$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024145344$AMGEN$$$$$$Y$$$20240725$$PH$US$US
241354412$24135441$2$F$$20240724$20240725$20240806$EXP$$US-ALVOGEN-2024095125$ALVOGEN$Schneegurt NR, Wright C, Glenn N, Thethi I. Flecainide-Induced Acute Respiratory Distress Syndrome: A Case Report. Cureus. 2024-Jun-04;16(6):e61637. doi:https://dx.doi.org/10.7759/cureus.61637$74$YR$$M$Y$$$20240806$$HP$US$US
241354421$24135442$1$I$20240709$20240715$20240725$20240725$EXP$$IT-EMD Serono-2024038947$EMD SERONO INC$$86$YR$E$F$Y$$$20240725$$PH$IT$IT
241354434$24135443$4$F$$20240920$20240725$20240927$30DAY$$DE-JNJFOC-20240754393$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$DE$DE
241354441$24135444$1$I$$20240715$20240725$20240725$EXP$$FR-REGENERON PHARMACEUTICALS, INC.-2024-101819$REGENERON$$68$YR$$$Y$$$20240725$$PH$FR$FR
241354451$24135445$1$I$$20240701$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06655$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241354461$24135446$1$I$20240701$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146388$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241354472$24135447$2$F$20240630$20240729$20240725$20240731$PER$$US-AMGEN-USASP2024146485$AMGEN$$68$YR$E$M$Y$$$20240731$$CN$US$US
241354481$24135448$1$I$$20240716$20240725$20240725$EXP$$CA-APOTEX-2024AP008506$APOTEX$$59$YR$$M$Y$$$20240725$$CN$CA$CA
241354491$24135449$1$I$$20240712$20240725$20240725$EXP$$US-ALVOGEN-2024095126$ALVOGEN$Ghalayni R, Kalaji B A, Malik K. From Friend to Foe: A Case of Naloxone-Induced Pulmonary Edema. Hospital Pharmacy. 2024;59(4):407-410. doi:https://doi.org/10.1177/00185787241230074$66$YR$$F$Y$$$20240725$$HP$US$US
241354501$24135450$1$I$20220101$20240723$20240725$20240725$EXP$$KR-ABBVIE-5851300$ABBVIE$$57$YR$$F$Y$$$20240725$$MD$KR$KR
241354511$24135451$1$I$$20240723$20240725$20240725$EXP$$US-ABBVIE-5851217$ABBVIE$$$$$$Y$$$20240725$$HP$US$US
241354521$24135452$1$I$20240301$20240722$20240725$20240725$PER$$US-ABBVIE-5849283$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241354531$24135453$1$I$$20240718$20240725$20240725$PER$$US-HALEON-2187795$Haleon PLC$$$$$F$Y$$$20240719$$CN$US$US
241354541$24135454$1$I$20240617$20240722$20240725$20240725$EXP$$US-ABBVIE-5823360$ABBVIE$$79$YR$$F$Y$109$KG$20240725$$CN$US$US
241354551$24135455$1$I$$20240724$20240725$20240725$PER$$US-HALEON-2188812$Haleon PLC$$75$YR$$M$Y$$$20240725$$CN$US$US
241354561$24135456$1$I$20240718$20240718$20240725$20240725$PER$$US-AMGEN-USASP2024145092$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241354571$24135457$1$I$$20240723$20240725$20240725$PER$$US-HALEON-2188689$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241354581$24135458$1$I$$20240714$20240725$20240725$EXP$GB-MHRA-MED-202407131625572030-BPNRG$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15873$ALKEM$$$$$$Y$$$20240725$$CN$GB$GB
241354591$24135459$1$I$20240710$20240714$20240725$20240725$EXP$GB-MHRA-MED-202407131808148350-KDJRZ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15875$ALKEM$$47$YR$$F$Y$$$20240725$$HP$GB$GB
241354601$24135460$1$I$20240412$20240710$20240725$20240725$EXP$$US-PHARMAAND GMBH-2024PHR00417$pharmaAND$$74$YR$$F$Y$$$20240725$$HP$US$US
241354611$24135461$1$I$20240722$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117847$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240725$$CN$US$CA
241354621$24135462$1$I$$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A164971$ASTRAZENECA$Fusegi A, et al. Ovarian surveillance including endometrial cytology for patients with hereditary breast and ovarian cancer before risk-reducing salpingo-oohporectomy: A retrospective analysis. The Journal of Obstetrics and Gynaecology Research 2024;50(6):1002-1009.$64$YR$$F$Y$$$20240725$$MD$JP$
241354631$24135463$1$I$$20240701$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06705$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241354641$24135464$1$I$$20240724$20240725$20240725$PER$$US-HALEON-2188802$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241354651$24135465$1$I$$20240708$20240725$20240725$PER$$US-AstraZeneca-2024A157584$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241354661$24135466$1$I$$20220221$20240725$20240725$EXP$$US-AstraZeneca-2022A082083$ASTRAZENECA$$$$$F$Y$$$20240725$$MD$US$
241354671$24135467$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165577$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241354681$24135468$1$I$$20240717$20240725$20240725$EXP$$US-AstraZeneca-2024A163730$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241354691$24135469$1$I$20240627$20240722$20240725$20240725$EXP$$CN-AstraZeneca-2024A168111$ASTRAZENECA$$22881$DY$$M$Y$$$20240725$$MD$CN$
241354701$24135470$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165560$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241354711$24135471$1$I$$20240717$20240725$20240725$PER$$US-ROCHE-10000033737$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241354721$24135472$1$I$$20240722$20240725$20240725$PER$$US-ROCHE-10000033663$ROCHE$$$$A$F$Y$$$20240725$$CN$US$US
241354731$24135473$1$I$$20240722$20240725$20240725$PER$$US-ROCHE-3487672$ROCHE$$19$YR$A$M$Y$$$20240725$$CN$US$US
241354741$24135474$1$I$20240701$20240723$20240725$20240725$PER$$US-ROCHE-10000034661$ROCHE$$$$$F$Y$$$20240725$$HP$US$US
241354751$24135475$1$I$$20240715$20240725$20240725$EXP$$CA-HALEON-2187975$Haleon PLC$$43$YR$$F$Y$$$20240725$$HP$CA$CA
241354761$24135476$1$I$$20240711$20240725$20240725$EXP$$US-HALEON-2186676$Haleon PLC$$$$$$Y$$$20240715$$CN$US$US
241354771$24135477$1$I$$20240719$20240725$20240725$EXP$$US-ABBVIE-5849593$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
2413547810$24135478$10$F$$20240916$20240725$20240923$EXP$$US-ROCHE-10000028941$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
241354794$24135479$4$F$$20240813$20240725$20240815$EXP$$CA-ROCHE-10000017179$ROCHE$$64$YR$A$M$Y$$$20240815$$CN$CA$CA
241354801$24135480$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000035248$ROCHE$$$$$$Y$$$20240725$$MD$US$US
241354811$24135481$1$I$20240701$20240715$20240725$20240725$EXP$$US-ENDO USA, INC.-2024-002981$ENDO$$48$YR$$M$Y$$$20240725$$CN$US$US
241354831$24135483$1$I$$20240715$20240725$20240725$30DAY$$US-GSK-US2024AMR089644$GLAXOSMITHKLINE$$$$$M$Y$$$20240725$$CN$US$US
241354841$24135484$1$I$$20240722$20240725$20240725$EXP$$CA-GSK-CA2024AMR092125$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$CA$CA
241354851$24135485$1$I$$20240718$20240725$20240725$PER$$US-HALEON-2187910$Haleon PLC$$$$$F$Y$$$20240719$$CN$US$US
241354861$24135486$1$I$$20240715$20240725$20240725$EXP$$US-GSK-US2024AMR089250$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
241354881$24135488$1$I$$20240703$20240725$20240725$PER$$US-JNJFOC-20240712362$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$CN$US$US
241354891$24135489$1$I$$20240719$20240725$20240725$EXP$$BE-Bion-013501$BIONPHARMA$$82$YR$E$F$Y$$$20240725$$HP$BE$BE
241354902$24135490$2$F$20240101$20240723$20240725$20240729$EXP$$GB-ABBVIE-5846077$ABBVIE$$79$YR$$F$Y$$$20240729$$CN$GB$GB
241354911$24135491$1$I$$20240717$20240725$20240725$EXP$$GB-CELLTRION INC.-2024GB017791$CELLTRION$$$$$$Y$$$20240725$$CN$GB$GB
241354921$24135492$1$I$20240415$20240723$20240725$20240725$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041621$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240725$$MD$US$US
241354931$24135493$1$I$$20240718$20240725$20240725$PER$$US-HALEON-2187889$Haleon PLC$$$$$F$Y$$$20240719$$CN$US$US
241354941$24135494$1$I$$20240722$20240725$20240725$EXP$$JP-Bion-013510$BIONPHARMA$$63$YR$A$F$Y$$$20240725$$HP$JP$JP
241354951$24135495$1$I$$20240717$20240725$20240725$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01362$NOVITIUM PHARMA$Binlin Da.Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue of the ileum in an adult presenting with intussusception: a case report and literature review.Frontiers in Oncology.11-JUN-2024;NA:1-6$32$YR$A$M$Y$$$20240725$$HP$CN$CN
241354962$24135496$2$F$20240701$20240830$20240725$20240906$EXP$$US-SANDOZ INC.-SDZ2024US059049$SANDOZ$$$$$F$Y$$$20240906$$CN$US$US
241354971$24135497$1$I$$20240722$20240725$20240725$EXP$$GR-GILEAD-2024-0681685$GILEAD$Magaliou S. et al. ACUTE RENAL FAILURE AND SEVERE METABOLIC ACIDOSIS INDUCED BY METFORMIN AND TENOFOVIR. 50th ANNUAL PANHELLENIC MEDICAL CONGRESS, 25-27 APRIL 2024_POSTERS. 2024;unk:unk$74$YR$E$M$Y$$$20240725$$HP$GR$GR
241354981$24135498$1$I$$20240716$20240725$20240725$EXP$$CN-ROCHE-10000010628$ROCHE$Luo S, Yan P, Wang X, Ren X, Sun K, Guo L, et al. Talaromyces marneffei: A challenging diagnosis in a kidney transplant patient. Clinical Case Reports. 2024-Jul;12 (7):1-6. doi:10.1002/ccr3.9028.$68$YR$E$M$Y$$$20240725$$HP$CN$CN
241354991$24135499$1$I$$20240715$20240725$20240725$EXP$$US-GSK-US2024088671$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
241355001$24135500$1$I$$20240715$20240725$20240725$EXP$$US-GSK-US2024088583$GLAXOSMITHKLINE$$$$$M$Y$$$20240725$$CN$US$US
241355011$24135501$1$I$$20240715$20240725$20240725$30DAY$$US-GSK-US2024088769$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
241355021$24135502$1$I$$20240724$20240725$20240725$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041845$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240725$$CN$US$US
241355031$24135503$1$I$$20240719$20240725$20240725$EXP$$GB-AMGEN-GBRNI2024146677$AMGEN$$25$YR$A$F$Y$$$20240725$$CN$GB$GB
241355041$24135504$1$I$20240719$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145685$AMGEN$$$$$$Y$$$20240725$$PH$US$US
241355051$24135505$1$I$$20240718$20240725$20240725$EXP$$US-TAKEDA-2021TUS070016$TAKEDA$$$$$F$Y$$$20240725$$CN$US$US
241355063$24135506$3$F$20240809$20240916$20240725$20240920$EXP$$US-TAKEDA-2024TUS074867$TAKEDA$$61$YR$$F$Y$$$20240920$$CN$US$US
241355071$24135507$1$I$$20240720$20240725$20240725$EXP$$CA-TAKEDA-2024TUS074162$TAKEDA$$$$$M$Y$$$20240725$$CN$CA$CA
241355081$24135508$1$I$$20240717$20240725$20240725$PER$$US-ALXN-202407USA001357US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241355092$24135509$2$F$20230627$20240513$20240725$20240919$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06494$HIKMA$Torres HA, Mustafayev K, Nastoupil LJ, Shelburne SA.. Torres HA, Mustafayev K, Nastoupil LJ, Shelburne SA. Severe reactivation of seronegative occult hepatitis B after chemotherapy for lymphoma. The Lancet. 2024;403(10434):1372-1373$78$YR$$M$Y$65$KG$20240919$$MD$US$US
241355101$24135510$1$I$20210101$20240715$20240725$20240725$EXP$$BR-STERISCIENCE B.V.-2024-ST-001077$Steriscience PTE$Almeida AS, Yonamine FK, Soares AD, Penido NO, Cruz OLM.. Cochlear implant for profound hearing loss post COVID-19 complications.. Brazi-J-Otorhinolaryngol. 2023;89 (6)$55$YR$$M$Y$$$20240725$$HP$BR$BR
241355121$24135512$1$I$$20240722$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116958$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240725$$HP$US$US
241355131$24135513$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118028$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240725$$HP$US$US
241355141$24135514$1$I$$20240718$20240725$20240725$PER$$US-HALEON-2187953$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
241355151$24135515$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146099$AMGEN$$$$$M$Y$$$20240725$$CN$US$US
241355161$24135516$1$I$20240722$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145703$AMGEN$$72$YR$E$M$Y$$$20240725$$CN$US$US
241355181$24135518$1$I$$20240710$20240725$20240725$EXP$$US-CHATTEMPRD-2024OHG023865$CHATTEM$$$$$F$Y$$$20240725$$LW$US$US
241355191$24135519$1$I$$20240716$20240725$20240725$EXP$$CA-ROCHE-3571550$ROCHE$$$$E$M$Y$$$20240725$$CN$CA$CA
241355201$24135520$1$I$20230101$20240617$20240725$20240725$PER$$JP-WT-2024-03336$Waylis$$$$$$Y$$$20240725$$PH$JP$JP
241355211$24135521$1$I$20240101$20240716$20240725$20240725$EXP$$CN-SA-2024SA214004$SANOFI AVENTIS$$48$YR$A$F$Y$51$KG$20240725$$HP$CN$CN
241355222$24135522$2$F$20200401$20240820$20240725$20240827$EXP$$AU-SA-2024SA200250$SANOFI AVENTIS$Thorburn S, Majumdar A, Smibert O.. Chronic hepatitis E masquerading as allograft rejection in a liver transplant recipient.. Transpl Infect Dis.. 2024;26(3):1-3$41$YR$A$M$Y$$$20240827$$MD$AU$AU
241355242$24135524$2$F$20240513$20240821$20240725$20240827$EXP$$AU-TAKEDA-2024TUS052839$TAKEDA$$72$YR$$F$Y$$$20240827$$CN$AU$AU
241355251$24135525$1$I$20240709$20240713$20240725$20240725$EXP$$US-Accord-436278$ACCORD$$45$YR$A$M$Y$$$20240725$$HP$US$US
241355261$24135526$1$I$20240710$20240713$20240725$20240725$EXP$$US-Accord-436248$ACCORD$$51$YR$A$F$Y$$$20240725$$HP$US$US
241355271$24135527$1$I$20240625$20240713$20240725$20240725$EXP$$US-Accord-436663$ACCORD$$27$YR$A$F$Y$$$20240725$$HP$US$US
241355282$24135528$2$F$$20240807$20240725$20240819$EXP$NL-LRB-00985383$NL-Accord-437102$ACCORD$$61$YR$A$F$Y$$$20240819$$PH$NL$NL
241355291$24135529$1$I$$20240718$20240725$20240725$PER$$US-HALEON-2187985$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
241355301$24135530$1$I$20240709$20240716$20240725$20240725$EXP$$US-Accord-436917$ACCORD$$32$YR$A$M$Y$$$20240725$$HP$US$US
241355311$24135531$1$I$20220801$20240714$20240725$20240725$EXP$$TW-Accord-437926$ACCORD$Peng TR, Wu TW, Chen HF, Kao WY, Chan CH. Gemcitabine-Associated Hyperammonemia in a Patient With Cholangiocarcinoma. Am J Ther. 2024 Jul-Aug 01;31(4):e439-e440. doi: 10.1097/MJT.0000000000001653.$57$YR$A$F$Y$$$20240725$$PH$TW$TW
241355321$24135532$1$I$$20240715$20240725$20240725$EXP$CA-MHPD-E2B_07055396$CA-Accord-436454$ACCORD$$3$YR$C$F$Y$$$20240725$$MD$CA$CA
241355331$24135533$1$I$$20240715$20240725$20240725$EXP$$CN-TEYRO-2024-TY-000369$Teyro Labs$Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, et.al.Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nature Medicine.2024$$$$$Y$$$20240725$$HP$CN$CN
241355341$24135534$1$I$$20240717$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092568$VIIV$$$$$$Y$$$20240725$$HP$US$US
241355352$24135535$2$F$$20240726$20240725$20240807$EXP$$US-ALVOGEN-2024095167$ALVOGEN$Ballotari M, Truver MT, Dhoble LR, Kinsey AM, Hoyer JL, Chronister CW, Goldberger BA. A Postmortem Case Report involving Fentanyl, Desalkylgidazepam and Bromazolam. Journal of Analytical Toxicology. 2024-Jul-05;00:1-5. doi:https://doi.org/10.1093/jat/bkae059$24$YR$$M$Y$$$20240807$$HP$US$US
241355362$24135536$2$F$$20240812$20240725$20240816$EXP$$GB-TAKEDA-2024TUS073359$TAKEDA$$$$$F$Y$$$20240816$$CN$GB$GB
241355371$24135537$1$I$20240716$20240722$20240725$20240725$PER$$US-ABBVIE-5850377$ABBVIE$$37$YR$$F$Y$$$20240725$$HP$US$US
241355381$24135538$1$I$20240329$20240716$20240725$20240725$EXP$FR-AFSSAPS-LL2024001296$FR-BAXTER-2024BAX021695$BAXTER$$69$YR$$F$Y$100$KG$20240725$$MD$FR$FR
241355391$24135539$1$I$$20240717$20240725$20240725$EXP$$CA-BAXTER-2024BAX022060$BAXTER$$43$YR$$M$Y$$$20240725$$HP$CA$CA
241355401$24135540$1$I$20240619$20240717$20240725$20240725$EXP$CN-NMPACDR-4301011002666202400399$CN-BAXTER-2024BAX021974$BAXTER$$52$YR$$F$Y$61$KG$20240725$$MD$CN$CN
241355411$24135541$1$I$20231010$20240715$20240725$20240725$EXP$AT-EMA-DD-20240709-7482661-082429$AT-BAXTER-2024BAX021615$BAXTER$$60$YR$$F$Y$80$KG$20240725$$MD$AT$AT
241355421$24135542$1$I$20240530$20240717$20240725$20240725$EXP$CN-NMPACDR-3301051038103202400165$CN-BAXTER-2024BAX021975$BAXTER$$53$YR$$F$Y$46$KG$20240725$$MD$CN$CN
241355432$24135543$2$F$$20240718$20240725$20240725$EXP$$US-ROCHE-10000031790$ROCHE$$$$$F$Y$$$20240725$$MD$US$US
241355441$24135544$1$I$$20240723$20240725$20240725$PER$$PR-ROCHE-10000034431$ROCHE$$31$YR$A$F$Y$$$20240725$$CN$PR$PR
241355452$24135545$2$F$20240601$20240802$20240725$20240812$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00531$PARATEK PHARMACEUTICALS$$54$YR$$M$Y$106.58$KG$20240812$$CN$US$US
241355462$24135546$2$F$$20240723$20240725$20240807$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00590$Phathom Pharmaceuticals$$7$DEC$$M$Y$$$20240807$$MD$JP$JP
241355472$24135547$2$F$20240531$20240823$20240725$20240906$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00606$Phathom Pharmaceuticals$$73$YR$$F$Y$36.5$KG$20240906$$MD$JP$JP
241355481$24135548$1$I$$20240711$20240725$20240725$EXP$$BR-PHATHOM PHARMACEUTICALS INC.-2024PHT00617$Phathom Pharmaceuticals$$$$$M$Y$73$KG$20240725$$HP$BR$BR
241355492$24135549$2$F$20240713$20240816$20240725$20240824$PER$$US-ROCHE-10000032478$ROCHE$$28$YR$A$M$Y$$$20240824$$CN$US$US
241355501$24135550$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034866$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241355511$24135551$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034818$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241355521$24135552$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000035161$ROCHE$$$$$F$Y$$$20240725$$CN$US$US
241355531$24135553$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034597$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241355541$24135554$1$I$$20240723$20240725$20240725$EXP$$US-UCBSA-2024037392$UCB$$$$$$Y$$$20240725$$MD$US$US
241355551$24135555$1$I$$20240722$20240725$20240725$PER$$US-ABBVIE-5850964$ABBVIE$$$$$F$Y$$$20240725$$MD$US$US
241355571$24135557$1$I$20171128$20240723$20240725$20240725$EXP$$CA-TAKEDA-2017TUS010851$TAKEDA$$48$YR$$F$Y$$$20240725$$CN$CA$CA
241355583$24135558$3$F$$20240822$20240725$20240828$EXP$$JP-TAKEDA-2024TUS073948$TAKEDA$$70$YR$$$Y$$$20240828$$MD$JP$JP
241355602$24135560$2$F$$20240807$20240725$20240809$PER$$US-AMGEN-USASP2024146476$AMGEN$$$$$F$Y$$$20240808$$PH$US$US
241355611$24135561$1$I$$20240711$20240725$20240725$EXP$$JP-AMGEN-JPNSP2024144339$AMGEN$$$$$$Y$$$20240725$$MD$JP$JP
241355621$24135562$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06344$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241355631$24135563$1$I$$20240717$20240725$20240725$EXP$$US-AMGEN-USASP2024142575$AMGEN$Ahmed N.; Kimbrough B.; Koster M.. Relapsing IgG4-related disease presenting with unilateral parotid mass and facial palsy. Rheumatology. 2024;63 (7):e204-e205$62$YR$A$M$Y$$$20240725$$HP$US$US
241355641$24135564$1$I$20240717$20240718$20240725$20240725$PER$$US-ABBVIE-5847760$ABBVIE$$27$YR$$F$Y$$$20240725$$CN$US$US
241355654$24135565$4$F$$20240819$20240725$20240822$PER$$US-ROCHE-10000032096$ROCHE$$36$YR$A$F$Y$$$20240822$$CN$US$US
241355671$24135567$1$I$$20240717$20240725$20240725$EXP$$US-AMGEN-USASP2024143138$AMGEN$Sun F.; Batra A.; Dickson D. et.al.. Efgartigimod infusion in the treatment regimen for myasthenic crisis: A case report. Muscle + Nerve. 2024;70:290-292$48$YR$A$F$Y$$$20240725$$MD$US$US
241355681$24135568$1$I$$20240717$20240725$20240725$EXP$$PT-ROCHE-10000033227$ROCHE$$$$$$Y$$$20240725$$MD$PT$PT
241355691$24135569$1$I$20240718$20240718$20240725$20240725$PER$$US-ABBVIE-5848270$ABBVIE$$83$YR$$M$Y$$$20240725$$CN$US$US
241355701$24135570$1$I$20240101$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024144835$AMGEN$$46$YR$A$F$Y$$$20240725$$PH$US$US
241355713$24135571$3$F$$20240626$20240725$20240726$EXP$$US-CHATTEMPRD-2024OHG023445$CHATTEM$$31$YR$A$$Y$$$20240726$$CN$US$US
241355721$24135572$1$I$$20240717$20240725$20240725$EXP$$US-AMGEN-USASP2024145102$AMGEN$Chiu C.; Beam E.; Brumble L.M. et al.. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clinical Transplantation. 2024;38 (7):1-9$$$$$Y$$$20240725$$HP$US$US
241355731$24135573$1$I$$20240719$20240725$20240725$EXP$$US-AMGEN-USASP2024145099$AMGEN$Bhatia S.; Yan C.; Richard M. A. et al.. Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma. Journal of Clinical Oncology. 2024;42 (20):2415-2424$$$$$Y$$$20240725$$MD$US$US
241355742$24135574$2$F$$20240719$20240725$20240731$EXP$$LV-ROCHE-10000031503$ROCHE$$42$YR$A$M$Y$$$20240731$$CN$LV$LV
241355751$24135575$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118000$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240725$$HP$US$US
241355761$24135576$1$I$$20240715$20240725$20240725$EXP$$CN-TEYRO-2024-TY-000365$Teyro Labs$Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, et.al.Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nature Medicine.2024$$$$$Y$$$20240725$$HP$CN$CN
241355772$24135577$2$F$$20240909$20240725$20240911$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-116919$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240911$$PH$AU$AU
241355781$24135578$1$I$$20240719$20240725$20240725$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-116287$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$PH$ES$ES
241355791$24135579$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117519$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240725$$CN$US$US
241355802$24135580$2$F$20240701$20240723$20240725$20240729$EXP$$GB-MYLANLABS-2024M1067956$MYLAN$$58$YR$$F$Y$$$20240729$$CN$GB$GB
241355811$24135581$1$I$$20240717$20240725$20240725$EXP$$US-AMGEN-USASP2024144912$AMGEN$Chiu C.; Brumble L.; Vikram H.R. et al.. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clinical Transplantation. 2024;38 (7):1-9$59$YR$A$M$Y$$$20240725$$HP$US$US
241355821$24135582$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015399$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240725$$CN$US$US
241355831$24135583$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015194$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240725$$CN$US$US
241355841$24135584$1$I$20240701$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015071$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240725$$CN$US$US
241355851$24135585$1$I$20240722$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015506$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240725$$CN$US$US
241355861$24135586$1$I$20240721$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015157$ELI LILLY AND CO$$59$YR$A$$Y$$$20240725$$CN$US$US
241355871$24135587$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015202$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240725$$CN$US$US
241355881$24135588$1$I$20240723$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015095$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240725$$CN$US$US
241355891$24135589$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015146$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240725$$CN$US$US
241355902$24135590$2$F$$20240801$20240725$20240802$EXP$$IT-ROCHE-10000031528$ROCHE$$$$$M$Y$$$20240802$$MD$IT$IT
241355911$24135591$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06773$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241355921$24135592$1$I$$20240712$20240725$20240725$PER$$US-TEVA-VS-3224485$TEVA$$$$A$F$Y$$$20240725$$PH$US$US
241355931$24135593$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165623$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241355951$24135595$1$I$$20240717$20240725$20240725$EXP$$US-AstraZeneca-2024A166172$ASTRAZENECA$$85$YR$$M$Y$$$20240725$$CN$US$
241355961$24135596$1$I$$20201001$20240725$20240725$EXP$$US-AstraZeneca-2020SF27701$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241355971$24135597$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024090727$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241355981$24135598$1$I$$20240718$20240725$20240725$EXP$$CA-TAKEDA-2023TUS027564$TAKEDA$$$$$M$Y$$$20240725$$CN$CA$CA
241355991$24135599$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165728$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241356001$24135600$1$I$$20240717$20240725$20240725$EXP$$ZA-AstraZeneca-2024A163576$ASTRAZENECA$$86$YR$$M$Y$$$20240725$$CN$ZA$
241356011$24135601$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165547$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241356021$24135602$1$I$$20210426$20240725$20240725$EXP$$US-AstraZeneca-2021A360398$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$US$
241356031$24135603$1$I$$20240702$20240725$20240725$PER$$US-JNJFOC-20240713654$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$CN$US$US
241356042$24135604$2$F$$20240718$20240725$20240728$PER$$GB-BEH-2024176041$CSL BEHRING$$$$A$$Y$$$20240728$$PH$GB$GB
241356054$24135605$4$F$$20240919$20240725$20240924$EXP$$NVSC2024US151538$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
241356061$24135606$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06739$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241356071$24135607$1$I$$20240722$20240725$20240725$EXP$$US-ORGANON-O2407USA002261$ORGANON$$$$$F$Y$$$20240725$$CN$US$US
241356081$24135608$1$I$$20240722$20240725$20240725$PER$$NVSC2024US150377$NOVARTIS$$$$$M$Y$$$20240725$$CN$US$US
241356091$24135609$1$I$20240508$20240723$20240725$20240725$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-030341$BOEHRINGER INGELHEIM$$$$$$Y$$$20240725$$MD$US$US
241356101$24135610$1$I$$20240718$20240725$20240725$PER$$US-ABBVIE-5848253$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241356112$24135611$2$F$$20240814$20240725$20240821$30DAY$$US-GSK-US2024090748$GLAXOSMITHKLINE$$$$$M$Y$$$20240821$$CN$US$US
241356121$24135612$1$I$$20240724$20240725$20240725$PER$$US-HALEON-2188849$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241356131$24135613$1$I$$20240717$20240725$20240725$EXP$$US-AMGEN-USASP2024143410$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241356141$24135614$1$I$$20240702$20240725$20240725$PER$$US-JNJFOC-20240711746$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
241356151$24135615$1$I$$20240715$20240725$20240725$EXP$$PT-TEVA-VS-3222513$TEVA$Nunes AP, Jardim M, Gomes S, Almada S, Fernandes AC, Pestana A et al. CO-0177 - (4798) - DRIFTING WITHDRAWAL. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional de Medicina Interna - Livro de resumos [CNMI]. 2024 May; 277.$63$YR$$F$Y$$$20240725$$MD$PT$PT
241356161$24135616$1$I$$20240719$20240725$20240725$EXP$$NVSC2024AU150057$NOVARTIS$$$$$F$Y$$$20240725$$CN$AU$AU
241356171$24135617$1$I$20240601$20240722$20240725$20240725$EXP$$SG-JNJFOC-20240760257$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240725$$HP$SG$SG
241356182$24135618$2$F$20230101$20240808$20240725$20240813$EXP$$CA-JNJFOC-20240755602$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240813$$HP$CA$CA
241356202$24135620$2$F$20170101$20240729$20240725$20240802$EXP$$BR-TAKEDA-2024TUS073020$TAKEDA$$$$$F$Y$$$20240802$$CN$BR$BR
241356211$24135621$1$I$$20240719$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117461$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$88$KG$20240725$$CN$US$US
241356221$24135622$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117904$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240725$$CN$US$US
241356231$24135623$1$I$$20240717$20240725$20240725$EXP$$US-AstraZeneca-2024A163768$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$US$
241356241$24135624$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116814$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240725$$CN$US$US
241356251$24135625$1$I$$20240716$20240725$20240725$EXP$$US-NOVITIUMPHARMA-2024USNVP01340$NOVITIUM PHARMA$Zheng J.SEVERE COVID-19 INFECTION COMPLICATED BY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH).Journal of Investigative Medicine.15-JUL-2023;71:1-3$55$YR$A$M$Y$$$20240725$$HP$US$US
241356261$24135626$1$I$$20240723$20240725$20240725$PER$$US-AstraZeneca-2024A168094$ASTRAZENECA$$$$A$M$Y$$$20240725$$MD$US$
241356274$24135627$4$F$20200101$20240813$20240725$20240819$EXP$$NVSC2024DE151922$NOVARTIS$$$$A$F$Y$62$KG$20240819$$CN$DE$DE
241356281$24135628$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165443$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241356291$24135629$1$I$20240702$20240702$20240725$20240725$PER$$TR-TOLMAR, INC.-24TR050737$TOLMAR$$76$YR$$$Y$$$20240725$$HP$TR$TR
241356301$24135630$1$I$20240702$20240702$20240725$20240725$PER$$TR-TOLMAR, INC.-24TR050741$TOLMAR$$98$YR$$M$Y$$$20240725$$MD$TR$TR
241356311$24135631$1$I$$20240702$20240725$20240725$PER$$IT-TOLMAR, INC.-24IT050739$TOLMAR$$81$YR$$M$Y$$$20240725$$HP$IT$IT
241356321$24135632$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165587$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241356331$24135633$1$I$$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A164951$ASTRAZENECA$$$$$$Y$$$20240725$$PH$JP$
241356341$24135634$1$I$20240701$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A163871$ASTRAZENECA$$95$YR$$M$Y$$$20240725$$PH$JP$
241356351$24135635$1$I$$20240529$20240725$20240725$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108054$ZYDUS PHARM$$$$$$Y$$$20240725$$PH$US$US
241356361$24135636$1$I$20240101$20240523$20240725$20240725$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108055$ZYDUS PHARM$$$$$$Y$$$20240725$$CN$US$US
241356371$24135637$1$I$20240401$20240429$20240725$20240725$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-107031$ZYDUS PHARM$$$$$$Y$$$20240725$$CN$US$US
241356381$24135638$1$I$$20240711$20240725$20240725$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109755$ZYDUS PHARM$Contag CA, Studemeister L, Bogler Y, Cooper JD.. Q fever presenting as splenic infarct without endocarditis.. IDCases. 2024$$$$$Y$$$20240725$$HP$US$US
241356392$24135639$2$F$$20240726$20240725$20240802$EXP$$US-ROCHE-10000028519$ROCHE$$42$YR$A$F$Y$$$20240802$$CN$US$US
241356401$24135640$1$I$20240101$20240426$20240725$20240725$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-106796$ZYDUS PHARM$$$$$$Y$$$20240725$$CN$US$US
241356411$24135641$1$I$20240401$20240404$20240725$20240725$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-105615$ZYDUS PHARM$$$$$$Y$$$20240725$$CN$US$US
241356421$24135642$1$I$20230101$20240403$20240725$20240725$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-105586$ZYDUS PHARM$$$$$$Y$$$20240725$$CN$US$US
241356431$24135643$1$I$$20240215$20240725$20240725$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-103755$ZYDUS PHARM$$$$$$Y$$$20240725$$CN$US$US
241356441$24135644$1$I$20240101$20240412$20240725$20240725$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-106138$ZYDUS PHARM$$$$$$Y$$$20240725$$CN$US$US
241356451$24135645$1$I$20240101$20240209$20240725$20240725$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-103490$ZYDUS PHARM$$$$$$Y$$$20240725$$CN$US$US
241356461$24135646$1$I$20230101$20231106$20240725$20240725$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-100064$ZYDUS PHARM$$$$$$Y$$$20240725$$CN$US$US
241356471$24135647$1$I$20240628$20240715$20240725$20240725$EXP$FR-AFSSAPS-MP2024001121$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109833$ZYDUS PHARM$$$$$$Y$$$20240725$$PH$FR$FR
241356481$24135648$1$I$20240512$20240715$20240725$20240725$EXP$FR-AFSSAPS-TS2024000776$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109836$ZYDUS PHARM$$$$$$Y$$$20240725$$MD$FR$FR
241356491$24135649$1$I$20230826$20240715$20240725$20240725$EXP$FR-AFSSAPS-TO2024001046$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109835$ZYDUS PHARM$$$$$$Y$$$20240725$$PH$FR$FR
241356501$24135650$1$I$$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024146708$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241356521$24135652$1$I$20240606$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145325$AMGEN$$68$YR$E$F$Y$$$20240725$$HP$US$US
241356532$24135653$2$F$20240714$20240826$20240725$20240828$PER$$US-AMGEN-USASP2024141242$AMGEN$$51$YR$A$F$Y$$$20240827$$CN$US$US
241356541$24135654$1$I$$20240723$20240725$20240725$EXP$$NVSC2024NP151833$NOVARTIS$$$$$M$Y$$$20240725$$MD$NP$NP
241356551$24135655$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024091747$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$US$US
241356561$24135656$1$I$$20240724$20240725$20240725$PER$$US-ROCHE-10000035832$ROCHE$$13$YR$T$F$Y$$$20240725$$CN$US$AL
241356571$24135657$1$I$$20240719$20240725$20240725$EXP$AU-TGA-0000812488$NVSC2024AU150061$NOVARTIS$$$$$F$Y$$$20240725$$CN$AU$AU
241356581$24135658$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034998$ROCHE$$$$$$Y$$$20240725$$MD$US$US
241356592$24135659$2$F$20240627$20240802$20240725$20240805$EXP$SI-JAZMP-NCPHV-2024SI0768_0768$SI-ARGENX-2024-ARGX-SI005821$ARGENX BVBA$$$$$$Y$$$20240805$$MD$SI$SI
241356601$24135660$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146360$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241356611$24135661$1$I$$20240722$20240725$20240725$EXP$$AU-ABBVIE-5851757$ABBVIE$$$$$F$Y$$$20240725$$CN$AU$AU
241356622$24135662$2$F$20230101$20240813$20240725$20240823$EXP$DK-DKMA-30733850$DK-TEVA-VS-3221845$TEVA$$$$I$M$Y$5$KG$20240823$$MD$DK$DK
241356631$24135663$1$I$$20240312$20240725$20240725$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-104811$ZYDUS PHARM$$$$$$Y$$$20240725$$CN$US$US
241356641$24135664$1$I$$20240721$20240725$20240725$PER$$US-AMGEN-USASP2024145636$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241356654$24135665$4$F$20240624$20240816$20240725$20240820$PER$$US-AMGEN-USASP2024145299$AMGEN$$72$YR$E$F$Y$$$20240820$$CN$US$US
241356661$24135666$1$I$20240722$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145812$AMGEN$$39$YR$A$F$Y$$$20240725$$CN$US$US
241356672$24135667$2$F$20240716$20240819$20240725$20240823$EXP$$BR-AMGEN-BRASP2024143580$AMGEN$$$$$F$Y$$$20240823$$PH$BR$BR
241356682$24135668$2$F$20240401$20240731$20240725$20240814$EXP$$US-UCBSA-2024037328$UCB$$56$YR$$F$Y$118.82$KG$20240814$$HP$US$US
241356691$24135669$1$I$$20240724$20240725$20240725$EXP$$NVSC2024US151986$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241356701$24135670$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152102$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
241356722$24135672$2$F$20240708$20240730$20240725$20240731$EXP$$NVSC2024DE144609$NOVARTIS$$65$YR$$M$Y$65$KG$20240731$$CN$DE$DE
241356731$24135673$1$I$$20240711$20240725$20240725$EXP$$OM-Unichem Pharmaceuticals (USA) Inc-UCM202407-000891$UNICHEM$$73$YR$E$F$Y$$$20240725$$HP$OM$
241356741$24135674$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034432$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241356751$24135675$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034595$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241356761$24135676$1$I$$20240711$20240725$20240725$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-109753$ZYDUS PHARM$Meenakshi R, Balamurali K, Anbazhagan G.. A unique case of galactorrhea caused by tramadol dependency in a 32-year-old female- a case report.. Indian-J-Psychiatry. 2024;66:71$$$$$Y$$$20240725$$MD$IN$IN
241356771$24135677$1$I$$20240712$20240725$20240725$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-109772$ZYDUS PHARM$Kumar SVRB, Elango I, Balasubramanian K, Nair SV, Ramasamy A, Kathir C.. Renal allograft cortical necrosis in a COVID-19 positive patient.. Indian-J-Nephrol. 2023;33(2):125-127$$$$$Y$$$20240725$$HP$IN$IN
241356781$24135678$1$I$$20240712$20240725$20240725$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109860$ZYDUS PHARM$Kassels A, Edwards L, Kraus CN.. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series.. JAAD-Case-Rep. 2023;40:14-18$$$$$Y$$$20240725$$HP$US$US
241356791$24135679$1$I$20240717$20240717$20240725$20240725$PER$$US-ROCHE-10000030911$ROCHE$$$$$$Y$$$20240725$$PH$US$US
241356802$24135680$2$F$$20240729$20240725$20240806$EXP$$JP-TEVA-VS-3222609$TEVA$Mamesaya N, Kodama H, Iida Y, Kobayashi H, Ko R, Wakuda K, et al. Efficacy and safety of carboplatin and etoposide in older extensive-stage small-cell lung cancer patients with a poor performance status. Thoracic-Cancer 2023; 14 (9): 805-814; Mamesaya N, Kodama H, Iida Y, Kobayashi H, Ko R, Wakuda K, et al. Efficacy and safety of carboplatin and etoposide in older extensive-stage small-cell lung cancer patients with a poor performance status. Thoracic-Cancer 2023; 14 (9): 805-814.; Mamesaya N...$$$E$$Y$$$20240806$$HP$JP$JP
241356821$24135682$1$I$20240627$20240717$20240725$20240725$EXP$$US-VANTIVE-2024VAN018419$Vantive US Healthcare$$54$YR$$M$Y$$$20240725$$HP$US$US
241356831$24135683$1$I$20220901$20240717$20240725$20240725$EXP$$BR-JNJFOC-20240749932$JOHNSON AND JOHNSON$$74$YR$E$M$Y$66$KG$20240725$$CN$BR$BR
241356841$24135684$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117476$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240725$$CN$US$US
241356852$24135685$2$F$$20240814$20240725$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117400$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240818$$HP$US$US
241356861$24135686$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117978$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240725$$HP$US$US
241356871$24135687$1$I$20240724$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117914$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$65.77$KG$20240725$$CN$US$US
241356881$24135688$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117527$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240725$$CN$US$US
241356892$24135689$2$F$$20240808$20240725$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117602$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240815$$CN$US$US
241356902$24135690$2$F$20240701$20240730$20240725$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117937$BRISTOL MYERS SQUIBB$$27$YR$A$F$Y$$$20240801$$HP$US$US
241356911$24135691$1$I$$20240723$20240725$20240725$EXP$$CA-ORGANON-O2407CAN002179$ORGANON$$44$YR$$F$Y$$$20240725$$HP$CA$CA
241356921$24135692$1$I$20240626$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117557$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240725$$HP$US$US
241356931$24135693$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015167$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240725$$CN$US$US
241356941$24135694$1$I$$20240711$20240725$20240725$EXP$$OM-AZURITY PHARMACEUTICALS, INC.-AZR202407-000105$AZURITY PHARMACEUTICALS$Hazra D, Ellouze NF, Abri SA.. Baclofen-induced neurotoxicity in a dialysis patient managed with continuous venovenous hemodialysis: A case report and literature review. Turk. J. Emerg. Med. 2024;24 (3):176-9$73$YR$$F$Y$$$20240725$$MD$OM$OM
241356951$24135695$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016023$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240725$$CN$US$US
241356961$24135696$1$I$20230901$20240720$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015188$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240725$$CN$US$US
241356971$24135697$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015316$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240725$$CN$US$US
241356981$24135698$1$I$20240715$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015186$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240725$$CN$US$US
241356991$24135699$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015913$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240725$$HP$US$US
241357001$24135700$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014752$ELI LILLY AND CO$$$$$F$Y$$$20240725$$CN$US$US
241357011$24135701$1$I$20240719$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015263$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240725$$CN$US$US
241357021$24135702$1$I$20240607$20240723$20240725$20240725$EXP$IT-MINISAL02-995709$IT-SANDOZ INC.-SDZ2024IT067330$SANDOZ$$70$YR$$M$Y$$$20240725$$MD$IT$IT
241357032$24135703$2$F$$20240731$20240725$20240813$EXP$$AU-RICHTER-2024-GR-007604$SUNOVION$$$$$$Y$$$20240813$$CN$AU$AU
241357041$24135704$1$I$20240719$20240724$20240725$20240725$EXP$$CN-ROCHE-10000035804$ROCHE$$37$YR$A$F$Y$55$KG$20240725$$HP$CN$CN
241357051$24135705$1$I$20240101$20240719$20240725$20240725$EXP$$US-ABBVIE-5850420$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241357061$24135706$1$I$20240301$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036210$AUROBINDO$$65$YR$$M$Y$$$20240725$$MD$FR$FR
241357072$24135707$2$F$$20240726$20240725$20240802$PER$$US-ALXN-202407USA001382US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241357081$24135708$1$I$20200514$20240722$20240725$20240725$EXP$$NVSC2024KR150439$NOVARTIS$$$$A$M$Y$$$20240725$$HP$KR$KR
241357091$24135709$1$I$$20240719$20240725$20240725$EXP$$US-ABBVIE-5849813$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241357102$24135710$2$F$$20240731$20240725$20240810$EXP$$US-VIIV HEALTHCARE LIMITED-US2024088722$VIIV$$$$$M$Y$$$20240810$$CN$US$US
241357111$24135711$1$I$$20240717$20240725$20240725$30DAY$$US-GSK-US2024090072$GLAXOSMITHKLINE$$$$$M$Y$$$20240725$$HP$US$US
241357121$24135712$1$I$20240717$20240718$20240725$20240725$30DAY$$US-GSK-US2024090674$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240725$$CN$US$US
241357131$24135713$1$I$20240708$20240716$20240725$20240725$EXP$$CN-AUROBINDO-AUR-APL-2024-036872$AUROBINDO$$64$YR$$F$Y$$$20240725$$HP$CN$CN
241357141$24135714$1$I$$20240717$20240725$20240725$EXP$$GB-TAKEDA-2024TUS055969$TAKEDA$$$$$M$Y$$$20240725$$CN$GB$GB
241357151$24135715$1$I$$20240717$20240725$20240725$PER$$US-TAKEDA-2024TUS072650$TAKEDA$$$$$$Y$$$20240725$$CN$US$US
241357161$24135716$1$I$$20240716$20240725$20240725$EXP$$IN-MYLANLABS-2024M1068085$MYLAN$Kaur B, Kundu K, Singh P, Saini LK, Gupta R. Positive airway pressure (PAP) as a remedy for treatment-resistant migraine - A case report. Lung-India 2024; 41 (4): 322-324.$33$YR$$F$Y$$$20240725$$HP$IN$IN
241357181$24135718$1$I$$20240716$20240725$20240725$EXP$$BE-MYLANLABS-2024M1068168$MYLAN$Saad M, Flament J. Paracetamol overdose causing acute kidney injury without hepatotoxicity: a case report. Int-J-Emerg-Med 2024; 17 (1):.$15$YR$$F$Y$57$KG$20240725$$HP$BE$BE
241357191$24135719$1$I$$20240715$20240725$20240725$EXP$$JP-VIATRISJAPAN-2024M1067417AA$MYLAN$Inoue F, Okazaki Y, Ichiba T, Chiba T, Namera A. Giant T waves and QT interval prolongation associated with guanfacine toxicity. Clin-Toxicol-(Phila) 2024; 62 (4): 269-271.. 2024;62 (4):269-271$51$YR$$M$Y$$$20240725$$HP$JP$JP
241357201$24135720$1$I$$20240715$20240725$20240725$EXP$$US-MYLANLABS-2024M1068120$MYLAN$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J-Ophthalmic-Inflamm-Infect 2024; 14.$89$YR$$F$Y$$$20240725$$HP$US$US
241357211$24135721$1$I$$20240719$20240725$20240725$EXP$$US-ABBVIE-5848706$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241357221$24135722$1$I$$20210513$20240725$20240725$EXP$$AU-AstraZeneca-2021A433985$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$AU$
241357231$24135723$1$I$$20240717$20240725$20240725$EXP$$AU-AstraZeneca-2024A164528$ASTRAZENECA$$$$$F$Y$$$20240725$$MD$AU$
241357244$24135724$4$F$$20240905$20240725$20240915$EXP$$PT-AUROBINDO-AUR-APL-2024-036241$AUROBINDO$Vasconcelos AL, Da Silva LN, Ferreira PC, Pinto  RR, Monteiro M, Ara?jo R.. S?ndrome  serotonin?rgico: uma longa lista de agentes  causais.. Medicina Interna.. 2024;30(Sup 1 ):279$80$YR$$F$Y$$$20240915$$MD$PT$PT
241357251$24135725$1$I$$20240722$20240725$20240725$EXP$$US-AstraZeneca-2024A168051$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241357261$24135726$1$I$20211121$20220310$20240725$20240725$EXP$$CO-AstraZeneca-2022A113464$ASTRAZENECA$$20480$DY$$M$Y$$$20240725$$CN$CO$
241357271$24135727$1$I$$20240722$20240725$20240725$PER$$US-AstraZeneca-2024A167204$ASTRAZENECA$$$$$M$Y$$$20240725$$HP$US$
241357281$24135728$1$I$20240514$20240717$20240725$20240725$EXP$$IT-AstraZeneca-2024A162754$ASTRAZENECA$$77$YR$$M$Y$$$20240725$$MD$IT$
241357291$24135729$1$I$20240501$20240722$20240725$20240725$PER$$US-ORGANON-O2407USA002233$ORGANON$$$$$F$Y$$$20240725$$CN$US$US
241357301$24135730$1$I$20240701$20240715$20240725$20240725$30DAY$$US-GSK-US2024088775$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240725$$CN$US$US
241357313$24135731$3$F$$20240808$20240725$20240821$EXP$$FR-AUROBINDO-AUR-APL-2024-035494$AUROBINDO$Bennassi A, Rivin Del Campo E, Theodore C, Huguet F.. Breast cancer in a transgender man and hypofractionated radiotherapy: A case report and review of literature. Cancer/Radiotherapie.. 2024;28(3):272-4$77$YR$$$Y$$$20240821$$MD$FR$FR
241357321$24135732$1$I$$20240723$20240725$20240725$PER$$US-TAKEDA-2024TUS074443$TAKEDA$$$$$F$Y$$$20240725$$CN$US$US
241357331$24135733$1$I$20240621$20240716$20240725$20240725$EXP$$DE-AUROBINDO-AUR-APL-2024-035610$AUROBINDO$$69$YR$$M$Y$125$KG$20240725$$MD$DE$DE
241357341$24135734$1$I$$20240724$20240725$20240725$EXP$$JP-TAKEDA-2024TJP011172$TAKEDA$$8$DEC$$F$Y$$$20240725$$MD$JP$JP
241357351$24135735$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024AMR091978$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241357362$24135736$2$F$$20240821$20240725$20240830$30DAY$$US-GSK-US2024AMR090284$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$PH$US$US
241357371$24135737$1$I$20230419$20240715$20240725$20240725$EXP$FR-AFSSAPS-TS2024000773$FR-TEVA-VS-3221935$TEVA$$42$YR$$F$Y$77$KG$20240725$$MD$FR$FR
241357381$24135738$1$I$20240501$20240718$20240725$20240725$EXP$$NVSC2024ES119411$NOVARTIS$$58$YR$$M$Y$$$20240725$$MD$ES$ES
241357391$24135739$1$I$$20240718$20240725$20240725$EXP$$CA-BAXTER-2024BAX022152$BAXTER$$$$$F$Y$$$20240725$$HP$CA$CA
241357401$24135740$1$I$20240513$20240716$20240725$20240725$EXP$IE-HPRA-2024-114186$IE-BAXTER-2024BAX021692$BAXTER$$51$YR$$F$Y$$$20240725$$PH$IE$IE
241357411$24135741$1$I$$20240711$20240725$20240725$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06679$LUPIN$Rodriguez C, Yosry N, Qaiser S, Luzuriaga A, Adelizzi A. BRASH: A deadly acronym. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1596$84$YR$$F$Y$$$20240725$$HP$US$US
241357421$24135742$1$I$20240610$20240722$20240725$20240725$EXP$$SG-JNJFOC-20240760136$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240725$$HP$SG$SG
241357431$24135743$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117925$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240725$$CN$US$US
241357441$24135744$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117670$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240725$$CN$US$US
241357451$24135745$1$I$20190911$20240723$20240725$20240725$EXP$$FR-SANDOZ INC.-NVSC2020FR148069$SANDOZ$$74$YR$$M$Y$$$20240725$$MD$FR$FR
241357461$24135746$1$I$$20240711$20240725$20240725$EXP$$US-PADAGIS-2024PAD01181$PADAGIS$$$$$$Y$$$20240725$$CN$US$US
241357471$24135747$1$I$$20240711$20240725$20240725$EXP$$US-PADAGIS-2024PAD01191$PADAGIS$$$$$$Y$$$20240725$$PH$US$US
241357481$24135748$1$I$$20240711$20240725$20240725$EXP$$US-PADAGIS-2024PAD01167$PADAGIS$Griffin J., Asel M.. Diffuse eruptive squamous atypia, also known as eruptive keratoacanthoma: Unique case presentation. JAAD Case Reports. 2024;49:121-4$$$$$Y$$$20240725$$HP$US$US
241357491$24135749$1$I$$20240708$20240725$20240725$EXP$$US-PADAGIS-2024PAD01193$PADAGIS$$$$$$Y$$$20240725$$CN$US$US
241357501$24135750$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116882$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$61.6$KG$20240725$$PH$US$US
241357511$24135751$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034494$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241357521$24135752$1$I$$20240722$20240725$20240725$PER$$US-ABBVIE-5851491$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241357531$24135753$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034342$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241357541$24135754$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034355$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241357551$24135755$1$I$20240721$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145991$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241357561$24135756$1$I$$20240719$20240725$20240725$PER$$US-ABBVIE-5850133$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241357571$24135757$1$I$$20240717$20240725$20240725$PER$$US-AMGEN-USASP2024145005$AMGEN$Chiu C.; Beam E.; Brumble L.M.et. al. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clinical Transplantation. 2024;38 (7):1-9$$$$$Y$$$20240725$$HP$US$US
241357581$24135758$1$I$20240416$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036195$AUROBINDO$$37$YR$$M$Y$$$20240725$$PH$FR$FR
241357592$24135759$2$F$$20240727$20240725$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024089368$VIIV$$5$DEC$$M$Y$$$20240807$$CN$US$US
241357604$24135760$4$F$20240715$20240826$20240725$20240826$PER$$US-ALXN-202407USA001324US$ALEXION PHARMACEUTICALS$$73$YR$$M$Y$$$20240826$$CN$US$US
241357611$24135761$1$I$20160718$20240722$20240725$20240725$PER$$US-JNJFOC-20240761218$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240725$$LW$US$US
241357622$24135762$2$F$20240716$20240726$20240725$20240731$PER$$US-AMGEN-USASP2024143538$AMGEN$$46$YR$A$F$Y$$$20240730$$HP$US$US
241357641$24135764$1$I$$20240723$20240725$20240725$PER$$US-TAKEDA-2024TUS074818$TAKEDA$$$$$$Y$$$20240725$$CN$US$US
241357651$24135765$1$I$$20240715$20240725$20240725$EXP$$JP-TEVA-VS-3222610$TEVA$Mamesaya N, Kodama H, Iida Y, Kobayashi H, Ko R, Wakuda K, et al. Efficacy and safety of carboplatin and etoposide in older extensive-stage small-cell lung cancer patients with a poor performance status. Thoracic-Cancer 2023; 14 (9): 805-814.; Mamesaya N, Kodama H, Iida Y, Kobayashi H, Ko R, Wakuda K, et al. Efficacy and safety of carboplatin and etoposide in older extensive-stage small-cell lung cancer patients with a poor performance status. Thoracic-Cancer 2023; 14 (9): 805-814.$$$E$$Y$$$20240725$$HP$JP$JP
241357661$24135766$1$I$$20240723$20240725$20240725$PER$$US-TAKEDA-2024TUS074784$TAKEDA$$$$$M$Y$$$20240725$$CN$US$US
241357671$24135767$1$I$$20240724$20240725$20240725$PER$$US-HALEON-2188819$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241357681$24135768$1$I$$20240717$20240725$20240725$PER$$US-AMGEN-USASP2024145025$AMGEN$Chiu C.; Beam E.; Brumble L.M.et. al. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clinical Transplantation. 2024;38 (7):1-9$$$$$Y$$$20240725$$HP$US$US
241357691$24135769$1$I$$20240715$20240725$20240725$PER$$US-ROCHE-10000028340$ROCHE$$38$YR$A$F$Y$$$20240725$$CN$US$US
241357701$24135770$1$I$20240611$20240723$20240725$20240725$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700089$RIGEL PHARMACEUTICALS$$70$YR$$M$Y$72.575$KG$20240725$$CN$US$US
241357712$24135771$2$F$20221001$20240829$20240725$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-036975$AUROBINDO$$$$$M$Y$$$20240909$$CN$US$US
241357721$24135772$1$I$20240415$20240717$20240725$20240725$EXP$$IT-AUROBINDO-AUR-APL-2024-036277$AUROBINDO$$17$YR$$F$Y$$$20240725$$MD$IT$IT
241357733$24135773$3$F$20240718$20240827$20240725$20240905$30DAY$$CA-JNJFOC-20240754140$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$HP$CA$CA
241357741$24135774$1$I$20240401$20240718$20240725$20240725$EXP$$IL-ABBVIE-5845712$ABBVIE$$42$YR$$M$Y$$$20240725$$CN$IL$IL
241357752$24135775$2$F$$20240801$20240725$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111508$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240805$$CN$US$US
241357761$24135776$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117926$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$107.05$KG$20240725$$CN$US$US
241357771$24135777$1$I$20240603$20240712$20240725$20240725$EXP$$FR-CIPLA LTD.-2024FR07725$CIPLA$$$$$$Y$$$20240725$$MD$FR$FR
241357781$24135778$1$I$$20230206$20240725$20240725$EXP$$US-AstraZeneca-2023A033056$ASTRAZENECA$$$$$F$Y$84$KG$20240725$$CN$US$
241357791$24135779$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A167107$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$US$
241357801$24135780$1$I$$20240717$20240725$20240725$EXP$$US-AstraZeneca-2024A163757$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241357811$24135781$1$I$$20240712$20240725$20240725$EXP$$JP-VALIDUS PHARMACEUTICALS LLC-JP-VDP-2024-019321$VALIDUS$Sakamoto K, Maebashi K, Matsumoto S, Iwadate K. A case of acute drug intoxication death due to abuse of psychotropic and other prescription and over-thecounter drugs.. The Japanese Journal of Clinical Toxicology. 2023;36:381-4$$$$$Y$$$20240725$$HP$JP$JP
241357821$24135782$1$I$$20240718$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115247$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240725$$PH$US$US
241357831$24135783$1$I$$20221213$20240725$20240725$EXP$$US-AstraZeneca-2022A406434$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241357841$24135784$1$I$20200601$20240717$20240725$20240725$EXP$$US-AMGEN-USASP2024142476$AMGEN$Shakoor A.; Sylvester B.; Fuller S.D. et al.. Bacillus coagulans-associated severe necrotizing scleral infection. American Journal of Ophthalmology Case Reports. 2024;36:1-5$39$YR$A$M$Y$$$20240725$$HP$US$US
241357851$24135785$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015088$ELI LILLY AND CO$$$$$F$Y$$$20240725$$CN$US$US
241357861$24135786$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015051$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240725$$CN$US$US
241357871$24135787$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015266$ELI LILLY AND CO$$$$$$Y$$$20240725$$CN$US$US
241357881$24135788$1$I$$20240719$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015096$ELI LILLY AND CO$$$$$$Y$$$20240725$$CN$US$US
241357891$24135789$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015217$ELI LILLY AND CO$$$$$F$Y$$$20240725$$HP$US$US
241357901$24135790$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014564$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240725$$CN$US$US
241357911$24135791$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015210$ELI LILLY AND CO$$$$$M$Y$$$20240725$$CN$US$US
241357921$24135792$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015015$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240725$$CN$US$US
241357931$24135793$1$I$20240701$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015369$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240725$$CN$US$US
241357942$24135794$2$F$$20240723$20240725$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407014713$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240801$$HP$US$US
241357952$24135795$2$F$$20240723$20240725$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202407015036$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240822$$CN$US$US
241357961$24135796$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015284$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240725$$CN$US$US
241357971$24135797$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016119$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240725$$CN$US$US
241357982$24135798$2$F$20240717$20240731$20240725$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407014922$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240801$$CN$US$US
241357991$24135799$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015976$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240725$$CN$US$US
241358001$24135800$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016225$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240725$$CN$US$US
241358012$24135801$2$F$$20240809$20240725$20240815$EXP$$AU-BAUSCH-BL-2024-010961$BAUSCH AND LOMB$$83$YR$$F$Y$$$20240815$$MD$AU$AU
241358021$24135802$1$I$20201101$20240721$20240725$20240725$EXP$PL-URPL-1-4246-2020$PL-BAUSCH-BL-2024-011190$BAUSCH AND LOMB$$30$YR$$M$Y$75$KG$20240725$$MD$PL$PL
241358031$24135803$1$I$$20240724$20240725$20240725$PER$$US-BAUSCH-BL-2024-011341$BAUSCH AND LOMB$$49$YR$$F$Y$$$20240725$$CN$US$US
241358041$24135804$1$I$20240610$20240720$20240725$20240725$EXP$ES-AEMPS-1550297$ES-BAUSCH-BL-2024-011165$BAUSCH AND LOMB$$82$YR$$F$Y$$$20240725$$MD$ES$ES
241358051$24135805$1$I$20240101$20240719$20240725$20240725$EXP$$CA-ABBVIE-5846798$ABBVIE$$48$YR$$M$Y$$$20240725$$CN$CA$CA
241358063$24135806$3$F$$20240802$20240725$20240805$EXP$$CA-ROCHE-10000031462$ROCHE$$$$E$M$Y$$$20240805$$CN$CA$CA
241358072$24135807$2$F$$20240731$20240725$20240801$EXP$$CA-SANDOZ INC.-SDZ2023CA025747$SANDOZ$$$$$M$Y$$$20240801$$CN$CA$CA
241358081$24135808$1$I$$20240722$20240725$20240725$EXP$$GB-MYLANLABS-2024M1068399$MYLAN$$69$YR$$M$Y$64$KG$20240725$$MD$GB$GB
241358091$24135809$1$I$20240619$20240710$20240725$20240725$EXP$$DE-ROCHE-10000034947$ROCHE$$46$YR$A$F$Y$$$20240725$$MD$DE$DE
241358101$24135810$1$I$20240715$20240725$20240725$20240725$EXP$$AU-MYLANLABS-2024M1069235$MYLAN$$69$YR$$F$Y$$$20240725$$HP$AU$AU
241358111$24135811$1$I$$20240722$20240725$20240725$EXP$$AU-MYLANLABS-2024M1068590$MYLAN$$$$$M$Y$$$20240725$$PH$AU$AU
241358121$24135812$1$I$$20240724$20240725$20240725$EXP$$GB-MYLANLABS-2024M1069217$MYLAN$$$$$M$Y$$$20240725$$CN$GB$GB
241358132$24135813$2$F$20230503$20240729$20240725$20240801$EXP$$AR-MYLANLABS-2024M1068370$MYLAN$$16$YR$$F$Y$$$20240801$$CN$AR$AR
241358141$24135814$1$I$20240701$20240719$20240725$20240725$EXP$$GB-MYLANLABS-2024M1067988$MYLAN$$$$$F$Y$$$20240725$$MD$GB$GB
241358151$24135815$1$I$20240528$20240719$20240725$20240725$EXP$$CN-MYLANLABS-2024M1068336$MYLAN$$61$YR$$F$Y$57$KG$20240725$$HP$CN$CN
241358161$24135816$1$I$$20240716$20240725$20240725$EXP$$US-GSK-US2024090194$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$US$US
241358171$24135817$1$I$$20240717$20240725$20240725$EXP$$US-NOVITIUMPHARMA-2024USNVP01361$NOVITIUM PHARMA$F. W. Wireko.Lung Transplant for Acute Exacerbation in Interstitial Pneumonia With Autoimmune Features (IPAF).American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;209:A5934$63$YR$A$M$Y$$$20240725$$HP$US$US
241358182$24135818$2$F$20240101$20240809$20240725$20240813$EXP$$US-ABBVIE-5833441$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
241358191$24135819$1$I$$20240716$20240725$20240725$EXP$$US-NOVITIUMPHARMA-2024USNVP01343$NOVITIUM PHARMA$Fangyu Chen.Aortoesophageal Fistula Following a Cervical Epidural Steroid Injection: Case Report.Pain Medicine Case Reports.31-DEC-2023;7(8):345-347$$$$M$Y$$$20240725$$HP$US$US
241358201$24135820$1$I$$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036132$AUROBINDO$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N, Pelletier R and al. a national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxicologie Analytique + Clinique. 2023;35:376-394$27$YR$$M$Y$$$20240725$$MD$FR$FR
241358211$24135821$1$I$20240715$20240718$20240725$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-022421$UNITED THERAPEUTICS$$17$YR$$F$Y$$$20240725$$$US$US
241358221$24135822$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024147908$AMGEN$$$$$M$Y$$$20240725$$CN$US$US
241358233$24135823$3$F$$20240807$20240725$20240812$EXP$$US-AMGEN-USASP2024145472$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241358241$24135824$1$I$20240721$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145626$AMGEN$$57$YR$A$F$Y$$$20240725$$CN$US$US
241358251$24135825$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145450$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241358261$24135826$1$I$$20240716$20240725$20240725$EXP$$US-SANDOZ INC.-SDZ2024US065871$SANDOZ$Caitlin A. Contag a , Lucy Studemeister b , Yael Bogler c , Joseph D. Cooper c. Q fever presenting as splenic infarct without endocarditis. Mycobacterial Diseases and International Health. 2024$44$YR$$M$Y$$$20240725$$HP$US$US
241358271$24135827$1$I$20240101$20240717$20240725$20240725$EXP$$US-PROCTER_AND_GAMBLE-GS24079025$PROCTER AND GAMBLE$$60$YR$$F$Y$$$20240725$$CN$US$US
241358283$24135828$3$F$$20240808$20240725$20240822$EXP$$US-AUROBINDO-AUR-APL-2024-035534$AUROBINDO$Homiack DR, Yan LE, Petry LG, Lloyd JR, Najjar F, Cook EH. Successful Electroconvulsive Therapy in a Patient With Catatonia and Maternal Duplication 15q11-13 Syndrome. The journal of ECT. 2024;1-2$24$YR$$M$Y$$$20240822$$MD$US$US
241358291$24135829$1$I$$20240716$20240725$20240725$EXP$$US-862174955-ML2023-06045$Unknown Manufacturer$Haddad AW, Farouji A, Kloub M, Amy P, Miller R. A Case of Metformin-Associated Lactic Acidosis Complicated by Acute Liver Failure, Acute Renal Failure, and Shock. Cureus. 2024;16(6): doi:10.7759/cureus.61911.$63$YR$A$F$Y$$$20240725$$MD$US$US
241358301$24135830$1$I$$20240716$20240725$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-036626$AUROBINDO$Simpson CE, Fenner EG. An adult patient with pulmonary arterial hypertension, a NOTCH3 mutation, and leflunomide exposure. Pulmonary Circulation. 2024;14:1-4$39$YR$$F$Y$$$20240725$$HP$US$US
241358311$24135831$1$I$20240708$20240718$20240725$20240725$EXP$$PK-ROCHE-10000032302$ROCHE$$34$YR$A$M$Y$$$20240725$$CN$PK$PK
241358321$24135832$1$I$20240421$20240611$20240725$20240725$EXP$$RO-ARGENX-2024-ARGX-RO003202$ARGENX BVBA$$$$$$Y$$$20240725$$MD$RO$RO
241358331$24135833$1$I$20240101$20240717$20240725$20240725$EXP$GB-MHRA-MED-202407121426166340-RWFMK$GB-862174955-ML2024-04056$Unknown Manufacturer$$34$YR$A$F$Y$59$KG$20240725$$CN$GB$GB
241358341$24135834$1$I$20240720$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146437$AMGEN$$67$YR$E$M$Y$$$20240725$$CN$US$US
241358351$24135835$1$I$20221214$20240722$20240725$20240725$EXP$$US-TAKEDA-2022TUS097426$TAKEDA$$65$YR$$F$Y$$$20240725$$MD$US$US
241358361$24135836$1$I$$20240717$20240725$20240725$30DAY$$US-GSK-US2024090159$GLAXOSMITHKLINE$$$$$M$Y$$$20240725$$CN$US$US
241358371$24135837$1$I$$20240712$20240725$20240725$EXP$$GB-INTERCEPT-PM2023000953$INTERCEPT PHARMACEUTICALS$$$$A$F$Y$$$20240725$$CN$GB$GB
241358381$24135838$1$I$20211029$20240716$20240725$20240725$EXP$$US-INTERCEPT-PM2024001243$INTERCEPT PHARMACEUTICALS$$78$YR$$F$Y$53.968$KG$20240725$$CN$US$US
241358401$24135840$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50976$$FDA-CTU$$73$YR$$M$N$$$20240724$N$$US$
241358411$24135841$1$I$20240713$20240716$20240725$20240725$PER$$PR-ABBVIE-5847135$ABBVIE$$$$A$F$Y$$$20240725$$MD$PR$PR
241358421$24135842$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117259$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240725$$HP$US$US
241358441$24135844$1$I$20240601$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118075$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240725$$HP$US$US
241358461$24135846$1$I$$20240724$20240725$20240725$PER$$US-HALEON-2188791$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241358472$24135847$2$F$$20240719$20240725$20240726$EXP$$ES-AUROBINDO-AUR-APL-2024-036484$AUROBINDO$Garcia IC, Pedroza JB, Rodriguez IM, Rincon I. Trabectedin and Radiotherapy in Endometrial Stromal Sarcoma: A Case Report. Case reports in Oncology. 2024;17 (1):82-90$47$YR$$F$Y$$$20240726$$MD$ES$ES
241358483$24135848$3$F$$20240809$20240725$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117831$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240819$$CN$US$US
241358491$24135849$1$I$20240719$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145451$AMGEN$$74$YR$E$F$Y$$$20240725$$CN$US$US
241358501$24135850$1$I$$20240718$20240725$20240725$EXP$$IN-NOVITIUMPHARMA-2024INNVP01392$NOVITIUM PHARMA$Abdullah.The Unusual Adverse Effects of Antituberculosis Therapy in Kidney Patients.International Journal of Mycobacteriology.15-JUN-2024;13(2):183-190$22$YR$A$M$Y$$$20240725$$HP$IN$IN
241358512$24135851$2$F$20240716$20240723$20240725$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003317$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240816$$CN$US$US
241358521$24135852$1$I$20240130$20240723$20240725$20240725$EXP$$CA-TAKEDA-2024TUS074644$TAKEDA$$80$YR$$M$Y$$$20240725$$CN$CA$CA
241358534$24135853$4$F$$20240822$20240725$20240902$EXP$$JP-TAKEDA-2024TUS072952$TAKEDA$$59$YR$$$Y$$$20240902$$MD$JP$JP
241358541$24135854$1$I$$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024145050$AMGEN$$$$$F$Y$$$20240725$$MD$US$US
241358551$24135855$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146671$AMGEN$$$$$$Y$$$20240725$$HP$US$US
241358561$24135856$1$I$$20240717$20240725$20240725$EXP$$JP-009507513-2407JPN003247J$MERCK$$$$$F$Y$$$20240725$$MD$JP$JP
241358571$24135857$1$I$20240411$20240515$20240725$20240725$EXP$$US-ARGENX-2024-ARGX-US003358$ARGENX BVBA$$$$$$Y$$$20240725$$CN$US$US
241358581$24135858$1$I$$20240719$20240725$20240725$PER$$US-AstraZeneca-2024A165610$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241358591$24135859$1$I$20210301$20210419$20240725$20240725$EXP$$US-AstraZeneca-2021A339588$ASTRAZENECA$$867$MON$$F$Y$52.2$KG$20240725$$CN$US$
241358601$24135860$1$I$20240707$20240717$20240725$20240725$EXP$CN-NMPACDR-3302011031658202401127$CN-BAXTER-2024BAX021972$BAXTER$$59$YR$$F$Y$48$KG$20240725$$MD$CN$CN
241358611$24135861$1$I$$20240717$20240725$20240725$EXP$GB-MHRA-MED-202407171042467250-HLSVN$GB-BAXTER-2024BAX021849$BAXTER$$60$YR$$F$Y$$$20240725$$PH$GB$GB
241358631$24135863$1$I$$20210419$20240725$20240725$EXP$$CA-AstraZeneca-2020SF21989$ASTRAZENECA$$67$YR$$F$Y$$$20240725$$MD$CA$
241358641$24135864$1$I$20230101$20240718$20240725$20240725$EXP$$FR-AZURITY PHARMACEUTICALS, INC.-AZR202407-000135$AZURITY PHARMACEUTICALS$$51$YR$$F$Y$54$KG$20240725$$CN$FR$FR
241358651$24135865$1$I$20220315$20240718$20240725$20240725$EXP$PL-URPL-DML-MLP.4401.1.743.2022$PL-CHEPLA-2024009182$CHEPLAPHARM$$17$YR$T$F$Y$53$KG$20240725$$MD$COUNTRY NOT SPECIFIED$PL
241358661$24135866$1$I$20150201$20240722$20240725$20240725$PER$$US-JNJFOC-20240759402$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240725$$HP$US$US
241358671$24135867$1$I$20240528$20240717$20240725$20240725$EXP$CN-NMPACDR-3301051038103202400164$CN-BAXTER-2024BAX021980$BAXTER$$68$YR$$F$Y$56$KG$20240725$$MD$CN$CN
241358681$24135868$1$I$$20240719$20240725$20240725$EXP$$HR-SANDOZ INC.-NVSC2022HR222802$SANDOZ$$43$YR$$M$Y$$$20240725$$HP$HR$HR
241358691$24135869$1$I$20240709$20240712$20240725$20240725$EXP$GB-MHRA-MED-202407111100441400-DSWBG$GB-MACLEODS PHARMA-MAC2024048399$MACLEODS$$55$YR$A$M$Y$$$20240725$$MD$GB$GB
241358701$24135870$1$I$20230213$20240712$20240725$20240725$EXP$IT-MINISAL02-994755$IT-MACLEODS PHARMA-MAC2024048372$MACLEODS$$$$$$Y$$$20240725$$MD$IT$IT
241358711$24135871$1$I$20240714$20240714$20240725$20240725$EXP$GB-MHRA-MED-202407141136241030-SLPZT$GB-MACLEODS PHARMA-MAC2024048409$MACLEODS$$$$$$Y$$$20240725$$CN$GB$GB
241358721$24135872$1$I$20240706$20240712$20240725$20240725$EXP$ES-AEMPS-1547791$ES-MACLEODS PHARMA-MAC2024048371$MACLEODS$$$$$$Y$$$20240725$$MD$ES$ES
241358731$24135873$1$I$$20240715$20240725$20240725$EXP$$CN-TEYRO-2024-TY-000370$Teyro Labs$Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, et.al.Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nature Medicine.2024$$$$$Y$$$20240725$$HP$CN$CN
241358742$24135874$2$F$20240626$20240813$20240725$20240826$EXP$GB-MHRA-MED-202407121035475230-VWCPD$GB-MACLEODS PHARMA-MAC2024048402$MACLEODS$$$$$$Y$$$20240826$$MD$GB$GB
241358751$24135875$1$I$20240626$20240713$20240725$20240725$EXP$GB-MHRA-MED-202407131000570760-VFCNS$GB-MACLEODS PHARMA-MAC2024048408$MACLEODS$$$$$$Y$$$20240725$$CN$GB$GB
241358761$24135876$1$I$$20240719$20240725$20240725$EXP$$IN-MYLANLABS-2024M1068996$MYLAN$Sil A, Thangaraj A, Pandiarajan V, Suri DA, Gupta. Persistent anemia in a child with chronic arthritis - Think beyond juvenile idiopathic arthritis. Indian-J-Rheumatol 2023; 18 (Suppl.) S370 abstr. CAS142.$14$YR$$F$Y$$$20240725$$HP$IN$IN
241358771$24135877$1$I$20240625$20240719$20240725$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022486$UNITED THERAPEUTICS$$59$YR$$F$Y$49.977$KG$20240725$$$US$US
241358781$24135878$1$I$$20231219$20240725$20240725$PER$$US-STRIDES ARCOLAB LIMITED-2023SP018873$STRIDES$$44$YR$$F$Y$$$20240725$$CN$US$US
241358791$24135879$1$I$$20240124$20240725$20240725$PER$$US-STRIDES ARCOLAB LIMITED-2024SP001021$STRIDES$$$$$F$Y$$$20240725$$CN$US$US
241358801$24135880$1$I$20240228$20240305$20240725$20240725$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002736$STRIDES$$71$YR$$F$Y$58.957$KG$20240725$$CN$US$US
241358811$24135881$1$I$$20240717$20240725$20240725$EXP$$AU-SANDOZ INC.-SDZ2024AU066376$SANDOZ$$20$YR$$F$Y$$$20240725$$HP$AU$AU
241358821$24135882$1$I$20230901$20240723$20240725$20240725$EXP$$US-AMGEN-USASP2024146615$AMGEN$$64$YR$A$F$Y$$$20240725$$CN$US$US
241358831$24135883$1$I$20240717$20240725$20240725$20240725$EXP$DE-CADRBFARM-2024329451$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041874$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$82$KG$20240725$$MD$DE$DE
241358841$24135884$1$I$20240719$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50982$$FDA-CTU$$3$YR$$F$N$$$20240723$N$HP$US$
241358851$24135885$1$I$$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50994$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241358862$24135886$2$F$$20240728$20240725$20240730$EXP$$AU-ABBVIE-5850728$ABBVIE$$$$E$$Y$$$20240730$$MD$AU$AU
241358872$24135887$2$F$$20240729$20240725$20240808$EXP$$US-TEVA-VS-3222735$TEVA$Ren Z, Zhao S, Li T, Wedner HJ, Atkinson JP. Insights into the pathogenesis of hereditary angioedema using genetic sequencing and recombinant protein expression analyses. J-Allergy-Clin-Immunol 2023; 151 (4): 1040-1049.; Ren Z, Zhao S, Li T, Wedner HJ, Atkinson JP. Insights into the pathogenesis of hereditary angioedema using genetic sequencing and recombinant protein expression analyses. J-Allergy-Clin-Immunol 2023; 151 (4): 1040-1049.$22$YR$$F$Y$$$20240808$$MD$US$US
241358881$24135888$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-061908$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$73.94$KG$20240725$$CN$US$US
241358891$24135889$1$I$$20240717$20240725$20240725$EXP$$TN-MYLANLABS-2024M1069247$MYLAN$Chabbouh A, Rebhi F, Ben Slimene M, Jaber K, Dhaoui A. Sildenafil-induced drug reaction with eosinophilia and systemic symptoms. Urol-Case-Rep 2024; 55 (0): 1-2.$50$YR$$M$Y$$$20240725$$HP$TN$TN
241358912$24135891$2$F$$20240827$20240725$20240903$30DAY$$US-JNJFOC-20240752021$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
241358921$24135892$1$I$20240627$20240715$20240725$20240725$PER$$US-Nobelpharma America, LLC-NPA-2024-01238$NOBELPHARMA$$12$YR$T$M$Y$$$20240725$$PH$US$US
241358931$24135893$1$I$$20240717$20240725$20240725$EXP$$IN-MYLANLABS-2024M1068105$MYLAN$Sivagnanam H, Kumar PKS, Velu KB, Viswanathan R. Mucormycosis-Associated Colon Perforation in the Early Postrenal Transplant Period. Indian-J-Transplant 2024; 18 (2): 189-193.$32$YR$$M$Y$$$20240725$$MD$IN$IN
241358941$24135894$1$I$$20240717$20240725$20240725$EXP$$IT-MYLANLABS-2024M1067549$MYLAN$Lazzari L, Bongiovanni L, Ronchi P, Bergonzi GM, Gariazzo C, Diral E, et al. Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura. Curr-Res-Transl-Med 2024; 72 (1).$65$YR$$M$Y$$$20240725$$HP$IT$IT
241358951$24135895$1$I$$20240717$20240725$20240725$EXP$$US-MYLANLABS-2024M1068379$MYLAN$Mcgourty M, Adams EW, Lyons J, Ayyaswami V, Holdorf JD. MDA-5 Associated Dermatomyositis: A Case of Delayed Care and Dire Consequences. Am-J-Respir-Crit-Care-Med 2024; 209 (0).$43$YR$$M$Y$$$20240725$$HP$US$US
241358961$24135896$1$I$$20240711$20240725$20240725$EXP$$IT-B.Braun Medical Inc.-2159546$B BRAUN$Literature Article$81$YR$$F$Y$$$20240725$$$IT$IT
241358971$24135897$1$I$$20240711$20240725$20240725$EXP$$IT-B.Braun Medical Inc.-2159548$B BRAUN$Literature Article$68$YR$$F$Y$$$20240725$$$IT$IT
241358991$24135899$1$I$$20240711$20240725$20240725$EXP$$US-B.Braun Medical Inc.-2159555$B BRAUN$Literature Article$46$YR$$M$Y$$$20240725$$$US$US
241359001$24135900$1$I$20240718$20240718$20240725$20240725$EXP$$CN-AMGEN-CHNSP2024144697$AMGEN$$$$$M$Y$$$20240725$$CN$CN$CN
241359011$24135901$1$I$$20240711$20240725$20240725$EXP$$IT-B.Braun Medical Inc.-2159564$B BRAUN$Literature Article$62$YR$$F$Y$$$20240725$$$IT$IT
241359021$24135902$1$I$20240708$20240718$20240725$20240725$EXP$$PT-Integrated Therapeutic Solutions Inc.-2159552$Integrated Therapeutic Solutions$$61$YR$$F$Y$$$20240725$$$PT$PT
241359031$24135903$1$I$$20240711$20240725$20240725$EXP$$JP-B.Braun Medical Inc.-2159558$B BRAUN$Literature Article$71$YR$$M$Y$$$20240725$$$JP$JP
241359041$24135904$1$I$$20240711$20240725$20240725$EXP$$GB-B.Braun Medical Inc.-2159567$B BRAUN$Literature Article$24$MON$$F$Y$$$20240725$$$GB$GB
241359051$24135905$1$I$$20240718$20240725$20240725$EXP$$IN-NOVITIUMPHARMA-2024INNVP01401$NOVITIUM PHARMA$Abdullah.The Unusual Adverse Effects of Antituberculosis Therapy in Kidney Patients.International Journal of Mycobacteriology.15-JUN-2024;13(2):183-190$66$YR$E$M$Y$$$20240725$$HP$IN$IN
241359061$24135906$1$I$$20240701$20240725$20240725$PER$$US-ROCHE-10000028681$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241359071$24135907$1$I$20240601$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-035834$AUROBINDO$$68$YR$$F$Y$54$KG$20240725$$MD$FR$FR
241359081$24135908$1$I$20240101$20240711$20240725$20240725$EXP$$DE-Ascend Therapeutics US, LLC-2159539$ASCEND$$53$YR$$F$Y$$$20240725$$$DE$DE
241359091$24135909$1$I$$20240711$20240725$20240725$EXP$$IT-B.Braun Medical Inc.-2159559$B BRAUN$Literature Article$57$YR$$M$Y$$$20240725$$$IT$IT
241359101$24135910$1$I$$20240722$20240725$20240725$PER$$US-Mission Pharmacal Company-2159538$MISSION$$31$YR$$M$Y$$$20240725$$LW$US$US
241359111$24135911$1$I$$20240711$20240725$20240725$EXP$$IT-B.Braun Medical Inc.-2159566$B BRAUN$Literature Article$75$YR$$F$Y$$$20240725$$$IT$IT
241359121$24135912$1$I$$20240711$20240725$20240725$EXP$$CA-B.Braun Medical Inc.-2159565$B BRAUN$$59$YR$$M$Y$$$20240725$$$CA$CA
241359131$24135913$1$I$$20240529$20240725$20240725$PER$$US-Breckenridge Pharmaceutical, Inc.-2159557$BRECKENRIDGE$$88$YR$$F$Y$52.273$KG$20240725$$$US$US
241359141$24135914$1$I$$20240528$20240725$20240725$PER$$US-Breckenridge Pharmaceutical, Inc.-2159543$BRECKENRIDGE$$$$$F$Y$$$20240725$$$US$US
241359152$24135915$2$F$20240325$20240918$20240725$20240926$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159584$JIANGSU HANSOH PHARMACEUTICAL$$$$$F$Y$$$20240926$$MD$CN$CN
241359161$24135916$1$I$$20240711$20240725$20240725$EXP$$CN-B.Braun Medical Inc.-2159561$B BRAUN$Literature Article$57$YR$$M$Y$$$20240725$$$CN$CN
241359181$24135918$1$I$20240706$20240709$20240725$20240725$EXP$$US-Edgewell Personal Care, LLC-2159568$EDGEWELL PERSONAL CARE BRANDS$$23$YR$$F$Y$$$20240725$$$US$US
241359191$24135919$1$I$20230403$20240711$20240725$20240725$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2159582$JIANGSU HENGRUI MEDICINE$20240711 144 H2024001203977 Lower-extremity deep vein thrombosis... A case report INI$64$YR$$M$Y$76$KG$20240725$$MD$CN$CN
241359201$24135920$1$I$$20230215$20240725$20240725$EXP$$US-Appco Pharma LLC-2159576$APPCO PHARMA$Initial$$$$$Y$$$20240725$$$US$US
241359211$24135921$1$I$$20240711$20240725$20240725$EXP$$CN-B.Braun Medical Inc.-2159562$B BRAUN$Literature Article$83$YR$$M$Y$$$20240725$$$CN$CN
241359221$24135922$1$I$$20240710$20240725$20240725$EXP$$US-Innogenix, LLC-2159573$INNOGENIX$Full text$25$YR$$F$Y$$$20240725$$$US$US
241359241$24135924$1$I$20240716$20240717$20240725$20240725$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159586$JIANGSU HANSOH PHARMACEUTICAL$$74$YR$$M$Y$54.5$KG$20240725$$MD$CN$CN
241359251$24135925$1$I$$20230215$20240725$20240725$EXP$$US-Appco Pharma LLC-2159581$APPCO PHARMA$Initial$28$YR$$F$Y$$$20240725$$$US$US
241359261$24135926$1$I$$20240710$20240725$20240725$EXP$$PT-Eywa Pharma Inc.-2159575$EYWA PHARMA$Abstract$63$YR$$F$Y$$$20240725$$$PT$PT
241359271$24135927$1$I$$20230215$20240725$20240725$EXP$$CN-Appco Pharma LLC-2159585$APPCO PHARMA$Initial$52$YR$$F$Y$$$20240725$$$CN$CN
241359281$24135928$1$I$$20230215$20240725$20240725$EXP$$US-Appco Pharma LLC-2159579$APPCO PHARMA$Initial$45$YR$$F$Y$$$20240725$$MD$US$US
241359291$24135929$1$I$20240711$20240715$20240725$20240725$EXP$$US-Accord-436692$ACCORD$$60$YR$A$M$Y$$$20240725$$PH$US$US
241359301$24135930$1$I$$20240714$20240725$20240725$EXP$$JP-Accord-436797$ACCORD$Nambu K, Kinoshita M, Sato Y, Tamai S, Nakajima R, Harada K et al. Systemic Candida abscess after hypofractionated radiotherapy with temozolomide for glioblastoma in an older patient: illustrative case. J Neurosurg Case Lessons. 2024 Jul 8;8(2):CASE24175.$86$YR$E$M$Y$$$20240725$$MD$JP$JP
241359311$24135931$1$I$$20240715$20240725$20240725$EXP$$IT-Accord-436119$ACCORD$Delbon P, Attico F, De Nadai M, Almici C, Ferrari E, Malagola M, et al. Ethical and legal issues in haematopoietic stem cells (HSC) donation: the controversial and problematic aspects in minors. Acta Biomedica. 2024;95(3):e2024082. DOI: 10.23750/abm.v95i3.15820.$62$YR$A$M$Y$$$20240725$$MD$IT$IT
241359321$24135932$1$I$$20240715$20240725$20240725$EXP$$CN-Oxford Pharmaceuticals, LLC-2159572$OXFORD PHARMACEUTICALS$Source document$50$YR$$M$Y$$$20240725$$$CN$CN
241359331$24135933$1$I$$20240715$20240725$20240725$EXP$$JP-Accord-436123$ACCORD$Shiraiwa T, Katayama H, Iwasaki Y, Kimura S, Satake Y, Sato T, et al. A case of testicular tumor and respiratory failure caused by choriocarcinoma syndrome managed through modified chemotherapy and extracorporeal membrane oxygenation. IJU case reports. 2024;7(4):285-8$35$YR$A$M$Y$$$20240725$$MD$JP$JP
241359341$24135934$1$I$20220804$20240717$20240725$20240725$EXP$BE-EMA-2024710-AUTODUP-1720646695041$BE-Accord-437324$ACCORD$$49$YR$A$F$Y$62.8$KG$20240725$$MD$BE$BE
241359351$24135935$1$I$$20240710$20240725$20240725$EXP$$US-Innogenix, LLC-2159574$INNOGENIX$Full text$49$YR$$M$Y$$$20240725$$$US$US
241359361$24135936$1$I$$20240713$20240725$20240725$EXP$AU-TGA-809435$AU-Accord-435667$ACCORD$$53$YR$A$F$Y$$$20240725$$HP$AU$AU
241359371$24135937$1$I$$20230301$20240725$20240725$EXP$$IN-Appco Pharma LLC-2159587$APPCO PHARMA$Initial$4$DY$$F$Y$$$20240725$$$IN$IN
241359381$24135938$1$I$20240717$20240717$20240725$20240725$EXP$$CA-JNJFOC-20240752693$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20240725$$HP$CA$CA
241359391$24135939$1$I$20240701$20240719$20240725$20240725$EXP$$BR-JNJFOC-20240757867$JOHNSON AND JOHNSON$$44$YR$A$F$Y$54$KG$20240725$$CN$BR$BR
241359401$24135940$1$I$$20230215$20240725$20240725$EXP$$CA-Appco Pharma LLC-2159580$APPCO PHARMA$Initial$41$YR$$F$Y$$$20240725$$MD$CA$CA
241359411$24135941$1$I$$20240715$20240725$20240725$EXP$$US-UCBSA-2024035780$UCB$$$$$F$Y$$$20240725$$MD$US$US
241359421$24135942$1$I$$20240425$20240725$20240725$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005206$STRIDES$Ghawji M, Beard V, Oktaei H.. Pheochromocytoma in pregnancy.. American Journal of the Medical Sciences. 2024;367 (Suppl.):S109-S110 abstr. 190.$33$YR$$F$Y$$$20240725$$HP$US$US
241359431$24135943$1$I$$20240117$20240725$20240725$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000922$STRIDES$Sosa-Pagan M, Sarmiento-Ramon JC, Panunti BA.. Lifestyle Modifications or Adrenalectomy? Pheochromocytoma Presenting with New Onset Diabetes Mellitus.. J-Endocr-Soc. 2020;4 (Suppl. 1):A104$42$YR$$F$Y$$$20240725$$MD$US$US
241359441$24135944$1$I$$20230712$20240725$20240725$PER$$US-STRIDES ARCOLAB LIMITED-2023SP011705$STRIDES$Young E, Stotter B, Dandamudi R, Barton K.. Refractory Hypertension Secondary to Mercury Intoxication.. Pediatr-Nephrol. 2023;38(7):2319-2320 abstr. P1-133$11$YR$$F$Y$$$20240725$$HP$US$US
241359451$24135945$1$I$$20240116$20240725$20240725$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000906$STRIDES$Lloyd J, Abdulwahid T, Harvey P, Willard L. Metoclopramide Induced Pheochromocytoma Multisystem Crisis: An Unusual Initial Presentation of Pheochromocytoma. J-Endocr-Soc. 2022;6 (Suppl. 1):A102$41$YR$$F$Y$$$20240725$$MD$US$US
241359461$24135946$1$I$$20240117$20240725$20240725$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000914$STRIDES$Bustos M, DiCenso DM, Ayala A.. Is Doxazosin the Right Choice for Preoperative Management of Pheochromocytoma in Pregnancy?.. J-Endocr-Soc. 2020;4 (Suppl. 1):A550 abstr. SAT-211.$39$YR$$F$Y$$$20240725$$HP$US$US
241359481$24135948$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50975$$FDA-CTU$$44$YR$$F$N$$$20240724$N$$US$
241359491$24135949$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51004$$FDA-CTU$$38$YR$$F$N$$$20240724$N$CN$US$
241359501$24135950$1$I$20080101$20240719$20240725$20240725$PER$$US-ABBVIE-5849202$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241359511$24135951$1$I$$20240716$20240725$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-035414$AUROBINDO$Shah D.. Diagnostic Challenges of Psoriasis: A Multifaceted Case of Triple-Drug Interaction and Literature Review.. Consultant.. 2024;64(6):e3$37$YR$$F$Y$$$20240725$$MD$US$US
241359521$24135952$1$I$$20240718$20240725$20240725$PER$$US-ALXN-202407USA001376US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240725$$HP$US$US
241359532$24135953$2$F$20240718$20240722$20240725$20240729$PER$$US-ALXN-202407USA001202US$ALEXION PHARMACEUTICALS$$65$YR$$F$Y$$$20240729$$CN$US$US
241359542$24135954$2$F$20240717$20240813$20240725$20240813$PER$$US-ALXN-202407USA001326US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241359551$24135955$1$I$$20240715$20240725$20240725$EXP$$US-UCBSA-2024037291$UCB$$$$$$Y$$$20240725$$MD$US$US
241359562$24135956$2$F$20240612$20240731$20240725$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-036124$AUROBINDO$$74$YR$$M$Y$87$KG$20240808$$MD$FR$FR
241359574$24135957$4$F$20240716$20240802$20240725$20240808$PER$$US-ROCHE-10000029737$ROCHE$$51$YR$A$F$Y$$$20240808$$HP$US$US
241359581$24135958$1$I$$20240722$20240725$20240725$EXP$$ZA-ROCHE-10000035125$ROCHE$$84$YR$E$M$Y$$$20240725$$MD$ZA$ZA
241359601$24135960$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50969$$FDA-CTU$$60$YR$$F$N$$$20240724$N$$US$
241359611$24135961$1$I$$20240716$20240725$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-036467$AUROBINDO$Meeder R, Peterson A, Reynard H, Andersen L. Dyadic Work in Conjunction With Electroconvulsive Therapy in a 12-Year-Old Female With Autism Spectrum Disorder and Catatonia. Ochsner-J. 2024;24(2):141-146$12$YR$$F$Y$$$20240725$$HP$US$US
241359621$24135962$1$I$20240722$20240723$20240725$20240725$PER$$US-JNJFOC-20240762895$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240725$$CN$US$US
241359631$24135963$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50973$$FDA-CTU$$64$YR$$F$N$$$20240724$N$$US$
241359641$24135964$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51001$$FDA-CTU$$$$$F$N$$$20240724$N$HP$US$
241359651$24135965$1$I$$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036209$AUROBINDO$I.A Larabi, A.Ghich, P.Kintz, M.Marillier, N. Fabresse, R.Pelletier, et al... a national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).. Toxicologie Analytique + Clinique. 2023;376-394:35$33$YR$$M$Y$$$20240725$$MD$FR$FR
241359661$24135966$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024090780$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241359671$24135967$1$I$20240618$20240723$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117824$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240725$$CN$US$US
241359691$24135969$1$I$$20230123$20240725$20240725$EXP$$US-AstraZeneca-2023A019300$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241359701$24135970$1$I$20240625$20240717$20240725$20240725$EXP$$FR-AstraZeneca-2024A162860$ASTRAZENECA$$81$YR$$F$Y$87.8$KG$20240725$$MD$FR$
241359711$24135971$1$I$20240701$20240723$20240725$20240725$EXP$$US-KYOWAKIRIN-2024KK017660$KYOWA$$$$$$Y$$$20240725$$HP$US$US
241359722$24135972$2$F$$20240725$20240725$20240802$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022207$UNITED THERAPEUTICS$$$$$M$Y$83.447$KG$20240802$$$US$US
241359731$24135973$1$I$$20240717$20240725$20240725$EXP$$IT-MYLANLABS-2024M1068397$MYLAN$Lecis M, Stefanelli F, Montanari F, Biase ARD, Lucaccioni L, Iughetti L. Mesalamine-induced myopericarditis in children: a case report and a short revision of the literature. Acta-Biomed 2024; 95 (3):.$14$YR$$M$Y$$$20240725$$MD$IT$IT
241359741$24135974$1$I$20060101$20240715$20240725$20240725$EXP$$US-MYLANLABS-2024M1049020$MYLAN$$$$$F$Y$61.23$KG$20240725$$CN$US$US
241359751$24135975$1$I$20230329$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036150$AUROBINDO$$33$YR$$F$Y$116$KG$20240725$$MD$FR$FR
241359761$24135976$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024AMR091981$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241359771$24135977$1$I$$20240715$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092554$VIIV$$$$$$Y$$$20240725$$HP$US$US
241359782$24135978$2$F$$20240821$20240725$20240830$30DAY$$US-GSK-US2024090161$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
241359791$24135979$1$I$$20240718$20240725$20240725$30DAY$$US-GSK-US2024090760$GLAXOSMITHKLINE$$$$A$F$Y$$$20240725$$CN$US$US
241359801$24135980$1$I$20240714$20240715$20240725$20240725$EXP$$GB-TEVA-VS-3222329$TEVA$$$$A$F$Y$$$20240725$$CN$GB$GB
241359811$24135981$1$I$20240430$20240719$20240725$20240725$EXP$FR-AFSSAPS-RN2024000755$FR-CHEPLA-2024009259$CHEPLAPHARM$$76$YR$$M$Y$69$KG$20240725$$MD$COUNTRY NOT SPECIFIED$FR
241359821$24135982$1$I$$20240717$20240725$20240725$EXP$$US-NOVITIUMPHARMA-2024USNVP01383$NOVITIUM PHARMA$Sabrina D. Herzberg BS.Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease.Annals of Allergy, Asthma + Immunology.22-JUL-2023;131:528-530$$$$F$Y$$$20240725$$HP$US$US
241359831$24135983$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06670$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241359842$24135984$2$F$$20240821$20240725$20240828$30DAY$$US-JNJFOC-20240750914$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$CN$US$US
241359851$24135985$1$I$$20240722$20240725$20240725$PER$$US-JNJFOC-20240760189$JOHNSON AND JOHNSON$$$$$M$Y$$$20240725$$HP$US$US
241359861$24135986$1$I$20210901$20240719$20240725$20240725$EXP$$MX-JNJFOC-20240757702$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$CN$MX$MX
241359871$24135987$1$I$$20240719$20240725$20240725$EXP$$US-JNJFOC-20240757277$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240725$$HP$US$US
241359881$24135988$1$I$$20240715$20240725$20240725$EXP$$CN-TEYRO-2024-TY-000364$Teyro Labs$Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, et.al.Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nature Medicine.2024$$$$$Y$$$20240725$$HP$CN$CN
241359891$24135989$1$I$20231201$20240717$20240725$20240725$EXP$$CO-ROCHE-10000030850$ROCHE$$41$YR$A$F$Y$60$KG$20240725$$CN$CO$CO
241359901$24135990$1$I$$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50970$$FDA-CTU$$$$$M$N$$$20240723$N$HP$US$
241359911$24135991$1$I$20240714$20240719$20240724$20240724$DIR$FDA-CDER-CTU-2024-51007$$FDA-CTU$$59$YR$$M$N$$$20240719$N$HP$US$
241359921$24135992$1$I$20240724$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51116$$FDA-CTU$$66$YR$$F$N$$$20240724$N$$US$
241359931$24135993$1$I$20240701$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50983$$FDA-CTU$$76$YR$$F$N$$$20240724$N$$US$
241359941$24135994$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50985$$FDA-CTU$$50$YR$$F$N$117.48$KG$20240724$N$$US$
241359953$24135995$3$F$20240101$20240912$20240725$20240920$EXP$$CA-CELLTRION INC.-2024CA013532$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
241359971$24135997$1$I$20230401$20240716$20240725$20240725$EXP$$RS-NOVITIUMPHARMA-2024RSNVP01346$NOVITIUM PHARMA$Andrej Pesic.UNIQUE PRESENTATION OF T-CELL/HISTIOCYTE-RICH LARGE B CELL LYMPHOMA COMPLICATED WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: CASE REPORT AND REVIEW OF THE LITERATURE.Journal of Medical Biochemistry.2024;43(4):631-637$32$YR$A$M$Y$$$20240725$$HP$RS$RS
241359981$24135998$1$I$20231113$20240723$20240725$20240725$EXP$$US-UCBSA-2023054662$UCB$$55$YR$$F$Y$$$20240725$$CN$US$US
241359991$24135999$1$I$$20240722$20240725$20240725$EXP$$NVSC2024US152089$NOVARTIS$$$$$$Y$$$20240725$$MD$US$US
241360001$24136000$1$I$$20240717$20240725$20240725$30DAY$$US-GSK-US2024090152$GLAXOSMITHKLINE$$$$$M$Y$$$20240725$$PH$US$US
241360015$24136001$5$F$20240722$20240815$20240725$20240820$EXP$$CN-SANDOZ INC.-SDZ2024CN067677$SANDOZ$$68$YR$$F$Y$50$KG$20240820$$MD$CN$CN
241360021$24136002$1$I$20240328$20240716$20240725$20240725$EXP$DK-DKMA-30734524$DK-TEVA-VS-3222002$TEVA$$52$YR$$F$Y$104$KG$20240725$$MD$DK$DK
241360031$24136003$1$I$$20240715$20240725$20240725$EXP$$CN-TEYRO-2024-TY-000371$Teyro Labs$Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, et.al.Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nature Medicine.2024$$$$$Y$$$20240725$$HP$CN$CN
241360041$24136004$1$I$$20240703$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06715$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241360051$24136005$1$I$$20240718$20240725$20240725$PER$$US-JNJFOC-20240755240$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240725$$CN$US$US
241360062$24136006$2$F$$20240823$20240725$20240827$30DAY$$IN-JNJFOC-20240750800$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$PH$IN$IN
241360072$24136007$2$F$20240101$20240729$20240725$20240806$EXP$$JP-JNJFOC-20240764441$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240806$$MD$JP$JP
241360081$24136008$1$I$$20240721$20240725$20240725$EXP$$IT-JNJFOC-20240763198$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240725$$MD$IT$IT
241360091$24136009$1$I$$20240717$20240725$20240725$EXP$$LB-JNJFOC-20240752351$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240725$$HP$LB$LB
241360101$24136010$1$I$$20240717$20240725$20240725$EXP$$US-JNJFOC-20240746357$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$HP$US$US
241360111$24136011$1$I$20240722$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145937$AMGEN$$61$YR$A$F$Y$$$20240725$$CN$US$US
241360121$24136012$1$I$$20240718$20240725$20240725$EXP$$NVSC2024KR149315$NOVARTIS$$12$YR$$F$Y$$$20240725$$MD$KR$KR
241360131$24136013$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015195$ELI LILLY AND CO$$$$$F$Y$$$20240725$$CN$US$US
241360141$24136014$1$I$20240101$20240722$20240725$20240725$PER$$US-BAUSCH-BL-2024-011209$BAUSCH AND LOMB$$60$YR$$F$Y$$$20240725$$CN$US$US
241360151$24136015$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014363$ELI LILLY AND CO$$$$$F$Y$$$20240725$$CN$US$US
241360161$24136016$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015531$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240725$$CN$US$US
241360171$24136017$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015368$ELI LILLY AND CO$$$$$M$Y$$$20240725$$CN$US$US
241360182$24136018$2$F$20240501$20240807$20240725$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202407014395$ELI LILLY AND CO$$29$YR$A$F$Y$67.574$KG$20240815$$HP$US$US
241360191$24136019$1$I$$20240718$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014409$ELI LILLY AND CO$$$$$$Y$$$20240725$$CN$US$US
241360201$24136020$1$I$20240101$20240718$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407012388$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240725$$CN$US$US
241360211$24136021$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015264$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240725$$CN$US$US
241360221$24136022$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015122$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240725$$CN$US$US
241360231$24136023$1$I$20240722$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015116$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240725$$CN$US$US
241360241$24136024$1$I$$20240722$20240725$20240725$EXP$$JP-PFIZER INC-PV202400095629$PFIZER$$9$DEC$$M$Y$$$20240725$$MD$JP$JP
241360251$24136025$1$I$$20240723$20240725$20240725$PER$$US-BAUSCH-BL-2024-011337$BAUSCH AND LOMB$$23$YR$$F$Y$$$20240725$$HP$US$US
241360261$24136026$1$I$20231101$20240722$20240725$20240725$EXP$GR-GREOF-202400772$GR-PFIZER INC-202400220165$PFIZER$$75$YR$$F$Y$$$20240725$$MD$GR$GR
241360272$24136027$2$F$20210215$20240829$20240725$20240829$EXP$$FR-PFIZER INC-2021SGN01832$PFIZER$$49$YR$$F$Y$47$KG$20240829$$MD$FR$FR
241360281$24136028$1$I$$20240720$20240725$20240725$EXP$$CN-PFIZER INC-202400220462$PFIZER$$$$$F$Y$$$20240725$$MD$CN$CN
241360291$24136029$1$I$20240101$20240717$20240725$20240725$EXP$$JP-PFIZER INC-202400220443$PFIZER$$8$DEC$$M$Y$$$20240725$$MD$JP$JP
241360302$24136030$2$F$20240325$20240729$20240725$20240731$EXP$$IN-PFIZER INC-PV202400094569$PFIZER$$49$YR$$F$Y$$$20240731$$CN$IN$IN
241360312$24136031$2$F$$20240915$20240725$20240916$EXP$$CA-PFIZER INC-202400222471$PFIZER$$88$YR$$F$Y$$$20240916$$MD$CA$CA
241360321$24136032$1$I$20240705$20240719$20240725$20240725$EXP$$ES-PFIZER INC-202400220430$PFIZER$$59$YR$$F$Y$$$20240725$$PH$ES$ES
241360331$24136033$1$I$20240710$20240722$20240725$20240725$EXP$$CN-PFIZER INC-PV202400095751$PFIZER$$37$YR$$F$Y$53$KG$20240725$$HP$CN$CN
241360341$24136034$1$I$20240709$20240722$20240725$20240725$EXP$$CN-PFIZER INC-PV202400095792$PFIZER$$14$YR$$M$Y$61.6$KG$20240725$$HP$CN$CN
241360352$24136035$2$F$20240601$20240807$20240725$20240813$EXP$$IN-PFIZER INC-PV202200097869$PFIZER$$61$YR$$F$Y$$$20240813$$CN$IN$IN
241360361$24136036$1$I$$20240720$20240725$20240725$EXP$$IN-PFIZER INC-PV202300043826$PFIZER$$46$YR$$F$Y$$$20240725$$CN$IN$IN
241360371$24136037$1$I$20210220$20240722$20240725$20240725$EXP$$FR-PFIZER INC-2021SGN01899$PFIZER$$$$A$F$Y$$$20240725$$MD$FR$FR
241360381$24136038$1$I$20240504$20240719$20240725$20240725$EXP$GB-MHRA-MED-202407181605107870-TDGMR$GB-PFIZER INC-202400219296$PFIZER$$$$$F$Y$73$KG$20240725$$CN$GB$GB
241360391$24136039$1$I$20240714$20240719$20240725$20240725$EXP$$CN-PFIZER INC-PV202400094915$PFIZER$$25$YR$$F$Y$49$KG$20240725$$HP$CN$CN
241360402$24136040$2$F$20240724$20240725$20240725$20240730$EXP$$US-PFIZER INC-PV202300207399$PFIZER$$82$YR$$M$Y$$$20240730$$CN$US$US
241360411$24136041$1$I$20240520$20240722$20240725$20240725$EXP$IT-MINISAL02-995675$IT-PFIZER INC-202400220371$PFIZER$$7$DY$$F$Y$0.62$KG$20240725$$MD$IT$IT
241360422$24136042$2$F$20210112$20240829$20240725$20240829$EXP$$FR-PFIZER INC-2021SGN00338$PFIZER$$66$YR$$F$Y$63$KG$20240829$$HP$FR$FR
241360433$24136043$3$F$20240704$20240911$20240725$20240912$EXP$$PL-PFIZER INC-202400220346$PFIZER$$72$YR$$F$Y$75$KG$20240912$$MD$PL$PL
241360442$24136044$2$F$20210613$20240725$20240725$20240729$EXP$$KR-PFIZER INC-202400222784$PFIZER$$82$YR$$F$Y$53.4$KG$20240729$$MD$KR$KR
241360451$24136045$1$I$$20240715$20240725$20240725$EXP$$CN-TEYRO-2024-TY-000363$Teyro Labs$Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, et.al.Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nature Medicine.2024$$$$$Y$$$20240725$$HP$CN$CN
241360462$24136046$2$F$20070101$20240726$20240725$20240802$EXP$$HU-BAUSCH-BL-2024-011156$BAUSCH AND LOMB$Irsai G, Tatjana T, Balazs D, Zsofia M, Arpad I, Gabor M. Szisztemas cytomegalovirus-fertozes es szovodmenyei ter?piarefrakter klasszikus Hodgkin-lymphomaban. Orvosi hetilap. 2012;153(19):751-755. doi:10.1556/OH.2012.29364$29$YR$$F$Y$$$20240802$$MD$HU$HU
241360471$24136047$1$I$$20240703$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06764$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241360481$24136048$1$I$20240701$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146332$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241360493$24136049$3$F$$20240829$20240725$20240903$EXP$$JP-009507513-2407JPN003703J$MERCK$Matsuura T, Ushiwaka T, Higuchi Y, Ujihara Y, Maeda N. P-182 Investigation of pembrolizumab combination chemotherapy for advanced and recurrent cervix carcinoma in our department. The journal of the Japan Society of Gynecologic Oncology The 66th Annual Meeting. 2024;42(3):400$$$$F$Y$$$20240903$$HP$JP$JP
241360501$24136050$1$I$$20240715$20240725$20240725$EXP$$NZ-ABBVIE-5851699$ABBVIE$$$$$$Y$$$20240725$$CN$NZ$NZ
241360511$24136051$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50984$$FDA-CTU$$26$YR$$F$N$$$20240724$N$$US$
241360522$24136052$2$F$20240722$20240903$20240725$20240904$PER$$NVSC2024US152421$NOVARTIS$$73$YR$$F$Y$$$20240904$$CN$US$US
241360531$24136053$1$I$$20240722$20240725$20240725$EXP$$CA-BAUSCH-BL-2024-011235$BAUSCH AND LOMB$$42$YR$$F$Y$$$20240725$$CN$CA$CA
241360541$24136054$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50996$$FDA-CTU$$$$$F$N$$$20240724$N$HP$US$
241360561$24136056$1$I$20240626$20240712$20240725$20240725$EXP$FR-AFSSAPS-PB2024000761$FR-OCTA-GENA02124$OCTAPHARMA$$75$YR$E$M$Y$58$KG$20240724$$MD$EU$EU
241360572$24136057$2$F$$20240905$20240725$20240912$EXP$$TH-BLUEPRINT MEDICINES CORPORATION-2024BUS003983$Unknown Manufacturer$$$$$$Y$$$20240911$$CN$TH$TH
241360581$24136058$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50974$$FDA-CTU$$33$YR$$F$N$$$20240724$N$$US$
241360591$24136059$1$I$$20240717$20240725$20240725$EXP$$CA-AstraZeneca-2024A163921$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$CA$
241360601$24136060$1$I$20240201$20240723$20240725$20240725$EXP$FR-AFSSAPS-PO2024000805$FR-ABBVIE-5849790$ABBVIE$$26$YR$$F$Y$$$20240725$$MD$FR$FR
241360611$24136061$1$I$20200601$20240722$20240725$20240725$EXP$$SG-JNJFOC-20240760065$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240725$$HP$SG$SG
241360621$24136062$1$I$$20240717$20240725$20240725$EXP$$ZA-AstraZeneca-2024A163601$ASTRAZENECA$$70$YR$$M$Y$$$20240725$$CN$ZA$
241360631$24136063$1$I$$20240712$20240725$20240725$EXP$$GB-ROCHE-10000027221$ROCHE$$$$E$M$Y$$$20240725$$CN$GB$GB
241360641$24136064$1$I$$20240715$20240725$20240725$EXP$$CN-TEYRO-2024-TY-000367$Teyro Labs$Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, et.al.Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nature Medicine.2024$$$$$Y$$$20240725$$HP$CN$CN
241360652$24136065$2$F$$20240729$20240725$20240806$EXP$$FR-TEVA-VS-3223729$TEVA$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6); Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$18$YR$$F$Y$$$20240806$$HP$FR$FR
241360661$24136066$1$I$$20240723$20240725$20240725$EXP$$NZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041573$BOEHRINGER INGELHEIM$$22$YR$A$F$Y$$$20240725$$MD$NZ$NZ
241360671$24136067$1$I$$20240723$20240725$20240725$EXP$$NVSC2024US151930$NOVARTIS$$$$$M$Y$$$20240725$$CN$US$US
241360683$24136068$3$F$20240418$20240826$20240725$20240828$PER$$FR-IDORSIA-008286-2024-FR$IDORSIA PHARMACEUTICALS$$52$YR$$M$Y$94$KG$20240828$$MD$FR$FR
241360691$24136069$1$I$$20230320$20240725$20240725$EXP$$NVSC2023US280896$NOVARTIS$$$$$M$Y$$$20240725$$CN$US$US
241360701$24136070$1$I$20240601$20240719$20240725$20240725$EXP$$NVSC2024BR151490$NOVARTIS$$61$YR$$F$Y$$$20240725$$CN$BR$BR
241360713$24136071$3$F$20240701$20240903$20240725$20240909$EXP$$JP-BEH-2024175953$CSL BEHRING$$69$YR$E$M$Y$$$20240909$$MD$JP$JP
241360721$24136072$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024090681$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$MD$US$US
241360731$24136073$1$I$20240301$20240702$20240725$20240725$EXP$$TH-BLUEPRINT MEDICINES CORPORATION-2024BUS003976$BLUEPRINT MEDICINES$$$$$$Y$$$20240724$$CN$TH$TH
241360741$24136074$1$I$$20240722$20240725$20240725$EXP$$ES-ROCHE-10000010664$ROCHE$$40$YR$A$F$Y$65$KG$20240725$$MD$ES$ES
241360751$24136075$1$I$$20240717$20240725$20240725$EXP$GB-MHRA-MED-202407161710424160-TSGMF$GB-MSNLABS-2024MSNSPO01618$MSN LABORATORIES$$$$$$Y$$$20240725$$HP$GB$GB
241360771$24136077$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50977$$FDA-CTU$$31$YR$$F$N$95.71$KG$20240724$N$$US$
241360781$24136078$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50978$$FDA-CTU$$77$YR$$F$N$$$20240724$N$$US$
241360791$24136079$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50989$$FDA-CTU$$62$YR$$F$N$$$20240724$N$$US$
241360801$24136080$1$I$$20240711$20240725$20240725$EXP$$US-Stemline Therapeutics, Inc.-2024ST004265$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240724$$CN$US$US
241360812$24136081$2$F$20240101$20240809$20240725$20240819$EXP$$US-Vifor (International) Inc.-VIT-2024-06485$VIFOR$$$$A$F$Y$$$20240819$$HP$US$US
241360823$24136082$3$F$20230802$20240726$20240725$20240808$EXP$$KR-BLUEPRINT MEDICINES CORPORATION-2024BUS000144$UNKNOWN$$$$$$Y$$$20240808$$HP$KR$KR
241360831$24136083$1$I$20240709$20240717$20240725$20240725$PER$$US-ABBVIE-5851029$ABBVIE$$25$YR$$F$Y$$$20240725$$MD$US$US
241360842$24136084$2$F$20240101$20240829$20240725$20240907$EXP$$CA-CELLTRION INC.-2024CA006980$CELLTRION$$$$$$Y$$$20240907$$CN$CA$CA
241360851$24136085$1$I$20240623$20240716$20240725$20240725$EXP$FR-AFSSAPS-TO2024001298$FR-Accord-437074$ACCORD$$83$YR$E$F$Y$$$20240725$$MD$FR$FR
241360861$24136086$1$I$$20240714$20240725$20240725$EXP$$JP-Accord-436793$ACCORD$Matsuki S, Taniuchi N, Okada N, Sato J, Nishijima N, Kamio K et al. A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung Cancer. J Nippon Med Sch. 2024;91(3):339-346.$67$YR$E$M$Y$$$20240725$$HP$JP$JP
241360871$24136087$1$I$$20240713$20240725$20240725$EXP$$US-Accord-436649$ACCORD$$72$YR$E$M$Y$$$20240725$$PH$US$US
241360881$24136088$1$I$20240621$20240717$20240725$20240725$EXP$FR-AFSSAPS-LL2024001281$FR-Accord-436994$ACCORD$$69$YR$E$M$Y$$$20240725$$MD$FR$FR
241360891$24136089$1$I$$20240716$20240725$20240725$EXP$GB-MHRA-MED-202407152259070450-CVPYM$GB-Accord-436463$ACCORD$$53$YR$A$F$Y$82$KG$20240725$$CN$GB$GB
241360901$24136090$1$I$20200301$20240716$20240725$20240725$EXP$$IN-Accord-437513$ACCORD$Sivagnanam H, Kumar PK, Palaniselvam S, Viswanathan R. Two-Year Follow-up of Necrotic Herpetic Retinopathy in a Renal Transplant Recipient. Indian Journal of Transplantation. 2024;18(2):184-8. DOI:10.4103/ijot.ijot_113_23$32$YR$A$M$Y$$$20240725$$MD$IN$IN
241360911$24136091$1$I$$20240716$20240725$20240725$EXP$CA-MHPD-E2B_07114477$CA-Accord-436600$ACCORD$$32$YR$A$M$Y$$$20240725$$MD$CA$CA
241360921$24136092$1$I$$20240716$20240725$20240725$EXP$CA-MHPD-E2B_07113542$CA-Accord-436782$ACCORD$$88$YR$E$F$Y$$$20240725$$HP$CA$CA
241360932$24136093$2$F$20180718$20240722$20240725$20240802$EXP$AU-TGA-810979$AU-Accord-435610$ACCORD$$56$YR$A$F$Y$$$20240802$$MD$AU$AU
241360941$24136094$1$I$20220101$20240714$20240725$20240725$EXP$$CN-Accord-436974$ACCORD$Wang X, Yuan Y, Zhang Y, Qiao G, Chen S, Huang W, et al. Case report: Immunotherapy-based combination therapy achieving complete remission and prolonged survival in nasopharyngeal carcinoma with extensive bone marrow metastasis. Front Immunol. 2024 Jun 24;15:1410250.$64$YR$A$M$Y$$$20240725$$HP$CN$CN
241360951$24136095$1$I$$20240719$20240725$20240725$EXP$$US-EXELIXIS-CABO-24079679$EXELIXIS$$$$$M$Y$$$20240725$$CN$US$US
241360981$24136098$1$I$$20240715$20240725$20240725$EXP$$CN-TEYRO-2024-TY-000366$Teyro Labs$Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, et.al.Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nature Medicine.2024$$$$$Y$$$20240725$$HP$CN$CN
241360991$24136099$1$I$$20240717$20240725$20240725$EXP$$JP-Orion Corporation ORION PHARMA-ENTC2024-0088$ORION$$8$DEC$E$F$Y$$$20240725$$PH$JP$
241361001$24136100$1$I$$20240714$20240725$20240725$EXP$$DE-Accord-437203$ACCORD$Heinz P, Wolf B, Schuldes S. Locked-in Syndrome After Pontine Hemorrhage in an Amphetamine Abuser. Dtsch Arztebl Int. 2024 May 17;121(10):330.$37$YR$A$F$Y$$$20240725$$MD$DE$DE
241361011$24136101$1$I$20240708$20240713$20240725$20240725$EXP$$US-Accord-436169$ACCORD$$74$YR$E$F$Y$$$20240725$$HP$US$US
241361021$24136102$1$I$20231201$20240716$20240725$20240725$EXP$$CN-Accord-436540$ACCORD$Zhou D, Tang S, Li J. Systemic Lupus Erythematosus Complicated with Mycobacterium Leprae Infection: a Rare Case Report. Clinical laboratory. 2024;70(7):1388-91. DOI: 10.7754/Clin.Lab.2024.240149.$42$YR$A$F$Y$$$20240725$$MD$CN$CN
241361031$24136103$1$I$$20240716$20240725$20240725$EXP$$IN-Accord-436544$ACCORD$Barman L, Pandey C, Gowrishankar S. Autonomic Cascade Secondary to Acute Urinary Retention in a Patient undergoing Open Reduction of Forearm Fracture under General Anaesthesia: A Case Report. Journal of Clinical and Diagnostic Research. 2024;18(7):UD01-3.$62$YR$A$F$Y$50$KG$20240725$$MD$IN$IN
241361041$24136104$1$I$20190101$20240716$20240725$20240725$EXP$$TR-Accord-436553$ACCORD$Atalay F, Yesilaltay A. long term sucessfull use of belinostat in a patient with relapsed refractory angioimmunoblastic lymphoma who has previously been heavily treated. Journal of Cancer Research and Therapeutics. 2024;20(3):1049-52.$79$YR$E$F$Y$$$20240725$$MD$TR$TR
241361052$24136105$2$F$$20240729$20240725$20240808$EXP$$US-TEVA-VS-3222394$TEVA$Chu AF, Sagi V, Amin AK, Rajagopal G, Shantanu S, Pederson KS, et al. Continuous QT interval monitoring using insertable cardiac monitors during antiarrhythmic loading hospitalization: Results from the ^LINQ QT^ Study. Europace 2024; 26 (Suppl.) i43-i44.; Chu AF, Sagi V, Amin AK, Rajagopal G, Shantanu S, Pederson KS, et al. Continuous QT interval monitoring using insertable cardiac monitors during antiarrhythmic loading hospitalization: Results from the ^LINQ QT^ Study. Europace 2024; 26 (Sup...$75$YR$$M$Y$$$20240808$$HP$US$US
241361061$24136106$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50993$$FDA-CTU$$33$YR$$F$N$165$LBS$20240724$N$$US$
241361071$24136107$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51045$$FDA-CTU$$83$YR$$F$N$$$20240724$N$HP$US$
241361081$24136108$1$I$20240517$20240717$20240725$20240725$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022268$UNITED THERAPEUTICS$$72$YR$$F$Y$$$20240725$$$US$US
241361091$24136109$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51000$$FDA-CTU$$39$YR$$F$N$$$20240724$N$$US$
241361101$24136110$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51065$$FDA-CTU$$48$YR$$F$N$183.3$LBS$20240724$N$$US$
241361111$24136111$1$I$20240708$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50999$$FDA-CTU$$69$YR$$F$N$$$20240724$Y$PH$US$
241361121$24136112$1$I$$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50991$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241361131$24136113$1$I$$20240717$20240725$20240725$PER$$US-AMGEN-USASP2024145745$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241361141$24136114$1$I$$20240718$20240725$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-022197$UNITED THERAPEUTICS$$$$$F$Y$$$20240725$$$US$US
241361151$24136115$1$I$$20240722$20240725$20240725$EXP$$TR-UCBSA-2024037501$UCB$Demiral GZ, Akin SB, Gunday OK, Sahbaz FG, Boru UT. Maternal and fetal outcomes of antiepileptic treatments during pregnancy: A retrospective study. Epilepsy + behavior. 2024;158:1-7$$$N$$Y$$$20240725$$HP$TR$TR
241361162$24136116$2$F$$20240723$20240725$20240726$EXP$$NVSC2024DE151973$NOVARTIS$$86$YR$$M$Y$$$20240726$$MD$DE$DE
241361172$24136117$2$F$20240712$20240723$20240725$20240731$EXP$$US-KYOWAKIRIN-2024KK017663$KYOWA$$$$$$Y$$$20240731$$PH$US$US
241361181$24136118$1$I$20240101$20240723$20240725$20240725$EXP$$US-PFIZER INC-PV202400096485$PFIZER$$84$YR$$M$Y$$$20240725$$HP$US$US
241361192$24136119$2$F$$20240722$20240725$20240726$EXP$$US-PFIZER INC-PV202400018665$PFIZER$$70$YR$$F$Y$77.11$KG$20240726$$CN$US$US
241361211$24136121$1$I$20231201$20240722$20240725$20240725$EXP$$US-PFIZER INC-2024SGN00323$PFIZER$$68$YR$$F$Y$$$20240725$$CN$US$US
241361221$24136122$1$I$20240601$20240722$20240725$20240725$EXP$FR-AFSSAPS-GR2024000910$FR-PFIZER INC-202400220299$PFIZER$$88$YR$$F$Y$$$20240725$$PH$FR$FR
241361231$24136123$1$I$20240118$20240722$20240725$20240725$EXP$FR-AFSSAPS-DJ2024000846$FR-PFIZER INC-202400220304$PFIZER$$44$YR$$F$Y$63$KG$20240725$$MD$FR$FR
241361241$24136124$1$I$$20240722$20240725$20240725$EXP$$CA-PFIZER INC-202400222017$PFIZER$$65$YR$$M$Y$$$20240725$$CN$CA$CA
241361261$24136126$1$I$20240605$20240722$20240725$20240725$EXP$FR-AFSSAPS-ST2024001180$FR-PFIZER INC-202400220230$PFIZER$$70$YR$$M$Y$63$KG$20240725$$HP$FR$FR
241361271$24136127$1$I$$20240722$20240725$20240725$EXP$$FR-PFIZER INC-202400220232$PFIZER$$87$YR$$F$Y$$$20240725$$PH$FR$FR
241361281$24136128$1$I$20240614$20240722$20240725$20240725$EXP$FR-AFSSAPS-TO2024001321$FR-PFIZER INC-202400220292$PFIZER$$94$YR$$M$Y$67.5$KG$20240725$$MD$FR$FR
241361291$24136129$1$I$20240702$20240722$20240725$20240725$EXP$FR-AFSSAPS-RS2024000701$FR-PFIZER INC-202400220311$PFIZER$$60$YR$$M$Y$81$KG$20240725$$PH$FR$FR
241361301$24136130$1$I$20170727$20240722$20240725$20240725$EXP$$IT-PFIZER INC-2018SGN00256$PFIZER$$32$YR$$M$Y$98$KG$20240725$$MD$IT$IT
241361311$24136131$1$I$20240603$20240722$20240725$20240725$EXP$$SG-JNJFOC-20240760053$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240725$$HP$SG$SG
241361321$24136132$1$I$20070301$20240722$20240725$20240725$PER$$US-JNJFOC-20240760367$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240725$$LW$US$US
241361331$24136133$1$I$20240722$20240723$20240725$20240725$PER$$US-JNJFOC-20240760703$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240725$$CN$US$US
241361341$24136134$1$I$$20240715$20240725$20240725$EXP$$CN-TEYRO-2024-TY-000368$Teyro Labs$Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, et.al.Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nature Medicine.2024$$$$$Y$$$20240725$$HP$CN$CN
241361351$24136135$1$I$$20240717$20240725$20240725$EXP$DE-BFARM-24004918$DE-MSNLABS-2024MSNSPO01626$MSN LABORATORIES$$$$$$Y$$$20240725$$MD$DE$DE
241361361$24136136$1$I$$20240715$20240725$20240725$EXP$$FR-TEVA-VS-3223741$TEVA$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$33$YR$$F$Y$$$20240725$$HP$FR$FR
241361382$24136138$2$F$20240703$20240819$20240725$20240821$EXP$$NVSC2024US151092$NOVARTIS$$22$YR$$F$Y$$$20240821$$CN$US$US
241361391$24136139$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146952$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241361401$24136140$1$I$$20240722$20240725$20240725$EXP$$GB-MYLANLABS-2024M1068308$MYLAN$$$$$M$Y$$$20240725$$CN$GB$GB
241361421$24136142$1$I$20240710$20240722$20240725$20240725$EXP$GB-MHRA-MED-202407210043259370-YPNWZ$GB-MYLANLABS-2024M1068408$MYLAN$$39$YR$$F$Y$84$KG$20240725$$CN$GB$GB
241361431$24136143$1$I$$20240722$20240725$20240725$EXP$GB-MHRA-MED-202407220105453600-HQGWS$GB-MYLANLABS-2024M1068147$MYLAN$$19$YR$$M$Y$$$20240725$$CN$GB$GB
241361441$24136144$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024AMR091979$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241361451$24136145$1$I$20240716$20240722$20240725$20240725$EXP$GB-MHRA-31250470$GB-MYLANLABS-2024M1068305$MYLAN$$$$$M$Y$$$20240725$$HP$GB$GB
241361461$24136146$1$I$$20240517$20240725$20240725$EXP$$US-ROCHE-10000014535$ROCHE$$$$$$Y$$$20240725$$HP$US$US
241361471$24136147$1$I$20240708$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117613$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240725$$CN$US$US
241361481$24136148$1$I$$20240715$20240725$20240725$PER$$US-AstraZeneca-2024A161482$ASTRAZENECA$$$$$$Y$$$20240725$$CN$US$
241361491$24136149$1$I$$20240717$20240725$20240725$EXP$$US-AstraZeneca-2024A163691$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241361502$24136150$2$F$20240415$20240729$20240725$20240806$EXP$$JP-AstraZeneca-2024A152689$ASTRAZENECA$$93$YR$$F$Y$45$KG$20240806$$PH$JP$
241361513$24136151$3$F$20240722$20240905$20240725$20240913$PER$$US-UNITED THERAPEUTICS-UNT-2024-022725$UNITED THERAPEUTICS$$46$YR$$F$Y$74.83$KG$20240913$$$US$US
241361522$24136152$2$F$$20240724$20240725$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016319$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240730$$CN$US$US
241361531$24136153$1$I$20240723$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015252$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240725$$CN$US$US
241361541$24136154$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015153$ELI LILLY AND CO$$64$YR$A$$Y$$$20240725$$CN$US$US
241361551$24136155$1$I$20240701$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015389$ELI LILLY AND CO$$33$YR$A$$Y$$$20240725$$CN$US$US
241361561$24136156$1$I$$20240717$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407011963$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240725$$CN$US$US
241361571$24136157$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015101$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240725$$CN$US$US
241361581$24136158$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015343$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240725$$CN$US$US
241361591$24136159$1$I$20240501$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015329$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240725$$MD$US$US
241361601$24136160$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015059$ELI LILLY AND CO$$$$$$Y$$$20240725$$CN$US$US
241361611$24136161$1$I$20240501$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015362$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240725$$CN$US$US
241361621$24136162$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014921$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240725$$CN$US$US
241361632$24136163$2$F$20240630$20240715$20240725$20240921$PER$$US-ROCHE-10000031018$ROCHE$$$$$F$Y$$$20240921$$CN$US$US
241361641$24136164$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015390$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240725$$CN$US$US
241361651$24136165$1$I$$20240723$20240725$20240725$EXP$$US-PFIZER INC-PV202400096465$PFIZER$$85$YR$$M$Y$$$20240725$$CN$US$US
241361661$24136166$1$I$20240719$20240723$20240725$20240725$EXP$$CN-PFIZER INC-PV202400096311$PFIZER$$39$YR$$M$Y$70$KG$20240725$$HP$CN$CN
241361671$24136167$1$I$$20240723$20240725$20240725$EXP$$US-PFIZER INC-PV202400096411$PFIZER$$17$YR$$F$Y$$$20240725$$HP$US$US
241361683$24136168$3$F$$20240915$20240725$20240916$EXP$$US-PFIZER INC-PV202400082162$PFIZER$$70$YR$$F$Y$$$20240916$$CN$US$US
241361691$24136169$1$I$$20240723$20240725$20240725$EXP$GB-MHRA-MIDB-12cf47a7-7140-475f-b81e-a5d07502392c$GB-PFIZER INC-202400222070$PFIZER$$33$YR$$M$Y$$$20240725$$PH$GB$GB
241361701$24136170$1$I$20200901$20240722$20240725$20240725$EXP$$PT-PFIZER INC-202400220331$PFIZER$$72$YR$$M$Y$$$20240725$$MD$PT$PT
241361711$24136171$1$I$$20240723$20240725$20240725$EXP$$GB-PFIZER INC-202400222824$PFIZER$$40$YR$$F$Y$$$20240725$$MD$GB$GB
241361721$24136172$1$I$20240714$20240722$20240725$20240725$EXP$IT-MINISAL02-995817$IT-PFIZER INC-202400220387$PFIZER$$81$YR$$M$Y$74$KG$20240725$$MD$IT$IT
241361731$24136173$1$I$$20240723$20240725$20240725$EXP$$CA-PFIZER INC-PV202400096592$PFIZER$$79$YR$$M$Y$$$20240725$$HP$CA$CA
241361741$24136174$1$I$20240718$20240723$20240725$20240725$EXP$$IN-PFIZER INC-202400222380$PFIZER$$$$C$M$Y$$$20240725$$CN$IN$IN
241361751$24136175$1$I$20240607$20240723$20240725$20240725$EXP$FR-AFSSAPS-NC2024000868$FR-PFIZER INC-202400221710$PFIZER$$56$YR$$F$Y$71$KG$20240725$$PH$FR$FR
241361761$24136176$1$I$20240708$20240722$20240725$20240725$EXP$ES-AEMPS-1550001$ES-PFIZER INC-202400220440$PFIZER$$75$YR$$M$Y$$$20240725$$PH$ES$ES
241361771$24136177$1$I$$20240723$20240725$20240725$EXP$GB-MHRA-MED-202407231406193540-WSZVF$GB-PFIZER INC-202400222196$PFIZER$$$$$F$Y$$$20240725$$HP$GB$GB
241361781$24136178$1$I$$20240723$20240725$20240725$EXP$$US-PFIZER INC-PV202400096451$PFIZER$$$$$$Y$$$20240725$$CN$US$US
241361792$24136179$2$F$20240701$20240724$20240725$20240729$EXP$$IN-PFIZER INC-PV202400095397$PFIZER$$78$YR$$M$Y$$$20240729$$CN$IN$IN
241361801$24136180$1$I$$20240723$20240725$20240725$EXP$$US-PFIZER INC-202400222497$PFIZER$$15$YR$$F$Y$$$20240725$$HP$US$US
241361821$24136182$1$I$20240614$20240723$20240725$20240725$EXP$FR-AFSSAPS-MA2024001107$FR-PFIZER INC-202400221514$PFIZER$$76$YR$$F$Y$$$20240725$$MD$FR$FR
241361831$24136183$1$I$20240401$20240722$20240725$20240725$EXP$$BR-PFIZER INC-PV202400082829$PFIZER$$87$YR$$M$Y$65$KG$20240725$$HP$BR$BR
241361841$24136184$1$I$$20240722$20240725$20240725$EXP$$US-PFIZER INC-202400222265$PFIZER$$63$YR$$F$Y$$$20240725$$HP$US$US
241361852$24136185$2$F$$20240723$20240725$20240730$PER$$US-AMGEN-USASP2024147303$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241361861$24136186$1$I$$20240715$20240725$20240725$EXP$$US-HETERO-HET2024US02373$HETERO$$$$$F$Y$$$20240725$$HP$US$US
241361871$24136187$1$I$$20240715$20240725$20240725$EXP$$CN-TEYRO-2024-TY-000361$Teyro Labs$Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, et.al.Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nature Medicine.2024$$$$$Y$$$20240725$$HP$CN$CN
241361881$24136188$1$I$$20240717$20240725$20240725$EXP$$NVSJ2024JP008824$NOVARTIS$Oshiro H, Shiga T, Naito J, Isobe M, Furui T. A case of refractory nephrosis which developed during pregnancy. Journal of Japan Society of Perinatal and Neonatal Medicine, the 60th Annual Mee. 2024;60:O80-1$$$N$M$Y$1.35$KG$20240725$$HP$JP$JP
241361891$24136189$1$I$20240610$20240717$20240725$20240725$EXP$$US-ROCHE-10000030066$ROCHE$$14$YR$T$F$Y$64.8$KG$20240725$$CN$US$US
241361901$24136190$1$I$$20240717$20240725$20240725$EXP$$US-ROCHE-10000029595$ROCHE$$76$YR$E$F$Y$$$20240725$$CN$US$US
241361912$24136191$2$F$$20240829$20240725$20240906$30DAY$$US-GSK-US2024AMR092127$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
241361924$24136192$4$F$20240419$20240819$20240725$20240826$EXP$$CA-CELLTRION INC.-2024CA010917$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
241361931$24136193$1$I$20240716$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024144862$AMGEN$$61$YR$A$M$Y$$$20240725$$CN$US$US
241361941$24136194$1$I$20240701$20240723$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117858$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$78.47$KG$20240725$$CN$US$US
241361951$24136195$1$I$$20240723$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117206$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240725$$CN$US$US
241361961$24136196$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117583$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240725$$CN$US$US
241361971$24136197$1$I$20240701$20240724$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117907$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240725$$CN$US$US
241361981$24136198$1$I$$20240722$20240725$20240725$EXP$GB-MHRA-MED-202407221708120220-SDNHV$GB-MYLANLABS-2024M1068440$MYLAN$$$$$F$Y$$$20240725$$HP$GB$GB
241361991$24136199$1$I$$20240715$20240725$20240725$EXP$$CN-TEYRO-2024-TY-000362$Teyro Labs$Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, et.al.Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nature Medicine.2024$$$$$Y$$$20240725$$HP$CN$CN
241362001$24136200$1$I$20231201$20240722$20240725$20240725$EXP$$DE-MYLANLABS-2024M1068521$MYLAN$$63$YR$$F$Y$$$20240725$$MD$DE$DE
241362011$24136201$1$I$20130901$20240718$20240725$20240725$EXP$$NVSJ2024JP008840$NOVARTIS$$71$YR$$F$Y$$$20240725$$CN$JP$JP
241362021$24136202$1$I$20240701$20240723$20240725$20240725$PER$$US-DSJP-DSU-2024-137159$DAIICHI$$8$DEC$$F$Y$$$20240725$$HP$US$US
241362031$24136203$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-202400223167$PFIZER$$$$A$M$Y$$$20240725$$HP$US$US
241362043$24136204$3$F$20240626$20240801$20240725$20240812$EXP$$NVSC2024ES149347$NOVARTIS$$70$YR$$F$Y$80.1$KG$20240812$$MD$ES$ES
241362051$24136205$1$I$$20240722$20240725$20240725$PER$$US-PFIZER INC-202400221585$PFIZER$$36$YR$$F$Y$$$20240725$$MD$US$US
241362062$24136206$2$F$20240708$20240809$20240725$20240813$PER$$US-PFIZER INC-202400221644$PFIZER$$74$YR$$F$Y$76.19$KG$20240813$$HP$US$US
241362072$24136207$2$F$20240701$20240802$20240725$20240802$PER$$US-PFIZER INC-202400222221$PFIZER$$59$YR$$F$Y$$$20240802$$CN$US$US
241362081$24136208$1$I$$20240722$20240725$20240725$PER$$US-PFIZER INC-202400222138$PFIZER$$51$YR$$F$Y$$$20240725$$HP$US$US
241362091$24136209$1$I$$20240722$20240725$20240725$PER$$US-PFIZER INC-202400221009$PFIZER$$$$$M$Y$$$20240725$$MD$US$US
241362101$24136210$1$I$20240724$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223298$PFIZER$$81$YR$$M$Y$$$20240725$$CN$US$US
241362111$24136211$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-202400098857$PFIZER$$69$YR$$F$Y$$$20240725$$CN$US$US
241362121$24136212$1$I$20240723$20240723$20240725$20240725$PER$$US-PFIZER INC-202400222126$PFIZER$$58$YR$$F$Y$$$20240725$$CN$US$US
241362131$24136213$1$I$$20240722$20240725$20240725$PER$$US-PFIZER INC-PV202400095940$PFIZER$$78$YR$$F$Y$$$20240725$$PH$US$US
241362141$24136214$1$I$20240724$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223084$PFIZER$$58$YR$$F$Y$$$20240725$$CN$US$US
241362151$24136215$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-202400222357$PFIZER$$$$$$Y$$$20240725$$CN$US$US
241362161$24136216$1$I$20240717$20240722$20240725$20240725$PER$$US-PFIZER INC-202400221552$PFIZER$$35$YR$$F$Y$$$20240725$$CN$US$US
241362171$24136217$1$I$20240101$20240723$20240725$20240725$PER$$US-PFIZER INC-202400222666$PFIZER$$12$YR$$M$Y$$$20240725$$CN$US$US
241362182$24136218$2$F$20240913$20240924$20240725$20240926$EXP$$US-PFIZER INC-202400223198$PFIZER$$48$YR$$F$Y$$$20240926$$CN$US$US
241362192$24136219$2$F$$20240728$20240725$20240730$PER$$US-PFIZER INC-202400221975$PFIZER$$68$YR$$F$Y$63.5$KG$20240730$$CN$US$US
241362203$24136220$3$F$$20240923$20240725$20240926$PER$$US-PFIZER INC-PV202300038245$PFIZER$$75$YR$$F$Y$$$20240926$$MD$US$US
241362211$24136221$1$I$$20240722$20240725$20240725$PER$$US-PFIZER INC-202400067467$PFIZER$$16$YR$$F$Y$$$20240725$$HP$US$US
241362221$24136222$1$I$20240720$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223101$PFIZER$$72$YR$$M$Y$$$20240725$$CN$US$US
241362231$24136223$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-202300290550$PFIZER$$14$YR$$M$Y$$$20240725$$CN$US$US
241362241$24136224$1$I$20240724$20240724$20240725$20240725$PER$$US-PFIZER INC-202400222981$PFIZER$$62$YR$$F$Y$$$20240725$$CN$US$US
241362252$24136225$2$F$$20240826$20240725$20240904$PER$$US-PFIZER INC-202400222984$PFIZER$$59$YR$$F$Y$$$20240904$$CN$US$US
241362261$24136226$1$I$$20240711$20240725$20240725$EXP$$CA-CHATTEMPRD-2024OHG024499$CHATTEM$$50$YR$A$F$Y$68$KG$20240725$$HP$CA$CA
241362271$24136227$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-PV202400096408$PFIZER$$$$$M$Y$$$20240725$$CN$US$US
241362281$24136228$1$I$20240724$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223202$PFIZER$$46$YR$$M$Y$$$20240725$$CN$US$US
241362291$24136229$1$I$$20240722$20240725$20240725$PER$$US-PFIZER INC-PV202400095995$PFIZER$$45$YR$$F$Y$$$20240725$$CN$US$US
241362301$24136230$1$I$$20240724$20240725$20240725$PER$$US-PFIZER INC-PV202400096783$PFIZER$$62$YR$$F$Y$$$20240725$$HP$US$US
241362311$24136231$1$I$20240721$20240722$20240725$20240725$PER$$US-PFIZER INC-202400221423$PFIZER$$68$YR$$F$Y$$$20240725$$HP$US$US
241362321$24136232$1$I$20240715$20240723$20240725$20240725$PER$$US-PFIZER INC-202400222373$PFIZER$$64$YR$$F$Y$$$20240725$$CN$US$US
241362332$24136233$2$F$20190101$20240729$20240725$20240731$PER$$US-PFIZER INC-202400221628$PFIZER$$74$YR$$F$Y$$$20240731$$CN$US$US
241362341$24136234$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-202400222756$PFIZER$$14$YR$$$Y$$$20240725$$HP$US$US
241362355$24136235$5$F$20240101$20240926$20240725$20240930$PER$$US-PFIZER INC-PV202400096905$PFIZER$$46$YR$$F$Y$$$20240930$$HP$US$US
241362361$24136236$1$I$20240720$20240724$20240725$20240725$PER$$US-PFIZER INC-202400222964$PFIZER$$69$YR$$F$Y$$$20240725$$CN$US$US
241362371$24136237$1$I$$20240720$20240725$20240725$PER$$US-PFIZER INC-202400220684$PFIZER$$$$$$Y$$$20240725$$CN$US$US
241362381$24136238$1$I$20240721$20240722$20240725$20240725$PER$$US-PFIZER INC-202400221578$PFIZER$$52$YR$$F$Y$$$20240725$$CN$US$US
241362392$24136239$2$F$20240723$20240730$20240725$20240802$PER$$US-PFIZER INC-PV202400096367$PFIZER$$29$YR$$F$Y$$$20240802$$CN$US$US
241362401$24136240$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-202400222655$PFIZER$$16$YR$$F$Y$$$20240725$$HP$US$US
241362412$24136241$2$F$20240722$20240808$20240725$20240813$PER$$US-PFIZER INC-202400223098$PFIZER$$77$YR$$F$Y$68.027$KG$20240813$$CN$US$US
241362421$24136242$1$I$20240718$20240723$20240725$20240725$PER$$US-PFIZER INC-202400222341$PFIZER$$53$YR$$F$Y$$$20240725$$HP$US$US
241362431$24136243$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-202400222372$PFIZER$$71$YR$$F$Y$$$20240725$$PH$US$US
241362441$24136244$1$I$20240722$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223076$PFIZER$$57$YR$$F$Y$$$20240725$$CN$US$US
241362452$24136245$2$F$$20240724$20240725$20240726$PER$$US-PFIZER INC-202400223094$PFIZER$$$$$$Y$$$20240726$$HP$US$US
241362461$24136246$1$I$20240722$20240723$20240725$20240725$PER$$US-PFIZER INC-202400222292$PFIZER$$45$YR$$F$Y$$$20240725$$CN$US$US
241362471$24136247$1$I$$20240722$20240725$20240725$PER$$US-PFIZER INC-202400221409$PFIZER$$16$YR$$M$Y$$$20240725$$CN$US$US
241362482$24136248$2$F$20230501$20240904$20240725$20240908$EXP$$US-ABBVIE-5611411$ABBVIE$$58$YR$$M$Y$106.59$KG$20240908$$CN$US$US
241362491$24136249$1$I$$20240722$20240725$20240725$PER$$US-JNJFOC-20150924394$JOHNSON AND JOHNSON$$$$$M$Y$$$20240725$$LW$US$US
241362502$24136250$2$F$$20240726$20240725$20240813$PER$$US-JNJFOC-20240703222$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240813$$CN$US$US
241362511$24136251$1$I$20240717$20240717$20240725$20240725$PER$$US-ABBVIE-5847410$ABBVIE$$1$YR$$F$Y$$$20240725$$CN$US$US
241362521$24136252$1$I$20240114$20240716$20240725$20240725$PER$$JP-Eisai-EC-2024-158000$EISAI$$74$YR$E$M$Y$54$KG$20240725$$MD$JP$JP
241362531$24136253$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06847$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241362541$24136254$1$I$$20240723$20240725$20240725$EXP$$LK-TAKEDA-2024TUS074677$TAKEDA$$$$$M$Y$$$20240725$$CN$IN$LK
241362551$24136255$1$I$20240708$20240719$20240725$20240725$PER$$US-AMGEN-USASP2024144820$AMGEN$$63$YR$A$F$Y$$$20240725$$CN$US$US
241362561$24136256$1$I$$20240708$20240725$20240725$PER$$US-Appco Pharma LLC-2159588$APPCO PHARMA$$$$$F$Y$$$20240725$$$US$US
241362573$24136257$3$F$$20240913$20240725$20240918$PER$$US-BIOVITRUM-2024-US-010156$BIOVITRUM$$64$YR$$F$Y$$$20240918$$CN$US$US
241362581$24136258$1$I$20240601$20240719$20240725$20240725$PER$$US-ROCHE-10000008155$ROCHE$$86$YR$E$F$Y$$$20240725$$CN$US$US
241362591$24136259$1$I$$20240715$20240725$20240725$EXP$$JP-Accord-436127$ACCORD$Shiraiwa T, Katayama H, Iwasaki Y, Kimura S, Satake Y, Sato T, et al. A case of testicular tumor and respiratory failure caused by choriocarcinoma syndrome managed through modified chemotherapy and extracorporeal membrane oxygenation. IJU case reports. 2024;7(4):285-8. DOI: 10.1002/iju5.12725.$35$YR$A$M$Y$$$20240725$$MD$JP$JP
241362601$24136260$1$I$20240709$20240713$20240725$20240725$EXP$$US-Accord-436252$ACCORD$$28$YR$A$F$Y$$$20240725$$MD$US$US
241362611$24136261$1$I$20240613$20240713$20240725$20240725$EXP$$US-Accord-436659$ACCORD$$61$YR$A$M$Y$$$20240725$$MD$US$US
241362621$24136262$1$I$19981108$20240716$20240725$20240725$EXP$$DE-AUROBINDO-AUR-APL-2024-036185$AUROBINDO$$63$YR$$M$Y$65$KG$20240725$$MD$DE$DE
241362631$24136263$1$I$$20240722$20240725$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-004429$UNITED THERAPEUTICS$$$$$F$Y$58.503$KG$20240725$$$US$US
241362641$24136264$1$I$$20240719$20240725$20240725$PER$$US-ROCHE-10000031762$ROCHE$$$$E$F$Y$$$20240725$$CN$US$US
241362651$24136265$1$I$20240717$20240717$20240725$20240725$EXP$GB-MHRA-TPP49468386C8579691YC1721224124845$GB-Accord-436771$ACCORD$$82$YR$E$M$Y$79$KG$20240725$$MD$GB$GB
241362661$24136266$1$I$$20240724$20240724$20240724$DIR$711359$$FDA-CTU$$$$$F$N$$$20240724$Y$PH$US$
241362671$24136267$1$I$$20240723$20240725$20240725$EXP$$CA-ORGANON-O2407CAN002178$ORGANON$$40$YR$$F$Y$$$20240725$$HP$CA$CA
241362691$24136269$1$I$$20240717$20240725$20240725$30DAY$$US-GSK-US2024090177$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
241362701$24136270$1$I$20240712$20240715$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024089322$VIIV$$35$YR$$M$Y$$$20240725$$CN$US$US
241362711$24136271$1$I$20240605$20240724$20240724$20240724$DIR$711361$$FDA-CTU$$74$YR$$F$N$63$KG$20240724$Y$CN$US$
241362722$24136272$2$F$$20240803$20240725$20240816$EXP$$CZ-AUROBINDO-AUR-APL-2024-036164$AUROBINDO$Hockickova I, Hockicko J, Ruzickova T, et al.. Malaria ? coraz castejsi problem aj naSlovensku.. Vseobecny lekar. 2024;3(1):25-7$59$YR$$F$Y$$$20240816$$MD$CZ$CZ
241362733$24136273$3$F$$20240913$20240725$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118074$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$67.13$KG$20240919$$CN$US$US
241362741$24136274$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117222$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240725$$HP$US$US
241362751$24136275$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117529$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$76.66$KG$20240725$$CN$US$US
241362761$24136276$1$I$20240722$20240722$20240725$20240725$EXP$$US-JNJFOC-20240758098$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$HP$US$US
241362771$24136277$1$I$$20240722$20240725$20240725$PER$$US-ROCHE-10000033899$ROCHE$$81$YR$E$F$Y$$$20240725$$CN$US$US
241362781$24136278$1$I$$20240716$20240725$20240725$EXP$$CZ-AUROBINDO-AUR-APL-2024-036116$AUROBINDO$Hockickova I, Hockicko J, Ruzickova T, et al.. Malaria - coraz castejsi problem aj naSlovensku.. Vseobecny lekar. 2024;3(1):25-7$70$YR$$F$Y$$$20240725$$MD$CZ$CZ
241362791$24136279$1$I$20240721$20240722$20240725$20240725$PER$$US-PFIZER INC-202400221765$PFIZER$$92$YR$$$Y$$$20240725$$CN$US$US
241362801$24136280$1$I$20230101$20240722$20240725$20240725$PER$$US-PFIZER INC-PV202400096054$PFIZER$$65$YR$$F$Y$$$20240725$$HP$US$US
241362811$24136281$1$I$$20240719$20240725$20240725$PER$$US-PFIZER INC-PV202400096231$PFIZER$$$$$F$Y$$$20240725$$CN$US$US
241362822$24136282$2$F$$20240816$20240725$20240820$PER$$US-PFIZER INC-202400222027$PFIZER$$52$YR$$F$Y$$$20240820$$CN$US$US
241362832$24136283$2$F$$20240728$20240725$20240731$PER$$US-PFIZER INC-PV202400095667$PFIZER$$71$YR$$$Y$$$20240731$$CN$US$US
241362842$24136284$2$F$$20240813$20240725$20240813$PER$$US-ALXN-202407USA001303US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240813$$CN$US$US
241362851$24136285$1$I$$20240718$20240725$20240725$PER$$US-ALXN-202407USA001298US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240725$$HP$US$US
241362862$24136286$2$F$$20240806$20240725$20240812$PER$$US-ALXN-202407USA001268US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241362871$24136287$1$I$$20240718$20240725$20240725$PER$$US-ALXN-202407USA001300US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241362881$24136288$1$I$20220101$20240718$20240725$20240725$PER$$US-ALXN-202407USA001286US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
241362891$24136289$1$I$20231101$20240716$20240725$20240725$EXP$$DE-AUROBINDO-AUR-APL-2024-036105$AUROBINDO$$$$$M$Y$2.6$KG$20240725$$MD$DE$DE
241362901$24136290$1$I$$20240715$20240725$20240725$EXP$$CA-SA-2024SA215771$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240725$$CN$AU$CA
241362911$24136291$1$I$20230110$20230110$20240725$20240725$EXP$$KW-BIOVITRUM-2023KW00917$BIOVITRUM$$47$DY$$F$Y$$$20240725$$CN$KW$KW
241362921$24136292$1$I$$20240721$20240725$20240725$PER$$NVSC2024US150107$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
241362931$24136293$1$I$20240509$20240724$20240725$20240725$EXP$GB-MHRA-MED-202405161417555930-YSQJT$GB-MYLANLABS-2024M1063178$MYLAN$$82$YR$$F$Y$77$KG$20240725$$MD$GB$GB
241362941$24136294$1$I$$20240722$20240725$20240725$EXP$$GB-CHATTEMPRD-2024OHG025004$CHATTEM$$$$$$Y$$$20240725$$CN$GB$GB
241362951$24136295$1$I$$20240715$20240725$20240725$EXP$$US-VIIV HEALTHCARE LIMITED-US2024088723$VIIV$$$$$M$Y$$$20240725$$CN$US$US
241362971$24136297$1$I$20240717$20240717$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090132$VIIV$$66$YR$$M$Y$$$20240725$$CN$US$US
241362981$24136298$1$I$$20240711$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117523$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240725$$CN$US$US
241363001$24136300$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152292$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
241363011$24136301$1$I$20100210$20240724$20240724$20240724$DIR$711373$$FDA-CTU$$62$YR$$M$N$94.95$KG$20240724$N$$US$
241363021$24136302$1$I$20240713$20240718$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115388$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$48.99$KG$20240725$$HP$US$US
241363031$24136303$1$I$$20240722$20240725$20240725$PER$$US-ABBVIE-5851235$ABBVIE$$$$$F$Y$$$20240725$$HP$US$US
241363042$24136304$2$F$$20240926$20240725$20240926$PER$$NVSC2024US150927$NOVARTIS$$$$$F$Y$$$20240926$$MD$US$US
241363051$24136305$1$I$$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458765$RANBAXY$Garcia IC, Pedroza JB, Rodriguez IM, Rincon I.. Trabectedin and Radiotherapy in Endometrial Stromal Sarcoma: A Case Report. Case Rep Oncol. 2024;17 (1):82-90$47$YR$$F$Y$$$20240725$$HP$ES$ES
241363061$24136306$1$I$20240210$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458708$RANBAXY$$55$YR$$F$Y$72$KG$20240725$$PH$FR$FR
241363071$24136307$1$I$20240616$20240724$20240724$20240724$DIR$711369$$FDA-CTU$$87$YR$$F$N$$$20240724$Y$PH$US$
241363081$24136308$1$I$$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458732$RANBAXY$$32$YR$$M$Y$$$20240725$$MD$FR$FR
241363091$24136309$1$I$$20240710$20240725$20240725$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458738$RANBAXY$Goh DSL, Yuson R, Gounder P, Yun J, Limaye S. Strategic testing following toxic epidermal necrolysis allows reintroduction of chemotherapy in a patient with progressive myeloma. Asia Pac Allergy. 2024;14(2):90-92$73$YR$$M$Y$$$20240725$$HP$AU$AU
241363102$24136310$2$F$$20240803$20240725$20240816$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458840$RANBAXY$Kam I, Prentice D, Kho LK, Dharsono F. Inflammatory epilepsy (FIRES) and haemophagocytic lymphohistiocytosis (HLH): an adult case. BMJ Case Rep. 2023;16 (1):e252637$4$DEC$$M$Y$$$20240816$$HP$AU$AU
241363112$24136311$2$F$20230908$20240911$20240725$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458682$RANBAXY$$83$DY$$F$Y$49$KG$20240926$$MD$FR$FR
241363121$24136312$1$I$20240329$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458656$RANBAXY$$59$YR$$M$Y$$$20240725$$MD$FR$FR
241363131$24136313$1$I$$20240710$20240725$20240725$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458772$RANBAXY$Yamamoto A, Ieki H, Shimamura M, Tsujiura M, Yokoe T, Sanuki N, et al. Symptom palliation with QUAD Shot radiation therapy to penile metastasis derived from descending colon cancer: a case report. Int Canc Conf J. 2023;12(3):210-215$54$YR$$F$Y$$$20240725$$HP$JP$JP
241363141$24136314$1$I$20221108$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458652$RANBAXY$$82$YR$$M$Y$$$20240725$$PH$ES$ES
241363151$24136315$1$I$20240403$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458503$RANBAXY$$74$YR$$F$Y$$$20240725$$MD$FR$FR
241363161$24136316$1$I$20210521$20240710$20240725$20240725$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458865$RANBAXY$$54$YR$$F$Y$50$KG$20240725$$CN$GB$GB
241363171$24136317$1$I$20231106$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458560$RANBAXY$$$$$M$Y$$$20240725$$MD$FR$FR
241363181$24136318$1$I$20240329$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458555$RANBAXY$$76$YR$$F$Y$$$20240725$$PH$FR$FR
241363191$24136319$1$I$20230801$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458559$RANBAXY$$41$YR$$F$Y$59$KG$20240725$$MD$FR$FR
241363211$24136321$1$I$20240328$20240710$20240725$20240725$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458511$RANBAXY$$54$YR$$M$Y$$$20240725$$MD$IT$IT
241363221$24136322$1$I$$20240710$20240725$20240725$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458712$RANBAXY$Linardos G, Coltella L, Ranno S, Di Maio VC, Colagrossi L, Pandolfi E, et al. Whooping Cough Cases Increase in Central Italy after COVID-19 Pandemic. Antibiotics (Basel). 2024;13 (5):no pagination$7$MON$$F$Y$$$20240725$$HP$IT$IT
241363231$24136323$1$I$$20240710$20240725$20240725$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458729$RANBAXY$$$$$F$Y$80$KG$20240725$$MD$IT$IT
241363241$24136324$1$I$20240218$20240710$20240725$20240725$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458497$RANBAXY$$40$YR$$M$Y$$$20240725$$MD$DE$DE
241363251$24136325$1$I$20180101$20240710$20240725$20240725$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458673$RANBAXY$$83$YR$$M$Y$$$20240725$$MD$IT$IT
241363261$24136326$1$I$20240320$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458671$RANBAXY$$66$YR$$F$Y$102$KG$20240725$$MD$FR$FR
241363271$24136327$1$I$20231113$20240710$20240725$20240725$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458530$RANBAXY$$52$YR$$M$Y$$$20240725$$MD$DE$DE
241363281$24136328$1$I$$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458697$RANBAXY$Alberola-Amores FJ, Moral-Rubio J. Drug-resistant epicrania fugax: Responding to onabotulinumtoxinA. Headache. 2023;63 (6):839-842$84$YR$$F$Y$$$20240725$$MD$ES$ES
241363291$24136329$1$I$20211107$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458675$RANBAXY$$87$YR$$M$Y$68$KG$20240725$$PH$FR$FR
241363301$24136330$1$I$$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458741$RANBAXY$Alberola-Amores FJ, Moral-Rubio J. Drug-resistant epicrania fugax: Responding to onabotulinumtoxinA. Headache. 2023;63 (6):839-842$75$YR$$F$Y$$$20240725$$MD$ES$ES
241363311$24136331$1$I$$20240717$20240725$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-016842$AUROBINDO$Lee AY-C, Seto J, Hu J, Banerjee D, Moreno JP.. A CHALLENGING CASE OF HYPERTROPHIC CARDIOMYOPATHY IN A CARDIO-ONCOLOGY PATIENT WITH END-STAGE KIDNEY DISEASE. IS THERE ANY ROLE FOR MAVACAMTEN. Journal of the American College of Cardiology. 2024;83(13)Supplemen:3158$58$YR$$M$Y$$$20240725$$HP$US$US
241363321$24136332$1$I$20231226$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458663$RANBAXY$$76$YR$$F$Y$$$20240725$$PH$FR$FR
241363331$24136333$1$I$20240406$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458638$RANBAXY$$57$YR$$F$Y$63$KG$20240725$$MD$FR$FR
241363341$24136334$1$I$20180101$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223044$PFIZER$$65$YR$$F$Y$$$20240725$$HP$US$US
241363351$24136335$1$I$20221228$20240710$20240725$20240725$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458516$RANBAXY$$20$YR$$F$Y$67$KG$20240725$$MD$PL$PL
241363361$24136336$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-PV202400096256$PFIZER$$47$YR$$F$Y$$$20240725$$HP$US$US
241363371$24136337$1$I$20240724$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223172$PFIZER$$64$YR$$F$Y$$$20240725$$CN$US$US
241363381$24136338$1$I$$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223188$PFIZER$$36$YR$$M$Y$$$20240725$$HP$US$US
241363391$24136339$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-PV202400085738$PFIZER$$29$YR$$F$Y$$$20240725$$CN$US$US
241363401$24136340$1$I$$20240716$20240725$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-036315$AUROBINDO$Music S, Suvar T, Tan M, Amin S.. Severe Bilateral Glossopharyngeal Neuralgia Managed With Nerve Blocks Following Plasmodium falciparum Malaria Infection Treated With Mefloquine. PainMed-Case-Rep. 2024;8(3):119-126$38$YR$$F$Y$$$20240725$$MD$US$US
241363411$24136341$1$I$20240722$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223043$PFIZER$$70$YR$$M$Y$$$20240725$$CN$US$US
241363423$24136342$3$F$$20240910$20240725$20240911$PER$$US-PFIZER INC-202400106345$PFIZER$$78$YR$$F$Y$$$20240911$$HP$US$US
241363432$24136343$2$F$$20240724$20240725$20240726$PER$$US-PFIZER INC-202400223085$PFIZER$$$$$$Y$$$20240726$$CN$US$US
241363441$24136344$1$I$20240721$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223185$PFIZER$$53$YR$$M$Y$$$20240725$$CN$US$US
241363451$24136345$1$I$$20240724$20240725$20240725$PER$$US-PFIZER INC-PV202400096546$PFIZER$$50$YR$$F$Y$$$20240725$$CN$US$US
241363461$24136346$1$I$$20240722$20240725$20240725$PER$$JP-PFIZER INC-202400219887$PFIZER$$$$$$Y$$$20240725$$PH$JP$JP
241363471$24136347$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-PV202400096747$PFIZER$$20$YR$$F$Y$$$20240725$$HP$US$US
241363481$24136348$1$I$20240723$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223110$PFIZER$$51$YR$$M$Y$$$20240725$$CN$US$US
241363491$24136349$1$I$$20240724$20240725$20240725$PER$$US-JNJFOC-20240766128$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$PH$US$US
241363503$24136350$3$F$$20240814$20240725$20240822$30DAY$$BR-JNJFOC-20240750705$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$BR$BR
241363511$24136351$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024140884$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241363521$24136352$1$I$$20240716$20240725$20240725$EXP$$ES-SA-2024SA213226$SANOFI AVENTIS$$$$E$M$Y$$$20240725$$CN$ES$ES
241363531$24136353$1$I$20220901$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036184$AUROBINDO$$69$YR$$M$Y$93$KG$20240725$$PH$FR$FR
241363542$24136354$2$F$$20240920$20240725$20240923$EXP$$US-INCYTE CORPORATION-2024IN007777$INCYTE$$$$$$Y$$$20240923$$MD$US$US
241363561$24136356$1$I$$20240716$20240725$20240725$EXP$$IT-AUROBINDO-AUR-APL-2024-036487$AUROBINDO$Perno C F, Linardos G, Coltella L, Ranno S, Di Maio VC, Colagrossi L, et al.. Whooping Cough Cases Increase in Central Italy after COVID-19 Pandemic. Antibiotics-(Basel). 2024;13:No. 5$7$MON$$F$Y$$$20240725$$HP$IT$IT
241363571$24136357$1$I$20230501$20240724$20240725$20240725$EXP$$DE-ORGANON-O2405DEU002559$ORGANON$$47$YR$$M$Y$143.5$KG$20240725$$CN$DE$DE
241363581$24136358$1$I$19670101$20240705$20240725$20240725$PER$$US-TEVA-VS-3219569$TEVA$$$$C$M$Y$$$20240725$$CN$US$US
241363591$24136359$1$I$$20240712$20240725$20240725$EXP$$AU-INCYTE CORPORATION-2024IN007775$INCYTE$Christolyn R, Lewis L. Late presentation of pseudophakic macula edema from oral kinase inhibitors: A case series and literature review. CASE REPORTS IN OPHTHALMOLOGY. 2024;15:15-22$$$$$Y$$$20240725$$HP$AU$AU
241363601$24136360$1$I$$20240722$20240725$20240725$EXP$$NVSJ2024JP009006$NOVARTIS$$57$YR$$M$Y$$$20240725$$MD$JP$JP
241363611$24136361$1$I$20240401$20240715$20240725$20240725$30DAY$$US-GSK-US2024088622$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240725$$CN$US$US
241363621$24136362$1$I$20240714$20240717$20240725$20240725$EXP$$US-SA-2024SA214674$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240725$$MD$US$US
241363631$24136363$1$I$$20240718$20240725$20240725$EXP$$NVSC2024US149388$NOVARTIS$$48$YR$$M$Y$81.646$KG$20240725$$CN$US$US
241363641$24136364$1$I$20240601$20240715$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024088717$VIIV$$26$YR$$F$Y$$$20240725$$CN$US$US
241363651$24136365$1$I$20240711$20240718$20240725$20240725$PER$$US-ROCHE-10000033313$ROCHE$$72$YR$E$F$Y$81.64$KG$20240725$$CN$US$US
241363662$24136366$2$F$20240701$20240723$20240725$20240809$PER$$US-AMGEN-USASP2024146423$AMGEN$$68$YR$E$M$Y$$$20240809$$CN$US$US
241363671$24136367$1$I$$20240723$20240725$20240725$PER$$US-DSJP-DSU-2024-137355$DAIICHI$$$$$F$Y$$$20240725$$MD$US$US
241363681$24136368$1$I$$20240629$20240725$20240725$30DAY$$US-VEROBIOTECH-2024USVEROSPO00151$VERO BIOTECH$$$$$$Y$$$20240725$$HP$US$US
241363691$24136369$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117883$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240725$$CN$US$US
241363702$24136370$2$F$$20240821$20240725$20240822$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-117043$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240822$$PH$AU$AU
241363721$24136372$1$I$$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036206$AUROBINDO$Larabi I.A, Ghich. A, Kintz. P, Marillier. M, Fabresse. N, Pelletier. R, et al.. a national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).. Toxicologie Analytique + Clinique.. 2023;35:376-394.$49$YR$$M$Y$$$20240725$$MD$FR$FR
241363731$24136373$1$I$$20240722$20240725$20240725$EXP$$CA-MYLANLABS-2024M1068276$MYLAN$$$$$$Y$$$20240725$$CN$CA$CA
241363741$24136374$1$I$$20240716$20240725$20240725$EXP$$US-AUROBINDO-AUR-APL-2024-035478$AUROBINDO$Schneegurt NR, Wright C, Glenn N, Thethi I.. Flecainide-induced acute respiratory distress syndrome: A case report.. Cureus. 2024;16(6):e61637$74$YR$$M$Y$$$20240725$$MD$US$US
241363751$24136375$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024147008$AMGEN$$$$$$Y$$$20240725$$PH$US$US
241363761$24136376$1$I$20240718$20240723$20240725$20240725$EXP$$US-INCYTE CORPORATION-2024IN007728$INCYTE$$$$$$Y$$$20240725$$CN$US$US
241363771$24136377$1$I$$20240718$20240725$20240725$PER$$US-AMGEN-USASP2024144368$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241363781$24136378$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145705$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241363792$24136379$2$F$$20240724$20240725$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407015318$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240729$$HP$US$US
241363801$24136380$1$I$20231101$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015145$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240725$$CN$US$US
241363811$24136381$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015159$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240725$$CN$US$US
241363821$24136382$1$I$20240723$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015631$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240725$$CN$US$US
241363831$24136383$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015007$ELI LILLY AND CO$$17$YR$T$M$Y$$$20240725$$CN$US$US
241363842$24136384$2$F$20240626$20240923$20240725$20240930$EXP$$US-Vifor (International) Inc.-VIT-2024-06503$VIFOR$$77$YR$$M$Y$83.4$KG$20240930$$HP$US$US
241363851$24136385$1$I$$20240719$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407012994$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240725$$CN$US$US
241363861$24136386$1$I$20230724$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016355$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240725$$CN$US$US
241363871$24136387$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015247$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240725$$CN$US$US
241363881$24136388$1$I$20240409$20240724$20240724$20240724$DIR$711375$$FDA-CTU$$65$YR$$F$N$63$KG$20240724$N$CN$US$
241363891$24136389$1$I$$20240724$20240724$20240724$DIR$711378$$FDA-CTU$$$$$UNK$N$$$20240724$N$CN$US$
241363901$24136390$1$I$20240722$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015154$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240725$$CN$US$US
241363911$24136391$1$I$$20240710$20240725$20240725$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458327$RANBAXY$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J Cardiovas Thorac Res. 2022;14 (4):258-262$32$YR$$$Y$$$20240725$$HP$IR$IR
241363921$24136392$1$I$$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458440$RANBAXY$$37$YR$$M$Y$$$20240725$$MD$FR$FR
241363931$24136393$1$I$$20240710$20240725$20240725$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458329$RANBAXY$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J Cardiovas Thorac Res. 2022;14 (4):258-262$31$YR$$$Y$$$20240725$$HP$IR$IR
241363941$24136394$1$I$$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458809$RANBAXY$Vela-Casasempere P, Alameda RC, Sabater SG, Aznar SC, Pascual EP. Considering belimumab during pregnancy: A more viable option over time. Lupus. 2024;33 (7):700-715$33$YR$$F$Y$$$20240725$$HP$ES$ES
241363951$24136395$1$I$20240404$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458495$RANBAXY$$80$YR$$M$Y$$$20240725$$MD$FR$FR
241363961$24136396$1$I$$20240710$20240725$20240725$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458370$RANBAXY$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J Cardiovas Thorac Res. 2022;14 (4):258-262$35$YR$$$Y$$$20240725$$HP$IR$IR
241363971$24136397$1$I$$20240710$20240725$20240725$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458364$RANBAXY$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J Cardiovas Thorac Res. 2022;14 (4):258-262$37$YR$$$Y$$$20240725$$HP$IR$IR
241363981$24136398$1$I$$20240710$20240725$20240725$EXP$$QA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458227$RANBAXY$Alshurafa A, Adil A, Yassin MA. Safety and Efficacy of Asciminib in Chronic Myeloid Leukemia Patient with Chronic Kidney Diseases: A Case Report. Case Rep Oncol. 2024;17 (1):96-100$62$YR$$M$Y$$$20240725$$HP$QA$QA
241363991$24136399$1$I$$20240710$20240725$20240725$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458345$RANBAXY$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J Cardiovas Thorac Res. 2022;14 (4):258-262$30$YR$$$Y$$$20240725$$HP$IR$IR
241364001$24136400$1$I$20240116$20240710$20240725$20240725$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458488$RANBAXY$$39$YR$$M$Y$$$20240725$$MD$DE$DE
241364011$24136401$1$I$$20240718$20240725$20240725$PER$$US-ROCHE-10000032144$ROCHE$$70$YR$E$M$Y$$$20240725$$CN$US$US
241364021$24136402$1$I$20240414$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458432$RANBAXY$$88$YR$$F$Y$57.6$KG$20240725$$MD$FR$FR
241364031$24136403$1$I$$20240710$20240725$20240725$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458355$RANBAXY$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J Cardiovas Thorac Res. 2022;14 (4):258-262$39$YR$$$Y$$$20240725$$HP$IR$IR
241364041$24136404$1$I$$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458694$RANBAXY$Vela-Casasempere P, Alameda RC, Sabater SG, Aznar SC, Pascual EP. Considering belimumab during pregnancy: A more viable option over time. Lupus. 2024;33 (7):700-715$38$YR$$F$Y$$$20240725$$HP$ES$ES
241364051$24136405$1$I$20240623$20240710$20240725$20240725$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458174$RANBAXY$$36$YR$$M$Y$83$KG$20240725$$CN$GB$GB
241364062$24136406$2$F$$20240808$20240725$20240823$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458807$RANBAXY$Vela-Casasempere P, Alameda RC, Sabater SG, Aznar SC, Pascual EP. Considering belimumab during pregnancy: A more viable option over time. Lupus. 2024;33 (7):700-715$$$N$$Y$$$20240823$$HP$ES$ES
241364073$24136407$3$F$$20240729$20240725$20240808$EXP$$PE-ROCHE-10000032926$ROCHE$$$$$F$Y$57.5$KG$20240808$$CN$PE$PE
241364081$24136408$1$I$$20240710$20240725$20240725$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458378$RANBAXY$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J Cardiovas Thorac Res. 2022;14 (4):258-262$34$YR$$$Y$$$20240725$$HP$IR$IR
241364091$24136409$1$I$$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458822$RANBAXY$Vela-Casasempere P, Alameda RC, Sabater SG, Aznar SC, Pascual EP. Considering belimumab during pregnancy: A more viable option over time. Lupus. 2024;33 (7):700-715$$$N$$Y$$$20240725$$HP$ES$ES
241364101$24136410$1$I$$20240710$20240725$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458483$RANBAXY$Lee R, Gonsalves Z, Wang S, Hussain A, Herrera K. Case study: Autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks gestation. Case Rep Perinat Med. 2024;13 (1):no pagination$29$YR$$F$Y$$$20240725$$MD$US$US
241364111$24136411$1$I$$20240710$20240725$20240725$EXP$$AE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458443$RANBAXY$Alao DO, Moin K, Abraham. Multiorgan failure and death from a mixed Dettol and Clorox poisoning: a case report. J Med Case Rep. 2023;17 (1):95(1-7)$26$YR$$M$Y$$$20240725$$HP$AE$AE
241364122$24136412$2$F$$20240718$20240725$20240802$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458701$RANBAXY$Krzowski B, Balsam P. Antihypertensive therapy optimization- case report. Medycyna Faktow. 2024;17(1);62:153-5$52$YR$$M$Y$$$20240802$$MD$PL$PL
241364131$24136413$1$I$$20240710$20240725$20240725$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458888$RANBAXY$DeTemple VK, Hassel JC, Sachse MM, Grimmelmann I, Leiter U, Gebhardt C. Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients. Cancers. 2022;14(21):1-9$$$$$Y$$$20240725$$HP$DE$DE
241364141$24136414$1$I$20231104$20240710$20240725$20240725$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458305$RANBAXY$$24$YR$$F$Y$$$20240725$$MD$DE$DE
241364151$24136415$1$I$$20240710$20240725$20240725$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458486$RANBAXY$$25$YR$$F$Y$60$KG$20240725$$CN$GB$GB
241364161$24136416$1$I$$20240710$20240725$20240725$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458317$RANBAXY$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J Cardiovas Thorac Res. 2022;14 (4):258-262$18$YR$$$Y$$$20240725$$HP$IR$IR
241364171$24136417$1$I$20240131$20240710$20240725$20240725$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458302$RANBAXY$$78$YR$$F$Y$76$KG$20240725$$MD$IT$IT
241364181$24136418$1$I$$20240710$20240725$20240725$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458517$RANBAXY$Arora K, Singh AS, Bedi R, Dang K, Kaur A. Navigating the Uncharted: A Rare Case of Ocular Flutter and Intermittent Jaw Movements in a Case of Chronic Lymphoid Leukemia. Ann Indian Acad Neurol. 2024;May-Jun; 27 (3):313-315$63$YR$$F$Y$$$20240725$$HP$IN$IN
241364191$24136419$1$I$$20240710$20240725$20240725$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458350$RANBAXY$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J Cardiovas Thorac Res. 2022;14 (4):258-262$42$YR$$$Y$$$20240725$$HP$IR$IR
241364201$24136420$1$I$$20240710$20240725$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458566$RANBAXY$Kraus MJ, Nguyen J. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report. Case Rep Neurol. 2024;16 (1):142-147$38$YR$$F$Y$$$20240725$$HP$US$US
241364211$24136421$1$I$$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458396$RANBAXY$Leclercq M, Goupillou P, Gomez H, Muraine M, Benhamou Y, Girszyn N, et al. Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non?infectious non?anterior uveitis. Inflamm Infect. 2023;Jul;13:32(1-6)$61$YR$$M$Y$77$KG$20240725$$HP$FR$FR
241364221$24136422$1$I$$20240710$20240725$20240725$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458876$RANBAXY$DeTemple VK, Hassel JC, Sachse MM, Grimmelmann I, Leiter U, Gebhardt C. Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients. Cancers. 2022;14(21):1-9$$$$$Y$$$20240725$$HP$DE$DE
241364231$24136423$1$I$20240123$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458180$RANBAXY$$61$YR$$M$Y$$$20240725$$MD$FR$FR
241364241$24136424$1$I$$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458812$RANBAXY$Vela-Casasempere P, Alameda RC, Sabater SG, Aznar SC, Pascual EP. Considering belimumab during pregnancy: A more viable option over time. Lupus. 2024;33 (7):700-715$40$YR$$F$Y$$$20240725$$HP$ES$ES
241364251$24136425$1$I$$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458799$RANBAXY$Vela-Casasempere P, Alameda RC, Sabater SG, Aznar SC, Pascual EP. Considering belimumab during pregnancy: A more viable option over time. Lupus. 2024;33 (7):700-715$40$YR$$F$Y$$$20240725$$HP$ES$ES
241364261$24136426$1$I$$20240710$20240725$20240725$EXP$$MX-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458382$RANBAXY$Bautista-Sanchez CD, Martinez-Bravo LE, Hidalgo-Diaz DA. Pancytopenia in neuromyelitis optica spectrum disorder induced by azathioprine-allopurinol interaction. Neuroimmunol rep. 2024;6(0):100219$63$YR$$F$Y$$$20240725$$HP$MX$MX
241364271$24136427$1$I$$20240710$20240725$20240725$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458175$RANBAXY$$32$YR$$M$Y$$$20240725$$MD$GB$GB
241364282$24136428$2$F$$20240718$20240725$20240802$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458363$RANBAXY$Xu X, Li Y, Han T, Zhao Y, Wang X, Fu X, et al. The hidden dangers of short-termglucocorticoid use in children: A genomic analysis. Int Immunopharmacol. 2024;135 (0):112323(1-7)$7$YR$$M$Y$40$KG$20240802$$HP$CN$CN
241364291$24136429$1$I$$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458392$RANBAXY$Leclercq M, Goupillou P, Gomez H, Muraine M, Benhamou Y, Girszyn N, et al. Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non?infectious non?anterior uveitis. J Opthalmic Inflammm Infect. 2023;Jul;13:32(1-6)$35$YR$$F$Y$98$KG$20240725$$HP$FR$FR
241364301$24136430$1$I$$20240710$20240725$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458563$RANBAXY$Binod KC, Jabbour A, Poudel P, Banki K, Perl A. IL-17A inhibitor-induced leucocytoclastic vasculitis is responsive to IL-23 blockade in a psoriatic arthritis patient. Ann Rheum Dis. 2024;83:265-267$59$YR$$M$Y$$$20240725$$HP$US$US
241364311$24136431$1$I$$20240710$20240725$20240725$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458891$RANBAXY$DeTemple VK, Hassel JC, Sachse MM, Grimmelmann I, Leiter U, Gebhardt C. Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients. Cancers. 2022;14(21):1-9$$$$$Y$$$20240725$$HP$DE$DE
241364322$24136432$2$F$$20240718$20240725$20240802$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458359$RANBAXY$Kaya Akca U, Sener S, Batu ED, Balik Z, Basaran O, Bilginer Y, et al. Drug-induced lupus erythematosus in childhood: Case-based review. Case based review Lupus. 2024;33 (7):737-748$9$YR$$M$Y$$$20240802$$HP$TR$TR
241364331$24136433$1$I$$20240710$20240725$20240725$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458315$RANBAXY$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J Cardiovas Thorac Res. 2022;14 (4):258-262$34$YR$$$Y$$$20240725$$HP$IR$IR
241364342$24136434$2$F$$20240808$20240725$20240823$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458803$RANBAXY$Vela-Casasempere P, Alameda RC, Sabater SG, Aznar SC, Pascual EP. Considering belimumab during pregnancy: A more viable option over time. Lupus. 2024;33 (7):700-715$$$N$$Y$$$20240823$$HP$ES$ES
241364351$24136435$1$I$$20240710$20240725$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458538$RANBAXY$Saigal K, Maleki A. Intravitreal Fluocinolone Acetonide 0.19 mg Implant in a Patient with Resistant Blau Syndrome: A Case Report. Case Rep Ophthalmol. 2024;15:63-70$6$YR$$F$Y$$$20240725$$HP$US$US
241364361$24136436$1$I$20231114$20240717$20240725$20240725$EXP$$BR-SA-2023SA364746$SANOFI AVENTIS$$38$YR$A$F$Y$68$KG$20240725$$CN$BR$BR
241364371$24136437$1$I$20240516$20240717$20240725$20240725$EXP$FR-AFSSAPS-RN2024000759$FR-SA-2024SA210737$SANOFI AVENTIS$$40$YR$A$M$Y$78$KG$20240725$$PH$FR$FR
241364381$24136438$1$I$$20240710$20240725$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457768$RANBAXY$$$$$F$Y$$$20240725$$CN$US$US
241364392$24136439$2$F$$20240718$20240725$20240802$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458335$RANBAXY$Vaselli NM, Du Preez S, Kankanamage NJ. Clozapine-induced pneumonitis mimicking an atypical pneumonia. BMJ Case Rep. 2024;17(3):1-4$$$A$F$Y$$$20240802$$MD$AU$AU
241364401$24136440$1$I$$20240710$20240725$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458316$RANBAXY$Meeder R, Peterson A, Reynard H, Andersen L. Dyadic Work in Conjunction With Electroconvulsive Therapy in a 12-Year-Old Female With Autism Spectrum Disorder and Catatonia. Ochsner J. 2024;24 (2):141-146$12$YR$$F$Y$$$20240725$$MD$US$US
241364411$24136441$1$I$20220901$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457785$RANBAXY$$56$YR$$M$Y$73$KG$20240725$$PH$ES$ES
241364421$24136442$1$I$$20240710$20240725$20240725$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458545$RANBAXY$Cui Y, Yang L, Wu P, Shao S, Luo S, Zhou K, et al. Case Report: unexpected cause of cyanosis in an infant after acute exposure to high altitude-severe tricuspid regurgitation secondary to tricuspid valve prolapse. Front Cardiovasc Med. 2024;11(0):1335218;01-06$3$MON$$M$Y$$$20240725$$HP$CN$CN
241364431$24136443$1$I$$20240710$20240725$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458585$RANBAXY$Agarwal A, Amit M, Chaffin J, Strobel A. Blastic plasmacytoid dendritic cell neoplasm in an adolescent female: A rare entity with challenging diagnosis and management. BMJ Case Rep. 2023;16 (5):e254008/1-7$$$T$F$Y$$$20240725$$HP$US$US
241364441$24136444$1$I$$20240710$20240725$20240725$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458331$RANBAXY$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J Cardiovas Thorac Res. 2022;14 (4):258-262$51$YR$$$Y$$$20240725$$HP$IR$IR
241364451$24136445$1$I$$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458792$RANBAXY$Vela-Casasempere P, Alameda RC, Sabater SG, Aznar SC, Pascual EP. Considering belimumab during pregnancy: A more viable option over time. Lupus. 2024;33 (7):700-715$37$YR$$F$Y$$$20240725$$HP$ES$ES
241364462$24136446$2$F$$20240718$20240725$20240830$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458357$RANBAXY$Kaya Akca U, Sener S, Batu ED, Balik Z, Basaran O, Bilginer Y, et al. Drug-induced lupus erythematosus in childhood: Case-based review. Case based review Lupus. 2024;33 (7):737-748$11$YR$$F$Y$$$20240830$$HP$TR$TR
241364471$24136447$1$I$20240101$20240710$20240725$20240725$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457974$RANBAXY$$72$YR$$F$Y$60$KG$20240725$$MD$GB$GB
241364481$24136448$1$I$$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458813$RANBAXY$Vela-Casasempere P, Alameda RC, Sabater SG, Aznar SC, Pascual EP. Considering belimumab during pregnancy: A more viable option over time. Lupus. 2024;33 (7):700-715$41$YR$$F$Y$$$20240725$$HP$ES$ES
241364491$24136449$1$I$$20240710$20240725$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458519$RANBAXY$Brin G, Duff JP. Severe Hypotension Associated with Guanfacine: Case Report of an Unexpected Drug Reaction. Can J Hosp Pharm. 2024;77 (1):e3311 (1-3)$15$YR$$M$Y$50$KG$20240725$$MD$US$US
241364501$24136450$1$I$$20240710$20240725$20240725$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458796$RANBAXY$$56$YR$$M$Y$78$KG$20240725$$PH$GB$GB
241364512$24136451$2$F$$20240717$20240725$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458480$RANBAXY$Naumann J, Naumann T. Acute Precipitated Opioid Withdrawal With Akathisia, Delirium, and Lactic Acidosis from Low-Dose Naltrexone for Chronic Pain:Case Report. Pain Med Case Rep. 2023;7(8):353-356$66$YR$$M$Y$$$20240801$$HP$US$US
241364542$24136454$2$F$$20240717$20240725$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458322$RANBAXY$Garman JC, Mahgoub Y, Pathare A. Psychogenic Hyperphagia: Excessive Eating as Stereotypy in a Patient with Catatonia. J Psychiatr Pract. 2024;May; 30 (3):242-244$30$YR$$M$Y$$$20240801$$MD$US$US
241364551$24136455$1$I$20240708$20240715$20240725$20240725$EXP$GB-MHRA-MED-202407091643058170-KHFPJ$GB-Vifor (International) Inc.-VIT-2024-06453$VIFOR$$69$YR$$F$Y$$$20240725$$HP$GB$GB
241364562$24136456$2$F$$20240917$20240725$20240920$EXP$$NVSJ2024JP008833$NOVARTIS$$85$YR$$M$Y$$$20240920$$PH$JP$JP
241364572$24136457$2$F$$20240827$20240725$20240904$EXP$$GB-AstraZeneca-2024A160658$ASTRAZENECA$$$$$F$Y$$$20240904$$HP$GB$
241364582$24136458$2$F$$20240828$20240725$20240830$PER$$US-ROCHE-10000031340$ROCHE$$$$A$F$Y$$$20240830$$CN$US$US
241364591$24136459$1$I$$20240722$20240725$20240725$PER$$US-ROCHE-10000033152$ROCHE$$73$YR$E$M$Y$$$20240725$$CN$US$US
241364601$24136460$1$I$$20240702$20240725$20240725$30DAY$$US-VEROBIOTECH-2024USVEROSPO00152$VERO BIOTECH$$$$$$Y$$$20240725$$HP$US$US
241364611$24136461$1$I$$20240716$20240725$20240725$EXP$$US-AMERICAN REGENT INC-2024002779$AMERICAN REGENT$Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al.. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management.. Journal of Pediatric Orthopaedics B. 2024;33(4):407-410$3$YR$$F$Y$$$20240725$$MD$US$US
241364621$24136462$1$I$$20240717$20240725$20240725$EXP$$CA-TAKEDA-2024TUS032727$TAKEDA$$$$$F$Y$$$20240725$$CN$CA$CA
241364631$24136463$1$I$20240526$20240717$20240725$20240725$EXP$$GB-AUROBINDO-AUR-APL-2024-035751$AUROBINDO$$85$YR$$F$Y$43$KG$20240725$$PH$GB$GB
241364642$24136464$2$F$$20240828$20240725$20240903$30DAY$$US-GSK-US2024AMR091191$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$CN$US$US
241364651$24136465$1$I$$20240717$20240725$20240725$30DAY$$US-GSK-US2024AMR090482$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241364662$24136466$2$F$$20240912$20240725$20240927$PER$$US-RISINGPHARMA-US-2024RISSPO00250$RISING PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241364671$24136467$1$I$$20240719$20240725$20240725$EXP$$MX-TAKEDA-2024TUS041637$TAKEDA$$$$$M$Y$$$20240725$$CN$MX$MX
241364681$24136468$1$I$$20240710$20240725$20240725$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458885$RANBAXY$DeTemple VK, Hassel JC, Sachse MM, Grimmelmann I, Leiter U, Gebhardt C. Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients. Cancers. 2022;14(21):1-9$$$$$Y$$$20240725$$HP$DE$DE
241364691$24136469$1$I$$20240710$20240725$20240725$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458896$RANBAXY$DeTemple VK, Hassel JC, Sachse MM, Grimmelmann I, Leiter U, Gebhardt C. Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients. Cancers. 2022;14(21):no pagnation$$$$$Y$$$20240725$$HP$DE$DE
241364701$24136470$1$I$$20240710$20240725$20240725$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458588$RANBAXY$Zengarini C, Clarizio G, Bardazzi F, Mussi M, Baraldi C, Piraccini BM, et al. Unilateral eosinophilic fasciitis (Shulman syndrome) with excellent response to combined treatment with methotrexate therapy and compression brace. Dermatol Rep. 2024;16 (2):9807$78$YR$$M$Y$$$20240725$$HP$IT$IT
241364711$24136471$1$I$$20240724$20240724$20240724$DIR$711387$$FDA-CTU$$$$$UNK$N$$$20240724$N$CN$US$
241364721$24136472$1$I$20231006$20240716$20240725$20240725$EXP$$US-RECORDATI-2023005691$RECORDATI$$$$$$Y$$$20240725$$CN$US$US
241364731$24136473$1$I$$20240710$20240725$20240725$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458177$RANBAXY$$41$YR$$M$Y$102$KG$20240725$$CN$GB$GB
241364751$24136475$1$I$20240705$20240724$20240724$20240724$DIR$711383$$FDA-CTU$$70$YR$$M$N$$$20240724$Y$HP$US$
241364761$24136476$1$I$20240216$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458269$RANBAXY$$75$YR$$F$Y$55$KG$20240725$$MD$FR$FR
241364771$24136477$1$I$$20240710$20240725$20240725$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458029$RANBAXY$Troisi S, Giudice V, Troisi M, Morini D, Crudele A, Cuffa B, et al.. Transient Daratumumab Induced  Refractive Shift in Multidrug Resistant Multiple Myeloma: Case Report and Literature Review. Acta Haematol. 2023;146:424-430$42$YR$$F$Y$$$20240725$$HP$IT$IT
241364791$24136479$1$I$$20240710$20240725$20240725$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458314$RANBAXY$Zhang X, Jiao F, Li G, Yu X, Pei Y, Zhang Y et al. Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants. Front Pharmacol. 2023;14:1191608 (1-6)$70$YR$$M$Y$$$20240725$$HP$CN$CN
241364802$24136480$2$F$20240319$20240906$20240725$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458272$RANBAXY$$85$YR$$M$Y$64$KG$20240920$$MD$FR$FR
241364811$24136481$1$I$20240601$20240710$20240725$20240725$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457459$RANBAXY$$56$YR$$F$Y$85$KG$20240725$$CN$BR$BR
241364821$24136482$1$I$$20240710$20240725$20240725$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458886$RANBAXY$DeTemple VK, Hassel JC, Sachse MM, Grimmelmann I, Leiter U, Gebhardt C. Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients. Cancers. 2022;14(21):1-9$$$$$Y$$$20240725$$HP$DE$DE
241364831$24136483$1$I$$20240710$20240725$20240725$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458375$RANBAXY$Taghavi S, Jelodar HR, Rafati A, Naderi N, Mirtajaddini M, Amin A, et al.. COVID-19 in heart transplant recipients.. J Cardiovas Thorac Res. 2022;14 (4):258-262$30$YR$$$Y$$$20240725$$HP$IR$IR
241364841$24136484$1$I$$20240710$20240725$20240725$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458787$RANBAXY$Vela-Casasempere P, Alameda RC, Sabater SG, Aznar SC, Pascual EP. Considering belimumab during pregnancy: A more viable option over time. Lupus. 2024;33 (7):700-715$37$YR$$F$Y$$$20240725$$HP$ES$ES
241364851$24136485$1$I$$20240710$20240725$20240725$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458473$RANBAXY$Perananthan V, Sparrow MP, Foley A. Thiopurines and risk of lymphoproliferative disorders. Aust Prescr. 2024;Jun 47(3):91-93$29$YR$$M$Y$$$20240725$$HP$AU$AU
241364861$24136486$1$I$$20240710$20240725$20240725$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458500$RANBAXY$Lee R, Gonsalves Z, Wang S, Hussain A, Herrera K.. Case study: autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks gestation. Case Rep Perinat Med. 2024;13 (1):1-3$$$I$$Y$$$20240725$$MD$US$US
241364872$24136487$2$F$20220420$20240919$20240725$20240919$EXP$$CA-PFIZER INC-202200520127$PFIZER$$68$YR$$F$Y$75$KG$20240919$$HP$CA$CA
241364883$24136488$3$F$20180101$20240724$20240725$20240730$EXP$$US-PFIZER INC-PV202400096645$PFIZER$$38$YR$$F$Y$80.726$KG$20240730$$MD$US$US
241364891$24136489$1$I$20240614$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145332$AMGEN$$70$YR$E$F$Y$$$20240725$$HP$US$US
241364901$24136490$1$I$$20240715$20240725$20240725$EXP$$DE-TEVA-VS-3223590$TEVA$Olkus A, Tomczak A, Berger AK, Rauber C, Puchas P, Wehling C, et al. Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data. Target-Oncol 2024; 19 (2): 213-221.; Olkus A, Tomczak A, Berger AK, Rauber C, Puchas P, Wehling C, et al. Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data. Target-Oncol 2024; 19 (2): 213-221.$$$$$Y$$$20240725$$HP$DE$DE
241364911$24136491$1$I$$20240703$20240725$20240725$30DAY$$US-VEROBIOTECH-2024USVEROSPO00153$VERO BIOTECH$$$$$M$Y$$$20240725$$HP$US$US
241364921$24136492$1$I$20231226$20240715$20240725$20240725$EXP$$US-RDY-SPO/USA/24/0010560$DR REDDYS$$74$YR$E$F$Y$51.7$KG$20240725$$MD$US$US
241364931$24136493$1$I$$20240722$20240725$20240725$EXP$$US-BEH-2024176207$CSL BEHRING$$$$A$M$Y$$$20240725$$HP$US$US
241364942$24136494$2$F$20240717$20240725$20240725$20240726$EXP$$US-INCYTE CORPORATION-2024IN007716$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241364961$24136496$1$I$20240601$20240710$20240725$20240725$EXP$$DE-ROCHE-10000035403$ROCHE$$58$YR$A$M$Y$$$20240725$$CN$DE$DE
241364971$24136497$1$I$$20240717$20240725$20240725$EXP$$JP-ROCHE-10000033134$ROCHE$$5$DEC$A$F$Y$$$20240725$$MD$JP$JP
241364981$24136498$1$I$20240529$20240710$20240725$20240725$PER$$US-RISINGPHARMA-US-2024RISSPO00249$RISING PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
241364991$24136499$1$I$$20240718$20240725$20240725$EXP$$FR-MYLANLABS-2024M1068827$MYLAN$Vatignez T, Lemee L, Morisse-Pradier H, Carvalho-Lallement P, Alexandre K, Artaud-Macari E. A 52-year-old immunocompromised man with an unusual cause of infectious lung cavitary inducing acute respiratory failure. Respir-Med-Res 2024; 86 101101.$52$YR$$M$Y$$$20240725$$HP$FR$FR
241365001$24136500$1$I$$20240718$20240725$20240725$EXP$$US-MYLANLABS-2024M1068601$MYLAN$Marvin JE, McSweeney T, Cohen E, Davis MW, Belfield K, Do V, et al. Nocardiosis in Kidney Transplant Recipients and Possible Association With Decreased Utilization of Trimethoprim/Sulfamethoxazole During COVID-19. Transplantation 2024; 108 (7): e150-e151.$$$$$Y$$$20240725$$MD$US$US
241365011$24136501$1$I$$20240718$20240725$20240725$EXP$$US-MYLANLABS-2024M1068789$MYLAN$Whitford R. A Case Report of Unusual Differential Hypoxia. ASAIO-J 2024; 70 (Suppl. 3) 103 abstr. SHOCK9.$18$YR$$M$Y$$$20240725$$HP$US$US
241365021$24136502$1$I$$20240718$20240725$20240725$EXP$$US-MYLANLABS-2024M1068559$MYLAN$Behbahani-Nejad N, Palepu R, Kotha A, Nayef HA. Fentanyl-Induced Wooden Chest Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209.$30$YR$$F$Y$$$20240725$$HP$US$US
241365031$24136503$1$I$20220101$20240718$20240725$20240725$EXP$$NL-MYLANLABS-2024M1068546$MYLAN$Conradi PM, Heidendael JF, Lucas CMHB, Yazdi MT, Handoko ML. A classical case report of constrictive pericarditis, highlighting the role of magnetic resonance imaging and haemodynamic assessment. Eur-Heart-J-Case-Rep 2024; 8 (2).$67$YR$$M$Y$$$20240725$$HP$NL$NL
241365041$24136504$1$I$$20240718$20240725$20240725$EXP$$US-MYLANLABS-2024M1068849$MYLAN$Adesina J, Patel A, Khan S. Many reasons for restless legs, not to rest. Sleep 2024; 47 (Suppl.) A494 abstr. 1153.$52$YR$$M$Y$$$20240725$$HP$US$US
241365051$24136505$1$I$$20240718$20240725$20240725$EXP$$US-MYLANLABS-2024M1068781$MYLAN$Lawson CT, Portz BJ. A Case of Steroid Refractory Lupus Podocytopathy: Is Glucocorticoid Monotherapy Sufficient? J-Am-Soc-Nephrol 2023; 34 1013.$38$YR$$F$Y$$$20240725$$HP$US$US
241365061$24136506$1$I$$20240718$20240725$20240725$EXP$$US-MYLANLABS-2024M1068553$MYLAN$Marvin JE, McSweeney T, Cohen E, Davis MW, Belfield K, Do V, et al. Nocardiosis in Kidney Transplant Recipients and Possible Association With Decreased Utilization of Trimethoprim/Sulfamethoxazole During COVID-19. Transplantation 2024; 108 (7): e150-e151.$$$$$Y$$$20240725$$MD$US$US
241365071$24136507$1$I$20240101$20240718$20240725$20240725$EXP$$FI-MYLANLABS-2024M1068402$MYLAN$$47$YR$$M$Y$$$20240725$$MD$FI$FI
241365081$24136508$1$I$$20240718$20240725$20240725$EXP$$US-MYLANLABS-2024M1068835$MYLAN$Walgamage M, Nunez Cuello L, Walgamage T. Can MRSA Really Do That? A Rare Case of Acute Cholecystitis With MRSA Bacteremia. Am-J-Respir-Crit-Care-Med 2024; 209.$70$YR$$F$Y$$$20240725$$HP$US$US
241365091$24136509$1$I$$20240718$20240725$20240725$EXP$$US-MYLANLABS-2024M1068542$MYLAN$Quo SW, Mederos N, Parianos M, Idrisov E. Significant esophageal and intestiinal ulcerations in the setting of recent chemotherapy for pancreatic adenocarcinoma. Gastroenterology 2023; 164 (Suppl.) (6): S-1209-S-1210 abstr. EP84.$72$YR$$M$Y$$$20240725$$HP$US$US
241365101$24136510$1$I$$20240722$20240725$20240725$EXP$$US-MYOVANT SCIENCES GMBH-2024MYSCI0700887$MYOVANT SCIENCES$$$$$M$Y$$$20240725$$CN$US$US
241365111$24136511$1$I$20240722$20240722$20240725$20240725$PER$$US-ABBVIE-5851343$ABBVIE$$67$YR$$F$Y$105$KG$20240725$$PH$US$US
241365122$24136512$2$F$20240101$20240723$20240725$20240727$PER$$US-AMGEN-USASP2024145648$AMGEN$$72$YR$E$M$Y$$$20240727$$CN$US$US
241365131$24136513$1$I$$20240718$20240725$20240725$EXP$$CN-AMGEN-CHNSP2024145116$AMGEN$Huiying Q.; Yan P.; Xiangyue Z. et al.. Clinical efficacy and safety of blinatumomab bridging CAR-T cell therapy in the treatment of patients with adult acute B-cell lymphoblastic leukemia. Chin J Hematol. 2024;45 (4):339-344$$$$$Y$$$20240725$$HP$CN$CN
241365141$24136514$1$I$20240612$20240724$20240724$20240724$DIR$711385$$FDA-CTU$$76$YR$$M$N$$$20240724$Y$PH$US$
241365151$24136515$1$I$20240710$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51005$$FDA-CTU$$69$YR$$F$N$$$20240724$Y$HP$US$
241365161$24136516$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146691$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241365171$24136517$1$I$$20240724$20240725$20240725$PER$$US-HALEON-2188851$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241365181$24136518$1$I$20240706$20240724$20240724$20240724$DIR$711376$$FDA-CTU$$76$YR$$M$N$$$20240724$Y$HP$US$
241365191$24136519$1$I$20240717$20240724$20240724$20240724$DIR$711386$$FDA-CTU$$85$YR$$F$N$$$20240724$Y$PH$US$
241365201$24136520$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118033$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240725$$HP$US$US
241365211$24136521$1$I$20240415$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50998$$FDA-CTU$$64$YR$$UNK$N$$$20240724$N$HP$US$
241365221$24136522$1$I$20240508$20240611$20240724$20240724$DIR$FDA-CDER-CTU-2024-50997$$FDA-CTU$$62$YR$$M$N$$$20240611$N$HP$US$
241365231$24136523$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118007$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240725$$HP$US$US
241365242$24136524$2$F$20240701$20240729$20240725$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118062$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$84.37$KG$20240805$$HP$US$US
241365251$24136525$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117923$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240725$$CN$US$US
241365261$24136526$1$I$$20240703$20240725$20240725$PER$$US-AstraZeneca-2024A162171$ASTRAZENECA$$68$YR$$F$Y$$$20240725$$CN$US$
241365271$24136527$1$I$$20240715$20240725$20240725$EXP$$US-AMGEN-USASP2024142712$AMGEN$Dean R.M. Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial. Blood. 2012;120 (21):1990$$$$$Y$$$20240725$$MD$US$US
241365281$24136528$1$I$$20240718$20240725$20240725$EXP$$VN-AMGEN-VNMSP2024144683$AMGEN$Do T.; Nguyen T.; Nguyen H. et al.. Survival outcome and prognostic factors in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with abiraterone acetate - real-world experience in Vietnam. European Journal of Clinical and Experimental Medicine. 2024;22 (2):262-269$$$$$Y$$$20240725$$HP$VN$VN
241365314$24136531$4$F$$20240725$20240725$20240730$PER$$NVSC2024US152394$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
241365321$24136532$1$I$$20240723$20240725$20240725$EXP$GB-MHRA-MED-202407231643541750-DKNHJ$GB-ABBVIE-5852002$ABBVIE$$$$$F$Y$$$20240725$$CN$GB$GB
241365342$24136534$2$F$$20240729$20240725$20240806$EXP$$DE-TEVA-VS-3223579$TEVA$Olkus A, Tomczak A, Berger AK, Rauber C, Puchas P, Wehling C, et al. Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data. Target-Oncol 2024; 19 (2): 213-221; Olkus A, Tomczak A, Berger AK, Rauber C, Puchas P, Wehling C, et al. Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data. Target-Oncol 2024; 19 (2): 213-221.; Olkus A, Tomczak A...$$$$$Y$$$20240806$$HP$DE$DE
241365352$24136535$2$F$20240101$20240721$20240725$20240802$EXP$$ES-ALXN-202407EEA001373ES$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$MD$ES$ES
241365362$24136536$2$F$$20240813$20240725$20240813$PER$$US-ALXN-202407USA001323US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241365372$24136537$2$F$20240601$20240917$20240725$20240924$EXP$$IT-GSK-IT2024091271$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$IT$IT
241365381$24136538$1$I$$20240716$20240725$20240725$EXP$$US-AMERICAN REGENT INC-2024002819$AMERICAN REGENT$Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al.. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management.. Journal of Pediatric Orthopaedics B. 2024;33(4):407-410$15$YR$$M$Y$$$20240725$$MD$US$US
241365391$24136539$1$I$20240202$20240716$20240725$20240725$EXP$FR-AFSSAPS-MP2024001060$FR-TEVA-VS-3222251$TEVA$$77$YR$$M$Y$$$20240725$$MD$FR$FR
241365402$24136540$2$F$20230201$20240802$20240725$20240809$EXP$$US-ABBVIE-5852268$ABBVIE$$65$YR$$F$Y$58$KG$20240809$$CN$US$US
241365411$24136541$1$I$$20240705$20240725$20240725$EXP$$US-SERVIER-S24008595$SERVIER$$$$$$Y$$$20240725$$CN$US$US
241365421$24136542$1$I$$20240718$20240725$20240725$EXP$$BE-BEH-2024175906$CSL BEHRING$$$$$F$Y$$$20240725$$MD$BE$BE
241365431$24136543$1$I$$20240722$20240725$20240725$EXP$$US-BEH-2024176209$CSL BEHRING$$$$E$F$Y$$$20240725$$HP$US$US
241365441$24136544$1$I$20240408$20240715$20240725$20240725$EXP$$ES-TEVA-VS-3224195$TEVA$$69$YR$$F$Y$$$20240725$$CN$ES$ES
241365453$24136545$3$F$20240715$20240724$20240725$20240811$PER$$US-AMGEN-USASP2024144974$AMGEN$$23$YR$A$F$Y$$$20240811$$CN$US$US
241365463$24136546$3$F$20240708$20240905$20240725$20240912$30DAY$$MX-AMGEN-MEXSP2024144270$AMGEN$$44$YR$A$F$Y$$$20240912$$MD$MX$MX
241365471$24136547$1$I$20240719$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145603$AMGEN$$54$YR$A$M$Y$$$20240725$$CN$US$US
241365481$24136548$1$I$$20240713$20240725$20240725$EXP$$IT-ROCHE-3576102$ROCHE$$$$$$Y$$$20240725$$HP$IT$IT
241365491$24136549$1$I$20240101$20240717$20240725$20240725$EXP$DK-DKMA-30735196$DK-JUBILANT CADISTA PHARMACEUTICALS-2024DK001042$JUBILANT$$55$YR$$F$Y$65$KG$20240725$$MD$DK$DK
241365503$24136550$3$F$20240716$20240819$20240725$20240821$PER$$US-AMGEN-USASP2024147161$AMGEN$$63$YR$A$M$Y$$$20240821$$CN$US$US
241365521$24136552$1$I$20240527$20240724$20240724$20240724$DIR$711367$$FDA-CTU$$66$YR$$M$N$$$20240724$N$PH$US$
241365531$24136553$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50987$$FDA-CTU$$63$YR$$M$N$$$20240724$N$$US$
241365541$24136554$1$I$20240715$20240719$20240724$20240724$DIR$FDA-CDER-CTU-2024-51124$$FDA-CTU$$71$YR$$F$N$$$20240719$N$PH$US$
241365551$24136555$1$I$20240629$20240724$20240724$20240724$DIR$711366$$FDA-CTU$$80$YR$$F$N$$$20240724$Y$PH$US$
241365561$24136556$1$I$20240709$20240724$20240724$20240724$DIR$711391$$FDA-CTU$$74$YR$$F$N$$$20240724$Y$HP$US$
241365571$24136557$1$I$20240722$20240722$20240725$20240725$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-102050$REGENERON$$$$$F$Y$$$20240725$$MD$DE$DE
241365591$24136559$1$I$20240701$20240711$20240725$20240725$PER$$US-Appco Pharma LLC-2159590$APPCO PHARMA$$77$YR$$F$Y$$$20240725$$$US$US
241365601$24136560$1$I$$20240722$20240725$20240725$PER$$US-TAKEDA-2024TUS074334$TAKEDA$$$$$$Y$$$20240725$$HP$US$US
241365612$24136561$2$F$$20240729$20240725$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117722$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240813$$HP$US$US
241365621$24136562$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117936$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240725$$HP$US$US
241365631$24136563$1$I$$20240724$20240725$20240725$EXP$$US-BAYER-2024A107578$BAYER$$57$YR$A$M$Y$$$20240725$$HP$US$US
241365641$24136564$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015289$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240725$$HP$US$US
241365651$24136565$1$I$20240701$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145403$AMGEN$$40$YR$A$F$Y$$$20240725$$CN$US$US
241365671$24136567$1$I$20240101$20240718$20240725$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-013582$UNITED THERAPEUTICS$$$$$M$Y$58.957$KG$20240725$$$US$US
241365681$24136568$1$I$$20240716$20240725$20240725$EXP$$US-AMERICAN REGENT INC-2024002820$AMERICAN REGENT$Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al.. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management.. Journal of Pediatric Orthopaedics B. 2024;33(4):407-410$$$$$Y$$$20240725$$MD$US$US
241365692$24136569$2$F$$20240731$20240725$20240806$PER$$US-ALXN-202407USA001299US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
241365701$24136570$1$I$20240101$20240718$20240725$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-022308$UNITED THERAPEUTICS$$$$$M$Y$64.853$KG$20240725$$$US$US
241365714$24136571$4$F$$20240826$20240725$20240903$30DAY$$AT-JNJFOC-20240745474$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$MD$AT$AT
241365721$24136572$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152592$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
241365731$24136573$1$I$$20240717$20240725$20240725$EXP$$CA-APOTEX-2024AP008541$APOTEX$$$$$M$Y$$$20240725$$MD$CA$CA
241365741$24136574$1$I$$20240719$20240725$20240725$EXP$$US-EMD Serono-2024039789$EMD SERONO INC$$$$E$M$Y$$$20240725$$CN$US$US
241365751$24136575$1$I$20240506$20240725$20240725$20240725$EXP$BE-FAMHP-DHH-N2024-122418$BE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041883$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$80$KG$20240725$$MD$BE$BE
241365761$24136576$1$I$$20240716$20240725$20240725$EXP$$US-AMGEN-USASP2024141816$AMGEN$Ignatowicz A. Transient Acquired Amegakaryocytic Thrombocytopenia in the Setting of Severe Sepsis: A Case Report. Cureus. 2024$57$YR$A$M$Y$$$20240725$$HP$US$US
241365771$24136577$1$I$20240525$20240722$20240725$20240725$EXP$$AU-BEH-2024176229$CSL BEHRING$$47$YR$A$F$Y$60$KG$20240725$$HP$AU$AU
241365781$24136578$1$I$20240717$20240723$20240725$20240725$EXP$$CN-PFIZER INC-PV202400096315$PFIZER$$25$YR$$F$Y$70$KG$20240725$$HP$CN$CN
241365791$24136579$1$I$20240601$20240723$20240725$20240725$EXP$$CN-PFIZER INC-PV202400096282$PFIZER$$31$YR$$F$Y$$$20240725$$HP$CN$CN
241365801$24136580$1$I$20240715$20240723$20240725$20240725$EXP$$CN-PFIZER INC-PV202400096281$PFIZER$$27$YR$$F$Y$58$KG$20240725$$HP$CN$CN
241365811$24136581$1$I$20240717$20240723$20240725$20240725$EXP$$CN-PFIZER INC-PV202400096299$PFIZER$$38$YR$$F$Y$60$KG$20240725$$HP$CN$CN
241365821$24136582$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51009$$FDA-CTU$$72$YR$$F$N$$$20240724$N$$US$
241365833$24136583$3$F$20240415$20240903$20240725$20240906$EXP$$US-PFIZER INC-202300457200$PFIZER$$68$YR$$F$Y$69.85$KG$20240906$$HP$US$US
241365842$24136584$2$F$20240701$20240903$20240725$20240905$EXP$$JP-PFIZER INC-PV202400096752$PFIZER$$68$YR$$M$Y$$$20240905$$MD$JP$JP
241365854$24136585$4$F$20240101$20240828$20240725$20240902$EXP$$US-PFIZER INC-202400222262$PFIZER$$69$YR$$F$Y$53.52$KG$20240902$$CN$US$US
241365861$24136586$1$I$20240704$20240723$20240725$20240725$EXP$FR-AFSSAPS-TS2024000844$FR-PFIZER INC-202400221707$PFIZER$$56$YR$$F$Y$70$KG$20240725$$MD$FR$FR
241365871$24136587$1$I$20240723$20240723$20240725$20240725$EXP$$JP-PFIZER INC-PV202400096738$PFIZER$$8$DEC$$M$Y$$$20240725$$MD$JP$JP
241365881$24136588$1$I$$20240719$20240725$20240725$EXP$$US-GSK-US2024091117$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241365901$24136590$1$I$20240403$20240710$20240725$20240725$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458569$RANBAXY$$65$YR$$F$Y$69$KG$20240725$$CN$FR$FR
241365911$24136591$1$I$20240724$20240724$20240724$20240724$DIR$711365$$FDA-CTU$$26$YR$$F$N$61.2$KG$20240724$N$CN$US$
241365921$24136592$1$I$20240628$20240716$20240725$20240725$EXP$FR-AFSSAPS-LL2024001261$FR-TEVA-VS-3221998$TEVA$$58$YR$$F$Y$62$KG$20240725$$MD$FR$FR
241365932$24136593$2$F$20240716$20240812$20240725$20240820$EXP$$US-JNJFOC-20240746246$JOHNSON AND JOHNSON$$64$YR$A$M$Y$57.204$KG$20240820$$PH$US$US
241365942$24136594$2$F$20220508$20240723$20240725$20240918$EXP$$DE-SANDOZ INC.-NVSC2022DE232048$SANDOZ$$72$YR$$F$Y$109.5$KG$20240918$$MD$DE$DE
241365951$24136595$1$I$20240719$20240719$20240725$20240725$PER$$US-UNITED THERAPEUTICS-UNT-2024-022467$UNITED THERAPEUTICS$$66$YR$$M$Y$120.18$KG$20240725$$$US$US
241365961$24136596$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50992$$FDA-CTU$$63$YR$$M$N$$$20240724$N$$US$
241365971$24136597$1$I$$20240724$20240725$20240725$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041873$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240725$$CN$US$US
241365991$24136599$1$I$$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003197$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241366001$24136600$1$I$$20240524$20240725$20240725$PER$$US-LUNDBECK-DKLU3078588$LUNDBECK$$$$$$Y$$$20240725$$CN$US$US
241366011$24136601$1$I$$20240716$20240725$20240725$EXP$$US-AMERICAN REGENT INC-2024002821$AMERICAN REGENT$Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al.. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management.. Journal of Pediatric Orthopaedics B. 2024;33(4):407-410$$$$$Y$$$20240725$$MD$US$US
241366031$24136603$1$I$20201029$20240711$20240725$20240725$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06658$HIKMA$Vittorio DM, Brigitta P, Alberto Z, Fabrizio Z, Paola T, Francesco B.. Vittorio DM, Brigitta P, Alberto Z, Fabrizio Z, Paola T, Francesco B. COVID-19 and lupus nephritis exacerbation in unvaccinated patients: a clinical case and literature review.. Italian Journal of Nephrology. 2024;3$28$YR$$F$Y$$$20240725$$MD$IT$IT
241366041$24136604$1$I$20240718$20240724$20240724$20240724$DIR$711368$$FDA-CTU$$42$YR$$M$N$$$20240724$N$$US$
241366051$24136605$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51094$$FDA-CTU$$73$YR$$F$N$$$20240724$N$$US$
241366081$24136608$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50981$$FDA-CTU$$56$YR$$F$N$$$20240724$N$$US$
241366103$24136610$3$F$$20240903$20240725$20240913$EXP$$US-GSK-US2024AMR091189$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
241366111$24136611$1$I$$20240715$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112493$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240725$$HP$US$US
241366121$24136612$1$I$20180928$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117874$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240725$$HP$US$US
241366131$24136613$1$I$20240723$20240723$20240725$20240725$EXP$$GB-MYLANLABS-2024M1068881$MYLAN$$76$YR$$F$Y$90$KG$20240725$$MD$GB$GB
241366151$24136615$1$I$$20240723$20240725$20240725$PER$$NVSC2024US151834$NOVARTIS$$$$$M$Y$$$20240725$$CN$US$US
241366161$24136616$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117962$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$52.16$KG$20240725$$CN$US$US
241366172$24136617$2$F$$20240730$20240725$20240730$EXP$$CA-BAYER-2024A107700$BAYER$$$$$F$Y$$$20240730$$MD$CA$CA
241366182$24136618$2$F$$20240801$20240725$20240826$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002774$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
241366191$24136619$1$I$$20240724$20240725$20240725$EXP$$US-ROCHE-10000035985$ROCHE$$$$C$M$Y$$$20240725$$CN$US$US
241366203$24136620$3$F$$20240724$20240725$20240806$EXP$$CA-HALEON-2188676$Haleon PLC$$$$$F$Y$$$20240805$$HP$CA$CA
241366211$24136621$1$I$20240717$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51016$$FDA-CTU$$43$YR$$F$N$$$20240724$N$HP$US$
241366221$24136622$1$I$20240719$20240723$20240725$20240725$EXP$$US-GILEAD-2024-0681716$GILEAD$$71$YR$E$F$Y$$$20240725$$CN$US$US
241366231$24136623$1$I$$20240627$20240725$20240725$PER$$US-SLATERUN-2024SRSPO00107$SLATE RUN$$$$$F$Y$$$20240725$$PH$US$US
241366251$24136625$1$I$20240306$20240710$20240725$20240725$EXP$$GB-AZURITY PHARMACEUTICALS, INC.-AZR202407-000128$AZURITY PHARMACEUTICALS$$60$YR$$$Y$77$KG$20240725$$CN$GB$GB
241366261$24136626$1$I$20240716$20240724$20240724$20240724$DIR$711407$$FDA-CTU$$47$YR$$F$N$$$20240724$N$CN$US$
241366271$24136627$1$I$20240409$20240415$20240725$20240725$PER$$US-MEITHEAL-2024MPSPO00098$MEITHEAL PHARMACEUTICALS$$63$YR$A$F$Y$$$20240725$$PH$US$US
241366282$24136628$2$F$$20240729$20240725$20240802$EXP$$GB-MYLANLABS-2024M1068416$MYLAN$$$$$M$Y$$$20240802$$CN$GB$GB
241366291$24136629$1$I$20240506$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50986$$FDA-CTU$$19$YR$$F$N$67$KG$20240724$N$PH$US$
241366302$24136630$2$F$20240101$20240912$20240725$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-022515$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240917$$$US$US
241366311$24136631$1$I$20240403$20240415$20240725$20240725$PER$$US-MEITHEAL-2024MPSPO00099$MEITHEAL PHARMACEUTICALS$$36$YR$A$F$Y$$$20240725$$PH$US$US
241366321$24136632$1$I$$20240723$20240725$20240725$EXP$$PL-GILEAD-2024-0681621$GILEAD$$65$YR$E$F$Y$$$20240725$$CN$PL$PL
241366331$24136633$1$I$$20240701$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003201$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240725$$CN$US$US
241366341$24136634$1$I$$20240626$20240725$20240725$EXP$$SG-ROCHE-10000010452$ROCHE$$77$YR$E$F$Y$$$20240725$$CN$SG$SG
241366361$24136636$1$I$20240403$20240415$20240725$20240725$PER$$US-MEITHEAL-2024MPSPO00100$MEITHEAL PHARMACEUTICALS$$58$YR$A$M$Y$$$20240725$$PH$US$US
241366371$24136637$1$I$20240701$20240723$20240725$20240725$EXP$$US-GILEAD-2024-0681757$GILEAD$$55$YR$A$F$Y$$$20240725$$CN$US$US
241366382$24136638$2$F$$20240715$20240725$20240925$PER$$US-GSK-US2024AMR089873$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
241366401$24136640$1$I$20231004$20240415$20240725$20240725$PER$$US-MEITHEAL-2024MPSPO00101$MEITHEAL PHARMACEUTICALS$$75$YR$E$F$Y$$$20240725$$PH$US$US
241366411$24136641$1$I$20240719$20240720$20240725$20240725$PER$$US-AMGEN-USASP2024145925$AMGEN$$63$YR$A$M$Y$$$20240725$$PH$US$US
241366421$24136642$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024AMR091971$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241366431$24136643$1$I$$20240603$20240725$20240725$PER$$US-MEITHEAL-2024MPSPO00159$MEITHEAL PHARMACEUTICALS$$$$$$Y$$$20240725$$HP$US$US
241366441$24136644$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50988$$FDA-CTU$$63$YR$$M$N$$$20240724$N$$US$
241366451$24136645$1$I$20240628$20240724$20240725$20240725$EXP$$ES-PFIZER INC-202400222605$PFIZER$$67$YR$$M$Y$65.5$KG$20240725$$HP$ES$ES
241366461$24136646$1$I$$20240724$20240725$20240725$EXP$GB-MHRA-MIDB-4642ce8c-7c42-43b6-9c96-2183271b92fa$GB-PFIZER INC-202400222909$PFIZER$$44$YR$$$Y$$$20240725$$PH$GB$GB
241366471$24136647$1$I$$20240611$20240725$20240725$PER$$US-MEITHEAL-2024MPSPO00175$MEITHEAL PHARMACEUTICALS$$$$$$Y$$$20240725$$HP$US$US
241366482$24136648$2$F$20240701$20240802$20240725$20240802$EXP$$CN-BAYER-2024A107760$BAYER$$85$YR$E$F$Y$55$KG$20240802$$HP$CN$CN
241366491$24136649$1$I$20240615$20240722$20240725$20240725$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-14625$IPSEN$$79$YR$E$M$Y$$$20240725$$HP$US$US
241366501$24136650$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51006$$FDA-CTU$$40$YR$$F$N$$$20240724$N$CN$US$
241366511$24136651$1$I$$20240611$20240725$20240725$PER$$US-MEITHEAL-2024MPSPO00176$MEITHEAL PHARMACEUTICALS$$$$$$Y$$$20240725$$HP$US$US
241366521$24136652$1$I$$20240716$20240725$20240725$EXP$$US-AMERICAN REGENT INC-2024002822$AMERICAN REGENT$Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al.. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management.. Journal of Pediatric Orthopaedics B. 2024;33(4):407-410$$$$$Y$$$20240725$$MD$US$US
241366531$24136653$1$I$$20240611$20240725$20240725$PER$$US-MEITHEAL-2024MPSPO00177$MEITHEAL PHARMACEUTICALS$$$$$$Y$$$20240725$$HP$US$US
241366542$24136654$2$F$20240627$20240807$20240725$20240808$PER$$US-AMGEN-USASP2024146896$AMGEN$$66$YR$E$F$Y$$$20240808$$CN$US$US
241366551$24136655$1$I$20240529$20240716$20240725$20240725$EXP$$FR-AUROBINDO-AUR-APL-2024-036086$AUROBINDO$$53$YR$$M$Y$90$KG$20240725$$MD$FR$FR
241366572$24136657$2$F$$20240725$20240725$20240801$EXP$$NVSC2024AU152030$NOVARTIS$$45$YR$$F$Y$$$20240801$$MD$AU$AU
241366591$24136659$1$I$20240719$20240724$20240724$20240724$DIR$711399$$FDA-CTU$$72$YR$$M$N$$$20240724$Y$PH$US$
241366601$24136660$1$I$$20240724$20240724$20240724$DIR$711401$$FDA-CTU$$72$YR$$F$N$$$20240724$N$PH$US$
241366615$24136661$5$F$20220101$20240923$20240725$20240925$EXP$$US-PFIZER INC-PV202400096952$PFIZER$$70$YR$$F$Y$$$20240925$$CN$US$US
241366621$24136662$1$I$$20240719$20240725$20240725$EXP$GB-MHRA-TPP49423561C11562390YC1721321484481$GB-RDY-SPO/GBR/24/0010784$DR REDDYS$$5$YR$C$M$Y$17$KG$20240725$$MD$GB$GB
241366631$24136663$1$I$20240712$20240724$20240724$20240724$DIR$711394$$FDA-CTU$$60$YR$$M$N$$$20240724$Y$HP$US$
241366641$24136664$1$I$20240601$20240724$20240725$20240725$EXP$FR-AFSSAPS-LY2024001030$FR-ROCHE-10000035443$ROCHE$$76$YR$E$F$Y$$$20240725$$PH$FR$FR
241366651$24136665$1$I$20240401$20240716$20240725$20240725$EXP$DK-DKMA-30730738$DK-TEVA-VS-3222009$TEVA$$78$YR$$M$Y$$$20240725$$HP$DK$DK
241366661$24136666$1$I$20240708$20240722$20240725$20240725$EXP$$CN-GILEAD-2024-0681604$GILEAD$$43$YR$A$F$Y$50$KG$20240725$$HP$CN$CN
241366671$24136667$1$I$$20240724$20240724$20240724$DIR$711403$$FDA-CTU$$$$$UNK$N$$$20240724$$CN$US$
241366682$24136668$2$F$$20240823$20240725$20240829$EXP$$CA-Orion Corporation ORION PHARMA-24_00031010$ORION$$73$YR$E$M$Y$$$20240829$$CN$CA$
241366691$24136669$1$I$20240212$20240715$20240725$20240725$EXP$ES-AEMPS-1544073$ES-MYLANLABS-2024M1066272$MYLAN$$72$YR$$M$Y$$$20240725$$MD$ES$ES
241366702$24136670$2$F$20240320$20240716$20240725$20240905$EXP$ES-AEMPS-1546464$ES-MYLANLABS-2024M1068302$MYLAN$$50$YR$$M$Y$$$20240905$$MD$ES$ES
241366711$24136671$1$I$20231201$20240718$20240725$20240725$EXP$$JP-VIATRISJAPAN-2024M1066967AA$MYLAN$Nakayama T, Kawamura M, Utsumi S, Takahashi T, Yago S, Suzuki N, et al. Three cases of duodenal ulcer haemorrhage with difficulty in endoscopic treatment. The 172nd Tohoku Regional Conference of The JGES. 2024;93$65$YR$$M$Y$$$20240725$$MD$JP$JP
241366721$24136672$1$I$$20240718$20240725$20240725$EXP$$US-MYLANLABS-2024M1068108$MYLAN$Abdelmajid HA, Mustafa GMA, Fernandez A, Franco SD, Esquibies AE, Valencia GB, et al. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring. Case-Rep-Perinat-Med 2024; 13 (1): 1-5.$45$DY$$M$Y$$$20240725$$MD$US$US
241366733$24136673$3$F$20240715$20240731$20240725$20240923$EXP$$US-BAXTER-2024BAX021848$BAXTER$$0$YR$$M$Y$$$20240923$$PH$US$US
241366741$24136674$1$I$20240312$20240718$20240725$20240725$EXP$$US-BAXTER-2024BAX022014$BAXTER$$$$$F$Y$$$20240725$$MD$US$US
241366751$24136675$1$I$20230401$20240718$20240725$20240725$EXP$CH-SM-2024-13325$CH-MYLANLABS-2024M1068260$MYLAN$$37$YR$$F$Y$$$20240725$$PH$CH$CH
241366761$24136676$1$I$20240405$20240718$20240725$20240725$EXP$$ES-MYLANLABS-2024M1067665$MYLAN$$48$YR$$M$Y$$$20240725$$MD$ES$ES
241366781$24136678$1$I$$20240715$20240725$20240725$EXP$$US-BAXTER-2024BAX021907$BAXTER$$15$YR$$M$Y$$$20240725$$PH$US$US
241366791$24136679$1$I$20240604$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003202$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240725$$CN$US$US
241366801$24136680$1$I$$20240719$20240725$20240725$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-116498$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$MD$AU$AU
241366811$24136681$1$I$$20240722$20240725$20240725$PER$$NVSC2024US152186$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
241366821$24136682$1$I$$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-51070$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241366831$24136683$1$I$20240724$20240724$20240724$20240724$DIR$711417$$FDA-CTU$$56$YR$$F$N$$$20240724$N$$US$
241366842$24136684$2$F$20240101$20240823$20240725$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-022649$UNITED THERAPEUTICS$$$$$M$Y$73.469$KG$20240829$$$US$US
241366851$24136685$1$I$$20240724$20240724$20240724$DIR$711404$$FDA-CTU$$$$$UNK$N$$$20240724$$CN$US$
241366861$24136686$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-202400222395$PFIZER$$$$A$F$Y$$$20240725$$CN$US$US
241366872$24136687$2$F$20240722$20240806$20240725$20240807$PER$$US-PFIZER INC-202400222452$PFIZER$$27$YR$$F$Y$64.399$KG$20240807$$HP$US$US
241366882$24136688$2$F$$20240824$20240725$20240826$PER$$US-PFIZER INC-PV202400096537$PFIZER$$78$YR$$$Y$$$20240826$$CN$US$US
241366892$24136689$2$F$20240628$20240919$20240725$20240924$PER$$US-PFIZER INC-202400209133$PFIZER$$11$YR$$F$Y$$$20240924$$CN$US$US
241366901$24136690$1$I$$20240724$20240725$20240725$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202407016141$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240725$$CN$CA$CA
241366911$24136691$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407013884$ELI LILLY AND CO$$$$$M$Y$$$20240725$$CN$US$US
241366921$24136692$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015938$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240725$$CN$US$US
241366932$24136693$2$F$20240723$20240723$20240725$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015333$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240726$$CN$US$US
241366941$24136694$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015191$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240725$$CN$US$US
241366951$24136695$1$I$$20240718$20240725$20240725$PER$$US-ALXN-A202311138$ALEXION PHARMACEUTICALS$$$$E$F$Y$$$20240725$$CN$US$US
241366961$24136696$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024AMR092031$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241366972$24136697$2$F$20240718$20240806$20240725$20240809$PER$$US-AMGEN-USASP2024145258$AMGEN$$70$YR$E$M$Y$$$20240809$$CN$US$US
241366981$24136698$1$I$20240722$20240724$20240725$20240725$EXP$$CN-BAYER-2024A107786$BAYER$$56$YR$A$F$Y$46.5$KG$20240725$$HP$CN$CN
241366991$24136699$1$I$$20240710$20240725$20240725$PER$$US-BAUSCH-BL-2024-010561$BAUSCH AND LOMB$$$$$M$Y$$$20240725$$MD$US$US
241367001$24136700$1$I$20240311$20240722$20240725$20240725$EXP$FR-AFSSAPS-LL2024001336$FR-GSK-FR2024092046$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$FR$FR
241367011$24136701$1$I$20240701$20240724$20240725$20240725$EXP$$US-UCBSA-2024037515$UCB$$56$YR$$F$Y$$$20240725$$CN$US$US
241367021$24136702$1$I$$20240724$20240725$20240725$PER$$US-PFIZER INC-PV202400096992$PFIZER$$64$YR$$F$Y$$$20240725$$HP$US$US
241367031$24136703$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-202400103868$PFIZER$$29$YR$$F$Y$$$20240725$$MD$US$US
241367041$24136704$1$I$$20240701$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003340$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241367051$24136705$1$I$$20240722$20240725$20240725$EXP$$CA-PFIZER INC-202400221946$PFIZER$$64$YR$$F$Y$$$20240725$$HP$CA$CA
241367061$24136706$1$I$$20240724$20240725$20240725$PER$$US-PFIZER INC-PV202400096773$PFIZER$$73$YR$$F$Y$$$20240725$$HP$US$US
241367071$24136707$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146923$AMGEN$$$$$$Y$$$20240725$$HP$US$US
241367081$24136708$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152585$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241367092$24136709$2$F$20231201$20240903$20240725$20240913$EXP$$CH-TAKEDA-2024TUS068267$TAKEDA$$68$YR$$M$Y$90$KG$20240913$$MD$CH$CH
241367101$24136710$1$I$$20240711$20240725$20240725$EXP$$CA-ROCHE-10000028602$ROCHE$$71$YR$E$M$Y$$$20240725$$MD$CA$CA
241367111$24136711$1$I$$20240702$20240725$20240725$EXP$$SG-ROCHE-10000028287$ROCHE$$66$YR$E$F$Y$$$20240725$$CN$SG$SG
241367121$24136712$1$I$$20240724$20240725$20240725$EXP$$US-TAKEDA-2024TUS059612$TAKEDA$$$$$F$Y$43$KG$20240725$$MD$US$US
241367131$24136713$1$I$$20240718$20240725$20240725$PER$$US-BEH-2024176152$CSL BEHRING$$$$A$F$Y$47.619$KG$20240725$$PH$US$US
241367142$24136714$2$F$$20240715$20240725$20240725$PER$$US-ROCHE-10000028965$ROCHE$$$$T$F$Y$$$20240725$$MD$US$US
241367151$24136715$1$I$20230401$20240724$20240725$20240725$EXP$$PL-ROCHE-10000036365$ROCHE$$75$YR$E$F$Y$$$20240725$$MD$PL$PL
241367161$24136716$1$I$20240501$20240715$20240725$20240725$EXP$ES-ABBVIE-5766430$ES-UCBSA-2024035755$UCB$$66$YR$$F$Y$58$KG$20240725$$CN$ES$ES
241367171$24136717$1$I$$20240712$20240725$20240725$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06831$LUPIN$Ghalayni R, Al Kalaji B, Malik K. From friend to foe: A case of naloxone-induced pulmonary edema. Hospital Pharmacy. 2024;59 (4):407-410$66$YR$$F$Y$$$20240725$$HP$US$US
241367181$24136718$1$I$20240501$20240716$20240725$20240725$EXP$$US-COLGATE PALMOLIVE COMPANY-20240701168$COLGATE$$69$YR$$F$Y$$$20240724$$CN$US$US
241367191$24136719$1$I$$20240722$20240725$20240725$EXP$$US-TAKEDA-2024TUS074223$TAKEDA$$$$$M$Y$$$20240725$$CN$US$US
241367201$24136720$1$I$$20240715$20240725$20240725$EXP$$MX-TRIS PHARMA, INC.-24MX011571$TRIS PHARM$Medina AR., Hammerness P, Ihyembe D, Plummer S, Diekroger E, Fogler J.. Complex ADHD Challenging Case: Managing Co-Occurring Attention- Deficit Hyperactivity Disorder and Congenital Heart Disease with a Limited Medication Formulary: A Case from Mexico. J Dev Behav Pediatr. 2024;45:e271-e273$$$$$Y$$$20240725$$MD$MX$MX
241367211$24136721$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51010$$FDA-CTU$$70$YR$$F$N$$$20240724$N$$US$
241367221$24136722$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50979$$FDA-CTU$$55$YR$$M$N$$$20240724$N$$US$
241367231$24136723$1$I$20240714$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-50990$$FDA-CTU$$80$YR$$M$N$$$20240723$N$HP$US$
241367241$24136724$1$I$20240630$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51019$$FDA-CTU$$96$YR$$M$N$$$20240724$N$$US$
241367251$24136725$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51008$$FDA-CTU$$60$YR$$F$N$$$20240724$N$$US$
241367261$24136726$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-50995$$FDA-CTU$$79$YR$$M$N$$$20240724$N$$US$
241367271$24136727$1$I$20240714$20240723$20240725$20240725$EXP$$NVSC2024CN152355$NOVARTIS$$14$YR$$M$Y$79$KG$20240725$$HP$CN$CN
241367292$24136729$2$F$$20240911$20240725$20240918$EXP$$GB-TAKEDA-2024TUS074191$TAKEDA$$$$$M$Y$$$20240918$$CN$GB$GB
241367301$24136730$1$I$$20240716$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092569$VIIV$$$$$$Y$$$20240725$$HP$US$US
241367312$24136731$2$F$$20240710$20240725$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113943$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240719$$MD$JP$JP
241367321$24136732$1$I$$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51149$$FDA-CTU$$$$$M$N$$$20240724$N$HP$US$
241367331$24136733$1$I$$20240719$20240725$20240725$PER$$US-ALXN-202407USA001356US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
241367341$24136734$1$I$$20240718$20240725$20240725$PER$$US-BAYER-2024A104912$BAYER$$35$YR$A$F$Y$$$20240725$$HP$US$US
241367351$24136735$1$I$$20240719$20240725$20240725$PER$$US-BAYER-2024A106071$BAYER$$$$$$Y$$$20240725$$CN$US$US
241367361$24136736$1$I$20240501$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51136$$FDA-CTU$$58$YR$$F$N$$$20240724$N$HP$US$
241367382$24136738$2$F$20240701$20240809$20240725$20240813$PER$$US-PFIZER INC-202400223087$PFIZER$$81$YR$$F$Y$51.71$KG$20240813$$CN$US$US
241367391$24136739$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-PV202400096255$PFIZER$$$$$$Y$$$20240725$$CN$US$US
241367401$24136740$1$I$$20240716$20240725$20240725$EXP$$US-AMERICAN REGENT INC-2024002823$AMERICAN REGENT$Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, et al.. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management.. Journal of Pediatric Orthopaedics B. 2024;33(4):407-410$$$$$Y$$$20240725$$MD$US$US
241367411$24136741$1$I$20240708$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51015$$FDA-CTU$$64$YR$$M$N$84$KG$20240724$N$$US$
241367422$24136742$2$F$$20240720$20240725$20240802$EXP$$US-MYLANLABS-2024M1068967$MYLAN$$16$YR$$M$Y$$$20240802$$CN$US$US
241367431$24136743$1$I$20240510$20240716$20240725$20240725$EXP$SE-SEMPA-2024-004563$SE-TEVA-VS-3222040$TEVA$$58$YR$$M$Y$74$KG$20240725$$MD$SE$SE
241367441$24136744$1$I$20240701$20240718$20240725$20240725$PER$$US-BAYER-2024A104927$BAYER$$54$YR$A$F$Y$$$20240725$$MD$US$US
241367451$24136745$1$I$$20240722$20240725$20240725$EXP$$JP-ABBVIE-5849718$ABBVIE$$60$YR$$M$Y$$$20240725$$MD$JP$JP
241367461$24136746$1$I$20240101$20240712$20240725$20240725$EXP$$US-UCBSA-2024032571$UCB$$$$$F$Y$$$20240725$$HP$US$US
241367471$24136747$1$I$$20240719$20240725$20240725$PER$$US-BAYER-2024A106467$BAYER$$$$$F$Y$$$20240725$$CN$US$US
241367481$24136748$1$I$20240712$20240716$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003595$ACADIA PHARMACEUTICALS$$5$YR$$F$Y$$$20240725$$CN$US$US
241367491$24136749$1$I$20211105$20240722$20240725$20240725$EXP$ES-AEMPS-1549197$ES-GILEAD-2024-0681491$GILEAD$$62$YR$A$F$Y$48$KG$20240725$$MD$ES$ES
241367501$24136750$1$I$20240705$20240716$20240725$20240725$EXP$CN-SA-SAC20240722000301$CN-SA-2024SA212997$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240725$$HP$CN$CN
241367511$24136751$1$I$20240101$20240719$20240725$20240725$PER$$US-BAYER-2024A105439$BAYER$$32$YR$A$F$Y$$$20240725$$CN$US$US
241367521$24136752$1$I$$20240717$20240725$20240725$EXP$$CA-MYLANLABS-2024M1067880$MYLAN$$32$YR$$F$Y$$$20240725$$CN$CA$CA
241367534$24136753$4$F$$20240925$20240725$20240930$EXP$$EC-PFIZER INC-PV202400093827$PFIZER$Llerena-Rengel, P.. Organic failure secondary to methotrexate poisoning, is dialysis an alternative? Case report. Mexican Journal of Oncology. 2024;23 (Supl):31-35$45$YR$$M$Y$67$KG$20240930$$HP$EC$EC
241367541$24136754$1$I$$20240718$20240725$20240725$PER$$US-ABBVIE-5848835$ABBVIE$$$$$$Y$$$20240725$$CN$US$US
241367551$24136755$1$I$$20240719$20240725$20240725$PER$$US-BAYER-2024A106468$BAYER$$$$$$Y$$$20240725$$CN$US$US
241367561$24136756$1$I$$20240719$20240725$20240725$PER$$US-BAYER-2024A105507$BAYER$$45$YR$A$F$Y$$$20240725$$MD$US$US
241367571$24136757$1$I$$20240722$20240725$20240725$EXP$$PL-PFIZER INC-202400220514$PFIZER$Panejko, A.. Life-saving treatment with anakinra in severe relapse of Still disease with perimyocarditis and aseptic pneumonia.. Pol Arch Intern Med.. 2024;134(6):16725$27$YR$$M$Y$$$20240725$$MD$PL$PL
241367581$24136758$1$I$20240601$20240719$20240725$20240725$PER$$US-BAYER-2024A105509$BAYER$$37$YR$A$F$Y$$$20240725$$MD$US$US
241367592$24136759$2$F$20240401$20240723$20240725$20240729$EXP$DE-CADRBFARM-2024329281$DE-RDY-SPO/DEU/24/0010437$DR REDDYS$$67$YR$E$F$Y$85$KG$20240729$$MD$DE$DE
241367601$24136760$1$I$$20240718$20240725$20240725$EXP$$US-SA-2024SA215879$SANOFI AVENTIS$$$$A$F$Y$117$KG$20240725$$MD$US$US
241367611$24136761$1$I$$20240720$20240725$20240725$EXP$$US-SA-2024SA216260$SANOFI AVENTIS$$$$E$M$Y$$$20240725$$MD$US$US
241367623$24136762$3$F$20240712$20240826$20240725$20240905$EXP$$US-BEH-2024175907$CSL BEHRING$$38$YR$A$F$Y$$$20240905$$HP$US$US
241367631$24136763$1$I$$20240715$20240725$20240725$EXP$$US-RDY-LIT/USA/24/0010700$DR REDDYS$Ozer S, Farabi B, Kann R, Atak MF, Shulman K, Marmon S. Refractory antimelanoma differentiation-associated gene 5 antibody negative ulcerative dermatomyositis responsive to mycophenolate mofetil. JAAD Case. 2024;50: 1-3. doi:10.1016/j.jdcr.2024.05.017.$52$YR$A$F$Y$$$20240725$$MD$US$US
241367641$24136764$1$I$$20240715$20240725$20240725$EXP$$DE-RDY-LIT/DEU/24/0010701$DR REDDYS$Kohle F, Wunderlich G, Fink GR, Schroeter M, Lehmann HC, Schneider C. Rituximab in non-systemic vasculitic neuropathy: a single-center experience. Journal of Neurology. 2024 Jul;271(7): 4406-4411. doi:10.1007/s00415-024-12378-1.$$$A$$Y$$$20240725$$HP$DE$DE
241367651$24136765$1$I$$20240720$20240725$20240725$PER$$US-BAYER-2024A106070$BAYER$$$$$$Y$$$20240725$$CN$US$US
241367661$24136766$1$I$$20240721$20240725$20240725$PER$$US-AMGEN-USASP2024145301$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241367671$24136767$1$I$20240720$20240722$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116514$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240725$$CN$US$US
241367681$24136768$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116298$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$75$KG$20240725$$PH$US$US
241367691$24136769$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117022$BRISTOL MYERS SQUIBB$$64$YR$A$$Y$$$20240725$$MD$US$US
241367702$24136770$2$F$20240606$20240816$20240725$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117861$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240826$$PH$US$US
241367711$24136771$1$I$20240715$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51012$$FDA-CTU$$76$YR$$M$N$135.3$KG$20240724$N$$US$
241367722$24136772$2$F$$20240715$20240725$20240730$EXP$$IL-TEVA-VS-3221475$TEVA$$41$YR$$F$Y$$$20240730$$CN$IL$IL
241367731$24136773$1$I$20240719$20240719$20240725$20240725$PER$$US-BAYER-2024A105511$BAYER$$38$YR$A$F$Y$$$20240725$$MD$US$US
241367741$24136774$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015105$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240725$$CN$US$US
241367751$24136775$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015352$ELI LILLY AND CO$$58$YR$A$$Y$$$20240725$$CN$US$US
241367761$24136776$1$I$20240701$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015459$ELI LILLY AND CO$$$$$$Y$$$20240725$$CN$US$US
241367771$24136777$1$I$20240718$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51011$$FDA-CTU$$64$YR$$M$N$103.9$KG$20240724$N$$US$
241367781$24136778$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015287$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240725$$CN$US$US
241367791$24136779$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015087$ELI LILLY AND CO$$52$YR$A$$Y$$$20240725$$CN$US$US
241367801$24136780$1$I$$20240719$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116939$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240725$$CN$US$US
241367811$24136781$1$I$$20240711$20240725$20240725$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008433$ELI LILLY AND CO$$$$$$Y$$$20240725$$PH$US$US
241367821$24136782$1$I$20240201$20240718$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407013060$ELI LILLY AND CO$$65$YR$E$$Y$$$20240725$$CN$US$US
241367832$24136783$2$F$$20240724$20240725$20240729$EXP$$US-PFIZER INC-202400222307$PFIZER$Xia, J.. Rapidly progressive locked-in syndrome secondary to atypical herpes simplex virus-1 rhombencephalitis in an immunocompromised individual. IDCases. 2024;37:10.1016/j.idcr.2024.e02027$61$YR$$M$Y$$$20240729$$MD$US$US
241367841$24136784$1$I$$20240723$20240725$20240725$EXP$$CA-TAKEDA-2021TUS079996$TAKEDA$$$$$F$Y$$$20240725$$CN$CA$CA
241367851$24136785$1$I$$20240722$20240725$20240725$EXP$$TR-UCBSA-2024037503$UCB$Demiral GZ, Akin SB, Gunday OK, Sahbaz FG, Boru UT. Maternal and fetal outcomes of antiepileptic treatments during pregnancy: A retrospective study. Epilepsy + behavior. 2024;158:1-7$$$N$$Y$$$20240725$$HP$TR$TR
241367863$24136786$3$F$$20240912$20240725$20240920$EXP$$TH-EXELIXIS-CABO-24076230$EXELIXIS$$39$YR$$M$Y$$$20240920$$CN$TH$TH
241367871$24136787$1$I$$20240719$20240725$20240725$EXP$GB-MHRA-MED-202407191204055840-HSDLT$GB-KEDRION-009550$KEDRION$$52$YR$$F$Y$61$KG$20240725$$HP$GB$GB
241367881$24136788$1$I$$20240723$20240725$20240725$PER$$US-BAYER-2024A107280$BAYER$$$$$$Y$$$20240725$$CN$US$US
241367895$24136789$5$F$20230401$20240919$20240725$20240923$EXP$$US-SA-2024SA214369$SANOFI AVENTIS$$$$$F$Y$$$20240923$$CN$US$US
241367911$24136791$1$I$20240601$20240722$20240725$20240725$EXP$FR-AFSSAPS-LL2024001392$FR-EXELIXIS-CABO-24079809$EXELIXIS$$46$YR$$M$Y$$$20240725$$MD$FR$FR
241367921$24136792$1$I$$20240724$20240725$20240725$PER$$US-BAYER-2024A107718$BAYER$$$$$$Y$$$20240725$$CN$US$US
241367931$24136793$1$I$20240614$20240716$20240725$20240725$EXP$PT-INFARMED-R202407-61$PT-TEVA-VS-3222173$TEVA$$77$YR$$F$Y$$$20240725$$MD$PT$PT
241367941$24136794$1$I$$20230301$20240725$20240725$EXP$$US-Appco Pharma LLC-2159591$APPCO PHARMA$Initial$64$YR$$M$Y$$$20240725$$$US$US
241367951$24136795$1$I$$20240715$20240725$20240725$EXP$$US-CELLTRION INC.-2024US017501$CELLTRION$Kaseb A, Chamseddine S, LaPelusa M, Carter K, Nguyen V, Mohamed YI et. al. Severe febrile neutropenia and pancytopenia in a patient with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: a case report. Journal of Gastrointestinal Oncology. 2024;15(3):1324-1330$$$$$Y$$$20240725$$MD$US$US
241367961$24136796$1$I$$20240722$20240725$20240725$EXP$$TR-SA-2024SA214873$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240725$$HP$TR$TR
241367971$24136797$1$I$$20240724$20240725$20240725$PER$$US-BAYER-2024A107927$BAYER$$$$$$Y$$$20240725$$CN$US$US
241367981$24136798$1$I$$20240716$20240725$20240725$EXP$$MA-EMD Serono-2024038895$EMD SERONO INC$Mourabiti H, Hoummani H, Amrani HS, Achour S, Belahsen F, Esayh G, et al. Paraparesis secondary to metformin: A rare condition to be aware of, with characteristic MRI images. analytical and clinical toxicology. 2024 Jul 04;3-5. doi:https://doi.org/10.1016/j.toxac.2024.06.001.$63$YR$A$F$Y$$$20240725$$HP$MA$MA
241367991$24136799$1$I$$20240715$20240725$20240725$EXP$$IN-ROCHE-10000033143$ROCHE$Kakkar D, Singh A, Pillai RH, Panda T, Palatty RJ, Halder R, et al. A tertiary care centre experience with Elranatamab: A report of three cases. Leukemia Research Reports. 2024;21:100466. DOI: 10.1016/j.lrr.2024.100466.$4$DEC$A$M$Y$$$20240725$$HP$IN$IN
241368001$24136800$1$I$$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51140$$FDA-CTU$$$$$M$N$$$20240724$N$HP$US$
241368041$24136804$1$I$20240721$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51135$$FDA-CTU$$64$YR$$M$N$$$20240725$N$$US$
241368061$24136806$1$I$20230101$20240722$20240725$20240725$EXP$FR-AFSSAPS-PA2024001271$FR-SA-2024SA215303$SANOFI AVENTIS$$55$YR$A$F$Y$64$KG$20240725$$MD$FR$FR
241368071$24136807$1$I$$20240715$20240725$20240725$EXP$$AU-TAKEDA-2024TUS074345$TAKEDA$$$$E$F$Y$$$20240725$$HP$AU$AU
241368081$24136808$1$I$$20240721$20240725$20240725$PER$$US-ABBVIE-5852421$ABBVIE$$$$$$Y$$$20240725$$CN$US$US
241368091$24136809$1$I$20240614$20240722$20240725$20240725$EXP$$CN-PFIZER INC-PV202400095782$PFIZER$$67$YR$$F$Y$$$20240725$$HP$CN$CN
241368101$24136810$1$I$20240527$20240719$20240725$20240725$EXP$$ES-PFIZER INC-202400220412$PFIZER$$62$YR$$M$Y$$$20240725$$PH$ES$ES
241368111$24136811$1$I$20240101$20240722$20240725$20240725$EXP$IT-MINISAL02-995889$IT-PFIZER INC-202400220220$PFIZER$$39$YR$$F$Y$$$20240725$$MD$IT$IT
241368121$24136812$1$I$$20240719$20240725$20240725$EXP$$DE-AMERICAN REGENT INC-2024002799$AMERICAN REGENT$$$$$M$Y$$$20240725$$MD$DE$DE
241368131$24136813$1$I$$20240718$20240725$20240725$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006303$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241368142$24136814$2$F$20240725$20240913$20240725$20240924$EXP$$CA-LUNDBECK-DKLU4001979$LUNDBECK$$$$$$Y$$$20240924$$CN$CA$CA
241368151$24136815$1$I$$20240717$20240725$20240725$PER$$US-009507513-2407USA001433$MERCK$$$$$$Y$51.7$KG$20240725$$PH$US$US
241368161$24136816$1$I$20240618$20240724$20240725$20240725$EXP$HR-HALMED-300086198$HR-TAKEDA-2024TUS074752$TAKEDA$$46$YR$$M$Y$$$20240725$$HP$HR$HR
241368172$24136817$2$F$$20240801$20240725$20240807$PER$$US-ABBVIE-5849331$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241368181$24136818$1$I$$20240715$20240725$20240725$PER$$SA-Eisai-EC-2024-170443$EISAI$Sulais A, Alhedaithy A, Alghamdi F, Ad-Dab^bagh Y. On Seizures and Knives: Perampanel-Induced  Psychosis: A Case Report and Literature Review. Journal of epilepsy research. 2024;37-41. doi:10.14581/jer.24006.$15$YR$T$F$Y$$$20240725$$MD$SA$SA
241368191$24136819$1$I$20240723$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024147282$AMGEN$$62$YR$A$F$Y$$$20240725$$PH$US$US
241368221$24136822$1$I$$20240719$20240725$20240725$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006301$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$MD$US$US
241368232$24136823$2$F$20240615$20240729$20240725$20240807$EXP$$ES-RICHTER-2024-GR-006977$SUNOVION$$$$$$Y$$$20240807$$MD$ES$ES
241368241$24136824$1$I$$20240723$20240725$20240725$DIR$FDA-CDER-CTU-2024-51146$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241368251$24136825$1$I$20240712$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116784$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$141.4$KG$20240725$$PH$US$US
241368261$24136826$1$I$20240501$20240723$20240725$20240725$DIR$FDA-CDER-CTU-2024-51139$$FDA-CTU$$84$YR$$F$N$$$20240723$N$HP$US$
241368271$24136827$1$I$$20240719$20240725$20240725$EXP$$US-LUNDBECK-DKLU4001980$LUNDBECK$$$$$$Y$$$20240725$$HP$US$US
241368281$24136828$1$I$$20240719$20240725$20240725$PER$$US-BAYER-2024A105546$BAYER$$36$YR$A$F$Y$$$20240725$$HP$US$US
241368291$24136829$1$I$$20240719$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116075$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240725$$HP$US$US
241368301$24136830$1$I$$20240710$20240725$20240725$EXP$$IL-GRANULES-IL-2024GRALIT00295$GRANULES INDIA$Joseph Zohar.Off-label higher doses of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Safety and tolerability.Comprehensive Psychiatry.2024;133:1-6$$$$$Y$$$20240725$$HP$IL$IL
241368311$24136831$1$I$$20240716$20240725$20240725$30DAY$$US-GSK-US2024089546$GLAXOSMITHKLINE$$$$A$F$Y$$$20240725$$CN$US$US
241368321$24136832$1$I$$20240723$20240725$20240725$EXP$$GR-PFIZER INC-2023SGN13576$PFIZER$$$$$F$Y$$$20240725$$MD$GR$GR
241368331$24136833$1$I$$20240723$20240725$20240725$EXP$$GR-PFIZER INC-2023SGN02197$PFIZER$$36$YR$$F$Y$$$20240725$$MD$GR$GR
241368341$24136834$1$I$$20240723$20240725$20240725$EXP$$CA-ORGANON-O2407CAN002172$ORGANON$$$$$F$Y$$$20240725$$HP$CA$CA
241368351$24136835$1$I$$20240627$20240725$20240725$PER$$US-TOLMAR, INC.-24US050669$TOLMAR$$$$$$Y$$$20240725$$MD$US$US
241368361$24136836$1$I$20240617$20240701$20240725$20240725$PER$$US-TOLMAR, INC.-24US050429$TOLMAR$$$$$M$Y$$$20240725$$CN$US$US
241368371$24136837$1$I$20240701$20240701$20240725$20240725$PER$$US-TOLMAR, INC.-24US050704$TOLMAR$$10$YR$$F$Y$$$20240725$$PH$US$US
241368381$24136838$1$I$$20240628$20240725$20240725$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03493$HIKMA$$$$$$Y$$$20240725$$HP$US$US
241368391$24136839$1$I$$20231010$20240725$20240725$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64939$HIKMA$$$$$F$Y$$$20240725$$CN$US$US
241368401$24136840$1$I$$20240719$20240725$20240725$PER$$US-BAYER-2024A105634$BAYER$$$$$F$Y$$$20240725$$CN$US$US
241368411$24136841$1$I$$20240101$20240725$20240725$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00085$HIKMA$$$$$M$Y$$$20240725$$CN$US$US
241368422$24136842$2$F$20240722$20240822$20240725$20240905$PER$$US-JNJFOC-20240758277$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240905$$HP$US$US
241368432$24136843$2$F$$20240808$20240725$20240814$30DAY$$GB-JNJFOC-20240744833$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$GB$GB
241368462$24136846$2$F$20240719$20240802$20240725$20240809$PER$$US-BAYER-2024A107368$BAYER$$26$YR$A$F$Y$$$20240809$$HP$US$US
241368481$24136848$1$I$$20240718$20240725$20240725$EXP$$FR-TAKEDA-2024TUS074812$TAKEDA$$56$YR$$F$Y$$$20240725$$MD$FR$FR
241368491$24136849$1$I$$20240724$20240725$20240725$PER$$US-BAYER-2024A108080$BAYER$$$$$F$Y$$$20240725$$CN$US$US
241368501$24136850$1$I$20240626$20240722$20240725$20240725$EXP$$US-GILEAD-2024-0676358$GILEAD$$73$YR$E$F$Y$$$20240725$$CN$US$US
241368511$24136851$1$I$$20240530$20240725$20240725$PER$$US-LUNDBECK-DKLU4000106$LUNDBECK$$$$$$Y$$$20240725$$CN$US$US
241368522$24136852$2$F$$20240819$20240725$20240823$PER$$US-JNJFOC-20240758092$JOHNSON AND JOHNSON$$68$YR$E$F$Y$113.5$KG$20240823$$HP$US$US
241368531$24136853$1$I$$20240710$20240725$20240725$EXP$$BG-GRANULES-BG-2024GRALIT00293$GRANULES INDIA$Z Vassileva.Fetal ductal constriction caused by SSRI: A case report. Journal of Clinical Ultrasound.JAN-2024;1-4$$$$F$Y$$$20240725$$HP$BG$BG
241368541$24136854$1$I$$20210130$20240725$20240725$EXP$$DE-DSJP-DSJ-2021-104716$DAIICHI$$$$A$F$Y$$$20240725$$MD$DE$DE
241368551$24136855$1$I$20240719$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145883$AMGEN$$$$$F$Y$$$20240725$$PH$US$US
241368561$24136856$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146723$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241368582$24136858$2$F$20240701$20240720$20240725$20240725$EXP$$US-AMGEN-USASP2024145940$AMGEN$$$$$$Y$$$20240725$$MD$US$US
241368591$24136859$1$I$20240722$20240724$20240724$20240724$DIR$711415$$FDA-CTU$$25$YR$$F$N$92.25$KG$20240724$N$CN$US$
241368601$24136860$1$I$$20240717$20240725$20240725$EXP$AU-TGA-0000812477$NVSC2024AU150082$NOVARTIS$$$$$F$Y$$$20240725$$CN$AU$AU
241368611$24136861$1$I$$20240718$20240725$20240725$PER$$US-ALXN-202407USA001360US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241368632$24136863$2$F$$20240715$20240725$20240807$EXP$$JP-TEVA-VS-3222406$TEVA$Takei S, Kinoshita H, Jamal M, Yamashita T, Tanaka E, Kawahara S, et al. An autopsy case of intoxication caused by drug interaction with multiple psychotropic drugs, fluvoxamine, levomepromazine, and trihexyphenidyl. Leg-Med-Tokyo 2024; 70 (0): 102482.; Takei S, Kinoshita H, Jamal M, Yamashita T, Tanaka E, Kawahara S, et al. An autopsy case of intoxication caused by drug interaction with multiple psychotropic drugs, fluvoxamine, levomepromazine, and trihexyphenidyl. Leg-Med-Tokyo 2024; 70 (0)...$$$A$F$Y$40$KG$20240807$$HP$JP$JP
241368641$24136864$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016022$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240725$$CN$US$US
241368651$24136865$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015293$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240725$$CN$US$US
241368663$24136866$3$F$20240201$20240821$20240725$20240830$EXP$$JP-CELLTRION INC.-2024JP017808$CELLTRION$Kawamura K, Yoko Y, Ishii A, Ishikura K, Minami K, Tamura K.. A case of drug-induced abdominal aortic thrombosis in which a pharmacist supported administration of warfarin in view of drug interactions. The 13th Annual Academic Meeting of the Tohoku Block of the Japanese Society of. 2024;191$$$$$Y$$$20240830$$PH$JP$JP
241368681$24136868$1$I$20240712$20240716$20240725$20240725$PER$$US-INCYTE CORPORATION-2024IN007518$INCYTE$$$$$$Y$$$20240725$$CN$US$US
241368691$24136869$1$I$20240527$20240718$20240725$20240725$EXP$$US-RIGEL-20240600057$RIGEL PHARMACEUTICALS$$64$YR$$M$Y$$$20240725$$CN$US$US
241368701$24136870$1$I$$20240710$20240725$20240725$EXP$$US-GRANULES-US-2024GRALIT00286$GRANULES INDIA$M. Singh.Lamotrigine Induced Drug Reaction With Eosinophilia With Systemic Symptoms (DRESS)With HHV-6 Reactivation Causing Severe Encephalitis and Status Epilepticus.American Journal of Respiratory and Critical Care Medicine.2024;209:A3158$18$YR$T$F$Y$$$20240725$$HP$US$US
241368712$24136871$2$F$$20240726$20240725$20240730$EXP$$US-AMGEN-USASP2024145083$AMGEN$El Jurdi N.; Herzog S.; Shanley R. et al.. Treatment-Responsive Acute Graft-versus-Host Disease after Post- Transplantation Cyclophosphamide-Based Prophylaxis: Incidence and Clinical Outcomes. Transplantation and Cellular Therapy. 2024;30 (7):688.e1-688.e9$$$$$Y$$$20240730$$MD$US$US
241368721$24136872$1$I$20240701$20240716$20240725$20240725$EXP$$US-ARGENX-2024-ARGX-US005453$ARGENX BVBA$$$$$$Y$$$20240725$$CN$US$US
241368741$24136874$1$I$$20240718$20240725$20240725$PER$$US-BAYER-2024A105345$BAYER$$$$$$Y$$$20240725$$HP$US$US
241368751$24136875$1$I$$20240717$20240725$20240725$EXP$$AU-TORRENT-00000549$TORRENT$$25$YR$A$F$Y$$$20240725$$CN$AU$AU
241368763$24136876$3$F$20240709$20240813$20240725$20240829$EXP$$US-BAYER-2024A107060$BAYER$$75$YR$E$F$Y$$$20240829$$CN$US$US
241368771$24136877$1$I$$20240712$20240725$20240725$EXP$$US-Accord-436439$ACCORD$$$$$F$Y$118.39$KG$20240725$$MD$US$US
241368781$24136878$1$I$$20240717$20240725$20240725$EXP$$AU-TORRENT-00000550$TORRENT$$51$YR$A$M$Y$$$20240725$$CN$AU$AU
241368791$24136879$1$I$20230601$20240722$20240725$20240725$EXP$DE-CADRBFARM-2024329316$DE-TORRENT-00027055$TORRENT$$32$YR$A$M$Y$60$KG$20240725$$CN$DE$DE
241368801$24136880$1$I$$20240716$20240725$20240725$EXP$$DE-TORRENT-00027037$TORRENT$$38$YR$A$M$Y$$$20240725$$HP$DE$DE
241368811$24136881$1$I$$20240717$20240725$20240725$EXP$GB-MHRA-MED-202407170959334590-PCSYF$GB-TORRENT-00037292$TORRENT$$69$YR$E$F$Y$$$20240725$$HP$GB$GB
241368821$24136882$1$I$$20240722$20240725$20240725$EXP$$US-GILEAD-2024-0681212$GILEAD$$$$E$M$Y$$$20240725$$CN$US$US
241368831$24136883$1$I$20240503$20240717$20240725$20240725$EXP$GB-MHRA-MED-202407172153053820-VQFYM$GB-TORRENT-00037294$TORRENT$$36$YR$A$F$Y$62$KG$20240725$$CN$GB$GB
241368841$24136884$1$I$20210101$20240717$20240725$20240725$EXP$GB-MHRA-MED-202407170207018590-HQMJK$GB-TORRENT-00037289$TORRENT$$34$YR$A$M$Y$80$KG$20240725$$CN$GB$GB
241368851$24136885$1$I$20240718$20240718$20240725$20240725$EXP$GB-MHRA-MED-202407180743068270-GHYWV$GB-TORRENT-00037298$TORRENT$$63$YR$A$M$Y$69$KG$20240725$$CN$GB$GB
241368861$24136886$1$I$20140101$20240716$20240725$20240725$EXP$GB-ELI_LILLY_AND_COMPANY-GB202407005819$GB-TORRENT-00037288$TORRENT$$$$A$M$Y$73$KG$20240725$$MD$GB$GB
241368871$24136887$1$I$$20240719$20240725$20240725$EXP$GB-MHRA-TPP11996333C8869821YC1721150757586$GB-TORRENT-00037306$TORRENT$$86$YR$E$F$Y$68$KG$20240725$$HP$GB$GB
241368882$24136888$2$F$$20240719$20240725$20240729$EXP$$IN-TORRENT-00003612$TORRENT$$55$YR$A$M$Y$$$20240729$$MD$IN$IN
241368901$24136890$1$I$$20240717$20240725$20240725$EXP$$US-TORRENT-00013689$TORRENT$$$$$M$Y$$$20240725$$CN$US$US
241368911$24136891$1$I$$20240716$20240725$20240725$EXP$$US-TORRENT-00013687$TORRENT$$24$YR$A$M$Y$$$20240725$$MD$US$US
241368921$24136892$1$I$20240717$20240717$20240725$20240725$PER$$US-ABBVIE-5846051$ABBVIE$$27$YR$$F$Y$$$20240725$$PH$US$US
241368931$24136893$1$I$$20240722$20240725$20240725$EXP$$ID-BAYER-2024A106473$BAYER$$$$$$Y$$$20240725$$MD$ID$ID
241368942$24136894$2$F$20240713$20240726$20240725$20240803$EXP$$PL-TEVA-VS-3223938$TEVA$$85$YR$$M$Y$$$20240803$$CN$PL$PL
241368952$24136895$2$F$20240716$20240729$20240725$20240802$EXP$$US-BAYER-2024A106769$BAYER$$63$YR$A$M$Y$$$20240802$$CN$US$US
241368961$24136896$1$I$$20240716$20240725$20240725$EXP$$AU-TEVA-VS-3223300$TEVA$$79$YR$$M$Y$$$20240725$$HP$AU$AU
241368971$24136897$1$I$$20240718$20240725$20240725$EXP$$US-RDY-SPO/USA/24/0010777$DR REDDYS$$76$YR$E$M$Y$$$20240725$$CN$US$US
241368981$24136898$1$I$20240716$20240716$20240725$20240725$EXP$GB-MHRA-MED-202407161419025260-TJVZM$GB-TEVA-VS-3222280$TEVA$$51$YR$$F$Y$$$20240725$$HP$GB$GB
241368991$24136899$1$I$20240624$20240718$20240725$20240725$EXP$$CA-BEH-2024176026$CSL BEHRING$$41$YR$A$F$Y$103.4$KG$20240725$$CN$CA$CA
241369001$24136900$1$I$20240514$20240611$20240725$20240725$PER$$US-JNJFOC-20240764381$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240725$$PH$US$US
241369011$24136901$1$I$$20240723$20240725$20240725$EXP$GB-MHRA-31183392$GB-MYLANLABS-2024M1068883$MYLAN$$$$$F$Y$$$20240725$$PH$GB$GB
241369021$24136902$1$I$$20240715$20240725$20240725$EXP$$CA-GALDERMA-CA2024011454$GALDERMA$$$$$$Y$$$20240725$$HP$CA$CA
241369033$24136903$3$F$20240701$20240725$20240725$20240812$EXP$$US-Eisai-EC-2024-170758$EISAI$$62$YR$A$F$Y$108.6$KG$20240812$$CN$US$US
241369041$24136904$1$I$$20230301$20240725$20240725$EXP$$US-Appco Pharma LLC-2159593$APPCO PHARMA$Initial$38$YR$$M$Y$$$20240725$$$US$US
241369051$24136905$1$I$$20240718$20240725$20240725$PER$$US-ALXN-202407USA001355US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
241369061$24136906$1$I$20240712$20240722$20240725$20240725$EXP$$CN-BAYER-2024A106694$BAYER$$57$YR$A$M$Y$70$KG$20240725$$HP$CN$CN
241369071$24136907$1$I$20240704$20240718$20240725$20240725$PER$$US-AMGEN-USASP2024144400$AMGEN$$84$YR$E$M$Y$$$20240725$$CN$US$US
241369091$24136909$1$I$20240724$20240724$20240724$20240724$DIR$711419$$FDA-CTU$$9$YR$$M$N$33.75$KG$20240724$N$HP$US$
241369111$24136911$1$I$20240719$20240724$20240724$20240724$DIR$711423$$FDA-CTU$$68$YR$$M$N$87.54$KG$20240724$N$HP$US$
241369141$24136914$1$I$20240701$20240724$20240725$20240725$PER$$US-BAYER-2024A107690$BAYER$$77$YR$E$M$Y$$$20240725$$CN$US$US
241369151$24136915$1$I$20230710$20240724$20240724$20240724$DIR$711408$$FDA-CTU$$$$$F$N$$$20240724$Y$CN$US$
241369162$24136916$2$F$$20240815$20240725$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118107$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$114.76$KG$20240816$$CN$US$US
241369171$24136917$1$I$$20240719$20240725$20240725$PER$$US-BAYER-2024A106210$BAYER$$$$$$Y$$$20240725$$CN$US$US
241369181$24136918$1$I$$20240722$20240725$20240725$EXP$$CA-BAYER-2024A107580$BAYER$$88$YR$E$F$Y$71$KG$20240725$$PH$CA$CA
241369191$24136919$1$I$$20240723$20240725$20240725$PER$$US-GILEAD-2024-0681735$GILEAD$$52$YR$A$F$Y$$$20240725$$PH$US$US
241369212$24136921$2$F$20240701$20240822$20240725$20240823$30DAY$$AR-PFIZER INC-202400214939$PFIZER$$5$YR$$M$Y$$$20240823$$CN$AR$AR
241369221$24136922$1$I$20240722$20240724$20240724$20240724$DIR$711421$$FDA-CTU$$30$YR$$M$N$83.25$KG$20240724$N$CN$US$
241369231$24136923$1$I$$20240723$20240725$20240725$PER$$US-HALEON-2188614$Haleon PLC$$$$$F$Y$$$20240725$$CN$US$US
241369241$24136924$1$I$$20240710$20240725$20240725$EXP$$US-GRANULES-US-2024GRALIT00294$GRANULES INDIA$J. Ouyang.How High Can Anion Gaps Be in Patients With Metabolic Acidosis? A Case Report.American Journal of Respiratory and Critical Care Medicine.2024;209:A3409$61$YR$A$F$Y$$$20240725$$HP$US$US
241369251$24136925$1$I$$20240717$20240725$20240725$EXP$$US-AMGEN-USASP2024145097$AMGEN$Chiu C.; Beam E.; Brumble L.M.et. al. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clinical Transplantation. 2024;38 (7):1-9$$$$$Y$$$20240725$$HP$US$US
241369261$24136926$1$I$20240724$20240724$20240724$20240724$DIR$711426$$FDA-CTU$$73$YR$$F$N$68.03$KG$20240724$Y$HP$US$
241369271$24136927$1$I$$20240717$20240725$20240725$EXP$$US-AMGEN-USASP2024145070$AMGEN$Chiu C.; Beam E.; Brumble L.M.et.al. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clinical Transplantation. 2024;38 (7):1-9$$$$$Y$$$20240725$$HP$US$US
241369281$24136928$1$I$$20240718$20240725$20240725$PER$$US-ABBVIE-5848629$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241369291$24136929$1$I$20240101$20240702$20240725$20240725$30DAY$$BR-UCBSA-2024034246$UCB$$$$$M$Y$$$20240725$$CN$BR$BR
241369311$24136931$1$I$20240723$20240724$20240724$20240724$DIR$711440$$FDA-CTU$$77$YR$$F$N$$$20240724$N$HP$US$
241369321$24136932$1$I$$20240716$20240725$20240725$EXP$HU-OGYI-0088424$HU-TEVA-VS-3222022$TEVA$$17$YR$$F$Y$50$KG$20240725$$CN$HU$HU
241369331$24136933$1$I$$20240530$20240725$20240725$PER$$US-LUNDBECK-DKLU4000118$LUNDBECK$$$$$$Y$$$20240725$$CN$US$US
241369341$24136934$1$I$$20240723$20240725$20240725$EXP$$NVSC2024RO151690$NOVARTIS$$70$YR$$F$Y$$$20240725$$MD$RO$RO
241369351$24136935$1$I$$20240711$20240725$20240725$30DAY$$GB-PFIZER INC-PV202400091722$PFIZER$$2$YR$$M$Y$$$20240725$$CN$GB$GB
241369361$24136936$1$I$$20240717$20240725$20240725$EXP$$US-AMGEN-USASP2024145088$AMGEN$Chiu C.; Beam E.; Brumble L.M.et. al. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clinical Transplantation. 2024;38 (7):1-9$$$$$Y$$$20240725$$HP$US$US
241369372$24136937$2$F$$20240917$20240725$20240920$30DAY$$GB-PFIZER INC-202400217262$PFIZER$$71$YR$$M$Y$$$20240920$$CN$GB$GB
241369383$24136938$3$F$$20240829$20240725$20240906$30DAY$$GB-PFIZER INC-202400212405$PFIZER$$17$YR$$M$Y$$$20240906$$CN$GB$GB
241369401$24136940$1$I$20240709$20240724$20240725$20240725$EXP$$CN-BAYER-2024A107973$BAYER$$76$YR$E$F$Y$55$KG$20240725$$HP$CN$CN
241369413$24136941$3$F$$20240718$20240725$20240802$EXP$$US-RDY-SPO/USA/23/0160118$DR REDDYS$$73$YR$E$F$Y$74.7$KG$20240802$$CN$US$US
241369423$24136942$3$F$$20240813$20240725$20240820$EXP$$JP-TAKEDA-2024TUS073448$TAKEDA$$67$YR$$$Y$$$20240820$$MD$JP$JP
241369441$24136944$1$I$$20240715$20240725$20240725$EXP$$US-GSK-US2024088698$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
241369451$24136945$1$I$$20240710$20240725$20240725$EXP$$US-GRANULES-US-2024GRALIT00296$GRANULES INDIA$Adam Habib.BRASH syndrome: A rare but reversible cause of sinus node dysfunction.Heart Rhythm Society.2024;10:398-401$57$YR$A$F$Y$$$20240725$$MD$US$US
241369463$24136946$3$F$20230419$20240828$20240725$20240903$PER$$US-009507513-2407USA004605$MERCK$Piemonti L,Vettor L, Contro E.. A case report of metastatic gastric cancer treated with pembrolizumab during pregnancy. Fetal diagnosis and therapy. 2024;1-7$35$YR$$F$Y$$$20240903$$HP$IT$US
241369471$24136947$1$I$20240501$20240718$20240725$20240725$EXP$$CA-JNJFOC-20240755678$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240725$$HP$CA$CA
241369481$24136948$1$I$20240627$20240718$20240725$20240725$PER$$JP-Eisai-EC-2024-170516$EISAI$$$$E$F$Y$$$20240725$$PH$JP$JP
241369491$24136949$1$I$$20240716$20240725$20240725$PER$$JP-Eisai-EC-2024-170432$EISAI$Fujioka Shinya. Molecular targeted therapy for thymic carcinoma. Medical Oncology. 2023; 32(6): 648-653.$$$$$Y$$$20240725$$MD$JP$JP
241369503$24136950$3$F$20240101$20240805$20240725$20240807$PER$$US-Eisai-EC-2024-170237$EISAI$$48$YR$A$F$Y$$$20240807$$CN$US$US
241369511$24136951$1$I$20240705$20240719$20240725$20240725$EXP$$JP-Eisai-EC-2024-170597$EISAI$$$$E$M$Y$$$20240725$$MD$JP$JP
241369532$24136953$2$F$20240606$20240809$20240725$20240818$PER$$GB-Eisai-EC-2024-170636$EISAI$$36$YR$A$F$Y$55.6$KG$20240818$$PH$GB$GB
241369541$24136954$1$I$$20240530$20240725$20240725$PER$$US-LUNDBECK-DKLU4000061$LUNDBECK$$$$$$Y$$$20240725$$CN$US$US
241369551$24136955$1$I$$20240719$20240725$20240725$EXP$AU-TGA-0000812319$AU-ORGANON-O2407AUS002046$ORGANON$Holmes Z, Foley P, Baker C, Daniel BS.. Dupilumab for chronic actinic dermatitis: A case series and review of the literature. Australasian Journal of Dermatology. 2024;65(3):287-91$85$YR$$M$Y$$$20240725$$HP$AU$AU
241369561$24136956$1$I$20240101$20240719$20240725$20240725$PER$$US-BAYER-2024A105508$BAYER$$45$YR$A$F$Y$$$20240725$$MD$US$US
241369571$24136957$1$I$20240708$20240722$20240725$20240725$EXP$FR-AFSSAPS-PA2024001364$NVSC2024FR150020$NOVARTIS$$58$YR$$M$Y$$$20240725$$MD$FR$FR
241369581$24136958$1$I$$20240718$20240725$20240725$PER$$AU-Waylis Therapeutics LLC-ATNAHS20240702084$Waylis$$34$YR$A$M$Y$$$20240725$$HP$AU$AU
241369591$24136959$1$I$$20240723$20240725$20240725$EXP$$TW-ROCHE-10000034268$ROCHE$$$$$$Y$$$20240725$$MD$TW$TW
241369601$24136960$1$I$$20240712$20240725$20240725$EXP$$ES-ASTELLAS-2024US020855$ASTELLAS$Izquierdo Ant? C, Sim? Nebot S, Celma Sanchez M. Use of isavuconazole in children with invasive fungal infection: Experience in a paediatric and tertiary care centre. 69 Congreso de la AEP, celebrado en Granada del 1 al 3 de junio de 2023. 2023;493:Unk$5$YR$$M$Y$17$KG$20240725$$CN$ES$ES
241369611$24136961$1$I$$20240717$20240725$20240725$EXP$$ZA-AstraZeneca-2024A163450$ASTRAZENECA$$75$YR$$F$Y$$$20240725$$CN$ZA$
241369622$24136962$2$F$20240101$20240916$20240725$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117975$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240918$$HP$US$US
241369631$24136963$1$I$20240723$20240724$20240724$20240724$DIR$711430$$FDA-CTU$$66$YR$$M$N$93.4$KG$20240724$Y$$US$
241369641$24136964$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118157$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240725$$CN$US$US
241369651$24136965$1$I$$20240717$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115402$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$84.82$KG$20240725$$HP$US$US
241369661$24136966$1$I$20240601$20240719$20240725$20240725$EXP$$LT-BRISTOL-MYERS SQUIBB COMPANY-2024-098422$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240725$$MD$LT$LT
241369671$24136967$1$I$20240717$20240722$20240725$20240725$EXP$$CN-AstraZeneca-2024A168991$ASTRAZENECA$$66$YR$$F$Y$$$20240725$$MD$CN$
241369682$24136968$2$F$$20240822$20240725$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118094$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240902$$HP$US$US
241369691$24136969$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118064$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240725$$CN$US$US
241369702$24136970$2$F$20240723$20240904$20240725$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118217$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240905$$CN$US$US
241369711$24136971$1$I$20240724$20240724$20240724$20240724$DIR$711432$$FDA-CTU$$39$YR$$F$N$76.5$KG$20240724$N$CN$US$
241369732$24136973$2$F$20240701$20240729$20240725$20240806$EXP$$JP-AstraZeneca-2024A163623$ASTRAZENECA$$85$YR$$F$Y$$$20240806$$MD$JP$
241369741$24136974$1$I$20240718$20240718$20240725$20240725$EXP$$US-ABBVIE-5846103$ABBVIE$$80$YR$$F$Y$$$20240725$$CN$US$US
241369751$24136975$1$I$$20240718$20240725$20240725$PER$$US-BAYER-2024A106094$BAYER$$$$$$Y$$$20240725$$CN$US$US
241369761$24136976$1$I$20240705$20240716$20240725$20240725$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407013566$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240725$$CN$DE$CN
241369771$24136977$1$I$20240611$20240716$20240725$20240725$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407010989$ELI LILLY AND CO$$15$YR$T$F$Y$$$20240725$$HP$GB$GB
241369781$24136978$1$I$$20240716$20240725$20240725$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011084$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240725$$CN$US$US
241369791$24136979$1$I$20240717$20240718$20240725$20240725$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407012366$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240725$$CN$JP$JP
241369801$24136980$1$I$$20240715$20240725$20240725$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009246$ELI LILLY AND CO$$$$$M$Y$$$20240725$$CN$DE$US
241369811$24136981$1$I$20240712$20240722$20240725$20240725$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407014679$ELI LILLY AND CO$$51$YR$A$M$Y$69$KG$20240725$$CN$CN$CN
241369821$24136982$1$I$20240522$20240719$20240725$20240725$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202407013757$ELI LILLY AND CO$$87$YR$E$M$Y$70$KG$20240725$$CN$ES$ES
241369831$24136983$1$I$$20240717$20240725$20240725$PER$$US-BAYER-2024A106132$BAYER$$9$YR$C$M$Y$$$20240725$$CN$US$US
241369841$24136984$1$I$$20240716$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090029$VIIV$$$$$F$Y$$$20240725$$HP$US$US
241369851$24136985$1$I$$20240718$20240725$20240725$PER$$AU-Waylis Therapeutics LLC-ATNAHS20240702083$Waylis$$$$$$Y$$$20240725$$HP$AU$AU
241369861$24136986$1$I$20240101$20240715$20240725$20240725$EXP$$AU-JNJFOC-20240767856$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240725$$CN$AU$AU
241369871$24136987$1$I$$20240710$20240725$20240725$EXP$$JP-GRANULES-JP-2024GRALIT00285$GRANULES INDIA$Yasuyoshi Hiramatsu .Hypothermia, bradycardia, and hypotension during glucocorticoid or cyclosporine A therapy in a boy with Kikuchi-Fujimoto disease.Modern Rheumatology Case Reports : no pagination.08-JUL-2024;8:1-2$17$YR$T$M$Y$$$20240725$$HP$JP$JP
241369881$24136988$1$I$$20240722$20240725$20240725$EXP$$US-JNJFOC-20240757171$JOHNSON AND JOHNSON$$$$$M$Y$$$20240725$$CN$US$US
241369901$24136990$1$I$20240713$20240717$20240725$20240725$PER$$US-ABBVIE-5844919$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241369912$24136991$2$F$$20240722$20240725$20240801$PER$$US-AMGEN-USASP2024147205$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241369922$24136992$2$F$20240716$20240730$20240725$20240806$30DAY$$US-AMGEN-USASP2024144301$AMGEN$$21$YR$A$M$Y$76.84$KG$20240806$$HP$US$US
241369931$24136993$1$I$20240401$20240531$20240725$20240725$PER$$US-LUNDBECK-DKLU4000674$LUNDBECK$$$$$$Y$$$20240725$$HP$US$US
241369942$24136994$2$F$$20240731$20240725$20240809$EXP$$FR-TEVA-VS-3223373$TEVA$Gendarme S, Pastre J, Billaud EM, Gibault L, Guillemain R, Oudard S, et al. Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patients. Therapie 2023; 78 (3): 267-278.; Gendarme S, Pastre J, Billaud EM, Gibault L, Guillemain R, Oudard S, et al. Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patients. Therapie 2023; 78 (3): 267-278.$$$$$Y$$$20240809$$HP$FR$FR
241369951$24136995$1$I$$20240723$20240725$20240725$PER$$US-BAYER-2024A106897$BAYER$$79$YR$E$M$Y$$$20240725$$CN$US$US
241369961$24136996$1$I$$20240719$20240725$20240725$EXP$$US-RDY-SPO/USA/24/0010771$DR REDDYS$$$$$M$Y$$$20240725$$CN$US$US
241369971$24136997$1$I$$20240715$20240725$20240725$EXP$$FR-TEVA-VS-3223374$TEVA$Gendarme S, Pastre J, Billaud EM, Gibault L, Guillemain R, Oudard S, et al. Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patients. Therapie 2023; 78 (3): 267-278.$$$$$Y$$$20240725$$HP$FR$FR
241369981$24136998$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51175$$FDA-CTU$$76$YR$$F$N$104.78$KG$20240725$N$HP$US$
241369991$24136999$1$I$$20240530$20240725$20240725$PER$$US-LUNDBECK-DKLU4000111$LUNDBECK$$$$$$Y$$$20240725$$CN$US$US
241370001$24137000$1$I$$20240715$20240725$20240725$EXP$$FR-TEVA-VS-3223387$TEVA$Gendarme S, Pastre J, Billaud EM, Gibault L, Guillemain R, Oudard S, et al. Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patients. Therapie 2023; 78 (3): 267-278.$$$$M$Y$$$20240725$$HP$FR$FR
241370012$24137001$2$F$20240708$20240822$20240725$20240828$30DAY$$US-JNJFOC-20240723838$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240828$$CN$US$US
241370021$24137002$1$I$$20240715$20240725$20240725$EXP$$PT-TEVA-VS-3222734$TEVA$Vasconcelos C, Magalh?es RT, Relvas R, Monteiro NF, Cruz D. PO-0019 - (2483) - SEVERE IATROGENIC NEUTROPENIA - AN UNUSUAL CULPRIT. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional de Medicina Interna - Livro de resumos [CNMI]. 2024 May; 394.$81$YR$$M$Y$$$20240725$$MD$PT$PT
241370031$24137003$1$I$$20240717$20240725$20240725$EXP$$AU-Eisai-EC-2024-170463$EISAI$$80$YR$E$M$Y$$$20240725$$MD$AU$AU
241370041$24137004$1$I$20240202$20240718$20240725$20240725$PER$$US-Eisai-EC-2024-170537$EISAI$$57$YR$A$F$Y$$$20240725$$CN$US$US
241370051$24137005$1$I$20240710$20240717$20240725$20240725$PER$$CN-Eisai-EC-2024-170503$EISAI$$50$YR$A$F$Y$60$KG$20240725$$HP$CN$CN
241370061$24137006$1$I$20240404$20240716$20240725$20240725$EXP$ES-AEMPS-1542797$ES-TEVA-VS-3222044$TEVA$$26$YR$$M$Y$$$20240725$$MD$ES$ES
241370071$24137007$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51171$$FDA-CTU$$50$YR$$F$N$$$20240725$N$$US$
241370081$24137008$1$I$$20240722$20240725$20240725$EXP$CZ-CZSUKL-24002023$CZ-BAYER-2024A105856$BAYER$$$$A$F$Y$58$KG$20240725$$CN$CZ$CZ
241370091$24137009$1$I$$20240719$20240725$20240725$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012076$VERTEX$$$$A$M$Y$$$20240725$$CN$GB$GB
241370111$24137011$1$I$$20240718$20240725$20240725$PER$$US-VERTEX PHARMACEUTICALS-2024-012016$VERTEX$$$$$F$Y$$$20240725$$PH$US$US
241370121$24137012$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51172$$FDA-CTU$$75$YR$$F$N$$$20240725$N$$US$
241370141$24137014$1$I$20240501$20240719$20240725$20240725$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012081$VERTEX$$$$A$M$Y$$$20240725$$CN$GB$GB
241370151$24137015$1$I$$20240716$20240725$20240725$EXP$$RU-VERTEX PHARMACEUTICALS-2024-011885$VERTEX$$15$YR$$$Y$$$20240725$$MD$RU$RU
241370161$24137016$1$I$$20240717$20240725$20240725$EXP$$US-VERTEX PHARMACEUTICALS-2024-011775$VERTEX$$$$$F$Y$$$20240725$$PH$US$US
241370181$24137018$1$I$$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51150$$FDA-CTU$$$$$F$N$$$20240724$N$HP$US$
241370191$24137019$1$I$$20240711$20240725$20240725$EXP$PT-INFARMED-T202108-4150$PT-ABBVIE-2211804US$ABBVIE$$37$YR$$F$Y$$$20240724$$CN$PT$PT
241370201$24137020$1$I$$20240710$20240725$20240725$EXP$$RO-GRANULES-RO-2024GRALIT00287$GRANULES INDIA$Claudiu Barsac.Cardiac Arrest and Complete Heart Block: Complications after Electrical Cardioversion for Unstable Supraventricular Tachycardia in the Emergency Department.Journal of Personalized Medicine.09-MAR-2024;14:1-9$53$YR$A$M$Y$$$20240725$$HP$RO$RO
241370211$24137021$1$I$20240101$20240715$20240725$20240725$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-118096$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240725$$MD$BR$BR
241370222$24137022$2$F$20240630$20240809$20240725$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113932$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$71.21$KG$20240813$$CN$US$US
241370231$24137023$1$I$$20240717$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115328$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$70.76$KG$20240725$$CN$US$US
241370241$24137024$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117349$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240725$$HP$US$US
241370252$24137025$2$F$$20240724$20240725$20240806$PER$$US-BIOVITRUM-2024-US-010211$BIOVITRUM$$24$MON$$F$Y$$$20240806$$CN$US$US
241370261$24137026$1$I$20240423$20240718$20240725$20240725$EXP$$IT-TAKEDA-2024TUS074599$TAKEDA$$70$YR$$M$Y$$$20240725$$MD$IT$IT
241370272$24137027$2$F$$20240926$20240725$20240927$PER$$US-BIOVITRUM-2024-US-010213$BIOVITRUM$$$$E$F$Y$$$20240927$$CN$US$US
241370281$24137028$1$I$20230407$20240716$20240725$20240725$EXP$FR-AFSSAPS-TO2024001283$FR-SA-2024SA213308$SANOFI AVENTIS$$82$YR$E$M$Y$75$KG$20240725$$PH$FR$FR
241370291$24137029$1$I$20240713$20240722$20240725$20240725$EXP$SE-SEMPA-2024-005525$SE-BAYER-2024A105864$BAYER$$28$YR$A$F$Y$$$20240725$$MD$SE$SE
241370301$24137030$1$I$20231101$20240724$20240725$20240725$EXP$ES-AEMPS-1549720$ES-ABBVIE-5851763$ABBVIE$$44$YR$$F$Y$$$20240725$$PH$ES$ES
241370311$24137031$1$I$$20240715$20240725$20240725$PER$$US-JNJFOC-20240764640$JOHNSON AND JOHNSON$$$$$M$Y$$$20240725$$HP$US$US
241370321$24137032$1$I$$20240722$20240725$20240725$PER$$US-JNJFOC-20240760350$JOHNSON AND JOHNSON$$$$$M$Y$$$20240725$$MD$US$US
241370331$24137033$1$I$$20240723$20240725$20240725$PER$$US-JNJFOC-20240762228$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$MD$US$US
241370341$24137034$1$I$$20240724$20240725$20240725$EXP$$US-JNJFOC-20240766111$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$HP$US$US
241370351$24137035$1$I$$20240711$20240725$20240725$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092347$GLENMARK$LeBlanc FR, Grier DD, Myers KC, Shimamura A, Pommert L.. A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome.. Pediatric Blood and Cancer.. 2024;71 (8):e31137$$$$$Y$$$20240725$$MD$US$US
241370371$24137037$1$I$$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51133$$FDA-CTU$$$$$F$N$$$20240724$N$HP$US$
241370381$24137038$1$I$20240717$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51137$$FDA-CTU$$81$YR$$F$N$$$20240724$N$HP$US$
241370391$24137039$1$I$20240724$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51154$$FDA-CTU$$60$YR$$F$N$86.4$KG$20240725$N$$US$
241370401$24137040$1$I$20240719$20240719$20240725$20240725$DIR$FDA-CDER-CTU-2024-51134$$FDA-CTU$$63$YR$$M$N$$$20240719$N$HP$US$
241370411$24137041$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51132$$FDA-CTU$$83$YR$$M$N$$$20240725$N$$US$
241370421$24137042$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51167$$FDA-CTU$$74$YR$$F$N$$$20240725$N$$US$
241370431$24137043$1$I$20240724$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51170$$FDA-CTU$$40$YR$$F$N$$$20240725$N$$US$
241370441$24137044$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51144$$FDA-CTU$$52$YR$$F$N$255$LBS$20240725$N$$US$
241370451$24137045$1$I$20240722$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146922$AMGEN$$49$YR$A$M$Y$$$20240725$$CN$US$US
241370461$24137046$1$I$$20240722$20240725$20240725$EXP$$US-SA-2024SA215932$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240725$$MD$US$US
241370475$24137047$5$F$$20240926$20240725$20240930$EXP$$NVSC2024GB149330$NOVARTIS$$$$$$Y$$$20240930$$HP$GB$GB
241370483$24137048$3$F$20240629$20240821$20240725$20240829$PER$$US-ROCHE-10000033853$ROCHE$$73$YR$E$F$Y$$$20240829$$MD$US$US
241370493$24137049$3$F$$20240824$20240725$20240826$30DAY$$US-PFIZER INC-202400221438$PFIZER$$10$YR$$M$Y$$$20240826$$CN$US$US
241370512$24137051$2$F$$20240824$20240725$20240826$30DAY$$US-PFIZER INC-202400221027$PFIZER$$13$YR$$M$Y$$$20240826$$MD$US$US
241370524$24137052$4$F$$20240830$20240725$20240830$30DAY$$US-PFIZER INC-202400221225$PFIZER$$12$YR$$F$Y$$$20240830$$HP$US$US
241370532$24137053$2$F$$20240722$20240725$20240730$EXP$$BG-PFIZER INC-PV202400095933$PFIZER$Petrusheva, V.. Cardiotoxicity in patient with breast cancer treated with HER-2 targeted therapy - a case report.. CARDIOVASCULAR DISEASES. 2024;(2):14-23$54$YR$$F$Y$$$20240730$$MD$BG$BG
241370541$24137054$1$I$20220101$20240719$20240725$20240725$EXP$$CN-PFIZER INC-PV202400094842$PFIZER$Wang, Y.. Diagnosis and treatment of adenoviral encephalitis in a patient with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Shandong Medical Journal. 2024;64(17):60-62$52$YR$$M$Y$$$20240725$$HP$CN$CN
241370551$24137055$1$I$$20240723$20240725$20240725$EXP$$GR-PFIZER INC-PV202400096192$PFIZER$Oikonomou, G.. THE IMPORTANCE OF PHARMACOVIGILANCE: AN EXAMPLE OF SEVERE TOXICITY FROM METHOTREXATE. 50th ANNUAL PANHELLENIC MEDICAL CONGRESS (poster). 2024$78$YR$$F$Y$$$20240725$$MD$GR$GR
241370564$24137056$4$F$20240621$20240926$20240725$20240930$30DAY$$US-PFIZER INC-202400219707$PFIZER$$37$YR$$F$Y$86.168$KG$20240930$$CN$US$US
241370573$24137057$3$F$$20240912$20240725$20240923$30DAY$$US-PFIZER INC-202400215772$PFIZER$$15$YR$$M$Y$90.72$KG$20240923$$CN$US$US
241370581$24137058$1$I$$20240718$20240725$20240725$EXP$$US-PFIZER INC-PV202400094362$PFIZER$Calley, B.. Stevens-Johnson syndrome in a pregnant woman who received the influenza vaccine. JAAD Case Reports. 2022;23:35-37$34$YR$$F$Y$$$20240725$$HP$US$US
241370594$24137059$4$F$20240701$20240823$20240725$20240829$30DAY$$US-PFIZER INC-202400221011$PFIZER$$12$YR$$M$Y$31.1$KG$20240829$$HP$US$US
241370603$24137060$3$F$$20240829$20240725$20240829$30DAY$$US-PFIZER INC-202400221756$PFIZER$$15$YR$$M$Y$$$20240829$$CN$US$US
241370611$24137061$1$I$$20240722$20240725$20240725$EXP$$JP-PFIZER INC-PV202400096405$PFIZER$Osumi, H.. Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy. Nature Communications. 2024;15(1):10.1038/s41467-024-50026-4$46$YR$$F$Y$$$20240725$$HP$JP$JP
241370621$24137062$1$I$$20240719$20240725$20240725$EXP$$CN-PFIZER INC-PV202400094858$PFIZER$Han, Y.. Clinical study of diffuse large B-cell lymphoma combined with lymphoplasmacytic lymphoma/Waldenstrom^s macroglobulinemia with biclclonic IgM and IgG. Laboratory Medicine and Clinic. 2024;21(11):1655-1659$61$YR$$M$Y$$$20240725$$MD$CN$CN
241370632$24137063$2$F$$20240723$20240725$20240731$EXP$$US-PFIZER INC-PV202400095550$PFIZER$Desai, A.. Adult lymphoma-associated hemophagocytic lymphohistiocytosis: a clinical case series in a predominantly hispanic cohort. Journal of Medical Cases. 2020;11(8):256-261$51$YR$$F$Y$$$20240731$$HP$US$US
241370642$24137064$2$F$$20240723$20240725$20240730$EXP$$FR-PFIZER INC-PV202400096129$PFIZER$Matet, A.. Systemic adalimumab induces peripheral corneal infiltrates: a case report. BMC Ophthalmology. 2015;15:57$34$YR$$F$Y$$$20240730$$HP$FR$FR
241370653$24137065$3$F$$20240824$20240725$20240826$30DAY$$US-PFIZER INC-202400220755$PFIZER$$17$YR$$M$Y$$$20240826$$CN$US$US
241370661$24137066$1$I$$20240724$20240725$20240725$PER$$US-BIOVITRUM-2024-US-010224$BIOVITRUM$$14$YR$$M$Y$$$20240725$$CN$US$US
241370672$24137067$2$F$20240101$20240801$20240725$20240809$PER$$US-ABBVIE-5847496$ABBVIE$$57$YR$$F$Y$$$20240809$$CN$US$US
241370681$24137068$1$I$20240315$20240715$20240725$20240725$EXP$FR-AFSSAPS-PP2024000772$FR-CTRS-202400147$ADDMEDICA$$74$YR$$F$Y$45.2$KG$20240725$$MD$FR$
241370693$24137069$3$F$$20240819$20240725$20240821$PER$$US-AMGEN-USASP2024146985$AMGEN$$$$$M$Y$$$20240821$$CN$US$US
241370701$24137070$1$I$$20240724$20240725$20240725$EXP$$US-UCBSA-2024037455$UCB$$$$$F$Y$$$20240725$$CN$US$US
241370711$24137071$1$I$$20240710$20240725$20240725$PER$$US-GRANULES-US-2024GRASPO00283$GRANULES INDIA$$$$$F$Y$$$20240725$$CN$US$US
241370721$24137072$1$I$20230301$20240716$20240725$20240725$EXP$HR-HALMED-300085966$HR-TEVA-VS-3222161$TEVA$$85$YR$$F$Y$60$KG$20240725$$MD$HR$HR
241370731$24137073$1$I$$20240716$20240725$20240725$EXP$$AU-TEVA-VS-3222833$TEVA$$47$YR$$F$Y$$$20240725$$HP$AU$AU
241370741$24137074$1$I$20240704$20240722$20240725$20240725$DIR$FDA-CDER-CTU-2024-51143$$FDA-CTU$$26$YR$$M$N$$$20240722$N$HP$US$
241370762$24137076$2$F$20151115$20240725$20240725$20240731$EXP$$CA-TAKEDA-2015TUS016643$TAKEDA$$52$YR$$F$Y$$$20240731$$MD$CA$CA
241370773$24137077$3$F$20240703$20240920$20240725$20240924$EXP$$US-ABBVIE-5851247$ABBVIE$$64$YR$$F$Y$$$20240924$$CN$US$US
241370781$24137078$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51204$$FDA-CTU$$56$YR$$F$N$$$20240725$N$$US$
241370792$24137079$2$F$20240708$20240731$20240725$20240808$PER$$US-ROCHE-10000033833$ROCHE$$84$YR$E$F$Y$$$20240808$$MD$US$US
241370801$24137080$1$I$$20240717$20240725$20240725$EXP$$GB-MYLANLABS-2024M1067052$MYLAN$$$$$F$Y$$$20240725$$CN$GB$GB
241370821$24137082$1$I$20240701$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51145$$FDA-CTU$$37$YR$$M$N$$$20240724$N$HP$US$
241370831$24137083$1$I$$20240718$20240725$20240725$EXP$GB-MHRA-MED-202407181530177560-BLQJZ$GB-TEVA-VS-3223509$TEVA$$67$YR$$F$Y$$$20240725$$CN$GB$GB
241370865$24137086$5$F$$20240911$20240725$20240913$30DAY$$US-PFIZER INC-202400209722$PFIZER$$14$YR$$F$Y$$$20240913$$MD$US$US
241370872$24137087$2$F$20240711$20240824$20240725$20240826$30DAY$$US-PFIZER INC-202400214008$PFIZER$$12$YR$$M$Y$$$20240826$$CN$US$US
241370883$24137088$3$F$20211123$20240914$20240725$20240916$EXP$$US-PFIZER INC-PV202400095240$PFIZER$$6$YR$$F$Y$22.68$KG$20240916$$MD$US$US
241370902$24137090$2$F$$20240824$20240725$20240826$30DAY$$US-PFIZER INC-202400215390$PFIZER$$3$YR$$F$Y$$$20240826$$CN$US$US
241370912$24137091$2$F$20240719$20240809$20240725$20240814$30DAY$$US-PFIZER INC-202400220999$PFIZER$$17$YR$$M$Y$113.4$KG$20240814$$CN$US$US
241370923$24137092$3$F$20240718$20240828$20240725$20240828$30DAY$$US-PFIZER INC-202400219867$PFIZER$$7$MON$$F$Y$6.58$KG$20240828$$CN$US$US
241370932$24137093$2$F$$20240825$20240725$20240826$30DAY$$US-PFIZER INC-202400218292$PFIZER$$9$YR$$M$Y$$$20240826$$CN$US$US
241370943$24137094$3$F$$20240912$20240725$20240918$30DAY$$US-PFIZER INC-202400215656$PFIZER$$10$YR$$F$Y$$$20240918$$CN$US$US
241370951$24137095$1$I$$20240715$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118209$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$83.91$KG$20240725$$MD$US$US
241370961$24137096$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117930$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$47.17$KG$20240725$$CN$US$US
241370971$24137097$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117952$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240725$$HP$US$US
241370981$24137098$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117968$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240725$$HP$US$US
241370991$24137099$1$I$$20240710$20240725$20240725$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07008$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240725$$MD$US$US
241371001$24137100$1$I$$20240710$20240725$20240725$PER$$US-GLANDPHARMA-US-2024GLNSPO00476$GLAND PHARMA$$$$$F$Y$$$20240725$$HP$US$US
241371011$24137101$1$I$20240720$20240724$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118270$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240725$$CN$US$US
241371021$24137102$1$I$20240630$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117673$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240725$$PH$US$US
241371031$24137103$1$I$$20240722$20240725$20240725$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407014769$ELI LILLY AND CO$$59$YR$A$$Y$$$20240725$$HP$AU$AU
241371041$24137104$1$I$$20240717$20240725$20240725$EXP$$CA-ABBVIE-5852074$ABBVIE$$56$YR$$F$Y$$$20240725$$CN$CA$CA
241371051$24137105$1$I$$20240711$20240725$20240725$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-022045$UNITED THERAPEUTICS$Yamashita N, et al.. A infant case of pulmonary hypertension with T-box transcription factor 4 (TBX4) abnormalities in which complete response to Treprostinil subcutaneous injection was observed$3$YR$$F$Y$$$20240725$$MD$JP$JP
241371061$24137106$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015286$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240725$$CN$US$US
241371071$24137107$1$I$$20240722$20240725$20240725$PER$$US-ROCHE-10000033632$ROCHE$$$$$$Y$$$20240725$$MD$US$US
241371081$24137108$1$I$$20240716$20240725$20240725$EXP$$US-Calliditas-2024CAL01337$CALLIDITAS THERAPEUTICS$$$$A$M$Y$$$20240725$$MD$US$US
241371091$24137109$1$I$20240606$20240616$20240725$20240725$EXP$$ES-TEVA-VS-3209721$TEVA$$62$YR$$F$Y$$$20240725$$CN$ES$ES
241371111$24137111$1$I$$20240717$20240725$20240725$EXP$$US-AstraZeneca-2024A163512$ASTRAZENECA$$55$YR$$F$Y$$$20240725$$CN$US$
241371121$24137112$1$I$$20240723$20240725$20240725$EXP$$GB-UCBSA-2023007902$UCB$$$$$F$Y$$$20240725$$CN$GB$GB
241371131$24137113$1$I$$20240716$20240725$20240725$EXP$$CN-TAKEDA-2024TUS074101$TAKEDA$$49$YR$$M$Y$$$20240725$$HP$CN$CN
241371171$24137117$1$I$$20240712$20240725$20240725$EXP$$GB-B.Braun Medical Inc.-2159595$B BRAUN$$33$YR$$F$Y$$$20240725$$$GB$GB
241371181$24137118$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06718$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241371191$24137119$1$I$$20240724$20240725$20240725$EXP$$AU-ABBVIE-5852970$ABBVIE$$$$$F$Y$$$20240725$$CN$AU$AU
241371201$24137120$1$I$$20240717$20240725$20240725$EXP$$BR-ALXN-202407SAM001128BR$ALEXION PHARMACEUTICALS$$37$YR$$M$Y$$$20240725$$CN$BR$BR
241371211$24137121$1$I$20240718$20240719$20240725$20240725$EXP$GB-MHRA-MED-202407191459520230-ZCNRK$GB-RDY-SPO/GBR/24/0010803$DR REDDYS$$64$YR$A$M$Y$$$20240725$$HP$GB$GB
241371221$24137122$1$I$20240201$20240724$20240725$20240725$EXP$$US-BAYER-2024A107662$BAYER$$71$YR$E$M$Y$$$20240725$$MD$US$US
241371231$24137123$1$I$$20240720$20240725$20240725$PER$$US-ROCHE-10000033959$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241371241$24137124$1$I$$20240716$20240725$20240725$EXP$$JP-ROCHE-10000031510$ROCHE$Kanno M, Harada S, Usubuchi M. O6-3 A case of a home-care terminal cancer patient where cooperation with multiple medical/ nursing care staffs was made to perform oral healthcare management by a house call dentistry. The 35th Annual Meeting of Japanese Society of Gerodontology. 2024$66$YR$E$M$Y$$$20240725$$MD$JP$JP
241371251$24137125$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146912$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241371261$24137126$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146957$AMGEN$$$$$$Y$$$20240725$$PH$US$US
241371271$24137127$1$I$$20230301$20240725$20240725$EXP$$CN-Appco Pharma LLC-2159596$APPCO PHARMA$Initial$28$YR$$M$Y$$$20240725$$$CN$CN
241371282$24137128$2$F$$20240708$20240725$20240725$PER$$US-ROCHE-10000034859$ROCHE$$$$$$Y$$$20240725$$PH$US$US
241371292$24137129$2$F$$20240903$20240725$20240905$PER$$US-ROCHE-10000033735$ROCHE$$$$E$F$Y$$$20240905$$CN$US$US
241371301$24137130$1$I$$20240718$20240725$20240725$EXP$NL-LRB-00981719$NL-MYLANLABS-2024M1067740$MYLAN$$33$YR$$F$Y$75$KG$20240725$$CN$NL$NL
241371311$24137131$1$I$20240713$20240715$20240725$20240725$PER$$US-APELLIS-2024-APL-0000491$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
241371321$24137132$1$I$20240701$20240717$20240725$20240725$EXP$$JP-BAYER-2024A094957$BAYER$$$$$$Y$$$20240725$$PH$JP$JP
241371331$24137133$1$I$20231201$20240723$20240725$20240725$EXP$FR-AFSSAPS-AN2024000916$FR-TAKEDA-2024TUS074469$TAKEDA$$74$YR$$$Y$$$20240725$$HP$FR$FR
241371342$24137134$2$F$$20240910$20240725$20240912$PER$$US-ROCHE-10000032514$ROCHE$$22$YR$A$F$Y$$$20240912$$CN$US$US
241371351$24137135$1$I$$20240719$20240725$20240725$PER$$US-ROCHE-10000032640$ROCHE$$8$YR$C$M$Y$$$20240725$$MD$US$US
241371362$24137136$2$F$$20240722$20240725$20240730$EXP$$CA-AstraZeneca-2024A164534$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$CA$
241371371$24137137$1$I$20240716$20240722$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117721$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240725$$CN$US$US
241371381$24137138$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118029$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240725$$HP$US$US
241371391$24137139$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000035338$ROCHE$$39$YR$A$F$Y$$$20240725$$CN$US$US
241371401$24137140$1$I$$20240712$20240725$20240725$EXP$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01066$TARO$Noe G, Shah K, Cinderella M, Munjal S. Multiple Medication Use Resulting in Serotonin Syndrome with Deprescribing Resulting in Acute Dystonia. J Clin Psychopharmacol. 2024;44 (3):326-328$$$$$Y$$$20240725$$HP$US$US
241371413$24137141$3$F$$20240730$20240725$20240731$PER$$US-ABBVIE-5849547$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241371424$24137142$4$F$20240101$20240917$20240725$20240930$EXP$$CA-UCBSA-2024036347$UCB$$$$$F$Y$$$20240930$$CN$CA$CA
241371431$24137143$1$I$$20240719$20240725$20240725$EXP$$US-LUNDBECK-DKLU4002029$LUNDBECK$$$$$$Y$$$20240725$$PH$US$US
241371442$24137144$2$F$$20240730$20240725$20240812$EXP$$GB-ADVANZ PHARMA-202407005910$ADVANZ PHARMA$$$$$$Y$$$20240812$$HP$GB$GB
241371452$24137145$2$F$$20240808$20240725$20240813$PER$$US-TAKEDA-2024TUS073513$TAKEDA$$$$$M$Y$$$20240813$$CN$US$US
241371461$24137146$1$I$20230718$20240723$20240725$20240725$EXP$$US-INCYTE CORPORATION-2024IN007738$INCYTE$$$$$$Y$$$20240725$$HP$US$US
241371471$24137147$1$I$20240722$20240723$20240725$20240725$PER$$US-ROCHE-10000034472$ROCHE$$17$YR$T$M$Y$$$20240725$$MD$US$US
241371481$24137148$1$I$$20240717$20240725$20240725$PER$$US-TAKEDA-2024TUS073856$TAKEDA$$40$YR$$F$Y$$$20240725$$PH$US$US
241371491$24137149$1$I$$20240723$20240725$20240725$EXP$$US-INCYTE CORPORATION-2024IN007732$INCYTE$$$$$$Y$$$20240725$$CN$US$US
241371512$24137151$2$F$$20240718$20240725$20240730$EXP$$NVSC2023CZ077242$NOVARTIS$Holanek M. Lecba metastatickeho lobularniho karcinomu prsu kombinaci inhibitoru aromatazy a ribociclibu [Treatment of metastatic lobular breast carcinoma with an aromatase inhibitor and ribociclib combination]. ACTA MEDICINAE. 2023;12:11-2$58$YR$$F$Y$$$20240731$$HP$CZ$CZ
241371521$24137152$1$I$$20240724$20240725$20240725$PER$$US-ROCHE-10000036213$ROCHE$$$$A$M$Y$$$20240725$$CN$US$US
241371531$24137153$1$I$20240705$20240719$20240725$20240725$EXP$GB-MHRA-MED-202407181411456990-GQPDN$GB-TEVA-VS-3223703$TEVA$$77$YR$$M$Y$71$KG$20240725$$CN$GB$GB
241371541$24137154$1$I$$20240720$20240725$20240725$EXP$$CA-ASTELLAS-2024US020859$ASTELLAS$$23$MON$$M$Y$11$KG$20240725$$CN$CA$CA
241371551$24137155$1$I$$20240722$20240725$20240725$PER$$US-BAYER-2024A107094$BAYER$$$$$$Y$$$20240725$$CN$US$US
241371562$24137156$2$F$$20240725$20240725$20240731$EXP$$IN-ROCHE-3551199$ROCHE$$65$YR$E$M$Y$$$20240731$$MD$IN$IN
241371571$24137157$1$I$$20240724$20240725$20240725$PER$$US-HALEON-2188915$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241371581$24137158$1$I$$20240715$20240725$20240725$EXP$$US-RDY-LIT/USA/24/0010722$DR REDDYS$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15(3): doi:10.14309/ctg.0000000000000679.$54$YR$A$F$Y$$$20240725$$MD$US$US
241371592$24137159$2$F$$20240723$20240725$20240828$EXP$$FR-GILEAD-2024-0681623$GILEAD$$$$$F$Y$$$20240828$$MD$FR$FR
241371601$24137160$1$I$$20240710$20240725$20240725$PER$$US-Nuvo Pharmaceuticals Inc-2159597$NUVO PHARMACEUTICALS$$88$YR$$M$Y$$$20240725$$$US$US
241371612$24137161$2$F$20210101$20240730$20240725$20240802$EXP$$CO-LUNDBECK-DKLU4001760$LUNDBECK$$$$$$Y$$$20240802$$CN$CO$CO
241371621$24137162$1$I$20240530$20240723$20240725$20240725$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041843$BOEHRINGER INGELHEIM$$63$YR$A$F$Y$$$20240725$$CN$US$US
241371632$24137163$2$F$$20240816$20240725$20240823$PER$$US-MYLANLABS-2024M1066878$MYLAN$$$$$$Y$$$20240823$$CN$US$US
241371641$24137164$1$I$20240722$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146764$AMGEN$$85$YR$E$F$Y$$$20240725$$CN$US$US
241371651$24137165$1$I$$20240716$20240725$20240725$PER$$US-EMD Serono-2024038801$EMD SERONO INC$$63$YR$A$F$Y$$$20240725$$PH$US$US
241371661$24137166$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118219$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240725$$HP$US$US
241371671$24137167$1$I$20240701$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118047$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240725$$HP$US$US
241371681$24137168$1$I$$20240723$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117157$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240725$$CN$US$US
241371691$24137169$1$I$20240715$20240718$20240725$20240725$EXP$GB-MHRA-MED-202407181601386220-MVWZQ$GB-ELI_LILLY_AND_COMPANY-GB202407012528$ELI LILLY AND CO$$33$YR$A$F$Y$63$KG$20240725$$CN$GB$GB
241371701$24137170$1$I$$20240719$20240725$20240725$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013412$ELI LILLY AND CO$$$$$F$Y$$$20240725$$CN$US$US
241371711$24137171$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015070$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240725$$CN$US$US
241371721$24137172$1$I$20240712$20240713$20240725$20240725$EXP$GB-MHRA-MED-202407130724593400-LKGPB$GB-ELI_LILLY_AND_COMPANY-GB202407009094$ELI LILLY AND CO$$42$YR$A$M$Y$128$KG$20240725$$CN$GB$GB
241371731$24137173$1$I$$20240722$20240725$20240725$EXP$$US-ELI_LILLY_AND_COMPANY-US202407014227$ELI LILLY AND CO$$$$$F$Y$$$20240725$$CN$US$US
241371741$24137174$1$I$$20240718$20240725$20240725$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407013165$ELI LILLY AND CO$$$$$$Y$$$20240725$$CN$JP$JP
241371752$24137175$2$F$20240703$20240731$20240725$20240812$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407003662$ELI LILLY AND CO$$49$YR$A$F$Y$56$KG$20240812$$CN$CN$CN
241371761$24137176$1$I$$20240712$20240725$20240725$EXP$$US-ELI_LILLY_AND_COMPANY-US202407008699$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240725$$CN$US$US
241371772$24137177$2$F$20230324$20240731$20240725$20240812$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407009948$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$BR$BR
241371781$24137178$1$I$20240601$20240713$20240725$20240725$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407008750$ELI LILLY AND CO$$$$$M$Y$$$20240725$$CN$DE$DE
241371791$24137179$1$I$20240712$20240713$20240725$20240725$EXP$GB-MHRA-MED-202407132058346160-PSZBL$GB-ELI_LILLY_AND_COMPANY-GB202407009099$ELI LILLY AND CO$$27$YR$A$F$Y$101$KG$20240725$$CN$GB$GB
241371811$24137181$1$I$20240701$20240718$20240725$20240725$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407012385$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240725$$CN$JP$JP
241371821$24137182$1$I$$20240722$20240725$20240725$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202407015206$ELI LILLY AND CO$$$$$F$Y$$$20240725$$MD$SA$SA
241371831$24137183$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407013711$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240725$$CN$US$US
241371841$24137184$1$I$$20240718$20240725$20240725$30DAY$$US-GSK-US2024090781$GLAXOSMITHKLINE$$$$$M$Y$$$20240725$$CN$US$US
241371852$24137185$2$F$20240301$20240808$20240725$20240813$EXP$$DE-ROCHE-10000031172$ROCHE$$51$YR$A$M$Y$$$20240813$$MD$DE$DE
241371864$24137186$4$F$$20240813$20240725$20240814$EXP$$RU-JNJFOC-20240763257$JOHNSON AND JOHNSON$$77$YR$E$M$Y$75$KG$20240814$$CN$RU$RU
241371871$24137187$1$I$$20240719$20240725$20240725$EXP$$AR-JNJFOC-20240757775$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$CN$AR$AR
241371881$24137188$1$I$$20230301$20240725$20240725$EXP$$FR-Appco Pharma LLC-2159598$APPCO PHARMA$Initial$45$YR$$M$Y$$$20240725$$$FR$FR
241371891$24137189$1$I$20240601$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A152744$ASTRAZENECA$$66$YR$$M$Y$$$20240725$$MD$JP$
241371901$24137190$1$I$20240201$20240724$20240725$20240725$EXP$$US-UCBSA-2024019360$UCB$$67$YR$$$Y$$$20240725$$CN$US$US
241371911$24137191$1$I$$20240715$20240725$20240725$EXP$$US-009507513-2407USA010925$MERCK$$53$YR$$M$Y$$$20240725$$MD$US$US
241371921$24137192$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146860$AMGEN$$$$$M$Y$$$20240725$$CN$US$US
241371931$24137193$1$I$20230927$20231024$20240725$20240725$EXP$$GB-ULTRAGENYX PHARMACEUTICAL INC.-GB-UGX-23-01218$ULTRAGENYX PHARMACEUTICAL$$17$YR$$M$Y$52.9$KG$20240725$$PH$GB$GB
241371941$24137194$1$I$$20240715$20240725$20240725$PER$$US-LEO Pharma-372062$LEO PHARM$$66$YR$$F$Y$$$20240725$$PH$US$US
241371951$24137195$1$I$20240401$20240724$20240724$20240724$DIR$711442$$FDA-CTU$$13$YR$$F$N$54$KG$20240724$N$CN$US$
241371961$24137196$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152774$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241371971$24137197$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152770$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241371981$24137198$1$I$20240625$20240722$20240725$20240725$EXP$$US-GILEAD-2024-0681720$GILEAD$$42$YR$A$F$Y$$$20240725$$CN$US$US
241371991$24137199$1$I$$20240722$20240725$20240725$EXP$$US-GILEAD-2024-0681728$GILEAD$$77$YR$E$F$Y$$$20240725$$CN$US$US
241372011$24137201$1$I$$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51218$$FDA-CTU$$$$$F$N$$$20240724$N$HP$US$
241372041$24137204$1$I$20240716$20240724$20240724$20240724$DIR$711444$$FDA-CTU$$75$YR$$F$N$76.9$KG$20240724$N$PH$US$
241372061$24137206$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118313$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240725$$CN$US$US
241372071$24137207$1$I$$20240711$20240725$20240725$PER$$US-ROCHE-10000025235$ROCHE$$$$E$F$Y$$$20240725$$CN$US$US
241372081$24137208$1$I$$20240710$20240725$20240725$EXP$$CA-UCBSA-2023024775$UCB$$$$$F$Y$$$20240725$$CN$CA$CA
241372091$24137209$1$I$$20240716$20240725$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115463$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240725$$HP$CA$CA
241372101$24137210$1$I$$20240722$20240725$20240725$30DAY$$US-GSK-US2024091718$GLAXOSMITHKLINE$$$$$F$Y$101.6$KG$20240725$$MD$US$US
241372111$24137211$1$I$$20240712$20240725$20240725$EXP$CZ-002147023-NVSC2024CZ119095$CZ-ROCHE-10000021397$ROCHE$Vydra J,  Sinusoidal obstruction syndrome / hepatic veno-occlusive disease after allogeneic transplantation of hematopoiesis].. Acta medicinae. 2024;13 (4):33-4.$40$YR$A$M$Y$$$20240725$$HP$CZ$CZ
241372121$24137212$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152769$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241372131$24137213$1$I$20240716$20240722$20240725$20240725$DIR$FDA-CDER-CTU-2024-51215$$FDA-CTU$$56$YR$$F$N$$$20240722$N$HP$US$
241372142$24137214$2$F$20240704$20240726$20240725$20240730$PER$AT-BASGAGES-2024-005355$AT-BRACCO-2024AT04435$BRACCO$$47$YR$$M$Y$$$20240730$$MD$AT$AT
241372151$24137215$1$I$$20240719$20240725$20240725$EXP$$US-ABBVIE-5848020$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241372161$24137216$1$I$$20240712$20240725$20240725$EXP$$IT-SAMSUNG BIOEPIS-SB-2024-21900$SAMSUNG BIOEPIS$Lattice radiotherapy in inflammatory breast cancer: report of a first case treated with curative aim. Radiation oncology Journal. 2024;42 (2):164-165. doi:10.3857/roj.2024.00038$49$YR$A$F$Y$$$20240725$$HP$IT$IT
241372171$24137217$1$I$$20240722$20240725$20240725$EXP$$CA-JNJFOC-20240765474$JOHNSON AND JOHNSON$$48$YR$A$M$Y$144$KG$20240725$$HP$CA$CA
241372181$24137218$1$I$$20240715$20240725$20240725$EXP$$US-RDY-LIT/USA/24/0010723$DR REDDYS$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B. Sevelamer-Induced Gastrointestinal Disease in 12 Patients with End-Stage Renal Disease: A Case Series. Clinical and Translational Gastroenterology. 2024;15(3): doi:10.14309/ctg.0000000000000679.$55$YR$A$F$Y$$$20240725$$MD$US$US
241372191$24137219$1$I$20240614$20240723$20240725$20240725$PER$$JP-Eisai-EC-2024-170851$EISAI$$$$E$F$Y$$$20240725$$MD$JP$JP
241372201$24137220$1$I$$20240712$20240725$20240725$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-21869$SAMSUNG BIOEPIS$$82$YR$E$M$Y$$$20240725$$CN$GB$GB
241372211$24137221$1$I$$20240716$20240725$20240725$EXP$$BR-TAKEDA-2024TUS046581$TAKEDA$$$$$M$Y$63$KG$20240725$$CN$BR$BR
241372221$24137222$1$I$20240601$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51230$$FDA-CTU$$53$YR$$M$N$$$20240724$N$HP$US$
241372231$24137223$1$I$$20240721$20240725$20240725$PER$$US-LEO Pharma-372233$LEO PHARM$$66$YR$$F$Y$$$20240725$$PH$US$US
241372241$24137224$1$I$$20240715$20240725$20240725$EXP$$MY-Vifor (International) Inc.-VIT-2024-05651$VIFOR$Badrin S, Mohd Shukri M, Abdul Kadir A, Hasan N, Chung T. The pregnancy journey of a patient with end-stage renal disease on hemodialysis: A case study. Electronic Journal of General Medicine. 2024 APR 21;21(2):EM575:1-4. doi:10.29333/ejgm/14352$37$YR$$F$Y$$$20240725$$HP$MY$MY
241372252$24137225$2$F$$20240717$20240725$20240726$EXP$$US-ABBVIE-5850471$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241372261$24137226$1$I$20240718$20240718$20240725$20240725$EXP$$US-ABBVIE-5852261$ABBVIE$$$$$$Y$$$20240725$$MD$US$US
241372271$24137227$1$I$20240701$20240718$20240725$20240725$PER$$US-BIOGEN-2024BI01274472$BIOGEN$$56$YR$$F$Y$$$20240725$$CN$US$US
241372282$24137228$2$F$20240701$20240812$20240725$20240909$PER$$US-009507513-2407USA012019$MERCK$$67$YR$$M$Y$102.04$KG$20240909$$PH$US$US
241372291$24137229$1$I$$20240723$20240725$20240725$PER$$US-BAUSCH-BL-2024-011339$BAUSCH AND LOMB$$$$$F$Y$$$20240725$$CN$US$US
241372301$24137230$1$I$$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A163028$ASTRAZENECA$Miyamoto K.;  Ogino H.;  Kakimoto T.;  Matsumura Y.;  Haji K.;  Mitsuhashi A.;  Morita Y.;  Tsukazaki Y.;  Yabuki Y.;  Ozaki R.;  Yoneda H.;  Sato S.;  Hanibuchi M.;  Bando Y.; Nokihara H.;  Nishioka Y. Transformation of epidermal growth factor receptor mutated lung adenocarcinoma to small-cell carcinoma long after the cessation of tyrosine kinase inhibitor treatment: A case series and literature review. Respiratory Medicine Case Reports 2024;51:102076.$26$YR$$F$Y$$$20240725$$HP$JP$
241372311$24137231$1$I$20240707$20240718$20240725$20240725$EXP$$IN-AstraZeneca-2024A165479$ASTRAZENECA$$25378$DY$$F$Y$$$20240725$$CN$IN$
241372321$24137232$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117910$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240725$$CN$US$US
241372331$24137233$1$I$$20240722$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116302$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240725$$HP$US$US
241372341$24137234$1$I$$20240724$20240724$20240724$DIR$711402$$FDA-CTU$$$$$M$N$133.2$KG$20240724$N$CN$US$
241372351$24137235$1$I$20240713$20240724$20240724$20240724$DIR$711437$$FDA-CTU$$36$YR$$F$N$57.15$KG$20240724$N$CN$US$
241372361$24137236$1$I$$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51245$$FDA-CTU$$$$$F$N$$$20240724$N$HP$US$
241372371$24137237$1$I$20240101$20240719$20240725$20240725$PER$$US-BAUSCH-BL-2024-011150$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240725$$CN$US$US
241372381$24137238$1$I$20240724$20240724$20240724$20240724$DIR$711447$$FDA-CTU$$34$YR$$F$N$106.2$KG$20240724$N$CN$US$
241372391$24137239$1$I$20240716$20240718$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407012367$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240725$$HP$US$US
241372411$24137241$1$I$20240722$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146901$AMGEN$$58$YR$A$F$Y$$$20240725$$CN$US$US
241372431$24137243$1$I$20240723$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024147184$AMGEN$$56$YR$A$F$Y$$$20240725$$CN$US$US
241372441$24137244$1$I$$20240722$20240725$20240725$EXP$$US-AMGEN-USASP2024146171$AMGEN$$$$$F$Y$$$20240725$$HP$US$US
241372451$24137245$1$I$20240601$20240710$20240725$20240725$PER$$US-EPICPHARMA-US-2024EPCSPO00837$EPIC PHARM$$70$YR$E$F$Y$217$KG$20240725$$CN$US$US
241372461$24137246$1$I$20231101$20240712$20240725$20240725$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-21794$SAMSUNG BIOEPIS$$65$YR$E$F$Y$100.8$KG$20240725$$HP$GB$GB
241372472$24137247$2$F$$20240806$20240725$20240809$PER$$US-BIOGEN-2024BI01274430$BIOGEN$$$$$F$Y$$$20240809$$CN$US$US
241372482$24137248$2$F$20240501$20240731$20240725$20240807$PER$$US-BIOGEN-2024BI01274428$BIOGEN$$59$YR$$M$Y$$$20240807$$CN$US$US
241372492$24137249$2$F$20230101$20240730$20240725$20240805$PER$$US-BIOGEN-2024BI01257137$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
241372501$24137250$1$I$$20240722$20240725$20240725$PER$$US-ROCHE-10000033564$ROCHE$$$$$$Y$$$20240725$$PH$US$US
241372511$24137251$1$I$$20240722$20240725$20240725$PER$$US-ROCHE-10000033410$ROCHE$$$$$$Y$$$20240725$$PH$US$US
241372522$24137252$2$F$20231201$20240815$20240725$20240819$PER$$US-ALXN-202407USA001364US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241372531$24137253$1$I$$20240724$20240725$20240725$EXP$$CA-BAUSCH-BL-2024-011359$BAUSCH AND LOMB$$74$YR$$F$Y$67$KG$20240725$$HP$CA$CA
241372541$24137254$1$I$$20240724$20240725$20240725$EXP$$CA-BAUSCH-BL-2024-011361$BAUSCH AND LOMB$$69$YR$$F$Y$75$KG$20240725$$HP$CA$CA
241372551$24137255$1$I$$20240724$20240725$20240725$EXP$$CA-BAUSCH-BL-2024-011362$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240725$$HP$CA$CA
241372561$24137256$1$I$20240625$20240724$20240725$20240725$EXP$$US-UCBSA-2024032378$UCB$$65$YR$$F$Y$$$20240725$$CN$US$US
241372571$24137257$1$I$$20240722$20240725$20240725$PER$$US-ABBVIE-5851619$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241372581$24137258$1$I$20240627$20240716$20240725$20240725$EXP$DE-BFARM-24004821$DE-GUERBET / LLC-DE-20240029$GUERBET$$19$YR$A$F$Y$60$KG$20240725$$MD$DE$DE
241372591$24137259$1$I$20240427$20240716$20240725$20240725$EXP$DK-DKMA-30730579$DK-TEVA-VS-3221979$TEVA$$96$YR$$M$Y$72$KG$20240725$$MD$DK$DK
241372601$24137260$1$I$20240713$20240722$20240725$20240725$EXP$$US-BAYER-2024A107247$BAYER$$36$YR$A$M$Y$$$20240725$$CN$US$US
241372611$24137261$1$I$$20240724$20240725$20240725$EXP$GB-MHRA-MED-202407241757008190-HLMYR$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041886$BOEHRINGER INGELHEIM$$$$$$Y$$$20240725$$HP$GB$GB
241372621$24137262$1$I$$20240715$20240725$20240725$EXP$$CA-SA-2024SA215496$SANOFI AVENTIS$$76$YR$E$M$Y$74.84$KG$20240725$$CN$AU$CA
241372651$24137265$1$I$20240501$20240717$20240725$20240725$EXP$$US-AMERICAN REGENT INC-2024002786$AMERICAN REGENT$$40$YR$$M$Y$$$20240725$$HP$US$US
241372681$24137268$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117918$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240725$$CN$US$US
241372691$24137269$1$I$20240724$20240724$20240724$20240724$DIR$711418$$FDA-CTU$$61$YR$$M$N$$$20240724$N$HP$US$
241372721$24137272$1$I$20231001$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51264$$FDA-CTU$$54$YR$$F$N$$$20240724$N$HP$US$
241372732$24137273$2$F$20180615$20240912$20240725$20240920$EXP$$AT-JNJFOC-20240751708$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240920$$MD$AT$AT
241372741$24137274$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034520$ROCHE$$17$YR$T$F$Y$$$20240725$$MD$US$US
241372751$24137275$1$I$20240101$20240717$20240725$20240725$EXP$$US-SA-2024SA211501$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240725$$CN$US$US
241372761$24137276$1$I$20240627$20240717$20240725$20240725$EXP$$CN-SA-2024SA215017$SANOFI AVENTIS$$67$YR$E$M$Y$58$KG$20240725$$HP$CN$CN
241372771$24137277$1$I$20240719$20240719$20240725$20240725$EXP$$JP-AMGEN-JPNSP2024145142$AMGEN$$$$$M$Y$$$20240725$$MD$JP$JP
241372791$24137279$1$I$$20240701$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06642$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241372811$24137281$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034828$ROCHE$$$$E$F$Y$$$20240725$$CN$US$US
241372821$24137282$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034832$ROCHE$$$$A$F$Y$$$20240725$$CN$US$US
241372831$24137283$1$I$$20240715$20240725$20240725$EXP$$JP-TEVA-VS-3222408$TEVA$Nakanoh H, Takeuchi H, Shiho M, Terajima Y, Okamoto S, Onishi Y, et al. Successful treatment for life threatening recurrent non-traumatic rectus sheath hematoma in a case with microscopic polyangiitis with rapidly progressive glomerulonephritis. Intern-Med 2024;.; Nakanoh H, Takeuchi H, Shiho M, Terajima Y, Okamoto S, Onishi Y, et al. Successful treatment for life threatening recurrent non-traumatic rectus sheath hematoma in a case with microscopic polyangiitis with rapidly progressive glomer...$68$YR$$F$Y$$$20240725$$HP$JP$JP
241372841$24137284$1$I$$20240723$20240725$20240725$EXP$$US-TAKEDA-2024TUS075040$TAKEDA$$$$$M$Y$$$20240725$$MD$US$US
241372851$24137285$1$I$20231106$20240718$20240725$20240725$EXP$$AR-GSK-AR2023AMR155155$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$AR$AR
241372871$24137287$1$I$20240629$20240722$20240725$20240725$DIR$FDA-CDER-CTU-2024-51238$$FDA-CTU$$69$YR$$F$N$$$20240722$N$HP$US$
241372891$24137289$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51268$$FDA-CTU$$31$YR$$M$N$$$20240725$N$$US$
241372942$24137294$2$F$$20240826$20240725$20240925$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22087$SAMSUNG BIOEPIS$$85$YR$E$F$Y$$$20240925$$CN$CA$CA
241372951$24137295$1$I$$20240720$20240725$20240725$EXP$$RO-JNJFOC-20240760011$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$MD$RO$RO
241372961$24137296$1$I$20240722$20240722$20240725$20240725$PER$$US-JNJFOC-20240758903$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
241372971$24137297$1$I$$20240715$20240725$20240725$EXP$$US-IMMUNOGEN, INC.-US-IMGN-24-00570$IMMUNOGEN$$$$$F$Y$$$20240725$$CN$US$US
241372981$24137298$1$I$$20240716$20240725$20240725$EXP$$AU-ABBVIE-5852175$ABBVIE$$25$YR$$F$Y$$$20240725$$HP$AU$AU
241372991$24137299$1$I$$20240724$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117881$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240725$$CN$US$US
241373001$24137300$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117268$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$112$KG$20240725$$CN$US$US
241373011$24137301$1$I$20240712$20240724$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118293$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240725$$CN$US$US
241373021$24137302$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117278$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240725$$HP$US$US
241373031$24137303$1$I$20240709$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117598$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240725$$CN$US$US
241373041$24137304$1$I$20240717$20240723$20240725$20240725$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-118194$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$53.98$KG$20240725$$MD$PR$PR
241373051$24137305$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51278$$FDA-CTU$$40$YR$$F$N$$$20240725$N$$US$
241373061$24137306$1$I$20240617$20240717$20240725$20240725$EXP$$CN-AstraZeneca-2024A165494$ASTRAZENECA$$19177$DY$$F$Y$63$KG$20240725$$MD$CN$
241373071$24137307$1$I$$20240723$20240725$20240725$DIR$FDA-CDER-CTU-2024-51263$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241373081$24137308$1$I$$20240717$20240725$20240725$PER$$US-AstraZeneca-2024A163428$ASTRAZENECA$$69$YR$$$Y$$$20240725$$HP$US$
241373092$24137309$2$F$$20240717$20240725$20240826$EXP$$JP-AstraZeneca-2024A164852$ASTRAZENECA$Tsuihiji A, et al. OS-109 Two cases of recurrent peritoneal cancer, in which myelodysplastic syndrome developed after the administration of PARP inhibitor.. Japanese Journal of Gynecological Oncology 2024;42(3):285.$$$$F$Y$$$20240826$$MD$JP$
241373101$24137310$1$I$20240706$20240719$20240725$20240725$EXP$$IT-AstraZeneca-2024A164955$ASTRAZENECA$$89$YR$$F$Y$$$20240725$$MD$IT$
241373111$24137311$1$I$$20240717$20240725$20240725$EXP$$US-AstraZeneca-2024A166321$ASTRAZENECA$$69$YR$$M$Y$$$20240725$$HP$US$
241373121$24137312$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51270$$FDA-CTU$$51$YR$$F$N$185$LBS$20240725$N$$US$
241373141$24137314$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51262$$FDA-CTU$$20$YR$$F$N$$$20240725$N$HP$US$
241373151$24137315$1$I$20240716$20240717$20240725$20240725$EXP$$CO-AstraZeneca-2024A164939$ASTRAZENECA$$20416$DY$$F$Y$$$20240725$$CN$CO$
241373161$24137316$1$I$20240719$20240722$20240725$20240725$EXP$$US-AstraZeneca-2024A166586$ASTRAZENECA$$$$$M$Y$$$20240725$$HP$US$
241373172$24137317$2$F$$20240721$20240725$20240729$EXP$$US-AstraZeneca-2024A165780$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241373181$24137318$1$I$$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A164967$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$JP$
241373201$24137320$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51213$$FDA-CTU$$46$YR$$F$N$190$LBS$20240725$N$$US$
241373231$24137323$1$I$$20240530$20240725$20240725$EXP$$CA-AstraZeneca-2024A089338$ASTRAZENECA$$$$$F$Y$$$20240725$$MD$CA$
241373241$24137324$1$I$$20240722$20240725$20240725$EXP$$US-TAKEDA-US202026596$TAKEDA$$$$$F$Y$$$20240725$$HP$US$US
241373253$24137325$3$F$20240605$20240819$20240725$20240820$EXP$$JP-Eisai-EC-2024-170609$EISAI$$86$YR$E$F$Y$$$20240820$$MD$JP$JP
241373271$24137327$1$I$20240620$20240723$20240725$20240725$EXP$$US-AMERICAN REGENT INC-2024002848$AMERICAN REGENT$$43$YR$$M$Y$102$KG$20240725$$HP$US$US
241373281$24137328$1$I$$20240718$20240725$20240725$EXP$$DE-VANTIVE-2024VAN018195$Vantive US Healthcare$$$$$M$Y$$$20240725$$HP$DE$DE
241373292$24137329$2$F$$20240712$20240725$20240823$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14094$IPSEN$$58$YR$A$F$Y$$$20240823$$HP$US$US
241373301$24137330$1$I$20230601$20240717$20240725$20240725$EXP$$AU-JNJFOC-20240765445$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240725$$CN$AU$AU
241373321$24137332$1$I$20240626$20240717$20240725$20240725$EXP$$EC-VANTIVE-2024VAN018376$Vantive US Healthcare$$59$YR$$F$Y$67$KG$20240725$$HP$EC$EC
241373331$24137333$1$I$20240505$20240719$20240725$20240725$EXP$$CL-VANTIVE-2024VAN018411$Vantive US Healthcare$$82$YR$$F$Y$54$KG$20240725$$HP$CL$CL
241373341$24137334$1$I$$20240725$20240725$20240725$PER$$US-HALEON-2188931$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241373351$24137335$1$I$$20240724$20240725$20240725$PER$$US-BAYER-2024A108020$BAYER$$70$YR$E$F$Y$$$20240725$$CN$US$US
241373362$24137336$2$F$$20240722$20240725$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116977$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240730$$HP$US$US
241373372$24137337$2$F$$20240822$20240725$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117954$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240824$$CN$US$US
241373382$24137338$2$F$20240714$20240823$20240725$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113871$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240830$$CN$US$US
241373391$24137339$1$I$20240721$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014536$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240725$$CN$US$US
241373401$24137340$1$I$$20240719$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116010$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240725$$HP$US$US
241373411$24137341$1$I$20240722$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024147093$AMGEN$$75$YR$E$$Y$$$20240725$$CN$US$US
241373424$24137342$4$F$$20240819$20240725$20240822$PER$$US-ROCHE-10000031949$ROCHE$$$$E$F$Y$$$20240822$$CN$US$US
241373432$24137343$2$F$20240901$20240917$20240725$20240920$EXP$$CA-GSK-CA2024066269$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$PH$CA$CA
241373441$24137344$1$I$$20240718$20240725$20240725$PER$$US-BAYER-2024A104967$BAYER$$39$YR$A$F$Y$$$20240725$$HP$US$US
241373451$24137345$1$I$20240601$20240715$20240725$20240725$EXP$IT-MINISAL02-994386$IT-EMD Serono-2024038444$EMD SERONO INC$$60$YR$A$F$Y$$$20240725$$MD$IT$IT
241373461$24137346$1$I$$20240716$20240725$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114672$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$73$KG$20240725$$MD$CA$CA
241373471$24137347$1$I$$20240718$20240725$20240725$PER$$US-ROCHE-10000032583$ROCHE$$$$A$F$Y$$$20240725$$CN$US$US
241373481$24137348$1$I$20240718$20240724$20240725$20240725$PER$$US-BAYER-2024A107652$BAYER$$47$YR$A$F$Y$$$20240725$$MD$US$US
241373491$24137349$1$I$20210927$20240722$20240725$20240725$EXP$$CA-SANDOZ INC.-NVSC2021CA223791$SANDOZ$$23$YR$$M$Y$$$20240725$$PH$CA$CA
241373511$24137351$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51280$$FDA-CTU$$50$YR$$F$N$$$20240725$N$$US$
241373541$24137354$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51153$$FDA-CTU$$42$YR$$M$N$270$LBS$20240725$N$$US$
241373552$24137355$2$F$$20240724$20240725$20240730$PER$$US-ROCHE-10000035697$ROCHE$$$$E$F$Y$92.08$KG$20240730$$CN$US$US
241373561$24137356$1$I$$20240716$20240725$20240725$PER$$US-ROCHE-10000032968$ROCHE$$15$MON$I$M$Y$$$20240725$$CN$US$US
241373571$24137357$1$I$$20240725$20240725$20240725$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041958$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240725$$CN$US$US
241373581$24137358$1$I$20240620$20240722$20240725$20240725$EXP$FR-AFSSAPS-LL2024001308$FR-MYLANLABS-2024M1068264$MYLAN$$76$YR$$F$Y$$$20240725$$MD$FR$FR
241373591$24137359$1$I$20240721$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145463$AMGEN$$75$YR$E$F$Y$$$20240725$$CN$US$US
241373606$24137360$6$F$$20240902$20240725$20240904$PER$$US-AMGEN-USASP2024146688$AMGEN$$$$$M$Y$$$20240904$$CN$US$US
241373612$24137361$2$F$$20240712$20240725$20240822$PER$$US-ROCHE-10000026120$ROCHE$$$$$$Y$$$20240822$$CN$US$US
241373622$24137362$2$F$20240710$20240917$20240725$20240924$EXP$$MX-SANDOZ INC.-SDZ2024MX067840$SANDOZ$$8$YR$$M$Y$27$KG$20240924$$CN$MX$MX
241373631$24137363$1$I$20240622$20240717$20240725$20240725$EXP$FR-AFSSAPS-AN2024000901$FR-GUERBET / LLC-FR-20240270$GUERBET$$81$YR$E$M$Y$$$20240725$$PH$FR$FR
241373651$24137365$1$I$$20240724$20240725$20240725$PER$$US-ROCHE-10000035707$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241373662$24137366$2$F$20240707$20240913$20240725$20240918$PER$$US-ROCHE-10000034653$ROCHE$$19$YR$A$M$Y$65.77$KG$20240918$$CN$US$US
241373671$24137367$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034695$ROCHE$$$$C$M$Y$$$20240725$$CN$US$US
241373682$24137368$2$F$$20240813$20240725$20240814$PER$$US-ROCHE-3571604$ROCHE$$$$E$F$Y$$$20240814$$CN$US$US
241373691$24137369$1$I$$20240723$20240725$20240725$PER$$US-ROCHE-10000034984$ROCHE$$$$C$M$Y$$$20240725$$CN$US$US
241373701$24137370$1$I$$20240719$20240725$20240725$PER$$IN-ROCHE-10000030711$ROCHE$Deshpande A,  Delayed-onset serum sickness due to rituximab in pemphigus vulgaris. Indian J Drugs in Dermatol. 2019;5 (1):54-7. doi:10.4103/ijdd.ijdd_5_19.$17$YR$T$M$Y$$$20240725$$MD$IN$US
241373711$24137371$1$I$$20240724$20240725$20240725$PER$$US-ROCHE-10000035553$ROCHE$$$$$$Y$$$20240725$$CN$US$US
241373721$24137372$1$I$20240719$20240719$20240725$20240725$PER$$US-ROCHE-10000031670$ROCHE$$$$$M$Y$$$20240725$$PH$US$US
241373732$24137373$2$F$$20240724$20240725$20240726$PER$$US-ROCHE-10000034994$ROCHE$$$$$M$Y$$$20240726$$CN$US$US
241373741$24137374$1$I$$20240724$20240725$20240725$PER$$US-ROCHE-3575901$ROCHE$$$$E$F$Y$$$20240725$$CN$US$US
241373771$24137377$1$I$$20240722$20240725$20240725$PER$$US-ROCHE-10000033210$ROCHE$$$$A$M$Y$$$20240725$$CN$US$US
241373781$24137378$1$I$20240605$20240724$20240725$20240725$EXP$FR-AFSSAPS-AN2024000920$FR-ORGANON-O2407FRA002268$ORGANON$$53$YR$$F$Y$48.5$KG$20240725$$MD$FR$FR
241373791$24137379$1$I$$20240719$20240725$20240725$DIR$FDA-CDER-CTU-2024-51157$$FDA-CTU$$$$$F$N$$$20240719$N$HP$US$
241373801$24137380$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51165$$FDA-CTU$$57$YR$$M$N$$$20240725$N$$US$
241373811$24137381$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5851114$ABBVIE$$$$$$Y$$$20240725$$CN$US$US
241373841$24137384$1$I$$20200706$20240725$20240725$EXP$$GB-AstraZeneca-2020SE87721$ASTRAZENECA$$$$$F$Y$$$20240725$$HP$GB$
241373851$24137385$1$I$$20240717$20240725$20240725$EXP$$US-AstraZeneca-2024A163808$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241373861$24137386$1$I$$20191213$20240725$20240725$EXP$$RU-AstraZeneca-2019SF82825$ASTRAZENECA$$46$YR$$M$Y$$$20240725$$CN$RU$
241373871$24137387$1$I$20240601$20240718$20240725$20240725$EXP$$US-AMERICAN REGENT INC-2024002795$AMERICAN REGENT$$43$YR$$M$Y$89$KG$20240725$$HP$US$US
241373881$24137388$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51164$$FDA-CTU$$64$YR$$F$N$$$20240725$N$$US$
241373891$24137389$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118189$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$71.67$KG$20240725$$CN$US$US
241373903$24137390$3$F$$20240801$20240725$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-109023$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240814$$PH$JP$JP
241373911$24137391$1$I$$20240724$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118324$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240725$$CN$US$US
241373921$24137392$1$I$$20240722$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116602$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240725$$HP$US$US
241373931$24137393$1$I$$20200817$20240725$20240725$EXP$$US-AstraZeneca-2020SF05549$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241373951$24137395$1$I$$20240712$20240725$20240725$EXP$$ES-ASTELLAS-2024US020793$ASTELLAS$$7$YR$$M$Y$24$KG$20240725$$CN$CH$ES
241373966$24137396$6$F$20240201$20240927$20240725$20240927$EXP$$US-PFIZER INC-202400222187$PFIZER$$68$YR$$F$Y$$$20240927$$MD$US$US
241373971$24137397$1$I$20240724$20240724$20240725$20240725$EXP$GB-MHRA-MED-202407241847205650-HNVSF$GB-PFIZER INC-202400222979$PFIZER$$$$$$Y$$$20240725$$PH$GB$GB
241373981$24137398$1$I$$20240723$20240725$20240725$EXP$$JP-PFIZER INC-202400223277$PFIZER$$$$$$Y$$$20240725$$MD$JP$JP
241373992$24137399$2$F$20220101$20240801$20240725$20240805$EXP$NL-LRB-00993246$NL-PFIZER INC-202400223480$PFIZER$$59$YR$$F$Y$61$KG$20240805$$CN$NL$NL
241374011$24137401$1$I$20240719$20240723$20240725$20240725$EXP$$CN-PFIZER INC-202400221767$PFIZER$$5$DEC$$M$Y$$$20240725$$MD$CN$CN
241374041$24137404$1$I$$20240723$20240725$20240725$EXP$$GB-PFIZER INC-202400222098$PFIZER$$96$YR$$F$Y$$$20240725$$HP$GB$GB
241374051$24137405$1$I$20240602$20240718$20240725$20240725$EXP$HR-HALMED-300086045$HR-PFIZER INC-202400223704$PFIZER$$14$YR$$F$Y$43$KG$20240725$$MD$HR$HR
241374061$24137406$1$I$$20240722$20240725$20240725$EXP$$US-PFIZER INC-202400222490$PFIZER$$$$$$Y$$$20240725$$MD$US$US
241374081$24137408$1$I$$20240724$20240725$20240725$EXP$$CL-PFIZER INC-202400221973$PFIZER$$$$$$Y$$$20240725$$MD$CL$CL
241374091$24137409$1$I$20240429$20240716$20240725$20240725$EXP$$CH-PFIZER INC-202400223327$PFIZER$$54$YR$$F$Y$$$20240725$$MD$CH$CH
241374105$24137410$5$F$20240101$20240928$20240725$20240930$EXP$$US-PFIZER INC-202400222270$PFIZER$$46$YR$$M$Y$$$20240930$$MD$US$US
241374111$24137411$1$I$$20240720$20240725$20240725$EXP$$CN-SANDOZ INC.-SDZ2024CN068020$SANDOZ$$$$$$Y$$$20240725$$CN$CN$CN
241374121$24137412$1$I$$20240715$20240725$20240725$EXP$$PT-TEVA-VS-3222902$TEVA$Roias C., Couto C., Cardoso B, Oom V, Oliveira RP. DRESS SYNDROME IN CHRONIC KIDNEY DISEASE Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 1207$47$YR$$M$Y$$$20240725$$MD$PT$PT
241374131$24137413$1$I$$20240715$20240725$20240725$PER$$US-JNJFOC-20240762335$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$HP$US$US
241374141$24137414$1$I$20240723$20240723$20240725$20240725$EXP$$US-TAKEDA-2024TUS074534$TAKEDA$$41$YR$$M$Y$$$20240725$$CN$US$US
241374151$24137415$1$I$20240418$20240717$20240725$20240725$PER$$US-IGSA-BIG0029121$GRIFOLS$$58$YR$$M$Y$97.052$KG$20240725$$CN$US$US
241374161$24137416$1$I$$20240724$20240725$20240725$EXP$$US-SANDOZ INC.-SDZ2024US068097$SANDOZ$$$$$F$Y$$$20240725$$CN$US$US
241374171$24137417$1$I$$20240723$20240725$20240725$EXP$GB-MHRA-31008345$GB-SANDOZ INC.-SDZ2024GB068049$SANDOZ$$62$YR$$F$Y$62$KG$20240725$$CN$GB$GB
241374181$24137418$1$I$$20240719$20240725$20240725$PER$$US-BAYER-2024A106801$BAYER$$65$YR$E$$Y$$$20240725$$CN$US$US
241374191$24137419$1$I$20201212$20240723$20240725$20240725$EXP$$FR-OTSUKA-2024_020555$OTSUKA$$54$YR$$F$Y$$$20240725$$CN$FR$FR
241374201$24137420$1$I$$20240718$20240725$20240725$30DAY$$US-SANDOZ INC.-NVSC2020US289944$SANDOZ$$$$$M$Y$$$20240725$$CN$US$US
241374231$24137423$1$I$$20240718$20240725$20240725$EXP$$CN-AMGEN-CHNSP2024143595$AMGEN$Chen S.; Shen L.; Cao W. et al.. Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation. Blood cancer journal. 2024;14 (1)$47$YR$A$F$Y$$$20240725$$HP$CN$CN
241374252$24137425$2$F$20240719$20240730$20240725$20240806$PER$$US-AMGEN-USASP2024144055$AMGEN$$$$$M$Y$103$KG$20240805$$HP$US$US
241374261$24137426$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51290$$FDA-CTU$$80$YR$$M$N$$$20240725$N$$US$
241374271$24137427$1$I$20230329$20240718$20240725$20240725$EXP$FR-AFSSAPS-MA2024001187$FR-GUERBET / LLC-FR-20240273$GUERBET$$42$YR$A$F$Y$70$KG$20240725$$CN$FR$FR
241374281$24137428$1$I$$20240715$20240725$20240725$EXP$$PT-FreseniusKabi-FK202411357$FRESENIUS KABI$Nunes AP, Jardim M, Gomes S, Almada S, Fernandes AC, Pestana A. CO-0177 -(4798) -Drifting abstinence. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. 2024 May;277.$63$YR$A$F$Y$$$20240725$$MD$PT$PT
241374311$24137431$1$I$$20240719$20240725$20240725$PER$$US-ROCHE-10000031875$ROCHE$$10$YR$C$M$Y$$$20240725$$CN$US$US
241374321$24137432$1$I$20240402$20240709$20240725$20240725$EXP$$DE-ROCHE-10000035363$ROCHE$$27$YR$A$F$Y$56$KG$20240725$$MD$DE$DE
241374331$24137433$1$I$$20240715$20240725$20240725$EXP$$CA-FreseniusKabi-FK202411245$FRESENIUS KABI$$79$YR$E$F$Y$$$20240725$$HP$CA$CA
241374361$24137436$1$I$20240504$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51151$$FDA-CTU$$66$YR$$M$N$$$20240724$N$$US$
241374372$24137437$2$F$20240501$20240911$20240725$20240920$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004878$SAREPTA THERAPEUTICS$$29$YR$$F$Y$$$20240920$$MD$US$US
241374381$24137438$1$I$20240330$20240723$20240725$20240725$EXP$$HU-MYLANLABS-2024M1068869$MYLAN$$69$YR$$F$Y$$$20240725$$CN$HU$HU
241374401$24137440$1$I$20240723$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-51184$$FDA-CTU$$70$YR$$M$N$$$20240723$N$$US$
241374411$24137441$1$I$$20240719$20240725$20240725$DIR$FDA-CDER-CTU-2024-51155$$FDA-CTU$$$$$F$N$$$20240719$N$HP$US$
241374431$24137443$1$I$20240509$20240724$20240725$20240725$30DAY$$US-SANDOZ INC.-SDZ2024US068037$SANDOZ$$19$YR$$F$Y$$$20240725$$HP$US$US
241374451$24137445$1$I$20240723$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-51197$$FDA-CTU$$79$YR$$F$N$61.23$KG$20240723$Y$$US$
241374461$24137446$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51303$$FDA-CTU$$76$YR$$F$N$$$20240725$N$$US$
241374481$24137448$1$I$$20240723$20240723$20240723$DIR$FDA-CDER-CTU-2024-51198$$FDA-CTU$$$$$$N$$$20240723$N$$US$
241374491$24137449$1$I$$20240724$20240725$20240725$PER$$US-BAYER-2024A108191$BAYER$$$$$$Y$$$20240725$$CN$US$US
241374502$24137450$2$F$20240719$20240726$20240725$20240729$PER$$US-ROCHE-10000034571$ROCHE$$$$$$Y$$$20240729$$PH$US$US
241374511$24137451$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51306$$FDA-CTU$$59$YR$$F$N$187$LBS$20240725$N$$US$
241374531$24137453$1$I$20240624$20240712$20240725$20240725$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000645$PAREXEL$$$$$$Y$$$20240725$$HP$CN$CN
241374541$24137454$1$I$$20240718$20240725$20240725$EXP$$NVSC2024US149517$NOVARTIS$$$$$F$Y$$$20240725$$CN$US$US
241374551$24137455$1$I$20240702$20240712$20240725$20240725$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000644$PAREXEL$$$$$$Y$$$20240725$$HP$CN$CN
241374561$24137456$1$I$20240617$20240722$20240725$20240725$EXP$$US-SANDOZ INC.-SDZ2024US067453$SANDOZ$$67$YR$$F$Y$73$KG$20240725$$HP$US$US
241374574$24137457$4$F$20240726$20240906$20240725$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118018$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$51.71$KG$20240910$$CN$US$US
241374581$24137458$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118220$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240725$$CN$US$US
241374591$24137459$1$I$20240723$20240724$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117913$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$92.53$KG$20240725$$CN$US$US
241374601$24137460$1$I$$20240723$20240725$20240725$EXP$$IT-SANDOZ INC.-SDZ2024IT067488$SANDOZ$$15$YR$$F$Y$48$KG$20240725$$HP$IT$IT
241374613$24137461$3$F$20220101$20240722$20240725$20240730$PER$$US-AMGEN-USASP2024145880$AMGEN$$76$YR$E$M$Y$$$20240730$$CN$US$US
241374622$24137462$2$F$$20240719$20240725$20240725$PER$$US-ROCHE-10000033670$ROCHE$$7$YR$C$M$Y$$$20240725$$CN$US$US
241374631$24137463$1$I$$20240719$20240725$20240725$PER$$US-ROCHE-10000033055$ROCHE$$1$YR$I$F$Y$$$20240725$$CN$US$US
241374641$24137464$1$I$$20240723$20240725$20240725$EXP$$US-BAYER-2024A107099$BAYER$$$$$$Y$$$20240725$$CN$US$US
241374651$24137465$1$I$20240718$20240719$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407013714$ELI LILLY AND CO$$$$$$Y$$$20240725$$CN$US$US
241374661$24137466$1$I$$20240723$20240725$20240725$EXP$$BE-SANDOZ INC.-SDZ2024BE067396$SANDOZ$$32$YR$$$Y$$$20240725$$MD$BE$BE
241374671$24137467$1$I$$20240718$20240725$20240725$EXP$$JP-OTSUKA-2024_020206$OTSUKA$$$$$M$Y$$$20240725$$CN$JP$JP
241374681$24137468$1$I$$20240720$20240725$20240725$EXP$$IN-SANDOZ INC.-SDZ2024IN041207$SANDOZ$$$$$F$Y$$$20240725$$CN$IN$IN
241374691$24137469$1$I$$20240718$20240725$20240725$EXP$$CH-SANDOZ INC.-SDZ2024CH068104$SANDOZ$$$$$$Y$$$20240725$$CN$CH$CH
241374701$24137470$1$I$20240301$20240719$20240725$20240725$EXP$$CN-PURDUE-USA-2024-0310928$PURDUE$$60$YR$$M$Y$60$KG$20240725$$HP$CN$CN
241374711$24137471$1$I$$20240723$20240725$20240725$EXP$$FR-PURDUE-USA-2024-0310939$PURDUE$I.A Larabi, A.Ghich, P.Kintz, M.Marillier, N. Fabresse, R.Pelletier, et al;. A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxicologie Analytique + Clinique. 2023;35:376-394$$$$M$Y$$$20240725$$MD$FR$FR
241374721$24137472$1$I$$20240723$20240725$20240725$EXP$$FR-PURDUE-USA-2024-0310955$PURDUE$I.A Larabi, A.Ghich, P.Kintz, M.Marillier, N. Fabresse, R.Pelletier, et al.. A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).. Toxicologie Analytique + Clinique. 2023;35:376-394$49$YR$$M$Y$$$20240725$$MD$FR$FR
241374731$24137473$1$I$$20240723$20240725$20240725$EXP$$FR-PURDUE-USA-2024-0310940$PURDUE$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N and al. Chemsex in France: a national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxicologie Analytique + Clinique. 2023;35:376-394$62$YR$$M$Y$$$20240725$$MD$FR$FR
241374742$24137474$2$F$20240613$20240801$20240725$20240806$EXP$$DE-JNJFOC-20240755733$JOHNSON AND JOHNSON$$70$YR$E$M$Y$85.5$KG$20240806$$MD$DE$DE
241374751$24137475$1$I$$20240718$20240725$20240725$EXP$$AT-MYLANLABS-2024M1067375$MYLAN$$43$YR$$M$Y$$$20240725$$CN$AT$AT
241374761$24137476$1$I$20240703$20240724$20240725$20240725$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006331$AURINIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240725$$CN$US$US
241374771$24137477$1$I$$20240722$20240725$20240725$EXP$$TR-UCBSA-2024037502$UCB$Demiral GZ, Akin SB, Gunday OK, Sahbaz FG, Boru UT. Maternal and fetal outcomes of antiepileptic treatments during pregnancy: A retrospective study. Epilepsy + behavior. 2024;158:1-7$$$N$$Y$$$20240725$$HP$TR$TR
241374781$24137478$1$I$$20240723$20240725$20240725$30DAY$$US-SANDOZ INC.-SDZ2024US067889$SANDOZ$$$$$M$Y$$$20240725$$CN$US$US
241374801$24137480$1$I$20240624$20240714$20240725$20240725$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22091$SAMSUNG BIOEPIS$$43$YR$A$$Y$$$20240725$$HP$CA$CA
241374811$24137481$1$I$$20210427$20240725$20240725$EXP$$US-AstraZeneca-2021A365797$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$US$
241374822$24137482$2$F$20240713$20240805$20240725$20240813$EXP$$EG-AstraZeneca-2024A165107$ASTRAZENECA$$25032$DY$$F$Y$$$20240813$$CN$EG$
241374831$24137483$1$I$$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A164332$ASTRAZENECA$$74$YR$$F$Y$41$KG$20240725$$MD$JP$
241374852$24137485$2$F$$20240806$20240725$20240814$EXP$$CA-AstraZeneca-2024A163869$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$CA$
241374861$24137486$1$I$$20240723$20240725$20240725$EXP$$CA-ORGANON-O2407CAN002175$ORGANON$$40$YR$$F$Y$96$KG$20240725$$HP$CA$CA
241374871$24137487$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06338$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241374881$24137488$1$I$$20240722$20240725$20240725$PER$$US-ABBVIE-5850724$ABBVIE$$59$YR$$M$Y$$$20240725$$CN$US$US
241374891$24137489$1$I$$20240723$20240725$20240725$EXP$$US-SANDOZ INC.-SDZ2024US067862$SANDOZ$$$$$F$Y$$$20240725$$CN$US$US
241374901$24137490$1$I$$20240722$20240725$20240725$30DAY$$US-SANDOZ INC.-SDZ2024US067641$SANDOZ$$$$$F$Y$$$20240725$$CN$US$US
241374911$24137491$1$I$$20240718$20240725$20240725$EXP$$US-JNJFOC-20240752633$JOHNSON AND JOHNSON$$$$$M$Y$84.898$KG$20240725$$CN$US$US
241374921$24137492$1$I$20240718$20240718$20240725$20240725$EXP$$US-RDY-CLI/USA/24/0010767$DR REDDYS$$21$YR$T$F$Y$$$20240725$$MD$US$US
241374932$24137493$2$F$$20240802$20240725$20240810$PER$$US-RDY-CLI/USA/24/0010651$DR REDDYS$$40$YR$A$F$Y$$$20240810$$MD$US$US
241374941$24137494$1$I$$20240703$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06912$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241374951$24137495$1$I$$20240723$20240725$20240725$EXP$$ES-WAYLIS-2024-ES-000075$Waylis$$$$$M$Y$$$20240724$$PH$ES$ES
241374961$24137496$1$I$$20240717$20240725$20240725$PER$$US-TAKEDA-2024TUS072514$TAKEDA$$$$$$Y$$$20240725$$CN$US$US
241374971$24137497$1$I$20240720$20240723$20240725$20240725$PER$$US-009507513-2407USA012938$MERCK$$29$YR$$F$Y$$$20240725$$HP$US$US
241374981$24137498$1$I$20240101$20240719$20240725$20240725$EXP$$AR-MERCK SHARP + DOHME LLC-2405ARG008390$MERCK$$52$YR$$M$Y$80$KG$20240725$$MD$AR$AR
241374992$24137499$2$F$$20240806$20240725$20240809$30DAY$$GB-MYLANLABS-2024M1068783$MYLAN$$$$$M$Y$$$20240809$$PH$GB$GB
241375003$24137500$3$F$20240718$20240829$20240725$20240903$PER$$US-AMGEN-USASP2024144335$AMGEN$$62$YR$A$F$Y$93$KG$20240903$$PH$US$US
241375012$24137501$2$F$$20240731$20240725$20240807$PER$$US-AMGEN-USASP2024143993$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241375021$24137502$1$I$20240620$20240722$20240725$20240725$EXP$FR-AFSSAPS-ST2024001142$FR-FreseniusKabi-FK202411557$FRESENIUS KABI$$24$YR$A$M$Y$85$KG$20240725$$MD$FR$FR
241375031$24137503$1$I$$20240715$20240725$20240725$EXP$$PT-FreseniusKabi-FK202411344$FRESENIUS KABI$Damaso F, Ribeiro AM, Oliveira JC, Anastacio M, Duarte J, Eliseu A. PO-0331 - (4887) ? Atypical hemolytic uremic syndrome. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional de Medicina Interna - Livro de resumos.. 2024 May;695-695.$58$YR$A$M$Y$$$20240725$$HP$PT$PT
241375041$24137504$1$I$$20240716$20240725$20240725$EXP$$US-FreseniusKabi-FK202411454$FRESENIUS KABI$Torelli VA, Ernest Jean R, Tran E. Acute Hypoxic Respiratory Failure Secondary to Daptomycin-induced Eosinophilic Pneumonia.. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: doi:https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2019.$86$YR$E$F$Y$$$20240725$$HP$US$US
241375051$24137505$1$I$$20240715$20240725$20240725$EXP$$CA-FreseniusKabi-FK202411248$FRESENIUS KABI$$81$YR$E$M$Y$$$20240725$$HP$CA$CA
241375061$24137506$1$I$$20240719$20240725$20240725$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006310$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$HP$US$US
241375071$24137507$1$I$$20240717$20240725$20240725$PER$$US-BEH-2024175911$CSL BEHRING$$$$A$F$Y$$$20240725$$CN$US$US
241375121$24137512$1$I$$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51168$$FDA-CTU$$$$$M$N$$$20240724$N$HP$US$
241375151$24137515$1$I$20240711$20240715$20240725$20240725$DIR$FDA-CDER-CTU-2024-51014$$FDA-CTU$$47$YR$$F$N$82.1$KG$20240715$N$$US$
241375171$24137517$1$I$$20240702$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06797$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241375191$24137519$1$I$$20240724$20240725$20240725$PER$$US-BAYER-2024A108167$BAYER$$$$$$Y$$$20240725$$CN$US$US
241375201$24137520$1$I$$20240718$20240725$20240725$PER$$US-BEH-2024176001$CSL BEHRING$$10$YR$C$M$Y$$$20240725$$CN$US$US
241375211$24137521$1$I$20240601$20240718$20240725$20240725$PER$$US-BEH-2024175990$CSL BEHRING$$60$YR$A$F$Y$$$20240725$$HP$US$US
241375221$24137522$1$I$$20240718$20240725$20240725$PER$$US-BEH-2024175999$CSL BEHRING$$$$A$F$Y$$$20240725$$CN$US$US
241375232$24137523$2$F$20240701$20240718$20240725$20240809$PER$$US-BEH-2024175991$CSL BEHRING$$31$YR$A$F$Y$47.619$KG$20240809$$PH$US$US
241375242$24137524$2$F$$20240716$20240725$20240802$PER$$US-ABBVIE-5844538$ABBVIE$$$$$F$Y$61$KG$20240802$$CN$US$US
241375251$24137525$1$I$20220201$20240717$20240725$20240725$EXP$$US-AMGEN-USASL2024143981$AMGEN$$61$YR$A$F$Y$$$20240725$$MD$US$US
241375271$24137527$1$I$$20240703$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06803$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241375283$24137528$3$F$20240715$20240912$20240725$20240918$EXP$$CA-TAKEDA-2024TUS072391$TAKEDA$$93$YR$$M$Y$$$20240918$$CN$CA$CA
241375291$24137529$1$I$20240424$20240501$20240725$20240725$PER$$US-GE HEALTHCARE-2024CSU004664$GE HEALTHCARE$$40$YR$$M$Y$$$20240725$$PH$US$US
241375301$24137530$1$I$20240424$20240501$20240725$20240725$PER$$US-GE HEALTHCARE-2024CSU004661$GE HEALTHCARE$$71$YR$$F$Y$$$20240725$$HP$US$US
241375311$24137531$1$I$20240606$20240607$20240725$20240725$PER$$US-GE HEALTHCARE-2024CSU006409$GE HEALTHCARE$$46$YR$$F$Y$89.342$KG$20240725$$HP$US$US
241375321$24137532$1$I$20240606$20240607$20240725$20240725$PER$$US-GE HEALTHCARE-2024CSU006411$GE HEALTHCARE$$49$YR$$F$Y$89.796$KG$20240725$$HP$US$US
241375331$24137533$1$I$20240606$20240607$20240725$20240725$PER$$US-GE HEALTHCARE-2024CSU006410$GE HEALTHCARE$$44$YR$$F$Y$94.331$KG$20240725$$HP$US$US
241375341$24137534$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51253$$FDA-CTU$$64$YR$$F$N$257$LBS$20240725$N$$US$
241375351$24137535$1$I$20240424$20240501$20240725$20240725$PER$$US-GE HEALTHCARE-2024CSU004663$GE HEALTHCARE$$45$YR$$M$Y$76.5$KG$20240725$$PH$US$US
241375361$24137536$1$I$20240424$20240501$20240725$20240725$PER$$US-GE HEALTHCARE-2024CSU004662$GE HEALTHCARE$$64$YR$$M$Y$108$KG$20240725$$PH$US$US
241375371$24137537$1$I$20240524$20240722$20240725$20240725$EXP$SE-SEMPA-2024-005041$SE-MYLANLABS-2024M1068474$MYLAN$$90$YR$$F$Y$$$20240725$$MD$SE$SE
241375391$24137539$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024AMR091985$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241375411$24137541$1$I$$20240724$20240725$20240725$PER$$US-HALEON-2188936$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241375421$24137542$1$I$$20240722$20240725$20240725$EXP$$US-JNJFOC-20240760816$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240725$$HP$US$US
241375431$24137543$1$I$$20240723$20240725$20240725$DIR$FDA-CDER-CTU-2024-51315$$FDA-CTU$$$$$F$N$$$20240723$N$HP$US$
241375441$24137544$1$I$$20240703$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06804$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241375451$24137545$1$I$20240101$20240722$20240725$20240725$PER$$US-Eisai-EC-2024-168674$EISAI$$63$YR$A$M$Y$$$20240725$$CN$US$US
241375471$24137547$1$I$20240618$20240712$20240725$20240725$PER$$US-FreseniusKabi-FK202411115$FRESENIUS KABI$$58$YR$A$F$Y$90.34$KG$20240725$$HP$US$US
241375481$24137548$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024147358$AMGEN$$$$$M$Y$$$20240725$$CN$US$US
241375492$24137549$2$F$$20240723$20240725$20240725$PER$$NVSC2024US151927$NOVARTIS$$$$$M$Y$$$20240726$$HP$US$US
241375501$24137550$1$I$$20240719$20240725$20240725$DIR$FDA-CDER-CTU-2024-51317$$FDA-CTU$$$$$F$N$$$20240719$N$HP$US$
241375511$24137551$1$I$$20240703$20240725$20240725$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06921$LUPIN$$$$$$Y$$$20240725$$CN$US$US
241375521$24137552$1$I$20240606$20240722$20240725$20240725$EXP$$GB-AMGEN-GBRSP2024145246$AMGEN$$48$YR$A$M$Y$86$KG$20240725$$CN$GB$GB
241375531$24137553$1$I$$20240604$20240725$20240725$EXP$$DE-AstraZeneca-2024A133917$ASTRAZENECA$$$$$F$Y$$$20240725$$HP$DE$
241375542$24137554$2$F$20240403$20240718$20240725$20240729$EXP$$CN-009507513-2407CHN012518$MERCK$$68$YR$$M$Y$59.6$KG$20240729$$HP$CN$CN
241375551$24137555$1$I$$20220223$20240725$20240725$EXP$$IT-AstraZeneca-2022A088005$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$IT$
241375561$24137556$1$I$$20200706$20240725$20240725$EXP$$US-AstraZeneca-2020SE86726$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$US$
241375571$24137557$1$I$20240708$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117989$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$91.17$KG$20240725$$HP$US$US
241375581$24137558$1$I$$20240722$20240725$20240725$EXP$$NVSC2024CN152724$NOVARTIS$$42$YR$$M$Y$$$20240725$$CN$CN$CN
241375601$24137560$1$I$20240713$20240718$20240725$20240725$EXP$$NVSC2024US150183$NOVARTIS$$68$YR$$M$Y$81.6$KG$20240725$$HP$US$US
241375611$24137561$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016002$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240725$$CN$US$US
241375622$24137562$2$F$$20240724$20240725$20240730$EXP$$HU-PFIZER INC-202400221791$PFIZER$Mehes, L.. The pathophysiology, clinical signs and therapy of urate nephropathy.. Orvosi Hetilap. 2007;148(16):745-8$52$YR$$M$Y$$$20240730$$MD$HU$HU
241375641$24137564$1$I$20240401$20240718$20240725$20240725$EXP$$US-SPRINGWORKS THERAPEUTICS-SW-001844$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240725$$CN$US$US
241375651$24137565$1$I$$20240719$20240725$20240725$EXP$$CA-OTSUKA-2024_020345$OTSUKA$$$$$M$Y$$$20240725$$CN$CA$CA
241375661$24137566$1$I$$20240710$20240725$20240725$EXP$$US-HLS-202400321$HLS THERAPEUTICS$$48$YR$A$M$Y$$$20240725$$CN$US$US
241375681$24137568$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024AMR091982$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241375691$24137569$1$I$20230503$20240717$20240725$20240725$EXP$$US-AMYLYX PHARMACEUTICALS, INC-AMX-001444$AMYLYX PHARMACEUTICALS$$53$YR$$M$Y$$$20240725$$CN$US$US
241375703$24137570$3$F$20240701$20240905$20240725$20240909$EXP$$JP-009507513-2407JPN003960J$MERCK$$$$E$$Y$$$20240909$$PH$JP$JP
241375711$24137571$1$I$20240621$20240722$20240725$20240725$EXP$$SG-JNJFOC-20240760020$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240725$$HP$SG$SG
241375721$24137572$1$I$20240618$20240722$20240725$20240725$EXP$$SG-JNJFOC-20240760010$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240725$$HP$SG$SG
241375731$24137573$1$I$$20240724$20240725$20240725$EXP$$CA-SANDOZ INC.-SDZ2024CA068072$SANDOZ$$8$YR$$M$Y$$$20240725$$HP$CA$CA
241375741$24137574$1$I$$20240724$20240725$20240725$30DAY$$US-SANDOZ INC.-SDZ2024US067671$SANDOZ$$$$$M$Y$$$20240725$$CN$US$US
241375753$24137575$3$F$20070901$20240903$20240725$20240909$EXP$FR-EMA-DD-20240717-7482677-080126$FR-SANDOZ INC.-SDZ2024FR067508$SANDOZ$$21$YR$$M$Y$$$20240909$$MD$FR$FR
241375763$24137576$3$F$20210901$20240722$20240725$20240917$EXP$$BG-SANDOZ INC.-NVSC2022BG209975$SANDOZ$$65$YR$$M$Y$$$20240917$$MD$BG$BG
241375771$24137577$1$I$20240717$20240723$20240725$20240725$EXP$$US-SANDOZ INC.-SDZ2024US067875$SANDOZ$$59$YR$$F$Y$$$20240725$$HP$US$US
241375781$24137578$1$I$20240717$20240724$20240725$20240725$EXP$GB-MHRA-MED-202407241020397610-KDWHG$GB-SANDOZ INC.-SDZ2024GB068076$SANDOZ$$55$YR$$M$Y$91$KG$20240725$$PH$GB$GB
241375791$24137579$1$I$$20240722$20240725$20240725$30DAY$$US-SANDOZ INC.-SDZ2024US067624$SANDOZ$$19$YR$$F$Y$$$20240725$$CN$US$US
241375804$24137580$4$F$20240701$20240805$20240725$20240807$EXP$$US-ABBVIE-5850716$ABBVIE$$34$YR$$F$Y$38$KG$20240807$$CN$US$US
241375811$24137581$1$I$20240627$20240718$20240725$20240725$EXP$HU-OGYI-0091224$HU-GUERBET / LLC-HU-20240006$GUERBET$$67$YR$E$M$Y$120$KG$20240725$$HP$HU$HU
241375821$24137582$1$I$20240720$20240712$20240725$20240725$PER$$US-FreseniusKabi-FK202411117$FRESENIUS KABI$$59$YR$A$F$Y$75.98$KG$20240725$$HP$US$US
241375841$24137584$1$I$20200930$20240719$20240725$20240725$EXP$$US-TAKEDA-2024TUS074820$TAKEDA$$7$YR$$M$Y$$$20240725$$CN$US$US
241375851$24137585$1$I$$20240722$20240725$20240725$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003494$CURRAX PHARMACEUTICALS$$63$YR$$F$Y$$$20240725$$HP$CA$CA
241375862$24137586$2$F$$20240906$20240725$20240911$PER$$US-ABBVIE-5847539$ABBVIE$$37$YR$$F$Y$95$KG$20240911$$CN$US$US
241375871$24137587$1$I$$20240724$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118305$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240725$$CN$US$US
241375883$24137588$3$F$$20240905$20240725$20240910$PER$$US-ALXN-202407USA001045US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
241375901$24137590$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117705$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$HP$US$US
241375911$24137591$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118073$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$111.58$KG$20240725$$CN$US$US
241375921$24137592$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117763$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240725$$CN$US$US
241375932$24137593$2$F$20240708$20240802$20240725$20240807$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-115984$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$95$KG$20240808$$MD$AU$AU
241375941$24137594$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118066$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$73.94$KG$20240725$$CN$US$US
241375951$24137595$1$I$20240722$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223652$PFIZER$$65$YR$$F$Y$$$20240725$$CN$US$US
241375961$24137596$1$I$$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223326$PFIZER$$70$YR$$F$Y$$$20240725$$CN$US$US
241375971$24137597$1$I$$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223080$PFIZER$$47$YR$$F$Y$$$20240725$$CN$US$US
241375981$24137598$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51219$$FDA-CTU$$$$$$N$$$20240724$N$CN$US$
241375991$24137599$1$I$$20240723$20240725$20240725$PER$$US-PFIZER INC-202400222498$PFIZER$$15$YR$$F$Y$$$20240725$$HP$US$US
241376001$24137600$1$I$20240701$20240724$20240725$20240725$PER$$US-PFIZER INC-202400222618$PFIZER$$68$YR$$F$Y$$$20240725$$CN$US$US
241376011$24137601$1$I$$20240723$20240725$20240725$EXP$$CZ-SANDOZ INC.-SDZ2024CZ067580$SANDOZ$$51$YR$$F$Y$$$20240725$$HP$CZ$CZ
241376022$24137602$2$F$$20240913$20240725$20240917$PER$$US-PFIZER INC-202400221451$PFIZER$$$$$M$Y$$$20240917$$CN$US$US
241376031$24137603$1$I$$20240722$20240725$20240725$PER$$US-PFIZER INC-202400223719$PFIZER$$62$YR$$M$Y$104.12$KG$20240725$$MD$US$US
241376041$24137604$1$I$$20240626$20240725$20240725$PER$$US-009507513-2406USA009525$MERCK$$$$$F$Y$$$20240725$$CN$US$US
241376053$24137605$3$F$20230901$20240829$20240725$20240902$EXP$$JP-009507513-2407JPN004060J$MERCK$Matsubara S, Fujita K, Kansai R, Fukumi S, Igawa Y, Niwa F, et al.. [O-150 A case of drug-induced pneumatosis coli with sitagliptin]. Japanese Journal of Hospital General Medicine/The 28th Annual Meeting of Japanes. 2024;20(S1):201$81$YR$$M$Y$$$20240902$$MD$JP$JP
241376061$24137606$1$I$20240707$20240717$20240725$20240725$EXP$$CN-SA-2024SA213452$SANOFI AVENTIS$$78$YR$E$F$Y$50$KG$20240725$$HP$CN$CN
241376081$24137608$1$I$$20240724$20240725$20240725$PER$$US-AMGEN-USASP2024147818$AMGEN$$$$$F$Y$$$20240725$$MD$US$US
241376091$24137609$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5850690$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241376111$24137611$1$I$20240709$20240719$20240725$20240725$EXP$$EG-SA-2024SA214559$SANOFI AVENTIS$$68$YR$E$M$Y$100$KG$20240725$$HP$EG$EG
241376121$24137612$1$I$20240706$20240719$20240725$20240725$EXP$$EG-SA-2024SA215420$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240725$$HP$EG$EG
241376131$24137613$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51203$$FDA-CTU$$$$$$N$$$20240724$N$CN$US$
241376161$24137616$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51217$$FDA-CTU$$$$$$N$$$20240724$N$$US$
241376171$24137617$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51249$$FDA-CTU$$$$$$N$$$20240724$$CN$US$
241376181$24137618$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51227$$FDA-CTU$$$$$$N$$$20240724$$CN$US$
241376201$24137620$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51208$$FDA-CTU$$$$$$N$$$20240724$N$CN$US$
241376211$24137621$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51228$$FDA-CTU$$$$$$N$$$20240724$$CN$US$
241376232$24137623$2$F$20240401$20240729$20240725$20240802$EXP$$US-ABBVIE-5850986$ABBVIE$$72$YR$$M$Y$77$KG$20240802$$CN$US$US
241376241$24137624$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5851020$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241376252$24137625$2$F$$20240813$20240725$20240820$EXP$$US-JNJFOC-20240760711$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$HP$US$US
241376261$24137626$1$I$20230101$20240718$20240725$20240725$EXP$$GB-JNJFOC-20240752156$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240725$$HP$GB$GB
241376271$24137627$1$I$$20240723$20240725$20240725$EXP$$US-ABBVIE-5851620$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241376282$24137628$2$F$$20240911$20240725$20240917$EXP$$US-ABBVIE-5850181$ABBVIE$$$$$F$Y$63$KG$20240917$$CN$US$US
241376301$24137630$1$I$$20240715$20240725$20240725$PER$$US-BRACCO-2024US04329$BRACCO$Moody R, Tinker D, Hurley MY,  and Heinecke G. Rapid-onset DRESS syndrome secondary to iopamidol contrast media with subsequent syndrome of inappropriate antidiuretic hormone secretion. Journal of the American Academy of Dermatology (JAAD) Case Reports. 2024;50:85-7$65$YR$$F$Y$$$20240725$$MD$US$US
241376311$24137631$1$I$$20240712$20240725$20240725$EXP$$US-RDY-LIT/USA/24/0010385$DR REDDYS$Voelz K, Miller G, Lee-Miller C. 6-Mercaptopurine-associated Sinusoidal Obstructive Syndrome During Interim Maintenance I: A Case Report. Journal of Pediatric Hematology/Oncology. 2024 Jul 01;46(5): e317-e321. doi:10.1097/MPH.0000000000002883.$14$YR$T$M$Y$$$20240725$$MD$US$US
241376321$24137632$1$I$20240624$20240712$20240725$20240725$PER$$US-FreseniusKabi-FK202411116$FRESENIUS KABI$$58$YR$A$F$Y$77.64$KG$20240725$$HP$US$US
241376331$24137633$1$I$$20240717$20240725$20240725$EXP$NL-LRB-00982629$NL-FreseniusKabi-FK202411267$FRESENIUS KABI$$75$YR$E$M$Y$$$20240725$$CN$NL$NL
241376341$24137634$1$I$$20240530$20240725$20240725$PER$$US-TEVA-VS-3220791$TEVA$$60$YR$$F$Y$$$20240725$$CN$US$US
241376351$24137635$1$I$20210924$20240722$20240725$20240725$EXP$$NVSC2024KR150597$NOVARTIS$$$$A$F$Y$$$20240725$$HP$KR$KR
241376361$24137636$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118181$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240725$$CN$US$US
241376371$24137637$1$I$20240601$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116828$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240725$$CN$US$US
241376381$24137638$1$I$20240710$20240716$20240725$20240725$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407011622$ELI LILLY AND CO$$42$YR$A$F$Y$45$KG$20240725$$CN$CN$CN
241376391$24137639$1$I$$20240703$20240725$20240725$PER$$AU-TOLMAR, INC.-24AU050809$TOLMAR$$$$$M$Y$$$20240725$$CN$AU$AU
241376401$24137640$1$I$$20240704$20240725$20240725$PER$$BE-TOLMAR, INC.-24BE050829$TOLMAR$$$$$F$Y$$$20240725$$PH$BE$BE
241376411$24137641$1$I$$20240705$20240725$20240725$PER$$AU-TOLMAR, INC.-24AU050834$TOLMAR$$$$$M$Y$$$20240725$$CN$AU$AU
241376421$24137642$1$I$20240627$20240703$20240725$20240725$PER$$BR-TOLMAR, INC.-24BR050667$TOLMAR$$8$YR$$F$Y$$$20240725$$CN$BR$BR
241376431$24137643$1$I$20240601$20240703$20240725$20240725$PER$$BR-TOLMAR, INC.-24BR050804$TOLMAR$$10$YR$$F$Y$$$20240725$$CN$BR$BR
241376441$24137644$1$I$$20240626$20240725$20240725$PER$$US-ABBVIE-5853378$ABBVIE$$$$$$Y$$$20240725$$CN$US$US
241376451$24137645$1$I$$20240715$20240725$20240725$EXP$$JP-INSUD PHARMA-2407JP05874$INSUD PHARMA$Inoue F, Okazaki Y, Ichiba T, Chiba T, Namera A. Giant T waves and QT interval prolongation associated with guanfacine toxicity. CLINICAL TOXICOLOGY. 2024;62, 4:269-271$$$$$Y$$$20240725$$HP$JP$JP
241376461$24137646$1$I$$20240715$20240725$20240725$EXP$$JP-INSUD PHARMA-2407JP05878$INSUD PHARMA$Inoue F, Okazaki Y, Ichiba T, Chiba T, Namera A. Giant T waves and QT interval prolongation associated with guanfacine toxicity. CLINICAL TOXICOLOGY. 2024;62, 4:269-271$$$$$Y$$$20240725$$HP$JP$JP
241376471$24137647$1$I$$20240715$20240725$20240725$EXP$$JP-INSUD PHARMA-2407JP05879$INSUD PHARMA$Inoue F, Okazaki Y, Ichiba T, Chiba T, Namera A. Giant T waves and QT interval prolongation associated with guanfacine toxicity. CLINICAL TOXICOLOGY. 2024;62, 4:269-271$$$$$Y$$$20240725$$HP$JP$JP
241376481$24137648$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51234$$FDA-CTU$$$$$$N$$$20240724$$CN$US$
241376491$24137649$1$I$$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-51190$$FDA-CTU$$$$$M$N$$$20240723$N$HP$US$
241376501$24137650$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51279$$FDA-CTU$$77$YR$$M$N$$$20240724$N$$US$
241376511$24137651$1$I$20240617$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51338$$FDA-CTU$$85$YR$$F$N$$$20240724$N$PH$US$
241376531$24137653$1$I$20240720$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51239$$FDA-CTU$$35$YR$$F$N$63.5$KG$20240724$Y$CN$US$
241376571$24137657$1$I$$20240717$20240725$20240725$EXP$$US-AstraZeneca-2024A163514$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$US$
241376581$24137658$1$I$$20200915$20240725$20240725$EXP$$US-AstraZeneca-2020SF23758$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$US$
241376591$24137659$1$I$20190801$20200424$20240725$20240725$EXP$$US-AstraZeneca-2020SE48161$ASTRAZENECA$$560$MON$$F$Y$$$20240725$$CN$US$
241376603$24137660$3$F$$20240726$20240725$20240802$EXP$$CA-AstraZeneca-2024A167081$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$CA$
241376611$24137661$1$I$20240101$20240722$20240725$20240725$PER$$US-ABBVIE-5851582$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241376621$24137662$1$I$$20240723$20240725$20240725$EXP$$US-TAKEDA-2023TUS023948$TAKEDA$$$$$M$Y$$$20240725$$CN$US$US
241376631$24137663$1$I$20230430$20240724$20240725$20240725$EXP$$US-PFIZER INC-202400222855$PFIZER$$83$YR$$M$Y$$$20240725$$CN$US$US
241376641$24137664$1$I$$20240723$20240725$20240725$EXP$$CA-PFIZER INC-202400222145$PFIZER$$51$YR$$F$Y$$$20240725$$HP$CA$CA
241376652$24137665$2$F$$20240826$20240725$20240827$EXP$$CA-PFIZER INC-202400222170$PFIZER$$45$YR$$F$Y$$$20240827$$HP$CA$CA
241376661$24137666$1$I$$20240718$20240725$20240725$EXP$$CN-AMGEN-CHNSP2024143663$AMGEN$Chen S.; Huang J.; Shi B. et al.. Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation. Blood Cancer Journal. 2024;14 (1):1-13$46$YR$A$M$Y$$$20240725$$HP$CN$CN
241376671$24137667$1$I$$20240718$20240725$20240725$EXP$$CA-TAKEDA-2024TUS073185$TAKEDA$$57$YR$$M$Y$$$20240725$$HP$CA$CA
241376681$24137668$1$I$20240624$20240712$20240725$20240725$PER$$US-FreseniusKabi-FK202411113$FRESENIUS KABI$$55$YR$A$F$Y$77.34$KG$20240725$$HP$US$US
241376691$24137669$1$I$$20240722$20240725$20240725$EXP$$FR-FreseniusKabi-FK202411561$FRESENIUS KABI$$87$YR$E$F$Y$$$20240725$$PH$FR$FR
241376701$24137670$1$I$$20240717$20240725$20240725$EXP$NL-LRB-00981518$NL-FreseniusKabi-FK202411287$FRESENIUS KABI$$64$YR$A$M$Y$87$KG$20240725$$PH$NL$NL
241376711$24137671$1$I$$20240718$20240725$20240725$EXP$NL-LRB-00985171$NL-TEVA-VS-3223294$TEVA$$49$YR$$F$Y$86$KG$20240725$$MD$NL$NL
241376721$24137672$1$I$$20240718$20240725$20240725$EXP$$CA-TAKEDA-2024TUS073238$TAKEDA$$49$YR$$F$Y$$$20240725$$HP$CA$CA
241376731$24137673$1$I$20220124$20220124$20240725$20240725$EXP$$US-AstraZeneca-2022A043510$ASTRAZENECA$$79$YR$$M$Y$$$20240725$$CN$US$
241376741$24137674$1$I$$20240722$20240725$20240725$PER$$US-ABBVIE-5851652$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241376751$24137675$1$I$$20240715$20240725$20240725$EXP$$US-ORPHANEU-2024005541$RECORDATI$Heldman MR, Ma J, Gauthier J, Ohara RA, Cowan AJ, Yoke ML et al.. CMV and HSV Pneumonia after Immunosuppressive Agents  for Treatment of Cytokine Release Syndrome due to Chimeric  Antigen Receptor-Modified T (CAR-T)-Cell Immunotherapy. J Immunother. 2021;44(9):351-354$$$$$Y$$$20240725$$MD$US$US
241376761$24137676$1$I$$20240724$20240725$20240725$EXP$$CA-SANDOZ INC.-SDZ2024CA067959$SANDOZ$$52$YR$$F$Y$$$20240725$$HP$CA$CA
241376771$24137677$1$I$20240101$20240721$20240725$20240725$EXP$$SA-ABBVIE-5849461$ABBVIE$$58$YR$$F$Y$$$20240725$$CN$SA$SA
241376782$24137678$2$F$20240717$20240925$20240725$20240925$30DAY$$CO-PFIZER INC-PV202400095510$PFIZER$$10$YR$$M$Y$$$20240925$$CN$CO$CO
241376791$24137679$1$I$$20240718$20240725$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210203179$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240725$$CN$CA$CA
241376802$24137680$2$F$$20240731$20240725$20240805$30DAY$$CO-PFIZER INC-PV202400095508$PFIZER$$14$YR$$M$Y$$$20240805$$CN$CO$CO
241376811$24137681$1$I$$20240718$20240725$20240725$EXP$$US-TAKEDA-2024TUS073399$TAKEDA$$56$YR$$M$Y$$$20240725$$CN$US$US
241376821$24137682$1$I$20240101$20240719$20240725$20240725$EXP$$US-ABBVIE-5848536$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241376861$24137686$1$I$$20240716$20240725$20240725$EXP$$AU-TEVA-VS-3222466$TEVA$$$$$F$Y$$$20240725$$HP$AU$AU
241376871$24137687$1$I$$20240718$20240725$20240725$EXP$$CN-AMGEN-CHNSP2024143665$AMGEN$Chen S.; Huang J.; Shi B. et al.. Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation. Blood Cancer Journal. 2024;14 (1):1-13$19$YR$A$M$Y$$$20240725$$HP$CN$CN
241376881$24137688$1$I$$20240716$20240725$20240725$EXP$$AU-TEVA-VS-3222524$TEVA$$73$YR$$M$Y$$$20240725$$HP$AU$AU
241376891$24137689$1$I$$20240716$20240725$20240725$PER$$US-IGSA-BIG0030006$GRIFOLS$$$$$F$Y$36.281$KG$20240725$$HP$US$US
241376901$24137690$1$I$20240601$20240719$20240725$20240725$PER$$US-JNJFOC-20240752523$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240725$$CN$US$US
241376911$24137691$1$I$$20240716$20240725$20240725$EXP$$AU-TEVA-VS-3222489$TEVA$$$$$$Y$$$20240725$$HP$AU$AU
241376921$24137692$1$I$20240703$20240718$20240725$20240725$EXP$$CN-JNJFOC-20240751915$JOHNSON AND JOHNSON$$59$YR$A$M$Y$80$KG$20240725$$HP$CN$CN
241376931$24137693$1$I$$20240722$20240725$20240725$PER$$US-ABBVIE-5851888$ABBVIE$$$$$$Y$$$20240725$$HP$US$US
241376951$24137695$1$I$$20240723$20240725$20240725$PER$$US-ABBVIE-5852605$ABBVIE$$$$$$Y$$$20240725$$CN$US$US
241376981$24137698$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51332$$FDA-CTU$$$$$F$N$$$20240725$N$HP$US$
241377012$24137701$2$F$20240701$20240807$20240725$20240813$EXP$$JP-Eisai-EC-2024-170506$EISAI$$71$YR$E$M$Y$$$20240813$$MD$JP$JP
241377021$24137702$1$I$20240616$20240716$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010685$DR REDDYS$$19$YR$A$$Y$$$20240725$$HP$US$US
241377031$24137703$1$I$$20240717$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010737$DR REDDYS$$44$YR$A$F$Y$$$20240725$$MD$US$US
241377041$24137704$1$I$20240716$20240718$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010714$DR REDDYS$$19$YR$A$F$Y$$$20240725$$MD$US$US
241377051$24137705$1$I$$20240719$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010766$DR REDDYS$$18$YR$T$F$Y$$$20240725$$MD$US$US
241377061$24137706$1$I$20240712$20240717$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010653$DR REDDYS$$16$YR$$$Y$$$20240725$$HP$US$US
241377071$24137707$1$I$$20240717$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010740$DR REDDYS$$16$YR$T$F$Y$$$20240725$$MD$US$US
241377081$24137708$1$I$$20240716$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010654$DR REDDYS$$17$YR$T$$Y$$$20240725$$MD$US$US
241377091$24137709$1$I$$20240717$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010652$DR REDDYS$$$$$F$Y$$$20240725$$CN$US$US
241377101$24137710$1$I$20240619$20240712$20240725$20240725$PER$$US-FreseniusKabi-FK202411118$FRESENIUS KABI$$60$YR$A$F$Y$76.43$KG$20240725$$HP$US$US
241377111$24137711$1$I$$20240717$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010730$DR REDDYS$$23$YR$A$F$Y$$$20240725$$MD$US$US
241377121$24137712$1$I$$20240719$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010764$DR REDDYS$$16$YR$T$F$Y$$$20240725$$CN$US$US
241377131$24137713$1$I$20240715$20240716$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010682$DR REDDYS$$14$YR$T$F$Y$$$20240725$$CN$US$US
241377141$24137714$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51342$$FDA-CTU$$$$$F$N$$$20240724$N$HP$US$
241377151$24137715$1$I$$20240716$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010655$DR REDDYS$$$$$F$Y$$$20240725$$MD$US$US
241377161$24137716$1$I$20240711$20240722$20240725$20240725$EXP$$US-ABBVIE-5852034$ABBVIE$$86$YR$$F$Y$$$20240725$$CN$US$US
241377171$24137717$1$I$$20240715$20240725$20240725$EXP$$US-TEVA-VS-3222694$TEVA$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatr-Blood-Cancer 2024; 71 (7): e31004.$22$YR$$F$Y$$$20240725$$HP$US$US
241377181$24137718$1$I$$20240723$20240724$20240724$DIR$FDA-CDER-CTU-2024-51347$$FDA-CTU$$$$$M$N$$$20240723$N$HP$US$
241377191$24137719$1$I$$20240719$20240725$20240725$EXP$$NVSC2024FR143583$NOVARTIS$Gendarme S, Pastre J, Billaud EM, Gibault L, Guillemain R, Oudard S et al.. Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patients. THERAPIE. 2023;78(3):267-78$$$$M$Y$$$20240725$$HP$FR$FR
241377201$24137720$1$I$$20240722$20240725$20240725$EXP$$NVSC2024CN151802$NOVARTIS$Zhi C, Zhuo W, Li Y, Wenjie L, Fang T, Yu D et al.. Therapeutic effect of haploidentical hematopoietic stem cell transplantation for treatment of infant acute leukemia harboring KMT2A-r gene  rearrangements. J CHINA PEDIATR BLOOD CANCER. 2024;29 (3):186-93$8$MON$$F$Y$$$20240725$$HP$CN$CN
241377211$24137721$1$I$20210327$20240722$20240725$20240725$EXP$$NVSC2024KR150569$NOVARTIS$$1$YR$$F$Y$$$20240725$$CN$KR$KR
241377221$24137722$1$I$20240419$20240724$20240724$20240724$DIR$711360$$FDA-CTU$$42$YR$$F$N$69$KG$20240724$N$CN$US$
241377231$24137723$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5850987$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241377242$24137724$2$F$$20240729$20240725$20240807$EXP$$CO-TEVA-VS-3223548$TEVA$Mejia-Salgado G, Cardozo-Perez C, Cifuentes-Gonzalez C, Duran-Merino C, de-la-Torre A. Coinfection Suspicion is Imperative in Immunosuppressed Patients with Suspected Infectious Uveitis and Inadequate Treatment Response: A Case Report. Ocular-Immunol-Inflamm 2024; 0 (0); Mejia-Salgado G, Cardozo-Perez C, Cifuentes-Gonzalez C, Duran-Merino C, de-la-Torre A. Coinfection Suspicion is Imperative in Immunosuppressed Patients with Suspected Infectious Uveitis and Inadequate Treatment Response: A Ca...$70$YR$$F$Y$$$20240807$$MD$CO$CO
241377251$24137725$1$I$20240101$20240718$20240725$20240725$EXP$$US-GSK-US2024090677$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241377261$24137726$1$I$$20240716$20240725$20240725$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-117701$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240725$$MD$AU$AU
241377271$24137727$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024090663$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241377281$24137728$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51352$$FDA-CTU$$$$$M$N$$$20240724$N$$US$
241377291$24137729$1$I$20240503$20240718$20240725$20240725$EXP$$US-GSK-US2024090742$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241377301$24137730$1$I$$20240722$20240725$20240725$PER$$US-JNJFOC-20240758953$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$MD$US$US
241377311$24137731$1$I$$20240723$20240725$20240725$EXP$$GB-SANDOZ INC.-SDZ2024GB067724$SANDOZ$$33$YR$$M$Y$$$20240725$$PH$GB$GB
241377321$24137732$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152147$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
241377331$24137733$1$I$20200214$20240723$20240725$20240725$EXP$FR-AFSSAPS-LL20200416$FR-SANDOZ INC.-NVSC2020FR143597$SANDOZ$$64$YR$$M$Y$$$20240725$$PH$FR$FR
241377341$24137734$1$I$20240711$20240722$20240725$20240725$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004081$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
241377351$24137735$1$I$$20240722$20240725$20240725$PER$$NVSC2024US151904$NOVARTIS$$$$$M$Y$$$20240725$$CN$US$US
241377361$24137736$1$I$$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51353$$FDA-CTU$$44$YR$$M$N$$$20240724$N$$US$
241377371$24137737$1$I$$20240724$20240725$20240725$EXP$$CA-SANDOZ INC.-SDZ2024CA068103$SANDOZ$$$$$F$Y$$$20240725$$CN$CA$CA
241377381$24137738$1$I$$20240717$20240725$20240725$EXP$$US-BIOGEN-2023BI01237361$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
241377392$24137739$2$F$$20240731$20240725$20240807$PER$$US-APELLIS-APL-2024-003899$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240807$$CN$US$US
241377401$24137740$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5851467$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241377411$24137741$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146420$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241377421$24137742$1$I$$20240717$20240725$20240725$EXP$$US-AstraZeneca-2024A165995$ASTRAZENECA$$$$$F$Y$$$20240725$$CN$US$
241377431$24137743$1$I$$20240719$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010763$DR REDDYS$$18$YR$T$$Y$$$20240725$$CN$US$US
241377441$24137744$1$I$20240101$20240718$20240725$20240725$EXP$$CN-FERRINGPH-2024FE04026$FERRING$$$$$$Y$$$20240725$$MD$CN$CN
241377453$24137745$3$F$20230720$20240826$20240725$20240828$EXP$$JP-DSJP-DSJ-2023-133572$DAIICHI$$84$YR$$F$Y$47$KG$20240828$$MD$JP$JP
241377461$24137746$1$I$$20240718$20240725$20240725$EXP$$CN-FERRINGPH-2024FE04024$FERRING$$$$$$Y$$$20240725$$CN$CN$CN
241377471$24137747$1$I$$20240715$20240725$20240725$EXP$$AU-009507513-2407AUS011432$MERCK$$64$YR$$F$Y$$$20240725$$CN$AU$AU
241377481$24137748$1$I$$20240718$20240725$20240725$EXP$$CN-FERRINGPH-2024FE04023$FERRING$$$$$$Y$$$20240725$$CN$CN$CN
241377491$24137749$1$I$$20240715$20240725$20240725$EXP$$US-MYLANLABS-2024M1067250$MYLAN$$42$YR$$F$Y$$$20240725$$HP$US$US
241377501$24137750$1$I$20240618$20240716$20240725$20240725$EXP$$CA-FERRINGPH-2024FE03945$FERRING$$$$$$Y$$$20240725$$HP$CA$CA
241377512$24137751$2$F$20240625$20240805$20240725$20240812$EXP$CZ-CZSUKL-24002014$CZ-FERRINGPH-2024FE03986$FERRING$$$$$$Y$$$20240812$$MD$CZ$CZ
241377521$24137752$1$I$$20240718$20240725$20240725$EXP$$FI-FERRINGPH-2024FE03985$FERRING$$$$$$Y$$$20240725$$HP$FI$FI
241377532$24137753$2$F$$20240807$20240725$20240814$PER$$US-FreseniusKabi-FK202411308$FRESENIUS KABI$$$$$$Y$$$20240814$$MD$US$US
241377541$24137754$1$I$20240711$20240717$20240725$20240725$EXP$$US-ABBVIE-5849253$ABBVIE$$17$YR$$F$Y$$$20240725$$CN$US$US
241377551$24137755$1$I$20240624$20240716$20240725$20240725$EXP$GB-MHRA-MED-202407161310431130-BFNHC$GB-TEVA-VS-3221965$TEVA$$51$YR$$F$Y$56$KG$20240725$$HP$GB$GB
241377561$24137756$1$I$$20240717$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091372$VIIV$$$$$F$Y$$$20240725$$HP$US$US
241377571$24137757$1$I$$20240722$20240725$20240725$EXP$$DE-ABBVIE-5850659$ABBVIE$$$$$F$Y$$$20240725$$CN$DE$DE
241377591$24137759$1$I$20240724$20240724$20240724$20240724$DIR$FDA-CDER-CTU-2024-51354$$FDA-CTU$$82$YR$$M$N$$$20240724$Y$HP$US$
241377611$24137761$1$I$$20240712$20240725$20240725$EXP$GB-MHRA-MED-202407121609474360-QJFYN$GB-GLENMARK PHARMACEUTICALS-2024GMK092389$GLENMARK$$$$$$Y$$$20240725$$CN$GB$GB
241377631$24137763$1$I$$20240724$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118124$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240725$$MD$US$US
241377641$24137764$1$I$20240702$20240724$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118196$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240725$$HP$US$US
241377651$24137765$1$I$20230101$20240718$20240725$20240725$EXP$$JP-009507513-2407JPN003540J$MERCK$$59$YR$$F$Y$$$20240725$$MD$JP$JP
241377661$24137766$1$I$$20240716$20240725$20240725$EXP$$JP-009507513-2407JPN003235J$MERCK$$64$YR$$F$Y$$$20240725$$MD$JP$JP
241377671$24137767$1$I$20200101$20240715$20240725$20240725$EXP$$US-PERRIGO-24US006763$PERRIGO$$$$A$$Y$$$20240725$$CN$US$US
241377681$24137768$1$I$$20240711$20240725$20240725$EXP$$US-TEVA-VS-3221168$TEVA$$$$$$Y$$$20240725$$CN$US$US
241377691$24137769$1$I$$20240712$20240725$20240725$PER$$US-LUNDBECK-DKLU4001734$LUNDBECK$$$$$$Y$$$20240725$$PH$US$US
241377701$24137770$1$I$20240604$20240717$20240725$20240725$EXP$ES-AEMPS-1546593$ES-TEVA-VS-3222729$TEVA$$26$YR$$F$Y$$$20240725$$MD$ES$ES
241377711$24137771$1$I$$20240716$20240725$20240725$EXP$PL-URPL-1-3695-2020$PL-TEVA-VS-3222370$TEVA$$34$YR$$F$Y$53$KG$20240725$$MD$PL$PL
241377721$24137772$1$I$20240603$20240722$20240725$20240725$EXP$FR-AFSSAPS-LL2024001307$FR-MYLANLABS-2024M1068641$MYLAN$$75$YR$$M$Y$$$20240725$$MD$FR$FR
241377731$24137773$1$I$$20240718$20240725$20240725$EXP$$ES-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004019$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240725$$MD$ES$ES
241377741$24137774$1$I$20240719$20240722$20240725$20240725$EXP$$CN-SANDOZ INC.-SDZ2024CN068099$SANDOZ$$10$YR$$M$Y$45$KG$20240725$$HP$CN$CN
241377751$24137775$1$I$20240701$20240722$20240725$20240725$PER$$US-ABBVIE-5851379$ABBVIE$$$$$M$Y$$$20240725$$MD$US$US
241377761$24137776$1$I$20240722$20240723$20240725$20240725$EXP$GB-MHRA-MED-202407231643113080-GKQLD$GB-SANDOZ INC.-SDZ2024GB068044$SANDOZ$$49$YR$$F$Y$63$KG$20240725$$CN$GB$GB
241377771$24137777$1$I$$20240716$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092572$VIIV$$$$$$Y$$$20240725$$HP$US$US
241377781$24137778$1$I$$20240722$20240725$20240725$EXP$$US-AMGEN-USASL2024145588$AMGEN$$53$YR$A$F$Y$$$20240725$$CN$US$US
241377791$24137779$1$I$$20240712$20240725$20240725$PER$$US-RDY-SPO/USA/24/0010425$DR REDDYS$$33$YR$A$M$Y$$$20240725$$CN$US$US
241377801$24137780$1$I$20210101$20240722$20240725$20240725$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041386$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$83$KG$20240725$$CN$BR$BR
241377811$24137781$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5850972$ABBVIE$$$$$$Y$$$20240725$$HP$US$US
241377821$24137782$1$I$20240626$20240722$20240725$20240725$EXP$FR-AFSSAPS-CN2024000699$FR-MYLANLABS-2024M1068234$MYLAN$$91$YR$$F$Y$$$20240725$$MD$FR$FR
241377831$24137783$1$I$$20240717$20240725$20240725$EXP$$DE-AstraZeneca-2024A163824$ASTRAZENECA$$$$$F$Y$$$20240725$$MD$DE$
241377861$24137786$1$I$$20240725$20240725$20240725$DIR$711469$$FDA-CTU$$$$$UNK$N$$$20240725$N$CN$US$
241377871$24137787$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016545$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240725$$CN$US$US
241377881$24137788$1$I$20240724$20240725$20240725$20240725$DIR$711474$$FDA-CTU$$$$$UNK$N$$$20240725$N$CN$US$
241377891$24137789$1$I$$20240719$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407013776$ELI LILLY AND CO$$31$YR$A$M$Y$$$20240725$$CN$US$US
241377901$24137790$1$I$20240711$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015357$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240725$$PH$US$US
241377912$24137791$2$F$20230101$20240731$20240725$20240805$EXP$$CA-JNJFOC-20240459963$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240805$$HP$CA$CA
241377921$24137792$1$I$20240718$20240725$20240725$20240725$DIR$711475$$FDA-CTU$$76$YR$$M$N$$$20240725$N$$US$
241377943$24137794$3$F$$20240829$20240725$20240905$EXP$$AR-GSK-AR2024AMR074103$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$PH$AR$AR
241377952$24137795$2$F$$20240823$20240725$20240830$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004870$SAREPTA THERAPEUTICS$$$$$M$Y$30.3$KG$20240830$$HP$US$US
241377961$24137796$1$I$20190516$20240722$20240725$20240725$EXP$$KR-009507513-2407KOR012024$MERCK$$$$$M$Y$49.2$KG$20240725$$HP$KR$KR
241377971$24137797$1$I$$20240722$20240725$20240725$EXP$$US-JNJFOC-20240760679$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240725$$HP$US$US
241377981$24137798$1$I$20240325$20240725$20240725$20240725$DIR$711479$$FDA-CTU$$40$YR$$M$N$108$KG$20240725$N$CN$US$
241377991$24137799$1$I$20210101$20240715$20240725$20240725$EXP$$US-JNJFOC-20240748443$JOHNSON AND JOHNSON$$$$$M$Y$$$20240725$$LW$US$US
241378002$24137800$2$F$20240701$20240813$20240725$20240820$PER$$US-JNJFOC-20240732148$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240820$$CN$US$US
241378011$24137801$1$I$20240625$20240722$20240725$20240725$EXP$$CA-JNJFOC-20240713139$JOHNSON AND JOHNSON$$12$YR$T$F$Y$$$20240725$$CN$CA$CA
241378021$24137802$1$I$$20240712$20240725$20240725$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092524$GLENMARK$$$$$$Y$$$20240725$$CN$US$US
241378031$24137803$1$I$20240501$20240722$20240725$20240725$PER$$US-009507513-2407USA012760$MERCK$$82$YR$$F$Y$$$20240725$$CN$US$US
241378042$24137804$2$F$$20240722$20240725$20240801$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010954$JAZZ$$$$$F$Y$$$20240801$$CN$US$US
241378051$24137805$1$I$20240424$20240529$20240725$20240725$EXP$$JP-DSJP-DSJ-2024-118878$DAIICHI$$51$YR$$F$Y$$$20240725$$PH$JP$JP
241378061$24137806$1$I$20240625$20240712$20240725$20240725$PER$$US-FreseniusKabi-FK202411027$FRESENIUS KABI$$41$YR$A$F$Y$73.48$KG$20240725$$HP$US$US
241378071$24137807$1$I$20240626$20240712$20240725$20240725$PER$$US-FreseniusKabi-FK202411119$FRESENIUS KABI$$60$YR$A$F$Y$58.06$KG$20240725$$HP$US$US
241378081$24137808$1$I$$20240722$20240725$20240725$EXP$$US-GILEAD-2024-0681734$GILEAD$$$$E$M$Y$$$20240725$$CN$US$US
241378091$24137809$1$I$20240101$20240711$20240725$20240725$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01162$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240725$$CN$US$US
241378101$24137810$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118265$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240725$$CN$US$US
241378111$24137811$1$I$20240719$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118087$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240725$$CN$US$US
241378121$24137812$1$I$20240625$20240715$20240725$20240725$EXP$FR-AFSSAPS-PP2024000779$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-112837$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$76$KG$20240725$$PH$FR$FR
241378131$24137813$1$I$$20240717$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115389$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240725$$CN$US$US
241378141$24137814$1$I$$20240721$20240725$20240725$EXP$$CA-LUNDBECK-DKLU4002067$LUNDBECK$$$$$$Y$$$20240725$$CN$CA$CA
241378151$24137815$1$I$$20240724$20240725$20240725$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041806$BOEHRINGER INGELHEIM$$$$$$Y$$$20240725$$MD$US$US
241378161$24137816$1$I$20220901$20240722$20240725$20240725$EXP$FR-AFSSAPS-AVPO2024000133$FR-MYLANLABS-2024M1068202$MYLAN$$36$YR$$F$Y$$$20240725$$PH$FR$FR
241378182$24137818$2$F$20220208$20240729$20240725$20240807$EXP$$FR-TEVA-VS-3223191$TEVA$Arnould B, Miranda S, Mignon F, Camus V. G-CSF-induced TIPIC syndrome and large vessel vasculitis: A case report. Clin-Case-Rep 2023; 11 (9): no pagination.; Arnould B, Miranda S, Mignon F, Camus V. G-CSF-induced TIPIC syndrome and large vessel vasculitis: A case report. Clin-Case-Rep 2023; 11 (9): no pagination.$73$YR$$F$Y$$$20240807$$HP$FR$FR
241378191$24137819$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152389$NOVARTIS$$$$$M$Y$$$20240725$$HP$US$US
241378201$24137820$1$I$20240525$20240725$20240725$20240725$DIR$711471$$FDA-CTU$$59$YR$$M$N$84.6$KG$20240725$N$HP$US$
241378221$24137822$1$I$20240725$20240725$20240725$20240725$DIR$711455$$FDA-CTU$$26$YR$$F$N$69.75$KG$20240725$N$CN$US$
241378261$24137826$1$I$$20240725$20240725$20240725$DIR$711495$$FDA-CTU$$$$$UNK$N$$$20240725$N$CN$US$
241378281$24137828$1$I$20240719$20240725$20240725$20240725$DIR$711498$$FDA-CTU$$48$YR$$F$N$53.55$KG$20240725$N$CN$US$
241378291$24137829$1$I$20240201$20240725$20240725$20240725$DIR$711499$$FDA-CTU$$84$YR$$M$N$72.9$KG$20240725$N$$US$
241378301$24137830$1$I$$20240725$20240725$20240725$DIR$711501$$FDA-CTU$$$$$UNK$N$$$20240725$N$CN$US$
241378311$24137831$1$I$$20240725$20240725$20240725$DIR$711503$$FDA-CTU$$$$$M$N$$$20240725$N$$US$
241378321$24137832$1$I$$20240725$20240725$20240725$DIR$711453$$FDA-CTU$$86$YR$$M$N$63$KG$20240725$N$CN$CA$
241378331$24137833$1$I$20240725$20240725$20240725$20240725$DIR$711504$$FDA-CTU$$70$YR$$F$N$$$20240725$N$$US$
241378341$24137834$1$I$20240101$20240718$20240725$20240725$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700034$UPSHER SMITH LABORATORIES$$$$$$Y$$$20240725$$$US$US
241378351$24137835$1$I$20240601$20240718$20240725$20240725$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700035$UPSHER SMITH LABORATORIES$$0$YR$$$Y$$$20240725$$$US$US
241378361$24137836$1$I$20240601$20240617$20240725$20240725$PER$$US-PERRIGO-24US005911$PERRIGO$$79$YR$$F$Y$68.027$KG$20240725$$CN$US$US
241378371$24137837$1$I$$20230827$20240725$20240725$PER$$US-PERRIGO-23US009628$PERRIGO$$72$YR$$M$Y$102.04$KG$20240725$$CN$US$US
241378381$24137838$1$I$20230901$20231004$20240725$20240725$PER$$US-PERRIGO-23US011657$PERRIGO$$$$A$$Y$$$20240725$$CN$US$US
241378391$24137839$1$I$20160729$20231209$20240725$20240725$PER$$US-PERRIGO-23US014017$PERRIGO$$$$A$$Y$$$20240725$$CN$US$US
241378401$24137840$1$I$20231001$20231025$20240725$20240725$PER$$US-PERRIGO-23US012487$PERRIGO$$$$A$$Y$$$20240725$$CN$US$US
241378411$24137841$1$I$$20240621$20240725$20240725$PER$$US-PERRIGO-24US005970$PERRIGO$$$$$F$Y$$$20240725$$CN$US$US
241378421$24137842$1$I$20230707$20230727$20240725$20240725$PER$$US-PERRIGO-23US008391$PERRIGO$$55$YR$$M$Y$$$20240725$$CN$US$US
241378431$24137843$1$I$20231202$20231205$20240725$20240725$PER$$US-PERRIGO-23US013949$PERRIGO$$76$YR$$F$Y$59.864$KG$20240725$$CN$US$US
241378441$24137844$1$I$20240701$20240707$20240725$20240725$PER$$US-PERRIGO-24US006536$PERRIGO$$$$$F$Y$$$20240725$$CN$US$US
241378451$24137845$1$I$20240328$20240328$20240725$20240725$PER$$US-PERRIGO-24US003180$PERRIGO$$$$A$$Y$$$20240725$$CN$US$US
241378461$24137846$1$I$$20231202$20240725$20240725$PER$$US-PERRIGO-23US013833$PERRIGO$$$$A$$Y$$$20240725$$CN$US$US
241378471$24137847$1$I$20231001$20231020$20240725$20240725$PER$$US-PERRIGO-23US012298$PERRIGO$$$$A$$Y$$$20240725$$CN$US$US
241378481$24137848$1$I$20180101$20230807$20240725$20240725$PER$$US-PERRIGO-23US008978$PERRIGO$$$$$$Y$$$20240725$$CN$US$US
241378491$24137849$1$I$20240101$20240722$20240725$20240725$EXP$$US-ABBVIE-5849945$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241378501$24137850$1$I$20240712$20240719$20240725$20240725$EXP$$TW-MYLANLABS-2024M1069465$MYLAN$$$$$M$Y$$$20240725$$CN$TW$BR
241378511$24137851$1$I$$20240719$20240725$20240725$EXP$$HN-MYLANLABS-2024M1068633$MYLAN$$$$$M$Y$$$20240725$$CN$HN$HN
241378521$24137852$1$I$$20240724$20240725$20240725$EXP$$US-ROCHE-10000036436$ROCHE$$68$YR$E$F$Y$$$20240725$$CN$US$US
241378531$24137853$1$I$$20240719$20240725$20240725$PER$$US-ABBVIE-5848984$ABBVIE$$$$$$Y$$$20240725$$HP$US$US
241378543$24137854$3$F$20240723$20240813$20240725$20240815$EXP$$US-AstraZeneca-2024A169051$ASTRAZENECA$$26009$DY$$M$Y$80.3$KG$20240815$$MD$US$
241378561$24137856$1$I$$20240716$20240725$20240725$EXP$$US-ABBVIE-5851443$ABBVIE$$$$$M$Y$$$20240725$$HP$US$US
241378571$24137857$1$I$20240707$20240722$20240725$20240725$EXP$$US-ABBVIE-5851657$ABBVIE$$88$YR$$M$Y$$$20240725$$CN$US$US
241378581$24137858$1$I$20240101$20240715$20240725$20240725$EXP$CH-SM-2024-12814$CH-TEVA-VS-3221659$TEVA$$54$YR$$F$Y$$$20240725$$MD$CH$CH
241378592$24137859$2$F$20240512$20240826$20240725$20240829$EXP$$FR-MYLANLABS-2024M1068762$MYLAN$$80$YR$$M$Y$75$KG$20240829$$CN$FR$FR
241378601$24137860$1$I$$20240723$20240725$20240725$EXP$GB-MHRA-MED-202407231643541750-DKNHJ$GB-MYLANLABS-2024M1068806$MYLAN$$$$$F$Y$$$20240725$$CN$GB$GB
241378611$24137861$1$I$20240724$20240725$20240725$20240725$DIR$711459$$FDA-CTU$$55$YR$$F$N$61.65$KG$20240725$N$CN$US$
241378622$24137862$2$F$20220407$20240827$20240725$20240903$EXP$$GB-MYLANLABS-2024M1066121$MYLAN$$68$YR$$M$Y$$$20240903$$MD$GB$GB
241378633$24137863$3$F$$20240725$20240725$20240911$PER$$NVSC2024US152548$NOVARTIS$$$$$M$Y$$$20240911$$CN$US$US
241378641$24137864$1$I$$20240724$20240725$20240725$PER$$US-BAYER-2024A108121$BAYER$$44$YR$A$F$Y$$$20240725$$HP$US$US
241378651$24137865$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118233$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$84.37$KG$20240725$$CN$US$US
241378661$24137866$1$I$$20240723$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117963$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240725$$HP$US$US
241378671$24137867$1$I$20240701$20240722$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116627$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240725$$HP$US$US
241378681$24137868$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118407$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240725$$CN$US$US
241378691$24137869$1$I$$20240725$20240725$20240725$DIR$711490$$FDA-CTU$$$$$UNK$N$$$20240725$$CN$US$
241378701$24137870$1$I$$20240717$20240725$20240725$PER$$US-ALXN-202407USA001330US$ALEXION PHARMACEUTICALS$$$$$F$Y$163.27$KG$20240725$$CN$US$US
241378711$24137871$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118364$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240725$$CN$US$US
241378721$24137872$1$I$$20240724$20240725$20240725$PER$$US-ROCHE-10000036202$ROCHE$$69$YR$E$M$Y$$$20240725$$HP$US$US
241378732$24137873$2$F$$20240809$20240725$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202407016114$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240814$$CN$US$US
241378741$24137874$1$I$$20240625$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202406018005$ELI LILLY AND CO$$10$YR$C$F$Y$$$20240725$$CN$US$US
241378751$24137875$1$I$20240102$20240725$20240725$20240725$DIR$711463$$FDA-CTU$$66$YR$$M$N$87.75$KG$20240725$N$CN$US$
241378761$24137876$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015687$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240725$$CN$US$US
241378772$24137877$2$F$$20240724$20240725$20240726$EXP$$CA-ORGANON-O2407CAN002306$ORGANON$$72$YR$$F$Y$$$20240726$$CN$CA$CA
241378781$24137878$1$I$20230801$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145484$AMGEN$$23$YR$A$M$Y$$$20240725$$CN$US$US
241378792$24137879$2$F$20240720$20240913$20240725$20240917$EXP$$US-BAYER-2024A107212$BAYER$$35$YR$A$M$Y$102.04$KG$20240917$$HP$US$US
241378801$24137880$1$I$$20240718$20240725$20240725$EXP$$CN-INCYTE CORPORATION-2024IN007686$INCYTE$$$$$$Y$$$20240725$$HP$CN$CN
241378811$24137881$1$I$20240101$20240722$20240725$20240725$EXP$$US-JNJFOC-20240760480$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240725$$HP$US$US
241378823$24137882$3$F$20240613$20240826$20240725$20240903$EXP$$US-ROCHE-10000035790$ROCHE$$75$YR$E$F$Y$84.2$KG$20240903$$CN$US$US
241378831$24137883$1$I$20111021$20240716$20240725$20240725$EXP$$DK-ORGANON-2011SP051883$ORGANON$$72$YR$$F$Y$103$KG$20240725$$MD$DK$DK
241378841$24137884$1$I$$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146131$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241378851$24137885$1$I$20240724$20240723$20240725$20240725$DIR$FDA-CDER-CTU-2024-51355$$FDA-CTU$$70$YR$$M$N$109$KG$20240723$N$$US$
241378861$24137886$1$I$20240708$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51356$$FDA-CTU$$45$YR$$M$N$55.5$KG$20240724$N$$US$
241378871$24137887$1$I$20240622$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51360$$FDA-CTU$$59$YR$$F$N$64.3$KG$20240724$N$$US$
241378881$24137888$1$I$20240601$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223137$PFIZER$$$$$$Y$$$20240725$$MD$US$US
241378891$24137889$1$I$20240601$20240724$20240725$20240725$PER$$US-PFIZER INC-202400223162$PFIZER$$$$$$Y$$$20240725$$MD$US$US
241378911$24137891$1$I$20230412$20240722$20240725$20240725$EXP$FR-AFSSAPS-PC2024000565$FR-009507513-2407FRA012467$MERCK$$72$YR$$F$Y$80$KG$20240725$$MD$FR$FR
241378921$24137892$1$I$20240723$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51296$$FDA-CTU$$31$YR$$F$N$165$LBS$20240725$N$CN$US$
241378931$24137893$1$I$20240617$20240712$20240725$20240725$PER$$US-FreseniusKabi-FK202411120$FRESENIUS KABI$$63$YR$A$F$Y$$$20240725$$HP$US$US
241378941$24137894$1$I$20240617$20240712$20240725$20240725$PER$$US-FreseniusKabi-FK202411121$FRESENIUS KABI$$66$YR$E$F$Y$66.22$KG$20240725$$HP$US$US
241378953$24137895$3$F$20240601$20240917$20240725$20240924$PER$$US-BIOGEN-2024BI01274616$BIOGEN$$57$YR$$F$Y$$$20240924$$CN$US$US
241378961$24137896$1$I$$20240531$20240725$20240725$PER$$US-Breckenridge Pharmaceutical, Inc.-2159603$BRECKENRIDGE$$88$YR$$F$Y$52.273$KG$20240725$$$US$US
241378971$24137897$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117770$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$PH$US$US
241378985$24137898$5$F$20240701$20240820$20240725$20240822$EXP$$US-ABBVIE-5851671$ABBVIE$$95$YR$$M$Y$125$KG$20240822$$CN$US$US
241378991$24137899$1$I$20240701$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A164291$ASTRAZENECA$$$$A$$Y$$$20240725$$MD$JP$
241379001$24137900$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152793$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241379012$24137901$2$F$20240301$20240912$20240725$20240917$PER$$US-AstraZeneca-2024A163398$ASTRAZENECA$$824$MON$$F$Y$$$20240917$$CN$US$
241379021$24137902$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152795$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241379041$24137904$1$I$$20240716$20240725$20240725$PER$$US-ABBVIE-5846925$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241379051$24137905$1$I$$20240724$20240725$20240725$PER$$US-AMGEN-USASP2024148095$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241379062$24137906$2$F$$20240815$20240725$20240821$EXP$$CA-GSK-CA2023135010$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$CA$CA
241379071$24137907$1$I$20240701$20240716$20240725$20240725$PER$$US-MYLANLABS-2024M1067297$MYLAN$$76$YR$$F$Y$65.77$KG$20240725$$CN$US$US
241379082$24137908$2$F$$20240822$20240725$20240828$PER$$US-JNJFOC-20240763236$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240828$$CN$US$US
241379091$24137909$1$I$$20240724$20240725$20240725$PER$$US-HALEON-2188956$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241379102$24137910$2$F$20221201$20240723$20240725$20240729$EXP$$NVSC2024DE152684$NOVARTIS$$$$E$F$Y$71$KG$20240729$$CN$DE$DE
241379111$24137911$1$I$20240101$20240710$20240725$20240725$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0656$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240725$$HP$US$US
241379121$24137912$1$I$$20240712$20240725$20240725$PER$$US-TEVA-VS-3222255$TEVA$$20$YR$$F$Y$$$20240725$$CN$US$US
241379132$24137913$2$F$$20240729$20240725$20240730$EXP$$HK-ABBVIE-5852873$ABBVIE$$65$YR$$F$Y$$$20240730$$MD$HK$HK
241379142$24137914$2$F$$20240808$20240725$20240814$EXP$$MA-GSK-MA2024EME091581$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$MA$MA
241379151$24137915$1$I$$20240716$20240725$20240725$EXP$$JP-009507513-2407JPN003504J$MERCK$Harada A, Kodera R, Nishi M, Nagata K, Ohashi K, Kawashita S, et al.. P-197 Experience with pembrolizumab + lenvatinib combination therapy for corpus uteri carcinoma in our hospital. The journal of the Japan Society of Gynecologic Oncology  The 66th Annual Meetin. 2024;42(3):404$$$$F$Y$$$20240725$$MD$JP$JP
241379161$24137916$1$I$20240429$20240722$20240725$20240725$EXP$ES-AEMPS-1548967$ES-MYLANLABS-2024M1068441$MYLAN$$$$$M$Y$$$20240725$$PH$ES$ES
241379171$24137917$1$I$20240522$20240715$20240725$20240725$EXP$FR-AFSSAPS-CN2024000658$FR-TEVA-VS-3221940$TEVA$$64$YR$$F$Y$77$KG$20240725$$PH$FR$FR
241379181$24137918$1$I$20230101$20240721$20240725$20240725$EXP$$CA-PFIZER INC-202400220915$PFIZER$$71$YR$$M$Y$$$20240725$$MD$CA$CA
241379191$24137919$1$I$20240617$20240723$20240725$20240725$EXP$IT-MINISAL02-995934$IT-PFIZER INC-202400221903$PFIZER$$82$YR$$F$Y$$$20240725$$PH$IT$IT
241379202$24137920$2$F$$20240823$20240725$20240823$PER$$US-ALXN-202407USA001294US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241379211$24137921$1$I$$20240724$20240725$20240725$EXP$$CA-SANDOZ INC.-SDZ2024CA066811$SANDOZ$$23$YR$$F$Y$$$20240725$$HP$CA$CA
241379221$24137922$1$I$$20240723$20240725$20240725$EXP$$CA-ORGANON-O2407CAN002135$ORGANON$$44$YR$$F$Y$$$20240725$$HP$CA$CA
241379251$24137925$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51318$$FDA-CTU$$$$$$N$$$20240725$N$$US$
241379261$24137926$1$I$20240724$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51335$$FDA-CTU$$89$YR$$$N$$$20240725$N$PH$US$
241379271$24137927$1$I$$20240718$20240725$20240725$EXP$US-MLMSERVICE-20240711-PI128680-00139-2$US-RDY-SPO/USA/24/0010768$DR REDDYS$Wiese J, Derian NA, Ghimire S, Bambhroliya Z, Joshi T. Glecaprevir-Pibrentasvir and Ethinyl Estradiol-Induced Liver Injury in a Patient Without Cirrhosis. Cureus. 2024;16(6):e61980. DOI: 10.7759/cureus.61980.$33$YR$A$F$Y$$$20240725$$MD$US$US
241379281$24137928$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152792$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241379291$24137929$1$I$20240608$20240617$20240725$20240725$DIR$FDA-CDER-CTU-2024-51361$$FDA-CTU$$58$YR$$M$N$80$KG$20240617$N$$US$
241379301$24137930$1$I$$20240716$20240725$20240725$EXP$$NVSC2024US149334$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
241379321$24137932$1$I$20240608$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51362$$FDA-CTU$$58$YR$$M$N$80$KG$20240724$N$$US$
241379331$24137933$1$I$20240724$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51333$$FDA-CTU$$15$YR$$F$N$$$20240725$N$PH$US$
241379341$24137934$1$I$$20240717$20240725$20240725$EXP$$NO-TAKEDA-2024TUS072428$TAKEDA$$$$$F$Y$$$20240725$$MD$NO$NO
241379353$24137935$3$F$20230814$20240820$20240725$20240830$EXP$$JP-ABBVIE-5852314$ABBVIE$$85$YR$$M$Y$57$KG$20240829$$CN$JP$JP
241379361$24137936$1$I$20231116$20240716$20240725$20240725$EXP$$US-ABBVIE-5851715$ABBVIE$$80$YR$$M$Y$$$20240725$$MD$US$US
241379372$24137937$2$F$$20240722$20240725$20240730$PER$$US-AMGEN-USASP2024146013$AMGEN$$$$A$F$Y$$$20240730$$HP$US$US
241379382$24137938$2$F$$20240731$20240725$20240731$EXP$$US-AMERICAN REGENT INC-2024002753$AMERICAN REGENT$$$$$M$Y$$$20240731$$HP$US$US
241379391$24137939$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118186$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$108.86$KG$20240725$$HP$US$US
241379401$24137940$1$I$$20240724$20240725$20240725$EXP$$CA-SANDOZ INC.-SDZ2024CA068023$SANDOZ$$68$YR$$F$Y$73$KG$20240725$$CN$CA$CA
241379412$24137941$2$F$$20240717$20240725$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114236$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$55.34$KG$20240719$$CN$US$US
241379425$24137942$5$F$$20240822$20240725$20240904$PER$$NVSC2024US152790$NOVARTIS$$$$$M$Y$150$KG$20240904$$HP$US$US
241379431$24137943$1$I$$20240724$20240725$20240725$30DAY$$US-SANDOZ INC.-SDZ2024US068165$SANDOZ$$$$$F$Y$$$20240725$$CN$US$US
241379441$24137944$1$I$20240402$20240715$20240725$20240725$EXP$$FR-KREUSSLER-2024-FR-000005$CHEMISCHE FABRIK KREUSSLER$$44$YR$A$F$Y$$$20240725$$CN$FR$FR
241379452$24137945$2$F$20240701$20240724$20240725$20240727$PER$$US-ABBVIE-5852395$ABBVIE$$$$A$$Y$$$20240727$$HP$US$US
241379461$24137946$1$I$$20240722$20240725$20240725$EXP$GB-MHRA-MED-202407221705070370-GDJTH$GB-MYLANLABS-2024M1068431$MYLAN$$$$$F$Y$$$20240725$$CN$GB$GB
241379471$24137947$1$I$20240228$20240710$20240725$20240725$EXP$$CA-HLS-202401730$HLS THERAPEUTICS$$73$YR$E$F$Y$$$20240725$$HP$CA$CA
241379481$24137948$1$I$$20240719$20240725$20240725$EXP$$CA-BAYER-2024A105656$BAYER$$$$$$Y$$$20240725$$MD$CA$CA
241379492$24137949$2$F$20240530$20240819$20240725$20240826$EXP$$US-MYLANLABS-2024M1066858$MYLAN$$77$YR$$F$Y$76.2$KG$20240826$$CN$US$US
241379501$24137950$1$I$$20240718$20240725$20240725$EXP$$CA-TAKEDA-2024TUS073211$TAKEDA$$76$YR$$M$Y$$$20240725$$HP$CA$CA
241379511$24137951$1$I$20231004$20240718$20240725$20240725$EXP$$US-GSK-US2021207521$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241379521$24137952$1$I$20240714$20240717$20240725$20240725$EXP$$CA-AstraZeneca-2024A164880$ASTRAZENECA$$27678$DY$$F$Y$$$20240725$$CN$CA$
241379531$24137953$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152794$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241379541$24137954$1$I$$20240724$20240725$20240725$EXP$$NVSC2024ET152683$NOVARTIS$$$$$F$Y$$$20240725$$MD$ET$ET
241379551$24137955$1$I$$20240723$20240725$20240725$PER$$NVSC2024US152797$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241379562$24137956$2$F$$20240729$20240725$20240731$PER$$NVSC2024US152789$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
241379571$24137957$1$I$$20240718$20240725$20240725$EXP$$US-GSK-US2024090644$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$CN$US$US
241379581$24137958$1$I$$20240715$20240725$20240725$30DAY$$US-GSK-US2024088761$GLAXOSMITHKLINE$$$$$M$Y$$$20240725$$CN$US$US
241379591$24137959$1$I$$20240715$20240725$20240725$30DAY$$US-GSK-US2024088759$GLAXOSMITHKLINE$$$$$F$Y$$$20240725$$CN$US$US
241379601$24137960$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5850957$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241379612$24137961$2$F$20240101$20240823$20240725$20240829$EXP$$US-ABBVIE-5850886$ABBVIE$$$$$M$Y$132$KG$20240829$$CN$US$US
241379621$24137962$1$I$20211201$20240628$20240725$20240725$PER$$US-JNJFOC-20240703559$JOHNSON AND JOHNSON$$7$DEC$$F$Y$$$20240725$$CN$US$US
241379631$24137963$1$I$20200525$20240716$20240725$20240725$EXP$KR-GUERBET-KR-20200060$KR-GUERBET / LLC-KR-20200060$GUERBET$$40$YR$A$F$Y$110$KG$20240725$$HP$KR$KR
241379641$24137964$1$I$20240708$20240719$20240725$20240725$EXP$$JP-BAYER-2024A106175$BAYER$$$$$M$Y$$$20240725$$MD$JP$JP
241379652$24137965$2$F$20240711$20240716$20240725$20240802$EXP$$NZ-ROCHE-10000030919$ROCHE$$63$YR$A$M$Y$$$20240803$$MD$NZ$NZ
241379661$24137966$1$I$$20240724$20240725$20240725$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-025697$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240725$$MD$US$US
241379671$24137967$1$I$$20240725$20240725$20240725$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041961$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240725$$CN$US$US
241379681$24137968$1$I$20240701$20240719$20240725$20240725$EXP$$AR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041644$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$$$20240725$$CN$AR$AR
241379691$24137969$1$I$20231207$20240717$20240725$20240725$DIR$FDA-CDER-CTU-2024-51022$$FDA-CTU$$77$YR$$M$N$225$LBS$20240717$N$CN$US$
241379701$24137970$1$I$20240201$20240712$20240725$20240725$DIR$FDA-CDER-CTU-2024-51087$$FDA-CTU$$71$YR$$F$N$63.05$KG$20240712$N$CN$US$
241379721$24137972$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152800$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241379731$24137973$1$I$$20240719$20240725$20240725$PER$$US-ABBVIE-5849934$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241379741$24137974$1$I$20240601$20240716$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114100$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240725$$CN$US$US
241379752$24137975$2$F$$20240726$20240725$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118184$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$63.5$KG$20240731$$CN$US$US
241379761$24137976$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118306$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$$$20240725$$HP$US$US
241379771$24137977$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118257$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240725$$CN$US$US
241379781$24137978$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118014$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240725$$CN$US$US
241379791$24137979$1$I$20240501$20240718$20240725$20240725$EXP$$US-GSK-US2024090807$GLAXOSMITHKLINE$$$$$$Y$$$20240725$$MD$US$US
241379802$24137980$2$F$$20240723$20240725$20240802$EXP$$HU-MYLANLABS-2024M1068755$MYLAN$$15$YR$$$Y$$$20240802$$HP$HU$HU
241379811$24137981$1$I$20240626$20240723$20240725$20240725$EXP$EE-SAM-1982407022$EE-MYLANLABS-2024M1068556$MYLAN$$85$YR$$F$Y$87$KG$20240725$$MD$EE$EE
241379821$24137982$1$I$20240620$20240723$20240725$20240725$EXP$FR-AFSSAPS-ST2024001148$FR-MYLANLABS-2024M1068646$MYLAN$$24$YR$$M$Y$85$KG$20240725$$MD$FR$FR
241379831$24137983$1$I$$20240628$20240725$20240725$PER$$US-SCIEGENP-2024SCSPO00324$SCIEGEN$$$$$F$Y$$$20240725$$CN$US$US
241379841$24137984$1$I$$20240712$20240725$20240725$PER$$US-SA-2024SA210380$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240725$$MD$US$US
241379851$24137985$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214333$SANOFI AVENTIS$$$$A$F$Y$74.38$KG$20240725$$MD$US$US
241379861$24137986$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA212207$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240725$$CN$US$US
241379871$24137987$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA213779$SANOFI AVENTIS$$$$A$F$Y$39$KG$20240725$$MD$US$US
241379882$24137988$2$F$20240101$20240819$20240725$20240829$PER$$US-SA-2023SA389377$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240829$$MD$US$US
241379891$24137989$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA212445$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240725$$MD$US$US
241379901$24137990$1$I$20240701$20240717$20240725$20240725$PER$$US-SA-2024SA214343$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240725$$MD$US$US
241379911$24137991$1$I$20240501$20240716$20240725$20240725$PER$$US-SA-2024SA213582$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240725$$MD$US$US
241379921$24137992$1$I$20240701$20240717$20240725$20240725$PER$$US-SA-2024SA210874$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240725$$MD$US$US
241379931$24137993$1$I$20240101$20240716$20240725$20240725$PER$$US-SA-2024SA213658$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240725$$MD$US$US
241379942$24137994$2$F$20240101$20240806$20240725$20240815$PER$$US-SA-2024SA211973$SANOFI AVENTIS$$81$YR$E$F$Y$79.35$KG$20240815$$HP$US$US
241379951$24137995$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA217778$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240725$$MD$US$US
241379961$24137996$1$I$20240101$20240716$20240725$20240725$PER$$US-SA-2024SA213158$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240725$$CN$US$US
241379971$24137997$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA212485$SANOFI AVENTIS$$$$E$M$Y$$$20240725$$MD$US$US
241379981$24137998$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214393$SANOFI AVENTIS$$$$A$F$Y$70.306$KG$20240725$$MD$US$US
241379991$24137999$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA212650$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240725$$MD$US$US
241380001$24138000$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA216107$SANOFI AVENTIS$$$$A$F$Y$79.3$KG$20240725$$MD$US$US
241380011$24138001$1$I$20240621$20240716$20240725$20240725$DIR$FDA-CDER-CTU-2024-51075$$FDA-CTU$$$$$$N$$$20240716$Y$CN$US$
241380021$24138002$1$I$20240601$20240717$20240725$20240725$PER$$US-SA-2024SA214058$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240725$$MD$US$US
241380031$24138003$1$I$$20240702$20240725$20240725$PER$$US-ALXN-202407USA000146US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240709$$CN$US$US
241380041$24138004$1$I$20240101$20240716$20240725$20240725$PER$$US-SA-2024SA213387$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241380051$24138005$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA170723$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240725$$CN$US$US
241380061$24138006$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA213657$SANOFI AVENTIS$$$$C$F$Y$36.6$KG$20240725$$MD$US$US
241380071$24138007$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA214537$SANOFI AVENTIS$$$$A$F$Y$87.9$KG$20240725$$MD$US$US
241380082$24138008$2$F$20240101$20240918$20240725$20240926$PER$$US-SA-2024SA207149$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240926$$MD$US$US
241380091$24138009$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA215655$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241380101$24138010$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214163$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241380111$24138011$1$I$20240101$20240716$20240725$20240725$PER$$US-SA-2024SA213403$SANOFI AVENTIS$$44$YR$A$M$Y$68.03$KG$20240725$$MD$US$US
241380121$24138012$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA213651$SANOFI AVENTIS$$$$E$F$Y$95.2$KG$20240725$$MD$US$US
241380131$24138013$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA212421$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240725$$MD$US$US
241380141$24138014$1$I$20240701$20240717$20240725$20240725$PER$$US-SA-2024SA212434$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240725$$MD$US$US
241380154$24138015$4$F$20240101$20240903$20240725$20240926$PER$$US-SA-2024SA213406$SANOFI AVENTIS$$53$YR$A$F$Y$73.64$KG$20240926$$CN$US$US
241380161$24138016$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA213473$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240725$$HP$US$US
241380171$24138017$1$I$20240531$20240717$20240725$20240725$PER$$US-SA-2021SA114339$SANOFI AVENTIS$$60$YR$A$M$Y$86.1$KG$20240725$$MD$US$US
241380181$24138018$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA214790$SANOFI AVENTIS$$$$A$$Y$$$20240725$$CN$US$US
241380191$24138019$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA213765$SANOFI AVENTIS$$11$YR$C$F$Y$45.35$KG$20240725$$MD$US$US
241380201$24138020$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA212451$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240725$$MD$US$US
241380211$24138021$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA213762$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240725$$MD$US$US
241380222$24138022$2$F$20240101$20240731$20240725$20240809$PER$$US-SA-2024SA212989$SANOFI AVENTIS$$36$YR$A$F$Y$97$KG$20240809$$MD$US$US
241380231$24138023$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA216317$SANOFI AVENTIS$$$$A$F$Y$72.57$KG$20240725$$MD$US$US
241380241$24138024$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214901$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241380251$24138025$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA216483$SANOFI AVENTIS$$$$A$F$Y$73$KG$20240725$$MD$US$US
241380261$24138026$1$I$20240601$20240716$20240725$20240725$PER$$US-SA-2024SA213074$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240725$$MD$US$US
241380271$24138027$1$I$20240101$20240716$20240725$20240725$PER$$US-SA-2024SA211825$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240725$$MD$US$US
241380282$24138028$2$F$20240409$20240819$20240725$20240828$PER$$US-SA-2024SA214094$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240828$$MD$US$US
241380302$24138030$2$F$20240628$20240904$20240725$20240915$PER$$US-SA-2024SA213385$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240915$$MD$US$US
241380311$24138031$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA211245$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240725$$MD$US$US
241380321$24138032$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214712$SANOFI AVENTIS$$$$E$F$Y$63.9$KG$20240725$$MD$US$US
241380332$24138033$2$F$20240101$20240801$20240725$20240810$PER$$US-SA-2024SA212571$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240810$$MD$US$US
241380341$24138034$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214405$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240725$$MD$US$US
241380351$24138035$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA213983$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240725$$MD$US$US
241380362$24138036$2$F$20240701$20240726$20240725$20240805$EXP$$US-VIIV HEALTHCARE LIMITED-US2024088616$VIIV$$56$YR$$M$Y$$$20240805$$CN$US$US
241380371$24138037$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214995$SANOFI AVENTIS$$$$A$F$Y$65.3$KG$20240725$$MD$US$US
241380381$24138038$1$I$20240717$20240717$20240725$20240725$PER$$US-SA-2024SA214362$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240725$$HP$US$US
241380391$24138039$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA215188$SANOFI AVENTIS$$$$A$F$Y$68.94$KG$20240725$$MD$US$US
241380401$24138040$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA211879$SANOFI AVENTIS$$$$A$$Y$$$20240725$$HP$US$US
241380411$24138041$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA212040$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240725$$MD$US$US
241380421$24138042$1$I$$20240715$20240725$20240725$PER$$US-SA-2024SA213507$SANOFI AVENTIS$$$$A$M$Y$70.3$KG$20240725$$MD$US$US
241380431$24138043$1$I$20240101$20240716$20240725$20240725$PER$$US-SA-2024SA212425$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240725$$MD$US$US
241380441$24138044$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA214909$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240725$$MD$US$US
241380451$24138045$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA212319$SANOFI AVENTIS$$2$YR$C$$Y$$$20240725$$HP$US$US
241380461$24138046$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA215115$SANOFI AVENTIS$$$$A$$Y$$$20240725$$PH$US$US
241380471$24138047$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA143180$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240725$$MD$US$US
241380481$24138048$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA213164$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240725$$MD$US$US
241380493$24138049$3$F$20220101$20240903$20240725$20240927$PER$$US-SA-2024SA213398$SANOFI AVENTIS$$31$YR$A$F$Y$111.13$KG$20240927$$MD$US$US
241380501$24138050$1$I$20240501$20240717$20240725$20240725$PER$$US-SA-2024SA214706$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240725$$MD$US$US
241380511$24138051$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA216603$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240725$$CN$US$US
241380521$24138052$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA215921$SANOFI AVENTIS$$$$I$$Y$$$20240725$$CN$US$US
241380531$24138053$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA216713$SANOFI AVENTIS$$61$YR$A$M$Y$131$KG$20240725$$MD$US$US
241380541$24138054$1$I$20220101$20240716$20240725$20240725$PER$$US-SA-2024SA213186$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241380551$24138055$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA211465$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240725$$MD$US$US
241380561$24138056$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA212501$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241380571$24138057$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA212439$SANOFI AVENTIS$$$$A$F$Y$111.5$KG$20240725$$MD$US$US
241380581$24138058$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA212373$SANOFI AVENTIS$$95$YR$E$F$Y$$$20240725$$CN$US$US
241380592$24138059$2$F$$20240809$20240725$20240816$PER$$US-SA-2024SA214541$SANOFI AVENTIS$$$$E$M$Y$81.193$KG$20240817$$MD$US$US
241380601$24138060$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA212487$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241380611$24138061$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA214125$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240725$$MD$US$US
241380622$24138062$2$F$$20240911$20240725$20240926$PER$$US-SA-2024SA213643$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$CN$US$US
241380631$24138063$1$I$20240701$20240717$20240725$20240725$PER$$US-SA-2024SA214697$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240725$$MD$US$US
241380641$24138064$1$I$20240601$20240723$20240725$20240725$PER$$US-ABBVIE-5852390$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241380651$24138065$1$I$$20240725$20240725$20240725$EXP$$AU-MYLANLABS-2024M1069319$MYLAN$$$$$M$Y$$$20240725$$HP$AU$AU
241380661$24138066$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA213090$SANOFI AVENTIS$$$$A$M$Y$87$KG$20240725$$MD$US$US
241380671$24138067$1$I$20240101$20240716$20240725$20240725$PER$$US-SA-2024SA212435$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240725$$MD$US$US
241380681$24138068$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA212430$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240725$$MD$US$US
241380691$24138069$1$I$20240413$20240713$20240725$20240725$DIR$FDA-CDER-CTU-2024-51026$$FDA-CTU$$40$YR$$M$N$90.72$KG$20240713$N$$US$
241380701$24138070$1$I$20240429$20240716$20240725$20240725$PER$$US-SA-2024SA213389$SANOFI AVENTIS$$63$YR$A$F$Y$90.703$KG$20240725$$MD$US$US
241380711$24138071$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214847$SANOFI AVENTIS$$$$A$M$Y$132$KG$20240725$$MD$US$US
241380721$24138072$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA212483$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241380741$24138074$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA214011$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240725$$MD$US$US
241380751$24138075$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA212006$SANOFI AVENTIS$$$$$$Y$$$20240725$$MD$US$US
241380762$24138076$2$F$20230417$20240829$20240725$20240927$PER$$US-SA-2024SA214419$SANOFI AVENTIS$$6$YR$C$F$Y$20.45$KG$20240927$$CN$US$US
241380771$24138077$1$I$20240701$20240717$20240725$20240725$PER$$US-SA-2024SA213010$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240725$$CN$US$CA
241380781$24138078$1$I$20240101$20240716$20240725$20240725$PER$$US-SA-2024SA213396$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240725$$MD$US$US
241380791$24138079$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA212702$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240725$$MD$US$US
241380801$24138080$1$I$20240101$20240716$20240725$20240725$PER$$US-SA-2024SA213240$SANOFI AVENTIS$$$$A$M$Y$$$20240725$$MD$US$US
241380812$24138081$2$F$20240717$20240723$20240725$20240731$PER$$US-SA-2024SA212358$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240731$$MD$US$US
241380823$24138082$3$F$20240229$20240822$20240725$20240903$PER$$US-SA-2024SA209999$SANOFI AVENTIS$$3$YR$C$F$Y$15$KG$20240903$$PH$US$US
241380831$24138083$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214738$SANOFI AVENTIS$$$$A$F$Y$47.6$KG$20240725$$MD$US$US
241380841$24138084$1$I$20240717$20240717$20240725$20240725$PER$$US-SA-2024SA214675$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240725$$HP$US$US
241380851$24138085$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214485$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240725$$MD$US$US
241380861$24138086$1$I$20240601$20240716$20240725$20240725$PER$$US-SA-2024SA213560$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240725$$MD$US$US
241380871$24138087$1$I$20240401$20240716$20240725$20240725$PER$$US-SA-2024SA215284$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240725$$MD$US$US
241380881$24138088$1$I$$20240719$20240725$20240725$EXP$$AR-BIOMARINAP-AR-2024-159194$BIOMARIN$$$$$$Y$$$20240725$$CN$AR$AR
241380894$24138089$4$F$20170101$20240916$20240725$20240919$EXP$$US-ABBVIE-5851765$ABBVIE$$$$$F$Y$58.966$KG$20240919$$CN$US$US
241380902$24138090$2$F$20240101$20240723$20240725$20240801$PER$$US-SA-2024SA213663$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240801$$MD$US$US
241380911$24138091$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214036$SANOFI AVENTIS$$$$C$M$Y$$$20240725$$CN$US$US
241380921$24138092$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA212273$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240725$$CN$US$US
241380932$24138093$2$F$$20240729$20240725$20240807$PER$$US-SA-2024SA214456$SANOFI AVENTIS$$27$YR$A$F$Y$68$KG$20240807$$MD$US$US
241380941$24138094$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA214414$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240725$$MD$US$US
241380951$24138095$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5851209$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241380961$24138096$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA214407$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240725$$MD$US$US
241380971$24138097$1$I$20231220$20240717$20240725$20240725$PER$$US-SA-2024SA213600$SANOFI AVENTIS$$$$$M$Y$$$20240725$$CN$US$US
241380981$24138098$1$I$$20240716$20240725$20240725$PER$$US-SA-2023SA225856$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240725$$MD$US$US
241380991$24138099$1$I$20240601$20240717$20240725$20240725$PER$$US-SA-2024SA214468$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240725$$CN$US$US
241381001$24138100$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA213781$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241381011$24138101$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA214489$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240725$$MD$US$US
241381021$24138102$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214299$SANOFI AVENTIS$$$$A$M$Y$81.6$KG$20240725$$MD$US$US
241381031$24138103$1$I$20240716$20240716$20240725$20240725$PER$$US-SA-2024SA213470$SANOFI AVENTIS$$62$YR$A$M$Y$90$KG$20240725$$MD$US$US
241381041$24138104$1$I$20240704$20240717$20240725$20240725$DIR$FDA-CDER-CTU-2024-51127$$FDA-CTU$$72$YR$$F$N$97$LBS$20240717$N$CN$US$
241381051$24138105$1$I$20240701$20240717$20240725$20240725$PER$$US-SA-2024SA214041$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240725$$MD$US$US
241381061$24138106$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214917$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240725$$CN$US$US
241381071$24138107$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA213526$SANOFI AVENTIS$$$$A$M$Y$59.874$KG$20240725$$MD$US$US
241381083$24138108$3$F$$20240717$20240725$20240801$PER$$US-SA-2024SA213182$SANOFI AVENTIS$$84$YR$E$M$Y$88.45$KG$20240801$$MD$US$US
241381091$24138109$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA212233$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240725$$MD$US$US
241381101$24138110$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA214742$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240725$$MD$US$US
241381111$24138111$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214438$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240725$$MD$US$US
241381121$24138112$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214964$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240725$$CN$US$US
241381131$24138113$1$I$20240301$20240716$20240725$20240725$PER$$US-SA-2024SA213493$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240725$$MD$US$US
241381141$24138114$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214429$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240725$$MD$US$US
241381151$24138115$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA213844$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240725$$MD$US$US
241381161$24138116$1$I$20240701$20240717$20240725$20240725$PER$$US-SA-2024SA214685$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240725$$MD$US$US
241381171$24138117$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA213646$SANOFI AVENTIS$$$$A$F$Y$104$KG$20240725$$CN$US$US
241381181$24138118$1$I$20240701$20240716$20240725$20240725$PER$$US-SA-2024SA213655$SANOFI AVENTIS$$$$E$F$Y$$$20240725$$MD$US$US
241381191$24138119$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214078$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240725$$MD$US$US
241381201$24138120$1$I$20240716$20240717$20240725$20240725$PER$$US-SA-2024SA212272$SANOFI AVENTIS$$$$$M$Y$$$20240725$$CN$US$US
241381212$24138121$2$F$20240723$20240723$20240725$20240801$PER$$NVSC2024US152022$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
241381221$24138122$1$I$20240711$20240723$20240725$20240725$EXP$$NVSC2024CN152380$NOVARTIS$$9$YR$$F$Y$38$KG$20240725$$HP$CN$CN
241381241$24138124$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA212360$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240725$$MD$US$US
241381251$24138125$1$I$20240620$20240718$20240725$20240725$EXP$$US-ABBVIE-5835659$ABBVIE$$53$YR$$F$Y$$$20240725$$CN$US$US
241381261$24138126$1$I$20220101$20240716$20240725$20240725$PER$$US-SA-2024SA212506$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240725$$MD$US$US
241381271$24138127$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA214883$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240725$$MD$US$US
241381281$24138128$1$I$20240601$20240716$20240725$20240725$PER$$US-SA-2024SA212221$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240725$$MD$US$US
241381291$24138129$1$I$20240601$20240717$20240725$20240725$PER$$US-SA-2024SA214622$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240725$$MD$US$US
241381301$24138130$1$I$20240607$20240717$20240725$20240725$PER$$US-SA-2024SA214957$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240725$$MD$US$US
241381311$24138131$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA212509$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241381321$24138132$1$I$20240601$20240717$20240725$20240725$PER$$US-SA-2024SA214517$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240725$$MD$US$US
241381331$24138133$1$I$20240601$20240716$20240725$20240725$PER$$US-SA-2024SA216624$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240725$$MD$US$US
241381341$24138134$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA213235$SANOFI AVENTIS$$$$A$M$Y$72.57$KG$20240725$$MD$US$US
241381351$24138135$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA212493$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240725$$MD$US$US
241381361$24138136$1$I$20240701$20240718$20240725$20240725$PER$$US-SA-2024SA216588$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240725$$MD$US$US
241381371$24138137$1$I$20240718$20240718$20240725$20240725$PER$$US-SA-2024SA215102$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240725$$MD$US$US
241381381$24138138$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA216100$SANOFI AVENTIS$$$$A$M$Y$92.9$KG$20240725$$MD$US$US
241381391$24138139$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA212762$SANOFI AVENTIS$$$$E$F$Y$$$20240725$$MD$US$US
241381402$24138140$2$F$20240714$20240718$20240725$20240730$PER$$US-SA-2024SA213901$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240730$$CN$US$US
241381411$24138141$1$I$20231101$20240718$20240725$20240725$PER$$US-SA-2024SA213394$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240725$$HP$US$US
241381421$24138142$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA215203$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240725$$MD$US$US
241381431$24138143$1$I$20240717$20240718$20240725$20240725$PER$$US-SA-2024SA216165$SANOFI AVENTIS$$7$YR$C$M$Y$46.8$KG$20240725$$MD$US$US
241381442$24138144$2$F$20240716$20240718$20240725$20240728$PER$$US-SA-2024SA213137$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240728$$CN$US$US
241381451$24138145$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA214691$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241381461$24138146$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA214729$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241381471$24138147$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA213118$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240725$$CN$US$US
241381481$24138148$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA214906$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240725$$MD$US$US
241381491$24138149$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA215891$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240725$$MD$US$US
241381501$24138150$1$I$20240701$20240718$20240725$20240725$PER$$US-SA-2024SA213514$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240725$$MD$US$US
241381512$24138151$2$F$20240701$20240829$20240725$20240910$PER$$US-SA-2024SA214134$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240910$$MD$US$US
241381521$24138152$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA216195$SANOFI AVENTIS$$$$A$F$Y$73$KG$20240725$$MD$US$US
241381531$24138153$1$I$20240101$20240718$20240725$20240725$PER$$US-SA-2024SA214074$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240725$$MD$US$US
241381541$24138154$1$I$20240714$20240718$20240725$20240725$PER$$US-SA-2024SA215847$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240725$$MD$US$US
241381551$24138155$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA214131$SANOFI AVENTIS$$$$A$F$Y$83.46$KG$20240725$$MD$US$US
241381561$24138156$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA213383$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240725$$CN$US$US
241381572$24138157$2$F$20240101$20240718$20240725$20240729$PER$$US-SA-2024SA213126$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240729$$CN$US$US
241381581$24138158$1$I$20240601$20240718$20240725$20240725$PER$$US-SA-2024SA214142$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240725$$MD$US$US
241381591$24138159$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA216441$SANOFI AVENTIS$$$$A$F$Y$72$KG$20240725$$MD$US$US
241381601$24138160$1$I$20240101$20240718$20240725$20240725$PER$$US-SA-2024SA213178$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240725$$CN$US$US
241381611$24138161$1$I$20240501$20240718$20240725$20240725$PER$$US-SA-2024SA214720$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240725$$MD$US$US
241381621$24138162$1$I$20240101$20240718$20240725$20240725$PER$$US-SA-2024SA214724$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240725$$MD$US$US
241381631$24138163$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA212688$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240725$$MD$US$US
241381641$24138164$1$I$20240101$20240718$20240725$20240725$PER$$US-SA-2024SA213340$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240725$$MD$US$US
241381653$24138165$3$F$20240101$20240802$20240725$20240812$PER$$US-SA-2024SA215208$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240812$$MD$US$US
241381661$24138166$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA213006$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240725$$CN$US$US
241381671$24138167$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA213616$SANOFI AVENTIS$$$$$$Y$$$20240725$$HP$US$US
241381681$24138168$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA214546$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240725$$CN$US$US
241381691$24138169$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA204964$SANOFI AVENTIS$$$$A$F$Y$98.4$KG$20240725$$MD$US$US
241381711$24138171$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA214351$SANOFI AVENTIS$$$$A$F$Y$114.3$KG$20240725$$MD$US$US
241381722$24138172$2$F$20240101$20240815$20240725$20240829$PER$$US-SA-2024SA213902$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240829$$MD$US$US
241381731$24138173$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA215031$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240725$$MD$US$US
241381741$24138174$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA215882$SANOFI AVENTIS$$$$E$F$Y$59$KG$20240725$$MD$US$US
241381751$24138175$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA215008$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240725$$MD$US$US
241381761$24138176$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA214719$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240725$$MD$US$US
241381771$24138177$1$I$$20240723$20240725$20240725$EXP$$US-ABBVIE-5851271$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241381782$24138178$2$F$$20240805$20240725$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116783$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240812$$CN$US$US
241381791$24138179$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118539$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240725$$CN$US$US
241381801$24138180$1$I$20240610$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51018$$FDA-CTU$$75$YR$$F$N$81.65$KG$20240725$$CN$US$
241381811$24138181$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118375$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240725$$CN$US$US
241381821$24138182$1$I$$20240722$20240725$20240725$PER$$US-SA-2024SA215741$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240725$$CN$US$US
241381831$24138183$1$I$$20240719$20240725$20240725$PER$$US-SA-2024SA215249$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240725$$MD$US$US
241381844$24138184$4$F$20240101$20240813$20240725$20240816$EXP$$US-SA-2024SA216598$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240816$$MD$US$US
241381851$24138185$1$I$$20240721$20240725$20240725$PER$$US-SA-2024SA214408$SANOFI AVENTIS$$$$$F$Y$$$20240725$$CN$US$US
241381861$24138186$1$I$20240101$20240718$20240725$20240725$PER$$US-SA-2024SA214684$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240725$$MD$US$US
241381871$24138187$1$I$20240101$20240719$20240725$20240725$PER$$US-SA-2024SA213402$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240725$$CN$US$US
241381881$24138188$1$I$$20240719$20240725$20240725$PER$$US-SA-2024SA216434$SANOFI AVENTIS$$$$A$F$Y$$$20240725$$MD$US$US
241381891$24138189$1$I$$20240722$20240725$20240725$PER$$US-SA-2024SA216862$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240725$$CN$US$US
241381901$24138190$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA215015$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240725$$MD$US$US
241381911$24138191$1$I$20240721$20240722$20240725$20240725$PER$$US-SA-2024SA216114$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240725$$MD$US$US
241381921$24138192$1$I$$20240722$20240725$20240725$PER$$US-SA-2024SA216091$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240725$$CN$US$US
241381932$24138193$2$F$20240712$20240722$20240725$20240731$PER$$US-SA-2024SA213418$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240731$$CN$US$US
241381941$24138194$1$I$20160101$20240722$20240725$20240725$PER$$US-SA-2024SA216874$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240725$$CN$US$US
241381951$24138195$1$I$$20240719$20240725$20240725$PER$$US-SA-2024SA215182$SANOFI AVENTIS$$$$A$M$Y$$$20240725$$HP$US$US
241381962$24138196$2$F$20230101$20240916$20240725$20240923$PER$$US-SA-2024SA214326$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240923$$MD$US$US
241381971$24138197$1$I$$20240722$20240725$20240725$PER$$US-SA-2021SA256359$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240725$$CN$US$US
241381981$24138198$1$I$20240101$20240718$20240725$20240725$PER$$US-SA-2024SA213433$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240725$$MD$US$US
241381992$24138199$2$F$20220101$20240822$20240725$20240906$PER$$US-SA-2024SA215652$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240906$$CN$US$US
241382001$24138200$1$I$$20240722$20240725$20240725$PER$$US-SA-2024SA215634$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240725$$CN$US$US
241382011$24138201$1$I$20240301$20240719$20240725$20240725$PER$$US-SA-2024SA216560$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240725$$MD$US$US
241382021$24138202$1$I$20240720$20240722$20240725$20240725$PER$$US-SA-2024SA215590$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240725$$CN$US$US
241382031$24138203$1$I$$20240719$20240725$20240725$PER$$US-SA-2024SA216569$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240725$$CN$US$US
241382041$24138204$1$I$$20240719$20240725$20240725$PER$$US-SA-2024SA215665$SANOFI AVENTIS$$$$$$Y$$$20240725$$MD$US$US
241382051$24138205$1$I$20210901$20240721$20240725$20240725$PER$$US-SA-2024SA217225$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240725$$MD$US$US
241382061$24138206$1$I$20230101$20240719$20240725$20240725$PER$$US-SA-2024SA214952$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240725$$MD$US$US
241382071$24138207$1$I$$20240722$20240725$20240725$PER$$US-SA-2024SA216468$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240725$$CN$US$US
241382082$24138208$2$F$$20240724$20240725$20240729$EXP$$US-PFIZER INC-202400222709$PFIZER$Sharma, R.. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy. Experimental and Clinical Transplantation.. 2024;22 (5):392-395$68$YR$$F$Y$$$20240729$$MD$US$US
241382091$24138209$1$I$$20240711$20240725$20240725$PER$$US-ALXN-A202307869$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240719$$HP$US$US
241382101$24138210$1$I$$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014299$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240725$$CN$US$US
241382111$24138211$1$I$20240605$20240719$20240725$20240725$EXP$FR-AFSSAPS-ST2024001180$FR-ELI_LILLY_AND_COMPANY-FR202407013627$ELI LILLY AND CO$$70$YR$E$M$Y$63$KG$20240725$$CN$FR$FR
241382121$24138212$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015709$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240725$$CN$US$US
241382131$24138213$1$I$$20240724$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407016352$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240725$$CN$US$US
241382161$24138216$1$I$20240101$20240708$20240725$20240725$PER$$US-INSUD PHARMA-2407US05460$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241382171$24138217$1$I$$20240708$20240725$20240725$PER$$US-INSUD PHARMA-2407US05457$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241382181$24138218$1$I$$20240709$20240725$20240725$PER$$US-INSUD PHARMA-2407US05461$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241382191$24138219$1$I$$20240708$20240725$20240725$PER$$US-INSUD PHARMA-2407US05459$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241382201$24138220$1$I$$20240708$20240725$20240725$PER$$US-INSUD PHARMA-2407US05456$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241382211$24138221$1$I$$20240709$20240725$20240725$PER$$US-MYLANLABS-2024M1065407$MYLAN$$$$$F$Y$$$20240725$$CN$US$US
241382221$24138222$1$I$$20240724$20240725$20240725$PER$$US-HALEON-2188946$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241382231$24138223$1$I$20240101$20240718$20240725$20240725$EXP$FR-AFSSAPS-TO2024001309$FR-SA-2024SA213204$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240725$$PH$FR$FR
241382244$24138224$4$F$20240710$20240819$20240725$20240827$PER$$US-ALXN-202407USA000767US$ALEXION PHARMACEUTICALS$$72$YR$$M$Y$113.38$KG$20240827$$CN$US$US
241382254$24138225$4$F$20240101$20240815$20240725$20240821$EXP$$US-SA-2024SA215463$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240821$$MD$US$US
241382261$24138226$1$I$20240201$20240712$20240725$20240725$PER$$US-SA-2024SA182307$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240725$$MD$US$US
241382271$24138227$1$I$$20240723$20240725$20240725$EXP$$CA-SA-2024SA216393$SANOFI AVENTIS$$71$YR$E$F$Y$86.1$KG$20240725$$HP$CA$CA
241382291$24138229$1$I$$20240718$20240725$20240725$PER$$US-SA-2024SA214961$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240725$$MD$US$US
241382301$24138230$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214072$SANOFI AVENTIS$$59$YR$A$M$Y$99$KG$20240725$$CN$US$US
241382311$24138231$1$I$$20240716$20240725$20240725$PER$$US-SA-2024SA212442$SANOFI AVENTIS$$$$A$F$Y$90.71$KG$20240725$$MD$US$US
241382321$24138232$1$I$20240516$20240709$20240725$20240725$PER$$US-MYLANLABS-2024M1052426$MYLAN$$82$YR$$F$Y$56.25$KG$20240725$$CN$US$US
241382332$24138233$2$F$$20240814$20240725$20240828$PER$$US-SA-2024SA216152$SANOFI AVENTIS$$47$YR$A$F$Y$99.79$KG$20240828$$MD$US$US
241382345$24138234$5$F$20231201$20240820$20240725$20240918$PER$$US-SA-2024SA213729$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240918$$PH$US$US
241382351$24138235$1$I$20240710$20240718$20240725$20240725$EXP$$US-SA-2024SA216025$SANOFI AVENTIS$$66$YR$E$F$Y$79.378$KG$20240725$$MD$US$US
241382361$24138236$1$I$20240101$20240718$20240725$20240725$PER$$US-SA-2024SA213778$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240725$$MD$US$US
241382371$24138237$1$I$20231001$20240718$20240725$20240725$PER$$US-SA-2024SA215001$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240725$$MD$US$US
241382381$24138238$1$I$20240603$20240719$20240725$20240725$PER$$US-SA-2024SA215178$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240725$$HP$US$US
241382391$24138239$1$I$20240718$20240719$20240725$20240725$PER$$US-SA-2024SA215248$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240725$$CN$US$US
241382401$24138240$1$I$20240701$20240719$20240725$20240725$PER$$US-SA-2024SA214319$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240725$$MD$US$US
241382412$24138241$2$F$$20240814$20240725$20240819$EXP$$US-TAKEDA-2024TUS042951$TAKEDA$$$$$M$Y$$$20240819$$CN$US$US
241382421$24138242$1$I$20240621$20240723$20240725$20240725$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004096$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
241382431$24138243$1$I$$20240721$20240725$20240725$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004068$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$US$US
241382442$24138244$2$F$$20240826$20240725$20240827$EXP$$CH-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004064$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240827$$HP$CH$CH
241382452$24138245$2$F$20240625$20240820$20240725$20240823$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004010$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240823$$CN$US$US
241382461$24138246$1$I$$20240719$20240725$20240725$PER$$US-ABBVIE-5848792$ABBVIE$$$$$$Y$$$20240725$$HP$US$US
241382471$24138247$1$I$$20240710$20240725$20240725$EXP$$KR-BRAINTREE LABORATORIES, INC.-2024BTE00447$BRAINTREE$Kim G., Lee W.H., Kang, S. et al.. Vomiting-induced pharyngeal perforation during bowel preparation for colonoscopy: A case report. World J Clin Cases. 2024;12(18):3615-3621$38$YR$$M$Y$$$20240725$$HP$KR$KR
241382482$24138248$2$F$20240501$20240910$20240725$20240917$EXP$$JP-009507513-2407JPN003184J$MERCK$$7$DEC$$F$Y$$$20240917$$MD$JP$JP
241382491$24138249$1$I$20221129$20240725$20240725$20240725$EXP$$JP-ABBVIE-5853005$ABBVIE$$78$YR$$F$Y$42$KG$20240725$$MD$JP$JP
241382502$24138250$2$F$20240724$20240729$20240725$20240731$EXP$$IT-GILEAD-2024-0681843$GILEAD$$53$YR$A$M$Y$$$20240731$$CN$IT$IT
241382512$24138251$2$F$20220705$20240730$20240725$20240802$EXP$$TW-TAKEDA-2022TUS047362$TAKEDA$$45$YR$$F$Y$$$20240802$$CN$TW$TW
241382531$24138253$1$I$$20240712$20240725$20240725$PER$$US-ALXN-202407USA000872US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
241382543$24138254$3$F$$20240812$20240725$20240812$PER$$US-ALXN-202407USA000863US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241382552$24138255$2$F$$20240809$20240725$20240816$EXP$$US-ALXN-202407USA000727US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240816$$HP$US$US
241382563$24138256$3$F$$20240812$20240725$20240812$PER$$US-ALXN-202407USA000922US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241382572$24138257$2$F$20240626$20240807$20240725$20240808$PER$$US-ALXN-202407USA000879US$ALEXION PHARMACEUTICALS$$42$YR$$F$Y$$$20240808$$CN$US$US
241382581$24138258$1$I$20240101$20240712$20240725$20240725$PER$$US-ALXN-202407USA000908US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240719$$CN$US$US
241382592$24138259$2$F$$20240807$20240725$20240808$PER$$US-ALXN-202407USA000952US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241382601$24138260$1$I$$20240712$20240725$20240725$PER$$US-MYLANLABS-2024M1065528$MYLAN$$$$$F$Y$$$20240725$$CN$US$US
241382611$24138261$1$I$$20240712$20240725$20240725$PER$$US-ALXN-202407USA000964US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
241382621$24138262$1$I$20240708$20240724$20240725$20240725$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011257$JAZZ$$20$YR$$M$Y$$$20240725$$CN$US$US
241382631$24138263$1$I$$20240716$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114551$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240725$$CN$US$US
241382644$24138264$4$F$20240719$20240726$20240725$20240809$EXP$$CO-BIOMARINAP-CO-2024-159384$BIOMARIN$$$$$$Y$$$20240809$$CN$CO$CO
241382651$24138265$1$I$$20240712$20240725$20240725$PER$$US-BIOMARINAP-US-2024-159312$BIOMARIN$$$$$$Y$$$20240725$$CN$US$US
241382663$24138266$3$F$20240101$20240812$20240725$20240813$30DAY$$TR-PFIZER INC-202400186166$PFIZER$$$$$$Y$$$20240813$$CN$TR$TR
241382673$24138267$3$F$$20240822$20240725$20240826$30DAY$$FR-PFIZER INC-202400206691$PFIZER$$58$YR$$F$Y$68$KG$20240826$$PH$FR$FR
241382681$24138268$1$I$20240101$20240719$20240725$20240725$EXP$$CA-PFIZER INC-202400221116$PFIZER$$61$YR$$F$Y$$$20240725$$HP$CA$CA
241382691$24138269$1$I$20240601$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118122$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$89.81$KG$20240725$$CN$US$US
241382702$24138270$2$F$20240703$20240718$20240725$20240731$PER$$US-BIOMARINAP-US-2024-159347$BIOMARIN$$$$$$Y$$$20240731$$CN$US$US
241382711$24138271$1$I$$20240716$20240725$20240725$30DAY$$US-PFIZER INC-202400216521$PFIZER$$$$$F$Y$$$20240725$$CN$US$US
241382723$24138272$3$F$$20240830$20240725$20240830$30DAY$$US-PFIZER INC-PV202400093879$PFIZER$$$$$M$Y$$$20240830$$CN$US$US
241382741$24138274$1$I$20240101$20240719$20240725$20240725$PER$$US-SA-2024SA215231$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240725$$MD$US$US
241382751$24138275$1$I$20240705$20240717$20240725$20240725$EXP$IT-MINISAL02-994398$IT-TEVA-VS-3222495$TEVA$$55$YR$$F$Y$$$20240725$$MD$IT$IT
241382761$24138276$1$I$$20240722$20240725$20240725$EXP$$CA-TAKEDA-2024TUS074662$TAKEDA$$$$$M$Y$$$20240725$$CN$CA$CA
241382771$24138277$1$I$$20240522$20240725$20240725$PER$$US-PHOTOCURE ASA-PHCUS2024000004$PHOTOCURE$$76$YR$$M$Y$$$20240723$$HP$US$US
241382792$24138279$2$F$$20240729$20240725$20240808$EXP$$ES-TEVA-VS-3223381$TEVA$Garcia Ruiz PJ, Feliz LD, Feliz CE, Sanchez IL, Fernandez AA, Kelly FB, et al. The enduring enigma of sporadic chorea: A single center case series. Tremor-Other-Hyperkinet-Mov 2023; 13 (1): 1-10.; Garcia Ruiz PJ, Feliz LD, Feliz CE, Sanchez IL, Fernandez AA, Kelly FB, et al. The enduring enigma of sporadic chorea: A single center case series. Tremor-Other-Hyperkinet-Mov 2023; 13 (1): 1-10.$58$YR$$F$Y$$$20240808$$MD$ES$ES
241382801$24138280$1$I$20240718$20240718$20240725$20240725$PER$$US-SA-2024SA211702$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240725$$CN$US$US
241382812$24138281$2$F$$20240912$20240725$20240916$30DAY$$SE-PFIZER INC-202400215966$PFIZER$$$$$M$Y$$$20240916$$PH$SE$SE
241382821$24138282$1$I$$20240722$20240725$20240725$30DAY$$FR-PFIZER INC-PV202400096212$PFIZER$$12$YR$$F$Y$$$20240725$$CN$FR$FR
241382831$24138283$1$I$$20240716$20240725$20240725$EXP$$CA-GILEAD-2024-0681628$GILEAD$$49$YR$A$F$Y$$$20240725$$MD$CA$CA
241382841$24138284$1$I$$20240711$20240725$20240725$PER$$US-TPU-TPU-2024-00395$TEIKOKU$$$$$F$Y$$$20240725$$CN$US$US
241382851$24138285$1$I$$20240718$20240725$20240725$PER$$US-TPU-TPU-2024-00401$TEIKOKU$$$$$M$Y$$$20240725$$CN$US$US
241382861$24138286$1$I$$20240723$20240725$20240725$PER$$NVSC2024US151899$NOVARTIS$$$$$$Y$$$20240725$$CN$US$US
241382871$24138287$1$I$$20240709$20240725$20240725$PER$$US-TPU-TPU-2024-00384$TEIKOKU$$$$$F$Y$$$20240725$$CN$US$US
241382882$24138288$2$F$20240101$20240903$20240725$20240905$EXP$$CA-PFIZER INC-202400220931$PFIZER$$77$YR$$F$Y$$$20240905$$CN$CA$CA
241382891$24138289$1$I$$20240711$20240725$20240725$PER$$US-TPU-TPU-2024-00396$TEIKOKU$$$$$F$Y$$$20240725$$PH$US$US
241382901$24138290$1$I$$20240711$20240725$20240725$PER$$US-TPU-TPU-2024-00390$TEIKOKU$$$$$F$Y$$$20240725$$CN$US$US
241382911$24138291$1$I$20040101$20240716$20240725$20240725$PER$$US-TPU-TPU-2024-00399$TEIKOKU$$44$YR$A$F$Y$$$20240725$$CN$US$US
241382921$24138292$1$I$$20240718$20240725$20240725$EXP$$US-ABBVIE-5848516$ABBVIE$$$$$$Y$$$20240725$$HP$US$US
241382931$24138293$1$I$$20240718$20240725$20240725$EXP$$US-AMGEN-USASP2024144319$AMGEN$$$$$F$Y$$$20240725$$HP$US$US
241382941$24138294$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117983$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240725$$HP$US$US
241382951$24138295$1$I$$20240722$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116990$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240725$$HP$US$US
241382961$24138296$1$I$$20240709$20240725$20240725$PER$$US-MYLANLABS-2024M1065649$MYLAN$$$$$F$Y$$$20240725$$CN$US$US
241382971$24138297$1$I$$20240717$20240725$20240725$EXP$$US-ABBVIE-5846156$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241382981$24138298$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA214230$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240725$$MD$US$US
241382992$24138299$2$F$20240714$20240915$20240725$20240916$30DAY$$CO-PFIZER INC-202400217281$PFIZER$$14$YR$$M$Y$$$20240916$$CN$CO$CO
241383002$24138300$2$F$$20240829$20240725$20240903$30DAY$$CA-PFIZER INC-202400222854$PFIZER$$$$$$Y$$$20240903$$HP$CA$CA
241383011$24138301$1$I$$20240723$20240725$20240725$30DAY$$US-PFIZER INC-202400221992$PFIZER$$36$YR$$F$Y$$$20240725$$MD$US$US
241383021$24138302$1$I$20240702$20240723$20240725$20240725$PER$$US-ROCHE-10000035175$ROCHE$$70$YR$E$M$Y$$$20240725$$CN$US$US
241383032$24138303$2$F$$20240911$20240725$20240912$30DAY$$FR-PFIZER INC-202400217551$PFIZER$$1$YR$$M$Y$$$20240912$$PH$FR$FR
241383041$24138304$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015775$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240725$$CN$US$US
241383051$24138305$1$I$20240718$20240718$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407013716$ELI LILLY AND CO$$$$$$Y$$$20240725$$CN$US$US
241383061$24138306$1$I$$20240723$20240725$20240725$EXP$GB-MHRA-MIDB- e2fb15c5-177f-4401-9ff0-374d0a288bbe$GB-DSJP-DSE-2024-137153$DAIICHI$$84$YR$$M$Y$$$20240725$$PH$GB$GB
241383071$24138307$1$I$$20240723$20240725$20240725$EXP$CA-HEALTHCANVIG-E2B_07182025$CA-PURDUE-USA-2024-0310934$PURDUE$$83$YR$$M$Y$$$20240725$$CN$CA$CA
241383082$24138308$2$F$$20240829$20240725$20240903$EXP$$CA-PURDUE-USA-2024-0310942$PURDUE$$54$YR$$F$Y$$$20240903$$CN$CA$CA
241383091$24138309$1$I$$20240717$20240725$20240725$EXP$$JP-TEVA-VS-3223936$TEVA$$48$YR$$M$Y$$$20240725$$MD$JP$JP
241383103$24138310$3$F$20240520$20240809$20240725$20240819$EXP$$US-TEVA-VS-3222763$TEVA$$22$YR$$F$Y$$$20240819$$MD$US$US
241383112$24138311$2$F$$20240807$20240725$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118160$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240808$$HP$US$US
241383122$24138312$2$F$$20240724$20240725$20240729$PER$$NVSC2024US152003$NOVARTIS$$$$$F$Y$$$20240729$$CN$US$US
241383131$24138313$1$I$$20240718$20240725$20240725$EXP$$NVSC2024RU150914$NOVARTIS$Salugina S, Fedorov E, Torgashina A. IL-1 inhibitors in the treatment of patients with CINCA/NOMID - experience of the Russian federal center. PEDIATRIC RHEUMATOLOGY. 2023;21 (Suppl 2):P352 (243)$$$$$Y$$$20240725$$HP$RU$RU
241383141$24138314$1$I$$20240718$20240725$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114963$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240725$$HP$CA$CA
241383151$24138315$1$I$$20240716$20240725$20240725$EXP$$JP-ROCHE-10000033178$ROCHE$Kudou T, Kikuchi T, Okazaki N. 17 Review of a case in which acute psychiatric symptom developed after the use of anti-IL-6 receptor antibody preparations. Psychiatria et Neurologia Japonica / The 77th Tohoku Association of Neuropsychiatry.. 2024;16 (6):411.$8$DEC$E$F$Y$$$20240725$$MD$JP$JP
241383161$24138316$1$I$$20240719$20240725$20240725$EXP$CA-HEALTHCANVIG-E2B_07093247$CA-PURDUE-USA-2024-0310956$PURDUE$$44$YR$$F$Y$$$20240725$$HP$CA$CA
241383181$24138318$1$I$20240701$20240718$20240725$20240725$EXP$$IN-ABBVIE-5853745$ABBVIE$$$$$F$Y$$$20240725$$CN$IN$IN
241383191$24138319$1$I$20240601$20240722$20240725$20240725$EXP$GB-MHRA-TPP17278041C22275880YC1721659900714$GB-ABBVIE-5851965$ABBVIE$$$$$$Y$$$20240725$$MD$GB$GB
241383201$24138320$1$I$$20240716$20240725$20240725$EXP$$CA-009507513-2407CAN010745$MERCK$$73$YR$$F$Y$63$KG$20240725$$HP$CA$CA
241383211$24138321$1$I$20240625$20240717$20240725$20240725$PER$$US-Eisai-EC-2024-169146$EISAI$$78$YR$E$M$Y$72$KG$20240725$$CN$US$US
241383231$24138323$1$I$$20240723$20240725$20240725$PER$$US-ABBVIE-5852794$ABBVIE$$$$$$Y$$$20240725$$CN$US$US
241383241$24138324$1$I$20240723$20240723$20240725$20240725$EXP$$GB-TEVA-VS-3224805$TEVA$$76$YR$$F$Y$90$KG$20240725$$MD$GB$GB
241383251$24138325$1$I$$20240719$20240725$20240725$EXP$$NL-PERRIGO-24NL006880$PERRIGO$Dekker MJHJ, Heerdink GC, Plattel CHM. Vitamin B12 Deficiency-Induced Neuropathy and Cognitive and Motor Impairment in the Elderly: A Case Study. Food and nutrition bulletin. 2024;45(1_suppl):S53-7. DOI: 10.1177/03795721241226886.$71$YR$$M$Y$$$20240725$$MD$NL$NL
241383261$24138326$1$I$20240101$20240723$20240725$20240725$PER$$NVSC2024US152077$NOVARTIS$$66$YR$$F$Y$$$20240725$$CN$US$US
241383271$24138327$1$I$$20240717$20240725$20240725$EXP$$TW-AstraZeneca-2024A165119$ASTRAZENECA$$$$$M$Y$$$20240725$$CN$TW$
241383281$24138328$1$I$20240629$20240702$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003108$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240725$$CN$US$US
241383291$24138329$1$I$$20240702$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003114$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241383303$24138330$3$F$$20240912$20240725$20240919$30DAY$$US-PFIZER INC-202400217907$PFIZER$$14$YR$$M$Y$43.09$KG$20240919$$CN$US$US
241383311$24138331$1$I$$20240702$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003113$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241383326$24138332$6$F$$20240925$20240725$20240927$30DAY$$US-PFIZER INC-202400219015$PFIZER$$$$$$Y$$$20240927$$PH$US$US
241383331$24138333$1$I$$20240725$20240725$20240725$EXP$NL-LRB-00984773$NL-ROCHE-10000035963$ROCHE$$49$YR$A$F$Y$$$20240725$$HP$NL$NL
241383342$24138334$2$F$20240401$20240730$20240725$20240802$EXP$DE-CADRBFARM-2024329281$DE-MYLANLABS-2024M1068214$MYLAN$$67$YR$$F$Y$85$KG$20240802$$MD$DE$DE
241383351$24138335$1$I$$20240723$20240725$20240725$EXP$$ES-GILEAD-2024-0681826$GILEAD$$$$$$Y$$$20240725$$MD$ES$ES
241383363$24138336$3$F$20240706$20240808$20240725$20240816$EXP$$JP-ALXN-202407JPN001027JP$ALEXION PHARMACEUTICALS$$0$YR$$$Y$$$20240816$$CN$JP$JP
241383374$24138337$4$F$20240717$20240906$20240725$20240910$EXP$$US-ALXN-202407USA001243US$ALEXION PHARMACEUTICALS$$14$YR$$F$Y$90.9$KG$20240910$$MD$US$US
241383381$24138338$1$I$$20240719$20240725$20240725$PER$$US-ABBVIE-5848407$ABBVIE$$$$$$Y$$$20240725$$CN$US$US
241383391$24138339$1$I$20240721$20240721$20240725$20240725$30DAY$$JP-PFIZER INC-PV202400095017$PFIZER$$$$$F$Y$$$20240725$$CN$JP$JP
241383401$24138340$1$I$$20240716$20240725$20240725$EXP$$BR-RDY-SPO/BRA/24/0010620$DR REDDYS$$52$YR$A$M$Y$$$20240725$$CN$BR$BR
241383441$24138344$1$I$20240701$20240717$20240725$20240725$EXP$IT-MINISAL02-994241$IT-TEVA-VS-3222500$TEVA$$71$YR$$M$Y$$$20240725$$PH$IT$IT
241383451$24138345$1$I$$20240724$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118179$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240725$$CN$US$US
241383461$24138346$1$I$20240627$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118359$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240725$$HP$US$US
241383472$24138347$2$F$$20240903$20240725$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118303$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$69.85$KG$20240904$$CN$US$US
241383481$24138348$1$I$20240101$20240724$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118069$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$67.59$KG$20240725$$CN$US$US
241383491$24138349$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA213281$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240725$$CN$US$US
241383501$24138350$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA212496$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240725$$MD$US$US
241383521$24138352$1$I$20240601$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015371$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240725$$CN$US$US
241383531$24138353$1$I$$20240718$20240725$20240725$EXP$$IE-MYLANLABS-2024M1068796$MYLAN$Doran S, Kernan R, McEniff N. Isolated pulmonary artery choriocarcinoma masquerading as pulmonary embolism diagnosed by endovascular biopsy. Radiol-Case-Rep 2024; 19 (8): 3525-3528.$52$YR$$F$Y$$$20240725$$HP$IE$IE
241383541$24138354$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152870$NOVARTIS$$$$$M$Y$$$20240725$$HP$US$US
241383551$24138355$1$I$$20240718$20240725$20240725$EXP$NL-LRB-00985215$NL-TEVA-VS-3223421$TEVA$$73$YR$$F$Y$57.1$KG$20240725$$MD$NL$NL
241383571$24138357$1$I$$20240717$20240725$20240725$PER$$US-SA-2024SA212766$SANOFI AVENTIS$$$$A$F$Y$88.45$KG$20240725$$MD$US$US
241383581$24138358$1$I$20240101$20240717$20240725$20240725$PER$$US-SA-2024SA213125$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240725$$MD$US$US
241383591$24138359$1$I$20240716$20240718$20240725$20240725$EXP$GB-MHRA-MED-202407181214568440-TJQDG$GB-TEVA-VS-3222783$TEVA$$54$YR$$M$Y$82$KG$20240725$$CN$GB$GB
241383602$24138360$2$F$20240702$20240717$20240725$20240801$EXP$$US-AMGEN-USASL2024132210$AMGEN$$57$YR$A$M$Y$$$20240801$$HP$US$US
241383611$24138361$1$I$$20240722$20240725$20240725$EXP$$RO-MYLANLABS-2024M1068193$MYLAN$Nechita L, Niculet E, Baroiu L, Stefania Balta AA, Nechita A, Voinescu DC, et al.. Acute Myocardial Infarction in COVID-19 Patients-A Review of Literature Data and Two-Case Report Series.. Journal of Clinical Medicine. 2024;13(10):1-2$57$YR$$M$Y$$$20240725$$HP$RO$RO
241383621$24138362$1$I$$20240708$20240725$20240725$PER$$JP-Eisai-EC-2023-132552$EISAI$$66$YR$E$F$Y$$$20240725$$MD$JP$JP
241383631$24138363$1$I$$20240721$20240725$20240725$EXP$$US-ABBVIE-5848811$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241383682$24138368$2$F$$20240923$20240725$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118275$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240926$$CN$US$US
241383693$24138369$3$F$$20240909$20240725$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118159$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$90.72$KG$20240913$$PH$US$US
241383701$24138370$1$I$20240701$20240719$20240725$20240725$EXP$$HN-MYLANLABS-2024M1068645$MYLAN$$64$YR$$F$Y$64.41$KG$20240725$$CN$HN$HN
241383711$24138371$1$I$20240703$20240722$20240725$20240725$EXP$GB-MHRA-MED-202407192347449660-PJWFZ$GB-MYLANLABS-2024M1068395$MYLAN$$36$YR$$F$Y$73$KG$20240725$$CN$GB$GB
241383722$24138372$2$F$20240101$20240903$20240725$20240913$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000018$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240912$$CN$US$US
241383741$24138374$1$I$$20240716$20240725$20240725$PER$$US-MYLANLABS-2024M1067264$MYLAN$$91$YR$$M$Y$$$20240725$$CN$US$US
241383751$24138375$1$I$$20240722$20240725$20240725$PER$$US-MYLANLABS-2024M1068710$MYLAN$$$$$$Y$$$20240725$$CN$US$US
241383761$24138376$1$I$$20240718$20240725$20240725$PER$$US-MYLANLABS-2024M1067412$MYLAN$$$$$F$Y$$$20240725$$CN$US$US
241383771$24138377$1$I$$20240717$20240725$20240725$PER$$US-MYLANLABS-2024M1067645$MYLAN$$$$$F$Y$53.52$KG$20240725$$CN$US$US
241383787$24138378$7$F$20240703$20240909$20240725$20240909$PER$$US-GILEAD-2024-0681862$GILEAD$$29$YR$A$M$Y$$$20240909$$HP$US$US
241383791$24138379$1$I$$20240724$20240725$20240725$EXP$$CA-PFIZER INC-202400222878$PFIZER$$70$YR$$F$Y$$$20240725$$MD$CA$CA
241383801$24138380$1$I$$20240723$20240725$20240725$EXP$$CA-PFIZER INC-202400222154$PFIZER$$67$YR$$F$Y$$$20240725$$HP$CA$CA
241383811$24138381$1$I$$20240717$20240725$20240725$EXP$$US-ALXN-202407GLO001193US$ALEXION PHARMACEUTICALS$Wilson A, Kister I. Response to: Eculizumab use throughout pregnancy in two patients with aquaporin-4-positive neuromyelitis optica spectrum disorder. Clinical and experimental neuroimmunology. 2024;1 - 2$$$N$F$Y$$$20240725$$HP$US$US
241383821$24138382$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014854$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240725$$CN$US$US
241383831$24138383$1$I$20240512$20240715$20240725$20240725$DIR$FDA-CDER-CTU-2024-51032$$FDA-CTU$$58$YR$$F$N$58.97$KG$20240715$N$$US$
241383861$24138386$1$I$20240612$20240715$20240725$20240725$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024088762$VIIV$$$$$F$Y$$$20240725$$MD$US$US
241383871$24138387$1$I$$20240710$20240725$20240725$EXP$$CA-HLS-202401724$HLS THERAPEUTICS$$$$A$M$Y$$$20240725$$PH$CA$CA
241383881$24138388$1$I$$20240724$20240725$20240725$PER$$US-BAUSCH-BL-2024-011364$BAUSCH AND LOMB$$$$$F$Y$$$20240725$$CN$US$US
241383891$24138389$1$I$20220101$20240710$20240725$20240725$EXP$$CN-ACELLA PHARMACEUTICALS, LLC-2024ALO00335$Unknown Manufacturer$Liu H.H.W, Ho T.W, Tsang N.S.K, Lam J.T.W, Hui Y.T.. Doxycycline-induced gastric injury.. Hong Kong Med J. 2024$28$YR$$M$Y$$$20240725$$HP$CN$CN
241383901$24138390$1$I$$20240716$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118174$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240725$$HP$US$US
241383912$24138391$2$F$$20240902$20240725$20240905$30DAY$$NZ-PFIZER INC-202400218243$PFIZER$$59$YR$$M$Y$$$20240905$$CN$NZ$NZ
241383921$24138392$1$I$$20240711$20240725$20240725$EXP$$US-HLS-202400351$HLS THERAPEUTICS$$$$A$M$Y$$$20240725$$MD$US$US
241383931$24138393$1$I$20240101$20240717$20240725$20240725$PER$$US-BAUSCH-BL-2024-011001$BAUSCH AND LOMB$$68$YR$$F$Y$$$20240725$$PH$US$US
241383941$24138394$1$I$20240201$20240717$20240725$20240725$EXP$US-MLMSERVICE-20240710-PI128527-00306-1$US-RDY-SPO/USA/24/0010679$DR REDDYS$Zieneldien T, Kim J, Greene J. Breakthrough pneumocystis jirovecii pneumonia in an allogeneic hematopoietic stem cell transplant recipient. Cureus. 2024;16(6):e61890. DOI: 10.7759/cureus.61890.$50$YR$A$F$Y$$$20240725$$MD$US$US
241383951$24138395$1$I$$20240717$20240725$20240725$PER$$US-MYLANLABS-2024M1067232$MYLAN$$$$$F$Y$$$20240725$$CN$US$US
241383962$24138396$2$F$20240621$20240814$20240725$20240820$EXP$$JP-AMERICAN REGENT INC-2024002815$AMERICAN REGENT$$42$YR$$F$Y$$$20240820$$MD$JP$JP
241383981$24138398$1$I$$20240717$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114150$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240725$$HP$US$US
241383992$24138399$2$F$20240101$20240913$20240725$20240918$EXP$$SE-PFIZER INC-202400223175$PFIZER$$81$YR$$F$Y$$$20240918$$CN$SE$SE
241384001$24138400$1$I$$20240724$20240725$20240725$EXP$$US-PFIZER INC-202400223334$PFIZER$$23$YR$$M$Y$$$20240725$$MD$US$US
241384022$24138402$2$F$$20240911$20240725$20240912$EXP$$US-ABBVIE-5852316$ABBVIE$$$$$M$Y$$$20240912$$MD$US$US
241384032$24138403$2$F$20240101$20240717$20240725$20240729$PER$$US-ABBVIE-5848281$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241384042$24138404$2$F$$20240808$20240725$20240808$PER$$US-JNJFOC-20240764369$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$HP$US$US
241384061$24138406$1$I$$20240719$20240725$20240725$EXP$$US-MYLANLABS-2024M1069249$MYLAN$Delgado D, Gomez M. Hanging and Hypoxia: An Unexpected Diagnostic Surprise of Methemoglobinemia. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$55$YR$$M$Y$$$20240725$$HP$US$US
241384071$24138407$1$I$20240603$20240722$20240725$20240725$EXP$FR-AFSSAPS-GR2024000889$FR-009507513-2407FRA012693$MERCK$$65$YR$$M$Y$$$20240725$$PH$FR$FR
241384081$24138408$1$I$$20240724$20240725$20240725$EXP$$US-KYOWAKIRIN-2024KK017890$KYOWA$$$$$$Y$$$20240725$$HP$US$US
241384091$24138409$1$I$20240629$20240722$20240725$20240725$EXP$HR-HALMED-300086139$HR-MYLANLABS-2024M1068245$MYLAN$$42$YR$$F$Y$$$20240725$$MD$HR$HR
241384101$24138410$1$I$20240601$20240718$20240725$20240725$EXP$DE-AMK-278067$DE-Ipsen Biopharmaceuticals, Inc.-2024-14286$IPSEN$$71$YR$E$M$Y$78$KG$20240725$$PH$DE$DE
241384111$24138411$1$I$20240712$20240718$20240725$20240725$PER$$CN-Eisai-EC-2024-170587$EISAI$$59$YR$A$F$Y$66$KG$20240725$$MD$CN$CN
241384122$24138412$2$F$20240101$20240822$20240725$20240826$EXP$$JP-Eisai-EC-2024-170441$EISAI$$68$YR$E$F$Y$64$KG$20240826$$PH$JP$JP
241384141$24138414$1$I$20240601$20240715$20240725$20240725$EXP$$US-Eisai-EC-2024-170867$EISAI$$76$YR$E$M$Y$96$KG$20240725$$HP$US$US
241384153$24138415$3$F$$20240805$20240725$20240808$PER$$JP-Eisai-EC-2024-169410$EISAI$$8$DEC$E$M$Y$$$20240808$$MD$JP$JP
241384161$24138416$1$I$$20240717$20240725$20240725$PER$$US-GILEAD-2024-0681673$GILEAD$$79$YR$E$F$Y$$$20240725$$CN$US$US
241384171$24138417$1$I$$20240719$20240725$20240725$EXP$$HK-BRISTOL-MYERS SQUIBB COMPANY-2024-089613$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240725$$MD$HK$HK
241384181$24138418$1$I$20240215$20240710$20240725$20240725$EXP$$US-HLS-202400265$HLS THERAPEUTICS$$37$YR$A$M$Y$80$KG$20240725$$PH$US$US
241384191$24138419$1$I$$20240724$20240725$20240725$PER$$US-PFIZER INC-PV202400096945$PFIZER$$70$YR$$F$Y$$$20240725$$HP$US$US
241384202$24138420$2$F$20240415$20240808$20240725$20240828$PER$$US-TEVA-VS-3221493$TEVA$$48$YR$$F$Y$$$20240828$$HP$US$US
241384211$24138421$1$I$$20240722$20240725$20240725$PER$$US-PFIZER INC-PV202400096021$PFIZER$$70$YR$$M$Y$$$20240725$$CN$US$US
241384222$24138422$2$F$20200422$20240722$20240725$20240729$EXP$PL-URPL-1-3287-2020$PL-ELI_LILLY_AND_COMPANY-PL202407013686$ELI LILLY AND CO$$35$YR$A$F$Y$60$KG$20240729$$CN$PL$PL
241384231$24138423$1$I$$20240715$20240725$20240725$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009980$ELI LILLY AND CO$$$$$M$Y$$$20240725$$CN$US$US
241384241$24138424$1$I$20230101$20240716$20240725$20240725$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010480$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240725$$CN$US$US
241384251$24138425$1$I$20240723$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015787$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240725$$CN$US$US
241384261$24138426$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152888$NOVARTIS$$$$$$Y$$$20240725$$HP$US$US
241384271$24138427$1$I$20240109$20240711$20240725$20240725$EXP$$CN-ROCHE-3514381$ROCHE$$62$YR$A$M$Y$$$20240725$$MD$CN$CN
241384281$24138428$1$I$$20240723$20240725$20240725$EXP$GB-MHRA-MED-202407231052238850-FZQPD$GB-MYLANLABS-2024M1068893$MYLAN$$$$$F$Y$$$20240725$$HP$GB$GB
241384293$24138429$3$F$20160101$20240723$20240725$20240801$EXP$$NVSC2024MX152367$NOVARTIS$Acevedo-Quijano DS, Fuentes L.. Tuberculosis en injerto renal: reporte  de caso y revisi?n de literatura [Tuberculosis in an allogeneic transplant kidney: a case report and review of literature]. REV MEX TRASPL.. 2024;13 (2):92-7$30$YR$$M$Y$$$20240801$$HP$MX$MX
241384303$24138430$3$F$$20240822$20240725$20240902$EXP$$JP-TAKEDA-2024TUS073531$TAKEDA$$56$YR$$$Y$$$20240902$$MD$JP$JP
241384311$24138431$1$I$$20240718$20240725$20240725$PER$US-MLMSERVICE-20240711-PI128887-00175-1$US-RDY-SPO/USA/24/0010756$DR REDDYS$Bosley A, Abdou C, Ahmad S, Barssoum K, Chatila K. Successful long-term percutaneous transvalvular mechanical circulatory support without anticoagulation as a bridge to heart transplant: a case report. ASAIO Journal. 2024;70(Supplement 3):119-20. DOI: 10.1016/j.explore.2024.05.002.$62$YR$A$M$Y$$$20240725$$MD$US$US
241384322$24138432$2$F$$20240815$20240725$20240821$EXP$$CA-MYLANLABS-2024M1015804$MYLAN$$$$$F$Y$$$20240821$$CN$CA$CA
241384341$24138434$1$I$20240101$20240723$20240725$20240725$EXP$$US-GILEAD-2023-0655385$GILEAD$$67$YR$E$F$Y$$$20240725$$CN$US$US
241384351$24138435$1$I$20240625$20240722$20240725$20240725$EXP$$DE-009507513-2407DEU012570$MERCK$$$$$M$Y$79$KG$20240725$$MD$DE$DE
241384361$24138436$1$I$20240716$20240724$20240725$20240725$EXP$$CA-MYLANLABS-2024M1069477$MYLAN$$74$YR$$M$Y$$$20240725$$CN$CA$CA
241384371$24138437$1$I$$20240717$20240725$20240725$PER$$US-ALXN-202407USA001634US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241384381$24138438$1$I$20220101$20240702$20240725$20240725$PER$$US-JNJFOC-20240710844$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240725$$CN$US$US
241384392$24138439$2$F$$20240902$20240725$20240904$30DAY$$GB-PFIZER INC-PV202400094606$PFIZER$$6$YR$$M$Y$$$20240904$$CN$GB$GB
241384401$24138440$1$I$$20240722$20240725$20240725$EXP$$TR-ASTELLAS-2024EU007286$ASTELLAS$Arabaci IC, Tabakci BN, Onal I, Yildirim Y. Erlotinib-induced blepharitis: Management of two challenging cases. Journal francais d^ophtalmologie. 2024;104247:e1-3$70$YR$$M$Y$$$20240725$$HP$TR$TR
241384411$24138441$1$I$20240701$20240708$20240725$20240725$PER$$US-INSUD PHARMA-2407US05462$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241384421$24138442$1$I$20240101$20240708$20240725$20240725$PER$$US-INSUD PHARMA-2407US05512$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241384431$24138443$1$I$20240101$20240708$20240725$20240725$PER$$US-INSUD PHARMA-2407US05509$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241384441$24138444$1$I$20240101$20240709$20240725$20240725$PER$$US-INSUD PHARMA-2407US05504$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241384451$24138445$1$I$20240101$20240709$20240725$20240725$PER$$US-INSUD PHARMA-2407US05522$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241384461$24138446$1$I$20230101$20240708$20240725$20240725$PER$$US-INSUD PHARMA-2407US05519$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241384471$24138447$1$I$20240101$20240709$20240725$20240725$PER$$US-INSUD PHARMA-2407US05523$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241384481$24138448$1$I$20240101$20240709$20240725$20240725$PER$$US-INSUD PHARMA-2407US05514$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241384491$24138449$1$I$20240601$20240708$20240725$20240725$PER$$US-INSUD PHARMA-2407US05520$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241384512$24138451$2$F$$20240725$20240725$20240730$EXP$$CA-BAUSCH-BL-2024-011368$BAUSCH AND LOMB$Black M, Yoo J, Fung K, Macneil D, Palma D, Mymryk J, Kuruvilla S, Barrett J, Winquist E, Nicholas A. Personalized Treatment of Recurrent, Metastatic Head and Neck Cancer Guided by Patient-Derived Xenograft Models. Cureus. 2024 MAY 02;16(2):1-13. doi:10.7759/cureus.53645$$$$$Y$$$20240730$$HP$CA$CA
241384521$24138452$1$I$$20240719$20240725$20240725$EXP$$IN-BAUSCH-BL-2024-011169$BAUSCH AND LOMB$Khurana K, Mahajan S, Acharya S, Pantbalekundri N. Bridging immune realms: A striking case report on autoimmune thyroiditis co-existing with immune thrombocytopenic purpura. Journal of Clinical and Diagnostic Research.. 2024 JUL 01;18(7):1-4. doi:10.7860/JCDR/2024/67860.19573.$60$YR$$F$Y$$$20240725$$MD$IN$IN
241384531$24138453$1$I$$20240717$20240725$20240725$PER$$US-BAUSCH-BL-2024-010970$BAUSCH AND LOMB$$$$$M$Y$$$20240725$$CN$US$US
241384543$24138454$3$F$$20240725$20240725$20240802$PER$$NVSC2024US152761$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241384551$24138455$1$I$$20240716$20240725$20240725$PER$$US-BAUSCH-BL-2024-010926$BAUSCH AND LOMB$$55$YR$$F$Y$$$20240725$$CN$US$US
241384563$24138456$3$F$$20240923$20240725$20240927$EXP$$CA-BAUSCH-BL-2024-011218$BAUSCH AND LOMB$$52$YR$$F$Y$113$KG$20240927$$HP$CA$CA
241384571$24138457$1$I$20240719$20240719$20240725$20240725$EXP$$FR-DSJP-DSE-2024-137144$DAIICHI$$$$A$F$Y$89$KG$20240725$$MD$FR$FR
241384581$24138458$1$I$$20240722$20240725$20240725$EXP$$TR-PFIZER INC-PV202400095584$PFIZER$Demirkan, N.. Surgical treatment of a rare brachial artery aneurysm postarteriovenous fistula closure after kidney transplant: A case report. World Journal of Clinical Cases. 2024;12(21):4755-4761$61$YR$$M$Y$$$20240725$$HP$TR$TR
241384601$24138460$1$I$$20240716$20240725$20240725$PER$$US-ABBVIE-5847411$ABBVIE$$$$$$Y$$$20240725$$HP$US$US
241384612$24138461$2$F$$20240723$20240725$20240729$EXP$$US-PFIZER INC-202400222514$PFIZER$$75$YR$$F$Y$$$20240729$$CN$US$US
241384622$24138462$2$F$$20240802$20240725$20240806$EXP$$BR-009507513-2407BRA012881$MERCK$$$$$F$Y$$$20240806$$MD$BR$BR
241384631$24138463$1$I$$20240722$20240725$20240725$PER$$US-ABBVIE-5853815$ABBVIE$$$$$$Y$$$20240725$$CN$US$US
241384643$24138464$3$F$$20240920$20240725$20240927$PER$$NVSC2024US146894$NOVARTIS$$$$$F$Y$102$KG$20240927$$CN$US$US
241384651$24138465$1$I$$20240722$20240725$20240725$PER$$US-ABBVIE-5853813$ABBVIE$$$$$$Y$$$20240725$$HP$US$US
241384661$24138466$1$I$$20240723$20240725$20240725$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-137095$DAIICHI$Nishihara T, Nakamura K, Endo T. O8-3 A Case of Torsades de pointes/Ventricular fibrillation from QT prolongation after pharmacological atrial defibrillation with bepridil: From the standpoint of ER nursing, Journal of the Japanese Society of Clinical Emergency Medicine, 27th Annual Meeting of the Japanese Society of Clinical Emergency Medicine. See Journal Title following Article Title. 2024;27:330$81$YR$$M$Y$$$20240725$$HP$JP$JP
241384681$24138468$1$I$20240601$20240723$20240725$20240725$PER$$US-ABBVIE-5852656$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241384691$24138469$1$I$20240718$20240722$20240725$20240725$EXP$$DE-GILEAD-2024-0681159$GILEAD$$54$YR$A$F$Y$$$20240725$$MD$DE$DE
241384701$24138470$1$I$$20230420$20240725$20240725$EXP$$CA-DSJP-DSJ-2023-116651$DAIICHI$$$$$F$Y$$$20240725$$HP$CA$CA
241384711$24138471$1$I$20240717$20240718$20240725$20240725$PER$$US-ABBVIE-5847884$ABBVIE$$57$YR$$F$Y$$$20240725$$CN$US$US
241384731$24138473$1$I$20240723$20240724$20240725$20240725$EXP$$US-GILEAD-2024-0680808$GILEAD$$25$YR$A$F$Y$$$20240725$$HP$US$US
241384741$24138474$1$I$20240701$20240718$20240725$20240725$EXP$$US-SMPA-2024SPA000153$SUNOVION$$$$$$Y$$$20240725$$CN$US$US
241384751$24138475$1$I$20240717$20240719$20240725$20240725$EXP$$US-SMPA-2024SPA000156$SUNOVION$$$$$$Y$$$20240725$$CN$US$US
241384761$24138476$1$I$20240606$20240719$20240725$20240725$EXP$IT-MINISAL02-995482$IT-DSJP-DSE-2024-136814$DAIICHI$$93$YR$$M$Y$72$KG$20240725$$MD$IT$IT
241384772$24138477$2$F$$20240913$20240725$20240923$PER$$US-GSK-US2024AMR092970$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$HP$US$US
241384781$24138478$1$I$20240601$20240723$20240725$20240725$PER$$US-ABBVIE-5852485$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241384802$24138480$2$F$20240101$20240812$20240725$20240813$EXP$$US-JNJFOC-20240760577$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240813$$HP$US$US
241384811$24138481$1$I$$20240716$20240725$20240725$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI07335$NEUROCRINE BIOSCIENCES$$41$YR$$F$Y$$$20240725$$MD$JP$JP
241384825$24138482$5$F$20220401$20240902$20240725$20240910$EXP$$CO-Ipsen Biopharmaceuticals, Inc.-2023-20490$IPSEN$$25$YR$A$F$Y$34$KG$20240910$$CN$CO$CO
241384841$24138484$1$I$$20240722$20240725$20240725$EXP$$US-MYLANLABS-2024M1069078$MYLAN$$$$$F$Y$$$20240725$$CN$US$US
241384851$24138485$1$I$20240601$20240723$20240725$20240725$PER$$US-ABBVIE-5852654$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241384861$24138486$1$I$$20240719$20240725$20240725$PER$$US-BIOGEN-2024BI01274629$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
241384872$24138487$2$F$$20240911$20240725$20240923$PER$$US-TRAVERE-2024TVT00727$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240923$$PH$US$US
241384882$24138488$2$F$$20240731$20240725$20240807$EXP$US-MLMSERVICE-20240711-PI128955-00217-1$US-RDY-SPO/USA/24/0010754$DR REDDYS$Sahyouni MJ, Acevedo LA, Rodriguez SC, Chiles JA, Pennings NJ. Neuropathy of diabetes following initiation of a low-carbohydrate diet: Case report. Obesity pillars. 2024;11:100115. DOI:10.1016/j.obpill.2024.100115.$50$YR$A$M$Y$$$20240807$$MD$US$US
241384891$24138489$1$I$$20240718$20240725$20240725$EXP$$CA-Eisai-EC-2024-170523$EISAI$$$$A$F$Y$$$20240725$$MD$CA$CA
241384901$24138490$1$I$$20240718$20240725$20240725$PER$$US-BIOGEN-2024BI01274407$BIOGEN$$$$$F$Y$$$20240725$$CN$US$US
241384912$24138491$2$F$20240101$20240807$20240725$20240812$PER$$US-BIOGEN-2024BI01274617$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
241384921$24138492$1$I$20240719$20240719$20240725$20240725$PER$$US-BIOGEN-2024BI01274601$BIOGEN$$39$YR$$F$Y$$$20240725$$CN$US$US
241384931$24138493$1$I$$20240723$20240725$20240725$PER$$US-BIOGEN-2024BI01275000$BIOGEN$$$$$M$Y$$$20240725$$CN$US$US
241384941$24138494$1$I$20240701$20240719$20240725$20240725$PER$$US-BIOGEN-2024BI01274650$BIOGEN$$68$YR$$F$Y$$$20240725$$CN$US$US
241384952$24138495$2$F$20240701$20240723$20240725$20240730$PER$$US-BIOGEN-2024BI01275222$BIOGEN$$33$YR$$F$Y$$$20240730$$CN$US$US
241384961$24138496$1$I$$20240718$20240725$20240725$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115613$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240725$$HP$CA$CA
241384972$24138497$2$F$20240701$20240723$20240725$20240731$EXP$$IT-AstraZeneca-2024A166173$ASTRAZENECA$$64$YR$$F$Y$$$20240731$$MD$IT$
241384981$24138498$1$I$$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A163586$ASTRAZENECA$$$$$$Y$$$20240725$$MD$JP$
241384991$24138499$1$I$20200502$20240722$20240725$20240725$EXP$$CN-AstraZeneca-2020SE63791$ASTRAZENECA$$23718$DY$$F$Y$$$20240725$$CN$CN$
241385002$24138500$2$F$20210801$20240726$20240725$20240801$PER$$US-BIOGEN-2021BI01038785$BIOGEN$$69$YR$$F$Y$$$20240801$$CN$US$US
241385041$24138504$1$I$20240721$20240722$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014788$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240725$$CN$US$US
241385052$24138505$2$F$20240101$20240723$20240725$20240730$PER$$US-BIOGEN-2024BI01274857$BIOGEN$$$$$F$Y$$$20240730$$CN$US$US
241385061$24138506$1$I$20240401$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117298$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240725$$HP$US$US
241385072$24138507$2$F$20240101$20240726$20240725$20240802$PER$$US-BIOGEN-2024BI01274550$BIOGEN$$$$$F$Y$$$20240802$$CN$US$US
241385081$24138508$1$I$$20240717$20240725$20240725$EXP$$NVSC2024IN149854$NOVARTIS$Shetty SS, AnnajiGowda HH, Dahale AB.. Valproate-induced hyperammonemia, neuroleptic sensitivity, and cerebellar atrophy - a clinical conundrum in the management of bipolar disorder. BIPOLAR DISORDERS. 2024;26:200-3$36$YR$$M$Y$$$20240725$$HP$IN$IN
241385091$24138509$1$I$$20240531$20240725$20240725$PER$$US-LUNDBECK-DKLU4000671$LUNDBECK$$$$$$Y$$$20240725$$CN$US$US
241385102$24138510$2$F$$20240823$20240725$20240823$EXP$$US-ALXN-202407USA001301US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$HP$US$US
241385111$24138511$1$I$$20240719$20240725$20240725$EXP$$US-MYLANLABS-2024M1068985$MYLAN$Beshay L, Thakkar A. A Case Of Mature Onset Diabetes Of The Young. J-Endocr-Soc 2023; 7 (Suppl. 1) A513.$21$YR$$F$Y$$$20240725$$MD$US$US
241385122$24138512$2$F$$20230925$20240725$20240801$PER$$US-SEBELA IRELAND LIMITED-2023SEB00071$SEBELA$$$$$F$Y$$$20240801$$CN$US$US
241385132$24138513$2$F$$20231116$20240725$20240801$PER$$US-SEBELA IRELAND LIMITED-2023SEB00082$SEBELA$$$$$M$Y$$$20240801$$CN$US$US
241385141$24138514$1$I$20240601$20240715$20240725$20240725$PER$$US-JNJFOC-20240768816$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$CN$US$US
241385152$24138515$2$F$$20240808$20240725$20240821$PER$$US-JNJFOC-20240764420$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$PH$US$US
241385161$24138516$1$I$20240712$20240715$20240725$20240725$PER$$US-JNJFOC-20240768553$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240725$$CN$US$US
241385171$24138517$1$I$20240710$20240717$20240725$20240725$PER$$US-JNJFOC-20240767826$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240725$$PH$US$US
241385182$24138518$2$F$$20240723$20240725$20240731$EXP$$CA-BAUSCH-BL-2024-011219$BAUSCH AND LOMB$Farrell B, Shamji S, Ingar N. Reducing fall risk while managing hypotension, pain, and poor sleep in an 83-year-old woman. Canadian Family Physician. 2013 DEC;59(12):1300-1305.$83$YR$$F$Y$$$20240731$$HP$CA$CA
241385191$24138519$1$I$$20240531$20240725$20240725$PER$$US-LUNDBECK-DKLU4000103$LUNDBECK$$$$$$Y$$$20240725$$CN$US$US
241385201$24138520$1$I$$20240723$20240725$20240725$PER$$US-DSJP-DSU-2024-137356$DAIICHI$$$$$F$Y$$$20240725$$CN$US$US
241385212$24138521$2$F$$20240718$20240725$20240725$PER$$US-GILEAD-2024-0681259$GILEAD$$$$A$M$Y$$$20240725$$CN$US$US
241385222$24138522$2$F$20240716$20240723$20240725$20240801$PER$$US-APELLIS-2024-APL-0000512$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
241385261$24138526$1$I$$20240725$20240725$20240725$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042003$BOEHRINGER INGELHEIM$$$$$$Y$$$20240725$$HP$US$US
241385271$24138527$1$I$$20240717$20240725$20240725$PER$$US-JNJFOC-20240769423$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$HP$US$US
241385282$24138528$2$F$20240601$20240722$20240725$20240729$EXP$$NVSC2024BR148843$NOVARTIS$$61$YR$$F$Y$$$20240729$$CN$BR$BR
241385301$24138530$1$I$$20240723$20240725$20240725$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137351$DAIICHI$$$$$F$Y$$$20240725$$CN$US$US
241385311$24138531$1$I$$20240710$20240725$20240725$PER$$US-INSUD PHARMA-2407US05524$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241385321$24138532$1$I$20240101$20240710$20240725$20240725$PER$$US-INSUD PHARMA-2407US05541$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241385331$24138533$1$I$20240703$20240710$20240725$20240725$PER$$US-INSUD PHARMA-2407US05540$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241385341$24138534$1$I$20240701$20240711$20240725$20240725$PER$$US-INSUD PHARMA-2407US05584$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241385351$24138535$1$I$20240705$20240710$20240725$20240725$PER$$US-INSUD PHARMA-2407US05543$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241385361$24138536$1$I$20240612$20240710$20240725$20240725$PER$$US-INSUD PHARMA-2407US05586$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241385371$24138537$1$I$20240101$20240711$20240725$20240725$PER$$US-INSUD PHARMA-2407US05587$INSUD PHARMA$$$$$$Y$$$20240725$$CN$US$US
241385381$24138538$1$I$20240101$20240719$20240725$20240725$PER$$US-TPU-TPU-2024-00403$TEIKOKU$$73$YR$E$M$Y$$$20240725$$CN$US$US
241385392$24138539$2$F$$20240727$20240725$20240808$PER$$US-JNJFOC-20240768234$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240808$$CN$US$US
241385401$24138540$1$I$$20240715$20240725$20240725$PER$$US-JNJFOC-20240768067$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240725$$HP$US$US
241385412$24138541$2$F$$20240903$20240725$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118392$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240904$$CN$US$US
241385421$24138542$1$I$20240723$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014871$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240725$$CN$US$US
241385431$24138543$1$I$20240101$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145435$AMGEN$$40$YR$A$$Y$$$20240725$$PH$US$US
241385442$24138544$2$F$$20240917$20240725$20240925$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016658$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240925$$CN$US$US
241385451$24138545$1$I$$20240717$20240725$20240725$EXP$$JP-AstraZeneca-2024A163810$ASTRAZENECA$$93$YR$$F$Y$$$20240725$$MD$JP$
241385462$24138546$2$F$$20240725$20240725$20240729$PER$$NVSC2024US152866$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241385501$24138550$1$I$$20240724$20240725$20240725$PER$$US-JNJFOC-20240765389$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240725$$HP$US$US
241385511$24138551$1$I$$20240718$20240725$20240725$PER$$US-ALXN-202407USA001305US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240725$$CN$US$US
241385522$24138552$2$F$20240704$20240726$20240725$20240806$EXP$FR-AFSSAPS-LL2024001383$FR-GILEAD-2024-0681664$GILEAD$$53$YR$A$F$Y$38$KG$20240806$$MD$FR$FR
241385532$24138553$2$F$$20240822$20240725$20240829$EXP$ES-ASTELLAS-2022US026364$ES-RDY-SPO/ESP/24/0010676$DR REDDYS$$73$YR$E$M$Y$$$20240829$$HP$ES$ES
241385561$24138556$1$I$$20240722$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116792$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$97.52$KG$20240723$$CN$US$US
241385571$24138557$1$I$$20240719$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115813$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240723$$HP$US$US
241385582$24138558$2$F$$20240823$20240725$20240901$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-115338$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240902$$MD$FR$FR
241385592$24138559$2$F$20240601$20240712$20240725$20240725$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112198$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240719$$HP$US$US
241385603$24138560$3$F$20240403$20240913$20240725$20240917$EXP$IT-MINISAL02-995336$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-115232$BRISTOL MYERS SQUIBB$$29$YR$A$F$Y$$$20240917$$MD$IT$IT
241385611$24138561$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152536$NOVARTIS$$$$$F$Y$$$20240725$$PH$US$US
241385621$24138562$1$I$$20240724$20240725$20240725$EXP$$US-GILEAD-2024-0681942$GILEAD$$30$YR$A$M$Y$$$20240725$$CN$US$US
241385632$24138563$2$F$$20240719$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117312$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240724$$MD$US$US
241385642$24138564$2$F$$20240914$20240725$20240918$EXP$$US-009507513-2407USA012712$MERCK$$$$$F$Y$61.7$KG$20240918$$CN$US$US
241385661$24138566$1$I$20240331$20240722$20240725$20240725$EXP$$US-GILEAD-2024-0681581$GILEAD$$40$YR$A$F$Y$$$20240725$$HP$US$US
241385672$24138567$2$F$20210101$20240731$20240725$20240808$EXP$$CA-AstraZeneca-2023A073310$ASTRAZENECA$$59$YR$$F$Y$$$20240808$$MD$CA$
241385681$24138568$1$I$$20240617$20240725$20240725$EXP$$CA-ANIPHARMA-2020-CA-001561$ANI$$65$MON$$M$Y$$$20240725$$CN$CA$CA
241385692$24138569$2$F$20240711$20240916$20240725$20240925$PER$$US-INCYTE CORPORATION-2024IN007603$INCYTE$$$$$$Y$$$20240925$$CN$US$US
241385711$24138571$1$I$$20240723$20240725$20240725$EXP$$US-GILEAD-2024-0681804$GILEAD$$$$A$M$Y$$$20240725$$HP$US$US
241385721$24138572$1$I$$20240723$20240725$20240725$EXP$$ES-GILEAD-2024-0681832$GILEAD$$$$$$Y$$$20240725$$MD$ES$ES
241385732$24138573$2$F$20231010$20240729$20240725$20240730$EXP$IT-MINISAL02-996224$IT-GILEAD-2024-0681970$GILEAD$$58$YR$A$M$Y$62$KG$20240730$$MD$IT$IT
241385742$24138574$2$F$$20240726$20240725$20240729$EXP$$CA-ROCHE-10000029947$ROCHE$$$$A$F$Y$$$20240729$$CN$CA$CA
241385762$24138576$2$F$$20240813$20240725$20240813$PER$$US-ALXN-202407USA001254US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241385771$24138577$1$I$20240619$20240718$20240725$20240725$PER$$US-INCYTE CORPORATION-2024IN007625$INCYTE$$$$$$Y$$$20240725$$CN$US$US
241385781$24138578$1$I$$20240715$20240725$20240725$EXP$$ES-TEVA-VS-3224532$TEVA$Gonzalez-Gomez A, Caro-Teller JM, Gonzalez-Barrios I, Castro-Frontinan A, Rodriguez-Quesada PP, Ferrari-Piquero JM. Safety profile of nirmatrelvir-ritonavir: Evidence of adverse events due to drug-drug interactions. Farm-Hosp 2024; 48 (2): 70-74.$$$$$Y$$$20240725$$HP$ES$ES
241385792$24138579$2$F$20240630$20240715$20240725$20240729$EXP$$CN-009507513-2407CHN011704$MERCK$$46$YR$$F$Y$64$KG$20240729$$HP$CN$CN
241385801$24138580$1$I$$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407014908$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240725$$CN$US$US
241385811$24138581$1$I$20240212$20240712$20240725$20240725$EXP$$CA-APELLIS-APL-2024-004190$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240725$$CN$CA$CA
241385821$24138582$1$I$$20240716$20240725$20240725$PER$$US-VERTEX PHARMACEUTICALS-2024-011908$VERTEX$$6$YR$$F$Y$$$20240725$$HP$US$US
241385831$24138583$1$I$$20240715$20240725$20240725$EXP$$IT-VERTEX PHARMACEUTICALS-2024-012162$VERTEX$Terlizzi V, Fevola C, Presti S, Castaldo A, Dacco V, Claut L, et al.. Reported adverse events in a multicenter cohort of patients ages 6-18 years with cystic fibrosis and at least one F508del allele receiving elexacaftor/tezacaftor/ivacaftor. J Pediatr. 2024$13$YR$$$Y$$$20240725$$MD$IT$IT
241385841$24138584$1$I$$20240715$20240725$20240725$EXP$$US-VERTEX PHARMACEUTICALS-2024-011753$VERTEX$Pingree G, Bentan M, Fitzpatrick T, Schuman T.. Impact of elexacaftor/tezacaftor/ivacaftor CFTR modulator therapy on rates of endoscopic sinus surgery in Cystic fibrosis. Int Forum Allergy Rhinol. 2024;1-8$$$$$Y$$$20240725$$MD$US$US
241385851$24138585$1$I$$20240717$20240725$20240725$EXP$NL-LRB-00978962$NL-TEVA-VS-3223159$TEVA$$26$YR$$F$Y$71$KG$20240725$$CN$NL$NL
241385862$24138586$2$F$$20240710$20240725$20240805$PER$$US-INCYTE CORPORATION-2024IN007272$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241385872$24138587$2$F$20240703$20240731$20240725$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117855$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240808$$CN$US$US
241385881$24138588$1$I$$20240711$20240725$20240725$PER$$US-INCYTE CORPORATION-2024IN006758$INCYTE$$$$$$Y$$$20240725$$CN$US$US
241385901$24138590$1$I$20240701$20240718$20240725$20240725$PER$$US-AMGEN-USASP2024143449$AMGEN$$65$YR$E$F$Y$$$20240725$$CN$US$US
241385911$24138591$1$I$$20240724$20240725$20240725$EXP$$IN-PAIPHARMA-2024-IN-000125$PHARMACEUTICAL ASSOC$Sood A, Nayyar V, Roychoudhury A, et al.Post-COVID steroid induced avascular necrosis of the jaw: Emerging challenge in India..Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology.2023;135(4):e89-e93.$65$YR$$M$Y$$$20240725$$HP$IN$IN
241385921$24138592$1$I$$20240715$20240725$20240725$EXP$$US-TEVA-VS-3222686$TEVA$Marathe PH, Santibanez V, Meyers PA, Padilla ML, Friedman DN. Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series. Pediatr-Blood-Cancer 2024; 71 (7): e31004.$31$YR$$M$Y$$$20240725$$HP$US$US
241385931$24138593$1$I$$20240716$20240725$20240725$EXP$$US-The Proactiv LLC-2159614$PROACTIV$$$$$F$Y$$$20240725$$$US$US
241385951$24138595$1$I$$20240720$20240725$20240725$PER$$US-BIOGEN-2024BI01275105$BIOGEN$$$$$M$Y$$$20240725$$CN$US$US
241385962$24138596$2$F$$20240802$20240725$20240808$EXP$$US-JNJFOC-20240753318$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241385971$24138597$1$I$$20240715$20240725$20240725$EXP$$ES-TEVA-VS-3224533$TEVA$Gonzalez-Gomez A, Caro-Teller JM, Gonzalez-Barrios I, Castro-Frontinan A, Rodriguez-Quesada PP, Ferrari-Piquero JM. Safety profile of nirmatrelvir-ritonavir: Evidence of adverse events due to drug-drug interactions. Farm-Hosp 2024; 48 (2): 70-74.$$$$$Y$$$20240725$$HP$ES$ES
241385981$24138598$1$I$20240501$20240611$20240725$20240725$PER$$US-JNJFOC-20240767351$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240725$$PH$US$US
241385991$24138599$1$I$$20240724$20240725$20240725$PER$$US-JNJFOC-20240767643$JOHNSON AND JOHNSON$$$$$F$Y$$$20240725$$CN$US$US
241386012$24138601$2$F$$20240731$20240725$20240803$EXP$$NVSC2024AU151696$NOVARTIS$$$$$F$Y$$$20240803$$HP$AU$AU
241386031$24138603$1$I$$20240710$20240725$20240725$EXP$$CN-Breckenridge Pharmaceutical, Inc.-2159615$BRECKENRIDGE$Literature$40$YR$$M$Y$$$20240725$$$IN$CN
241386042$24138604$2$F$20240621$20240711$20240725$20240913$EXP$$BR-SAMSUNG BIOEPIS-SB-2024-22008$SAMSUNG BIOEPIS$$59$YR$A$F$Y$$$20240913$$HP$BR$BR
241386051$24138605$1$I$$20240725$20240725$20240725$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042018$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240725$$CN$US$US
241386061$24138606$1$I$$20240724$20240725$20240725$PER$$US-JNJFOC-20240769296$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240725$$CN$US$US
241386071$24138607$1$I$$20240724$20240725$20240725$PER$$US-JNJFOC-20240765311$JOHNSON AND JOHNSON$$$$$$Y$$$20240725$$CN$US$US
241386081$24138608$1$I$20240715$20240723$20240725$20240725$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01139$AIMMUNE$$$$$$Y$$$20240725$$CN$US$US
241386092$24138609$2$F$$20240813$20240725$20240821$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001443$BLUEPRINT MEDICINES$$$$$F$Y$$$20240822$$CN$US$US
241386101$24138610$1$I$$20240716$20240725$20240725$PER$$SA-Blueprint Medicines Corporation-LT-SA-2024-001447$BLUEPRINT MEDICINES$$40$YR$A$M$Y$$$20240725$$MD$SA$SA
241386111$24138611$1$I$20240723$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015731$ELI LILLY AND CO$$$$$$Y$$$20240725$$CN$US$US
241386122$24138612$2$F$$20240808$20240725$20240821$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06992$NEUROCRINE BIOSCIENCES$$62$YR$$F$Y$$$20240821$$HP$US$US
241386131$24138613$1$I$$20240711$20240725$20240725$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07143$NEUROCRINE BIOSCIENCES$$7$DEC$$F$Y$$$20240725$$HP$US$US
241386143$24138614$3$F$20240706$20240816$20240725$20240820$EXP$$US-ALKERMES INC.-ALK-2024-001912$ALKERMES$$43$YR$$M$Y$156.92$KG$20240820$$HP$US$US
241386151$24138615$1$I$$20240712$20240725$20240725$EXP$$US-ALKERMES INC.-ALK-2024-001893$ALKERMES$Moore J, Foo K.  Egu E,  Gao X,  Ehrman-Dupre R, Salzman M. Diagnosis and Treatment of Presumed Naltrexone-XRprecipitated Opioid Withdrawal in  a Patient Chronically Treated With  Buprenorphine-XR: A Case Report.. Journal of AddictionMedicine. 2024 Jul 05. 2024;00:00?00$61$YR$$M$Y$$$20240725$$MD$US$US
241386161$24138616$1$I$$20240711$20240725$20240725$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07147$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240725$$MD$US$US
241386171$24138617$1$I$$20240705$20240725$20240725$EXP$$ZA-AstraZeneca-2024A155825$ASTRAZENECA$$84$YR$$F$Y$$$20240725$$CN$ZA$
241386182$24138618$2$F$$20240805$20240725$20240814$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011276$JAZZ$$$$A$M$Y$$$20240814$$MD$JP$JP
241386191$24138619$1$I$20240723$20240723$20240725$20240725$PER$$US-JNJFOC-20240761571$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240725$$CN$US$US
241386201$24138620$1$I$20240725$20240725$20240725$20240725$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042025$BOEHRINGER INGELHEIM$$66$YR$E$F$Y$$$20240725$$CN$US$US
241386214$24138621$4$F$20240101$20240828$20240725$20240905$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011266$JAZZ$$$$$F$Y$$$20240905$$MD$JP$JP
241386221$24138622$1$I$$20240725$20240725$20240725$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042022$BOEHRINGER INGELHEIM$$$$$$Y$$$20240725$$CN$US$US
241386231$24138623$1$I$$20240719$20240725$20240725$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041875$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240725$$MD$US$US
241386242$24138624$2$F$20240701$20240903$20240725$20240912$EXP$$US-IOVANCE BIOTHERAPEUTICS, INC-2024IOV000044$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240912$$CN$US$US
241386251$24138625$1$I$20240718$20240718$20240725$20240725$EXP$$US-GE HEALTHCARE-2024CSU008283$GE HEALTHCARE$$$$A$M$Y$$$20240726$$HP$US$US
241386262$24138626$2$F$$20240725$20240725$20240729$PER$$US-ALXN-202407USA001499US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
241386271$24138627$1$I$$20240715$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407009238$ELI LILLY AND CO$$15$YR$T$M$Y$$$20240725$$CN$US$US
241386291$24138629$1$I$20240718$20240722$20240725$20240725$EXP$$US-TAKEDA-2024TUS074507$TAKEDA$$10$YR$$M$Y$$$20240725$$MD$US$US
241386301$24138630$1$I$20240720$20240723$20240725$20240725$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01140$AIMMUNE$$$$$$Y$$$20240725$$CN$US$US
241386311$24138631$1$I$$20240719$20240725$20240725$EXP$$ES-009507513-2012ESP004111$MERCK$Lopez Raigada A, Vega F, Bartha I, Vera A, Mamula J, Mugica MV, et al.. Intraoperative anaphylaxis due to sensitization to the sugammadex-rocuronium complex. Allergy. 2020;75(SUPPL 109):482$71$YR$$F$Y$$$20240725$$HP$ES$ES
241386321$24138632$1$I$$20240722$20240725$20240725$EXP$$CA-JNJFOC-20240768137$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240725$$PH$CA$CA
241386331$24138633$1$I$$20240716$20240725$20240725$EXP$$AU-APELLIS-2024-APL-0000513$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240725$$MD$AU$AU
241386342$24138634$2$F$$20240716$20240725$20240808$EXP$$JP-009507513-2407JPN003360J$MERCK$Mizusaki M , Katayama H, Sato M, Hayashi N, Itabashi A, Ueda A , et al.Mizusaki M , Katayama H, Sato M, Hayashi N, Itabashi A, Ueda A , et al.. P-020 [Our hospital^s experience with TC+ Pembrolizmab therapy for advanced and recurrent cervical cancer]. The journal of the Japan Society of Gynecologic Oncology/The 66th Annual Meeting. 2024;42(3):359$$$$F$Y$$$20240808$$HP$JP$JP
241386351$24138635$1$I$$20240724$20240725$20240725$PER$$US-009507513-2407USA013724$MERCK$$42$YR$$F$Y$$$20240725$$CN$US$US
241386361$24138636$1$I$$20240711$20240725$20240725$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07075$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240725$$MD$US$US
241386381$24138638$1$I$20240701$20240723$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015178$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240725$$CN$US$US
241386391$24138639$1$I$20240721$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145470$AMGEN$$68$YR$E$F$Y$$$20240725$$PH$US$US
241386402$24138640$2$F$20240717$20240827$20240725$20240904$PER$$US-APELLIS-2024-APL-0000518$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240904$$CN$US$US
241386411$24138641$1$I$$20240715$20240725$20240725$EXP$CZ-SAMSUNG BIOEPIS-SB-2022-20374$CZ-ROCHE-10000027775$ROCHE$Jurica J, Gonec R, Bartova A, Gregorova J. Immune mediated adverse effects of checkpoint inhibitors: A clinical experience. EUROPEAN PHARMACEUTICAL JOURNAL. 2022;69(S1):84-6. doi:10.2478/afpuc-2022-0006$52$YR$A$F$Y$88$KG$20240725$$HP$CZ$CZ
241386421$24138642$1$I$$20240720$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407015214$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240725$$CN$US$US
241386431$24138643$1$I$20240722$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145994$AMGEN$$70$YR$E$M$Y$$$20240725$$CN$US$US
241386441$24138644$1$I$20240630$20240723$20240725$20240725$EXP$$CN-ROCHE-10000035000$ROCHE$$73$YR$E$F$Y$49$KG$20240726$$HP$CN$CN
241386451$24138645$1$I$$20240718$20240725$20240725$PER$$US-APELLIS-2024-APL-0000515$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$US$US
241386461$24138646$1$I$20240715$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146175$AMGEN$$71$YR$E$F$Y$$$20240725$$CN$US$US
241386472$24138647$2$F$$20240710$20240725$20240725$EXP$$US-GILEAD-2024-0680318$GILEAD$$$$A$M$Y$$$20240725$$MD$US$US
241386481$24138648$1$I$$20240712$20240725$20240725$PER$$US-TEVA-VS-3221612$TEVA$$67$YR$$F$Y$$$20240725$$HP$US$US
241386491$24138649$1$I$$20240724$20240725$20240725$EXP$$CA-SANDOZ INC.-SDZ2024CA067868$SANDOZ$$76$YR$$F$Y$77$KG$20240725$$HP$CA$CA
241386501$24138650$1$I$20240723$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146561$AMGEN$$79$YR$E$M$Y$$$20240725$$CN$US$US
241386511$24138651$1$I$$20240723$20240725$20240725$PER$$US-JNJFOC-20240767129$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240726$$MD$US$US
241386522$24138652$2$F$20240625$20240911$20240725$20240912$EXP$$NVSJ2024JP009048$NOVARTIS$$68$YR$$F$Y$$$20240913$$MD$JP$JP
241386531$24138653$1$I$20210101$20240723$20240725$20240725$EXP$$FR-SANDOZ INC.-SDZ2024FR067397$SANDOZ$$53$YR$$M$Y$$$20240725$$HP$FR$FR
241386541$24138654$1$I$20240712$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146878$AMGEN$$66$YR$E$F$Y$$$20240725$$CN$US$US
241386551$24138655$1$I$20240701$20240718$20240725$20240725$PER$$US-SA-2024SA216159$SANOFI AVENTIS$$33$YR$A$F$Y$70.76$KG$20240726$$MD$US$US
241386561$24138656$1$I$$20240724$20240725$20240725$EXP$$CA-SANDOZ INC.-SDZ2024CA067902$SANDOZ$$73$YR$$F$Y$$$20240725$$MD$CA$CA
241386571$24138657$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117586$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$75.75$KG$20240726$$CN$US$US
241386581$24138658$1$I$20240101$20240719$20240725$20240725$PER$$US-SA-2024SA216316$SANOFI AVENTIS$$14$YR$T$F$Y$48.39$KG$20240726$$MD$US$US
241386591$24138659$1$I$20240402$20240722$20240725$20240725$EXP$$DE-BIOGEN-2024BI01275136$BIOGEN$$37$YR$$M$Y$64$KG$20240725$$CN$DE$DE
241386601$24138660$1$I$$20240716$20240725$20240725$PER$US-MLMSERVICE-20240709-PI126821-00150-1$US-RDY-SPO/USA/24/0010581$DR REDDYS$Price NB, Cormack ES, Matthias KR, Shehab KW. Chronic paronychia associated with fluconazole use in two pediatric patients with coccidioidomycosis. IDCases. 2024;37:e02026. DOI:10.1016/j.idcr.2024.e02026.$13$YR$T$M$Y$$$20240726$$MD$US$US
241386621$24138662$1$I$20240311$20240724$20240725$20240725$EXP$BE-FAMHP-DHH-N2024-122334$BE-ROCHE-10000035732$ROCHE$$69$YR$E$F$Y$63$KG$20240726$$MD$BE$BE
241386634$24138663$4$F$20231208$20240814$20240725$20240822$EXP$$IL-JNJFOC-20240755798$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240822$$MD$IL$IL
241386641$24138664$1$I$20240715$20240718$20240725$20240725$EXP$$CN-JNJFOC-20240752502$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$CN$CN
241386651$24138665$1$I$$20240725$20240725$20240725$PER$$NVSC2024US152913$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241386662$24138666$2$F$20240622$20240916$20240725$20240923$EXP$$AU-009507513-2407AUS012934$MERCK$$70$YR$$F$Y$$$20240923$$MD$AU$AU
241386671$24138667$1$I$20240601$20240719$20240725$20240725$EXP$$US-ABBVIE-5847718$ABBVIE$$64$YR$$F$Y$$$20240725$$CN$US$US
241386682$24138668$2$F$$20240808$20240725$20240812$EXP$$US-ABBVIE-5850601$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241386693$24138669$3$F$20240721$20240826$20240725$20240828$PER$$US-AMGEN-USASP2024146935$AMGEN$$76$YR$E$M$Y$$$20240827$$CN$US$US
241386701$24138670$1$I$$20240716$20240725$20240725$PER$US-MLMSERVICE-20240709-PI126821-00150-2$US-RDY-SPO/USA/24/0010585$DR REDDYS$Price NB, Cormack ES, Matthias KR, Shehab KW. Chronic paronychia associated with fluconazole use in two pediatric patients with coccidioidomycosis. IDCases. 2024;37:e02026. DOI:10.1016/j.idcr.2024.e02026.$11$YR$C$F$Y$$$20240726$$MD$US$US
241386711$24138671$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152911$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241386722$24138672$2$F$$20240918$20240725$20240925$PER$$US-BAUSCHBL-2024BNL030214$BAUSCH AND LOMB$$75$YR$$M$Y$$$20240926$$CN$US$US
241386731$24138673$1$I$$20240715$20240725$20240725$EXP$$IN-PRINSTON PHARMACEUTICAL INC.-2024PRN00278$PRINSTON PHARMACEUTICAL$Ancilla L.C., Sundaram B, Pathak N, Raj A.. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. Journal of Nephropharmacology. 2024;(13)2$55$YR$$M$Y$$$20240725$$HP$IN$IN
241386741$24138674$1$I$$20240715$20240725$20240725$EXP$$IN-PRINSTON PHARMACEUTICAL INC.-2024PRN00279$PRINSTON PHARMACEUTICAL$Leyole Claudine Ancilla. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. Journal of Nephropharmacology. 2024;(13) 2: e11681$58$YR$$M$Y$$$20240725$$HP$IN$IN
241386751$24138675$1$I$$20240719$20240725$20240725$PER$$US-SA-2024SA216431$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240726$$HP$US$US
241386771$24138677$1$I$20240101$20240718$20240725$20240725$PER$$US-SA-2024SA216373$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240726$$MD$US$US
241386781$24138678$1$I$$20240719$20240725$20240725$PER$$US-SA-2024SA216365$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240726$$MD$US$US
241386791$24138679$1$I$$20240719$20240725$20240725$PER$$US-SA-2024SA216471$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240726$$MD$US$US
241386801$24138680$1$I$20240701$20240719$20240725$20240725$PER$$US-SA-2024SA216486$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240726$$MD$US$US
241386811$24138681$1$I$$20240717$20240725$20240725$PER$$US-BAUSCHBL-2024BNL030328$BAUSCH AND LOMB$$57$YR$$F$Y$$$20240726$$CN$US$US
241386821$24138682$1$I$$20240719$20240725$20240725$PER$$US-BAUSCHBL-2024BNL030425$BAUSCH AND LOMB$$60$YR$$F$Y$$$20240726$$MD$US$US
241386831$24138683$1$I$$20240719$20240725$20240725$PER$$US-BAUSCHBL-2024BNL030445$BAUSCH AND LOMB$$$$$M$Y$$$20240726$$CN$US$US
241386841$24138684$1$I$$20240716$20240725$20240725$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-117416$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$MD$JP$JP
241386851$24138685$1$I$20240719$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024146594$AMGEN$$76$YR$E$M$Y$$$20240725$$PH$US$US
241386861$24138686$1$I$$20240716$20240725$20240725$EXP$$HK-JNJFOC-20240745478$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$MD$HK$HK
241386872$24138687$2$F$20240521$20240731$20240725$20240806$EXP$$IE-JNJFOC-20240749281$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240806$$HP$IE$IE
241386881$24138688$1$I$$20240719$20240725$20240725$EXP$$CA-JNJFOC-20240767293$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240726$$CN$CA$CA
241386892$24138689$2$F$$20240813$20240725$20240814$PER$$NVSC2024US152918$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
241386901$24138690$1$I$20240701$20240701$20240725$20240725$PER$$US-INCYTE CORPORATION-2024IN006978$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241386911$24138691$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146967$AMGEN$$$$$$Y$$$20240725$$MD$US$US
241386921$24138692$1$I$$20240718$20240725$20240725$EXP$$US-ABBVIE-5843750$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241386931$24138693$1$I$$20240723$20240725$20240725$EXP$$US-ABBVIE-5851930$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241386942$24138694$2$F$20240101$20240726$20240725$20240729$EXP$$US-ABBVIE-5853249$ABBVIE$$$$$M$Y$52.163$KG$20240729$$CN$US$US
241386961$24138696$1$I$20240721$20240722$20240725$20240725$EXP$$FR-ABBVIE-5850543$ABBVIE$$43$YR$$F$Y$$$20240725$$HP$FR$FR
241386972$24138697$2$F$20240513$20240723$20240725$20240728$EXP$$NVSJ2024JP009029$NOVARTIS$$$$A$$Y$$$20240729$$MD$JP$JP
241386981$24138698$1$I$20240501$20240723$20240725$20240725$EXP$$US-ABBVIE-5850787$ABBVIE$$50$YR$$F$Y$$$20240725$$CN$US$US
241386991$24138699$1$I$20240626$20240705$20240725$20240725$PER$$US-009507513-2407USA003430$MERCK$$79$YR$$F$Y$$$20240725$$CN$US$US
241387001$24138700$1$I$$20240723$20240725$20240725$PER$$US-AMGEN-USASP2024146876$AMGEN$$$$$$Y$$$20240725$$MD$US$US
241387011$24138701$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152804$NOVARTIS$$$$$F$Y$$$20240726$$HP$US$US
241387023$24138702$3$F$$20240809$20240725$20240827$EXP$$JP-009507513-2405JPN002247J$MERCK$Shibata N, Matsui C, Hirai C, Tada M, Yauchi Y, Kikawa Y, et al.. EP-0451 Treatment outcomes of the KYENOTE-522 regimen for early-stage triple-negative breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 290$65$YR$$F$Y$$$20240827$$MD$JP$JP
241387031$24138703$1$I$20240720$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145893$AMGEN$$75$YR$E$F$Y$$$20240725$$CN$US$US
241387041$24138704$1$I$$20240716$20240725$20240725$PER$$US-JNJFOC-20240764432$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$MD$US$US
241387062$24138706$2$F$$20240823$20240725$20240827$EXP$$CZ-JNJFOC-20240746832$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240827$$MD$CZ$CZ
241387071$24138707$1$I$$20240717$20240725$20240725$PER$$US-JNJFOC-20240765183$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$MD$US$US
241387083$24138708$3$F$20240101$20240821$20240725$20240822$EXP$$US-JNJFOC-20240760565$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240822$$HP$US$US
241387092$24138709$2$F$$20240802$20240725$20240813$PER$$US-JNJFOC-20240764641$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$PH$US$US
241387103$24138710$3$F$20240712$20240829$20240725$20240902$PER$$US-AMGEN-USASP2024145430$AMGEN$$60$YR$A$F$Y$$$20240902$$CN$US$US
241387111$24138711$1$I$$20240717$20240725$20240725$EXP$$JP-AMGEN-JPNSP2024147836$AMGEN$$$$$$Y$$$20240725$$PH$JP$JP
241387121$24138712$1$I$20200401$20240722$20240725$20240725$EXP$$EU-BAUSCHBL-2023BNL004802$BAUSCH AND LOMB$$51$YR$$M$Y$73$KG$20240726$$MD$EU$EU
241387131$24138713$1$I$$20240719$20240725$20240725$PER$$US-ABBVIE-5849643$ABBVIE$$$$$$Y$$$20240725$$CN$US$US
241387141$24138714$1$I$20240101$20240718$20240725$20240725$PER$$US-SA-2024SA217733$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240726$$MD$US$US
241387151$24138715$1$I$20240101$20240718$20240725$20240725$PER$$US-SA-2024SA216499$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240726$$MD$US$US
241387161$24138716$1$I$$20240724$20240725$20240725$PER$$US-JNJFOC-20240766407$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240726$$HP$US$US
241387171$24138717$1$I$20240717$20240717$20240725$20240725$PER$$US-ABBVIE-5848334$ABBVIE$$49$YR$$F$Y$$$20240725$$CN$US$US
241387182$24138718$2$F$$20240808$20240725$20240809$PER$$NVSC2024US152108$NOVARTIS$$$$$M$Y$$$20240809$$HP$US$US
241387191$24138719$1$I$20240717$20240717$20240725$20240725$EXP$$US-ABBVIE-5844596$ABBVIE$$56$YR$$M$Y$$$20240725$$HP$US$US
241387201$24138720$1$I$$20240717$20240725$20240725$EXP$$US-ABBVIE-5445720$ABBVIE$$$$$M$Y$$$20240725$$HP$US$US
241387221$24138722$1$I$$20240722$20240725$20240725$PER$$US-009507513-2407USA013388$MERCK$$$$$M$Y$$$20240725$$MD$US$US
241387231$24138723$1$I$20240716$20240716$20240725$20240725$PER$$US-JNJFOC-20240742832$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240726$$PH$US$US
241387242$24138724$2$F$20240101$20240911$20240725$20240917$EXP$$US-ABBVIE-5849339$ABBVIE$$$$$M$Y$80$KG$20240917$$CN$US$US
241387261$24138726$1$I$20240525$20240722$20240725$20240725$EXP$$US-ABBVIE-5852716$ABBVIE$$74$YR$$F$Y$$$20240725$$MD$US$US
241387271$24138727$1$I$20240722$20240722$20240725$20240725$PER$$US-AMGEN-USASP2024145656$AMGEN$$81$YR$E$F$Y$$$20240725$$CN$US$US
241387282$24138728$2$F$20240617$20240816$20240725$20240821$EXP$$BR-PFIZER INC-202400222774$PFIZER$$68$YR$$M$Y$73$KG$20240821$$PH$BR$BR
241387291$24138729$1$I$20240529$20240724$20240725$20240725$EXP$$CN-PFIZER INC-PV202400096890$PFIZER$$16$YR$$F$Y$61$KG$20240725$$HP$CN$CN
241387301$24138730$1$I$20231101$20240723$20240725$20240725$EXP$$US-PFIZER INC-PV202400096267$PFIZER$$88$YR$$M$Y$$$20240725$$HP$US$US
241387311$24138731$1$I$20240721$20240724$20240725$20240725$EXP$$CN-PFIZER INC-PV202400096813$PFIZER$$10$YR$$M$Y$64$KG$20240725$$HP$CN$CN
241387322$24138732$2$F$20240511$20240812$20240725$20240814$EXP$FR-AFSSAPS-AM2024000586$FR-PFIZER INC-202400221699$PFIZER$$67$YR$$F$Y$74$KG$20240814$$PH$FR$FR
241387331$24138733$1$I$$20240718$20240725$20240725$PER$$US-JNJFOC-20240750527$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$HP$US$US
241387352$24138735$2$F$$20240916$20240725$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003115$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241387362$24138736$2$F$20240724$20240805$20240725$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003122$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240828$$CN$US$US
241387371$24138737$1$I$$20240702$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003130$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241387382$24138738$2$F$$20240912$20240725$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003129$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241387391$24138739$1$I$$20240719$20240725$20240725$PER$$US-SA-2024SA215186$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240726$$CN$US$US
241387402$24138740$2$F$20240608$20240820$20240725$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003131$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240912$$CN$US$US
241387413$24138741$3$F$$20240913$20240725$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003124$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241387421$24138742$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152957$NOVARTIS$$$$$$Y$$$20240726$$PH$US$US
241387434$24138743$4$F$20240701$20240830$20240725$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003123$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$67$KG$20240924$$CN$US$US
241387442$24138744$2$F$20240101$20240820$20240725$20240826$EXP$$US-ABBVIE-5851948$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
241387451$24138745$1$I$20240509$20240724$20240725$20240725$EXP$PT-INFARMED-T202407-347$PT-JNJFOC-20240768625$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240726$$PH$PT$PT
241387461$24138746$1$I$$20240724$20240725$20240725$EXP$$CA-SANDOZ INC.-SDZ2024CA068100$SANDOZ$$10$MON$$M$Y$$$20240725$$HP$CA$CA
241387471$24138747$1$I$20240701$20240703$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003127$ACADIA PHARMACEUTICALS$$90$YR$$M$Y$$$20240726$$CN$US$US
241387485$24138748$5$F$20240701$20240823$20240725$20240829$EXP$$US-JNJFOC-20240743798$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240829$$HP$US$US
241387491$24138749$1$I$$20240724$20240725$20240725$EXP$$IT-ABBVIE-5853750$ABBVIE$$68$YR$$F$Y$$$20240725$$HP$IT$IT
241387501$24138750$1$I$$20240723$20240725$20240725$EXP$$JP-TAKEDA-2024TJP011125$TAKEDA$$$$$$Y$$$20240725$$MD$JP$JP
241387521$24138752$1$I$$20240716$20240725$20240725$EXP$$GR-Unichem Pharmaceuticals (USA) Inc-UCM202407-000917$UNICHEM$$$$I$$Y$1.67$KG$20240726$$$COUNTRY NOT SPECIFIED$
241387531$24138753$1$I$20231226$20240723$20240725$20240725$EXP$$JP-TAKEDA-2024TJP011008$TAKEDA$$9$YR$$M$Y$27$KG$20240725$$MD$JP$JP
241387543$24138754$3$F$20240804$20240912$20240725$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003139$ACADIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240923$$CN$US$US
241387551$24138755$1$I$$20240723$20240725$20240725$EXP$$GB-ABBVIE-5850300$ABBVIE$$65$YR$$F$Y$$$20240725$$PH$GB$GB
241387561$24138756$1$I$20240612$20240703$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003128$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240726$$CN$US$US
241387571$24138757$1$I$20240601$20240719$20240725$20240725$EXP$$DE-ABBVIE-5848642$ABBVIE$$83$YR$$M$Y$$$20240725$$CN$DE$DE
241387581$24138758$1$I$$20240703$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003142$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241387591$24138759$1$I$$20240703$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003147$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$HP$US$US
241387601$24138760$1$I$$20240703$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003141$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$HP$US$US
241387611$24138761$1$I$$20240703$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003140$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241387622$24138762$2$F$$20240722$20240725$20240801$EXP$$FR-ROCHE-3578348$ROCHE$$74$YR$E$F$Y$$$20240801$$MD$FR$FR
241387641$24138764$1$I$$20240723$20240725$20240725$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118473$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240726$$HP$US$US
241387651$24138765$1$I$$20240723$20240725$20240725$EXP$$US-ABBVIE-5851724$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241387661$24138766$1$I$20240711$20240718$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011250$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241387671$24138767$1$I$$20240724$20240725$20240725$PER$$NVSC2024US152965$NOVARTIS$$$$$$Y$$$20240726$$MD$US$US
241387681$24138768$1$I$$20240719$20240725$20240725$EXP$$BG-ABBVIE-5848174$ABBVIE$$63$YR$$M$Y$$$20240725$$CN$BG$BG
241387691$24138769$1$I$20240101$20240712$20240725$20240725$EXP$$US-UCBSA-2024027391$UCB$$$$$F$Y$$$20240726$$MD$US$US
241387701$24138770$1$I$$20240722$20240725$20240725$EXP$$FR-ABBVIE-5853280$ABBVIE$$66$YR$$M$Y$$$20240725$$HP$FR$FR
241387711$24138771$1$I$20240627$20240723$20240725$20240725$EXP$$US-JNJFOC-20240761028$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$HP$US$US
241387722$24138772$2$F$$20240722$20240725$20240802$EXP$$US-ABBVIE-5850155$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241387731$24138773$1$I$20240701$20240717$20240725$20240725$PER$$US-ABBVIE-5847268$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241387741$24138774$1$I$20240704$20240716$20240725$20240725$EXP$$CN-Eisai-EC-2024-170433$EISAI$$63$YR$A$F$Y$58$KG$20240726$$HP$CN$CN
241387752$24138775$2$F$20240718$20240726$20240725$20240805$EXP$$US-Eisai-EC-2024-170572$EISAI$$80$YR$E$F$Y$$$20240805$$HP$US$US
241387761$24138776$1$I$$20240719$20240725$20240725$PER$$JP-Eisai-EC-2024-170596$EISAI$$$$$M$Y$$$20240726$$MD$JP$JP
241387771$24138777$1$I$20240704$20240718$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011254$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241387781$24138778$1$I$20240501$20240717$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011166$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241387791$24138779$1$I$20240701$20240718$20240725$20240725$EXP$$DE-ABBVIE-5847377$ABBVIE$$66$YR$$F$Y$$$20240725$$CN$DE$DE
241387803$24138780$3$F$20240703$20240808$20240725$20240812$30DAY$$FR-JNJFOC-20240718920$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240812$$PH$FR$FR
241387813$24138781$3$F$20231030$20240905$20240725$20240913$EXP$$ES-ABBVIE-5852446$ABBVIE$$82$YR$$F$Y$$$20240913$$MD$ES$ES
241387821$24138782$1$I$$20240722$20240725$20240725$EXP$$US-ABBVIE-5745446$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241387831$24138783$1$I$20240101$20240724$20240725$20240725$EXP$$US-ABBVIE-5853482$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241387841$24138784$1$I$20240101$20240722$20240725$20240725$EXP$$US-ABBVIE-5850663$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241387851$24138785$1$I$$20240725$20240725$20240725$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042054$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240726$$MD$US$US
241387863$24138786$3$F$$20240826$20240725$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US038883$SANDOZ$$$$$M$Y$$$20240827$$HP$US$US
241387871$24138787$1$I$$20240719$20240725$20240725$PER$$US-SA-2024SA215184$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240726$$CN$US$US
241387881$24138788$1$I$$20240722$20240725$20240725$EXP$$GB-ABBVIE-5847662$ABBVIE$Premraj S, Lane S, Camilleri B. IgA crescentic glomerulonephritis in psoriatic arthritis - disease or treatment related? Clinical Medicine. 2024;24:100108.$64$YR$$F$Y$$$20240725$$HP$GB$GB
241387891$24138789$1$I$20240101$20240712$20240725$20240725$EXP$$US-UCBSA-2024035799$UCB$$$$$F$Y$$$20240726$$HP$US$US
241387904$24138790$4$F$$20240822$20240725$20240827$PER$$NVSC2024US152896$NOVARTIS$$$$A$F$Y$$$20240827$$CN$US$US
241387911$24138791$1$I$$20240718$20240725$20240725$EXP$$US-ABBVIE-5847610$ABBVIE$$$$$$Y$$$20240725$$HP$US$US
241387921$24138792$1$I$$20240723$20240725$20240725$EXP$$CA-HALEON-2188454$Haleon PLC$$73$YR$$M$Y$88.451$KG$20240725$$CN$CA$CA
241387931$24138793$1$I$20240308$20240718$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011225$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241387942$24138794$2$F$$20240723$20240725$20240731$EXP$$CN-BEIGENE-BGN-2024-011266$BEIGENE$$$$$$Y$$$20240731$$CN$CN$CN
241387951$24138795$1$I$20240707$20240718$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011227$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241387963$24138796$3$F$20240711$20240917$20240725$20240925$EXP$$CA-ABBVIE-5845664$ABBVIE$$70$YR$$M$Y$$$20240925$$MD$CA$CA
241387971$24138797$1$I$$20240722$20240725$20240725$EXP$$CA-HALEON-2188397$Haleon PLC$$$$$F$Y$$$20240725$$HP$CA$CA
241387981$24138798$1$I$$20240708$20240725$20240725$EXP$$US-ABBVIE-5851012$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241387991$24138799$1$I$20240619$20240718$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011228$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241388001$24138800$1$I$20240628$20240716$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011089$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241388011$24138801$1$I$20240709$20240718$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011229$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241388033$24138803$3$F$20240625$20240808$20240725$20240814$EXP$$US-BIOGEN-2024BI01274963$BIOGEN$$56$YR$$M$Y$$$20240814$$MD$US$US
241388041$24138804$1$I$20200301$20240719$20240725$20240725$EXP$$BR-BIOGEN-2024BI01274960$BIOGEN$$35$YR$$M$Y$72$KG$20240725$$CN$BR$BR
241388051$24138805$1$I$$20240722$20240725$20240725$EXP$$US-BIOGEN-2024BI01274864$BIOGEN$$$$$$Y$$$20240725$$HP$US$US
241388061$24138806$1$I$20240101$20240722$20240725$20240725$EXP$$US-BIOGEN-2024BI01274777$BIOGEN$$74$YR$$F$Y$$$20240725$$HP$US$US
241388071$24138807$1$I$20240514$20240611$20240725$20240725$PER$$US-JNJFOC-20240769569$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240726$$PH$US$US
241388082$24138808$2$F$$20240730$20240725$20240802$EXP$$US-ABBVIE-5850865$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241388091$24138809$1$I$20240718$20240723$20240725$20240725$EXP$$US-ABBVIE-5852147$ABBVIE$$66$YR$$M$Y$$$20240725$$CN$US$US
241388101$24138810$1$I$20240715$20240718$20240725$20240725$EXP$$CN-BEIGENE-BGN-2024-011248$BEIGENE$$$$$$Y$$$20240725$$HP$CN$CN
241388111$24138811$1$I$$20240715$20240725$20240725$EXP$$IT-VERTEX PHARMACEUTICALS-2024-011903$VERTEX$Terlizzi V, Fevola C, Presti S, Castaldo A, Dacco V, Claut L, et al.. Reported adverse events in a multicenter cohort of patients ages 6-18 years with cystic fibrosis and at least one F508del allele receiving elexacaftor/tezacaftor/ivacaftor. J Pediatr. 2024$$$$$Y$$$20240725$$MD$IT$IT
241388123$24138812$3$F$20200101$20240819$20240725$20240823$EXP$$US-ABBVIE-5851185$ABBVIE$$$$$M$Y$73$KG$20240823$$CN$US$US
241388131$24138813$1$I$$20240724$20240725$20240725$PER$$NVSC2024US153002$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241388142$24138814$2$F$20240716$20240731$20240725$20240809$PER$$US-ABBVIE-5845436$ABBVIE$$36$YR$$F$Y$89$KG$20240809$$MD$US$US
241388151$24138815$1$I$20240601$20240702$20240725$20240725$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003132$ACADIA PHARMACEUTICALS$$89$YR$$M$Y$$$20240726$$CN$US$US
241388162$24138816$2$F$20180101$20240723$20240725$20240806$EXP$$CZ-ASTELLAS-2024EU007374$ASTELLAS$$58$YR$$M$Y$$$20240806$$CN$NL$CZ
241388171$24138817$1$I$$20240723$20240725$20240725$EXP$$DE-ASTELLAS-2024US001663$ASTELLAS$$$$$F$Y$$$20240726$$MD$DE$DE
241388182$24138818$2$F$20231209$20240722$20240725$20240726$PER$$US-ABBVIE-5852000$ABBVIE$$8$YR$$F$Y$35$KG$20240726$$CN$US$US
241388191$24138819$1$I$20240601$20240723$20240725$20240725$EXP$$US-ABBVIE-5852028$ABBVIE$$77$YR$$F$Y$$$20240725$$CN$US$US
241388201$24138820$1$I$20240601$20240716$20240725$20240725$PER$$PR-ABBVIE-5843599$ABBVIE$$15$YR$$M$Y$$$20240725$$MD$PR$PR
241388211$24138821$1$I$20240601$20240718$20240725$20240725$EXP$$CN-HALEON-2187698$Haleon PLC$$52$YR$$M$Y$70$KG$20240725$$HP$CN$CN
241388223$24138822$3$F$$20240821$20240725$20240904$EXP$$US-ASTELLAS-2024EU007297$ASTELLAS$$$$E$M$Y$$$20240904$$CN$US$US
241388233$24138823$3$F$20240101$20240917$20240725$20240925$EXP$$US-ABBVIE-5852062$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
241388241$24138824$1$I$$20240723$20240725$20240725$EXP$$US-ABBVIE-5852135$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241388251$24138825$1$I$20070101$20240722$20240725$20240725$PER$$US-JNJFOC-20240761540$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20240726$$HP$US$US
241388262$24138826$2$F$20240613$20240807$20240725$20240816$EXP$$FR-BIOGEN-2024BI01274692$BIOGEN$$59$YR$$F$Y$86$KG$20240816$$MD$FR$FR
241388272$24138827$2$F$$20240807$20240725$20240807$PER$$NVSC2024US152898$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
241388281$24138828$1$I$$20240715$20240725$20240725$EXP$$CA-HALEON-2188497$Haleon PLC$$63$YR$$F$Y$$$20240725$$HP$CA$CA
241388291$24138829$1$I$$20240724$20240725$20240725$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041805$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240726$$CN$US$US
241388301$24138830$1$I$20240722$20240722$20240725$20240725$EXP$$CA-ABBVIE-5851807$ABBVIE$$73$YR$$F$Y$$$20240725$$CN$CA$CA
241388311$24138831$1$I$$20240723$20240725$20240725$EXP$$US-ABBVIE-5852139$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241388321$24138832$1$I$20240614$20240719$20240725$20240725$EXP$HR-HALMED-300086203$HR-BRISTOL-MYERS SQUIBB COMPANY-2024-117036$BRISTOL MYERS SQUIBB$$68$YR$A$M$Y$120$KG$20240726$$MD$HR$HR
241388331$24138833$1$I$$20240725$20240725$20240725$PER$$NVSC2024US152961$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241388353$24138835$3$F$$20240731$20240725$20240823$EXP$$CA-HALEON-2187999$Haleon PLC$$40$YR$$F$Y$$$20240823$$HP$CA$CA
241388361$24138836$1$I$20170101$20240716$20240725$20240725$PER$$US-ELI_LILLY_AND_COMPANY-US202407011332$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240725$$CN$US$US
241388371$24138837$1$I$$20240715$20240725$20240725$PER$$US-JNJFOC-20240739749$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$HP$US$US
241388381$24138838$1$I$20240601$20240722$20240725$20240725$EXP$$US-ABBVIE-5851398$ABBVIE$$67$YR$$M$Y$$$20240725$$CN$US$US
241388391$24138839$1$I$$20240702$20240725$20240725$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003135$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241388401$24138840$1$I$$20240723$20240725$20240725$EXP$$US-ABBVIE-5851676$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241388412$24138841$2$F$$20240725$20240725$20240805$EXP$$CA-HALEON-2187990$Haleon PLC$$40$YR$$F$Y$$$20240805$$HP$CA$CA
241388422$24138842$2$F$$20240724$20240725$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003136$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
241388431$24138843$1$I$20240707$20240723$20240725$20240725$EXP$$US-ABBVIE-5852155$ABBVIE$$68$YR$$M$Y$$$20240725$$CN$US$US
241388441$24138844$1$I$20240101$20240723$20240725$20240725$EXP$$US-ABBVIE-5746546$ABBVIE$$$$$M$Y$$$20240725$$CN$US$US
241388451$24138845$1$I$20240101$20240719$20240725$20240725$EXP$$UY-BRISTOL-MYERS SQUIBB COMPANY-2024-115836$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240726$$HP$UY$UY
241388462$24138846$2$F$$20240829$20240725$20240904$EXP$$US-ABBVIE-5844524$ABBVIE$$$$$M$Y$101$KG$20240904$$CN$US$US
241388471$24138847$1$I$$20240716$20240725$20240725$EXP$$CH-NOVITIUMPHARMA-2024CHNVP01344$NOVITIUM PHARMA$Graeme A. Fenton.Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report.Case Reports in Oncology.09-JAN-2024;17(1):75-81$64$YR$A$F$Y$$$20240726$$HP$CH$CH
241388481$24138848$1$I$20240425$20240716$20240725$20240725$EXP$$US-ABBVIE-5747832$ABBVIE$$54$YR$$F$Y$65$KG$20240725$$CN$US$US
241388491$24138849$1$I$20240701$20240724$20240725$20240725$PER$$NVSC2024US152467$NOVARTIS$$$$$$Y$$$20240726$$CN$US$US
241388501$24138850$1$I$20230101$20240723$20240725$20240725$EXP$$US-ABBVIE-5851684$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241388511$24138851$1$I$20240722$20240724$20240725$20240725$EXP$$US-ABBVIE-5852843$ABBVIE$$95$YR$$M$Y$$$20240725$$CN$US$US
241388521$24138852$1$I$20240720$20240722$20240725$20240725$EXP$$AR-ABBVIE-5851702$ABBVIE$$35$YR$$F$Y$$$20240725$$CN$AR$AR
241388532$24138853$2$F$20240720$20240828$20240725$20240902$EXP$$DO-ABBVIE-5853537$ABBVIE$$69$YR$$F$Y$66$KG$20240902$$CN$DO$DO
241388541$24138854$1$I$20200101$20240723$20240725$20240725$EXP$$US-ABBVIE-5851438$ABBVIE$$62$YR$$M$Y$$$20240725$$CN$US$US
241388551$24138855$1$I$20240301$20240723$20240725$20240725$EXP$$US-ABBVIE-5851988$ABBVIE$$72$YR$$M$Y$$$20240725$$CN$US$US
241388561$24138856$1$I$$20240723$20240725$20240725$EXP$$US-ABBVIE-5852184$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241388571$24138857$1$I$20240701$20240722$20240725$20240725$EXP$$US-ABBVIE-5850940$ABBVIE$$50$YR$$F$Y$$$20240725$$CN$US$US
241388581$24138858$1$I$$20240723$20240726$20240726$EXP$$US-ABBVIE-5852160$ABBVIE$$$$$F$Y$$$20240725$$CN$US$US
241388591$24138859$1$I$$20240718$20240726$20240726$PER$$US-AMGEN-USASP2024145048$AMGEN$$$$$M$Y$$$20240725$$HP$US$US
241388601$24138860$1$I$20240601$20240723$20240726$20240726$PER$$US-ABBVIE-5852974$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241388611$24138861$1$I$20240501$20240722$20240725$20240725$EXP$$US-ABBVIE-5851394$ABBVIE$$74$YR$$M$Y$$$20240725$$CN$US$US
241388624$24138862$4$F$20240601$20240910$20240726$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003179$ACADIA PHARMACEUTICALS$$5$YR$$F$Y$15$KG$20240927$$CN$US$US
241388631$24138863$1$I$$20240702$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003180$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241388641$24138864$1$I$20240523$20240723$20240726$20240726$EXP$$GB-GSK-GB2024EME092664$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$GB$GB
241388651$24138865$1$I$$20240719$20240726$20240726$EXP$$DE-JNJFOC-20240759707$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$MD$DE$DE
241388661$24138866$1$I$$20240502$20240726$20240726$PER$$US-AUROBINDO-AUR-APL-2024-020981$AUROBINDO$$$$$F$Y$$$20240726$$MD$US$US
241388672$24138867$2$F$$20240821$20240726$20240826$30DAY$$DE-SANDOZ INC.-SDZ2024DE067594$SANDOZ$$$$$M$Y$$$20240826$$MD$DE$DE
241388681$24138868$1$I$$20240506$20240726$20240726$PER$$US-AUROBINDO-AUR-APL-2024-023280$AUROBINDO$$22$YR$$F$Y$54.43$KG$20240726$$CN$US$US
241388691$24138869$1$I$$20240716$20240726$20240726$EXP$$US-ABBVIE-5851455$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241388701$24138870$1$I$$20240613$20240726$20240726$PER$$US-AUROBINDO-AUR-APL-2024-030476$AUROBINDO$$33$YR$$F$Y$102$KG$20240726$$CN$US$US
241388713$24138871$3$F$$20240912$20240726$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003181$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241388721$24138872$1$I$$20240723$20240726$20240726$EXP$$US-ABBVIE-5851736$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241388731$24138873$1$I$20240101$20240723$20240726$20240726$EXP$$US-ABBVIE-5851756$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241388741$24138874$1$I$20240101$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118479$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240726$$HP$US$US
241388751$24138875$1$I$$20240722$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116806$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240726$$CN$US$US
241388761$24138876$1$I$20240101$20240722$20240726$20240726$EXP$$US-ABBVIE-5852259$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241388771$24138877$1$I$20240613$20240724$20240726$20240726$EXP$GB-MHRA-31115663$GB-GSK-GB2024092827$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$PH$GB$GB
241388781$24138878$1$I$20240423$20240724$20240726$20240726$EXP$GB-MHRA-MED-202407241303134050-FKTGS$GB-GSK-GB2024092803$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$GB$GB
241388791$24138879$1$I$$20240718$20240726$20240726$30DAY$$US-GSK-US2024AMR091164$GLAXOSMITHKLINE$$$$$M$Y$$$20240726$$CN$US$US
241388801$24138880$1$I$$20240718$20240726$20240726$EXP$$DE-ABBVIE-5850680$ABBVIE$$$$$M$Y$$$20240726$$CN$DE$DE
241388823$24138882$3$F$20240701$20240920$20240726$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003182$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240927$$CN$US$US
241388832$24138883$2$F$20240101$20240913$20240726$20240917$EXP$$US-ABBVIE-5781423$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
241388842$24138884$2$F$20240722$20240729$20240726$20240731$EXP$$US-ABBVIE-5853483$ABBVIE$$62$YR$$M$Y$$$20240731$$CN$US$US
241388851$24138885$1$I$20240101$20240724$20240726$20240726$EXP$$US-ABBVIE-5853102$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241388872$24138887$2$F$$20240813$20240726$20240813$PER$$US-ALXN-202407USA001315US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241388882$24138888$2$F$20240101$20240729$20240726$20240801$EXP$$US-ABBVIE-5694557$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241388891$24138889$1$I$20240101$20240724$20240726$20240726$EXP$$US-ABBVIE-5853012$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241388901$24138890$1$I$$20240716$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091190$VIIV$$$$$$Y$$$20240726$$MD$US$US
241388912$24138891$2$F$$20240801$20240726$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003185$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241388921$24138892$1$I$$20240508$20240726$20240726$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446868$RANBAXY$$$$$$Y$$$20240726$$PH$US$US
241388931$24138893$1$I$$20240724$20240726$20240726$EXP$$JP-TAKEDA-2024TJP011169$TAKEDA$$$$$$Y$$$20240726$$MD$JP$JP
241388941$24138894$1$I$20240701$20240702$20240726$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003186$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240726$$CN$US$US
241388953$24138895$3$F$$20240826$20240726$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003187$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
241388962$24138896$2$F$$20240729$20240726$20240801$EXP$$IT-SA-2024SA216532$SANOFI AVENTIS$Vischini G, Speciale S, Przygocka A, Martano L, La Manna G, Baraldi O.. Lessons for the clinical nephrologist: acute kidney injury during therapy with apixaban.. J-Nephrol.. 2023;37:511-3$81$YR$E$M$Y$$$20240801$$HP$IT$IT
241388972$24138897$2$F$20240701$20240826$20240726$20240909$PER$$US-SA-2024SA215455$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240909$$MD$US$US
241388982$24138898$2$F$20240722$20240726$20240726$20240729$EXP$$JP-TAKEDA-2024TJP011024$TAKEDA$$8$DEC$$$Y$$$20240729$$MD$JP$JP
241388991$24138899$1$I$$20240718$20240726$20240726$EXP$$GB-AMGEN-GBRSP2024145529$AMGEN$$63$YR$A$F$Y$$$20240725$$CN$GB$GB
241389012$24138901$2$F$$20240801$20240726$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003194$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241389021$24138902$1$I$$20240724$20240726$20240726$PER$$NVSC2024US153034$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241389032$24138903$2$F$20240301$20240730$20240726$20240808$EXP$$JP-BIOGEN-2024BI01274413$BIOGEN$$60$YR$$F$Y$$$20240808$$MD$JP$JP
241389041$24138904$1$I$20240716$20240718$20240726$20240726$PER$$US-SA-2024SA215365$SANOFI AVENTIS$$58$YR$A$F$Y$136$KG$20240726$$CN$US$US
241389051$24138905$1$I$20240101$20240722$20240726$20240726$EXP$$JP-SA-2024SA213078$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240726$$CN$JP$JP
241389063$24138906$3$F$$20240822$20240726$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003205$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
241389071$24138907$1$I$$20240110$20240726$20240726$EXP$$ZA-ABBVIE-5852004$ABBVIE$$65$YR$$M$Y$$$20240726$$CN$ZA$ZA
241389083$24138908$3$F$20240528$20240802$20240726$20240805$EXP$$US-ROCHE-10000035761$ROCHE$$80$YR$E$M$Y$63.5$KG$20240805$$CN$US$US
241389091$24138909$1$I$$20240715$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009994$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240726$$CN$US$US
241389101$24138910$1$I$20240711$20240715$20240726$20240726$EXP$GB-MHRA-MED-202407150937036900-CWMQL$GB-ELI_LILLY_AND_COMPANY-GB202407009108$ELI LILLY AND CO$$$$$M$Y$105$KG$20240726$$CN$GB$GB
241389111$24138911$1$I$$20240717$20240726$20240726$EXP$$ZA-ABBVIE-5854010$ABBVIE$$80$YR$$F$Y$$$20240726$$CN$ZA$ZA
241389122$24138912$2$F$$20240723$20240726$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003695$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
241389131$24138913$1$I$$20240720$20240726$20240726$EXP$$GB-JNJFOC-20240759944$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240726$$CN$GB$GB
241389142$24138914$2$F$20240701$20240726$20240726$20240731$PER$$US-AMGEN-USASP2024146729$AMGEN$$75$YR$E$F$Y$$$20240731$$CN$US$US
241389151$24138915$1$I$$20240718$20240726$20240726$EXP$$GB-SANDOZ INC.-SDZ2024GB066699$SANDOZ$$$$$F$Y$$$20240726$$CN$GB$GB
241389161$24138916$1$I$20240611$20240723$20240726$20240726$EXP$$US-AstraZeneca-2024A167750$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241389171$24138917$1$I$20240719$20240722$20240726$20240726$EXP$$US-AstraZeneca-2024A167961$ASTRAZENECA$$21847$DY$$M$Y$$$20240726$$CN$US$
241389181$24138918$1$I$20240618$20240722$20240726$20240726$EXP$$US-AstraZeneca-2024A166832$ASTRAZENECA$$34098$DY$$F$Y$$$20240726$$MD$US$
241389191$24138919$1$I$20240601$20240723$20240726$20240726$PER$$US-ABBVIE-5853000$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241389201$24138920$1$I$$20240724$20240726$20240726$EXP$$US-BAUSCH-BL-2024-001525$BAUSCH AND LOMB$$83$YR$$F$Y$$$20240726$$CN$US$US
241389211$24138921$1$I$$20240722$20240726$20240726$PER$$US-JNJFOC-20240757960$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$HP$US$US
241389221$24138922$1$I$$20240716$20240726$20240726$EXP$$AR-STERISCIENCE B.V.-2024-ST-001081$Steriscience PTE$Almuzara M, Cittadini R, Traglia G, Haim MS, De Belder D, Alvarez C, et al. Phytobacter spp: the emergence of a new genus of healthcare-associated Enterobacterales encoding carbapenemases in Argentina: a case series. Infect-Prevent-Pract. 2024;6 (3)$26$DY$$F$Y$1$KG$20240726$$HP$AR$AR
241389232$24138923$2$F$20240101$20240802$20240726$20240807$EXP$$JP-009507513-2407JPN001821J$MERCK$$59$YR$$F$Y$$$20240807$$MD$JP$JP
241389251$24138925$1$I$$20240702$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003192$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241389261$24138926$1$I$$20240724$20240726$20240726$PER$$NVSC2024US152811$NOVARTIS$$53$YR$$F$Y$$$20240726$$HP$US$US
241389271$24138927$1$I$20240717$20240724$20240726$20240726$EXP$$US-ABBVIE-5853260$ABBVIE$$89$YR$$M$Y$$$20240726$$CN$US$US
241389281$24138928$1$I$$20240716$20240726$20240726$EXP$$KR-NOVITIUMPHARMA-2024KRNVP01352$NOVITIUM PHARMA$Jung Min Lee.Atypical Presentations of Hydroxychloroquine Retinopathy: A Case Series Study..Journal of Clinical Medicine.11-JUN-2024;13(12):3411$72$YR$E$F$Y$$$20240726$$HP$KR$KR
241389291$24138929$1$I$20240709$20240716$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024089468$VIIV$$47$YR$$$Y$$$20240726$$CN$US$US
241389301$24138930$1$I$$20240723$20240726$20240726$EXP$$JP-GSK-JP2024092153$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$PH$JP$JP
241389311$24138931$1$I$$20240718$20240726$20240726$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00383$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240726$$MD$US$US
241389321$24138932$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA216409$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240726$$CN$US$US
241389331$24138933$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA213489$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240726$$CN$US$US
241389341$24138934$1$I$20240628$20240712$20240726$20240726$EXP$$GB-CIPLA LTD.-2024GB07688$CIPLA$$$$$$Y$$$20240726$$MD$GB$GB
241389351$24138935$1$I$20240101$20240716$20240726$20240726$PER$$US-ABBVIE-5845586$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241389362$24138936$2$F$$20240801$20240726$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003206$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241389371$24138937$1$I$$20240702$20240726$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003196$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241389381$24138938$1$I$20240417$20240702$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003237$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240726$$CN$US$US
241389391$24138939$1$I$20240715$20240724$20240726$20240726$EXP$$US-ABBVIE-5852701$ABBVIE$$90$YR$$F$Y$$$20240726$$HP$US$US
241389401$24138940$1$I$$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003210$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241389411$24138941$1$I$$20240702$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003137$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241389422$24138942$2$F$20240715$20240802$20240726$20240802$EXP$GB-MHRA-MED-202407240808085920-WDRBP$GB-SANDOZ INC.-SDZ2024GB067847$SANDOZ$$60$YR$$M$Y$68$KG$20240802$$CN$GB$GB
241389431$24138943$1$I$$20240723$20240726$20240726$EXP$$CA-SANDOZ INC.-NVSC2022CA174165$SANDOZ$$$$$M$Y$$$20240726$$CN$CA$CA
241389442$24138944$2$F$20240719$20240815$20240726$20240815$PER$$US-ALXN-202407USA001426US$ALEXION PHARMACEUTICALS$$48$YR$$F$Y$$$20240815$$CN$US$US
241389453$24138945$3$F$$20240905$20240726$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003195$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241389461$24138946$1$I$$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003212$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241389471$24138947$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015172$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240726$$CN$US$US
241389481$24138948$1$I$$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015460$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240726$$CN$US$US
241389492$24138949$2$F$$20240729$20240726$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407015967$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240731$$CN$US$US
241389501$24138950$1$I$20240501$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015454$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240726$$CN$US$US
241389511$24138951$1$I$$20240702$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003144$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241389522$24138952$2$F$$20240819$20240726$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003143$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
241389532$24138953$2$F$$20240717$20240726$20240730$PER$$NVSC2024US147666$NOVARTIS$$25$YR$$M$Y$$$20240730$$CN$US$US
241389542$24138954$2$F$20231123$20240822$20240726$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003238$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240913$$CN$US$US
241389551$24138955$1$I$20230101$20240718$20240726$20240726$PER$$US-SA-2024SA215798$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240726$$MD$US$US
241389561$24138956$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215864$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240726$$MD$US$US
241389571$24138957$1$I$$20240717$20240726$20240726$PER$$US-SA-2023SA135982$SANOFI AVENTIS$$$$E$M$Y$$$20240726$$MD$US$US
241389582$24138958$2$F$$20240812$20240726$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003145$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
241389591$24138959$1$I$$20240724$20240726$20240726$EXP$$GB-ABBVIE-5853976$ABBVIE$$$$E$F$Y$$$20240726$$CN$GB$GB
241389601$24138960$1$I$$20240717$20240726$20240726$EXP$GB-MHRA-MED-202407172230252900-SDKZM$GB-CHATTEMPRD-2024OHG024530$CHATTEM$$$$$$Y$$$20240726$$CN$GB$GB
241389611$24138961$1$I$20240101$20240719$20240726$20240726$EXP$$US-ABBVIE-5848228$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241389621$24138962$1$I$20240624$20240702$20240726$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003200$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240726$$CN$US$US
241389631$24138963$1$I$$20240702$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003146$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241389642$24138964$2$F$$20240716$20240726$20240808$EXP$$JP-009507513-2407JPN003507J$MERCK$Kuratomi Y, Gun Y, Takao M, Odai T, Oshima N, Wakana K, et al.. P-016 Experience with pembrolizumab for cervical cancer in our hospital. The journal of the Japan Society of Gynecologic Oncology The 66th Annual Meeting. 2024;42(3):358$$$$F$Y$$$20240808$$HP$JP$JP
241389651$24138965$1$I$$20240723$20240726$20240726$EXP$$US-ABBVIE-5851190$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241389661$24138966$1$I$20240101$20240719$20240726$20240726$EXP$$US-ABBVIE-5850456$ABBVIE$$$$$M$Y$$$20240726$$HP$US$US
241389671$24138967$1$I$20170914$20210225$20240726$20240726$EXP$$FR-CHATTEMPRD-2018SA106385$CHATTEM$$33$YR$A$F$Y$77$KG$20240726$$PH$FR$FR
241389683$24138968$3$F$$20240906$20240726$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003149$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241389692$24138969$2$F$20240708$20240830$20240726$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003198$ACADIA PHARMACEUTICALS$$18$YR$$F$Y$$$20240924$$CN$US$US
241389701$24138970$1$I$$20240715$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116101$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$HP$US$US
241389711$24138971$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118099$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240726$$HP$US$US
241389722$24138972$2$F$$20240809$20240726$20240813$EXP$$ES-AUROBINDO-AUR-APL-2024-036920$AUROBINDO$Anto, C... USE OF ISAVUCONAZOLE IN CHILDREN WITH INVASIVE FUNGAL INFECTION: experience in a tertiary pediatric center. 69? Congreso de la Asociacion Espanola de Pediatria (AEP):Libro de comunicacio. 2023;493$16$YR$$F$Y$52$KG$20240813$$MD$ES$ES
241389731$24138973$1$I$20240716$20240719$20240726$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003824$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240726$$HP$US$US
241389743$24138974$3$F$$20240812$20240726$20240902$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003252$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
241389752$24138975$2$F$$20240815$20240726$20240820$EXP$$US-AMGEN-USASP2024145847$AMGEN$$2$YR$C$F$Y$$$20240819$$HP$US$US
241389761$24138976$1$I$20240215$20240711$20240726$20240726$PER$$US-JNJFOC-20240732889$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$US$US
241389771$24138977$1$I$20240301$20240717$20240726$20240726$PER$$US-SA-2024SA212713$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240726$$MD$US$US
241389782$24138978$2$F$$20240808$20240726$20240812$EXP$$ES-AUROBINDO-AUR-APL-2024-036928$AUROBINDO$Anto. C. USE OF ISAVUCONAZOLE IN CHILDREN WITH INVASIVE FUNGAL INFECTION: EXPERIENCE IN A PAEDIATRIC AND TERTIARY CARE CENTRE. 69? Congreso de la Asociacion Espanola de Pediatria (AEP) : Libro de comunicacio. 2023;493$7$YR$$M$Y$24$KG$20240812$$MD$ES$ES
241389792$24138979$2$F$$20240920$20240726$20240925$EXP$$JP-SA-2024SA212979$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240925$$MD$JP$JP
241389801$24138980$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215872$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240726$$MD$US$US
241389811$24138981$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA216242$SANOFI AVENTIS$$$$$F$Y$$$20240726$$CN$US$US
241389821$24138982$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214557$SANOFI AVENTIS$$$$E$M$Y$$$20240726$$MD$US$US
241389831$24138983$1$I$20171212$20240722$20240726$20240726$EXP$$CO-UCBSA-2024037590$UCB$$81$YR$$M$Y$$$20240726$$CN$CO$CO
241389841$24138984$1$I$$20240702$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003199$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241389851$24138985$1$I$$20240723$20240726$20240726$PER$$US-JNJFOC-20240763187$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$HP$US$US
241389861$24138986$1$I$20230101$20240718$20240726$20240726$EXP$$US-ABBVIE-5395705$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241389871$24138987$1$I$$20240719$20240726$20240726$PER$$US-JNJFOC-20240753569$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$US$US
241389881$24138988$1$I$$20240720$20240726$20240726$EXP$$US-ABBVIE-5850602$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241389892$24138989$2$F$$20240808$20240726$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003203$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
241389903$24138990$3$F$$20240730$20240726$20240801$EXP$$US-ABBVIE-5854103$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241389911$24138991$1$I$$20240716$20240726$20240726$EXP$$CO-UNITED THERAPEUTICS-UNT-2024-012731$UNITED THERAPEUTICS$$58$YR$$$Y$72$KG$20240726$$$CO$CO
241389931$24138993$1$I$20240624$20240722$20240726$20240726$EXP$$US-UCBSA-2024037019$UCB$$59$YR$$F$Y$$$20240726$$CN$US$US
241389941$24138994$1$I$$20240722$20240726$20240726$EXP$$US-ABBVIE-5850780$ABBVIE$$$$$M$Y$$$20240726$$HP$US$US
241389952$24138995$2$F$20240621$20240813$20240726$20240814$PER$$US-AMGEN-USASP2024145741$AMGEN$$63$YR$A$F$Y$$$20240814$$HP$US$US
241389965$24138996$5$F$20240424$20240918$20240726$20240925$PER$$US-JNJFOC-20240760404$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240925$$HP$US$US
241389972$24138997$2$F$$20240820$20240726$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003674$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241389981$24138998$1$I$$20240712$20240726$20240726$EXP$US-MLMSERVICE-20240705-PI124430-00030-2$US-STRIDES ARCOLAB LIMITED-2024SP008793$STRIDES$Tallmadge M, MacBeth M, Palatnik A.. New Onset of Symptomatic Peptic Ulcer Disease Postpartum Secondary to Nonsteroidal Anti-Inflammatory Drug Use.. Case reports in obstetrics and gynecology.. 2024;2024:6422824$$$$$Y$$$20240726$$MD$US$US
241389991$24138999$1$I$$20240720$20240726$20240726$PER$$US-SA-2024SA216116$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240726$$MD$US$US
241390001$24139000$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214696$SANOFI AVENTIS$$$$E$F$Y$$$20240726$$MD$US$US
241390011$24139001$1$I$20240101$20240719$20240726$20240726$PER$$US-SA-2024SA214708$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240726$$MD$US$US
241390021$24139002$1$I$20240501$20240718$20240726$20240726$PER$$US-SA-2024SA215922$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240726$$MD$US$US
241390031$24139003$1$I$20240621$20240718$20240726$20240726$PER$$US-SA-2024SA215949$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240726$$MD$US$US
241390041$24139004$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215933$SANOFI AVENTIS$$17$YR$T$F$Y$44.99$KG$20240726$$MD$US$US
241390053$24139005$3$F$$20240815$20240726$20240827$PER$$US-SA-2024SA213989$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240827$$CN$US$US
241390063$24139006$3$F$20240610$20240808$20240726$20240906$EXP$$JP-AstraZeneca-2024A167633$ASTRAZENECA$$73$YR$$F$Y$$$20240906$$MD$JP$
241390071$24139007$1$I$$20240723$20240726$20240726$PER$$US-AstraZeneca-2024A167859$ASTRAZENECA$$71$YR$$M$Y$$$20240726$$MD$US$
241390081$24139008$1$I$$20240722$20240726$20240726$EXP$$US-AstraZeneca-2024A167591$ASTRAZENECA$$$$$M$Y$$$20240726$$MD$US$
241390093$24139009$3$F$$20240903$20240726$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118519$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240906$$CN$US$US
241390114$24139011$4$F$20240601$20240807$20240726$20240822$EXP$$NVSC2024SA152008$NOVARTIS$$30$YR$$M$Y$$$20240822$$MD$SA$SA
241390121$24139012$1$I$$20231119$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017481$STRIDES$Wani K, Patel K, Dabak V.. Hepatotoxicity After CDK 4/6 Inhibitor Initiation in the Treatment of Hormone-Positive Metastatic Breast Cancer.. Cureus. 2023;15(6):e40871$67$YR$$F$Y$$$20240726$$HP$US$US
241390131$24139013$1$I$$20240111$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000653$STRIDES$Yoong Hee NK, Lim QH, Lim L-L, Paramasivam S, Vethakkan S, Chan SP, et al.. Yoong Hee NK,Control of Alpelisib-Induced Hyperglycemia With DPP4- Inhibitors as add on to Metformin and Insulin. J-Endocr-Soc. 2022;6 (Suppl.) (1):A303 abstr. ODP173$$$A$F$Y$$$20240726$$MD$US$US
241390141$24139014$1$I$20220101$20231011$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015766$STRIDES$Ghotra M, Parsa K, Dolan B, Lim S, Kumar S, Berger N, et al.. (NOT SO) DIABETIC KETOACIDOSIS.. Chest. 2023;164 (Suppl.)(4):A2892-A2893$52$YR$$F$Y$$$20240726$$HP$US$US
241390152$24139015$2$F$$20240916$20240726$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003211$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
241390171$24139017$1$I$$20240717$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001475$BLUEPRINT MEDICINES$$$$$F$Y$$$20240726$$CN$US$US
241390181$24139018$1$I$20240713$20240717$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001474$BLUEPRINT MEDICINES$$66$YR$E$F$Y$$$20240726$$CN$US$US
241390191$24139019$1$I$$20240717$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001467$BLUEPRINT MEDICINES$$$$$F$Y$$$20240726$$CN$US$US
241390201$24139020$1$I$20240701$20240718$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001473$BLUEPRINT MEDICINES$$69$YR$E$F$Y$$$20240726$$CN$US$US
241390211$24139021$1$I$$20240717$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001463$BLUEPRINT MEDICINES$$$$$F$Y$$$20240726$$CN$US$US
241390221$24139022$1$I$20220101$20230605$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2023SP009264$STRIDES$Kancharla S, Alaniz A, Kothari P, Norton S.. Primary peritoneal serous psammocarcinoma, rare variant: A case report.. Gynecol-Oncol-Rep.. 2023$49$YR$$F$Y$$$20240726$$HP$US$US
241390231$24139023$1$I$$20240409$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004422$STRIDES$Albright BB, Shuey S, Alvarez Secord A, Havrilesky LJ, Berchuck A, Previs RA. Efficacy of cyclin-dependent kinase 4/6 inhibitors in combination with hormonal therapy in patients with recurrent granulosa cell tumor of the ovary: A case series.. Gynecol-Oncol-Rep. 2023;50$$$A$F$Y$$$20240726$$HP$US$US
241390241$24139024$1$I$20210101$20240305$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002825$STRIDES$Wilson KL, Grewelle RE, Gupta T, Kim SH, Katsumoto TR. Aromatase inhibitor-induced arthralgia ameliorated by Mediterranean diet and active lifestyle guided by continuous glucose monitoring: a case report and review of the literature.. Front-Oncol. 2024;14$46$YR$$F$Y$$$20240726$$HP$US$US
241390251$24139025$1$I$$20231022$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016268$STRIDES$Singhal R, Daily K, Wheeler S.. Systemic absorption of intrathecal methotrexate.. BMJ-Case-Rep.. 2023;16No. 4.$$$$F$Y$$$20240726$$HP$US$US
241390265$24139026$5$F$20240712$20240809$20240726$20240823$30DAY$$US-JNJFOC-20240753634$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240823$$PH$US$US
241390271$24139027$1$I$20170401$20231127$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017838$STRIDES$$12$YR$$M$Y$56.689$KG$20240726$$CN$US$US
241390281$24139028$1$I$20230617$20230622$20240726$20240726$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00310$PRINSTON PHARMACEUTICAL$$75$YR$$M$Y$84.807$KG$20240708$$CN$US$US
241390291$24139029$1$I$$20230911$20240726$20240726$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00447$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240708$$CN$US$US
241390301$24139030$1$I$$20230911$20240726$20240726$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00451$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240708$$CN$US$US
241390311$24139031$1$I$$20230911$20240726$20240726$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00452$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240708$$CN$US$US
241390321$24139032$1$I$20230101$20231019$20240726$20240726$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00551$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240708$$CN$US$US
241390331$24139033$1$I$20230101$20231115$20240726$20240726$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00584$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240708$$CN$US$US
241390341$24139034$1$I$20220101$20231208$20240726$20240726$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00625$PRINSTON PHARMACEUTICAL$$51$YR$$F$Y$69.853$KG$20240708$$CN$US$US
241390351$24139035$1$I$$20240123$20240726$20240726$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00032$PRINSTON PHARMACEUTICAL$$8$DEC$$F$Y$$$20240708$$CN$US$US
241390362$24139036$2$F$$20240806$20240726$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003138$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
241390372$24139037$2$F$$20240716$20240726$20240809$EXP$$JP-009507513-2407JPN003471J$MERCK$Akita H, Fujiwara S, Kagawa M, Akita H, Ikeda S, Sano M, et al.. OS-110 Clinical study of 8 cases of advanced/recurrent cervical cancer treated with pembrolizumab at our hospital. Oncology The 66th Annual Meeting of Japan Society of Gynecologic Oncology. 2024;42(3):285$$$$F$Y$$$20240809$$MD$JP$JP
241390382$24139038$2$F$$20240802$20240726$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003213$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
241390391$24139039$1$I$$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003214$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241390401$24139040$1$I$20240720$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024145858$AMGEN$$78$YR$E$M$Y$$$20240725$$CN$US$US
241390411$24139041$1$I$$20240703$20240726$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003081$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241390421$24139042$1$I$20221001$20240415$20240726$20240726$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00171$PRINSTON PHARMACEUTICAL$$82$YR$$F$Y$60.146$KG$20240708$$CN$US$US
241390431$24139043$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147342$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241390441$24139044$1$I$20240722$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118002$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240726$$PH$US$US
241390451$24139045$1$I$$20230208$20240726$20240726$EXP$$US-AstraZeneca-2023A034433$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241390462$24139046$2$F$20240613$20240828$20240726$20240830$EXP$JP-MMM-1VOMN2WJ$JP-GSK-JP2024092475$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$JP$JP
241390471$24139047$1$I$$20240502$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005410$STRIDES$Minta A, Rose L, Park C, Ramaswamy B, Stover D, Gatti-Mays M, et al.. Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients.. Support-Care-Cancer. 2023;31$$$$F$Y$$$20240726$$HP$US$US
241390481$24139048$1$I$20240501$20240702$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003223$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240726$$CN$US$US
241390491$24139049$1$I$$20240704$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050817$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241390501$24139050$1$I$$20240703$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050791$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241390512$24139051$2$F$20240701$20240724$20240726$20240819$PER$$CA-TOLMAR, INC.-24CA050816$TOLMAR$$60$YR$$M$Y$$$20240819$$CN$CA$CA
241390521$24139052$1$I$$20240703$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050807$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241390531$24139053$1$I$20240703$20240703$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050789$TOLMAR$$80$YR$$M$Y$$$20240726$$CN$CA$CA
241390541$24139054$1$I$$20240704$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050820$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241390551$24139055$1$I$$20240705$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050827$TOLMAR$$$$$M$Y$$$20240726$$MD$CA$CA
241390562$24139056$2$F$20240703$20240805$20240726$20240826$PER$$CA-TOLMAR, INC.-24CA050822$TOLMAR$$78$YR$$M$Y$$$20240826$$CN$CA$CA
241390581$24139058$1$I$$20240705$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050843$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241390591$24139059$1$I$$20240705$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050840$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241390601$24139060$1$I$$20240705$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050844$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241390611$24139061$1$I$$20240704$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050852$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241390631$24139063$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA172212$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240726$$CN$US$US
241390641$24139064$1$I$20200101$20240723$20240726$20240726$EXP$GB-MHRA-MED-202407231946560420-MPHKV$GB-ABBVIE-5853535$ABBVIE$$$$$$Y$$$20240726$$CN$GB$GB
241390651$24139065$1$I$$20240716$20240726$20240726$EXP$$KR-NOVITIUMPHARMA-2024KRNVP01353$NOVITIUM PHARMA$Jung Min Lee.Atypical Presentations of Hydroxychloroquine Retinopathy: A Case Series Study..Journal of Clinical Medicine.11-JUN-2024;13(12):3411$75$YR$E$F$Y$$$20240726$$HP$KR$KR
241390661$24139066$1$I$$20240721$20240726$20240726$PER$$NVSC2024US150090$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
241390671$24139067$1$I$$20240718$20240726$20240726$EXP$$US-STERISCIENCE B.V.-2024-ST-001091$Steriscience PTE$Rozenbaum Lerner G, Villamizar JP, Pelaez A, Salgado JC.. Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis.. Am-J-Respir-Crit-Care-Med. 2024;209:(plus Poster)$68$YR$$M$Y$$$20240726$$HP$US$US
241390693$24139069$3$F$20240701$20240830$20240726$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003226$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240909$$CN$US$US
241390702$24139070$2$F$20240401$20240729$20240726$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003218$ACADIA PHARMACEUTICALS$$56$YR$$M$Y$$$20240821$$CN$US$US
241390711$24139071$1$I$20230501$20240724$20240726$20240726$EXP$$NVSC2024US152750$NOVARTIS$$64$YR$$F$Y$90.72$KG$20240726$$CN$US$US
241390722$24139072$2$F$20240709$20240729$20240726$20240812$PER$$US-AMGEN-USASP2024147134$AMGEN$$$$$$Y$$$20240812$$PH$US$US
241390731$24139073$1$I$$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003215$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241390741$24139074$1$I$20240718$20240723$20240726$20240726$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041744$BOEHRINGER INGELHEIM$$57$YR$A$M$Y$80$KG$20240726$$MD$DE$DE
241390754$24139075$4$F$20240719$20240830$20240726$20240905$30DAY$$US-JNJFOC-20240753830$JOHNSON AND JOHNSON$$26$YR$A$$Y$$$20240905$$CN$US$US
241390761$24139076$1$I$20240611$20240724$20240726$20240726$EXP$$CN-JNJFOC-20240767368$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240726$$HP$CN$CN
241390771$24139077$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215223$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240726$$MD$US$US
241390781$24139078$1$I$$20240718$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116109$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$92.99$KG$20240726$$HP$US$US
241390791$24139079$1$I$20211201$20240715$20240726$20240726$EXP$$SA-BRISTOL-MYERS SQUIBB COMPANY-2024-113638$BRISTOL MYERS SQUIBB$Alshamrani HM, Alsaedi M, Alaradati H. Second-generation tyrosine kinase inhibitors nilotinib and dasatinib induced keratosis pilaris: a case report and review of the literature. Journal of Dermatology and Dermatologic Surgery. 2024 Jul 02;28(1): 55-7. doi:10.4103/jdds.jdds_48_23.$41$YR$A$M$Y$$$20240726$$MD$SA$SA
241390804$24139080$4$F$$20240917$20240726$20240921$PER$$US-ROCHE-10000034080$ROCHE$$$$E$M$Y$$$20240921$$CN$US$US
241390811$24139081$1$I$20240621$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003158$ACADIA PHARMACEUTICALS$$87$YR$$F$Y$$$20240726$$CN$US$US
241390821$24139082$1$I$$20240724$20240726$20240726$PER$$NVSC2024US153064$NOVARTIS$$$$$F$Y$$$20240726$$PH$US$US
241390832$24139083$2$F$$20240819$20240726$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003219$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
241390841$24139084$1$I$$20240717$20240726$20240726$EXP$$US-GSK-US2024083100$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$HP$US$US
241390851$24139085$1$I$$20240722$20240726$20240726$EXP$$JP-GSK-JP2024JPN091458$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$PH$JP$JP
241390862$24139086$2$F$$20240814$20240726$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003166$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
241390871$24139087$1$I$$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003253$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241390892$24139089$2$F$20240705$20240724$20240726$20240826$PER$$US-AMGEN-USASP2024147124$AMGEN$$57$YR$A$F$Y$$$20240826$$CN$US$US
241390901$24139090$1$I$$20240719$20240726$20240726$PER$$US-AstraZeneca-2024A165490$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241390911$24139091$1$I$$20240719$20240726$20240726$PER$$US-AstraZeneca-2024A165535$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241390921$24139092$1$I$$20240722$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117044$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$CN$US$US
241390931$24139093$1$I$$20240716$20240726$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-114871$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$MD$JP$JP
241390943$24139094$3$F$$20240827$20240726$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003159$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$CN$US$US
241390952$24139095$2$F$$20240730$20240726$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003364$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$HP$US$US
241390961$24139096$1$I$20240723$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147122$AMGEN$$61$YR$A$F$Y$$$20240725$$CN$US$US
241390971$24139097$1$I$20240722$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147108$AMGEN$$76$YR$E$F$Y$$$20240725$$CN$US$US
241390981$24139098$1$I$$20240718$20240726$20240726$PER$$US-AMGEN-USASP2024146210$AMGEN$Davis D.R.; Wang K.L.; Lehman J.S. et al.. Adult-onset linear IgA bullous dermatosis: a retrospective single-center cohort study of 81 patients and literature review. International Journal of Dermatology. 2024;63 (7):936-941$$$$$Y$$$20240725$$HP$US$US
241390991$24139099$1$I$$20240716$20240726$20240726$EXP$$AU-RDY-LIT/AUS/24/0010481$DR REDDYS$Ali SB, Lee W, Horvath N, Le TA, Smith W, Hissaria P. Lenalidomide Desensitization for Delayed Cutaneous Reaction: A Case Series and Review of the Literature. Journal of Allergy and Clinical Immunology: In Practice. 2023 May 01;11(5): 1503-1508. doi:10.1016/j.jaip.2023.01.036.$64$YR$A$M$Y$$$20240726$$MD$AU$AU
241391001$24139100$1$I$20240721$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024146731$AMGEN$$$$$M$Y$$$20240725$$CN$US$US
241391012$24139101$2$F$$20240905$20240726$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003368$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
241391023$24139102$3$F$20240531$20240806$20240726$20240810$EXP$$US-ABBVIE-5851144$ABBVIE$$41$YR$$M$Y$$$20240810$$MD$US$US
241391031$24139103$1$I$20240714$20240719$20240726$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019931$UNITED THERAPEUTICS$$40$YR$$F$Y$70.748$KG$20240726$$$US$US
241391042$24139104$2$F$20240531$20240722$20240726$20240731$EXP$$US-Eisai-EC-2024-169856$EISAI$$73$YR$E$M$Y$84.1$KG$20240731$$MD$US$US
241391051$24139105$1$I$$20240703$20240726$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003228$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241391061$24139106$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000036342$ROCHE$$$$A$F$Y$$$20240726$$CN$US$US
241391071$24139107$1$I$20240401$20240701$20240726$20240726$PER$$US-JNJFOC-20240704099$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$CN$US$US
241391082$24139108$2$F$$20240730$20240726$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003224$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
241391091$24139109$1$I$$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003167$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241391101$24139110$1$I$$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003164$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241391111$24139111$1$I$20230916$20240717$20240726$20240726$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-116458$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$53$KG$20240726$$MD$KR$KR
241391121$24139112$1$I$20240613$20240703$20240726$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003230$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240726$$CN$US$US
241391133$24139113$3$F$$20240830$20240726$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003188$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
241391141$24139114$1$I$20240701$20240715$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024088672$VIIV$$59$YR$$M$Y$$$20240726$$CN$US$US
241391153$24139115$3$F$20240905$20240910$20240726$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003229$ACADIA PHARMACEUTICALS$$14$YR$$F$Y$$$20240926$$CN$US$US
241391161$24139116$1$I$$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003161$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241391171$24139117$1$I$20240721$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024146074$AMGEN$$59$YR$A$F$Y$$$20240725$$CN$US$US
241391181$24139118$1$I$$20240718$20240726$20240726$PER$$US-AMGEN-USASP2024146246$AMGEN$Davis D.R.; Wang K.L.; Lehman J.S. et al.. Adult-onset linear IgA bullous dermatosis: a retrospective single-center cohort study of 81 patients and literature review. International Journal of Dermatology. 2024;63 (7):936-941$$$$$Y$$$20240725$$HP$US$US
241391192$24139119$2$F$$20240729$20240726$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003189$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
241391201$24139120$1$I$20230210$20240719$20240726$20240726$EXP$$AU-ABBVIE-5852150$ABBVIE$$81$YR$$M$Y$$$20240726$$HP$AU$AU
241391213$24139121$3$F$$20240725$20240726$20240731$30DAY$$DE-UCBSA-2024036353$UCB$$$$$F$Y$$$20240731$$PH$DE$DE
241391221$24139122$1$I$$20240718$20240726$20240726$PER$$US-ABBVIE-5847441$ABBVIE$$$$I$$Y$$$20240726$$CN$US$US
241391231$24139123$1$I$$20240716$20240726$20240726$EXP$$KR-NOVITIUMPHARMA-2024KRNVP01355$NOVITIUM PHARMA$Jung Min Lee.Atypical Presentations of Hydroxychloroquine Retinopathy: A Case Series Study..Journal of Clinical Medicine.11-JUN-2024;13(12):3411$54$YR$A$F$Y$$$20240726$$HP$KR$KR
241391243$24139124$3$F$$20240905$20240726$20240925$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003191$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
241391251$24139125$1$I$20240718$20240723$20240726$20240726$PER$$US-ROCHE-10000034731$ROCHE$$43$YR$A$M$Y$$$20240726$$CN$US$US
241391261$24139126$1$I$20240620$20240718$20240726$20240726$EXP$$US-ROCHE-10000032006$ROCHE$$45$YR$A$F$Y$$$20240726$$MD$US$US
241391271$24139127$1$I$$20240423$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004997$STRIDES$Brown K, Corin S, Handel AS.. Doxycycline for the Treatment of Lyme Disease in Young Children.. Pediatr-Infect-Dis-J. 2023;42 (12):e470-e472$$$$$Y$$$20240726$$MD$US$US
241391281$24139128$1$I$$20240423$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004996$STRIDES$Brown K, Corin S, Handel AS.. Doxycycline for the Treatment of Lyme Disease in Young Children.. Pediatr-Infect-Dis-J. 2023;42 (12):e470-e472$$$$$Y$$$20240726$$MD$US$US
241391292$24139129$2$F$20240716$20240821$20240726$20240826$EXP$$NVSJ2024JP009065$NOVARTIS$$$$$$Y$$$20240827$$MD$JP$JP
241391302$24139130$2$F$$20240816$20240726$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003193$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
241391311$24139131$1$I$20240629$20240722$20240726$20240726$EXP$$CN-JNJFOC-20240766966$JOHNSON AND JOHNSON$$72$YR$E$F$Y$60$KG$20240726$$HP$CN$CN
241391322$24139132$2$F$$20240724$20240726$20240731$PER$$US-JNJFOC-20240764258$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240731$$CN$US$US
241391331$24139133$1$I$$20240423$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004998$STRIDES$Brown K, Corin S, Handel AS.. Doxycycline for the Treatment of Lyme Disease in Young Children.. Pediatr-Infect-Dis-J. 2023;42 (12):e470-e472$$$$$Y$$$20240726$$MD$US$US
241391341$24139134$1$I$$20240513$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005841$STRIDES$Lum K, Sanchez R, Zhou C, Sangar S, Dao H, Elsensohn A.. Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab. JAAD-Case-Rep. 2024;46:95-99$58$YR$$F$Y$$$20240726$$MD$US$US
241391351$24139135$1$I$$20240604$20240726$20240726$PER$$US-CHATTEMPRD-2024OHG020082$CHATTEM$$$$A$$Y$$$20240719$$CN$US$US
241391361$24139136$1$I$$20240530$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006554$STRIDES$Ghafari-Saravi A, Foster E.. Treatment of Refractory Vulvar Lichen Sclerosus With Methotrexate. J-Low-Genit-Tract-Dis. 2024;28 (2):202-204$35$YR$$F$Y$$$20240726$$HP$US$US
241391371$24139137$1$I$$20240719$20240726$20240726$PER$$US-AstraZeneca-2024A165525$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241391382$24139138$2$F$$20240911$20240726$20240914$PER$$US-AstraZeneca-2024A164496$ASTRAZENECA$$$$$F$Y$$$20240914$$CN$US$
241391391$24139139$1$I$20240201$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015998$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240726$$CN$US$US
241391401$24139140$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016224$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240726$$CN$US$US
241391411$24139141$1$I$20231215$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407014324$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240726$$CN$US$US
241391422$24139142$2$F$$20240827$20240726$20240902$PER$$US-BEH-2024175860$CSL BEHRING$$56$YR$A$F$Y$$$20240902$$HP$US$US
241391431$24139143$1$I$20240712$20240716$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407011138$ELI LILLY AND CO$$$$$M$Y$$$20240726$$CN$US$US
241391441$24139144$1$I$$20240719$20240726$20240726$PER$$US-ROCHE-10000032407$ROCHE$$$$$$Y$$$20240726$$CN$US$US
241391451$24139145$1$I$$20240719$20240726$20240726$PER$$US-ABBVIE-5850384$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241391461$24139146$1$I$20240601$20240724$20240726$20240726$EXP$$US-UCBSA-2024037592$UCB$$29$YR$$F$Y$$$20240726$$HP$US$US
241391473$24139147$3$F$20240401$20240727$20240726$20240731$EXP$$GR-ABBVIE-5847787$ABBVIE$$85$YR$$M$Y$$$20240731$$CN$GR$GR
241391481$24139148$1$I$20240206$20220927$20240726$20240726$EXP$$CA-CELLTRION INC.-2022CA022468$CELLTRION$$$$$$Y$$$20240726$$CN$CA$CA
241391491$24139149$1$I$20240724$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024147364$AMGEN$$80$YR$E$F$Y$$$20240725$$CN$US$US
241391501$24139150$1$I$20240101$20240723$20240726$20240726$EXP$$US-ABBVIE-5851946$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241391511$24139151$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146659$AMGEN$$$$$M$Y$$$20240725$$CN$US$US
241391523$24139152$3$F$$20240815$20240726$20240819$PER$$US-ALXN-202407USA001410US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241391531$24139153$1$I$20240101$20240722$20240726$20240726$EXP$$JP-GENMAB-2024-02643$GENMAB$$66$YR$$F$Y$$$20240726$$MD$JP$JP
241391542$24139154$2$F$$20240910$20240726$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06587$LUPIN$$$$$$Y$$$20240926$$CN$US$US
241391551$24139155$1$I$20240717$20240718$20240726$20240726$EXP$$TR-AMGEN-TURSP2024143225$AMGEN$$10$YR$C$F$Y$$$20240725$$MD$TR$TR
241391562$24139156$2$F$$20240725$20240726$20240808$PER$$US-APOTEX-2024AP008179$APOTEX$$$$$$Y$$$20240808$$CN$US$US
241391573$24139157$3$F$$20240805$20240726$20240812$EXP$SK-MYLANLABS-2024M1065811$SK-UCBSA-2024036901$UCB$$21$YR$$F$Y$$$20240812$$MD$SK$SK
241391581$24139158$1$I$$20240720$20240726$20240726$PER$$US-AMGEN-USASP2024145326$AMGEN$$$$$F$Y$$$20240725$$CN$US$US
241391591$24139159$1$I$$20240724$20240726$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118411$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$MD$JP$JP
241391601$24139160$1$I$$20240712$20240726$20240726$PER$$US-CHATTEMPRD-2024OHG024093$CHATTEM$$$$$$Y$$$20240719$$CN$US$US
241391611$24139161$1$I$20201015$20240717$20240726$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-073721$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240726$$MD$JP$JP
241391631$24139163$1$I$$20240710$20240726$20240726$PER$$US-CHATTEMPRD-2024OHG023911$CHATTEM$$$$$F$Y$$$20240719$$CN$US$US
241391641$24139164$1$I$20240710$20240710$20240726$20240726$30DAY$$MX-JNJFOC-20240734718$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$CN$MX$MX
241391651$24139165$1$I$20240707$20240723$20240726$20240726$EXP$$US-AstraZeneca-2024A168018$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241391661$24139166$1$I$$20240719$20240726$20240726$PER$$US-AstraZeneca-2024A165668$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241391671$24139167$1$I$20210601$20240717$20240726$20240726$EXP$$GB-CELLTRION INC.-2024GB016049$CELLTRION$$$$$$Y$$$20240726$$HP$GB$GB
241391681$24139168$1$I$$20240717$20240726$20240726$EXP$$CO-MSNLABS-2024MSNLIT01633$MSN LABORATORIES$Tabares B, Sarmiento-Suarez AD, Gil O, Hernandez-Pabon JC, Firacative C.Fatal co-infection by multiple pathogens in an indigenous woman with autoimmune hemolytic anemia and tuberculosis: a case report.BMC Infectious Diseases.2024;24(1):645$$$$$Y$$$20240726$$MD$CO$CO
241391691$24139169$1$I$$20240705$20240726$20240726$PER$$US-CHATTEMPRD-2024OHG023374$CHATTEM$$$$$$Y$$$20240719$$CN$US$US
241391702$24139170$2$F$20240713$20240917$20240726$20240927$PER$$US-GSK-US2024086999$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240927$$CN$US$US
241391711$24139171$1$I$$20240715$20240726$20240726$EXP$$US-CELLTRION INC.-2024US017573$CELLTRION$Li XJ, Fung BM, and Kumar R. Successful Treatment of Rituximab-Induced Crohn^s Disease With Ustekinumab. ACG CASE REPORTS JOURNAL. 2024;11 (7):e01403$$$$$Y$$$20240726$$MD$US$US
241391722$24139172$2$F$20240101$20240819$20240726$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022809$UNITED THERAPEUTICS$$$$$F$Y$$$20240828$$$US$US
241391731$24139173$1$I$$20240716$20240726$20240726$EXP$$US-CHATTEMPRD-2024OHG024435$CHATTEM$$$$$F$Y$$$20240719$$CN$US$US
241391741$24139174$1$I$$20240716$20240726$20240726$EXP$$US-CHATTEMPRD-2024OHG024439$CHATTEM$$90$YR$E$M$Y$$$20240719$$CN$US$US
241391751$24139175$1$I$$20240702$20240726$20240726$PER$$US-CHATTEMPRD-2024OHG023019$CHATTEM$$$$$$Y$$$20240719$$CN$US$US
241391763$24139176$3$F$$20240807$20240726$20240808$EXP$$GB-JNJFOC-20240764982$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240809$$HP$GB$GB
241391775$24139177$5$F$$20240926$20240726$20240928$PER$$US-AMGEN-USASP2024147550$AMGEN$$$$$F$Y$$$20240927$$CN$US$US
241391782$24139178$2$F$20240704$20240718$20240726$20240726$EXP$$US-AMGEN-USASP2024143772$AMGEN$$$$A$F$Y$$$20240726$$MD$US$US
241391791$24139179$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147248$AMGEN$$$$$M$Y$$$20240725$$CN$US$US
241391801$24139180$1$I$20240601$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015780$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240726$$HP$US$US
241391811$24139181$1$I$20240720$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015783$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240726$$CN$US$US
241391823$24139182$3$F$20240723$20240815$20240726$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202407016111$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240820$$CN$US$US
241391831$24139183$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016209$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$US$US
241391843$24139184$3$F$$20240711$20240726$20240910$EXP$$US-CHATTEMPRD-2024OHG023986$CHATTEM$$$$E$F$Y$$$20240910$$CN$US$US
241391851$24139185$1$I$$20240716$20240726$20240726$EXP$$JP-VANTIVE-2024VAN018290$Vantive US Healthcare$$$$$$Y$$$20240726$$MD$JP$JP
241391861$24139186$1$I$20180101$20240708$20240726$20240726$EXP$$US-CHATTEMPRD-2024OHG023580$CHATTEM$$62$YR$A$F$Y$$$20240719$$LW$US$US
241391871$24139187$1$I$20240709$20240716$20240726$20240726$EXP$$JP-VANTIVE-2024VAN018269$Vantive US Healthcare$$9$DEC$$M$Y$$$20240726$$HP$JP$JP
241391881$24139188$1$I$20240714$20240718$20240726$20240726$EXP$$JP-VANTIVE-2024VAN018341$Vantive US Healthcare$$$$$M$Y$$$20240726$$HP$JP$JP
241391891$24139189$1$I$$20240717$20240726$20240726$EXP$$US-VANTIVE-2024VAN018420$Vantive US Healthcare$$$$$$Y$$$20240726$$HP$US$US
241391901$24139190$1$I$20231218$20240718$20240726$20240726$EXP$$CA-CELLTRION INC.-2024CA000636$CELLTRION$$$$$$Y$$$20240726$$HP$CA$CA
241391922$24139192$2$F$$20240801$20240726$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-022412$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240806$$$US$US
241391931$24139193$1$I$20240101$20240719$20240726$20240726$PER$$US-UNITED THERAPEUTICS-UNT-2024-022011$UNITED THERAPEUTICS$$$$$F$Y$53.741$KG$20240726$$$US$US
241391942$24139194$2$F$20240401$20240731$20240726$20240809$EXP$DE-CADRBFARM-2024329281$DE-MSNLABS-2024MSNSPO01629$MSN LABORATORIES$$$$$$Y$$$20240809$$MD$DE$DE
241391952$24139195$2$F$$20240821$20240726$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118398$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240827$$MD$JP$JP
241391961$24139196$1$I$$20240717$20240726$20240726$EXP$$US-ROCHE-10000030632$ROCHE$$65$YR$E$F$Y$77.11$KG$20240726$$MD$US$US
241391972$24139197$2$F$20240723$20240802$20240726$20240805$PER$$US-AMGEN-USASP2024147509$AMGEN$$61$YR$A$$Y$$$20240805$$CN$US$US
241391981$24139198$1$I$$20231017$20240726$20240726$EXP$$US-AstraZeneca-2023A239685$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241391991$24139199$1$I$$20221125$20240726$20240726$EXP$$US-AstraZeneca-2022A324437$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241392001$24139200$1$I$20240601$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118494$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240726$$HP$US$US
241392012$24139201$2$F$$20240822$20240726$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118497$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240824$$HP$US$US
241392021$24139202$1$I$$20240716$20240726$20240726$EXP$$JP-ROCHE-10000032337$ROCHE$Tani Y, Kaneda H, Oka T, Kawaguchi T, Mizutani M, Sugimoto A et al.. 25 A case of thoracic SMARCA4-deficient undifferentiated tumor that showed antitumor effect by palliative radiation and docetaxel. The 120th Kansai Branch Scientific Meeting of the Japan Lung Cancer Society. 2024;53$38$YR$A$M$Y$$$20240726$$MD$JP$JP
241392031$24139203$1$I$20240714$20240723$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118287$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$83.91$KG$20240726$$HP$US$US
241392041$24139204$1$I$$20240718$20240726$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-117407$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240726$$HP$CA$CA
241392051$24139205$1$I$$20240627$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-103804$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$PH$US$US
241392061$24139206$1$I$20240601$20240715$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112277$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240726$$HP$US$US
241392072$24139207$2$F$$20240720$20240726$20240726$EXP$$US-AMGEN-USASP2024146109$AMGEN$$$$$$Y$$$20240726$$MD$US$US
241392091$24139209$1$I$$20240708$20240726$20240726$EXP$$US-CHATTEMPRD-2024OHG023772$CHATTEM$$$$E$M$Y$$$20240719$$LW$US$US
241392101$24139210$1$I$$20240718$20240726$20240726$PER$$US-ADVANZ PHARMA-202407006127$ADVANZ PHARMA$$$$$$Y$$$20240726$$CN$US$US
241392111$24139211$1$I$$20240716$20240726$20240726$EXP$$US-GSK-US2024089475$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241392121$24139212$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214690$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240726$$MD$US$US
241392132$24139213$2$F$$20240711$20240726$20240906$EXP$CA-SA-SAC20240712000973$CA-CHATTEMPRD-2024OHG024392$CHATTEM$$43$YR$A$F$Y$$$20240906$$HP$CA$CA
241392141$24139214$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA216608$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241392151$24139215$1$I$20240718$20240718$20240726$20240726$PER$$US-SA-2024SA214682$SANOFI AVENTIS$$40$YR$A$M$Y$95.7$KG$20240726$$MD$US$US
241392163$24139216$3$F$20240710$20240815$20240726$20240822$30DAY$$US-AMGEN-USASP2024145447$AMGEN$$74$YR$E$F$Y$75.8$KG$20240822$$PH$US$US
241392171$24139217$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024146822$AMGEN$$$$$$Y$$$20240725$$CN$US$US
241392191$24139219$1$I$20240702$20240704$20240726$20240726$EXP$$GR-CHATTEMPRD-2024OHG024109$CHATTEM$$43$YR$A$F$Y$$$20240719$$HP$GR$GR
241392201$24139220$1$I$20220101$20240724$20240726$20240726$EXP$$DE-JNJFOC-20240766664$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240726$$MD$DE$DE
241392211$24139221$1$I$20240706$20240717$20240726$20240726$EXP$IT-MINISAL02-994686$IT-SA-2024SA211991$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240726$$MD$IT$IT
241392222$24139222$2$F$$20240813$20240726$20240813$PER$$US-ALXN-202407USA001275US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241392232$24139223$2$F$$20240731$20240726$20240802$PER$$US-ROCHE-10000027745$ROCHE$$$$E$$Y$$$20240802$$MD$US$US
241392242$24139224$2$F$$20240730$20240726$20240809$EXP$$CN-TEVA-VS-3222791$TEVA$Li W, Chang Y, Liu X, Chen Z, Sun J, Geng Z, et al. Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study. Ann-Hematol 2024; 103 (6): 2003-2012.; Li W, Chang Y, Liu X, Chen Z, Sun J, Geng Z, et al. Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study. Ann-Hematol 2024; 103 (6): 2003-2012.; Li W, Chang Y, Liu X, Chen Z, Sun J, Geng...$$$$$Y$$$20240809$$HP$CN$CN
241392264$24139226$4$F$20230322$20240821$20240726$20240829$EXP$$IT-MSNLABS-2024MSNLIT01632$MSN LABORATORIES$Gunnellini M, Tornincasa A, Montedoro M, Caprodossi A, Prosperi E, Peverini M.Neoadjuvant Treatment for a cT4cN+ HER2+ Breast Cancer: Case Report of a Therapeutic Success.Anticancer Research.2024;44(6):2755-8$$$$$Y$$$20240829$$MD$IT$IT
241392272$24139227$2$F$20240101$20240729$20240726$20240803$EXP$$US-ABBVIE-5851571$ABBVIE$$$$$F$Y$65$KG$20240803$$CN$US$US
241392281$24139228$1$I$20240702$20240723$20240726$20240726$EXP$$CA-ABBVIE-5852065$ABBVIE$$$$E$M$Y$$$20240726$$CN$CA$CA
241392291$24139229$1$I$20240101$20240724$20240726$20240726$EXP$$US-ABBVIE-5852614$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241392301$24139230$1$I$20220101$20240723$20240726$20240726$EXP$$US-ABBVIE-5852254$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241392311$24139231$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015216$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240726$$CN$US$US
241392321$24139232$1$I$20240716$20240716$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407011272$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240726$$CN$US$US
241392331$24139233$1$I$$20240723$20240726$20240726$PER$$CA-ELI_LILLY_AND_COMPANY-US202407016016$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$CA$US
241392341$24139234$1$I$$20240724$20240726$20240726$PER$$NVSC2024US152732$NOVARTIS$$$$$F$Y$$$20240726$$PH$US$US
241392351$24139235$1$I$$20240716$20240726$20240726$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009090$STRIDES$Rhoads S, Maloney J, Mantha A, Van Hook R, Henao-Martinez AF.. Pneumocystis jirovecii Pneumonia in HIV-Negative, Non-transplant Patients: Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention.. Curr-Fungal-Infect-Rep. 2024;18 (2):125-135$$$$$Y$$$20240726$$HP$US$US
241392361$24139236$1$I$$20240717$20240726$20240726$PER$$US-CHATTEMPRD-2024OHG024516$CHATTEM$$$$$$Y$$$20240726$$CN$US$US
241392371$24139237$1$I$$20240716$20240726$20240726$EXP$NL-LRB-00982527$NL-GLENMARK PHARMACEUTICALS-2024GMK092481$GLENMARK$$$$$$Y$$$20240726$$MD$NL$NL
241392381$24139238$1$I$20240626$20240718$20240726$20240726$EXP$$CA-BEH-2024174711$CSL BEHRING$$40$YR$A$F$Y$94$KG$20240726$$HP$CA$CA
241392391$24139239$1$I$$20240717$20240726$20240726$PER$$US-CHATTEMPRD-2024OHG024726$CHATTEM$$$$A$F$Y$$$20240726$$HP$US$US
241392401$24139240$1$I$20220801$20240725$20240726$20240726$EXP$LV-AMGEN-LVASP2024132502$LV-ROCHE-10000037313$ROCHE$Kreslina L.; Gasenko E.. Challenges in the treatment of metastatic colon and rectall cancer and the role of genetic testing. Journal Latvijas Arsts. 2024;46-49$48$YR$A$F$Y$$$20240726$$HP$LV$LV
241392411$24139241$1$I$$20240724$20240726$20240726$PER$$US-CHATTEMPRD-2024OHG025285$CHATTEM$$77$YR$E$F$Y$$$20240726$$CN$US$US
241392421$24139242$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024146374$AMGEN$$$$$$Y$$$20240725$$PH$US$US
241392432$24139243$2$F$20240720$20240905$20240726$20240908$PER$$US-AMGEN-USASP2024147240$AMGEN$$51$YR$A$M$Y$$$20240908$$CN$US$US
241392441$24139244$1$I$20240722$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147032$AMGEN$$79$YR$E$F$Y$$$20240725$$PH$US$US
241392451$24139245$1$I$20240721$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024148225$AMGEN$$74$YR$E$M$Y$$$20240725$$CN$US$US
241392461$24139246$1$I$20240720$20240720$20240726$20240726$PER$$US-AMGEN-USASP2024145794$AMGEN$$92$YR$E$F$Y$$$20240725$$CN$US$US
241392471$24139247$1$I$$20240718$20240726$20240726$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009054$STRIDES$Abdelmajid HA, Mustafa GMA, Fernandez A, Franco SD, Esquibies AE, Valencia GB, et al.. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring.. Case-Rep-Perinat-Med. 2024;13(1):1-5$$$$$Y$$$20240726$$MD$US$US
241392481$24139248$1$I$$20240718$20240726$20240726$EXP$$CA-APOTEX-2024AP008606$APOTEX$$64$YR$$F$Y$$$20240726$$HP$CA$CA
241392491$24139249$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024147005$AMGEN$$$$$$Y$$$20240725$$PH$US$US
241392501$24139250$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA215058$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240726$$MD$US$US
241392511$24139251$1$I$20240101$20240719$20240726$20240726$PER$$US-SA-2024SA215802$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240726$$MD$US$US
241392522$24139252$2$F$20240601$20240812$20240726$20240821$PER$$US-SA-2024SA215680$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240821$$MD$US$US
241392531$24139253$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA215981$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240726$$CN$US$US
241392541$24139254$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA214521$SANOFI AVENTIS$$$$A$M$Y$$$20240726$$CN$US$US
241392551$24139255$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA214798$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240726$$MD$US$US
241392561$24139256$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215127$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240726$$MD$US$US
241392571$24139257$1$I$20240601$20240718$20240726$20240726$PER$$US-SA-2024SA214815$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240726$$MD$US$US
241392581$24139258$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA216295$SANOFI AVENTIS$$$$T$F$Y$$$20240726$$MD$US$US
241392591$24139259$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA214710$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240726$$MD$US$US
241392603$24139260$3$F$20240101$20240822$20240726$20240912$PER$$US-APOTEX-2024AP008242$APOTEX$$$$$M$Y$$$20240912$$CN$US$US
241392611$24139261$1$I$$20240719$20240726$20240726$EXP$$US-GSK-US2024091263$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241392621$24139262$1$I$$20240723$20240726$20240726$EXP$$US-ABBVIE-5852162$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241392631$24139263$1$I$$20240716$20240726$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114991$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240726$$HP$CA$CA
241392641$24139264$1$I$$20240702$20240726$20240726$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06345$LUPIN$$$$$$Y$$$20240726$$CN$US$US
241392652$24139265$2$F$$20240802$20240726$20240806$EXP$$JP-UCBSA-2024034058$UCB$Yukiko S. Learning from a Case Report; Nutrition assessment of eating/swallowing disorder and tips for its intervention vol.20, ^A Case of Successful Transition from Nasogastric Tube Feeding to Complete Oral Ingestion with Nutrient Support Provided at Home and/or a Housing-Type Private Nursing Home, after Subarachnoid Hemorrhage due to Ruptured Anterior Communicating Artery Aneurysm^.. Clinical Nutrition/Journal of Japanese Society of Clinical Nutriiton. 2024;144(5):676-80$6$DEC$$M$Y$62.5$KG$20240806$$HP$JP$JP
241392661$24139266$1$I$20240718$20240724$20240726$20240726$EXP$$SE-ABBVIE-5853706$ABBVIE$$88$YR$$F$Y$$$20240726$$HP$SE$SE
241392672$24139267$2$F$$20240810$20240726$20240814$PER$$NVSC2024US147279$NOVARTIS$$35$YR$$F$Y$$$20240814$$CN$US$US
241392681$24139268$1$I$20240704$20240722$20240726$20240726$EXP$$CO-ABBVIE-5854064$ABBVIE$$66$YR$$M$Y$59$KG$20240726$$HP$CO$CO
241392691$24139269$1$I$$20240724$20240726$20240726$EXP$$US-UCBSA-2024037616$UCB$$$$$F$Y$$$20240726$$HP$US$US
241392702$24139270$2$F$20240716$20240725$20240726$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003780$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240816$$CN$US$US
241392711$24139271$1$I$$20240717$20240726$20240726$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009134$STRIDES$Mcgourty M, Adams EW, Lyons J, Ayyaswami V, Holdorf JD.. MDA-5 Associated Dermatomyositis: A Case of Delayed Care and Dire Consequences.. Am-J-Respir-Crit-Care-Med. 2024;209 (0):no pagination.$$$$$Y$$$20240726$$HP$US$US
241392722$24139272$2$F$20240819$20240822$20240726$20240829$EXP$$JP-AMGEN-JPNSP2024147316$AMGEN$$5$DEC$A$F$Y$$$20240828$$MD$JP$JP
241392731$24139273$1$I$$20240702$20240726$20240726$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06328$LUPIN$$$$$$Y$$$20240726$$CN$US$US
241392741$24139274$1$I$$20240718$20240726$20240726$EXP$US-MLMSERVICE-20240430-PI040956-00323-1$US-STRIDES ARCOLAB LIMITED-2024SP009193$STRIDES$Patel EJ, Ahmad M, Schwartz BS, van Zante A, Kersten R, Loftus P.. Invasive Fungal Sinusitis in an Immunocompetent Patient After Sinus Surgery for Chronic Rhinosinusitis with Nasal Polyps and a Mycetoma.. Laryngoscope. 2024$$$$$Y$$$20240726$$MD$US$US
241392751$24139275$1$I$20240301$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024145699$AMGEN$$55$YR$A$F$Y$$$20240725$$HP$US$US
241392763$24139276$3$F$20240101$20240822$20240726$20240830$EXP$$PT-ABBVIE-5850656$ABBVIE$$$$A$M$Y$$$20240828$$CN$PT$PT
241392771$24139277$1$I$20240713$20240716$20240726$20240726$PER$$US-ABBVIE-5847164$ABBVIE$$20$YR$$M$Y$$$20240726$$CN$US$US
241392782$24139278$2$F$20240720$20240724$20240726$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003600$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240816$$CN$US$US
241392791$24139279$1$I$$20240718$20240726$20240726$EXP$$US-GSK-US2024090707$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$HP$US$US
241392801$24139280$1$I$20240510$20240718$20240726$20240726$EXP$$FR-AstraZeneca-2024A163914$ASTRAZENECA$$79$YR$$F$Y$52$KG$20240726$$MD$FR$
241392811$24139281$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA214794$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240726$$MD$US$US
241392821$24139282$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214812$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240726$$MD$US$US
241392831$24139283$1$I$20240501$20240717$20240726$20240726$EXP$$US-ROCHE-10000030965$ROCHE$$54$YR$A$M$Y$113.39$KG$20240726$$CN$US$US
241392841$24139284$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214825$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240726$$MD$US$US
241392851$24139285$1$I$20240517$20240711$20240726$20240726$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00356$MELINTA THERAPEUTICS$$$$$$Y$$$20240726$$MD$CN$CN
241392861$24139286$1$I$$20240716$20240726$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118012$BRISTOL MYERS SQUIBB$Harima E, et al. 34 A case of liver injury with hyperaccumulation throughout the liver on PET. The 244th Annual Meeting of The Japanese Society of Internal Medicine, Kinki District Meeting. 2024 Jun 29;$67$YR$E$F$Y$$$20240726$$HP$JP$JP
241392872$24139287$2$F$$20240819$20240726$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118553$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240820$$CN$US$US
241392881$24139288$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118599$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240726$$HP$US$US
241392891$24139289$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118394$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240726$$CN$US$US
241392901$24139290$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153057$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241392911$24139291$1$I$$20240717$20240726$20240726$PER$$US-APOTEX-2024AP008615$APOTEX$Daniels Z, Walczak AB, Lloyd EA, Deitemeyer M, Duffy V, Kistler IS, et al. Breaking Tradition: The Bivalirudin Advantage in Pediatric Mechanical Circulatory Support. ASAIO Journal. 2024;70 (Suppl.):84-85$$$C$$Y$$$20240726$$HP$US$US
241392931$24139293$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA215046$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241392941$24139294$1$I$$20240719$20240726$20240726$EXP$$US-SA-2024SA217802$SANOFI AVENTIS$$$$A$F$Y$72.5$KG$20240726$$MD$US$US
241392951$24139295$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA216423$SANOFI AVENTIS$$$$E$F$Y$56.6$KG$20240726$$MD$US$US
241392961$24139296$1$I$$20240716$20240726$20240726$PER$$US-SA-2024SA213634$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241392971$24139297$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214390$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240726$$MD$US$US
241392981$24139298$1$I$20240709$20240711$20240726$20240726$EXP$$US-EPICPHARMA-US-2024EPCSPO00858$EPIC PHARM$$$$$M$Y$$$20240726$$HP$US$US
241392991$24139299$1$I$20240711$20240722$20240726$20240726$EXP$CZ-CZSUKL-24002095$CZ-EXELIXIS-CABO-24079783$EXELIXIS$$70$YR$$M$Y$90$KG$20240725$$PH$CZ$CZ
241393001$24139300$1$I$$20240720$20240726$20240726$PER$$US-BIOGEN-2024BI01275053$BIOGEN$$$$$M$Y$$$20240726$$CN$US$US
241393011$24139301$1$I$$20240702$20240726$20240726$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06336$LUPIN$$$$$$Y$$$20240726$$CN$US$US
241393021$24139302$1$I$$20240717$20240726$20240726$30DAY$$US-GSK-US2024090163$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241393031$24139303$1$I$20240716$20240717$20240726$20240726$30DAY$$US-GSK-US2024089975$GLAXOSMITHKLINE$$70$YR$$M$Y$$$20240726$$CN$US$US
241393044$24139304$4$F$20240516$20240922$20240726$20240926$EXP$$JP-JNJFOC-20240770600$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240927$$MD$JP$JP
241393052$24139305$2$F$20240719$20240828$20240726$20240911$PER$$US-JNJFOC-20240752684$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240911$$PH$US$US
241393072$24139307$2$F$$20240730$20240726$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-022569$UNITED THERAPEUTICS$$$$$F$Y$59.864$KG$20240806$$$US$US
241393081$24139308$1$I$20240717$20240717$20240726$20240726$EXP$$GB-TEVA-VS-3223134$TEVA$$68$YR$$M$Y$97$KG$20240726$$MD$GB$GB
241393101$24139310$1$I$20240627$20240719$20240726$20240726$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-06941$HIKMA$$62$YR$$F$Y$$$20240726$$HP$EG$EG
241393111$24139311$1$I$$20240715$20240726$20240726$EXP$$UG-STRIDES ARCOLAB LIMITED-2024SP009079$STRIDES$Nambuya M, Mayanja-Kizza H.. A case report: recurrent anemia related to long term acyclovir use in a pregnant HIV infected Ugandan.. Afr-Health-Sci. 2024;24(1):91-93$19$YR$$F$Y$$$20240726$$HP$UG$UG
241393121$24139312$1$I$$20240717$20240726$20240726$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP009142$STRIDES$Tarhan G, Karabulut EGT, Karaci R, Sonmez Gungor E, Kaya GK, Ulker M, et al.. Multiorgan dysfunction precipitated by disulfiram use and posterior reversible encephalopathy syndrome with atypical presentation: a case report.. J-Subst-Use. 2024;29 (2):175-179$57$YR$$F$Y$$$20240726$$HP$TR$TR
241393131$24139313$1$I$$20240724$20240726$20240726$PER$$US-HALEON-2188924$Haleon PLC$$$$$$Y$$$20240726$$CN$US$US
241393142$24139314$2$F$$20240722$20240726$20240809$PER$$US-SA-2024SA215669$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240809$$CN$US$US
241393151$24139315$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA214832$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240726$$MD$US$US
241393162$24139316$2$F$$20240801$20240726$20240806$PER$$US-JNJFOC-20240761823$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$PH$US$US
241393172$24139317$2$F$20240501$20240729$20240726$20240801$EXP$$US-ABBVIE-5851150$ABBVIE$$52$YR$$F$Y$$$20240801$$CN$US$US
241393181$24139318$1$I$$20240717$20240726$20240726$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009121$STRIDES$Kita Y, Shirai S, Koyama T, Makinouchi R, Machida S, Matsui K, et al.. Fanconi syndrome with karyomegalic interstitial nephritis after ifosfamide treatment for osteosarcoma: a case report.. CEN-Case-Rep. 2024;0 (0)$18$YR$$M$Y$$$20240726$$HP$JP$JP
241393194$24139319$4$F$20240101$20240913$20240726$20240921$EXP$$CA-CELLTRION INC.-2024CA005196$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
241393201$24139320$1$I$$20240718$20240726$20240726$PER$$US-ABBVIE-5849971$ABBVIE$$$$$M$Y$$$20240726$$HP$US$US
241393211$24139321$1$I$$20240719$20240726$20240726$PER$$US-ABBVIE-5850364$ABBVIE$$$$$$Y$$$20240726$$CN$US$US
241393221$24139322$1$I$$20240718$20240726$20240726$PER$$US-ALXN-202407USA001399US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241393231$24139323$1$I$20230101$20240717$20240726$20240726$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009122$STRIDES$Jiang C, Yan X, Xia P, Luo X, Zheng H, Tong H, et al.. Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus.. Front-Pharmacol. 2024;15:1-13$32$YR$$M$Y$$$20240726$$HP$CN$CN
241393241$24139324$1$I$$20240716$20240726$20240726$EXP$$US-GSK-US2024089456$GLAXOSMITHKLINE$$$$$M$Y$$$20240726$$MD$US$US
241393251$24139325$1$I$$20240717$20240726$20240726$30DAY$$US-GSK-US2024AMR090444$GLAXOSMITHKLINE$$$$$M$Y$$$20240726$$CN$US$US
241393261$24139326$1$I$$20240702$20240726$20240726$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06463$LUPIN$$$$$$Y$$$20240726$$CN$US$US
241393271$24139327$1$I$$20240723$20240726$20240726$PER$$US-ROCHE-10000034914$ROCHE$$$$A$F$Y$$$20240726$$CN$US$US
241393281$24139328$1$I$$20240723$20240726$20240726$EXP$$US-BIOVITRUM-2024-US-010223$BIOVITRUM$$$$I$F$Y$$$20240726$$CN$US$US
241393291$24139329$1$I$20240712$20240719$20240726$20240726$EXP$$ZA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458844$RANBAXY$-. -. -. -;-:-$36$YR$$M$Y$$$20240726$$MD$ZA$ZA
241393301$24139330$1$I$$20240718$20240726$20240726$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009203$STRIDES$Wei J, Ning J.. Successful treatment of penicillin-resistant pneumococcal meningitis following ventriculo-peritoneal shunt for congenital hydrocephalus: A case report on the efficacy of linezolid.. Asian-J-Surg. 2024;47 (7):3389$1$YR$$F$Y$$$20240726$$HP$CN$CN
241393311$24139331$1$I$$20240725$20240726$20240726$EXP$$NVSC2024US152801$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241393322$24139332$2$F$20240719$20240723$20240726$20240801$EXP$$NVSC2024CA151681$NOVARTIS$$38$YR$$F$Y$$$20240801$$CN$CA$CA
241393332$24139333$2$F$20240701$20240911$20240726$20240924$EXP$$US-UCBSA-2024037289$UCB$$78$YR$$F$Y$$$20240924$$CN$US$US
241393341$24139334$1$I$$20240718$20240726$20240726$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009210$STRIDES$Torres JW, Collazo Santiago HO, Torrens Olan J, Quiles-Cruz CV, Ortiz Velez I, Gonzalez Santiago G, et al.. Crisis in the Lungs: EVALI Unveiled in a Young Male Patient.. Am-J-Respir-Crit-Care-Med. 2024;209(plusPoster)$23$YR$$M$Y$$$20240726$$HP$US$US
241393361$24139336$1$I$20240722$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024148020$AMGEN$$44$YR$A$F$Y$$$20240726$$CN$US$US
241393372$24139337$2$F$$20240722$20240726$20240801$PER$$US-AMGEN-USASP2024147080$AMGEN$$$$$F$Y$$$20240801$$HP$US$US
241393381$24139338$1$I$$20240718$20240726$20240726$EXP$$US-ARDELYX-2024ARDX005485$ARDELYX$$$$$M$Y$$$20240726$$HP$US$US
241393391$24139339$1$I$20240627$20240717$20240726$20240726$EXP$$CN-BEIGENE-BGN-2024-011174$BEIGENE$$$$$$Y$$$20240726$$HP$CN$CN
241393401$24139340$1$I$20240207$20240716$20240726$20240726$EXP$ES-AEMPS-1544685$ES-TEVA-VS-3222305$TEVA$$46$YR$$F$Y$$$20240726$$MD$ES$ES
241393411$24139341$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016321$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240726$$CN$US$US
241393422$24139342$2$F$$20240725$20240726$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407016277$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240807$$CN$US$US
241393431$24139343$1$I$20240617$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147147$AMGEN$$$$$M$Y$$$20240726$$HP$US$US
241393441$24139344$1$I$$20240718$20240726$20240726$EXP$$CO-STRIDES ARCOLAB LIMITED-2024SP009160$STRIDES$Mantilla-Florez YF, Tuta-Quintero E, Rodriguez-Segura PV, Casallas-Rivera A, Osejo-Diago PP, Russy Buitrago PA.. Fatal Calciphylaxis in Tertiary Hyperparathyroidism due to Long-Lasting End-Stage Renal Disease; A Case Report.. Aging-Med-Healthc. 2024;15 (2):88-92$30$YR$$F$Y$$$20240726$$MD$CO$CO
241393451$24139345$1$I$$20240718$20240726$20240726$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009181$STRIDES$Cheng TW, Colakovic RN, Pearson DR, Sio TT, Fiessinger LA.. Treatment of sclerotic chronic graft-versus-host disease with injections of hyaluronidase.. JAAD-Case-Rep. 2023;38:55-58$35$YR$$M$Y$$$20240726$$MD$US$US
241393461$24139346$1$I$$20240723$20240726$20240726$PER$$US-GRUNENTHAL-2024-123407$AVERITAS$$71$YR$$F$Y$$$20240725$$HP$US$US
241393471$24139347$1$I$20240724$20240724$20240726$20240726$PER$$US-GRUNENTHAL-2024-123406$AVERITAS$$63$YR$$M$Y$$$20240725$$HP$US$US
241393481$24139348$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214834$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240726$$CN$US$US
241393491$24139349$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214853$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240726$$MD$US$US
241393501$24139350$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA214777$SANOFI AVENTIS$$27$YR$A$F$Y$54.422$KG$20240726$$MD$US$US
241393511$24139351$1$I$$20240718$20240726$20240726$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009161$STRIDES$Patel KH, Halicki J, Dachert S, Mamary A.. Large Pericardial Cyst in a Lung Transplant Patient.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$74$YR$$M$Y$$$20240726$$HP$US$US
241393521$24139352$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214862$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240726$$MD$US$US
241393531$24139353$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214833$SANOFI AVENTIS$$$$A$M$Y$91.6$KG$20240726$$MD$US$US
241393541$24139354$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA216501$SANOFI AVENTIS$$79$YR$E$F$Y$99$KG$20240726$$MD$US$US
241393551$24139355$1$I$$20240718$20240726$20240726$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009166$STRIDES$Sada I, Harada Y, Hiyama T, Mizukami M, Kan T, Kawai M, et al.. Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma.. Melanoma-Res. 2023;33:539-546$57$YR$$M$Y$$$20240726$$HP$JP$JP
241393562$24139356$2$F$$20240926$20240726$20240927$EXP$$NVSC2024US150387$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
241393572$24139357$2$F$20240722$20240904$20240726$20240918$PER$$US-JNJFOC-20240761577$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240918$$CN$US$US
241393582$24139358$2$F$20240717$20240823$20240726$20240909$PER$$US-JNJFOC-20240761750$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240909$$PH$US$US
241393592$24139359$2$F$$20240906$20240726$20240910$PER$$US-AstraZeneca-2024A166649$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
241393601$24139360$1$I$20210621$20210621$20240726$20240726$EXP$$US-AstraZeneca-2021A551780$ASTRAZENECA$$18744$DY$$F$Y$$$20240726$$CN$US$
241393612$24139361$2$F$20240223$20240718$20240726$20240828$EXP$$DE-AstraZeneca-2024A167883$ASTRAZENECA$$58$YR$$F$Y$$$20240828$$MD$DE$
241393623$24139362$3$F$20240202$20240821$20240726$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113272$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240829$$CN$US$US
241393631$24139363$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA213525$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240726$$MD$US$US
241393641$24139364$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA214882$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240726$$MD$US$US
241393651$24139365$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214877$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240726$$CN$US$US
241393661$24139366$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214766$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240726$$MD$US$US
241393671$24139367$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214768$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240726$$MD$US$US
241393681$24139368$1$I$20240614$20240717$20240726$20240726$EXP$$CN-BEIGENE-BGN-2024-011175$BEIGENE$$$$$$Y$$$20240726$$HP$CN$CN
241393691$24139369$1$I$$20240718$20240726$20240726$PER$$US-ABBVIE-5847989$ABBVIE$$$$$$Y$$$20240726$$CN$US$US
241393701$24139370$1$I$20240709$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024146433$AMGEN$$67$YR$E$$Y$$$20240726$$CN$US$US
241393712$24139371$2$F$20240707$20240729$20240726$20240731$PER$$US-AMGEN-USASP2024146934$AMGEN$$83$YR$E$F$Y$$$20240731$$CN$US$US
241393721$24139372$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153168$NOVARTIS$$$$$F$Y$$$20240726$$PH$US$US
241393731$24139373$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165907$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241393741$24139374$1$I$$20240716$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-035483$AUROBINDO$Estrada Paz OA, Young TJ.. Paraneoplastic pemphigus with airway involvement. Respiratory Medicine Case Reports. 2024;51$55$YR$$F$Y$$$20240726$$MD$US$US
241393751$24139375$1$I$$20240718$20240726$20240726$PER$$US-EMD Serono-2024039348$EMD SERONO INC$$$$$M$Y$$$20240726$$PH$US$US
241393761$24139376$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024146826$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241393771$24139377$1$I$$20240717$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-13660709$BRISTOL MYERS SQUIBB$Okere K, Jones MC. A case of skin hypopigmentation secondary to a corticosteroid injection. Southern Medical Journal. 2006 Dec 01;99(12):1393-4.$47$YR$A$M$Y$$$20240726$$MD$US$US
241393781$24139378$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024146664$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241393791$24139379$1$I$$20240621$20240726$20240726$PER$$JP-WT-2024-03563$Waylis$$62$YR$$M$Y$$$20240726$$PH$JP$JP
241393801$24139380$1$I$$20240719$20240726$20240726$PER$$US-GILEAD-2024-0681410$GILEAD$$$$A$M$Y$$$20240726$$MD$US$US
241393813$24139381$3$F$20220501$20240826$20240726$20240904$PER$$FR-IGSA-BIG0029849$GRIFOLS$$52$YR$$M$Y$59$KG$20240904$$MD$FR$FR
241393821$24139382$1$I$20240618$20240718$20240726$20240726$30DAY$$US-GSK-US2024090581$GLAXOSMITHKLINE$$73$YR$$M$Y$$$20240726$$HP$US$US
241393831$24139383$1$I$20240717$20240722$20240726$20240726$EXP$$US-ABBVIE-5851103$ABBVIE$$25$YR$$M$Y$$$20240726$$CN$US$US
241393841$24139384$1$I$20240622$20240717$20240726$20240726$PER$$US-SA-2024SA215039$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240726$$MD$US$US
241393851$24139385$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA214980$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240726$$MD$US$US
241393861$24139386$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA215746$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240726$$MD$US$US
241393871$24139387$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA215068$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240726$$MD$US$US
241393882$24139388$2$F$$20240724$20240726$20240802$PER$$US-SA-2024SA215202$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240802$$MD$US$US
241393892$24139389$2$F$$20240726$20240726$20240807$EXP$$US-AUROBINDO-AUR-APL-2024-036679$AUROBINDO$Voelz K, Miller G, Lee-Miller C.. 6-Mercaptopurine-associated Sinusoidal Obstructive Syndrome During Interim Maintenance I: A Case Report. J-Pediatr-Hematol-Oncol. 2024;46(5):e317-e321$14$YR$$M$Y$$$20240807$$MD$US$US
241393901$24139390$1$I$20240619$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003236$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240726$$CN$US$US
241393911$24139391$1$I$$20240717$20240726$20240726$EXP$CA-DRL-USA-SPO/CAN/24/0010614$CA-RDY-SPO/CAN/24/0010614$DR REDDYS$$85$YR$E$M$Y$$$20240726$$HP$CA$CA
241393921$24139392$1$I$20240426$20240626$20240726$20240726$EXP$$US-ADVANZ PHARMA-202404003755$ADVANZ PHARMA$$$$$$Y$$$20240726$$CN$US$US
241393931$24139393$1$I$$20240716$20240726$20240726$EXP$$HU-AUROBINDO-AUR-APL-2024-035603$AUROBINDO$Lakatos V, Gopcsa L, Balogh A, Fabian J, Remenyi P.. T-sejtes prolimfocitas leukemia kezelese es transzplantacioja ket eset bemutatasaval [T-cell prolymphocytic leukaemia treatment and transplantation presented through two case reports].. Haematology - Transfusiology.. 2024;65-6.$$$A$M$Y$$$20240726$$MD$HU$HU
241393941$24139394$1$I$$20240716$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036196$AUROBINDO$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N, Pelletier R et al. A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).. Toxicologie Analytique + Clinique. 2023;35:76-394$43$YR$$M$Y$$$20240726$$MD$FR$FR
241393951$24139395$1$I$20240711$20240718$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090740$VIIV$$28$YR$$M$Y$$$20240726$$MD$US$US
241393971$24139397$1$I$$20240710$20240726$20240726$PER$$US-APOTEX-2024AP008306$APOTEX$Komal FNU, Olajide O.. A Very Rare Case of Diabetes Mellitus Occurring in a Patient With Hyperinsulinism Hyperammonemia Syndrome. AACE Clinical Case Reports. 2023;9 (4):122-124$36$YR$$F$Y$$$20240726$$MD$US$US
241393981$24139398$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118559$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240726$$CN$US$US
241393991$24139399$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117825$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240726$$HP$US$US
241394001$24139400$1$I$20240701$20240724$20240726$20240726$EXP$FR-AFSSAPS-PB2024000824$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-118566$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240726$$MD$FR$FR
241394011$24139401$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016063$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240726$$CN$US$US
241394021$24139402$1$I$20240701$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015726$ELI LILLY AND CO$$$$$M$Y$$$20240726$$CN$US$US
241394031$24139403$1$I$20240701$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015428$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240726$$CN$US$US
241394042$24139404$2$F$$20240723$20240726$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407014310$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240730$$CN$US$US
241394051$24139405$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016778$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240726$$CN$US$US
241394061$24139406$1$I$20240301$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016284$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240726$$CN$US$US
241394071$24139407$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016173$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240726$$HP$US$US
241394081$24139408$1$I$$20240716$20240726$20240726$EXP$$NZ-GALDERMA-NZ2024011400$GALDERMA$$$$$$Y$$$20240726$$HP$NZ$NZ
241394091$24139409$1$I$$20240722$20240726$20240726$PER$$US-JNJFOC-20240760013$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$US$US
241394101$24139410$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215812$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240726$$MD$US$US
241394111$24139411$1$I$20240701$20240718$20240726$20240726$PER$$US-SA-2024SA214876$SANOFI AVENTIS$$92$YR$E$F$Y$$$20240726$$MD$US$US
241394121$24139412$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215204$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240726$$MD$US$US
241394131$24139413$1$I$20240601$20240718$20240726$20240726$PER$$US-SA-2024SA215225$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240726$$MD$US$US
241394141$24139414$1$I$$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003239$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241394152$24139415$2$F$20240710$20240724$20240726$20240814$PER$$US-AMGEN-USASP2024145440$AMGEN$$71$YR$E$F$Y$$$20240814$$CN$US$US
241394161$24139416$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA215106$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240726$$MD$US$US
241394171$24139417$1$I$$20240702$20240726$20240726$PER$$US-ABBVIE-5850394$ABBVIE$$$$$F$Y$$$20240726$$MD$US$US
241394191$24139419$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024147449$AMGEN$Schmidt. L. Provider burden associated with apremilast adverse events (AEs). Journal of Investigative Dermatology. 2024;144 (8):S31$$$$$Y$$$20240726$$HP$US$US
241394201$24139420$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024146703$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241394211$24139421$1$I$20240701$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024147857$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241394221$24139422$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA216454$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240726$$MD$US$US
241394231$24139423$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214715$SANOFI AVENTIS$$$$A$M$Y$$$20240726$$MD$US$US
241394241$24139424$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA213985$SANOFI AVENTIS$$46$YR$A$F$Y$64.8$KG$20240726$$CN$US$US
241394261$24139426$1$I$$20240720$20240726$20240726$PER$$US-SA-2024SA213056$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241394271$24139427$1$I$$20240703$20240726$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003241$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241394281$24139428$1$I$$20240717$20240726$20240726$EXP$$JP-CHEPLA-2024009316$CHEPLAPHARM$Tanaka Y, et al. A case of chronic myelogenous leukemia with severe intramuscular hemorrhage successfully treated with platelet apheresis. The 253rd Tokai Regional Meeting of the Japanese Society of Internal Medicine.2024.$72$YR$$M$Y$$$20240726$$MD$COUNTRY NOT SPECIFIED$JP
241394291$24139429$1$I$20240418$20240719$20240726$20240726$EXP$FR-AFSSAPS-TS2024000772$FR-CHEPLA-2024009355$CHEPLAPHARM$$14$MON$$M$Y$11$KG$20240725$$MD$COUNTRY NOT SPECIFIED$FR
241394302$24139430$2$F$$20240725$20240726$20240731$EXP$$JP-JNJFOC-20240770483$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$PH$JP$JP
241394312$24139431$2$F$$20240828$20240726$20240903$30DAY$$FR-JNJFOC-20240760114$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$FR$FR
241394322$24139432$2$F$$20240730$20240726$20240806$PER$$US-JNJFOC-20240766451$JOHNSON AND JOHNSON$$$$$M$Y$82.7$KG$20240806$$MD$US$US
241394331$24139433$1$I$20050901$20240722$20240726$20240726$PER$$US-JNJFOC-20240761252$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20240726$$HP$US$US
241394341$24139434$1$I$$20240722$20240726$20240726$EXP$$CA-JNJFOC-20230956156$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240726$$HP$CA$CA
241394351$24139435$1$I$$20240725$20240726$20240726$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041897$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240726$$MD$IT$IT
241394361$24139436$1$I$$20240722$20240726$20240726$EXP$$US-ABBVIE-5850382$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241394371$24139437$1$I$$20240723$20240726$20240726$EXP$$CA-ORGANON-O2407CAN002164$ORGANON$$$$$F$Y$$$20240726$$HP$CA$CA
241394381$24139438$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000036689$ROCHE$$31$YR$A$F$Y$$$20240726$$HP$US$US
241394391$24139439$1$I$$20240722$20240726$20240726$EXP$$DE-ROCHE-10000033397$ROCHE$Jovanovski A, Mengert L, Lukacs M, Wagner J. Anti-Hu associated paraneoplastic upper and lower motor neuropathy triggered by atezolizumab. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2024; doi:10.1007/s10072-024-07666-7.$74$YR$E$F$Y$$$20240726$$HP$DE$DE
241394401$24139440$1$I$20240710$20240711$20240726$20240726$EXP$$US-GRANULES-US-2024GRASPO00284$GRANULES INDIA$$83$YR$E$F$Y$$$20240726$$CN$US$US
241394412$24139441$2$F$20240301$20240809$20240726$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115416$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$84.82$KG$20240814$$MD$US$US
241394421$24139442$1$I$20230101$20240717$20240726$20240726$EXP$$CA-APOTEX-2023AP017937$APOTEX$$$$E$M$Y$$$20240726$$PH$CA$CA
241394431$24139443$1$I$20240622$20240703$20240726$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003242$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240726$$CN$US$US
241394441$24139444$1$I$20240101$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024147861$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241394452$24139445$2$F$$20240829$20240726$20240905$EXP$$CA-ROCHE-10000031052$ROCHE$$65$YR$E$F$Y$34$KG$20240905$$HP$CA$CA
241394461$24139446$1$I$$20240626$20240726$20240726$PER$$JP-WT-2024-03748$Waylis$$49$YR$$M$Y$$$20240726$$PH$JP$JP
241394471$24139447$1$I$20240701$20240723$20240726$20240726$EXP$GB-MHRA-MED-202407231423568390-WLSMH$GB-BEH-2024176154$CSL BEHRING$$82$YR$E$F$Y$$$20240726$$HP$GB$GB
241394481$24139448$1$I$20240619$20240716$20240726$20240726$EXP$IT-MINISAL02-994214$IT-TEVA-VS-3222059$TEVA$$72$YR$$F$Y$$$20240726$$MD$IT$IT
241394491$24139449$1$I$20240401$20240717$20240726$20240726$EXP$$JP-ROCHE-3557809$ROCHE$$8$DEC$E$F$Y$$$20240726$$MD$JP$JP
241394501$24139450$1$I$$20240717$20240726$20240726$EXP$$TN-SPC-000461$SOLARIS PHARMA$Dridi B, Agrebi M, Sahnoun D, Ben Salem C. Metronidazole-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome With Parvovirus B19 Reactivation: A Pediatric Case. Cureus. 2024 Jun 11;16(6):e62125. doi: 10.7759/cureus.62125.$10$YR$C$F$Y$$$20240726$$HP$TN$TN
241394511$24139451$1$I$$20240715$20240726$20240726$EXP$$IR-SPC-000459$SOLARIS PHARMA$Ghazavi M, Allameh Z. Levofloxacin-Induced Oromandibular Dystonia in a 9-Year-Old Patient. Iran J Child Neurol. 2024 Summer;18(3):151-157. doi: 10.22037/ijcn.v18i3.18054.$9$YR$C$M$Y$$$20240726$$MD$IR$IR
241394522$24139452$2$F$$20240807$20240726$20240812$30DAY$$CH-JNJFOC-20240730964$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$PH$CH$CH
241394531$24139453$1$I$$20240719$20240726$20240726$EXP$$GB-AMAROX PHARMA-AMR2024GB02393$HETERO$$93$YR$$F$Y$$$20240726$$MD$GB$GB
241394542$24139454$2$F$20240101$20240729$20240726$20240809$EXP$$US-INSMED-2024-01060-USAA$INSMED$$$$$F$Y$$$20240809$$CN$US$US
241394551$24139455$1$I$$20240627$20240726$20240726$PER$$US-JNJFOC-20240700318$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240726$$CN$US$US
241394561$24139456$1$I$$20240718$20240726$20240726$EXP$$JP-AstraZeneca-2024A165359$ASTRAZENECA$$74$YR$$M$Y$$$20240726$$MD$JP$
241394571$24139457$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A166868$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241394581$24139458$1$I$$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003244$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241394611$24139461$1$I$$20240718$20240726$20240726$EXP$$DE-CTRS-202400145$ADDMEDICA$Pruessmann W, Kirfel J, Sailer VW, Rose C. Dermatomyositis-like skin eruptions under hydroxyurea therapy conceal TP53-mutated atypical keratinocytes: A histopathologic and molecular pathologic case series. J Cutan Pathol. 2024 Jul 15;:1-8. doi:10.1111/cup.14690$64$YR$A$M$Y$$$20240725$$MD$DE$
241394621$24139462$1$I$$20240725$20240726$20240726$PER$$US-HALEON-2189050$Haleon PLC$$82$YR$$$Y$$$20240726$$CN$US$US
241394632$24139463$2$F$20230113$20240730$20240726$20240812$EXP$$JP-UCBSA-2023005292$UCB$$51$YR$$F$Y$45$KG$20240812$$HP$JP$JP
241394641$24139464$1$I$$20240723$20240726$20240726$EXP$$NVSC2024ZA151583$NOVARTIS$$51$YR$$M$Y$$$20240726$$HP$ZA$ZA
241394651$24139465$1$I$$20240722$20240726$20240726$EXP$$GH-ROCHE-10000034545$ROCHE$$$$$$Y$$$20240726$$MD$GH$ZA
241394661$24139466$1$I$$20240715$20240726$20240726$EXP$$US-PBT-009544$PANACEA BIOTEC$Joly L, Virgilio R, Yother C. Posttransplant Lymphoproliferative Disorder in a Patient With Alpha-1 Antitrypsin Deficiency: A Case Report. Cureus. 2024 Jun 10;16(6):e62107. doi: 10.7759/cureus.62107.$13$YR$T$M$Y$$$20240726$$HP$US$US
241394671$24139467$1$I$20220101$20240715$20240726$20240726$EXP$$US-PBT-009549$PANACEA BIOTEC$Zieneldien T, Kim J, Greene J. Breakthrough Pneumocystis jirovecii Pneumonia in an Allogeneic Hematopoietic Stem Cell Transplant Recipient. Cureus. 2024 Jun 7;16(6):e61890. doi: 10.7759/cureus.61890.$50$YR$A$F$Y$$$20240726$$HP$US$US
241394681$24139468$1$I$$20240619$20240726$20240726$PER$$US-ROCHE-3485227$ROCHE$$42$YR$A$M$Y$$$20240726$$HP$US$US
241394692$24139469$2$F$20240721$20240726$20240726$20240730$PER$$US-AMGEN-USASP2024146419$AMGEN$$59$YR$A$F$Y$$$20240730$$CN$US$US
241394701$24139470$1$I$20231101$20231208$20240726$20240726$PER$$US-ENDO PHARMACEUTICALS INC-2023-006138$ENDO$$$$$$Y$$$20240726$$CN$US$US
241394711$24139471$1$I$$20231103$20240726$20240726$PER$$US-ENDO PHARMACEUTICALS INC-2023-005708$ENDO$$$$$$Y$$$20240726$$CN$US$US
241394721$24139472$1$I$19890101$20231205$20240726$20240726$PER$$US-ENDO PHARMACEUTICALS INC-2023-002853$ENDO$$$$$F$Y$$$20240726$$CN$US$US
241394731$24139473$1$I$$20231110$20240726$20240726$PER$$US-ENDO PHARMACEUTICALS INC-2023-005788$ENDO$$$$$$Y$$$20240726$$CN$US$US
241394741$24139474$1$I$$20240716$20240726$20240726$EXP$$US-GSK-US2024089551$GLAXOSMITHKLINE$$$$$M$Y$$$20240726$$CN$US$US
241394751$24139475$1$I$$20240716$20240726$20240726$EXP$$CA-APOTEX-2024AP008516$APOTEX$$$$$M$Y$$$20240726$$HP$CA$CA
241394761$24139476$1$I$$20240711$20240726$20240726$PER$$BR-TOLMAR, INC.-24BR050981$TOLMAR$$10$YR$$F$Y$$$20240726$$MD$BR$BR
241394771$24139477$1$I$20240101$20240710$20240726$20240726$PER$$BR-TOLMAR, INC.-24BR050991$TOLMAR$$$$$F$Y$$$20240726$$MD$BR$BR
241394782$24139478$2$F$20240708$20240730$20240726$20240822$PER$$BR-TOLMAR, INC.-24BR050956$TOLMAR$$$$$$Y$$$20240822$$PH$BR$BR
241394791$24139479$1$I$$20240709$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050499$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241394801$24139480$1$I$20240601$20240712$20240726$20240726$PER$$BR-TOLMAR, INC.-24BR050998$TOLMAR$$61$YR$$M$Y$$$20240726$$CN$BR$BR
241394811$24139481$1$I$20240401$20240709$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050513$TOLMAR$$63$YR$$M$Y$$$20240726$$CN$CA$CA
241394821$24139482$1$I$20240601$20240709$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050905$TOLMAR$$72$YR$$M$Y$$$20240726$$CN$CA$CA
241394831$24139483$1$I$$20240709$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050591$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241394841$24139484$1$I$$20240709$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050906$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241394851$24139485$1$I$$20240709$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050907$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241394861$24139486$1$I$$20240709$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050908$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241394871$24139487$1$I$20240401$20240709$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050911$TOLMAR$$69$YR$$M$Y$$$20240726$$CN$CA$CA
241394881$24139488$1$I$20240709$20240709$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050930$TOLMAR$$76$YR$$M$Y$$$20240726$$CN$CA$CA
241394891$24139489$1$I$20240709$20240709$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050931$TOLMAR$$64$YR$$M$Y$$$20240726$$CN$CA$CA
241394901$24139490$1$I$20240709$20240709$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050933$TOLMAR$$70$YR$$M$Y$$$20240726$$CN$CA$CA
241394911$24139491$1$I$$20240722$20240726$20240726$PER$$US-CHATTEMPRD-2024OHG025016$CHATTEM$$$$$F$Y$$$20240726$$CN$US$US
241394922$24139492$2$F$20240701$20240912$20240726$20240920$EXP$$CA-CELLTRION INC.-2024CA017878$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
241394931$24139493$1$I$$20240717$20240726$20240726$EXP$CA-DRL-USA-SPO/CAN/24/0010616$CA-RDY-SPO/CAN/24/0010616$DR REDDYS$$75$YR$E$F$Y$$$20240726$$MD$CA$CA
241394941$24139494$1$I$20240609$20240711$20240726$20240726$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00358$Unknown Manufacturer$$$$$$Y$$$20240726$$MD$CN$CN
241394952$24139495$2$F$20240101$20240913$20240726$20240921$EXP$$CA-CELLTRION INC.-2024CA009122$CELLTRION$$$$$$Y$$$20240921$$CN$CA$CA
241394962$24139496$2$F$20210601$20240830$20240726$20240904$EXP$$JP-009507513-2405JPN000726J$MERCK$$58$YR$$M$Y$52$KG$20240904$$MD$JP$JP
241394971$24139497$1$I$20230201$20240723$20240726$20240726$EXP$$JP-ORGANON-O2407JPN002181$ORGANON$Tanabe Y, Hirata R, Oogane S. Conservative treatment to support quality of life in patient with pathological mandibular fracture due to MRONJ-A case report-. The 78th Annual Meeting of the Japanese Stomatological Society. 2024;324$77$YR$$F$Y$$$20240726$$MD$JP$JP
241394991$24139499$1$I$$20240703$20240726$20240726$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003254$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241395001$24139500$1$I$$20240723$20240726$20240726$EXP$$EG-ABBVIE-5854078$ABBVIE$$75$YR$$M$Y$$$20240726$$CN$EG$EG
241395011$24139501$1$I$$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118080$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$PH$US$US
241395021$24139502$1$I$$20240722$20240726$20240726$EXP$$US-ABBVIE-5850517$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241395032$24139503$2$F$$20240715$20240726$20240726$EXP$$US-ROCHE-10000027801$ROCHE$$88$YR$E$F$Y$$$20240726$$CN$US$US
241395041$24139504$1$I$20240618$20240712$20240726$20240726$EXP$FR-AFSSAPS-NC2024000815$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-06749$HIKMA$$57$YR$$F$Y$$$20240726$$MD$FR$FR
241395051$24139505$1$I$20240624$20240717$20240726$20240726$EXP$$AU-GE HEALTHCARE-2024CSU007714$GE HEALTHCARE$$70$YR$$M$Y$$$20240726$$HP$AU$AU
241395062$24139506$2$F$20240715$20240828$20240726$20240905$EXP$$US-JNJFOC-20240768258$JOHNSON AND JOHNSON$$56$YR$A$F$Y$59.474$KG$20240905$$HP$US$US
241395071$24139507$1$I$$20240716$20240726$20240726$PER$$US-JNJFOC-20240769046$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$HP$US$US
241395081$24139508$1$I$20120101$20240724$20240726$20240726$PER$$US-JNJFOC-20240767014$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240726$$HP$US$US
241395091$24139509$1$I$$20240719$20240726$20240726$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003830$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241395101$24139510$1$I$$20240723$20240726$20240726$EXP$CA-LEO Pharma-372255$CA-LEO Pharma-372255$LEO PHARM$$42$YR$$F$Y$$$20240726$$HP$CA$CA
241395111$24139511$1$I$$20240718$20240726$20240726$EXP$$DE-CTRS-202400148$ADDMEDICA$Pruessmann W, Kirfel J, Sailer VW, Rose C. Dermatomyositis-like skin eruptions under hydroxyurea therapy conceal TP53-mutated atypical keratinocytes: A histopathologic and molecular pathologic case series. J Cutan Pathol. 2024 Jul 15;:1-8. doi:10.1111/cup.14690$85$YR$$F$Y$$$20240726$$MD$DE$
241395121$24139512$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153131$NOVARTIS$$$$$$Y$$$20240726$$MD$US$US
241395131$24139513$1$I$$20240719$20240726$20240726$PER$$US-ABBVIE-5851906$ABBVIE$$$$$$Y$$$20240726$$CN$US$US
241395141$24139514$1$I$20240704$20240717$20240726$20240726$EXP$$CN-SA-2024SA214386$SANOFI AVENTIS$$67$YR$E$M$Y$70$KG$20240726$$HP$CN$CN
241395151$24139515$1$I$20240621$20240722$20240726$20240726$PER$$US-HALEON-2188419$Haleon PLC$$72$YR$$F$Y$$$20240726$$CN$US$US
241395162$24139516$2$F$$20240808$20240726$20240812$PER$$US-HALEON-2189019$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
241395173$24139517$3$F$20240723$20240809$20240726$20240812$PER$$US-AMGEN-USASP2024147577$AMGEN$$72$YR$E$M$Y$$$20240812$$PH$US$US
241395182$24139518$2$F$20240101$20240827$20240726$20240830$PER$$US-AMGEN-USASP2024146347$AMGEN$$87$YR$E$M$Y$$$20240830$$CN$US$US
241395192$24139519$2$F$20240301$20240723$20240726$20240801$PER$$US-AMGEN-USASP2024146983$AMGEN$$56$YR$A$F$Y$$$20240801$$CN$US$US
241395201$24139520$1$I$20230901$20240725$20240726$20240726$EXP$GB-MHRA-MED-202407250858138140-DTCHN$GB-JNJFOC-20240767747$JOHNSON AND JOHNSON$$35$YR$A$M$Y$81$KG$20240726$$CN$GB$GB
241395221$24139522$1$I$$20240724$20240726$20240726$EXP$$GB-ABBVIE-5853975$ABBVIE$$$$A$M$Y$$$20240726$$HP$GB$GB
241395231$24139523$1$I$20240712$20240723$20240726$20240726$EXP$$AR-UCBSA-2024037607$UCB$$74$YR$$M$Y$$$20240726$$CN$AR$AR
241395243$24139524$3$F$20240713$20240812$20240726$20240821$30DAY$$US-AMGEN-USASP2024144235$AMGEN$$65$YR$E$F$Y$85.3$KG$20240821$$PH$US$US
241395251$24139525$1$I$20240623$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147125$AMGEN$$66$YR$E$F$Y$$$20240726$$CN$US$US
241395262$24139526$2$F$20240718$20240726$20240726$20240801$PER$$US-AMGEN-USASP2024144215$AMGEN$$64$YR$A$F$Y$73.8$KG$20240801$$PH$US$US
241395271$24139527$1$I$20240101$20240724$20240726$20240726$EXP$$CN-ABBVIE-5852041$ABBVIE$$11$YR$$M$Y$34$KG$20240726$$MD$CN$CN
241395281$24139528$1$I$20240624$20240719$20240726$20240726$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-06955$HIKMA$$60$YR$$F$Y$82$KG$20240726$$HP$EG$EG
241395292$24139529$2$F$$20240815$20240726$20240819$PER$$US-ALXN-202407USA001437US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241395301$24139530$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016682$ELI LILLY AND CO$$$$$$Y$$$20240726$$CN$US$US
241395311$24139531$1$I$20240629$20240716$20240726$20240726$EXP$$CO-VANTIVE-2024VAN018309$Vantive US Healthcare$$64$YR$$F$Y$$$20240726$$HP$CO$CO
241395321$24139532$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015977$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240726$$CN$US$US
241395333$24139533$3$F$20230420$20240913$20240726$20240923$EXP$$CA-CELLTRION INC.-2023CA005140$CELLTRION$$$$$$Y$$$20240923$$MD$CA$CA
241395341$24139534$1$I$20240706$20240720$20240726$20240726$EXP$$CO-VANTIVE-2024VAN018410$Vantive US Healthcare$$60$YR$$F$Y$68.7$KG$20240726$$HP$CO$CO
241395351$24139535$1$I$$20240716$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407011147$ELI LILLY AND CO$$56$YR$A$$Y$$$20240726$$CN$US$US
241395361$24139536$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015788$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240726$$HP$US$US
241395371$24139537$1$I$$20240718$20240726$20240726$EXP$$DE-CTRS-202400149$ADDMEDICA$Pruessmann W, Kirfel J, Sailer VW, Rose C. Dermatomyositis-like skin eruptions under hydroxyurea therapy conceal TP53-mutated atypical keratinocytes: A histopathologic and molecular pathologic case series. J Cutan Pathol. 2024 Jul 15;:1-8. doi:10.1111/cup.14690$73$YR$$M$Y$$$20240726$$MD$DE$
241395381$24139538$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016046$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240726$$CN$US$US
241395391$24139539$1$I$20240723$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015448$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240726$$CN$US$US
241395411$24139541$1$I$$20240718$20240726$20240726$EXP$NL-LRB-00990058$NL-TEVA-VS-3223578$TEVA$$44$YR$$F$Y$114$KG$20240726$$CN$NL$NL
241395421$24139542$1$I$20240710$20240717$20240726$20240726$EXP$GB-MHRA-MED-202407172024309530-SVLGH$GB-TEVA-VS-3222193$TEVA$$33$YR$$F$Y$86$KG$20240726$$CN$GB$GB
241395431$24139543$1$I$$20240719$20240726$20240726$PER$$US-ABBVIE-5850419$ABBVIE$$$$$$Y$$$20240726$$MD$US$US
241395441$24139544$1$I$20240601$20240718$20240726$20240726$EXP$$GB-TEVA-VS-3222846$TEVA$$29$YR$$M$Y$114$KG$20240726$$MD$GB$GB
241395451$24139545$1$I$20240623$20240722$20240726$20240726$EXP$GB-MHRA-MED-202407171523034070-PJNQD$GB-ABBVIE-5848848$ABBVIE$$65$YR$$M$Y$$$20240726$$PH$GB$GB
241395462$24139546$2$F$$20240725$20240726$20240730$PER$$US-ROCHE-10000035145$ROCHE$$$$$$Y$$$20240730$$CN$US$US
241395471$24139547$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024146669$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241395481$24139548$1$I$20240516$20240724$20240726$20240726$EXP$FR-AFSSAPS-TS2024000779$FR-ROCHE-10000036336$ROCHE$$54$YR$A$M$Y$$$20240726$$MD$FR$FR
241395491$24139549$1$I$$20240722$20240726$20240726$EXP$$CA-JNJFOC-20240765479$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240726$$HP$CA$CA
241395501$24139550$1$I$$20240719$20240726$20240726$EXP$$US-BEH-2024175862$CSL BEHRING$$22$YR$A$F$Y$54.422$KG$20240726$$HP$US$US
241395511$24139551$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000037203$ROCHE$$$$$F$Y$$$20240726$$CN$US$US
241395521$24139552$1$I$20240717$20240717$20240726$20240726$EXP$$US-JNJFOC-20240747739$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240726$$HP$US$US
241395531$24139553$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000036434$ROCHE$$$$$$Y$$$20240726$$MD$US$US
241395541$24139554$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000036721$ROCHE$$49$YR$A$F$Y$$$20240726$$CN$US$US
241395551$24139555$1$I$$20240723$20240726$20240726$PER$$US-ROCHE-10000036188$ROCHE$$$$$$Y$$$20240726$$CN$US$US
241395561$24139556$1$I$$20240717$20240726$20240726$EXP$$CA-APOTEX-2024AP008546$APOTEX$$$$$F$Y$$$20240726$$CN$CA$CA
241395571$24139557$1$I$$20240722$20240726$20240726$EXP$$US-ABBVIE-5852688$ABBVIE$$$$$F$Y$$$20240726$$HP$US$US
241395581$24139558$1$I$20240601$20240716$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024089419$VIIV$$32$YR$$M$Y$$$20240726$$HP$US$US
241395591$24139559$1$I$$20240722$20240726$20240726$EXP$$US-GSK-US2024AMR092123$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241395601$24139560$1$I$20240701$20240724$20240726$20240726$PER$$US-ROCHE-10000035914$ROCHE$$$$A$M$Y$$$20240726$$MD$US$US
241395612$24139561$2$F$20230914$20240815$20240726$20240822$EXP$$CA-GSK-CA2023127416$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$CA$CA
241395621$24139562$1$I$$20240514$20240726$20240726$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06875$HIKMA$Kuczmarski TM, Lynch RC.. Kuczmarski TM, Lynch RC. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma.. British journal of haematology. 2024;02:1-9$58$YR$$M$Y$$$20240726$$MD$US$US
241395631$24139563$1$I$$20240718$20240726$20240726$EXP$$JP-AMGEN-JPNSP2024147456$AMGEN$$$$$$Y$$$20240726$$PH$JP$JP
241395641$24139564$1$I$20240701$20240716$20240726$20240726$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011171$JAZZ$$67$YR$$M$Y$$$20240726$$CN$US$US
241395664$24139566$4$F$$20240911$20240726$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118709$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240923$$CN$US$US
241395671$24139567$1$I$20240603$20240718$20240726$20240726$EXP$$CN-009507513-2407CHN012564$MERCK$$82$YR$$M$Y$60$KG$20240726$$HP$CN$CN
241395681$24139568$1$I$$20240717$20240726$20240726$PER$$US-ROCHE-10000031691$ROCHE$$$$$$Y$$$20240726$$CN$US$US
241395694$24139569$4$F$$20240829$20240726$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003155$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
241395702$24139570$2$F$20240713$20240805$20240726$20240809$PER$$US-AMGEN-USASP2024145719$AMGEN$$78$YR$E$M$Y$88.9$KG$20240809$$PH$US$US
241395712$24139571$2$F$$20240905$20240726$20240906$PER$$US-ROCHE-10000033955$ROCHE$$40$YR$A$M$Y$$$20240906$$CN$US$US
241395731$24139573$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000036398$ROCHE$$35$YR$A$F$Y$$$20240726$$HP$US$US
241395741$24139574$1$I$20060413$20240717$20240726$20240726$EXP$$AU-ROCHE-10000030301$ROCHE$$68$YR$E$F$Y$$$20240726$$MD$AU$AU
241395751$24139575$1$I$20211201$20240718$20240726$20240726$EXP$$NVSC2024TH148266$NOVARTIS$$41$YR$$F$Y$$$20240726$$MD$TH$TH
241395761$24139576$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117661$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240726$$CN$US$US
241395771$24139577$1$I$20240626$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118258$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240726$$HP$US$US
241395781$24139578$1$I$$20240717$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114288$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$41.28$KG$20240726$$HP$US$US
241395795$24139579$5$F$20240601$20240911$20240726$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-036465$AUROBINDO$$24$YR$$M$Y$66.6$KG$20240920$$CN$GB$GB
241395801$24139580$1$I$20240601$20240716$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036187$AUROBINDO$$54$YR$$M$Y$72$KG$20240726$$MD$FR$FR
241395811$24139581$1$I$$20240724$20240726$20240726$PER$$NVSC2024US152962$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
241395833$24139583$3$F$$20240806$20240726$20240813$EXP$$US-ROCHE-3552739$ROCHE$$81$YR$E$F$Y$$$20240813$$CN$US$US
241395844$24139584$4$F$20240723$20240902$20240726$20240912$30DAY$$US-JNJFOC-20240762478$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240913$$HP$US$US
241395851$24139585$1$I$$20240724$20240726$20240726$EXP$$US-ABBVIE-5854050$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241395861$24139586$1$I$$20240722$20240726$20240726$EXP$$US-JNJFOC-20240762490$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240726$$CN$US$US
241395871$24139587$1$I$20240707$20240719$20240726$20240726$EXP$$PK-ROCHE-10000033932$ROCHE$$78$YR$E$M$Y$$$20240726$$CN$PK$PK
241395882$24139588$2$F$$20240723$20240726$20240727$EXP$$AU-ABBVIE-5853277$ABBVIE$$$$$M$Y$$$20240727$$HP$AU$AU
241395892$24139589$2$F$$20240920$20240726$20240930$EXP$$CA-CELLTRION INC.-2024CA017879$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
241395903$24139590$3$F$20240101$20240828$20240726$20240831$EXP$$US-ABBVIE-5851728$ABBVIE$$$$$M$Y$77.11$KG$20240831$$CN$US$US
241395921$24139592$1$I$$20240717$20240726$20240726$EXP$$GB-AUROBINDO-AUR-APL-2024-035755$AUROBINDO$$60$YR$$F$Y$$$20240726$$PH$GB$GB
241395932$24139593$2$F$20220519$20240724$20240726$20240801$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-06914$HIKMA$$$$$$Y$$$20240801$$MD$GB$GB
241395941$24139594$1$I$$20240719$20240726$20240726$PER$$US-ROCHE-10000032859$ROCHE$$28$YR$A$M$Y$$$20240726$$CN$US$US
241395953$24139595$3$F$$20240726$20240726$20240807$PER$$US-ROCHE-10000029896$ROCHE$$$$A$F$Y$$$20240807$$CN$US$US
241395961$24139596$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118299$BRISTOL MYERS SQUIBB$$68$YR$E$$Y$80.74$KG$20240726$$HP$US$US
241395972$24139597$2$F$20240501$20240731$20240726$20240805$PER$$US-AMGEN-USASP2024144991$AMGEN$$45$YR$A$F$Y$57.61$KG$20240805$$HP$US$US
241395982$24139598$2$F$20240701$20240806$20240726$20240814$PER$$US-AMGEN-USASP2024144987$AMGEN$$70$YR$E$F$Y$75.5$KG$20240814$$PH$US$US
241395991$24139599$1$I$20211001$20240719$20240726$20240726$EXP$$AT-AMGEN-AUTNI2024144616$AMGEN$$26$YR$A$M$Y$$$20240726$$MD$AT$AT
241396011$24139601$1$I$20240606$20240719$20240726$20240726$PER$$US-ROCHE-3579640$ROCHE$$52$YR$A$F$Y$$$20240726$$CN$US$US
241396021$24139602$1$I$$20240722$20240726$20240726$EXP$$CN-ROCHE-10000031992$ROCHE$$41$YR$A$M$Y$$$20240726$$MD$CN$CN
241396031$24139603$1$I$20240101$20240722$20240726$20240726$EXP$$US-ABBVIE-5851267$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241396041$24139604$1$I$$20240716$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407011581$ELI LILLY AND CO$$34$YR$A$$Y$$$20240726$$CN$US$US
241396051$24139605$1$I$20240722$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016149$ELI LILLY AND CO$$$$$M$Y$$$20240726$$CN$US$US
241396061$24139606$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016304$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240726$$CN$US$US
241396071$24139607$1$I$$20240715$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407009642$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240726$$CN$US$US
241396081$24139608$1$I$20240721$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015108$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240726$$CN$US$US
241396093$24139609$3$F$20230801$20240913$20240726$20240925$EXP$$CA-JNJFOC-20230829283$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240925$$HP$CA$CA
241396102$24139610$2$F$$20240725$20240726$20240726$PER$$US-ROCHE-10000008681$ROCHE$$56$YR$A$F$Y$$$20240726$$CN$US$US
241396111$24139611$1$I$$20240723$20240726$20240726$PER$$US-ROCHE-10000035860$ROCHE$$76$YR$E$F$Y$$$20240726$$CN$US$US
241396121$24139612$1$I$$20240723$20240726$20240726$PER$$US-ROCHE-10000005235$ROCHE$$19$YR$A$F$Y$$$20240726$$CN$US$US
241396131$24139613$1$I$$20240717$20240726$20240726$EXP$$CR-JNJFOC-20240749839$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$MD$CR$CR
241396141$24139614$1$I$$20240717$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US068215$SANDOZ$$$$$$Y$$$20240726$$MD$US$US
241396153$24139615$3$F$$20240819$20240726$20240821$EXP$$AU-SANDOZ INC.-SDZ2024AU068136$SANDOZ$$$$$F$Y$$$20240821$$MD$AU$AU
241396161$24139616$1$I$20240720$20240722$20240726$20240726$PER$$US-CHATTEMPRD-2024OHG024980$CHATTEM$$$$$F$Y$$$20240726$$CN$US$US
241396171$24139617$1$I$20240720$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147045$AMGEN$$81$YR$E$F$Y$$$20240726$$CN$US$US
241396181$24139618$1$I$20240501$20240724$20240726$20240726$EXP$$JP-TAKEDA-2024TJP011192$TAKEDA$$3$DEC$$M$Y$$$20240726$$MD$JP$JP
241396191$24139619$1$I$$20240713$20240726$20240726$EXP$$IN-ROCHE-10000026467$ROCHE$$3$YR$C$M$Y$$$20240726$$CN$IN$IN
241396201$24139620$1$I$$20240725$20240726$20240726$PER$$US-ROCHE-10000036831$ROCHE$$15$YR$T$F$Y$$$20240726$$HP$US$US
241396216$24139621$6$F$20240715$20240910$20240726$20240918$EXP$$CA-CELLTRION INC.-2024CA017914$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
241396221$24139622$1$I$$20240725$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068219$SANDOZ$$57$YR$$F$Y$$$20240726$$MD$CA$CA
241396233$24139623$3$F$20240723$20240920$20240726$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US068318$SANDOZ$$60$YR$$F$Y$$$20240924$$HP$US$US
241396241$24139624$1$I$20240707$20240718$20240726$20240726$EXP$$GB-AUROBINDO-AUR-APL-2024-035938$AUROBINDO$$61$YR$$M$Y$85$KG$20240726$$CN$GB$GB
241396251$24139625$1$I$$20240722$20240726$20240726$PER$$US-JNJFOC-20240760347$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$HP$US$US
241396273$24139627$3$F$20240703$20240805$20240726$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010387$JAZZ$$49$YR$$F$Y$$$20240807$$HP$US$US
241396282$24139628$2$F$$20240717$20240726$20240731$EXP$$CA-HALEON-2188692$Haleon PLC$$56$YR$$F$Y$$$20240731$$HP$CA$CA
241396291$24139629$1$I$20240624$20240722$20240726$20240726$EXP$$CN-ROCHE-10000033036$ROCHE$$62$YR$A$F$Y$64$KG$20240726$$HP$CN$CN
241396301$24139630$1$I$$20240715$20240726$20240726$EXP$$HR-ROCHE-3567609$ROCHE$Koledic M, Kanizaj T, Pazur M, Antolic M and Smoljanovic I. Kronicna Mijeloicna Leukemija Nakon Transplantacije Jetre. Lijecnicki Vjesnik 2024;143 (SUP 3):24-.$45$YR$A$F$Y$$$20240726$$MD$HR$HR
241396311$24139631$1$I$$20240722$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US067846$SANDOZ$$$$$F$Y$$$20240726$$CN$US$US
241396321$24139632$1$I$$20240723$20240726$20240726$EXP$GB-MHRA-30767071$GB-ORGANON-O2407GBR002214$ORGANON$$$$$$Y$$$20240726$$CN$GB$GB
241396331$24139633$1$I$$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118373$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240726$$CN$US$US
241396342$24139634$2$F$20240722$20240729$20240726$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118413$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240731$$PH$US$US
241396351$24139635$1$I$$20240514$20240726$20240726$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06876$HIKMA$Kuczmarski TM, Lynch RC.. Kuczmarski TM, Lynch RC. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma. British journal of haematology. 2024;02:1-9$49$YR$$F$Y$$$20240726$$MD$US$US
241396361$24139636$1$I$$20240718$20240726$20240726$EXP$$PL-AUROBINDO-AUR-APL-2024-036595$AUROBINDO$$33$YR$$M$Y$100$KG$20240726$$MD$PL$PL
241396371$24139637$1$I$$20240716$20240726$20240726$EXP$$CA-APOTEX-2024AP008487$APOTEX$$52$YR$$M$Y$$$20240726$$HP$CA$CA
241396384$24139638$4$F$20240601$20240904$20240726$20240910$EXP$$JP-AMGEN-JPNSP2024123009$AMGEN$$60$YR$A$M$Y$$$20240909$$PH$JP$JP
241396401$24139640$1$I$20240514$20240723$20240726$20240726$EXP$FR-AFSSAPS-LY2024001076$FR-SANDOZ INC.-SDZ2024FR067547$SANDOZ$$51$YR$$F$Y$68$KG$20240726$$PH$FR$FR
241396411$24139641$1$I$20240722$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146870$AMGEN$$77$YR$E$M$Y$$$20240726$$CN$US$US
241396422$24139642$2$F$20240606$20240808$20240726$20240810$PER$$US-AMGEN-USASP2024146801$AMGEN$$68$YR$E$F$Y$$$20240810$$CN$US$US
241396431$24139643$1$I$$20240709$20240726$20240726$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000607$DECIPHERA PHARMACEUTICALS$$63$YR$A$M$Y$$$20240726$$CN$US$US
241396441$24139644$1$I$$20240718$20240726$20240726$EXP$$JP-ROCHE-10000014670$ROCHE$$9$DEC$E$F$Y$$$20240726$$MD$JP$JP
241396451$24139645$1$I$$20240725$20240726$20240726$30DAY$$US-SANDOZ INC.-SDZ2024US068333$SANDOZ$$$$$F$Y$$$20240726$$HP$US$US
241396461$24139646$1$I$$20240718$20240726$20240726$EXP$$US-GSK-US2024090717$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241396471$24139647$1$I$$20240722$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US067557$SANDOZ$Fitzsimons J, Phelan K, Dhanarajan A. Hearing Loss in a Patient withWaldenstromMacroglobulinemiaReceiving Bortezomib. Case repots in oncology. 2024;17:653-657$67$YR$$M$Y$$$20240726$$MD$US$US
241396481$24139648$1$I$20240202$20240723$20240726$20240726$EXP$$KR-UNITED THERAPEUTICS-UNT-2024-022612$UNITED THERAPEUTICS$$35$YR$$F$Y$47$KG$20240726$$$KR$KR
241396491$24139649$1$I$$20240717$20240726$20240726$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109855$ZYDUS PHARM$$$$$$Y$$$20240726$$MD$US$US
241396501$24139650$1$I$20170601$20240716$20240726$20240726$EXP$$DE-SANDOZ INC.-PHHY2018DE028326$SANDOZ$$17$YR$$F$Y$68$KG$20240726$$MD$DE$DE
241396511$24139651$1$I$20240529$20240715$20240726$20240726$EXP$FR-AFSSAPS-LY2024001070$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110047$ZYDUS PHARM$$$$$$Y$$$20240726$$HP$FR$FR
241396521$24139652$1$I$20240418$20240715$20240726$20240726$EXP$FR-AFSSAPS-MP2024001149$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110044$ZYDUS PHARM$$$$$$Y$$$20240726$$MD$FR$FR
241396532$24139653$2$F$20240531$20240805$20240726$20240814$EXP$FR-AFSSAPS-RN2024000740$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109841$ZYDUS PHARM$$$$$$Y$$$20240814$$PH$FR$FR
241396541$24139654$1$I$$20240719$20240726$20240726$EXP$$GB-EMD Serono-2024039586$EMD SERONO INC$$79$YR$E$F$Y$$$20240726$$HP$GB$GB
241396551$24139655$1$I$20230407$20240715$20240726$20240726$EXP$FR-AFSSAPS-TO2024001283$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109994$ZYDUS PHARM$$$$$$Y$$$20240726$$PH$FR$FR
241396561$24139656$1$I$20240715$20240724$20240726$20240726$EXP$$BR-ROCHE-10000031522$ROCHE$$61$YR$A$M$Y$80.85$KG$20240726$$MD$BR$BR
241396571$24139657$1$I$20240430$20240715$20240726$20240726$EXP$FR-AFSSAPS-TO2024001230$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109850$ZYDUS PHARM$$$$$$Y$$$20240726$$PH$FR$FR
241396582$24139658$2$F$20240701$20240813$20240726$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116261$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$98$KG$20240820$$PH$US$US
241396591$24139659$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118672$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240726$$$US$US
241396601$24139660$1$I$$20240724$20240726$20240726$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-118552$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240726$$PH$FR$FR
241396611$24139661$1$I$$20240723$20240726$20240726$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-118245$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240726$$MD$PT$PT
241396621$24139662$1$I$20240629$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118420$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240726$$CN$US$US
241396642$24139664$2$F$20240101$20240809$20240726$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-022457$UNITED THERAPEUTICS$$$$$F$Y$91.156$KG$20240817$$$US$US
241396651$24139665$1$I$$20240723$20240726$20240726$PER$$US-AstraZeneca-2024A168890$ASTRAZENECA$$$$$F$Y$$$20240726$$MD$US$
241396662$24139666$2$F$20230627$20240724$20240726$20240801$EXP$$US-ROCHE-10000035604$ROCHE$$35$YR$A$F$Y$$$20240801$$CN$US$US
241396671$24139667$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016226$ELI LILLY AND CO$$$$$M$Y$$$20240726$$CN$US$US
241396681$24139668$1$I$$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407013470$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240726$$CN$US$US
241396691$24139669$1$I$$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407014067$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240726$$CN$US$US
241396701$24139670$1$I$$20240716$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407011468$ELI LILLY AND CO$$58$YR$A$$Y$$$20240726$$LW$US$US
241396711$24139671$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015253$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240726$$CN$US$US
241396721$24139672$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015874$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240726$$CN$US$US
241396732$24139673$2$F$$20240816$20240726$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202407013550$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240821$$CN$US$US
241396741$24139674$1$I$20240716$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016669$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240726$$CN$US$US
241396751$24139675$1$I$$20240724$20240726$20240726$EXP$$CA-HALEON-2188694$Haleon PLC$$72$YR$$M$Y$$$20240726$$HP$CA$CA
241396761$24139676$1$I$$20240724$20240726$20240726$EXP$$CN-TAKEDA-2024TUS075024$TAKEDA$$$$$M$Y$$$20240726$$CN$CN$CN
241396772$24139677$2$F$20240601$20240815$20240726$20240819$PER$$US-ALXN-202407USA001402US$ALEXION PHARMACEUTICALS$$69$YR$$M$Y$$$20240819$$CN$US$US
241396781$24139678$1$I$$20240718$20240726$20240726$EXP$GB-MHRA-MED-202407180945033220-DTZNS$GB-AMAROX PHARMA-AMR2024GB02368$HETERO$$$$$$Y$$$20240726$$CN$GB$GB
241396792$24139679$2$F$20240701$20240809$20240726$20240814$EXP$$JP-TAKEDA-2024TJP011232$TAKEDA$$$$A$M$Y$$$20240814$$MD$JP$JP
241396801$24139680$1$I$20240722$20240724$20240726$20240726$EXP$$CN-BEIGENE-BGN-2024-011537$BEIGENE$$$$$$Y$$$20240726$$MD$CN$CN
241396812$24139681$2$F$20220801$20240808$20240726$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-035685$AUROBINDO$Krause PJ, Rogers R, Shah MK, Kang H, Parsonnet J, Kodama R, et al. Tafenoquine for Relapsing Babesiosis: A Case Series. Clinical infectious diseases. 2024;79:130-137$70$YR$$F$Y$$$20240820$$MD$US$US
241396821$24139682$1$I$$20240723$20240726$20240726$EXP$$US-JNJFOC-20240762178$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240726$$HP$US$US
241396831$24139683$1$I$$20240723$20240726$20240726$PER$$US-JNJFOC-20240761459$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$HP$US$US
241396841$24139684$1$I$$20240715$20240726$20240726$EXP$$JP-PBT-009553$PANACEA BIOTEC$Kawaguchi T, Matsuda M, Umekita K, Miyazaki T. Treatment with low-dose nintedanib and tacrolimus in patients with progressive fibrosing interstitial lung diseases with anti-ARS antibody-positive dermatomyositis. Respirol Case Rep. 2024 Jul 9;12(7):e01428. doi: 10.1002/rcr2.1428.$$$E$F$Y$$$20240726$$HP$JP$JP
241396851$24139685$1$I$$20240715$20240726$20240726$EXP$$JP-PBT-009547$PANACEA BIOTEC$Kawaguchi T, Matsuda M, Umekita K, Miyazaki T. Treatment with low-dose nintedanib and tacrolimus in patients with progressive fibrosing interstitial lung diseases with anti-ARS antibody-positive dermatomyositis. Respirol Case Rep. 2024 Jul 9;12(7):e01428. doi: 10.1002/rcr2.1428.$$$$F$Y$$$20240726$$HP$JP$JP
241396872$24139687$2$F$20240101$20240731$20240726$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-019568$UNITED THERAPEUTICS$$$$$F$Y$65.079$KG$20240809$$$US$US
241396883$24139688$3$F$20240719$20240812$20240726$20240820$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022496$UNITED THERAPEUTICS$$59$YR$$F$Y$71.655$KG$20240820$$$US$US
241396891$24139689$1$I$$20240718$20240726$20240726$EXP$$US-GSK-US2024090636$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$MD$US$US
241396901$24139690$1$I$$20240724$20240726$20240726$EXP$$CO-GILEAD-2024-0681801$GILEAD$$30$YR$A$F$Y$$$20240726$$HP$CO$CO
241396911$24139691$1$I$$20240718$20240726$20240726$EXP$GB-MHRA-MED-202407180940550910-ZYRGB$GB-AMAROX PHARMA-AMR2024GB02370$HETERO$$28$YR$$M$Y$$$20240726$$CN$GB$GB
241396921$24139692$1$I$20240129$20240724$20240726$20240726$EXP$$ZA-SANDOZ INC.-SDZ2024ZA001123$SANDOZ$$56$YR$$F$Y$$$20240726$$CN$ZA$ZA
241396941$24139694$1$I$$20230103$20240726$20240726$EXP$$CA-CELLTRION INC.-2022CA022610$CELLTRION$$$$$$Y$$$20240726$$MD$CA$CA
241396951$24139695$1$I$20240712$20240716$20240726$20240726$EXP$$US-Accord-436913$ACCORD$$24$YR$$F$Y$$$20240726$$HP$US$US
241396961$24139696$1$I$20210401$20240715$20240726$20240726$EXP$$CZ-Accord-437029$ACCORD$Vostry M, Stiburkova B, Mann H, Balajkova V, Ciferska H, Soukupova Maaloufova J, et al. VEXAS syndrome - a diagnosis at the interface of rheumatology and haematology. TRANSFUZE A HEMATOLOGIE DNES. 2024;30(2):83-90.$76$YR$E$M$Y$$$20240726$$HP$CZ$CZ
241396971$24139697$1$I$$20240717$20240726$20240726$EXP$CA-MHPD-001083160$CA-Accord-437003$ACCORD$$82$YR$E$M$Y$170$KG$20240726$$MD$CA$CA
241396981$24139698$1$I$$20240618$20240726$20240726$EXP$$IN-SA-2024SA184211$SANOFI AVENTIS$$$$$$Y$$$20240726$$CN$IN$IN
241396991$24139699$1$I$$20240723$20240726$20240726$EXP$$US-TAKEDA-2024TUS069236$TAKEDA$$$$$M$Y$$$20240726$$HP$US$US
241397001$24139700$1$I$$20240722$20240726$20240726$EXP$$US-TAKEDA-2024TUS073967$TAKEDA$$$$$F$Y$$$20240726$$MD$US$US
241397011$24139701$1$I$20240707$20240719$20240726$20240726$EXP$SE-SEMPA-2024-005516$SE-STRIDES ARCOLAB LIMITED-2024SP008999$STRIDES$$44$YR$$M$Y$$$20240726$$MD$SE$SE
241397021$24139702$1$I$20240323$20240722$20240726$20240726$EXP$FR-AFSSAPS-TO2024001222$FR-HALEON-2188405$Haleon PLC$$52$YR$$M$Y$84$KG$20240726$$PH$FR$FR
241397031$24139703$1$I$20240715$20240718$20240726$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022323$UNITED THERAPEUTICS$$61$YR$$F$Y$63.946$KG$20240726$$$US$US
241397041$24139704$1$I$$20240725$20240726$20240726$EXP$$GB-SANDOZ INC.-SDZ2024GB068259$SANDOZ$$72$YR$$F$Y$96$KG$20240726$$HP$GB$GB
241397051$24139705$1$I$$20240715$20240726$20240726$EXP$$US-ROCHE-10000027561$ROCHE$$$$E$F$Y$$$20240726$$CN$US$US
241397062$24139706$2$F$20240708$20240716$20240726$20240726$PER$$US-ROCHE-10000028521$ROCHE$$30$YR$A$M$Y$58.5$KG$20240726$$PH$US$US
241397071$24139707$1$I$$20240716$20240726$20240726$EXP$$NL-AUROBINDO-AUR-APL-2024-036152$AUROBINDO$$57$YR$$M$Y$80$KG$20240726$$MD$NL$NL
241397083$24139708$3$F$$20240815$20240726$20240819$PER$$US-ALXN-202407USA001428US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
241397091$24139709$1$I$$20240722$20240726$20240726$EXP$$GB-AMGEN-GBRSP2024145247$AMGEN$$$$$M$Y$64$KG$20240726$$CN$GB$GB
241397101$24139710$1$I$$20240326$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003729$STRIDES$Pennington KM, Katta R, Weathered C, Pienaar E, Escalante P.. Characteristics and outcomes of anti-mycobacterial therapy compared to no anti-mycobacterial therapy for NTM pulmonary disease.. Respir-Med. 2022;197:1-4$69$YR$$F$Y$$$20240726$$HP$US$US
241397111$24139711$1$I$20240506$20240723$20240726$20240726$EXP$$ES-SANDOZ INC.-SDZ2024ES067454$SANDOZ$$67$YR$$F$Y$69.1$KG$20240726$$MD$ES$ES
241397121$24139712$1$I$20240201$20240719$20240726$20240726$EXP$GB-MHRA-MED-202407181443113020-RYQDH$GB-TEVA-VS-3223645$TEVA$$70$YR$$M$Y$89$KG$20240726$$CN$GB$GB
241397131$24139713$1$I$20240719$20240719$20240726$20240726$EXP$$US-SA-2024SA216350$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240726$$MD$US$US
241397141$24139714$1$I$$20240724$20240726$20240726$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-118351$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$PH$DE$DE
241397151$24139715$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118228$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240726$$MD$US$US
241397162$24139716$2$F$20240101$20240801$20240726$20240810$EXP$$US-SA-2024SA187696$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240810$$MD$US$US
241397171$24139717$1$I$20240712$20240724$20240726$20240726$EXP$FR-AFSSAPS-MP2024001193$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-118409$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240726$$PH$FR$FR
241397181$24139718$1$I$20240601$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118468$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240726$$HP$US$US
241397191$24139719$1$I$$20240717$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114185$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240726$$HP$US$US
241397201$24139720$1$I$$20240716$20240726$20240726$EXP$$CA-APOTEX-2024AP008475$APOTEX$$42$YR$$M$Y$95$KG$20240726$$HP$CA$CA
241397211$24139721$1$I$$20240724$20240726$20240726$PER$$NVSC2024US153325$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241397221$24139722$1$I$20231010$20240723$20240726$20240726$EXP$$AU-TAKEDA-2023TUS098067$TAKEDA$$37$YR$$F$Y$$$20240726$$HP$AU$AU
241397231$24139723$1$I$$20240712$20240726$20240726$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06727$HIKMA$Kraus MJ, Nguyen J.. Kraus MJ, Nguyen J. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report. Case Rep Neurol. 2024;16(1):142-7$38$YR$$F$Y$63.5$KG$20240726$$MD$US$US
241397242$24139724$2$F$20240719$20240723$20240726$20240731$PER$$US-AMGEN-USASP2024146804$AMGEN$$73$YR$E$F$Y$$$20240731$$HP$US$US
241397251$24139725$1$I$20240721$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024145726$AMGEN$$63$YR$A$F$Y$$$20240726$$CN$US$US
241397261$24139726$1$I$$20240723$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US067766$SANDOZ$$$$$M$Y$$$20240726$$CN$US$US
241397271$24139727$1$I$$20240717$20240726$20240726$EXP$$IT-AUROBINDO-AUR-APL-2024-036231$AUROBINDO$$31$YR$$M$Y$$$20240726$$CN$IT$IT
241397281$24139728$1$I$20240301$20240719$20240726$20240726$EXP$$US-SA-2024SA217909$SANOFI AVENTIS$$61$YR$A$M$Y$95.2$KG$20240726$$MD$US$US
241397291$24139729$1$I$$20240514$20240726$20240726$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06877$HIKMA$Kuczmarski TM, Lynch RC.. Kuczmarski TM, Lynch RC. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma.. British journal of haematology.. 2024;02:1-9$24$YR$$M$Y$$$20240726$$MD$US$US
241397301$24139730$1$I$20100401$20240719$20240726$20240726$PER$$PR-BIOGEN-2024BI01274603$BIOGEN$$57$YR$$F$Y$87.622$KG$20240726$$CN$PR$PR
241397311$24139731$1$I$$20240719$20240726$20240726$PER$$US-BIOGEN-2024BI01274155$BIOGEN$$$$$F$Y$$$20240726$$CN$US$US
241397321$24139732$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024145848$AMGEN$$81$YR$E$$Y$$$20240726$$PH$US$US
241397331$24139733$1$I$$20240719$20240726$20240726$EXP$$US-SA-2024SA144653$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240726$$MD$US$US
241397343$24139734$3$F$20240701$20240725$20240726$20240731$PER$$US-AMGEN-USASP2024148082$AMGEN$$36$YR$A$M$Y$$$20240730$$HP$US$US
241397351$24139735$1$I$20231204$20231204$20240726$20240726$PER$$US-IGSA-BIG0026770$GRIFOLS$$$$$M$Y$$$20240726$$HP$US$US
241397361$24139736$1$I$20240101$20240722$20240726$20240726$PER$$US-UNITED THERAPEUTICS-UNT-2024-022138$UNITED THERAPEUTICS$$$$$M$Y$109.3$KG$20240726$$$US$US
241397371$24139737$1$I$$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407014295$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240726$$CN$US$US
241397381$24139738$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016137$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240726$$MD$US$US
241397391$24139739$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015714$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$US$US
241397401$24139740$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015144$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240726$$CN$US$US
241397411$24139741$1$I$20220630$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016056$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240726$$HP$US$US
241397421$24139742$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015302$ELI LILLY AND CO$$31$YR$A$M$Y$$$20240726$$CN$US$US
241397432$24139743$2$F$$20240829$20240726$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202407015296$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240903$$CN$US$US
241397441$24139744$1$I$20240605$20240718$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036540$AUROBINDO$$75$YR$$M$Y$$$20240726$$PH$FR$FR
241397452$24139745$2$F$20240630$20240726$20240726$20240805$EXP$$HU-EMD Serono-2024040050$EMD SERONO INC$$31$YR$A$M$Y$$$20240805$$MD$HU$HU
241397462$24139746$2$F$$20240904$20240726$20240912$EXP$$TH-ROCHE-10000033280$ROCHE$$75$YR$E$M$Y$$$20240912$$CN$TH$TH
241397471$24139747$1$I$20221102$20240719$20240726$20240726$PER$$US-ALXN-A202213535$ALEXION PHARMACEUTICALS$$20$YR$$M$Y$$$20240726$$CN$US$US
241397481$24139748$1$I$$20240722$20240726$20240726$EXP$$EG-EMD Serono-2024039910$EMD SERONO INC$$42$YR$A$F$Y$$$20240726$$CN$EG$EG
241397492$24139749$2$F$20240713$20240802$20240726$20240809$EXP$$JP-ROCHE-10000033409$ROCHE$$8$DEC$E$F$Y$$$20240809$$PH$JP$JP
241397502$24139750$2$F$20211004$20240826$20240726$20240909$EXP$$CA-UCBSA-2024035123$UCB$$35$YR$$F$Y$$$20240909$$CN$CA$CA
241397511$24139751$1$I$20240702$20240720$20240726$20240726$EXP$$PT-AUROBINDO-AUR-APL-2024-036680$AUROBINDO$$38$YR$$F$Y$$$20240726$$PH$PT$PT
241397522$24139752$2$F$$20240725$20240726$20240731$PER$$NVSC2024US153285$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
241397531$24139753$1$I$$20240718$20240726$20240726$EXP$$IT-AstraZeneca-2024A166838$ASTRAZENECA$$$$$$Y$$$20240726$$MD$IT$
241397541$24139754$1$I$20240501$20240718$20240726$20240726$EXP$$RU-AstraZeneca-2024A165795$ASTRAZENECA$$67$YR$$F$Y$76$KG$20240726$$MD$RU$
241397551$24139755$1$I$$20210709$20240726$20240726$EXP$$US-AstraZeneca-2021A614697$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241397561$24139756$1$I$20210101$20210911$20240726$20240726$EXP$$SG-AstraZeneca-2021A727507$ASTRAZENECA$$70$YR$$F$Y$$$20240726$$HP$SG$
241397571$24139757$1$I$$20230131$20240726$20240726$EXP$$US-AstraZeneca-2023A027241$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241397581$24139758$1$I$20240315$20240716$20240726$20240726$EXP$FR-AFSSAPS-PP2024000768$FR-TEVA-VS-3222366$TEVA$$40$YR$$M$Y$68$KG$20240726$$MD$FR$FR
241397591$24139759$1$I$$20240717$20240726$20240726$30DAY$$US-GSK-US2024090170$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241397601$24139760$1$I$$20240718$20240726$20240726$30DAY$$US-GSK-US2024090672$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241397611$24139761$1$I$20240719$20240719$20240726$20240726$PER$$US-AMGEN-USASP2024144858$AMGEN$$79$YR$E$M$Y$$$20240726$$CN$US$US
241397621$24139762$1$I$20240424$20240722$20240726$20240726$EXP$ES-AEMPS-1537606$ES-EXELIXIS-CABO-24079823$EXELIXIS$$67$YR$$M$Y$$$20240726$$MD$ES$ES
241397631$24139763$1$I$20240715$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024146974$AMGEN$$42$YR$A$F$Y$$$20240726$$CN$US$US
241397641$24139764$1$I$$20240719$20240726$20240726$EXP$$US-AMGEN-USASP2024145252$AMGEN$$$$$$Y$$$20240726$$HP$US$US
241397651$24139765$1$I$$20240716$20240726$20240726$EXP$$CA-APOTEX-2024AP008470$APOTEX$$85$YR$$F$Y$$$20240726$$HP$CA$CA
241397661$24139766$1$I$$20240717$20240726$20240726$EXP$$GB-TAKEDA-2024TUS074137$TAKEDA$$$$$F$Y$$$20240726$$CN$GB$GB
241397672$24139767$2$F$20240627$20240823$20240726$20240826$PER$$US-JNJFOC-20240762056$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240826$$CN$US$US
241397682$24139768$2$F$$20240812$20240726$20240816$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14554$IPSEN$$$$$M$Y$$$20240816$$CN$US$US
241397691$24139769$1$I$$20240724$20240726$20240726$EXP$$US-ABBVIE-5852764$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241397701$24139770$1$I$20240601$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117920$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240726$$CN$US$US
241397711$24139771$1$I$$20240722$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117397$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240726$$CN$US$US
241397721$24139772$1$I$$20230417$20240726$20240726$EXP$$US-AstraZeneca-2023A090058$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241397731$24139773$1$I$$20210605$20240726$20240726$EXP$$GB-AstraZeneca-2021A512343$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$GB$
241397741$24139774$1$I$$20230911$20240726$20240726$EXP$$US-AstraZeneca-2023A207476$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241397751$24139775$1$I$$20210709$20240726$20240726$EXP$$US-AstraZeneca-2021A617039$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241397761$24139776$1$I$$20210602$20240726$20240726$EXP$$US-AstraZeneca-2021A496512$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241397771$24139777$1$I$$20191203$20240726$20240726$EXP$$MX-AstraZeneca-2019SF74577$ASTRAZENECA$$70$YR$$F$Y$85$KG$20240726$$CN$MX$
241397781$24139778$1$I$$20210630$20240726$20240726$EXP$$GB-AstraZeneca-2021A586283$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$GB$
241397791$24139779$1$I$$20220623$20240726$20240726$EXP$$US-AstraZeneca-2022A233267$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241397801$24139780$1$I$$20210514$20240726$20240726$EXP$$US-AstraZeneca-2021A438542$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241397811$24139781$1$I$$20210614$20240726$20240726$EXP$$US-AstraZeneca-2021A527223$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241397821$24139782$1$I$$20220511$20240726$20240726$EXP$$US-AstraZeneca-2022A183599$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241397831$24139783$1$I$$20230602$20240726$20240726$EXP$$US-AstraZeneca-2023A129385$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241397841$24139784$1$I$$20210224$20240726$20240726$EXP$$GB-AstraZeneca-2021A096587$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$GB$
241397851$24139785$1$I$20240115$20240718$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036593$AUROBINDO$$70$YR$$F$Y$60$KG$20240726$$PH$FR$FR
241397861$24139786$1$I$20240219$20240723$20240726$20240726$EXP$$US-TAKEDA-2024TUS020765$TAKEDA$$34$YR$$F$Y$$$20240726$$MD$US$US
241397871$24139787$1$I$$20240716$20240726$20240726$EXP$NL-LRB-00980844$NL-009507513-2407NLD010491$MERCK$$48$YR$$M$Y$90$KG$20240726$$MD$NL$NL
241397881$24139788$1$I$20240101$20240724$20240726$20240726$EXP$$US-UCBSA-2024037583$UCB$$$$$F$Y$$$20240726$$HP$US$US
241397891$24139789$1$I$$20240702$20240726$20240726$PER$$US-JNJFOC-20240707643$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$US$US
241397901$24139790$1$I$20240717$20240718$20240726$20240726$PER$$US-ALXN-202407USA001367US$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240726$$CN$US$US
241397911$24139791$1$I$$20240718$20240726$20240726$EXP$$GB-AUROBINDO-AUR-APL-2024-035942$AUROBINDO$$28$YR$$M$Y$$$20240726$$CN$GB$GB
241397931$24139793$1$I$20240224$20240718$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036600$AUROBINDO$$15$YR$$M$Y$57$KG$20240726$$PH$FR$FR
241397941$24139794$1$I$20240626$20240718$20240726$20240726$PER$$US-AMGEN-USASP2024148328$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
241397951$24139795$1$I$20240719$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147167$AMGEN$$45$YR$A$M$Y$$$20240726$$CN$US$US
241397961$24139796$1$I$$20240715$20240726$20240726$EXP$$JP-ROCHE-10000017663$ROCHE$$68$YR$E$M$Y$$$20240726$$PH$JP$JP
241397972$24139797$2$F$$20240724$20240726$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US068157$SANDOZ$$$$$F$Y$$$20240729$$CN$US$US
241397981$24139798$1$I$$20240722$20240726$20240726$EXP$$US-ABBVIE-5850219$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241397991$24139799$1$I$$20240717$20240726$20240726$EXP$$US-STERISCIENCE B.V.-2024-ST-001095$Steriscience PTE$Mcgourty M, Adams EW, Lyons J, Ayyaswami V, Holdorf JD. MDA-5 Associated Dermatomyositis: A Case of Delayed Care and Dire Consequences.. Am-J-Respir-Crit-Care-Med. 2024;209(0)$43$YR$$M$Y$$$20240726$$HP$US$US
241398001$24139800$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118165$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$94.35$KG$20240726$$CN$US$US
241398011$24139801$1$I$20240611$20240716$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036158$AUROBINDO$$58$YR$$$Y$$$20240726$$MD$FR$FR
241398021$24139802$1$I$$20240719$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115998$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240726$$CN$US$US
241398031$24139803$1$I$20240712$20240712$20240726$20240726$PER$$US-ROCHE-10000026752$ROCHE$$$$$M$Y$$$20240726$$CN$US$US
241398051$24139805$1$I$20240601$20240724$20240726$20240726$EXP$$DE-ABBVIE-5851881$ABBVIE$$24$YR$$F$Y$48$KG$20240726$$MD$DE$DE
241398061$24139806$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016276$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240726$$CN$US$US
241398071$24139807$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015119$ELI LILLY AND CO$$52$YR$A$$Y$$$20240726$$CN$US$US
241398081$24139808$1$I$$20240721$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016770$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240726$$CN$US$US
241398091$24139809$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016047$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$US$US
241398101$24139810$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016058$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240726$$CN$US$US
241398111$24139811$1$I$20240722$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016414$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240726$$CN$US$US
241398121$24139812$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016429$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240726$$CN$US$US
241398131$24139813$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015164$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240726$$CN$US$US
241398141$24139814$1$I$$20240722$20240726$20240726$EXP$$JP-GILEAD-2024-0681691$GILEAD$Yamamoto S, Matsui H, Shirakawa K, Takaori A. 10. A case of a patient with cryptosporidiosis and AIDS diagnosed after being treated for inflammatory bowel disease. The 37th Annual Meeting of Kinki AIDS Research Society. 2024;unk:18$3$DEC$A$M$Y$$$20240726$$MD$JP$JP
241398153$24139815$3$F$20240712$20240813$20240726$20240822$EXP$$DE-ROCHE-10000036791$ROCHE$$59$YR$A$F$Y$$$20240822$$CN$DE$DE
241398162$24139816$2$F$$20240724$20240726$20240801$EXP$$US-ROCHE-10000033789$ROCHE$$50$YR$A$F$Y$$$20240801$$CN$US$US
241398171$24139817$1$I$20240101$20240716$20240726$20240726$EXP$$DE-ROCHE-10000033066$ROCHE$$63$YR$A$M$Y$$$20240726$$MD$DE$DE
241398182$24139818$2$F$20240701$20240731$20240726$20240802$EXP$$PR-ABBVIE-5851689$ABBVIE$$74$YR$$F$Y$$$20240802$$CN$PR$PR
241398191$24139819$1$I$$20240723$20240726$20240726$EXP$$NVSJ2024JP009069$NOVARTIS$$$$$$Y$$$20240726$$PH$JP$JP
241398201$24139820$1$I$$20210614$20240726$20240726$EXP$$US-AstraZeneca-2021A528258$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241398211$24139821$1$I$$20210227$20240726$20240726$EXP$$US-AstraZeneca-2021A099219$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241398221$24139822$1$I$$20230720$20240726$20240726$EXP$$US-AstraZeneca-2023A168367$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241398241$24139824$1$I$$20210713$20240726$20240726$EXP$$US-AstraZeneca-2021A622264$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241398251$24139825$1$I$$20210426$20240726$20240726$EXP$$CA-AstraZeneca-2021A404134$ASTRAZENECA$$$$$M$Y$$$20240726$$MD$CA$
241398261$24139826$1$I$20200801$20210329$20240726$20240726$EXP$$US-AstraZeneca-2021A249909$ASTRAZENECA$$1050$MON$$F$Y$57.7$KG$20240726$$CN$US$
241398271$24139827$1$I$20240717$20240717$20240726$20240726$EXP$$CA-APOTEX-2024AP008548$APOTEX$$66$YR$E$M$Y$$$20240726$$CN$CA$CA
241398281$24139828$1$I$$20220707$20240726$20240726$EXP$$US-AstraZeneca-2022A248371$ASTRAZENECA$$$$$$Y$$$20240726$$MD$US$
241398291$24139829$1$I$$20240719$20240726$20240726$PER$$US-AstraZeneca-2024A165908$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241398301$24139830$1$I$$20230524$20240726$20240726$EXP$$AU-AstraZeneca-2023A120053$ASTRAZENECA$$$$$$Y$$$20240726$$MD$AU$
241398311$24139831$1$I$$20210324$20240726$20240726$EXP$$US-AstraZeneca-2021A208936$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241398321$24139832$1$I$20240723$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024148027$AMGEN$$57$YR$A$F$Y$$$20240726$$CN$US$US
241398331$24139833$1$I$$20240718$20240726$20240726$EXP$$CN-AMGEN-CHNSP2024145147$AMGEN$Huiying Q.; Yan P.; Xiangyue Z. et al.. Clinical efficacy and safety of blinatumomab bridging CAR- T cell therapy in the treatment of patients with adult acute B-cell lymphoblastic leukemia. Chin J Hematol. 2024;45 (4):339-343$$$$$Y$$$20240726$$HP$CN$CN
241398351$24139835$1$I$$20240717$20240726$20240726$PER$$US-AMGEN-USASP2024148024$AMGEN$$$$$$Y$$$20240726$$MD$US$US
241398361$24139836$1$I$$20240711$20240726$20240726$PER$$US-GRANULES-US-2024GRASPO00290$GRANULES INDIA$$$$$M$Y$$$20240726$$CN$US$US
241398371$24139837$1$I$20240202$20240719$20240726$20240726$EXP$$CL-VANTIVE-2024VAN018412$Vantive US Healthcare$$62$YR$$F$Y$86$KG$20240726$$HP$CL$CL
241398382$24139838$2$F$$20240923$20240726$20240926$EXP$$US-GILEAD-2024-0681960$GILEAD$$$$E$F$Y$$$20240926$$CN$US$US
241398401$24139840$1$I$20240630$20240719$20240726$20240726$EXP$$CO-VANTIVE-2024VAN018499$Vantive US Healthcare$$83$YR$$M$Y$69$KG$20240726$$HP$CO$CO
241398411$24139841$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASL2024146776$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241398422$24139842$2$F$20240723$20240807$20240726$20240809$PER$$US-AMGEN-USASP2024147913$AMGEN$$63$YR$A$F$Y$$$20240808$$CN$US$US
241398431$24139843$1$I$20240701$20240722$20240726$20240726$EXP$$US-BIOGEN-2024BI01274962$BIOGEN$$54$YR$$M$Y$$$20240726$$HP$US$US
241398441$24139844$1$I$$20240722$20240726$20240726$EXP$$US-ABBVIE-5850960$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241398451$24139845$1$I$$20240718$20240726$20240726$EXP$$US-BIOGEN-2024BI01274606$BIOGEN$$$$$F$Y$$$20240726$$MD$US$US
241398464$24139846$4$F$20240418$20240916$20240726$20240917$EXP$$DE-SANDOZ INC.-SDZ2024DE067324$SANDOZ$$59$YR$$F$Y$$$20240917$$MD$DE$DE
241398471$24139847$1$I$$20240716$20240726$20240726$EXP$$IN-HETERO-ASP2024IN02428$ASPIRO PHARMA$Barman L, Pandey C, Gowrishankar S.. Autonomic Cascade Secondary to Acute Urinary Retention in a Patient undergoing Open Reduction of Forearm Fracture under General  Anaesthesia: A Case Report.. Journal of Clinical and Diagnostic Research. 2024;18(7):UD01-3$62$YR$$F$Y$50$KG$20240726$$MD$IN$IN
241398481$24139848$1$I$20240620$20240722$20240726$20240726$EXP$$US-ORGANON-O2407USA002170$ORGANON$$73$YR$$F$Y$$$20240726$$CN$US$US
241398491$24139849$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118714$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$74.39$KG$20240726$$CN$US$US
241398521$24139852$1$I$$20240725$20240726$20240726$PER$$US-ROCHE-10000036944$ROCHE$Swearingen A, Strome A., Levine A.. Cutaneous Cryptococcosis Evaluation on Reflectance Confocal Microscopy (RCM) (Abstract: LB893).. Journal of Investigative Dermatology. 2024-Aug;144 (8):S156. doi:10.1016/j.jid.2024.06.1065.$69$YR$E$F$Y$$$20240726$$HP$US$US
241398531$24139853$1$I$$20240712$20240726$20240726$PER$$US-GRANULES-US-2024GRASPO00289$GRANULES INDIA$$56$YR$A$F$Y$$$20240726$$CN$US$US
241398541$24139854$1$I$$20240725$20240726$20240726$PER$$US-ROCHE-10000037889$ROCHE$$$$A$F$Y$$$20240726$$CN$US$US
241398551$24139855$1$I$$20240326$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003730$STRIDES$Pennington KM, Katta R, Weathered C, Pienaar E, Escalante P.. Characteristics and outcomes of anti-mycobacterial therapy compared to no anti-mycobacterial therapy for NTM pulmonary disease.. Respir-Med. 2022;197:1-4$67$YR$$F$Y$$$20240726$$HP$US$US
241398561$24139856$1$I$20210609$20240716$20240726$20240726$EXP$$PL-ORG100014127-2024000207$HRA PHARMA$$25$YR$A$M$Y$106$KG$20240726$$PH$PL$
241398571$24139857$1$I$$20240719$20240726$20240726$PER$$US-CHATTEMPRD-2024OHG024984$CHATTEM$$$$$$Y$$$20240726$$CN$US$US
241398581$24139858$1$I$20240707$20240715$20240726$20240726$EXP$FR-AFSSAPS-MP2024001141$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110046$ZYDUS PHARM$$$$$$Y$$$20240726$$PH$FR$FR
241398591$24139859$1$I$20240401$20240715$20240726$20240726$EXP$FR-AFSSAPS-DJ2024000818$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109974$ZYDUS PHARM$$$$$$Y$$$20240726$$PH$FR$FR
241398601$24139860$1$I$20231201$20240715$20240726$20240726$EXP$FR-AFSSAPS-PP2024000770$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109837$ZYDUS PHARM$$$$$$Y$$$20240726$$MD$FR$FR
241398611$24139861$1$I$20240714$20240717$20240726$20240726$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109867$ZYDUS PHARM$$$$$$Y$$$20240726$$CN$US$US
241398621$24139862$1$I$$20240722$20240726$20240726$EXP$$GB-TAKEDA-2024TUS074465$TAKEDA$$$$$F$Y$$$20240726$$CN$GB$GB
241398631$24139863$1$I$$20240723$20240726$20240726$EXP$$US-ABBVIE-5852167$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241398641$24139864$1$I$$20240722$20240726$20240726$PER$$US-CHATTEMPRD-2024OHG024989$CHATTEM$$$$$$Y$$$20240726$$CN$US$US
241398651$24139865$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118621$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240726$$HP$US$US
241398661$24139866$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118135$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$92.53$KG$20240726$$CN$US$US
241398671$24139867$1$I$$20240722$20240726$20240726$EXP$$US-ABBVIE-5850768$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241398683$24139868$3$F$$20240803$20240726$20240813$EXP$$US-HETERO-HET2024US02385$HETERO$$$$$M$Y$120$KG$20240813$$CN$US$US
241398691$24139869$1$I$20240509$20240712$20240726$20240726$PER$$US-TEVA-VS-3224881$TEVA$$64$YR$$F$Y$$$20240726$$CN$US$US
241398701$24139870$1$I$$20240717$20240726$20240726$EXP$$US-APOTEX-2024AP008620$APOTEX$Sharayah S, Agner SC, Shinawi M, Rudnick D, Mar S.. Neurological Improvement in a Patient with Cerebroretinal Microangiopathy with Calcifications and Cysts-1 Treated with Bevacizumab. Annals of child neurology. 2023;31(1):52-55$16$YR$$M$Y$$$20240726$$MD$US$US
241398711$24139871$1$I$$20240311$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003086$STRIDES$Abu Hussein N, Lin D.. Chronic Cough, Sometimes There Is Something to Find: A Case of Organizing Pneumonia Secondary to Infectious Etiology With Actinomyces Species. Am-J-Respir-Crit-Care-Med. 2023;207:A3234.$66$YR$$F$Y$$$20240726$$HP$US$US
241398721$24139872$1$I$$20240722$20240726$20240726$PER$$US-HALEON-2188378$Haleon PLC$$72$YR$$M$Y$$$20240726$$CN$US$US
241398731$24139873$1$I$$20240719$20240726$20240726$PER$$US-ALXN-202407USA001398US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$US$US
241398741$24139874$1$I$20221101$20240717$20240726$20240726$EXP$US-MLMSERVICE-20240708-PI084222-00271-1$US-RDY-SPO/USA/24/0010673$DR REDDYS$Krause PJ, Rogers R, Shah MK, Kang H, Parsonnet J, Kodama R, et al. Tafenoquine for Relapsing Babesiosis: A Case Series. Clinical infectious diseases. 2024. DOI:10.1093/cid/ciae238.$52$YR$A$M$Y$$$20240726$$MD$US$US
241398751$24139875$1$I$$20240328$20240726$20240726$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003965$STRIDES$Kufel WD, Hitchcock AM, Delbalso AN, Paolino KM.. Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance.. J-Antimicrob-Chemother. 2023;78(4):1127-1128$$$$$Y$$$20240726$$HP$US$US
241398761$24139876$1$I$20190719$20240722$20240726$20240726$EXP$$CO-UCBSA-2024013071$UCB$$60$YR$$F$Y$69$KG$20240726$$CN$CO$CO
241398771$24139877$1$I$$20240722$20240726$20240726$EXP$$US-BIOGEN-2024BI01274830$BIOGEN$$$$$F$Y$$$20240726$$CN$US$US
241398782$24139878$2$F$20240701$20240724$20240726$20240730$EXP$$US-ORGANON-O2407USA002257$ORGANON$$18$YR$$F$Y$53.515$KG$20240730$$MD$US$US
241398792$24139879$2$F$20231128$20240910$20240726$20240916$EXP$$CA-TAKEDA-2023TUS116626$TAKEDA$$22$YR$$F$Y$$$20240916$$HP$CA$CA
241398801$24139880$1$I$$20240724$20240726$20240726$PER$$US-JNJFOC-20240768571$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$MD$US$US
241398811$24139881$1$I$20240624$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407014774$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240726$$CN$US$US
241398821$24139882$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016027$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240726$$CN$US$US
241398831$24139883$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015974$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240726$$CN$US$US
241398841$24139884$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015511$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240726$$CN$US$US
241398851$24139885$1$I$20240601$20240718$20240726$20240726$EXP$FR-AFSSAPS-GR2024000910$FR-BIOCON BIOLOGICS LIMITED-BBL2024005342$BIOCON$$$$$$Y$$$20240726$$PH$FR$FR
241398861$24139886$1$I$$20210426$20240726$20240726$EXP$$CA-AstraZeneca-2021A366830$ASTRAZENECA$$$$$M$Y$$$20240726$$MD$CA$
241398871$24139887$1$I$$20240723$20240726$20240726$PER$$US-ROCHE-10000034621$ROCHE$$$$E$M$Y$$$20240726$$CN$US$US
241398881$24139888$1$I$20240620$20240722$20240726$20240726$EXP$$US-TAKEDA-2024TUS037436$TAKEDA$$81$YR$$F$Y$72$KG$20240726$$MD$US$US
241398891$24139889$1$I$$20240719$20240726$20240726$EXP$$JP-009507513-2407JPN004149J$MERCK$$75$YR$$M$Y$$$20240726$$MD$JP$JP
241398901$24139890$1$I$20240101$20240723$20240726$20240726$EXP$$US-ABBVIE-5852073$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241398911$24139891$1$I$$20240716$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092553$VIIV$$$$$$Y$$$20240726$$HP$US$US
241398922$24139892$2$F$$20240730$20240726$20240803$PER$$US-AMGEN-USASP2024146670$AMGEN$$$$$F$Y$$$20240803$$CN$US$US
241398932$24139893$2$F$20240721$20240906$20240726$20240909$PER$$US-AMGEN-USASP2024146145$AMGEN$$60$YR$A$M$Y$$$20240909$$CN$US$US
241398941$24139894$1$I$20240723$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024147698$AMGEN$$45$YR$A$F$Y$$$20240726$$CN$US$US
241398951$24139895$1$I$$20240719$20240726$20240726$EXP$GB-MHRA-MED-202407160951268160-QPBKC$GB-ROCHE-10000031799$ROCHE$$$$$F$Y$$$20240726$$HP$GB$GB
241398961$24139896$1$I$20240711$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118197$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$91.63$KG$20240726$$HP$US$US
241398975$24139897$5$F$20240701$20240821$20240726$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118230$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240823$$PH$US$US
241398981$24139898$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118086$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240726$$HP$US$US
241398991$24139899$1$I$$20240716$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-036349$AUROBINDO$Ibarra F, Holzmann S, Shah S, Fountain C, Saleh S, Kapoor V, et al.. Utility of nicardipine in the management of hypertensive crises in adults with reduced ejection fractions.. Am-J-Emerg-Med. 2024;75:79-82$$$A$$Y$$$20240726$$HP$US$US
241399002$24139900$2$F$20240710$20240826$20240726$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117294$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$63.05$KG$20240827$$PH$US$US
241399011$24139901$1$I$$20240721$20240726$20240726$EXP$$JP-ABBVIE-5836605$ABBVIE$$40$YR$$M$Y$$$20240726$$PH$JP$JP
241399021$24139902$1$I$20240713$20240716$20240726$20240726$EXP$$US-TEVA-VS-3223789$TEVA$$$$$F$Y$$$20240726$$CN$US$US
241399031$24139903$1$I$20240621$20240716$20240726$20240726$EXP$$US-VIIV HEALTHCARE LIMITED-US2024089409$VIIV$$27$YR$$M$Y$$$20240726$$CN$US$US
241399041$24139904$1$I$$20240717$20240726$20240726$EXP$$US-APOTEX-2024AP008622$APOTEX$Golob S, Ting P, Pires K, Soetanto V, Pagano B, Wan K-L, et al.. Bupropion Overdose Requiring Veno-Arterial Extracorporeal Membrane Oxygenation. Circulation. 2023;148 (Suppl. 1)$32$YR$$F$Y$$$20240726$$HP$US$US
241399051$24139905$1$I$$20240716$20240726$20240726$EXP$$CZ-AUROBINDO-AUR-APL-2024-036233$AUROBINDO$Sitina M, Sramek V.. Euglykemicka ketoacidoza asociovana se SGLT2 inhibitory a DPP4 inhibitory ? rozbor kazuistik. Anesteziologie a intenzivni medicina. 2024;35(2):116-21$61$YR$$M$Y$$$20240726$$MD$CZ$CZ
241399061$24139906$1$I$$20240723$20240726$20240726$EXP$$NVSC2024BR152975$NOVARTIS$$$$$M$Y$$$20240726$$CN$BR$BR
241399073$24139907$3$F$$20240812$20240726$20240813$EXP$$NVSC2024US153372$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
241399082$24139908$2$F$$20240815$20240726$20240819$PER$$US-ALXN-202407USA001429US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241399091$24139909$1$I$20220401$20240709$20240726$20240726$PER$$US-EMD Serono-2024038805$EMD SERONO INC$$53$YR$A$F$Y$107$KG$20240726$$MD$US$US
241399101$24139910$1$I$20231125$20240715$20240726$20240726$EXP$FR-AFSSAPS-AVMA2024000303$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109843$ZYDUS PHARM$$$$$$Y$$$20240726$$PH$FR$FR
241399111$24139911$1$I$$20240719$20240726$20240726$EXP$$US-TAKEDA-2024TUS040190$TAKEDA$$$$$F$Y$$$20240726$$CN$US$US
241399121$24139912$1$I$20240614$20240715$20240726$20240726$EXP$FR-AFSSAPS-NT2024000841$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110005$ZYDUS PHARM$$$$$$Y$$$20240726$$MD$FR$FR
241399131$24139913$1$I$$20240717$20240726$20240726$EXP$$CA-APOTEX-2024AP008558$APOTEX$$95$YR$$F$Y$$$20240726$$PH$CA$CA
241399141$24139914$1$I$$20240722$20240726$20240726$PER$$US-BEH-2024176220$CSL BEHRING$$$$E$F$Y$$$20240726$$CN$US$US
241399151$24139915$1$I$20240418$20240716$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036140$AUROBINDO$$34$YR$$M$Y$$$20240726$$PH$FR$FR
241399161$24139916$1$I$20240101$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118102$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240726$$CN$US$US
241399171$24139917$1$I$20240721$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147096$AMGEN$$62$YR$A$$Y$$$20240726$$CN$US$US
241399181$24139918$1$I$20240715$20240716$20240726$20240726$EXP$$US-GSK-US2024089430$GLAXOSMITHKLINE$$41$YR$$M$Y$$$20240726$$CN$US$US
241399192$24139919$2$F$$20240722$20240726$20240726$PER$$US-GILEAD-2024-0681577$GILEAD$$$$$M$Y$$$20240726$$MD$US$US
241399201$24139920$1$I$$20240718$20240726$20240726$PER$$US-ROCHE-10000032875$ROCHE$$$$$$Y$$$20240726$$CN$US$US
241399212$24139921$2$F$20240705$20240814$20240726$20240824$30DAY$$US-GSK-US2024090763$GLAXOSMITHKLINE$$83$YR$$F$Y$$$20240824$$CN$US$US
241399221$24139922$1$I$20190301$20240717$20240726$20240726$PER$$US-ROCHE-10000030968$ROCHE$$44$YR$A$F$Y$86.18$KG$20240726$$CN$US$US
241399232$24139923$2$F$$20240718$20240726$20240823$PER$$US-ROCHE-10000033783$ROCHE$$$$E$M$Y$$$20240823$$CN$US$US
241399251$24139925$1$I$$20240719$20240726$20240726$EXP$$CA-TAKEDA-2024TUS074069$TAKEDA$$$$$M$Y$$$20240726$$CN$CA$CA
241399261$24139926$1$I$20170101$20240717$20240726$20240726$EXP$$PL-AUROBINDO-AUR-APL-2024-036363$AUROBINDO$$33$YR$$M$Y$$$20240726$$CN$PL$PL
241399271$24139927$1$I$20240101$20240710$20240726$20240726$PER$$US-JNJFOC-20240727747$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240726$$CN$US$US
241399282$24139928$2$F$20240720$20240812$20240726$20240814$PER$$US-AMGEN-USASP2024145389$AMGEN$$69$YR$E$F$Y$$$20240814$$HP$US$US
241399291$24139929$1$I$20240708$20240716$20240726$20240726$PER$$US-AMGEN-USASP2024148005$AMGEN$$$$$$Y$$$20240726$$HP$US$US
241399301$24139930$1$I$$20240620$20240726$20240726$PER$$US-ROCHE-10000006520$ROCHE$$$$$$Y$$$20240726$$PH$US$US
241399311$24139931$1$I$$20240720$20240726$20240726$PER$$US-HALEON-2188414$Haleon PLC$$$$$$Y$$$20240726$$CN$US$US
241399321$24139932$1$I$$20240711$20240726$20240726$PER$$US-GLANDPHARMA-US-2024GLNSPO00477$GLAND PHARMA$$$$$$Y$$$20240726$$PH$US$US
241399332$24139933$2$F$20240101$20240813$20240726$20240822$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021304$UNITED THERAPEUTICS$$$$$F$Y$45.351$KG$20240822$$$US$US
241399341$24139934$1$I$$20240724$20240726$20240726$PER$$NVSC2024US153373$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241399351$24139935$1$I$20240722$20240722$20240726$20240726$EXP$$US-ABBVIE-5850938$ABBVIE$$46$YR$$F$Y$$$20240726$$CN$US$US
241399361$24139936$1$I$20230101$20240719$20240726$20240726$EXP$FR-AFSSAPS-LY2024001077$FR-STRIDES ARCOLAB LIMITED-2024SP008998$STRIDES$$34$YR$$M$Y$$$20240726$$MD$FR$FR
241399371$24139937$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000035779$ROCHE$$$$A$F$Y$$$20240726$$CN$US$US
241399381$24139938$1$I$$20240719$20240726$20240726$EXP$$US-SA-2024SA217263$SANOFI AVENTIS$$$$A$M$Y$84.36$KG$20240726$$MD$US$US
241399391$24139939$1$I$$20240723$20240726$20240726$EXP$$GR-AstraZeneca-2024A169212$ASTRAZENECA$$74$YR$$M$Y$90$KG$20240726$$MD$GR$
241399401$24139940$1$I$20240101$20240713$20240726$20240726$PER$$US-TEVA-VS-3221826$TEVA$$77$YR$$F$Y$$$20240726$$CN$US$US
241399411$24139941$1$I$$20240715$20240726$20240726$EXP$$CN-ROCHE-10000027807$ROCHE$$72$YR$E$M$Y$$$20240726$$CN$CN$CN
241399421$24139942$1$I$20240524$20240719$20240726$20240726$EXP$$PK-ROCHE-10000033922$ROCHE$$59$YR$A$M$Y$$$20240726$$CN$PK$PK
241399431$24139943$1$I$20231201$20240716$20240726$20240726$EXP$FR-AFSSAPS-PP2024000770$FR-TEVA-VS-3222256$TEVA$$26$YR$$F$Y$$$20240726$$MD$FR$FR
241399441$24139944$1$I$$20240711$20240726$20240726$EXP$$UG-CPL-004448$CADILA$Nambuya M, Mayanja-Kizza H. A case report: recurrent anemia related to long term acyclovir use in a pregnant HIV infected Ugandan. Afr Health Sci. 2024 Mar;24(1):91-93.$19$YR$A$F$Y$$$20240726$$HP$UG$UG
241399451$24139945$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-036594$AUROBINDO$Andrews E, O^Leary ET, Tedrow UB, Tadros TM. VT ABLATION UTILIZING A RIGHT VENTRICULAR BASOLATERAL ANEURYSM IN A PATIENT WITH REPAIRED TETRALOGYOF FALLOT. Heart-Rhythm. 2024;21 (Suppl. 5):S719$57$YR$$F$Y$$$20240726$$HP$US$US
241399461$24139946$1$I$20231009$20240711$20240726$20240726$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041110$BOEHRINGER INGELHEIM$$$$$$Y$$$20240726$$CN$DE$DE
241399471$24139947$1$I$20240701$20240718$20240726$20240726$EXP$$JP-009507513-2407JPN003704J$MERCK$$92$YR$$F$Y$$$20240726$$CN$JP$JP
241399481$24139948$1$I$$20240719$20240726$20240726$EXP$$CA-TAKEDA-2024TUS074082$TAKEDA$$$$$F$Y$$$20240726$$MD$CA$CA
241399491$24139949$1$I$$20240715$20240726$20240726$EXP$$CA-ROCHE-10000033942$ROCHE$$65$YR$E$F$Y$$$20240726$$MD$CA$CA
241399502$24139950$2$F$20240710$20240919$20240726$20240923$PER$$US-BIOGEN-2024BI01274869$BIOGEN$$59$YR$$F$Y$$$20240923$$CN$US$US
241399511$24139951$1$I$$20240717$20240726$20240726$PER$$US-BIOGEN-2024BI01275271$BIOGEN$$$$$F$Y$$$20240726$$MD$US$US
241399522$24139952$2$F$20210101$20240729$20240726$20240801$EXP$$CN-SA-2024SA215611$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240801$$MD$CN$CN
241399531$24139953$1$I$20240719$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118506$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240726$$HP$US$US
241399541$24139954$1$I$20240722$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117554$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240726$$HP$US$US
241399551$24139955$1$I$20221001$20240717$20240726$20240726$EXP$EU-AFSSAPS-AVCN2024000519$EU-ETHYPHARM-2024001931$ETHYPHARM$$$$$$Y$$$20240725$$MD$EU$EU
241399561$24139956$1$I$20240620$20240718$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036604$AUROBINDO$$71$YR$$F$Y$$$20240726$$MD$FR$FR
241399571$24139957$1$I$20240724$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016206$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240726$$CN$US$US
241399581$24139958$1$I$$20240716$20240726$20240726$EXP$$IN-KOANAAP-SML-IN-2024-00755$Unknown Manufacturer$Gupta D, Sivaramakrishnan P, Layek A, Mishra M. Exudative pleural effusion during sunitinib treatment. BMJ-Case-Rep. 2024;doi:10.1136/bcr-2023-257191.$4$DEC$$M$Y$$$20240726$$MD$IN$IN
241399591$24139959$1$I$$20240722$20240726$20240726$EXP$$ES-TAKEDA-2024TUS075048$TAKEDA$$$$$$Y$$$20240726$$CN$ES$ES
241399602$24139960$2$F$20240719$20240926$20240726$20240927$PER$$US-AMGEN-USASP2024146958$AMGEN$$90$YR$E$M$Y$$$20240927$$CN$US$US
241399611$24139961$1$I$$20240717$20240726$20240726$EXP$$US-APOTEX-2024AP008624$APOTEX$Gault KS.. THE ROLE OF PHYSICAL THERAPY WITHIN A MULTIDISCIPLINARY PANCREATIC CANCER CLINIC TO OPTIMIZE CARE. Rehabilitation Oncology. 2024;42 (2):119$78$YR$$F$Y$$$20240726$$HP$US$US
241399621$24139962$1$I$20240218$20240712$20240726$20240726$EXP$$SG-ROCHE-10000030903$ROCHE$$76$YR$E$F$Y$$$20240726$$CN$SG$SG
241399632$24139963$2$F$$20240722$20240726$20240729$PER$$NVSC2024US147593$NOVARTIS$$25$YR$$M$Y$$$20240729$$CN$US$US
241399642$24139964$2$F$$20240724$20240726$20240801$EXP$$FR-AUROBINDO-AUR-APL-2024-036471$AUROBINDO$Archer E, Bosdure L, Lejeune J, Faucheux L, Guery EA, Sillamy N et al.. Hypofibrinogenemie induite par les corticoides seuls au cours du traitement d^une leucemie aigue lymphoblastique: a propos d^un cas clinique au CHU de Tours (Hypofibrinogenemia induced by corticosteroids alone during treatment of acute  lymphoblastic leukemia: a case report from Tours University Hospital). REVUE FRANCOPHONE O^HEMOSTASE ET THROMBOSE. 2024;6(2):67-70$14$YR$$M$Y$$$20240801$$HP$FR$FR
241399651$24139965$1$I$20240527$20240715$20240726$20240726$EXP$$TH-ROCHE-10000033330$ROCHE$$60$YR$A$M$Y$$$20240726$$CN$TH$TH
241399661$24139966$1$I$$20240718$20240726$20240726$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006306$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241399671$24139967$1$I$$20240716$20240726$20240726$EXP$$US-KOANAAP-SML-US-2024-00753$Unknown Manufacturer$Gravenmier C, Shah B, Hussainia M, Zhang L. Chimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment. Leukemia + Lymphoma. 2024 Jan 19;65(5): 674-678. doi:10.1080/10428194.2023.2301038.$58$YR$A$M$Y$$$20240726$$MD$US$US
241399681$24139968$1$I$$20240723$20240726$20240726$EXP$$FR-TAKEDA-2024TUS074932$TAKEDA$$$$$F$Y$$$20240726$$CN$FR$FR
241399691$24139969$1$I$20240717$20240722$20240726$20240726$EXP$$US-ABBVIE-5850811$ABBVIE$$71$YR$$M$Y$$$20240726$$CN$US$US
241399701$24139970$1$I$$20240718$20240726$20240726$PER$$US-AMGEN-USASP2024144877$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241399711$24139971$1$I$20240717$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147162$AMGEN$$45$YR$A$F$Y$$$20240726$$CN$US$US
241399721$24139972$1$I$$20240718$20240726$20240726$PER$$US-ROCHE-10000033507$ROCHE$$$$A$F$Y$$$20240726$$CN$US$US
241399731$24139973$1$I$$20240717$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113983$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240726$$HP$US$US
241399743$24139974$3$F$$20240923$20240726$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118628$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240924$$HP$US$US
241399761$24139976$1$I$20240715$20240719$20240726$20240726$EXP$$US-ROCHE-10000031900$ROCHE$$65$YR$E$M$Y$$$20240726$$CN$US$US
241399771$24139977$1$I$20240515$20240717$20240726$20240726$EXP$$BR-TAKEDA-2024TUS069516$TAKEDA$$67$YR$$M$Y$64$KG$20240726$$CN$BR$BR
241399781$24139978$1$I$$20240712$20240726$20240726$EXP$$IT-UCBSA-2024036097$UCB$$$$A$M$Y$$$20240726$$CN$IT$IT
241399791$24139979$1$I$20240719$20240719$20240726$20240726$EXP$$US-GSK-US2024091261$GLAXOSMITHKLINE$$19$YR$$M$Y$$$20240726$$CN$US$US
241399801$24139980$1$I$20240719$20240719$20240726$20240726$EXP$GB-MHRA-TPP979304C579002YC1721390830630$GB-RDY-SPO/GBR/24/0010812$DR REDDYS$$71$YR$E$F$Y$63$KG$20240726$$MD$GB$GB
241399811$24139981$1$I$$20240703$20240726$20240726$EXP$$DE-ROCHE-10000035114$ROCHE$$$$$M$Y$$$20240726$$MD$DE$DE
241399823$24139982$3$F$20231219$20240918$20240726$20240924$EXP$AT-Merck Healthcare KGaA-2024034983$AT-ROCHE-10000031767$ROCHE$$60$YR$A$F$Y$80$KG$20240924$$MD$AT$AT
241399831$24139983$1$I$$20240709$20240726$20240726$EXP$$TH-ROCHE-10000032491$ROCHE$$$$$M$Y$$$20240726$$CN$TH$TH
241399841$24139984$1$I$$20240722$20240726$20240726$EXP$$US-TAKEDA-2024TUS074147$TAKEDA$$27$YR$$F$Y$$$20240726$$CN$US$US
241399851$24139985$1$I$20230529$20240716$20240726$20240726$EXP$ES-AEMPS-1545538$ES-TEVA-VS-3222031$TEVA$$76$YR$$F$Y$$$20240726$$MD$ES$ES
241399861$24139986$1$I$$20240718$20240726$20240726$EXP$$CA-TAKEDA-2024TUS073230$TAKEDA$$5$YR$$M$Y$16$KG$20240726$$HP$CA$CA
241399872$24139987$2$F$$20240801$20240726$20240809$EXP$$AT-JNJFOC-20240757456$JOHNSON AND JOHNSON$$47$YR$A$$Y$$$20240809$$MD$AT$AT
241399882$24139988$2$F$$20240809$20240726$20240816$EXP$$FR-JNJFOC-20240771611$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$FR$FR
241399901$24139990$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118548$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240726$$CN$US$US
241399911$24139991$1$I$20240718$20240718$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116212$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240726$$HP$US$US
241399922$24139992$2$F$$20240826$20240726$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117323$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240830$$CN$US$US
241399933$24139993$3$F$$20240810$20240726$20240820$PER$$NVSC2024US147572$NOVARTIS$$$$N$F$Y$$$20240820$$CN$US$US
241399941$24139994$1$I$$20240718$20240726$20240726$EXP$$JP-AstraZeneca-2024A166520$ASTRAZENECA$$$$$$Y$$$20240726$$PH$JP$
241399952$24139995$2$F$20240701$20240725$20240726$20240731$EXP$$US-ABBVIE-5848505$ABBVIE$$70$YR$$F$Y$62.142$KG$20240731$$CN$US$US
241399961$24139996$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147367$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241399972$24139997$2$F$20240714$20240813$20240726$20240822$EXP$$US-VIIV HEALTHCARE LIMITED-US2024089992$VIIV$$39$YR$$F$Y$108.9$KG$20240822$$HP$US$US
241399981$24139998$1$I$$20240717$20240726$20240726$PER$$US-AMGEN-USASP2024144902$AMGEN$Chiu C.; Beam E.; Brumble L.M.et. al. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clinical Transplantation. 2024;38 (7):1-9$44$YR$A$F$Y$$$20240726$$HP$US$US
241399991$24139999$1$I$20240101$20240722$20240726$20240726$EXP$$US-ABBVIE-5851907$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241400002$24140000$2$F$$20240809$20240726$20240812$PER$$US-JNJFOC-20240765962$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$HP$US$US
241400012$24140001$2$F$20240715$20240828$20240726$20240906$PER$$US-TAKEDA-2024TUS071823$TAKEDA$$74$YR$$F$Y$$$20240906$$CN$US$US
241400021$24140002$1$I$20240708$20240720$20240726$20240726$EXP$$US-JNJFOC-20240765092$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240726$$CN$US$US
241400031$24140003$1$I$$20240717$20240726$20240726$EXP$NL-LRB-00986074$NL-JUBILANT CADISTA PHARMACEUTICALS-2024NL001050$JUBILANT$$73$YR$$F$Y$62$KG$20240726$$CN$NL$NL
241400042$24140004$2$F$$20240726$20240726$20240807$EXP$$US-AUROBINDO-AUR-APL-2024-036737$AUROBINDO$Kiskaddon AL, Wilsey M, Gonzalez-Gomez I, Laks J, Miles A, Carapellucci J, et al.. Basiliximab therapy for immune-mediated bowel disease in a pediatric heart transplant patient.. Pediatr-Transplant. 2023;27(2):e14443$10$YR$$F$Y$$$20240807$$HP$US$US
241400051$24140005$1$I$20240625$20240716$20240726$20240726$EXP$FR-AFSSAPS-TS2024000777$FR-TEVA-VS-3222254$TEVA$$51$YR$$M$Y$$$20240726$$MD$FR$FR
241400061$24140006$1$I$20240717$20240722$20240726$20240726$EXP$GB-MHRA-TPP29324321C8579691YC1721221023804$GB-JUBILANT PHARMA LTD-2024GB001066$JUBILANT$$94$YR$$F$Y$53$KG$20240726$$MD$GB$GB
241400071$24140007$1$I$20240722$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146657$AMGEN$$80$YR$E$M$Y$$$20240726$$CN$US$US
241400081$24140008$1$I$$20240703$20240726$20240726$PER$$TR-TOLMAR, INC.-24TR050478$TOLMAR$$74$YR$$M$Y$$$20240726$$MD$TR$TR
241400091$24140009$1$I$$20240705$20240726$20240726$PER$$NL-TOLMAR, INC.-24NL050825$TOLMAR$$$$$M$Y$$$20240726$$CN$NL$NL
241400101$24140010$1$I$20240703$20240704$20240726$20240726$PER$$TR-TOLMAR, INC.-24TR050835$TOLMAR$$$$E$M$Y$$$20240726$$MD$TR$TR
241400111$24140011$1$I$20240704$20240704$20240726$20240726$PER$$TR-TOLMAR, INC.-24TR050830$TOLMAR$$79$YR$$M$Y$$$20240726$$HP$TR$TR
241400121$24140012$1$I$20240501$20240611$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091299$VIIV$$61$YR$$M$Y$$$20240726$$PH$US$US
241400131$24140013$1$I$20240514$20240611$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090372$VIIV$$25$YR$$M$Y$$$20240726$$PH$US$US
241400142$24140014$2$F$20240613$20240730$20240726$20240826$PER$$US-TOLMAR, INC.-24US050252$TOLMAR$$74$YR$$M$Y$$$20240826$$PH$US$US
241400152$24140015$2$F$20240702$20240815$20240726$20240909$PER$$US-TOLMAR, INC.-24US050747$TOLMAR$$63$YR$$M$Y$$$20240909$$HP$US$US
241400161$24140016$1$I$$20240712$20240726$20240726$EXP$$RU-RDY-LIT/RUS/24/0010607$DR REDDYS$Lyadova MA, Gerus AY, Lyadov VK. Development of finger bone necrosis after administration of immune checkpoint inhibitors in a patient with Hodgkin^s lymphoma. Onkologiya. Zhurnal imeni P.A. Gercena. 2021 Jan;10(2): 50-54. doi:10.17116/onkolog20211002150.$36$YR$A$M$Y$$$20240726$$HP$RU$RU
241400171$24140017$1$I$$20240723$20240726$20240726$EXP$GB-MHRA-MIDB-11813d5e-addf-462b-af18-ad8dbe82397e$GB-HALEON-2188723$Haleon PLC$$52$YR$$F$Y$$$20240726$$PH$GB$GB
241400181$24140018$1$I$20240319$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036052$AUROBINDO$$71$YR$$F$Y$$$20240726$$MD$FR$FR
241400191$24140019$1$I$20240304$20240717$20240726$20240726$EXP$$GB-AUROBINDO-AUR-APL-2024-035739$AUROBINDO$$1$DY$$M$Y$185$KG$20240726$$CN$GB$GB
241400201$24140020$1$I$$20240723$20240726$20240726$EXP$GB-MHRA-30767189$GB-ORGANON-O2407GBR002216$ORGANON$$$$$$Y$$$20240726$$CN$GB$GB
241400212$24140021$2$F$20240101$20240812$20240726$20240813$EXP$$US-UCBSA-2024037604$UCB$$$$$F$Y$$$20240813$$CN$US$US
241400221$24140022$1$I$$20240717$20240726$20240726$EXP$$JP-JNJFOC-20240770865$JOHNSON AND JOHNSON$Nakagawa K, Nagatsuka M, Yanai S, Oizumi T, Toriya Y, Matsumoto M, et al. [O-029 A case of small and large intestine CD developing ileal cancer] The 172nd Annual Meeting of the Tohoku Branch of the Japan Gastroenterological Endoscopy Society. 2024.7.6;97$35$YR$A$M$Y$$$20240726$$MD$JP$JP
241400231$24140023$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117778$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$CN$US$US
241400241$24140024$1$I$20240716$20240717$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114478$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240726$$PH$US$US
241400251$24140025$1$I$20240708$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117947$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240726$$HP$US$US
241400262$24140026$2$F$20240501$20240715$20240726$20240801$EXP$$GB-LEO Pharma-372025$LEO PHARM$$29$YR$$F$Y$$$20240801$$HP$GB$GB
241400271$24140027$1$I$$20240715$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407010574$ELI LILLY AND CO$$$$$$Y$$$20240726$$CN$US$US
241400281$24140028$1$I$20240710$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146742$AMGEN$$82$YR$E$F$Y$$$20240726$$CN$US$US
241400291$24140029$1$I$20230703$20240719$20240726$20240726$EXP$$GB-AMGEN-GBRSP2024144632$AMGEN$$51$YR$A$F$Y$$$20240726$$PH$GB$GB
241400301$24140030$1$I$$20240719$20240726$20240726$PER$$US-BAUSCHBL-2024BNL030372$BAUSCH AND LOMB$$$$$F$Y$$$20240724$$CN$US$US
241400312$24140031$2$F$20240701$20240918$20240726$20240925$PER$$US-BAUSCHBL-2024BNL030170$BAUSCH AND LOMB$$$$$F$Y$$$20240926$$CN$US$US
241400322$24140032$2$F$$20240813$20240726$20240820$PER$$US-BAUSCHBL-2024BNL030204$BAUSCH AND LOMB$$$$$F$Y$$$20240821$$CN$US$US
241400331$24140033$1$I$$20240717$20240726$20240726$PER$$US-BAUSCHBL-2024BNL030288$BAUSCH AND LOMB$$$$$F$Y$$$20240725$$CN$US$US
241400342$24140034$2$F$20190416$20240729$20240726$20240806$EXP$$JP-BAUSCHBL-2024BNL030465$BAUSCH AND LOMB$$78$YR$$M$Y$$$20240806$$MD$JP$JP
241400352$24140035$2$F$$20240724$20240726$20240730$PER$$US-BAUSCHBL-2024BNL030431$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240730$$CN$US$US
241400361$24140036$1$I$20220601$20240720$20240726$20240726$EXP$FR-AFSSAPS-BR2024000589$FR-AMGEN-FRASP2024144430$AMGEN$$60$YR$A$F$Y$58$KG$20240726$$MD$FR$FR
241400371$24140037$1$I$$20231023$20240726$20240726$PER$$US-NOVAST LABORATORIES INC.-2023NOV000322$NOVAST$$$$$$Y$$$20240726$$CN$US$US
241400381$24140038$1$I$$20231002$20240726$20240726$PER$$US-NOVAST LABORATORIES INC.-2023NOV000315$NOVAST$$$$$$Y$$$20240726$$MD$US$US
241400391$24140039$1$I$$20240718$20240726$20240726$PER$$US-HALEON-2187949$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
241400402$24140040$2$F$20240723$20240904$20240726$20240911$EXP$$JP-SANDOZ INC.-SDZ2024JP067321$SANDOZ$$88$YR$$F$Y$$$20240911$$PH$JP$JP
241400411$24140041$1$I$$20240718$20240726$20240726$EXP$$NL-AUROBINDO-AUR-APL-2024-036605$AUROBINDO$$85$YR$$F$Y$$$20240726$$MD$NL$NL
241400422$24140042$2$F$20240101$20240816$20240726$20240823$EXP$$US-ABBVIE-5852156$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
241400431$24140043$1$I$$20240715$20240726$20240726$EXP$$TH-ROCHE-10000033900$ROCHE$$$$$M$Y$$$20240726$$MD$TH$TH
241400441$24140044$1$I$20231125$20231126$20240726$20240726$PER$$US-NOVAST LABORATORIES INC.-2023NOV000336$NOVAST$$$$$$Y$$$20240726$$CN$US$US
241400451$24140045$1$I$20240626$20240718$20240726$20240726$EXP$$PK-ROCHE-10000032548$ROCHE$$70$YR$E$M$Y$$$20240726$$CN$PK$PK
241400461$24140046$1$I$20230420$20240717$20240726$20240726$EXP$$FR-ROCHE-3358032$ROCHE$$$$E$F$Y$57$KG$20240726$$MD$FR$FR
241400491$24140049$1$I$$20240718$20240726$20240726$PER$$US-HALEON-2187914$Haleon PLC$$$$$$Y$$$20240719$$CN$US$US
241400501$24140050$1$I$20240601$20240719$20240726$20240726$EXP$$SE-AstraZeneca-2024A164882$ASTRAZENECA$$81$YR$$F$Y$$$20240726$$MD$SE$
241400511$24140051$1$I$$20240718$20240726$20240726$EXP$$BE-ROCHE-10000032769$ROCHE$$15$YR$T$F$Y$$$20240726$$MD$BE$BE
241400521$24140052$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A166141$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241400541$24140054$1$I$20200526$20240723$20240726$20240726$PER$$US-ABBVIE-5853366$ABBVIE$$40$YR$$M$Y$$$20240726$$HP$US$US
241400551$24140055$1$I$20240709$20240724$20240726$20240726$EXP$$CN-ROCHE-10000035524$ROCHE$$78$YR$E$F$Y$48$KG$20240726$$HP$CN$CN
241400561$24140056$1$I$$20231201$20240726$20240726$PER$$US-NOVAST LABORATORIES INC.-2023NOV000337$NOVAST$$$$$$Y$$$20240726$$CN$US$US
241400571$24140057$1$I$$20240723$20240726$20240726$PER$$US-ABBVIE-5854144$ABBVIE$$$$$$Y$$$20240726$$MD$US$US
241400582$24140058$2$F$20240228$20240806$20240726$20240814$EXP$FR-AFSSAPS-TO2024001226$FR-TEVA-VS-3222233$TEVA$$80$YR$$M$Y$69$KG$20240814$$HP$FR$FR
241400591$24140059$1$I$$20231226$20240726$20240726$PER$$US-NOVAST LABORATORIES INC.-2023NOV000354$NOVAST$$$$$$Y$$$20240726$$CN$US$US
241400601$24140060$1$I$$20240722$20240726$20240726$EXP$IE-HPRA-2024-114142$IE-HALEON-2188633$Haleon PLC$$77$YR$$M$Y$$$20240726$$PH$IE$IE
241400611$24140061$1$I$20240709$20240723$20240726$20240726$EXP$$NVSC2024US152005$NOVARTIS$$66$YR$$F$Y$$$20240726$$MD$US$US
241400621$24140062$1$I$$20240109$20240726$20240726$PER$$US-NOVAST LABORATORIES INC.-2024NOV000001$NOVAST$$$$$$Y$$$20240726$$CN$US$US
241400641$24140064$1$I$$20240719$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115923$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240726$$CN$US$US
241400651$24140065$1$I$$20240312$20240726$20240726$PER$$US-NOVAST LABORATORIES INC.-2024NOV000210$NOVAST$$$$$$Y$$$20240726$$CN$US$US
241400664$24140066$4$F$20240626$20240922$20240726$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118526$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240927$$CN$US$US
241400671$24140067$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117332$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240726$$HP$US$US
241400682$24140068$2$F$$20240730$20240726$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118120$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240806$$HP$US$US
241400691$24140069$1$I$$20240702$20240726$20240726$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06366$LUPIN$$$$$$Y$$$20240726$$CN$US$US
241400701$24140070$1$I$20240601$20240722$20240726$20240726$EXP$$GB-AMGEN-GBRSP2024146152$AMGEN$$70$YR$E$F$Y$$$20240726$$CN$GB$GB
241400711$24140071$1$I$$20240329$20240726$20240726$PER$$US-NOVAST LABORATORIES INC.-2024NOV000218$NOVAST$$$$$$Y$$$20240726$$CN$US$US
241400721$24140072$1$I$$20240704$20240726$20240726$EXP$$CA-GSK-CA2023030364$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$CA$CA
241400731$24140073$1$I$20240711$20240722$20240726$20240726$EXP$$US-UCBSA-2024037364$UCB$$32$YR$$F$Y$$$20240726$$CN$US$US
241400741$24140074$1$I$$20240401$20240726$20240726$PER$$US-NOVAST LABORATORIES INC.-2024NOV000222$NOVAST$$$$$$Y$$$20240726$$CN$US$US
241400751$24140075$1$I$20220301$20240723$20240726$20240726$EXP$$AR-ABBVIE-5853878$ABBVIE$$85$YR$$F$Y$$$20240726$$MD$AR$AR
241400762$24140076$2$F$20240605$20240726$20240726$20240802$EXP$$IT-EMD Serono-2024039651$EMD SERONO INC$$79$YR$E$F$Y$$$20240802$$MD$IT$IT
241400771$24140077$1$I$20230101$20240716$20240726$20240726$EXP$$US-BAUSCHBL-2024BNL030250$BAUSCH AND LOMB$$78$YR$$F$Y$$$20240724$$CN$US$US
241400781$24140078$1$I$$20240716$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR089913$VIIV$$$$A$$Y$$$20240726$$CN$US$US
241400791$24140079$1$I$$20240716$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092567$VIIV$$$$$$Y$$$20240726$$HP$US$US
241400801$24140080$1$I$$20240702$20240726$20240726$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06341$LUPIN$$$$$$Y$$$20240726$$CN$US$US
241400811$24140081$1$I$$20240521$20240726$20240726$PER$$US-NOVAST LABORATORIES INC.-2024NOV000246$NOVAST$$$$$$Y$$$20240726$$PH$US$US
241400831$24140083$1$I$$20240718$20240726$20240726$PER$$US-ABBVIE-5849914$ABBVIE$$$$$F$Y$$$20240726$$HP$US$US
241400843$24140084$3$F$$20240819$20240726$20240820$PER$$US-ROCHE-10000032938$ROCHE$$26$YR$A$M$Y$$$20240820$$CN$US$US
241400862$24140086$2$F$$20240801$20240726$20240806$PER$$US-LEO Pharma-372276$LEO PHARM$$81$YR$$M$Y$$$20240806$$CN$US$US
241400872$24140087$2$F$20240702$20240802$20240726$20240812$EXP$$US-VIIV HEALTHCARE LIMITED-US2024089435$VIIV$$74$YR$$M$Y$$$20240812$$CN$US$US
241400881$24140088$1$I$$20240722$20240726$20240726$EXP$$JP-ROCHE-10000012205$ROCHE$$76$YR$E$M$Y$$$20240726$$MD$JP$JP
241400891$24140089$1$I$20240629$20240716$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024089407$VIIV$$31$YR$$M$Y$$$20240726$$HP$US$US
241400901$24140090$1$I$$20240715$20240726$20240726$EXP$$US-RDY-LIT/USA/24/0010747$DR REDDYS$Acosta C, Zhang C, Deutsch G, Graw-Panzer K. A Case of Persistent Tachypnea in a Two-month-old Infant. American Journal of Respiratory and Critical Care Medicine. 2024;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2330.$2$MON$I$M$Y$$$20240726$$HP$US$US
241400911$24140091$1$I$$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024148127$AMGEN$$$$$F$Y$$$20240726$$HP$US$US
241400922$24140092$2$F$20240410$20240731$20240726$20240802$EXP$FR-AFSSAPS-TO2024001252$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039163$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240802$$PH$FR$FR
241400931$24140093$1$I$$20240719$20240726$20240726$EXP$$US-ARGENX-2024-ARGX-US005761$ARGENX BVBA$$$$$$Y$$$20240726$$CN$US$US
241400951$24140095$1$I$20240717$20240719$20240726$20240726$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-116047$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$93.44$KG$20240726$$CN$PR$PR
241400961$24140096$1$I$$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118119$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240726$$CN$US$US
241400971$24140097$1$I$$20240724$20240726$20240726$EXP$GB-MHRA-31081389$GB-ORGANON-O2407GBR002327$ORGANON$$$$$F$Y$$$20240726$$CN$GB$GB
241400981$24140098$1$I$$20240722$20240726$20240726$EXP$$AU-ABBVIE-5850622$ABBVIE$$45$YR$$F$Y$$$20240726$$MD$AU$AU
241401003$24140100$3$F$20240617$20240807$20240726$20240816$30DAY$$US-JNJFOC-20240711133$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240816$$HP$US$US
241401011$24140101$1$I$20240720$20240723$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118382$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240726$$CN$US$US
241401021$24140102$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118595$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240726$$HP$US$US
241401031$24140103$1$I$$20240705$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108427$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240726$$CN$US$US
241401042$24140104$2$F$$20240718$20240726$20240730$EXP$$CA-AstraZeneca-2024A158385$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$CA$
241401051$24140105$1$I$$20210621$20240726$20240726$EXP$$US-AstraZeneca-2021A553421$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241401061$24140106$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A165441$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241401071$24140107$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146812$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
241401081$24140108$1$I$20200201$20200420$20240726$20240726$EXP$$CA-AstraZeneca-2020SE54543$ASTRAZENECA$$688$MON$$M$Y$$$20240726$$CN$CA$
241401091$24140109$1$I$20240723$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146928$AMGEN$$53$YR$A$F$Y$$$20240726$$CN$US$US
241401102$24140110$2$F$20240701$20240824$20240726$20240906$PER$$US-AMGEN-USASP2024147912$AMGEN$$67$YR$E$M$Y$$$20240906$$CN$US$US
241401111$24140111$1$I$20240722$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146835$AMGEN$$46$YR$A$$Y$$$20240726$$CN$US$US
241401121$24140112$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146550$AMGEN$$$$$M$Y$$$20240726$$CN$US$US
241401131$24140113$1$I$$20240722$20240726$20240726$EXP$$ES-TAKEDA-2024TUS075047$TAKEDA$$$$$$Y$$$20240726$$CN$ES$ES
241401141$24140114$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016559$ELI LILLY AND CO$$$$A$M$Y$$$20240726$$CN$US$US
241401151$24140115$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015890$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240726$$CN$US$US
241401161$24140116$1$I$20240724$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016700$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240726$$CN$US$US
241401172$24140117$2$F$$20240830$20240726$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202407016062$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240903$$CN$US$US
241401183$24140118$3$F$$20240824$20240726$20240903$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015732$ELI LILLY AND CO$$70$YR$E$M$Y$88$KG$20240903$$CN$US$US
241401191$24140119$1$I$20240701$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016067$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240726$$CN$US$US
241401201$24140120$1$I$$20240723$20240726$20240726$EXP$$ES-Bion-013528$BIONPHARMA$$32$YR$A$F$Y$$$20240726$$HP$ES$ES
241401212$24140121$2$F$20170301$20240913$20240726$20240921$EXP$$JP-ABBVIE-5847104$ABBVIE$$60$YR$$M$Y$$$20240921$$HP$JP$JP
241401221$24140122$1$I$$20240718$20240726$20240726$EXP$$US-Bion-013525$BIONPHARMA$$$$E$F$Y$$$20240726$$CN$US$US
241401231$24140123$1$I$$20240719$20240726$20240726$EXP$$US-Bion-013526$BIONPHARMA$$$$E$F$Y$$$20240726$$CN$US$US
241401241$24140124$1$I$$20240723$20240726$20240726$EXP$$ES-Bion-013532$BIONPHARMA$$40$YR$A$F$Y$$$20240726$$HP$ES$ES
241401261$24140126$1$I$$20240717$20240726$20240726$EXP$$PL-GSK-PL2024GSK090885$GLAXOSMITHKLINE$Smyk J, Kaminska A, Borowy P, Major P, Go?ojuch K, Batko B. Pityriasis Rubra Pilaris - a difficult path to optimal treatment. Case report. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 2024;52(3):363-367$$$$$Y$$$20240726$$MD$PL$PL
241401273$24140127$3$F$$20240828$20240726$20240904$EXP$PT-JNJFOC-20240725730$PT-GSK-PT2024092650$GLAXOSMITHKLINE$Cabrita SA, Lopo J, Sousa D.. A Paradigmatic Case of Cushing^s Syndrome: A Rare Physiopathology in a Young Patient.. IMAGES IN MEDICINE (IMAGES IN MEDICINE). 2024;2 N.? 2:84-86$$$$$Y$$$20240904$$HP$PT$PT
241401283$24140128$3$F$$20240805$20240726$20240809$EXP$SK-MYLANLABS-2024M1065811$SK-GSK-SK2024092026$GLAXOSMITHKLINE$Pakosova Eva. Courage pays off -a journey to seizure-free. NEUROLOGIA PRE PRAX. 2024;25(3):217-220$$$$$Y$$$20240809$$MD$SK$SK
241401291$24140129$1$I$20240705$20240722$20240726$20240726$EXP$$CO-UCBSA-2024037631$UCB$$36$YR$$F$Y$$$20240726$$CN$CO$CO
241401303$24140130$3$F$20240412$20240829$20240726$20240905$EXP$$CO-ROCHE-10000033138$ROCHE$$$$$F$Y$33.8$KG$20240905$$CN$CO$CO
241401321$24140132$1$I$$20240723$20240726$20240726$EXP$$US-KYOWAKIRIN-2024KK017737$KYOWA$$$$$$Y$$$20240726$$HP$US$US
241401331$24140133$1$I$$20240719$20240726$20240726$PER$$US-ALXN-202407USA001438US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241401341$24140134$1$I$$20240712$20240726$20240726$EXP$$IN-CIPLA LTD.-2024IN07817$CIPLA$Athish KK, Nayak Rao S, Marimuthu VH, Krishna V, Arun A.. Tenofovir-associated kidney dysfunction and bone fracture: A case report and literature review.. Cureus. 2024;16(6):e61562$$$$$Y$$$20240726$$HP$IN$IN
241401352$24140135$2$F$$20240730$20240726$20240802$EXP$$CA-JNJFOC-20240769013$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240802$$CN$CA$CA
241401372$24140137$2$F$$20240726$20240726$20240730$EXP$$US-ROCHE-10000036900$ROCHE$$79$YR$E$M$Y$$$20240730$$CN$US$US
241401381$24140138$1$I$$20240723$20240726$20240726$PER$$US-ABBVIE-5852645$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241401401$24140140$1$I$$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024148306$AMGEN$$$$A$F$Y$$$20240726$$HP$US$US
241401411$24140141$1$I$20240722$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024147540$AMGEN$$$$E$M$Y$$$20240726$$CN$US$US
241401421$24140142$1$I$20240702$20240718$20240726$20240726$EXP$ES-AEMPS-1548344$ES-HIKMA PHARMACEUTICALS-ES-H14001-24-06902$HIKMA$$69$YR$$F$Y$$$20240726$$HP$ES$ES
241401441$24140144$1$I$$20240717$20240726$20240726$EXP$$US-GSK-US2024AMR091313$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241401451$24140145$1$I$$20240717$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092631$VIIV$$$$$$Y$$$20240726$$HP$US$US
241401462$24140146$2$F$$20240829$20240726$20240906$EXP$$CA-CELLTRION INC.-2023CA025518$CELLTRION$$$$$$Y$$$20240906$$MD$CA$CA
241401471$24140147$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118134$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240726$$CN$US$US
241401481$24140148$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117431$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240726$$CN$US$US
241401491$24140149$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117845$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240726$$HP$US$US
241401501$24140150$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118438$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$MD$US$US
241401511$24140151$1$I$$20240715$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113797$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$68.9$KG$20240726$$PH$US$US
241401521$24140152$1$I$20240101$20240719$20240726$20240726$EXP$$NVSC2024FR151309$NOVARTIS$$54$YR$$F$Y$$$20240726$$MD$FR$FR
241401531$24140153$1$I$20240623$20240716$20240726$20240726$EXP$FR-AFSSAPS-PC2024000551$FR-TEVA-VS-3222278$TEVA$$54$YR$$M$Y$76$KG$20240726$$MD$FR$FR
241401541$24140154$1$I$20200503$20240718$20240726$20240726$EXP$PL-URPL-1-3709-2020$PL-TEVA-VS-3223357$TEVA$$26$YR$$F$Y$53$KG$20240726$$MD$PL$PL
241401551$24140155$1$I$20240522$20240716$20240726$20240726$EXP$FR-AFSSAPS-TO2024001158$FR-TEVA-VS-3222353$TEVA$$64$YR$$M$Y$88$KG$20240726$$PH$FR$FR
241401561$24140156$1$I$20240721$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024147040$AMGEN$$63$YR$A$M$Y$$$20240726$$CN$US$US
241401581$24140158$1$I$$20240717$20240726$20240726$EXP$$NL-AUROBINDO-AUR-APL-2024-036993$AUROBINDO$Ten Brinck MFM, Verheijen IWH, van de Wardt J, van Dijk GW, Nijhuis FAP, Verrips A. Dilated fixed pupils and respiratory failure: a rare clinical course of Lambert-Eaton myasthenic syndrome. BMJNeurol-Open. 2023;5 (2):1-4$62$YR$$F$Y$$$20240726$$HP$NL$NL
241401591$24140159$1$I$$20240724$20240726$20240726$EXP$$JP-GILEAD-2024-0681756$GILEAD$$$$E$$Y$$$20240726$$PH$JP$JP
241401601$24140160$1$I$20240719$20240722$20240726$20240726$EXP$$CN-HALEON-2188444$Haleon PLC$$36$YR$$M$Y$$$20240726$$HP$CN$CN
241401611$24140161$1$I$20240501$20240719$20240726$20240726$30DAY$$US-GSK-US2024091104$GLAXOSMITHKLINE$$25$YR$$F$Y$$$20240726$$CN$US$US
241401621$24140162$1$I$20231001$20240719$20240726$20240726$EXP$$CA-GSK-CA2023152224$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$CA$CA
241401631$24140163$1$I$20240718$20240718$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090650$VIIV$$41$YR$$M$Y$$$20240726$$CN$US$US
241401651$24140165$1$I$20231205$20240722$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2023CA030851$SANDOZ$$62$YR$$F$Y$$$20240726$$CN$CA$CA
241401661$24140166$1$I$$20240723$20240726$20240726$PER$$US-ABBVIE-5854394$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241401672$24140167$2$F$$20240726$20240726$20240807$EXP$$US-AUROBINDO-AUR-APL-2024-036501$AUROBINDO$Gravenmier C, Shah B, Hussaini M, Zhang L. Chimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment.. Leukemia + Lymphoma. 2024;65(5):674-678$58$YR$$M$Y$$$20240807$$HP$US$US
241401683$24140168$3$F$20240705$20240919$20240726$20240925$EXP$$US-JNJFOC-20240748220$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240925$$MD$US$US
241401691$24140169$1$I$$20240626$20240726$20240726$EXP$$US-Vifor (International) Inc.-VIT-2024-05801$VIFOR$$$$$F$Y$$$20240726$$CN$US$US
241401702$24140170$2$F$20240701$20240826$20240726$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003091$ACADIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240905$$CN$US$US
241401713$24140171$3$F$20240715$20240730$20240726$20240809$EXP$$US-GSK-US2024AMR092140$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240809$$CN$US$US
241401721$24140172$1$I$$20240715$20240726$20240726$PER$$US-TEVA-VS-3221687$TEVA$$$$A$F$Y$$$20240726$$CN$US$US
241401732$24140173$2$F$$20240730$20240726$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-035747$AUROBINDO$$$$$F$Y$$$20240809$$HP$GB$GB
241401742$24140174$2$F$20240618$20240724$20240726$20240820$PER$$US-APOTEX-2024AP008763$APOTEX$$$$$M$Y$$$20240820$$CN$US$US
241401751$24140175$1$I$$20240719$20240726$20240726$PER$$US-EMD Serono-2024039793$EMD SERONO INC$$25$YR$A$M$Y$$$20240726$$CN$US$US
241401761$24140176$1$I$$20240717$20240726$20240726$EXP$$NL-AUROBINDO-AUR-APL-2024-036283$AUROBINDO$$73$YR$$F$Y$62$KG$20240726$$CN$NL$NL
241401772$24140177$2$F$20230405$20240821$20240726$20240824$EXP$$US-ABBVIE-5850801$ABBVIE$$86$YR$$F$Y$39.009$KG$20240824$$CN$US$US
241401792$24140179$2$F$20240101$20240823$20240726$20240829$EXP$$US-ABBVIE-5850980$ABBVIE$$81$YR$$M$Y$109$KG$20240829$$CN$US$US
241401802$24140180$2$F$$20240724$20240726$20240821$PER$$US-ROCHE-10000036071$ROCHE$$$$T$M$Y$$$20240821$$CN$US$US
241401811$24140181$1$I$$20240720$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117138$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240726$$CN$US$US
241401821$24140182$1$I$20200901$20240717$20240726$20240726$EXP$$PT-AUROBINDO-AUR-APL-2024-036307$AUROBINDO$$72$YR$$M$Y$$$20240726$$MD$PT$PT
241401832$24140183$2$F$20240707$20240909$20240726$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118272$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240911$$CN$US$US
241401841$24140184$1$I$20240628$20240716$20240726$20240726$EXP$FR-AFSSAPS-MP2024001121$FR-TEVA-VS-3222363$TEVA$$79$YR$$F$Y$75$KG$20240726$$PH$FR$FR
241401851$24140185$1$I$$20240724$20240726$20240726$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-118507$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$CN$ES$ES
241401861$24140186$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000035737$ROCHE$$$$$$Y$$$20240726$$CN$US$US
241401871$24140187$1$I$20240501$20240724$20240726$20240726$EXP$$US-ABBVIE-5852722$ABBVIE$$62$YR$$F$Y$$$20240726$$CN$US$US
241401881$24140188$1$I$$20240717$20240726$20240726$EXP$$PT-AUROBINDO-AUR-APL-2024-036461$AUROBINDO$Cruz L. Endocardite com N?dulos e Les?es Janeway. SPMI Case Reports. 2024;2:62-63$52$YR$$M$Y$$$20240726$$MD$PT$PT
241401891$24140189$1$I$$20240716$20240726$20240726$EXP$$AU-TEVA-VS-3222533$TEVA$$4$YR$$F$Y$$$20240726$$HP$AU$AU
241401901$24140190$1$I$$20240723$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US067826$SANDOZ$Sakshi Jain , Sonia Sekhon , Angelin Shamili Leo Pradeep Chandran , Jyotsna Gummadi , Premalkumar Patel , Raghuma Nakka , Tharajan Gunendran , Athmananda Nanjundappa , Tom Jose , Hari Naga Garapati ,. Metformin-Associated Lactic Acidosis in an OlderAdult: A Case Report and Review. Cureus. 2024$82$YR$$M$Y$$$20240726$$HP$US$US
241401911$24140191$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015956$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240726$$CN$US$US
241401921$24140192$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016136$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240726$$CN$US$US
241401931$24140193$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015943$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$US$US
241401942$24140194$2$F$$20240726$20240726$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016978$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240729$$CN$US$US
241401951$24140195$1$I$$20240716$20240726$20240726$EXP$$AU-TEVA-VS-3222558$TEVA$$86$YR$$M$Y$$$20240726$$HP$AU$AU
241401971$24140197$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016129$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$US$US
241401981$24140198$1$I$$20240718$20240726$20240726$EXP$$GB-TAKEDA-2024TUS074152$TAKEDA$$$$$M$Y$$$20240726$$CN$GB$GB
241401992$24140199$2$F$$20240729$20240726$20240731$EXP$$CA-ROCHE-3477102$ROCHE$$$$A$F$Y$$$20240731$$CN$CA$CA
241402003$24140200$3$F$20240101$20240808$20240726$20240810$PER$$US-AMGEN-USASP2024146511$AMGEN$$$$$$Y$$$20240810$$CN$US$US
241402012$24140201$2$F$20240101$20240723$20240726$20240730$PER$$US-AMGEN-USASP2024146939$AMGEN$$78$YR$E$F$Y$$$20240730$$PH$US$US
241402032$24140203$2$F$20240701$20240814$20240726$20240823$EXP$$US-INTERCEPT-PM2024001435$INTERCEPT PHARMACEUTICALS$$50$YR$$F$Y$$$20240823$$CN$US$US
241402041$24140204$1$I$$20240716$20240726$20240726$PER$$US-TEVA-VS-3222566$TEVA$$$$$$Y$$$20240726$$PH$US$US
241402051$24140205$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000035598$ROCHE$$28$YR$A$F$Y$$$20240726$$HP$US$US
241402061$24140206$1$I$20240101$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036267$AUROBINDO$$37$YR$$F$Y$$$20240726$$MD$FR$FR
241402071$24140207$1$I$20240531$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036255$AUROBINDO$$23$YR$$F$Y$$$20240726$$CN$FR$FR
241402081$24140208$1$I$20240718$20240724$20240726$20240726$EXP$$US-TAKEDA-2024TUS074942$TAKEDA$$65$YR$$M$Y$$$20240726$$CN$US$US
241402091$24140209$1$I$20240715$20240722$20240726$20240726$EXP$$AR-ABBVIE-5851631$ABBVIE$$43$YR$$F$Y$$$20240726$$CN$AR$AR
241402101$24140210$1$I$$20240701$20240726$20240726$PER$$US-SCIEGENP-2024SCSPO00326$SCIEGEN$$74$YR$E$M$Y$248$KG$20240726$$CN$US$US
241402111$24140211$1$I$$20240718$20240726$20240726$EXP$$JP-ROCHE-10000034343$ROCHE$$8$DEC$E$M$Y$$$20240726$$MD$JP$JP
241402121$24140212$1$I$$20240712$20240726$20240726$EXP$$ES-ASTELLAS-2024US020886$ASTELLAS$$14$YR$$M$Y$48$KG$20240726$$CN$ES$ES
241402132$24140213$2$F$$20240719$20240726$20240726$EXP$$US-ROCHE-10000032024$ROCHE$$$$E$M$Y$$$20240726$$HP$US$US
241402141$24140214$1$I$$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024148315$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241402152$24140215$2$F$$20240724$20240726$20240726$EXP$$US-ROCHE-10000035731$ROCHE$$64$YR$A$M$Y$$$20240726$$CN$US$US
241402161$24140216$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164425$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241402171$24140217$1$I$$20240719$20240726$20240726$EXP$$ZA-AstraZeneca-2024A165885$ASTRAZENECA$$78$YR$$F$Y$$$20240726$$CN$ZA$
241402182$24140218$2$F$$20240828$20240726$20240905$EXP$$JP-AstraZeneca-2024A166541$ASTRAZENECA$$$$$$Y$$$20240905$$PH$JP$
241402192$24140219$2$F$$20240821$20240726$20240826$EXP$$AU-TAKEDA-2024TUS074450$TAKEDA$$$$$F$Y$$$20240826$$CN$AU$AU
241402201$24140220$1$I$$20240717$20240726$20240726$PER$$US-ROCHE-10000030487$ROCHE$$$$A$F$Y$$$20240726$$MD$US$US
241402211$24140221$1$I$20231101$20240724$20240726$20240726$EXP$$US-ROCHE-10000010144$ROCHE$$73$YR$E$M$Y$106.59$KG$20240726$$CN$US$US
241402221$24140222$1$I$$20240717$20240726$20240726$EXP$$GB-AUROBINDO-AUR-APL-2024-035750$AUROBINDO$$59$YR$$F$Y$$$20240726$$PH$GB$GB
241402231$24140223$1$I$20230401$20240717$20240726$20240726$EXP$$IT-AMGEN-ITANI2024142736$AMGEN$$61$YR$A$F$Y$100$KG$20240726$$MD$IT$IT
241402251$24140225$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214728$SANOFI AVENTIS$$$$A$F$Y$56.689$KG$20240726$$MD$US$US
241402262$24140226$2$F$$20240712$20240726$20240801$PER$$US-SA-2024SA207774$SANOFI AVENTIS$$$$$F$Y$$$20240719$$CN$US$US
241402271$24140227$1$I$20240715$20240717$20240726$20240726$PER$$US-SA-2024SA214118$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240726$$MD$US$US
241402281$24140228$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA215214$SANOFI AVENTIS$$$$A$M$Y$165$KG$20240726$$MD$US$US
241402291$24140229$1$I$20240716$20240717$20240726$20240726$PER$$US-SA-2024SA215090$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240726$$MD$US$US
241402301$24140230$1$I$20240701$20240717$20240726$20240726$PER$$US-SA-2024SA214686$SANOFI AVENTIS$$63$YR$A$M$Y$83.9$KG$20240726$$MD$US$US
241402311$24140231$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA213364$SANOFI AVENTIS$$52$YR$A$M$Y$90.7$KG$20240726$$MD$US$US
241402322$24140232$2$F$20240101$20240813$20240726$20240826$PER$$US-SA-2024SA215148$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240826$$CN$US$US
241402331$24140233$1$I$20240201$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-035674$AUROBINDO$Zieneldien T, Kim J, Greene J. Breakthrough pneumocystis jirovecii pneumonia in an allogeneic hematopoietic stem cell transplant recipient. Cureus. 2024;16(6):e61890$50$YR$$F$Y$$$20240726$$MD$US$US
241402351$24140235$1$I$$20240715$20240726$20240726$EXP$$US-PBT-009555$PANACEA BIOTEC$Shirini K, Kamberi S, Drachenberg C, Haririan A, Saharia K, Meier RPH. Renal transplantation using kidneys from a donor with high grade cytomegalovirus viraemia: case report and literature review. Lancet Infect Dis. 2024 Jul 8:S1473-3099(24)00359-1. doi: 10.1016/S1473-3099(24)00359-1.$61$YR$A$M$Y$$$20240726$$MD$US$US
241402361$24140236$1$I$20240701$20240717$20240726$20240726$PER$$US-SA-2024SA214717$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240726$$MD$US$US
241402371$24140237$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA214785$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240726$$MD$US$US
241402381$24140238$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA215065$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240726$$MD$US$US
241402393$24140239$3$F$$20240726$20240726$20240805$PER$$US-SA-2024SA216611$SANOFI AVENTIS$$$$A$F$Y$63$KG$20240805$$MD$US$US
241402401$24140240$1$I$20240712$20240717$20240726$20240726$PER$$US-SA-2024SA212095$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240726$$MD$US$US
241402412$24140241$2$F$20240101$20240805$20240726$20240813$PER$$US-SA-2024SA215135$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240814$$MD$US$US
241402421$24140242$1$I$20240717$20240717$20240726$20240726$PER$$US-SA-2024SA214745$SANOFI AVENTIS$$$$$F$Y$$$20240726$$MD$US$US
241402431$24140243$1$I$20210810$20240717$20240726$20240726$PER$$US-SA-2023SA223172$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240726$$MD$US$US
241402442$24140244$2$F$20240704$20240829$20240726$20240903$EXP$$PK-ROCHE-10000033385$ROCHE$$34$YR$A$F$Y$$$20240903$$CN$PK$PK
241402454$24140245$4$F$20240713$20240827$20240726$20240903$EXP$$US-TAKEDA-2024TUS073174$TAKEDA$$70$YR$$M$Y$$$20240903$$CN$US$US
241402464$24140246$4$F$20240822$20240917$20240726$20240920$EXP$$US-TAKEDA-2024TUS073941$TAKEDA$$28$YR$$M$Y$$$20240920$$CN$US$US
241402471$24140247$1$I$20240701$20240718$20240726$20240726$PER$$US-SA-2024SA214881$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240726$$CN$US$US
241402481$24140248$1$I$20240301$20240717$20240726$20240726$PER$$US-SA-2024SA213345$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240726$$MD$US$US
241402491$24140249$1$I$20240601$20240717$20240726$20240726$PER$$US-SA-2024SA215071$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240726$$MD$US$US
241402501$24140250$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA217038$SANOFI AVENTIS$$$$$F$Y$$$20240726$$CN$US$US
241402511$24140251$1$I$20240712$20240717$20240726$20240726$PER$$US-SA-2024SA215120$SANOFI AVENTIS$$33$YR$A$M$Y$63$KG$20240726$$MD$US$US
241402521$24140252$1$I$20240701$20240718$20240726$20240726$PER$$US-SA-2024SA214903$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240726$$MD$US$US
241402531$24140253$1$I$20230201$20240717$20240726$20240726$PER$$US-SA-2024SA083628$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240726$$MD$US$US
241402541$24140254$1$I$20240715$20240717$20240726$20240726$PER$$US-SA-2024SA213602$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240726$$MD$US$US
241402551$24140255$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA212376$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240726$$MD$US$US
241402561$24140256$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216469$SANOFI AVENTIS$$$$E$M$Y$78.47$KG$20240726$$MD$US$US
241402571$24140257$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA215105$SANOFI AVENTIS$$$$A$F$Y$107$KG$20240726$$MD$US$US
241402581$24140258$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA213515$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240726$$MD$US$US
241402591$24140259$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA213113$SANOFI AVENTIS$$$$$$Y$$$20240726$$CN$US$US
241402601$24140260$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216190$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240726$$MD$US$US
241402611$24140261$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA217793$SANOFI AVENTIS$$$$T$M$Y$73.48$KG$20240726$$MD$US$US
241402621$24140262$1$I$$20240722$20240726$20240726$EXP$$JP-ASTELLAS-2024JP004649$ASTELLAS$$9$DEC$$M$Y$$$20240726$$MD$JP$JP
241402631$24140263$1$I$$20240724$20240726$20240726$EXP$NL-LRB-00992850$NL-ASTELLAS-2024EU007360$ASTELLAS$$70$YR$$M$Y$$$20240726$$CN$NL$NL
241402641$24140264$1$I$20240702$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036299$AUROBINDO$$60$YR$$M$Y$81$KG$20240726$$PH$FR$FR
241402651$24140265$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216594$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241402661$24140266$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA214818$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240726$$MD$US$US
241402671$24140267$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216583$SANOFI AVENTIS$$$$T$M$Y$$$20240726$$MD$US$US
241402681$24140268$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216244$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241402691$24140269$1$I$20240101$20240719$20240726$20240726$PER$$US-SA-2024SA217592$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240726$$MD$US$US
241402701$24140270$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA215640$SANOFI AVENTIS$$$$A$$Y$$$20240726$$MD$US$US
241402711$24140271$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215509$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240726$$MD$US$US
241402721$24140272$1$I$20240701$20240719$20240726$20240726$PER$$US-SA-2024SA216559$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240726$$MD$US$US
241402732$24140273$2$F$$20240905$20240726$20240914$PER$$US-SA-2024SA216730$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240914$$HP$US$US
241402741$24140274$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA215688$SANOFI AVENTIS$$17$YR$T$F$Y$55.329$KG$20240726$$PH$US$US
241402751$24140275$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214985$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240726$$MD$US$US
241402761$24140276$1$I$20240101$20240719$20240726$20240726$PER$$US-SA-2024SA216530$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240726$$MD$US$US
241402771$24140277$1$I$20240718$20240718$20240726$20240726$PER$$US-SA-2024SA216710$SANOFI AVENTIS$$89$YR$E$F$Y$69.8$KG$20240726$$MD$US$US
241402782$24140278$2$F$20240301$20240802$20240726$20240816$PER$$US-SA-2024SA216889$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240816$$MD$US$US
241402791$24140279$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA217732$SANOFI AVENTIS$$$$C$F$Y$$$20240726$$MD$US$US
241402801$24140280$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215157$SANOFI AVENTIS$$$$$F$Y$$$20240726$$HP$US$US
241402811$24140281$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216256$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240726$$MD$US$US
241402821$24140282$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA216552$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241402831$24140283$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA215722$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240726$$MD$US$US
241402841$24140284$1$I$20230101$20240719$20240726$20240726$PER$$US-SA-2024SA216883$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240726$$MD$US$US
241402851$24140285$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA216547$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240726$$MD$US$US
241402861$24140286$1$I$20240601$20240719$20240726$20240726$PER$$US-SA-2024SA216708$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240726$$MD$US$US
241402871$24140287$1$I$20240401$20240719$20240726$20240726$PER$$US-SA-2024SA215415$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240726$$MD$US$US
241402881$24140288$1$I$$20240722$20240726$20240726$EXP$$JP-LEO Pharma-372238$LEO PHARM$$74$YR$$F$Y$$$20240726$$MD$JP$JP
241402891$24140289$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA214948$SANOFI AVENTIS$$$$C$M$Y$$$20240726$$HP$US$US
241402901$24140290$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA214707$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240726$$CN$US$US
241402912$24140291$2$F$20240101$20240815$20240726$20240828$PER$$US-SA-2024SA216752$SANOFI AVENTIS$$49$YR$A$F$Y$89.3$KG$20240828$$MD$US$US
241402921$24140292$1$I$20240101$20240719$20240726$20240726$PER$$US-SA-2024SA217671$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240726$$CN$US$US
241402931$24140293$1$I$$20240723$20240726$20240726$PER$$US-SA-2024SA218397$SANOFI AVENTIS$$$$$F$Y$$$20240726$$CN$US$US
241402941$24140294$1$I$$20240723$20240726$20240726$PER$$US-SA-2024SA217792$SANOFI AVENTIS$$$$$F$Y$$$20240726$$CN$US$US
241402953$24140295$3$F$$20240820$20240726$20240902$PER$$US-SA-2024SA216936$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240902$$CN$US$US
241402961$24140296$1$I$20240101$20240719$20240726$20240726$PER$$US-SA-2024SA217724$SANOFI AVENTIS$$14$YR$T$F$Y$50$KG$20240726$$CN$US$US
241402971$24140297$1$I$20240501$20240722$20240726$20240726$PER$$US-SA-2024SA216080$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240726$$MD$US$US
241402981$24140298$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA214854$SANOFI AVENTIS$$11$YR$C$F$Y$35.9$KG$20240726$$MD$US$US
241402991$24140299$1$I$20240101$20240719$20240726$20240726$PER$$US-SA-2024SA217517$SANOFI AVENTIS$$13$YR$T$F$Y$62.686$KG$20240726$$MD$US$US
241403001$24140300$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA216447$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240726$$MD$US$US
241403011$24140301$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA218031$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240726$$CN$US$US
241403021$24140302$1$I$$20240723$20240726$20240726$PER$$US-SA-2024SA218324$SANOFI AVENTIS$$$$$F$Y$$$20240726$$CN$US$US
241403031$24140303$1$I$20240101$20240719$20240726$20240726$PER$$US-SA-2024SA214930$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240726$$CN$US$US
241403041$24140304$1$I$$20240723$20240726$20240726$PER$$US-SA-2024SA218381$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240726$$CN$US$US
241403052$24140305$2$F$$20240724$20240726$20240802$PER$$US-SA-2024SA218358$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240802$$CN$US$US
241403061$24140306$1$I$20240101$20240722$20240726$20240726$PER$$US-SA-2024SA216969$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240726$$MD$US$US
241403071$24140307$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA217620$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240726$$MD$US$US
241403081$24140308$1$I$$20240717$20240726$20240726$EXP$$NL-AUROBINDO-AUR-APL-2024-036374$AUROBINDO$$75$YR$$M$Y$80$KG$20240726$$CN$NL$NL
241403091$24140309$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA216376$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240726$$CN$US$US
241403101$24140310$1$I$20240101$20240723$20240726$20240726$PER$$US-009507513-2407USA013062$MERCK$$66$YR$$F$Y$$$20240726$$CN$US$US
241403111$24140311$1$I$$20240718$20240726$20240726$EXP$NL-LRB-00985460$NL-TEVA-VS-3223327$TEVA$$39$YR$$F$Y$74$KG$20240726$$CN$NL$NL
241403121$24140312$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118647$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240726$$HP$US$US
241403132$24140313$2$F$20240701$20240905$20240726$20240924$EXP$$US-SA-2024SA214428$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240924$$MD$US$US
241403141$24140314$1$I$$20240717$20240726$20240726$EXP$NO-NOMAADVRE-PASRAPP-2024-Vdkdz5$NO-TEVA-VS-3222505$TEVA$$63$YR$$M$Y$98$KG$20240726$$CN$NO$NO
241403151$24140315$1$I$20240101$20240719$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116077$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240726$$CN$US$US
241403161$24140316$1$I$$20240724$20240726$20240726$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-118520$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$CN$ES$ES
241403171$24140317$1$I$$20210709$20240726$20240726$EXP$$US-AstraZeneca-2021A614910$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241403181$24140318$1$I$$20240723$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117426$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$HP$US$US
241403191$24140319$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118032$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240726$$CN$US$US
241403201$24140320$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117249$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240726$$HP$US$US
241403211$24140321$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118576$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240726$$CN$US$US
241403221$24140322$1$I$$20240724$20240726$20240726$EXP$$US-AstraZeneca-2024A168756$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241403231$24140323$1$I$$20240717$20240726$20240726$EXP$$US-JNJFOC-20240749160$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$CN$US$US
241403241$24140324$1$I$$20240718$20240726$20240726$EXP$$PL-AstraZeneca-2024A166935$ASTRAZENECA$$$$$F$Y$$$20240726$$MD$PL$
241403251$24140325$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164698$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241403261$24140326$1$I$$20240702$20240726$20240726$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092144$GLENMARK$$$$$$Y$$$20240726$$CN$US$US
241403271$24140327$1$I$20240329$20240723$20240726$20240726$PER$$US-ORGANON-O2407USA002225$ORGANON$$17$YR$$F$Y$42.63$KG$20240726$$CN$US$US
241403281$24140328$1$I$20240711$20240718$20240726$20240726$EXP$$JP-ROCHE-10000036044$ROCHE$$$$$F$Y$$$20240726$$MD$JP$JP
241403291$24140329$1$I$$20240722$20240726$20240726$EXP$$BR-ASTELLAS-2024US020910$ASTELLAS$$$$$M$Y$$$20240726$$PH$BR$BR
241403301$24140330$1$I$20220101$20240723$20240726$20240726$EXP$$US-ROCHE-10000034843$ROCHE$$51$YR$A$F$Y$85.72$KG$20240726$$CN$US$US
241403312$24140331$2$F$20231201$20240808$20240726$20240813$PER$$US-SA-2024SA216633$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240814$$MD$US$US
241403321$24140332$1$I$$20240722$20240726$20240726$PER$$US-ABBVIE-5851373$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241403331$24140333$1$I$$20240724$20240726$20240726$PER$$US-ABBVIE-5854605$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241403341$24140334$1$I$20240724$20240724$20240726$20240726$EXP$$AE-ABBVIE-5852818$ABBVIE$$72$YR$$M$Y$$$20240726$$CN$AE$AE
241403351$24140335$1$I$$20240719$20240726$20240726$PER$$US-BIOGEN-2024BI01274760$BIOGEN$$$$$M$Y$$$20240726$$CN$US$US
241403361$24140336$1$I$20240708$20240719$20240726$20240726$PER$$US-BIOGEN-2024BI01274797$BIOGEN$$57$YR$$F$Y$$$20240726$$CN$US$US
241403371$24140337$1$I$$20240712$20240726$20240726$EXP$$US-ROCHE-10000026562$ROCHE$$17$YR$T$F$Y$$$20240726$$MD$US$US
241403382$24140338$2$F$$20240808$20240726$20240814$EXP$$JP-GSK-JP2024JPN091414$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$PH$JP$JP
241403401$24140340$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024145375$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241403411$24140341$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214711$SANOFI AVENTIS$$$$A$M$Y$$$20240726$$MD$US$US
241403421$24140342$1$I$20231115$20240716$20240726$20240726$EXP$FR-AFSSAPS-TO2024001137$FR-TEVA-VS-3222359$TEVA$$45$YR$$F$Y$$$20240726$$MD$FR$FR
241403431$24140343$1$I$20240610$20240717$20240726$20240726$EXP$$GB-TEVA-VS-3222696$TEVA$$51$YR$$F$Y$67$KG$20240726$$HP$GB$GB
241403441$24140344$1$I$20240614$20240722$20240726$20240726$PER$$US-SA-2024SA217973$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240726$$MD$US$US
241403451$24140345$1$I$$20240712$20240726$20240726$PER$$US-ADVANZ PHARMA-202407005761$ADVANZ PHARMA$$$$$$Y$$$20240726$$CN$US$US
241403462$24140346$2$F$20240628$20240730$20240726$20240807$EXP$$RS-COLLEGIUM PHARMACEUTICAL, INC.-20240700535$COLLEGIUM PHARMACEUTICAL$$60$YR$$M$Y$$$20240807$$MD$RS$RS
241403471$24140347$1$I$20211025$20240715$20240726$20240726$EXP$$JP-COLLEGIUM PHARMACEUTICAL, INC.-20240700540$COLLEGIUM PHARMACEUTICAL$$$$$F$Y$$$20240726$$MD$JP$JP
241403481$24140348$1$I$$20240722$20240726$20240726$EXP$$US-JNJFOC-20240757777$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$CN$US$US
241403491$24140349$1$I$20240507$20240717$20240726$20240726$EXP$FR-AFSSAPS-PA2024001285$FR-TEVA-VS-3222769$TEVA$$67$YR$$M$Y$86$KG$20240726$$PH$FR$FR
241403501$24140350$1$I$$20240724$20240726$20240726$PER$$NVSC2024US152778$NOVARTIS$$$$$M$Y$$$20240726$$CN$US$US
241403511$24140351$1$I$$20240723$20240726$20240726$EXP$$CA-HALEON-2188484$Haleon PLC$$65$YR$$F$Y$34$KG$20240726$$HP$CA$CA
241403521$24140352$1$I$$20240718$20240726$20240726$PER$$US-APOTEX-2024AP008621$APOTEX$Adesina J, Patel A, Khan S.. MANY REASONS FOR RESTLESS LEGS, NOT TO REST. Sleep. 2024;47(Suppl 1):A494$52$YR$$M$Y$$$20240726$$HP$US$US
241403531$24140353$1$I$$20240717$20240726$20240726$PER$$US-ADVANZ PHARMA-202407006077$ADVANZ PHARMA$$$$$$Y$$$20240726$$HP$US$US
241403543$24140354$3$F$20240612$20240903$20240726$20240905$EXP$$CA-ROCHE-10000035419$ROCHE$$47$YR$A$F$Y$$$20240905$$CN$CA$CA
241403551$24140355$1$I$20230101$20240724$20240726$20240726$PER$$US-ROCHE-10000037335$ROCHE$$53$YR$A$F$Y$$$20240726$$CN$US$US
241403562$24140356$2$F$$20240724$20240726$20240730$EXP$$US-ABBVIE-5850124$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241403572$24140357$2$F$20230901$20240730$20240726$20240807$EXP$$CN-REGENERON PHARMACEUTICALS, INC.-2023-127105$REGENERON$$61$YR$$M$Y$$$20240807$$CN$CN$CN
241403582$24140358$2$F$$20240715$20240726$20240726$EXP$$US-ROCHE-10000033137$ROCHE$Menke BA, Wagner W, Song H, Thomas W, Almeida NEC, Conrady CD, et al. Case report: CMV retinitis following local and systemic immunosuppression. Frontiers in Ophthalmology.2024;4:1354104. doi: 10.3389/fopht.2024.1354104.$71$YR$E$M$Y$$$20240726$$HP$US$US
241403591$24140359$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000036645$ROCHE$$$$$$Y$$$20240726$$CN$US$US
241403602$24140360$2$F$20240721$20240805$20240726$20240815$EXP$$IT-UCBSA-2024036089$UCB$$$$E$M$Y$$$20240815$$CN$IT$IT
241403611$24140361$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-036596$AUROBINDO$Song JJ, Eyabi JC, Awatramani PD, Mitchell BG, Nene SY. Sudden Reduction in Caffeine Intake Increases Serum Lithium Concentration to Supratherapeutic Level: A Case Report. Prim-Care-Comp-CNS-Disorders. 2024;26:2$59$YR$$M$Y$$$20240726$$HP$US$US
241403621$24140362$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-036966$AUROBINDO$Lee R, Gonsalves Z, Wang S, Hussain A, Herrera K.. Case study: Autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks^ gestation.. Case-Rep-Perinat-Med. 2024;13 (1):20240007$29$YR$$F$Y$$$20240726$$MD$US$US
241403631$24140363$1$I$$20240722$20240726$20240726$EXP$$JP-ASTELLAS-2024JP005242$ASTELLAS$$71$YR$$F$Y$$$20240726$$PH$JP$JP
241403642$24140364$2$F$20240718$20240821$20240726$20240830$EXP$$JP-VANTIVE-2024VAN018459$Vantive US Healthcare$$$$$M$Y$$$20240830$$MD$JP$JP
241403651$24140365$1$I$$20240723$20240726$20240726$EXP$$CN-VANTIVE-2024VAN018558$Vantive US Healthcare$$$$$M$Y$$$20240726$$CN$CN$CN
241403661$24140366$1$I$$20240723$20240726$20240726$EXP$$CN-VANTIVE-2024VAN018557$Vantive US Healthcare$$$$$M$Y$$$20240726$$CN$CN$CN
241403671$24140367$1$I$20240704$20240719$20240726$20240726$EXP$$CO-VANTIVE-2024VAN018507$Vantive US Healthcare$$46$YR$$F$Y$$$20240726$$HP$CO$CO
241403682$24140368$2$F$20240702$20240816$20240726$20240822$EXP$$CZ-SA-2024SA212709$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240822$$MD$CZ$CZ
241403691$24140369$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117743$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240726$$CN$US$US
241403701$24140370$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016057$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$US$US
241403711$24140371$1$I$20240101$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015111$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$US$US
241403731$24140373$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016192$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240726$$CN$US$US
241403742$24140374$2$F$$20240724$20240726$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407016040$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240731$$CN$US$US
241403751$24140375$1$I$20240617$20240712$20240726$20240726$EXP$$IE-ROCHE-10000032858$ROCHE$$36$YR$A$F$Y$$$20240726$$HP$IE$IE
241403771$24140377$1$I$$20240720$20240726$20240726$EXP$$US-JNJFOC-20240759190$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$CN$US$US
241403781$24140378$1$I$20240701$20240724$20240726$20240726$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01049$AIMMUNE$$$$$$Y$$$20240726$$HP$US$US
241403792$24140379$2$F$20240701$20240829$20240726$20240909$EXP$$US-ASTELLAS-2024US021088$ASTELLAS$$82$YR$E$M$Y$$$20240909$$CN$US$US
241403811$24140381$1$I$$20240717$20240726$20240726$EXP$$MT-AUROBINDO-AUR-APL-2024-036799$AUROBINDO$Debrincat, M., Pullicino, R., + Pace, A.. An unusual case of adult-onset acute disseminated encephalomyelitis. 2024$57$YR$$M$Y$$$20240726$$HP$MT$MT
241403821$24140382$1$I$20240701$20240716$20240726$20240726$EXP$$US-VIIV HEALTHCARE LIMITED-US2024089428$VIIV$$65$YR$$M$Y$$$20240726$$CN$US$US
241403831$24140383$1$I$20240709$20240716$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024089493$VIIV$$28$YR$$M$Y$$$20240726$$HP$US$US
241403841$24140384$1$I$$20240722$20240726$20240726$EXP$$CA-TAKEDA-2024TUS074446$TAKEDA$$$$$M$Y$$$20240726$$CN$CA$CA
241403851$24140385$1$I$$20240719$20240726$20240726$EXP$$CA-TAKEDA-2024TUS074136$TAKEDA$$$$$M$Y$$$20240726$$MD$CA$CA
241403861$24140386$1$I$20240721$20240721$20240726$20240726$EXP$GB-MHRA-MED-202407211006196690-CFHYB$GB-TORRENT-00037321$TORRENT$$56$YR$A$M$Y$80$KG$20240726$$CN$GB$GB
241403871$24140387$1$I$$20240719$20240726$20240726$EXP$GB-MHRA-TPP49423561C11562390YC1721321484481$GB-TORRENT-00037314$TORRENT$$5$YR$C$M$Y$17$KG$20240726$$MD$GB$GB
241403881$24140388$1$I$$20240717$20240726$20240726$EXP$$IN-TORRENT-00003613$TORRENT$$58$YR$A$M$Y$$$20240726$$HP$IN$IN
241403891$24140389$1$I$$20240716$20240726$20240726$EXP$$US-TORRENT-00013688$TORRENT$$$$$F$Y$$$20240726$$CN$US$US
241403901$24140390$1$I$$20240722$20240726$20240726$EXP$$US-GSK-US2024AMR092451$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241403911$24140391$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165534$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241403921$24140392$1$I$$20240716$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113498$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240726$$HP$US$US
241403931$24140393$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165460$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241403941$24140394$1$I$$20240724$20240726$20240726$PER$$NVSC2024US153012$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
241403951$24140395$1$I$$20230316$20240726$20240726$EXP$$GB-AstraZeneca-2022A248193$ASTRAZENECA$$$$$$Y$$$20240726$$HP$GB$
241403961$24140396$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165737$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241403971$24140397$1$I$20210101$20220207$20240726$20240726$EXP$$SG-AstraZeneca-2022A064723$ASTRAZENECA$$74$YR$$$Y$$$20240726$$CN$SG$
241403981$24140398$1$I$$20240718$20240726$20240726$EXP$$US-TAKEDA-2024TUS039294$TAKEDA$$$$$F$Y$$$20240726$$CN$US$US
241403991$24140399$1$I$$20240722$20240726$20240726$EXP$$ZA-AstraZeneca-2024A166708$ASTRAZENECA$$52$YR$$M$Y$$$20240726$$CN$ZA$
241404001$24140400$1$I$$20240719$20240726$20240726$EXP$$CA-TOLMAR, INC.-24CA051167$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241404012$24140401$2$F$20240812$20240812$20240726$20240821$PER$$CA-TOLMAR, INC.-24CA051202$TOLMAR$$83$YR$$M$Y$$$20240821$$CN$CA$CA
241404021$24140402$1$I$$20240719$20240726$20240726$EXP$$CA-TOLMAR, INC.-24CA051221$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241404031$24140403$1$I$20160802$20240719$20240726$20240726$EXP$$CA-TAKEDA-2024TUS074266$TAKEDA$$65$YR$$M$Y$$$20240726$$CN$CA$CA
241404041$24140404$1$I$20200427$20240717$20240726$20240726$EXP$$AU-002147023-NVSC2020AU143499$Haleon PLC$$80$YR$$F$Y$$$20240726$$HP$AU$AU
241404051$24140405$1$I$20240715$20240726$20240726$20240726$EXP$IT-MINISAL02-996302$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042127$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$70$KG$20240726$$MD$IT$IT
241404061$24140406$1$I$20230901$20240717$20240726$20240726$EXP$$PT-AUROBINDO-AUR-APL-2024-036372$AUROBINDO$$45$YR$$F$Y$$$20240726$$MD$PT$PT
241404082$24140408$2$F$20240719$20240724$20240726$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003524$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240816$$CN$US$US
241404091$24140409$1$I$$20230823$20240726$20240726$PER$$US-APOTEX-2023AP012906$APOTEX$Park L, Green C, Arutyunyan S, Vasile G, Buckley C, Weiss E.. Effects of canary seed on two patients with disseminated granuloma annulare. Dermatology Reports. 2023;15(2):9614$80$YR$$F$Y$$$20240726$$HP$US$US
241404101$24140410$1$I$$20240712$20240726$20240726$EXP$$VN-ROCHE-10000035752$ROCHE$Nguyen T, Sang P, Hoa N, Quy N. Evaluation of the effectiveness of treatment for stage III-IV epithelial ovarian cancer with paclitaxel-carboplatin regimen combined with bevacizumab at Viet Tiep friendship hospital. Vietnam medical journal. 2024-Jun;539:496-504.$$$$$Y$$$20240726$$MD$VN$VN
241404111$24140411$1$I$$20240717$20240726$20240726$EXP$$US-MYLANLABS-2024M1068427$MYLAN$Wilson P, Rosenstengle C, Spak C. Underrecognized cause diarrhea in solid organ transplant: a report of astroviridae enteritis in liver transplant. Transpl-Infect-Dis 2024; 26 (2):.$72$YR$$M$Y$$$20240726$$MD$US$US
241404121$24140412$1$I$$20240716$20240726$20240726$EXP$$ZA-MYLANLABS-2024M1068124$MYLAN$Frigati LJ, Rabie H. Third-Line Antiretroviral Therapy: What Do We Do When the Appropriate Formulations Are Not Available?. Children-(Basel) 2022; 9 (4): 1-6.$2$YR$$M$Y$10.9$KG$20240726$$HP$ZA$ZA
241404131$24140413$1$I$$20240716$20240726$20240726$EXP$$US-MYLANLABS-2024M1068554$MYLAN$Rhoads S, Maloney J, Mantha A, Van Hook R, Henao-Martinez AF. Pneumocystis jirovecii Pneumonia in HIV-Negative, Non-transplant Patients: Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention. Curr-Fungal-Infect-Rep 2024; 18 (2): 125-135.$34$YR$$F$Y$$$20240726$$HP$US$US
241404141$24140414$1$I$$20240722$20240726$20240726$EXP$$NVSC2024CZ153009$NOVARTIS$$$$A$F$Y$$$20240726$$MD$CZ$CZ
241404151$24140415$1$I$20240716$20240716$20240726$20240726$30DAY$$US-GSK-US2024089541$GLAXOSMITHKLINE$$45$YR$$M$Y$$$20240726$$CN$US$US
241404161$24140416$1$I$20240524$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036234$AUROBINDO$$87$YR$$M$Y$$$20240726$$MD$FR$FR
241404171$24140417$1$I$$20240719$20240726$20240726$EXP$$NVSC2024AU151489$NOVARTIS$Forcey DS, Wong V, Pham A, Patil S, Basu G. Post allogeneic stem cell transplant nephrotic syndrome secondary to de novo glomerulopathy: A case series. JOURNAL OF ONCO-NEPHROLOGY. 2024;8(1):3-12$58$YR$$M$Y$$$20240726$$HP$AU$AU
241404181$24140418$1$I$$20240717$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092221$VIIV$$$$$$Y$$$20240726$$HP$US$US
241404191$24140419$1$I$$20240718$20240726$20240726$EXP$$US-TAKEDA-2024TUS073417$TAKEDA$$70$YR$$M$Y$$$20240726$$CN$US$US
241404201$24140420$1$I$20240625$20240717$20240726$20240726$EXP$$CN-TAKEDA-2024TUS074514$TAKEDA$$77$YR$$M$Y$80$KG$20240726$$HP$CN$CN
241404211$24140421$1$I$20240404$20240718$20240726$20240726$EXP$$CN-ROCHE-10000033356$ROCHE$$51$YR$A$F$Y$$$20240726$$MD$CN$CN
241404221$24140422$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA218171$SANOFI AVENTIS$$60$YR$A$M$Y$107$KG$20240726$$MD$US$US
241404231$24140423$1$I$$20231107$20240726$20240726$PER$$US-APOTEX-2023AP015408$APOTEX$$$$$M$Y$$$20240726$$PH$US$US
241404242$24140424$2$F$20240713$20240723$20240726$20240731$EXP$$CN-TAKEDA-2024TUS074614$TAKEDA$$46$YR$$M$Y$65$KG$20240731$$HP$CN$CN
241404252$24140425$2$F$$20240719$20240726$20240802$EXP$$AU-ORGANON-O2407AUS002027$ORGANON$Malhi G.S, Bell E, Bassett D, Boyce P, Hopwood M, Mulder R, et al.. Difficult decision-making in major depressive disorder: Practical guidance based on clinical research and experience. Bipolar-Disord. 2023;25 (5):355-78$41$YR$$M$Y$$$20240802$$HP$AU$AU
241404271$24140427$1$I$$20240718$20240726$20240726$PER$$US-ABBVIE-5851068$ABBVIE$$$$$$Y$$$20240726$$CN$US$US
241404281$24140428$1$I$20240620$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036336$AUROBINDO$$38$YR$$F$Y$$$20240726$$HP$FR$FR
241404291$24140429$1$I$20201104$20240718$20240726$20240726$EXP$$US-TAKEDA-2024TUS073164$TAKEDA$$57$YR$$M$Y$71.3$KG$20240726$$MD$US$US
241404302$24140430$2$F$$20240726$20240726$20240805$EXP$$CN-MYLANLABS-2024M1027313$MYLAN$$$$A$M$Y$$$20240805$$CN$CN$CN
241404311$24140431$1$I$20230726$20240716$20240726$20240726$EXP$FR-EMA-DD-20240708-7482715-134933$FR-TEVA-VS-3222685$TEVA$$64$YR$$F$Y$57.2$KG$20240726$$PH$FR$FR
241404321$24140432$1$I$$20240725$20240726$20240726$PER$$US-HALEON-2189026$Haleon PLC$$68$YR$$$Y$$$20240726$$CN$US$US
241404331$24140433$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000035566$ROCHE$$52$YR$A$M$Y$$$20240726$$MD$US$US
241404342$24140434$2$F$$20240801$20240726$20240805$EXP$$US-KYOWAKIRIN-2024KK017788$KYOWA$$$$$$Y$$$20240805$$CN$US$US
241404352$24140435$2$F$$20240822$20240726$20240831$30DAY$$US-GSK-US2024091840$GLAXOSMITHKLINE$$$$$F$Y$$$20240831$$CN$US$US
241404362$24140436$2$F$$20240814$20240726$20240819$30DAY$$US-GSK-US2024090168$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
241404371$24140437$1$I$20231115$20240719$20240726$20240726$EXP$$CA-GSK-CA2023161720$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$CA$CA
241404381$24140438$1$I$20210101$20240717$20240726$20240726$EXP$$GB-AUROBINDO-AUR-APL-2024-035771$AUROBINDO$$34$YR$$M$Y$80$KG$20240726$$CN$GB$GB
241404391$24140439$1$I$$20240718$20240726$20240726$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009199$STRIDES$Adesina J, Patel A, Khan S.. MANY REASONS FOR RESTLESS LEGS, NOT TO REST.. Sleep. 2024;47 (Suppl.):A494 abstr. 1153$$$$M$Y$$$20240726$$HP$US$US
241404401$24140440$1$I$20130101$20240716$20240726$20240726$EXP$$GB-AUROBINDO-AUR-APL-2013-06018$AUROBINDO$$50$YR$$M$Y$$$20240726$$MD$GB$GB
241404411$24140441$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000036726$ROCHE$$$$$$Y$$$20240726$$HP$US$US
241404421$24140442$1$I$$20240109$20240726$20240726$PER$$US-APOTEX-2024AP001046$APOTEX$Borja A, Khandelwal M, Morgan F.. Management of Severe Gestational Hypertriglyceridemia. Journal of the Endocrine Society. 2020;4 (Supple. 1):A408-A409$29$YR$$F$Y$$$20240726$$HP$US$US
241404432$24140443$2$F$20240101$20240809$20240726$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-014719$UNITED THERAPEUTICS$$$$$M$Y$60.771$KG$20240817$$$US$US
241404441$24140444$1$I$20240101$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118191$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240726$$HP$US$US
241404451$24140445$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117698$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$66.68$KG$20240726$$CN$US$US
241404461$24140446$1$I$20240710$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118314$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$73.3$KG$20240726$$PH$US$US
241404471$24140447$1$I$20240614$20240715$20240726$20240726$EXP$FR-AFSSAPS-AN2024000900$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109982$ZYDUS PHARM$$$$$$Y$$$20240726$$MD$FR$FR
241404481$24140448$1$I$20240519$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036312$AUROBINDO$$58$YR$$F$Y$58$KG$20240726$$MD$FR$FR
241404491$24140449$1$I$20240601$20240715$20240726$20240726$EXP$FR-AFSSAPS-AVNT2024000506$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109992$ZYDUS PHARM$$$$$$Y$$$20240726$$PH$FR$FR
241404501$24140450$1$I$20240101$20240715$20240726$20240726$EXP$FR-AFSSAPS-PA2024001336$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110035$ZYDUS PHARM$$$$$$Y$$$20240726$$PH$FR$FR
241404511$24140451$1$I$$20240722$20240726$20240726$EXP$$SG-JNJFOC-20240763238$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240726$$HP$SG$SG
241404521$24140452$1$I$20240701$20240722$20240726$20240726$EXP$$JP-GENMAB-2024-02640$GENMAB$$8$DEC$$M$Y$$$20240726$$MD$JP$JP
241404531$24140453$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222613$TEVA$$83$YR$$M$Y$$$20240726$$HP$CA$CA
241404541$24140454$1$I$$20240718$20240726$20240726$EXP$NL-LRB-00985419$NL-TEVA-VS-3223772$TEVA$$57$YR$$M$Y$72$KG$20240726$$CN$NL$NL
241404551$24140455$1$I$$20240722$20240726$20240726$EXP$$NVSC2024CA042290$NOVARTIS$$43$YR$$F$Y$$$20240726$$CN$CA$CA
241404562$24140456$2$F$$20240729$20240726$20240801$EXP$$US-ROCHE-2881891$ROCHE$$52$YR$A$M$Y$$$20240801$$MD$US$US
241404572$24140457$2$F$$20240815$20240726$20240815$PER$$US-ALXN-202407USA001439US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240815$$PH$US$US
241404581$24140458$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215731$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241404591$24140459$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164495$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241404601$24140460$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118710$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240726$$CN$US$US
241404611$24140461$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214802$SANOFI AVENTIS$$$$I$M$Y$1.793$KG$20240726$$MD$US$US
241404621$24140462$1$I$$20240719$20240726$20240726$EXP$$ZA-AstraZeneca-2024A165709$ASTRAZENECA$$72$YR$$M$Y$$$20240726$$CN$ZA$
241404631$24140463$1$I$$20210427$20240726$20240726$EXP$$CA-AstraZeneca-2021A365131$ASTRAZENECA$$$$$M$Y$$$20240726$$PH$CA$
241404641$24140464$1$I$20240701$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016699$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240726$$CN$US$US
241404651$24140465$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016426$ELI LILLY AND CO$$55$YR$A$$Y$$$20240726$$CN$US$US
241404662$24140466$2$F$$20240906$20240726$20240912$PER$$US-AstraZeneca-2024A167158$ASTRAZENECA$$79$YR$$M$Y$$$20240912$$MD$US$
241404681$24140468$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164570$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241404691$24140469$1$I$$20240725$20240726$20240726$PER$$US-ROCHE-10000038395$ROCHE$$49$YR$A$M$Y$$$20240726$$MD$US$US
241404701$24140470$1$I$$20240718$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407013064$ELI LILLY AND CO$$71$YR$E$F$Y$120.18$KG$20240726$$CN$US$US
241404711$24140471$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016093$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240726$$CN$US$US
241404721$24140472$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016270$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240726$$CN$US$US
241404732$24140473$2$F$$20240909$20240726$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202407015907$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240912$$CN$US$US
241404741$24140474$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015980$ELI LILLY AND CO$$$$A$M$Y$$$20240726$$CN$US$US
241404751$24140475$1$I$20240101$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016140$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240726$$CN$US$US
241404761$24140476$1$I$$20240725$20240726$20240726$EXP$AT-Accord-433729$AT-ROCHE-10000036673$ROCHE$Schuller-Gotzburg D. Unklare Wesensveranderung und Aphasie. JATROS NEUROLOGIE +amp; PSYCHIATRIE. 2024;32(03):31-33$52$YR$A$F$Y$$$20240726$$MD$AT$AT
241404773$24140477$3$F$20240101$20240807$20240726$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-022717$UNITED THERAPEUTICS$$$$$F$Y$77.098$KG$20240816$$$US$US
241404781$24140478$1$I$$20240717$20240726$20240726$PER$$US-JNJFOC-20240764674$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$MD$US$US
241404791$24140479$1$I$20240701$20240719$20240726$20240726$PER$$US-ABBVIE-5848899$ABBVIE$$$$$$Y$$$20240726$$CN$US$US
241404801$24140480$1$I$20240620$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036300$AUROBINDO$$24$YR$$M$Y$85$KG$20240726$$MD$FR$FR
241404811$24140481$1$I$20240624$20240724$20240726$20240726$EXP$$AR-ABBVIE-5853272$ABBVIE$$37$YR$$M$Y$$$20240726$$HP$AR$AR
241404821$24140482$1$I$20240706$20240722$20240726$20240726$EXP$$PK-ROCHE-10000034592$ROCHE$$39$YR$A$M$Y$$$20240726$$CN$PK$PK
241404831$24140483$1$I$20230101$20230714$20240726$20240726$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004474$ARBOR$$$$$F$Y$$$20240726$$CN$US$US
241404841$24140484$1$I$20190101$20240718$20240726$20240726$EXP$$FR-AMGEN-FRASP2024144681$AMGEN$Baruchel A.; Dourthe M.; Yakouben K. et al.. Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia. British Journal of Haematology. 2024;205 (1):373-377$4$YR$C$M$Y$$$20240726$$HP$FR$FR
241404851$24140485$1$I$20240701$20240717$20240726$20240726$PER$$US-SA-2024SA215121$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240726$$MD$US$US
241404861$24140486$1$I$$20240719$20240726$20240726$EXP$$SI-AMGEN-SVNSP2024144253$AMGEN$$86$YR$E$F$Y$$$20240726$$HP$SI$SI
241404871$24140487$1$I$$20240725$20240726$20240726$PER$$US-HALEON-2189103$Haleon PLC$$$$$$Y$$$20240726$$CN$US$US
241404881$24140488$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146966$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
241404891$24140489$1$I$$20240723$20240726$20240726$EXP$$US-AMGEN-USASP2024146814$AMGEN$Hu X.; Chirovsky D.; Walker M.S. et al.. A retrospective analysis of treatment patterns, overall survival, and real-world disease-free survival in early-stage non-small cell lung cancer following complete resection. BMC Pulmonary Medicine. 2024;24 (1):1-11$$$$$Y$$$20240726$$HP$US$US
241404901$24140490$1$I$$20240725$20240726$20240726$PER$$US-ROCHE-3554347$ROCHE$$$$$F$Y$$$20240726$$MD$US$US
241404911$24140491$1$I$20240101$20240529$20240726$20240726$30DAY$$US-UCBSA-2024027952$UCB$$$$$F$Y$$$20240726$$CN$US$US
241404921$24140492$1$I$20240709$20240723$20240726$20240726$EXP$GB-MHRA-MED-202407231210550910-LSYKQ$GB-MYLANLABS-2024M1068916$MYLAN$$$$$M$Y$$$20240726$$PH$GB$GB
241404931$24140493$1$I$20240224$20240723$20240726$20240726$EXP$$HU-MYLANLABS-2024M1068888$MYLAN$$40$YR$$M$Y$$$20240726$$HP$HU$HU
241404941$24140494$1$I$$20240717$20240726$20240726$EXP$$US-RDY-SPO/USA/24/0010770$DR REDDYS$$32$YR$A$F$Y$$$20240726$$CN$US$US
241404951$24140495$1$I$$20240722$20240726$20240726$EXP$$GB-MYLANLABS-2024M1068533$MYLAN$$$$$M$Y$$$20240726$$CN$GB$GB
241404961$24140496$1$I$$20240719$20240726$20240726$EXP$$IR-MYLANLABS-2024M1069369$MYLAN$Vahedi M, Malek A. Raynaud^s phenomenon and ischemic fingers in a 6-year-old child: Coagulopathy following COVID-19 or the first presentation of rheumatic disease: Case report and literature review abstract. Pediatr-Rheumatol 2023; 21 (Suppl. 2) abstr. P253.$6$YR$$F$Y$$$20240726$$HP$IR$IR
241404971$24140497$1$I$20240101$20240719$20240726$20240726$EXP$$FI-MYLANLABS-2024M1069275$MYLAN$$62$YR$$F$Y$$$20240726$$MD$FI$FI
241404981$24140498$1$I$$20240718$20240726$20240726$EXP$$US-GALDERMA-US2024011831$GALDERMA$$$$$$Y$$$20240726$$CN$US$US
241404991$24140499$1$I$$20240715$20240726$20240726$PER$$US-ROCHE-10000027802$ROCHE$$$$E$M$Y$$$20240726$$CN$US$US
241405001$24140500$1$I$$20240725$20240726$20240726$EXP$$FR-ABBVIE-5852845$ABBVIE$$70$YR$$M$Y$$$20240726$$PH$FR$FR
241405011$24140501$1$I$$20231129$20240726$20240726$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67789$HIKMA$$$$$$Y$$$20240725$$MD$US$US
241405021$24140502$1$I$$20230909$20240726$20240726$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65279$HIKMA$$$$$$Y$$$20240725$$MD$US$US
241405031$24140503$1$I$20240313$20240715$20240726$20240726$EXP$DK-DKMA-30729344$DK-ROCHE-10000027249$ROCHE$$52$YR$A$F$Y$64$KG$20240726$$MD$DK$DK
241405041$24140504$1$I$$20230621$20240726$20240726$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-62852$HIKMA$$$$$$Y$$$20240725$$HP$US$US
241405051$24140505$1$I$20240708$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147472$AMGEN$$71$YR$E$M$Y$$$20240726$$CN$US$US
241405061$24140506$1$I$20240712$20240716$20240726$20240726$EXP$$US-Accord-436896$ACCORD$$29$YR$A$M$Y$$$20240726$$HP$US$US
241405072$24140507$2$F$20240621$20240829$20240726$20240909$EXP$DE-BFARM-24004931$DE-Accord-437286$ACCORD$$85$YR$E$F$Y$$$20240909$$MD$DE$DE
241405081$24140508$1$I$$20240717$20240726$20240726$EXP$IT-MINISAL02-994828$IT-Accord-437042$ACCORD$$72$YR$E$F$Y$$$20240726$$MD$IT$IT
241405091$24140509$1$I$20240709$20240716$20240726$20240726$EXP$$US-Accord-437216$ACCORD$$30$YR$A$F$Y$$$20240726$$HP$US$US
241405101$24140510$1$I$20230222$20240717$20240726$20240726$EXP$BE-EMA-2024711-AUTODUP-1720651253832$BE-Accord-436996$ACCORD$$63$YR$A$F$Y$56$KG$20240726$$MD$BE$BE
241405111$24140511$1$I$$20240714$20240726$20240726$EXP$$IT-Accord-437164$ACCORD$Mura C, Sonnino R, Crispino L, Rota CA, Pontecorvi A. Graves^ Disease in Hypopituitarism Due to Pituitary Apoplexy. Endocr Metab Immune Disord Drug Targets. 2024 Jul 11.$41$YR$A$F$Y$$$20240726$$HP$IT$
241405121$24140512$1$I$$20240717$20240726$20240726$EXP$CA-MHPD-001083681$CA-Accord-436969$ACCORD$$36$YR$A$M$Y$$$20240726$$CN$CA$CA
241405131$24140513$1$I$20230209$20240717$20240726$20240726$EXP$BE-EMA-2024710-AUTODUP-1720643455977$BE-Accord-437329$ACCORD$$48$YR$A$F$Y$62$KG$20240726$$MD$BE$BE
241405141$24140514$1$I$$20240722$20240726$20240726$PER$$FR-IDORSIA-008306-2024-FR$IDORSIA PHARMACEUTICALS$$45$YR$$F$Y$$$20240726$$MD$FR$FR
241405151$24140515$1$I$$20240722$20240726$20240726$EXP$$US-BEH-2024176224$CSL BEHRING$$$$A$M$Y$$$20240726$$CN$US$US
241405161$24140516$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118549$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240726$$CN$US$US
241405171$24140517$1$I$$20240723$20240726$20240726$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-008883$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240726$$MD$TW$TW
241405181$24140518$1$I$20240719$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118445$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$65.32$KG$20240726$$PH$US$US
241405191$24140519$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118543$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240726$$CN$US$US
241405202$24140520$2$F$$20240801$20240726$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06951$LUPIN$$$$$$Y$$$20240818$$CN$US$US
241405212$24140521$2$F$$20240812$20240726$20240812$EXP$$US-ALXN-202407USA001669US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240812$$PH$US$US
241405222$24140522$2$F$$20240906$20240726$20240909$PER$$NVSC2024US152967$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
241405232$24140523$2$F$20240703$20240906$20240726$20240909$EXP$$PK-ROCHE-10000032537$ROCHE$$53$YR$A$F$Y$$$20240909$$CN$PK$PK
241405245$24140524$5$F$20220601$20240828$20240726$20240902$30DAY$$CA-SANDOZ INC.-NVSC2022CA132128$SANDOZ$$35$YR$$F$Y$$$20240902$$CN$CA$CA
241405251$24140525$1$I$20240503$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036313$AUROBINDO$$47$YR$$F$Y$63$KG$20240726$$MD$FR$FR
241405263$24140526$3$F$20240723$20240826$20240726$20240901$PER$$US-AMGEN-USASP2024147252$AMGEN$$43$YR$A$M$Y$$$20240901$$HP$US$US
241405272$24140527$2$F$$20240830$20240726$20240913$EXP$$AU-JUBILANT CADISTA PHARMACEUTICALS-2024AU001062$JUBILANT$$78$YR$$F$Y$$$20240913$$HP$AU$AU
241405284$24140528$4$F$20240101$20240909$20240726$20240919$EXP$$JP-INSMED, INC.-2024-00789-JP$INSMED$$69$YR$$M$Y$$$20240919$$CN$JP$JP
241405291$24140529$1$I$$20240723$20240726$20240726$EXP$$CA-ORGANON-O2407CAN002147$ORGANON$$44$YR$$F$Y$$$20240726$$HP$CA$CA
241405311$24140531$1$I$$20240717$20240726$20240726$30DAY$$US-GSK-US2024090088$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$MD$US$US
241405321$24140532$1$I$$20240717$20240726$20240726$30DAY$$US-GSK-US2024090081$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241405331$24140533$1$I$20240715$20240716$20240726$20240726$30DAY$$US-GSK-US2024090144$GLAXOSMITHKLINE$$42$YR$$F$Y$$$20240726$$CN$US$US
241405341$24140534$1$I$$20240718$20240726$20240726$EXP$$CA-APOTEX-2024AP008604$APOTEX$$62$YR$$M$Y$$$20240726$$CN$CA$CA
241405351$24140535$1$I$20240618$20240722$20240726$20240726$EXP$$US-AstraZeneca-2024A167078$ASTRAZENECA$$34098$DY$$F$Y$$$20240726$$HP$US$
241405362$24140536$2$F$20240605$20240827$20240726$20240830$EXP$$JP-AstraZeneca-2024A134706$ASTRAZENECA$$74$YR$$F$Y$$$20240830$$MD$JP$
241405373$24140537$3$F$20240501$20240730$20240726$20240827$EXP$$IE-AstraZeneca-2024A169769$ASTRAZENECA$$51$YR$$F$Y$$$20240827$$MD$IE$
241405381$24140538$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165866$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241405392$24140539$2$F$$20240730$20240726$20240809$EXP$$US-TEVA-VS-3223145$TEVA$Pokhriyal SC, Chowdhury T, Al-Ghuraibawi MM, Aryal B, Bellamkonda A, Nagpal S, et al. Navigating Antiphospholipid Syndrome- Failure of Suction Thrombectomy and Recurrent Saddle Embolus. Am-J-Respir-Crit-Care-Med 2024; 209.; Pokhriyal SC, Chowdhury T, Al-Ghuraibawi MM, Aryal B, Bellamkonda A, Nagpal S, et al. Navigating Antiphospholipid Syndrome- Failure of Suction Thrombectomy and Recurrent Saddle Embolus. Am-J-Respir-Crit-Care-Med 2024; 209.$41$YR$$F$Y$$$20240809$$HP$US$US
241405401$24140540$1$I$$20240722$20240726$20240726$PER$$US-ABBVIE-5853576$ABBVIE$$$$$$Y$$$20240726$$CN$US$US
241405411$24140541$1$I$20240606$20240717$20240726$20240726$EXP$$ES-AUROBINDO-AUR-APL-2024-036229$AUROBINDO$$83$YR$$F$Y$$$20240726$$MD$ES$ES
241405421$24140542$1$I$20240607$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-035766$AUROBINDO$$89$YR$$F$Y$36.5$KG$20240726$$MD$FR$FR
241405432$24140543$2$F$20240603$20240918$20240726$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-036262$AUROBINDO$$26$YR$$M$Y$$$20240927$$MD$ES$ES
241405441$24140544$1$I$20240501$20240718$20240726$20240726$EXP$$GB-862174955-ML2024-04069$Unknown Manufacturer$$62$YR$A$F$Y$82$KG$20240726$$MD$GB$GB
241405451$24140545$1$I$$20240716$20240726$20240726$EXP$$US-862174955-ML2024-04079$Unknown Manufacturer$Kim HJ, Brill D, Giuliari GP. OCCLUSIVE CYTOMEGALOVIRUS PANUVEITIS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT. RETINAL CASES AND BRIEF REPORTS. 2024;18(4): 442-445.$60$YR$A$M$Y$$$20240726$$MD$US$US
241405462$24140546$2$F$20231201$20240819$20240726$20240826$PER$$US-ROCHE-10000034148$ROCHE$$55$YR$A$F$Y$$$20240826$$CN$US$US
241405471$24140547$1$I$$20240425$20240726$20240726$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06397$HIKMA$Madero-Marroquin R, DuVall AS, Saygin C, Wang P, Gurbuxani S, Larson RA. Madero-Marroquin R, DuVall AS, Saygin C, Wang P, Gurbuxani S, Larson RA, et al. Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors.. British Journal of Haematology. 2024;204(4):1238-42$$$$$Y$$$20240726$$MD$US$US
241405481$24140548$1$I$$20240716$20240726$20240726$EXP$$IN-862174955-ML2024-04067$UNKNOWN$Dehade A, Chakrabarti SS, Reddy NTS, Kaur U. Dopaminergic Drugs and Valproate-associated Refractory Hyponatremia Over Levosulpiride-induced Parkinsonism in an Elderly Female Patient When Deprescribing was the Only Therapy. Curr-Drug-Saf 2024; no pagination.$74$YR$E$F$Y$$$20240726$$HP$IN$IN
241405492$24140549$2$F$20240711$20240730$20240726$20240805$EXP$$US-BAYER-2024A103437$BAYER$$26$YR$A$F$Y$$$20240805$$MD$US$US
241405501$24140550$1$I$$20240719$20240726$20240726$EXP$$PT-MYLANLABS-2024M1069237$MYLAN$Maio MB, Ferreira R. Epidural test dose in obstetrics - is it really a reassuring test?. Region-Anesth-Pain-Med 2023; 48 (Suppl. 1) A239-A240 abstr. 36308.$$$$F$Y$$$20240726$$HP$PT$PT
241405511$24140551$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-036689$AUROBINDO$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF.. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult.. J-Pain-Symptom-Manage. 2023;66(4):e455-e459$$$A$$Y$$$20240726$$HP$US$US
241405521$24140552$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214822$SANOFI AVENTIS$$$$T$F$Y$$$20240726$$MD$US$US
241405531$24140553$1$I$20240717$20240717$20240726$20240726$PER$$US-SA-2024SA212060$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240726$$MD$US$US
241405541$24140554$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-037109$AUROBINDO$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage. 2023;66(4):e455-e459$$$A$$Y$$$20240726$$HP$US$US
241405552$24140555$2$F$20240714$20240808$20240726$20240819$EXP$$JP-INSMED, INC.-2024-02919-JP$INSMED$$71$YR$$M$Y$$$20240819$$PH$JP$JP
241405571$24140557$1$I$20240101$20240723$20240726$20240726$EXP$$NVSC2024CA151590$NOVARTIS$$$$E$F$Y$$$20240726$$CN$CA$CA
241405582$24140558$2$F$$20240821$20240726$20240829$EXP$$GB-VANTIVE-2024VAN018505$Vantive US Healthcare$$$$$M$Y$$$20240829$$MD$GB$GB
241405591$24140559$1$I$20240601$20240719$20240726$20240726$EXP$$US-GSK-US2024091074$GLAXOSMITHKLINE$$84$YR$$F$Y$$$20240726$$CN$US$US
241405603$24140560$3$F$20240701$20240827$20240726$20240903$EXP$$NVSJ2024JP009013$NOVARTIS$$57$YR$$F$Y$$$20240903$$MD$JP$JP
241405621$24140562$1$I$20240715$20240717$20240726$20240726$EXP$$GB-AUROBINDO-AUR-APL-2024-035824$AUROBINDO$$80$YR$$F$Y$77$KG$20240726$$HP$GB$GB
241405631$24140563$1$I$20211129$20240717$20240726$20240726$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-116124$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240726$$HP$KR$KR
241405641$24140564$1$I$$20240722$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116810$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240726$$CN$US$US
241405651$24140565$1$I$20240724$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118952$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240726$$CN$US$US
241405661$24140566$1$I$$20240718$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116425$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$39.01$KG$20240726$$CN$US$US
241405671$24140567$1$I$$20240719$20240726$20240726$EXP$$NVSC2024AU150568$NOVARTIS$Holmes Z, Foley P, Baker C, Daniel BS. Dupilumab for chronic actinic dermatitis: A case series and review of the literature. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2024;65(3):287-91$85$YR$$M$Y$$$20240726$$HP$AU$AU
241405682$24140568$2$F$$20240725$20240726$20240808$EXP$$ES-ORGANON-O2407ESP002424$ORGANON$Bascuas Arribas M, Camino Serrano M, Sanz Santiago V, Lppez-Neyra A.. Severe asthma resistant to biological treatment.. Anales de Pediatria. 2024$$$$F$Y$$$20240808$$HP$ES$ES
241405691$24140569$1$I$$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036225$AUROBINDO$$14$YR$$M$Y$$$20240726$$MD$FR$FR
241405711$24140571$1$I$20240611$20240717$20240726$20240726$EXP$$ES-AUROBINDO-AUR-APL-2024-036282$AUROBINDO$$84$YR$$F$Y$49$KG$20240726$$MD$ES$ES
241405721$24140572$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015920$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240726$$CN$US$US
241405731$24140573$1$I$20240701$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015268$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240726$$CN$US$US
241405741$24140574$1$I$$20240717$20240726$20240726$EXP$$IT-AUROBINDO-AUR-APL-2024-036692$AUROBINDO$Raveglia F, Libretti L, Cioffi U, Guttadauro A, Petrella F. Minimally Invasive Surgical Management of Chronic Cough-Induced Rib Fracture Non-Union: A Case Report. American Journal of Case Reports. 2024;25:e943222$54$YR$$M$Y$$$20240726$$HP$IT$IT
241405751$24140575$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015990$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240726$$CN$US$US
241405761$24140576$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016167$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240726$$HP$US$US
241405771$24140577$1$I$20240713$20240719$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407011835$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240726$$CN$US$US
241405781$24140578$1$I$20240621$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407014888$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240726$$CN$US$US
241405791$24140579$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016103$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240726$$CN$US$US
241405801$24140580$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016272$ELI LILLY AND CO$$46$YR$A$$Y$$$20240726$$CN$US$US
241405811$24140581$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016205$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240726$$CN$US$US
241405821$24140582$1$I$20240705$20240715$20240726$20240726$PER$$US-TAKEDA-2024TUS071827$TAKEDA$$66$YR$$$Y$$$20240726$$MD$US$US
241405831$24140583$1$I$20240721$20240723$20240726$20240726$EXP$$CN-ROCHE-10000034654$ROCHE$$71$YR$E$F$Y$$$20240726$$CN$CN$CN
241405841$24140584$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-036917$AUROBINDO$Ayman S, Rayna P. A CD1A NEGATIVE BIOPSY AND A CD1A POSITIVE BIOPSY: AN EXTREMELY RARE PRESENTATION OF  ROSAI-DORFMAN DISEASE WITH LANGERHANS CELL HISTIOCYTOSIS. Journal of Investigative Medicine. 2023;7(7):144-146$14$YR$$F$Y$$$20240726$$HP$US$US
241405851$24140585$1$I$$20240717$20240726$20240726$EXP$$GB-AUROBINDO-AUR-APL-2024-036701$AUROBINDO$Byrne F, Sethi K, Mooney H. 8 The gym, a Spanish holiday and a headache. Clinical Infection in Practice. 2023;20 (Suppl. 1)$46$YR$$M$Y$$$20240726$$HP$GB$GB
241405861$24140586$1$I$$20240719$20240726$20240726$PER$$US-ALXN-202407USA001383US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$US$US
241405871$24140587$1$I$20240702$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036320$AUROBINDO$$$DY$$M$Y$$$20240726$$PH$FR$FR
241405882$24140588$2$F$$20240802$20240726$20240814$EXP$$US-UCBSA-2024037600$UCB$$$$$F$Y$$$20240814$$HP$US$US
241405891$24140589$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146457$AMGEN$$$$$M$Y$$$20240726$$CN$US$US
241405901$24140590$1$I$$20240719$20240726$20240726$EXP$$US-MYLANLABS-2024M1069227$MYLAN$Dillon J, Bernik S, Zeizafoun N, Balija T. Benign phyllodes tumour in a transgender woman receiving hormonal therapy. BMJ-Case-Rep 2024; 17 (3).$5$DEC$$M$Y$$$20240726$$MD$US$US
241405911$24140591$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214064$SANOFI AVENTIS$$$$E$F$Y$$$20240726$$MD$US$US
241405921$24140592$1$I$20240101$20240712$20240726$20240726$PER$$US-SA-2024SA210291$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240726$$MD$US$US
241405933$24140593$3$F$20240603$20240923$20240726$20240927$EXP$ES-ACRAF SpA-2024-035047$ES-UCBSA-2024036888$UCB$$26$YR$$M$Y$$$20240927$$MD$ES$ES
241405941$24140594$1$I$$20240718$20240726$20240726$EXP$$US-SA-2024SA214360$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241405951$24140595$1$I$$20240425$20240726$20240726$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06395$HIKMA$Madero-Marroquin R, DuVall AS, Saygin C, Wang P, Gurbuxani S, Larson RA, et al.. Madero-Marroquin R, DuVall AS, Saygin C, Wang P, Gurbuxani S, Larson RA, et al. Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors. British Journal of Haematology. 2024;204(4):1238-42$65$YR$$M$Y$$$20240726$$MD$US$US
241405962$24140596$2$F$20231101$20240830$20240726$20240909$EXP$$JP-JNJFOC-20240771621$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240909$$MD$JP$JP
241405971$24140597$1$I$20240724$20240725$20240726$20240726$EXP$$NVSC2024KE153267$NOVARTIS$$67$YR$$M$Y$$$20240726$$CN$KE$KE
241405981$24140598$1$I$$20240725$20240726$20240726$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042027$BOEHRINGER INGELHEIM$$$$$$Y$$$20240726$$MD$US$US
241405991$24140599$1$I$20240701$20240725$20240726$20240726$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042074$BOEHRINGER INGELHEIM$$50$YR$A$M$Y$$$20240726$$HP$US$US
241406001$24140600$1$I$20240612$20240717$20240726$20240726$EXP$AT-BASGAGES-2024-005038$AT-TEVA-VS-3222384$TEVA$$61$YR$$M$Y$64$KG$20240726$$MD$AT$AT
241406012$24140601$2$F$$20240923$20240726$20240925$EXP$$AU-JNJFOC-20240752634$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240925$$MD$AU$AU
241406022$24140602$2$F$20221101$20240808$20240726$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-035687$AUROBINDO$Krause PJ, Rogers R, Shah MK, Kang H, Parsonnet J, Kodama R, et al.. Tafenoquine for Relapsing Babesiosis: A Case Series. Clinical infectious diseases. 2024;79:130-137$52$YR$$M$Y$$$20240820$$MD$US$US
241406031$24140603$1$I$$20230215$20240726$20240726$EXP$$US-Appco Pharma LLC-2159634$APPCO PHARMA$Initial$27$YR$$F$Y$$$20240726$$$US$US
241406041$24140604$1$I$$20230301$20240726$20240726$EXP$$IN-Appco Pharma LLC-2159627$APPCO PHARMA$Initial$65$YR$$F$Y$$$20240726$$MD$IN$IN
241406051$24140605$1$I$$20230301$20240726$20240726$EXP$$GB-Appco Pharma LLC-2159629$APPCO PHARMA$Initial$9$MON$$M$Y$$$20240726$$$GB$GB
241406061$24140606$1$I$$20240327$20240726$20240726$EXP$$IN-Appco Pharma LLC-2159636$APPCO PHARMA$Initial$56$YR$$M$Y$$$20240726$$$IN$IN
241406071$24140607$1$I$$20240327$20240726$20240726$EXP$$US-Appco Pharma LLC-2159639$APPCO PHARMA$Initial$$$$$Y$$$20240726$$$US$US
241406081$24140608$1$I$$20230301$20240726$20240726$EXP$$US-Appco Pharma LLC-2159628$APPCO PHARMA$Initial$26$YR$$M$Y$$$20240726$$MD$US$US
241406091$24140609$1$I$20231201$20240722$20240726$20240726$EXP$ES-AEMPS-1539248$ES-AMGEN-ESPSP2024145350$AMGEN$$53$YR$A$F$Y$$$20240726$$CN$ES$ES
241406101$24140610$1$I$$20240716$20240726$20240726$EXP$$US-GSK-US2024089558$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241406111$24140611$1$I$$20230301$20240726$20240726$EXP$$DE-Appco Pharma LLC-2159632$APPCO PHARMA$Initial$40$YR$$F$Y$$$20240726$$$DE$DE
241406122$24140612$2$F$20240201$20240724$20240726$20240802$PER$$US-SA-2024SA214148$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240802$$MD$US$US
241406131$24140613$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA069622$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240726$$MD$US$US
241406141$24140614$1$I$20240617$20240717$20240726$20240726$EXP$$DE-SERB S.A.S.-2159631$LABORATOIRES SERB$$59$YR$$M$Y$$$20240726$$MD$DE$DE
241406152$24140615$2$F$20240501$20240808$20240726$20240812$EXP$$US-GILEAD-2024-0681875$GILEAD$$14$YR$T$M$Y$43.1$KG$20240812$$HP$US$US
241406161$24140616$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165634$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241406171$24140617$1$I$20240712$20240718$20240726$20240726$EXP$GB-MHRA-MED-202407181319587480-RBTVC$GB-TEVA-VS-3223165$TEVA$$32$YR$$M$Y$64$KG$20240726$$PH$GB$GB
241406181$24140618$1$I$$20230815$20240726$20240726$EXP$$US-AstraZeneca-2023A186836$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241406191$24140619$1$I$$20240719$20240726$20240726$PER$$US-AstraZeneca-2024A165651$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241406201$24140620$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153031$NOVARTIS$$$$$M$Y$$$20240726$$CN$US$US
241406211$24140621$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165513$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241406221$24140622$1$I$20240210$20240717$20240726$20240726$EXP$$DE-SERB S.A.S.-2159633$LABORATOIRES SERB$$49$YR$$F$Y$$$20240726$$MD$DE$DE
241406231$24140623$1$I$$20240724$20240726$20240726$EXP$$IT-ORGANON-O2407ITA002421$ORGANON$Pozzi A, Bonfanti P, Bartesaghi G, Refugjati T, Marini A, Corrado G.. NON RESPONSE TO INCLISIRAN THERAPY IN THREE PATIENTS WITH STATIN INTOLERANCE: A CASE SERIES.. Eur Heart J Suppl.. 2024;26 (2)$79$YR$$F$Y$$$20240726$$HP$IT$IT
241406241$24140624$1$I$$20240327$20240726$20240726$EXP$$US-Appco Pharma LLC-2159637$APPCO PHARMA$Initial$18$YR$$F$Y$$$20240726$$$US$US
241406251$24140625$1$I$20231201$20240724$20240726$20240726$EXP$FR-AFSSAPS-LL2024001317$FR-ORGANON-O2407FRA002298$ORGANON$$31$YR$$F$Y$70$KG$20240726$$CN$FR$FR
241406261$24140626$1$I$$20230301$20240726$20240726$EXP$$US-Appco Pharma LLC-2159635$APPCO PHARMA$Initial$50$YR$$F$Y$$$20240726$$$US$US
241406271$24140627$1$I$$20240712$20240726$20240726$EXP$$IL-ACI HealthCare Limited-2159640$ACI HEALTHCARE$Full text$$$$$Y$$$20240726$$$IL$IL
241406281$24140628$1$I$$20240719$20240726$20240726$EXP$$US-MYLANLABS-2024M1069228$MYLAN$Kundu S, Mehra I, Stevasarova A, Chahal K. Anticonvulsant Hypersensitivity Syndrome in a Patient with Phenytoin Toxicity. South-Med-J 2022; 115 (7): 571.$53$YR$$F$Y$$$20240726$$MD$US$US
241406291$24140629$1$I$20240709$20240716$20240726$20240726$EXP$$CN-BAYER-2024A103631$BAYER$$30$YR$A$F$Y$69$KG$20240726$$HP$CN$CN
241406301$24140630$1$I$$20240719$20240726$20240726$EXP$$US-MYLANLABS-2024M1068974$MYLAN$Gwiazdowski M, Niraula S, Bewley B. A Unique Case Presentation of Takotsubo Cardiomyopathy After Cardiac Arrest and Resuscitation Without CPR. Am-J-Respir-Crit-Care-Med 2023; 207.$81$YR$$F$Y$$$20240726$$HP$US$US
241406311$24140631$1$I$$20240719$20240726$20240726$EXP$$US-MYLANLABS-2024M1069219$MYLAN$Viswanath P, Zhao H, Wayland J, Dean J, Heynekamp TR. Decoding the Enigma of Eosinophils in Pleural Fluid. Am-J-Respir-Crit-Care-Med 2024; 209 (0).$34$YR$$M$Y$$$20240726$$HP$US$US
241406321$24140632$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3224191$TEVA$$$$$M$Y$$$20240726$$HP$CA$CA
241406333$24140633$3$F$$20240919$20240726$20240919$EXP$$US-PFIZER INC-202300271433$PFIZER$$14$YR$$M$Y$$$20240919$$MD$US$US
241406341$24140634$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400224029$PFIZER$$11$YR$$F$Y$$$20240726$$CN$US$US
241406351$24140635$1$I$20240626$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-035767$AUROBINDO$$78$YR$$M$Y$94$KG$20240726$$PH$FR$FR
241406361$24140636$1$I$$20240725$20240726$20240726$PER$$US-ROCHE-10000038251$ROCHE$$85$YR$E$F$Y$$$20240726$$CN$US$US
241406372$24140637$2$F$$20240806$20240726$20240808$EXP$$ES-ORGANON-O2407ESP002422$ORGANON$Casasempere PV, Alameda RC, Sabater SG, Aznar SC, Pascual EP.. Considering belimumab during pregnancy: A more viable option over time.. Lupus.. 2024;33(7):700-15$40$YR$$F$Y$$$20240808$$HP$ES$ES
241406381$24140638$1$I$20210801$20240723$20240726$20240726$EXP$FR-AFSSAPS-RN20212674$FR-SANDOZ INC.-NVSC2021FR202533$SANDOZ$$72$YR$$F$Y$$$20240726$$PH$FR$FR
241406391$24140639$1$I$20240718$20240722$20240726$20240726$EXP$$JP-GENMAB-2024-02648$GENMAB$$8$DEC$$F$Y$$$20240726$$PH$JP$JP
241406401$24140640$1$I$$20240717$20240726$20240726$EXP$$GB-AUROBINDO-AUR-APL-2024-035778$AUROBINDO$$69$YR$$F$Y$65$KG$20240726$$MD$GB$GB
241406411$24140641$1$I$20240723$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146487$AMGEN$$$$$M$Y$$$20240726$$PH$US$US
241406421$24140642$1$I$20230710$20240722$20240726$20240726$EXP$$CO-UCBSA-2024013725$UCB$$78$YR$$M$Y$64$KG$20240726$$CN$CO$CO
241406431$24140643$1$I$20240719$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024145386$AMGEN$$75$YR$E$F$Y$$$20240726$$CN$US$US
241406441$24140644$1$I$20240628$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024145618$AMGEN$$92$YR$E$M$Y$$$20240726$$CN$US$US
241406451$24140645$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA213772$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240726$$MD$US$US
241406462$24140646$2$F$$20240823$20240726$20240905$PER$$US-SA-2024SA216765$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240905$$MD$US$US
241406471$24140647$1$I$20240527$20240719$20240726$20240726$EXP$$IT-AMGEN-ITASP2024144115$AMGEN$$72$YR$E$M$Y$70$KG$20240726$$HP$IT$IT
241406481$24140648$1$I$$20240719$20240726$20240726$PER$$US-TAKEDA-2024TUS074071$TAKEDA$$$$$$Y$$$20240726$$CN$US$US
241406493$24140649$3$F$$20240923$20240726$20240927$EXP$$US-MYLANLABS-2024M1069046$MYLAN$$$$$F$Y$43.09$KG$20240927$$CN$US$US
241406501$24140650$1$I$20211201$20240719$20240726$20240726$EXP$$NVSC2024ZA149869$NOVARTIS$$52$YR$$F$Y$$$20240726$$HP$ZA$ZA
241406511$24140651$1$I$$20221123$20240726$20240726$EXP$$NVSC2022CL304832$NOVARTIS$$$$$F$Y$$$20240726$$MD$CL$CL
241406521$24140652$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA216246$SANOFI AVENTIS$$$$E$F$Y$$$20240726$$MD$US$US
241406531$24140653$1$I$$20240716$20240726$20240726$EXP$CA-MHPD-E2B_07108420$CA-Accord-436591$ACCORD$$17$YR$T$M$Y$$$20240726$$HP$CA$CA
241406541$24140654$1$I$$20240717$20240726$20240726$EXP$GB-MHRA-MED-202407171056261430-WSPDC$GB-Accord-436865$ACCORD$$59$YR$A$F$Y$$$20240726$$PH$GB$GB
241406552$24140655$2$F$20200528$20240805$20240726$20240817$EXP$$TR-Accord-436559$ACCORD$Atahan C, Ugurluer G, Kumbasar B, Ozyar E, Atalar B. Myonecrosis as a rare side effect of stereotactic body radiotherapy for bone metastases: Report of two cases and a comprehensive literature review. Cancer/Radiotherapie. 2024;28(3):275-9$58$YR$A$F$Y$68$KG$20240817$$MD$TR$TR
241406561$24140656$1$I$20240716$20240717$20240726$20240726$EXP$$US-Accord-437155$ACCORD$$43$YR$A$F$Y$$$20240726$$HP$US$US
241406571$24140657$1$I$$20240717$20240726$20240726$EXP$GB-MHRA-MED-202407161710424160-TSGMF$GB-Accord-436878$ACCORD$$67$YR$E$F$Y$$$20240726$$HP$GB$GB
241406581$24140658$1$I$$20240718$20240726$20240726$EXP$$US-BAYER-2024A105212$BAYER$$21$YR$A$F$Y$$$20240726$$MD$US$US
241406592$24140659$2$F$$20240716$20240726$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113757$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240729$$CN$US$US
241406601$24140660$1$I$20240706$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118138$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$69.85$KG$20240726$$MD$US$US
241406611$24140661$1$I$20240722$20240722$20240726$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-117932$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$MD$JP$JP
241406621$24140662$1$I$$20240725$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118589$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240726$$CN$US$US
241406631$24140663$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118163$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$82.1$KG$20240726$$CN$US$US
241406641$24140664$1$I$20130101$20240723$20240726$20240726$EXP$$FR-SANDOZ INC.-SDZ2024FR067567$SANDOZ$$78$YR$$F$Y$$$20240726$$CN$FR$FR
241406651$24140665$1$I$$20240716$20240726$20240726$EXP$CA-MHPD-E2B_07108450$CA-Accord-436592$ACCORD$$29$YR$A$F$Y$$$20240726$$HP$CA$CA
241406661$24140666$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222617$TEVA$$60$YR$$F$Y$$$20240726$$HP$CA$CA
241406671$24140667$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118815$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240726$$CN$US$US
241406683$24140668$3$F$20240703$20240819$20240726$20240822$EXP$IT-MINISAL02-995978$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-116985$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$83$KG$20240822$$MD$IT$IT
241406694$24140669$4$F$20230101$20240826$20240726$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118141$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240902$$CN$US$US
241406701$24140670$1$I$$20240716$20240726$20240726$EXP$$CA-ROCHE-10000031686$ROCHE$$57$YR$A$F$Y$44$KG$20240726$$CN$CA$CA
241406711$24140671$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-3532245$ROCHE$$$$$F$Y$$$20240726$$PH$US$US
241406721$24140672$1$I$$20240716$20240726$20240726$EXP$$IN-EMD Serono-2024039406$EMD SERONO INC$Ancilla LC, Sundaram B, Pathak N, Raj A. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. Journal of Nephropharmacology. 2024 Jun 29;13(2): 1-5. doi:10.34172/npj.2024.11681.$58$YR$A$M$Y$$$20240726$$HP$IN$IN
241406731$24140673$1$I$$20240716$20240726$20240726$EXP$$IN-EMD Serono-2024039099$EMD SERONO INC$Ancilla LC, Sundaram B, Pathak N, Raj A. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. Journal of Nephropharmacology. 2024 Jun 29;13(2): 1-5. doi:10.34172/npj.2024.11681.$55$YR$A$M$Y$$$20240726$$HP$IN$IN
241406742$24140674$2$F$$20240808$20240726$20240813$EXP$$BR-TAKEDA-2024TUS008301$TAKEDA$$$$$F$Y$80$KG$20240813$$CN$BR$BR
241406752$24140675$2$F$20240101$20240805$20240726$20240812$EXP$$HR-AMERICAN REGENT INC-2024002855$AMERICAN REGENT$$35$YR$$F$Y$62$KG$20240812$$CN$HR$HR
241406762$24140676$2$F$$20240717$20240726$20240729$EXP$$JP-JNJFOC-20240771620$JOHNSON AND JOHNSON$Konya Y, Watanabe Y, Suzuki S, Kanemura H, Takahama T, Iwaasa T, et al. [30 A case of immune checkpoint inhibitor-associated enterocolitis successfully treated with vedolizumab] The 244th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2024.6.29$72$YR$E$F$Y$$$20240729$$MD$JP$JP
241406771$24140677$1$I$$20240717$20240726$20240726$EXP$$AU-BAXTER-2024BAX021780$BAXTER$$$$I$M$Y$$$20240726$$PH$AU$AU
241406781$24140678$1$I$20240526$20240716$20240726$20240726$EXP$FR-AFSSAPS-PB2024000790$FR-BAXTER-2024BAX021689$BAXTER$$19$YR$$F$Y$$$20240726$$MD$FR$FR
241406791$24140679$1$I$20240713$20240717$20240726$20240726$EXP$CN-NMPACDR-2101021025837202400719$CN-BAXTER-2024BAX021965$BAXTER$$59$YR$$F$Y$66$KG$20240726$$MD$CN$CN
241406801$24140680$1$I$$20240717$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118550$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$CN$US$US
241406811$24140681$1$I$$20240719$20240726$20240726$PER$$US-ROCHE-10000038458$ROCHE$Lopez J, Hua HU, Toy BC. A case of herpes simplex virus and cytomegalovirus retinitis coinfection. Retinal cases and brief reports. 2024;18(4):451-454. Doi: 10.1097/icb.0000000000001424.$64$YR$A$M$Y$$$20240726$$MD$US$US
241406821$24140682$1$I$$20240723$20240726$20240726$EXP$$US-AMGEN-USASL2024147268$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241406831$24140683$1$I$20240723$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016359$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240726$$CN$US$US
241406841$24140684$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016791$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240726$$CN$US$US
241406851$24140685$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016316$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240726$$CN$US$US
241406861$24140686$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016261$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240726$$CN$US$US
241406871$24140687$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016766$ELI LILLY AND CO$$$$$$Y$$$20240726$$CN$US$US
241406881$24140688$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016273$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240726$$CN$US$US
241406891$24140689$1$I$20240715$20240718$20240726$20240726$EXP$CN-NMPACDR-3404011520197202400064$CN-BAXTER-2024BAX022026$BAXTER$$48$YR$$F$Y$63$KG$20240726$$MD$CN$CN
241406901$24140690$1$I$20240715$20240718$20240726$20240726$EXP$$CN-TAKEDA-2024TUS073106$TAKEDA$$73$YR$$M$Y$75$KG$20240726$$HP$CN$CN
241406911$24140691$1$I$$20240718$20240726$20240726$EXP$$IT-BAXTER-2024BAX021858$BAXTER$$$$$F$Y$$$20240726$$CN$IT$IT
241406921$24140692$1$I$20240603$20240718$20240726$20240726$EXP$CN-NMPACDR-1301021520221202400257$CN-BAXTER-2024BAX022019$BAXTER$$60$YR$$M$Y$82$KG$20240726$$MD$CN$CN
241406931$24140693$1$I$20240511$20240718$20240726$20240726$EXP$$GB-BAXTER-2024BAX022007$BAXTER$$64$YR$$M$Y$78$KG$20240726$$MD$GB$GB
241406951$24140695$1$I$20240101$20240718$20240726$20240726$EXP$$US-BAYER-2024A105245$BAYER$$69$YR$E$F$Y$$$20240726$$MD$US$US
241406963$24140696$3$F$$20240809$20240726$20240815$PER$$NVSC2024US153447$NOVARTIS$$$$$F$Y$$$20240815$$CN$US$US
241406972$24140697$2$F$$20240902$20240726$20240904$EXP$$GB-SANDOZ INC.-SDZ2024GB006835$SANDOZ$$$$$F$Y$$$20240904$$CN$GB$GB
241406981$24140698$1$I$20240708$20240719$20240726$20240726$EXP$CN-NMPACDR-4103231508628202400108$CN-BAXTER-2024BAX022111$BAXTER$$63$YR$$M$Y$78$KG$20240726$$MD$CN$CN
241406991$24140699$1$I$$20240725$20240726$20240726$EXP$$CA-TAKEDA-2024TUS074845$TAKEDA$$$$$M$Y$$$20240726$$CN$CA$CA
241407001$24140700$1$I$20230101$20240722$20240726$20240726$EXP$$CA-Orion Corporation ORION PHARMA-24_00031039$ORION$$71$YR$E$M$Y$$$20240726$$MD$CA$
241407011$24140701$1$I$20240531$20240719$20240726$20240726$EXP$CN-NMPACDR-4602001068793202400097$CN-BAXTER-2024BAX022119$BAXTER$$63$YR$$F$Y$46$KG$20240726$$MD$CN$CN
241407021$24140702$1$I$20240714$20240720$20240726$20240726$EXP$CN-NMPACDR-4307011003555202400556$CN-BAXTER-2024BAX022121$BAXTER$$37$YR$$F$Y$59$KG$20240726$$MD$CN$CN
241407031$24140703$1$I$20191201$20240722$20240726$20240726$EXP$$US-ABBVIE-5850180$ABBVIE$$66$YR$$F$Y$93$KG$20240726$$CN$US$US
241407041$24140704$1$I$20240713$20240720$20240726$20240726$EXP$CN-NMPACDR-4307011003555202400551$CN-BAXTER-2024BAX022122$BAXTER$$31$YR$$F$Y$62.5$KG$20240726$$MD$CN$CN
241407051$24140705$1$I$20240719$20240722$20240726$20240726$EXP$$DE-BAXTER-2024BAX022074$BAXTER$$70$YR$$F$Y$$$20240726$$HP$DE$DE
241407081$24140708$1$I$$20240719$20240726$20240726$PER$$US-AMGEN-USASP2024144906$AMGEN$$$$$$Y$$$20240726$$HP$US$US
241407091$24140709$1$I$20240101$20240719$20240726$20240726$EXP$$US-AMGEN-USASP2024143985$AMGEN$$70$YR$E$F$Y$$$20240726$$CN$US$US
241407102$24140710$2$F$$20240820$20240726$20240821$EXP$$US-ALXN-202407USA001405US$ALEXION PHARMACEUTICALS$$22$YR$$F$Y$$$20240821$$HP$US$US
241407113$24140711$3$F$$20240812$20240726$20240815$EXP$$US-ALXN-202407USA001321US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240815$$CN$US$US
241407121$24140712$1$I$$20240719$20240726$20240726$EXP$$US-GSK-US2024091105$GLAXOSMITHKLINE$$52$YR$$$Y$$$20240726$$MD$US$US
241407131$24140713$1$I$$20240716$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090336$VIIV$$$$$$Y$$$20240726$$CN$US$US
241407142$24140714$2$F$20231226$20240718$20240726$20240905$EXP$$FR-AstraZeneca-2024A170192$ASTRAZENECA$$77$YR$$F$Y$$$20240905$$MD$FR$
241407151$24140715$1$I$$20240718$20240726$20240726$EXP$NL-LRB-00985302$NL-TEVA-VS-3224152$TEVA$$55$YR$$F$Y$92$KG$20240726$$CN$NL$NL
241407161$24140716$1$I$$20240722$20240726$20240726$EXP$$ZA-AstraZeneca-2024A166707$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$ZA$
241407171$24140717$1$I$20240716$20240725$20240726$20240726$EXP$$NVSC2024TR152881$NOVARTIS$$74$YR$$M$Y$$$20240726$$CN$TR$TR
241407181$24140718$1$I$$20240719$20240726$20240726$EXP$$ZA-AstraZeneca-2024A165495$ASTRAZENECA$$34$YR$$M$Y$$$20240726$$CN$ZA$
241407191$24140719$1$I$20240630$20240718$20240726$20240726$EXP$$IE-AstraZeneca-2024A163889$ASTRAZENECA$$55$YR$$M$Y$86$KG$20240726$$MD$IE$
241407201$24140720$1$I$$20240718$20240726$20240726$EXP$$PL-AstraZeneca-2024A166883$ASTRAZENECA$$$$$F$Y$$$20240726$$MD$PL$
241407211$24140721$1$I$$20240718$20240726$20240726$EXP$$JP-AstraZeneca-2024A165346$ASTRAZENECA$$80$YR$$M$Y$$$20240726$$MD$JP$
241407223$24140722$3$F$$20240819$20240726$20240822$PER$$US-ABBVIE-5852854$ABBVIE$$72$YR$$F$Y$$$20240822$$MD$US$US
241407231$24140723$1$I$20240418$20240718$20240726$20240726$PER$$US-BAYER-2024A104602$BAYER$$33$YR$A$F$Y$52.7$KG$20240726$$CN$US$US
241407241$24140724$1$I$$20240719$20240726$20240726$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07014$HIKMA$Vrionis AN, Olsen KR.. Vrionis AN, Olsen KR. Images in Anesthesiology: Carotid Sinus Reflex From Neck Mass and Opioids.. Cureus. 2024;16(6):e62048$$$$$Y$$$20240726$$HP$US$US
241407251$24140725$1$I$$20240725$20240725$20240725$DIR$711548$$FDA-CTU$$$$$F$N$$$20240725$Y$HP$US$
241407261$24140726$1$I$20240724$20240725$20240725$20240725$DIR$711587$$FDA-CTU$$13$MON$$M$N$$$20240725$N$HP$US$
241407271$24140727$1$I$20240619$20240712$20240725$20240725$DIR$FDA-CDER-CTU-2024-51099$$FDA-CTU$$84$YR$$F$N$68.95$KG$20240712$N$CN$US$
241407281$24140728$1$I$$20240718$20240726$20240726$EXP$$CA-BAXTER-2024BAX022154$BAXTER$$43$YR$$F$Y$68$KG$20240726$$HP$CA$CA
241407291$24140729$1$I$20240722$20240725$20240725$20240725$DIR$711585$$FDA-CTU$$24$YR$$M$N$149.4$KG$20240725$N$PH$US$
241407301$24140730$1$I$20240701$20240719$20240726$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022485$UNITED THERAPEUTICS$$61$YR$$F$Y$104.31$KG$20240726$$$US$US
241407311$24140731$1$I$$20240719$20240726$20240726$EXP$$US-MYLANLABS-2024M1069221$MYLAN$Kreit H, Rehman AU, Bright TM. Graves^ Disease, a Late Complication of Chronic Graft vs Host Disease. J-Endocr-Soc 2021; 5 (Suppl. 1) A906.$62$YR$$M$Y$$$20240726$$MD$US$US
241407321$24140732$1$I$$20240719$20240726$20240726$EXP$$US-MYLANLABS-2024M1069220$MYLAN$Lloyd J, Abdulwahid T, Seethala R, Selk K. Graves^ Thyrotoxicosis Resistant to Medical Therapy Found to Have Isolated Thyroid Sarcoidosis Without Systemic Involvement. J-Endocr-Soc 2022; 6 (Suppl. 1) A824-A825 abstr. PSAT326.$31$YR$$F$Y$$$20240726$$MD$US$US
241407331$24140733$1$I$$20240719$20240726$20240726$EXP$$US-MYLANLABS-2024M1069231$MYLAN$Satta T, Papadopoulos EB, Gyurkocza B, Susman P, Singh A, Calafiore M, et al. Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd. Blood 2023; 142 (Suppl. 1) 7019.$46$YR$$$Y$$$20240726$$HP$US$US
241407341$24140734$1$I$$20240719$20240726$20240726$EXP$$CA-BAXTER-2024BAX022245$BAXTER$$44$YR$$F$Y$97$KG$20240726$$HP$CA$CA
241407351$24140735$1$I$$20240719$20240726$20240726$EXP$$US-MYLANLABS-2024M1069222$MYLAN$Pollack ED, Richardson C, Powell B, Patel K. Meningoencephalitis With Transverse Myelitis in a Patient With West Nile Virus - Clinical Insights and Awareness. Am-J-Respir-Crit-Care-Med 2024; 209 A5619 (plus Poster).$42$YR$$M$Y$$$20240726$$HP$US$US
241407365$24140736$5$F$$20240829$20240726$20240904$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114858$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$96$KG$20240905$$HP$CA$CA
241407372$24140737$2$F$$20240730$20240726$20240809$EXP$$US-TEVA-VS-3223147$TEVA$: Tseng M, Feder R. Topical Ripasudil for the Treatment of Segmental Corneal Edema: A Case Series. Cornea 2023; 42 (7): 903-907.; Tseng M, Feder R. Topical Ripasudil for the Treatment of Segmental Corneal Edema: A Case Series. Cornea 2023; 42 (7): 903-907.$80$YR$$F$Y$$$20240809$$MD$US$US
241407381$24140738$1$I$$20240719$20240726$20240726$EXP$$US-MYLANLABS-2024M1069232$MYLAN$Lee E, Lin A, Su Y, Cho C, Seo SK. The Clinical Significance of the Drug-Drug Interaction between Letermovir and Voriconazole in Stem Cell Transplantation. Transplant-Cell-Ther 2024; 30 (Suppl.) (2): S438.$$$A$$Y$$$20240726$$PH$US$US
241407391$24140739$1$I$20240325$20240717$20240726$20240726$EXP$$DE-SERB S.A.S.-2159641$LABORATOIRES SERB$$45$YR$$M$Y$$$20240726$$MD$DE$DE
241407411$24140741$1$I$$20240717$20240726$20240726$EXP$AU-TGA-0000814101$AU-SANDOZ INC.-SDZ2024AU066165$SANDOZ$$$$$$Y$$$20240726$$HP$AU$AU
241407421$24140742$1$I$20240719$20240719$20240726$20240726$PER$$US-AMGEN-USASP2024144846$AMGEN$$60$YR$A$M$Y$$$20240726$$CN$US$US
241407431$24140743$1$I$$20240712$20240726$20240726$EXP$$BG-ACI HealthCare Limited-2159642$ACI HEALTHCARE$Abstract$$$$F$Y$$$20240726$$$BG$BG
241407441$24140744$1$I$$20240711$20240726$20240726$EXP$$HR-ROCHE-10000012946$ROCHE$Penezic L, Nad-Skegro S, Hadzavdic A, Ganoci L, Kastelan Z, Trkulja V. Inosine monophosphate dehydrogenase type 2 polymorphism IMPDH2 3757T}C (rs11706052) and 12-month evolution of the graft function in renal transplant recipients on mycophenolate-based immunosuppression.. The Pharmacogenomics Journal. 2024;24 (15):1-9. doi:10.1038/s41397-024-00335-0.$$$$$Y$$$20240726$$HP$HR$US
241407451$24140745$1$I$$20240718$20240726$20240726$EXP$$DK-MYLANLABS-2024M1068775$MYLAN$Foslund IT, Von Magius SAV, Ainsworth AP, Detlefsen S, Fristrup CW, Knudsen AO, et al. Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). Pleura-Peritoneum 2024; 9 (2): 69-77.$$$$F$Y$$$20240726$$MD$DK$DK
241407461$24140746$1$I$$20240718$20240726$20240726$EXP$$US-MYLANLABS-2024M1068653$MYLAN$Ortiz-Jaimes GE, Gallo De Moraes A, Oeckler RA. Real Time Bedside Echocardiography-guided Mechanical Ventilation Optimization in a Patient With Carcinoid Heart Disease, Right Ventricular Failure, and Severe ARDS. Am-J-Respir-Crit-Care-Med 2023; 207.$56$YR$$F$Y$$$20240726$$HP$US$US
241407481$24140748$1$I$$20240718$20240726$20240726$EXP$$IT-MYLANLABS-2024M1068855$MYLAN$Perlato M, Mecheri V, Vivarelli E, Accinno M, Vultaggio A, Matucci A. ^Patient remodeling^ as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend. J-Asthma 2024; 61 (1): 72-75.$28$YR$$F$Y$$$20240726$$MD$IT$IT
241407491$24140749$1$I$$20240718$20240726$20240726$EXP$$IT-MYLANLABS-2024M1068799$MYLAN$Perlato M, Mecheri V, Vivarelli E, Accinno M, Vultaggio A, Matucci A. ^Patient remodeling^ as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend. J-Asthma 2024; 61 (1): 72-75.$39$YR$$M$Y$$$20240726$$MD$IT$IT
241407501$24140750$1$I$$20240719$20240726$20240726$EXP$$IN-MYLANLABS-2024M1069236$MYLAN$GaUr U, Gadkari C, PUndkar A. Hypokalaemic Periodic Paralysis in a Patient with Rheumatoid Arthritis: A Case Report. J-Clin-Diagnostic-Res 2024; 18 (7): OD01-OD03.$37$YR$$F$Y$$$20240726$$MD$IN$IN
241407511$24140751$1$I$20240704$20240716$20240726$20240726$EXP$CN-NMPA-3201271886349202400137$CN-Ipsen Biopharmaceuticals, Inc.-2024-14761$IPSEN$$55$YR$A$M$Y$60$KG$20240726$$HP$CN$CN
241407521$24140752$1$I$$20240718$20240726$20240726$EXP$$JP-MYE-2024M1067092AA$MYLAN$Takamizawa M, Ichikawa Y, Shinohara T, Horiuchi K, Shimaya H, and Furuhata S. A Case of a Dementia Patient with Visual Hallucination due to Amantadine Overdose Triggered by Acute Exacerbation of Chronic Kidney Disease. Journal of the Japanese Association of Rural Medicine. 2024;73(1):38-44$8$DEC$$M$Y$54.1$KG$20240726$$PH$JP$JP
241407531$24140753$1$I$$20240722$20240726$20240726$EXP$$US-BEH-2024176259$CSL BEHRING$$63$YR$A$M$Y$179$KG$20240726$$CN$US$US
241407541$24140754$1$I$20240718$20240718$20240726$20240726$EXP$GB-MHRA-MED-202407181639307210-KLRVN$GB-TEVA-VS-3223616$TEVA$$75$YR$$F$Y$$$20240726$$HP$GB$GB
241407551$24140755$1$I$$20240327$20240726$20240726$EXP$$US-Appco Pharma LLC-2159643$APPCO PHARMA$Initial$20$YR$$F$Y$$$20240726$$$US$US
241407561$24140756$1$I$$20240718$20240726$20240726$EXP$$US-MYLANLABS-2024M1068804$MYLAN$Patel EJ, Ahmad M, Schwartz BS, van Zante A, Kersten R, Loftus P. Invasive Fungal Sinusitis in an Immunocompetent Patient After Sinus Surgery for Chronic Rhinosinusitis with Nasal Polyps and a Mycetoma. Laryngoscope 2024;.$38$YR$$F$Y$$$20240726$$MD$US$US
241407581$24140758$1$I$$20240715$20240726$20240726$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07102$LUPIN$$$$$$Y$$$20240726$$CN$AU$AU
241407591$24140759$1$I$20231107$20240717$20240725$20240725$DIR$FDA-CDER-CTU-2024-51120$$FDA-CTU$$82$YR$$M$N$102.06$KG$20240717$N$CN$US$
241407601$24140760$1$I$$20240725$20240725$20240725$DIR$711527$$FDA-CTU$$$$$UNK$N$$$20240725$N$CN$US$
241407611$24140761$1$I$$20240719$20240726$20240726$EXP$$US-SA-2024SA217945$SANOFI AVENTIS$$$$A$F$Y$63$KG$20240726$$MD$US$US
241407621$24140762$1$I$20240715$20240717$20240726$20240726$EXP$$NVSC2024IR150992$NOVARTIS$$54$YR$$M$Y$$$20240726$$CN$IR$IR
241407631$24140763$1$I$$20240712$20240726$20240726$EXP$$DE-ROCHE-10000038428$ROCHE$$$$$$Y$$$20240726$$CN$DE$DE
241407644$24140764$4$F$20240101$20240830$20240726$20240910$EXP$$AU-IMP-2024000494$Harrow Health$$55$YR$A$F$Y$$$20240910$$CN$AU$AU
241407651$24140765$1$I$20240528$20240719$20240726$20240726$EXP$$EG-HIKMA PHARMACEUTICALS USA INC.-EG-H14001-24-06956$HIKMA$$51$YR$$F$Y$$$20240726$$HP$EG$EG
241407661$24140766$1$I$$20240722$20240726$20240726$EXP$$IN-ROCHE-10000038062$ROCHE$$71$YR$E$M$Y$$$20240726$$CN$IN$IN
241407671$24140767$1$I$$20240722$20240726$20240726$EXP$$US-SA-2024SA216630$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240726$$MD$US$US
241407681$24140768$1$I$20240701$20240718$20240726$20240726$PER$$US-SA-2024SA213771$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240726$$MD$US$US
241407691$24140769$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA213744$SANOFI AVENTIS$$$$$$Y$$$20240726$$HP$US$US
241407701$24140770$1$I$$20240718$20240726$20240726$30DAY$$US-GSK-US2024AMR091697$GLAXOSMITHKLINE$$$$$M$Y$$$20240726$$CN$US$US
241407711$24140771$1$I$$20240718$20240726$20240726$PER$$US-ABBVIE-5848342$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241407723$24140772$3$F$$20240827$20240726$20240909$EXP$$AU-IMP-2024000499$Harrow Health$$35$YR$A$M$Y$$$20240909$$CN$AU$US
241407731$24140773$1$I$$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118114$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$131.54$KG$20240726$$CN$US$US
241407741$24140774$1$I$20240720$20240722$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116952$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240726$$HP$US$US
241407752$24140775$2$F$$20240708$20240726$20240910$PER$$US-TEVA-VS-3219743$TEVA$$67$YR$$F$Y$$$20240910$$HP$US$US
241407761$24140776$1$I$$20240722$20240726$20240726$EXP$$JP-AMGEN-JPNSP2024145364$AMGEN$$$$$F$Y$$$20240726$$CN$JP$JP
241407772$24140777$2$F$$20240903$20240726$20240903$PER$$US-ALXN-202407USA001489US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
241407781$24140778$1$I$20240701$20240723$20240726$20240726$EXP$$ES-ABBVIE-5852886$ABBVIE$$67$YR$$M$Y$$$20240726$$CN$ES$ES
241407791$24140779$1$I$$20240715$20240726$20240726$EXP$$CN-CHEPLA-2024009476$CHEPLAPHARM$Yao XM, Yu J, Yuan N, Shao M, Ping F. A case of juvenile occult autoimmune?diabetes mellitus induced by olanzapine in?a patient with eating disorder?. Chin J Diabetes Mellitus. 2022;14(4): 378-380. DOI: 10.3760/cma.j.cn115791-20210716-00387.$12$YR$$F$Y$34$KG$20240726$$HP$COUNTRY NOT SPECIFIED$CN
241407801$24140780$1$I$$20240716$20240726$20240726$EXP$$US-RDY-LIT/USA/24/0010795$DR REDDYS$Torelli VA, Jean RE, Tran E. Acute Hypoxic Respiratory Failure Secondary to Daptomycin-induced Eosinophilic Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2019.$86$YR$E$F$Y$$$20240726$$HP$US$US
241407814$24140781$4$F$20240708$20240918$20240726$20240926$EXP$$JP-ASTELLAS-2024JP005334$ASTELLAS$$7$DEC$E$M$Y$$$20240926$$MD$JP$JP
241407821$24140782$1$I$$20240715$20240726$20240726$PER$$CA-IGSA-BIG0029915$GRIFOLS$$30$YR$$M$Y$$$20240726$$HP$CA$CA
241407831$24140783$1$I$$20240724$20240726$20240726$EXP$$IT-ABBVIE-5853974$ABBVIE$$76$YR$$F$Y$$$20240726$$CN$IT$IT
241407841$24140784$1$I$20240722$20240724$20240726$20240726$EXP$$US-UCBSA-2023008835$UCB$$44$YR$$F$Y$$$20240726$$CN$US$US
241407851$24140785$1$I$$20240715$20240726$20240726$EXP$$IL-MACLEODS PHARMA-MAC-AE-092$MACLEODS$Slobodin G, Elias N, Zaygraikin N, Sheikh-Ahmad M, Sabetay S etal.Levofloxacin-induced delirium..Neurological sciences.2009 \;30(2):159-61$$$$$Y$$$20240726$$HP$IL$IL
241407861$24140786$1$I$20220601$20240716$20240726$20240726$EXP$$PL-MACLEODS PHARMA-MAC2024048423$MACLEODS$Kozlowska A, Obtulowicz A, Pizun A, Radzimowska-Dudek J, Staron A, Dyduch G, et al..Drug-induced subacute cutaneous lupus erythematosus initially diagnosed as erythema annulare centrifugum..Dermatology Review.2024;11(1):52-8$$$$$Y$$$20240726$$MD$PL$PL
241407872$24140787$2$F$$20240812$20240726$20240823$EXP$$JP-MACLEODS PHARMA-MAC2024048406$MACLEODS$Maruyama T, Kondo S, Nomura H..Case series of bradycardia, renal failure, atrioventricular nodal blockers, shock and hyperkalemia syndrome in patients with dementia.Geriatrics and Gerontology International.08 JUL 2024;24(7):737-8$$$$$Y$$$20240823$$MD$JP$JP
241407881$24140788$1$I$20240716$20240716$20240726$20240726$EXP$GB-MHRA-MED-202407162205103540-HYBPQ$GB-MACLEODS PHARMA-MAC2024048430$MACLEODS$$$$$$Y$$$20240726$$CN$GB$GB
241407892$24140789$2$F$$20240723$20240726$20240802$EXP$$US-MACLEODS PHARMA-MAC2024048448$MACLEODS$Martin RD, Scanlon M, McCabe K, Scanlon MP..Lidocaine-Associated CNS Toxicity at Therapeutic Dosage: A Case Report and Literature Review.Cureus.12-JUN-2024;16(6):e62231$$$$$Y$$$20240802$$MD$US$US
241407901$24140790$1$I$$20240715$20240726$20240726$EXP$$US-MACLEODS PHARMA-MAC-AE-097$MACLEODS$Kiangkitiwan B, Doppalapudi A, Fonder M, Solberg K, Bohner B..Levofloxacin-induced delirium with psychoticfeatures.General hospital psychiatry.2008;30(4):381-3$$$$$Y$$$20240726$$MD$US$US
241407912$24140791$2$F$$20240729$20240726$20240812$EXP$$US-MACLEODS PHARMA-MAC2024048380$MACLEODS$$$$$$Y$$$20240812$$CN$US$US
241407922$24140792$2$F$20160101$20240726$20240726$20240731$EXP$$BR-CHEPLA-2024009361$CHEPLAPHARM$$$$A$F$Y$$$20240731$$HP$COUNTRY NOT SPECIFIED$BR
241407931$24140793$1$I$$20240717$20240726$20240726$EXP$GB-MHRA-MED-202407170959334590-PCSYF$GB-MACLEODS PHARMA-MAC2024048452$MACLEODS$$$$$$Y$$$20240726$$HP$GB$GB
241407943$24140794$3$F$$20240731$20240726$20240812$EXP$$JP-MACLEODS PHARMA-MAC2024048436$MACLEODS$Takahashi Y, Nakano H, Motoki M, Wakimoto Y, Ikechi D, Koyama Y, etal.Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review.Acute Medicine and Surgery.2024;11(1):e981$$$$$Y$$$20240812$$MD$JP$JP
241407952$24140795$2$F$$20240723$20240726$20240802$EXP$$IN-MACLEODS PHARMA-MAC2024048449$MACLEODS$Oli A, Bhatia A..Unusual clinical features and histopathological findings in a case of Pseudo-endophthalmitis in neovascular glaucoma.Romanian Journal of Ophthalmology.APR-2024;68(2):182$$$$$Y$$$20240802$$MD$IN$IN
241407961$24140796$1$I$$20240713$20240726$20240726$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-04969$LUPIN$$$$$$Y$$$20240726$$CN$US$US
241407971$24140797$1$I$20240710$20240715$20240726$20240726$EXP$GB-MHRA-MED-202407151147209780-NGTWM$GB-MACLEODS PHARMA-MAC2024048416$MACLEODS$$$$$$Y$$$20240726$$MD$GB$GB
241407981$24140798$1$I$$20240724$20240726$20240726$EXP$$TH-ASTELLAS-2024US021255$ASTELLAS$$$$A$M$Y$$$20240726$$CN$TH$TH
241407991$24140799$1$I$$20240725$20240726$20240726$PER$$US-HALEON-2189056$Haleon PLC$$$$$$Y$$$20240726$$CN$US$US
241408002$24140800$2$F$20240420$20240730$20240726$20240807$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-102525$REGENERON$$66$YR$$M$Y$$$20240807$$HP$DE$DE
241408011$24140801$1$I$20240610$20240715$20240726$20240726$EXP$FR-AFSSAPS-LL2024001275$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109997$ZYDUS PHARM$$$$$$Y$$$20240726$$PH$FR$FR
241408021$24140802$1$I$20240328$20240715$20240726$20240726$EXP$FR-AFSSAPS-BS2024000421$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110032$ZYDUS PHARM$$$$$$Y$$$20240726$$MD$FR$FR
241408032$24140803$2$F$20240101$20240816$20240726$20240821$PER$$US-AMGEN-USASP2024147118$AMGEN$$55$YR$A$M$Y$$$20240821$$CN$US$US
241408042$24140804$2$F$20240623$20240830$20240726$20240903$PER$$US-AMGEN-USASP2024147003$AMGEN$$78$YR$E$$Y$$$20240902$$CN$US$US
241408051$24140805$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024146730$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241408061$24140806$1$I$20240708$20240715$20240726$20240726$EXP$FR-AFSSAPS-CN2024000687$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110025$ZYDUS PHARM$$$$$$Y$$$20240726$$PH$FR$FR
241408071$24140807$1$I$$20240723$20240726$20240726$EXP$$UA-TAKEDA-2024TUS075502$TAKEDA$$$$$M$Y$$$20240726$$MD$UA$UA
241408082$24140808$2$F$20240501$20240722$20240726$20240730$EXP$$GB-SA-2024SA218446$SANOFI AVENTIS$$77$YR$E$M$Y$71$KG$20240730$$CN$GB$GB
241408091$24140809$1$I$20240703$20240722$20240726$20240726$EXP$GB-MHRA-MED-202407192347449660-PJWFZ$GB-BAYER-2024A106269$BAYER$$36$YR$A$F$Y$73$KG$20240726$$CN$GB$GB
241408114$24140811$4$F$20240722$20240906$20240726$20240925$PER$$US-JNJFOC-20240762421$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240925$$CN$US$US
241408121$24140812$1$I$$20240717$20240726$20240726$EXP$$JP-JNJFOC-20240771293$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$PH$JP$JP
241408151$24140815$1$I$20240718$20240719$20240726$20240726$PER$$US-SA-2024SA218615$SANOFI AVENTIS$$68$YR$E$M$Y$72.57$KG$20240726$$MD$US$US
241408161$24140816$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA213516$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240726$$MD$US$US
241408171$24140817$1$I$$20240722$20240726$20240726$EXP$$AU-BEH-2024176262$CSL BEHRING$$$$E$M$Y$$$20240726$$MD$AU$AU
241408181$24140818$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A166822$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241408192$24140819$2$F$20231023$20240724$20240726$20240730$EXP$$BE-EXELIXIS-XL18424073744$EXELIXIS$$$$$$Y$$$20240729$$MD$BE$BE
241408211$24140821$1$I$$20240719$20240726$20240726$EXP$$ZA-AstraZeneca-2024A165829$ASTRAZENECA$$96$YR$$M$Y$$$20240726$$CN$ZA$
241408221$24140822$1$I$20240301$20240717$20240726$20240726$PER$$US-SA-2024SA215011$SANOFI AVENTIS$$46$YR$A$F$Y$74.8$KG$20240726$$MD$US$US
241408232$24140823$2$F$$20240719$20240726$20240801$EXP$$GB-AstraZeneca-2024A165071$ASTRAZENECA$$76$YR$$M$Y$123$KG$20240801$$MD$GB$
241408241$24140824$1$I$$20240722$20240726$20240726$EXP$$PH-AstraZeneca-2024A166596$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$PH$
241408251$24140825$1$I$$20240719$20240726$20240726$EXP$$JP-AstraZeneca-2024A166539$ASTRAZENECA$$84$YR$$F$Y$$$20240726$$MD$JP$
241408261$24140826$1$I$$20240718$20240726$20240726$EXP$$ZA-AstraZeneca-2024A164299$ASTRAZENECA$$50$YR$$F$Y$$$20240726$$CN$ZA$
241408272$24140827$2$F$$20240906$20240726$20240913$EXP$$US-AstraZeneca-2024A166921$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
241408281$24140828$1$I$$20240712$20240726$20240726$EXP$$CN-QUAGEN-2024QUALIT00224$QUAGEN PHARMACEUTICALS$Dai B.Central Retinal Artery Occlusion after Peribulbar Injection of Triamcinolone Acetonide in Thyroid-associated Ophthalmopathy.Journal of Craniofacial Surgery.MAY-2024;1-2$38$YR$A$F$Y$$$20240726$$HP$CN$CN
241408291$24140829$1$I$$20240722$20240726$20240726$EXP$$CA-MYLANLABS-2024M1069061$MYLAN$$$$$F$Y$$$20240726$$CN$CA$CA
241408302$24140830$2$F$20240501$20240903$20240726$20240911$EXP$$JP-ASTELLAS-2024JP003276$ASTELLAS$$72$YR$E$$Y$$$20240911$$MD$JP$JP
241408311$24140831$1$I$$20240716$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407011714$ELI LILLY AND CO$$46$YR$A$$Y$$$20240726$$CN$US$US
241408322$24140832$2$F$20240820$20240820$20240726$20240823$EXP$$CA-TAKEDA-2024TUS074483$TAKEDA$$30$YR$$F$Y$$$20240823$$CN$CA$CA
241408331$24140833$1$I$$20240722$20240726$20240726$EXP$$US-TAKEDA-2024TUS074229$TAKEDA$$$$$M$Y$$$20240726$$MD$US$US
241408341$24140834$1$I$20240705$20240718$20240726$20240726$EXP$$CN-ROCHE-10000035626$ROCHE$$54$YR$A$F$Y$$$20240726$$HP$CN$CN
241408351$24140835$1$I$20240621$20240722$20240726$20240726$EXP$$US-GILEAD-2024-0681570$GILEAD$$68$YR$E$F$Y$$$20240726$$CN$US$US
241408361$24140836$1$I$$20240722$20240726$20240726$EXP$$US-JNJFOC-20240759670$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$US$US
241408371$24140837$1$I$$20240720$20240726$20240726$PER$$US-UNITED THERAPEUTICS-UNT-2024-022579$UNITED THERAPEUTICS$$$$$F$Y$49.887$KG$20240726$$$US$US
241408381$24140838$1$I$$20220916$20240726$20240726$EXP$$NVSC2022US304833$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
241408394$24140839$4$F$$20240902$20240726$20240917$EXP$$CZ-UCBSA-2024036916$UCB$$$$I$$Y$3.68$KG$20240917$$MD$CZ$CZ
241408401$24140840$1$I$$20240716$20240726$20240726$EXP$$CA-ROCHE-10000031656$ROCHE$$36$YR$A$F$Y$$$20240726$$CN$CA$CA
241408412$24140841$2$F$20240716$20240806$20240726$20240809$EXP$$SA-GRUNENTHAL-2024-123141$AVERITAS$$46$YR$$M$Y$$$20240808$$MD$SA$SA
241408421$24140842$1$I$$20240722$20240726$20240726$EXP$$US-BAYER-2024A107062$BAYER$$20$YR$A$M$Y$$$20240726$$CN$US$US
241408432$24140843$2$F$$20240726$20240726$20240730$EXP$$CO-GSK-CO2024AMR093156$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$CO$CO
241408441$24140844$1$I$$20240717$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090005$VIIV$$$$$M$Y$$$20240726$$CN$US$US
241408451$24140845$1$I$$20240723$20240726$20240726$EXP$$US-TAKEDA-2024TUS074409$TAKEDA$$$$$F$Y$64$KG$20240726$$MD$US$US
241408461$24140846$1$I$20240702$20240723$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117577$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$121.25$KG$20240726$$HP$US$US
241408471$24140847$1$I$20240723$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117437$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240726$$HP$US$US
241408482$24140848$2$F$$20240722$20240726$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118388$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240726$$MD$JP$JP
241408491$24140849$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117442$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240726$$CN$US$US
241408502$24140850$2$F$20230101$20240902$20240726$20240909$EXP$$JP-009507513-2405JPN000550J$MERCK$$63$YR$$F$Y$$$20240909$$MD$JP$JP
241408511$24140851$1$I$$20240714$20240726$20240726$EXP$$US-Accord-437092$ACCORD$Zhao CQM, Steinberg J, Otero Espinal D, Vele O. Haemolysis index conundrum in a COVID-19 patient. J Clin Pathol. 2024 Jul 11:jcp-2023-209196.$7$DEC$E$M$Y$$$20240726$$HP$US$US
241408521$24140852$1$I$$20240719$20240726$20240726$PER$$US-ALXN-202407USA001401US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241408532$24140853$2$F$20240718$20240813$20240726$20240813$PER$$US-ALXN-202407USA001343US$ALEXION PHARMACEUTICALS$$60$YR$$F$Y$$$20240813$$CN$US$US
241408541$24140854$1$I$$20240715$20240726$20240726$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07116$LUPIN$$$$$$Y$$$20240726$$CN$AU$AU
241408551$24140855$1$I$20240704$20240725$20240725$20240725$DIR$711518$$FDA-CTU$$45$YR$$M$N$$$20240725$N$CN$US$
241408561$24140856$1$I$20240615$20240725$20240725$20240725$DIR$711519$$FDA-CTU$$21$YR$$M$N$90$KG$20240725$N$CN$US$
241408571$24140857$1$I$20240710$20240724$20240726$20240726$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042050$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$60$KG$20240726$$HP$CN$CN
241408581$24140858$1$I$20240723$20240725$20240725$20240725$DIR$711542$$FDA-CTU$$15$YR$$F$N$97.8$KG$20240725$N$HP$US$
241408591$24140859$1$I$20240628$20240717$20240726$20240726$EXP$$US-Eisai-EC-2024-170627$EISAI$$65$YR$E$M$Y$108$KG$20240726$$CN$US$US
241408601$24140860$1$I$20240101$20240718$20240726$20240726$EXP$$PR-Eisai-EC-2024-168388$EISAI$$76$YR$E$F$Y$63.5$KG$20240726$$CN$PR$PR
241408611$24140861$1$I$20240101$20240723$20240726$20240726$PER$$US-ABBVIE-5854463$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241408621$24140862$1$I$20240713$20240724$20240726$20240726$EXP$$US-ROCHE-10000036740$ROCHE$$67$YR$E$F$Y$$$20240726$$MD$US$US
241408641$24140864$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222808$TEVA$$$$$F$Y$$$20240726$$HP$CA$CA
241408651$24140865$1$I$20240718$20240725$20240725$20240725$DIR$711470$$FDA-CTU$$70$YR$$F$N$61.5$KG$20240725$N$$US$
241408681$24140868$1$I$20240725$20240725$20240725$20240725$DIR$711500$$FDA-CTU$$33$YR$$M$N$68.4$KG$20240725$N$PH$US$
241408701$24140870$1$I$20240725$20240725$20240725$20240725$DIR$711567$$FDA-CTU$$65$YR$$F$N$88.2$KG$20240725$N$PH$US$
241408711$24140871$1$I$20230621$20240725$20240725$20240725$DIR$711555$$FDA-CTU$$47$YR$$F$N$67.5$KG$20240725$N$CN$US$
241408722$24140872$2$F$$20240730$20240726$20240809$EXP$$CH-TEVA-VS-3223160$TEVA$Shai B, Morgane C, Guillaume M, Fabian S. An apple detergent a day doesn^t always keep the doctor away. Swiss-Med-Wkly 2024; 154 (Suppl. 277) 39S (plus Poster) abstr. P 56; Shai B, Morgane C, Guillaume M, Fabian S. An apple detergent a day doesn^t always keep the doctor away. Swiss-Med-Wkly 2024; 154 (Suppl. 277) 39S (plus Poster) abstr. P 56.$10$MON$$M$Y$$$20240809$$HP$CH$CH
241408731$24140873$1$I$$20240716$20240726$20240726$EXP$$AU-TEVA-VS-3222478$TEVA$$$$$$Y$$$20240726$$HP$AU$AU
241408741$24140874$1$I$$20240718$20240726$20240726$EXP$$CN-AMGEN-CHNSP2024143589$AMGEN$Chen S.; Shen L.; Cao W. et al.. Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation. Blood cancer journal. 2024;14 (1)$59$YR$A$M$Y$$$20240726$$HP$CN$CN
241408751$24140875$1$I$$20240327$20240726$20240726$EXP$$AM-Appco Pharma LLC-2159644$APPCO PHARMA$Initial$30$YR$$F$Y$$$20240726$$$AM$AM
241408761$24140876$1$I$20240101$20240722$20240726$20240726$PER$$US-BIOGEN-2024BI01264933$BIOGEN$$$$$F$Y$$$20240726$$CN$US$US
241408771$24140877$1$I$20240701$20240718$20240726$20240726$30DAY$$US-GSK-US2024090603$GLAXOSMITHKLINE$$82$YR$$M$Y$$$20240726$$CN$US$US
241408781$24140878$1$I$20240423$20240725$20240726$20240726$EXP$GB-MHRA-MED-202407251459411040-CZMBR$GB-BEH-2024176305$CSL BEHRING$$77$YR$E$M$Y$82$KG$20240726$$PH$GB$GB
241408802$24140880$2$F$$20240926$20240726$20240930$EXP$$NVSC2024GB153026$NOVARTIS$$$$$$Y$$$20240930$$HP$GB$GB
241408811$24140881$1$I$20240101$20240725$20240726$20240726$EXP$$US-UCBSA-2024037624$UCB$$$$$F$Y$$$20240726$$CN$US$US
241408822$24140882$2$F$20240101$20240723$20240726$20240728$PER$$US-AMGEN-USASP2024147073$AMGEN$$68$YR$E$F$Y$$$20240728$$CN$US$US
241408833$24140883$3$F$$20240909$20240726$20240911$PER$$NVSC2024US151909$NOVARTIS$$$$$M$Y$$$20240911$$CN$US$US
241408841$24140884$1$I$$20240722$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117772$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$76.66$KG$20240726$$CN$US$US
241408851$24140885$1$I$20240723$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024147989$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241408861$24140886$1$I$20240623$20240717$20240726$20240726$EXP$FR-AFSSAPS-TO2024001296$FR-Accord-436838$ACCORD$$81$YR$E$M$Y$68$KG$20240726$$MD$FR$FR
241408871$24140887$1$I$20210202$20240717$20240726$20240726$EXP$FR-EMA-2024710-AUTODUP-1720643573685$FR-Accord-437115$ACCORD$$$$$F$Y$$$20240726$$HP$FR$FR
241408882$24140888$2$F$$20240805$20240726$20240817$EXP$$TR-Accord-436562$ACCORD$Atahan C, Ugurluer G, Kumbasar B, Ozyar E, Atalar B. Myonecrosis as a rare side effect of stereotactic body radiotherapy for bone metastases: Report of two cases and a comprehensive literature review. Cancer/Radiotherapie. 2024;28(3):275-9$63$YR$A$M$Y$67$KG$20240817$$MD$TR$TR
241408891$24140889$1$I$$20240716$20240726$20240726$EXP$$IE-Accord-436543$ACCORD$Babiker S, Hajalamin M. An atypical encounter: Mounir-Kuhn syndrome and aspergilloma coexistence: A case report. Radiology Case Reports. 2024;19(9):3962-5. DOI: 10.1016/j.radcr.2024.06.001.$69$YR$E$M$Y$39$KG$20240726$$MD$IE$IE
241408901$24140890$1$I$20240601$20240722$20240726$20240726$EXP$FR-AFSSAPS-GR2024000910$FR-Accord-438082$ACCORD$$88$YR$E$F$Y$$$20240726$$PH$FR$FR
241408911$24140891$1$I$$20240714$20240726$20240726$EXP$$NL-Accord-438226$ACCORD$Crouwel F, Simsek M, de Boer MA, van Asseldonk DP, Bhalla A, Weusthuis et al. Multicentre study and systematic review: Allopurinol exposure during pregnancy. Aliment Pharmacol Ther. 2024 Jul 10.$$$N$$Y$$$20240726$$HP$NL$NL
241408921$24140892$1$I$20240630$20240723$20240726$20240726$EXP$$CO-UCBSA-2024037685$UCB$$25$YR$$F$Y$$$20240726$$CN$CO$CO
241408931$24140893$1$I$$20240708$20240726$20240726$EXP$$US-JNJFOC-20240769482$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$CN$US$US
241408941$24140894$1$I$$20240717$20240726$20240726$EXP$$IT-EMD Serono-2024039388$EMD SERONO INC$$$$$F$Y$$$20240726$$MD$IT$IT
241408951$24140895$1$I$$20240229$20240726$20240726$EXP$$US-SERB S.A.S.-2159646$LABORATOIRES SERB$Litterature article about Vistogard$78$YR$$F$Y$$$20240726$$MD$US$US
241408971$24140897$1$I$$20240718$20240726$20240726$EXP$$US-Stemline Therapeutics, Inc.-2024ST004399$STEMLINE THERAPEUTICS$$54$YR$A$F$Y$$$20240723$$CN$US$US
241408981$24140898$1$I$20240706$20240718$20240726$20240726$EXP$$US-Stemline Therapeutics, Inc.-2024ST004394$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240723$$CN$US$US
241408991$24140899$1$I$$20240718$20240726$20240726$EXP$$US-GSK-US2024AMR091690$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241409001$24140900$1$I$$20240725$20240726$20240726$PER$$US-ROCHE-10000038206$ROCHE$$68$YR$E$M$Y$$$20240726$$HP$US$US
241409021$24140902$1$I$$20240604$20240726$20240726$PER$$US-Breckenridge Pharmaceutical, Inc.-2159647$BRECKENRIDGE$$94$YR$$F$Y$56.818$KG$20240726$$$US$US
241409031$24140903$1$I$20240101$20240722$20240726$20240726$EXP$$US-SA-2024SA216340$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240726$$MD$US$US
241409041$24140904$1$I$20240715$20240722$20240726$20240726$EXP$$US-SA-2024SA216345$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240726$$CN$US$US
241409051$24140905$1$I$$20240719$20240726$20240726$EXP$$US-SA-2024SA216644$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241409061$24140906$1$I$20240101$20240712$20240726$20240726$PER$$US-SA-2024SA210326$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240726$$MD$US$US
241409071$24140907$1$I$20240405$20240718$20240726$20240726$EXP$ES-AEMPS-1549632$ES-SA-2024SA213175$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240726$$MD$ES$ES
241409081$24140908$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024145926$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
241409091$24140909$1$I$20240717$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024148116$AMGEN$$84$YR$E$M$Y$$$20240726$$CN$US$US
241409101$24140910$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216544$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240726$$CN$US$US
241409111$24140911$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA217044$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240726$$MD$US$US
241409121$24140912$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214898$SANOFI AVENTIS$$$$A$M$Y$$$20240726$$MD$US$US
241409131$24140913$1$I$20240714$20240719$20240726$20240726$EXP$$US-Stemline Therapeutics, Inc.-2024ST004421$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240723$$CN$US$US
241409141$24140914$1$I$20240501$20240603$20240726$20240726$PER$$US-LUNDBECK-DKLU4000228$LUNDBECK$$$$$$Y$$$20240726$$PH$US$US
241409151$24140915$1$I$20240703$20240719$20240726$20240726$EXP$$US-Stemline Therapeutics, Inc.-2024ST004433$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240724$$CN$US$US
241409161$24140916$1$I$20240712$20240715$20240726$20240726$EXP$GB-MHRA-MED-202407151201209090-BFPTY$GB-JUBILANT CADISTA PHARMACEUTICALS-2024GB001035$JUBILANT$$$$A$M$Y$$$20240726$$HP$GB$GB
241409171$24140917$1$I$$20240722$20240726$20240726$EXP$$IT-MYLANLABS-2024M1068270$MYLAN$Tondulli, L.. Po a rare case of pulmonary vasculitis due to new antiangiogenic drugs. Annals of Oncology. 2009;20 (Suppl 5):10$67$YR$$F$Y$$$20240726$$HP$IT$IT
241409181$24140918$1$I$$20240716$20240726$20240726$EXP$$AU-MYLANLABS-2024M1068096$MYLAN$Dunn A, Wu N, Cordaro F. Management of loperamide-related opioid use disorder with buprenorphine within an Australian context: A case report. Drug-Alcohol-Rev 2024; 1-4.$28$YR$$M$Y$$$20240726$$HP$AU$AU
241409191$24140919$1$I$$20240719$20240726$20240726$EXP$$US-Stemline Therapeutics, Inc.-2024ST004428$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240724$$CN$US$US
241409201$24140920$1$I$$20240725$20240725$20240725$DIR$711537$$FDA-CTU$$$$$M$N$$$20240725$N$HP$US$
241409211$24140921$1$I$20240620$20240724$20240726$20240726$EXP$FR-AFSSAPS-ST2024001142$FR-MYLANLABS-2024M1068987$MYLAN$$24$YR$$M$Y$85$KG$20240726$$MD$FR$FR
241409221$24140922$1$I$$20240721$20240726$20240726$EXP$$BR-JNJFOC-20240602590$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$HP$BR$BR
241409231$24140923$1$I$$20240723$20240726$20240726$EXP$$US-ABBVIE-5854377$ABBVIE$$$$E$$Y$$$20240726$$CN$US$US
241409241$24140924$1$I$$20240718$20240726$20240726$EXP$$US-Stemline Therapeutics, Inc.-2024ST004406$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240723$$CN$US$US
241409261$24140926$1$I$$20240718$20240726$20240726$EXP$$JP-009507513-2405JPN002360J$MERCK$$75$YR$$F$Y$$$20240726$$MD$JP$JP
241409271$24140927$1$I$20240717$20240717$20240726$20240726$EXP$$US-VIIV HEALTHCARE LIMITED-US2024090035$VIIV$$45$YR$$M$Y$$$20240726$$CN$US$US
241409281$24140928$1$I$$20240718$20240726$20240726$30DAY$$US-GSK-US2024090629$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$HP$US$US
241409291$24140929$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118390$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$99.79$KG$20240726$$CN$US$US
241409301$24140930$1$I$$20240725$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407017182$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240726$$CN$US$US
241409311$24140931$1$I$$20240717$20240726$20240726$EXP$$US-Stemline Therapeutics, Inc.-2024ST004387$STEMLINE THERAPEUTICS$$85$YR$E$F$Y$$$20240723$$CN$US$US
241409321$24140932$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118607$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240726$$HP$US$US
241409331$24140933$1$I$20240706$20240716$20240726$20240726$EXP$$CA-ROCHE-10000029186$ROCHE$$86$YR$E$F$Y$$$20240726$$CN$CA$CA
241409341$24140934$1$I$$20240715$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015398$ELI LILLY AND CO$$$$$$Y$$$20240726$$CN$US$US
241409352$24140935$2$F$20240601$20240724$20240726$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016194$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240729$$CN$US$US
241409362$24140936$2$F$$20240724$20240726$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016350$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240730$$CN$US$US
241409371$24140937$1$I$$20240725$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407017266$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240726$$CN$US$US
241409381$24140938$1$I$20240724$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016777$ELI LILLY AND CO$$$$$$Y$$$20240726$$CN$US$US
241409391$24140939$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016105$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240726$$CN$US$US
241409401$24140940$1$I$$20240717$20240726$20240726$EXP$$US-Stemline Therapeutics, Inc.-2024ST004374$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240722$$CN$US$US
241409411$24140941$1$I$20240708$20240709$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407005926$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240726$$CN$US$US
241409421$24140942$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222936$TEVA$$45$YR$$M$Y$$$20240726$$MD$CA$CA
241409442$24140944$2$F$$20240724$20240726$20240730$EXP$$US-UCBSA-2024037594$UCB$$$$$M$Y$$$20240730$$CN$US$US
241409451$24140945$1$I$$20240718$20240726$20240726$EXP$$JP-EMD Serono-2024039676$EMD SERONO INC$$8$DEC$E$M$Y$$$20240726$$MD$JP$JP
241409464$24140946$4$F$$20240819$20240726$20240820$PER$$US-ROCHE-10000036402$ROCHE$$$$A$F$Y$$$20240820$$CN$US$US
241409471$24140947$1$I$20240501$20240718$20240726$20240726$PER$$US-SA-2024SA216524$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240726$$MD$US$US
241409481$24140948$1$I$20240601$20240718$20240726$20240726$PER$$US-SA-2024SA214166$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240726$$MD$US$US
241409491$24140949$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214187$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240726$$MD$US$US
241409511$24140951$1$I$$20240327$20240726$20240726$EXP$$TH-Appco Pharma LLC-2159648$APPCO PHARMA$Initial$29$YR$$F$Y$$$20240726$$MD$TH$TH
241409521$24140952$1$I$20240713$20240718$20240726$20240726$EXP$$CN-ROCHE-10000031004$ROCHE$$51$YR$A$F$Y$45$KG$20240726$$HP$CN$CN
241409531$24140953$1$I$$20240722$20240726$20240726$PER$$US-BIOVITRUM-2024-US-010146$BIOVITRUM$$17$YR$$F$Y$$$20240726$$MD$US$US
241409551$24140955$1$I$20240716$20240722$20240726$20240726$PER$$US-BIOGEN-2024BI01274798$BIOGEN$$26$YR$$F$Y$$$20240726$$CN$US$US
241409561$24140956$1$I$$20240719$20240726$20240726$EXP$$CA-APOTEX-2024AP008639$APOTEX$$$$$F$Y$184$KG$20240726$$MD$CA$CA
241409571$24140957$1$I$$20240716$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091180$VIIV$$$$$$Y$$$20240726$$MD$US$US
241409581$24140958$1$I$20240512$20240725$20240725$20240725$DIR$711577$$FDA-CTU$$60$YR$$F$N$76.5$KG$20240725$N$CN$US$
241409591$24140959$1$I$20240612$20240725$20240725$20240725$DIR$711509$$FDA-CTU$$64$YR$$M$N$135$KG$20240725$N$CN$US$
241409601$24140960$1$I$20240724$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51389$$FDA-CTU$$66$YR$$F$N$$$20240724$N$HP$US$
241409611$24140961$1$I$20240724$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51460$$FDA-CTU$$59$YR$$F$N$$$20240724$N$HP$US$
241409631$24140963$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51437$$FDA-CTU$$$$$F$N$$$20240725$N$HP$US$
241409652$24140965$2$F$20240701$20240806$20240726$20240807$EXP$$US-UCBSA-2024037697$UCB$$40$YR$$F$Y$$$20240807$$CN$US$US
241409661$24140966$1$I$$20240717$20240726$20240726$EXP$$IT-EMD Serono-2024039727$EMD SERONO INC$$$$N$$Y$$$20240726$$MD$IT$IT
241409671$24140967$1$I$20240707$20240719$20240726$20240726$EXP$$CN-AstraZeneca-2024A167764$ASTRAZENECA$$83$YR$$M$Y$70$KG$20240726$$MD$CN$
241409681$24140968$1$I$20240209$20240722$20240726$20240726$EXP$$PH-AstraZeneca-2024A167202$ASTRAZENECA$$25933$DY$$M$Y$$$20240726$$CN$PH$
241409691$24140969$1$I$$20240718$20240726$20240726$EXP$$CA-AstraZeneca-2024A164910$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$CA$
241409701$24140970$1$I$20240710$20240721$20240726$20240726$EXP$$GB-ANIPHARMA-2024-UK-000140$ANI$$39$YR$$F$Y$84$KG$20240726$$CN$GB$GB
241409711$24140971$1$I$$20240724$20240726$20240726$EXP$$US-ROCHE-10000036679$ROCHE$$$$A$F$Y$$$20240726$$CN$US$US
241409721$24140972$1$I$$20240716$20240726$20240726$EXP$$ES-KOANAAP-SML-ES-2024-00754$UNKNOWN$R A, MG L, A A, M A, RAG C, A C. Prolonged survival of a patient with desmoplastic small round cell tumor. Cancer + Chemotherapy Rev. 2022;41-46.$34$YR$A$M$Y$$$20240726$$MD$ES$ES
241409731$24140973$1$I$$20240719$20240726$20240726$EXP$US-MLMSERVICE-20240717-PI130051-00050-2$US-RDY-SPO/USA/24/0010824$DR REDDYS$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70(7):e92-6. DOI: 10.1097/MAT.0000000000002102.$14$YR$T$F$Y$129$KG$20240726$$MD$US$US
241409741$24140974$1$I$$20240716$20240726$20240726$EXP$$US-RDY-LIT/USA/24/0010791$DR REDDYS$Anderson M, Brozzi N, Rosenthal R, Hernandez-Montfort JA, Reddy R, Gopalan R. Panel Discussion: Non-cardiac Surgery Interventions on Patients Receiving Impella Support. Interventional Cardiology: Reviews, Research, Resources. 2024;19: 31-34. doi:10.15420/icr.2024.19.S1.$66$YR$E$F$Y$$$20240726$$HP$US$US
241409751$24140975$1$I$20240725$20240725$20240726$20240726$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042069$BOEHRINGER INGELHEIM$$$$$$Y$$$20240726$$CN$US$US
241409761$24140976$1$I$$20240708$20240726$20240726$PER$$US-Eisai-EC-2024-169800$EISAI$$$$E$F$Y$$$20240726$$HP$US$US
241409781$24140978$1$I$$20240724$20240726$20240726$PER$$US-ABBVIE-5854658$ABBVIE$$$$$$Y$$$20240726$$HP$US$US
241409801$24140980$1$I$20231025$20231025$20240726$20240726$EXP$$IN-INCYTE CORPORATION-2023IN013650$INCYTE$$$$$$Y$$$20240726$$CN$IN$IN
241409811$24140981$1$I$20240725$20240725$20240725$20240725$DIR$711566$$FDA-CTU$$32$YR$$UNK$N$52$KG$20240725$N$CN$CA$
241409831$24140983$1$I$20240625$20240725$20240726$20240726$EXP$$CN-ROCHE-10000038053$ROCHE$$60$YR$A$F$Y$49$KG$20240726$$HP$CN$CN
241409842$24140984$2$F$20240618$20240813$20240726$20240823$EXP$$FR-ROCHE-10000021227$ROCHE$$71$YR$E$M$Y$78$KG$20240823$$MD$FR$FR
241409851$24140985$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51411$$FDA-CTU$$89$YR$$M$N$$$20240725$N$$US$
241409861$24140986$1$I$20240725$20240725$20240725$20240725$DIR$711571$$FDA-CTU$$44$YR$$F$N$67.5$KG$20240725$N$CN$US$
241409871$24140987$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51459$$FDA-CTU$$63$YR$$M$N$$$20240725$N$$US$
241409881$24140988$1$I$$20240720$20240726$20240726$EXP$$BR-TAKEDA-2023TUS055000$TAKEDA$$$$$F$Y$$$20240726$$CN$BR$BR
241409901$24140990$1$I$20240702$20240718$20240726$20240726$EXP$PT-INFARMED-J202407-51$PT-SA-2024SA214196$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240726$$MD$PT$PT
241409912$24140991$2$F$20240627$20240920$20240726$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118779$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240924$$MD$JP$JP
241409931$24140993$1$I$$20240715$20240726$20240726$EXP$$US-NOVAST LABORATORIES INC.-2024NOV000277$NOVAST$Sendil S, Yarlagadda K, Lawal H, Nookala V, Shingala H.. Metformin Associated Lactic Acidosis in the Intensive Care Unit: A Rare Condition Mimicking Sepsis.. Cureus. 2020;12(7)$63$YR$$M$Y$$$20240726$$HP$US$US
241409941$24140994$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118568$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240726$$CN$US$US
241409951$24140995$1$I$$20240717$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114625$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$107.5$KG$20240726$$CN$US$US
241409961$24140996$1$I$20240704$20240719$20240726$20240726$EXP$$EG-SA-2024SA216790$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240726$$HP$EG$EG
241409971$24140997$1$I$20240716$20240716$20240726$20240726$EXP$$US-ACORDA-ACO_177589_2024$ACORDA$$61$YR$$F$Y$$$20240726$$CN$US$US
241409983$24140998$3$F$20240719$20240723$20240726$20240802$EXP$$CH-BEH-2024176263$CSL BEHRING$$$$T$F$Y$$$20240802$$PH$CH$CH
241409992$24140999$2$F$20231116$20240717$20240726$20240726$EXP$$US-ABBVIE-5851672$ABBVIE$$82$YR$$M$Y$$$20240726$$CN$US$US
241410001$24141000$1$I$$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024148387$AMGEN$$$$$$Y$$$20240726$$HP$US$US
241410011$24141001$1$I$$20240712$20240726$20240726$EXP$$US-QUAGEN-2024QUALIT00228$QUAGEN PHARMACEUTICALS$PA Hirt.Cutaneous Mycobacterium avium-intracellulare infection masquerading as sarcoidosis.Pediatric Dermatology.MAY-2024;41 (3):497-500$14$YR$T$M$Y$$$20240726$$HP$US$US
241410021$24141002$1$I$$20240718$20240726$20240726$EXP$$CN-AMGEN-CHNSP2024143604$AMGEN$Chen S.; Shen L.; Cao W. et al.. Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation. Blood cancer journal. 2024;14 (1)$22$YR$A$M$Y$$$20240726$$HP$CN$CN
241410031$24141003$1$I$20240717$20240718$20240726$20240726$EXP$$FR-AstraZeneca-2024A166841$ASTRAZENECA$$65$YR$$F$Y$$$20240726$$MD$FR$
241410041$24141004$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165878$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241410051$24141005$1$I$$20240722$20240726$20240726$EXP$$IN-VANTIVE-2024VAN018568$Vantive US Healthcare$$7$YR$$M$Y$$$20240726$$CN$IN$IN
241410061$24141006$1$I$20231128$20240716$20240726$20240726$EXP$FR-AFSSAPS-ST2024001137$FR-TEVA-VS-3222246$TEVA$$65$YR$$F$Y$56.5$KG$20240726$$HP$FR$FR
241410071$24141007$1$I$$20240722$20240726$20240726$EXP$$IN-VANTIVE-2024VAN018588$Vantive US Healthcare$$26$YR$$M$Y$$$20240726$$CN$IN$IN
241410082$24141008$2$F$$20240823$20240726$20240830$EXP$$IN-VANTIVE-2024VAN018582$Vantive US Healthcare$$12$YR$$F$Y$$$20240830$$CN$IN$IN
241410102$24141010$2$F$20240528$20240912$20240726$20240920$PER$$US-IGSA-BIG0029975$GRIFOLS$$32$YR$$F$Y$$$20240920$$MD$US$US
241410112$24141011$2$F$20240221$20240807$20240726$20240813$EXP$$US-TAKEDA-2024TUS020546$TAKEDA$$37$YR$$F$Y$$$20240813$$CN$US$US
241410131$24141013$1$I$20240722$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147021$AMGEN$$60$YR$A$M$Y$$$20240726$$CN$US$US
241410141$24141014$1$I$20240722$20240723$20240726$20240726$EXP$$CN-AMGEN-CHNSP2024146105$AMGEN$$73$YR$E$F$Y$66.6$KG$20240726$$HP$CN$CN
241410151$24141015$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118202$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$68.49$KG$20240726$$CN$US$US
241410161$24141016$1$I$20240101$20240718$20240726$20240726$EXP$$US-AMGEN-USASL2024124548$AMGEN$$73$YR$E$F$Y$$$20240726$$MD$US$US
241410171$24141017$1$I$$20240703$20240726$20240726$PER$$US-009507513-2407USA001961$MERCK$$$$$F$Y$75.7$KG$20240726$$CN$US$US
241410181$24141018$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-037106$AUROBINDO$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF.. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult.. J-Pain-Symptom-Manage. 2023;66(4):e455-e459$$$A$$Y$$$20240726$$HP$US$US
241410191$24141019$1$I$$20240712$20240726$20240726$EXP$$PT-QUAGEN-2024QUALIT00227$QUAGEN PHARMACEUTICALS$BSGC Sousa.Decoding the enigma: Valproate encephalopathy in a bipolar affective disorder without hyperammonemia..Bipolar Disorders.JUN-2024$63$YR$A$F$Y$$$20240726$$HP$PT$PT
241410201$24141020$1$I$20240711$20240719$20240726$20240726$EXP$$US-PFIZER INC-202400222786$PFIZER$$$$$$Y$$$20240726$$HP$US$US
241410212$24141021$2$F$$20240730$20240726$20240802$EXP$$US-PFIZER INC-PV202400067140$PFIZER$$81$YR$$F$Y$$$20240802$$CN$US$US
241410221$24141022$1$I$20240624$20240722$20240726$20240726$EXP$FR-AFSSAPS-TS2024000826$FR-PFIZER INC-202400220318$PFIZER$$68$YR$$M$Y$61$KG$20240726$$MD$FR$FR
241410231$24141023$1$I$20240415$20240722$20240726$20240726$EXP$IT-MINISAL02-995433$IT-PFIZER INC-202400220529$PFIZER$$17$YR$$F$Y$$$20240726$$MD$IT$IT
241410241$24141024$1$I$20240709$20240719$20240726$20240726$EXP$$CN-PFIZER INC-202400219740$PFIZER$$80$YR$$M$Y$46$KG$20240726$$HP$CN$CN
241410252$24141025$2$F$20190815$20240731$20240726$20240806$EXP$$ZA-PFIZER INC-202400221930$PFIZER$$51$YR$$F$Y$$$20240806$$MD$ZA$ZA
241410261$24141026$1$I$20231220$20240722$20240726$20240726$EXP$$CA-PFIZER INC-202300455953$PFIZER$$74$YR$$F$Y$$$20240726$$HP$CA$CA
241410271$24141027$1$I$$20240515$20240726$20240726$PER$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00197$Unknown Manufacturer$$$$$M$Y$$$20240726$$CN$US$US
241410281$24141028$1$I$$20240506$20240726$20240726$PER$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00290$Unknown Manufacturer$$12$YR$$M$Y$$$20240726$$CN$US$US
241410291$24141029$1$I$20230601$20240625$20240726$20240726$PER$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00217$Unknown Manufacturer$$1$YR$$M$Y$$$20240726$$CN$US$US
241410301$24141030$1$I$20230601$20240531$20240726$20240726$PER$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00032$Unknown Manufacturer$$9$YR$$F$Y$27.211$KG$20240726$$CN$US$US
241410311$24141031$1$I$$20240408$20240726$20240726$PER$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00207$Unknown Manufacturer$$$$$M$Y$$$20240726$$CN$US$US
241410322$24141032$2$F$20240604$20240805$20240726$20240807$EXP$$IT-PFIZER INC-202400220273$PFIZER$$69$YR$$F$Y$65$KG$20240807$$MD$IT$IT
241410331$24141033$1$I$$20240530$20240726$20240726$PER$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00338$Unknown Manufacturer$$$$$F$Y$$$20240726$$CN$US$US
241410341$24141034$1$I$$20240506$20240726$20240726$PER$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00289$Unknown Manufacturer$$$$$F$Y$$$20240726$$CN$US$US
241410351$24141035$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153515$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241410361$24141036$1$I$20240714$20240717$20240726$20240726$EXP$$ES-AUROBINDO-AUR-APL-2024-036328$AUROBINDO$$50$YR$$F$Y$65$KG$20240726$$PH$ES$ES
241410381$24141038$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51414$$FDA-CTU$$89$YR$$M$N$$$20240725$N$$US$
241410391$24141039$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51458$$FDA-CTU$$61$YR$$F$N$$$20240725$N$$US$
241410401$24141040$1$I$20240719$20240725$20240725$20240725$DIR$711580$$FDA-CTU$$64$YR$$F$N$70.76$KG$20240725$N$$US$
241410411$24141041$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51401$$FDA-CTU$$81$YR$$F$N$63.5$KG$20240725$N$HP$US$
241410441$24141044$1$I$20190919$20240725$20240725$20240725$DIR$711511$$FDA-CTU$$71$YR$$M$N$89.1$KG$20240725$N$CN$US$
241410451$24141045$1$I$20240408$20240725$20240726$20240726$EXP$FR-AFSSAPS-DJ2024000844$FR-KOANAAP-SML-FR-2024-00775$SHILPA MEDICARE$$51$YR$A$M$Y$108$KG$20240726$$MD$FR$FR
241410461$24141046$1$I$20240101$20240702$20240726$20240726$PER$$US-Eisai-EC-2024-169546$EISAI$$$$$F$Y$$$20240726$$MD$US$US
241410471$24141047$1$I$20240101$20240701$20240726$20240726$PER$$US-Eisai-EC-2024-169361$EISAI$$66$YR$E$F$Y$$$20240726$$CN$US$US
241410482$24141048$2$F$20240101$20240726$20240726$20240805$EXP$$US-ABBVIE-5850090$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241410491$24141049$1$I$20240701$20240717$20240726$20240726$PER$$US-SA-2024SA215213$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240726$$MD$US$US
241410501$24141050$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214413$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240726$$MD$US$US
241410511$24141051$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA215122$SANOFI AVENTIS$$$$C$M$Y$41.7$KG$20240726$$MD$US$US
241410521$24141052$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA215190$SANOFI AVENTIS$$35$YR$A$M$Y$127$KG$20240726$$MD$US$US
241410531$24141053$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-037108$AUROBINDO$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF.. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult.. J-Pain-Symptom-Manage. 2023;66(4):e455-e459$$$A$$Y$$$20240726$$HP$US$US
241410541$24141054$1$I$20240504$20240712$20240726$20240726$EXP$$CH-ASTELLAS-2024US020733$ASTELLAS$$78$YR$$F$Y$52$KG$20240726$$CN$CH$CH
241410561$24141056$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222988$TEVA$$48$YR$$F$Y$$$20240726$$HP$CA$CA
241410572$24141057$2$F$$20240726$20240726$20240807$EXP$$IT-AUROBINDO-AUR-APL-2024-020490$AUROBINDO$Di Rauso G, Orlandi N, Jacopetti M, Bigliardi G, Antonelli F, Meletti S et al.. Botulinum neurotoxin as early treatment in acute-onset lesional hemiballism.. Neurological sciences. 2024;45:3509-3511$78$YR$$M$Y$$$20240807$$MD$IT$IT
241410581$24141058$1$I$20240415$20240723$20240726$20240726$EXP$FR-AFSSAPS-AN2024000807$FR-MYLANLABS-2024M1068522$MYLAN$$76$YR$$M$Y$$$20240726$$PH$FR$FR
241410591$24141059$1$I$$20240723$20240726$20240726$EXP$$US-MYLANLABS-2024M1058182$MYLAN$$$$$M$Y$70.1$KG$20240726$$MD$US$US
241410601$24141060$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216563$SANOFI AVENTIS$$$$A$F$Y$56.6$KG$20240726$$MD$US$US
241410611$24141061$1$I$20240701$20240718$20240726$20240726$PER$$US-SA-2024SA216773$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240726$$MD$US$US
241410622$24141062$2$F$20240101$20240828$20240726$20240923$PER$$US-SA-2024SA217913$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240923$$MD$US$US
241410632$24141063$2$F$20240601$20240807$20240726$20240821$PER$$US-SA-2024SA212252$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240821$$MD$US$US
241410641$24141064$1$I$$20240725$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016800$ELI LILLY AND CO$$61$YR$A$$Y$$$20240726$$CN$US$US
241410651$24141065$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA213775$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240726$$MD$US$US
241410661$24141066$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016344$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240726$$CN$US$US
241410671$24141067$1$I$20240101$20240720$20240726$20240726$PER$$US-SA-2024SA217952$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240726$$MD$US$US
241410681$24141068$1$I$20240701$20240718$20240726$20240726$PER$$US-SA-2024SA213852$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240726$$CN$US$US
241410691$24141069$1$I$20240723$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016185$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240726$$CN$US$US
241410701$24141070$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA217067$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240726$$MD$US$US
241410711$24141071$1$I$20240724$20240725$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407017007$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240726$$CN$US$US
241410721$24141072$1$I$20240301$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015728$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240726$$CN$US$US
241410731$24141073$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216721$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241410741$24141074$1$I$20240701$20240718$20240726$20240726$PER$$US-SA-2024SA213780$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240726$$MD$US$US
241410751$24141075$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA214181$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240726$$MD$US$US
241410771$24141077$1$I$$20240717$20240726$20240726$EXP$$PL-AUROBINDO-AUR-APL-2024-036035$AUROBINDO$$53$YR$$F$Y$62$KG$20240726$$MD$PL$PL
241410781$24141078$1$I$20240401$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-035763$AUROBINDO$$79$YR$$F$Y$$$20240726$$MD$FR$FR
241410791$24141079$1$I$20240618$20240723$20240726$20240726$EXP$ES-AEMPS-1551605$ES-PFIZER INC-202400221799$PFIZER$$53$YR$$F$Y$$$20240726$$PH$ES$ES
241410804$24141080$4$F$20240101$20240821$20240726$20240918$PER$$US-SA-2024SA215806$SANOFI AVENTIS$$59$YR$A$M$Y$142$KG$20240918$$MD$US$US
241410811$24141081$1$I$20240503$20240723$20240726$20240726$EXP$FR-AFSSAPS-LL2024001380$FR-PFIZER INC-202400221711$PFIZER$$54$YR$$F$Y$71$KG$20240726$$MD$FR$FR
241410821$24141082$1$I$20240715$20240723$20240726$20240726$EXP$GB-MHRA-MED-202407161503495630-WLTRZ$GB-PFIZER INC-202400221925$PFIZER$$50$YR$$F$Y$$$20240726$$HP$GB$GB
241410831$24141083$1$I$20240610$20240723$20240726$20240726$EXP$FR-AFSSAPS-LL2024001385$FR-PFIZER INC-202400221714$PFIZER$$49$YR$$F$Y$52.5$KG$20240726$$MD$FR$FR
241410841$24141084$1$I$20230501$20240723$20240726$20240726$EXP$$CA-PFIZER INC-PV202300139792$PFIZER$$80$YR$$F$Y$$$20240726$$HP$CA$CA
241410854$24141085$4$F$$20240925$20240726$20240927$EXP$$JP-PFIZER INC-202400223034$PFIZER$$81$YR$$M$Y$$$20240927$$MD$JP$JP
241410861$24141086$1$I$20240101$20240723$20240726$20240726$EXP$$CN-PFIZER INC-PV202400096298$PFIZER$$62$YR$$M$Y$$$20240726$$HP$CN$CN
241410871$24141087$1$I$20240702$20240723$20240726$20240726$EXP$$CN-PFIZER INC-PV202400096280$PFIZER$$48$YR$$F$Y$82$KG$20240726$$HP$CN$CN
241410881$24141088$1$I$20240620$20240723$20240726$20240726$EXP$FR-AFSSAPS-RE2024000751$FR-PFIZER INC-202400221701$PFIZER$$88$YR$$F$Y$40$KG$20240726$$MD$FR$FR
241410892$24141089$2$F$20240101$20240724$20240726$20240730$EXP$$US-ABBVIE-5853015$ABBVIE$$40$YR$$F$Y$$$20240730$$MD$US$US
241410902$24141090$2$F$20240719$20240807$20240726$20240809$EXP$$JP-ARGENX-2024-ARGX-JP005793$ARGENX BVBA$$$$$$Y$$$20240809$$PH$JP$JP
241410913$24141091$3$F$20240701$20240813$20240726$20240821$EXP$$GE-MIRUM PHARMACEUTICALS, INC.-GE-MIR-24-00576$MIRUM PHARMACEUTICALS$$$$$$Y$$$20240821$$MD$GE$GE
241410922$24141092$2$F$20240625$20240730$20240726$20240730$EXP$$GB-BAYER-2024A106449$BAYER$$$$$F$Y$$$20240730$$MD$GB$GB
241410932$24141093$2$F$$20240802$20240726$20240811$EXP$$JP-AMGEN-JPNSP2024146590$AMGEN$$51$YR$A$F$Y$$$20240811$$PH$JP$JP
241410941$24141094$1$I$20240701$20240725$20240726$20240726$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042076$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240726$$CN$US$US
241410952$24141095$2$F$$20240729$20240726$20240731$PER$$US-ROCHE-10000023627$ROCHE$$38$YR$A$F$Y$$$20240731$$CN$US$US
241410961$24141096$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-018266$AUROBINDO$Simpson M, Johnson L, Goldfine C. Sodium bicarbonate treatment for QRS widening in bupropion overdoses. CLINICAL TOXICOLOGY. 2023;61(6):436-444$$$A$$Y$$$20240726$$HP$US$US
241410972$24141097$2$F$$20240808$20240726$20240814$EXP$$IE-EMD Serono-2024039990$EMD SERONO INC$$$$A$M$Y$$$20240814$$CN$IE$IE
241410991$24141099$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-036770$AUROBINDO$Gonzalez KA, Lutz K, Garcia JL, Kelly J, Sanghai S. PO-02-001 WHEN THE ANSWER IS RIGHT UNDER YOUR FEET: A CASE OF CARVAJAL SYNDROME. Heart-Rhythm. 2024;21 (Suppl.) (5):S304$38$YR$$F$Y$$$20240726$$HP$US$US
241411001$24141100$1$I$20240715$20240716$20240726$20240726$PER$$US-TEVA-VS-3222504$TEVA$$13$YR$$M$Y$$$20240726$$PH$US$US
241411011$24141101$1$I$$20240722$20240726$20240726$EXP$$ZA-BAYER-2024A106457$BAYER$$25$YR$A$F$Y$$$20240726$$CN$ZA$ZA
241411021$24141102$1$I$20240725$20240725$20240725$20240725$DIR$711528$$FDA-CTU$$75$YR$$F$N$91.35$KG$20240725$N$$US$
241411031$24141103$1$I$$20240719$20240726$20240726$EXP$$US-CHATTEMPRD-2024OHG024759$CHATTEM$$$$$F$Y$$$20240726$$LW$US$US
241411042$24141104$2$F$20240725$20240725$20240726$20240822$EXP$$US-UCBSA-2024037633$UCB$$48$YR$$M$Y$$$20240822$$CN$US$US
241411051$24141105$1$I$20240705$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51422$$FDA-CTU$$60$YR$$F$N$$$20240725$N$HP$US$
241411071$24141107$1$I$20240522$20240725$20240725$20240725$DIR$711552$$FDA-CTU$$72$YR$$F$N$$$20240725$N$MD$US$
241411081$24141108$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118540$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240726$$CN$US$US
241411091$24141109$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118535$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240726$$CN$US$US
241411101$24141110$1$I$$20240717$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114592$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240726$$CN$US$US
241411111$24141111$1$I$$20240724$20240726$20240726$EXP$$US-PFIZER INC-202400223027$PFIZER$$68$YR$$M$Y$$$20240726$$CN$US$US
241411122$24141112$2$F$$20240819$20240726$20240822$EXP$$FR-PFIZER INC-PV202400097238$PFIZER$$$$$M$Y$$$20240822$$MD$FR$FR
241411153$24141115$3$F$20240101$20240903$20240726$20240905$EXP$$AR-PFIZER INC-202400193034$PFIZER$$75$YR$$F$Y$$$20240905$$CN$AR$AR
241411161$24141116$1$I$20240620$20240723$20240726$20240726$EXP$FR-AFSSAPS-LL2024001386$FR-PFIZER INC-202400221709$PFIZER$$46$YR$$F$Y$63$KG$20240726$$MD$FR$FR
241411171$24141117$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51418$$FDA-CTU$$$$$M$N$$$20240725$N$HP$US$
241411181$24141118$1$I$20240630$20240723$20240726$20240726$EXP$$CN-PFIZER INC-PV202400096288$PFIZER$$77$YR$$M$Y$52$KG$20240726$$HP$CN$CN
241411192$24141119$2$F$20240721$20240731$20240726$20240802$EXP$$CN-PFIZER INC-PV202400096869$PFIZER$$45$YR$$F$Y$65$KG$20240802$$HP$CN$CN
241411201$24141120$1$I$20240607$20240723$20240726$20240726$EXP$ES-AEMPS-1551742$ES-PFIZER INC-202400221572$PFIZER$$66$YR$$M$Y$$$20240726$$PH$ES$ES
241411211$24141121$1$I$20240309$20240723$20240726$20240726$EXP$GB-MHRA-MED-202407230336454090-WCBTH$GB-MYLANLABS-2024M1068504$MYLAN$$31$YR$$F$Y$$$20240726$$CN$GB$GB
241411221$24141122$1$I$$20240723$20240726$20240726$EXP$$GB-MYLANLABS-2024M1068965$MYLAN$$$$$$Y$$$20240726$$CN$GB$GB
241411231$24141123$1$I$$20240723$20240726$20240726$EXP$GB-MHRA-30767071$GB-MYLANLABS-2024M1068991$MYLAN$$$$$$Y$$$20240726$$CN$GB$GB
241411242$24141124$2$F$$20240723$20240726$20240731$EXP$GB-MHRA-MED-202407220953288720-CYPQG$GB-MYLANLABS-2024M1068839$MYLAN$$75$YR$$M$Y$$$20240731$$CN$GB$GB
241411251$24141125$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51392$$FDA-CTU$$67$YR$$F$N$207$LBS$20240725$N$$US$
241411261$24141126$1$I$20240721$20240725$20240725$20240725$DIR$711565$$FDA-CTU$$38$YR$$F$N$60.75$KG$20240725$N$CN$US$
241411281$24141128$1$I$$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024148271$AMGEN$$$$$F$Y$$$20240726$$PH$US$US
241411291$24141129$1$I$20240718$20240722$20240726$20240726$EXP$$US-AMGEN-USASP2024145901$AMGEN$$78$YR$E$M$Y$$$20240726$$CN$US$US
241411301$24141130$1$I$20231125$20240716$20240726$20240726$EXP$FR-AFSSAPS-AVMA2024000303$FR-TEVA-VS-3222369$TEVA$$49$YR$$M$Y$$$20240726$$PH$FR$FR
241411311$24141131$1$I$$20221010$20240726$20240726$EXP$$DK-TEVA-VS-3217319$TEVA$Borresen SW, Klose M, Glintborg D, Watt T, Andersen MS, Feldt-Rasmussen U. Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency. [Review]. J-Clin-Endocrinol-Metab 2022;107(7):2065-2076.; Borresen SW, Klose M, Glintborg D, Watt T, Andersen MS, Feldt-Rasmussen U. Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency. [Review]. J-Clin-Endocrinol-Metab 2022;107(7):2065-2076.; Borresen SW, Klose M, Glintborg D, Watt T, Andersen MS, Feldt-Rasmussen U. Approa...$24$YR$$F$Y$$$20240726$$HP$DK$DK
241411321$24141132$1$I$20240515$20240719$20240726$20240726$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011198$JAZZ$$32$YR$$F$Y$$$20240726$$CN$US$US
241411332$24141133$2$F$$20240730$20240726$20240730$EXP$$CA-BAYER-2024A106847$BAYER$$$$$F$Y$$$20240730$$HP$CA$CA
241411341$24141134$1$I$20240417$20240723$20240726$20240726$EXP$$IT-TAKEDA-2024TUS074421$TAKEDA$$82$YR$$F$Y$$$20240726$$HP$IT$IT
241411351$24141135$1$I$$20240717$20240726$20240726$EXP$$JP-BAXTER-2024BAX022163$BAXTER$$3$DEC$$F$Y$40$KG$20240726$$CN$JP$JP
241411361$24141136$1$I$20240717$20240722$20240726$20240726$EXP$$GB-Eisai-EC-2024-170638$EISAI$$94$YR$E$F$Y$53$KG$20240726$$MD$GB$GB
241411371$24141137$1$I$20240626$20240711$20240726$20240726$PER$$US-Eisai-EC-2024-170101$EISAI$$82$YR$E$F$Y$$$20240726$$HP$US$US
241411381$24141138$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-037050$AUROBINDO$Lee R, Gonsalves Z, Wang S, Hussain A, Herrera K.. Case study: Autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks^ gestation.. Case-Rep-Perinat-Med. 2024;13 (1):20240007$$$I$$Y$$$20240726$$MD$US$US
241411391$24141139$1$I$$20240722$20240726$20240726$EXP$$ES-BAXTER-2024BAX022140$BAXTER$$$$$M$Y$$$20240726$$CN$ES$ES
241411401$24141140$1$I$20240615$20240719$20240726$20240726$EXP$CN-NMPACDR-3301821041099202400041$CN-BAXTER-2024BAX022120$BAXTER$$67$YR$$F$Y$57$KG$20240726$$MD$CN$CN
241411421$24141142$1$I$$20240712$20240726$20240726$EXP$$CN-QUAGEN-2024QUALIT00225$QUAGEN PHARMACEUTICALS$Xiaoxue Xu.Reversible blindness after stellate ganglion block.Quantitative Imaging in Medicine and Surgery.26-APR-2024;14:3744-3750$53$YR$A$M$Y$65$KG$20240726$$MD$CN$CN
241411432$24141143$2$F$$20240911$20240726$20240917$EXP$$US-CHATTEMPRD-2024OHG025181$CHATTEM$$77$YR$E$M$Y$$$20240917$$LW$US$US
241411441$24141144$1$I$$20240723$20240726$20240726$PER$$US-ABBVIE-5854292$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241411452$24141145$2$F$20240719$20240812$20240726$20240816$EXP$$GB-MYLANLABS-2024M1068785$MYLAN$$62$YR$$M$Y$68.25$KG$20240816$$CN$GB$GB
241411462$24141146$2$F$20240529$20240722$20240726$20240801$EXP$FR-AFSSAPS-LY2024001070$FR-MYLANLABS-2024M1068349$MYLAN$$$$N$M$Y$4.135$KG$20240801$$HP$FR$FR
241411481$24141148$1$I$$20240719$20240726$20240726$EXP$$CA-BAXTER-2024BAX022244$BAXTER$$$$$F$Y$$$20240726$$HP$CA$CA
241411511$24141151$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51371$$FDA-CTU$$84$YR$$F$N$$$20240725$N$CN$US$
241411521$24141152$1$I$20240725$20240725$20240725$20240725$DIR$711581$$FDA-CTU$$50$YR$$M$N$$$20240725$N$HP$US$
241411531$24141153$1$I$20240724$20240725$20240725$20240725$DIR$711547$$FDA-CTU$$78$YR$$M$N$$$20240725$N$HP$US$
241411541$24141154$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51399$$FDA-CTU$$50$YR$$F$N$$$20240725$N$$US$
241411551$24141155$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51404$$FDA-CTU$$58$YR$$M$N$$$20240725$N$$US$
241411571$24141157$1$I$$20240720$20240726$20240726$EXP$$BG-VELOXIS PHARMACEUTICALS, INC.-2022-VEL-00515$VELOXIS PHARMACEUTICALS$$30$YR$$F$Y$$$20240726$$MD$BG$BG
241411592$24141159$2$F$20240717$20240827$20240726$20240829$PER$$US-AMGEN-USASP2024146380$AMGEN$$$$$$Y$$$20240829$$HP$US$US
241411601$24141160$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146714$AMGEN$$$$$M$Y$$$20240726$$HP$US$US
241411611$24141161$1$I$20240715$20240718$20240726$20240726$PER$$US-AMGEN-USASP2024145065$AMGEN$$64$YR$A$M$Y$$$20240726$$CN$US$US
241411622$24141162$2$F$20240701$20240723$20240726$20240801$EXP$$CA-BEH-2024175951$CSL BEHRING$$76$YR$E$M$Y$76.1$KG$20240801$$HP$CA$CA
241411631$24141163$1$I$$20240723$20240726$20240726$EXP$$US-CHATTEMPRD-2024OHG025229$CHATTEM$$74$YR$E$F$Y$$$20240726$$LW$US$US
241411641$24141164$1$I$$20240724$20240726$20240726$PER$$ZA-REGENERON PHARMACEUTICALS, INC.-2024-102111$REGENERON$$$$$M$Y$$$20240726$$MD$ZA$ZA
241411652$24141165$2$F$20240719$20240728$20240726$20240802$PER$$IQ-REGENERON PHARMACEUTICALS, INC.-2024-102503$REGENERON$$61$YR$$M$Y$$$20240802$$CN$IQ$IQ
241411663$24141166$3$F$$20240905$20240726$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118013$BRISTOL MYERS SQUIBB$Kimura. T, Nabe. Y, Yoshino. H, Urusiba. R, Tsuji. N, kondo. Y. A case of chronic myelogenous leukemia in the chronic phase that developed lung damage due to sarcoidosis-like reaction (DISR) after treatment withDasatinib. The 42nd Meeting of the Japanese Society of HematologyProgram and Abstracts. P23.$53$YR$A$F$Y$$$20240917$$MD$JP$JP
241411672$24141167$2$F$$20240726$20240726$20240805$PER$$US-ROCHE-10000038039$ROCHE$$57$YR$A$F$Y$$$20240806$$CN$US$US
241411693$24141169$3$F$20240717$20240819$20240726$20240826$PER$$US-ROCHE-10000034064$ROCHE$$36$YR$A$F$Y$$$20240826$$CN$US$US
241411701$24141170$1$I$$20240716$20240726$20240726$EXP$$CA-APOTEX-2024AP002370$APOTEX$$54$YR$$F$Y$$$20240726$$HP$CA$CA
241411711$24141171$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000035863$ROCHE$$$$A$M$Y$$$20240726$$CN$US$US
241411721$24141172$1$I$$20240722$20240726$20240726$EXP$$TR-UCBSA-2024037061$UCB$Demiral GZ, Akin SB, Gunday OK, Sahbaz FG, Boru UT. Maternal and fetal outcomes of antiepileptic treatments during pregnancy: A retrospective study. Epilepsy + behavior. 2024;158:1-7$$$N$$Y$$$20240726$$HP$TR$TR
241411732$24141173$2$F$$20240812$20240726$20240819$PER$$US-ROCHE-10000038022$ROCHE$$24$YR$A$F$Y$$$20240819$$CN$US$US
241411741$24141174$1$I$20240717$20240724$20240726$20240726$EXP$$CO-BAYER-2024A108184$BAYER$$89$YR$E$F$Y$$$20240726$$CN$CO$CO
241411753$24141175$3$F$$20240919$20240726$20240923$EXP$$CA-TAKEDA-2024TUS074802$TAKEDA$$$$$M$Y$$$20240923$$CN$CA$CA
241411763$24141176$3$F$$20240809$20240726$20240827$EXP$$JP-009507513-2405JPN002355J$MERCK$Shibata N, Matsui C, Hirai C, Tada M, Yauchi Y, Kikawa Y, et al.. EP-0451 Treatment outcomes of the KYENOTE-522 regimen for early-stage triple-negative breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 290$66$YR$$F$Y$$$20240827$$MD$JP$JP
241411771$24141177$1$I$20240723$20240724$20240726$20240726$EXP$GB-MHRA-MED-202407241529395400-TFBPS$GB-BEH-2024176252$CSL BEHRING$$38$YR$A$F$Y$$$20240726$$HP$GB$GB
241411781$24141178$1$I$$20240725$20240726$20240726$EXP$$BR-DSJP-DSE-2024-137482$DAIICHI$$66$YR$$F$Y$$$20240726$$MD$BR$BR
241411791$24141179$1$I$20240522$20240725$20240725$20240725$DIR$711573$$FDA-CTU$$45$YR$$F$N$$$20240725$N$CN$US$
241411811$24141181$1$I$$20240723$20240726$20240726$EXP$$US-CHATTEMPRD-2024OHG025185$CHATTEM$$64$YR$A$M$Y$$$20240726$$LW$US$US
241411821$24141182$1$I$20230901$20240715$20240726$20240726$EXP$$SG-ROCHE-10000033003$ROCHE$$62$YR$A$F$Y$$$20240726$$CN$SG$SG
241411831$24141183$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51428$$FDA-CTU$$$$$M$N$$$20240725$N$HP$US$
241411841$24141184$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51416$$FDA-CTU$$19$YR$$M$N$$$20240725$N$$US$
241411851$24141185$1$I$20240504$20240725$20240725$20240725$DIR$711539$$FDA-CTU$$13$YR$$F$N$70.8$KG$20240725$N$$US$
241411861$24141186$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51380$$FDA-CTU$$81$YR$$F$N$75.3$KG$20240725$N$$US$
241411871$24141187$1$I$$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024147888$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
241411881$24141188$1$I$20240702$20240722$20240726$20240726$EXP$$CN-CHEPLA-2024009405$CHEPLAPHARM$$77$YR$E$M$Y$74.4$KG$20240726$$HP$COUNTRY NOT SPECIFIED$CN
241411891$24141189$1$I$$20240719$20240726$20240726$EXP$$AU-CHEPLA-2024009325$CHEPLAPHARM$$$$A$M$Y$$$20240726$$HP$COUNTRY NOT SPECIFIED$AU
241411911$24141191$1$I$$20240716$20240726$20240726$EXP$$AU-TEVA-VS-3222590$TEVA$$$$$$Y$$$20240726$$HP$AU$AU
241411921$24141192$1$I$$20240723$20240726$20240726$EXP$$GB-MYLANLABS-2024M1068752$MYLAN$$$$$F$Y$$$20240726$$CN$GB$GB
241411931$24141193$1$I$20240603$20240717$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114418$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240726$$HP$US$US
241411941$24141194$1$I$$20240719$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115959$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240726$$CN$US$US
241411951$24141195$1$I$$20240723$20240726$20240726$PER$$NVSC2024US153519$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241411963$24141196$3$F$$20240917$20240726$20240919$EXP$$JP-PFIZER INC-PV202400096986$PFIZER$$50$YR$$M$Y$$$20240919$$MD$JP$JP
241411972$24141197$2$F$20240612$20240821$20240726$20240826$EXP$$CN-PFIZER INC-PV202400096885$PFIZER$$67$YR$$F$Y$55$KG$20240826$$HP$CN$CN
241411981$24141198$1$I$$20240722$20240726$20240726$EXP$$JP-PFIZER INC-PV202400095643$PFIZER$Sakaguchi, Y.. A case of drug-induced kidney injury due to fluconazole that was diagnosed at an early stage by intervention of a pharmacist dedicated to the ER. Journal of Japanese Society for Emergency Medicine. 2024;27(3):408$6$DEC$$M$Y$$$20240726$$HP$JP$JP
241411991$24141199$1$I$$20240725$20240726$20240726$EXP$$CA-PFIZER INC-202400223777$PFIZER$$16$YR$$F$Y$$$20240726$$PH$CA$CA
241412001$24141200$1$I$$20240725$20240726$20240726$EXP$$JP-PFIZER INC-202400223107$PFIZER$$$$$$Y$$$20240726$$PH$JP$JP
241412011$24141201$1$I$$20240724$20240726$20240726$EXP$$US-PFIZER INC-PV202400097079$PFIZER$$53$YR$$$Y$$$20240726$$CN$US$US
241412021$24141202$1$I$$20240722$20240726$20240726$EXP$$JP-PFIZER INC-PV202400095694$PFIZER$Akutsu, J.. A case of EBV-positive mucocutaneous ulcer with extensive ulcer affecting from the maxillary gingiva to the palate. The 78th Annual Meeting of Japanese Stomatological Society. 2024;78th:295$87$YR$$F$Y$$$20240726$$HP$JP$JP
241412031$24141203$1$I$$20240724$20240726$20240726$EXP$$US-PFIZER INC-202400223944$PFIZER$$58$YR$$M$Y$$$20240726$$MD$US$US
241412042$24141204$2$F$$20240725$20240726$20240730$EXP$$US-PFIZER INC-202400222798$PFIZER$Martin, R.. Lidocaine-Associated CNS Toxicity at Therapeutic Dosage: A Case Report and Literature Review. Cureus. 2024;16(6):10.7759/cureus.62231$47$YR$$M$Y$133.9$KG$20240730$$MD$US$US
241412051$24141205$1$I$20171220$20240724$20240726$20240726$EXP$$CA-PFIZER INC-2017205728$PFIZER$$85$YR$$M$Y$$$20240726$$CN$CA$CA
241412071$24141207$1$I$20220906$20240725$20240726$20240726$EXP$FR-AFSSAPS-PB2023000100$FR-PFIZER INC-202300052093$PFIZER$$65$YR$$F$Y$$$20240726$$MD$FR$FR
241412081$24141208$1$I$20240529$20240724$20240726$20240726$EXP$$CN-PFIZER INC-PV202400096873$PFIZER$$17$YR$$F$Y$58$KG$20240726$$HP$CN$CN
241412091$24141209$1$I$20240612$20240724$20240726$20240726$EXP$$CN-PFIZER INC-PV202400096843$PFIZER$$69$YR$$M$Y$$$20240726$$HP$CN$CN
241412101$24141210$1$I$$20240724$20240726$20240726$EXP$$US-PFIZER INC-202400223099$PFIZER$$$$$M$Y$$$20240726$$MD$US$US
241412111$24141211$1$I$$20240718$20240726$20240726$EXP$$CN-AMGEN-CHNSP2024143656$AMGEN$Chen S.; Shen L.; Cao W. et al.. Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation. Blood cancer journal. 2024;14 (1)$15$YR$T$M$Y$$$20240726$$HP$CN$CN
241412121$24141212$1$I$20240707$20240724$20240726$20240726$EXP$$CN-PFIZER INC-PV202400096846$PFIZER$$73$YR$$M$Y$$$20240726$$HP$CN$CN
241412132$24141213$2$F$20240701$20240722$20240726$20240809$PER$$US-AMGEN-USASP2024145469$AMGEN$$90$YR$E$F$Y$$$20240809$$CN$US$US
241412141$24141214$1$I$$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024148126$AMGEN$$$$$$Y$$$20240726$$HP$US$US
241412151$24141215$1$I$20240301$20240719$20240726$20240726$PER$$US-AMGEN-USASP2024144911$AMGEN$$78$YR$E$F$Y$$$20240726$$HP$US$US
241412161$24141216$1$I$20200508$20240716$20240726$20240726$EXP$PL-URPL-1-3694-2020$PL-TEVA-VS-3222231$TEVA$$63$YR$$F$Y$70$KG$20240726$$MD$PL$PL
241412171$24141217$1$I$$20240301$20240726$20240726$PER$$US-Eisai-EC-2024-159522$EISAI$$$$$$Y$$$20240726$$MD$US$US
241412181$24141218$1$I$20240614$20240717$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036289$AUROBINDO$$94$YR$$M$Y$67.5$KG$20240726$$MD$FR$FR
241412191$24141219$1$I$$20240718$20240726$20240726$PER$$US-ALXN-202407USA001377US$ALEXION PHARMACEUTICALS$$$$$M$Y$112.47$KG$20240726$$CN$US$US
241412201$24141220$1$I$20240701$20240719$20240726$20240726$PER$$US-SA-2024SA215478$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240726$$MD$US$US
241412211$24141221$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA212436$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240726$$MD$US$US
241412221$24141222$1$I$20240717$20240717$20240726$20240726$PER$$US-JNJFOC-20240768518$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240726$$CN$US$US
241412242$24141224$2$F$20240101$20240910$20240726$20240918$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-14408$IPSEN$$80$YR$E$F$Y$$$20240918$$HP$CA$CA
241412251$24141225$1$I$20240601$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165996$ASTRAZENECA$$802$MON$$M$Y$70.3$KG$20240726$$CN$US$
241412261$24141226$1$I$$20240723$20240726$20240726$EXP$$CA-PERRIGO-24CA007041$PERRIGO$$71$YR$$M$Y$$$20240726$$HP$CA$CA
241412283$24141228$3$F$$20240917$20240726$20240926$PER$$US-GSK-US2024AMR090227$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$HP$US$US
241412291$24141229$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-037107$AUROBINDO$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage. 2023;66(4):e455-e459$$$A$$Y$$$20240726$$HP$US$US
241412301$24141230$1$I$20240724$20240725$20240725$20240725$DIR$711516$$FDA-CTU$$50$YR$$F$N$$$20240725$Y$HP$US$
241412321$24141232$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51441$$FDA-CTU$$39$YR$$F$N$$$20240725$N$$US$
241412341$24141234$1$I$$20240718$20240726$20240726$EXP$NL-LRB-00985434$NL-TEVA-VS-3223460$TEVA$$74$YR$$M$Y$94$KG$20240726$$MD$NL$NL
241412351$24141235$1$I$$20240723$20240726$20240726$EXP$$NVSC2024US152901$NOVARTIS$$70$YR$$F$Y$$$20240726$$MD$US$US
241412361$24141236$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153522$NOVARTIS$$$$$$Y$$$20240726$$MD$US$US
241412372$24141237$2$F$$20240726$20240726$20240730$EXP$$US-ROCHE-10000035904$ROCHE$$67$YR$E$M$Y$$$20240730$$CN$US$US
241412381$24141238$1$I$$20240718$20240726$20240726$PER$$US-ROCHE-10000034113$ROCHE$$$$A$F$Y$86$KG$20240726$$CN$US$US
241412391$24141239$1$I$$20240723$20240726$20240726$EXP$$CA-PERRIGO-24CA007052$PERRIGO$$78$YR$$F$Y$$$20240726$$HP$CA$CA
241412403$24141240$3$F$20240724$20240818$20240726$20240821$PER$$US-AMGEN-USASP2024148446$AMGEN$$43$YR$A$F$Y$$$20240820$$HP$US$US
241412412$24141241$2$F$20240722$20240903$20240726$20240906$PER$$US-AMGEN-USASP2024147272$AMGEN$$37$YR$A$M$Y$$$20240906$$CN$US$US
241412421$24141242$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000036321$ROCHE$$67$YR$E$F$Y$$$20240726$$CN$US$US
241412432$24141243$2$F$$20240722$20240726$20240731$EXP$$PL-009507513-2407POL013109$MERCK$$58$YR$$F$Y$$$20240731$$PH$PL$PL
241412441$24141244$1$I$$20240717$20240726$20240726$PER$$US-009507513-2407USA011350$MERCK$$$$$$Y$46.7$KG$20240726$$PH$US$US
241412451$24141245$1$I$20240101$20240722$20240726$20240726$EXP$$US-009507513-2407USA012711$MERCK$$$$$F$Y$$$20240726$$MD$US$US
241412461$24141246$1$I$$20240627$20240726$20240726$PER$$US-009507513-2407USA001881$MERCK$Vlachou E, Johnson BA, Guancial E, Lombardo KA, Hoffman-Censits J. Frontline immune checkpoint inhibitors in patients = 90 years with advanced urothelial cancer: a single center experience. The Canadian journal of urology. 2024;31(3):11875-9$94$YR$$M$Y$$$20240726$$MD$US$US
241412472$24141247$2$F$20240710$20240724$20240726$20240802$EXP$$ES-MYLANLABS-2024M1068906$MYLAN$$57$YR$$F$Y$$$20240802$$MD$ES$ES
241412481$24141248$1$I$20240124$20240717$20240726$20240726$EXP$FR-AFSSAPS-AN2024000887$FR-TEVA-VS-3222809$TEVA$$56$YR$$M$Y$98$KG$20240726$$PH$FR$FR
241412491$24141249$1$I$20240429$20240722$20240726$20240726$EXP$FR-AFSSAPS-PC2024000471$FR-TAKEDA-2024TUS074481$TAKEDA$$43$YR$$F$Y$$$20240726$$HP$FR$FR
241412501$24141250$1$I$20240717$20240717$20240726$20240726$EXP$$US-VIIV HEALTHCARE LIMITED-US2024090063$VIIV$$37$YR$$M$Y$$$20240726$$HP$US$US
241412511$24141251$1$I$20240519$20240716$20240726$20240726$EXP$FR-AFSSAPS-BX2024001319$FR-TEVA-VS-3222351$TEVA$$75$YR$$F$Y$$$20240726$$MD$FR$FR
241412521$24141252$1$I$$20240723$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117471$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240726$$HP$US$US
241412531$24141253$1$I$$20240725$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118883$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240726$$CN$US$US
241412541$24141254$1$I$$20240719$20240726$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118796$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$MD$JP$JP
241412551$24141255$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118172$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240726$$PH$US$US
241412561$24141256$1$I$$20240724$20240726$20240726$PER$$US-JNJFOC-20240768437$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240726$$CN$US$US
241412572$24141257$2$F$20240628$20240822$20240726$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116833$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240830$$CN$US$US
241412581$24141258$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA216869$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240726$$CN$US$US
241412591$24141259$1$I$$20240718$20240726$20240726$PER$$US-ABBVIE-5849119$ABBVIE$$25$YR$$F$Y$$$20240726$$HP$US$US
241412601$24141260$1$I$20230901$20240718$20240726$20240726$PER$$US-SA-2024SA100539$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240726$$MD$US$US
241412622$24141262$2$F$$20240815$20240726$20240819$PER$$US-ALXN-202407USA001409US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241412632$24141263$2$F$$20240808$20240726$20240814$EXP$$JP-009507513-2407JPN003753J$MERCK$$70$YR$$M$Y$$$20240814$$MD$JP$JP
241412641$24141264$1$I$20240515$20240725$20240726$20240726$EXP$$US-INCYTE CORPORATION-2024IN007818$INCYTE$$$$$$Y$$$20240726$$HP$US$US
241412651$24141265$1$I$$20240717$20240726$20240726$EXP$CA-DRL-USA-SPO/CAN/24/0010621$CA-RDY-SPO/CAN/24/0010621$DR REDDYS$$70$YR$E$F$Y$$$20240726$$MD$CA$CA
241412661$24141266$1$I$20240722$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147023$AMGEN$$48$YR$A$M$Y$$$20240726$$CN$US$US
241412671$24141267$1$I$$20240723$20240726$20240726$EXP$$CA-MYLANLABS-2024M1069519$MYLAN$$$$$M$Y$$$20240726$$PH$CA$CA
241412681$24141268$1$I$$20240717$20240726$20240726$EXP$CA-DRL-USA-SPO/CAN/24/0010593$CA-RDY-SPO/CAN/24/0010593$DR REDDYS$$63$YR$A$F$Y$$$20240726$$HP$CA$CA
241412691$24141269$1$I$$20240717$20240726$20240726$PER$$US-AMGEN-USASP2024146771$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241412701$24141270$1$I$20240701$20240712$20240726$20240726$PER$$US-Eisai-EC-2024-170159$EISAI$$69$YR$E$M$Y$$$20240726$$CN$US$US
241412711$24141271$1$I$20240625$20240712$20240726$20240726$PER$$US-Eisai-EC-2024-170132$EISAI$$83$YR$E$F$Y$$$20240726$$HP$US$US
241412721$24141272$1$I$$20240719$20240726$20240726$EXP$DE-EMA-DD-20240718-7482645-080313$DE-RDY-SPO/DEU/24/0010744$DR REDDYS$$35$YR$A$M$Y$$$20240726$$HP$DE$DE
241412731$24141273$1$I$$20240715$20240726$20240726$EXP$$JP-MEITHEAL-2024MPLIT00221$MEITHEAL PHARMACEUTICALS$Miyahara et al..Case report: Ten cases of acquired idiopathic generalized anhidrosis treated with oral pilocarpine.Journal of Cutaneous Immunology and Allergy.04-JUN-2024;7 (1):1-5$28$YR$A$M$Y$$$20240726$$HP$JP$JP
241412741$24141274$1$I$20240704$20240711$20240726$20240726$EXP$$CN-BEH-2024175703$CSL BEHRING$$52$YR$A$F$Y$59.5$KG$20240726$$CN$CN$CN
241412752$24141275$2$F$$20240824$20240726$20240902$EXP$$IN-VANTIVE-2024VAN018619$Vantive US Healthcare$$63$YR$$F$Y$$$20240902$$CN$IN$IN
241412762$24141276$2$F$$20240725$20240726$20240801$EXP$$IN-VANTIVE-2024VAN018618$Vantive US Healthcare$$54$YR$$F$Y$$$20240801$$CN$IN$IN
241412771$24141277$1$I$$20240716$20240726$20240726$PER$$US-TAKEDA-2024TUS072177$TAKEDA$$$$A$M$Y$$$20240726$$CN$US$US
241412781$24141278$1$I$$20240717$20240726$20240726$EXP$$US-AUROBINDO-AUR-APL-2024-018241$AUROBINDO$Al-Toubah T, Pelle E, Hallanger-Johnson J, Haider M, Strosberg J. ACTH-secreting pancreatic neuroendocrine neoplasms: A case-series. J-Neuroendocrinol. 2023;351-8$39$YR$$F$Y$$$20240726$$HP$US$US
241412791$24141279$1$I$$20240725$20240725$20240725$DIR$711576$$FDA-CTU$$$$$M$N$63$KG$20240725$N$CN$US$
241412801$24141280$1$I$20240701$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51373$$FDA-CTU$$33$YR$$F$N$$$20240725$N$HP$US$
241412811$24141281$1$I$20240718$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51386$$FDA-CTU$$84$YR$$M$N$$$20240725$N$$US$
241412841$24141284$1$I$$20240715$20240726$20240726$EXP$$JP-MEITHEAL-2024MPLIT00222$MEITHEAL PHARMACEUTICALS$$6$YR$C$M$Y$$$20240726$$HP$JP$JP
241412851$24141285$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51456$$FDA-CTU$$$$$F$N$$$20240725$N$HP$US$
241412861$24141286$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3224728$TEVA$$43$YR$$F$Y$68$KG$20240726$$HP$CA$CA
241412871$24141287$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51433$$FDA-CTU$$58$YR$$F$N$$$20240725$N$$US$
241412881$24141288$1$I$20240724$20240725$20240725$20240725$DIR$711514$$FDA-CTU$$39$YR$$F$N$67.05$KG$20240725$N$CN$US$
241412891$24141289$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51407$$FDA-CTU$$71$YR$$M$N$$$20240725$N$$US$
241412901$24141290$1$I$20220930$20240725$20240725$20240725$DIR$711568$$FDA-CTU$$29$YR$$F$N$85.4$KG$20240725$N$$US$
241412911$24141291$1$I$$20240722$20240726$20240726$PER$$US-JNJFOC-20240762434$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240726$$HP$US$US
241412921$24141292$1$I$$20240715$20240726$20240726$EXP$$TW-MEITHEAL-2024MPLIT00223$MEITHEAL PHARMACEUTICALS$Tang SY, Peng CH, Lin TY, Chang FP, Hung SC.Palbociclib-associated nephrotoxicity in a patient with breast cancer.Journal of Onco-Nephrology.FEB-2024;8 (1):31-4$68$YR$A$F$Y$$$20240726$$HP$TW$TW
241412931$24141293$1$I$20240429$20240718$20240726$20240726$30DAY$$US-BAXTER-2024BAX022005$BAXTER$$$$$F$Y$$$20240726$$MD$US$US
241412941$24141294$1$I$$20240719$20240726$20240726$PER$$US-TAKEDA-2024TUS073340$TAKEDA$$$$$M$Y$84$KG$20240726$$MD$US$US
241412951$24141295$1$I$20230901$20240723$20240726$20240726$PER$$US-TAKEDA-2024TUS075337$TAKEDA$$$$$M$Y$$$20240726$$CN$US$US
241412962$24141296$2$F$$20240807$20240726$20240809$EXP$GB-MHRA-MIDB-fadd5e0d-e13f-46d0-b5ec-a270925b4c91$GB-ORGANON-O2407GBR002320$ORGANON$$41$YR$$M$Y$$$20240809$$PH$GB$GB
241412972$24141297$2$F$20240722$20240807$20240726$20240809$PER$$US-AMGEN-USASP2024145623$AMGEN$$67$YR$E$F$Y$$$20240808$$MD$US$US
241412981$24141298$1$I$$20240719$20240726$20240726$EXP$$JP-009507513-2407JPN004156J$MERCK$$71$YR$$M$Y$$$20240726$$MD$JP$JP
241412991$24141299$1$I$$20240716$20240726$20240726$EXP$$AU-TEVA-VS-3222816$TEVA$$$$$F$Y$$$20240726$$HP$AU$AU
241413001$24141300$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118349$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240726$$CN$US$US
241413011$24141301$1$I$20240527$20240723$20240726$20240726$EXP$$CO-UCBSA-2024037667$UCB$$30$YR$$M$Y$$$20240726$$CN$CO$CO
241413021$24141302$1$I$$20240719$20240726$20240726$PER$$US-ALXN-A202309529$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241413032$24141303$2$F$20240722$20240726$20240726$20240802$PER$$US-ALXN-202407USA001599US$ALEXION PHARMACEUTICALS$$6$YR$$M$Y$$$20240802$$MD$US$US
241413041$24141304$1$I$$20240723$20240726$20240726$EXP$$US-AstraZeneca-2024A167794$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241413074$24141307$4$F$20240424$20240924$20240726$20240930$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-102492$REGENERON$$64$YR$$F$Y$$$20240930$$CN$CO$CO
241413082$24141308$2$F$$20240906$20240726$20240906$PER$$NVSC2024US153366$NOVARTIS$$$$$$Y$$$20240906$$MD$US$US
241413091$24141309$1$I$$20240716$20240726$20240726$EXP$$IN-ROCHE-10000033086$ROCHE$$68$YR$E$M$Y$$$20240726$$CN$IN$IN
241413101$24141310$1$I$20230901$20240704$20240726$20240726$PER$$US-009507513-2407USA002497$MERCK$$60$YR$$M$Y$$$20240726$$CN$US$US
241413111$24141311$1$I$20230501$20240725$20240725$20240725$DIR$711582$$FDA-CTU$$64$YR$$F$N$67.5$KG$20240725$N$CN$US$
241413121$24141312$1$I$$20240722$20240726$20240726$EXP$$AU-009507513-2407AUS013383$MERCK$$70$YR$$M$Y$$$20240726$$HP$AU$AU
241413141$24141314$1$I$$20240718$20240726$20240726$30DAY$$US-GSK-US2024090585$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241413151$24141315$1$I$20240415$20240716$20240726$20240726$EXP$$US-ROCHE-10000029384$ROCHE$$77$YR$E$M$Y$$$20240726$$CN$US$US
241413161$24141316$1$I$20230806$20240722$20240726$20240726$EXP$IT-MINISAL02-996027$IT-Eisai-EC-2024-170637$EISAI$$69$YR$E$F$Y$$$20240726$$MD$IT$IT
241413171$24141317$1$I$20240701$20240723$20240726$20240726$PER$$CA-Eisai-EC-2024-170229$EISAI$$64$YR$A$F$Y$$$20240726$$CN$CA$CA
241413181$24141318$1$I$$20240724$20240726$20240726$PER$$US-ABBVIE-5854725$ABBVIE$$$$$$Y$$$20240726$$MD$US$US
241413191$24141319$1$I$20240701$20240718$20240726$20240726$EXP$$JP-009507513-2407JPN003534J$MERCK$$42$YR$$F$Y$$$20240726$$MD$JP$JP
241413201$24141320$1$I$$20240723$20240726$20240726$EXP$CA-LEO Pharma-372254$CA-LEO Pharma-372254$LEO PHARM$$24$YR$$M$Y$$$20240726$$CN$CA$CA
241413211$24141321$1$I$$20240712$20240726$20240726$PER$$US-Calliditas-2024CAL01320$CALLIDITAS THERAPEUTICS$$81$YR$E$F$Y$48.53$KG$20240726$$MD$US$US
241413221$24141322$1$I$$20240715$20240726$20240726$EXP$$CN-MSNLABS-2024MSNLIT01642$MSN LABORATORIES$$$$$$Y$$$20240726$$HP$CN$CN
241413234$24141323$4$F$$20240926$20240726$20240930$EXP$DE-VERTEX PHARMACEUTICALS-2024-010454$DE-ROCHE-10000027797$ROCHE$Othmer J, Roehmel J, Temmesfeld-Wollbruck B, Mall M, Thee S, Syunyaeva Z. Idiopathic pulmonary fibrosis in a patient with cystic fibrosis.. J Cyst Fibros.. 2024;23 (SUP: 1):S112. doi:10.1016/S1569-1993(24)00447-8.$70$YR$E$M$Y$$$20241001$$HP$DE$DE
241413241$24141324$1$I$$20240708$20240726$20240726$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-07069$HIKMA$Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al.. Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports. Journal of pediatric hematology/oncology. 2024$13$YR$$M$Y$$$20240726$$MD$IT$IT
241413251$24141325$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA215056$SANOFI AVENTIS$$36$YR$A$M$Y$83.91$KG$20240726$$MD$US$US
241413261$24141326$1$I$$20240718$20240726$20240726$EXP$NL-LRB-00985267$NL-TEVA-VS-3223558$TEVA$$40$YR$$M$Y$80$KG$20240726$$CN$NL$NL
241413271$24141327$1$I$20240701$20240717$20240726$20240726$PER$$US-SA-2022SA425182$SANOFI AVENTIS$$$$A$M$Y$$$20240726$$MD$US$US
241413283$24141328$3$F$20240712$20240820$20240726$20240826$PER$$US-ROCHE-10000030317$ROCHE$$$$$$Y$$$20240826$$CN$US$US
241413291$24141329$1$I$$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024147601$AMGEN$$$$$M$Y$$$20240726$$HP$US$US
241413301$24141330$1$I$20210801$20240717$20240726$20240726$PER$$US-SA-2024SA215199$SANOFI AVENTIS$$58$YR$A$F$Y$81.19$KG$20240726$$MD$US$US
241413311$24141331$1$I$20230415$20240123$20240726$20240726$EXP$FR-AFSSAPS-BX2023002032$FR-TEVA-VS-3149342$TEVA$$82$YR$$M$Y$134$KG$20240726$$MD$FR$FR
241413321$24141332$1$I$$20240716$20240726$20240726$EXP$$US-AMGEN-USASP2024147654$AMGEN$Sabio, H. Sustained hematologic response to hydroxyurea and erythropoietin in a child with homozygous beta-thalassemia (IVS-II-1-(G-to-A). Blood. 2000;96 (11):26B$$$$F$Y$$$20240726$$HP$US$US
241413331$24141333$1$I$20240721$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024146068$AMGEN$$58$YR$A$F$Y$$$20240726$$CN$US$US
241413341$24141334$1$I$$20240717$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090166$VIIV$$$$$F$Y$$$20240726$$PH$US$US
241413351$24141335$1$I$20240717$20240717$20240726$20240726$EXP$$US-VIIV HEALTHCARE LIMITED-US2024090058$VIIV$$46$YR$$F$Y$$$20240726$$HP$US$US
241413361$24141336$1$I$$20240723$20240726$20240726$EXP$$JP-ORGANON-O2407JPN002186$ORGANON$Kageyama Y, Sukigara A, Goto A, Inoue K. CASE REPORT Hoarding medication and suicide attempts with 1180 tablets of mirtazapine overdose: A case report. Psychiatry and Clinical Neurosciences Reports (PCN Reports). 2024;3(2):1-4$44$YR$$M$Y$$$20240726$$MD$JP$JP
241413371$24141337$1$I$$20240711$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458905$RANBAXY$Louisy A, Rochefort J, Plantier F, Kervarrec T, Quilhot P, Agbo Godeau S, et al. ^Plasma cell gingivitis^ encompasses multiple entities: a retrospective series of 37 cases. Eur J Dermatol. 2023;33 (2):109- 120$83$YR$$M$Y$$$20240726$$HP$FR$FR
241413381$24141338$1$I$$20240711$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458901$RANBAXY$Louisy A, Rochefort J, Plantier F, Kervarrec T, Quilhot P, Agbo Godeau S, et al. ^Plasma cell gingivitis^ encompasses multiple entities: a retrospective series of 37 cases. Eur J Dermatol. 2023;33 (2):109- 120$61$YR$$M$Y$$$20240726$$HP$FR$FR
241413391$24141339$1$I$$20240711$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458892$RANBAXY$Louisy A, Rochefort J, Plantier F, Kervarrec T, Quilhot P, Agbo Godeau S, et al. ^Plasma cell gingivitis^ encompasses multiple entities: a retrospective series of 37 cases. Eur J Dermatol. 2023;33 (2):109-120$83$YR$$M$Y$$$20240726$$HP$FR$FR
241413401$24141340$1$I$20221210$20240711$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458871$RANBAXY$$78$YR$$$Y$76$KG$20240726$$CN$GB$GB
241413411$24141341$1$I$$20240716$20240726$20240726$PER$$US-TAKEDA-2024TUS073847$TAKEDA$$$$$$Y$$$20240726$$CN$US$US
241413421$24141342$1$I$$20240711$20240726$20240726$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458782$RANBAXY$Neha Kumta, Lawrence Huang, Gururaj Nagaraj, Lindsey Papacostas, Shradha Subedi. Post operative abdominal wall mucormycosis infection after laparotomy for bowel perforation. IDCases. 2024;36:no pagination$8$DEC$$M$Y$$$20240726$$HP$AU$AU
241413432$24141343$2$F$20240704$20240729$20240726$20240813$EXP$$CL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458940$RANBAXY$$73$YR$$M$Y$$$20240813$$HP$CL$CL
241413441$24141344$1$I$$20240711$20240726$20240726$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458750$RANBAXY$Yamada H, Toko M, Nakamori M, Ueno H, Aoki S, Sugimoto T, et al. Progressive multifocal leukoencephalopathy associated with systemic lupus erythematosus: longitudinal observation of lymphocytes, JC virus in cerebrospinal fluid, and brain magnetic resonance imaging. J Neurovirol. 2024;0 (0):no pagination$60$YR$$F$Y$$$20240726$$HP$JP$JP
241413451$24141345$1$I$20200101$20240709$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20201106863$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$97.02$KG$20240726$$PH$US$US
241413461$24141346$1$I$$20240711$20240726$20240726$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458786$RANBAXY$Guerra NL, Matas-Garcia A, Serra-Garcia L, Morgado-Carrasco D, Padrosa J, Aldecoa I, et al. Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature. Autoimmunity Reviews. 2023;22 (8):no pagination$75$YR$$F$Y$$$20240726$$HP$ES$ES
241413471$24141347$1$I$20240110$20240711$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458827$RANBAXY$$39$YR$$M$Y$$$20240726$$CN$GB$GB
241413481$24141348$1$I$$20240711$20240726$20240726$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458800$RANBAXY$Radu C. D.,Gogirla C.,Coverca E.,Istratescu D.,Meianu C.,Lucuta R.,Stroie T.,Diculescu M. EP51. VEDOLIZUMAB - THE KEY TO CLINICAL REMISSION FOR REFRACTORY. Journal of Gastrointestinal and Liver Diseases. 2024;33 Suppl. 2:68$37$YR$$F$Y$$$20240726$$HP$RO$RO
241413492$24141349$2$F$$20240718$20240726$20240731$EXP$$NVSC2023IN267726$NOVARTIS$$$$$F$Y$$$20240731$$CN$IN$IN
241413501$24141350$1$I$20240629$20240715$20240726$20240726$PER$$US-BAYER-2024A101732$BAYER$$74$YR$E$F$Y$$$20240726$$CN$US$US
241413511$24141351$1$I$20240601$20240725$20240726$20240726$EXP$$CN-BAYER-2024A108533$BAYER$$56$YR$A$F$Y$60$KG$20240726$$HP$CN$CN
241413521$24141352$1$I$20240601$20240717$20240726$20240726$PER$$US-SA-2021SA247066$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240726$$MD$US$US
241413531$24141353$1$I$20240101$20240722$20240726$20240726$PER$$US-SA-2024SA216151$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240726$$MD$US$US
241413541$24141354$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214963$SANOFI AVENTIS$$$$C$F$Y$$$20240726$$MD$US$US
241413551$24141355$1$I$20240515$20240717$20240726$20240726$EXP$$US-RADIUS HEALTH, INC.-2024US003531$RADIUS PHARM$$92$YR$$M$Y$$$20240726$$MD$US$US
241413561$24141356$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222422$TEVA$$57$YR$$M$Y$$$20240726$$HP$CA$CA
241413571$24141357$1$I$20240701$20240718$20240726$20240726$PER$$US-ALXN-202407USA001424US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241413581$24141358$1$I$$20240716$20240726$20240726$EXP$$CA-APOTEX-2024AP008486$APOTEX$$38$YR$$M$Y$$$20240726$$HP$CA$CA
241413591$24141359$1$I$$20240722$20240726$20240726$EXP$$CH-BEH-2024176284$CSL BEHRING$$$$E$M$Y$76$KG$20240726$$HP$CH$CH
241413601$24141360$1$I$20230618$20240717$20240726$20240726$EXP$DE-CADRBFARM-2024329184$DE-MSNLABS-2024MSNSPO01624$MSN LABORATORIES$$$$$$Y$$$20240726$$CN$DE$DE
241413611$24141361$1$I$$20240722$20240726$20240726$EXP$$US-ABBVIE-5850528$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241413622$24141362$2$F$20240501$20240822$20240726$20240826$EXP$$GB-MYLANLABS-2024M1069058$MYLAN$$$$E$F$Y$$$20240826$$HP$GB$GB
241413631$24141363$1$I$20240418$20240725$20240725$20240725$DIR$711492$$FDA-CTU$$77$YR$$M$N$83.25$KG$20240725$N$CN$US$
241413641$24141364$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51374$$FDA-CTU$$64$YR$$M$N$$$20240725$N$$US$
241413651$24141365$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51462$$FDA-CTU$$84$YR$$F$N$$$20240725$N$$US$
241413661$24141366$1$I$$20240725$20240725$20240725$DIR$711549$$FDA-CTU$$$$$UNK$N$$$20240725$N$CN$US$
241413671$24141367$1$I$20240724$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51461$$FDA-CTU$$59$YR$$F$N$$$20240724$N$$US$
241413701$24141370$1$I$20240725$20240725$20240725$20240725$DIR$711521$$FDA-CTU$$83$YR$$F$N$78.7$KG$20240725$N$PH$US$
241413711$24141371$1$I$20240724$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51396$$FDA-CTU$$66$YR$$F$N$$$20240724$N$$US$
241413733$24141373$3$F$20240101$20240819$20240726$20240829$EXP$$JP-JNJFOC-20240767719$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240829$$MD$JP$JP
241413751$24141375$1$I$20240621$20240726$20240726$20240726$EXP$FR-AFSSAPS-GR2024000922$FR-BAYER-2024A108610$BAYER$$51$YR$A$F$Y$$$20240726$$PH$FR$FR
241413761$24141376$1$I$$20240725$20240726$20240726$EXP$$JP-PFIZER INC-202400223367$PFIZER$$$$$$Y$$$20240726$$PH$JP$JP
241413801$24141380$1$I$$20240722$20240726$20240726$EXP$$FR-PFIZER INC-202400220578$PFIZER$Celant A.. Letter from the Hepato-Gastroenterologist. 2024;27(3):158-161$67$YR$$M$Y$$$20240726$$HP$FR$FR
241413811$24141381$1$I$$20240723$20240726$20240726$EXP$$GB-PFIZER INC-PV202400096598$PFIZER$Mundo, J. A rare presentation of geriatric non-epileptic seizures due to carotid artery encasement of a diffuse large B-cell lymphoma: A case report. Clinical Medicine. 2024;24:100041$75$YR$$M$Y$$$20240726$$HP$GB$GB
241413822$24141382$2$F$20230101$20240724$20240726$20240801$EXP$$ES-PFIZER INC-202400222097$PFIZER$Posado-Dominguez, L.. Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review. Chinese Clinical Oncology. 2024;13(3):10.21037/cco-23-146.$65$YR$$M$Y$$$20240801$$MD$ES$ES
241413831$24141383$1$I$20240419$20240725$20240726$20240726$EXP$$VE-PFIZER INC-PV202400097288$PFIZER$$53$YR$$M$Y$$$20240726$$CN$VE$VE
241413841$24141384$1$I$$20240716$20240726$20240726$EXP$$AU-TEVA-VS-3222675$TEVA$$81$YR$$M$Y$$$20240726$$HP$AU$AU
241413851$24141385$1$I$$20240722$20240726$20240726$EXP$$JP-PFIZER INC-PV202400095637$PFIZER$Osako, M.. A case of triazolam poisoning death that was negative with a simplified drug test kit. The Japanese Journal of Clinical Toxicology. 2024;37(2):257$9$DEC$$F$Y$39.5$KG$20240726$$HP$JP$JP
241413861$24141386$1$I$$20240725$20240726$20240726$EXP$$US-PFIZER INC-202400224018$PFIZER$$71$YR$$M$Y$$$20240726$$CN$US$US
241413872$24141387$2$F$$20240723$20240726$20240731$EXP$$US-PFIZER INC-202400219427$PFIZER$Bosley, A.. Successful long-term percutaneous transvalvular mechanical circulatory support without anticoagulation as a bridge to heart transplant: a case report. ASAIO Journal. 2024;70(Supplement 3:119-120$62$YR$$M$Y$$$20240731$$MD$US$US
241413881$24141388$1$I$$20240725$20240726$20240726$EXP$$CA-PFIZER INC-202400223922$PFIZER$$23$YR$$F$Y$$$20240726$$HP$CA$CA
241413892$24141389$2$F$$20240725$20240726$20240730$EXP$$US-PFIZER INC-202400223484$PFIZER$Lenz, T.. Acute non-ST segment elevation myocardial infarction following intravenous injection of sublingual Suboxone. Prehospital emergency care. 2024;1-11:10.1080/10903127.2024.2374999$41$YR$$M$Y$$$20240730$$MD$US$US
241413901$24141390$1$I$20240528$20240716$20240726$20240726$30DAY$$US-GSK-US2024089404$GLAXOSMITHKLINE$$80$YR$$M$Y$$$20240726$$CN$US$US
241413911$24141391$1$I$20190930$20240723$20240726$20240726$EXP$$CO-UCBSA-2024037689$UCB$$57$YR$$F$Y$$$20240726$$CN$CO$CO
241413923$24141392$3$F$20240809$20240815$20240726$20240823$EXP$$CO-TAKEDA-2024TUS024809$TAKEDA$$72$YR$$F$Y$64$KG$20240823$$HP$CO$CO
241413931$24141393$1$I$20240711$20240722$20240726$20240726$EXP$$US-ABBVIE-5850674$ABBVIE$$79$YR$$M$Y$$$20240726$$CN$US$US
241413941$24141394$1$I$20240626$20240716$20240726$20240726$EXP$FR-AFSSAPS-LL2024001263$FR-TEVA-VS-3222014$TEVA$$17$YR$$F$Y$$$20240726$$MD$FR$FR
241413955$24141395$5$F$20230924$20240918$20240726$20240924$EXP$$JP-Eisai-EC-2024-170860$EISAI$$55$YR$A$F$Y$62$KG$20240924$$MD$JP$JP
241413961$24141396$1$I$$20240716$20240726$20240726$EXP$$JP-ROCHE-10000032364$ROCHE$Muroka I, Imamura N, Nakanishi T, Sei H, Okugawa T, Tomita T. 31 Two cases of irAE enterocolitis complicated by cytomegalovirus enterocolitis. The 244th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2024;$79$YR$E$M$Y$$$20240726$$MD$JP$JP
241413971$24141397$1$I$$20240721$20240726$20240726$PER$$US-BAYER-2024A106536$BAYER$$$$$F$Y$$$20240726$$CN$US$US
241413982$24141398$2$F$20240720$20240801$20240726$20240807$30DAY$$US-AMGEN-USASP2024145401$AMGEN$$66$YR$E$F$Y$$$20240807$$HP$US$US
241414001$24141400$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA216867$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240726$$CN$US$US
241414012$24141401$2$F$$20240918$20240726$20240920$EXP$$GR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041709$BOEHRINGER INGELHEIM$DIABETIC KETOACIDOSIS DUE TO TYPE 3C  DIABETES AS THE INITIAL MANIFESTATION  OF PANCREATIC HEAD ADENOCARCINOMA  IN A PATIENT WITH PSYCHOSIS. 50th ANNUAL PANHELLENIC MEDICAL CONGRESS, 25-27 APRIL 2024_ABSTRACTS.$61$YR$A$F$Y$$$20240920$$MD$GR$GR
241414021$24141402$1$I$20240611$20240726$20240726$20240726$EXP$ES-AEMPS-1551555$ES-BAYER-2024A108616$BAYER$$63$YR$A$M$Y$$$20240726$$MD$ES$ES
241414031$24141403$1$I$20240127$20240716$20240726$20240726$EXP$FR-AFSSAPS-ST2024001138$FR-TEVA-VS-3222240$TEVA$$56$YR$$M$Y$77.2$KG$20240726$$HP$FR$FR
241414041$24141404$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA217154$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241414051$24141405$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA216868$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240726$$CN$US$US
241414061$24141406$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA130132$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240726$$CN$US$US
241414071$24141407$1$I$20240101$20240719$20240726$20240726$EXP$$BR-JNJFOC-20240760424$JOHNSON AND JOHNSON$$62$YR$A$F$Y$74$KG$20240726$$CN$BR$BR
241414081$24141408$1$I$$20240722$20240726$20240726$EXP$$JP-ROCHE-10000037843$ROCHE$Yoshikawa T, Kamitani N, Nakata Y, Nedu D, Nishioka A, Fukuoka K et al.. MO37?3 Conversion surgery for initial advanced hepatocellular carcinoma after Atezolizumab plus Bevacizumab therapy: two cases report. The 36th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery. 2024;505$81$YR$E$M$Y$$$20240726$$MD$JP$JP
241414091$24141409$1$I$$20240718$20240726$20240726$EXP$$JP-JNJFOC-20240771321$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240726$$MD$JP$JP
241414102$24141410$2$F$20240606$20240805$20240726$20240812$EXP$$FR-JNJFOC-20240760173$JOHNSON AND JOHNSON$$22$YR$A$F$Y$94$KG$20240812$$MD$FR$FR
241414112$24141411$2$F$$20240726$20240726$20240729$PER$$US-AMGEN-USASP2024146936$AMGEN$$$$$M$Y$$$20240729$$CN$US$US
241414121$24141412$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164544$ASTRAZENECA$$$$$M$Y$$$20240726$$MD$US$
241414131$24141413$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216741$SANOFI AVENTIS$$$$A$M$Y$120$KG$20240726$$MD$US$US
241414141$24141414$1$I$$20240703$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107838$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$PH$US$US
241414151$24141415$1$I$$20240714$20240726$20240726$PER$$US-BAYER-2024A108601$BAYER$$$$$F$Y$$$20240726$$CN$US$US
241414161$24141416$1$I$20240515$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118240$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240726$$CN$US$US
241414171$24141417$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119059$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240726$$CN$US$US
241414181$24141418$1$I$$20240718$20240726$20240726$EXP$$CA-BAXTER-2024BAX022153$BAXTER$$56$YR$$M$Y$$$20240726$$CN$CA$CA
241414192$24141419$2$F$$20240726$20240726$20240805$30DAY$$US-GSK-US2024089433$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241414201$24141420$1$I$$20240720$20240726$20240726$EXP$$NVSC2024US150623$NOVARTIS$$$$$$Y$$$20240726$$CN$US$US
241414211$24141421$1$I$20230622$20240723$20240726$20240726$EXP$$CO-UCBSA-2024037652$UCB$$54$YR$$F$Y$$$20240726$$CN$CO$CO
241414221$24141422$1$I$$20240711$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458829$RANBAXY$Glick J, Canaday F, Roberts D, Palka S, Falsey A, Nead MA. An Exceptional Instance: Severe Malaria With Cerebral Complications in Western New York. Am J Respir Crit Care Med. 2024;209(0):A5630$24$YR$$M$Y$$$20240726$$HP$US$US
241414231$24141423$1$I$$20240715$20240726$20240726$PER$$US-TEVA-VS-3222018$TEVA$$$$T$M$Y$$$20240726$$CN$US$US
241414241$24141424$1$I$$20240711$20240726$20240726$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458777$RANBAXY$Guerra NL, Matas-Garcia A, Serra-Garcia L, Morgado-Carrasco D, Padrosa J, Aldecoa I, et al. Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature. Autoimmun Rev. 2023;22 (8):103375/1-8$73$YR$$M$Y$$$20240726$$HP$ES$ES
241414251$24141425$1$I$$20240711$20240726$20240726$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458624$RANBAXY$Mand N, Donath C, Leonhardt A, Weber S, Komhoff M. Case report: Rhabdomyolysis in children in acute and chronic disease-a challenging condition in pediatric emergency medicine. Front Pediatr. 2023;11:1070465/1-6$4$YR$$M$Y$$$20240726$$HP$DE$DE
241414261$24141426$1$I$20240707$20240711$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458725$RANBAXY$$$$$F$Y$287$KG$20240726$$CN$GB$GB
241414271$24141427$1$I$20240101$20240718$20240726$20240726$PER$$US-BAYER-2024A104974$BAYER$$71$YR$E$M$Y$104.3$KG$20240726$$CN$US$US
241414281$24141428$1$I$$20240711$20240726$20240726$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458672$RANBAXY$Kian W, Krayim B, Alsana H, Giles B, Purim O, Alguayn W, et al. Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib. Front Oncol. 2023;13:1-9$75$YR$$F$Y$$$20240726$$HP$IL$IL
241414291$24141429$1$I$$20240725$20240726$20240726$PER$$US-BAYER-2024A108382$BAYER$$17$YR$T$$Y$$$20240726$$CN$US$US
241414301$24141430$1$I$$20240712$20240726$20240726$EXP$$SI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458965$RANBAXY$Ocepek A. Colitis due to cancer treatment with immune check-point inhibitors - review of literature and presentation of clinical cases. Radiol Oncol. 2024;58 (2):179-185$72$YR$$M$Y$$$20240726$$HP$SI$SI
241414311$24141431$1$I$20240512$20240716$20240726$20240726$EXP$FR-AFSSAPS-TS2024000776$FR-TEVA-VS-3222365$TEVA$$50$YR$$M$Y$89$KG$20240726$$MD$FR$FR
241414321$24141432$1$I$$20240711$20240726$20240726$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458949$RANBAXY$Medina I, Carpio C, Ruiz Camps I, Albasanz Puig A, Lopez Godino O, Esperalba J, et al. Adenovirus induced hemorrhagic cystitis after CD19 targeted chimeric antigen receptor T cell therapy in a patient with large B cell lymphoma. Immunotherapy. 2023;15(16):1369-1374$40$YR$$M$Y$$$20240726$$HP$ES$ES
241414331$24141433$1$I$$20240711$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458833$RANBAXY$Wireko FW, Ryu JH. Lung Transplant for Acute Exacerbation in Interstitial Pneumonia With Autoimmune Features (IPAF). Am J Respir Crit Care Med. 2024;May 21;209 (0):A5934;C54$63$YR$$M$Y$$$20240726$$HP$US$US
241414341$24141434$1$I$$20240712$20240726$20240726$EXP$$SI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458963$RANBAXY$Ocepek A. Colitis due to cancer treatment with immune check-point inhibitors - review of literature and presentation of clinical cases. Radiol Oncol. 2024;58 (2):179-185$75$YR$$M$Y$$$20240726$$MD$SI$SI
241414351$24141435$1$I$$20240711$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457632$RANBAXY$$$$E$M$Y$$$20240726$$HP$US$US
241414361$24141436$1$I$$20240711$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458785$RANBAXY$Rodriguez C, Yosry N, Qaiser S, Luzuriaga A, Adelizzi A. BRASH: A Deadly Acronym. Am J Respir Crit Care Med. 2024;209 (0):A1596$84$YR$$F$Y$$$20240726$$HP$US$US
241414371$24141437$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459048$RANBAXY$Miller MJ, Lee P, Lee BG, Flegel WA, West-Mitchell K, Conry-Cantilena K et al. Consideration for alpha-gal syndrome in two critically ill persons with group O blood who received group B plasma. Transfusion. 2024;64:949-951$57$YR$$M$Y$$$20240726$$HP$US$US
241414381$24141438$1$I$$20240712$20240726$20240726$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459004$RANBAXY$Cascallana JL, Gordo V, Montes R. Severe necrosis of oesophageal and gastric mucosa in fatal methanol poisoning. Forensic Sci Int. 2012;220:e9-e12$67$YR$$F$Y$$$20240726$$HP$ES$ES
241414391$24141439$1$I$$20240711$20240726$20240726$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457920$RANBAXY$Wu H, Hill V. Serotonin Syndrome and Catatonia in the Absence of a Serotonergic Agent Following Abrupt Withdrawal of Clozapine. Can J Hosp Pharm. 2024;77 (1):e3453(1-3)$47$YR$$M$Y$$$20240726$$MD$CA$CA
241414401$24141440$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459025$RANBAXY$Edwards K, Nagy TR, Fabiano S, Jacotin J, Ellis D. Leptospirosis in the Air: A Case Review Series During Air Medical Transport in Haiti. Air Med J. 2023;42:380-383$13$YR$$M$Y$$$20240726$$HP$US$US
241414411$24141441$1$I$$20240711$20240726$20240726$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458914$RANBAXY$Pouxe M, Abdulkarim A, de Valliere S, Seremet T, Favrat B, Kokkinakis I. Diagnosis and management of COVID toes in outpatients: a case report. J  Med Case Rep. 2024;18(1):307$22$YR$$F$Y$$$20240726$$HP$CH$CH
241414421$24141442$1$I$$20240712$20240726$20240726$EXP$$SI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458960$RANBAXY$Ocepek A. Colitis due to cancer treatment with immune check-point inhibitors - review of literature and presentation of clinical cases. Radiol Oncol. 2024;58 (2):179-185$71$YR$$M$Y$$$20240726$$MD$SI$SI
241414432$24141443$2$F$$20240717$20240726$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458818$RANBAXY$Chen F, Boominathan P. Aortoesophageal Fistula Following a Cervical Epidural Steroid Injection: Case Report. Pain Med Case Rep. 2023;7 (8):345-347$$$$M$Y$$$20240731$$HP$US$US
241414443$24141444$3$F$20230901$20240829$20240726$20240906$EXP$$MX-TAKEDA-2024TUS074539$TAKEDA$$22$YR$$F$Y$$$20240906$$CN$MX$MX
241414451$24141445$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459232$RANBAXY$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch Dermatol Res. 2024;316 (5):194;1-6$$$$$Y$$$20240726$$HP$US$US
241414461$24141446$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458937$RANBAXY$Wireko FW, Ryu JH. Successful Pregnancies in a Patient With Severe Antisynthetase Syndrome- Related Interstitial Lung Disease (AS-ILD). Am J Respir Crit Care Med. 2024;209(0):A7061$$$$F$Y$$$20240726$$HP$US$US
241414471$24141447$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459237$RANBAXY$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch Dermatol Res. 2024;316 (5):194;1-6$$$$$Y$$$20240726$$HP$US$US
241414481$24141448$1$I$$20240711$20240726$20240726$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457812$RANBAXY$$$$E$F$Y$50$KG$20240726$$MD$AU$AU
241414491$24141449$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458995$RANBAXY$Subhadarshani S, Waters M, Shaughnessy CN. Bintrafusp alfa induced multiple self-healing cutaneous keratoacanthoma-like squamous proliferations. Clin Exp Dermatol. 2024;49 (6):629-631$49$YR$$F$Y$$$20240726$$HP$US$US
241414501$24141450$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459052$RANBAXY$Sanjeevi A, Clark BL, Aguirre A, Verghese BG. Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature. Clin Immunol Commun. 2024;6(0):1-4$65$YR$$F$Y$$$20240726$$HP$US$US
241414511$24141451$1$I$$20240711$20240726$20240726$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458707$RANBAXY$Mertens B, Elkayal O, Dreesen E, Wauters J, Meersseman P, Debaveye Y, et al. Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review. Antibiotics (Basel). 2023;12 (7):1085;1-19$61$YR$$M$Y$81$KG$20240726$$HP$BE$BE
241414521$24141452$1$I$$20240711$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458842$RANBAXY$Mak J, Gandhi R, Zaidan MF, Murthy V. Rituximab for Rapidly Progressive MDA5 Dermatomyositis-Associated Interstitial Lung Disease. Am J Respir Crit Care Med. 2024;May 19;209(0):A1986;A51$41$YR$$F$Y$$$20240726$$HP$US$US
241414531$24141453$1$I$$20240712$20240726$20240726$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458259$RANBAXY$Fage S, Johansen C. Severe and therapeutic challenging oral erosive lichen planus treated with oral roflumilast.. Clin Exp Dermatol. 2023;48(5):556-557$23$YR$$F$Y$$$20240726$$HP$DK$DK
241414541$24141454$1$I$20211001$20240712$20240726$20240726$EXP$$SG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459054$RANBAXY$Boey JJH, Ng KYY, Krisnadi C, Lim DW-T, Ang M-K. Response to fam-Trastuzumab-Deruxtecan in patients with metastatic HER2-positive salivary duct carcinoma: A case series. Oral Oncol. 2023;146:106566; 1-3$46$YR$$M$Y$$$20240726$$HP$SG$SG
241414551$24141455$1$I$$20240711$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458688$RANBAXY$Kuruppu D, Nguyen J, Milas M, Nasr C, Niu J, Shellenberger T. Neoadjuvant Tyrosine Kinase Inhibitor Therapy Enables Surgery for Previously Unresectable 15cm Anaplastic Thyroid Cancer. Endocr Pract. 2024;30 (Suppl.)(5):S163$63$YR$$M$Y$$$20240726$$MD$US$US
241414561$24141456$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459236$RANBAXY$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch Dermatol Res. 2024;316 (5):194;1-6$$$$$Y$$$20240726$$HP$US$US
241414571$24141457$1$I$$20240711$20240726$20240726$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458699$RANBAXY$Grigorescu RR, Alexandra I, Sburlan H, Radu EC, Manea CE, Copca N. Unforeseen Outcome of An Alcoholic Hepatitis Patient. JGLD. 2024;33 (2):99 (1-2)/EP113$42$YR$$$Y$$$20240726$$HP$RO$RO
241414581$24141458$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457273$RANBAXY$Sueblinvong V, Zhang S, Varga P. Atrial arrhythmia and bradycardia as a presentation of congenital long QT syndrome. Pediatr Cardiol. 2024;Jul 11:online ahead of print$$$N$$Y$$$20240726$$HP$US$US
241414591$24141459$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458103$RANBAXY$Gupta A, Wojnowski K, Gurung P. Mucormycosis - A Rare Etiology of Empyema Nessisitans. Am J Respir Crit Care Med. 2024;209:A2386$55$YR$$M$Y$$$20240726$$HP$US$US
241414601$24141460$1$I$20231101$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458102$RANBAXY$$71$YR$$M$Y$75$KG$20240726$$MD$FR$FR
241414611$24141461$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458990$RANBAXY$Gravenmier C, Shah B, Hussaini M, Zhang L. Chimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment. Leuk Lymphoma. 2024;65 (5):674-678$58$YR$$M$Y$$$20240726$$HP$US$US
241414621$24141462$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458947$RANBAXY$Wireko FW, Ryu JH. Successful Pregnancies in a Patient With Severe Antisynthetase Syndrome-Related Interstitial Lung Disease (AS-ILD). Am J Respir Crit Care Med. 2024;209(0):A7061$$$$$Y$$$20240726$$HP$US$US
241414632$24141463$2$F$$20240717$20240726$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452972$RANBAXY$Piccoli C, Rocha ACT, Sakamuri S. Chasing CK: A Case of Persistent HyperCKemia in an Adolescent. J Clin Neuromuscul Dis. 2024;Feb; 25(S1):S8/B-4$16$YR$$F$Y$$$20240801$$HP$US$US
241414641$24141464$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459239$RANBAXY$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch Dermatol Res. 2024;316 (5):194;1-6$$$$$Y$$$20240726$$HP$US$US
241414651$24141465$1$I$$20240711$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458804$RANBAXY$Shostak E, Amin R, Braverman G, Steinberger S, Magro C. Progressive Dyspnea in a Woman With Tracheal Stenosis and Rheumatoid Arthritis. Chest. 2024;Jul;166 (1):e15-e20$82$YR$$F$Y$$$20240726$$MD$US$US
241414661$24141466$1$I$20240328$20240711$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458221$RANBAXY$$$$A$F$Y$$$20240726$$HP$FR$FR
241414671$24141467$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459026$RANBAXY$Edwards K, Nagy TR, Fabiano S, Jacotin J, Ellis D. Leptospirosis in the Air: A Case Review Series During Air Medical Transport in Haiti. Air Medi J. 2023;42:380-383$65$YR$$F$Y$$$20240726$$HP$US$US
241414681$24141468$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459234$RANBAXY$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch Dermatol Res. 2024;316 (5):194;1-6$$$$$Y$$$20240726$$HP$US$US
241414691$24141469$1$I$$20240711$20240726$20240726$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458661$RANBAXY$Li X-L, Luan C-Y, Fan Y-J, Lin XY, Jiang D, Su M-X, et al. A Rare Case of Acute Infectious Purpura Fulminans Caused by Klebsiella Pneumoniae and Human Herpesvirus Type 5. J Inflamm Res. 2022;Jul 26; 15:4251-4260$22$YR$$M$Y$90$KG$20240726$$HP$CN$CN
241414701$24141470$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458906$RANBAXY$Nichols MM, Pozdnyakova O. Snapper-Schneid bodies (coarse cytoplasmic granules) in a patient with multiply relapsed multiple myeloma. Blood. 2024;Jun 13;143 (24):2559$66$YR$$M$Y$$$20240726$$HP$US$US
241414711$24141471$1$I$$20240712$20240726$20240726$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457592$RANBAXY$Kolczynska N, Masajtis-Zagajewska A, Jagodzinska M, Nowicki M. Bilateral renal arteries stenosis in a patient with treatment-resistant hypertension and acute kidney injury. POL NEPHROL DIAL. 2024;28(2):27-28$49$YR$$M$Y$$$20240726$$HP$PL$PL
241414721$24141472$1$I$$20240712$20240726$20240726$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458931$RANBAXY$-. A rare case report of Olanzapine induced paralytic ileus. Indian J Psychiatry. 2024;Jan; 66(Suppl1):S191$18$YR$$M$Y$$$20240726$$HP$IN$IN
241414731$24141473$1$I$$20240712$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458866$RANBAXY$Kozeluhova J. Biological therapy of ulcerative colitis during pregnancy. Gastroent Hepatol. 2023;77(1):26- 29$$$$F$Y$$$20240726$$HP$GB$GB
241414741$24141474$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459044$RANBAXY$Miller MJ, Lee P, Lee BG, Flegel WA, West-Mitchell K, Conry-Cantilena K, et al. Consideration for alpha-gal syndrome in two critically ill persons with group O blood who received group B plasma. Transfusion. 2024;64(5):949-951$64$YR$$M$Y$$$20240726$$HP$US$US
241414751$24141475$1$I$$20240712$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459154$RANBAXY$Karkia R, Giacchino T, Hii F, Bradshaw C, Ramadan G, Akolekar R. Gestational diabetes mellitus: relationship of adverse outcomes with severity of disease. J Matern Fetal Neonat Med. 2024;37 (1):2356031/1-10$$$$F$Y$$$20240726$$HP$GB$GB
241414761$24141476$1$I$$20240711$20240726$20240726$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458756$RANBAXY$O^ Reilly M, Krstic A, Iglesias Martinez LF, Ryan EJ , Moron B, Winter D, et al. Genomic and Transcriptomic Analysis of a Patient with Early-Onset Colorectal Cancer and Therapy-Induced Focal Nodular Hyperplasia: A Case Report. J Pers Med. 2024;14 (6):639(1-8)$24$YR$$F$Y$$$20240726$$HP$IE$IE
241414781$24141478$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459051$RANBAXY$Li A, Manak KC. Management of Agitation Secondary to Immune Cell-Effector Associated Neurotoxicity Syndrome (ICANS) in a Pediatric Patient. J Acad consult Lia Psychiatry. 2023;64 (S):S14-S15/029$18$YR$$F$Y$$$20240726$$HP$US$US
241414791$24141479$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459028$RANBAXY$Edwards K, Nagy TR, Fabiano S, Jacotin J, Ellis D. Leptospirosis in the Air: A Case Review Series During Air Medical Transport in Haiti. Air Medi J. 2023;42:380?383$8$YR$$M$Y$$$20240726$$HP$US$US
241414801$24141480$1$I$20240501$20240712$20240726$20240726$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458186$RANBAXY$$70$YR$$F$Y$73$KG$20240726$$HP$DE$DE
241414811$24141481$1$I$$20240712$20240726$20240726$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458899$RANBAXY$Hijab A, Taha T, Charas T, Bar-Sela G, Stein P, Agbarya A. Anti-androgen for myoepithelial tumor: a potent therapy yet a potential misleader. AntiCancer Drugs. 2022;33(1):e747-e751$74$YR$$M$Y$$$20240726$$MD$IL$IL
241414831$24141483$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459233$RANBAXY$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch Dermatol Res. 2024;316 (5):194;1-6$$$$$Y$$$20240726$$HP$US$US
241414841$24141484$1$I$$20240712$20240726$20240726$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458951$RANBAXY$Du C, Lu C, Li G, Deng D, Chen W. Electroacupuncture for oculomotor nerve palsy after chemotherapy A case report. Medicine. 2024;103 (24):e38547(1-4)$56$YR$$F$Y$$$20240726$$HP$CN$CN
241414851$24141485$1$I$$20240711$20240726$20240726$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458974$RANBAXY$Wang X, Deng Y, He G, Lai S, Li Y, Zhang S, et al. A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL. Hematology. 2024;29 (1):2356300; 1-7$28$YR$$M$Y$$$20240726$$HP$CN$CN
241414861$24141486$1$I$$20240716$20240726$20240726$EXP$$US-GSK-US2024089436$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$HP$US$US
241414871$24141487$1$I$$20240718$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091617$VIIV$$$$A$M$Y$$$20240726$$CN$US$US
241414882$24141488$2$F$$20240821$20240726$20240831$30DAY$$US-GSK-US2024089539$GLAXOSMITHKLINE$$$$$F$Y$60.6$KG$20240831$$MD$US$US
241414893$24141489$3$F$20240101$20240828$20240726$20240906$EXP$$US-TG THERAPEUTICS INC.-TGT003818$TG THERAPEUTICS$$$$$$Y$$$20240906$$CN$US$US
241414901$24141490$1$I$$20240712$20240726$20240726$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458893$RANBAXY$Liu X-H, Zhang L, Li J, Pan B-J. Rare forms of idiopathic multicentric Castleman disease presenting with intrahepatic cholestatic jaundice successfully treated with the bortezomib?based regimen: two case reports. Ann Hematol. 2023;102:977-979$35$YR$$M$Y$$$20240726$$HP$CN$CN
241414911$24141491$1$I$$20240712$20240726$20240726$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458895$RANBAXY$Hu W, Zhang S, Lian C. Treatment of Discoid Lupus Erythematosus with Upadacitinib: A Case Report. Clin Cosmet Invest Dermatol. 2023;16:2793-2800$26$YR$$F$Y$$$20240726$$HP$CN$CN
241414921$24141492$1$I$20240229$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458919$RANBAXY$$99$YR$$F$Y$$$20240726$$PH$FR$FR
241414931$24141493$1$I$$20240712$20240726$20240726$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458903$RANBAXY$Mannini E, Misirocchi F, Lazzari S, Balella G, Bottignole D, Frapporti M, et al. Off-label use of cannabidiol in genetic epileptic and developmental encephalopathies: A case report. Epilepsy Behav Rep. 2024;27 (0):1-4 (100687)$30$YR$$F$Y$$$20240726$$HP$IT$IT
241414941$24141494$1$I$20210901$20240712$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458894$RANBAXY$$73$YR$$F$Y$$$20240726$$PH$GB$GB
241414951$24141495$1$I$20240512$20240717$20240726$20240726$EXP$SE-SEMPA-2024-004510$SE-TEVA-VS-3222994$TEVA$$89$YR$$F$Y$$$20240726$$MD$SE$SE
241414961$24141496$1$I$$20240712$20240726$20240726$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458574$RANBAXY$$60$YR$$M$Y$80$KG$20240726$$CN$NL$NL
241414971$24141497$1$I$20240601$20240716$20240726$20240726$EXP$FR-AFSSAPS-NY2024000764$FR-TEVA-VS-3222367$TEVA$$95$YR$$F$Y$65$KG$20240726$$MD$FR$FR
241414981$24141498$1$I$20220315$20240712$20240726$20240726$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458923$RANBAXY$$17$YR$$F$Y$53$KG$20240726$$MD$PL$PL
241414991$24141499$1$I$$20240712$20240726$20240726$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459097$RANBAXY$Lee SJ, Baek JY, Lee JY, Kang JM, Ahn JG. The first case of a korean patient with a mutationconfirmed tumor necrosis factor receptor-associated periodic syndrome. Yonsei Med J. 2024;65(4):241-245$25$YR$$F$Y$$$20240726$$HP$KR$KR
241415002$24141500$2$F$$20240806$20240726$20240821$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458928$RANBAXY$Iuliana IORDAN, Ana-Maria VLADAREANU, Cristina MAMBET, Ion DUMITRU, Minodora ONISAI, Diana CISLEANU et. al. Atypical Presentation for Adult T-Cell Leukemia/Lymphoma: a Case Report and Short Review of the Literature. Maedica - a Journal of Clinical Medicine. 2024;Vol. 19, No. 2:428-433$32$YR$$M$Y$$$20240821$$HP$RO$RO
241415011$24141501$1$I$20190412$20240712$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458997$RANBAXY$$66$YR$$F$Y$$$20240726$$PH$GB$GB
241415021$24141502$1$I$20230901$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458926$RANBAXY$$61$YR$$F$Y$$$20240726$$CN$FR$FR
241415031$24141503$1$I$20240301$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459116$RANBAXY$$73$YR$$F$Y$91$KG$20240726$$MD$FR$FR
241415041$24141504$1$I$$20240712$20240726$20240726$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458581$RANBAXY$$50$YR$$M$Y$81$KG$20240726$$CN$NL$NL
241415051$24141505$1$I$$20240712$20240726$20240726$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458976$RANBAXY$Muto T, Kyono H. A woman with schizophrenia who died due to Takotsubo cardiomyopathy occurring after electroconvulsive therapy. BMC Psychiatry. 2024;24:139$67$YR$$F$Y$$$20240726$$HP$JP$JP
241415061$24141506$1$I$20240226$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459143$RANBAXY$$48$YR$$M$Y$$$20240726$$MD$FR$FR
241415071$24141507$1$I$20240130$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459167$RANBAXY$$77$YR$$M$Y$75$KG$20240726$$MD$FR$FR
241415081$24141508$1$I$$20240712$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458784$RANBAXY$$71$YR$$M$Y$72$KG$20240726$$MD$GB$GB
241415091$24141509$1$I$20200503$20240712$20240726$20240726$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458924$RANBAXY$$39$YR$$M$Y$75$KG$20240726$$MD$PL$PL
241415101$24141510$1$I$20240212$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459113$RANBAXY$$56$YR$$M$Y$85$KG$20240726$$MD$FR$FR
241415111$24141511$1$I$20240313$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458959$RANBAXY$$80$YR$$M$Y$78.6$KG$20240726$$PH$FR$FR
241415121$24141512$1$I$20211026$20240712$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458910$RANBAXY$$75$YR$$M$Y$$$20240726$$PH$GB$GB
241415141$24141514$1$I$20240101$20240712$20240726$20240726$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458936$RANBAXY$$38$YR$$F$Y$$$20240726$$CN$RO$RO
241415151$24141515$1$I$$20240712$20240726$20240726$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458961$RANBAXY$$20$YR$$M$Y$$$20240726$$MD$IT$IT
241415161$24141516$1$I$20240311$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459095$RANBAXY$$56$YR$$F$Y$$$20240726$$MD$FR$FR
241415171$24141517$1$I$20231001$20240712$20240726$20240726$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458848$RANBAXY$$81$YR$$F$Y$$$20240726$$MD$ES$ES
241415181$24141518$1$I$$20240712$20240726$20240726$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458933$RANBAXY$$87$YR$$M$Y$65$KG$20240726$$MD$NL$NL
241415191$24141519$1$I$20240331$20240712$20240726$20240726$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459089$RANBAXY$$54$YR$$F$Y$$$20240726$$MD$ES$ES
241415201$24141520$1$I$20220501$20240712$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458915$RANBAXY$$67$YR$$F$Y$$$20240726$$PH$GB$GB
241415211$24141521$1$I$20240418$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458922$RANBAXY$$28$YR$$F$Y$78$KG$20240726$$MD$FR$FR
241415221$24141522$1$I$20240216$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459150$RANBAXY$$54$YR$$M$Y$$$20240726$$MD$FR$FR
241415231$24141523$1$I$20240401$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459176$RANBAXY$$71$YR$$M$Y$93.5$KG$20240726$$MD$FR$FR
241415241$24141524$1$I$$20240712$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459006$RANBAXY$$45$YR$$F$Y$111$KG$20240726$$PH$GB$GB
241415251$24141525$1$I$$20240712$20240726$20240726$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459014$RANBAXY$$26$YR$$F$Y$53$KG$20240726$$MD$PL$PL
241415261$24141526$1$I$20240418$20240712$20240726$20240726$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458989$RANBAXY$$66$YR$$M$Y$74$KG$20240726$$CN$DE$DE
241415271$24141527$1$I$20240415$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459161$RANBAXY$$25$YR$$M$Y$104$KG$20240726$$MD$FR$FR
241415281$24141528$1$I$$20240712$20240726$20240726$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458991$RANBAXY$$22$YR$$F$Y$$$20240726$$MD$DE$DE
241415291$24141529$1$I$$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458934$RANBAXY$$70$YR$$F$Y$$$20240726$$MD$FR$FR
241415301$24141530$1$I$20240422$20240712$20240726$20240726$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459144$RANBAXY$$26$YR$$F$Y$$$20240726$$MD$IT$IT
241415311$24141531$1$I$20240601$20240720$20240726$20240726$EXP$$EG-TERSERA THERAPEUTICS LLC-2024TRS003774$TERSERA THERAPEUTICS$$$$$$Y$$$20240726$$CN$EG$EG
241415321$24141532$1$I$20240401$20240716$20240726$20240726$EXP$FR-AFSSAPS-DJ2024000818$FR-TEVA-VS-3222371$TEVA$$75$YR$$F$Y$50$KG$20240726$$PH$FR$FR
241415331$24141533$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146970$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241415341$24141534$1$I$20240606$20240722$20240726$20240726$EXP$$CH-AMGEN-CHESP2024145708$AMGEN$$$$$F$Y$$$20240726$$PH$CH$CH
241415352$24141535$2$F$$20240815$20240726$20240819$PER$$US-ALXN-202407USA001379US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241415362$24141536$2$F$$20240730$20240726$20240809$EXP$$TH-TEVA-VS-3223506$TEVA$Penthinapong T, Saelue P, Sripakdee W, Doungngern T, Tanvejsilp P. Realistic efficacy of oxymetholone compared with rabbit-antithymocyte globulin for severe acquired aplastic anemia. Pharm-Sci-Asia 2024; 51 (2): 155-163.; Penthinapong T, Saelue P, Sripakdee W, Doungngern T, Tanvejsilp P. Realistic efficacy of oxymetholone compared with rabbit-antithymocyte globulin for severe acquired aplastic anemia. Pharm-Sci-Asia 2024; 51 (2): 155-163.; Penthinapong T, Saelue P, Sripakdee W, Doungngern T, ...$$$$$Y$$$20240809$$HP$TH$TH
241415371$24141537$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA217180$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240726$$MD$US$US
241415381$24141538$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA217073$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240726$$MD$US$US
241415391$24141539$1$I$20201201$20240718$20240726$20240726$PER$$US-ROCHE-10000034973$ROCHE$$27$YR$A$F$Y$$$20240726$$CN$US$US
241415401$24141540$1$I$$20240725$20240726$20240726$PER$$US-BAYER-2024A108384$BAYER$$67$YR$E$$Y$$$20240726$$CN$US$US
241415411$24141541$1$I$$20240721$20240726$20240726$PER$$US-BAYER-2024A108628$BAYER$$$$$F$Y$$$20240726$$CN$US$US
241415451$24141545$1$I$$20240712$20240726$20240726$PER$$US-JNJFOC-20240736994$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$US$US
241415461$24141546$1$I$$20240725$20240726$20240726$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137532$DAIICHI$$$$$F$Y$$$20240726$$CN$US$US
241415471$24141547$1$I$$20240716$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090272$VIIV$$19$YR$$F$Y$$$20240726$$HP$US$US
241415481$24141548$1$I$$20240717$20240726$20240726$EXP$$US-VIIV HEALTHCARE LIMITED-US2024090182$VIIV$$$$$M$Y$$$20240726$$HP$US$US
241415491$24141549$1$I$$20240717$20240726$20240726$30DAY$$US-GSK-US2024090067$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$HP$US$US
241415511$24141551$1$I$20240601$20240719$20240726$20240726$PER$$US-ABBVIE-5847793$ABBVIE$$60$YR$$M$Y$$$20240726$$CN$US$US
241415521$24141552$1$I$20240401$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459263$RANBAXY$$71$YR$$M$Y$93.5$KG$20240726$$MD$FR$FR
241415531$24141553$1$I$$20240713$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459029$RANBAXY$$$$$F$Y$$$20240726$$CN$GB$GB
241415541$24141554$1$I$20240401$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459178$RANBAXY$$75$YR$$M$Y$$$20240726$$MD$FR$FR
241415551$24141555$1$I$20240229$20240712$20240726$20240726$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459209$RANBAXY$$59$YR$$F$Y$63$KG$20240726$$MD$DE$DE
241415561$24141556$1$I$$20240712$20240726$20240726$EXP$$JM-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459347$RANBAXY$Gibson S, Hunter T, Johnson N. Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy. Am J Trop Med Hyg. 2024;110(6):1198-1200$29$YR$$F$Y$$$20240726$$HP$JM$JM
241415571$24141557$1$I$$20240712$20240726$20240726$EXP$$JM-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459354$RANBAXY$Gibson S, Hunter T, Johnson N. Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy. Am J Trop Med Hyg. 2024;110(6):1198-1200$31$YR$$F$Y$$$20240726$$HP$JM$JM
241415581$24141558$1$I$$20240725$20240726$20240726$PER$$US-BAYER-2024A108409$BAYER$$$$$$Y$$$20240726$$CN$US$US
241415591$24141559$1$I$20240521$20240725$20240725$20240725$DIR$711529$$FDA-CTU$$19$YR$$M$N$118.35$KG$20240725$N$$US$
241415601$24141560$1$I$$20240711$20240726$20240726$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458667$RANBAXY$Kian W, Krayim B, Alsana H, Giles B, Purim O, Alguayn W, et al. Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib. Front Oncol. 2023;13:1124949;1-9$73$YR$$F$Y$$$20240726$$HP$IL$IL
241415611$24141561$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457641$RANBAXY$$$$$F$Y$$$20240726$$CN$US$US
241415621$24141562$1$I$$20240712$20240726$20240726$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458897$RANBAXY$Liu X-H, Zhang L, Li J, Pan B-J. Rare forms of idiopathic multicentric Castleman disease presenting with intrahepatic cholestatic jaundice successfully treated with the bortezomib?based regimen: two case reports. Ann Hematol. 2023;102:977-979$36$YR$$M$Y$$$20240726$$HP$CN$CN
241415631$24141563$1$I$20210101$20240712$20240726$20240726$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458898$RANBAXY$Li Y, Lu S, Yao P, Huang W, Huang Y, Zhou Y, et al. Lung adenocarcinoma with brain metastasis detected dual fusion of LOC399815-ALK and ALK-EML4 in combined treatment of Alectinib and CyberKnife:A case report. Medicine. 2024;103(3):E36992;1-4$56$YR$$F$Y$$$20240726$$HP$CN$CN
241415641$24141564$1$I$$20240711$20240726$20240726$EXP$$SI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458767$RANBAXY$Mlinsek G, Blagus T, Vrecko MM, Rigler AA, Dolzan V. Genetic variability in rosuvastatin metabolism explains rhabdomyolysis and consequent acute renal failure. Nephrol Dial Transplant. 2024;39 (Suppl.):i2823-i2824;gfae069.1804;2436$79$YR$$F$Y$$$20240726$$HP$SI$SI
241415652$24141565$2$F$$20240719$20240726$20240802$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458737$RANBAXY$Vadi S, Ismail A, Kapoor D. Fournier^s gangrene and diabetic ketoacidosis with lower-than-anticipated glucose levels associated with SGLT-2 inhibitor: A double trouble. Med J Armed Forces India. 2023;79 (2):225-228$56$YR$$M$Y$$$20240802$$HP$IN$IN
241415661$24141566$1$I$$20240712$20240726$20240726$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458912$RANBAXY$Bodor TLW, Webber JC, Scheske JA. Primary Cardiac Lymphoma in an 85-Year-Old Man, With Highly Suggestive Features on Imaging. CJC Open. 2023;5 (2):167-169$85$YR$$M$Y$$$20240726$$HP$CA$CA
241415671$24141567$1$I$$20240711$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458808$RANBAXY$Guck D, Mullholand J. Rescue Awake Venovenous Extracorporeal Membrane Oxygenation With Right Ventricular Support in Secondary to COVID-19, A Case Series. Am J Respir Crit Care Med. 2024;209 (0):A5562$55$YR$$F$Y$$$20240726$$HP$US$US
241415681$24141568$1$I$$20240711$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458789$RANBAXY$Rodriguez H, Tan J, Reddy S. A Missed Mass: An Exceedingly Rare Round Cell Sarcoma Leading to Respiratory Failure in a 19-year-old. Am J Respir Crit Care Med. 2024;209 (0):A6532$19$YR$$F$Y$$$20240726$$HP$US$US
241415691$24141569$1$I$20240612$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457644$RANBAXY$$75$YR$E$M$Y$$$20240726$$CN$US$US
241415701$24141570$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459235$RANBAXY$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch Dermatol Res. 2024;316 (5):194;1-6$$$$$Y$$$20240726$$HP$US$US
241415711$24141571$1$I$20240715$20240725$20240725$20240725$DIR$711464$$FDA-CTU$$58$YR$$M$N$90.4$KG$20240725$N$$US$
241415721$24141572$1$I$$20240711$20240726$20240726$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458970$RANBAXY$Wang X, Deng Y, He G, Lai S, Li Y, Zhang S, et al. A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL. Hematology. 2024;29 (1):2356300; 1-7$28$YR$$M$Y$$$20240726$$HP$CN$CN
241415731$24141573$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459136$RANBAXY$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch Dermatol Res. 2024;316 (5):194;1-6$$$$$Y$$$20240726$$HP$US$US
241415741$24141574$1$I$$20240711$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458851$RANBAXY$Maurya A, Sivanandham R, Bagheri S, Moshtahedian K. Immune-mediated Myositis With Bulbar Involvement Leading to Respiratory Failure: A Rare Adverse Effect of Pembrolizumab. Am J Respir Crit Care Med. 2024;209 (0):A1980$72$YR$$M$Y$$$20240726$$HP$US$US
241415751$24141575$1$I$$20240712$20240726$20240726$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459018$RANBAXY$Tamil Selvi E, Rahangan A. Methotrexate Induced Muco-Cutaneous Ulcer: A Case Report. Int J Pharm Sci Rev Res. 2024;84 (5):75-76$59$YR$$F$Y$$$20240726$$MD$IN$IN
241415761$24141576$1$I$$20240712$20240726$20240726$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459241$RANBAXY$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch Dermatol Res. 2024;316 (5):194;1-6$$$$$Y$$$20240726$$HP$US$US
241415771$24141577$1$I$$20240711$20240726$20240726$EXP$$NP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458556$RANBAXY$Sahi R, Simkhada R, Koirala P, Neupane KR. Undiagnosed Hypothyroidism: Culprit for Fenofibrate Induced Rhabdomyolysis. Nepal Heart J. 2024;21(1):49-50$38$YR$$M$Y$$$20240726$$HP$NP$NP
241415781$24141578$1$I$$20240711$20240726$20240726$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458674$RANBAXY$Kian W, Krayim B, Alsana H, Giles B, Purim O, Alguayn W, et al. Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib. Front Oncol. 2023;13:1-9$68$YR$$F$Y$$$20240726$$HP$IL$IL
241415791$24141579$1$I$$20240715$20240726$20240726$EXP$$US-MSNLABS-2024MSNLIT01623$MSN LABORATORIES$Khadraoui H, Herzog TJ, Jackson A, Billingsley C.Acute pulmonary complications in the setting of high risk gestational trophoblastic neoplasia and induction of chemotherapy.Gynecologic Oncology Reports.2023;48:101224$$$$$Y$$$20240726$$HP$US$US
241415801$24141580$1$I$$20240711$20240726$20240726$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458623$RANBAXY$Liu T, Kong Q, Wang H, Wei H, Liu T, Kong Q, Wang H, Wei H,. Long-term, 13-year survival after immune cell therapy combined with chemotherapy for extensive-stage small-cell lung cancer: a case report. Front Oncol. 2024;14(0):1389725/1-6$40$YR$$M$Y$$$20240726$$HP$CN$CN
241415811$24141581$1$I$20240709$20240718$20240726$20240726$PER$$US-SA-2024SA216847$SANOFI AVENTIS$$86$YR$E$F$Y$63$KG$20240726$$MD$US$US
241415821$24141582$1$I$20240711$20240717$20240726$20240726$EXP$$DE-BEH-2024175962$CSL BEHRING$$76$YR$E$F$Y$75$KG$20240726$$HP$DE$DE
241415831$24141583$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153578$NOVARTIS$$$$$$Y$$$20240726$$MD$US$US
241415842$24141584$2$F$$20240729$20240726$20240812$EXP$$PT-AUROBINDO-AUR-APL-2024-037279$AUROBINDO$Ana Margarida F, Jorge A, Sofia P. NON CIRRHOTIC PORTAL HYPERTENSION DUE TO OXALIPLATIN LIVER INJURY. Gastroenterological diseases and liver diseases | Clinical case. 1282$61$YR$$$Y$$$20240812$$MD$PT$PT
241415851$24141585$1$I$$20240723$20240726$20240726$EXP$GB-MHRA-MIDB-27e8b15b-04f2-445e-8370-394215c93f1e$GB-009507513-2407GBR013448$MERCK$$64$YR$$F$Y$$$20240726$$HP$GB$GB
241415861$24141586$1$I$$20240722$20240726$20240726$EXP$$AU-009507513-2407AUS013510$MERCK$$$$$M$Y$$$20240726$$HP$AU$AU
241415871$24141587$1$I$20240701$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024145585$AMGEN$$60$YR$A$M$Y$$$20240726$$HP$US$US
241415881$24141588$1$I$20240723$20240725$20240726$20240726$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137533$DAIICHI$$47$YR$$F$Y$$$20240726$$PH$US$US
241415891$24141589$1$I$20240725$20240725$20240726$20240726$PER$$US-BAYER-2024A108583$BAYER$$$$$$Y$$$20240726$$CN$US$US
241415901$24141590$1$I$$20240719$20240726$20240726$EXP$$CA-TAKEDA-2024TUS073976$TAKEDA$$$$$M$Y$$$20240726$$MD$CA$CA
241415911$24141591$1$I$20240601$20240717$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115367$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240726$$HP$US$US
241415922$24141592$2$F$$20240808$20240726$20240819$EXP$$IT-BAXTER-2024BAX021860$BAXTER$$61$YR$$M$Y$$$20240819$$MD$IT$IT
241415932$24141593$2$F$$20240729$20240726$20240808$EXP$$JP-ROCHE-10000031647$ROCHE$Toge H, Yamamoto M, Ikeuchi T, Tomita K, Yamasaki A. A case of lung adenocarcinoma that developedin which cytokine release syndrome was triggered by contracting influenza A one month after the discontinuation of nivolumab (Abstract number:H-02). The 62nd Chugoku-Shikoku Branch Scientific Meeting of the Japan Lung Cancer Society. 2024;110.$68$YR$E$F$Y$$$20240808$$MD$JP$JP
241415941$24141594$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222673$TEVA$$79$YR$$M$Y$$$20240726$$HP$CA$CA
241415957$24141595$7$F$$20240831$20240726$20240910$EXP$$PT-AUROBINDO-AUR-APL-2024-037290$AUROBINDO$Pereira I, Costa CA, Reinas A, Concei??o P, Costa AM. PO-0696 - (4833) - O SUSPEITO DO COSTUME:ENTEROPATIA INDUZIDA PELO OLMESARTAN. Doen?as gastrenterol?gicas e doen?as hep?ticas | Caso cl?nico$74$YR$$F$Y$$$20240910$$MD$PT$PT
241415971$24141597$1$I$20240721$20240722$20240726$20240726$PER$$US-BAYER-2024A106229$BAYER$$61$YR$A$F$Y$$$20240726$$CN$US$US
241415981$24141598$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA216366$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240726$$MD$US$US
241415992$24141599$2$F$20231213$20240724$20240726$20240802$EXP$$AU-VALIDUS PHARMACEUTICALS LLC-AU-VDP-2024-019327$VALIDUS$$$$$$Y$$$20240802$$MD$AU$AU
241416001$24141600$1$I$20240614$20240722$20240726$20240726$EXP$$US-TAKEDA-2024TUS061178$TAKEDA$$75$YR$$F$Y$$$20240726$$MD$US$US
241416011$24141601$1$I$20240715$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51457$$FDA-CTU$$64$YR$$F$N$$$20240725$N$$US$
241416021$24141602$1$I$$20240718$20240726$20240726$EXP$$JP-ROCHE-10000033383$ROCHE$$8$DEC$E$M$Y$$$20240726$$MD$JP$JP
241416031$24141603$1$I$$20240725$20240726$20240726$PER$$US-BAYER-2024A108369$BAYER$$$$A$M$Y$$$20240726$$CN$US$US
241416043$24141604$3$F$$20240902$20240726$20240911$EXP$$PT-AUROBINDO-AUR-APL-2024-037276$AUROBINDO$Silva BC, Flores MA, Domingos GJ, Paulo S, Santos CM, Badura R. IMI-012 - (2100) - LES?ES UMBILICADASNA ?POCA DE MONKEYPOX (UMBILICATED INJURIES IN THE MONKEYPOX TIME). Doen?as infeciosas e parasit?rias / Imagem em Medicina Interna (Infectious and p$25$YR$$F$Y$$$20240911$$MD$PT$PT
241416051$24141605$1$I$$20240722$20240726$20240726$PER$$US-BAYER-2024A106458$BAYER$$$$$F$Y$$$20240726$$CN$US$US
241416061$24141606$1$I$$20240722$20240726$20240726$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011182$JAZZ$$$$$M$Y$$$20240726$$HP$US$US
241416072$24141607$2$F$20240101$20240730$20240726$20240809$EXP$$US-RADIUS HEALTH, INC.-2024US005409$RADIUS PHARM$$$$$F$Y$$$20240809$$CN$US$US
241416081$24141608$1$I$$20240716$20240726$20240726$EXP$$JP-ROCHE-10000033121$ROCHE$Tomonobe H, Kawakami M, Hachisuga K, Maenohara S, Kodama K, Yagi H et al.. OS-262 A case of ovarian cancer recurrent with cardiophrenic tumour after treatment of ovarian cancer which had difficulty in differential diagnosis with pulmonary pleomorphic carcinoma. Japanese Journal of Gynecologic Oncology /The 66th Annual Meeting of Japan Socie. 2024;42(3):323$48$YR$A$F$Y$$$20240726$$MD$JP$JP
241416091$24141609$1$I$$20240716$20240726$20240726$EXP$$NL-AUROBINDO-AUR-APL-2024-036623$AUROBINDO$$47$YR$$F$Y$67$KG$20240726$$CN$NL$NL
241416101$24141610$1$I$$20240722$20240726$20240726$PER$$US-ABBVIE-5850467$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241416113$24141611$3$F$20240101$20240717$20240726$20240917$EXP$$CA-BEH-2024174820$CSL BEHRING$$71$YR$E$F$Y$107$KG$20240917$$CN$CA$CA
241416121$24141612$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117621$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$102.97$KG$20240726$$CN$US$US
241416132$24141613$2$F$20240627$20240731$20240726$20240809$EXP$$ES-AstraZeneca-2024A168604$ASTRAZENECA$$76$YR$$M$Y$$$20240809$$MD$ES$
241416151$24141615$1$I$20240703$20240719$20240726$20240726$EXP$$AR-JNJFOC-20240756544$JOHNSON AND JOHNSON$$76$YR$E$M$Y$99$KG$20240726$$CN$AR$AR
241416162$24141616$2$F$20240715$20240909$20240726$20240917$PER$$JP-Eisai-EC-2024-170521$EISAI$$74$YR$E$F$Y$$$20240918$$MD$JP$JP
241416172$24141617$2$F$$20240715$20240726$20240803$EXP$$PT-AUROBINDO-AUR-APL-2024-037278$AUROBINDO$Marques M,Da Mota RV, Salgueiro D, Ferreira I, Gouveia M, Oliveira R et al.,. PO-0679 - (4269) - ?CARCINOMATOSE E HIPOFOSFAT?MIA: A ETIOLOGIA MULTIFATORIAL DO DELIRIUM? (PO-0679 - (4269) - ?CARCINOMATOSIS AND HYPOPHOSPHATEMIA: THE MULTIFACTORIAL ETIOLOGY OF DELIRIUM?). Doen?as cerebrovasculares e neurol?gicas | Caso cl?nico. 1024$65$YR$$M$Y$$$20240803$$HP$PT$PT
241416181$24141618$1$I$20240101$20240715$20240726$20240726$PER$$US-MYLANLABS-2024M1066444$MYLAN$$$$$M$Y$$$20240726$$CN$US$US
241416191$24141619$1$I$$20240718$20240726$20240726$EXP$$CN-INCYTE CORPORATION-2024IN007715$INCYTE$Liang J, Xu X, Chen Z, Yu J, Tang Y.. Combined use of emapalumab with ruxolitinib and dexamethasone as an effective treatment for epstein-barr virus-associated hemophagocytic lymphohistiocytosis complicated with multiorgan damage and severe infection. J PEDIATR HEMATOL ONCOL. 2024;46:e360-e362$$$$$Y$$$20240726$$HP$CN$CN
241416211$24141621$1$I$$20240725$20240726$20240726$PER$$US-BAYER-2024A108381$BAYER$$$$$$Y$$$20240726$$CN$US$US
241416224$24141622$4$F$$20240831$20240726$20240911$EXP$$PT-AUROBINDO-AUR-APL-2024-037251$AUROBINDO$Correia AR, Lamas A, Brandao M.. CO-0133 - (4713) - NECROTIZING MYOPATHY IMMUNE-MEDIATED WITH ANTI-HMGCR ANTIBODIES IN A PATIENT WITH MIXED CONNECTIVE TISSUE DISEASE.. Congresses of the Portuguese Society of Internal Medicine: 30th National Congres. 2024;30:234$41$YR$$F$Y$$$20240911$$MD$PT$PT
241416231$24141623$1$I$20240719$20240720$20240726$20240726$EXP$$CN-VANTIVE-2024VAN018529$Vantive US Healthcare$$72$YR$$$Y$62$KG$20240726$$CN$CN$CN
241416241$24141624$1$I$$20240718$20240726$20240726$30DAY$$US-GSK-US2024092249$GLAXOSMITHKLINE$$$$$M$Y$$$20240726$$CN$US$US
241416251$24141625$1$I$$20240715$20240726$20240726$EXP$$US-FARMAPROD-202407-2619$DOMPE FARMACEUTICI$$10$YR$C$F$Y$20.5$KG$20240726$$CN$US$US
241416261$24141626$1$I$20230919$20240718$20240726$20240726$PER$$US-INCYTE CORPORATION-2023IN010175$INCYTE$$$$$$Y$$$20240726$$MD$US$US
241416281$24141628$1$I$$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51484$$FDA-CTU$$$$$F$N$$$20240725$N$HP$US$
241416291$24141629$1$I$20240204$20240726$20240726$20240726$DIR$711594$$FDA-CTU$$26$YR$$M$N$77.4$KG$20240726$Y$CN$US$
241416321$24141632$1$I$$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51483$$FDA-CTU$$$$$M$N$$$20240725$N$HP$US$
241416331$24141633$1$I$$20240726$20240726$20240726$DIR$711597$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241416341$24141634$1$I$$20240726$20240726$20240726$DIR$711598$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241416351$24141635$1$I$$20240726$20240726$20240726$DIR$711602$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241416361$24141636$1$I$20240101$20240722$20240726$20240726$EXP$$SG-JNJFOC-20240762783$JOHNSON AND JOHNSON$$24$YR$A$F$Y$$$20240726$$HP$SG$SG
241416371$24141637$1$I$20240425$20240724$20240726$20240726$EXP$FR-AFSSAPS-TS2024000845$FR-JNJFOC-20240766590$JOHNSON AND JOHNSON$$41$YR$A$F$Y$60$KG$20240726$$MD$FR$FR
241416382$24141638$2$F$20220601$20240820$20240726$20240830$EXP$$JP-ROCHE-10000032468$ROCHE$Shinjo K, Tanaka R, Doyama H, Kamiya C, Shimbo A , Hariyama Y. P-173 A case of fistula formation and urinary bladder rupture which occurred after radiotherapy and treatment with bevacizumab for cervix carcinoma, leading to treatment difficulty. Japanese Journal of Gynecological Oncology / The 66th Annual Meeting of Japan So. 2024;42(3):398$59$YR$A$F$Y$$$20240830$$MD$JP$JP
241416393$24141639$3$F$20240712$20240726$20240726$20240730$EXP$$US-AMGEN-USASP2024146702$AMGEN$$77$YR$E$F$Y$$$20240730$$HP$US$US
241416401$24141640$1$I$$20240715$20240726$20240726$EXP$$US-BAYER-2024A103699$BAYER$$68$YR$E$M$Y$$$20240726$$CN$US$US
241416411$24141641$1$I$20230321$20240718$20240726$20240726$EXP$$KR-Vifor (International) Inc.-VIT-2024-06455$VIFOR$$84$YR$$F$Y$$$20240726$$HP$KR$KR
241416421$24141642$1$I$20240704$20240715$20240726$20240726$EXP$$US-FARMAPROD-202407-2622$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240726$$CN$US$US
241416434$24141643$4$F$20240624$20240917$20240726$20240925$EXP$$US-BEH-2024175803$CSL BEHRING$$33$YR$A$F$Y$70.295$KG$20240925$$HP$US$US
241416441$24141644$1$I$$20240718$20240726$20240726$EXP$$CZ-AUROBINDO-AUR-APL-2024-036417$AUROBINDO$Krysl, D.. Nonconvulsive status epilepticus. (Nekonvulzivni status epilepticus). Neurologia pre pre prax. (Neurologia pre pre prax). 2024;25 (3):161-169$66$YR$$$Y$$$20240726$$MD$CZ$CZ
241416452$24141645$2$F$$20240808$20240726$20240812$PER$$US-AMGEN-USASP2024147792$AMGEN$$$$$$Y$$$20240812$$CN$US$US
241416461$24141646$1$I$$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024148117$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241416471$24141647$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147222$AMGEN$$$$$$Y$$$20240726$$HP$US$US
241416481$24141648$1$I$$20240718$20240726$20240726$EXP$$GB-AUROBINDO-AUR-APL-2024-035931$AUROBINDO$$$$$$Y$$$20240726$$CN$GB$GB
241416491$24141649$1$I$20240101$20240717$20240726$20240726$EXP$NL-LRB-00990248$NL-SA-2024SA213159$SANOFI AVENTIS$$72$YR$E$F$Y$55$KG$20240726$$HP$NL$NL
241416501$24141650$1$I$$20240719$20240726$20240726$EXP$$CH-SA-2024SA217686$SANOFI AVENTIS$$$$A$M$Y$$$20240726$$MD$CH$CH
241416511$24141651$1$I$$20240723$20240726$20240726$EXP$$US-INCYTE CORPORATION-2024IN007731$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241416521$24141652$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA215661$SANOFI AVENTIS$$$$$F$Y$$$20240726$$CN$US$US
241416531$24141653$1$I$20230201$20240723$20240726$20240726$EXP$$US-INCYTE CORPORATION-2024IN007729$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241416541$24141654$1$I$$20240726$20240726$20240726$DIR$711603$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241416551$24141655$1$I$20220418$20240726$20240726$20240726$DIR$711588$$FDA-CTU$$26$YR$$M$N$72$KG$20240726$N$CN$US$
241416561$24141656$1$I$$20240719$20240726$20240726$PER$$US-ROCHE-10000032001$ROCHE$$$$$F$Y$$$20240726$$MD$US$US
241416571$24141657$1$I$$20240725$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118903$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240726$$CN$US$US
241416581$24141658$1$I$20231231$20240718$20240726$20240726$EXP$$GB-TEVA-VS-3222972$TEVA$$50$YR$$F$Y$76$KG$20240726$$MD$GB$GB
241416591$24141659$1$I$20240715$20240722$20240726$20240726$DIR$FDA-CDER-CTU-2024-51455$$FDA-CTU$$9$YR$$M$N$28.4$KG$20240722$N$$US$
241416601$24141660$1$I$$20240726$20240726$20240726$DIR$711605$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241416611$24141661$1$I$$20240722$20240726$20240726$PER$$US-BIOGEN-2024BI01274854$BIOGEN$$$$$F$Y$$$20240726$$CN$US$US
241416621$24141662$1$I$$20240724$20240726$20240726$PER$$US-TAKEDA-2024TUS075526$TAKEDA$$$$$F$Y$$$20240726$$CN$US$US
241416634$24141663$4$F$$20240903$20240726$20240905$PER$$US-BIOGEN-2023BI01239469$BIOGEN$$$$$M$Y$$$20240905$$CN$US$US
241416642$24141664$2$F$$20240826$20240726$20240910$PER$$US-GRANULES-US-2024GRASPO00288$GRANULES INDIA$$$$$$Y$$$20240910$$CN$US$US
241416651$24141665$1$I$$20240715$20240726$20240726$PER$$US-ALKERMES INC.-ALK-2024-001892$ALKERMES$$$$$$Y$$$20240726$$CN$US$US
241416661$24141666$1$I$$20240719$20240726$20240726$PER$$US-BIOGEN-2024BI01274815$BIOGEN$$$$$F$Y$$$20240726$$CN$US$US
241416671$24141667$1$I$20240310$20240724$20240726$20240726$EXP$$US-ABBVIE-5854058$ABBVIE$$53$YR$$F$Y$$$20240726$$CN$US$US
241416682$24141668$2$F$20240723$20240806$20240726$20240813$EXP$$IN-VANTIVE-2024VAN018650$Vantive US Healthcare$$74$YR$$M$Y$$$20240813$$CN$IN$IN
241416692$24141669$2$F$$20240930$20240726$20240930$EXP$$NVSC2024CH149251$NOVARTIS$$47$YR$$F$Y$$$20240930$$CN$CH$CH
241416701$24141670$1$I$20240610$20240718$20240726$20240726$EXP$$ES-AUROBINDO-AUR-APL-2024-036481$AUROBINDO$$82$YR$$F$Y$$$20240726$$MD$ES$ES
241416711$24141671$1$I$20240712$20240718$20240726$20240726$EXP$$US-BAYER-2024A105145$BAYER$$29$YR$A$M$Y$$$20240726$$CN$US$US
241416721$24141672$1$I$$20240716$20240726$20240726$EXP$$FR-BEH-2024176006$CSL BEHRING$$36$YR$A$F$Y$$$20240726$$HP$FR$FR
241416732$24141673$2$F$20240717$20240731$20240726$20240813$EXP$$GB-AUROBINDO-AUR-APL-2024-035961$AUROBINDO$$94$YR$$F$Y$53$KG$20240813$$MD$GB$GB
241416741$24141674$1$I$$20240718$20240726$20240726$PER$$US-ROCHE-10000033925$ROCHE$$$$$$Y$$$20240726$$MD$US$US
241416751$24141675$1$I$$20240718$20240726$20240726$EXP$$AU-Atnahs Limited-ATNAHS20240702082$Atnahs Healthcare$$$$$$Y$$$20240726$$HP$AU$AU
241416761$24141676$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3224867$TEVA$$85$YR$$F$Y$$$20240726$$HP$CA$CA
241416771$24141677$1$I$20240401$20240722$20240726$20240726$PER$$US-BAYER-2024A106562$BAYER$$$$$F$Y$$$20240726$$CN$US$US
241416781$24141678$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216700$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240726$$CN$US$US
241416791$24141679$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215673$SANOFI AVENTIS$$$$E$M$Y$92$KG$20240726$$MD$US$US
241416801$24141680$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA216863$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240726$$CN$US$US
241416811$24141681$1$I$20240701$20240718$20240726$20240726$PER$$US-SA-2024SA216767$SANOFI AVENTIS$$62$YR$A$F$Y$62.14$KG$20240726$$MD$US$US
241416821$24141682$1$I$20240101$20240722$20240726$20240726$PER$$US-ABBVIE-5852325$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241416831$24141683$1$I$$20240723$20240726$20240726$EXP$$GR-INCYTE CORPORATION-2024IN007725$INCYTE$$$$$$Y$$$20240726$$MD$GR$GR
241416841$24141684$1$I$$20240725$20240726$20240726$PER$$US-TAKEDA-2024TUS075438$TAKEDA$$$$$$Y$$$20240726$$CN$US$US
241416851$24141685$1$I$$20240723$20240726$20240726$EXP$$US-AstraZeneca-2024A168636$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241416861$24141686$1$I$20240512$20240719$20240726$20240726$EXP$$FR-AstraZeneca-2024A170095$ASTRAZENECA$$18$YR$$F$Y$59.5$KG$20240726$$MD$FR$
241416871$24141687$1$I$20180401$20240720$20240726$20240726$EXP$$CN-AstraZeneca-2024A167428$ASTRAZENECA$Li J, Jin M, Diao Y, Li X. Dacomitinib overcomes acquired resistance to osimertinib in advanced NSCLC patients with EGFR L718Q mutation: A two-case report. Medicine 2024;103(28):e38789.$77$YR$$F$Y$$$20240726$$HP$CN$
241416881$24141688$1$I$$20240719$20240726$20240726$PER$$US-TAKEDA-2024TUS073550$TAKEDA$$$$$F$Y$77$KG$20240726$$MD$US$US
241416891$24141689$1$I$$20240723$20240726$20240726$EXP$$US-AstraZeneca-2024A167818$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241416901$24141690$1$I$$20240722$20240726$20240726$EXP$$JP-PFIZER INC-202400222753$PFIZER$Saito, K.. Real-world comparative study of drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis. PLOS ONE. 2024;19(7):10.1371/journal.pone.0306714$$$E$$Y$$$20240726$$HP$JP$JP
241416911$24141691$1$I$$20240722$20240726$20240726$EXP$$JP-PFIZER INC-202400222747$PFIZER$Saito, K.. Real-world comparative study of drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis. PLoS ONE. 2024;19(7):10.1371/journal.pone.0306714$$$E$$Y$$$20240726$$HP$JP$JP
241416921$24141692$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3223068$TEVA$$48$YR$$F$Y$68$KG$20240726$$HP$CA$CA
241416931$24141693$1$I$$20240722$20240726$20240726$EXP$$JP-PFIZER INC-202400222746$PFIZER$Saito, K.. Real-world comparative study of drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis. PLOS ONE. 2024;19(7):10.1371/journal.pone.0306714$$$E$$Y$$$20240726$$HP$JP$JP
241416941$24141694$1$I$$20240722$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117998$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240726$$MD$US$US
241416951$24141695$1$I$20240724$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119051$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240726$$CN$US$US
241416961$24141696$1$I$$20240717$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114281$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240726$$HP$US$US
241416972$24141697$2$F$$20240819$20240726$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118716$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$56.25$KG$20240822$$CN$US$US
241416991$24141699$1$I$20240615$20240722$20240726$20240726$PER$$US-BAYER-2024A106689$BAYER$$50$YR$A$F$Y$$$20240726$$CN$US$US
241417001$24141700$1$I$20240724$20240725$20240726$20240726$PER$$US-ROCHE-10000037668$ROCHE$$92$YR$E$M$Y$77.11$KG$20240726$$CN$US$US
241417011$24141701$1$I$20240717$20240722$20240726$20240726$EXP$$JP-AMGEN-JPNSP2024144970$AMGEN$$79$YR$E$M$Y$$$20240726$$MD$JP$JP
241417021$24141702$1$I$20240101$20240719$20240726$20240726$EXP$$US-AMGEN-USASP2024145256$AMGEN$$83$YR$E$F$Y$$$20240726$$CN$US$US
241417031$24141703$1$I$20240611$20240718$20240726$20240726$EXP$$FR-AUROBINDO-AUR-APL-2024-036525$AUROBINDO$$36$YR$$F$Y$$$20240726$$CN$FR$FR
241417041$24141704$1$I$20240601$20240717$20240726$20240726$PER$$US-SA-2024SA217614$SANOFI AVENTIS$$19$YR$A$F$Y$79$KG$20240726$$MD$US$US
241417052$24141705$2$F$$20240927$20240726$20240930$EXP$$NVSC2024US134927$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
241417065$24141706$5$F$20240723$20240909$20240726$20240912$EXP$$US-INCYTE CORPORATION-2024IN007659$INCYTE$$$$$$Y$$$20240912$$CN$US$US
241417071$24141707$1$I$$20240719$20240726$20240726$PER$$US-ALXN-202407USA001544US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241417081$24141708$1$I$$20240716$20240726$20240726$EXP$$TH-ROCHE-10000032469$ROCHE$$67$YR$E$M$Y$$$20240726$$HP$TH$TH
241417091$24141709$1$I$20240705$20240711$20240726$20240726$PER$$US-COSETTE-CP2024US000177$COSETTE PHARMACEUTICALS$$$$$F$Y$130$KG$20240726$$CN$US$US
241417102$24141710$2$F$20221003$20240723$20240726$20240802$EXP$$HU-MYLANLABS-2024M1068894$MYLAN$$46$YR$$F$Y$$$20240802$$HP$HU$HU
241417111$24141711$1$I$$20240723$20240726$20240726$EXP$$GB-MYLANLABS-2024M1069022$MYLAN$$33$YR$$M$Y$$$20240726$$PH$GB$GB
241417121$24141712$1$I$$20240719$20240726$20240726$EXP$$MX-AMGEN-MEXSP2024145717$AMGEN$$$$$F$Y$$$20240726$$MD$MX$MX
241417131$24141713$1$I$20240705$20240722$20240726$20240726$EXP$PL-URPL-DML-MLP.4401.1.156.2024$PL-TAKEDA-2024TUS074056$TAKEDA$$50$YR$$F$Y$58$KG$20240726$$HP$PL$PL
241417141$24141714$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-PV202400097294$PFIZER$$80$YR$$F$Y$81.64$KG$20240726$$MD$US$US
241417152$24141715$2$F$$20240801$20240726$20240801$PER$$US-PFIZER INC-202400222495$PFIZER$$$$$M$Y$$$20240801$$PH$US$US
241417161$24141716$1$I$$20240723$20240726$20240726$PER$$US-PFIZER INC-PV202400096486$PFIZER$$68$YR$$F$Y$$$20240726$$CN$US$US
241417171$24141717$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400222940$PFIZER$$$$T$M$Y$$$20240726$$HP$US$US
241417181$24141718$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400224016$PFIZER$$$$$$Y$$$20240726$$MD$US$US
241417192$24141719$2$F$$20240730$20240726$20240801$PER$US-PFIZERINC-GRACE01254498$US-PFIZER INC-202400222076$PFIZER$$79$YR$$F$Y$$$20240801$$CN$US$US
241417202$24141720$2$F$20240718$20240812$20240726$20240814$PER$$US-PFIZER INC-202400223909$PFIZER$$68$YR$$F$Y$$$20240814$$HP$US$US
241417211$24141721$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400220510$PFIZER$$67$YR$$F$Y$$$20240726$$CN$US$US
241417222$24141722$2$F$$20240825$20240726$20240826$PER$$US-PFIZER INC-PV202400096677$PFIZER$$65$YR$$F$Y$$$20240826$$MD$US$US
241417231$24141723$1$I$$20240723$20240726$20240726$PER$$US-PFIZER INC-202400222354$PFIZER$$49$YR$$F$Y$$$20240726$$HP$US$US
241417241$24141724$1$I$$20240725$20240726$20240726$PER$$US-PFIZER INC-202400223854$PFIZER$$53$YR$$F$Y$$$20240726$$CN$US$US
241417251$24141725$1$I$20240715$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118378$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240726$$CN$US$US
241417261$24141726$1$I$20240601$20240725$20240726$20240726$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-118659$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$58.06$KG$20240726$$CN$PR$PR
241417271$24141727$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118991$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$HP$US$US
241417281$24141728$1$I$$20240717$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001461$BLUEPRINT MEDICINES$$$$$M$Y$$$20240726$$CN$US$US
241417291$24141729$1$I$20240101$20240712$20240726$20240726$PER$$US-COSETTE-CP2024US000179$COSETTE PHARMACEUTICALS$$41$YR$A$F$Y$$$20240726$$CN$US$US
241417301$24141730$1$I$20240616$20240723$20240726$20240726$PER$$US-Eisai-EC-2024-170879$EISAI$$63$YR$A$M$Y$$$20240726$$CN$US$US
241417312$24141731$2$F$$20240905$20240726$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090171$VIIV$$$$$$Y$$$20240913$$PH$US$US
241417321$24141732$1$I$$20240722$20240726$20240726$EXP$$US-BAYER-2024A106439$BAYER$$$$$$Y$$$20240726$$CN$US$US
241417332$24141733$2$F$$20240904$20240726$20240912$PER$$US-TAKEDA-2024TUS074188$TAKEDA$$$$$F$Y$$$20240912$$CN$US$US
241417341$24141734$1$I$$20240724$20240726$20240726$PER$$US-HALEON-2188957$Haleon PLC$$98$YR$$F$Y$$$20240726$$CN$US$US
241417351$24141735$1$I$$20240722$20240726$20240726$EXP$$BY-MYLANLABS-2024M1068972$MYLAN$Yatskevich N. V.. Preliminary Assessment of Safety of Six Month BPaLM/C Regimens in Patients with Rifampicin-Resistant Tuberculosis in the Republic of Belarus. Clinical infectology and parasitology. 2024;13:2$69$YR$$$Y$$$20240726$$HP$BY$BY
241417361$24141736$1$I$20240724$20240726$20240726$20240726$DIR$711596$$FDA-CTU$$62$YR$$F$N$64.35$KG$20240726$N$CN$US$
241417371$24141737$1$I$20230824$20240726$20240726$20240726$DIR$711595$$FDA-CTU$$46$YR$$UNK$N$76.5$KG$20240726$N$CN$US$
241417381$24141738$1$I$20240709$20240726$20240726$20240726$DIR$711612$$FDA-CTU$$30$YR$$F$N$60.75$KG$20240726$N$CN$US$
241417391$24141739$1$I$$20240722$20240726$20240726$DIR$FDA-CDER-CTU-2024-51509$$FDA-CTU$$$$$M$N$$$20240722$N$HP$US$
241417401$24141740$1$I$20240721$20240725$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118512$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240726$$CN$US$US
241417411$24141741$1$I$20240201$20240725$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118562$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240726$$HP$US$US
241417421$24141742$1$I$20240611$20240723$20240726$20240726$EXP$$CA-LUNDBECK-DKLU4002107$LUNDBECK$$$$$$Y$$$20240726$$HP$CA$CA
241417431$24141743$1$I$$20240717$20240726$20240726$EXP$$US-INDIVIOR UK LIMITED-INDV-146067-2024$RECKITT BENCKISER$Lucas Belmore, Timothy Ahn, Eric Nguyen, Timothy Lenz. Acute non-ST segment elevation myocardial infarction following intravenous injection of sublingual Suboxone. Prehospital emergency care. 2024$41$YR$$M$Y$$$20240726$$MD$US$US
241417441$24141744$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222418$TEVA$$70$YR$$F$Y$$$20240726$$CN$CA$CA
241417451$24141745$1$I$$20240714$20240726$20240726$EXP$$TR-Aprecia Pharmaceuticals-APRE20241041$APRECIA PHARMACEUTICALS$Demiral G, Akin S, Gunday O, Sahbaz F, Boru U. Maternal and fetal outcomes of antiepileptic treatments during pregnancy: a retrospective study. Epilepsy + Behavior. 2024;158:1-7. doi:10.1016/j.yebeh.2024.109937$$$$$Y$$$20240726$$HP$TR$TR
241417461$24141746$1$I$$20240717$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001468$BLUEPRINT MEDICINES$$$$$M$Y$$$20240726$$CN$US$US
241417471$24141747$1$I$$20240719$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001481$BLUEPRINT MEDICINES$$$$$F$Y$$$20240726$$CN$US$US
241417481$24141748$1$I$20240510$20240719$20240726$20240726$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14581$IPSEN$$39$YR$A$F$Y$54$KG$20240726$$HP$US$US
241417491$24141749$1$I$20230101$20240719$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001491$BLUEPRINT MEDICINES$$69$YR$E$F$Y$$$20240726$$CN$US$US
241417501$24141750$1$I$20201207$20240718$20240726$20240726$EXP$$CA-TAKEDA-2020TUS057009$TAKEDA$$36$YR$$F$Y$$$20240726$$HP$CA$CA
241417511$24141751$1$I$$20240716$20240726$20240726$30DAY$$US-GSK-US2024AMR091317$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241417522$24141752$2$F$$20240812$20240726$20240819$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001471$BLUEPRINT MEDICINES$$$$$F$Y$$$20240819$$CN$US$US
241417551$24141755$1$I$20240722$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51444$$FDA-CTU$$57$YR$$F$N$149.7$KG$20240725$N$$US$
241417561$24141756$1$I$$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51467$$FDA-CTU$$$$$F$N$$$20240725$N$HP$US$
241417571$24141757$1$I$$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51471$$FDA-CTU$$$$$F$N$$$20240725$N$HP$US$
241417581$24141758$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51486$$FDA-CTU$$46$YR$$M$N$$$20240726$N$$US$
241417601$24141760$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51517$$FDA-CTU$$$$$M$N$$$20240726$N$HP$US$
241417611$24141761$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51503$$FDA-CTU$$52$YR$$F$N$99.79$KG$20240726$N$$US$
241417621$24141762$1$I$20230718$20240719$20240726$20240726$EXP$$IE-TAKEDA-2023TUS079575$TAKEDA$$78$YR$$F$Y$$$20240726$$MD$IE$IE
241417631$24141763$1$I$20240101$20240722$20240726$20240726$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14599$IPSEN$$47$YR$A$F$Y$$$20240726$$HP$US$US
241417642$24141764$2$F$$20240814$20240726$20240829$PER$$US-LEADINGPHARMA-US-2024LEASPO00321$LEADING PHARMA$$$$$$Y$$$20240829$$PH$US$US
241417651$24141765$1$I$$20240717$20240726$20240726$EXP$NO-NOMAADVRE-PASRAPP-2024-Vewnkk$NO-TEVA-VS-3222671$TEVA$$$$$$Y$$$20240726$$CN$NO$NO
241417671$24141767$1$I$$20240724$20240726$20240726$EXP$$US-BAYER-2024A043226$BAYER$$54$YR$A$F$Y$$$20240726$$CN$US$US
241417681$24141768$1$I$$20240723$20240726$20240726$EXP$$GR-PFIZER INC-2024SGN00648$PFIZER$$$$$F$Y$$$20240726$$MD$GR$GR
241417691$24141769$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119089$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240726$$CN$US$US
241417703$24141770$3$F$20240101$20240826$20240726$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022471$UNITED THERAPEUTICS$$$$$F$Y$87.528$KG$20240904$$$US$US
241417711$24141771$1$I$20240724$20240725$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119016$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240726$$CN$US$US
241417721$24141772$1$I$$20240716$20240726$20240726$EXP$$CA-APOTEX-2024AP008508$APOTEX$$61$YR$$M$Y$$$20240726$$HP$CA$CA
241417732$24141773$2$F$$20240722$20240726$20240726$EXP$$US-AMGEN-USASP2024146946$AMGEN$$$$A$$Y$$$20240726$$PH$US$US
241417741$24141774$1$I$20240723$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024147734$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241417751$24141775$1$I$20240607$20240719$20240726$20240726$EXP$FR-AFSSAPS-LL2024001322$FR-AMGEN-FRASP2024144167$AMGEN$$71$YR$E$F$Y$60$KG$20240726$$PH$FR$FR
241417761$24141776$1$I$20240101$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024147185$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241417771$24141777$1$I$20240701$20240717$20240726$20240726$PER$$US-AMGEN-USASP2024142526$AMGEN$$$$$$Y$$$20240726$$HP$US$US
241417781$24141778$1$I$20240714$20240719$20240726$20240726$EXP$CN-NMPACDR-3708281020400202400548$CN-BAXTER-2024BAX022105$BAXTER$$55$YR$$F$Y$64$KG$20240726$$MD$CN$CN
241417791$24141779$1$I$$20240719$20240726$20240726$EXP$$FR-BAXTER-2024BAX022053$BAXTER$$$$$$Y$$$20240726$$CN$FR$FR
241417803$24141780$3$F$20210916$20240801$20240726$20240816$EXP$$JP-Merz Pharmaceuticals GmbH-23-02879$MERZ$$68$YR$$F$Y$$$20240816$$MD$JP$JP
241417811$24141781$1$I$20240601$20240717$20240726$20240726$EXP$FR-AFSSAPS-AVNT2024000506$FR-TEVA-VS-3223310$TEVA$$44$YR$$F$Y$$$20240726$$PH$FR$FR
241417821$24141782$1$I$20230405$20240716$20240726$20240726$EXP$$US-JNJFOC-20240755842$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$HP$US$US
241417831$24141783$1$I$$20240714$20240726$20240726$EXP$$TR-Aprecia Pharmaceuticals-APRE20241042$APRECIA PHARMACEUTICALS$Demiral G, Akin S, Gunday O, Sahbaz F, Boru U. Maternal and fetal outcomes of antiepileptic treatments during pregnancy: a retrospective study. Epilepsy + Behavior. 2024;158:1-7. doi:10.1016/j.yebeh.2024.109937$$$$$Y$$$20240726$$HP$TR$TR
241417841$24141784$1$I$$20240716$20240726$20240726$30DAY$$US-GSK-US2024089406$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$MD$US$US
241417851$24141785$1$I$$20240719$20240726$20240726$EXP$$US-GSK-US2024091239$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241417881$24141788$1$I$20240722$20240724$20240726$20240726$EXP$$US-BAYER-2024A107930$BAYER$$36$YR$A$M$Y$$$20240726$$CN$US$US
241417891$24141789$1$I$20240715$20240716$20240726$20240726$EXP$$GR-ELI_LILLY_AND_COMPANY-GR202407012027$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240726$$CN$GR$GR
241417901$24141790$1$I$$20240717$20240726$20240726$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407012676$ELI LILLY AND CO$$$$A$F$Y$$$20240726$$CN$GB$GB
241417911$24141791$1$I$$20240715$20240726$20240726$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07237$LUPIN$$$$$$Y$$$20240726$$CN$AU$AU
241417921$24141792$1$I$$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51480$$FDA-CTU$$$$$F$N$$$20240725$N$HP$US$
241417932$24141793$2$F$$20240901$20240726$20240904$EXP$$GR-PFIZER INC-2024SGN04265$PFIZER$$$$$F$Y$$$20240904$$MD$GR$GR
241417941$24141794$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51489$$FDA-CTU$$64$YR$$F$N$$$20240726$N$$US$
241417951$24141795$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118790$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$97.07$KG$20240726$$CN$US$US
241417961$24141796$1$I$$20240718$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116017$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240726$$HP$US$US
241417981$24141798$1$I$$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51465$$FDA-CTU$$$$$M$N$$$20240725$N$HP$US$
241417991$24141799$1$I$$20240714$20240726$20240726$EXP$$TR-Aprecia Pharmaceuticals-APRE20241044$APRECIA PHARMACEUTICALS$Demiral G, Akin S, Gunday O, Sahbaz F, Boru U. Maternal and fetal outcomes of antiepileptic treatments during pregnancy: a retrospective study. Epilepsy + Behavior. 2024;158:1-7. doi:10.1016/j.yebeh.2024.109937$$$I$$Y$$$20240726$$HP$TR$TR
241418001$24141800$1$I$$20240714$20240726$20240726$EXP$$TR-Aprecia Pharmaceuticals-APRE20241043$APRECIA PHARMACEUTICALS$Demiral G, Akin S, Gunday O, Sahbaz F, Boru U. Maternal and fetal outcomes of antiepileptic treatments during pregnancy: a retrospective study. Epilepsy + Behavior. 2024;158:1-7. doi:10.1016/j.yebeh.2024.109937$$$$$Y$$$20240726$$HP$TR$TR
241418012$24141801$2$F$20240722$20240822$20240726$20240824$PER$$US-JNJFOC-20240758004$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240824$$PH$US$US
241418021$24141802$1$I$20240215$20240716$20240726$20240726$EXP$FR-AFSSAPS-LY2024000867$FR-ROCHE-10000030214$ROCHE$$67$YR$E$F$Y$50$KG$20240726$$PH$FR$FR
241418031$24141803$1$I$$20240718$20240726$20240726$EXP$$GB-JNJFOC-20240767148$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240726$$HP$GB$GB
241418041$24141804$1$I$$20240718$20240726$20240726$EXP$$GB-JNJFOC-20240767289$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240726$$HP$GB$GB
241418051$24141805$1$I$20240717$20240718$20240726$20240726$EXP$$IL-TAKEDA-2024TUS074319$TAKEDA$$$$$M$Y$$$20240726$$CN$IL$IL
241418061$24141806$1$I$20240705$20240724$20240726$20240726$EXP$FR-AFSSAPS-PB2024000801$FR-ORGANON-O2407FRA002412$ORGANON$$60$YR$$F$Y$72$KG$20240726$$MD$FR$FR
241418071$24141807$1$I$$20230301$20240726$20240726$EXP$$US-Appco Pharma LLC-2159651$APPCO PHARMA$INITIAL$27$YR$$F$Y$$$20240726$$$US$US
241418081$24141808$1$I$$20240715$20240726$20240726$EXP$$AU-Nova Laboratories Limited-2159653$NOVA LABORATORIES$$23$YR$$F$Y$$$20240726$$$AU$AU
241418091$24141809$1$I$$20240716$20240726$20240726$30DAY$$US-GSK-US2024089555$GLAXOSMITHKLINE$$$$$M$Y$$$20240726$$CN$US$US
241418101$24141810$1$I$$20240724$20240726$20240726$EXP$$US-ACIC Fine Chemicals Inc-2159662$ACIC FINE CHEMICALS$$$$$M$Y$$$20240726$$$US$US
241418111$24141811$1$I$$20240715$20240726$20240726$EXP$$GB-B.Braun Medical Inc.-2159650$B BRAUN$$64$YR$$M$Y$89$KG$20240726$$$GB$GB
241418121$24141812$1$I$$20230301$20240726$20240726$EXP$$IT-Appco Pharma LLC-2159657$APPCO PHARMA$Initial$57$YR$$F$Y$$$20240726$$$IT$IT
241418131$24141813$1$I$$20240724$20240726$20240726$PER$$US-ACIC Fine Chemicals Inc-2159661$ACIC FINE CHEMICALS$$$$$F$Y$$$20240726$$$US$US
241418141$24141814$1$I$$20240229$20240726$20240726$EXP$$US-SERB S.A.S.-2159652$LABORATOIRES SERB$Case for Vistogard in article$60$YR$$F$Y$$$20240726$$MD$US$US
241418151$24141815$1$I$20231201$20240715$20240726$20240726$EXP$$AU-Nova Laboratories Limited-2159656$NOVA LABORATORIES$$30$YR$$F$Y$$$20240726$$$AU$AU
241418161$24141816$1$I$$20240711$20240726$20240726$EXP$$US-Nuvo Pharmaceuticals Inc-2159660$NUVO PHARMACEUTICALS$Source document (Abstract)$67$YR$$M$Y$$$20240726$$$US$US
241418171$24141817$1$I$$20240715$20240726$20240726$EXP$$AU-Nova Laboratories Limited-2159655$NOVA LABORATORIES$$23$YR$$F$Y$$$20240726$$$AU$AU
241418181$24141818$1$I$$20240715$20240726$20240726$EXP$$AU-Nova Laboratories Limited-2159654$NOVA LABORATORIES$$56$YR$$F$Y$$$20240726$$$AU$AU
241418191$24141819$1$I$$20240716$20240726$20240726$EXP$$ZA-ROCHE-10000031668$ROCHE$$79$YR$E$M$Y$$$20240726$$MD$ZA$ZA
241418201$24141820$1$I$$20240710$20240726$20240726$PER$$US-HALEON-2188964$Haleon PLC$Didomenico L, Garrity LC, Poisson KE, Broomall E. Enteral Ketamine for Status Epilepticus in Children with Epilepsy. Pediatric Neurology. 2024 158 (41-48): DOI:10.1016/j.pediatrneurol.2024.05.006)$20$YR$$M$Y$$$20240726$$HP$US$US
241418211$24141821$1$I$20240227$20240720$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007666$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241418221$24141822$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51464$$FDA-CTU$$77$YR$$F$N$$$20240726$N$$US$
241418231$24141823$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51485$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241418241$24141824$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51490$$FDA-CTU$$66$YR$$M$N$$$20240726$N$$US$
241418251$24141825$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51500$$FDA-CTU$$45$YR$$F$N$$$20240726$N$$US$
241418261$24141826$1$I$20240717$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51478$$FDA-CTU$$67$YR$$F$N$$$20240726$N$HP$US$
241418271$24141827$1$I$20240601$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51463$$FDA-CTU$$42$YR$$F$N$$$20240725$N$HP$US$
241418281$24141828$1$I$$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51518$$FDA-CTU$$$$$F$N$$$20240725$N$HP$US$
241418291$24141829$1$I$$20240718$20240726$20240726$EXP$NL-LRB-00985481$NL-TEVA-VS-3223755$TEVA$$67$YR$$F$Y$98$KG$20240726$$CN$NL$NL
241418301$24141830$1$I$$20240723$20240726$20240726$EXP$$US-AstraZeneca-2024A168332$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241418311$24141831$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222901$TEVA$$3$YR$$M$Y$$$20240726$$HP$CA$CA
241418321$24141832$1$I$20240604$20240723$20240726$20240726$EXP$$FI-AstraZeneca-2024A167075$ASTRAZENECA$$71$YR$$F$Y$$$20240726$$MD$FI$
241418331$24141833$1$I$20180201$20240724$20240726$20240726$EXP$$DZ-PFIZER INC-202400223779$PFIZER$$$$$F$Y$$$20240726$$MD$DZ$DZ
241418343$24141834$3$F$20240801$20240812$20240726$20240814$EXP$$CA-PFIZER INC-202400222856$PFIZER$$15$YR$$F$Y$50$KG$20240814$$HP$CA$CA
241418352$24141835$2$F$20240701$20240731$20240726$20240805$EXP$$CN-PFIZER INC-PV202400096333$PFIZER$$61$YR$$M$Y$71$KG$20240805$$HP$CN$CN
241418371$24141837$1$I$20240401$20240724$20240726$20240726$EXP$$US-PFIZER INC-202400223866$PFIZER$$51$YR$$M$Y$$$20240726$$HP$US$US
241418381$24141838$1$I$$20240724$20240726$20240726$EXP$$IN-PFIZER INC-PV202400097223$PFIZER$$71$YR$$F$Y$$$20240726$$CN$IN$IN
241418391$24141839$1$I$20240612$20240723$20240726$20240726$EXP$ES-AEMPS-1551741$ES-PFIZER INC-202400221595$PFIZER$$35$YR$$M$Y$$$20240726$$PH$ES$ES
241418401$24141840$1$I$20240713$20240718$20240726$20240726$PER$$BR-BRACCO-2024BR04446$BRACCO$$29$YR$$F$Y$$$20240726$$HP$BR$BR
241418412$24141841$2$F$$20240729$20240726$20240808$EXP$$IN-TEVA-VS-3220695$TEVA$Babu BS, Fernandes CZ, Bhat B. Acitretin induced primary hypothyroidism in Darier^s disease: A rare case report. Indian-J-Pharmacol 2024; 56 (3): 220-223.; Babu BS, Fernandes CZ, Bhat B. Acitretin induced primary hypothyroidism in Darier^s disease: A rare case report. Indian Journal of Pharmacology. 2024;56(3):220-3.; Babu BS, Fernandes CZ, Bhat B. Acitretin induced primary hypothyroidism in Darier^s disease: A rare case report. Indian Journal of Pharmacology. 2024;56(3):220-3.$41$YR$$M$Y$$$20240808$$HP$IN$IN
241418422$24141842$2$F$$20240918$20240726$20240923$EXP$$GB-AMGEN-GBRSP2024147469$AMGEN$$55$YR$A$F$Y$$$20240922$$CN$GB$GB
241418436$24141843$6$F$20240517$20240912$20240726$20240920$EXP$$ZA-CELLTRION INC.-2024ZA016877$CELLTRION$$$$$$Y$$$20240920$$CN$ZA$ZA
241418441$24141844$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51520$$FDA-CTU$$61$YR$$M$N$$$20240726$N$$US$
241418451$24141845$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51488$$FDA-CTU$$64$YR$$F$N$$$20240726$N$$US$
241418461$24141846$1$I$20210505$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51469$$FDA-CTU$$83$YR$$M$N$$$20240725$N$$CA$
241418471$24141847$1$I$$20240722$20240726$20240726$EXP$$JP-AMGEN-JPNSP2024145134$AMGEN$$82$YR$E$F$Y$$$20240726$$PH$JP$JP
241418481$24141848$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51522$$FDA-CTU$$66$YR$$F$N$65.32$KG$20240726$N$$US$
241418521$24141852$1$I$20240722$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146432$AMGEN$$95$YR$E$F$Y$$$20240726$$CN$US$US
241418531$24141853$1$I$20231227$20240723$20240726$20240726$EXP$$ES-PFIZER INC-202400221574$PFIZER$$65$YR$$M$Y$67.2$KG$20240726$$HP$ES$ES
241418541$24141854$1$I$20240101$20240722$20240726$20240726$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14603$IPSEN$$55$YR$A$F$Y$$$20240726$$HP$US$US
241418551$24141855$1$I$20240101$20240719$20240726$20240726$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14676$IPSEN$$35$YR$A$F$Y$$$20240726$$HP$US$US
241418571$24141857$1$I$20240101$20240712$20240726$20240726$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01208$AVADEL CNS PHARMA$$$$$F$Y$$$20240726$$CN$US$US
241418582$24141858$2$F$$20240829$20240726$20240904$EXP$$US-TAKEDA-2024TUS073401$TAKEDA$$$$$F$Y$65$KG$20240904$$MD$US$US
241418591$24141859$1$I$$20240719$20240726$20240726$EXP$$CN-TAKEDA-2024TUS073564$TAKEDA$$$$$M$Y$$$20240726$$CN$CN$CN
241418601$24141860$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153178$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
241418612$24141861$2$F$20231201$20240716$20240726$20240726$EXP$$US-ROCHE-10000029980$ROCHE$$64$YR$A$F$Y$94.8$KG$20240726$$CN$US$US
241418621$24141862$1$I$$20240718$20240726$20240726$EXP$$FI-AMGEN-FINSP2024144311$AMGEN$$$$$$Y$$$20240726$$MD$FI$FI
241418631$24141863$1$I$$20240715$20240726$20240726$EXP$$LB-B.Braun Medical Inc.-2159663$B BRAUN$Literature Article$82$YR$$F$Y$$$20240726$$$LB$LB
241418641$24141864$1$I$20240711$20240719$20240726$20240726$EXP$$US-AMGEN-USASP2024146954$AMGEN$$71$YR$E$M$Y$$$20240726$$HP$US$US
241418652$24141865$2$F$20220711$20240911$20240726$20240919$EXP$$CA-SAMSUNG BIOEPIS-SB-2022-17386$SAMSUNG BIOEPIS$$75$YR$E$F$Y$$$20240919$$HP$CA$CA
241418661$24141866$1$I$$20240719$20240726$20240726$PER$$US-AMGEN-USASP2024144927$AMGEN$$$$$$Y$$$20240726$$MD$US$US
241418671$24141867$1$I$$20240716$20240726$20240726$EXP$$JP-ROCHE-10000033477$ROCHE$Yamane S, Sumikawa T, Matsushita M, Ueda Y, Hasegawa Y, Sugimoto Y. KT-14 A case of COVID-19 complicated with endocarditis infective. The 70th Chugoku-Shikoku Regional Meeting of the Japanese Respiratory Society. 2024;80.$51$YR$A$F$Y$$$20240726$$MD$JP$JP
241418681$24141868$1$I$$20240715$20240726$20240726$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07115$LUPIN$$$$$$Y$$$20240726$$CN$AU$AU
241418691$24141869$1$I$20240719$20240722$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117026$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240726$$PH$US$US
241418701$24141870$1$I$$20240724$20240726$20240726$EXP$$US-PFIZER INC-PV202400097102$PFIZER$$$$$F$Y$$$20240726$$CN$US$US
241418711$24141871$1$I$20240723$20240725$20240726$20240726$EXP$$CN-PFIZER INC-PV202400097546$PFIZER$$60$YR$$M$Y$65$KG$20240726$$HP$CN$CN
241418721$24141872$1$I$20240314$20240725$20240726$20240726$EXP$CH-SM-2024-13908$CH-PFIZER INC-202400223680$PFIZER$$88$YR$$M$Y$$$20240726$$PH$CH$CH
241418731$24141873$1$I$20240101$20240724$20240726$20240726$EXP$$IN-PFIZER INC-PV202400070293$PFIZER$$55$YR$$M$Y$$$20240726$$CN$IN$IN
241418742$24141874$2$F$$20240829$20240726$20240902$EXP$$CA-PFIZER INC-202400223923$PFIZER$$$$$$Y$$$20240902$$CN$CA$CA
241418752$24141875$2$F$$20240807$20240726$20240814$EXP$$FR-ROCHE-10000031486$ROCHE$$75$YR$E$F$Y$$$20240814$$MD$FR$FR
241418761$24141876$1$I$$20240422$20240726$20240726$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000055$LANNETT$$$$$$Y$$$20240726$$CN$US$US
241418771$24141877$1$I$$20240725$20240726$20240726$EXP$$CA-PFIZER INC-202400223885$PFIZER$$59$YR$$M$Y$70$KG$20240726$$HP$CA$CA
241418781$24141878$1$I$$20240624$20240726$20240726$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000160$LANNETT$$$$$$Y$$$20240726$$CN$US$US
241418791$24141879$1$I$20240101$20240523$20240726$20240726$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000126$LANNETT$$$$$$Y$$$20240726$$CN$US$US
241418801$24141880$1$I$20240421$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459255$RANBAXY$$$$E$M$Y$$$20240726$$PH$FR$FR
241418811$24141881$1$I$20240210$20240713$20240726$20240726$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459030$RANBAXY$$33$YR$$M$Y$80$KG$20240726$$CN$GB$GB
241418821$24141882$1$I$20221214$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459256$RANBAXY$$58$YR$$F$Y$66$KG$20240726$$MD$FR$FR
241418831$24141883$1$I$20230809$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459265$RANBAXY$$39$YR$$M$Y$56$KG$20240726$$MD$FR$FR
241418841$24141884$1$I$20230613$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459402$RANBAXY$$$$$F$Y$1.038$KG$20240726$$MD$FR$FR
241418851$24141885$1$I$20220101$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459210$RANBAXY$$61$YR$$M$Y$$$20240726$$MD$FR$FR
241418861$24141886$1$I$20230101$20240712$20240726$20240726$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459266$RANBAXY$$76$YR$$F$Y$44$KG$20240726$$MD$FR$FR
241418871$24141887$1$I$20231104$20240712$20240726$20240726$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459275$RANBAXY$$59$YR$$F$Y$$$20240726$$MD$SE$SE
241418881$24141888$1$I$$20240712$20240726$20240726$EXP$$JM-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459360$RANBAXY$Gibson S, Hunter T, Johnson N. Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy. Am J Trop Med Hyg. 2024;110(6):1198-1200$23$YR$$F$Y$$$20240726$$HP$JM$JM
241418891$24141889$1$I$$20240712$20240726$20240726$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452250$RANBAXY$Zhu X, Chen G, Yao M, Shi G, Zhou X, Zhang W, et al. Efficacy analysis of anti-platelet in the treatment of high-risk non-disabling ischemic cerebrovascular events guided by point-of-care testing of CYP2C19 gene. Chin J Neurol. 2023;Apr; 56 (4):365-373$$$$$Y$$$20240726$$HP$CN$CN
241418901$24141890$1$I$$20240724$20240726$20240726$EXP$$CZ-ORGANON-O2407CZE001188$ORGANON$Ruzickova O. Complicated osteoporosis-a case report. FARMAKOTERAPEUTICKA REVUE. 2024;9(3):233-7$51$YR$$F$Y$$$20240726$$MD$CZ$CZ
241418911$24141891$1$I$$20240712$20240726$20240726$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459181$RANBAXY$Ono M, Okabe T, Isomura N, Ochiai M. Successful treatment of vasospastic angina refractory to various therapies using stenting: A case report. J Cardiol Cases. 2024;1-4$47$YR$$F$Y$$$20240726$$MD$JP$JP
241418931$24141893$1$I$$20240712$20240726$20240726$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459017$RANBAXY$Kobayashi Y, Iijima K, Kondo Y, Yamamoto K, Sekijima Y. Chronic polyradiculoneuropathy associated with pembrolizumab for bladder cancer. Acta Neurologica Belgica. 2024;124:1063-1065$73$YR$$M$Y$$$20240726$$HP$JP$JP
241418951$24141895$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA216806$SANOFI AVENTIS$$$$A$M$Y$72.5$KG$20240726$$MD$US$US
241418961$24141896$1$I$20240101$20240701$20240726$20240726$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000141$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$US$US
241418971$24141897$1$I$20240610$20240717$20240726$20240726$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00241$AMNEAL$$95$YR$$F$Y$$$20240726$$CN$US$US
241418981$24141898$1$I$$20240723$20240726$20240726$EXP$$JP-GILEAD-2024-0681702$GILEAD$$56$YR$A$M$Y$$$20240726$$MD$JP$JP
241418991$24141899$1$I$20230216$20230310$20240726$20240726$EXP$$CO-BIOVITRUM-2023-CO-007009$BIOVITRUM$$88$DY$$F$Y$3.4$KG$20240726$$CN$CO$CO
241419001$24141900$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118918$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240726$$CN$US$US
241419011$24141901$1$I$20140101$20240722$20240726$20240726$EXP$$US-ABBVIE-5850626$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241419031$24141903$1$I$$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51466$$FDA-CTU$$$$$F$N$$$20240725$N$HP$US$
241419041$24141904$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51523$$FDA-CTU$$72$YR$$F$N$$$20240726$N$$US$
241419051$24141905$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222839$TEVA$$43$YR$$F$Y$$$20240726$$MD$CA$CA
241419061$24141906$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51510$$FDA-CTU$$83$YR$$F$N$$$20240726$N$$US$
241419071$24141907$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51482$$FDA-CTU$$59$YR$$F$N$$$20240726$N$$US$
241419081$24141908$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51495$$FDA-CTU$$61$YR$$M$N$$$20240726$N$$US$
241419091$24141909$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51519$$FDA-CTU$$57$YR$$M$N$$$20240726$N$$US$
241419121$24141912$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51479$$FDA-CTU$$32$YR$$F$N$280$LBS$20240726$N$$US$
241419161$24141916$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51481$$FDA-CTU$$32$YR$$F$N$127.01$KG$20240726$N$$US$
241419171$24141917$1$I$$20240705$20240726$20240726$PER$$US-JNJFOC-20240716062$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$US$US
241419181$24141918$1$I$$20240718$20240726$20240726$EXP$$US-AMGEN-USASP2024145131$AMGEN$Elbanna M.; Eid F.; Zaalouk M. et al.. UNMASKING A CASE OF SITOSTEROLAEMIA: AN APPROACH FOR DIAGNOSIS AND MANAGEMENT. European Journal of Case Reports in Internal Medicine. 2024;11 (7):1-3$57$YR$A$F$Y$$$20240726$$HP$US$US
241419191$24141919$1$I$20240723$20240724$20240726$20240726$EXP$$US-GILEAD-2024-0681894$GILEAD$$25$YR$A$F$Y$$$20240726$$CN$US$US
241419201$24141920$1$I$20240531$20240719$20240726$20240726$PER$$FR-Eisai-EC-2024-170671$EISAI$$70$YR$E$M$Y$85.1$KG$20240726$$MD$FR$FR
241419211$24141921$1$I$$20240718$20240726$20240726$EXP$$CA-TAKEDA-2024TUS026901$TAKEDA$$68$YR$$F$Y$$$20240726$$HP$CA$CA
241419221$24141922$1$I$20230707$20240719$20240726$20240726$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001482$BLUEPRINT MEDICINES$$42$YR$A$F$Y$$$20240726$$CN$US$US
241419231$24141923$1$I$20240701$20240723$20240726$20240726$EXP$$US-ROCHE-10000034439$ROCHE$$69$YR$E$F$Y$$$20240726$$CN$US$US
241419241$24141924$1$I$$20240724$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US068110$SANDOZ$$$$$$Y$$$20240726$$CN$US$US
241419251$24141925$1$I$20240601$20240724$20240726$20240726$EXP$$CA-ABBVIE-5853715$ABBVIE$$74$YR$$M$Y$$$20240726$$HP$CA$CA
241419261$24141926$1$I$$20240715$20240726$20240726$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07280$LUPIN$$$$$$Y$$$20240726$$CN$AU$AU
241419281$24141928$1$I$$20240718$20240726$20240726$EXP$$CA-BAXTER-2024BAX022151$BAXTER$$52$YR$$F$Y$$$20240726$$CN$CA$CA
241419291$24141929$1$I$$20240712$20240726$20240726$EXP$$ES-ASTELLAS-2024US020873$ASTELLAS$$16$YR$$F$Y$52$KG$20240726$$CN$ES$ES
241419301$24141930$1$I$$20240621$20240726$20240726$PER$$US-TEVA-VS-3222263$TEVA$$$$A$F$Y$$$20240726$$CN$US$US
241419311$24141931$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118585$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240726$$CN$US$US
241419321$24141932$1$I$20231204$20240717$20240726$20240726$EXP$ES-AEMPS-1543334$ES-TEVA-VS-3222485$TEVA$$30$YR$$F$Y$$$20240726$$MD$ES$ES
241419342$24141934$2$F$20240701$20240829$20240726$20240904$EXP$$JP-EXELIXIS-CABO-24079859$EXELIXIS$$8$DEC$$F$Y$$$20240904$$MD$JP$JP
241419351$24141935$1$I$$20240724$20240726$20240726$EXP$$US-ROCHE-10000035753$ROCHE$$69$YR$E$F$Y$$$20240726$$CN$US$US
241419361$24141936$1$I$$20240715$20240726$20240726$EXP$$US-ASTELLAS-2024US020407$ASTELLAS$$$$$M$Y$$$20240726$$CN$US$US
241419371$24141937$1$I$$20240725$20240726$20240726$EXP$GB-MHRA-MED-202407251011475310-VZQYH$GB-ORGANON-O2407GBR002440$ORGANON$$$$$M$Y$$$20240726$$CN$GB$GB
241419381$24141938$1$I$20231213$20240717$20240726$20240726$EXP$NO-NOMAADVRE-RELISV-2024-Vzb8g8$NO-ROCHE-10000029271$ROCHE$$43$YR$A$F$Y$$$20240726$$MD$NO$NO
241419391$24141939$1$I$$20240722$20240726$20240726$EXP$$US-ABBVIE-5850761$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241419401$24141940$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA214803$SANOFI AVENTIS$$44$YR$A$F$Y$63.5$KG$20240726$$MD$US$US
241419411$24141941$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA215880$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240726$$MD$US$US
241419422$24141942$2$F$$20240730$20240726$20240807$EXP$$TR-ASTELLAS-2024EU007067$ASTELLAS$$61$YR$$M$Y$$$20240807$$MD$TR$TR
241419431$24141943$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA215126$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240726$$MD$US$US
241419441$24141944$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA215196$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240726$$MD$US$US
241419452$24141945$2$F$$20240725$20240726$20240729$PER$$NVSC2024US153636$NOVARTIS$$$$$$Y$$$20240729$$MD$US$US
241419461$24141946$1$I$20240601$20240718$20240726$20240726$EXP$HR-HALMED-300086105$HR-SA-2024SA213165$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240726$$MD$HR$HR
241419471$24141947$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA216145$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240726$$MD$US$US
241419483$24141948$3$F$20240101$20240918$20240726$20240923$EXP$$US-SA-2024SA216359$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240924$$MD$US$US
241419492$24141949$2$F$$20240805$20240726$20240813$PER$$US-SA-2024SA217200$SANOFI AVENTIS$$$$E$M$Y$89.7$KG$20240814$$MD$US$US
241419501$24141950$1$I$$20240723$20240726$20240726$EXP$$GR-AstraZeneca-2024A168819$ASTRAZENECA$$68$YR$$F$Y$$$20240726$$MD$GR$
241419511$24141951$1$I$$20240718$20240726$20240726$PER$$US-BEH-2024176140$CSL BEHRING$$$$A$M$Y$$$20240726$$CN$US$US
241419521$24141952$1$I$20240601$20240719$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115795$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240726$$HP$US$US
241419531$24141953$1$I$20240601$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118651$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240726$$HP$US$US
241419541$24141954$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118936$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$53.52$KG$20240726$$HP$US$US
241419551$24141955$1$I$$20240724$20240726$20240726$EXP$$US-ROCHE-10000035741$ROCHE$$81$YR$E$F$Y$$$20240726$$CN$US$US
241419561$24141956$1$I$$20240720$20240726$20240726$PER$$US-APELLIS-APL-2023-002680$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$US$US
241419571$24141957$1$I$20230101$20240723$20240726$20240726$EXP$$US-ROCHE-10000035183$ROCHE$$86$YR$E$F$Y$$$20240726$$CN$US$US
241419601$24141960$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51524$$FDA-CTU$$71$YR$$F$N$73.48$KG$20240726$N$$US$
241419611$24141961$1$I$$20240724$20240726$20240726$EXP$$US-GILEAD-2024-0681890$GILEAD$$$$E$F$Y$$$20240726$$CN$US$US
241419621$24141962$1$I$$20240716$20240726$20240726$EXP$$US-VIVUS, Inc.-2024V1000906$VIVUS$$$$A$F$Y$$$20240723$$CN$US$UM
241419631$24141963$1$I$20240719$20240722$20240726$20240726$EXP$GB-MHRA-MED-202407221601327880-LPMWF$GB-LUNDBECK-DKLU4002077$LUNDBECK$$$$$$Y$$$20240726$$HP$GB$GB
241419651$24141965$1$I$20240722$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51525$$FDA-CTU$$57$YR$$M$N$$$20240726$N$$US$
241419662$24141966$2$F$$20240809$20240726$20240822$PER$$US-MYLANLABS-2024M1069478$MYLAN$$$$$M$Y$71.21$KG$20240822$$CN$US$US
241419671$24141967$1$I$20240620$20240708$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050465$TOLMAR$$86$YR$$M$Y$$$20240726$$CN$CA$CA
241419681$24141968$1$I$$20240708$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050511$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241419691$24141969$1$I$20240101$20240708$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050871$TOLMAR$$$$C$F$Y$$$20240726$$HP$CA$CA
241419701$24141970$1$I$$20240708$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050877$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241419711$24141971$1$I$$20240708$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050876$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241419721$24141972$1$I$$20240708$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050879$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241419731$24141973$1$I$20240708$20240708$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050880$TOLMAR$$72$YR$$M$Y$$$20240726$$CN$CA$CA
241419751$24141975$1$I$$20240708$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050886$TOLMAR$$$$$M$Y$$$20240726$$CN$CA$CA
241419781$24141978$1$I$20240708$20240708$20240726$20240726$PER$$CA-TOLMAR, INC.-24CA050904$TOLMAR$$75$YR$$M$Y$$$20240726$$CN$CA$CA
241419791$24141979$1$I$20240708$20240708$20240726$20240726$PER$$FR-TOLMAR, INC.-24FR050853$TOLMAR$$84$YR$$M$Y$$$20240726$$PH$FR$FR
241419801$24141980$1$I$20240708$20240708$20240726$20240726$PER$$FR-TOLMAR, INC.-24FR050863$TOLMAR$$85$YR$$M$Y$$$20240726$$PH$FR$FR
241419811$24141981$1$I$20240708$20240708$20240726$20240726$PER$$FR-TOLMAR, INC.-24FR050893$TOLMAR$$75$YR$$M$Y$$$20240726$$PH$FR$FR
241419821$24141982$1$I$20240722$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118722$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240726$$CN$US$US
241419831$24141983$1$I$$20240725$20240726$20240726$EXP$$US-BAYER-2024A108702$BAYER$$78$YR$E$M$Y$$$20240726$$HP$US$US
241419841$24141984$1$I$$20240724$20240726$20240726$PER$$NVSC2024US152897$NOVARTIS$$$$$F$Y$$$20240726$$HP$US$US
241419851$24141985$1$I$20100101$20240725$20240726$20240726$EXP$$GR-TAKEDA-2024TUS075278$TAKEDA$$$$A$M$Y$$$20240726$$HP$GR$GR
241419861$24141986$1$I$$20240724$20240726$20240726$PER$$US-JNJFOC-20240768434$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240726$$CN$US$US
241419871$24141987$1$I$$20240718$20240726$20240726$EXP$$US-ACORDA-ACO_177619_2024$ACORDA$$$$$F$Y$62.132$KG$20240726$$CN$US$US
241419881$24141988$1$I$20240719$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024145704$AMGEN$$66$YR$E$M$Y$$$20240726$$CN$US$US
241419891$24141989$1$I$$20240723$20240726$20240726$PER$$US-ORGANON-O2407USA002347$ORGANON$$$$$F$Y$$$20240726$$CN$US$US
241419901$24141990$1$I$$20240716$20240726$20240726$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06874$HIKMA$Homiack DR, Yan LE, Petry LG, Lloyd JR,. Homiack DR, Yan LE, Petry LG, Lloyd JR, Najjar F, Cook EH. Successful Electroconvulsive Therapy in a Patient With Catatonia and Maternal Duplication 15q11-13 Syndrome. J ECT. 2024;/:/$24$YR$$M$Y$$$20240726$$MD$US$US
241419911$24141991$1$I$$20240719$20240726$20240726$EXP$$FR-AMGEN-FRASP2024145115$AMGEN$Mekinian A.; Abisror N.; Cheloufi M. et. al.. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies. American Journal of Reproductive Immunology. 2024;92:1-6$37$YR$A$F$Y$$$20240726$$HP$FR$FR
241419922$24141992$2$F$20240617$20240926$20240726$20240926$EXP$$NVSC2024US149489$NOVARTIS$$21$YR$$F$Y$70$KG$20240926$$MD$US$US
241419931$24141993$1$I$20240526$20240722$20240726$20240726$EXP$FR-AFSSAPS-PB2024000790$FR-MYLANLABS-2024M1068241$MYLAN$$19$YR$$F$Y$$$20240726$$MD$FR$FR
241419941$24141994$1$I$20240625$20240722$20240726$20240726$EXP$FR-AFSSAPS-LY2024000964$FR-MYLANLABS-2024M1068208$MYLAN$$81$YR$$F$Y$87.8$KG$20240726$$PH$FR$FR
241419951$24141995$1$I$$20240722$20240726$20240726$PER$$US-BAYER-2024A106251$BAYER$$$$$F$Y$$$20240726$$CN$US$US
241419962$24141996$2$F$20230101$20240730$20240726$20240809$EXP$$PL-TEVA-VS-3222576$TEVA$Smyk J, Kami ska A, Borowy P, Major P, Go ojuch K, Batko B. Pityriasis Rubra Pilaris - a difficult path to optimal treatment. Case report. Polski Merkuriusz Lekarski. 2024;52(3):363-7.; Smyk J, Kami ska A, Borowy P, Major P, Go ojuch K, Batko B. Pityriasis Rubra Pilaris - a difficult path to optimal treatment. Case report. Polski Merkuriusz Lekarski. 2024;52(3):363-7.$73$YR$$M$Y$$$20240809$$MD$PL$PL
241419971$24141997$1$I$$20240717$20240726$20240726$30DAY$$US-GSK-US2024090148$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241419991$24141999$1$I$20240701$20240725$20240726$20240726$EXP$FI-FIMEA-202402628$FI-ORGANON-O2407FIN002417$ORGANON$$31$YR$$F$Y$$$20240726$$MD$FI$FI
241420001$24142000$1$I$$20240724$20240726$20240726$EXP$$NVSC2024US152310$NOVARTIS$$$$$M$Y$$$20240726$$HP$US$US
241420011$24142001$1$I$20240101$20240723$20240726$20240726$PER$$US-ORGANON-O2407USA002350$ORGANON$$$$$F$Y$$$20240726$$CN$US$US
241420021$24142002$1$I$20240615$20240717$20240726$20240726$30DAY$$US-GSK-US2024090100$GLAXOSMITHKLINE$$59$YR$$M$Y$$$20240726$$CN$US$US
241420031$24142003$1$I$20240620$20240723$20240726$20240726$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-14686$IPSEN$$77$YR$E$F$Y$$$20240726$$CN$GB$GB
241420041$24142004$1$I$20231101$20240716$20240726$20240726$EXP$FR-AFSSAPS-AN2024000899$FR-SK LIFE SCIENCE, INC-SKPVG-2024-001644$SK LIFE SCIENCE$$$$$$Y$$$20240726$$MD$FR$FR
241420052$24142005$2$F$20240101$20240723$20240726$20240805$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-000442$SK LIFE SCIENCE$$$$$$Y$$$20240805$$HP$CA$CA
241420061$24142006$1$I$$20240718$20240726$20240726$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001635$SK LIFE SCIENCE$$$$$$Y$$$20240726$$CN$US$US
241420071$24142007$1$I$20240707$20240719$20240726$20240726$PER$$US-MYLANLABS-2024M1065534$MYLAN$$52$YR$$F$Y$$$20240726$$CN$US$US
241420091$24142009$1$I$$20240723$20240726$20240726$PER$$US-ABBVIE-5854293$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241420101$24142010$1$I$$20240718$20240726$20240726$EXP$GR-GREOF-202400750$NL-KOWA-24EU001927$KOWA PHARM$$$$$$Y$$$20240726$$HP$NL$GR
241420111$24142011$1$I$$20240724$20240726$20240726$PER$$US-JNJFOC-20240767763$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240726$$CN$US$US
241420122$24142012$2$F$20240601$20240808$20240726$20240813$EXP$$US-Eisai-EC-2024-170712$EISAI$$75$YR$E$M$Y$$$20240813$$HP$US$US
241420131$24142013$1$I$20240101$20240527$20240726$20240726$EXP$$AT-Taiho Oncology Inc-2024-000527$TAIHO ONCOLOGY INC$$53$YR$A$M$Y$87$KG$20240726$$MD$AT$AT
241420141$24142014$1$I$$20240718$20240726$20240726$PER$$US-SA-2023SA013965$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240726$$MD$US$US
241420161$24142016$1$I$$20240626$20240726$20240726$PER$$US-009507513-2406USA009261$MERCK$$$$$F$Y$$$20240726$$CN$US$US
241420173$24142017$3$F$20240327$20240913$20240726$20240920$EXP$$US-BAYER-2024A105222$BAYER$$76$YR$E$M$Y$$$20240920$$CN$US$US
241420182$24142018$2$F$$20240911$20240726$20240913$PER$$US-PFIZER INC-PV202400097007$PFIZER$$42$YR$$M$Y$$$20240913$$HP$US$US
241420191$24142019$1$I$$20240723$20240726$20240726$PER$$US-PFIZER INC-202400222433$PFIZER$$$$$$Y$$$20240726$$HP$US$US
241420212$24142021$2$F$$20240729$20240726$20240731$PER$$US-PFIZER INC-202400223379$PFIZER$$70$YR$$F$Y$$$20240731$$HP$US$US
241420221$24142022$1$I$20240701$20240724$20240726$20240726$PER$$US-PFIZER INC-202400222825$PFIZER$$$$$$Y$$$20240726$$CN$US$US
241420231$24142023$1$I$$20240723$20240726$20240726$PER$$US-PFIZER INC-PV202400096348$PFIZER$$60$YR$$F$Y$$$20240726$$HP$US$US
241420243$24142024$3$F$20240520$20240906$20240726$20240911$PER$$US-PFIZER INC-PV202400095976$PFIZER$$53$YR$$M$Y$$$20240911$$PH$US$US
241420251$24142025$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400222903$PFIZER$$12$YR$$F$Y$$$20240726$$HP$US$US
241420261$24142026$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400223157$PFIZER$$27$YR$$$Y$$$20240726$$CN$US$US
241420271$24142027$1$I$20240725$20240725$20240726$20240726$PER$$US-PFIZER INC-202400224192$PFIZER$$53$YR$$F$Y$$$20240726$$CN$US$US
241420281$24142028$1$I$20240101$20240722$20240726$20240726$PER$$US-PFIZER INC-PV202400096005$PFIZER$$46$YR$$F$Y$$$20240726$$CN$US$US
241420291$24142029$1$I$$20240723$20240726$20240726$PER$$US-PFIZER INC-202400222321$PFIZER$$$$$M$Y$$$20240726$$CN$US$US
241420301$24142030$1$I$$20240723$20240726$20240726$PER$$US-PFIZER INC-202400222601$PFIZER$$$$$F$Y$$$20240726$$CN$US$US
241420312$24142031$2$F$$20240728$20240726$20240730$PER$$US-PFIZER INC-PV202400097689$PFIZER$$57$YR$$F$Y$$$20240730$$HP$US$US
241420321$24142032$1$I$20240722$20240725$20240726$20240726$PER$$US-PFIZER INC-202400223784$PFIZER$$55$YR$$F$Y$$$20240726$$HP$US$US
241420333$24142033$3$F$$20240821$20240726$20240826$PER$$US-PFIZER INC-202400223183$PFIZER$$79$YR$$F$Y$$$20240826$$CN$US$US
241420341$24142034$1$I$$20240723$20240726$20240726$PER$$KR-PFIZER INC-PV202400096100$PFIZER$$$$$M$Y$$$20240726$$CN$KR$KR
241420352$24142035$2$F$$20240801$20240726$20240805$PER$$US-PFIZER INC-202400224094$PFIZER$$68$YR$$M$Y$$$20240805$$MD$US$US
241420362$24142036$2$F$20240716$20240802$20240726$20240807$PER$$US-PFIZER INC-202400223872$PFIZER$$63$YR$$F$Y$45.351$KG$20240807$$CN$US$US
241420371$24142037$1$I$$20240725$20240726$20240726$PER$$US-PFIZER INC-PV202400097448$PFIZER$$57$YR$$F$Y$$$20240726$$HP$US$US
241420382$24142038$2$F$$20240820$20240726$20240822$PER$$US-PFIZER INC-PV202400097668$PFIZER$$45$YR$$M$Y$$$20240822$$HP$US$US
241420391$24142039$1$I$20240101$20240723$20240726$20240726$PER$$US-PFIZER INC-PV202400096469$PFIZER$$82$YR$$F$Y$$$20240726$$CN$US$US
241420401$24142040$1$I$20240724$20240726$20240726$20240726$PER$$US-PFIZER INC-202400224399$PFIZER$$45$YR$$F$Y$$$20240726$$CN$US$US
241420411$24142041$1$I$$20240725$20240726$20240726$PER$$US-PFIZER INC-202400224089$PFIZER$$51$YR$$F$Y$$$20240726$$CN$US$US
241420422$24142042$2$F$20240701$20240801$20240726$20240806$PER$$US-PFIZER INC-202400222136$PFIZER$$$$$F$Y$$$20240806$$CN$US$US
241420431$24142043$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-PV202400096804$PFIZER$$75$YR$$F$Y$$$20240726$$HP$US$US
241420442$24142044$2$F$$20240820$20240726$20240822$PER$$US-PFIZER INC-PV202400096944$PFIZER$$89$YR$$F$Y$$$20240822$$HP$US$US
241420451$24142045$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400223927$PFIZER$$71$YR$$F$Y$$$20240726$$MD$US$US
241420461$24142046$1$I$20240701$20240724$20240726$20240726$PER$$US-PFIZER INC-PV202400096987$PFIZER$$66$YR$$M$Y$$$20240726$$HP$US$US
241420471$24142047$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400224032$PFIZER$$41$YR$$F$Y$$$20240726$$HP$US$US
241420481$24142048$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400223260$PFIZER$$60$YR$$M$Y$$$20240726$$PH$US$US
241420491$24142049$1$I$$20240723$20240726$20240726$PER$$US-PFIZER INC-202400222954$PFIZER$$38$YR$$M$Y$$$20240726$$CN$US$US
241420501$24142050$1$I$20240630$20240718$20240726$20240726$EXP$$CN-AstraZeneca-2024A166355$ASTRAZENECA$$35$YR$$M$Y$80$KG$20240726$$MD$CN$
241420511$24142051$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118581$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240726$$CN$US$US
241420521$24142052$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118530$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240726$$PH$US$US
241420531$24142053$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119026$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240726$$CN$US$US
241420541$24142054$1$I$$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117387$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240726$$HP$US$US
241420551$24142055$1$I$20240726$20240726$20240726$20240726$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042175$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240726$$CN$US$US
241420561$24142056$1$I$20220101$20240722$20240726$20240726$PER$$US-PFIZER INC-202400221809$PFIZER$$70$YR$$F$Y$76.2$KG$20240726$$CN$US$US
241420571$24142057$1$I$20240724$20240725$20240726$20240726$PER$$US-PFIZER INC-202400224097$PFIZER$$70$YR$$M$Y$$$20240726$$CN$US$US
241420583$24142058$3$F$$20240924$20240726$20240926$PER$$US-PFIZER INC-202400224070$PFIZER$$$$$$Y$$$20240926$$CN$US$US
241420592$24142059$2$F$$20240819$20240726$20240830$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-117287$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240830$$HP$CA$CA
241420601$24142060$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400223919$PFIZER$$63$YR$$F$Y$$$20240726$$HP$US$US
241420611$24142061$1$I$$20240723$20240726$20240726$PER$$US-PFIZER INC-202400223178$PFIZER$$74$YR$$F$Y$$$20240726$$CN$US$US
241420621$24142062$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400224073$PFIZER$$62$YR$$F$Y$$$20240726$$HP$US$US
241420632$24142063$2$F$$20240725$20240726$20240730$PER$$US-PFIZER INC-PV202400097072$PFIZER$$69$YR$$M$Y$$$20240730$$CN$US$US
241420642$24142064$2$F$20240520$20240906$20240726$20240911$PER$$US-PFIZER INC-PV202400095935$PFIZER$$46$YR$$F$Y$$$20240911$$PH$US$US
241420651$24142065$1$I$$20240723$20240726$20240726$PER$$US-PFIZER INC-PV202400096249$PFIZER$$15$YR$$F$Y$$$20240726$$HP$US$US
241420661$24142066$1$I$20240723$20240725$20240726$20240726$PER$$US-PFIZER INC-202400223908$PFIZER$$47$YR$$F$Y$$$20240726$$HP$US$US
241420671$24142067$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400223180$PFIZER$$62$YR$$F$Y$$$20240726$$HP$US$US
241420682$24142068$2$F$$20240730$20240726$20240801$PER$$US-PFIZER INC-202400224175$PFIZER$$65$YR$$F$Y$$$20240801$$MD$US$US
241420692$24142069$2$F$20240723$20240724$20240726$20240730$PER$$US-PFIZER INC-202400223045$PFIZER$$84$YR$$F$Y$52.16$KG$20240730$$CN$US$US
241420702$24142070$2$F$20240601$20240808$20240726$20240812$PER$$US-PFIZER INC-202400222980$PFIZER$$81$YR$$F$Y$$$20240812$$CN$US$US
241420711$24142071$1$I$20240722$20240723$20240726$20240726$PER$$US-PFIZER INC-202400222377$PFIZER$$76$YR$$F$Y$$$20240726$$CN$US$US
241420721$24142072$1$I$20210101$20240723$20240726$20240726$PER$$US-PFIZER INC-202400222572$PFIZER$$74$YR$$F$Y$$$20240726$$CN$US$US
241420731$24142073$1$I$$20240723$20240726$20240726$PER$$US-PFIZER INC-202400223348$PFIZER$$61$YR$$F$Y$$$20240726$$HP$US$US
241420741$24142074$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-202400224084$PFIZER$$42$YR$$F$Y$$$20240726$$HP$US$US
241420751$24142075$1$I$$20240723$20240726$20240726$PER$$US-PFIZER INC-PV202400096392$PFIZER$$$$$$Y$$$20240726$$MD$US$US
241420762$24142076$2$F$$20240728$20240726$20240730$PER$$US-PFIZER INC-202400224024$PFIZER$$65$YR$$F$Y$$$20240730$$HP$US$US
241420781$24142078$1$I$$20240715$20240726$20240726$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07295$LUPIN$$$$$$Y$$$20240726$$CN$AU$AU
241420811$24142081$1$I$$20240719$20240726$20240726$EXP$$US-BAYER-2024A105596$BAYER$$$$$$Y$$$20240726$$CN$US$US
241420821$24142082$1$I$$20240718$20240726$20240726$PER$$US-AMGEN-USASP2024146158$AMGEN$Davis D.R.; Wang K.L.; Lehman J.S. et al.. Adult-onset linear IgA bullous dermatosis: a retrospective single-center cohort study of 81 patients and literature review. International Journal of Dermatology. 2024;63 (7):936-941$$$$$Y$$$20240726$$HP$US$US
241420831$24142083$1$I$$20240718$20240726$20240726$PER$$US-AMGEN-USASP2024146239$AMGEN$Davis D.R.; Wang K.L.; Lehman J.S. et al.. Adult-onset linear IgA bullous dermatosis: a retrospective single-center cohort study of 81 patients and literature review. International Journal of Dermatology. 2024;63  (7):936-941$$$$$Y$$$20240726$$HP$US$US
241420841$24142084$1$I$$20240717$20240726$20240726$EXP$$US-AMGEN-USASP2024142442$AMGEN$Young T. J.; Estrada Paz.O. A. Paraneoplastic pemphigus with airway involvement. Respiratory Medicine Case Reports. 2024;51:1-4$55$YR$A$F$Y$$$20240726$$HP$US$US
241420851$24142085$1$I$$20240717$20240726$20240726$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00281$PRINSTON PHARMACEUTICAL$$$$A$F$Y$$$20240726$$CN$US$US
241420861$24142086$1$I$20240716$20240717$20240726$20240726$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00282$PRINSTON PHARMACEUTICAL$$96$YR$$F$Y$$$20240726$$CN$US$US
241420871$24142087$1$I$$20240714$20240726$20240726$PER$$US-Calliditas-2024CAL01318$CALLIDITAS THERAPEUTICS$$$$A$F$Y$$$20240726$$MD$US$US
241420881$24142088$1$I$$20240722$20240726$20240726$PER$$US-BAYER-2024A107056$BAYER$$18$YR$A$F$Y$$$20240726$$MD$US$US
241420891$24142089$1$I$20240704$20240716$20240726$20240726$EXP$IT-MINISAL02-994093$IT-TEVA-VS-3221986$TEVA$$6$YR$$M$Y$$$20240726$$MD$IT$IT
241420902$24142090$2$F$20210101$20240821$20240726$20240903$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00376$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
241420911$24142091$1$I$20230701$20240724$20240726$20240726$EXP$$US-INCYTE CORPORATION-2024IN006946$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241420931$24142093$1$I$20230727$20230908$20240726$20240726$EXP$$US-CIPLA (EU) LIMITED-2023US04698$CIPLA$$$$$$Y$$$20240719$$CN$US$US
241420941$24142094$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118415$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240726$$CN$US$US
241420951$24142095$1$I$20240603$20240722$20240726$20240726$EXP$SE-SEMPA-2024-005330$SE-TAKEDA-2024TUS073844$TAKEDA$$38$YR$$F$Y$93$KG$20240726$$HP$SE$SE
241420961$24142096$1$I$$20240719$20240726$20240726$PER$$US-MYLANLABS-2024M1068304$MYLAN$$$$$F$Y$83.01$KG$20240726$$CN$US$US
241420971$24142097$1$I$20050101$20240717$20240726$20240726$EXP$EU-AFSSAPS-AVCN2024000536$EU-ETHYPHARM-2024001930$ETHYPHARM$$$$$$Y$$$20240726$$MD$EU$EU
241420991$24142099$1$I$$20240717$20240726$20240726$PER$$US-FreseniusKabi-FK202411387$FRESENIUS KABI$$$$I$$Y$$$20240726$$PH$US$US
241421002$24142100$2$F$20240708$20240906$20240726$20240916$EXP$GB-MHRA-MED-202407081623476080-TCFKN$GB-TEVA-VS-3222189$TEVA$$77$YR$$M$Y$116$KG$20240916$$MD$GB$GB
241421011$24142101$1$I$$20240712$20240726$20240726$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06918$LUPIN$Noe G, Shah K, Cinderella M, Munjal S. Multiple medication use resulting in serotonin syndrome with deprescribing resulting in acute dystonia. Journal of Clinical Psychopharmacology. 2024;44 (3):326-328$42$YR$$F$Y$$$20240726$$MD$US$US
241421021$24142102$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA214879$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240726$$MD$US$US
241421031$24142103$1$I$20240701$20240725$20240726$20240726$EXP$$NVSC2024DE153433$NOVARTIS$$52$YR$$F$Y$$$20240726$$MD$DE$DE
241421072$24142107$2$F$$20240801$20240726$20240808$PER$$US-VERTEX PHARMACEUTICALS-2024-011913$VERTEX$$54$YR$$F$Y$$$20240808$$CN$US$US
241421081$24142108$1$I$$20240717$20240726$20240726$EXP$$GB-VERTEX PHARMACEUTICALS-2024-011926$VERTEX$$$$A$M$Y$$$20240726$$CN$GB$GB
241421091$24142109$1$I$20240718$20240719$20240726$20240726$EXP$$US-VERTEX PHARMACEUTICALS-2024-012124$VERTEX$$4$YR$$F$Y$$$20240726$$HP$US$US
241421101$24142110$1$I$$20240720$20240726$20240726$PER$$US-VERTEX PHARMACEUTICALS-2024-012127$VERTEX$$22$YR$$F$Y$$$20240726$$HP$US$US
241421112$24142111$2$F$20240101$20240729$20240726$20240801$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012145$VERTEX$$$$$M$Y$$$20240801$$CN$GB$GB
241421121$24142112$1$I$$20240722$20240726$20240726$PER$$US-VERTEX PHARMACEUTICALS-2024-012182$VERTEX$$$$$$Y$$$20240726$$CN$US$US
241421132$24142113$2$F$$20240815$20240726$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117892$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240816$$CN$US$US
241421141$24142114$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118561$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240726$$CN$US$US
241421151$24142115$1$I$$20240715$20240726$20240726$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07277$LUPIN$$$$$$Y$$$20240726$$CN$AU$AU
241421162$24142116$2$F$$20240719$20240726$20240729$EXP$$US-JNJFOC-20240759310$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241421171$24142117$1$I$$20240719$20240726$20240726$EXP$$US-TAKEDA-2024TUS074581$TAKEDA$$$$$F$Y$$$20240726$$MD$US$US
241421181$24142118$1$I$20240401$20240725$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118931$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240726$$CN$US$US
241421191$24142119$1$I$20240510$20240716$20240726$20240726$EXP$$FR-Blueprint Medicines Corporation-SP-FR-2024-001441$BLUEPRINT MEDICINES$$$$$$Y$$$20240726$$CN$FR$FR
241421201$24142120$1$I$$20240723$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007750$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241421212$24142121$2$F$20240101$20240826$20240726$20240909$EXP$$US-UCBSA-2024037755$UCB$$$$$M$Y$$$20240909$$CN$US$US
241421221$24142122$1$I$20231122$20240716$20240726$20240726$EXP$IT-MINISAL02-994151$IT-TEVA-VS-3222323$TEVA$$63$YR$$M$Y$$$20240726$$MD$IT$IT
241421231$24142123$1$I$20240201$20240719$20240726$20240726$EXP$GB-MHRA-MED-202407181443113020-RYQDH$GB-SA-2024SA217799$SANOFI AVENTIS$$70$YR$E$M$Y$89$KG$20240726$$CN$GB$GB
241421244$24142124$4$F$20190101$20240919$20240726$20240920$EXP$$CL-BIOMARINAP-CL-2024-159320$BIOMARIN$$$$$$Y$$$20240920$$CN$US$CL
241421251$24142125$1$I$20240625$20240722$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007702$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241421261$24142126$1$I$$20240722$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007701$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241421271$24142127$1$I$$20240531$20240726$20240726$PER$$US-LUNDBECK-DKLU4000104$LUNDBECK$$$$$$Y$$$20240726$$HP$US$US
241421281$24142128$1$I$20240703$20240711$20240726$20240726$EXP$$US-HLS-202400345$HLS THERAPEUTICS$$63$YR$A$F$Y$$$20240726$$CN$US$US
241421301$24142130$1$I$20211001$20240718$20240726$20240726$EXP$$KR-AstraZeneca-2024A166653$ASTRAZENECA$$56$YR$$M$Y$$$20240726$$MD$KR$
241421311$24142131$1$I$$20240719$20240726$20240726$EXP$$NL-INCYTE CORPORATION-2024IN007118$INCYTE$$$$$$Y$$$20240726$$MD$NL$NL
241421321$24142132$1$I$$20240719$20240726$20240726$EXP$$US-OTSUKA-2024_001220$OTSUKA$$$$$M$Y$84.82$KG$20240726$$CN$US$US
241421331$24142133$1$I$$20240719$20240726$20240726$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041525$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240726$$MD$US$US
241421341$24142134$1$I$20240101$20240724$20240726$20240726$EXP$$US-ABBVIE-5852754$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241421351$24142135$1$I$$20240607$20240726$20240726$PER$$US-Breckenridge Pharmaceutical, Inc.-2159664$BRECKENRIDGE$$$$$F$Y$$$20240726$$$US$US
241421361$24142136$1$I$$20240722$20240726$20240726$EXP$$ES-FreseniusKabi-FK202411513$FRESENIUS KABI$$56$YR$A$M$Y$$$20240726$$CN$US$ES
241421371$24142137$1$I$20230701$20240715$20240726$20240726$EXP$$IL-ALXN-202406EEA001022IL$ALEXION PHARMACEUTICALS$$23$YR$$M$Y$72$KG$20240726$$MD$IL$IL
241421383$24142138$3$F$$20240805$20240726$20240810$PER$$US-ALXN-202407USA001445US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240810$$CN$US$US
241421391$24142139$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA218116$SANOFI AVENTIS$$46$YR$A$F$Y$127$KG$20240726$$MD$US$US
241421412$24142141$2$F$$20240723$20240726$20240729$EXP$$NVSC2024US152058$NOVARTIS$$$$$M$Y$$$20240729$$CN$US$US
241421421$24142142$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214925$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241421431$24142143$1$I$20240101$20240722$20240726$20240726$EXP$$US-ABBVIE-5850726$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241421441$24142144$1$I$20240506$20240722$20240726$20240726$EXP$$ES-FreseniusKabi-FK202411502$FRESENIUS KABI$$67$YR$E$F$Y$69.1$KG$20240726$$MD$ES$ES
241421451$24142145$1$I$$20240724$20240726$20240726$EXP$$US-GILEAD-2024-0681820$GILEAD$$$$E$F$Y$$$20240726$$CN$US$US
241421461$24142146$1$I$$20240719$20240726$20240726$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001493$BLUEPRINT MEDICINES$$$$$M$Y$$$20240726$$HP$US$US
241421471$24142147$1$I$$20240705$20240726$20240726$EXP$$GB-CIPLA LTD.-2024GB07363$CIPLA$$$$$$Y$$$20240719$$PH$GB$GB
241421481$24142148$1$I$$20240706$20240726$20240726$EXP$$GB-CIPLA LTD.-2024GB07415$CIPLA$$$$$$Y$$$20240719$$PH$GB$GB
241421491$24142149$1$I$$20240719$20240726$20240726$EXP$$CA-GILEAD-2024-0681584$GILEAD$$$$A$F$Y$$$20240726$$MD$CA$CA
241421501$24142150$1$I$20240212$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119020$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$74.84$KG$20240726$$CN$US$US
241421512$24142151$2$F$$20240820$20240726$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118827$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$111.58$KG$20240826$$CN$US$US
241421522$24142152$2$F$$20240826$20240726$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118525$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240827$$CN$US$US
241421533$24142153$3$F$$20240822$20240726$20240905$EXP$$FR-Merck Healthcare KGaA-2024038787$MERCK KGAA$$$$$F$Y$$$20240905$$CN$FR$FR
241421551$24142155$1$I$$20240723$20240726$20240726$EXP$$CA-PERRIGO-24CA007053$PERRIGO$$73$YR$$F$Y$$$20240726$$CN$CA$CA
241421561$24142156$1$I$$20240723$20240726$20240726$EXP$$VN-TAKEDA-2024TUS041266$TAKEDA$$53$YR$$F$Y$33$KG$20240726$$CN$VN$VN
241421571$24142157$1$I$20240713$20240724$20240726$20240726$PER$$US-DSJP-DSU-2024-137524$DAIICHI$$62$YR$$F$Y$$$20240726$$MD$US$US
241421581$24142158$1$I$$20240724$20240726$20240726$EXP$$PL-GILEAD-2024-0681799$GILEAD$$$$$F$Y$$$20240726$$MD$PL$PL
241421591$24142159$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000036401$ROCHE$$50$YR$A$F$Y$$$20240726$$HP$US$US
241421601$24142160$1$I$$20240627$20240726$20240726$PER$$US-009507513-2407USA001882$MERCK$Vlachou E, Johnson BA, Guancial E, Lombardo KA, Hoffman-Censits J. Frontline immune checkpoint inhibitors in patients = 90 years with advanced urothelial cancer: a single center experience. The Canadian journal of urology. 2024;31(3):11875-9$90$YR$$F$Y$$$20240726$$MD$US$US
241421611$24142161$1$I$20230712$20240722$20240726$20240726$EXP$$KR-009507513-2407KOR012041$MERCK$$$$$M$Y$55.1$KG$20240726$$PH$KR$KR
241421621$24142162$1$I$20221201$20240722$20240726$20240726$EXP$FR-AFSSAPS-PP2024000799$FR-TAKEDA-2024TUS073526$TAKEDA$$77$YR$$M$Y$82$KG$20240726$$HP$FR$FR
241421631$24142163$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA217877$SANOFI AVENTIS$$$$$$Y$$$20240726$$HP$US$US
241421642$24142164$2$F$$20240812$20240726$20240815$EXP$$AU-MYLANLABS-2024M1068918$MYLAN$$$$$F$Y$$$20240815$$HP$AU$AU
241421651$24142165$1$I$20240401$20240718$20240726$20240726$PER$$US-SA-2024SA176744$SANOFI AVENTIS$$58$YR$A$F$Y$77$KG$20240726$$MD$US$US
241421672$24142167$2$F$$20240914$20240726$20240916$EXP$$US-PFIZER INC-202400222159$PFIZER$$17$YR$$M$Y$$$20240916$$CN$US$US
241421681$24142168$1$I$$20240725$20240726$20240726$PER$$US-BAYER-2024A108657$BAYER$$$$$M$Y$$$20240726$$CN$US$US
241421691$24142169$1$I$20240702$20240723$20240726$20240726$EXP$$JP-GENMAB-2024-02666$GENMAB$$73$YR$$F$Y$$$20240726$$MD$JP$JP
241421711$24142171$1$I$$20240718$20240726$20240726$PER$$US-FreseniusKabi-FK202411426$FRESENIUS KABI$$$$$$Y$$$20240726$$PH$US$US
241421721$24142172$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216323$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240726$$MD$US$US
241421731$24142173$1$I$20240709$20240722$20240726$20240726$EXP$PT-INFARMED-F202407-307$PT-FreseniusKabi-FK202411550$FRESENIUS KABI$$64$YR$A$F$Y$59$KG$20240726$$HP$PT$PT
241421741$24142174$1$I$$20240715$20240726$20240726$PER$$US-TEVA-VS-3221719$TEVA$$$$$$Y$$$20240726$$CN$US$US
241421751$24142175$1$I$20240702$20240722$20240726$20240726$EXP$FR-AFSSAPS-RS2024000701$FR-FreseniusKabi-FK202411560$FRESENIUS KABI$$60$YR$A$M$Y$81$KG$20240726$$PH$FR$FR
241421771$24142177$1$I$20220101$20240723$20240726$20240726$EXP$CN-MLMSERVICE-20240708-PI125005-00232-1$CN-SA-2024SA208151$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240726$$MD$CN$CN
241421781$24142178$1$I$20240716$20240717$20240726$20240726$PER$$US-GRUNENTHAL-2024-123108$AVERITAS$$$$$M$Y$$$20240726$$CN$US$US
241421793$24142179$3$F$20240101$20240820$20240726$20240821$PER$$US-GRUNENTHAL-2024-123199$AVERITAS$$54$YR$$F$Y$$$20240821$$HP$US$US
241421801$24142180$1$I$20240718$20240719$20240726$20240726$EXP$$GB-AMGEN-GBRSP2024144634$AMGEN$$61$YR$A$F$Y$$$20240726$$HP$GB$GB
241421811$24142181$1$I$20231201$20240722$20240726$20240726$EXP$FR-AFSSAPS-AN2024000916$FR-FreseniusKabi-FK202411586$FRESENIUS KABI$$74$YR$E$$Y$$$20240726$$MD$FR$FR
241421821$24142182$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51528$$FDA-CTU$$$$$M$N$$$20240725$N$HP$US$
241421831$24142183$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA216849$SANOFI AVENTIS$$57$YR$A$F$Y$70$KG$20240726$$CN$US$US
241421841$24142184$1$I$$20240722$20240726$20240726$EXP$$US-GILEAD-2024-0681578$GILEAD$$$$E$$Y$$$20240726$$MD$US$US
241421851$24142185$1$I$$20240724$20240726$20240726$EXP$$CN-AstraZeneca-2024A170145$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$CN$
241421861$24142186$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165575$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241421871$24142187$1$I$$20240528$20240726$20240726$PER$$US-AstraZeneca-2024A087667$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241421881$24142188$1$I$$20240430$20240726$20240726$PER$$US-AstraZeneca-2024A103796$ASTRAZENECA$$$$$$Y$$$20240726$$MD$US$
241421891$24142189$1$I$$20240502$20240726$20240726$PER$$US-AstraZeneca-2024A105166$ASTRAZENECA$$$$$M$Y$$$20240726$$MD$US$
241421901$24142190$1$I$20240724$20240725$20240726$20240726$EXP$$US-GILEAD-2024-0681966$GILEAD$$67$YR$E$M$Y$$$20240726$$CN$US$US
241421911$24142191$1$I$$20240528$20240726$20240726$PER$$US-AstraZeneca-2024A105928$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241421921$24142192$1$I$20240201$20240529$20240726$20240726$PER$$US-AstraZeneca-2024A108627$ASTRAZENECA$$786$MON$$M$Y$$$20240726$$CN$US$
241421931$24142193$1$I$20230101$20240517$20240726$20240726$PER$$US-AstraZeneca-2024A117368$ASTRAZENECA$$70$YR$$M$Y$$$20240726$$MD$US$
241421941$24142194$1$I$20230101$20240517$20240726$20240726$PER$$US-AstraZeneca-2024A117592$ASTRAZENECA$$80$YR$$F$Y$$$20240726$$MD$US$
241421951$24142195$1$I$$20240522$20240726$20240726$PER$$US-AstraZeneca-2024A119157$ASTRAZENECA$$$$$M$Y$$$20240726$$HP$US$
241421961$24142196$1$I$20240601$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118596$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240726$$HP$US$US
241421971$24142197$1$I$$20240527$20240726$20240726$PER$$US-AstraZeneca-2024A125799$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241421981$24142198$1$I$$20240530$20240726$20240726$PER$$US-AstraZeneca-2024A134141$ASTRAZENECA$$70$YR$$F$Y$$$20240726$$CN$US$
241421991$24142199$1$I$$20240610$20240726$20240726$PER$$US-AstraZeneca-2024A135329$ASTRAZENECA$$$$$$Y$$$20240726$$MD$US$
241422001$24142200$1$I$$20240719$20240726$20240726$EXP$$IN-AstraZeneca-2024A165364$ASTRAZENECA$$$$$M$Y$60$KG$20240726$$CN$IN$
241422011$24142201$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A166851$ASTRAZENECA$$56$YR$$M$Y$$$20240726$$MD$US$
241422022$24142202$2$F$$20240828$20240726$20240828$30DAY$$US-PFIZER INC-202400219762$PFIZER$$12$YR$$M$Y$$$20240828$$CN$US$US
241422032$24142203$2$F$$20240825$20240726$20240826$30DAY$$US-PFIZER INC-202400219185$PFIZER$$17$YR$$M$Y$$$20240826$$CN$US$US
241422042$24142204$2$F$$20240828$20240726$20240828$30DAY$$US-PFIZER INC-202400216433$PFIZER$$12$YR$$M$Y$$$20240828$$CN$US$US
241422052$24142205$2$F$20231201$20240831$20240726$20240903$30DAY$$CO-PFIZER INC-PV202400096085$PFIZER$$13$YR$$M$Y$$$20240903$$CN$CO$CO
241422063$24142206$3$F$$20240830$20240726$20240830$30DAY$$US-PFIZER INC-PV202400095695$PFIZER$$11$YR$$F$Y$$$20240830$$CN$US$US
241422071$24142207$1$I$20240703$20240724$20240726$20240726$EXP$$NVSC2024CN153420$NOVARTIS$$29$YR$$F$Y$54$KG$20240726$$HP$CN$CN
241422081$24142208$1$I$$20240716$20240726$20240726$PER$$US-JNJFOC-20240770840$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$MD$US$US
241422091$24142209$1$I$20240612$20240715$20240726$20240726$PER$$US-JNJFOC-20240769557$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$MD$US$US
241422104$24142210$4$F$20240721$20240905$20240726$20240916$30DAY$$US-JNJFOC-20240757666$JOHNSON AND JOHNSON$$5$YR$C$F$Y$$$20240916$$CN$US$US
241422111$24142211$1$I$$20240715$20240726$20240726$EXP$$CA-GENMAB-2024-02709$GENMAB$$74$YR$$F$Y$$$20240726$$CN$CA$CA
241422134$24142213$4$F$20020101$20240917$20240726$20240920$EXP$$ES-MYLANLABS-2024M1068747$MYLAN$$$$$M$Y$$$20240920$$CN$ES$ES
241422151$24142215$1$I$20240701$20240717$20240726$20240726$PER$$US-SA-2024SA215087$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240726$$MD$US$US
241422161$24142216$1$I$20240221$20240722$20240726$20240726$EXP$$CO-UCBSA-2024037643$UCB$$71$YR$$M$Y$$$20240726$$CN$CO$CO
241422172$24142217$2$F$$20240815$20240726$20240819$PER$$US-ALXN-202407USA001491US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241422181$24142218$1$I$$20240723$20240726$20240726$EXP$$CA-MYLANLABS-2024M1069020$MYLAN$$71$YR$$F$Y$$$20240726$$CN$CA$CA
241422191$24142219$1$I$$20240717$20240726$20240726$EXP$$US-MYLANLABS-2024M1068429$MYLAN$Migally K, Monge M, Wolfe B, Hammond N, Joong A. Paracorporeal Ventricular Assist Device as Bridge to Transplant after Suspected SARS-CoV-2 Myocarditis in Child with Stage II Single Ventricle Palliation. ASAIO-J 2024; 70 (Suppl.) 149 abstr. P70.$10$MON$$M$Y$9.2$KG$20240726$$HP$US$US
241422201$24142220$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222770$TEVA$$44$YR$$F$Y$$$20240726$$HP$CA$CA
241422211$24142221$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51532$$FDA-CTU$$$$$F$N$$$20240725$N$HP$US$
241422221$24142222$1$I$$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51529$$FDA-CTU$$$$$F$N$$$20240724$N$HP$US$
241422231$24142223$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51536$$FDA-CTU$$71$YR$$F$N$58.97$KG$20240725$N$$US$
241422271$24142227$1$I$20240601$20240722$20240726$20240726$EXP$FR-AFSSAPS-GR2024000910$FR-FreseniusKabi-FK202411578$FRESENIUS KABI$$88$YR$E$F$Y$$$20240726$$PH$FR$FR
241422281$24142228$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51526$$FDA-CTU$$81$YR$$M$N$$$20240726$N$$US$
241422291$24142229$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51527$$FDA-CTU$$33$YR$$F$N$112.49$KG$20240726$N$HP$US$
241422301$24142230$1$I$20240601$20240722$20240726$20240726$EXP$FR-AFSSAPS-LL2024001360$FR-FreseniusKabi-FK202411581$FRESENIUS KABI$$61$YR$A$F$Y$$$20240726$$MD$FR$FR
241422311$24142231$1$I$20240627$20240718$20240726$20240726$EXP$$CN-FreseniusKabi-FK202411421$FRESENIUS KABI$$84$YR$E$F$Y$40$KG$20240726$$HP$CN$CN
241422321$24142232$1$I$20240622$20240722$20240726$20240726$EXP$FR-AFSSAPS-GR2024000921$FR-FreseniusKabi-FK202411622$FRESENIUS KABI$$70$YR$E$M$Y$79$KG$20240726$$PH$FR$FR
241422331$24142233$1$I$20240709$20240722$20240726$20240726$PER$$US-FreseniusKabi-FK202411484$FRESENIUS KABI$$34$YR$A$F$Y$97.52$KG$20240726$$PH$US$US
241422341$24142234$1$I$20240111$20240722$20240726$20240726$EXP$FR-AFSSAPS-ST2024001188$FR-FreseniusKabi-FK202411582$FRESENIUS KABI$$59$YR$A$M$Y$$$20240726$$HP$FR$FR
241422351$24142235$1$I$$20240724$20240726$20240726$PER$$US-GILEAD-2024-0681868$GILEAD$$34$YR$A$F$Y$$$20240726$$HP$US$US
241422361$24142236$1$I$$20240725$20240726$20240726$PER$$US-ABBVIE-5855867$ABBVIE$$$$$$Y$$$20240726$$MD$US$US
241422382$24142238$2$F$$20240801$20240726$20240810$PER$$US-SA-2024SA216291$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240810$$MD$US$US
241422391$24142239$1$I$$20240717$20240726$20240726$PER$$US-SA-2023SA385675$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240726$$MD$US$US
241422402$24142240$2$F$$20240722$20240726$20240904$EXP$$CA-UCBSA-2024037790$UCB$$7$DEC$$F$Y$$$20240904$$MD$CA$CA
241422411$24142241$1$I$$20240719$20240726$20240726$EXP$$JP-009507513-2407JPN004160J$MERCK$$65$YR$$M$Y$$$20240726$$MD$JP$JP
241422421$24142242$1$I$20240701$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117999$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240726$$HP$US$US
241422431$24142243$1$I$20230826$20240716$20240726$20240726$EXP$FR-AFSSAPS-TO2024001046$FR-TEVA-VS-3222364$TEVA$$91$YR$$F$Y$$$20240726$$PH$FR$FR
241422441$24142244$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153529$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241422461$24142246$1$I$20240205$20240716$20240726$20240726$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001138$AKEBIA THERAPEUTICS$$84$YR$$F$Y$49$KG$20240726$$MD$JP$JP
241422471$24142247$1$I$$20240610$20240726$20240726$PER$$US-AstraZeneca-2024A136163$ASTRAZENECA$$$$$$Y$$$20240726$$MD$US$
241422481$24142248$1$I$20240613$20240613$20240726$20240726$PER$$US-AstraZeneca-2024A138774$ASTRAZENECA$$$$$F$Y$$$20240726$$HP$US$
241422492$24142249$2$F$$20240806$20240726$20240814$PER$$US-AstraZeneca-2024A148748$ASTRAZENECA$$77$YR$$F$Y$$$20240814$$CN$US$
241422501$24142250$1$I$$20240719$20240726$20240726$EXP$$ZA-AstraZeneca-2024A165675$ASTRAZENECA$$56$YR$$F$Y$$$20240726$$CN$ZA$
241422511$24142251$1$I$$20240723$20240726$20240726$EXP$$US-AstraZeneca-2024A169719$ASTRAZENECA$Hewitt, Sage T.; Wang, Danfeng; Poursheykhi, Meryim; Patel, Shaily; Shah, Shailee S.. Immune Checkpoint Inhibitor Related Myositis/Myasthenia Gravis Overlap Syndrome Treated with Eculizumab. 2024 Summer Conference of the American Academy of Neurology (AAN) 2024;$64$YR$$M$Y$$$20240726$$MD$US$
241422521$24142252$1$I$$20240716$20240726$20240726$EXP$$PT-AstraZeneca-2024A169198$ASTRAZENECA$Governa J, Marques B, Avelar P, Ribeiro M, Simoes L, Borges S, et al.. PO-0116 - (4016) - Drug Intoxication By Quetiapine - Beyond Anamnesis.. Emergency, intermediate care and the critically ill | Clinical case 2024;486.$61$YR$$F$Y$$$20240726$$HP$PT$
241422543$24142254$3$F$$20240806$20240726$20240814$EXP$$RO-AstraZeneca-2024A163988$ASTRAZENECA$Desiderio G, Maria FD, Alkojok A, Galizia V, Arena G, Macarie I et al.. Progresses and challenges in the management of multiple myeloma: navigating through a relapsing-remitting course.. Acta Medica Marisiensis 2024;70(3):194.$58$YR$$M$Y$$$20240814$$MD$RO$
241422551$24142255$1$I$$20240725$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068294$SANDOZ$$60$YR$$M$Y$$$20240726$$CN$CA$CA
241422561$24142256$1$I$$20240722$20240726$20240726$EXP$$CA-MYLANLABS-2024M1068279$MYLAN$$57$YR$$M$Y$$$20240726$$HP$CA$CA
241422571$24142257$1$I$20220906$20240725$20240726$20240726$EXP$FR-AFSSAPS-PB2023000100$FR-PFIZER INC-2023SGN01351$PFIZER$$65$YR$$F$Y$$$20240726$$MD$FR$FR
241422601$24142260$1$I$$20240702$20240726$20240726$PER$$US-JNJFOC-20240711220$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$CN$US$US
241422611$24142261$1$I$$20240717$20240726$20240726$PER$$US-JNJFOC-20240770211$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240726$$LW$US$US
241422621$24142262$1$I$$20240724$20240726$20240726$PER$$NVSC2024US153495$NOVARTIS$$$$$F$Y$$$20240726$$MD$US$US
241422631$24142263$1$I$$20240725$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068301$SANDOZ$$49$YR$$M$Y$$$20240726$$HP$CA$CA
241422641$24142264$1$I$$20240717$20240726$20240726$EXP$CA-DRL-USA-SPO/CAN/24/0010619$CA-RDY-SPO/CAN/24/0010619$DR REDDYS$$72$YR$E$M$Y$$$20240726$$MD$CA$CA
241422651$24142265$1$I$20240101$20240724$20240726$20240726$EXP$$CN-ABBVIE-5850899$ABBVIE$$36$YR$$M$Y$60$KG$20240726$$MD$CN$CN
241422681$24142268$1$I$20240605$20240722$20240726$20240726$EXP$FR-AFSSAPS-ST2024001180$FR-FreseniusKabi-FK202411583$FRESENIUS KABI$$70$YR$E$M$Y$63$KG$20240726$$HP$FR$FR
241422691$24142269$1$I$$20240722$20240726$20240726$EXP$$DE-FreseniusKabi-FK202411496$FRESENIUS KABI$$56$YR$A$F$Y$$$20240726$$MD$DE$DE
241422701$24142270$1$I$20240701$20240722$20240726$20240726$EXP$FR-AFSSAPS-LL2024001385$FR-FreseniusKabi-FK202411608$FRESENIUS KABI$$49$YR$A$F$Y$52.5$KG$20240726$$MD$FR$FR
241422711$24142271$1$I$20240625$20240722$20240726$20240726$EXP$$DE-FreseniusKabi-FK202411492$FRESENIUS KABI$$$$$M$Y$79$KG$20240726$$MD$DE$DE
241422722$24142272$2$F$20240620$20240809$20240726$20240813$EXP$$US-009507513-2407USA013712$MERCK$$68$YR$$M$Y$$$20240813$$HP$US$US
241422732$24142273$2$F$20240724$20240808$20240726$20240810$PER$$US-AMGEN-USASP2024147755$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241422741$24142274$1$I$20240101$20240717$20240726$20240726$EXP$$US-TEVA-VS-3223458$TEVA$$17$YR$$F$Y$78.4$KG$20240726$$CN$US$US
241422751$24142275$1$I$20240718$20240723$20240726$20240726$DIR$FDA-CDER-CTU-2024-51530$$FDA-CTU$$87$YR$$M$N$80.29$KG$20240723$N$HP$US$
241422761$24142276$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51531$$FDA-CTU$$65$YR$$M$N$$$20240726$N$$US$
241422781$24142278$1$I$$20240726$20240726$20240726$DIR$711619$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241422791$24142279$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51533$$FDA-CTU$$82$YR$$F$N$$$20240726$N$$US$
241422801$24142280$1$I$20240726$20240726$20240726$20240726$DIR$711600$$FDA-CTU$$51$YR$$M$N$156$KG$20240726$N$$US$
241422811$24142281$1$I$20240725$20240726$20240726$20240726$DIR$711613$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241422821$24142282$1$I$20240720$20240723$20240726$20240726$DIR$FDA-CDER-CTU-2024-51534$$FDA-CTU$$83$YR$$M$N$87.09$KG$20240723$N$HP$US$
241422831$24142283$1$I$$20240723$20240726$20240726$EXP$$US-MYLANLABS-2024M1069788$MYLAN$Sahni T, Vessal A, Mayo-Olano S, Silverman B. Catastrophic Antiphospholipid Syndrome as a Unique Trigger for Rapidly Progressive Interstitial Lung Disease. Am-J-Respir-Crit-Care-Med 2024; 209 A1974.$46$YR$$F$Y$$$20240726$$HP$US$US
241422841$24142284$1$I$$20240725$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068268$SANDOZ$$81$YR$$M$Y$77$KG$20240726$$MD$CA$CA
241422851$24142285$1$I$20221026$20240717$20240726$20240726$EXP$IT-MINISAL02-993802$IT-TEVA-VS-3222935$TEVA$$67$YR$$M$Y$$$20240726$$MD$IT$IT
241422861$24142286$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51537$$FDA-CTU$$43$YR$$F$N$$$20240726$N$$US$
241422871$24142287$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216172$SANOFI AVENTIS$$65$YR$E$F$Y$45$KG$20240726$$MD$US$US
241422891$24142289$1$I$$20240724$20240726$20240726$EXP$$IT-ABBVIE-5854089$ABBVIE$$78$YR$$M$Y$$$20240726$$CN$IT$IT
241422901$24142290$1$I$20240714$20240724$20240726$20240726$EXP$$BG-ABBVIE-5854958$ABBVIE$$65$YR$$F$Y$$$20240726$$CN$BG$BG
241422911$24142291$1$I$20240101$20240722$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116549$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240726$$HP$US$US
241422921$24142292$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51540$$FDA-CTU$$72$YR$$M$N$$$20240726$N$HP$US$
241422931$24142293$1$I$20220101$20240711$20240726$20240726$EXP$DE-BFARM-23009796$DE-LUPIN PHARMACEUTICALS INC.-2023-11629$LUPIN$$35$YR$$F$Y$$$20240726$$MD$DE$DE
241422941$24142294$1$I$20240601$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117943$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240726$$HP$US$US
241422951$24142295$1$I$$20240719$20240726$20240726$EXP$$US-MYLANLABS-2024M1069233$MYLAN$Munaim JR, Thwe EE, Ibrahim S, Easley L, Loli A. Simultaneous arterial and venous system thrombus in patient with suspected malignancy. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 4168 (plus Poster) abstr. 1460-057.$50$YR$$M$Y$$$20240726$$HP$US$US
241422961$24142296$1$I$$20240722$20240726$20240726$EXP$$BY-MYLANLABS-2024M1069708$MYLAN$Yatskevich N, Sinha A, Alvarez J.L, Lachenal N, Solodovnikova V, Hurevich H, et.al.,. Preliminary Assessment of Safety of Six Month BPaLM/C Regimens in Patients with Rifampicin- Resistant Tuberculosis in the Republic of Belarus. Clinical infectology and parasitology. 2024;13 (2):164-176$90$YR$$$Y$$$20240726$$HP$BY$BY
241422971$24142297$1$I$$20240724$20240726$20240726$PER$$NVSC2024US153685$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241422981$24142298$1$I$20240726$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51541$$FDA-CTU$$76$YR$$M$N$$$20240726$N$HP$US$
241422991$24142299$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA215597$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240726$$MD$US$US
241423001$24142300$1$I$20240601$20240717$20240726$20240726$PER$$US-SA-2024SA216629$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240726$$MD$US$US
241423021$24142302$1$I$$20240718$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US066723$SANDOZ$$$$$$Y$$$20240726$$CN$US$US
241423031$24142303$1$I$$20240711$20240726$20240726$EXP$$US-HLS-202400349$HLS THERAPEUTICS$$65$YR$E$M$Y$$$20240726$$MD$US$US
241423041$24142304$1$I$$20240715$20240726$20240726$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07279$LUPIN$$$$$$Y$$$20240726$$CN$AU$AU
241423051$24142305$1$I$20220101$20240723$20240726$20240726$EXP$$FR-BIOVITRUM-2024-FR-010203$BIOVITRUM$$26$YR$$F$Y$$$20240726$$MD$FR$FR
241423061$24142306$1$I$20240703$20240718$20240726$20240726$PER$$US-BIOGEN-2024BI01274689$BIOGEN$$29$YR$$M$Y$$$20240726$$CN$US$US
241423071$24142307$1$I$20210622$20240719$20240726$20240726$EXP$$CA-BIOGEN-2021BI01026352$BIOGEN$$52$YR$$F$Y$$$20240726$$CN$CA$CA
241423081$24142308$1$I$20240514$20240726$20240726$20240726$EXP$$DE-SANDOZ INC.-SDZ2024DE068371$SANDOZ$$53$YR$$F$Y$$$20240726$$MD$DE$DE
241423091$24142309$1$I$20240101$20240722$20240726$20240726$EXP$$US-ABBVIE-5851003$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241423101$24142310$1$I$$20240717$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001476$BLUEPRINT MEDICINES$$$$$F$Y$$$20240726$$CN$US$US
241423111$24142311$1$I$20230926$20240722$20240726$20240726$EXP$$AR-JNJFOC-20240761156$JOHNSON AND JOHNSON$$15$YR$T$F$Y$53$KG$20240726$$CN$AR$AR
241423121$24142312$1$I$$20240723$20240726$20240726$EXP$$GB-SANDOZ INC.-SDZ2023GB053997$SANDOZ$$$$$M$Y$$$20240726$$CN$GB$GB
241423131$24142313$1$I$$20240717$20240726$20240726$EXP$NL-LRB-00979103$NL-TEVA-VS-3223177$TEVA$$56$YR$$F$Y$84$KG$20240726$$HP$NL$NL
241423141$24142314$1$I$$20240717$20240726$20240726$EXP$$US-APOTEX-2024AP008623$APOTEX$McQuinn D, Hyun M, Kim K, Kenkre VP, Fletcher CD, Rajguru SA, et al.. Minimal Residual Disease (MRD) Testing By Next Generation Sequencing (NGS) after Two Cycles (CY) of Non-Intensive Chemoimmunotherapy Is Predictive of Remission Duration and Need for Maintenance Therapy (MT) in Previously Untreated Mantle Cell Lymphoma (MCL): A Wisconsin Oncology Network Study. Blood. 2023;142 (suppl.1):4407-4408$$$$$Y$$$20240726$$MD$US$US
241423151$24142315$1$I$$20240723$20240726$20240726$EXP$$CA-ABBVIE-5853591$ABBVIE$$$$A$M$Y$$$20240726$$CN$CA$CA
241423161$24142316$1$I$20240501$20240724$20240726$20240726$EXP$GB-MHRA-31122984$GB-SANDOZ INC.-SDZ2024GB068217$SANDOZ$$69$YR$$F$Y$61$KG$20240726$$MD$GB$GB
241423171$24142317$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA215104$SANOFI AVENTIS$$$$E$F$Y$85.261$KG$20240726$$MD$US$US
241423181$24142318$1$I$20240718$20240723$20240726$20240726$EXP$$US-ABBVIE-5853142$ABBVIE$$45$YR$$F$Y$$$20240726$$CN$US$US
241423191$24142319$1$I$$20240724$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068134$SANDOZ$$14$YR$$M$Y$$$20240726$$MD$CA$CA
241423201$24142320$1$I$20240621$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146415$AMGEN$$74$YR$E$$Y$$$20240726$$CN$US$US
241423211$24142321$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147549$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241423222$24142322$2$F$$20240927$20240726$20240930$PER$$NVSC2024US152787$NOVARTIS$$79$YR$$$Y$$$20240930$$HP$US$US
241423231$24142323$1$I$$20230623$20240726$20240726$EXP$$US-AstraZeneca-2023A146463$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241423242$24142324$2$F$$20240726$20240726$20240802$EXP$$JP-AstraZeneca-2024A167079$ASTRAZENECA$Uruga H.; Miyamoto A.; Fujii T.; Okuma T.; Mitsumura T.; Tamaoka M.; Takazawa Y.. A case of hepatoid adenocarcinoma of the lung harboring KRAS G12C responded favorably to sotorasib. Pathology International 2024;1-6.$80$YR$$M$Y$$$20240802$$HP$JP$
241423251$24142325$1$I$$20240723$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068039$SANDOZ$$$$$M$Y$$$20240726$$CN$CA$CA
241423271$24142327$1$I$20230101$20240724$20240726$20240726$EXP$$US-PFIZER INC-PV202400022358$PFIZER$$80$YR$$M$Y$$$20240726$$HP$US$US
241423281$24142328$1$I$$20240722$20240726$20240726$EXP$$US-PFIZER INC-202400221647$PFIZER$$43$YR$$F$Y$$$20240726$$HP$US$US
241423291$24142329$1$I$20240101$20240725$20240726$20240726$EXP$$US-BAYER-2024A092206$BAYER$$68$YR$E$M$Y$$$20240726$$CN$US$US
241423301$24142330$1$I$$20240722$20240726$20240726$EXP$$FR-PFIZER INC-202400220694$PFIZER$$$$$F$Y$75$KG$20240726$$PH$FR$FR
241423313$24142331$3$F$$20240913$20240726$20240918$EXP$$MA-PFIZER INC-PV202400083442$PFIZER$$$$$M$Y$$$20240918$$MD$MA$MA
241423321$24142332$1$I$20240721$20240725$20240726$20240726$EXP$$CO-PFIZER INC-PV202400097384$PFIZER$$88$YR$$M$Y$$$20240726$$HP$CO$CO
241423331$24142333$1$I$$20240719$20240726$20240726$EXP$$US-BAXTER-2024BAX022068$BAXTER$$$$$$Y$$$20240726$$PH$US$US
241423342$24142334$2$F$$20240814$20240726$20240820$EXP$$US-PFIZER INC-PV202300207466$PFIZER$$34$YR$$F$Y$$$20240820$$CN$US$US
241423351$24142335$1$I$20210308$20240725$20240726$20240726$EXP$$FR-PFIZER INC-2021SGN02572$PFIZER$$$$$F$Y$$$20240726$$HP$FR$FR
241423361$24142336$1$I$$20240725$20240726$20240726$EXP$$CA-PFIZER INC-202400223945$PFIZER$$52$YR$$F$Y$$$20240726$$HP$CA$CA
241423372$24142337$2$F$20240530$20240918$20240726$20240918$EXP$$TR-PFIZER INC-PV202400097206$PFIZER$$$$A$M$Y$$$20240918$$MD$TR$TR
241423381$24142338$1$I$$20220422$20240726$20240726$EXP$$TW-AstraZeneca-2022A162342$ASTRAZENECA$$73$YR$$M$Y$$$20240726$$CN$TW$
241423391$24142339$1$I$$20200526$20240726$20240726$EXP$$GB-AstraZeneca-2020SE69227$ASTRAZENECA$$$$$F$Y$$$20240726$$HP$GB$
241423401$24142340$1$I$$20240722$20240726$20240726$EXP$$CA-ABBVIE-5853682$ABBVIE$$$$E$M$Y$$$20240726$$MD$CA$CA
241423411$24142341$1$I$20240720$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A168035$ASTRAZENECA$$26844$DY$$F$Y$$$20240726$$CN$US$
241423421$24142342$1$I$$20240725$20240726$20240726$EXP$$AU-AstraZeneca-2024A170052$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$AU$
241423431$24142343$1$I$$20240723$20240726$20240726$EXP$$ZA-AstraZeneca-2024A167869$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$ZA$
241423442$24142344$2$F$20240607$20240822$20240726$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118781$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240824$$HP$US$US
241423451$24142345$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A165555$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241423461$24142346$1$I$20240710$20240713$20240726$20240726$EXP$GB-MHRA-MED-202407130457158150-LVNHK$GB-ELI_LILLY_AND_COMPANY-GB202407009093$ELI LILLY AND CO$$28$YR$A$F$Y$90$KG$20240726$$CN$GB$GB
241423471$24142347$1$I$20230120$20240719$20240726$20240726$EXP$$KR-AstraZeneca-2024A166032$ASTRAZENECA$$833$MON$$F$Y$55.5$KG$20240726$$MD$KR$
241423481$24142348$1$I$$20240723$20240726$20240726$PER$$US-ROCHE-10000034942$ROCHE$$$$$$Y$$$20240726$$CN$US$US
241423491$24142349$1$I$$20200630$20240726$20240726$EXP$$US-AstraZeneca-2020SE84047$ASTRAZENECA$$58$YR$$F$Y$$$20240726$$CN$US$
241423501$24142350$1$I$$20240723$20240726$20240726$PER$$US-ROCHE-10000034681$ROCHE$$$$$$Y$$$20240726$$CN$US$US
241423511$24142351$1$I$$20200603$20240726$20240726$EXP$$US-AstraZeneca-2020SE73605$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241423521$24142352$1$I$20210501$20240720$20240726$20240726$EXP$$CN-AstraZeneca-2024A167442$ASTRAZENECA$Li J, Jin M, Diao Y, Li X. Dacomitinib overcomes acquired resistance to osimertinib in advanced NSCLC patients with EGFR L718Q mutation: A two-case report. Medicine 2024;103(28):e38789.$64$YR$$F$Y$$$20240726$$HP$CN$
241423531$24142353$1$I$$20200917$20240726$20240726$EXP$$US-AstraZeneca-2020SF21162$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241423541$24142354$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165914$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241423551$24142355$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A165435$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241423561$24142356$1$I$20240101$20240720$20240726$20240726$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041523$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240726$$CN$US$US
241423571$24142357$1$I$$20240711$20240726$20240726$EXP$$US-HLS-202400350$HLS THERAPEUTICS$$$$A$M$Y$$$20240726$$HP$US$US
241423581$24142358$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000036581$ROCHE$$$$A$M$Y$$$20240726$$CN$US$US
241423591$24142359$1$I$$20240725$20240726$20240726$PER$$US-ROCHE-10000037458$ROCHE$$$$$$Y$$$20240726$$CN$US$US
241423601$24142360$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000037492$ROCHE$$$$$$Y$$$20240726$$CN$US$US
241423611$24142361$1$I$20231208$20240723$20240726$20240726$EXP$$US-DSJP-DSU-2023-151694$DAIICHI$$68$YR$$F$Y$117.2$KG$20240726$$HP$US$US
241423621$24142362$1$I$$20240725$20240726$20240726$PER$$US-ROCHE-10000037494$ROCHE$$$$$$Y$$$20240726$$CN$US$US
241423641$24142364$1$I$$20240722$20240726$20240726$PER$$US-BIOVITRUM-2024-US-006884$BIOVITRUM$lkizler TA, Hung AM, Ellis CD, Shintani A, Booker C. IL-1 ? Receptor Antagonist Reduces Inflammation in Hemodialysis Patients. Journal of the American Society of Nephrology. 22(3): 437-442. doi:10.1681/ASN.2010070760.$40$YR$$M$Y$$$20240726$$MD$US$US
241423651$24142365$1$I$20240417$20240717$20240726$20240726$PER$$US-SA-2024SA213142$SANOFI AVENTIS$$$$$F$Y$$$20240726$$CN$US$US
241423671$24142367$1$I$20240501$20240717$20240726$20240726$PER$$US-SA-2024SA215036$SANOFI AVENTIS$$19$YR$A$M$Y$49$KG$20240726$$MD$US$US
241423681$24142368$1$I$$20240725$20240726$20240726$PER$$US-ROCHE-10000037514$ROCHE$$$$$M$Y$$$20240726$$CN$US$US
241423692$24142369$2$F$$20240726$20240726$20240729$PER$$US-ROCHE-10000037080$ROCHE$$$$A$M$Y$$$20240729$$CN$US$US
241423701$24142370$1$I$$20240725$20240726$20240726$PER$$US-ROCHE-10000037616$ROCHE$$2$YR$C$M$Y$$$20240726$$CN$US$US
241423711$24142371$1$I$$20240723$20240726$20240726$PER$$US-HALEON-2189111$Haleon PLC$$$$$M$Y$$$20240726$$CN$US$US
241423721$24142372$1$I$$20240715$20240726$20240726$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK092407$GLENMARK$Mohan V, Jain S, Naithani R.. Low-dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe-BIRD) in a child with relapsed/refractory B-cell acute lymphoblastic leukemia with TP53 mutation.. Pediatric Blood and Cancer.. 2024;e31152.$$$$$Y$$$20240726$$MD$IN$IN
241423731$24142373$1$I$$20240723$20240726$20240726$PER$$US-HALEON-2188662$Haleon PLC$$$$$$Y$$$20240726$$CN$US$US
241423741$24142374$1$I$$20240722$20240726$20240726$PER$$US-Breckenridge Pharmaceutical, Inc.-2159665$BRECKENRIDGE$$82$YR$$F$Y$61.818$KG$20240726$$$US$US
241423751$24142375$1$I$20240203$20240717$20240726$20240726$EXP$FR-AFSSAPS-AN2024000886$FR-TEVA-VS-3223227$TEVA$$38$YR$$M$Y$$$20240726$$PH$FR$FR
241423761$24142376$1$I$20240614$20240723$20240726$20240726$EXP$$US-OTSUKA-2024_020594$OTSUKA$$76$YR$$F$Y$$$20240726$$MD$US$US
241423772$24142377$2$F$$20240805$20240726$20240815$EXP$$US-LUNDBECK-DKLU4002031$LUNDBECK$$$$$$Y$$$20240815$$HP$GB$GB
241423781$24142378$1$I$$20240723$20240726$20240726$30DAY$$US-SANDOZ INC.-SDZ2024US067927$SANDOZ$$$$$F$Y$$$20240726$$CN$US$US
241423791$24142379$1$I$$20240723$20240726$20240726$EXP$$IT-SANDOZ INC.-SDZ2024IT067803$SANDOZ$$83$YR$$M$Y$$$20240726$$MD$IT$IT
241423812$24142381$2$F$20240601$20240723$20240726$20240730$PER$$US-AMGEN-USASP2024147253$AMGEN$$52$YR$A$M$Y$$$20240730$$HP$US$US
241423821$24142382$1$I$20240629$20240726$20240726$20240726$DIR$711621$$FDA-CTU$$52$YR$$M$N$71.55$KG$20240726$N$CN$US$
241423831$24142383$1$I$20240611$20240722$20240726$20240726$EXP$FR-AFSSAPS-AM2024000577$FR-MYLANLABS-2024M1068291$MYLAN$$45$YR$$F$Y$54$KG$20240726$$MD$FR$FR
241423841$24142384$1$I$20240122$20240722$20240726$20240726$EXP$FR-AFSSAPS-TO2024001303$FR-MYLANLABS-2024M1068268$MYLAN$$76$YR$$M$Y$$$20240726$$MD$FR$FR
241423851$24142385$1$I$$20240718$20240726$20240726$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001470$BLUEPRINT MEDICINES$$$$$M$Y$$$20240726$$CN$US$US
241423864$24142386$4$F$20240701$20240911$20240726$20240920$PER$$JP-Eisai-EC-2024-170694$EISAI$$66$YR$E$M$Y$$$20240920$$MD$JP$JP
241423871$24142387$1$I$$20240708$20240726$20240726$PER$$US-EMD Serono-2024037552$EMD SERONO INC$$80$YR$E$M$Y$$$20240726$$CN$US$US
241423881$24142388$1$I$20240201$20240724$20240726$20240726$EXP$$IN-SANDOZ INC.-SDZ2024IN068127$SANDOZ$$33$YR$$M$Y$$$20240726$$CN$IN$IN
241423891$24142389$1$I$$20240717$20240726$20240726$30DAY$$US-GSK-US2024090145$GLAXOSMITHKLINE$$$$$M$Y$$$20240726$$CN$US$US
241423902$24142390$2$F$$20240724$20240726$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US067895$SANDOZ$$$$$F$Y$$$20240729$$HP$US$US
241423911$24142391$1$I$$20240717$20240726$20240726$EXP$$US-SA-2024SA212981$SANOFI AVENTIS$$$$A$F$Y$$$20240726$$MD$US$US
241423921$24142392$1$I$20240101$20240718$20240726$20240726$EXP$$MX-SANDOZ INC.-SDZ2024MX066160$SANDOZ$$86$YR$$F$Y$85$KG$20240726$$CN$MX$MX
241423931$24142393$1$I$$20240722$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2023CA003626$SANDOZ$$$$$M$Y$$$20240726$$CN$CA$CA
241423941$24142394$1$I$$20240726$20240726$20240726$DIR$711617$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241423951$24142395$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51542$$FDA-CTU$$38$YR$$F$N$$$20240726$N$$US$
241423961$24142396$1$I$20240716$20240726$20240726$20240726$DIR$711620$$FDA-CTU$$60$YR$$M$N$69$KG$20240726$Y$HP$US$
241423971$24142397$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51538$$FDA-CTU$$42$YR$$UNK$N$$$20240725$N$$US$
241423981$24142398$1$I$20240725$20240726$20240726$20240726$DIR$711608$$FDA-CTU$$48$YR$$F$N$90.45$KG$20240726$N$CN$US$
241424001$24142400$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51539$$FDA-CTU$$$$$M$N$$$20240725$N$HP$US$
241424011$24142401$1$I$20240715$20240726$20240726$20240726$DIR$711627$$FDA-CTU$$71$YR$$F$N$91.2$KG$20240726$N$$US$
241424021$24142402$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51543$$FDA-CTU$$76$YR$$M$N$$$20240726$N$$US$
241424041$24142404$1$I$$20240726$20240726$20240726$DIR$711611$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241424051$24142405$1$I$$20240726$20240726$20240726$DIR$711606$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241424061$24142406$1$I$20240502$20240726$20240726$20240726$DIR$711629$$FDA-CTU$$14$YR$$F$N$49.95$KG$20240726$N$CN$US$
241424071$24142407$1$I$$20240718$20240726$20240726$PER$$US-ALXN-A202207556$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240726$$HP$US$US
241424081$24142408$1$I$20240711$20240718$20240726$20240726$EXP$$CN-ALCON LABORATORIES-ALC2024CN003480$ALCON$$63$YR$$F$Y$69$KG$20240726$$HP$CN$CN
241424102$24142410$2$F$$20240815$20240726$20240819$PER$$US-ALXN-202407USA001404US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241424111$24142411$1$I$20240701$20240718$20240726$20240726$EXP$$US-INDIVIOR US-INDV-146056-2024$RECKITT BENCKISER$$$$$$Y$$$20240726$$CN$US$US
241424123$24142412$3$F$$20240808$20240726$20240812$EXP$$GR-MYLANLABS-2024M1069750$MYLAN$G. Oikonomou, E. Mugakou, V. Tzavara. The importance of pharmacovigilance: a severe example of methotrexate toxicity from methotrexate. 50th annual panhellenic medical congress (abstract). ? Pathology Clinic ?Korgialenio-Benakio^. 2024;266$78$YR$$F$Y$$$20240812$$MD$GR$GR
241424131$24142413$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119140$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240726$$CN$US$US
241424141$24142414$1$I$$20240723$20240726$20240726$30DAY$$US-SANDOZ INC.-SDZ2024US067833$SANDOZ$$$$$$Y$$$20240726$$CN$US$US
241424161$24142416$1$I$20230830$20230907$20240726$20240726$EXP$$AR-BIOVITRUM-2023-AR-014891$BIOVITRUM$$156$DY$$$Y$$$20240726$$CN$AR$AR
241424173$24142417$3$F$20240717$20240724$20240726$20240824$PER$$US-AMGEN-USASP2024147765$AMGEN$$79$YR$E$M$Y$$$20240824$$PH$US$US
241424181$24142418$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118580$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240726$$CN$US$US
241424191$24142419$1$I$$20240724$20240726$20240726$30DAY$$FR-SANDOZ INC.-SDZ2024FR039053$SANDOZ$$9$YR$$F$Y$$$20240726$$PH$FR$FR
241424202$24142420$2$F$$20240725$20240726$20240729$EXP$$GB-SANDOZ INC.-SDZ2024GB068276$SANDOZ$$$$$M$Y$$$20240729$$CN$GB$GB
241424221$24142422$1$I$19991101$20240722$20240726$20240726$PER$$US-JNJFOC-20240760037$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20240726$$HP$US$US
241424232$24142423$2$F$20240101$20240729$20240726$20240801$EXP$$US-JNJFOC-20240760768$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240801$$HP$US$US
241424241$24142424$1$I$$20240726$20240726$20240726$DIR$711632$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241424251$24142425$1$I$$20240726$20240726$20240726$DIR$711634$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241424262$24142426$2$F$$20240719$20240726$20240816$PER$$US-JNJFOC-20240752647$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$HP$US$US
241424271$24142427$1$I$20240723$20240724$20240726$20240726$PER$$US-JNJFOC-20240766092$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$US$US
241424281$24142428$1$I$$20240719$20240726$20240726$EXP$$US-MYLANLABS-2024M1069252$MYLAN$Satta T, Papadopoulos EB, Gyurkocza B, Susman P, Singh A, Calafiore M, et al. Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd. Blood 2023; 142 (Suppl. 1) 7019.$70$YR$$$Y$$$20240726$$HP$US$US
241424292$24142429$2$F$$20240730$20240726$20240809$EXP$$IT-TEVA-VS-3223453$TEVA$Sanna S, Lampus M. A PARTICULAR CASE OF CARDIAC ARREST. Eur-Heart-J-Suppl 2024; 26 (Suppl.) ii70-ii71.; Sanna S, Lampus M. A PARTICULAR CASE OF CARDIAC ARREST. Eur-Heart-J-Suppl 2024; 26 (Suppl.) ii70-ii71.$88$YR$$M$Y$$$20240809$$HP$IT$IT
241424301$24142430$1$I$$20240722$20240726$20240726$PER$$US-SA-2024SA216072$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240726$$MD$US$US
241424312$24142431$2$F$$20240904$20240726$20240913$PER$$US-SA-2024SA107262$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240913$$MD$US$US
241424321$24142432$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA215931$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240726$$CN$US$US
241424331$24142433$1$I$$20240723$20240726$20240726$EXP$$GB-SANDOZ INC.-SDZ2023GB041664$SANDOZ$$$$$F$Y$$$20240726$$CN$GB$GB
241424341$24142434$1$I$20240719$20240726$20240726$20240726$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042192$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240726$$CN$US$US
241424351$24142435$1$I$$20240724$20240726$20240726$EXP$$GB-SANDOZ INC.-SDZ2024GB068233$SANDOZ$$$$$F$Y$$$20240726$$CN$GB$GB
241424361$24142436$1$I$20240517$20240716$20240726$20240726$EXP$FR-AFSSAPS-AN2024000798$FR-TEVA-VS-3215893$TEVA$$69$YR$$F$Y$68$KG$20240726$$PH$FR$FR
241424371$24142437$1$I$20190418$20240718$20240726$20240726$EXP$$CA-TAKEDA-2024TUS026378$TAKEDA$$70$YR$$F$Y$$$20240726$$HP$CA$CA
241424381$24142438$1$I$$20240725$20240726$20240726$EXP$$NVSC2024US152874$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
241424393$24142439$3$F$20240101$20240802$20240726$20240806$EXP$$US-JNJFOC-20240764974$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240807$$HP$US$US
241424401$24142440$1$I$20240721$20240724$20240726$20240726$EXP$$US-DSJP-DSU-2024-137358$DAIICHI$$34$YR$$M$Y$$$20240726$$HP$US$US
241424411$24142441$1$I$$20240724$20240726$20240726$EXP$$GB-SANDOZ INC.-SDZ2024GB068218$SANDOZ$$$$$M$Y$$$20240726$$CN$GB$GB
241424421$24142442$1$I$20240629$20240716$20240726$20240726$EXP$$CA-TEVA-VS-3225060$TEVA$$74$YR$$F$Y$$$20240726$$CN$CA$CA
241424431$24142443$1$I$$20240725$20240726$20240726$EXP$NL-LRB-00985930$NL-ROCHE-10000035884$ROCHE$$52$YR$A$F$Y$$$20240726$$HP$NL$NL
241424441$24142444$1$I$$20240724$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US068324$SANDOZ$$$$$M$Y$$$20240726$$CN$US$US
241424452$24142445$2$F$$20240730$20240726$20240809$EXP$$HR-TEVA-VS-3223511$TEVA$Dilber I., Toki  M., et al. Intrahepatic portal hypertension caused by oxaliplatin in the treatment of gastric cancer - patient report and literature review. Med Jad 2024; 54(2):129-134; Literature Reference:  Dilber I., Toki  M., et al. Intrahepatic portal hypertension caused by oxaliplatin in the treatment of gastric cancer - patient report and literature review. Med Jad 2024; 54(2):129-134$73$YR$$M$Y$$$20240809$$MD$HR$HR
241424462$24142446$2$F$$20240906$20240726$20240913$PER$$US-TAKEDA-2024TUS074619$TAKEDA$$$$$F$Y$$$20240913$$HP$US$US
241424471$24142447$1$I$$20240720$20240726$20240726$EXP$$US-TAKEDA-2024TUS074744$TAKEDA$$63$YR$$$Y$$$20240726$$CN$US$US
241424481$24142448$1$I$20240601$20240717$20240726$20240726$PER$$US-SA-2024SA214050$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240726$$MD$US$US
241424491$24142449$1$I$$20240722$20240726$20240726$PER$$US-UNITED THERAPEUTICS-UNT-2024-022686$UNITED THERAPEUTICS$$$$$M$Y$81.633$KG$20240726$$$US$US
241424502$24142450$2$F$20240601$20240808$20240726$20240820$PER$$US-SA-2024SA214893$SANOFI AVENTIS$$52$YR$A$M$Y$87$KG$20240820$$CN$US$US
241424511$24142451$1$I$20240301$20240719$20240726$20240726$PER$$US-SA-2024SA215887$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240726$$MD$US$US
241424521$24142452$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214891$SANOFI AVENTIS$$$$A$M$Y$$$20240726$$MD$US$US
241424531$24142453$1$I$$20240703$20240726$20240726$PER$$AU-TOLMAR, INC.-24AU050764$TOLMAR$$$$$M$Y$$$20240726$$CN$AU$AU
241424542$24142454$2$F$$20240802$20240726$20240826$PER$$AU-TOLMAR, INC.-24AU050774$TOLMAR$$$$$M$Y$$$20240826$$CN$AU$AU
241424551$24142455$1$I$$20240704$20240726$20240726$PER$$AU-TOLMAR, INC.-24AU050802$TOLMAR$$$$$M$Y$$$20240726$$CN$AU$AU
241424562$24142456$2$F$$20240814$20240726$20240906$PER$$US-TOLMAR, INC.-24US050707$TOLMAR$$$$$$Y$$$20240906$$PH$US$US
241424572$24142457$2$F$20240617$20240731$20240726$20240805$EXP$$TR-TITCK-300105320$SANDOZ$$35$YR$$F$Y$75$KG$20240805$$CN$TR$TR
241424581$24142458$1$I$$20240725$20240726$20240726$EXP$$GB-SANDOZ INC.-SDZ2024GB068327$SANDOZ$$$$$F$Y$$$20240726$$PH$GB$GB
241424601$24142460$1$I$$20240716$20240726$20240726$PER$$US-ABBVIE-5849048$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241424611$24142461$1$I$$20240723$20240726$20240726$EXP$$CA-PERRIGO-24CA007044$PERRIGO$$72$YR$$F$Y$$$20240726$$HP$CA$CA
241424621$24142462$1$I$$20240711$20240726$20240726$EXP$$US-HLS-202400329$HLS THERAPEUTICS$$$$A$M$Y$$$20240726$$HP$US$US
241424632$24142463$2$F$20240501$20240813$20240726$20240813$PER$$US-ALXN-202407USA001348US$ALEXION PHARMACEUTICALS$$69$YR$$F$Y$$$20240813$$CN$US$US
241424641$24142464$1$I$$20240719$20240726$20240726$EXP$$US-ABBVIE-5854086$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241424651$24142465$1$I$20240719$20240719$20240726$20240726$PER$$US-BIOGEN-2024BI01274965$BIOGEN$$59$YR$$F$Y$$$20240726$$CN$US$US
241424662$24142466$2$F$$20240913$20240726$20240923$EXP$$JP-009507513-2407JPN003501J$MERCK$Kudo A, Yamamoto K, Makio S, Hikino K, Okawa M, Iida Y, et al.. OS-269 Measures against irAE at our hospital: Efforts of the irAE working group.. The journal of the Japan Society of Gynecologic Oncology The 66th Annual Meeting. 2024;42(3):325$73$YR$$F$Y$$$20240923$$MD$JP$JP
241424671$24142467$1$I$$20240708$20240726$20240726$PER$$US-EMD Serono-2024037247$EMD SERONO INC$$$$E$F$Y$$$20240726$$CN$US$US
241424681$24142468$1$I$$20240725$20240726$20240726$EXP$GB-MHRA-MED-202407251356400930-ZGKRJ$GB-SANDOZ INC.-SDZ2024GB068260$SANDOZ$$65$YR$$M$Y$83$KG$20240726$$CN$GB$GB
241424693$24142469$3$F$20240701$20240820$20240726$20240823$EXP$$US-ABBVIE-5848712$ABBVIE$$91$YR$$F$Y$57.152$KG$20240823$$CN$US$US
241424704$24142470$4$F$20240722$20240906$20240726$20240916$30DAY$$US-JNJFOC-20240762154$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240916$$CN$US$US
241424712$24142471$2$F$$20240802$20240726$20240812$EXP$$US-KERYX BIOPHARMACEUTICALS INC.-US-AKEB-24-001108$AKEBIA THERAPEUTICS$$$$$F$Y$$$20240812$$HP$US$US
241424721$24142472$1$I$$20240715$20240726$20240726$EXP$$US-SABAL THERAPEUTICS LLC-2024-ATH-000061$ATHENA$Dalal S, Chang Z, Chamberlain C.. Hiccups Should Not Be a Hiccup in Patient Care: Utilizing Inhaled Lidocaine for Intractable Hiccups.. Journal of Pain and Symptom Management. 2024;67(5):e740$$$$$Y$$$20240726$$MD$US$US
241424732$24142473$2$F$20230101$20240903$20240726$20240913$EXP$$CA-ASTELLAS-2024US017659$ASTELLAS$$42$YR$A$F$Y$$$20240913$$HP$CA$CA
241424741$24142474$1$I$20240711$20240716$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024089429$VIIV$$35$YR$$F$Y$$$20240726$$MD$US$US
241424751$24142475$1$I$$20240723$20240726$20240726$EXP$$FI-SANDOZ INC.-PHHY2017FI021264$SANDOZ$$49$YR$$M$Y$$$20240726$$MD$FI$FI
241424761$24142476$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51551$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241424771$24142477$1$I$20240726$20240726$20240726$20240726$DIR$711633$$FDA-CTU$$77$YR$$M$N$94.5$KG$20240726$N$CN$US$
241424781$24142478$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51557$$FDA-CTU$$59$YR$$F$N$$$20240726$N$$US$
241424791$24142479$1$I$20240725$20240726$20240726$20240726$DIR$711607$$FDA-CTU$$35$YR$$M$N$144$KG$20240726$N$$US$
241424801$24142480$1$I$$20240726$20240726$20240726$DIR$711635$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241424811$24142481$1$I$20240718$20240726$20240726$20240726$DIR$711609$$FDA-CTU$$45$YR$$F$N$103.5$KG$20240726$N$CN$US$
241424821$24142482$1$I$20240701$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146722$AMGEN$$1$YR$I$F$Y$$$20240726$$CN$US$US
241424831$24142483$1$I$20240623$20240724$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118061$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240726$$CN$US$US
241424841$24142484$1$I$20240705$20240725$20240726$20240726$EXP$FR-AFSSAPS-PV2024000668$FR-SANDOZ INC.-SDZ2024FR068296$SANDOZ$$89$YR$$M$Y$70$KG$20240726$$PH$FR$FR
241424852$24142485$2$F$$20240801$20240726$20240807$EXP$$CA-AstraZeneca-2024A149361$ASTRAZENECA$$$$$F$Y$$$20240807$$MD$CA$
241424861$24142486$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3223009$TEVA$$65$YR$$F$Y$95$KG$20240726$$HP$CA$CA
241424871$24142487$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165529$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241424881$24142488$1$I$20240718$20240718$20240726$20240726$EXP$$KE-AstraZeneca-2024A165794$ASTRAZENECA$$3959$WK$$F$Y$$$20240726$$CN$KE$
241424893$24142489$3$F$$20240813$20240726$20240816$EXP$$US-AstraZeneca-2024A167036$ASTRAZENECA$$$$$M$Y$124$KG$20240816$$PH$US$
241424901$24142490$1$I$$20240719$20240726$20240726$EXP$$ET-AstraZeneca-2024A167885$ASTRAZENECA$$62$YR$$F$Y$$$20240726$$MD$ET$
241424911$24142491$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A166253$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241424921$24142492$1$I$20240703$20240717$20240726$20240726$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000651$PAREXEL$$$$$$Y$$$20240726$$HP$CN$CN
241424932$24142493$2$F$20230904$20240819$20240726$20240827$EXP$$JP-AstraZeneca-2023A267952$ASTRAZENECA$$79$YR$$M$Y$69$KG$20240827$$MD$JP$
241424941$24142494$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164441$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241424953$24142495$3$F$20240601$20240820$20240726$20240828$EXP$$US-AstraZeneca-2024A165301$ASTRAZENECA$$26069$DY$$F$Y$$$20240828$$CN$US$
241424963$24142496$3$F$$20240807$20240726$20240808$EXP$$US-ROCHE-10000037511$ROCHE$$70$YR$E$F$Y$$$20240808$$PH$US$US
241424971$24142497$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164396$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241424981$24142498$1$I$$20240718$20240726$20240726$EXP$$DE-AstraZeneca-2024A164972$ASTRAZENECA$$$$$M$Y$46.5$KG$20240726$$MD$DE$
241424992$24142499$2$F$20240718$20240729$20240726$20240806$EXP$$AR-AstraZeneca-2024A169123$ASTRAZENECA$$26412$DY$$F$Y$$$20240806$$CN$AR$
241425001$24142500$1$I$20240601$20240725$20240726$20240726$EXP$GB-MHRA-MED-202407250739342500-QMYNB$GB-SANDOZ INC.-SDZ2024GB068225$SANDOZ$$63$YR$$F$Y$$$20240726$$CN$GB$GB
241425011$24142501$1$I$20240611$20240724$20240726$20240726$EXP$$IN-AstraZeneca-2024A168811$ASTRAZENECA$$22093$DY$$M$Y$$$20240726$$CN$IN$
241425021$24142502$1$I$$20200820$20240726$20240726$EXP$$CA-AstraZeneca-2020SE92408$ASTRAZENECA$$10768$DY$$F$Y$$$20240726$$CN$CA$
241425031$24142503$1$I$20231123$20240719$20240726$20240726$EXP$$JP-AstraZeneca-2024A167325$ASTRAZENECA$$82$YR$$F$Y$49$KG$20240726$$PH$JP$
241425042$24142504$2$F$$20240906$20240726$20240913$EXP$$US-AstraZeneca-2024A165543$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
241425051$24142505$1$I$20240201$20240723$20240726$20240726$EXP$$EG-AstraZeneca-2024A169269$ASTRAZENECA$$804$MON$$F$Y$$$20240726$$CN$EG$
241425061$24142506$1$I$20090101$20240718$20240726$20240726$EXP$$DE-AstraZeneca-2024A168763$ASTRAZENECA$$39$YR$$F$Y$77$KG$20240726$$MD$DE$
241425071$24142507$1$I$$20240725$20240726$20240726$EXP$$BE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042152$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240726$$MD$BE$BE
241425091$24142509$1$I$$20240725$20240726$20240726$PER$$US-TAKEDA-2024TUS075403$TAKEDA$$$$$M$Y$$$20240726$$HP$US$US
241425101$24142510$1$I$$20240725$20240726$20240726$EXP$$NVSC2024US153061$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
241425111$24142511$1$I$$20240725$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068306$SANDOZ$$66$YR$$F$Y$$$20240726$$CN$CA$CA
241425121$24142512$1$I$$20240716$20240726$20240726$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14265$IPSEN$$$$$M$Y$$$20240726$$CN$US$US
241425131$24142513$1$I$$20240718$20240726$20240726$EXP$$US-GSK-US2024AMR091493$GLAXOSMITHKLINE$$$$$F$Y$$$20240726$$CN$US$US
241425141$24142514$1$I$$20240722$20240726$20240726$EXP$$ZA-AstraZeneca-2024A166356$ASTRAZENECA$$72$YR$$M$Y$$$20240726$$CN$ZA$
241425151$24142515$1$I$20240705$20240723$20240726$20240726$EXP$$CN-AstraZeneca-2024A168822$ASTRAZENECA$$14$YR$$F$Y$44$KG$20240726$$MD$CN$
241425161$24142516$1$I$$20240703$20240726$20240726$EXP$$CA-AstraZeneca-2024A154690$ASTRAZENECA$$$$$F$Y$$$20240726$$HP$CA$
241425171$24142517$1$I$$20210111$20240726$20240726$EXP$$US-AstraZeneca-2021A005438$ASTRAZENECA$$57$YR$$F$Y$$$20240726$$CN$US$
241425181$24142518$1$I$$20240723$20240726$20240726$PER$$US-ABBVIE-5855456$ABBVIE$$$$$$Y$$$20240726$$HP$US$US
241425191$24142519$1$I$$20240719$20240726$20240726$EXP$$ZA-AstraZeneca-2024A165393$ASTRAZENECA$$39$YR$$F$Y$$$20240726$$CN$ZA$
241425201$24142520$1$I$20240606$20240719$20240726$20240726$PER$$US-AstraZeneca-2024A165684$ASTRAZENECA$$16307$DY$$F$Y$$$20240726$$HP$US$
241425211$24142521$1$I$20230601$20240718$20240726$20240726$EXP$$CH-AstraZeneca-2024A170105$ASTRAZENECA$$24$YR$$F$Y$$$20240726$$MD$CH$
241425221$24142522$1$I$$20240723$20240726$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118732$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240726$$MD$JP$JP
241425231$24142523$1$I$20240406$20240722$20240726$20240726$EXP$$US-AstraZeneca-2024A166831$ASTRAZENECA$$27207$DY$$M$Y$$$20240726$$CN$US$
241425241$24142524$1$I$20210424$20210514$20240726$20240726$EXP$$US-AstraZeneca-2021A438484$ASTRAZENECA$$28919$DY$$M$Y$$$20240726$$CN$US$
241425251$24142525$1$I$$20240718$20240726$20240726$EXP$$ZA-AstraZeneca-2024A164280$ASTRAZENECA$$57$YR$$M$Y$$$20240726$$CN$ZA$
241425261$24142526$1$I$$20240719$20240726$20240726$EXP$$US-VIIV HEALTHCARE LIMITED-US2024091082$VIIV$$$$$M$Y$$$20240726$$CN$US$US
241425281$24142528$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164459$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241425301$24142530$1$I$20240712$20240723$20240726$20240726$EXP$$DE-AstraZeneca-2024A167220$ASTRAZENECA$$23$YR$$F$Y$$$20240726$$MD$DE$
241425311$24142531$1$I$20220524$20220627$20240726$20240726$EXP$$SG-AstraZeneca-2022A240604$ASTRAZENECA$$28512$DY$$M$Y$$$20240726$$CN$SG$
241425321$24142532$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153308$NOVARTIS$$$$$M$Y$$$20240726$$CN$US$US
241425331$24142533$1$I$20220222$20240718$20240726$20240726$EXP$PL-URPL-DML-MLP.4401.1.761.2022$PL-TEVA-VS-3223419$TEVA$$66$YR$$F$Y$57$KG$20240726$$MD$PL$PL
241425347$24142534$7$F$20240522$20240921$20240726$20240926$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2024064869$VIIV$$$$$$Y$$$20240926$$HP$CA$CA
241425361$24142536$1$I$$20240722$20240726$20240726$EXP$$PL-PFIZER INC-202400222712$PFIZER$Kaminski, M.. Myositis with creatinine phosphokinase activity over 13,500 U/L in the course of granulomatosis with polyangiitis. Rheumatol. Forum. 2024;vol. 10, no. 2:100-102$66$YR$$F$Y$$$20240726$$MD$PL$PL
241425372$24142537$2$F$$20240726$20240726$20240730$EXP$$CO-GSK-CO2024AMR093151$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$CO$CO
241425381$24142538$1$I$20240723$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024147840$AMGEN$$72$YR$E$F$Y$$$20240726$$CN$US$US
241425391$24142539$1$I$$20240723$20240726$20240726$EXP$$CA-PERRIGO-24CA007050$PERRIGO$$55$YR$$M$Y$$$20240726$$HP$CA$CA
241425402$24142540$2$F$$20240727$20240726$20240806$PER$$US-RDY-SPO/USA/24/0010335$DR REDDYS$$$$$$Y$$$20240806$$CN$US$US
241425411$24142541$1$I$$20240715$20240726$20240726$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092466$GLENMARK$$$$$$Y$$$20240726$$PH$US$US
241425423$24142542$3$F$$20240829$20240726$20240903$30DAY$$AT-MYLANLABS-2024M1069028$MYLAN$$$$$$Y$$$20240903$$PH$AT$AT
241425431$24142543$1$I$$20240726$20240726$20240726$DIR$711636$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241425441$24142544$1$I$20240724$20240726$20240726$20240726$DIR$711610$$FDA-CTU$$69$YR$$F$N$75.7$KG$20240726$N$PH$US$
241425451$24142545$1$I$$20240725$20240726$20240726$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042070$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240726$$CN$US$US
241425461$24142546$1$I$$20240717$20240726$20240726$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-14381$IPSEN$$$$$$Y$$$20240726$$MD$US$US
241425472$24142547$2$F$$20240903$20240726$20240911$EXP$$CA-OTSUKA-2024_020407$OTSUKA$$$$$M$Y$$$20240911$$HP$CA$CA
241425481$24142548$1$I$$20240723$20240726$20240726$EXP$$CA-PERRIGO-24CA007051$PERRIGO$$66$YR$$F$Y$$$20240726$$HP$CA$CA
241425501$24142550$1$I$20240708$20240723$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118718$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240726$$MD$US$US
241425511$24142551$1$I$$20240717$20240726$20240726$EXP$$US-VIIV HEALTHCARE LIMITED-US2024090073$VIIV$$$$$F$Y$$$20240726$$HP$US$US
241425521$24142552$1$I$$20240719$20240726$20240726$EXP$$US-GSK-US2024091266$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241425531$24142553$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-PV202400097200$PFIZER$$22$YR$$M$Y$$$20240726$$CN$US$US
241425542$24142554$2$F$$20240822$20240726$20240822$PER$$US-PFIZER INC-202400222378$PFIZER$$69$YR$$F$Y$$$20240822$$CN$US$US
241425551$24142555$1$I$$20240724$20240726$20240726$PER$$US-PFIZER INC-PV202400097209$PFIZER$$29$YR$$M$Y$$$20240726$$CN$US$US
241425562$24142556$2$F$$20240821$20240726$20240827$PER$$US-PFIZER INC-PV202400097572$PFIZER$$56$YR$$F$Y$$$20240827$$HP$US$US
241425573$24142557$3$F$$20240920$20240726$20240923$PER$$US-PFIZER INC-202400223577$PFIZER$$58$YR$$M$Y$$$20240923$$CN$US$US
241425583$24142558$3$F$$20240730$20240726$20240814$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092470$GLENMARK$$$$$$Y$$$20240814$$CN$US$US
241425591$24142559$1$I$20240702$20240717$20240726$20240726$EXP$EU-SAM-2024078288$EU-SEPTODONT-2024018810$SEPTODONT$$$$A$$Y$58$KG$20240726$$HP$EU$EU
241425611$24142561$1$I$$20240716$20240726$20240726$EXP$$JP-009507513-2407JPN003503J$MERCK$Harada A, Kodera R, Nishi M, Nagata K, Ohashi K, Kawashita S, et al.. P-197 Experience with pembrolizumab + lenvatinib combination therapy for corpus uteri carcinoma in our hospital. The journal of the Japan Society of Gynecologic Oncology  The 66th Annual Meetin. 2024;42(3):404$$$$F$Y$$$20240726$$MD$JP$JP
241425621$24142562$1$I$20240501$20240723$20240726$20240726$EXP$FR-AFSSAPS-LY2024001097$FR-ABBVIE-5852179$ABBVIE$$63$YR$$F$Y$$$20240726$$PH$FR$FR
241425631$24142563$1$I$$20240718$20240726$20240726$EXP$$NVSC2024BR150210$NOVARTIS$$$$$F$Y$$$20240726$$CN$BR$BR
241425641$24142564$1$I$20240101$20240722$20240726$20240726$EXP$$US-ABBVIE-5852123$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241425654$24142565$4$F$20240101$20240909$20240726$20240912$EXP$$US-ABBVIE-5852689$ABBVIE$$$$$M$Y$77$KG$20240912$$CN$US$US
241425662$24142566$2$F$$20240820$20240726$20240821$EXP$$US-ALXN-202407USA001442US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240821$$HP$US$US
241425671$24142567$1$I$$20240720$20240726$20240726$PER$$US-ORGANON-O2407USA002293$ORGANON$$$$$M$Y$$$20240726$$CN$US$US
241425681$24142568$1$I$$20240715$20240726$20240726$30DAY$$ES-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004066$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240726$$HP$ES$ES
241425691$24142569$1$I$20240715$20240718$20240726$20240726$PER$$US-SA-2024SA215051$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240726$$MD$US$US
241425701$24142570$1$I$20240717$20240717$20240726$20240726$PER$$US-SA-2024SA214807$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240726$$MD$US$US
241425711$24142571$1$I$20240101$20240724$20240726$20240726$EXP$DE-BFARM-24005048$DE-009507513-2407DEU013569$MERCK$$59$YR$$M$Y$93$KG$20240726$$MD$DE$DE
241425721$24142572$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216070$SANOFI AVENTIS$$$$E$F$Y$100.2$KG$20240726$$MD$US$US
241425731$24142573$1$I$$20240724$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2023US040843$SANDOZ$$$$$F$Y$72.562$KG$20240726$$CN$US$US
241425741$24142574$1$I$$20200724$20240726$20240726$EXP$$US-AstraZeneca-2020SE94189$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241425751$24142575$1$I$20240707$20240723$20240726$20240726$EXP$$ZA-AstraZeneca-2024A167781$ASTRAZENECA$$63$YR$$M$Y$$$20240726$$CN$ZA$
241425761$24142576$1$I$$20240723$20240726$20240726$EXP$$SG-AstraZeneca-2024A167516$ASTRAZENECA$$$$$M$Y$$$20240726$$MD$SG$
241425771$24142577$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165771$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241425781$24142578$1$I$20240714$20240718$20240726$20240726$EXP$$JP-AstraZeneca-2024A165935$ASTRAZENECA$$$$A$F$Y$$$20240726$$PH$JP$
241425791$24142579$1$I$$20210521$20240726$20240726$EXP$$US-AstraZeneca-2021A458672$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241425801$24142580$1$I$20220327$20240716$20240726$20240726$EXP$FR-AFSSAPS-RN2024000745$FR-TEVA-VS-3222265$TEVA$$26$YR$$M$Y$$$20240726$$MD$FR$FR
241425811$24142581$1$I$20240608$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165882$ASTRAZENECA$$$$$F$Y$84.8$KG$20240726$$CN$US$
241425821$24142582$1$I$$20240718$20240726$20240726$EXP$$JP-AstraZeneca-2024A165347$ASTRAZENECA$$$$$$Y$$$20240726$$MD$JP$
241425831$24142583$1$I$20240326$20240718$20240726$20240726$EXP$$ES-AstraZeneca-2024A169020$ASTRAZENECA$$88$YR$$M$Y$62.4$KG$20240726$$MD$ES$
241425842$24142584$2$F$20240717$20240906$20240726$20240910$EXP$$US-AstraZeneca-2024A164877$ASTRAZENECA$$36$YR$$F$Y$$$20240910$$HP$US$
241425851$24142585$1$I$$20240722$20240726$20240726$EXP$$DE-009507513-2407DEU013182$MERCK$$$$$M$Y$$$20240726$$PH$DE$DE
241425862$24142586$2$F$$20240719$20240726$20240815$EXP$$JP-AstraZeneca-2024A167235$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$JP$
241425871$24142587$1$I$20210407$20210507$20240726$20240726$EXP$$CO-AstraZeneca-2021A414500$ASTRAZENECA$$25859$DY$$F$Y$$$20240726$$CN$CO$
241425883$24142588$3$F$20240708$20240903$20240726$20240905$EXP$$NZ-MYLANLABS-2024M1068608$MYLAN$$64$YR$$F$Y$$$20240905$$HP$NZ$NZ
241425891$24142589$1$I$$20240722$20240726$20240726$EXP$$US-GSK-US2024AMR092599$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241425902$24142590$2$F$20240712$20240816$20240726$20240822$30DAY$$US-AMGEN-USASP2024144329$AMGEN$$70$YR$E$M$Y$81$KG$20240822$$PH$US$US
241425911$24142591$1$I$$20240722$20240726$20240726$EXP$$US-GSK-US2024AMR092521$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241425921$24142592$1$I$20240429$20240715$20240726$20240726$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000659$PAREXEL$$$$$$Y$$$20240726$$HP$CN$CN
241425941$24142594$1$I$20240101$20240725$20240726$20240726$EXP$$US-ABBVIE-5854441$ABBVIE$$67$YR$$M$Y$$$20240726$$HP$US$US
241425951$24142595$1$I$20240710$20240726$20240726$20240726$EXP$$US-KYOWAKIRIN-2024KK017987$KYOWA$$$$$$Y$$$20240726$$HP$US$US
241425961$24142596$1$I$$20240722$20240726$20240726$EXP$$US-GSK-US2024AMR092781$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241425971$24142597$1$I$20240518$20240718$20240726$20240726$PER$$US-SA-2024SA215027$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240726$$MD$US$US
241425981$24142598$1$I$20240501$20240722$20240726$20240726$EXP$$US-GSK-US2024091875$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241425991$24142599$1$I$20240721$20240721$20240726$20240726$PER$$US-SA-2024SA216707$SANOFI AVENTIS$$$$$F$Y$$$20240726$$CN$US$US
241426001$24142600$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA211653$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240726$$MD$US$US
241426011$24142601$1$I$$20240723$20240726$20240726$EXP$$CA-PERRIGO-24CA007062$PERRIGO$$55$YR$$M$Y$$$20240726$$CN$CA$CA
241426021$24142602$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222749$TEVA$$$$$F$Y$97$KG$20240726$$HP$CA$CA
241426031$24142603$1$I$$20240719$20240726$20240726$PER$$US-009507513-2407USA012321$MERCK$$$$$F$Y$$$20240726$$HP$US$US
241426041$24142604$1$I$$20240718$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092571$VIIV$$$$$$Y$$$20240726$$HP$US$US
241426051$24142605$1$I$$20240720$20240726$20240726$PER$$US-BAUSCH-BL-2024-011170$BAUSCH AND LOMB$$69$YR$$F$Y$74.4$KG$20240726$$CN$US$US
241426061$24142606$1$I$$20240725$20240726$20240726$PER$$US-BAYER-2024A108403$BAYER$$90$YR$E$M$Y$$$20240726$$CN$US$US
241426071$24142607$1$I$20240712$20240725$20240726$20240726$EXP$GB-MHRA-MED-202407251503395980-STHPD$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042096$BOEHRINGER INGELHEIM$$57$YR$A$M$Y$79$KG$20240726$$CN$GB$GB
241426081$24142608$1$I$$20240722$20240726$20240726$EXP$$US-ABBVIE-5850754$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241426101$24142610$1$I$20240725$20240726$20240726$20240726$DIR$711624$$FDA-CTU$$73$YR$$F$N$74$KG$20240726$N$HP$US$
241426111$24142611$1$I$$20240725$20240726$20240726$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137527$DAIICHI$$$$$F$Y$$$20240726$$CN$US$US
241426121$24142612$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA214953$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240726$$MD$US$US
241426131$24142613$1$I$20240101$20240719$20240726$20240726$EXP$$US-SA-2024SA123981$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240726$$CN$US$US
241426141$24142614$1$I$$20240718$20240726$20240726$PER$$US-BAUSCH-BL-2024-011102$BAUSCH AND LOMB$$$$$F$Y$$$20240726$$CN$US$US
241426151$24142615$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214031$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240726$$MD$US$US
241426161$24142616$1$I$$20240723$20240726$20240726$EXP$$CA-PERRIGO-24CA007054$PERRIGO$$51$YR$$F$Y$$$20240726$$CN$CA$CA
241426172$24142617$2$F$$20240925$20240726$20240925$EXP$$NVSC2024US149861$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
241426181$24142618$1$I$$20240724$20240726$20240726$EXP$$US-BAUSCH-BL-2024-008434$BAUSCH AND LOMB$$37$YR$$M$Y$$$20240726$$CN$US$US
241426192$24142619$2$F$20240304$20240726$20240726$20240731$EXP$$US-BAUSCH-BL-2024-003714$BAUSCH AND LOMB$$74$YR$$F$Y$$$20240731$$MD$US$US
241426201$24142620$1$I$$20240716$20240726$20240726$EXP$$US-KERYX BIOPHARMACEUTICALS INC.-US-AKEB-24-001109$AKEBIA THERAPEUTICS$$$$$M$Y$$$20240726$$CN$US$US
241426212$24142621$2$F$$20240726$20240726$20240801$EXP$$JP-CARA THERAPEUTICS, INC.-2024-00360-JP$CARA THERAPEUTICS$$74$YR$$M$Y$$$20240801$$HP$JP$JP
241426222$24142622$2$F$$20240725$20240726$20240729$EXP$$US-BAUSCH-BL-2024-011428$BAUSCH AND LOMB$$60$YR$$F$Y$$$20240729$$CN$US$US
241426231$24142623$1$I$$20240723$20240726$20240726$EXP$$NVSC2024US152178$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
241426242$24142624$2$F$$20240906$20240726$20240906$PER$$NVSC2024US152806$NOVARTIS$$$$$F$Y$$$20240906$$HP$US$US
241426251$24142625$1$I$$20240724$20240726$20240726$PER$$NVSC2024US153718$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241426263$24142626$3$F$20240701$20240809$20240726$20240814$EXP$$JP-009507513-2407JPN004200J$MERCK$$58$YR$$M$Y$$$20240814$$MD$JP$JP
241426271$24142627$1$I$$20240723$20240726$20240726$EXP$$US-JNJFOC-20240764898$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$CN$US$US
241426281$24142628$1$I$20240619$20240717$20240726$20240726$EXP$FR-AFSSAPS-GR2024000871$FR-TEVA-VS-3222817$TEVA$$60$YR$$F$Y$71$KG$20240726$$PH$FR$FR
241426291$24142629$1$I$$20240711$20240726$20240726$EXP$$US-HLS-202400334$HLS THERAPEUTICS$$30$YR$A$F$Y$$$20240726$$CN$US$US
241426301$24142630$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA216546$SANOFI AVENTIS$$$$A$F$Y$97.5$KG$20240726$$MD$US$US
241426321$24142632$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119077$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$52.62$KG$20240726$$HP$US$US
241426331$24142633$1$I$$20240724$20240726$20240726$EXP$$RO-BAUSCH-BL-2024-011386$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240726$$CN$RO$RO
241426341$24142634$1$I$20240706$20240718$20240726$20240726$EXP$$CO-AstraZeneca-2024A165790$ASTRAZENECA$$17928$DY$$F$Y$$$20240726$$CN$CO$
241426351$24142635$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164599$ASTRAZENECA$$$$$$Y$$$20240726$$MD$US$
241426361$24142636$1$I$$20210713$20240726$20240726$EXP$$AU-AstraZeneca-2021A287588$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$AU$
241426371$24142637$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119086$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240726$$HP$US$US
241426381$24142638$1$I$$20240715$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010845$ELI LILLY AND CO$$$$$$Y$$$20240726$$CN$US$US
241426391$24142639$1$I$20210330$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119156$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$59.5$KG$20240726$$PH$US$US
241426401$24142640$1$I$$20240723$20240726$20240726$EXP$$DE-AstraZeneca-2024A168816$ASTRAZENECA$$$$A$F$Y$64$KG$20240726$$MD$DE$
241426411$24142641$1$I$$20240715$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009499$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240726$$CN$US$US
241426421$24142642$1$I$20240624$20240718$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115362$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240726$$HP$US$US
241426432$24142643$2$F$20240301$20240729$20240726$20240806$EXP$$MX-AstraZeneca-2024A167365$ASTRAZENECA$$29312$DY$$F$Y$59$KG$20240806$$CN$MX$
241426441$24142644$1$I$$20240715$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009569$ELI LILLY AND CO$$71$YR$E$$Y$$$20240726$$LW$US$US
241426451$24142645$1$I$20231201$20240715$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011050$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240726$$CN$US$US
241426461$24142646$1$I$20240501$20240716$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010440$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240726$$CN$US$US
241426471$24142647$1$I$20240701$20240722$20240726$20240726$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202407016981$ELI LILLY AND CO$$$$E$F$Y$$$20240726$$CN$CO$CO
241426482$24142648$2$F$20240701$20240913$20240726$20240924$EXP$$ZA-ELI_LILLY_AND_COMPANY-ZA202407009923$ELI LILLY AND CO$$$$$M$Y$75$KG$20240924$$MD$ZA$ZA
241426491$24142649$1$I$20240601$20240716$20240726$20240726$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407010777$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240726$$CN$KR$KR
241426501$24142650$1$I$$20240715$20240726$20240726$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407010125$ELI LILLY AND CO$$$$$$Y$$$20240726$$PH$KR$KR
241426511$24142651$1$I$$20240715$20240726$20240726$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202407010874$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$SA$SA
241426521$24142652$1$I$20240614$20240726$20240726$20240726$DIR$711622$$FDA-CTU$$56$YR$$F$N$62.1$KG$20240726$N$CN$US$
241426531$24142653$1$I$20240601$20240716$20240726$20240726$EXP$GB-MHRA-MED-202407162115540930-SCPKD$GB-ELI_LILLY_AND_COMPANY-GB202407010875$ELI LILLY AND CO$$$$$$Y$$$20240726$$CN$GB$GB
241426541$24142654$1$I$$20240715$20240726$20240726$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202407010497$ELI LILLY AND CO$$$$$F$Y$$$20240726$$MD$SA$SA
241426551$24142655$1$I$$20240715$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009858$ELI LILLY AND CO$$$$$M$Y$$$20240726$$CN$US$US
241426572$24142657$2$F$$20240809$20240726$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010774$ELI LILLY AND CO$$45$YR$A$F$Y$90$KG$20240816$$HP$US$US
241426581$24142658$1$I$20230101$20240716$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011043$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240726$$CN$US$US
241426592$24142659$2$F$$20240716$20240726$20240806$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407006395$ELI LILLY AND CO$$$$$F$Y$$$20240806$$CN$DE$DE
241426601$24142660$1$I$$20240716$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010705$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240726$$CN$US$US
241426611$24142661$1$I$20240701$20240715$20240726$20240726$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407008899$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240726$$CN$DE$DE
241426621$24142662$1$I$$20240716$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010722$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240726$$CN$US$US
241426631$24142663$1$I$$20240715$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009598$ELI LILLY AND CO$$58$YR$A$$Y$$$20240726$$CN$US$US
241426641$24142664$1$I$$20240716$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011247$ELI LILLY AND CO$$$$$F$Y$$$20240726$$MD$US$US
241426651$24142665$1$I$20240601$20240715$20240726$20240726$EXP$GB-MHRA-MED-202407150724403310-YCJKH$GB-ELI_LILLY_AND_COMPANY-GB202407009111$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240726$$CN$GB$GB
241426661$24142666$1$I$20240714$20240716$20240726$20240726$EXP$GB-MHRA-MED-202407161553284770-RWHPL$GB-ELI_LILLY_AND_COMPANY-GB202407010971$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240726$$CN$GB$GB
241426671$24142667$1$I$$20200416$20240726$20240726$EXP$$US-AstraZeneca-2020SE21997$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241426681$24142668$1$I$20240101$20240718$20240726$20240726$EXP$$JP-AstraZeneca-2024A165357$ASTRAZENECA$$$$$M$Y$$$20240726$$MD$JP$
241426691$24142669$1$I$20240605$20240719$20240726$20240726$EXP$$CN-AstraZeneca-2024A167767$ASTRAZENECA$$79$YR$$M$Y$$$20240726$$MD$CN$
241426701$24142670$1$I$20060101$20240723$20240726$20240726$EXP$$US-ABBVIE-5851932$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241426711$24142671$1$I$20221125$20240719$20240726$20240726$EXP$$KR-AstraZeneca-2024A166067$ASTRAZENECA$$831$MON$$F$Y$55.5$KG$20240726$$MD$KR$
241426721$24142672$1$I$20230327$20240723$20240726$20240726$EXP$$FR-AstraZeneca-2024A169770$ASTRAZENECA$$39$YR$$F$Y$110$KG$20240726$$MD$FR$
241426731$24142673$1$I$20230530$20240719$20240726$20240726$EXP$$JP-AstraZeneca-2024A167351$ASTRAZENECA$$82$YR$$F$Y$49$KG$20240726$$PH$JP$
241426741$24142674$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164389$ASTRAZENECA$$$$$M$Y$$$20240726$$MD$US$
241426751$24142675$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164604$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241426763$24142676$3$F$20110101$20240821$20240726$20240829$EXP$$US-AstraZeneca-2024A165437$ASTRAZENECA$$57$YR$$F$Y$$$20240829$$CN$US$
241426772$24142677$2$F$20240508$20240731$20240726$20240805$EXP$$FR-AstraZeneca-2024A168827$ASTRAZENECA$$58$YR$$M$Y$$$20240805$$MD$FR$
241426781$24142678$1$I$20240717$20240719$20240726$20240726$EXP$$CN-AstraZeneca-2024A167839$ASTRAZENECA$$23497$DY$$M$Y$48$KG$20240726$$MD$CN$
241426792$24142679$2$F$$20240716$20240726$20240730$EXP$$US-TEVA-VS-3221876$TEVA$$66$YR$$F$Y$$$20240730$$CN$US$US
241426801$24142680$1$I$20210707$20210721$20240726$20240726$EXP$$GB-AstraZeneca-2021A634051$ASTRAZENECA$$$$$$Y$$$20240726$$HP$GB$
241426811$24142681$1$I$20240722$20240723$20240726$20240726$EXP$$US-AstraZeneca-2024A168205$ASTRAZENECA$$$$$M$Y$$$20240726$$HP$US$
241426822$24142682$2$F$$20240801$20240726$20240803$PER$$US-AMGEN-USASP2024149236$AMGEN$$$$E$F$Y$$$20240803$$HP$US$US
241426831$24142683$1$I$$20240502$20240726$20240726$PER$$US-AstraZeneca-2024A105498$ASTRAZENECA$$$$A$F$Y$$$20240726$$MD$US$
241426841$24142684$1$I$20240201$20240521$20240726$20240726$PER$$US-AstraZeneca-2024A119422$ASTRAZENECA$$$$$F$Y$$$20240726$$MD$US$
241426851$24142685$1$I$$20240625$20240726$20240726$PER$$US-AstraZeneca-2024A120226$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241426861$24142686$1$I$$20240508$20240726$20240726$PER$$US-AstraZeneca-2024A114261$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241426871$24142687$1$I$$20240604$20240726$20240726$PER$$US-AstraZeneca-2024A130957$ASTRAZENECA$$$$$$Y$$$20240726$$HP$US$
241426881$24142688$1$I$$20240711$20240726$20240726$PER$$US-AstraZeneca-2024A159953$ASTRAZENECA$$$$$F$Y$$$20240726$$MD$US$
241426892$24142689$2$F$$20240819$20240726$20240824$PER$$US-AstraZeneca-2024A163613$ASTRAZENECA$$$$$F$Y$$$20240824$$MD$US$
241426902$24142690$2$F$20240628$20240819$20240726$20240824$PER$$US-AstraZeneca-2024A163777$ASTRAZENECA$$11776$DY$$F$Y$$$20240824$$CN$US$
241426911$24142691$1$I$20240702$20240719$20240726$20240726$EXP$$ES-BIOGEN-2024BI01274974$BIOGEN$$$$$M$Y$$$20240726$$MD$ES$ES
241426922$24142692$2$F$20240720$20240822$20240726$20240830$EXP$$CA-OTSUKA-2024_020396$OTSUKA$$17$YR$$M$Y$$$20240830$$HP$CA$CA
241426931$24142693$1$I$$20240718$20240726$20240726$EXP$$US-ABBVIE-5847969$ABBVIE$$$$$M$Y$$$20240726$$CN$US$US
241426941$24142694$1$I$$20230622$20240726$20240726$EXP$$AR-BIOVITRUM-2023-AR-012270$BIOVITRUM$$$$I$F$Y$$$20240726$$CN$AR$AR
241426951$24142695$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA216030$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240726$$MD$US$US
241426962$24142696$2$F$$20240730$20240726$20240809$EXP$$IT-TEVA-VS-3223476$TEVA$Carpenedo M, Zappaterra A, Ferrari B, Cotilli G. Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists. Mediterr-J-Hematol-Infect-Dis 2023; 15 (1):.; Carpenedo M, Zappaterra A, Ferrari B, Cotilli G. Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Recept...$80$YR$$M$Y$$$20240809$$HP$IT$IT
241426971$24142697$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215912$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240726$$MD$US$US
241426981$24142698$1$I$$20240723$20240726$20240726$EXP$$CZ-MYLANLABS-2024M1068868$MYLAN$Hockickova I, Hockicko J, Ruzickova T, et al.. Malaria - an increasingly common problem even in Slovakia. Vseobecny lekar. 2024;3(1):25-7$70$YR$$F$Y$$$20240726$$MD$CZ$CZ
241426991$24142699$1$I$$20240723$20240726$20240726$PER$$US-JNJFOC-20240767035$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$MD$US$US
241427001$24142700$1$I$$20240723$20240726$20240726$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011236$JAZZ$$$$$M$Y$46.8$KG$20240726$$CN$US$US
241427011$24142701$1$I$20240527$20240718$20240726$20240726$EXP$$SA-RDY-SPO/SAU/24/0008646$DR REDDYS$$84$YR$E$M$Y$$$20240726$$PH$SA$SA
241427022$24142702$2$F$$20240725$20240726$20240729$PER$$NVSC2024US153557$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241427031$24142703$1$I$$20240714$20240726$20240726$EXP$$US-JNJFOC-20240756468$JOHNSON AND JOHNSON$Applegarth J, Finn D, Tolkacz M, Iacco A. Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome. ASAIO Journal. 2024;70:151--.$18$YR$A$F$Y$$$20240726$$HP$US$US
241427043$24142704$3$F$$20240802$20240726$20240809$EXP$$NVSC2024AR151242$NOVARTIS$$$$$F$Y$$$20240809$$CN$AR$AR
241427061$24142706$1$I$20240716$20240716$20240726$20240726$EXP$$US-JNJFOC-20240747925$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240726$$HP$US$US
241427071$24142707$1$I$20240718$20240718$20240726$20240726$PER$$US-MYLANLABS-2024M1069506$MYLAN$$51$YR$$F$Y$$$20240726$$CN$US$US
241427082$24142708$2$F$20240716$20240910$20240726$20240917$EXP$$BE-EXELIXIS-XL18424079855$EXELIXIS$$70$YR$$M$Y$70$KG$20240917$$MD$BE$BE
241427091$24142709$1$I$$20240726$20240726$20240726$DIR$711648$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241427101$24142710$1$I$$20240722$20240726$20240726$EXP$$US-009507513-2407USA012890$MERCK$$$$$M$Y$$$20240726$$CN$US$US
241427111$24142711$1$I$20240101$20240722$20240726$20240726$EXP$$CA-ABBVIE-5852017$ABBVIE$$$$E$F$Y$$$20240726$$MD$CA$CA
241427121$24142712$1$I$$20240723$20240726$20240726$EXP$$IT-009507513-2407ITA013700$MERCK$$$$$F$Y$$$20240726$$MD$IT$IT
241427131$24142713$1$I$20240101$20240722$20240726$20240726$EXP$$FR-ABBVIE-5852151$ABBVIE$$61$YR$$F$Y$$$20240726$$HP$FR$FR
241427141$24142714$1$I$$20240710$20240726$20240726$PER$$US-MYLANLABS-2024M1065449$MYLAN$$$$$F$Y$$$20240726$$CN$US$US
241427161$24142716$1$I$$20240724$20240726$20240726$PER$$NVSC2024US153715$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241427171$24142717$1$I$20240718$20240722$20240726$20240726$EXP$$AU-ABBVIE-5850709$ABBVIE$$43$YR$$F$Y$$$20240726$$CN$AU$AU
241427191$24142719$1$I$$20240722$20240726$20240726$EXP$$JP-OTSUKA-2024_020406$OTSUKA$$40$YR$$F$Y$$$20240726$$MD$JP$JP
241427203$24142720$3$F$20240405$20240917$20240726$20240926$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001142$AKEBIA THERAPEUTICS$$65$YR$$M$Y$69.5$KG$20240926$$MD$JP$JP
241427251$24142725$1$I$20240725$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51570$$FDA-CTU$$57$YR$$M$N$$$20240725$N$PH$US$
241427262$24142726$2$F$20240101$20240821$20240726$20240824$EXP$$JP-ABBVIE-5853160$ABBVIE$$40$YR$$M$Y$$$20240824$$MD$JP$JP
241427271$24142727$1$I$20240722$20240723$20240726$20240726$EXP$$CA-OTSUKA-2024_020667$OTSUKA$$65$YR$$M$Y$$$20240726$$HP$CA$CA
241427281$24142728$1$I$$20240721$20240726$20240726$EXP$$SY-TAKEDA-2024TUS074999$TAKEDA$$$$$M$Y$$$20240726$$CN$SY$SY
241427291$24142729$1$I$20240101$20240717$20240726$20240726$PER$$US-SA-2024SA214902$SANOFI AVENTIS$$67$YR$E$F$Y$56.6$KG$20240726$$MD$US$US
241427301$24142730$1$I$20240624$20240718$20240726$20240726$EXP$FR-AFSSAPS-PP2024000778$FR-SA-2024SA213502$SANOFI AVENTIS$$58$YR$A$F$Y$75$KG$20240726$$PH$FR$FR
241427311$24142731$1$I$$20240724$20240726$20240726$PER$$US-JNJFOC-20240767926$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$MD$US$US
241427321$24142732$1$I$20230101$20240716$20240726$20240726$EXP$$NZ-JNJFOC-20240772212$JOHNSON AND JOHNSON$$31$YR$A$F$Y$55$KG$20240726$$HP$NZ$NZ
241427332$24142733$2$F$20240101$20240729$20240726$20240731$EXP$$US-ABBVIE-5851056$ABBVIE$$$$$M$Y$140.61$KG$20240731$$CN$US$US
241427341$24142734$1$I$$20240723$20240726$20240726$EXP$$RO-AstraZeneca-2024A169955$ASTRAZENECA$$75$YR$$M$Y$$$20240726$$MD$RO$
241427351$24142735$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A167456$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241427361$24142736$1$I$20240615$20240722$20240726$20240726$EXP$$PH-AstraZeneca-2024A166367$ASTRAZENECA$$31524$DY$$F$Y$$$20240726$$CN$PH$
241427371$24142737$1$I$$20240718$20240726$20240726$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091429$VIIV$$$$$F$Y$85.714$KG$20240726$$CN$US$US
241427381$24142738$1$I$20120201$20240722$20240726$20240726$EXP$$US-ABBVIE-5852276$ABBVIE$$49$YR$$M$Y$$$20240726$$CN$US$US
241427391$24142739$1$I$20240630$20240718$20240726$20240726$EXP$$HR-AstraZeneca-2024A169557$ASTRAZENECA$$$$T$F$Y$$$20240726$$MD$DE$HR
241427402$24142740$2$F$20240701$20240805$20240726$20240807$EXP$$FR-AstraZeneca-2024A164888$ASTRAZENECA$$86$YR$$M$Y$$$20240807$$MD$FR$
241427411$24142741$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A167043$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241427421$24142742$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164643$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241427431$24142743$1$I$20130101$20240718$20240726$20240726$EXP$$ZA-AstraZeneca-2024A164257$ASTRAZENECA$$67$YR$$F$Y$$$20240726$$CN$ZA$
241427443$24142744$3$F$$20240819$20240726$20240827$EXP$$RS-AstraZeneca-2024A165550$ASTRAZENECA$$$$$F$Y$$$20240827$$MD$RS$
241427451$24142745$1$I$$20240719$20240726$20240726$EXP$$AU-AstraZeneca-2024A169863$ASTRAZENECA$$$$$$Y$$$20240726$$MD$AU$
241427461$24142746$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164556$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241427471$24142747$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A164895$ASTRAZENECA$$$$$$Y$$$20240726$$PH$US$
241427481$24142748$1$I$$20240719$20240726$20240726$PER$$US-ALXN-202407USA001412US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241427493$24142749$3$F$$20240809$20240726$20240819$PER$$US-ABBVIE-5855093$ABBVIE$$$$$F$Y$$$20240819$$HP$US$US
241427503$24142750$3$F$20240722$20240827$20240726$20240906$30DAY$$US-JNJFOC-20240757769$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240906$$PH$US$US
241427511$24142751$1$I$$20240722$20240726$20240726$PER$$US-JNJFOC-20240763195$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$MD$US$US
241427522$24142752$2$F$20240101$20240725$20240726$20240730$PER$$US-SA-2024SA216001$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240730$$MD$US$US
241427531$24142753$1$I$20240720$20240720$20240726$20240726$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022450$UNITED THERAPEUTICS$$64$YR$$M$Y$81.633$KG$20240726$$$US$US
241427541$24142754$1$I$20240527$20240719$20240726$20240726$EXP$$NVSC2024MX138577$NOVARTIS$$49$YR$$F$Y$46$KG$20240726$$CN$MX$MX
241427551$24142755$1$I$$20240724$20240726$20240726$EXP$$NVSC2024US152617$NOVARTIS$$$$$F$Y$$$20240726$$CN$US$US
241427561$24142756$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153340$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241427571$24142757$1$I$20240701$20240718$20240726$20240726$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14570$IPSEN$$$$$$Y$$$20240726$$HP$US$US
241427581$24142758$1$I$$20230707$20240726$20240726$PER$$US-JUBILANT CADISTA PHARMACEUTICALS INC.-2023JUB00265$JUBILANT$$$$$M$Y$$$20240726$$PH$US$US
241427591$24142759$1$I$$20231024$20240726$20240726$PER$$US-JUBILANT CADISTA PHARMACEUTICALS INC.-2023JUB00341$JUBILANT$$83$YR$$F$Y$$$20240726$$CN$US$US
241427601$24142760$1$I$20240522$20240723$20240726$20240726$EXP$$US-KYOWAKIRIN-2024KK017895$KYOWA$$$$$$Y$$$20240726$$HP$US$US
241427612$24142761$2$F$$20240723$20240726$20240805$EXP$$CA-ORGANON-O2407CAN002136$ORGANON$$43$YR$$F$Y$$$20240805$$HP$CA$CA
241427621$24142762$1$I$20220101$20240718$20240726$20240726$EXP$DE-EMA-DD-20240710-7482647-081633$DE-TEVA-VS-3223762$TEVA$$35$YR$$F$Y$$$20240726$$MD$DE$DE
241427631$24142763$1$I$20231225$20240725$20240726$20240726$EXP$$US-PURDUE PHARMA-USA-2024-0310981$PURDUE$$$$$M$Y$$$20240726$$CN$US$US
241427641$24142764$1$I$20240723$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147604$AMGEN$$62$YR$A$F$Y$$$20240726$$PH$US$US
241427661$24142766$1$I$19981108$20240723$20240726$20240726$EXP$$DE-PURDUE-USA-2024-0310970$PURDUE$$63$YR$$M$Y$65$KG$20240726$$MD$DE$DE
241427671$24142767$1$I$20191003$20240718$20240726$20240726$EXP$$BR-TAKEDA-BR201933353$TAKEDA$$44$YR$$F$Y$$$20240726$$CN$BR$BR
241427681$24142768$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147344$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241427692$24142769$2$F$20240722$20240801$20240726$20240809$PER$$US-INCYTE CORPORATION-2024IN007780$INCYTE$$$$$$Y$$$20240809$$CN$US$US
241427701$24142770$1$I$$20240715$20240726$20240726$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-21981$SAMSUNG BIOEPIS$$68$YR$E$F$Y$$$20240726$$CN$GB$GB
241427711$24142771$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51582$$FDA-CTU$$$$$M$N$$$20240725$N$HP$US$
241427721$24142772$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51589$$FDA-CTU$$52$YR$$M$N$$$20240725$N$$US$
241427731$24142773$1$I$$20240723$20240726$20240726$EXP$$NVSC2024PL152903$NOVARTIS$$57$YR$$F$Y$66$KG$20240726$$MD$PL$PL
241427751$24142775$1$I$$20240722$20240726$20240726$EXP$$US-SA-2024SA217713$SANOFI AVENTIS$$$$E$F$Y$$$20240726$$MD$US$US
241427761$24142776$1$I$$20240725$20240726$20240726$EXP$$CN-TAKEDA-2024TUS075648$TAKEDA$$$$$M$Y$$$20240726$$CN$CN$CN
241427771$24142777$1$I$$20231024$20240726$20240726$PER$$US-JUBILANT CADISTA PHARMACEUTICALS INC.-2023JUB00343$JUBILANT$$$$$$Y$49.887$KG$20240726$$CN$US$US
241427781$24142778$1$I$$20240724$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007793$INCYTE$$$$$$Y$$$20240726$$MD$US$US
241427791$24142779$1$I$20240725$20240725$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118895$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240726$$CN$US$US
241427801$24142780$1$I$$20240718$20240726$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-117485$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$MD$CA$CA
241427811$24142781$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3223248$TEVA$$$$$F$Y$$$20240726$$HP$CA$CA
241427821$24142782$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51597$$FDA-CTU$$68$YR$$F$N$130$LBS$20240725$N$$US$
241427831$24142783$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51601$$FDA-CTU$$5$YR$$F$N$$$20240725$N$$US$
241427841$24142784$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51602$$FDA-CTU$$69$YR$$F$N$$$20240725$N$$US$
241427851$24142785$1$I$20240725$20240726$20240726$20240726$DIR$711650$$FDA-CTU$$82$YR$$M$N$98$KG$20240726$Y$HP$US$
241427861$24142786$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA212780$SANOFI AVENTIS$$$$E$M$Y$$$20240726$$MD$US$US
241427871$24142787$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA214534$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240726$$MD$US$US
241427881$24142788$1$I$20231101$20240717$20240726$20240726$PER$$US-SA-2024SA214797$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240726$$MD$US$US
241427891$24142789$1$I$$20240722$20240726$20240726$EXP$$US-SA-2024SA217524$SANOFI AVENTIS$$$$E$M$Y$80.7$KG$20240726$$MD$US$US
241427901$24142790$1$I$$20240718$20240726$20240726$PER$$US-SA-2022SA399865$SANOFI AVENTIS$$$$E$M$Y$$$20240726$$MD$US$US
241427911$24142791$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214857$SANOFI AVENTIS$$$$A$M$Y$111$KG$20240726$$MD$US$US
241427921$24142792$1$I$20240701$20240719$20240726$20240726$EXP$$US-ABBVIE-5849735$ABBVIE$$65$YR$$F$Y$$$20240726$$CN$US$US
241427931$24142793$1$I$$20240725$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068325$SANDOZ$$83$YR$$$Y$$$20240726$$HP$CA$CA
241427941$24142794$1$I$$20240719$20240726$20240726$EXP$NL-LRB-00983918$NL-TEVA-VS-3224311$TEVA$$90$YR$$F$Y$$$20240726$$CN$NL$NL
241427951$24142795$1$I$$20240722$20240726$20240726$EXP$$CA-DSJP-DSJ-2024-137401$DAIICHI$$29$YR$$F$Y$$$20240726$$HP$CA$CA
241427962$24142796$2$F$$20240724$20240726$20240729$PER$$NVSC2024US153719$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241427971$24142797$1$I$$20240725$20240726$20240726$EXP$$IN-PFIZER INC-PV202400070282$PFIZER$$52$YR$$F$Y$$$20240726$$CN$IN$IN
241427981$24142798$1$I$20240709$20240726$20240726$20240726$DIR$711623$$FDA-CTU$$62$YR$$F$N$79.2$KG$20240726$N$CN$US$
241427991$24142799$1$I$20240716$20240726$20240726$20240726$DIR$711628$$FDA-CTU$$59$YR$$F$N$65.3$KG$20240726$Y$HP$US$
241428001$24142800$1$I$$20240726$20240726$20240726$DIR$711656$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241428011$24142801$1$I$20240718$20240725$20240726$20240726$EXP$$CN-PFIZER INC-PV202400097477$PFIZER$$61$YR$$F$Y$44$KG$20240726$$HP$CN$CN
241428023$24142802$3$F$$20240823$20240726$20240827$EXP$$BE-PFIZER INC-202400224559$PFIZER$$72$YR$$F$Y$$$20240827$$MD$BE$BE
241428032$24142803$2$F$20240722$20240802$20240726$20240807$EXP$$BR-PFIZER INC-202400222922$PFIZER$$61$YR$$M$Y$81.45$KG$20240807$$HP$BR$BR
241428041$24142804$1$I$$20240725$20240726$20240726$EXP$$US-PFIZER INC-PV202400097635$PFIZER$$67$YR$$$Y$$$20240726$$CN$US$US
241428062$24142806$2$F$$20240808$20240726$20240816$EXP$$FR-PFIZER INC-202400223552$PFIZER$$54$YR$$M$Y$$$20240815$$PH$FR$FR
241428073$24142807$3$F$20240514$20240731$20240726$20240805$EXP$$JP-PFIZER INC-202400222630$PFIZER$$8$DEC$$F$Y$$$20240805$$MD$JP$JP
241428081$24142808$1$I$$20240725$20240726$20240726$EXP$$CA-PFIZER INC-202400223897$PFIZER$$$$$F$Y$48$KG$20240726$$HP$CA$CA
241428091$24142809$1$I$20231024$20240719$20240726$20240726$EXP$$CA-GSK-CA2024AMR090927$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$MD$CA$CA
241428101$24142810$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51603$$FDA-CTU$$39$YR$$F$N$$$20240725$N$$US$
241428111$24142811$1$I$$20240723$20240726$20240726$EXP$NL-LRB-00993217$NL-RDY-SPO/NLD/24/0010911$DR REDDYS$$91$YR$E$M$Y$$$20240726$$MD$NL$NL
241428121$24142812$1$I$$20240723$20240726$20240726$EXP$$AT-DSJP-DSE-2024-137333$DAIICHI$$61$YR$$F$Y$$$20240726$$MD$AT$AT
241428131$24142813$1$I$$20240716$20240726$20240726$EXP$$IT-ASCENT-2024ASLIT00012$ASCENT$Scollo C, et al.CARDIOVASCULAR CONSIDERATIONS IN ANTIDEPRESSANT THERAPY: SINUS ARREST DUE TO SERTRALINE.European Heart Journal Supplements.apr-2024;26(2):1-1$39$YR$A$F$Y$$$20240726$$HP$IT$IT
241428141$24142814$1$I$$20240724$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007796$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241428151$24142815$1$I$$20240723$20240726$20240726$PER$$US-ABBVIE-5854327$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241428171$24142817$1$I$20240614$20240723$20240726$20240726$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004097$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$US$US
241428181$24142818$1$I$20240620$20240722$20240726$20240726$EXP$HR-HALMED-300086105$HR-MYLANLABS-2024M1068371$MYLAN$$68$YR$$F$Y$$$20240726$$MD$HR$HR
241428191$24142819$1$I$$20240716$20240726$20240726$EXP$$CH-ASCENT-2024ASLIT00013$ASCENT$Sopi BB, et al..UNHAPPY HEARTS WITH THE ANTIDEPRESSANT VENLAFAXINE.Swiss Medical Weekly.JUN-2024;154 (6):S63-4$52$YR$A$F$Y$$$20240726$$HP$CH$CH
241428211$24142821$1$I$$20240726$20240726$20240726$DIR$711658$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241428221$24142822$1$I$$20240722$20240726$20240726$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004107$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$FR$FR
241428231$24142823$1$I$$20240723$20240726$20240726$EXP$$US-ABBVIE-5852563$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241428241$24142824$1$I$20230101$20240717$20240726$20240726$EXP$$CN-DSJP-DSJ-2024-136272$DAIICHI$$89$YR$$M$Y$$$20240726$$CN$CN$CN
241428251$24142825$1$I$20240619$20240723$20240726$20240726$EXP$$GT-AstraZeneca-2024A169081$ASTRAZENECA$$19273$DY$$M$Y$$$20240726$$CN$GT$
241428261$24142826$1$I$20240315$20240327$20240726$20240726$PER$$US-GREER Laboratories, Inc.-2159667$GREER$$32$YR$$F$Y$159.55$KG$20240726$$PH$US$US
241428271$24142827$1$I$$20240716$20240726$20240726$EXP$$JP-ASCENT-2024ASLIT00014$ASCENT$Ichiro Kobayashi.et, al..Hypothermia, bradycardia, and hypotension during  glucocorticoid or cyclosporine A therapy in a boy with  Kikuchi-Fujimoto disease.Modern Rheumatology Case Reports.23-MAY-2024;8 (2):352-6$12$YR$T$M$Y$$$20240726$$HP$JP$JP
241428281$24142828$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165589$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241428291$24142829$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A166752$ASTRAZENECA$$$$$F$Y$96.3$KG$20240726$$MD$US$
241428301$24142830$1$I$20230710$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A167171$ASTRAZENECA$$70$YR$$M$Y$108$KG$20240726$$HP$US$
241428311$24142831$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165438$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241428321$24142832$1$I$$20240718$20240726$20240726$EXP$$JP-AstraZeneca-2024A165931$ASTRAZENECA$$$$$$Y$$$20240726$$PH$JP$
241428332$24142833$2$F$20240701$20240801$20240726$20240806$EXP$$CA-AstraZeneca-2024A169088$ASTRAZENECA$$21575$DY$$M$Y$$$20240806$$PH$CA$
241428341$24142834$1$I$$20240715$20240726$20240726$EXP$$IT-NOVOPROD-1256063$NOVO NORDISK$$69$YR$$M$Y$80$KG$20240726$$HP$IT$IT
241428351$24142835$1$I$20240701$20240715$20240726$20240726$EXP$$US-PERRIGO-24US006758$PERRIGO$$86$YR$$M$Y$77.098$KG$20240726$$CN$US$US
241428362$24142836$2$F$$20240820$20240726$20240827$EXP$$JP-DSJP-DSJ-2024-137267$DAIICHI$$63$YR$$M$Y$$$20240827$$MD$JP$JP
241428371$24142837$1$I$20240101$20240722$20240726$20240726$PER$$US-009507513-2407USA012852$MERCK$$$$$F$Y$$$20240726$$HP$US$US
241428382$24142838$2$F$20190918$20240814$20240726$20240821$EXP$$PL-GSK-PL2021EME156025$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$PL$PL
241428391$24142839$1$I$$20240716$20240726$20240726$EXP$$US-GENEYORK-2024PPLIT00043$GENEYORK PHARMA$Patrick McMullan, PhD, Regina Brown, MD, Lorin Bibb, MD, and Katalin Ferenczi, MD.Cutaneous CD30 positive anaplastic large cell lymphoma mimicking breast carcinoma en cuirasse. JAAD Case Reports.OCT-2023;40 (1):37-40$80$YR$E$F$Y$$$20240726$$MD$US$US
241428401$24142840$1$I$$20240717$20240726$20240726$EXP$$US-JNJFOC-20240746078$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$MD$US$US
241428415$24142841$5$F$20240709$20240829$20240726$20240830$PER$$US-JNJFOC-20240768826$JOHNSON AND JOHNSON$$71$YR$E$$Y$$$20240830$$PH$US$US
241428421$24142842$1$I$$20240723$20240726$20240726$EXP$$US-PERRIGO-24US006893$PERRIGO$$$$A$$Y$$$20240726$$CN$US$US
241428431$24142843$1$I$$20240716$20240726$20240726$EXP$$CN-GENEYORK-2024PPLIT00044$GENEYORK PHARMA$Chaoyue Zhang, Yangtao Lin, Qianjin Kuang, Hongjin Li, Qilong Jiang and Xiaojun Yang.Case report: A highly active refractory myasthenia gravis with treatment of telitacicept combined with efgartigimod. Frontiers in Immunology.MAY-2024;15:1-6$37$YR$A$F$Y$$$20240726$$HP$CN$CN
241428441$24142844$1$I$$20240715$20240726$20240726$EXP$$US-SLATERUN-2024SRLIT00132$SLATE RUN$S. C. Oomrigar, J. Fernandez, C. Rivera Ortiz, H. Rajen, A. Toll, E. Perez Colome.et.al.%The Highest Form of Flatter%y.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:1-1$$$$F$Y$$$20240726$$HP$US$US
241428451$24142845$1$I$20240607$20240717$20240726$20240726$EXP$IT-MINISAL02-994356$IT-TEVA-VS-3222378$TEVA$$13$YR$$F$Y$42$KG$20240726$$PH$IT$IT
241428471$24142847$1$I$$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51568$$FDA-CTU$$$$$F$N$$$20240725$N$HP$US$
241428481$24142848$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51569$$FDA-CTU$$20$YR$$F$N$$$20240726$N$$US$
241428501$24142850$1$I$$20240726$20240726$20240726$DIR$711653$$FDA-CTU$$77$YR$$M$N$$$20240726$N$PH$US$
241428511$24142851$1$I$20121204$20240719$20240726$20240726$EXP$$NVSC2023AU118922$NOVARTIS$$75$YR$$F$Y$$$20240726$$MD$AU$AU
241428521$24142852$1$I$$20240718$20240726$20240726$EXP$$US-FreseniusKabi-FK202411660$FRESENIUS KABI$Quo SW, Mederos N, Parianos M, Idrisov E. SIGNIFICANT ESOPHAGEAL AND INTESTIINAL ULCERATIONS IN THE SETTING OF RECENT CHEMOTHERAPY FOR PANCREATIC ADENOCARCINOMA. Gastroenterology. 2023 May;164(6): 1209-1209. doi:https://dx.doi.org/10.1016/S0016-5085%2823%2903795-2.$72$YR$E$M$Y$$$20240726$$HP$US$US
241428531$24142853$1$I$20240315$20240327$20240726$20240726$PER$$US-Allermed Laboratories, Inc.-2159668$ALLERMED LABORATORIES$$32$YR$$F$Y$159.55$KG$20240726$$PH$US$US
241428541$24142854$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214138$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240726$$MD$US$US
241428551$24142855$1$I$$20240724$20240726$20240726$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137536$DAIICHI$$$$$F$Y$$$20240726$$CN$US$US
241428567$24142856$7$F$20240730$20240905$20240726$20240911$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-137535$DAIICHI$$64$YR$$M$Y$57.143$KG$20240911$$HP$US$US
241428573$24142857$3$F$$20240830$20240726$20240909$PER$$US-JNJFOC-20240757298$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$CN$US$US
241428591$24142859$1$I$20230327$20240718$20240726$20240726$EXP$FR-AFSSAPS-PO2024000789$FR-ROCHE-10000032831$ROCHE$$39$YR$A$F$Y$110$KG$20240726$$MD$FR$FR
241428601$24142860$1$I$$20240723$20240726$20240726$EXP$$NVSC2024US152900$NOVARTIS$$70$YR$$F$Y$$$20240726$$MD$US$US
241428611$24142861$1$I$20240401$20240720$20240726$20240726$EXP$$EG-GSK-EG2024EME091507$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$EG$EG
241428621$24142862$1$I$$20240716$20240726$20240726$EXP$$JP-009507513-2407JPN003469J$MERCK$Misaka S, Yunokawa M, Yoshimitsu T, Fusegi A, Abe A, Kanno M. et al.. P-256 A case of ovarian cancer with prolonged anaphylactic shock due to contrast medium during administration of pembrolizumab. The journal of the Japan Society of Gynecologic Oncology The 66th Annual Meeting. 2024;42?3?:418$57$YR$$F$Y$$$20240726$$MD$JP$JP
241428632$24142863$2$F$$20240729$20240726$20240807$EXP$$US-KERYX BIOPHARMACEUTICALS INC.-US-AKEB-24-001118$AKEBIA THERAPEUTICS$$$$$M$Y$$$20240807$$HP$US$US
241428641$24142864$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153732$NOVARTIS$$$$$$Y$$$20240726$$PH$US$US
241428651$24142865$1$I$$20240719$20240726$20240726$EXP$$IT-009507513-2407ITA012863$MERCK$$$$$F$Y$$$20240726$$MD$IT$IT
241428661$24142866$1$I$20240408$20240722$20240726$20240726$EXP$FR-AFSSAPS-MA2024001204$FR-009507513-2407FRA012647$MERCK$$59$YR$$M$Y$$$20240726$$MD$FR$FR
241428671$24142867$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214325$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240726$$MD$US$US
241428681$24142868$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119084$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240726$$MD$US$US
241428691$24142869$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119080$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240726$$CN$US$US
241428701$24142870$1$I$20240624$20240719$20240726$20240726$EXP$$FR-AstraZeneca-2024A164928$ASTRAZENECA$$57$YR$$M$Y$71$KG$20240726$$MD$FR$
241428711$24142871$1$I$20240201$20240723$20240726$20240726$EXP$FR-AFSSAPS-PO2024000805$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-118395$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$$$20240726$$MD$FR$FR
241428721$24142872$1$I$$20240722$20240726$20240726$EXP$$US-OTSUKA-2024_007192$OTSUKA$$$$$M$Y$$$20240726$$HP$US$US
241428731$24142873$1$I$20200422$20240724$20240726$20240726$EXP$$PL-AstraZeneca-2024A168512$ASTRAZENECA$$18$YR$$F$Y$70$KG$20240726$$MD$PL$
241428741$24142874$1$I$$20240722$20240726$20240726$EXP$$US-JNJFOC-20240757299$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$CN$US$US
241428751$24142875$1$I$$20240718$20240726$20240726$EXP$$US-AstraZeneca-2024A167387$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241428761$24142876$1$I$$20240718$20240726$20240726$EXP$$ZA-AstraZeneca-2024A164358$ASTRAZENECA$$29220$DY$$M$Y$$$20240726$$CN$ZA$
241428771$24142877$1$I$20240713$20240723$20240726$20240726$EXP$$US-AstraZeneca-2024A168086$ASTRAZENECA$$30680$DY$$F$Y$$$20240726$$CN$US$
241428782$24142878$2$F$$20240802$20240726$20240809$EXP$$CA-AstraZeneca-2024A165453$ASTRAZENECA$$$$$M$Y$$$20240809$$MD$CA$
241428791$24142879$1$I$$20240723$20240726$20240726$EXP$$CN-AstraZeneca-2024A168942$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$CN$
241428801$24142880$1$I$$20240719$20240726$20240726$EXP$$EG-AstraZeneca-2024A168071$ASTRAZENECA$$44$YR$$M$Y$85$KG$20240726$$MD$EG$
241428811$24142881$1$I$20231026$20240719$20240726$20240726$EXP$$JP-AstraZeneca-2024A167357$ASTRAZENECA$$82$YR$$F$Y$49$KG$20240726$$PH$JP$
241428821$24142882$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A166186$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241428831$24142883$1$I$20240723$20240724$20240726$20240726$EXP$$MX-AstraZeneca-2024A170130$ASTRAZENECA$$26836$DY$$M$Y$$$20240726$$CN$MX$
241428841$24142884$1$I$$20240725$20240726$20240726$EXP$$CA-MYLANLABS-2024M1069900$MYLAN$$58$YR$$M$Y$65$KG$20240726$$CN$CA$CA
241428851$24142885$1$I$$20240723$20240726$20240726$EXP$$US-AstraZeneca-2024A168043$ASTRAZENECA$$$$$F$Y$$$20240726$$HP$US$
241428861$24142886$1$I$20240601$20240723$20240726$20240726$EXP$$FR-AstraZeneca-2024A168759$ASTRAZENECA$$54$YR$$M$Y$72$KG$20240726$$MD$FR$
241428871$24142887$1$I$20240101$20240719$20240726$20240726$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003514$CURRAX PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$CA$CA
241428881$24142888$1$I$20240703$20240719$20240726$20240726$EXP$$GB-AstraZeneca-2024A169015$ASTRAZENECA$$$$$F$Y$$$20240726$$MD$GB$
241428893$24142889$3$F$$20240719$20240726$20240827$EXP$$RU-AstraZeneca-2024A166700$ASTRAZENECA$$50$YR$$M$Y$70$KG$20240827$$HP$RU$
241428902$24142890$2$F$$20240725$20240726$20240730$EXP$$CA-AstraZeneca-2024A170208$ASTRAZENECA$$50$YR$$F$Y$$$20240730$$MD$CA$
241428911$24142891$1$I$$20240723$20240726$20240726$EXP$$US-AstraZeneca-2024A167975$ASTRAZENECA$$$$$M$Y$$$20240726$$HP$US$
241428921$24142892$1$I$$20240719$20240726$20240726$EXP$$GB-AstraZeneca-2024A165785$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$GB$
241428931$24142893$1$I$20240711$20240722$20240726$20240726$EXP$FR-AFSSAPS-RE2024000745$FR-RDY-SPO/FRA/24/0010829$DR REDDYS$$73$YR$E$F$Y$108.5$KG$20240726$$MD$FR$FR
241428952$24142895$2$F$20230101$20240724$20240726$20240730$EXP$$NVSC2024GE151854$NOVARTIS$$62$YR$$F$Y$65$KG$20240730$$MD$GE$GE
241428972$24142897$2$F$20240701$20240725$20240726$20240822$PER$$US-Eisai-EC-2024-170179$EISAI$$91$YR$E$F$Y$$$20240822$$CN$US$US
241428982$24142898$2$F$$20240826$20240726$20240828$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-136944$DAIICHI$Nagashima K, Ueki C, Numari J, Yamaki N, Yamamoto T, Matsuyama S. Andexanet Alfa-Induced Heparin Resistance: Sustained Anticoagulant Inefficacy Despite Antithrombin Therapy.. Journal of cardiothoracic and vascular anesthesia. 2024;38(8):1727-1729$59$YR$$F$Y$57$KG$20240828$$MD$JP$JP
241428992$24142899$2$F$20161001$20240830$20240726$20240904$EXP$$JP-OTSUKA-2024_020454$OTSUKA$$5$DEC$$M$Y$81$KG$20240904$$MD$JP$JP
241429001$24142900$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51575$$FDA-CTU$$62$YR$$F$N$$$20240726$N$$US$
241429011$24142901$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51578$$FDA-CTU$$51$YR$$M$N$$$20240726$N$$US$
241429021$24142902$1$I$$20240726$20240726$20240726$DIR$711662$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241429031$24142903$1$I$$20240724$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068084$SANDOZ$$12$YR$$F$Y$$$20240726$$CN$CA$CA
241429041$24142904$1$I$20240702$20240726$20240726$20240726$DIR$711664$$FDA-CTU$$54$YR$$F$N$$$20240726$N$HP$US$
241429051$24142905$1$I$20240724$20240726$20240726$20240726$DIR$711669$$FDA-CTU$$59$YR$$F$N$$$20240726$N$HP$US$
241429061$24142906$1$I$20240724$20240726$20240726$20240726$DIR$711657$$FDA-CTU$$55$YR$$F$N$$$20240726$N$HP$US$
241429071$24142907$1$I$20240724$20240726$20240726$20240726$DIR$711663$$FDA-CTU$$55$YR$$F$N$$$20240726$N$HP$US$
241429091$24142909$1$I$20240701$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51583$$FDA-CTU$$60$YR$$M$N$$$20240725$N$HP$US$
241429101$24142910$1$I$$20240726$20240726$20240726$DIR$711665$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241429111$24142911$1$I$20240724$20240726$20240726$20240726$DIR$711668$$FDA-CTU$$55$YR$$F$N$$$20240726$N$PH$US$
241429121$24142912$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51584$$FDA-CTU$$58$YR$$M$N$$$20240726$N$$US$
241429131$24142913$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222713$TEVA$$43$YR$$F$Y$$$20240726$$HP$CA$CA
241429142$24142914$2$F$20240110$20240730$20240726$20240805$EXP$NO-NOMAADVRE-PASRAPP-2024-V9za5j$NO-MYLANLABS-2024M1068244$MYLAN$$31$YR$$F$Y$79$KG$20240805$$CN$NO$NO
241429151$24142915$1$I$20240301$20240722$20240726$20240726$EXP$FR-AFSSAPS-PO2024000783$FR-MYLANLABS-2024M1068242$MYLAN$$67$YR$$M$Y$101$KG$20240726$$MD$FR$FR
241429161$24142916$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214867$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240726$$MD$US$US
241429171$24142917$1$I$$20240722$20240726$20240726$EXP$$BR-DSJP-DSE-2024-137148$DAIICHI$$$$$F$Y$$$20240726$$MD$BR$BR
241429181$24142918$1$I$20240201$20240722$20240726$20240726$EXP$SE-SEMPA-2024-005626$SE-DSJP-DSE-2024-136833$DAIICHI$$55$YR$$F$Y$62$KG$20240726$$MD$SE$SE
241429191$24142919$1$I$20231101$20240723$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US068093$SANDOZ$$29$YR$$M$Y$$$20240726$$MD$US$US
241429201$24142920$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119038$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240726$$CN$US$US
241429211$24142921$1$I$20240101$20240717$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114390$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240726$$CN$US$US
241429221$24142922$1$I$$20240711$20240726$20240726$EXP$$CA-HLS-202401734$HLS THERAPEUTICS$$$$E$F$Y$$$20240726$$HP$CA$CA
241429231$24142923$1$I$$20240723$20240726$20240726$EXP$$JP-OTSUKA-2024_020648$OTSUKA$$$$$$Y$$$20240726$$MD$JP$JP
241429241$24142924$1$I$$20240718$20240726$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210203180$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240726$$HP$CA$CA
241429252$24142925$2$F$20240630$20240903$20240726$20240906$EXP$$US-BAYER-2024A098252$BAYER$$76$YR$E$F$Y$$$20240906$$CN$US$US
241429261$24142926$1$I$$20240724$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068116$SANDOZ$$9$YR$$M$Y$$$20240726$$HP$CA$CA
241429271$24142927$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024145614$AMGEN$$$$$$Y$$$20240726$$HP$US$US
241429281$24142928$1$I$20240701$20240723$20240726$20240726$EXP$$US-ABBVIE-5840056$ABBVIE$$53$YR$$F$Y$$$20240726$$CN$US$US
241429292$24142929$2$F$$20240910$20240726$20240919$EXP$$JP-AMRYT PHARMACEUTICALS DAC-AEGR007286$AEGERION$Kyoko Inagaki, Masato Iwabe. A case of homozygous familial hypercholesterolemia with repeated occlusion of a retinal artery branch$$$$$Y$$$20240919$$MD$JP$JP
241429302$24142930$2$F$$20240819$20240726$20240822$30DAY$$JP-MYLANLABS-2024M1064975$MYLAN$$76$YR$$F$Y$$$20240822$$PH$JP$JP
241429311$24142931$1$I$20240711$20240715$20240726$20240726$PER$$US-MYLANLABS-2024M1066506$MYLAN$$64$YR$$F$Y$$$20240726$$CN$US$US
241429321$24142932$1$I$$20240724$20240726$20240726$PER$$US-ABBVIE-5855166$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241429331$24142933$1$I$$20240718$20240726$20240726$PER$$US-ABBVIE-5848742$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241429341$24142934$1$I$$20240712$20240726$20240726$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240600039$UPSHER SMITH LABORATORIES$$$$$M$Y$81.647$KG$20240726$$CN$US$US
241429351$24142935$1$I$$20240719$20240726$20240726$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000644$DECIPHERA PHARMACEUTICALS$$58$YR$A$F$Y$$$20240726$$CN$US$US
241429361$24142936$1$I$$20240725$20240726$20240726$EXP$GB-MHRA-MED-202407251012454120-CJPMW$GB-ORGANON-O2407GBR002485$ORGANON$$$$$M$Y$$$20240726$$CN$GB$GB
241429371$24142937$1$I$20210425$20240722$20240726$20240726$EXP$$NVSC2024TW153652$NOVARTIS$$39$YR$$M$Y$$$20240726$$MD$TW$TW
241429382$24142938$2$F$20240701$20240730$20240726$20240801$EXP$$US-ABBVIE-5853226$ABBVIE$$78$YR$$M$Y$$$20240801$$CN$US$US
241429391$24142939$1$I$$20240723$20240726$20240726$EXP$GB-MHRA-MED-202407231406193540-WSZVF$GB-MYLANLABS-2024M1068969$MYLAN$$$$$F$Y$$$20240726$$HP$GB$GB
241429401$24142940$1$I$20240329$20240722$20240726$20240726$EXP$FR-AFSSAPS-AM2024000570$FR-MYLANLABS-2024M1068298$MYLAN$$72$YR$$F$Y$60$KG$20240726$$MD$FR$FR
241429411$24142941$1$I$$20240723$20240726$20240726$PER$$US-JNJFOC-20240764972$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$MD$US$US
241429441$24142944$1$I$$20240720$20240726$20240726$EXP$$US-GILEAD-2024-0681426$GILEAD$$$$$F$Y$$$20240726$$MD$US$US
241429452$24142945$2$F$$20240830$20240726$20240904$EXP$$JP-OTSUKA-2024_020462$OTSUKA$$7$DEC$$M$Y$71$KG$20240904$$MD$JP$JP
241429461$24142946$1$I$20240601$20240717$20240726$20240726$EXP$IT-MINISAL02-994385$IT-TEVA-VS-3222496$TEVA$$77$YR$$F$Y$$$20240726$$MD$IT$IT
241429472$24142947$2$F$20240715$20240729$20240726$20240812$EXP$$US-GILEAD-2024-0681607$GILEAD$$38$YR$A$F$Y$49.2$KG$20240812$$MD$US$US
241429481$24142948$1$I$20240101$20240626$20240726$20240726$PER$$US-009507513-2406USA008997$MERCK$$$$$F$Y$$$20240726$$CN$US$US
241429491$24142949$1$I$20240101$20240722$20240726$20240726$EXP$$US-ABBVIE-5851369$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241429502$24142950$2$F$20240705$20240808$20240726$20240813$PER$$US-AMGEN-USASP2024147967$AMGEN$$76$YR$E$F$Y$$$20240812$$CN$US$US
241429511$24142951$1$I$$20240724$20240726$20240726$EXP$$JP-ABBVIE-5853704$ABBVIE$$$$E$$Y$$$20240726$$PH$JP$JP
241429521$24142952$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA215005$SANOFI AVENTIS$$$$T$M$Y$90.71$KG$20240726$$HP$US$US
241429531$24142953$1$I$$20240724$20240726$20240726$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118289$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$PH$JP$JP
241429541$24142954$1$I$20240701$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119041$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240726$$CN$US$US
241429551$24142955$1$I$$20240724$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118873$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240726$$HP$US$US
241429561$24142956$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153734$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241429571$24142957$1$I$20240720$20240722$20240726$20240726$EXP$$US-MFDS-2021000061-2407USA012691$MERCK$$$$$F$Y$$$20240726$$CN$US$US
241429581$24142958$1$I$20240530$20240722$20240726$20240726$EXP$$US-AstraZeneca-2024A167206$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241429591$24142959$1$I$20240706$20240720$20240726$20240726$EXP$$CN-AstraZeneca-2024A167725$ASTRAZENECA$$78$YR$$F$Y$60$KG$20240726$$MD$CN$
241429601$24142960$1$I$$20240718$20240726$20240726$EXP$$CA-AstraZeneca-2024A167082$ASTRAZENECA$$54$YR$$M$Y$$$20240726$$MD$CA$
241429621$24142962$1$I$$20240723$20240726$20240726$EXP$$VN-AstraZeneca-2024A168854$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$VN$
241429631$24142963$1$I$$20240718$20240726$20240726$EXP$$ZA-AstraZeneca-2024A164317$ASTRAZENECA$$51$YR$$M$Y$$$20240726$$CN$ZA$
241429641$24142964$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165678$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241429651$24142965$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165511$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$US$
241429672$24142967$2$F$20230915$20240718$20240726$20240806$EXP$$BR-AstraZeneca-2024A170655$ASTRAZENECA$$63$YR$$F$Y$$$20240806$$MD$BR$
241429681$24142968$1$I$$20240719$20240726$20240726$PER$$US-AstraZeneca-2024A165650$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241429691$24142969$1$I$20170801$20240722$20240726$20240726$EXP$$FR-AstraZeneca-2024A166072$ASTRAZENECA$$78$YR$$F$Y$$$20240726$$MD$FR$
241429701$24142970$1$I$$20240726$20240726$20240726$DIR$711666$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241429714$24142971$4$F$20240101$20240815$20240719$20240822$EXP$$CA-ABBVIE-5844034$ABBVIE$$64$YR$$F$Y$$$20240822$$CN$CA$CA
241429731$24142973$1$I$20240722$20240723$20240726$20240726$PER$$US-HALEON-2188718$Haleon PLC$$$$$F$Y$$$20240726$$CN$US$US
241429741$24142974$1$I$20240301$20240719$20240726$20240726$EXP$$US-VIIV HEALTHCARE LIMITED-US2024091119$VIIV$$$$$$Y$$$20240726$$CN$US$US
241429752$24142975$2$F$20240103$20240730$20240726$20240813$EXP$$CA-HLS-202401658$HLS THERAPEUTICS$$67$YR$E$M$Y$$$20240813$$PH$CA$CA
241429762$24142976$2$F$20240624$20240808$20240726$20240816$EXP$$US-GILEAD-2024-0681879$GILEAD$$65$YR$E$F$Y$55.782$KG$20240816$$HP$US$US
241429771$24142977$1$I$20240415$20240725$20240726$20240726$EXP$$CN-GILEAD-2024-0681915$GILEAD$$29$YR$A$M$Y$$$20240726$$HP$CN$CN
241429781$24142978$1$I$20240614$20240717$20240726$20240726$EXP$FR-AFSSAPS-AN2024000900$FR-TEVA-VS-3223224$TEVA$$72$YR$$F$Y$52$KG$20240726$$MD$FR$FR
241429792$24142979$2$F$$20240726$20240726$20240730$EXP$$JP-CARA THERAPEUTICS, INC.-2024-00361-JP$CARA THERAPEUTICS$$67$YR$$M$Y$$$20240730$$PH$JP$JP
241429801$24142980$1$I$$20240725$20240726$20240726$PER$$US-TAKEDA-2024TUS075519$TAKEDA$$29$YR$$F$Y$$$20240726$$CN$US$US
241429811$24142981$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3224733$TEVA$$44$YR$$F$Y$70$KG$20240726$$HP$CA$CA
241429824$24142982$4$F$20151216$20240925$20240726$20240928$EXP$$US-ABBVIE-16P-163-1598916-00$ABBVIE$$64$YR$$F$Y$$$20240928$$MD$US$US
241429831$24142983$1$I$20200503$20240718$20240726$20240726$EXP$PL-URPL-1-3712-2020$PL-TEVA-VS-3223580$TEVA$$39$YR$$M$Y$75$KG$20240726$$MD$PL$PL
241429851$24142985$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214792$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240726$$MD$US$US
241429861$24142986$1$I$20240627$20240725$20240726$20240726$EXP$$US-GILEAD-2024-0682010$GILEAD$$79$YR$E$F$Y$$$20240726$$CN$US$US
241429871$24142987$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA215101$SANOFI AVENTIS$$$$E$M$Y$73.48$KG$20240726$$CN$US$US
241429891$24142989$1$I$$20240712$20240726$20240726$EXP$$CA-BAUSCHBL-2024BNL030677$BAUSCH AND LOMB$$61$YR$$F$Y$58$KG$20240726$$HP$CA$CA
241429901$24142990$1$I$20220101$20240718$20240726$20240726$EXP$AU-MLMSERVICE-20240711-PI128640-00077-5$AU-RDY-SPO/AUS/24/0010748$DR REDDYS$Hush JM, Steffens D, Solomon MJ. A patient-designed integrative oncology intervention for stage IV locally recurrent rectal cancer: A case report. Explore. 2024;20(5):103004. DOI:10.1016/j.explore.2024.05.002.$59$YR$A$F$Y$$$20240726$$MD$AU$AU
241429911$24142991$1$I$20240701$20240723$20240726$20240726$EXP$$TW-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004106$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240726$$HP$TW$TW
241429921$24142992$1$I$20240701$20240722$20240726$20240726$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004069$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$US$US
241429931$24142993$1$I$20240724$20240725$20240726$20240726$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004131$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240726$$CN$IT$IT
241429941$24142994$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51586$$FDA-CTU$$37$YR$$M$N$$$20240726$N$$US$
241429952$24142995$2$F$20240516$20240819$20240726$20240819$EXP$FR-AFSSAPS-PO2024000807$NVSC2024FR152480$NOVARTIS$$80$YR$$F$Y$47$KG$20240819$$MD$FR$FR
241429961$24142996$1$I$20240201$20240722$20240726$20240726$EXP$$KR-TAKEDA-2024TUS075319$TAKEDA$$$$A$F$Y$$$20240726$$MD$KR$KR
241429971$24142997$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118820$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240726$$CN$US$US
241429981$24142998$1$I$$20240718$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115481$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$MD$US$US
241429991$24142999$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119081$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240726$$CN$US$US
241430001$24143000$1$I$20240301$20240725$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118969$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240726$$HP$US$US
241430011$24143001$1$I$20231001$20240722$20240726$20240726$EXP$$DE-GILEAD-2024-0681146$GILEAD$$82$YR$E$F$Y$$$20240726$$MD$DE$DE
241430022$24143002$2$F$$20240808$20240726$20240812$EXP$$CZ-MYLANLABS-2024M1068607$MYLAN$Hockickova I, Hockicko J, Ruzickova T, et al.. Malaria - an increasingly common problem even in Slovakia.. Vseobecny lekar. 2024;3(1):25-7$59$YR$$F$Y$$$20240812$$MD$CZ$CZ
241430031$24143003$1$I$20240706$20240723$20240726$20240726$EXP$$CO-BAYER-2024A108539$BAYER$$67$YR$E$F$Y$70$KG$20240726$$HP$CO$CO
241430042$24143004$2$F$20230208$20240829$20240726$20240904$EXP$$US-ABBVIE-5854141$ABBVIE$$46$YR$$F$Y$$$20240904$$CN$US$US
241430052$24143005$2$F$20240701$20240809$20240726$20240812$EXP$$US-BAYER-2024A104243$BAYER$$78$YR$E$M$Y$$$20240812$$CN$US$US
241430061$24143006$1$I$20240725$20240726$20240726$20240726$DIR$711652$$FDA-CTU$$72$YR$$F$N$62.1$KG$20240726$N$CN$US$
241430071$24143007$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51587$$FDA-CTU$$34$YR$$M$N$$$20240726$N$$US$
241430091$24143009$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51579$$FDA-CTU$$41$YR$$F$N$$$20240726$N$$US$
241430101$24143010$1$I$20240627$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51604$$FDA-CTU$$40$YR$$M$N$$$20240725$N$PH$US$
241430111$24143011$1$I$$20240722$20240726$20240726$EXP$$GB-INCYTE CORPORATION-2024IN007776$INCYTE$$$$$$Y$$$20240726$$MD$GB$GB
241430121$24143012$1$I$$20240717$20240726$20240726$PER$$DE-Eisai-EC-2024-170547$EISAI$$$$$F$Y$$$20240726$$MD$DE$DE
241430131$24143013$1$I$$20240721$20240726$20240726$PER$$AU-Eisai-EC-2024-170790$EISAI$$65$YR$E$F$Y$$$20240726$$MD$AU$AU
241430141$24143014$1$I$$20240515$20240726$20240726$PER$$US-JUBILANT CADISTA PHARMACEUTICALS INC.-2024JUB00035$JUBILANT$$$$$F$Y$$$20240726$$CN$US$US
241430151$24143015$1$I$$20240723$20240726$20240726$EXP$$JP-Eisai-EC-2024-170986$EISAI$Iwata Tomoaki. Hepatocellular carcinoma treatment at Sendai City Hospital. Eisai In-house Training Session; 2024 Jul 23-2024 Jul 23; .$76$YR$E$M$Y$$$20240726$$MD$JP$JP
241430161$24143016$1$I$20240608$20240719$20240726$20240726$EXP$CH-SM-2024-14142$CH-TEVA-VS-3222806$TEVA$$73$YR$$M$Y$72.6$KG$20240726$$MD$CH$CH
241430172$24143017$2$F$20240510$20240906$20240726$20240910$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2024-101753$REGENERON$$54$YR$$M$Y$$$20240910$$MD$GB$GB
241430181$24143018$1$I$$20240722$20240726$20240726$PER$$US-MYLANLABS-2024M1069052$MYLAN$$$$$$Y$$$20240726$$CN$US$US
241430191$24143019$1$I$20240711$20240717$20240726$20240726$PER$$US-MYLANLABS-2024M1067577$MYLAN$$69$YR$$F$Y$90.72$KG$20240726$$CN$US$US
241430211$24143021$1$I$$20240722$20240726$20240726$EXP$$CA-INCYTE CORPORATION-2024IN007735$INCYTE$$$$$$Y$$$20240726$$CN$CA$CA
241430221$24143022$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119049$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$HP$US$US
241430231$24143023$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118832$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240726$$CN$US$US
241430241$24143024$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119052$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240726$$CN$US$US
241430251$24143025$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118824$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240726$$HP$US$US
241430261$24143026$1$I$$20240719$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115612$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240726$$HP$US$US
241430271$24143027$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153690$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241430293$24143029$3$F$20240709$20240808$20240726$20240813$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-112392$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240813$$PH$JP$JP
241430301$24143030$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119054$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240726$$HP$US$US
241430321$24143032$1$I$$20240725$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US068459$SANDOZ$$$$$F$Y$$$20240726$$HP$US$US
241430331$24143033$1$I$$20240725$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068317$SANDOZ$$51$YR$$F$Y$$$20240726$$MD$CA$CA
241430351$24143035$1$I$20240610$20240725$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US061712$SANDOZ$$39$YR$$F$Y$67$KG$20240726$$CN$US$US
241430361$24143036$1$I$$20240725$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068348$SANDOZ$$27$YR$$F$Y$$$20240726$$CN$CA$CA
241430373$24143037$3$F$20240601$20240906$20240726$20240911$EXP$$US-SANDOZ INC.-SDZ2024US068423$SANDOZ$$51$YR$$F$Y$$$20240911$$CN$US$US
241430381$24143038$1$I$$20240725$20240726$20240726$EXP$$CA-SANDOZ INC.-SDZ2024CA068391$SANDOZ$$38$YR$$M$Y$$$20240726$$CN$CA$CA
241430391$24143039$1$I$$20240722$20240726$20240726$EXP$$DE-SANDOZ INC.-SDZ2024DE067568$SANDOZ$Satirer, Ozlem, Henes, et al. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD open. 2024;10(3)$$$C$F$Y$$$20240726$$HP$DE$DE
241430401$24143040$1$I$$20240722$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US068108$SANDOZ$$$$$F$Y$$$20240726$$MD$US$US
241430411$24143041$1$I$20240310$20240717$20240726$20240726$EXP$FR-AFSSAPS-NY2024000786$FR-TEVA-VS-3223288$TEVA$$20$YR$$F$Y$55$KG$20240726$$MD$FR$FR
241430431$24143043$1$I$$20240724$20240726$20240726$EXP$$US-GILEAD-2024-0680478$GILEAD$$$$T$F$Y$$$20240726$$CN$US$US
241430442$24143044$2$F$$20240920$20240726$20240926$EXP$$US-BAYER-2024A108873$BAYER$$59$YR$A$M$Y$$$20240926$$CN$US$US
241430451$24143045$1$I$20240118$20240509$20240726$20240726$EXP$$US-APELLIS-APL-2024-004177$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240726$$MD$US$US
241430461$24143046$1$I$$20240724$20240726$20240726$PER$$NVSC2024US153760$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241430471$24143047$1$I$$20240725$20240726$20240726$EXP$$CA-SANDOZ INC.-NVSC2023CA114964$SANDOZ$$74$YR$$F$Y$54$KG$20240726$$CN$CA$CA
241430481$24143048$1$I$$20240717$20240726$20240726$EXP$PL-URPL-1-3696-2020$PL-TEVA-VS-3222755$TEVA$$42$YR$$M$Y$150$KG$20240726$$MD$PL$PL
241430491$24143049$1$I$$20240723$20240726$20240726$EXP$$US-JNJFOC-20240763041$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$CN$US$US
241430501$24143050$1$I$$20240724$20240726$20240726$PER$$US-JNJFOC-20240767860$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$CN$US$US
241430511$24143051$1$I$$20240717$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001459$BLUEPRINT MEDICINES$$$$$F$Y$$$20240726$$CN$US$US
241430522$24143052$2$F$$20240725$20240726$20240805$PER$$US-AstraZeneca-2024A165620$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241430531$24143053$1$I$20240630$20240723$20240726$20240726$EXP$$CN-AstraZeneca-2024A170042$ASTRAZENECA$$51$YR$$F$Y$55$KG$20240726$$MD$CN$
241430541$24143054$1$I$20240706$20240722$20240726$20240726$EXP$$ZA-AstraZeneca-2024A166736$ASTRAZENECA$$70$YR$$M$Y$$$20240726$$CN$ZA$
241430552$24143055$2$F$20240723$20240724$20240726$20240726$PER$$US-GILEAD-2024-0681895$GILEAD$$$$$F$Y$$$20240726$$CN$US$US
241430561$24143056$1$I$$20240718$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001472$BLUEPRINT MEDICINES$$$$$M$Y$$$20240726$$CN$US$US
241430571$24143057$1$I$$20240724$20240726$20240726$EXP$$US-BAUSCH-BL-2024-011381$BAUSCH AND LOMB$$82$YR$$F$Y$$$20240726$$CN$US$US
241430581$24143058$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153738$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241430591$24143059$1$I$$20240716$20240726$20240726$PER$$US-ABBVIE-5850434$ABBVIE$$$$$$Y$$$20240726$$CN$US$US
241430601$24143060$1$I$20240709$20240724$20240726$20240726$EXP$$US-GSK-US2024092872$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241430611$24143061$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118849$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240726$$CN$US$US
241430622$24143062$2$F$20240531$20240809$20240726$20240819$EXP$FR-AFSSAPS-RN2024000740$FR-TEVA-VS-3222368$TEVA$$3$YR$$F$Y$$$20240819$$PH$FR$FR
241430631$24143063$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3223253$TEVA$$40$YR$$F$Y$$$20240726$$HP$CA$CA
241430641$24143064$1$I$20100126$20240716$20240726$20240726$EXP$$FI-009507513-1101FIN00012$MERCK$$51$YR$$F$Y$$$20240726$$MD$FI$FI
241430652$24143065$2$F$$20240725$20240726$20240802$EXP$$JP-PFIZER INC-202400223196$PFIZER$Yoneto, T.. Long-lasting complete remission in a patient with systemic metastases of recurrent breast cancer treated with cyclin-dependent kinases 4/6 inhibitors: a case report. Journal of Medical Case Reports. 2023;17(1):10.1186/s13256-023-03902-4$74$YR$$F$Y$$$20240802$$HP$JP$JP
241430661$24143066$1$I$20240601$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118812$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$45.36$KG$20240726$$CN$US$US
241430671$24143067$1$I$$20240719$20240726$20240726$EXP$$CA-AstraZeneca-2024A153755$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$CA$
241430681$24143068$1$I$$20240709$20240726$20240726$PER$$US-MYLANLABS-2024M1065159$MYLAN$$$$$F$Y$27$KG$20240726$$HP$US$US
241430691$24143069$1$I$$20240719$20240726$20240726$EXP$$CN-AstraZeneca-2024A166398$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$CN$
241430701$24143070$1$I$$20240719$20240726$20240726$EXP$$ZA-AstraZeneca-2024A165249$ASTRAZENECA$$68$YR$$F$Y$$$20240726$$CN$ZA$
241430711$24143071$1$I$$20240724$20240726$20240726$PER$$NVSC2024US153731$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241430721$24143072$1$I$$20240718$20240726$20240726$EXP$NL-LRB-00984779$NL-TEVA-VS-3224149$TEVA$$33$YR$$F$Y$65$KG$20240726$$CN$NL$NL
241430731$24143073$1$I$$20240722$20240726$20240726$EXP$$JP-BAUSCH-BL-2024-011458$BAUSCH AND LOMB$$8$DEC$$M$Y$$$20240726$$PH$JP$JP
241430741$24143074$1$I$$20240724$20240726$20240726$PER$$US-ROCHE-10000037094$ROCHE$$69$YR$E$F$Y$$$20240726$$CN$US$US
241430751$24143075$1$I$$20240723$20240726$20240726$EXP$$GB-MYLANLABS-2024M1068911$MYLAN$$$$$M$Y$$$20240726$$HP$GB$GB
241430762$24143076$2$F$20240620$20240903$20240726$20240918$EXP$$US-APELLIS-2024-APL-0000527$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240918$$MD$US$US
241430771$24143077$1$I$20230201$20240724$20240726$20240726$EXP$$FR-BAUSCH-BL-2024-011384$BAUSCH AND LOMB$$58$YR$$F$Y$$$20240726$$MD$FR$FR
241430782$24143078$2$F$20240721$20240821$20240726$20240906$PER$$US-JNJFOC-20240757275$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240906$$CN$US$US
241430801$24143080$1$I$$20240712$20240726$20240726$EXP$$US-BRAEBURN-US-BRA-24-000651$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240726$$HP$US$US
241430821$24143082$1$I$$20240722$20240726$20240726$PER$$US-AMGEN-USASP2024145448$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241430831$24143083$1$I$$20240722$20240726$20240726$PER$$US-JNJFOC-20240760443$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$MD$US$US
241430841$24143084$1$I$20230208$20240723$20240726$20240726$EXP$$GB-MYLANLABS-2023M1086494$MYLAN$Baigent AV, Morris EAJ.. Severe acute drug-induced dystonia in the post-operative period requiring tracheal re-intubation.. Anaesth-Rep. 2023;11$14$YR$$F$Y$57$KG$20240726$$PH$GB$GB
241430861$24143086$1$I$$20240725$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118867$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240726$$CN$US$US
241430873$24143087$3$F$$20240823$20240726$20240825$PER$$NVSC2024US153764$NOVARTIS$$$$$$Y$$$20240826$$HP$US$US
241430881$24143088$1$I$20240201$20240718$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115489$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$58.97$KG$20240726$$CN$US$US
241430891$24143089$1$I$20240424$20240717$20240726$20240726$EXP$ES-AEMPS-1546993$ES-TEVA-VS-3222893$TEVA$$32$YR$$F$Y$$$20240726$$MD$ES$ES
241430901$24143090$1$I$$20240723$20240726$20240726$EXP$$FR-MYLANLABS-2024M1069876$MYLAN$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N, Pelletier R and al... A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).. Toxicologie Analytique + Clinique. 2023;35:376-394$52$YR$$M$Y$$$20240726$$MD$FR$FR
241430911$24143091$1$I$$20240715$20240726$20240726$EXP$$AU-009507513-2407AUS009869$MERCK$$$$E$M$Y$$$20240726$$CN$AU$AU
241430921$24143092$1$I$20240718$20240724$20240726$20240726$EXP$$US-ABBVIE-5854243$ABBVIE$$$$$M$Y$$$20240726$$HP$US$US
241430934$24143093$4$F$20240701$20240906$20240726$20240910$EXP$$JP-009507513-2407JPN003976J$MERCK$$64$YR$$M$Y$$$20240910$$PH$JP$JP
241430941$24143094$1$I$$20240718$20240726$20240726$EXP$$ZA-AstraZeneca-2024A165235$ASTRAZENECA$$60$YR$$F$Y$$$20240726$$CN$ZA$
241430951$24143095$1$I$$20240719$20240726$20240726$EXP$$CN-AstraZeneca-2024A166365$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$CN$
241430961$24143096$1$I$$20240725$20240726$20240726$PER$$US-AstraZeneca-2024A170678$ASTRAZENECA$$$$$$Y$$$20240726$$HP$US$
241430972$24143097$2$F$20240717$20240717$20240726$20240730$EXP$$US-CSL-2024-006865$CSL Plasma$$37$YR$$M$Y$$$20240730$$HP$US$US
241430981$24143098$1$I$20240710$20240719$20240726$20240726$EXP$$CN-AstraZeneca-2024A167487$ASTRAZENECA$$68$YR$$M$Y$65$KG$20240726$$MD$CN$
241430991$24143099$1$I$$20240723$20240726$20240726$PER$$US-TAKEDA-2024TUS074706$TAKEDA$$$$$$Y$$$20240726$$HP$US$US
241431001$24143100$1$I$$20240723$20240726$20240726$EXP$$US-GILEAD-2024-0680774$GILEAD$$$$A$M$Y$$$20240726$$CN$US$US
241431012$24143101$2$F$$20240826$20240726$20240829$PER$$US-BIOGEN-2024BI01274723$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
241431042$24143104$2$F$$20240724$20240726$20240731$PER$$US-BIOGEN-2024BI01275357$BIOGEN$$$$$M$Y$$$20240731$$CN$US$US
241431051$24143105$1$I$$20240724$20240726$20240726$PER$$US-JNJFOC-20240768941$JOHNSON AND JOHNSON$$85$YR$E$F$Y$51.2$KG$20240726$$CN$US$US
241431063$24143106$3$F$20230430$20240904$20240726$20240912$EXP$$ES-APELLIS-APL-2024-003878$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240911$$MD$ES$ES
241431081$24143108$1$I$20240723$20240723$20240726$20240726$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041716$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240726$$CN$BR$BR
241431091$24143109$1$I$$20240722$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116900$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240726$$HP$US$US
241431101$24143110$1$I$20090101$20240717$20240726$20240726$EXP$$DE-TEVA-VS-3222762$TEVA$$39$YR$$F$Y$77$KG$20240726$$MD$DE$DE
241431111$24143111$1$I$$20240722$20240726$20240726$EXP$$AR-BAYER-2024A108755$BAYER$$47$YR$A$F$Y$49$KG$20240726$$MD$AR$MX
241431121$24143112$1$I$20240101$20240722$20240726$20240726$PER$$US-BIOGEN-2024BI01274843$BIOGEN$$$$$F$Y$$$20240726$$CN$US$US
241431132$24143113$2$F$20230101$20240731$20240726$20240806$PER$$US-BIOGEN-2024BI01274876$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241431142$24143114$2$F$$20240923$20240726$20240926$PER$$US-BIOGEN-2024BI01274683$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
241431152$24143115$2$F$$20240731$20240726$20240806$PER$$US-BIOGEN-2019BI00734811$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241431171$24143117$1$I$20240501$20240722$20240726$20240726$PER$$US-BIOGEN-2024BI01269035$BIOGEN$$67$YR$$M$Y$$$20240726$$CN$US$US
241431184$24143118$4$F$20240714$20240731$20240726$20240801$EXP$$US-SANDOZ INC.-SDZ2024US068042$SANDOZ$$47$YR$$M$Y$$$20240801$$HP$US$US
241431192$24143119$2$F$20240701$20240809$20240726$20240819$EXP$$US-RIGEL-20240700068$RIGEL PHARMACEUTICALS$$83$YR$$F$Y$56.699$KG$20240819$$CN$US$US
241431202$24143120$2$F$20240120$20240828$20240726$20240904$EXP$$JP-APELLIS-APL-2024-003983$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240904$$CN$JP$JP
241431211$24143121$1$I$20240101$20240722$20240726$20240726$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700086$RIGEL PHARMACEUTICALS$$$$$F$Y$86.636$KG$20240726$$CN$US$US
241431221$24143122$1$I$20191025$20240725$20240726$20240726$EXP$$CA-SANDOZ INC.-NVSC2019CA036959$SANDOZ$$64$YR$$F$Y$$$20240726$$CN$CA$CA
241431231$24143123$1$I$20240630$20240710$20240726$20240726$PER$$US-MYLANLABS-2024M1066808$MYLAN$$$$$F$Y$$$20240726$$CN$US$US
241431241$24143124$1$I$20211224$20240717$20240726$20240726$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-116105$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$71$KG$20240726$$MD$KR$KR
241431251$24143125$1$I$$20240718$20240726$20240726$EXP$NL-LRB-00985143$NL-TEVA-VS-3223402$TEVA$$31$YR$$F$Y$78$KG$20240726$$CN$NL$NL
241431261$24143126$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222886$TEVA$$5$YR$$F$Y$$$20240726$$HP$CA$CA
241431271$24143127$1$I$$20240722$20240726$20240726$EXP$$KZ-BAUSCH-BL-2024-011392$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240726$$MD$KZ$KZ
241431281$24143128$1$I$20240716$20240719$20240726$20240726$EXP$$JP-009507513-2407JPN003733J$MERCK$$79$YR$$F$Y$$$20240726$$PH$JP$JP
241431293$24143129$3$F$20240701$20240725$20240726$20240805$EXP$$IE-BIOMARINAP-IE-2024-159399$BIOMARIN$$$$$$Y$$$20240805$$CN$IE$IE
241431311$24143131$1$I$$20240720$20240726$20240726$EXP$$CA-ASTELLAS-2024US020928$ASTELLAS$$35$YR$$M$Y$$$20240726$$CN$CA$CA
241431321$24143132$1$I$20240524$20240718$20240726$20240726$EXP$$US-VERTEX PHARMACEUTICALS-2024-011286$VERTEX$$28$YR$$F$Y$$$20240726$$HP$US$US
241431334$24143133$4$F$$20240730$20240726$20240802$PER$$NVSC2024US151685$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
241431341$24143134$1$I$20240711$20240725$20240726$20240726$PER$$NVSC2024US153759$NOVARTIS$$81$YR$$F$Y$$$20240726$$HP$US$US
241431351$24143135$1$I$$20240723$20240726$20240726$EXP$$GB-MYLANLABS-2024M1069642$MYLAN$$$$$F$Y$$$20240726$$HP$GB$GB
241431361$24143136$1$I$$20240725$20240726$20240726$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009422$JAZZ$$$$$F$Y$$$20240726$$CN$US$US
241431371$24143137$1$I$20240715$20240718$20240726$20240726$EXP$GB-MHRA-MED-202407161003047020-YVRCW$GB-TEVA-VS-3222714$TEVA$$35$YR$$M$Y$96$KG$20240726$$MD$GB$GB
241431381$24143138$1$I$$20240724$20240726$20240726$PER$$US-JNJFOC-20240770634$JOHNSON AND JOHNSON$$$$$F$Y$$$20240726$$HP$US$US
241431391$24143139$1$I$$20240724$20240726$20240726$PER$$US-JNJFOC-20240770716$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$CN$US$US
241431401$24143140$1$I$$20240725$20240726$20240726$PER$$US-JNJFOC-20240771028$JOHNSON AND JOHNSON$$$$$M$Y$$$20240726$$HP$US$US
241431411$24143141$1$I$$20240718$20240726$20240726$PER$$US-MYLANLABS-2024M1067984$MYLAN$$$$$F$Y$$$20240726$$CN$US$US
241431421$24143142$1$I$20240718$20240718$20240726$20240726$EXP$$GB-TEVA-VS-3223323$TEVA$$84$YR$$M$Y$75$KG$20240726$$MD$GB$GB
241431431$24143143$1$I$20240501$20240718$20240726$20240726$EXP$$GB-TEVA-VS-3222871$TEVA$$62$YR$$F$Y$82$KG$20240726$$MD$GB$GB
241431441$24143144$1$I$20240717$20240718$20240726$20240726$EXP$$GB-TEVA-VS-3223087$TEVA$$30$YR$$F$Y$63$KG$20240726$$MD$GB$GB
241431451$24143145$1$I$$20240726$20240726$20240726$PER$$NVSC2024US153755$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241431461$24143146$1$I$$20240719$20240726$20240726$EXP$$CA-Amarin Pharma, Inc-2024AMR000368$AMARIN$$45$YR$A$F$Y$$$20240726$$CN$CA$CA
241431473$24143147$3$F$$20240724$20240726$20240905$PER$$US-LUNDBECK-DKLU4000798$LUNDBECK$$$$$$Y$$$20240905$$CN$US$US
241431482$24143148$2$F$$20240830$20240726$20240830$30DAY$$US-PFIZER INC-202400223114$PFIZER$$14$YR$$F$Y$$$20240830$$CN$US$US
241431501$24143150$1$I$$20240112$20240726$20240726$EXP$$CN-PFIZER INC-PV202400096425$PFIZER$$35$YR$$M$Y$$$20240726$$CN$CN$CN
241431511$24143151$1$I$20240601$20240719$20240726$20240726$EXP$$HR-ABBVIE-5502246$ABBVIE$$28$YR$$F$Y$$$20240726$$MD$HR$HR
241431521$24143152$1$I$$20240715$20240726$20240726$EXP$$US-B.Braun Medical Inc.-2159669$B BRAUN$Literature Article$51$YR$$F$Y$$$20240726$$$US$US
241431532$24143153$2$F$$20240730$20240726$20240809$EXP$$US-TEVA-VS-3223146$TEVA$Herzberg SD, Bosso AM, Sangal NR, Bosso JV. Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease. Ann-Allergy-Asthma-Immunol 2023; 131 (4): 528-530.; Herzberg SD, Bosso AM, Sangal NR, Bosso JV. Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease. Ann-Allergy-Asthma-Immunol 2023; 131 (4): 528-530.; Herzberg SD, Bosso AM, Sangal NR, Bosso JV. Eosinophilic granulomatosis with polyangiitis presenting as...$$$$F$Y$$$20240809$$HP$US$US
241431542$24143154$2$F$$20240723$20240726$20240813$EXP$$JP-AstraZeneca-2024A169162$ASTRAZENECA$$60$YR$$F$Y$$$20240813$$MD$JP$
241431552$24143155$2$F$$20240808$20240726$20240816$EXP$$CA-AstraZeneca-2024A165939$ASTRAZENECA$$$$$F$Y$$$20240816$$MD$CA$
241431561$24143156$1$I$20240427$20240719$20240726$20240726$EXP$ES-AEMPS-1538265$ES-Amarin Pharma, Inc-2024AMR000362$AMARIN$$64$YR$A$M$Y$$$20240726$$MD$ES$ES
241431571$24143157$1$I$$20240722$20240726$20240726$EXP$$KR-PFIZER INC-202400221731$PFIZER$Lee, Y.. Corticosteroid-free adalimumab-cyclophosphamide combination therapy for acute phase neuro-Beh?et^s disease: a case report. Journal of Rheumatic Diseases. 2024;31(3):178-81$48$YR$$M$Y$$$20240726$$MD$KR$KR
241431581$24143158$1$I$20230101$20240513$20240726$20240726$EXP$$US-APELLIS-APL-2023-002620$APELLIS PHARMACEUTICALS$Andre J. Witkin, MD, FASRS1 , Glenn J. Jaffe, MD2, Sunil K. Srivastava, MD3, Janet L. Davis, MD4, Judy E. Kim, MD, FARVO, FASRS5, and the ReST Committee. Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee.Journal of VitreoRetinal Diseases . 2023;. doi:10.1177/24741264231220224$$$$$Y$$$20240726$$MD$US$US
241431592$24143159$2$F$20240715$20240812$20240726$20240816$EXP$$NVSC2024ZA152205$NOVARTIS$$42$YR$$F$Y$$$20240816$$HP$ZA$ZA
241431601$24143160$1$I$20240501$20240722$20240726$20240726$EXP$FR-AFSSAPS-BR2024000540$FR-MYLANLABS-2024M1068507$MYLAN$$68$YR$$F$Y$$$20240726$$MD$FR$FR
241431611$24143161$1$I$20240101$20240717$20240726$20240726$EXP$$US-PHARMAESSENTIA-US-2024-PEC-004163$PHARMAESSENTIA$$$$$F$Y$$$20240727$$CN$US$US
241431621$24143162$1$I$20240101$20240722$20240726$20240726$EXP$FR-AFSSAPS-PA2024001336$FR-MYLANLABS-2024M1068255$MYLAN$$50$YR$$M$Y$87.7$KG$20240726$$PH$FR$FR
241431631$24143163$1$I$$20240712$20240726$20240726$PER$$US-JNJFOC-20240737494$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$CN$US$US
241431641$24143164$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3223169$TEVA$$70$YR$$M$Y$$$20240726$$MD$CA$CA
241431651$24143165$1$I$$20240718$20240726$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118204$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240726$$HP$CA$CA
241431661$24143166$1$I$$20240715$20240726$20240726$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407016690$ELI LILLY AND CO$$$$$$Y$$$20240726$$PH$CN$CN
241431671$24143167$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016462$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240726$$CN$US$US
241431681$24143168$1$I$$20240722$20240726$20240726$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407016666$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$BR$BR
241431691$24143169$1$I$20230104$20240715$20240726$20240726$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407016683$ELI LILLY AND CO$$$$$$Y$$$20240726$$PH$CN$CN
241431701$24143170$1$I$$20240715$20240726$20240726$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407016686$ELI LILLY AND CO$$$$$$Y$$$20240726$$PH$CN$CN
241431711$24143171$1$I$$20240715$20240726$20240726$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407016689$ELI LILLY AND CO$$$$$$Y$$$20240726$$PH$CN$CN
241431721$24143172$1$I$$20240715$20240726$20240726$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407016684$ELI LILLY AND CO$$$$$$Y$$$20240726$$PH$CN$CN
241431731$24143173$1$I$$20240715$20240726$20240726$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407016687$ELI LILLY AND CO$$$$$$Y$$$20240726$$PH$CN$CN
241431741$24143174$1$I$$20240715$20240726$20240726$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202407011019$ELI LILLY AND CO$Khandelwal H,Jain K,Raj AB,Chahar A,Rajpurohit SS,Biyyala D,Nebhinani N,Suthar N,Soni P,Gupta T.Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD.Journal of Clinical Psychopharmacology. 2024;44(4):434-436.$16$YR$T$M$Y$$$20240726$$MD$IN$IN
241431751$24143175$1$I$20240628$20240715$20240726$20240726$EXP$FR-AFSSAPS-PB2024000776$FR-ELI_LILLY_AND_COMPANY-FR202407009174$ELI LILLY AND CO$$51$YR$A$F$Y$51$KG$20240726$$CN$FR$FR
241431761$24143176$1$I$$20240715$20240726$20240726$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407016685$ELI LILLY AND CO$$$$$$Y$$$20240726$$PH$CN$CN
241431771$24143177$1$I$$20240720$20240726$20240726$EXP$$EG-ELI_LILLY_AND_COMPANY-EG202407013582$ELI LILLY AND CO$$65$YR$E$F$Y$57$KG$20240726$$CN$EG$EG
241431781$24143178$1$I$20240529$20240716$20240726$20240726$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407010158$ELI LILLY AND CO$$53$YR$A$M$Y$90$KG$20240726$$CN$FR$FR
241431791$24143179$1$I$$20240716$20240726$20240726$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013113$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240726$$CN$US$US
241431801$24143180$1$I$$20240715$20240726$20240726$EXP$GB-MHRA-MED-202407151032510880-YMJKN$GB-ELI_LILLY_AND_COMPANY-GB202407009107$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$GB$GB
241431811$24143181$1$I$20240301$20240715$20240726$20240726$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407016680$ELI LILLY AND CO$$$$$$Y$$$20240726$$CN$BR$BR
241431821$24143182$1$I$$20240715$20240726$20240726$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202407010950$ELI LILLY AND CO$Khandelwal H,Jain K,Raj AB,Chahar A,Rajpurohit SS,Biyyala D,Nebhinani N,Suthar N,Soni P,Gupta T.Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD.Journal of Clinical Psychopharmacology. 2024;44(4):434-436.$12$YR$C$M$Y$$$20240726$$MD$IN$IN
241431832$24143183$2$F$$20240717$20240726$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013666$ELI LILLY AND CO$Lianne Beunk, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne-Marie Buunk, Henk-Jan Guchelaar.Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants.European Journal of Human Genetics 2024;:.DOI:https://doi.org/10.1038/s41431-024-01648-1$47$YR$A$M$Y$$$20240731$$HP$NL$US
241431841$24143184$1$I$$20240716$20240726$20240726$EXP$$MY-ELI_LILLY_AND_COMPANY-MY202407011188$ELI LILLY AND CO$$$$A$F$Y$$$20240726$$CN$MY$MY
241431861$24143186$1$I$$20240726$20240726$20240726$PER$$NVSC2024US153741$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241431871$24143187$1$I$20240707$20240722$20240726$20240726$EXP$FR-AFSSAPS-MP2024001141$FR-MYLANLABS-2024M1068346$MYLAN$$79$YR$$F$Y$$$20240726$$PH$FR$FR
241431881$24143188$1$I$20181004$20240722$20240726$20240726$EXP$FR-AFSSAPS-AM2024000569$FR-MYLANLABS-2024M1068307$MYLAN$$67$YR$$F$Y$60$KG$20240726$$MD$FR$FR
241431891$24143189$1$I$$20240717$20240726$20240726$PER$$US-SA-2024SA214154$SANOFI AVENTIS$$$$E$M$Y$$$20240726$$MD$US$US
241431901$24143190$1$I$$20240719$20240726$20240726$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119177$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240726$$CN$US$US
241431921$24143192$1$I$20240722$20240722$20240726$20240726$EXP$$US-JNJFOC-20240765112$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240726$$MD$US$US
241431931$24143193$1$I$$20240726$20240726$20240726$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042219$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240726$$CN$US$US
241431942$24143194$2$F$20230622$20240813$20240726$20240820$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-005792$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240820$$MD$JP$JP
241431951$24143195$1$I$20240101$20240717$20240726$20240726$EXP$DE-BFARM-24004819$DE-TEVA-VS-3223048$TEVA$$87$YR$$M$Y$$$20240726$$CN$DE$DE
241431961$24143196$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3222978$TEVA$$82$YR$$F$Y$72$KG$20240726$$HP$CA$CA
241431971$24143197$1$I$$20240724$20240726$20240726$EXP$$JP-INCYTE CORPORATION-2024IN007824$INCYTE$$$$$$Y$$$20240726$$MD$JP$JP
241431981$24143198$1$I$$20240723$20240726$20240726$EXP$$US-PHARMING-PHAUS2024000627$PHARMING GROUP$$$$$$Y$$$20240726$$CN$US$US
241431992$24143199$2$F$$20240913$20240726$20240923$EXP$$US-PHARMING-PHAUS2024000629$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
241432001$24143200$1$I$$20240723$20240726$20240726$PER$$US-PHARMING-PHAUS2024000628$PHARMING GROUP$$$$$$Y$$$20240726$$CN$US$US
241432011$24143201$1$I$$20240715$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007450$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241432021$24143202$1$I$$20240722$20240726$20240726$PER$$US-PHARMING-PHAUS2024000617$PHARMING GROUP$$$$$$Y$$$20240726$$CN$US$US
241432032$24143203$2$F$$20240814$20240726$20240815$PER$$NVSC2024US153762$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
241432041$24143204$1$I$$20240715$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007446$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241432051$24143205$1$I$$20240705$20240726$20240726$PER$$US-B.Braun Medical Inc.-2159670$B BRAUN$$$$$$Y$$$20240726$$$US$US
241432061$24143206$1$I$$20240715$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007449$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241432071$24143207$1$I$$20240715$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007439$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241432081$24143208$1$I$20240713$20240715$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007438$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241432091$24143209$1$I$20120101$20240716$20240726$20240726$EXP$$FR-009507513-1201FRA00051$MERCK$$$$$M$Y$$$20240726$$PH$FR$FR
241432101$24143210$1$I$$20240722$20240726$20240726$PER$$US-PHARMING-PHAUS2024000621$PHARMING GROUP$$$$$$Y$$$20240726$$CN$US$US
241432112$24143211$2$F$$20240730$20240726$20240809$EXP$$ES-TEVA-VS-3223235$TEVA$Martin-Aguilar S, Lopez-Rodriguez E, Puentes-Zarzuela MC. Complete response to switch immunodepression of late-onset post-transplant lymphoproliferative disease (PTLD). Med-Clin-Barc 2023; 161 (2): 86-87.; Martin-Aguilar S, Lopez-Rodriguez E, Puentes-Zarzuela MC. Complete response to switch immunodepression of late-onset post-transplant lymphoproliferative disease (PTLD). Med-Clin-Barc 2023; 161 (2): 86-87.$$$A$M$Y$$$20240809$$HP$ES$ES
241432121$24143212$1$I$$20240722$20240726$20240726$EXP$$US-PHARMING-PHAUS2024000623$PHARMING GROUP$$$$$$Y$$$20240726$$CN$US$US
241432131$24143213$1$I$$20240701$20240726$20240726$PER$$US-JNJFOC-20240707816$JOHNSON AND JOHNSON$$$$$$Y$$$20240726$$CN$US$US
241432141$24143214$1$I$20240625$20240703$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007080$INCYTE$$$$$$Y$$$20240726$$HP$US$US
241432151$24143215$1$I$$20240703$20240726$20240726$PER$$US-INCYTE CORPORATION-2024IN007065$INCYTE$$$$$$Y$$$20240726$$CN$US$US
241432162$24143216$2$F$$20240801$20240726$20240806$EXP$$NVSC2024CA030778$NOVARTIS$$56$YR$$F$Y$$$20240807$$HP$CA$CA
241432171$24143217$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153753$NOVARTIS$$$$$$Y$$$20240726$$HP$US$US
241432182$24143218$2$F$$20240731$20240726$20240809$EXP$$BE-TEVA-VS-3224489$TEVA$Mertens B, Elkayal O, Dreesen E, Wauters J, Meersseman P, Debaveye Y, et al. Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review. Antibiotics-(Basel) 2023; 12 (7): no pagination.; Mertens B, Elkayal O, Dreesen E, Wauters J, Meersseman P, Debaveye Y, et al. Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literatu...$52$YR$$F$Y$$$20240809$$HP$BE$BE
241432191$24143219$1$I$$20240722$20240726$20240726$EXP$$GB-MYLANLABS-2024M1068811$MYLAN$$$$$M$Y$$$20240726$$PH$GB$GB
241432201$24143220$1$I$$20240718$20240726$20240726$EXP$$TW-SA-2024SA211598$SANOFI AVENTIS$Huang, X; Zeng, Y.. Rasburicase ?????????????????????? Respiratory Care of Rasburicase-Induced Methemoglobinemia With Respiratory Failure.. Respiratory Therapy. 2024;23:73-74$72$YR$E$M$Y$62$KG$20240726$$HP$TW$TW
241432211$24143221$1$I$$20240718$20240726$20240726$EXP$$CA-AstraZeneca-2024A147508$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$CA$
241432221$24143222$1$I$$20240719$20240726$20240726$PER$$US-AstraZeneca-2024A165669$ASTRAZENECA$$$$$$Y$$$20240726$$CN$US$
241432231$24143223$1$I$20240701$20240710$20240726$20240726$PER$$US-JNJFOC-20240737459$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240726$$CN$US$US
241432241$24143224$1$I$$20240719$20240726$20240726$PER$$US-ABBVIE-5848463$ABBVIE$$$$$$Y$$$20240726$$CN$US$US
241432251$24143225$1$I$$20240724$20240726$20240726$PER$$JP-Eisai-EC-2024-170908$EISAI$$$$$$Y$$$20240726$$MD$JP$JP
241432263$24143226$3$F$20240101$20240827$20240726$20240910$PER$$PH-Eisai-EC-2024-170973$EISAI$$58$YR$A$F$Y$$$20240910$$CN$PH$PH
241432271$24143227$1$I$$20240716$20240726$20240726$EXP$$US-TEVA-VS-3222539$TEVA$$$$A$M$Y$$$20240726$$CN$US$US
241432281$24143228$1$I$$20240717$20240726$20240726$EXP$$JP-Breckenridge Pharmaceutical, Inc.-2159671$BRECKENRIDGE$$12$YR$$F$Y$29$KG$20240726$$$JP$JP
241432291$24143229$1$I$$20240717$20240726$20240726$EXP$$CA-TEVA-VS-3223076$TEVA$$50$YR$$F$Y$68$KG$20240726$$HP$CA$CA
241432301$24143230$1$I$$20240719$20240726$20240726$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-101028$REGENERON$$$$$F$Y$$$20240726$$MD$JP$JP
241432311$24143231$1$I$$20240725$20240726$20240726$PER$$US-PFIZER INC-202400224080$PFIZER$$75$YR$$M$Y$$$20240726$$CN$US$US
241432321$24143232$1$I$$20240723$20240726$20240726$PER$$US-PFIZER INC-PV202400096658$PFIZER$$$$$$Y$$$20240726$$CN$US$US
241432331$24143233$1$I$20240718$20240723$20240726$20240726$PER$$US-PFIZER INC-202400222127$PFIZER$$77$YR$$F$Y$90.26$KG$20240726$$CN$US$US
241432341$24143234$1$I$$20240711$20240726$20240726$EXP$$US-MAYNE PHARMA-2024MYN000289$MAYNE$Caitlin A. Contag, Lucy Studemeister, Yael Bogler, Joseph, Cooper. Q fever presenting as splenic infarct without endocarditis. IDcases. 2024;37:e02012$$$$$Y$$$20240726$$HP$US$US
241432352$24143235$2$F$$20240910$20240726$20240925$EXP$$DE-PHARMAAND GMBH-2024PHR00437$pharmaAND$Hanitsch L, Muche M, Radbruch H, Hofmann J, Corman V. Fatal Disseminated Hepatitis E in an Adult Patient with IKBKB GOF Mutation. Journal of Clinical Immunology. 2024;44 (5):1-4$52$YR$$F$Y$$$20240925$$HP$DE$DE
241432361$24143236$1$I$20200101$20240717$20240726$20240726$EXP$FR-AFSSAPS-AVCN2024000525$FR-TEVA-VS-3223305$TEVA$$21$YR$$M$Y$$$20240726$$MD$FR$FR
241432371$24143237$1$I$20220315$20240718$20240726$20240726$EXP$PL-URPL-DML-MLP.4401.1.743.2022$PL-TEVA-VS-3223744$TEVA$$17$YR$$F$Y$53$KG$20240726$$MD$PL$PL
241432382$24143238$2$F$$20240731$20240726$20240809$EXP$$BR-TEVA-VS-3224155$TEVA$Dias e SilvaD, Borba GB, Beal JR, Botrus G, Osawa A, Araujo SEA, et al. Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report. Int-J-Molecular-Sci 2023; 24 (4): 1-9.; Dias e SilvaD, Borba GB, Beal JR, Botrus G, Osawa A, Araujo SEA, et al. Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a He...$60$YR$$M$Y$$$20240809$$HP$BR$BR
241432391$24143239$1$I$20240701$20240722$20240726$20240726$EXP$$JP-Eisai-EC-2024-170772$EISAI$$$$E$M$Y$$$20240726$$MD$JP$JP
241432402$24143240$2$F$20240723$20240808$20240726$20240809$PER$$JP-Eisai-EC-2024-170836$EISAI$$$$$F$Y$$$20240809$$PH$JP$JP
241432411$24143241$1$I$$20240722$20240726$20240726$PER$$JP-Eisai-EC-2024-170698$EISAI$$$$E$M$Y$$$20240726$$MD$JP$JP
241432421$24143242$1$I$20240709$20240720$20240726$20240726$EXP$GB-MHRA-MED-202407201249278820-RCNYT$GB-Eisai-EC-2024-170612$EISAI$$59$YR$A$F$Y$86$KG$20240726$$CN$GB$GB
241432432$24143243$2$F$20240709$20240910$20240726$20240920$PER$$JP-Eisai-EC-2024-170933$EISAI$$75$YR$E$M$Y$$$20240920$$MD$JP$JP
241432453$24143245$3$F$$20240828$20240726$20240828$PER$$US-PFIZER INC-PV202400096443$PFIZER$$10$YR$$M$Y$49.07$KG$20240828$$MD$US$US
241432471$24143247$1$I$20220301$20240724$20240726$20240726$EXP$SE-SEMPA-2024-005445$SE-PURDUE-USA-2024-0310976$PURDUE$$25$YR$$M$Y$77$KG$20240726$$CN$SE$SE
241432481$24143248$1$I$$20240717$20240726$20240726$EXP$$CA-ROCHE-10000031291$ROCHE$$$$A$F$Y$$$20240726$$CN$CA$CA
241432491$24143249$1$I$$20240718$20240726$20240726$EXP$$US-APELLIS-2024-APL-0000516$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240726$$HP$US$US
241432502$24143250$2$F$$20240730$20240726$20240802$PER$$NVSC2024US153754$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241432511$24143251$1$I$$20240725$20240726$20240726$PER$$US-PURDUE PHARMA-USA-2024-0310960$PURDUE$$$$$F$Y$58.97$KG$20240726$$CN$US$US
241432521$24143252$1$I$$20240725$20240726$20240726$PER$$US-PURDUE PHARMA-USA-2024-0310959$PURDUE$$55$YR$$M$Y$$$20240726$$CN$US$US
241432531$24143253$1$I$$20240725$20240726$20240726$PER$$US-PURDUE PHARMA-USA-2024-0310977$PURDUE$$$$$F$Y$$$20240726$$PH$US$US
241432541$24143254$1$I$$20240724$20240726$20240726$PER$$US-PURDUE PHARMA-USA-2024-0310958$PURDUE$$51$YR$$F$Y$$$20240726$$CN$US$US
241432562$24143256$2$F$20240907$20240909$20240726$20240911$PER$$NVSC2024US153749$NOVARTIS$$80$YR$$M$Y$51.81$KG$20240911$$HP$US$US
241432571$24143257$1$I$20240712$20240717$20240726$20240726$EXP$$CN-GE HEALTHCARE-2024CSU008192$GE HEALTHCARE$$61$YR$$M$Y$80$KG$20240726$$HP$CN$CN
241432581$24143258$1$I$20240315$20240719$20240726$20240726$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-100598$REGENERON$$45$YR$$F$Y$$$20240726$$MD$JP$JP
241432591$24143259$1$I$$20240725$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US068428$SANDOZ$$$$$F$Y$$$20240726$$CN$US$US
241432602$24143260$2$F$$20240731$20240726$20240808$EXP$$HR-ABBVIE-5848602$ABBVIE$$$$$$Y$$$20240808$$MD$HR$HR
241432612$24143261$2$F$20240722$20240723$20240726$20240806$EXP$$CA-HLS-202401840$HLS THERAPEUTICS$$56$YR$A$M$Y$$$20240806$$PH$CA$CA
241432621$24143262$1$I$20220101$20240724$20240726$20240726$PER$$US-ROCHE-10000036362$ROCHE$$33$YR$A$F$Y$$$20240726$$CN$US$US
241432631$24143263$1$I$20240614$20240715$20240726$20240726$PER$$US-ALKERMES INC.-ALK-2024-001890$ALKERMES$$60$YR$$M$Y$131.52$KG$20240726$$CN$US$US
241432641$24143264$1$I$20240708$20240716$20240726$20240726$EXP$$CN-009507513-2407CHN012010$MERCK$$28$YR$$F$Y$$$20240726$$HP$CN$CN
241432652$24143265$2$F$20240601$20240814$20240726$20240827$PER$$US-ABBVIE-5851199$ABBVIE$$70$YR$$M$Y$$$20240827$$CN$US$GB
241432661$24143266$1$I$$20240628$20240726$20240726$PER$$US-009507513-2406USA010156$MERCK$$$$$F$Y$72.6$KG$20240726$$CN$US$US
241432682$24143268$2$F$$20240717$20240726$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407016128$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240731$$CN$US$US
241432691$24143269$1$I$20240717$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016356$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240726$$CN$US$US
241432701$24143270$1$I$$20240722$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407014293$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240726$$CN$US$US
241432711$24143271$1$I$20220530$20240718$20240726$20240726$EXP$ES-AEMPS-1544782$ES-TEVA-VS-3223770$TEVA$$61$YR$$M$Y$$$20240726$$MD$ES$ES
241432721$24143272$1$I$20240201$20240718$20240726$20240726$PER$$US-BAUSCHBL-2024BNL030318$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240726$$CN$US$US
241432731$24143273$1$I$20240101$20240722$20240726$20240726$EXP$$US-009507513-2407USA012817$MERCK$$68$YR$$F$Y$$$20240726$$HP$US$US
241432741$24143274$1$I$20221001$20240722$20240726$20240726$EXP$$DE-009507513-2407DEU012754$MERCK$$$$$F$Y$$$20240726$$MD$DE$DE
241432751$24143275$1$I$20240717$20240723$20240726$20240726$PER$$US-BAYER-2024A107216$BAYER$$64$YR$A$F$Y$$$20240726$$CN$US$US
241432761$24143276$1$I$20240721$20240722$20240726$20240726$EXP$$JP-009507513-2407JPN004374J$MERCK$$63$YR$$F$Y$$$20240726$$MD$JP$JP
241432772$24143277$2$F$20240301$20240823$20240726$20240823$EXP$$US-ALXN-202407USA001369US$ALEXION PHARMACEUTICALS$$65$YR$$M$Y$$$20240823$$CN$US$US
241432781$24143278$1$I$20240409$20240719$20240726$20240726$PER$ES-AEMPS-1550351$ES-Blueprint Medicines Corporation-SP-ES-2024-001478$BLUEPRINT MEDICINES$$52$YR$A$M$Y$$$20240726$$MD$ES$ES
241432801$24143280$1$I$$20240724$20240726$20240726$EXP$$CA-ROCHE-10000037371$ROCHE$$$$A$M$Y$$$20240726$$HP$CA$CA
241432811$24143281$1$I$$20240725$20240726$20240726$PER$$US-ROCHE-10000037811$ROCHE$$23$YR$A$F$Y$$$20240726$$CN$US$US
241432821$24143282$1$I$$20240723$20240726$20240726$EXP$$US-SANDOZ INC.-SDZ2024US068199$SANDOZ$$$$$F$Y$$$20240726$$HP$US$US
241432832$24143283$2$F$$20240716$20240726$20240808$EXP$$JP-009507513-2407JPN003344J$MERCK$Kume S, Takada Y, Uno S, Imao M, Nanba K, Fujimoto Y, et al.. 54 A Case of Eosinophilic pneumonia Caused by Pembrolizumab.. The 120th Kansai Branch Meeting of the Japan Lung Cancer Society. 60$71$YR$$M$Y$$$20240808$$MD$JP$JP
241432841$24143284$1$I$20231118$20240716$20240726$20240726$EXP$$CN-009507513-2407CHN011921$MERCK$Feng J. Analysis of Drug Therapy in A Patient with Complicated Urinary Tract Infection with Secondary Epilepsy. CHINESE JOURNAL OF RATIONAL DRUG USE. 2024;6 (21):70-5$78$YR$$F$Y$$$20240726$$PH$CN$CN
241432851$24143285$1$I$$20240712$20240726$20240726$EXP$$US-HLS-202400369$HLS THERAPEUTICS$$31$YR$A$F$Y$$$20240726$$HP$US$US
241432861$24143286$1$I$$20240718$20240726$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115112$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240726$$HP$CA$CA
241432871$24143287$1$I$$20240718$20240726$20240726$PER$$US-ROCHE-10000032647$ROCHE$$$$$$Y$$$20240726$$PH$US$US
241432881$24143288$1$I$$20240712$20240726$20240726$EXP$$HU-IMP-2024000524$Harrow Health$Nagy KI, Pribelszki E, Sira A, Fullajtar B, Racz T, Major T, . Francisella tularensis Infection Causing Parinaud Oculoglandular Syndrome. 2024 Jun 28; doi:10.12659/AJCR.943915.$66$YR$E$M$Y$$$20240726$$HP$HU$HU
241432891$24143289$1$I$20231108$20240724$20240726$20240726$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011300$JAZZ$$51$YR$$F$Y$$$20240726$$HP$US$US
241432901$24143290$1$I$$20240628$20240726$20240726$PER$$US-009507513-2407USA000992$MERCK$Cheng T, Curley M, Barmettler A.. Pseudocholinesterase deficiency in ophthalmology: a systematic review. Orbit. 2024;43(3):429-37$60$YR$$F$Y$$$20240726$$HP$US$US
241432914$24143291$4$F$$20240801$20240726$20240805$PER$$NVSC2024US152899$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241432921$24143292$1$I$$20240711$20240726$20240726$EXP$$US-HLS-202400342$HLS THERAPEUTICS$$$$A$M$Y$$$20240726$$HP$US$US
241432932$24143293$2$F$$20240815$20240726$20240819$PER$$US-ALXN-202407USA001436US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241432942$24143294$2$F$$20240730$20240726$20240813$PER$$US-APELLIS-2024-APL-0000507$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
241432951$24143295$1$I$$20240725$20240726$20240726$EXP$$LT-PFIZER INC-PV202400097149$PFIZER$$65$YR$$F$Y$$$20240726$$MD$LT$LT
241432963$24143296$3$F$$20240922$20240726$20240924$EXP$$TR-PFIZER INC-PV202400097210$PFIZER$$64$YR$$M$Y$$$20240924$$MD$TR$TR
241432971$24143297$1$I$20240718$20240724$20240726$20240726$EXP$$CN-PFIZER INC-PV202400096884$PFIZER$$72$YR$$M$Y$60$KG$20240726$$HP$CN$CN
241432981$24143298$1$I$20240708$20240725$20240726$20240726$EXP$$US-PFIZER INC-202400224113$PFIZER$$68$YR$$F$Y$$$20240726$$HP$US$US
241433001$24143300$1$I$20240704$20240712$20240726$20240726$EXP$$CA-HLS-202401748$HLS THERAPEUTICS$$65$YR$E$M$Y$$$20240726$$PH$CA$CA
241433011$24143301$1$I$$20240720$20240726$20240726$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-100968$REGENERON$$$$$F$Y$$$20240726$$MD$JP$JP
241433022$24143302$2$F$20231112$20240731$20240726$20240731$EXP$$DE-GILEAD-2024-0682125$GILEAD$$61$YR$A$F$Y$$$20240731$$MD$DE$DE
241433031$24143303$1$I$20230222$20240722$20240726$20240726$EXP$$KR-009507513-2407KOR012026$MERCK$$$$$M$Y$46.9$KG$20240726$$HP$KR$KR
241433041$24143304$1$I$20240626$20240722$20240726$20240726$EXP$$ID-AstraZeneca-2024A170863$ASTRAZENECA$$26282$DY$$F$Y$$$20240726$$CN$ID$
241433053$24143305$3$F$20240101$20240919$20240726$20240923$PER$$US-ABBVIE-5849311$ABBVIE$$87$YR$$F$Y$$$20240923$$MD$US$US
241433062$24143306$2$F$20240417$20240729$20240726$20240805$EXP$$CN-PFIZER INC-2024SGN05623$PFIZER$$71$YR$$M$Y$58$KG$20240805$$MD$CN$CN
241433071$24143307$1$I$$20240704$20240726$20240726$PER$$US-009507513-2407USA002865$MERCK$Mullis CE., Heldman M, Bahr NC, Minamoto GY, Puius YA, Malinis M.. Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient. Transplant Infect Disease. 2024;26(3)::e14271$64$YR$$M$Y$$$20240726$$HP$US$US
241433081$24143308$1$I$20240703$20240725$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407017076$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240726$$CN$US$US
241433091$24143309$1$I$20240101$20240715$20240726$20240726$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407010549$ELI LILLY AND CO$$84$YR$E$M$Y$71.6$KG$20240726$$CN$DE$DE
241433102$24143310$2$F$20240623$20240729$20240726$20240813$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0683$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
241433111$24143311$1$I$$20240710$20240726$20240726$EXP$$CN-GSK-CN2024APC093132$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$MD$CN$CN
241433121$24143312$1$I$20240722$20240724$20240726$20240726$EXP$$CN-ROCHE-10000037645$ROCHE$$72$YR$E$M$Y$93$KG$20240726$$HP$CN$CN
241433132$24143313$2$F$20240716$20240716$20240726$20240808$EXP$$GB-GSK-GB2024EME091402$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$HP$GB$GB
241433141$24143314$1$I$$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024147207$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
241433151$24143315$1$I$$20240715$20240726$20240726$EXP$$TW-AstraZeneca-2024A170891$ASTRAZENECA$$$$$$Y$$$20240726$$HP$TW$
241433161$24143316$1$I$$20240725$20240726$20240726$EXP$$CN-AstraZeneca-2024A170892$ASTRAZENECA$$$$$M$Y$$$20240726$$CN$CN$
241433181$24143318$1$I$$20240718$20240726$20240726$PER$$US-ABBVIE-5847800$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241433191$24143319$1$I$20230913$20240725$20240726$20240726$EXP$FR-AFSSAPS-MA2024001064$FR-009507513-2407FRA014386$MERCK$$80$YR$$F$Y$71$KG$20240726$$PH$FR$FR
241433201$24143320$1$I$20240722$20240725$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016923$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240726$$CN$US$US
241433211$24143321$1$I$20240707$20240711$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407007820$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240726$$CN$US$US
241433221$24143322$1$I$20240724$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016174$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$US$US
241433231$24143323$1$I$20240701$20240725$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407017071$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240726$$CN$US$US
241433241$24143324$1$I$20240701$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016228$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240726$$CN$US$US
241433251$24143325$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016216$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240726$$CN$US$US
241433261$24143326$1$I$20240411$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015995$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240726$$CN$US$US
241433274$24143327$4$F$$20240823$20240726$20240823$EXP$$US-ALXN-202407USA001397US$ALEXION PHARMACEUTICALS$$$$$M$Y$102$KG$20240823$$CN$US$US
241433281$24143328$1$I$$20240719$20240726$20240726$PER$$US-ALXN-202407USA001385US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240726$$CN$US$US
241433291$24143329$1$I$$20240712$20240726$20240726$EXP$$US-HLS-202400367$HLS THERAPEUTICS$$17$YR$T$F$Y$$$20240726$$CN$US$US
241433303$24143330$3$F$20240701$20240903$20240726$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001477$BLUEPRINT MEDICINES$$28$YR$A$F$Y$$$20240911$$CN$US$US
241433311$24143331$1$I$20240718$20240719$20240726$20240726$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001479$BLUEPRINT MEDICINES$$56$YR$A$F$Y$$$20240726$$CN$US$US
241433321$24143332$1$I$20100708$20240716$20240726$20240726$EXP$$FR-009507513-1102FRA00030$MERCK$$67$YR$$M$Y$$$20240726$$HP$FR$FR
241433332$24143333$2$F$20240719$20240826$20240726$20240904$EXP$$FR-GILEAD-2024-0681396$GILEAD$$$$$F$Y$$$20240904$$MD$FR$FR
241433343$24143334$3$F$20240701$20240913$20240726$20240920$EXP$$CA-GILEAD-2024-0682126$GILEAD$$62$YR$A$M$Y$62.993$KG$20240920$$MD$CA$CA
241433351$24143335$1$I$$20240724$20240726$20240726$PER$$NVSC2024US153713$NOVARTIS$$$$$F$Y$$$20240727$$HP$US$US
241433361$24143336$1$I$$20240725$20240726$20240726$PER$$NVSC2024US153770$NOVARTIS$$$$$M$Y$$$20240727$$MD$US$US
241433372$24143337$2$F$$20240726$20240726$20240729$PER$$NVSC2024US153742$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241433381$24143338$1$I$$20240713$20240726$20240726$EXP$$US-HLS-202400373$HLS THERAPEUTICS$$60$YR$A$F$Y$$$20240726$$PH$US$US
241433392$24143339$2$F$$20240819$20240726$20240822$EXP$$US-GILEAD-2024-0681878$GILEAD$$$$E$F$Y$$$20240822$$CN$US$US
241433402$24143340$2$F$$20240725$20240726$20240726$PER$$US-ROCHE-10000037974$ROCHE$$$$A$F$Y$$$20240726$$CN$US$US
241433412$24143341$2$F$20230901$20240730$20240726$20240814$PER$$US-009507513-2407USA013154$MERCK$$48$YR$$F$Y$$$20240814$$CN$US$US
241433421$24143342$1$I$$20240715$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407010196$ELI LILLY AND CO$$$$$$Y$$$20240726$$CN$US$US
241433431$24143343$1$I$20240712$20240715$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407010391$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240726$$CN$US$US
241433441$24143344$1$I$$20240724$20240726$20240726$EXP$$US-ROCHE-10000036614$ROCHE$$$$A$F$Y$$$20240726$$CN$US$US
241433451$24143345$1$I$$20240712$20240726$20240726$EXP$$US-HLS-202400377$HLS THERAPEUTICS$$$$A$F$Y$$$20240726$$HP$US$US
241433461$24143346$1$I$20240722$20240723$20240726$20240726$PER$$US-ABBVIE-5852951$ABBVIE$$69$YR$$F$Y$$$20240726$$CN$US$US
241433471$24143347$1$I$$20240718$20240726$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118234$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240726$$HP$CA$CA
241433481$24143348$1$I$$20240725$20240726$20240726$PER$$US-AstraZeneca-2024A170584$ASTRAZENECA$$$$$F$Y$$$20240726$$CN$US$
241433502$24143350$2$F$$20240815$20240726$20240819$PER$$US-ALXN-202407USA001492US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241433511$24143351$1$I$$20240701$20240726$20240726$PER$$US-009507513-2407USA000942$MERCK$Asif AA, Roy M, Ahmad S. Paecilomyces Pneumonia Despite Voriconazole Prophylaxis: A Case Report and Literature Review. European Journal of Case Reports in Internal Medicine. 2021;8 (7)$47$YR$$F$Y$$$20240726$$HP$US$US
241433521$24143352$1$I$20240714$20240718$20240726$20240726$PER$$US-ABBVIE-5851577$ABBVIE$$53$YR$$F$Y$$$20240726$$CN$US$US
241433531$24143353$1$I$$20240718$20240726$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118308$BRISTOL MYERS SQUIBB$Literature citation unavailable.$$$$$Y$$$20240726$$HP$CA$CA
241433542$24143354$2$F$20240101$20240813$20240726$20240826$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07178$NEUROCRINE BIOSCIENCES$$63$YR$$M$Y$$$20240826$$MD$US$US
241433551$24143355$1$I$$20240719$20240726$20240726$PER$$US-ALXN-202407USA001484US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240726$$CN$US$US
241433561$24143356$1$I$20240715$20240724$20240726$20240726$EXP$$US-BIOMARINAP-US-2024-159429$BIOMARIN$$$$$$Y$$$20240726$$CN$US$US
241433571$24143357$1$I$20240701$20240723$20240726$20240726$EXP$$DE-BIOMARINAP-DE-2024-159171$BIOMARIN$$$$$$Y$$$20240726$$CN$DE$DE
241433581$24143358$1$I$$20240724$20240726$20240726$EXP$$IE-GILEAD-2023-0651011$GILEAD$$$$$F$Y$69$KG$20240726$$PH$IE$IE
241433592$24143359$2$F$20051117$20240716$20240726$20240801$EXP$$FR-009507513-0511FRA00099$MERCK$$69$YR$$F$Y$$$20240801$$MD$FR$FR
241433601$24143360$1$I$$20240723$20240726$20240726$EXP$$CA-BIOMARINAP-CA-2024-159396$BIOMARIN$$$$$$Y$$$20240726$$CN$CA$CA
241433611$24143361$1$I$20240516$20240725$20240726$20240726$EXP$FR-AFSSAPS-LY2024001100$FR-009507513-2407FRA014210$MERCK$$54$YR$$M$Y$81$KG$20240726$$PH$FR$FR
241433621$24143362$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407015274$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240726$$CN$US$US
241433631$24143363$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407014901$ELI LILLY AND CO$$$$$F$Y$$$20240726$$CN$US$US
241433641$24143364$1$I$20240722$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016405$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240726$$CN$US$US
241433651$24143365$1$I$20240723$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016032$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240726$$CN$US$US
241433671$24143367$1$I$$20240718$20240726$20240726$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114894$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240726$$HP$CA$CA
241433682$24143368$2$F$$20240724$20240726$20240729$EXP$$US-ROCHE-10000038214$ROCHE$$65$YR$E$F$Y$$$20240729$$CN$US$US
241433702$24143370$2$F$$20240722$20240726$20240729$PER$$US-JAZZ PHARMACEUTICALS-2023-US-008428$JAZZ$$$$$F$Y$$$20240729$$CN$US$US
241433712$24143371$2$F$20240708$20240724$20240726$20240726$PER$$US-ROCHE-10000035674$ROCHE$$50$YR$A$F$Y$$$20240726$$HP$US$US
241433721$24143372$1$I$$20240712$20240726$20240726$EXP$$US-HLS-202400455$HLS THERAPEUTICS$$17$YR$T$F$Y$$$20240726$$MD$US$US
241433731$24143373$1$I$$20240719$20240726$20240726$EXP$$US-AstraZeneca-2024A165754$ASTRAZENECA$$50$YR$$$Y$$$20240727$$CN$US$
241433745$24143374$5$F$$20240819$20240726$20240822$EXP$$PL-009507513-2407POL013219$MERCK$$55$YR$$F$Y$$$20240822$$PH$PL$PL
241433752$24143375$2$F$$20240712$20240726$20240729$EXP$$US-HLS-202400380$HLS THERAPEUTICS$$$$A$F$Y$$$20240729$$PH$US$US
241433761$24143376$1$I$$20240718$20240726$20240726$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115165$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240726$$CN$US$US
241433771$24143377$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016253$ELI LILLY AND CO$$$$$$Y$$$20240726$$CN$US$US
241433782$24143378$2$F$20240501$20240722$20240726$20240726$EXP$$US-ROCHE-10000033761$ROCHE$$$$$F$Y$$$20240727$$CN$US$US
241433791$24143379$1$I$$20240725$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016821$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240726$$CN$US$US
241433822$24143382$2$F$20240712$20240815$20240726$20240822$EXP$$US-BIOMARINAP-US-2024-159415$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
241433831$24143383$1$I$20240126$20240726$20240726$20240726$EXP$FR-AFSSAPS-AN2024000300$FR-GILEAD-2024-0664072$GILEAD$$57$YR$A$M$Y$69$KG$20240726$$MD$FR$FR
241433841$24143384$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016418$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240726$$CN$US$US
241433852$24143385$2$F$$20240903$20240726$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202407016560$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240905$$CN$US$US
241433861$24143386$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016260$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240726$$CN$US$US
241433871$24143387$1$I$$20240724$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016066$ELI LILLY AND CO$$63$YR$A$$Y$$$20240726$$CN$US$US
241433881$24143388$1$I$20240723$20240723$20240726$20240726$PER$$US-AMGEN-USASP2024146715$AMGEN$$37$YR$A$F$Y$$$20240726$$CN$US$US
241433891$24143389$1$I$$20240723$20240726$20240726$PER$$US-ELI_LILLY_AND_COMPANY-US202407016535$ELI LILLY AND CO$$$$$$Y$$$20240726$$CN$US$US
241433902$24143390$2$F$$20240827$20240726$20240903$EXP$$US-ABBVIE-5852494$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
241433911$24143391$1$I$$20240724$20240726$20240726$PER$$US-SA-2024SA218972$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240727$$MD$US$US
241433921$24143392$1$I$20240101$20240724$20240726$20240726$EXP$$US-ABBVIE-5852595$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241433931$24143393$1$I$$20240724$20240726$20240726$EXP$$US-ABBVIE-5854133$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241433941$24143394$1$I$20240724$20240726$20240726$20240726$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042253$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240727$$CN$US$US
241433951$24143395$1$I$$20240715$20240726$20240726$EXP$$TH-ROCHE-10000034020$ROCHE$$62$YR$A$F$Y$$$20240727$$CN$TH$TH
241433961$24143396$1$I$20240523$20240718$20240726$20240726$EXP$$PK-ROCHE-10000032346$ROCHE$$53$YR$A$M$Y$$$20240727$$CN$PK$PK
241433971$24143397$1$I$20240528$20240718$20240726$20240726$EXP$$PK-ROCHE-10000032327$ROCHE$$62$YR$A$M$Y$$$20240727$$CN$PK$PK
241433981$24143398$1$I$20240101$20240725$20240726$20240726$PER$$US-ABBVIE-5855178$ABBVIE$$49$YR$$F$Y$$$20240726$$MD$US$US
241433991$24143399$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA214896$SANOFI AVENTIS$$$$A$F$Y$$$20240727$$MD$US$US
241434001$24143400$1$I$$20240718$20240726$20240726$PER$$US-APOTEX-2024AP008767$APOTEX$Becker DA.. The Positive Assistance of Assisted Reproductive Technology. Epilepsy Currents (English-Edition). 2024;24 (3):180-181$$$$F$Y$$$20240726$$MD$US$US
241434011$24143401$1$I$$20240724$20240726$20240726$PER$$US-AMGEN-USASP2024148232$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241434022$24143402$2$F$20240723$20240723$20240726$20240731$PER$$US-AMGEN-USASP2024146802$AMGEN$$70$YR$E$F$Y$$$20240731$$CN$US$US
241434031$24143403$1$I$$20240722$20240726$20240726$EXP$$US-ROCHE-10000033786$ROCHE$$52$YR$A$F$Y$$$20240727$$HP$US$US
241434051$24143405$1$I$$20240718$20240726$20240726$PER$$US-SA-2024SA215207$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240727$$MD$US$US
241434061$24143406$1$I$20240601$20240719$20240726$20240726$EXP$$US-GSK-US2024090714$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241434072$24143407$2$F$20240131$20240802$20240726$20240803$EXP$$KZ-ABBVIE-5847744$ABBVIE$$55$YR$$F$Y$$$20240803$$MD$KZ$KZ
241434081$24143408$1$I$$20240718$20240726$20240726$EXP$$CA-ABBVIE-5854586$ABBVIE$$$$A$M$Y$$$20240726$$CN$CA$CA
241434091$24143409$1$I$$20240724$20240726$20240726$EXP$$NVSC2024US152737$NOVARTIS$$$$$M$Y$$$20240727$$CN$US$US
241434101$24143410$1$I$$20240722$20240726$20240726$EXP$$US-GSK-US2024AMR092121$GLAXOSMITHKLINE$$$$$$Y$$$20240726$$CN$US$US
241434111$24143411$1$I$$20240724$20240726$20240726$PER$$US-ABBVIE-5855682$ABBVIE$$$$$$Y$$$20240726$$HP$US$US
241434121$24143412$1$I$$20240724$20240726$20240726$EXP$$CA-ABBVIE-5854922$ABBVIE$$$$$M$Y$$$20240726$$CN$CA$CA
241434131$24143413$1$I$20240101$20240708$20240726$20240726$EXP$$CA-ABBVIE-5834186$ABBVIE$$84$YR$$F$Y$$$20240726$$CN$CA$CA
241434141$24143414$1$I$$20240724$20240726$20240726$EXP$$TH-ROCHE-10000035211$ROCHE$$53$YR$A$M$Y$$$20240727$$HP$TH$TH
241434151$24143415$1$I$$20240724$20240726$20240726$PER$$US-ABBVIE-5855852$ABBVIE$$$$$$Y$$$20240726$$HP$US$US
241434161$24143416$1$I$$20240724$20240726$20240726$EXP$$CA-ABBVIE-5853156$ABBVIE$$$$A$F$Y$$$20240726$$CN$CA$CA
241434171$24143417$1$I$20240101$20240724$20240726$20240726$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137530$DAIICHI$$$$$F$Y$$$20240727$$MD$US$US
241434184$24143418$4$F$$20240909$20240726$20240918$EXP$SE-SEMPA-2022-017817$SE-ABBVIE-5847833$ABBVIE$$37$YR$$F$Y$65$KG$20240918$$CN$SE$SE
241434191$24143419$1$I$20240525$20240718$20240726$20240726$EXP$$US-ABBVIE-5845741$ABBVIE$$59$YR$$M$Y$$$20240726$$CN$US$US
241434201$24143420$1$I$20240724$20240725$20240726$20240726$PER$$US-ABBVIE-5855126$ABBVIE$$32$YR$$F$Y$$$20240726$$CN$US$US
241434211$24143421$1$I$20240401$20240717$20240726$20240726$PER$$US-SA-2024SA218551$SANOFI AVENTIS$$$$$$Y$$$20240727$$MD$US$US
241434221$24143422$1$I$$20240717$20240726$20240726$EXP$$CA-NOVITIUMPHARMA-2024CANVP01384$NOVITIUM PHARMA$Tyson L.W. Bodor.Primary Cardiac Lymphoma in an 85-Year-Old Man, With Highly Suggestive Features on Imaging. Canadian Journal of Cardiology .02-DEC-2022;5(2):167-169$85$YR$E$M$Y$$$20240727$$HP$CA$CA
241434231$24143423$1$I$20240725$20240725$20240726$20240726$PER$$US-AMGEN-USASP2024148801$AMGEN$$44$YR$A$F$Y$$$20240726$$CN$US$US
241434241$24143424$1$I$20240101$20240718$20240726$20240726$PER$$US-SA-2024SA215648$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240727$$MD$US$US
241434251$24143425$1$I$$20240719$20240726$20240726$PER$$US-SA-2024SA216885$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240727$$MD$US$US
241434262$24143426$2$F$20240505$20240729$20240726$20240730$EXP$$IN-ROCHE-10000038199$ROCHE$$73$YR$E$F$Y$$$20240730$$CN$IN$IN
241434272$24143427$2$F$20240701$20240818$20240726$20240827$PER$$US-SA-2024SA217971$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240827$$MD$US$US
241434281$24143428$1$I$$20240723$20240726$20240726$EXP$$US-ABBVIE-5854279$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241434291$24143429$1$I$20240709$20240722$20240726$20240726$EXP$$PK-ROCHE-10000034544$ROCHE$$78$YR$E$F$Y$$$20240727$$CN$PK$PK
241434302$24143430$2$F$$20240724$20240726$20240727$EXP$$CA-ABBVIE-5854576$ABBVIE$$$$E$M$Y$$$20240727$$CN$CA$CA
241434312$24143431$2$F$$20240820$20240726$20240827$EXP$$CA-APOTEX-2024AP008596$APOTEX$$8$YR$$F$Y$28$KG$20240827$$MD$CA$CA
241434321$24143432$1$I$20240719$20240719$20240726$20240726$EXP$$US-ABBVIE-5850179$ABBVIE$$42$YR$$F$Y$$$20240726$$CN$US$US
241434332$24143433$2$F$20240724$20240726$20240726$20240729$PER$$US-AMGEN-USASP2024148989$AMGEN$$$$$$Y$$$20240729$$PH$US$US
241434343$24143434$3$F$20231207$20240821$20240726$20240829$EXP$$JP-UNITED THERAPEUTICS-UNT-2023-035789$UNITED THERAPEUTICS$$55$YR$$M$Y$$$20240829$$$JP$JP
241434351$24143435$1$I$$20240718$20240726$20240726$EXP$$CA-APOTEX-2024AP008593$APOTEX$$14$YR$$F$Y$$$20240726$$MD$CA$CA
241434361$24143436$1$I$$20240717$20240726$20240726$PER$$US-ABBVIE-5853347$ABBVIE$$$$$F$Y$$$20240726$$CN$US$US
241434372$24143437$2$F$20240625$20240806$20240726$20240812$30DAY$$US-AMGEN-USASP2024145666$AMGEN$$60$YR$A$M$Y$92.7$KG$20240812$$PH$US$US
241434381$24143438$1$I$$20240722$20240726$20240726$EXP$$CA-APOTEX-2024AP008680$APOTEX$$8$YR$$M$Y$30$KG$20240726$$HP$CA$CA
241434391$24143439$1$I$$20240620$20240726$20240726$EXP$$CA-JNJFOC-20240657510$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240727$$PH$CA$CA
241434402$24143440$2$F$20240101$20240731$20240726$20240803$PER$$US-AMGEN-USASP2024145499$AMGEN$$67$YR$E$M$Y$$$20240803$$CN$US$US
241434411$24143441$1$I$$20240724$20240726$20240726$EXP$$DE-ROCHE-2909745$ROCHE$Bakhtiar S, Salzmann-Manrique E, Donath H, Woelke S, Duecker R, Fritzemeyer S, Schubert R, Huenecke S, Kieslich M, Klingebiel T, Bader P and Zielen S. The incidence and type of cancer in patients with ataxia-telangiectasia via a retrospective single-centre study. British Journal of Haematology 2021 Sep;194 (5):879-87.$14$YR$T$M$Y$$$20240727$$HP$DE$DE
241434424$24143442$4$F$20240101$20240829$20240726$20240902$EXP$$CO-ABBVIE-5853296$ABBVIE$$$$$F$Y$56$KG$20240902$$CN$CO$CO
241434431$24143443$1$I$$20240724$20240727$20240727$PER$$US-ABBVIE-5855869$ABBVIE$$$$$$Y$$$20240727$$CN$US$US
241434441$24143444$1$I$20240524$20240722$20240727$20240727$EXP$$US-ABBVIE-5852682$ABBVIE$$81$YR$$F$Y$$$20240727$$HP$US$US
241434451$24143445$1$I$$20240717$20240726$20240726$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01377$NOVITIUM PHARMA$Xiaolin Xu.The hidden dangers of short-term glucocorticoid use in children: A genomic analysis.International Immunopharmacology.30-JUN-2024;135:112323$7$YR$C$M$Y$40$KG$20240727$$HP$CN$CN
241434461$24143446$1$I$$20240711$20240727$20240727$PER$$US-JNJFOC-20240737507$JOHNSON AND JOHNSON$$$$$$Y$$$20240727$$CN$US$US
241434471$24143447$1$I$$20240723$20240727$20240727$PER$$US-ABBVIE-5854711$ABBVIE$$$$$$Y$$$20240727$$MD$US$US
241434481$24143448$1$I$$20240610$20240727$20240727$EXP$$AU-JNJFOC-20240770795$JOHNSON AND JOHNSON$$$$$F$Y$$$20240727$$HP$AU$AU
241434491$24143449$1$I$$20240719$20240727$20240727$PER$$US-ABBVIE-5851202$ABBVIE$$$$$$Y$$$20240727$$CN$US$US
241434501$24143450$1$I$$20240723$20240727$20240727$EXP$$CA-ABBVIE-5856172$ABBVIE$$50$YR$$F$Y$$$20240727$$MD$CA$CA
241434513$24143451$3$F$20240101$20240828$20240727$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022891$UNITED THERAPEUTICS$$$$$F$Y$77.098$KG$20240905$$$US$US
241434521$24143452$1$I$20231201$20240719$20240727$20240727$EXP$$US-ABBVIE-5710219$ABBVIE$$64$YR$$M$Y$102$KG$20240727$$CN$US$US
241434531$24143453$1$I$$20240722$20240727$20240727$EXP$$US-ABBVIE-5850455$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241434541$24143454$1$I$$20240718$20240727$20240727$EXP$$GB-CELLTRION INC.-2024GB017897$CELLTRION$$$$$$Y$$$20240727$$CN$GB$GB
241434551$24143455$1$I$20240701$20240718$20240727$20240727$PER$$US-SA-2024SA214091$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240727$$MD$US$US
241434561$24143456$1$I$$20240717$20240727$20240727$EXP$$US-NOVITIUMPHARMA-2024USNVP01388$NOVITIUM PHARMA$Rachel Lee.Case study: Autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks^ gestation.Case Reports in Perinatal Medicine.26-APR-2024;13(1):1-4$$$N$$Y$$$20240727$$HP$US$US
241434571$24143457$1$I$20240715$20240716$20240727$20240727$EXP$$US-Accord-437680$ACCORD$$21$YR$A$M$Y$$$20240726$$HP$US$US
241434581$24143458$1$I$$20240714$20240727$20240727$EXP$$NL-Accord-438053$ACCORD$Crouwel F, Simsek M, de Boer MA, van Asseldonk DP, Bhalla A, Weusthuis et al. Multicentre study and systematic review: Allopurinol exposure during pregnancy. Aliment Pharmacol Ther. 2024 Jul 10.$$$$F$Y$$$20240726$$HP$NL$NL
241434591$24143459$1$I$$20240725$20240727$20240727$EXP$AU-TGA-809801$AU-Accord-438068$ACCORD$$$$$F$Y$$$20240726$$HP$AU$AU
241434601$24143460$1$I$20240705$20240716$20240727$20240727$EXP$$US-Accord-437718$ACCORD$$24$YR$A$M$Y$$$20240726$$HP$US$US
241434611$24143461$1$I$$20240716$20240727$20240727$EXP$$JP-Accord-436549$ACCORD$Yamane K, Tsukano K, Umino Y, Nagami T, Tarumoto K, Hattori K, et al. Successful curative treatment for a ruptured pancreatic acinar cell carcinoma by radical resection following modified FOLFIRINOX: a case report and literature review. International Cancer Conference Journal. 2024;13(3):281-8. DOI:10.1007/s13691-024-00679-1.$48$YR$A$M$Y$$$20240726$$MD$JP$JP
241434622$24143462$2$F$$20240807$20240727$20240812$PER$$US-AMGEN-USASP2024145383$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
241434631$24143463$1$I$20240710$20240719$20240727$20240727$PER$$US-ABBVIE-5852231$ABBVIE$$36$YR$$F$Y$$$20240727$$MD$US$US
241434641$24143464$1$I$$20240719$20240727$20240727$PER$$US-ABBVIE-5852785$ABBVIE$$$$$$Y$$$20240727$$CN$US$US
241434651$24143465$1$I$20200305$20240725$20240727$20240727$EXP$$CA-SANDOZ INC.-NVSC2020CA071322$SANDOZ$$62$YR$$F$Y$$$20240727$$MD$CA$CA
241434661$24143466$1$I$20240701$20240723$20240727$20240727$EXP$$US-ABBVIE-5851168$ABBVIE$$62$YR$$F$Y$$$20240727$$CN$US$US
241434671$24143467$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA217311$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240727$$MD$US$US
241434681$24143468$1$I$20240701$20240722$20240727$20240727$EXP$$US-ABBVIE-5841533$ABBVIE$$67$YR$$F$Y$$$20240727$$CN$US$US
241434692$24143469$2$F$20240629$20240823$20240727$20240925$EXP$$CA-ABBVIE-5850736$ABBVIE$$70$YR$$M$Y$$$20240925$$MD$CA$CA
241434702$24143470$2$F$20240210$20240722$20240727$20240730$EXP$$KR-ABBVIE-5849656$ABBVIE$$20$YR$$M$Y$$$20240730$$MD$KR$KR
241434711$24143471$1$I$$20240716$20240727$20240727$EXP$$US-ABBVIE-5620384$ABBVIE$$$$$F$Y$$$20240727$$MD$US$US
241434721$24143472$1$I$$20240722$20240727$20240727$EXP$$US-ABBVIE-5850732$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241434731$24143473$1$I$20240708$20240722$20240727$20240727$EXP$$US-ABBVIE-5850758$ABBVIE$$25$YR$$M$Y$$$20240727$$CN$US$US
241434743$24143474$3$F$20240101$20240827$20240727$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022283$UNITED THERAPEUTICS$$$$$F$Y$94.24$KG$20240905$$$US$US
241434751$24143475$1$I$$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024148623$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241434761$24143476$1$I$20240601$20240725$20240727$20240727$EXP$$US-ABBVIE-5854760$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241434772$24143477$2$F$20240718$20240729$20240727$20240731$EXP$$ES-ABBVIE-5850557$ABBVIE$$66$YR$$F$Y$43$KG$20240731$$CN$ES$ES
241434781$24143478$1$I$$20240718$20240727$20240727$EXP$NL-LRB-00985279$NL-TEVA-VS-3223864$TEVA$$43$YR$$F$Y$85$KG$20240727$$CN$NL$NL
241434793$24143479$3$F$20240712$20240729$20240727$20240802$EXP$$US-ABBVIE-5847986$ABBVIE$$70$YR$$M$Y$$$20240802$$CN$US$US
241434801$24143480$1$I$$20240725$20240727$20240727$EXP$$US-ABBVIE-5854923$ABBVIE$$$$$M$Y$$$20240727$$MD$US$US
241434812$24143481$2$F$$20240729$20240727$20240731$EXP$$US-ABBVIE-5855589$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241434821$24143482$1$I$20240701$20240717$20240727$20240727$PER$$US-ABBVIE-5848343$ABBVIE$$36$YR$$F$Y$$$20240727$$CN$US$US
241434831$24143483$1$I$20240101$20240722$20240727$20240727$PER$$US-SA-2024SA217294$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240727$$MD$US$US
241434842$24143484$2$F$20240715$20240808$20240727$20240810$EXP$$ES-ABBVIE-5849309$ABBVIE$$60$YR$$M$Y$64$KG$20240810$$CN$ES$ES
241434853$24143485$3$F$20240701$20240809$20240727$20240817$PER$$US-SA-2024SA215686$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240817$$MD$US$US
241434861$24143486$1$I$20230424$20240722$20240727$20240727$PER$$US-SA-2024SA217356$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240727$$HP$US$US
241434881$24143488$1$I$$20240722$20240727$20240727$EXP$$US-ABBVIE-5850766$ABBVIE$$$$$F$Y$$$20240727$$MD$US$US
241434892$24143489$2$F$20230101$20240729$20240727$20240803$EXP$$US-ABBVIE-5497048$ABBVIE$$$$$M$Y$75$KG$20240803$$CN$US$US
241434901$24143490$1$I$$20240717$20240727$20240727$EXP$$US-NOVITIUMPHARMA-2024USNVP01375$NOVITIUM PHARMA$Rachel Lee.Case study: Autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks^ gestation.Case Reports in Perinatal Medicine.26-APR-2024;13(1):1-4$29$YR$A$F$Y$$$20240727$$HP$US$US
241434911$24143491$1$I$$20240723$20240727$20240727$EXP$$US-ABBVIE-5852408$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241434921$24143492$1$I$20240101$20240722$20240727$20240727$PER$$US-SA-2024SA216004$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240727$$CN$US$US
241434932$24143493$2$F$20240101$20240729$20240727$20240801$EXP$$US-ABBVIE-5847101$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241434941$24143494$1$I$20240501$20240619$20240727$20240727$PER$$JP-WT-2024-03272$Waylis$$$$$F$Y$$$20240727$$CN$JP$JP
241434951$24143495$1$I$20240101$20240721$20240727$20240727$EXP$$US-ABBVIE-5850412$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241434961$24143496$1$I$20240701$20240719$20240727$20240727$PER$$US-ABBVIE-5852009$ABBVIE$$42$YR$$F$Y$$$20240727$$CN$US$US
241434971$24143497$1$I$20240712$20240723$20240727$20240727$EXP$$US-ABBVIE-5852021$ABBVIE$$77$YR$$F$Y$$$20240727$$CN$US$US
241434981$24143498$1$I$$20240724$20240727$20240727$EXP$$CA-ABBVIE-5854921$ABBVIE$$$$E$F$Y$$$20240727$$CN$CA$CA
241434991$24143499$1$I$$20240718$20240727$20240727$PER$$US-ABBVIE-5848484$ABBVIE$$$$$$Y$$$20240727$$CN$US$US
241435001$24143500$1$I$20230626$20240722$20240727$20240727$EXP$$KR-009507513-2407KOR012036$MERCK$$$$$F$Y$$$20240727$$HP$KR$KR
241435012$24143501$2$F$20240101$20240723$20240727$20240801$PER$$US-SA-2024SA216057$SANOFI AVENTIS$$74$YR$E$F$Y$106.59$KG$20240801$$MD$US$US
241435022$24143502$2$F$20240717$20240722$20240727$20240805$EXP$GB-MHRA-TPP29324321C8579691YC1721221023804$GB-CPL-004459$CADILA$$94$YR$E$F$Y$53$KG$20240803$$MD$GB$GB
241435031$24143503$1$I$$20240718$20240727$20240727$PER$$US-SA-2024SA212778$SANOFI AVENTIS$$$$T$F$Y$$$20240727$$HP$US$US
241435041$24143504$1$I$20240122$20240722$20240727$20240727$EXP$FR-AFSSAPS-LL2024001327$FR-ABBVIE-5856112$ABBVIE$$77$YR$$M$Y$86$KG$20240727$$PH$FR$FR
241435051$24143505$1$I$$20240722$20240727$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-022659$UNITED THERAPEUTICS$$$$$F$Y$50.975$KG$20240727$$$US$US
241435061$24143506$1$I$$20240719$20240727$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-022578$UNITED THERAPEUTICS$$$$$F$Y$122.45$KG$20240727$$$US$US
241435071$24143507$1$I$20240201$20240723$20240727$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-015845$UNITED THERAPEUTICS$$85$YR$$F$Y$56.689$KG$20240727$$$US$US
241435081$24143508$1$I$$20240723$20240727$20240727$EXP$$GB-ABBVIE-5854747$ABBVIE$$$$$$Y$$$20240727$$CN$GB$GB
241435091$24143509$1$I$20240101$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024146495$AMGEN$$71$YR$E$F$Y$$$20240726$$CN$US$US
241435101$24143510$1$I$20240720$20240723$20240727$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-022784$UNITED THERAPEUTICS$$85$YR$$F$Y$50.34$KG$20240727$$$US$US
241435111$24143511$1$I$20240101$20240722$20240727$20240727$PER$$US-AMGEN-USASP2024146711$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
241435121$24143512$1$I$20240709$20240716$20240727$20240727$PER$$US-JNJFOC-20240770896$JOHNSON AND JOHNSON$$47$YR$A$$Y$$$20240727$$CN$US$US
241435131$24143513$1$I$20240710$20240716$20240727$20240727$EXP$$US-BIOGEN-2024BI01275599$BIOGEN$$41$YR$$F$Y$$$20240727$$CN$US$US
241435141$24143514$1$I$$20240723$20240727$20240727$EXP$$VE-ROCHE-10000037000$ROCHE$$61$YR$A$F$Y$56.9$KG$20240727$$MD$VE$VE
241435151$24143515$1$I$20240101$20240722$20240727$20240727$EXP$NO-NOMAADVRE-PASRAPP-2024-Vakek8$NO-ABBVIE-5847872$ABBVIE$$43$YR$$F$Y$58$KG$20240727$$CN$NO$NO
241435161$24143516$1$I$20240601$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024148514$AMGEN$$74$YR$E$F$Y$$$20240726$$HP$US$US
241435171$24143517$1$I$$20240722$20240727$20240727$PER$$US-AMGEN-USASP2024146697$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241435181$24143518$1$I$$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024146319$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
241435191$24143519$1$I$$20240621$20240727$20240727$PER$$JP-WT-2024-03304$Waylis$$80$YR$$M$Y$$$20240727$$HP$JP$JP
241435201$24143520$1$I$20230901$20240717$20240727$20240727$PER$$US-009507513-2407USA012338$MERCK$$$$$F$Y$$$20240727$$CN$US$US
241435221$24143522$1$I$$20240719$20240727$20240727$PER$$US-AMGEN-USASP2024144504$AMGEN$$$$$F$Y$$$20240726$$PH$US$US
241435231$24143523$1$I$$20240717$20240727$20240727$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01386$NOVITIUM PHARMA$Sella Takei.An autopsy case of intoxication caused by drug interaction with multiple psychotropic drugs, fluvoxamine, levomepromazine, and trihexyphenidyl.Legal Medicine.02-JUL-2024;70:102482$$$A$F$Y$$$20240727$$HP$JP$JP
241435241$24143524$1$I$$20240718$20240727$20240727$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109959$ZYDUS PHARM$$$$$$Y$$$20240727$$CN$US$US
241435252$24143525$2$F$$20240828$20240727$20240904$PER$$US-SA-2024SA217568$SANOFI AVENTIS$$$$E$F$Y$$$20240904$$MD$US$US
241435261$24143526$1$I$$20240717$20240727$20240727$EXP$$US-ABBVIE-5851566$ABBVIE$$81$YR$$M$Y$$$20240727$$MD$US$US
241435271$24143527$1$I$$20240603$20240727$20240727$PER$$JP-WT-2024-02656$Waylis$$$$$$Y$$$20240727$$PH$JP$JP
241435281$24143528$1$I$$20240725$20240727$20240727$PER$$US-AMGEN-USASP2024148564$AMGEN$$$$$F$Y$$$20240726$$CN$US$US
241435291$24143529$1$I$20240101$20240722$20240727$20240727$PER$$US-ABBVIE-5853230$ABBVIE$$$$$$Y$$$20240727$$CN$US$US
241435301$24143530$1$I$20231001$20240722$20240727$20240727$EXP$$CA-ABBVIE-5852042$ABBVIE$$81$YR$$F$Y$$$20240727$$CN$CA$CA
241435311$24143531$1$I$$20240718$20240727$20240727$PER$$US-SA-2024SA215038$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240727$$CN$US$US
241435322$24143532$2$F$$20240731$20240727$20240809$EXP$$IT-TEVA-VS-3223662$TEVA$Samperi S, Laura C, Trambaiolo P, D^Ambrosi A, Mustilli M, Romano S, et al. A STRANGE CASE OF CARDIOTOXICITY FROM ANTIBLASTIC TREATMENT: A HIGH PRICE TO PAY. Eur-Heart-J-Suppl 2024; 26 (Suppl.) ii178-ii179.; Samperi S, Laura C, Trambaiolo P, D^Ambrosi A, Mustilli M, Romano S, et al. A STRANGE CASE OF CARDIOTOXICITY FROM ANTIBLASTIC TREATMENT: A HIGH PRICE TO PAY. Eur-Heart-J-Suppl 2024; 26 (Suppl.) ii178-ii179.$58$YR$$F$Y$$$20240809$$HP$IT$IT
241435332$24143533$2$F$$20240730$20240727$20240809$EXP$$IT-TEVA-VS-3223499$TEVA$Malavasi M, Notarianni G, Pontillo D, Luciani M, Petrungaro M, Zampi G, et al. THE CONUNDRUM OF DRUG INTERACTIONS AND HOLTER MONITORING: LAMIN GENE MUTATION DISCOVERED BY A TORSADE DE POINTES EPISODE FOLLOWED BY OUT-OF-THE-HOSPITAL RESUSCITATION. Eur-Heart-J-Suppl 2024; 26 (Suppl. 2) ii55-ii56 abstr. suae036.124; Malavasi M, Notarianni G, Pontillo D, Luciani M, Petrungaro M, Zampi G, et al. THE CONUNDRUM OF DRUG INTERACTIONS AND HOLTER MONITORING: LAMIN GENE MUTATION DISCOVERED BY A TORSADE D...$57$YR$$F$Y$$$20240809$$HP$IT$IT
241435341$24143534$1$I$$20240716$20240727$20240727$EXP$NL-LRB-00981144$NL-GLENMARK PHARMACEUTICALS-2024GMK092458$GLENMARK$$$$$$Y$$$20240727$$CN$NL$NL
241435352$24143535$2$F$20240722$20240802$20240727$20240810$PER$$US-SA-2024SA217400$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240810$$PH$US$US
241435361$24143536$1$I$20240610$20240724$20240727$20240727$EXP$$CZ-ABBVIE-5853849$ABBVIE$$60$YR$$M$Y$$$20240727$$MD$CZ$CZ
241435371$24143537$1$I$20240101$20240722$20240727$20240727$PER$$US-SA-2024SA217591$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240727$$MD$US$US
241435381$24143538$1$I$$20240722$20240727$20240727$EXP$$US-ABBVIE-5850177$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241435391$24143539$1$I$20240101$20240722$20240727$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-021335$UNITED THERAPEUTICS$$$$$M$Y$$$20240727$$$US$US
241435403$24143540$3$F$20240101$20240905$20240727$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-021494$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240912$$$US$US
241435411$24143541$1$I$$20240725$20240727$20240727$PER$$US-AMGEN-USASP2024148994$AMGEN$$$$$$Y$$$20240726$$CN$US$US
241435421$24143542$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218182$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240727$$MD$US$US
241435432$24143543$2$F$20201201$20240731$20240727$20240807$EXP$RO-AMGEN-ROUSP2024131791$RO-ROCHE-10000038122$ROCHE$$64$YR$A$F$Y$$$20240807$$MD$RO$RO
241435441$24143544$1$I$20240723$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024147518$AMGEN$$65$YR$E$M$Y$$$20240726$$CN$US$US
241435451$24143545$1$I$$20240717$20240727$20240727$EXP$$US-NOVITIUMPHARMA-2024USNVP01382$NOVITIUM PHARMA$Patrick McMullan.Cutaneous CD30 positive anaplastic large cell lymphoma mimicking breast carcinoma en cuirasse.JAAD Case Reports.18-AUG-2023;40:37-40$80$YR$E$F$Y$$$20240727$$HP$US$US
241435461$24143546$1$I$20240629$20240722$20240727$20240727$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022869$UNITED THERAPEUTICS$$69$YR$$M$Y$82.857$KG$20240727$$$US$US
241435472$24143547$2$F$20240717$20240822$20240727$20240829$30DAY$$US-GSK-US2024090174$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240829$$CN$US$US
241435482$24143548$2$F$20240718$20240723$20240727$20240801$PER$$US-SA-2024SA215787$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240801$$HP$US$US
241435492$24143549$2$F$$20240725$20240727$20240727$EXP$$US-ROCHE-10000037941$ROCHE$$$$A$F$Y$$$20240727$$CN$US$US
241435501$24143550$1$I$$20240719$20240727$20240727$PER$$US-ABBVIE-5849965$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241435511$24143551$1$I$$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024147636$AMGEN$$$$$$Y$$$20240726$$PH$US$US
241435521$24143552$1$I$20220601$20240724$20240727$20240727$EXP$DK-DKMA-30734302$DK-ROCHE-10000035877$ROCHE$$41$YR$A$M$Y$$$20240727$$MD$DK$DK
241435531$24143553$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148255$AMGEN$Cassaday R.D.; Kopmar N.E.; Quach. K. et. al. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435541$24143554$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148229$AMGEN$Cassaday R.D.; Kopmar N.E.; Quach. K. et. al. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435551$24143555$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148244$AMGEN$Cassaday R.D.; Kopmar N.E.; Quach. K. et. al. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435561$24143556$1$I$20240101$20240719$20240727$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-022530$UNITED THERAPEUTICS$$$$$M$Y$67.574$KG$20240727$$$US$US
241435571$24143557$1$I$$20240715$20240727$20240727$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092664$GLENMARK$Ballotari M, Truver MT, Dhoble LR, Kinsey AM, Hoyer JL, Chronister CW, et al. A Postmortem Case Report involving Fentanyl, Desalkylgidazepam and Bromazolam. Journal of analytical toxicology. 2024$$$$$Y$$$20240727$$HP$US$US
241435581$24143558$1$I$20240301$20240322$20240727$20240727$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-105303$ZYDUS PHARM$$$$$$Y$$$20240727$$CN$US$US
241435591$24143559$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148310$AMGEN$Cassaday R.D.; Kopmar N.E.; Quach. K. et. al. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435601$24143560$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148319$AMGEN$Cassaday R.D.; Kopmar N.E.; Quach. K. et. al. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435611$24143561$1$I$20200104$20240724$20240727$20240727$EXP$FR-AFSSAPS-PB20200036$FR-ROCHE-10000035433$ROCHE$$33$YR$A$F$Y$60$KG$20240727$$PH$FR$FR
241435622$24143562$2$F$20240101$20240725$20240727$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-022489$UNITED THERAPEUTICS$$$$$F$Y$87.075$KG$20240731$$$US$US
241435631$24143563$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148381$AMGEN$Cassaday R. D.; Kopmar N. E.; Quach K. et al.. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435641$24143564$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148389$AMGEN$Cassaday R.D.; Kopmar N.E.; Quach. K. et. Al. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435651$24143565$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148385$AMGEN$Cassaday R. D.; Kopmar N. E.; Quach K. et al.. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435661$24143566$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148334$AMGEN$Cassaday R.D.; Kopmar N.E.; Quach. K. et. al. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435671$24143567$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148339$AMGEN$Cassaday R. D.; Kopmar N. E.; Quach K. et al.. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435681$24143568$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148391$AMGEN$Cassaday R.D.; Kopmar N.E.; Quach. K. et. Al. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435691$24143569$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148394$AMGEN$Cassaday R. D.; Kopmar N. E.; Quach K. et al.. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435701$24143570$1$I$$20240607$20240727$20240727$PER$$AP-2024-US-5936$AILEX PHARMACEUTICALS$$73$YR$$M$Y$$$20240727$$CN$US$US
241435711$24143571$1$I$20240101$20240722$20240727$20240727$PER$$US-ABBVIE-5854142$ABBVIE$$$$$$Y$$$20240727$$CN$US$US
241435721$24143572$1$I$20230303$20240724$20240727$20240727$EXP$FR-AFSSAPS-TO2023001107$FR-ROCHE-3369674$ROCHE$$30$YR$A$F$Y$$$20240727$$MD$FR$FR
241435741$24143574$1$I$$20240723$20240727$20240727$EXP$$US-ROCHE-10000035041$ROCHE$$$$$M$Y$$$20240727$$CN$US$US
241435761$24143576$1$I$20240205$20240723$20240727$20240727$EXP$ES-AEMPS-1545644$ES-ROCHE-10000034025$ROCHE$$43$YR$A$M$Y$$$20240727$$PH$ES$ES
241435771$24143577$1$I$$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024147089$AMGEN$$66$YR$E$M$Y$$$20240726$$MD$US$US
241435781$24143578$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148414$AMGEN$Cassaday R.D.; Kopmar N.E.; Quach. K. et. Al. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240726$$MD$US$US
241435791$24143579$1$I$20240701$20240723$20240727$20240727$EXP$$US-ROCHE-10000034323$ROCHE$$$$$F$Y$$$20240727$$CN$US$US
241435801$24143580$1$I$$20240714$20240727$20240727$EXP$$PL-Nexus Pharma-000293$NEXUS PHARMACEUTICALS$Cheyne I, Hassan K, Dunkel T, Sota M, Wroblewski L, Mikaszewska-Sokolewicz M. Effective Treatment of Acinetobacter baumannii Ventriculitis With Interventricular Colistin: A Case Report. Cureus. 2024 Jun 11;16(6):e62169.$22$YR$A$M$Y$$$20240727$$HP$PL$PL
241435811$24143581$1$I$$20240714$20240727$20240727$EXP$$US-Indicus Pharma-001026$INDICUS$Farouji A, Haddad AW, Kloub M, Paige A, Miller R. A Case of Metformin-Associated Lactic Acidosis Complicated by Acute Liver Failure, Acute Renal Failure, and Shock. Cureus. 2024 Jun 7;16(6):e61911.$63$YR$A$F$Y$$$20240727$$HP$US$US
241435821$24143582$1$I$20240601$20240719$20240727$20240727$EXP$$CA-CELLTRION INC.-2024CA017985$CELLTRION$$$$$$Y$$$20240727$$HP$CA$CA
241435832$24143583$2$F$20240101$20240821$20240727$20240903$PER$$US-SA-2024SA218837$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240903$$MD$US$US
241435841$24143584$1$I$20240603$20240723$20240727$20240727$EXP$FR-AFSSAPS-PP2024000822$FR-ABBVIE-5849724$ABBVIE$$19$YR$$F$Y$$$20240727$$PH$FR$FR
241435851$24143585$1$I$$20240724$20240727$20240727$PER$$US-ROCHE-10000036860$ROCHE$$$$$M$Y$$$20240727$$CN$US$US
241435861$24143586$1$I$$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024147453$AMGEN$$$$$M$Y$$$20240727$$CN$US$US
241435871$24143587$1$I$20240701$20240723$20240727$20240727$PER$$US-ABBVIE-5853097$ABBVIE$$41$YR$$F$Y$$$20240727$$HP$US$US
241435884$24143588$4$F$20240711$20240806$20240727$20240813$EXP$$BR-CELLTRION INC.-2024BR015651$CELLTRION$$$$$$Y$$$20240813$$HP$BR$BR
241435891$24143589$1$I$$20240723$20240727$20240727$EXP$$US-ABBVIE-5854172$ABBVIE$$$$$F$Y$$$20240727$$HP$US$US
241435901$24143590$1$I$$20240723$20240727$20240727$PER$$US-SA-2024SA218066$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240727$$MD$US$US
241435911$24143591$1$I$20200901$20240717$20240727$20240727$PER$$US-SA-2020SA267722$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240727$$MD$US$US
241435921$24143592$1$I$20240601$20240719$20240727$20240727$EXP$$US-SA-2024SA215930$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240727$$MD$US$US
241435931$24143593$1$I$20240701$20240701$20240727$20240727$PER$$US-CSL-2024-006281$CSL Plasma$$37$YR$$F$Y$$$20240727$$HP$US$US
241435941$24143594$1$I$20231219$20240712$20240727$20240727$EXP$$US-TEVA-VS-3225443$TEVA$$67$YR$$F$Y$$$20240727$$PH$US$US
241435952$24143595$2$F$$20240730$20240727$20240809$EXP$$CA-TEVA-VS-3223326$TEVA$Lee J, Chopra N, Costa T, George TP. Treatment of ketamine use disorder with combined gabapentin and topiramate: two case reports. Am-J-Drug-Alcohol-Abuse 2024;.; Lee J, Chopra N, Costa T, George TP. Treatment of ketamine use disorder with combined gabapentin and topiramate: two case reports. Am-J-Drug-Alcohol-Abuse 2024;.; Lee J, Chopra N, Costa T, George TP. Treatment of ketamine use disorder with combined gabapentin and topiramate: two case reports. Am-J-Drug-Alcohol-Abuse 2024;.$35$YR$$M$Y$$$20240809$$HP$CA$CA
241435961$24143596$1$I$$20240718$20240727$20240727$PER$$US-SA-2024SA217005$SANOFI AVENTIS$$$$A$F$Y$63.6$KG$20240727$$MD$US$US
241435971$24143597$1$I$$20240711$20240727$20240727$PER$$US-JNJFOC-20240732864$JOHNSON AND JOHNSON$$$$$$Y$$$20240727$$CN$US$US
241435981$24143598$1$I$20240709$20240725$20240727$20240727$EXP$$CN-ROCHE-10000038077$ROCHE$$58$YR$A$F$Y$61$KG$20240727$$HP$CN$CN
241435991$24143599$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218570$SANOFI AVENTIS$$$$C$M$Y$$$20240727$$MD$US$US
241436002$24143600$2$F$$20240730$20240727$20240809$EXP$$JP-TEVA-VS-3222421$TEVA$Yokota H, Asahi R, Akamine Y, Kobayashi M, Wakabayashi H, Sakamoto S, et al. Case report of QT interval prolongation induced by anamorelin in an obese patient with non-small cell lung cancer. J-Pharm-Health-Care-Sci 2024; 10.; Yokota H, Asahi R, Akamine Y, Kobayashi M, Wakabayashi H, Sakamoto S, et al. Case report of QT interval prolongation induced by anamorelin in an obese patient with non-small cell lung cancer. J-Pharm-Health-Care-Sci 2024; 10.; Yokota H, Asahi R, Akamine Y, Kobayashi M, ...$$$$F$Y$$$20240809$$HP$JP$JP
241436011$24143601$1$I$$20240718$20240727$20240727$EXP$$ZA-ROCHE-10000032443$ROCHE$$56$YR$A$M$Y$$$20240727$$CN$ZA$ZA
241436021$24143602$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA215737$SANOFI AVENTIS$$$$$F$Y$$$20240727$$CN$US$US
241436031$24143603$1$I$$20240723$20240727$20240727$EXP$$US-ABBVIE-5852097$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241436042$24143604$2$F$20240101$20240913$20240727$20240923$EXP$$CA-CELLTRION INC.-2024CA017921$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
241436051$24143605$1$I$$20240718$20240727$20240727$EXP$$AU-NOVITIUMPHARMA-2024AUNVP01394$NOVITIUM PHARMA$Ian Kam. Inflammatory epilepsy (FIRES) and haemophagocytic lymphohistiocytosis (HLH): an adult case.BMJ Case Reports.31-JAN-2023;16:e252637$$$$M$Y$$$20240727$$HP$AU$AU
241436062$24143606$2$F$20240715$20240731$20240727$20240802$PER$$US-AMGEN-USASP2024145524$AMGEN$$62$YR$A$F$Y$$$20240802$$CN$US$US
241436071$24143607$1$I$20240630$20240720$20240727$20240727$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021205$UNITED THERAPEUTICS$$72$YR$$F$Y$63.492$KG$20240727$$$US$US
241436081$24143608$1$I$20240717$20240722$20240727$20240727$PER$$US-AMGEN-USASP2024146910$AMGEN$$65$YR$E$F$Y$$$20240727$$CN$US$US
241436091$24143609$1$I$20240715$20240719$20240727$20240727$EXP$$US-AMGEN-USASP2024145425$AMGEN$$79$YR$E$F$Y$$$20240727$$CN$US$US
241436101$24143610$1$I$$20240723$20240727$20240727$PER$$US-SA-2024SA219069$SANOFI AVENTIS$$$$A$M$Y$$$20240727$$MD$US$US
241436112$24143611$2$F$20240101$20240923$20240727$20240926$PER$$US-SA-2024SA218919$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240926$$MD$US$US
241436121$24143612$1$I$$20240724$20240727$20240727$EXP$NL-LRB-00993122$NL-SA-2024SA217727$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240727$$MD$NL$NL
241436131$24143613$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218177$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240727$$MD$US$US
241436141$24143614$1$I$$20240723$20240727$20240727$EXP$$US-ABBVIE-5851938$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241436151$24143615$1$I$20240608$20240718$20240727$20240727$PER$$US-SA-2024SA216200$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240727$$MD$US$US
241436162$24143616$2$F$20231225$20240921$20240727$20240926$EXP$$US-ABBVIE-5852126$ABBVIE$$72$YR$$F$Y$$$20240926$$CN$US$US
241436171$24143617$1$I$$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024147171$AMGEN$$$$$$Y$$$20240727$$CN$US$US
241436181$24143618$1$I$20240506$20240723$20240727$20240727$EXP$$CN-ABBVIE-5852055$ABBVIE$$60$YR$$M$Y$56$KG$20240727$$MD$CN$CN
241436191$24143619$1$I$20240101$20240723$20240727$20240727$EXP$$CA-ABBVIE-5765522$ABBVIE$$75$YR$$F$Y$$$20240727$$CN$CA$CA
241436211$24143621$1$I$20230101$20240723$20240727$20240727$EXP$$US-ABBVIE-5852736$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241436221$24143622$1$I$$20240723$20240727$20240727$EXP$$US-ABBVIE-5852738$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241436231$24143623$1$I$$20240719$20240727$20240727$PER$$US-ABBVIE-5849230$ABBVIE$$$$$F$Y$$$20240727$$HP$US$US
241436242$24143624$2$F$20240617$20240726$20240727$20240730$EXP$$CA-ABBVIE-5852707$ABBVIE$$54$YR$$F$Y$$$20240730$$MD$CA$CA
241436251$24143625$1$I$20240101$20240723$20240727$20240727$EXP$$US-ABBVIE-5837585$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241436261$24143626$1$I$$20240723$20240727$20240727$EXP$$US-ABBVIE-5852658$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241436271$24143627$1$I$20240722$20240725$20240727$20240727$EXP$$TR-ABBVIE-5855687$ABBVIE$$80$YR$$M$Y$65$KG$20240727$$CN$TR$TR
241436281$24143628$1$I$$20240718$20240727$20240727$EXP$$US-GSK-US2024090559$GLAXOSMITHKLINE$$$$$F$Y$$$20240727$$MD$US$US
241436291$24143629$1$I$20231218$20240721$20240727$20240727$EXP$GB-MHRA-MED-202407212301224030-FGVRW$GB-ROCHE-10000032848$ROCHE$$57$YR$A$F$Y$$$20240727$$CN$GB$GB
241436301$24143630$1$I$$20240722$20240727$20240727$EXP$$US-ABBVIE-5851182$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241436311$24143631$1$I$$20240723$20240727$20240727$EXP$$US-ABBVIE-5852735$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241436321$24143632$1$I$$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024147220$AMGEN$$$$$$Y$$$20240727$$CN$US$US
241436331$24143633$1$I$20240101$20240722$20240727$20240727$EXP$$IE-ABBVIE-5671226$ABBVIE$$62$YR$$M$Y$$$20240727$$HP$IE$IE
241436343$24143634$3$F$20240419$20240801$20240727$20240806$PER$$US-ABBVIE-5855131$ABBVIE$$37$YR$$F$Y$$$20240806$$HP$US$US
241436351$24143635$1$I$20230301$20240723$20240727$20240727$PER$$US-ABBVIE-5850748$ABBVIE$$71$YR$$F$Y$$$20240727$$CN$US$US
241436361$24143636$1$I$20230101$20240723$20240727$20240727$EXP$$US-ABBVIE-5851955$ABBVIE$$$$$$Y$$$20240727$$HP$US$US
241436372$24143637$2$F$$20240918$20240727$20240923$EXP$$NL-AMGEN-NLDSP2024145982$AMGEN$Quaak C. H.; Kluivers A.; Baart S.J. et al.. Tumor Necrosis Factor Inhibitor Use Increases Birth Weight in Pregnant Women With Rheumatoid Arthritis Independently of the Soluble Fms-Like Tyrosine Kinase- 1 /Placental Growth Factor Ratio. Journal of the American Heart Association. 2023;13:1-10$$$$F$Y$$$20240923$$MD$NL$NL
241436382$24143638$2$F$20240101$20240828$20240727$20240905$EXP$$CO-AMGEN-COLSL2024119033$AMGEN$$74$YR$E$M$Y$$$20240905$$CN$CO$CO
241436392$24143639$2$F$$20240822$20240727$20240917$PER$$US-SA-2024SA219075$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
241436411$24143641$1$I$20240610$20240715$20240727$20240727$PER$$US-JNJFOC-20240741746$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240727$$CN$US$US
241436424$24143642$4$F$$20240920$20240727$20240930$EXP$$FR-CELLTRION INC.-2024FR016839$CELLTRION$Darres A, Del Bello A, Marion O, de Lamballerie X, Malvy D, Izopet J, et al.. Failure of favipiravir to treat chronic norovirus infection in a kidney-transplant patient (Letter to the Editor). Transplant Infectious Disease. 2024;26 (1):1-2$$$$$Y$$$20240930$$HP$FR$FR
241436431$24143643$1$I$20240421$20240717$20240727$20240727$EXP$FR-AFSSAPS-AVMA2024000307$FR-TEVA-VS-3223333$TEVA$$35$YR$$M$Y$$$20240727$$MD$FR$FR
241436441$24143644$1$I$20240101$20240719$20240727$20240727$PER$$US-SA-2024SA217283$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240727$$MD$US$US
241436451$24143645$1$I$20240101$20240722$20240727$20240727$EXP$$US-SA-2024SA217728$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240727$$MD$US$US
241436461$24143646$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218143$SANOFI AVENTIS$$$$$$Y$$$20240727$$MD$US$US
241436471$24143647$1$I$$20240718$20240727$20240727$EXP$$US-AMGEN-USASP2024144971$AMGEN$Kupcha A.C.; Swain D.L.; Green M.B.. A Case of Lepromatous Leprosy (Lucio^s Phenomenon) Presenting as Periorbital Edema. Ophthalmic Plastic and Reconstructive Surgery. 2024;40 (4):e128-e132$38$YR$A$F$Y$$$20240727$$MD$US$US
241436481$24143648$1$I$$20240723$20240727$20240727$EXP$$US-ABBVIE-5854255$ABBVIE$$$$$F$Y$$$20240727$$HP$US$US
241436502$24143650$2$F$20221201$20240723$20240727$20240801$EXP$$DE-SANDOZ INC.-SDZ2024DE068307$SANDOZ$$$$E$F$Y$71$KG$20240801$$CN$DE$DE
241436511$24143651$1$I$$20240718$20240727$20240727$EXP$NL-LRB-00985701$NL-TEVA-VS-3224244$TEVA$$75$YR$$M$Y$66$KG$20240727$$MD$NL$NL
241436522$24143652$2$F$$20240821$20240727$20240829$EXP$$US-TAKEDA-2023TUS043759$TAKEDA$$$$$M$Y$$$20240829$$MD$US$US
241436531$24143653$1$I$20240101$20240723$20240727$20240727$PER$$US-SA-2024SA219082$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240727$$MD$US$US
241436541$24143654$1$I$$20240723$20240727$20240727$EXP$$US-ABBVIE-5851047$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241436551$24143655$1$I$20240516$20240718$20240727$20240727$EXP$$US-SA-2024SA214033$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240727$$MD$US$US
241436562$24143656$2$F$20240101$20240820$20240727$20240825$EXP$$US-ABBVIE-5819791$ABBVIE$$$$$F$Y$89$KG$20240825$$CN$US$US
241436571$24143657$1$I$20240101$20240724$20240727$20240727$EXP$$US-ABBVIE-5853897$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241436581$24143658$1$I$$20240725$20240727$20240727$EXP$$US-ABBVIE-5855817$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241436591$24143659$1$I$20240101$20240723$20240727$20240727$EXP$$US-ABBVIE-5846791$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241436601$24143660$1$I$$20240716$20240727$20240727$PER$$US-NOVITIUMPHARMA-2024USNVP01429$NOVITIUM PHARMA$$74$YR$E$F$Y$77.1$KG$20240727$$CN$US$US
241436611$24143661$1$I$20240723$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024147100$AMGEN$$$$$$Y$$$20240727$$PH$US$US
241436621$24143662$1$I$20160914$20240725$20240727$20240727$EXP$$CA-SANDOZ INC.-PHHY2016CA132520$SANDOZ$$53$YR$$F$Y$$$20240727$$CN$CA$CA
241436632$24143663$2$F$$20240920$20240727$20240920$EXP$$NVSC2024US041075$NOVARTIS$$$$$F$Y$86.5$KG$20240920$$CN$US$US
241436641$24143664$1$I$$20240718$20240727$20240727$PER$$US-ABBVIE-5847956$ABBVIE$$$$$F$Y$$$20240727$$MD$US$US
241436651$24143665$1$I$20240101$20240722$20240727$20240727$PER$$US-SA-2024SA217255$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240727$$MD$US$US
241436661$24143666$1$I$20240219$20240716$20240727$20240727$EXP$$US-UCBSA-2024010101$UCB$$29$YR$$M$Y$$$20240727$$CN$US$US
241436671$24143667$1$I$20240719$20240725$20240727$20240727$EXP$$US-ABBVIE-5855842$ABBVIE$$75$YR$$M$Y$$$20240727$$CN$US$US
241436681$24143668$1$I$20240722$20240722$20240727$20240727$PER$$US-SA-2024SA218670$SANOFI AVENTIS$$59$YR$A$F$Y$58.06$KG$20240727$$MD$US$US
241436691$24143669$1$I$20231026$20240718$20240727$20240727$PER$$US-SA-2024SA214653$SANOFI AVENTIS$$70$YR$E$M$Y$108$KG$20240727$$MD$US$US
241436701$24143670$1$I$20240703$20240725$20240727$20240727$EXP$$IT-ABBVIE-5845102$ABBVIE$$70$YR$$F$Y$$$20240727$$MD$IT$IT
241436721$24143672$1$I$20240502$20240725$20240727$20240727$EXP$$US-ABBVIE-5854919$ABBVIE$$67$YR$$M$Y$$$20240727$$CN$US$US
241436731$24143673$1$I$20240701$20240724$20240727$20240727$EXP$$CA-ABBVIE-5853777$ABBVIE$$74$YR$$F$Y$$$20240727$$CN$CA$CA
241436741$24143674$1$I$20240604$20240717$20240727$20240727$EXP$FR-AFSSAPS-AN2024000838$FR-TEVA-VS-3223116$TEVA$$81$YR$$M$Y$57$KG$20240727$$PH$FR$FR
241436752$24143675$2$F$$20240801$20240727$20240809$EXP$$SK-TEVA-VS-3223318$TEVA$Eva Pakosova. Courage pays off - a journey to seizure-free. Neurol. prax 2024; 25(3):217-220$21$YR$$F$Y$$$20240809$$MD$SK$SK
241436761$24143676$1$I$20240708$20240718$20240727$20240727$EXP$PT-INFARMED-J202407-207$PT-SA-2024SA214199$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240727$$HP$PT$PT
241436771$24143677$1$I$$20240717$20240727$20240727$EXP$$US-TEVA-VS-3224125$TEVA$$65$YR$$M$Y$95.25$KG$20240727$$PH$US$US
241436781$24143678$1$I$$20240724$20240727$20240727$PER$$US-ABBVIE-5854906$ABBVIE$$$$$F$Y$$$20240727$$MD$US$US
241436791$24143679$1$I$20240710$20240718$20240727$20240727$EXP$$ES-TEVA-VS-3224427$TEVA$$55$YR$$F$Y$$$20240727$$CN$ES$ES
241436802$24143680$2$F$20240701$20240725$20240727$20240803$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022156$UNITED THERAPEUTICS$$68$YR$$M$Y$76.19$KG$20240803$$$US$US
241436812$24143681$2$F$20191201$20240919$20240727$20240928$EXP$$AU-CELLTRION INC.-2024AU017926$CELLTRION$$$$$$Y$$$20240928$$MD$AU$AU
241436821$24143682$1$I$$20240717$20240727$20240727$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090562$VIIV$$$$$M$Y$$$20240727$$MD$US$US
241436831$24143683$1$I$$20240718$20240727$20240727$PER$$US-ABBVIE-5847470$ABBVIE$$$$$$Y$$$20240727$$CN$US$US
241436841$24143684$1$I$$20240724$20240727$20240727$EXP$$US-ABBVIE-5853816$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241436851$24143685$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA215582$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240727$$MD$US$US
241436861$24143686$1$I$$20240720$20240727$20240727$PER$$US-SA-2024SA216880$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240727$$MD$US$US
241436871$24143687$1$I$20240724$20240724$20240727$20240727$EXP$$US-ABBVIE-5853484$ABBVIE$$55$YR$$F$Y$$$20240727$$CN$US$US
241436881$24143688$1$I$$20240724$20240727$20240727$EXP$$SA-TAKEDA-2024TUS065850$TAKEDA$$$$$F$Y$$$20240727$$MD$SA$SA
241436892$24143689$2$F$20240724$20240730$20240727$20240829$PER$$US-AstraZeneca-2024A169521$ASTRAZENECA$$28035$DY$$$Y$$$20240829$$CN$US$
241436902$24143690$2$F$$20240731$20240727$20240807$EXP$$ES-TAKEDA-2024TUS074339$TAKEDA$$73$YR$$M$Y$$$20240807$$CN$ES$ES
241436911$24143691$1$I$20240628$20240724$20240727$20240727$EXP$$CA-ABBVIE-5855627$ABBVIE$$43$YR$$F$Y$$$20240727$$PH$CA$CA
241436931$24143693$1$I$$20240717$20240727$20240727$EXP$$US-TEVA-VS-3224474$TEVA$$$$E$F$Y$$$20240727$$CN$US$US
241436941$24143694$1$I$20240716$20240723$20240727$20240727$EXP$$US-TAKEDA-2024TUS074489$TAKEDA$$57$YR$$M$Y$123$KG$20240727$$MD$US$US
241436951$24143695$1$I$20240722$20240722$20240727$20240727$PER$$US-ABBVIE-5849684$ABBVIE$$$$$$Y$$$20240727$$CN$US$US
241436961$24143696$1$I$20240113$20240722$20240727$20240727$EXP$ES-AEMPS-1550895$ES-ABBVIE-5850307$ABBVIE$$75$YR$$M$Y$$$20240727$$MD$ES$ES
241436971$24143697$1$I$$20240722$20240727$20240727$EXP$$US-ABBVIE-5850603$ABBVIE$$50$YR$$M$Y$$$20240727$$MD$US$US
241436981$24143698$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA218609$SANOFI AVENTIS$$$$A$F$Y$$$20240727$$MD$US$US
241436992$24143699$2$F$20240630$20240731$20240727$20240805$EXP$$NVSC2024ZA151745$NOVARTIS$$38$YR$$F$Y$$$20240803$$CN$ZA$ZA
241437001$24143700$1$I$$20240722$20240727$20240727$PER$$US-AMGEN-USASP2024145913$AMGEN$$$$$$Y$$$20240727$$MD$US$US
241437013$24143701$3$F$20240719$20240814$20240727$20240816$PER$$US-AMGEN-USASP2024145390$AMGEN$$68$YR$E$F$Y$$$20240816$$CN$US$US
241437021$24143702$1$I$$20240722$20240727$20240727$EXP$$PT-AMGEN-PRTSP2024147279$AMGEN$Almeida C.. Therapeutic Sequence Challenges in Acute Lymphoblastic Leukemia. HEMATOLOGY AND ONCOLOGY. 22-25$16$YR$T$M$Y$$$20240727$$HP$PT$PT
241437031$24143703$1$I$$20240722$20240727$20240727$EXP$$CA-AMGEN-CANSP2024145731$AMGEN$$$$$$Y$$$20240727$$PH$CA$CA
241437041$24143704$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA215790$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240727$$MD$US$US
241437052$24143705$2$F$20240501$20240729$20240727$20240806$EXP$$US-AMGEN-USASP2024148709$AMGEN$$66$YR$E$M$Y$$$20240806$$CN$US$US
241437061$24143706$1$I$20240130$20240719$20240727$20240727$EXP$$US-AMGEN-USASP2024148717$AMGEN$$65$YR$E$F$Y$69.85$KG$20240727$$CN$US$US
241437071$24143707$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218183$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240727$$MD$US$US
241437082$24143708$2$F$20240601$20240725$20240727$20240805$PER$$US-SA-2024SA217242$SANOFI AVENTIS$$47$YR$A$F$Y$92.533$KG$20240804$$MD$US$US
241437091$24143709$1$I$$20240722$20240727$20240727$EXP$$KR-GSK-KR2024APC092546$GLAXOSMITHKLINE$$$$$$Y$$$20240727$$CN$KR$KR
241437101$24143710$1$I$$20240716$20240727$20240727$EXP$$US-Accord-429581$ACCORD$$78$YR$E$M$Y$$$20240727$$CN$US$US
241437116$24143711$6$F$20240101$20240917$20240727$20240924$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021666$UNITED THERAPEUTICS$$$$$M$Y$83.9$KG$20240924$$$US$US
241437121$24143712$1$I$20240707$20240720$20240727$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-022525$UNITED THERAPEUTICS$$72$YR$$F$Y$122.45$KG$20240727$$$US$US
241437131$24143713$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA212052$SANOFI AVENTIS$$$$A$M$Y$$$20240727$$MD$US$US
241437141$24143714$1$I$20240716$20240717$20240727$20240727$EXP$$US-Accord-437221$ACCORD$$43$YR$A$M$Y$$$20240727$$HP$US$US
241437151$24143715$1$I$20240712$20240717$20240727$20240727$EXP$$US-Accord-437685$ACCORD$$45$YR$A$M$Y$$$20240727$$HP$US$US
241437161$24143716$1$I$20220801$20240717$20240727$20240727$EXP$$US-Accord-436818$ACCORD$Krause PJ, Rogers R, Shah MK, Kang H, Parsonnet J, Kodama R, et al. Tafenoquine for Relapsing Babesiosis: A Case Series. Clinical infectious diseases. 2024. DOI:10.1093/cid/ciae238.$70$YR$E$F$Y$$$20240727$$MD$US$US
241437171$24143717$1$I$20240320$20240716$20240727$20240727$EXP$$US-Accord-437217$ACCORD$$46$YR$A$M$Y$$$20240727$$HP$US$US
241437182$24143718$2$F$$20240729$20240727$20240730$PER$$US-AMGEN-USASP2024145947$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241437191$24143719$1$I$20230202$20240717$20240727$20240727$EXP$BE-EMA-2024711-AUTODUP-1720655214078$BE-Accord-436713$ACCORD$$$$A$M$Y$65$KG$20240727$$MD$BE$BE
241437201$24143720$1$I$$20240715$20240727$20240727$EXP$$KR-TEVA-VS-3223487$TEVA$Kim J, Lee J, Lee S, Kim K. Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report. Medicina-Kaunas 2024; 60 (6):.; Kim J, Lee J, Lee S, Kim K. Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report. Medicina-Kaunas 2024; 60 (6):.$79$YR$$M$Y$$$20240727$$HP$KR$KR
241437212$24143721$2$F$20240717$20240718$20240727$20240816$EXP$$CA-CELLTRION INC.-2024CA017967$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
241437221$24143722$1$I$20240511$20240722$20240727$20240727$EXP$$SG-GSK-SG2024APC091953$GLAXOSMITHKLINE$$$$$$Y$$$20240727$$HP$SG$SG
241437231$24143723$1$I$20240101$20240718$20240727$20240727$EXP$$DE-TEVA-VS-3223621$TEVA$$83$YR$$F$Y$$$20240727$$CN$DE$DE
241437241$24143724$1$I$20240721$20240722$20240727$20240727$PER$$US-AMGEN-USASP2024145486$AMGEN$$70$YR$E$M$Y$$$20240727$$CN$US$US
241437251$24143725$1$I$20240701$20240724$20240727$20240727$PER$$US-ABBVIE-5853800$ABBVIE$$38$YR$$M$Y$$$20240727$$CN$US$US
241437261$24143726$1$I$20240501$20240723$20240727$20240727$EXP$$US-ABBVIE-5850868$ABBVIE$$72$YR$$M$Y$$$20240727$$CN$US$US
241437281$24143728$1$I$20240101$20240724$20240727$20240727$EXP$$ZA-ABBVIE-5853612$ABBVIE$$65$YR$$F$Y$$$20240727$$HP$ZA$ZA
241437291$24143729$1$I$20240401$20240722$20240727$20240727$PER$$US-SA-2024SA218740$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240727$$MD$US$US
241437303$24143730$3$F$20240715$20240802$20240727$20240814$PER$$US-SA-2024SA218280$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240814$$MD$US$US
241437311$24143731$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218190$SANOFI AVENTIS$$$$A$M$Y$$$20240727$$MD$US$US
241437321$24143732$1$I$$20240722$20240727$20240727$PER$$US-ABBVIE-5853961$ABBVIE$$$$$F$Y$$$20240727$$HP$US$US
241437332$24143733$2$F$20240717$20240726$20240727$20240813$EXP$$US-ABBVIE-5852529$ABBVIE$$38$YR$$F$Y$77.11$KG$20240813$$MD$US$US
241437342$24143734$2$F$20240701$20240725$20240727$20240731$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021882$UNITED THERAPEUTICS$$37$YR$$F$Y$78.912$KG$20240731$$$US$US
241437351$24143735$1$I$$20240719$20240727$20240727$PER$$US-ABBVIE-5850052$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241437361$24143736$1$I$$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024148955$AMGEN$$$$$$Y$$$20240727$$CN$US$US
241437381$24143738$1$I$$20240726$20240727$20240727$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042261$BOEHRINGER INGELHEIM$$$$$$Y$$$20240727$$MD$US$US
241437401$24143740$1$I$20240723$20240723$20240727$20240727$EXP$$US-AMGEN-USASP2024147762$AMGEN$$70$YR$E$M$Y$$$20240727$$HP$US$US
241437412$24143741$2$F$20240401$20240807$20240727$20240816$PER$$US-AMGEN-USASP2024149674$AMGEN$$62$YR$A$F$Y$$$20240815$$MD$US$US
241437421$24143742$1$I$$20240723$20240727$20240727$EXP$$US-AMGEN-USASP2024148034$AMGEN$$$$$$Y$$$20240727$$MD$US$US
241437432$24143743$2$F$$20240723$20240727$20240729$EXP$$US-AMGEN-USASP2024147647$AMGEN$$$$$$Y$$$20240729$$HP$US$US
241437443$24143744$3$F$20210201$20240801$20240727$20240808$EXP$$PT-ABBVIE-5856102$ABBVIE$$74$YR$$M$Y$$$20240808$$MD$PT$PT
241437453$24143745$3$F$20240101$20240813$20240727$20240821$EXP$$CA-CELLTRION INC.-2024CA016383$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
241437462$24143746$2$F$20211101$20240729$20240727$20240805$EXP$$DE-JNJFOC-20240773698$JOHNSON AND JOHNSON$Eberl W.. First experiences with rivaroxaban in children and adolescents. Vasomed. 2024;36:3:92-93$14$YR$T$M$Y$$$20240805$$MD$DE$DE
241437471$24143747$1$I$20240101$20240724$20240727$20240727$EXP$$US-ABBVIE-5854073$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241437481$24143748$1$I$$20240704$20240727$20240727$PER$$US-009507513-2407USA002625$MERCK$Kerai A, Doshi S, Laleker A, Majumdar A. Fungal Foe and Mechanical Hearts: A Retrospective Case Series on Candida auris Bloodstream Infection With Left Ventricular Assist Devices. Open Forum Infectious Diseases. 2024;11 (6):1-5$52$YR$$M$Y$$$20240727$$MD$US$US
241437492$24143749$2$F$$20240816$20240727$20240821$EXP$$US-ABBVIE-5852187$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
241437502$24143750$2$F$20240701$20240731$20240727$20240803$PER$$US-AMGEN-USASP2024145500$AMGEN$$$$$F$Y$$$20240803$$CN$US$US
241437511$24143751$1$I$$20240722$20240727$20240727$EXP$$BR-JNJFOC-20240773390$JOHNSON AND JOHNSON$$$$$F$Y$$$20240727$$CN$BR$BR
241437522$24143752$2$F$20200101$20240730$20240727$20240812$PER$$US-009507513-2407USA000665$MERCK$$$$$M$Y$$$20240812$$CN$US$US
241437531$24143753$1$I$$20240722$20240727$20240727$EXP$$US-SA-2024SA217087$SANOFI AVENTIS$$$$E$F$Y$58.9$KG$20240727$$MD$US$US
241437541$24143754$1$I$20240701$20240722$20240727$20240727$PER$$US-SA-2024SA217080$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240727$$MD$US$US
241437551$24143755$1$I$$20240723$20240727$20240727$EXP$$CA-ABBVIE-4738809$ABBVIE$$$$$M$Y$$$20240727$$CN$CA$CA
241437561$24143756$1$I$$20240717$20240727$20240727$EXP$$SK-TEVA-VS-3223316$TEVA$Eva Pakosova. Courage pays off - a journey to seizure-free. Neurol. prax 2024;25(3):217-220; Eva Pakosova. Courage pays off - a journey to seizure-free. Neurol. prax 2024;25(3):217-220; Eva Pakosova. Courage pays off - a journey to seizure-free. Neurol. prax 2024;25(3):217-220; Eva Pakosova. Courage pays off - a journey to seizure-free. Neurol. prax 2024;25(3):217-220$21$YR$$F$Y$$$20240727$$MD$SK$SK
241437572$24143757$2$F$$20240722$20240727$20240730$EXP$$US-ABBVIE-5851999$ABBVIE$$15$YR$$F$Y$$$20240730$$MD$US$US
241437582$24143758$2$F$20240723$20240917$20240727$20240924$PER$$US-AMGEN-USASP2024147415$AMGEN$$56$YR$A$F$Y$$$20240924$$HP$US$US
241437591$24143759$1$I$$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024147477$AMGEN$$$$$F$Y$$$20240727$$HP$US$US
241437601$24143760$1$I$$20240724$20240727$20240727$EXP$$US-ABBVIE-5854062$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241437611$24143761$1$I$20240101$20240723$20240727$20240727$PER$$US-SA-2024SA218534$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240727$$MD$US$US
241437621$24143762$1$I$20240701$20240722$20240727$20240727$PER$$US-SA-2024SA218309$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240727$$MD$US$US
241437631$24143763$1$I$20240701$20240719$20240727$20240727$PER$$US-ABBVIE-5848178$ABBVIE$$80$YR$$M$Y$$$20240727$$CN$US$US
241437641$24143764$1$I$$20240724$20240727$20240727$EXP$$US-ABBVIE-5853773$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241437652$24143765$2$F$$20240813$20240727$20240816$EXP$$AU-ABBVIE-5855982$ABBVIE$$$$$M$Y$$$20240816$$MD$AU$AU
241437661$24143766$1$I$20230401$20240717$20240727$20240727$EXP$FR-AFSSAPS-PO2024000764$FR-TEVA-VS-3223292$TEVA$$45$YR$$F$Y$$$20240727$$MD$FR$FR
241437671$24143767$1$I$20240610$20240717$20240727$20240727$EXP$FR-AFSSAPS-NC2024000828$FR-TEVA-VS-3223279$TEVA$$62$YR$$F$Y$$$20240727$$MD$FR$FR
241437682$24143768$2$F$20240718$20240805$20240727$20240812$EXP$$CO-ABBVIE-5856041$ABBVIE$$72$YR$$M$Y$60$KG$20240812$$HP$CO$CO
241437691$24143769$1$I$$20240718$20240727$20240727$EXP$NL-LRB-00984828$NL-TEVA-VS-3223345$TEVA$$43$YR$$M$Y$78$KG$20240727$$MD$NL$NL
241437701$24143770$1$I$$20240722$20240727$20240727$EXP$$DE-SA-2024SA217393$SANOFI AVENTIS$$$$$M$Y$$$20240727$$MD$DE$DE
241437712$24143771$2$F$$20240724$20240727$20240801$PER$$US-AMGEN-USASP2024147864$AMGEN$$$$$$Y$$$20240801$$HP$US$US
241437721$24143772$1$I$20240701$20240717$20240727$20240727$EXP$$US-VIIV HEALTHCARE LIMITED-US2024090143$VIIV$$31$YR$$$Y$56.7$KG$20240727$$PH$US$US
241437731$24143773$1$I$$20240724$20240727$20240727$30DAY$$US-SANDOZ INC.-SDZ2023US025292$SANDOZ$$$$$$Y$$$20240727$$PH$US$US
241437741$24143774$1$I$20240617$20240717$20240727$20240727$EXP$$US-Accord-437198$ACCORD$$58$YR$A$M$Y$$$20240727$$PH$US$US
241437751$24143775$1$I$$20240717$20240727$20240727$EXP$GB-MHRA-MED-202407171042467250-HLSVN$GB-Accord-436867$ACCORD$$60$YR$A$F$Y$$$20240727$$PH$GB$GB
241437761$24143776$1$I$20240626$20240717$20240727$20240727$EXP$$US-Accord-437497$ACCORD$$60$YR$A$F$Y$$$20240727$$HP$US$US
241437771$24143777$1$I$20240710$20240717$20240727$20240727$EXP$GB-MHRA-MED-202407171518311550-JQRPW$GB-Accord-436881$ACCORD$$74$YR$E$F$Y$$$20240727$$PH$GB$GB
241437781$24143778$1$I$20240712$20240717$20240727$20240727$EXP$$US-Accord-437190$ACCORD$$46$YR$A$M$Y$$$20240727$$HP$US$US
241437802$24143780$2$F$20220101$20240811$20240727$20240822$EXP$$TW-Accord-436563$ACCORD$Hsieh C, Yu S, Lee J, Tsai T. Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosed in a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Association? Indian Journal of Dermatology. 2024;69(3):264-7. DOI:10.4103/ijd.ijd_93_23.$66$YR$E$M$Y$$$20240822$$MD$TW$TW
241437812$24143781$2$F$20240101$20240819$20240727$20240825$EXP$$CA-ABBVIE-5702656$ABBVIE$$74$YR$$F$Y$$$20240825$$CN$CA$CA
241437821$24143782$1$I$20240101$20240716$20240727$20240727$PER$$US-SA-2024SA212440$SANOFI AVENTIS$$$$$M$Y$$$20240727$$MD$US$US
241437831$24143783$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218735$SANOFI AVENTIS$$$$A$M$Y$74.8$KG$20240727$$MD$US$US
241437841$24143784$1$I$$20240722$20240727$20240727$EXP$$US-SA-2024SA217527$SANOFI AVENTIS$$$$E$F$Y$$$20240727$$MD$US$US
241437852$24143785$2$F$$20240731$20240727$20240809$EXP$$FR-TEVA-VS-3224104$TEVA$Rodrigues M, Eberst L, Follana P, Gauthier L, Jacquemin V, Tessier C, et al. Real-world dostarlimab use in advanced/recurrent endometrial cancer in France. Bull-Cancer 2023; 110 (10): 1041-1050.; Rodrigues M, Eberst L, Follana P, Gauthier L, Jacquemin V, Tessier C, et al. Real-world dostarlimab use in advanced/recurrent endometrial cancer in France. Bull-Cancer 2023; 110 (10): 1041-1050.$$$A$F$Y$$$20240809$$HP$FR$FR
241437866$24143786$6$F$20240419$20240904$20240727$20240909$EXP$$US-ABBVIE-5852660$ABBVIE$$76$YR$$F$Y$71$KG$20240909$$CN$US$US
241437871$24143787$1$I$$20240724$20240727$20240727$EXP$$US-ABBVIE-5853833$ABBVIE$$$$$F$Y$$$20240727$$HP$US$US
241437881$24143788$1$I$20240501$20240724$20240727$20240727$EXP$$US-ABBVIE-5853916$ABBVIE$$71$YR$$F$Y$$$20240727$$CN$US$US
241437891$24143789$1$I$20240101$20240724$20240727$20240727$EXP$$US-ABBVIE-5853913$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241437902$24143790$2$F$$20240731$20240727$20240809$EXP$$CA-TEVA-VS-3224103$TEVA$Herrington J, Batthish M, Takrouri H, Yarascavitch B, Gross A. Asymptomatic intraspinal epidermoid cyst in a 7-year-old male with juvenile idiopathic arthritis identified by an advanced physiotherapist practitioner: a case report. J-Man-Manip-Ther 2024; 32 (3): 343-351.; Herrington J, Batthish M, Takrouri H, Yarascavitch B, Gross A. Asymptomatic intraspinal epidermoid cyst in a 7-year-old male with juvenile idiopathic arthritis identified by an advanced physiotherapist practitioner: a case re...$7$YR$$M$Y$$$20240809$$HP$CA$CA
241437911$24143791$1$I$20240502$20240725$20240727$20240727$EXP$$CA-ABBVIE-5856131$ABBVIE$$$$E$M$Y$$$20240727$$CN$CA$CA
241437921$24143792$1$I$20240211$20240717$20240727$20240727$EXP$FR-AFSSAPS-RE2024000684$FR-TEVA-VS-3223298$TEVA$$80$YR$$M$Y$82$KG$20240727$$MD$FR$FR
241437931$24143793$1$I$$20240718$20240727$20240727$EXP$NL-LRB-00985246$NL-TEVA-VS-3223353$TEVA$$52$YR$$M$Y$84$KG$20240727$$MD$NL$NL
241437942$24143794$2$F$20240701$20240805$20240727$20240807$EXP$$US-ABBVIE-5853905$ABBVIE$$70$YR$$F$Y$$$20240807$$CN$US$US
241437951$24143795$1$I$20240601$20240724$20240727$20240727$EXP$$US-ABBVIE-5853887$ABBVIE$$74$YR$$M$Y$$$20240727$$CN$US$US
241437961$24143796$1$I$$20240723$20240727$20240727$EXP$$US-ABBVIE-5854271$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241437972$24143797$2$F$20240702$20240905$20240727$20240914$EXP$$CA-CELLTRION INC.-2024CA007778$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
241437981$24143798$1$I$20240624$20240716$20240727$20240727$PER$$US-SA-2024SA204991$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240727$$MD$US$US
241437991$24143799$1$I$20240504$20240724$20240727$20240727$EXP$$CN-ABBVIE-5853176$ABBVIE$$65$YR$$M$Y$67$KG$20240727$$MD$CN$CN
241438001$24143800$1$I$20240101$20240719$20240727$20240727$PER$$US-ABBVIE-5848957$ABBVIE$$73$YR$$$Y$$$20240727$$CN$US$US
241438011$24143801$1$I$$20240717$20240727$20240727$EXP$$CA-TEVA-VS-3224315$TEVA$$77$YR$$F$Y$53$KG$20240727$$HP$CA$CA
241438021$24143802$1$I$20240101$20240724$20240727$20240727$EXP$$GB-ABBVIE-5853233$ABBVIE$$45$YR$$F$Y$$$20240727$$CN$GB$GB
241438031$24143803$1$I$$20240724$20240727$20240727$EXP$$CA-ABBVIE-5853568$ABBVIE$$$$E$F$Y$$$20240727$$CN$CA$CA
241438041$24143804$1$I$$20240719$20240727$20240727$EXP$$BE-JNJFOC-20240768072$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240727$$MD$BE$BE
241438052$24143805$2$F$20240101$20240723$20240727$20240730$EXP$$GB-ABBVIE-5801001$ABBVIE$$33$YR$$F$Y$$$20240730$$CN$GB$GB
241438061$24143806$1$I$$20240717$20240727$20240727$EXP$$US-TEVA-VS-3224201$TEVA$$21$YR$$F$Y$$$20240727$$CN$US$US
241438071$24143807$1$I$$20240715$20240727$20240727$EXP$$FR-TEVA-VS-3223721$TEVA$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiol-Drug-Saf 2024; 33 (6):.$7$YR$$F$Y$$$20240727$$HP$FR$FR
241438082$24143808$2$F$20240721$20240816$20240727$20240821$PER$$US-AMGEN-USASP2024145513$AMGEN$$58$YR$A$F$Y$$$20240820$$CN$US$US
241438091$24143809$1$I$$20240723$20240727$20240727$EXP$$US-AMGEN-USASP2024148089$AMGEN$$$$A$M$Y$$$20240727$$HP$US$US
241438101$24143810$1$I$20240703$20240703$20240727$20240727$PER$$US-009507513-2407USA002597$MERCK$$68$YR$$F$Y$$$20240727$$CN$US$US
241438112$24143811$2$F$20240101$20240827$20240727$20240831$EXP$$US-ABBVIE-5853915$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
241438131$24143813$1$I$20240504$20240724$20240727$20240727$EXP$$CN-ABBVIE-5853295$ABBVIE$$65$YR$$F$Y$45$KG$20240727$$MD$CN$CN
241438141$24143814$1$I$$20240716$20240727$20240727$PER$$US-SA-2024SA218709$SANOFI AVENTIS$$$$$F$Y$$$20240727$$CN$US$US
241438161$24143816$1$I$$20240724$20240727$20240727$EXP$$US-ABBVIE-5853312$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241438171$24143817$1$I$20240101$20240717$20240727$20240727$EXP$$US-TEVA-VS-3222790$TEVA$$68$YR$$F$Y$$$20240727$$CN$US$US
241438181$24143818$1$I$$20240724$20240727$20240727$EXP$$US-ABBVIE-5853523$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241438191$24143819$1$I$$20240723$20240727$20240727$EXP$GB-MHRA-31100994$GB-JNJFOC-20240772753$JOHNSON AND JOHNSON$$$$$M$Y$$$20240727$$CN$GB$GB
241438202$24143820$2$F$20240101$20240828$20240727$20240904$EXP$$US-ABBVIE-5853588$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
241438212$24143821$2$F$$20240806$20240727$20240809$EXP$$CA-ABBVIE-5854651$ABBVIE$$81$YR$$M$Y$$$20240809$$HP$CA$CA
241438223$24143822$3$F$20240719$20240729$20240727$20240806$PER$$US-AMGEN-USASP2024147062$AMGEN$$81$YR$E$M$Y$$$20240806$$CN$US$US
241438231$24143823$1$I$20240131$20240201$20240727$20240727$PER$$US-AMGEN-USASP2024145993$AMGEN$$77$YR$E$F$Y$$$20240727$$CN$US$US
241438241$24143824$1$I$20240701$20240723$20240727$20240727$EXP$$US-ABBVIE-5855059$ABBVIE$$82$YR$$F$Y$$$20240727$$CN$US$US
241438252$24143825$2$F$20240101$20240729$20240727$20240805$EXP$$US-ABBVIE-5853810$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241438261$24143826$1$I$20240618$20240724$20240727$20240727$EXP$$CN-ABBVIE-5853826$ABBVIE$$77$YR$$M$Y$56$KG$20240727$$MD$CN$CN
241438274$24143827$4$F$20240713$20240911$20240727$20240919$EXP$$US-TAKEDA-2024TUS074759$TAKEDA$$4$YR$$F$Y$$$20240919$$HP$US$US
241438281$24143828$1$I$$20240715$20240727$20240727$EXP$$FR-TEVA-VS-3223566$TEVA$Castex MP, Stefanowicz J, Clement L, Weclawek-Tompol J, Hameury F, Fresneau B, et al. Choriocarcinoma in neonates and infants: A severe but curable disease. Pediatr-Blood-Cancer 2024; 71 (8): 1-5.; Castex MP, Stefanowicz J, Clement L, Weclawek-Tompol J, Hameury F, Fresneau B, et al. Choriocarcinoma in neonates and infants: A severe but curable disease. Pediatr-Blood-Cancer 2024; 71 (8): 1-5.$1$MON$$M$Y$$$20240727$$HP$FR$FR
241438291$24143829$1$I$$20240717$20240727$20240727$EXP$$US-RDY-LIT/USA/24/0010798$DR REDDYS$Osei KM, Wuni G, Mehta N, Gupta SK. Comparative Analysis of Right Ventricular (RV) Apical Pacing versus Physiologic Left Bundle Branch Area Pacing (LBBAP) in Hypertrophic Cardiomyopathy With Left Ventricular Outflow Tract Obstruction (LVOTO): A Case Study. Circulation. 148: doi:10.1161/circ.148.suppl_1.18100.$69$YR$E$F$Y$$$20240727$$HP$US$US
241438301$24143830$1$I$$20240715$20240727$20240727$EXP$$US-RDY-LIT/USA/24/0010796$DR REDDYS$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran AN, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. Journal of Ophthalmic Inflammation and Infection. 14: doi:10.1186/s12348-023-00372-z.$70$YR$E$M$Y$$$20240727$$HP$US$US
241438311$24143831$1$I$20240718$20240719$20240727$20240727$PER$$US-ABBVIE-5851983$ABBVIE$$29$YR$$F$Y$$$20240727$$CN$US$US
241438321$24143832$1$I$$20240718$20240727$20240727$PER$$US-JNJFOC-20240752324$JOHNSON AND JOHNSON$$$$$F$Y$$$20240727$$CN$US$US
241438331$24143833$1$I$$20240718$20240727$20240727$PER$$US-ABBVIE-5847578$ABBVIE$$$$$$Y$$$20240727$$CN$US$US
241438341$24143834$1$I$$20240722$20240727$20240727$EXP$$US-ABBVIE-5851219$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241438352$24143835$2$F$$20240731$20240727$20240809$EXP$$HR-TEVA-VS-3224497$TEVA$Pavicic Klancir K, Habek D, Duranovic V, Tripalo Batos A, Pejic Rosko S, Stanojevic M. Hemispherotomy in an infant with hemimegalencephaly and Ohtahara syndrome. Wien-Med-Wochenschr 2024; 174 (5-6): 107-110.; Pavicic Klancir K, Habek D, Duranovic V, Tripalo Batos A, Pejic Rosko S, Stanojevic M. Hemispherotomy in an infant with hemimegalencephaly and Ohtahara syndrome. Wien-Med-Wochenschr 2024; 174 (5-6): 107-110.$$$N$F$Y$$$20240809$$HP$HR$HR
241438371$24143837$1$I$20220101$20240717$20240727$20240727$EXP$$US-TEVA-VS-3224724$TEVA$$$$I$M$Y$$$20240727$$HP$US$US
241438381$24143838$1$I$$20240718$20240727$20240727$EXP$NL-LRB-00984864$NL-TEVA-VS-3223485$TEVA$$63$YR$$M$Y$85$KG$20240727$$MD$NL$NL
241438391$24143839$1$I$$20240718$20240727$20240727$EXP$NL-LRB-00984456$NL-TEVA-VS-3223817$TEVA$$36$YR$$F$Y$105$KG$20240727$$CN$NL$NL
241438402$24143840$2$F$20240101$20240913$20240727$20240923$EXP$$CA-CELLTRION INC.-2024CA017930$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
241438412$24143841$2$F$$20240731$20240727$20240809$EXP$$FR-TEVA-VS-3223540$TEVA$Castex MP, Stefanowicz J, Clement L, Weclawek-Tompol J, Hameury F, Fresneau B, et al. Choriocarcinoma in neonates and infants: A severe but curable disease. Pediatr-Blood-Cancer 2024; 71 (8): 1-5.; Castex MP, Stefanowicz J, Clement L, Weclawek-Tompol J, Hameury F, Fresneau B, et al. Choriocarcinoma in neonates and infants: A severe but curable disease. Pediatr-Blood-Cancer 2024; 71 (8): 1-5.; Castex MP, Stefanowicz J, Clement L, Weclawek-Tompol J, Hameury F, Fresneau B, et al. Choriocarcinoma...$10$MON$$M$Y$$$20240809$$HP$FR$FR
241438421$24143842$1$I$20200408$20240718$20240727$20240727$EXP$PL-URPL-1-1262-2020$PL-TEVA-VS-3223862$TEVA$$55$YR$$F$Y$70$KG$20240727$$MD$PL$PL
241438431$24143843$1$I$20240713$20240723$20240727$20240727$EXP$$NVSC2024KW054331$NOVARTIS$$41$YR$$F$Y$$$20240727$$CN$KW$KW
241438441$24143844$1$I$$20240718$20240727$20240727$EXP$NL-LRB-00983934$NL-TEVA-VS-3223865$TEVA$$85$YR$$F$Y$84.6$KG$20240727$$MD$NL$NL
241438451$24143845$1$I$20230821$20240716$20240727$20240727$EXP$$DE-UCBSA-2024018203$UCB$$$$E$F$Y$$$20240727$$MD$DE$DE
241438471$24143847$1$I$$20240725$20240727$20240727$PER$$US-AMGEN-USASP2024148751$AMGEN$$$$A$F$Y$$$20240727$$CN$US$US
241438481$24143848$1$I$20240721$20240722$20240727$20240727$PER$$US-AMGEN-USASP2024145607$AMGEN$$43$YR$A$M$Y$$$20240727$$CN$US$US
241438491$24143849$1$I$$20240717$20240727$20240727$EXP$$US-TEVA-VS-3225517$TEVA$$$$$$Y$$$20240727$$CN$US$US
241438501$24143850$1$I$$20240722$20240727$20240727$EXP$$US-ABBVIE-5851275$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241438511$24143851$1$I$$20240724$20240727$20240727$PER$$US-ROCHE-10000036922$ROCHE$$53$YR$A$F$Y$$$20240727$$CN$US$US
241438521$24143852$1$I$20240628$20240715$20240727$20240727$EXP$FR-AFSSAPS-GR2024000885$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110055$ZYDUS PHARM$$$$$$Y$$$20240727$$PH$FR$FR
241438531$24143853$1$I$20240614$20240715$20240727$20240727$EXP$FR-AFSSAPS-AN2024000867$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109986$ZYDUS PHARM$$$$$$Y$$$20240727$$PH$FR$FR
241438541$24143854$1$I$20240310$20240715$20240727$20240727$EXP$FR-AFSSAPS-NY2024000786$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109988$ZYDUS PHARM$$$$$$Y$$$20240727$$MD$FR$FR
241438551$24143855$1$I$20240507$20240715$20240727$20240727$EXP$FR-AFSSAPS-AN2024000913$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110002$ZYDUS PHARM$$$$$$Y$$$20240727$$PH$FR$FR
241438561$24143856$1$I$20240601$20240715$20240727$20240727$EXP$FR-AFSSAPS-NY2024000764$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-109839$ZYDUS PHARM$$$$$$Y$$$20240727$$MD$FR$FR
241438571$24143857$1$I$20240702$20240715$20240727$20240727$EXP$FR-AFSSAPS-AN2024000909$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110003$ZYDUS PHARM$$$$$$Y$$$20240727$$MD$FR$FR
241438581$24143858$1$I$20240701$20240715$20240727$20240727$EXP$FR-AFSSAPS-RS2024000678$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110012$ZYDUS PHARM$$$$$$Y$$$20240727$$MD$FR$FR
241438591$24143859$1$I$$20240719$20240727$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-022514$UNITED THERAPEUTICS$$$$$F$Y$51.701$KG$20240727$$$US$US
241438605$24143860$5$F$20240101$20240821$20240727$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015750$UNITED THERAPEUTICS$$$$$F$Y$88.889$KG$20240828$$$US$US
241438611$24143861$1$I$20240628$20240718$20240727$20240727$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-021314$JAZZ$$83$YR$$M$Y$$$20240727$$CN$US$US
241438622$24143862$2$F$$20240822$20240727$20240827$EXP$$NVSC2024US152346$NOVARTIS$$$$$F$Y$208$KG$20240827$$CN$US$US
241438631$24143863$1$I$20240713$20240725$20240727$20240727$EXP$$CN-JNJFOC-20240772034$JOHNSON AND JOHNSON$$79$YR$E$F$Y$70$KG$20240727$$HP$CN$CN
241438641$24143864$1$I$$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024147742$AMGEN$$$$A$M$Y$$$20240727$$MD$US$US
241438651$24143865$1$I$20240101$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024148132$AMGEN$$18$YR$A$F$Y$$$20240727$$CN$US$US
241438661$24143866$1$I$$20240716$20240727$20240727$PER$$US-TAKEDA-2024TUS072300$TAKEDA$$$$E$M$Y$69.7$KG$20240727$$MD$US$US
241438671$24143867$1$I$20240501$20240718$20240727$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-014637$UNITED THERAPEUTICS$$78$YR$$F$Y$77.551$KG$20240727$$$US$US
241438681$24143868$1$I$20240101$20240718$20240727$20240727$PER$$US-SA-2024SA215262$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240727$$CN$US$US
241438692$24143869$2$F$20240718$20240806$20240727$20240924$EXP$$CA-ABBVIE-5856188$ABBVIE$$68$YR$$F$Y$$$20240924$$MD$CA$CA
241438701$24143870$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA214530$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240727$$CN$US$US
241438712$24143871$2$F$20240701$20240719$20240727$20240802$PER$$US-SA-2024SA215256$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240802$$MD$US$US
241438721$24143872$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218340$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240727$$PH$US$US
241438741$24143874$1$I$$20240720$20240727$20240727$PER$$US-TAKEDA-2024TUS074033$TAKEDA$$$$$$Y$$$20240727$$CN$US$US
241438751$24143875$1$I$$20240719$20240727$20240727$PER$$US-ABBVIE-5849995$ABBVIE$$$$E$$Y$$$20240727$$CN$US$US
241438761$24143876$1$I$$20240718$20240727$20240727$PER$$US-JNJFOC-20240752369$JOHNSON AND JOHNSON$$$$$$Y$$$20240727$$CN$US$US
241438772$24143877$2$F$$20240731$20240727$20240809$EXP$$TR-TEVA-VS-3224249$TEVA$Herdi O. A combination of fluoxetine and olanzapine for the treatment of an adolescent with severe misophonia. Dusunen-Adam 2024; 37 (1): 57-58.; Herdi O. A combination of fluoxetine and olanzapine for the treatment of an adolescent with severe misophonia. Dusunen-Adam 2024; 37 (1): 57-58.$12$YR$$M$Y$$$20240809$$HP$TR$TR
241438781$24143878$1$I$$20240716$20240727$20240727$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109884$ZYDUS PHARM$Fitzsimons J, Phelan K, Dhanarajan A.. Hearing Loss in a Patient with Waldenstrom Macroglobulinemia Receiving Bortezomib.. Case-Rep-Oncol. 2024;17 (1):653-657$$$$$Y$$$20240727$$HP$US$US
241438791$24143879$1$I$$20240723$20240727$20240727$PER$$US-SA-2024SA218439$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240727$$MD$US$US
241438801$24143880$1$I$$20240719$20240727$20240727$PER$$US-ABBVIE-5849125$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241438811$24143881$1$I$$20240722$20240727$20240727$EXP$$US-ABBVIE-5851191$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241438822$24143882$2$F$20240101$20240914$20240727$20240923$EXP$$CA-CELLTRION INC.-2024CA007422$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
241438831$24143883$1$I$$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024146718$AMGEN$$$$$$Y$$$20240727$$HP$US$US
241438841$24143884$1$I$$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024148130$AMGEN$$$$$$Y$$$20240727$$CN$US$US
241438851$24143885$1$I$$20240725$20240727$20240727$PER$$US-TAKEDA-2024TUS075454$TAKEDA$$$$$$Y$$$20240727$$PH$US$US
241438861$24143886$1$I$$20240718$20240727$20240727$EXP$NL-LRB-00984293$NL-TEVA-VS-3223903$TEVA$$92$YR$$F$Y$71$KG$20240727$$MD$NL$NL
241438871$24143887$1$I$20240101$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024148697$AMGEN$$47$YR$A$F$Y$$$20240727$$HP$US$US
241438891$24143889$1$I$20240610$20240718$20240727$20240727$EXP$FR-AFSSAPS-LL2024001275$FR-TEVA-VS-3223928$TEVA$$62$YR$$F$Y$$$20240727$$PH$FR$FR
241438902$24143890$2$F$20240101$20240911$20240727$20240923$PER$$US-SA-2024SA217104$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240923$$MD$US$US
241438911$24143891$1$I$20240616$20240719$20240727$20240727$PER$$US-SA-2024SA218580$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240727$$MD$US$US
241438921$24143892$1$I$$20240724$20240727$20240727$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011248$JAZZ$$$$$F$Y$$$20240727$$HP$US$US
241438931$24143893$1$I$20240701$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024147512$AMGEN$$$$$F$Y$$$20240727$$HP$US$US
241438951$24143895$1$I$$20240718$20240727$20240727$PER$$US-TEVA-VS-3175106$TEVA$$51$YR$$F$Y$$$20240727$$HP$US$US
241438962$24143896$2$F$20240701$20240722$20240727$20240729$EXP$GB-MHRA-MED-202407221126306860-YQBVR$GB-ABBVIE-5848599$ABBVIE$$54$YR$$M$Y$84$KG$20240729$$PH$GB$GB
241438971$24143897$1$I$20240523$20240718$20240727$20240727$EXP$FR-AFSSAPS-LL2024001276$FR-TEVA-VS-3223749$TEVA$$73$YR$$F$Y$$$20240727$$PH$FR$FR
241438982$24143898$2$F$$20240730$20240727$20240809$EXP$$US-TEVA-VS-3222718$TEVA$Salar T, Al-Hosainat N, Subedi R, Hameed M, Brodsky S, Dahhan A. A CASE OF HYDRALAZINE INDUCED SEVERE RENAL- LIMITED ANCA VASCULITIS LEADING TO ESRD IN A 63-YEAR-OLD MAN. Am-J-Kidney-Dis 2023; 81 (Suppl. 1) (4): S42 abstr. 142.; Salar T, Al-Hosainat N, Subedi R, Hameed M, Brodsky S, Dahhan A. A CASE OF HYDRALAZINE INDUCED SEVERE RENAL- LIMITED ANCA VASCULITIS LEADING TO ESRD IN A 63-YEAR-OLD MAN. Am-J-Kidney-Dis 2023; 81 (Suppl. 1) (4): S42 abstr. 142.$63$YR$$M$Y$$$20240809$$HP$US$US
241438991$24143899$1$I$$20240723$20240727$20240727$PER$$US-ABBVIE-5856296$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241439001$24143900$1$I$$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024147177$AMGEN$$$$$$Y$$$20240727$$HP$US$US
241439011$24143901$1$I$20190407$20240717$20240727$20240727$EXP$$IE-TEVA-VS-3223266$TEVA$$54$YR$$F$Y$$$20240727$$CN$IE$IE
241439021$24143902$1$I$$20240718$20240727$20240727$EXP$$US-NOVITIUMPHARMA-2024USNVP01390$NOVITIUM PHARMA$Moga Tiberiu MD.HSV Esophagitis With Hematemesis and Recalcitrant Food Bolus.American Journal of Gastroenterology.OCT-2023;117(10):S1570$58$YR$A$F$Y$$$20240727$$HP$US$US
241439031$24143903$1$I$20240716$20240717$20240727$20240727$EXP$$US-Accord-437085$ACCORD$$66$YR$E$M$Y$$$20240727$$HP$US$US
241439042$24143904$2$F$20240709$20240726$20240727$20240806$EXP$IT-MINISAL02-994697$IT-Accord-437053$ACCORD$$43$YR$A$M$Y$73$KG$20240806$$MD$IT$IT
241439051$24143905$1$I$$20240717$20240727$20240727$EXP$CA-MHPD-E2B_001082614$CA-Accord-437001$ACCORD$$89$YR$E$F$Y$$$20240727$$PH$CA$CA
241439061$24143906$1$I$$20240717$20240727$20240727$EXP$AU-TGA-809410$AU-Accord-436321$ACCORD$$$$$$Y$$$20240727$$HP$AU$AU
241439071$24143907$1$I$20240117$20240717$20240727$20240727$EXP$FR-AFSSAPS-PC2024000572$FR-Accord-437277$ACCORD$$75$YR$E$F$Y$$$20240727$$HP$FR$FR
241439081$24143908$1$I$$20240717$20240727$20240727$EXP$AU-TGA-805016$AU-Accord-436308$ACCORD$$16$YR$T$F$Y$$$20240727$$HP$AU$AU
241439091$24143909$1$I$$20240717$20240727$20240727$EXP$AU-TGA-810377$AU-Accord-436282$ACCORD$$33$YR$A$F$Y$$$20240727$$HP$AU$AU
241439102$24143910$2$F$$20240813$20240727$20240824$EXP$$US-Accord-437313$ACCORD$$24$YR$A$F$Y$$$20240824$$HP$US$US
241439111$24143911$1$I$20240330$20240717$20240727$20240727$EXP$FR-AFSSAPS-DJ2024000826$FR-TEVA-VS-3222823$TEVA$$0$DY$$M$Y$3.48$KG$20240727$$MD$FR$FR
241439121$24143912$1$I$$20240715$20240727$20240727$EXP$$CA-ROCHE-10000030349$ROCHE$$$$A$M$Y$$$20240727$$MD$CA$CA
241439131$24143913$1$I$$20240718$20240727$20240727$PER$$US-JNJFOC-20240752644$JOHNSON AND JOHNSON$$$$$$Y$$$20240727$$CN$US$US
241439142$24143914$2$F$20240101$20240912$20240727$20240920$EXP$$CA-CELLTRION INC.-2024CA017984$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
241439151$24143915$1$I$20240716$20240717$20240727$20240727$EXP$$US-Accord-437129$ACCORD$$44$YR$A$F$Y$$$20240727$$HP$US$US
241439161$24143916$1$I$$20240717$20240727$20240727$EXP$$CZ-Accord-402533$ACCORD$Viktorova K, Mann H. Deset let s inhibitory JAK v realne klinicke praxi. REMEDIA. 2023;33(6):480-484$53$YR$A$F$Y$$$20240727$$MD$CZ$CZ
241439171$24143917$1$I$$20240717$20240727$20240727$EXP$CA-MHPD-001082751$CA-Accord-436967$ACCORD$$44$YR$A$M$Y$$$20240727$$HP$CA$CA
241439191$24143919$1$I$20240702$20240717$20240727$20240727$EXP$ES-AEMPS-1548344$ES-Accord-436850$ACCORD$$69$YR$E$F$Y$$$20240727$$HP$ES$ES
241439201$24143920$1$I$20240513$20240717$20240727$20240727$EXP$CN-HENLIUS-24CN015939$CN-Accord-438324$ACCORD$$53$YR$A$F$Y$50$KG$20240727$$MD$CN$CN
241439212$24143921$2$F$$20240828$20240727$20240912$EXP$$US-Accord-433306$ACCORD$$62$YR$$M$Y$$$20240912$$CN$US$US
241439232$24143923$2$F$$20240809$20240727$20240814$EXP$$US-AMGEN-USASP2024148080$AMGEN$$$$$$Y$$$20240814$$CN$US$US
241439241$24143924$1$I$$20240716$20240727$20240727$EXP$$SY-Accord-436552$ACCORD$Musleh M, Alhusein Q. A rare presentation and treatment challenges for multiple myeloma in down syndrome: A case report and literature review. Clinical Case Reports. 2024;12(7):e9154. DOI: 10.1002/ccr3.9154$45$YR$A$F$Y$$$20240727$$MD$SY$SY
241439251$24143925$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA218530$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240727$$MD$US$US
241439261$24143926$1$I$20240719$20240719$20240727$20240727$PER$$US-SA-2024SA216234$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240727$$MD$US$US
241439271$24143927$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA217924$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240727$$HP$US$US
241439281$24143928$1$I$20240101$20240719$20240727$20240727$PER$$US-SA-2024SA216701$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240727$$CN$US$US
241439291$24143929$1$I$$20240718$20240727$20240727$EXP$$IT-AMGEN-ITASP2024144948$AMGEN$Carubbi F.; Mariani F.M.; Alunno A. et al.. A rare case of symptomatic creatine kinase elevation in a patient with rheumatoid arthritis treated with baricitinib. Reumatismo. 2024;76 (2):133-136$68$YR$E$F$Y$$$20240727$$MD$IT$IT
241439301$24143930$1$I$20240101$20240722$20240727$20240727$EXP$$CA-ABBVIE-5852063$ABBVIE$$$$E$F$Y$$$20240727$$MD$CA$CA
241439311$24143931$1$I$$20240724$20240727$20240727$EXP$$US-ABBVIE-5853857$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241439321$24143932$1$I$20240705$20240724$20240727$20240727$EXP$FR-AFSSAPS-AM2024000594$FR-GSK-FR2024093347$GLAXOSMITHKLINE$$$$$$Y$$$20240727$$MD$FR$FR
241439341$24143934$1$I$20230101$20240725$20240727$20240727$EXP$$CN-TAKEDA-2024TUS001427$TAKEDA$$$$$M$Y$$$20240727$$CN$CN$CN
241439351$24143935$1$I$20240701$20240722$20240727$20240727$PER$$US-SA-2024SA218431$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240727$$MD$US$US
241439361$24143936$1$I$20240101$20240718$20240727$20240727$PER$$US-SA-2024SA215353$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240727$$MD$US$US
241439373$24143937$3$F$20240101$20240912$20240727$20240923$PER$$US-SA-2024SA218376$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240923$$MD$US$US
241439382$24143938$2$F$$20240821$20240727$20240828$EXP$$US-TAKEDA-2024TUS072551$TAKEDA$$$$$F$Y$$$20240828$$CN$US$US
241439391$24143939$1$I$$20240724$20240727$20240727$EXP$$US-ABBVIE-5853519$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241439401$24143940$1$I$20231101$20240724$20240727$20240727$EXP$$US-ABBVIE-5853548$ABBVIE$$51$YR$$M$Y$$$20240727$$CN$US$US
241439411$24143941$1$I$20240617$20240717$20240727$20240727$EXP$FR-AFSSAPS-MP2024001127$FR-TEVA-VS-3222785$TEVA$$86$YR$$F$Y$65$KG$20240727$$MD$FR$FR
241439421$24143942$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA217831$SANOFI AVENTIS$$16$YR$T$M$Y$57.4$KG$20240727$$HP$US$US
241439441$24143944$1$I$20240101$20240723$20240727$20240727$PER$$US-SA-2024SA218070$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240727$$MD$US$US
241439463$24143946$3$F$20240101$20240818$20240727$20240906$PER$$US-SA-2024SA216613$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240906$$MD$US$US
241439474$24143947$4$F$20220501$20240905$20240727$20240912$EXP$$US-SA-2024SA217936$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240912$$MD$US$US
241439482$24143948$2$F$20240719$20240826$20240727$20240903$PER$$US-AstraZeneca-2024A168089$ASTRAZENECA$$30438$DY$$F$Y$$$20240903$$CN$US$
241439491$24143949$1$I$$20240718$20240727$20240727$EXP$NL-LRB-00981334$NL-TEVA-VS-3223338$TEVA$$42$YR$$M$Y$$$20240727$$PH$NL$NL
241439501$24143950$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA217974$SANOFI AVENTIS$$65$YR$E$F$Y$42.18$KG$20240727$$MD$US$US
241439511$24143951$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA215712$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240727$$CN$US$US
241439522$24143952$2$F$$20240926$20240727$20240927$EXP$$NVSC2024US151192$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
241439531$24143953$1$I$$20240719$20240727$20240727$PER$$US-ABBVIE-5849192$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241439541$24143954$1$I$$20240716$20240727$20240727$EXP$$US-Accord-432273$ACCORD$$69$YR$E$M$Y$$$20240727$$CN$US$US
241439551$24143955$1$I$20240501$20240717$20240727$20240727$EXP$FR-AFSSAPS-RN2024000770$FR-Accord-436835$ACCORD$$80$YR$E$M$Y$$$20240727$$MD$FR$FR
241439561$24143956$1$I$20240101$20240717$20240727$20240727$EXP$GB-MHRA-MED-202407121426166340-RWFMK$GB-Accord-436860$ACCORD$$34$YR$A$F$Y$59$KG$20240727$$CN$GB$GB
241439571$24143957$1$I$20240530$20240717$20240727$20240727$EXP$FR-AFSSAPS-RE2024000697$FR-Accord-437285$ACCORD$$23$YR$A$F$Y$56.1$KG$20240727$$MD$FR$FR
241439581$24143958$1$I$20240417$20240716$20240727$20240727$EXP$$US-Accord-437434$ACCORD$$73$YR$E$M$Y$$$20240727$$MD$US$US
241439591$24143959$1$I$$20240718$20240727$20240727$EXP$$US-TEVA-VS-3224199$TEVA$$$$$F$Y$67$KG$20240727$$CN$US$US
241439601$24143960$1$I$20240430$20240717$20240727$20240727$EXP$FR-AFSSAPS-TO2024001230$FR-Accord-437281$ACCORD$$75$YR$E$M$Y$$$20240727$$PH$FR$FR
241439612$24143961$2$F$20240715$20240808$20240727$20240813$PER$$US-AMGEN-USASP2024146808$AMGEN$$62$YR$A$F$Y$70.748$KG$20240813$$MD$US$US
241439621$24143962$1$I$20240711$20240725$20240727$20240727$EXP$$CN-ROCHE-10000038225$ROCHE$$57$YR$A$F$Y$45.4$KG$20240727$$HP$CN$CN
241439631$24143963$1$I$20240603$20240725$20240727$20240727$EXP$$CN-ROCHE-10000038100$ROCHE$$51$YR$A$M$Y$52$KG$20240727$$HP$CN$CN
241439643$24143964$3$F$20240722$20240815$20240727$20240822$PER$$US-AMGEN-USASP2024147725$AMGEN$$52$YR$A$M$Y$$$20240822$$CN$US$US
241439652$24143965$2$F$20240603$20240725$20240727$20240808$EXP$$CN-ROCHE-10000038197$ROCHE$$56$YR$A$F$Y$55$KG$20240808$$HP$CN$CN
241439661$24143966$1$I$20240101$20240717$20240727$20240727$PER$$US-SA-2024SA214481$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240727$$MD$US$US
241439671$24143967$1$I$$20240717$20240727$20240727$PER$$US-SA-2024SA216456$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240727$$MD$US$US
241439681$24143968$1$I$20240101$20240717$20240727$20240727$PER$$US-SA-2024SA214549$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240727$$MD$US$US
241439692$24143969$2$F$20230927$20240809$20240727$20240820$PER$$US-SA-2024SA214844$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240820$$MD$US$US
241439701$24143970$1$I$20240724$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024147748$AMGEN$$75$YR$E$F$Y$$$20240727$$CN$US$US
241439711$24143971$1$I$$20240724$20240727$20240727$PER$$NVSC2024US153027$NOVARTIS$$$$$$Y$$$20240727$$MD$US$US
241439721$24143972$1$I$20240601$20240719$20240727$20240727$PER$$US-ABBVIE-5847832$ABBVIE$$30$YR$$F$Y$$$20240727$$CN$US$US
241439731$24143973$1$I$$20240716$20240727$20240727$EXP$$US-UCBSA-2024036460$UCB$$$$$M$Y$$$20240727$$MD$US$US
241439741$24143974$1$I$$20240718$20240727$20240727$EXP$NL-LRB-00983932$NL-TEVA-VS-3223309$TEVA$$22$YR$$F$Y$64$KG$20240727$$CN$NL$NL
241439751$24143975$1$I$20240321$20240719$20240727$20240727$EXP$$US-AMGEN-USASP2024148711$AMGEN$$67$YR$E$F$Y$$$20240727$$CN$US$US
241439762$24143976$2$F$$20240719$20240727$20240727$EXP$$US-AMGEN-USASP2024145029$AMGEN$Caldera F.; Desai A.; Soni A. et. al.. Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Diseas Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study. Inflammatory Bowel Diseases. 2023;30 (7):1094-1102$$$$$Y$$$20240727$$MD$US$US
241439771$24143977$1$I$$20240722$20240727$20240727$EXP$$US-AMGEN-USASP2024148201$AMGEN$Cassaday R. D.; Kopmar N. E.; Quach K. et al.. Dose-Adjusted EPOCH Plus lnotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial. JAMA Oncology. 2024;10 (7):E1-E5$$$$$Y$$$20240727$$MD$US$US
241439781$24143978$1$I$20231201$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024147418$AMGEN$$60$YR$A$F$Y$$$20240727$$CN$US$US
241439791$24143979$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218040$SANOFI AVENTIS$$$$T$F$Y$$$20240727$$MD$US$US
241439801$24143980$1$I$20240701$20240719$20240727$20240727$PER$$US-SA-2024SA217847$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240727$$CN$US$US
241439812$24143981$2$F$$20240927$20240727$20240930$EXP$$NVSC2024US151480$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
241439821$24143982$1$I$$20240722$20240727$20240727$EXP$$US-TAKEDA-2024TUS074167$TAKEDA$$$$$F$Y$$$20240727$$CN$US$US
241439831$24143983$1$I$$20240718$20240727$20240727$EXP$$US-TEVA-VS-3223546$TEVA$$$$A$M$Y$$$20240727$$CN$US$US
241439841$24143984$1$I$$20240724$20240727$20240727$PER$$US-SA-2024SA218845$SANOFI AVENTIS$$$$$M$Y$$$20240727$$HP$US$US
241439851$24143985$1$I$20240722$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024146750$AMGEN$$77$YR$E$M$Y$$$20240727$$CN$US$US
241439861$24143986$1$I$$20240724$20240727$20240727$EXP$$US-ABBVIE-5853556$ABBVIE$$$$$F$Y$$$20240727$$CN$US$US
241439871$24143987$1$I$$20240719$20240727$20240727$PER$$US-AMGEN-USASP2024148721$AMGEN$$$$E$M$Y$104.8$KG$20240727$$MD$US$US
241439882$24143988$2$F$20240717$20240911$20240727$20240921$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090699$VIIV$$34$YR$$M$Y$$$20240921$$HP$US$US
241439891$24143989$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA216787$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240727$$CN$US$US
241439901$24143990$1$I$$20240723$20240727$20240727$PER$$US-ROCHE-10000035055$ROCHE$$50$YR$A$F$Y$$$20240727$$CN$US$US
241439911$24143991$1$I$20240101$20240725$20240727$20240727$PER$$US-AMGEN-USASP2024149185$AMGEN$$$$$F$Y$$$20240727$$MD$US$US
241439923$24143992$3$F$$20240823$20240727$20240827$PER$$US-ROCHE-10000035135$ROCHE$$72$YR$E$F$Y$$$20240827$$CN$US$US
241439931$24143993$1$I$$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024148687$AMGEN$$$$$$Y$$$20240727$$MD$US$US
241439942$24143994$2$F$20240716$20240817$20240727$20240826$PER$$US-SA-2024SA215189$SANOFI AVENTIS$$63$YR$A$F$Y$67$KG$20240826$$MD$US$US
241439951$24143995$1$I$20240101$20240721$20240727$20240727$PER$$US-SA-2024SA218516$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240727$$MD$US$US
241439962$24143996$2$F$20240701$20240816$20240727$20240821$EXP$$US-ABBVIE-5847420$ABBVIE$$42$YR$$F$Y$54$KG$20240821$$HP$US$US
241439971$24143997$1$I$$20240717$20240727$20240727$EXP$$CA-TEVA-VS-3222899$TEVA$$44$YR$$F$Y$$$20240727$$MD$CA$CA
241439982$24143998$2$F$20231201$20240802$20240727$20240807$PER$$US-ABBVIE-5855360$ABBVIE$$57$YR$$F$Y$63$KG$20240807$$CN$US$US
241439991$24143999$1$I$20240723$20240724$20240727$20240727$EXP$$IT-ABBVIE-5853628$ABBVIE$$67$YR$$M$Y$$$20240727$$MD$IT$IT
241440001$24144000$1$I$$20240718$20240727$20240727$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090784$VIIV$$$$$$Y$$$20240727$$MD$US$US
241440011$24144001$1$I$$20240725$20240727$20240727$PER$$US-ROCHE-10000036884$ROCHE$$$$A$F$Y$$$20240727$$CN$US$US
241440021$24144002$1$I$$20240724$20240727$20240727$PER$$US-ROCHE-10000036949$ROCHE$$$$E$F$Y$$$20240727$$CN$US$US
241440031$24144003$1$I$20240609$20240717$20240727$20240727$EXP$FR-AFSSAPS-AM2024000553$FR-TEVA-VS-3222697$TEVA$$38$YR$$F$Y$36.5$KG$20240727$$PH$FR$FR
241440042$24144004$2$F$$20240723$20240727$20240802$EXP$$US-ADVANZ PHARMA-202407006132$ADVANZ PHARMA$$$$$$Y$$$20240802$$MD$US$US
241440051$24144005$1$I$$20240722$20240727$20240727$PER$$US-AMGEN-USASP2024146981$AMGEN$$$$$F$Y$$$20240727$$CN$US$US
241440061$24144006$1$I$20111201$20240723$20240727$20240727$EXP$$NVSC2024MX152934$NOVARTIS$$57$YR$$F$Y$96$KG$20240727$$CN$MX$MX
241440071$24144007$1$I$$20240725$20240727$20240727$PER$$US-ROCHE-10000038058$ROCHE$$$$A$F$Y$95.71$KG$20240727$$CN$US$US
241440082$24144008$2$F$20240713$20240723$20240727$20240801$EXP$GB-MHRA-MED-202407181517399340-TJPDY$GB-TEVA-VS-3222852$TEVA$$33$YR$$F$Y$64$KG$20240801$$PH$GB$GB
241440091$24144009$1$I$20221202$20240717$20240727$20240727$EXP$$CA-TAKEDA-2024TUS075665$TAKEDA$$36$YR$$F$Y$$$20240727$$MD$CA$CA
241440101$24144010$1$I$$20240726$20240727$20240727$EXP$$US-TAKEDA-2024TUS075763$TAKEDA$$$$$F$Y$$$20240727$$CN$US$US
241440111$24144011$1$I$$20210721$20240727$20240727$EXP$$US-AstraZeneca-2021A634950$ASTRAZENECA$$$$$F$Y$$$20240727$$CN$US$
241440121$24144012$1$I$$20220715$20240727$20240727$EXP$$US-AstraZeneca-2022A260546$ASTRAZENECA$$$$$M$Y$$$20240727$$CN$US$
241440131$24144013$1$I$$20210709$20240727$20240727$EXP$$US-AstraZeneca-2021A614914$ASTRAZENECA$$$$$F$Y$$$20240727$$CN$US$
241440141$24144014$1$I$$20210816$20240727$20240727$EXP$$US-AstraZeneca-2021A685069$ASTRAZENECA$$$$$M$Y$$$20240727$$CN$US$
241440151$24144015$1$I$$20220210$20240727$20240727$EXP$$US-AstraZeneca-2022A068937$ASTRAZENECA$$$$$F$Y$$$20240727$$CN$US$
241440161$24144016$1$I$$20210616$20240727$20240727$EXP$$US-AstraZeneca-2021A536256$ASTRAZENECA$$$$$M$Y$$$20240727$$CN$US$
241440171$24144017$1$I$$20220225$20240727$20240727$EXP$$US-AstraZeneca-2022A090629$ASTRAZENECA$$$$$$Y$$$20240727$$HP$US$
241440181$24144018$1$I$$20230327$20240727$20240727$EXP$$US-AstraZeneca-2023A073225$ASTRAZENECA$$$$$M$Y$$$20240727$$CN$US$
241440191$24144019$1$I$20220401$20221123$20240727$20240727$EXP$$SG-AstraZeneca-2022A389401$ASTRAZENECA$$71$YR$$M$Y$$$20240727$$CN$SG$
241440201$24144020$1$I$$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024147761$AMGEN$$$$$$Y$$$20240727$$PH$US$US
241440211$24144021$1$I$20210917$20240718$20240727$20240727$EXP$FR-AFSSAPS-AM20213268$FR-TEVA-202112_00012561$TEVA$$90$YR$$F$Y$56.5$KG$20240727$$PH$FR$FR
241440221$24144022$1$I$$20240721$20240727$20240727$PER$$US-SA-2024SA216084$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240727$$MD$US$US
241440231$24144023$1$I$$20240724$20240727$20240727$EXP$$US-ABBVIE-5852852$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241440241$24144024$1$I$20230526$20240718$20240727$20240727$EXP$$GB-TEVA-VS-3222778$TEVA$$73$YR$$F$Y$61$KG$20240727$$HP$GB$GB
241440252$24144025$2$F$20240101$20240729$20240727$20240802$EXP$$US-AMGEN-USASP2024144121$AMGEN$$68$YR$E$M$Y$$$20240802$$CN$US$US
241440261$24144026$1$I$20231001$20240724$20240727$20240727$EXP$$US-ABBVIE-5595876$ABBVIE$$55$YR$$F$Y$49.895$KG$20240727$$CN$US$US
241440271$24144027$1$I$20240712$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024147594$AMGEN$$52$YR$A$F$Y$$$20240727$$CN$US$US
241440281$24144028$1$I$$20240723$20240727$20240727$EXP$$JP-AMGEN-JPNSP2024147408$AMGEN$$90$YR$E$F$Y$$$20240727$$HP$JP$JP
241440291$24144029$1$I$20240712$20240717$20240727$20240727$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090000$VIIV$$46$YR$$F$Y$$$20240727$$HP$US$US
241440301$24144030$1$I$$20230424$20240727$20240727$EXP$$US-AstraZeneca-2023A095872$ASTRAZENECA$$$$$$Y$$$20240727$$HP$US$
241440311$24144031$1$I$$20221104$20240727$20240727$EXP$$US-AstraZeneca-2022A368607$ASTRAZENECA$$$$$F$Y$$$20240727$$CN$US$
241440321$24144032$1$I$20230802$20230901$20240727$20240727$EXP$$US-AstraZeneca-2023A203247$ASTRAZENECA$$24436$DY$$F$Y$$$20240727$$CN$US$
241440331$24144033$1$I$$20230821$20240727$20240727$EXP$$US-AstraZeneca-2023A191385$ASTRAZENECA$$$$T$$Y$$$20240727$$HP$US$
241440341$24144034$1$I$$20210614$20240727$20240727$EXP$$US-AstraZeneca-2021A528061$ASTRAZENECA$$$$$M$Y$$$20240727$$CN$US$
241440351$24144035$1$I$20210719$20210823$20240727$20240727$EXP$$US-AstraZeneca-2021A700431$ASTRAZENECA$$25920$DY$$F$Y$$$20240727$$CN$US$
241440361$24144036$1$I$$20220912$20240727$20240727$EXP$$US-AstraZeneca-2022A317148$ASTRAZENECA$$$$$F$Y$$$20240727$$CN$US$
241440371$24144037$1$I$$20221117$20240727$20240727$EXP$$US-AstraZeneca-2022A383185$ASTRAZENECA$$$$$F$Y$$$20240727$$CN$US$
241440381$24144038$1$I$20240703$20240725$20240727$20240727$EXP$$US-TAKEDA-US202033149$TAKEDA$$52$YR$$F$Y$$$20240727$$CN$US$US
241440391$24144039$1$I$20240101$20240718$20240727$20240727$EXP$$BR-TEVA-VS-3201082$TEVA$$$$A$F$Y$$$20240727$$CN$BR$BR
241440401$24144040$1$I$$20240715$20240727$20240727$EXP$$JP-CELLTRION INC.-2024JP017515$CELLTRION$Matsuki S, Taniuchi N, Okada N, Sato J, Nishijima N, Kamio K, et al.. A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung Cancer. J Nippon Med Sch. 2024;91 (3)$$$$$Y$$$20240727$$HP$JP$JP
241440411$24144041$1$I$20240716$20240717$20240727$20240727$EXP$$ES-JNJFOC-20240749083$JOHNSON AND JOHNSON$$65$YR$E$F$Y$76$KG$20240727$$MD$ES$ES
241440421$24144042$1$I$$20240724$20240727$20240727$EXP$$US-ABBVIE-5854107$ABBVIE$$$$$M$Y$$$20240727$$CN$US$US
241440441$24144044$1$I$20240701$20240717$20240727$20240727$EXP$FR-AFSSAPS-AN2024000911$FR-TEVA-VS-3223218$TEVA$$51$YR$$F$Y$$$20240727$$MD$FR$FR
241440452$24144045$2$F$20240710$20240723$20240727$20240730$PER$$US-AMGEN-USASP2024144568$AMGEN$$46$YR$A$F$Y$$$20240730$$CN$US$US
241440462$24144046$2$F$$20240730$20240727$20240809$EXP$$US-TEVA-VS-3222856$TEVA$Zardoost P, Buckman Z, Weaver J, Elston S, Prouty A, Stuart R, et al. Continuous renal replacement therapy for lithium toxicity: A worthy treatment to avoid intradialytic hypotension and vasopressors. Clin-Case-Rep 2024; 12 (4):.; Zardoost P, Buckman Z, Weaver J, Elston S, Prouty A, Stuart R, et al. Continuous renal replacement therapy for lithium toxicity: A worthy treatment to avoid intradialytic hypotension and vasopressors. Clin-Case-Rep 2024; 12 (4):.$54$YR$$F$Y$$$20240809$$HP$US$US
241440471$24144047$1$I$20240713$20240722$20240727$20240727$EXP$$AR-JNJFOC-20240761164$JOHNSON AND JOHNSON$$60$YR$A$F$Y$67$KG$20240727$$CN$AR$AR
241440492$24144049$2$F$$20240730$20240727$20240809$EXP$$US-TEVA-VS-3222641$TEVA$Rockhold M, Kunkel L, Lacoste JL, Szymanski T, Rothenberg P, Zimmerman P, et al. Comparison of direct oral anticoagulants and warfarin in chronic limb-threatening ischemia. J-Vasc-Surg 2024; 79 (6): 1466-1472.; Rockhold M, Kunkel L, Lacoste JL, Szymanski T, Rothenberg P, Zimmerman P, et al. Comparison of direct oral anticoagulants and warfarin in chronic limb-threatening ischemia. J-Vasc-Surg 2024; 79 (6): 1466-1472.$$$$$Y$$$20240809$$PH$US$US
241440503$24144050$3$F$20240718$20240823$20240727$20240827$PER$$US-AMGEN-USASP2024147750$AMGEN$$72$YR$E$F$Y$$$20240827$$CN$US$US
241440511$24144051$1$I$$20240722$20240727$20240727$EXP$$AR-TAKEDA-2024TUS075002$TAKEDA$$$$$M$Y$$$20240727$$CN$AR$AR
241440521$24144052$1$I$20240101$20240717$20240727$20240727$EXP$$CA-TEVA-VS-3224338$TEVA$$64$YR$$M$Y$$$20240727$$CN$CA$CA
241440531$24144053$1$I$20240601$20240723$20240727$20240727$PER$$US-SA-2024SA218704$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240727$$MD$US$US
241440542$24144054$2$F$$20240826$20240727$20240903$PER$$US-AstraZeneca-2024A168941$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
241440552$24144055$2$F$$20240814$20240727$20240819$PER$$US-JNJFOC-20240771874$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$US$US
241440562$24144056$2$F$$20240731$20240727$20240809$EXP$$IT-TEVA-VS-3224348$TEVA$Grimaudo MS, Laffi A, Gennaro N, Fazio R, D^Orazio F, Sama L, et al. Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule. Front-Oncol 2023; 13.; Grimaudo MS, Laffi A, Gennaro N, Fazio R, D^Orazio F, Sama L, et al. Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule. Front-On...$50$YR$$M$Y$$$20240809$$HP$IT$IT
241440571$24144057$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218898$SANOFI AVENTIS$$$$A$F$Y$$$20240727$$MD$US$US
241440581$24144058$1$I$$20240717$20240727$20240727$EXP$$CA-TEVA-VS-3224095$TEVA$$64$YR$$M$Y$$$20240727$$HP$CA$CA
241440591$24144059$1$I$$20240722$20240727$20240727$EXP$$MY-TAKEDA-2024TUS075731$TAKEDA$$$$$M$Y$$$20240727$$CN$MY$MY
241440601$24144060$1$I$$20240722$20240727$20240727$PER$$US-ELI_LILLY_AND_COMPANY-US202407014823$ELI LILLY AND CO$$$$$$Y$$$20240727$$CN$US$US
241440611$24144061$1$I$$20240724$20240727$20240727$PER$$US-ELI_LILLY_AND_COMPANY-US202407016946$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240727$$CN$US$US
241440621$24144062$1$I$20240714$20240722$20240727$20240727$PER$$PR-ELI_LILLY_AND_COMPANY-US202407016654$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240727$$PH$PR$US
241440633$24144063$3$F$20240301$20240808$20240727$20240907$PER$$US-JNJFOC-20240747079$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240907$$CN$US$US
241440641$24144064$1$I$$20240719$20240727$20240727$PER$$US-ABBVIE-5848319$ABBVIE$$$$$$Y$$$20240727$$CN$US$US
241440651$24144065$1$I$20240301$20240724$20240727$20240727$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009328$UNITED THERAPEUTICS$$65$YR$$M$Y$68.027$KG$20240727$$$US$US
241440661$24144066$1$I$$20240722$20240727$20240727$PER$$US-UNITED THERAPEUTICS-UNT-2024-022767$UNITED THERAPEUTICS$$$$$F$Y$45.351$KG$20240727$$$US$US
241440671$24144067$1$I$20240630$20240716$20240727$20240727$EXP$$US-ACORDA-ACO_177588_2024$ACORDA$$74$YR$$F$Y$$$20240727$$CN$US$US
241440681$24144068$1$I$$20240722$20240727$20240727$PER$$US-AMGEN-USASP2024146297$AMGEN$$$$$$Y$$$20240727$$CN$US$US
241440691$24144069$1$I$$20240722$20240727$20240727$PER$$US-AMGEN-USASP2024146592$AMGEN$$$$$$Y$$$20240727$$CN$US$US
241440702$24144070$2$F$20240401$20240731$20240727$20240807$EXP$$NVSC2024GB082934$NOVARTIS$$$$$M$Y$$$20240807$$CN$GB$GB
241440711$24144071$1$I$20240603$20240722$20240727$20240727$EXP$$JP-009507513-2407JPN003956J$MERCK$$7$DEC$$F$Y$$$20240727$$PH$JP$JP
241440721$24144072$1$I$$20240715$20240727$20240727$EXP$$PT-TEVA-VS-3222199$TEVA$Carrilho M, Nobre MB, Santos MC, Silva RC, Martins JR. CO-0062 - (4147) - MYOCARDITIS A CMV .Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts [CNMI]. 2024 May; 162.$72$YR$$F$Y$$$20240727$$MD$PT$PT
241440731$24144073$1$I$20240724$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024147687$AMGEN$$73$YR$E$F$Y$$$20240727$$CN$US$US
241440741$24144074$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA217883$SANOFI AVENTIS$$$$C$M$Y$$$20240727$$MD$US$US
241440752$24144075$2$F$$20240730$20240727$20240809$EXP$$US-TEVA-VS-3222868$TEVA$Sanchez A, Elliott EI, Wang P, Spichler-Moffarah A. Legionella pneumophila and Staphylococcus aureus co-infections in a patient with SARS-CoV-2. BMJ-Case-Rep 2022; 15 (3).; Sanchez A, Elliott EI, Wang P, Spichler-Moffarah A. Legionella pneumophila and Staphylococcus aureus co-infections in a patient with SARS-CoV-2. BMJ-Case-Rep 2022; 15 (3):.$$$A$M$Y$$$20240809$$HP$US$US
241440762$24144076$2$F$$20240730$20240727$20240808$EXP$$DK-TEVA-VS-3223332$TEVA$Knudsen GHo, Kermanian N, Kock-Jensen CH, Antulov R. Opioid-Induced Leukoencephalopathies: A Report of Two Cases. Case-Rep-Neurol 2022; 14 (1): 25-30.; Knudsen GHo, Kermanian N, Kock-Jensen CH, Antulov R. Opioid-Induced Leukoencephalopathies: A Report of Two Cases. Case-Rep-Neurol 2022; 14 (1): 25-30.; Knudsen GHo, Kermanian N, Kock-Jensen CH, Antulov R. Opioid-Induced Leukoencephalopathies: A Report of Two Cases. Case-Rep-Neurol 2022; 14 (1): 25-30.$30$YR$$M$Y$$$20240808$$HP$DK$DK
241440771$24144077$1$I$20240722$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024147835$AMGEN$$62$YR$A$F$Y$$$20240727$$CN$US$US
241440781$24144078$1$I$20221119$20240717$20240727$20240727$EXP$$NL-TEVA-VS-3222863$TEVA$$$$$F$Y$$$20240727$$MD$NL$NL
241440791$24144079$1$I$20230620$20240724$20240727$20240727$EXP$$US-ABBVIE-5854067$ABBVIE$$74$YR$$M$Y$$$20240727$$CN$US$US
241440802$24144080$2$F$20240101$20240729$20240727$20240802$EXP$$US-ABBVIE-5853919$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241440811$24144081$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA216764$SANOFI AVENTIS$$$$$M$Y$$$20240727$$CN$US$US
241440821$24144082$1$I$20240623$20240724$20240727$20240727$PER$$US-AMGEN-USASP2024147597$AMGEN$$69$YR$E$M$Y$$$20240727$$CN$US$US
241440831$24144083$1$I$20240620$20240723$20240727$20240727$EXP$$CO-ABBVIE-5818422$ABBVIE$$84$YR$$F$Y$52$KG$20240727$$HP$CO$CO
241440841$24144084$1$I$$20240722$20240727$20240727$EXP$$BR-JNJFOC-20240761220$JOHNSON AND JOHNSON$$$$$$Y$$$20240727$$MD$BR$BR
241440851$24144085$1$I$$20230619$20240727$20240727$EXP$$US-AstraZeneca-2023A142237$ASTRAZENECA$$$$$F$Y$$$20240727$$CN$US$
241440861$24144086$1$I$$20240717$20240727$20240727$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090175$VIIV$$$$$$Y$$$20240727$$HP$US$US
241440871$24144087$1$I$20240708$20240716$20240727$20240727$EXP$CN-NMPA-2102011010986202400121$CN-Ipsen Biopharmaceuticals, Inc.-2024-14760$IPSEN$$73$YR$E$M$Y$55$KG$20240727$$HP$CN$CN
241440881$24144088$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA216097$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240727$$CN$US$US
241440891$24144089$1$I$20210515$20240722$20240727$20240727$EXP$$NVSC2021IN123594$NOVARTIS$$62$YR$$F$Y$$$20240727$$CN$IN$IN
241440901$24144090$1$I$$20240723$20240727$20240727$PER$$US-SA-2024SA218352$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240727$$MD$US$US
241440912$24144091$2$F$20240101$20240722$20240727$20240731$EXP$FR-AFSSAPS-PA2024001336$FR-TEVA-VS-3222984$TEVA$$50$YR$$M$Y$87.7$KG$20240731$$PH$FR$FR
241440922$24144092$2$F$$20240730$20240727$20240809$EXP$$US-TEVA-VS-3222829$TEVA$Khadraoui H, Herzog TJ, Jackson A, Billingsley C. Acute pulmonary complications in the setting of high risk gestational trophoblastic neoplasia and induction of chemotherapy. Gynecol-Oncol-Rep 2023; 48.; Khadraoui H, Herzog TJ, Jackson A, Billingsley C. Acute pulmonary complications in the setting of high risk gestational trophoblastic neoplasia and induction of chemotherapy. Gynecol-Oncol-Rep 2023; 48.$33$YR$$F$Y$$$20240809$$HP$US$US
241440931$24144093$1$I$20231001$20240717$20240727$20240727$EXP$FR-AFSSAPS-TO2024001014$FR-TEVA-VS-3223213$TEVA$$84$YR$$M$Y$$$20240727$$PH$FR$FR
241440942$24144094$2$F$$20240730$20240727$20240809$EXP$$FR-TEVA-VS-3223308$TEVA$Varengue R, Delion M, De Carli E, Fournier LL, Durigneux J, Dinomais M, et al. Evaluation of safety of fluoxetine for cerebellar mutism syndrome in children after posterior fossa surgery. Arch-Pediatr 2024; 31 231-237.; Varengue R, Delion M, De Carli E, Fournier LL, Durigneux J, Dinomais M, et al. Evaluation of safety of fluoxetine for cerebellar mutism syndrome in children after posterior fossa surgery. Arch-Pediatr 2024; 31 231-237.$$$$$Y$$$20240809$$HP$FR$FR
241440951$24144095$1$I$$20240715$20240727$20240727$EXP$$DK-TEVA-VS-3223420$TEVA$Knudsen GHo, Kermanian N, Kock-Jensen CH, Antulov R. Opioid-Induced Leukoencephalopathies: A Report of Two Cases. Case-Rep-Neurol 2022; 14 (1): 25-30.; Knudsen GHo, Kermanian N, Kock-Jensen CH, Antulov R. Opioid-Induced Leukoencephalopathies: A Report of Two Cases. Case-Rep-Neurol 2022; 14 (1): 25-30.$24$YR$$M$Y$$$20240727$$HP$DK$DK
241440961$24144096$1$I$20230915$20240717$20240727$20240727$EXP$FR-AFSSAPS-PO2024000656$FR-TEVA-VS-3223302$TEVA$$81$YR$$F$Y$61$KG$20240727$$MD$FR$FR
241440971$24144097$1$I$20240705$20240722$20240727$20240727$PER$$US-AMGEN-USASP2024146154$AMGEN$$75$YR$E$M$Y$$$20240727$$HP$US$US
241440981$24144098$1$I$20240701$20240725$20240727$20240727$PER$$US-AstraZeneca-2024A170450$ASTRAZENECA$$745$MON$$F$Y$65.3$KG$20240727$$HP$US$
241440991$24144099$1$I$20210101$20240722$20240727$20240727$PER$$US-SA-2024SA218282$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240727$$MD$US$US
241441001$24144100$1$I$20240724$20240724$20240727$20240727$PER$$US-AstraZeneca-2024A169238$ASTRAZENECA$$23748$DY$$F$Y$$$20240727$$CN$US$
241441011$24144101$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA217916$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240727$$MD$US$US
241441021$24144102$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA216871$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240727$$CN$US$US
241441031$24144103$1$I$$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024147136$AMGEN$$$$$M$Y$$$20240727$$CN$US$US
241441041$24144104$1$I$$20240717$20240727$20240727$EXP$$US-GSK-US2024AMR090350$GLAXOSMITHKLINE$$$$$F$Y$$$20240727$$CN$US$US
241441051$24144105$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218338$SANOFI AVENTIS$$$$A$F$Y$74.8$KG$20240727$$MD$US$US
241441062$24144106$2$F$$20240730$20240727$20240809$EXP$$FR-TEVA-VS-3223362$TEVA$Rocanieres P, Lamure S, Geny C, Hillaire-Buys D, Faillie J-L, Bres V. Parkinsonian Patients Requiring Proteasome Inhibitors for Multiple Myeloma: Exceptional Circumstances Call for Extra Caution. J-Parkinsons-Dis 2022; 12 (8): 2601-2603.; Rocanieres P, Lamure S, Geny C, Hillaire-Buys D, Faillie J-L, Bres V. Parkinsonian Patients Requiring Proteasome Inhibitors for Multiple Myeloma: Exceptional Circumstances Call for Extra Caution. J-Parkinsons-Dis 2022; 12 (8): 2601-2603.; Rocanieres P, Lamur...$68$YR$$M$Y$$$20240809$$HP$FR$FR
241441071$24144107$1$I$20240711$20240715$20240727$20240727$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14302$IPSEN$$46$YR$A$F$Y$$$20240727$$HP$US$US
241441081$24144108$1$I$20240101$20240718$20240727$20240727$PER$$US-SA-2024SA215043$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240727$$MD$US$US
241441092$24144109$2$F$$20240730$20240727$20240809$EXP$$US-TEVA-VS-3222722$TEVA$Jaspersen SL, Bruns DA, Candee MS, Battaglia A, Carey JC, Fishler KP. Seizures in trisomy 18: Prevalence, description, and treatment. Am-J-Med-Genet-A 2023; 191 (4): 1026-1037.; Jaspersen SL, Bruns DA, Candee MS, Battaglia A, Carey JC, Fishler KP. Seizures in trisomy 18: Prevalence, description, and treatment. Am-J-Med-Genet-A 2023; 191 (4): 1026-1037.$$$$$Y$$$20240809$$HP$US$US
241441101$24144110$1$I$20240722$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024147056$AMGEN$$76$YR$E$M$Y$$$20240727$$CN$US$US
241441111$24144111$1$I$$20240725$20240727$20240727$PER$$US-JNJFOC-20240770006$JOHNSON AND JOHNSON$$$$$$Y$$$20240727$$CN$US$US
241441121$24144112$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA216955$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240727$$CN$US$US
241441132$24144113$2$F$$20240730$20240727$20240808$EXP$$US-TEVA-VS-3222842$TEVA$Memon R, Mehreen R, Mack MA, Okoyeze K, Shaikh A, Shan Ul Abedin M, et al. Biopsy of Thoracic Lymph Node Diagnosing Mystery of Distributive Shock Caused by Idiopathic Multicenteric Castleman Disease With TAFRO Syndrome. Am-J-Respir-Crit-Care-Med 2023; 207 (plus Poster).; Memon R, Mehreen R, Mack MA, Okoyeze K, Shaikh A, Shan Ul Abedin M, et al. Biopsy of Thoracic Lymph Node Diagnosing Mystery of Distributive Shock Caused by Idiopathic Multicenteric Castleman Disease With TAFRO Syndrome. Am-J-...$36$YR$$M$Y$$$20240808$$HP$US$US
241441141$24144114$1$I$$20240717$20240727$20240727$PER$$US-AstraZeneca-2024A164391$ASTRAZENECA$$$$$M$Y$$$20240727$$MD$US$
241441151$24144115$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218398$SANOFI AVENTIS$$2$YR$C$M$Y$14.5$KG$20240727$$MD$US$US
241441161$24144116$1$I$20240601$20240718$20240727$20240727$PER$$US-SA-2024SA216101$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240727$$MD$US$US
241441171$24144117$1$I$$20240718$20240727$20240727$PER$$US-SA-2024SA217408$SANOFI AVENTIS$$59$YR$A$M$Y$107$KG$20240727$$MD$US$US
241441181$24144118$1$I$20231204$20240717$20240727$20240727$EXP$ES-AEMPS-1543556$ES-TEVA-VS-3222487$TEVA$$58$YR$$F$Y$$$20240727$$MD$ES$ES
241441192$24144119$2$F$20240724$20240729$20240727$20240730$PER$$US-JNJFOC-20240768665$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$MD$US$US
241441201$24144120$1$I$20230828$20240717$20240727$20240727$EXP$FR-AFSSAPS-AVCN2024000524$FR-TEVA-VS-3222851$TEVA$$37$YR$$M$Y$$$20240727$$MD$FR$FR
241441211$24144121$1$I$20240701$20240722$20240727$20240727$EXP$$CN-ABBVIE-5849659$ABBVIE$$55$YR$$F$Y$45$KG$20240727$$MD$CN$CN
241441221$24144122$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218436$SANOFI AVENTIS$$$$A$F$Y$61.2$KG$20240727$$MD$US$US
241441232$24144123$2$F$$20240731$20240727$20240809$EXP$$ES-TEVA-VS-3224461$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ale...$5$YR$$M$Y$$$20240809$$HP$ES$ES
241441241$24144124$1$I$$20240715$20240727$20240727$EXP$$ES-TEVA-VS-3224462$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$1$YR$$F$Y$$$20240727$$HP$ES$ES
241441251$24144125$1$I$$20240725$20240727$20240727$PER$$US-AstraZeneca-2024A170710$ASTRAZENECA$$$$$F$Y$$$20240727$$CN$US$
241441263$24144126$3$F$20240721$20240925$20240727$20240927$PER$$US-AMGEN-USASP2024147479$AMGEN$$77$YR$E$M$Y$$$20240927$$CN$US$US
241441273$24144127$3$F$20230301$20240723$20240727$20240805$PER$$US-SA-2024SA217638$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240805$$MD$US$US
241441281$24144128$1$I$20240101$20240723$20240727$20240727$PER$$US-SA-2024SA217648$SANOFI AVENTIS$$$$A$M$Y$$$20240727$$MD$US$US
241441291$24144129$1$I$$20240715$20240727$20240727$EXP$$ES-TEVA-VS-3224464$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$3$YR$$F$Y$$$20240727$$HP$ES$ES
241441303$24144130$3$F$$20240917$20240727$20240918$PER$$US-ALXN-202407USA001440US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
241441312$24144131$2$F$$20240730$20240727$20240809$EXP$$US-TEVA-VS-3223143$TEVA$Baker M, Thakker S, Cardis M, DeSimone J, Larson A. A Vexing Case of a Treatment-Refractory, Idiopathic Rash Resembling Histiocytoid Sweet Syndrome: Insights into the Diagnostic Challenge of Vexas Syndrome. Am-J-Dermatopathol 2024; 46 (7) S1-S2.; Baker M, Thakker S, Cardis M, DeSimone J, Larson A. A Vexing Case of a Treatment-Refractory, Idiopathic Rash Resembling Histiocytoid Sweet Syndrome: Insights into the Diagnostic Challenge of Vexas Syndrome. Am-J-Dermatopathol 2024; 46 (7) S1-S2.$71$YR$$M$Y$$$20240809$$HP$US$US
241441321$24144132$1$I$$20240722$20240727$20240727$PER$$US-SA-2024SA218464$SANOFI AVENTIS$$$$A$M$Y$$$20240727$$MD$US$US
241441331$24144133$1$I$$20240717$20240727$20240727$30DAY$$US-GSK-US2024090133$GLAXOSMITHKLINE$$$$$F$Y$$$20240727$$CN$US$US
241441341$24144134$1$I$$20240719$20240727$20240727$PER$$US-AstraZeneca-2024A165425$ASTRAZENECA$$$$$$Y$$$20240727$$CN$US$
241441361$24144136$1$I$$20240723$20240727$20240727$PER$$US-AMGEN-USASP2024146831$AMGEN$$$$$$Y$$$20240727$$PH$US$US
241441371$24144137$1$I$$20240717$20240727$20240727$30DAY$$US-GSK-US2024090180$GLAXOSMITHKLINE$$$$$F$Y$$$20240727$$CN$US$US
241441381$24144138$1$I$$20240716$20240727$20240727$EXP$$FR-RDY-LIT/FRA/24/0010815$DR REDDYS$Sahloul O, Louapre C, Beigneux Y, Lubetzki C, Maillart E, Roux T. Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapies. Multiple Sclerosis and Related Disorders. 2024 May;85: doi:10.1016/j.msard.2024.105557.$$$N$$Y$$$20240727$$HP$FR$FR
241441391$24144139$1$I$$20240718$20240727$20240727$PER$$US-SA-2024SA215733$SANOFI AVENTIS$$$$C$$Y$$$20240727$$HP$US$US
241441401$24144140$1$I$$20240712$20240727$20240727$EXP$$US-HLS-202400356$HLS THERAPEUTICS$$$$E$F$Y$$$20240727$$HP$US$US
241441411$24144141$1$I$$20240717$20240727$20240727$EXP$$US-RDY-LIT/USA/24/0010842$DR REDDYS$Chhetri C, Haseeb S, Ansari UA, Goyal R. Tricyclic Antidepressant Induced Wide Complex Tachycardia With Brugada Pattern. Circulation. 2023 Nov;148: doi:10.1161/circ.148.suppl_1.16851.$52$YR$A$M$Y$$$20240727$$HP$US$US
241441422$24144142$2$F$$20240805$20240727$20240813$PER$$US-SA-2024SA217028$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240814$$MD$US$US
241441431$24144143$1$I$20240101$20240719$20240727$20240727$PER$$US-SA-2024SA216248$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240727$$MD$US$US
241441441$24144144$1$I$20240724$20240725$20240727$20240727$PER$$US-JNJFOC-20240770097$JOHNSON AND JOHNSON$$$$$$Y$$$20240727$$PH$US$US
241441451$24144145$1$I$$20240722$20240727$20240727$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036050$BOEHRINGER INGELHEIM$$$$$M$Y$102$KG$20240727$$CN$US$US
241441461$24144146$1$I$$20240712$20240727$20240727$EXP$$US-HLS-202400018$HLS THERAPEUTICS$$68$YR$E$M$Y$$$20240727$$CN$US$US
241441471$24144147$1$I$$20240718$20240727$20240727$PER$$US-SA-2024SA215779$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240727$$MD$US$US
241441481$24144148$1$I$$20240725$20240727$20240727$PER$$US-ABBVIE-5856254$ABBVIE$$$$$$Y$$$20240727$$CN$US$US
241441491$24144149$1$I$$20240712$20240727$20240727$EXP$$US-HLS-202400363$HLS THERAPEUTICS$$36$YR$A$M$Y$$$20240727$$HP$US$US
241441502$24144150$2$F$$20240730$20240727$20240809$EXP$$US-TEVA-VS-3222812$TEVA$Kiskaddon AL, Wilsey M, Gonzalez-Gomez I, Laks J, Miles A, Carapellucci J, et al. Basiliximab therapy for immune-mediated bowel disease in a pediatric heart transplant patient. Pediatr-Transplant 2023; 27 (2): e14443.; Kiskaddon AL, Wilsey M, Gonzalez-Gomez I, Laks J, Miles A, Carapellucci J, et al. Basiliximab therapy for immune-mediated bowel disease in a pediatric heart transplant patient. Pediatr-Transplant 2023; 27 (2): e14443.$8$YR$$F$Y$$$20240809$$HP$US$US
241441511$24144151$1$I$20240712$20240712$20240727$20240727$EXP$$US-HLS-202400370$HLS THERAPEUTICS$$54$YR$A$F$Y$$$20240727$$CN$US$US
241441521$24144152$1$I$$20240718$20240727$20240727$PER$$US-SA-2024SA214207$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240727$$HP$US$US
241441531$24144153$1$I$20240701$20240719$20240727$20240727$PER$$US-SA-2024SA215807$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240727$$MD$US$US
241441541$24144154$1$I$$20240717$20240727$20240727$EXP$$US-RDY-LIT/USA/24/0010846$DR REDDYS$Mcgourty M, Adams EW, Lyons J. MDA-5 Associated Dermatomyositis: A Case of Delayed Care and Dire Consequences. American Journal of Respiratory and Critical Care Medicine. 2024 May;209(0): A1994. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1994.$43$YR$A$M$Y$$$20240727$$HP$US$US
241441551$24144155$1$I$$20240718$20240727$20240727$PER$$US-SA-2024SA214255$SANOFI AVENTIS$$$$A$$Y$$$20240727$$HP$US$US
241441561$24144156$1$I$$20240717$20240727$20240727$PER$$US-RDY-LIT/USA/24/0010841$DR REDDYS$Daniels Z, Walczak AB, Lloyd EA, Deitemeyer M, Duffy V, Kistler IS, et al. Breaking Tradition: The Bivalirudin Advantage in Pediatric Mechanical Circulatory Support. ASAIO Journal. 2024 May;70: 84-85.$$$$$Y$$$20240727$$HP$US$US
241441571$24144157$1$I$$20240719$20240727$20240727$PER$$US-ABBVIE-5848351$ABBVIE$$$$$$Y$$$20240727$$CN$US$US
241441581$24144158$1$I$20240601$20240725$20240727$20240727$PER$$US-ELI_LILLY_AND_COMPANY-US202407017205$ELI LILLY AND CO$$72$YR$E$$Y$$$20240727$$CN$US$US
241441591$24144159$1$I$$20240717$20240727$20240727$EXP$$US-RDY-LIT/USA/24/0010843$DR REDDYS$Sohal A, Kowdley KV. Complete Biochemical Remission with Oral Vancomycin in a Patient with Primary Sclerosing Cholangitis and High Serum Immunoglobulin G4 Levels. ACG Case Reports Journal. 2024 Jan 01;11(1): E01256. doi:10.14309/crj.0000000000001256.$20$YR$A$M$Y$$$20240727$$MD$US$US
241441601$24144160$1$I$20240101$20240719$20240727$20240727$PER$$US-SA-2024SA214336$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240727$$MD$US$US
241441611$24144161$1$I$$20240718$20240727$20240727$PER$$US-SA-2024SA214373$SANOFI AVENTIS$$$$$M$Y$$$20240727$$MD$US$US
241441622$24144162$2$F$$20240730$20240727$20240809$EXP$$US-TEVA-VS-3222876$TEVA$Matthews BJ, Froehlich A, Goicochea L, Levinson K. Postmenopausal mixed gestational trophoblastic neoplasia with complete response to immunotherapy - A case report. Gynecol-Oncol-Rep 2023; 46.; Matthews BJ, Froehlich A, Goicochea L, Levinson K. Postmenopausal mixed gestational trophoblastic neoplasia with complete response to immunotherapy - A case report. Gynecol-Oncol-Rep 2023; 46.; Matthews BJ, Froehlich A, Goicochea L, Levinson K. Postmenopausal mixed gestational trophoblastic neoplasia w...$66$YR$$F$Y$$$20240809$$HP$US$US
241441641$24144164$1$I$$20240722$20240727$20240727$PER$$US-009507513-2407USA013241$MERCK$$$$$F$Y$$$20240727$$CN$US$US
241441652$24144165$2$F$$20240815$20240727$20240819$PER$$US-ALXN-202407USA001423US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241441661$24144166$1$I$20240101$20240718$20240727$20240727$PER$$US-SA-2024SA214397$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240727$$MD$US$US
241441671$24144167$1$I$$20240717$20240727$20240727$EXP$$US-RDY-LIT/USA/24/0010844$DR REDDYS$Wilson P, Rosenstengle C, Spak C. Underrecognized cause diarrhea in solid organ transplant: a report of astroviridae enteritis in liver transplant. Transplant Infectious Disease. 2024 Feb 26;26(2): doi:10.1111/tid.14257.$72$YR$E$M$Y$$$20240727$$HP$US$US
241441681$24144168$1$I$20240701$20240719$20240727$20240727$PER$$US-SA-2024SA214430$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240727$$MD$US$US
241441691$24144169$1$I$$20240716$20240727$20240727$EXP$$US-RDY-LIT/USA/24/0010797$DR REDDYS$Lapiano K, Roto D. Case Report: Nelarabine Neurotoxicity Induced Respiratory Failure. American Journal of Respiratory and Critical Care Medicine. 2024;209: A5696. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5696.$30$YR$A$F$Y$$$20240727$$HP$US$US
241441701$24144170$1$I$$20240718$20240727$20240727$PER$$US-SA-2024SA214525$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240727$$MD$US$US
241441711$24144171$1$I$$20240717$20240727$20240727$EXP$$US-RDY-LIT/USA/24/0010845$DR REDDYS$Bollam RR, Reddy VK. Persistent Pseudomonas Aeruginosa Pneumonia Due to Antimicrobial Resistance Development Requiring Lobectomy. American Journal of Respiratory and Critical Care Medicine. 2024 May;209(0): A2400. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2400.$56$YR$A$F$Y$$$20240727$$HP$US$US
241441721$24144172$1$I$$20240718$20240727$20240727$30DAY$$US-GSK-US2024090776$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240727$$CN$US$US
241441732$24144173$2$F$20240601$20240809$20240727$20240815$EXP$$CO-ABBVIE-5853252$ABBVIE$$68$YR$$M$Y$55$KG$20240815$$CN$CO$CO
241441741$24144174$1$I$$20240712$20240727$20240727$PER$$US-AMGEN-USASP2024144633$AMGEN$$$$A$M$Y$$$20240727$$CN$US$US
241441751$24144175$1$I$$20240718$20240727$20240727$PER$$US-SA-2024SA214764$SANOFI AVENTIS$$$$T$M$Y$71.6$KG$20240727$$MD$US$US
241441762$24144176$2$F$$20240819$20240727$20240826$PER$$US-SA-2024SA214721$SANOFI AVENTIS$$$$E$M$Y$$$20240826$$MD$US$US
241441781$24144178$1$I$$20240718$20240727$20240727$30DAY$$US-GSK-US2024090778$GLAXOSMITHKLINE$$$$$F$Y$$$20240727$$CN$US$US
241441791$24144179$1$I$20240722$20240725$20240727$20240727$EXP$$US-ABBVIE-5855826$ABBVIE$$37$YR$$F$Y$$$20240727$$CN$US$US
241441803$24144180$3$F$20240101$20240820$20240727$20240828$PER$$US-ABBVIE-5849463$ABBVIE$$$$$M$Y$86.182$KG$20240828$$CN$US$US
241441811$24144181$1$I$20240718$20240722$20240727$20240727$PER$$US-SA-2024SA215811$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240727$$MD$US$US
241441821$24144182$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA174459$SANOFI AVENTIS$$81$YR$E$M$Y$160$KG$20240727$$HP$US$US
241441831$24144183$1$I$$20240718$20240727$20240727$PER$$US-SA-2024SA215906$SANOFI AVENTIS$$$$E$F$Y$$$20240727$$MD$US$US
241441841$24144184$1$I$$20240723$20240727$20240727$PER$$US-AstraZeneca-2024A168459$ASTRAZENECA$$$$$F$Y$$$20240727$$CN$US$
241441851$24144185$1$I$$20240717$20240727$20240727$EXP$$IT-RDY-LIT/ITA/24/0010858$DR REDDYS$Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports. Journal of pediatric hematology/oncology. 2024 Jun 24;0(0): 1-4. doi:10.1097/MPH.0000000000002904.$13$YR$T$M$Y$$$20240727$$MD$IT$IT
241441861$24144186$1$I$$20240718$20240727$20240727$30DAY$$US-GSK-US2024090791$GLAXOSMITHKLINE$$$$$F$Y$$$20240727$$CN$US$US
241441871$24144187$1$I$$20240716$20240727$20240727$EXP$$IT-RDY-LIT/ITA/24/0010794$DR REDDYS$Di Renzo N, Dargenio NM, Sgherza N, Federico PV, Fina MP, Matera R, et al. REAL-WORLD DATA WITH LENALIDOMIDE AS MAINTENANCE THERAPY FOR PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: THE EXPERIENCE OF THE RETE EMATOLOGICA PUGLIESE (REP). Haematologica. 2024 Apr;109: 26-27.$$$$$Y$$$20240727$$HP$IT$IT
241441881$24144188$1$I$20230101$20240723$20240727$20240727$EXP$$US-009507513-2407USA013247$MERCK$$$$$M$Y$55$KG$20240727$$PH$US$US
241441891$24144189$1$I$20240601$20240719$20240727$20240727$PER$$US-SA-2024SA216258$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240728$$MD$US$US
241441902$24144190$2$F$$20240808$20240727$20240818$PER$$US-AstraZeneca-2024A154419$ASTRAZENECA$$$$$F$Y$$$20240818$$MD$US$
241441911$24144191$1$I$$20240717$20240727$20240727$PER$$US-009507513-2407USA011291$MERCK$$$$$M$Y$$$20240727$$MD$US$US
241441922$24144192$2$F$20240701$20240814$20240727$20240828$PER$$US-SA-2024SA216298$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240828$$CN$US$US
241441941$24144194$1$I$$20240722$20240727$20240727$EXP$GB-MHRA-MED-202407221232108990-VTZFY$GB-LABORATORIOS LICONSA S.A.-2407GB05829$INSUD PHARMA$$$$$F$Y$$$20240728$$CN$GB$GB
241441951$24144195$1$I$$20240723$20240727$20240727$EXP$$US-INSUD PHARMA-2407US05924$INSUD PHARMA$$$$$$Y$$$20240728$$MD$US$US
241441962$24144196$2$F$$20240729$20240727$20240805$PER$$US-INSUD PHARMA-2407US05920$INSUD PHARMA$$$$$$Y$$$20240805$$HP$US$US
241441972$24144197$2$F$20240101$20240804$20240727$20240809$PER$$US-INSUD PHARMA-2407US05942$INSUD PHARMA$$$$$$Y$$$20240809$$CN$US$US
241441981$24144198$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA217950$SANOFI AVENTIS$$$$A$F$Y$109$KG$20240728$$MD$US$US
241441991$24144199$1$I$$20240719$20240727$20240727$PER$$US-SA-2024SA217975$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240728$$MD$US$US
241442001$24144200$1$I$20240101$20240719$20240727$20240727$PER$$US-SA-2024SA217988$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240728$$MD$US$US
241442011$24144201$1$I$20240524$20240725$20240727$20240727$EXP$FR-AFSSAPS-LL2024001272$FR-ROCHE-10000036764$ROCHE$$58$YR$A$F$Y$$$20240728$$MD$FR$FR
241442021$24144202$1$I$20240723$20240724$20240727$20240727$PER$$US-ELI_LILLY_AND_COMPANY-US202407016178$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240727$$CN$US$US
241442031$24144203$1$I$$20240725$20240727$20240727$PER$$US-ELI_LILLY_AND_COMPANY-US202407017190$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240727$$CN$US$US
241442041$24144204$1$I$$20240709$20240727$20240727$PER$$US-INSUD PHARMA-2407US05517$INSUD PHARMA$$$$$$Y$$$20240728$$CN$US$US
241442051$24144205$1$I$20240716$20240722$20240727$20240727$30DAY$$US-GSK-US2024091850$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240727$$CN$US$US
241442061$24144206$1$I$$20240715$20240728$20240728$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07167$LUPIN$$$$$$Y$$$20240728$$CN$AU$AU
241442071$24144207$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06657$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442081$24144208$1$I$20240601$20240715$20240728$20240728$EXP$$US-UCBSA-2024036095$UCB$$45$YR$$F$Y$$$20240728$$HP$US$US
241442091$24144209$1$I$$20240715$20240728$20240728$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07235$LUPIN$$$$$$Y$$$20240728$$CN$AU$AU
241442101$24144210$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06378$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442111$24144211$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06675$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442121$24144212$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06720$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442131$24144213$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06731$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442141$24144214$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06732$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442151$24144215$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06747$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442161$24144216$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06751$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442172$24144217$2$F$20240101$20240808$20240728$20240817$PER$$US-JNJFOC-20240737012$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240817$$CN$US$US
241442181$24144218$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06771$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442191$24144219$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06793$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442201$24144220$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06798$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442211$24144221$1$I$$20240723$20240728$20240728$PER$$US-SA-2024SA218366$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240728$$CN$US$US
241442221$24144222$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06799$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442232$24144223$2$F$$20240723$20240728$20240801$EXP$$US-NOVITIUMPHARMA-2024USNVP01404$NOVITIUM PHARMA$$19$YR$A$M$Y$118$KG$20240801$$CN$US$US
241442241$24144224$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06800$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442252$24144225$2$F$$20240830$20240728$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06801$LUPIN$$$$$$Y$$$20240920$$CN$US$US
241442261$24144226$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06811$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442271$24144227$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06810$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442281$24144228$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06850$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442291$24144229$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06882$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442301$24144230$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06884$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442311$24144231$1$I$20240701$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016632$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240728$$CN$US$US
241442322$24144232$2$F$20231201$20240828$20240728$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202407014538$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
241442331$24144233$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06627$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442341$24144234$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06628$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442351$24144235$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06646$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442363$24144236$3$F$20240101$20240827$20240728$20240911$EXP$$TW-UCBSA-2024036596$UCB$$$$$M$Y$35.3$KG$20240911$$MD$TW$TW
241442371$24144237$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06677$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442381$24144238$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06690$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442391$24144239$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06691$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442401$24144240$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06692$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442412$24144241$2$F$$20240814$20240728$20240828$PER$$US-SA-2024SA216683$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240828$$MD$US$US
241442421$24144242$1$I$$20240719$20240728$20240728$PER$$US-SA-2024SA218127$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240728$$CN$US$US
241442431$24144243$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06694$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442446$24144244$6$F$20240701$20240816$20240728$20240827$PER$$US-AMGEN-USASP2024143831$AMGEN$$64$YR$A$F$Y$57.8$KG$20240827$$HP$US$US
241442453$24144245$3$F$20240701$20240821$20240728$20240826$EXP$$PH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041915$BOEHRINGER INGELHEIM$$89$YR$E$F$Y$$$20240827$$CN$PH$PH
241442461$24144246$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06738$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442471$24144247$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06775$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442481$24144248$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06776$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442491$24144249$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06777$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442501$24144250$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06778$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442511$24144251$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06815$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442521$24144252$1$I$20240101$20240718$20240728$20240728$PER$$US-SA-2024SA216715$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240728$$MD$US$US
241442531$24144253$1$I$$20240719$20240728$20240728$PER$$US-AstraZeneca-2024A168510$ASTRAZENECA$$$$$$Y$$$20240728$$CN$US$
241442543$24144254$3$F$$20240904$20240728$20240905$PER$$US-AstraZeneca-2024A168485$ASTRAZENECA$$$$$F$Y$70.8$KG$20240905$$MD$US$
241442551$24144255$1$I$$20240725$20240728$20240728$PER$$US-AstraZeneca-2024A170581$ASTRAZENECA$$$$$F$Y$$$20240728$$MD$US$
241442561$24144256$1$I$20240721$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016182$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240728$$CN$US$US
241442571$24144257$1$I$20240701$20240722$20240728$20240728$EXP$PT-INFARMED-F202407-307$PT-SA-2024SA217425$SANOFI AVENTIS$$64$YR$A$F$Y$59$KG$20240728$$HP$PT$PT
241442581$24144258$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06816$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442591$24144259$1$I$20240720$20240720$20240728$20240728$PER$$US-SA-2024SA216802$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240728$$MD$US$US
241442601$24144260$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06821$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442611$24144261$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA218554$SANOFI AVENTIS$$$$$M$Y$$$20240728$$MD$US$US
241442621$24144262$1$I$20220801$20240714$20240728$20240728$EXP$GB-GE HEALTHCARE-2024CSU007334$GB-DEXPHARM-2024-2339$DEXCEL$$61$YR$A$F$Y$61$KG$20240728$$PH$GB$GB
241442631$24144263$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06823$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442641$24144264$1$I$20210901$20240714$20240728$20240728$EXP$GB-MHRA-MED-202407121200052970-HPVRW$GB-DEXPHARM-2024-2348$DEXCEL$$73$YR$E$F$Y$$$20240728$$PH$GB$GB
241442651$24144265$1$I$$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016324$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240728$$CN$US$US
241442661$24144266$1$I$$20240722$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407014461$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240728$$CN$US$US
241442672$24144267$2$F$20240401$20240923$20240728$20240928$EXP$$CN-ROCHE-10000030651$ROCHE$$$$$F$Y$51$KG$20240928$$HP$CN$CN
241442681$24144268$1$I$$20240716$20240728$20240728$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-02683$AMNEAL$Ishikawa H, Takeshima M, Ishikawa H, Ayabe N, Ohta H, et al.. Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review. Neuropsychopharmacol Rep.. 2021;41(3):434-439$39$YR$$M$Y$$$20240728$$HP$JP$JP
241442691$24144269$1$I$20211026$20240714$20240728$20240728$EXP$GB-MHRA-MED-202407121137445660-DWTPJ$GB-DEXPHARM-2024-2349$DEXCEL$$75$YR$E$M$Y$$$20240728$$PH$GB$GB
241442701$24144270$1$I$$20240712$20240728$20240728$PER$$US-JNJFOC-20240737064$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240728$$CN$US$US
241442721$24144272$1$I$20190412$20240714$20240728$20240728$EXP$GB-MHRA-MED-202407121113045010-HLCWN$GB-DEXPHARM-2024-2350$DEXCEL$$66$YR$E$F$Y$$$20240728$$PH$GB$GB
241442731$24144273$1$I$20240710$20240718$20240728$20240728$PER$$US-SA-2024SA212572$SANOFI AVENTIS$$55$YR$A$F$Y$95.238$KG$20240728$$PH$US$US
241442742$24144274$2$F$$20240826$20240728$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202407016942$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240828$$CN$US$US
241442751$24144275$1$I$$20240725$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407017187$ELI LILLY AND CO$$$$$F$Y$$$20240728$$CN$US$US
241442762$24144276$2$F$20240724$20240724$20240728$20240801$PER$$US-SA-2024SA219122$SANOFI AVENTIS$$72$YR$E$F$Y$59.87$KG$20240801$$MD$US$US
241442771$24144277$1$I$20240701$20240723$20240728$20240728$PER$$US-SA-2024SA218418$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240728$$MD$US$US
241442781$24144278$1$I$20220501$20240714$20240728$20240728$EXP$GB-MHRA-MED-202407121049254540-GFMHJ$GB-DEXPHARM-2024-2351$DEXCEL$$67$YR$E$F$Y$$$20240728$$PH$GB$GB
241442791$24144279$1$I$20211026$20240714$20240728$20240728$EXP$GB-GE HEALTHCARE-2024CSU007489$GB-DEXPHARM-2024-2355$DEXCEL$$75$YR$E$M$Y$92$KG$20240728$$PH$GB$GB
241442801$24144280$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06859$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442811$24144281$1$I$$20240702$20240728$20240728$PER$$US-JNJFOC-20240708277$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240728$$CN$US$US
241442822$24144282$2$F$$20240726$20240728$20240730$PER$$US-JNJFOC-20240765972$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$MD$US$US
241442831$24144283$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06935$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442842$24144284$2$F$20240725$20240731$20240728$20240830$PER$$US-AstraZeneca-2024A170457$ASTRAZENECA$$22266$DY$$F$Y$$$20240830$$CN$US$
241442851$24144285$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06913$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442861$24144286$1$I$$20240717$20240728$20240728$PER$$US-JNJFOC-20240748523$JOHNSON AND JOHNSON$$$$$F$Y$$$20240728$$CN$US$US
241442871$24144287$1$I$$20240722$20240728$20240728$PER$$US-009507513-2407USA012986$MERCK$$$$$F$Y$$$20240728$$CN$US$US
241442882$24144288$2$F$20240601$20240725$20240728$20240729$EXP$$US-ROCHE-10000037490$ROCHE$$59$YR$A$F$Y$63.5$KG$20240729$$CN$US$US
241442891$24144289$1$I$$20240725$20240728$20240728$PER$$US-ROCHE-10000036853$ROCHE$$84$YR$E$M$Y$$$20240728$$CN$US$US
241442902$24144290$2$F$$20230410$20240728$20240731$PER$$US-SMPA-202304-URV-002089$SUNOVION$$$$$$Y$$$20240731$$PH$US$US
241442921$24144292$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06922$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241442931$24144293$1$I$20240501$20240722$20240728$20240728$PER$$US-SA-2024SA218222$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240728$$CN$US$US
241442941$24144294$1$I$$20240723$20240728$20240728$PER$$US-SA-2024SA218794$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240728$$MD$US$US
241442951$24144295$1$I$20240702$20240725$20240728$20240728$EXP$$CN-ROCHE-10000038138$ROCHE$$58$YR$A$F$Y$65$KG$20240728$$HP$CN$CN
241442961$24144296$1$I$$20240724$20240728$20240728$PER$$US-AstraZeneca-2024A168984$ASTRAZENECA$$$$$M$Y$$$20240728$$CN$US$
241442972$24144297$2$F$20240501$20240819$20240728$20240829$PER$$US-SA-2024SA217596$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240829$$MD$US$US
241442981$24144298$1$I$$20240716$20240728$20240728$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-02685$AMNEAL$Ishikawa H, Takeshima M, Ishikawa H, Ayabe N, Ohta H, et al. Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review. Neuropsychopharmacol Rep.. 2021;41(3):434-439$69$YR$$M$Y$$$20240728$$HP$JP$JP
241442991$24144299$1$I$$20240724$20240728$20240728$PER$$US-SA-2024SA218909$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240728$$MD$US$US
241443002$24144300$2$F$$20240820$20240728$20240829$PER$$US-SA-2024SA216632$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240829$$CN$US$US
241443012$24144301$2$F$$20221204$20240728$20240731$PER$$US-SMPA-202212-URV-001902$SUNOVION$$92$YR$$F$Y$$$20240731$$PH$US$US
241443021$24144302$1$I$20240101$20240722$20240728$20240728$PER$$US-SA-2024SA216985$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240728$$MD$US$US
241443032$24144303$2$F$20240101$20240725$20240728$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407015340$ELI LILLY AND CO$$51$YR$A$$Y$$$20240806$$CN$US$US
241443041$24144304$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA217743$SANOFI AVENTIS$$$$A$F$Y$70$KG$20240728$$MD$US$US
241443051$24144305$1$I$20240101$20240726$20240728$20240728$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042262$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240728$$CN$US$US
241443061$24144306$1$I$20240101$20240718$20240728$20240728$PER$$US-SA-2024SA014731$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240728$$MD$US$US
241443071$24144307$1$I$20240706$20240723$20240728$20240728$EXP$$GB-ROCHE-10000035089$ROCHE$$23$YR$A$F$Y$$$20240728$$HP$GB$GB
241443081$24144308$1$I$$20240726$20240728$20240728$EXP$$CA-SANDOZ INC.-SDZ2024CA068546$SANDOZ$$9$YR$$M$Y$$$20240728$$HP$CA$CA
241443091$24144309$1$I$$20240719$20240728$20240728$EXP$$FR-JNJFOC-20240752106$JOHNSON AND JOHNSON$$$$$F$Y$$$20240728$$MD$FR$FR
241443101$24144310$1$I$$20240724$20240728$20240728$PER$$US-SA-2024SA218591$SANOFI AVENTIS$$$$A$M$Y$$$20240728$$HP$US$US
241443111$24144311$1$I$$20240718$20240728$20240728$PER$$US-SA-2024SA215004$SANOFI AVENTIS$$$$A$F$Y$$$20240728$$MD$US$US
241443121$24144312$1$I$$20240718$20240728$20240728$PER$$US-SA-2024SA215098$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240728$$MD$US$US
241443132$24144313$2$F$$20240821$20240728$20240902$PER$$US-SA-2024SA216666$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240902$$MD$US$US
241443142$24144314$2$F$$20240827$20240728$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06741$LUPIN$$$$$$Y$$$20240918$$CN$US$US
241443151$24144315$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06824$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241443161$24144316$1$I$$20240723$20240728$20240728$EXP$$US-ROCHE-10000034804$ROCHE$$$$A$F$Y$$$20240728$$CN$US$US
241443171$24144317$1$I$$20240724$20240728$20240728$PER$$US-SA-2024SA218608$SANOFI AVENTIS$$$$$$Y$$$20240728$$CN$US$US
241443182$24144318$2$F$$20240826$20240728$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06840$LUPIN$$$$$$Y$$$20240916$$CN$US$US
241443191$24144319$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06856$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241443201$24144320$1$I$19981108$20240722$20240728$20240728$EXP$$DE-SANDOZ INC.-SDZ2024DE066941$SANDOZ$$63$YR$$M$Y$65$KG$20240728$$MD$DE$DE
241443211$24144321$1$I$$20240716$20240728$20240728$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-22143$SAMSUNG BIOEPIS$$65$YR$E$M$Y$$$20240728$$CN$GB$GB
241443221$24144322$1$I$$20240701$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06758$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241443231$24144323$1$I$20240701$20240722$20240728$20240728$PER$$US-SA-2024SA218535$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240728$$MD$US$US
241443241$24144324$1$I$$20240722$20240728$20240728$EXP$$TR-SANDOZ INC.-SDZ2024TR068506$SANDOZ$$$$$F$Y$$$20240728$$CN$TR$TR
241443251$24144325$1$I$$20240715$20240728$20240728$EXP$813207$AU-LUPIN PHARMACEUTICALS INC.-2024-07124$LUPIN$$$$$$Y$$$20240728$$CN$AU$AU
241443261$24144326$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA216996$SANOFI AVENTIS$$$$E$F$Y$$$20240728$$MD$US$US
241443272$24144327$2$F$20220215$20240726$20240728$20240731$EXP$$JP-JNJFOC-20220245450$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240731$$$COUNTRY NOT SPECIFIED$JP
241443281$24144328$1$I$20240704$20240720$20240728$20240728$EXP$$IN-JNJFOC-20240756513$JOHNSON AND JOHNSON$$53$YR$A$F$Y$53$KG$20240728$$CN$IN$IN
241443291$24144329$1$I$$20240722$20240728$20240728$EXP$$US-SANDOZ INC.-SDZ2024US067592$SANDOZ$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D. Rhabdomyolysis Risk: The Dangers of Tribulus terrestris, an Over-the-Counter Supplement. American Journal of Case Reports. 2024;25:e943492$71$YR$$M$Y$$$20240728$$HP$US$US
241443301$24144330$1$I$$20240723$20240728$20240728$PER$$US-SA-2024SA217651$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240728$$MD$US$US
241443331$24144333$1$I$20240601$20240722$20240728$20240728$PER$$US-SA-2024SA218529$SANOFI AVENTIS$$7$YR$C$M$Y$32$KG$20240728$$MD$US$US
241443341$24144334$1$I$$20240724$20240728$20240728$EXP$$GB-SANDOZ INC.-NVSC2021GB036996$SANDOZ$$$$$M$Y$$$20240728$$CN$GB$GB
241443351$24144335$1$I$$20240722$20240728$20240728$EXP$$US-JNJFOC-20240757612$JOHNSON AND JOHNSON$$$$$F$Y$$$20240728$$CN$US$US
241443361$24144336$1$I$20240510$20240726$20240728$20240728$EXP$FR-AFSSAPS-TO2024000979$FR-JNJFOC-20240775036$JOHNSON AND JOHNSON$$13$YR$T$F$Y$40.9$KG$20240728$$PH$FR$FR
241443371$24144337$1$I$$20240724$20240728$20240728$EXP$$ZA-SANDOZ INC.-SDZ2023ZA009376$SANDOZ$$$$$M$Y$92$KG$20240728$$CN$ZA$ZA
241443381$24144338$1$I$$20240717$20240728$20240728$PER$$US-RDY-LIT/USA/24/0010899$DR REDDYS$Andrews T, Arnold, Cimen SS, Yucel E, Suleyman A. Hypersensitivity to Ibuprofen: Real-Life Experience in Children With History of Suspected Immediate Reactions. Pediatrics. 2023 Dec;152: S18-S19. doi:10.1542/peds.2023-064344FD.$$$$$Y$$$20240728$$MD$US$US
241443392$24144339$2$F$$20240801$20240728$20240806$EXP$$CA-SANDOZ INC.-SDZ2024CA068187$SANDOZ$$$$$M$Y$$$20240806$$MD$CA$CA
241443401$24144340$1$I$$20240720$20240728$20240728$EXP$GB-MHRA-MED-202407201634330970-JDYGN$GB-RDY-SPO/GBR/24/0010810$DR REDDYS$$60$YR$A$F$Y$89$KG$20240728$$CN$GB$GB
241443411$24144341$1$I$$20240719$20240728$20240728$EXP$US-MLMSERVICE-20240717-PI130051-00050-3$US-RDY-SPO/USA/24/0010823$DR REDDYS$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70(7):e92-6. DOI: 10.1097/MAT.0000000000002102.$15$YR$T$F$Y$49$KG$20240728$$MD$US$US
241443421$24144342$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA216864$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240728$$CN$US$US
241443431$24144343$1$I$20240701$20240718$20240728$20240728$PER$$US-SA-2024SA217889$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240728$$MD$US$US
241443441$24144344$1$I$20240720$20240722$20240728$20240728$PER$$US-SA-2024SA218506$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240728$$PH$US$US
241443452$24144345$2$F$20240712$20240723$20240728$20240801$PER$$US-SA-2024SA217635$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240801$$HP$US$US
241443461$24144346$1$I$20240701$20240722$20240728$20240728$PER$$US-SA-2024SA217115$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240728$$MD$US$US
241443471$24144347$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA216866$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240728$$CN$US$US
241443481$24144348$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA216875$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240728$$CN$US$US
241443491$24144349$1$I$$20240725$20240728$20240728$EXP$$CA-SANDOZ INC.-SDZ2024CA068334$SANDOZ$$38$YR$$M$Y$$$20240728$$CN$CA$CA
241443502$24144350$2$F$$20240904$20240728$20240913$PER$$US-SA-2024SA216529$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240913$$MD$US$US
241443511$24144351$1$I$$20240718$20240728$20240728$PER$$US-SA-2024SA212236$SANOFI AVENTIS$$$$C$F$Y$$$20240728$$CN$US$US
241443521$24144352$1$I$$20240716$20240728$20240728$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22274$SAMSUNG BIOEPIS$$51$YR$A$M$Y$$$20240728$$CN$CA$CA
241443531$24144353$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA213654$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240728$$CN$US$US
241443541$24144354$1$I$$20240716$20240728$20240728$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22332$SAMSUNG BIOEPIS$$55$YR$A$F$Y$$$20240728$$CN$CA$CA
241443551$24144355$1$I$$20240716$20240728$20240728$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-22364$SAMSUNG BIOEPIS$$$$$M$Y$77$KG$20240728$$HP$AU$AU
241443572$24144357$2$F$$20240917$20240728$20240927$PER$$US-SA-2024SA218492$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240927$$MD$US$US
241443581$24144358$1$I$20240701$20240721$20240728$20240728$PER$$US-SA-2024SA216213$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240728$$MD$US$US
241443592$24144359$2$F$20240101$20240819$20240728$20240828$PER$$US-SA-2024SA215501$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240828$$MD$US$US
241443601$24144360$1$I$20240601$20240718$20240728$20240728$PER$$US-JNJFOC-20240752850$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240728$$CN$US$US
241443611$24144361$1$I$$20240723$20240728$20240728$EXP$GB-MHRA-30742974$GB-ABBVIE-5854721$ABBVIE$$79$YR$$F$Y$$$20240728$$PH$GB$GB
241443621$24144362$1$I$$20240719$20240728$20240728$PER$$US-SA-2024SA218833$SANOFI AVENTIS$$$$A$M$Y$140.61$KG$20240728$$MD$US$US
241443631$24144363$1$I$$20240724$20240728$20240728$EXP$$NVSC2024ZA108955$NOVARTIS$$58$YR$$F$Y$$$20240728$$MD$ZA$ZA
241443641$24144364$1$I$20240716$20240718$20240728$20240728$EXP$$TW-JNJFOC-20240750673$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240728$$CN$TW$TW
241443652$24144365$2$F$$20240811$20240728$20240814$EXP$$NVSC2024US152623$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
241443661$24144366$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA216065$SANOFI AVENTIS$$$$A$F$Y$$$20240728$$HP$US$US
241443671$24144367$1$I$$20240715$20240728$20240728$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07104$LUPIN$$$$$$Y$$$20240728$$CN$AU$AU
241443681$24144368$1$I$$20240715$20240728$20240728$PER$$US-RDY-CLI/USA/24/0010543$DR REDDYS$$$$$M$Y$$$20240728$$HP$US$US
241443691$24144369$1$I$$20240715$20240728$20240728$PER$$US-RDY-CLI/USA/24/0010558$DR REDDYS$$$$$M$Y$$$20240728$$CN$US$US
241443701$24144370$1$I$$20240715$20240728$20240728$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07177$LUPIN$$44$YR$$F$Y$$$20240728$$CN$AU$AU
241443711$24144371$1$I$$20240715$20240728$20240728$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07118$LUPIN$$$$$$Y$$$20240728$$CN$AU$AU
241443721$24144372$1$I$20240722$20240722$20240728$20240728$PER$$US-SA-2024SA217938$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240728$$HP$US$US
241443731$24144373$1$I$20240724$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407017337$ELI LILLY AND CO$$$$$$Y$$$20240728$$CN$US$US
241443741$24144374$1$I$20211101$20240721$20240728$20240728$PER$$US-SA-2024SA215873$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240728$$MD$US$US
241443751$24144375$1$I$$20240715$20240728$20240728$EXP$813072$AU-LUPIN PHARMACEUTICALS INC.-2024-07289$LUPIN$$33$YR$$M$Y$$$20240728$$CN$AU$AU
241443761$24144376$1$I$$20240724$20240728$20240728$PER$$US-SA-2024SA218331$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240728$$CN$US$US
241443771$24144377$1$I$$20240724$20240728$20240728$EXP$$NL-AMGEN-NLDSP2024147400$AMGEN$$63$YR$A$F$Y$93$KG$20240728$$CN$NL$NL
241443781$24144378$1$I$20240603$20240722$20240728$20240728$PER$$US-SA-2024SA218180$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240728$$MD$US$US
241443791$24144379$1$I$20240601$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06938$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241443801$24144380$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06857$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241443811$24144381$1$I$20240601$20240722$20240728$20240728$PER$$US-SA-2024SA217897$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240728$$MD$US$US
241443822$24144382$2$F$20240724$20240812$20240728$20240820$PER$$US-SA-2024SA219072$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240820$$MD$US$US
241443831$24144383$1$I$$20240723$20240728$20240728$PER$$US-SA-2024SA218264$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240728$$MD$US$US
241443841$24144384$1$I$$20240724$20240728$20240728$PER$$US-SA-2024SA219049$SANOFI AVENTIS$$$$$$Y$$$20240728$$MD$US$US
241443851$24144385$1$I$$20240723$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016143$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240728$$MD$US$US
241443861$24144386$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06858$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241443873$24144387$3$F$20240422$20240819$20240728$20240821$EXP$FR-AFSSAPS-LY2024000788$FR-JNJFOC-20240773116$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240821$$PH$FR$FR
241443881$24144388$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06350$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241443891$24144389$1$I$20240724$20240725$20240728$20240728$PER$$US-AMGEN-USASP2024148695$AMGEN$$46$YR$A$F$Y$$$20240728$$CN$US$US
241443901$24144390$1$I$20180101$20240722$20240728$20240728$PER$$US-SA-2024SA218483$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240728$$MD$US$US
241443911$24144391$1$I$20240301$20240718$20240728$20240728$PER$$US-SA-2024SA215822$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240728$$MD$US$US
241443921$24144392$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06862$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241443941$24144394$1$I$20240701$20240725$20240728$20240728$PER$$US-SA-2024SA219010$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240728$$CN$US$US
241443951$24144395$1$I$20240722$20240723$20240728$20240728$PER$$US-SA-2024SA218884$SANOFI AVENTIS$$$$$F$Y$$$20240728$$CN$US$US
241443961$24144396$1$I$$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407017213$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240728$$CN$US$US
241443971$24144397$1$I$20240701$20240724$20240728$20240728$PER$$US-SA-2024SA218963$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240728$$MD$US$US
241443981$24144398$1$I$20240701$20240722$20240728$20240728$PER$$US-AstraZeneca-2024A167309$ASTRAZENECA$$68$YR$$F$Y$108.4$KG$20240728$$HP$US$
241443991$24144399$1$I$20240718$20240718$20240728$20240728$PER$$US-SA-2024SA187941$SANOFI AVENTIS$$53$YR$A$F$Y$86.1$KG$20240728$$MD$US$US
241444001$24144400$1$I$$20240725$20240728$20240728$PER$$US-AstraZeneca-2024A170498$ASTRAZENECA$$$$$$Y$$$20240728$$CN$US$
241444011$24144401$1$I$$20240716$20240728$20240728$PER$$US-Merck Healthcare KGaA-2024039366$MERCK KGAA$$$$$F$Y$$$20240724$$CN$US$US
241444021$24144402$1$I$20240124$20240718$20240728$20240728$EXP$NL-LRB-00985375$NL-Ipsen Biopharmaceuticals, Inc.-2024-14289$IPSEN$$65$YR$E$F$Y$78$KG$20240728$$CN$NL$NL
241444031$24144403$1$I$$20240723$20240728$20240728$EXP$$CA-JNJFOC-20240228446$JOHNSON AND JOHNSON$$47$YR$A$F$Y$69$KG$20240728$$HP$CA$CA
241444041$24144404$1$I$$20240723$20240728$20240728$PER$$US-AstraZeneca-2024A168989$ASTRAZENECA$$$$$$Y$$$20240728$$CN$US$
241444061$24144406$1$I$$20240718$20240728$20240728$EXP$$FR-Merck Healthcare KGaA-2024039178$MERCK KGAA$$$$$F$Y$$$20240726$$CN$FR$FR
241444071$24144407$1$I$$20240722$20240728$20240728$PER$$US-Merck Healthcare KGaA-2024040339$MERCK KGAA$$$$$$Y$$$20240726$$CN$US$US
241444081$24144408$1$I$20240101$20240720$20240728$20240728$PER$$US-SA-2024SA217703$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240728$$MD$US$US
241444091$24144409$1$I$20240514$20240725$20240728$20240728$EXP$FR-AFSSAPS-NC2024000879$FR-JNJFOC-20240771354$JOHNSON AND JOHNSON$$14$YR$T$M$Y$102$KG$20240728$$MD$FR$FR
241444101$24144410$1$I$20240628$20240719$20240728$20240728$EXP$$CN-JNJFOC-20240755884$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240728$$HP$CN$CN
241444111$24144411$1$I$$20240701$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06647$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241444121$24144412$1$I$$20240701$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06650$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241444132$24144413$2$F$$20240826$20240728$20240831$PER$$US-AstraZeneca-2024A168642$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
241444141$24144414$1$I$$20240701$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06653$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241444151$24144415$1$I$$20240701$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06656$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241444174$24144417$4$F$20240713$20240823$20240728$20240904$PER$$US-AstraZeneca-2024A168448$ASTRAZENECA$$83$YR$$F$Y$$$20240904$$CN$US$
241444181$24144418$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06470$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241444192$24144419$2$F$20220101$20240724$20240728$20240802$PER$$US-SA-2024SA218881$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240802$$CN$US$US
241444202$24144420$2$F$20240724$20240724$20240728$20240801$PER$$US-SA-2024SA218824$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240801$$MD$US$US
241444211$24144421$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06673$LUPIN$$$$$$Y$$$20240728$$PH$US$US
241444221$24144422$1$I$$20240701$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06652$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241444232$24144423$2$F$20231120$20240801$20240728$20240805$EXP$FR-AFSSAPS-NY2024000788$FR-ROCHE-10000037649$ROCHE$$40$YR$A$F$Y$50$KG$20240804$$MD$FR$FR
241444241$24144424$1$I$20240101$20240717$20240728$20240728$PER$$US-SA-2024SA213906$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240728$$MD$US$US
241444251$24144425$1$I$$20240715$20240728$20240728$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092468$GLENMARK$$$$$$Y$$$20240728$$CN$US$US
241444263$24144426$3$F$20240606$20240805$20240728$20240808$EXP$$FR-JNJFOC-20240760230$JOHNSON AND JOHNSON$$$$$F$Y$2.7$KG$20240808$$MD$FR$FR
241444271$24144427$1$I$20240708$20240723$20240728$20240728$EXP$$CN-ROCHE-10000035693$ROCHE$$52$YR$A$M$Y$65$KG$20240728$$HP$CN$CN
241444281$24144428$1$I$$20240723$20240728$20240728$PER$$US-SA-2024SA218981$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240728$$MD$US$US
241444291$24144429$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA218679$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240728$$MD$US$US
241444301$24144430$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA218191$SANOFI AVENTIS$$$$E$F$Y$$$20240728$$MD$US$US
241444311$24144431$1$I$20240101$20240712$20240728$20240728$PER$$US-JNJFOC-20240737073$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240728$$CN$US$US
241444321$24144432$1$I$20240724$20240725$20240728$20240728$EXP$$CN-ROCHE-10000038051$ROCHE$$41$YR$A$F$Y$59$KG$20240728$$HP$CN$CN
241444331$24144433$1$I$$20240726$20240728$20240728$PER$$US-JNJFOC-20240773282$JOHNSON AND JOHNSON$$$$$$Y$$$20240728$$HP$US$US
241444341$24144434$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06315$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241444351$24144435$1$I$20240304$20240712$20240728$20240728$PER$$US-RDY-SPO/USA/24/0010790$DR REDDYS$$37$YR$A$F$Y$$$20240728$$CN$US$US
241444361$24144436$1$I$20240404$20240724$20240728$20240728$EXP$$NVSC2024IL061454$NOVARTIS$$50$YR$$F$Y$$$20240728$$HP$IL$IL
241444371$24144437$1$I$$20240703$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06308$LUPIN$$$$$$Y$$$20240728$$MD$US$US
241444381$24144438$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA218719$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240728$$MD$US$US
241444391$24144439$1$I$$20240725$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016985$ELI LILLY AND CO$$$$$F$Y$$$20240728$$CN$US$US
241444401$24144440$1$I$$20240716$20240728$20240728$EXP$$IN-DEXPHARM-2024-2471$DEXCEL$Khanam, A.; Ahmad Wani, Z.; Ahmad, S.; Nazir, N.  CYPROHEPTADINE AND DEXAMETHASONE INDUCED SUICIDALITY AND OBSESSIONS PRESENTING TO LIASON PSYCHIATRY- A CASE REPORT. Indian Journal of Psychiatry 2024, V66 (Suppl. 1), PS177$20$YR$A$M$Y$$$20240728$$HP$IN$IN
241444421$24144442$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06603$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241444431$24144443$1$I$$20240715$20240728$20240728$PER$$US-RDY-LIT/USA/24/0010698$DR REDDYS$King S, Johnson A, Jelsing E. Gluteus Maximus Distal Myotendinous Junction Tear in a Pickleball Player: A Case Report. Current Sports Medicine Reports. 2024;23(6): 213-215. doi:10.1249/JSR.0000000000001177.$72$YR$E$M$Y$$$20240728$$HP$US$US
241444441$24144444$1$I$20240612$20240723$20240728$20240728$EXP$$PK-ROCHE-3528178$ROCHE$$28$YR$A$M$Y$$$20240728$$CN$PK$PK
241444451$24144445$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06664$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241444461$24144446$1$I$$20240725$20240728$20240728$PER$$US-AstraZeneca-2024A170574$ASTRAZENECA$$$$A$M$Y$$$20240728$$MD$US$
241444471$24144447$1$I$$20240702$20240728$20240728$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06806$LUPIN$$$$$$Y$$$20240728$$CN$US$US
241444482$24144448$2$F$20240101$20240802$20240728$20240809$EXP$$AE-SA-2024SA217773$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240809$$MD$AE$AE
241444491$24144449$1$I$$20240725$20240728$20240728$EXP$$GB-JNJFOC-20240772700$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240728$$CN$GB$GB
241444501$24144450$1$I$$20240718$20240728$20240728$PER$$US-SA-2024SA214307$SANOFI AVENTIS$$$$$F$Y$$$20240728$$CN$US$US
241444511$24144451$1$I$$20240722$20240728$20240728$EXP$$CN-ROCHE-10000014883$ROCHE$Huang Z, Chen T, Li W, Qiu J, Liu S, Wu Z, et al. PD-L1 inhibitor versus PD-1 inhibitor plus bevacizumab with transvascular intervention in unresectable hepatocellular carcinoma. Clinical and experimental medicine. 2024-Jun-28;24 (1):1-10. doi:10.1007/s10238-024-01415-y.$$$$$Y$$$20240728$$HP$CN$CN
241444521$24144452$1$I$$20240714$20240728$20240728$EXP$$NL-Indoco-000592$INDOCO$Crouwel F, Simsek M, de Boer MA, van Asseldonk DP, Bhalla A, Weusthuis et al. Multicentre study and systematic review: Allopurinol exposure during pregnancy. Aliment Pharmacol Ther. 2024 Jul 10.$$$$F$Y$$$20240727$$HP$NL$NL
241444531$24144453$1$I$$20240714$20240728$20240728$EXP$$NL-Indoco-000594$INDOCO$Crouwel F, Simsek M, de Boer MA, van Asseldonk DP, Bhalla A, Weusthuis et al. Multicentre study and systematic review: Allopurinol exposure during pregnancy. Aliment Pharmacol Ther. 2024 Jul 10.$$$N$$Y$$$20240727$$HP$NL$NL
241444541$24144454$1$I$$20240714$20240728$20240728$EXP$$PL-Axellia-005279$XELLIA PHARMACEUTICALS$Cheyne I, Hassan K, Dunkel T, Sota M, Wroblewski L, Mikaszewska-Sokolewicz M. Effective Treatment of Acinetobacter baumannii Ventriculitis With Interventricular Colistin: A Case Report. Cureus. 2024 Jun 11;16(6):e62169.$22$YR$A$M$Y$$$20240727$$HP$PL$US
241444551$24144455$1$I$$20240714$20240728$20240728$EXP$$US-Inventia-000733$INVENTIA HEALTHCARE$Farouji A, Haddad AW, Kloub M, Paige A, Miller R. A Case of Metformin-Associated Lactic Acidosis Complicated by Acute Liver Failure, Acute Renal Failure, and Shock. Cureus. 2024 Jun 7;16(6):e61911.$63$YR$A$F$Y$$$20240727$$HP$US$US
241444561$24144456$1$I$$20240715$20240728$20240728$EXP$$DE-RDY-LIT/DEU/24/0010704$DR REDDYS$Kohle F, Wunderlich G, Fink GR, Schroeter M, Lehmann HC, Schneider C. Rituximab in non-systemic vasculitic neuropathy: a single-center experience. Journal of Neurology. 2024 Jul;271(7): 4406-4411. doi:10.1007/s00415-024-12378-1.$$$A$$Y$$$20240728$$HP$DE$DE
241444581$24144458$1$I$$20240715$20240728$20240728$EXP$$DE-RDY-LIT/DEU/24/0010703$DR REDDYS$Kohle F, Wunderlich G, Fink GR, Schroeter M, Lehmann HC, Schneider C. Rituximab in non-systemic vasculitic neuropathy: a single-center experience. Journal of Neurology. 2024 Jul;271(7): 4406-4411. doi:10.1007/s00415-024-12378-1.$$$A$$Y$$$20240728$$HP$DE$DE
241444591$24144459$1$I$$20240715$20240728$20240728$EXP$$DE-RDY-LIT/DEU/24/0010702$DR REDDYS$Kohle F, Wunderlich G, Fink GR, Schroeter M, Lehmann HC, Schneider C. Rituximab in non-systemic vasculitic neuropathy: a single-center experience. Journal of Neurology. 2024 Jul;271(7): 4406-4411. doi:10.1007/s00415-024-12378-1.$$$A$$Y$$$20240728$$HP$DE$DE
241444601$24144460$1$I$$20240715$20240728$20240728$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092660$GLENMARK$Rothman RL, Stewart TG, Mourad A, Boulware DR, McCarthy MW, Thicklin F, et. al.. Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial.. medRxiv. 2024;1-26$$$$$Y$$$20240728$$MD$US$US
241444611$24144461$1$I$$20240719$20240728$20240728$EXP$$CN-ROCHE-10000038715$ROCHE$Wang H, Li H S. Clinical characteristic and treatment of breast cancer patients with interstitial lung disease. Oncology Progress. 2024-Feb;22 (3):257-61.$64$YR$A$F$Y$$$20240728$$HP$CN$CN
241444621$24144462$1$I$$20240715$20240728$20240728$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092661$GLENMARK$Rothman RL, Stewart TG, Mourad A, Boulware DR, McCarthy MW, Thicklin F, et. al.. Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial.. medRxiv. 2024;1-26$$$$$Y$$$20240728$$MD$US$US
241444631$24144463$1$I$20240715$20240716$20240728$20240728$PER$$US-RDY-SPO/USA/24/0010544$DR REDDYS$$73$YR$E$M$Y$102$KG$20240728$$CN$US$US
241444641$24144464$1$I$$20240716$20240728$20240728$EXP$$IT-RDY-LIT/ITA/24/0010792$DR REDDYS$Di Renzo N, Dargenio NM, Sgherza N, Federico PV, Fina MP, Matera R, et al. REAL-WORLD DATA WITH LENALIDOMIDE AS MAINTENANCE THERAPY FOR PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: THE EXPERIENCE OF THE RETE EMATOLOGICA PUGLIESE (REP). Haematologica. 2024 Apr;109: 26-27.$$$$$Y$$$20240728$$HP$IT$IT
241444651$24144465$1$I$$20240715$20240728$20240728$PER$$US-RDY-SPO/USA/24/0010563$DR REDDYS$$$$$F$Y$$$20240728$$CN$US$US
241444661$24144466$1$I$20161101$20240717$20240728$20240728$EXP$$CN-ROCHE-3001440$ROCHE$$69$YR$E$M$Y$58$KG$20240728$$CN$CN$CN
241444671$24144467$1$I$$20240716$20240728$20240728$EXP$$IT-RDY-LIT/ITA/24/0010793$DR REDDYS$Di Renzo N, Dargenio NM, Sgherza N, Federico PV, Fina MP, Matera R, et al. REAL-WORLD DATA WITH LENALIDOMIDE AS MAINTENANCE THERAPY FOR PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: THE EXPERIENCE OF THE RETE EMATOLOGICA PUGLIESE (REP). Haematologica. 2024 Apr;109: 26-27.$$$$$Y$$$20240728$$HP$IT$IT
241444683$24144468$3$F$20210920$20240821$20240728$20240827$PER$$US-009507513-2407USA011951$MERCK$$38$YR$$F$Y$250$KG$20240827$$HP$US$US
241444691$24144469$1$I$$20240725$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016992$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240728$$CN$US$US
241444701$24144470$1$I$20240101$20240710$20240728$20240728$PER$$US-APOTEX-2024AP008297$APOTEX$$$$$F$Y$$$20240728$$CN$US$US
241444711$24144471$1$I$$20240725$20240728$20240728$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118591$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240728$$HP$US$US
241444722$24144472$2$F$20070608$20240716$20240728$20240801$EXP$$FR-009507513-0707FRA00039$MERCK$$$$$F$Y$$$20240801$$HP$FR$FR
241444731$24144473$1$I$20240722$20240723$20240728$20240728$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117969$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240728$$PH$US$US
241444742$24144474$2$F$20240723$20240904$20240728$20240911$PER$$US-AstraZeneca-2024A169386$ASTRAZENECA$$18807$DY$$M$Y$$$20240911$$CN$US$
241444751$24144475$1$I$$20240723$20240728$20240728$PER$$US-SA-2024SA219198$SANOFI AVENTIS$$$$A$M$Y$$$20240728$$MD$US$US
241444762$24144476$2$F$$20240902$20240728$20240903$PER$$US-AstraZeneca-2024A170719$ASTRAZENECA$$$$$$Y$$$20240903$$MD$US$
241444771$24144477$1$I$$20240715$20240728$20240728$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092662$GLENMARK$Rothman RL, Stewart TG, Mourad A, Boulware DR, McCarthy MW, Thicklin F, et. al.. Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial.. medRxiv.. 2024;1-26$$$$$Y$$$20240728$$MD$US$US
241444781$24144478$1$I$$20240725$20240728$20240728$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118626$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240728$$HP$US$US
241444791$24144479$1$I$20240425$20240717$20240728$20240728$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024049444$VIIV$$24$YR$$M$Y$$$20240728$$MD$US$US
241444801$24144480$1$I$$20240725$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407017146$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240728$$CN$US$US
241444811$24144481$1$I$20240705$20240724$20240728$20240728$EXP$GB-MHRA-MED-202407241145264890-DBKYG$GB-ABBVIE-5852182$ABBVIE$$$$$$Y$$$20240728$$PH$GB$GB
241444822$24144482$2$F$20240601$20240805$20240728$20240814$EXP$$FR-SA-2024SA214851$SANOFI AVENTIS$$52$YR$A$F$Y$60$KG$20240814$$MD$FR$FR
241444831$24144483$1$I$20240101$20240719$20240728$20240728$PER$$US-SA-2024SA218129$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240728$$MD$US$US
241444841$24144484$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA218176$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240728$$MD$US$US
241444851$24144485$1$I$20230601$20240722$20240728$20240728$EXP$$US-ABBVIE-5850521$ABBVIE$$69$YR$$F$Y$$$20240728$$CN$US$US
241444861$24144486$1$I$20240701$20240718$20240728$20240728$EXP$$US-VIIV HEALTHCARE LIMITED-US2024090608$VIIV$$60$YR$$M$Y$$$20240728$$CN$US$US
241444871$24144487$1$I$20240101$20240725$20240728$20240728$EXP$$US-ABBVIE-5855801$ABBVIE$$$$$F$Y$$$20240728$$CN$US$US
241444881$24144488$1$I$$20240724$20240728$20240728$EXP$$US-ABBVIE-5854110$ABBVIE$$$$$M$Y$$$20240728$$CN$US$US
241444891$24144489$1$I$$20240723$20240728$20240728$PER$$US-ROCHE-10000035118$ROCHE$$$$$$Y$$$20240728$$PH$US$US
241444901$24144490$1$I$20240620$20240722$20240728$20240728$EXP$$US-ABBVIE-5855834$ABBVIE$$88$YR$$F$Y$$$20240728$$HP$US$US
241444911$24144491$1$I$$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407015939$ELI LILLY AND CO$$$$$M$Y$$$20240728$$CN$US$US
241444921$24144492$1$I$20240501$20240722$20240728$20240728$EXP$$US-ABBVIE-5851627$ABBVIE$$62$YR$$F$Y$$$20240728$$CN$US$US
241444951$24144495$1$I$$20240724$20240728$20240728$PER$$US-AstraZeneca-2024A169111$ASTRAZENECA$$$$$F$Y$$$20240728$$CN$US$
241444961$24144496$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA217779$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240728$$MD$US$US
241444971$24144497$1$I$$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407015957$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240728$$CN$US$US
241444983$24144498$3$F$20230101$20240927$20240728$20240930$EXP$$NVSC2024CA151109$NOVARTIS$$$$$F$Y$$$20240930$$MD$CA$CA
241444991$24144499$1$I$$20240718$20240728$20240728$30DAY$$US-GSK-US2024090753$GLAXOSMITHKLINE$$$$$F$Y$$$20240728$$CN$US$US
241445001$24144500$1$I$20240101$20240718$20240728$20240728$PER$$US-SA-2024SA216136$SANOFI AVENTIS$$50$YR$A$F$Y$93$KG$20240728$$MD$US$US
241445021$24144502$1$I$$20240718$20240728$20240728$30DAY$$US-GSK-US2024090771$GLAXOSMITHKLINE$$$$$F$Y$$$20240728$$HP$US$US
241445031$24144503$1$I$$20240723$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016546$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240728$$CN$US$US
241445041$24144504$1$I$20240401$20240722$20240728$20240728$PER$$US-SA-2024SA216257$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240728$$CN$US$US
241445053$24144505$3$F$20240101$20240903$20240728$20240911$PER$$US-SA-2024SA218877$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240911$$MD$US$US
241445071$24144507$1$I$$20240719$20240728$20240728$PER$$US-SA-2024SA216168$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240728$$MD$US$US
241445081$24144508$1$I$$20240723$20240728$20240728$PER$$US-SA-2024SA218605$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240728$$MD$US$US
241445091$24144509$1$I$$20240722$20240728$20240728$EXP$$PH-SA-2024SA209053$SANOFI AVENTIS$Legaspi LA, Igot MO, Fernando G.. Rare Metastatic Primary Intra-Abdominal Follicular Dendritic Cell Sarcoma Poorly Responsive to Chemotherapy: A Case Report.. Phillippine Journal of Internal Medicine. 2024;62(1):308-13$33$YR$A$F$Y$$$20240728$$MD$PH$PH
241445101$24144510$1$I$20240710$20240722$20240728$20240728$EXP$GB-MHRA-MED-202407221710403620-ZPDQF$GB-SA-2024SA215581$SANOFI AVENTIS$$$$$M$Y$$$20240728$$HP$GB$GB
241445111$24144511$1$I$$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016133$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240728$$CN$US$US
241445121$24144512$1$I$$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407015988$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240728$$CN$US$US
241445131$24144513$1$I$$20240717$20240728$20240728$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22301$SAMSUNG BIOEPIS$$46$YR$A$M$Y$134$KG$20240728$$CN$CA$CA
241445141$24144514$1$I$$20240716$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407010826$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240728$$CN$US$US
241445151$24144515$1$I$$20240717$20240728$20240728$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22300$SAMSUNG BIOEPIS$$66$YR$E$F$Y$$$20240728$$CN$CA$CA
241445161$24144516$1$I$20240101$20240722$20240728$20240728$PER$$US-SA-2024SA216077$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240728$$CN$US$US
241445171$24144517$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA217787$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240728$$MD$US$US
241445181$24144518$1$I$$20240719$20240728$20240728$PER$$US-SA-2024SA217839$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240728$$MD$US$US
241445232$24144523$2$F$20220201$20240730$20240728$20240809$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-22458$SAMSUNG BIOEPIS$$52$YR$A$F$Y$101$KG$20240809$$HP$AU$AU
241445241$24144524$1$I$20240712$20240717$20240728$20240728$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22520$SAMSUNG BIOEPIS$$21$YR$A$M$Y$134$KG$20240728$$HP$CA$CA
241445251$24144525$1$I$20240101$20240717$20240728$20240728$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22441$SAMSUNG BIOEPIS$$65$YR$E$M$Y$$$20240728$$CN$CA$CA
241445262$24144526$2$F$20240717$20240718$20240728$20240730$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22488$SAMSUNG BIOEPIS$$71$YR$E$F$Y$$$20240730$$CN$CA$CA
241445271$24144527$1$I$$20240723$20240728$20240728$PER$$US-AstraZeneca-2024A168656$ASTRAZENECA$$$$$F$Y$57.6$KG$20240728$$CN$US$
241445282$24144528$2$F$$20240718$20240728$20240912$PER$$US-SA-2024SA213982$SANOFI AVENTIS$$$$$F$Y$$$20240912$$CN$US$US
241445301$24144530$1$I$$20240719$20240728$20240728$PER$$US-SA-2024SA216024$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240728$$CN$US$US
241445311$24144531$1$I$$20240718$20240728$20240728$PER$$US-SA-2024SA214000$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240728$$CN$US$US
241445321$24144532$1$I$$20240718$20240728$20240728$PER$$US-SA-2024SA213736$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240728$$CN$US$US
241445331$24144533$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA216878$SANOFI AVENTIS$$$$A$F$Y$$$20240728$$CN$US$US
241445341$24144534$1$I$20240628$20240719$20240728$20240728$PER$$US-SA-2024SA216143$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240728$$MD$US$US
241445351$24144535$1$I$$20240723$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407015257$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240728$$CN$US$US
241445371$24144537$1$I$20240701$20240719$20240728$20240728$PER$$US-SA-2024SA218124$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240728$$PH$US$US
241445411$24144541$1$I$20240722$20240722$20240728$20240728$PER$$US-AstraZeneca-2024A166963$ASTRAZENECA$$28830$DY$$$Y$$$20240728$$CN$US$
241445421$24144542$1$I$$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016139$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240728$$CN$US$US
241445451$24144545$1$I$20240101$20240719$20240728$20240728$PER$$US-SA-2024SA216824$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240728$$CN$US$US
241445461$24144546$1$I$$20240703$20240728$20240728$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106597$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240728$$PH$US$US
241445481$24144548$1$I$$20240722$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407014412$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240728$$CN$US$US
241445491$24144549$1$I$20240621$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016153$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240728$$CN$US$US
241445501$24144550$1$I$$20240719$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407013691$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240728$$CN$US$US
241445542$24144554$2$F$20240720$20240731$20240728$20240808$PER$$US-HETERO-HET2024US02417$HETERO$$3$YR$$M$Y$$$20240808$$CN$US$US
241445611$24144561$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA217949$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240728$$MD$US$US
241445642$24144564$2$F$20240101$20240801$20240728$20240806$PER$$US-AMGEN-USASP2024146712$AMGEN$$77$YR$E$F$Y$79.819$KG$20240806$$CN$US$US
241445651$24144565$1$I$$20240724$20240728$20240728$EXP$$US-AMAROX PHARMA-HET2024US02292$HETERO$$$$$$Y$$$20240728$$CN$US$US
241445701$24144570$1$I$20240710$20240722$20240728$20240728$PER$$CN-Eisai-EC-2024-170684$EISAI$$52$YR$A$F$Y$$$20240728$$HP$CN$CN
241445711$24144571$1$I$$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016127$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240728$$HP$US$US
241445772$24144577$2$F$20240101$20240903$20240728$20240903$PER$$US-ALXN-202407USA001460US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
241445802$24144580$2$F$20240319$20240729$20240728$20240802$EXP$$NVSC2024EG075538$NOVARTIS$$46$YR$$F$Y$$$20240802$$CN$EG$EG
241445811$24144581$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA217656$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240729$$MD$US$US
241445821$24144582$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA217665$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240729$$MD$US$US
241445831$24144583$1$I$$20240724$20240728$20240728$EXP$$JP-SAKK-2024SA205033AA$SANOFI AVENTIS$$70$YR$E$F$Y$45$KG$20240729$$MD$JP$JP
241445841$24144584$1$I$20240101$20240724$20240728$20240728$EXP$$NVSJ2024JP007287$NOVARTIS$$$$E$F$Y$$$20240729$$PH$JP$JP
241445851$24144585$1$I$20240101$20240722$20240728$20240728$EXP$$US-ABBVIE-5851453$ABBVIE$$$$$M$Y$$$20240728$$CN$US$US
241445862$24144586$2$F$20230101$20240722$20240728$20240805$EXP$$CA-ABBVIE-5851011$ABBVIE$$56$YR$$F$Y$$$20240805$$CN$CA$CA
241445871$24144587$1$I$20240101$20240723$20240728$20240728$EXP$$CO-ABBVIE-5854758$ABBVIE$$$$$F$Y$77$KG$20240728$$CN$CO$CO
241445881$24144588$1$I$20240601$20240722$20240728$20240728$PER$$US-SA-2024SA217679$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240729$$MD$US$US
241445891$24144589$1$I$$20240724$20240728$20240728$30DAY$$US-SANDOZ INC.-SDZ2023US018933$SANDOZ$$$$$F$Y$$$20240728$$PH$US$US
241445901$24144590$1$I$$20240723$20240728$20240728$30DAY$$US-SANDOZ INC.-SDZ2023US034016$SANDOZ$$$$$M$Y$$$20240728$$CN$US$US
241445912$24144591$2$F$20240101$20240830$20240728$20240908$EXP$$US-SANDOZ INC.-SDZ2024US068544$SANDOZ$$$$$F$Y$52.6$KG$20240908$$CN$US$US
241445921$24144592$1$I$$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016296$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240728$$CN$US$US
241445931$24144593$1$I$$20240719$20240728$20240728$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118147$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240729$$MD$JP$JP
241445941$24144594$1$I$20240722$20240724$20240728$20240728$30DAY$$US-SANDOZ INC.-SDZ2024US068070$SANDOZ$$9$YR$$M$Y$$$20240728$$CN$US$US
241445951$24144595$1$I$$20240726$20240728$20240728$PER$$NVSC2024US153856$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241445961$24144596$1$I$20240101$20240724$20240728$20240728$EXP$$US-SANDOZ INC.-SDZ2024US068408$SANDOZ$$$$$M$Y$$$20240728$$CN$US$US
241445971$24144597$1$I$$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016392$ELI LILLY AND CO$$$$$F$Y$$$20240728$$CN$US$US
241445981$24144598$1$I$20240719$20240719$20240728$20240728$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2159693$JIANGSU HENGRUI MEDICINE$$68$YR$$F$Y$55$KG$20240728$$MD$CN$CN
241445991$24144599$1$I$$20240716$20240728$20240728$PER$$US-JNJFOC-20240758414$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$CN$US$US
241446001$24144600$1$I$$20240716$20240728$20240728$PER$$US-ABBVIE-5851662$ABBVIE$$$$$F$Y$$$20240728$$CN$US$US
241446013$24144601$3$F$20240719$20240822$20240728$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115717$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$MD$JP$JP
241446021$24144602$1$I$$20240719$20240728$20240728$PER$$US-ABBVIE-5848884$ABBVIE$$$$$$Y$$$20240728$$CN$US$US
241446032$24144603$2$F$20230301$20240806$20240728$20240806$EXP$$NVSJ2024JP009038$NOVARTIS$$$$E$F$Y$$$20240807$$MD$JP$JP
241446041$24144604$1$I$20240101$20240722$20240728$20240728$EXP$$US-ABBVIE-5855606$ABBVIE$$$$$M$Y$$$20240728$$CN$US$US
241446051$24144605$1$I$20230101$20240717$20240728$20240728$EXP$$US-ABBVIE-5399080$ABBVIE$$$$$F$Y$$$20240728$$CN$US$US
241446061$24144606$1$I$20240601$20240723$20240728$20240728$EXP$$JP-ABBVIE-5854722$ABBVIE$$$$E$M$Y$$$20240728$$MD$JP$JP
241446071$24144607$1$I$$20240724$20240728$20240728$30DAY$$US-SANDOZ INC.-SDZ2024US068158$SANDOZ$$$$$F$Y$$$20240728$$CN$US$US
241446081$24144608$1$I$$20240722$20240728$20240728$EXP$$US-ABBVIE-5825013$ABBVIE$$$$$F$Y$$$20240728$$CN$US$US
241446091$24144609$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-116588$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241446101$24144610$1$I$20240701$20240719$20240728$20240728$PER$$US-BAUSCHBL-2024BNL030407$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240729$$CN$US$US
241446111$24144611$1$I$20240101$20240722$20240728$20240728$EXP$$US-BAUSCHBL-2024BNL030557$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240729$$CN$US$US
241446131$24144613$1$I$20230201$20240724$20240728$20240728$EXP$$EU-BAUSCHBL-2024BNL030618$BAUSCH AND LOMB$$58$YR$$F$Y$$$20240729$$MD$EU$EU
241446141$24144614$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-117453$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241446151$24144615$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115627$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241446161$24144616$1$I$20240718$20240723$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407016772$ELI LILLY AND CO$$$$A$F$Y$$$20240728$$CN$US$US
241446171$24144617$1$I$$20240723$20240728$20240728$PER$$US-SA-2024SA218928$SANOFI AVENTIS$$12$YR$T$M$Y$54$KG$20240729$$HP$US$US
241446181$24144618$1$I$$20240719$20240728$20240728$PER$$US-SA-2024SA217304$SANOFI AVENTIS$$62$YR$A$F$Y$60.3$KG$20240729$$MD$US$US
241446191$24144619$1$I$20240601$20240718$20240728$20240728$PER$$US-SA-2024SA217619$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240729$$MD$US$US
241446201$24144620$1$I$20240717$20240718$20240728$20240728$PER$$US-SA-2024SA217646$SANOFI AVENTIS$$35$YR$A$F$Y$83.9$KG$20240729$$MD$US$US
241446211$24144621$1$I$$20240723$20240728$20240728$PER$$US-SA-2024SA218674$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240729$$MD$US$US
241446221$24144622$1$I$$20240722$20240728$20240728$EXP$$JP-GSK-JP2024JPN092075$GLAXOSMITHKLINE$$$$$$Y$$$20240728$$MD$JP$JP
241446243$24144624$3$F$20240101$20240809$20240728$20240813$EXP$$US-ABBVIE-5852043$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
241446251$24144625$1$I$20240611$20240724$20240728$20240728$EXP$$US-ABBVIE-5853764$ABBVIE$$59$YR$$F$Y$$$20240728$$CN$US$US
241446261$24144626$1$I$20240718$20240724$20240728$20240728$EXP$$AU-ABBVIE-5853328$ABBVIE$$85$YR$$M$Y$90$KG$20240728$$CN$AU$AU
241446271$24144627$1$I$$20240719$20240728$20240728$EXP$$US-ABBVIE-5849924$ABBVIE$$$$$F$Y$$$20240728$$CN$US$US
241446282$24144628$2$F$$20240813$20240728$20240820$EXP$$DE-ABBVIE-5853279$ABBVIE$$$$$M$Y$$$20240820$$CN$DE$DE
241446291$24144629$1$I$$20240724$20240728$20240728$EXP$$CA-ABBVIE-5853689$ABBVIE$$$$E$M$Y$$$20240728$$CN$CA$CA
241446301$24144630$1$I$20240101$20240723$20240728$20240728$EXP$$US-ABBVIE-5853106$ABBVIE$$$$$M$Y$$$20240728$$CN$US$US
241446311$24144631$1$I$$20240725$20240728$20240728$PER$$US-AstraZeneca-2024A170701$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241446321$24144632$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118208$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241446331$24144633$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115598$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241446341$24144634$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118214$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241446351$24144635$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118268$BRISTOL MYERS SQUIBB$Literature citation unavailable.$$$$$Y$$$20240729$$HP$CA$CA
241446362$24144636$2$F$$20240729$20240728$20240805$EXP$$US-ABBVIE-5853577$ABBVIE$$$$$M$Y$$$20240804$$CN$US$US
241446371$24144637$1$I$$20240719$20240728$20240728$PER$$US-SA-2024SA217362$SANOFI AVENTIS$$42$YR$A$F$Y$46.7$KG$20240729$$MD$US$US
241446381$24144638$1$I$$20240719$20240728$20240728$PER$$US-SA-2024SA217355$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240729$$MD$US$US
241446391$24144639$1$I$20240101$20240723$20240728$20240728$PER$$US-SA-2024SA218934$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240729$$MD$US$US
241446401$24144640$1$I$$20240725$20240728$20240728$30DAY$$US-SANDOZ INC.-SDZ2024US068362$SANDOZ$$$$$M$Y$$$20240728$$CN$US$US
241446412$24144641$2$F$20240304$20240813$20240728$20240819$EXP$$NVSJ2024JP009035$NOVARTIS$$30$YR$$F$Y$46$KG$20240819$$MD$JP$JP
241446421$24144642$1$I$20240601$20240723$20240728$20240728$EXP$$US-009507513-2407USA013374$MERCK$$$$A$F$Y$$$20240728$$MD$US$US
241446431$24144643$1$I$$20240718$20240728$20240728$PER$$US-ABBVIE-5852429$ABBVIE$$$$$F$Y$$$20240728$$CN$US$US
241446441$24144644$1$I$$20240724$20240728$20240728$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118260$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240729$$CN$US$US
241446451$24144645$1$I$20240701$20240723$20240728$20240728$EXP$$JP-009507513-2407JPN004165J$MERCK$$60$YR$$F$Y$$$20240728$$PH$JP$JP
241446461$24144646$1$I$$20240725$20240728$20240728$PER$$US-HALEON-2189058$Haleon PLC$$$$$$Y$$$20240728$$CN$US$US
241446471$24144647$1$I$20240101$20240722$20240728$20240728$EXP$$US-ABBVIE-5852178$ABBVIE$$$$$M$Y$$$20240728$$CN$US$US
241446481$24144648$1$I$20240625$20240724$20240728$20240728$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118447$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240729$$CN$US$US
241446492$24144649$2$F$$20240816$20240728$20240821$EXP$$BR-BEIGENE-BGN-2024-011428$BEIGENE$$$$$$Y$$$20240821$$MD$BR$BR
241446501$24144650$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118250$BRISTOL MYERS SQUIBB$Literature citation unavailable.$$$$$Y$$$20240729$$HP$CA$CA
241446511$24144651$1$I$$20240709$20240728$20240728$30DAY$$US-JNJFOC-20240750186$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$CN$US$US
241446521$24144652$1$I$20240101$20240724$20240728$20240728$EXP$$US-ABBVIE-5852636$ABBVIE$$$$$F$Y$$$20240728$$CN$US$US
241446531$24144653$1$I$20201104$20240718$20240728$20240728$EXP$$US-JNJFOC-20240772239$JOHNSON AND JOHNSON$$57$YR$A$M$Y$71.3$KG$20240729$$MD$US$US
241446541$24144654$1$I$20240723$20240724$20240728$20240728$PER$$US-SA-2024SA218828$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240729$$CN$US$US
241446551$24144655$1$I$$20240719$20240728$20240728$PER$$US-SA-2024SA217405$SANOFI AVENTIS$$$$E$M$Y$$$20240729$$MD$US$US
241446562$24144656$2$F$20240724$20240819$20240728$20240822$EXP$$CA-ABBVIE-5854597$ABBVIE$$69$YR$$F$Y$$$20240822$$CN$CA$CA
241446572$24144657$2$F$20240101$20240813$20240728$20240816$EXP$$CO-ABBVIE-5856288$ABBVIE$$$$$F$Y$66$KG$20240816$$CN$CO$CO
241446581$24144658$1$I$20230601$20240725$20240728$20240728$EXP$$AR-ABBVIE-5856332$ABBVIE$$65$YR$$F$Y$$$20240728$$CN$AR$AR
241446591$24144659$1$I$$20240718$20240728$20240728$EXP$$GB-ABBVIE-5854783$ABBVIE$Erblich T, Manisty C, Gribben J. Pericarditis and cardiac tamponade in patients treated with first and second generation bruton tyrosine kinase inhibitors: an underappreciated risk. Reikvam H, editor. Case Reports in Hematology. 2024;2024(1):2312182.$80$YR$$F$Y$$$20240728$$HP$GB$GB
241446601$24144660$1$I$20230501$20240718$20240728$20240728$PER$$US-SA-2024SA218063$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240729$$MD$US$US
241446612$24144661$2$F$20240101$20240827$20240728$20240916$PER$$US-SA-2024SA217410$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240916$$MD$US$US
241446632$24144663$2$F$$20240925$20240728$20240927$EXP$$JP-TAKEDA-2024TJP011271$TAKEDA$$6$DEC$$F$Y$$$20240927$$MD$JP$JP
241446642$24144664$2$F$20240716$20240805$20240728$20240812$EXP$$BR-PFIZER INC-202400222775$PFIZER$$53$YR$$M$Y$72.1$KG$20240812$$PH$BR$BR
241446651$24144665$1$I$20240101$20240725$20240728$20240728$EXP$$AU-PFIZER INC-PV202400097086$PFIZER$$79$YR$$M$Y$$$20240728$$CN$AU$AU
241446661$24144666$1$I$20181116$20240719$20240728$20240728$EXP$$TW-AMGEN-TWNSP2024146837$AMGEN$$$$E$M$Y$$$20240728$$HP$TW$TW
241446671$24144667$1$I$$20240719$20240728$20240728$PER$$US-SA-2024SA217371$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
241446681$24144668$1$I$$20240719$20240728$20240728$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118148$BRISTOL MYERS SQUIBB$$60$YR$A$$Y$$$20240729$$MD$JP$JP
241446691$24144669$1$I$$20240724$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407015948$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240728$$CN$US$US
241446701$24144670$1$I$$20240723$20240728$20240728$EXP$$IE-TAKEDA-2024TUS075439$TAKEDA$$$$$$Y$$$20240728$$MD$IE$IE
241446711$24144671$1$I$20240701$20240723$20240728$20240728$EXP$$US-ABBVIE-5852383$ABBVIE$$60$YR$$M$Y$$$20240728$$CN$US$US
241446724$24144672$4$F$20240801$20240819$20240728$20240826$PER$$US-SA-2024SA217958$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240826$$MD$US$US
241446731$24144673$1$I$$20240725$20240728$20240728$EXP$$DK-ABBVIE-5856126$ABBVIE$$$$$F$Y$$$20240728$$HP$DK$DK
241446741$24144674$1$I$20240701$20240719$20240728$20240728$PER$$US-SA-2024SA217461$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240729$$MD$US$US
241446762$24144676$2$F$$20240809$20240728$20240815$EXP$$JP-GSK-JP2024JPN091459$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$PH$JP$JP
241446771$24144677$1$I$$20240719$20240728$20240728$PER$$US-ABBVIE-5849631$ABBVIE$$$$$F$Y$$$20240728$$HP$US$US
241446781$24144678$1$I$20240515$20240724$20240728$20240728$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119029$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240729$$CN$US$US
241446792$24144679$2$F$20230101$20240918$20240728$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118167$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240927$$MD$JP$JP
241446801$24144680$1$I$$20240724$20240728$20240728$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118428$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240729$$CN$US$US
241446811$24144681$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118226$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241446821$24144682$1$I$$20240725$20240728$20240728$PER$$US-ABBVIE-5856731$ABBVIE$$$$$M$Y$$$20240728$$HP$US$US
241446832$24144683$2$F$20240621$20240813$20240728$20240820$EXP$$SK-BIOGEN-2024BI01275418$BIOGEN$$43$YR$$F$Y$$$20240820$$MD$SK$SK
241446842$24144684$2$F$20240719$20240905$20240728$20240912$EXP$$TN-BIOGEN-2024BI01275238$BIOGEN$$15$YR$$F$Y$$$20240912$$MD$TN$TN
241446851$24144685$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118242$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241446861$24144686$1$I$$20240725$20240728$20240728$EXP$NL-LRB-00993217$NL-JNJFOC-20240774747$JOHNSON AND JOHNSON$$91$YR$E$M$Y$$$20240729$$MD$NL$NL
241446871$24144687$1$I$$20240709$20240728$20240728$PER$$US-ELI_LILLY_AND_COMPANY-US202407006001$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240728$$CN$US$US
241446881$24144688$1$I$$20240719$20240728$20240728$PER$$US-SA-2024SA212765$SANOFI AVENTIS$$$$$$Y$$$20240729$$MD$US$US
241446891$24144689$1$I$20240724$20240724$20240728$20240728$PER$$US-SA-2024SA218762$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240729$$CN$US$US
241446901$24144690$1$I$$20240725$20240728$20240728$EXP$$CZ-ABBVIE-5855644$ABBVIE$$$$$F$Y$$$20240728$$HP$CZ$CZ
241446911$24144691$1$I$20240101$20240724$20240728$20240728$EXP$$US-ABBVIE-5739540$ABBVIE$$$$$F$Y$$$20240728$$CN$US$US
241446921$24144692$1$I$20240101$20240724$20240728$20240728$EXP$$US-ABBVIE-5853910$ABBVIE$$$$$M$Y$$$20240728$$CN$US$US
241446931$24144693$1$I$20240628$20240722$20240728$20240728$PER$$US-ABBVIE-5850442$ABBVIE$$22$YR$$F$Y$$$20240728$$HP$US$US
241446942$24144694$2$F$20240101$20240824$20240728$20240829$EXP$$CA-ABBVIE-5855623$ABBVIE$$73$YR$$F$Y$$$20240829$$CN$CA$CA
241446952$24144695$2$F$$20240729$20240728$20240805$EXP$$JP-SA-2024SA213846$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240805$$MD$JP$JP
241446961$24144696$1$I$20240101$20240724$20240728$20240728$EXP$$NL-ABBVIE-5856055$ABBVIE$$$$E$M$Y$$$20240728$$CN$NL$NL
241446971$24144697$1$I$$20240726$20240728$20240728$PER$$US-JNJFOC-20240773621$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$MD$US$US
241446981$24144698$1$I$20240622$20240719$20240728$20240728$EXP$$CN-Shanghai Hengrui Pharmaceutical Co., Ltd.-2159694$SHANGHAI HENGRUI PHARMACEUTICAL$$9$DY$$M$Y$2$KG$20240728$$MD$CN$CN
241446992$24144699$2$F$20240524$20240827$20240728$20240902$EXP$$US-JNJFOC-20240764622$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240902$$HP$US$US
241447001$24144700$1$I$20240528$20240719$20240728$20240728$EXP$$CN-BEIGENE-BGN-2024-011271$BEIGENE$$$$$$Y$$$20240728$$HP$CN$CN
241447012$24144701$2$F$20240607$20240726$20240728$20240730$PER$$NVSC2024US153525$NOVARTIS$$38$YR$$F$Y$$$20240730$$CN$US$US
241447021$24144702$1$I$20230101$20240722$20240728$20240728$EXP$$US-ABBVIE-5852219$ABBVIE$$$$$F$Y$$$20240728$$CN$US$US
241447033$24144703$3$F$$20240919$20240728$20240925$EXP$$JP-GSK-JP2024091556$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$JP$JP
241447041$24144704$1$I$$20240719$20240728$20240728$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118149$BRISTOL MYERS SQUIBB$$55$YR$A$$Y$$$20240729$$MD$JP$JP
241447051$24144705$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-117390$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241447061$24144706$1$I$20240101$20240725$20240728$20240728$PER$$US-AMGEN-USASP2024149017$AMGEN$$75$YR$E$F$Y$$$20240728$$CN$US$US
241447071$24144707$1$I$20240101$20240723$20240728$20240728$EXP$$US-ABBVIE-5853726$ABBVIE$$$$$F$Y$$$20240728$$CN$US$US
241447081$24144708$1$I$$20240719$20240728$20240728$EXP$$US-APOTEX-2024AP008747$APOTEX$Liu Z, Oktaei H.. A Rare Case of Necrotizing Myopathy after Statin Use. Journal of the Endocrine Society. 2022;6 (Suppl. 1):A237-A238$35$YR$$M$Y$$$20240728$$HP$US$US
241447091$24144709$1$I$$20240725$20240728$20240728$EXP$$US-PFIZER INC-202400224196$PFIZER$$77$YR$$F$Y$$$20240728$$CN$US$US
241447103$24144710$3$F$$20240919$20240728$20240919$EXP$$CA-PFIZER INC-202400224637$PFIZER$$59$YR$$F$Y$$$20240919$$HP$CA$CA
241447112$24144711$2$F$20240722$20240816$20240728$20240819$EXP$$US-PFIZER INC-PV202400097688$PFIZER$$61$YR$$M$Y$$$20240819$$HP$US$US
241447121$24144712$1$I$$20240723$20240728$20240728$EXP$$US-SANDOZ INC.-SDZ2024US068387$SANDOZ$$$$$F$Y$$$20240728$$MD$US$US
241447131$24144713$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-117376$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241447151$24144715$1$I$$20240722$20240728$20240728$EXP$$US-ABBVIE-5851899$ABBVIE$$$$$F$Y$$$20240728$$CN$US$US
241447161$24144716$1$I$20210601$20240726$20240728$20240728$EXP$$GB-JNJFOC-20240772592$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$HP$GB$GB
241447173$24144717$3$F$$20240917$20240728$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003246$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241447183$24144718$3$F$$20240909$20240728$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003247$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241447202$24144720$2$F$$20240729$20240728$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003250$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
241447211$24144721$1$I$20240626$20240722$20240728$20240728$EXP$$US-ABBVIE-5851551$ABBVIE$$61$YR$$F$Y$$$20240728$$CN$US$US
241447221$24144722$1$I$$20240705$20240728$20240728$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003249$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241447231$24144723$1$I$20240601$20240720$20240728$20240728$PER$$US-SA-2024SA217315$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240729$$MD$US$US
241447241$24144724$1$I$$20240705$20240728$20240728$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003251$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241447251$24144725$1$I$$20240724$20240728$20240728$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119106$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240729$$CN$US$US
241447261$24144726$1$I$$20240719$20240728$20240728$PER$$US-SA-2024SA217712$SANOFI AVENTIS$$60$YR$A$F$Y$67$KG$20240729$$MD$US$US
241447275$24144727$5$F$20240707$20240823$20240728$20240828$PER$$NVSC2024US153936$NOVARTIS$$70$YR$$M$Y$$$20240828$$HP$US$US
241447281$24144728$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118198$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241447291$24144729$1$I$$20240724$20240728$20240728$PER$$US-TAKEDA-2024TUS074792$TAKEDA$$$$$$Y$$$20240728$$CN$US$US
241447301$24144730$1$I$$20240722$20240728$20240728$PER$$US-SA-2024SA219057$SANOFI AVENTIS$$$$E$F$Y$$$20240729$$MD$US$US
241447321$24144732$1$I$$20240722$20240728$20240728$PER$$US-TAKEDA-2024TUS074444$TAKEDA$$$$$$Y$$$20240728$$CN$US$US
241447331$24144733$1$I$$20240719$20240728$20240728$PER$$US-ABBVIE-5852220$ABBVIE$$$$$$Y$$$20240728$$HP$US$US
241447341$24144734$1$I$$20240723$20240728$20240728$EXP$$US-ABBVIE-5851581$ABBVIE$$$$$M$Y$$$20240728$$CN$US$US
241447351$24144735$1$I$$20240724$20240728$20240728$EXP$$JP-ASTELLAS-2024JP005314$ASTELLAS$$84$YR$$M$Y$$$20240729$$MD$JP$JP
241447361$24144736$1$I$$20240724$20240728$20240728$EXP$$US-ASTELLAS-2024EU007413$ASTELLAS$$$$$M$Y$$$20240729$$CN$US$US
241447371$24144737$1$I$$20240718$20240728$20240728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115661$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241447381$24144738$1$I$$20240725$20240728$20240728$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119046$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240729$$CN$US$US
241447391$24144739$1$I$$20240705$20240728$20240728$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003258$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241447402$24144740$2$F$$20240904$20240728$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003256$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241447411$24144741$1$I$20240719$20240724$20240728$20240728$EXP$$US-ABBVIE-5853932$ABBVIE$$63$YR$$F$Y$$$20240728$$CN$US$US
241447422$24144742$2$F$$20240819$20240729$20240902$PER$$US-AstraZeneca-2024A164832$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
241447431$24144743$1$I$$20240706$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003325$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241447441$24144744$1$I$20240101$20240722$20240729$20240729$PER$$US-SA-2024SA217928$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240729$$MD$US$US
241447451$24144745$1$I$20240712$20240722$20240729$20240729$PER$$US-ALXN-202407USA001462US$ALEXION PHARMACEUTICALS$$78$YR$$M$Y$$$20240729$$HP$US$US
241447461$24144746$1$I$20240101$20240723$20240729$20240729$EXP$$US-JNJFOC-20240768170$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240729$$HP$US$US
241447471$24144747$1$I$20231101$20240718$20240729$20240729$EXP$$JP-JNJFOC-20231266448$JOHNSON AND JOHNSON$$80$YR$E$M$Y$60.3$KG$20240729$$CN$JP$JP
241447481$24144748$1$I$$20240723$20240729$20240729$EXP$$US-JNJFOC-20240762968$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$MD$US$US
241447493$24144749$3$F$$20240905$20240729$20240912$EXP$$DE-ABBVIE-5850552$ABBVIE$$$$$M$Y$$$20240912$$CN$DE$DE
241447501$24144750$1$I$$20240726$20240729$20240729$PER$$NVSC2024US153965$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241447511$24144751$1$I$$20240723$20240729$20240729$PER$$US-TAKEDA-2024TUS074719$TAKEDA$$$$$$Y$$$20240729$$CN$US$US
241447521$24144752$1$I$$20240716$20240729$20240729$EXP$$US-Emmaus Medical, Inc.-EMM202407-000345$EMMAUS LIFE SCIENCES$$$$$M$Y$71$KG$20240729$$CN$US$
241447531$24144753$1$I$$20240725$20240729$20240729$PER$$US-TAKEDA-2024TUS075368$TAKEDA$$$$$M$Y$64$KG$20240729$$MD$US$US
241447542$24144754$2$F$20240601$20240812$20240729$20240815$EXP$$PT-ABBVIE-5853555$ABBVIE$$79$YR$$F$Y$$$20240815$$HP$PT$PT
241447551$24144755$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092119$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241447561$24144756$1$I$$20240719$20240729$20240729$EXP$$US-VIIV HEALTHCARE LIMITED-US2024091023$VIIV$$$$$F$Y$$$20240729$$CN$US$US
241447571$24144757$1$I$20240701$20240726$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042293$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240729$$CN$US$US
241447581$24144758$1$I$$20240725$20240729$20240729$PER$$NVSC2024US153660$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241447591$24144759$1$I$$20240719$20240729$20240729$EXP$$GB-SA-2024SA214662$SANOFI AVENTIS$$93$YR$E$F$Y$$$20240729$$MD$GB$GB
241447601$24144760$1$I$$20240723$20240729$20240729$EXP$$CA-SA-2024SA215881$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240729$$CN$CA$CA
241447611$24144761$1$I$$20240717$20240729$20240729$EXP$GB-MHRA-MED-202407171042467250-HLSVN$GB-LUPIN PHARMACEUTICALS INC.-2024-06965$LUPIN$$$$$$Y$$$20240729$$PH$GB$GB
241447623$24144762$3$F$20240101$20240828$20240729$20240911$PER$$US-SA-2024SA216535$SANOFI AVENTIS$$63$YR$A$M$Y$120.45$KG$20240911$$MD$US$US
241447631$24144763$1$I$20240101$20240722$20240729$20240729$PER$$US-SA-2024SA219064$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240729$$CN$US$US
241447641$24144764$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA217861$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$MD$US$US
241447651$24144765$1$I$$20240606$20240729$20240729$PER$$US-AUROBINDO-AUR-APL-2024-029506$AUROBINDO$$$$$F$Y$$$20240729$$CN$US$US
241447661$24144766$1$I$$20240430$20240729$20240729$PER$$US-AUROBINDO-AUR-APL-2024-029990$AUROBINDO$$$$$F$Y$$$20240729$$CN$US$US
241447671$24144767$1$I$20240724$20240724$20240729$20240729$PER$$US-SA-2024SA218693$SANOFI AVENTIS$$$$$F$Y$$$20240729$$HP$US$US
241447681$24144768$1$I$$20240724$20240729$20240729$EXP$$US-ABBVIE-5853917$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241447691$24144769$1$I$20240719$20240722$20240729$20240729$PER$$US-ALXN-202407USA001443US$ALEXION PHARMACEUTICALS$$16$YR$$F$Y$$$20240729$$CN$US$US
241447703$24144770$3$F$20240712$20240912$20240729$20240915$EXP$$CA-ABBVIE-5853543$ABBVIE$$79$YR$$F$Y$$$20240915$$CN$CA$CA
241447712$24144771$2$F$$20240822$20240729$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118828$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$69.4$KG$20240902$$HP$US$US
241447721$24144772$1$I$20240725$20240725$20240729$20240729$EXP$$AU-ABBVIE-5855624$ABBVIE$$72$YR$$M$Y$$$20240729$$HP$AU$AU
241447731$24144773$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA217612$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240729$$MD$US$US
241447741$24144774$1$I$20240701$20240719$20240729$20240729$PER$$US-SA-2024SA217607$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240729$$CN$US$US
241447753$24144775$3$F$20240819$20240826$20240729$20240831$EXP$$US-ABBVIE-5739362$ABBVIE$$81$YR$$M$Y$$$20240831$$CN$US$US
241447761$24144776$1$I$20240614$20240718$20240729$20240729$EXP$$CA-BEH-2024175982$CSL BEHRING$$21$YR$A$F$Y$102$KG$20240729$$CN$CA$CA
241447771$24144777$1$I$20240101$20240717$20240729$20240729$PER$$US-ABBVIE-5848686$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241447781$24144778$1$I$$20240715$20240729$20240729$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07163$LUPIN$$$$$$Y$$$20240729$$CN$AU$AU
241447791$24144779$1$I$$20240721$20240729$20240729$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001497$BLUEPRINT MEDICINES$$$$$F$Y$$$20240729$$CN$US$US
241447801$24144780$1$I$$20240721$20240729$20240729$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001498$BLUEPRINT MEDICINES$$$$$M$Y$$$20240729$$CN$US$US
241447812$24144781$2$F$20221027$20240813$20240729$20240819$EXP$$NVSJ2023JP011947$NOVARTIS$$51$YR$$M$Y$69.4$KG$20240820$$MD$JP$JP
241447821$24144782$1$I$$20240723$20240729$20240729$PER$$US-JNJFOC-20240762064$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$MD$US$US
241447832$24144783$2$F$$20240723$20240729$20240731$EXP$$US-JNJFOC-20240764540$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$HP$US$US
241447842$24144784$2$F$20240520$20240725$20240729$20240802$EXP$$CO-ABBVIE-5856289$ABBVIE$$68$YR$$M$Y$90$KG$20240802$$CN$CO$CO
241447851$24144785$1$I$$20240725$20240729$20240729$EXP$$IT-ABBVIE-5855924$ABBVIE$$77$YR$$M$Y$$$20240729$$CN$IT$IT
241447861$24144786$1$I$$20240720$20240729$20240729$EXP$GB-MHRA-MED-202407201036217040-FNMRV$GB-ESPERIONTHERAPEUTICS-2024GBR01168$ESPERION THERAPEUTICS$$82$YR$$M$Y$$$20240729$$PH$GB$GB
241447871$24144787$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA217664$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240729$$MD$US$US
241447881$24144788$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA217810$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240729$$MD$US$US
241447891$24144789$1$I$20240624$20240719$20240729$20240729$EXP$BE-FAMHP-DHH-N2024-122359$BE-ESPERIONTHERAPEUTICS-2024BEL01163$ESPERION THERAPEUTICS$$70$YR$$F$Y$$$20240729$$PH$BE$BE
241447901$24144790$1$I$20240318$20240718$20240729$20240729$EXP$GB-MHRA-MED-202407181650598410-CFMZJ$GB-ESPERIONTHERAPEUTICS-2024GBR01149$ESPERION THERAPEUTICS$$66$YR$$M$Y$$$20240729$$PH$GB$GB
241447911$24144791$1$I$20240630$20240722$20240729$20240729$EXP$GB-MHRA-MED-202407221735441280-BNMZF$GB-ESPERIONTHERAPEUTICS-2024GBR01166$ESPERION THERAPEUTICS$$71$YR$$F$Y$$$20240729$$CN$GB$GB
241447925$24144792$5$F$20240101$20240823$20240729$20240828$EXP$$ES-ABBVIE-5855021$ABBVIE$$$$$F$Y$$$20240828$$CN$ES$ES
241447932$24144793$2$F$20240101$20240729$20240729$20240731$EXP$$TW-ABBVIE-5854951$ABBVIE$$$$$F$Y$55$KG$20240731$$MD$TW$TW
241447944$24144794$4$F$20240101$20240805$20240729$20240810$EXP$$BR-ABBVIE-5854447$ABBVIE$$61$YR$$F$Y$$$20240810$$CN$BR$BR
241447961$24144796$1$I$$20240724$20240729$20240729$EXP$$JP-TAKEDA-2024TJP011233$TAKEDA$$4$DEC$$M$Y$$$20240729$$MD$JP$JP
241447972$24144797$2$F$20240701$20240824$20240729$20240830$PER$$US-ABBVIE-5856803$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
241447981$24144798$1$I$$20240718$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116150$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240729$$CN$US$US
241447991$24144799$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118860$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$76.2$KG$20240729$$HP$US$US
241448001$24144800$1$I$$20240712$20240729$20240729$30DAY$$DE-UCBSA-2024036463$UCB$$$$A$F$Y$$$20240729$$CN$DE$DE
241448011$24144801$1$I$20230101$20240725$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119110$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240729$$CN$US$US
241448022$24144802$2$F$20240719$20240809$20240729$20240814$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-119007$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240814$$MD$DE$DE
241448031$24144803$1$I$20231009$20240724$20240729$20240729$EXP$$US-ABBVIE-5853898$ABBVIE$$83$YR$$F$Y$$$20240729$$CN$US$US
241448041$24144804$1$I$20230908$20240719$20240729$20240729$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000258$EMCURE$$$$$$Y$$$20240729$$CN$US$US
241448051$24144805$1$I$20240718$20240719$20240729$20240729$EXP$$CN-BEIGENE-BGN-2024-011278$BEIGENE$$$$$$Y$$$20240729$$HP$CN$CN
241448072$24144807$2$F$20240701$20240828$20240729$20240903$EXP$$BG-ABBVIE-5854577$ABBVIE$$49$YR$$M$Y$$$20240903$$CN$BG$BG
241448081$24144808$1$I$20240201$20240724$20240729$20240729$EXP$$CH-ABBVIE-5851973$ABBVIE$$60$YR$$F$Y$$$20240729$$MD$CH$CH
241448091$24144809$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA216890$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240729$$CN$US$US
241448101$24144810$1$I$$20240715$20240729$20240729$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02676$AMNEAL$Okuda D.T, Burgess K.W, Moog T.M, Patel M.A.. Underdosed generic specialty medications: A prescription for patient harm?. Mult. Scler. J.. 2024;88$$$$F$Y$$$20240729$$HP$US$US
241448111$24144811$1$I$20240101$20240723$20240729$20240729$EXP$$US-ABBVIE-5852933$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241448122$24144812$2$F$$20240722$20240729$20240731$EXP$$US-AMGEN-USASP2024148251$AMGEN$Kamali A.; Khalaj K.; Jacobs M.A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$47$YR$A$$Y$$$20240731$$HP$US$US
241448131$24144813$1$I$20240101$20240723$20240729$20240729$EXP$$US-ABBVIE-5852661$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241448151$24144815$1$I$$20240724$20240729$20240729$PER$$US-JNJFOC-20240768068$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$MD$US$US
241448161$24144816$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA217709$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240729$$MD$US$US
241448171$24144817$1$I$$20240724$20240729$20240729$EXP$$US-ABBVIE-5853531$ABBVIE$$$$$F$Y$$$20240729$$HP$US$US
241448182$24144818$2$F$20231117$20240813$20240729$20240822$PER$$US-SA-2024SA218681$SANOFI AVENTIS$$44$YR$A$F$Y$73.93$KG$20240822$$MD$US$US
241448191$24144819$1$I$20240611$20240724$20240729$20240729$EXP$$FR-ABBVIE-5855939$ABBVIE$$46$YR$$F$Y$$$20240729$$HP$FR$FR
241448201$24144820$1$I$$20240725$20240729$20240729$PER$$US-ROCHE-10000037495$ROCHE$$$$$$Y$$$20240729$$CN$US$US
241448211$24144821$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5854779$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241448221$24144822$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5854826$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241448231$24144823$1$I$20240101$20240723$20240729$20240729$EXP$$US-ABBVIE-5852092$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241448242$24144824$2$F$20240101$20240729$20240729$20240731$EXP$$US-ABBVIE-5854043$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241448251$24144825$1$I$$20240723$20240729$20240729$PER$$US-ROCHE-10000035312$ROCHE$$15$YR$T$F$Y$$$20240729$$MD$US$US
241448261$24144826$1$I$$20240725$20240729$20240729$PER$$US-ROCHE-10000037506$ROCHE$$2$YR$C$M$Y$$$20240729$$CN$US$US
241448273$24144827$3$F$20240101$20240913$20240729$20240923$PER$$US-SA-2024SA216046$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240923$$HP$US$US
241448281$24144828$1$I$$20240722$20240729$20240729$PER$$US-AMGEN-USASP2024148320$AMGEN$Parraga S. P.; Hrin M. L.; Jorizzo J. L.. Management of brunsting-perry pemphigoid (BPP): A single-center retrospective case series. Journal of Investigative Dermatology. 2024;144 (8):S42$$$$$Y$$$20240728$$HP$US$US
241448291$24144829$1$I$20240701$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148916$AMGEN$$49$YR$A$F$Y$$$20240728$$CN$US$US
241448301$24144830$1$I$$20240724$20240729$20240729$EXP$$US-ABBVIE-5853353$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241448312$24144831$2$F$20240401$20240724$20240729$20240731$EXP$$US-ABBVIE-5856385$ABBVIE$$80$YR$$F$Y$$$20240731$$HP$US$US
241448321$24144832$1$I$20240723$20240725$20240729$20240729$EXP$$CN-BEIGENE-BGN-2024-011598$BEIGENE$$$$$$Y$$$20240729$$HP$CN$CN
241448331$24144833$1$I$20220101$20221019$20240729$20240729$EXP$$US-AstraZeneca-2022A352049$ASTRAZENECA$$79$YR$$F$Y$$$20240729$$CN$US$
241448342$24144834$2$F$$20240722$20240729$20240731$EXP$$US-AMGEN-USASP2024148013$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et. al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$67$YR$E$$Y$$$20240731$$HP$US$US
241448351$24144835$1$I$20230801$20231128$20240729$20240729$EXP$$US-AstraZeneca-2023A236285$ASTRAZENECA$$683$MON$$F$Y$95.9$KG$20240729$$CN$US$
241448361$24144836$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016914$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241448371$24144837$1$I$$20240719$20240729$20240729$EXP$$EG-STRIDES ARCOLAB LIMITED-2024SP009225$STRIDES$El-Tooney A, Kasem A.. A Case Report of COVID-19 With an Uncommon Presentation and an Unfavorable Outcome.. Am-J-Respir-Crit-Care-Med. 2023;207$40$YR$$M$Y$$$20240729$$HP$EG$EG
241448382$24144838$2$F$20240711$20240808$20240729$20240813$EXP$$JP-TAKEDA-2024TJP011266$TAKEDA$$5$DEC$$$Y$$$20240813$$MD$JP$JP
241448401$24144840$1$I$20240518$20240620$20240729$20240729$EXP$$FR-TEVA-VS-3211178$TEVA$$47$YR$$F$Y$$$20240729$$CN$FR$FR
241448411$24144841$1$I$$20240720$20240729$20240729$EXP$$US-HALEON-2188407$Haleon PLC$$$$$M$Y$$$20240726$$CN$US$US
241448421$24144842$1$I$$20240724$20240729$20240729$EXP$$US-ABBVIE-5852499$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241448431$24144843$1$I$$20240719$20240729$20240729$PER$$US-ABBVIE-5849822$ABBVIE$$$$$F$Y$$$20240729$$MD$US$US
241448441$24144844$1$I$$20240719$20240729$20240729$EXP$$GR-STRIDES ARCOLAB LIMITED-2024SP009243$STRIDES$Gazouni E, Betsikos A, Zisis C, Paschou E, Patrikalou E, Zorbas A, et al.. LIGHT-CHAIN MULTIPLE MYELOMA IN A PATIENT WITH IGDA-MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS): A PUZZLING DIAGNOSIS.. Eur-J-Case-Rep-Intern-Med. 2023;10 (Suppl. 1):393$76$YR$$F$Y$$$20240729$$HP$GR$GR
241448451$24144845$1$I$20240101$20240724$20240729$20240729$EXP$$US-ABBVIE-5853844$ABBVIE$$56$YR$$F$Y$$$20240729$$CN$US$US
241448461$24144846$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA217801$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240729$$MD$US$US
241448471$24144847$1$I$$20240717$20240729$20240729$PER$$US-SA-2024SA214679$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
241448481$24144848$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA217794$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240729$$MD$US$US
241448491$24144849$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA217717$SANOFI AVENTIS$$$$A$F$Y$63.8$KG$20240729$$MD$US$US
241448501$24144850$1$I$$20240724$20240729$20240729$EXP$$CA-ROCHE-10000036827$ROCHE$$$$E$F$Y$$$20240729$$HP$CA$CA
241448511$24144851$1$I$20240701$20240719$20240729$20240729$PER$$US-SA-2024SA217535$SANOFI AVENTIS$$22$YR$A$F$Y$63.503$KG$20240729$$MD$US$US
241448521$24144852$1$I$$20240723$20240729$20240729$PER$$US-ROCHE-10000034670$ROCHE$$$$$$Y$$$20240729$$CN$US$US
241448531$24144853$1$I$20240101$20240722$20240729$20240729$EXP$$JP-GENMAB-2024-00518AA$GENMAB$$9$DEC$$$Y$$$20240729$$MD$JP$JP
241448541$24144854$1$I$20240616$20240726$20240729$20240729$EXP$$FR-SANDOZ INC.-SDZ2024FR068489$SANDOZ$$22$YR$$F$Y$59$KG$20240729$$MD$FR$FR
241448552$24144855$2$F$20240101$20240723$20240729$20240731$EXP$$JP-JNJFOC-20240713910$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$MD$JP$JP
241448561$24144856$1$I$$20240723$20240729$20240729$PER$$US-AMGEN-USASP2024148139$AMGEN$$$$A$M$Y$$$20240728$$HP$US$US
241448581$24144858$1$I$20240715$20240724$20240729$20240729$EXP$GB-MHRA-MED-202407161003047020-YVRCW$GB-STRIDES ARCOLAB LIMITED-2024SP009266$STRIDES$$35$YR$$M$Y$96$KG$20240729$$MD$GB$GB
241448591$24144859$1$I$20240629$20240722$20240729$20240729$EXP$$US-ABBVIE-5856443$ABBVIE$$77$YR$$M$Y$$$20240729$$MD$US$US
241448601$24144860$1$I$$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117985$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240729$$HP$US$US
241448611$24144861$1$I$20240101$20240724$20240729$20240729$EXP$$US-ABBVIE-5852731$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241448621$24144862$1$I$$20240720$20240729$20240729$EXP$$SE-HALEON-2188474$Haleon PLC$$$$$$Y$$$20240726$$CN$SE$SE
241448631$24144863$1$I$$20240725$20240729$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US068367$SANDOZ$$$$$M$Y$$$20240729$$CN$US$US
241448641$24144864$1$I$20190909$20240717$20240729$20240729$EXP$$CN-SA-2024SA214990$SANOFI AVENTIS$$66$YR$E$M$Y$54$KG$20240729$$HP$CN$CN
241448651$24144865$1$I$20240715$20240722$20240729$20240729$EXP$$US-AMGEN-USASP2024145968$AMGEN$$79$YR$E$M$Y$$$20240728$$CN$US$US
241448661$24144866$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA217035$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240729$$MD$US$US
241448672$24144867$2$F$$20240719$20240729$20240729$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009254$STRIDES$Pollack ED, Richardson C, Powell B, Patel K.. Meningoencephalitis With Transverse Myelitis in a Patient With West Nile Virus - Clinical Insights and Awareness.. Am-J-Respir-Crit-Care-Med. 2024;209:A5619 (plus Poster)$$$$$Y$$$20240729$$HP$US$US
241448681$24144868$1$I$$20240724$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118967$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$96$KG$20240729$$HP$CA$CA
241448691$24144869$1$I$$20240722$20240729$20240729$PER$$US-ALXN-202407USA001434US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241448701$24144870$1$I$20240724$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148597$AMGEN$$59$YR$A$F$Y$$$20240728$$CN$US$US
241448711$24144871$1$I$$20240719$20240729$20240729$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009255$STRIDES$Afriyie F, Gilani N, Fanous M, Mansoor A, Shah K, Waller AH. CHASING THE HIGH TOWARDS DEATH, A CASE OF LOPERAMIDE INDUCED CARDIAC ARREST.. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):2941(plusPoster)abstr.1200-074$$$$$Y$$$20240729$$HP$US$US
241448721$24144872$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA217062$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240729$$CN$US$US
241448731$24144873$1$I$$20240724$20240729$20240729$PER$$US-ROCHE-10000037198$ROCHE$$43$YR$A$$Y$$$20240729$$CN$US$US
241448741$24144874$1$I$20240101$20240724$20240729$20240729$EXP$GB-MHRA-MED-202407121426166340-RWFMK$GB-STRIDES ARCOLAB LIMITED-2024SP009233$STRIDES$$34$YR$$F$Y$59$KG$20240729$$CN$GB$GB
241448751$24144875$1$I$$20240724$20240729$20240729$EXP$GB-MHRA-MED-202407190926201320-QNYGS$GB-STRIDES ARCOLAB LIMITED-2024SP009214$STRIDES$$$$$$Y$$$20240729$$HP$GB$GB
241448761$24144876$1$I$20240304$20240724$20240729$20240729$EXP$GB-MHRA-WEBRADR-202407180129240070-NYGQZ$GB-STRIDES ARCOLAB LIMITED-2024SP009236$STRIDES$$1$DY$$M$Y$185$KG$20240729$$CN$GB$GB
241448772$24144877$2$F$20240101$20240909$20240729$20240918$PER$$US-SA-2024SA143219$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240918$$MD$US$US
241448781$24144878$1$I$20240601$20240718$20240729$20240729$PER$$US-SA-2024SA216306$SANOFI AVENTIS$$58$YR$A$M$Y$134$KG$20240729$$MD$US$US
241448791$24144879$1$I$20240101$20240718$20240729$20240729$PER$$US-SA-2024SA214722$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240729$$MD$US$US
241448801$24144880$1$I$$20240722$20240729$20240729$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02697$AMNEAL$$$$$F$Y$70.295$KG$20240729$$CN$US$US
241448811$24144881$1$I$20240722$20240723$20240729$20240729$PER$$US-AMGEN-USASP2024146490$AMGEN$$58$YR$A$F$Y$$$20240728$$CN$US$US
241448822$24144882$2$F$20230101$20240724$20240729$20240805$EXP$$BR-NOVOPROD-1257404$NOVO NORDISK$$512$MON$$F$Y$$$20240805$$CN$BR$BR
241448833$24144883$3$F$20231101$20240723$20240729$20240801$EXP$$DK-NOVOPROD-1258078$NOVO NORDISK$$52$YR$$M$Y$$$20240801$$CN$DK$DK
241448841$24144884$1$I$$20240723$20240729$20240729$EXP$$CA-HALEON-2188496$Haleon PLC$$57$YR$$F$Y$$$20240726$$CN$CA$CA
241448851$24144885$1$I$20240715$20240724$20240729$20240729$EXP$GB-MHRA-TPP28718033C22543987YC1721048475207$GB-STRIDES ARCOLAB LIMITED-2024SP009234$STRIDES$$80$YR$$F$Y$77$KG$20240729$$HP$GB$GB
241448861$24144886$1$I$$20240719$20240729$20240729$EXP$$ZA-HALEON-2188389$Haleon PLC$$$$$$Y$$$20240726$$CN$ZA$ZA
241448871$24144887$1$I$20240508$20240703$20240729$20240729$PER$$US-AstraZeneca-2024A109718$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241448881$24144888$1$I$$20240722$20240729$20240729$PER$$US-CHATTEMPRD-2024OHG025059$CHATTEM$$$$$$Y$$$20240729$$CN$US$US
241448892$24144889$2$F$$20240801$20240729$20240806$PER$$US-CHATTEMPRD-2024OHG025146$CHATTEM$$70$YR$E$F$Y$$$20240806$$CN$US$US
241448901$24144890$1$I$$20240722$20240729$20240729$PER$$US-CHATTEMPRD-2024OHG025182$CHATTEM$$$$$$Y$$$20240729$$CN$US$US
241448912$24144891$2$F$20240726$20240826$20240729$20240827$PER$$US-AMGEN-USASP2024149537$AMGEN$$74$YR$E$F$Y$$$20240827$$CN$US$US
241448921$24144892$1$I$$20240718$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118249$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241448931$24144893$1$I$20240723$20240723$20240729$20240729$PER$$US-AMGEN-USASP2024146522$AMGEN$$83$YR$E$F$Y$$$20240728$$CN$US$US
241448941$24144894$1$I$$20240724$20240729$20240729$PER$$US-JNJFOC-20240769920$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$PH$US$US
241448951$24144895$1$I$$20240725$20240729$20240729$PER$$US-JNJFOC-20240770635$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$HP$US$US
241448965$24144896$5$F$$20240905$20240729$20240918$PER$$US-JNJFOC-20240773262$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$HP$US$US
241448971$24144897$1$I$20240129$20240725$20240729$20240729$EXP$FR-AFSSAPS-GR2024000933$FR-JNJFOC-20240772583$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20240729$$MD$FR$FR
241448981$24144898$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024149030$AMGEN$$$$$$Y$$$20240728$$HP$US$US
241448991$24144899$1$I$$20240629$20240729$20240729$PER$$US-Appco Pharma LLC-2159695$APPCO PHARMA$$$$$$Y$$$20240729$$$US$US
241449001$24144900$1$I$20180901$20240724$20240729$20240729$EXP$FR-AFSSAPS-GR2024000924$FR-VIIV HEALTHCARE LIMITED-FR2024093361$VIIV$$$$$$Y$$$20240729$$PH$FR$FR
241449021$24144902$1$I$$20240720$20240729$20240729$PER$$US-SA-2024SA216929$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240729$$MD$US$US
241449032$24144903$2$F$20240101$20240912$20240729$20240920$PER$$US-SA-2024SA217734$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240920$$MD$US$US
241449041$24144904$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA216805$SANOFI AVENTIS$$$$$$Y$$$20240729$$CN$US$US
241449051$24144905$1$I$20240101$20240718$20240729$20240729$PER$$US-SA-2024SA216171$SANOFI AVENTIS$$66$YR$E$F$Y$57$KG$20240729$$MD$US$US
241449061$24144906$1$I$$20240724$20240729$20240729$EXP$PL-URPL-1-3695-2020$PL-HALEON-2189062$Haleon PLC$$34$YR$$F$Y$53$KG$20240726$$MD$PL$PL
241449071$24144907$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219111$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240729$$MD$US$US
241449081$24144908$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA217220$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240729$$MD$US$US
241449091$24144909$1$I$$20240717$20240729$20240729$PER$$US-SA-2024SA214765$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240729$$MD$US$US
241449101$24144910$1$I$20201123$20240724$20240729$20240729$EXP$PL-URPL-1-4248-2020$PL-GSK-PL2024093369$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$MD$PL$PL
241449122$24144912$2$F$$20240809$20240729$20240819$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024091845$VIIV$$$$$M$Y$$$20240819$$HP$US$US
241449131$24144913$1$I$20240321$20240722$20240729$20240729$EXP$ES-GILEAD-2024-0679677$ES-VIIV HEALTHCARE LIMITED-ES2024091614$VIIV$$$$$$Y$$$20240729$$MD$ES$ES
241449141$24144914$1$I$20240703$20240725$20240729$20240729$EXP$FR-AFSSAPS-NC2024000887$FR-JNJFOC-20240771365$JOHNSON AND JOHNSON$$16$YR$T$F$Y$45.6$KG$20240729$$MD$FR$FR
241449151$24144915$1$I$$20240715$20240729$20240729$EXP$$BR-RDY-LIT/BRA/24/0010728$DR REDDYS$Carvalho NB, Freitas VL, Seguro FS, Bezerra RC, Fatobene G, Nakanishi EY, et al. Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review. Revista do Instituto de Medicina Tropical de Sao Paulo. 2023;66: doi:10.1590/S1678-9946202466010.$57$YR$A$M$Y$$$20240729$$HP$BR$BR
241449161$24144916$1$I$$20240724$20240729$20240729$PER$$US-ROCHE-10000035058$ROCHE$$$$$$Y$$$20240729$$HP$US$US
241449171$24144917$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016389$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241449181$24144918$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016311$ELI LILLY AND CO$$32$YR$A$M$Y$$$20240729$$CN$US$US
241449191$24144919$1$I$20240701$20240725$20240729$20240729$PER$$US-ROCHE-10000038104$ROCHE$$$$$F$Y$$$20240729$$HP$US$US
241449201$24144920$1$I$20240719$20240719$20240729$20240729$PER$$US-SA-2024SA217296$SANOFI AVENTIS$$60$YR$A$F$Y$77.1$KG$20240729$$MD$US$US
241449211$24144921$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017176$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241449221$24144922$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016243$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240729$$CN$US$US
241449231$24144923$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147633$AMGEN$$$$$F$Y$$$20240728$$PH$US$US
241449241$24144924$1$I$20240714$20240718$20240729$20240729$EXP$$CN-TAKEDA-2024TUS075041$TAKEDA$$61$YR$$F$Y$62$KG$20240729$$HP$CN$CN
241449261$24144926$1$I$20240719$20240722$20240729$20240729$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041135$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240729$$MD$JP$JP
241449271$24144927$1$I$$20240723$20240729$20240729$PER$$US-ROCHE-10000035255$ROCHE$$$$$$Y$$$20240729$$CN$US$US
241449281$24144928$1$I$$20240715$20240729$20240729$EXP$813463$AU-LUPIN PHARMACEUTICALS INC.-2024-07284$LUPIN$$$$$$Y$$$20240729$$CN$AU$AU
241449291$24144929$1$I$$20240722$20240729$20240729$EXP$$US-HALEON-2188701$Haleon PLC$$71$YR$$F$Y$$$20240726$$HP$US$US
241449301$24144930$1$I$$20240716$20240729$20240729$PER$$US-SA-2024SA212653$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$MD$US$US
241449311$24144931$1$I$20240220$20240723$20240729$20240729$EXP$$DE-HALEON-2188623$Haleon PLC$$86$YR$$M$Y$68$KG$20240726$$MD$DE$DE
241449321$24144932$1$I$$20240723$20240729$20240729$EXP$$CA-HALEON-2188439$Haleon PLC$$65$YR$$M$Y$$$20240725$$HP$CA$CA
241449331$24144933$1$I$$20240723$20240729$20240729$EXP$$CA-HALEON-2188375$Haleon PLC$$44$YR$$F$Y$$$20240729$$HP$CA$CA
241449341$24144934$1$I$$20240722$20240729$20240729$EXP$$CA-HALEON-2188164$Haleon PLC$$44$YR$$F$Y$$$20240729$$MD$CA$CA
241449351$24144935$1$I$$20240722$20240729$20240729$PER$$US-JNJFOC-20240764272$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$CN$US$US
241449363$24144936$3$F$$20240809$20240729$20240814$EXP$$JP-ABBVIE-5852846$ABBVIE$Nagatsuka Y, Fujita S, Sakamoto R, Kimura Y, Sakamoto S, Kataoka Y. O-006: A case of severe atopic dermatitis aggravated with abnormally high TARC and IgE levels during JAK inhibitor treatment. The 29th Symposium of Research Society for the Treatment of Atopic Dermatitis (2024);39.; Nagatsuka Y, Fujita S, Sakamoto R. O-006: A case of severe atopic dermatitis aggravated with abnormally high TARC and IgE levels during JAK inhibitor treatment. The 29th Symposium of Research Society for the Treat...$40$YR$$F$Y$$$20240814$$MD$JP$JP
241449371$24144937$1$I$$20240723$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118379$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240729$$CN$US$US
241449381$24144938$1$I$$20240724$20240729$20240729$PER$$US-JNJFOC-20240766112$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$MD$US$US
241449391$24144939$1$I$$20240718$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119039$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$78.02$KG$20240729$$CN$US$US
241449401$24144940$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA213620$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240729$$CN$US$US
241449411$24144941$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA217306$SANOFI AVENTIS$$19$YR$A$F$Y$97.5$KG$20240729$$MD$US$US
241449421$24144942$1$I$20240627$20240722$20240729$20240729$EXP$$US-AMGEN-USASP2024145811$AMGEN$$66$YR$E$M$Y$$$20240728$$PH$US$US
241449431$24144943$1$I$$20240723$20240729$20240729$EXP$$CA-HALEON-2188466$Haleon PLC$$68$YR$$F$Y$$$20240724$$CN$CA$CA
241449442$24144944$2$F$$20240716$20240729$20240731$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2014R1-90322$RANBAXY$Karinen R, Fosen JT, Rogde S, Vindenes V. An accidental poisoning with mitragynine. Forensic Sci Int. 2014;245:e29-32$$$A$M$Y$$$20240731$$HP$NO$NO
241449451$24144945$1$I$20240707$20240719$20240729$20240729$EXP$$CN-BEIGENE-BGN-2024-011258$BEIGENE$$$$$$Y$$$20240729$$HP$CN$CN
241449462$24144946$2$F$20240830$20240830$20240729$20240905$EXP$$US-TAKEDA-2024TUS074312$TAKEDA$$20$YR$$M$Y$$$20240905$$CN$US$US
241449471$24144947$1$I$20240719$20240722$20240729$20240729$PER$$US-AMGEN-USASP2024146489$AMGEN$$64$YR$A$F$Y$$$20240728$$CN$US$US
241449482$24144948$2$F$20240705$20240801$20240729$20240807$PER$$US-AMGEN-USASP2024148033$AMGEN$$$$A$$Y$$$20240807$$CN$US$US
241449491$24144949$1$I$$20240716$20240729$20240729$PER$$US-JNJFOC-20240764596$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$82.7$KG$20240729$$MD$US$US
241449501$24144950$1$I$20240718$20240723$20240729$20240729$EXP$$US-TAKEDA-2024TUS070374$TAKEDA$$65$YR$$M$Y$$$20240729$$HP$US$US
241449511$24144951$1$I$$20220815$20240729$20240729$EXP$$US-AstraZeneca-2022A241153$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241449521$24144952$1$I$$20230307$20240729$20240729$EXP$$US-AstraZeneca-2023A018472$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241449541$24144954$1$I$$20240718$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118300$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241449551$24144955$1$I$$20240718$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115494$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241449562$24144956$2$F$$20240726$20240729$20240808$EXP$$US-HALEON-2188939$Haleon PLC$Longobardi, Stefan A, Alkowati, et al. Ibuprofen-Induced Pancytopenia and Erythema Multiforme in an Elderly Female Patient.. Cureus.?#PY#;16(6):e62785. https://dx.doi.org/10.7759/cureus.62785$75$YR$$F$Y$$$20240808$$HP$US$US
241449571$24144957$1$I$$20240506$20240729$20240729$PER$$US-ENDO PHARMACEUTICALS INC-2024-000995$ENDO$$$$$F$Y$$$20240729$$CN$US$US
241449581$24144958$1$I$$20240423$20240729$20240729$PER$$US-ENDO USA, INC.-2024-001935$ENDO$$$$$F$Y$$$20240729$$CN$US$US
241449591$24144959$1$I$$20231212$20240729$20240729$PER$$US-ENDO PHARMACEUTICALS INC-2023-006144$ENDO$$$$$M$Y$$$20240729$$CN$US$US
241449601$24144960$1$I$$20240725$20240729$20240729$EXP$NL-LRB-00985654$NL-ROCHE-10000037326$ROCHE$$61$YR$A$F$Y$75$KG$20240729$$HP$NL$NL
241449611$24144961$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148777$AMGEN$$$$$$Y$$$20240728$$HP$US$US
241449621$24144962$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA216853$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240729$$CN$US$US
241449631$24144963$1$I$$20240724$20240729$20240729$EXP$$US-SA-2024SA218502$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240729$$MD$US$US
241449641$24144964$1$I$20240101$20240722$20240729$20240729$PER$$US-SA-2024SA216438$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240729$$CN$US$US
241449651$24144965$1$I$$20240723$20240729$20240729$EXP$$IE-TAKEDA-2024TUS075755$TAKEDA$$$$$$Y$$$20240729$$MD$IE$IE
241449661$24144966$1$I$20190701$20240716$20240729$20240729$EXP$$MG-AMNEAL PHARMACEUTICALS-2024-AMRX-02713$AMNEAL$Dyer C.. Doxycycline: Coroner calls for MHRA to review side effects after student jumped from plane. BMJ. 2020;371:m4102$19$YR$$F$Y$$$20240729$$HP$MG$MG
241449671$24144967$1$I$$20240719$20240729$20240729$EXP$GB-MHRA-MED-202407190926201320-QNYGS$GB-TEVA-VS-3223635$TEVA$$$$$$Y$$$20240729$$HP$GB$GB
241449691$24144969$1$I$20240603$20240705$20240729$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003281$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240729$$CN$US$US
241449701$24144970$1$I$$20240725$20240729$20240729$PER$$US-ABBVIE-5856608$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241449711$24144971$1$I$20240711$20240719$20240729$20240729$EXP$$CN-BEIGENE-BGN-2024-011277$BEIGENE$$$$$$Y$$$20240729$$HP$CN$CN
241449721$24144972$1$I$$20240717$20240729$20240729$EXP$$CA-ALVOTECHPMS-2022-ALVOTECHPMS-000220$Alvotech$$$$$M$Y$$$20240729$$MD$CA$CA
241449731$24144973$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA217148$SANOFI AVENTIS$$66$YR$E$M$Y$70.3$KG$20240729$$MD$US$US
241449741$24144974$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148094$AMGEN$$$$$$Y$$$20240728$$MD$US$US
241449751$24144975$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003284$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
241449773$24144977$3$F$$20240818$20240729$20240908$30DAY$$SA-JNJFOC-20240737596$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$PH$SA$SA
241449781$24144978$1$I$$20240716$20240729$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-117324$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240729$$MD$JP$JP
241449791$24144979$1$I$$20240718$20240729$20240729$PER$$US-ABBVIE-5849514$ABBVIE$$$$$$Y$$$20240729$$HP$US$US
241449801$24144980$1$I$20230101$20240722$20240729$20240729$PER$$US-AMGEN-USASP2024147000$AMGEN$$66$YR$E$M$Y$$$20240728$$CN$US$US
241449811$24144981$1$I$20231201$20240717$20240729$20240729$EXP$$CA-TAKEDA-2023TUS118734$TAKEDA$$75$YR$$F$Y$$$20240729$$MD$CA$CA
241449831$24144983$1$I$$20240715$20240729$20240729$EXP$$CA-HALEON-2187239$Haleon PLC$$$$$F$Y$$$20240726$$HP$CA$CA
241449842$24144984$2$F$$20240726$20240729$20240805$EXP$$CA-HALEON-2188532$Haleon PLC$$50$YR$$F$Y$$$20240802$$HP$CA$CA
241449851$24144985$1$I$$20240705$20240729$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003286$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
241449863$24144986$3$F$$20240820$20240729$20240829$30DAY$$CA-JNJFOC-20240754652$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$PH$CA$CA
241449871$24144987$1$I$20000101$20240724$20240729$20240729$EXP$$US-JNJFOC-20240768238$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240729$$HP$US$US
241449881$24144988$1$I$20240716$20240719$20240729$20240729$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02660$AMNEAL$$72$YR$$F$Y$$$20240729$$CN$US$US
241449891$24144989$1$I$20240629$20240703$20240729$20240729$PER$$US-JNJFOC-20240713832$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$CN$US$US
241449901$24144990$1$I$$20240724$20240729$20240729$EXP$$CA-HALEON-2188697$Haleon PLC$$41$YR$$M$Y$75$KG$20240729$$HP$CA$CA
241449912$24144991$2$F$20230327$20240918$20240729$20240925$EXP$$JP-009507513-2407JPN001403J$MERCK$$54$YR$$M$Y$$$20240925$$MD$JP$JP
241449923$24144992$3$F$$20240801$20240729$20240809$EXP$$PT-AUROBINDO-AUR-APL-2024-037281$AUROBINDO$Magalh?es SD M, Vieira CJ, Junqueira V, Gaspar T,  Amorim R. POSA-127 - (4350) - NEUTROPENIA IATROG?NICA  A  PIPERACILINA/TAZOBACTAM (IATROG?NIC NEUTROPENIA TO PIPERCILLIN/TAZOBACTAM). Hospitaliza??o Domicili?ria | Caso cl?nico (home hospitalization/clinical case). 2024;1200$30$YR$$M$Y$$$20240809$$MD$PT$PT
241449931$24144993$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003269$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
241449943$24144994$3$F$20240610$20240729$20240729$20240809$EXP$$HR-HALEON-2187532$Haleon PLC$$24$YR$$M$Y$$$20240809$$MD$HR$HR
241449952$24144995$2$F$$20240923$20240729$20240930$EXP$$PT-AUROBINDO-AUR-APL-2024-037274$AUROBINDO$Fernandes AC, Sobrosa P, Ara?jo P, Risto MI, Parente AF, Bezerra J, et al.. COMPLICAC?ES DA QUIMIOTERAPIA: MUCOSITE, NEUTROPENIA FEBRIL E SiNDROME M?O-P? (COMPLICATIONS OF CHEMOTHERAPY: MUCOSITIS, FEBRILE NEUTROPENIA AND HAND-FOOT SYNDROME). Doencas oncologicas (30 CNMI Oncological Diseases). 961$82$YR$$M$Y$$$20240930$$HP$PT$PT
241449961$24144996$1$I$$20240722$20240729$20240729$EXP$$US-HALEON-2188967$Haleon PLC$$60$YR$$M$Y$$$20240729$$CN$US$US
241449971$24144997$1$I$$20240714$20240729$20240729$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459043$RANBAXY$Peng J, Partanen A, Pichardo S, Staruch R, Perry K, McGuffin M, et al. Mild hyperthermia with magnetic resonance- guided high intensity focused ultrasound combined with salvage chemoradiation for recurrent rectal cancer. Int J Hyperthermia. 2024;41 (1):2365385$54$YR$$M$Y$$$20240729$$HP$CA$CA
241449982$24144998$2$F$$20240801$20240729$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003328$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241449991$24144999$1$I$$20240723$20240729$20240729$EXP$$US-TAKEDA-2024TUS074987$TAKEDA$$$$$F$Y$$$20240729$$MD$US$US
241450001$24145000$1$I$$20240724$20240729$20240729$EXP$$CA-HALEON-2188611$Haleon PLC$$15$YR$$F$Y$46$KG$20240729$$HP$CA$CA
241450011$24145001$1$I$$20240725$20240729$20240729$EXP$$US-JNJFOC-20240769892$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$HP$US$US
241450021$24145002$1$I$$20240719$20240729$20240729$EXP$$US-GSK-US2024GSK092094$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241450031$24145003$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147798$AMGEN$$$$$$Y$$$20240728$$HP$US$US
241450041$24145004$1$I$20240705$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119221$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240729$$CN$US$US
241450051$24145005$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003304$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241450061$24145006$1$I$$20240715$20240729$20240729$EXP$$IT-EPICPHARMA-IT-2024EPCLIT00888$EPIC PHARM$Massimo Carollo.Not only Van Gogh: a case of BRASH syndrome with concomitant digoxin toxicity.Journal of Medical Case Reports.2024;18:1-7$66$YR$E$F$Y$$$20240729$$HP$IT$IT
241450071$24145007$1$I$$20240724$20240729$20240729$EXP$$US-ABBVIE-5855084$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241450081$24145008$1$I$20240725$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017158$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240729$$CN$US$US
241450091$24145009$1$I$20240712$20240722$20240729$20240729$PER$$US-ALXN-202407USA001449US$ALEXION PHARMACEUTICALS$$59$YR$$$Y$$$20240729$$MD$US$US
241450101$24145010$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016998$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240729$$CN$US$US
241450111$24145011$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016840$ELI LILLY AND CO$$$$$$Y$$$20240729$$CN$US$US
241450121$24145012$1$I$20240501$20240719$20240729$20240729$EXP$SE-SEMPA-2024-005419$SE-SA-2024SA215318$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240729$$MD$SE$SE
241450131$24145013$1$I$$20240719$20240729$20240729$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-102515$REGENERON$Hui M.; Gunzenhauser R.; Dillon A.; Tsui I. Unexpected Vision Loss following Six Intravitreal Injections for Neovascular Age-Related Macular Degeneration.. Case Reports in Ophthalmology.. 2024;15:1:518-524$83$YR$$M$Y$$$20240729$$HP$US$US
241450144$24145014$4$F$20240725$20240829$20240729$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202407016894$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240905$$CN$US$US
241450151$24145015$1$I$20240626$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119228$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240729$$CN$US$US
241450162$24145016$2$F$$20240808$20240729$20240809$PER$$US-JNJFOC-20240741563$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241450171$24145017$1$I$20240723$20240724$20240729$20240729$EXP$$US-JNJFOC-20240770818$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240729$$MD$US$US
241450181$24145018$1$I$$20240725$20240729$20240729$PER$$US-JNJFOC-20240772919$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$PH$US$US
241450191$24145019$1$I$$20240716$20240729$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-036553$AUROBINDO$Salar T, Al-Hosainat N, Subedi R, Hameed M, Brodsky S, Dahhan A.. A CASE OF HYDRALAZINE INDUCED SEVERE RENAL- LIMITED ANCA VASCULITIS LEADING TO ESRD IN A 63-YEAR-OLD MAN. Am-J-Kidney-Dis. 2024;81 (Suppl. 1)(4:S42 abstr. 142$63$YR$$M$Y$$$20240729$$HP$US$US
241450201$24145020$1$I$$20240715$20240729$20240729$EXP$$FR-IPCA LABORATORIES LIMITED-IPC-2024-FR-001865$IPCA$Noemie Abisror, Meryam Cheloufi, Jonathan Cohen et al.. Intravenous immunoglobulins for recurrent chronic histiocytic intervillositis: a series of case studies. American Journal of Reproductive Immunology. 2024;92:1-6$$$$$Y$$$20240729$$HP$FR$IN
241450211$24145021$1$I$$20240724$20240729$20240729$EXP$$US-TAKEDA-2024TUS075574$TAKEDA$$$$$M$Y$$$20240729$$MD$US$US
241450221$24145022$1$I$$20240719$20240729$20240729$EXP$$US-ABBVIE-5850233$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241450231$24145023$1$I$$20240725$20240729$20240729$EXP$$CA-ABBVIE-5856355$ABBVIE$$$$E$M$Y$$$20240729$$HP$CA$CA
241450253$24145025$3$F$20240501$20240806$20240729$20240810$EXP$$US-ABBVIE-5853177$ABBVIE$$72$YR$$F$Y$86.182$KG$20240810$$CN$US$US
241450262$24145026$2$F$20240101$20240902$20240729$20240906$EXP$$NL-ABBVIE-5856168$ABBVIE$$$$A$M$Y$$$20240906$$CN$NL$NL
241450271$24145027$1$I$$20240723$20240729$20240729$EXP$$US-TAKEDA-2024TUS075010$TAKEDA$$$$$F$Y$$$20240729$$MD$US$US
241450281$24145028$1$I$20240620$20240724$20240729$20240729$EXP$$JP-TAKEDA-2024TJP009512$TAKEDA$$6$DEC$$F$Y$$$20240729$$MD$JP$JP
241450291$24145029$1$I$20231206$20240717$20240729$20240729$EXP$$CN-SA-2024SA218029$SANOFI AVENTIS$$45$YR$A$F$Y$55$KG$20240729$$HP$CN$CN
241450312$24145031$2$F$$20230807$20240729$20240731$EXP$$BE-AstraZeneca-2023A182354$ASTRAZENECA$$$$$M$Y$$$20240731$$MD$BE$
241450321$24145032$1$I$20240717$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148752$AMGEN$$$$$$Y$$$20240728$$PH$US$US
241450331$24145033$1$I$20240614$20240722$20240729$20240729$EXP$$US-ABBVIE-5856753$ABBVIE$$78$YR$$M$Y$$$20240729$$HP$US$US
241450343$24145034$3$F$$20240911$20240729$20240913$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-117436$BRISTOL MYERS SQUIBB$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S, et al. Direct oral anticoagulants and concomitant anti-seizure medications: a retrospective, case-control study in a real-world setting. Clinical Therapeutics. 2024 Jul 01;46(7):e26-30. doi:10.1016/j.clinthera.2024.06.002.$88$YR$E$M$Y$$$20240913$$MD$IT$IT
241450351$24145035$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA216709$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$CN$US$US
241450361$24145036$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA214749$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240729$$MD$US$US
241450371$24145037$1$I$$20240718$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118310$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241450382$24145038$2$F$20240101$20240724$20240729$20240731$PER$$US-SA-2024SA218314$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240731$$CN$US$US
241450391$24145039$1$I$20240101$20240724$20240729$20240729$EXP$$US-ABBVIE-5856036$ABBVIE$$$$A$M$Y$$$20240729$$MD$US$US
241450402$24145040$2$F$20240723$20240808$20240729$20240813$PER$$US-AMGEN-USASP2024147746$AMGEN$$62$YR$A$$Y$$$20240813$$CN$US$US
241450412$24145041$2$F$$20240724$20240729$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-119155$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240731$$HP$CA$CA
241450421$24145042$1$I$20240722$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148653$AMGEN$$74$YR$E$M$Y$$$20240728$$CN$US$US
241450432$24145043$2$F$$20240729$20240729$20240802$EXP$$GB-TAKEDA-2024TUS075609$TAKEDA$$$$$F$Y$$$20240802$$CN$GB$GB
241450441$24145044$1$I$20240722$20240722$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116512$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240729$$HP$US$US
241450451$24145045$1$I$$20240401$20240729$20240729$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089879$GLENMARK$$$$$$Y$$$20240729$$CN$US$US
241450461$24145046$1$I$20200901$20240605$20240729$20240729$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090759$GLENMARK$$$$$$Y$$$20240729$$CN$US$US
241450471$24145047$1$I$20231001$20231120$20240729$20240729$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086807$GLENMARK$$$$$$Y$$$20240729$$CN$US$US
241450481$24145048$1$I$$20231031$20240729$20240729$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086287$GLENMARK$$$$$$Y$$$20240729$$CN$US$US
241450491$24145049$1$I$$20240129$20240729$20240729$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088757$GLENMARK$$$$$$Y$$$20240729$$CN$US$US
241450501$24145050$1$I$20231207$20231207$20240729$20240729$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087287$GLENMARK$$$$$$Y$$$20240729$$CN$US$US
241450511$24145051$1$I$20230101$20240110$20240729$20240729$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087343$GLENMARK$$$$$$Y$$$20240729$$CN$US$US
241450521$24145052$1$I$$20240111$20240729$20240729$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087355$GLENMARK$$$$$$Y$$$20240729$$CN$US$US
241450531$24145053$1$I$20230928$20231122$20240729$20240729$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087029$GLENMARK$$$$$$Y$$$20240729$$CN$US$US
241450551$24145055$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003310$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241450561$24145056$1$I$20240101$20240725$20240729$20240729$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-006947$BOEHRINGER INGELHEIM$$59$YR$A$F$Y$$$20240729$$CN$FR$FR
241450571$24145057$1$I$$20240723$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042242$BOEHRINGER INGELHEIM$$56$YR$A$F$Y$$$20240729$$CN$US$IN
241450581$24145058$1$I$$20240726$20240729$20240729$EXP$$US-JNJFOC-20240772571$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240729$$HP$US$US
241450591$24145059$1$I$$20240725$20240729$20240729$EXP$$PL-JNJFOC-20240770443$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$MD$PL$PL
241450601$24145060$1$I$$20240715$20240729$20240729$EXP$$US-PURACAP-US-2024EPCLIT00872$PURACAP$Caitlin A. Contag.Q fever presenting as splenic infarct without endocarditis .IDCases.15-JUN-2024;37:1-3$44$YR$A$M$Y$$$20240729$$HP$US$US
241450611$24145061$1$I$$20240718$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118327$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241450621$24145062$1$I$20230901$20240717$20240729$20240729$EXP$$PT-AUROBINDO-AUR-APL-2024-036394$AUROBINDO$$39$YR$$F$Y$$$20240729$$MD$PT$PT
241450634$24145063$4$F$$20240904$20240729$20240915$EXP$$PT-AUROBINDO-AUR-APL-2024-036395$AUROBINDO$Vasconcelos AL, Da Silva LN, Ferreira PC, Pinto RR, Monteiro M, Ara?jo R.. S?ndrome serotonin?rgico: uma longa lista de agentes causais.. Medicina Interna.. 2024;30(Sup 1 ):279$80$YR$$F$Y$$$20240915$$MD$PT$PT
241450641$24145064$1$I$$20240725$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119149$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240729$$CN$US$US
241450651$24145065$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092520$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241450661$24145066$1$I$20240101$20240722$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116874$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$79.7$KG$20240729$$PH$US$US
241450671$24145067$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017508$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240729$$CN$US$US
241450691$24145069$1$I$20240725$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017478$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240729$$CN$US$US
241450701$24145070$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016909$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240729$$CN$US$US
241450711$24145071$1$I$20240701$20240722$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116832$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240729$$HP$US$US
241450722$24145072$2$F$20230920$20240911$20240729$20240920$PER$$US-JNJFOC-20240768877$JOHNSON AND JOHNSON$$6$YR$C$F$Y$16.4$KG$20240920$$CN$US$US
241450731$24145073$1$I$20210801$20240718$20240729$20240729$EXP$IN-MLMSERVICE-20240711-PI128919-00232-1$IN-STRIDES ARCOLAB LIMITED-2024SP009111$STRIDES$Giri K, Sahay M, Ismal KM, Kavadi A.. A Rare Malignancy Postrenal Transplantation-The Dark Side of Success.. Indian Journal of Transplantation. 2024;18(2):171-73$32$YR$$M$Y$$$20240729$$MD$IN$IN
241450741$24145074$1$I$20240726$20240724$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042243$BOEHRINGER INGELHEIM$$77$YR$E$$Y$$$20240729$$CN$US$US
241450751$24145075$1$I$$20240719$20240729$20240729$EXP$$US-APOTEX-2024AP008742$APOTEX$Greenfield MJ, Fobian AD, Fargason RE, Birur B. Optimizing outcomes when treating functional neurological disorder in acute care settings: case reports depicting the value of diagnostic precision and timely and appropriate psychological interventions using an interdisciplinary framework. Frontiers in Psychiatry. 2024;15:01-09$27$YR$$F$Y$$$20240729$$HP$US$US
241450761$24145076$1$I$20230901$20231016$20240729$20240729$EXP$$US-AstraZeneca-2023A236521$ASTRAZENECA$$693$MON$$F$Y$$$20240729$$CN$US$
241450771$24145077$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024149109$AMGEN$$$$$$Y$$$20240728$$HP$US$US
241450781$24145078$1$I$$20231102$20240729$20240729$EXP$$US-AstraZeneca-2023A250713$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241450791$24145079$1$I$20240701$20240724$20240729$20240729$EXP$$US-ABBVIE-5852432$ABBVIE$$71$YR$$M$Y$$$20240729$$CN$US$US
241450801$24145080$1$I$$20240715$20240729$20240729$EXP$$FR-IPCA LABORATORIES LIMITED-IPC-2024-FR-001866$IPCA$Noemie Abisror, Meryam Cheloufi, Jonathan Cohen et al.. Intravenous immunoglobulins for recurrent chronic histiocytic intervillositis: a series of case studies.. American Journal of Reproductive Immunology. 2024;92:1-6$$$$$Y$$$20240729$$HP$FR$FR
241450811$24145081$1$I$$20240715$20240729$20240729$EXP$$US-PURACAP-US-2024EPCLIT00864$PURACAP$S. Sasidharan.Triple Whammy of Amlodipine, Carvedilol and Diphenhydramine Overdose.American Journal of Respiratory and Critical Care Medicine.2024;209:A5669$27$YR$A$F$Y$$$20240729$$HP$US$US
241450821$24145082$1$I$20240702$20240715$20240729$20240729$EXP$$CZ-Jiangsu Hengrui Medicine Co., Ltd.-2159696$JIANGSU HENGRUI MEDICINE$$60$YR$$F$Y$$$20240729$$MD$CN$CZ
241450831$24145083$1$I$20180101$20240719$20240729$20240729$EXP$$BR-TAKEDA-BR202000447$TAKEDA$$$$$F$Y$74$KG$20240729$$HP$BR$BR
241450842$24145084$2$F$20240724$20240903$20240729$20240905$PER$$US-JNJFOC-20240764946$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240905$$CN$US$US
241450851$24145085$1$I$20240718$20240719$20240729$20240729$EXP$GB-MHRA-MED-202407191459520230-ZCNRK$GB-TEVA-VS-3223591$TEVA$$64$YR$$M$Y$$$20240729$$HP$GB$GB
241450861$24145086$1$I$20240501$20240719$20240729$20240729$PER$$US-SA-2024SA217863$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240729$$MD$US$US
241450871$24145087$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA214730$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240729$$MD$US$US
241450881$24145088$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA214944$SANOFI AVENTIS$$$$$$Y$$$20240729$$PH$US$US
241450891$24145089$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA216621$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
241450901$24145090$1$I$$20240722$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116489$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240729$$HP$US$US
241450911$24145091$1$I$$20240718$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118285$BRISTOL MYERS SQUIBB$Literature citation unavailable.$$$$$Y$$$20240729$$HP$CA$CA
241450921$24145092$1$I$$20240725$20240729$20240729$EXP$$NVSC2024GR153782$NOVARTIS$$$$$$Y$$$20240729$$MD$GR$GR
241450931$24145093$1$I$$20240718$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118262$BRISTOL MYERS SQUIBB$Literature Citation Unavailable.$$$$$Y$$$20240729$$HP$CA$CA
241450942$24145094$2$F$$20240819$20240729$20240829$30DAY$$US-GSK-US2024092423$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
241450951$24145095$1$I$$20240723$20240729$20240729$30DAY$$US-GSK-US2024092394$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241450971$24145097$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA217274$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240729$$MD$US$US
241450982$24145098$2$F$$20240916$20240729$20240917$EXP$$PT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039503$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240918$$MD$PT$PT
241450992$24145099$2$F$$20240723$20240729$20240801$EXP$IR-MLMSERVICE-20240718-PI130562-00270-2$IR-STRIDES ARCOLAB LIMITED-2024SP009153$STRIDES$Tajerian A, Pourvali A, Movahedi M, Mohammadi M, Khansarinejad B, Pourmatin M, et al.. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Myocarditis: A Case Report and Literature Review on Fatal Complications of Reactivated Viral Infections.. Iranian Journal of Allergy, Asthma and Immunology. 2024;23(3):339-346$21$YR$$F$Y$$$20240801$$MD$IR$IR
241451001$24145100$1$I$$20240723$20240729$20240729$PER$$US-ABBVIE-5853058$ABBVIE$$40$YR$$F$Y$$$20240729$$CN$US$US
241451011$24145101$1$I$20240701$20240724$20240729$20240729$EXP$$NVSC2024FR153047$NOVARTIS$$74$YR$$F$Y$$$20240729$$PH$FR$FR
241451021$24145102$1$I$$20230705$20240729$20240729$PER$$US-APOTEX-2023AP010274$APOTEX$Stoilova J., Torres R., Martinez K.. Post herpetic pruritus successfully treated with Onabotulinum toxin: A case report. Neurology. 2023;100 (Suppl.2)17$78$YR$$F$Y$$$20240729$$HP$US$US
241451031$24145103$1$I$$20240716$20240729$20240729$EXP$$CA-NOVOPROD-1258079$NOVO NORDISK$$51$YR$$M$Y$$$20240729$$MD$CA$CA
241451041$24145104$1$I$20240716$20240716$20240729$20240729$EXP$$US-NOVOPROD-1258191$NOVO NORDISK$$$$$F$Y$$$20240729$$PH$US$US
241451051$24145105$1$I$20240531$20240716$20240729$20240729$EXP$$GB-NOVOPROD-1257707$NOVO NORDISK$$41$YR$$F$Y$$$20240729$$CN$GB$GB
241451061$24145106$1$I$$20240716$20240729$20240729$EXP$$US-NOVOPROD-1258080$NOVO NORDISK$$63$YR$$F$Y$$$20240729$$CN$US$US
241451071$24145107$1$I$$20240716$20240729$20240729$EXP$$US-NOVOPROD-1257485$NOVO NORDISK$$$$$F$Y$$$20240729$$CN$US$US
241451081$24145108$1$I$20240625$20240716$20240729$20240729$EXP$$US-NOVOPROD-1257904$NOVO NORDISK$$63$YR$$F$Y$$$20240729$$CN$US$US
241451091$24145109$1$I$$20240716$20240729$20240729$EXP$$US-NOVOPROD-1258198$NOVO NORDISK$$$$$M$Y$$$20240729$$CN$US$US
241451101$24145110$1$I$20220101$20240716$20240729$20240729$EXP$$US-NOVOPROD-1257653$NOVO NORDISK$$67$YR$$F$Y$$$20240729$$CN$US$US
241451111$24145111$1$I$20240713$20240716$20240729$20240729$EXP$$US-NOVOPROD-1257612$NOVO NORDISK$$60$YR$$F$Y$$$20240729$$CN$US$US
241451122$24145112$2$F$20240703$20240826$20240729$20240901$PER$$US-AMGEN-USASP2024148784$AMGEN$$77$YR$E$F$Y$$$20240901$$HP$US$US
241451132$24145113$2$F$$20240724$20240729$20240807$PER$$US-AMGEN-USASP2024147660$AMGEN$$$$A$F$Y$$$20240807$$MD$US$US
241451141$24145114$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003336$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241451151$24145115$1$I$$20240716$20240729$20240729$EXP$$US-RDY-LIT/USA/24/0010705$DR REDDYS$Al-Shokri S, Shimizu S, Warren EL, Kourouni IL. Pneumocystis Jirovecii Pneumonia in an Immunocompetent Patient With Inhalation Injury, A Case Report With Literature Review. American Journal of Respiratory and Critical Care Medicine. 2024;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A3559.$57$YR$A$M$Y$$$20240729$$HP$US$US
241451161$24145116$1$I$$20240723$20240729$20240729$EXP$$US-GSK-US2024092387$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241451173$24145117$3$F$20220101$20240822$20240729$20240904$EXP$$JP-009507513-2306JPN001798J$MERCK$Fujimoto T, Sugino Y, Takahashi D, Kohashiguchi K, Iwamura H, Tono Y, et al.. 15 A Case of Multiple Lung Metastases from Right Renal Pelvic Carcinoma which was Successfully Treated With Enfortumab Vedotin. The 253th Kansai Regional Meeting of the Japanese Urological Association. 9$71$YR$$M$Y$$$20240904$$MD$JP$JP
241451182$24145118$2$F$$20240722$20240729$20240731$EXP$$CA-JNJFOC-20240762798$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240731$$MD$CA$CA
241451191$24145119$1$I$20200508$20240722$20240729$20240729$EXP$$CA-TAKEDA-CA202026466$TAKEDA$$70$YR$$M$Y$$$20240729$$CN$CA$CA
241451201$24145120$1$I$$20240715$20240729$20240729$EXP$$FR-IPCA LABORATORIES LIMITED-IPC-2024-FR-001867$IPCA$Noemie Abisror, Meryam Cheloufi, Jonathan Cohen et al.. Intravenous immunoglobulins for recurrent chronic histiocytic intervillositis: a series of case studies. American Journal of Reproductive Immunology. 2024;92:1-6$$$$$Y$$$20240729$$HP$FR$FR
241451211$24145121$1$I$$20240702$20240729$20240729$PER$$US-AstraZeneca-2024A129094$ASTRAZENECA$$75$YR$$M$Y$71$KG$20240729$$CN$US$
241451221$24145122$1$I$$20231115$20240729$20240729$EXP$$US-AstraZeneca-2023A260842$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241451231$24145123$1$I$$20230404$20240729$20240729$EXP$$US-AstraZeneca-2023A080256$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241451241$24145124$1$I$$20240725$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118986$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240729$$HP$US$US
241451251$24145125$1$I$$20240718$20240729$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119127$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240729$$MD$JP$JP
241451261$24145126$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003341$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241451271$24145127$1$I$$20240718$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115636$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241451281$24145128$1$I$$20240722$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116959$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240729$$HP$US$US
241451291$24145129$1$I$$20240722$20240729$20240729$PER$$US-ABBVIE-5851896$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241451301$24145130$1$I$20090820$20240716$20240729$20240729$EXP$$FR-009507513-1101FRA00151$MERCK$$56$YR$$M$Y$$$20240729$$HP$FR$FR
241451311$24145131$1$I$20240101$20240724$20240729$20240729$EXP$$US-SA-2024SA218635$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240729$$MD$US$US
241451322$24145132$2$F$$20240724$20240729$20240729$PER$$US-ROCHE-10000035905$ROCHE$$80$YR$E$F$Y$$$20240729$$CN$US$US
241451333$24145133$3$F$$20240909$20240729$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003263$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241451342$24145134$2$F$20100130$20240726$20240729$20240801$EXP$$JP-009507513-1002USA01815$MERCK$$32$YR$$F$Y$42$KG$20240801$$MD$JP$JP
241451351$24145135$1$I$$20240725$20240729$20240729$EXP$$JP-JNJFOC-20240775829$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240729$$PH$JP$JP
241451362$24145136$2$F$20240722$20240906$20240729$20240911$EXP$$DE-TAKEDA-2024TUS074716$TAKEDA$$38$YR$$M$Y$$$20240911$$CN$DE$DE
241451371$24145137$1$I$$20240718$20240729$20240729$EXP$$US-APOTEX-2024AP008617$APOTEX$Vincent J, Greenberg J, Sanghani S, Finneran K, Nguyen N.. Profound Lactic Acidosis and Shock in a Patient Taking Metformin. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5702$52$YR$$F$Y$$$20240729$$HP$US$US
241451381$24145138$1$I$20240718$20240719$20240729$20240729$EXP$GB-MHRA-MED-202407191513307800-WYNPS$GB-TEVA-VS-3224085$TEVA$$66$YR$$M$Y$$$20240729$$HP$GB$GB
241451392$24145139$2$F$$20240820$20240729$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003344$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
241451401$24145140$1$I$20240101$20240718$20240729$20240729$PER$$US-SA-2024SA178625$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240729$$MD$US$US
241451411$24145141$1$I$20220101$20240719$20240729$20240729$EXP$JP-MLMSERVICE-20240712-PI130167-00270-1$JP-STRIDES ARCOLAB LIMITED-2024SP009154$STRIDES$Hirano S, Takahashi H, Nakamura S, Matsuda K, Ishikawa R, Tamura K, et al.. A case of pulmonary tuberculosis that developed during nivolumab and ipilimumab treatment for pulmonary adenocarcinoma that recurred two months after completion of anti-tuberculous treatment.. Chinese Clinical Oncology. 2024;13(3):43$7$DEC$$M$Y$$$20240729$$MD$JP$JP
241451421$24145142$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA216723$SANOFI AVENTIS$$$$E$F$Y$$$20240729$$MD$US$US
241451431$24145143$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA216215$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240729$$HP$US$US
241451441$24145144$1$I$20240611$20240717$20240729$20240729$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000124-2024$QILU PHARMACEUTICAL$$68$YR$E$F$Y$74$KG$20240725$$HP$CN$CN
241451452$24145145$2$F$20240703$20240731$20240729$20240807$EXP$$JP-009507513-2407JPN004368J$MERCK$$64$YR$$F$Y$$$20240807$$MD$JP$JP
241451461$24145146$1$I$$20240708$20240729$20240729$PER$$US-P+L Developments of Newyork Corporation-2159697$PL DEVELOPMENTS$$$$$M$Y$$$20240729$$$US$US
241451472$24145147$2$F$20220101$20240722$20240729$20240730$EXP$$JP-SA-2024SA213008$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240731$$CN$JP$JP
241451481$24145148$1$I$$20240718$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-117401$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240729$$HP$CA$CA
241451491$24145149$1$I$$20240719$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116148$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240729$$PH$US$US
241451502$24145150$2$F$$20240813$20240729$20240815$EXP$$CA-TAKEDA-2021TUS031732$TAKEDA$$$$$M$Y$$$20240815$$CN$CA$CA
241451512$24145151$2$F$20240701$20240726$20240729$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119139$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$64.41$KG$20240730$$PH$US$US
241451521$24145152$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003351$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241451531$24145153$1$I$$20240718$20240729$20240729$EXP$$CA-TAKEDA-2024TUS073864$TAKEDA$$$$$F$Y$$$20240729$$MD$CA$CA
241451542$24145154$2$F$$20240729$20240729$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-037267$AUROBINDO$Patr?cia Sobrosa1; Mariana Azevedo2; Emanuel Matias2; Filipa Ceia2; Lurdes Santos2. MENINGITE ERADICULONEVRITE POR V?RUS HERPESSIMPLEX 2 EM DOENTE IMUNOCOMPETENTE. (POSA-116 - (4164) - MENINGITIS AND RADICULONEURITIS DUE TO HERPES SIMPLEX VIRUS IN AN IMMUNOCOMPETENT PATIENT). Doen?as infeciosas e parasit?rias | Caso cl?nico (Infectious and parasitic disea$40$YR$$F$Y$$$20240808$$HP$PT$PT
241451552$24145155$2$F$20240101$20240807$20240729$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117990$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240813$$CN$US$US
241451562$24145156$2$F$20240527$20240828$20240729$20240830$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR094046$VIIV$$$$$$Y$$$20240830$$HP$US$US
241451571$24145157$1$I$20220815$20240723$20240729$20240729$EXP$$CA-TAKEDA-2024TUS074946$TAKEDA$$80$YR$$F$Y$$$20240729$$CN$CA$CA
241451581$24145158$1$I$$20240722$20240729$20240729$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005423$BIOCON$$$$$$Y$$$20240729$$HP$CA$CA
241451593$24145159$3$F$20240701$20240813$20240729$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-036323$AUROBINDO$$86$YR$$M$Y$$$20240826$$MD$FR$FR
241451601$24145160$1$I$20240722$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147844$AMGEN$$59$YR$A$M$Y$$$20240728$$CN$US$US
241451612$24145161$2$F$$20240808$20240729$20240820$EXP$$JP-ARDELYX-2024ARDX005195$ARDELYX$$$$$M$Y$$$20240820$$MD$JP$JP
241451621$24145162$1$I$$20240723$20240729$20240729$EXP$$CA-TAKEDA-2024TUS074963$TAKEDA$$$$$M$Y$$$20240729$$CN$CA$CA
241451632$24145163$2$F$$20240729$20240729$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003355$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
241451641$24145164$1$I$$20240725$20240729$20240729$EXP$$US-JNJFOC-20240769975$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$HP$US$US
241451653$24145165$3$F$20240729$20240911$20240729$20240918$EXP$$CA-TAKEDA-2024TUS074989$TAKEDA$$28$YR$$M$Y$$$20240918$$HP$CA$CA
241451671$24145167$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148100$AMGEN$$$$$$Y$$$20240729$$MD$US$US
241451684$24145168$4$F$20240726$20240729$20240729$20240816$PER$$US-AMGEN-USASP2024149679$AMGEN$$62$YR$A$F$Y$$$20240815$$HP$US$US
241451693$24145169$3$F$20240708$20240906$20240729$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-035835$AUROBINDO$$77$YR$$M$Y$116$KG$20240919$$MD$GB$GB
241451701$24145170$1$I$20231011$20240725$20240729$20240729$EXP$$GB-UCBSA-2024037527$UCB$$55$YR$$F$Y$66.2$KG$20240729$$HP$GB$GB
241451711$24145171$1$I$20240721$20240722$20240729$20240729$PER$$US-ALXN-202407USA001432US$ALEXION PHARMACEUTICALS$$4$YR$$F$Y$$$20240729$$CN$US$US
241451721$24145172$1$I$$20240715$20240729$20240729$EXP$$FR-IPCA LABORATORIES LIMITED-IPC-2024-FR-001868$IPCA$Noemie Abisror, Meryam Cheloufi, Jonathan Cohen et al.. Intravenous immunoglobulins for recurrent chronic histiocytic intervillositis: a series of case studies. American Journal of Reproductive Immunology. 2024;92:1-6$$$$$Y$$$20240729$$HP$FR$FR
241451731$24145173$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003398$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241451741$24145174$1$I$20240201$20240724$20240729$20240729$PER$$US-009507513-2407USA013884$MERCK$$$$$M$Y$$$20240729$$CN$US$US
241451751$24145175$1$I$20240120$20240722$20240729$20240729$EXP$$AR-JNJFOC-20240264381$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240729$$CN$AR$AR
241451761$24145176$1$I$$20240712$20240729$20240729$PER$$US-JNJFOC-20240737265$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$CN$US$US
241451782$24145178$2$F$$20240806$20240729$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003692$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
241451792$24145179$2$F$20161229$20240726$20240729$20240731$EXP$$CA-TAKEDA-2024TUS075624$TAKEDA$$16$YR$$M$Y$$$20240731$$CN$CA$CA
241451801$24145180$1$I$$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117886$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240729$$CN$US$US
241451812$24145181$2$F$20240701$20240729$20240729$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017080$ELI LILLY AND CO$$86$YR$E$M$Y$$$20240731$$CN$US$US
241451821$24145182$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016115$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241451831$24145183$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016835$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240729$$CN$US$US
241451842$24145184$2$F$$20240730$20240729$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003353$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
241451851$24145185$1$I$20230807$20230929$20240729$20240729$EXP$$US-AstraZeneca-2023A187818$ASTRAZENECA$$25081$DY$$M$Y$$$20240729$$CN$US$
241451861$24145186$1$I$20231201$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017082$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240729$$CN$US$US
241451873$24145187$3$F$20240701$20240806$20240729$20240816$EXP$$US-INSMED, INC.-2024-02906-US$INSMED$$66$YR$$F$Y$$$20240816$$CN$US$US
241451881$24145188$1$I$20170419$20240717$20240729$20240729$EXP$$DK-AUROBINDO-AUR-APL-2024-036257$AUROBINDO$$79$YR$$F$Y$170$KG$20240729$$MD$DK$DK
241451891$24145189$1$I$$20240715$20240729$20240729$EXP$$BR-UCBSA-2024036054$UCB$$$$$$Y$$$20240729$$MD$BR$BR
241451901$24145190$1$I$$20240723$20240729$20240729$EXP$$HR-ROCHE-10000035307$ROCHE$$$$A$F$Y$$$20240729$$MD$HR$HR
241451911$24145191$1$I$$20240628$20240729$20240729$EXP$$US-BEH-2024175049$CSL BEHRING$$65$YR$E$M$Y$$$20240729$$CN$US$US
241451921$24145192$1$I$$20240726$20240729$20240729$EXP$$CA-BEIGENE-BGN-2024-011612$BEIGENE$$$$$$Y$$$20240729$$PH$CA$CA
241451931$24145193$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5855984$ABBVIE$Tribble JT, Johnson M, Moon Y, Rajpara A, Whitsitt J. Kaposi sarcoma in a men-who-have-sex-with-men patient without human immunodeficiency virus who was treated with upadacitinib for ulcerative colitis. JAAD Case Reports. 2024;50:119-122.$45$YR$$M$Y$$$20240729$$HP$US$US
241451941$24145194$1$I$$20231218$20240729$20240729$EXP$$US-TEVA-VS-3223023$TEVA$$$$A$F$Y$$$20240729$$CN$US$US
241451955$24145195$5$F$$20240831$20240729$20240911$EXP$$PT-AUROBINDO-AUR-APL-2024-037250$AUROBINDO$Chumbo C, Figueiredo F, Sarmento M, Valido T, Cruz T. PO-0253 - (2707) - O CULPADO DISSIMULADO (THE DISSIMULATED GUILTY). Doen?as gastrenterol?gicas e doen?as hep?ticas | Caso cl?nico (Gastroenterologic. 2024;618$88$YR$$F$Y$$$20240911$$MD$PT$PT
241451961$24145196$1$I$20240101$20240719$20240729$20240729$EXP$$US-EDENBRIDGE PHARMACEUTICALS, LLC-US-2024EDE000046$EDENBRIDGE PHARMACEUTICALS$$85$YR$$F$Y$$$20240729$$CN$US$US
241451971$24145197$1$I$20230601$20240715$20240729$20240729$EXP$$US-UCBSA-2024036305$UCB$$21$YR$$F$Y$$$20240729$$CN$US$US
241451981$24145198$1$I$$20221024$20240729$20240729$EXP$$US-AstraZeneca-2022A355677$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241451991$24145199$1$I$20230830$20230830$20240729$20240729$EXP$$US-AstraZeneca-2023A199673$ASTRAZENECA$$86$YR$$M$Y$$$20240729$$CN$US$
241452001$24145200$1$I$20230305$20230308$20240729$20240729$EXP$$SA-AstraZeneca-2023A059980$ASTRAZENECA$$62$YR$$M$Y$$$20240729$$CN$SA$
241452011$24145201$1$I$$20230109$20240729$20240729$EXP$$PH-AstraZeneca-2023A005601$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$PH$
241452021$24145202$1$I$20210101$20210727$20240729$20240729$EXP$$US-AstraZeneca-2021A654647$ASTRAZENECA$$60$YR$$M$Y$$$20240729$$CN$US$
241452031$24145203$1$I$$20230714$20240729$20240729$EXP$$US-AstraZeneca-2023A163102$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241452041$24145204$1$I$$20230830$20240729$20240729$EXP$$US-AstraZeneca-2023A202416$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241452051$24145205$1$I$$20240717$20240729$20240729$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092570$VIIV$$$$$$Y$$$20240729$$HP$US$US
241452061$24145206$1$I$$20240726$20240729$20240729$PER$$US-HALEON-2189274$Haleon PLC$$$$$F$Y$$$20240729$$CN$US$US
241452073$24145207$3$F$20240719$20240912$20240729$20240918$EXP$$JP-GENMAB-2024-02705$GENMAB$$8$DEC$$M$Y$$$20240919$$MD$JP$JP
241452081$24145208$1$I$20240711$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147849$AMGEN$$68$YR$E$M$Y$$$20240729$$CN$US$US
241452094$24145209$4$F$20240613$20240803$20240729$20240814$PER$$US-ROCHE-10000030105$ROCHE$$$$$F$Y$$$20240814$$CN$US$US
241452111$24145211$1$I$$20230920$20240729$20240729$PER$$US-APOTEX-2023AP014149$APOTEX$Savarino J, Mokszycki R, Tubbs R, Wightman R. Refractory hypoglycemia due to sulfonylurea contamination of illicit opioid medication.. Clinical Toxicology. 2023;61 (Suppl. 2):171$67$YR$$M$Y$$$20240729$$HP$US$US
241452121$24145212$1$I$$20231227$20240729$20240729$PER$$US-APOTEX-2023AP018448$APOTEX$Banerjee E, Doshi SB, Lebastchi J, Fernandes A. What^s in a Bottle? the Importance of Careful Medication Review to Prevent Life Threatening Hypoglycemia. Journal of the Endocrine Society. 2020;4 (Suppl. 1):A786$73$YR$$M$Y$$$20240729$$MD$US$US
241452132$24145213$2$F$20240701$20240730$20240729$20240803$PER$$US-ABBVIE-5855840$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241452141$24145214$1$I$$20240722$20240729$20240729$EXP$GB-MHRA-31137098$GB-RDY-SPO/GBR/24/0010872$DR REDDYS$$$$$M$Y$$$20240729$$CN$GB$GB
241452151$24145215$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092763$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241452161$24145216$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5854931$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241452171$24145217$1$I$$20240722$20240729$20240729$EXP$$JP-ROCHE-10000037583$ROCHE$Sakai T, Kuroda R, Chiko Y, Fujiwara M, Itagaki K, Maruyama K et al.. O-111 A case of a patient who contracted COVID-19 and experienced prolongation a year after BG therapy. Japanese Journal of Hospital General Medicine / The 28th Annual Meeting of Japan. 2024;20(S1):182$7$DEC$E$M$Y$$$20240729$$MD$JP$JP
241452181$24145218$1$I$20220415$20240718$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036602$AUROBINDO$$60$YR$$F$Y$75$KG$20240729$$MD$FR$FR
241452192$24145219$2$F$20240701$20240821$20240729$20240827$EXP$$US-ABBVIE-5853918$ABBVIE$$53$YR$$M$Y$$$20240827$$CN$US$US
241452201$24145220$1$I$20240101$20240416$20240729$20240729$PER$$US-AJANTA-2024AJA00079$AJANTA PHARMA$$68$YR$E$F$Y$182$KG$20240729$$CN$US$US
241452211$24145221$1$I$$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119141$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240729$$HP$US$US
241452223$24145222$3$F$$20240829$20240729$20240907$EXP$$PT-AUROBINDO-AUR-APL-2024-037196$AUROBINDO$Monteiro SC, Vieira R, Bravo S, Nogueira J, Paracana B, Henriques J. HIPERSENSIBILIDADE CORON?RIA: A PROP?SITO DE UM CASO CL?NICO (HYPERSENSITIVITY CORONARY: THE PURPOSE OF A CLINICAL CASE). Cardiovascular diseases. 2024;189$77$YR$$F$Y$$$20240907$$HP$PT$PT
241452232$24145223$2$F$20240101$20240726$20240729$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118465$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$90.72$KG$20240730$$HP$US$US
241452241$24145224$1$I$$20240723$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118729$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240729$$CN$US$US
241452251$24145225$1$I$20240705$20240719$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116066$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240729$$PH$US$US
241452262$24145226$2$F$20240723$20240813$20240729$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202407016816$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240816$$CN$US$US
241452271$24145227$1$I$20240724$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017014$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240729$$CN$US$US
241452281$24145228$1$I$$20240723$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017470$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241452291$24145229$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016859$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240729$$CN$US$US
241452301$24145230$1$I$20240710$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016147$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240729$$CN$US$US
241452311$24145231$1$I$$20240722$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407014210$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240729$$CN$US$US
241452321$24145232$1$I$$20240723$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017046$ELI LILLY AND CO$$$$$M$Y$$$20240729$$CN$US$US
241452331$24145233$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016870$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240729$$CN$US$US
241452341$24145234$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016851$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240729$$CN$US$US
241452351$24145235$1$I$20231001$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016979$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240729$$CN$US$US
241452361$24145236$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016850$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240729$$CN$US$US
241452371$24145237$1$I$20240722$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016990$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241452381$24145238$1$I$$20240724$20240729$20240729$PER$$US-GILEAD-2024-0681865$GILEAD$$22$YR$A$M$Y$$$20240729$$CN$US$US
241452391$24145239$1$I$20240610$20240718$20240729$20240729$EXP$$DE-AUROBINDO-AUR-APL-2024-036455$AUROBINDO$$27$YR$$M$Y$70$KG$20240729$$CN$DE$DE
241452401$24145240$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092454$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241452413$24145241$3$F$$20240820$20240729$20240821$EXP$$JP-GSK-JP2024JPN091972$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$JP$JP
241452421$24145242$1$I$$20240722$20240729$20240729$PER$$US-AMGEN-USASP2024146577$AMGEN$$$$$$Y$$$20240729$$PH$US$US
241452432$24145243$2$F$20240723$20240905$20240729$20240906$PER$$US-AMGEN-USASP2024148048$AMGEN$$82$YR$E$F$Y$$$20240906$$CN$US$US
241452441$24145244$1$I$20240718$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148425$AMGEN$$$$$$Y$$$20240729$$MD$US$US
241452462$24145246$2$F$$20240729$20240729$20240801$EXP$$GR-ABBVIE-5857052$ABBVIE$$$$$F$Y$$$20240801$$MD$GR$GR
241452471$24145247$1$I$$20230823$20240729$20240729$EXP$$US-AstraZeneca-2023A193549$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241452481$24145248$1$I$$20240715$20240729$20240729$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07187$LUPIN$$$$$$Y$$$20240729$$CN$AU$AU
241452492$24145249$2$F$20240309$20240903$20240729$20240910$EXP$$JP-GSK-JP2024JPN092446$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$JP$JP
241452501$24145250$1$I$$20240723$20240729$20240729$EXP$$CA-AMGEN-CANSL2024147996$AMGEN$$67$YR$E$F$Y$$$20240729$$CN$CA$CA
241452511$24145251$1$I$$20240722$20240729$20240729$PER$$US-AMGEN-USASP2024148309$AMGEN$Parraga S. P.; Hrin M. L.; Jorizzo J. L.. Management of brunsting-perry pemphigoid (BPP): A single-center retrospective case series. Journal of Investigative Dermatology. 2024;144 (8):S42$$$$$Y$$$20240729$$HP$US$US
241452521$24145252$1$I$$20240725$20240729$20240729$PER$$US-HALEON-2189138$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241452541$24145254$1$I$$20240716$20240729$20240729$EXP$$JP-ROCHE-10000034487$ROCHE$Funakoshi T, Funakoshi T, Yashiro K, Tanaka R, Et al.. Clinical Trial of Rituximab Treatment for Refractory Pemphigus Conducted under the Patient-proposed Health Services Criteria. The Japanese Journal of Dermatology. 2024-Jun-20;134 (7):1869-76.$$$$$Y$$$20240729$$HP$JP$JP
241452551$24145255$1$I$$20240722$20240729$20240729$EXP$$US-TAKEDA-2024TUS074133$TAKEDA$$$$$M$Y$$$20240729$$CN$US$US
241452561$24145256$1$I$$20240717$20240729$20240729$EXP$$US-APOTEX-2024AP008619$APOTEX$Wilson P, Rosenstengle C, Spak C.. Underrecognized cause diarrhea in solid organ transplant: a report of astroviridae enteritis in liver transplant. Transplant Infectious Disease. 2024;26 (2) e14257:1-3$72$YR$$M$Y$$$20240729$$MD$US$US
241452581$24145258$1$I$$20240722$20240729$20240729$PER$$US-ALXN-202407USA001447US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241452591$24145259$1$I$20240715$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119143$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240729$$PH$US$US
241452601$24145260$1$I$$20240724$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119065$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240729$$CN$US$US
241452611$24145261$1$I$20240601$20240719$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116088$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240729$$PH$US$US
241452621$24145262$1$I$$20240715$20240729$20240729$EXP$$FR-TWI PHARMACEUTICAL, INC-20240700029$TWI PHARMACEUTICALS$Bennassi A.; Rivin Del Campo E.; Theodore C.; Huguet F. Breast cancer in a transgender man and hypofractionated radiotherapy: A case report and review of literature. Cancer/Radiotherapie. 2024;28:3:272-274$77$YR$$$Y$$$20240725$$$FR$FR
241452631$24145263$1$I$20240123$20240718$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036552$AUROBINDO$$64$YR$$M$Y$92$KG$20240729$$MD$FR$FR
241452641$24145264$1$I$20230131$20240719$20240729$20240729$EXP$PL-URPL-DML-MLP.4401.1.811.2023$PL-TEVA-VS-3223399$TEVA$$46$YR$$F$Y$160$KG$20240729$$MD$PL$PL
241452652$24145265$2$F$20240723$20240827$20240729$20240828$PER$$US-AMGEN-USASP2024147870$AMGEN$$56$YR$A$F$Y$$$20240828$$CN$US$US
241452661$24145266$1$I$$20240723$20240729$20240729$EXP$GB-MHRA-MIDB-bd114c69-677f-435a-a19f-c1b558e7d6db$GB-AMGEN-GBRSP2024146621$AMGEN$$76$YR$E$$Y$$$20240729$$PH$GB$GB
241452671$24145267$1$I$20240315$20240718$20240729$20240729$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002057$Alvotech$$64$YR$$F$Y$$$20240729$$PH$CA$CA
241452681$24145268$1$I$$20240726$20240729$20240729$PER$$US-ROCHE-10000039990$ROCHE$$$$$F$Y$$$20240729$$MD$US$US
241452691$24145269$1$I$20240127$20240724$20240729$20240729$EXP$FR-AFSSAPS-ST2024001138$FR-ROCHE-10000036293$ROCHE$$56$YR$A$M$Y$77.2$KG$20240729$$HP$FR$FR
241452701$24145270$1$I$20240713$20240718$20240729$20240729$EXP$$CN-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000173-2024$QILU PHARMACEUTICAL$$54$YR$A$M$Y$55$KG$20240729$$HP$CN$CN
241452711$24145271$1$I$20240613$20240719$20240729$20240729$EXP$$CA-CELLTRION INC.-2024CA015583$CELLTRION$$$$$$Y$$$20240729$$HP$CA$CA
241452721$24145272$1$I$$20240717$20240729$20240729$EXP$$CN-Appco Pharma LLC-2159698$APPCO PHARMA$Initial$43$YR$$F$Y$$$20240729$$$CN$CN
241452731$24145273$1$I$20240608$20240725$20240729$20240729$EXP$$IN-ROCHE-10000039989$ROCHE$$54$YR$A$M$Y$$$20240729$$CN$IN$IN
241452741$24145274$1$I$$20240703$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06714$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241452751$24145275$1$I$$20240717$20240729$20240729$EXP$$US-ROCHE-10000029786$ROCHE$$$$A$F$Y$$$20240729$$CN$US$US
241452761$24145276$1$I$20240110$20240725$20240729$20240729$PER$$NVSC2024US153922$NOVARTIS$$65$YR$$M$Y$$$20240729$$CN$US$US
241452771$24145277$1$I$$20231204$20240729$20240729$PER$$US-APOTEX-2023AP017713$APOTEX$$$$$$Y$$$20240729$$MD$US$US
241452782$24145278$2$F$20210101$20240726$20240729$20240802$EXP$ID-MLMSERVICE-20221115-3918732-1$ID-SA-2024SA215799$SANOFI AVENTIS$Rohmah SN, Kuswadi I, Prasanto H, Puspitasari M, Wardhani Y.. CLINICAL PROFILE AND OUTCOME OF TUBERCULOSIS IN KIDNEY TRANSPLANT RECIPIENTS: A CASE SERIES IN DR. SARDJITO GENERAL HOSPITAL, INDONESIA.. Nephrology.. 2022;27(Supplement 1:112$42$YR$A$M$Y$$$20240802$$MD$ID$ID
241452791$24145279$1$I$$20240717$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036466$AUROBINDO$Furst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R, et al.. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLAimmunized adults with sickle cell disease. Bone Marrow Transplantation. 2024;59 (7):918-27$22$YR$$M$Y$$$20240729$$MD$FR$FR
241452801$24145280$1$I$20240101$20240722$20240729$20240729$EXP$$US-SA-2024SA152232$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240729$$MD$US$US
241452812$24145281$2$F$$20240729$20240729$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-037295$AUROBINDO$Tenreiro P, Pacheco M, Salgueiro R, Santos C, Cardoso A,. POSA-028 - (2398) - ENDOCARDITE E AVC: A PROP?SITO DE UM CASO CL?NICO (POSA-028 - (2398) - ENDOCARDITIS AND STROKE:  THE PURPOSE OF A CLINICAL CASE). Doen?as cerebrovasculares e neurol?gicas | Caso cl?nico (Cerebrovascular and ne). 1100$69$YR$$M$Y$$$20240808$$HP$PT$PT
241452822$24145282$2$F$20240620$20240807$20240729$20240818$EXP$$IT-AUROBINDO-AUR-APL-2024-036270$AUROBINDO$$95$YR$$F$Y$$$20240818$$MD$IT$IT
241452831$24145283$1$I$20220215$20240722$20240729$20240729$EXP$$US-SA-2024SA219036$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240729$$MD$US$US
241452843$24145284$3$F$20240701$20240827$20240729$20240830$PER$$US-JNJFOC-20240768476$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240830$$HP$US$US
241452852$24145285$2$F$$20240911$20240729$20240928$PER$$US-JNJFOC-20240765270$JOHNSON AND JOHNSON$$$$$M$Y$$$20240928$$CN$US$US
241452861$24145286$1$I$$20240724$20240729$20240729$EXP$$NVSC2024US153812$NOVARTIS$$$$$F$Y$$$20240729$$HP$US$US
241452882$24145288$2$F$$20240715$20240729$20240729$EXP$$ES-AUROBINDO-AUR-APL-2024-035505$AUROBINDO$Garcia Ruiz PJ, Feliz LD, Feliz CE, Sanchez IL, Fernandez AA, Kelly FB, et al.. The enduring enigma of sporadic chorea: A single center case series.. Tremor-Other-Hyperkinet-M. 2023;13(1):1- 10$58$YR$$F$Y$$$20240729$$MD$ES$ES
241452891$24145289$1$I$$20240703$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06861$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241452902$24145290$2$F$20240723$20240808$20240729$20240809$PER$$US-AMGEN-USASP2024148036$AMGEN$$51$YR$A$M$Y$$$20240809$$CN$US$US
241452911$24145291$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148978$AMGEN$$$$$$Y$$$20240729$$PH$US$US
241452921$24145292$1$I$20230213$20240719$20240729$20240729$EXP$IT-MINISAL02-994755$IT-TEVA-VS-3223426$TEVA$$61$YR$$F$Y$$$20240729$$MD$IT$IT
241452931$24145293$1$I$$20240725$20240729$20240729$EXP$$NVSC2024US153767$NOVARTIS$$$$$$Y$$$20240729$$MD$US$US
241452941$24145294$1$I$20240120$20240726$20240729$20240729$EXP$GB-MHRA-MED-202407261059510910-RLYDC$GB-JNJFOC-20240772313$JOHNSON AND JOHNSON$$60$YR$A$F$Y$75$KG$20240729$$PH$GB$GB
241452951$24145295$1$I$$20240723$20240729$20240729$EXP$$US-JNJFOC-20240761982$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$MD$US$US
241452961$24145296$1$I$20230101$20240724$20240729$20240729$EXP$DK-DKMA-30734300$DK-ROCHE-10000035067$ROCHE$$69$YR$E$F$Y$$$20240729$$MD$DK$DK
241452972$24145297$2$F$20240724$20240822$20240729$20240826$PER$$US-AMGEN-USASP2024147878$AMGEN$$62$YR$A$F$Y$$$20240825$$HP$US$US
241452982$24145298$2$F$$20240821$20240729$20240902$EXP$$PT-AUROBINDO-AUR-APL-2024-037252$AUROBINDO$Quadrado F, Vieira AT, Jacinto M, Ribeirinho R. PO-0292 - (2710) -MENINGOENCEFALITE A VHS (MENINGOENCEPHALITIS AT VHS-7). Doen?as infeciosas e parasit?rias | Caso cl?nico (Infectious and parasitic disea. 2024;30:657$20$YR$$F$Y$$$20240902$$HP$PT$PT
241452991$24145299$1$I$20240721$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147635$AMGEN$$64$YR$A$F$Y$$$20240729$$CN$US$US
241453001$24145300$1$I$20240724$20240726$20240729$20240729$PER$$US-AMGEN-USASP2024149770$AMGEN$$$$$$Y$$$20240729$$PH$US$US
241453021$24145302$1$I$$20240719$20240729$20240729$EXP$$PL-TAKEDA-2024TUS073931$TAKEDA$$50$YR$$F$Y$$$20240729$$CN$PL$PL
241453031$24145303$1$I$$20240722$20240729$20240729$EXP$$US-SANDOZ INC.-SDZ2024US068383$SANDOZ$$$$$$Y$$$20240729$$PH$US$US
241453041$24145304$1$I$20231201$20240715$20240729$20240729$PER$$US-ROCHE-10000028363$ROCHE$$79$YR$E$F$Y$71.67$KG$20240729$$CN$US$US
241453051$24145305$1$I$$20240722$20240729$20240729$PER$$US-ROCHE-10000035181$ROCHE$Bandali T, Kim Y, Khodadoust M, Rieger K, Fernandez-Pol S, Saleem A, et al. Polatuzumab vedotin-piiq for treatment of primary cutaneous diffuse large Bcell lymphoma, leg-type (PCDLBCL-LT) in older adults (Abstract number: 282). Journal of Investigative Dermatology. 2024-Aug;144 (8):S49. doi:10.1016/j.jid.2024.06.298.$92$YR$E$M$Y$$$20240729$$HP$US$US
241453061$24145306$1$I$$20240718$20240729$20240729$PER$$US-ROCHE-10000035264$ROCHE$KROOKS J, Weatheral A. Rituximab-induced Serum Sickness in Pemphigus Vulgaris: A Case Report and Literature Review. Practical dermatology. 2019;75-78.$38$YR$A$F$Y$$$20240729$$HP$US$US
241453071$24145307$1$I$20230614$20240722$20240729$20240729$EXP$$CN-ROCHE-10000033462$ROCHE$Zheng G, Qiu R, Li J. Case Analysis and Literature Review of Severe Cutaneous Reactions caused by Tocilizumab. Central South Pharmacy. 2024-Jun;22 (6):1678-81. doi:10.7539/j.issn.1672-2981.2024.06.044.$37$YR$A$F$Y$$$20240729$$HP$CN$CN
241453091$24145309$1$I$$20240716$20240729$20240729$PER$$US-TEVA-VS-3224402$TEVA$$$$$$Y$$$20240729$$CN$US$US
241453102$24145310$2$F$$20240830$20240729$20240903$EXP$$US-TAKEDA-2024TUS074314$TAKEDA$$$$$F$Y$$$20240903$$CN$US$US
241453111$24145311$1$I$$20240625$20240729$20240729$PER$$US-ROCHE-10000016275$ROCHE$$82$YR$E$F$Y$$$20240729$$CN$US$US
241453121$24145312$1$I$$20210901$20240729$20240729$EXP$$AU-AstraZeneca-2021A711224$ASTRAZENECA$$$$$F$Y$$$20240729$$MD$AU$
241453132$24145313$2$F$$20240920$20240729$20240924$EXP$$NVSC2024US047955$NOVARTIS$$$$$M$Y$$$20240924$$CN$US$US
241453141$24145314$1$I$20240623$20240726$20240729$20240729$EXP$$PK-ROCHE-10000039873$ROCHE$$68$YR$E$M$Y$$$20240729$$CN$PK$PK
241453151$24145315$1$I$$20240717$20240729$20240729$EXP$$JP-LAURUS LABS LIMITED-2024LAU000057$LAURUS LABS LIMITED$Takahashi Y, Nakano H, Motoki M, Wakimoto Y, Ikechi D, Koyama Y, Hashimoto H. Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review. Acute Med Surg.. 2024;11(1)$45$YR$$F$Y$90$KG$20240729$$HP$JP$JP
241453161$24145316$1$I$20230501$20240719$20240729$20240729$EXP$IT-MINISAL02-994741$IT-TEVA-VS-3223444$TEVA$$34$YR$$M$Y$$$20240729$$MD$IT$IT
241453171$24145317$1$I$$20240725$20240729$20240729$EXP$$NVSC2024US153722$NOVARTIS$$68$YR$$F$Y$$$20240729$$CN$US$US
241453181$24145318$1$I$20210701$20240719$20240729$20240729$EXP$$HR-LAURUS LABS LIMITED-2024LAU000058$LAURUS LABS LIMITED$Vicic M, Hlaca N, Skender K, Kastelan M, Jonjic N, Prpic-Massari L. Lichen planus pigmentosus-like reaction to pirfenidone in a patient with idiopathic pulmonary fibrosis. Int J Dermatol.. Int J Dermatol. 2024$69$YR$$F$Y$$$20240729$$HP$HR$HR
241453191$24145319$1$I$20240101$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147781$AMGEN$$69$YR$E$F$Y$$$20240729$$HP$US$US
241453202$24145320$2$F$20240718$20240816$20240729$20240822$30DAY$$US-AMGEN-USASP2024146774$AMGEN$$45$YR$A$M$Y$69.3$KG$20240822$$PH$US$US
241453211$24145321$1$I$$20240722$20240729$20240729$EXP$$US-EMD Serono-2024040456$EMD SERONO INC$$$$A$M$Y$$$20240729$$CN$US$US
241453222$24145322$2$F$$20240913$20240729$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119152$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$82.1$KG$20240916$$CN$US$US
241453231$24145323$1$I$20240720$20240724$20240729$20240729$EXP$$NVSC2024CN153707$NOVARTIS$$$$$F$Y$$$20240729$$MD$CN$CN
241453242$24145324$2$F$$20240912$20240729$20240912$PER$$NVSC2024US149312$NOVARTIS$$47$YR$$F$Y$$$20240913$$HP$US$US
241453251$24145325$1$I$$20240711$20240729$20240729$PER$$US-TEVA-VS-3225473$TEVA$$$$$F$Y$$$20240729$$CN$US$US
241453261$24145326$1$I$20240724$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148154$AMGEN$$$$$$Y$$$20240729$$HP$US$US
241453271$24145327$1$I$20240724$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148062$AMGEN$$76$YR$E$F$Y$$$20240729$$CN$US$US
241453281$24145328$1$I$20240726$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017687$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240729$$CN$US$US
241453291$24145329$1$I$20240705$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017018$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240729$$CN$US$US
241453301$24145330$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016889$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241453313$24145331$3$F$20220901$20240911$20240729$20240917$EXP$$BR-TAKEDA-2024TUS074095$TAKEDA$$87$YR$$F$Y$60$KG$20240917$$HP$BR$BR
241453321$24145332$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016972$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240729$$CN$US$US
241453331$24145333$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016831$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240729$$CN$US$US
241453341$24145334$1$I$20240701$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016999$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240729$$CN$US$US
241453352$24145335$2$F$$20240725$20240729$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017318$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240730$$CN$US$US
241453362$24145336$2$F$$20240725$20240729$20240802$PER$$US-AMGEN-USASP2024148906$AMGEN$$$$$M$Y$$$20240801$$HP$US$US
241453373$24145337$3$F$20240606$20240820$20240729$20240821$EXP$FR-AFSSAPS-TS2024000829$FR-ORGANON-O2407FRA002308$ORGANON$$$$$F$Y$2.7$KG$20240821$$MD$FR$FR
241453381$24145338$1$I$20240704$20240719$20240729$20240729$EXP$$DK-VALIDUS PHARMACEUTICALS LLC-DK-VDP-2024-019333$VALIDUS$$$$$$Y$$$20240729$$MD$DK$DK
241453391$24145339$1$I$$20240715$20240729$20240729$PER$$US-ROCHE-10000035917$ROCHE$Shirini K, Kamberi S, Drachenberg C, Haririan A, Saharia K, Meier RPH. Renal transplantation using kidneys from a donor with high grade cytomegalovirus viraemia: case report and literature review. Grand Round. 2024. https://doi.org/10.1016/S1473-3099(24)00359-1.$61$YR$A$M$Y$69.4$KG$20240729$$MD$US$US
241453401$24145340$1$I$20240718$20240718$20240729$20240729$EXP$$US-009507513-2407USA011519$MERCK$$$$$F$Y$$$20240729$$CN$US$US
241453411$24145341$1$I$20240101$20240722$20240729$20240729$PER$$US-ABBVIE-5855680$ABBVIE$$$$$F$Y$$$20240729$$HP$US$US
241453422$24145342$2$F$20240725$20240806$20240729$20240808$PER$$US-AMGEN-USASP2024149717$AMGEN$$58$YR$A$M$Y$$$20240807$$CN$US$US
241453431$24145343$1$I$$20240723$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117808$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240729$$HP$US$US
241453442$24145344$2$F$$20240813$20240729$20240814$EXP$$JP-TAKEDA-2024TJP011175$TAKEDA$$65$YR$$F$Y$$$20240814$$MD$JP$JP
241453451$24145345$1$I$20240719$20240722$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116147$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240729$$CN$US$US
241453462$24145346$2$F$20240701$20240924$20240729$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119053$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240926$$CN$US$US
241453471$24145347$1$I$$20240718$20240729$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106806$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240729$$MD$JP$JP
241453481$24145348$1$I$20220510$20220531$20240729$20240729$EXP$$CO-AstraZeneca-2022A210030$ASTRAZENECA$$23163$DY$$M$Y$$$20240729$$CN$CO$
241453491$24145349$1$I$$20211006$20240729$20240729$EXP$$US-AstraZeneca-2021A765773$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241453501$24145350$1$I$$20210730$20240729$20240729$EXP$$US-AstraZeneca-2021A655788$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241453511$24145351$1$I$$20230925$20240729$20240729$EXP$$US-AstraZeneca-2023A219298$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241453521$24145352$1$I$20210712$20210713$20240729$20240729$EXP$$ZA-AstraZeneca-2021A624656$ASTRAZENECA$$39$YR$$F$Y$$$20240729$$CN$ZA$
241453531$24145353$1$I$$20231003$20240729$20240729$PER$$US-APOTEX-2023AP014986$APOTEX$Lyes M, Yang KH, Castellanos J, Furnish T. Microdosing psilocybin for chronic pain: a case series. Pain. 2023;164(4):698-702$69$YR$$F$Y$$$20240729$$HP$US$US
241453541$24145354$1$I$$20240722$20240729$20240729$EXP$$CA-JNJFOC-20240764152$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240729$$HP$CA$CA
241453551$24145355$1$I$$20240723$20240729$20240729$PER$$US-ABBVIE-5852456$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241453563$24145356$3$F$$20240827$20240729$20240829$EXP$$US-GILEAD-2024-0676308$GILEAD$$$$A$M$Y$1.002$KG$20240829$$CN$US$US
241453571$24145357$1$I$$20240715$20240729$20240729$EXP$$CN-PBT-009554$PANACEA BIOTEC$Fu P, Hu Z, Zhang G, Li Z. Case report: Ofatumumab treatment in anti-DPPX autoimmune encephalitis. Front Immunol. 2024 Jun 27;15:1320608. doi: 10.3389/fimmu.2024.1320608.$51$YR$A$M$Y$$$20240729$$HP$CN$CN
241453581$24145358$1$I$$20240703$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06865$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241453591$24145359$1$I$$20240716$20240729$20240729$PER$$US-TEVA-VS-3222670$TEVA$$$$$$Y$$$20240729$$CN$US$US
241453601$24145360$1$I$$20240723$20240729$20240729$EXP$$JP-GSK-JP2024JPN092444$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$PH$JP$JP
241453612$24145361$2$F$20240701$20240724$20240729$20240802$EXP$DE-BFARM-24005127$DE-ORGANON-O2407DEU002288$ORGANON$$34$YR$$F$Y$$$20240802$$MD$DE$DE
241453621$24145362$1$I$20240705$20240724$20240729$20240729$EXP$$CA-TAKEDA-2024TUS075644$TAKEDA$$28$YR$$F$Y$$$20240729$$MD$CA$CA
241453632$24145363$2$F$$20240718$20240729$20240729$EXP$$CA-ROCHE-3551761$ROCHE$$47$YR$A$F$Y$$$20240729$$CN$CA$CA
241453641$24145364$1$I$$20240725$20240729$20240729$EXP$$NVSC2024IT153726$NOVARTIS$$$$$M$Y$$$20240729$$MD$IT$IT
241453651$24145365$1$I$20240520$20240723$20240729$20240729$EXP$ES-AEMPS-1545421$ES-HALEON-2188840$Haleon PLC$$86$YR$$F$Y$60$KG$20240729$$MD$ES$ES
241453662$24145366$2$F$$20240722$20240729$20240730$EXP$$AU-009507513-2407AUS013910$MERCK$$$$$F$Y$$$20240730$$MD$AU$AU
241453672$24145367$2$F$20240101$20240819$20240729$20240823$EXP$$US-UCBSA-2024037856$UCB$$$$$M$Y$$$20240823$$CN$US$US
241453682$24145368$2$F$20240608$20240705$20240729$20240815$PER$$US-TRAVERE-2024TVT00588$TRAVERE THERAPEUTICS$$35$YR$A$F$Y$$$20240815$$CN$US$US
241453691$24145369$1$I$20240128$20240723$20240729$20240729$EXP$GB-MHRA-30722942$GB-RDY-SPO/GBR/24/0010925$DR REDDYS$$85$YR$E$M$Y$80$KG$20240729$$CN$GB$GB
241453701$24145370$1$I$$20240719$20240729$20240729$EXP$$IN-NOVITIUMPHARMA-2024INNVP01393$NOVITIUM PHARMA$Simran Arora.A case report of continuous theta-burst transcranial magnetic stimulation induced seizures in a patient with bipolar depression on selective serotonin reuptake inhibitors.Brain Stimulation Journal.07-JUN-2024;17(4):731-733$22$YR$A$M$Y$74$KG$20240729$$HP$IN$IN
241453711$24145371$1$I$20240701$20240715$20240729$20240729$PER$$US-TEVA-VS-3225785$TEVA$$$$$F$Y$$$20240729$$CN$US$US
241453721$24145372$1$I$20240714$20240722$20240729$20240729$EXP$$NVSC2024GT153056$NOVARTIS$$67$YR$$F$Y$$$20240729$$CN$GT$GT
241453731$24145373$1$I$$20240724$20240729$20240729$EXP$$NVSC2024US152447$NOVARTIS$$$$$M$Y$$$20240729$$CN$US$US
241453741$24145374$1$I$$20240723$20240729$20240729$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2024JPN093190$VIIV$$$$$$Y$$$20240729$$MD$JP$JP
241453751$24145375$1$I$20240529$20240719$20240729$20240729$EXP$FR-AFSSAPS-MA2024000993$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-06921$HIKMA$$$$$$Y$$$20240729$$MD$FR$FR
241453761$24145376$1$I$$20240726$20240729$20240729$PER$$US-GILEAD-2024-0682114$GILEAD$$57$YR$A$F$Y$$$20240729$$HP$US$US
241453771$24145377$1$I$20240719$20240722$20240729$20240729$EXP$$CN-ALCON LABORATORIES-ALC2024CN003513$ALCON$$56$YR$$M$Y$81$KG$20240729$$HP$CN$CN
241453781$24145378$1$I$$20240725$20240729$20240729$EXP$$US-UCBSA-2024037655$UCB$$$$$M$Y$$$20240729$$CN$US$US
241453791$24145379$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119197$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240729$$CN$US$US
241453801$24145380$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118973$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240729$$CN$US$US
241453811$24145381$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148180$AMGEN$$$$E$F$Y$$$20240729$$HP$US$US
241453821$24145382$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017006$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240729$$MD$US$US
241453831$24145383$1$I$20240725$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016847$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240729$$CN$US$US
241453841$24145384$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016975$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240729$$CN$US$US
241453851$24145385$1$I$$20240723$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017286$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241453861$24145386$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016828$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240729$$CN$US$US
241453871$24145387$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017020$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240729$$CN$US$US
241453882$24145388$2$F$$20240730$20240729$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017183$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240731$$CN$US$US
241453891$24145389$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017012$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240729$$CN$US$US
241453901$24145390$1$I$20240101$20240722$20240729$20240729$PER$$US-ABBVIE-5851771$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241453911$24145391$1$I$20240715$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149736$AMGEN$$$$$$Y$$$20240729$$PH$US$US
241453921$24145392$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148336$AMGEN$$$$$M$Y$$$20240729$$MD$US$US
241453931$24145393$1$I$20240705$20240719$20240729$20240729$EXP$IT-MINISAL02-994725$IT-TEVA-VS-3223497$TEVA$$60$YR$$F$Y$$$20240729$$MD$IT$IT
241453941$24145394$1$I$$20240725$20240729$20240729$EXP$GB-MHRA-FAKE-202407080853418920-FDLTV$GB-ORGANON-O2407GBR002474$ORGANON$$$$$$Y$$$20240729$$CN$GB$GB
241453951$24145395$1$I$20240101$20240705$20240729$20240729$PER$$US-009507513-2407USA011028$MERCK$$$$$F$Y$49.5$KG$20240729$$HP$US$US
241453961$24145396$1$I$20210801$20240719$20240729$20240729$EXP$$GB-TEVA-VS-3224058$TEVA$$72$YR$$F$Y$$$20240729$$HP$GB$GB
241453971$24145397$1$I$$20240724$20240729$20240729$EXP$$CA-BEH-2024175411$CSL BEHRING$$38$YR$A$F$Y$52$KG$20240729$$CN$CA$CA
241453982$24145398$2$F$20231208$20240716$20240729$20240731$EXP$$CN-ROCHE-10000029854$ROCHE$$$$$F$Y$$$20240731$$HP$CN$CN
241453991$24145399$1$I$$20240725$20240729$20240729$PER$$US-TAKEDA-2024TUS075371$TAKEDA$$$$$M$Y$120$KG$20240729$$MD$US$US
241454001$24145400$1$I$$20240725$20240729$20240729$PER$$NVSC2024US154066$NOVARTIS$$$$$M$Y$$$20240729$$CN$US$US
241454011$24145401$1$I$$20231117$20240729$20240729$EXP$$US-AstraZeneca-2023A263719$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241454023$24145402$3$F$20240717$20240822$20240729$20240827$EXP$$KR-ROCHE-10000033653$ROCHE$$63$YR$A$F$Y$40.7$KG$20240827$$MD$KR$KR
241454031$24145403$1$I$$20240725$20240729$20240729$EXP$$JP-TAKEDA-2024TJP011267$TAKEDA$$8$DEC$$$Y$$$20240729$$MD$JP$JP
241454041$24145404$1$I$$20220414$20240729$20240729$EXP$$US-AstraZeneca-2022A152124$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241454051$24145405$1$I$20211001$20211027$20240729$20240729$EXP$$US-AstraZeneca-2021A789773$ASTRAZENECA$$930$MON$$M$Y$$$20240729$$CN$US$
241454061$24145406$1$I$$20220311$20240729$20240729$EXP$$US-AstraZeneca-2022A112730$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241454071$24145407$1$I$20210721$20210722$20240729$20240729$EXP$$US-AstraZeneca-2021A637934$ASTRAZENECA$$24054$DY$$F$Y$$$20240729$$CN$US$
241454081$24145408$1$I$$20221206$20240729$20240729$EXP$$US-AstraZeneca-2022A401070$ASTRAZENECA$$$$$F$Y$62.6$KG$20240729$$CN$US$
241454091$24145409$1$I$$20231016$20240729$20240729$EXP$$US-AstraZeneca-2023A238918$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241454101$24145410$1$I$$20230125$20240729$20240729$EXP$$US-AstraZeneca-2023A023117$ASTRAZENECA$$$$$F$Y$67$KG$20240729$$CN$US$
241454111$24145411$1$I$$20210726$20240729$20240729$EXP$$US-AstraZeneca-2021A540030$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241454121$24145412$1$I$$20240723$20240729$20240729$PER$$US-TAKEDA-2024TUS075289$TAKEDA$$$$$$Y$$$20240729$$CN$US$US
241454131$24145413$1$I$$20240715$20240729$20240729$EXP$$PT-AUROBINDO-AUR-APL-2024-037311$AUROBINDO$Martins B M, Pinto G R, Mesquita P P, Andrade J, Alves A, Gomes V.. PO-0198 - (2726) - ERITEMA NODOSO - WHAT ELSE? (ERITEMA NODOSO - WHAT ELSE?). Doen?as autoimunes, reumatol?gicas e vasculites (Autoimmune, rheumatological di). 566$56$YR$$F$Y$$$20240729$$HP$PT$PT
241454141$24145414$1$I$20240715$20240716$20240729$20240729$PER$$US-TEVA-VS-3224174$TEVA$$23$YR$$M$Y$74.84$KG$20240729$$CN$US$US
241454161$24145416$1$I$20240101$20240725$20240729$20240729$EXP$$US-UCBSA-2024037773$UCB$$$$$F$Y$$$20240729$$HP$US$US
241454171$24145417$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118785$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$65.32$KG$20240729$$CN$US$US
241454181$24145418$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118843$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240729$$HP$US$US
241454191$24145419$1$I$$20240718$20240729$20240729$EXP$$CA-APOTEX-2024AP008613$APOTEX$$44$YR$$F$Y$$$20240729$$HP$CA$CA
241454201$24145420$1$I$$20240719$20240729$20240729$EXP$$GB-TEVA-VS-3224111$TEVA$$5$YR$$M$Y$17$KG$20240729$$MD$GB$GB
241454211$24145421$1$I$$20240724$20240729$20240729$EXP$$US-JNJFOC-20240766526$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$CN$US$US
241454228$24145422$8$F$$20240909$20240729$20240921$EXP$$PT-AUROBINDO-AUR-APL-2024-037266$AUROBINDO$I Correia; R E?a; MJ Barbosa; L Soares; M Monteiro; U Boxes. DRESS SYNDROME: A RARE SECONDARY RESPONSE. Autoimmune, rheumatological diseases and vasculitis; Clinical case. 2024;846$30$YR$$M$Y$$$20240921$$MD$PT$PT
241454232$24145423$2$F$$20240729$20240729$20240730$PER$$US-AMGEN-USASP2024148982$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241454241$24145424$1$I$20230101$20240715$20240729$20240729$EXP$$US-ROCHE-10000027626$ROCHE$$69$YR$E$F$Y$78.92$KG$20240729$$CN$US$US
241454251$24145425$1$I$20110101$20240724$20240729$20240729$EXP$SE-SEMPA-2024-005604$SE-ORGANON-O2407SWE002286$ORGANON$$51$YR$$M$Y$102$KG$20240729$$CN$SE$SE
241454265$24145426$5$F$$20240903$20240729$20240912$EXP$$PT-AUROBINDO-AUR-APL-2024-037306$AUROBINDO$Desir?e F, Matilde C, Jo?o B, Carolina G, Monica Reis. MIOPATIA IMUNOMEDIADA  POR ANTICORPOS ANTI-HMGCR ?  RELATO DE UM CASO CL?NICO (MYOPATHY IMMUNMEDIATED BY ANTI-HMGCR ANTIBODIES ? REPORT OF A CLINICAL CASE). Autoimmune, rheumatological diseases and vasculitis Clinical case. 853$69$YR$$M$Y$$$20240912$$MD$PT$PT
241454271$24145427$1$I$20240723$20240725$20240729$20240729$EXP$$JP-TAKEDA-2024TJP010115$TAKEDA$$8$DEC$$F$Y$$$20240729$$MD$JP$JP
241454281$24145428$1$I$$20240719$20240729$20240729$PER$$US-ABBVIE-5851971$ABBVIE$$$$$$Y$$$20240729$$MD$US$US
241454292$24145429$2$F$$20240717$20240729$20240801$EXP$$NZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459152$RANBAXY$Ferguson L, Hooper S. Lidocaine Infusion: An Analgesic Option for Checkpoint Inhibitor Arthritis: A Case Report. J Pain Pall Care Pharmacother. 2024;38 (2):153-156$49$YR$$M$Y$$$20240801$$MD$NZ$NZ
241454301$24145430$1$I$$20240717$20240729$20240729$EXP$GB-MHRA-MED-202407171451504760-RDBJV$GB-NOVOPROD-1257451$NOVO NORDISK$$$$$$Y$75$KG$20240729$$PH$GB$GB
241454312$24145431$2$F$$20240722$20240729$20240813$PER$$US-BEH-2024176301$CSL BEHRING$$9$YR$C$F$Y$$$20240813$$CN$US$US
241454321$24145432$1$I$$20240717$20240729$20240729$EXP$$US-NOVOPROD-1258487$NOVO NORDISK$$60$YR$$F$Y$$$20240729$$MD$US$US
241454332$24145433$2$F$20210614$20240826$20240729$20240905$EXP$$US-NOVOPROD-1258476$NOVO NORDISK$$64$YR$$M$Y$104.04$KG$20240905$$MD$US$US
241454341$24145434$1$I$20220501$20240716$20240729$20240729$EXP$$US-NOVOPROD-1258474$NOVO NORDISK$$48$YR$$M$Y$$$20240729$$CN$US$US
241454351$24145435$1$I$$20240717$20240729$20240729$EXP$$US-NOVOPROD-1258478$NOVO NORDISK$$$$$F$Y$$$20240729$$PH$US$US
241454361$24145436$1$I$$20240717$20240729$20240729$EXP$$US-NOVOPROD-1258475$NOVO NORDISK$$$$$F$Y$$$20240729$$MD$US$US
241454371$24145437$1$I$20220101$20240717$20240729$20240729$EXP$$US-NOVOPROD-1258372$NOVO NORDISK$$64$YR$$M$Y$$$20240729$$CN$US$US
241454381$24145438$1$I$20230901$20240717$20240729$20240729$EXP$$CA-NOVOPROD-1258841$NOVO NORDISK$$57$YR$$M$Y$$$20240729$$CN$CA$CA
241454391$24145439$1$I$20240104$20240717$20240729$20240729$EXP$$US-NOVOPROD-1258489$NOVO NORDISK$$$$$F$Y$$$20240729$$CN$US$US
241454401$24145440$1$I$$20240717$20240729$20240729$EXP$$FR-NOVOPROD-1258854$NOVO NORDISK$$62$YR$$M$Y$$$20240729$$MD$FR$FR
241454411$24145441$1$I$20220119$20240716$20240729$20240729$EXP$$US-NOVOPROD-1258318$NOVO NORDISK$$$$$F$Y$$$20240729$$CN$US$US
241454421$24145442$1$I$20240716$20240717$20240729$20240729$EXP$$US-NOVOPROD-1258466$NOVO NORDISK$$$$$F$Y$$$20240729$$CN$US$US
241454431$24145443$1$I$$20240716$20240729$20240729$EXP$$US-NOVOPROD-1258382$NOVO NORDISK$$96$YR$$$Y$$$20240729$$CN$US$US
241454441$24145444$1$I$20240101$20240717$20240729$20240729$EXP$$CA-NOVOPROD-1258794$NOVO NORDISK$$51$YR$$M$Y$120$KG$20240729$$HP$CA$CA
241454451$24145445$1$I$$20240717$20240729$20240729$EXP$$US-NOVOPROD-1259160$NOVO NORDISK$$$$A$F$Y$$$20240729$$CN$US$US
241454462$24145446$2$F$20220401$20240812$20240729$20240821$EXP$$US-NOVOPROD-1258823$NOVO NORDISK$$63$YR$$F$Y$$$20240821$$CN$US$US
241454471$24145447$1$I$$20240719$20240729$20240729$EXP$$US-GILEAD-2024-0681559$GILEAD$$$$A$M$Y$$$20240729$$CN$US$US
241454481$24145448$1$I$$20240725$20240729$20240729$EXP$$JP-TAKEDA-2024TJP010990$TAKEDA$$$$$M$Y$$$20240729$$CN$JP$JP
241454491$24145449$1$I$$20240717$20240729$20240729$PER$US-MLMSERVICE-20240715-PI097334-00198-5$US-RDY-SPO/USA/24/0010670$DR REDDYS$Pokhriyal SC, Tan EF, Bhatt PK, Khan AA, Pasha MN, Pierre L, et al. Assay Interference Causing Persistently Elevated Vancomycin Levels Leading to Treatment Failure and Fatal Outcome. Cureus. 2024;16(6):e61943.DOI:10.7759/cureus.61943$69$YR$E$F$Y$$$20240729$$MD$US$US
241454501$24145450$1$I$$20240717$20240729$20240729$EXP$$TR-NOVOPROD-1259784$NOVO NORDISK$$$$$M$Y$$$20240729$$CN$TR$TR
241454513$24145451$3$F$$20240814$20240729$20240827$EXP$$PT-AUROBINDO-AUR-APL-2024-037254$AUROBINDO$Salgueiro D, Oliveira AR, Pardal N, Mota RV, Matos AS, Guerra D.. ANAMNESE: A PRINCIPAL ARMA DIAGN?STICA (ANAMNESIS: THE MAIN DIAGNOSTIC WEAPON). Doen?as hematol?gicas (Hematological diseases). 2024;682:PO-0318 - 4320$65$YR$$F$Y$$$20240827$$MD$PT$PT
241454521$24145452$1$I$20240101$20240717$20240729$20240729$EXP$$GB-NOVOPROD-1256435$NOVO NORDISK$$45$YR$$F$Y$99.8$KG$20240729$$HP$GB$GB
241454531$24145453$1$I$20000101$20240717$20240729$20240729$EXP$$US-NOVOPROD-1259173$NOVO NORDISK$$$$$M$Y$$$20240729$$CN$US$US
241454541$24145454$1$I$20240501$20240716$20240729$20240729$EXP$$US-NOVOPROD-1259063$NOVO NORDISK$$74$YR$$F$Y$$$20240729$$CN$US$US
241454551$24145455$1$I$$20240717$20240729$20240729$EXP$$JO-NOVOPROD-1259185$NOVO NORDISK$$$$A$F$Y$$$20240729$$MD$JO$JO
241454562$24145456$2$F$$20240926$20240729$20240927$EXP$$NVSC2024US152504$NOVARTIS$$$$$M$Y$$$20240927$$MD$US$US
241454571$24145457$1$I$$20240726$20240729$20240729$PER$$US-GILEAD-2024-0682112$GILEAD$$$$$M$Y$$$20240729$$PH$US$US
241454582$24145458$2$F$$20240726$20240729$20240810$PER$$US-009507513-2407USA013889$MERCK$$$$$F$Y$$$20240810$$MD$US$US
241454591$24145459$1$I$$20240715$20240729$20240729$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07281$LUPIN$$$$$$Y$$$20240729$$CN$AU$AU
241454601$24145460$1$I$$20240719$20240729$20240729$EXP$$US-NOVITIUMPHARMA-2024USNVP01395$NOVITIUM PHARMA$John C. Garman.Psychogenic Hyperphagia: Excessive Eating as Stereotypy in a Patient with Catatonia.Journal of Psychiatric Practice.MAY-2024;30(3):242-244$30$YR$A$M$Y$$$20240729$$HP$US$US
241454611$24145461$1$I$$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119045$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240729$$HP$US$US
241454621$24145462$1$I$$20230823$20240729$20240729$EXP$$US-AstraZeneca-2023A194579$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241454631$24145463$1$I$$20231009$20240729$20240729$EXP$$US-AstraZeneca-2023A229642$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241454641$24145464$1$I$$20230209$20240729$20240729$EXP$$US-AstraZeneca-2023A034711$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241454651$24145465$1$I$20240719$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118728$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240729$$PH$US$US
241454661$24145466$1$I$$20240722$20240729$20240729$EXP$$IN-ROCHE-10000032503$ROCHE$Kshirsagar V, Nandu D, Mahale D, Johar S. Drug-Drug Interactions among Critically Ill Patients with Chronic Kidney Disease Management. European Journal of Cardiovascular Medicine. 2023-Jan;13 (1):400-7.$$$$$Y$$$20240729$$MD$IN$IN
241454671$24145467$1$I$20240701$20240718$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036015$AUROBINDO$$78$YR$$F$Y$$$20240729$$MD$FR$FR
241454681$24145468$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017650$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240729$$CN$US$US
241454701$24145470$1$I$$20240722$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407014469$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240729$$CN$US$US
241454711$24145471$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016804$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240729$$CN$US$US
241454721$24145472$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017674$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240729$$CN$US$US
241454731$24145473$1$I$$20240723$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407015790$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240729$$CN$US$US
241454742$24145474$2$F$$20240805$20240729$20240808$EXP$$JP-JNJFOC-20240775562$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$PH$JP$JP
241454751$24145475$1$I$20240726$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017643$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240729$$CN$US$US
241454761$24145476$1$I$$20240702$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000250$AMARIN$$66$YR$E$F$Y$$$20240729$$CN$US$US
241454771$24145477$1$I$20240701$20240702$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000331$AMARIN$$68$YR$E$F$Y$$$20240729$$CN$US$US
241454781$24145478$1$I$20240101$20240702$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000315$AMARIN$$40$YR$A$F$Y$$$20240729$$CN$US$US
241454791$24145479$1$I$$20240703$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000332$AMARIN$$$$$M$Y$$$20240729$$CN$US$US
241454801$24145480$1$I$20240704$20240705$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000336$AMARIN$$$$$M$Y$$$20240729$$CN$US$US
241454811$24145481$1$I$20240101$20240710$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000343$AMARIN$$57$YR$A$M$Y$$$20240729$$CN$US$US
241454821$24145482$1$I$$20240708$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000339$AMARIN$$58$YR$A$M$Y$$$20240729$$CN$US$US
241454831$24145483$1$I$$20240709$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000342$AMARIN$$68$YR$E$M$Y$$$20240729$$CN$US$US
241454841$24145484$1$I$$20240711$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000347$AMARIN$$51$YR$A$M$Y$$$20240729$$CN$US$US
241454851$24145485$1$I$$20240719$20240729$20240729$PER$$US-ABBVIE-5852934$ABBVIE$$$$$$Y$$$20240729$$MD$US$US
241454861$24145486$1$I$$20240715$20240729$20240729$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07181$LUPIN$$$$$$Y$$$20240729$$CN$AU$AU
241454871$24145487$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147851$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241454881$24145488$1$I$20240716$20240716$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000357$AMARIN$$$$$F$Y$$$20240729$$CN$US$US
241454892$24145489$2$F$20231201$20240808$20240729$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000370$AMARIN$$73$YR$E$F$Y$$$20240913$$CN$US$US
241454901$24145490$1$I$$20240725$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000372$AMARIN$$79$YR$E$M$Y$$$20240729$$CN$US$US
241454911$24145491$1$I$$20240719$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000366$AMARIN$$$$$M$Y$$$20240729$$CN$US$US
241454921$24145492$1$I$20240101$20240712$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000351$AMARIN$$66$YR$E$F$Y$$$20240729$$CN$US$US
241454931$24145493$1$I$$20240725$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000358$AMARIN$$57$YR$A$M$Y$$$20240729$$CN$US$US
241454941$24145494$1$I$$20240725$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000373$AMARIN$$64$YR$A$M$Y$$$20240729$$CN$US$US
241454951$24145495$1$I$$20240725$20240729$20240729$EXP$$US-Amarin Pharma, Inc-2024AMR000374$AMARIN$$$$$$Y$$$20240729$$HP$US$US
241454961$24145496$1$I$$20240720$20240729$20240729$EXP$$FR-BIOGEN-2024BI01267224$BIOGEN$$34$YR$$M$Y$68$KG$20240729$$MD$FR$FR
241454971$24145497$1$I$20230201$20230301$20240729$20240729$EXP$$CA-CELLTRION INC.-2022CA022650$CELLTRION$$$$$$Y$$$20240729$$MD$CA$CA
241454981$24145498$1$I$20240601$20240718$20240729$20240729$EXP$$GB-AUROBINDO-AUR-APL-2024-036050$AUROBINDO$$23$YR$$F$Y$254$KG$20240729$$HP$GB$GB
241455001$24145500$1$I$$20240717$20240729$20240729$PER$US-MLMSERVICE-20240715-PI097334-00103-3$US-RDY-SPO/USA/24/0010684$DR REDDYS$Pokhriyal SC, Tan EF, Bhatt PK, Khan AA, Pasha MN, Pierre L, et al. Assay Interference Causing Persistently Elevated Vancomycin Levels Leading to Treatment Failure and Fatal Outcome. Cureus. 2024;16(6):e61943.DOI:10.7759/cureus.61943$69$YR$E$F$Y$$$20240729$$MD$US$US
241455011$24145501$1$I$$20240714$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010545$DR REDDYS$$$$$F$Y$$$20240729$$CN$US$US
241455021$24145502$1$I$20240711$20240723$20240729$20240729$EXP$$CA-JNJFOC-20240764770$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240729$$CN$CA$CA
241455031$24145503$1$I$$20240723$20240729$20240729$EXP$GB-MHRA-31008345$GB-RDY-SPO/GBR/24/0010930$DR REDDYS$$62$YR$A$F$Y$62$KG$20240729$$CN$GB$GB
241455041$24145504$1$I$20240119$20240718$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036557$AUROBINDO$$55$YR$$M$Y$69$KG$20240729$$MD$FR$FR
241455051$24145505$1$I$$20240716$20240729$20240729$EXP$$GB-AMNEAL PHARMACEUTICALS-2024-AMRX-02688$AMNEAL$Lazzari C. Nusair A.. Pregabalin addiction and withdrawal in primary and secondary care. Eur Psychiatry.. 2019;56(1):S208$50$YR$$F$Y$$$20240729$$HP$GB$GB
241455062$24145506$2$F$20240601$20240805$20240729$20240812$EXP$$US-MTPC-MTDA2024-0014504$MITSUBISHI TANABE PHARMA$$65$YR$$M$Y$$$20240812$$CN$US$US
241455071$24145507$1$I$20240601$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119097$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240729$$CN$US$US
241455081$24145508$1$I$$20240723$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118695$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240729$$HP$US$US
241455091$24145509$1$I$$20240717$20240729$20240729$EXP$$US-NOVITIUMPHARMA-2024USNVP01381$NOVITIUM PHARMA$Lee B.Botulinum Toxicity Managed With Pyridostigmine Following Botulinum Toxin Injections for Bilateral Neurogenic Thoracic Outlet Syndrome: A Case Report.Pain Medicine Case Reports.31-JAN-2023;7:15-19$$$$F$Y$$$20240729$$HP$US$US
241455101$24145510$1$I$20240724$20240724$20240729$20240729$PER$$US-GILEAD-2024-0681876$GILEAD$$$$$F$Y$$$20240729$$PH$US$US
241455111$24145511$1$I$20240522$20240715$20240729$20240729$EXP$ES-AEMPS-1546377$ES-SA-2024SA211551$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240729$$HP$ES$ES
241455121$24145512$1$I$$20240724$20240729$20240729$EXP$$US-JNJFOC-20240768174$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$CN$US$US
241455133$24145513$3$F$20240722$20240831$20240729$20240909$PER$$US-ROCHE-10000034935$ROCHE$$45$YR$A$F$Y$$$20240910$$CN$US$US
241455141$24145514$1$I$20240712$20240717$20240729$20240729$EXP$$IR-SA-2024SA218940$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240729$$CN$IR$IR
241455151$24145515$1$I$20230406$20240717$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036246$AUROBINDO$$73$YR$$F$Y$100$KG$20240729$$PH$FR$FR
241455161$24145516$1$I$20240111$20240718$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036014$AUROBINDO$$61$YR$$M$Y$100$KG$20240729$$MD$FR$FR
241455171$24145517$1$I$$20240723$20240729$20240729$30DAY$$US-GSK-US2024092429$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241455181$24145518$1$I$$20240723$20240729$20240729$EXP$$US-GILEAD-2024-0681764$GILEAD$$$$A$M$Y$$$20240729$$CN$US$US
241455191$24145519$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154255$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241455201$24145520$1$I$$20240726$20240729$20240729$EXP$$CA-BEIGENE-BGN-2024-011635$BEIGENE$$$$$$Y$$$20240729$$HP$CA$CA
241455212$24145521$2$F$20240710$20240816$20240729$20240823$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011342$JAZZ$$$$$M$Y$$$20240823$$MD$JP$JP
241455221$24145522$1$I$20240508$20240723$20240729$20240729$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011240$JAZZ$$58$YR$$F$Y$$$20240728$$MD$US$US
241455231$24145523$1$I$20240217$20240718$20240729$20240729$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002531$JAZZ$$41$YR$$F$Y$$$20240728$$CN$US$US
241455242$24145524$2$F$$20240730$20240729$20240801$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011308$JAZZ$$$$$M$Y$$$20240801$$HP$US$US
241455251$24145525$1$I$20240401$20240715$20240729$20240729$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-025364$JAZZ$$27$YR$$F$Y$$$20240728$$CN$US$US
241455261$24145526$1$I$$20240716$20240729$20240729$EXP$$US-INFO-20240213$INFORLIFE$$$$$$Y$$$20240717$$PH$US$
241455271$24145527$1$I$$20231103$20240729$20240729$EXP$$US-AstraZeneca-2023A251696$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241455281$24145528$1$I$20240719$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A169244$ASTRAZENECA$$26930$DY$$M$Y$$$20240729$$HP$US$
241455291$24145529$1$I$20240716$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A169023$ASTRAZENECA$$25653$DY$$F$Y$$$20240729$$HP$US$
241455301$24145530$1$I$20240718$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148277$AMGEN$$39$YR$A$F$Y$$$20240729$$CN$US$US
241455311$24145531$1$I$20240627$20240718$20240729$20240729$EXP$$ES-AUROBINDO-AUR-APL-2024-036322$AUROBINDO$$15$YR$$F$Y$103$KG$20240729$$MD$ES$ES
241455323$24145532$3$F$20240101$20240816$20240729$20240830$EXP$$US-UCBSA-2024029867$UCB$$$$$F$Y$$$20240830$$CN$US$US
241455331$24145533$1$I$$20240716$20240729$20240729$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0261$GRAVITI PHARMACEUTICALS$Meeder R, Peterson A, Reynard H, Andersen L.Dyadic Work in Conjunction With Electroconvulsive Therapy in a 12-Year-Old Female With Autism Spectrum Disorder and Catatonia..Ochsner Journal.2024;24 (2):141-146$12$YR$C$F$Y$$$20240729$$MD$US$US
241455341$24145534$1$I$20240501$20240726$20240729$20240729$EXP$$AR-ABBVIE-5856317$ABBVIE$$57$YR$$F$Y$$$20240729$$CN$AR$AR
241455352$24145535$2$F$20240703$20240805$20240729$20240806$EXP$FR-AFSSAPS-PV2024000680$FR-SANDOZ INC.-SDZ2024FR068495$SANDOZ$$14$YR$$M$Y$32$KG$20240806$$MD$FR$FR
241455361$24145536$1$I$$20240723$20240729$20240729$EXP$GB-MHRA-MED-202407232053358180-ZLGPY$GB-RDY-SPO/GBR/24/0010928$DR REDDYS$$29$YR$A$F$Y$$$20240729$$CN$GB$GB
241455372$24145537$2$F$$20240726$20240729$20240729$PER$$US-JNJFOC-20240775795$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241455381$24145538$1$I$20240724$20240724$20240729$20240729$PER$$US-JNJFOC-20240766608$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$PH$US$US
241455401$24145540$1$I$20240621$20240719$20240729$20240729$EXP$$DE-TEVA-VS-3223365$TEVA$$85$YR$$F$Y$$$20240729$$MD$DE$DE
241455413$24145541$3$F$20211013$20240802$20240729$20240813$EXP$$CA-TAKEDA-2024TUS059802$TAKEDA$$51$YR$$F$Y$$$20240813$$CN$CA$CA
241455421$24145542$1$I$$20240725$20240729$20240729$EXP$$JP-GSK-JP2024JPN093055$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$PH$JP$JP
241455431$24145543$1$I$20220101$20240725$20240729$20240729$EXP$PT-MEN-2024-107248$PT-MEN-2024-107248$MENARINI$$$$A$F$Y$$$20240729$$CN$PT$PT
241455441$24145544$1$I$$20240725$20240729$20240729$PER$$US-ROCHE-3566522$ROCHE$$$$A$F$Y$$$20240729$$MD$US$US
241455461$24145546$1$I$20240521$20240726$20240729$20240729$EXP$FR-AFSSAPS-MA2024000997$FR-SANDOZ INC.-SDZ2024FR068543$SANDOZ$$17$YR$$F$Y$49$KG$20240729$$MD$FR$FR
241455471$24145547$1$I$20240701$20240724$20240729$20240729$EXP$$US-ABBVIE-5855034$ABBVIE$$74$YR$$F$Y$$$20240729$$CN$US$US
241455482$24145548$2$F$20240101$20240729$20240729$20240731$EXP$FR-AFSSAPS-BX2024001472$FR-SANDOZ INC.-SDZ2024FR068499$SANDOZ$$37$YR$$F$Y$$$20240731$$MD$FR$FR
241455491$24145549$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118666$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240729$$HP$US$US
241455501$24145550$1$I$20230828$20240722$20240729$20240729$EXP$FR-AFSSAPS-AVCN2024000524$FR-CHEPLA-2024009302$CHEPLAPHARM$$37$YR$$M$Y$$$20240729$$MD$COUNTRY NOT SPECIFIED$FR
241455511$24145551$1$I$20240721$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119288$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240729$$HP$US$US
241455521$24145552$1$I$20240620$20240723$20240729$20240729$EXP$FR-AFSSAPS-RN2024000778$FR-CHEPLA-2024009358$CHEPLAPHARM$$38$YR$$F$Y$$$20240729$$HP$COUNTRY NOT SPECIFIED$FR
241455531$24145553$1$I$20090211$20240722$20240729$20240729$EXP$$HK-CHEPLA-2024009280$CHEPLAPHARM$$43$YR$$M$Y$$$20240729$$HP$COUNTRY NOT SPECIFIED$HK
241455541$24145554$1$I$$20240727$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119270$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$76.66$KG$20240729$$CN$US$US
241455551$24145555$1$I$20240709$20240724$20240729$20240729$EXP$$US-KYOWAKIRIN-2024KK017907$KYOWA$$$$$$Y$$$20240729$$HP$US$US
241455562$24145556$2$F$$20240724$20240729$20240802$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118983$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240802$$HP$CA$CA
241455571$24145557$1$I$$20240722$20240729$20240729$EXP$$US-BIOGEN-2024BI01275168$BIOGEN$$$$$F$Y$$$20240729$$CN$US$US
241455581$24145558$1$I$$20240722$20240729$20240729$EXP$$IN-SANDOZ INC.-SDZ2024IN068186$SANDOZ$$$$A$M$Y$$$20240729$$HP$IN$IN
241455591$24145559$1$I$20240611$20240729$20240729$20240729$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042346$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$86$KG$20240729$$MD$DE$DE
241455601$24145560$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016784$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240729$$HP$US$US
241455611$24145561$1$I$20220322$20240423$20240729$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US043772$SANDOZ$$14$YR$$M$Y$$$20240729$$HP$US$US
241455622$24145562$2$F$$20240724$20240729$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407016434$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240806$$CN$US$US
241455631$24145563$1$I$20240720$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017551$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240729$$CN$US$US
241455641$24145564$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017123$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240729$$HP$US$US
241455651$24145565$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017027$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240729$$CN$US$US
241455661$24145566$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016845$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240729$$CN$US$US
241455671$24145567$1$I$20240401$20240726$20240729$20240729$EXP$$US-SANDOZ INC.-SDZ2024US068681$SANDOZ$$15$YR$$M$Y$$$20240729$$CN$US$US
241455682$24145568$2$F$20240501$20240820$20240729$20240903$EXP$$US-UCBSA-2024029373$UCB$$14$YR$$M$Y$46.2$KG$20240903$$CN$US$US
241455692$24145569$2$F$$20240905$20240729$20240909$PER$$US-GILEAD-2024-0682163$GILEAD$$77$YR$E$M$Y$$$20240909$$CN$US$US
241455701$24145570$1$I$$20240725$20240729$20240729$EXP$$NVSC2024US153532$NOVARTIS$$51$YR$$M$Y$$$20240729$$CN$US$US
241455711$24145571$1$I$$20240724$20240729$20240729$EXP$$NVSC2024US153004$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241455721$24145572$1$I$20240718$20240725$20240729$20240729$EXP$$NVSC2024IE153201$NOVARTIS$$40$YR$$F$Y$$$20240729$$CN$IE$IE
241455733$24145573$3$F$20240101$20240806$20240729$20240809$PER$$US-AMGEN-USASP2024148759$AMGEN$$63$YR$A$F$Y$$$20240809$$CN$US$US
241455743$24145574$3$F$20140101$20240829$20240729$20240902$EXP$$DE-SANDOZ INC.-GXKR2014DE004582$SANDOZ$$37$YR$$F$Y$63$KG$20240902$$MD$DE$DE
241455751$24145575$1$I$20240706$20240722$20240729$20240729$EXP$$US-BIOGEN-2024BI01274037$BIOGEN$$56$YR$$F$Y$$$20240729$$CN$US$US
241455762$24145576$2$F$$20240730$20240729$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003265$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
241455771$24145577$1$I$$20240706$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003334$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
241455781$24145578$1$I$20220101$20240725$20240729$20240729$EXP$PT-MEN-2024-107512$PT-MEN-2024-107512$MENARINI$$51$YR$$F$Y$$$20240729$$CN$PT$PT
241455791$24145579$1$I$20240601$20240719$20240729$20240729$EXP$FR-AFSSAPS-AVNT2024000521$FR-TEVA-VS-3223393$TEVA$$42$YR$$M$Y$$$20240729$$PH$FR$FR
241455801$24145580$1$I$20240723$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147422$AMGEN$$50$YR$A$$Y$$$20240729$$CN$US$US
241455811$24145581$1$I$20240601$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003277$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240729$$CN$US$US
241455825$24145582$5$F$20240909$20240912$20240729$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003267$ACADIA PHARMACEUTICALS$$31$YR$$F$Y$$$20240930$$CN$US$US
241455831$24145583$1$I$$20240725$20240729$20240729$EXP$$CA-TAKEDA-2024TUS075725$TAKEDA$$$$$M$Y$$$20240729$$CN$CA$CA
241455841$24145584$1$I$$20240725$20240729$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA023821$SANDOZ$$$$$M$Y$$$20240729$$HP$CA$CA
241455851$24145585$1$I$20240701$20240723$20240729$20240729$EXP$$CA-JNJFOC-20240720907$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240729$$CN$CA$CA
241455861$24145586$1$I$$20240718$20240729$20240729$PER$$US-JNJFOC-20240748913$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$CN$US$US
241455871$24145587$1$I$20240709$20240723$20240729$20240729$EXP$$AR-JNJFOC-20240765210$JOHNSON AND JOHNSON$$75$YR$E$F$Y$65$KG$20240729$$CN$AR$AR
241455881$24145588$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154317$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241455901$24145590$1$I$20230901$20240726$20240729$20240729$EXP$$DE-SANDOZ INC.-SDZ2024DE068496$SANDOZ$$63$YR$$F$Y$$$20240729$$MD$DE$DE
241455911$24145591$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119285$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240729$$HP$US$US
241455921$24145592$1$I$$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118212$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240729$$HP$US$US
241455931$24145593$1$I$$20240727$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119277$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$90.72$KG$20240729$$CN$US$US
241455941$24145594$1$I$20231116$20240724$20240729$20240729$EXP$$CA-TAKEDA-2024TUS075447$TAKEDA$$42$YR$$M$Y$$$20240729$$CN$CA$CA
241455951$24145595$1$I$20240701$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148145$AMGEN$$$$A$F$Y$$$20240729$$MD$US$US
241455962$24145596$2$F$20240701$20240729$20240729$20240730$PER$$US-AMGEN-USASP2024149428$AMGEN$$73$YR$E$F$Y$$$20240730$$CN$US$US
241455973$24145597$3$F$20240715$20240827$20240729$20240904$EXP$$CA-AMGEN-CANSP2024141205$AMGEN$$$$$F$Y$$$20240904$$CN$CA$CA
241455981$24145598$1$I$20240701$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148837$AMGEN$$$$$$Y$$$20240729$$PH$US$US
241455991$24145599$1$I$20240724$20240725$20240729$20240729$EXP$$US-KYOWAKIRIN-2024KK018029$KYOWA$$$$$$Y$$$20240729$$HP$US$US
241456001$24145600$1$I$$20230707$20240729$20240729$EXP$$US-AstraZeneca-2023A157106$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241456011$24145601$1$I$$20240726$20240729$20240729$EXP$$IT-SANDOZ INC.-SDZ2024IT068637$SANDOZ$$88$YR$$M$Y$$$20240729$$MD$IT$IT
241456023$24145602$3$F$20240724$20240829$20240729$20240910$30DAY$$US-JNJFOC-20240766619$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240910$$PH$US$US
241456034$24145603$4$F$20240723$20240820$20240729$20240827$EXP$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000413$REVANCE THERAPEUTICS$$$$$$Y$$$20240827$$HP$US$US
241456041$24145604$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148404$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241456051$24145605$1$I$20240702$20240706$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003279$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240729$$CN$US$US
241456072$24145607$2$F$$20240725$20240729$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003275$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
241456081$24145608$1$I$$20240717$20240729$20240729$EXP$$PL-SANDOZ INC.-SDZ2024PL068640$SANDOZ$Lubon W, Lubon M, Mrukwa-Kominek E. Carotid-cavernous fistula -an ophthalmic condition requiring interdisciplinary management. KLINIKA DCZNA/ACTA OPHTHALMOLOGICA POLONICA. 2024;126(2):92-98$78$YR$$F$Y$$$20240729$$HP$PL$PL
241456091$24145609$1$I$$20240719$20240729$20240729$EXP$$US-ASPIRO-ASP2024US02411$ASPIRO PHARMA$Xia J, Ahmed R.. Rapidly progressive locked-in syndrome secondary to atypical herpes simplex  virus-1 rhombencephalitis in an immunocompromised individual.. IDCases. 2024;37:1-20$61$YR$$M$Y$$$20240729$$MD$US$US
241456101$24145610$1$I$20240718$20240725$20240729$20240729$PER$$US-ABBVIE-5856128$ABBVIE$$$$A$F$Y$$$20240729$$MD$US$US
241456111$24145611$1$I$20240724$20240726$20240729$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA066784$SANDOZ$$63$YR$$F$Y$$$20240729$$CN$CA$CA
241456122$24145612$2$F$20240708$20240829$20240729$20240905$EXP$$NL-BIOGEN-2024BI01275605$BIOGEN$$73$YR$$M$Y$$$20240905$$CN$NL$NL
241456131$24145613$1$I$20180511$20240723$20240729$20240729$EXP$FR-AFSSAPS-MP20182017$FR-SANDOZ INC.-NVSC2018FR015206$SANDOZ$$36$YR$$F$Y$54$KG$20240729$$MD$FR$FR
241456141$24145614$1$I$20240624$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148119$AMGEN$$$$$$Y$$$20240729$$PH$US$US
241456151$24145615$1$I$$20240718$20240729$20240729$EXP$$IN-ROCHE-10000034320$ROCHE$$68$YR$E$M$Y$$$20240729$$MD$IN$IN
241456161$24145616$1$I$$20240722$20240729$20240729$EXP$$JP-Taiho Oncology Inc-2024-007160$TAIHO ONCOLOGY INC$Yamada M, et al. A Case of Palliative Surgery for Gastrointestinal Obstruction Caused by Peritoneal Dissemination Following Surgery for Colorectal Cancer (translated by Taiho, original title in Japanese). Proceedings of the 46th Annual Meeting of Japanese Society for Research of Loco-Regional Cancer Therapy (the 46th Annual Meeting of Japanese Society for Research of Loco-Regional Cancer Therapy). 2024 January 01;O-2.$51$YR$A$F$Y$$$20240729$$HP$JP$JP
241456171$24145617$1$I$$20240723$20240729$20240729$EXP$$CA-JNJFOC-20240763612$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240729$$HP$CA$CA
241456181$24145618$1$I$$20240722$20240729$20240729$EXP$$JP-JNJFOC-20240766559$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$MD$JP$JP
241456191$24145619$1$I$$20240725$20240729$20240729$PER$$NVSC2024US154322$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241456201$24145620$1$I$20240627$20240725$20240729$20240729$EXP$$US-GILEAD-2024-0678204$GILEAD$$76$YR$E$F$Y$$$20240729$$CN$US$US
241456212$24145621$2$F$20220101$20240808$20240729$20240812$EXP$$SG-ROCHE-10000034659$ROCHE$$61$YR$A$F$Y$$$20240812$$CN$SG$SG
241456221$24145622$1$I$20211203$20240717$20240729$20240729$EXP$$IT-AUROBINDO-AUR-APL-2023-079487$AUROBINDO$$81$YR$$$Y$$$20240729$$MD$IT$IT
241456241$24145624$1$I$20240701$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119326$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240729$$CN$US$US
241456251$24145625$1$I$20240715$20240719$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116916$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240729$$CN$US$US
241456261$24145626$1$I$20240719$20240719$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116895$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$68.9$KG$20240729$$PH$US$US
241456272$24145627$2$F$$20240730$20240729$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106187$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240801$$CN$US$US
241456281$24145628$1$I$$20240717$20240729$20240729$EXP$$ES-Appco Pharma LLC-2159699$APPCO PHARMA$Initial$41$YR$$F$Y$$$20240729$$$ES$ES
241456291$24145629$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154337$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241456301$24145630$1$I$20240101$20240719$20240729$20240729$EXP$$AR-KYOWAKIRIN-2024KK018039$KYOWA$$$$$$Y$$$20240729$$HP$US$AR
241456311$24145631$1$I$20240725$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017637$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241456322$24145632$2$F$20240724$20240802$20240729$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407017278$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240807$$CN$US$US
241456331$24145633$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017078$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241456341$24145634$1$I$$20240716$20240729$20240729$EXP$$JP-ROCHE-10000033103$ROCHE$Maki A, Komagome M, Nagata R, Okada N, Urahashi T, Matsudaira S et al.. WS3-4 Two cases of mid- and long-term complications of pancreas transplant-report from a new institution. Pancreas/The 55th Annual Meeting of the Japan Pancreas Society. 2024;39(3):A277$22$YR$A$M$Y$$$20240729$$MD$JP$JP
241456351$24145635$1$I$20240702$20240719$20240729$20240729$EXP$ES-AEMPS-1548344$ES-TEVA-VS-3223415$TEVA$$69$YR$$F$Y$$$20240729$$HP$ES$ES
241456361$24145636$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017754$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240729$$CN$US$US
241456381$24145638$1$I$20240710$20240723$20240729$20240729$EXP$$DE-ABBVIE-5853270$ABBVIE$$$$$$Y$$$20240729$$HP$DE$DE
241456391$24145639$1$I$20240101$20240723$20240729$20240729$EXP$$CA-ABBVIE-5853739$ABBVIE$$49$YR$$F$Y$$$20240729$$CN$CA$CA
241456401$24145640$1$I$20240621$20240719$20240729$20240729$EXP$$CN-ROCHE-10000031755$ROCHE$$59$YR$A$M$Y$59$KG$20240729$$HP$CN$CN
241456411$24145641$1$I$$20240715$20240729$20240729$EXP$$GB-ROCHE-10000028752$ROCHE$Ediriwickrema K, Haynes E, Vickers M, Wilson W, Kuhnl A, Lawless S, et al. Glofitamab efficacy, tolerability, and practical implications in the real world: a uk multicentre, retrospective analysis. European Hematology Association (EHA) 2024. 2024;17-8. doi:10.1111/bjh.19397.$$$$$Y$$$20240729$$HP$GB$US
241456421$24145642$1$I$$20240718$20240729$20240729$EXP$$IT-AUROBINDO-AUR-APL-2018-051024$AUROBINDO$Sarti L, Liccioli G, Piccorossi A, Mori F, Barni S, Giovannini M, et al.. Anaphylaxis to non-steroidal anti-inflammatory drugs (NSAIDs) in a paediatric population.. Allergy. 2018;73(Suppl. 105):149abstr. 0238.$10$YR$$F$Y$$$20240729$$HP$IT$IT
241456431$24145643$1$I$$20240724$20240729$20240729$EXP$$US-ABBVIE-5853401$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241456441$24145644$1$I$20240101$20240723$20240729$20240729$EXP$$CA-ABBVIE-5853422$ABBVIE$$61$YR$$F$Y$$$20240729$$CN$CA$CA
241456451$24145645$1$I$$20240718$20240729$20240729$EXP$$US-ROCHE-10000031815$ROCHE$$$$$F$Y$$$20240729$$MD$US$US
241456471$24145647$1$I$20240601$20240717$20240729$20240729$EXP$$DE-AUROBINDO-AUR-APL-2024-036280$AUROBINDO$$46$YR$$F$Y$78$KG$20240729$$CN$DE$DE
241456481$24145648$1$I$20220101$20240724$20240729$20240729$EXP$$US-009507513-2407USA014698$MERCK$$$$$M$Y$$$20240729$$CN$US$US
241456491$24145649$1$I$20230712$20240719$20240729$20240729$EXP$$ES-AUROBINDO-AUR-APL-2024-036693$AUROBINDO$$60$YR$$F$Y$$$20240729$$MD$ES$ES
241456501$24145650$1$I$$20240725$20240729$20240729$PER$$NVSC2024US154140$NOVARTIS$$$$$F$Y$$$20240729$$HP$US$US
241456511$24145651$1$I$$20240726$20240729$20240729$EXP$$US-JNJFOC-20240773838$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$MD$US$US
241456521$24145652$1$I$$20240716$20240729$20240729$PER$$US-JNJFOC-20240772660$JOHNSON AND JOHNSON$$19$YR$A$F$Y$$$20240729$$HP$US$US
241456531$24145653$1$I$20240101$20240718$20240729$20240729$EXP$$US-RECORDATI RARE DISEASES-2024005628$RECORDATI$$$$$$Y$$$20240729$$CN$US$US
241456551$24145655$1$I$$20240715$20240729$20240729$EXP$$PT-TEVA-VS-3222516$TEVA$Andrade J, Lopes D, Sim?es FDO, Martins AF, Carvalho A, ?ngela C. POSA-192 - (4960) - NECROTIZING PNEUMONIA CAUSED BY PARVIMONAS MICRA: DIAGNOSTIC CHALLENGE . Congresses of the Portuguese Society of Internal Medicine: 30th Congress  .National Internal Medicine - Book of abstracts. 2024 May: 1269.$48$YR$$F$Y$$$20240729$$MD$PT$PT
241456562$24145656$2$F$20240720$20240817$20240729$20240912$EXP$$US-AMAROX PHARMA-HET2024US02449$HETERO$$88$YR$$M$Y$$$20240822$$MD$US$US
241456571$24145657$1$I$$20240715$20240729$20240729$EXP$$US-PURACAP-US-2024EPCLIT00875$PURACAP$Almazan EP.Another Case of the Blues, Methylene Blue as Adjunctive Therapy in Calcium-channel Blocker Induced Vasoplegia.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$65$YR$A$F$Y$$$20240729$$HP$US$US
241456581$24145658$1$I$$20240718$20240729$20240729$EXP$$NL-AUROBINDO-AUR-APL-2024-036620$AUROBINDO$$66$YR$$F$Y$69$KG$20240729$$CN$NL$NL
241456592$24145659$2$F$$20240906$20240729$20240916$30DAY$$US-GSK-US2024091861$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
241456602$24145660$2$F$$20240802$20240729$20240816$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0262$GRAVITI PHARMACEUTICALS$$44$YR$A$F$Y$81$KG$20240816$$MD$US$US
241456611$24145661$1$I$$20240725$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119006$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240729$$CN$US$US
241456621$24145662$1$I$20221222$20240722$20240729$20240729$EXP$$CO-UCBSA-2024037646$UCB$$63$YR$$F$Y$$$20240729$$CN$CO$CO
241456631$24145663$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118939$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240729$$PH$US$US
241456641$24145664$1$I$$20240722$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117447$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$110.68$KG$20240729$$CN$US$US
241456651$24145665$1$I$20240724$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118998$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240729$$CN$US$US
241456661$24145666$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092780$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241456671$24145667$1$I$$20240719$20240729$20240729$EXP$$US-GSK-US2024AMR092290$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241456681$24145668$1$I$20240705$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118902$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$70.31$KG$20240729$$HP$US$US
241456692$24145669$2$F$20220901$20240902$20240729$20240909$EXP$$FR-BIOGEN-2024BI01275386$BIOGEN$$47$YR$$M$Y$$$20240909$$MD$FR$FR
241456701$24145670$1$I$$20240718$20240729$20240729$EXP$$IT-AUROBINDO-AUR-APL-2024-018640$AUROBINDO$Laguardia M, Giannone S, Iacovelli A, Migliarini A, Attilia I, Palange P. Case Report of Pulmonary Nocardiosis in a Patient with Bronchiectasis and Systemic Sclerosis. Respiration. 2023;102(8):716; abstr. 137$76$YR$$F$Y$$$20240729$$HP$IT$IT
241456711$24145671$1$I$20240715$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148793$AMGEN$$82$YR$E$F$Y$$$20240729$$CN$US$US
241456721$24145672$1$I$20240301$20240724$20240729$20240729$EXP$$GB-AMGEN-GBRSL2024057515$AMGEN$$84$YR$E$F$Y$$$20240729$$CN$GB$GB
241456731$24145673$1$I$$20240717$20240729$20240729$PER$$US-JNJFOC-20240772654$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$CN$US$US
241456741$24145674$1$I$20240709$20240716$20240729$20240729$PER$$US-JNJFOC-20240772203$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240729$$HP$US$US
241456751$24145675$1$I$20240608$20240715$20240729$20240729$EXP$$CO-ROCHE-10000028330$ROCHE$$42$YR$A$M$Y$64$KG$20240729$$CN$CO$CO
241456761$24145676$1$I$$20240719$20240729$20240729$EXP$$US-JNJFOC-20240753861$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$CN$US$US
241456771$24145677$1$I$$20240724$20240729$20240729$PER$$US-JNJFOC-20240770067$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241456781$24145678$1$I$$20240724$20240729$20240729$PER$$US-ABBVIE-5855485$ABBVIE$$$$$$Y$$$20240729$$HP$US$US
241456791$24145679$1$I$$20240718$20240729$20240729$EXP$GB-MHRA-MED-202407172339535370-LGRCB$GB-DEXPHARM-2024-2409$DEXCEL$$$$A$M$Y$$$20240729$$CN$GB$GB
241456801$24145680$1$I$$20240705$20240729$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003243$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241456811$24145681$1$I$20240716$20240718$20240729$20240729$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00735$CATALYST PHARMA$$10$YR$$M$Y$51.519$KG$20240729$$CN$US$US
241456821$24145682$1$I$$20240716$20240729$20240729$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00721$CATALYST PHARMA$$$$$F$Y$$$20240729$$CN$US$US
241456832$24145683$2$F$20240101$20240916$20240729$20240924$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00740$CATALYST PHARMA$$$$$M$Y$$$20240924$$CN$US$US
241456841$24145684$1$I$20240101$20240715$20240729$20240729$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00540$CATALYST PHARMA$$$$$M$Y$36.735$KG$20240729$$CN$US$US
241456851$24145685$1$I$20240701$20240724$20240729$20240729$EXP$$US-ABBVIE-5855851$ABBVIE$$29$YR$$M$Y$$$20240729$$CN$US$US
241456861$24145686$1$I$20240701$20240718$20240729$20240729$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00741$CATALYST PHARMA$$81$YR$$F$Y$63.492$KG$20240729$$CN$US$US
241456871$24145687$1$I$$20240723$20240729$20240729$PER$$US-ROCHE-10000034309$ROCHE$$41$YR$A$M$Y$$$20240729$$CN$US$US
241456881$24145688$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092122$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241456892$24145689$2$F$20240723$20240821$20240729$20240823$PER$$US-AMGEN-USASP2024148060$AMGEN$$28$YR$A$F$Y$$$20240823$$CN$US$US
241456902$24145690$2$F$20240612$20240721$20240729$20240921$EXP$$CA-CELLTRION INC.-2024CA018031$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
241456931$24145693$1$I$$20240719$20240729$20240729$EXP$$BR-ROCHE-10000032969$ROCHE$$72$YR$E$M$Y$$$20240729$$MD$BR$BR
241456941$24145694$1$I$$20240724$20240729$20240729$EXP$$AR-BIOGEN-2024BI01275634$BIOGEN$$2$YR$$M$Y$$$20240729$$MD$AR$AR
241456951$24145695$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5855017$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241456972$24145697$2$F$$20240724$20240729$20240802$EXP$$AT-JNJFOC-20240776073$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240802$$CN$AT$AT
241456982$24145698$2$F$$20240720$20240729$20240731$EXP$$US-JNJFOC-20240759485$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241456992$24145699$2$F$$20240802$20240729$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003264$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
241457001$24145700$1$I$$20240718$20240729$20240729$EXP$$US-APOTEX-2024AP008649$APOTEX$Applegarth J, Finn D, Tolkacz M, Iacco A.. Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome. ASAIO Journal. 2024;70 (suppl 3):151$18$YR$$F$Y$$$20240729$$HP$US$US
241457016$24145701$6$F$20240719$20240916$20240729$20240930$30DAY$$US-JNJFOC-20240766418$JOHNSON AND JOHNSON$$10$YR$C$F$Y$$$20240930$$HP$US$US
241457021$24145702$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003261$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241457031$24145703$1$I$20240101$20240723$20240729$20240729$EXP$$US-ABBVIE-5853673$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241457041$24145704$1$I$$20240722$20240729$20240729$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005474$BIOCON$$$$$$Y$$$20240729$$CN$CA$CA
241457051$24145705$1$I$$20240719$20240729$20240729$EXP$GB-MHRA-TPP62074436C23115445YC1720601153561$GB-JUBILANT PHARMA LTD-2024GB001065$JUBILANT$$93$YR$$F$Y$$$20240729$$MD$GB$GB
241457061$24145706$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092452$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241457071$24145707$1$I$20230401$20240724$20240729$20240729$EXP$$EG-ABBVIE-5853595$ABBVIE$$12$YR$$M$Y$$$20240729$$CN$EG$EG
241457081$24145708$1$I$20240725$20240725$20240729$20240729$PER$$NVSC2024US153724$NOVARTIS$$60$YR$$F$Y$$$20240729$$MD$US$US
241457091$24145709$1$I$$20210708$20240729$20240729$EXP$$US-AstraZeneca-2021A608880$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241457101$24145710$1$I$$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A169513$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241457111$24145711$1$I$20240701$20240725$20240729$20240729$PER$$NVSC2024US154333$NOVARTIS$$77$YR$$F$Y$$$20240729$$HP$US$US
241457121$24145712$1$I$$20210624$20240729$20240729$EXP$$US-AstraZeneca-2021A564648$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241457131$24145713$1$I$$20240724$20240729$20240729$EXP$$ZA-AstraZeneca-2024A168891$ASTRAZENECA$$88$YR$$F$Y$$$20240729$$CN$ZA$
241457141$24145714$1$I$$20240702$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06330$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241457151$24145715$1$I$$20240716$20240729$20240729$EXP$$JP-SERB S.A.S.-2159700$LABORATOIRES SERB$$80$YR$$F$Y$$$20240729$$$JP$JP
241457162$24145716$2$F$20240619$20240724$20240729$20240731$EXP$$US-KYOWAKIRIN-2024KK017789$KYOWA$$$$$$Y$$$20240731$$HP$US$US
241457171$24145717$1$I$20240223$20240722$20240729$20240729$PER$$US-BIOGEN-2024BI01252880$BIOGEN$$65$YR$$M$Y$$$20240729$$CN$US$US
241457181$24145718$1$I$$20240722$20240729$20240729$PER$$US-BIOGEN-2024BI01274987$BIOGEN$$$$$F$Y$$$20240729$$CN$US$US
241457192$24145719$2$F$$20240731$20240729$20240802$PER$$US-JNJFOC-20240766637$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$HP$US$US
241457201$24145720$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016585$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240729$$HP$US$US
241457211$24145721$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016893$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240729$$CN$US$US
241457221$24145722$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017609$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240729$$CN$US$US
241457231$24145723$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017735$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241457251$24145725$1$I$20240723$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016588$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240729$$PH$US$US
241457261$24145726$1$I$$20240715$20240729$20240729$EXP$$US-CIPLA LTD.-2024US07846$CIPLA$O Meara KT., Fansiwala K, Kathuria-Prakash N, El-Masry M, Oh S. Acute hypoxic respiratory failure due to Lenalidomide-induced interstitial pneumonitis in a patient with multiple myeloma. BMC Pulmonary Medicine. 2024;24 (321):1 to 5$$$$$Y$$$20240729$$HP$US$US
241457271$24145727$1$I$20240708$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149179$AMGEN$$74$YR$E$F$Y$$$20240729$$MD$US$US
241457281$24145728$1$I$20240101$20240725$20240729$20240729$EXP$$US-ABBVIE-5854804$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241457291$24145729$1$I$$20240724$20240729$20240729$EXP$GB-MHRA-FAKE-202406020338525820-FCKND$GB-TAKEDA-2024TUS074699$TAKEDA$$$$$$Y$$$20240729$$HP$GB$GB
241457301$24145730$1$I$$20240725$20240729$20240729$PER$$US-009507513-2407USA013932$MERCK$$$$$M$Y$$$20240729$$MD$US$US
241457311$24145731$1$I$$20240718$20240729$20240729$PER$$US-EMD Serono-2024039550$EMD SERONO INC$$$$$F$Y$$$20240729$$PH$US$US
241457322$24145732$2$F$20240101$20240813$20240729$20240815$EXP$$US-ABBVIE-5855205$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
241457331$24145733$1$I$20240711$20240725$20240729$20240729$EXP$$US-ABBVIE-5855735$ABBVIE$$52$YR$$M$Y$$$20240729$$CN$US$US
241457341$24145734$1$I$20240724$20240724$20240729$20240729$EXP$$FR-ABBVIE-5856051$ABBVIE$$65$YR$$M$Y$$$20240729$$MD$FR$FR
241457362$24145736$2$F$$20240728$20240729$20240731$EXP$$IL-UCBSA-2024037928$UCB$$$$$M$Y$$$20240731$$MD$IL$IL
241457371$24145737$1$I$$20240723$20240729$20240729$PER$$US-GILEAD-2024-0681807$GILEAD$$$$$M$Y$$$20240729$$CN$US$US
241457381$24145738$1$I$$20240722$20240729$20240729$PER$$US-AMGEN-USASP2024146982$AMGEN$Geara A. S.; Taki E.; Wirtshafter S.. Influenza vaccination-associated cryoglobulinemic vasculitis. Clinical nephrology. 2024$68$YR$E$M$Y$$$20240729$$MD$US$US
241457391$24145739$1$I$$20240722$20240729$20240729$PER$$US-BIOGEN-2019BI00785649$BIOGEN$$$$$M$Y$$$20240729$$CN$US$US
241457401$24145740$1$I$$20240723$20240729$20240729$PER$$US-BIOGEN-2016BI00277024$BIOGEN$$$$$F$Y$$$20240729$$CN$US$US
241457411$24145741$1$I$20240701$20240724$20240729$20240729$EXP$$NVSC2024HR152868$NOVARTIS$$$$$F$Y$$$20240729$$MD$HR$HR
241457421$24145742$1$I$20240614$20240719$20240729$20240729$EXP$ES-AEMPS-1550749$ES-HETERO-AMR2024ES02379$HETERO$$90$YR$$M$Y$53$KG$20240729$$MD$ES$ES
241457432$24145743$2$F$20240603$20240729$20240729$20240802$EXP$$CA-JNJFOC-20240759570$JOHNSON AND JOHNSON$$30$YR$A$F$Y$83$KG$20240802$$HP$CA$CA
241457441$24145744$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002571$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
241457451$24145745$1$I$$20240722$20240729$20240729$EXP$$BR-TAKEDA-2024TUS075262$TAKEDA$$$$$F$Y$$$20240729$$CN$BR$BR
241457461$24145746$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119264$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240729$$CN$US$US
241457471$24145747$1$I$20240101$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148850$AMGEN$$$$$$Y$$$20240729$$MD$US$US
241457481$24145748$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119254$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240729$$HP$US$US
241457491$24145749$1$I$$20240725$20240729$20240729$EXP$$GB-UCBSA-2024028585$UCB$$$$$M$Y$$$20240729$$CN$GB$GB
241457513$24145751$3$F$20231213$20240806$20240729$20240831$EXP$$BE-AUROBINDO-AUR-APL-2024-036691$AUROBINDO$$85$YR$$M$Y$$$20240831$$HP$BE$BE
241457521$24145752$1$I$$20240723$20240729$20240729$EXP$$ES-AUROBINDO-AUR-APL-2024-036924$AUROBINDO$Anto, C. USE OF ISAVUCONAZOLE IN CHILDREN WITH INVASIVE FUNGAL INFECTION: EXPERIENCE IN A PAEDIATRIC AND TERTIARY CARE CENTRE. 493$15$YR$$M$Y$60$KG$20240729$$MD$ES$ES
241457531$24145753$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147916$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241457542$24145754$2$F$$20240722$20240729$20240731$EXP$$US-AMGEN-USASP2024147897$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):1-12$48$YR$A$$Y$$$20240731$$HP$US$US
241457552$24145755$2$F$$20240722$20240729$20240731$EXP$$US-AMGEN-USASP2024147824$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):1-12$45$YR$A$$Y$$$20240731$$HP$US$US
241457561$24145756$1$I$20240723$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148679$AMGEN$$$$$F$Y$$$20240729$$HP$US$US
241457571$24145757$1$I$20240408$20240718$20240729$20240729$EXP$IT-MINISAL02-994926$IT-SA-2024SA213271$SANOFI AVENTIS$$49$YR$A$F$Y$47$KG$20240729$$MD$IT$IT
241457582$24145758$2$F$$20240722$20240729$20240730$EXP$$US-JNJFOC-20240763927$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$CN$US$US
241457591$24145759$1$I$20240724$20240724$20240729$20240729$PER$$US-JNJFOC-20240768470$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240729$$HP$US$US
241457602$24145760$2$F$20240701$20240826$20240729$20240910$PER$$US-JNJFOC-20240761728$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$PH$US$US
241457611$24145761$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003268$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241457621$24145762$1$I$$20240719$20240729$20240729$EXP$$US-APOTEX-2024AP008739$APOTEX$Curtis TM, Sady KM, Randall JT, Kervin P, Mosher DM, Dailey MW. 18-Month-Old with Lethargy and Accelerated Idioventricular Rhythm in Prehospital Setting: A Case Report. Prehospital Emergency Care. 2024;1-4$18$MON$$M$Y$$$20240729$$HP$US$US
241457631$24145763$1$I$$20240719$20240729$20240729$PER$$US-BEH-2024176285$CSL BEHRING$$$$A$F$Y$$$20240729$$HP$US$US
241457641$24145764$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092449$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241457651$24145765$1$I$20240101$20240726$20240729$20240729$EXP$$US-ABBVIE-5856851$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241457661$24145766$1$I$$20230906$20240729$20240729$EXP$$US-AstraZeneca-2023A204203$ASTRAZENECA$$$$$$Y$$$20240729$$MD$US$
241457671$24145767$1$I$$20240724$20240729$20240729$EXP$$ZA-AstraZeneca-2024A169032$ASTRAZENECA$$77$YR$$F$Y$$$20240729$$CN$ZA$
241457681$24145768$1$I$20240127$20240715$20240729$20240729$EXP$$FR-CIPLA LTD.-2024FR07724$CIPLA$$$$$$Y$$$20240729$$MD$FR$FR
241457691$24145769$1$I$$20230718$20240729$20240729$EXP$$US-AstraZeneca-2023A164919$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241457701$24145770$1$I$$20210709$20240729$20240729$EXP$$US-AstraZeneca-2021A613485$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241457711$24145771$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003274$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
241457721$24145772$1$I$20240630$20240705$20240729$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003271$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240729$$CN$US$US
241457731$24145773$1$I$20240506$20240722$20240729$20240729$EXP$$CO-UCBSA-2024037807$UCB$$36$YR$$M$Y$$$20240729$$CN$CO$CO
241457741$24145774$1$I$$20240725$20240729$20240729$EXP$$US-GILEAD-2024-0682013$GILEAD$$$$E$F$Y$$$20240729$$CN$US$US
241457751$24145775$1$I$$20240719$20240729$20240729$EXP$$BR-AMGEN-BRASL2024034417$AMGEN$$89$YR$E$F$Y$$$20240729$$MD$BR$BR
241457761$24145776$1$I$20240406$20240718$20240729$20240729$EXP$GB-MHRA-MED-202407180821035580-NGJLC$GB-NOVOPROD-1257986$NOVO NORDISK$$48$YR$$F$Y$70$KG$20240729$$CN$GB$GB
241457771$24145777$1$I$20240101$20240718$20240729$20240729$EXP$$JP-NOVOPROD-1259188$NOVO NORDISK$$$$$M$Y$$$20240729$$CN$JP$JP
241457781$24145778$1$I$$20240717$20240729$20240729$EXP$$US-NOVOPROD-1259944$NOVO NORDISK$$$$$M$Y$$$20240729$$CN$US$US
241457791$24145779$1$I$20240701$20240718$20240729$20240729$EXP$$DK-NOVOPROD-1258091$NOVO NORDISK$$$$$$Y$$$20240729$$CN$DK$DK
241457801$24145780$1$I$20240712$20240718$20240729$20240729$EXP$GB-MHRA-MED-202407180855241780-GWMVN$GB-NOVOPROD-1257987$NOVO NORDISK$$53$YR$$$Y$$$20240729$$PH$GB$GB
241457811$24145781$1$I$20240417$20240717$20240729$20240729$EXP$$US-NOVOPROD-1260153$NOVO NORDISK$$63$YR$$F$Y$$$20240729$$CN$US$US
241457821$24145782$1$I$$20240718$20240729$20240729$EXP$$GB-NOVOPROD-1258048$NOVO NORDISK$$43$YR$$F$Y$$$20240729$$HP$GB$GB
241457831$24145783$1$I$$20240718$20240729$20240729$EXP$$JP-NOVOPROD-1259310$NOVO NORDISK$$$$$M$Y$$$20240729$$CN$JP$JP
241457841$24145784$1$I$$20240718$20240729$20240729$EXP$$US-NOVOPROD-1258986$NOVO NORDISK$$$$$M$Y$$$20240729$$CN$US$US
241457851$24145785$1$I$$20240718$20240729$20240729$EXP$$US-NOVOPROD-1259139$NOVO NORDISK$$55$YR$$F$Y$$$20240729$$CN$US$US
241457861$24145786$1$I$20240709$20240718$20240729$20240729$EXP$$US-NOVOPROD-1259010$NOVO NORDISK$$$$$F$Y$$$20240729$$CN$US$US
241457871$24145787$1$I$$20240718$20240729$20240729$EXP$$US-NOVOPROD-1258985$NOVO NORDISK$$$$A$M$Y$$$20240729$$CN$US$US
241457881$24145788$1$I$20240701$20240718$20240729$20240729$EXP$$US-NOVOPROD-1259783$NOVO NORDISK$$69$YR$$M$Y$$$20240729$$CN$US$US
241457891$24145789$1$I$20240101$20240718$20240729$20240729$EXP$$US-NOVOPROD-1259198$NOVO NORDISK$$$$$F$Y$$$20240729$$CN$US$US
241457901$24145790$1$I$$20240724$20240729$20240729$PER$$NVSC2024US152894$NOVARTIS$$$$$$Y$$$20240729$$CN$US$US
241457911$24145791$1$I$20240601$20240719$20240729$20240729$EXP$$IE-TAKEDA-2024TUS074470$TAKEDA$$26$YR$$M$Y$$$20240729$$HP$IE$IE
241457921$24145792$1$I$$20240722$20240729$20240729$EXP$$BR-TAKEDA-2024TUS075257$TAKEDA$$$$$M$Y$$$20240729$$CN$BR$BR
241457931$24145793$1$I$$20240721$20240729$20240729$EXP$$CN-BEIGENE-BGN-2024-011294$BEIGENE$$$$$$Y$$$20240729$$HP$CN$CN
241457941$24145794$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147338$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241457951$24145795$1$I$$20240723$20240729$20240729$PER$$US-AMGEN-USASP2024149608$AMGEN$$$$$F$Y$$$20240729$$HP$US$US
241457961$24145796$1$I$$20240722$20240729$20240729$EXP$$US-SA-2024SA217965$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240729$$MD$US$US
241457971$24145797$1$I$20240726$20240726$20240729$20240729$PER$$US-JNJFOC-20240773527$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240729$$HP$US$US
241457982$24145798$2$F$$20240726$20240729$20240729$PER$$US-JNJFOC-20240768308$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241457991$24145799$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003240$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241458002$24145800$2$F$$20240809$20240729$20240813$EXP$$ES-AUROBINDO-AUR-APL-2024-036926$AUROBINDO$Anto, C.. USE OF ISAVUCONAZOLE IN CHILDREN WITH INVASIVE FUNGAL INFECTION. EXPERIENCE IN A PAEDIATRIC AND TERTIARY CARE CENTRE.. 493$14$YR$$M$Y$48$KG$20240813$$MD$ES$ES
241458012$24145801$2$F$20240701$20240725$20240729$20240816$EXP$$CA-ABBVIE-5856129$ABBVIE$$80$YR$$$Y$$$20240816$$MD$CA$CA
241458021$24145802$1$I$20200828$20240729$20240729$20240729$EXP$PL-URPL-2-1289-2020$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042352$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$65$KG$20240729$$CN$PL$PL
241458033$24145803$3$F$$20240910$20240729$20240912$PER$$US-ROCHE-10000037991$ROCHE$$51$YR$A$F$Y$$$20240912$$CN$US$US
241458042$24145804$2$F$20240721$20240824$20240729$20240829$PER$$US-ROCHE-10000033308$ROCHE$$$$$F$Y$$$20240829$$CN$US$US
241458051$24145805$1$I$20240529$20240722$20240729$20240729$EXP$FR-AFSSAPS-BS2024000431$FR-SA-2024SA215622$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240729$$PH$FR$FR
241458061$24145806$1$I$20240602$20240723$20240729$20240729$PER$$US-ROCHE-3577775$ROCHE$$45$YR$A$F$Y$$$20240729$$CN$US$US
241458071$24145807$1$I$20240401$20240723$20240729$20240729$EXP$$US-TAKEDA-2024TUS034958$TAKEDA$$32$YR$$F$Y$91$KG$20240729$$MD$US$US
241458081$24145808$1$I$20240501$20240719$20240729$20240729$EXP$$GB-MSNLABS-2024MSNSPO01646$MSN LABORATORIES$$$$$$Y$$$20240729$$MD$GB$GB
241458091$24145809$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003235$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241458101$24145810$1$I$20240101$20240725$20240729$20240729$EXP$$US-UCBSA-2024033980$UCB$$$$$M$Y$$$20240729$$CN$US$US
241458121$24145812$1$I$20240101$20240717$20240729$20240729$EXP$$AU-UCBSA-2024037766$UCB$$$$$M$Y$$$20240729$$CN$AU$AU
241458141$24145814$1$I$20240628$20240722$20240729$20240729$EXP$$US-AMGEN-USASP2024145363$AMGEN$$74$YR$E$M$Y$121$KG$20240729$$HP$US$US
241458153$24145815$3$F$20240724$20240903$20240729$20240903$PER$$US-AMGEN-USASP2024149172$AMGEN$$52$YR$A$F$Y$$$20240903$$MD$US$US
241458163$24145816$3$F$$20240920$20240729$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119209$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240923$$HP$US$US
241458171$24145817$1$I$20240725$20240725$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118850$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$73.48$KG$20240729$$CN$US$US
241458182$24145818$2$F$$20240913$20240729$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119274$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$59.42$KG$20240917$$CN$US$US
241458191$24145819$1$I$$20240719$20240729$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118696$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240729$$MD$JP$JP
241458201$24145820$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016977$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240729$$CN$US$US
241458211$24145821$1$I$20240719$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017567$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240729$$CN$US$US
241458221$24145822$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017081$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240729$$CN$US$US
241458232$24145823$2$F$$20240805$20240729$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003233$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241458241$24145824$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016285$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241458251$24145825$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017730$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240729$$CN$US$US
241458261$24145826$1$I$$20240725$20240729$20240729$PER$$US-ROCHE-3559522$ROCHE$$41$YR$A$F$Y$$$20240729$$CN$US$US
241458271$24145827$1$I$$20240725$20240729$20240729$PER$$US-ROCHE-10000038089$ROCHE$$72$YR$E$F$Y$$$20240729$$CN$US$US
241458281$24145828$1$I$20240705$20240723$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036935$AUROBINDO$$89$YR$$M$Y$70$KG$20240729$$PH$FR$FR
241458291$24145829$1$I$20240101$20240724$20240729$20240729$EXP$$US-KYOWAKIRIN-2024KK017930$KYOWA$$$$$$Y$$$20240729$$HP$US$US
241458301$24145830$1$I$20230606$20240717$20240729$20240729$EXP$$GB-AUROBINDO-AUR-APL-2024-036406$AUROBINDO$$52$YR$$M$Y$$$20240729$$MD$GB$GB
241458311$24145831$1$I$$20240717$20240729$20240729$EXP$$TW-MEDLEY-000013$MEDLEY PHARMACEUTICALS$$33$YR$A$F$Y$$$20240719$$MD$TW$TW
241458321$24145832$1$I$20240101$20240725$20240729$20240729$EXP$$US-ABBVIE-5850366$ABBVIE$$$$$F$Y$40.823$KG$20240729$$CN$US$US
241458331$24145833$1$I$$20240719$20240729$20240729$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00748$CATALYST PHARMA$$$$$M$Y$$$20240729$$CN$US$US
241458341$24145834$1$I$20240711$20240719$20240729$20240729$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00763$CATALYST PHARMA$$44$YR$$M$Y$$$20240729$$CN$US$US
241458351$24145835$1$I$20240301$20240719$20240729$20240729$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00765$CATALYST PHARMA$$$$$$Y$$$20240729$$CN$US$US
241458361$24145836$1$I$20240701$20240717$20240729$20240729$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00732$CATALYST PHARMA$$27$YR$$M$Y$$$20240729$$CN$US$US
241458371$24145837$1$I$20180612$20240724$20240729$20240729$EXP$$RU-SA-2024SA218653$SANOFI AVENTIS$$51$YR$A$F$Y$68$KG$20240729$$MD$RU$RU
241458381$24145838$1$I$$20240724$20240729$20240729$EXP$$CA-SA-2024SA218840$SANOFI AVENTIS$$28$YR$A$F$Y$72$KG$20240729$$HP$CA$CA
241458391$24145839$1$I$$20240723$20240729$20240729$EXP$$JP-ORGANON-O2407JPN002390$ORGANON$$48$YR$$M$Y$$$20240729$$MD$JP$JP
241458401$24145840$1$I$$20240722$20240729$20240729$EXP$$US-TAKEDA-2024TUS074568$TAKEDA$$$$$M$Y$$$20240729$$CN$US$US
241458412$24145841$2$F$20240601$20240731$20240729$20240807$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00758$CATALYST PHARMA$$86$YR$$F$Y$74.385$KG$20240807$$CN$US$US
241458421$24145842$1$I$$20240705$20240729$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003232$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
241458431$24145843$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092526$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241458443$24145844$3$F$$20240909$20240729$20240916$EXP$$CA-GSK-CA2023144005$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$CA$CA
241458452$24145845$2$F$$20240731$20240729$20240809$EXP$$IT-TEVA-VS-3223414$TEVA$Lazzeroni M, Reato S, Antinori S, Milazzo L, Pignataro L, Cantarella G. Laryngeal Leishmaniasis: A Neglected, Emerging Disease in Northern Italy. J-Voice 2024; 0 (0): no pagination.; Lazzeroni M, Reato S, Antinori S, Milazzo L, Pignataro L, Cantarella G. Laryngeal Leishmaniasis: A Neglected, Emerging Disease in Northern Italy. J-Voice 2024; 0 (0): no pagination.$56$YR$$F$Y$$$20240809$$HP$IT$IT
241458461$24145846$1$I$20240716$20240718$20240729$20240729$EXP$$GB-AUROBINDO-AUR-APL-2024-035979$AUROBINDO$$54$YR$$M$Y$82$KG$20240729$$CN$GB$GB
241458472$24145847$2$F$20240722$20240826$20240729$20240827$EXP$$US-TAKEDA-2024TUS047194$TAKEDA$$84$YR$$M$Y$$$20240827$$CN$US$US
241458481$24145848$1$I$20231101$20240729$20240729$20240729$EXP$FR-AFSSAPS-MP2024001189$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042353$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$67$KG$20240729$$PH$FR$FR
241458491$24145849$1$I$20240101$20240724$20240729$20240729$EXP$$US-ABBVIE-5852545$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241458501$24145850$1$I$20240701$20240705$20240729$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003231$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240729$$CN$US$US
241458512$24145851$2$F$20240101$20240816$20240729$20240828$EXP$$US-INSMED, INC.-2024-02955-US$INSMED$$$$$F$Y$$$20240828$$CN$US$US
241458521$24145852$1$I$$20240722$20240729$20240729$EXP$GB-MHRA-31191563$GB-RDY-SPO/GBR/24/0010876$DR REDDYS$$$$$$Y$$$20240729$$CN$GB$GB
241458531$24145853$1$I$20240503$20240722$20240729$20240729$EXP$FR-AFSSAPS-LL2024001380$FR-RDY-SPO/FRA/24/0010828$DR REDDYS$$54$YR$A$F$Y$71$KG$20240729$$MD$FR$FR
241458541$24145854$1$I$$20240724$20240729$20240729$EXP$$US-AMGEN-USASL2024147580$AMGEN$$24$YR$A$F$Y$$$20240729$$CN$US$US
241458551$24145855$1$I$20240101$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148534$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241458562$24145856$2$F$$20240816$20240729$20240819$PER$$US-ALXN-202407USA001578US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241458571$24145857$1$I$$20240715$20240729$20240729$EXP$$US-ENDO USA, INC.-2024-002964$ENDO$$$$$M$Y$$$20240729$$CN$US$US
241458581$24145858$1$I$$20240723$20240729$20240729$EXP$$US-JNJFOC-20240764520$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240729$$HP$US$US
241458591$24145859$1$I$$20240722$20240729$20240729$EXP$$BR-JNJFOC-20240768667$JOHNSON AND JOHNSON$$$$$F$Y$62$KG$20240729$$CN$BR$BR
241458601$24145860$1$I$20240722$20240723$20240729$20240729$EXP$$JP-JNJFOC-20240775628$JOHNSON AND JOHNSON$$58$YR$A$$Y$$$20240729$$MD$JP$JP
241458611$24145861$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003227$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241458621$24145862$1$I$20240709$20240725$20240729$20240729$EXP$$US-GILEAD-2024-0682127$GILEAD$$75$YR$E$M$Y$$$20240729$$CN$US$US
241458631$24145863$1$I$$20240723$20240729$20240729$EXP$$GB-AUROBINDO-AUR-APL-2024-037128$AUROBINDO$$33$YR$$M$Y$$$20240729$$PH$GB$GB
241458641$24145864$1$I$20201001$20240716$20240729$20240729$EXP$$CN-ENDO USA, INC.-2024-002966$ENDO$Li X, Jin Y.. Zolpidem-triggered atrial fibrillation in a patient with cardiomyopathy: a case report. BMC Cardiovascular Disorders. 2024;24:339:1-7$40$YR$$M$Y$$$20240729$$HP$CN$CN
241458651$24145865$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119390$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$73.94$KG$20240729$$CN$US$US
241458662$24145866$2$F$20240901$20240920$20240729$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119276$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$101.6$KG$20240925$$CN$US$US
241458671$24145867$1$I$$20240722$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118547$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240729$$MD$US$US
241458682$24145868$2$F$20220801$20240730$20240729$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-036914$AUROBINDO$$$$A$F$Y$$$20240809$$PH$US$US
241458691$24145869$1$I$20230926$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119068$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240729$$HP$US$US
241458704$24145870$4$F$20240704$20240730$20240729$20240808$EXP$$JP-ROCHE-10000033819$ROCHE$$9$DEC$E$M$Y$$$20240808$$MD$JP$JP
241458711$24145871$1$I$$20240726$20240729$20240729$PER$$US-AMGEN-USASP2024149989$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241458731$24145873$1$I$$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A168971$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241458741$24145874$1$I$$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A170167$ASTRAZENECA$$$$$$Y$$$20240729$$MD$US$
241458751$24145875$1$I$20240601$20240722$20240729$20240729$PER$$US-AstraZeneca-2024A171011$ASTRAZENECA$$65$YR$$F$Y$$$20240729$$MD$US$
241458761$24145876$1$I$$20240717$20240729$20240729$PER$$US-AMGEN-USASP2024144983$AMGEN$Lee N.; Lin L. Y.; Azad A. D. et. al.. Antisynthetase Syndrome Causing Necrotizing Myositis Involving Extraocular Muscles. Ophthalmic Plastic and Reconstructive Surgery. 2024;40 (4):e111-e114$39$YR$A$F$Y$$$20240729$$MD$US$US
241458771$24145877$1$I$$20230627$20240729$20240729$EXP$$US-AstraZeneca-2023A148752$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241458782$24145878$2$F$20240101$20240829$20240729$20240904$EXP$$GB-ABBVIE-5855583$ABBVIE$$$$E$M$Y$$$20240904$$HP$GB$GB
241458791$24145879$1$I$$20240717$20240729$20240729$EXP$$JP-ROCHE-10000032320$ROCHE$$8$DEC$E$$Y$$$20240729$$MD$JP$JP
241458811$24145881$1$I$$20240724$20240729$20240729$EXP$$US-ABBVIE-5855873$ABBVIE$$$$$F$Y$$$20240729$$HP$US$US
241458821$24145882$1$I$20240703$20240729$20240729$20240729$EXP$FR-AFSSAPS-MA2024001255$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042366$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240729$$MD$FR$FR
241458831$24145883$1$I$$20240725$20240729$20240729$EXP$$NVSC2024US153914$NOVARTIS$$$$$$Y$$$20240729$$MD$US$US
241458842$24145884$2$F$$20240725$20240729$20240731$PER$$NVSC2024US153453$NOVARTIS$$$$$F$Y$$$20240731$$MD$US$US
241458861$24145886$1$I$20240501$20240718$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036541$AUROBINDO$$41$YR$$M$Y$76$KG$20240729$$PH$FR$FR
241458871$24145887$1$I$20240725$20240726$20240729$20240729$EXP$$KR-TAKEDA-2024TUS075634$TAKEDA$$75$YR$$F$Y$$$20240729$$CN$KR$KR
241458881$24145888$1$I$$20240719$20240729$20240729$EXP$$CA-APOTEX-2024AP008638$APOTEX$$$$$F$Y$$$20240729$$MD$CA$CA
241458892$24145889$2$F$$20240814$20240729$20240820$EXP$$PT-ROCHE-10000037928$ROCHE$Carrilho M, Nobre M, Santos M, Silva R, Martins J. MYOCARDITIS A CMV {Abstract number: CO-0062 - (4147)]. Infectious and parasitic diseases.. 2024-May;162.$72$YR$E$F$Y$$$20240820$$HP$PT$PT
241458901$24145890$1$I$20231001$20240719$20240729$20240729$EXP$NL-LRB-00981481$NL-TEVA-VS-3223408$TEVA$$13$YR$$M$Y$34.5$KG$20240729$$MD$NL$NL
241458911$24145891$1$I$20240101$20240725$20240729$20240729$EXP$$GB-UCBSA-2024037796$UCB$$$$$M$Y$$$20240729$$CN$GB$GB
241458921$24145892$1$I$$20240716$20240729$20240729$EXP$CA-NOVARTIS PHARMA S.A.-NVSC2024CA147004$CA-ROCHE-10000031768$ROCHE$$35$YR$A$F$Y$$$20240729$$CN$CA$CA
241458931$24145893$1$I$$20240726$20240729$20240729$EXP$$PK-ROCHE-10000040202$ROCHE$$29$YR$A$M$Y$$$20240729$$CN$PK$PK
241458941$24145894$1$I$20240301$20240717$20240729$20240729$EXP$$US-ROCHE-10000030613$ROCHE$$48$YR$A$F$Y$55.78$KG$20240729$$CN$US$US
241458952$24145895$2$F$20240201$20240815$20240729$20240819$PER$$US-ALXN-202407USA001520US$ALEXION PHARMACEUTICALS$$40$YR$$M$Y$$$20240819$$CN$US$US
241458962$24145896$2$F$$20240816$20240729$20240821$EXP$$US-ABBVIE-5851414$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
241458971$24145897$1$I$20240701$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119456$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240729$$CN$US$US
241458981$24145898$1$I$20240708$20240725$20240729$20240729$EXP$FR-AFSSAPS-MA2024001251$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-119146$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240729$$MD$FR$FR
241458992$24145899$2$F$20221201$20240718$20240729$20240730$EXP$$US-AUROBINDO-AUR-APL-2024-035960$AUROBINDO$Khan S, Yetiskul E, Khattar G, Ghada A, Afif S, Khan MW, et al. FAILURE OF THE PD-1 BLOCKING AGENT PEMBROLIZUMAB TO BENEFIT A PATIENT WITH RENAL SQUAMOUS CELL CANCER. European journal of case reports in internal medicine. 2024;11$80$YR$$F$Y$$$20240730$$MD$US$US
241459002$24145900$2$F$20231206$20240718$20240729$20240730$EXP$$IT-AUROBINDO-AUR-APL-2024-036534$AUROBINDO$$94$YR$$M$Y$$$20240730$$MD$IT$IT
241459011$24145901$1$I$$20240725$20240729$20240729$PER$$US-ROCHE-10000038698$ROCHE$$18$YR$A$M$Y$$$20240729$$HP$US$US
241459022$24145902$2$F$20240719$20240923$20240729$20240927$EXP$$US-ABBVIE-5852544$ABBVIE$$64$YR$$F$Y$$$20240927$$CN$US$US
241459031$24145903$1$I$20240725$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017692$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240729$$CN$US$US
241459042$24145904$2$F$$20240725$20240729$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017164$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240730$$MD$US$US
241459051$24145905$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016815$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240729$$CN$US$US
241459061$24145906$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016393$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240729$$CN$US$US
241459071$24145907$1$I$$20240723$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407015953$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240729$$MD$US$US
241459081$24145908$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016299$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240729$$CN$US$US
241459091$24145909$1$I$20240722$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017479$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240729$$CN$US$US
241459101$24145910$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017069$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240729$$CN$US$US
241459111$24145911$1$I$20240606$20240722$20240729$20240729$EXP$FR-AFSSAPS-TS2024000829$FR-GSK-FR2024092018$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$MD$FR$FR
241459122$24145912$2$F$$20240808$20240729$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003245$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
241459132$24145913$2$F$20230406$20240724$20240729$20240801$EXP$FR-AFSSAPS-NY2024000819$FR-EMD Serono-2024039701$EMD SERONO INC$$73$YR$E$F$Y$100$KG$20240801$$PH$FR$FR
241459143$24145914$3$F$20240724$20240822$20240729$20240826$PER$$US-AMGEN-USASP2024148077$AMGEN$$64$YR$A$F$Y$$$20240826$$CN$US$US
241459151$24145915$1$I$20240719$20240719$20240729$20240729$EXP$$AR-AMGEN-ARGSP2024147486$AMGEN$$66$YR$E$F$Y$$$20240729$$CN$AR$AR
241459161$24145916$1$I$$20240724$20240729$20240729$EXP$$DE-TAKEDA-2024TUS075475$TAKEDA$$$$$F$Y$$$20240729$$CN$DE$DE
241459171$24145917$1$I$$20240719$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036832$AUROBINDO$$47$YR$$M$Y$$$20240729$$MD$FR$FR
241459181$24145918$1$I$$20240723$20240729$20240729$EXP$$CA-TAKEDA-2019TUS065561$TAKEDA$$$$$M$Y$$$20240729$$HP$CA$CA
241459192$24145919$2$F$20240630$20240730$20240729$20240801$EXP$$US-BAUSCH-BL-2024-011450$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240801$$CN$US$US
241459201$24145920$1$I$$20240717$20240729$20240729$PER$$US-JNJFOC-20240775072$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$HP$US$US
241459212$24145921$2$F$20240601$20240811$20240729$20240812$PER$$US-JNJFOC-20240706721$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
241459221$24145922$1$I$$20240726$20240729$20240729$PER$$US-JNJFOC-20240774932$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$HP$US$US
241459231$24145923$1$I$20240701$20240719$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036714$AUROBINDO$$78$YR$$F$Y$$$20240729$$MD$FR$FR
241459241$24145924$1$I$20240601$20240722$20240729$20240729$EXP$$US-JNJFOC-20240761125$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240729$$HP$US$US
241459251$24145925$1$I$$20240715$20240729$20240729$EXP$$TN-PURACAP-TN-2024EPCLIT00893$PURACAP$N Brahmi.High-dose norepinephrine infusion (100 microg/kg/min) in a near-fatal amlodipine and perindopril poisoning: are there any limits?.Clinical Toxicology.APR-2024;62:273-274$23$YR$A$F$Y$$$20240729$$HP$TN$TN
241459261$24145926$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5855053$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241459271$24145927$1$I$20240101$20240725$20240729$20240729$EXP$$US-ABBVIE-5855296$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241459282$24145928$2$F$$20240801$20240729$20240802$EXP$$US-BAUSCH-BL-2024-011485$BAUSCH AND LOMB$$64$YR$$M$Y$78.996$KG$20240802$$CN$US$US
241459292$24145929$2$F$$20240808$20240729$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003225$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
241459301$24145930$1$I$$20240717$20240729$20240729$PER$$US-EMD Serono-2024039102$EMD SERONO INC$$$$$F$Y$$$20240729$$HP$US$US
241459321$24145932$1$I$$20240715$20240729$20240729$EXP$$NL-TEVA-VS-3224493$TEVA$Wichers R, Heller HM, van Veen S. Deciding on life-saving treatment after a violent suicide attempt: an ethical case report. Gen-Psychiatr 2024; 37 (2):.$39$YR$$M$Y$$$20240729$$MD$NL$NL
241459331$24145933$1$I$$20230921$20240729$20240729$EXP$$US-AstraZeneca-2023A218822$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241459341$24145934$1$I$$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A169495$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241459351$24145935$1$I$$20230302$20240729$20240729$EXP$$CA-AstraZeneca-2023A053512$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$CA$
241459361$24145936$1$I$20240521$20240726$20240729$20240729$EXP$$ZA-AstraZeneca-2024A171163$ASTRAZENECA$$78$YR$$M$Y$$$20240729$$CN$ZA$
241459371$24145937$1$I$20230907$20240720$20240729$20240729$EXP$$IT-AUROBINDO-AUR-APL-2024-036659$AUROBINDO$$92$YR$$M$Y$$$20240729$$MD$IT$IT
241459382$24145938$2$F$$20240725$20240729$20240805$PER$$US-ABBVIE-5856752$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241459391$24145939$1$I$20230720$20230724$20240729$20240729$PER$$US-IGSA-BIG0024963$GRIFOLS$$72$YR$$F$Y$$$20240729$$HP$US$US
241459401$24145940$1$I$20230101$20231112$20240729$20240729$PER$$US-IGSA-BIG0026467$GRIFOLS$$$$$M$Y$$$20240729$$MD$US$US
241459411$24145941$1$I$20230101$20230724$20240729$20240729$PER$$US-IGSA-BIG0024872$GRIFOLS$$57$YR$$M$Y$$$20240729$$MD$US$US
241459421$24145942$1$I$$20240726$20240729$20240729$PER$$US-BAUSCH-BL-2024-011457$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240729$$CN$US$US
241459431$24145943$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003222$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241459441$24145944$1$I$$20240719$20240729$20240729$PER$$US-BAUSCH-BL-2024-011332$BAUSCH AND LOMB$$53$YR$$M$Y$$$20240729$$CN$US$US
241459451$24145945$1$I$$20240717$20240729$20240729$PER$$US-JNJFOC-20240774800$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$MD$US$US
241459461$24145946$1$I$$20240726$20240729$20240729$EXP$$NVSC2024US153876$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241459481$24145948$1$I$$20240722$20240729$20240729$EXP$$BR-TAKEDA-2024TUS074754$TAKEDA$$$$$M$Y$$$20240729$$CN$BR$BR
241459491$24145949$1$I$20240715$20240715$20240729$20240729$EXP$GB-MHRA-MED-202407151917259180-CSJYM$GB-DEXPHARM-2024-2413$DEXCEL$$45$YR$A$M$Y$97$KG$20240729$$CN$GB$GB
241459501$24145950$1$I$20240515$20240720$20240729$20240729$EXP$FR-AFSSAPS-CN2024000586$FR-AMGEN-FRASP2024144382$AMGEN$$79$YR$E$M$Y$67$KG$20240729$$MD$FR$FR
241459511$24145951$1$I$20240601$20240726$20240729$20240729$EXP$$IL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041059$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$70$KG$20240729$$MD$IL$IL
241459522$24145952$2$F$$20240815$20240729$20240819$PER$$US-ALXN-202407USA001482US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241459531$24145953$1$I$20240713$20240726$20240729$20240729$EXP$$CN-ABBVIE-5855780$ABBVIE$$34$YR$$F$Y$70$KG$20240729$$MD$CN$CN
241459541$24145954$1$I$$20240719$20240729$20240729$EXP$$US-APOTEX-2024AP008705$APOTEX$Belnavis G, Goyal A, Boudoulas KD, Breckenridge MB. A CASE OF MYOCARDIAL INFARCTION IN A YOUNG BODYBUILDER ON TESTOSTERONE. Journal of the American College of Cardiology. 2024;83: 13:3294$33$YR$$M$Y$$$20240729$$HP$US$US
241459561$24145956$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119009$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240729$$CN$US$US
241459571$24145957$1$I$20240501$20240725$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119216$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240729$$CN$US$US
241459581$24145958$1$I$$20240726$20240729$20240729$EXP$CA-GLAXOSMITHKLINE-CA2021AMR077270$CA-WT-2021-AMR-077270$Waylis$$$$$M$Y$$$20240729$$HP$CA$CA
241459591$24145959$1$I$$20240715$20240729$20240729$EXP$$IT-EPICPHARMA-IT-2024EPCLIT00867$EPIC PHARM$Maniezzi C.Electrophysiological effects of estrogen on hiPSC-derived cardiomyocytes of a patient affected by estrogen-sensitive Long-QT Syndrome Type 2.Vascular Pharmacology.JUN-2024;155$$$$F$Y$$$20240729$$HP$IT$IT
241459601$24145960$1$I$20240501$20240719$20240729$20240729$EXP$$NVSC2024IT106471$NOVARTIS$$$$A$F$Y$80$KG$20240729$$MD$IT$IT
241459612$24145961$2$F$20230301$20240808$20240729$20240823$EXP$$US-KHC-000055$Kilitch Healthcare$$$$$F$Y$$$20240823$$CN$US$US
241459621$24145962$1$I$20230101$20231111$20240729$20240729$EXP$$US-KHC-000053$Kilitch Healthcare$$31$YR$A$F$Y$$$20240729$$CN$US$US
241459631$24145963$1$I$$20240725$20240729$20240729$PER$$US-TAKEDA-2024TUS075399$TAKEDA$$$$$$Y$$$20240729$$CN$US$US
241459641$24145964$1$I$$20240724$20240729$20240729$PER$$US-JNJFOC-20240768705$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$HP$US$US
241459654$24145965$4$F$20240701$20240809$20240729$20240820$30DAY$$GB-JNJFOC-20240711167$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240820$$CN$GB$GB
241459662$24145966$2$F$$20240719$20240729$20240729$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009260$STRIDES$Satta T, Papadopoulos EB, Gyurkocza B, Susman P, Singh A, Calafiore M, et al.. Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd.. Blood. 2023;142 (Suppl. 1):7019$37$YR$$$Y$$$20240729$$HP$US$US
241459672$24145967$2$F$20240621$20240708$20240729$20240805$PER$$US-ABBVIE-5848081$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241459681$24145968$1$I$$20240719$20240729$20240729$EXP$$US-GSK-US2024AMR092630$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241459691$24145969$1$I$20240721$20240723$20240729$20240729$PER$$US-AMGEN-USASP2024146889$AMGEN$$43$YR$A$M$Y$$$20240729$$CN$US$US
241459701$24145970$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147906$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241459711$24145971$1$I$20220601$20240718$20240729$20240729$EXP$DE-PEI-202400014559$DE-ROCHE-10000030920$ROCHE$$56$YR$A$F$Y$67$KG$20240729$$CN$DE$DE
241459722$24145972$2$F$$20240724$20240729$20240731$EXP$$NVSC2024BR153125$NOVARTIS$$$$$M$Y$$$20240731$$CN$BR$BR
241459731$24145973$1$I$$20240719$20240729$20240729$EXP$NL-LRB-00985993$NL-TEVA-VS-3223372$TEVA$$63$YR$$F$Y$66$KG$20240729$$CN$NL$NL
241459742$24145974$2$F$$20240826$20240729$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003154$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
241459752$24145975$2$F$$20240814$20240729$20240822$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-102932$REGENERON$$68$YR$$F$Y$$$20240822$$HP$CO$CO
241459763$24145976$3$F$$20240731$20240729$20240805$EXP$$US-ROCHE-10000033623$ROCHE$$65$YR$E$M$Y$$$20240805$$HP$US$US
241459772$24145977$2$F$20240718$20240805$20240729$20240808$EXP$GB-MHRA-MED-202407190927291090-WHMSP$GB-STRIDES ARCOLAB LIMITED-2024SP009215$STRIDES$$11$YR$$F$Y$$$20240808$$CN$GB$GB
241459781$24145978$1$I$20240209$20240726$20240729$20240729$EXP$DE-PEI-CADR2024329506$DE-JNJFOC-20240775617$JOHNSON AND JOHNSON$$58$YR$A$F$Y$53$KG$20240729$$CN$DE$DE
241459791$24145979$1$I$20240701$20240705$20240729$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003153$ACADIA PHARMACEUTICALS$$92$YR$$M$Y$$$20240729$$HP$US$US
241459801$24145980$1$I$$20240719$20240729$20240729$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP009223$STRIDES$GaUr U, Gadkari C, PUndkar A.. Hypokalaemic Periodic Paralysis in a Patient with Rheumatoid Arthritis: A Case Report.. J-Clin-Diagnostic-Res. 2024;18 (7):OD01-OD03.$37$YR$$F$Y$$$20240729$$MD$IN$IN
241459811$24145981$1$I$20240605$20240719$20240729$20240729$EXP$FR-AFSSAPS-LL2024001284$FR-TEVA-VS-3223385$TEVA$$61$YR$$F$Y$$$20240729$$PH$FR$FR
241459821$24145982$1$I$20240704$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003157$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240729$$CN$US$US
241459831$24145983$1$I$$20240724$20240729$20240729$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003794$TERSERA THERAPEUTICS$$$$$$Y$$$20240729$$CN$AU$AU
241459841$24145984$1$I$20240525$20240724$20240729$20240729$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003793$TERSERA THERAPEUTICS$$$$$$Y$$$20240729$$CN$AU$AU
241459861$24145986$1$I$$20240715$20240729$20240729$EXP$$US-EPICPHARMA-US-2024EPCLIT00873$EPIC PHARM$E. Lam.A Case of Critical Bupropion, Olanzapine, and Oxcarbazepine Overdose.American Journal of Respiratory and Critical Care Medicine.2024;209:A5651$32$YR$A$F$Y$$$20240729$$HP$US$US
241459872$24145987$2$F$$20240729$20240729$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003156$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
241459881$24145988$1$I$20240501$20240611$20240729$20240729$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091304$VIIV$$27$YR$$M$Y$$$20240729$$PH$US$US
241459891$24145989$1$I$20240501$20240611$20240729$20240729$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091301$VIIV$$61$YR$$F$Y$$$20240729$$PH$US$US
241459902$24145990$2$F$20240501$20240808$20240729$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090633$VIIV$$33$YR$$M$Y$$$20240816$$PH$US$US
241459911$24145991$1$I$20240501$20240611$20240729$20240729$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091303$VIIV$$32$YR$$M$Y$$$20240729$$PH$US$US
241459921$24145992$1$I$20240711$20240729$20240729$20240729$EXP$IT-MINISAL02-996791$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042355$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$65$KG$20240729$$MD$IT$IT
241459932$24145993$2$F$$20240826$20240729$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118941$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$70.76$KG$20240828$$CN$US$US
241459941$24145994$1$I$$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A169232$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241459951$24145995$1$I$$20240725$20240729$20240729$EXP$$US-AMGEN-USASP2024148715$AMGEN$Rives T.A.; Stewart M.A.; Blanton K. et al.. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecologic Oncology Reports. 2024;54:1-3$33$YR$A$F$Y$$$20240729$$HP$US$US
241459961$24145996$1$I$$20240718$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115171$BRISTOL MYERS SQUIBB$Literature citation unavailable.$$$$$Y$$$20240729$$HP$CA$CA
241459971$24145997$1$I$$20230419$20240729$20240729$EXP$$US-AstraZeneca-2023A092288$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241459981$24145998$1$I$$20230714$20240729$20240729$EXP$$US-AstraZeneca-2023A163049$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241459992$24145999$2$F$$20240816$20240729$20240819$PER$$US-ALXN-202407USA001547US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241460002$24146000$2$F$20240801$20240827$20240729$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003162$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240919$$CN$US$US
241460012$24146001$2$F$20240902$20240903$20240729$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003160$ACADIA PHARMACEUTICALS$$55$YR$$M$Y$$$20240926$$CN$US$US
241460022$24146002$2$F$20240704$20240731$20240729$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003168$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240823$$CN$US$US
241460031$24146003$1$I$20240601$20240719$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017108$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240729$$CN$US$US
241460041$24146004$1$I$20240724$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016860$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240729$$CN$US$US
241460051$24146005$1$I$$20240719$20240729$20240729$PER$$US-APOTEX-2024AP008740$APOTEX$Ganesh MK, Gao L. ITRACONAZOLE- ASSOCIATED HEART FAILURE EXACERBATION. J-Am-Coll-Cardiol. 2024;83 (13):4518$84$YR$$F$Y$$$20240729$$HP$US$US
241460062$24146006$2$F$$20240802$20240729$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407017181$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240806$$CN$US$US
241460071$24146007$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016779$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240729$$CN$US$US
241460082$24146008$2$F$20240909$20240910$20240729$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202407017133$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240911$$CN$US$US
241460091$24146009$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003163$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241460101$24146010$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003216$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241460111$24146011$1$I$20240501$20240719$20240729$20240729$EXP$FR-AFSSAPS-RN2024000770$FR-TEVA-VS-3223568$TEVA$$80$YR$$M$Y$$$20240729$$MD$FR$FR
241460121$24146012$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003209$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241460131$24146013$1$I$$20240705$20240729$20240729$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003175$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240729$$HP$US$US
241460143$24146014$3$F$$20240903$20240729$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003260$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
241460151$24146015$1$I$20240621$20240706$20240729$20240729$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003165$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240729$$CN$US$US
241460161$24146016$1$I$$20240722$20240729$20240729$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005469$BIOCON$$$$$$Y$$$20240729$$HP$CA$CA
241460171$24146017$1$I$20240724$20240726$20240729$20240729$EXP$$US-SANDOZ INC.-SDZ2024US068680$SANDOZ$$63$YR$$F$Y$$$20240729$$HP$US$US
241460181$24146018$1$I$$20240701$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06753$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241460191$24146019$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149003$AMGEN$$$$$$Y$$$20240729$$HP$US$US
241460201$24146020$1$I$20240707$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147606$AMGEN$$64$YR$A$M$Y$$$20240729$$CN$US$US
241460211$24146021$1$I$$20240701$20240729$20240729$PER$$US-JNJFOC-20240708058$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241460221$24146022$1$I$20240101$20240725$20240729$20240729$EXP$$US-BAUSCH-BL-2024-011454$BAUSCH AND LOMB$$53$YR$$M$Y$$$20240729$$HP$US$US
241460231$24146023$1$I$20240720$20240724$20240729$20240729$EXP$$NVSC2024US153042$NOVARTIS$$62$YR$$M$Y$$$20240729$$CN$US$US
241460242$24146024$2$F$$20240911$20240729$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA068628$SANDOZ$$74$YR$$F$Y$$$20240916$$CN$CA$CA
241460251$24146025$1$I$$20240717$20240729$20240729$EXP$$US-SCIEGENP-2024SCLIT00342$SCIEGEN$Salar T, et al..A CASE OF HYDRALAZINE INDUCED SEVERE RENALLIMITED ANCA VASCULITIS LEADING TO ESRD IN A  63-YEAR-OLD MAN.American Journal of Kidney Diseases.APR-2023;81 (4):S42$63$YR$A$M$Y$$$20240729$$HP$US$US
241460261$24146026$1$I$$20240717$20240729$20240729$EXP$$US-SCIEGENP-2024SCLIT00341$SCIEGEN$S. C. Oomrigar, J. Fernandez, C. Rivera Ortiz, H. Rajen, A. Toll and E. Perez Colome. Et.al.The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:1-1$$$$F$Y$$$20240729$$HP$US$US
241460271$24146027$1$I$$20240716$20240729$20240729$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109899$ZYDUS PHARM$Rodriguez C, Yosry N, Qaiser S, Luzuriaga A, Adelizzi A.. BRASH: A Deadly Acronym.. Am-J-Respir-Crit-Care-Med. 2024;209:A1596$$$$$Y$$$20240729$$HP$US$US
241460281$24146028$1$I$$20240715$20240729$20240729$EXP$$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109871$ZYDUS PHARM$Garcia Ruiz PJ, Feliz LD, Feliz CE, Sanchez IL, Fernandez AA, Kelly FB, et al.. The enduring enigma of sporadic chorea: A single center case series.. Tremor-Other-Hyperkinet-Mov. 2023;13(1):1-10$$$$$Y$$$20240729$$MD$ES$ES
241460291$24146029$1$I$20220901$20240715$20240729$20240729$EXP$FR-AFSSAPS-AVPO2024000133$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110070$ZYDUS PHARM$$$$$$Y$$$20240729$$PH$FR$FR
241460311$24146031$1$I$$20240717$20240729$20240729$EXP$$IT-SCIEGENP-2024SCLIT00343$SCIEGEN$C. Scollo, D. Rossi, R. D Andria, R. Magnano, L. Pezzi, A. D Alleva, et al.CARDIOVASCULAR CONSIDERATIONS IN ANTIDEPRESSANT THERAPY: SINUS ARREST DUE TO SERTRALINE.European Heart Journal.APR-2024;26 (2):ii78$39$YR$A$F$Y$$$20240729$$HP$IT$IT
241460321$24146032$1$I$$20240717$20240729$20240729$EXP$$PS-SCIEGENP-2024SCLIT00344$SCIEGEN$$49$YR$A$M$Y$$$20240729$$HP$PS$PS
241460331$24146033$1$I$20240619$20240715$20240729$20240729$EXP$FR-AFSSAPS-AVCN2024000517$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110030$ZYDUS PHARM$$$$$$Y$$$20240729$$MD$FR$FR
241460341$24146034$1$I$20240626$20240715$20240729$20240729$EXP$ES-AEMPS-1549106$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-110089$ZYDUS PHARM$$$$$$Y$$$20240729$$PH$ES$ES
241460352$24146035$2$F$20240622$20240730$20240729$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003262$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240823$$CN$US$US
241460361$24146036$1$I$$20240717$20240729$20240729$PER$$US-AMGEN-USASP2024148017$AMGEN$$$$$$Y$$$20240729$$MD$US$US
241460371$24146037$1$I$$20240724$20240729$20240729$EXP$$US-Taiho Oncology Inc-2024-007223$TAIHO ONCOLOGY INC$$67$YR$E$M$Y$$$20240729$$CN$US$US
241460381$24146038$1$I$20240712$20240719$20240729$20240729$EXP$GB-MHRA-MED-202407191215278630-CQKSY$GB-TEVA-VS-3223658$TEVA$$74$YR$$M$Y$$$20240729$$HP$GB$GB
241460392$24146039$2$F$20240601$20240723$20240729$20240730$EXP$$CA-JNJFOC-20240763221$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240730$$HP$CA$CA
241460401$24146040$1$I$$20240718$20240729$20240729$EXP$$CA-APOTEX-2024AP008609$APOTEX$$9$YR$$M$Y$$$20240729$$HP$CA$CA
241460413$24146041$3$F$$20240821$20240729$20240826$PER$$US-JNJFOC-20240771519$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20240826$$CN$US$US
241460425$24146042$5$F$20240615$20240909$20240729$20240919$30DAY$$US-JNJFOC-20240766487$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240919$$CN$US$US
241460431$24146043$1$I$$20240726$20240729$20240729$EXP$$GB-GSK-GB2024EME093965$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$GB$GB
241460442$24146044$2$F$20240501$20240917$20240729$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115907$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240920$$CN$US$US
241460451$24146045$1$I$$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119116$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240729$$CN$US$US
241460461$24146046$1$I$20240501$20240725$20240729$20240729$EXP$CH-SM-2024-13961$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-119015$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$70$KG$20240729$$MD$CH$CH
241460472$24146047$2$F$$20240822$20240729$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118237$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240828$$CN$US$US
241460481$24146048$1$I$$20240724$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118994$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240729$$CN$US$US
241460491$24146049$1$I$$20240702$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06671$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241460501$24146050$1$I$$20240716$20240729$20240729$EXP$$HU-ROCHE-10000029648$ROCHE$Voros K, Nagy Z. Treatment and follow-up  of cystoid macular  oedema as a result of targeted therapy of disseminated  cutaneous melanoma. Ophthalmology. 2024;161 (2):94-98. doi:10.55342/SZEMHUNGARICA.2024.161.2.94.$52$YR$A$M$Y$$$20240729$$MD$HU$HU
241460511$24146051$1$I$$20240722$20240729$20240729$PER$$US-ABBVIE-5851762$ABBVIE$$$$$M$Y$$$20240729$$HP$US$US
241460521$24146052$1$I$$20240715$20240729$20240729$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07168$LUPIN$$$$$$Y$$$20240729$$CN$AU$AU
241460541$24146054$1$I$$20240718$20240729$20240729$PER$$US-TAKEDA-2024TUS073298$TAKEDA$$$$$F$Y$59$KG$20240729$$MD$US$US
241460551$24146055$1$I$20240625$20240723$20240729$20240729$EXP$$US-AMGEN-USASL2024147558$AMGEN$$66$YR$E$F$Y$$$20240729$$CN$US$US
241460562$24146056$2$F$$20240729$20240729$20240808$EXP$$US-INTERCEPT-PM2024001510$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241460571$24146057$1$I$$20240716$20240729$20240729$PER$$US-TEVA-VS-3225868$TEVA$$$$$M$Y$$$20240729$$MD$US$US
241460581$24146058$1$I$20231204$20231204$20240729$20240729$PER$$US-IGSA-BIG0026771$GRIFOLS$$$$$M$Y$$$20240729$$HP$US$US
241460592$24146059$2$F$$20240715$20240729$20240806$EXP$$PT-TEVA-VS-3222987$TEVA$Literature Reference: Velho RM, Maia M, Easter F, Paix?o J, Silva F, Teixeira AS et al. PO-0097 - (4625) - Severe hyponatremia secondary to ciprofloxacin Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts [CNMI]. 2024 May; 469.$84$YR$$M$Y$$$20240806$$MD$PT$PT
241460601$24146060$1$I$$20240725$20240729$20240729$30DAY$$US-GSK-US2024093552$GLAXOSMITHKLINE$$87$YR$$F$Y$$$20240729$$CN$US$US
241460611$24146061$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147812$AMGEN$$$$$$Y$$$20240729$$HP$US$US
241460621$24146062$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149116$AMGEN$$$$$F$Y$$$20240729$$MD$US$US
241460632$24146063$2$F$$20240725$20240729$20240807$PER$$US-AMGEN-USASP2024148703$AMGEN$$$$A$M$Y$$$20240807$$HP$US$US
241460641$24146064$1$I$20221101$20240724$20240729$20240729$EXP$$BG-SA-2024SA217102$SANOFI AVENTIS$Petrusheva V, Samardzieva M, Simova I, Chilingirova N, Vekov T.. Cardiotoxicity in Patient with Breast Cancer treated with HER-2 Targeted Therapy - A Case Report.. Cardiovascular Diseases. 2024;55(2):14-23$54$YR$A$F$Y$$$20240729$$HP$BG$BG
241460651$24146065$1$I$20240721$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148598$AMGEN$$60$YR$A$M$Y$$$20240729$$CN$US$US
241460661$24146066$1$I$20240723$20240723$20240729$20240729$EXP$$US-ABBVIE-5851784$ABBVIE$$58$YR$$M$Y$$$20240729$$CN$US$US
241460671$24146067$1$I$$20240723$20240729$20240729$EXP$$US-ABBVIE-5852036$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241460681$24146068$1$I$20240524$20240719$20240729$20240729$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-102886$REGENERON$$66$YR$$F$Y$$$20240729$$HP$CO$CO
241460691$24146069$1$I$$20240719$20240729$20240729$PER$$US-ROCHE-10000032005$ROCHE$$35$YR$A$F$Y$$$20240729$$CN$US$US
241460702$24146070$2$F$20240101$20240729$20240729$20240802$EXP$$US-ABBVIE-5854766$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241460711$24146071$1$I$$20240723$20240729$20240729$EXP$$JP-009507513-2407JPN004342J$MERCK$$$$$F$Y$$$20240729$$MD$JP$JP
241460721$24146072$1$I$20240101$20240715$20240729$20240729$EXP$FR-AFSSAPS-TO2024001282$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110020$ZYDUS PHARM$$$$$$Y$$$20240729$$PH$FR$FR
241460731$24146073$1$I$20240313$20240715$20240729$20240729$EXP$FR-AFSSAPS-AN2024000668$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110013$ZYDUS PHARM$$$$$$Y$$$20240729$$PH$FR$FR
241460741$24146074$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119245$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240729$$CN$US$US
241460751$24146075$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118739$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240729$$HP$US$US
241460761$24146076$1$I$20240724$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016793$ELI LILLY AND CO$$$$A$F$Y$$$20240729$$CN$US$US
241460771$24146077$1$I$20240701$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016950$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240729$$CN$US$US
241460782$24146078$2$F$20240326$20240724$20240729$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017086$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240731$$HP$US$US
241460791$24146079$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016945$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240729$$CN$US$US
241460811$24146081$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017547$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240729$$CN$US$US
241460821$24146082$1$I$20230101$20240725$20240729$20240729$EXP$$US-ABBVIE-5855613$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241460841$24146084$1$I$20240101$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016869$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240729$$CN$US$US
241460852$24146085$2$F$$20240725$20240729$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407017075$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240807$$CN$US$US
241460861$24146086$1$I$20240715$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017056$ELI LILLY AND CO$$$$A$F$Y$$$20240729$$CN$US$US
241460871$24146087$1$I$$20240719$20240729$20240729$PER$$US-ROCHE-10000033423$ROCHE$$$$$$Y$$$20240729$$PH$US$US
241460881$24146088$1$I$$20240719$20240729$20240729$EXP$$GB-TEVA-VS-3223577$TEVA$$93$YR$$F$Y$$$20240729$$MD$GB$GB
241460891$24146089$1$I$20240718$20240719$20240729$20240729$PER$$GB-REGENERON PHARMACEUTICALS, INC.-2024-102885$REGENERON$$59$YR$$F$Y$$$20240729$$CN$GB$GB
241460901$24146090$1$I$20230303$20240716$20240729$20240729$EXP$$CA-ROCHE-3454331$ROCHE$$70$YR$E$F$Y$$$20240729$$CN$CA$CA
241460911$24146091$1$I$$20240718$20240729$20240729$PER$$US-ROCHE-10000033512$ROCHE$$75$YR$E$F$Y$$$20240729$$CN$US$US
241460921$24146092$1$I$$20240715$20240729$20240729$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06824$HIKMA$Dogrul BN, Park C.. Dogrul BN, Park C. Hydralazine-Induced Visual and Auditory Hallucinations in a Kidney Transplant Patient: Case Report. Journal of the Academy of Consultation Liaison Psychiatry. 2024$$$$$Y$$$20240729$$MD$COUNTRY NOT SPECIFIED$US
241460932$24146093$2$F$$20240729$20240729$20240731$EXP$$CA-UCBSA-2024037869$UCB$$$$$F$Y$$$20240731$$MD$CA$CA
241460941$24146094$1$I$$20240723$20240729$20240729$PER$$US-ABBVIE-5852906$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241460951$24146095$1$I$$20240724$20240729$20240729$EXP$$NVSC2024US152351$NOVARTIS$$$$$$Y$$$20240729$$CN$US$US
241460961$24146096$1$I$$20240724$20240729$20240729$EXP$$DE-AstraZeneca-2024A168915$ASTRAZENECA$$$$$F$Y$$$20240729$$PH$DE$
241460971$24146097$1$I$$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A169415$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241460981$24146098$1$I$20240616$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A169109$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241460991$24146099$1$I$20240720$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A169293$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241461001$24146100$1$I$$20240717$20240729$20240729$PER$$US-AstraZeneca-2024A163736$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241461011$24146101$1$I$$20230125$20240729$20240729$EXP$$US-AstraZeneca-2023A023449$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241461021$24146102$1$I$$20240719$20240729$20240729$PER$$US-AstraZeneca-2024A165609$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241461031$24146103$1$I$20240614$20240709$20240729$20240729$PER$$US-TEVA-VS-3219657$TEVA$$76$YR$$F$Y$64$KG$20240729$$PH$US$US
241461041$24146104$1$I$$20240719$20240729$20240729$EXP$$JP-ARGENX-2024-ARGX-JP005777AA$ARGENX BVBA$$$$$$Y$$$20240729$$CN$JP$JP
241461052$24146105$2$F$$20240726$20240729$20240730$EXP$$GB-MYLANLABS-2024M1069332$MYLAN$$$$$F$Y$$$20240730$$CN$GB$GB
241461081$24146108$1$I$$20240724$20240729$20240729$EXP$$IN-Bion-013545$BIONPHARMA$$24$YR$A$M$Y$$$20240729$$HP$IN$IN
241461091$24146109$1$I$$20240723$20240729$20240729$EXP$$QA-Bion-013517$BIONPHARMA$$41$YR$A$M$Y$$$20240729$$HP$QA$QA
241461101$24146110$1$I$20240717$20240722$20240729$20240729$EXP$$US-Bion-013548$BIONPHARMA$$69$YR$E$F$Y$$$20240729$$CN$US$US
241461111$24146111$1$I$$20240724$20240729$20240729$EXP$$US-Bion-013549$BIONPHARMA$$83$YR$E$F$Y$97.52$KG$20240729$$CN$US$US
241461121$24146112$1$I$$20240724$20240729$20240729$EXP$$US-Bion-013546$BIONPHARMA$$3$WK$N$F$Y$$$20240729$$HP$US$US
241461131$24146113$1$I$20240201$20240724$20240729$20240729$EXP$FR-AFSSAPS-TO2024001325$FR-ORGANON-O2407FRA002296$ORGANON$$80$YR$$F$Y$$$20240729$$PH$FR$FR
241461141$24146114$1$I$$20240723$20240729$20240729$EXP$$ZA-Bion-013521$BIONPHARMA$$48$YR$A$M$Y$$$20240729$$HP$ZA$ZA
241461151$24146115$1$I$$20240726$20240729$20240729$PER$$US-ROCHE-10000040433$ROCHE$$$$E$M$Y$78.01$KG$20240729$$CN$US$US
241461161$24146116$1$I$$20240719$20240729$20240729$PER$$US-ABBVIE-5849270$ABBVIE$$$$A$F$Y$$$20240729$$MD$US$US
241461171$24146117$1$I$$20240719$20240729$20240729$EXP$US-MLMSERVICE-20240712-PI130051-00050-1$US-RDY-SPO/USA/24/0010825$DR REDDYS$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70(7):e92-6. DOI: 10.1097/MAT.0000000000002102.$12$YR$T$F$Y$63$KG$20240729$$MD$US$US
241461191$24146119$1$I$$20240725$20240729$20240729$PER$$US-ROCHE-10000038085$ROCHE$$66$YR$E$M$Y$99.8$KG$20240729$$HP$US$US
241461201$24146120$1$I$20240701$20240726$20240729$20240729$EXP$$US-UCBSA-2024037867$UCB$$65$YR$$F$Y$$$20240729$$CN$US$US
241461211$24146121$1$I$$20240722$20240729$20240729$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005473$BIOCON$$$$$$Y$$$20240729$$PH$CA$CA
241461221$24146122$1$I$20240430$20240719$20240729$20240729$EXP$FR-AFSSAPS-TO2024001230$FR-TEVA-VS-3223551$TEVA$$75$YR$$M$Y$$$20240729$$PH$FR$FR
241461231$24146123$1$I$$20240717$20240729$20240729$EXP$$CN-ROCHE-10000030172$ROCHE$Wu Y, Yang Y, Hu M, Zhou D, Li Y. Retrospective cohort study of the efficacy and safety of trastuzumab biosimilar versus originator trastuzumab in combination with pertuzumab in patients with HER2-positive breast cancer. Chinese Journal of Bases and Clinics in General Surgery. 2024-Mar;31 (3):349-53. doi:10.7507/1007-9424.202310022.$$$$$Y$$$20240729$$HP$CN$CN
241461241$24146124$1$I$$20240703$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06906$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241461251$24146125$1$I$20230105$20240716$20240729$20240729$EXP$$SG-ROCHE-10000032807$ROCHE$$55$YR$A$F$Y$$$20240729$$CN$SG$SG
241461261$24146126$1$I$$20240726$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042396$BOEHRINGER INGELHEIM$$$$$$Y$$$20240729$$CN$US$US
241461271$24146127$1$I$$20240717$20240729$20240729$EXP$$IN-SPC-000463$SOLARIS PHARMA$Hithesh G Jr, Moorthy S, M L, Bhaskar E. Unveiling the Neurotoxicity of Metronidazole: A Clinical Conundrum. Cureus. 2024 Jun 12;16(6):e62219. doi: 10.7759/cureus.62219.$61$YR$A$M$Y$$$20240729$$HP$IN$IN
241461292$24146129$2$F$20240722$20240807$20240729$20240808$PER$$US-JNJFOC-20240764869$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240808$$CN$US$US
241461301$24146130$1$I$20240710$20240725$20240729$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US068478$SANDOZ$$41$YR$$F$Y$93$KG$20240729$$HP$US$US
241461312$24146131$2$F$$20240829$20240729$20240905$30DAY$$FR-JNJFOC-20240768496$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$PH$FR$FR
241461322$24146132$2$F$$20240819$20240729$20240829$PER$$US-ROCHE-10000034288$ROCHE$$56$YR$A$F$Y$$$20240829$$CN$US$US
241461331$24146133$1$I$20240601$20240724$20240729$20240729$PER$$US-JNJFOC-20240765223$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240729$$CN$US$US
241461351$24146135$1$I$$20240717$20240729$20240729$PER$$US-JNJFOC-20240751984$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$HP$US$US
241461361$24146136$1$I$20240605$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A168777$ASTRAZENECA$$27798$DY$$F$Y$$$20240729$$CN$US$
241461371$24146137$1$I$20240723$20240724$20240729$20240729$EXP$$GB-JNJFOC-20240767456$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240729$$CN$GB$GB
241461381$24146138$1$I$20240613$20240715$20240729$20240729$EXP$FR-AFSSAPS-PC2024000557$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110015$ZYDUS PHARM$$$$$$Y$$$20240729$$MD$FR$FR
241461391$24146139$1$I$20240116$20240715$20240729$20240729$EXP$FR-AFSSAPS-TO2024000498$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110016$ZYDUS PHARM$$$$$$Y$$$20240729$$PH$FR$FR
241461401$24146140$1$I$20240601$20240715$20240729$20240729$EXP$FR-AFSSAPS-AM2024000571$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110014$ZYDUS PHARM$$$$$$Y$$$20240729$$MD$FR$FR
241461411$24146141$1$I$$20230131$20240729$20240729$EXP$$US-AstraZeneca-2023A026483$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241461421$24146142$1$I$20240401$20240715$20240729$20240729$EXP$FR-AFSSAPS-AVCN2024000533$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110028$ZYDUS PHARM$$$$$$Y$$$20240729$$MD$FR$FR
241461431$24146143$1$I$$20240718$20240729$20240729$EXP$$US-GSK-US2024090756$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$HP$US$US
241461441$24146144$1$I$$20240719$20240729$20240729$EXP$$US-GSK-US2024AMR092183$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241461472$24146147$2$F$$20240726$20240729$20240802$EXP$$US-TAKEDA-2024TUS075507$TAKEDA$$$$$F$Y$$$20240802$$MD$US$US
241461482$24146148$2$F$$20240816$20240729$20240819$PER$$US-ALXN-202407USA001461US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241461492$24146149$2$F$20240718$20240903$20240729$20240903$PER$$US-ALXN-202407USA001466US$ALEXION PHARMACEUTICALS$$75$YR$$M$Y$$$20240903$$CN$US$US
241461502$24146150$2$F$$20240801$20240729$20240806$30DAY$$IN-JNJFOC-20240767658$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$IN$IN
241461511$24146151$1$I$20240101$20240723$20240729$20240729$PER$$US-ABBVIE-5852666$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241461522$24146152$2$F$$20240815$20240729$20240828$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07351$LUPIN$$$$$$Y$$$20240828$$HP$US$US
241461531$24146153$1$I$20240719$20240726$20240729$20240729$EXP$$US-ABBVIE-5856203$ABBVIE$$72$YR$$F$Y$72$KG$20240729$$CN$US$US
241461561$24146156$1$I$$20240720$20240729$20240729$EXP$$US-GSK-US2024AMR091992$GLAXOSMITHKLINE$$59$YR$$$Y$$$20240729$$CN$US$US
241461571$24146157$1$I$$20240724$20240729$20240729$PER$$US-HALEON-2188826$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241461581$24146158$1$I$$20240725$20240729$20240729$PER$$US-HALEON-2189023$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241461591$24146159$1$I$$20240703$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06934$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241461602$24146160$2$F$$20240806$20240729$20240814$EXP$NL-LRB-00985383$NL-TEVA-VS-3223627$TEVA$$61$YR$$F$Y$$$20240814$$PH$NL$NL
241461611$24146161$1$I$20230101$20240719$20240729$20240729$EXP$$BR-EMD Serono-2023469640$EMD SERONO INC$$52$YR$A$F$Y$$$20240729$$CN$BR$BR
241461621$24146162$1$I$20230101$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148184$AMGEN$$$$A$$Y$$$20240729$$CN$US$US
241461633$24146163$3$F$$20240819$20240729$20240902$EXP$$JP-AMGEN-JPNSP2024149232$AMGEN$$$$$F$Y$$$20240902$$PH$JP$JP
241461641$24146164$1$I$$20240719$20240729$20240729$EXP$$ZA-ROCHE-10000034758$ROCHE$$$$A$M$Y$$$20240729$$MD$ZA$ZA
241461661$24146166$1$I$$20240719$20240729$20240729$EXP$$BR-TAKEDA-2024TUS074956$TAKEDA$$$$$F$Y$$$20240729$$CN$BR$BR
241461681$24146168$1$I$$20240725$20240729$20240729$EXP$$US-TAKEDA-2021TUS036932$TAKEDA$$$$$F$Y$$$20240729$$HP$US$US
241461691$24146169$1$I$$20240719$20240729$20240729$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-117901$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240729$$HP$ES$ES
241461701$24146170$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118821$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$56.7$KG$20240729$$CN$US$US
241461711$24146171$1$I$20240601$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119407$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240729$$CN$US$US
241461721$24146172$1$I$$20240716$20240729$20240729$PER$$US-JNJFOC-20240748528$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240729$$CN$US$US
241461731$24146173$1$I$20240722$20240722$20240729$20240729$PER$$US-MYLANLABS-2024M1069001$MYLAN$$42$YR$$F$Y$$$20240729$$CN$US$US
241461741$24146174$1$I$20240624$20240725$20240729$20240729$PER$$NVSC2024US153765$NOVARTIS$$9$YR$$M$Y$25.3$KG$20240729$$CN$US$US
241461751$24146175$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016902$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240729$$CN$US$US
241461761$24146176$1$I$20240724$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016883$ELI LILLY AND CO$$$$$$Y$$$20240729$$CN$US$US
241461781$24146178$1$I$20240301$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016826$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240729$$CN$US$US
241461791$24146179$1$I$$20240723$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407015233$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240729$$CN$US$US
241461801$24146180$1$I$20240611$20240729$20240729$20240729$EXP$HR-HALMED-300086181$HR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042383$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$112$KG$20240729$$MD$HR$HR
241461811$24146181$1$I$$20240719$20240729$20240729$EXP$$US-GSK-US2024AMR091598$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241461823$24146182$3$F$20240701$20240823$20240729$20240829$30DAY$$US-AMGEN-USASP2024146562$AMGEN$$56$YR$A$F$Y$$$20240829$$HP$US$US
241461831$24146183$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148749$AMGEN$$$$$M$Y$$$20240729$$CN$US$US
241461841$24146184$1$I$$20240724$20240729$20240729$PER$$US-LEO Pharma-372330$LEO PHARM$$55$YR$$F$Y$$$20240729$$PH$US$US
241461851$24146185$1$I$20240722$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147839$AMGEN$$18$YR$A$M$Y$99.773$KG$20240729$$CN$US$US
241461861$24146186$1$I$$20240724$20240729$20240729$PER$$US-JNJFOC-20240765921$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240729$$PH$US$US
241461872$24146187$2$F$$20240828$20240729$20240902$30DAY$$FR-JNJFOC-20240766868$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$PH$FR$FR
241461881$24146188$1$I$$20240715$20240729$20240729$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0258$GRAVITI PHARMACEUTICALS$Oomrigar SC, Fernandez J, Rivera Ortiz C, Rajen H, Toll A, Perez Colome E, et al.The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death.Am-J-Respir-Crit-Care-Med.2024;209:A5653$$$$F$Y$$$20240729$$HP$US$US
241461891$24146189$1$I$$20240725$20240729$20240729$EXP$GB-MHRA-MED-202407251004357380-PQSYK$GB-ORGANON-O2407GBR002451$ORGANON$$$$$M$Y$$$20240729$$CN$GB$GB
241461901$24146190$1$I$20230312$20240719$20240729$20240729$EXP$IT-MINISAL02-994776$IT-TEVA-VS-3223432$TEVA$$54$YR$$F$Y$$$20240729$$MD$IT$IT
241461911$24146191$1$I$20240718$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A169225$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241461921$24146192$1$I$$20240719$20240729$20240729$EXP$$FR-TEVA-VS-3224029$TEVA$$$$$M$Y$$$20240729$$PH$FR$FR
241461931$24146193$1$I$$20240724$20240729$20240729$EXP$$ZA-AstraZeneca-2024A170043$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$ZA$
241461941$24146194$1$I$$20240719$20240729$20240729$EXP$$US-GSK-US2024091052$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$MD$US$US
241461951$24146195$1$I$$20240718$20240729$20240729$EXP$$US-MYLANLABS-2024M1068545$MYLAN$Patel KH, Halicki J, Dachert S, Mamary A. Large Pericardial Cyst in a Lung Transplant Patient. Am-J-Respir-Crit-Care-Med 2024; 209 (0).$74$YR$$M$Y$$$20240729$$HP$US$US
241461961$24146196$1$I$$20240718$20240729$20240729$EXP$$US-MYLANLABS-2024M1068070$MYLAN$Taylor JL, Gott J, Weisenthal K, Colicchio P, Dyer S, Komaromy MS. Post-Overdose Extended-Release Buprenorphine Initiation Facilitated by a Partnership Between Emergency Medical Services and an Outpatient Substance Use Disorder Observation Unit. Subst-Use-Addctn-J 2024; 0 (0): 29767342241249386.$5$DEC$$M$Y$$$20240729$$MD$US$US
241461973$24146197$3$F$$20240829$20240729$20240903$EXP$$GB-MYLANLABS-2024M1068089$MYLAN$$$$$F$Y$$$20240903$$MD$GB$GB
241461981$24146198$1$I$$20240718$20240729$20240729$EXP$$US-MYLANLABS-2024M1068794$MYLAN$Kwon L. Portable Percussive Massage Device-Related Rectus Sheath Hematoma and Obstructive Uropathy: A Case Report. Biomed-Hub 2024; 9 (1): 89-93.$6$DEC$$M$Y$$$20240729$$HP$US$US
241461991$24146199$1$I$20240201$20240723$20240729$20240729$EXP$DE-EMBRYOTOX-202306428$DE-RDY-SPO/DEU/24/0010907$DR REDDYS$$1$DY$N$M$Y$3.905$KG$20240729$$MD$DE$DE
241462001$24146200$1$I$$20240726$20240729$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US068647$SANDOZ$$$$$F$Y$$$20240729$$CN$US$US
241462011$24146201$1$I$$20240718$20240729$20240729$EXP$$US-RDY-LIT/USA/24/0010941$DR REDDYS$Becker DA. The Positive Assistance of Assisted Reproductive Technology. Epilepsy Currents. 24(3): 180-181.$$$$F$Y$$$20240729$$MD$US$US
241462031$24146203$1$I$$20240703$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06958$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241462041$24146204$1$I$$20240722$20240729$20240729$EXP$$CA-TAKEDA-2024TUS074384$TAKEDA$$$$$M$Y$$$20240729$$CN$CA$CA
241462052$24146205$2$F$20240829$20240829$20240729$20240902$EXP$$CA-TAKEDA-2024TUS009187$TAKEDA$$58$YR$$M$Y$$$20240902$$CN$CA$CA
241462061$24146206$1$I$$20240724$20240729$20240729$PER$$US-LEO Pharma-372317$LEO PHARM$$64$YR$$M$Y$$$20240729$$CN$US$US
241462112$24146211$2$F$20240101$20240802$20240729$20240807$PER$$US-AMGEN-USASP2024147802$AMGEN$$75$YR$E$M$Y$$$20240807$$CN$US$US
241462121$24146212$1$I$$20240725$20240729$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA068372$SANDOZ$$27$YR$$F$Y$$$20240729$$CN$CA$CA
241462131$24146213$1$I$$20240726$20240729$20240729$PER$$US-AMGEN-USASP2024149388$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241462141$24146214$1$I$$20240716$20240729$20240729$PER$$US-JNJFOC-20240748392$JOHNSON AND JOHNSON$$71$YR$E$$Y$$$20240729$$CN$US$US
241462151$24146215$1$I$$20240721$20240729$20240729$EXP$$AR-JNJFOC-20240757491$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$HP$AR$AR
241462162$24146216$2$F$20240723$20240821$20240729$20240912$EXP$$US-HETERO-HET2024US02460$HETERO$$$$$F$Y$$$20240830$$CN$US$US
241462171$24146217$1$I$$20240719$20240729$20240729$EXP$$NL-HETERO-AMR2024NL02408$HETERO$Dekker MJHJ, Heerdink GC, Plattel CHM. Vitamin B12 Deficiency-Induced Neuropathy and  Cognitive and Motor Impairment in the Elderly: A Case Study. Food and nutrition bulletin.. 2024;45(1):S53-7$71$YR$$M$Y$$$20240729$$MD$NL$NL
241462182$24146218$2$F$20240605$20240729$20240729$20240806$EXP$$US-TAKEDA-2021TUS063551$TAKEDA$$42$YR$$F$Y$61$KG$20240806$$MD$US$US
241462191$24146219$1$I$20230124$20240724$20240729$20240729$EXP$$CA-TAKEDA-2024TUS075528$TAKEDA$$78$YR$$F$Y$$$20240729$$MD$CA$CA
241462202$24146220$2$F$20240725$20240911$20240729$20240918$EXP$$CA-TAKEDA-2024TUS075819$TAKEDA$$64$YR$$M$Y$$$20240918$$CN$CA$CA
241462211$24146221$1$I$20240624$20240724$20240729$20240729$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-102128$REGENERON$$$$$M$Y$$$20240729$$CN$US$US
241462231$24146223$1$I$$20240704$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06877$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241462242$24146224$2$F$$20240730$20240729$20240803$EXP$$DE-TAKEDA-2024TUS067133$TAKEDA$$55$YR$$F$Y$$$20240803$$CN$DE$DE
241462252$24146225$2$F$$20240807$20240729$20240813$PER$$US-LEO Pharma-372303$LEO PHARM$$60$YR$$M$Y$$$20240813$$CN$US$US
241462262$24146226$2$F$20120101$20240724$20240729$20240801$PER$$US-AMGEN-USASP2024150040$AMGEN$$$$$F$Y$$$20240801$$HP$US$US
241462271$24146227$1$I$$20240723$20240729$20240729$EXP$$US-AMGEN-USASP2024147293$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241462281$24146228$1$I$$20240726$20240729$20240729$PER$$US-ROCHE-10000040536$ROCHE$$50$YR$A$F$Y$$$20240729$$CN$US$US
241462292$24146229$2$F$20240725$20240808$20240729$20240830$PER$$US-ROCHE-10000040038$ROCHE$$43$YR$A$F$Y$$$20240830$$CN$US$US
241462301$24146230$1$I$$20240726$20240729$20240729$PER$$US-ROCHE-10000040344$ROCHE$$$$A$M$Y$$$20240729$$CN$US$US
241462312$24146231$2$F$$20240819$20240729$20240822$PER$$US-ROCHE-10000040480$ROCHE$$55$YR$A$F$Y$$$20240822$$CN$US$US
241462321$24146232$1$I$$20240715$20240729$20240729$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06827$HIKMA$Delbon P, Attico F, De Nadai M, Almici C, Ferrari E, Malagola M, et al.. Delbon P, Attico F, De Nadai M, Almici C, Ferrari E, Malagola M, et al. Ethical and legal issues in haematopoietic stem cells (HSC) donation: the controversial and problematic aspects in minors.. Acta Biomedica. 2024;95(3):e2024082$62$YR$$M$Y$$$20240729$$MD$IT$IT
241462332$24146233$2$F$$20240820$20240729$20240821$PER$$NVSC2024US153752$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
241462341$24146234$1$I$$20240704$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06819$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241462351$24146235$1$I$20170301$20240717$20240729$20240729$EXP$CH-SM-2024-13776$CH-ROCHE-10000030781$ROCHE$$63$YR$A$F$Y$65$KG$20240729$$MD$CH$CH
241462362$24146236$2$F$$20240723$20240729$20240801$EXP$$GR-ABBVIE-5857585$ABBVIE$Siderakis E. 2nd Metatarsal head osteomyelitis in a patient with newly diagnosed diabetes mellitus after injury from a sharp object. 50th Annual panhellenic medical congress, Book of abstracts. 2024;209.; Siderakis E. 2nd Metatarsal head osteomyelitis in a patient with newly diagnosed diabetes mellitus after injury from a sharp object. 50th Annual panhellenic medical congress, poster. 2024.$58$YR$$M$Y$$$20240801$$MD$GR$GR
241462371$24146237$1$I$20240703$20240703$20240729$20240729$PER$$US-CSL-2024-006303$CSL Plasma$$25$YR$$F$Y$$$20240729$$HP$US$US
241462381$24146238$1$I$$20240717$20240729$20240729$EXP$$IT-Appco Pharma LLC-2159703$APPCO PHARMA$Initial$15$YR$$F$Y$48$KG$20240729$$$IT$IT
241462391$24146239$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118881$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240729$$CN$US$US
241462401$24146240$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119505$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$79$KG$20240729$$HP$US$US
241462411$24146241$1$I$$20240723$20240729$20240729$PER$$US-LEO Pharma-372296$LEO PHARM$$77$YR$$F$Y$58$KG$20240729$$CN$US$US
241462431$24146243$1$I$$20240715$20240729$20240729$EXP$$PT-AUROBINDO-AUR-APL-2024-037298$AUROBINDO$Ribeiro M, D?maso F, Oliveira J, Medeiros I, Eliseu A, Duarte J.. POSA-073 - (2757) - IATROGENIAS INESPERADAS (UNEXPECTED IATROGENIES). Outro | Caso cl?nico (Other | Clinical case). 1145$74$YR$$M$Y$$$20240729$$HP$PT$PT
241462441$24146244$1$I$$20240719$20240729$20240729$EXP$$US-TORRENT-00013690$TORRENT$$17$YR$T$M$Y$85$KG$20240729$$MD$US$US
241462451$24146245$1$I$$20240722$20240729$20240729$EXP$GB-MHRA-MED-202407221705070370-GDJTH$GB-TORRENT-00037324$TORRENT$$$$$F$Y$$$20240729$$CN$GB$GB
241462461$24146246$1$I$$20240722$20240729$20240729$PER$$US-ALXN-202407USA001509US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241462471$24146247$1$I$$20240723$20240729$20240729$EXP$$DZ-BIOVITRUM-2024-DZ-010191$BIOVITRUM$$12$YR$$M$Y$$$20240729$$MD$DZ$DZ
241462482$24146248$2$F$$20240902$20240729$20240913$EXP$$JP-ROCHE-10000035918$ROCHE$Saburi M, Nishikawa T, Miyazaki Y. Real-world outcomes of venetoclax and rituximab for chronic lymphocytic leukemia/small lymphocytic lymphoma: A retrospective analysis of nine Japanese cases. Journal of Clinical and Experimental Hematopathology. 2024-Jun-27;64 (2):152-5.$$$$$Y$$$20240913$$MD$JP$JP
241462491$24146249$1$I$$20240722$20240729$20240729$EXP$$US-TAKEDA-2024TUS074175$TAKEDA$$13$YR$$F$Y$$$20240729$$CN$US$US
241462502$24146250$2$F$20240715$20240819$20240729$20240826$EXP$$CA-GSK-CA2023166282$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$CA$CA
241462511$24146251$1$I$$20240722$20240729$20240729$EXP$$US-TAKEDA-2024TUS074113$TAKEDA$$$$$F$Y$$$20240729$$PH$US$US
241462521$24146252$1$I$$20240722$20240729$20240729$EXP$$GB-AMAROX PHARMA-AMR2024GB02422$HETERO$$$$$M$Y$$$20240729$$CN$GB$GB
241462533$24146253$3$F$20240706$20240909$20240729$20240916$EXP$$CA-TAKEDA-2024TUS073114$TAKEDA$$74$YR$$M$Y$94$KG$20240916$$MD$CA$CA
241462541$24146254$1$I$$20240718$20240729$20240729$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003789$TERSERA THERAPEUTICS$$$$$$Y$$$20240729$$CN$AU$AU
241462551$24146255$1$I$$20240722$20240729$20240729$EXP$$CA-TAKEDA-2024TUS074884$TAKEDA$$$$$F$Y$$$20240729$$CN$CA$CA
241462561$24146256$1$I$20240601$20240718$20240729$20240729$PER$$US-ABBVIE-5850502$ABBVIE$$72$YR$$F$Y$$$20240729$$CN$US$US
241462571$24146257$1$I$20240501$20240717$20240729$20240729$EXP$$BR-UCBSA-2024025717$UCB$$$$A$M$Y$$$20240729$$CN$BR$BR
241462581$24146258$1$I$$20240725$20240729$20240729$PER$$US-HALEON-2189296$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241462591$24146259$1$I$$20240426$20240729$20240729$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01568$AMNEAL$$$$$F$Y$$$20240729$$MD$US$US
241462602$24146260$2$F$20240723$20240823$20240729$20240827$PER$$US-AMGEN-USASP2024150032$AMGEN$$47$YR$A$F$Y$$$20240827$$HP$US$US
241462611$24146261$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149124$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241462621$24146262$1$I$20240607$20240717$20240729$20240729$EXP$$CN-ROCHE-10000030081$ROCHE$$56$YR$A$F$Y$42$KG$20240729$$HP$CN$CN
241462631$24146263$1$I$$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A168803$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241462651$24146265$1$I$20240705$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A168960$ASTRAZENECA$$25441$DY$$M$Y$$$20240729$$CN$US$
241462661$24146266$1$I$$20230131$20240729$20240729$EXP$$US-AstraZeneca-2023A026616$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241462671$24146267$1$I$$20240724$20240729$20240729$EXP$$ZA-AstraZeneca-2024A170160$ASTRAZENECA$$76$YR$$F$Y$$$20240729$$CN$ZA$
241462681$24146268$1$I$20240202$20240722$20240729$20240729$EXP$FR-AFSSAPS-RN2024000771$FR-REGENERON PHARMACEUTICALS, INC.-2024-102922$REGENERON$$70$YR$$M$Y$$$20240729$$MD$FR$FR
241462691$24146269$1$I$20240101$20240725$20240729$20240729$EXP$$US-UCBSA-2024037767$UCB$$$$$F$Y$$$20240729$$HP$US$US
241462701$24146270$1$I$20060101$20200424$20240729$20240729$EXP$$US-AstraZeneca-2018SE31532$ASTRAZENECA$$52$YR$$M$Y$$$20240729$$CN$US$
241462721$24146272$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016915$ELI LILLY AND CO$$$$A$$Y$$$20240729$$CN$US$US
241462731$24146273$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016913$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240729$$CN$US$US
241462741$24146274$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016947$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240729$$CN$US$US
241462751$24146275$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016966$ELI LILLY AND CO$$$$$M$Y$$$20240729$$MD$US$US
241462761$24146276$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017558$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240729$$CN$US$US
241462771$24146277$1$I$20240716$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016361$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240729$$HP$US$US
241462781$24146278$1$I$20240720$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017326$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240729$$CN$US$US
241462801$24146280$1$I$20240330$20240723$20240729$20240729$30DAY$$US-GSK-US2024092386$GLAXOSMITHKLINE$$34$YR$$F$Y$58.06$KG$20240729$$CN$US$US
241462822$24146282$2$F$20240722$20240909$20240729$20240912$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-103587$REGENERON$$71$YR$$M$Y$$$20240912$$MD$JP$JP
241462831$24146283$1$I$$20240722$20240729$20240729$EXP$$CA-TAKEDA-2024TUS074678$TAKEDA$$$$$M$Y$$$20240729$$CN$CA$CA
241462841$24146284$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASL2024149035$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241462851$24146285$1$I$20240723$20240723$20240729$20240729$PER$$US-AMGEN-USASP2024146523$AMGEN$$72$YR$E$F$Y$$$20240729$$CN$US$US
241462861$24146286$1$I$$20240715$20240729$20240729$EXP$$PT-AUROBINDO-AUR-APL-2024-037241$AUROBINDO$Silva P, Ferreira M, Grilo A, Gon?alves F.. S?NDROME SEROTONIN?RGICA:  A PROP?SITO DE UM CASO CL?NICO (SEROTONINERGIC SYNDROME: THE  PURPOSE OF A CLINICAL CASE). Urg?ncia, cuidados interm?dios e doente cr?tico (Emergency, intermediate care. 481$48$YR$$F$Y$$$20240729$$HP$PT$PT
241462871$24146287$1$I$$20240725$20240729$20240729$PER$$US-ROCHE-10000038055$ROCHE$$43$YR$A$M$Y$$$20240729$$CN$US$US
241462882$24146288$2$F$$20240729$20240729$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-037272$AUROBINDO$Carlota Lalanda; Mafalda Leal; Maria Meneses Rebelo; Jorge Salsinha Frade; Maria Beatriz Sampaio; Beatriz Barata. POSA-157 - (4645) - A NECESSIDADE DE UM OLHAR MAIS ATENTO. Doen?as infeciosas e parasit?rias | Caso cl?nico. 1234$69$YR$$$Y$$$20240808$$HP$PT$PT
241462902$24146290$2$F$$20240802$20240729$20240808$PER$$US-ABBVIE-5854959$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241462911$24146291$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092455$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241462921$24146292$1$I$$20240723$20240729$20240729$EXP$$US-SANDOZ INC.-SDZ2024US068160$SANDOZ$Justin J. Cheng, John Shen, Yashila Suresh, Nelli A. Akopyan, Nimmi S. Kapoor. Synchronous metastatic prostate cancer and male breast cancer while ontestosterone replacement therapy: Case report. International Journal of Surgery Case Reports. 2024$72$YR$$M$Y$$$20240729$$CN$US$US
241462931$24146293$1$I$20240716$20240718$20240729$20240729$EXP$$US-Accord-437304$ACCORD$$54$YR$A$M$Y$$$20240729$$HP$US$US
241462941$24146294$1$I$20240501$20240718$20240729$20240729$EXP$GB-MHRA-TPP10772581C22275880YC1721237511184$GB-Accord-436941$ACCORD$$62$YR$A$F$Y$82$KG$20240729$$MD$GB$GB
241462951$24146295$1$I$20240708$20240718$20240729$20240729$EXP$GB-MHRA-MED-202407182009487710-VRMJW$GB-Accord-436938$ACCORD$$57$YR$A$M$Y$$$20240729$$CN$GB$GB
241462961$24146296$1$I$20220805$20240717$20240729$20240729$EXP$IT-MINISAL02-994751$IT-Accord-436841$ACCORD$$33$YR$A$F$Y$60$KG$20240729$$MD$IT$IT
241462972$24146297$2$F$$20240812$20240729$20240819$EXP$$GB-TAKEDA-2024TUS074913$TAKEDA$$$$$F$Y$$$20240819$$CN$GB$GB
241462981$24146298$1$I$20240718$20240722$20240729$20240729$EXP$$IT-TAKEDA-2024TUS075473$TAKEDA$$61$YR$$M$Y$111$KG$20240729$$MD$IT$IT
241463009$24146300$9$F$$20240917$20240729$20240926$EXP$$PT-AUROBINDO-AUR-APL-2024-037288$AUROBINDO$Albuquerque P, Regateiro D, Velho R, Paixao J, Santos L. S?NDROME MALIGNA DOS NEUROL?PTICOS (NEUROLE0PTIC MALIGNANT SYNDROME: REPORT OF A CLINICAL CASE). Other | Clinical case. 2024;1071$70$YR$$F$Y$$$20240926$$MD$PT$PT
241463012$24146301$2$F$$20240730$20240729$20240812$EXP$$PT-AUROBINDO-AUR-APL-2024-037284$AUROBINDO$M Castro; L Pinheiro; J Silva; B Faria; M Fernandes; J Portuguese, et,al... IS IT EVEN HEART FAILURE WITH PRESERVED EJECTION FRACTION? PLATYPNEA?ORTHODEOXIA SYNDROME: A LATE AND CHALLENGING DIAGNOSIS IN ELDERLY PATIENTS. Doen?as cardiovasculares | Caso cl?nico. 2024;1063$75$YR$$F$Y$$$20240812$$HP$PT$PT
241463021$24146302$1$I$$20240722$20240729$20240729$EXP$$NVSC2023CA239118$NOVARTIS$$40$YR$$$Y$119$KG$20240729$$MD$CA$CA
241463041$24146304$1$I$$20240724$20240729$20240729$EXP$$AU-MYLANLABS-2024M1069264$MYLAN$$$$$M$Y$$$20240729$$HP$AU$AU
241463051$24146305$1$I$$20240723$20240729$20240729$EXP$$GB-MYLANLABS-2024M1069357$MYLAN$$$$$M$Y$$$20240729$$CN$GB$GB
241463061$24146306$1$I$20240624$20240717$20240729$20240729$EXP$$CA-TAKEDA-2018TUS032573$TAKEDA$$70$YR$$F$Y$$$20240729$$MD$CA$CA
241463071$24146307$1$I$$20240724$20240729$20240729$EXP$$GB-MYLANLABS-2024M1069254$MYLAN$$$$$F$Y$$$20240729$$CN$GB$GB
241463081$24146308$1$I$$20240723$20240729$20240729$EXP$$GB-MYLANLABS-2024M1069368$MYLAN$$$$$M$Y$$$20240729$$CN$GB$GB
241463093$24146309$3$F$$20240813$20240729$20240819$EXP$$GB-MYLANLABS-2024M1069373$MYLAN$$$$$F$Y$$$20240819$$HP$GB$GB
241463101$24146310$1$I$$20240724$20240729$20240729$EXP$$GB-MYLANLABS-2024M1065031$MYLAN$$$$$F$Y$$$20240729$$MD$GB$GB
241463112$24146311$2$F$$20240806$20240729$20240809$EXP$$GB-MYLANLABS-2024M1069316$MYLAN$$$$$M$Y$$$20240809$$CN$GB$GB
241463121$24146312$1$I$20240717$20240724$20240729$20240729$EXP$GB-MHRA-MED-202407241020397610-KDWHG$GB-MYLANLABS-2024M1069110$MYLAN$$55$YR$$M$Y$91$KG$20240729$$PH$GB$GB
241463141$24146314$1$I$$20240723$20240729$20240729$EXP$$GB-MYLANLABS-2024M1068812$MYLAN$$$$$M$Y$$$20240729$$PH$GB$GB
241463151$24146315$1$I$$20240723$20240729$20240729$EXP$$IE-MYLANLABS-2024M1069775$MYLAN$$$$$F$Y$$$20240729$$PH$IE$IE
241463161$24146316$1$I$$20240719$20240729$20240729$EXP$$ZA-TAKEDA-2024TUS074138$TAKEDA$$$$$F$Y$$$20240729$$MD$ZA$ZA
241463172$24146317$2$F$20210831$20240930$20240729$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-104634$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240930$$MD$JP$JP
241463181$24146318$1$I$$20240724$20240729$20240729$PER$$US-HALEON-2188942$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241463192$24146319$2$F$20240101$20240815$20240729$20240822$EXP$$US-INSMED, INC.-2024-02743-US$INSMED$$$$$M$Y$$$20240822$$CN$US$US
241463201$24146320$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092453$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241463213$24146321$3$F$20240723$20240808$20240729$20240815$EXP$$JP-009507513-2407JPN004396J$MERCK$$$$$F$Y$$$20240815$$PH$JP$JP
241463221$24146322$1$I$$20240723$20240729$20240729$EXP$$IE-TAKEDA-2024TUS075900$TAKEDA$$$$$$Y$$$20240729$$MD$IE$IE
241463231$24146323$1$I$20240201$20240716$20240729$20240729$EXP$$DE-AUROBINDO-AUR-APL-2024-036148$AUROBINDO$$$$$M$Y$$$20240729$$CN$DE$DE
241463242$24146324$2$F$$20240723$20240729$20240806$EXP$IR-MLMSERVICE-20240705-PI124397-00097-1$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-15903$ALKEM$Rahbar M, Latifi M, Pourhosein E, Mahmoudi E, Seyhoun I, Dehghani S.. Long-term graft survival in a kidney transplant recipient with glioblastoma: Case report. Transplantation Reports. 2024;9(3):100158$61$YR$$F$Y$$$20240806$$MD$IR$IR
241463251$24146325$1$I$$20240715$20240729$20240729$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16267$ALKEM$$$$$M$Y$$$20240729$$CN$US$US
241463262$24146326$2$F$20220101$20240723$20240729$20240806$EXP$IN-MLMSERVICE-20240710-PI124734-00232-2$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-15901$ALKEM$Sivagnanam H, Kumar PKS, Velu KB, Viswanathan R. Mucormycosis-Associated Colon Perforation in the Early Postrenal Transplant Period. Indian Journal of Transplantation. 2024;18(2):189-193$32$YR$$M$Y$$$20240806$$MD$IN$IN
241463272$24146327$2$F$20240401$20240723$20240729$20240806$EXP$DE-CADRBFARM-2024329281$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-15894$ALKEM$$67$YR$$F$Y$85$KG$20240806$$MD$DE$DE
241463281$24146328$1$I$20240720$20240722$20240729$20240729$EXP$$US-GSK-US2024091652$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241463291$24146329$1$I$20240701$20240719$20240729$20240729$EXP$IT-MINISAL02-994722$IT-TEVA-VS-3223496$TEVA$$63$YR$$F$Y$$$20240729$$MD$IT$IT
241463302$24146330$2$F$$20240723$20240729$20240806$EXP$QA-MLMSERVICE-20240705-PI124185-00030-1$QA-ALKEM LABORATORIES LIMITED-QA-ALKEM-2024-15863$ALKEM$Kannappilly N, Peediyakkal MZ, Khatib MY, Ananthegowda DC, Elshafei  MS, El Zeer H, Shaik KS, AlFayoumi MM, Mutkule DP, Soliman AA, Nashwan AJ. Ibuprofen-Induced Toxic Epidermal Necrolysis: A Case Report.. International Journal of Dermatology and Venereology. 2024;7(2):108-10$41$YR$$M$Y$$$20240806$$MD$QA$QA
241463351$24146335$1$I$20230101$20240726$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042311$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$$$20240729$$CN$US$US
241463361$24146336$1$I$20240711$20240724$20240729$20240729$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-14848$IPSEN$$82$YR$E$M$Y$$$20240729$$HP$CA$CA
241463371$24146337$1$I$20240701$20240718$20240729$20240729$EXP$$PK-ROCHE-RCA5204070$ROCHE$$59$YR$A$F$Y$$$20240729$$CN$PK$PK
241463381$24146338$1$I$$20240726$20240729$20240729$PER$$US-ROCHE-10000040543$ROCHE$$58$YR$A$F$Y$$$20240729$$MD$US$US
241463391$24146339$1$I$$20240711$20240729$20240729$PER$$US-JNJFOC-20240737101$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241463402$24146340$2$F$20220722$20240919$20240729$20240930$EXP$$DE-JNJFOC-20240757416$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240930$$HP$DE$DE
241463421$24146342$1$I$$20230125$20240729$20240729$EXP$$US-AstraZeneca-2023A021943$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241463431$24146343$1$I$$20240719$20240729$20240729$PER$$US-AstraZeneca-2024A168526$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241463441$24146344$1$I$20201130$20240724$20240729$20240729$EXP$$AT-AstraZeneca-2024A168542$ASTRAZENECA$$63$YR$$F$Y$55$KG$20240729$$MD$AT$
241463451$24146345$1$I$$20240719$20240729$20240729$PER$$US-AstraZeneca-2024A165544$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241463461$24146346$1$I$$20220923$20240729$20240729$EXP$$US-AstraZeneca-2022A329739$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241463471$24146347$1$I$$20240722$20240729$20240729$EXP$$DE-TAKEDA-2024TUS074941$TAKEDA$$26$YR$$F$Y$$$20240729$$CN$DE$DE
241463481$24146348$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024091803$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241463492$24146349$2$F$$20240729$20240729$20240802$PER$$US-BIOGEN-2024BI01274950$BIOGEN$$$$$F$Y$$$20240802$$CN$US$US
241463511$24146351$1$I$20240606$20240617$20240729$20240729$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02246$AMNEAL$$61$YR$$M$Y$$$20240729$$CN$US$US
241463522$24146352$2$F$20240611$20240627$20240729$20240731$PER$$US-TRAVERE-2024TVT00589$TRAVERE THERAPEUTICS$$67$YR$E$M$Y$$$20240731$$MD$US$US
241463532$24146353$2$F$$20240919$20240729$20240927$EXP$$CA-TAKEDA-2024TUS056077$TAKEDA$$$$$F$Y$$$20240927$$CN$CA$CA
241463541$24146354$1$I$$20240723$20240729$20240729$EXP$DE-BFARM-24005167$DE-RDY-SPO/DEU/24/0010906$DR REDDYS$$61$YR$A$M$Y$$$20240729$$CN$DE$DE
241463551$24146355$1$I$$20240718$20240729$20240729$EXP$$SE-ASTELLAS-2024US020971$ASTELLAS$$$$$M$Y$$$20240729$$HP$SE$SE
241463561$24146356$1$I$20240614$20240722$20240729$20240729$EXP$FR-AFSSAPS-TO2024001321$FR-SA-2024SA215831$SANOFI AVENTIS$$94$YR$E$M$Y$67.5$KG$20240729$$MD$FR$FR
241463571$24146357$1$I$20230406$20240722$20240729$20240729$EXP$FR-AFSSAPS-NY2024000819$FR-SA-2024SA218105$SANOFI AVENTIS$$73$YR$E$F$Y$100$KG$20240729$$PH$FR$FR
241463582$24146358$2$F$20240401$20240903$20240729$20240912$EXP$$TR-ASTELLAS-2024US020979$ASTELLAS$$74$YR$E$M$Y$$$20240912$$MD$TR$TR
241463593$24146359$3$F$20240722$20240830$20240729$20240906$EXP$$NL-Eisai-EC-2024-170875$EISAI$$84$YR$E$M$Y$$$20240906$$MD$NL$NL
241463601$24146360$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2024091267$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241463611$24146361$1$I$20240716$20240719$20240729$20240729$30DAY$$US-GSK-US2024091257$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240729$$CN$US$US
241463621$24146362$1$I$$20240725$20240729$20240729$EXP$$JP-ASTELLAS-2024JP005373$ASTELLAS$$$$E$$Y$$$20240729$$HP$JP$JP
241463631$24146363$1$I$20240721$20240722$20240729$20240729$PER$$US-ALXN-202407USA001514US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241463641$24146364$1$I$20231101$20240725$20240729$20240729$EXP$$TW-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042065$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240729$$CN$TW$TW
241463651$24146365$1$I$$20240724$20240729$20240729$PER$$US-ROCHE-10000035694$ROCHE$$$$A$$Y$$$20240729$$CN$US$US
241463664$24146366$4$F$20240619$20240920$20240729$20240924$EXP$$AR-MYLANLABS-2024M1056349$MYLAN$$14$YR$$F$Y$$$20240924$$HP$AR$AR
241463671$24146367$1$I$$20240315$20240729$20240729$PER$$US-BAYER-2024A108253$BAYER$$$$$F$Y$$$20240729$$CN$US$US
241463681$24146368$1$I$20240204$20240729$20240729$20240729$EXP$ES-AEMPS-1553616$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042393$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240729$$MD$ES$ES
241463692$24146369$2$F$$20240725$20240729$20240730$EXP$$US-ROCHE-10000037694$ROCHE$$70$YR$E$F$Y$$$20240730$$HP$US$US
241463701$24146370$1$I$$20240722$20240729$20240729$EXP$$AU-AMGEN-AUSSP2024145096$AMGEN$$59$YR$A$F$Y$$$20240729$$CN$AU$AU
241463711$24146371$1$I$$20240723$20240729$20240729$EXP$$JP-AMGEN-JPNSP2024146820$AMGEN$$$$$$Y$$$20240729$$MD$JP$JP
241463721$24146372$1$I$$20240723$20240729$20240729$EXP$$US-AMGEN-USASL2024146843$AMGEN$$59$YR$A$M$Y$$$20240729$$CN$US$US
241463731$24146373$1$I$$20240722$20240729$20240729$EXP$$US-AMGEN-USASP2024146777$AMGEN$Yamada MM. Talimogene laherparepvec is an effective salvage therapy for advanced melanoma: A real-world study. Journal of Investigative Dermatology. 2024;144(8):S28$$$$$Y$$$20240729$$HP$US$US
241463741$24146374$1$I$20240723$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147585$AMGEN$$81$YR$E$M$Y$$$20240729$$CN$US$US
241463751$24146375$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119447$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240729$$HP$US$US
241463761$24146376$1$I$20240201$20240719$20240729$20240729$EXP$NL-LRB-00990354$NL-TEVA-VS-3223529$TEVA$$41$YR$$F$Y$$$20240729$$PH$NL$NL
241463771$24146377$1$I$$20240723$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118424$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240729$$CN$US$US
241463783$24146378$3$F$$20240923$20240729$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119423$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$64.41$KG$20240924$$CN$US$US
241463791$24146379$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119432$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240729$$CN$US$US
241463811$24146381$1$I$$20240722$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116822$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240729$$MD$US$US
241463824$24146382$4$F$$20240924$20240729$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119481$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$55.79$KG$20240926$$CN$US$US
241463831$24146383$1$I$$20240717$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407012477$ELI LILLY AND CO$$38$YR$A$$Y$$$20240729$$CN$US$US
241463841$24146384$1$I$20240725$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017624$ELI LILLY AND CO$$$$$$Y$$$20240729$$CN$US$US
241463851$24146385$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016925$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241463861$24146386$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016750$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240729$$CN$US$US
241463871$24146387$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016964$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240729$$CN$US$US
241463881$24146388$1$I$$20240717$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407012489$ELI LILLY AND CO$$$$A$M$Y$$$20240729$$CN$US$US
241463891$24146389$1$I$20240726$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017778$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240729$$CN$US$US
241463901$24146390$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017099$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240729$$CN$US$US
241463911$24146391$1$I$20240724$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016853$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240729$$CN$US$US
241463921$24146392$1$I$20240720$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017305$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240729$$CN$US$US
241463931$24146393$1$I$20240530$20240719$20240729$20240729$EXP$FR-AFSSAPS-RE2024000697$FR-TEVA-VS-3223611$TEVA$$23$YR$$F$Y$56.1$KG$20240729$$MD$FR$FR
241463941$24146394$1$I$20240701$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149101$AMGEN$$77$YR$E$F$Y$$$20240729$$CN$US$US
241463951$24146395$1$I$$20240715$20240729$20240729$EXP$$NL-TEVA-VS-3224318$TEVA$Lin L, Houwink API, van Dieren JM, Wolthuis EK, van Thienen JV, van der HeijdenMS, et al. Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitors. Cancer-Med 2024; 13 (12):.$$$$$Y$$$20240729$$HP$NL$NL
241463961$24146396$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2024091221$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241463971$24146397$1$I$20240701$20240723$20240729$20240729$EXP$$US-ASTELLAS-2024US021222$ASTELLAS$$66$YR$$M$Y$$$20240729$$CN$US$US
241463981$24146398$1$I$$20240723$20240729$20240729$PER$$US-ABBVIE-5853675$ABBVIE$$66$YR$$M$Y$$$20240729$$CN$US$US
241463991$24146399$1$I$20231101$20240719$20240729$20240729$30DAY$$US-GSK-US2024091077$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240729$$CN$US$US
241464002$24146400$2$F$20240701$20240724$20240729$20240730$EXP$$CA-ABBVIE-5854019$ABBVIE$$31$YR$$M$Y$$$20240730$$CN$CA$CA
241464011$24146401$1$I$20240317$20240725$20240729$20240729$EXP$$US-ABBVIE-5855203$ABBVIE$$54$YR$$F$Y$$$20240729$$CN$US$US
241464021$24146402$1$I$20240701$20240701$20240729$20240729$PER$$US-UniquePharma-US-2024UPLSPO00017$UNIQUE PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
241464032$24146403$2$F$20240131$20240722$20240729$20240906$PER$$US-ROCHE-10000033350$ROCHE$$46$YR$A$F$Y$99.33$KG$20240906$$CN$US$US
241464041$24146404$1$I$$20240724$20240729$20240729$EXP$$US-SA-2024SA217836$SANOFI AVENTIS$$$$E$M$Y$$$20240729$$CN$US$US
241464061$24146406$1$I$20240708$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51629$$FDA-CTU$$70$YR$$F$N$70.9$KG$20240725$N$$US$
241464071$24146407$1$I$20240628$20240716$20240725$20240725$DIR$FDA-CDER-CTU-2024-51131$$FDA-CTU$$64$YR$$F$N$150$LBS$20240716$N$CN$US$
241464081$24146408$1$I$$20240715$20240729$20240729$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-06847$HIKMA$M.Castro; L.Pinheiro; J.Silva; B.Faria; M.Fernandes; J.Portugues; A.Louren?o. M.Castro; L.Pinheiro; J.Silva; B.Faria; M.Fernandes; J.Portugues; A.Louren?o. Is it even heart failure with preserved ejection fraction? Platypnea-orthodeoxia syndrome: a late and challenging diagnosis in elderly patients.. Doencas cardiovasculares. 2024$$$$$Y$$$20240729$$CN$PT$PT
241464091$24146409$1$I$20240704$20240718$20240729$20240729$EXP$$ES-AUROBINDO-AUR-APL-2024-036476$AUROBINDO$$75$YR$$F$Y$$$20240729$$MD$ES$ES
241464101$24146410$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154423$NOVARTIS$$$$$M$Y$$$20240729$$HP$US$US
241464121$24146412$1$I$20240302$20240716$20240729$20240729$EXP$$SG-ROCHE-10000034101$ROCHE$$63$YR$A$F$Y$$$20240729$$CN$SG$SG
241464131$24146413$1$I$20240719$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148840$AMGEN$$$$$$Y$$$20240729$$HP$US$US
241464152$24146415$2$F$20240701$20240910$20240729$20240917$EXP$$CN-GSK-CN2024APC092625$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$CN$CN
241464162$24146416$2$F$$20240815$20240729$20240823$30DAY$$US-GSK-US2024091270$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
241464191$24146419$1$I$$20240724$20240729$20240729$PER$$US-HALEON-2189098$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241464201$24146420$1$I$20240717$20240718$20240729$20240729$EXP$$GB-MACLEODS PHARMA-MAC2024048465$MACLEODS$$$$$$Y$$$20240729$$MD$GB$GB
241464211$24146421$1$I$20240718$20240718$20240729$20240729$EXP$$GB-MACLEODS PHARMA-MAC2024048466$MACLEODS$$$$$$Y$$$20240729$$MD$GB$GB
241464221$24146422$1$I$20240621$20240718$20240729$20240729$EXP$$ZA-MACLEODS PHARMA-MAC2024048441$MACLEODS$$$$$$Y$$$20240729$$CN$ZA$ZA
241464231$24146423$1$I$$20240726$20240729$20240729$PER$$US-HALEON-2189292$Haleon PLC$$70$YR$$F$Y$$$20240729$$CN$US$US
241464241$24146424$1$I$$20240718$20240729$20240729$EXP$$US-MACLEODS PHARMA-MAC2024048475$MACLEODS$Applegarth J, Finn D, Tolkacz M, Iacco A..Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome.ASAIO Journal.2024;70 (Supplement 3):151$$$$$Y$$$20240729$$MD$US$US
241464251$24146425$1$I$20240201$20240718$20240729$20240729$EXP$$IT-MACLEODS PHARMA-MAC2024048468$MACLEODS$$$$$$Y$$$20240729$$MD$IT$IT
241464271$24146427$1$I$$20240724$20240729$20240729$EXP$$US-GILEAD-2024-0682050$GILEAD$$$$E$M$Y$$$20240729$$HP$US$US
241464281$24146428$1$I$20240401$20240724$20240729$20240729$EXP$$BR-Ipsen Biopharmaceuticals, Inc.-2022-22920$IPSEN$$73$YR$E$F$Y$53$KG$20240729$$CN$BR$BR
241464302$24146430$2$F$$20240722$20240729$20240729$EXP$$IT-STRIDES PHARMA UK LTD.-2024SP006718$STRIDES$Giovannini M, Lucrezia S. ANAFILASSI A UN FANS DOPO ASSUNZIONE DI UN FARMACO DA BANCO/NSAID-INDUCED ANAPHYLAXIS AFTER TAKING AN OVER THE COUNTER MEDICATION. Medico e Bambino. 2021;24(1)$$$$$Y$$$20240729$$MD$IT$IT
241464321$24146432$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119207$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240729$$CN$US$US
241464331$24146433$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119237$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240729$$CN$US$US
241464341$24146434$1$I$20240101$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118924$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$102.06$KG$20240729$$CN$US$US
241464351$24146435$1$I$$20240726$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042295$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240729$$CN$US$US
241464361$24146436$1$I$20240724$20240726$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042301$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240729$$CN$US$US
241464391$24146439$1$I$20240707$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51630$$FDA-CTU$$$$$M$N$148$KG$20240725$N$$US$
241464401$24146440$1$I$20240701$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51615$$FDA-CTU$$86$YR$$M$N$$$20240725$N$PH$US$
241464411$24146441$1$I$$20240723$20240729$20240729$EXP$$GB-MYLANLABS-2024M1068768$MYLAN$$$$$M$Y$$$20240729$$CN$GB$GB
241464421$24146442$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2024091228$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$HP$US$US
241464431$24146443$1$I$$20240722$20240729$20240729$30DAY$$US-GSK-US2024AMR093595$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241464441$24146444$1$I$$20240725$20240729$20240729$EXP$$US-GSK-US2024093452$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$HP$US$US
241464451$24146445$1$I$$20240715$20240729$20240729$PER$$US-UniquePharma-US-2024UPLSPO00021$UNIQUE PHARMACEUTICALS$$54$YR$A$M$Y$180$KG$20240729$$CN$US$US
241464461$24146446$1$I$20240717$20240718$20240729$20240729$EXP$$GB-AUROBINDO-AUR-APL-2024-035975$AUROBINDO$$61$YR$$F$Y$107$KG$20240729$$MD$GB$GB
241464471$24146447$1$I$20240619$20240719$20240729$20240729$EXP$FR-AFSSAPS-AVCN2024000517$FR-TEVA-VS-3223678$TEVA$$22$YR$$M$Y$$$20240729$$MD$FR$FR
241464481$24146448$1$I$$20240726$20240729$20240729$PER$$US-HALEON-2189383$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241464491$24146449$1$I$20240502$20240718$20240729$20240729$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000282$NOVAST$$$$$$Y$$$20240729$$HP$CN$CN
241464501$24146450$1$I$$20240715$20240729$20240729$EXP$$PT-AUROBINDO-AUR-APL-2024-037198$AUROBINDO$Ricardo Martins-Ascencao; H?lia Martins; Jo?o Santos; Jo?o Morais. ENDOCARDITE DE  V?LVULA NATIVA A CATETER ALOJADO  EM CAVIDADE CARD?ACA. Infectious and parasitic diseases | Clinical case. 274$66$YR$$F$Y$$$20240729$$HP$PT$PT
241464511$24146451$1$I$20240420$20240729$20240729$20240729$EXP$FR-AFSSAPS-AM2024000601$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042350$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$80$KG$20240729$$MD$FR$FR
241464521$24146452$1$I$$20240726$20240729$20240729$PER$$US-HALEON-2189268$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241464531$24146453$1$I$$20240606$20240729$20240729$EXP$$US-ROCHE-10000040956$ROCHE$$58$YR$A$M$Y$$$20240729$$CN$US$US
241464541$24146454$1$I$20240101$20240726$20240729$20240729$PER$$US-AMGEN-USASP2024149560$AMGEN$$28$YR$A$F$Y$$$20240729$$HP$US$US
241464551$24146455$1$I$$20240722$20240729$20240729$EXP$$US-AMGEN-USASP2024147689$AMGEN$Fleischli, A.. Dupilumab and other biologic therapies may influence the course and prognosis of cutaneous-T cell lymphoma.. Journal of Investigative Dermatology. 2024;144 (8):S45$$$$$Y$$$20240729$$HP$US$US
241464561$24146456$1$I$20240301$20240717$20240729$20240729$EXP$$US-BAYER-2024A104465$BAYER$$81$YR$E$M$Y$$$20240729$$CN$US$US
241464591$24146459$1$I$20240722$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51608$$FDA-CTU$$30$YR$$M$N$83.91$KG$20240725$N$$US$
241464601$24146460$1$I$20230527$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51631$$FDA-CTU$$46$YR$$M$N$159$KG$20240725$N$$US$
241464611$24146461$1$I$20240726$20240726$20240726$20240726$DIR$711681$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241464621$24146462$1$I$$20240725$20240729$20240729$PER$$US-ABBVIE-5857144$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241464641$24146464$1$I$$20240722$20240729$20240729$EXP$GB-MHRA-MED-202405151353006080-KDBHY$GB-862174955-ML2024-03951$MICRO LABS$$93$YR$E$M$Y$$$20240729$$MD$GB$GB
241464652$24146465$2$F$$20240727$20240729$20240812$EXP$$US-862174955-ML2024-04115$MICRO LABS$$$$$M$Y$$$20240812$$CN$US$US
241464661$24146466$1$I$$20240719$20240729$20240729$EXP$$GB-862174955-ML2024-04099$MICRO LABS$$79$YR$E$F$Y$$$20240729$$HP$GB$GB
241464672$24146467$2$F$$20240731$20240729$20240812$EXP$$US-862174955-ML2024-04100$MICRO LABS$Sahyouni MJ, Acevedo LA, Rodriguez SC, Chiles JA, Pennings NJ. Neuropathy of diabetes following initiation of a low-carbohydrate diet: Case report. Obesity pillars. 2024;11:100115. DOI:10.1016/j.obpill.2024.100115.$50$YR$A$M$Y$$$20240812$$MD$US$US
241464681$24146468$1$I$$20240716$20240729$20240729$EXP$$US-862174955-ML2024-04065$MICRO LABS$Oomrigar SC, Fernandez J, Rivera CR, Rajen H, Toll A, Colome EP, et al. The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death. Am J Respir Crit Care Med. 2024 May 21;209:$$$$F$Y$$$20240729$$HP$US$US
241464691$24146469$1$I$20240705$20240718$20240729$20240729$PER$$US-ROCHE-10000031054$ROCHE$$46$YR$A$F$Y$$$20240729$$CN$US$US
241464701$24146470$1$I$$20240719$20240729$20240729$EXP$$US-APOTEX-2024AP008741$APOTEX$Murphy A, Cordisco A, Khan AH, Craft CA. AN UNCOMMON CUASE OF COMPLETE HEART BLOCK IN A PATIENT WITH A HISTORY OF SEIZURES. J-Am-Coll-Cardiol. 2024;83 (13):2881$64$YR$$M$Y$$$20240729$$HP$US$US
241464711$24146471$1$I$20240525$20240716$20240729$20240729$EXP$$DE-ROCHE-10000040033$ROCHE$$63$YR$A$M$Y$$$20240729$$MD$DE$DE
241464721$24146472$1$I$20231001$20240723$20240729$20240729$EXP$$ES-VIIV HEALTHCARE LIMITED-ES2024039714$VIIV$$$$$$Y$$$20240729$$MD$ES$ES
241464731$24146473$1$I$$20240719$20240729$20240729$PER$$US-ROCHE-10000031741$ROCHE$$$$$$Y$$$20240729$$PH$US$US
241464741$24146474$1$I$20231221$20240725$20240729$20240729$EXP$$KZ-ABBVIE-5847798$ABBVIE$$77$YR$$F$Y$$$20240729$$MD$KZ$KZ
241464751$24146475$1$I$$20240718$20240729$20240729$EXP$$ES-AUROBINDO-AUR-APL-2024-036658$AUROBINDO$M?guez-Mart?n L, Higelmo-G?mez H, G?mez-Farp?n ?, ?lvarez-Caro F.. Reacci?n tard?a a aminopenicilina asociada con infecci?n por el virus del herpes humano 6 que simula s?ndrome DRESS. Revista alergia Mexico (Tecamachalco, Puebla, Mexico: 1993). 2019;66(3):375-378$8$YR$$M$Y$$$20240729$$HP$ES$ES
241464761$24146476$1$I$20221111$20240719$20240729$20240729$EXP$FR-AFSSAPS-MA2024000886$FR-TEVA-VS-3223564$TEVA$$69$YR$$F$Y$84$KG$20240729$$PH$FR$FR
241464771$24146477$1$I$$20240719$20240729$20240729$EXP$$US-BAYER-2024A105565$BAYER$$63$YR$A$F$Y$86.4$KG$20240729$$HP$US$US
241464782$24146478$2$F$$20240826$20240729$20240829$EXP$$US-AMGEN-USASP2024147730$AMGEN$$$$$F$Y$$$20240829$$HP$US$US
241464791$24146479$1$I$$20240723$20240729$20240729$EXP$$GB-MYLANLABS-2024M1046959$MYLAN$$$$$F$Y$$$20240729$$PH$GB$GB
241464801$24146480$1$I$$20240719$20240729$20240729$EXP$$GB-MYLANLABS-2024M1069246$MYLAN$Hagan AJ, Verity SJ. Key Questions on the Long-Term Utility of Methylphenidate in Paediatric Brain Tumour Survivorship: A Retrospective Clinical Case Series. Children-(Basel) 2024; 11 (2): 187.$13$YR$$M$Y$$$20240729$$HP$GB$GB
241464811$24146481$1$I$$20240719$20240729$20240729$EXP$$US-MYLANLABS-2024M1069262$MYLAN$Khachatryan A, Isseh I, Vavilin I, Saeed IM, Harutyunyan H, Bansro V, et al. Recurrent perimyocarditis associated with long-term methylphenidate use. J-Am-Coll-Cardiol 2024; 83 (Suppl. 2) (13): 3543.$19$YR$$M$Y$$$20240729$$HP$US$US
241464821$24146482$1$I$$20240719$20240729$20240729$EXP$$US-MYLANLABS-2024M1069226$MYLAN$McKay K, Ferrante M, Tran A, Tzoumas A, Sibilia R, Wayne dl, et al. set in stone: a case of cement pulmonary embolism and right atrial thrombus. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 4454.$56$YR$$F$Y$$$20240729$$HP$US$US
241464831$24146483$1$I$$20240726$20240726$20240726$DIR$711670$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241464841$24146484$1$I$$20240719$20240729$20240729$EXP$$US-MYLANLABS-2024M1068978$MYLAN$Afriyie F, Gilani N, Fanous M, Mansoor A, Shah K, Waller AH. Chasing the high towards death, a case of loperamide induced cardiac arrest. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 2941 (plus Poster) abstr. 1200-074.$49$YR$$M$Y$$$20240729$$HP$US$US
241464851$24146485$1$I$20240616$20240726$20240726$20240726$DIR$711742$$FDA-CTU$$46$YR$$F$N$179.1$KG$20240726$N$CN$US$
241464861$24146486$1$I$$20240726$20240726$20240726$DIR$711714$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241464871$24146487$1$I$$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118704$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240729$$MD$US$US
241464881$24146488$1$I$$20240726$20240729$20240729$PER$$US-AMGEN-USASP2024149390$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241464892$24146489$2$F$$20240815$20240729$20240819$PER$$US-ALXN-202407USA001463US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241464901$24146490$1$I$$20240613$20240729$20240729$PER$US-MLMSERVICE-20240606-PI090779-00153-1$US-STRIDES ARCOLAB LIMITED-2024SP007152$STRIDES$Leiby L, Shiplett L, Lin W, Dick M, Thornton H.. Pharmacologic management of adolescent catatonia: A dual-case series.. The mental health clinician. 2024;14(3):215-9$17$YR$$M$Y$$$20240729$$PH$US$US
241464911$24146491$1$I$20240506$20240718$20240729$20240729$EXP$$ES-AUROBINDO-AUR-APL-2024-036589$AUROBINDO$$71$YR$$M$Y$$$20240729$$HP$ES$ES
241464921$24146492$1$I$$20240722$20240729$20240729$PER$$US-ALXN-A202211508$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240729$$CN$US$US
241464931$24146493$1$I$$20240719$20240729$20240729$EXP$$US-GSK-US2024AMR092168$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241464941$24146494$1$I$20240531$20240718$20240729$20240729$EXP$$US-BAYER-2024A105112$BAYER$$$$$F$Y$$$20240729$$MD$US$US
241464951$24146495$1$I$$20240719$20240729$20240729$EXP$$US-GSK-US2024091095$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241464971$24146497$1$I$$20240722$20240729$20240729$PER$$US-ABBVIE-5851066$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241464981$24146498$1$I$$20240507$20240729$20240729$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005513$STRIDES$Richardson C, Yuh J, Su J, Forsberg M.. Case series: Continued remission of PTSD symptoms after discontinuation of prazosin. Front-Psychiatry. 2023;14.$6$DEC$$F$Y$$$20240729$$HP$US$US
241464991$24146499$1$I$20240722$20240719$20240729$20240729$EXP$$ID-BAYER-2024A084448$BAYER$$$$$$Y$$$20240729$$MD$ID$ID
241465002$24146500$2$F$20240701$20240906$20240729$20240930$30DAY$$US-JNJFOC-20240720648$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240930$$CN$US$US
241465021$24146502$1$I$$20240717$20240729$20240729$EXP$$IT-Appco Pharma LLC-2159706$APPCO PHARMA$Initial$19$YR$$F$Y$$$20240729$$$IT$IT
241465042$24146504$2$F$$20240730$20240729$20240730$EXP$$CA-BAYER-2024A105539$BAYER$$$$$F$Y$$$20240730$$HP$CA$CA
241465051$24146505$1$I$$20240723$20240729$20240729$EXP$$US-ASTELLAS-2024US021196$ASTELLAS$$$$$M$Y$$$20240729$$CN$US$US
241465061$24146506$1$I$$20240725$20240729$20240729$PER$$US-TAKEDA-2024TUS075710$TAKEDA$$55$YR$$M$Y$$$20240729$$CN$US$US
241465071$24146507$1$I$$20240722$20240729$20240729$EXP$$ES-ASTELLAS-2024EU007367$ASTELLAS$$38$YR$$F$Y$$$20240729$$HP$ES$ES
241465081$24146508$1$I$20240720$20240722$20240729$20240729$EXP$$KR-JNJFOC-20240762609$JOHNSON AND JOHNSON$$7$DEC$E$M$Y$$$20240729$$HP$KR$KR
241465091$24146509$1$I$20140101$20240716$20240729$20240729$EXP$$GB-AUROBINDO-AUR-APL-2024-035732$AUROBINDO$$$$A$M$Y$73$KG$20240729$$MD$GB$GB
241465102$24146510$2$F$$20240821$20240729$20240822$30DAY$$JP-MYLANLABS-2024M1068487$MYLAN$$$$$M$Y$$$20240822$$CN$JP$JP
241465121$24146512$1$I$$20240719$20240729$20240729$EXP$$PT-MYLANLABS-2024M1069242$MYLAN$Maio MB, Ferreira R. Epidural test dose in obstetrics - is it really a reassuring test?. Region-Anesth-Pain-Med 2023; 48 (Suppl. 1) A239-A240 abstr. 36308.$$$$F$Y$$$20240729$$HP$PT$PT
241465141$24146514$1$I$20220412$20240726$20240729$20240729$EXP$FR-AFSSAPS-ST2024001192$NVSC2024FR153286$NOVARTIS$$34$YR$$M$Y$$$20240729$$MD$FR$FR
241465152$24146515$2$F$20230801$20240919$20240729$20240925$EXP$$NVSJ2024JP009079$NOVARTIS$$$$A$F$Y$$$20240925$$MD$JP$JP
241465162$24146516$2$F$$20240731$20240729$20240809$EXP$$PL-TEVA-VS-3224376$TEVA$Rzepczyk S, Swiderski P, Sommerfeld-Klatta K, Tezyk A, Lukasik-Glebocka M, Zielinska-Psuja B, et al. Causes of Death during the Intravenous Infusion of Dimethylsulphoxide and Hydrogen Peroxide in the Course of Alternative Medicine Therapy. Toxics 2023; 11 (8): 1-8.; Rzepczyk S, Swiderski P, Sommerfeld-Klatta K, Tezyk A, Lukasik-Glebocka M, Zielinska-Psuja B, et al. Causes of Death during the Intravenous Infusion of Dimethylsulphoxide and Hydrogen Peroxide in the Course of Alternative Medicine...$37$YR$$F$Y$$$20240809$$HP$PL$PL
241465171$24146517$1$I$$20240716$20240729$20240729$EXP$$TR-862174955-ML2024-04070$MICRO LABS$Gul EE, Bektasoglu G, Dogan Z. Brugada phenocopy associated with multiple psychotic drugs. Journal of Electrocardiology. 2023 Sep 17;81: 156-158. doi:10.1016/j.jelectrocard.2023.09.003.$17$YR$T$F$Y$$$20240729$$MD$TR$TR
241465184$24146518$4$F$$20240819$20240729$20240821$EXP$$NVSC2024AU153513$NOVARTIS$$$$$F$Y$$$20240821$$MD$AU$AU
241465191$24146519$1$I$$20240724$20240729$20240729$EXP$$NVSC2024DO153928$NOVARTIS$$$$$F$Y$$$20240729$$CN$DO$DO
241465203$24146520$3$F$$20240919$20240729$20240925$EXP$$JP-ASTELLAS-2024JP005344$ASTELLAS$$7$DEC$E$M$Y$$$20240925$$MD$JP$JP
241465211$24146521$1$I$$20240722$20240729$20240729$EXP$$NVSC2024FR149753$NOVARTIS$Gendarme S, Pastre J, Billaud EM, Gibault L, Guillemain R, Oudard S, et al.. Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patients. THERAPIE. 2023;78 (3):267-278.$$$$M$Y$$$20240729$$HP$FR$FR
241465222$24146522$2$F$20220101$20240726$20240729$20240805$EXP$$NVSC2024FR152412$NOVARTIS$Furst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R et al.. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA immunized adults with sickle cell disease. BONE MARROW TRANSPLANTATION. 2024;59(7):918-27$30$YR$$F$Y$$$20240805$$HP$FR$FR
241465232$24146523$2$F$20230101$20240827$20240729$20240903$EXP$$NVSC2024BR153136$NOVARTIS$$$$$F$Y$54$KG$20240903$$CN$BR$BR
241465241$24146524$1$I$20210101$20240722$20240729$20240729$EXP$$NVSC2024FR149799$NOVARTIS$Smolenschi C, Vasseur D, Rodriguez J. Case report: Microsatellite instability determination is not always black and white in Lynch syndrome diagnosis. FRONTIERS IN ONCOLOGY. 2024;14:1-6$26$YR$$M$Y$$$20240729$$HP$FR$FR
241465251$24146525$1$I$20220522$20240726$20240729$20240729$EXP$FR-AFSSAPS-ST2024001193$NVSC2024FR153390$NOVARTIS$$34$YR$$M$Y$$$20240729$$MD$FR$FR
241465271$24146527$1$I$$20240723$20240729$20240729$EXP$$CA-APOTEX-2024AP008750$APOTEX$$51$YR$$F$Y$$$20240729$$PH$CA$CA
241465281$24146528$1$I$20240726$20240726$20240726$20240726$DIR$711683$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241465301$24146530$1$I$20211015$20240724$20240726$20240726$DIR$FDA-CDER-CTU-2024-51633$$FDA-CTU$$68$YR$$F$N$$$20240724$N$$CA$
241465312$24146531$2$F$$20240718$20240729$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459103$RANBAXY$Chaleff A, Gang A, Relich RF, Lavik J-P. Utilizing confocal microscopy and topical natamycin in metarhizium keratitis of Caribbean origin. Diagn Microbiol Infect Dis. 2024;110 (1):116369$32$YR$$M$Y$$$20240802$$HP$US$US
241465321$24146532$1$I$$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51634$$FDA-CTU$$$$$M$N$$$20240725$N$HP$US$
241465332$24146533$2$F$20240717$20240807$20240729$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118823$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240815$$PH$JP$JP
241465341$24146534$1$I$$20240722$20240729$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118442$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240729$$MD$JP$JP
241465351$24146535$1$I$$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119412$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240729$$CN$US$US
241465361$24146536$1$I$20240620$20240718$20240729$20240729$EXP$FR-AFSSAPS-LL2024001308$FR-Accord-437119$ACCORD$$76$YR$E$F$Y$$$20240729$$MD$FR$FR
241465371$24146537$1$I$20240717$20240718$20240729$20240729$EXP$GB-MHRA-TPP29324321C8579691YC1721221023804$GB-Accord-436959$ACCORD$$94$YR$E$F$Y$53$KG$20240729$$MD$GB$GB
241465382$24146538$2$F$20240716$20240723$20240729$20240802$EXP$$US-Accord-437506$ACCORD$$59$YR$A$F$Y$$$20240802$$PH$US$US
241465391$24146539$1$I$20240503$20240718$20240729$20240729$EXP$$US-Accord-438193$ACCORD$$24$YR$A$M$Y$$$20240729$$HP$US$US
241465401$24146540$1$I$$20240718$20240729$20240729$EXP$$IN-Accord-437761$ACCORD$Kapoor R, Sadda S, Tyagi M. Suspected Retinal Toxicity After Multiple Intravitreal Ganciclovir Injections in a Patient of CMV Retinitis. Ocular Immunology and Inflammation. 2024;32(5): :525-28. DOI: 10.1080/09273948.2024.2316754.$69$YR$E$M$Y$$$20240729$$MD$IN$IN
241465411$24146541$1$I$20181004$20240718$20240729$20240729$EXP$FR-AFSSAPS-AM2024000569$FR-Accord-437099$ACCORD$$67$YR$E$F$Y$60$KG$20240729$$MD$FR$FR
241465421$24146542$1$I$20240501$20240718$20240729$20240729$EXP$IE-HPRA-2024-114186$IE-Accord-437068$ACCORD$$51$YR$A$F$Y$$$20240729$$PH$IE$IE
241465431$24146543$1$I$20240626$20240718$20240729$20240729$EXP$ES-AEMPS-1549106$ES-Accord-437593$ACCORD$$83$YR$E$M$Y$$$20240729$$PH$ES$ES
241465441$24146544$1$I$20240716$20240718$20240729$20240729$EXP$$US-Accord-438304$ACCORD$$37$YR$A$M$Y$$$20240729$$HP$US$US
241465451$24146545$1$I$20230101$20240718$20240729$20240729$EXP$NL-EMA-DD-20240712-7482701-064706$NL-Accord-437292$ACCORD$$$$A$F$Y$$$20240729$$MD$NL$NL
241465461$24146546$1$I$20240201$20240718$20240729$20240729$EXP$PT-INFARMED-T202407-140$PT-Accord-437107$ACCORD$$69$YR$E$F$Y$69$KG$20240729$$MD$PT$PT
241465481$24146548$1$I$$20240718$20240729$20240729$EXP$$US-Accord-436952$ACCORD$Applegarth J, Finn D, Tolkacz M, Iacco A. Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome. ASAIO Journal. 2024;70(Supplement 3):151.$18$YR$A$F$Y$$$20240729$$MD$US$US
241465491$24146549$1$I$20240706$20240718$20240729$20240729$EXP$CN-HENLIUS-24CN015968$CN-Accord-438494$ACCORD$$51$YR$A$F$Y$50$KG$20240729$$MD$CN$CN
241465501$24146550$1$I$20240626$20240718$20240729$20240729$EXP$$US-Accord-437836$ACCORD$$28$YR$A$M$Y$$$20240729$$HP$US$US
241465521$24146552$1$I$$20240722$20240729$20240729$EXP$$BR-EMD Serono-2024039908$EMD SERONO INC$$$$E$F$Y$$$20240729$$CN$BR$BR
241465531$24146553$1$I$20211101$20240717$20240729$20240729$EXP$$SG-ROCHE-10000031344$ROCHE$$66$YR$E$F$Y$$$20240729$$CN$SG$SG
241465541$24146554$1$I$$20240726$20240729$20240729$PER$$US-AMGEN-USASP2024149743$AMGEN$$6$YR$C$M$Y$$$20240729$$PH$US$US
241465551$24146555$1$I$20240713$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147722$AMGEN$$72$YR$E$M$Y$$$20240729$$CN$US$US
241465563$24146556$3$F$20240101$20240812$20240729$20240814$PER$$US-AMGEN-USASP2024148449$AMGEN$$74$YR$E$M$Y$$$20240814$$CN$US$US
241465571$24146557$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148903$AMGEN$$$$$$Y$$$20240729$$HP$US$US
241465581$24146558$1$I$20240101$20240719$20240729$20240729$PER$$US-009507513-2407USA012438$MERCK$$$$$M$Y$$$20240729$$CN$US$US
241465591$24146559$1$I$$20240715$20240729$20240729$EXP$$PT-AUROBINDO-AUR-APL-2024-037270$AUROBINDO$Matilde C, Desir?e F, Mariana M. IMPORT?NCIA  DA VALORIZA??O CL?NICA - UM CASO  DE VARICELA COMPLICADA (IMPORTANCE OF CLINICAL EVALUATION - A CASE OF COMPLICATED VARCELLA). Infectious and parasitic diseases. 1243$36$YR$$F$Y$$$20240729$$HP$PT$PT
241465601$24146560$1$I$$20240725$20240729$20240729$PER$$US-TAKEDA-2024TUS075631$TAKEDA$$22$YR$$F$Y$$$20240729$$MD$US$US
241465611$24146561$1$I$$20240722$20240729$20240729$PER$$US-TAKEDA-2024TUS074118$TAKEDA$$70$YR$$M$Y$86$KG$20240729$$MD$US$US
241465621$24146562$1$I$20240531$20240723$20240729$20240729$EXP$$HU-MYLANLABS-2024M1068860$MYLAN$$53$YR$$F$Y$$$20240729$$HP$HU$HU
241465631$24146563$1$I$20240623$20240723$20240729$20240729$EXP$HR-HALMED-300086116$HR-MYLANLABS-2024M1068882$MYLAN$$79$YR$$M$Y$$$20240729$$MD$HR$HR
241465641$24146564$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2024091215$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241465653$24146565$3$F$20240717$20240821$20240729$20240829$EXP$$JP-ASTELLAS-2024JP005304$ASTELLAS$$8$DEC$E$M$Y$$$20240829$$MD$JP$JP
241465662$24146566$2$F$$20240801$20240729$20240802$PER$$US-ROCHE-10000040494$ROCHE$$50$YR$A$F$Y$$$20240802$$CN$US$US
241465671$24146567$1$I$$20240715$20240729$20240729$EXP$$DE-ROCHE-10000039899$ROCHE$$$$$F$Y$$$20240729$$PH$DE$DE
241465681$24146568$1$I$20240710$20240719$20240729$20240729$EXP$$CN-ROCHE-10000031793$ROCHE$$27$YR$A$M$Y$$$20240729$$HP$CN$CN
241465691$24146569$1$I$$20240724$20240729$20240729$EXP$$PL-GILEAD-2024-0681802$GILEAD$$60$YR$A$F$Y$$$20240729$$MD$PL$PL
241465701$24146570$1$I$20221001$20240724$20240729$20240729$EXP$$NVSC2024BR154008$NOVARTIS$$76$YR$$F$Y$$$20240729$$CN$BR$BR
241465711$24146571$1$I$$20240724$20240729$20240729$PER$$US-TAKEDA-2024TUS075276$TAKEDA$$$$$F$Y$$$20240729$$CN$US$US
241465721$24146572$1$I$20240101$20240722$20240729$20240729$EXP$$SG-JNJFOC-20240762654$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240729$$HP$SG$SG
241465731$24146573$1$I$20240724$20240725$20240729$20240729$PER$$US-JNJFOC-20240768783$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240729$$CN$US$US
241465741$24146574$1$I$20240117$20240719$20240729$20240729$EXP$FR-AFSSAPS-PC2024000572$FR-TEVA-VS-3223384$TEVA$$75$YR$$F$Y$$$20240729$$HP$FR$FR
241465751$24146575$1$I$20240707$20240718$20240729$20240729$EXP$GB-MHRA-MED-202407181820541080-BLPYH$GB-BAYER-2024A105042$BAYER$$61$YR$A$M$Y$85$KG$20240729$$CN$GB$GB
241465761$24146576$1$I$$20240716$20240729$20240729$EXP$$SG-ROCHE-10000031168$ROCHE$$65$YR$E$F$Y$$$20240729$$CN$SG$SG
241465771$24146577$1$I$$20240718$20240729$20240729$EXP$$JP-ROCHE-10000034376$ROCHE$$$$E$$Y$$$20240729$$MD$JP$JP
241465782$24146578$2$F$20240723$20240816$20240729$20240822$EXP$$US-GILEAD-2024-0681883$GILEAD$$69$YR$E$M$Y$220$KG$20240822$$HP$US$US
241465792$24146579$2$F$$20240813$20240729$20240815$EXP$$CA-ROCHE-10000032947$ROCHE$$$$A$F$Y$$$20240815$$CN$CA$CA
241465802$24146580$2$F$20240611$20240909$20240729$20240916$EXP$$AU-ROCHE-3568242$ROCHE$$34$YR$A$F$Y$88$KG$20240916$$MD$AU$AU
241465811$24146581$1$I$$20240717$20240729$20240729$EXP$$PH-ROCHE-10000034566$ROCHE$$$$$$Y$$$20240729$$MD$PH$PH
241465821$24146582$1$I$20240712$20240719$20240729$20240729$30DAY$$US-GSK-US2024091057$GLAXOSMITHKLINE$$60$YR$$M$Y$$$20240729$$CN$US$US
241465831$24146583$1$I$20220901$20240718$20240729$20240729$EXP$GB-MHRA-MED-202407181604249700-FQLCJ$GB-Accord-436998$ACCORD$$19$YR$A$F$Y$80$KG$20240729$$HP$GB$GB
241465861$24146586$1$I$$20240718$20240729$20240729$EXP$$US-Accord-437493$ACCORD$$27$YR$A$M$Y$$$20240729$$HP$US$US
241465871$24146587$1$I$20240715$20240718$20240729$20240729$EXP$GB-MHRA-MED-202407161003047020-YVRCW$GB-Accord-436986$ACCORD$$35$YR$A$M$Y$96$KG$20240729$$MD$GB$GB
241465881$24146588$1$I$20240522$20240717$20240729$20240729$EXP$$US-Accord-437908$ACCORD$$37$YR$A$M$Y$$$20240729$$HP$US$US
241465891$24146589$1$I$20240625$20240718$20240729$20240729$EXP$FR-AFSSAPS-LY2024000964$FR-Accord-437046$ACCORD$$81$YR$E$F$Y$87.8$KG$20240729$$PH$FR$FR
241465901$24146590$1$I$20240715$20240718$20240729$20240729$EXP$$US-Accord-437458$ACCORD$$38$YR$A$F$Y$$$20240729$$HP$US$US
241465911$24146591$1$I$$20240718$20240729$20240729$EXP$AU-TGA-813683$AU-Accord-436650$ACCORD$$35$YR$A$F$Y$$$20240729$$HP$AU$AU
241465921$24146592$1$I$20240705$20240718$20240729$20240729$EXP$$US-Accord-437498$ACCORD$$33$YR$A$F$Y$$$20240729$$HP$US$US
241465931$24146593$1$I$20240707$20240718$20240729$20240729$EXP$FR-AFSSAPS-MP2024001141$FR-Accord-437619$ACCORD$$79$YR$E$F$Y$$$20240729$$PH$FR$FR
241465942$24146594$2$F$20240601$20240731$20240729$20240806$EXP$$CA-GSK-CA2024091795$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$HP$CA$CA
241465951$24146595$1$I$$20240625$20240729$20240729$PER$$US-ABBVIE-5848091$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241465961$24146596$1$I$$20240718$20240729$20240729$EXP$$JP-Accord-436950$ACCORD$Sekiguchi E, Kurosawa S, Iketani Y, Yoshimura Y, Nakazato T. Disseminated Mycobacterium kansasii infection due to surgical site infection following allogeneic hematopoietic stem cell transplantation: A case report and literature review. International Journal of Infectious Diseases. 2024;146:107123. DOI: 10.1016/j.ijid.2024.107123.$53$YR$A$M$Y$$$20240729$$MD$JP$JP
241465971$24146597$1$I$20240524$20240717$20240729$20240729$EXP$FR-AFSSAPS-RE2024000707$FR-Accord-437032$ACCORD$$50$YR$A$F$Y$57.5$KG$20240729$$MD$FR$FR
241465981$24146598$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148429$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241465991$24146599$1$I$20240710$20240710$20240726$20240726$DIR$FDA-CDER-CTU-2024-51635$$FDA-CTU$$37$YR$$F$N$$$20240710$N$HP$US$
241466001$24146600$1$I$20220101$20240722$20240729$20240729$PER$$US-AMGEN-USASP2024146682$AMGEN$$88$YR$E$M$Y$$$20240729$$CN$US$US
241466011$24146601$1$I$$20240723$20240729$20240729$PER$$US-AMGEN-USASP2024148159$AMGEN$$$$A$F$Y$$$20240729$$MD$US$US
241466023$24146602$3$F$$20240815$20240729$20240826$30DAY$$TR-JNJFOC-20240714935$JOHNSON AND JOHNSON$$$$$F$Y$75$KG$20240826$$PH$TR$TR
241466031$24146603$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51636$$FDA-CTU$$59$YR$$F$N$142$LBS$20240726$N$HP$US$
241466041$24146604$1$I$20240312$20240719$20240729$20240729$EXP$$US-BAYER-2024A105547$BAYER$$60$YR$A$M$Y$$$20240729$$CN$US$US
241466054$24146605$4$F$20240721$20240826$20240729$20240829$EXP$$US-GILEAD-2024-0681561$GILEAD$$84$YR$E$F$Y$$$20240829$$HP$US$US
241466063$24146606$3$F$$20240715$20240729$20240823$PER$$US-ROCHE-10000028247$ROCHE$$$$E$M$Y$$$20240823$$CN$US$US
241466071$24146607$1$I$$20240722$20240729$20240729$EXP$$US-AstraZeneca-2024A166681$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241466081$24146608$1$I$$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118376$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240729$$CN$US$US
241466091$24146609$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119269$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240729$$MD$US$US
241466101$24146610$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119363$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$74.39$KG$20240729$$CN$US$US
241466111$24146611$1$I$20240322$20240726$20240729$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US068671$SANDOZ$$32$YR$$M$Y$$$20240729$$HP$US$US
241466121$24146612$1$I$$20240715$20240729$20240729$EXP$$AU-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000996$ALEMBIC$$$$$$Y$$$20240729$$HP$AU$AU
241466133$24146613$3$F$$20240916$20240729$20240924$EXP$$AU-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000997$ALEMBIC$$$$$$Y$$$20240924$$HP$AU$AU
241466141$24146614$1$I$$20240715$20240729$20240729$EXP$$AU-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000998$ALEMBIC$$$$$$Y$$$20240729$$HP$AU$AU
241466151$24146615$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017021$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240729$$CN$US$US
241466161$24146616$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017606$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240729$$CN$US$US
241466171$24146617$1$I$$20240715$20240729$20240729$EXP$$AU-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000994$ALEMBIC$$$$$$Y$$$20240729$$HP$AU$AU
241466181$24146618$1$I$20240726$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017596$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240729$$CN$US$US
241466191$24146619$1$I$20240724$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017602$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240729$$CN$US$US
241466201$24146620$1$I$$20240722$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407014732$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240729$$CN$US$US
241466211$24146621$1$I$20240717$20240723$20240729$20240729$EXP$$US-BAYER-2024A107817$BAYER$$66$YR$E$F$Y$65.76$KG$20240729$$CN$US$US
241466233$24146623$3$F$$20240919$20240729$20240920$PER$$US-AMGEN-USASP2024149886$AMGEN$$$$$F$Y$$$20240920$$CN$US$US
241466244$24146624$4$F$20220803$20240910$20240729$20240918$EXP$$CA-CELLTRION INC.-2022CA022616$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
241466251$24146625$1$I$$20240723$20240729$20240729$EXP$$CZ-MYLANLABS-2024M1068531$MYLAN$$60$YR$$F$Y$$$20240729$$MD$CZ$CZ
241466261$24146626$1$I$20240520$20240723$20240729$20240729$EXP$$GB-MYLANLABS-2024M1068968$MYLAN$$91$YR$$$Y$$$20240729$$PH$GB$GB
241466281$24146628$1$I$20240601$20240723$20240729$20240729$EXP$$UA-MYLANLABS-2024M1069350$MYLAN$$51$YR$$M$Y$$$20240729$$HP$UA$UA
241466292$24146629$2$F$20240422$20240820$20240729$20240823$EXP$$US-MYLANLABS-2024M1069531$MYLAN$$18$YR$$F$Y$$$20240823$$CN$US$US
241466302$24146630$2$F$$20240723$20240729$20240730$EXP$$GR-MYLANLABS-2024M1068657$MYLAN$$78$YR$$F$Y$$$20240730$$MD$GR$GR
241466314$24146631$4$F$20230427$20240813$20240729$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US068691$SANDOZ$$10$YR$$M$Y$24.04$KG$20240820$$HP$US$US
241466323$24146632$3$F$$20240918$20240729$20240924$PER$$US-GSK-US2024092376$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
241466331$24146633$1$I$$20240724$20240729$20240729$EXP$$AR-BEH-2024176401$CSL BEHRING$$$$A$F$Y$$$20240729$$MD$AR$AR
241466351$24146635$1$I$$20240715$20240729$20240729$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-06866$HIKMA$Mata E, Garcia BL, Oliveira AP, Santos F, Fernandes C, Cotte J. Mata E, Garcia BL, Oliveira AP, Santos F, Fernandes C, Cotte J. PO-0016 - (2389) - Lyme neuroborreliosis as the initial expression of Lyme disease in an elderly patient.. Caso clinico$84$YR$$M$Y$$$20240729$$MD$PT$PT
241466362$24146636$2$F$$20240801$20240729$20240805$PER$$US-ROCHE-10000040401$ROCHE$$$$$$Y$$$20240805$$PH$US$US
241466382$24146638$2$F$$20240731$20240729$20240809$EXP$$IL-TEVA-VS-3224483$TEVA$Kian W, Krayim B, Alsana H, Giles B, Purim O, Alguayn W, et al. Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib. Front-Oncol 2023; 13 no pagination.; Kian W, Krayim B, Alsana H, Giles B, Purim O, Alguayn W, et al. Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib. Front-Oncol 2023; 13 no pagination.; Kian W, Krayim B, Alsana H, Giles B, Purim O, Alguayn W, et al. Overcom...$73$YR$$F$Y$$$20240809$$HP$IL$IL
241466391$24146639$1$I$20240610$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51691$$FDA-CTU$$63$YR$$F$N$$$20240726$Y$$US$
241466401$24146640$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51710$$FDA-CTU$$$$$F$N$$$20240726$N$$US$
241466411$24146641$1$I$20231218$20240724$20240729$20240729$EXP$$NVSC2024AU004849$NOVARTIS$$16$YR$$M$Y$76$KG$20240729$$MD$AU$AU
241466421$24146642$1$I$20240708$20240709$20240729$20240729$PER$$FR-TOLMAR, INC.-24FR050861$TOLMAR$$78$YR$$M$Y$$$20240729$$PH$FR$FR
241466431$24146643$1$I$20240709$20240709$20240729$20240729$PER$$CA-TOLMAR, INC.-24CA050935$TOLMAR$$71$YR$$M$Y$$$20240729$$CN$CA$CA
241466451$24146645$1$I$20240608$20240726$20240729$20240729$EXP$FR-AFSSAPS-TO2024001081$NVSC2024FR153327$NOVARTIS$$63$YR$$F$Y$47$KG$20240729$$PH$FR$FR
241466461$24146646$1$I$20240709$20240709$20240729$20240729$PER$$FR-TOLMAR, INC.-24FR050925$TOLMAR$$61$YR$$M$Y$$$20240729$$PH$FR$FR
241466471$24146647$1$I$$20240724$20240729$20240729$EXP$$NVSC2024US153028$NOVARTIS$$$$$M$Y$$$20240729$$CN$US$US
241466482$24146648$2$F$20240614$20240809$20240729$20240903$PER$$US-TOLMAR, INC.-24US050495$TOLMAR$$68$YR$$M$Y$$$20240903$$HP$US$US
241466491$24146649$1$I$20240718$20240722$20240729$20240729$PER$$US-Vifor (International) Inc.-VIT-2024-06591$VIFOR$$57$YR$$F$Y$77.7$KG$20240729$$HP$US$US
241466501$24146650$1$I$$20240719$20240729$20240729$EXP$$JP-009507513-2407JPN004157J$MERCK$$79$YR$$F$Y$$$20240729$$MD$JP$JP
241466511$24146651$1$I$$20240716$20240729$20240729$EXP$$CN-B.Braun Medical Inc.-2159707$B BRAUN$$90$YR$$M$Y$$$20240729$$$CN$CN
241466521$24146652$1$I$20240501$20240718$20240729$20240729$EXP$$ES-AUROBINDO-AUR-APL-2024-036486$AUROBINDO$$86$YR$$F$Y$$$20240729$$MD$ES$ES
241466531$24146653$1$I$$20240719$20240729$20240729$EXP$$US-GSK-US2024091041$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$MD$US$US
241466541$24146654$1$I$$20240702$20240729$20240729$PER$$US-Eisai-EC-2024-169686$EISAI$Wei M. Immunotherapy in a case of low titre GAD65 antibody-associated spectrum neurological disorders.. BMJ Case Reports. 2024 May 21;6(17): 1-9. doi:10.1136/bcr-2024-260503.$$$A$F$Y$$$20240729$$MD$US$US
241466552$24146655$2$F$20240625$20240730$20240729$20240801$PER$$US-AMGEN-USASP2024148112$AMGEN$$29$YR$A$F$Y$$$20240801$$HP$US$US
241466561$24146656$1$I$$20240722$20240729$20240729$EXP$$NVSC2024US151137$NOVARTIS$$$$$F$Y$$$20240729$$CN$US$US
241466571$24146657$1$I$20240615$20240718$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036601$AUROBINDO$$89$YR$$F$Y$$$20240729$$MD$FR$FR
241466581$24146658$1$I$$20240727$20240729$20240729$EXP$GB-MHRA-MED-202407270735169410-MQLDJ$GB-SANDOZ INC.-SDZ2024GB068701$SANDOZ$$67$YR$$F$Y$66$KG$20240729$$CN$GB$GB
241466601$24146660$1$I$20240723$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51708$$FDA-CTU$$69$YR$$F$N$$$20240726$Y$HP$US$
241466611$24146661$1$I$$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51715$$FDA-CTU$$$$$F$N$$$20240725$N$HP$US$
241466621$24146662$1$I$20240721$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51700$$FDA-CTU$$65$YR$$F$N$$$20240726$Y$HP$US$
241466631$24146663$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51712$$FDA-CTU$$53$YR$$F$N$$$20240726$N$$US$
241466651$24146665$1$I$20231101$20240726$20240729$20240729$EXP$$US-UCBSA-2024037889$UCB$$59$YR$$F$Y$$$20240729$$CN$US$US
241466661$24146666$1$I$$20240724$20240729$20240729$EXP$$US-SHIRE-US201908463AA$TAKEDA$$$$$F$Y$$$20240729$$HP$US$US
241466671$24146667$1$I$$20240726$20240729$20240729$EXP$$PK-ROCHE-10000039870$ROCHE$$43$YR$A$F$Y$$$20240729$$CN$PK$PK
241466682$24146668$2$F$20230817$20240814$20240729$20240820$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2023-110635$REGENERON$$$$$F$Y$$$20240820$$CN$CO$CO
241466691$24146669$1$I$$20240724$20240729$20240729$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2024-101262$REGENERON$$81$YR$$F$Y$$$20240729$$CN$CO$CO
241466713$24146671$3$F$$20240909$20240729$20240920$EXP$$PT-AUROBINDO-AUR-APL-2024-037244$AUROBINDO$Jo?o Lagarteira1; Carla Oliveira Ferreiratwo; Sara S?1; Rita Pera1; Andres Carrascal1; Eugenia Madureira1. PO-0091 - (4099) - UM CASO DE CARDIOTOXICIDADE POR QUIMIOTERAPIA. Cardiovascular diseases | Clinical case$66$YR$$M$Y$$$20240920$$MD$PT$PT
241466722$24146672$2$F$$20240925$20240729$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA053345$SANDOZ$$66$YR$$F$Y$$$20240927$$CN$CA$CA
241466731$24146673$1$I$20240604$20240722$20240729$20240729$EXP$$SG-JNJFOC-20240759891$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240729$$HP$SG$SG
241466741$24146674$1$I$20240101$20240723$20240729$20240729$PER$$US-ABBVIE-5854538$ABBVIE$$$$$$Y$$$20240729$$HP$US$US
241466752$24146675$2$F$$20240724$20240729$20240805$EXP$$PT-AUROBINDO-AUR-APL-2024-037367$AUROBINDO$Carolina Ant?nio Santos; In?s Parreira; Sara Salema Travassos;Ana Mafalda Abrantes; Ana Alves Cardoso; Ant?nio Pais De Lacerda et al. PO-0004 - (2159) - UMA CAUSA RARADE LES?O RENAL AGUDA. Doen?as infeciosas e parasit?rias | Caso cl?nico$87$YR$$F$Y$$$20240805$$MD$PT$PT
241466761$24146676$1$I$20240101$20240722$20240729$20240729$EXP$$US-AMGEN-USASP2024145458$AMGEN$$84$YR$E$F$Y$$$20240729$$CN$US$US
241466771$24146677$1$I$$20240719$20240729$20240729$EXP$$US-VIIV HEALTHCARE LIMITED-US2024092217$VIIV$$$$$M$Y$$$20240729$$MD$US$US
241466792$24146679$2$F$$20240729$20240729$20240805$PER$$US-AMGEN-USASP2024149751$AMGEN$$$$$$Y$$$20240805$$MD$US$US
241466801$24146680$1$I$20240112$20240717$20240729$20240729$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00177$OPKO HEALTH$$74$YR$$M$Y$74.376$KG$20240725$$PH$US$US
241466811$24146681$1$I$$20240715$20240729$20240729$EXP$$PT-AUROBINDO-AUR-APL-2024-037275$AUROBINDO$J?ssica O, Martim B, Mariana C, Duarte C.. FOCO IMPROV?VELDE BACTERI?MIA A  MRSA (UNLIKELY FOOT OF MRSA BACTEREMIA). Doen?as raras | Imagem em Medicina Interna (Rare diseases I Imaging in Internal. 1299$73$YR$$M$Y$$$20240729$$HP$PT$PT
241466821$24146682$1$I$$20240723$20240729$20240729$EXP$$JP-009507513-2407JPN004171J$MERCK$$62$YR$$F$Y$$$20240729$$MD$JP$JP
241466831$24146683$1$I$20240601$20240719$20240729$20240729$PER$$US-AMGEN-USASP2024143922$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241466841$24146684$1$I$20240723$20240723$20240729$20240729$EXP$$US-BAYER-2024A108083$BAYER$$84$YR$E$F$Y$58.05$KG$20240729$$HP$US$US
241466851$24146685$1$I$$20240723$20240729$20240729$EXP$$CA-JNJFOC-20240765081$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$HP$CA$CA
241466861$24146686$1$I$$20240723$20240729$20240729$EXP$$US-JNJFOC-20240764508$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241466871$24146687$1$I$$20240718$20240729$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-035934$AUROBINDO$Menke BA, Wagner W, Song H, Thomas W, Almeida NE, Yeh S, Conrady CD et al. Case report: CMV retinitis following local and systemic immunosuppression. Frontiers in ophthalmology. 2024;4:1354104$71$YR$$M$Y$$$20240729$$MD$US$US
241466883$24146688$3$F$20240527$20240826$20240729$20240903$EXP$$CH-OPKO PHARMACEUTICALS, LLC.-2024OPK00182$OPKO HEALTH$$69$YR$$M$Y$78$KG$20240830$$CN$CH$DE
241466892$24146689$2$F$$20240716$20240729$20240731$EXP$$US-BEH-2024175917$CSL BEHRING$$$$$F$Y$$$20240731$$CN$US$US
241466901$24146690$1$I$20240720$20240726$20240729$20240729$PER$$US-HALEON-2189188$Haleon PLC$$65$YR$$F$Y$$$20240729$$CN$US$US
241466911$24146691$1$I$$20240719$20240729$20240729$PER$$US-PFM-2024-04174$PIERRE FABRE MEDICAMENT$$$$$M$Y$10.998$KG$20240729$$CN$US$US
241466921$24146692$1$I$$20240726$20240729$20240729$EXP$$US-BAYER-2024A108924$BAYER$$70$YR$E$F$Y$$$20240729$$MD$US$US
241466931$24146693$1$I$20190326$20240717$20240729$20240729$EXP$PL-URPL-1-4011-2019$PL-ROCHE-10000029344$ROCHE$$78$YR$E$F$Y$46$KG$20240729$$MD$PL$PL
241466942$24146694$2$F$20230101$20240807$20240729$20240812$EXP$$US-SA-2024SA218504$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240812$$MD$US$US
241466951$24146695$1$I$20240601$20240723$20240729$20240729$EXP$$US-SA-2024SA218750$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240729$$MD$US$US
241466961$24146696$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51723$$FDA-CTU$$68$YR$$F$N$$$20240726$N$$US$
241466971$24146697$1$I$$20240722$20240729$20240729$EXP$$NVSC2024BR153943$NOVARTIS$$$$$F$Y$$$20240729$$CN$BR$BR
241466981$24146698$1$I$$20240724$20240729$20240729$EXP$$US-TAKEDA-2024TUS074813$TAKEDA$$$$$F$Y$$$20240729$$CN$US$US
241466992$24146699$2$F$20231215$20240721$20240729$20240806$EXP$$NVSC2024DE016077$NOVARTIS$$54$YR$$F$Y$94$KG$20240806$$MD$DE$DE
241467001$24146700$1$I$$20230512$20240729$20240729$EXP$$NVSC2023CA111333$NOVARTIS$$$$$$Y$$$20240729$$MD$CA$CA
241467011$24146701$1$I$$20240725$20240729$20240729$PER$$US-GILEAD-2024-0682042$GILEAD$$$$$M$Y$$$20240729$$CN$US$US
241467022$24146702$2$F$20110101$20240723$20240729$20240801$EXP$$US-SA-2024SA217765$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240801$$CN$US$US
241467031$24146703$1$I$20240703$20240723$20240729$20240729$EXP$FR-AFSSAPS-RS2024000724$FR-SA-2024SA215294$SANOFI AVENTIS$$69$YR$E$M$Y$79$KG$20240729$$PH$FR$FR
241467041$24146704$1$I$20240523$20240719$20240729$20240729$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00183$OPKO HEALTH$$69$YR$$F$Y$$$20240725$$PH$US$US
241467051$24146705$1$I$20240724$20240725$20240729$20240729$EXP$$US-BAUSCH-BL-2023-018403$BAUSCH AND LOMB$$81$YR$$F$Y$$$20240729$$CN$US$US
241467061$24146706$1$I$20240101$20240721$20240729$20240729$EXP$$CA-CELLTRION INC.-2024CA009941$CELLTRION$$$$$$Y$$$20240729$$CN$CA$CA
241467072$24146707$2$F$20240701$20240822$20240729$20240827$EXP$$US-BAUSCH-BL-2024-011446$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240827$$CN$US$US
241467091$24146709$1$I$$20240725$20240729$20240729$EXP$$US-BAYER-2024A108995$BAYER$$78$YR$E$M$Y$100.68$KG$20240729$$CN$US$US
241467102$24146710$2$F$20240101$20240716$20240729$20240802$PER$$US-TEVA-VS-3221857$TEVA$$61$YR$$F$Y$55.34$KG$20240802$$PH$US$US
241467111$24146711$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51693$$FDA-CTU$$74$YR$$M$N$$$20240726$N$$US$
241467122$24146712$2$F$$20240819$20240729$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115789$BRISTOL MYERS SQUIBB$Menke BA, Wagner W, Song H, Thomas W, Almeida NE, Conrady CD, et al. Case report: CMV retinitis following local and systemic immunosuppression. Frontiers in Ophthalmology. 2024 Mar 06;4:1-5. doi:10.3389/fopht.2024.1354104.$71$YR$E$M$Y$$$20240826$$HP$US$US
241467133$24146713$3$F$20240718$20240723$20240729$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118631$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240809$$MD$JP$JP
241467142$24146714$2$F$$20240819$20240729$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202407016809$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240822$$CN$US$US
241467151$24146715$1$I$$20240702$20240729$20240729$PER$$US-JNJFOC-20240708116$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240729$$CN$US$US
241467161$24146716$1$I$20240701$20240723$20240729$20240729$EXP$$CA-JNJFOC-20240764412$JOHNSON AND JOHNSON$$76$YR$$F$Y$75$KG$20240729$$HP$CA$CA
241467171$24146717$1$I$20240617$20240723$20240729$20240729$EXP$$US-JNJFOC-20240764301$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240729$$CN$US$US
241467191$24146719$1$I$$20240723$20240729$20240729$EXP$$FR-MYLANLABS-2024M1068663$MYLAN$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N, Pelletier R and al.. A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxicologie Analytique + Clinique. 2023;35:376-394$$$$M$Y$$$20240729$$MD$FR$FR
241467202$24146720$2$F$$20240808$20240729$20240812$EXP$$CZ-MYLANLABS-2024M1068575$MYLAN$Sitina M, Sramek V.. Glycemic ketoacidosis associated with SGLT2 inhibitors and DPP 4 inhibitors ? analysis of case reports.. Anesteziologie a intenzivni medicina.. 2024;35(2):116-21$61$YR$$M$Y$$$20240812$$MD$CZ$CZ
241467212$24146721$2$F$20171201$20240801$20240729$20240809$EXP$$AT-BAUSCH-BL-2024-011467$BAUSCH AND LOMB$Spanberger T. Therapieerfolg im Rezidiv des Multiplen Myeloms. Spectrum Onkologie. 2024 MAR;(NR. 3):99.$66$YR$$F$Y$$$20240809$$MD$AT$AT
241467221$24146722$1$I$20240625$20240726$20240729$20240729$EXP$$PT-BAUSCH-BL-2024-011477$BAUSCH AND LOMB$$37$YR$$M$Y$$$20240729$$CN$PT$PT
241467241$24146724$1$I$20240716$20240716$20240729$20240729$PER$$US-AstraZeneca-2024A162483$ASTRAZENECA$$21446$DY$$F$Y$$$20240729$$CN$US$
241467251$24146725$1$I$$20240723$20240729$20240729$EXP$$IN-MYLANLABS-2024M1069864$MYLAN$Mohan V, Jain S, Naithani R. Low-dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe-BIRD) in a child with relapsed/refractory B-cell acute lymphoblastic leukemia with TP53 mutation. Pediatr-Blood-Cancer 2024; 71 (9):.$11$YR$$M$Y$$$20240729$$HP$IN$IN
241467261$24146726$1$I$$20240723$20240729$20240729$EXP$$US-MYLANLABS-2024M1070290$MYLAN$Duarte A, Teague TT. Acute Epiglottitis Due to Combined COVID-19 Infection and Haemophilus Influenzae Bacteremia. Am-J-Respir-Crit-Care-Med 2024; 209.$67$YR$$M$Y$$$20240729$$HP$US$US
241467271$24146727$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51716$$FDA-CTU$$79$YR$$F$N$$$20240726$N$$US$
241467281$24146728$1$I$$20240702$20240729$20240729$PER$$US-Vifor (International) Inc.-VIT-2024-05948$VIFOR$$53$YR$$M$Y$$$20240729$$HP$US$US
241467291$24146729$1$I$$20240721$20240729$20240729$EXP$$US-AstraZeneca-2024A169233$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241467301$24146730$1$I$$20240722$20240729$20240729$EXP$$US-BAYER-2024A043300$BAYER$$79$YR$E$M$Y$66.667$KG$20240729$$CN$US$US
241467312$24146731$2$F$$20240807$20240729$20240816$EXP$$US-GSK-US2024AMR092258$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
241467322$24146732$2$F$$20240827$20240729$20240906$30DAY$$US-GSK-US2024091208$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
241467332$24146733$2$F$20240101$20240729$20240729$20240731$PER$$US-AMGEN-USASP2024147629$AMGEN$$82$YR$E$F$Y$$$20240731$$CN$US$US
241467341$24146734$1$I$$20240723$20240729$20240729$PER$$US-AMGEN-USASP2024148202$AMGEN$$$$A$F$Y$$$20240729$$HP$US$US
241467351$24146735$1$I$$20240721$20240729$20240729$EXP$$US-ALEMBIC-2024SCAL001030$ALEMBIC$$$$$$Y$$$20240729$$CN$US$US
241467361$24146736$1$I$20080227$20240722$20240729$20240729$EXP$FR-BAYER-200814409GPV$FR-CHEPLA-2024009270$CHEPLAPHARM$$52$YR$$F$Y$$$20240729$$HP$COUNTRY NOT SPECIFIED$FR
241467371$24146737$1$I$$20240716$20240729$20240729$EXP$$HK-CHEPLA-2024009646$CHEPLAPHARM$$33$YR$$M$Y$$$20240729$$HP$COUNTRY NOT SPECIFIED$HK
241467391$24146739$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51732$$FDA-CTU$$53$YR$$F$N$$$20240726$N$$US$
241467401$24146740$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51717$$FDA-CTU$$60$YR$$M$N$$$20240726$N$$US$
241467411$24146741$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51713$$FDA-CTU$$62$YR$$F$N$$$20240726$N$$US$
241467431$24146743$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51722$$FDA-CTU$$67$YR$$M$N$$$20240726$N$$US$
241467441$24146744$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51729$$FDA-CTU$$25$YR$$M$N$$$20240726$N$$US$
241467471$24146747$1$I$$20240725$20240729$20240729$PER$$US-HALEON-2189255$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241467481$24146748$1$I$$20240721$20240729$20240729$EXP$$US-JNJFOC-20240759935$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$HP$US$US
241467492$24146749$2$F$$20240814$20240729$20240903$30DAY$$US-JNJFOC-20240766865$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
241467502$24146750$2$F$$20240903$20240729$20240905$EXP$$CN-JNJFOC-20240773104$JOHNSON AND JOHNSON$$90$YR$E$M$Y$$$20240905$$CN$CN$CN
241467511$24146751$1$I$20240723$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51688$$FDA-CTU$$80$YR$$M$N$$$20240726$Y$$US$
241467521$24146752$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51728$$FDA-CTU$$31$YR$$F$N$$$20240726$N$$US$
241467531$24146753$1$I$20240701$20240722$20240729$20240729$EXP$IT-MINISAL02-994391$IT-CHEPLA-2024009494$CHEPLAPHARM$$86$YR$$F$Y$$$20240729$$MD$COUNTRY NOT SPECIFIED$IT
241467541$24146754$1$I$20240326$20240722$20240729$20240729$EXP$$BE-CHEPLA-2024009330$CHEPLAPHARM$$$$A$F$Y$59$KG$20240729$$CN$COUNTRY NOT SPECIFIED$BE
241467551$24146755$1$I$$20240723$20240729$20240729$EXP$$US-CHEPLA-2024009363$CHEPLAPHARM$$$$$F$Y$$$20240729$$CN$COUNTRY NOT SPECIFIED$US
241467561$24146756$1$I$20240501$20240715$20240729$20240729$EXP$$US-MDD US Operations-MDD202407-002532$MDD OPERATIONS$$71$YR$$M$Y$$$20240729$$CN$US$
241467571$24146757$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51702$$FDA-CTU$$43$YR$$F$N$$$20240726$N$$US$
241467581$24146758$1$I$20240701$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51689$$FDA-CTU$$64$YR$$F$N$$$20240726$N$HP$US$
241467601$24146760$1$I$20240531$20240718$20240729$20240729$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00178$OPKO HEALTH$$70$YR$$F$Y$$$20240725$$PH$US$US
241467611$24146761$1$I$20240609$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51707$$FDA-CTU$$55$YR$$F$N$$$20240726$Y$HP$US$
241467621$24146762$1$I$20240621$20240718$20240729$20240729$EXP$$US-Accord-437467$ACCORD$$65$YR$E$M$Y$$$20240729$$HP$US$US
241467631$24146763$1$I$20240710$20240718$20240729$20240729$EXP$$US-Accord-437501$ACCORD$$86$YR$E$M$Y$$$20240729$$HP$US$US
241467643$24146764$3$F$20240715$20240730$20240729$20240813$EXP$$US-Accord-437302$ACCORD$$22$YR$A$M$Y$$$20240813$$HP$US$US
241467651$24146765$1$I$$20240718$20240729$20240729$EXP$AU-TGA-813624$AU-Accord-436652$ACCORD$$65$YR$E$F$Y$$$20240729$$HP$AU$AU
241467661$24146766$1$I$$20240718$20240729$20240729$EXP$AU-TGA-813651$AU-Accord-436651$ACCORD$$72$YR$E$M$Y$$$20240729$$HP$AU$AU
241467671$24146767$1$I$20240717$20240718$20240729$20240729$EXP$$US-Accord-437504$ACCORD$$64$YR$A$M$Y$$$20240729$$HP$US$US
241467681$24146768$1$I$$20240718$20240729$20240729$EXP$IT-EMA-2024713-AUTODUP-1720821980914$IT-Accord-437294$ACCORD$$61$YR$A$M$Y$$$20240729$$MD$IT$IT
241467691$24146769$1$I$$20231212$20240729$20240729$EXP$$NVSC2023CA280907$NOVARTIS$$$$$F$Y$$$20240729$$CN$CA$CA
241467702$24146770$2$F$20240606$20240731$20240729$20240813$EXP$ES-AEMPS-1549718$ES-ORGANON-O2407ESP002305$ORGANON$$83$YR$$F$Y$$$20240813$$MD$ES$ES
241467712$24146771$2$F$$20240808$20240729$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-035970$AUROBINDO$Lathiya MK, Errabelli P, Roy S, Mareedu N. Severe acute kidney injury due to oxalate crystal induced severe interstitial nephritis: A case report. World journal of nephrology. 2024;13(2):1 to 10$71$YR$$F$Y$76$KG$20240821$$MD$US$US
241467721$24146772$1$I$$20240716$20240729$20240729$EXP$$IN-RDY-LIT/IND/24/0010799$DR REDDYS$Batra CM, Jain S, Kumar KP, Goyal M, Kachroo V, Takkar S, et al. Spontaneous Hypoglycaemia due to Insulin Autoimmune Syndrome in Six Cases, Response to Steroid Therapy and Rituximab. Indian Journal of Endocrinology and Metabolism. 28(3): 295-301. doi:10.4103/ijem.ijem_378_23.$73$YR$E$M$Y$$$20240729$$HP$IN$IN
241467731$24146773$1$I$$20240722$20240729$20240729$30DAY$$US-GSK-US2024091866$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241467741$24146774$1$I$20240701$20240718$20240729$20240729$EXP$$BR-UCBSA-2024036307$UCB$$69$YR$$M$Y$90$KG$20240729$$HP$BR$BR
241467751$24146775$1$I$$20240719$20240729$20240729$EXP$IT-MINISAL02-994828$IT-TEVA-VS-3223828$TEVA$$72$YR$$F$Y$$$20240729$$MD$IT$IT
241467761$24146776$1$I$20240601$20240718$20240729$20240729$EXP$$SE-AUROBINDO-AUR-APL-2024-036426$AUROBINDO$$73$YR$$M$Y$$$20240729$$MD$SE$SE
241467771$24146777$1$I$$20240725$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119658$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240729$$HP$US$US
241467781$24146778$1$I$$20240725$20240729$20240729$EXP$$NVSC2024BR154005$NOVARTIS$$71$YR$$F$Y$$$20240729$$MD$BR$BR
241467791$24146779$1$I$$20240718$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-119463$BRISTOL MYERS SQUIBB$Literature citation unavailable.$$$$$Y$$$20240729$$HP$CA$CA
241467801$24146780$1$I$$20240715$20240729$20240729$EXP$$PT-AUROBINDO-AUR-APL-2024-037260$AUROBINDO$Peixoto J, Ramalho AR,  Mendes P, Lima J, Santos L. PO-0367 - (3944) - FEBRE REUM?TICA AGUDA NO ADULTO: CASO CL?NICO. Doen?as autoimunes, reumatol?gicas e vasculites | Caso cl?nico. 730$54$YR$$M$Y$$$20240729$$HP$PT$PT
241467811$24146781$1$I$$20240723$20240729$20240729$EXP$$US-JNJFOC-20240764228$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241467821$24146782$1$I$20140301$20240725$20240729$20240729$EXP$$US-INCYTE CORPORATION-2024IN007834$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241467831$24146783$1$I$20230703$20240723$20240729$20240729$EXP$$JP-AstraZeneca-2023A251562$ASTRAZENECA$$79$YR$$M$Y$$$20240729$$HP$JP$
241467841$24146784$1$I$$20240723$20240729$20240729$EXP$$TH-MYLANLABS-2024M1069823$MYLAN$Thammongkolchai T, Termsarasab P. Malignant Catatonia Secondary to Clozapine Withdrawal: A Case Report. Mov-Disord 2022;.$53$YR$$F$Y$$$20240729$$HP$TH$TH
241467853$24146785$3$F$20240701$20240910$20240729$20240926$30DAY$$US-BECTON DICKINSON-US-BD-24-000457$BECTON DICKINSON$$76$YR$$F$Y$$$20240926$$HP$US$US
241467861$24146786$1$I$20240530$20240726$20240729$20240729$EXP$$DE-SANDOZ INC.-SDZ2024DE068542$SANDOZ$$$$E$F$Y$$$20240729$$HP$DE$DE
241467871$24146787$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092525$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241467881$24146788$1$I$$20240723$20240729$20240729$EXP$$US-MYLANLABS-2024M1070288$MYLAN$Kalsoom S, Khan M, Zaman MA, Vitellas M. A Silent Inferior Wall ST Segment Elevation Myocardial Infarction. Arterioscler-Thromb-Vasc-Biol 2023; 43 (Suppl.).$36$YR$$M$Y$$$20240729$$HP$US$US
241467892$24146789$2$F$20230101$20240730$20240729$20240806$EXP$$US-AMGEN-USASP2024147893$AMGEN$$$$$M$Y$$$20240806$$LW$US$US
241467901$24146790$1$I$20220420$20240723$20240729$20240729$EXP$$CA-TAKEDA-2024TUS063951$TAKEDA$$69$YR$$F$Y$$$20240729$$MD$CA$CA
241467912$24146791$2$F$20240724$20240812$20240729$20240819$PER$$US-AMGEN-USASP2024148044$AMGEN$$79$YR$E$F$Y$$$20240819$$CN$US$US
241467921$24146792$1$I$20240528$20240722$20240729$20240729$EXP$$GR-CELLTRION INC.-2024GR008403$CELLTRION$$$$$$Y$$$20240729$$CN$GR$GR
241467933$24146793$3$F$20240701$20240910$20240729$20240926$30DAY$$US-BECTON DICKINSON-US-BD-24-000458$BECTON DICKINSON$$56$YR$$F$Y$$$20240926$$HP$US$US
241467941$24146794$1$I$$20240715$20240729$20240729$EXP$$PT-AUROBINDO-AUR-APL-2024-037301$AUROBINDO$Monteiro ID, Cardoso JC, Guedes F, Party S, Neves PM, Solomon J, et al.. UMA INFE??O NUNCA VEM S? ? A PROP?SITO DE UM CASO CL?NICO (AN INFECTION NEVER COMES ONLY ? FOR THE PURPOSE OF A CLINICAL CASE). Doen?as infeciosas e parasit?rias (Infectious and parasitic diseases). 530$76$YR$$F$Y$$$20240729$$HP$PT$PT
241467951$24146795$1$I$$20240722$20240729$20240729$EXP$$NVSC2024CA152544$NOVARTIS$$41$YR$$M$Y$130$KG$20240729$$HP$CA$CA
241467962$24146796$2$F$$20240731$20240729$20240802$EXP$$CA-UCBSA-2024037630$UCB$$$$$M$Y$$$20240802$$CN$CA$CA
241467971$24146797$1$I$20201117$20240718$20240729$20240729$EXP$$BE-AUROBINDO-AUR-APL-2024-036670$AUROBINDO$$71$YR$$F$Y$76$KG$20240729$$MD$BE$BE
241467981$24146798$1$I$$20240726$20240729$20240729$EXP$$US-INCYTE CORPORATION-2024IN007863$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241467991$24146799$1$I$20240707$20240722$20240729$20240729$EXP$$US-RDY-SPO/USA/24/0010865$DR REDDYS$$22$YR$A$$Y$$$20240729$$CN$US$US
241468001$24146800$1$I$20230101$20240716$20240729$20240729$EXP$$GR-AVS-000013$AAVIS PHARMACEUTICALS$Andrikopoulou A, Goga K, Stefanaki K, Paschou SA, Athanasopoulos S, Zagouri F, et al. Ectopic Cushing syndrome in metastatic castration-resistant prostate cancer: A case report and review of literature. Oncol Lett. 2024 Jul 1;28(3):417. doi: 10.3892/ol.2024.14550.$76$YR$E$M$Y$$$20240729$$MD$GR$GR
241468011$24146801$1$I$20240330$20240722$20240729$20240729$PER$$US-ALXN-202407USA001537US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
241468022$24146802$2$F$$20240815$20240729$20240819$PER$$US-ALXN-202407USA001494US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241468033$24146803$3$F$$20240816$20240729$20240819$PER$$US-ALXN-202407USA001575US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241468051$24146805$1$I$20240411$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51705$$FDA-CTU$$61$YR$$M$N$$$20240726$Y$HP$US$
241468061$24146806$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51721$$FDA-CTU$$72$YR$$F$N$$$20240726$N$$US$
241468071$24146807$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51701$$FDA-CTU$$74$YR$$M$N$$$20240726$N$$US$
241468081$24146808$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51711$$FDA-CTU$$58$YR$$M$N$$$20240726$N$$US$
241468101$24146810$1$I$20240614$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51696$$FDA-CTU$$67$YR$$F$N$$$20240726$N$HP$US$
241468111$24146811$1$I$$20240726$20240726$20240726$DIR$711688$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241468121$24146812$1$I$20240723$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51704$$FDA-CTU$$80$YR$$M$N$$$20240726$Y$PH$US$
241468131$24146813$1$I$20240612$20240726$20240726$20240726$DIR$711735$$FDA-CTU$$54$MON$$F$N$53.1$KG$20240726$N$CN$US$
241468141$24146814$1$I$20240726$20240726$20240726$20240726$DIR$711721$$FDA-CTU$$64$YR$$M$N$$$20240726$N$$US$
241468151$24146815$1$I$20240709$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51706$$FDA-CTU$$48$YR$$F$N$$$20240726$Y$PH$US$
241468162$24146816$2$F$$20240709$20240729$20240809$PER$$US-009507513-2407USA004494$MERCK$$$$$$Y$$$20240809$$PH$US$US
241468171$24146817$1$I$20240524$20240718$20240729$20240729$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02664$AMNEAL$$81$YR$$M$Y$79.38$KG$20240729$$CN$US$US
241468181$24146818$1$I$20240401$20240723$20240729$20240729$EXP$$JP-AMGEN-JPNSP2024104252$AMGEN$$8$DEC$E$M$Y$$$20240729$$MD$JP$JP
241468191$24146819$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148817$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241468202$24146820$2$F$$20240909$20240729$20240920$EXP$$PT-AUROBINDO-AUR-APL-2024-037236$AUROBINDO$Maria Guilherme M, Jos? Diogo M, Patr?cia S, Maria In?s R, Ana Patr?cia C, Joana Urbano. SEROTONINERGIC SYNDROME: THE  PURPOSE OF A CLINICAL CASE. Emergency, intermediate care and critically ill patients | Clinical case. 481$79$YR$$F$Y$$$20240920$$MD$PT$PT
241468211$24146821$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148760$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241468223$24146822$3$F$20240711$20240926$20240729$20240930$EXP$$DE-SERVIER-S24009294$SERVIER$$$$$$Y$$$20240930$$PH$DE$DE
241468231$24146823$1$I$$20240722$20240729$20240729$EXP$$NVSC2024CA151686$NOVARTIS$$$$E$F$Y$$$20240729$$MD$CA$CA
241468242$24146824$2$F$$20240722$20240729$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-035924$AUROBINDO$Applegarth J, Finn D, Tolkacz M, Iacco A.. Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome. ASAIO Journal. 2024;70(Supple 3):151$18$YR$$F$Y$$$20240802$$MD$US$US
241468251$24146825$1$I$20240605$20240718$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036532$AUROBINDO$$53$YR$$F$Y$48.5$KG$20240729$$MD$FR$FR
241468261$24146826$1$I$$20240725$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119104$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240729$$HP$US$US
241468271$24146827$1$I$$20240723$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407015628$ELI LILLY AND CO$$$$$$Y$$$20240729$$CN$US$US
241468281$24146828$1$I$$20240715$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010000$ELI LILLY AND CO$$$$$$Y$$$20240729$$HP$US$US
241468291$24146829$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118987$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240729$$CN$US$US
241468301$24146830$1$I$20240530$20240715$20240729$20240729$EXP$ES-AEMPS-1546293$ES-ELI_LILLY_AND_COMPANY-ES202407010005$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240729$$CN$ES$ES
241468311$24146831$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017812$ELI LILLY AND CO$$$$$M$Y$$$20240729$$CN$US$US
241468321$24146832$1$I$20240723$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016691$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240729$$CN$US$US
241468332$24146833$2$F$$20240726$20240729$20240730$EXP$$US-UCBSA-2024036294$UCB$$$$$F$Y$$$20240730$$HP$US$US
241468341$24146834$1$I$$20240718$20240729$20240729$PER$$US-BAUSCHBL-2024BNL030373$BAUSCH AND LOMB$$82$YR$$F$Y$$$20240729$$CN$US$US
241468353$24146835$3$F$20240630$20240810$20240729$20240813$EXP$$US-ABBVIE-5836639$ABBVIE$$78$YR$$F$Y$$$20240813$$CN$US$US
241468361$24146836$1$I$$20240718$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036521$AUROBINDO$$87$YR$$F$Y$$$20240729$$PH$FR$FR
241468371$24146837$1$I$$20240723$20240729$20240729$EXP$$US-TAKEDA-2024TUS072039$TAKEDA$$$$$F$Y$$$20240729$$CN$US$US
241468381$24146838$1$I$$20240718$20240729$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-037030$AUROBINDO$Mostovaya M, Kalinchenko S, Vorslov. Statin Intake as a Cause of Decreased Steroid Hormone Secretion. Journal of the Endocrine Society. 2022;6 (1):A729$58$YR$$M$Y$$$20240729$$MD$US$US
241468391$24146839$1$I$20240101$20240716$20240729$20240729$EXP$$US-UCBSA-2024036304$UCB$$$$$F$Y$$$20240729$$HP$US$US
241468402$24146840$2$F$$20240801$20240729$20240802$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042278$BOEHRINGER INGELHEIM$$$$$$Y$$$20240802$$PH$JP$JP
241468411$24146841$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2024091226$GLAXOSMITHKLINE$$$$$M$Y$$$20240729$$CN$US$US
241468421$24146842$1$I$20240626$20240719$20240729$20240729$EXP$$US-Accord-438348$ACCORD$$21$YR$A$M$Y$$$20240729$$HP$US$US
241468432$24146843$2$F$20240701$20240730$20240729$20240819$PER$$US-AMGEN-USASP2024149550$AMGEN$$33$YR$A$F$Y$$$20240819$$CN$US$US
241468441$24146844$1$I$$20240722$20240729$20240729$EXP$$CA-APOTEX-2024AP008671$APOTEX$$50$YR$$F$Y$$$20240729$$HP$CA$CA
241468451$24146845$1$I$$20240717$20240729$20240729$EXP$$FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2024-019328$VALIDUS$$$$$$Y$$$20240729$$PH$FR$FR
241468471$24146847$1$I$20240301$20240719$20240729$20240729$EXP$$DE-JNJFOC-20240759943$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$CN$DE$DE
241468481$24146848$1$I$20240701$20240719$20240729$20240729$PER$$US-BAUSCHBL-2024BNL030453$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240729$$CN$US$US
241468491$24146849$1$I$20240701$20240719$20240729$20240729$PER$$US-BAUSCHBL-2024BNL030375$BAUSCH AND LOMB$$37$YR$$M$Y$$$20240729$$MD$US$US
241468501$24146850$1$I$$20240724$20240729$20240729$EXP$$US-ABBVIE-5854057$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241468512$24146851$2$F$20070901$20240821$20240729$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-036638$AUROBINDO$Yameogo TM et al.. Organ damage and prognosis during Lyell^s syndrome. Two case reports.. Lettres a la redaction/annales francaises d-anesthesia et de reanimation. 2010;29:592-598$21$YR$$M$Y$$$20240902$$MD$FR$FR
241468522$24146852$2$F$20231201$20240909$20240729$20240912$EXP$$JP-JNJFOC-20240503875$JOHNSON AND JOHNSON$$60$YR$A$M$Y$53.4$KG$20240912$$MD$JP$JP
241468531$24146853$1$I$$20230330$20240729$20240729$EXP$$US-AstraZeneca-2023A075885$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241468541$24146854$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069874$MYLAN$Pesantez M, Perez C, Gra S. The role of MEK inhibitors in papillary thyroid cancer: A case report. Thyroid 2023; 33 (1) A109-A110 abstr. POSTER 438.$$$A$M$Y$$$20240729$$HP$US$US
241468551$24146855$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069684$MYLAN$Shih J, Hamera L. Multiorgan Failure in the Aftermath of Pre-eclampsia With Intracerebral Hemorrhage and HELLP Syndrome. Am-J-Respir-Crit-Care-Med 2023; 207.$18$YR$$F$Y$$$20240729$$HP$US$US
241468561$24146856$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069676$MYLAN$Joshi A, Ghnaima H, Nader G, Alattal S. A Trifecta of Challenges: A Case Report of Triple Valve Endocarditis. Am-J-Respir-Crit-Care-Med 2024; 209 (0).$37$YR$$M$Y$$$20240729$$HP$US$US
241468571$24146857$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1070028$MYLAN$Mariano A, Muralidharan S, Beri A, Jain T. Ticagrelor^s arresting performance after elective PCI. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3324.$66$YR$$M$Y$$$20240729$$HP$US$US
241468581$24146858$1$I$$20240722$20240729$20240729$EXP$$ES-MYLANLABS-2024M1069674$MYLAN$Yanez DC, Ruano MTF, Perez MCC, Viergol Agrafojo EMD. Young male with pancoast tumor and severe neuropathic pain that improves with methadone. Eur-J-Case-Rep-Intern-Med 2022; 9 (Suppl. 1) 498.$48$YR$$M$Y$$$20240729$$HP$ES$ES
241468591$24146859$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069772$MYLAN$Riestra I, Carmona Porquera EM. Fibrocystic Sarcoidosis: Should Patients Be on Prophylaxis for Opportunistic Infections?. Am-J-Respir-Crit-Care-Med 2023; 207.$53$YR$$M$Y$$$20240729$$HP$US$US
241468601$24146860$1$I$$20240722$20240729$20240729$EXP$$PT-MYLANLABS-2024M1069692$MYLAN$Mosca AM, Garcia D, Martins JJ, Araujo R, E Silva AO. A case report of a complicated infective endocarditis. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl. 1) 461 abstr. 1042.$65$YR$$M$Y$$$20240729$$HP$PT$PT
241468611$24146861$1$I$$20240722$20240729$20240729$EXP$$IN-MYLANLABS-2024M1069673$MYLAN$Nagashiromani D, Vignesh M. Case series of methotrexate induced pancytopenia. Indian-J-Rheumatol 2023; 18 (Suppl. 2) S170-S171 (plus Poster) abstr. POS071.$$$$$Y$$$20240729$$HP$IN$IN
241468621$24146862$1$I$$20240722$20240729$20240729$EXP$$IN-MYLANLABS-2024M1069680$MYLAN$Nagashiromani D, Vignesh M. Case series of methotrexate induced pancytopenia. Indian-J-Rheumatol 2023; 18 (Suppl. 2) S170-S171 (plus Poster) abstr. POS071.$$$$$Y$$$20240729$$HP$IN$IN
241468632$24146863$2$F$20240101$20240722$20240729$20240808$EXP$$BR-ORGANON-O2407BRA002323$ORGANON$$$$$F$Y$$$20240808$$CN$BR$BR
241468651$24146865$1$I$$20240722$20240729$20240729$30DAY$$IT-SANDOZ INC.-SDZ2024IT068194$SANDOZ$$$$$F$Y$$$20240729$$CN$IT$IT
241468661$24146866$1$I$$20240717$20240729$20240729$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019323$VALIDUS$$$$$$Y$$$20240729$$CN$US$US
241468671$24146867$1$I$$20240716$20240729$20240729$EXP$$US-UCBSA-2024036349$UCB$$$$$M$Y$$$20240729$$HP$US$US
241468683$24146868$3$F$$20240917$20240729$20240918$PER$$US-ALXN-202407USA001536US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
241468691$24146869$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148822$AMGEN$$$$$M$Y$$$20240729$$HP$US$US
241468701$24146870$1$I$$20240714$20240729$20240729$EXP$$CN-ROCHE-10000040554$ROCHE$$40$YR$A$F$Y$$$20240729$$CN$CN$CN
241468711$24146871$1$I$$20240722$20240729$20240729$EXP$$DE-MYLANLABS-2024M1069670$MYLAN$Sahly AN, Sierra-Marquez J, Bungert-Plumke S, Franzen A, Mougharbel L, Berrahmoune S, et al. Genotype-phenotype correlation in CLCN4-related developmental and epileptic encephalopathy. Hum-Genet 2024; 143 667-681.$$$$M$Y$$$20240729$$HP$DE$DE
241468731$24146873$1$I$20240724$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51694$$FDA-CTU$$74$YR$$F$N$$$20240726$N$$US$
241468741$24146874$1$I$20240601$20240723$20240729$20240729$EXP$$US-AMGEN-USASP2024146716$AMGEN$$62$YR$A$M$Y$$$20240729$$CN$US$US
241468751$24146875$1$I$20240715$20240723$20240729$20240729$PER$$US-AMGEN-USASP2024147656$AMGEN$$$$$F$Y$52.608$KG$20240729$$CN$US$US
241468761$24146876$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069663$MYLAN$Pina FJR, Sottosanti E, Bulat E, Madabhushi S, Alrowaily F, Kollenburg L, et al. Prior Hypermobile Spinal Cord Stimulator Removal With Difficult Reimplantation due to Epidural Scarring Provides Relief in Postlaminectomy Syndrome. Pain-Med-Case-Rep 2024; 8 (2): 61-64.$$$$M$Y$$$20240729$$MD$US$US
241468771$24146877$1$I$20240701$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51724$$FDA-CTU$$65$YR$$F$N$$$20240726$N$PH$US$
241468781$24146878$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51734$$FDA-CTU$$70$YR$$F$N$$$20240726$N$$US$
241468791$24146879$1$I$20240711$20240726$20240726$20240726$DIR$711687$$FDA-CTU$$36$YR$$M$N$108.9$KG$20240726$N$CN$US$
241468801$24146880$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51692$$FDA-CTU$$43$YR$$F$N$$$20240726$N$$US$
241468811$24146881$1$I$$20240726$20240729$20240729$EXP$$CA-ABBVIE-5857277$ABBVIE$$$$A$F$Y$$$20240729$$CN$CA$CA
241468825$24146882$5$F$20231230$20240911$20240729$20240918$EXP$$NL-009507513-2407NLD012637$MERCK$$69$YR$$F$Y$64.6$KG$20240918$$MD$NL$NL
241468831$24146883$1$I$20240718$20240724$20240729$20240729$EXP$$CN-ROCHE-10000035530$ROCHE$$60$YR$A$F$Y$52$KG$20240729$$HP$CN$CN
241468841$24146884$1$I$20240701$20240716$20240729$20240729$EXP$$US-UCBSA-2024036388$UCB$$46$YR$$F$Y$$$20240729$$HP$US$US
241468851$24146885$1$I$20240725$20240725$20240729$20240729$PER$$US-ABBVIE-5854731$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241468861$24146886$1$I$20240401$20240724$20240729$20240729$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-119153$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$83$KG$20240729$$MD$PL$PL
241468871$24146887$1$I$20240701$20240717$20240729$20240729$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00381$XERIS PHARMACEUTICALS$$55$YR$$F$Y$$$20240726$$CN$US$US
241468881$24146888$1$I$$20240718$20240729$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-037031$AUROBINDO$Mostovaya M, Kalinchenko S, Vorslov. Statin Intake as a Cause of Decreased Steroid Hormone Secretion. Journal of the Endocrine Society. 2022;6 (1):A729$64$YR$$M$Y$$$20240729$$MD$US$US
241468891$24146889$1$I$$20240719$20240729$20240729$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092773$VIIV$$$$$$Y$$$20240729$$HP$US$US
241468901$24146890$1$I$$20240718$20240729$20240729$EXP$$US-AUROBINDO-AUR-APL-2024-037049$AUROBINDO$Cordero-garate J, Naranjo EPL, Godoy R, Jacome PC, Dominguez CM, P?rez CR et al.. Black Thyroid ? Is It a Benign or a Malignant Finding?: A Case Report and Review of the Literatur. Journal of the Endocrine Society. 2022;Vol 6, supl (1):A816,A817$30$YR$$F$Y$$$20240729$$MD$US$US
241468911$24146891$1$I$20240301$20240723$20240729$20240729$EXP$$UA-REGENERON PHARMACEUTICALS, INC.-2024-103591$REGENERON$$$$$$Y$$$20240729$$CN$UA$UA
241468921$24146892$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51737$$FDA-CTU$$24$YR$$M$N$$$20240726$N$$US$
241468931$24146893$1$I$$20240726$20240726$20240726$DIR$711691$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241468941$24146894$1$I$20240711$20240718$20240729$20240729$EXP$$JP-ROCHE-10000034725$ROCHE$$$$$F$Y$$$20240729$$HP$JP$JP
241468951$24146895$1$I$$20240724$20240729$20240729$EXP$$HU-MYLANLABS-2024M1069352$MYLAN$$3$MON$$M$Y$$$20240729$$HP$HU$HU
241468961$24146896$1$I$$20240725$20240729$20240729$EXP$$JP-ABBVIE-5853629$ABBVIE$$47$YR$$F$Y$$$20240729$$MD$JP$JP
241468971$24146897$1$I$20240726$20240726$20240726$20240726$DIR$711686$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241468991$24146899$1$I$$20240715$20240729$20240729$EXP$$AU-LUPIN HEALTHCARE (UK) LIMITED-2024-07236$LUPIN$$$$$$Y$$$20240729$$CN$AU$AU
241469001$24146900$1$I$20240703$20240703$20240729$20240729$PER$$US-CSL-2024-006555$CSL Plasma$$24$YR$$M$Y$$$20240729$$HP$US$US
241469011$24146901$1$I$20240724$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024149137$AMGEN$$$$A$F$Y$$$20240729$$PH$US$US
241469021$24146902$1$I$20240301$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149287$AMGEN$$54$YR$A$F$Y$$$20240729$$CN$US$US
241469031$24146903$1$I$$20240718$20240729$20240729$EXP$$IN-RDY-LIT/IND/24/0010942$DR REDDYS$Paturu R, Lingaiah R, Singh S, Kumari N, Krishnani N. A Case of Dynamic Molecular Profile in Metastatic Lung Adenocarcinoma and the Significance of Multiple-site Testing. Asia Pacific Journal of Cancer Biology. 2024;9(2): 247-250. doi:10.31557/APJCB.2024.9.2.247.$30$YR$A$M$Y$$$20240729$$HP$IN$IN
241469042$24146904$2$F$$20240726$20240729$20240807$EXP$$NL-AUROBINDO-AUR-APL-2024-035956$AUROBINDO$Dorsthorst-Maas MT, Vissers YLJ, Grupa NM, Deben DS, Boselie TFM.. Bupivacaine pleural effusion mimicking a hemothorax after a thoracoscopic microdiscectomy with epidural anesthesia. Acta Neurochirurgica. 2024;166:284$42$YR$$F$Y$$$20240807$$MD$NL$NL
241469051$24146905$1$I$20240614$20240722$20240729$20240729$EXP$$CN-BAYER-2024A106349$BAYER$$63$YR$A$M$Y$53$KG$20240729$$HP$CN$CN
241469061$24146906$1$I$$20240725$20240729$20240729$EXP$GB-MHRA-MED-202407251356400930-ZGKRJ$GB-MYLANLABS-2024M1069885$MYLAN$$65$YR$$M$Y$83$KG$20240729$$CN$GB$GB
241469071$24146907$1$I$20210918$20240725$20240729$20240729$EXP$$KR-MYLANLABS-2024M1069657$MYLAN$$73$YR$$M$Y$57.4$KG$20240729$$MD$KR$KR
241469081$24146908$1$I$20240503$20240717$20240729$20240729$EXP$$GB-AUROBINDO-AUR-APL-2024-035756$AUROBINDO$$50$YR$$M$Y$98$KG$20240729$$CN$GB$GB
241469091$24146909$1$I$20240201$20240718$20240729$20240729$EXP$$DE-AUROBINDO-AUR-APL-2024-036727$AUROBINDO$$$$$M$Y$$$20240729$$CN$DE$DE
241469102$24146910$2$F$$20240827$20240729$20240829$EXP$$NVSC2024CA153802$NOVARTIS$$59$YR$$F$Y$$$20240829$$CN$CA$CA
241469111$24146911$1$I$$20240724$20240729$20240729$PER$$US-ALXN-202407USA001786US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241469121$24146912$1$I$$20240722$20240729$20240729$EXP$$PT-009507513-2407PRT014016$MERCK$$80$YR$$M$Y$$$20240729$$MD$PT$PT
241469131$24146913$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016924$ELI LILLY AND CO$$66$YR$E$$Y$$$20240729$$CN$US$US
241469144$24146914$4$F$20220401$20240828$20240729$20240907$EXP$$PT-AUROBINDO-AUR-APL-2024-037265$AUROBINDO$Henriques C, Melo J, Vasconcelos S, Ramos R, Costa MM.. INFE??ES RESPIRAT?RIAS: QUANDO AS APAR?NCIAS ILUDEM (RESPIRATORY INFECTIONS: WHEN APPEARANCES DECEIVE). Doen?as respirat?rias (Respiratory diseases). 2024;30(Sup 1 ):905$60$YR$$F$Y$$$20240907$$MD$PT$PT
241469151$24146915$1$I$20240718$20240722$20240729$20240729$EXP$$CA-PFIZER INC-PV202400096666$PFIZER$$18$YR$$M$Y$$$20240729$$HP$CA$CA
241469161$24146916$1$I$20240720$20240725$20240729$20240729$EXP$$CN-PFIZER INC-PV202400097517$PFIZER$$28$YR$$F$Y$97$KG$20240729$$HP$CN$CN
241469171$24146917$1$I$$20240723$20240729$20240729$EXP$$JP-PFIZER INC-PV202400096744$PFIZER$$$$$$Y$$$20240729$$MD$JP$JP
241469181$24146918$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016862$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240729$$CN$US$US
241469191$24146919$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017157$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240729$$CN$US$US
241469204$24146920$4$F$20240701$20240906$20240729$20240910$30DAY$$US-PFIZER INC-202400219796$PFIZER$$4$YR$$M$Y$14.97$KG$20240910$$CN$US$US
241469211$24146921$1$I$$20240723$20240729$20240729$EXP$$PT-PFIZER INC-202400221671$PFIZER$$57$YR$$M$Y$$$20240729$$MD$PT$PT
241469221$24146922$1$I$20240712$20240724$20240729$20240729$EXP$$CN-PFIZER INC-PV202400096818$PFIZER$$66$YR$$M$Y$$$20240729$$HP$CN$CN
241469231$24146923$1$I$20240622$20240723$20240729$20240729$EXP$FR-AFSSAPS-GR2024000921$FR-PFIZER INC-202400221703$PFIZER$$70$YR$$M$Y$79$KG$20240729$$PH$FR$FR
241469241$24146924$1$I$$20240711$20240729$20240729$EXP$$NVSC2024CA153619$NOVARTIS$$43$YR$$F$Y$68$KG$20240729$$HP$CA$CA
241469251$24146925$1$I$$20240724$20240729$20240729$EXP$$US-PFIZER INC-202400223796$PFIZER$$25$YR$$F$Y$$$20240729$$HP$US$US
241469263$24146926$3$F$20240606$20240909$20240729$20240910$EXP$$US-PFIZER INC-PV202400097139$PFIZER$$89$YR$$M$Y$$$20240910$$HP$US$MW
241469271$24146927$1$I$$20240724$20240729$20240729$EXP$$US-PFIZER INC-202400222995$PFIZER$$$$$M$Y$$$20240729$$HP$US$US
241469281$24146928$1$I$$20240724$20240729$20240729$EXP$$DZ-PFIZER INC-202400224576$PFIZER$$$$$F$Y$$$20240729$$MD$DZ$DZ
241469292$24146929$2$F$20240701$20240825$20240729$20240826$30DAY$$US-PFIZER INC-202400216942$PFIZER$$8$YR$$M$Y$$$20240826$$HP$US$US
241469301$24146930$1$I$$20240724$20240729$20240729$EXP$$SK-PFIZER INC-PV202400097175$PFIZER$$24$YR$$F$Y$$$20240729$$MD$SK$SK
241469311$24146931$1$I$$20240724$20240729$20240729$EXP$$DZ-PFIZER INC-202400223846$PFIZER$$$$$F$Y$$$20240729$$MD$DZ$DZ
241469321$24146932$1$I$$20240724$20240729$20240729$EXP$$DZ-PFIZER INC-202400224577$PFIZER$$$$$F$Y$$$20240729$$MD$DZ$DZ
241469331$24146933$1$I$20240701$20240723$20240729$20240729$EXP$$IN-PFIZER INC-PV202400096775$PFIZER$$76$YR$$F$Y$64.6$KG$20240729$$CN$IN$IN
241469341$24146934$1$I$$20240724$20240729$20240729$EXP$$US-PFIZER INC-202400224000$PFIZER$$76$YR$$F$Y$$$20240729$$HP$US$US
241469352$24146935$2$F$$20240825$20240729$20240826$30DAY$$US-PFIZER INC-202400220223$PFIZER$$29$YR$$F$Y$$$20240826$$CN$US$US
241469361$24146936$1$I$$20240724$20240729$20240729$EXP$$US-PFIZER INC-PV202400097861$PFIZER$$56$YR$$F$Y$$$20240729$$HP$US$US
241469372$24146937$2$F$20210317$20240831$20240729$20240902$EXP$$FR-PFIZER INC-2021SGN02205$PFIZER$$50$YR$$F$Y$126$KG$20240902$$MD$FR$FR
241469381$24146938$1$I$20150701$20240724$20240729$20240729$EXP$$CA-PFIZER INC-202400223740$PFIZER$$55$YR$$F$Y$$$20240729$$HP$CA$CA
241469401$24146940$1$I$20240717$20240725$20240726$20240726$DIR$FDA-CDER-CTU-2024-51714$$FDA-CTU$$57$YR$$F$N$$$20240725$N$HP$US$
241469411$24146941$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51697$$FDA-CTU$$68$YR$$M$N$$$20240726$N$$US$
241469421$24146942$1$I$20240601$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51733$$FDA-CTU$$59$YR$$F$N$$$20240726$Y$$US$
241469432$24146943$2$F$20240304$20240729$20240729$20240731$EXP$$NZ-MYLANLABS-2024M1020882$MYLAN$$94$YR$$M$Y$$$20240731$$CN$NZ$NZ
241469441$24146944$1$I$$20240725$20240729$20240729$EXP$$US-GILEAD-2024-0678286$GILEAD$$$$A$F$Y$$$20240729$$CN$US$US
241469451$24146945$1$I$20131201$20240718$20240729$20240729$EXP$$FR-AUROBINDO-AUR-APL-2024-036998$AUROBINDO$$58$YR$$M$Y$66$KG$20240729$$MD$FR$FR
241469461$24146946$1$I$20240725$20240725$20240729$20240729$PER$$US-GILEAD-2024-0682046$GILEAD$$80$YR$E$M$Y$$$20240729$$CN$US$US
241469471$24146947$1$I$$20240723$20240729$20240729$EXP$$US-ASTELLAS-2024US021188$ASTELLAS$$$$$M$Y$$$20240729$$CN$US$US
241469491$24146949$1$I$20240101$20240723$20240729$20240729$EXP$$US-RIGEL-20240700094$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241469501$24146950$1$I$$20240718$20240729$20240729$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240700101$RIGEL PHARMACEUTICALS$$$$$$Y$$$20240729$$PH$JP$JP
241469511$24146951$1$I$20231019$20240722$20240729$20240729$EXP$GB-MHRA-ADR 28597003$GB-MYLANLABS-2024M1024147$MYLAN$$70$YR$$F$Y$60.09$KG$20240729$$MD$GB$GB
241469521$24146952$1$I$$20240719$20240729$20240729$EXP$$JP-009507513-2407JPN003971J$MERCK$$7$DEC$$F$Y$$$20240729$$MD$JP$JP
241469531$24146953$1$I$$20240718$20240729$20240729$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240700100$RIGEL PHARMACEUTICALS$$43$YR$$F$Y$$$20240729$$PH$JP$JP
241469552$24146955$2$F$20240520$20240915$20240729$20240916$EXP$$US-PFIZER INC-202400222268$PFIZER$$16$MON$$F$Y$$$20240916$$CN$US$US
241469562$24146956$2$F$$20240828$20240729$20240828$30DAY$$US-PFIZER INC-202400217554$PFIZER$$6$YR$$F$Y$$$20240828$$CN$US$US
241469571$24146957$1$I$$20240725$20240729$20240729$EXP$$CA-TAKEDA-2023TUS081141$TAKEDA$$$$$M$Y$$$20240729$$HP$CA$CA
241469581$24146958$1$I$20240704$20240723$20240729$20240729$EXP$$US-ASTELLAS-2024US021275$ASTELLAS$$45$YR$$M$Y$$$20240729$$CN$US$US
241469591$24146959$1$I$$20240723$20240729$20240729$EXP$US-MLMSERVICE-20240723-PI125181-00073-5$US-RDY-SPO/USA/24/0010974$DR REDDYS$Kumar P, Kaliamurthy S, Thomas J. Initiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments. Pediatrics. 2024;154(2):e2024066226. DOI:10.1542/peds.2024-066226.$16$YR$T$M$Y$$$20240729$$MD$US$US
241469604$24146960$4$F$20240318$20240809$20240729$20240816$EXP$$US-TAKEDA-2023TUS115394$TAKEDA$$67$YR$$F$Y$58$KG$20240816$$CN$US$US
241469611$24146961$1$I$$20240722$20240729$20240729$PER$$US-ALXN-202407USA001518US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241469621$24146962$1$I$$20240722$20240729$20240729$PER$$US-ALXN-202407USA001533US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
241469631$24146963$1$I$$20240506$20240729$20240729$PER$$US-ALXN-202405USA002362US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241469641$24146964$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51725$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241469651$24146965$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51687$$FDA-CTU$$39$YR$$F$N$$$20240726$N$$US$
241469671$24146967$1$I$20230715$20240523$20240729$20240729$EXP$$NVSC2024RU153062$NOVARTIS$$62$YR$$F$Y$$$20240729$$MD$RU$RU
241469681$24146968$1$I$20240101$20240724$20240729$20240729$EXP$$NVSC2024BR153869$NOVARTIS$$$$$M$Y$$$20240729$$CN$BR$BR
241469691$24146969$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149495$AMGEN$$$$E$F$Y$$$20240729$$HP$US$US
241469701$24146970$1$I$$20240723$20240729$20240729$EXP$$IE-TAKEDA-2024TUS075899$TAKEDA$$$$$$Y$$$20240729$$MD$IE$IE
241469711$24146971$1$I$20240720$20240726$20240729$20240729$EXP$$CN-ROCHE-10000040257$ROCHE$$60$YR$A$F$Y$61.5$KG$20240729$$HP$CN$CN
241469721$24146972$1$I$20240515$20240718$20240729$20240729$EXP$$ES-AUROBINDO-AUR-APL-2024-036330$AUROBINDO$$4$YR$$F$Y$$$20240729$$MD$ES$ES
241469731$24146973$1$I$$20240718$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115524$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240729$$CN$US$US
241469741$24146974$1$I$$20240724$20240729$20240729$PER$$US-LEO Pharma-372323$LEO PHARM$$79$YR$$F$Y$$$20240729$$PH$US$US
241469751$24146975$1$I$20221006$20240122$20240729$20240729$EXP$$CA-CELLTRION INC.-2022CA022630$CELLTRION$$$$$$Y$$$20240729$$MD$CA$CA
241469761$24146976$1$I$$20240724$20240729$20240729$EXP$$IT-AMGEN-ITASP2024148670$AMGEN$Fruscio R.; Bianchi T.; Grassi T. et al.. The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis. European Journal of Surgical Oncology. 2024;50 (9):1-7$$$$$Y$$$20240729$$HP$IT$IT
241469771$24146977$1$I$20240101$20240719$20240729$20240729$EXP$FR-AFSSAPS-MP2024001146$FR-TEVA-VS-3223604$TEVA$$33$YR$$F$Y$$$20240729$$MD$FR$FR
241469781$24146978$1$I$20231204$20240719$20240729$20240729$EXP$ES-AEMPS-1544954$ES-TEVA-VS-3223854$TEVA$$77$YR$$F$Y$$$20240729$$MD$ES$ES
241469792$24146979$2$F$20240625$20240731$20240729$20240802$PER$$US-AMGEN-USASP2024148996$AMGEN$$66$YR$E$F$Y$$$20240802$$CN$US$US
241469801$24146980$1$I$$20240724$20240729$20240729$EXP$$US-BAYER-2024A107683$BAYER$$67$YR$E$F$Y$$$20240729$$CN$US$US
241469811$24146981$1$I$20240101$20240719$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007646$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241469831$24146983$1$I$$20240715$20240729$20240729$EXP$$PT-TEVA-VS-3223097$TEVA$Zanga AG, Duarte M, Monteiro M, Pereira BS, Aldomiro F. DRUG-INDUCED LIVER INJURY: A CLINICAL CASE. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 1068.$63$YR$$M$Y$$$20240729$$MD$PT$PT
241469841$24146984$1$I$20240712$20240717$20240729$20240729$EXP$$CN-GE HEALTHCARE-2024CSU008198$GE HEALTHCARE$$55$YR$$F$Y$55$KG$20240729$$HP$CN$CN
241469851$24146985$1$I$20240629$20240629$20240729$20240729$EXP$$CN-GE HEALTHCARE-2024CSU008476$GE HEALTHCARE$$60$YR$$F$Y$$$20240729$$HP$CN$CN
241469861$24146986$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51727$$FDA-CTU$$53$YR$$F$N$$$20240726$N$$US$
241469871$24146987$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51726$$FDA-CTU$$20$YR$$F$N$$$20240726$N$$US$
241469881$24146988$1$I$$20240726$20240726$20240726$DIR$711705$$FDA-CTU$$$$$F$N$96.3$KG$20240726$N$CN$US$
241469891$24146989$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51698$$FDA-CTU$$71$YR$$M$N$$$20240726$N$$US$
241469901$24146990$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51739$$FDA-CTU$$30$YR$$M$N$$$20240726$N$$US$
241469911$24146991$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51735$$FDA-CTU$$46$YR$$F$N$84.82$KG$20240726$N$$US$
241469931$24146993$1$I$20240726$20240726$20240726$20240726$DIR$711697$$FDA-CTU$$65$YR$$F$N$92.25$KG$20240726$N$HP$US$
241469951$24146995$1$I$$20240715$20240729$20240729$EXP$$IL-TEVA-VS-3224484$TEVA$Kian W, Krayim B, Alsana H, Giles B, Purim O, Alguayn W, et al. Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib. Front-Oncol 2023; 13 no pagination.; Kian W, Krayim B, Alsana H, Giles B, Purim O, Alguayn W, et al. Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib. Front-Oncol 2023; 13 no pagination.$75$YR$$F$Y$$$20240729$$HP$IL$IL
241469962$24146996$2$F$$20240801$20240729$20240806$EXP$$US-TAKEDA-2024TUS074541$TAKEDA$$$$$M$Y$$$20240806$$CN$US$US
241469972$24146997$2$F$$20240815$20240729$20240827$PER$$US-INCYTE CORPORATION-2024IN007638$INCYTE$$$$$$Y$$$20240827$$HP$US$US
241469981$24146998$1$I$20240618$20240725$20240729$20240729$EXP$$CN-ROCHE-10000038119$ROCHE$$41$YR$A$F$Y$55.5$KG$20240729$$HP$CN$CN
241469991$24146999$1$I$$20240723$20240729$20240729$EXP$$US-ABBVIE-5854790$ABBVIE$$$$$F$Y$$$20240729$$MD$US$US
241470022$24147002$2$F$$20240723$20240729$20240730$30DAY$$US-PFIZER INC-202400219921$PFIZER$$13$YR$$M$Y$$$20240730$$CN$US$US
241470033$24147003$3$F$$20240828$20240729$20240828$30DAY$$US-PFIZER INC-202400219169$PFIZER$$10$YR$$F$Y$$$20240828$$CN$US$US
241470042$24147004$2$F$$20240828$20240729$20240828$30DAY$$US-PFIZER INC-202400217927$PFIZER$$15$YR$$M$Y$$$20240828$$CN$US$US
241470051$24147005$1$I$$20240722$20240729$20240729$30DAY$$US-PFIZER INC-202400221777$PFIZER$$5$YR$$M$Y$$$20240729$$CN$US$US
241470061$24147006$1$I$$20240725$20240729$20240729$EXP$$US-MYLANLABS-2024M1042045$MYLAN$$$$$F$Y$77.11$KG$20240729$$CN$US$US
241470071$24147007$1$I$$20240724$20240729$20240729$EXP$$US-TAKEDA-2024TUS075479$TAKEDA$$$$$F$Y$$$20240729$$CN$US$US
241470082$24147008$2$F$20181011$20240918$20240729$20240923$EXP$$CA-TAKEDA-2024TUS075406$TAKEDA$$43$YR$$F$Y$$$20240923$$CN$CA$CA
241470092$24147009$2$F$$20240726$20240729$20240801$EXP$$CA-TAKEDA-2024TUS074788$TAKEDA$$$$$F$Y$$$20240801$$CN$CA$CA
241470101$24147010$1$I$$20240725$20240729$20240729$EXP$$US-TAKEDA-2023TUS046277$TAKEDA$$$$$M$Y$$$20240729$$CN$US$US
241470112$24147011$2$F$$20240924$20240729$20240930$EXP$$FR-SA-2024SA219011$SANOFI AVENTIS$$63$YR$A$M$Y$60$KG$20240930$$MD$FR$FR
241470124$24147012$4$F$20221101$20240920$20240729$20240926$EXP$$CZ-SA-2024SA215599$SANOFI AVENTIS$Celakovska J, Boudkova P, Wertzova V, Cakova L.. Ramsay Hunt syndrome in atopic dermatitis patient treated with dupilumab.. International Immunopharmacology.. 2024;136:1-3$45$YR$A$F$Y$$$20240926$$HP$CZ$CZ
241470131$24147013$1$I$$20240722$20240729$20240729$EXP$$US-ADC THERAPEUTICS SA-ADC-2024-000248$ADC THERAPEUTICS$$$$$M$Y$$$20240729$$CN$US$US
241470142$24147014$2$F$20240722$20240730$20240729$20240803$EXP$$CA-ROCHE-10000035536$ROCHE$$69$YR$E$M$Y$$$20240803$$PH$CA$CA
241470151$24147015$1$I$$20240716$20240729$20240729$PER$$US-TEVA-VS-3221854$TEVA$$$$E$F$Y$$$20240729$$CN$US$US
241470161$24147016$1$I$20240715$20240724$20240729$20240729$EXP$$BR-BAYER-2024A108333$BAYER$$10$YR$C$F$Y$$$20240729$$CN$BR$BR
241470172$24147017$2$F$20220518$20220601$20240729$20240902$EXP$$CA-CELLTRION INC.-2022CA022634$CELLTRION$$$$$$Y$$$20240902$$MD$CA$CA
241470183$24147018$3$F$$20240911$20240729$20240927$30DAY$$US-BECTON DICKINSON-US-BD-24-000464$BECTON DICKINSON$$$$$$Y$$$20240927$$HP$US$US
241470191$24147019$1$I$20240609$20240723$20240729$20240729$EXP$$US-ABBVIE-5855083$ABBVIE$$78$YR$$F$Y$$$20240729$$CN$US$US
241470201$24147020$1$I$$20240723$20240729$20240729$EXP$$US-SA-2024SA218101$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240729$$CN$US$US
241470221$24147022$1$I$$20240716$20240729$20240729$EXP$$US-BAYER-2024A104848$BAYER$Mingyue Luo,Lu Sun,Rongping Dai,Youxin Chen,+Chan Wu.. Central retinal vein occlusion in patients with metastatic solid tumors on tyrosine kinase inhibitors: a report of case series and literature review. Frontiers in Medicine. 2024$65$YR$E$M$Y$$$20240729$$HP$US$US
241470232$24147023$2$F$$20240815$20240729$20240819$PER$$US-ALXN-202407USA001483US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241470241$24147024$1$I$20190101$20240723$20240729$20240729$EXP$RO-EMA-DD-20240717-7482661-101258$RO-SA-2024SA217633$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240729$$MD$RO$RO
241470251$24147025$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51731$$FDA-CTU$$45$YR$$M$N$$$20240726$N$$US$
241470263$24147026$3$F$$20240911$20240729$20240930$30DAY$$US-BECTON DICKINSON-US-BD-24-000465$BECTON DICKINSON$$$$$$Y$$$20240930$$HP$US$US
241470271$24147027$1$I$20240611$20240725$20240729$20240729$EXP$$CN-ROCHE-10000038186$ROCHE$$37$YR$A$F$Y$$$20240729$$HP$CN$CN
241470281$24147028$1$I$$20240725$20240729$20240729$EXP$$US-MYLANLABS-2024M1070316$MYLAN$Beesley S, Lanspa MJ. Calcium Channel Overdose and Insulin Therapy Dosing. Am-J-Respir-Crit-Care-Med 2024; 209.$28$YR$$M$Y$$$20240729$$HP$US$US
241470301$24147030$1$I$20240101$20240719$20240729$20240729$EXP$$JP-009507513-2405JPN002935J$MERCK$$67$YR$$F$Y$$$20240729$$MD$JP$JP
241470311$24147031$1$I$20240725$20240726$20240726$20240726$DIR$711676$$FDA-CTU$$46$YR$$F$N$81$KG$20240726$Y$CN$US$
241470321$24147032$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51703$$FDA-CTU$$87$YR$$M$N$$$20240726$N$$US$
241470341$24147034$1$I$$20240726$20240729$20240729$PER$$US-HALEON-2189382$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241470352$24147035$2$F$20231201$20240814$20240729$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-090275$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240822$$CN$US$US
241470361$24147036$1$I$$20240718$20240729$20240729$EXP$$AU-Atnahs Limited-ATNAHS20240702122$Atnahs Healthcare$$$$$$Y$$$20240729$$HP$AU$AU
241470371$24147037$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51709$$FDA-CTU$$83$YR$$F$N$$$20240726$N$$US$
241470381$24147038$1$I$20240717$20240726$20240726$20240726$DIR$711724$$FDA-CTU$$85$YR$$F$N$75.15$KG$20240726$N$CN$US$
241470391$24147039$1$I$$20240726$20240726$20240726$DIR$711680$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241470402$24147040$2$F$20240711$20240819$20240729$20240823$30DAY$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115949$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240823$$CN$US$US
241470411$24147041$1$I$$20240722$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116683$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240729$$CN$US$US
241470422$24147042$2$F$$20240729$20240729$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407016897$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240731$$CN$US$US
241470431$24147043$1$I$20230104$20240715$20240729$20240729$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407014850$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240729$$PH$CN$CN
241470441$24147044$1$I$20240701$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017709$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240729$$CN$US$US
241470451$24147045$1$I$$20240726$20240726$20240726$DIR$711694$$FDA-CTU$$93$YR$$F$N$52.1$KG$20240726$N$PH$US$
241470461$24147046$1$I$$20240722$20240729$20240729$EXP$$US-BEH-2024176199$CSL BEHRING$$$$A$M$Y$$$20240729$$CN$US$US
241470471$24147047$1$I$20240101$20240717$20240729$20240729$EXP$$US-ALKERMES INC.-ALK-2024-001928$ALKERMES$$$$$M$Y$$$20240729$$CN$US$US
241470481$24147048$1$I$$20240719$20240729$20240729$EXP$DE-BFARM-24004918$DE-TEVA-VS-3223593$TEVA$$$$A$F$Y$64$KG$20240729$$MD$DE$DE
241470491$24147049$1$I$$20240722$20240729$20240729$PER$$US-ROCHE-10000038533$ROCHE$Kim K, Ziyeh S, Kim P. Extranodal diffuse large B-cell lymphoma presenting with extensive organ involvement. BMJ Case Reports. 2024-Jun-30;17 (6):1-4. doi:10.1136/bcr-2023-257416.$$$$F$Y$$$20240729$$HP$US$US
241470501$24147050$1$I$20240624$20240724$20240729$20240729$EXP$$CN-ROCHE-10000035901$ROCHE$$41$YR$A$F$Y$50$KG$20240729$$HP$CN$CN
241470511$24147051$1$I$20240723$20240725$20240729$20240729$EXP$$AU-MYLANLABS-2024M1069272$MYLAN$$58$YR$$M$Y$$$20240729$$HP$AU$AU
241470531$24147053$1$I$20231020$20240725$20240729$20240729$EXP$$HU-MYLANLABS-2024M1069745$MYLAN$$12$YR$$M$Y$$$20240729$$HP$HU$HU
241470541$24147054$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154271$NOVARTIS$$$$$$Y$$$20240729$$PH$US$US
241470551$24147055$1$I$20240701$20240719$20240729$20240729$EXP$FR-AFSSAPS-CN2024000683$FR-TEVA-VS-3223584$TEVA$$89$YR$$M$Y$58.1$KG$20240729$$PH$FR$FR
241470561$24147056$1$I$$20240718$20240729$20240729$EXP$$CA-Atnahs Limited-ATNAHS20240702116$Atnahs Healthcare$$7$YR$C$M$Y$$$20240729$$MD$CA$CA
241470571$24147057$1$I$$20240725$20240729$20240729$PER$$US-HALEON-2189307$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241470581$24147058$1$I$$20240711$20240729$20240729$PER$$US-BAYER-2024A108363$BAYER$Pokhriyal SC; Tan EF; Bhatt PK; Khan AA; Pasha MN; Pierre L et al. Assay Interference Causing Persistently Elevated Vancomycin Levels Leading to Treatment Failure and Fatal Outcome. ~Cureus. 2024;16(6):e61943$69$YR$E$F$Y$$$20240729$$HP$US$US
241470591$24147059$1$I$$20240716$20240729$20240729$EXP$$AU-TEVA-VS-3222799$TEVA$$78$YR$$F$Y$$$20240729$$HP$AU$AU
241470601$24147060$1$I$20240330$20240724$20240729$20240729$EXP$$CA-BEH-2024176415$CSL BEHRING$$70$YR$E$M$Y$90.703$KG$20240729$$CN$CA$CA
241470611$24147061$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148490$AMGEN$$$$$M$Y$$$20240729$$CN$US$US
241470621$24147062$1$I$$20240724$20240729$20240729$EXP$$US-ABBVIE-5852407$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241470631$24147063$1$I$20230414$20240719$20240729$20240729$EXP$FR-AFSSAPS-TO2024001217$FR-TEVA-VS-3223797$TEVA$$69$YR$$F$Y$$$20240729$$PH$FR$FR
241470641$24147064$1$I$20240723$20240726$20240726$20240726$DIR$711678$$FDA-CTU$$73$YR$$UNK$N$67.5$KG$20240726$N$MD$US$
241470651$24147065$1$I$20240726$20240727$20240727$20240727$DIR$FDA-CDER-CTU-2024-51718$$FDA-CTU$$30$YR$$F$N$$$20240727$Y$HP$US$
241470661$24147066$1$I$20240717$20240726$20240726$20240726$DIR$711722$$FDA-CTU$$66$YR$$F$N$$$20240726$N$HP$US$
241470671$24147067$1$I$$20240718$20240729$20240729$EXP$$US-MYLANLABS-2024M1068053$MYLAN$Rozenbaum Lerner G, Villamizar JP, Pelaez A, Salgado JC. Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$68$YR$$M$Y$$$20240729$$HP$US$US
241470681$24147068$1$I$$20240718$20240729$20240729$EXP$$US-MYLANLABS-2024M1068854$MYLAN$Cheng TW, Colakovic RN, Pearson DR, Sio TT, Fiessinger LA. Treatment of sclerotic chronic graft-versus-host disease with injections of hyaluronidase. JAAD-Case-Rep 2023; 38 55-58.$35$YR$$M$Y$$$20240729$$MD$US$US
241470691$24147069$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069422$MYLAN$Woods HB, Bharathidasan K, Yang M, Nichols J, Nugent K. Delayed onset graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency virus: a case series. Am-J-Med-Sci 2024; 367 (Suppl. 1) S9-S10.$49$YR$$M$Y$$$20240729$$HP$US$US
241470701$24147070$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069686$MYLAN$Carranza Morales A, Blanco Jimenez JA, Madhavan A. A Painful Case of Asthma. Am-J-Respir-Crit-Care-Med 2024; 209.$43$YR$$F$Y$$$20240729$$HP$US$US
241470711$24147071$1$I$$20240722$20240729$20240729$EXP$$IN-MYLANLABS-2024M1069652$MYLAN$Nagashiromani D, Vignesh M. Case series of methotrexate induced pancytopenia. Indian-J-Rheumatol 2023; 18 (Suppl. 2) S170-S171 (plus Poster) abstr. POS071.$$$$$Y$$$20240729$$HP$IN$IN
241470721$24147072$1$I$20240618$20240719$20240729$20240729$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14535$IPSEN$$63$YR$A$F$Y$59.7$KG$20240729$$HP$US$US
241470731$24147073$1$I$$20240722$20240729$20240729$EXP$$DK-MYLANLABS-2024M1069651$MYLAN$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic-Sci-Int 2009; 184 (1-3): 74-79.$48$YR$$F$Y$$$20240729$$HP$DK$DK
241470751$24147075$1$I$$20240719$20240729$20240729$EXP$$FR-TEVA-VS-3224310$TEVA$$$$$$Y$$$20240729$$MD$FR$FR
241470761$24147076$1$I$20240129$20240723$20240729$20240729$EXP$FR-AFSSAPS-GR2024000933$FR-Waylis Therapeutics LLC-ATNAHS20240702114$Waylis$$23$YR$A$M$Y$$$20240729$$MD$FR$FR
241470771$24147077$1$I$20240701$20240723$20240729$20240729$EXP$$CA-Eisai-EC-2024-170336$EISAI$$65$YR$E$F$Y$$$20240729$$CN$CA$CA
241470781$24147078$1$I$20240101$20240725$20240729$20240729$EXP$$CN-BAYER-2024A108047$BAYER$$$$$M$Y$$$20240729$$CN$CN$CN
241470793$24147079$3$F$$20240913$20240729$20240923$PER$$US-GSK-US2024AMR091432$GLAXOSMITHKLINE$$$$$M$Y$$$20240923$$CN$US$US
241470801$24147080$1$I$$20240726$20240729$20240729$EXP$$TW-AstraZeneca-2024A171207$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$TW$
241470811$24147081$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119165$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240729$$PH$US$US
241470821$24147082$1$I$$20240726$20240726$20240726$DIR$711689$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241470831$24147083$1$I$20150101$20240725$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118582$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240729$$CN$US$US
241470841$24147084$1$I$20240701$20240722$20240729$20240729$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-117636$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$60$KG$20240729$$CN$DE$DE
241470851$24147085$1$I$20240701$20240718$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115373$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$63.5$KG$20240729$$CN$US$US
241470861$24147086$1$I$$20240711$20240729$20240729$PER$$US-TEVA-VS-3225469$TEVA$$57$YR$$F$Y$$$20240729$$PH$US$US
241470871$24147087$1$I$20240704$20240715$20240729$20240729$EXP$FR-AFSSAPS-LL2024001311$FR-SERVIER-S24009175$SERVIER$$$$$$Y$$$20240729$$MD$FR$FR
241470881$24147088$1$I$$20240718$20240729$20240729$EXP$$JP-AMGEN-JPNSP2024149286$AMGEN$$$$$F$Y$$$20240729$$MD$JP$JP
241470891$24147089$1$I$$20240722$20240729$20240729$EXP$$NVSC2024SA123342$NOVARTIS$$55$YR$$M$Y$$$20240729$$MD$SA$SA
241470901$24147090$1$I$20240617$20240725$20240729$20240729$EXP$$US-AMGEN-USASP2024148493$AMGEN$$80$YR$E$M$Y$$$20240729$$CN$US$US
241470911$24147091$1$I$$20240725$20240729$20240729$PER$$NVSC2024US153977$NOVARTIS$$$$$M$Y$$$20240729$$CN$US$US
241470921$24147092$1$I$$20240719$20240729$20240729$EXP$$JP-009507513-2407JPN004159J$MERCK$$81$YR$$F$Y$$$20240729$$MD$JP$JP
241470931$24147093$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024091816$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241470941$24147094$1$I$20240101$20240723$20240729$20240729$EXP$$US-ABBVIE-5856307$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241470952$24147095$2$F$20240703$20240905$20240729$20240913$EXP$$AU-TOLMAR, INC.-24AU050848$TOLMAR$$76$YR$$M$Y$$$20240913$$HP$AU$AU
241470961$24147096$1$I$$20240708$20240729$20240729$PER$$AU-TOLMAR, INC.-24AU050859$TOLMAR$$$$$M$Y$$$20240726$$CN$AU$AU
241470971$24147097$1$I$20240707$20240707$20240729$20240729$PER$$CA-TOLMAR, INC.-24CA050869$TOLMAR$$88$YR$$M$Y$$$20240726$$CN$CA$CA
241470982$24147098$2$F$$20240802$20240729$20240826$PER$$CA-TOLMAR, INC.-24CA050422$TOLMAR$$$$$M$Y$$$20240826$$MD$CA$CA
241470992$24147099$2$F$$20240815$20240729$20240906$PER$$US-TOLMAR, INC.-24US050720$TOLMAR$$$$$M$Y$$$20240906$$HP$US$US
241471005$24147100$5$F$20240718$20240910$20240729$20240913$PER$$US-AMGEN-USASP2024146318$AMGEN$$66$YR$E$M$Y$$$20240913$$PH$US$US
241471011$24147101$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149007$AMGEN$$$$$$Y$$$20240729$$PH$US$US
241471021$24147102$1$I$20230101$20240719$20240729$20240729$EXP$$US-AMGEN-USASP2024148720$AMGEN$$74$YR$E$M$Y$62$KG$20240729$$CN$US$US
241471032$24147103$2$F$20240101$20240909$20240729$20240913$EXP$$US-AMGEN-USASP2024146907$AMGEN$$32$YR$A$M$Y$$$20240912$$MD$US$US
241471041$24147104$1$I$20240101$20240723$20240729$20240729$PER$$US-ABBVIE-5853093$ABBVIE$$$$$F$Y$$$20240729$$HP$US$US
241471051$24147105$1$I$20240501$20240603$20240729$20240729$PER$$US-Vifor (International) Inc.-VIT-2024-06512$VIFOR$$$$$M$Y$$$20240729$$HP$US$US
241471061$24147106$1$I$20240610$20240722$20240729$20240729$EXP$$US-ASTELLAS-2024US018846$ASTELLAS$$$$$M$Y$$$20240729$$HP$US$US
241471071$24147107$1$I$20240723$20240724$20240727$20240727$DIR$FDA-CDER-CTU-2024-51720$$FDA-CTU$$81$YR$$M$N$74.4$KG$20240724$N$$US$
241471081$24147108$1$I$20240723$20240726$20240727$20240727$DIR$FDA-CDER-CTU-2024-51751$$FDA-CTU$$81$YR$$M$N$74.4$KG$20240726$N$$US$
241471091$24147109$1$I$$20240727$20240727$20240727$DIR$FDA-CDER-CTU-2024-51748$$FDA-CTU$$80$YR$$F$N$$$20240727$N$$US$
241471101$24147110$1$I$20240709$20240726$20240726$20240726$DIR$711700$$FDA-CTU$$70$YR$$M$N$83.25$KG$20240726$N$CN$US$
241471111$24147111$1$I$20240725$20240726$20240727$20240727$DIR$FDA-CDER-CTU-2024-51719$$FDA-CTU$$79$YR$$F$N$84.4$KG$20240726$N$$US$
241471121$24147112$1$I$$20240727$20240727$20240727$DIR$FDA-CDER-CTU-2024-51747$$FDA-CTU$$21$YR$$M$N$$$20240727$N$$US$
241471131$24147113$1$I$$20240301$20240729$20240729$EXP$$CA-TEVA-VS-3198718$TEVA$$50$YR$$F$Y$$$20240729$$HP$CA$CA
241471141$24147114$1$I$20240721$20240727$20240727$20240727$DIR$FDA-CDER-CTU-2024-51750$$FDA-CTU$$64$YR$$M$N$$$20240727$Y$PH$US$
241471151$24147115$1$I$20240720$20240727$20240727$20240727$DIR$FDA-CDER-CTU-2024-51744$$FDA-CTU$$55$YR$$M$N$$$20240727$N$$US$
241471161$24147116$1$I$$20240726$20240726$20240726$DIR$711684$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241471171$24147117$1$I$20240724$20240725$20240729$20240729$EXP$$GB-ORGANON-O2407GBR002573$ORGANON$$10$YR$$M$Y$50$KG$20240729$$HP$GB$GB
241471181$24147118$1$I$$20240726$20240727$20240727$DIR$FDA-CDER-CTU-2024-51749$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241471191$24147119$1$I$$20240722$20240729$20240729$PER$$US-ALXN-202407USA001541US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241471201$24147120$1$I$$20240726$20240726$20240726$DIR$711693$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241471211$24147121$1$I$20240717$20240718$20240729$20240729$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00384$XERIS PHARMACEUTICALS$$70$YR$$M$Y$$$20240726$$CN$US$US
241471221$24147122$1$I$20240725$20240726$20240726$20240726$DIR$711679$$FDA-CTU$$$$$UNK$N$$$20240726$N$CN$US$
241471232$24147123$2$F$$20240801$20240729$20240809$PER$$US-INCYTE CORPORATION-2024IN007631$INCYTE$$$$$$Y$$$20240809$$CN$US$US
241471241$24147124$1$I$$20240729$20240729$20240729$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042399$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240729$$MD$DE$DE
241471251$24147125$1$I$$20240722$20240729$20240729$EXP$$JP-ASTELLAS-2024JP005266$ASTELLAS$$9$DEC$$M$Y$$$20240729$$MD$JP$JP
241471261$24147126$1$I$20240702$20240719$20240729$20240729$EXP$IT-MINISAL02-994716$IT-TEVA-VS-3223834$TEVA$$73$YR$$F$Y$$$20240729$$MD$IT$IT
241471271$24147127$1$I$20240221$20240725$20240727$20240727$DIR$FDA-CDER-CTU-2024-51752$$FDA-CTU$$36$YR$$M$N$83.3$KG$20240725$N$$US$
241471281$24147128$1$I$$20240719$20240729$20240729$EXP$$US-GALDERMA-US2024011788$GALDERMA$Khalil H, Cota D.. Multiorgan failure from ivermectin and deet toxicity concealed behind alcohol withdrawal. Critical Care Medicine. 2024;52(1):S440$$$$$Y$$$20240729$$HP$US$US
241471301$24147130$1$I$20240516$20240726$20240726$20240726$DIR$711698$$FDA-CTU$$53$YR$$M$N$$$20240726$N$$US$
241471311$24147131$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119217$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240729$$CN$US$US
241471321$24147132$1$I$20240720$20240729$20240729$20240729$EXP$IT-MINISAL02-996644$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042375$BOEHRINGER INGELHEIM$$93$YR$E$F$Y$$$20240729$$MD$IT$IT
241471331$24147133$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017676$ELI LILLY AND CO$$$$$M$Y$$$20240729$$CN$US$US
241471341$24147134$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017739$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240729$$CN$US$US
241471351$24147135$1$I$$20240723$20240729$20240729$EXP$$IE-TAKEDA-2024TUS075897$TAKEDA$$$$$$Y$$$20240729$$MD$IE$IE
241471361$24147136$1$I$$20240717$20240729$20240729$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407013371AA$ELI LILLY AND CO$Okada H, et al..A case of favorable outcome in which MET ex14 skipping was identified during relapse of lung adenocarcinoma with brain metastasis.The 62nd Annual Meeting of the Chugoku-Shikoku Branch of the Japan Lung Cancer S 2024;:122.$71$YR$E$M$Y$$$20240729$$MD$JP$JP
241471371$24147137$1$I$$20240717$20240729$20240729$EXP$$CH-ELI_LILLY_AND_COMPANY-CH202407012840$ELI LILLY AND CO$Beunk, L., Nijenhuis, M., Soree, B. et al..Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants.Eur J Hum Genet 2024;:.DOI:10.1038/s41431-024-01648-1$32$YR$A$F$Y$$$20240729$$CN$COUNTRY NOT SPECIFIED$CH
241471384$24147138$4$F$20240709$20240911$20240729$20240923$EXP$$DE-BEH-2024175915$CSL BEHRING$$71$YR$E$F$Y$51$KG$20240923$$HP$DE$DE
241471391$24147139$1$I$20240708$20240722$20240729$20240729$PER$$US-BAYER-2024A107096$BAYER$$$$$F$Y$$$20240729$$CN$US$US
241471401$24147140$1$I$20240601$20240711$20240729$20240729$PER$$US-TEVA-VS-3225650$TEVA$$51$YR$$F$Y$$$20240729$$PH$US$US
241471422$24147142$2$F$$20240829$20240729$20240905$30DAY$$FR-JNJFOC-20240766838$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$PH$FR$FR
241471433$24147143$3$F$20240722$20240806$20240729$20240808$EXP$$VN-JNJFOC-20240758999$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240808$$MD$VN$VN
241471441$24147144$1$I$20240701$20240725$20240729$20240729$EXP$$KR-DSJP-DSJ-2024-137484AA$DAIICHI$$67$YR$$M$Y$$$20240729$$CN$KR$KR
241471451$24147145$1$I$20240717$20240722$20240729$20240729$PER$$US-BAYER-2024A108956$BAYER$$37$YR$A$F$Y$$$20240729$$MD$US$US
241471461$24147146$1$I$$20240724$20240729$20240729$EXP$$ZA-AstraZeneca-2024A169949$ASTRAZENECA$$87$YR$$F$Y$$$20240729$$CN$ZA$
241471471$24147147$1$I$20210714$20210723$20240729$20240729$EXP$$CO-AstraZeneca-2021A646399$ASTRAZENECA$$27296$DY$$F$Y$89$KG$20240729$$CN$CO$
241471482$24147148$2$F$20240515$20240808$20240729$20240810$EXP$FR-AFSSAPS-TO2024001232$FR-ROCHE-10000032757$ROCHE$$81$YR$E$M$Y$86$KG$20240810$$PH$FR$FR
241471491$24147149$1$I$20220601$20230125$20240729$20240729$EXP$$CA-CELLTRION INC.-2022CA022637$CELLTRION$$$$$$Y$$$20240729$$CN$CA$CA
241471522$24147152$2$F$20230301$20240805$20240729$20240812$EXP$$US-AMGEN-USASP2024145492$AMGEN$$$$$F$Y$$$20240812$$HP$US$US
241471532$24147153$2$F$$20240814$20240729$20240822$EXP$$JP-AMGEN-JPNSP2024146161$AMGEN$$$$$$Y$$$20240822$$PH$JP$JP
241471561$24147156$1$I$$20240727$20240727$20240727$DIR$FDA-CDER-CTU-2024-51753$$FDA-CTU$$56$YR$$M$N$$$20240727$N$$US$
241471571$24147157$1$I$20240716$20240726$20240726$20240726$DIR$711672$$FDA-CTU$$28$YR$$F$N$$$20240726$Y$HP$US$
241471581$24147158$1$I$$20240723$20240727$20240727$DIR$FDA-CDER-CTU-2024-51741$$FDA-CTU$$$$$M$N$$$20240723$N$HP$US$
241471591$24147159$1$I$$20240727$20240727$20240727$DIR$FDA-CDER-CTU-2024-51746$$FDA-CTU$$88$YR$$M$N$$$20240727$N$$US$
241471601$24147160$1$I$20240726$20240726$20240726$20240726$DIR$711703$$FDA-CTU$$77$YR$$M$N$68.5$KG$20240726$Y$HP$US$
241471611$24147161$1$I$20240722$20240727$20240727$20240727$DIR$FDA-CDER-CTU-2024-51743$$FDA-CTU$$66$YR$$F$N$$$20240727$N$$US$
241471621$24147162$1$I$$20240727$20240727$20240727$DIR$FDA-CDER-CTU-2024-51745$$FDA-CTU$$70$YR$$F$N$$$20240727$N$$US$
241471631$24147163$1$I$20240718$20240726$20240726$20240726$DIR$711675$$FDA-CTU$$26$YR$$F$N$$$20240726$Y$HP$US$
241471651$24147165$1$I$$20240726$20240726$20240726$DIR$711685$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241471661$24147166$1$I$$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51814$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241471671$24147167$1$I$$20240723$20240729$20240729$PER$$US-BAYER-2024A106894$BAYER$$$$$F$Y$$$20240729$$CN$US$US
241471681$24147168$1$I$20240712$20240724$20240729$20240729$EXP$$NVSC2024CN153700$NOVARTIS$$$$$F$Y$$$20240729$$MD$CN$CN
241471691$24147169$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092784$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241471701$24147170$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092116$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241471711$24147171$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2024091259$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241471721$24147172$1$I$20240101$20240723$20240729$20240729$EXP$$GB-AMGEN-GBRSP2024147971$AMGEN$$65$YR$E$M$Y$$$20240729$$CN$GB$GB
241471731$24147173$1$I$20240718$20240723$20240729$20240729$PER$$CN-BRACCO-2024CN04559$BRACCO$$61$YR$$F$Y$$$20240729$$HP$CN$CN
241471741$24147174$1$I$20240715$20240717$20240729$20240729$PER$$US-BAYER-2024A105389$BAYER$$71$YR$E$M$Y$$$20240729$$CN$US$US
241471751$24147175$1$I$20240723$20240723$20240729$20240729$PER$$US-BAYER-2024A106915$BAYER$$38$YR$A$F$Y$$$20240729$$MD$US$US
241471761$24147176$1$I$$20240724$20240729$20240729$EXP$$US-GILEAD-2024-0681922$GILEAD$$51$YR$A$F$Y$68.934$KG$20240729$$CN$US$US
241471771$24147177$1$I$$20240719$20240729$20240729$PER$$US-BAYER-2024A106180$BAYER$$$$$$Y$$$20240729$$CN$US$US
241471791$24147179$1$I$$20240722$20240729$20240729$EXP$$CN-009507513-2407CHN014327$MERCK$$39$YR$$F$Y$$$20240729$$HP$CN$CN
241471801$24147180$1$I$$20240723$20240729$20240729$PER$$US-ROCHE-10000034886$ROCHE$$$$$$Y$$$20240729$$CN$US$US
241471812$24147181$2$F$$20240731$20240729$20240809$EXP$$US-TEVA-VS-3222619$TEVA$Gouda MA, Janku F, Somaiah N, Hunt KK, Yedururi S, Subbiah V. Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery. Oncoscience 2023; 10 38-43.; Gouda MA, Janku F, Somaiah N, Hunt KK, Yedururi S, Subbiah V. Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery. Onco...$$$A$F$Y$$$20240809$$HP$US$US
241471831$24147183$1$I$$20240724$20240729$20240729$PER$$US-ROCHE-10000036442$ROCHE$$70$YR$E$F$Y$$$20240729$$HP$US$US
241471842$24147184$2$F$$20240729$20240729$20240801$PER$$US-ROCHE-10000038467$ROCHE$$$$$$Y$$$20240801$$PH$US$US
241471852$24147185$2$F$$20240731$20240729$20240809$EXP$$PT-TEVA-VS-3222439$TEVA$Nogueira JV, Rodrigues L, Neves CF, Mesquita P, Vieira RM, Alves DR et al. CO-0173 - (2446) - Rare disease, effective treatment: HHV-6B pneumonia in an immunosuppressed patient. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts [CNMI]. 2024 May; 273.; Literature: Nogueira JV, Rodrigues L, Neves CF, Mesquita P, Vieira RM, Alves DR et al. CO-0173 - (2446) - Rare disease, effective treatment: HHV-6B pneumonia in an immunosu...$83$YR$$M$Y$$$20240809$$MD$PT$PT
241471861$24147186$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119646$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$98.55$KG$20240729$$HP$US$US
241471871$24147187$1$I$$20240725$20240729$20240729$PER$$US-BAYER-2024A108198$BAYER$$$$$$Y$$$20240729$$CN$US$US
241471881$24147188$1$I$20130101$20240723$20240729$20240729$PER$$US-BAYER-2024A107242$BAYER$$$$$F$Y$$$20240729$$CN$US$US
241471891$24147189$1$I$$20240710$20240729$20240729$PER$$US-TEVA-VS-3225628$TEVA$$74$YR$$F$Y$$$20240729$$PH$US$US
241471902$24147190$2$F$20220620$20240723$20240729$20240731$EXP$$CA-CELLTRION INC.-2022CA022639$CELLTRION$$$$$$Y$$$20240731$$CN$CA$CA
241471911$24147191$1$I$$20240722$20240729$20240729$PER$$US-AMGEN-USASP2024148316$AMGEN$Parraga S. P.; Hrin M. L.; Jorizzo J. L.. Management of brunsting-perry pemphigoid (BPP): A single-center retrospective case series. Journal of Investigative dermatology. 2024;144 (8):S42$$$$$Y$$$20240729$$HP$US$US
241471921$24147192$1$I$$20240722$20240729$20240729$EXP$$US-AMGEN-USASP2024148701$AMGEN$Swearingen A.; Strome A.; Levine A.. Cutaneous Cryptococcosis Evaluation on Reflectance Confocal Microscopy (RCM). Journal of Investigative Dermatology. 2024;144 (8):S156$69$YR$E$F$Y$$$20240729$$HP$US$US
241471931$24147193$1$I$$20240719$20240729$20240729$PER$$US-AMGEN-USASP2024145348$AMGEN$$$$$F$Y$$$20240729$$HP$US$US
241471941$24147194$1$I$20240726$20240726$20240729$20240729$PER$$US-AMGEN-USASP2024149758$AMGEN$$26$YR$A$M$Y$$$20240729$$CN$US$US
241471951$24147195$1$I$$20240724$20240729$20240729$EXP$$NVSC2024DO153861$NOVARTIS$$$$$F$Y$$$20240729$$MD$DO$DO
241471961$24147196$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154449$NOVARTIS$$$$$$Y$$$20240729$$HP$US$US
241471971$24147197$1$I$$20240722$20240729$20240729$PER$$US-AMGEN-USASP2024147974$AMGEN$Imhof R.; Dai C.; Alavi A. et al.. Management and outcomes of hidradenitis suppurativa in solid organ transplant recipients. Journal of Investigative dermatology. 2024;144 (8):S25$$$$$Y$$$20240729$$HP$US$US
241471981$24147198$1$I$$20240727$20240729$20240729$PER$$US-HALEON-2189408$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241471991$24147199$1$I$20240704$20240725$20240729$20240729$EXP$IT-MINISAL02-995970$IT-EMD Serono-2024040540$EMD SERONO INC$$62$YR$A$F$Y$52$KG$20240729$$MD$IT$IT
241472001$24147200$1$I$20230101$20240723$20240729$20240729$EXP$$NVSC2024CO120677$NOVARTIS$$$$$F$Y$$$20240729$$CN$CO$CO
241472011$24147201$1$I$$20220708$20240729$20240729$EXP$$US-AstraZeneca-2022A198670$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241472021$24147202$1$I$$20220118$20240729$20240729$EXP$$US-AstraZeneca-2022A030996$ASTRAZENECA$$$$$M$Y$72.6$KG$20240729$$CN$US$
241472031$24147203$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092117$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241472041$24147204$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2024091245$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241472051$24147205$1$I$$20240726$20240729$20240729$EXP$$CA-GILEAD-2024-0682157$GILEAD$$88$YR$E$M$Y$69$KG$20240729$$HP$CA$CA
241472061$24147206$1$I$20240726$20240725$20240729$20240729$EXP$$AU-GILEAD-2024-0682039$GILEAD$$$$$F$Y$$$20240729$$MD$AU$AU
241472071$24147207$1$I$$20220425$20240729$20240729$EXP$$AR-AstraZeneca-2022A167007$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$AR$
241472081$24147208$1$I$20240201$20240719$20240729$20240729$EXP$$PL-AMGEN-POLSP2024145507$AMGEN$$$$$F$Y$$$20240729$$CN$PL$PL
241472091$24147209$1$I$$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119678$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$$$20240729$$CN$US$US
241472101$24147210$1$I$20240626$20240726$20240726$20240726$DIR$711723$$FDA-CTU$$55$YR$$F$N$79.2$KG$20240726$N$CN$US$
241472111$24147211$1$I$$20240726$20240726$20240726$DIR$711690$$FDA-CTU$$$$$UNK$N$$$20240726$$CN$US$
241472121$24147212$1$I$$20240719$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119137$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240729$$HP$US$US
241472131$24147213$1$I$20240726$20240726$20240726$20240726$DIR$711710$$FDA-CTU$$73$YR$$F$N$$$20240726$N$$US$
241472141$24147214$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119473$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240729$$PH$US$US
241472161$24147216$1$I$$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118444$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240729$$PH$US$US
241472171$24147217$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119112$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240729$$PH$US$US
241472181$24147218$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119494$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240729$$HP$US$US
241472191$24147219$1$I$20240719$20240726$20240726$20240726$DIR$711728$$FDA-CTU$$73$YR$$F$N$72.45$KG$20240726$N$CN$US$
241472201$24147220$1$I$20240714$20240726$20240726$20240726$DIR$711708$$FDA-CTU$$47$YR$$M$N$131.9$KG$20240726$N$PH$US$
241472211$24147221$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017582$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240729$$CN$US$US
241472221$24147222$1$I$20240725$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017150$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240729$$CN$US$US
241472231$24147223$1$I$$20240717$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407015708$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240729$$CN$US$US
241472241$24147224$1$I$20240711$20240726$20240726$20240726$DIR$711696$$FDA-CTU$$54$YR$$M$N$$$20240726$N$HP$US$
241472251$24147225$1$I$20240716$20240726$20240726$20240726$DIR$711702$$FDA-CTU$$60$YR$$F$N$84.4$KG$20240726$Y$HP$US$
241472261$24147226$1$I$$20240718$20240729$20240729$EXP$$BR-EMD Serono-2024039394$EMD SERONO INC$$$$A$F$Y$$$20240729$$CN$BR$BR
241472271$24147227$1$I$$20240719$20240729$20240729$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14547$IPSEN$$$$$M$Y$$$20240729$$CN$US$US
241472281$24147228$1$I$20240726$20240726$20240726$20240726$DIR$711729$$FDA-CTU$$58$YR$$F$N$$$20240726$Y$HP$US$
241472301$24147230$1$I$$20240724$20240729$20240729$PER$$US-BAYER-2024A108368$BAYER$$52$YR$A$F$Y$$$20240729$$CN$US$US
241472311$24147231$1$I$20240712$20240722$20240729$20240729$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-103085$REGENERON$$$$$F$Y$$$20240729$$CN$CA$CA
241472321$24147232$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092517$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241472331$24147233$1$I$$20240722$20240729$20240729$EXP$$BR-GSK-BR2024AMR092445$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$MD$BR$BR
241472341$24147234$1$I$$20240723$20240729$20240729$EXP$$CA-PFIZER INC-202400222141$PFIZER$$57$YR$$M$Y$$$20240729$$HP$CA$CA
241472352$24147235$2$F$20240608$20240810$20240729$20240812$EXP$$CO-UCBSA-2024037851$UCB$$37$YR$$M$Y$$$20240812$$CN$CO$CO
241472361$24147236$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092528$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241472372$24147237$2$F$20230101$20240915$20240729$20240916$EXP$$CA-PFIZER INC-202300224940$PFIZER$$19$YR$$F$Y$$$20240916$$MD$CA$CA
241472381$24147238$1$I$$20240723$20240729$20240729$EXP$$US-JNJFOC-20240764930$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241472392$24147239$2$F$$20240825$20240729$20240826$30DAY$$US-PFIZER INC-202400077892$PFIZER$$13$YR$$M$Y$40.37$KG$20240826$$HP$US$US
241472401$24147240$1$I$20240715$20240724$20240729$20240729$EXP$GB-MHRA-MED-202407241446599570-YNRCZ$GB-RDY-SPO/GBR/24/0011000$DR REDDYS$$95$YR$E$F$Y$$$20240729$$MD$GB$GB
241472411$24147241$1$I$20240101$20240723$20240729$20240729$PER$$CA-Eisai-EC-2024-169537$EISAI$$57$YR$A$F$Y$$$20240729$$CN$CA$CA
241472421$24147242$1$I$20220101$20240715$20240729$20240729$EXP$$CN-AMGEN-CHNSP2024144748$AMGEN$Li, J.. Salvage treatment of ruxolitinib for refractory adenovirus-associated hemophagocytic syndrome post-haploidentical allogeneic stem cell transplantation: a case report.. Translational pediatrics. 2024;13(6):994-1000$11$YR$C$M$Y$$$20240729$$MD$CN$CN
241472431$24147243$1$I$$20240704$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06873$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241472441$24147244$1$I$$20240723$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007727$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241472451$24147245$1$I$$20240724$20240729$20240729$PER$$US-BAYER-2024A108545$BAYER$$$$$$Y$$$20240729$$CN$US$US
241472462$24147246$2$F$20240619$20240719$20240729$20240729$PER$$US-ROCHE-10000032628$ROCHE$$4$YR$C$M$Y$$$20240729$$CN$US$US
241472471$24147247$1$I$$20240726$20240729$20240729$PER$$US-ROCHE-10000040098$ROCHE$$51$YR$A$F$Y$$$20240729$$CN$US$US
241472481$24147248$1$I$$20240719$20240729$20240729$PER$$US-ABBVIE-5852310$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241472491$24147249$1$I$$20240723$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007753$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241472503$24147250$3$F$20100101$20240726$20240729$20240801$EXP$$JP-009507513-1011USA03553$MERCK$$$$$M$Y$44$KG$20240801$$MD$JP$JP
241472514$24147251$4$F$$20240731$20240729$20240920$PER$$US-BRAEBURN-US-BRA-24-000686$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
241472523$24147252$3$F$$20240829$20240729$20240829$30DAY$$US-PFIZER INC-202400222632$PFIZER$$18$YR$$F$Y$$$20240829$$HP$US$US
241472534$24147253$4$F$$20240827$20240729$20240903$30DAY$$US-PFIZER INC-202400073365$PFIZER$$2$YR$$F$Y$11.1$KG$20240903$$MD$US$US
241472543$24147254$3$F$$20240830$20240729$20240830$30DAY$$US-PFIZER INC-PV202400088054$PFIZER$$12$YR$$F$Y$$$20240830$$HP$US$US
241472552$24147255$2$F$$20240828$20240729$20240828$30DAY$$US-PFIZER INC-202400222599$PFIZER$$16$YR$$M$Y$$$20240828$$HP$US$US
241472563$24147256$3$F$$20240830$20240729$20240830$30DAY$$US-PFIZER INC-202400220970$PFIZER$$17$YR$$M$Y$74.39$KG$20240830$$HP$US$US
241472573$24147257$3$F$20240701$20240906$20240729$20240909$30DAY$$US-PFIZER INC-202400222608$PFIZER$$12$YR$$M$Y$$$20240909$$CN$US$US
241472583$24147258$3$F$$20240828$20240729$20240828$30DAY$$US-PFIZER INC-202400220121$PFIZER$$4$YR$$M$Y$$$20240828$$CN$US$US
241472593$24147259$3$F$$20240830$20240729$20240830$30DAY$$US-PFIZER INC-PV202400097131$PFIZER$$15$YR$$M$Y$$$20240830$$CN$US$US
241472602$24147260$2$F$20240101$20240919$20240729$20240919$EXP$$CA-PFIZER INC-202400224558$PFIZER$$35$YR$$F$Y$$$20240919$$HP$CA$CA
241472613$24147261$3$F$20240718$20240901$20240729$20240903$30DAY$$AR-PFIZER INC-202400220688$PFIZER$$12$YR$$M$Y$$$20240903$$HP$AR$AR
241472622$24147262$2$F$$20240828$20240729$20240828$30DAY$$US-PFIZER INC-202400221024$PFIZER$$5$YR$$M$Y$$$20240828$$CN$US$US
241472633$24147263$3$F$$20240828$20240729$20240828$30DAY$$US-PFIZER INC-202400221531$PFIZER$$14$YR$$M$Y$$$20240828$$CN$US$US
241472642$24147264$2$F$20240721$20240828$20240729$20240828$30DAY$$US-PFIZER INC-202400221472$PFIZER$$15$YR$$M$Y$74.84$KG$20240828$$CN$US$US
241472652$24147265$2$F$$20240830$20240729$20240830$30DAY$$US-PFIZER INC-202400219799$PFIZER$$10$YR$$M$Y$$$20240830$$CN$US$US
241472662$24147266$2$F$$20240801$20240729$20240802$30DAY$$US-PFIZER INC-202400222272$PFIZER$$15$YR$$M$Y$$$20240802$$CN$US$US
241472672$24147267$2$F$$20240828$20240729$20240828$30DAY$$US-PFIZER INC-202400221546$PFIZER$$14$YR$$M$Y$$$20240828$$CN$US$US
241472681$24147268$1$I$20240519$20240726$20240726$20240726$DIR$711743$$FDA-CTU$$31$YR$$F$N$49.5$KG$20240726$N$CN$US$
241472691$24147269$1$I$20220101$20240726$20240726$20240726$DIR$711740$$FDA-CTU$$68$YR$$M$N$67.5$KG$20240726$N$CN$US$
241472701$24147270$1$I$20231125$20240726$20240726$20240726$DIR$711745$$FDA-CTU$$42$YR$$F$N$83.25$KG$20240726$N$CN$US$
241472711$24147271$1$I$20240501$20240723$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007756$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241472722$24147272$2$F$20240101$20240919$20240729$20240919$EXP$$CA-PFIZER INC-202400222785$PFIZER$$51$YR$$M$Y$$$20240919$$HP$CA$CA
241472731$24147273$1$I$$20240729$20240729$20240729$EXP$$CA-BAYER-2024A108108$BAYER$$$$$F$Y$$$20240729$$HP$CA$CA
241472743$24147274$3$F$20240722$20240723$20240729$20240816$EXP$$US-BEH-2024176402$CSL BEHRING$$16$YR$T$F$Y$49.887$KG$20240816$$CN$US$US
241472751$24147275$1$I$20240716$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51891$$FDA-CTU$$86$YR$$M$N$$$20240726$N$HP$US$
241472761$24147276$1$I$$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51882$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241472781$24147278$1$I$20240724$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51810$$FDA-CTU$$42$YR$$M$N$$$20240726$N$HP$US$
241472791$24147279$1$I$$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51829$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241472801$24147280$1$I$20240704$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51811$$FDA-CTU$$74$YR$$M$N$$$20240726$N$HP$US$
241472811$24147281$1$I$$20240724$20240729$20240729$DIR$FDA-CDER-CTU-2024-51822$$FDA-CTU$$$$$UNK$N$$$20240724$N$HP$US$
241472821$24147282$1$I$$20240618$20240729$20240729$DIR$FDA-CDER-CTU-2024-51901$$FDA-CTU$$$$$M$N$$$20240618$N$HP$US$
241472832$24147283$2$F$20240501$20240729$20240729$20240801$EXP$$US-SA-2024SA217737$SANOFI AVENTIS$$95$YR$E$M$Y$65.7$KG$20240801$$MD$US$US
241472851$24147285$1$I$$20240721$20240729$20240729$EXP$$ZA-SA-2024SA203273$SANOFI AVENTIS$$$$$F$Y$$$20240729$$HP$ZA$ZA
241472861$24147286$1$I$$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51890$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241472871$24147287$1$I$20210607$20240717$20240729$20240729$EXP$$CA-TAKEDA-2024TUS075829$TAKEDA$$36$YR$$F$Y$$$20240729$$MD$CA$CA
241472881$24147288$1$I$$20240726$20240729$20240729$EXP$$US-ABBVIE-5856912$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241472901$24147290$1$I$$20240716$20240729$20240729$EXP$$US-SOCIETAL CDMO GAINESVILLE, LLC-SOC-2024-000018$RECRO PHARMA$Sorabella RA, et al.. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70(7):e92-e96$17$YR$$M$Y$85$KG$20240729$$MD$US$US
241472911$24147291$1$I$20240715$20240722$20240729$20240729$EXP$DE-AMK-278462$DE-RDY-SPO/DEU/24/0010822$DR REDDYS$$80$YR$E$F$Y$$$20240729$$PH$DE$DE
241472921$24147292$1$I$20240101$20240726$20240729$20240729$EXP$$US-UCBSA-2024036127$UCB$$$$$F$Y$$$20240729$$CN$US$US
241472931$24147293$1$I$$20240710$20240729$20240729$PER$$US-Karo Pharma-2159716$Karo Pharma$$45$YR$$M$Y$$$20240729$$$US$US
241472941$24147294$1$I$20240723$20240726$20240729$20240729$EXP$$US-ROCHE-10000040027$ROCHE$$62$YR$A$M$Y$95.25$KG$20240729$$CN$US$US
241472981$24147298$1$I$$20240724$20240729$20240729$EXP$$US-LUNDBECK-DKLU4002106$LUNDBECK$$$$$$Y$$$20240729$$HP$US$US
241473001$24147300$1$I$$20240723$20240729$20240729$PER$$US-VERTEX PHARMACEUTICALS-2024-012204$VERTEX$$$$I$$Y$$$20240729$$CN$US$US
241473011$24147301$1$I$$20240720$20240729$20240729$EXP$$US-VERTEX PHARMACEUTICALS-2024-012126$VERTEX$$37$YR$$$Y$$$20240729$$MD$US$US
241473021$24147302$1$I$$20240718$20240729$20240729$PER$$US-VERTEX PHARMACEUTICALS-2024-012044$VERTEX$$$$$$Y$$$20240729$$MD$US$US
241473032$24147303$2$F$$20240808$20240729$20240816$EXP$$PT-MYLANLABS-2024M1069349$MYLAN$Baptista M.. Immunotherapy applied to multiple myeloma. Hematology and Oncology Magazine. 2024;12(46):13-16$46$YR$$F$Y$$$20240816$$MD$PT$PT
241473041$24147304$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069412$MYLAN$Schambach S, Esteitie R, Nader A. Diffuse Disseminated Demyelination: A Detrimental Outcome. Am-J-Respir-Crit-Care-Med 2023; 207.$27$YR$$M$Y$$$20240729$$HP$US$US
241473052$24147305$2$F$$20240806$20240729$20240812$EXP$$GR-MYLANLABS-2024M1069190$MYLAN$$47$YR$$M$Y$$$20240812$$MD$GR$GR
241473061$24147306$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069405$MYLAN$Garg A, Joong A, Gambetta K, Monge M, Thrush P. To VAD or Not VAD? How to Get to Heart Transplant in a Child with Duchenne Muscular Dystrophy. J-Heart-Lung-Transplant 2024; 43 (Suppl.) (4): S633 abstr. 1376.$9$YR$$M$Y$$$20240729$$HP$US$US
241473071$24147307$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069414$MYLAN$Beavin S, Ahmed S. Mind the Gap: Pyroglutamic Acidosis as a Not-so-Rare Cause of High Anion Gap Metabolic Acidosis (HAGMA). J-Am-Soc-Nephrol 2023; 34 (11): 202 abstr. TH-PO397.$39$YR$$M$Y$$$20240729$$HP$US$US
241473082$24147308$2$F$$20240822$20240729$20240829$EXP$$DE-MYLANLABS-2024M1068830$MYLAN$Dierks, S., Buchholz, SM., K?nig, A., Liersch, T., Schanz, J.. Incomplete DPYD haplotype B3 in a patient with locally advanced gastric cancer: Reconsidering the 5-fu dosage strategy. European Journal of Cancer. 2024;204:114076$65$YR$$M$Y$$$20240829$$MD$DE$DE
241473091$24147309$1$I$20240101$20240722$20240729$20240729$EXP$$US-RVL_Pharmaceuticals-USA-POI1255202400162$RVL PHARMACEUTICALS$$82$YR$E$F$Y$$$20240729$$$US$US
241473101$24147310$1$I$$20240715$20240729$20240729$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07101$LUPIN$$49$YR$$F$Y$$$20240729$$CN$AU$AU
241473111$24147311$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069409$MYLAN$Usman S, Ashraf A, Badar F, Iftikhar A. Evidence Based Management of Right Heart Failure in Intensive Care Unit: A Case Report. Am-J-Respir-Crit-Care-Med 2023; 207 A1785.$93$YR$$F$Y$$$20240729$$HP$US$US
241473121$24147312$1$I$$20240723$20240729$20240729$EXP$$IN-SA-2024SA217019$SANOFI AVENTIS$Ramalingam TR, Vaidhyanathan L, NK HR, Uppuluri R, Raj R.. Clinical, immunological, and molecular findings in two patients with MHC class I deficiency and post-transplant outcome.. Pediatr Allergy Immunol.. 2024;35:1-6$10$YR$C$M$Y$$$20240729$$MD$IN$IN
241473131$24147313$1$I$$20240722$20240729$20240729$EXP$$CZ-MYLANLABS-2024M1068808$MYLAN$Klocperk A, Bloomfield AM, Schneiderova H, Hlavackova E, Turnovec M, Tichy L, Cech Z, Chrastina P, Dvorakova L, Peskova K et all.. Novorozenecky screening tezke kombinovane imunodeficience (SCID) v Ceske republice [Neonatal screening of severe combined immunodeficiency (SCID) in the Czech Republic]. Alergie. 2024;26(2):85-9$$$I$$Y$$$20240729$$MD$CZ$CZ
241473141$24147314$1$I$$20240728$20240729$20240729$PER$$US-ROCHE-10000040578$ROCHE$$$$$$Y$$$20240729$$CN$US$US
241473151$24147315$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024091863$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$HP$US$US
241473162$24147316$2$F$$20240812$20240729$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119063$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240814$$CN$US$US
241473171$24147317$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017721$ELI LILLY AND CO$$$$$$Y$$$20240729$$CN$US$US
241473181$24147318$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017943$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240729$$CN$US$US
241473191$24147319$1$I$$20240723$20240729$20240729$PER$$US-ABBVIE-5853002$ABBVIE$$$$$F$Y$45.359$KG$20240729$$CN$US$US
241473211$24147321$1$I$20240201$20240717$20240729$20240729$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14594$IPSEN$$$$$F$Y$$$20240729$$CN$US$US
241473221$24147322$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51893$$FDA-CTU$$65$YR$$M$N$$$20240729$N$$US$
241473231$24147323$1$I$$20240722$20240729$20240729$EXP$$JP-ROCHE-10000040682$ROCHE$Oyama T, Sasaki H, Minamisono K, Nishida S, Iwami D. A case of orthotopic renal transplant from a living donor which was performed after surgery for obstructive arteriosclerosis of bilateral lower extremities. Japanese Journal of Urological Surgery / The 99th Tochigi Regional Meeting of th. 2024;37(6):550-551$56$YR$A$F$Y$$$20240729$$MD$JP$JP
241473241$24147324$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51887$$FDA-CTU$$88$YR$$F$N$$$20240729$N$$US$
241473251$24147325$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51860$$FDA-CTU$$52$YR$$F$N$83.91$KG$20240729$N$HP$US$
241473271$24147327$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51854$$FDA-CTU$$42$YR$$F$N$119.29$KG$20240729$N$$US$
241473283$24147328$3$F$$20240731$20240729$20240805$EXP$US-MLMSERVICE-20240722-PI139705-00232-1$US-SA-2024SA221147$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240805$$MD$US$US
241473301$24147330$1$I$$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51820$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241473311$24147331$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51889$$FDA-CTU$$68$YR$$F$N$90.26$KG$20240729$N$$US$
241473321$24147332$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51865$$FDA-CTU$$69$YR$$F$N$$$20240729$N$$US$
241473331$24147333$1$I$$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51825$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241473341$24147334$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51892$$FDA-CTU$$67$YR$$F$N$90.72$KG$20240729$N$$US$
241473351$24147335$1$I$$20240725$20240729$20240729$EXP$$CA-SA-2024SA217919$SANOFI AVENTIS$unk. unk. unk. unk;unk:unk$74$YR$E$F$Y$$$20240729$$HP$CA$CA
241473361$24147336$1$I$20240501$20240725$20240729$20240729$EXP$$QA-INCYTE CORPORATION-2024IN007821$INCYTE$$$$$$Y$$$20240729$$PH$QA$QA
241473372$24147337$2$F$$20240722$20240729$20240731$EXP$$US-AMGEN-USASP2024148023$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et. al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2024$64$YR$A$$Y$$$20240731$$HP$US$US
241473381$24147338$1$I$$20240722$20240729$20240729$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004098$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
241473391$24147339$1$I$$20210723$20240729$20240729$EXP$$US-AstraZeneca-2021A646575$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241473401$24147340$1$I$$20210726$20240729$20240729$EXP$$US-AstraZeneca-2021A646765$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241473411$24147341$1$I$20211025$20211110$20240729$20240729$EXP$$TW-AstraZeneca-2021A802913$ASTRAZENECA$$56$YR$$M$Y$$$20240729$$HP$TW$
241473421$24147342$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2024091118$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$HP$US$US
241473431$24147343$1$I$$20240722$20240729$20240729$PER$$US-ABBVIE-5851884$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241473442$24147344$2$F$$20240819$20240729$20240821$EXP$$NZ-JNJFOC-20240767711$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$MD$NZ$NZ
241473462$24147346$2$F$$20240808$20240729$20240816$30DAY$$CA-JNJFOC-20240763563$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$PH$CA$CA
241473471$24147347$1$I$$20240718$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010715$DR REDDYS$$65$YR$A$M$Y$$$20240729$$MD$US$US
241473481$24147348$1$I$20240709$20240723$20240729$20240729$EXP$CN-91110000556821568D-2024DRL001352$CN-RDY-SPO/CHN/24/0010983$DR REDDYS$$75$YR$E$F$Y$48$KG$20240729$$HP$CN$CN
241473501$24147350$1$I$$20240717$20240729$20240729$PER$US-MLMSERVICE-20240715-PI097334-00099-2$US-RDY-SPO/USA/24/0010683$DR REDDYS$Pokhriyal SC, Tan EF, Bhatt PK, Khan AA, Pasha MN, Pierre L, et al. Assay Interference Causing Persistently Elevated Vancomycin Levels Leading to Treatment Failure and Fatal Outcome. Cureus. 2024;16(6):e61943.DOI:10.7759/cureus.61943$69$YR$E$F$Y$$$20240729$$MD$US$US
241473511$24147351$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51883$$FDA-CTU$$84$YR$$M$N$$$20240729$N$$US$
241473521$24147352$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51895$$FDA-CTU$$69$YR$$$N$60.78$KG$20240729$N$HP$US$
241473531$24147353$1$I$20210202$20240722$20240729$20240729$EXP$$FR-FreseniusKabi-FK202411601$FRESENIUS KABI$$62$YR$A$M$Y$63$KG$20240729$$HP$FR$FR
241473541$24147354$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51910$$FDA-CTU$$80$YR$$F$N$$$20240729$N$HP$US$
241473551$24147355$1$I$20211007$20240718$20240729$20240729$EXP$$JP-ROCHE-3155518$ROCHE$$73$YR$E$M$Y$$$20240729$$MD$JP$JP
241473561$24147356$1$I$20240725$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149146$AMGEN$$$$$$Y$$$20240729$$HP$US$US
241473572$24147357$2$F$20240724$20240814$20240729$20240820$PER$$US-AMGEN-USASP2024148148$AMGEN$$56$YR$A$F$Y$97.9$KG$20240820$$HP$US$US
241473581$24147358$1$I$20240428$20240716$20240729$20240729$EXP$$NL-VALIDUS PHARMACEUTICALS LLC-NL-VDP-2024-019331$VALIDUS$$$$$$Y$$$20240729$$MD$NL$NL
241473591$24147359$1$I$20230831$20230918$20240729$20240729$EXP$$BR-BIOVITRUM-2023-BR-015183$BIOVITRUM$$$$$M$Y$5.2$KG$20240729$$CN$BR$BR
241473601$24147360$1$I$$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A168775$ASTRAZENECA$$$$$F$Y$$$20240729$$HP$US$
241473611$24147361$1$I$$20240719$20240729$20240729$30DAY$$CO-PFIZER INC-202400220775$PFIZER$$$$$M$Y$$$20240729$$CN$CO$CO
241473634$24147363$4$F$20240701$20240918$20240729$20240918$30DAY$$AR-PFIZER INC-202400222167$PFIZER$$8$YR$$M$Y$$$20240918$$HP$AR$AR
241473642$24147364$2$F$$20240901$20240729$20240903$30DAY$$CL-PFIZER INC-202400223928$PFIZER$$$$$$Y$$$20240903$$CN$CL$CL
241473661$24147366$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119109$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240729$$HP$US$US
241473683$24147368$3$F$$20240912$20240729$20240913$30DAY$$CL-PFIZER INC-PV202400092554$PFIZER$$12$YR$$F$Y$$$20240913$$CN$CL$CL
241473691$24147369$1$I$$20240724$20240729$20240729$EXP$$GB-AMGEN-GBRSL2024147388$AMGEN$$74$YR$E$M$Y$$$20240729$$CN$GB$GB
241473701$24147370$1$I$$20240715$20240729$20240729$EXP$$US-EPICPHARMA-US-2024EPCLIT00879$EPIC PHARM$M Simpson.Early Extra Corporeal Membrane Oxygenation (ECMO) and Esophagogastroduodenoscopy (EGD) Implementation: A Timely Intervention in a Patient With Extended-Release Bupropion Overdose..American Journal of Respiratory and Critical Care Medicine.2024;209:A5672$41$YR$A$M$Y$$$20240729$$HP$US$US
241473711$24147371$1$I$$20240721$20240729$20240729$PER$$US-ABBVIE-5851081$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241473721$24147372$1$I$20240601$20240716$20240729$20240729$EXP$$NL-VALIDUS PHARMACEUTICALS LLC-NL-VDP-2024-019334$VALIDUS$$$$$$Y$$$20240729$$MD$NL$NL
241473732$24147373$2$F$$20240813$20240729$20240830$30DAY$$DE-JNJFOC-20240762872$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$DE$DE
241473741$24147374$1$I$20230201$20240725$20240729$20240729$EXP$$IE-ASTELLAS-2024US021452$ASTELLAS$$$$$M$Y$$$20240729$$CN$IE$IE
241473761$24147376$1$I$$20240724$20240729$20240729$EXP$$US-INCYTE CORPORATION-2024IN007794$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241473771$24147377$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2024091253$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241473782$24147378$2$F$20230101$20240801$20240729$20240807$EXP$$US-ROCHE-10000033334$ROCHE$$74$YR$E$F$Y$79.38$KG$20240807$$CN$US$US
241473791$24147379$1$I$20230202$20240719$20240729$20240729$EXP$$BE-TEVA-VS-3224572$TEVA$$$$A$M$Y$65$KG$20240729$$MD$BE$BE
241473801$24147380$1$I$$20240722$20240729$20240729$PER$$US-ABBVIE-5851841$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241473812$24147381$2$F$20240716$20240729$20240729$20240805$EXP$$JP-009507513-2407JPN003959J$MERCK$$82$YR$$F$Y$$$20240805$$MD$JP$JP
241473821$24147382$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092524$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241473831$24147383$1$I$$20240722$20240729$20240729$EXP$$TR-ASTELLAS-2024EU007405$ASTELLAS$Arabaci IC, Tabakci BN, Onal I, Yildirim Y. Erlotinib-induced blepharitis: Management of two challenging cases. Journal francais d^ophtalmologie. 2024;104247:e1-3$40$YR$$F$Y$$$20240729$$HP$TR$TR
241473841$24147384$1$I$20240201$20240723$20240729$20240729$EXP$FR-AFSSAPS-PO2024000805$FR-RDY-SPO/FRA/24/0010910$DR REDDYS$$26$YR$A$F$Y$$$20240729$$MD$FR$FR
241473852$24147385$2$F$20240718$20240828$20240729$20240902$PER$$US-JNJFOC-20240758784$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240902$$CN$US$US
241473861$24147386$1$I$20240701$20240722$20240729$20240729$EXP$$FR-ORGANON-O2407FRA001926$ORGANON$$48$YR$$F$Y$$$20240729$$MD$FR$FR
241473871$24147387$1$I$20240622$20240719$20240729$20240729$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-06943$HIKMA$$$$$$Y$$$20240729$$MD$EG$EG
241473881$24147388$1$I$$20240726$20240729$20240729$PER$$US-TAKEDA-2024TUS075996$TAKEDA$$$$$F$Y$$$20240729$$CN$US$US
241473892$24147389$2$F$$20240715$20240729$20240812$EXP$$PT-TEVA-VS-3222019$TEVA$Lopes T, Antes J, Melo B, Gon?alves F, Cruz C. CO-0237 - (4707) - Organizing pneumonia due to human Metapneumovirus in a lung transplant recipient. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts [CNMI]. 2024 May; 331$25$YR$$M$Y$$$20240812$$MD$PT$PT
241473901$24147390$1$I$20230425$20240724$20240729$20240729$EXP$FR-AFSSAPS-NT2024000848$FR-009507513-2407FRA013500$MERCK$$57$YR$$M$Y$60.5$KG$20240729$$MD$FR$FR
241473911$24147391$1$I$$20240716$20240729$20240729$EXP$$NVSC2024BE149111$NOVARTIS$$$$C$F$Y$$$20240729$$MD$BE$BE
241473922$24147392$2$F$20240320$20240724$20240729$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407017311$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240801$$HP$US$US
241473931$24147393$1$I$$20240715$20240729$20240729$EXP$$US-EPICPHARMA-US-2024EPCLIT00892$EPIC PHARM$S. C. Oomrigar.The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death.American Journal of Respiratory and Critical Care Medicine.2024;209:A5653$$$A$F$Y$$$20240729$$HP$US$US
241473941$24147394$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092447$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241473951$24147395$1$I$20150401$20240723$20240729$20240729$PER$$US-BIOGEN-2015BI057967$BIOGEN$$60$YR$$F$Y$$$20240729$$CN$US$US
241473971$24147397$1$I$20230101$20240723$20240729$20240729$EXP$$GB-MYLANLABS-2024M1069021$MYLAN$$$$$M$Y$$$20240729$$CN$GB$GB
241473981$24147398$1$I$$20240724$20240729$20240729$EXP$$US-ABBVIE-5797654$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241473992$24147399$2$F$$20240731$20240729$20240802$EXP$$CA-TAKEDA-2024TUS075427$TAKEDA$$$$$F$Y$$$20240802$$CN$CA$CA
241474001$24147400$1$I$20240720$20240722$20240729$20240729$PER$$US-AMGEN-USASP2024146504$AMGEN$$65$YR$E$F$Y$$$20240729$$CN$US$US
241474012$24147401$2$F$$20240731$20240729$20240808$EXP$$PL-AMGEN-POLSP2024146169$AMGEN$Koper:A.. Metastasis of colorectal cancer to the ovary in a patient treated with panitumumab and FOLFOX4 chemotherapy after achieving complete remission in imaging tests$67$YR$E$F$Y$$$20240808$$MD$PL$PL
241474021$24147402$1$I$20240425$20240722$20240729$20240729$EXP$$IE-CELLTRION INC.-2024IE010457$CELLTRION$$$$$$Y$$$20240729$$PH$IE$IE
241474031$24147403$1$I$$20240725$20240729$20240729$EXP$$TR-AstraZeneca-2024A170116$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$TR$
241474041$24147404$1$I$20240130$20240724$20240729$20240729$EXP$$US-OTSUKA-2024_003304$OTSUKA$$$$$F$Y$$$20240729$$HP$US$US
241474051$24147405$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2023171757$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241474061$24147406$1$I$20240715$20240724$20240729$20240729$EXP$$US-ABBVIE-5853947$ABBVIE$$59$YR$$M$Y$$$20240729$$CN$US$US
241474071$24147407$1$I$20240105$20240723$20240729$20240729$EXP$FR-AFSSAPS-TS2024000818$FR-MYLANLABS-2024M1069690$MYLAN$$75$YR$$F$Y$60$KG$20240729$$MD$FR$FR
241474081$24147408$1$I$$20240722$20240729$20240729$EXP$$US-VIVUS, Inc.-2024V1000921$VIVUS$$$$A$F$Y$$$20240726$$CN$US$US
241474091$24147409$1$I$$20240722$20240729$20240729$EXP$$US-VIVUS LLC-2024V1000924$VIVUS$$$$A$F$Y$$$20240729$$CN$US$US
241474101$24147410$1$I$$20240726$20240729$20240729$PER$$US-AMGEN-USASP2024149732$AMGEN$$71$YR$E$M$Y$$$20240729$$CN$US$US
241474111$24147411$1$I$$20240715$20240729$20240729$EXP$$AU-LUPIN EUROPE GMBH-2024-07290$LUPIN$$65$YR$$M$Y$$$20240729$$CN$AU$AU
241474121$24147412$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5855538$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241474131$24147413$1$I$$20240715$20240729$20240729$EXP$$US-PURACAP-US-2024EPCLIT00870$PURACAP$A. Gans.A Case of Drug-Induced Stevens-Johnson Syndrome With Primarily Visceral Involvement.American Journal of Respiratory and Critical Care Medicine .MAY-2024;209:A5678$76$YR$E$F$Y$$$20240729$$HP$US$US
241474141$24147414$1$I$$20240727$20240729$20240729$EXP$GB-MHRA-MED-202407262113594890-VKHFP$GB-ORGANON-O2407GBR002604$ORGANON$$63$YR$$M$Y$78$KG$20240729$$CN$GB$GB
241474151$24147415$1$I$20240712$20240718$20240729$20240729$EXP$$TW-JNJFOC-20240751141$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$HP$TW$TW
241474161$24147416$1$I$20210127$20240726$20240729$20240729$EXP$$US-UCBSA-2022064092$UCB$$31$YR$$F$Y$74$KG$20240729$$MD$US$US
241474171$24147417$1$I$20240704$20240719$20240729$20240729$EXP$$CN-JNJFOC-20240760012$JOHNSON AND JOHNSON$$71$YR$E$F$Y$55$KG$20240729$$HP$CN$CN
241474181$24147418$1$I$$20240722$20240729$20240729$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005477$BIOCON$$$$$$Y$$$20240729$$MD$CA$CA
241474191$24147419$1$I$$20240723$20240729$20240729$EXP$$GB-MYLANLABS-2024M1069013$MYLAN$$$$$M$Y$$$20240729$$CN$GB$GB
241474201$24147420$1$I$20240328$20240719$20240729$20240729$EXP$FR-AFSSAPS-BS2024000421$FR-TEVA-VS-3223709$TEVA$$75$YR$$M$Y$85$KG$20240729$$MD$FR$FR
241474211$24147421$1$I$20240428$20240729$20240729$20240729$EXP$GR-GREOF-202400824$GR-BAYER-2024A109323$BAYER$$$$$M$Y$$$20240729$$MD$GR$GR
241474221$24147422$1$I$20240702$20240723$20240729$20240729$EXP$FR-AFSSAPS-RS2024000701$FR-009507513-2407FRA012946$MERCK$$60$YR$$M$Y$81$KG$20240729$$PH$FR$FR
241474231$24147423$1$I$$20240718$20240729$20240729$EXP$$TR-ROCHE-10000030330$ROCHE$Turkel A, Karacin C, Oksuzoglu B. Investigation of Clinical Course and Possible Drug Interactions in Patients with Multiple Sclerosis and Breast Cancer. Journal of the College of Physicians and Surgeons Pakistan. 2024-Jul;34 (7):842-844. doi:10.29271/jcpsp.2024.07.842.$$$$F$Y$$$20240729$$MD$TR$TR
241474241$24147424$1$I$20240721$20240723$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117741$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240729$$MD$US$US
241474251$24147425$1$I$$20240725$20240729$20240729$EXP$$CA-PFIZER INC-202400223770$PFIZER$$4$YR$$F$Y$11$KG$20240729$$PH$CA$CA
241474261$24147426$1$I$20240620$20240725$20240729$20240729$EXP$$CN-PFIZER INC-PV202400097504$PFIZER$$45$YR$$F$Y$73$KG$20240729$$HP$CN$CN
241474271$24147427$1$I$20240702$20240725$20240729$20240729$EXP$$CN-PFIZER INC-PV202400097507$PFIZER$$12$YR$$F$Y$30.1$KG$20240729$$HP$CN$CN
241474281$24147428$1$I$$20240725$20240729$20240729$EXP$NL-LRB-00990664$NL-PFIZER INC-202400223492$PFIZER$$30$YR$$F$Y$$$20240729$$MD$NL$NL
241474301$24147430$1$I$20240711$20240725$20240729$20240729$EXP$$US-PFIZER INC-202400224974$PFIZER$$65$YR$$F$Y$$$20240729$$HP$US$US
241474311$24147431$1$I$20240703$20240725$20240729$20240729$EXP$NO-NOMAADVRE-RELISM-2024-Vp373e$NO-PFIZER INC-202400223392$PFIZER$$57$YR$$M$Y$$$20240729$$MD$NO$NO
241474321$24147432$1$I$20240603$20240725$20240729$20240729$EXP$FR-AFSSAPS-MA2024000995$FR-PFIZER INC-202400223486$PFIZER$$55$YR$$F$Y$$$20240729$$MD$FR$FR
241474331$24147433$1$I$$20240725$20240729$20240729$EXP$$JP-PFIZER INC-202400223562$PFIZER$$$$$$Y$$$20240729$$PH$JP$JP
241474341$24147434$1$I$$20240725$20240729$20240729$EXP$$CA-PFIZER INC-202400223775$PFIZER$$5$YR$$M$Y$16$KG$20240729$$PH$CA$CA
241474352$24147435$2$F$20240701$20240807$20240729$20240809$EXP$$AR-PFIZER INC-202400223879$PFIZER$$86$YR$$F$Y$$$20240809$$CN$AR$AR
241474361$24147436$1$I$20170622$20240725$20240729$20240729$EXP$$BR-PFIZER INC-2017268592$PFIZER$$75$YR$$M$Y$$$20240729$$CN$BR$BR
241474371$24147437$1$I$$20240725$20240729$20240729$EXP$$CA-PFIZER INC-202400223859$PFIZER$$18$YR$$F$Y$49$KG$20240729$$HP$CA$CA
241474381$24147438$1$I$$20240725$20240729$20240729$EXP$$CA-PFIZER INC-202400223848$PFIZER$$3$YR$$M$Y$14$KG$20240729$$PH$CA$CA
241474391$24147439$1$I$20230803$20240725$20240729$20240729$EXP$FR-AFSSAPS-NT2024000835$FR-PFIZER INC-202400223471$PFIZER$$11$YR$$M$Y$22.5$KG$20240729$$PH$FR$FR
241474401$24147440$1$I$20240119$20240725$20240729$20240729$EXP$$CN-PFIZER INC-PV202400097487$PFIZER$$21$YR$$F$Y$55$KG$20240729$$HP$CN$CN
241474411$24147441$1$I$$20240725$20240729$20240729$EXP$$CA-PFIZER INC-202400224516$PFIZER$$36$YR$$F$Y$$$20240729$$CN$CA$CA
241474421$24147442$1$I$20240712$20240725$20240729$20240729$EXP$FR-AFSSAPS-DJ2024000858$FR-PFIZER INC-202400223478$PFIZER$$80$YR$$F$Y$$$20240729$$MD$FR$FR
241474431$24147443$1$I$$20240715$20240729$20240729$PER$$US-ALKERMES INC.-ALK-2024-001906$ALKERMES$$2$DEC$$F$Y$$$20240729$$HP$US$US
241474441$24147444$1$I$20240723$20240723$20240729$20240729$PER$$US-BAYER-2024A106909$BAYER$$29$YR$A$F$Y$$$20240729$$MD$US$US
241474451$24147445$1$I$$20240715$20240729$20240729$EXP$$TN-Saptalis Pharmaceuticals LLC-2159718$SAPTALIS PHARMACEUTICALS$This case is a Forign Literature report of Metronidazole administered intravenously. the adverse event is relavant regardless of route of administration; so Saptalis (the manufacturer) decided to report it. This case highlights the possibility of metronidazole-induced DRESS syndrome.$10$YR$$F$Y$$$20240729$$$US$TN
241474461$24147446$1$I$$20240715$20240729$20240729$EXP$$IN-ROCHE-10000007942$ROCHE$$66$YR$E$M$Y$73$KG$20240729$$CN$IN$IN
241474471$24147447$1$I$$20240723$20240729$20240729$PER$$US-BAYER-2024A107342$BAYER$$$$$F$Y$$$20240729$$CN$US$US
241474482$24147448$2$F$$20240830$20240729$20240913$EXP$$AU-Ascend Therapeutics US, LLC-2159719$ASCEND$$$$$F$Y$$$20240913$$MD$AU$AU
241474492$24147449$2$F$20140101$20240909$20240729$20240916$EXP$$GB-JUBILANT CADISTA PHARMACEUTICALS-2024GB001036$JUBILANT$$$$A$M$Y$73$KG$20240916$$MD$GB$GB
241474502$24147450$2$F$$20240731$20240729$20240802$EXP$$CA-JNJFOC-20240772926$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240802$$HP$CA$CA
241474511$24147451$1$I$$20240723$20240729$20240729$EXP$$US-JNJFOC-20240761920$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240729$$HP$US$US
241474522$24147452$2$F$$20240820$20240729$20240903$EXP$$SE-ORPHALAN-SE-ORP-24-00119$ORPHALAN$Andreas Schult, Matts Andersson, Jorge Asin-Cayuela, Karl Sigvard Olsson. Hemorrhagic colitis induced by trientine in a 51-year-old patient with Wilson^s disease waiting for liver transplantation: A case report. World J Hepatol. 2022;14(8):1687-1691$$$$$Y$$$20240903$$MD$SE$SE
241474531$24147453$1$I$$20240715$20240729$20240729$EXP$$US-PURACAP-US-2024EPCLIT00874$PURACAP$S Goswami.Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series.Pediatric Nephrology.JAN-2024$6$YR$C$F$Y$$$20240729$$HP$US$US
241474542$24147454$2$F$20240725$20240802$20240729$20240805$PER$$US-AMGEN-USASP2024149291$AMGEN$$41$YR$A$F$Y$$$20240805$$CN$US$US
241474551$24147455$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147608$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241474561$24147456$1$I$20240510$20240718$20240729$20240729$EXP$$AU-BEH-2024176014$CSL BEHRING$$81$YR$E$M$Y$$$20240729$$HP$AU$AU
241474573$24147457$3$F$20240624$20240809$20240729$20240815$30DAY$$BE-PFIZER INC-202400216079$PFIZER$$78$YR$$M$Y$92$KG$20240815$$PH$BE$BE
241474582$24147458$2$F$20240713$20240823$20240729$20240827$30DAY$$CA-PFIZER INC-202400062565$PFIZER$$80$YR$$F$Y$$$20240827$$MD$CA$CA
241474592$24147459$2$F$20240706$20240726$20240729$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118897$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240805$$PH$US$US
241474601$24147460$1$I$$20240723$20240729$20240729$EXP$$CH-PFIZER INC-202400221961$PFIZER$$33$YR$$F$Y$$$20240729$$CN$CH$CH
241474611$24147461$1$I$20240229$20240715$20240729$20240729$30DAY$$UY-PFIZER INC-202400216233$PFIZER$$6$YR$$F$Y$$$20240729$$CN$UY$UY
241474623$24147462$3$F$$20240919$20240729$20240919$EXP$$CA-PFIZER INC-202400037486$PFIZER$$54$YR$$M$Y$$$20240919$$PH$CA$CA
241474631$24147463$1$I$20240101$20240718$20240729$20240729$PER$$US-ALKERMES INC.-ALK-2024-001950$ALKERMES$$$$$F$Y$$$20240729$$CN$US$US
241474641$24147464$1$I$$20240719$20240729$20240729$PER$$US-ALKERMES INC.-ALK-2024-001933$ALKERMES$$$$$M$Y$$$20240729$$CN$US$US
241474652$24147465$2$F$$20240814$20240729$20240819$EXP$SE-SEMPA-2022-017817$SE-INSUD PHARMA-2407SE05972$INSUD PHARMA$$37$YR$$F$Y$65$KG$20240819$$CN$SE$SE
241474661$24147466$1$I$$20240723$20240729$20240729$EXP$GB-MHRA-31008345$GB-LABORATORIOS LICONSA S.A.-2407GB05911$INSUD PHARMA$$62$YR$$F$Y$62$KG$20240729$$CN$GB$GB
241474673$24147467$3$F$20240101$20240814$20240729$20240829$PER$$US-BIOMARINAP-US-2024-159432$BIOMARIN$$$$$$Y$$$20240829$$CN$US$US
241474681$24147468$1$I$20240708$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149262$AMGEN$$88$YR$E$F$Y$$$20240729$$MD$US$US
241474691$24147469$1$I$$20240715$20240729$20240729$EXP$$US-PURACAP-US-2024EPCLIT00876$PURACAP$S Goswami.Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series.Pediatric Nephrology.JAN-2024$15$YR$T$M$Y$$$20240729$$HP$US$US
241474701$24147470$1$I$20240714$20240724$20240729$20240729$EXP$IT-MINISAL02-996111$IT-ORGANON-O2407ITA002297$ORGANON$$1$YR$$F$Y$$$20240729$$PH$IT$IT
241474711$24147471$1$I$$20240726$20240729$20240729$EXP$$US-GILEAD-2024-0682156$GILEAD$$$$E$F$Y$$$20240729$$MD$US$US
241474721$24147472$1$I$20220530$20240722$20240729$20240729$EXP$FR-AFSSAPS-PC2024000564$FR-009507513-2407FRA012529$MERCK$$40$YR$$F$Y$70$KG$20240729$$MD$FR$FR
241474731$24147473$1$I$20240621$20240719$20240729$20240729$EXP$FR-AFSSAPS-ST2024001167$FR-TEVA-VS-3223563$TEVA$$71$YR$$M$Y$$$20240729$$MD$FR$FR
241474741$24147474$1$I$$20240722$20240729$20240729$EXP$$CA-APOTEX-2024AP008694$APOTEX$$75$YR$$F$Y$$$20240729$$HP$CA$CA
241474751$24147475$1$I$$20240715$20240729$20240729$EXP$$PS-EPICPHARMA-PS-2024EPCLIT00885$EPIC PHARM$Mahmoud R. Manasra.Ceftriaxone-induced symptomatic cholelithiasis in a child: case report and literature review.Oxford Medical Case Reports.2024;6:255-257$8$YR$C$F$Y$$$20240729$$HP$PS$PS
241474761$24147476$1$I$20240601$20240716$20240729$20240729$PER$$US-ALKERMES INC.-ALK-2024-001903$ALKERMES$$59$YR$$F$Y$95.238$KG$20240729$$CN$US$US
241474771$24147477$1$I$20240710$20240724$20240729$20240729$EXP$$ZA-AstraZeneca-2024A169904$ASTRAZENECA$$31411$DY$$M$Y$$$20240729$$CN$ZA$
241474781$24147478$1$I$$20211110$20240729$20240729$EXP$$US-AstraZeneca-2021A805059$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241474791$24147479$1$I$$20240718$20240729$20240729$30DAY$$US-GSK-US1952000002$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241474801$24147480$1$I$$20240719$20240729$20240729$EXP$$AU-AstraZeneca-2024A171008$ASTRAZENECA$$$$$$Y$$$20240729$$MD$AU$
241474811$24147481$1$I$$20211213$20240729$20240729$EXP$$US-AstraZeneca-2021A872560$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241474821$24147482$1$I$20240627$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A168776$ASTRAZENECA$$26741$DY$$M$Y$$$20240729$$CN$US$
241474831$24147483$1$I$20230609$20230905$20240729$20240729$EXP$$US-AstraZeneca-2023A203455$ASTRAZENECA$$27121$DY$$F$Y$$$20240729$$CN$US$
241474842$24147484$2$F$$20220704$20240729$20240819$EXP$$PH-AstraZeneca-2022A240649$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$PH$
241474851$24147485$1$I$$20220420$20240729$20240729$EXP$$US-AstraZeneca-2022A160618$ASTRAZENECA$$$$$M$Y$$$20240729$$HP$US$
241474862$24147486$2$F$$20240724$20240729$20240801$EXP$$DE-AstraZeneca-2024A169144$ASTRAZENECA$$$$$F$Y$$$20240801$$HP$DE$
241474872$24147487$2$F$$20240806$20240729$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119636$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240808$$CN$US$US
241474881$24147488$1$I$20240724$20240724$20240729$20240729$EXP$$US-BAYER-2024A107677$BAYER$$67$YR$E$F$Y$$$20240729$$CN$US$US
241474891$24147489$1$I$20240722$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016640$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240729$$CN$US$US
241474901$24147490$1$I$$20240714$20240729$20240729$EXP$$US-Saptalis Pharmaceuticals LLC-2159720$SAPTALIS PHARMACEUTICALS$A domestic case of PubMed reported literature to state the importance of having MALA high on the differential in a patient with a history of liver disease, specifically alcoholic liver disease presenting with a very elevated lactic acidosis and anion gap and being knowledgeable that prompt hemodialysis could be lifesaving. The case is categorised as a Serious- Listed -Domestic .$63$YR$$F$Y$$$20240729$$$US$US
241474911$24147491$1$I$$20240716$20240729$20240729$PER$$US-TEVA-VS-3225800$TEVA$$69$YR$$F$Y$$$20240729$$PH$US$US
241474923$24147492$3$F$20240721$20240828$20240729$20240830$PER$$US-ROCHE-10000035278$ROCHE$$77$YR$E$F$Y$76.66$KG$20240830$$CN$US$US
241474931$24147493$1$I$20240601$20240715$20240729$20240729$PER$$US-ROCHE-10000027367$ROCHE$$35$YR$A$M$Y$$$20240729$$HP$US$US
241474941$24147494$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5856004$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241474952$24147495$2$F$$20240718$20240729$20240729$EXP$$US-ROCHE-10000033431$ROCHE$$62$YR$A$F$Y$$$20240729$$CN$US$US
241474962$24147496$2$F$$20240726$20240729$20240730$PER$$US-ROCHE-10000035867$ROCHE$$$$$$Y$$$20240730$$CN$US$US
241474971$24147497$1$I$$20240729$20240729$20240729$EXP$$TR-GILEAD-2024-0682194$GILEAD$$$$$F$Y$$$20240729$$MD$TR$TR
241474981$24147498$1$I$$20240715$20240729$20240729$EXP$$IL-EPICPHARMA-IL-2024EPCLIT00871$EPIC PHARM$A Schattner.Ceftriaxone near-fatal anaphylaxis.Postgraduate Medical Journal.MAY-2024$75$YR$E$F$Y$$$20240729$$HP$IL$IL
241474992$24147499$2$F$20240609$20240725$20240729$20240801$EXP$DE-CADRBFARM-2024329453$DE-RDY-SPO/DEU/24/0010874$DR REDDYS$$34$YR$A$M$Y$117$KG$20240801$$CN$DE$DE
241475001$24147500$1$I$20240725$20240725$20240729$20240729$EXP$$AU-ROCHE-10000004187$ROCHE$$61$YR$A$M$Y$$$20240729$$HP$AU$AU
241475011$24147501$1$I$$20240716$20240729$20240729$EXP$$US-ADMA BIOLOGICS INC.-US-2024ADM000100$ADMA BIOLOGICS$Syc-Mazurek SB, Zhao-Fleming H, Guo Y, Tisavipat N, Chen JJ, Zekeridou A et al.. MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use. Neurology Neuroimmunology Neuroinflammation. 2024;11:e200249$52$YR$$M$Y$$$20240729$$MD$US$US
241475021$24147502$1$I$$20240716$20240729$20240729$EXP$$US-ADMA BIOLOGICS INC.-US-2024ADM000101$ADMA BIOLOGICS$Syc-Mazurek SB, Zhao-Fleming H, Guo Y, Tisavipat N, Chen JJ, Zekeridou A, et al.. MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use. Neurology Neuroimmunology Neuroinflammation. 2024;11:e200249$52$YR$$M$Y$$$20240729$$MD$US$US
241475031$24147503$1$I$$20240722$20240729$20240729$EXP$GB-MHRA-MED-202407160911013230-CVHYG$GB-BAYER-2024A106268$BAYER$$$$$F$Y$50$KG$20240729$$CN$GB$GB
241475041$24147504$1$I$20240709$20240723$20240729$20240729$EXP$IT-MINISAL02-995195$IT-MYLANLABS-2024M1069389$MYLAN$$86$YR$$F$Y$$$20240729$$PH$IT$IT
241475051$24147505$1$I$20240418$20240723$20240729$20240729$EXP$FR-AFSSAPS-AVPA2024000647$FR-MYLANLABS-2024M1069165$MYLAN$$34$YR$$M$Y$$$20240729$$PH$FR$FR
241475065$24147506$5$F$20240524$20240913$20240729$20240917$EXP$$US-ORGANON-O2406USA000141$ORGANON$$30$YR$$M$Y$$$20240917$$CN$US$US
241475072$24147507$2$F$$20240729$20240729$20240730$PER$$US-ROCHE-10000040503$ROCHE$$63$YR$A$M$Y$$$20240730$$CN$US$US
241475082$24147508$2$F$$20240829$20240729$20240906$PER$$US-ROCHE-3542478$ROCHE$$$$E$M$Y$$$20240906$$CN$US$US
241475092$24147509$2$F$$20240913$20240729$20240917$PER$$US-ROCHE-10000038673$ROCHE$$$$E$F$Y$$$20240917$$CN$US$US
241475101$24147510$1$I$$20240723$20240729$20240729$EXP$$US-ABBVIE-5851970$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241475111$24147511$1$I$$20240716$20240729$20240729$EXP$$AU-Ascend Therapeutics US, LLC-2159721$ASCEND$$$$$F$Y$$$20240729$$$AU$AU
241475121$24147512$1$I$20230316$20230610$20240729$20240729$EXP$$CO-BIOVITRUM-2023-CO-012013$BIOVITRUM$$158$DY$$M$Y$10.2$KG$20240729$$CN$CO$CO
241475131$24147513$1$I$20240717$20240717$20240729$20240729$PER$$US-ALKERMES INC.-ALK-2024-001918$ALKERMES$$36$YR$$M$Y$$$20240729$$HP$US$US
241475142$24147514$2$F$$20240802$20240729$20240808$PER$$US-ROCHE-10000037717$ROCHE$$$$E$F$Y$$$20240808$$CN$US$US
241475151$24147515$1$I$20240708$20240726$20240729$20240729$PER$$US-ROCHE-10000040560$ROCHE$$15$YR$T$M$Y$$$20240729$$CN$US$US
241475161$24147516$1$I$$20240715$20240729$20240729$EXP$$EC-EPICPHARMA-EC-2024EPCLIT00881$EPIC PHARM$Juan S. Izquierdo-Condoy.Takotsubo syndrome as an acute cardiac complication following combined chemotherapy.International Journal of Cardiology: Cardiovascular Risk and Prevention.31-MAY-2024;22:1-5$61$YR$A$F$Y$$$20240729$$HP$EC$EC
241475171$24147517$1$I$20240709$20240719$20240729$20240729$EXP$NL-LRB-00990265$NL-SA-2024SA214890$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240729$$MD$NL$NL
241475181$24147518$1$I$$20240726$20240729$20240729$PER$$US-ROCHE-10000040476$ROCHE$$$$C$M$Y$$$20240729$$CN$US$US
241475191$24147519$1$I$$20240723$20240729$20240729$EXP$FR-AFSSAPS-AVNT2024000504$FR-MYLANLABS-2024M1069068$MYLAN$$26$YR$$M$Y$$$20240729$$MD$FR$FR
241475201$24147520$1$I$20240701$20240725$20240729$20240729$PER$$US-ABBVIE-5856994$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241475211$24147521$1$I$20240101$20240724$20240729$20240729$EXP$$US-ABBVIE-5853906$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241475221$24147522$1$I$$20240723$20240729$20240729$EXP$$IE-TAKEDA-2024TUS076035$TAKEDA$$$$$$Y$$$20240729$$MD$IE$IE
241475231$24147523$1$I$$20240724$20240729$20240729$EXP$$GB-ABBVIE-5853853$ABBVIE$$$$A$F$Y$$$20240729$$CN$GB$GB
241475241$24147524$1$I$$20240722$20240729$20240729$EXP$$CA-APOTEX-2024AP008697$APOTEX$$$$$F$Y$$$20240729$$CN$CA$CA
241475251$24147525$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092779$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241475261$24147526$1$I$$20240723$20240729$20240729$EXP$$CA-TAKEDA-2024TUS075046$TAKEDA$$$$$M$Y$$$20240729$$CN$CA$CA
241475271$24147527$1$I$$20240715$20240729$20240729$EXP$$TR-EPICPHARMA-TR-2024EPCLIT00883$EPIC PHARM$Ali Osman Saatci.Endogenous Endophthalmitis Caused by Aspergillus lentulus in an  Immunocompromised Patient with Lung Cancer.Turkish Journal of Ophthalmology.27-MAY-2024;54:175-179$78$YR$E$M$Y$$$20240729$$HP$TR$TR
241475281$24147528$1$I$$20240723$20240729$20240729$EXP$$US-SA-2024SA217576$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240729$$MD$US$US
241475292$24147529$2$F$20240717$20240730$20240729$20240812$PER$$US-ALKERMES INC.-ALK-2024-001921$ALKERMES$$54$YR$$F$Y$83.447$KG$20240812$$HP$US$US
241475311$24147531$1$I$$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51919$$FDA-CTU$$$$$M$N$$$20240726$N$HP$US$
241475321$24147532$1$I$$20240725$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042221$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240729$$MD$US$US
241475331$24147533$1$I$$20240722$20240729$20240729$EXP$$GB-MYLANLABS-2024M1068753$MYLAN$$$$$M$Y$$$20240729$$CN$GB$GB
241475341$24147534$1$I$$20240722$20240729$20240729$EXP$FR-AFSSAPS-AVNT2024000543$FR-MYLANLABS-2024M1068310$MYLAN$$43$YR$$M$Y$$$20240729$$PH$FR$FR
241475351$24147535$1$I$$20240722$20240729$20240729$EXP$$CA-MYLANLABS-2024M1068721$MYLAN$$$$$M$Y$$$20240729$$CN$CA$CA
241475361$24147536$1$I$20240523$20240722$20240729$20240729$EXP$FR-AFSSAPS-NT2024000800$FR-MYLANLABS-2024M1068494$MYLAN$$79$YR$$F$Y$$$20240729$$MD$FR$FR
241475371$24147537$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069797$MYLAN$Sinha Ray A, Ghosh M, Plambeck R. Intractable Pain and Digital Ulceration From Severe Digital Ischemia With Raynauds- How to ^Cut It^?. Am-J-Respir-Crit-Care-Med 2023; 207 abstr. A47.$60$YR$$F$Y$$$20240729$$HP$US$US
241475381$24147538$1$I$$20240719$20240729$20240729$EXP$$TW-AMGEN-TWNSP2024145086$AMGEN$Chen, S. CMV Retinitis with Panretinal Occlusive Vasculitis. Ocular Immunology and Inflammation. 2024;32 (5):477-484$58$YR$A$M$Y$$$20240729$$MD$TW$TW
241475391$24147539$1$I$$20240722$20240729$20240729$EXP$$CA-MYLANLABS-2024M1068269$MYLAN$$29$YR$$F$Y$$$20240729$$CN$CA$CA
241475401$24147540$1$I$20240718$20240719$20240729$20240729$30DAY$$US-AMGEN-USASP2024144860$AMGEN$$$$$M$Y$100$KG$20240729$$PH$US$US
241475412$24147541$2$F$20240501$20240805$20240729$20240811$EXP$$US-SA-2024SA220699$SANOFI AVENTIS$$$$A$M$Y$68.04$KG$20240811$$MD$US$US
241475431$24147543$1$I$20231201$20240724$20240729$20240729$EXP$FR-AFSSAPS-AN2024000916$FR-SA-2024SA220713$SANOFI AVENTIS$$74$YR$E$$Y$$$20240729$$MD$FR$FR
241475441$24147544$1$I$$20240725$20240729$20240729$EXP$$US-SA-2024SA218612$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240729$$MD$US$US
241475461$24147546$1$I$20230101$20240724$20240729$20240729$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-098678$REGENERON$$$$$M$Y$$$20240729$$CN$US$US
241475471$24147547$1$I$20220124$20220811$20240729$20240729$EXP$$BR-AstraZeneca-2022A285776$ASTRAZENECA$$$$$F$Y$$$20240729$$MD$BR$
241475481$24147548$1$I$$20230720$20240729$20240729$EXP$$US-AstraZeneca-2023A167442$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241475491$24147549$1$I$20220515$20220711$20240729$20240729$EXP$$US-AstraZeneca-2022A199485$ASTRAZENECA$$27140$DY$$F$Y$$$20240729$$CN$US$
241475501$24147550$1$I$$20240716$20240729$20240729$EXP$$JP-AstraZeneca-2024A171421$ASTRAZENECA$Misaka S, Yunokawa M, Yoshimitsu T, Fusegi A, Abe A, Kanno M. et al... P-256 A case of ovarian cancer with prolonged anaphylactic shock due to contrast medium during administration of pembrolizumab.. The journal of the Japan Society of Gynecologic Oncology The 66th Annual Meeting. 2024;42?3?:418.$57$YR$$F$Y$$$20240729$$MD$JP$
241475551$24147555$1$I$$20240717$20240729$20240729$EXP$$BR-PFIZER INC-202400224502$PFIZER$$67$YR$$M$Y$64$KG$20240729$$CN$BR$BR
241475562$24147556$2$F$20240619$20240812$20240729$20240815$EXP$FR-AFSSAPS-BX2024001461$FR-PFIZER INC-202400223411$PFIZER$$80$YR$$F$Y$$$20240815$$PH$FR$FR
241475581$24147558$1$I$20240726$20240726$20240729$20240729$EXP$$US-PFIZER INC-202400224739$PFIZER$$$$$F$Y$$$20240729$$CN$US$US
241475591$24147559$1$I$20240712$20240726$20240729$20240729$EXP$$AR-PFIZER INC-202400224702$PFIZER$$76$YR$$M$Y$$$20240729$$CN$AR$AR
241475601$24147560$1$I$$20240726$20240729$20240729$EXP$$US-PFIZER INC-202400224600$PFIZER$$$$$F$Y$$$20240729$$CN$US$US
241475611$24147561$1$I$$20240726$20240729$20240729$EXP$$US-PFIZER INC-PV202400098413$PFIZER$$75$YR$$F$Y$$$20240729$$CN$US$US
241475631$24147563$1$I$$20240725$20240729$20240729$EXP$$CA-PFIZER INC-202400223773$PFIZER$$3$YR$$M$Y$15$KG$20240729$$PH$CA$CA
241475651$24147565$1$I$20240720$20240726$20240729$20240729$EXP$$US-PFIZER INC-PV202400098137$PFIZER$$71$YR$$F$Y$$$20240729$$CN$US$US
241475672$24147567$2$F$20240708$20240826$20240729$20240904$EXP$$US-KERYX BIOPHARMACEUTICALS INC.-US-AKEB-24-001120$AKEBIA THERAPEUTICS$$62$YR$$M$Y$$$20240904$$HP$US$US
241475682$24147568$2$F$20220630$20240921$20240729$20240924$EXP$$GB-PFIZER INC-202400222068$PFIZER$$61$YR$$M$Y$109$KG$20240924$$MD$GB$GB
241475691$24147569$1$I$$20240726$20240729$20240729$EXP$$MA-PFIZER INC-PV202400098342$PFIZER$$$$$F$Y$$$20240729$$CN$MA$MA
241475712$24147571$2$F$$20240903$20240729$20240904$30DAY$$CO-PFIZER INC-202400218729$PFIZER$$14$YR$$M$Y$$$20240904$$CN$CO$CO
241475722$24147572$2$F$$20240813$20240729$20240816$30DAY$$IE-PFIZER INC-PV202400093090$PFIZER$$$$$$Y$$$20240816$$HP$IE$IE
241475733$24147573$3$F$20240913$20240913$20240729$20240918$EXP$$CA-TAKEDA-2024TUS075415$TAKEDA$$41$YR$$M$Y$$$20240918$$CN$CA$CA
241475741$24147574$1$I$20240101$20240724$20240729$20240729$PER$$US-009507513-2407USA014717$MERCK$$58$YR$$F$Y$$$20240729$$HP$US$US
241475751$24147575$1$I$$20240723$20240729$20240729$EXP$GB-MHRA-30766910$GB-PFIZER INC-202400222083$PFIZER$$$$$$Y$$$20240729$$CN$GB$GB
241475761$24147576$1$I$$20240724$20240729$20240729$PER$$US-JNJFOC-20240768510$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$PH$US$US
241475772$24147577$2$F$$20240830$20240729$20240905$30DAY$$BR-JNJFOC-20240759090$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$PH$BR$BR
241475781$24147578$1$I$20240101$20240716$20240729$20240729$PER$$US-TEVA-VS-3224891$TEVA$$$$$F$Y$$$20240729$$CN$US$US
241475791$24147579$1$I$$20240725$20240729$20240729$EXP$$US-INCYTE CORPORATION-2024IN007823$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241475801$24147580$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069429$MYLAN$Simpson T, Aljareh A, Shah U, Yoon S, Petrovic Elbaz M, Khan Z, et al. Atypical Presentation of Rhinovirus Infection With Rapid Deterioration Requiring Mechanical Ventilation. Am-J-Respir-Crit-Care-Med 2023; 207.$45$YR$$M$Y$$$20240729$$HP$US$US
241475812$24147581$2$F$$20240815$20240729$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119647$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$45.36$KG$20240823$$CN$US$US
241475822$24147582$2$F$20240501$20240804$20240729$20240911$EXP$$BR-GSK-BR2024AMR092377$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$BR$BR
241475831$24147583$1$I$$20240717$20240729$20240729$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07125$LUPIN$Haynes TM, Kukuc L, Proute M, Fishberg R.. A PCSK9 and APOB double heterozygote presenting phenotypically similar to homozygous familial hypercholesterolemia. Circulation. 2023;148 (1)$73$YR$$F$Y$$$20240729$$HP$US$US
241475841$24147584$1$I$20231201$20240724$20240729$20240729$EXP$$DE-ABBVIE-5855556$ABBVIE$$72$YR$$F$Y$$$20240729$$MD$DE$DE
241475861$24147586$1$I$20240626$20240718$20240729$20240729$PER$$US-ALKERMES INC.-ALK-2024-001931$ALKERMES$$72$YR$$F$Y$$$20240729$$PH$US$US
241475871$24147587$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016641$ELI LILLY AND CO$$50$YR$A$$Y$$$20240729$$CN$US$US
241475881$24147588$1$I$$20240723$20240729$20240729$PER$$US-GILEAD-2024-0681748$GILEAD$$$$$M$Y$$$20240729$$CN$US$US
241475895$24147589$5$F$20240703$20240814$20240729$20240820$30DAY$$US-ALKERMES INC.-ALK-2024-001929$ALKERMES$$18$YR$$M$Y$117.46$KG$20240820$$HP$US$US
241475901$24147590$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2024091214$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241475912$24147591$2$F$20240605$20240823$20240729$20240829$EXP$$CA-TAKEDA-2024TUS041727$TAKEDA$$65$YR$$F$Y$$$20240829$$CN$CA$CA
241475921$24147592$1$I$20240723$20240724$20240729$20240729$EXP$GB-MHRA-MED-202407241113464250-NKMQV$GB-MYLANLABS-2024M1069140$MYLAN$$70$YR$$F$Y$$$20240729$$CN$GB$GB
241475931$24147593$1$I$20240715$20240724$20240729$20240729$EXP$GB-MHRA-MED-202407241456547200-RCYQG$GB-MYLANLABS-2024M1069307$MYLAN$$95$YR$$F$Y$$$20240729$$MD$GB$GB
241475941$24147594$1$I$$20240724$20240729$20240729$EXP$GB-MHRA-MIDB-b0ac154e-0835-4945-b18d-d0ea9223a0c0$GB-MYLANLABS-2024M1069288$MYLAN$$83$YR$$F$Y$$$20240729$$PH$GB$GB
241475951$24147595$1$I$20240722$20240724$20240729$20240729$EXP$$GB-MYLANLABS-2024M1040106$MYLAN$$$$$M$Y$$$20240729$$MD$GB$GB
241475961$24147596$1$I$20240724$20240725$20240729$20240729$EXP$$US-ABBVIE-5857028$ABBVIE$$42$YR$$F$Y$$$20240729$$MD$US$US
241475971$24147597$1$I$20240718$20240724$20240729$20240729$EXP$GB-MHRA-MED-202407241532363370-NMHFK$GB-MYLANLABS-2024M1069317$MYLAN$$83$YR$$M$Y$60$KG$20240729$$CN$GB$GB
241475982$24147598$2$F$20240620$20240724$20240729$20240731$EXP$IT-MINISAL02-995494$IT-MYLANLABS-2024M1069064$MYLAN$$95$YR$$F$Y$$$20240731$$MD$IT$IT
241475991$24147599$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224465$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$10$YR$$F$Y$$$20240729$$HP$ES$ES
241476001$24147600$1$I$20240512$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149161$AMGEN$$66$YR$E$F$Y$$$20240729$$HP$US$US
241476011$24147601$1$I$$20240726$20240729$20240729$PER$$US-JNJFOC-20240773861$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$HP$US$US
241476031$24147603$1$I$20240723$20240727$20240727$20240727$DIR$711800$$FDA-CTU$$31$YR$$F$N$98$KG$20240727$N$CN$US$
241476041$24147604$1$I$20240719$20240719$20240729$20240729$EXP$$BR-TEVA-VS-3224495$TEVA$$72$YR$$M$Y$$$20240729$$PH$BR$BR
241476051$24147605$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224466$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$14$YR$$F$Y$$$20240729$$HP$ES$ES
241476061$24147606$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51920$$FDA-CTU$$71$YR$$F$N$$$20240729$N$$US$
241476071$24147607$1$I$20240718$20240727$20240727$20240727$DIR$711774$$FDA-CTU$$41$YR$$F$N$85.05$KG$20240727$N$CN$US$
241476081$24147608$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51931$$FDA-CTU$$55$YR$$F$N$69.4$KG$20240729$N$$US$
241476101$24147610$1$I$$20240727$20240729$20240729$DIR$FDA-CDER-CTU-2024-51932$$FDA-CTU$$$$$F$N$$$20240727$N$HP$US$
241476111$24147611$1$I$20240725$20240727$20240727$20240727$DIR$711772$$FDA-CTU$$55$YR$$F$N$72$KG$20240727$N$CN$NZ$
241476121$24147612$1$I$20240226$20240724$20240729$20240729$EXP$$GB-MYLANLABS-2024M1008499$MYLAN$$38$YR$$F$Y$$$20240729$$MD$GB$GB
241476133$24147613$3$F$20240720$20240807$20240729$20240815$PER$$US-APELLIS-2024-APL-0000534$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240815$$CN$US$US
241476141$24147614$1$I$20240501$20240718$20240729$20240729$EXP$$GB-AUROBINDO-AUR-APL-2024-035957$AUROBINDO$$62$YR$$F$Y$82$KG$20240729$$MD$GB$GB
241476151$24147615$1$I$$20240718$20240729$20240729$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07059$LUPIN$Hamill G, Burchard T, Khan EK. Gazing into the crystal ball: Correlating ATP-binding cassette protein a3 (abca3) pathogenic variant genotypes and phenotypes. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2326$3$WK$$F$Y$$$20240729$$HP$US$US
241476161$24147616$1$I$20220307$20240723$20240729$20240729$PER$$US-RDY-SPO/USA/24/0011014$DR REDDYS$$16$YR$T$F$Y$$$20240729$$MD$US$US
241476171$24147617$1$I$$20240717$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010778$DR REDDYS$$54$YR$E$$Y$$$20240729$$MD$US$US
241476181$24147618$1$I$20240528$20240722$20240729$20240729$EXP$$CA-BAYER-2024A107625$BAYER$$76$YR$E$M$Y$$$20240729$$HP$CA$CA
241476191$24147619$1$I$$20240715$20240729$20240729$EXP$$US-NOVOPROD-1260354$NOVO NORDISK$Sheth et al. Wernicke Encephalopathy Associated WithSemaglutide Use. Cureus part of springer nature. 2024;16 (6):1,2,3$37$YR$$M$Y$$$20240729$$HP$US$US
241476201$24147620$1$I$$20240722$20240729$20240729$PER$$CA-BRACCO-2024CA04497$BRACCO$$74$YR$$M$Y$$$20240729$$HP$CA$CA
241476212$24147621$2$F$20221101$20240907$20240729$20240919$EXP$$IT-SAMSUNG BIOEPIS-SB-2024-22334$SAMSUNG BIOEPIS$Setti G. Anti TNF-? induced mucous membrane pemphigoid-like disease.. ORAL SURG ORAL MED ORAL PATHOL ORAL RADIOL. doi:10.1016/j.oooo.2024.07.002.$40$YR$A$F$Y$$$20240919$$HP$IT$IT
241476221$24147622$1$I$$20240718$20240729$20240729$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22276$SAMSUNG BIOEPIS$$$$$$Y$$$20240729$$CN$CA$CA
241476231$24147623$1$I$$20240718$20240729$20240729$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22283$SAMSUNG BIOEPIS$$45$YR$A$F$Y$77$KG$20240729$$HP$CA$CA
241476241$24147624$1$I$$20240715$20240729$20240729$PER$$US-LEO Pharma-372055$LEO PHARM$$63$YR$$F$Y$$$20240729$$PH$US$US
241476251$24147625$1$I$20240724$20240724$20240729$20240729$PER$$US-JNJFOC-20240766624$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240729$$CN$US$US
241476261$24147626$1$I$$20240720$20240729$20240729$PER$$US-ABBVIE-5851137$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241476271$24147627$1$I$$20230714$20240729$20240729$EXP$$US-AstraZeneca-2023A163333$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241476281$24147628$1$I$20221001$20221206$20240729$20240729$EXP$$US-AstraZeneca-2022A402183$ASTRAZENECA$$25963$DY$$F$Y$$$20240729$$CN$US$
241476292$24147629$2$F$$20240731$20240729$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-035965$AUROBINDO$Sahyouni MJ, Acevedo LA, Rodriguez SC, Chiles JA, Pennings NJ.. Neuropathy of diabetes following initiation of a low-carbohydrate diet: Case report.. Obesity Pillars. 2024;11:1-6$50$YR$$M$Y$$$20240813$$MD$US$US
241476301$24147630$1$I$$20230731$20240729$20240729$EXP$$US-AstraZeneca-2023A174729$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241476311$24147631$1$I$$20230130$20240729$20240729$EXP$$US-AstraZeneca-2023A025473$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241476321$24147632$1$I$20220301$20220622$20240729$20240729$EXP$$HN-AstraZeneca-2022A233080$ASTRAZENECA$$31475$DY$$F$Y$$$20240729$$CN$HN$
241476331$24147633$1$I$$20230330$20240729$20240729$EXP$$US-AstraZeneca-2023A076218$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241476342$24147634$2$F$20240101$20240809$20240729$20240815$PER$$US-AMGEN-USASP2024149305$AMGEN$$38$YR$A$F$Y$$$20240815$$CN$US$US
241476352$24147635$2$F$20240701$20240730$20240729$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119860$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240801$$CN$US$US
241476361$24147636$1$I$$20240727$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119624$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$75.75$KG$20240729$$CN$US$US
241476371$24147637$1$I$$20240717$20240729$20240729$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-04210$SAMSUNG BIOEPIS$$47$YR$A$M$Y$$$20240729$$CN$GB$GB
241476381$24147638$1$I$$20240722$20240729$20240729$PER$$US-ALXN-202407USA001471US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241476391$24147639$1$I$$20240717$20240729$20240729$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-22409$SAMSUNG BIOEPIS$$$$$M$Y$90$KG$20240729$$HP$AU$AU
241476401$24147640$1$I$$20240724$20240729$20240729$EXP$$PT-MYLANLABS-2024M1069100$MYLAN$Cruz L. Endocarditis with Janeway Nodules and Lesions. SPMI Case Reports. 2024;2:62-63$52$YR$$M$Y$$$20240729$$MD$PT$PT
241476411$24147641$1$I$20240101$20240712$20240729$20240729$PER$$US-TEVA-VS-3225461$TEVA$$56$YR$$F$Y$75.75$KG$20240729$$CN$US$US
241476421$24147642$1$I$$20240724$20240729$20240729$PER$$US-TAKEDA-2024TUS075300$TAKEDA$$$$$$Y$$$20240729$$CN$US$US
241476431$24147643$1$I$$20240722$20240729$20240729$EXP$$US-TAKEDA-2024TUS074281$TAKEDA$$$$E$M$Y$$$20240729$$CN$US$US
241476441$24147644$1$I$$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51922$$FDA-CTU$$$$$M$N$$$20240726$N$HP$US$
241476451$24147645$1$I$$20240719$20240729$20240729$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07247$LUPIN$Belnavis G, Goyal A, Boudoulas KD, Breckenridge MB. A case of myocardial infarction in a young bodybuilder on Testosterone. Journal of the American College of Cardiology. 2024;83(13)$33$YR$$M$Y$$$20240729$$HP$US$US
241476462$24147646$2$F$$20240729$20240729$20240802$EXP$$US-PFIZER INC-PV202400097094$PFIZER$Howell, J.. Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor: A case report. Urology Case Reports. 2024;56:10.1016/j.eucr.2024.102799$62$YR$$F$Y$$$20240802$$HP$US$US
241476481$24147648$1$I$$20240722$20240729$20240729$EXP$$JP-PFIZER INC-202400223134$PFIZER$Osako, M.. A case of triazolam poisoning death that was negative with a simplified drug test kit. The Japanese Journal of Clinical Toxicology. 2024;37(2):257$$$E$F$Y$$$20240729$$HP$JP$JP
241476491$24147649$1$I$$20240724$20240729$20240729$EXP$$US-PFIZER INC-PV202400097705$PFIZER$Sawhney, K.. Daptomycin-Induced Severe Hyperkalemia With Normal Creatine Kinase in a Patient With Methicillin-Resistant Staphylococcus aureus Osteomyelitis. Cureus. 2023;15(9):10.7759/cureus.44674$60$YR$$F$Y$$$20240729$$HP$US$US
241476503$24147650$3$F$20240720$20240725$20240729$20240730$PER$$US-JNJFOC-20240765662$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$US$US
241476511$24147651$1$I$20240706$20240727$20240727$20240727$DIR$711757$$FDA-CTU$$53$YR$$F$N$67.5$KG$20240727$N$CN$US$
241476521$24147652$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092527$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241476532$24147653$2$F$$20240828$20240729$20240903$EXP$$GB-TAKEDA-2024TUS074855$TAKEDA$$$$$M$Y$$$20240903$$CN$GB$GB
241476541$24147654$1$I$$20240723$20240729$20240729$PER$$US-AMGEN-USASP2024147699$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241476551$24147655$1$I$$20240716$20240729$20240729$EXP$$US-MALLINCKRODT-MNK202404660$MALLINCKRODT$Tolani D.C, Miyari S, Murray J, Profita E, Chen S, Rosenthal D, Martin E, Dykes J, Ma M..Novel Stabilization of a Heartmate 3 Atrial Cannulated Ventricular Assist Device in a Fontan patient.ASAIO J..MAY-2024;70(Supplement 3):88$$$$M$Y$$$20240729$$HP$US$US
241476562$24147656$2$F$20240723$20240802$20240729$20240806$30DAY$$US-AMGEN-USASL2024147133$AMGEN$$61$YR$A$F$Y$29.206$KG$20240806$$CN$US$US
241476572$24147657$2$F$$20240716$20240729$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06948$LUPIN$$$$$$Y$$$20240813$$CN$US$US
241476582$24147658$2$F$20240410$20240823$20240729$20240830$PER$$US-AMGEN-USASP2024147871$AMGEN$$$$$M$Y$$$20240830$$HP$US$US
241476601$24147660$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51914$$FDA-CTU$$72$YR$$F$N$90.72$KG$20240729$N$HP$US$
241476621$24147662$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51934$$FDA-CTU$$82$YR$$F$N$$$20240729$N$$US$
241476631$24147663$1$I$20240213$20240727$20240727$20240727$DIR$711759$$FDA-CTU$$79$YR$$M$N$57$KG$20240727$N$CN$GB$
241476641$24147664$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51916$$FDA-CTU$$62$YR$$M$N$$$20240729$N$$US$
241476651$24147665$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51935$$FDA-CTU$$70$YR$$M$N$$$20240729$N$$US$
241476661$24147666$1$I$20230901$20240722$20240729$20240729$EXP$$PT-FreseniusKabi-FK202411552$FRESENIUS KABI$$39$YR$A$F$Y$$$20240729$$MD$PT$PT
241476671$24147667$1$I$$20240718$20240729$20240729$PER$$US-RDY-LIT/USA/24/0010938$DR REDDYS$Nguyen AP, Hoffman W, Penn BH, Pham D, Teuber SS. Successful treatment of neurocysticercosis with albendazole desensitization. Asian Pacific Journal of Allergy and Immunology. 2024 Jun;42(2): 176-179. doi:10.12932/ap-191020-0983.$41$YR$A$M$Y$$$20240729$$HP$US$US
241476681$24147668$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224467$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$3$YR$$F$Y$$$20240729$$HP$ES$ES
241476691$24147669$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224468$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$3$YR$$F$Y$$$20240729$$HP$ES$ES
241476702$24147670$2$F$20240524$20240826$20240729$20240904$EXP$$US-KERYX BIOPHARMACEUTICALS INC.-US-AKEB-24-001121$AKEBIA THERAPEUTICS$$49$YR$$M$Y$$$20240904$$HP$US$US
241476711$24147671$1$I$20240719$20240726$20240729$20240729$EXP$GB-MHRA-TPP19516521C7216619YC1721413742543$GB-ORGANON-O2407GBR002600$ORGANON$$47$YR$$M$Y$89$KG$20240729$$PH$GB$GB
241476721$24147672$1$I$20240709$20240729$20240729$20240729$EXP$IT-MINISAL02-996274$IT-BAYER-2024A109264$BAYER$$50$YR$A$F$Y$$$20240729$$MD$IT$IT
241476731$24147673$1$I$$20240715$20240729$20240729$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07200$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240729$$HP$US$US
241476743$24147674$3$F$$20240801$20240729$20240802$EXP$$AU-JNJFOC-20240755767$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$CN$AU$AU
241476751$24147675$1$I$$20240703$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06634$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241476761$24147676$1$I$$20240713$20240729$20240729$PER$$US-EMERGENT BIOSOLUTIONS,-24000114$EMERGENT BIOSOLUTIONS$$$$A$F$Y$$$20240729$$PH$US$US
241476771$24147677$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51912$$FDA-CTU$$41$YR$$M$N$$$20240729$N$$US$
241476781$24147678$1$I$$20240719$20240729$20240729$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-117635$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240729$$PH$FR$FR
241476791$24147679$1$I$$20240727$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119638$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$87.54$KG$20240729$$CN$US$US
241476801$24147680$1$I$$20240719$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116065$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240729$$PH$US$US
241476811$24147681$1$I$$20240723$20240729$20240729$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407015606$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$BR$BR
241476821$24147682$1$I$20240610$20240716$20240729$20240729$EXP$FR-AFSSAPS-RS2024000686$FR-ELI_LILLY_AND_COMPANY-FR202407015633$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240729$$CN$DE$FR
241476831$24147683$1$I$$20240717$20240729$20240729$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407011504$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240729$$CN$JP$JP
241476841$24147684$1$I$20240612$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51917$$FDA-CTU$$$$$$N$$$20240729$N$HP$US$
241476851$24147685$1$I$20240520$20240717$20240729$20240729$EXP$ES-AEMPS-1549718$ES-ELI_LILLY_AND_COMPANY-ES202407011817$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240729$$CN$ES$ES
241476862$24147686$2$F$$20240815$20240729$20240826$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407010997$ELI LILLY AND CO$$$$$$Y$$$20240826$$CN$CN$CN
241476871$24147687$1$I$$20240717$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011613$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240729$$CN$US$US
241476881$24147688$1$I$20240712$20240719$20240729$20240729$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407017353$ELI LILLY AND CO$$53$YR$A$M$Y$60$KG$20240729$$CN$DE$CN
241476891$24147689$1$I$$20240727$20240727$20240727$DIR$711749$$FDA-CTU$$$$$M$N$$$20240727$N$HP$US$
241476901$24147690$1$I$20240710$20240717$20240729$20240729$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407014535$ELI LILLY AND CO$$72$YR$E$M$Y$54$KG$20240729$$CN$DE$CN
241476911$24147691$1$I$20240702$20240717$20240729$20240729$EXP$FR-AFSSAPS-RS2024000701$FR-ELI_LILLY_AND_COMPANY-FR202407011947$ELI LILLY AND CO$$60$YR$A$M$Y$81$KG$20240729$$CN$FR$FR
241476921$24147692$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017921$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240729$$CN$US$US
241476931$24147693$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017942$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240729$$CN$US$US
241476941$24147694$1$I$20240718$20240719$20240729$20240729$EXP$$MY-ELI_LILLY_AND_COMPANY-MY202407014016$ELI LILLY AND CO$$38$YR$A$M$Y$72$KG$20240729$$CN$MY$MY
241476952$24147695$2$F$20240705$20240815$20240729$20240821$EXP$PT-INFARMED-F202407-160$PT-ELI_LILLY_AND_COMPANY-PT202407017270$ELI LILLY AND CO$$51$YR$A$M$Y$86$KG$20240821$$CN$DE$PT
241476962$24147696$2$F$$20240812$20240729$20240822$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407012584$ELI LILLY AND CO$$67$YR$E$M$Y$95$KG$20240822$$CN$GB$GB
241476971$24147697$1$I$$20240508$20240729$20240729$EXP$$CA-AUROBINDO-AUR-APL-2024-023824$AUROBINDO$$43$YR$$F$Y$$$20240729$$CN$CA$CA
241476983$24147698$3$F$20240708$20240813$20240729$20240820$EXP$$US-GSK-US2024075079$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$HP$US$US
241476991$24147699$1$I$$20240719$20240729$20240729$EXP$$CA-TEVA-VS-3223398$TEVA$$59$YR$$F$Y$65$KG$20240729$$PH$CA$CA
241477001$24147700$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092450$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241477011$24147701$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092456$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241477021$24147702$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092602$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241477031$24147703$1$I$20240129$20240725$20240729$20240729$EXP$FR-AFSSAPS-PP2024000356$FR-PFIZER INC-2024SGN04258$PFIZER$$77$YR$$F$Y$56$KG$20240729$$PH$FR$FR
241477041$24147704$1$I$20221114$20240725$20240729$20240729$EXP$FR-AFSSAPS-AM2023000128$FR-PFIZER INC-2023SGN01661$PFIZER$$65$YR$$F$Y$$$20240729$$PH$FR$FR
241477052$24147705$2$F$$20240830$20240729$20240902$30DAY$$CA-JNJFOC-20240758857$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$HP$CA$CA
241477062$24147706$2$F$$20240809$20240729$20240813$EXP$$US-JNJFOC-20240768316$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240814$$HP$US$US
241477071$24147707$1$I$$20240726$20240729$20240729$PER$$US-BAYER-2024A109086$BAYER$$50$YR$A$F$Y$$$20240729$$MD$US$US
241477081$24147708$1$I$$20200122$20240729$20240729$EXP$$US-AstraZeneca-2020SE13186$ASTRAZENECA$$$$$$Y$$$20240729$$MD$US$
241477091$24147709$1$I$$20240719$20240729$20240729$EXP$$CA-TEVA-VS-3223463$TEVA$$29$YR$$F$Y$$$20240729$$HP$CA$CA
241477101$24147710$1$I$$20240722$20240729$20240729$EXP$$NVSC2024DE154328$NOVARTIS$Satirer, Ozlem, Henes et al.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD OPEN. 2024;10(3)$$$C$F$Y$$$20240729$$HP$DE$DE
241477111$24147711$1$I$20240619$20240724$20240729$20240729$EXP$$ID-AstraZeneca-2024A171402$ASTRAZENECA$$23650$DY$$F$Y$$$20240729$$CN$ID$
241477122$24147712$2$F$$20240722$20240729$20240814$PER$$US-INCYTE CORPORATION-2024IN007706$INCYTE$$$$$$Y$$$20240814$$CN$US$US
241477131$24147713$1$I$$20240722$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007688$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241477141$24147714$1$I$$20240703$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06914$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241477151$24147715$1$I$20240719$20240722$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007687$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241477161$24147716$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092785$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241477171$24147717$1$I$$20240722$20240729$20240729$EXP$$NVSC2024KR152537$NOVARTIS$$7$YR$$$Y$$$20240729$$PH$KR$KR
241477181$24147718$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092523$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241477192$24147719$2$F$$20240802$20240729$20240808$EXP$$NL-MYLANLABS-2024M1069283$MYLAN$$65$YR$$M$Y$102$KG$20240808$$HP$NL$NL
241477212$24147721$2$F$$20240729$20240729$20240812$EXP$$DE-BAYER-2024A109420$BAYER$$75$YR$E$F$Y$$$20240812$$CN$DE$DE
241477221$24147722$1$I$20240705$20240727$20240727$20240727$DIR$711763$$FDA-CTU$$49$YR$$F$N$73.35$KG$20240727$N$CN$US$
241477231$24147723$1$I$20240725$20240727$20240727$20240727$DIR$711767$$FDA-CTU$$40$YR$$F$N$79.2$KG$20240727$N$PH$US$
241477241$24147724$1$I$$20240722$20240729$20240729$EXP$$JP-009507513-2407JPN004218J$MERCK$Kawase T, Kobayashi A, Oneyama M. MO34-9 A very rare case of granulomatous liver disease mimicking a metastatic tumor possibly caused by immune checkpoint inhibitors. The 36th Meeting of Japanese Society of Hepato -Biliary -Pancreatic Surgery. 499$72$YR$$F$Y$$$20240729$$HP$JP$JP
241477251$24147725$1$I$$20240725$20240729$20240729$PER$$US-GILEAD-2024-0682024$GILEAD$$$$$M$Y$$$20240729$$CN$US$US
241477262$24147726$2$F$20240201$20240807$20240729$20240808$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042071$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$$$20240808$$PH$DE$DE
241477271$24147727$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092601$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241477281$24147728$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092606$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241477292$24147729$2$F$$20240729$20240729$20240805$EXP$$CA-GSK-CA2024091775$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$CA$CA
241477301$24147730$1$I$$20240704$20240729$20240729$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06817$LUPIN$$$$$$Y$$$20240729$$CN$US$US
241477311$24147731$1$I$$20240725$20240729$20240729$EXP$$BR-ABBVIE-5856999$ABBVIE$$$$$$Y$$$20240729$$MD$BR$BR
241477322$24147732$2$F$20240101$20240730$20240729$20240802$PER$$US-JNJFOC-20240774020$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240802$$CN$US$US
241477341$24147734$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119663$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240729$$CN$US$US
241477352$24147735$2$F$20240701$20240805$20240729$20240807$PER$$US-AMGEN-USASP2024149359$AMGEN$$77$YR$E$F$Y$48.98$KG$20240807$$MD$US$US
241477361$24147736$1$I$20240707$20240725$20240729$20240729$EXP$FR-AFSSAPS-DJ2024000849$FR-009507513-2407FRA014035$MERCK$$72$YR$$M$Y$$$20240729$$PH$FR$FR
241477381$24147738$1$I$20230301$20240724$20240729$20240729$EXP$SE-SEMPA-2024-005567$SE-FreseniusKabi-FK202411591$FRESENIUS KABI$$79$YR$E$M$Y$$$20240729$$MD$SE$SE
241477391$24147739$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51943$$FDA-CTU$$73$YR$$F$N$$$20240729$N$$US$
241477401$24147740$1$I$20240511$20240722$20240729$20240729$EXP$FR-AFSSAPS-AM2024000586$FR-FreseniusKabi-FK202411635$FRESENIUS KABI$$67$YR$A$F$Y$74$KG$20240729$$PH$FR$FR
241477412$24147741$2$F$$20240912$20240729$20240912$PER$$NVSC2024US153958$NOVARTIS$$$$$$Y$$$20240912$$MD$US$US
241477421$24147742$1$I$$20240721$20240729$20240729$EXP$$NVSC2024CH151983$NOVARTIS$$$$$F$Y$$$20240729$$CN$CH$CH
241477431$24147743$1$I$20210202$20240719$20240729$20240729$EXP$$FR-TEVA-VS-3224551$TEVA$$$$$F$Y$$$20240729$$HP$FR$FR
241477441$24147744$1$I$20230329$20240727$20240727$20240727$DIR$711768$$FDA-CTU$$50$YR$$F$N$75.15$KG$20240727$Y$CN$US$
241477454$24147745$4$F$20240717$20240828$20240729$20240904$30DAY$$CA-JNJFOC-20240747381$JOHNSON AND JOHNSON$$38$YR$A$F$Y$58$KG$20240904$$HP$CA$CA
241477461$24147746$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51941$$FDA-CTU$$64$YR$$F$N$59.87$KG$20240729$N$$US$
241477471$24147747$1$I$20240316$20240727$20240727$20240727$DIR$711770$$FDA-CTU$$76$YR$$F$N$54$KG$20240727$N$CN$US$
241477481$24147748$1$I$20240725$20240727$20240727$20240727$DIR$711766$$FDA-CTU$$63$YR$$M$N$71.1$KG$20240727$N$CN$US$
241477491$24147749$1$I$$20210805$20240729$20240729$EXP$$US-AstraZeneca-2021A670758$ASTRAZENECA$$$$$M$Y$$$20240729$$MD$US$
241477511$24147751$1$I$$20240722$20240729$20240729$PER$$US-ABBVIE-5850688$ABBVIE$$$$$F$Y$$$20240729$$HP$US$US
241477521$24147752$1$I$$20220607$20240729$20240729$EXP$$CA-AstraZeneca-2022A168915$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$CA$
241477531$24147753$1$I$20210101$20210317$20240729$20240729$EXP$$US-AstraZeneca-2021A178317$ASTRAZENECA$$69$YR$$F$Y$72.6$KG$20240729$$CN$US$
241477541$24147754$1$I$20230106$20230110$20240729$20240729$EXP$$CO-AstraZeneca-2023A008105$ASTRAZENECA$$3267$WK$$M$Y$$$20240729$$CN$CO$
241477551$24147755$1$I$20240626$20240727$20240727$20240727$DIR$711777$$FDA-CTU$$59$YR$$M$N$93.15$KG$20240727$N$CN$US$
241477561$24147756$1$I$20240617$20240715$20240729$20240729$EXP$IT-MINISAL02-994082$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06785$HIKMA$$83$YR$$F$Y$$$20240729$$MD$IT$IT
241477571$24147757$1$I$20240609$20240723$20240729$20240729$EXP$$BR-JNJFOC-20240766167$JOHNSON AND JOHNSON$$69$YR$E$F$Y$60$KG$20240729$$CN$BR$BR
241477581$24147758$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154669$NOVARTIS$$$$$$Y$$$20240729$$PH$US$US
241477592$24147759$2$F$$20240807$20240729$20240809$PER$$NVSC2024US154403$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
241477601$24147760$1$I$$20240717$20240729$20240729$EXP$$BR-TAKEDA-2024TUS074297$TAKEDA$$31$YR$$M$Y$$$20240729$$MD$BR$BR
241477611$24147761$1$I$$20240726$20240729$20240729$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042334$BOEHRINGER INGELHEIM$$$$$$Y$$$20240729$$MD$JP$JP
241477621$24147762$1$I$$20240726$20240729$20240729$EXP$$US-BAYER-2024A109084$BAYER$$33$YR$A$M$Y$$$20240729$$CN$US$US
241477631$24147763$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224407$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$9$YR$$M$Y$$$20240729$$HP$ES$ES
241477641$24147764$1$I$$20240722$20240729$20240729$EXP$$NVSC2024CA153362$NOVARTIS$$$$A$F$Y$$$20240729$$MD$CA$CA
241477651$24147765$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092604$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241477661$24147766$1$I$$20240716$20240729$20240729$PER$$US-JNJFOC-20240748122$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$CN$US$US
241477671$24147767$1$I$20240708$20240719$20240729$20240729$EXP$FR-AFSSAPS-CN2024000687$FR-TEVA-VS-3223725$TEVA$$86$YR$$F$Y$40$KG$20240729$$PH$FR$FR
241477681$24147768$1$I$20240721$20240722$20240729$20240729$PER$$US-APELLIS-2024-APL-0000535$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
241477691$24147769$1$I$$20240715$20240729$20240729$30DAY$$US-JNJFOC-20240759010$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241477701$24147770$1$I$20240101$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119713$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240729$$CN$US$US
241477711$24147771$1$I$20240701$20240722$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117337$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$59.87$KG$20240729$$CN$US$US
241477721$24147772$1$I$20240603$20240725$20240729$20240729$EXP$FR-AFSSAPS-LY2024001007$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-119718$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$67.2$KG$20240729$$PH$FR$FR
241477731$24147773$1$I$$20240723$20240729$20240729$PER$$US-ABBVIE-5852437$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241477741$24147774$1$I$20240708$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149260$AMGEN$$73$YR$E$F$Y$$$20240729$$MD$US$US
241477751$24147775$1$I$$20240717$20240729$20240729$EXP$$CZ-BAYER-2024A105150$BAYER$Dr Jana Pavl??kov?. Adherence to treatment in multiple sclerosis: case reports of three female patients on high-efficacy therapy with ocrelizumab. Neurol?gia pre prax. 2024;25(03)$65$YR$E$F$Y$$$20240729$$MD$CZ$CZ
241477761$24147776$1$I$20240101$20240702$20240729$20240729$PER$$US-009507513-2407USA001457$MERCK$$$$$$Y$$$20240729$$CN$US$US
241477771$24147777$1$I$20190701$20240722$20240729$20240729$EXP$$US-TAKEDA-2024TUS073943$TAKEDA$$69$YR$$M$Y$93$KG$20240729$$CN$US$US
241477781$24147778$1$I$20240101$20240723$20240729$20240729$EXP$$US-SA-2024SA218509$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240729$$CN$US$US
241477791$24147779$1$I$$20240723$20240729$20240729$PER$$US-MYLANLABS-2024M1069565$MYLAN$$$$$F$Y$$$20240729$$HP$US$US
241477801$24147780$1$I$20240701$20240724$20240729$20240729$EXP$FR-AFSSAPS-DJ2024000851$FR-SA-2024SA220931$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240729$$MD$FR$FR
241477811$24147781$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51947$$FDA-CTU$$72$YR$$F$N$100.24$KG$20240729$N$HP$US$
241477821$24147782$1$I$20240602$20240727$20240727$20240727$DIR$711789$$FDA-CTU$$$$$F$N$$$20240727$N$CN$US$
241477831$24147783$1$I$20240726$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51915$$FDA-CTU$$49$YR$$F$N$64.86$KG$20240726$N$PH$US$
241477841$24147784$1$I$$20240723$20240729$20240729$EXP$$IE-TAKEDA-2024TUS075901$TAKEDA$$$$$$Y$$$20240729$$MD$IE$IE
241477851$24147785$1$I$20240602$20240727$20240727$20240727$DIR$711789$$FDA-CTU$$24$YR$$M$N$81.9$KG$20240727$N$CN$US$
241477861$24147786$1$I$20240708$20240719$20240729$20240729$EXP$IT-MINISAL02-994721$IT-TEVA-VS-3223624$TEVA$$58$YR$$F$Y$$$20240729$$MD$IT$IT
241477871$24147787$1$I$$20240727$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119611$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$78.02$KG$20240729$$CN$US$US
241477891$24147789$1$I$20240713$20240727$20240727$20240727$DIR$711799$$FDA-CTU$$74$YR$$M$N$72.45$KG$20240727$N$CN$US$
241477901$24147790$1$I$$20240715$20240729$20240729$EXP$$AU-LUPIN HEALTHCARE (UK) LIMITED-2024-07282$LUPIN$$$$$$Y$$$20240729$$CN$AU$AU
241477911$24147791$1$I$20240630$20240717$20240729$20240729$EXP$$GB-Ascend Therapeutics US, LLC-2159728$ASCEND$$48$YR$$F$Y$$$20240729$$$GB$GB
241477921$24147792$1$I$20240701$20240719$20240729$20240729$EXP$$CA-TEVA-VS-3222389$TEVA$$23$YR$$F$Y$$$20240729$$PH$CA$CA
241477931$24147793$1$I$20200101$20240725$20240729$20240729$EXP$$HN-MYLANLABS-2024M1070212$MYLAN$$$$$M$Y$81.64$KG$20240729$$CN$HN$HN
241477941$24147794$1$I$20240724$20240725$20240729$20240729$EXP$$GB-MYLANLABS-2024M1069693$MYLAN$$10$YR$$M$Y$50$KG$20240729$$HP$GB$GB
241477951$24147795$1$I$$20240725$20240729$20240729$EXP$$US-MYLANLABS-2024M1046371$MYLAN$$$$$F$Y$$$20240729$$HP$US$US
241477961$24147796$1$I$$20240725$20240729$20240729$EXP$$CA-MYLANLABS-2024M1069931$MYLAN$$43$YR$$F$Y$$$20240729$$HP$CA$CA
241477971$24147797$1$I$20240724$20240725$20240729$20240729$EXP$$AU-MYLANLABS-2023M1135678$MYLAN$$48$YR$$M$Y$$$20240729$$HP$AU$AU
241477981$24147798$1$I$$20240722$20240729$20240729$PER$$US-ABBVIE-5852067$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241477991$24147799$1$I$20240708$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149243$AMGEN$$73$YR$E$F$Y$$$20240729$$MD$US$US
241478001$24147800$1$I$$20240722$20240729$20240729$PER$$US-MYLANLABS-2024M1069492$MYLAN$$$$$F$Y$81.64$KG$20240729$$CN$US$US
241478011$24147801$1$I$$20240718$20240729$20240729$PER$$US-FreseniusKabi-FK202411538$FRESENIUS KABI$$$$$$Y$$$20240729$$PH$US$US
241478022$24147802$2$F$20240325$20240908$20240729$20240913$EXP$$CA-009507513-2407CAN014303$MERCK$$$$$F$Y$$$20240913$$MD$CA$CA
241478032$24147803$2$F$20230713$20240730$20240729$20240802$EXP$BE-FAMHP-DHH-N2024-122410$BE-OTSUKA-2024_020787$OTSUKA$$29$YR$$M$Y$96$KG$20240802$$MD$BE$BE
241478041$24147804$1$I$20240625$20240722$20240729$20240729$EXP$FR-AFSSAPS-NC2024000872$FR-FreseniusKabi-FK202411626$FRESENIUS KABI$$57$YR$A$M$Y$$$20240729$$PH$FR$FR
241478051$24147805$1$I$$20240726$20240729$20240729$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-022351$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$$$20240729$$CN$US$US
241478068$24147806$8$F$$20240909$20240729$20240912$EXP$$PT-ORGANON-O2407PRT001600$ORGANON$Vasconcelos AL, Neves da Silva L, Ferreira PC, et al. Serotonergic syndrome: a long list of causal agents. Congresses of the Portuguese Society of Internal Medicine: 30th National Congres. 2024;30 (1):279$80$YR$$F$Y$$$20240912$$HP$PT$PT
241478071$24147807$1$I$20240101$20240722$20240729$20240729$EXP$$NVSC2024BR153956$NOVARTIS$$$$$M$Y$$$20240729$$CN$BR$BR
241478081$24147808$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119700$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$103.87$KG$20240729$$CN$US$US
241478091$24147809$1$I$$20240719$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115881$BRISTOL MYERS SQUIBB$$21$YR$A$M$Y$$$20240729$$HP$US$US
241478101$24147810$1$I$20240709$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119125$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240729$$HP$US$US
241478111$24147811$1$I$$20240723$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407015767$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241478121$24147812$1$I$$20240717$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011579$ELI LILLY AND CO$$$$A$F$Y$$$20240729$$CN$US$US
241478133$24147813$3$F$20240715$20240823$20240729$20240903$30DAY$$FI-JNJFOC-20240746996$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240903$$PH$FI$FI
241478141$24147814$1$I$20240723$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148138$AMGEN$$$$$$Y$$$20240729$$PH$US$US
241478151$24147815$1$I$20240701$20240725$20240729$20240729$PER$$US-ABBVIE-5855125$ABBVIE$$$$$F$Y$$$20240729$$MD$US$US
241478161$24147816$1$I$$20240726$20240729$20240729$PER$$US-HALEON-2189401$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241478171$24147817$1$I$20240701$20240719$20240729$20240729$EXP$IT-MINISAL02-994724$IT-TEVA-VS-3223440$TEVA$$71$YR$$F$Y$$$20240729$$MD$IT$IT
241478181$24147818$1$I$$20240726$20240729$20240729$PER$$US-HALEON-2189286$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241478191$24147819$1$I$$20240722$20240729$20240729$EXP$$US-BAYER-2024A106813$BAYER$$69$YR$E$M$Y$$$20240729$$CN$US$US
241478201$24147820$1$I$$20240726$20240729$20240729$PER$$US-HALEON-2189294$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241478211$24147821$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224469$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$5$YR$$M$Y$$$20240729$$HP$ES$ES
241478221$24147822$1$I$$20240723$20240729$20240729$EXP$$US-MYLANLABS-2024M1069664$MYLAN$Tran DH, Patel V, Krupnick AS, Reed RM. A Case of Fatal Adenovirus Infection After Lung Transplant. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster) abstr. A6291.$60$YR$$M$Y$$$20240729$$HP$US$US
241478231$24147823$1$I$$20240723$20240729$20240729$EXP$$FR-TAKEDA-2024TUS074994$TAKEDA$$46$YR$$F$Y$$$20240729$$HP$FR$FR
241478241$24147824$1$I$19981108$20240723$20240729$20240729$EXP$$DE-MYLANLABS-2024M1069707$MYLAN$$63$YR$$M$Y$65$KG$20240729$$MD$DE$DE
241478253$24147825$3$F$$20240722$20240729$20240801$EXP$$NVSC2024IN154421$NOVARTIS$$$$A$M$Y$$$20240801$$HP$IN$IN
241478264$24147826$4$F$20240302$20240815$20240729$20240816$EXP$$US-PFIZER INC-2024SGN02347$PFIZER$$57$YR$$F$Y$$$20240816$$CN$US$US
241478271$24147827$1$I$$20240725$20240729$20240729$EXP$$CA-PFIZER INC-202400223886$PFIZER$$58$YR$$M$Y$110$KG$20240729$$HP$CA$CA
241478301$24147830$1$I$$20240723$20240729$20240729$EXP$$GB-SANDOZ INC.-NVSC2021GB141351$SANDOZ$$$$$F$Y$$$20240729$$CN$GB$GB
241478311$24147831$1$I$20240601$20240727$20240727$20240727$DIR$711794$$FDA-CTU$$10$YR$$M$N$58.5$KG$20240727$N$CN$US$
241478321$24147832$1$I$$20240719$20240729$20240729$EXP$$US-TAKEDA-2024TUS074416$TAKEDA$$$$$F$Y$$$20240729$$CN$US$US
241478331$24147833$1$I$$20240727$20240729$20240729$PER$$US-HALEON-2189375$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241478341$24147834$1$I$$20240715$20240729$20240729$EXP$$OM-BEXIMCO-2024BEX00032$BEXIMCO PHARMACEUTICALS$Ellouze N.F, Hazra D, Abri S.A.. BACLOFEN?induced neurotoxicity in  a dialysis patient managed with  continuous venovenous hemodialysis:  A case report and literature review. Turkish Journal of Emergency Medicine. 2024;24 (3):176-179$73$YR$$F$Y$$$20240725$$HP$OM$OM
241478351$24147835$1$I$$20240715$20240729$20240729$EXP$$IN-BEXIMCO-2024BEX00033$BEXIMCO PHARMACEUTICALS$Ancilla L.C, Sundaram B, Pathak N, Raj A. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. Journal of Nephropharmacology. 2024;(13) 2$55$YR$$M$Y$$$20240725$$HP$IN$IN
241478361$24147836$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51964$$FDA-CTU$$78$YR$$F$N$$$20240729$N$$US$
241478371$24147837$1$I$20240720$20240727$20240727$20240727$DIR$711776$$FDA-CTU$$49$YR$$M$N$85.5$KG$20240727$N$CN$US$
241478381$24147838$1$I$$20240715$20240729$20240729$EXP$$IN-BEXIMCO-2024BEX00034$BEXIMCO PHARMACEUTICALS$Ancilla L.C., Sundaram B, Pathak N, Raj A.. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. Journal of Nephropharmacology. 2024;(13)2$58$YR$$M$Y$$$20240725$$HP$IN$IN
241478401$24147840$1$I$20240724$20240727$20240727$20240727$DIR$711801$$FDA-CTU$$27$YR$$F$N$72.45$KG$20240727$N$CN$US$
241478411$24147841$1$I$20240726$20240727$20240727$20240727$DIR$711797$$FDA-CTU$$21$YR$$M$N$66.6$KG$20240727$N$CN$US$
241478421$24147842$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51962$$FDA-CTU$$59$YR$$M$N$$$20240729$N$$US$
241478431$24147843$1$I$20200304$20240727$20240727$20240727$DIR$711798$$FDA-CTU$$4$MON$$F$N$$$20240727$N$CN$US$
241478441$24147844$1$I$$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51961$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241478451$24147845$1$I$20240630$20240725$20240729$20240729$EXP$$CN-AstraZeneca-2024A171532$ASTRAZENECA$$76$YR$$M$Y$50$KG$20240729$$MD$CN$
241478461$24147846$1$I$$20240725$20240729$20240729$EXP$$RU-MYLANLABS-2024M1069659$MYLAN$$14$YR$$F$Y$$$20240729$$CN$RU$RU
241478472$24147847$2$F$$20240726$20240729$20240808$EXP$$GB-MYLANLABS-2024M1070108$MYLAN$$$$$F$Y$$$20240808$$HP$GB$TR
241478481$24147848$1$I$20240712$20240725$20240729$20240729$EXP$GB-MHRA-MED-202407251503395980-STHPD$GB-MYLANLABS-2024M1069949$MYLAN$$57$YR$$M$Y$79$KG$20240729$$CN$GB$GB
241478491$24147849$1$I$$20240716$20240729$20240729$EXP$$US-AstraZeneca-2019SF10979$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241478501$24147850$1$I$$20240725$20240729$20240729$PER$$US-HALEON-2189186$Haleon PLC$$$$$F$Y$$$20240729$$CN$US$US
241478511$24147851$1$I$20240701$20240724$20240729$20240729$EXP$$ID-AstraZeneca-2024A170996$ASTRAZENECA$$17348$DY$$M$Y$$$20240729$$CN$ID$
241478521$24147852$1$I$20240609$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A169453$ASTRAZENECA$$$$$M$Y$$$20240729$$HP$US$
241478531$24147853$1$I$$20240724$20240729$20240729$EXP$$MX-AstraZeneca-2024A171254$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$MX$
241478541$24147854$1$I$20240720$20240726$20240729$20240729$EXP$GB-MHRA-MED-202407221255186970-WCKQY$GB-SANDOZ INC.-SDZ2024GB068559$SANDOZ$$66$YR$$F$Y$$$20240729$$HP$GB$GB
241478551$24147855$1$I$$20240723$20240729$20240729$PER$$US-ALXN-202407USA001590US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241478561$24147856$1$I$20240115$20240719$20240729$20240729$EXP$$IE-ROCHE-3493446$ROCHE$$$$$M$Y$$$20240729$$HP$IE$IE
241478571$24147857$1$I$20240708$20240719$20240729$20240729$EXP$IT-MINISAL02-994730$IT-TEVA-VS-3224028$TEVA$$44$YR$$F$Y$$$20240729$$MD$IT$IT
241478581$24147858$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024091740$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241478592$24147859$2$F$20231001$20240725$20240729$20240801$EXP$$US-GSK-US2024091597$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
241478603$24147860$3$F$20240604$20240903$20240729$20240909$EXP$FR-AFSSAPS-RE2024000723$FR-009507513-2407FRA013034$MERCK$$50$YR$$F$Y$62$KG$20240909$$MD$FR$FR
241478612$24147861$2$F$$20240815$20240729$20240819$EXP$$PH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042302$BOEHRINGER INGELHEIM$$32$YR$A$F$Y$$$20240819$$MD$PH$PH
241478622$24147862$2$F$20240501$20240724$20240729$20240730$EXP$$CN-009507513-2407CHN014727$MERCK$$72$YR$$F$Y$67.5$KG$20240730$$HP$CN$CN
241478631$24147863$1$I$20240101$20240725$20240729$20240729$EXP$GB-MHRA-MED-202407251426042420-MRKHP$GB-ABBVIE-5854343$ABBVIE$$$$$M$Y$$$20240729$$HP$GB$GB
241478644$24147864$4$F$20240720$20240825$20240729$20240903$EXP$$US-UROGEN PHARMA LTD.-2024-UGN-000107$UROGEN PHARMA$$$$$$Y$$$20240903$$MD$US$US
241478652$24147865$2$F$$20240815$20240729$20240820$EXP$$CA-SANDOZ INC.-NVSC2023CA115235$SANDOZ$$$$$F$Y$47$KG$20240820$$CN$CA$CA
241478661$24147866$1$I$$20240716$20240729$20240729$EXP$$GB-Ascend Therapeutics US, LLC-2159729$ASCEND$$$$$F$Y$$$20240729$$$GB$GB
241478671$24147867$1$I$$20240715$20240729$20240729$PER$$US-TEVA-VS-3225797$TEVA$$52$YR$$F$Y$$$20240729$$HP$US$US
241478691$24147869$1$I$$20240729$20240729$20240729$EXP$GB-MHRA-TPP19665692C21550945YC1721826781416$GB-SANDOZ INC.-SDZ2024GB068714$SANDOZ$$72$YR$$M$Y$91$KG$20240729$$PH$GB$GB
241478701$24147870$1$I$20240727$20240727$20240727$20240727$DIR$711783$$FDA-CTU$$13$YR$$F$N$48.6$KG$20240727$N$HP$US$
241478711$24147871$1$I$$20240726$20240729$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA068551$SANDOZ$$28$YR$$F$Y$$$20240729$$PH$CA$CA
241478721$24147872$1$I$20240716$20240727$20240727$20240727$DIR$711784$$FDA-CTU$$80$YR$$F$N$47.7$KG$20240727$N$CN$US$
241478731$24147873$1$I$$20240724$20240729$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA068052$SANDOZ$$40$YR$$F$Y$$$20240729$$HP$CA$CA
241478741$24147874$1$I$$20230426$20240729$20240729$EXP$$US-AstraZeneca-2023A098562$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241478751$24147875$1$I$$20210728$20240729$20240729$EXP$$US-AstraZeneca-2021A650385$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241478761$24147876$1$I$$20240718$20240729$20240729$EXP$$GB-JNJFOC-20240774782$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$HP$GB$GB
241478771$24147877$1$I$$20211213$20240729$20240729$EXP$$CA-AstraZeneca-2021A874888$ASTRAZENECA$$$$$F$Y$$$20240729$$MD$CA$
241478781$24147878$1$I$20240705$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A168804$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241478791$24147879$1$I$$20240724$20240729$20240729$PER$$US-HALEON-2189046$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241478801$24147880$1$I$20171001$20240725$20240729$20240729$EXP$$CA-SANDOZ INC.-PHHY2017CA152812$SANDOZ$$$$E$F$Y$$$20240729$$CN$CA$CA
241478822$24147882$2$F$$20240805$20240729$20240806$EXP$$NVSC2024IT153703$NOVARTIS$Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al.. Pickering Syndrome: An Overlooked Renovascular Cause of Recurrent Heart Failure. JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2024;12: e030474:1-11$75$YR$$M$Y$$$20240806$$HP$IT$IT
241478834$24147883$4$F$20240723$20240828$20240729$20240909$30DAY$$US-JNJFOC-20240765381$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240910$$HP$US$US
241478841$24147884$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092608$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241478851$24147885$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092120$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241478861$24147886$1$I$20100101$20240719$20240729$20240729$EXP$FR-AFSSAPS-SE2024000567$FR-TEVA-VS-3224366$TEVA$$33$YR$$F$Y$$$20240729$$MD$FR$FR
241478882$24147888$2$F$$20240723$20240729$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117256$BRISTOL MYERS SQUIBB$$15$YR$T$F$Y$$$20240823$$HP$US$US
241478891$24147889$1$I$20240725$20240726$20240729$20240729$PER$$US-AMGEN-USASP2024149375$AMGEN$$$$$M$Y$$$20240729$$CN$US$US
241478901$24147890$1$I$20240725$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149112$AMGEN$$68$YR$E$M$Y$$$20240729$$CN$US$US
241478913$24147891$3$F$20240722$20240805$20240729$20240813$PER$$US-AMGEN-USASP2024147010$AMGEN$$$$$$Y$$$20240813$$PH$US$US
241478922$24147892$2$F$20220627$20240802$20240729$20240808$EXP$$CA-SANDOZ INC.-NVSC2021CA124779$SANDOZ$$47$YR$$F$Y$$$20240808$$CN$CA$CA
241478931$24147893$1$I$20240611$20240727$20240727$20240727$DIR$711786$$FDA-CTU$$61$YR$$F$N$51.75$KG$20240727$N$CN$US$
241478951$24147895$1$I$20240726$20240727$20240727$20240727$DIR$711758$$FDA-CTU$$27$YR$$F$N$67.5$KG$20240727$N$CN$US$
241478961$24147896$1$I$20200601$20240727$20240727$20240727$DIR$711796$$FDA-CTU$$33$YR$$F$N$60.3$KG$20240727$N$CN$US$
241478971$24147897$1$I$$20240725$20240729$20240729$EXP$$MX-SANDOZ INC.-SDZ2024MX068509$SANDOZ$$$$$M$Y$60$KG$20240729$$CN$MX$MX
241478981$24147898$1$I$$20240723$20240729$20240729$PER$$US-ALXN-202407USA001594US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241478991$24147899$1$I$20240606$20240722$20240729$20240729$EXP$GB-MHRA-31205853$GB-FreseniusKabi-FK202411649$FRESENIUS KABI$$48$YR$A$M$Y$86$KG$20240729$$CN$GB$GB
241479001$24147900$1$I$20240607$20240719$20240729$20240729$EXP$HR-HALMED-300086066$HR-TEVA-VS-3223697$TEVA$$26$YR$$M$Y$$$20240729$$MD$HR$HR
241479011$24147901$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092768$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241479021$24147902$1$I$20230127$20240722$20240729$20240729$EXP$$FR-FreseniusKabi-FK202411474$FRESENIUS KABI$$76$YR$E$M$Y$60$KG$20240729$$MD$FR$FR
241479031$24147903$1$I$20240701$20240723$20240729$20240729$EXP$$JP-009507513-2407JPN004360J$MERCK$$75$YR$$F$Y$$$20240729$$MD$JP$JP
241479041$24147904$1$I$20230410$20231101$20240729$20240729$EXP$$CN-PFIZER INC-PV202300183591$PFIZER$$50$YR$$M$Y$$$20240729$$CN$CN$CN
241479051$24147905$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119731$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240729$$CN$US$US
241479061$24147906$1$I$20240709$20240724$20240729$20240729$EXP$$US-ABBVIE-5857100$ABBVIE$$$$A$F$Y$$$20240729$$MD$US$US
241479072$24147907$2$F$20240101$20240730$20240729$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407017395$ELI LILLY AND CO$$47$YR$A$$Y$$$20240804$$CN$US$US
241479081$24147908$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407015765$ELI LILLY AND CO$$$$$$Y$$$20240729$$CN$US$US
241479091$24147909$1$I$$20240718$20240729$20240729$EXP$$US-JNJFOC-20240752739$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241479102$24147910$2$F$20240701$20240805$20240729$20240808$EXP$$CH-JNJFOC-20240774683$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240808$$MD$CH$CH
241479113$24147911$3$F$20240601$20240812$20240729$20240816$PER$$US-ABBVIE-5852709$ABBVIE$$40$YR$$F$Y$86$KG$20240816$$PH$US$US
241479121$24147912$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224409$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$1$YR$$F$Y$$$20240729$$HP$ES$ES
241479131$24147913$1$I$$20240722$20240729$20240729$EXP$$DE-SANDOZ INC.-SDZ2024DE068659$SANDOZ$Satirer, Ozlem, Henes, Joerg C, Doring, Michaela, Lesk, Till, Benseler, Susanne, Kuemmerle-Deschner, Jasmin Beate. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD Open$$$$M$Y$$$20240729$$HP$DE$DE
241479141$24147914$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224435$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$0$YR$$M$Y$$$20240729$$HP$ES$ES
241479151$24147915$1$I$20240723$20240724$20240729$20240729$30DAY$$IT-SANDOZ INC.-SDZ2024IT068587$SANDOZ$$13$YR$$M$Y$38$KG$20240729$$CN$IT$IT
241479161$24147916$1$I$$20240719$20240729$20240729$PER$$US-ABBVIE-5850347$ABBVIE$$$$$F$Y$$$20240729$$MD$US$US
241479171$24147917$1$I$$20240723$20240729$20240729$PER$$US-BIOVITRUM-2024-US-010198$BIOVITRUM$$15$YR$$F$Y$$$20240729$$MD$US$US
241479181$24147918$1$I$20240709$20240723$20240729$20240729$EXP$$US-ABBVIE-5851135$ABBVIE$$81$YR$$F$Y$64$KG$20240729$$CN$US$US
241479191$24147919$1$I$$20240724$20240729$20240729$EXP$FR-AFSSAPS-AVLY2024000091$FR-MYLANLABS-2024M1069602$MYLAN$$14$YR$$M$Y$$$20240729$$MD$FR$FR
241479202$24147920$2$F$$20240918$20240729$20240920$EXP$$NVSC2024US154457$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
241479211$24147921$1$I$$20240724$20240729$20240729$PER$$US-JNJFOC-20240765016$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20240729$$HP$US$US
241479221$24147922$1$I$$20240722$20240729$20240729$EXP$$DE-SANDOZ INC.-SDZ2024DE068663$SANDOZ$Satirer, Ozlem, Henes, Joerg C, Doring, Michaela, Lesk, Till, Benseler, Susanne, Kuemmerle-Deschner, Jasmin Beate. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD Open$$$$M$Y$$$20240729$$HP$DE$DE
241479231$24147923$1$I$$20230727$20240729$20240729$EXP$$US-AstraZeneca-2024A171588$ASTRAZENECA$$$$$F$Y$$$20240729$$HP$US$
241479241$24147924$1$I$$20240724$20240729$20240729$EXP$$JP-AstraZeneca-2024A169441$ASTRAZENECA$$$$$$Y$$$20240729$$MD$JP$
241479251$24147925$1$I$$20240725$20240729$20240729$EXP$$JP-AstraZeneca-2024A170419$ASTRAZENECA$$61$YR$$M$Y$$$20240729$$MD$JP$
241479261$24147926$1$I$20240713$20240724$20240729$20240729$EXP$$ID-AstraZeneca-2024A171210$ASTRAZENECA$$30857$DY$$M$Y$$$20240729$$CN$ID$
241479272$24147927$2$F$20240615$20240724$20240729$20240730$EXP$$DE-AstraZeneca-2024A169157$ASTRAZENECA$$25080$DY$$F$Y$$$20240730$$MD$DE$
241479281$24147928$1$I$$20240722$20240729$20240729$EXP$$CN-AMGEN-CHNSP2024148657$AMGEN$Li J.; Zheng  B.; Wu H. et al.. The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment. Journal of Orthopaedic Surgery and Research. 2024;19 (1):1-12$$$$$Y$$$20240729$$HP$CN$CN
241479291$24147929$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5854839$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241479303$24147930$3$F$$20240808$20240729$20240814$EXP$$CZ-MYLANLABS-2024M1069517$MYLAN$Sitina M, Sramek V.. Euglycemic ketoacidosis associated with SGLT2 inhibitors and DPP4 inhibitors ? analysis of case reports.. Anesteziologie a intenzivni medicina. 2024;35(2):116-21$65$YR$$M$Y$$$20240814$$MD$CZ$CZ
241479311$24147931$1$I$20220530$20240723$20240729$20240729$EXP$FR-AFSSAPS-PC2024000564$FR-MYLANLABS-2024M1068966$MYLAN$$40$YR$$F$Y$70$KG$20240729$$MD$FR$FR
241479321$24147932$1$I$20240605$20240725$20240729$20240729$EXP$FR-AFSSAPS-AN2024000920$FR-MYLANLABS-2024M1069505$MYLAN$$53$YR$$F$Y$48.5$KG$20240729$$MD$FR$FR
241479331$24147933$1$I$20240301$20240726$20240729$20240729$PER$$US-AMGEN-USASP2024149417$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241479343$24147934$3$F$$20240819$20240729$20240828$30DAY$$GB-JNJFOC-20240741364$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240828$$CN$GB$GB
241479351$24147935$1$I$$20240719$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010762$DR REDDYS$$$$$F$Y$$$20240729$$CN$US$US
241479361$24147936$1$I$$20240719$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010875$DR REDDYS$$24$YR$A$$Y$$$20240729$$CN$US$US
241479371$24147937$1$I$20240717$20240719$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010769$DR REDDYS$$79$YR$E$F$Y$94$KG$20240729$$CN$US$US
241479381$24147938$1$I$$20240719$20240729$20240729$EXP$$US-ABBVIE-5850486$ABBVIE$$$$$F$Y$$$20240729$$HP$US$US
241479391$24147939$1$I$$20240718$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010752$DR REDDYS$$18$YR$T$$Y$$$20240729$$CN$US$US
241479401$24147940$1$I$20240602$20240719$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010772$DR REDDYS$$35$YR$A$F$Y$$$20240729$$CN$US$US
241479411$24147941$1$I$$20240719$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010883$DR REDDYS$$17$YR$T$F$Y$$$20240729$$MD$US$US
241479421$24147942$1$I$$20240716$20240729$20240729$PER$$US-RDY-CLI/USA/24/0010540$DR REDDYS$$41$YR$A$F$Y$77.56$KG$20240729$$CN$US$US
241479431$24147943$1$I$$20240718$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010775$DR REDDYS$$18$YR$A$F$Y$$$20240729$$HP$US$US
241479441$24147944$1$I$$20240719$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010773$DR REDDYS$$62$YR$E$F$Y$57$KG$20240729$$CN$US$US
241479451$24147945$1$I$$20240718$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010757$DR REDDYS$$39$YR$A$M$Y$$$20240729$$MD$US$US
241479461$24147946$1$I$20240709$20240718$20240729$20240729$PER$$US-RDY-SPO/USA/24/0010776$DR REDDYS$$17$YR$T$F$Y$$$20240729$$PH$US$US
241479471$24147947$1$I$$20240722$20240729$20240729$EXP$$JP-GENMAB-2024-02653$GENMAB$$56$YR$$M$Y$$$20240729$$MD$JP$JP
241479481$24147948$1$I$20240522$20240725$20240729$20240729$EXP$$NL-SANDOZ INC.-SDZ2024NL055486$SANDOZ$$52$YR$$F$Y$$$20240729$$HP$NL$NL
241479491$24147949$1$I$$20240718$20240729$20240729$EXP$$FR-ROCHE-10000032845$ROCHE$$72$YR$E$M$Y$$$20240729$$MD$FR$FR
241479501$24147950$1$I$20231213$20240722$20240729$20240729$EXP$FI-FIMEA-202402603$FI-FreseniusKabi-FK202411599$FRESENIUS KABI$$78$YR$E$F$Y$$$20240729$$PH$FI$FI
241479511$24147951$1$I$20240704$20240722$20240729$20240729$EXP$FR-AFSSAPS-LL2024001386$FR-FreseniusKabi-FK202411605$FRESENIUS KABI$$46$YR$A$F$Y$63$KG$20240729$$MD$FR$FR
241479521$24147952$1$I$$20240722$20240729$20240729$EXP$$AT-FreseniusKabi-FK202411532$FRESENIUS KABI$$85$YR$E$F$Y$$$20240729$$MD$AT$AT
241479531$24147953$1$I$$20240722$20240729$20240729$EXP$$NVSC2024CN153708$NOVARTIS$Li Y, Zhou X, Wang X, Yang C, Wang C, Zhang Y et al.. Successful treatment of massive pericardial effusion after hematopoietic stem cell transplantation with tocilizumab: two cases report. J CLIN PEDIATR. 2024;42(7):595-9$4$YR$$M$Y$$$20240729$$HP$CN$CN
241479542$24147954$2$F$$20240903$20240729$20240903$PER$$US-ALXN-202407USA001597US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
241479551$24147955$1$I$20240529$20240722$20240729$20240729$EXP$$FR-FreseniusKabi-FK202411475$FRESENIUS KABI$$53$YR$A$M$Y$90$KG$20240729$$MD$FR$FR
241479562$24147956$2$F$20240101$20240729$20240729$20240801$EXP$$AT-FreseniusKabi-FK202411534$FRESENIUS KABI$$34$YR$A$$Y$$$20240801$$MD$AT$AT
241479572$24147957$2$F$20240101$20240912$20240729$20240918$EXP$$US-ABBVIE-5722267$ABBVIE$$$$$M$Y$88.45$KG$20240918$$CN$US$US
241479591$24147959$1$I$$20240723$20240729$20240729$PER$$US-APELLIS-2024-APL-0000548$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
241479601$24147960$1$I$20240707$20240724$20240729$20240729$EXP$$JP-OTSUKA-2024_019271$OTSUKA$$85$YR$$M$Y$$$20240729$$PH$JP$JP
241479611$24147961$1$I$$20220209$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210303368$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240729$$CN$CA$CA
241479623$24147962$3$F$$20240909$20240729$20240912$EXP$$AT-SANDOZ INC.-SDZ2024AT066683$SANDOZ$$66$YR$$F$Y$$$20240912$$MD$AT$AT
241479631$24147963$1$I$20240715$20240727$20240729$20240729$DIR$FDA-CDER-CTU-2024-51972$$FDA-CTU$$22$YR$$F$N$$$20240727$N$HP$US$
241479641$24147964$1$I$$20240722$20240729$20240729$EXP$$DE-SANDOZ INC.-SDZ2024DE068003$SANDOZ$Satirer ?, Henes JC, D?ring M, Lesk T, Benseler S, Kuemmerle-Deschner JB.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD Open. 2024;10(3)$$$$M$Y$$$20240729$$HP$DE$DE
241479651$24147965$1$I$$20240722$20240729$20240729$EXP$$US-JNJFOC-20240758499$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241479661$24147966$1$I$$20240718$20240729$20240729$EXP$$US-JNJFOC-20240750259$JOHNSON AND JOHNSON$$$$$$Y$$$20240729$$CN$US$US
241479671$24147967$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51974$$FDA-CTU$$35$YR$$F$N$$$20240729$N$$US$
241479691$24147969$1$I$20240715$20240719$20240729$20240729$EXP$$BR-TEVA-VS-3224791$TEVA$$42$YR$$M$Y$$$20240729$$PH$BR$BR
241479701$24147970$1$I$20240725$20240726$20240729$20240729$PER$$US-AMGEN-USASP2024149985$AMGEN$$56$YR$A$F$Y$$$20240729$$CN$US$US
241479711$24147971$1$I$$20240722$20240729$20240729$EXP$$US-AMGEN-USASL2024145922$AMGEN$$73$YR$E$F$Y$$$20240729$$CN$US$US
241479721$24147972$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5855603$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241479731$24147973$1$I$20240101$20240724$20240729$20240729$EXP$$CA-ABBVIE-5854848$ABBVIE$$$$A$M$Y$$$20240729$$CN$CA$CA
241479741$24147974$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092776$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241479752$24147975$2$F$20240401$20240815$20240729$20240820$EXP$$US-ABBVIE-5854445$ABBVIE$$62$YR$$F$Y$$$20240820$$CN$US$US
241479761$24147976$1$I$20140101$20240724$20240729$20240729$EXP$$US-ABBVIE-5499114$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241479772$24147977$2$F$20240630$20240821$20240729$20240829$EXP$$US-JNJFOC-20240724550$JOHNSON AND JOHNSON$$67$YR$E$F$Y$74.5$KG$20240829$$HP$US$US
241479781$24147978$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024091732$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$MD$US$US
241479791$24147979$1$I$20240721$20240725$20240729$20240729$PER$$NVSC2024US154698$NOVARTIS$$50$YR$$M$Y$$$20240729$$HP$US$US
241479801$24147980$1$I$20211006$20240722$20240729$20240729$EXP$$NVSC2024TW153493$NOVARTIS$$43$YR$$F$Y$$$20240729$$MD$TW$TW
241479811$24147981$1$I$20240604$20240729$20240729$20240729$EXP$FR-AFSSAPS-AN2024000964$NVSC2024FR154448$NOVARTIS$$73$YR$$M$Y$$$20240729$$MD$FR$FR
241479821$24147982$1$I$20220101$20240726$20240729$20240729$EXP$$FR-SANDOZ INC.-SDZ2024FR068385$SANDOZ$$30$YR$$F$Y$$$20240729$$HP$FR$FR
241479832$24147983$2$F$20240503$20240722$20240729$20240801$EXP$$NVSC2024BR139081$NOVARTIS$$61$YR$$F$Y$85.6$KG$20240801$$PH$BR$BR
241479841$24147984$1$I$$20240717$20240729$20240729$PER$$US-SA-2024SA215081$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
241479851$24147985$1$I$20240422$20240723$20240729$20240729$EXP$FR-AFSSAPS-DJ2024000838$FR-MYLANLABS-2024M1068896$MYLAN$$86$YR$$F$Y$60$KG$20240729$$MD$FR$FR
241479861$24147986$1$I$20240709$20240709$20240729$20240729$PER$$US-SA-2024SA218347$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240729$$PH$US$US
241479871$24147987$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA214999$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240729$$MD$US$US
241479882$24147988$2$F$20240101$20240827$20240729$20240910$PER$$US-SA-2024SA215206$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240910$$MD$US$US
241479891$24147989$1$I$20240501$20240718$20240729$20240729$PER$$US-SA-2024SA215568$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240729$$MD$US$US
241479901$24147990$1$I$20240701$20240718$20240729$20240729$PER$$US-SA-2024SA218716$SANOFI AVENTIS$$11$YR$C$M$Y$26.7$KG$20240729$$MD$US$US
241479912$24147991$2$F$20240101$20240819$20240729$20240828$PER$$US-SA-2024SA194975$SANOFI AVENTIS$$60$YR$A$M$Y$127$KG$20240828$$MD$US$US
241479921$24147992$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA216881$SANOFI AVENTIS$$$$A$F$Y$74.29$KG$20240729$$MD$US$US
241479931$24147993$1$I$20240101$20240718$20240729$20240729$PER$$US-SA-2024SA215858$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240729$$MD$US$US
241479941$24147994$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA216534$SANOFI AVENTIS$$$$A$M$Y$131$KG$20240729$$MD$US$US
241479952$24147995$2$F$20240101$20240903$20240729$20240930$PER$$US-SA-2024SA214836$SANOFI AVENTIS$$68$YR$E$F$Y$72.73$KG$20240930$$MD$US$US
241479961$24147996$1$I$20240601$20240718$20240729$20240729$PER$$US-SA-2024SA214971$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240729$$MD$US$US
241479971$24147997$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA214905$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$CN$US$US
241479981$24147998$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA215224$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240729$$MD$US$US
241479991$24147999$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA214776$SANOFI AVENTIS$$$$$M$Y$$$20240729$$CN$US$US
241480001$24148000$1$I$20200101$20240718$20240729$20240729$PER$$US-SA-2024SA216106$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240729$$MD$US$US
241480021$24148002$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA214874$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240729$$MD$US$US
241480031$24148003$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA215009$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240729$$MD$US$US
241480042$24148004$2$F$20240701$20240722$20240729$20240805$EXP$$CN-009507513-2407CHN012903$MERCK$$92$YR$$M$Y$$$20240805$$HP$CN$CN
241480052$24148005$2$F$20240101$20240726$20240729$20240806$PER$$US-SA-2024SA217416$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240806$$MD$US$US
241480061$24148006$1$I$$20240724$20240729$20240729$EXP$$US-ABBVIE-5853559$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241480071$24148007$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224436$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$5$YR$$M$Y$$$20240729$$HP$ES$ES
241480081$24148008$1$I$20240401$20240718$20240729$20240729$PER$$US-SA-2024SA216095$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240729$$CN$US$US
241480091$24148009$1$I$20220701$20240726$20240729$20240729$EXP$$ES-SANDOZ INC.-SDZ2024ES068563$SANDOZ$$$$E$M$Y$$$20240729$$HP$ES$ES
241480101$24148010$1$I$20240101$20240718$20240729$20240729$PER$$US-SA-2024SA216167$SANOFI AVENTIS$$24$YR$A$M$Y$99.7$KG$20240729$$MD$US$US
241480111$24148011$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA215229$SANOFI AVENTIS$$$$C$$Y$$$20240729$$HP$US$US
241480121$24148012$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA216076$SANOFI AVENTIS$$$$A$F$Y$69.3$KG$20240729$$MD$US$US
241480133$24148013$3$F$20240611$20240808$20240729$20240817$PER$$US-SA-2024SA216462$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240817$$MD$US$US
241480141$24148014$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA215532$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240729$$MD$US$US
241480151$24148015$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA216706$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240729$$CN$US$US
241480161$24148016$1$I$20240101$20240718$20240729$20240729$PER$$US-SA-2024SA213776$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240729$$MD$US$US
241480182$24148018$2$F$$20240829$20240729$20240923$PER$$US-SA-2024SA215620$SANOFI AVENTIS$$$$C$M$Y$33.1$KG$20240923$$MD$US$US
241480191$24148019$1$I$20240701$20240718$20240729$20240729$PER$$US-SA-2024SA215438$SANOFI AVENTIS$$$$$$Y$$$20240729$$HP$US$US
241480201$24148020$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA216628$SANOFI AVENTIS$$$$A$M$Y$97.522$KG$20240729$$MD$US$US
241480211$24148021$1$I$20240725$20240725$20240729$20240729$EXP$$US-BAYER-2024A109401$BAYER$$73$YR$E$M$Y$83.9$KG$20240729$$HP$US$US
241480221$24148022$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA216732$SANOFI AVENTIS$$$$A$M$Y$71.2$KG$20240729$$MD$US$US
241480231$24148023$1$I$20240721$20240728$20240728$20240728$DIR$711809$$FDA-CTU$$69$YR$$M$N$126$KG$20240728$N$CN$US$
241480241$24148024$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA218631$SANOFI AVENTIS$$$$A$F$Y$99.7$KG$20240729$$MD$US$US
241480251$24148025$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA215614$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240729$$MD$US$US
241480261$24148026$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA217556$SANOFI AVENTIS$$$$C$M$Y$$$20240729$$MD$US$US
241480271$24148027$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA216162$SANOFI AVENTIS$$$$A$F$Y$59.8$KG$20240729$$MD$US$US
241480281$24148028$1$I$20230101$20240719$20240729$20240729$PER$$US-SA-2024SA217512$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240729$$MD$US$US
241480291$24148029$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA215825$SANOFI AVENTIS$$$$$$Y$$$20240729$$HP$US$US
241480301$24148030$1$I$20220725$20240728$20240728$20240728$DIR$711808$$FDA-CTU$$50$YR$$UNK$N$72$KG$20240728$N$CN$US$
241480311$24148031$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA217363$SANOFI AVENTIS$$$$E$F$Y$40$KG$20240729$$MD$US$US
241480321$24148032$1$I$20240726$20240728$20240728$20240728$DIR$711813$$FDA-CTU$$31$YR$$F$N$58.5$KG$20240728$N$CN$US$
241480341$24148034$1$I$20240701$20240718$20240729$20240729$PER$$US-SA-2024SA216727$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240729$$MD$US$US
241480352$24148035$2$F$20240101$20240826$20240729$20240909$PER$$US-SA-2024SA216147$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240909$$MD$US$US
241480363$24148036$3$F$20240101$20240816$20240729$20240830$PER$$US-SA-2024SA216419$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240830$$MD$US$US
241480371$24148037$1$I$20240101$20240718$20240729$20240729$PER$$US-SA-2024SA215804$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240729$$MD$US$US
241480381$24148038$1$I$20240101$20240718$20240729$20240729$PER$$US-SA-2024SA216538$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240729$$MD$US$US
241480391$24148039$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA217146$SANOFI AVENTIS$$$$A$M$Y$99.79$KG$20240729$$MD$US$US
241480401$24148040$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51978$$FDA-CTU$$71$YR$$F$N$104.78$KG$20240729$N$HP$US$
241480411$24148041$1$I$20240501$20240718$20240729$20240729$PER$$US-SA-2024SA216326$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240729$$MD$US$US
241480421$24148042$1$I$20240619$20240719$20240729$20240729$EXP$FR-AFSSAPS-TS2024000801$FR-TEVA-VS-3223656$TEVA$$15$YR$$F$Y$46$KG$20240729$$MD$FR$FR
241480431$24148043$1$I$20240715$20240719$20240729$20240729$PER$$US-SA-2024SA207412$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240729$$MD$US$US
241480451$24148045$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA218687$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$MD$US$US
241480462$24148046$2$F$20240101$20240904$20240729$20240916$PER$$US-SA-2024SA215517$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240916$$MD$US$US
241480471$24148047$1$I$20240701$20240719$20240729$20240729$PER$$US-SA-2024SA216626$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
241480481$24148048$1$I$20240719$20240719$20240729$20240729$PER$$US-SA-2024SA217314$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$CN$US$US
241480491$24148049$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA215564$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240729$$MD$US$US
241480501$24148050$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA216543$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240729$$CN$US$US
241480511$24148051$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA216982$SANOFI AVENTIS$$$$A$F$Y$96.2$KG$20240729$$MD$US$US
241480521$24148052$1$I$20190101$20240719$20240729$20240729$PER$$US-SA-2024SA219410$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240729$$MD$US$US
241480531$24148053$1$I$20240701$20240719$20240729$20240729$PER$$US-SA-2024SA219655$SANOFI AVENTIS$$77$YR$E$F$Y$78$KG$20240729$$MD$US$US
241480541$24148054$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA216505$SANOFI AVENTIS$$$$$$Y$$$20240729$$MD$US$US
241480551$24148055$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA215868$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240729$$CN$US$US
241480561$24148056$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA215441$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240729$$MD$US$US
241480571$24148057$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA215740$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$CN$US$US
241480581$24148058$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA216325$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240729$$MD$US$US
241480591$24148059$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA216568$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240729$$MD$US$US
241480601$24148060$1$I$20240125$20240719$20240729$20240729$PER$$US-SA-2024SA216369$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240729$$MD$US$US
241480611$24148061$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA219604$SANOFI AVENTIS$$$$C$M$Y$$$20240729$$MD$US$US
241480621$24148062$1$I$20240717$20240719$20240729$20240729$PER$$US-SA-2024SA153215$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240729$$CN$US$US
241480631$24148063$1$I$20240702$20240726$20240729$20240729$EXP$FR-AFSSAPS-PP2024000807$FR-009507513-2407FRA014730$MERCK$$51$YR$$F$Y$95.5$KG$20240729$$MD$FR$FR
241480641$24148064$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA215736$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240729$$MD$US$US
241480651$24148065$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51976$$FDA-CTU$$70$YR$$M$N$89.81$KG$20240729$N$$US$
241480661$24148066$1$I$20231001$20240719$20240729$20240729$PER$$US-SA-2024SA216615$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240729$$MD$US$US
241480671$24148067$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA216705$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240729$$CN$US$US
241480681$24148068$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA214732$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240729$$CN$US$US
241480691$24148069$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA217759$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240729$$MD$US$US
241480701$24148070$1$I$20240715$20240719$20240729$20240729$PER$$US-SA-2024SA216399$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240729$$MD$US$US
241480711$24148071$1$I$20240701$20240719$20240729$20240729$PER$$US-SA-2024SA216255$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240729$$MD$US$US
241480721$24148072$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA216214$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240729$$MD$US$US
241480731$24148073$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA218983$SANOFI AVENTIS$$$$A$M$Y$46$KG$20240729$$MD$US$US
241480741$24148074$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA216185$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240729$$MD$US$US
241480751$24148075$1$I$20240724$20240728$20240728$20240728$DIR$711816$$FDA-CTU$$24$YR$$F$N$141.75$KG$20240728$N$CN$US$
241480761$24148076$1$I$20240718$20240722$20240729$20240729$EXP$$CN-FreseniusKabi-FK202411609$FRESENIUS KABI$$88$YR$E$F$Y$31.5$KG$20240729$$HP$CN$CN
241480771$24148077$1$I$20240712$20240722$20240729$20240729$EXP$$CN-FreseniusKabi-FK202411612$FRESENIUS KABI$$44$YR$A$F$Y$40$KG$20240729$$HP$CN$CN
241480781$24148078$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51980$$FDA-CTU$$55$YR$$M$N$$$20240729$N$$US$
241480801$24148080$1$I$20240726$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51983$$FDA-CTU$$56$YR$$F$N$$$20240729$N$HP$US$
241480821$24148082$1$I$20240624$20240722$20240729$20240729$EXP$FR-AFSSAPS-TS2024000826$FR-FreseniusKabi-FK202411559$FRESENIUS KABI$$68$YR$E$M$Y$61$KG$20240729$$MD$FR$FR
241480841$24148084$1$I$20240704$20240722$20240729$20240729$EXP$IT-MINISAL02-995150$IT-FreseniusKabi-FK202411521$FRESENIUS KABI$$52$YR$A$M$Y$70$KG$20240729$$MD$IT$IT
241480852$24148085$2$F$20240603$20240717$20240729$20240802$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000073$UROGEN PHARMA$$$$$$Y$$$20240803$$HP$US$US
241480861$24148086$1$I$20240529$20240604$20240729$20240729$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000072$UROGEN PHARMA$$$$$$Y$$$20240729$$MD$US$US
241480871$24148087$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA215889$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240729$$MD$US$US
241480881$24148088$1$I$$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-51987$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241480891$24148089$1$I$$20240712$20240729$20240729$PER$$US-TEVA-VS-3225782$TEVA$$70$YR$$F$Y$99.79$KG$20240729$$CN$US$US
241480901$24148090$1$I$20240401$20240719$20240729$20240729$PER$$US-SA-2024SA216208$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240729$$MD$US$US
241480911$24148091$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA215972$SANOFI AVENTIS$$$$T$M$Y$$$20240729$$MD$US$US
241480921$24148092$1$I$20230101$20240719$20240729$20240729$PER$$US-SA-2024SA216139$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240729$$MD$US$US
241480931$24148093$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA218741$SANOFI AVENTIS$$$$A$F$Y$86.1$KG$20240729$$MD$US$US
241480941$24148094$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA217205$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240729$$MD$US$US
241480951$24148095$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA215878$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240729$$MD$US$US
241480961$24148096$1$I$20240618$20240719$20240729$20240729$PER$$US-SA-2024SA212966$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240729$$MD$US$US
241480971$24148097$1$I$$20240720$20240729$20240729$PER$$US-SA-2024SA215867$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240729$$MD$US$US
241480981$24148098$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA218811$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240729$$MD$US$US
241480991$24148099$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA218054$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240729$$MD$US$US
241481001$24148100$1$I$20240701$20240719$20240729$20240729$PER$$US-SA-2024SA215943$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240729$$CN$US$US
241481011$24148101$1$I$20240601$20240720$20240729$20240729$PER$$US-SA-2024SA215513$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240729$$MD$US$US
241481022$24148102$2$F$$20240824$20240729$20240905$PER$$US-SA-2024SA216631$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240905$$MD$US$US
241481031$24148103$1$I$$20240720$20240729$20240729$PER$$US-SA-2024SA217807$SANOFI AVENTIS$$$$C$F$Y$$$20240729$$MD$US$US
241481041$24148104$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA216229$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240729$$MD$US$US
241481051$24148105$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA218654$SANOFI AVENTIS$$$$A$M$Y$106.5$KG$20240729$$MD$US$US
241481062$24148106$2$F$20240101$20240916$20240729$20240924$PER$$US-SA-2024SA216984$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240924$$MD$US$US
241481071$24148107$1$I$$20240719$20240729$20240729$PER$$US-SA-2020SA314529$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
241481081$24148108$1$I$20220501$20240720$20240729$20240729$PER$$US-SA-2024SA219378$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240729$$MD$US$US
241481093$24148109$3$F$20240101$20240726$20240729$20240807$PER$$US-SA-2024SA209439$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240807$$MD$US$US
241481101$24148110$1$I$$20240720$20240729$20240729$PER$$US-SA-2024SA215697$SANOFI AVENTIS$$63$YR$A$F$Y$93.424$KG$20240729$$MD$US$US
241481111$24148111$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA217729$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240729$$MD$US$US
241481123$24148112$3$F$20240101$20240826$20240729$20240911$PER$$US-SA-2024SA216901$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240911$$MD$US$US
241481131$24148113$1$I$20240101$20240725$20240729$20240729$EXP$$IL-GENMAB-2024-02733$GENMAB$$$$$F$Y$$$20240729$$MD$IL$IL
241481141$24148114$1$I$$20240727$20240729$20240729$EXP$GB-MHRA-MED-202407270735169410-MQLDJ$GB-SANDOZ INC.-SDZ2024GB068696$SANDOZ$$67$YR$$F$Y$66$KG$20240729$$CN$GB$GB
241481151$24148115$1$I$20240101$20240721$20240729$20240729$PER$$US-SA-2024SA217870$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240729$$MD$US$US
241481162$24148116$2$F$20240701$20240903$20240729$20240912$PER$$US-SA-2024SA217268$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240912$$MD$US$US
241481172$24148117$2$F$20240721$20240722$20240729$20240731$PER$$US-SA-2024SA215846$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240731$$MD$US$US
241481182$24148118$2$F$$20240729$20240729$20240807$PER$$US-SA-2024SA219812$SANOFI AVENTIS$$$$$$Y$$$20240807$$MD$US$US
241481201$24148120$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218892$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240729$$MD$US$US
241481211$24148121$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA217397$SANOFI AVENTIS$$$$E$M$Y$$$20240729$$MD$US$US
241481221$24148122$1$I$20240101$20240722$20240729$20240729$PER$$US-SA-2024SA217292$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240729$$MD$US$US
241481231$24148123$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA215721$SANOFI AVENTIS$$$$A$$Y$$$20240729$$MD$US$US
241481241$24148124$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA219446$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240729$$MD$US$US
241481251$24148125$1$I$20240101$20240723$20240729$20240729$PER$$US-SA-2024SA218822$SANOFI AVENTIS$$$$$F$Y$$$20240729$$MD$US$US
241481261$24148126$1$I$20240701$20240723$20240729$20240729$PER$$US-SA-2024SA217969$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240729$$CN$US$US
241481271$24148127$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219631$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240729$$MD$US$US
241481281$24148128$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219313$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240729$$CN$US$US
241481291$24148129$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA219216$SANOFI AVENTIS$$16$YR$T$M$Y$59$KG$20240729$$MD$US$US
241481302$24148130$2$F$20240101$20240916$20240729$20240923$PER$$US-SA-2024SA218757$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240923$$MD$US$US
241481311$24148131$1$I$20240711$20240723$20240729$20240729$PER$$US-SA-2024SA219250$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240729$$MD$US$US
241481321$24148132$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218414$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240729$$MD$US$US
241481331$24148133$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA217280$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240729$$CN$US$US
241481341$24148134$1$I$20240101$20240723$20240729$20240729$PER$$US-SA-2024SA219784$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240729$$MD$US$US
241481351$24148135$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218373$SANOFI AVENTIS$$63$YR$A$F$Y$92.9$KG$20240729$$CN$US$US
241481361$24148136$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA219189$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240729$$CN$US$US
241481371$24148137$1$I$$20210726$20240729$20240729$EXP$$US-AstraZeneca-2021A646929$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241481381$24148138$1$I$20231201$20240725$20240729$20240729$EXP$$RO-BRISTOL-MYERS SQUIBB COMPANY-2024-119213$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240729$$MD$RO$RO
241481391$24148139$1$I$20220104$20220221$20240729$20240729$EXP$$US-AstraZeneca-2022A022174$ASTRAZENECA$$29698$DY$$M$Y$$$20240729$$CN$US$
241481401$24148140$1$I$$20220331$20240729$20240729$EXP$$US-AstraZeneca-2022A135214$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241481411$24148141$1$I$$20210727$20240729$20240729$EXP$$US-AstraZeneca-2021A648721$ASTRAZENECA$$$$$M$Y$90.9$KG$20240729$$CN$US$
241481421$24148142$1$I$20220210$20220425$20240729$20240729$EXP$$CO-AstraZeneca-2022A166165$ASTRAZENECA$$20532$DY$$F$Y$64$KG$20240729$$CN$CO$
241481431$24148143$1$I$$20240717$20240729$20240729$PER$$US-APELLIS-2024-APL-0000506$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
241481441$24148144$1$I$20231001$20240722$20240729$20240729$PER$$US-SA-2024SA217828$SANOFI AVENTIS$$27$YR$A$M$Y$106$KG$20240729$$MD$US$US
241481451$24148145$1$I$20240701$20240722$20240729$20240729$PER$$US-SA-2024SA219716$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240729$$CN$US$US
241481472$24148147$2$F$20240723$20240820$20240729$20240828$PER$$US-SA-2024SA218512$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240828$$MD$US$US
241481481$24148148$1$I$20240720$20240722$20240729$20240729$PER$$US-SA-2024SA217869$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240729$$MD$US$US
241481491$24148149$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA219713$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240729$$MD$US$US
241481501$24148150$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218181$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240729$$MD$US$US
241481511$24148151$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219586$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240729$$CN$US$US
241481521$24148152$1$I$20240723$20240723$20240729$20240729$PER$$US-SA-2024SA220803$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240729$$MD$US$US
241481531$24148153$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA217579$SANOFI AVENTIS$$$$E$F$Y$76.19$KG$20240729$$MD$US$US
241481541$24148154$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218862$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240729$$MD$US$US
241481551$24148155$1$I$20240101$20240723$20240729$20240729$PER$$US-SA-2024SA218524$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240729$$MD$US$US
241481562$24148156$2$F$20240101$20240813$20240729$20240822$PER$$US-SA-2024SA218563$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240822$$MD$US$US
241481572$24148157$2$F$20240601$20240805$20240729$20240813$PER$$US-SA-2024SA219844$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240814$$MD$US$US
241481581$24148158$1$I$20240101$20240722$20240729$20240729$PER$$US-SA-2024SA217231$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240729$$MD$US$US
241481593$24148159$3$F$20240101$20240906$20240729$20240918$PER$$US-SA-2024SA217010$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240918$$MD$US$US
241481601$24148160$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51985$$FDA-CTU$$31$YR$$F$N$$$20240729$N$PH$US$
241481611$24148161$1$I$20240715$20240728$20240728$20240728$DIR$711822$$FDA-CTU$$68$YR$$F$N$45.27$KG$20240728$N$CN$US$
241481621$24148162$1$I$20240718$20240728$20240728$20240728$DIR$711820$$FDA-CTU$$56$YR$$F$N$72$KG$20240728$N$CN$US$
241481631$24148163$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51988$$FDA-CTU$$68$YR$$F$N$$$20240729$N$$US$
241481641$24148164$1$I$20240331$20240728$20240728$20240728$DIR$711824$$FDA-CTU$$64$YR$$F$N$$$20240728$N$PH$US$
241481651$24148165$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-51989$$FDA-CTU$$65$YR$$F$N$$$20240729$N$$US$
241481671$24148167$1$I$20240728$20240728$20240728$20240728$DIR$711829$$FDA-CTU$$28$YR$$F$N$71.1$KG$20240728$N$CN$US$
241481681$24148168$1$I$20240722$20240728$20240728$20240728$DIR$711835$$FDA-CTU$$72$YR$$M$N$76.5$KG$20240728$N$CN$US$
241481691$24148169$1$I$20240727$20240728$20240728$20240728$DIR$711823$$FDA-CTU$$44$YR$$F$N$121.5$KG$20240728$N$CN$US$
241481721$24148172$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA217692$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240729$$MD$US$US
241481731$24148173$1$I$20240101$20240720$20240729$20240729$PER$$US-SA-2024SA216813$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240729$$MD$US$US
241481742$24148174$2$F$$20240909$20240729$20240914$EXP$$US-ABBVIE-5855139$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
241481752$24148175$2$F$$20240819$20240729$20240820$PER$$US-ALXN-202407USA001579US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
241481761$24148176$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA217948$SANOFI AVENTIS$$$$A$F$Y$86$KG$20240729$$MD$US$US
241481771$24148177$1$I$20240501$20240722$20240729$20240729$PER$$US-SA-2024SA217850$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240729$$MD$US$US
241481781$24148178$1$I$20240101$20240722$20240729$20240729$PER$$US-SA-2024SA217338$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240729$$MD$US$US
241481791$24148179$1$I$$20240724$20240729$20240729$PER$$US-SA-2024SA220667$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240729$$MD$US$US
241481801$24148180$1$I$20240727$20240728$20240728$20240728$DIR$711804$$FDA-CTU$$34$YR$$F$N$$$20240728$N$CN$US$
241481823$24148182$3$F$20230119$20240910$20240729$20240912$EXP$$JP-PFIZER INC-202400184844$PFIZER$$66$YR$$F$Y$57.5$KG$20240912$$MD$JP$JP
241481863$24148186$3$F$20240101$20240903$20240729$20240906$EXP$$US-PFIZER INC-202400189820$PFIZER$$68$YR$$F$Y$62.132$KG$20240906$$HP$US$US
241481872$24148187$2$F$20230405$20240807$20240729$20240813$EXP$$CN-PFIZER INC-2023SGN05020$PFIZER$$62$YR$$F$Y$52.5$KG$20240813$$MD$CN$CN
241481885$24148188$5$F$20240701$20240815$20240729$20240822$EXP$$DE-PFIZER INC-202400223616$PFIZER$$$$E$F$Y$48$KG$20240822$$HP$DE$DE
241481891$24148189$1$I$20231228$20240725$20240729$20240729$EXP$$PR-PFIZER INC-202300261686$PFIZER$$45$YR$$F$Y$$$20240729$$HP$PR$PR
241481901$24148190$1$I$20180130$20240725$20240729$20240729$EXP$$PT-PFIZER INC-2021273399$PFIZER$$64$YR$$F$Y$87$KG$20240729$$MD$PT$PT
241481913$24148191$3$F$$20240730$20240729$20240806$EXP$$MY-PFIZER INC-2023SGN09773$PFIZER$$47$YR$$M$Y$$$20240806$$PH$MY$MY
241481921$24148192$1$I$$20240726$20240729$20240729$EXP$$CA-PFIZER INC-202400224668$PFIZER$$73$YR$$F$Y$$$20240729$$HP$CA$CA
241481933$24148193$3$F$20240605$20240918$20240729$20240920$EXP$IT-MINISAL02-995969$IT-PFIZER INC-202400221502$PFIZER$$52$YR$$F$Y$64$KG$20240920$$MD$IT$IT
241481941$24148194$1$I$$20240726$20240729$20240729$EXP$$US-PFIZER INC-202400004980$PFIZER$$64$YR$$F$Y$$$20240729$$HP$US$US
241481951$24148195$1$I$20240723$20240723$20240729$20240729$PER$$US-SA-2024SA219251$SANOFI AVENTIS$$18$YR$A$F$Y$39$KG$20240729$$MD$US$US
241481961$24148196$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA220585$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240729$$MD$US$US
241481972$24148197$2$F$$20240725$20240729$20240805$PER$$US-SA-2024SA218350$SANOFI AVENTIS$$12$YR$T$M$Y$49.8$KG$20240804$$HP$US$US
241481981$24148198$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219188$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240729$$MD$US$US
241481991$24148199$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218453$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240729$$MD$US$US
241482001$24148200$1$I$20240721$20240722$20240729$20240729$PER$$US-SA-2024SA217045$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240729$$CN$US$US
241482013$24148201$3$F$$20240805$20240729$20240811$PER$$US-SA-2024SA219877$SANOFI AVENTIS$$$$E$F$Y$83$KG$20240811$$MD$US$US
241482021$24148202$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA218677$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240729$$MD$US$US
241482031$24148203$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA217601$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240729$$MD$US$US
241482041$24148204$1$I$20240721$20240723$20240729$20240729$PER$$US-SA-2024SA219822$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240729$$CN$US$US
241482051$24148205$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219688$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
241482061$24148206$1$I$20240101$20240723$20240729$20240729$PER$$US-SA-2024SA218751$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240729$$CN$US$US
241482071$24148207$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219255$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$MD$US$US
241482081$24148208$1$I$20240101$20240722$20240729$20240729$PER$$US-SA-2024SA219852$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240729$$MD$US$US
241482091$24148209$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218262$SANOFI AVENTIS$$$$A$F$Y$64$KG$20240729$$MD$US$US
241482101$24148210$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219071$SANOFI AVENTIS$$48$YR$A$F$Y$77.11$KG$20240729$$MD$US$US
241482111$24148211$1$I$$20240724$20240729$20240729$PER$$US-SA-2024SA220706$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
241482121$24148212$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA218579$SANOFI AVENTIS$$$$E$F$Y$104.1$KG$20240729$$MD$US$US
241482131$24148213$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA213717$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$MD$US$US
241482141$24148214$1$I$20240422$20240715$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010981$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240729$$CN$US$US
241482151$24148215$1$I$20240101$20240715$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407009952$ELI LILLY AND CO$$35$YR$A$F$Y$84.4$KG$20240729$$CN$US$US
241482161$24148216$1$I$20240625$20240717$20240729$20240729$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407010884$ELI LILLY AND CO$$65$YR$E$M$Y$88$KG$20240729$$CN$GB$GB
241482171$24148217$1$I$$20240723$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015891$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240729$$HP$US$US
241482182$24148218$2$F$20230326$20240724$20240729$20240731$EXP$$CH-ELI_LILLY_AND_COMPANY-CH202407015776$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240731$$HP$CH$CH
241482191$24148219$1$I$$20240724$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016278$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241482201$24148220$1$I$$20240717$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011487$ELI LILLY AND CO$$$$$M$Y$$$20240729$$CN$US$US
241482211$24148221$1$I$$20240717$20240729$20240729$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202405015028$ELI LILLY AND CO$$72$YR$E$M$Y$92.063$KG$20240729$$CN$CA$CA
241482222$24148222$2$F$$20240724$20240729$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016211$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240805$$MD$US$US
241482232$24148223$2$F$$20240812$20240729$20240815$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011777$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240815$$CN$US$US
241482241$24148224$1$I$20240427$20240715$20240729$20240729$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202407010131$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240729$$CN$CA$CA
241482251$24148225$1$I$$20240716$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010458$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240729$$CN$US$US
241482261$24148226$1$I$$20240717$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011776$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240729$$CN$US$US
241482271$24148227$1$I$$20240717$20240729$20240729$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407011148$ELI LILLY AND CO$$$$$M$Y$$$20240729$$MD$AU$AU
241482281$24148228$1$I$$20240716$20240729$20240729$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407010032$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240729$$CN$GB$GB
241482291$24148229$1$I$$20240715$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010308$ELI LILLY AND CO$$$$A$M$Y$$$20240729$$CN$US$US
241482301$24148230$1$I$$20240718$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013014$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240729$$CN$US$US
241482311$24148231$1$I$$20240715$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010452$ELI LILLY AND CO$$$$$$Y$$$20240729$$CN$US$US
241482321$24148232$1$I$$20240723$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015917$ELI LILLY AND CO$$$$A$M$Y$$$20240729$$CN$US$US
241482331$24148233$1$I$20240308$20240717$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407012140$ELI LILLY AND CO$$$$$$Y$$$20240729$$CN$US$US
241482342$24148234$2$F$20231129$20240814$20240729$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015548$ELI LILLY AND CO$$64$YR$A$M$Y$96$KG$20240820$$CN$US$US
241482351$24148235$1$I$$20240715$20240729$20240729$EXP$GB-MHRA-MED-202407151924088070-VJSYP$GB-ELI_LILLY_AND_COMPANY-GB202407010015$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$GB$GB
241482362$24148236$2$F$20240713$20240723$20240729$20240729$EXP$GB-MHRA-MED-202407181517399340-TJPDY$GB-ELI_LILLY_AND_COMPANY-GB202407012508$ELI LILLY AND CO$$33$YR$A$F$Y$64$KG$20240729$$CN$GB$GB
241482371$24148237$1$I$20240722$20240723$20240729$20240729$PER$$US-SA-2024SA219080$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240729$$CN$US$US
241482381$24148238$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA220622$SANOFI AVENTIS$$$$C$M$Y$$$20240729$$MD$US$US
241482391$24148239$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219448$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240729$$MD$US$US
241482401$24148240$1$I$20240701$20240722$20240729$20240729$PER$$US-SA-2024SA218589$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240729$$CN$US$US
241482411$24148241$1$I$20240101$20240722$20240729$20240729$PER$$US-SA-2024SA220627$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240729$$MD$US$US
241482421$24148242$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA218273$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240729$$MD$US$US
241482431$24148243$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219846$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240729$$MD$US$US
241482441$24148244$1$I$$20240724$20240729$20240729$PER$$US-SA-2024SA218396$SANOFI AVENTIS$$$$C$$Y$$$20240729$$MD$US$US
241482452$24148245$2$F$20240724$20240724$20240729$20240802$PER$$US-SA-2024SA219870$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240802$$MD$US$US
241482461$24148246$1$I$20230803$20240728$20240728$20240728$DIR$711842$$FDA-CTU$$61$YR$$F$N$69.3$KG$20240728$Y$CN$US$
241482471$24148247$1$I$20240629$20240728$20240728$20240728$DIR$711849$$FDA-CTU$$54$YR$$F$N$70.2$KG$20240728$N$CN$US$
241482481$24148248$1$I$20230301$20240722$20240729$20240729$PER$$US-SA-2024SA218072$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240729$$MD$US$US
241482491$24148249$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA217979$SANOFI AVENTIS$$$$$M$Y$$$20240729$$MD$US$US
241482501$24148250$1$I$20230101$20240723$20240729$20240729$PER$$US-SA-2024SA218649$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
241482511$24148251$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA216791$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
241482521$24148252$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA218360$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240729$$MD$US$US
241482531$24148253$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA217855$SANOFI AVENTIS$$$$$M$Y$$$20240729$$MD$US$US
241482541$24148254$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA216751$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
241482551$24148255$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218630$SANOFI AVENTIS$$$$A$F$Y$65$KG$20240729$$MD$US$US
241482561$24148256$1$I$20240101$20240722$20240729$20240729$PER$$US-SA-2024SA218859$SANOFI AVENTIS$$48$YR$A$M$Y$111.13$KG$20240729$$MD$US$US
241482571$24148257$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218850$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240729$$MD$US$US
241482581$24148258$1$I$$20240724$20240729$20240729$PER$$US-SA-2024SA218624$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240729$$CN$US$US
241482591$24148259$1$I$20240501$20240722$20240729$20240729$PER$$US-SA-2024SA215576$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240729$$HP$US$US
241482601$24148260$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219073$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240729$$MD$US$US
241482611$24148261$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA217344$SANOFI AVENTIS$$$$C$F$Y$$$20240729$$MD$US$US
241482621$24148262$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA216380$SANOFI AVENTIS$$$$$$Y$$$20240729$$CN$US$US
241482631$24148263$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA217318$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240729$$MD$US$US
241482641$24148264$1$I$$20240725$20240729$20240729$PER$$US-SA-2024SA220601$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240729$$CN$US$US
241482652$24148265$2$F$$20240819$20240729$20240828$PER$$US-SA-2024SA217702$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240828$$MD$US$US
241482663$24148266$3$F$$20240820$20240729$20240829$PER$$US-SA-2024SA216865$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240829$$CN$US$US
241482671$24148267$1$I$20230501$20240722$20240729$20240729$PER$$US-SA-2024SA218081$SANOFI AVENTIS$$78$YR$E$F$Y$52.1$KG$20240729$$CN$US$US
241482682$24148268$2$F$$20240724$20240729$20240802$PER$$US-SA-2024SA217266$SANOFI AVENTIS$$$$A$F$Y$$$20240802$$MD$US$US
241482691$24148269$1$I$20240724$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149122$AMGEN$$63$YR$A$M$Y$$$20240729$$PH$US$US
241482701$24148270$1$I$$20240723$20240729$20240729$EXP$$US-AMGEN-USASP2024146442$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241482712$24148271$2$F$$20240910$20240729$20240912$PER$$US-BIOGEN-2024BI01275017$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
241482731$24148273$1$I$$20240719$20240729$20240729$EXP$$CO-ROCHE-10000032665$ROCHE$$37$YR$A$F$Y$$$20240729$$CN$CO$CO
241482742$24148274$2$F$$20240725$20240729$20240801$PER$$US-BIOGEN-2024BI01275553$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
241482752$24148275$2$F$20240702$20240827$20240729$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119312$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$38.4$KG$20240904$$PH$JP$JP
241482761$24148276$1$I$20230427$20240722$20240729$20240729$EXP$$NVSC2023KR202938$NOVARTIS$$74$YR$$M$Y$$$20240729$$MD$KR$KR
241482772$24148277$2$F$$20240809$20240729$20240814$EXP$$US-SA-2024SA220801$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240814$$MD$US$US
241482783$24148278$3$F$20240715$20240808$20240729$20240820$30DAY$$GB-JNJFOC-20240741324$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$CN$GB$GB
241482791$24148279$1$I$$20240723$20240729$20240729$EXP$$US-SA-2024SA217741$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$MD$US$US
241482801$24148280$1$I$$20240727$20240729$20240729$PER$$US-HALEON-2189395$Haleon PLC$$$$$$Y$$$20240729$$CN$US$US
241482812$24148281$2$F$$20240724$20240729$20240806$PER$$US-SA-2024SA218404$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240806$$CN$US$US
241482821$24148282$1$I$20240101$20240720$20240729$20240729$PER$$US-SA-2024SA217691$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240729$$MD$US$US
241482841$24148284$1$I$20240101$20240723$20240729$20240729$PER$$US-SA-2024SA219271$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240729$$MD$US$US
241482851$24148285$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA218192$SANOFI AVENTIS$$51$YR$A$M$Y$115$KG$20240729$$CN$US$US
241482861$24148286$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA216062$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240729$$MD$US$US
241482871$24148287$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA219458$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240729$$MD$US$US
241482881$24148288$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219436$SANOFI AVENTIS$$$$A$M$Y$113.39$KG$20240729$$CN$US$US
241482891$24148289$1$I$$20240721$20240729$20240729$PER$$US-SA-2024SA216857$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240729$$CN$US$US
241482901$24148290$1$I$20240101$20240722$20240729$20240729$PER$$US-SA-2024SA219439$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240729$$MD$US$US
241482911$24148291$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219613$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240729$$CN$US$US
241482922$24148292$2$F$$20240827$20240729$20240924$PER$$US-SA-2024SA219727$SANOFI AVENTIS$$17$YR$T$M$Y$74.376$KG$20240924$$MD$US$US
241482931$24148293$1$I$20240701$20240722$20240729$20240729$PER$$US-SA-2024SA218388$SANOFI AVENTIS$$4$YR$C$M$Y$17.23$KG$20240729$$MD$US$US
241482941$24148294$1$I$$20240720$20240729$20240729$PER$$US-SA-2024SA219005$SANOFI AVENTIS$$$$C$F$Y$$$20240729$$MD$US$US
241482951$24148295$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA218090$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240729$$MD$US$US
241482961$24148296$1$I$20240701$20240720$20240729$20240729$PER$$US-SA-2024SA218497$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240729$$MD$US$US
241482972$24148297$2$F$$20240730$20240729$20240802$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-103154$REGENERON$$71$YR$$M$Y$$$20240802$$HP$DE$DE
241482981$24148298$1$I$$20240724$20240729$20240729$PER$$US-BAYER-2024A108631$BAYER$Austin J.E.; Begotka A.M.. A Diaper Fading Protocol to Treat Toilet Refusal: Four Case Studies. Cognitive and Behavioral Practice (2024) 31:3 (335-344). 2024;31:3:(335-344)$3$YR$C$M$Y$$$20240729$$MD$US$US
241482992$24148299$2$F$20240717$20240905$20240729$20240908$EXP$$US-AMGEN-USASP2024146591$AMGEN$$63$YR$A$F$Y$$$20240908$$CN$US$US
241483004$24148300$4$F$20240719$20240823$20240729$20240828$PER$$US-AMGEN-USASP2024146692$AMGEN$$55$YR$A$F$Y$$$20240828$$CN$US$US
241483011$24148301$1$I$$20240726$20240729$20240729$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042394$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240729$$MD$PL$PL
241483021$24148302$1$I$$20240725$20240729$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US068440$SANDOZ$$$$$F$Y$$$20240729$$CN$US$US
241483032$24148303$2$F$$20240807$20240729$20240812$EXP$$CO-SANDOZ INC.-SDZ2024CO068617$SANDOZ$$$$$F$Y$$$20240812$$CN$CO$CO
241483042$24148304$2$F$$20240719$20240729$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116557$BRISTOL MYERS SQUIBB$$31$YR$A$M$Y$$$20240731$$CN$US$US
241483051$24148305$1$I$$20240724$20240729$20240729$EXP$$CN-FERRINGPH-2024FE04166$FERRING$$$$$$Y$$$20240729$$CN$CN$CN
241483062$24148306$2$F$20240716$20240729$20240729$20240802$EXP$$CO-FERRINGPH-2024FE04089$FERRING$$$$$$Y$$$20240802$$CN$CO$CO
241483072$24148307$2$F$20240101$20240729$20240729$20240802$EXP$$GB-FERRINGPH-2024FE04068$FERRING$$$$$$Y$$$20240802$$HP$GB$GB
241483083$24148308$3$F$20230101$20240917$20240729$20240923$EXP$$CA-FERRINGPH-2023FE05523$FERRING$$$$$$Y$$$20240923$$HP$CA$CA
241483091$24148309$1$I$20240525$20240719$20240729$20240729$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-115583$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$83$KG$20240729$$MD$FR$FR
241483101$24148310$1$I$20240627$20240725$20240729$20240729$EXP$ES-AEMPS-1547363$ES-MYLANLABS-2024M1069446$MYLAN$$15$YR$$F$Y$103$KG$20240729$$MD$ES$ES
241483111$24148311$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154498$NOVARTIS$$$$$F$Y$$$20240729$$CN$US$US
241483122$24148312$2$F$$20240816$20240729$20240819$PER$$US-ALXN-202407USA001621US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241483132$24148313$2$F$$20240726$20240729$20240731$PER$$NVSC2024US154473$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
241483141$24148314$1$I$$20240723$20240729$20240729$EXP$$TR-INCYTE CORPORATION-2024IN007875$INCYTE$$$$$$Y$$$20240729$$MD$TR$TR
241483151$24148315$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092600$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241483161$24148316$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092529$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241483171$24148317$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219382$SANOFI AVENTIS$$$$A$F$Y$136$KG$20240729$$MD$US$US
241483181$24148318$1$I$20240101$20240725$20240729$20240729$PER$$US-ABBVIE-5856635$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241483192$24148319$2$F$20240718$20240724$20240729$20240801$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22715$SAMSUNG BIOEPIS$$24$YR$A$M$Y$$$20240801$$HP$CA$CA
241483201$24148320$1$I$$20240719$20240729$20240729$EXP$$US-AMGEN-USASP2024146126$AMGEN$$$$$F$Y$$$20240729$$MD$US$US
241483212$24148321$2$F$20240724$20240822$20240729$20240827$PER$$US-AMGEN-USASP2024149131$AMGEN$$81$YR$E$F$Y$$$20240826$$CN$US$US
241483222$24148322$2$F$$20240826$20240729$20240830$PER$$US-JNJFOC-20240761936$JOHNSON AND JOHNSON$$60$YR$A$F$Y$53.1$KG$20240830$$PH$US$US
241483232$24148323$2$F$20240501$20240808$20240729$20240820$PER$$US-JNJFOC-20240775881$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240820$$PH$US$US
241483271$24148327$1$I$20230127$20240723$20240729$20240729$EXP$$FR-MYLANLABS-2024M1068771$MYLAN$$76$YR$$M$Y$60$KG$20240729$$MD$FR$FR
241483281$24148328$1$I$20240331$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A169314$ASTRAZENECA$$30648$DY$$F$Y$$$20240729$$HP$US$
241483291$24148329$1$I$$20240725$20240729$20240729$EXP$$JP-AstraZeneca-2024A170418$ASTRAZENECA$$65$YR$$M$Y$$$20240729$$MD$JP$
241483301$24148330$1$I$20210222$20210723$20240729$20240729$EXP$$US-AstraZeneca-2021A643956$ASTRAZENECA$$23715$DY$$F$Y$$$20240729$$CN$US$
241483311$24148331$1$I$20240728$20240728$20240728$20240728$DIR$711844$$FDA-CTU$$32$YR$$F$N$$$20240728$N$CN$US$
241483321$24148332$1$I$$20240719$20240729$20240729$EXP$$IT-TEVA-VS-3224422$TEVA$$59$YR$$M$Y$$$20240729$$MD$IT$IT
241483331$24148333$1$I$20240717$20240725$20240729$20240729$EXP$$CN-AstraZeneca-2024A171179$ASTRAZENECA$$24811$DY$$M$Y$50$KG$20240729$$MD$CN$
241483341$24148334$1$I$20240724$20240724$20240729$20240729$PER$$US-PFIZER INC-202400224746$PFIZER$$$$$M$Y$$$20240729$$MD$US$US
241483352$24148335$2$F$$20240726$20240729$20240801$PER$$US-PFIZER INC-PV202300027715$PFIZER$$79$YR$$F$Y$$$20240801$$MD$US$US
241483362$24148336$2$F$$20240808$20240729$20240808$PER$$US-PFIZER INC-202400222973$PFIZER$$41$YR$$M$Y$$$20240808$$CN$US$US
241483371$24148337$1$I$$20240723$20240729$20240729$PER$$US-PFIZER INC-202400223309$PFIZER$$84$YR$$F$Y$$$20240729$$HP$US$US
241483381$24148338$1$I$$20240724$20240729$20240729$PER$$US-PFIZER INC-PV202400096602$PFIZER$$64$YR$$F$Y$$$20240729$$HP$US$US
241483393$24148339$3$F$20240629$20240828$20240729$20240904$PER$$US-PFIZER INC-PV202400097370$PFIZER$$58$YR$$F$Y$70.748$KG$20240904$$CN$US$US
241483401$24148340$1$I$20240501$20240724$20240729$20240729$PER$$US-PFIZER INC-202400223988$PFIZER$$60$YR$$F$Y$$$20240729$$HP$US$US
241483411$24148341$1$I$$20240724$20240729$20240729$PER$$US-PFIZER INC-202400223520$PFIZER$$$$$$Y$$$20240729$$CN$US$US
241483421$24148342$1$I$$20240724$20240729$20240729$PER$$US-PFIZER INC-202400223994$PFIZER$$33$YR$$F$Y$$$20240729$$HP$US$US
241483431$24148343$1$I$20240701$20240724$20240729$20240729$PER$$US-PFIZER INC-202400223679$PFIZER$$88$YR$$F$Y$$$20240729$$HP$US$US
241483442$24148344$2$F$$20240801$20240729$20240802$PER$$US-PFIZER INC-202400223013$PFIZER$$57$YR$$F$Y$$$20240802$$CN$US$US
241483451$24148345$1$I$$20240724$20240729$20240729$PER$$US-PFIZER INC-202400223229$PFIZER$$$$$F$Y$$$20240729$$CN$US$US
241483462$24148346$2$F$$20240724$20240729$20240729$PER$$US-PFIZER INC-202400223530$PFIZER$$$$$F$Y$$$20240729$$CN$US$US
241483481$24148348$1$I$$20240724$20240729$20240729$PER$$US-PFIZER INC-PV202400096923$PFIZER$$42$YR$$F$Y$$$20240729$$HP$US$US
241483491$24148349$1$I$$20240724$20240729$20240729$PER$$US-PFIZER INC-PV202400095133$PFIZER$$63$YR$$F$Y$45.36$KG$20240729$$CN$US$US
241483501$24148350$1$I$$20240724$20240729$20240729$PER$$US-PFIZER INC-PV202400097858$PFIZER$$51$YR$$F$Y$$$20240729$$HP$US$US
241483521$24148352$1$I$$20210817$20240729$20240729$EXP$$JP-AstraZeneca-2021A687386$ASTRAZENECA$Not reported. Not reported. Not reported$$$$$Y$$$20240729$$HP$JP$
241483532$24148353$2$F$20240701$20240802$20240729$20240802$PER$$US-PFIZER INC-202400222992$PFIZER$$$$$F$Y$$$20240802$$CN$US$US
241483541$24148354$1$I$$20240724$20240729$20240729$PER$$US-PFIZER INC-202400224178$PFIZER$$$$$$Y$$$20240729$$CN$US$US
241483553$24148355$3$F$20240723$20240808$20240729$20240809$PER$$ES-PFIZER INC-PV202400097744$PFIZER$$54$YR$$M$Y$$$20240809$$MD$ES$ES
241483561$24148356$1$I$20240601$20240724$20240729$20240729$PER$$US-PFIZER INC-PV202400097847$PFIZER$$63$YR$$M$Y$$$20240729$$HP$US$US
241483571$24148357$1$I$20240724$20240724$20240729$20240729$PER$$US-PFIZER INC-202400223301$PFIZER$$46$YR$$M$Y$$$20240729$$CN$US$US
241483581$24148358$1$I$$20240724$20240729$20240729$EXP$$US-AstraZeneca-2024A168904$ASTRAZENECA$$$$$F$Y$$$20240729$$HP$US$
241483591$24148359$1$I$20211101$20211112$20240729$20240729$EXP$$US-AstraZeneca-2021A754713$ASTRAZENECA$$25273$DY$$F$Y$78$KG$20240729$$HP$US$
241483601$24148360$1$I$20240723$20240723$20240729$20240729$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-103727$REGENERON$$$$$M$Y$$$20240729$$CN$CA$CA
241483611$24148361$1$I$$20240726$20240729$20240729$EXP$$CN-TAKEDA-2024TUS076009$TAKEDA$$$$$M$Y$$$20240729$$CN$CN$CN
241483621$24148362$1$I$20240712$20240722$20240729$20240729$PER$$US-FreseniusKabi-FK202411563$FRESENIUS KABI$$32$YR$A$F$Y$83.46$KG$20240729$$PH$US$US
241483633$24148363$3$F$20230327$20240829$20240729$20240903$EXP$FR-AFSSAPS-PO2024000789$FR-MYLANLABS-2024M1069146$MYLAN$$39$YR$$F$Y$110$KG$20240903$$MD$FR$FR
241483651$24148365$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092522$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241483661$24148366$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218505$SANOFI AVENTIS$$10$YR$C$M$Y$38.1$KG$20240729$$HP$US$US
241483681$24148368$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092118$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241483691$24148369$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092772$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241483701$24148370$1$I$$20240722$20240729$20240729$EXP$$IT-GSK-IT2024091764$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$IT$IT
241483711$24148371$1$I$20240716$20240723$20240729$20240729$EXP$$CN-PURDUE-USA-2024-0310999$PURDUE$$82$YR$$M$Y$55$KG$20240729$$HP$CN$CN
241483722$24148372$2$F$$20240725$20240729$20240731$EXP$$US-PURDUE PHARMA-USA-2024-0310983$PURDUE$Emily G., Matthew G., Chris D., Meghan B.S., Puja S.. Suspected Counterfeit M-30 Oxycodone Pill Exposures and Acute Withdrawals Reported from a Single Hospital - Toxicology Investigators Consortium Core Registry, U.S. Census Bureau Western Region, 2017-2022. Morbidity and Mortality Weekly Report. 2024;73 (29):642-647$$$$$Y$$$20240731$$HP$US$US
241483731$24148373$1$I$$20240725$20240729$20240729$EXP$$US-PURDUE PHARMA-USA-2024-0310982$PURDUE$Emily G, Matthew G, Chris D, Meghan BS, Puja S. Suspected Counterfeit M-30 Oxycodone Pill Exposures and Acute Withdrawals Reported from a Single Hospital -Toxicology Investigators Consortium Core Registry, U.S. Census Bureau Western Region, 2017-2022. Morbidity and Mortality Weekly Report. 2024;73 (29):642-647$$$$$Y$$$20240729$$HP$US$US
241483741$24148374$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119705$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240729$$CN$US$US
241483751$24148375$1$I$$20240715$20240729$20240729$EXP$$US-TEVA-VS-3225616$TEVA$$76$YR$$F$Y$$$20240729$$CN$US$US
241483762$24148376$2$F$20230101$20240802$20240729$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202407012180$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240814$$CN$US$US
241483771$24148377$1$I$$20240723$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407015653$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240729$$CN$US$US
241483781$24148378$1$I$20231021$20240728$20240728$20240728$DIR$711837$$FDA-CTU$$29$YR$$M$N$83.25$KG$20240728$N$CN$US$
241483791$24148379$1$I$$20240724$20240729$20240729$PER$$US-JNJFOC-20240767139$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240729$$HP$US$US
241483801$24148380$1$I$20201001$20240722$20240729$20240729$EXP$$US-GSK-US2021005893$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241483811$24148381$1$I$$20240719$20240729$20240729$EXP$$US-AMGEN-USASP2024147063$AMGEN$$$$E$F$Y$$$20240729$$CN$US$US
241483822$24148382$2$F$$20240813$20240729$20240821$PER$$US-AMGEN-USASP2024149911$AMGEN$$54$YR$A$F$Y$$$20240821$$CN$US$US
241483831$24148383$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092605$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241483841$24148384$1$I$$20240724$20240729$20240729$EXP$$US-APELLIS-2024-APL-0000554$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
241483851$24148385$1$I$$20240716$20240729$20240729$30DAY$$US-GSK-US2024AMR094089$GLAXOSMITHKLINE$$$$$M$Y$$$20240729$$CN$US$US
241483861$24148386$1$I$20240501$20240717$20240729$20240729$EXP$$NVSC2024HN149305$NOVARTIS$$58$YR$$F$Y$$$20240729$$CN$HN$HN
241483871$24148387$1$I$$20240723$20240729$20240729$PER$$US-ALXN-202407USA001598US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241483882$24148388$2$F$20230723$20240816$20240729$20240819$PER$$US-ALXN-202407USA001601US$ALEXION PHARMACEUTICALS$$55$YR$$M$Y$$$20240819$$CN$US$US
241483891$24148389$1$I$$20230124$20240729$20240729$EXP$$NL-BIOVITRUM-2023NL01702$BIOVITRUM$$$$I$M$Y$4.6$KG$20240729$$HP$NL$NL
241483901$24148390$1$I$20230901$20240725$20240729$20240729$EXP$$DE-PFIZER INC-202400223451$PFIZER$$63$YR$$F$Y$$$20240729$$MD$DE$DE
241483911$24148391$1$I$20240501$20240719$20240729$20240729$EXP$$JP-TAKEDA-2024TUS075688$TAKEDA$$7$DEC$$F$Y$$$20240729$$MD$JP$JP
241483921$24148392$1$I$$20240729$20240729$20240729$EXP$$IL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042427$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240729$$MD$IL$IL
241483941$24148394$1$I$20240728$20240728$20240728$20240728$DIR$711855$$FDA-CTU$$18$YR$$F$N$60.75$KG$20240728$N$CN$US$
241483951$24148395$1$I$20240718$20240718$20240729$20240729$PER$$US-BRACCO-2024US04443$BRACCO$$72$YR$$M$Y$$$20240729$$CN$US$US
241483962$24148396$2$F$$20240721$20240729$20240730$EXP$$US-JNJFOC-20240759176$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$MD$US$US
241483971$24148397$1$I$$20240723$20240729$20240729$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000647$DECIPHERA PHARMACEUTICALS$$75$YR$E$F$Y$$$20240729$$CN$US$US
241483981$24148398$1$I$20240708$20240708$20240729$20240729$PER$$US-CSL-2024-006611$CSL Plasma$$24$YR$$F$Y$$$20240729$$HP$US$US
241483991$24148399$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137734$DAIICHI$$56$YR$$F$Y$$$20240729$$MD$CA$CA
241484002$24148400$2$F$$20240819$20240729$20240826$EXP$$CA-DSJP-DSJ-2024-137730$DAIICHI$$49$YR$$F$Y$$$20240826$$MD$CA$CA
241484011$24148401$1$I$$20240724$20240729$20240729$PER$$US-SA-2024SA218968$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240729$$MD$US$US
241484021$24148402$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA217848$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240729$$CN$US$US
241484031$24148403$1$I$20240506$20240723$20240729$20240729$EXP$FR-AFSSAPS-AVNY2024000188$FR-MYLANLABS-2024M1069070$MYLAN$$40$YR$$M$Y$$$20240729$$MD$FR$FR
241484051$24148405$1$I$$20240728$20240728$20240728$DIR$711861$$FDA-CTU$$31$YR$$M$N$58.5$KG$20240728$N$CN$US$
241484061$24148406$1$I$$20240726$20240729$20240729$EXP$$GB-Karo Pharma-2159732$Karo Pharma$$18$YR$$M$Y$75$KG$20240729$$$GB$GB
241484071$24148407$1$I$$20240722$20240729$20240729$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-137728$DAIICHI$$$$$F$Y$79$KG$20240729$$CN$CA$CA
241484081$24148408$1$I$20240228$20240728$20240728$20240728$DIR$711857$$FDA-CTU$$59$YR$$F$N$49.5$KG$20240728$Y$CN$US$
241484091$24148409$1$I$$20240722$20240729$20240729$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-137729$DAIICHI$$$$$F$Y$$$20240729$$CN$CA$CA
241484101$24148410$1$I$$20240726$20240729$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US068721$SANDOZ$$$$$F$Y$$$20240729$$HP$US$US
241484121$24148412$1$I$20240701$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119641$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240729$$CN$US$US
241484131$24148413$1$I$20240628$20240725$20240729$20240729$EXP$FR-AFSSAPS-RN2024000830$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-119777$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240729$$MD$FR$FR
241484142$24148414$2$F$$20240924$20240729$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119680$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$108.86$KG$20240925$$HP$US$US
241484151$24148415$1$I$20240704$20240719$20240729$20240729$EXP$RO-NMA-2024-SP0463$RO-TEVA-VS-3223808$TEVA$$47$YR$$F$Y$77$KG$20240729$$MD$RO$RO
241484161$24148416$1$I$20230804$20230929$20240729$20240729$EXP$$US-AstraZeneca-2023A186520$ASTRAZENECA$$24469$DY$$M$Y$$$20240729$$CN$US$
241484171$24148417$1$I$$20230804$20240729$20240729$EXP$$US-AstraZeneca-2023A146483$ASTRAZENECA$$$$$$Y$$$20240729$$HP$US$
241484181$24148418$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137726$DAIICHI$$39$YR$$F$Y$$$20240729$$MD$CA$CA
241484192$24148419$2$F$$20240819$20240729$20240827$EXP$$CA-DSJP-DSJ-2024-137727$DAIICHI$$7$DEC$$F$Y$72$KG$20240827$$PH$CA$CA
241484202$24148420$2$F$$20240809$20240729$20240820$PER$$US-JNJFOC-20240775823$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$US$US
241484211$24148421$1$I$20240501$20240611$20240729$20240729$PER$$US-JNJFOC-20240776018$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240729$$PH$US$US
241484221$24148422$1$I$$20240725$20240729$20240729$EXP$$US-JNJFOC-20240774934$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240729$$CN$US$US
241484231$24148423$1$I$20240501$20240611$20240729$20240729$PER$$US-JNJFOC-20240776081$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240729$$PH$US$US
241484241$24148424$1$I$20240718$20240718$20240729$20240729$PER$$US-AMGEN-USASP2024144876$AMGEN$$$$$$Y$$$20240729$$HP$US$US
241484251$24148425$1$I$20240724$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149168$AMGEN$$80$YR$E$$Y$$$20240729$$PH$US$US
241484262$24148426$2$F$20240719$20240808$20240729$20240812$30DAY$$US-AMGEN-USASP2024145436$AMGEN$$$$$F$Y$$$20240812$$HP$US$US
241484273$24148427$3$F$20240718$20240822$20240729$20240829$PER$$US-AMGEN-USASP2024145691$AMGEN$$65$YR$E$F$Y$75$KG$20240828$$PH$US$US
241484283$24148428$3$F$20220801$20240731$20240729$20240816$PER$$US-ALXN-202407USA001830US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240816$$MD$US$US
241484291$24148429$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224442$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$14$YR$$M$Y$$$20240729$$HP$ES$ES
241484301$24148430$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137724$DAIICHI$$44$YR$$F$Y$$$20240729$$CN$CA$CA
241484321$24148432$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224441$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$10$YR$$M$Y$$$20240729$$HP$ES$ES
241484331$24148433$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137723AA$DAIICHI$$$$$F$Y$$$20240729$$CN$CA$CA
241484342$24148434$2$F$20240801$20240822$20240729$20240827$EXP$$AR-SANDOZ INC.-SDZ2024AR068619$SANDOZ$$11$YR$$F$Y$25$KG$20240827$$CN$AR$AR
241484351$24148435$1$I$20240718$20240719$20240729$20240729$EXP$$US-GSK-US2024091054$GLAXOSMITHKLINE$$20$YR$$F$Y$$$20240729$$HP$US$US
241484361$24148436$1$I$$20240719$20240729$20240729$EXP$$FR-GSK-FR2024EME092113$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$MD$FR$FR
241484371$24148437$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092448$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241484381$24148438$1$I$$20240725$20240729$20240729$EXP$$NVSC2024CN154571$NOVARTIS$$40$YR$$M$Y$$$20240729$$CN$CN$CN
241484391$24148439$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-202400224039$PFIZER$$58$YR$$F$Y$$$20240729$$CN$US$US
241484401$24148440$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-PV202400097731$PFIZER$$77$YR$$M$Y$$$20240729$$CN$US$US
241484411$24148441$1$I$$20240726$20240729$20240729$PER$$US-PFIZER INC-202400224797$PFIZER$$$$A$$Y$$$20240729$$MD$US$US
241484421$24148442$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-202400223756$PFIZER$$71$YR$$M$Y$$$20240729$$CN$US$US
241484431$24148443$1$I$20240724$20240725$20240729$20240729$PER$$US-PFIZER INC-202400223949$PFIZER$$60$YR$$M$Y$$$20240729$$CN$US$US
241484442$24148444$2$F$20240701$20240729$20240729$20240731$PER$$US-PFIZER INC-PV202400097659$PFIZER$$70$YR$$F$Y$$$20240731$$HP$US$US
241484451$24148445$1$I$20240722$20240725$20240729$20240729$PER$$US-PFIZER INC-202400224115$PFIZER$$68$YR$$F$Y$$$20240729$$CN$US$US
241484461$24148446$1$I$20240726$20240727$20240729$20240729$PER$$US-PFIZER INC-202400225151$PFIZER$$37$YR$$F$Y$$$20240729$$CN$US$US
241484471$24148447$1$I$$20240726$20240729$20240729$PER$$US-PFIZER INC-202400224789$PFIZER$$$$A$$Y$$$20240729$$MD$US$US
241484481$24148448$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-202400224350$PFIZER$$$$$$Y$$$20240729$$CN$US$US
241484493$24148449$3$F$20240724$20240923$20240729$20240924$PER$$US-PFIZER INC-202400223661$PFIZER$$46$YR$$F$Y$56.245$KG$20240924$$CN$US$US
241484501$24148450$1$I$$20240726$20240729$20240729$PER$$US-PFIZER INC-202400224993$PFIZER$$71$YR$$F$Y$$$20240729$$CN$US$US
241484511$24148451$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-PV202400097684$PFIZER$$61$YR$$F$Y$$$20240729$$HP$US$US
241484521$24148452$1$I$$20240726$20240729$20240729$PER$$US-PFIZER INC-202400224793$PFIZER$$$$A$$Y$$$20240729$$MD$US$US
241484531$24148453$1$I$20240712$20240726$20240729$20240729$PER$$US-PFIZER INC-202400224776$PFIZER$$$$E$$Y$$$20240729$$CN$US$US
241484541$24148454$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-PV202400097577$PFIZER$$73$YR$$F$Y$$$20240729$$HP$US$US
241484551$24148455$1$I$$20240726$20240729$20240729$PER$$US-PFIZER INC-PV202400098097$PFIZER$$$$$F$Y$$$20240729$$CN$US$US
241484561$24148456$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-202400224326$PFIZER$$65$YR$$F$Y$$$20240729$$MD$US$US
241484571$24148457$1$I$20240101$20240725$20240729$20240729$PER$$US-PFIZER INC-PV202400097682$PFIZER$$49$YR$$F$Y$$$20240729$$HP$US$US
241484581$24148458$1$I$20240723$20240725$20240729$20240729$PER$$US-PFIZER INC-202400224116$PFIZER$$78$YR$$M$Y$$$20240729$$CN$US$US
241484591$24148459$1$I$20240726$20240726$20240729$20240729$PER$$US-PFIZER INC-202400224944$PFIZER$$58$YR$$F$Y$$$20240729$$CN$US$US
241484601$24148460$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-PV202400067430$PFIZER$$60$YR$$F$Y$$$20240729$$HP$US$US
241484611$24148461$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-202400224019$PFIZER$$80$YR$$F$Y$$$20240729$$CN$US$US
241484631$24148463$1$I$20240727$20240728$20240729$20240729$PER$$US-PFIZER INC-202400225203$PFIZER$$65$YR$$F$Y$$$20240729$$CN$US$US
241484641$24148464$1$I$20240701$20240725$20240729$20240729$PER$$US-PFIZER INC-202400224118$PFIZER$$55$YR$$F$Y$$$20240729$$CN$US$US
241484651$24148465$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-PV202400097591$PFIZER$$85$YR$$F$Y$$$20240729$$HP$US$US
241484671$24148467$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-PV202400097676$PFIZER$$65$YR$$F$Y$$$20240729$$HP$US$US
241484681$24148468$1$I$20240727$20240728$20240729$20240729$PER$$US-PFIZER INC-202400225412$PFIZER$$57$YR$$M$Y$$$20240729$$CN$US$US
241484692$24148469$2$F$20240726$20240729$20240729$20240801$PER$$US-PFIZER INC-202400225489$PFIZER$$64$YR$$F$Y$$$20240801$$CN$US$US
241484701$24148470$1$I$$20240726$20240729$20240729$PER$$US-PFIZER INC-PV202400098191$PFIZER$$13$YR$$M$Y$56.8$KG$20240729$$MD$US$US
241484711$24148471$1$I$20150503$20240728$20240728$20240728$DIR$711856$$FDA-CTU$$24$YR$$M$N$$$20240728$N$CN$US$
241484721$24148472$1$I$20180510$20240728$20240728$20240728$DIR$711859$$FDA-CTU$$41$YR$$M$N$76.5$KG$20240728$N$CN$US$
241484731$24148473$1$I$20240702$20240728$20240728$20240728$DIR$711830$$FDA-CTU$$58$YR$$F$N$99$KG$20240728$N$CN$US$
241484742$24148474$2$F$20240801$20240830$20240729$20240904$PER$$US-PFIZER INC-PV202400097594$PFIZER$$93$YR$$F$Y$$$20240904$$CN$US$US
241484751$24148475$1$I$20240724$20240725$20240729$20240729$PER$$US-PFIZER INC-202400223929$PFIZER$$60$YR$$F$Y$$$20240729$$CN$US$US
241484762$24148476$2$F$20240721$20240816$20240729$20240820$PER$$US-PFIZER INC-202400223926$PFIZER$$73$YR$$F$Y$68.04$KG$20240820$$CN$US$US
241484771$24148477$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-202400224037$PFIZER$$52$YR$$F$Y$$$20240729$$HP$US$US
241484781$24148478$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-PV202400097381$PFIZER$$79$YR$$F$Y$$$20240729$$HP$US$US
241484791$24148479$1$I$20240709$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-52003$$FDA-CTU$$42$YR$$F$N$93.85$KG$20240726$N$HP$US$
241484801$24148480$1$I$20240719$20240727$20240729$20240729$PER$$US-PFIZER INC-202400225480$PFIZER$$59$YR$$F$Y$$$20240729$$CN$US$US
241484814$24148481$4$F$20240801$20240824$20240729$20240828$EXP$$US-PFIZER INC-202400224744$PFIZER$$70$YR$$F$Y$$$20240828$$CN$US$US
241484821$24148482$1$I$$20240725$20240729$20240729$PER$$US-PFIZER INC-PV202400097929$PFIZER$$$$$F$Y$$$20240729$$CN$US$US
241484831$24148483$1$I$$20240726$20240729$20240729$PER$$US-PFIZER INC-202400224790$PFIZER$$$$A$$Y$$$20240729$$MD$US$US
241484841$24148484$1$I$20240726$20240728$20240729$20240729$PER$$US-PFIZER INC-202400225166$PFIZER$$45$YR$$F$Y$$$20240729$$CN$US$US
241484851$24148485$1$I$20240721$20240725$20240729$20240729$PER$$US-PFIZER INC-202400223955$PFIZER$$66$YR$$F$Y$$$20240729$$HP$US$US
241484861$24148486$1$I$$20240726$20240729$20240729$EXP$$US-BAYER-2024A109519$BAYER$$41$YR$A$M$Y$$$20240729$$HP$US$US
241484871$24148487$1$I$20240510$20240723$20240729$20240729$EXP$FR-AFSSAPS-PP2024000777$FR-MYLANLABS-2024M1068936$MYLAN$$79$YR$$F$Y$52$KG$20240729$$MD$FR$FR
241484882$24148488$2$F$20240706$20240821$20240729$20240826$EXP$$US-RDY-SPO/USA/24/0010786$DR REDDYS$$21$YR$A$M$Y$$$20240826$$CN$US$US
241484892$24148489$2$F$20240307$20240801$20240729$20240806$EXP$$RO-MYLANLABS-2024M1068941$MYLAN$Desiderio G, Maria FD, Alkojok A, Galizia V, Arena G, Macarie I et al. PROGRESSES AND CHALLENGES IN THE MANAGEMENT OF MULTIPLE MYELOMA: NAVIGATING THROUGH A RELAPSING-REMITTING COURSE. Acta Medica Marisiensis. 2024;70$58$YR$$M$Y$$$20240806$$HP$RO$RO
241484902$24148490$2$F$20240101$20240903$20240729$20240925$PER$$US-SA-2024SA219265$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240925$$MD$US$US
241484911$24148491$1$I$$20240724$20240729$20240729$PER$$US-SA-2024SA219657$SANOFI AVENTIS$$$$A$F$Y$$$20240729$$MD$US$US
241484921$24148492$1$I$$20240726$20240729$20240729$EXP$$CA-GILEAD-2024-0682135$GILEAD$$71$YR$E$M$Y$103$KG$20240729$$HP$CA$CA
241484932$24148493$2$F$$20240722$20240729$20240731$EXP$$US-AMGEN-USASP2024147881$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):1-12$57$YR$A$$Y$$$20240731$$HP$US$US
241484941$24148494$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137722AA$DAIICHI$$$$$F$Y$$$20240729$$CN$CA$CA
241484951$24148495$1$I$$20240727$20240729$20240729$EXP$GB-MHRA-MED-202407272225156400-FJKLZ$GB-TEVA-VS-3225970$TEVA$$30$YR$$M$Y$$$20240729$$CN$GB$GB
241484962$24148496$2$F$20120209$20240716$20240729$20240731$EXP$$FR-009507513-1203USA01524$MERCK$$65$YR$$F$Y$$$20240731$$HP$FR$FR
241484971$24148497$1$I$$20240723$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118356$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240729$$CN$US$US
241484981$24148498$1$I$20240724$20240725$20240729$20240729$EXP$$US-OTSUKA-2024_020943$OTSUKA$$74$YR$$F$Y$$$20240729$$CN$US$US
241484991$24148499$1$I$$20240723$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407015656$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240729$$CN$US$US
241485001$24148500$1$I$$20240727$20240729$20240729$EXP$GB-MHRA-MED-202407272224566460-HYGZR$GB-TEVA-VS-3225975$TEVA$$29$YR$$F$Y$$$20240729$$CN$GB$GB
241485011$24148501$1$I$$20240718$20240729$20240729$EXP$$US-BEH-2024176445$CSL BEHRING$Cornblath D.. [Unpublished manuscript]. [Unpublished]$$$A$M$Y$$$20240729$$HP$US$US
241485023$24148502$3$F$20240529$20240808$20240729$20240814$EXP$$DE-MYLANLABS-2024M1069007$MYLAN$$17$YR$$F$Y$63.9$KG$20240814$$MD$DE$DE
241485031$24148503$1$I$20240625$20240726$20240729$20240729$EXP$$CA-PFIZER INC-202400224768$PFIZER$$80$YR$$M$Y$$$20240729$$CN$CA$CA
241485041$24148504$1$I$$20240724$20240729$20240729$EXP$$FR-PFIZER INC-PV202400097795$PFIZER$Leclercq, M.. Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitis. The British journal of ophthalmology. 2024;1-7$$$A$$Y$$$20240729$$HP$FR$FR
241485051$24148505$1$I$$20240724$20240729$20240729$EXP$$FR-PFIZER INC-202400224566$PFIZER$Leclercq, M.. Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitis. The British journal of ophthalmology. 2024;10.1136/bjo-2024-325163$$$A$$Y$$$20240729$$HP$FR$FR
241485061$24148506$1$I$20180101$20240724$20240729$20240729$EXP$IE-HPRA-2024-114485$IE-ABBVIE-5851624$ABBVIE$$65$YR$$F$Y$$$20240729$$CN$IE$IE
241485071$24148507$1$I$$20240725$20240729$20240729$EXP$$CA-PFIZER INC-202400223893$PFIZER$$57$YR$$F$Y$81$KG$20240729$$HP$CA$CA
241485081$24148508$1$I$$20240729$20240729$20240729$EXP$LT-MYLANLABS-2024M1067850$NVSC2024LT154367$NOVARTIS$Civinskas P, Vitosyte M, Zaleckas L. Metastasis of renal cell carcinoma to the buccal mucosa and drug-induced osteonecrosis of the jaws. CLINICAL CASE. 2024;40-4$66$YR$$F$Y$$$20240729$$HP$LT$LT
241485091$24148509$1$I$20240420$20240729$20240729$20240729$EXP$FR-AFSSAPS-AM2024000601$NVSC2024FR154471$NOVARTIS$$70$YR$$M$Y$80$KG$20240729$$MD$FR$FR
241485101$24148510$1$I$$20240726$20240729$20240729$EXP$GB-MHRA-MED-202407261611297380-YCDKF$GB-JNJFOC-20240773477$JOHNSON AND JOHNSON$$$$$F$Y$$$20240729$$MD$GB$GB
241485114$24148511$4$F$20240101$20240920$20240729$20240926$EXP$$US-KARYOPHARM-2024KPT001234$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240926$$CN$US$US
241485121$24148512$1$I$20240701$20240724$20240729$20240729$EXP$$US-SA-2024SA218169$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240729$$MD$US$US
241485131$24148513$1$I$$20240509$20240729$20240729$PER$$US-MYLANLABS-2024M1042910$MYLAN$$$$$F$Y$$$20240729$$CN$US$US
241485141$24148514$1$I$$20240611$20240729$20240729$PER$$US-MYLANLABS-2024M1054303$MYLAN$$$$$F$Y$$$20240729$$CN$US$US
241485151$24148515$1$I$$20240516$20240729$20240729$PER$$US-MYLANLABS-2024M1045379$MYLAN$$$$$M$Y$$$20240729$$CN$US$US
241485161$24148516$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137721$DAIICHI$$$$$F$Y$$$20240729$$CN$CA$CA
241485181$24148518$1$I$$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-52001$$FDA-CTU$$$$$M$N$$$20240726$N$PH$US$
241485192$24148519$2$F$$20240821$20240729$20240904$EXP$$CA-Ascend Therapeutics US, LLC-2159733$ASCEND$$44$YR$$F$Y$$$20240904$$$CA$CA
241485201$24148520$1$I$$20240723$20240729$20240729$PER$$US-ALXN-202407USA001558US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241485211$24148521$1$I$$20230816$20240729$20240729$EXP$$US-AstraZeneca-2023A187984$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241485221$24148522$1$I$20240301$20240726$20240729$20240729$EXP$$MX-AstraZeneca-2024A171233$ASTRAZENECA$$73$YR$$F$Y$$$20240729$$CN$MX$
241485231$24148523$1$I$20230101$20240725$20240729$20240729$EXP$$JP-AstraZeneca-2023A204784$ASTRAZENECA$$54$YR$$F$Y$$$20240729$$MD$JP$
241485241$24148524$1$I$$20220718$20240729$20240729$EXP$$US-AstraZeneca-2022A260133$ASTRAZENECA$$$$$M$Y$80.2$KG$20240729$$CN$US$
241485251$24148525$1$I$$20240725$20240729$20240729$EXP$$MX-AstraZeneca-2024A171292$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$MX$
241485261$24148526$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137719$DAIICHI$$73$YR$$F$Y$$$20240729$$MD$CA$CA
241485271$24148527$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137717AA$DAIICHI$$$$$F$Y$$$20240729$$CN$CA$CA
241485281$24148528$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137718AA$DAIICHI$$$$$F$Y$$$20240729$$MD$CA$CA
241485291$24148529$1$I$$20230502$20240729$20240729$EXP$$US-AstraZeneca-2023A104539$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241485301$24148530$1$I$20230801$20240725$20240729$20240729$EXP$$US-GSK-US2024093522$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$HP$US$US
241485311$24148531$1$I$$20240726$20240729$20240729$EXP$$IN-AstraZeneca-2024A171297$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$IN$
241485321$24148532$1$I$$20230206$20240729$20240729$EXP$$US-AstraZeneca-2023A031910$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241485332$24148533$2$F$$20240917$20240729$20240918$EXP$$AU-AstraZeneca-2024A158505$ASTRAZENECA$$$$$M$Y$$$20240918$$HP$AU$
241485341$24148534$1$I$$20240727$20240729$20240729$EXP$$EG-ROCHE-10000040448$ROCHE$$42$YR$A$M$Y$115$KG$20240729$$CN$EG$EG
241485351$24148535$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148088$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241485362$24148536$2$F$$20240927$20240729$20240930$EXP$$NVSC2024US154417$NOVARTIS$$$$$F$Y$$$20241001$$CN$US$US
241485371$24148537$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137715$DAIICHI$$$$$F$Y$$$20240729$$MD$CA$CA
241485381$24148538$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137716$DAIICHI$$$$$F$Y$$$20240729$$MD$CA$CA
241485391$24148539$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137714AA$DAIICHI$$60$YR$$F$Y$$$20240729$$MD$CA$CA
241485401$24148540$1$I$$20240729$20240729$20240729$EXP$$GB-SANDOZ INC.-SDZ2024GB068706$SANDOZ$$72$YR$$M$Y$$$20240729$$HP$GB$GB
241485411$24148541$1$I$20240510$20240725$20240729$20240729$EXP$$CO-BAYER-2024A063382$BAYER$$58$YR$A$F$Y$$$20240729$$CN$CO$CO
241485421$24148542$1$I$$20240725$20240729$20240729$PER$$US-ABBVIE-5856501$ABBVIE$$$$$$Y$$$20240729$$CN$US$US
241485431$24148543$1$I$20240726$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-52005$$FDA-CTU$$56$YR$$F$N$$$20240726$N$PH$US$
241485442$24148544$2$F$$20240806$20240729$20240809$30DAY$$HR-MYLANLABS-2024M1068720$MYLAN$$$$$$Y$$$20240809$$PH$HR$HR
241485451$24148545$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119495$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240729$$HP$US$US
241485461$24148546$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119864$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240729$$CN$US$US
241485481$24148548$1$I$20240720$20240725$20240729$20240729$EXP$$US-BAYER-2024A109076$BAYER$$76$YR$E$M$Y$$$20240729$$CN$US$US
241485491$24148549$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2024091247$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241485502$24148550$2$F$20231001$20240725$20240729$20240801$PER$$NVSC2024US153951$NOVARTIS$$$$A$F$Y$$$20240801$$CN$US$US
241485512$24148551$2$F$20240723$20240911$20240729$20240911$PER$$NVSC2024US153434$NOVARTIS$$54$YR$$F$Y$$$20240911$$CN$US$US
241485523$24148552$3$F$20231201$20240925$20240729$20240926$EXP$$NVSC2024US041081$NOVARTIS$$62$YR$$M$Y$$$20240926$$CN$US$US
241485531$24148553$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137712AA$DAIICHI$$$$$F$Y$$$20240729$$CN$CA$CA
241485541$24148554$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137713AA$DAIICHI$$$$$F$Y$$$20240729$$MD$CA$CA
241485551$24148555$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137711$DAIICHI$$55$YR$$F$Y$64$KG$20240729$$CN$CA$CA
241485561$24148556$1$I$$20240723$20240729$20240729$EXP$FR-AFSSAPS-GR2024000892$FR-MYLANLABS-2024M1068884$MYLAN$$68$YR$$M$Y$$$20240729$$MD$FR$FR
241485571$24148557$1$I$20240320$20240723$20240729$20240729$EXP$ES-AEMPS-1549453$ES-MYLANLABS-2024M1069040$MYLAN$$81$YR$$F$Y$$$20240729$$MD$ES$ES
241485582$24148558$2$F$20230101$20240731$20240729$20240809$EXP$$BE-TEVA-VS-3224106$TEVA$Rossignon P, Nguyen LDK, Boegner P, Ku J, Herpain A. Refractory insulin resistance and hemophagocytic lymphohistiocytosis following enfortumab vedotin treatment: A case report. Mol-Clin-Oncol 2024; 20 (6): 1-7.; Rossignon P, Nguyen LDK, Boegner P, Ku J, Herpain A. Refractory insulin resistance and hemophagocytic lymphohistiocytosis following enfortumab vedotin treatment: A case report. Mol-Clin-Oncol 2024; 20 (6): 1-7.$58$YR$$M$Y$$$20240809$$HP$BE$BE
241485591$24148559$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137707$DAIICHI$$61$YR$$F$Y$$$20240729$$CN$CA$CA
241485601$24148560$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137710$DAIICHI$$80$YR$$F$Y$$$20240729$$CN$CA$CA
241485611$24148561$1$I$20240508$20240723$20240729$20240729$EXP$FR-AFSSAPS-PP2024000797$FR-MYLANLABS-2024M1068905$MYLAN$$58$YR$$M$Y$$$20240729$$MD$FR$FR
241485621$24148562$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137705AA$DAIICHI$$$$$F$Y$$$20240729$$CN$CA$CA
241485632$24148563$2$F$$20240816$20240729$20240819$PER$$US-ALXN-202407USA001563US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241485641$24148564$1$I$$20240722$20240729$20240729$EXP$$US-GSK-US2024AMR092124$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$CN$US$US
241485651$24148565$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137702$DAIICHI$$$$$F$Y$$$20240729$$PH$CA$CA
241485661$24148566$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137704$DAIICHI$$82$YR$$F$Y$$$20240729$$MD$CA$CA
241485671$24148567$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137701AA$DAIICHI$$697$MON$$F$Y$$$20240729$$HP$CA$CA
241485681$24148568$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137703$DAIICHI$$55$YR$$F$Y$$$20240729$$CN$CA$CA
241485691$24148569$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA216858$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240729$$CN$US$US
241485702$24148570$2$F$$20240917$20240729$20240925$PER$$US-SA-2024SA219241$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240925$$MD$US$US
241485711$24148571$1$I$20240501$20240722$20240729$20240729$EXP$$US-SA-2024SA219025$SANOFI AVENTIS$$67$YR$E$M$Y$124.99$KG$20240729$$MD$US$US
241485721$24148572$1$I$20230101$20240725$20240729$20240729$EXP$$NVSC2023DE143080$NOVARTIS$$$$A$F$Y$$$20240729$$CN$DE$DE
241485731$24148573$1$I$20231120$20240725$20240729$20240729$EXP$$HU-MYLANLABS-2024M1069587$MYLAN$$38$YR$$F$Y$$$20240729$$HP$HU$HU
241485741$24148574$1$I$20230110$20240725$20240729$20240729$EXP$$HU-MYLANLABS-2024M1069434$MYLAN$$76$YR$$F$Y$$$20240729$$HP$HU$HU
241485751$24148575$1$I$19670101$20240720$20240729$20240729$EXP$$US-MYLANLABS-2024M1070428$MYLAN$$$$$M$Y$$$20240729$$CN$US$US
241485761$24148576$1$I$20200412$20240725$20240729$20240729$EXP$PL-URPL-1-3856-2020$PL-MYLANLABS-2024M1069500$MYLAN$$33$YR$$M$Y$100$KG$20240729$$MD$PL$PL
241485771$24148577$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137700AA$DAIICHI$$787$MON$$F$Y$$$20240729$$MD$CA$CA
241485782$24148578$2$F$20240718$20240722$20240729$20240731$PER$$US-TEVA-VS-3224214$TEVA$$73$YR$$M$Y$$$20240731$$CN$US$US
241485801$24148580$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119913$BRISTOL MYERS SQUIBB$$19$YR$A$F$Y$$$20240729$$PH$US$US
241485811$24148581$1$I$$20240725$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119608$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240729$$HP$US$US
241485822$24148582$2$F$$20240822$20240729$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119306$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240824$$CN$US$US
241485831$24148583$1$I$$20210521$20240729$20240729$EXP$$US-AstraZeneca-2021A459469$ASTRAZENECA$$$$$F$Y$86.2$KG$20240729$$CN$US$
241485841$24148584$1$I$20240723$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118410$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240729$$PH$US$US
241485851$24148585$1$I$$20240724$20240729$20240729$EXP$$FR-PFIZER INC-202400224564$PFIZER$Leclercq, M.. Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitis. The British journal of ophthalmology. 2024;10.1136/bjo-2024-325163$$$A$$Y$$$20240729$$HP$FR$FR
241485861$24148586$1$I$$20230225$20240729$20240729$EXP$$EC-AstraZeneca-2023A050801$ASTRAZENECA$$$$$F$Y$$$20240729$$MD$EC$
241485871$24148587$1$I$$20240724$20240729$20240729$EXP$$FR-PFIZER INC-202400224565$PFIZER$Leclercq, M.. Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitis. The British journal of ophthalmology. 2024;10.1136/bjo-2024-325163$$$A$$Y$$$20240729$$HP$FR$FR
241485881$24148588$1$I$$20210619$20240729$20240729$EXP$$US-AstraZeneca-2021A555151$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241485891$24148589$1$I$$20220226$20240729$20240729$EXP$$US-AstraZeneca-2022A090583$ASTRAZENECA$$$$$$Y$$$20240729$$CN$US$
241485901$24148590$1$I$$20210720$20240729$20240729$EXP$$US-AstraZeneca-2021A634794$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241485911$24148591$1$I$20240407$20240719$20240729$20240729$30DAY$$US-GSK-US2024091127$GLAXOSMITHKLINE$$58$YR$$F$Y$48$KG$20240729$$CN$US$US
241485921$24148592$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017788$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240729$$CN$US$US
241485931$24148593$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016867$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240729$$CN$US$US
241485941$24148594$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137647$DAIICHI$$$$$F$Y$$$20240729$$MD$CA$CA
241485951$24148595$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137651$DAIICHI$$52$YR$$F$Y$$$20240729$$MD$CA$CA
241485961$24148596$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137699$DAIICHI$$$$$F$Y$60$KG$20240729$$MD$CA$CA
241485971$24148597$1$I$20240201$20240722$20240729$20240729$PER$$US-SA-2024SA219730$SANOFI AVENTIS$$$$E$M$Y$$$20240729$$MD$US$US
241485981$24148598$1$I$$20240719$20240729$20240729$EXP$$US-RADIUS HEALTH, INC.-2024US005494$RADIUS PHARM$$$$$M$Y$$$20240729$$CN$US$US
241485991$24148599$1$I$$20240722$20240729$20240729$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-137643$DAIICHI$$$$$F$Y$$$20240729$$MD$CA$CA
241486001$24148600$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137645$DAIICHI$$64$YR$$F$Y$$$20240729$$MD$CA$CA
241486012$24148601$2$F$$20240723$20240729$20240820$PER$$US-009507513-2407USA013701$MERCK$$$$$M$Y$$$20240820$$CN$US$US
241486021$24148602$1$I$20211014$20231101$20240729$20240729$EXP$$SE-Ipsen Biopharmaceuticals, Inc.-2023-24211$IPSEN$$5$YR$C$M$Y$$$20240729$$MD$SE$SE
241486033$24148603$3$F$$20240912$20240729$20240912$PER$$NVSC2024US150983$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
241486041$24148604$1$I$$20240604$20240729$20240729$PER$$US-LUNDBECK-DKLU4000353$LUNDBECK$$$$$$Y$$$20240729$$HP$US$US
241486051$24148605$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137640$DAIICHI$$51$YR$$F$Y$$$20240729$$MD$CA$CA
241486062$24148606$2$F$$20240816$20240729$20240819$PER$$US-ALXN-202407USA001555US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
241486071$24148607$1$I$20230709$20240723$20240729$20240729$EXP$$NVSC2024CO153862$NOVARTIS$$39$YR$$F$Y$60$KG$20240729$$CN$CO$CO
241486091$24148609$1$I$$20240722$20240729$20240729$EXP$$US-BAYER-2024A106854$BAYER$$83$YR$E$M$Y$$$20240729$$CN$US$US
241486106$24148610$6$F$20240830$20240917$20240729$20240927$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-135232$DAIICHI$$65$YR$$F$Y$$$20240927$$CN$US$US
241486113$24148611$3$F$20240401$20240829$20240729$20240902$EXP$$US-AMGEN-USASP2024145694$AMGEN$$68$YR$$F$Y$$$20240902$$HP$US$US
241486122$24148612$2$F$20240701$20240830$20240729$20240910$EXP$$US-BIOMARINAP-US-2024-159332$BIOMARIN$$$$$$Y$$$20240910$$MD$US$US
241486131$24148613$1$I$$20240719$20240729$20240729$EXP$$US-BIOMARINAP-US-2024-159433$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241486141$24148614$1$I$20240701$20240715$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159343$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241486151$24148615$1$I$$20240711$20240729$20240729$PER$$US-BIOMARINAP-US-2022-159316$BIOMARIN$$$$$$Y$$$20240729$$MD$US$US
241486161$24148616$1$I$20240101$20240711$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159317$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241486171$24148617$1$I$$20240715$20240729$20240729$EXP$$US-MALLINCKRODT-MNK202404673$MALLINCKRODT$$$$$M$Y$$$20240729$$HP$US$US
241486181$24148618$1$I$$20240724$20240729$20240729$EXP$$IN-SANDOZ INC.-SDZ2023IN067283$SANDOZ$$$$$M$Y$$$20240729$$CN$IN$IN
241486193$24148619$3$F$$20240820$20240729$20240825$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-115645$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240826$$HP$DE$DE
241486201$24148620$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119521$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$72.57$KG$20240729$$CN$US$US
241486212$24148621$2$F$$20240906$20240729$20240916$30DAY$$US-GSK-US2024091206$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
241486222$24148622$2$F$$20240909$20240729$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA068450$SANDOZ$$$$$F$Y$$$20240912$$MD$CA$CA
241486232$24148623$2$F$$20240819$20240729$20240826$EXP$$JP-DSJP-DSJ-2024-136369$DAIICHI$$4$DEC$$F$Y$$$20240826$$PH$JP$JP
241486243$24148624$3$F$20240101$20240723$20240729$20240830$PER$$US-SA-2024SA217608$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240830$$MD$US$US
241486251$24148625$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA217389$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240729$$MD$US$US
241486262$24148626$2$F$$20240729$20240729$20240731$PER$$US-TAKEDA-2024TUS076118$TAKEDA$$$$$M$Y$$$20240731$$HP$US$US
241486272$24148627$2$F$$20240304$20240729$20240802$PER$$US-TEVA-VS-3168480$TEVA$Ali W, Ahmad T, Ali A, Ahmad K. Status Epilepticus in Myxedema Coma, A Rare Entity. Am-J-Respir-Crit-Care-Med 2023; 207 abstr. A48.$70$YR$$F$Y$$$20240802$$HP$US$US
241486284$24148628$4$F$$20240920$20240729$20240930$PER$$US-GSK-US2024AMR092223$GLAXOSMITHKLINE$$$$$F$Y$80$KG$20240930$$CN$US$US
241486301$24148630$1$I$20240725$20240726$20240726$20240726$DIR$FDA-CDER-CTU-2024-51998$$FDA-CTU$$84$YR$$F$N$59.87$KG$20240726$N$HP$US$
241486311$24148631$1$I$$20240723$20240729$20240729$EXP$$US-PFIZER INC-PV202400096619$PFIZER$Desai, A.. Adult Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: A Clinical Case Series in a Predominantly Hispanic Cohort. Journal of Medical Cases. 2020;11(8):256-261$73$YR$$F$Y$$$20240729$$HP$US$US
241486321$24148632$1$I$20240712$20240725$20240729$20240729$EXP$FR-AFSSAPS-PV2024000672$FR-MYLANLABS-2024M1069396$MYLAN$$1$YR$$M$Y$7.6$KG$20240729$$HP$FR$FR
241486331$24148633$1$I$20240610$20240725$20240729$20240729$EXP$ES-AEMPS-1550297$ES-MYLANLABS-2024M1069433$MYLAN$$82$YR$$F$Y$$$20240729$$MD$ES$ES
241486341$24148634$1$I$$20240724$20240729$20240729$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137695$DAIICHI$$50$YR$$F$Y$$$20240729$$CN$US$US
241486351$24148635$1$I$$20240725$20240729$20240729$EXP$$SE-MYLANLABS-2024M1069507$MYLAN$Grundberg O, Skribek M, Swerkersson S, Skorpil M, K?lbeck K, Grozman V, et al.. Diffusion weighted MRI and apparent diffusion coefficient as a prognostic biomarker in evaluating chemotherapy-antiangiogenic treated stage IV non-small cell lung cancer: A prospective, single-arm, open-label, clinical trial (BevMar).. European Journal of Radiology.. 2024;177$67$YR$$F$Y$$$20240729$$HP$SE$SE
241486361$24148636$1$I$$20240724$20240729$20240729$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137696$DAIICHI$$50$YR$$F$Y$$$20240729$$CN$US$US
241486371$24148637$1$I$20240701$20240725$20240729$20240729$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004149$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
241486381$24148638$1$I$20240718$20240724$20240729$20240729$EXP$$IE-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004137$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240729$$HP$IE$IE
241486391$24148639$1$I$20230903$20240725$20240729$20240729$EXP$$US-OTSUKA-2024_020836$OTSUKA$$58$YR$$F$Y$$$20240729$$HP$US$US
241486402$24148640$2$F$$20240805$20240729$20240815$EXP$$US-RADIUS HEALTH, INC.-2024US005007$RADIUS PHARM$$$$$F$Y$$$20240815$$CN$US$US
241486411$24148641$1$I$20231001$20231201$20240729$20240729$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2023OPK00100$OPKO HEALTH$$74$YR$$F$Y$$$20231213$$PH$US$US
241486421$24148642$1$I$20240611$20240719$20240729$20240729$EXP$$US-TEVA-VS-3222807$TEVA$$73$YR$$M$Y$58.97$KG$20240729$$HP$US$US
241486431$24148643$1$I$20230605$20240723$20240729$20240729$EXP$FR-AFSSAPS-GR2024000887$FR-MYLANLABS-2024M1069575$MYLAN$$56$YR$$M$Y$$$20240729$$MD$FR$FR
241486441$24148644$1$I$20190101$20240723$20240729$20240729$EXP$$DE-MYLANLABS-2024M1069014$MYLAN$$$$A$F$Y$$$20240729$$MD$DE$DE
241486451$24148645$1$I$20240701$20240722$20240729$20240729$PER$$US-SA-2024SA217823$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240729$$MD$US$US
241486461$24148646$1$I$20240701$20240726$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042297$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240729$$CN$US$US
241486471$24148647$1$I$20230209$20240719$20240729$20240729$EXP$$BE-TEVA-VS-3224491$TEVA$$48$YR$$F$Y$62$KG$20240729$$MD$BE$BE
241486482$24148648$2$F$20240201$20240812$20240729$20240822$EXP$$BG-TEVA-VS-3224543$TEVA$$78$YR$$F$Y$$$20240822$$MD$BG$BG
241486491$24148649$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119773$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$83.46$KG$20240729$$CN$US$US
241486501$24148650$1$I$20240601$20240723$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117238$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240729$$HP$US$US
241486511$24148651$1$I$$20240724$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119358$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240729$$CN$US$US
241486521$24148652$1$I$$20240712$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119246$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240729$$MD$US$US
241486531$24148653$1$I$20230101$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017036$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240729$$CN$US$US
241486541$24148654$1$I$20240723$20240723$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407015764$ELI LILLY AND CO$$$$$$Y$$$20240729$$CN$US$US
241486552$24148655$2$F$20240101$20240828$20240729$20240904$EXP$$DE-ABBVIE-5849155$ABBVIE$$$$$M$Y$73$KG$20240904$$CN$DE$DE
241486561$24148656$1$I$20240101$20240719$20240729$20240729$30DAY$$US-GSK-US2024091114$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240729$$CN$US$US
241486572$24148657$2$F$20240101$20240830$20240729$20240906$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00388$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
241486582$24148658$2$F$20240501$20240724$20240729$20240802$EXP$$GB-SANDOZ INC.-SDZ2024GB068270$SANDOZ$$68$YR$$F$Y$$$20240802$$CN$GB$GB
241486601$24148660$1$I$$20240722$20240729$20240729$EXP$$JP-JNJFOC-20240771603$JOHNSON AND JOHNSON$Takafumi NAKANO, et al.; Department of Pharmacy, Fukuoka University/Department of Pharmacy, Fukuoka University Hospital. A case of ADRENALINE-resistant anaphylactic shock induced by contrast medium in a patient who took an excessive dose of RISPERIDONE. Journal of Japanese Society for Emergency Medicine. Proceedings of the 27th Congress of Japanese Society for Emergency Medicine; 2024.7.18,19,20; Kagoshima-shi Kagoshima:2024; 27(3)418$4$DEC$A$M$Y$$$20240729$$PH$JP$JP
241486611$24148661$1$I$$20240724$20240729$20240729$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-14859$IPSEN$$$$$$Y$$$20240729$$MD$JP$JP
241486622$24148662$2$F$20240331$20240909$20240729$20240912$EXP$$NVSC2024RU152993$NOVARTIS$$60$YR$$F$Y$76$KG$20240912$$MD$RU$RU
241486631$24148663$1$I$$20240726$20240729$20240729$PER$$US-ROCHE-10000040639$ROCHE$$$$$$Y$$$20240729$$MD$US$US
241486641$24148664$1$I$$20220118$20240729$20240729$EXP$$US-AstraZeneca-2022A031151$ASTRAZENECA$$$$$F$Y$51.7$KG$20240729$$CN$US$
241486651$24148665$1$I$$20240724$20240729$20240729$EXP$$ZA-009507513-2407ZAF014157$MERCK$$$$$$Y$$$20240729$$MD$ZA$ZA
241486661$24148666$1$I$20240718$20240719$20240729$20240729$EXP$$US-RADIUS HEALTH, INC.-2024US005578$RADIUS PHARM$$83$YR$$F$Y$70.295$KG$20240729$$CN$US$US
241486671$24148667$1$I$20211020$20240729$20240729$20240729$EXP$IT-MINISAL02-996790$IT-GILEAD-2024-0682226$GILEAD$$31$YR$A$F$Y$55.7$KG$20240729$$MD$IT$IT
241486681$24148668$1$I$$20240724$20240729$20240729$EXP$$BE-PFIZER INC-PV202400097177$PFIZER$Aleksandrova, N.. A diagnostic dilemma: distinguishing a sulfasalazine induced DRESS hypersensitivity syndrome from a CD30 + lymphoma in a young patient. International Journal of Emergency Medicine. 2024;17(1):10.1186/s12245-024-00665-7$26$YR$$M$Y$$$20240729$$HP$BE$BE
241486691$24148669$1$I$20200901$20240723$20240729$20240729$EXP$$ES-PFIZER INC-PV202400096158$PFIZER$Melian, H.. Acute neurologic deterioration in a patient with asymptomatic Charcot-Marie-Tooth disease following three doses of Brentuximab-Vedotin. Leuk Lymphoma. 2024;3:1-3$27$YR$$M$Y$$$20240729$$HP$ES$ES
241486701$24148670$1$I$$20240723$20240729$20240729$EXP$$HU-MYLANLABS-2024M1069525$MYLAN$Lakatos V, Gopcsa L, Balogh A, Fabian J, Remenyi P.. T-cell prolymphocytic leukaemia treatment and transplantation presented through two case reports. Haematology - Transfusiology. 2024;65-6$$$A$M$Y$$$20240729$$MD$HU$HU
241486711$24148671$1$I$20230412$20240723$20240729$20240729$EXP$FR-AFSSAPS-PC2024000565$FR-MYLANLABS-2024M1069430$MYLAN$$72$YR$$F$Y$80$KG$20240729$$MD$FR$FR
241486721$24148672$1$I$20240611$20240723$20240729$20240729$EXP$$FR-MYLANLABS-2024M1069608$MYLAN$$58$YR$$F$Y$$$20240729$$MD$FR$FR
241486731$24148673$1$I$$20240723$20240729$20240729$EXP$NL-LRB-00985955$NL-MYLANLABS-2024M1068946$MYLAN$$85$YR$$F$Y$$$20240729$$MD$NL$NL
241486742$24148674$2$F$$20240815$20240729$20240819$PER$$US-ALXN-202407USA001478US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
241486753$24148675$3$F$20240101$20240813$20240729$20240827$EXP$$US-MALLINCKRODT-MNK202403382$MALLINCKRODT$$$$$F$Y$$$20240827$$CN$US$US
241486761$24148676$1$I$20240722$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119630$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240729$$HP$US$US
241486776$24148677$6$F$20240101$20240913$20240729$20240926$EXP$$US-MALLINCKRODT-MNK202404628$MALLINCKRODT$$60$YR$A$F$Y$83$KG$20240926$$HP$US$US
241486781$24148678$1$I$20230605$20240719$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117118$BRISTOL MYERS SQUIBB$$25$YR$A$M$Y$$$20240729$$HP$US$US
241486791$24148679$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154450$NOVARTIS$$$$$M$Y$$$20240729$$CN$US$US
241486801$24148680$1$I$$20240726$20240729$20240729$EXP$$CA-SANDOZ INC.-PHHY2011CA100353$SANDOZ$$27$YR$$F$Y$$$20240729$$MD$CA$CA
241486811$24148681$1$I$20240101$20240725$20240729$20240729$EXP$$AU-MYLANLABS-2024M1069828$MYLAN$$$$$M$Y$$$20240729$$PH$AU$AU
241486821$24148682$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137607$DAIICHI$$$$$F$Y$$$20240729$$MD$CA$CA
241486831$24148683$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137616AA$DAIICHI$$68$YR$$F$Y$$$20240729$$HP$CA$CA
241486841$24148684$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137619AA$DAIICHI$$$$$F$Y$$$20240729$$MD$CA$CA
241486851$24148685$1$I$$20240722$20240729$20240729$EXP$$CA-DSJP-DSJ-2024-137642$DAIICHI$$51$YR$$F$Y$$$20240729$$CN$CA$CA
241486861$24148686$1$I$20240708$20240723$20240729$20240729$PER$$US-SA-2024SA219774$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240729$$HP$US$US
241486872$24148687$2$F$20240713$20240808$20240729$20240822$EXP$$CO-MYLANLABS-2024M1069529$MYLAN$$10$YR$$M$Y$18$KG$20240822$$CN$CO$CO
241486882$24148688$2$F$20240701$20240801$20240729$20240806$30DAY$$US-AMGEN-USASL2024146785$AMGEN$$67$YR$E$F$Y$$$20240806$$HP$US$US
241486892$24148689$2$F$$20240731$20240729$20240809$EXP$$IT-TEVA-VS-3224522$TEVA$Lombardi P, Aimar G, Peraldo-Neia C, Bonzano A, Depetris I, Fenocchio E, et al. Fluoropyrimidine-induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT). Oncol-Reports 2023; 49 (2): 6468.; Lombardi P, Aimar G, Peraldo-Neia C, Bonzano A, Depetris I, Fenocchio E, et al. Fluoropyrimidine-induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT). Oncol-Reports 2023; 49 (2): 6468.; Lombardi P, Aimar G, Peraldo-...$$$$$Y$$$20240809$$HP$IT$IT
241486902$24148690$2$F$$20240807$20240729$20240808$30DAY$$NL-PFIZER INC-202400217408$PFIZER$$26$YR$$F$Y$$$20240808$$PH$NL$NL
241486911$24148691$1$I$$20240716$20240729$20240729$EXP$$TR-ROCHE-10000032542$ROCHE$Ozer O, Dinc E, Dursun O, Yilmaz E, Turkmen I, Eroz P. P24-05128: The effect of subretinal recombinant tissue plasminogen activator application for submacular hemorrhage. Retina-Vitreus. 2024;33 (2):129-35. doi:10.37845/ret.vit.2024.33.20.$$$E$$Y$$$20240729$$HP$TR$TR
241486922$24148692$2$F$$20240820$20240729$20240822$30DAY$$GB-PFIZER INC-202400218590$PFIZER$$85$YR$$M$Y$$$20240822$$HP$GB$GB
241486932$24148693$2$F$$20240919$20240729$20240919$EXP$$CA-PFIZER INC-202300226546$PFIZER$$35$YR$$F$Y$$$20240919$$HP$CA$CA
241486951$24148695$1$I$$20240726$20240729$20240729$EXP$$NVSC2024US153881$NOVARTIS$$$$$F$Y$$$20240729$$CN$US$US
241486962$24148696$2$F$20240705$20240826$20240729$20240905$EXP$$JP-RADIUS HEALTH, INC.-2024JP005580$RADIUS PHARM$$84$YR$$F$Y$$$20240905$$MD$JP$JP
241486972$24148697$2$F$20240101$20240814$20240729$20240828$PER$$US-SA-2024SA218087$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240828$$MD$US$US
241486981$24148698$1$I$20240501$20240611$20240729$20240729$PER$$US-JNJFOC-20240776072$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240729$$PH$US$US
241486992$24148699$2$F$$20240820$20240729$20240829$EXP$$JP-Eisai-EC-2024-170911$EISAI$$$$$M$Y$$$20240829$$PH$JP$JP
241487002$24148700$2$F$$20240903$20240729$20240904$PER$$NVSC2024US153917$NOVARTIS$$$$$$Y$$$20240904$$CN$US$US
241487011$24148701$1$I$20220601$20240724$20240729$20240729$EXP$$TH-SANDOZ INC.-NVSC2021TH122255$SANDOZ$$62$YR$$F$Y$$$20240729$$HP$TH$TH
241487021$24148702$1$I$$20240723$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117544$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240729$$CN$US$US
241487031$24148703$1$I$$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119788$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240729$$CN$US$US
241487041$24148704$1$I$$20240723$20240729$20240729$EXP$$IE-TAKEDA-2024TUS075898$TAKEDA$$$$$$Y$$$20240729$$MD$IE$IE
241487051$24148705$1$I$$20240725$20240729$20240729$EXP$$CA-ABBVIE-5856007$ABBVIE$$$$A$M$Y$$$20240729$$HP$CA$CA
241487061$24148706$1$I$$20240719$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118866$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$108.86$KG$20240729$$CN$US$US
241487072$24148707$2$F$20240710$20240725$20240729$20240902$PER$$US-AMGEN-USASL2024149284$AMGEN$$83$YR$E$F$Y$$$20240901$$CN$US$US
241487082$24148708$2$F$20240703$20240808$20240729$20240816$30DAY$$US-AMGEN-USASP2024147142$AMGEN$$63$YR$A$M$Y$64.35$KG$20240816$$HP$US$US
241487091$24148709$1$I$20220323$20240725$20240729$20240729$EXP$$KG-PAIPHARMA-2024-KG-000004$PHARMACEUTICAL ASSOC$Mukashev MS, Turganbaev AE, Toktosun Uulu B, et al.Medical poisoning with chlorhexidine and its consequences, forensic assessment (expert case)..Bulletin of the Kyrgyz State Medical Academy.2023;153-58.$$$$F$Y$$$20240729$$HP$KG$KG
241487103$24148710$3$F$$20240726$20240729$20240816$PER$$NVSC2024US154476$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
241487121$24148712$1$I$$20240722$20240729$20240729$EXP$$BG-ABBVIE-5851387$ABBVIE$$77$YR$$M$Y$$$20240729$$CN$BG$BG
241487131$24148713$1$I$20240401$20240719$20240729$20240729$EXP$FR-AFSSAPS-AVCN2024000533$FR-TEVA-VS-3223587$TEVA$$20$YR$$M$Y$$$20240729$$MD$FR$FR
241487141$24148714$1$I$20240703$20240705$20240729$20240729$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000613$PAREXEL$$$$$$Y$$$20240729$$PH$US$US
241487151$24148715$1$I$20240703$20240705$20240729$20240729$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000611$PAREXEL$$$$$$Y$$$20240729$$PH$US$US
241487171$24148717$1$I$20240703$20240705$20240729$20240729$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000574$PAREXEL$$$$$$Y$$$20240729$$HP$US$US
241487182$24148718$2$F$$20240716$20240729$20240806$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000669$PAREXEL$Shi Jin, Ziyan Shen, Jie Li, Xueguang Liu, Qifan Zhu, Fang Li, Yiqin Shi, Pan Lin, Xialian Xu, Xiaohong Chen, Xuemei Geng, Xiaoqiang Ding, Hong Liu. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. J Clin Pathol. 2024;77:471-477$$$$$Y$$$20240806$$MD$CN$CN
241487191$24148719$1$I$20150101$20240723$20240729$20240729$EXP$$IN-MYLANLABS-2024M1069863$MYLAN$Kumar S, Mishra Y, Koshy V, Khurana H. The Janus face of the immune system: Acute myeloid leukaemia with systemic lupus erythematosus. Indian-J-Rheumatol 2023; 18 (Suppl. 2) S327 (plus Poster) abstr. CAS077.$$$A$F$Y$$$20240729$$HP$IN$IN
241487201$24148720$1$I$20240622$20240716$20240729$20240729$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000660$PAREXEL$$$$$$Y$$$20240729$$HP$CN$CN
241487211$24148721$1$I$$20240719$20240729$20240729$EXP$$US-GSK-US2024AMR092199$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241487221$24148722$1$I$$20240726$20240729$20240729$PER$$US-JNJFOC-20240776365$JOHNSON AND JOHNSON$$$$A$$Y$$$20240729$$HP$US$US
241487241$24148724$1$I$$20240604$20240729$20240729$PER$$US-LUNDBECK-DKLU4000236$LUNDBECK$$$$$$Y$$$20240729$$HP$US$US
241487261$24148726$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118524$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240729$$CN$US$US
241487271$24148727$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119271$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240729$$MD$US$US
241487281$24148728$1$I$$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118108$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240729$$CN$US$US
241487292$24148729$2$F$$20240923$20240729$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119785$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$88$KG$20240926$$CN$US$US
241487303$24148730$3$F$$20240920$20240729$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118788$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$85.28$KG$20240924$$CN$US$US
241487311$24148731$1$I$20240719$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119712$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240729$$CN$US$US
241487321$24148732$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118583$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240729$$HP$US$US
241487331$24148733$1$I$$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119166$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240729$$CN$US$US
241487341$24148734$1$I$$20240723$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117889$BRISTOL MYERS SQUIBB$$33$YR$A$M$Y$81.65$KG$20240729$$CN$US$US
241487351$24148735$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5856017$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241487361$24148736$1$I$20240101$20240722$20240729$20240729$EXP$$US-JNJFOC-20240769429$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240729$$HP$US$US
241487371$24148737$1$I$20240723$20240724$20240729$20240729$30DAY$$IT-SANDOZ INC.-SDZ2024IT068562$SANDOZ$$11$YR$$F$Y$28$KG$20240729$$CN$IT$IT
241487381$24148738$1$I$20240712$20240718$20240729$20240729$PER$$US-MYLANLABS-2024M1067916$MYLAN$$46$YR$$F$Y$99.79$KG$20240729$$CN$US$US
241487391$24148739$1$I$$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118027$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240729$$HP$US$US
241487401$24148740$1$I$20240622$20240719$20240729$20240729$EXP$HR-HALMED-300086113$HR-TEVA-VS-3223598$TEVA$$32$YR$$F$Y$$$20240729$$MD$HR$HR
241487411$24148741$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119674$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240729$$HP$US$US
241487421$24148742$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147754$AMGEN$$$$$M$Y$$$20240729$$MD$US$US
241487431$24148743$1$I$$20240429$20240729$20240729$PER$$US-AMERICAN REGENT INC-2024001623$AMERICAN REGENT$$$$$F$Y$$$20240729$$MD$US$US
241487441$24148744$1$I$$20240724$20240729$20240729$EXP$$VN-PFIZER INC-PV202400097586$PFIZER$Phan, N.. Eosinophilic Gastrointestinal Disease Presenting as Chronic Diarrhea: A Case Report. Biomedical Research and Therapy. 2024;11(6):6520-6531$63$YR$$M$Y$$$20240729$$HP$VN$VN
241487452$24148745$2$F$$20240729$20240729$20240801$EXP$$US-PFIZER INC-202400223502$PFIZER$Howell, J.. Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor: A case report. Urology Case Reports. 2024;56:10.1016/j.eucr.2024.102799$62$YR$$F$Y$$$20240801$$HP$US$US
241487463$24148746$3$F$20230701$20240807$20240729$20240813$EXP$$CN-SMPA-2024SMP011178$SUNOVION$$$$$$Y$$$20240813$$CN$CN$CN
241487472$24148747$2$F$$20240730$20240729$20240731$EXP$$US-ABBVIE-5855202$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241487482$24148748$2$F$$20240723$20240729$20240731$PER$$JP-Eisai-EC-2024-170838$EISAI$$62$YR$A$F$Y$$$20240731$$MD$JP$JP
241487501$24148750$1$I$20240701$20240722$20240729$20240729$EXP$$JP-Eisai-EC-2024-170777$EISAI$$$$E$M$Y$$$20240729$$MD$JP$JP
241487511$24148751$1$I$20240718$20240722$20240729$20240729$EXP$$CO-BAYER-2024A108134$BAYER$$64$YR$A$F$Y$$$20240729$$HP$CO$CO
241487521$24148752$1$I$$20230317$20240729$20240729$EXP$$US-AstraZeneca-2023A065321$ASTRAZENECA$$$$$F$Y$$$20240729$$CN$US$
241487531$24148753$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118673$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240729$$MD$US$US
241487541$24148754$1$I$20240724$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119128$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240729$$CN$US$US
241487551$24148755$1$I$20240719$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119764$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240729$$HP$US$US
241487561$24148756$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118680$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240729$$HP$US$US
241487571$24148757$1$I$20240608$20240725$20240729$20240729$EXP$CZ-CZSUKL-24001970$CZ-ROCHE-10000036929$ROCHE$$44$YR$A$F$Y$53$KG$20240729$$MD$CZ$CZ
241487581$24148758$1$I$$20240723$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118723$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240729$$HP$US$US
241487591$24148759$1$I$20240118$20240718$20240729$20240729$EXP$FR-AFSSAPS-DJ2024000846$FR-ELI_LILLY_AND_COMPANY-FR202407012679$ELI LILLY AND CO$$44$YR$A$F$Y$63$KG$20240729$$CN$FR$FR
241487601$24148760$1$I$20240301$20240717$20240729$20240729$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407012768$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240729$$CN$GB$GB
241487611$24148761$1$I$20240229$20240723$20240729$20240729$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202407014775$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$ES$ES
241487621$24148762$1$I$$20240717$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407012086$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240729$$MD$US$US
241487631$24148763$1$I$$20240717$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407012605$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240729$$CN$US$US
241487641$24148764$1$I$20200901$20240717$20240729$20240729$EXP$$PT-ELI_LILLY_AND_COMPANY-PT202407011949$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240729$$CN$PT$PT
241487651$24148765$1$I$$20240721$20240729$20240729$EXP$$KW-ELI_LILLY_AND_COMPANY-KW202405005015$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$KW$KW
241487661$24148766$1$I$20240624$20240717$20240729$20240729$EXP$FR-AFSSAPS-AN2024000914$FR-ELI_LILLY_AND_COMPANY-FR202407011945$ELI LILLY AND CO$$57$YR$A$M$Y$71$KG$20240729$$CN$FR$FR
241487671$24148767$1$I$$20240717$20240729$20240729$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407012586$ELI LILLY AND CO$$66$YR$E$F$Y$47.5$KG$20240729$$CN$CN$CN
241487681$24148768$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5857018$ABBVIE$$$$$$Y$$$20240729$$MD$US$US
241487692$24148769$2$F$20240601$20240823$20240729$20240828$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-137170$DAIICHI$$7$DEC$$F$Y$$$20240828$$MD$JP$JP
241487712$24148771$2$F$20240719$20240816$20240729$20240822$EXP$$JP-009507513-2407JPN004361J$MERCK$$54$YR$$M$Y$$$20240822$$MD$JP$JP
241487724$24148772$4$F$20240608$20240823$20240729$20240830$EXP$$NVSC2024RU152398$NOVARTIS$$0$YR$$F$Y$4.2$KG$20240830$$CN$RU$RU
241487733$24148773$3$F$20240501$20240807$20240729$20240924$PER$$US-LUNDBECK-DKLU4000339$LUNDBECK$$$$$$Y$$$20240924$$CN$US$US
241487741$24148774$1$I$20240101$20240725$20240729$20240729$EXP$$BE-ABBVIE-5855934$ABBVIE$$$$$F$Y$$$20240729$$CN$BE$BE
241487751$24148775$1$I$20221017$20240719$20240729$20240729$EXP$PT-INFARMED-B202407-4$PT-TEVA-VS-3223492$TEVA$$31$YR$$M$Y$$$20240729$$MD$PT$PT
241487761$24148776$1$I$$20240722$20240729$20240729$PER$$US-EMD Serono-2024040022$EMD SERONO INC$$$$$$Y$$$20240729$$CN$US$US
241487772$24148777$2$F$$20240903$20240729$20240911$PER$$JP-Eisai-EC-2024-170850$EISAI$$$$$M$Y$$$20240911$$MD$JP$JP
241487781$24148778$1$I$$20240725$20240729$20240729$EXP$$US-Eisai-EC-2024-171005$EISAI$$$$$F$Y$$$20240729$$HP$US$US
241487802$24148780$2$F$20240626$20240809$20240729$20240819$EXP$$US-BAYER-2024A096561$BAYER$$84$YR$E$M$Y$102.95$KG$20240819$$CN$US$US
241487821$24148782$1$I$20240704$20240722$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116724$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$88.45$KG$20240729$$CN$US$US
241487831$24148783$1$I$20240717$20240724$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118972$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240729$$CN$US$US
241487841$24148784$1$I$$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119457$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240729$$CN$US$US
241487881$24148788$1$I$$20240719$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007660$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241487892$24148789$2$F$$20230310$20240729$20240904$EXP$$BR-AstraZeneca-2023A061538$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$BR$
241487902$24148790$2$F$20230726$20240808$20240729$20240819$EXP$$AR-KYOWAKIRIN-2024KK018049$KYOWA$$$$$$Y$$$20240819$$HP$AR$AR
241487911$24148791$1$I$20240702$20240717$20240729$20240729$PER$$US-MYLANLABS-2024M1067406$MYLAN$$67$YR$$M$Y$$$20240729$$CN$US$US
241487921$24148792$1$I$20240201$20240722$20240729$20240729$PER$$US-SA-2024SA217287$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240729$$MD$US$US
241487932$24148793$2$F$20240701$20240903$20240729$20240905$PER$$US-AMGEN-USASP2024149904$AMGEN$$73$YR$E$M$Y$$$20240904$$CN$US$US
241487941$24148794$1$I$20240716$20240717$20240729$20240729$PER$$US-MYLANLABS-2024M1067619$MYLAN$$78$YR$$M$Y$$$20240729$$CN$US$US
241487951$24148795$1$I$20240619$20240723$20240729$20240729$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14771$IPSEN$$33$YR$A$F$Y$$$20240729$$HP$US$US
241487963$24148796$3$F$20240812$20240919$20240729$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119871$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240926$$CN$US$US
241487971$24148797$1$I$20240701$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120007$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240729$$CN$US$US
241487982$24148798$2$F$$20240813$20240729$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119688$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$62.6$KG$20240814$$CN$US$US
241487991$24148799$1$I$20240601$20240722$20240729$20240729$EXP$$US-LUNDBECK-DKLU4002150$LUNDBECK$$$$$$Y$$$20240729$$CN$US$US
241488001$24148800$1$I$$20240725$20240729$20240729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119533$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240729$$MD$JP$JP
241488012$24148801$2$F$20200101$20240830$20240729$20240906$EXP$$JP-OTSUKA-2024_020431$OTSUKA$$5$DEC$$M$Y$82$KG$20240906$$MD$JP$JP
241488022$24148802$2$F$$20240726$20240729$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118575$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$74.1$KG$20240802$$PH$US$US
241488032$24148803$2$F$20240716$20240730$20240729$20240809$EXP$$IL-INCYTE CORPORATION-2024IN007870$INCYTE$$$$$$Y$$$20240809$$HP$IL$IL
241488042$24148804$2$F$20221215$20240819$20240729$20240822$EXP$$NVSC2023KR202926$NOVARTIS$$76$YR$$M$Y$76.1$KG$20240822$$MD$KR$KR
241488051$24148805$1$I$$20240725$20240729$20240729$EXP$$US-BAUSCH-BL-2024-011416$BAUSCH AND LOMB$$90$YR$$M$Y$105.78$KG$20240729$$CN$US$US
241488061$24148806$1$I$20240420$20240724$20240729$20240729$EXP$$CO-LUNDBECK-DKLU4002217$LUNDBECK$$$$$$Y$$$20240729$$CN$CO$CO
241488072$24148807$2$F$$20240724$20240729$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US068102$SANDOZ$$$$$$Y$$$20240729$$CN$US$US
241488091$24148809$1$I$$20240728$20240729$20240729$EXP$$FR-BAUSCH-BL-2024-011530$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240729$$MD$FR$FR
241488101$24148810$1$I$$20240722$20240729$20240729$EXP$$US-MYLANLABS-2024M1069783$MYLAN$Chittal A, Kumar K, Rao S, Baydarian M. Herpes Simplex Virus 1 Meningitis Presenting as Status Epilepticus. Am-J-Respir-Crit-Care-Med 2023; 207.$54$YR$$M$Y$$$20240729$$HP$US$US
241488112$24148811$2$F$$20240726$20240729$20240801$EXP$$CA-ABBVIE-5853802$ABBVIE$$$$A$F$Y$$$20240801$$PH$CA$CA
241488131$24148813$1$I$$20240725$20240729$20240729$PER$$US-AstraZeneca-2024A170276$ASTRAZENECA$$$$$$Y$$$20240729$$PH$US$
241488141$24148814$1$I$20240722$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120029$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240729$$MD$US$US
241488153$24148815$3$F$$20240911$20240729$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119673$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240913$$CN$US$US
241488161$24148816$1$I$20240701$20240725$20240729$20240729$PER$$US-ABBVIE-5854691$ABBVIE$$30$YR$$F$Y$$$20240729$$MD$US$US
241488171$24148817$1$I$20240627$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119575$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$88.45$KG$20240729$$PH$US$US
241488181$24148818$1$I$20160524$20240722$20240729$20240729$PER$$US-MYLANLABS-2024M1069578$MYLAN$$82$YR$$M$Y$$$20240729$$MD$US$US
241488201$24148820$1$I$20220901$20240721$20240729$20240729$PER$$US-SA-2024SA217141$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240729$$MD$US$US
241488212$24148821$2$F$$20240830$20240729$20240904$EXP$$JP-OTSUKA-2024_020476$OTSUKA$$6$DEC$$M$Y$$$20240904$$MD$JP$JP
241488223$24148822$3$F$20240701$20240927$20240729$20240927$30DAY$$GR-PFIZER INC-PV202400095996$PFIZER$$6$YR$$M$Y$18$KG$20240927$$CN$GR$GR
241488232$24148823$2$F$$20240805$20240729$20240808$30DAY$$AT-PFIZER INC-PV202400096439$PFIZER$$$$$M$Y$$$20240808$$MD$AT$AT
241488252$24148825$2$F$20240721$20240904$20240729$20240904$30DAY$$CL-PFIZER INC-PV202400095612$PFIZER$$13$YR$$F$Y$$$20240904$$CN$CL$CL
241488262$24148826$2$F$$20240919$20240729$20240923$30DAY$$US-PFIZER INC-202400218850$PFIZER$$14$YR$$M$Y$$$20240923$$CN$US$US
241488273$24148827$3$F$$20240904$20240729$20240906$30DAY$$CA-PFIZER INC-202400222150$PFIZER$$63$YR$$M$Y$$$20240906$$HP$CA$CA
241488285$24148828$5$F$20240722$20240829$20240729$20240903$30DAY$$NO-PFIZER INC-202400221865$PFIZER$$33$YR$$M$Y$$$20240903$$PH$NO$NO
241488291$24148829$1$I$20240501$20240723$20240729$20240729$30DAY$$AU-PFIZER INC-202400085455$PFIZER$$57$YR$$F$Y$70$KG$20240729$$CN$AU$AU
241488302$24148830$2$F$$20240918$20240729$20240920$30DAY$$CO-PFIZER INC-202400219436$PFIZER$$14$YR$$M$Y$$$20240920$$CN$CO$CO
241488312$24148831$2$F$$20240906$20240729$20240910$30DAY$$AU-PFIZER INC-202400218186$PFIZER$$$$$F$Y$$$20240910$$PH$AU$AU
241488332$24148833$2$F$20240101$20240905$20240729$20240919$EXP$$US-SA-2024SA147693$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240919$$MD$US$US
241488341$24148834$1$I$20240723$20240723$20240729$20240729$30DAY$$US-PFIZER INC-202400222414$PFIZER$$13$YR$$M$Y$$$20240729$$CN$US$US
241488351$24148835$1$I$20240709$20240719$20240729$20240729$30DAY$$US-GSK-US2024AMR091535$GLAXOSMITHKLINE$$21$YR$$M$Y$$$20240729$$CN$US$US
241488361$24148836$1$I$$20240726$20240729$20240729$EXP$$ID-INCYTE CORPORATION-2024IN007889$INCYTE$$$$$$Y$$$20240729$$MD$ID$ID
241488371$24148837$1$I$$20240717$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407011552$ELI LILLY AND CO$$58$YR$A$$Y$$$20240729$$LW$US$US
241488381$24148838$1$I$$20240717$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011486$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240729$$CN$US$US
241488392$24148839$2$F$20240628$20240722$20240729$20240820$EXP$IT-MINISAL02-995722$IT-Ipsen Biopharmaceuticals, Inc.-2024-14432$IPSEN$$71$YR$E$F$Y$$$20240820$$MD$IT$IT
241488401$24148840$1$I$20240718$20240719$20240729$20240729$PER$$US-SA-2024SA216318$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240729$$PH$US$US
241488411$24148841$1$I$$20240716$20240729$20240729$EXP$$US-LNK INTERNATIONAL, INC.-2159738$LNK INTERNATIONAL$$$$$F$Y$$$20240729$$$US$US
241488422$24148842$2$F$20240703$20240828$20240729$20240828$PER$$US-PFIZER INC-PV202400096587$PFIZER$$15$YR$$M$Y$76.7$KG$20240828$$MD$US$US
241488432$24148843$2$F$20240720$20240829$20240729$20240829$PER$$US-PFIZER INC-202400222370$PFIZER$$11$YR$$F$Y$$$20240829$$CN$US$US
241488442$24148844$2$F$$20240828$20240729$20240828$PER$$US-PFIZER INC-202400219848$PFIZER$$60$YR$$F$Y$$$20240828$$CN$US$US
241488453$24148845$3$F$20240101$20240906$20240729$20240909$30DAY$$US-PFIZER INC-202400221573$PFIZER$$15$YR$$M$Y$44$KG$20240909$$CN$US$US
241488462$24148846$2$F$$20240828$20240729$20240828$PER$$US-PFIZER INC-202400222429$PFIZER$$8$YR$$M$Y$$$20240828$$CN$US$US
241488471$24148847$1$I$20220505$20240719$20240729$20240729$EXP$IT-MINISAL02-994418$IT-TEVA-VS-3223536$TEVA$$60$YR$$M$Y$$$20240729$$MD$IT$IT
241488482$24148848$2$F$20240720$20240813$20240729$20240820$EXP$$US-PFIZER INC-202400223984$PFIZER$$63$YR$$F$Y$54.43$KG$20240820$$CN$US$US
241488491$24148849$1$I$$20210816$20240729$20240729$EXP$$US-AstraZeneca-2021A686218$ASTRAZENECA$$$$$M$Y$$$20240729$$CN$US$
241488501$24148850$1$I$20240704$20240716$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007489$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241488511$24148851$1$I$20240701$20240718$20240729$20240729$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-22580$SAMSUNG BIOEPIS$$23$YR$A$F$Y$54$KG$20240729$$HP$AU$AU
241488522$24148852$2$F$$20240716$20240729$20240924$PER$$US-INCYTE CORPORATION-2024IN007491$INCYTE$$$$$$Y$$$20240924$$CN$US$US
241488531$24148853$1$I$$20240722$20240729$20240729$PER$$US-ALXN-202407USA001472US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
241488551$24148855$1$I$20240627$20240726$20240729$20240729$EXP$FR-AFSSAPS-MP2024001153$NVSC2024FR153319$NOVARTIS$$75$YR$$F$Y$54$KG$20240729$$PH$FR$FR
241488561$24148856$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154743$NOVARTIS$$$$$F$Y$$$20240729$$HP$US$US
241488571$24148857$1$I$20240704$20240717$20240729$20240729$EXP$$US-OTSUKA-2024_020278$OTSUKA$$27$YR$$F$Y$$$20240729$$CN$US$US
241488583$24148858$3$F$$20240716$20240729$20240924$PER$$US-INCYTE CORPORATION-2024IN007496$INCYTE$$$$$$Y$$$20240924$$CN$US$US
241488592$24148859$2$F$$20240828$20240729$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119569$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$MD$JP$JP
241488602$24148860$2$F$20240701$20240725$20240729$20240731$EXP$$JP-PFIZER INC-PV202400096991$PFIZER$$$$$$Y$$$20240731$$PH$JP$JP
241488611$24148861$1$I$20231127$20240724$20240729$20240729$EXP$FR-AFSSAPS-TS2024000835$FR-LUNDBECK-DKLU4002216$LUNDBECK$$$$$$Y$$$20240729$$MD$FR$FR
241488621$24148862$1$I$$20240716$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007498$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241488631$24148863$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218577$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240729$$MD$US$US
241488641$24148864$1$I$20240601$20240722$20240729$20240729$PER$$US-SA-2024SA218682$SANOFI AVENTIS$$39$YR$A$F$Y$45.3$KG$20240729$$MD$US$US
241488651$24148865$1$I$20240201$20240722$20240729$20240729$PER$$US-SA-2024SA217065$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240729$$MD$US$US
241488661$24148866$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218390$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240729$$MD$US$US
241488671$24148867$1$I$$20240716$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007542$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241488684$24148868$4$F$20240701$20240911$20240729$20240917$EXP$$CA-BAUSCH-BL-2024-011390$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240917$$CN$CA$CA
241488701$24148870$1$I$$20240722$20240729$20240729$EXP$$US-ANIPHARMA-2024-US-039933$ANI$Song JJ, Eyabi JC, Awatramani PD, et al.Sudden Reduction in caffeine intake increases serum lithium concentration to supratherapeutic level: a case report..Primary Care Companion for CNS Disorders.2024;26(2):.$59$YR$$M$Y$$$20240729$$HP$US$US
241488711$24148871$1$I$$20240725$20240729$20240729$EXP$$US-LUNDBECK-DKLU4002210$LUNDBECK$$$$$$Y$$$20240729$$CN$US$US
241488721$24148872$1$I$$20240729$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042508$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240729$$CN$US$US
241488742$24148874$2$F$20240701$20240726$20240729$20240730$PER$$US-ABBVIE-5856813$ABBVIE$$50$YR$$F$Y$52$KG$20240730$$CN$US$US
241488751$24148875$1$I$20220123$20220126$20240729$20240729$EXP$$US-AstraZeneca-2022A051157$ASTRAZENECA$$23611$DY$$F$Y$$$20240729$$CN$US$
241488761$24148876$1$I$$20240727$20240729$20240729$EXP$FR-AFSSAPS-AVPO2024000146$FR-BAUSCH-BL-2024-011509$BAUSCH AND LOMB$$23$YR$$M$Y$$$20240729$$PH$FR$FR
241488772$24148877$2$F$20240701$20240823$20240729$20240917$PER$$US-SA-2024SA219083$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240918$$MD$US$US
241488782$24148878$2$F$$20240715$20240729$20240812$EXP$$PT-TEVA-VS-3222200$TEVA$Correia I, E?a R, Barbodsa MJ, Soares L, Monteiro M, Boxes U. DRESS SYNDROME: A RARE SECONDARY RESPONSE Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 846.$30$YR$$M$Y$$$20240812$$MD$PT$PT
241488791$24148879$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119205$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240729$$HP$US$US
241488801$24148880$1$I$20240724$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119259$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240729$$HP$US$US
241488811$24148881$1$I$$20240726$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-119330$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$92$KG$20240729$$PH$CA$CA
241488821$24148882$1$I$20240601$20240724$20240729$20240729$EXP$$TN-ABBVIE-5853564$ABBVIE$$16$YR$$M$Y$$$20240729$$CN$TN$TN
241488831$24148883$1$I$20240715$20240716$20240729$20240729$PER$$US-FARMAPROD-202407-2643$DOMPE FARMACEUTICI$$53$YR$A$F$Y$$$20240729$$CN$US$US
241488841$24148884$1$I$20240301$20240725$20240729$20240729$EXP$$US-ABBVIE-5855510$ABBVIE$$46$YR$$M$Y$$$20240729$$CN$US$US
241488871$24148887$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154750$NOVARTIS$$$$$$Y$$$20240729$$CN$US$US
241488881$24148888$1$I$20240101$20240717$20240729$20240729$EXP$$US-MALLINCKRODT-MNK202404649$MALLINCKRODT$$68$YR$E$F$Y$213$KG$20240729$$HP$US$US
241488892$24148889$2$F$20240701$20240728$20240729$20240730$PER$$US-PURDUE PHARMA-USA-2024-0311008$PURDUE$$65$YR$$F$Y$$$20240730$$CN$US$US
241488902$24148890$2$F$20180101$20240726$20240729$20240730$PER$$US-PURDUE PHARMA-USA-2024-0311007$PURDUE$$$$$M$Y$73.935$KG$20240730$$CN$US$US
241488912$24148891$2$F$20240724$20240726$20240729$20240730$PER$$US-PURDUE-USA-2024-0311006$PURDUE$$48$YR$$F$Y$145.15$KG$20240730$$CN$US$US
241488922$24148892$2$F$20240101$20240729$20240729$20240730$PER$$US-PURDUE PHARMA-USA-2024-0310985$PURDUE$$$$$F$Y$65.77$KG$20240730$$CN$US$US
241488934$24148893$4$F$20240301$20240925$20240729$20240930$PER$$US-PURDUE-USA-2024-0310993$PURDUE$$53$YR$$M$Y$79.38$KG$20240930$$CN$US$US
241488941$24148894$1$I$$20240726$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-119359$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240729$$MD$CA$CA
241488951$24148895$1$I$$20240726$20240729$20240729$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-119462$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240729$$MD$CA$CA
241488971$24148897$1$I$20240715$20240726$20240729$20240729$EXP$$CN-PFIZER INC-PV202400097986$PFIZER$$75$YR$$F$Y$70$KG$20240729$$HP$CN$CN
241488981$24148898$1$I$20240726$20240726$20240729$20240729$EXP$$JP-PFIZER INC-202400224362$PFIZER$$$$T$F$Y$$$20240729$$MD$JP$JP
241488993$24148899$3$F$$20240814$20240729$20240816$EXP$$US-PFIZER INC-202400210028$PFIZER$$65$YR$$F$Y$$$20240816$$CN$US$US
241489001$24148900$1$I$20080101$20240725$20240729$20240729$EXP$$CA-PFIZER INC-202400225196$PFIZER$$59$YR$$F$Y$$$20240729$$MD$CA$CA
241489012$24148901$2$F$20240711$20240729$20240729$20240731$EXP$$CA-PFIZER INC-PV202400064289$PFIZER$$57$YR$$M$Y$$$20240731$$CN$CA$CA
241489021$24148902$1$I$$20240726$20240729$20240729$EXP$$JP-PFIZER INC-202400224462$PFIZER$$25$YR$$$Y$$$20240729$$CN$JP$JP
241489031$24148903$1$I$20240101$20240723$20240729$20240729$EXP$FR-AFSSAPS-RE2024000720$FR-009507513-2407FRA013291$MERCK$$80$YR$$F$Y$52$KG$20240729$$MD$FR$FR
241489041$24148904$1$I$$20240722$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159398$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241489051$24148905$1$I$20240717$20240722$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159385$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241489061$24148906$1$I$20240601$20240724$20240729$20240729$EXP$$US-BIOMARINAP-US-2024-159355$BIOMARIN$$$$$$Y$$$20240729$$HP$US$US
241489071$24148907$1$I$$20240722$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116248$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240729$$CN$US$US
241489081$24148908$1$I$20240711$20240718$20240729$20240729$PER$$US-SA-2024SA213554$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240729$$MD$US$US
241489091$24148909$1$I$20240707$20240715$20240729$20240729$EXP$$US-FMCRTG-FMC-2407-000848$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240729$$HP$US$US
241489113$24148911$3$F$20240709$20240821$20240729$20240822$EXP$$NVSC2024ZA142842$NOVARTIS$$73$YR$$F$Y$$$20240822$$CN$ZA$ZA
241489121$24148912$1$I$$20240723$20240729$20240729$EXP$$NVSC2024GR153761$NOVARTIS$$$$$F$Y$$$20240729$$MD$GR$GR
241489133$24148913$3$F$$20240812$20240729$20240815$PER$$US-ALXN-202407USA001600US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240815$$CN$US$US
241489141$24148914$1$I$$20240724$20240729$20240729$EXP$$US-SANDOZ INC.-SDZ2024US068308$SANDOZ$$$$$$Y$$$20240729$$CN$US$US
241489151$24148915$1$I$20200807$20240724$20240729$20240729$EXP$$CA-TAKEDA-2024TUS026410$TAKEDA$$80$YR$$F$Y$$$20240729$$MD$CA$CA
241489162$24148916$2$F$$20240801$20240729$20240802$PER$$US-JNJFOC-20240774486$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$HP$US$US
241489171$24148917$1$I$$20240719$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007639$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241489181$24148918$1$I$20220715$20240727$20240729$20240729$EXP$FR-AFSSAPS-AM2024000580$FR-BAUSCH-BL-2024-011508$BAUSCH AND LOMB$$56$YR$$F$Y$64$KG$20240729$$CN$FR$FR
241489191$24148919$1$I$20080105$20240718$20240729$20240729$EXP$$JP-OTSUKA-008090$OTSUKA$Uemura T. Switching to aripiprazole in two cases with chronic schizophrenia patients in long-term hospitalization -combined use of aripiprazole and clonazepam. Psychiatria et Neurologia Japonica. 2009;438$64$YR$$F$Y$45.2$KG$20240729$$MD$JP$JP
241489201$24148920$1$I$20240601$20240710$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110166$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240729$$CN$US$US
241489211$24148921$1$I$$20240719$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007647$INCYTE$$$$$$Y$$$20240729$$PH$US$US
241489221$24148922$1$I$20240601$20240722$20240729$20240729$PER$$US-SA-2023SA055161$SANOFI AVENTIS$$$$A$M$Y$$$20240729$$MD$US$US
241489235$24148923$5$F$$20240909$20240729$20240918$EXP$$DE-TEVA-VS-3223680$TEVA$$51$YR$$M$Y$$$20240918$$MD$DE$DE
241489251$24148925$1$I$20231019$20240724$20240729$20240729$EXP$$US-OTSUKA-2024_020705$OTSUKA$$49$YR$$F$Y$$$20240729$$HP$US$US
241489261$24148926$1$I$20240608$20240724$20240729$20240729$EXP$$NVSC2024AT122287$NOVARTIS$$$$A$M$Y$$$20240729$$MD$AT$AT
241489271$24148927$1$I$$20240723$20240729$20240729$PER$$US-ALXN-202407USA001619US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240729$$CN$US$US
241489281$24148928$1$I$$20240718$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007636$INCYTE$$$$$$Y$$$20240729$$MD$US$US
241489291$24148929$1$I$20070124$20240716$20240729$20240729$EXP$$FR-009507513-0707FRA00035$MERCK$$36$YR$$F$Y$$$20240729$$HP$FR$FR
241489301$24148930$1$I$20240101$20240719$20240729$20240729$EXP$FR-AFSSAPS-TO2024001282$FR-TEVA-VS-3223631$TEVA$$73$YR$$M$Y$$$20240729$$PH$FR$FR
241489311$24148931$1$I$$20240719$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007632$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241489321$24148932$1$I$20210301$20240723$20240729$20240729$EXP$$CN-009507513-2407CHN014150$MERCK$Liang J, Zeng F, Gu P.. Continued nursing in a patient with combined liver-lung transplantation.. Chin J Nurs. 2024;59(12):1497-500$41$YR$$M$Y$$$20240729$$HP$CN$CN
241489331$24148933$1$I$$20240718$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007591$INCYTE$$$$$$Y$$$20240729$$CN$US$US
241489341$24148934$1$I$20240101$20240726$20240729$20240729$EXP$$US-ABBVIE-5856461$ABBVIE$$$$$$Y$$$20240729$$MD$US$US
241489351$24148935$1$I$20230701$20240717$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007590$INCYTE$$$$$$Y$$$20240729$$PH$US$US
241489361$24148936$1$I$20240701$20240718$20240729$20240729$PER$$US-INCYTE CORPORATION-2024IN007589$INCYTE$$$$$$Y$$$20240729$$PH$US$US
241489371$24148937$1$I$$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119361$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240729$$PH$US$US
241489381$24148938$1$I$20050101$20240719$20240729$20240729$EXP$FR-AFSSAPS-AVCN2024000536$FR-TEVA-VS-3223719$TEVA$$39$YR$$M$Y$$$20240729$$MD$FR$FR
241489391$24148939$1$I$20240717$20240717$20240729$20240729$EXP$GB-MHRA-MED-202407170829250360-QZBLN$GB-ELI_LILLY_AND_COMPANY-GB202407010968$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$GB$GB
241489401$24148940$1$I$$20240717$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010978$ELI LILLY AND CO$$$$$M$Y$$$20240729$$CN$US$US
241489411$24148941$1$I$20231201$20240723$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015772$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240729$$CN$US$US
241489421$24148942$1$I$$20240719$20240729$20240729$EXP$$TR-OTSUKA-BMS-2014-006663$OTSUKA$Centin M,Celik M,Cakici M,Polat M,Sunder A. Aripiprazole Induced Non-Cardiogenic Pulmonary Edema. Turkish Journal of Psychiatry. 2014;1-4$35$YR$$F$Y$$$20240729$$HP$TR$TR
241489431$24148943$1$I$$20240717$20240729$20240729$EXP$GB-MHRA-MED-202407171152280170-VPLQZ$GB-ELI_LILLY_AND_COMPANY-GB202407011026$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240729$$CN$GB$GB
241489441$24148944$1$I$$20240717$20240729$20240729$EXP$GB-MHRA-MED-202407171419262310-CBDFP$GB-ELI_LILLY_AND_COMPANY-GB202407011044$ELI LILLY AND CO$$$$$M$Y$$$20240729$$CN$GB$GB
241489451$24148945$1$I$$20240723$20240729$20240729$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202407017780$ELI LILLY AND CO$$$$$M$Y$$$20240729$$MD$AE$AE
241489461$24148946$1$I$20240601$20240723$20240729$20240729$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407016422$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$CN$CN
241489481$24148948$1$I$20240714$20240717$20240729$20240729$EXP$GB-MHRA-MED-202407171330458990-TFLHD$GB-ELI_LILLY_AND_COMPANY-GB202407011042$ELI LILLY AND CO$$32$YR$A$F$Y$113$KG$20240729$$CN$GB$GB
241489492$24148949$2$F$20240713$20240801$20240729$20240813$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407010727$ELI LILLY AND CO$$60$YR$A$M$Y$93$KG$20240813$$CN$DE$DE
241489501$24148950$1$I$$20240717$20240729$20240729$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407010943$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240729$$CN$DE$DE
241489511$24148951$1$I$$20240717$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013298$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240729$$CN$US$US
241489521$24148952$1$I$$20240717$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407012097$ELI LILLY AND CO$$$$$$Y$$$20240729$$CN$US$US
241489531$24148953$1$I$$20240717$20240729$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US202407011655$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$US$US
241489541$24148954$1$I$$20240719$20240729$20240729$EXP$GB-MHRA-MED-202407191133222920-TMLCJ$GB-ELI_LILLY_AND_COMPANY-GB202407012721$ELI LILLY AND CO$$$$$F$Y$$$20240729$$CN$GB$GB
241489551$24148955$1$I$20240708$20240719$20240729$20240729$EXP$$CN-GE HEALTHCARE-2024CSU008322$GE HEALTHCARE$$71$YR$$M$Y$$$20240729$$HP$CN$CN
241489561$24148956$1$I$20240711$20240719$20240729$20240729$EXP$$CN-GE HEALTHCARE-2024CSU008318$GE HEALTHCARE$$57$YR$$F$Y$$$20240729$$HP$CN$CN
241489571$24148957$1$I$20240101$20240723$20240729$20240729$EXP$$US-TAKEDA-2023TUS119675$TAKEDA$$69$YR$$F$Y$86$KG$20240729$$CN$US$US
241489591$24148959$1$I$20240619$20240717$20240729$20240729$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407010954$ELI LILLY AND CO$$60$YR$A$M$Y$87.5$KG$20240729$$CN$GB$GB
241489601$24148960$1$I$20231107$20240719$20240729$20240729$EXP$ES-AEMPS-1545468$ES-TEVA-VS-3223407$TEVA$$74$YR$$F$Y$$$20240729$$MD$ES$ES
241489631$24148963$1$I$20240724$20240725$20240729$20240729$30DAY$$IT-SANDOZ INC.-SDZ2024IT068553$SANDOZ$$10$YR$$F$Y$24$KG$20240729$$CN$IT$IT
241489641$24148964$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154667$NOVARTIS$$$$$$Y$$$20240729$$CN$US$US
241489652$24148965$2$F$$20240815$20240729$20240819$PER$$US-ALXN-202407USA001510US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241489663$24148966$3$F$$20240816$20240729$20240819$PER$$US-ALXN-202407USA001554US$ALEXION PHARMACEUTICALS$$$$$M$Y$108.84$KG$20240819$$CN$US$US
241489671$24148967$1$I$$20240725$20240729$20240729$EXP$$CA-HLS-202401870$HLS THERAPEUTICS$$$$E$F$Y$$$20240729$$MD$CA$CA
241489681$24148968$1$I$$20240717$20240729$20240729$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07097$NEUROCRINE BIOSCIENCES$$39$YR$$M$Y$$$20240729$$HP$US$US
241489691$24148969$1$I$$20240724$20240729$20240729$PER$$US-PFIZER INC-PV202400097005$PFIZER$$$$$F$Y$$$20240729$$CN$US$US
241489701$24148970$1$I$$20240724$20240729$20240729$PER$$US-PFIZER INC-PV202400097043$PFIZER$$37$YR$$F$Y$$$20240729$$CN$US$US
241489711$24148971$1$I$20240519$20240725$20240729$20240729$PER$$US-PFIZER INC-PV202400097661$PFIZER$$37$YR$$M$Y$$$20240729$$HP$US$US
241489721$24148972$1$I$20240601$20240725$20240729$20240729$PER$$US-PFIZER INC-PV202400097675$PFIZER$$19$YR$$F$Y$$$20240729$$CN$US$US
241489732$24148973$2$F$20240701$20240725$20240729$20240731$PER$$US-PFIZER INC-PV202400088688$PFIZER$$69$YR$$F$Y$$$20240731$$CN$US$US
241489741$24148974$1$I$20240718$20240728$20240729$20240729$PER$$US-PFIZER INC-202400225097$PFIZER$$53$YR$$M$Y$$$20240729$$CN$US$US
241489751$24148975$1$I$$20240726$20240729$20240729$PER$$US-PFIZER INC-202400225476$PFIZER$$70$YR$$F$Y$$$20240729$$CN$US$US
241489761$24148976$1$I$20240724$20240724$20240729$20240729$PER$$US-PFIZER INC-202400223856$PFIZER$$$$$$Y$$$20240729$$CN$US$US
241489771$24148977$1$I$20240725$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017433$ELI LILLY AND CO$$$$$$Y$$$20240729$$CN$US$US
241489782$24148978$2$F$$20240715$20240729$20240806$EXP$$PT-TEVA-VS-3223077$TEVA$Pereira I, Costa CA, Reinas A, Concei??o P, Costa AM. THE USUAL SUSPECT: ENTEROPATHY INDUCED BY OLMESARTAN. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 1037.$74$YR$$F$Y$$$20240806$$MD$PT$PT
241489801$24148980$1$I$$20240725$20240729$20240729$EXP$GB-MHRA-31118704$GB-009507513-2407GBR014307$MERCK$$55$YR$$M$Y$$$20240729$$PH$GB$GB
241489811$24148981$1$I$$20240715$20240729$20240729$EXP$$US-FMCRTG-FMC-2407-000867$FRESENIUS MEDICAL CARE$$57$YR$A$F$Y$90$KG$20240729$$HP$US$US
241489821$24148982$1$I$20240601$20240715$20240729$20240729$PER$$CA-HLS-202401596$HLS THERAPEUTICS$$33$YR$A$F$Y$82$KG$20240729$$HP$CA$CA
241489831$24148983$1$I$$20240723$20240729$20240729$PER$$US-BEH-2024176320$CSL BEHRING$$$$$F$Y$$$20240729$$CN$US$US
241489851$24148985$1$I$$20240715$20240729$20240729$EXP$$CA-HLS-202401756$HLS THERAPEUTICS$$$$E$F$Y$$$20240729$$PH$CA$CA
241489861$24148986$1$I$20240701$20240726$20240729$20240729$PER$$US-JNJFOC-20240774312$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240729$$HP$US$US
241489871$24148987$1$I$$20240726$20240729$20240729$PER$$NVSC2024US154749$NOVARTIS$$$$$$Y$$$20240730$$CN$US$US
241489881$24148988$1$I$20240720$20240725$20240729$20240729$PER$$US-Sofgen Pharmaceuticals, LLC-2159743$SOFGEN PHARMACEUTICALS$$44$YR$$F$Y$77.1$KG$20240729$$PH$US$US
241489891$24148989$1$I$$20240726$20240729$20240729$PER$$US-TAKEDA-2024TUS076099$TAKEDA$$$$$F$Y$$$20240729$$PH$US$US
241489901$24148990$1$I$20240606$20240724$20240729$20240729$EXP$$ES-ANIPHARMA-2024-ES-000079$ANI$$39$YR$$M$Y$$$20240729$$MD$ES$ES
241489913$24148991$3$F$20240101$20240809$20240729$20240816$EXP$$US-MALLINCKRODT-MNK202404677$MALLINCKRODT$$60$YR$A$F$Y$$$20240816$$HP$US$US
241489922$24148992$2$F$20240515$20240822$20240729$20240822$EXP$FR-AFSSAPS-TS2024000856$FR-GILEAD-2024-0682241$GILEAD$$64$YR$A$M$Y$82$KG$20240822$$MD$FR$FR
241489933$24148993$3$F$$20240823$20240729$20240903$EXP$$US-MALLINCKRODT-MNK202404749$MALLINCKRODT$$$$$F$Y$$$20240903$$HP$US$US
241489942$24148994$2$F$$20240809$20240729$20240820$EXP$$US-MALLINCKRODT-MNK202404686$MALLINCKRODT$$$$A$F$Y$$$20240820$$HP$US$US
241489952$24148995$2$F$20240101$20240822$20240729$20240830$EXP$$US-MALLINCKRODT-MNK202404685$MALLINCKRODT$$70$YR$E$F$Y$$$20240830$$CN$US$US
241489961$24148996$1$I$$20240719$20240729$20240729$EXP$$US-MALLINCKRODT-MNK202404711$MALLINCKRODT$$$$$M$Y$$$20240729$$CN$US$US
241489971$24148997$1$I$$20240718$20240729$20240729$EXP$$US-MALLINCKRODT-MNK202404714$MALLINCKRODT$$$$$M$Y$$$20240729$$CN$US$US
241489992$24148999$2$F$$20240816$20240729$20240819$PER$$US-ALXN-202407USA001474US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241490002$24149000$2$F$20240726$20240726$20240729$20240806$30DAY$$US-SANDOZ INC.-SDZ2024US068732$SANDOZ$$86$YR$$F$Y$$$20240806$$CN$US$US
241490011$24149001$1$I$20240702$20240726$20240729$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US062759$SANDOZ$$61$YR$$M$Y$$$20240729$$HP$US$US
241490021$24149002$1$I$$20240715$20240729$20240729$EXP$$CA-HLS-202401755$HLS THERAPEUTICS$$$$A$M$Y$$$20240729$$MD$CA$CA
241490031$24149003$1$I$20220922$20240722$20240729$20240729$EXP$$US-009507513-2407USA012736$MERCK$$63$YR$$F$Y$$$20240729$$CN$US$US
241490041$24149004$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA219712$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240730$$MD$US$US
241490051$24149005$1$I$20240729$20240729$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042493$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240729$$CN$US$US
241490061$24149006$1$I$$20240726$20240729$20240729$PER$$US-JNJFOC-20240773980$JOHNSON AND JOHNSON$$$$$M$Y$$$20240729$$CN$US$US
241490071$24149007$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017327$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240729$$CN$US$US
241490081$24149008$1$I$$20240617$20240729$20240729$EXP$$NVSC2023CA280721$NOVARTIS$$44$YR$$F$Y$97$KG$20240730$$HP$CA$CA
241490091$24149009$1$I$$20240723$20240729$20240729$PER$$US-ALXN-202407USA001660US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240729$$CN$US$US
241490101$24149010$1$I$$20240716$20240729$20240729$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07105$NEUROCRINE BIOSCIENCES$$68$YR$$F$Y$$$20240729$$HP$US$US
241490111$24149011$1$I$$20240716$20240729$20240729$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07106$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240729$$MD$US$US
241490121$24149012$1$I$20240712$20240715$20240729$20240729$EXP$$CA-HLS-202401757$HLS THERAPEUTICS$$37$YR$A$M$Y$$$20240729$$HP$CA$CA
241490131$24149013$1$I$20240501$20240719$20240729$20240729$EXP$$JP-MALLINCKRODT-MNK202404700$MALLINCKRODT$$$$$M$Y$$$20240729$$CN$JP$JP
241490141$24149014$1$I$20240625$20240719$20240729$20240729$EXP$$JP-MALLINCKRODT-MNK202404762$MALLINCKRODT$$9$DEC$$F$Y$$$20240729$$HP$JP$JP
241490152$24149015$2$F$20240101$20240826$20240729$20240830$PER$$US-Eisai-EC-2024-166649$EISAI$$79$YR$E$F$Y$$$20240830$$CN$US$US
241490161$24149016$1$I$$20240722$20240729$20240729$PER$$US-ALXN-202407USA001524US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
241490171$24149017$1$I$$20240708$20240729$20240729$PER$$US-JNJFOC-20240724393$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240729$$CN$US$US
241490191$24149019$1$I$$20240722$20240729$20240729$PER$$US-ALXN-202407USA001473US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
241490201$24149020$1$I$20230101$20240708$20240729$20240729$EXP$$US-APELLIS-APL-2024-003799$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240729$$HP$US$US
241490211$24149021$1$I$20231108$20240717$20240729$20240729$EXP$FR-AFSSAPS-MA2024000764$FR-JAZZ PHARMACEUTICALS-2024-FR-011366$JAZZ$$$$$$Y$$$20240729$$HP$FR$FR
241490221$24149022$1$I$$20240723$20240729$20240729$PER$$US-BIOGEN-2024BI01275420$BIOGEN$$$$$F$Y$$$20240729$$CN$US$US
241490231$24149023$1$I$20100111$20240716$20240729$20240729$EXP$$FR-009507513-1102FRA00032$MERCK$$22$YR$$M$Y$$$20240729$$MD$FR$FR
241490241$24149024$1$I$20240701$20240723$20240729$20240729$PER$$US-BIOGEN-2024BI01274986$BIOGEN$$73$YR$$F$Y$$$20240729$$CN$US$US
241490251$24149025$1$I$$20240712$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407009237$ELI LILLY AND CO$$3$YR$C$$Y$$$20240729$$CN$US$US
241490261$24149026$1$I$20240603$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017428$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240729$$CN$US$US
241490271$24149027$1$I$$20240723$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159382$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241490281$24149028$1$I$$20240723$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159350$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241490291$24149029$1$I$20240618$20240724$20240729$20240729$EXP$$US-BIOMARINAP-US-2024-159430$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241490302$24149030$2$F$20240710$20240903$20240729$20240917$PER$$US-BIOMARINAP-US-2024-159352$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
241490311$24149031$1$I$$20240724$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159386$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241490321$24149032$1$I$$20240724$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159407$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241490331$24149033$1$I$20240422$20240722$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159321$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241490341$24149034$1$I$20240702$20240725$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159236$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241490351$24149035$1$I$20240101$20240724$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159387$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241490361$24149036$1$I$20240322$20240717$20240729$20240729$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI07458$NEUROCRINE BIOSCIENCES$$6$DEC$$F$Y$$$20240730$$MD$JP$JP
241490371$24149037$1$I$$20240723$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159413$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241490381$24149038$1$I$$20240725$20240729$20240729$PER$$US-AstraZeneca-2024A170625$ASTRAZENECA$$$$$$Y$$$20240730$$CN$US$
241490391$24149039$1$I$$20240715$20240729$20240729$EXP$$TR-Marksans Pharma Limited-2159747$MARKSANS$Gokalp G, Nalbant T, Bicilioglu Y. The Insidious Enemy of the Liver: The Situation in Childhood Acetaminophen Poisoning and Early N-AC Treatment. Pediatric Emergency Care. 2024 Jul 1;40(7):e89-e93. doi: 10.1097/PEC.0000000000003176. PMID: 38718420.$1$MON$$$Y$$$20240729$$MD$TR$TR
241490401$24149040$1$I$$20240715$20240729$20240729$EXP$$JP-Marksans Pharma Limited-2159748$MARKSANS$Hiramatsu Y, Takahashi K, Shimomura M, Taniguchi K, Okura Y, Nawate M, Takahashi Y, Kobayashi I. Hypothermia, bradycardia, and hypotension during glucocorticoid or cyclosporine A therapy in a boy with Kikuchi-Fujimoto disease. Mod Rheumatol Case Rep. 2024 Jul 8;8(2):352-356. doi: 10.1093/mrcr/rxae023. PMID: 38780240. (Abstract)$12$YR$$M$Y$$$20240729$$$JP$JP
241490411$24149041$1$I$20240729$20240729$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042544$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240730$$CN$US$US
241490421$24149042$1$I$$20240715$20240729$20240729$EXP$$US-Marksans Pharma Limited-2159749$MARKSANS$Farouji A, Haddad AW, Kloub M, Paige A, Miller R. A Case of Metformin-Associated Lactic Acidosis Complicated by Acute Liver Failure, Acute Renal Failure, and Shock. Cureus. 2024 Jun 7;16(6):e61911. doi: 10.7759/cureus.61911. PMID: 38975471.$63$YR$$F$Y$$$20240729$$$US$US
241490431$24149043$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017403$ELI LILLY AND CO$$$$$$Y$$$20240729$$HP$US$US
241490441$24149044$1$I$20240708$20240723$20240729$20240729$PER$$US-AMGEN-USASP2024146635$AMGEN$$78$YR$E$M$Y$$$20240729$$CN$US$US
241490451$24149045$1$I$20240520$20240715$20240729$20240729$EXP$$FR-CIPLA LTD.-2024FR07722$CIPLA$$$$$$Y$$$20240730$$MD$FR$FR
241490461$24149046$1$I$20230801$20240715$20240729$20240729$EXP$$ES-CIPLA LTD.-2024ES07788$CIPLA$$$$$$Y$$$20240730$$PH$ES$ES
241490471$24149047$1$I$20240520$20240715$20240729$20240729$EXP$$FR-CIPLA LTD.-2024FR07721$CIPLA$$$$$$Y$$$20240730$$PH$FR$FR
241490481$24149048$1$I$$20240722$20240729$20240729$EXP$$US-AMGEN-USASP2024146838$AMGEN$Bandali T.; Kim Y.; Khodadoust M. et al.. Polatuzumab vedotin-piiq for treatment of primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCL-LT) in older adults. Journal of Investigative Dermatology. 2024;144 (8):S49$92$YR$E$M$Y$$$20240729$$HP$US$US
241490493$24149049$3$F$20240601$20240912$20240729$20240917$PER$$US-ROCHE-10000022128$ROCHE$$14$YR$T$M$Y$46.72$KG$20240917$$CN$US$US
241490501$24149050$1$I$20240101$20240725$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042539$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240730$$CN$US$US
241490511$24149051$1$I$$20240726$20240729$20240729$EXP$$CA-SANDOZ INC.-SDZ2024CA068764$SANDOZ$$55$YR$$F$Y$$$20240729$$MD$CA$CA
241490521$24149052$1$I$20240520$20240722$20240729$20240729$EXP$$US-ABBVIE-5855601$ABBVIE$$76$YR$$F$Y$$$20240729$$CN$US$US
241490532$24149053$2$F$20120101$20240806$20240729$20240806$EXP$$NVSJ2024JP009034$NOVARTIS$$81$YR$$F$Y$$$20240807$$MD$JP$JP
241490542$24149054$2$F$$20240815$20240729$20240822$EXP$$US-ROCHE-10000038349$ROCHE$$$$E$M$Y$$$20240822$$CN$US$US
241490551$24149055$1$I$$20240719$20240729$20240729$30DAY$$US-GSK-US2024091213$GLAXOSMITHKLINE$$$$$F$Y$$$20240729$$CN$US$US
241490561$24149056$1$I$$20240725$20240729$20240729$EXP$$US-AMGEN-USASP2024149543$AMGEN$$$$$M$Y$$$20240729$$MD$US$US
241490571$24149057$1$I$20231201$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017335$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240729$$CN$US$US
241490581$24149058$1$I$$20240718$20240729$20240729$PER$$US-AMGEN-USASP2024144229$AMGEN$$80$YR$E$F$Y$$$20240729$$CN$US$US
241490591$24149059$1$I$$20240724$20240729$20240729$PER$$US-ABBVIE-5854683$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241490601$24149060$1$I$$20240725$20240729$20240729$EXP$$US-JNJFOC-20240771623$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$US$US
241490612$24149061$2$F$$20240809$20240729$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202306007271$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240816$$CN$US$US
241490621$24149062$1$I$20240401$20240727$20240729$20240729$EXP$$US-SANDOZ INC.-SDZ2024US068676$SANDOZ$$72$YR$$F$Y$$$20240729$$CN$US$US
241490631$24149063$1$I$$20240725$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159474$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241490641$24149064$1$I$$20240725$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159442$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241490651$24149065$1$I$$20240724$20240729$20240729$PER$$US-BIOMARINAP-US-2024-159400$BIOMARIN$$$$$$Y$$$20240729$$CN$US$US
241490661$24149066$1$I$$20240725$20240729$20240729$EXP$$JP-SANDOZ INC.-SDZ2024JP068776$SANDOZ$$$$$$Y$$$20240729$$CN$JP$JP
241490671$24149067$1$I$$20240702$20240729$20240729$PER$$US-Marksans Pharma Limited-2159751$MARKSANS$$50$YR$$F$Y$$$20240729$$$US$US
241490683$24149068$3$F$20240719$20240809$20240729$20240810$PER$$US-AMGEN-USASP2024148832$AMGEN$$46$YR$A$M$Y$$$20240810$$HP$US$US
241490692$24149069$2$F$20240722$20240821$20240729$20240828$EXP$$US-JNJFOC-20240768192$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240829$$HP$US$US
241490701$24149070$1$I$20240501$20240726$20240729$20240729$EXP$$DE-SANDOZ INC.-SDZ2024DE068583$SANDOZ$$$$$M$Y$$$20240729$$HP$DE$DE
241490711$24149071$1$I$$20240726$20240729$20240729$EXP$GB-MHRA-MED-202407262147142410-THDNB$GB-SANDOZ INC.-SDZ2024GB068668$SANDOZ$$39$YR$$$Y$59$KG$20240729$$CN$GB$GB
241490722$24149072$2$F$$20240918$20240729$20240919$PER$$NVSC2024US154765$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
241490731$24149073$1$I$20240715$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148390$AMGEN$$74$YR$E$F$Y$$$20240729$$PH$US$US
241490741$24149074$1$I$20240701$20240726$20240729$20240729$EXP$$NVSJ2024JP009165$NOVARTIS$$$$A$M$Y$$$20240730$$MD$JP$JP
241490751$24149075$1$I$20240729$20240729$20240729$20240729$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042467$BOEHRINGER INGELHEIM$$$$$$Y$$$20240730$$CN$US$US
241490761$24149076$1$I$20240601$20240727$20240729$20240729$EXP$$AR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042424$BOEHRINGER INGELHEIM$$57$YR$A$F$Y$$$20240730$$MD$AR$AR
241490782$24149078$2$F$20240715$20240819$20240729$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-106825$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240826$$MD$JP$JP
241490791$24149079$1$I$$20240727$20240729$20240729$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042471$BOEHRINGER INGELHEIM$$94$YR$E$F$Y$$$20240730$$HP$CO$CO
241490802$24149080$2$F$$20240731$20240729$20240802$PER$$NVSC2024US154763$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241490811$24149081$1$I$$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149011$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241490822$24149082$2$F$20240726$20240830$20240729$20240903$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042468$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$44$KG$20240903$$HP$CO$CO
241490831$24149083$1$I$20240101$20240722$20240729$20240729$EXP$$CA-JNJFOC-20240759809$JOHNSON AND JOHNSON$$27$YR$A$F$Y$66$KG$20240730$$HP$CA$CA
241490841$24149084$1$I$$20240725$20240729$20240729$EXP$$US-JNJFOC-20240772694$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$HP$US$US
241490851$24149085$1$I$$20240718$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115777$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240730$$CN$US$US
241490861$24149086$1$I$$20240721$20240729$20240729$EXP$$FI-JNJFOC-20240760493$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$HP$FI$FI
241490871$24149087$1$I$$20240724$20240729$20240729$PER$$US-JNJFOC-20240768007$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240730$$HP$US$US
241490891$24149089$1$I$20240722$20240722$20240729$20240729$PER$$US-ABBVIE-5850515$ABBVIE$$46$YR$$$Y$$$20240729$$CN$US$US
241490901$24149090$1$I$$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119795$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240730$$CN$US$US
241490912$24149091$2$F$$20240810$20240729$20240813$EXP$$US-SANDOZ INC.-SDZ2024US068825$SANDOZ$$$$$M$Y$$$20240813$$HP$US$US
241490921$24149092$1$I$$20240723$20240729$20240729$EXP$$GB-AMGEN-GBRSP2024149429$AMGEN$$85$YR$E$F$Y$$$20240729$$CN$GB$GB
241490933$24149093$3$F$20240601$20240913$20240729$20240918$EXP$$NVSJ2024JP009158$NOVARTIS$$$$A$M$Y$$$20240918$$MD$JP$JP
241490942$24149094$2$F$$20240731$20240729$20240808$EXP$$JP-AMGEN-JPNSP2024149294$AMGEN$$10$DEC$E$M$Y$$$20240808$$MD$JP$JP
241490951$24149095$1$I$20240717$20240719$20240729$20240729$PER$$US-SA-2024SA218310$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240730$$MD$US$US
241490961$24149096$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA219427$SANOFI AVENTIS$$$$A$M$Y$102$KG$20240730$$MD$US$US
241490972$24149097$2$F$20240801$20240801$20240729$20240808$PER$$US-SA-2024SA216739$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240808$$MD$US$US
241490982$24149098$2$F$20240101$20240812$20240729$20240813$PER$$US-ABBVIE-5856470$ABBVIE$$36$YR$$F$Y$$$20240813$$MD$US$US
241490991$24149099$1$I$$20240725$20240729$20240729$EXP$$NVSC2024IN153778$NOVARTIS$$$$$F$Y$$$20240730$$MD$IN$IN
241491001$24149100$1$I$20240702$20240723$20240729$20240729$EXP$$US-JNJFOC-20240761435$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240730$$CN$US$US
241491011$24149101$1$I$$20240716$20240729$20240729$PER$$US-JNJFOC-20240748484$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$CN$US$US
241491021$24149102$1$I$20220501$20240729$20240729$20240729$EXP$FR-AFSSAPS-AVPO2024000145$FR-JNJFOC-20240776812$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240730$$PH$FR$FR
241491031$24149103$1$I$$20240720$20240729$20240729$PER$$US-JNJFOC-20240756657$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$US$US
241491041$24149104$1$I$20240628$20240719$20240729$20240729$PER$$US-SA-2024SA217279$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240730$$MD$US$US
241491051$24149105$1$I$$20240724$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118503$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240730$$CN$US$US
241491061$24149106$1$I$20240716$20240723$20240729$20240729$EXP$$US-ABBVIE-5851586$ABBVIE$$51$YR$$F$Y$$$20240729$$CN$US$US
241491071$24149107$1$I$$20240726$20240729$20240729$EXP$$CA-ABBVIE-5857357$ABBVIE$$$$E$M$Y$$$20240729$$MD$CA$CA
241491081$24149108$1$I$20240511$20240726$20240729$20240729$EXP$$US-ABBVIE-5857378$ABBVIE$$77$YR$$F$Y$$$20240729$$HP$US$US
241491091$24149109$1$I$20240415$20240726$20240729$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US040059$SANDOZ$$$$$M$Y$$$20240729$$CN$US$US
241491101$24149110$1$I$$20240725$20240729$20240729$EXP$$CA-ABBVIE-5856536$ABBVIE$$$$E$M$Y$$$20240729$$CN$CA$CA
241491111$24149111$1$I$20240718$20240726$20240729$20240729$EXP$$US-ABBVIE-5856811$ABBVIE$$52$YR$$F$Y$$$20240729$$CN$US$US
241491121$24149112$1$I$20240101$20240718$20240729$20240729$PER$$US-SA-2024SA214173$SANOFI AVENTIS$$$$C$F$Y$$$20240730$$MD$US$US
241491131$24149113$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA219231$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240730$$CN$US$US
241491141$24149114$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA218804$SANOFI AVENTIS$$$$A$F$Y$$$20240730$$MD$US$US
241491151$24149115$1$I$20240101$20240719$20240729$20240729$PER$$US-SA-2024SA217109$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240730$$MD$US$US
241491161$24149116$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA214913$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240730$$CN$US$US
241491172$24149117$2$F$$20240722$20240729$20240730$EXP$$CA-APOTEX-2024AP008791$APOTEX$$$$E$F$Y$$$20240730$$CN$CA$CA
241491181$24149118$1$I$20240722$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024148981$AMGEN$$79$YR$E$F$Y$$$20240729$$HP$US$US
241491192$24149119$2$F$20240702$20240729$20240729$20240802$EXP$$JP-SAKK-2024SA218835AA$SANOFI AVENTIS$$82$YR$E$F$Y$35$KG$20240802$$MD$JP$JP
241491201$24149120$1$I$$20240515$20240729$20240729$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00215$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240719$$CN$US$US
241491211$24149121$1$I$20240101$20240418$20240729$20240729$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00182$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240719$$PH$US$US
241491221$24149122$1$I$20240101$20240603$20240729$20240729$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00232$PRINSTON PHARMACEUTICAL$$$$$F$Y$89.342$KG$20240719$$CN$US$US
241491233$24149123$3$F$20240101$20240910$20240729$20240912$PER$$US-009507513-2407USA000887$MERCK$$$$$M$Y$103.4$KG$20240912$$CN$US$US
241491241$24149124$1$I$$20240726$20240729$20240729$PER$$US-ROCHE-10000040555$ROCHE$$$$A$F$Y$$$20240730$$CN$US$US
241491251$24149125$1$I$20090101$20240724$20240729$20240729$PER$$US-JNJFOC-20240768623$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240730$$LW$US$US
241491262$24149126$2$F$20240716$20240910$20240729$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116619$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240918$$MD$JP$JP
241491271$24149127$1$I$$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119853$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240730$$CN$US$US
241491281$24149128$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148109$AMGEN$$$$$M$Y$$$20240729$$MD$US$US
241491292$24149129$2$F$20221207$20240919$20240729$20240924$EXP$$CA-TAKEDA-2024TUS075839$TAKEDA$$51$YR$$M$Y$$$20240924$$CN$CA$CA
241491301$24149130$1$I$20240724$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147589$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241491311$24149131$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA216761$SANOFI AVENTIS$$$$E$F$Y$$$20240730$$MD$US$US
241491322$24149132$2$F$20240723$20240724$20240729$20240802$PER$$US-AMGEN-USASP2024147389$AMGEN$$48$YR$A$$Y$$$20240802$$CN$US$US
241491331$24149133$1$I$$20240718$20240729$20240729$PER$$US-SA-2024SA214884$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240730$$MD$US$US
241491341$24149134$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA216877$SANOFI AVENTIS$$$$C$M$Y$$$20240730$$MD$US$US
241491352$24149135$2$F$20240101$20240828$20240729$20240910$PER$$US-SA-2024SA216977$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240910$$MD$US$US
241491361$24149136$1$I$20240601$20240718$20240729$20240729$PER$$US-SA-2024SA216807$SANOFI AVENTIS$$3$YR$C$F$Y$11.79$KG$20240730$$MD$US$US
241491371$24149137$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA216945$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240730$$MD$US$US
241491381$24149138$1$I$20240516$20240719$20240729$20240729$PER$$US-SA-2024SA216886$SANOFI AVENTIS$$57$YR$A$F$Y$67.131$KG$20240730$$MD$US$US
241491391$24149139$1$I$$20240725$20240729$20240729$PER$$US-ROCHE-10000037447$ROCHE$$$$A$M$Y$$$20240730$$MD$US$US
241491402$24149140$2$F$20240510$20240913$20240729$20240918$EXP$$JP-SA-2024SA154044$SANOFI AVENTIS$$77$YR$E$M$Y$64$KG$20240918$$MD$JP$JP
241491411$24149141$1$I$20240101$20240725$20240729$20240729$EXP$$CA-ABBVIE-5856001$ABBVIE$$63$YR$$F$Y$$$20240729$$CN$CA$CA
241491422$24149142$2$F$20240705$20240912$20240729$20240920$EXP$$JP-AMGEN-JPNSP2024149111$AMGEN$$57$YR$A$F$Y$48.6$KG$20240919$$PH$JP$JP
241491431$24149143$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148611$AMGEN$$$$A$M$Y$$$20240729$$HP$US$US
241491441$24149144$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224418$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$0$YR$$M$Y$$$20240729$$HP$ES$ES
241491451$24149145$1$I$$20240715$20240729$20240729$EXP$$ES-TEVA-VS-3224417$TEVA$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.; Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int-J-Molecular-Sci 2023; 24 (17):.$1$YR$$M$Y$$$20240729$$HP$ES$ES
241491461$24149146$1$I$20231101$20240719$20240729$20240729$PER$$US-SA-2024SA216212$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240730$$MD$US$US
241491472$24149147$2$F$20240101$20240725$20240729$20240801$EXP$$DE-AMGEN-DEUSP2024149106$AMGEN$$50$YR$A$F$Y$$$20240801$$MD$DE$DE
241491481$24149148$1$I$20240119$20240725$20240729$20240729$EXP$$US-JNJFOC-20240769590$JOHNSON AND JOHNSON$$76$YR$$M$Y$$$20240730$$CN$US$US
241491491$24149149$1$I$$20240724$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407017515$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240729$$CN$US$US
241491501$24149150$1$I$$20240722$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117055$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240730$$HP$US$US
241491511$24149151$1$I$20240719$20240719$20240729$20240729$PER$$US-SA-2024SA216998$SANOFI AVENTIS$$46$YR$A$M$Y$74.842$KG$20240730$$MD$US$US
241491521$24149152$1$I$20240725$20240725$20240729$20240729$PER$$US-AMGEN-USASP2024149740$AMGEN$$$$$M$Y$$$20240729$$HP$US$US
241491541$24149154$1$I$20240101$20240722$20240729$20240729$PER$$US-SA-2024SA218655$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240730$$MD$US$US
241491551$24149155$1$I$$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024147838$AMGEN$$$$$M$Y$$$20240729$$CN$US$US
241491561$24149156$1$I$$20240722$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116770$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240730$$PH$US$US
241491571$24149157$1$I$$20240726$20240729$20240729$EXP$$CA-SANDOZ INC.-SDZ2023CA037723$SANDOZ$$70$YR$$M$Y$$$20240729$$CN$CA$CA
241491581$24149158$1$I$$20240709$20240729$20240729$PER$$US-009507513-2407USA004411$MERCK$$$$$M$Y$$$20240729$$CN$US$US
241491592$24149159$2$F$20240101$20240805$20240729$20240812$EXP$$ES-ABBVIE-5779389$ABBVIE$$$$$F$Y$$$20240812$$HP$ES$ES
241491601$24149160$1$I$$20240725$20240729$20240729$EXP$$GB-ABBVIE-5854726$ABBVIE$$$$E$M$Y$$$20240729$$CN$GB$GB
241491611$24149161$1$I$20240101$20240725$20240729$20240729$EXP$$US-ABBVIE-5854975$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241491621$24149162$1$I$$20240724$20240729$20240729$EXP$$US-ABBVIE-5856020$ABBVIE$$$$$M$Y$$$20240729$$HP$US$US
241491631$24149163$1$I$$20240725$20240729$20240729$EXP$$US-ABBVIE-5855662$ABBVIE$$$$$F$Y$$$20240729$$HP$US$US
241491641$24149164$1$I$20240101$20240729$20240729$20240729$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042564$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240730$$CN$US$US
241491651$24149165$1$I$$20240715$20240729$20240729$EXP$$RU-TEVA-VS-3224312$TEVA$Skoropad VY, Mironova DY, Kolobaev IV, Ivanov SA, Kaprin AD. Toxicity analysis during neoadjuvant induction chemotherapy and subsequent chemoradiotherapy in patients with locally advanced gastric cancer. [Russian]. Onkol-Zhur-Imen-Gerc 2024; 13 (2): 15-20.$$$$$Y$$$20240729$$HP$RU$RU
241491661$24149166$1$I$20240101$20240725$20240729$20240729$EXP$$CA-ABBVIE-5856191$ABBVIE$$59$YR$$F$Y$$$20240729$$HP$CA$CA
241491671$24149167$1$I$$20240722$20240729$20240729$PER$$US-ABBVIE-5850202$ABBVIE$$$$$$Y$$$20240729$$HP$US$US
241491681$24149168$1$I$20240601$20240722$20240729$20240729$PER$$US-SA-2024SA217043$SANOFI AVENTIS$$18$YR$A$F$Y$85.2$KG$20240730$$MD$US$US
241491691$24149169$1$I$20240701$20240722$20240729$20240729$PER$$US-SA-2024SA217284$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240730$$MD$US$US
241491701$24149170$1$I$20230101$20240722$20240729$20240729$PER$$US-SA-2024SA218905$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240730$$MD$US$US
241491711$24149171$1$I$$20240729$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119962$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240730$$HP$US$US
241491721$24149172$1$I$$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119967$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240730$$CN$US$US
241491731$24149173$1$I$$20240726$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119992$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240730$$CN$US$US
241491742$24149174$2$F$$20240806$20240729$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119971$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240808$$HP$US$US
241491751$24149175$1$I$20240628$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119960$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240730$$MD$US$US
241491761$24149176$1$I$20240301$20240729$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407018398$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240729$$CN$US$US
241491771$24149177$1$I$20240726$20240726$20240729$20240729$PER$$US-AMGEN-USASP2024149975$AMGEN$$37$YR$A$M$Y$$$20240729$$CN$US$US
241491781$24149178$1$I$20240712$20240722$20240729$20240729$EXP$$US-ABBVIE-5450133$ABBVIE$$78$YR$$F$Y$$$20240729$$MD$US$US
241491792$24149179$2$F$20240101$20240919$20240729$20240925$EXP$$CA-ABBVIE-5857355$ABBVIE$$30$YR$$F$Y$$$20240925$$CN$CA$CA
241491802$24149180$2$F$20240301$20240828$20240729$20240901$EXP$$US-ABBVIE-5855861$ABBVIE$$67$YR$$M$Y$$$20240901$$CN$US$US
241491821$24149182$1$I$20240718$20240725$20240729$20240729$EXP$$CN-ABBVIE-5856009$ABBVIE$$54$YR$$F$Y$$$20240729$$MD$CN$CN
241491831$24149183$1$I$$20240726$20240729$20240729$PER$$US-TAKEDA-2024TUS076117$TAKEDA$$$$$F$Y$$$20240729$$MD$US$US
241491842$24149184$2$F$20240701$20240730$20240729$20240803$EXP$$CA-ABBVIE-5856212$ABBVIE$$30$YR$$F$Y$$$20240803$$CN$CA$CA
241491851$24149185$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA216993$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240730$$MD$US$US
241491861$24149186$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA216952$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240730$$MD$US$US
241491871$24149187$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA217002$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240730$$MD$US$US
241491892$24149189$2$F$20240703$20240904$20240729$20240906$PER$$US-AMGEN-USASP2024148821$AMGEN$$73$YR$E$M$Y$$$20240906$$CN$US$US
241491901$24149190$1$I$$20240725$20240729$20240729$EXP$$US-JNJFOC-20240772446$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$CN$US$US
241491911$24149191$1$I$$20240725$20240729$20240729$EXP$$US-JNJFOC-20240772843$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$CN$US$US
241491921$24149192$1$I$20240123$20240723$20240729$20240729$EXP$$US-BIOGEN-2024BI01275246$BIOGEN$$67$YR$$M$Y$$$20240729$$HP$US$US
241491931$24149193$1$I$$20240722$20240729$20240729$EXP$$US-BIOGEN-2024BI01275252$BIOGEN$$$$$M$Y$$$20240729$$CN$US$US
241491943$24149194$3$F$20240701$20240806$20240729$20240813$EXP$$NVSC2024US092339$NOVARTIS$$70$YR$$F$Y$52$KG$20240813$$CN$US$US
241491951$24149195$1$I$$20240722$20240729$20240729$PER$$US-SA-2024SA217031$SANOFI AVENTIS$$$$C$M$Y$$$20240730$$MD$US$US
241491961$24149196$1$I$20240501$20240723$20240729$20240729$PER$$US-SA-2024SA219766$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240730$$MD$US$US
241491972$24149197$2$F$20240101$20240823$20240729$20240917$PER$$US-SA-2024SA217050$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240918$$CN$US$US
241491981$24149198$1$I$20240702$20240726$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120026$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240730$$CN$US$US
241491991$24149199$1$I$20240717$20240725$20240729$20240729$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119148$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$66.68$KG$20240730$$CN$US$US
241492001$24149200$1$I$$20240725$20240729$20240729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119331$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240730$$MD$US$US
241492012$24149201$2$F$20240717$20240726$20240729$20240801$PER$$US-AMGEN-USASP2024143050$AMGEN$$55$YR$A$F$Y$87.7$KG$20240801$$PH$US$US
241492022$24149202$2$F$20230101$20240807$20240729$20240812$EXP$$EG-BIOGEN-2024BI01275507$BIOGEN$$$$$F$Y$60$KG$20240812$$CN$EG$EG
241492031$24149203$1$I$$20240729$20240729$20240729$EXP$$FR-JNJFOC-20240776764$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$FR$FR
241492041$24149204$1$I$$20240725$20240729$20240729$EXP$$JP-ORGANON-O2407JPN002495$ORGANON$$$$$F$Y$$$20240729$$CN$JP$JP
241492052$24149205$2$F$20240101$20240813$20240729$20240820$PER$$US-SA-2024SA217329$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240820$$MD$US$US
241492061$24149206$1$I$$20240719$20240729$20240729$PER$$US-SA-2024SA217003$SANOFI AVENTIS$$2$YR$C$M$Y$18$KG$20240730$$MD$US$US
241492071$24149207$1$I$20240717$20240719$20240729$20240729$PER$$US-SA-2024SA217179$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240730$$MD$US$US
241492081$24149208$1$I$20240724$20240725$20240729$20240729$PER$$US-SA-2024SA219685$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240730$$CN$US$US
241492091$24149209$1$I$20240701$20240719$20240729$20240729$PER$$US-SA-2024SA217114$SANOFI AVENTIS$$86$YR$E$M$Y$81$KG$20240730$$MD$US$US
241492101$24149210$1$I$20240724$20240724$20240729$20240729$PER$$US-AMGEN-USASP2024148049$AMGEN$$77$YR$E$M$Y$$$20240729$$CN$US$US
241492111$24149211$1$I$$20240722$20240729$20240729$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001488$BLUEPRINT MEDICINES$$$$$F$Y$$$20240730$$CN$US$US
241492121$24149212$1$I$20240701$20240722$20240729$20240729$PER$$US-SA-2024SA217387$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240730$$MD$US$US
241492134$24149213$4$F$$20240916$20240729$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001496$BLUEPRINT MEDICINES$$$$$F$Y$$$20240920$$CN$US$US
241492161$24149216$1$I$$20240722$20240729$20240729$EXP$$RO-BRISTOL-MYERS SQUIBB COMPANY-2024-117014$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240730$$CN$RO$RO
241492171$24149217$1$I$$20240715$20240729$20240729$EXP$$US-HLS-202400384$HLS THERAPEUTICS$$$$A$$Y$$$20240729$$PH$US$US
241492182$24149218$2$F$$20240802$20240729$20240810$PER$$US-ABBVIE-5851001$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241492193$24149219$3$F$20240630$20240820$20240729$20240830$30DAY$$AR-JNJFOC-20240738295$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$AR$AR
241492203$24149220$3$F$20240629$20240806$20240729$20240812$EXP$$JP-SA-2024SA215257$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240813$$MD$JP$JP
241492211$24149221$1$I$$20240725$20240729$20240729$EXP$$AR2024US00020056$SANDOZ$$$$$$Y$$$20240729$$HP$US$US
241492221$24149222$1$I$$20240725$20240729$20240729$EXP$NL-LRB-00979103$NL-HALEON-2189143$Haleon PLC$$56$YR$$F$Y$84$KG$20240729$$HP$NL$NL
241492241$24149224$1$I$$20240725$20240729$20240729$EXP$$CA-HALEON-2188869$Haleon PLC$$72$YR$$M$Y$$$20240729$$HP$CA$CA
241492252$24149225$2$F$$20240731$20240729$20240809$EXP$$US-TEVA-VS-3223341$TEVA$Peters R, Holland T, Hardy C. Primary Cutaneous g/d T Cell Lymphoma With Atypical Immunohistochemistry-An Odd Phenotype of a Rare Malignancy. Am-J-Dermatopathol 2024; 46 (7): S33.; Peters R, Holland T, Hardy C. Primary Cutaneous g/d T Cell Lymphoma With Atypical Immunohistochemistry-An Odd Phenotype of a Rare Malignancy. Am-J-Dermatopathol 2024; 46 (7): S33.$89$YR$$M$Y$$$20240809$$HP$US$US
241492261$24149226$1$I$$20240725$20240729$20240729$EXP$$NVSC2024TR057290$NOVARTIS$$38$YR$$F$Y$$$20240730$$CN$TR$TR
241492271$24149227$1$I$$20240723$20240729$20240729$EXP$FR-AFSSAPS-AN2024000934$FR-GSK-FR2024092180$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$MD$FR$FR
241492281$24149228$1$I$$20240724$20240729$20240729$EXP$$CA-HALEON-2188696$Haleon PLC$$55$YR$$M$Y$$$20240729$$CN$CA$CA
241492301$24149230$1$I$20101001$20240724$20240729$20240729$PER$$US-JNJFOC-20240769526$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240730$$LW$US$US
241492311$24149231$1$I$20240625$20240723$20240729$20240729$EXP$$US-ABBVIE-5852191$ABBVIE$$36$YR$$F$Y$$$20240729$$CN$US$US
241492323$24149232$3$F$20240101$20240731$20240729$20240803$EXP$$US-ABBVIE-5852192$ABBVIE$$$$$M$Y$80$KG$20240803$$CN$US$US
241492331$24149233$1$I$$20240723$20240729$20240729$EXP$$US-ABBVIE-5851712$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241492341$24149234$1$I$20220601$20220708$20240729$20240729$EXP$$SG-AstraZeneca-2022A252951$ASTRAZENECA$$655$MON$$F$Y$$$20240730$$CN$SG$
241492351$24149235$1$I$$20211223$20240729$20240729$EXP$$SG-AstraZeneca-2021A900439$ASTRAZENECA$$$$$$Y$$$20240730$$CN$SG$
241492361$24149236$1$I$20240101$20240722$20240729$20240729$PER$$US-SA-2024SA219802$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240730$$MD$US$US
241492371$24149237$1$I$20240720$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016871$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240729$$CN$US$US
241492381$24149238$1$I$20240714$20240723$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407015802$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240729$$CN$US$US
241492391$24149239$1$I$$20240726$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407018132$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240729$$CN$US$US
241492401$24149240$1$I$$20240725$20240729$20240729$PER$$US-ELI_LILLY_AND_COMPANY-US202407016846$ELI LILLY AND CO$$74$YR$E$$Y$$$20240729$$CN$US$US
241492411$24149241$1$I$$20240718$20240729$20240729$EXP$$GB-ABBVIE-5857765$ABBVIE$Erblich T, Manisty C, Gribben J. Pericarditis and cardiac tamponade in patients treated with first and second generation bruton tyrosine kinase inhibitors: an underappreciated risk. Reikvam H, editor. Case Reports in Hematology. 2024;2024(1):2312182$87$YR$$M$Y$$$20240729$$HP$GB$GB
241492421$24149242$1$I$$20240724$20240729$20240729$EXP$$JP-GSK-JP2024092722$GLAXOSMITHKLINE$$$$$$Y$$$20240729$$PH$JP$JP
241492431$24149243$1$I$$20240723$20240729$20240729$EXP$$CA-HALEON-2188597$Haleon PLC$$44$YR$$F$Y$$$20240729$$HP$CA$CA
241492441$24149244$1$I$$20240722$20240729$20240729$EXP$$CA-ABBVIE-5852811$ABBVIE$$$$A$M$Y$$$20240729$$CN$CA$CA
241492452$24149245$2$F$20240101$20240725$20240729$20240731$EXP$$CA-ABBVIE-5853740$ABBVIE$$27$YR$$M$Y$$$20240731$$CN$CA$CA
241492481$24149248$1$I$20240228$20240726$20240729$20240729$PER$$NVSC2024US154840$NOVARTIS$$72$YR$$F$Y$$$20240730$$HP$US$US
241492492$24149249$2$F$$20240816$20240729$20240819$PER$$US-ALXN-202407USA001542US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241492501$24149250$1$I$$20240723$20240729$20240729$PER$$US-SA-2024SA217617$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240730$$MD$US$US
241492511$24149251$1$I$$20240724$20240729$20240729$PER$$US-JNJFOC-20240767991$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$HP$US$US
241492521$24149252$1$I$$20240726$20240729$20240729$PER$$US-JNJFOC-20240773576$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$HP$US$US
241492531$24149253$1$I$20231111$20240725$20240729$20240729$EXP$$DE-JNJFOC-20240772596$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240730$$MD$DE$DE
241492541$24149254$1$I$20240101$20240725$20240729$20240729$EXP$$CA-ABBVIE-5856163$ABBVIE$$79$YR$$M$Y$$$20240729$$CN$CA$CA
241492551$24149255$1$I$20240707$20240726$20240729$20240729$EXP$$US-TAKEDA-2024TUS075822$TAKEDA$$45$YR$$M$Y$$$20240729$$CN$US$US
241492561$24149256$1$I$$20240724$20240729$20240729$PER$$US-JNJFOC-20240767417$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$HP$US$US
241492572$24149257$2$F$$20240212$20240729$20240806$EXP$$CA-HALEON-2188398$Haleon PLC$$44$YR$$F$Y$97$KG$20240806$$HP$CA$CA
241492581$24149258$1$I$$20240723$20240729$20240729$EXP$$CA-HALEON-2188512$Haleon PLC$$$$$F$Y$$$20240729$$HP$CA$CA
241492591$24149259$1$I$$20240724$20240729$20240729$30DAY$$US-SANDOZ INC.-SDZ2024US068449$SANDOZ$$$$$$Y$$$20240729$$CN$US$US
241492601$24149260$1$I$$20240719$20240729$20240729$EXP$$CA-ABBVIE-5857227$ABBVIE$$$$E$M$Y$$$20240729$$CN$CA$CA
241492611$24149261$1$I$20240718$20240724$20240729$20240729$EXP$$US-ABBVIE-5853911$ABBVIE$$59$YR$$F$Y$$$20240729$$CN$US$US
241492621$24149262$1$I$20240101$20240724$20240729$20240729$EXP$$US-ABBVIE-5854115$ABBVIE$$$$$M$Y$$$20240729$$CN$US$US
241492631$24149263$1$I$20240101$20240725$20240730$20240730$EXP$$US-ABBVIE-5855797$ABBVIE$$$$$F$Y$$$20240729$$CN$US$US
241492641$24149264$1$I$20240709$20240725$20240730$20240730$EXP$$CA-ABBVIE-5856235$ABBVIE$$75$YR$$$Y$$$20240730$$CN$CA$CA
241492652$24149265$2$F$20240701$20240726$20240730$20240802$PER$$US-AMGEN-USASP2024149880$AMGEN$$64$YR$A$F$Y$$$20240802$$CN$US$US
241492661$24149266$1$I$20231001$20240726$20240730$20240730$EXP$$CA-ABBVIE-5857358$ABBVIE$$$$A$F$Y$$$20240730$$CN$CA$CA
241492671$24149267$1$I$$20240725$20240730$20240730$EXP$$AU-GSK-AU2024093440$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$AU$AU
241492681$24149268$1$I$20240101$20240725$20240730$20240730$EXP$$US-ABBVIE-5856460$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241492691$24149269$1$I$20240620$20240726$20240730$20240730$EXP$$CA-ABBVIE-5857030$ABBVIE$$65$YR$$F$Y$$$20240730$$CN$CA$CA
241492701$24149270$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119464$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240730$$HP$US$US
241492711$24149271$1$I$$20240726$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-119369$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240730$$MD$CA$CA
241492722$24149272$2$F$$20240820$20240730$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118347$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240828$$CN$US$US
241492731$24149273$1$I$20240627$20240725$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119151$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240730$$CN$US$US
241492741$24149274$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114276$BRISTOL MYERS SQUIBB$$33$YR$A$M$Y$$$20240719$$CN$US$US
241492751$24149275$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219815$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240730$$CN$US$US
241492761$24149276$1$I$$20240724$20240730$20240730$EXP$GB-MHRA-MIDB-1d6f194f-9eff-4b8d-ac06-422583a7fbe3$GB-GSK-GB2024092661$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$PH$GB$GB
241492771$24149277$1$I$$20240715$20240730$20240730$EXP$$CA-HALEON-2188251$Haleon PLC$$44$YR$$F$Y$$$20240729$$MD$CA$CA
241492781$24149278$1$I$$20240722$20240730$20240730$EXP$$CA-HALEON-2188435$Haleon PLC$$40$YR$$F$Y$$$20240729$$HP$CA$CA
241492791$24149279$1$I$$20240723$20240730$20240730$PER$$US-ALXN-202407USA001690US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241492801$24149280$1$I$20240625$20240718$20240730$20240730$EXP$$US-VIIV HEALTHCARE LIMITED-US2024090601$VIIV$$28$YR$$M$Y$$$20240730$$HP$US$US
241492811$24149281$1$I$20240602$20240725$20240730$20240730$EXP$SE-SEMPA-2024-005623$SE-GSK-SE2024093839$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$SE$SE
241492821$24149282$1$I$20240619$20240725$20240730$20240730$EXP$GB-MHRA-MIDB-c4565ad1-67eb-439a-a7fe-28ba0cd5a806$GB-GSK-GB2024093332$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$PH$GB$GB
241492832$24149283$2$F$20240707$20240905$20240730$20240909$EXP$$JP-ABBVIE-5849716$ABBVIE$$50$YR$$M$Y$$$20240909$$PH$JP$JP
241492842$24149284$2$F$$20240801$20240730$20240810$EXP$$DE-TEVA-VS-3224296$TEVA$Fischbach F, Richter J, Pfeffer LK, Fehse B, Berger SC, Reinhardt S, et al. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med-(NY) 2024; 5 (6): 550-558.; Fischbach F, Richter J, Pfeffer LK, Fehse B, Berger SC, Reinhardt S, et al. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med-(NY) 2024; 5 (6): 550-558.; Fischbach F, Richter J, Pfeffer LK, Fehse B, Berger SC, Reinhardt S, et al. CD19-targeted...$47$YR$$F$Y$$$20240810$$HP$DE$DE
241492851$24149285$1$I$$20240722$20240730$20240730$EXP$$US-AMGEN-USASP2024145681$AMGEN$$$$$M$Y$$$20240729$$CN$US$US
241492863$24149286$3$F$$20240909$20240730$20240911$PER$$US-ROCHE-10000032208$ROCHE$$47$YR$A$F$Y$$$20240911$$CN$US$US
241492873$24149287$3$F$20240503$20240912$20240730$20240921$PER$$US-ROCHE-10000013750$ROCHE$$50$YR$A$F$Y$92.99$KG$20240921$$CN$US$US
241492881$24149288$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS076043$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241492891$24149289$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS076049$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241492901$24149290$1$I$20240722$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A170049$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241492911$24149291$1$I$$20240719$20240730$20240730$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01397$NOVITIUM PHARMA$M. Marano.Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars.Toxicology Reports.24-JUN-2024;13:101683$15$YR$T$F$Y$$$20240730$$HP$IT$IT
241492921$24149292$1$I$20240101$20240724$20240730$20240730$EXP$$JP-JNJFOC-20240776180$JOHNSON AND JOHNSON$$$$$F$Y$42$KG$20240730$$CN$JP$JP
241492931$24149293$1$I$$20240726$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-119372$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240730$$CN$CA$CA
241492943$24149294$3$F$20240601$20240924$20240730$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119002$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$87.09$KG$20240925$$CN$US$US
241492951$24149295$1$I$20240718$20240722$20240730$20240730$PER$$US-ABBVIE-5851693$ABBVIE$$47$YR$$M$Y$$$20240730$$CN$US$US
241492961$24149296$1$I$$20240725$20240730$20240730$PER$$US-ROCHE-10000036897$ROCHE$$$$$$Y$$$20240730$$CN$US$US
241492971$24149297$1$I$20240101$20240724$20240730$20240730$EXP$$US-ABBVIE-5853901$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241492982$24149298$2$F$20240701$20240731$20240730$20240806$EXP$$US-ABBVIE-5853585$ABBVIE$$64$YR$$M$Y$$$20240806$$CN$US$US
241492991$24149299$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS076051$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241493001$24149300$1$I$$20240722$20240730$20240730$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01410$NOVITIUM PHARMA$Takashi Matono.Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine. The American Journal of Tropical Medicine and Hygiene.23-JAN-2024;110(3):483-486$36$YR$A$F$Y$$$20240730$$HP$JP$JP
241493012$24149301$2$F$20240601$20240905$20240730$20240910$EXP$$JP-009507513-2407JPN004226J$MERCK$$62$YR$$F$Y$$$20240910$$MD$JP$JP
241493021$24149302$1$I$20240601$20240715$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112279$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240719$$HP$US$US
241493031$24149303$1$I$$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024149099$AMGEN$$62$YR$A$M$Y$$$20240729$$HP$US$US
241493044$24149304$4$F$20240728$20240808$20240730$20240815$PER$$US-AMGEN-USASP2024150396$AMGEN$$73$YR$E$M$Y$$$20240815$$CN$US$US
241493051$24149305$1$I$20240724$20240724$20240730$20240730$PER$$US-ROCHE-10000036441$ROCHE$$50$YR$A$F$Y$$$20240730$$CN$US$US
241493061$24149306$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS076038$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241493071$24149307$1$I$$20240725$20240730$20240730$PER$$US-ROCHE-10000039859$ROCHE$$46$YR$A$M$Y$$$20240730$$MD$US$US
241493081$24149308$1$I$$20240725$20240730$20240730$PER$$US-ROCHE-10000038680$ROCHE$$$$$$Y$$$20240730$$HP$US$US
241493092$24149309$2$F$20240101$20240822$20240730$20240830$EXP$$CA-ABBVIE-5854417$ABBVIE$$45$YR$$M$Y$$$20240828$$CN$CA$CA
241493101$24149310$1$I$20240701$20240724$20240730$20240730$EXP$$US-ABBVIE-5856560$ABBVIE$$60$YR$$M$Y$$$20240730$$HP$US$US
241493111$24149311$1$I$$20240728$20240730$20240730$PER$$US-ABBVIE-5858689$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241493121$24149312$1$I$$20240725$20240730$20240730$EXP$$US-ABBVIE-5855850$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241493131$24149313$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-10000040122$ROCHE$$$$$$Y$$$20240730$$CN$US$US
241493141$24149314$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-10000040772$ROCHE$$$$A$F$Y$$$20240730$$CN$US$US
241493151$24149315$1$I$$20240719$20240730$20240730$PER$$US-JNJFOC-20240772359$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$CN$US$US
241493161$24149316$1$I$20240201$20240722$20240730$20240730$EXP$$US-009507513-2407USA012532$MERCK$$62$YR$$F$Y$$$20240730$$CN$US$US
241493171$24149317$1$I$20240617$20240725$20240730$20240730$EXP$$US-ABBVIE-5855760$ABBVIE$$55$YR$$M$Y$$$20240730$$CN$US$US
241493181$24149318$1$I$20240701$20240725$20240730$20240730$EXP$$US-ABBVIE-5855016$ABBVIE$$70$YR$$F$Y$$$20240730$$CN$US$US
241493191$24149319$1$I$20240701$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024147903$AMGEN$$62$YR$A$F$Y$$$20240729$$CN$US$US
241493201$24149320$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA218092$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240730$$MD$US$US
241493211$24149321$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219866$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240730$$CN$US$US
241493221$24149322$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA219306$SANOFI AVENTIS$$81$YR$E$F$Y$58.059$KG$20240730$$MD$US$US
241493232$24149323$2$F$20240709$20240920$20240730$20240925$EXP$$US-TAKEDA-2024TUS075854$TAKEDA$$11$YR$$M$Y$$$20240925$$PH$US$US
241493241$24149324$1$I$20240624$20240722$20240730$20240730$EXP$$US-ABBVIE-5856561$ABBVIE$$75$YR$$F$Y$$$20240730$$MD$US$US
241493252$24149325$2$F$$20240814$20240730$20240825$30DAY$$AR-JNJFOC-20240738506$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$HP$AR$AR
241493261$24149326$1$I$$20240711$20240730$20240730$PER$$US-JNJFOC-20240732044$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$US$US
241493271$24149327$1$I$$20240724$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118693$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$58.97$KG$20240730$$CN$US$US
241493283$24149328$3$F$$20240926$20240730$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119541$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240930$$HP$US$US
241493292$24149329$2$F$20231001$20240726$20240730$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119257$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240805$$CN$US$US
241493302$24149330$2$F$20200101$20240731$20240730$20240806$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-103088$REGENERON$$86$YR$$M$Y$$$20240806$$CN$CH$CH
241493311$24149331$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018445$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240730$$CN$US$US
241493321$24149332$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018402$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240730$$CN$US$US
241493341$24149334$1$I$$20240726$20240730$20240730$EXP$$US-ABBVIE-5857005$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241493351$24149335$1$I$$20240725$20240730$20240730$EXP$$CA-ABBVIE-5856045$ABBVIE$$$$E$$Y$$$20240730$$HP$CA$CA
241493361$24149336$1$I$20240316$20240725$20240730$20240730$EXP$FR-AFSSAPS-NC2024000892$FR-GSK-FR2024093400$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$MD$FR$FR
241493371$24149337$1$I$$20240716$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114559$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240719$$CN$US$US
241493381$24149338$1$I$$20240723$20240730$20240730$EXP$$US-ABBVIE-5856863$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241493391$24149339$1$I$20240718$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149384$AMGEN$$68$YR$E$F$Y$$$20240729$$HP$US$US
241493401$24149340$1$I$$20240729$20240730$20240730$PER$$NVSC2024US154869$NOVARTIS$$$$$$Y$$$20240730$$HP$US$US
241493421$24149342$1$I$$20240716$20240730$20240730$EXP$$TW-ENDO USA, INC.-2024-002983$ENDO$Kuo C-L, Liang C-S, Sung Y-F, Tsai C-K. An Extremely Low Dosage of Baclofen?induced Neurotoxicity in a Patient with End?stage Renal Disease and Parkinsonism. Journal of Medical Sciences. 2022;42(6):296?298$58$YR$$M$Y$$$20240730$$HP$TW$TW
241493431$24149343$1$I$$20240722$20240730$20240730$EXP$$AE-NOVITIUMPHARMA-2024AENVP01406$NOVITIUM PHARMA$Shameer M. Habeeb.Relapsing and refractory peritoneal dialysis peritonitis caused by Corynebacterium amycolatum. Pediatric Nephrology.10-NOV-2022;38(5):1687-1692$5$YR$C$F$Y$$$20240730$$HP$AE$AE
241493441$24149344$1$I$$20240702$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106339$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240719$$CN$US$US
241493451$24149345$1$I$$20240726$20240730$20240730$EXP$$US-TAKEDA-2024TUS052178$TAKEDA$$$$$F$Y$$$20240730$$CN$US$US
241493461$24149346$1$I$20240717$20240724$20240730$20240730$PER$$US-ABBVIE-5853594$ABBVIE$$43$YR$$F$Y$$$20240730$$HP$US$US
241493471$24149347$1$I$20240703$20240725$20240730$20240730$EXP$$US-ABBVIE-5856037$ABBVIE$$59$YR$$F$Y$$$20240730$$CN$US$US
241493481$24149348$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113886$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240719$$CN$US$US
241493491$24149349$1$I$$20240718$20240730$20240730$EXP$$CN-STERISCIENCE B.V.-2024-ST-001100$Steriscience PTE$Wei J, Ning J.. Successful treatment of penicillin-resistant pneumococcal meningitis following ventriculo-peritoneal shunt for congenital hydrocephalus: A case report on the efficacy of linezolid. Asian-J-Surg. 2024;47 (7):3389$1$YR$$F$Y$$$20240730$$HP$CN$CN
241493501$24149350$1$I$$20240718$20240730$20240730$EXP$$US-STERISCIENCE B.V.-2024-ST-001088$Steriscience PTE$Abdelmajid HA, Mustafa GMA, Fernandez A, Franco SD, Esquibies AE, Valencia GB, et al. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring. Case-Rep-Perinat-Med. 2024;13 (1):1-5$45$DY$$M$Y$2.115$KG$20240730$$MD$US$US
241493511$24149351$1$I$$20240722$20240730$20240730$EXP$$US-GSK-US2023177828$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$US$US
241493521$24149352$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114148$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240719$$HP$US$US
241493531$24149353$1$I$$20240716$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114641$BRISTOL MYERS SQUIBB$$6$DEC$A$F$Y$$$20240719$$MD$US$US
241493541$24149354$1$I$$20240718$20240730$20240730$EXP$$US-STERISCIENCE B.V.-2024-ST-001087$Steriscience PTE$Abdelmajid HA, Mustafa GMA, Fernandez A, Franco SD, Esquibies AE, Valencia GB, et al. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring.. Case-Rep-Perinat-Med. 2024;13 (1):1-5$33$YR$$F$Y$$$20240730$$MD$US$US
241493551$24149355$1$I$20240716$20240725$20240730$20240730$EXP$$CA-ABBVIE-5857280$ABBVIE$$$$E$F$Y$$$20240730$$CN$CA$CA
241493561$24149356$1$I$$20240724$20240730$20240730$EXP$$CO-ABBVIE-5858484$ABBVIE$$$$$F$Y$54$KG$20240730$$HP$CO$CO
241493571$24149357$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114656$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240719$$CN$US$US
241493582$24149358$2$F$20240626$20240717$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114497$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$86.2$KG$20240719$$PH$US$US
241493591$24149359$1$I$20240719$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149442$AMGEN$$$$A$F$Y$$$20240729$$PH$US$US
241493601$24149360$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA219771$SANOFI AVENTIS$$$$E$F$Y$63.04$KG$20240730$$MD$US$US
241493622$24149362$2$F$$20240830$20240730$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118938$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240903$$CN$US$US
241493651$24149365$1$I$$20240716$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113915$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240719$$HP$US$US
241493661$24149366$1$I$20240712$20240726$20240730$20240730$EXP$$US-ABBVIE-5857008$ABBVIE$$73$YR$$F$Y$$$20240730$$CN$US$US
241493671$24149367$1$I$20240701$20240723$20240730$20240730$EXP$$IN-GSK-IN2024APC093040$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$IN$IN
241493681$24149368$1$I$$20240715$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112305$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240719$$HP$US$US
241493691$24149369$1$I$20240502$20240722$20240730$20240730$EXP$$JP-009507513-2407JPN004213J$MERCK$$6$DEC$$F$Y$$$20240730$$MD$JP$JP
241493701$24149370$1$I$$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024148243$AMGEN$$$$$M$Y$$$20240729$$CN$US$US
241493711$24149371$1$I$$20240715$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112271$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240719$$HP$US$US
241493721$24149372$1$I$$20240712$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111760$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240719$$HP$US$US
241493731$24149373$1$I$$20240726$20240730$20240730$PER$$US-ABBVIE-5857656$ABBVIE$$$$$$Y$$$20240730$$PH$US$US
241493741$24149374$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA219798$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240730$$MD$US$US
241493751$24149375$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA218476$SANOFI AVENTIS$$$$A$$Y$45.8$KG$20240730$$PH$US$US
241493761$24149376$1$I$20240101$20240723$20240730$20240730$PER$$US-SA-2024SA221423$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240730$$MD$US$US
241493771$24149377$1$I$20240601$20240724$20240730$20240730$EXP$$US-ABBVIE-5854047$ABBVIE$$72$YR$$F$Y$$$20240730$$CN$US$US
241493781$24149378$1$I$$20240712$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112250$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240719$$PH$US$US
241493791$24149379$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114527$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$99.34$KG$20240719$$CN$US$US
241493802$24149380$2$F$20230101$20240801$20240730$20240810$EXP$$RS-TEVA-VS-3224105$TEVA$Pesic A, Vukovic V, Kozarac S, Otasevic V, Bibic T, Mihaljevic B, et al. UNIQUE PRESENTATION OF T-CELL/HISTIOCYTE-RICH LARGE B CELL LYMPHOMA COMPLICATED WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: CASE REPORT AND REVIEW OF THE LITERATURE. J-Medicin-Biochem 2024; 43 (4): 631-637.; Pesic A, Vukovic V, Kozarac S, Otasevic V, Bibic T, Mihaljevic B, et al. UNIQUE PRESENTATION OF T-CELL/HISTIOCYTE-RICH LARGE B CELL LYMPHOMA COMPLICATED WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: CASE REPORT AND REVIEW OF...$32$YR$$M$Y$$$20240810$$HP$RS$RS
241493811$24149381$1$I$20240101$20240718$20240730$20240730$EXP$$US-ABBVIE-5855997$ABBVIE$$$$$M$Y$$$20240730$$MD$US$US
241493821$24149382$1$I$$20240729$20240730$20240730$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042570$BOEHRINGER INGELHEIM$$$$$$Y$$$20240730$$HP$US$US
241493832$24149383$2$F$$20240814$20240730$20240819$PER$$US-JNJFOC-20240747424$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240819$$CN$US$US
241493841$24149384$1$I$$20240715$20240730$20240730$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-103109$REGENERON$$$$$F$Y$$$20240730$$CN$CH$CH
241493851$24149385$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016940$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241493862$24149386$2$F$$20240821$20240730$20240828$EXP$$US-ABBVIE-5854882$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
241493872$24149387$2$F$$20240724$20240730$20240802$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118348$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$68$KG$20240802$$HP$CA$CA
241493882$24149388$2$F$20240101$20240725$20240730$20240802$EXP$$US-ABBVIE-5855625$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241493891$24149389$1$I$20240712$20240722$20240730$20240730$PER$$US-ABBVIE-5849834$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241493902$24149390$2$F$$20240816$20240730$20240820$EXP$$JP-ABBVIE-5858577$ABBVIE$$60$YR$$M$Y$$$20240820$$MD$JP$JP
241493912$24149391$2$F$$20240725$20240730$20240805$30DAY$$US-GSK-US2024091741$GLAXOSMITHKLINE$$$$$F$Y$$$20240804$$CN$US$US
241493921$24149392$1$I$$20240722$20240730$20240730$EXP$$US-NOVITIUMPHARMA-2024USNVP01408$NOVITIUM PHARMA$Sarah Rhoads.Pneumocystis jirovecii Pneumonia in HIV-Negative, Non-transplant Patients: Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention. Current Fungal Infection Reports.20-JAN-2024;18(2):125-135$34$YR$A$F$Y$$$20240730$$HP$US$US
241493931$24149393$1$I$20240705$20240729$20240730$20240730$EXP$IT-MINISAL02-996747$NVSC2024IT154598$NOVARTIS$$42$YR$$F$Y$$$20240730$$MD$IT$IT
241493941$24149394$1$I$20240701$20240717$20240730$20240730$EXP$$JP-ROCHE-10000024371$ROCHE$$73$YR$E$M$Y$60.5$KG$20240730$$MD$JP$JP
241493951$24149395$1$I$20240719$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149443$AMGEN$$$$A$M$Y$$$20240729$$PH$US$US
241493961$24149396$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA215759$SANOFI AVENTIS$$$$$M$Y$$$20240730$$CN$US$US
241493971$24149397$1$I$20240301$20240722$20240730$20240730$EXP$$US-ABBVIE-5855643$ABBVIE$$73$YR$$M$Y$$$20240730$$CN$US$US
241493991$24149399$1$I$20240101$20240724$20240730$20240730$EXP$$CA-ABBVIE-5856582$ABBVIE$$46$YR$$M$Y$$$20240730$$CN$CA$CA
241494001$24149400$1$I$$20240726$20240730$20240730$EXP$$CA-ABBVIE-5857266$ABBVIE$$$$E$$Y$$$20240730$$CN$CA$CA
241494011$24149401$1$I$$20240723$20240730$20240730$EXP$$TW-AMGEN-TWNSP2024149432$AMGEN$$$$A$M$Y$$$20240729$$HP$TW$TW
241494021$24149402$1$I$$20240725$20240730$20240730$PER$$US-ABBVIE-5857276$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241494031$24149403$1$I$20240306$20240716$20240730$20240730$EXP$$GB-VER-202400005$VERITY PHARMACEUTICALS$$60$YR$A$$Y$77$KG$20240730$$CN$GB$GB
241494042$24149404$2$F$$20240820$20240730$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116719$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240829$$HP$US$US
241494051$24149405$1$I$$20240726$20240730$20240730$PER$$PR-ABBVIE-5858180$ABBVIE$$$$$F$Y$$$20240730$$MD$PR$PR
241494061$24149406$1$I$20240301$20240722$20240730$20240730$EXP$$JP-009507513-2403JPN003067J$MERCK$$6$DEC$$M$Y$70$KG$20240730$$MD$JP$JP
241494071$24149407$1$I$20240701$20240716$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114576$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240719$$CN$US$US
241494081$24149408$1$I$20231129$20240723$20240730$20240730$EXP$$CA-ABBVIE-5853694$ABBVIE$$66$YR$$M$Y$$$20240730$$HP$CA$CA
241494092$24149409$2$F$20240712$20240730$20240730$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114238$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240801$$CN$US$US
241494101$24149410$1$I$20240601$20240724$20240730$20240730$PER$$US-SA-2024SA221229$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240730$$MD$US$US
241494111$24149411$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA216240$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240730$$MD$US$US
241494121$24149412$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150183$AMGEN$$$$$$Y$$$20240729$$PH$US$US
241494132$24149413$2$F$$20240730$20240730$20240731$EXP$GB-MHRA-MED-202407171329112380-FHGCW$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-114135$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240731$$HP$GB$GB
241494141$24149414$1$I$20240701$20240723$20240730$20240730$PER$$US-SA-2024SA217821$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240730$$MD$US$US
241494151$24149415$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150266$AMGEN$$$$$$Y$$$20240729$$HP$US$US
241494161$24149416$1$I$$20240715$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113424$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240719$$CN$US$US
241494171$24149417$1$I$20240720$20240726$20240730$20240730$EXP$$US-ABBVIE-5856620$ABBVIE$$56$YR$$F$Y$$$20240730$$CN$US$US
241494181$24149418$1$I$20240621$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003318$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240730$$CN$US$US
241494191$24149419$1$I$20240506$20240725$20240730$20240730$EXP$$US-ABBVIE-5856110$ABBVIE$$22$YR$$F$Y$$$20240730$$CN$US$US
241494201$24149420$1$I$$20240716$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114493$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240719$$CN$US$US
241494211$24149421$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149389$AMGEN$$$$$M$Y$$$20240729$$CN$US$US
241494222$24149422$2$F$20240717$20240821$20240730$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114558$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240828$$CN$US$US
241494232$24149423$2$F$20240701$20240911$20240730$20240915$EXP$$US-ABBVIE-5856003$ABBVIE$$81$YR$$F$Y$$$20240915$$CN$US$US
241494241$24149424$1$I$20240401$20240723$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407015782$ELI LILLY AND CO$$$$A$F$Y$$$20240730$$CN$US$US
241494251$24149425$1$I$20240725$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017697$ELI LILLY AND CO$$$$$F$Y$$$20240730$$CN$US$US
241494261$24149426$1$I$$20240515$20240730$20240730$EXP$$EG-HALEON-2188982$Haleon PLC$$$$C$F$Y$$$20240729$$CN$EG$EG
241494271$24149427$1$I$20240725$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016856$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240730$$CN$US$US
241494282$24149428$2$F$$20240725$20240730$20240731$EXP$$US-ABBVIE-5855573$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241494291$24149429$1$I$20230327$20240716$20240730$20240730$EXP$$FR-CIPLA LTD.-2024FR07838$CIPLA$$$$$$Y$$$20240730$$MD$FR$FR
241494301$24149430$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003333$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241494311$24149431$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003332$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241494321$24149432$1$I$20240101$20240717$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114372$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$57.15$KG$20240719$$CN$US$US
241494331$24149433$1$I$$20240717$20240730$20240730$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-114626$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240719$$MD$DE$DE
241494341$24149434$1$I$$20240722$20240730$20240730$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP009318$STRIDES$Nagashiromani D, Vignesh M.. Case series of methotrexate induced pancytopenia.. Indian-J-Rheumatol. 2023;18(Suppl2):S170-S171.POS071$$$$$Y$$$20240730$$HP$IN$IN
241494351$24149435$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003320$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241494361$24149436$1$I$$20240719$20240730$20240730$EXP$$JP-HALEON-2187896$Haleon PLC$$$$$$Y$$$20240729$$PH$JP$JP
241494371$24149437$1$I$20240701$20240723$20240730$20240730$EXP$$US-VIIV HEALTHCARE LIMITED-US2024092275$VIIV$$$$$$Y$$$20240730$$HP$US$US
241494381$24149438$1$I$$20240726$20240730$20240730$EXP$$US-ABBVIE-5856879$ABBVIE$$$$$F$Y$$$20240730$$MD$US$US
241494391$24149439$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114307$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$58.97$KG$20240719$$CN$US$US
241494401$24149440$1$I$$20240722$20240730$20240730$PER$$US-AstraZeneca-2024A166931$ASTRAZENECA$$$$$$Y$$$20240730$$CN$US$
241494411$24149441$1$I$$20230523$20240730$20240730$EXP$$US-AstraZeneca-2023A121650$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241494421$24149442$1$I$$20240716$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113832$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240719$$CN$US$US
241494431$24149443$1$I$$20240722$20240730$20240730$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP009319$STRIDES$Nagashiromani D, Vignesh M.. Case series of methotrexate induced pancytopenia.. Indian-J-Rheumatol. 2023;18 (Suppl. 2):S170-S171. POS071$$$$$Y$$$20240730$$HP$IN$IN
241494441$24149444$1$I$$20240708$20240730$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003321$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241494451$24149445$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003358$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241494461$24149446$1$I$20220501$20240722$20240730$20240730$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP009309$STRIDES$Ahn S, Lee Y, Han M, Lee JA, Kim JH, Jeong SJ, et al.. Within-host Viral Evolution and Neutralizing Antibody Response in Immunocompromised Patients with Persistent SARS-CoV-2 Infection Receiving B Cell Depleting Treatment.. Open-Forum-Infect-Dis. 2023;10 (Suppl. 2):S278-S279 (plus Poster) abstr$53$YR$$M$Y$$$20240730$$MD$KR$KR
241494471$24149447$1$I$$20240724$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042090$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$$$20240730$$CN$US$US
241494481$24149448$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003322$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241494491$24149449$1$I$$20240722$20240730$20240730$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009274$STRIDES$Sekine S, Oyama N, Io K, Fuseda T, Hasegawa M.. The use of oral colchicine as a therapeutic and prophylactic approach in a case of PFAPA syndrome with recurrent genital ulcers: an under-recognized manifestation?. Eur-J-Dermatol. 2024;34 (2):213-214$10$YR$$F$Y$$$20240730$$HP$JP$JP
241494502$24149450$2$F$$20240909$20240730$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114200$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240910$$CN$US$US
241494511$24149451$1$I$20240713$20240723$20240730$20240730$EXP$$NVSC2024DE153853$NOVARTIS$$91$YR$$F$Y$$$20240730$$MD$DE$DE
241494521$24149452$1$I$$20240712$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111758$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240719$$HP$US$US
241494531$24149453$1$I$$20240708$20240730$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003323$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241494541$24149454$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003369$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241494551$24149455$1$I$20240601$20240708$20240730$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003337$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240730$$CN$US$US
241494561$24149456$1$I$$20240721$20240730$20240730$EXP$$US-HALEON-2188432$Haleon PLC$$$$$$Y$$$20240725$$CN$US$US
241494571$24149457$1$I$$20240711$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112176$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240719$$CN$US$US
241494582$24149458$2$F$$20240805$20240730$20240826$PER$$AU-TOLMAR, INC.-24AU050890$TOLMAR$$$$$M$Y$$$20240826$$CN$AU$AU
241494591$24149459$1$I$$20240709$20240730$20240730$PER$$AU-TOLMAR, INC.-24AU050918$TOLMAR$$$$$M$Y$$$20240730$$CN$AU$AU
241494601$24149460$1$I$20240501$20240709$20240730$20240730$PER$$BR-TOLMAR, INC.-24BR050941$TOLMAR$$8$YR$$F$Y$$$20240730$$CN$BR$BR
241494611$24149461$1$I$20230701$20240709$20240730$20240730$PER$$BR-TOLMAR, INC.-24BR050960$TOLMAR$$8$YR$$F$Y$$$20240730$$CN$BR$BR
241494621$24149462$1$I$$20240715$20240730$20240730$EXP$$PT-TEVA-VS-3222038$TEVA$Velho RM, SEVERE ACUTE PANCREATITIS SECONDARY TO VALPROATE. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 780.$57$YR$$M$Y$$$20240730$$MD$PT$PT
241494631$24149463$1$I$20240723$20240723$20240730$20240730$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000651$DECIPHERA PHARMACEUTICALS$$73$YR$E$M$Y$$$20240730$$CN$US$US
241494651$24149465$1$I$$20240716$20240730$20240730$PER$$US-TEVA-VS-3222243$TEVA$$32$YR$$F$Y$$$20240730$$CN$US$US
241494661$24149466$1$I$20240725$20240729$20240730$20240730$PER$$US-AMGEN-USASP2024150270$AMGEN$$29$YR$A$$Y$$$20240729$$CN$US$US
241494671$24149467$1$I$$20240703$20240730$20240730$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2024US000909$JUBILANT$$$$$M$Y$58.957$KG$20240730$$CN$US$US
241494681$24149468$1$I$$20240722$20240730$20240730$EXP$$JP-AMGEN-JPNSP2024148168$AMGEN$$$$$$Y$$$20240729$$PH$JP$JP
241494691$24149469$1$I$$20240725$20240730$20240730$EXP$GB-MHRA-30827191$GB-STRIDES ARCOLAB LIMITED-2024SP009330$STRIDES$$$$$M$Y$$$20240730$$CN$GB$GB
241494701$24149470$1$I$$20240722$20240730$20240730$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009284$STRIDES$Matsuki S, Taniuchi N, Okada N, Sato J, Nishijima N, Kamio K, et al.. A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung Cancer.. J-Nippon-Med-Sch. 2024;91 (3):339-346$67$YR$$M$Y$$$20240730$$HP$JP$JP
241494711$24149471$1$I$$20230823$20240730$20240730$EXP$$US-AstraZeneca-2023A193688$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241494721$24149472$1$I$$20210908$20240730$20240730$EXP$$US-AstraZeneca-2021A720342$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241494731$24149473$1$I$$20210616$20240730$20240730$EXP$$US-AstraZeneca-2021A536253$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241494741$24149474$1$I$$20240723$20240730$20240730$EXP$$JP-HALEON-2188455$Haleon PLC$$$$$M$Y$$$20240729$$PH$JP$JP
241494751$24149475$1$I$$20240726$20240730$20240730$PER$$US-LEO Pharma-372338$LEO PHARM$$74$YR$$F$Y$$$20240730$$CN$US$US
241494761$24149476$1$I$$20240715$20240730$20240730$EXP$$PT-AZURITY PHARMACEUTICALS, INC.-AZR202407-000163$AZURITY PHARMACEUTICALS$Lima P.. More than arterial hypertension. Livro de Resumos - 30? Congresso Nacional de Medicina Interna. 2024;30(1):476$65$YR$$F$Y$$$20240729$$HP$PT$PT
241494771$24149477$1$I$20240706$20240722$20240730$20240730$EXP$$FR-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00385$VELOXIS PHARMACEUTICALS$$75$YR$$M$Y$$$20240730$$MD$FR$FR
241494783$24149478$3$F$$20240916$20240730$20240921$EXP$$PT-AUROBINDO-AUR-APL-2024-037514$AUROBINDO$Lage G, Fernandes L, Fernandes I, Clerigo V, Ferrao A. What hides behind the pink cloak. Congresses of the Portuguese Society of Internal Medicine. 2024;491$74$YR$$M$Y$$$20240921$$MD$PT$PT
241494791$24149479$1$I$20240701$20240708$20240730$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003345$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240730$$CN$US$US
241494801$24149480$1$I$$20240725$20240730$20240730$PER$$US-ROCHE-10000037834$ROCHE$$$$E$F$Y$$$20240730$$CN$US$US
241494811$24149481$1$I$20240404$20240716$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114655$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240719$$CN$US$US
241494822$24149482$2$F$20240612$20240814$20240730$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003324$ACADIA PHARMACEUTICALS$$14$YR$$F$Y$$$20240830$$CN$US$US
241494831$24149483$1$I$$20240725$20240730$20240730$EXP$GB-MHRA-MED-202407232209444480-NGZPL$GB-STRIDES ARCOLAB LIMITED-2024SP009331$STRIDES$$32$YR$$F$Y$$$20240730$$MD$GB$GB
241494841$24149484$1$I$20240611$20240726$20240730$20240730$EXP$FR-AFSSAPS-DJ2024000859$FR-JNJFOC-20240775633$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20240730$$PH$FR$FR
241494851$24149485$1$I$$20240725$20240730$20240730$PER$$US-LEO Pharma-372331$LEO PHARM$$55$YR$$M$Y$$$20240730$$CN$US$US
241494861$24149486$1$I$$20240725$20240730$20240730$EXP$GB-MHRA-MED-202407232053358180-ZLGPY$GB-STRIDES ARCOLAB LIMITED-2024SP009297$STRIDES$$29$YR$$F$Y$$$20240730$$CN$GB$GB
241494871$24149487$1$I$$20240725$20240730$20240730$PER$$US-LEO Pharma-372336$LEO PHARM$$59$YR$$F$Y$$$20240730$$CN$US$US
241494881$24149488$1$I$$20240718$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114784$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240719$$HP$US$US
241494891$24149489$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003347$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241494901$24149490$1$I$$20240716$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114583$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240719$$CN$US$US
241494911$24149491$1$I$20240715$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114591$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240719$$PH$US$US
241494931$24149493$1$I$$20240614$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-097229$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240719$$HP$US$US
241494942$24149494$2$F$$20240813$20240730$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003326$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
241494952$24149495$2$F$20240605$20240808$20240730$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003346$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240829$$CN$US$US
241494961$24149496$1$I$$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024148577$AMGEN$$$$$M$Y$$$20240729$$CN$US$US
241494971$24149497$1$I$$20240728$20240730$20240730$PER$$US-AMGEN-USASP2024150026$AMGEN$$$$A$F$Y$$$20240729$$CN$US$US
241494981$24149498$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114630$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240719$$CN$US$US
241494991$24149499$1$I$$20240715$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113390$BRISTOL MYERS SQUIBB$Lee M, Ayad M, Diz Ferre JL, Oliver LA, Ayad S. Paravertebral block for multiple rib fractures in an anticoagulated trauma patient. Cureus. 2024 Jun 06;16(6):1-3. doi:10.7759/cureus.61834.$52$YR$A$M$Y$$$20240719$$HP$US$US
241495001$24149500$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114205$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240719$$CN$US$US
241495011$24149501$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003373$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241495022$24149502$2$F$20240722$20240723$20240730$20240802$PER$$US-AMGEN-USASP2024147814$AMGEN$$58$YR$A$F$Y$$$20240802$$CN$US$US
241495031$24149503$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150010$AMGEN$$49$YR$A$F$Y$$$20240729$$HP$US$US
241495041$24149504$1$I$20240725$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017704$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241495051$24149505$1$I$20240719$20240722$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407014887$ELI LILLY AND CO$$$$$F$Y$$$20240730$$CN$US$US
241495061$24149506$1$I$20240716$20240716$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114225$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240719$$CN$US$US
241495071$24149507$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114260$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240719$$CN$US$US
241495081$24149508$1$I$20210801$20240718$20240730$20240730$PER$$US-SA-2024SA216711$SANOFI AVENTIS$$57$YR$A$M$Y$130.16$KG$20240730$$MD$US$US
241495091$24149509$1$I$20230101$20240719$20240730$20240730$PER$$US-SA-2024SA217218$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240730$$MD$US$US
241495101$24149510$1$I$$20240715$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113067$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240719$$PH$US$US
241495112$24149511$2$F$$20240828$20240730$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003348$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
241495121$24149512$1$I$20240710$20240725$20240730$20240730$EXP$$CN-TAKEDA-2024TUS075718$TAKEDA$$81$YR$$F$Y$66$KG$20240730$$HP$CN$CN
241495133$24149513$3$F$20240608$20240819$20240730$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114042$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240826$$HP$US$US
241495141$24149514$1$I$$20240726$20240730$20240730$EXP$$AR-BEIGENE-BGN-2024-010053$BEIGENE$$$$$$Y$$$20240730$$MD$AR$AR
241495151$24149515$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217302$SANOFI AVENTIS$$58$YR$A$F$Y$70.76$KG$20240730$$MD$US$US
241495161$24149516$1$I$$20240723$20240730$20240730$EXP$$US-JNJFOC-20240762034$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$MD$US$US
241495172$24149517$2$F$20240715$20240719$20240730$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114354$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$71.21$KG$20240731$$CN$US$US
241495181$24149518$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217864$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240730$$MD$US$US
241495191$24149519$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003350$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241495201$24149520$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003474$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240730$$CN$US$US
241495211$24149521$1$I$$20240719$20240730$20240730$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009247$STRIDES$Khachatryan A, Isseh I, Vavilin I, Saeed IM, Harutyunyan H, Bansro V, et al.. RECURRENT PERIMYOCARDITIS ASSOCIATED WITH LONG-TERM METHYLPHENIDATE USE.. J-Am-Coll-Cardiol. 2024;83 (Suppl2)(13):3543$$$$$Y$$$20240730$$HP$US$US
241495221$24149522$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217927$SANOFI AVENTIS$$$$T$$Y$$$20240730$$CN$US$US
241495232$24149523$2$F$$20240827$20240730$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113841$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240829$$CN$US$US
241495241$24149524$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA220684$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240730$$CN$US$US
241495251$24149525$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219838$SANOFI AVENTIS$$$$E$F$Y$$$20240730$$MD$US$US
241495263$24149526$3$F$20240401$20240916$20240730$20240925$PER$$US-SA-2024SA219603$SANOFI AVENTIS$$66$YR$E$M$Y$70$KG$20240925$$MD$US$US
241495271$24149527$1$I$$20240722$20240730$20240730$PER$$US-ALXN-202407USA001435US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241495281$24149528$1$I$20240630$20240717$20240730$20240730$EXP$$FR-ENDO USA, INC.-2024-003023$ENDO$$73$YR$$M$Y$$$20240730$$CN$FR$FR
241495291$24149529$1$I$$20210112$20240730$20240730$EXP$$US-AstraZeneca-2021A005884$ASTRAZENECA$$$$$M$Y$68$KG$20240730$$CN$US$
241495302$24149530$2$F$20240829$20240903$20240730$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003330$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240913$$CN$US$US
241495311$24149531$1$I$$20210407$20240730$20240730$EXP$$US-AstraZeneca-2021A287000$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241495321$24149532$1$I$$20240722$20240730$20240730$EXP$$US-STRIDES ARCOLAB LIMITED-2022SP011856$STRIDES$Antony M, Chaurasia A, Gopal N, Linehan M, Ball M.. Indications for and Outcomes of Renal Transplant in Patients With Hereditary Renal Cancer: A Case Series.. American Journal of Kidney Diseases. 2022;79(Suppl.2)(4):S92$$$$$Y$$$20240730$$HP$US$US
241495331$24149533$1$I$$20240726$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119686$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$74.39$KG$20240730$$HP$US$US
241495341$24149534$1$I$$20240723$20240730$20240730$PER$$US-AMGEN-USASP2024148122$AMGEN$$$$E$M$Y$$$20240729$$CN$US$US
241495351$24149535$1$I$$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024148230$AMGEN$$$$$F$Y$$$20240729$$CN$US$US
241495361$24149536$1$I$$20240722$20240730$20240730$EXP$$QA-HALEON-2186119$Haleon PLC$Kannappilly N, Peediyakkal MZ, Khatib MY, Ananthegowda DC, Ananthegowda MS, Zeer HE et al. Ibuprofen-Induced Toxic Epidermal Necrolysis: A Case Report. International Journal of Dermatology and Venereology. 2024;7(2):108-110. DOI: 10.1097/JD9.0000000000000249; Kan?na?ppillyN, PeediyakkalMZ, KhatibMY, et al.?Ibuprofen?-Induced Toxic Epidermal Necrolysis: A Case Report.?Inter?na?tio?na?l Jour?na?l of Dermatology andVenereology?. #PY#;7(2):108.?https://dx.doi.org/10.1097/JD9.0000000000000249; Kan...$41$YR$$M$Y$$$20240729$$HP$QA$QA
241495372$24149537$2$F$$20240909$20240730$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003352$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241495381$24149538$1$I$$20240726$20240730$20240730$PER$$US-ABBVIE-5856900$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241495391$24149539$1$I$$20240729$20240730$20240730$PER$$US-AMGEN-USASP2024150319$AMGEN$$$$$$Y$$$20240729$$CN$US$US
241495411$24149541$1$I$$20240725$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119249$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240730$$HP$US$US
241495423$24149542$3$F$$20240903$20240730$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003300$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241495431$24149543$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003298$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241495441$24149544$1$I$20240725$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149869$AMGEN$$$$$M$Y$$$20240729$$HP$US$US
241495451$24149545$1$I$$20240729$20240730$20240730$PER$$NVSC2024US154930$NOVARTIS$$$$$$Y$$$20240730$$HP$US$US
241495461$24149546$1$I$$20240725$20240730$20240730$EXP$$US-TAKEDA-2024TUS075640$TAKEDA$$$$$F$Y$$$20240730$$CN$US$US
241495472$24149547$2$F$$20240725$20240730$20240808$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-16192$ALKEM$Etta PK, Gowrishankar S. Clopidogrel induced thrombotic microangiopathy successfully treated with conservative approach. Indian Journal of Nephrology. 2020;30(3):209-10$44$YR$$M$Y$$$20240808$$HP$IN$IN
241495481$24149548$1$I$$20240715$20240730$20240730$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-16003$ALKEM$Simsek C, Wahlin S, Efe C. Autoimmune hepatitis: Mycophenolate mofetil vs. azathioprine as first-line therapy. Journal of Hepatology. 2024;81:e41-e42$$$$$Y$$$20240730$$HP$TR$TR
241495491$24149549$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003301$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$HP$US$US
241495501$24149550$1$I$20240704$20240715$20240730$20240730$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16717$ALKEM$$85$YR$$M$Y$72.562$KG$20240730$$CN$US$US
241495513$24149551$3$F$$20240911$20240730$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003302$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
241495522$24149552$2$F$20240709$20240809$20240730$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003927$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240830$$CN$US$US
241495531$24149553$1$I$$20240726$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US039975$SANDOZ$$$$$F$Y$$$20240730$$CN$US$US
241495543$24149554$3$F$20240627$20240915$20240730$20240925$EXP$$CA-CELLTRION INC.-2024CA014692$CELLTRION$$$$$$Y$$$20240925$$MD$CA$CA
241495551$24149555$1$I$$20240724$20240730$20240730$PER$$US-CHATTEMPRD-2024OHG025313$CHATTEM$$$$$$Y$$$20240730$$CN$US$US
241495561$24149556$1$I$$20240723$20240730$20240730$PER$$US-ROCHE-10000036616$ROCHE$$$$$$Y$$$20240730$$CN$US$US
241495572$24149557$2$F$$20240806$20240730$20240809$PER$$US-CHATTEMPRD-2024OHG025379$CHATTEM$$$$$F$Y$$$20240809$$CN$US$US
241495581$24149558$1$I$$20240723$20240730$20240730$PER$$US-ROCHE-10000035049$ROCHE$$$$$$Y$$$20240730$$CN$US$US
241495591$24149559$1$I$$20240725$20240730$20240730$30DAY$$US-GSK-US2024AMR094151$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$CN$US$US
241495601$24149560$1$I$$20240722$20240730$20240730$EXP$$US-AMAROX PHARMA-ASP2024US02463$ASPIRO PHARMA$Torelli VA, Jean RE, Tran E.. Acute Hypoxic Respiratory Failure Secondary to Daptomycin-induced Eosinophilic Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2019$86$YR$$F$Y$$$20240730$$HP$US$US
241495611$24149561$1$I$$20240723$20240730$20240730$PER$$US-ABBVIE-5855474$ABBVIE$$$$$$Y$$$20240730$$HP$US$US
241495621$24149562$1$I$$20211027$20240730$20240730$EXP$$US-AstraZeneca-2021A788406$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241495632$24149563$2$F$$20240731$20240730$20240802$PER$$US-HETERO-HET2024US02448$HETERO$$$$$M$Y$81.6$KG$20240802$$CN$US$US
241495641$24149564$1$I$$20200901$20240730$20240730$EXP$$US-AstraZeneca-2020SF12519$ASTRAZENECA$$$$$F$Y$63.5$KG$20240730$$CN$US$
241495651$24149565$1$I$$20220527$20240730$20240730$EXP$$US-AstraZeneca-2022A201960$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241495661$24149566$1$I$$20240723$20240730$20240730$EXP$$US-BIOGEN-2024BI01275243$BIOGEN$$$$$F$Y$$$20240730$$CN$US$US
241495671$24149567$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119956$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240730$$CN$US$US
241495681$24149568$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018118$ELI LILLY AND CO$$29$YR$A$$Y$$$20240730$$CN$US$US
241495691$24149569$1$I$$20240722$20240730$20240730$EXP$$CA-APOTEX-2024AP008695$APOTEX$$80$YR$$F$Y$$$20240730$$HP$CA$CA
241495701$24149570$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018120$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240730$$CN$US$US
241495711$24149571$1$I$20240721$20240721$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407015175$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240730$$CN$US$US
241495721$24149572$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017978$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240730$$CN$US$US
241495731$24149573$1$I$20240725$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017902$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240730$$CN$US$US
241495741$24149574$1$I$20240701$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017119$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240730$$CN$US$US
241495751$24149575$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017690$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240730$$HP$US$US
241495761$24149576$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218188$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
241495771$24149577$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-10000040307$ROCHE$$60$YR$A$F$Y$$$20240730$$CN$US$US
241495781$24149578$1$I$20240725$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148398$AMGEN$$57$YR$A$F$Y$$$20240729$$CN$US$US
241495801$24149580$1$I$$20240716$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113745$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240719$$CN$US$US
241495811$24149581$1$I$$20240729$20240730$20240730$PER$$NVSC2024US154950$NOVARTIS$$$$$$Y$$$20240730$$MD$US$US
241495821$24149582$1$I$$20240711$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-110746$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240719$$CN$CA$CA
241495831$24149583$1$I$$20240711$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110808$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$87.54$KG$20240719$$CN$US$US
241495841$24149584$1$I$$20240716$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113734$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240719$$HP$US$US
241495851$24149585$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114369$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$55.79$KG$20240719$$MD$US$US
241495861$24149586$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119930$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240730$$HP$US$US
241495871$24149587$1$I$20240701$20240711$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111556$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240719$$PH$US$US
241495881$24149588$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148953$AMGEN$$$$$$Y$$$20240729$$PH$US$US
241495892$24149589$2$F$20240614$20240731$20240730$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111875$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240801$$MD$US$US
241495901$24149590$1$I$$20240716$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113777$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240719$$MD$US$US
241495912$24149591$2$F$$20240903$20240730$20240910$EXP$$US-UCBSA-2024037438$UCB$$$$$F$Y$$$20240910$$MD$US$US
241495921$24149592$1$I$$20240723$20240730$20240730$EXP$GB-MHRA-30767071$GB-AMAROX PHARMA-AMR2024GB02439$HETERO$$$$$$Y$$$20240730$$CN$GB$GB
241495931$24149593$1$I$$20240716$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113923$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240719$$CN$US$US
241495941$24149594$1$I$$20240726$20240730$20240730$PER$$US-TAKEDA-2024TUS076093$TAKEDA$$$$$F$Y$$$20240730$$PH$US$US
241495961$24149596$1$I$20230911$20240711$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-113538$BRISTOL MYERS SQUIBB$$7$DEC$E$$Y$$$20240719$$MD$CA$CA
241495981$24149598$1$I$20240707$20240726$20240730$20240730$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040474$BOEHRINGER INGELHEIM$$88$YR$E$F$Y$49.7$KG$20240730$$PH$JP$JP
241495991$24149599$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003306$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241496011$24149601$1$I$$20200918$20240730$20240730$EXP$$US-AstraZeneca-2020SE80219$ASTRAZENECA$$62$YR$$M$Y$$$20240730$$CN$US$
241496021$24149602$1$I$$20240715$20240730$20240730$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK092622$GLENMARK$Mandloi U, Gogia N, Sonare D, Waghmare S.. Apremilast in Erythema Nodosum Leprosum: A Case Series. Journal of Dermatology and Dermatologic Surgery. 2024;28:42-5$$$$$Y$$$20240730$$HP$IN$IN
241496032$24149603$2$F$$20240819$20240730$20240827$EXP$$GB-CELLTRION INC.-2024GB010216$CELLTRION$$$$$$Y$$$20240827$$CN$GB$GB
241496041$24149604$1$I$$20240715$20240730$20240730$EXP$$PT-TEVA-VS-3222917$TEVA$Valente CT SMALL VESSEL VASCULITIS - A CASE OF DRUG LEUKOCYTOCLASTIC VASCULITIS. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 1210$70$YR$$F$Y$$$20240730$$MD$PT$PT
241496051$24149605$1$I$$20240716$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114569$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240719$$CN$US$US
241496061$24149606$1$I$20220801$20240715$20240730$20240730$EXP$IPSEN_Case_2024-13996$DK-AZURITY PHARMACEUTICALS, INC.-AZR202407-000159$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240729$$MD$DK$DK
241496071$24149607$1$I$20230101$20240716$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113801$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240719$$HP$US$US
241496082$24149608$2$F$$20240801$20240730$20240810$EXP$$IT-TEVA-VS-3224290$TEVA$Ricciardulli S, Lattanzi L, Barbuti M, Ceravolo R, Perugi G. Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report. Int-Clin-Psychopharmacol 2023; 38 (2): 117-120.; Ricciardulli S, Lattanzi L, Barbuti M, Ceravolo R, Perugi G. Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report. Int-Clin-Psychopharmacol 2023; 38 (2): 117-120.; Ricciardulli S, Lattanzi L, Barbuti M, Ceravolo R, Perugi G. Occurrence of involuntary movements after ...$69$YR$$F$Y$$$20240810$$HP$IT$IT
241496093$24149609$3$F$$20240910$20240730$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113843$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240919$$CN$US$US
241496101$24149610$1$I$20220101$20240724$20240730$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119596$BRISTOL MYERS SQUIBB$$8$DEC$E$$Y$$$20240730$$MD$JP$JP
241496111$24149611$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017707$ELI LILLY AND CO$$$$$F$Y$$$20240730$$CN$US$US
241496121$24149612$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018022$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240730$$CN$US$US
241496131$24149613$1$I$$20240724$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016059$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240730$$CN$US$US
241496141$24149614$1$I$20240718$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017714$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240730$$CN$US$US
241496151$24149615$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017063$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240730$$CN$US$US
241496161$24149616$1$I$$20240715$20240730$20240730$EXP$$US-SPECGX-T202401560$SPECGX$Atwood DT, Kohler JR, Vargas SO, Wong W, Klouda T. Identification of Irpex and Rhodotorula on surveillance bronchoscopy in a pediatric lung transplant recipient: A case report and review of literature of these atypical fungal organisms.?. Pediatric Transplantation. 2024;28:1-7$17$YR$$F$Y$$$20240730$$HP$US$US
241496171$24149617$1$I$20240708$20240708$20240730$20240730$PER$$US-CSL-2024-006681$CSL Plasma$$55$YR$$F$Y$$$20240730$$HP$US$US
241496182$24149618$2$F$$20240801$20240730$20240810$EXP$$NL-TEVA-VS-3224317$TEVA$Lin L, Houwink API, van Dieren JM, Wolthuis EK, van Thienen JV, van der HeijdenMS, et al. Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitors. Cancer-Med 2024; 13 (12):.; Lin L, Houwink API, van Dieren JM, Wolthuis EK, van Thienen JV, van der HeijdenMS, et al. Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of i...$$$$$Y$$$20240810$$HP$NL$NL
241496191$24149619$1$I$20240101$20240723$20240730$20240730$EXP$$CA-ROCHE-3551086$ROCHE$$69$YR$E$F$Y$$$20240730$$CN$CA$CA
241496201$24149620$1$I$$20240719$20240730$20240730$PER$$US-009507513-2407USA012332$MERCK$$$$$F$Y$$$20240730$$CN$US$US
241496212$24149621$2$F$$20240813$20240730$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003307$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
241496221$24149622$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114292$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240719$$HP$US$US
241496232$24149623$2$F$20240724$20240724$20240730$20240801$PER$$US-AMGEN-USASP2024147681$AMGEN$$65$YR$E$F$Y$$$20240801$$CN$US$US
241496241$24149624$1$I$20220813$20240716$20240730$20240730$EXP$FR-AFSSAPS-ST2024001170$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-114322$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$69.5$KG$20240719$$MD$FR$FR
241496251$24149625$1$I$$20240727$20240730$20240730$PER$$US-AMGEN-USASP2024150033$AMGEN$$38$YR$A$M$Y$$$20240729$$HP$US$US
241496261$24149626$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114314$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240719$$CN$US$US
241496283$24149628$3$F$$20240913$20240730$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003207$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241496291$24149629$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003234$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241496301$24149630$1$I$20240720$20240725$20240730$20240730$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-11178$IPSEN$$76$YR$E$M$Y$$$20240730$$CN$GB$GB
241496311$24149631$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003283$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241496321$24149632$1$I$$20240708$20240730$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003282$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241496331$24149633$1$I$$20240708$20240730$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003290$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241496341$24149634$1$I$$20240708$20240730$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003280$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$HP$US$US
241496351$24149635$1$I$20240710$20240716$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113917$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$95.71$KG$20240719$$PH$US$US
241496361$24149636$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003278$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241496371$24149637$1$I$20240628$20240708$20240730$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003287$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240730$$CN$US$US
241496381$24149638$1$I$20240701$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148818$AMGEN$$80$YR$E$F$Y$$$20240729$$PH$US$US
241496391$24149639$1$I$$20240711$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111101$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240719$$HP$US$US
241496401$24149640$1$I$$20240729$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042613$BOEHRINGER INGELHEIM$$$$$$Y$$$20240730$$CN$US$US
241496411$24149641$1$I$20240101$20240724$20240730$20240730$EXP$$CA-UCBSA-2024037617$UCB$$63$YR$$M$Y$$$20240730$$HP$CA$CA
241496421$24149642$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114144$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240719$$HP$US$US
241496432$24149643$2$F$$20240823$20240730$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114192$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240827$$CN$US$US
241496441$24149644$1$I$20221001$20240716$20240730$20240730$EXP$$DE-ROCHE-10000040019$ROCHE$$49$YR$A$F$Y$$$20240730$$MD$DE$DE
241496451$24149645$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003291$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241496461$24149646$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-07140$HIKMA$Toste A, Mendes JM, Neves FM, Antunes T, Almeida J.. Toste A, Mendes JM, Neves FM, Antunes T, Almeida J. PO-0417 - (4086) - Lesao hepatica induzida (DILI) por metilprednisolona - descri?ao de caso. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI. 2024;778$34$YR$$F$Y$$$20240730$$MD$PT$PT
241496471$24149647$1$I$$20240708$20240730$20240730$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003293$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241496482$24149648$2$F$$20240830$20240730$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003292$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
241496491$24149649$1$I$20240722$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119837$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240730$$CN$US$US
241496501$24149650$1$I$$20240715$20240730$20240730$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK092627$GLENMARK$Mandloi U, Gogia N, Sonare D, Waghmare S.. Apremilast in Erythema Nodosum Leprosum: A Case Series.. Journal of Dermatology and Dermatologic Surgery.. 2024;28:1:42-45$$$$$Y$$$20240730$$HP$IN$IN
241496511$24149651$1$I$$20240717$20240730$20240730$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-101904$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240719$$MD$PL$PL
241496521$24149652$1$I$20220723$20240726$20240730$20240730$EXP$$GB-ROCHE-3156198$ROCHE$$51$YR$A$M$Y$$$20240730$$HP$GB$GB
241496531$24149653$1$I$$20240721$20240730$20240730$EXP$$IN-JNJFOC-20240758466$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$HP$IN$US
241496551$24149655$1$I$$20240717$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114247$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240719$$CN$US$US
241496561$24149656$1$I$$20220314$20240730$20240730$EXP$$US-AstraZeneca-2022A115774$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241496571$24149657$1$I$$20210323$20240730$20240730$EXP$$US-AstraZeneca-2021A208930$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241496581$24149658$1$I$20210402$20210428$20240730$20240730$EXP$$US-AstraZeneca-2021A382676$ASTRAZENECA$$21070$DY$$F$Y$$$20240730$$CN$US$
241496592$24149659$2$F$$20240830$20240730$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003329$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
241496603$24149660$3$F$$20240905$20240730$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003309$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241496612$24149661$2$F$20240726$20240730$20240730$20240731$PER$$NVSC2024US154981$NOVARTIS$$62$YR$$$Y$49.887$KG$20240731$$CN$US$US
241496621$24149662$1$I$$20240729$20240730$20240730$EXP$$NVSC2023NP224876$NOVARTIS$$$$$F$Y$$$20240730$$MD$NP$NP
241496631$24149663$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148863$AMGEN$$$$$$Y$$$20240729$$MD$US$US
241496641$24149664$1$I$$20240108$20240730$20240730$PER$$US-CIPLA LTD.-2024US00791$CIPLA$$$$$$Y$$$20240730$$CN$US$US
241496651$24149665$1$I$$20240716$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114348$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240719$$CN$US$US
241496661$24149666$1$I$20240723$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024147876$AMGEN$$65$YR$E$F$Y$$$20240729$$CN$US$US
241496671$24149667$1$I$$20240711$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-110897$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$83.91$KG$20240719$$CN$US$US
241496682$24149668$2$F$20240827$20240821$20240730$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003313$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240913$$CN$US$US
241496692$24149669$2$F$20240724$20240826$20240730$20240827$PER$$US-AMGEN-USASP2024147493$AMGEN$$69$YR$E$M$Y$$$20240827$$CN$US$US
241496701$24149670$1$I$20240301$20240718$20240730$20240730$EXP$$US-NOVOPROD-1260205$NOVO NORDISK$$77$YR$$F$Y$$$20240730$$CN$US$US
241496711$24149671$1$I$20240101$20240718$20240730$20240730$EXP$$US-NOVOPROD-1260084$NOVO NORDISK$$$$$$Y$$$20240730$$CN$US$US
241496721$24149672$1$I$$20240718$20240730$20240730$EXP$$US-NOVOPROD-1259154$NOVO NORDISK$$55$YR$$$Y$$$20240730$$CN$US$US
241496731$24149673$1$I$20230401$20240718$20240730$20240730$EXP$$US-NOVOPROD-1259174$NOVO NORDISK$$51$YR$$F$Y$$$20240730$$CN$US$US
241496741$24149674$1$I$$20240718$20240730$20240730$EXP$$US-NOVOPROD-1259159$NOVO NORDISK$$49$YR$$$Y$$$20240730$$CN$US$US
241496761$24149676$1$I$$20240718$20240730$20240730$EXP$$US-NOVOPROD-1260080$NOVO NORDISK$$$$$F$Y$$$20240730$$CN$US$US
241496771$24149677$1$I$$20240717$20240730$20240730$EXP$$GB-NOVOPROD-1259042$NOVO NORDISK$$25$YR$$M$Y$$$20240730$$MD$GB$GB
241496781$24149678$1$I$20220101$20240718$20240730$20240730$EXP$$US-NOVOPROD-1260088$NOVO NORDISK$$63$YR$$F$Y$$$20240730$$CN$US$US
241496791$24149679$1$I$$20240717$20240730$20240730$EXP$$US-NOVOPROD-1258270$NOVO NORDISK$$$$$F$Y$$$20240730$$CN$US$US
241496802$24149680$2$F$20240331$20240916$20240730$20240926$EXP$$US-NOVOPROD-1259376$NOVO NORDISK$$86$YR$$M$Y$$$20240926$$CN$US$US
241496811$24149681$1$I$$20240719$20240730$20240730$EXP$GB-MHRA-MED-202407191129144740-YRGNP$GB-NOVOPROD-1258537$NOVO NORDISK$$$$$F$Y$$$20240730$$HP$GB$GB
241496821$24149682$1$I$$20240718$20240730$20240730$EXP$GB-MHRA-MED-202407181239394950-SWFYV$GB-NOVOPROD-1258074$NOVO NORDISK$$$$$F$Y$$$20240730$$HP$GB$GB
241496831$24149683$1$I$20240601$20240718$20240730$20240730$EXP$$US-NOVOPROD-1260145$NOVO NORDISK$$$$$M$Y$$$20240730$$MD$US$US
241496841$24149684$1$I$$20240717$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114403$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240719$$CN$US$US
241496851$24149685$1$I$20230501$20240716$20240730$20240730$EXP$$US-NOVOPROD-1258894$NOVO NORDISK$$49$YR$$F$Y$$$20240730$$CN$US$US
241496861$24149686$1$I$20240312$20240501$20240730$20240730$PER$$US-CIPLA LTD.-2024US04541$CIPLA$$$$$$Y$$$20240730$$CN$US$US
241496871$24149687$1$I$$20240715$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-112603$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240719$$HP$CA$CA
241496881$24149688$1$I$$20240712$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111501$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240719$$HP$US$US
241496891$24149689$1$I$$20240729$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042616$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240730$$CN$US$US
241496903$24149690$3$F$20230111$20240830$20240730$20240902$EXP$$CH-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-212820$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$49.7$KG$20240902$$CN$CH$CH
241496912$24149691$2$F$$20240829$20240730$20240831$EXP$$US-ROCHE-10000031651$ROCHE$$83$YR$E$F$Y$$$20240831$$CN$US$US
241496921$24149692$1$I$20240705$20240719$20240730$20240730$EXP$$US-JNJFOC-20240752841$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240730$$PH$US$US
241496931$24149693$1$I$$20240724$20240730$20240730$30DAY$$US-GSK-US2024AMR094150$GLAXOSMITHKLINE$$$$$M$Y$$$20240730$$CN$US$US
241496941$24149694$1$I$20240706$20240708$20240730$20240730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003331$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240730$$CN$US$US
241496951$24149695$1$I$20221201$20240718$20240730$20240730$EXP$$US-NOVOPROD-1260261$NOVO NORDISK$$$$$F$Y$$$20240730$$CN$US$US
241496961$24149696$1$I$20240717$20240718$20240730$20240730$EXP$$US-NOVOPROD-1260428$NOVO NORDISK$$78$YR$$F$Y$$$20240730$$CN$US$US
241496972$24149697$2$F$20240711$20240729$20240730$20240809$EXP$$US-NOVOPROD-1260239$NOVO NORDISK$$77$YR$$F$Y$$$20240809$$CN$US$US
241496981$24149698$1$I$$20240718$20240730$20240730$EXP$$US-NOVOPROD-1260262$NOVO NORDISK$$$$$F$Y$$$20240730$$CN$US$US
241496991$24149699$1$I$$20240722$20240730$20240730$EXP$$FR-CELLTRION INC.-2024FR018043$CELLTRION$$$$$$Y$$$20240730$$CN$FR$FR
241497001$24149700$1$I$$20240724$20240730$20240730$EXP$GB-MHRA-MED-202407231643541750-DKNHJ$GB-AMAROX PHARMA-AMR2024GB02440$HETERO$$$$$F$Y$$$20240730$$CN$GB$GB
241497011$24149701$1$I$$20240717$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407006929$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240730$$CN$US$US
241497021$24149702$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119548$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$77.6$KG$20240730$$PH$US$US
241497031$24149703$1$I$$20240711$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407010402$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240730$$CN$US$US
241497041$24149704$1$I$$20240725$20240730$20240730$PER$$US-JNJFOC-20240772593$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$HP$US$US
241497051$24149705$1$I$20231027$20240722$20240730$20240730$EXP$HR-HALMED-300086146$HR-AMGEN-HRVSP2024147529$AMGEN$$59$YR$A$F$Y$70$KG$20240729$$MD$HR$HR
241497061$24149706$1$I$$20240716$20240730$20240730$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109889$ZYDUS PHARM$Oomrigar SC, Fernandez J, Rivera Ortiz C, Rajen H, Toll A, Perez Colome E, et al.. The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death.. Am-J-Respir-Crit-Care-Med. 2024;209:A5653$$$$$Y$$$20240730$$HP$US$US
241497071$24149707$1$I$$20240715$20240730$20240730$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109870$ZYDUS PHARM$Zardoost P, Buckman Z, Weaver J, Elston S, Prouty A, Stuart R, et al.. Continuous renal replacement therapy for lithium toxicity: A worthy treatment to avoid intradialytic hypotension and vasopressors.. Clinical Case Reports. 2024;12:e8775:1-4$$$$$Y$$$20240730$$HP$US$US
241497081$24149708$1$I$$20201118$20240730$20240730$EXP$$US-AstraZeneca-2020SF55277$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241497091$24149709$1$I$20211013$20211028$20240730$20240730$EXP$$US-AstraZeneca-2021A790101$ASTRAZENECA$$27051$DY$$M$Y$$$20240730$$CN$US$
241497101$24149710$1$I$$20210712$20240730$20240730$EXP$$US-AstraZeneca-2021A617456$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241497111$24149711$1$I$$20240729$20240730$20240730$PER$$NVSC2024US154998$NOVARTIS$$$$$$Y$$$20240730$$HP$US$US
241497121$24149712$1$I$$20240702$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06660$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241497131$24149713$1$I$20231201$20240722$20240730$20240730$EXP$$GT-BIOGEN-2024BI01275466$BIOGEN$$26$YR$$F$Y$83$KG$20240730$$CN$GT$GT
241497141$24149714$1$I$20240719$20240722$20240730$20240730$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2159752$JIANGSU HENGRUI MEDICINE$$78$YR$$M$Y$41$KG$20240730$$MD$CN$CN
241497151$24149715$1$I$$20240719$20240730$20240730$EXP$$US-NOVOPROD-1259770$NOVO NORDISK$$49$YR$$F$Y$$$20240730$$CN$US$US
241497161$24149716$1$I$$20240722$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119701$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$MD$US$US
241497171$24149717$1$I$$20240723$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117819$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240730$$CN$US$US
241497181$24149718$1$I$20220201$20240719$20240730$20240730$EXP$FI-FIMEA-202402640$FI-NOVOPROD-1259189$NOVO NORDISK$$35$YR$$F$Y$$$20240730$$CN$FI$FI
241497191$24149719$1$I$$20240719$20240730$20240730$EXP$$US-NOVOPROD-1259709$NOVO NORDISK$$61$YR$$$Y$$$20240730$$CN$US$US
241497201$24149720$1$I$$20240719$20240730$20240730$EXP$$US-NOVOPROD-1259738$NOVO NORDISK$$48$YR$$$Y$$$20240730$$CN$US$US
241497211$24149721$1$I$$20240719$20240730$20240730$EXP$$US-NOVOPROD-1259708$NOVO NORDISK$$39$YR$$F$Y$$$20240730$$CN$US$US
241497221$24149722$1$I$20240614$20240719$20240730$20240730$EXP$ES-AEMPS-1551108$ES-NOVOPROD-1259179$NOVO NORDISK$$75$YR$$F$Y$$$20240730$$MD$ES$ES
241497232$24149723$2$F$20240629$20240806$20240730$20240816$EXP$$FR-NOVOPROD-1258548$NOVO NORDISK$$55$YR$$M$Y$$$20240816$$MD$FR$FR
241497241$24149724$1$I$$20240719$20240730$20240730$EXP$$US-NOVOPROD-1259715$NOVO NORDISK$$53$YR$$$Y$$$20240730$$CN$US$US
241497251$24149725$1$I$20240706$20240719$20240730$20240730$EXP$GB-MHRA-MED-202407191615478790-HZKQF$GB-NOVOPROD-1258545$NOVO NORDISK$$45$YR$$F$Y$93$KG$20240730$$MD$GB$GB
241497261$24149726$1$I$20240613$20240719$20240730$20240730$EXP$ES-AEMPS-1546353$ES-NOVOPROD-1259177$NOVO NORDISK$$39$YR$$F$Y$107$KG$20240730$$CN$ES$ES
241497271$24149727$1$I$$20240719$20240730$20240730$EXP$$US-NOVOPROD-1259705$NOVO NORDISK$$53$YR$$$Y$$$20240730$$CN$US$US
241497281$24149728$1$I$20240710$20240719$20240730$20240730$EXP$CN-NMPA-3714241015185202400125$CN-NOVOPROD-1259546$NOVO NORDISK$$73$YR$$M$Y$75$KG$20240730$$HP$CN$CN
241497291$24149729$1$I$$20240719$20240730$20240730$EXP$$US-NOVOPROD-1259702$NOVO NORDISK$$49$YR$$$Y$$$20240730$$CN$US$US
241497302$24149730$2$F$20240101$20240820$20240730$20240820$PER$$US-ALXN-202407USA001592US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
241497311$24149731$1$I$$20240723$20240730$20240730$EXP$$NVSC2024BR154041$NOVARTIS$$$$$$Y$$$20240730$$MD$BR$BR
241497321$24149732$1$I$$20240729$20240730$20240730$EXP$$NVSC2024BY154682$NOVARTIS$$$$E$F$Y$$$20240730$$CN$BY$BY
241497331$24149733$1$I$20240705$20240719$20240730$20240730$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000125-2024$QILU PHARMACEUTICAL$$35$YR$A$M$Y$54$KG$20240730$$HP$CN$CN
241497342$24149734$2$F$20220101$20240906$20240730$20240916$EXP$$CA-CELLTRION INC.-2022CA003966$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
241497351$24149735$1$I$$20240719$20240730$20240730$EXP$$CA-NOVOPROD-1259791$NOVO NORDISK$$$$$M$Y$$$20240730$$HP$CA$CA
241497361$24149736$1$I$$20240719$20240730$20240730$EXP$$IE-NOVOPROD-1259787$NOVO NORDISK$$$$$F$Y$$$20240730$$MD$IE$IE
241497371$24149737$1$I$20240715$20240725$20240730$20240730$EXP$$CN-ROCHE-10000040326$ROCHE$$79$YR$E$F$Y$53$KG$20240730$$HP$CN$CN
241497381$24149738$1$I$20240709$20240709$20240730$20240730$PER$$US-CSL-2024-006509$CSL Plasma$$24$YR$$F$Y$$$20240730$$HP$US$US
241497392$24149739$2$F$20220704$20240819$20240730$20240821$EXP$$JP-GSK-JP2024093815$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$JP$JP
241497404$24149740$4$F$20240617$20240815$20240730$20240822$PER$$US-TRAVERE-2024TVT00619$TRAVERE THERAPEUTICS$$35$YR$A$M$Y$$$20240822$$CN$US$US
241497412$24149741$2$F$20220513$20240823$20240730$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011305$JAZZ$$47$YR$$F$Y$$$20240828$$HP$US$US
241497421$24149742$1$I$$20240722$20240730$20240730$EXP$GB-MHRA-MED-202407221708120220-SDNHV$GB-TEVA-VS-3224659$TEVA$$$$$F$Y$$$20240730$$HP$GB$GB
241497431$24149743$1$I$20240515$20240722$20240730$20240730$EXP$GB-MHRA-MED-202407221746523650-VSWNY$GB-TEVA-VS-3224354$TEVA$$31$YR$$F$Y$90$KG$20240730$$CN$GB$GB
241497441$24149744$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-07143$HIKMA$Marques M, Vilar da Mota R, Salgueiro D, Ferreira I, Gouveia M, Oliveira R, Pestana P, Lascasas S, Caldeiro J.. Marques M, Vilar da Mota R, Salgueiro D, Ferreira I, Gouveia M, Oliveira R, Pestana P, Lascasas S, Caldeiro J. PO-0679 - (4269) - ^Carcinomatose e hipofosfat?mia: a etiologia multifatorial do delirium^. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI. 2024;1024$65$YR$$M$Y$$$20240730$$MD$PT$PT
241497451$24149745$1$I$20240715$20240726$20240730$20240730$EXP$$CN-ROCHE-10000040278$ROCHE$$59$YR$A$F$Y$60$KG$20240730$$HP$CN$CN
241497461$24149746$1$I$20240711$20240715$20240730$20240730$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR093953$VIIV$$55$YR$$M$Y$$$20240730$$MD$US$US
241497471$24149747$1$I$$20240702$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06812$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241497482$24149748$2$F$20240101$20240801$20240730$20240805$PER$$US-AMGEN-USASP2024150186$AMGEN$$25$YR$A$F$Y$$$20240805$$CN$US$US
241497491$24149749$1$I$$20240715$20240730$20240730$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK092628$GLENMARK$Mandloi U, Gogia N, Sonare D, Waghmare S.. Apremilast in Erythema Nodosum Leprosum: A Case Series. Journal of dermatology and dermatologic surgery. 2024;28:42-5$$$$$Y$$$20240730$$HP$IN$IN
241497503$24149750$3$F$20240101$20240808$20240730$20240815$PER$$US-AMGEN-USASP2024148834$AMGEN$$68$YR$E$F$Y$$$20240814$$CN$US$US
241497512$24149751$2$F$20240710$20240827$20240730$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116580$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$58$KG$20240904$$MD$JP$JP
241497531$24149753$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119394$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240730$$HP$US$US
241497541$24149754$1$I$$20210901$20240730$20240730$EXP$$US-AstraZeneca-2021A708903$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241497551$24149755$1$I$20201228$20210402$20240730$20240730$EXP$$US-AstraZeneca-2021A274394$ASTRAZENECA$$29582$DY$$M$Y$$$20240730$$CN$US$
241497561$24149756$1$I$$20210709$20240730$20240730$EXP$$US-AstraZeneca-2021A614891$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241497571$24149757$1$I$$20210407$20240730$20240730$EXP$$US-AstraZeneca-2021A292868$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241497581$24149758$1$I$$20240724$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-119868$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$68$KG$20240730$$HP$CA$CA
241497591$24149759$1$I$20240501$20240724$20240730$20240730$EXP$GB-MHRA-31122984$GB-AMAROX PHARMA-AMR2024GB02458$HETERO$$69$YR$$F$Y$61$KG$20240730$$MD$GB$GB
241497602$24149760$2$F$$20240801$20240730$20240810$EXP$$US-TEVA-VS-3224235$TEVA$Siler C, Fuller W, Whaley D, Keating J. Polypharmacy in Older Adults: A Case Study. S-D-Med 2023; 76 (3): 124-127.; Siler C, Fuller W, Whaley D, Keating J. Polypharmacy in Older Adults: A Case Study. S-D-Med 2023; 76 (3): 124-127.$64$YR$$F$Y$$$20240810$$MD$US$US
241497611$24149761$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017831$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240730$$CN$US$US
241497621$24149762$1$I$20240720$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017590$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240730$$CN$US$US
241497631$24149763$1$I$20240711$20240722$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407014366$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240730$$CN$US$US
241497641$24149764$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017653$ELI LILLY AND CO$$32$YR$A$M$Y$$$20240730$$CN$US$US
241497651$24149765$1$I$$20240724$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016018$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240730$$CN$US$US
241497661$24149766$1$I$20240725$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017910$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240730$$CN$US$US
241497671$24149767$1$I$20240718$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016986$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240730$$CN$US$US
241497681$24149768$1$I$20240601$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017825$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240730$$CN$US$US
241497692$24149769$2$F$$20240815$20240730$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202407017750$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240821$$CN$US$US
241497702$24149770$2$F$$20240915$20240730$20240924$EXP$$CA-CELLTRION INC.-2024CA018052$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
241497711$24149771$1$I$$20240724$20240730$20240730$PER$$US-ABBVIE-5855858$ABBVIE$$$$$$Y$$$20240730$$CN$US$US
241497721$24149772$1$I$20240321$20240722$20240730$20240730$EXP$FR-AFSSAPS-NC2024000839$FR-BIOGEN-2024BI01275426$BIOGEN$$30$YR$$F$Y$63$KG$20240730$$MD$FR$FR
241497735$24149773$5$F$20240702$20240912$20240730$20240918$30DAY$$US-AMGEN-USASP2024147539$AMGEN$$$$$M$Y$85$KG$20240918$$PH$US$US
241497751$24149775$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219880$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240730$$CN$US$US
241497761$24149776$1$I$$20240718$20240730$20240730$PER$$US-SA-2024SA215028$SANOFI AVENTIS$$$$A$M$Y$74.84$KG$20240730$$MD$US$US
241497771$24149777$1$I$20240101$20240718$20240730$20240730$PER$$US-SA-2024SA214860$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240730$$MD$US$US
241497781$24149778$1$I$20230801$20240723$20240730$20240730$PER$$US-SA-2024SA219232$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240730$$MD$US$US
241497791$24149779$1$I$20230518$20240423$20240730$20240730$EXP$$PH-ALKEM LABORATORIES LIMITED-PH-ALKEM-2024-09469$ALKEM$$74$YR$$F$Y$54$KG$20240730$$CN$PH$PH
241497801$24149780$1$I$$20231228$20240730$20240730$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-17147$ALKEM$$$$$F$Y$$$20240730$$CN$US$US
241497811$24149781$1$I$20240211$20240213$20240730$20240730$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-03234$ALKEM$$$$$$Y$$$20240730$$MD$IN$IN
241497821$24149782$1$I$$20230614$20240730$20240730$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-06720$ALKEM$$$$$F$Y$$$20240730$$HP$AU$AU
241497831$24149783$1$I$20231212$20240122$20240730$20240730$EXP$DE-CADRBFARM-2023324963$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-01191$ALKEM$$71$YR$$F$Y$60$KG$20240730$$CN$DE$DE
241497841$24149784$1$I$$20240523$20240730$20240730$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-11307$ALKEM$$54$YR$$F$Y$$$20240730$$CN$DE$DE
241497851$24149785$1$I$20231117$20231122$20240730$20240730$EXP$DE-CADRBFARM-2023324166$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-14714$ALKEM$$29$YR$$F$Y$$$20240730$$CN$DE$DE
241497861$24149786$1$I$20240123$20240127$20240730$20240730$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-01734$ALKEM$$85$YR$$F$Y$80$KG$20240730$$HP$IN$IN
241497871$24149787$1$I$20230715$20230831$20240730$20240730$EXP$DE-CADRBFARM-2023321987$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-10160$ALKEM$$36$YR$$F$Y$63$KG$20240730$$CN$DE$DE
241497881$24149788$1$I$$20231101$20240730$20240730$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-13601$ALKEM$$$$$F$Y$$$20240730$$CN$DE$DE
241497891$24149789$1$I$20231123$20231129$20240730$20240730$EXP$DE-CADRBFARM-2023324339$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15246$ALKEM$$22$YR$$F$Y$53$KG$20240730$$CN$DE$DE
241497901$24149790$1$I$20230721$20230828$20240730$20240730$EXP$DE-CADRBFARM-2023321912$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-09986$ALKEM$$79$YR$$M$Y$80$KG$20240730$$CN$DE$DE
241497911$24149791$1$I$$20231114$20240730$20240730$EXP$DE-AMK-269792$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-14260$ALKEM$$61$YR$$M$Y$$$20240730$$PH$DE$DE
241497921$24149792$1$I$20230326$20240423$20240730$20240730$EXP$$PH-ALKEM LABORATORIES LIMITED-PH-ALKEM-2024-09470$ALKEM$$$$$F$Y$$$20240730$$CN$PH$PH
241497931$24149793$1$I$$20230619$20240730$20240730$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-07046$ALKEM$$$$$$Y$$$20240730$$CN$US$US
241497941$24149794$1$I$$20240209$20240730$20240730$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-03192$ALKEM$Li ML, Shah AD. Micrococcus Peritonitis Complicating Peritoneal Dialysis. Rhode Island Medical journal. 2024;unk:16-19$42$YR$$F$Y$$$20240730$$MD$US$US
241497951$24149795$1$I$$20240227$20240730$20240730$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-04000$ALKEM$$$$$F$Y$$$20240730$$CN$US$US
241497961$24149796$1$I$$20240506$20240730$20240730$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-09157$ALKEM$Katta R, Anusuri V. Serum sickness-like reaction to cefuroxime: a case report and review of the literature. J Drugs Dermatol. 2007;6(7):747-748$34$YR$$F$Y$$$20240730$$HP$US$US
241497971$24149797$1$I$$20240213$20240730$20240730$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-03243$ALKEM$Cabanas R, Calderon O, Ramirez E, Fiandor A, Prior N, Caballero T, Herranz P, Bobolea I, Lopez-Serrano MC, Quirce S, Bellon T. Piperacillin-induced DRESS: Distinguishing features observed in a clinical and allergy study of 8 patients. J Investig Allergol Clin Immunol. 2014;24(6):425-430$59$YR$$M$Y$$$20240730$$HP$ES$ES
241497981$24149798$1$I$$20230614$20240730$20240730$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-06727$ALKEM$$23$YR$$F$Y$$$20240730$$HP$AU$AU
241497991$24149799$1$I$$20230614$20240730$20240730$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-06729$ALKEM$$75$YR$$F$Y$$$20240730$$HP$AU$AU
241498001$24149800$1$I$$20231229$20240730$20240730$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2023-17226$ALKEM$Liu Y, Xu X, Yang J, Zhang Y, He M, Liao W, Wang N, Liu P. New exploration of signal detection of Regional Risks from the perspective of data mining: a pharmacovigilance analysis based on spontaneous reporting data in Zhenjiang, China. Expert Opinion on Drug Safety. 2023;unk:1-12$81$YR$$F$Y$$$20240730$$HP$CN$CN
241498011$24149801$1$I$$20231107$20240730$20240730$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-13986$ALKEM$Hoeltzenbein M, Bartz I, Fietz AK, Lohse L, Onken M, Dathe K, Schaefer C. Antiepileptic treatment with levetiracetam during the first trimester and pregnancy outcome: an observational study. Epilepsia. 2023;unk:unk$32$YR$$F$Y$$$20240730$$HP$DE$DE
241498021$24149802$1$I$20220328$20231114$20240730$20240730$EXP$GB-MHRA-ADR 28314496$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-14253$ALKEM$$60$YR$$M$Y$$$20240730$$MD$GB$GB
241498031$24149803$1$I$20240129$20240201$20240730$20240730$EXP$GB-MHRA-ADR 28502160$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-02111$ALKEM$$$$$F$Y$$$20240730$$MD$GB$GB
241498041$24149804$1$I$$20230719$20240730$20240730$EXP$US-MLMSERVICE-20230703-4388618-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-07943$ALKEM$Espaillat A, Williams C, Gardner RA, Leigh MW, Willis Z, Gulati A, Zdanski C, Vece TJ. Endobronchial Mass in Patient With Very Early Onset Inflammatory Bowel Disease on JAK Inhibitor: TB or Not TB. American Journal of Respiratory and Critical Care Medicine. 2023;207(1):A5455$6$YR$$M$Y$$$20240730$$MD$US$US
241498051$24149805$1$I$$20231229$20240730$20240730$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2023-17227$ALKEM$Liu Y, Xu X, Yang J, Zhang Y, He M, Liao W, Wang N, Liu P.. New exploration of signal detection of Regional Risks from the perspective of data mining: a pharmacovigilance analysis based on spontaneous reporting data in Zhenjiang, China. Expert Opinion on Drug Safety. 2023;unk:1-12$25$YR$$M$Y$$$20240730$$HP$CN$CN
241498061$24149806$1$I$20211213$20231108$20240730$20240730$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-13863$ALKEM$$41$YR$$F$Y$$$20240730$$HP$DE$DE
241498071$24149807$1$I$$20230905$20240730$20240730$EXP$$PH-ALKEM LABORATORIES LIMITED-PH-ALKEM-2023-10449$ALKEM$$21$YR$$F$Y$$$20240730$$CN$PH$PH
241498081$24149808$1$I$$20230614$20240730$20240730$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-06721$ALKEM$$80$YR$$M$Y$$$20240730$$HP$AU$AU
241498091$24149809$1$I$20230818$20230824$20240730$20240730$EXP$GB-MHRA-ADR 28133309$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09887$ALKEM$$84$YR$$F$Y$$$20240730$$PH$GB$GB
241498101$24149810$1$I$$20231120$20240730$20240730$EXP$GB-MHRA-ADR 28330179$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-14530$ALKEM$$71$YR$$F$Y$$$20240730$$HP$GB$GB
241498111$24149811$1$I$20230612$20230619$20240730$20240730$EXP$GB-MHRA-ADR 27975522$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-06840$ALKEM$$77$YR$$M$Y$$$20240730$$MD$GB$GB
241498121$24149812$1$I$$20240213$20240730$20240730$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-03239$ALKEM$Cabanas R, Calderon O, Ramirez E, Fiandor A, Prior N, Caballero T, Herranz P, Bobolea I, Lopez-Serrano MC, Quirce S, Bellon T. Piperacillin-induced DRESS: Distinguishing features observed in a clinical and allergy study of 8 patients. J Investig Allergol Clin Immunol. 2014;24(6):425-430$83$YR$$M$Y$$$20240730$$HP$ES$ES
241498131$24149813$1$I$20230601$20231018$20240730$20240730$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-12829$ALKEM$$$$$F$Y$$$20240730$$CN$DE$DE
241498141$24149814$1$I$20230808$20230814$20240730$20240730$EXP$DE-CADRBFARM-2023321535$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-09399$ALKEM$$33$YR$$F$Y$120$KG$20240730$$CN$DE$DE
241498151$24149815$1$I$$20230804$20240730$20240730$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2023-08664$ALKEM$Shen Y, Yu W, Wang P. A Child With Large Pulmonary and Liver Cysts. JAMA Clinical Challenge. 2023;330(4):372-373$7$YR$$M$Y$$$20240730$$MD$CN$CN
241498161$24149816$1$I$$20240111$20240730$20240730$EXP$$HR-ALKEM LABORATORIES LIMITED-HR-ALKEM-2024-00587$ALKEM$Habek D, Cerovac A.. Full trisomy 14 in one of bichorionic biamniotic twins. Z Geburtshilfe Neonatol. 2024;unk:unk$28$YR$$F$Y$$$20240730$$HP$HR$HR
241498171$24149817$1$I$$20240313$20240730$20240730$EXP$$MY-ALKEM LABORATORIES LIMITED-MY-ALKEM-2024-05382$ALKEM$Nabil S, Isa MF, Abdul Wahab BI, Isa NM.. Oral mucosa sporotrichosis: Report of a rare case acquired by direct inoculation. Medical Mycology Case Reports. 2024;43:100631$61$YR$$M$Y$$$20240730$$HP$MY$MY
241498183$24149818$3$F$20240311$20240827$20240730$20240912$EXP$$IN-HETERO-HET2024IN02454$HETERO$$$$$F$Y$52.8$KG$20240906$$CN$IN$IN
241498192$24149819$2$F$20240101$20240813$20240730$20240814$PER$$US-AMGEN-USASP2024148011$AMGEN$$60$YR$A$M$Y$$$20240814$$CN$US$US
241498202$24149820$2$F$20240715$20240813$20240730$20240822$EXP$$US-HETERO-HET2024US02461$HETERO$$79$YR$$F$Y$63.04$KG$20240822$$CN$US$US
241498212$24149821$2$F$20240608$20240725$20240730$20240801$EXP$$NVSC2024FR153959$NOVARTIS$$54$YR$$F$Y$56$KG$20240801$$CN$FR$FR
241498222$24149822$2$F$$20240916$20240730$20240927$PER$$US-TRAVERE-2024TVT00592$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240927$$CN$US$US
241498233$24149823$3$F$20240501$20240806$20240730$20240814$EXP$$US-CHATTEMPRD-2024OHG025222$CHATTEM$$78$YR$E$M$Y$$$20240814$$CN$US$US
241498241$24149824$1$I$$20240722$20240730$20240730$EXP$$US-GSK-US2024091779$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$MD$US$US
241498251$24149825$1$I$$20240724$20240730$20240730$30DAY$$US-GSK-US2024093002$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240730$$MD$US$US
241498261$24149826$1$I$$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118831$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240730$$CN$US$US
241498271$24149827$1$I$20240701$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119677$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240730$$CN$US$US
241498281$24149828$1$I$$20240726$20240730$20240730$PER$$NVSC2024US155020$NOVARTIS$$$$$$Y$$$20240730$$HP$US$US
241498291$24149829$1$I$20240722$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024147753$AMGEN$$76$YR$E$F$Y$$$20240729$$CN$US$US
241498301$24149830$1$I$20240620$20240725$20240730$20240730$EXP$$ES-AUROBINDO-AUR-APL-2024-037465$AUROBINDO$$82$YR$$F$Y$$$20240730$$HP$ES$ES
241498312$24149831$2$F$20231101$20240801$20240730$20240815$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092667$GLENMARK$Okuda DT, Burgess KW, Moog TM, Patel MA.. Underdosed generic specialty medications: A prescription for patient harm?. Multiple Sclerosis and Related Disorders.. 2024;88:105760:1-3$$$$$Y$$$20240815$$HP$US$US
241498321$24149832$1$I$$20240724$20240730$20240730$PER$$US-ROCHE-10000037869$ROCHE$$$$$$Y$$$20240730$$HP$US$US
241498332$24149833$2$F$20240718$20240731$20240730$20240807$PER$$US-AMGEN-USASP2024146029$AMGEN$$73$YR$E$M$Y$85.7$KG$20240806$$PH$US$US
241498341$24149834$1$I$$20240716$20240730$20240730$EXP$$TH-ROCHE-10000033999$ROCHE$$54$YR$A$F$Y$$$20240730$$CN$TH$TH
241498352$24149835$2$F$20240724$20240729$20240730$20240731$PER$$US-AMGEN-USASP2024147502$AMGEN$$76$YR$E$M$Y$$$20240731$$CN$US$US
241498361$24149836$1$I$$20240726$20240730$20240730$EXP$$DE-SANDOZ INC.-SDZ2023DE003434$SANDOZ$$$$A$$Y$$$20240730$$MD$DE$DE
241498371$24149837$1$I$20240101$20240722$20240730$20240730$PER$$US-ABBVIE-5852919$ABBVIE$$$$$$Y$$$20240730$$CN$US$US
241498381$24149838$1$I$20240101$20240725$20240730$20240730$EXP$$US-ABBVIE-5854862$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241498391$24149839$1$I$$20240715$20240730$20240730$EXP$$US-GILEAD-2024-0681236$GILEAD$$$$A$M$Y$$$20240730$$CN$US$US
241498401$24149840$1$I$$20240723$20240730$20240730$EXP$$CA-APOTEX-2024AP008758$APOTEX$$58$YR$$M$Y$$$20240730$$PH$CA$CA
241498413$24149841$3$F$$20240803$20240730$20240816$EXP$$PT-AUROBINDO-AUR-APL-2024-036723$AUROBINDO$Ferreira DG, Brito A, Costa J, Jorge R. Drug-induced liver injury with bromocriptine. Gazz-Med-Ital-Arch-Sci-Med. 2024;183 (4):367-369$40$YR$$F$Y$$$20240816$$HP$PT$PT
241498422$24149842$2$F$20240101$20240816$20240730$20240826$EXP$$CA-CELLTRION INC.-2024CA018075$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
241498431$24149843$1$I$20240720$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149772$AMGEN$$58$YR$A$M$Y$$$20240730$$CN$US$US
241498441$24149844$1$I$$20240722$20240730$20240730$PER$$US-AMGEN-USASP2024147796$AMGEN$Kamali A.; Khalaj K.; Jacobs M.A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$59$YR$A$M$Y$$$20240730$$HP$US$US
241498451$24149845$1$I$20240723$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149170$AMGEN$$$$$M$Y$$$20240730$$CN$US$US
241498462$24149846$2$F$$20240726$20240730$20240802$EXP$$DE-BIOGEN-2024BI01275444$BIOGEN$$47$YR$$F$Y$$$20240802$$HP$DE$DE
241498471$24149847$1$I$20240614$20240719$20240730$20240730$EXP$$ES-AUROBINDO-AUR-APL-2024-036779$AUROBINDO$$90$YR$$M$Y$53$KG$20240730$$MD$ES$ES
241498481$24149848$1$I$$20240729$20240730$20240730$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042537$BOEHRINGER INGELHEIM$$43$YR$A$M$Y$$$20240730$$CN$US$US
241498491$24149849$1$I$$20240719$20240730$20240730$EXP$$US-AUROBINDO-AUR-APL-2024-036117$AUROBINDO$Sorabella RA, Gray WH,  Dabal RJ,  Padilla LA, Hock K, Clark MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70(7):e92-6$15$YR$$F$Y$49$KG$20240730$$MD$US$US
241498501$24149850$1$I$20240101$20240718$20240730$20240730$EXP$$CN-ROCHE-10000031529$ROCHE$$42$YR$A$F$Y$$$20240730$$CN$CN$CN
241498511$24149851$1$I$20240726$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119944$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240730$$CN$US$US
241498521$24149852$1$I$$20240619$20240730$20240730$PER$$US-ADVANZ PHARMA-202406005345$ADVANZ PHARMA$$$$$$Y$$$20240730$$CN$US$US
241498531$24149853$1$I$20240705$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036321$AUROBINDO$$82$YR$$F$Y$49$KG$20240730$$PH$FR$FR
241498551$24149855$1$I$20240720$20240722$20240730$20240730$EXP$GB-MHRA-MED-202407221657154820-VWGSM$GB-TEVA-VS-3224683$TEVA$$47$YR$$F$Y$$$20240730$$HP$GB$GB
241498563$24149856$3$F$20240726$20240730$20240730$20240802$EXP$$US-AMGEN-USASP2024150134$AMGEN$$82$YR$E$F$Y$$$20240802$$HP$US$US
241498571$24149857$1$I$20240719$20240725$20240730$20240730$EXP$$CN-AMGEN-CHNSP2024149916$AMGEN$$61$YR$A$M$Y$67$KG$20240730$$HP$CN$CN
241498591$24149859$1$I$$20240728$20240730$20240730$PER$$US-HALEON-2189499$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241498601$24149860$1$I$$20210528$20240730$20240730$EXP$$US-AstraZeneca-2021A324310$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241498611$24149861$1$I$20240325$20240716$20240730$20240730$EXP$$CN-ROCHE-10000028979$ROCHE$$69$YR$E$M$Y$$$20240730$$MD$CN$CN
241498621$24149862$1$I$20240214$20240724$20240730$20240730$PER$$US-002147023-NVSC2024CA045433$Haleon PLC$$69$YR$$M$Y$$$20240730$$HP$CA$CA
241498631$24149863$1$I$20240406$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A169836$ASTRAZENECA$$$$$F$Y$$$20240730$$HP$US$
241498641$24149864$1$I$$20210507$20240730$20240730$EXP$$US-AstraZeneca-2021A417875$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241498652$24149865$2$F$20240701$20240819$20240730$20240827$30DAY$$US-AMGEN-USASP2024148157$AMGEN$$73$YR$E$M$Y$67.95$KG$20240827$$HP$US$US
241498662$24149866$2$F$20240611$20240731$20240730$20240806$PER$$US-AMGEN-USASP2024149138$AMGEN$$77$YR$E$F$Y$61.224$KG$20240806$$CN$US$US
241498674$24149867$4$F$20240701$20240902$20240730$20240913$30DAY$$US-JNJFOC-20240769062$JOHNSON AND JOHNSON$$26$YR$$M$Y$$$20240913$$CN$US$US
241498681$24149868$1$I$$20240718$20240730$20240730$PER$$US-AMGEN-USASP2024148509$AMGEN$Calley, B.. stevens-johnson syndrome in a pregnant woman who received the influenza vaccine. JAAD Case Reports. 2022;23:35-37$34$YR$A$F$Y$$$20240730$$HP$US$US
241498691$24149869$1$I$20230201$20240723$20240730$20240730$EXP$$US-ALXN-202407USA001596US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240730$$HP$US$US
241498701$24149870$1$I$$20240612$20240730$20240730$PER$$US-TRAVERE-2024TVT00597$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240730$$HP$US$US
241498712$24149871$2$F$$20240913$20240730$20240930$PER$$US-TRAVERE-2024TVT00594$TRAVERE THERAPEUTICS$$50$YR$A$F$Y$$$20240930$$CN$US$US
241498726$24149872$6$F$20240501$20240827$20240730$20240917$PER$$US-TRAVERE-2024TVT00593$TRAVERE THERAPEUTICS$$64$YR$A$F$Y$$$20240917$$CN$US$US
241498731$24149873$1$I$$20240722$20240730$20240730$PER$$US-HALEON-2189261$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241498741$24149874$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106593$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240730$$CN$US$US
241498751$24149875$1$I$$20240726$20240730$20240730$EXP$$US-ROCHE-10000040886$ROCHE$$74$YR$E$F$Y$$$20240730$$CN$US$US
241498761$24149876$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS076039$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241498771$24149877$1$I$20230806$20230807$20240730$20240730$EXP$$US-AstraZeneca-2023A180753$ASTRAZENECA$$28804$DY$$F$Y$69.4$KG$20240730$$CN$US$
241498781$24149878$1$I$$20230821$20240730$20240730$EXP$$IN-AstraZeneca-2023A194822$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$IN$
241498791$24149879$1$I$$20210223$20240730$20240730$EXP$$US-AstraZeneca-2021A068315$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241498801$24149880$1$I$$20240723$20240730$20240730$PER$$US-APOTEX-2024AP008822$APOTEX$Anwar A, Chahine Z, Piecoro D, Kesler M, Qasrawi A.. Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia.. Human Pathology Reports. 2023;33:300713$51$YR$$F$Y$$$20240730$$HP$US$US
241498812$24149881$2$F$20240401$20240806$20240730$20240820$EXP$$US-ENDO USA, INC.-2024-002662$ENDO$$48$YR$$M$Y$97.052$KG$20240820$$HP$US$US
241498821$24149882$1$I$20240719$20240719$20240730$20240730$EXP$$GB-AUROBINDO-AUR-APL-2024-036548$AUROBINDO$$41$YR$$M$Y$100$KG$20240730$$MD$GB$GB
241498831$24149883$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS076041$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241498841$24149884$1$I$20240701$20240725$20240730$20240730$EXP$$FR-JNJFOC-20240768692$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20240730$$CN$FR$FR
241498851$24149885$1$I$$20240718$20240730$20240730$PER$$US-JNJFOC-20240774988$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$MD$US$US
241498862$24149886$2$F$20240709$20240821$20240730$20240829$EXP$$CO-JNJFOC-20240765368$JOHNSON AND JOHNSON$$40$YR$A$F$Y$69$KG$20240829$$HP$CO$CO
241498872$24149887$2$F$20240713$20240719$20240730$20240801$EXP$$FR-AUROBINDO-AUR-APL-2024-036749$AUROBINDO$$74$YR$$M$Y$93$KG$20240801$$PH$FR$FR
241498881$24149888$1$I$20240723$20240723$20240730$20240730$PER$$US-AMGEN-USASL2024147354$AMGEN$$29$YR$A$F$Y$$$20240730$$CN$US$US
241498891$24149889$1$I$20240701$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149614$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241498902$24149890$2$F$$20240819$20240730$20240828$30DAY$$US-GSK-US2024AMR093660$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$CN$US$US
241498911$24149891$1$I$20240401$20240719$20240730$20240730$EXP$$US-GSK-US2024091251$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$US$US
241498922$24149892$2$F$20240101$20240719$20240730$20240730$EXP$$US-ROCHE-10000031745$ROCHE$$34$YR$A$F$Y$114.76$KG$20240730$$CN$US$US
241498931$24149893$1$I$20240724$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148485$AMGEN$$40$YR$A$F$Y$$$20240730$$CN$US$US
241498941$24149894$1$I$20240724$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024147480$AMGEN$$58$YR$A$F$Y$$$20240730$$CN$US$US
241498951$24149895$1$I$$20240612$20240730$20240730$PER$$US-TRAVERE-2024TVT00600$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240730$$HP$US$US
241498961$24149896$1$I$$20240723$20240730$20240730$EXP$GB-MHRA-30767071$GB-RDY-SPO/GBR/24/0010955$DR REDDYS$$$$$$Y$$$20240730$$CN$GB$GB
241498971$24149897$1$I$$20240719$20240730$20240730$EXP$$US-AUROBINDO-AUR-APL-2024-036113$AUROBINDO$Sorabella RA, Gray WH,  Dabal RJ,  Padilla LA, Hock K, Clark MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70(7):e92-6$12$YR$$F$Y$63$KG$20240730$$MD$US$US
241498981$24149898$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155039$NOVARTIS$$$$$M$Y$$$20240730$$CN$US$US
241498991$24149899$1$I$20240701$20240718$20240730$20240730$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22676$SAMSUNG BIOEPIS$$63$YR$A$M$Y$$$20240730$$CN$CA$CA
241499001$24149900$1$I$$20240726$20240730$20240730$PER$$US-HALEON-2189376$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241499011$24149901$1$I$$20240716$20240730$20240730$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-06388$HIKMA$$$$T$F$Y$$$20240730$$MD$GB$GB
241499021$24149902$1$I$$20240725$20240730$20240730$EXP$$JP-ABBVIE-5858936$ABBVIE$$80$YR$$F$Y$$$20240730$$PH$JP$JP
241499031$24149903$1$I$$20240719$20240730$20240730$PER$$US-JNJFOC-20240776497$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$HP$US$US
241499041$24149904$1$I$$20240726$20240730$20240730$PER$$US-HALEON-2189247$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241499051$24149905$1$I$$20240722$20240730$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119340$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240730$$MD$JP$JP
241499061$24149906$1$I$20240601$20240718$20240730$20240730$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22497$SAMSUNG BIOEPIS$$77$YR$E$M$Y$$$20240730$$CN$CA$CA
241499073$24149907$3$F$20240201$20240912$20240730$20240920$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22500$SAMSUNG BIOEPIS$$71$YR$E$F$Y$$$20240920$$CN$CA$CA
241499082$24149908$2$F$$20240819$20240730$20240903$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22507$SAMSUNG BIOEPIS$$78$YR$E$F$Y$$$20240903$$CN$CA$CA
241499091$24149909$1$I$20240725$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149042$AMGEN$$80$YR$E$F$Y$$$20240730$$HP$US$US
241499101$24149910$1$I$$20240724$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016069$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240730$$CN$US$US
241499111$24149911$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016988$ELI LILLY AND CO$$68$YR$E$$Y$$$20240730$$CN$US$US
241499121$24149912$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017210$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240730$$CN$US$US
241499131$24149913$1$I$20220701$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017613$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240730$$CN$US$US
241499141$24149914$1$I$20240701$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017699$ELI LILLY AND CO$$$$$M$Y$$$20240730$$CN$US$US
241499151$24149915$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018480$ELI LILLY AND CO$$73$YR$E$$Y$$$20240730$$CN$US$US
241499161$24149916$1$I$20240721$20240722$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407015197$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240730$$CN$US$US
241499171$24149917$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018163$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240730$$CN$US$US
241499182$24149918$2$F$$20240801$20240730$20240808$EXP$$BR-CELLTRION INC.-2023BR001077$CELLTRION$$$$$$Y$$$20240808$$CN$BR$BR
241499191$24149919$1$I$$20240723$20240730$20240730$EXP$$US-SA-2024SA218372$SANOFI AVENTIS$$$$$F$Y$$$20240730$$CN$US$US
241499201$24149920$1$I$20240509$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036814$AUROBINDO$$59$YR$$F$Y$80$KG$20240730$$MD$FR$FR
241499221$24149922$1$I$20240723$20240723$20240730$20240730$PER$$US-ABBVIE-5854354$ABBVIE$$40$YR$$F$Y$$$20240730$$MD$US$US
241499231$24149923$1$I$20180101$20240717$20240730$20240730$EXP$$CN-MPL-000053$MLV PHARMA$$$$A$F$Y$$$20240718$$HP$CN$CN
241499241$24149924$1$I$$20240719$20240730$20240730$EXP$$US-JNJFOC-20240755391$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240730$$MD$US$US
241499251$24149925$1$I$20240101$20240724$20240730$20240730$EXP$$US-JNJFOC-20240766632$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240730$$CN$US$US
241499261$24149926$1$I$$20240722$20240730$20240730$EXP$$VN-AstraZeneca-2024A172002$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$VN$
241499272$24149927$2$F$$20240730$20240730$20240801$EXP$$CA-JNJFOC-20240776017$JOHNSON AND JOHNSON$$41$YR$A$F$Y$133$KG$20240801$$HP$CA$CA
241499282$24149928$2$F$20230101$20240725$20240730$20240730$EXP$$JP-SA-2024SA216919$SANOFI AVENTIS$$$$$M$Y$$$20240730$$CN$JP$JP
241499291$24149929$1$I$20240520$20240722$20240730$20240730$EXP$GB-MHRA-31198400$GB-TEVA-VS-3224514$TEVA$$47$YR$$M$Y$105$KG$20240730$$MD$GB$GB
241499301$24149930$1$I$20240628$20240725$20240730$20240730$EXP$$US-ABBVIE-5856062$ABBVIE$$71$YR$$F$Y$$$20240730$$CN$US$US
241499311$24149931$1$I$20240725$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148862$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241499323$24149932$3$F$$20240909$20240730$20240909$PER$$US-AMGEN-USASP2024149658$AMGEN$$$$$$Y$$$20240909$$CN$US$US
241499331$24149933$1$I$20240101$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148852$AMGEN$$70$YR$E$F$Y$$$20240730$$CN$US$US
241499341$24149934$1$I$20240601$20240722$20240730$20240730$EXP$$CO-ABBVIE-5851098$ABBVIE$$57$YR$$F$Y$51$KG$20240730$$CN$CO$CO
241499351$24149935$1$I$$20240612$20240730$20240730$PER$$US-TRAVERE-2024TVT00603$TRAVERE THERAPEUTICS$$66$YR$E$M$Y$$$20240730$$CN$US$US
241499361$24149936$1$I$$20240724$20240730$20240730$PER$$US-ADVANZ PHARMA-202407006314$ADVANZ PHARMA$$$$$$Y$$$20240730$$CN$US$US
241499371$24149937$1$I$$20240531$20240730$20240730$EXP$$CN-ROCHE-10000034969$ROCHE$$39$YR$A$F$Y$73$KG$20240730$$CN$CN$CN
241499381$24149938$1$I$$20240715$20240730$20240730$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01168$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240729$$HP$US$US
241499391$24149939$1$I$20240101$20240715$20240730$20240730$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01171$INTRA-CELLULAR THERAPIES$$30$YR$$F$Y$$$20240729$$HP$US$US
241499401$24149940$1$I$20240701$20240724$20240730$20240730$EXP$$US-ABBVIE-5858017$ABBVIE$$20$YR$$M$Y$$$20240730$$CN$US$US
241499411$24149941$1$I$20240710$20240710$20240730$20240730$PER$$US-CSL-2024-006655$CSL Plasma$$30$YR$$F$Y$$$20240730$$HP$US$US
241499421$24149942$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150158$AMGEN$$$$$$Y$$$20240730$$HP$US$US
241499431$24149943$1$I$20220301$20240722$20240730$20240730$EXP$$NVSJ2024JP009033$NOVARTIS$$80$YR$$F$Y$$$20240730$$MD$JP$JP
241499441$24149944$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189494$Haleon PLC$$$$$M$Y$$$20240730$$CN$US$US
241499451$24149945$1$I$$20240722$20240730$20240730$EXP$GB-MHRA-MED-202407220105453600-HQGWS$GB-TEVA-VS-3224512$TEVA$$19$YR$$M$Y$$$20240730$$CN$GB$GB
241499461$24149946$1$I$$20240719$20240730$20240730$PER$$US-HALEON-2188680$Haleon PLC$$$$$$Y$$$20240730$$LW$US$US
241499473$24149947$3$F$20240716$20240904$20240730$20240910$30DAY$$US-JNJFOC-20240769965$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240910$$PH$US$US
241499482$24149948$2$F$20240527$20240828$20240730$20240902$EXP$$US-JNJFOC-20240775956$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240902$$CN$US$US
241499491$24149949$1$I$$20240729$20240730$20240730$EXP$$GB-JNJFOC-20240777313$JOHNSON AND JOHNSON$$60$YR$A$F$Y$92$KG$20240730$$MD$GB$GB
241499502$24149950$2$F$$20240801$20240730$20240810$EXP$$PT-TEVA-VS-3224373$TEVA$Bouca B, Cascao M, Fiuza P, Amaral S, Bogalho P, Silva-Nunes J. Diagnosis of 17-alpha hydroxylase deficiency performed late in life in a patient with a 46,XY karyotype. Endocrinol-Diabetes-Metab-Case-Rep 2023; 2023 (2): no pagination.; Bouca B, Cascao M, Fiuza P, Amaral S, Bogalho P, Silva-Nunes J. Diagnosis of 17-alpha hydroxylase deficiency performed late in life in a patient with a 46,XY karyotype. Endocrinol-Diabetes-Metab-Case-Rep 2023; 2023 (2): no pagination.$44$YR$$F$Y$51.2$KG$20240810$$HP$PT$PT
241499511$24149951$1$I$20240426$20240613$20240730$20240730$PER$$US-AMGEN-USASP2024149915$AMGEN$$72$YR$E$F$Y$$$20240730$$CN$US$US
241499521$24149952$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149635$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241499531$24149953$1$I$$20240722$20240730$20240730$PER$$PR-ABBVIE-5852441$ABBVIE$$$$E$F$Y$$$20240730$$MD$PR$PR
241499552$24149955$2$F$20240621$20240812$20240730$20240821$EXP$$US-NOVOPROD-1260232$NOVO NORDISK$$70$YR$$M$Y$$$20240821$$CN$US$US
241499561$24149956$1$I$$20240719$20240730$20240730$EXP$$US-NOVOPROD-1260127$NOVO NORDISK$$$$$M$Y$$$20240730$$CN$US$US
241499571$24149957$1$I$$20240719$20240730$20240730$EXP$$US-NOVOPROD-1260258$NOVO NORDISK$$$$$F$Y$$$20240730$$HP$US$US
241499581$24149958$1$I$20230101$20240719$20240730$20240730$EXP$$US-NOVOPROD-1260096$NOVO NORDISK$$86$YR$$M$Y$$$20240730$$CN$US$US
241499591$24149959$1$I$20220101$20240719$20240730$20240730$EXP$$US-NOVOPROD-1260129$NOVO NORDISK$$$$$F$Y$$$20240730$$CN$US$US
241499601$24149960$1$I$$20240719$20240730$20240730$EXP$$US-NOVOPROD-1260255$NOVO NORDISK$$$$$M$Y$$$20240730$$MD$US$US
241499611$24149961$1$I$20240701$20240725$20240730$20240730$EXP$$BR-NOVOPROD-1261049$NOVO NORDISK$$20$YR$$F$Y$$$20240730$$MD$BR$BR
241499621$24149962$1$I$20230901$20240719$20240730$20240730$EXP$$US-NOVOPROD-1259872$NOVO NORDISK$$89$YR$$F$Y$$$20240730$$CN$US$US
241499631$24149963$1$I$20240725$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148988$AMGEN$$47$YR$A$F$Y$$$20240730$$CN$US$US
241499641$24149964$1$I$$20240725$20240730$20240730$PER$$US-ROCHE-10000038574$ROCHE$$$$$$Y$$$20240730$$CN$US$US
241499652$24149965$2$F$20230101$20240809$20240730$20240821$PER$$US-APOTEX-2024AP008236$APOTEX$$$$$F$Y$$$20240821$$CN$US$US
241499662$24149966$2$F$20240717$20240906$20240730$20240911$PER$$US-ROCHE-10000034032$ROCHE$$70$YR$E$M$Y$$$20240911$$CN$US$US
241499673$24149967$3$F$$20240801$20240730$20240812$EXP$$PT-TEVA-VS-3222514$TEVA$Maia CC DIFFUSE LARGE CELL LYMPHOMA B - AN INCIDENTAL DIAGNOSIS. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 954; Maia CC DIFFUSE LARGE CELL LYMPHOMA B - AN INCIDENTAL DIAGNOSIS. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 954$72$YR$$F$Y$$$20240812$$MD$PT$PT
241499681$24149968$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119721$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$58.97$KG$20240730$$HP$US$US
241499691$24149969$1$I$$20240729$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120077$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240730$$MD$US$US
241499701$24149970$1$I$$20211130$20240730$20240730$EXP$$US-AstraZeneca-2021A851721$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241499711$24149971$1$I$$20220225$20240730$20240730$EXP$$US-AstraZeneca-2022A091492$ASTRAZENECA$$$$$F$Y$$$20240730$$MD$US$
241499722$24149972$2$F$$20240909$20240730$20240923$EXP$$US-INSMED, INC.-2024-02930-US$INSMED$$$$$F$Y$$$20240923$$CN$US$US
241499731$24149973$1$I$20240707$20240725$20240730$20240730$EXP$$ID-AstraZeneca-2024A171114$ASTRAZENECA$$24733$DY$$F$Y$$$20240730$$CN$ID$
241499741$24149974$1$I$$20240723$20240730$20240730$EXP$$US-CHIESI-2024CHF04562$CHIESI$$$$$F$Y$58$KG$20240730$$CN$US$US
241499751$24149975$1$I$20240701$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017924$ELI LILLY AND CO$$70$YR$E$$Y$$$20240730$$CN$US$US
241499761$24149976$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017744$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240730$$MD$US$US
241499771$24149977$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017947$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241499781$24149978$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017529$ELI LILLY AND CO$$$$$F$Y$$$20240730$$CN$US$US
241499791$24149979$1$I$20220521$20240723$20240730$20240730$EXP$$US-CHIESI-2024CHF04571$CHIESI$$76$YR$$F$Y$63$KG$20240730$$CN$US$US
241499801$24149980$1$I$20240726$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017841$ELI LILLY AND CO$$23$YR$A$M$Y$$$20240730$$CN$US$US
241499811$24149981$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017966$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240730$$CN$US$US
241499821$24149982$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017843$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240730$$CN$US$US
241499831$24149983$1$I$20240726$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017722$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240730$$CN$US$US
241499843$24149984$3$F$20240712$20240724$20240730$20240816$EXP$$US-JNJFOC-20240752654$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240816$$CN$US$US
241499852$24149985$2$F$20240718$20240826$20240730$20240829$PER$$US-JNJFOC-20240762326$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240829$$CN$US$US
241499861$24149986$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149059$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241499871$24149987$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149039$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241499881$24149988$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150179$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241499891$24149989$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149040$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241499901$24149990$1$I$$20240715$20240730$20240730$EXP$$PT-TEVA-VS-3223000$TEVA$Literature: Buruian N, Valente T, Cerveira H, Gomes DO, Valentim M, Lume M. A RARE CAUSE OF SYNDROME OF INAPPROPRIATE SECRETION OF ANTIDIURETIC HORMONE, DESPITE WIDELY USED IN CLINICAL PRACTICE. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 1142.$64$YR$$F$Y$$$20240730$$MD$PT$PT
241499921$24149992$1$I$20240101$20240726$20240730$20240730$PER$$US-ABBVIE-5858508$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241499931$24149993$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149053$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241499941$24149994$1$I$20240701$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149483$AMGEN$$68$YR$E$M$Y$$$20240730$$CN$US$US
241499951$24149995$1$I$$20240725$20240730$20240730$PER$$US-UNITED THERAPEUTICS-UNT-2024-023102$UNITED THERAPEUTICS$$$$$M$Y$68.934$KG$20240730$$$US$US
241499961$24149996$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149045$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241499972$24149997$2$F$$20240731$20240730$20240802$EXP$$US-ABBVIE-5857133$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241499982$24149998$2$F$$20240828$20240730$20240902$EXP$$US-ABBVIE-5725462$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
241499991$24149999$1$I$20240726$20240729$20240730$20240730$PER$$US-HALEON-2189490$Haleon PLC$$29$YR$$$Y$$$20240730$$CN$US$US
241500011$24150001$1$I$$20240725$20240730$20240730$EXP$$JP-SANDOZ INC.-SDZ2024JP068793$SANDOZ$$87$YR$$M$Y$$$20240730$$CN$JP$JP
241500031$24150003$1$I$20231101$20240723$20240730$20240730$EXP$$US-ORG100016242-2024000486$PACIRA$$86$YR$E$F$Y$$$20240730$$CN$US$US
241500041$24150004$1$I$20240101$20240723$20240730$20240730$PER$$US-UNITED THERAPEUTICS-UNT-2024-022692$UNITED THERAPEUTICS$$$$$F$Y$$$20240730$$$US$US
241500051$24150005$1$I$$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119870$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240730$$CN$US$US
241500061$24150006$1$I$$20240724$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119033$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240730$$CN$US$US
241500071$24150007$1$I$$20240723$20240730$20240730$EXP$$US-CHATTEMPRD-2024OHG025145$CHATTEM$$$$A$F$Y$$$20240730$$LW$US$US
241500082$24150008$2$F$$20240722$20240730$20240730$EXP$$US-ROCHE-10000033286$ROCHE$$44$YR$A$F$Y$$$20240730$$CN$US$US
241500091$24150009$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189496$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241500101$24150010$1$I$$20240723$20240730$20240730$EXP$$US-CHATTEMPRD-2024OHG025232$CHATTEM$$$$$F$Y$$$20240730$$LW$US$US
241500111$24150011$1$I$$20240719$20240730$20240730$EXP$$ZA-ROCHE-10000034855$ROCHE$$$$$M$Y$$$20240730$$MD$ZA$ZA
241500131$24150013$1$I$20240713$20240723$20240730$20240730$PER$$US-BIOGEN-2022BI01103005$BIOGEN$$57$YR$$F$Y$$$20240730$$CN$US$US
241500141$24150014$1$I$19940101$20240723$20240730$20240730$EXP$$US-CHATTEMPRD-2024OHG025192$CHATTEM$$$$$F$Y$$$20240730$$LW$US$US
241500151$24150015$1$I$20240707$20240722$20240730$20240730$EXP$$CL-JNJFOC-20240764504$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240730$$CN$CL$CL
241500162$24150016$2$F$20240701$20240729$20240730$20240731$PER$$US-AMGEN-USASP2024148886$AMGEN$$60$YR$A$F$Y$$$20240731$$CN$US$US
241500173$24150017$3$F$20240712$20240814$20240730$20240820$EXP$$CA-JNJFOC-20240765447$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240820$$HP$CA$CA
241500181$24150018$1$I$20240603$20240723$20240730$20240730$PER$$US-AMGEN-USASP2024148727$AMGEN$$$$$$Y$$$20240730$$HP$US$US
241500191$24150019$1$I$$20240726$20240730$20240730$PER$$NVSC2024US155072$NOVARTIS$$$$$$Y$$$20240730$$HP$US$US
241500201$24150020$1$I$$20240728$20240730$20240730$PER$$NVSC2024US154712$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
241500211$24150021$1$I$$20240724$20240730$20240730$EXP$$US-CHATTEMPRD-2024OHG025344$CHATTEM$$$$$$Y$$$20240730$$LW$US$US
241500221$24150022$1$I$20240711$20240719$20240730$20240730$EXP$$PK-ROCHE-10000033487$ROCHE$$85$YR$E$M$Y$$$20240730$$CN$PK$PK
241500232$24150023$2$F$20220428$20240806$20240730$20240812$EXP$$US-ABBVIE-5853871$ABBVIE$$73$YR$$M$Y$91$KG$20240812$$CN$US$US
241500242$24150024$2$F$$20240821$20240730$20240828$PER$$US-BAUSCHBL-2024BNL030522$BAUSCH AND LOMB$$$$$F$Y$$$20240828$$CN$US$US
241500252$24150025$2$F$$20240801$20240730$20240810$EXP$$PT-TEVA-VS-3222517$TEVA$Bezerra J, et all. PANUVEITIS IN AN IMMUNOCOMPETENT PATIENT - A CASE OF TOXOPLASMOSIS. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 942; Bezerra J, et all. PANUVEITIS IN AN IMMUNOCOMPETENT PATIENT - A CASE OF TOXOPLASMOSIS. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 942$21$YR$$M$Y$$$20240810$$MD$PT$PT
241500261$24150026$1$I$$20240725$20240730$20240730$EXP$$US-ABBVIE-5855695$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241500271$24150027$1$I$20240711$20240712$20240730$20240730$PER$$US-CSL-2024-006680$CSL Plasma$$63$YR$$F$Y$$$20240730$$HP$US$US
241500291$24150029$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119908$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240730$$CN$US$US
241500301$24150030$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119510$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240730$$HP$US$US
241500311$24150031$1$I$$20240712$20240730$20240730$PER$$CA-TOLMAR, INC.-24CA048663$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
241500321$24150032$1$I$$20240709$20240730$20240730$PER$$CA-TOLMAR, INC.-24CA050460$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
241500331$24150033$1$I$20240629$20240704$20240730$20240730$PER$$FR-TOLMAR, INC.-24FR050686$TOLMAR$$$$E$M$Y$$$20240730$$HP$FR$FR
241500341$24150034$1$I$20240703$20240703$20240730$20240730$PER$$FR-TOLMAR, INC.-24FR050763$TOLMAR$$76$YR$$M$Y$$$20240730$$PH$FR$FR
241500351$24150035$1$I$20240704$20240704$20240730$20240730$PER$$FR-TOLMAR, INC.-24FR050811$TOLMAR$$93$YR$$M$Y$$$20240730$$PH$FR$FR
241500361$24150036$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018671$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240730$$CN$US$US
241500371$24150037$1$I$20240704$20240704$20240730$20240730$PER$$NL-TOLMAR, INC.-24NL050810$TOLMAR$$75$YR$$M$Y$$$20240730$$CN$NL$NL
241500381$24150038$1$I$20240724$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017785$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240730$$CN$US$US
241500391$24150039$1$I$20240501$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017745$ELI LILLY AND CO$$77$YR$E$$Y$$$20240730$$CN$US$US
241500401$24150040$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017938$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240730$$CN$US$US
241500411$24150041$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017861$ELI LILLY AND CO$$58$YR$A$$Y$$$20240730$$CN$US$US
241500421$24150042$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017668$ELI LILLY AND CO$$$$$M$Y$$$20240730$$CN$US$US
241500431$24150043$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017759$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240730$$CN$US$US
241500441$24150044$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017760$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240730$$CN$US$US
241500451$24150045$1$I$20240718$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017940$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240730$$CN$US$US
241500462$24150046$2$F$$20240923$20240730$20240930$EXP$$CA-GSK-CA2024AMR093180$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$CA$CA
241500471$24150047$1$I$$20240726$20240730$20240730$PER$$US-JNJFOC-20240775318$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$CN$US$US
241500482$24150048$2$F$20240501$20240810$20240730$20240821$PER$$US-JNJFOC-20240776615$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240821$$PH$US$US
241500491$24150049$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189488$Haleon PLC$$25$YR$$M$Y$$$20240730$$CN$US$US
241500502$24150050$2$F$$20240821$20240730$20240828$PER$$US-BIOGEN-2024BI01275204$BIOGEN$$$$$M$Y$$$20240828$$CN$US$US
241500521$24150052$1$I$$20240723$20240730$20240730$PER$$US-BIOGEN-2024BI01275163$BIOGEN$$$$$F$Y$$$20240730$$CN$US$US
241500531$24150053$1$I$$20240723$20240730$20240730$EXP$$US-SA-2024SA219425$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240730$$HP$US$US
241500541$24150054$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149842$AMGEN$$$$$M$Y$$$20240730$$HP$US$US
241500552$24150055$2$F$$20240723$20240730$20240809$EXP$$JP-AMGEN-JPNSP2024124536$AMGEN$$8$DEC$E$M$Y$$$20240809$$MD$JP$JP
241500561$24150056$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149297$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241500571$24150057$1$I$20240725$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148839$AMGEN$$67$YR$E$M$Y$$$20240730$$CN$US$US
241500581$24150058$1$I$20240701$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149983$AMGEN$$$$$F$Y$$$20240730$$HP$US$US
241500591$24150059$1$I$20240601$20240724$20240730$20240730$EXP$$US-ABBVIE-5853922$ABBVIE$$34$YR$$F$Y$$$20240730$$CN$US$US
241500601$24150060$1$I$$20240722$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118766$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$MD$US$US
241500613$24150061$3$F$20240619$20240802$20240730$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120322$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240812$$CN$US$US
241500621$24150062$1$I$$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120120$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$HP$US$US
241500631$24150063$1$I$$20240212$20240730$20240730$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432943$RANBAXY$$$$A$M$Y$$$20240730$$CN$US$US
241500641$24150064$1$I$$20240417$20240730$20240730$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-443304$RANBAXY$$$$E$$Y$$$20240730$$CN$US$US
241500651$24150065$1$I$$20230921$20240730$20240730$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410113$RANBAXY$$$$A$F$Y$$$20240730$$CN$US$US
241500661$24150066$1$I$$20240320$20240730$20240730$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438578$RANBAXY$$$$E$F$Y$$$20240730$$CN$US$US
241500671$24150067$1$I$$20230403$20240730$20240730$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420939$RANBAXY$$$$E$M$Y$$$20240730$$HP$US$US
241500681$24150068$1$I$20240101$20240724$20240730$20240730$EXP$$US-ABBVIE-5855037$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241500691$24150069$1$I$20240708$20240724$20240730$20240730$EXP$$EU-BAUSCHBL-2024BNL030619$BAUSCH AND LOMB$$79$YR$$M$Y$$$20240730$$MD$EU$EU
241500701$24150070$1$I$20240404$20240722$20240730$20240730$PER$FR-AFSSAPS-NC2024000870$FR-IGSA-BIG0029994$GRIFOLS$$73$YR$$M$Y$$$20240730$$MD$FR$FR
241500711$24150071$1$I$20240701$20240722$20240730$20240730$PER$$US-BIOGEN-2024BI01274867$BIOGEN$$49$YR$$F$Y$$$20240730$$CN$US$US
241500721$24150072$1$I$$20240725$20240730$20240730$EXP$$CA-SA-2024SA219021$SANOFI AVENTIS$$$$$F$Y$$$20240730$$HP$CA$CA
241500731$24150073$1$I$$20240726$20240730$20240730$EXP$$CA-ABBVIE-5857356$ABBVIE$$$$E$$Y$$$20240730$$CN$CA$CA
241500741$24150074$1$I$20210625$20240716$20240730$20240730$EXP$$US-COOPERSURGICAL, INC.-2024CPS002214$COOPERSURGICAL$$$$$F$Y$$$20240730$$LW$US$US
241500751$24150075$1$I$20220729$20240716$20240730$20240730$EXP$$US-COOPERSURGICAL, INC.-2024CPS002218$COOPERSURGICAL$$$$$F$Y$$$20240730$$LW$US$US
241500761$24150076$1$I$20190102$20240716$20240730$20240730$EXP$$US-COOPERSURGICAL, INC.-2024CPS002212$COOPERSURGICAL$$$$$F$Y$$$20240730$$LW$US$US
241500771$24150077$1$I$20240701$20240725$20240730$20240730$EXP$$US-ABBVIE-5856366$ABBVIE$$53$YR$$F$Y$$$20240730$$CN$US$US
241500781$24150078$1$I$20221201$20221214$20240730$20240730$EXP$$AU-TERSERA THERAPEUTICS LLC-2022TRS005865$TERSERA THERAPEUTICS$$$$$$Y$$$20240730$$CN$AU$AU
241500791$24150079$1$I$$20220711$20240730$20240730$EXP$$AU-TERSERA THERAPEUTICS LLC-2022TRS005485$TERSERA THERAPEUTICS$$$$$$Y$$$20240730$$CN$AU$AU
241500801$24150080$1$I$20240717$20240725$20240730$20240730$EXP$$CA-ABBVIE-5856005$ABBVIE$$55$YR$$M$Y$$$20240730$$CN$CA$CA
241500811$24150081$1$I$$20220425$20240730$20240730$EXP$$ZA-BIOVITRUM-2022ZA05810$BIOVITRUM$$117$DY$$F$Y$3$KG$20240730$$CN$ZA$ZA
241500821$24150082$1$I$$20240723$20240730$20240730$PER$$US-ABBVIE-5853078$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241500831$24150083$1$I$$20231128$20240730$20240730$EXP$$US-AstraZeneca-2023A270595$ASTRAZENECA$$$$$$Y$$$20240730$$CN$US$
241500841$24150084$1$I$20240718$20240722$20240730$20240730$EXP$$CO-BIOVITRUM-2024-CO-010328$BIOVITRUM$$162$DY$$M$Y$6.9$KG$20240730$$CN$CO$CO
241500851$24150085$1$I$20240711$20240713$20240730$20240730$30DAY$$SA-JNJFOC-20240737104$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240730$$CN$SA$SA
241500861$24150086$1$I$$20240723$20240730$20240730$PER$$US-ALXN-202407USA001570US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241500871$24150087$1$I$$20240729$20240730$20240730$EXP$$DE-ABBVIE-5857718$ABBVIE$$$$$F$Y$$$20240730$$MD$DE$DE
241500881$24150088$1$I$20231101$20240724$20240730$20240730$EXP$$US-ABBVIE-5853921$ABBVIE$$80$YR$$F$Y$$$20240730$$CN$US$US
241500891$24150089$1$I$$20240726$20240730$20240730$EXP$$EU-BAUSCHBL-2024BNL030698$BAUSCH AND LOMB$Schnallinger M. Teclistamab in light chain myeloma-Complete remission in the fifth Therapy line. Jatros Hematol Oncol. 2024 APR;.$47$YR$$$Y$$$20240730$$MD$EU$EU
241500903$24150090$3$F$20240910$20240919$20240730$20240928$EXP$$CA-CELLTRION INC.-2024CA018080$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
241500911$24150091$1$I$$20210818$20240730$20240730$EXP$$CA-AstraZeneca-2020SF33537$ASTRAZENECA$$79$YR$$M$Y$$$20240730$$MD$CA$
241500921$24150092$1$I$$20240724$20240730$20240730$EXP$$TR-AMGEN-TURSP2024147921$AMGEN$Cagir Y.; Durak M.B.; Simsek C. et al.. Specific Oral Manifestations in Adults with Crohn^s Disease. Journal of Clinical Medicine. 2024;13 (13):1-14$$$$$Y$$$20240730$$HP$TR$TR
241500931$24150093$1$I$20240723$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148358$AMGEN$$87$YR$E$$Y$$$20240730$$PH$US$US
241500941$24150094$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149671$AMGEN$$$$$$Y$$$20240730$$HP$US$US
241500951$24150095$1$I$20231001$20240723$20240730$20240730$EXP$$US-AMGEN-USASP2024146516$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241500961$24150096$1$I$$20240722$20240730$20240730$EXP$NL-LRB-00985611$NL-TEVA-VS-3224595$TEVA$$6$YR$$F$Y$16$KG$20240730$$CN$NL$NL
241500971$24150097$1$I$20240629$20240725$20240730$20240730$EXP$$CN-ABBVIE-5855928$ABBVIE$$30$YR$$M$Y$90$KG$20240730$$MD$CN$CN
241500981$24150098$1$I$20240101$20240725$20240730$20240730$EXP$$CA-UCBSA-2024037885$UCB$$$$$F$Y$$$20240730$$CN$CA$CA
241500991$24150099$1$I$$20240725$20240730$20240730$EXP$$JP-GSK-JP2024094404$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$PH$JP$JP
241501001$24150100$1$I$20240101$20240725$20240730$20240730$PER$$US-ORGANON-O2407USA002642$ORGANON$$$$$$Y$$$20240730$$CN$US$US
241501012$24150101$2$F$20240722$20240806$20240730$20240814$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011385$JAZZ$$3$YR$$F$Y$$$20240814$$MD$US$US
241501022$24150102$2$F$$20240726$20240730$20240802$PER$$US-AMGEN-USASP2024149862$AMGEN$$$$$M$Y$$$20240801$$CN$US$US
241501031$24150103$1$I$$20240723$20240730$20240730$PER$$US-ABBVIE-5853327$ABBVIE$$17$YR$$F$Y$$$20240730$$MD$US$US
241501041$24150104$1$I$20240710$20240730$20240730$20240730$EXP$AT-BASGAGES-2024-005517$AT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042634$BOEHRINGER INGELHEIM$$86$YR$E$F$Y$$$20240730$$PH$AT$AT
241501051$24150105$1$I$$20240723$20240730$20240730$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041446$BOEHRINGER INGELHEIM$Farouji A, Battah A, Hellou R, Ahmad A, Farouji L. Unique Presentation of Asymptomatic  Bacteriuria, Vertebral Osteomyelitis, and  Iliopsoas Abscess Due to Klebsiella pneumonia  in a 73-Year-Old Man with Type 2 Diabetes  Mellitus on Empagliflozin. American Journal of Case Reports. 2024 Jul 19;25: e943874. doi:10.12659/AJCR.943874.$73$YR$E$M$Y$$$20240730$$HP$US$US
241501061$24150106$1$I$20240101$20240716$20240730$20240730$EXP$$US-UCBSA-2024036311$UCB$$$$$F$Y$59.274$KG$20240730$$HP$US$US
241501072$24150107$2$F$20240410$20240827$20240730$20240902$EXP$$US-KYOWAKIRIN-2024KK018033$KYOWA$$$$$$Y$$$20240902$$CN$US$US
241501084$24150108$4$F$$20240903$20240730$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120203$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240904$$HP$US$US
241501091$24150109$1$I$$20240723$20240730$20240730$PER$$US-009507513-2407USA013378$MERCK$Mathur K. BCGosis-side effect of a treatment: A rare case report. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24:45-6$83$YR$$M$Y$$$20240730$$HP$US$US
241501101$24150110$1$I$20240726$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017797$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240730$$CN$US$US
241501121$24150112$1$I$20240718$20240718$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017142$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240730$$CN$US$US
241501131$24150113$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017768$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240730$$MD$US$US
241501141$24150114$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS076045$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241501151$24150115$1$I$$20240723$20240730$20240730$EXP$$US-GSK-US2024092356$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$MD$US$US
241501161$24150116$1$I$20240529$20240725$20240730$20240730$EXP$$US-CHATTEMPRD-2024OHG025407$CHATTEM$$70$YR$E$F$Y$$$20240730$$LW$US$US
241501182$24150118$2$F$20240101$20240823$20240730$20240829$EXP$$CA-ABBVIE-5853423$ABBVIE$$57$YR$$M$Y$$$20240829$$CN$CA$CA
241501191$24150119$1$I$20240705$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149362$AMGEN$$$$$F$Y$$$20240730$$PH$US$US
241501201$24150120$1$I$$20240711$20240730$20240730$PER$$US-JNJFOC-20240732578$JOHNSON AND JOHNSON$$81$YR$E$$Y$$$20240730$$CN$US$US
241501211$24150121$1$I$$20240715$20240730$20240730$EXP$$IN-IPCA LABORATORIES LIMITED-IPC-2024-IN-001850$IPCA$Leyole Claudine Ancilla, Bala Sundaram, Nabadwip Pathak et al.. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. Journal of Nephropharmacology. 2024;13(2):1-5$$$$$Y$$$20240730$$HP$IN$IN
241501221$24150122$1$I$20210806$20210816$20240730$20240730$EXP$$US-AstraZeneca-2021A690355$ASTRAZENECA$$26525$DY$$M$Y$$$20240730$$CN$US$
241501231$24150123$1$I$20240101$20240724$20240730$20240730$EXP$$US-ABBVIE-5790984$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241501241$24150124$1$I$$20210901$20240730$20240730$EXP$$US-AstraZeneca-2021A708971$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241501252$24150125$2$F$$20240731$20240730$20240803$EXP$$US-ABBVIE-5855805$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241501261$24150126$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS076047$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241501283$24150128$3$F$20240101$20240910$20240730$20240916$EXP$$US-ABBVIE-5856121$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
241501293$24150129$3$F$20240808$20240808$20240730$20240813$EXP$$CA-TAKEDA-2024TUS031758$TAKEDA$$72$YR$$F$Y$$$20240813$$HP$CA$CA
241501302$24150130$2$F$20240705$20240906$20240730$20240912$EXP$$US-ABBVIE-5748857$ABBVIE$$55$YR$$F$Y$71$KG$20240912$$CN$US$US
241501311$24150131$1$I$$20240723$20240730$20240730$EXP$GB-MHRA-MED-202407231312361510-RZTNV$GB-BIOGEN-2024BI01275362$BIOGEN$$$$$M$Y$$$20240730$$HP$GB$GB
241501322$24150132$2$F$$20240812$20240730$20240815$EXP$$US-ABBVIE-5857203$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
241501332$24150133$2$F$20210318$20240815$20240730$20240821$EXP$$AR-BIOGEN-2024BI01275406$BIOGEN$$48$YR$$F$Y$$$20240821$$CN$AR$AR
241501342$24150134$2$F$20240723$20240725$20240730$20240802$PER$$US-AMGEN-USASP2024149031$AMGEN$$68$YR$E$F$Y$$$20240801$$CN$US$US
241501351$24150135$1$I$20240701$20240728$20240730$20240730$EXP$$AU-ABBVIE-5857977$ABBVIE$$61$YR$$F$Y$$$20240730$$HP$AU$AU
241501362$24150136$2$F$20240720$20240803$20240730$20240813$PER$$US-ABBVIE-5852044$ABBVIE$$63$YR$$F$Y$$$20240813$$CN$US$US
241501382$24150138$2$F$20240701$20240816$20240730$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119753$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$54.43$KG$20240826$$CN$US$US
241501391$24150139$1$I$20230612$20240719$20240730$20240730$EXP$HR-ABBVIE-5823333$HR-ROCHE-10000031408$ROCHE$$75$YR$E$M$Y$$$20240730$$MD$HR$HR
241501402$24150140$2$F$$20240730$20240730$20240807$EXP$$US-CHATTEMPRD-2024OHG025223$CHATTEM$Bayless SL, Walker NV, Scott MM, Leo RJ. Clozapine-Related Cecal Volvulus. The primary care companion for CNS disorders. 2024 Jul 11;26(4):24cr03729. DOI: 10.4088/PCC.24cr03729$58$YR$A$F$Y$$$20240807$$MD$US$US
241501411$24150141$1$I$20200429$20240719$20240730$20240730$EXP$PL-URPL-1-1560-2020$PL-ROCHE-10000032045$ROCHE$$73$YR$E$M$Y$77$KG$20240730$$MD$PL$PL
241501421$24150142$1$I$$20240725$20240730$20240730$PER$$US-JNJFOC-20240773161$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$HP$US$US
241501431$24150143$1$I$$20240702$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06887$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241501441$24150144$1$I$20240725$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149571$AMGEN$$53$YR$A$F$Y$$$20240730$$CN$US$US
241501452$24150145$2$F$20240101$20240729$20240730$20240801$EXP$$GB-ABBVIE-5854874$ABBVIE$$79$YR$$F$Y$$$20240731$$CN$GB$GB
241501461$24150146$1$I$$20240715$20240730$20240730$EXP$$IN-IPCA LABORATORIES LIMITED-IPC-2024-IN-001851$IPCA$Leyole Claudine Ancilla, Bala Sundaram, Nabadwip Pathak et al.. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. Journal of Nephropharmacology. 2024;13(2):1-5$$$$$Y$$$20240730$$HP$IN$IN
241501482$24150148$2$F$20240522$20240914$20240730$20240923$EXP$$CA-CELLTRION INC.-2024CA013687$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
241501491$24150149$1$I$$20240720$20240730$20240730$PER$$NVSC2024US150244$NOVARTIS$$$$$$Y$$$20240730$$CN$US$US
241501503$24150150$3$F$20100303$20240726$20240730$20240805$EXP$$JP-009507513-1003USA01443$MERCK$$73$YR$$F$Y$48$KG$20240805$$MD$JP$JP
241501512$24150151$2$F$$20240718$20240730$20240802$EXP$$CN-ROCHE-10000032057$ROCHE$$66$YR$E$M$Y$$$20240802$$CN$CN$CN
241501521$24150152$1$I$$20240717$20240730$20240730$EXP$$US-ROCHE-10000030396$ROCHE$$52$YR$A$M$Y$$$20240730$$MD$US$US
241501531$24150153$1$I$20240701$20240726$20240730$20240730$PER$$NVSC2024US155105$NOVARTIS$$59$YR$$M$Y$$$20240730$$HP$US$US
241501541$24150154$1$I$$20240726$20240730$20240730$PER$$NVSC2024US154707$NOVARTIS$$$$$F$Y$$$20240730$$HP$US$US
241501552$24150155$2$F$$20240718$20240730$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06863$LUPIN$$$$$$Y$$$20240818$$CN$US$US
241501562$24150156$2$F$20240722$20240730$20240730$20240802$EXP$$AU-TAKEDA-2024TUS075258$TAKEDA$$71$YR$$F$Y$$$20240802$$HP$AU$AU
241501571$24150157$1$I$$20240726$20240730$20240730$PER$$US-ABBVIE-5857024$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241501581$24150158$1$I$$20240725$20240730$20240730$PER$$US-ORGANON-O2407USA002531$ORGANON$$$$$F$Y$$$20240730$$CN$US$US
241501601$24150160$1$I$$20240726$20240730$20240730$PER$$US-HALEON-2189316$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241501612$24150161$2$F$20240710$20240731$20240730$20240806$EXP$$US-ROCHE-10000033562$ROCHE$$20$YR$A$M$Y$$$20240806$$CN$US$US
241501621$24150162$1$I$$20240717$20240730$20240730$EXP$$US-Appco Pharma LLC-2159755$APPCO PHARMA$Initial$44$YR$$M$Y$$$20240730$$$US$US
241501631$24150163$1$I$$20240716$20240730$20240730$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00619$Phathom Pharmaceuticals$$$$$M$Y$$$20240730$$PH$JP$JP
241501641$24150164$1$I$$20240716$20240730$20240730$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00613$Phathom Pharmaceuticals$$$$$$Y$$$20240730$$PH$JP$JP
241501651$24150165$1$I$$20240716$20240730$20240730$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00620$Phathom Pharmaceuticals$$$$$F$Y$$$20240730$$PH$JP$JP
241501661$24150166$1$I$20191001$20240716$20240730$20240730$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00628$Phathom Pharmaceuticals$Nishimura, Naoyuki, Mizuno, et al.. Gastroduodenal Intussusception Due to Vonoprazan-induced Gastric Polyps.. Internal medicine (Tokyo, Japan).$67$YR$$F$Y$78$KG$20240730$$HP$JP$JP
241501671$24150167$1$I$$20240729$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120141$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$113.4$KG$20240730$$CN$US$US
241501682$24150168$2$F$20240719$20240820$20240730$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119297$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$81.19$KG$20240828$$CN$US$US
241501691$24150169$1$I$20240711$20240722$20240730$20240730$EXP$$CN-AstraZeneca-2024A168923$ASTRAZENECA$$13904$DY$$F$Y$79.9$KG$20240730$$MD$CN$
241501701$24150170$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A166867$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241501711$24150171$1$I$$20240716$20240730$20240730$EXP$$CA-ROCHE-10000033291$ROCHE$$24$YR$A$F$Y$$$20240730$$CN$CA$CA
241501741$24150174$1$I$$20240722$20240730$20240730$EXP$$CA-TOLMAR, INC.-24CA051209$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
241501751$24150175$1$I$$20240722$20240730$20240730$EXP$$CA-TOLMAR, INC.-24CA051208$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
241501771$24150177$1$I$20240717$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017871$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240730$$CN$US$US
241501781$24150178$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017329$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240730$$CN$US$US
241501791$24150179$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017772$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240730$$CN$US$US
241501801$24150180$1$I$$20240723$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018121$ELI LILLY AND CO$$$$$$Y$$$20240730$$HP$US$US
241501811$24150181$1$I$$20240724$20240730$20240730$EXP$$JP-GSK-JP2024JPN085175$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$PH$JP$JP
241501821$24150182$1$I$$20240725$20240730$20240730$EXP$GB-MHRA-MED-202407251012454120-CJPMW$GB-AMAROX PHARMA-AMR2024GB02475$HETERO$$$$$M$Y$$$20240730$$CN$GB$GB
241501831$24150183$1$I$$20240613$20240730$20240730$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000261$Tarsus Pharmaceuticals$$86$YR$$F$Y$$$20240730$$PH$US$US
241501841$24150184$1$I$20240724$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148919$AMGEN$$68$YR$E$M$Y$$$20240730$$PH$US$US
241501852$24150185$2$F$$20240722$20240730$20240731$EXP$$US-AMGEN-USASP2024147854$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et. al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$77$YR$E$$Y$$$20240731$$HP$US$US
241501861$24150186$1$I$20240722$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148790$AMGEN$$77$YR$E$F$Y$$$20240730$$CN$US$US
241501871$24150187$1$I$$20240723$20240730$20240730$EXP$$US-ADC THERAPEUTICS SA-ADC-2024-000253$ADC THERAPEUTICS$$$$A$$Y$$$20240730$$MD$US$US
241501881$24150188$1$I$$20240720$20240730$20240730$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110098$ZYDUS PHARM$$$$$$Y$$$20240730$$CN$US$US
241501891$24150189$1$I$20230101$20240719$20240730$20240730$EXP$$US-RECORDATI-2023003861$RECORDATI$$$$$$Y$$$20240730$$CN$US$US
241501901$24150190$1$I$$20240725$20240730$20240730$EXP$$US-TAKEDA-2024TUS042089$TAKEDA$$$$$F$Y$$$20240730$$CN$US$US
241501911$24150191$1$I$$20240727$20240730$20240730$PER$$US-TAKEDA-2024TUS076161$TAKEDA$$$$$F$Y$$$20240730$$CN$US$US
241501922$24150192$2$F$20220916$20240915$20240730$20240924$EXP$$CA-CELLTRION INC.-2022CA017156$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
241501932$24150193$2$F$20240722$20240731$20240730$20240807$EXP$$US-TAKEDA-2024TUS051208$TAKEDA$$74$YR$$M$Y$$$20240807$$MD$US$US
241501942$24150194$2$F$20190101$20240808$20240730$20240812$EXP$$JP-JNJFOC-20240779346$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240812$$PH$JP$JP
241501951$24150195$1$I$20240629$20240722$20240730$20240730$EXP$HR-HALMED-300086139$HR-TEVA-VS-3224979$TEVA$$42$YR$$F$Y$$$20240730$$MD$HR$HR
241501961$24150196$1$I$$20240728$20240730$20240730$PER$$US-HALEON-2189443$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241501971$24150197$1$I$$20240723$20240730$20240730$EXP$US-MLMSERVICE-20240717-PI132085-00108-1$US-RDY-SPO/USA/24/0010969$DR REDDYS$Bayless SL, Walker NV, Scott MM, Leo RJ. Clozapine-Related Cecal Volvulus. The primary care companion for CNS disorders. 2024 Jul 11;26(4):24cr03729. DOI: 10.4088/PCC.24cr03729.$58$YR$A$F$Y$$$20240730$$MD$US$US
241501982$24150198$2$F$$20240821$20240730$20240827$EXP$$CA-TAKEDA-2024TUS075585$TAKEDA$$$$$M$Y$$$20240827$$MD$CA$CA
241502011$24150201$1$I$20240725$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148937$AMGEN$$49$YR$A$F$Y$$$20240730$$PH$US$US
241502021$24150202$1$I$20220805$20240118$20240730$20240730$EXP$$LV-OCTA-LIT03724$OCTAPHARMA$Konovalova A, Gerula N, Hartmane I, Upeniece I, Scerbuks M, Bernate K et al. Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia. Case Reports in Dermatology 2023; 15(1):182-9. DOI: 10.1159/000533987$69$YR$E$F$Y$$$20240704$$HP$EU$EU
241502031$24150203$1$I$$20240722$20240730$20240730$EXP$$IN-AMGEN-INDSP2024145722$AMGEN$Khurana K.; Mahajan S.; Acharya S. et al.. Bridging Immune Realms: A Striking Case Report on Autoimmune Thyroiditis Co-existing with Immune Thrombocytopenic Purpura Internal Medicine Section. Journal of Clinical and Diagnostic Research. 2024;18 (7):OD01-OD04$60$YR$A$F$Y$$$20240730$$MD$IN$IN
241502041$24150204$1$I$20240720$20240725$20240730$20240730$EXP$IT-MINISAL02-996637$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-119202$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240730$$MD$IT$IT
241502052$24150205$2$F$$20240820$20240730$20240829$EXP$$US-TAKEDA-2022TUS075134$TAKEDA$$$$$F$Y$69.39$KG$20240829$$HP$US$US
241502062$24150206$2$F$$20240730$20240730$20240731$PER$$US-JNJFOC-20240773111$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$MD$US$US
241502071$24150207$1$I$$20240723$20240730$20240730$EXP$$US-TAKEDA-2024TUS028327$TAKEDA$$$$$M$Y$$$20240730$$CN$US$US
241502082$24150208$2$F$$20240723$20240730$20240802$EXP$$NVSC2024DE153934$NOVARTIS$$33$YR$$F$Y$$$20240802$$MD$DE$DE
241502091$24150209$1$I$$20240711$20240730$20240730$PER$$US-APOTEX-2024AP008352$APOTEX$Warus J, Hidalgo MA, Belzer M, Olson-Kennedy J.. Acute HIV Diagnosis After Initiation of Pre-exposure Prophylaxis in a Young Adult Patient: A Case Report. Journal of Adolescent Health. 2024;74:205-207$18$YR$$M$Y$$$20240730$$MD$US$US
241502111$24150211$1$I$$20240723$20240730$20240730$EXP$$US-SA-2024SA219676$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240730$$HP$US$US
241502121$24150212$1$I$20240724$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149408$AMGEN$$61$YR$A$F$Y$$$20240730$$CN$US$US
241502151$24150215$1$I$20240722$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149776$AMGEN$$82$YR$E$F$Y$$$20240730$$CN$US$US
241502161$24150216$1$I$20210701$20240717$20240730$20240730$EXP$$CH-Appco Pharma LLC-2159756$APPCO PHARMA$Initial$52$YR$$F$Y$$$20240730$$$CH$CH
241502173$24150217$3$F$20240723$20240913$20240730$20240917$EXP$$JP-Taiho Oncology Inc-2024-007196$TAIHO ONCOLOGY INC$$8$DEC$E$$Y$$$20240917$$PH$JP$JP
241502181$24150218$1$I$$20240722$20240730$20240730$EXP$$GB-CELLTRION INC.-2024GB018002$CELLTRION$$$$$$Y$$$20240730$$CN$GB$GB
241502192$24150219$2$F$$20240801$20240730$20240810$EXP$$CA-TEVA-VS-3224387$TEVA$Wilken BF, Moran-Mendoza O, Pourafkari M, Asai Y. Drug-induced interstitial lung disease associated with dupilumab for the treatment of atopic dermatitis. JAAD-Case-Rep 2024; 50 (0): 12-15.; Wilken BF, Moran-Mendoza O, Pourafkari M, Asai Y. Drug-induced interstitial lung disease associated with dupilumab for the treatment of atopic dermatitis. JAAD-Case-Rep 2024; 50 (0): 12-15.$75$YR$$F$Y$$$20240810$$HP$CA$CA
241502201$24150220$1$I$20240722$20240722$20240730$20240730$PER$$US-BAUSCHBL-2024BNL030478$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240730$$CN$US$US
241502211$24150221$1$I$20240701$20240719$20240730$20240730$PER$$US-BAUSCHBL-2024BNL030429$BAUSCH AND LOMB$$$$$M$Y$$$20240730$$CN$US$US
241502221$24150222$1$I$20240722$20240722$20240730$20240730$PER$$US-BAUSCHBL-2024BNL030501$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240730$$CN$US$US
241502241$24150224$1$I$20240724$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148754$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241502252$24150225$2$F$$20240730$20240730$20240808$PER$$US-MSNLABS-2024MSNSPO01622$MSN LABORATORIES$$$$$$Y$$$20240808$$CN$US$US
241502261$24150226$1$I$20231001$20240725$20240730$20240730$EXP$$US-TAKEDA-2023TUS104215$TAKEDA$$66$YR$$M$Y$$$20240730$$CN$US$US
241502273$24150227$3$F$20240701$20240820$20240730$20240824$PER$$US-AMGEN-USASP2024149854$AMGEN$$74$YR$$F$Y$$$20240824$$CN$US$US
241502281$24150228$1$I$20240501$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017713$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240730$$CN$US$US
241502291$24150229$1$I$20240725$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017804$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240730$$CN$US$US
241502301$24150230$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017893$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240730$$CN$US$US
241502311$24150231$1$I$20231201$20240723$20240730$20240730$EXP$$US-JNJFOC-20240768073$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240730$$HP$US$US
241502321$24150232$1$I$20240601$20240723$20240730$20240730$EXP$$US-GSK-US2024092362$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$MD$US$US
241502331$24150233$1$I$$20240724$20240730$20240730$PER$$US-ROCHE-10000036820$ROCHE$$$$A$F$Y$$$20240730$$CN$US$US
241502341$24150234$1$I$20240708$20240729$20240730$20240730$EXP$FR-AFSSAPS-MA2024001251$FR-JNJFOC-20240778871$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240730$$MD$FR$FR
241502351$24150235$1$I$20240630$20240722$20240730$20240730$EXP$HR-HALMED-300086130$HR-TEVA-VS-3225166$TEVA$$$$T$F$Y$$$20240730$$MD$HR$HR
241502371$24150237$1$I$$20240722$20240730$20240730$EXP$$US-MSNLABS-2024MSNLIT01647$MSN LABORATORIES$Osei KM, Wuni G, Mehta N, Gupta SK.Comparative Analysis of Right Ventricular (RV) Apical Pacing versus Physiologic Left Bundle Branch Area Pacing (LBBAP) in Hypertrophic Cardiomyopathy With Left Ventricular Outflow Tract Obstruction (LVOTO): A Case Study.Circulation.06-NOV-2023;148 (1):18100$$$$$Y$$$20240730$$HP$US$US
241502411$24150241$1$I$$20210624$20240730$20240730$EXP$$US-AstraZeneca-2021A569975$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241502421$24150242$1$I$$20221114$20240730$20240730$EXP$$US-AstraZeneca-2022A376941$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241502431$24150243$1$I$20210706$20210722$20240730$20240730$EXP$$US-AstraZeneca-2021A643515$ASTRAZENECA$$19948$DY$$F$Y$111.1$KG$20240730$$CN$US$
241502441$24150244$1$I$$20220106$20240730$20240730$EXP$$US-AstraZeneca-2022A011334$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241502451$24150245$1$I$$20230913$20240730$20240730$EXP$$US-AstraZeneca-2023A212190$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241502461$24150246$1$I$20210623$20240724$20240730$20240730$EXP$$JP-GILEAD-2022-0604350$GILEAD$$$$A$M$Y$$$20240730$$MD$JP$JP
241502471$24150247$1$I$$20210622$20240730$20240730$EXP$$US-AstraZeneca-2021A553677$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241502481$24150248$1$I$20240716$20240725$20240730$20240730$EXP$$CN-JNJFOC-20240769186$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$MD$CN$CN
241502491$24150249$1$I$$20240722$20240730$20240730$EXP$$US-GSK-US2024091879$GLAXOSMITHKLINE$$$$$M$Y$$$20240730$$CN$US$US
241502501$24150250$1$I$20240725$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148797$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241502511$24150251$1$I$20240501$20240718$20240730$20240730$EXP$FR-AFSSAPS-RN2024000770$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06901$HIKMA$$80$YR$$M$Y$$$20240730$$MD$FR$FR
241502521$24150252$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149718$AMGEN$$$$$M$Y$$$20240730$$CN$US$US
241502532$24150253$2$F$$20240804$20240730$20240808$EXP$$SA-EMD Serono-2024039865$EMD SERONO INC$$15$YR$T$F$Y$$$20240809$$CN$SA$SA
241502541$24150254$1$I$$20240725$20240730$20240730$PER$$US-AstraZeneca-2024A171628$ASTRAZENECA$$$$$$Y$$$20240730$$MD$US$
241502552$24150255$2$F$20240701$20240724$20240730$20240806$EXP$$NVSC2024DE153989$NOVARTIS$$$$A$M$Y$$$20240806$$MD$DE$DE
241502561$24150256$1$I$20240716$20240729$20240730$20240730$EXP$$US-TAKEDA-2024TUS016880$TAKEDA$$89$YR$$F$Y$$$20240730$$CN$US$US
241502571$24150257$1$I$$20240724$20240730$20240730$PER$$US-JNJFOC-20240771754$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$CN$US$US
241502581$24150258$1$I$20240601$20240719$20240730$20240730$PER$$US-MSNLABS-2024MSNSPO01650$MSN LABORATORIES$$$$$$Y$$$20240730$$CN$US$US
241502591$24150259$1$I$$20240717$20240730$20240730$EXP$$AU-Appco Pharma LLC-2159757$APPCO PHARMA$Initial$71$YR$$F$Y$$$20240730$$$AU$AU
241502601$24150260$1$I$20240713$20240713$20240730$20240730$PER$$US-CSL-2024-006683$CSL Plasma$$38$YR$$F$Y$$$20240730$$HP$US$US
241502611$24150261$1$I$$20240721$20240730$20240730$EXP$$IT-IHL-000593$INVENTIA HEALTHCARE$$15$YR$T$F$Y$48$KG$20240724$$MD$IT$IT
241502621$24150262$1$I$$20240726$20240730$20240730$30DAY$$US-SANDOZ INC.-SDZ2024US068679$SANDOZ$$$$$F$Y$$$20240730$$CN$US$US
241502631$24150263$1$I$20240703$20240725$20240730$20240730$EXP$$ZA-EMD Serono-2024040666$EMD SERONO INC$$49$YR$A$F$Y$$$20240730$$CN$ZA$ZA
241502641$24150264$1$I$20240726$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149986$AMGEN$$74$YR$E$F$Y$$$20240730$$CN$US$US
241502651$24150265$1$I$$20240726$20240730$20240730$EXP$$US-ABBVIE-5857012$ABBVIE$$$$$M$Y$$$20240730$$HP$US$US
241502661$24150266$1$I$20240208$20240729$20240730$20240730$EXP$FR-AFSSAPS-AN2024000952$FR-SANDOZ INC.-SDZ2024FR068796$SANDOZ$$77$YR$$M$Y$82$KG$20240730$$PH$FR$FR
241502673$24150267$3$F$20240724$20240823$20240730$20240904$PER$$US-BEH-2024176392$CSL BEHRING$$52$YR$A$F$Y$$$20240904$$PH$US$US
241502681$24150268$1$I$20240626$20240729$20240730$20240730$EXP$NO-NOMAADVRE-RELISN-2024-Vqdzj7$NO-SANDOZ INC.-SDZ2024NO068802$SANDOZ$$61$YR$$F$Y$$$20240730$$PH$NO$NO
241502691$24150269$1$I$20240629$20240722$20240730$20240730$EXP$$SG-VANTIVE-2024VAN018466$Vantive US Healthcare$$41$YR$$M$Y$$$20240730$$CN$SG$SG
241502702$24150270$2$F$$20240715$20240730$20240812$EXP$$PT-TEVA-VS-3222921$TEVA$Literature Reference: Silva BC, Flores MA, Domingos GJ, Paulo S, Santos CM, Badura R. UMBILICATED INJURIES IN THE TIME OF MONKEYPOX. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024:1296.$25$YR$$F$Y$$$20240812$$MD$PT$PT
241502711$24150271$1$I$$20240722$20240730$20240730$EXP$$DE-SANDOZ INC.-SDZ2024DE068664$SANDOZ$Satirer, Ozlem, Henes, Joerg C, Doring, Michaela, Lesk, Till, Benseler, Susanne, Kuemmerle-Deschner, Jasmin Beate. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD Open$$$$M$Y$$$20240730$$HP$DE$DE
241502721$24150272$1$I$$20240725$20240730$20240730$EXP$$CA-ABBVIE-5856234$ABBVIE$$$$A$M$Y$$$20240730$$PH$CA$CA
241502732$24150273$2$F$$20240802$20240730$20240807$PER$$US-AMGEN-USASP2024145680$AMGEN$$91$YR$E$F$Y$$$20240807$$CN$US$US
241502741$24150274$1$I$20230701$20240725$20240730$20240730$EXP$FR-AFSSAPS-LY2023001879$FR-GSK-FR2024093838$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$FR$FR
241502751$24150275$1$I$$20240723$20240730$20240730$PER$$US-JNJFOC-20240764142$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$CN$US$US
241502761$24150276$1$I$20240708$20240723$20240730$20240730$EXP$$CN-SANDOZ INC.-SDZ2024CN068871$SANDOZ$$32$YR$$M$Y$56$KG$20240730$$HP$CN$CN
241502771$24150277$1$I$20240724$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148930$AMGEN$$75$YR$E$F$Y$$$20240730$$CN$US$US
241502783$24150278$3$F$$20240816$20240730$20240822$PER$$US-AMGEN-USASP2024147143$AMGEN$$73$YR$E$F$Y$$$20240822$$CN$US$US
241502791$24150279$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149794$AMGEN$$$$$F$Y$$$20240730$$PH$US$US
241502803$24150280$3$F$20240717$20240801$20240730$20240808$30DAY$$US-AMGEN-USASP2024145548$AMGEN$$36$YR$A$F$Y$56$KG$20240807$$PH$US$US
241502811$24150281$1$I$20201001$20240726$20240730$20240730$PER$$US-ABBVIE-5856967$ABBVIE$$37$YR$$F$Y$72.574$KG$20240730$$CN$US$US
241502821$24150282$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189492$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241502832$24150283$2$F$$20240801$20240730$20240810$EXP$$CH-TEVA-VS-3223397$TEVA$Amandine D, Luiza De Bortolli N, Cecilia N, Jessica L, Mary K, Emmanuelle R, et al. Hypokalemic paralysis a side-effect of short action beta2-agonist. Swiss-Med-Wkly 2024; 154 (Suppl.) 35S.; Amandine D, Luiza De Bortolli N, Cecilia N, Jessica L, Mary K, Emmanuelle R, et al. Hypokalemic paralysis a side-effect of short action beta2-agonist. Swiss-Med-Wkly 2024; 154 (Suppl.) 35S.$6$YR$$F$Y$$$20240810$$HP$CH$CH
241502841$24150284$1$I$$20240724$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118307$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240730$$CN$US$US
241502853$24150285$3$F$20240720$20240905$20240730$20240908$EXP$$CA-ROCHE-10000035408$ROCHE$$39$YR$A$F$Y$$$20240908$$CN$CA$CA
241502862$24150286$2$F$20240728$20240812$20240730$20240814$EXP$$SA-SANDOZ INC.-SDZ2024SA068770$SANDOZ$$49$YR$$F$Y$$$20240814$$CN$SA$SA
241502871$24150287$1$I$$20240723$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017550$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241502881$24150288$1$I$20240724$20240724$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016353$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240730$$CN$US$US
241502891$24150289$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017854$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240730$$CN$US$US
241502901$24150290$1$I$$20240728$20240730$20240730$PER$$US-HALEON-2189489$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241502911$24150291$1$I$20240718$20240722$20240730$20240730$EXP$$JP-VANTIVE-2024VAN018549$Vantive US Healthcare$$$$$M$Y$$$20240730$$HP$JP$JP
241502922$24150292$2$F$$20240722$20240730$20240731$EXP$$FR-Stemline Therapeutics, Inc.-2024ST004461$STEMLINE THERAPEUTICS$$$$$F$Y$$$20240729$$MD$FR$FR
241502931$24150293$1$I$$20240725$20240730$20240730$30DAY$$US-SANDOZ INC.-SDZ2024US068503$SANDOZ$$$$$F$Y$$$20240730$$CN$US$US
241502941$24150294$1$I$$20240726$20240730$20240730$30DAY$$US-SANDOZ INC.-SDZ2024US068633$SANDOZ$$$$$M$Y$$$20240730$$CN$US$US
241502951$24150295$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155176$NOVARTIS$$$$$$Y$$$20240730$$HP$US$US
241502961$24150296$1$I$20240614$20240722$20240730$20240730$PER$$US-BIOGEN-2024BI01274841$BIOGEN$$57$YR$$M$Y$$$20240730$$CN$US$US
241502971$24150297$1$I$20240614$20240729$20240730$20240730$EXP$FR-AFSSAPS-NC2024000893$FR-SANDOZ INC.-SDZ2024FR068829$SANDOZ$$69$YR$$M$Y$60$KG$20240730$$MD$FR$FR
241502991$24150299$1$I$$20240702$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06886$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241503001$24150300$1$I$20240718$20240719$20240730$20240730$EXP$$US-Sprout Pharmaceuticals, Inc.-2024SP000225$SPROUT PHARMACEUTICALS$$32$YR$A$F$Y$$$20240726$$CN$US$US
241503011$24150301$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A166553$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241503021$24150302$1$I$$20240718$20240730$20240730$EXP$$US-Stemline Therapeutics, Inc.-2024ST004402$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240725$$CN$US$US
241503031$24150303$1$I$20240601$20240723$20240730$20240730$EXP$SE-SEMPA-2024-005422$SE-EMD Serono-2024039915$EMD SERONO INC$$73$YR$E$M$Y$$$20240730$$MD$SE$SE
241503042$24150304$2$F$$20240813$20240730$20240816$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-002348$JAZZ$$$$$F$Y$$$20240816$$CN$US$US
241503051$24150305$1$I$$20240722$20240730$20240730$EXP$$US-Stemline Therapeutics, Inc.-2024ST004462$STEMLINE THERAPEUTICS$$65$YR$E$F$Y$$$20240726$$CN$US$US
241503061$24150306$1$I$$20240722$20240730$20240730$EXP$$US-Stemline Therapeutics, Inc.-2024ST004451$STEMLINE THERAPEUTICS$$76$YR$E$F$Y$$$20240725$$CN$US$US
241503072$24150307$2$F$$20240806$20240730$20240808$EXP$$US-KYOWAKIRIN-2024KK018046$KYOWA$$$$$$Y$$$20240808$$CN$US$US
241503081$24150308$1$I$$20240729$20240730$20240730$PER$$US-ROCHE-10000041335$ROCHE$$$$I$M$Y$$$20240730$$CN$US$US
241503101$24150310$1$I$$20240703$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06851$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241503112$24150311$2$F$20240726$20240726$20240730$20240802$PER$$US-AMGEN-USASP2024149771$AMGEN$$74$YR$E$F$Y$$$20240802$$CN$US$US
241503121$24150312$1$I$20220601$20240702$20240730$20240730$PER$$US-JNJFOC-20240707963$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240730$$CN$US$US
241503141$24150314$1$I$20240301$20240719$20240730$20240730$PER$$US-Kiniksa Pharmaceuticals Ltd.-2024KPU001203$KINIKSA PHARMACEUTICALS$$30$YR$A$F$Y$$$20240725$$CN$US$US
241503152$24150315$2$F$$20240722$20240730$20240820$PER$$US-BIOGEN-2024BI01275250$BIOGEN$$$$A$$Y$$$20240820$$MD$US$US
241503162$24150316$2$F$20230526$20240812$20240730$20240822$EXP$$US-Rhythm Pharmaceuticals, Inc.-2023RHM000224$RHYTHM PHARMACEUTICALS$$10$YR$C$M$Y$$$20240821$$CN$US$US
241503191$24150319$1$I$20240724$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148750$AMGEN$$28$YR$A$F$Y$$$20240730$$CN$US$US
241503201$24150320$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-10000040862$ROCHE$$58$YR$A$F$Y$135$KG$20240730$$CN$US$US
241503212$24150321$2$F$$20240730$20240730$20240805$EXP$$CA-AMGEN-CANSP2024147661$AMGEN$Franco D.C.; Neupane N.C.; Riaza M. et al.. Chronic Inflammatory Demyelinating Polyradiculoneuropathy Association With Low Cholesterol Levels: A Case Report in a Patient Taking PCSK9 Inhibitor. J Neurol Res. 2019;9 (4-5):72-74$57$YR$A$F$Y$$$20240805$$HP$US$CA
241503221$24150322$1$I$$20240722$20240730$20240730$EXP$$US-AMGEN-USASP2024145969$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241503231$24150323$1$I$$20240715$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075364$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240730$$CN$US$US
241503241$24150324$1$I$$20240723$20240730$20240730$PER$$US-ALXN-202407USA001587US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241503253$24150325$3$F$$20240916$20240730$20240918$PER$$US-BIOVITRUM-2024-US-010277$BIOVITRUM$$66$YR$$M$Y$$$20240918$$CN$US$US
241503261$24150326$1$I$20240101$20240723$20240730$20240730$PER$$US-ABBVIE-5854548$ABBVIE$$$$$$Y$$$20240730$$HP$US$US
241503272$24150327$2$F$$20240806$20240730$20240809$EXP$$US-TAKEDA-2022TUS030257$TAKEDA$$$$$F$Y$$$20240809$$MD$US$US
241503281$24150328$1$I$$20240716$20240730$20240730$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01177$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240730$$HP$US$US
241503292$24150329$2$F$20240101$20240903$20240730$20240911$EXP$$CA-CELLTRION INC.-2024CA018045$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
241503301$24150330$1$I$$20240723$20240730$20240730$EXP$$PK-BRISTOL-MYERS SQUIBB COMPANY-2024-118658$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$HP$PK$PK
241503311$24150331$1$I$$20240716$20240730$20240730$PER$$US-APOTEX-2024AP008539$APOTEX$$$$$F$Y$$$20240730$$HP$US$US
241503321$24150332$1$I$$20240703$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06774$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241503331$24150333$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189538$Haleon PLC$$27$YR$$M$Y$$$20240730$$CN$US$US
241503341$24150334$1$I$20230701$20240729$20240730$20240730$EXP$FR-AFSSAPS-NC2024000905$NVSC2024FR154730$NOVARTIS$$5$YR$$M$Y$$$20240730$$MD$FR$FR
241503351$24150335$1$I$$20240108$20240730$20240730$PER$$US-CIPLA LTD.-2024US00770$CIPLA$$$$$$Y$$$20240730$$CN$US$US
241503361$24150336$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-10000041295$ROCHE$$$$$$Y$$$20240730$$HP$US$US
241503371$24150337$1$I$20240722$20240724$20240730$20240730$EXP$$US-TAKEDA-2024TUS030406$TAKEDA$$78$YR$$F$Y$$$20240730$$CN$US$US
241503381$24150338$1$I$$20240222$20240730$20240730$PER$$US-CIPLA LTD.-2024US02311$CIPLA$$$$$$Y$$$20240730$$CN$US$US
241503392$24150339$2$F$$20240802$20240730$20240807$EXP$$JP-JNJFOC-20240778409$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240807$$PH$JP$JP
241503401$24150340$1$I$$20240712$20240730$20240730$EXP$$JP-ABBVIE-5858422$ABBVIE$$9$DEC$$M$Y$$$20240730$$PH$JP$JP
241503413$24150341$3$F$20240721$20240729$20240730$20240731$EXP$$CA-ROCHE-3212905$ROCHE$$39$YR$A$F$Y$$$20240731$$CN$CA$CA
241503421$24150342$1$I$20240428$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150118$AMGEN$$75$YR$E$M$Y$$$20240730$$CN$US$US
241503431$24150343$1$I$20210208$20240723$20240730$20240730$EXP$$US-AMGEN-USASP2024146549$AMGEN$$64$YR$A$M$Y$$$20240730$$CN$US$US
241503452$24150345$2$F$$20240919$20240730$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119289$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$70.76$KG$20240920$$CN$US$US
241503461$24150346$1$I$$20240728$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119708$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$69.4$KG$20240730$$CN$US$US
241503471$24150347$1$I$$20240724$20240730$20240730$EXP$$CA-APOTEX-2024AP008793$APOTEX$$35$YR$$F$Y$$$20240730$$HP$CA$CA
241503481$24150348$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A166789$ASTRAZENECA$$$$T$M$Y$36.3$KG$20240730$$HP$US$
241503491$24150349$1$I$$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A169777$ASTRAZENECA$$$$$$Y$$$20240730$$MD$US$
241503501$24150350$1$I$$20201216$20240730$20240730$EXP$$US-AstraZeneca-2020SF70178$ASTRAZENECA$$74$YR$$F$Y$$$20240730$$CN$US$
241503511$24150351$1$I$$20210325$20240730$20240730$EXP$$AU-AstraZeneca-2021A224653$ASTRAZENECA$$$$E$M$Y$$$20240730$$CN$AU$
241503521$24150352$1$I$20220201$20220315$20240730$20240730$EXP$$US-AstraZeneca-2022A115284$ASTRAZENECA$$950$MON$$M$Y$$$20240730$$CN$US$
241503531$24150353$1$I$20201118$20201214$20240730$20240730$EXP$$CA-AstraZeneca-2020SF52540$ASTRAZENECA$$26479$DY$$M$Y$$$20240730$$HP$CA$
241503541$24150354$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A166571$ASTRAZENECA$$$$$F$Y$68$KG$20240730$$CN$US$
241503551$24150355$1$I$$20230104$20240730$20240730$EXP$$US-AstraZeneca-2023A002667$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241503571$24150357$1$I$$20240724$20240730$20240730$EXP$$US-ABBVIE-5853888$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241503581$24150358$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018865$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240730$$CN$US$US
241503591$24150359$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017819$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240730$$CN$US$US
241503601$24150360$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018302$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240730$$CN$US$US
241503611$24150361$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017971$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240730$$CN$US$US
241503621$24150362$1$I$$20240722$20240730$20240730$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001495$BLUEPRINT MEDICINES$$$$$F$Y$$$20240730$$CN$US$US
241503642$24150364$2$F$20240101$20240804$20240730$20240810$EXP$$US-ABBVIE-5856056$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241503662$24150366$2$F$$20240731$20240730$20240806$EXP$$CA-TAKEDA-2024TUS050738$TAKEDA$$$$$M$Y$$$20240806$$HP$CA$CA
241503671$24150367$1$I$20240726$20240729$20240730$20240730$EXP$GB-MHRA-MED-202407291235368430-RQPNZ$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042624$BOEHRINGER INGELHEIM$$55$YR$A$F$Y$85$KG$20240730$$PH$GB$GB
241503681$24150368$1$I$20220101$20240725$20240730$20240730$EXP$$US-ABBVIE-5855719$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241503691$24150369$1$I$20240715$20240723$20240730$20240730$PER$$US-BIOGEN-2024BI01275180$BIOGEN$$19$YR$$M$Y$$$20240730$$CN$US$US
241503701$24150370$1$I$20240101$20240725$20240730$20240730$EXP$$US-ABBVIE-5857325$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241503721$24150372$1$I$$20240722$20240730$20240730$EXP$US-MLMSERVICE-20240715-PI133231-00232-1$US-RDY-SPO/USA/24/0010916$DR REDDYS$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy. Experimental and Clinical Transplantation. 2024;22(5):392-5. DOI: 10.6002/ect.2024.0029.$68$YR$E$F$Y$$$20240730$$MD$US$US
241503731$24150373$1$I$20240608$20240719$20240730$20240730$EXP$$IT-AUROBINDO-AUR-APL-2024-036778$AUROBINDO$$58$YR$$F$Y$$$20240730$$PH$IT$IT
241503742$24150374$2$F$20240601$20240730$20240730$20240806$EXP$$CA-JNJFOC-20240611132$JOHNSON AND JOHNSON$$43$YR$A$F$Y$53$KG$20240806$$HP$CA$CA
241503751$24150375$1$I$20240201$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036840$AUROBINDO$$77$YR$$M$Y$58$KG$20240730$$MD$FR$FR
241503762$24150376$2$F$20240501$20240810$20240730$20240820$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091300$VIIV$$39$YR$$M$Y$80$KG$20240820$$PH$US$US
241503782$24150378$2$F$$20240802$20240730$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119774$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$84.37$KG$20240806$$CN$US$US
241503791$24150379$1$I$$20240719$20240730$20240730$EXP$$PL-AUROBINDO-AUR-APL-2024-037006$AUROBINDO$$24$YR$$F$Y$76$KG$20240730$$MD$PL$PL
241503811$24150381$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149625$AMGEN$$55$YR$A$F$Y$$$20240730$$HP$US$US
241503821$24150382$1$I$20240601$20240721$20240730$20240730$EXP$$EG-TAKEDA-2024TUS074903$TAKEDA$$28$YR$$M$Y$$$20240730$$CN$EG$EG
241503831$24150383$1$I$$20240725$20240730$20240730$EXP$$CA-TAKEDA-2024TUS075392$TAKEDA$$$$$M$Y$$$20240730$$HP$CA$CA
241503841$24150384$1$I$20240709$20240719$20240730$20240730$EXP$$IT-AUROBINDO-AUR-APL-2024-036794$AUROBINDO$$14$YR$$F$Y$$$20240730$$PH$IT$IT
241503851$24150385$1$I$20201103$20240719$20240730$20240730$EXP$$PL-AUROBINDO-AUR-APL-2024-036724$AUROBINDO$$29$YR$$F$Y$75$KG$20240730$$MD$PL$PL
241503862$24150386$2$F$20240703$20240913$20240730$20240930$PER$$US-UniquePharma-US-2024UPLSPO00020$UNIQUE PHARMACEUTICALS$$27$YR$A$M$Y$150$KG$20240930$$CN$US$US
241503871$24150387$1$I$20240513$20240722$20240730$20240730$EXP$$JP-GSK-JP2024JPN094489$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$MD$JP$JP
241503931$24150393$1$I$$20240725$20240730$20240730$PER$$US-TAKEDA-2024TUS075700$TAKEDA$$31$YR$$F$Y$$$20240730$$HP$US$US
241503941$24150394$1$I$20240201$20240726$20240730$20240730$EXP$$US-ABBVIE-5856897$ABBVIE$$74$YR$$M$Y$$$20240730$$CN$US$US
241503952$24150395$2$F$20240701$20240827$20240730$20240902$EXP$$US-ABBVIE-5858599$ABBVIE$$71$YR$$F$Y$49.89$KG$20240902$$CN$US$US
241503961$24150396$1$I$$20240723$20240730$20240730$PER$$US-JNJFOC-20240761528$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$CN$US$US
241503971$24150397$1$I$$20240723$20240730$20240730$PER$$US-BIOGEN-2024BI01275219$BIOGEN$$$$$F$Y$$$20240730$$MD$US$US
241503981$24150398$1$I$20231121$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036828$AUROBINDO$$78$YR$$M$Y$100$KG$20240730$$MD$FR$FR
241503991$24150399$1$I$$20220114$20240730$20240730$EXP$$US-AstraZeneca-2022A025385$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241504001$24150400$1$I$$20230612$20240730$20240730$EXP$$US-AstraZeneca-2023A136782$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241504011$24150401$1$I$$20220705$20240730$20240730$EXP$$US-AstraZeneca-2022A246713$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241504021$24150402$1$I$20230317$20230501$20240730$20240730$EXP$$US-AstraZeneca-2023A102123$ASTRAZENECA$$23771$DY$$F$Y$$$20240730$$HP$US$
241504031$24150403$1$I$20240501$20240725$20240730$20240730$EXP$$US-ABBVIE-5854948$ABBVIE$$54$YR$$M$Y$$$20240730$$CN$US$US
241504041$24150404$1$I$20221001$20221123$20240730$20240730$EXP$$CA-AstraZeneca-2022A382964$ASTRAZENECA$$773$MON$$F$Y$$$20240730$$PH$CA$
241504053$24150405$3$F$$20240925$20240730$20240927$EXP$$CA-TAKEDA-2022TUS036060$TAKEDA$$$$$F$Y$$$20240927$$CN$CA$CA
241504061$24150406$1$I$$20240724$20240730$20240730$PER$$US-TAKEDA-2024TUS075254$TAKEDA$$$$$M$Y$$$20240730$$CN$US$US
241504072$24150407$2$F$20240105$20240724$20240730$20240803$EXP$$US-BAXTER-2024BAX021847$BAXTER$$$$$$Y$$$20240803$$HP$US$US
241504082$24150408$2$F$$20240731$20240730$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06846$LUPIN$$$$$$Y$$$20240818$$CN$US$US
241504091$24150409$1$I$20230317$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036730$AUROBINDO$$46$YR$$F$Y$$$20240730$$MD$FR$FR
241504101$24150410$1$I$20201113$20210618$20240730$20240730$EXP$$US-AstraZeneca-2021A350266$ASTRAZENECA$$24488$DY$$M$Y$50.8$KG$20240730$$MD$US$
241504112$24150411$2$F$$20240725$20240730$20240801$EXP$$NVSC2023GB173792$NOVARTIS$$$$$F$Y$$$20240801$$CN$GB$GB
241504121$24150412$1$I$20240702$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036821$AUROBINDO$$79$YR$$F$Y$71$KG$20240730$$MD$FR$FR
241504131$24150413$1$I$$20240719$20240730$20240730$PER$$US-MTPC-MTDA2024-0014288$UNKNOWN$$$$A$M$Y$$$20240730$$CN$US$US
241504141$24150414$1$I$20230913$20240722$20240730$20240730$PER$FR-AFSSAPS-MA2024001064$FR-Eisai-EC-2024-170631$EISAI$$80$YR$E$F$Y$71$KG$20240730$$PH$FR$FR
241504153$24150415$3$F$20240610$20240730$20240730$20240815$PER$$US-TRAVERE-2024TVT00604$TRAVERE THERAPEUTICS$$29$YR$A$F$Y$$$20240815$$CN$US$US
241504161$24150416$1$I$$20240613$20240730$20240730$PER$$US-TRAVERE-2024TVT00605$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240730$$CN$US$US
241504171$24150417$1$I$$20240719$20240730$20240730$EXP$$LT-AUROBINDO-AUR-APL-2024-036854$AUROBINDO$Ruzelyte I, Vilkas V.. The association between malignant neoplastic process and atypical psychotic disorder: a clinical case study.. Biol Psychiatry Psychopharmacol.. 2024;26 (1):14-17$53$YR$$M$Y$$$20240730$$HP$LT$LT
241504182$24150418$2$F$20240501$20240808$20240730$20240809$EXP$$US-UCBSA-2023044458$UCB$$70$YR$$M$Y$136$KG$20240809$$CN$US$US
241504191$24150419$1$I$$20240719$20240730$20240730$EXP$$US-AUROBINDO-AUR-APL-2024-036110$AUROBINDO$Alsabbagh Alchirazi K, Bhavsar-Burke I, Syed H, Alkhayyat M, Bass S, Kapoor A, et al.. Molecular Adsorbent Recirculating System in Acute Liver Failure. ACG case reports journal. 2024;11(7):e01389$44$YR$$M$Y$$$20240730$$MD$US$US
241504201$24150420$1$I$$20240715$20240730$20240730$EXP$$CH-TEVA-VS-3223481$TEVA$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. UNHAPPY HEARTS WITH THE ANTIDEPRESSANT VENLAFAXINE. Swiss-Med-Wkly 2024; 154 (Suppl.) (6): 63S-64S (plus Poster) abstr. P27.$51$YR$$F$Y$$$20240730$$HP$CH$CH
241504211$24150421$1$I$20240702$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036726$AUROBINDO$$42$YR$$M$Y$110$KG$20240730$$MD$FR$FR
241504221$24150422$1$I$$20240723$20240730$20240730$PER$$US-BIOGEN-2024BI01275197$BIOGEN$$$$$M$Y$$$20240730$$HP$US$US
241504231$24150423$1$I$20240705$20240716$20240730$20240730$EXP$DE-BFARM-24004893$DE-ORGANON-O2407DEU001683$ORGANON$$39$YR$$F$Y$$$20240730$$MD$DE$DE
241504242$24150424$2$F$$20240826$20240730$20240829$PER$$US-BIOGEN-2024BI01275725$BIOGEN$$$$$F$Y$$$20240829$$PH$US$US
241504251$24150425$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119953$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$PH$US$US
241504261$24150426$1$I$20240605$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036793$AUROBINDO$$70$YR$$M$Y$63$KG$20240730$$HP$FR$FR
241504271$24150427$1$I$$20240702$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06885$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241504281$24150428$1$I$$20240719$20240730$20240730$EXP$$US-ROCHE-10000033790$ROCHE$$$$$M$Y$$$20240730$$CN$US$US
241504292$24150429$2$F$$20240806$20240730$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407018597$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240807$$HP$US$US
241504301$24150430$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017629$ELI LILLY AND CO$$$$$F$Y$$$20240730$$HP$US$US
241504311$24150431$1$I$20240701$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017990$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240730$$CN$US$US
241504321$24150432$1$I$20240705$20240719$20240730$20240730$EXP$$PT-AUROBINDO-AUR-APL-2024-037007$AUROBINDO$$41$YR$$M$Y$$$20240730$$MD$PT$PT
241504332$24150433$2$F$$20240805$20240730$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407017799$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240807$$CN$US$US
241504341$24150434$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018640$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240730$$CN$US$US
241504351$24150435$1$I$20240725$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018062$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240730$$CN$US$US
241504362$24150436$2$F$$20240726$20240730$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018124$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240731$$CN$US$US
241504371$24150437$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018097$ELI LILLY AND CO$$70$YR$E$$Y$$$20240730$$CN$US$US
241504381$24150438$1$I$20240711$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148595$AMGEN$$69$YR$E$F$Y$$$20240730$$CN$US$US
241504394$24150439$4$F$20240724$20240807$20240730$20240809$EXP$$GB-SANDOZ INC.-NVSC2021GB107836$SANDOZ$$$$A$F$Y$$$20240809$$CN$GB$GB
241504401$24150440$1$I$$20240719$20240730$20240730$EXP$$US-AUROBINDO-AUR-APL-2024-036121$AUROBINDO$Sorabella RA, Gray WH,  Dabal RJ,  Padilla LA, Hock K, Clark MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70(7):e92-6$17$YR$$M$Y$85$KG$20240730$$MD$US$US
241504411$24150441$1$I$20240721$20240726$20240730$20240730$EXP$$JP-GILEAD-2024-0682030$GILEAD$$84$YR$E$M$Y$$$20240730$$PH$JP$JP
241504421$24150442$1$I$$20240723$20240730$20240730$EXP$$CA-PUMA BIOTECHNOLOGY, LTD.-2024-PUM-CA001040$PUMA$$$$$$Y$$$20240730$$HP$CA$CA
241504431$24150443$1$I$20240401$20240718$20240730$20240730$EXP$$CN-ROCHE-10000033181$ROCHE$$59$YR$A$M$Y$$$20240730$$MD$CN$CN
241504441$24150444$1$I$$20240722$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US068925$SANDOZ$$$$$$Y$$$20240730$$PH$US$US
241504451$24150445$1$I$$20240729$20240730$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA068979$SANDOZ$$12$YR$$F$Y$$$20240730$$HP$CA$CA
241504461$24150446$1$I$$20240722$20240730$20240730$EXP$$DE-SANDOZ INC.-SDZ2024DE068001$SANDOZ$Satirer, Ozlem, Henes, Joerg C, Doring, Michaela, Lesk, Till, Benseler, Susanne, Kuemmerle-Deschner, Jasmin Beate. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD Open. 2024;10:e004381:1-10$29$YR$$F$Y$$$20240730$$HP$DE$DE
241504471$24150447$1$I$$20240725$20240730$20240730$EXP$$CA-SANDOZ INC.-SDZ2023CA052288$SANDOZ$$$$$F$Y$$$20240730$$CN$CA$CA
241504481$24150448$1$I$$20240719$20240730$20240730$EXP$$GB-AUROBINDO-AUR-APL-2024-036397$AUROBINDO$$$$$M$Y$$$20240730$$HP$GB$GB
241504491$24150449$1$I$20230728$20240716$20240730$20240730$EXP$IT-MINISAL02-994394$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06817$HIKMA$$68$YR$$F$Y$$$20240730$$MD$IT$IT
241504501$24150450$1$I$$20240725$20240730$20240730$PER$$US-GILEAD-2024-0681962$GILEAD$$$$$M$Y$$$20240730$$HP$US$US
241504511$24150451$1$I$20240710$20240719$20240730$20240730$EXP$$GB-AUROBINDO-AUR-APL-2024-036398$AUROBINDO$$39$YR$$F$Y$111$KG$20240730$$MD$GB$GB
241504523$24150452$3$F$$20240913$20240730$20240918$PER$$NVSC2024US154619$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
241504532$24150453$2$F$$20240904$20240730$20240906$EXP$$CA-SANDOZ INC.-SDZ2024CA068811$SANDOZ$$76$YR$$F$Y$$$20240906$$CN$CA$CA
241504541$24150454$1$I$$20240724$20240730$20240730$EXP$$AU-GSK-AU2024APC093224$GLAXOSMITHKLINE$Kamsani SH, Middeldorp ME, Chiang G, Stefil M, Evans S, Nguyen MT, et al. Safety of outpatient commencement of sotalol. Heart rhythm O2. 2024;5:6:341-350$$$$$Y$$$20240730$$MD$AU$AU
241504551$24150455$1$I$20191105$20240724$20240730$20240730$EXP$$CO-UCBSA-2024038137$UCB$$62$YR$$F$Y$$$20240730$$CN$CO$CO
241504562$24150456$2$F$$20240725$20240730$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA068392$SANDOZ$$38$YR$$F$Y$54$KG$20240731$$HP$CA$CA
241504571$24150457$1$I$$20240716$20240730$20240730$EXP$$CA-RISINGPHARMA-CA-2024RISLIT00258$RISING PHARMACEUTICALS$Stephen A. Hoption Cann.Acetaminophen as a cause of  ^^non-acetaminophen-related  acute liver failure^^.CMAJ.15-JUL-2024;196 (25):E883$18$YR$A$M$Y$$$20240730$$HP$CA$CA
241504581$24150458$1$I$20240701$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149378$AMGEN$$82$YR$E$F$Y$$$20240730$$CN$US$US
241504592$24150459$2$F$20240719$20240822$20240730$20240823$EXP$$US-TAKEDA-2024TUS074350$TAKEDA$$54$YR$$M$Y$$$20240823$$MD$US$US
241504601$24150460$1$I$20240713$20240713$20240730$20240730$PER$$US-CSL-2024-006757$CSL Plasma$$20$YR$$F$Y$$$20240730$$HP$US$US
241504611$24150461$1$I$20230517$20240719$20240730$20240730$EXP$$IT-AUROBINDO-AUR-APL-2024-036777$AUROBINDO$$91$YR$$M$Y$$$20240730$$MD$IT$IT
241504621$24150462$1$I$$20240722$20240730$20240730$EXP$NL-LRB-00981350$NL-TEVA-VS-3224959$TEVA$$13$YR$$M$Y$47$KG$20240730$$PH$NL$NL
241504631$24150463$1$I$$20240124$20240730$20240730$PER$$US-STRIDES ARCOLAB LIMITED-2024SP001022$STRIDES$$$$$M$Y$$$20240730$$CN$US$US
241504641$24150464$1$I$$20240209$20240730$20240730$PER$$US-STRIDES ARCOLAB LIMITED-2024SP001924$STRIDES$Bikk A, Chaudhari J, Navaran P, Johnson L, Pandit V.. Methamphetamine spasm in the large caliber arteries-the severity is likely underestimated.. J-Vasc-Surg-Cases-Innov-Tech. 2024;10 (1):1-5$60$YR$$M$Y$$$20240730$$MD$US$US
241504651$24150465$1$I$$20240716$20240730$20240730$EXP$$JP-ALVOGEN-2024095144$ALVOGEN$Ishiyama Y, Inakawa T, Yoshino M, Nishimura K, Horiuchi T, Ishihara H, Toki D, Kondo T. Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience. Anticancer Research. 2024;44:3213-3220. doi:10.21873/anticanres.17137$68$YR$$F$Y$$$20240730$$HP$JP$JP
241504662$24150466$2$F$$20240801$20240730$20240810$EXP$$US-TEVA-VS-3223187$TEVA$Rodriguez C, Yosry N, Qaiser S, Luzuriaga A, Adelizzi A. BRASH: A Deadly Acronym. Am-J-Respir-Crit-Care-Med 2024; 209.; Rodriguez C, Yosry N, Qaiser S, Luzuriaga A, Adelizzi A. BRASH: A Deadly Acronym. Am-J-Respir-Crit-Care-Med 2024; 209.$84$YR$$F$Y$$$20240810$$HP$US$US
241504672$24150467$2$F$20240510$20240729$20240730$20240731$PER$$US-ROCHE-10000040100$ROCHE$$$$$F$Y$$$20240731$$CN$US$US
241504681$24150468$1$I$$20240722$20240730$20240730$EXP$$IL-AstraZeneca-2024A169943$ASTRAZENECA$$30$YR$$F$Y$$$20240730$$MD$IL$
241504691$24150469$1$I$20240726$20240726$20240730$20240730$EXP$$US-TAKEDA-2024TUS076092$TAKEDA$$64$YR$$F$Y$$$20240730$$HP$US$US
241504701$24150470$1$I$$20201021$20240730$20240730$EXP$$US-AstraZeneca-2020SF38892$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241504711$24150471$1$I$20240101$20240726$20240730$20240730$EXP$$CN-BEIGENE-BGN-2024-011619$BEIGENE$$$$$$Y$$$20240730$$HP$CN$CN
241504721$24150472$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A167276$ASTRAZENECA$$$$$F$Y$$$20240730$$MD$US$
241504731$24150473$1$I$$20240722$20240730$20240730$EXP$$ZA-AstraZeneca-2024A166597$ASTRAZENECA$$75$YR$$F$Y$$$20240730$$CN$ZA$
241504741$24150474$1$I$20240701$20240724$20240730$20240730$EXP$$CO-ABBVIE-5858483$ABBVIE$$70$YR$$M$Y$77$KG$20240730$$HP$CO$CO
241504751$24150475$1$I$20240701$20240729$20240730$20240730$EXP$FR-AFSSAPS-AN2024000979$FR-UCBSA-2024038048$UCB$$41$YR$$M$Y$$$20240730$$MD$FR$FR
241504761$24150476$1$I$$20240729$20240730$20240730$PER$$US-ROCHE-10000041334$ROCHE$$$$A$$Y$$$20240730$$CN$US$US
241504771$24150477$1$I$$20231016$20240730$20240730$EXP$$US-AstraZeneca-2023A239657$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241504781$24150478$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189547$Haleon PLC$$21$YR$$F$Y$$$20240730$$CN$US$US
241504791$24150479$1$I$$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024147827$AMGEN$$$$$$Y$$$20240730$$HP$US$US
241504802$24150480$2$F$20240401$20240819$20240730$20240822$EXP$$US-ABBVIE-5823975$ABBVIE$$66$YR$$F$Y$$$20240822$$CN$US$US
241504813$24150481$3$F$20200101$20240815$20240730$20240822$EXP$$US-ABBVIE-5853822$ABBVIE$$$$$F$Y$73$KG$20240822$$CN$US$US
241504821$24150482$1$I$20240625$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036710$AUROBINDO$$83$YR$$M$Y$60$KG$20240730$$MD$FR$FR
241504833$24150483$3$F$20231214$20240814$20240730$20240827$EXP$$FR-AUROBINDO-AUR-APL-2024-036721$AUROBINDO$$47$YR$$M$Y$60.3$KG$20240827$$MD$FR$FR
241504851$24150485$1$I$$20240702$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06363$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241504861$24150486$1$I$$20240722$20240730$20240730$EXP$$US-TAKEDA-2024TUS074570$TAKEDA$$$$$F$Y$$$20240730$$MD$US$US
241504881$24150488$1$I$$20240716$20240730$20240730$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06867$HIKMA$Schneegurt NR, Wright C, Glenn N, Thethi I.. Schneegurt NR, Wright C, Glenn N, Thethi I. Flecainide-induced acute respiratory distress syndrome: A case report.. Cureus. 2024;16(6):e61637:1-5$74$YR$$M$Y$$$20240730$$MD$US$US
241504891$24150489$1$I$20240101$20240701$20240730$20240730$PER$$US-009507513-2407USA000671$MERCK$$$$$F$Y$58.5$KG$20240730$$CN$US$US
241504901$24150490$1$I$$20240719$20240730$20240730$EXP$$GB-AUROBINDO-AUR-APL-2024-036401$AUROBINDO$$5$YR$$M$Y$17$KG$20240730$$MD$GB$GB
241504911$24150491$1$I$$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036877$AUROBINDO$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N and al... Chemsex in France: a national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).. Toxicologie Analytique + Clinique. 2023;35:376-394$46$YR$$M$Y$$$20240730$$MD$FR$FR
241504921$24150492$1$I$20240722$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148335$AMGEN$$56$YR$A$$Y$$$20240730$$CN$US$US
241504931$24150493$1$I$20220807$20240723$20240730$20240730$EXP$$US-UCBSA-2024037345$UCB$$0$YR$$M$Y$$$20240730$$HP$US$US
241504941$24150494$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS074774$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241504951$24150495$1$I$$20240722$20240730$20240730$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005471$BIOCON$$$$$$Y$$$20240730$$MD$CA$CA
241504961$24150496$1$I$20240101$20240726$20240730$20240730$EXP$$US-ABBVIE-5857011$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241504972$24150497$2$F$20210809$20240819$20240730$20240821$EXP$$CA-ROCHE-2889801$ROCHE$$45$YR$A$M$Y$$$20240821$$CN$CA$CA
241504982$24150498$2$F$20240210$20240830$20240730$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-036716$AUROBINDO$$$$E$F$Y$$$20240910$$HP$DE$DE
241504991$24150499$1$I$20240101$20240715$20240730$20240730$EXP$FR-AFSSAPS-MP2024001146$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110021$ZYDUS PHARM$$$$$$Y$$$20240730$$MD$FR$FR
241505001$24150500$1$I$$20240717$20240730$20240730$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110143$ZYDUS PHARM$Nagi T, Barnes S, Weiss A. Rare Case of Endoscopically Diagnosed Ischemic Colitis Secondary to Chronic Phentermine Use. ACG-Case-Rep-J. 2024;11(6):e01363.$$$$$Y$$$20240730$$MD$US$US
241505011$24150501$1$I$$20240722$20240730$20240730$EXP$$US-JNJFOC-20240758468$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$CN$US$US
241505022$24150502$2$F$20240702$20240809$20240730$20240813$EXP$$CA-JNJFOC-20240732267$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240813$$CN$CA$CA
241505031$24150503$1$I$$20240722$20240730$20240730$EXP$$IT-JNJFOC-20240755184$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240730$$HP$IT$IT
241505041$24150504$1$I$$20240703$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06716$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241505054$24150505$4$F$20240509$20240913$20240730$20240918$EXP$$JP-JNJFOC-20240778292$JOHNSON AND JOHNSON$Asai H, Asai H, Asai H, Asai H. A case of IgA-lambda type multiple myeloma diagnosed with non-compensated renal failure requiring emergency dialysis.$67$YR$E$M$Y$87.8$KG$20240918$$MD$JP$JP
241505061$24150506$1$I$$20240719$20240730$20240730$EXP$$US-AUROBINDO-AUR-APL-2024-036115$AUROBINDO$Sorabella RA, Gray WH,  Dabal RJ,  Padilla LA, Hock K, Clark MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70(7):e92-6$14$YR$$F$Y$129$KG$20240730$$MD$US$US
241505071$24150507$1$I$20240409$20240719$20240730$20240730$EXP$IT-MINISAL02-983027$IT-SAMSUNG BIOEPIS-SB-2024-20767$SAMSUNG BIOEPIS$$$$$F$Y$$$20240730$$MD$IT$IT
241505081$24150508$1$I$20240729$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018859$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240730$$CN$US$US
241505091$24150509$1$I$20240701$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018549$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240730$$CN$US$US
241505102$24150510$2$F$20240625$20240910$20240730$20240925$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000462$BECTON DICKINSON$$$$$$Y$$$20240925$$CN$GB$GB
241505111$24150511$1$I$$20240724$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017695$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240730$$CN$US$US
241505121$24150512$1$I$$20240724$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016227$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240730$$CN$US$US
241505132$24150513$2$F$20240515$20240910$20240730$20240925$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000463$BECTON DICKINSON$$$$$$Y$$$20240925$$CN$GB$GB
241505141$24150514$1$I$20240709$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024147711$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241505151$24150515$1$I$20211105$20240719$20240730$20240730$EXP$$ES-AUROBINDO-AUR-APL-2024-036788$AUROBINDO$$62$YR$$F$Y$48$KG$20240730$$MD$ES$ES
241505161$24150516$1$I$$20240703$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06929$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241505171$24150517$1$I$$20240723$20240730$20240730$EXP$$CA-TAKEDA-2024TUS074983$TAKEDA$$$$$F$Y$$$20240730$$CN$CA$CA
241505191$24150519$1$I$$20240718$20240730$20240730$PER$$US-AstraZeneca-2024A168107$ASTRAZENECA$$75$YR$$F$Y$64.3$KG$20240730$$HP$US$
241505201$24150520$1$I$$20240723$20240730$20240730$PER$$US-JNJFOC-20240761539$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$MD$US$US
241505212$24150521$2$F$20240617$20240820$20240730$20240824$EXP$$CA-AstraZeneca-2024A171519$ASTRAZENECA$$25817$DY$$F$Y$$$20240823$$MD$CA$
241505222$24150522$2$F$20240725$20240725$20240730$20240802$PER$$US-AMGEN-USASP2024148469$AMGEN$$86$YR$E$F$Y$$$20240801$$CN$US$US
241505233$24150523$3$F$20240801$20240819$20240730$20240828$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001503$BLUEPRINT MEDICINES$$58$YR$A$F$Y$$$20240828$$CN$US$US
241505241$24150524$1$I$$20240722$20240730$20240730$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001499$BLUEPRINT MEDICINES$$$$$F$Y$$$20240730$$HP$US$US
241505251$24150525$1$I$$20240703$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06636$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241505261$24150526$1$I$$20240723$20240730$20240730$EXP$GB-MHRA-MED-202407230954383280-HWGYB$GB-ASPEN-GLO2024GB005092$ASPEN$$$$$$Y$$$20240730$$CN$GB$GB
241505272$24150527$2$F$20240517$20240722$20240730$20240821$PER$$US-ROCHE-10000033916$ROCHE$$68$YR$E$M$Y$$$20240821$$CN$US$US
241505282$24150528$2$F$$20240722$20240730$20240731$EXP$$US-AMGEN-USASP2024148237$AMGEN$Kamali A.; Khalaj K.; Jacobs M.A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$83$YR$E$$Y$$$20240731$$HP$US$US
241505292$24150529$2$F$20240605$20240724$20240730$20240803$EXP$$IT-AUROBINDO-AUR-APL-2024-036682$AUROBINDO$$79$YR$$F$Y$$$20240803$$MD$IT$IT
241505301$24150530$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS075376$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241505311$24150531$1$I$$20240724$20240730$20240730$EXP$$CA-TAKEDA-2024TUS075391$TAKEDA$$$$$M$Y$$$20240730$$CN$CA$CA
241505321$24150532$1$I$$20240726$20240730$20240730$EXP$$US-ABBVIE-5856911$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241505331$24150533$1$I$$20240726$20240730$20240730$EXP$$US-TAKEDA-2024TUS076086$TAKEDA$$$$$$Y$$$20240730$$CN$US$US
241505342$24150534$2$F$$20240727$20240730$20240808$EXP$$US-GSK-US2024AMR094554$GLAXOSMITHKLINE$$$$$M$Y$$$20240808$$HP$US$US
241505351$24150535$1$I$20240718$20240719$20240730$20240730$EXP$$GB-AUROBINDO-AUR-APL-2024-036556$AUROBINDO$$66$YR$$M$Y$$$20240730$$HP$GB$GB
241505371$24150537$1$I$20240727$20240729$20240730$20240730$PER$$US-HALEON-2189561$Haleon PLC$$29$YR$$M$Y$$$20240730$$CN$US$US
241505381$24150538$1$I$$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119392$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$CN$US$US
241505391$24150539$1$I$20240210$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119900$BRISTOL MYERS SQUIBB$$71$YR$E$$Y$$$20240730$$PH$US$US
241505401$24150540$1$I$20221201$20240722$20240730$20240730$EXP$$GR-BRISTOL-MYERS SQUIBB COMPANY-2024-117516$BRISTOL MYERS SQUIBB$Kandarakis SA, Doumazos L, Karageorgiou G, Petrou P, Doumazos S, Malamos P, et al. When uveitis and hypotony meets bilateral iris retraction syndrome: a rare but serious complication of nivolumab treatment. Case Reports in Ophthalmology. 2024 Jul 12;15(1):552-8. doi:10.1159/000539425.$58$YR$A$M$Y$$$20240730$$HP$GR$GR
241505411$24150541$1$I$20240712$20240725$20240730$20240730$PER$$US-009507513-2407USA014645$MERCK$$$$$F$Y$$$20240730$$CN$US$US
241505421$24150542$1$I$$20240716$20240730$20240730$EXP$$JO-ROCHE-10000036734$ROCHE$$57$YR$A$F$Y$$$20240730$$MD$JO$JO
241505433$24150543$3$F$$20240821$20240730$20240830$EXP$NL-LRB-00990443$NL-TEVA-VS-3225112$TEVA$$82$YR$$F$Y$70$KG$20240830$$CN$NL$NL
241505441$24150544$1$I$$20240704$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06722$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241505451$24150545$1$I$$20240717$20240730$20240730$EXP$$US-SERVIER-S24009099$SERVIER$Rai, S., Sharma, P., Nepal, A., Poudel, S., Guerra, Y.. Acute Pancreatitis Caused by Pegylated (PEG)-Asparaginase Associated With Severe Hypertriglyceridemia.. Cureus. 2024;16 (6)$$$$$Y$$$20240730$$MD$US$US
241505461$24150546$1$I$$20240715$20240730$20240730$EXP$$CH-TEVA-VS-3223482$TEVA$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. UNHAPPY HEARTS WITH THE ANTIDEPRESSANT VENLAFAXINE. Swiss-Med-Wkly 2024; 154 (Suppl.) (6): 63S-64S (plus Poster) abstr. P27.$52$YR$$F$Y$$$20240730$$HP$CH$CH
241505473$24150547$3$F$20240715$20240909$20240730$20240917$EXP$$US-CHIESI-2024CHF04553$CHIESI$$34$YR$$F$Y$$$20240917$$CN$US$US
241505481$24150548$1$I$$20240722$20240730$20240730$EXP$$GB-CHIESI-2024CHF04499$CHIESI$$$$A$M$Y$$$20240730$$HP$GB$GB
241505491$24150549$1$I$20240101$20240725$20240730$20240730$EXP$$US-ABBVIE-5619370$ABBVIE$$26$YR$$M$Y$$$20240730$$CN$US$US
241505501$24150550$1$I$$20240726$20240730$20240730$PER$$US-JNJFOC-20240776095$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$CN$US$US
241505511$24150551$1$I$$20240704$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06721$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241505522$24150552$2$F$20220405$20240913$20240730$20240920$EXP$$AU-TAKEDA-2022TUS021699$TAKEDA$$33$YR$$M$Y$$$20240920$$HP$AU$AU
241505531$24150553$1$I$$20240723$20240730$20240730$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024005457$BIOCON$$$$$$Y$$$20240730$$CN$AU$AU
241505541$24150554$1$I$$20240703$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06813$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241505551$24150555$1$I$$20240704$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06724$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241505563$24150556$3$F$20240724$20240820$20240730$20240823$PER$$US-AMGEN-USASP2024149891$AMGEN$$64$YR$A$F$Y$$$20240822$$CN$US$US
241505574$24150557$4$F$20240501$20240913$20240730$20240918$EXP$$US-AMGEN-USASP2024148294$AMGEN$$60$YR$A$M$Y$$$20240918$$CN$US$US
241505581$24150558$1$I$$20240704$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06975$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241505592$24150559$2$F$20240101$20240805$20240730$20240807$EXP$$CA-UCBSA-2024015418$UCB$$$$$M$Y$$$20240807$$CN$CA$CA
241505601$24150560$1$I$20240601$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119921$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240730$$CN$US$US
241505611$24150561$1$I$$20240725$20240730$20240730$EXP$$US-AMGEN-USASP2024150029$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241505621$24150562$1$I$$20240702$20240730$20240730$PER$$US-AMGEN-USASP2024150231$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241505641$24150564$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018012$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240730$$CN$US$US
241505651$24150565$1$I$20240717$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016971$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240730$$PH$US$US
241505661$24150566$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202406017499$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240730$$CN$US$US
241505672$24150567$2$F$20231001$20240717$20240730$20240730$EXP$$US-ROCHE-10000030923$ROCHE$$$$$F$Y$$$20240730$$CN$US$US
241505681$24150568$1$I$$20240719$20240730$20240730$EXP$$FR-ROCHE-10000035358$ROCHE$$$$E$M$Y$$$20240730$$MD$FR$FR
241505691$24150569$1$I$$20240703$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06726$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241505702$24150570$2$F$20240613$20240730$20240730$20240805$EXP$$JP-009507513-2407JPN003989J$MERCK$$9$DEC$$F$Y$$$20240805$$MD$JP$JP
241505711$24150571$1$I$$20240723$20240730$20240730$EXP$$US-JNJFOC-20240764256$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$CN$US$US
241505722$24150572$2$F$20060928$20240716$20240730$20240805$EXP$$US-009507513-0611USA00645$MERCK$$$$$F$Y$63.503$KG$20240805$$MD$US$US
241505731$24150573$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119887$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240730$$CN$US$US
241505741$24150574$1$I$20240601$20240716$20240730$20240730$EXP$$US-UCBSA-2024036312$UCB$$54$YR$$F$Y$$$20240730$$HP$US$US
241505751$24150575$1$I$$20231122$20240730$20240730$PER$$US-STERISCIENCE B.V.-2023-ST-002260$Steriscience PTE$Vakharia JD, Hadaway N, Muhammed M, Chwalisz BK, Nachtigall LB.. Steroid-sparing immunosuppressive therapy controls refractory headaches due to lymphocytic hypophysitis: a case report.. J-Endocr-Soc. 2022;6 (Suppl.):A510 abstr. ODP352$31$YR$$M$Y$$$20240730$$MD$US$US
241505762$24150576$2$F$$20240806$20240730$20240820$EXP$$US-PADAGIS-2024PAD01192$PADAGIS$$$$$$Y$$$20240820$$CN$US$US
241505771$24150577$1$I$$20240724$20240730$20240730$EXP$$CA-CHEPLA-2024009587$CHEPLAPHARM$$60$YR$$F$Y$$$20240730$$MD$COUNTRY NOT SPECIFIED$CA
241505781$24150578$1$I$$20240722$20240730$20240730$EXP$$BR-CHEPLA-2024009611$CHEPLAPHARM$Araujo Coelho DR, Melo Mendes IC, Flores Mamani R, Oliveira da Luz R, Martins de Oliveira AL, Pimentel C. Guillain-Barre Syndrome and Encephalitis Following a Cytomegalovirus Infection in an Immunocompetent Adult: A Case Report. American Journal Of Case Reports. 2024;25:e944337. doi: 10.12659/AJCR.944337.$58$YR$$F$Y$$$20240729$$HP$COUNTRY NOT SPECIFIED$BR
241505791$24150579$1$I$$20240723$20240730$20240730$EXP$$CO-CHEPLA-2024009442$CHEPLAPHARM$Tabares B, Sarmiento-Su?rez AD, Gil ?, Hern?ndez-Pab?n JC, Firacative C. Fatal co-infection by multiple pathogens in an indigenous woman with autoimmune hemolytic anemia and tuberculosis: a case report. BMC Infectious Diseases.2024;24(1):645. doi:10.1186/s12879-024-09557-w.$28$YR$$F$Y$$$20240730$$HP$COUNTRY NOT SPECIFIED$CO
241505801$24150580$1$I$$20240724$20240730$20240730$EXP$$CA-CHEPLA-2024009478$CHEPLAPHARM$$66$YR$$M$Y$68$KG$20240730$$HP$COUNTRY NOT SPECIFIED$CA
241505811$24150581$1$I$$20240724$20240730$20240730$EXP$$CA-CHEPLA-2024009466$CHEPLAPHARM$$66$YR$$F$Y$$$20240730$$HP$COUNTRY NOT SPECIFIED$CA
241505821$24150582$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149833$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241505833$24150583$3$F$20240721$20240807$20240730$20240809$PER$$US-AMGEN-USASP2024148448$AMGEN$$69$YR$E$M$Y$$$20240808$$CN$US$US
241505841$24150584$1$I$$20240724$20240730$20240730$EXP$$JP-CHEPLA-2024009630$CHEPLAPHARM$Takamizawa M, Ichikawa Y, Shimaya H, Furuhata S, Shinohara T and Horiuchi K. A case of a dementia patient who overdosed on amantadine due to an acute exacerbation of chronic kidney disease and visual hallucinations. The journal of Japanese Association of Rural Medicine. 2024;1:38-44$7$DEC$$M$Y$54$KG$20240730$$MD$COUNTRY NOT SPECIFIED$JP
241505851$24150585$1$I$$20240722$20240730$20240730$EXP$$CA-CHEPLA-2024009265$CHEPLAPHARM$$65$YR$$F$Y$$$20240730$$HP$COUNTRY NOT SPECIFIED$CA
241505871$24150587$1$I$20240618$20240716$20240730$20240730$EXP$NL-GILEAD-2024-0677262$NL-ROCHE-10000030230$ROCHE$$49$YR$A$M$Y$130$KG$20240730$$MD$NL$NL
241505881$24150588$1$I$20240715$20240716$20240730$20240730$PER$$US-ROCHE-10000033970$ROCHE$$49$YR$A$F$Y$78.02$KG$20240730$$CN$US$US
241505891$24150589$1$I$$20240723$20240730$20240730$PER$$US-ALXN-202407USA001636US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$US$US
241505902$24150590$2$F$$20240821$20240730$20240902$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001510$BLUEPRINT MEDICINES$$$$$M$Y$$$20240829$$CN$US$US
241505911$24150591$1$I$20240715$20240724$20240730$20240730$PER$$US-JNJFOC-20240767061$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240730$$HP$US$US
241505922$24150592$2$F$$20240831$20240730$20240906$EXP$$US-JNJFOC-20240764961$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
241505931$24150593$1$I$$20240716$20240730$20240730$EXP$$JP-ALVOGEN-2024095142$ALVOGEN$Ishiyama Y, Inakawa T, Yoshino M, Nishimura K, Horiuchi T, Ishihara H, Toki D, Kondo T. Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience. Anticancer Research. 2024;44:3213-3220. doi:10.21873/anticanres.17137$57$YR$$F$Y$$$20240730$$HP$JP$JP
241505941$24150594$1$I$20240612$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148963$AMGEN$$73$YR$E$F$Y$$$20240730$$CN$US$US
241505951$24150595$1$I$$20240613$20240730$20240730$EXP$$CH-TEVA-VS-3216832$TEVA$$$$$$Y$$$20240730$$HP$CH$CH
241505962$24150596$2$F$$20240801$20240730$20240810$EXP$$US-TEVA-VS-3223242$TEVA$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep 2023; 40 14-18.; Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep 2023; 40 14-18.; Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep 2023; 40 14-18.$$$$F$Y$$$20240810$$HP$US$US
241505972$24150597$2$F$20240725$20240828$20240730$20240830$PER$$US-AMGEN-USASP2024148420$AMGEN$$74$YR$E$F$Y$$$20240830$$CN$US$US
241505981$24150598$1$I$$20240723$20240730$20240730$EXP$$IT-AMGEN-ITASP2024149991$AMGEN$Stella L.; Pallozzi M.; Cerrito L. et al.. Can AtezoBev be a safe and effective option for treating hepatocellular carcinoma in patients with Child-Pugh B cirrhosis? A retrospective multicenter real-world study. Digestive and Liver Disease. 2024;56:p.S78$$$$$Y$$$20240730$$HP$IT$IT
241505991$24150599$1$I$$20240725$20240730$20240730$EXP$$IT-AMGEN-ITASP2024150006$AMGEN$Tovoli F.; Franceschini E.; Vivaldi C. et al.. Management of portal hypertension in patients receiving atezolizumab-bevacizumab for hepatocellular carcinoma. Digestive and Liver Disease. 2024;56:p.S87$$$$$Y$$$20240730$$HP$IT$IT
241506001$24150600$1$I$$20240716$20240730$20240730$EXP$$JP-ALVOGEN-2024095139$ALVOGEN$Ishiyama Y, Inakawa T, Yoshino M, Nishimura K, Horiuchi T, Ishihara H, Toki D, Kondo T. Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience. Anticancer Research. 2024;44:3213-3220. doi:10.21873/anticanres.17137$55$YR$$F$Y$$$20240730$$HP$JP$JP
241506021$24150602$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-10000040529$ROCHE$$$$A$F$Y$$$20240730$$CN$US$US
241506031$24150603$1$I$$20240723$20240730$20240730$PER$$US-TAKEDA-2024TUS074966$TAKEDA$$$$$$Y$$$20240730$$CN$US$US
241506051$24150605$1$I$$20240725$20240730$20240730$PER$$US-ROCHE-10000038015$ROCHE$$47$YR$A$F$Y$$$20240730$$CN$US$US
241506061$24150606$1$I$$20240725$20240730$20240730$PER$$US-ROCHE-10000038472$ROCHE$$$$A$F$Y$$$20240730$$CN$US$US
241506071$24150607$1$I$20240101$20240722$20240730$20240730$EXP$GB-MHRA-MED-202407221850381580-RYPNJ$GB-TEVA-VS-3224685$TEVA$$65$YR$$F$Y$84$KG$20240730$$CN$GB$GB
241506081$24150608$1$I$$20240716$20240730$20240730$EXP$$JP-ALVOGEN-2024095141$ALVOGEN$Ishiyama Y, Inakawa T, Yoshino M, Nishimura K, Horiuchi T, Ishihara H, Toki D, Kondo T. Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience. Anticancer Research. 2024;44:3213-3220. doi:10.21873/anticanres.17137$46$YR$$M$Y$$$20240730$$HP$JP$JP
241506091$24150609$1$I$20240717$20240724$20240730$20240730$EXP$$NVSC2024CA152660$NOVARTIS$$23$YR$$F$Y$$$20240730$$CN$CA$CA
241506101$24150610$1$I$20240101$20240725$20240730$20240730$EXP$$US-ABBVIE-5856026$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241506111$24150611$1$I$$20240725$20240730$20240730$EXP$$US-ABBVIE-5856435$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241506121$24150612$1$I$$20240715$20240730$20240730$EXP$$CH-TEVA-VS-3223483$TEVA$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. UNHAPPY HEARTS WITH THE ANTIDEPRESSANT VENLAFAXINE. Swiss-Med-Wkly 2024; 154 (Suppl.) (6): 63S-64S (plus Poster) abstr. P27.$77$YR$$F$Y$$$20240730$$HP$CH$CH
241506131$24150613$1$I$$20240722$20240730$20240730$EXP$$CA-JNJFOC-20240776011$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$HP$CA$CA
241506141$24150614$1$I$$20240716$20240730$20240730$EXP$$JP-ALVOGEN-2024095143$ALVOGEN$Ishiyama Y, Inakawa T, Yoshino M, Nishimura K, Horiuchi T, Ishihara H, Toki D, Kondo T. Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience. Anticancer Research. 2024;44:3213-3220. doi:10.21873/anticanres.17137$55$YR$$F$Y$$$20240730$$HP$JP$JP
241506151$24150615$1$I$20240501$20240725$20240730$20240730$EXP$$US-SA-2024SA221298$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240730$$MD$US$US
241506161$24150616$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120319$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240730$$HP$US$US
241506172$24150617$2$F$20240705$20240806$20240730$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119261$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240819$$PH$US$US
241506181$24150618$1$I$20240229$20240726$20240730$20240730$EXP$IT-MINISAL02-996830$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-119813$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240730$$MD$IT$IT
241506192$24150619$2$F$20240708$20240726$20240730$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-120052$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$MD$JP$JP
241506201$24150620$1$I$20240724$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119911$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$HP$US$US
241506211$24150621$1$I$20240618$20240725$20240730$20240730$EXP$ES-AEMPS-1551605$ES-SA-2024SA219197$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240730$$PH$ES$ES
241506221$24150622$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120004$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$74.84$KG$20240730$$PH$US$US
241506231$24150623$1$I$20221205$20230209$20240730$20240730$EXP$$CA-CELLTRION INC.-2022CA022661$CELLTRION$$$$$$Y$$$20240730$$MD$CA$CA
241506242$24150624$2$F$$20240726$20240730$20240803$EXP$$JP-ROCHE-10000012152$ROCHE$$83$YR$E$M$Y$$$20240803$$MD$JP$JP
241506253$24150625$3$F$20240823$20240823$20240730$20240829$EXP$$CA-TAKEDA-2024TUS076257$TAKEDA$$52$YR$$M$Y$$$20240829$$CN$CA$CA
241506261$24150626$1$I$$20240702$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06733$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241506271$24150627$1$I$20240101$20240729$20240730$20240730$EXP$FI-FIMEA-202402681$FI-SANDOZ INC.-SDZ2024FI068831$SANDOZ$$73$YR$$F$Y$$$20240730$$HP$FI$FI
241506281$24150628$1$I$$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036694$AUROBINDO$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N and al.. A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).. Toxicologie Analytique + Clinique. 2023;35:376-394$47$YR$$M$Y$$$20240730$$MD$FR$FR
241506291$24150629$1$I$$20240726$20240730$20240730$EXP$$IT-SANDOZ INC.-SDZ2024IT068549$SANDOZ$$15$YR$$F$Y$48$KG$20240730$$HP$IT$IT
241506301$24150630$1$I$20240313$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036810$AUROBINDO$$23$YR$$M$Y$51$KG$20240730$$MD$FR$FR
241506311$24150631$1$I$20240501$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036708$AUROBINDO$$63$YR$$F$Y$$$20240730$$PH$FR$FR
241506321$24150632$1$I$$20240722$20240730$20240730$PER$$US-ABBVIE-5854367$ABBVIE$$$$$$Y$$$20240730$$HP$US$US
241506341$24150634$1$I$$20240725$20240730$20240730$EXP$$IT-AMGEN-ITASP2024150007$AMGEN$Tovoli F.; Franceschini E.; Vivaldi C. et al.. Management of portal hypertension in patients receiving atezolizumab-bevacizumab for hepatocellular carcinoma. Digestive and Liver Disease. 2024;56:p.S87$$$$$Y$$$20240730$$HP$IT$IT
241506381$24150638$1$I$$20240717$20240730$20240730$EXP$$US-PADAGIS-2024PAD01203$PADAGIS$Lin A, Qiu J. A Woman With A Persistent Pruritic Arm. Consultant. 2024;64(6):e1$$$$$Y$$$20240730$$HP$US$US
241506391$24150639$1$I$$20240725$20240730$20240730$PER$$US-ABBVIE-5857447$ABBVIE$$$$$$Y$$$20240730$$CN$US$US
241506401$24150640$1$I$20160101$20240725$20240730$20240730$EXP$AU-TGA-0000809078$AU-JNJFOC-20240777103$JOHNSON AND JOHNSON$$35$YR$A$$Y$$$20240730$$CN$AU$AU
241506412$24150641$2$F$20240501$20240916$20240730$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-036348$AUROBINDO$$63$YR$$$Y$$$20240925$$MD$FR$FR
241506422$24150642$2$F$$20240819$20240730$20240822$PER$$US-AMGEN-USASP2024148803$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
241506431$24150643$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119899$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240730$$CN$US$US
241506441$24150644$1$I$20240707$20240709$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017845$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240730$$CN$US$US
241506451$24150645$1$I$20240725$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018076$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240730$$CN$US$US
241506461$24150646$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018083$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240730$$CN$US$US
241506471$24150647$1$I$20240726$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018088$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240730$$CN$US$US
241506481$24150648$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018018$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240730$$CN$US$US
241506491$24150649$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016849$ELI LILLY AND CO$$$$$F$Y$$$20240730$$CN$US$US
241506501$24150650$1$I$$20240725$20240730$20240730$EXP$$US-ABBVIE-5855000$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241506511$24150651$1$I$$20240722$20240730$20240730$EXP$$GB-TEVA-VS-3224398$TEVA$$69$YR$$M$Y$64$KG$20240730$$MD$GB$GB
241506521$24150652$1$I$20240701$20240710$20240730$20240730$PER$$US-TEVA-VS-3221250$TEVA$$47$YR$$F$Y$$$20240730$$CN$US$US
241506531$24150653$1$I$$20240719$20240730$20240730$EXP$$BE-AUROBINDO-AUR-APL-2024-036139$AUROBINDO$Dekock T, Taelman T, Vanhaverbeke G, Derijcke S, Ghysen K.. Immunotherapy-induced diabetes mellitus: A case study.. Tijdschrift voor Geneeskunde en Gezondheidszorg. 2024;80(7):585-93$73$YR$$M$Y$$$20240730$$MD$BE$BE
241506541$24150654$1$I$$20240728$20240730$20240730$PER$$US-ABBVIE-5858676$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241506551$24150655$1$I$$20240722$20240730$20240730$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009312$STRIDES$Joshi A, Ghnaima H, Nader G, Alattal S.. A Trifecta of Challenges: A Case Report of Triple Valve Endocarditis.. Am-J-Respir-Crit-Care-Med. 2024;209 (0):no pagination.$37$YR$$M$Y$$$20240730$$HP$US$US
241506562$24150656$2$F$20180101$20240807$20240730$20240820$EXP$$US-UCBSA-2024038000$UCB$$50$YR$$F$Y$$$20240820$$HP$US$US
241506571$24150657$1$I$20240301$20240719$20240730$20240730$EXP$$GB-AUROBINDO-AUR-APL-2024-036440$AUROBINDO$$$$$M$Y$$$20240730$$MD$GB$GB
241506582$24150658$2$F$$20240722$20240730$20240731$EXP$$US-AMGEN-USASP2024148000$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):1-12$68$YR$E$$Y$$$20240731$$HP$US$US
241506591$24150659$1$I$20240101$20240722$20240730$20240730$EXP$$RO-AMGEN-ROUSP2024146752$AMGEN$$41$YR$A$M$Y$$$20240730$$MD$RO$RO
241506602$24150660$2$F$$20240827$20240730$20240831$PER$$US-AMGEN-USASP2024148464$AMGEN$$$$$M$Y$$$20240830$$HP$US$US
241506612$24150661$2$F$$20240730$20240730$20240803$EXP$$US-CELLTRION INC.-2024US018162$CELLTRION$$$$$$Y$$$20240803$$HP$US$US
241506621$24150662$1$I$20240709$20240722$20240730$20240730$EXP$PT-INFARMED-J202407-277$PT-TEVA-VS-3225025$TEVA$$79$YR$$F$Y$$$20240730$$MD$PT$PT
241506631$24150663$1$I$$20240726$20240730$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA068794$SANDOZ$$14$YR$$F$Y$$$20240730$$HP$CA$CA
241506641$24150664$1$I$20240724$20240725$20240730$20240730$EXP$$NVSC2024US153278$NOVARTIS$$73$YR$$F$Y$$$20240730$$CN$US$US
241506651$24150665$1$I$20240601$20240716$20240730$20240730$EXP$$US-UCBSA-2024036411$UCB$$53$YR$$F$Y$$$20240730$$HP$US$US
241506671$24150667$1$I$20210301$20240722$20240730$20240730$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009306$STRIDES$Tanaka H, Sakakibara M, Hiratsuka M, Sugiura Y, Hiruta N.. [Improved QOL in a Case of Breast Cancer with Meningeal Carcinomatosis Treated with Radiation Therapy and Intrathecal Chemotherapy]. [Japanese].. Gan-To-Kagaku-Ryoho. 2022;49 (13):1938-1940$6$DEC$$F$Y$$$20240730$$HP$JP$JP
241506681$24150668$1$I$20240328$20240728$20240728$20240728$DIR$FDA-CDER-CTU-2024-52019$$FDA-CTU$$54$YR$$F$N$71.67$KG$20240728$N$CN$US$
241506691$24150669$1$I$20240718$20240728$20240728$20240728$DIR$FDA-CDER-CTU-2024-52020$$FDA-CTU$$58$YR$$F$N$79.38$KG$20240728$Y$HP$US$
241506711$24150671$1$I$20240501$20240719$20240730$20240730$EXP$$JP-EMD Serono-2024040655$EMD SERONO INC$$$$E$M$Y$$$20240730$$MD$JP$JP
241506721$24150672$1$I$20240516$20240729$20240730$20240730$EXP$$GB-GSK-GB2024094536$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$GB$GB
241506731$24150673$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A169203$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241506741$24150674$1$I$$20240722$20240730$20240730$EXP$$VN-AstraZeneca-2024A168862$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$VN$
241506751$24150675$1$I$$20240722$20240730$20240730$EXP$$ZA-AstraZeneca-2024A166887$ASTRAZENECA$$24837$DY$$F$Y$$$20240730$$CN$ZA$
241506771$24150677$1$I$$20240722$20240730$20240730$EXP$$ES-AstraZeneca-2024A167629$ASTRAZENECA$$74$YR$$M$Y$$$20240730$$MD$ES$
241506781$24150678$1$I$$20240722$20240730$20240730$EXP$$ZA-AstraZeneca-2024A166637$ASTRAZENECA$$65$YR$$F$Y$$$20240730$$CN$ZA$
241506791$24150679$1$I$$20240722$20240730$20240730$EXP$$CN-AstraZeneca-2024A167735$ASTRAZENECA$$$$E$M$Y$75$KG$20240730$$MD$CN$
241506801$24150680$1$I$$20240725$20240730$20240730$PER$$US-ROCHE-10000040965$ROCHE$$57$YR$A$M$Y$$$20240730$$HP$US$US
241506811$24150681$1$I$$20240718$20240730$20240730$PER$$US-BEH-2024175960$CSL BEHRING$$$$A$M$Y$$$20240730$$HP$US$US
241506821$24150682$1$I$$20240716$20240730$20240730$EXP$$IN-DEXPHARM-2024-2483$DEXCEL$Sood A, Nayyar V, Roychoudhury A, Bhalla AS, Mishra D. Post-COVID steroid induced avascular necrosis of the jaw: Emerging challenge in India. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023 Apr;135(4):e89-e93. doi: 10.1016/j.oooo.2022.08.014. Epub 2022 Sep 8. PMID: 36396587; PMCID: PMC9452415.$28$YR$A$M$Y$$$20240730$$HP$IN$US
241506831$24150683$1$I$$20240715$20240730$20240730$EXP$$US-TEVA-VS-3223245$TEVA$Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep 2023; 40 14-18.; Kassels A, Edwards L, Kraus CN. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep 2023; 40 14-18.$$$$F$Y$$$20240730$$HP$US$US
241506841$24150684$1$I$$20240716$20240730$20240730$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06873$HIKMA$Gaur D, Michalopulos MG, Drake KA, Gattineni J.. Gaur D, Michalopulos MG, Drake KA, Gattineni J. Acetaminophen sequence from a common medication.induced high anion gap metabolic acidosis: a potentially under-recognized con. Pediatric Nephrology. 2024$12$YR$$F$Y$$$20240730$$MD$US$US
241506851$24150685$1$I$20240701$20240716$20240730$20240730$PER$$US-JNJFOC-20240748151$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240730$$HP$US$US
241506861$24150686$1$I$$20240724$20240730$20240730$EXP$$CA-APOTEX-2024AP008796$APOTEX$$49$YR$$F$Y$$$20240730$$HP$CA$CA
241506872$24150687$2$F$20240725$20240805$20240730$20240807$PER$$US-AMGEN-USASP2024149386$AMGEN$$75$YR$E$F$Y$$$20240807$$CN$US$US
241506881$24150688$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120247$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240730$$CN$US$US
241506891$24150689$1$I$$20240724$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117974$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240730$$HP$US$US
241506901$24150690$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120197$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240730$$HP$US$US
241506911$24150691$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119982$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$HP$US$US
241506921$24150692$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119566$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240730$$CN$US$US
241506931$24150693$1$I$$20240722$20240730$20240730$EXP$$ES-AstraZeneca-2024A167877$ASTRAZENECA$$71$YR$$F$Y$$$20240730$$MD$ES$
241506941$24150694$1$I$$20240716$20240730$20240730$EXP$$IN-DEXPHARM-2024-2484$DEXCEL$Sood A, Nayyar V, Roychoudhury A, Bhalla AS, Mishra D. Post-COVID steroid induced avascular necrosis of the jaw: Emerging challenge in India. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023 Apr;135(4):e89-e93. doi: 10.1016/j.oooo.2022.08.014. Epub 2022 Sep 8. PMID: 36396587; PMCID: PMC9452415.$49$YR$A$M$Y$$$20240730$$HP$IN$US
241506951$24150695$1$I$20150701$20240725$20240730$20240730$EXP$$CA-Orion Corporation ORION PHARMA-24_00031052$ORION$$55$YR$A$F$Y$$$20240730$$HP$CA$
241506961$24150696$1$I$20240601$20240719$20240730$20240730$EXP$$US-ROCHE-10000032965$ROCHE$$44$YR$A$F$Y$$$20240730$$CN$US$US
241506971$24150697$1$I$20220101$20240719$20240730$20240730$EXP$$LU-AUROBINDO-AUR-APL-2024-036136$AUROBINDO$De Wilde S, Graux C.. Complete hematologic response in a patient with multiple pretreated angioimmunoblastic T-cell lymphoma after belinostat therapy followed by allogeneic stem cell transplantation: A case report.. Clinical Case Reports.. 2024;12(17):e9159.$63$YR$$M$Y$$$20240730$$MD$LU$LU
241506981$24150698$1$I$20130101$20240724$20240730$20240730$EXP$$AU-TAKEDA-2024TUS074694$TAKEDA$$$$$F$Y$$$20240730$$HP$AU$AU
241506991$24150699$1$I$20240101$20240521$20240730$20240730$EXP$$TR-TEVA-VS-3214710$TEVA$$38$YR$$F$Y$$$20240730$$CN$TR$TR
241507001$24150700$1$I$20240213$20240726$20240730$20240730$30DAY$$IT-SANDOZ INC.-SDZ2024IT016080$SANDOZ$$12$YR$$M$Y$$$20240730$$PH$IT$IT
241507021$24150702$1$I$20240714$20240715$20240730$20240730$EXP$$US-PADAGIS-2024PAD01209$PADAGIS$$$$$$Y$$$20240730$$CN$US$US
241507031$24150703$1$I$20240723$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148799$AMGEN$$67$YR$E$F$Y$$$20240730$$CN$US$US
241507041$24150704$1$I$$20240725$20240730$20240730$EXP$$BR-AMGEN-BRASP2024148352$AMGEN$Becker R.G.; Galia C.R.; Pestilho J. et al.. GIANT CELL TUMOR OF BONE: A MULTICENTER EPIDEMIOLOGICAL STUDY IN BRAZIL. Acta Ortopedica Brasileira. 2024;32 (1):1-5$$$$$Y$$$20240730$$HP$BR$BR
241507051$24150705$1$I$20240709$20240724$20240730$20240730$EXP$IT-MINISAL02-995888$IT-AMGEN-ITASP2024147475$AMGEN$$76$YR$E$F$Y$$$20240730$$MD$IT$IT
241507062$24150706$2$F$20240101$20240924$20240730$20240928$PER$$US-AMGEN-USASP2024149610$AMGEN$$56$YR$A$M$Y$$$20240928$$PH$US$US
241507071$24150707$1$I$20240622$20240724$20240730$20240730$EXP$IT-MINISAL02-995861$IT-AMGEN-ITASP2024147473$AMGEN$$83$YR$E$F$Y$$$20240730$$MD$IT$IT
241507081$24150708$1$I$20240320$20240724$20240730$20240730$EXP$SE-SEMPA-2024-005632$SE-AMGEN-SWESP2024147530$AMGEN$$68$YR$E$F$Y$$$20240730$$CN$SE$SE
241507091$24150709$1$I$$20240710$20240730$20240730$PER$$US-TEVA-VS-3221336$TEVA$$72$YR$$M$Y$$$20240730$$CN$US$US
241507104$24150710$4$F$$20240731$20240730$20240802$30DAY$$US-SANDOZ INC.-SDZ2024US068839$SANDOZ$$$$$F$Y$$$20240802$$CN$US$US
241507112$24150711$2$F$$20240807$20240730$20240808$PER$$US-JNJFOC-20240748216$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240808$$CN$US$US
241507122$24150712$2$F$20240601$20240826$20240730$20240829$PER$$US-AMGEN-USASP2024148418$AMGEN$$60$YR$A$F$Y$$$20240828$$CN$US$US
241507131$24150713$1$I$$20240719$20240730$20240730$EXP$US-ALVOGEN-2024094853$US-ALVOGEN-2024094853$ALVOGEN$$$$$$Y$$$20240730$$CN$US$US
241507141$24150714$1$I$$20240724$20240730$20240730$EXP$$US-GSK-US2024AMR093278$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$US$US
241507151$24150715$1$I$20240627$20240723$20240730$20240730$EXP$ES-AEMPS-1547363$ES-EMD Serono-2024039860$EMD SERONO INC$$15$YR$T$F$Y$103$KG$20240730$$MD$ES$ES
241507161$24150716$1$I$$20240718$20240730$20240730$EXP$$US-ROCHE-10000033747$ROCHE$$71$YR$E$F$Y$$$20240730$$CN$US$US
241507171$24150717$1$I$$20240703$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06894$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241507181$24150718$1$I$20240719$20240718$20240730$20240730$EXP$$JP-NOVOPROD-1259202$NOVO NORDISK$$75$YR$$M$Y$60$KG$20240730$$CN$JP$JP
241507191$24150719$1$I$20231023$20240729$20240729$20240729$DIR$711873$$FDA-CTU$$30$YR$$M$N$81$KG$20240729$Y$CN$US$
241507201$24150720$1$I$$20240729$20240729$20240729$DIR$711885$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241507261$24150726$1$I$20170101$20240718$20240730$20240730$EXP$$BG-ROCHE-10000031553$ROCHE$Ivanov K,  MALIGNANT ASCITES AND PERITONEAL SITE TUNNELED CATHETERS IN THEIR TREATMENT. Bulgarian Cancer Society. 2024;(2/2024):$64$YR$A$F$Y$$$20240730$$MD$BG$BG
241507271$24150727$1$I$$20240717$20240730$20240730$PER$$US-ROCHE-10000030959$ROCHE$$$$E$F$Y$$$20240730$$CN$US$US
241507281$24150728$1$I$$20240719$20240730$20240730$EXP$$JP-NOVAST LABORATORIES INC.-2024NOV000281$NOVAST$Takahashi Y, Nakano H, Motoki M, Wakimoto Y, Ikechi D, Koyama Y,et.all.. Successful use of methylene blue for catecholamine-refractory  vasoplegic shock due to metformin intoxication: A case report and  literature review. Acute Med Surg. 2024;11$45$YR$$F$Y$90$KG$20240730$$HP$JP$JP
241507291$24150729$1$I$20230403$20240719$20240730$20240730$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000280$NOVAST$Ju Y, Zhu Y, Zhu G, Wang M, Wu R.. Lower-extremity deep vein thrombosis induced by oxaliplatin and capecitabine chemotherapy: A case report. Asia-Pacific Journal of Oncology Nursing. 2024;11$64$YR$$M$Y$76$KG$20240730$$HP$CN$CN
241507302$24150730$2$F$$20240801$20240730$20240808$EXP$$JP-JNJFOC-20240775366$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$MD$JP$JP
241507312$24150731$2$F$$20240830$20240730$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06651$LUPIN$$$$$$Y$$$20240919$$CN$US$US
241507321$24150732$1$I$20240720$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119375$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240730$$PH$US$US
241507331$24150733$1$I$20240701$20240703$20240730$20240730$EXP$$US-NEBO-663611$PHARMACOSMOS$$30$YR$$F$Y$$$20240730$$HP$US$US
241507341$24150734$1$I$$20240726$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119450$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240730$$HP$US$US
241507351$24150735$1$I$20240718$20240729$20240730$20240730$PER$ES-AEMPS-1552542$ES-IDORSIA-008311-2024-ES$IDORSIA PHARMACEUTICALS$$51$YR$$M$Y$80$KG$20240730$$CN$ES$ES
241507362$24150736$2$F$$20240801$20240730$20240810$EXP$$CH-TEVA-VS-3223484$TEVA$Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. UNHAPPY HEARTS WITH THE ANTIDEPRESSANT VENLAFAXINE. Swiss-Med-Wkly 2024; 154 (Suppl.) (6): 63S-64S (plus Poster) abstr. P27.; Sopi BB, Yonekawa K, Bernheim J, Caselli S, Schmied C, Lam A, et al. UNHAPPY HEARTS WITH THE ANTIDEPRESSANT VENLAFAXINE. Swiss-Med-Wkly 2024; 154 (Suppl.) (6): 63S-64S (plus Poster) abstr. P27.$82$YR$$M$Y$$$20240810$$HP$CH$CH
241507371$24150737$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017983$ELI LILLY AND CO$$$$$F$Y$$$20240730$$CN$US$US
241507381$24150738$1$I$$20240723$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016934$ELI LILLY AND CO$$60$YR$A$$Y$$$20240730$$CN$US$US
241507391$24150739$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017040$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240730$$CN$US$US
241507401$24150740$1$I$$20240703$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06866$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241507411$24150741$1$I$$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024147538$AMGEN$$$$$F$Y$$$20240730$$PH$US$US
241507421$24150742$1$I$20240715$20240716$20240730$20240730$EXP$$US-PADAGIS-2024PAD01210$PADAGIS$$$$$$Y$$$20240730$$CN$US$US
241507431$24150743$1$I$$20240723$20240730$20240730$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00390$VELOXIS PHARMACEUTICALS$Joly L, Virgilio R, Yother C.. Posttransplant lymphoproliferative disorder in a patient with alpha-1 antitrypsin deficiency: A case report. Cureus. 2024;16(6):e62107$13$YR$$M$Y$$$20240730$$MD$US$US
241507442$24150744$2$F$20220101$20240724$20240730$20240807$EXP$CN-MLMSERVICE-20240708-PI125005-00232-1$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-15995$ALKEM$Li J, Wu Q, Guo X, Rong L, Fang Y.. Salvage treatment of ruxolitinib for refractory adenovirus-associated hemophagocytic syndrome post-haploidentical allogeneic stem cell transplantation: a case report. Translational Pediatrics. 2024;13(6):994-1000$11$YR$$M$Y$$$20240807$$MD$CN$CN
241507461$24150746$1$I$20240710$20240716$20240730$20240730$EXP$GB-MHRA-MED-202407151147209780-NGTWM$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15993$ALKEM$$62$YR$$M$Y$$$20240730$$MD$GB$GB
241507471$24150747$1$I$20240312$20240716$20240730$20240730$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000670$PAREXEL$$$$$$Y$$$20240730$$HP$CN$CN
241507481$24150748$1$I$$20240105$20240730$20240730$EXP$$GB-TEVA-VS-3218089$TEVA$$$$A$F$Y$$$20240730$$HP$GB$GB
241507491$24150749$1$I$$20240703$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06638$LUPIN$$28$YR$$M$Y$$$20240730$$CN$US$US
241507501$24150750$1$I$20221020$20240716$20240730$20240730$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-06913$HIKMA$$$$$$Y$$$20240730$$MD$GB$GB
241507512$24150751$2$F$20240324$20240821$20240730$20240829$PER$$US-BIOGEN-2024BI01271791$BIOGEN$$64$YR$$F$Y$$$20240829$$CN$US$US
241507521$24150752$1$I$20240623$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148789$AMGEN$$79$YR$E$F$Y$$$20240730$$CN$US$US
241507531$24150753$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-3559268$ROCHE$$58$YR$A$M$Y$$$20240730$$CN$US$US
241507541$24150754$1$I$20240701$20240725$20240730$20240730$PER$$US-ROCHE-10000039888$ROCHE$$75$YR$E$F$Y$$$20240730$$HP$US$US
241507551$24150755$1$I$20230819$20230821$20240730$20240730$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03034$AMNEAL$$$$$M$Y$$$20240730$$CN$US$US
241507561$24150756$1$I$$20230902$20240730$20240730$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03051$AMNEAL$$$$$F$Y$72.562$KG$20240730$$CN$US$US
241507571$24150757$1$I$20240620$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149728$AMGEN$$36$YR$A$F$Y$$$20240730$$CN$US$US
241507581$24150758$1$I$$20230324$20240730$20240730$EXP$$ZA-AstraZeneca-2023A070614$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$ZA$
241507592$24150759$2$F$$20240801$20240730$20240809$EXP$$BR-AstraZeneca-2024A169926$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$BR$
241507601$24150760$1$I$$20211117$20240730$20240730$EXP$$US-AstraZeneca-2021A811299$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241507611$24150761$1$I$$20230413$20240730$20240730$EXP$$US-AstraZeneca-2023A087320$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241507621$24150762$1$I$$20240722$20240730$20240730$EXP$$ES-AstraZeneca-2024A167987$ASTRAZENECA$$68$YR$$F$Y$$$20240730$$MD$ES$
241507631$24150763$1$I$$20240722$20240730$20240730$EXP$$ES-AstraZeneca-2024A167740$ASTRAZENECA$$53$YR$$F$Y$$$20240730$$MD$ES$
241507641$24150764$1$I$20000101$20240719$20240730$20240730$PER$$US-AstraZeneca-2024A171061$ASTRAZENECA$$85$YR$$F$Y$$$20240730$$CN$US$
241507651$24150765$1$I$$20240723$20240730$20240730$PER$$US-AstraZeneca-2024A171627$ASTRAZENECA$$79$YR$$M$Y$$$20240730$$CN$US$
241507661$24150766$1$I$20230701$20230901$20240730$20240730$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03153$AMNEAL$$69$YR$$F$Y$$$20240730$$CN$US$US
241507671$24150767$1$I$$20240514$20240730$20240730$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01850$AMNEAL$$$$$$Y$$$20240730$$CN$US$US
241507681$24150768$1$I$20240429$20240729$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US068983$SANDOZ$$54$YR$$M$Y$$$20240730$$HP$US$US
241507691$24150769$1$I$20240724$20240724$20240730$20240730$EXP$$GB-CHATTEMPRD-2024OHG025296$CHATTEM$$27$YR$A$F$Y$70$KG$20240730$$MD$GB$GB
241507701$24150770$1$I$20240602$20240717$20240730$20240730$EXP$CH-SM-2024-13866$CH-ROCHE-10000030901$ROCHE$$70$YR$E$F$Y$$$20240730$$MD$CH$CH
241507713$24150771$3$F$20240718$20240905$20240730$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-002965$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240916$$CN$US$US
241507731$24150773$1$I$$20240719$20240730$20240730$EXP$$IT-MYLANLABS-2024M1069000$MYLAN$Tolino E, Proietti I, Skroza N, Di Guardo A, Di Fraia M, Dybala A, et al. Atopic Dermatitis Onset in a Melanoma Patient Under Pembrolizumab Therapy: A Case of Successful Treatment with Dupilumab. Indian-J-Dermatol 2024; 69 (3): 268-269.$82$YR$$M$Y$$$20240730$$HP$IT$IT
241507743$24150774$3$F$20240206$20240923$20240730$20240930$EXP$$CO-UCBSA-2024038143$UCB$$61$YR$$F$Y$$$20240930$$CN$CO$CO
241507751$24150775$1$I$$20240719$20240730$20240730$EXP$$US-MYLANLABS-2024M1069259$MYLAN$Satta T, Papadopoulos EB, Gyurkocza B, Susman P, Singh A, Calafiore M, et al. Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd. Blood 2023; 142 (Suppl. 1) 7019.$37$YR$$$Y$$$20240730$$HP$US$US
241507761$24150776$1$I$20240201$20240719$20240730$20240730$EXP$$UY-ROCHE-10000006118$ROCHE$$65$YR$E$M$Y$$$20240730$$MD$UY$UY
241507771$24150777$1$I$$20240614$20240730$20240730$PER$$US-TRAVERE-2024TVT00606$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240730$$CN$US$US
241507781$24150778$1$I$$20240703$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06648$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241507801$24150780$1$I$20200501$20240715$20240730$20240730$EXP$$CH-ROCHE-10000041842$ROCHE$$58$YR$A$$Y$$$20240730$$MD$CH$CH
241507811$24150781$1$I$20240725$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148825$AMGEN$$73$YR$E$M$Y$$$20240730$$CN$US$US
241507821$24150782$1$I$20240724$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149237$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241507851$24150785$1$I$$20240729$20240729$20240729$DIR$711886$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241507861$24150786$1$I$20231201$20240725$20240730$20240730$EXP$$UY-ABBVIE-5856322$ABBVIE$$60$YR$$F$Y$$$20240730$$MD$UY$UY
241507871$24150787$1$I$20240726$20240729$20240729$20240729$DIR$711881$$FDA-CTU$$77$YR$$F$N$$$20240729$N$$US$
241507891$24150789$1$I$20240201$20240722$20240730$20240730$EXP$PT-INFARMED-T202407-140$PT-TEVA-VS-3225110$TEVA$$69$YR$$F$Y$69$KG$20240730$$MD$PT$PT
241507901$24150790$1$I$$20240723$20240730$20240730$EXP$$CO-GSK-CO2024AMR093220$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$CO$CO
241507921$24150792$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119551$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240730$$HP$US$US
241507931$24150793$1$I$20240720$20240726$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119488$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$79.38$KG$20240730$$HP$US$US
241507942$24150794$2$F$$20240924$20240730$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119729$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$114.76$KG$20240928$$CN$US$US
241507951$24150795$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119759$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$70.76$KG$20240730$$CN$US$US
241507961$24150796$1$I$$20240725$20240730$20240730$PER$$US-ABBVIE-5857077$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241507971$24150797$1$I$20240523$20240722$20240730$20240730$EXP$GB-MHRA-MED-202407221442026660-RBKYP$GB-TEVA-VS-3224677$TEVA$$21$YR$$M$Y$$$20240730$$MD$GB$GB
241507983$24150798$3$F$20240719$20240813$20240730$20240818$EXP$$US-AMGEN-USASP2024148016$AMGEN$$27$YR$A$M$Y$$$20240818$$HP$US$US
241508002$24150800$2$F$$20240801$20240730$20240810$EXP$$US-TEVA-VS-3223188$TEVA$Cardona Quinones RA, Salem Hernandez SA, Sekimitsu S, Antongiorgi Torres J, Yerstein O, Safar LT. A neuropsychiatric case of delayed post-hypoxic leukoencephalopathy from opioid intoxication resulting in Anton-Babinski syndrome and quadriplegia. Neurocase 2023; 29 (5): 160-166.; Cardona Quinones RA, Salem Hernandez SA, Sekimitsu S, Antongiorgi Torres J, Yerstein O, Safar LT. A neuropsychiatric case of delayed post-hypoxic leukoencephalopathy from opioid intoxication resulting in Anton-Babinsk...$26$YR$$M$Y$$$20240810$$HP$US$US
241508011$24150801$1$I$20240711$20240724$20240730$20240730$EXP$$CN-SANDOZ INC.-SDZ2024CN068923$SANDOZ$$75$YR$$F$Y$64$KG$20240730$$HP$CN$CN
241508021$24150802$1$I$$20240722$20240730$20240730$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009310$STRIDES$Isoshima Y, Kondo E, Uchiyama S, Iio K, Tajiri R, Amimoto S, et al.. A case of chorioamnionitis preceded by sudden intrauterine fetal death at 25 weeks 5 days gestation.. Placenta. 2023;141 (0):104$36$YR$$F$Y$$$20240730$$HP$JP$JP
241508031$24150803$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149158$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241508041$24150804$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149054$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241508051$24150805$1$I$20240702$20240723$20240730$20240730$EXP$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000078$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240730$$CN$US$US
241508061$24150806$1$I$20240715$20240716$20240730$20240730$EXP$$US-PADAGIS-2024PAD01212$PADAGIS$$$$$$Y$$$20240730$$CN$US$US
241508071$24150807$1$I$$20240719$20240730$20240730$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-001090$Alvotech$$40$YR$$F$Y$$$20240730$$CN$CA$CA
241508091$24150809$1$I$20240701$20240720$20240730$20240730$EXP$GB-MHRA-MED-202407201634330970-JDYGN$GB-TEVA-VS-3223661$TEVA$$60$YR$$F$Y$89$KG$20240730$$CN$GB$GB
241508104$24150810$4$F$$20240725$20240730$20240731$PER$$US-ROCHE-10000038036$ROCHE$$$$A$F$Y$$$20240731$$CN$US$US
241508111$24150811$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189606$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241508121$24150812$1$I$$20240704$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06878$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241508131$24150813$1$I$$20240723$20240730$20240730$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000079$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240730$$CN$US$US
241508142$24150814$2$F$$20240722$20240730$20240801$EXP$$US-ALXN-202407USA001498US$ALEXION PHARMACEUTICALS$$$$$F$Y$80.726$KG$20240801$$CN$US$US
241508154$24150815$4$F$20240619$20240827$20240730$20240829$EXP$$US-GILEAD-2024-0682252$GILEAD$$94$YR$E$F$Y$70.75$KG$20240829$$HP$US$US
241508161$24150816$1$I$$20240710$20240730$20240730$PER$$US-JNJFOC-20240731786$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240730$$CN$US$US
241508171$24150817$1$I$$20240724$20240730$20240730$PER$$NVSC2024US152946$NOVARTIS$$39$YR$$F$Y$$$20240730$$CN$US$US
241508182$24150818$2$F$$20240718$20240730$20240807$PER$$US-TEVA-VS-3224876$TEVA$$$$$F$Y$$$20240807$$CN$US$US
241508191$24150819$1$I$$20240719$20240730$20240730$EXP$$US-ROCHE-10000031931$ROCHE$$$$E$M$Y$$$20240730$$CN$US$US
241508202$24150820$2$F$$20240806$20240730$20240806$EXP$$HR-UCBSA-2024037343$UCB$$23$YR$$F$Y$$$20240806$$MD$HR$HR
241508211$24150821$1$I$$20240726$20240730$20240730$PER$$US-ABBVIE-5858015$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241508222$24150822$2$F$20240101$20240822$20240730$20240827$EXP$$US-AMGEN-USASP2024148462$AMGEN$$67$YR$E$M$Y$$$20240827$$MD$US$US
241508231$24150823$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148810$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241508241$24150824$1$I$20230801$20240723$20240730$20240730$EXP$$MX-JNJFOC-20240324736$JOHNSON AND JOHNSON$$45$YR$A$F$Y$65$KG$20240730$$CN$MX$MX
241508251$24150825$1$I$20240701$20240719$20240730$20240730$EXP$$JP-AMGEN-JPNSP2024149349$AMGEN$$$$$$Y$$$20240730$$MD$JP$JP
241508261$24150826$1$I$$20240722$20240730$20240730$EXP$$US-GSK-US2024AMR092623$GLAXOSMITHKLINE$$$$$M$Y$$$20240730$$MD$US$US
241508272$24150827$2$F$20240401$20240731$20240730$20240809$EXP$DE-CADRBFARM-2024329281$DE-TEVA-VS-3224575$TEVA$$67$YR$$F$Y$85$KG$20240809$$MD$DE$DE
241508281$24150828$1$I$$20240704$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06880$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241508291$24150829$1$I$20240601$20240722$20240730$20240730$EXP$DE-CADRBFARM-2024329351$DE-862174955-ML2024-04101$MICRO LABS$$46$YR$A$F$Y$78$KG$20240730$$CN$DE$DE
241508301$24150830$1$I$$20240723$20240730$20240730$EXP$GB-MHRA-31183392$GB-862174955-ML2024-04141$MICRO LABS$$$$$F$Y$$$20240730$$PH$GB$GB
241508311$24150831$1$I$$20240722$20240730$20240730$EXP$$GB-862174955-ML2024-04123$MICRO LABS$$$$$$Y$$$20240730$$CN$GB$GB
241508321$24150832$1$I$$20240724$20240730$20240730$EXP$GB-MHRA-MED-202407232038068870-BFWGY$GB-862174955-ML2024-04165$UNKNOWN$$40$YR$A$F$Y$$$20240730$$CN$GB$GB
241508331$24150833$1$I$20240717$20240724$20240730$20240730$EXP$GB-MHRA-MED-202407241020397610-KDWHG$GB-862174955-ML2024-04162$MICRO LABS$$55$YR$A$M$Y$91$KG$20240730$$PH$GB$GB
241508341$24150834$1$I$$20240722$20240730$20240730$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009308$STRIDES$Carranza Morales A, Blanco Jimenez JA, Madhavan A.. A Painful Case of Asthma.. Am-J-Respir-Crit-Care-Med. 2024;209$43$YR$$F$Y$$$20240730$$HP$US$US
241508351$24150835$1$I$$20240723$20240730$20240730$EXP$$IN-SANDOZ INC.-SDZ2024IN068968$SANDOZ$Yadav SS, Mulkutkar S, Balakrishnan C. Clinical profile and treatment outcomes of chronic auto-immune pan uveitis patients at an ocularimmunology eye clinic: A 15-month analysis. INDIAN JOURNAL OF RHEUMATOLOGY. 2023;18 (Suppl 2):S178-9$$$$$Y$$$20240730$$HP$IN$IN
241508361$24150836$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189532$Haleon PLC$$$$$M$Y$$$20240730$$CN$US$US
241508372$24150837$2$F$$20240812$20240730$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06903$LUPIN$$$$$$Y$$$20240828$$CN$US$US
241508381$24150838$1$I$$20240704$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06868$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241508393$24150839$3$F$20240101$20240813$20240730$20240819$EXP$$US-AMGEN-USASP2024147498$AMGEN$$$$$M$Y$$$20240819$$CN$US$US
241508405$24150840$5$F$20240701$20240911$20240730$20240917$PER$$US-AMGEN-USASP2024146809$AMGEN$$$$$$Y$$$20240917$$HP$US$US
241508411$24150841$1$I$$20231009$20240730$20240730$30DAY$$US-SANDOZ INC.-SDZ2023US076641$SANDOZ$$1$YR$$$Y$$$20240730$$CN$US$US
241508421$24150842$1$I$$20240723$20240730$20240730$30DAY$$US-GSK-US2024092399$GLAXOSMITHKLINE$$$$$M$Y$$$20240730$$CN$US$US
241508441$24150844$1$I$20220601$20221115$20240730$20240730$EXP$$US-AstraZeneca-2022A378431$ASTRAZENECA$$650$MON$$M$Y$$$20240730$$CN$US$
241508451$24150845$1$I$$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A169813$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241508461$24150846$1$I$$20220314$20240730$20240730$EXP$$US-AstraZeneca-2022A115169$ASTRAZENECA$$$$$F$Y$53.1$KG$20240730$$CN$US$
241508472$24150847$2$F$$20240903$20240730$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120053$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240905$$CN$US$US
241508481$24150848$1$I$$20240722$20240730$20240730$PER$$US-AstraZeneca-2024A168212$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241508491$24150849$1$I$$20240716$20240730$20240730$EXP$$ES-ROCHE-10000028035$ROCHE$Prieto-Pena D, Llobell-Uriel A, Castano A, Fernandez-Morales L, Gallardo-Diaz E, Gomez-Centeno A, et al. Immune checkpoint inhibitor-related myositis. Case reports and literature review [Abstract number: POS1315]. Doi: 10.1136/annrheumdis-2024-eular.5033. EULAR Congress 2024 - Annals of the Rheumatic Diseases. 2024-Jun;83 (SUP 1):634. doi:10.1136/annrheumdis-2024-eular.5033.$$$$$Y$$$20240730$$HP$ES$ES
241508501$24150850$1$I$$20240725$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118689$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$79$KG$20240730$$PH$US$US
241508511$24150851$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A167157$ASTRAZENECA$$$$$M$Y$$$20240730$$MD$US$
241508521$24150852$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018115$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241508531$24150853$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017833$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240730$$CN$US$US
241508541$24150854$1$I$$20240722$20240730$20240730$EXP$$IE-STRIDES ARCOLAB LIMITED-2024SP009286$STRIDES$Murphy D, Waldron D, Kennedy G, Molony J.. Central anticholinergic syndrome from hyoscine hydrobromide in an unresponsive patient.. BMJ-Support-Palliat-Care. 2023;13 (3):e953-e956$8$DEC$$F$Y$$$20240730$$MD$IE$IE
241508551$24150855$1$I$$20240729$20240729$20240729$DIR$711887$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241508561$24150856$1$I$20240726$20240729$20240729$20240729$DIR$711883$$FDA-CTU$$75$YR$$M$N$$$20240729$N$$US$
241508571$24150857$1$I$20240725$20240729$20240729$20240729$DIR$711888$$FDA-CTU$$48$YR$$M$N$85.7$KG$20240729$N$HP$US$
241508611$24150861$1$I$$20240718$20240730$20240730$EXP$$US-PADAGIS-2024PAD01214$PADAGIS$$$$$$Y$$$20240730$$CN$US$US
241508621$24150862$1$I$$20240710$20240730$20240730$EXP$$US-PADAGIS-2024PAD01169$PADAGIS$$$$$$Y$$$20240730$$CN$US$US
241508631$24150863$1$I$$20240718$20240730$20240730$EXP$$US-PADAGIS-2024PAD01215$PADAGIS$$$$$$Y$$$20240730$$CN$US$US
241508651$24150865$1$I$$20240725$20240730$20240730$EXP$GB-MHRA-MED-202407232038068870-BFWGY$GB-STRIDES ARCOLAB LIMITED-2024SP009282$STRIDES$$40$YR$$F$Y$$$20240730$$CN$GB$GB
241508661$24150866$1$I$$20240719$20240730$20240730$EXP$$CO-ROCHE-10000032752$ROCHE$$46$YR$A$F$Y$$$20240730$$CN$CO$CO
241508674$24150867$4$F$$20240802$20240730$20240809$EXP$$US-TORRENT-00013691$TORRENT$$$$$M$Y$83$KG$20240809$$PH$US$US
241508681$24150868$1$I$20240515$20240722$20240730$20240730$EXP$GB-MHRA-MED-202407221746523650-VSWNY$GB-TORRENT-00037332$TORRENT$$31$YR$A$F$Y$90$KG$20240730$$CN$GB$GB
241508691$24150869$1$I$20240705$20240719$20240730$20240730$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-21941$SAMSUNG BIOEPIS$$23$YR$A$M$Y$60$KG$20240730$$HP$CA$CA
241508701$24150870$1$I$$20240719$20240730$20240730$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-21140$SAMSUNG BIOEPIS$$17$YR$T$F$Y$$$20240730$$CN$CA$CA
241508711$24150871$1$I$$20240719$20240730$20240730$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-22416$SAMSUNG BIOEPIS$$57$YR$A$M$Y$$$20240730$$CN$GB$GB
241508721$24150872$1$I$20240715$20240715$20240730$20240730$PER$$US-JNJFOC-20240748217$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$US$US
241508731$24150873$1$I$$20240708$20240730$20240730$EXP$$US-JNJFOC-20240775553$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$MD$US$US
241508741$24150874$1$I$20221001$20240723$20240730$20240730$EXP$$NVSC2024VN153756$NOVARTIS$$58$YR$$F$Y$$$20240730$$MD$VN$VN
241508761$24150876$1$I$20240717$20240717$20240730$20240730$PER$$US-TEVA-VS-3225874$TEVA$$$$$F$Y$$$20240730$$CN$US$US
241508781$24150878$1$I$20240729$20240729$20240729$20240729$DIR$711889$$FDA-CTU$$65$YR$$M$N$$$20240729$N$$US$
241508791$24150879$1$I$20240709$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024149004$AMGEN$$$$$M$Y$$$20240730$$PH$US$US
241508801$24150880$1$I$20240724$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148436$AMGEN$$$$A$F$Y$$$20240730$$HP$US$US
241508821$24150882$1$I$$20240729$20240729$20240729$DIR$711897$$FDA-CTU$$$$$M$N$91$KG$20240729$Y$$US$
241508832$24150883$2$F$$20240809$20240730$20240814$PER$$US-AMGEN-USASP2024147677$AMGEN$$$$$$Y$$$20240814$$PH$US$US
241508841$24150884$1$I$20240724$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148973$AMGEN$$54$YR$A$F$Y$$$20240730$$CN$US$US
241508851$24150885$1$I$20240726$20240729$20240729$20240729$DIR$711901$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241508861$24150886$1$I$$20240729$20240729$20240729$DIR$711903$$FDA-CTU$$$$$UNK$N$$$20240729$$CN$US$
241508871$24150887$1$I$20240726$20240729$20240729$20240729$DIR$711904$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241508881$24150888$1$I$$20240729$20240729$20240729$DIR$711905$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241508891$24150889$1$I$$20240719$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010859$DR REDDYS$$19$YR$A$F$Y$$$20240730$$MD$US$US
241508901$24150890$1$I$20240706$20240724$20240730$20240730$EXP$$NVSC2024CN154789$NOVARTIS$$64$YR$$M$Y$66$KG$20240730$$HP$CN$CN
241508911$24150891$1$I$20240719$20240729$20240730$20240730$EXP$ES-AEMPS-1553645$NVSC2024ES154744$NOVARTIS$$59$YR$$F$Y$$$20240730$$MD$ES$ES
241508921$24150892$1$I$$20240722$20240730$20240730$PER$US-MLMSERVICE-20240715-PI132778-00307-1$US-RDY-SPO/USA/24/0010912$DR REDDYS$Sanchez J, Guevara N, Mekonen Y, Newman A, Chapiolkina V, Perez Rosario EM, et al. Metachronous Human Papillomavirus (HPV)-Related Eye Carcinoma in Previously Metastatic Breast Cancer: A Case Report. Cureus. 2024;16(7):e64198. DOI:10.7759/cureus.64198.$34$YR$A$F$Y$$$20240730$$MD$US$US
241508951$24150895$1$I$20240708$20240729$20240730$20240730$EXP$$JP-ABBVIE-5859064$ABBVIE$$75$YR$$F$Y$$$20240730$$MD$JP$JP
241508961$24150896$1$I$20240708$20240722$20240730$20240730$PER$$US-ABBVIE-5851873$ABBVIE$$60$YR$$F$Y$59$KG$20240730$$CN$US$US
241508971$24150897$1$I$20240712$20240718$20240730$20240730$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000673$PAREXEL$$$$$$Y$$$20240730$$HP$CN$CN
241508981$24150898$1$I$$20240725$20240730$20240730$EXP$$GB-MYLANLABS-2024M1069840$MYLAN$$$$$M$Y$$$20240730$$PH$GB$GB
241508991$24150899$1$I$20240717$20240725$20240730$20240730$EXP$$AU-MYLANLABS-2024M1069742$MYLAN$$54$YR$$M$Y$$$20240730$$HP$AU$AU
241509012$24150901$2$F$20240604$20240919$20240730$20240924$EXP$$GB-MYLANLABS-2024M1053772$MYLAN$$47$YR$$M$Y$91.9$KG$20240924$$PH$GB$GB
241509021$24150902$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-07150$HIKMA$Lopes D, Sim?es F, Sousa R, Martins AF, Andrade J, Angela C, et al.. Lopes D, Sim?es F, Sousa R, Martins AF, Andrade J, Angela C, Marques S, Matos R, Domingues R, Goncalves I, Costa AM, Cruz AS, Carvalho A. PO-0447 - (4044) - Endocardite infeciosa por haemophilus parainfluenzae resistente ?s cefalosporinas: quando s? existe uma op??o terap?utica. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional. 2024;/:807$42$YR$$F$Y$$$20240730$$MD$PT$PT
241509031$24150903$1$I$$20240715$20240730$20240730$PER$$US-CHATTEMPRD-2024OHG024994$CHATTEM$$$$A$M$Y$$$20240730$$CN$US$US
241509041$24150904$1$I$20240115$20240716$20240730$20240730$EXP$$DE-ROCHE-10000035436$ROCHE$$49$YR$A$F$Y$84$KG$20240730$$MD$DE$DE
241509051$24150905$1$I$$20240729$20240730$20240730$PER$$US-AMGEN-USASP2024150912$AMGEN$$$$$F$Y$$$20240730$$HP$US$US
241509062$24150906$2$F$20240425$20240809$20240730$20240812$PER$$US-AMGEN-USASP2024149272$AMGEN$$55$YR$A$F$Y$$$20240811$$MD$US$US
241509072$24150907$2$F$20240724$20240802$20240730$20240809$30DAY$$US-AMGEN-USASP2024147952$AMGEN$$65$YR$E$M$Y$60.408$KG$20240809$$HP$US$US
241509082$24150908$2$F$20240724$20240807$20240730$20240812$30DAY$$US-AMGEN-USASP2024147978$AMGEN$$69$YR$E$F$Y$81$KG$20240812$$HP$US$US
241509091$24150909$1$I$$20240723$20240730$20240730$EXP$$CZ-AMGEN-CZESP2024147114$AMGEN$Vesely S.; Capoun O.; Katolicka J. et al.. PSMA-PET in the diagnosis and treatment of prostate cancer - expectations versus clinical experience. Current topics in oncology. 2024;2:171-175$70$YR$E$M$Y$$$20240730$$HP$CZ$CZ
241509131$24150913$1$I$20240701$20240729$20240729$20240729$DIR$711900$$FDA-CTU$$92$YR$$F$N$72$KG$20240729$N$CN$US$
241509141$24150914$1$I$$20240729$20240729$20240729$DIR$711908$$FDA-CTU$$$$$UNK$N$$$20240729$$CN$US$
241509161$24150916$1$I$20240725$20240729$20240729$20240729$DIR$711912$$FDA-CTU$$40$YR$$M$N$150.75$KG$20240729$N$HP$US$
241509171$24150917$1$I$$20240729$20240729$20240729$DIR$711913$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241509191$24150919$1$I$$20240729$20240729$20240729$DIR$711916$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241509211$24150921$1$I$20240618$20240729$20240729$20240729$DIR$711911$$FDA-CTU$$66$YR$$F$N$$$20240729$Y$$US$
241509221$24150922$1$I$$20240729$20240729$20240729$DIR$711915$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241509251$24150925$1$I$20240101$20240716$20240730$20240730$EXP$$US-UCBSA-2024036572$UCB$$$$$F$Y$$$20240730$$HP$US$US
241509261$24150926$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS074729$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241509271$24150927$1$I$20240701$20240729$20240730$20240730$EXP$DE-ABBVIE-5845539$DE-UCBSA-2024038042$UCB$$83$YR$$M$Y$$$20240730$$CN$DE$DE
241509291$24150929$1$I$20240711$20240724$20240730$20240730$EXP$$JP-JNJFOC-20240721399$JOHNSON AND JOHNSON$$57$YR$A$M$Y$72$KG$20240730$$PH$JP$JP
241509301$24150930$1$I$$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024148108$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241509311$24150931$1$I$$20240722$20240730$20240730$EXP$$US-GSK-US2024092167$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$MD$US$US
241509322$24150932$2$F$20240701$20240801$20240730$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119964$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240805$$HP$US$US
241509331$24150933$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120060$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$42.18$KG$20240730$$CN$US$US
241509341$24150934$1$I$20240722$20240723$20240730$20240730$EXP$$HR-BRISTOL-MYERS SQUIBB COMPANY-2024-117714$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240730$$HP$HR$HR
241509361$24150936$1$I$20240101$20240727$20240730$20240730$EXP$$CA-UCBSA-2024026914$UCB$$$$$F$Y$$$20240730$$CN$CA$CA
241509372$24150937$2$F$$20240905$20240730$20240910$EXP$$US-ABBVIE-5856887$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
241509382$24150938$2$F$20240709$20240814$20240730$20240820$PER$$US-AMGEN-USASP2024147751$AMGEN$$74$YR$E$M$Y$73.9$KG$20240820$$PH$US$US
241509391$24150939$1$I$20240613$20240729$20240729$20240729$DIR$711918$$FDA-CTU$$43$YR$$F$N$$$20240729$N$HP$US$
241509401$24150940$1$I$$20240729$20240729$20240729$DIR$711919$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241509411$24150941$1$I$20230104$20240724$20240730$20240730$EXP$$CA-TAKEDA-2024TUS075408$TAKEDA$$44$YR$$F$Y$$$20240730$$CN$CA$CA
241509421$24150942$1$I$20240706$20240718$20240730$20240730$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000674$PAREXEL$$$$$$Y$$$20240730$$HP$CN$CN
241509431$24150943$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189605$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241509441$24150944$1$I$$20240729$20240729$20240729$DIR$711920$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241509451$24150945$1$I$$20240729$20240729$20240729$DIR$711921$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241509461$24150946$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52077$$FDA-CTU$$82$YR$$M$N$$$20240729$N$$US$
241509471$24150947$1$I$$20240723$20240730$20240730$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005513$BIOCON$$$$$$Y$$$20240730$$MD$CA$CA
241509482$24150948$2$F$$20240724$20240730$20240813$EXP$$AU-BEH-2024176371$CSL BEHRING$$55$YR$A$F$Y$77$KG$20240813$$CN$AU$AU
241509502$24150950$2$F$$20240919$20240730$20240926$EXP$$CA-TAKEDA-2024TUS075783$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
241509511$24150951$1$I$$20240726$20240730$20240730$EXP$$US-ABBVIE-5857338$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241509521$24150952$1$I$$20240722$20240730$20240730$EXP$$VN-AstraZeneca-2024A171575$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$VN$
241509531$24150953$1$I$20240503$20240725$20240730$20240730$EXP$$FR-AstraZeneca-2024A169500$ASTRAZENECA$$74$YR$$F$Y$64$KG$20240730$$MD$FR$
241509541$24150954$1$I$$20240722$20240730$20240730$PER$$US-AstraZeneca-2024A168931$ASTRAZENECA$$$$$F$Y$$$20240730$$PH$US$
241509551$24150955$1$I$20240510$20240722$20240730$20240730$EXP$$AT-TAKEDA-2024TUS049077$TAKEDA$$38$YR$$F$Y$$$20240730$$CN$AT$AT
241509561$24150956$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS076037$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241509571$24150957$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A166587$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241509581$24150958$1$I$20230403$20240717$20240730$20240730$EXP$FR-AFSSAPS-MA2024000808$FR-BAYER-2024A103941$BAYER$$39$YR$A$M$Y$$$20240730$$MD$FR$FR
241509591$24150959$1$I$20240101$20240718$20240730$20240730$EXP$$US-NOVOPROD-1259946$NOVO NORDISK$$$$$F$Y$$$20240730$$CN$US$US
241509601$24150960$1$I$$20240725$20240730$20240730$EXP$$CH-ABBVIE-5855979$ABBVIE$$17$YR$$M$Y$$$20240730$$MD$CH$CH
241509612$24150961$2$F$20240401$20240807$20240730$20240809$EXP$$US-UCBSA-2024021307$UCB$$79$YR$$F$Y$$$20240809$$CN$US$US
241509631$24150963$1$I$20240721$20240724$20240730$20240730$EXP$$CN-ABBVIE-5858275$ABBVIE$$74$YR$$F$Y$54$KG$20240730$$HP$CN$CN
241509641$24150964$1$I$20240701$20240723$20240730$20240730$PER$$US-ALXN-202407USA001589US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241509652$24150965$2$F$$20240821$20240730$20240821$PER$$US-ALXN-202407USA001618US$ALEXION PHARMACEUTICALS$$$$$M$Y$58.97$KG$20240821$$CN$US$US
241509661$24150966$1$I$20240720$20240721$20240730$20240730$EXP$$US-JNJFOC-20240756629$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240730$$CN$US$US
241509671$24150967$1$I$$20240722$20240730$20240730$EXP$$US-VIIV HEALTHCARE LIMITED-US2024091770$VIIV$$56$YR$$M$Y$$$20240730$$CN$US$US
241509681$24150968$1$I$20240426$20240715$20240730$20240730$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459743$RANBAXY$$67$YR$$M$Y$60$KG$20240730$$MD$ES$ES
241509691$24150969$1$I$20160101$20240715$20240730$20240730$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459792$RANBAXY$$80$YR$$M$Y$$$20240730$$CN$CZ$CZ
241509701$24150970$1$I$20240326$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459786$RANBAXY$$72$YR$$M$Y$$$20240730$$HP$FR$FR
241509711$24150971$1$I$20240414$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459781$RANBAXY$$70$YR$$F$Y$$$20240730$$MD$FR$FR
241509721$24150972$1$I$20240221$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459720$RANBAXY$$26$YR$$M$Y$$$20240730$$PH$FR$FR
241509731$24150973$1$I$20221206$20240722$20240730$20240730$EXP$$CO-UCBSA-2024037627$UCB$$50$YR$$M$Y$$$20240730$$CN$CO$CO
241509741$24150974$1$I$$20240723$20240730$20240730$EXP$$GB-TAKEDA-2024TUS075481$TAKEDA$$$$$M$Y$$$20240730$$CN$GB$GB
241509752$24150975$2$F$$20240801$20240730$20240806$PER$$US-AMGEN-USASP2024147737$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241509761$24150976$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148571$AMGEN$$$$$M$Y$$$20240730$$CN$US$US
241509771$24150977$1$I$$20240723$20240730$20240730$EXP$$RO-AMGEN-ROUSP2024146772$AMGEN$Ciobica M.; Valea A.; Nistor C. et al.. Brown Tumors: The Hidden Face of Primary and Renal Hyperparathyroidism Amid Real-Life Settings. Journal of Clinical Medicine. 2024;13 (13):1-23$38$YR$A$F$Y$$$20240730$$HP$RO$RO
241509791$24150979$1$I$$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459445$RANBAXY$$56$YR$$M$Y$$$20240730$$PH$FR$FR
241509801$24150980$1$I$$20240726$20240730$20240730$PER$$NVSC2024US154901$NOVARTIS$$63$YR$$F$Y$71.6$KG$20240730$$CN$US$US
241509811$24150981$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459754$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$18$MON$$M$Y$$$20240730$$HP$HR$HR
241509821$24150982$1$I$20240325$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459300$RANBAXY$$29$YR$$F$Y$$$20240730$$PH$FR$FR
241509831$24150983$1$I$20240402$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459299$RANBAXY$$3$MON$$F$Y$6.5$KG$20240730$$MD$FR$FR
241509841$24150984$1$I$$20240716$20240730$20240730$EXP$$CA-BIOVITRUM-2024-CA-009941$BIOVITRUM$$$$$F$Y$$$20240730$$HP$CA$CA
241509851$24150985$1$I$$20240715$20240730$20240730$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459438$RANBAXY$$$$$M$Y$$$20240730$$HP$GB$GB
241509861$24150986$1$I$$20240715$20240730$20240730$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459646$RANBAXY$Huynh A, Siggs OM, Wainstein BK, Gray PE. Infliximab Reverses Symptoms and May Protect from Developing Chronic Restrictive Ophthalmopathy in Children with Familial Orbital Myositis: A Case Report. Ocul Immunol Inflamm. 2023;31(5):1097-1100$9$YR$$F$Y$$$20240730$$MD$AU$AU
241509871$24150987$1$I$$20240715$20240730$20240730$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459146$RANBAXY$Fujikawa H, Saigusa S, Aono Y, Ikeda M, Tempaku N, Hashimoto K, et al. Small Bowel Obstruction Caused by Migration of Fractured Metal Stent in Patients with Malignant Gastric Outlet Obstruction: A Report of Two Cases and Review of the Literature. Intern Med. 2024;63 (13)::1873-1878$58$YR$$F$Y$$$20240730$$MD$JP$JP
241509881$24150988$1$I$$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459303$RANBAXY$$34$YR$$M$Y$$$20240730$$PH$FR$FR
241509891$24150989$1$I$$20240725$20240730$20240730$EXP$$NVSJ2024JP009123$NOVARTIS$$$$A$M$Y$$$20240730$$MD$JP$JP
241509901$24150990$1$I$20230606$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459295$RANBAXY$$16$YR$$F$Y$$$20240730$$MD$FR$FR
241509911$24150991$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459804$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$F$Y$$$20240730$$HP$HR$HR
241509921$24150992$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459800$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$M$Y$$$20240730$$HP$HR$HR
241509931$24150993$1$I$20231222$20240723$20240730$20240730$EXP$$NVSJ2024JP001311$NOVARTIS$$76$YR$$F$Y$68.7$KG$20240730$$MD$JP$JP
241509941$24150994$1$I$20240301$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459359$RANBAXY$$81$YR$$M$Y$$$20240730$$PH$FR$FR
241509951$24150995$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459798$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$F$Y$$$20240730$$HP$HR$HR
241509961$24150996$1$I$20240426$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459216$RANBAXY$$42$YR$$M$Y$$$20240730$$PH$FR$FR
241509971$24150997$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459789$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$M$Y$$$20240730$$HP$HR$HR
241509981$24150998$1$I$$20240724$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042106$BOEHRINGER INGELHEIM$$$$$F$Y$126$KG$20240730$$CN$US$US
241509991$24150999$1$I$20240423$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459284$RANBAXY$$81$YR$$M$Y$78$KG$20240730$$PH$FR$FR
241510001$24151000$1$I$$20240715$20240730$20240730$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459109$RANBAXY$Casado E, Costa E, Mezquita-Raya P, Andujar-Espinosa R, Neyro JL.. Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases. Drugs Cont. 2023;12:no pagination$67$YR$$M$Y$$$20240730$$HP$ES$ES
241510012$24151001$2$F$$20240730$20240730$20240806$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP009174$STRIDES$$65$YR$$M$Y$102$KG$20240806$$HP$NL$NL
241510031$24151003$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459377$RANBAXY$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J Ophthalmic Inflamm Infect. 2024;14 (1):12 (1-6)$43$YR$$M$Y$$$20240730$$HP$US$US
241510041$24151004$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459768$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$31$MON$$M$Y$$$20240730$$HP$HR$HR
241510051$24151005$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459318$RANBAXY$Li D, Qin W, Guo Y, Xia M, Li S, Zhang J, et al. Clinical, laboratory, and radiological features of cerebral amyloid angiopathy?related infammation (CAA?ri): retrospective, observational experience of a single centre. Neurol Sci. 2023;44 (2):631-638$67$YR$$F$Y$$$20240730$$HP$CN$CN
241510061$24151006$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459515$RANBAXY$Jiangyuan Z, Kaiying Y, Suhua P, Tong Q, Shiyi D, Xuepeng Z. Sirolimus combined with prednisone in the treatment of Kaposiform hemangioendothelioma complicated by Kasabach?Merritt phenomenon: a preliminary study. Chin J Dermatol. 2020;Jul;53(7):514-518$$$C$$Y$$$20240730$$HP$CN$CN
241510071$24151007$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459117$RANBAXY$Chawla R, Alqaisieh M, Connor L, Mcdonough C. Challenging Diagnosis and Management of Disseminated Histoplasmosis With Coexistent Adrenal Insufficiency. Am J Respir Crit Care Med. 2024;209:A3571$56$YR$$F$Y$$$20240730$$HP$US$US
241510081$24151008$1$I$$20240715$20240730$20240730$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459172$RANBAXY$Fujikawa H, Saigusa S, Aono Y, Ikeda M, Tempaku N, Hashimoto K, et al. Small Bowel Obstruction Caused by Migration of Fractured Metal Stent in Patients with Malignant Gastric Outlet Obstruction: A Report of Two Cases and Review of the Literature. Intern Med. 2024;63 (13)::1873-1878$65$YR$$M$Y$$$20240730$$MD$JP$JP
241510091$24151009$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459773$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$3$MON$$F$Y$$$20240730$$HP$HR$HR
241510101$24151010$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459772$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$16$MON$$M$Y$$$20240730$$HP$HR$HR
241510112$24151011$2$F$20240531$20240731$20240730$20240814$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458214$RANBAXY$$$$E$M$Y$$$20240814$$PH$FR$FR
241510121$24151012$1$I$20240101$20240723$20240730$20240730$EXP$$US-SA-2024SA220910$SANOFI AVENTIS$$63$YR$A$F$Y$65$KG$20240730$$MD$US$US
241510131$24151013$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459321$RANBAXY$Li D, Qin W, Guo Y, Xia M, Li S, Zhang J, et al. Clinical, laboratory, and radiological features of cerebral amyloid angiopathy?related infammation (CAA?ri): retrospective, observational experience of a single centre. Neurol Sci. 2023;44(2):631-638$53$YR$$F$Y$$$20240730$$HP$CN$CN
241510141$24151014$1$I$20230525$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459298$RANBAXY$$15$YR$$F$Y$$$20240730$$MD$FR$FR
241510151$24151015$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459163$RANBAXY$Wei S, Mei W, Wang Y. Association of thrombotic microangiopathy with interferon therapy for hepatitis B: a case report. J Med Case Rep. 2024;18 (1):321$36$YR$$M$Y$$$20240730$$HP$CN$CN
241510161$24151016$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459766$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$F$Y$$$20240730$$HP$HR$HR
241510171$24151017$1$I$20240204$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459214$RANBAXY$$65$YR$$F$Y$$$20240730$$PH$FR$FR
241510181$24151018$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459330$RANBAXY$Kommineni SS, Gullapalli D, Gray C, Vangara A, Ganti SS. What Is Growing in the Garden?A Case of Severe Blastomycosis in Poorly Controlled Diabetes Mellitus. Am J Respir Crii Care Med. 2024;209 (0):A2370$59$YR$$F$Y$$$20240730$$HP$US$US
241510191$24151019$1$I$$20240715$20240730$20240730$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458461$RANBAXY$Markus E, Bel-Ange A, Benbassat C, Steinschneider M, Koren R. Short- and long-term outcomes of patients with hyper or hypothyroidism following COVID vaccine. J Invest Med. 2023;71(7):700-706$41$YR$$F$Y$$$20240730$$HP$IL$IL
241510201$24151020$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459368$RANBAXY$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J Ophthalmic Inflamm Infect. 2024;14 (1):12 (1-6)$89$YR$$F$Y$$$20240730$$HP$US$US
241510211$24151021$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459765$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$19$MON$$F$Y$$$20240730$$HP$HR$HR
241510221$24151022$1$I$$20240715$20240730$20240730$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459115$RANBAXY$$$$$F$Y$$$20240730$$CN$RO$RO
241510231$24151023$1$I$$20240715$20240730$20240730$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459135$RANBAXY$Sood A, Nayyar V, Roychoudhury A, Bhalla AS, Mishra D. Post-COVID steroid induced avascular necrosis of the jaw:Emerging challenge in India. OMFP. 2023;Apr; 135(4):e89-e93$49$YR$$M$Y$$$20240730$$HP$IN$IN
241510241$24151024$1$I$$20240715$20240730$20240730$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459385$RANBAXY$Carvalho NB, de Freitas VLT, Seguro FS, Bezerra VLT, Seguro FS, Bezerra Nakanishi EYS, et al. Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review. Rev Inst Med Trop Sao Paulo. 2023;66:e10/1-15$59$YR$$M$Y$$$20240730$$HP$BR$BR
241510251$24151025$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459353$RANBAXY$Senchyna F, Murugesan K, Rotunno W, Nadimpalli SS, Deresinski S, Banaei N. Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-beta-lactamase-Producing Escherichia coli Causing Fatal Bloodstream Infection. Clin Infect Dis. 2024;Jun 15;78 (6):1425-1428$12$YR$$M$Y$$$20240730$$HP$US$US
241510261$24151026$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459378$RANBAXY$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J Ophthalmic Inflamm Infect. 2024;14 (1):12 (1-6)$65$YR$$F$Y$$$20240730$$HP$US$US
241510271$24151027$1$I$20240119$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459325$RANBAXY$$79$YR$E$M$Y$$$20240730$$CN$US$US
241510281$24151028$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459324$RANBAXY$Gao Y-H, Duan M-H, Li J,Zhang L. Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report. Turk J Hematol. 2024;44(1):61-63$46$YR$$F$Y$$$20240730$$HP$CN$CN
241510291$24151029$1$I$$20240715$20240730$20240730$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458462$RANBAXY$Markus E, Bel-Ange A, Benbassat C, Steinschneider M, Koren R. Short- and long-term outcomes of patients with hyper or hypothyroidism following COVID vaccine. J Invest Med. 2023;71(7):700-706$61$YR$$M$Y$$$20240730$$HP$IL$IL
241510301$24151030$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459335$RANBAXY$Shivaraj K, Tchakarov A, Dong Y, Lin JS. Tofacitinib for the treatment of refractory immune checkpoint inhibitor-associated immune nephritis. Clin Kidney J. 2024;17 (5):sfae127;1-3$65$YR$$F$Y$$$20240730$$HP$US$US
241510311$24151031$1$I$20050101$20240715$20240730$20240730$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459339$RANBAXY$Carvalho NB, de Freitas VLT, Seguro FS, Bezerra VLT, Seguro FS, Bezerra Nakanishi EYS, et al. Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review. Rev Inst Med Trop Sao Paulo. 2023;66:e10/1-15$51$YR$$M$Y$$$20240730$$HP$BR$BR
241510321$24151032$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459794$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$F$Y$$$20240730$$HP$HR$HR
241510331$24151033$1$I$$20240715$20240730$20240730$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457773$RANBAXY$Mura C, Sonnino R, Crispino L, Rota C, Pontecorvi A. Graves disease in hypopituitarism due to pituitary apoplexy. Endocr Metab Immune Disord Drug Targets. 2024;Jul 11:online ahead of print$41$YR$$F$Y$$$20240730$$HP$IT$IT
241510341$24151034$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459802$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$F$Y$$$20240730$$HP$HR$HR
241510351$24151035$1$I$$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459231$RANBAXY$$17$YR$$M$Y$$$20240730$$HP$FR$FR
241510361$24151036$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459769$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$8$MON$$F$Y$$$20240730$$HP$HR$HR
241510371$24151037$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459142$RANBAXY$Snowdin JW, Mercuro NJ, Madaio MP, Rawlings SA. Case report: Successful treatment of OXA-23 Acinetobacter baumannii neurosurgical infection and meningitis with sulbactam-durlobactam combination therapy. Front Med. 2024;May 15; 11 (0):1381123; 1-5$75$YR$$F$Y$$$20240730$$HP$US$US
241510381$24151038$1$I$$20240715$20240730$20240730$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459289$RANBAXY$Zpracovala R, Viktorova K. Development of osteology in the Czech Republic, denosumab and romosozumab in the treatment of osteoporosis. Remedia. 2024;34:247-252$$$$F$Y$61.5$KG$20240730$$PH$CZ$CZ
241510391$24151039$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459276$RANBAXY$Piao Y, Yang Y, Wu S, Han L. Toripalimab plus cetuximab combined with radiotherapy in a locally advanced platinum-based chemotherapy-insensitive nasopharyngeal carcinoma patient: a case report. Front Oncol. 2024;May;14:1383250(1-6)$55$YR$$F$Y$$$20240730$$HP$CN$CN
241510402$24151040$2$F$$20240730$20240730$20240814$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459139$RANBAXY$Skwarek-Dziekanowska A, Klaja B, Olajossy B, Miszczak M, Szewczuk R, Wojtowicz-Scislak A, et al. A stuck CSP lead: Should everyone have tools for TLE?. Kardiol Pol. 2024;82 (Suppl.):55$54$YR$$M$Y$$$20240814$$HP$PL$PL
241510411$24151041$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459320$RANBAXY$Li D, Qin W, Guo Y, Xia M, Li S, Zhang J, et al. Clinical, laboratory, and radiological features of cerebral amyloid angiopathy?related infammation (CAA?ri): retrospective, observational experience of a single centre. Neurol Sci. 2023;44(2):631-638$69$YR$$F$Y$$$20240730$$HP$CN$CN
241510421$24151042$1$I$$20240715$20240730$20240730$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459196$RANBAXY$Cabreira V, Ferreira D, Melo C, Rebelo J, Fonseca J, Sousa R, et al. Child Neurology: Anti-Hu Encephalitis in an Adolescent With a Mediastinal Seminoma. Neurology. 2023;Oct 17;101(16):e1640-e1645$15$YR$$M$Y$$$20240730$$MD$PT$PT
241510431$24151043$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459316$RANBAXY$Li D, Qin W, Guo Y, Xia M, Li S, Zhang J, et al. Clinical, laboratory, and radiological features of cerebral amyloid angiopathy?related infammation (CAA?ri): retrospective, observational experience of a single centre. Neurol Sci. 2023;44 (2):631-638$69$YR$$F$Y$$$20240730$$HP$CN$CN
241510441$24151044$1$I$$20240715$20240730$20240730$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459380$RANBAXY$Carvalho NB, de Freitas VLT, Seguro FS, Bezerra RC, Fatobene G, Nakanishi EYS, et al.. Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review. Rev Inst Med Trop Sao Paulo. 2024;66:e10/1-15$55$YR$$F$Y$$$20240730$$HP$BR$BR
241510451$24151045$1$I$20240726$20240729$20240729$20240729$DIR$711924$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241510462$24151046$2$F$$20240725$20240730$20240809$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459175$RANBAXY$Hazama T, Maruno K, Takahashi T, Yamada Y, Nakashima M, Kikkawa K, et al. A Case of Granulocyte Colony-Stimulating Factor-Related Aortitis that Developed during the Treatment of Advanced Prostate Cancer with Neuroendocrine Differentiation. Hinyokika Kiyo. 2024;70 (6):179-183$81$YR$$M$Y$$$20240809$$HP$JP$JP
241510471$24151047$1$I$$20240715$20240730$20240730$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459099$RANBAXY$Casado E, Costa E, Mezquita-Raya P, Andujar-Espinosa R, Neyro JL.. Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases.. Drugs Cont. 2023;12:no pagination$62$YR$$F$Y$$$20240730$$HP$ES$ES
241510481$24151048$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459767$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$30$MON$$F$Y$$$20240730$$HP$HR$HR
241510491$24151049$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459787$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$F$Y$$$20240730$$HP$HR$HR
241510501$24151050$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459315$RANBAXY$Li D, Qin W, Guo Y, Xia M, Li S, Zhang J, et al. Clinical, laboratory, and radiological features of cerebral amyloid angiopathy?related infammation (CAA?ri): retrospective, observational experience of a single centre. Neurol Sci. 2023;44 (2):631-638$67$YR$$M$Y$$$20240730$$HP$CN$CN
241510511$24151051$1$I$$20240715$20240730$20240730$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459283$RANBAXY$Wu W-L, Lee J-C, Su WC, Wang S-Y, Wu C-J. A rare case of an endobronchial mass due to Neurospora intermedia. Int J Infect Dis. 2024;146 (0):107119;1-4$25$YR$$M$Y$$$20240730$$HP$TW$TW
241510521$24151052$1$I$20240708$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52142$$FDA-CTU$$79$YR$$M$N$$$20240729$N$$US$
241510531$24151053$1$I$20240726$20240729$20240729$20240729$DIR$711928$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241510541$24151054$1$I$$20240729$20240729$20240729$DIR$711923$$FDA-CTU$$37$YR$$F$N$$$20240729$Y$CN$US$
241510551$24151055$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459238$RANBAXY$Han X-M, Zhou Y-M, Cen L-S. Ocular rosacea without facial erythema involvement manifesting as bilateral multiple recurrent chalazions: A case report. World J Clin Cases. 2024;Jun,; 12(17):3253-3258$63$YR$$F$Y$$$20240730$$HP$CN$CN
241510561$24151056$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459803$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$M$Y$$$20240730$$HP$HR$HR
241510571$24151057$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459312$RANBAXY$Li D, Qin W, Guo Y, Xia M, Li S, Zhang J, et al. Clinical, laboratory, and radiological features of cerebral amyloid angiopathy?related infammation (CAA?ri): retrospective, observational experience of a single centre. Neurol Sci. 2023;44 (2):631-638$62$YR$$M$Y$$$20240730$$HP$CN$CN
241510582$24151058$2$F$$20240801$20240730$20240810$EXP$$ES-TEVA-VS-3223517$TEVA$Alvarez R, Lopez MG, Arregui M, Alvarez A, Crisostomo RAG, Calles A, et al. Prolonged survival of a patient with desmoplastic small round cell tumor. Cancer-Chemo-Rev 2022; 17 (3): 41-46.; Alvarez R, Lopez MG, Arregui M, Alvarez A, Crisostomo RAG, Calles A, et al. Prolonged survival of a patient with desmoplastic small round cell tumor. Cancer-Chemo-Rev 2022; 17 (3): 41-46.$34$YR$$M$Y$$$20240810$$HP$ES$ES
241510591$24151059$1$I$$20240715$20240730$20240730$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458463$RANBAXY$Markus E, Bel-Ange A, Benbassat C, Steinschneider M, Koren R. Short- and long-term outcomes of patients with hyper or hypothyroidism following COVID vaccine. J Invest Med. 2023;71(7):700-706$62$YR$$M$Y$$$20240730$$HP$IL$IL
241510601$24151060$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459183$RANBAXY$O^Meara KT, Fansiwala K, Kathuria-Prakash N, El-Masry M, Oh S. Acute hypoxic respiratory failure due to Lenalidomide-induced interstitial pneumonitis in a patient with multiple myeloma. BMC Pulm Med. 2024;Jul;24 (1):321$80$YR$$M$Y$$$20240730$$HP$US$US
241510611$24151061$1$I$20231014$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459296$RANBAXY$$13$YR$$F$Y$$$20240730$$MD$FR$FR
241510621$24151062$1$I$$20240715$20240730$20240730$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458362$RANBAXY$Markus E, Bel-Ange A, Benbassat C, Steinschneider M, Koren R. Short- and long-term outcomes of patients with hyper or hypothyroidism following COVID vaccine. J Invest Med. 2023;71(7):700-706$49$YR$$F$Y$$$20240730$$HP$IL$IL
241510631$24151063$1$I$20240702$20240729$20240729$20240729$DIR$711930$$FDA-CTU$$83$YR$$F$N$81$KG$20240729$N$CN$US$
241510641$24151064$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459369$RANBAXY$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J Ophthalmic Inflamm Infect. 2024;14 (1):12 (1-6)$76$YR$$F$Y$$$20240730$$HP$US$US
241510651$24151065$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459805$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$F$Y$$$20240730$$HP$HR$HR
241510661$24151066$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459762$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$F$Y$$$20240730$$HP$HR$HR
241510671$24151067$1$I$$20240715$20240730$20240730$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459654$RANBAXY$Soravia A, Simeon V, Menchini F, Di Renzo G, Di Bin F, Olivieri J, et al. A CASE OF RETINOPATHY AFTER CAR-T THERAPY. Haematologica. 2024;109 (Suppl.):117$64$YR$$F$Y$$$20240730$$HP$IT$IT
241510681$24151068$1$I$20240725$20240727$20240730$20240730$EXP$$CA-TAKEDA-2024TUS076325$TAKEDA$$62$YR$$M$Y$$$20240730$$CN$CA$CA
241510692$24151069$2$F$$20240724$20240730$20240808$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457789$RANBAXY$Gurbuz AF, Ery?lmaz MK, Y?ld?z O, K?l?nc F, Araz M, Artac M. Rare case of myelodysplastic syndrome with excess blasts 2 developing after adjuvant chemoradiotherapy  for triple-negative breast cancer in apatient with Bloom syndrome. Strahlenther Onkol. 2024;Jul 12:Online ahead of print$30$YR$$F$Y$$$20240808$$HP$TR$TR
241510702$24151070$2$F$$20240808$20240730$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459890$RANBAXY$Imai T, Shoji H, Hirano H, Matsuguma K, Awatsu T, Hirose T, et al. BRAF V600E-mutant colorectal cancer with CNS metastases treated successfully with encorafenib, binimetinib and cetuximab. CNSOncol. 2024;13(1):1-6$53$YR$$M$Y$$$20240823$$HP$JP$JP
241510711$24151071$1$I$20240401$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459835$RANBAXY$$12$YR$$F$Y$40$KG$20240730$$HP$FR$FR
241510721$24151072$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456001$RANBAXY$Jiangyuan Z, Kaiying Y, Suhua P, Tong Q, Shiyi D, Xuepeng Z et al. Sirolimus combined with prednisone in the treatment of Kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: a preliminary study. Chin J Dermatol. 2020;Jul ; 53(7):514-518$$$I$$Y$$$20240730$$HP$CN$CN
241510731$24151073$1$I$$20240724$20240730$20240730$EXP$$US-SA-2024SA219184$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240730$$MD$US$US
241510741$24151074$1$I$$20240715$20240730$20240730$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459883$RANBAXY$$35$YR$$M$Y$78$KG$20240730$$CN$DE$DE
241510752$24151075$2$F$20240429$20240719$20240730$20240802$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459853$RANBAXY$$79$YR$$M$Y$$$20240802$$MD$IT$IT
241510761$24151076$1$I$$20240715$20240730$20240730$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459922$RANBAXY$$59$YR$$F$Y$57$KG$20240730$$CN$GB$GB
241510771$24151077$1$I$20240201$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459862$RANBAXY$$58$YR$$F$Y$69$KG$20240730$$PH$FR$FR
241510781$24151078$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456002$RANBAXY$Jiangyuan Z, Kaiying Y, Suhua P, Tong Q, Shiyi D, Xuepeng Z et al. Sirolimus combined with prednisone in the treatment of Kaposiform hemangioendothelioma complicated by Kasabach?Merritt phenomenon: a preliminary study. Chin J Dermatol. 2020;Jul ; 53(7):514-518$$$I$$Y$$$20240730$$HP$CN$CN
241510791$24151079$1$I$$20240715$20240730$20240730$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457121$RANBAXY$Sood A, Nayyar V, Roychoudhury A, Bhalla AS, Mishra D. Post-COVID steroid induced avascular necrosis of the jaw:Emerging challenge in India. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023;Apr;135 (4):e89-e93$28$YR$$M$Y$$$20240730$$HP$IN$IN
241510802$24151080$2$F$20231116$20240809$20240730$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459848$RANBAXY$$66$YR$$F$Y$71.8$KG$20240823$$MD$FR$FR
241510811$24151081$1$I$20240422$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459894$RANBAXY$$56$YR$$M$Y$$$20240730$$PH$FR$FR
241510821$24151082$1$I$20240329$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459809$RANBAXY$$64$YR$$F$Y$$$20240730$$MD$FR$FR
241510831$24151083$1$I$20240218$20240715$20240730$20240730$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459857$RANBAXY$$79$YR$$F$Y$$$20240730$$MD$ES$ES
241510841$24151084$1$I$20240715$20240715$20240730$20240730$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459921$RANBAXY$$71$YR$$F$Y$90$KG$20240730$$HP$GB$GB
241510851$24151085$1$I$20240502$20240715$20240730$20240730$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459928$RANBAXY$$36$YR$$F$Y$$$20240730$$MD$DE$DE
241510861$24151086$1$I$20230817$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459820$RANBAXY$$50$YR$$F$Y$$$20240730$$MD$FR$FR
241510871$24151087$1$I$20240331$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459871$RANBAXY$$58$YR$$M$Y$51$KG$20240730$$HP$FR$FR
241510891$24151089$1$I$20240402$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459878$RANBAXY$$57$YR$$M$Y$63$KG$20240730$$MD$FR$FR
241510901$24151090$1$I$20230618$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459891$RANBAXY$$17$YR$$F$Y$$$20240730$$MD$FR$FR
241510911$24151091$1$I$20240205$20240715$20240730$20240730$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459992$RANBAXY$$55$YR$$F$Y$$$20240730$$MD$IT$IT
241510927$24151092$7$F$20240624$20240906$20240730$20240920$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459961$RANBAXY$$85$YR$$M$Y$$$20240920$$HP$BE$BE
241510931$24151093$1$I$20240408$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459911$RANBAXY$$85$YR$$F$Y$60.2$KG$20240730$$MD$FR$FR
241510941$24151094$1$I$20240425$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459843$RANBAXY$$86$YR$$M$Y$$$20240730$$PH$FR$FR
241510951$24151095$1$I$$20240722$20240730$20240730$EXP$$AT-SANDOZ INC.-NVSC2023AT145424$SANDOZ$Haninger-Vacariu N, Aigner C, Gaggl M, Kain R, Prohaszka Z, Bohmig GA et al.. Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy. CLINICAL KIDNEY JOURNAL. 2021;14(4):1255-60$38$YR$$F$Y$$$20240730$$MD$AT$AT
241510961$24151096$1$I$20240701$20240725$20240730$20240730$EXP$$US-SA-2024SA221889$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240730$$CN$US$US
241510971$24151097$1$I$20240701$20240725$20240730$20240730$EXP$$US-SA-2024SA221933$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240730$$MD$US$US
241510981$24151098$1$I$$20240729$20240730$20240730$EXP$$GB-ORGANON-O2407GBR002684$ORGANON$$72$YR$$M$Y$$$20240730$$HP$GB$GB
241510991$24151099$1$I$$20240725$20240730$20240730$EXP$PT-INFARMED-F202407-301$PT-SA-2024SA221114$SANOFI AVENTIS$$66$YR$E$F$Y$50$KG$20240730$$HP$PT$PT
241511001$24151100$1$I$20240706$20240719$20240730$20240730$EXP$$CN-ROCHE-10000032124$ROCHE$$51$YR$A$F$Y$50$KG$20240730$$HP$CN$CN
241511011$24151101$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-10000041185$ROCHE$$61$YR$A$F$Y$$$20240730$$CN$US$US
241511021$24151102$1$I$20240719$20240729$20240730$20240730$EXP$$CN-ROCHE-10000041276$ROCHE$$74$YR$E$F$Y$60$KG$20240730$$HP$CN$CN
241511031$24151103$1$I$20240615$20240723$20240730$20240730$EXP$ES-AEMPS-1543259$ES-MYLANLABS-2024M1068566$MYLAN$$6$YR$$M$Y$$$20240730$$PH$ES$ES
241511042$24151104$2$F$20240724$20240822$20240730$20240828$30DAY$$US-AMGEN-USASP2024148892$AMGEN$$78$YR$E$F$Y$56.8$KG$20240828$$HP$US$US
241511051$24151105$1$I$20240601$20240722$20240730$20240730$EXP$$US-AMGEN-USASP2024145502$AMGEN$$86$YR$E$F$Y$$$20240730$$CN$US$US
241511063$24151106$3$F$20240717$20240823$20240730$20240829$30DAY$$US-AMGEN-USASL2024144174$AMGEN$$56$YR$A$F$Y$$$20240828$$HP$US$US
241511071$24151107$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120497$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240730$$CN$US$US
241511082$24151108$2$F$$20240911$20240730$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120058$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240913$$CN$US$US
241511091$24151109$1$I$$20240722$20240730$20240730$EXP$$US-AMGEN-USASP2024146735$AMGEN$Kranyak A.; Hodson E.; Salem I. et al.. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases. Journal of Tissue Viability. 2024;33 (3):449-451$54$YR$A$F$Y$$$20240730$$HP$US$US
241511101$24151110$1$I$20240723$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119925$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$PH$US$US
241511111$24151111$1$I$20240503$20240726$20240730$20240730$EXP$ES-AEMPS-1553910$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-119869$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240730$$MD$ES$ES
241511121$24151112$1$I$$20240722$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117759$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$47.17$KG$20240730$$PH$US$US
241511131$24151113$1$I$20240712$20240724$20240730$20240730$EXP$$NVSC2023AR250496$NOVARTIS$$75$YR$$F$Y$$$20240730$$CN$AR$AR
241511144$24151114$4$F$20240201$20240823$20240730$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202407017672$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240904$$CN$US$US
241511151$24151115$1$I$20240721$20240726$20240730$20240730$EXP$$GB-HALEON-2189198$Haleon PLC$$18$YR$$M$Y$$$20240730$$CN$GB$GB
241511161$24151116$1$I$20240724$20240724$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016334$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240730$$CN$US$US
241511171$24151117$1$I$$20240718$20240730$20240730$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06999$LUPIN$Wiese J, Derian NA, Ghimire S, Bambhroliya Z, Joshi T. Glecaprevir-Pibrentasvir and Ethinyl Estradiol-induced liver injury in a patient without cirrhosis. Cureus. 2024;16(6):e61980:1-6$33$YR$$F$Y$$$20240730$$HP$US$US
241511181$24151118$1$I$20240712$20240725$20240730$20240730$EXP$$CN-ROCHE-10000037938$ROCHE$$47$YR$A$F$Y$56.8$KG$20240730$$HP$CN$CN
241511191$24151119$1$I$20240330$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459363$RANBAXY$$57$YR$$M$Y$77$KG$20240730$$MD$FR$FR
241511207$24151120$7$F$20240701$20240808$20240730$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022535$UNITED THERAPEUTICS$$31$YR$$M$Y$70.748$KG$20240816$$$US$US
241511211$24151121$1$I$$20240716$20240730$20240730$EXP$$US-UCBSA-2024036308$UCB$$$$A$F$Y$$$20240730$$CN$US$US
241511221$24151122$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459791$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$M$Y$$$20240730$$HP$HR$HR
241511231$24151123$1$I$20240415$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459297$RANBAXY$$19$YR$$F$Y$44$KG$20240730$$HP$FR$FR
241511251$24151125$1$I$20240307$20240715$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459285$RANBAXY$$63$YR$$F$Y$$$20240730$$MD$FR$FR
241511262$24151126$2$F$20240422$20240805$20240730$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459148$RANBAXY$$68$YR$$F$Y$65$KG$20240820$$MD$FR$FR
241511271$24151127$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459329$RANBAXY$Bhimineni C, Mushlin N. SHIFT WORKERS ACTING OUT ? A CASE OF SHIFT WORK SLEEP DISORDER CAUSING REM BEHAVIOR  DISORDER. Sleep. 2024;47 (Suppl.):A523$67$YR$$M$Y$$$20240730$$HP$US$US
241511281$24151128$1$I$$20240715$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459317$RANBAXY$Li D, Qin W, Guo Y, Xia M, Li S, Zhang J, et al. Clinical, laboratory, and radiological features of cerebral amyloid angiopathy?related infammation (CAA?ri): retrospective, observational experience of a single centre. Neurol Sci. 2023;44 (2):631-632$61$YR$$F$Y$$$20240730$$HP$CN$CN
241511291$24151129$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459635$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$28$MON$$F$Y$$$20240730$$HP$HR$HR
241511301$24151130$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459379$RANBAXY$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J Ophthalmic Inflamm Infect. 2024;14 (1):12 (1-6)$50$YR$$M$Y$$$20240730$$HP$US$US
241511311$24151131$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459796$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$F$Y$$$20240730$$HP$HR$HR
241511321$24151132$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458448$RANBAXY$Song JJ, Eyabi JC, Awatramani PD, Mitchell BG, Nene SY. Sudden Reduction in Caffeine Intake Increases Serum Lithium Concentration to Supratherapeutic Level: A Case Report. Prim Care Comp CNS Disorders. 2024;26 (2):23cr03642 (e1e2)$59$YR$$M$Y$$$20240730$$HP$US$US
241511332$24151133$2$F$$20240803$20240730$20240816$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459461$RANBAXY$Nakamura Y, Itoh Y, Wakimoto N, Kanno R, Iida S, Yamamoto K.. Successful treatment with bortezomib for POEMS syndrome, overcoming complicated severe heart block. Clin Case Rep. 2023;11 (3)$75$YR$$F$Y$$$20240816$$HP$JP$JP
241511341$24151134$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459777$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$20$MON$$F$Y$$$20240730$$HP$HR$HR
241511351$24151135$1$I$$20240715$20240730$20240730$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459197$RANBAXY$Rozen TD, Devcic Z, Toskich BB, Fairweather D, Bruno KA. A Possible Newly Defined and Treatable Secondary Cause of Early Morning Wake-Up Headaches in an Older Hypermobile Woman: Nutcracker Physiology with Spinal Epidural Venous Congestion. Case Rep Neurol. 2024;16 (1):71-78$61$YR$$F$Y$$$20240730$$HP$US$US
241511361$24151136$1$I$$20240715$20240730$20240730$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459381$RANBAXY$Carvalho NB, de Freitas VLT, Seguro FS, Bezerra VLT, Seguro FS, Bezerra Nakanishi EYS, et al. Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review. Rev Inst Med Trop Sao Paulo. 2023;66:e10/1-15$37$YR$$F$Y$$$20240730$$HP$BR$BR
241511371$24151137$1$I$$20240715$20240730$20240730$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459271$RANBAXY$Pathania S, Rai A, Kumar S, Tyagi V, Agrawal T, Suvirya S. Inadvertent intra-arterial injection: Cutaneous complications and management. Indian  J Dermatol Venereol Leprol. 2024;90(4):496-498$24$YR$$M$Y$$$20240730$$HP$IN$IN
241511381$24151138$1$I$$20240715$20240730$20240730$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459776$RANBAXY$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children. 2022;9(7):943$$$C$M$Y$$$20240730$$HP$HR$HR
241511391$24151139$1$I$$20240715$20240730$20240730$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458076$RANBAXY$Bansal R, Zhamutashvili M, Gognadze T, Dolmazishvili E, Jojua N. A SEVERE CASE OF NON TYPHOIDAL SALMONELLA ASSOCIATED WITH MULTIPLE ORGAN DAMAGE- CASE STUDY AND LITERATURE REVIEW. Georgian Med News. 2024;Apr;349 (4):98-102$25$YR$$F$Y$$$20240730$$HP$IN$IN
241511401$24151140$1$I$$20240715$20240730$20240730$EXP$$UG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459486$RANBAXY$Nambuya M, Mayanja-Kizza H. A case report: recurrent anemia related to long term acyclovir use in a pregnant HIV infected Ugandan. Afr Health Sci. 2024;24 (1):91-93$19$YR$$F$Y$$$20240730$$HP$UG$UG
241511411$24151141$1$I$20240627$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148900$AMGEN$$32$YR$A$M$Y$$$20240730$$PH$US$US
241511421$24151142$1$I$20121201$20240715$20240730$20240730$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459132$RANBAXY$Urabe Y, Ishikawa H, Ishikawa A, Ishiguro S, Ishibashi K, Arihiro K, et al. Two Cases of Increased Gastrointestinal Polyps in Familial Adenomatous Polyposis following Antiacid Agent Intake. Case Rep Gastroenterol. 2024;18 (1):293-298$52$YR$$F$Y$$$20240730$$HP$JP$JP
241511431$24151143$1$I$20240719$20240723$20240730$20240730$EXP$$CH-Merz Pharmaceuticals GmbH-2024070000148$MERZ$$41$YR$$M$Y$$$20240730$$MD$CH$CH
241511441$24151144$1$I$20230101$20240719$20240730$20240730$EXP$$ES-AUROBINDO-AUR-APL-2024-036135$AUROBINDO$Posado-Dominguez L, Figuero-Perez L, Olivares-Hernandez A, Chinchilla-Tabora L, Antunez-Plaza P, Rivas-Hernandez R, et al.. Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review. Chinese Clinical Oncology. 2024;13(3):1 of 7$65$YR$$M$Y$$$20240730$$MD$ES$ES
241511451$24151145$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225790$TEVA$$40$YR$$F$Y$$$20240730$$HP$CA$CA
241511461$24151146$1$I$$20240719$20240730$20240730$EXP$$US-BAYER-2024A108651$BAYER$Louis M; Cawthon M; Gibson B; Kuhn B. Management of NSAID-Induced Penetrating Gastric Ulcer Complicated by Hemorrhagic Cholecystitis: The Role of Percutaneous Transhepatic Biliary Drainage. Radiology Case Reports (2024) 19:9 (4059-4065). 2024;19:9:(4059-4065)$68$YR$E$F$Y$$$20240730$$MD$US$US
241511471$24151147$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52075$$FDA-CTU$$58$YR$$M$N$$$20240729$Y$$US$
241511481$24151148$1$I$20240709$20240722$20240730$20240730$EXP$$US-GSK-US2024091692$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240730$$MD$US$US
241511491$24151149$1$I$20240724$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52065$$FDA-CTU$$36$YR$$F$N$$$20240729$Y$PH$US$
241511511$24151151$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189565$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241511521$24151152$1$I$$20240722$20240730$20240730$EXP$$US-AMAROX PHARMA-HET2024US02459$HETERO$Sanjeevi A, Clark BL, Aguirre A, Verghese BG.. Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A  case report and review of literature. Clinical Immunology Communications. 2024;6:1-4$65$YR$$F$Y$$$20240730$$HP$US$US
241511531$24151153$1$I$$20240725$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US068624$SANDOZ$$$$$M$Y$$$20240730$$CN$US$US
241511541$24151154$1$I$$20240725$20240730$20240730$PER$$NVSC2024US154956$NOVARTIS$$$$$$Y$$$20240730$$CN$US$US
241511551$24151155$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155306$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
241511561$24151156$1$I$$20240715$20240730$20240730$EXP$$UA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459222$RANBAXY$Synoverska OB, Alekseyeva YuI, Velychko TM, Vovk ZV, Fomenko NM. Case of acute recurrent myocardial infarction in a child. Mod Pediatr. 2023;3:104-110$21$MON$$F$Y$$$20240730$$HP$UA$UA
241511572$24151157$2$F$19860101$20240722$20240730$20240821$EXP$$AU-BEH-2024176373$CSL BEHRING$$6$YR$C$$Y$$$20240821$$CN$AU$AU
241511582$24151158$2$F$$20240731$20240730$20240809$EXP$$LB-ROCHE-10000026393$ROCHE$$63$YR$A$F$Y$$$20240809$$HP$LB$LB
241511591$24151159$1$I$$20240724$20240730$20240730$PER$$US-ABBVIE-5855451$ABBVIE$$$$$$Y$$$20240730$$HP$US$US
241511601$24151160$1$I$20240624$20240721$20240730$20240730$EXP$GB-MHRA-MED-202407211256251510-KJGCY$GB-BAYER-2024A105806$BAYER$$64$YR$A$M$Y$74$KG$20240730$$CN$GB$GB
241511611$24151161$1$I$$20240730$20240730$20240730$PER$$US-CIPLA LTD.-2024US00964$CIPLA$$$$$$Y$$$20240730$$PH$US$US
241511621$24151162$1$I$$20240724$20240730$20240730$EXP$GB-ROCHE-10000035348$GB-ROCHE-10000035348$ROCHE$$74$YR$E$F$Y$$$20240730$$PH$GB$GB
241511632$24151163$2$F$$20240725$20240730$20240902$EXP$GB-MHRA-MIDB-a188337a-c9a8-425a-8150-f53719a6f451$GB-HALEON-2188974$Haleon PLC$$38$YR$$$Y$$$20240830$$PH$GB$GB
241511641$24151164$1$I$$20230117$20240730$20240730$EXP$$US-AstraZeneca-2023A014751$ASTRAZENECA$$$$$M$Y$66.2$KG$20240730$$CN$US$
241511651$24151165$1$I$20240501$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A166763$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241511662$24151166$2$F$20240722$20240902$20240730$20240904$PER$$US-AstraZeneca-2024A169626$ASTRAZENECA$$30087$DY$$F$Y$$$20240904$$CN$US$
241511671$24151167$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119603$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240730$$CN$US$US
241511681$24151168$1$I$20240101$20240724$20240730$20240730$EXP$$CA-JNJFOC-20240767086$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240730$$HP$CA$CA
241511692$24151169$2$F$$20240725$20240730$20240731$PER$$US-JNJFOC-20240766150$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240731$$CN$US$US
241511711$24151171$1$I$$20240715$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113263$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$MD$US$US
241511721$24151172$1$I$$20240727$20240730$20240730$PER$$NVSC2024US154905$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
241511731$24151173$1$I$20240602$20240725$20240730$20240730$EXP$$NVSC2024CN154544$NOVARTIS$$71$YR$$F$Y$48$KG$20240730$$HP$CN$CN
241511741$24151174$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149840$AMGEN$$$$$M$Y$$$20240730$$CN$US$US
241511753$24151175$3$F$20240725$20240802$20240730$20240815$PER$$US-AMGEN-USASP2024148783$AMGEN$$$$$F$Y$$$20240815$$PH$US$US
241511761$24151176$1$I$20240718$20240729$20240729$20240729$DIR$711872$$FDA-CTU$$61$YR$$F$N$63$KG$20240729$N$CN$US$
241511771$24151177$1$I$20240724$20240729$20240729$20240729$DIR$711878$$FDA-CTU$$51$YR$$F$N$$$20240729$N$PH$US$
241511781$24151178$1$I$$20240729$20240729$20240729$DIR$711934$$FDA-CTU$$$$$UNK$N$$$20240729$$CN$US$
241511791$24151179$1$I$20240726$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150012$AMGEN$$76$YR$E$F$Y$$$20240730$$CN$US$US
241511801$24151180$1$I$$20240722$20240730$20240730$EXP$$ES-MYLANLABS-2024M1070331$MYLAN$Solaz-Ruiz MG, Perez LA, Cauto-Picazo C, Barranco-Gonzalez H, Pascual-Camps I, Espana-Gregori E. Toxicity to intravitreal melphalan in a patient with retinoblastoma. Rom-J-Ophthalmol 2023; 67 (3): 305-308.$3$YR$$M$Y$$$20240730$$MD$ES$ES
241511811$24151181$1$I$$20240719$20240730$20240730$EXP$$GB-MYLANLABS-2024M1069218$MYLAN$Hagan AJ, Verity SJ. Key Questions on the Long-Term Utility of Methylphenidate in Paediatric Brain Tumour Survivorship: A Retrospective Clinical Case Series. Children-(Basel) 2024; 11 (2): 187.$15$YR$$F$Y$$$20240730$$HP$GB$GB
241511831$24151183$1$I$20240703$20240729$20240729$20240729$DIR$711941$$FDA-CTU$$48$YR$$F$N$68.85$KG$20240729$N$CN$US$
241511841$24151184$1$I$$20240716$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-113555$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$96$KG$20240730$$HP$CA$CA
241511851$24151185$1$I$$20240722$20240730$20240730$EXP$$DE-MYLANLABS-2024M1069671$MYLAN$Sahly AN, Sierra-Marquez J, Bungert-Plumke S, Franzen A, Mougharbel L, Berrahmoune S, et al. Genotype-phenotype correlation in CLCN4-related developmental and epileptic encephalopathy. Hum-Genet 2024; 143 667-681.$$$$M$Y$$$20240730$$HP$DE$DE
241511861$24151186$1$I$$20240722$20240730$20240730$EXP$$US-MYLANLABS-2024M1070068$MYLAN$Zubair N, Isaac S, Westerman J. Drug-induced Euglycemic Diabetic Ketoacidosis in a Patient with Systemic Sarcoidosis. South-Med-J 2022; 116 93.$78$YR$$F$Y$$$20240730$$MD$US$US
241511871$24151187$1$I$$20240729$20240730$20240730$PER$$US-ROCHE-10000041353$ROCHE$$$$$$Y$$$20240730$$PH$US$US
241511892$24151189$2$F$$20240813$20240730$20240822$EXP$$GR-TEVA-VS-3225186$TEVA$$37$YR$$F$Y$$$20240822$$MD$GR$GR
241511901$24151190$1$I$$20240718$20240730$20240730$EXP$$CA-ROCHE-10000026177$ROCHE$$$$E$F$Y$$$20240730$$CN$CA$CA
241511911$24151191$1$I$$20240724$20240730$20240730$EXP$$ES-MYLANLABS-2024M1070393$MYLAN$Casanova Espinosa M, Hernandez Garcia MT, Soler Campos JA, Hernandez Rodriguez S, Moreno Belmonte MJ, Gonzalez Pardo MC, et al. Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain. Carinae Study. Blood 2023; 142 (Suppl. 1) 4694-4695 abstr. 652.$$$$$Y$$$20240730$$HP$ES$ES
241511922$24151192$2$F$20240725$20240726$20240730$20240801$PER$$US-AMGEN-USASP2024148466$AMGEN$$61$YR$A$F$Y$$$20240801$$CN$US$US
241511932$24151193$2$F$20240621$20240730$20240730$20240731$PER$$US-AMGEN-USASP2024148417$AMGEN$$65$YR$E$$Y$$$20240731$$CN$US$US
241511941$24151194$1$I$20240718$20240722$20240730$20240730$PER$$US-ABBVIE-5852936$ABBVIE$$73$YR$$F$Y$$$20240730$$CN$US$US
241511951$24151195$1$I$$20240724$20240730$20240730$PER$$US-ROCHE-10000037894$ROCHE$$$$$$Y$$$20240730$$CN$US$US
241511961$24151196$1$I$$20240715$20240730$20240730$PER$$US-JNJFOC-20240748307$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$CN$US$US
241512041$24151204$1$I$20240625$20240729$20240729$20240729$DIR$711947$$FDA-CTU$$63$YR$$F$N$92.25$KG$20240729$N$HP$US$
241512051$24151205$1$I$20230824$20240729$20240730$20240730$EXP$$DE-ABBVIE-5857987$ABBVIE$$69$YR$$M$Y$77$KG$20240730$$MD$DE$DE
241512061$24151206$1$I$$20240724$20240730$20240730$EXP$$EG-Oxford Pharmaceuticals, LLC-2159762$OXFORD PHARMACEUTICALS$Source document$48$YR$$F$Y$$$20240730$$$EG$EG
241512071$24151207$1$I$20240715$20240724$20240730$20240730$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159763$JIANGSU HANSOH PHARMACEUTICAL$$61$YR$$F$Y$69$KG$20240730$$MD$CN$CN
241512081$24151208$1$I$$20240717$20240730$20240730$EXP$$IN-Appco Pharma LLC-2159760$APPCO PHARMA$Initial$24$YR$$M$Y$$$20240730$$$IN$IN
241512091$24151209$1$I$$20240717$20240730$20240730$EXP$$IN-Appco Pharma LLC-2159761$APPCO PHARMA$Initial$38$YR$$F$Y$$$20240730$$$IN$IN
241512101$24151210$1$I$$20230615$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK082759$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512111$24151211$1$I$$20230628$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083158$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512121$24151212$1$I$$20230608$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK082542$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512131$24151213$1$I$$20230630$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083196$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512141$24151214$1$I$$20230706$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK082616$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512151$24151215$1$I$$20230914$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK082862$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512161$24151216$1$I$$20230714$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083516$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512171$24151217$1$I$$20230629$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083164$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512181$24151218$1$I$$20230628$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083477$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512191$24151219$1$I$$20230706$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083309$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512201$24151220$1$I$$20230630$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083184$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512211$24151221$1$I$$20230717$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083281$GLENMARK$$$$$$Y$$$20240730$$MD$US$US
241512221$24151222$1$I$$20230620$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK082952$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512231$24151223$1$I$$20230707$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083344$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512241$24151224$1$I$$20230713$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083496$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512251$24151225$1$I$$20230714$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083542$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512261$24151226$1$I$$20230613$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK082633$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512271$24151227$1$I$$20230714$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083540$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512281$24151228$1$I$$20230705$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083287$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512291$24151229$1$I$$20230925$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085365$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512301$24151230$1$I$$20230817$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084490$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512311$24151231$1$I$$20230907$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084929$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512321$24151232$1$I$$20230824$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084634$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512331$24151233$1$I$$20231005$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085617$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512341$24151234$1$I$$20231012$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085831$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512351$24151235$1$I$$20230803$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084107$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512361$24151236$1$I$$20230731$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084028$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512371$24151237$1$I$$20230718$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083711$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512381$24151238$1$I$$20230731$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084030$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512391$24151239$1$I$$20230810$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084255$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512401$24151240$1$I$$20230827$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084677$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512411$24151241$1$I$$20231024$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085687$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512421$24151242$1$I$$20230908$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084977$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512431$24151243$1$I$$20231002$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085505$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512441$24151244$1$I$$20231013$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085847$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512451$24151245$1$I$$20231108$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086441$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512461$24151246$1$I$$20230817$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084494$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512471$24151247$1$I$20231001$20231017$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085966$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512481$24151248$1$I$$20231214$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087711$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512491$24151249$1$I$$20231219$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087807$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512501$24151250$1$I$$20231121$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086828$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512511$24151251$1$I$$20231020$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086092$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512521$24151252$1$I$$20231130$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087217$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512531$24151253$1$I$$20231202$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085998$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512541$24151254$1$I$$20231129$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087117$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512551$24151255$1$I$$20231020$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086056$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512561$24151256$1$I$$20230817$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084487$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512571$24151257$1$I$$20230802$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084089$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512581$24151258$1$I$$20230922$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085363$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512591$24151259$1$I$$20231016$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086054$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512601$24151260$1$I$20231011$20231011$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085754$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512611$24151261$1$I$$20230821$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084545$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512621$24151262$1$I$$20230905$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084866$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512631$24151263$1$I$$20231004$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085599$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512641$24151264$1$I$$20231114$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086673$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512651$24151265$1$I$20231024$20231025$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086123$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512661$24151266$1$I$$20231227$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088088$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512671$24151267$1$I$$20231230$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086829$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512681$24151268$1$I$$20231215$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087738$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512691$24151269$1$I$$20231130$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087146$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512701$24151270$1$I$$20231208$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087371$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512711$24151271$1$I$$20240131$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087186$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512721$24151272$1$I$$20231023$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086058$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512731$24151273$1$I$$20231019$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086006$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512741$24151274$1$I$$20231116$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086734$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512751$24151275$1$I$$20231023$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086080$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512761$24151276$1$I$$20240102$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088123$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512771$24151277$1$I$$20240206$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087759$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512781$24151278$1$I$$20240110$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088286$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512791$24151279$1$I$$20231218$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086994$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512801$24151280$1$I$$20240104$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088188$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512811$24151281$1$I$$20231130$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087147$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512821$24151282$1$I$$20231017$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085965$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512831$24151283$1$I$$20231103$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086352$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512841$24151284$1$I$$20240127$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088725$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512851$24151285$1$I$$20240227$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089187$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512861$24151286$1$I$$20240222$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089126$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512871$24151287$1$I$20231201$20240224$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087959$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512881$24151288$1$I$$20240318$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089555$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512891$24151289$1$I$$20240221$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089096$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512901$24151290$1$I$$20240209$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088901$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512911$24151291$1$I$$20240123$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088672$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512921$24151292$1$I$$20240306$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089287$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512931$24151293$1$I$20230303$20240213$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088946$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512941$24151294$1$I$$20240202$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088817$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512951$24151295$1$I$20240101$20240126$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088700$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512961$24151296$1$I$20240208$20240209$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088904$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512971$24151297$1$I$$20240226$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088952$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512981$24151298$1$I$$20231228$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088042$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241512991$24151299$1$I$$20240220$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089099$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513001$24151300$1$I$$20240223$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089158$GLENMARK$$$$$$Y$$$20240730$$PH$US$US
241513011$24151301$1$I$$20240117$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088523$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513021$24151302$1$I$$20240102$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088124$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513031$24151303$1$I$$20240105$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088203$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513041$24151304$1$I$$20240228$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089199$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513061$24151306$1$I$$20240325$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089737$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513071$24151307$1$I$$20240403$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089935$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513081$24151308$1$I$$20240513$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090892$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513091$24151309$1$I$$20240506$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090729$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513101$24151310$1$I$$20240308$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089373$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513111$24151311$1$I$$20240415$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090265$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513121$24151312$1$I$$20240425$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090520$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513131$24151313$1$I$$20240409$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089616$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513142$24151314$2$F$$20240224$20240730$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089160$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241513152$24151315$2$F$$20240131$20240730$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088828$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241513161$24151316$1$I$$20240522$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091109$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513172$24151317$2$F$20231222$20240202$20240730$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088163$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241513182$24151318$2$F$$20240222$20240730$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089109$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241513192$24151319$2$F$$20240226$20240730$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088715$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241513202$24151320$2$F$$20240209$20240730$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088911$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241513212$24151321$2$F$$20240220$20240730$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089074$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241513222$24151322$2$F$$20240308$20240730$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088274$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241513232$24151323$2$F$$20240123$20240730$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088648$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241513242$24151324$2$F$$20240328$20240730$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089825$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241513251$24151325$1$I$$20240424$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090476$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513261$24151326$1$I$$20240422$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090431$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513271$24151327$1$I$$20240521$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091070$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513281$24151328$1$I$$20240320$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089631$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513291$24151329$1$I$$20240411$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090190$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513301$24151330$1$I$$20240513$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090848$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513311$24151331$1$I$$20240328$20240730$20240730$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089852$GLENMARK$$$$$$Y$$$20240730$$CN$US$US
241513321$24151332$1$I$20230902$20240723$20240730$20240730$PER$$US-ALXN-A202312657$ALEXION PHARMACEUTICALS$$77$YR$$M$Y$$$20240730$$CN$US$US
241513331$24151333$1$I$20230115$20240726$20240730$20240730$EXP$DE-CADRBFARM-2024329470$DE-ASTELLAS-2024EU007451$ASTELLAS$$74$YR$$M$Y$$$20240730$$CN$DE$DE
241513342$24151334$2$F$20240712$20240808$20240730$20240812$EXP$FR-AFSSAPS-ST2024001212$FR-ASTELLAS-2024EU007442$ASTELLAS$$61$YR$$F$Y$58$KG$20240812$$CN$FR$FR
241513351$24151335$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120215$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$44.45$KG$20240730$$HP$US$US
241513361$24151336$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52069$$FDA-CTU$$$$$F$N$$$20240729$N$HP$US$
241513381$24151338$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120212$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240730$$HP$US$US
241513391$24151339$1$I$$20240722$20240730$20240730$EXP$$BE-BRISTOL-MYERS SQUIBB COMPANY-2024-117797$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$MD$BE$BE
241513402$24151340$2$F$$20240807$20240730$20240817$30DAY$$US-GSK-US2024092836$GLAXOSMITHKLINE$$$$$M$Y$$$20240817$$MD$US$US
241513411$24151341$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52158$$FDA-CTU$$69$YR$$F$N$$$20240729$N$$US$
241513421$24151342$1$I$20240726$20240729$20240729$20240729$DIR$711879$$FDA-CTU$$66$YR$$F$N$58.5$KG$20240729$N$CN$US$
241513431$24151343$1$I$20240706$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120195$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$54.43$KG$20240730$$PH$US$US
241513441$24151344$1$I$20240727$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018735$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240730$$CN$US$US
241513451$24151345$1$I$20240701$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017999$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240730$$CN$US$US
241513461$24151346$1$I$20240729$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018725$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240730$$CN$US$US
241513471$24151347$1$I$20240320$20240723$20240730$20240730$EXP$$CA-TAKEDA-2024TUS049840$TAKEDA$$62$YR$$F$Y$$$20240730$$HP$CA$CA
241513482$24151348$2$F$20240501$20240723$20240730$20240801$EXP$$US-ABBVIE-5844634$ABBVIE$$71$YR$$F$Y$50$KG$20240801$$CN$US$US
241513491$24151349$1$I$20240531$20240724$20240730$20240730$EXP$FR-AFSSAPS-AVLL2024000181$FR-MYLANLABS-2024M1069877$MYLAN$$23$YR$$F$Y$$$20240730$$CN$FR$FR
241513503$24151350$3$F$20240716$20240814$20240730$20240820$30DAY$$US-AMGEN-USASP2024147981$AMGEN$$72$YR$E$M$Y$88.5$KG$20240820$$PH$US$US
241513511$24151351$1$I$20230104$20240605$20240730$20240730$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458740$RANBAXY$$54$YR$$M$Y$100$KG$20240730$$HP$FR$FR
241513531$24151353$1$I$$20240514$20240730$20240730$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-448485$RANBAXY$Lopez-Pardo Rico M, Bujan Bonino C, Moreiras Arias N, Saez Padilla J, Suarez Penaranda JM, Sanchez-Aguilar Rojas MD, et al. Photodistributed erythema multiforme in a polymedicated patient. JDtsch Dermatol Ges. 2023;21:1557-1559$78$YR$$F$Y$$$20240730$$HP$ES$ES
241513541$24151354$1$I$$20240409$20240730$20240730$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-443521$RANBAXY$$$$$F$Y$$$20240730$$CN$GB$GB
241513551$24151355$1$I$$20240410$20240730$20240730$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-443385$RANBAXY$$74$YR$$F$Y$$$20240730$$MD$IT$IT
241513561$24151356$1$I$$20240410$20240730$20240730$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-443875$RANBAXY$$$$$M$Y$$$20240730$$CN$ES$ES
241513571$24151357$1$I$20240714$20240717$20240730$20240730$EXP$CN-HENLIUS-24CN015961$CN-Accord-438815$ACCORD$$53$YR$A$M$Y$55$KG$20240730$$MD$CN$CN
241513582$24151358$2$F$20230901$20240816$20240730$20240828$EXP$FR-AFSSAPS-BX2024001446$FR-Accord-437033$ACCORD$$43$YR$A$F$Y$90$KG$20240828$$CN$FR$FR
241513591$24151359$1$I$20230327$20240719$20240730$20240730$EXP$FR-AFSSAPS-PO2024000789$FR-Accord-437167$ACCORD$$39$YR$A$F$Y$110$KG$20240730$$MD$FR$FR
241513601$24151360$1$I$$20240719$20240730$20240730$EXP$AU-TGA-808949$AU-Accord-436832$ACCORD$$$$$$Y$$$20240730$$HP$AU$AU
241513614$24151361$4$F$20240717$20240813$20240730$20240824$EXP$$US-Accord-438029$ACCORD$$43$YR$A$M$Y$$$20240824$$MD$US$US
241513632$24151363$2$F$20240723$20240802$20240730$20240807$PER$$US-AMGEN-USASP2024148771$AMGEN$$61$YR$A$F$Y$83$KG$20240807$$PH$US$US
241513641$24151364$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148824$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241513651$24151365$1$I$20240111$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036687$AUROBINDO$$59$YR$$M$Y$$$20240730$$HP$FR$FR
241513662$24151366$2$F$20240101$20240815$20240730$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459479$RANBAXY$$$$A$M$Y$$$20240830$$CN$GB$GB
241513671$24151367$1$I$$20240607$20240730$20240730$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455457$RANBAXY$Kozevnikovova R. A female patient with high risk triple negative breast cancer treated in collaboration by ROC (Regional Oncology Center) and COC (Complex Oncology Center). Acta medicinae. 2024;4:50-52$$$$F$Y$$$20240730$$MD$CZ$CZ
241513683$24151368$3$F$20240519$20240807$20240730$20240822$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455744$RANBAXY$$61$YR$A$M$Y$71.6$KG$20240822$$HP$CN$CN
241513691$24151369$1$I$$20240607$20240730$20240730$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455463$RANBAXY$Lachnit M, Hradska K, Duras J, Hajek R. Treatment of a patient with ALK-negative anaplastic large cell lymphoma. farmakoterapie. 2024;20(Suppl 6):30-31$$$$F$Y$32$KG$20240730$$MD$CZ$CZ
241513701$24151370$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-07151$HIKMA$Quelhas MB, Silva DN, Bravo JB, Mozzer R, Gomes DM, Jaime LB, Dominiguez MDMB, Botejara AC. Quelhas MB, Silva DN, Bravo JB, Mozzer R, Gomes DM, Jaime LB, Dominiguez MDMB, Botejara AC. PO-0478 - (4533) - S?ndrome confusional aguda e desequil?brio da marcha como apresenta??o de neoplasia pulmonar. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional. 2024;/:838$68$YR$$M$Y$$$20240730$$MD$PT$PT
241513711$24151371$1$I$20220530$20240719$20240730$20240730$EXP$FR-AFSSAPS-PC2024000564$FR-Accord-437300$ACCORD$$40$YR$A$F$Y$70$KG$20240730$$MD$FR$FR
241513721$24151372$1$I$20240413$20240719$20240730$20240730$EXP$FR-AFSSAPS-DJ2024000842$FR-Accord-437927$ACCORD$$46$YR$A$M$Y$53$KG$20240730$$MD$FR$FR
241513731$24151373$1$I$20240526$20240718$20240730$20240730$EXP$FR-AFSSAPS-PB2024000790$FR-Accord-437628$ACCORD$$19$YR$A$F$Y$$$20240730$$MD$FR$FR
241513741$24151374$1$I$$20240607$20240730$20240730$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455454$RANBAXY$Herman V. Treatment of a patient with angioimmunoblastic T-cell lymphoma. Farmocotherpie. 2024;20(6):28-29$56$YR$$M$Y$$$20240730$$MD$CZ$CZ
241513751$24151375$1$I$20230412$20240719$20240730$20240730$EXP$FR-AFSSAPS-PC2024000565$FR-Accord-437172$ACCORD$$72$YR$E$F$Y$80$KG$20240730$$MD$FR$FR
241513772$24151377$2$F$$20240725$20240730$20240805$EXP$$MA-MACLEODS PHARMA-MAC2024048476$MACLEODS$Mourabiti H, Esayh G, Hoummani H, Hanchi SA, Chaouche I, Achour S, Belahsen F..Paraparesis secondary to metformin: a rare situation to be aware of with characteristic MRI images..Toxicologie Analytique et Clinique.11-JUL-2024$63$YR$A$F$Y$$$20240805$$MD$MA$MA
241513782$24151378$2$F$$20240731$20240730$20240812$EXP$$US-MACLEODS PHARMA-MAC2024048478$MACLEODS$Sahyouni MJ, Acevedo LA, Rodriguez SC, Chiles JA, Pennings NJ..Neuropathy of diabetes following initiation of a low-carbohydrate diet: Case report.Obesity pillars.2024;11:100115$$$$$Y$$$20240812$$MD$US$US
241513791$24151379$1$I$20240705$20240719$20240730$20240730$EXP$GB-MHRA-MED-202407181411456990-GQPDN$GB-MACLEODS PHARMA-MAC2024048481$MACLEODS$$$$$$Y$$$20240730$$CN$GB$GB
241513801$24151380$1$I$20240524$20240722$20240730$20240730$EXP$GB-MHRA-31205921$GB-LEO Pharma-372191$LEO PHARM$$21$YR$$F$Y$70$KG$20240729$$CN$GB$GB
241513811$24151381$1$I$$20240719$20240730$20240730$EXP$$US-MACLEODS PHARMA-MAC2024048489$MACLEODS$Sorabekka RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al..Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children..ASAIO Journal.2024;70(7):e92-6$$$$$Y$$$20240730$$MD$US$US
241513821$24151382$1$I$20240712$20240719$20240730$20240730$EXP$GB-MHRA-MED-202407191215278630-CQKSY$GB-MACLEODS PHARMA-MAC2024048483$MACLEODS$$$$$$Y$$$20240730$$HP$GB$GB
241513831$24151383$1$I$$20240719$20240730$20240730$EXP$$US-MACLEODS PHARMA-MAC2024048490$MACLEODS$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG,.Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children.ASAIO Journal.01-JUL-224;70(7):e92-6$14$YR$T$F$Y$129$KG$20240730$$MD$US$US
241513841$24151384$1$I$$20240719$20240730$20240730$EXP$$US-MACLEODS PHARMA-MAC2024048491$MACLEODS$Sorabekka RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al..Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker  Overdose in Children.ASAIO Journal..2024;70(7):e92-6$$$$$Y$$$20240730$$MD$US$US
241513851$24151385$1$I$20240201$20240719$20240730$20240730$EXP$GB-MHRA-MED-202407181443113020-RYQDH$GB-MACLEODS PHARMA-MAC2024048482$MACLEODS$$$$$$Y$$$20240730$$CN$GB$GB
241513862$24151386$2$F$$20240725$20240730$20240805$EXP$$US-MACLEODS PHARMA-MAC2024048500$MACLEODS$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D..Rhabdomyolysis Risk: The Dangers of Tribulus Terrestris, an Over-the-Counter Supplement.The American journal of case reports..2024;25:e943492$$$$$Y$$$20240805$$MD$US$US
241513871$24151387$1$I$$20240719$20240730$20240730$EXP$$GB-MACLEODS PHARMA-MAC2024048487$MACLEODS$$$$$$Y$$$20240730$$MD$GB$GB
241513881$24151388$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A171411$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241513891$24151389$1$I$20231102$20240722$20240730$20240730$EXP$$FR-AstraZeneca-2024A166071$ASTRAZENECA$$64$YR$$M$Y$110$KG$20240730$$MD$FR$
241513901$24151390$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-07152$HIKMA$Correia I, Eca R, Barbosa MJ, Soares L, Monteiro M, Caixas U. Correia I, Eca R, Barbosa MJ, Soares L, Monteiro M, Caixas U. PO-0486 - (4480) - S?ndrome de DRESS: uma resposta secund?ria rara. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional. 2024;846$30$YR$$M$Y$$$20240730$$MD$PT$PT
241513911$24151391$1$I$$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024147712$AMGEN$$60$YR$A$F$Y$$$20240730$$MD$US$US
241513921$24151392$1$I$$20240722$20240730$20240730$EXP$$ES-AstraZeneca-2024A167923$ASTRAZENECA$$79$YR$$M$Y$$$20240730$$MD$ES$
241513931$24151393$1$I$20240424$20240722$20240730$20240730$EXP$$FR-AstraZeneca-2024A166058$ASTRAZENECA$$66$YR$$F$Y$65.5$KG$20240730$$MD$FR$
241513942$24151394$2$F$$20240902$20240730$20240910$EXP$$US-AstraZeneca-2024A166491$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
241513954$24151395$4$F$20240701$20240903$20240730$20240912$30DAY$$US-GSK-US2024091822$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240912$$HP$US$US
241513961$24151396$1$I$20200116$20200124$20240730$20240730$EXP$$US-AstraZeneca-2020SE13993$ASTRAZENECA$$24581$DY$$F$Y$$$20240730$$CN$US$
241513971$24151397$1$I$$20240724$20240730$20240730$EXP$$NVSC2024FR153852$NOVARTIS$$$$$M$Y$$$20240730$$HP$FR$FR
241513981$24151398$1$I$$20230925$20240730$20240730$EXP$$US-AstraZeneca-2023A220573$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241513991$24151399$1$I$$20230824$20240730$20240730$EXP$$US-AstraZeneca-2023A194624$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241514011$24151401$1$I$$20230608$20240730$20240730$EXP$$US-AstraZeneca-2023A132016$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241514021$24151402$1$I$$20210928$20240730$20240730$EXP$$US-AstraZeneca-2021A754438$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241514032$24151403$2$F$$20240809$20240730$20240812$EXP$$ID-ROCHE-10000034903$ROCHE$$$$$$Y$$$20240812$$MD$ID$ID
241514041$24151404$1$I$20221208$20240719$20240730$20240730$EXP$$CA-ROCHE-2076588$ROCHE$$76$YR$E$F$Y$$$20240730$$CN$CA$CA
241514051$24151405$1$I$$20240726$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US068941$SANDOZ$$7$MON$$M$Y$$$20240730$$CN$US$US
241514061$24151406$1$I$20240101$20240725$20240730$20240730$EXP$$US-ABBVIE-5856025$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241514071$24151407$1$I$20240701$20240717$20240730$20240730$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090038$VIIV$$39$YR$$M$Y$$$20240730$$PH$US$US
241514101$24151410$1$I$20240604$20240719$20240730$20240730$EXP$$US-Accord-437658$ACCORD$$64$YR$A$M$Y$$$20240730$$HP$US$US
241514111$24151411$1$I$$20240720$20240730$20240730$EXP$CA-MHPD-E2B_07133130$CA-Accord-437440$ACCORD$$80$YR$E$M$Y$$$20240730$$HP$CA$CA
241514121$24151412$1$I$$20240719$20240730$20240730$EXP$GB-MHRA-MED-202407190812063080-GKMCR$GB-Accord-437180$ACCORD$$$$$F$Y$$$20240730$$HP$GB$GB
241514131$24151413$1$I$$20240718$20240730$20240730$EXP$$JP-Accord-437684$ACCORD$Abematsu T, Nishikawa T, Kasabata H, Nakagawa S, Okamoto Y. Blinatumomab Maintenance Therapy Following Bone Marrow Transplantation for Early Relapsed Pediatric B-cell Precursor Acute Lymphoblastic Leukemia and Analysis of Lymphocyte Subset Changes. Cureus. 2024 Jun 12;16(6):e62263.$5$YR$C$M$Y$$$20240730$$HP$JP$JP
241514151$24151415$1$I$20240713$20240719$20240730$20240730$EXP$$US-Accord-437502$ACCORD$$62$YR$$F$Y$$$20240730$$HP$US$US
241514161$24151416$1$I$20240301$20240719$20240730$20240730$EXP$FR-AFSSAPS-BX2024001457$FR-Accord-437319$ACCORD$$65$YR$E$M$Y$$$20240730$$MD$FR$FR
241514171$24151417$1$I$20240715$20240719$20240730$20240730$EXP$$US-Accord-437407$ACCORD$$28$YR$A$M$Y$$$20240730$$HP$US$US
241514181$24151418$1$I$20240712$20240719$20240730$20240730$EXP$$US-Accord-438351$ACCORD$$32$YR$A$F$Y$$$20240730$$PH$US$US
241514191$24151419$1$I$$20240719$20240730$20240730$EXP$CA-MHPD-001089780$CA-Accord-437344$ACCORD$$74$YR$E$M$Y$$$20240730$$CN$CA$CA
241514211$24151421$1$I$$20240717$20240730$20240730$EXP$$SE-B.Braun Medical Inc.-2159764$B BRAUN$$36$YR$$F$Y$$$20240730$$MD$SE$SE
241514222$24151422$2$F$$20240921$20240730$20240924$PER$$NVSC2024US154907$NOVARTIS$$24$YR$$$Y$$$20240924$$CN$US$US
241514231$24151423$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155358$NOVARTIS$$$$$M$Y$$$20240730$$CN$US$US
241514241$24151424$1$I$$20240719$20240730$20240730$EXP$$US-Accord-437393$ACCORD$Sorabekka RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70(7):e92-6.$14$YR$T$F$Y$129$KG$20240730$$MD$US$US
241514251$24151425$1$I$20240718$20240719$20240730$20240730$EXP$$US-Accord-437885$ACCORD$$37$YR$A$M$Y$$$20240730$$HP$US$US
241514261$24151426$1$I$20240624$20240719$20240730$20240730$EXP$$US-Accord-437643$ACCORD$$26$YR$A$M$Y$$$20240730$$HP$US$US
241514271$24151427$1$I$$20240718$20240730$20240730$EXP$NL-LRB-00990443$NL-Accord-437623$ACCORD$$82$YR$E$F$Y$70$KG$20240730$$CN$NL$NL
241514282$24151428$2$F$$20240807$20240730$20240902$EXP$$JP-Accord-436146$ACCORD$Naganawa H, Katada Y, Nakagawa S, Umemura K, Ishimura H, Kajiwara M, et al. Influence of ensitrelvir or nirmatrelvir/ritonavir on tacrolimus clearance in kidney transplant recipients: a single-center case series. J Pharm Health Care Sci. 2024 Jul 10;10(1):37.$6$DEC$A$F$Y$54.6$KG$20240902$$HP$JP$JP
241514291$24151429$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52034$$FDA-CTU$$60$YR$$F$N$$$20240729$N$$US$
241514301$24151430$1$I$$20240729$20240729$20240729$DIR$711954$$FDA-CTU$$$$$F$N$$$20240729$Y$HP$US$
241514341$24151434$1$I$20240705$20240726$20240730$20240730$EXP$FR-AFSSAPS-AN2024000973$FR-ASTELLAS-2024EU007455$ASTELLAS$$79$YR$$M$Y$$$20240730$$CN$NL$FR
241514351$24151435$1$I$$20240729$20240729$20240729$DIR$711956$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241514361$24151436$1$I$20240610$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52039$$FDA-CTU$$34$YR$$M$N$99.79$KG$20240729$N$$US$
241514382$24151438$2$F$$20240913$20240730$20240925$EXP$$DE-MSNLABS-2024MSNLIT01648$MSN LABORATORIES$Hans FP, Benning L, Pooth J-S, Busch H-J..A potentially lifesaving error: unintentional high-dose adrenaline administration in anaphylaxis-induced cardiac arrest; a case report.International Journal of Emergency Medicine.2024;17:1-5$$$$$Y$$$20240925$$HP$DE$DE
241514391$24151439$1$I$$20240726$20240730$20240730$EXP$$US-GSK-US2024094202$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$US$US
241514401$24151440$1$I$20240615$20240729$20240729$20240729$DIR$711961$$FDA-CTU$$71$YR$$M$N$83.25$KG$20240729$N$CN$US$
241514411$24151441$1$I$$20240709$20240730$20240730$PER$$US-JNJFOC-20240723760$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$US$US
241514421$24151442$1$I$$20240610$20240730$20240730$EXP$$NL-ROCHE-10000029628$ROCHE$$11$YR$C$F$Y$$$20240730$$MD$NL$NL
241514431$24151443$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225231$TEVA$$50$YR$$F$Y$$$20240730$$HP$CA$CA
241514442$24151444$2$F$$20240731$20240730$20240801$EXP$$FR-BAYER-2024A109260$BAYER$$$$$F$Y$$$20240801$$PH$FR$FR
241514451$24151445$1$I$$20240726$20240730$20240730$EXP$$NVSC2024US154768$NOVARTIS$$$$$$Y$$$20240730$$CN$US$US
241514461$24151446$1$I$20240617$20240725$20240730$20240730$EXP$FR-AFSSAPS-MA2024001078$FR-ABBVIE-5859160$ABBVIE$$82$YR$$M$Y$$$20240730$$MD$FR$FR
241514471$24151447$1$I$$20240725$20240730$20240730$EXP$$US-JNJFOC-20240770686$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$MD$US$US
241514481$24151448$1$I$20230808$20240723$20240730$20240730$EXP$$NVSC2024TH150758$NOVARTIS$$84$YR$$F$Y$$$20240730$$MD$TH$TH
241514491$24151449$1$I$20240318$20240724$20240730$20240730$EXP$PL-URPL-DML-MLP.4401.2.157.2024$PL-BAYER-2024A107492$BAYER$$48$YR$A$F$Y$65$KG$20240730$$CN$PL$PL
241514501$24151450$1$I$20240201$20240725$20240730$20240730$EXP$$JP-BAYER-2024A079342$BAYER$$9$DEC$E$M$Y$$$20240730$$MD$JP$JP
241514511$24151451$1$I$20240724$20240724$20240730$20240730$PER$$US-BAYER-2024A108461$BAYER$$26$YR$A$F$Y$$$20240730$$MD$US$US
241514521$24151452$1$I$20240501$20240720$20240730$20240730$EXP$$DE-AUROBINDO-AUR-APL-2024-036668$AUROBINDO$$86$YR$$F$Y$50$KG$20240730$$MD$DE$DE
241514541$24151454$1$I$20221229$20240722$20240730$20240730$EXP$$CO-UCBSA-2024037732$UCB$$57$YR$$M$Y$$$20240730$$CN$CO$CO
241514561$24151456$1$I$20210301$20240717$20240730$20240730$EXP$$US-UCBSA-2024036556$UCB$$55$YR$$F$Y$92.472$KG$20240730$$HP$US$US
241514571$24151457$1$I$20230101$20240724$20240730$20240730$EXP$$US-AMGEN-USASP2024148093$AMGEN$$60$YR$A$F$Y$$$20240730$$HP$US$US
241514581$24151458$1$I$20240725$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148728$AMGEN$$$$$F$Y$$$20240730$$PH$US$US
241514591$24151459$1$I$20240715$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149546$AMGEN$$79$YR$E$F$Y$$$20240730$$CN$US$US
241514601$24151460$1$I$$20240723$20240730$20240730$EXP$$US-GSK-US2024092325$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$CN$US$US
241514611$24151461$1$I$$20240722$20240730$20240730$EXP$$CA-APOTEX-2024AP008693$APOTEX$$69$YR$$F$Y$$$20240730$$HP$CA$CA
241514621$24151462$1$I$$20240716$20240730$20240730$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004430$PPD DEVELOPMENT LP$$$$$$Y$$$20240729$$HP$US$US
241514632$24151463$2$F$$20240722$20240730$20240731$EXP$$CA-JNJFOC-20240764648$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240731$$HP$CA$CA
241514641$24151464$1$I$$20240717$20240730$20240730$EXP$$US-TEVA-VS-3225799$TEVA$$$$$M$Y$$$20240730$$CN$US$US
241514651$24151465$1$I$20230701$20230806$20240730$20240730$PER$$US-PERRIGO-23US008893$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514661$24151466$1$I$20230701$20230729$20240730$20240730$PER$$US-PERRIGO-23US008578$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514671$24151467$1$I$20230801$20230805$20240730$20240730$PER$$US-PERRIGO-23US008837$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514681$24151468$1$I$20230701$20230711$20240730$20240730$PER$$US-PERRIGO-23US007940$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514691$24151469$1$I$20230713$20230713$20240730$20240730$PER$$US-PERRIGO-23US007981$PERRIGO$$40$YR$$F$Y$65.76$KG$20240730$$CN$US$US
241514701$24151470$1$I$20230701$20230714$20240730$20240730$PER$$US-PERRIGO-23US008064$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514711$24151471$1$I$20230701$20230711$20240730$20240730$PER$$US-PERRIGO-23US007934$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514721$24151472$1$I$20230716$20230717$20240730$20240730$PER$$US-PERRIGO-23US008066$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514731$24151473$1$I$20230701$20230724$20240730$20240730$PER$$US-PERRIGO-23US008312$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514751$24151475$1$I$20230701$20230719$20240730$20240730$PER$$US-PERRIGO-23US008240$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514761$24151476$1$I$20230801$20230805$20240730$20240730$PER$$US-PERRIGO-23US008832$PERRIGO$$$$$F$Y$$$20240730$$CN$US$US
241514771$24151477$1$I$20230207$20230807$20240730$20240730$PER$$US-PERRIGO-23US008845$PERRIGO$$70$YR$$F$Y$81.633$KG$20240730$$CN$US$US
241514781$24151478$1$I$20230701$20230729$20240730$20240730$PER$$US-PERRIGO-23US008579$PERRIGO$$$$$M$Y$$$20240730$$CN$US$US
241514791$24151479$1$I$20230801$20230805$20240730$20240730$PER$$US-PERRIGO-23US008884$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514801$24151480$1$I$20230601$20230630$20240730$20240730$PER$$US-PERRIGO-23US007584$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514811$24151481$1$I$20230627$20230627$20240730$20240730$PER$$US-PERRIGO-23US007423$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514821$24151482$1$I$20230628$20230630$20240730$20240730$PER$$US-PERRIGO-23US007590$PERRIGO$$62$YR$$F$Y$106.12$KG$20240730$$CN$US$US
241514831$24151483$1$I$20230601$20230627$20240730$20240730$PER$$US-PERRIGO-23US007472$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514843$24151484$3$F$$20240729$20240730$20240809$EXP$$JP-ABBVIE-5859715$ABBVIE$$$$$$Y$$$20240809$$MD$JP$JP
241514851$24151485$1$I$20230701$20230705$20240730$20240730$PER$$US-PERRIGO-23US007633$PERRIGO$$89$YR$$F$Y$58.957$KG$20240730$$CN$US$US
241514861$24151486$1$I$20230601$20230727$20240730$20240730$PER$$US-PERRIGO-23US008492$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241514871$24151487$1$I$20240715$20240719$20240730$20240730$EXP$$US-Accord-437887$ACCORD$$45$YR$A$F$Y$$$20240730$$HP$US$US
241514881$24151488$1$I$20170101$20240720$20240730$20240730$EXP$PL-URPL-2-533-2020$PL-Accord-437560$ACCORD$$33$YR$A$M$Y$$$20240730$$CN$PL$PL
241514892$24151489$2$F$$20240802$20240730$20240813$EXP$$US-Accord-437546$ACCORD$Boleyn J, McLaury M, Wieman S. Suspected Pseudocholinesterase Deficiency During Left Thyroid Lobectomy and Isthmusectomy: A Case Report. S D Med. 2024 Jun;77(6):266-269.$59$YR$A$F$Y$$$20240813$$HP$US$US
241514901$24151490$1$I$20240717$20240719$20240730$20240730$EXP$$US-Accord-437641$ACCORD$$38$YR$A$M$Y$$$20240730$$PH$US$US
241514911$24151491$1$I$$20240718$20240730$20240730$EXP$AU-TGA-812219$AU-Accord-436655$ACCORD$$59$YR$A$M$Y$$$20240730$$HP$AU$AU
241514921$24151492$1$I$$20240719$20240730$20240730$EXP$GB-MHRA-TPP49423561C11562390YC1721321484481$GB-Accord-437114$ACCORD$$5$YR$C$M$Y$17$KG$20240730$$MD$GB$GB
241514932$24151493$2$F$$20240807$20240730$20240902$EXP$$JP-Accord-436145$ACCORD$Naganawa H, Katada Y, Nakagawa S, Umemura K, Ishimura H, Kajiwara M, et al. Influence of ensitrelvir or nirmatrelvir/ritonavir on tacrolimus clearance in kidney transplant recipients: a single-center case series. J Pharm Health Care Sci. 2024 Jul 10;10(1):37.$6$DEC$A$M$Y$58$KG$20240902$$HP$JP$JP
241514941$24151494$1$I$20211001$20240719$20240730$20240730$EXP$DE-EMA-DD-20240715-7482707-070002$DE-Accord-438329$ACCORD$$66$YR$E$M$Y$$$20240730$$MD$DE$DE
241514951$24151495$1$I$20221204$20240718$20240730$20240730$EXP$FR-AFSSAPS-ST2023000088$FR-Accord-437255$ACCORD$$76$YR$E$F$Y$48$KG$20240730$$PH$FR$FR
241514961$24151496$1$I$20240301$20240719$20240730$20240730$EXP$GB-MHRA-MED-202407191750325460-LJVQW$GB-Accord-437185$ACCORD$$$$$M$Y$$$20240730$$MD$GB$GB
241514971$24151497$1$I$20240620$20240729$20240729$20240729$DIR$711962$$FDA-CTU$$88$YR$$M$N$67.5$KG$20240729$N$CN$US$
241514981$24151498$1$I$20240514$20240729$20240729$20240729$DIR$711959$$FDA-CTU$$72$YR$$F$N$59.4$KG$20240729$N$CN$US$
241514991$24151499$1$I$20240722$20240729$20240729$20240729$DIR$711943$$FDA-CTU$$71$YR$$F$N$97.65$KG$20240729$N$CN$US$
241515001$24151500$1$I$$20240719$20240730$20240730$EXP$FR-AFSSAPS-AN2024000807$FR-Accord-437173$ACCORD$$76$YR$E$M$Y$$$20240730$$PH$FR$FR
241515011$24151501$1$I$$20240719$20240730$20240730$EXP$$BE-Accord-437366$ACCORD$Dekock T, Taelman T, Vanhaverbeke G, Derijcke S, Ghysen K. Immunotherapy-induced diabetes mellitus: A case study. Tijdschrift voor Geneeskunde en Gezondheidszorg. 2024;80(7):585-93. DOI: 10.47671/TVG.79.23.132.$73$YR$E$M$Y$$$20240730$$MD$BE$BE
241515021$24151502$1$I$$20240717$20240730$20240730$EXP$$FR-B.Braun Medical Inc.-2159765$B BRAUN$$34$YR$$M$Y$$$20240730$$$FR$FR
241515031$24151503$1$I$20230801$20230810$20240730$20240730$PER$$US-PERRIGO-23US009047$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515041$24151504$1$I$20230801$20230816$20240730$20240730$PER$$US-PERRIGO-23US009256$PERRIGO$$$$$M$Y$$$20240730$$CN$US$US
241515051$24151505$1$I$20230801$20230815$20240730$20240730$PER$$US-PERRIGO-23US009174$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515061$24151506$1$I$20230810$20230811$20240730$20240730$PER$$US-PERRIGO-23US009049$PERRIGO$$81$YR$$F$Y$61.678$KG$20240730$$CN$US$US
241515071$24151507$1$I$20240719$20240719$20240730$20240730$EXP$GB-MHRA-TPP979304C579002YC1721390830630$GB-Accord-437818$ACCORD$$71$YR$E$F$Y$63$KG$20240730$$MD$GB$GB
241515081$24151508$1$I$20230720$20230816$20240730$20240730$PER$$US-PERRIGO-23US009209$PERRIGO$$72$YR$$F$Y$58.957$KG$20240730$$CN$US$US
241515091$24151509$1$I$20230801$20230808$20240730$20240730$PER$$US-PERRIGO-23US009054$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515101$24151510$1$I$20230813$20230813$20240730$20240730$PER$$US-PERRIGO-23US009139$PERRIGO$$$$$M$Y$$$20240730$$CN$US$US
241515111$24151511$1$I$20230801$20230808$20240730$20240730$PER$$US-PERRIGO-23US009011$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515121$24151512$1$I$$20240723$20240730$20240730$EXP$GB-MHRA-31183392$GB-MSNLABS-2024MSNSPO01655$MSN LABORATORIES$$$$$$Y$$$20240730$$PH$GB$GB
241515131$24151513$1$I$$20240722$20240730$20240730$EXP$$US-PHARMING-PHAUS2024000624$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
241515141$24151514$1$I$20230615$20230811$20240730$20240730$PER$$US-PERRIGO-23US009048$PERRIGO$$78$YR$$F$Y$54.875$KG$20240730$$CN$US$US
241515151$24151515$1$I$20230817$20230821$20240730$20240730$PER$$US-PERRIGO-23US009378$PERRIGO$$68$YR$$F$Y$90.703$KG$20240730$$CN$US$US
241515161$24151516$1$I$20240702$20240719$20240730$20240730$EXP$$US-Accord-437886$ACCORD$$24$YR$A$F$Y$$$20240730$$MD$US$US
241515171$24151517$1$I$20240716$20240719$20240730$20240730$EXP$GB-MHRA-MED-202407191119188980-VBRWP$GB-Accord-437148$ACCORD$$84$YR$E$F$Y$$$20240730$$PH$GB$GB
241515181$24151518$1$I$20240718$20240719$20240730$20240730$EXP$GB-MHRA-MED-202407191513307800-WYNPS$GB-Accord-437140$ACCORD$$66$YR$E$M$Y$$$20240730$$HP$GB$GB
241515191$24151519$1$I$$20240718$20240730$20240730$EXP$$US-Accord-437727$ACCORD$Fitzsimons J, Phelan K, Dhanarajan A. Hearing Loss in a Patient with Waldenstrom Macroglobulinemia Receiving Bortezomib. Case Rep Oncol. 2024 Jun 18;17(1):653-657. doi: 10.1159/000539453.$67$YR$E$M$Y$$$20240730$$MD$US$US
241515201$24151520$1$I$20240620$20240719$20240730$20240730$EXP$$US-Accord-438406$ACCORD$$55$YR$A$F$Y$$$20240730$$HP$US$US
241515211$24151521$1$I$20210801$20240718$20240730$20240730$EXP$$IN-Accord-436948$ACCORD$Giri K, Sahay M, Ismal KM, Kavadi A. A Rare Malignancy Postrenal Transplantation-The Dark Side of Success. Indian Journal of Transplantation. 2024;18(2):171-73$32$YR$A$M$Y$$$20240730$$MD$IN$IN
241515221$24151522$1$I$$20230823$20240730$20240730$EXP$$US-AstraZeneca-2023A193400$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241515232$24151523$2$F$20240620$20240816$20240730$20240828$EXP$IT-MINISAL02-995494$IT-Accord-437693$ACCORD$$95$YR$E$F$Y$$$20240828$$MD$IT$IT
241515241$24151524$1$I$20240510$20240719$20240730$20240730$EXP$FR-AFSSAPS-PP2024000777$FR-Accord-437168$ACCORD$$79$YR$E$F$Y$52$KG$20240730$$MD$FR$FR
241515251$24151525$1$I$20240716$20240719$20240730$20240730$EXP$$US-Accord-437688$ACCORD$$73$YR$E$F$Y$$$20240730$$HP$US$US
241515261$24151526$1$I$20200101$20240719$20240730$20240730$EXP$$CN-Accord-437372$ACCORD$Wang H, Li Y, Qiu M, Wang J. Thrombocytopenia and hyperprogression after radiotherapy and camrelizumab treatment in an esophageal cancer patient with increased JAK2 gene copies: a case report. Front. Oncol. 2024;14:1283428.$62$YR$A$M$Y$$$20240730$$MD$CN$CN
241515271$24151527$1$I$$20231031$20240730$20240730$EXP$$US-AstraZeneca-2023A248175$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241515281$24151528$1$I$$20221027$20240730$20240730$EXP$$US-AstraZeneca-2022A327919$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241515291$24151529$1$I$$20240718$20240730$20240730$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22279$SAMSUNG BIOEPIS$$74$YR$E$M$Y$$$20240730$$PH$CA$CA
241515302$24151530$2$F$$20240719$20240730$20240819$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22733$SAMSUNG BIOEPIS$$74$YR$E$M$Y$$$20240819$$PH$CA$CA
241515311$24151531$1$I$20220101$20240718$20240730$20240730$EXP$$AU-Accord-436943$ACCORD$Hush JM, Steffens D, Solomon MJ. A patient-designed integrative oncology intervention for stage IV locally recurrent rectal cancer: A case report. Explore. 2024;20(5):103004. DOI:10.1016/j.explore.2024.05.002.$59$YR$A$F$Y$$$20240730$$MD$AU$AU
241515321$24151532$1$I$$20230811$20240730$20240730$EXP$$US-AstraZeneca-2023A184972$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241515331$24151533$1$I$$20230313$20240730$20240730$EXP$$US-AstraZeneca-2023A061543$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241515341$24151534$1$I$$20230228$20240730$20240730$EXP$$US-AstraZeneca-2023A050305$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241515351$24151535$1$I$20210101$20240718$20240730$20240730$EXP$$AU-Accord-436946$ACCORD$Hush JM, Steffens D, Solomon MJ. A patient-designed integrative oncology intervention for stage IV locally recurrent rectal cancer: A case report. Explore. 2024;20(5):103004. DOI:10.1016/j.explore.2024.05.002.$59$YR$A$F$Y$$$20240730$$MD$AU$AU
241515361$24151536$1$I$20230901$20230909$20240730$20240730$PER$$US-PERRIGO-23US010876$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515371$24151537$1$I$20230801$20230829$20240730$20240730$PER$$US-PERRIGO-23US009676$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515381$24151538$1$I$20230801$20230822$20240730$20240730$PER$$US-PERRIGO-23US009450$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515391$24151539$1$I$20230901$20230918$20240730$20240730$PER$$US-PERRIGO-23US011144$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515401$24151540$1$I$20230801$20230826$20240730$20240730$PER$$US-PERRIGO-23US009557$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515411$24151541$1$I$20230801$20230823$20240730$20240730$PER$$US-PERRIGO-23US009508$PERRIGO$$78$YR$$M$Y$68.027$KG$20240730$$CN$US$US
241515421$24151542$1$I$20230901$20230907$20240730$20240730$PER$$US-PERRIGO-23US010717$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515431$24151543$1$I$20231005$20231005$20240730$20240730$PER$$US-PERRIGO-23US011737$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515441$24151544$1$I$20230913$20230913$20240730$20240730$PER$$US-PERRIGO-23US011015$PERRIGO$$$$$F$Y$$$20240730$$CN$US$US
241515451$24151545$1$I$20231001$20231008$20240730$20240730$PER$$US-PERRIGO-23US011852$PERRIGO$$$$$M$Y$$$20240730$$CN$US$US
241515461$24151546$1$I$20230909$20230918$20240730$20240730$PER$$US-PERRIGO-23US011140$PERRIGO$$73$YR$$F$Y$76.644$KG$20240730$$CN$US$US
241515471$24151547$1$I$$20240724$20240730$20240730$EXP$$US-TAKEDA-2022TUS071563$TAKEDA$$$$$F$Y$$$20240730$$CN$US$US
241515481$24151548$1$I$$20230522$20240730$20240730$EXP$$US-AstraZeneca-2023A118762$ASTRAZENECA$$$$$$Y$$$20240730$$CN$US$
241515491$24151549$1$I$20230926$20230927$20240730$20240730$PER$$US-PERRIGO-23US011465$PERRIGO$$67$YR$$M$Y$$$20240730$$CN$US$US
241515501$24151550$1$I$20230818$20230825$20240730$20240730$PER$$US-PERRIGO-23US009534$PERRIGO$$87$YR$$M$Y$72.562$KG$20240730$$CN$US$US
241515511$24151551$1$I$20230901$20231002$20240730$20240730$PER$$US-PERRIGO-23US011631$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515521$24151552$1$I$$20230612$20240730$20240730$EXP$$US-AstraZeneca-2023A136526$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241515531$24151553$1$I$$20240702$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018855$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241515541$24151554$1$I$$20231010$20240730$20240730$EXP$$CA-AstraZeneca-2023A231788$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$CA$
241515551$24151555$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018093$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240730$$CN$US$US
241515561$24151556$1$I$20240729$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018630$ELI LILLY AND CO$$60$YR$A$$Y$$$20240730$$CN$US$US
241515571$24151557$1$I$20240701$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018580$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240730$$CN$US$US
241515581$24151558$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018886$ELI LILLY AND CO$$29$YR$A$$Y$$$20240730$$CN$US$US
241515591$24151559$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018644$ELI LILLY AND CO$$$$$F$Y$$$20240730$$CN$US$US
241515611$24151561$1$I$$20211201$20240730$20240730$EXP$$GB-AstraZeneca-2021A853800$ASTRAZENECA$$$$$M$Y$$$20240730$$HP$GB$
241515621$24151562$1$I$$20230411$20240730$20240730$EXP$$US-AstraZeneca-2023A047476$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241515631$24151563$1$I$20211111$20211115$20240730$20240730$EXP$$US-AstraZeneca-2021A809943$ASTRAZENECA$$26791$DY$$M$Y$$$20240730$$CN$US$
241515642$24151564$2$F$$20240726$20240730$20240802$EXP$$US-AstraZeneca-2024A171619$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241515654$24151565$4$F$20240713$20240904$20240730$20240906$EXP$$US-GILEAD-2024-0681047$GILEAD$$56$YR$A$F$Y$$$20240906$$CN$US$US
241515661$24151566$1$I$$20240626$20240730$20240730$EXP$$FR-JAZZ PHARMACEUTICALS-2024-FR-009714$JAZZ$$$$$$Y$$$20240730$$CN$FR$FR
241515673$24151567$3$F$20120101$20240802$20240730$20240808$EXP$$US-LEO Pharma-372302$LEO PHARM$$85$YR$$F$Y$$$20240808$$CN$US$US
241515682$24151568$2$F$$20240815$20240730$20240822$EXP$$US-GSK-US2024092902$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
241515691$24151569$1$I$20231013$20231013$20240730$20240730$PER$$US-PERRIGO-23US012023$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515701$24151570$1$I$20231001$20231009$20240730$20240730$PER$$US-PERRIGO-23US011866$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515711$24151571$1$I$20231030$20231030$20240730$20240730$PER$$US-PERRIGO-23US012561$PERRIGO$$53$YR$$F$Y$72.562$KG$20240730$$CN$US$US
241515721$24151572$1$I$$20231031$20240730$20240730$PER$$US-PERRIGO-23US012654$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515731$24151573$1$I$$20231115$20240730$20240730$PER$$US-PERRIGO-23US013256$PERRIGO$$$$$$Y$$$20240730$$CN$US$US
241515741$24151574$1$I$20230901$20231101$20240730$20240730$PER$$US-PERRIGO-23US012651$PERRIGO$$70$YR$$F$Y$71.655$KG$20240730$$CN$US$US
241515751$24151575$1$I$20231011$20231011$20240730$20240730$PER$$US-PERRIGO-23US011923$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515761$24151576$1$I$20231108$20231109$20240730$20240730$PER$$US-PERRIGO-23US012972$PERRIGO$$85$YR$$F$Y$71.202$KG$20240730$$CN$US$US
241515771$24151577$1$I$20231109$20231109$20240730$20240730$PER$$US-PERRIGO-23US012959$PERRIGO$$1$YR$$F$Y$12.245$KG$20240730$$CN$US$US
241515781$24151578$1$I$20231006$20231117$20240730$20240730$PER$$US-PERRIGO-23US013286$PERRIGO$$89$YR$$M$Y$79.365$KG$20240730$$CN$US$US
241515791$24151579$1$I$20231001$20231009$20240730$20240730$PER$$US-PERRIGO-23US012395$PERRIGO$$$$$M$Y$$$20240730$$CN$US$US
241515801$24151580$1$I$20231001$20231025$20240730$20240730$PER$$US-PERRIGO-23US012486$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515811$24151581$1$I$20220101$20231103$20240730$20240730$PER$$US-PERRIGO-23US012733$PERRIGO$$$$$F$Y$78.458$KG$20240730$$CN$US$US
241515821$24151582$1$I$20230901$20231116$20240730$20240730$PER$$US-PERRIGO-23US013258$PERRIGO$$$$$$Y$$$20240730$$CN$US$US
241515831$24151583$1$I$20231001$20231026$20240730$20240730$PER$$US-PERRIGO-23US012482$PERRIGO$$69$YR$$M$Y$68.027$KG$20240730$$CN$US$US
241515841$24151584$1$I$$20240717$20240730$20240730$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07132$LUPIN$Bollam RR, Reddy VK. Persistent pseudomonas aeruginosa pneumonia due to antimicrobial resistance development requiring lobectomy. American Journal of Respiratory and Critical Care Medicine. 2024;209$56$YR$$F$Y$$$20240730$$HP$US$US
241515852$24151585$2$F$$20240829$20240730$20240904$30DAY$$US-JNJFOC-20240772720$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
241515861$24151586$1$I$20221201$20240722$20240730$20240730$EXP$$MT-TEVA-VS-3225171$TEVA$$3$DEC$$F$Y$$$20240730$$MD$MT$MT
241515872$24151587$2$F$20240701$20240722$20240730$20240730$PER$$US-ROCHE-10000031714$ROCHE$$74$YR$E$F$Y$$$20240730$$CN$US$US
241515881$24151588$1$I$20240624$20240720$20240730$20240730$EXP$$IT-AUROBINDO-AUR-APL-2024-036904$AUROBINDO$$76$YR$$$Y$69$KG$20240730$$MD$IT$IT
241515891$24151589$1$I$20231202$20231206$20240730$20240730$PER$$US-PERRIGO-23US013944$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515901$24151590$1$I$20230401$20231122$20240730$20240730$PER$$US-PERRIGO-23US013498$PERRIGO$$73$YR$$F$Y$56.689$KG$20240730$$CN$US$US
241515911$24151591$1$I$$20240112$20240730$20240730$PER$$US-PERRIGO-24US000445$PERRIGO$$$$$F$Y$52.154$KG$20240730$$CN$US$US
241515921$24151592$1$I$$20231221$20240730$20240730$PER$$US-PERRIGO-23US015000$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515931$24151593$1$I$$20231218$20240730$20240730$PER$$US-PERRIGO-23US014862$PERRIGO$$$$$M$Y$$$20240730$$CN$US$US
241515941$24151594$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225223$TEVA$$12$YR$$M$Y$45$KG$20240730$$PH$CA$CA
241515951$24151595$1$I$20231227$20240125$20240730$20240730$PER$$US-PERRIGO-24US000892$PERRIGO$$$$$M$Y$$$20240730$$CN$US$US
241515961$24151596$1$I$20240101$20240115$20240730$20240730$PER$$US-PERRIGO-24US000465$PERRIGO$$69$YR$$M$Y$72.562$KG$20240730$$CN$US$US
241515971$24151597$1$I$$20240206$20240730$20240730$PER$$US-PERRIGO-24US001437$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241515981$24151598$1$I$20240204$20240205$20240730$20240730$PER$$US-PERRIGO-24US001320$PERRIGO$$$$$$Y$$$20240730$$CN$US$US
241515991$24151599$1$I$20231119$20231128$20240730$20240730$PER$$US-PERRIGO-23US013636$PERRIGO$$73$YR$$F$Y$88.889$KG$20240730$$CN$US$US
241516001$24151600$1$I$20231126$20231201$20240730$20240730$PER$$US-PERRIGO-23US013776$PERRIGO$$63$YR$$F$Y$$$20240730$$CN$US$US
241516011$24151601$1$I$20231227$20240109$20240730$20240730$PER$$US-PERRIGO-24US000282$PERRIGO$$64$YR$$M$Y$117.91$KG$20240730$$CN$US$US
241516021$24151602$1$I$20240105$20240105$20240730$20240730$PER$$US-PERRIGO-24US000161$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516031$24151603$1$I$20240205$20240205$20240730$20240730$PER$$US-PERRIGO-24US001360$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516041$24151604$1$I$20230101$20240105$20240730$20240730$PER$$US-PERRIGO-24US000154$PERRIGO$$73$YR$$$Y$$$20240730$$CN$US$US
241516051$24151605$1$I$$20240212$20240730$20240730$PER$$US-PERRIGO-24US001622$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516061$24151606$1$I$20231101$20231127$20240730$20240730$PER$$US-PERRIGO-23US013549$PERRIGO$$55$YR$$M$Y$81.633$KG$20240730$$CN$US$US
241516071$24151607$1$I$20231129$20231129$20240730$20240730$PER$$US-PERRIGO-23US013680$PERRIGO$$3$YR$$$Y$14.512$KG$20240730$$CN$US$US
241516081$24151608$1$I$$20240120$20240730$20240730$PER$$US-PERRIGO-24US000990$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516091$24151609$1$I$20240116$20240117$20240730$20240730$PER$$US-PERRIGO-24US000584$PERRIGO$$89$YR$$F$Y$60.771$KG$20240730$$CN$US$US
241516101$24151610$1$I$20231101$20231130$20240730$20240730$PER$$US-PERRIGO-23US013747$PERRIGO$$84$YR$$M$Y$93.424$KG$20240730$$CN$US$US
241516111$24151611$1$I$$20240113$20240730$20240730$PER$$US-PERRIGO-24US000534$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516121$24151612$1$I$$20240121$20240730$20240730$PER$$US-PERRIGO-24US000967$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516131$24151613$1$I$20231201$20231201$20240730$20240730$PER$$US-PERRIGO-23US013801$PERRIGO$$$$$M$Y$$$20240730$$CN$US$US
241516141$24151614$1$I$$20231208$20240730$20240730$PER$$US-PERRIGO-23US014099$PERRIGO$$$$$F$Y$$$20240730$$CN$US$US
241516151$24151615$1$I$$20240124$20240730$20240730$PER$$US-PERRIGO-24US000922$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516171$24151617$1$I$$20240210$20240730$20240730$PER$$US-PERRIGO-24US001539$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516181$24151618$1$I$$20240126$20240730$20240730$PER$$US-PERRIGO-24US001108$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516191$24151619$1$I$20231101$20231220$20240730$20240730$PER$$US-PERRIGO-23US014865$PERRIGO$$21$YR$$F$Y$87.528$KG$20240730$$CN$US$US
241516211$24151621$1$I$20240108$20240109$20240730$20240730$PER$$US-PERRIGO-24US000281$PERRIGO$$58$YR$$F$Y$99.773$KG$20240730$$CN$US$US
241516221$24151622$1$I$$20240726$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US068756$SANDOZ$$$$$F$Y$$$20240730$$CN$US$US
241516232$24151623$2$F$20240721$20240726$20240730$20240803$EXP$$IN-VANTIVE-2024VAN018575$Vantive US Healthcare$$71$YR$$M$Y$$$20240803$$CN$IN$IN
241516251$24151625$1$I$$20240722$20240730$20240730$EXP$$MX-BRISTOL-MYERS SQUIBB COMPANY-2024-116437$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240730$$HP$MX$MX
241516262$24151626$2$F$$20240807$20240730$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119332$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240815$$CN$US$US
241516271$24151627$1$I$20230804$20240729$20240729$20240729$DIR$711965$$FDA-CTU$$56$YR$$F$N$67.5$KG$20240729$N$CN$US$
241516281$24151628$1$I$20240725$20240729$20240729$20240729$DIR$711952$$FDA-CTU$$50$YR$$M$N$$$20240729$N$HP$US$
241516291$24151629$1$I$20240307$20240307$20240730$20240730$PER$$US-PERRIGO-24US002447$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516301$24151630$1$I$$20240305$20240730$20240730$PER$$US-PERRIGO-24US002561$PERRIGO$$$$$$Y$$$20240730$$CN$US$US
241516311$24151631$1$I$$20240310$20240730$20240730$PER$$US-PERRIGO-24US002606$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516321$24151632$1$I$20240101$20240326$20240730$20240730$PER$$US-PERRIGO-24US003095$PERRIGO$$74$YR$$M$Y$95.238$KG$20240730$$CN$US$US
241516331$24151633$1$I$20240316$20240325$20240730$20240730$PER$$US-PERRIGO-24US003102$PERRIGO$$70$YR$$F$Y$86.168$KG$20240730$$CN$US$US
241516341$24151634$1$I$20240302$20240302$20240730$20240730$PER$$US-PERRIGO-24US002326$PERRIGO$$1$YR$$F$Y$11.338$KG$20240730$$CN$US$US
241516361$24151636$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52044$$FDA-CTU$$$$$F$N$$$20240729$N$HP$US$
241516371$24151637$1$I$$20240322$20240730$20240730$PER$$US-PERRIGO-24US002946$PERRIGO$$$$$$Y$$$20240730$$CN$US$US
241516381$24151638$1$I$$20240325$20240730$20240730$PER$$US-PERRIGO-24US003036$PERRIGO$$83$YR$$M$Y$$$20240730$$CN$US$US
241516391$24151639$1$I$20240308$20240308$20240730$20240730$PER$$US-PERRIGO-24US002484$PERRIGO$$$$$$Y$$$20240730$$CN$US$US
241516401$24151640$1$I$$20240316$20240730$20240730$PER$$US-PERRIGO-24US003046$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516411$24151641$1$I$20240304$20240304$20240730$20240730$PER$$US-PERRIGO-24US002322$PERRIGO$$20$YR$$F$Y$$$20240730$$CN$US$US
241516421$24151642$1$I$20200101$20240219$20240730$20240730$PER$$US-PERRIGO-24US001816$PERRIGO$$$$$M$Y$77.098$KG$20240730$$CN$US$US
241516431$24151643$1$I$20240215$20240216$20240730$20240730$PER$$US-PERRIGO-24US001742$PERRIGO$$74$YR$$F$Y$79.365$KG$20240730$$CN$US$US
241516441$24151644$1$I$20240304$20240305$20240730$20240730$PER$$US-PERRIGO-24US002367$PERRIGO$$72$YR$$M$Y$74.83$KG$20240730$$CN$US$US
241516451$24151645$1$I$20220101$20240312$20240730$20240730$PER$$US-PERRIGO-24US002650$PERRIGO$$$$$F$Y$63.492$KG$20240730$$CN$US$US
241516461$24151646$1$I$$20240323$20240730$20240730$PER$$US-PERRIGO-24US003063$PERRIGO$$$$$M$Y$$$20240730$$CN$US$US
241516471$24151647$1$I$20231201$20240318$20240730$20240730$PER$$US-PERRIGO-24US002791$PERRIGO$$49$YR$$F$Y$61.224$KG$20240730$$CN$US$US
241516481$24151648$1$I$20240101$20240223$20240730$20240730$PER$$US-PERRIGO-24US002042$PERRIGO$$$$$$Y$$$20240730$$CN$US$US
241516491$24151649$1$I$$20240304$20240730$20240730$PER$$US-PERRIGO-24US002315$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516501$24151650$1$I$20240318$20240325$20240730$20240730$PER$$US-PERRIGO-24US002978$PERRIGO$$27$YR$$F$Y$70.295$KG$20240730$$CN$US$US
241516511$24151651$1$I$20240118$20240719$20240730$20240730$EXP$$CZ-SAMSUNG BIOEPIS-SB-2024-22652$SAMSUNG BIOEPIS$$62$YR$A$F$Y$$$20240730$$MD$CZ$CZ
241516531$24151653$1$I$20150501$20240723$20240730$20240730$EXP$$US-GSK-US2024092363$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$US$US
241516541$24151654$1$I$$20240726$20240730$20240730$30DAY$$US-GSK-US2024094310$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$CN$US$US
241516551$24151655$1$I$$20240722$20240730$20240730$30DAY$$US-GSK-US2024091818$GLAXOSMITHKLINE$$$$$M$Y$$$20240730$$CN$US$US
241516571$24151657$1$I$20240207$20240327$20240730$20240730$PER$$US-PERRIGO-24US003169$PERRIGO$$54$YR$$F$Y$90.703$KG$20240730$$CN$US$US
241516581$24151658$1$I$20240416$20240416$20240730$20240730$PER$$US-PERRIGO-24US003773$PERRIGO$$$$C$$Y$$$20240730$$CN$US$US
241516591$24151659$1$I$$20240406$20240730$20240730$PER$$US-PERRIGO-24US003451$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516601$24151660$1$I$$20240325$20240730$20240730$PER$$US-PERRIGO-24US003331$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516611$24151661$1$I$$20240329$20240730$20240730$PER$$US-PERRIGO-24US003227$PERRIGO$$$$$$Y$$$20240730$$CN$US$US
241516621$24151662$1$I$$20240414$20240730$20240730$PER$$US-PERRIGO-24US003779$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516631$24151663$1$I$$20240402$20240730$20240730$PER$$US-PERRIGO-24US003381$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516641$24151664$1$I$20240201$20240415$20240730$20240730$PER$$US-PERRIGO-24US003689$PERRIGO$$77$YR$$M$Y$61.224$KG$20240730$$CN$US$US
241516651$24151665$1$I$20240201$20240404$20240730$20240730$PER$$US-PERRIGO-24US003389$PERRIGO$$77$YR$$F$Y$50.794$KG$20240730$$CN$US$US
241516661$24151666$1$I$$20240408$20240730$20240730$PER$$US-PERRIGO-24US003501$PERRIGO$$$$$$Y$$$20240730$$CN$US$US
241516672$24151667$2$F$$20240709$20240730$20240830$PER$$US-JNJFOC-20240724557$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240830$$CN$US$US
241516681$24151668$1$I$$20240719$20240730$20240730$EXP$$SE-RDY-LIT/SWE/24/0011042$DR REDDYS$Ljungquist O, Haidl S, Dias N, Sonesson B, Sorelius K, Tragardh E, et al. Conservative Management First Strategy in Aortic Vascular Graft and Endograft Infections. European Journal of Vascular and Endovascular Surgery. 2023 Jun;65(6): 896-904. doi:10.1016/j.ejvs.2023.03.003.$$$$$Y$$$20240730$$HP$SE$SE
241516692$24151669$2$F$20240716$20240725$20240730$20240803$EXP$$US-AMGEN-USASP2024148512$AMGEN$$37$YR$A$F$Y$$$20240803$$HP$US$US
241516701$24151670$1$I$20240622$20240719$20240730$20240730$EXP$$CZ-SAMSUNG BIOEPIS-SB-2024-22669$SAMSUNG BIOEPIS$$63$YR$A$F$Y$$$20240730$$MD$CZ$CZ
241516711$24151671$1$I$20210101$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036118$AUROBINDO$Moal V, Boschi C, Pernin V, Fouilloux V, Motte A, Solignac J et al.. The question of screening organ donors for hepatitis e virus: a case report of transmission by kidney transplantation in France and a review of the literature. Virology journal. 2024;21(1):136$6$DEC$$F$Y$64$KG$20240730$$MD$FR$FR
241516724$24151672$4$F$20240101$20240916$20240730$20240927$EXP$$CA-UCBSA-2024013792$UCB$$$$$F$Y$$$20240927$$CN$CA$CA
241516731$24151673$1$I$$20240627$20240730$20240730$PER$$US-ROCHE-10000020886$ROCHE$$$$$$Y$$$20240730$$CN$US$US
241516741$24151674$1$I$$20240415$20240730$20240730$PER$$US-PERRIGO-24US003947$PERRIGO$$$$$F$Y$$$20240730$$CN$US$US
241516751$24151675$1$I$$20240502$20240730$20240730$PER$$US-PERRIGO-24US004401$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516761$24151676$1$I$20240515$20240515$20240730$20240730$PER$$US-PERRIGO-24US004769$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516771$24151677$1$I$$20240509$20240730$20240730$PER$$US-PERRIGO-24US004688$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516781$24151678$1$I$20240429$20240501$20240730$20240730$PER$$US-PERRIGO-24US004302$PERRIGO$$74$YR$$F$Y$66.667$KG$20240730$$CN$US$US
241516791$24151679$1$I$20240515$20240515$20240730$20240730$PER$$US-PERRIGO-24US004787$PERRIGO$$12$YR$$$Y$$$20240730$$CN$US$US
241516801$24151680$1$I$20240401$20240422$20240730$20240730$PER$$US-PERRIGO-24US004034$PERRIGO$$$$$F$Y$$$20240730$$CN$US$US
241516811$24151681$1$I$20240507$20240508$20240730$20240730$PER$$US-PERRIGO-24US004488$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516821$24151682$1$I$20240404$20240418$20240730$20240730$PER$$US-PERRIGO-24US003922$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516831$24151683$1$I$20240417$20240418$20240730$20240730$PER$$US-PERRIGO-24US003897$PERRIGO$$91$YR$$F$Y$45.805$KG$20240730$$CN$US$US
241516841$24151684$1$I$20230101$20240429$20240730$20240730$PER$$US-PERRIGO-24US004222$PERRIGO$$$$$F$Y$105.67$KG$20240730$$CN$US$US
241516851$24151685$1$I$20240512$20240513$20240730$20240730$PER$$US-PERRIGO-24US004695$PERRIGO$$$$$F$Y$$$20240730$$CN$US$US
241516861$24151686$1$I$$20240427$20240730$20240730$PER$$US-PERRIGO-24US004202$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516871$24151687$1$I$$20240418$20240730$20240730$PER$$US-PERRIGO-24US003933$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516881$24151688$1$I$20240201$20240422$20240730$20240730$PER$$US-PERRIGO-24US004049$PERRIGO$$$$$F$Y$$$20240730$$CN$US$US
241516891$24151689$1$I$$20240503$20240730$20240730$PER$$US-PERRIGO-24US004397$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516901$24151690$1$I$20240423$20240426$20240730$20240730$PER$$US-PERRIGO-24US004200$PERRIGO$$63$YR$$F$Y$141.95$KG$20240730$$CN$US$US
241516911$24151691$1$I$$20240507$20240730$20240730$PER$$US-PERRIGO-24US004630$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516921$24151692$1$I$20240501$20240502$20240730$20240730$PER$$US-PERRIGO-24US004354$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241516931$24151693$1$I$20240429$20240430$20240730$20240730$PER$$US-PERRIGO-24US004102$PERRIGO$$81$YR$$F$Y$63.946$KG$20240730$$CN$US$US
241516942$24151694$2$F$$20240913$20240730$20240917$30DAY$$GR-SANDOZ INC.-SDZ2024GR068106$SANDOZ$$12$YR$$F$Y$$$20240917$$CN$GR$GR
241516951$24151695$1$I$$20240722$20240730$20240730$PER$$US-MYLANLABS-2024M1069122$MYLAN$$$$$$Y$$$20240730$$CN$US$US
241516961$24151696$1$I$$20240719$20240730$20240730$PER$$US-MYLANLABS-2024M1068265$MYLAN$$$$$F$Y$$$20240730$$CN$US$US
241516971$24151697$1$I$$20240726$20240730$20240730$EXP$$US-BAYER-2024A109089$BAYER$$52$YR$A$M$Y$$$20240730$$CN$US$US
241516981$24151698$1$I$20240514$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036796$AUROBINDO$$51$YR$$F$Y$68$KG$20240730$$PH$FR$FR
241516991$24151699$1$I$$20240601$20240730$20240730$PER$$US-PERRIGO-24US005403$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241517001$24151700$1$I$20240604$20240604$20240730$20240730$PER$$US-PERRIGO-24US005437$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241517012$24151701$2$F$20230101$20240916$20240730$20240924$EXP$$CA-CELLTRION INC.-2023CA013373$CELLTRION$$$$$$Y$$$20240924$$MD$CA$CA
241517021$24151702$1$I$$20240528$20240730$20240730$PER$$US-PERRIGO-24US005223$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241517031$24151703$1$I$20240501$20240530$20240730$20240730$PER$$US-PERRIGO-24US005329$PERRIGO$$$$$$Y$$$20240730$$CN$US$US
241517041$24151704$1$I$20240518$20240520$20240730$20240730$PER$$US-PERRIGO-24US004936$PERRIGO$$$$$M$Y$$$20240730$$CN$US$US
241517051$24151705$1$I$$20240525$20240730$20240730$PER$$US-PERRIGO-24US005193$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241517061$24151706$1$I$20240530$20240604$20240730$20240730$PER$$US-PERRIGO-24US005444$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241517071$24151707$1$I$20240529$20240529$20240730$20240730$PER$$US-PERRIGO-24US005213$PERRIGO$$20$YR$$M$Y$113.38$KG$20240730$$CN$US$US
241517081$24151708$1$I$$20240725$20240730$20240730$PER$$US-LEO Pharma-372337$LEO PHARM$$65$YR$$M$Y$$$20240730$$PH$US$US
241517091$24151709$1$I$$20240517$20240730$20240730$PER$$US-PERRIGO-24US004864$PERRIGO$$$$$F$Y$$$20240730$$CN$US$US
241517101$24151710$1$I$20240524$20240524$20240730$20240730$PER$$US-PERRIGO-24US005143$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241517111$24151711$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149774$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241517121$24151712$1$I$20240601$20240610$20240730$20240730$PER$$US-PERRIGO-24US005649$PERRIGO$$$$$M$Y$$$20240730$$CN$US$US
241517131$24151713$1$I$20240605$20240605$20240730$20240730$PER$$US-PERRIGO-24US005497$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241517141$24151714$1$I$20230901$20240617$20240730$20240730$PER$$US-PERRIGO-24US005845$PERRIGO$$9$YR$$F$Y$74.83$KG$20240730$$CN$US$US
241517151$24151715$1$I$20240515$20240605$20240730$20240730$PER$$US-PERRIGO-24US005458$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241517161$24151716$1$I$20240422$20240618$20240730$20240730$PER$$US-PERRIGO-24US005915$PERRIGO$$60$YR$$F$Y$99.773$KG$20240730$$CN$US$US
241517171$24151717$1$I$$20240617$20240730$20240730$PER$$US-PERRIGO-24US005854$PERRIGO$$$$A$F$Y$$$20240730$$CN$US$US
241517181$24151718$1$I$20240605$20240606$20240730$20240730$PER$$US-PERRIGO-24US005549$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241517191$24151719$1$I$$20240606$20240730$20240730$PER$$US-PERRIGO-24US005532$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241517201$24151720$1$I$$20240613$20240730$20240730$PER$$US-PERRIGO-24US005912$PERRIGO$$$$A$$Y$$$20240730$$CN$US$US
241517211$24151721$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119368$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240730$$HP$US$US
241517222$24151722$2$F$$20240910$20240730$20240918$EXP$$BR-EMD Serono-2024040581$EMD SERONO INC$$$$A$F$Y$$$20240918$$CN$BR$BR
241517231$24151723$1$I$20240709$20240726$20240730$20240730$EXP$SE-SEMPA-2024-005709$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-119822$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240730$$MD$SE$SE
241517241$24151724$1$I$20220701$20240729$20240730$20240730$EXP$DE-002147023-NVSC2022DE167552$DE-UCBSA-2024038070$UCB$$81$YR$$F$Y$$$20240730$$CN$DE$DE
241517251$24151725$1$I$$20240723$20240730$20240730$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00391$VELOXIS PHARMACEUTICALS$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al.. Collapsing glomerulopathy leading to rapidly progressive allograft failure from cytomegalovirus and SARS-CoV-2 infection with concomitant bk virus nephropathy.. Experimental and Clinical Transplantation.. 2024;22(5):392-5$68$YR$$F$Y$$$20240730$$MD$US$US
241517261$24151726$1$I$$20240719$20240730$20240730$EXP$$DE-ASTELLAS-2024US021210$ASTELLAS$$$$E$M$Y$$$20240730$$CN$US$DE
241517271$24151727$1$I$$20240726$20240730$20240730$EXP$$JP-GSK-JP2024094909$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$PH$JP$JP
241517281$24151728$1$I$20240614$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036765$AUROBINDO$$21$YR$$M$Y$$$20240730$$MD$FR$FR
241517291$24151729$1$I$20240619$20240719$20240730$20240730$EXP$$ES-AUROBINDO-AUR-APL-2024-036823$AUROBINDO$$77$YR$$M$Y$$$20240730$$MD$ES$ES
241517302$24151730$2$F$20240701$20240730$20240730$20240813$EXP$$DE-AUROBINDO-AUR-APL-2024-036782$AUROBINDO$$58$YR$$M$Y$$$20240813$$MD$DE$DE
241517321$24151732$1$I$$20240722$20240730$20240730$EXP$$CA-JNJFOC-20240767114$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240730$$MD$CA$CA
241517331$24151733$1$I$20210101$20240717$20240730$20240730$EXP$$SG-ROCHE-10000031485$ROCHE$$57$YR$A$F$Y$$$20240730$$CN$SG$SG
241517341$24151734$1$I$$20240719$20240730$20240730$EXP$$NL-AUROBINDO-AUR-APL-2024-036108$AUROBINDO$Dekker MJHJ, Heerdink GC, Plattel CHM.. Vitamin B12 Deficiency-Induced Neuropathy and Cognitive and Motor Impairment in the Elderly:. A Case Study. Food and nutrition bulletin.. 45(1_suppl):S53-7$71$YR$$M$Y$$$20240730$$MD$NL$NL
241517351$24151735$1$I$20231201$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036350$AUROBINDO$$74$YR$$$Y$$$20240730$$MD$FR$FR
241517361$24151736$1$I$$20240723$20240730$20240730$EXP$$US-SA-2024SA219710$SANOFI AVENTIS$$$$E$M$Y$78$KG$20240730$$MD$US$US
241517372$24151737$2$F$20240719$20240923$20240730$20240930$EXP$$FR-SA-2024SA218697$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240930$$MD$FR$FR
241517391$24151739$1$I$20240501$20240729$20240729$20240729$DIR$711955$$FDA-CTU$$54$YR$$F$N$101.25$KG$20240729$N$PH$US$
241517401$24151740$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52123$$FDA-CTU$$64$YR$$F$N$$$20240729$N$$US$
241517411$24151741$1$I$$20240725$20240730$20240730$EXP$$NVSC2024SI153588$NOVARTIS$$71$YR$$F$Y$$$20240730$$MD$SI$SI
241517431$24151743$1$I$20191101$20240719$20240730$20240730$EXP$$US-AUROBINDO-AUR-APL-2024-036129$AUROBINDO$Platteter E, Wulf G. Durable Response to Programmed Death 1-Directed Antibodies in a Hypermutated Triple-Negative Breast Cancer: A Case Report. Case Reports in Oncology. 2024;17(1):392?398$65$YR$$F$Y$$$20240730$$MD$US$US
241517442$24151744$2$F$20220101$20240725$20240730$20240909$EXP$$US-SA-2024SA219119$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240909$$CN$US$US
241517451$24151745$1$I$$20240719$20240730$20240730$EXP$$GB-AUROBINDO-AUR-APL-2024-036399$AUROBINDO$$86$YR$$F$Y$68$KG$20240730$$HP$GB$GB
241517465$24151746$5$F$20240101$20240816$20240730$20240822$30DAY$$US-SANDOZ INC.-SDZ2024US068786$SANDOZ$$$$$M$Y$$$20240822$$HP$US$US
241517471$24151747$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120206$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240730$$CN$US$US
241517481$24151748$1$I$20240701$20240722$20240730$20240730$EXP$IT-MINISAL02-994216$IT-TEVA-VS-3224560$TEVA$$75$YR$$M$Y$$$20240730$$MD$IT$IT
241517491$24151749$1$I$20240707$20240729$20240730$20240730$EXP$IT-MINISAL02-996328$IT-GILEAD-2024-0682227$GILEAD$$73$YR$E$M$Y$$$20240730$$MD$IT$IT
241517501$24151750$1$I$$20240726$20240730$20240730$EXP$$NVSC2024DO154791$NOVARTIS$$$$$F$Y$$$20240730$$CN$DO$DO
241517513$24151751$3$F$$20240902$20240730$20240904$30DAY$$KR-JNJFOC-20240772098$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$KR$KR
241517521$24151752$1$I$20240101$20240722$20240730$20240730$EXP$$CA-CELLTRION INC.-2024CA018047$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
241517531$24151753$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52150$$FDA-CTU$$74$YR$$F$N$67.59$KG$20240729$N$$US$
241517541$24151754$1$I$$20240729$20240730$20240730$PER$$US-AMGEN-USASP2024150643$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241517552$24151755$2$F$20240725$20240725$20240730$20240802$PER$$US-AMGEN-USASP2024148812$AMGEN$$83$YR$E$F$Y$$$20240801$$PH$US$US
241517562$24151756$2$F$$20240726$20240730$20240807$PER$$US-AMGEN-USASP2024149335$AMGEN$$$$$F$Y$$$20240807$$HP$US$US
241517571$24151757$1$I$20240723$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149613$AMGEN$$76$YR$E$M$Y$$$20240730$$CN$US$US
241517581$24151758$1$I$$20240729$20240729$20240729$DIR$711970$$FDA-CTU$$$$$UNK$N$$$20240729$$CN$US$
241517591$24151759$1$I$$20240717$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010765$DR REDDYS$$$$$$Y$$$20240730$$HP$US$US
241517601$24151760$1$I$20220829$20240719$20240730$20240730$EXP$$ES-AUROBINDO-AUR-APL-2024-037056$AUROBINDO$$$$$F$Y$$$20240730$$MD$ES$ES
241517611$24151761$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52045$$FDA-CTU$$79$YR$$M$N$$$20240729$N$$US$
241517621$24151762$1$I$20240515$20240729$20240729$20240729$DIR$711968$$FDA-CTU$$44$YR$$M$N$58$KG$20240729$N$HP$US$
241517631$24151763$1$I$20240101$20240724$20240730$20240730$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-104188$REGENERON$$$$$M$Y$$$20240730$$CN$CA$CA
241517641$24151764$1$I$$20240719$20240730$20240730$EXP$$GB-Accord-437333$ACCORD$Bhatti A, Kalearasu A, Jayapalen V TACHYPHYLAXIS-INDUCED MYOCARDIAL INFARCTION IN A PATIENT WITH VASOSPASTIC ANGINA. Heart. 2024 Jun 24;110:A80-A81.$70$YR$E$F$Y$$$20240730$$MD$GB$GB
241517651$24151765$1$I$$20240719$20240730$20240730$EXP$$US-Accord-437392$ACCORD$Sorabekka RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70(7):e92-6. DOI: 10.1097/MAT.0000000000002102.$12$YR$T$F$Y$63$KG$20240730$$MD$US$US
241517661$24151766$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52067$$FDA-CTU$$71$YR$$F$N$$$20240729$N$$US$
241517671$24151767$1$I$20240705$20240726$20240730$20240730$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023237$UNITED THERAPEUTICS$$67$YR$$F$Y$49.887$KG$20240730$$$US$US
241517681$24151768$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52063$$FDA-CTU$$61$YR$$F$N$$$20240729$N$$US$
241517691$24151769$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-10000041643$ROCHE$$$$$$Y$$$20240730$$CN$US$US
241517701$24151770$1$I$20240715$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119477$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240730$$HP$US$US
241517711$24151771$1$I$20240708$20240729$20240729$20240729$DIR$711973$$FDA-CTU$$52$YR$$F$N$126$KG$20240729$Y$CN$US$
241517721$24151772$1$I$$20240728$20240730$20240730$EXP$$NVSC2024CG154776$NOVARTIS$$$$$F$Y$$$20240730$$MD$CG$CG
241517731$24151773$1$I$20210215$20240723$20240730$20240730$EXP$$NVSC2024US151371$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
241517741$24151774$1$I$20240728$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018832$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240730$$CN$US$US
241517751$24151775$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52131$$FDA-CTU$$67$YR$$F$N$104.33$KG$20240729$N$$US$
241517761$24151776$1$I$20240729$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018631$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240730$$CN$US$US
241517771$24151777$1$I$20240714$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018038$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240730$$CN$US$US
241517781$24151778$1$I$$20240722$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407015670$ELI LILLY AND CO$$44$YR$A$$Y$$$20240730$$CN$US$US
241517791$24151779$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017765$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240730$$CN$US$US
241517801$24151780$1$I$$20240726$20240730$20240730$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017501$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240730$$MD$US$US
241517811$24151781$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018301$ELI LILLY AND CO$$65$YR$E$$Y$$$20240730$$CN$US$US
241517821$24151782$1$I$20240718$20240719$20240730$20240730$EXP$$US-Accord-437412$ACCORD$$32$YR$A$M$Y$$$20240730$$HP$US$US
241517831$24151783$1$I$20240409$20240718$20240730$20240730$EXP$GB-PFM-2024-02565$GB-Accord-436955$ACCORD$$76$YR$E$M$Y$60$KG$20240730$$HP$GB$GB
241517841$24151784$1$I$$20240719$20240730$20240730$EXP$$US-Accord-437394$ACCORD$Sorabekka RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70(7):e92-6.$15$YR$T$F$Y$49$KG$20240730$$MD$US$US
241517851$24151785$1$I$$20240729$20240730$20240730$EXP$$CA-ORGANON-O2407CAN002633$ORGANON$$44$YR$$F$Y$$$20240730$$HP$CA$CA
241517861$24151786$1$I$$20240718$20240730$20240730$EXP$$US-Accord-437543$ACCORD$Bayless SL, Walker NV, Scott MM, Leo RJ. Clozapine-Related Cecal Volvulus. The primary care companion for CNS disorders. 2024 Jul 11;26(4):24cr03729.$58$YR$A$F$Y$$$20240730$$MD$US$
241517871$24151787$1$I$20240627$20240720$20240730$20240730$EXP$$US-Accord-437919$ACCORD$$35$YR$A$F$Y$$$20240730$$HP$US$US
241517881$24151788$1$I$$20240719$20240730$20240730$EXP$GB-MHRA-MED-202407191509250810-ZFNTB$GB-Accord-437141$ACCORD$$66$YR$E$M$Y$$$20240730$$HP$GB$GB
241517891$24151789$1$I$20240601$20240719$20240730$20240730$EXP$FR-AFSSAPS-LM2024000391$FR-Accord-437175$ACCORD$$68$YR$E$F$Y$54$KG$20240730$$MD$FR$FR
241517901$24151790$1$I$$20240727$20240730$20240730$PER$$US-ABBVIE-5858698$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241517921$24151792$1$I$$20240729$20240730$20240730$EXP$$CN-ROCHE-10000040590$ROCHE$$60$YR$A$F$Y$$$20240730$$CN$CN$CN
241517931$24151793$1$I$20231023$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036733$AUROBINDO$$64$YR$$F$Y$75$KG$20240730$$PH$FR$FR
241517952$24151795$2$F$$20240715$20240730$20240812$EXP$$PT-TEVA-VS-3222979$TEVA$Literature Reference: Calado D, Precipitating predispositions to the skin - a case of PRES Congresses of the Portuguese Society of Intermedicine.$60$YR$$M$Y$$$20240812$$MD$PT$PT
241517961$24151796$1$I$$20240724$20240730$20240730$EXP$$GB-MYLANLABS-2024M1069257$MYLAN$$$$$M$Y$$$20240730$$PH$GB$GB
241517971$24151797$1$I$$20240724$20240730$20240730$EXP$$GB-MYLANLABS-2024M1069758$MYLAN$$$$$F$Y$$$20240730$$CN$GB$GB
241517981$24151798$1$I$$20240724$20240730$20240730$EXP$$GB-MYLANLABS-2024M1069666$MYLAN$$$$$F$Y$$$20240730$$MD$GB$GB
241517991$24151799$1$I$20240711$20240723$20240730$20240730$EXP$$CN-GE HEALTHCARE-2024CSU008404$GE HEALTHCARE$$88$YR$$M$Y$62$KG$20240730$$HP$CN$CN
241518011$24151801$1$I$$20210901$20240730$20240730$EXP$$US-AstraZeneca-2021A708536$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241518021$24151802$1$I$$20231023$20240730$20240730$EXP$$US-AstraZeneca-2023A204312$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241518031$24151803$1$I$$20231115$20240730$20240730$EXP$$US-AstraZeneca-2023A260551$ASTRAZENECA$$$$$$Y$$$20240730$$CN$US$
241518041$24151804$1$I$20211106$20211126$20240730$20240730$EXP$$US-AstraZeneca-2021A843975$ASTRAZENECA$$88$YR$$M$Y$65.3$KG$20240730$$CN$US$
241518051$24151805$1$I$20240628$20240726$20240730$20240730$EXP$$JP-ASTELLAS-2024JP005429$ASTELLAS$$7$DEC$$F$Y$$$20240730$$PH$JP$JP
241518061$24151806$1$I$$20240718$20240730$20240730$EXP$$SG-ROCHE-10000034664$ROCHE$$68$YR$E$F$Y$$$20240730$$CN$SG$SG
241518081$24151808$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52055$$FDA-CTU$$67$YR$$F$N$104.33$KG$20240729$N$$US$
241518091$24151809$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52037$$FDA-CTU$$69$YR$$F$N$$$20240729$N$$US$
241518111$24151811$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52110$$FDA-CTU$$68$YR$$F$N$62.6$KG$20240729$N$HP$US$
241518121$24151812$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52036$$FDA-CTU$$64$YR$$F$N$66.22$KG$20240729$N$$US$
241518131$24151813$1$I$20240601$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52029$$FDA-CTU$$68$YR$$M$N$$$20240729$N$PH$US$
241518141$24151814$1$I$20240601$20240729$20240729$20240729$DIR$711969$$FDA-CTU$$27$YR$$M$N$92.5$KG$20240729$N$HP$US$
241518151$24151815$1$I$20240630$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52104$$FDA-CTU$$85$YR$$M$N$$$20240729$N$$US$
241518161$24151816$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52052$$FDA-CTU$$45$YR$$F$N$$$20240729$N$$US$
241518182$24151818$2$F$$20240724$20240730$20240816$EXP$$GB-BEH-2024176394$CSL BEHRING$$$$E$M$Y$$$20240816$$CN$GB$GB
241518192$24151819$2$F$20240722$20240731$20240730$20240806$PER$$US-BAUSCH-BL-2024-011360$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240806$$CN$US$US
241518201$24151820$1$I$$20240723$20240730$20240730$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06637$VIFOR$$$$A$F$Y$$$20240730$$HP$ZA$ZA
241518211$24151821$1$I$$20240729$20240730$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA068999$SANDOZ$$15$YR$$F$Y$58$KG$20240730$$HP$CA$CA
241518221$24151822$1$I$$20240724$20240730$20240730$PER$$US-Vifor (International) Inc.-VIT-2024-06666$VIFOR$$77$YR$$M$Y$$$20240730$$HP$US$US
241518231$24151823$1$I$20240701$20240724$20240730$20240730$EXP$$JP-009507513-2407JPN004510J$MERCK$$9$DEC$$M$Y$$$20240730$$MD$JP$JP
241518251$24151825$1$I$20240601$20240716$20240730$20240730$EXP$$FR-CIPLA LTD.-2024FR07781$CIPLA$$$$$$Y$$$20240730$$MD$FR$FR
241518261$24151826$1$I$$20240716$20240730$20240730$EXP$$GB-CIPLA LTD.-2024GB07815$CIPLA$$$$$$Y$$$20240730$$CN$GB$GB
241518271$24151827$1$I$$20240726$20240730$20240730$EXP$$US-GSK-US2024094278$GLAXOSMITHKLINE$$$$$M$Y$$$20240730$$CN$US$US
241518281$24151828$1$I$$20240716$20240730$20240730$EXP$$US-CIPLA LTD.-2024US07873$CIPLA$Bajwa NA, Bajwa AA, Ghazala S, Masood U.. Dimethyl fumarate-associated enterocolitis. American Journal of Therapeutics. 2024;31(4):e448 to e450$$$$$Y$$$20240730$$MD$US$US
241518291$24151829$1$I$20240716$20240729$20240729$20240729$DIR$711975$$FDA-CTU$$64$YR$$F$N$62.1$KG$20240729$Y$HP$US$
241518311$24151831$1$I$20240725$20240729$20240729$20240729$DIR$711981$$FDA-CTU$$38$YR$$F$N$69.75$KG$20240729$N$CN$US$
241518321$24151832$1$I$20200101$20240724$20240730$20240730$EXP$$ES-JNJFOC-20240775557$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240730$$MD$ES$ES
241518331$24151833$1$I$20240601$20240723$20240730$20240730$EXP$$US-AMERICAN REGENT INC-2024002860$AMERICAN REGENT$$$$$F$Y$$$20240730$$CN$US$US
241518341$24151834$1$I$20240729$20240729$20240729$20240729$DIR$711982$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241518351$24151835$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52035$$FDA-CTU$$63$YR$$F$N$145.15$KG$20240729$N$$US$
241518361$24151836$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52025$$FDA-CTU$$62$YR$$F$N$78.47$KG$20240729$N$$US$
241518371$24151837$1$I$$20240726$20240730$20240730$EXP$$JP-ASTELLAS-2024JP005443$ASTELLAS$$$$E$M$Y$$$20240730$$PH$JP$JP
241518381$24151838$1$I$20240508$20240716$20240730$20240730$EXP$$FR-CIPLA LTD.-2024FR07799$CIPLA$$$$$$Y$$$20240730$$MD$FR$FR
241518391$24151839$1$I$20240729$20240729$20240729$20240729$DIR$711986$$FDA-CTU$$65$YR$$F$N$$$20240729$N$HP$US$
241518401$24151840$1$I$20240729$20240729$20240729$20240729$DIR$711987$$FDA-CTU$$$$$UNK$N$$$20240729$N$CN$US$
241518411$24151841$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52100$$FDA-CTU$$82$YR$$F$N$$$20240729$N$$US$
241518421$24151842$1$I$$20240719$20240730$20240730$PER$$US-RDY-LIT/USA/24/0010993$DR REDDYS$Tu X, Matarese C, Lloyd R, Sorensen C, Schmidt S, Baughn J. PHARMACOLOGICAL TREATMENT OF PEDIATRIC INSOMNIA--A SUCCESSFUL TRIAL OF DOXEPIN. Sleep. 2024 May;47(1): A493-A494. doi:10.1093/sleep/zsae067.01151.$$$$M$Y$$$20240730$$HP$US$US
241518432$24151843$2$F$$20240807$20240730$20240812$EXP$$JP-ASTELLAS-2024JP005400$ASTELLAS$$9$DEC$$M$Y$$$20240812$$PH$JP$JP
241518441$24151844$1$I$20240726$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149960$AMGEN$$$$$F$Y$$$20240730$$HP$US$US
241518451$24151845$1$I$$20240627$20240730$20240730$PER$$US-AMGEN-USASP2024150770$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241518461$24151846$1$I$20240701$20240724$20240730$20240730$EXP$$US-AMGEN-USASP2024148101$AMGEN$$$$$M$Y$$$20240730$$CN$US$US
241518471$24151847$1$I$$20240705$20240730$20240730$EXP$$IT-BAYER-2024A109524$BAYER$The spectrum of cutaneous toxicities related to novel genitourinary cancer therapies Original Title~c. The spectrum of cutaneous toxicities related to novel genitourinary cancer therapies Original Title~c. Critical Reviews in Oncology/Hematology. 2024;200 Article Num:1040-8428$82$YR$E$M$Y$$$20240730$$HP$IT$IT
241518481$24151848$1$I$20240607$20240724$20240730$20240730$EXP$$CA-TAKEDA-2024TUS075442$TAKEDA$$31$YR$$F$Y$$$20240730$$CN$CA$CA
241518491$24151849$1$I$20231228$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036698$AUROBINDO$$86$YR$$F$Y$$$20240730$$PH$FR$FR
241518501$24151850$1$I$$20240723$20240730$20240730$PER$$US-EMD Serono-2024040116$EMD SERONO INC$$$$E$F$Y$$$20240730$$HP$US$US
241518511$24151851$1$I$$20240726$20240730$20240730$EXP$$US-GILEAD-2024-0682250$GILEAD$$$$E$F$Y$$$20240730$$CN$US$US
241518521$24151852$1$I$20231101$20240712$20240730$20240730$PER$$US-TEVA-VS-3225497$TEVA$$36$YR$$F$Y$$$20240730$$CN$US$US
241518531$24151853$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A166726$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241518541$24151854$1$I$$20240722$20240730$20240730$EXP$$IN-AstraZeneca-2024A170011$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$IN$
241518551$24151855$1$I$$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036865$AUROBINDO$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N and al.. A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxicologie Analytique + Clinique. 2023;35:376-394$26$YR$$M$Y$$$20240730$$MD$FR$FR
241518561$24151856$1$I$20170301$20240723$20240730$20240730$EXP$$US-TAKEDA-2024TUS074555$TAKEDA$$$$A$M$Y$83$KG$20240730$$MD$US$US
241518583$24151858$3$F$20240101$20240919$20240730$20240919$EXP$$CA-PFIZER INC-202400223966$PFIZER$$55$YR$$M$Y$$$20240919$$HP$CA$CA
241518592$24151859$2$F$$20240731$20240730$20240806$EXP$$TR-PFIZER INC-202400223843$PFIZER$Parlak, B.. Multidrug-Resistant Tuberculosis in the Child Presenting with ITP-like Clinic. J Pediatr Inf. 2024;18(2):e114-e118$6$YR$$F$Y$18.3$KG$20240806$$HP$TR$TR
241518601$24151860$1$I$20240725$20240729$20240730$20240730$EXP$$CN-BAYER-2024A109754$BAYER$$74$YR$E$F$Y$48$KG$20240730$$HP$CN$CN
241518611$24151861$1$I$$20240722$20240730$20240730$30DAY$$US-GSK-US2024091858$GLAXOSMITHKLINE$$$$$F$Y$$$20240730$$CN$US$US
241518622$24151862$2$F$$20240806$20240730$20240812$EXP$$GB-GSK-GB2024092103$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$HP$GB$GB
241518631$24151863$1$I$$20240708$20240730$20240730$EXP$$US-TEVA-VS-3193156$TEVA$$63$YR$$M$Y$$$20240730$$PH$US$US
241518641$24151864$1$I$$20240722$20240730$20240730$PER$$US-ABBVIE-5851388$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241518651$24151865$1$I$$20240716$20240730$20240730$EXP$$US-SHIELD THERAPEUTICS-US-STX-24-00178$IRON THERAPEUTICS$$69$YR$$M$Y$$$20240730$$CN$US$US
241518661$24151866$1$I$$20240729$20240730$20240730$EXP$$NVSC2024US155186$NOVARTIS$$$$$$Y$$$20240730$$HP$US$US
241518672$24151867$2$F$$20240829$20240730$20240905$30DAY$$US-JNJFOC-20240772042$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$PH$US$US
241518681$24151868$1$I$$20240719$20240730$20240730$EXP$$IT-AUROBINDO-AUR-APL-2024-037321$AUROBINDO$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al.. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case-Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$69$YR$$F$Y$$$20240730$$MD$IT$IT
241518691$24151869$1$I$$20240712$20240730$20240730$PER$$US-TEVA-VS-3225476$TEVA$$67$YR$$F$Y$$$20240730$$PH$US$US
241518701$24151870$1$I$20240729$20240729$20240730$20240730$EXP$$CN-BAYER-2024A109817$BAYER$$76$YR$E$F$Y$75$KG$20240730$$HP$CN$CN
241518712$24151871$2$F$20240721$20240911$20240730$20240913$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042654$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240913$$PH$DE$DE
241518721$24151872$1$I$$20240726$20240730$20240730$EXP$$BR-SANDOZ INC.-SDZ2024BR068896$SANDOZ$$45$YR$$F$Y$$$20240730$$MD$BR$BR
241518741$24151874$1$I$$20240724$20240730$20240730$EXP$$LB-ROCHE-10000040044$ROCHE$$$$A$$Y$$$20240730$$MD$LB$LB
241518752$24151875$2$F$$20240723$20240730$20240730$PER$$US-ROCHE-10000035301$ROCHE$$$$A$F$Y$$$20240730$$CN$US$US
241518761$24151876$1$I$20240719$20240722$20240730$20240730$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000195$DENDREON$$$$$$Y$$$20240730$$HP$US$US
241518771$24151877$1$I$$20240704$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06871$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241518791$24151879$1$I$20240719$20240726$20240730$20240730$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000208$DENDREON$$$$$$Y$$$20240730$$HP$US$US
241518812$24151881$2$F$20240505$20240822$20240730$20240830$PER$$US-JNJFOC-20240751168$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240830$$CN$US$US
241518821$24151882$1$I$$20240723$20240730$20240730$EXP$$BR-RDY-SPO/BRA/24/0010945$DR REDDYS$$63$YR$A$F$Y$$$20240730$$PH$BR$BR
241518832$24151883$2$F$$20240821$20240730$20240822$PER$$US-ALXN-202407USA001871US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
241518841$24151884$1$I$20240719$20240724$20240730$20240730$EXP$$CA-APOTEX-2024AP008894$APOTEX$$57$YR$A$F$Y$$$20240730$$CN$CA$CA
241518851$24151885$1$I$20210727$20240722$20240730$20240730$EXP$$CA-CELLTRION INC.-2021CA019477$CELLTRION$$$$$$Y$$$20240730$$HP$CA$CA
241518862$24151886$2$F$20091031$20240809$20240730$20240812$EXP$$FR-ASTELLAS-2024US020913$ASTELLAS$$69$YR$$M$Y$$$20240812$$HP$GB$FR
241518871$24151887$1$I$$20240729$20240729$20240729$DIR$711978$$FDA-CTU$$84$YR$$F$N$$$20240729$N$HP$US$
241518901$24151890$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52079$$FDA-CTU$$54$YR$$F$N$$$20240729$N$$US$
241518911$24151891$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52031$$FDA-CTU$$59$YR$$F$N$$$20240729$N$$US$
241518931$24151893$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52145$$FDA-CTU$$89$YR$$F$N$$$20240729$N$$US$
241518941$24151894$1$I$20240729$20240729$20240729$20240729$DIR$711990$$FDA-CTU$$60$YR$$F$N$$$20240729$N$$US$
241518951$24151895$1$I$20240517$20240729$20240729$20240729$DIR$711980$$FDA-CTU$$74$YR$$F$N$58.05$KG$20240729$N$HP$US$
241518971$24151897$1$I$20240716$20240729$20240729$20240729$DIR$711989$$FDA-CTU$$70$YR$$M$N$95$KG$20240729$Y$MD$US$
241518981$24151898$1$I$20240626$20240729$20240729$20240729$DIR$711898$$FDA-CTU$$57$YR$$F$N$113.4$KG$20240729$N$HP$US$
241519001$24151900$1$I$$20240723$20240730$20240730$PER$$US-ALXN-202407USA001567US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241519011$24151901$1$I$20240720$20240729$20240730$20240730$EXP$$CN-BAYER-2024A109942$BAYER$$67$YR$E$F$Y$70$KG$20240730$$HP$CN$CN
241519021$24151902$1$I$$20240715$20240730$20240730$EXP$$PT-TEVA-VS-3223544$TEVA$$79$YR$$F$Y$$$20240730$$MD$PT$PT
241519031$24151903$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149874$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241519041$24151904$1$I$$20240724$20240730$20240730$EXP$$US-AMGEN-USASP2024148075$AMGEN$$$$$M$Y$$$20240730$$CN$US$US
241519061$24151906$1$I$$20240722$20240730$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119338$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240730$$MD$JP$JP
241519071$24151907$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119670$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240730$$HP$US$US
241519081$24151908$1$I$$20240729$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120228$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240730$$HP$US$US
241519091$24151909$1$I$$20240722$20240730$20240730$EXP$$SI-BRISTOL-MYERS SQUIBB COMPANY-2024-116423$BRISTOL MYERS SQUIBB$Kurnik M, Peter F, Matej P. Tocilizumab and cytoSorb for delayed severe cytokine release syndrome after ipilimumab plus nivolumab immunotherapy. Immunotherapy. 2024 Jul 17;1-11.doi:10.1080/1750743X.2024.2370180.$62$YR$A$F$Y$$$20240730$$HP$SI$SI
241519101$24151910$1$I$20240613$20240726$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119194$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240730$$HP$US$US
241519111$24151911$1$I$20240709$20240726$20240730$20240730$EXP$FR-AFSSAPS-MP2024001210$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-119816$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240730$$MD$FR$FR
241519121$24151912$1$I$$20240704$20240730$20240730$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06870$LUPIN$$$$$$Y$$$20240730$$CN$US$US
241519131$24151913$1$I$20240130$20240724$20240730$20240730$EXP$$US-UCBSA-2024017373$UCB$$30$YR$$M$Y$$$20240730$$CN$US$US
241519141$24151914$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018858$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240730$$CN$US$US
241519152$24151915$2$F$$20240730$20240730$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407018756$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240802$$CN$US$US
241519162$24151916$2$F$20240501$20240725$20240730$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407017151$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240802$$CN$US$US
241519171$24151917$1$I$20240601$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018036$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240730$$CN$US$US
241519181$24151918$1$I$20240726$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018641$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240730$$CN$US$US
241519191$24151919$1$I$$20240719$20240730$20240730$EXP$$US-BIOCODEX2-2024000658$BIOCODEX$$4$YR$$M$Y$25.3$KG$20240729$$MD$US$US
241519201$24151920$1$I$$20240703$20240730$20240730$30DAY$$GB-UCBSA-2024034996$UCB$$$$$M$Y$$$20240730$$MD$GB$GB
241519211$24151921$1$I$$20240722$20240730$20240730$EXP$$US-JNJFOC-20240764105$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$CN$US$US
241519221$24151922$1$I$$20240727$20240730$20240730$PER$$US-HALEON-2189559$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241519241$24151924$1$I$20231101$20240415$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004350$SAREPTA THERAPEUTICS$$13$YR$$M$Y$$$20240730$$CN$US$US
241519251$24151925$1$I$20240206$20240424$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004343$SAREPTA THERAPEUTICS$$21$YR$$M$Y$$$20240730$$HP$US$US
241519261$24151926$1$I$20240411$20240416$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004561$SAREPTA THERAPEUTICS$$16$YR$$M$Y$$$20240730$$HP$US$US
241519271$24151927$1$I$20240208$20240329$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004347$SAREPTA THERAPEUTICS$$12$YR$$M$Y$46.4$KG$20240730$$PH$US$US
241519281$24151928$1$I$20240410$20240425$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004553$SAREPTA THERAPEUTICS$$18$YR$$M$Y$$$20240730$$HP$US$US
241519291$24151929$1$I$$20240329$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004523$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240730$$HP$US$US
241519301$24151930$1$I$20240321$20240628$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004495$SAREPTA THERAPEUTICS$$9$YR$$M$Y$$$20240730$$HP$US$US
241519311$24151931$1$I$20240303$20240404$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004438$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240730$$CN$US$US
241519321$24151932$1$I$$20240729$20240730$20240730$EXP$$US-GILEAD-2024-0682298$GILEAD$$50$YR$A$F$Y$$$20240730$$MD$US$US
241519331$24151933$1$I$20240612$20240718$20240730$20240730$PER$$US-BAYER-2024A104911$BAYER$$23$YR$A$F$Y$$$20240730$$MD$US$US
241519342$24151934$2$F$$20240730$20240730$20240803$PER$$US-ROCHE-10000038059$ROCHE$$45$YR$A$F$Y$$$20240803$$HP$US$US
241519361$24151936$1$I$$20240722$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US068965$SANDOZ$$$$$F$Y$$$20240730$$CN$US$US
241519371$24151937$1$I$20240101$20240729$20240730$20240730$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042591$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240730$$CN$US$US
241519381$24151938$1$I$$20240723$20240730$20240730$PER$$US-AMGEN-USASP2024147130$AMGEN$$$$$$Y$$$20240730$$HP$US$US
241519401$24151940$1$I$20240729$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52073$$FDA-CTU$$85$YR$$F$N$$$20240729$Y$HP$US$
241519421$24151942$1$I$$20240722$20240730$20240730$EXP$$ES-AstraZeneca-2024A167730$ASTRAZENECA$$70$YR$$F$Y$$$20240730$$MD$ES$
241519431$24151943$1$I$$20240502$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004707$SAREPTA THERAPEUTICS$$$$$M$Y$49.53$KG$20240730$$PH$US$US
241519441$24151944$1$I$20240418$20240418$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004566$SAREPTA THERAPEUTICS$$17$YR$$M$Y$$$20240730$$HP$US$US
241519451$24151945$1$I$20240724$20240729$20240729$20240729$DIR$711910$$FDA-CTU$$72$YR$$M$N$83.25$KG$20240729$N$HP$US$
241519461$24151946$1$I$20240729$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52147$$FDA-CTU$$73$YR$$M$N$$$20240729$Y$PH$US$
241519471$24151947$1$I$20240502$20240514$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004615$SAREPTA THERAPEUTICS$$16$YR$$M$Y$$$20240730$$HP$US$US
241519481$24151948$1$I$$20240601$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004712$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240730$$CN$US$US
241519491$24151949$1$I$$20240425$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004590$SAREPTA THERAPEUTICS$$$$$M$Y$29.4$KG$20240730$$HP$US$US
241519501$24151950$1$I$20240503$20240508$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004632$SAREPTA THERAPEUTICS$$32$YR$$M$Y$$$20240730$$HP$US$US
241519511$24151951$1$I$20240521$20240616$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004685$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240730$$HP$US$US
241519521$24151952$1$I$$20240517$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004628$SAREPTA THERAPEUTICS$$$$$M$Y$45.2$KG$20240730$$HP$US$US
241519531$24151953$1$I$$20240725$20240730$20240730$PER$$US-ROCHE-3573409$ROCHE$$$$E$F$Y$64.86$KG$20240730$$CN$US$US
241519541$24151954$1$I$$20240502$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004611$SAREPTA THERAPEUTICS$$$$$M$Y$66$KG$20240730$$HP$US$US
241519552$24151955$2$F$$20240911$20240730$20240918$EXP$$NVSC2024CA154816$NOVARTIS$$74$YR$$F$Y$$$20240918$$CN$CA$CA
241519573$24151957$3$F$20240516$20240808$20240730$20240820$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004662$SAREPTA THERAPEUTICS$$14$YR$$M$Y$54.8$KG$20240820$$HP$US$US
241519581$24151958$1$I$$20240725$20240730$20240730$PER$$US-ROCHE-3573899$ROCHE$$$$E$F$Y$$$20240730$$CN$US$US
241519591$24151959$1$I$$20240723$20240730$20240730$PER$$US-ALXN-202407USA001568US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241519601$24151960$1$I$$20240724$20240730$20240730$EXP$$US-LEO Pharma-372343$LEO PHARM$$56$YR$$F$Y$54$KG$20240730$$CN$US$US
241519621$24151962$1$I$$20240717$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010741$DR REDDYS$$13$YR$T$F$Y$$$20240730$$HP$US$US
241519631$24151963$1$I$$20240723$20240730$20240730$PER$$US-PCCINC-2024-PPL-000554$PIRAMAL$$$$$$Y$$$20240730$$HP$US$US
241519641$24151964$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189616$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241519651$24151965$1$I$$20240724$20240730$20240730$EXP$$SK-EMD Serono-2024040508$EMD SERONO INC$$$$$F$Y$$$20240730$$MD$SK$SK
241519662$24151966$2$F$20240601$20240819$20240730$20240829$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004734$SAREPTA THERAPEUTICS$$15$YR$$M$Y$97.7$KG$20240829$$HP$US$US
241519671$24151967$1$I$20240612$20240612$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004754$SAREPTA THERAPEUTICS$$21$YR$$M$Y$$$20240730$$HP$US$US
241519681$24151968$1$I$$20240624$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004787$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240730$$HP$US$US
241519691$24151969$1$I$20240602$20240717$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004714$SAREPTA THERAPEUTICS$$8$YR$$M$Y$39.002$KG$20240730$$HP$US$US
241519701$24151970$1$I$20240425$20240702$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004764$SAREPTA THERAPEUTICS$$14$YR$$M$Y$$$20240730$$HP$US$US
241519711$24151971$1$I$20240607$20240610$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004741$SAREPTA THERAPEUTICS$$19$YR$$M$Y$$$20240730$$HP$US$US
241519721$24151972$1$I$20240601$20240626$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004803$SAREPTA THERAPEUTICS$$18$YR$$M$Y$$$20240730$$HP$US$US
241519731$24151973$1$I$20240430$20240621$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004793$SAREPTA THERAPEUTICS$$41$YR$$M$Y$$$20240730$$HP$US$US
241519741$24151974$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155337$NOVARTIS$$$$$M$Y$$$20240730$$CN$US$US
241519751$24151975$1$I$20240628$20240715$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004811$SAREPTA THERAPEUTICS$$14$YR$$M$Y$$$20240730$$HP$US$US
241519761$24151976$1$I$$20240717$20240730$20240730$EXP$$JP-AMGEN-JPNSP2024149222$AMGEN$$83$YR$E$F$Y$$$20240730$$PH$JP$JP
241519771$24151977$1$I$20240620$20240709$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004800$SAREPTA THERAPEUTICS$$16$YR$$M$Y$102.06$KG$20240730$$HP$US$US
241519782$24151978$2$F$$20240730$20240730$20240801$PER$$US-ROCHE-10000040043$ROCHE$$55$YR$A$F$Y$$$20240801$$CN$US$US
241519791$24151979$1$I$20240101$20240726$20240730$20240730$PER$$US-ROCHE-10000041222$ROCHE$$68$YR$E$F$Y$$$20240730$$CN$US$US
241519811$24151981$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52028$$FDA-CTU$$27$YR$$F$N$$$20240729$N$HP$US$
241519821$24151982$1$I$20240728$20240728$20240729$20240729$DIR$FDA-CDER-CTU-2024-52041$$FDA-CTU$$53$YR$$F$N$$$20240728$N$HP$US$
241519831$24151983$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52155$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241519841$24151984$1$I$20240706$20240727$20240729$20240729$DIR$FDA-CDER-CTU-2024-52097$$FDA-CTU$$33$YR$$F$N$$$20240727$N$HP$US$
241519852$24151985$2$F$$20240801$20240730$20240806$PER$$US-ROCHE-2796709$ROCHE$$57$YR$A$F$Y$54.07$KG$20240806$$MD$US$US
241519861$24151986$1$I$20210101$20240724$20240730$20240730$PER$$US-009507513-2407USA013734$MERCK$Godart G.A, Elwasila S.M, Durvasula R.V. A rare case of candida osteomyelitis of the mandible associated with osteoradionecrosis and biofilm formation. IDCases. 2024;37 ()::e02029$73$YR$$F$Y$$$20240730$$HP$US$US
241519871$24151987$1$I$$20240725$20240730$20240730$EXP$$KR-009507513-2407KOR014254$MERCK$$$$A$M$Y$$$20240730$$HP$KR$KR
241519881$24151988$1$I$20240706$20240708$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004830$SAREPTA THERAPEUTICS$$24$YR$$M$Y$$$20240730$$HP$US$US
241519891$24151989$1$I$$20240703$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004817$SAREPTA THERAPEUTICS$$$$$M$Y$71.655$KG$20240730$$PH$US$US
241519901$24151990$1$I$20240101$20240712$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004860$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240730$$HP$US$US
241519911$24151991$1$I$20240601$20240628$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004815$SAREPTA THERAPEUTICS$$16$YR$$M$Y$$$20240730$$HP$US$US
241519921$24151992$1$I$$20240710$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004847$SAREPTA THERAPEUTICS$$$$$M$Y$59.6$KG$20240730$$CN$US$US
241519931$24151993$1$I$20240712$20240712$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004858$SAREPTA THERAPEUTICS$$13$YR$$M$Y$$$20240730$$HP$US$US
241519941$24151994$1$I$20231120$20240726$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119766$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$48.4$KG$20240730$$PH$US$US
241519951$24151995$1$I$$20240726$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119683$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$119.29$KG$20240730$$CN$US$US
241519961$24151996$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-10000041006$ROCHE$$57$YR$A$F$Y$$$20240730$$CN$US$US
241519971$24151997$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-10000040810$ROCHE$$$$A$F$Y$$$20240730$$CN$US$US
241519991$24151999$1$I$$20240723$20240730$20240730$EXP$$US-Umedica-000086$UMEDICA LABS$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D. Rhabdomyolysis Risk: The Dangers of Tribulus Terrestris, an Over-the-Counter Supplement. Am J Case Rep. 2024 Jul 16;25:e943492. doi: 10.12659/AJCR.943492.$71$YR$$M$Y$$$20240730$$MD$US$
241520022$24152002$2$F$20240730$20240730$20240730$20240808$EXP$$US-FARMAPROD-202407-2491$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240808$$MD$US$US
241520031$24152003$1$I$$20240724$20240730$20240730$PER$$US-009507513-2407USA014810$MERCK$$63$YR$$M$Y$79.69$KG$20240730$$CN$US$US
241520042$24152004$2$F$20240101$20240904$20240730$20240911$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016390$UNITED THERAPEUTICS$$$$$F$Y$117.91$KG$20240911$$$US$US
241520051$24152005$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155442$NOVARTIS$$$$$$Y$$$20240730$$HP$US$US
241520061$24152006$1$I$20240711$20240730$20240730$20240730$EXP$PT-INFARMED-B202407-438$PT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042673$BOEHRINGER INGELHEIM$$41$YR$A$M$Y$$$20240730$$MD$PT$PT
241520081$24152008$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150190$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241520092$24152009$2$F$20240725$20240726$20240730$20240816$PER$$US-AMGEN-USASP2024150002$AMGEN$$64$YR$A$F$Y$$$20240816$$CN$US$US
241520101$24152010$1$I$20240726$20240729$20240730$20240730$PER$$US-ROCHE-10000041446$ROCHE$$$$$$Y$$$20240730$$HP$US$US
241520111$24152011$1$I$$20240729$20240730$20240730$PER$$US-ROCHE-10000041624$ROCHE$$$$A$F$Y$$$20240730$$CN$US$US
241520121$24152012$1$I$$20240724$20240730$20240730$EXP$$IL-MPL-000054$MLV PHARMA$$71$YR$E$M$Y$$$20240726$$MD$IL$IL
241520131$24152013$1$I$$20240719$20240730$20240730$EXP$$CN-ROCHE-10000032015$ROCHE$$58$YR$A$M$Y$$$20240730$$CN$CN$CN
241520141$24152014$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52042$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241520151$24152015$1$I$20240719$20240729$20240730$20240730$PER$$US-ROCHE-10000041749$ROCHE$$$$$F$Y$$$20240730$$MD$US$US
241520161$24152016$1$I$20240129$20240404$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004311$SAREPTA THERAPEUTICS$$5$YR$$M$Y$17.46$KG$20240730$$HP$US$US
241520171$24152017$1$I$20240202$20240202$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004334$SAREPTA THERAPEUTICS$$15$YR$$M$Y$$$20240730$$HP$US$US
241520181$24152018$1$I$20240119$20240124$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004288$SAREPTA THERAPEUTICS$$13$YR$$M$Y$$$20240730$$HP$US$US
241520191$24152019$1$I$20240130$20240416$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004315$SAREPTA THERAPEUTICS$$10$YR$$M$Y$30.7$KG$20240730$$HP$US$US
241520201$24152020$1$I$20240201$20240202$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004333$SAREPTA THERAPEUTICS$$9$YR$$M$Y$$$20240730$$HP$US$US
241520211$24152021$1$I$$20240212$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004359$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240730$$HP$US$US
241520222$24152022$2$F$$20240715$20240730$20240801$EXP$$CN-INCYTE CORPORATION-2024IN007623$INCYTE$Zhao Y, Ma HH, Wang D, Lian HY, Wang TY, Zhang R.. Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis. ZHONGHUA-ER-KE-ZA-ZHI. 2024;62:60-5$$$$$Y$$$20240801$$HP$CN$CN
241520231$24152023$1$I$20240126$20240229$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004345$SAREPTA THERAPEUTICS$$10$YR$$M$Y$$$20240730$$HP$US$US
241520241$24152024$1$I$20240202$20240305$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004332$SAREPTA THERAPEUTICS$$15$YR$$M$Y$136.08$KG$20240730$$HP$US$US
241520251$24152025$1$I$20240719$20240726$20240730$20240730$EXP$$US-GILEAD-2024-0682219$GILEAD$$90$YR$E$F$Y$$$20240730$$CN$US$US
241520261$24152026$1$I$20231118$20240723$20240730$20240730$EXP$$US-ROCHE-3517417$ROCHE$$85$YR$E$M$Y$$$20240730$$CN$US$US
241520281$24152028$1$I$20240211$20240227$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004412$SAREPTA THERAPEUTICS$$10$YR$$M$Y$$$20240730$$HP$US$US
241520291$24152029$1$I$20240227$20240304$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004418$SAREPTA THERAPEUTICS$$20$YR$$M$Y$$$20240730$$HP$US$US
241520301$24152030$1$I$20240311$20240311$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004454$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240730$$HP$US$US
241520311$24152031$1$I$$20240424$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004385$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240730$$HP$US$US
241520321$24152032$1$I$20231229$20240213$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004365$SAREPTA THERAPEUTICS$$12$YR$$M$Y$$$20240730$$HP$US$US
241520331$24152033$1$I$20240216$20240216$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004380$SAREPTA THERAPEUTICS$$18$YR$$M$Y$$$20240730$$HP$US$US
241520341$24152034$1$I$$20240215$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004377$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240730$$CN$US$US
241520351$24152035$1$I$20231201$20240103$20240730$20240730$PER$$NVSC2024US004187$NOVARTIS$$65$YR$$F$Y$$$20240730$$CN$US$US
241520361$24152036$1$I$20240220$20240607$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004423$SAREPTA THERAPEUTICS$$10$YR$$M$Y$30$KG$20240730$$HP$US$US
241520371$24152037$1$I$$20240727$20240730$20240730$PER$$NVSC2024US154697$NOVARTIS$$$$$$Y$$$20240730$$CN$US$US
241520381$24152038$1$I$20240327$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52113$$FDA-CTU$$77$YR$$F$N$$$20240729$N$PH$US$
241520391$24152039$1$I$$20240402$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004435$SAREPTA THERAPEUTICS$$$$$M$Y$136.08$KG$20240730$$HP$US$US
241520401$24152040$1$I$$20240726$20240730$20240730$EXP$$NVSC2024CA154728$NOVARTIS$$70$YR$$F$Y$65$KG$20240730$$MD$CA$CA
241520412$24152041$2$F$$20240801$20240730$20240809$EXP$$US-TEVA-VS-3223149$TEVA$Voelz K, Miller G, Lee-Miller C. 6-Mercaptopurine-associated Sinusoidal Obstructive Syndrome During Interim Maintenance I: A Case Report. J-Pediatr-Hematol-Oncol 2024; 46 (5): e317-e321.; Voelz K, Miller G, Lee-Miller C. 6-Mercaptopurine-associated Sinusoidal Obstructive Syndrome During Interim Maintenance I: A Case Report. J-Pediatr-Hematol-Oncol 2024; 46 (5): e317-e321.$14$YR$$M$Y$$$20240809$$MD$US$US
241520421$24152042$1$I$20240201$20240315$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004369$SAREPTA THERAPEUTICS$$21$YR$$M$Y$54.9$KG$20240730$$HP$US$US
241520441$24152044$1$I$$20240726$20240730$20240730$PER$$US-JNJFOC-20240776063$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$CN$US$US
241520451$24152045$1$I$20240722$20240722$20240730$20240730$PER$$US-JNJFOC-20240760513$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240730$$HP$US$US
241520461$24152046$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52026$$FDA-CTU$$$$$F$N$$$20240729$N$HP$US$
241520471$24152047$1$I$$20240725$20240730$20240730$30DAY$$US-GSK-US2024AMR094145$GLAXOSMITHKLINE$$$$$M$Y$$$20240730$$CN$US$US
241520481$24152048$1$I$20240722$20240728$20240730$20240730$EXP$GB-MHRA-MED-202407280818213190-QLRMY$GB-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2407GB05985$INSUD PHARMA$$54$YR$$F$Y$71$KG$20240730$$CN$GB$GB
241520491$24152049$1$I$20230401$20240719$20240730$20240730$EXP$$DE-ROCHE-10000035243$ROCHE$$73$YR$E$F$Y$$$20240730$$MD$DE$DE
241520501$24152050$1$I$20240721$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52108$$FDA-CTU$$26$YR$$M$N$45.36$KG$20240729$N$HP$US$
241520511$24152051$1$I$$20240723$20240730$20240730$PER$$US-EMD Serono-2024040244$EMD SERONO INC$$$$A$F$Y$$$20240730$$HP$US$US
241520531$24152053$1$I$20240629$20240719$20240730$20240730$EXP$$US-BIOCODEX2-2024000987$BIOCODEX$$3$YR$$F$Y$13.6$KG$20240729$$HP$US$US
241520541$24152054$1$I$20240312$20240325$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004461$SAREPTA THERAPEUTICS$$15$YR$$M$Y$55.3$KG$20240730$$HP$US$US
241520551$24152055$1$I$$20240410$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004522$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240730$$HP$US$US
241520561$24152056$1$I$20240422$20240709$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004579$SAREPTA THERAPEUTICS$$19$YR$$M$Y$$$20240730$$HP$US$US
241520571$24152057$1$I$20240228$20240513$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004500$SAREPTA THERAPEUTICS$$9$YR$$M$Y$53.5$KG$20240730$$HP$US$US
241520581$24152058$1$I$20240330$20240617$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004718$SAREPTA THERAPEUTICS$$11$YR$$M$Y$57.4$KG$20240730$$HP$US$US
241520591$24152059$1$I$20240314$20240328$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004515$SAREPTA THERAPEUTICS$$12$YR$$M$Y$46.4$KG$20240730$$HP$US$US
241520601$24152060$1$I$20240404$20240415$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004535$SAREPTA THERAPEUTICS$$15$YR$$M$Y$40.82$KG$20240730$$PH$US$US
241520611$24152061$1$I$20231028$20240604$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004719$SAREPTA THERAPEUTICS$$11$YR$$M$Y$57.4$KG$20240730$$HP$US$US
241520621$24152062$1$I$20240520$20240604$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004679$SAREPTA THERAPEUTICS$$16$YR$$M$Y$136.08$KG$20240730$$HP$US$US
241520631$24152063$1$I$20240320$20240408$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004476$SAREPTA THERAPEUTICS$$10$YR$$M$Y$48$KG$20240730$$HP$US$US
241520641$24152064$1$I$20240720$20240722$20240730$20240730$EXP$$KR-TAKEDA-2024TUS076129$TAKEDA$$7$DEC$$M$Y$$$20240730$$HP$KR$KR
241520651$24152065$1$I$$20240715$20240730$20240730$EXP$$IN-EPICPHARMA-IN-2024EPCLIT00891$EPIC PHARM$Chiu SM.Interstitial Pneumonia With Autoimmune Features Mimicking Paradoxical Responses in a Patient Under Treatment for Tuberculosis: A Case Report.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$25$YR$A$M$Y$$$20240730$$HP$IN$IN
241520661$24152066$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120562$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240730$$CN$US$US
241520671$24152067$1$I$20240501$20240726$20240730$20240730$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-120105$BRISTOL MYERS SQUIBB$$97$YR$E$M$Y$$$20240730$$MD$DE$DE
241520682$24152068$2$F$$20240920$20240730$20240924$EXP$$US-PFIZER INC-2024SGN03027$PFIZER$$72$YR$$F$Y$$$20240924$$CN$US$US
241520692$24152069$2$F$20240717$20240801$20240730$20240802$EXP$$CN-PFIZER INC-PV202400097989$PFIZER$$14$YR$$M$Y$60$KG$20240802$$HP$CN$CN
241520701$24152070$1$I$$20240725$20240730$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119547$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$MD$JP$JP
241520711$24152071$1$I$20240724$20240726$20240730$20240730$EXP$$CN-PFIZER INC-PV202400097993$PFIZER$$32$YR$$F$Y$66$KG$20240730$$HP$CN$CN
241520722$24152072$2$F$$20240806$20240730$20240809$PER$$US-PFIZER INC-202400224805$PFIZER$$9$DEC$$F$Y$$$20240809$$CN$US$US
241520732$24152073$2$F$$20240801$20240730$20240802$EXP$$US-PFIZER INC-202400225201$PFIZER$$62$YR$$F$Y$$$20240802$$CN$US$US
241520741$24152074$1$I$20231001$20240729$20240730$20240730$EXP$$NP-PFIZER INC-PV202400098530$PFIZER$$78$YR$$M$Y$$$20240730$$MD$NP$NP
241520751$24152075$1$I$20231107$20240726$20240730$20240730$EXP$$DO-PFIZER INC-202400225964$PFIZER$$68$YR$$M$Y$$$20240730$$CN$DO$DO
241520761$24152076$1$I$20240715$20240726$20240730$20240730$EXP$$CN-PFIZER INC-PV202400097996$PFIZER$$75$YR$$F$Y$70$KG$20240730$$HP$CN$CN
241520771$24152077$1$I$20240704$20240726$20240730$20240730$EXP$FR-AFSSAPS-GR2024000941$FR-PFIZER INC-202400224258$PFIZER$$22$YR$$M$Y$89$KG$20240730$$PH$FR$FR
241520781$24152078$1$I$20231226$20240726$20240730$20240730$EXP$$CN-PFIZER INC-PV202400097971$PFIZER$$59$YR$$F$Y$70$KG$20240730$$HP$CN$CN
241520791$24152079$1$I$$20240726$20240730$20240730$EXP$$CN-PFIZER INC-PV202400097747$PFIZER$$$$E$M$Y$$$20240730$$CN$CN$CN
241520803$24152080$3$F$$20240820$20240730$20240822$EXP$$PT-PFIZER INC-202400225397$PFIZER$$79$YR$$F$Y$$$20240822$$MD$PT$PT
241520811$24152081$1$I$$20240726$20240730$20240730$EXP$$GB-PFIZER INC-PV202400098494$PFIZER$$48$YR$$M$Y$$$20240730$$CN$GB$GB
241520821$24152082$1$I$$20240726$20240730$20240730$EXP$$US-PFIZER INC-202400225979$PFIZER$$36$YR$$F$Y$$$20240730$$HP$US$US
241520831$24152083$1$I$20240101$20240726$20240730$20240730$EXP$$DE-PFIZER INC-202400225668$PFIZER$$67$YR$$F$Y$$$20240730$$HP$DE$DE
241520841$24152084$1$I$$20240725$20240730$20240730$EXP$$CA-PFIZER INC-202400223858$PFIZER$$2$YR$$M$Y$14$KG$20240730$$HP$CA$CA
241520851$24152085$1$I$20230101$20240729$20240730$20240730$EXP$$NP-PFIZER INC-PV202400098610$PFIZER$$45$YR$$F$Y$$$20240730$$MD$NP$IN
241520861$24152086$1$I$$20240725$20240730$20240730$EXP$$JP-PFIZER INC-202400223558$PFIZER$$8$DEC$$M$Y$$$20240730$$PH$JP$JP
241520872$24152087$2$F$20240720$20240805$20240730$20240805$EXP$$CN-PFIZER INC-PV202400098804$PFIZER$$52$YR$$M$Y$56$KG$20240805$$HP$CN$CN
241520891$24152089$1$I$20220101$20240725$20240730$20240730$EXP$$US-PFIZER INC-202400224003$PFIZER$$66$YR$$F$Y$$$20240730$$CN$US$US
241520901$24152090$1$I$20240724$20240724$20240730$20240730$EXP$$CA-PFIZER INC-202400205918$PFIZER$$88$YR$$F$Y$$$20240730$$MD$CA$CA
241520911$24152091$1$I$$20240729$20240730$20240730$EXP$$JP-PFIZER INC-202400225213$PFIZER$$$$$$Y$$$20240730$$PH$JP$JP
241520921$24152092$1$I$$20240729$20240730$20240730$EXP$$JP-PFIZER INC-202400225566$PFIZER$$$$$$Y$$$20240730$$PH$JP$JP
241520931$24152093$1$I$$20240729$20240730$20240730$EXP$$AR-PFIZER INC-202400225917$PFIZER$$84$YR$$M$Y$$$20240730$$CN$AR$AR
241520942$24152094$2$F$20240101$20240909$20240730$20240912$EXP$$CA-PFIZER INC-202400190564$PFIZER$$28$YR$$M$Y$$$20240911$$HP$CA$CA
241520951$24152095$1$I$$20240725$20240730$20240730$EXP$$CA-PFIZER INC-202400223853$PFIZER$$18$YR$$F$Y$84$KG$20240730$$HP$CA$CA
241520961$24152096$1$I$20240111$20240725$20240730$20240730$EXP$FR-AFSSAPS-TO2024001377$FR-PFIZER INC-202400223473$PFIZER$$90$YR$$F$Y$$$20240730$$PH$FR$FR
241520981$24152098$1$I$$20240726$20240730$20240730$EXP$$CA-PFIZER INC-202400225852$PFIZER$$67$YR$$M$Y$$$20240730$$HP$CA$CA
241520991$24152099$1$I$20240701$20240725$20240730$20240730$EXP$FR-AFSSAPS-SE2024000595$FR-PFIZER INC-202400223479$PFIZER$$18$YR$$M$Y$66$KG$20240730$$MD$FR$FR
241521001$24152100$1$I$20240603$20240725$20240730$20240730$EXP$$CN-PFIZER INC-PV202400097523$PFIZER$$39$YR$$M$Y$70.6$KG$20240730$$HP$CN$CN
241521011$24152101$1$I$20221001$20240726$20240730$20240730$EXP$$PT-PFIZER INC-202400224385$PFIZER$$54$YR$$M$Y$$$20240730$$MD$PT$PT
241521031$24152103$1$I$$20240726$20240730$20240730$EXP$GB-MHRA-MED-202407261147501430-LWKNT$GB-PFIZER INC-202400224575$PFIZER$$71$YR$$F$Y$$$20240730$$HP$GB$GB
241521041$24152104$1$I$20240622$20240726$20240730$20240730$EXP$$JP-PFIZER INC-PV202400097375$PFIZER$$36$YR$$F$Y$74.6$KG$20240730$$PH$JP$JP
241521051$24152105$1$I$$20240725$20240730$20240730$EXP$$CA-PFIZER INC-202400224942$PFIZER$$75$YR$$M$Y$$$20240730$$MD$CA$CA
241521062$24152106$2$F$20240718$20240812$20240730$20240814$EXP$$CA-PFIZER INC-202400225786$PFIZER$$81$YR$$M$Y$$$20240814$$MD$CA$CA
241521071$24152107$1$I$20240511$20240725$20240730$20240730$EXP$$CN-PFIZER INC-PV202400097539$PFIZER$$46$YR$$M$Y$62$KG$20240730$$HP$CN$CN
241521081$24152108$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-07160$HIKMA$Lobo Oliveira M, Peixoto AC, Alves L, Mendes Piedade N, Nogueira Silva L, Almeida J. Lobo Oliveira M, Peixoto AC, Alves L, Mendes Piedade N, Nogueira Silva L, Almeida J PO-0126 - (3983) -Pneumonia necrotizante, uma complica??o rara. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional. 2024$48$YR$$F$Y$$$20240730$$MD$PT$PT
241521091$24152109$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018697$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240730$$CN$US$US
241521101$24152110$1$I$20240729$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018764$ELI LILLY AND CO$$63$YR$A$$Y$$$20240730$$CN$US$US
241521121$24152112$1$I$$20240606$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004728$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240730$$PH$US$US
241521131$24152113$1$I$20240101$20240628$20240730$20240730$PER$$US-KARYOPHARM-2024KPT001244$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240730$$CN$US$US
241521141$24152114$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52128$$FDA-CTU$$50$YR$$M$N$77.11$KG$20240729$N$$US$
241521151$24152115$1$I$20240622$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-52084$$FDA-CTU$$29$YR$$F$N$$$20240726$N$HP$US$
241521161$24152116$1$I$20231118$20240619$20240730$20240730$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004720$SAREPTA THERAPEUTICS$$11$YR$$M$Y$57.4$KG$20240730$$HP$US$US
241521173$24152117$3$F$$20240822$20240730$20240826$EXP$$US-ROCHE-10000030047$ROCHE$$79$YR$E$F$Y$50.34$KG$20240826$$HP$US$US
241521181$24152118$1$I$20240624$20240724$20240730$20240730$EXP$FR-AFSSAPS-TS2024000826$FR-MYLANLABS-2024M1069311$MYLAN$$68$YR$$M$Y$61$KG$20240730$$MD$FR$FR
241521191$24152119$1$I$$20240724$20240730$20240730$EXP$$IN-MYLANLABS-2024M1070390$MYLAN$Jain HR, Vasdev V, Kartik S, Kumar A, Velangi V, Chandwani A. A case series of anti-MDA5 dermatomyositis patients: Distinct clinical phenotypes, prognostic factors and treatment challenges. Indian-J-Rheumatol 2023; 18 (Suppl.) S383 abstr. CAS161.$42$YR$$F$Y$$$20240730$$HP$IN$IN
241521201$24152120$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52030$$FDA-CTU$$43$YR$$F$N$$$20240729$N$$US$
241521211$24152121$1$I$$20240724$20240730$20240730$EXP$$IN-MYLANLABS-2024M1070395$MYLAN$Jain HR, Vasdev V, Kartik S, Kumar A, Velangi V, Chandwani A. A case series of anti-MDA5 dermatomyositis patients: Distinct clinical phenotypes, prognostic factors and treatment challenges. Indian-J-Rheumatol 2023; 18 (Suppl.) S383 abstr. CAS161.$25$YR$$F$Y$$$20240730$$HP$IN$IN
241521221$24152122$1$I$$20240725$20240730$20240730$PER$$US-ABBVIE-5858594$ABBVIE$$$$$$Y$$$20240730$$MD$US$US
241521231$24152123$1$I$$20240719$20240730$20240730$EXP$$US-ROCHE-10000033874$ROCHE$$71$YR$E$F$Y$$$20240730$$PH$US$US
241521241$24152124$1$I$$20240715$20240730$20240730$EXP$$CA-JNJFOC-20240777032$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240730$$PH$CA$CA
241521251$24152125$1$I$20240616$20240729$20240730$20240730$EXP$ES-AEMPS-1553312$ES-JNJFOC-20240779089$JOHNSON AND JOHNSON$$22$YR$A$F$Y$47$KG$20240730$$CN$ES$ES
241521261$24152126$1$I$20240604$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52102$$FDA-CTU$$70$YR$$F$N$$$20240729$N$PH$US$
241521271$24152127$1$I$$20240715$20240730$20240730$EXP$$SI-EPICPHARMA-SI-2024EPCLIT00882$EPIC PHARM$Alexander Jerman.Hemodialysis for salbutamol intoxication: patient case report.Nephrology Dialysis Transplantation.MAY-2024;39:i2452$$$E$$Y$$$20240730$$HP$SI$SI
241521291$24152129$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52046$$FDA-CTU$$54$YR$$F$N$116.12$KG$20240729$N$$US$
241521301$24152130$1$I$$20240723$20240730$20240730$EXP$$US-GILEAD-2024-0681732$GILEAD$$52$YR$A$F$Y$$$20240730$$CN$US$US
241521311$24152131$1$I$20240701$20240718$20240730$20240730$EXP$$GT-BAYER-2024A105631$BAYER$$36$YR$A$F$Y$$$20240730$$CN$GT$GT
241521321$24152132$1$I$$20240719$20240730$20240730$EXP$$US-ROCHE-3405623$ROCHE$$83$YR$E$M$Y$$$20240730$$CN$US$US
241521341$24152134$1$I$$20240722$20240730$20240730$PER$$US-ALXN-202407USA001451US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241521351$24152135$1$I$$20240719$20240730$20240730$EXP$$US-ROCHE-10000032126$ROCHE$$40$YR$A$M$Y$$$20240730$$CN$US$US
241521362$24152136$2$F$$20240729$20240730$20240918$30DAY$$ES-SA-2024SA218472$SANOFI AVENTIS$$$$$$Y$$$20240918$$PH$ES$ES
241521371$24152137$1$I$$20240722$20240730$20240730$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005475$BIOCON$$$$$$Y$$$20240730$$MD$CA$CA
241521381$24152138$1$I$$20240715$20240730$20240730$EXP$$IT-EPICPHARMA-IT-2024EPCLIT00884$EPIC PHARM$M. Malavasi.The Conundrum of Drug Interactions and Holter Monitoring: Lamin Gene Mutation Discovered by A Torsade De Pointes Episode Followed by Out-Of-The-Hospital Resuscitation.European Heart Journal Supplements.APR-2024;26:ii55-ii56$57$YR$A$F$Y$$$20240730$$HP$IT$IT
241521392$24152139$2$F$20240101$20240719$20240730$20240730$PER$$US-ROCHE-10000032136$ROCHE$$$$$F$Y$$$20240730$$PH$US$US
241521402$24152140$2$F$$20240806$20240730$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118923$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240808$$MD$JP$JP
241521411$24152141$1$I$20240604$20240723$20240730$20240730$PER$$US-BAYER-2024A107191$BAYER$$28$YR$A$F$Y$$$20240730$$CN$US$US
241521421$24152142$1$I$$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119656$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240730$$HP$US$US
241521431$24152143$1$I$$20240723$20240730$20240730$EXP$$US-ABBVIE-5854090$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241521441$24152144$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225220$TEVA$$7$YR$$M$Y$35$KG$20240730$$HP$CA$CA
241521461$24152146$1$I$$20240723$20240730$20240730$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005461$BIOCON$$$$$$Y$$$20240730$$HP$CA$CA
241521471$24152147$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225522$TEVA$$72$YR$$M$Y$$$20240730$$HP$CA$CA
241521491$24152149$1$I$$20240726$20240729$20240729$DIR$FDA-CDER-CTU-2024-52032$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241521501$24152150$1$I$20240620$20240718$20240730$20240730$EXP$$CN-ROCHE-10000031306$ROCHE$$77$YR$E$M$Y$75$KG$20240730$$HP$CN$CN
241521512$24152151$2$F$$20240801$20240730$20240810$EXP$$US-TEVA-VS-3223144$TEVA$Oomrigar SC, Fernandez J, Rivera Ortiz C, Rajen H, Toll A, Perez Colome E, et al. The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death. Am-J-Respir-Crit-Care-Med 2024; 209.; Oomrigar SC, Fernandez J, Rivera Ortiz C, Rajen H, Toll A, Perez Colome E, et al. The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death. Am-J-Respir-Crit-Care-Med 2024; 209.$$$$F$Y$$$20240810$$HP$US$US
241521521$24152152$1$I$$20240715$20240730$20240730$EXP$$CN-EPICPHARMA-CN-2024EPCLIT00886$EPIC PHARM$C Fan.Warfarin-related nephropathy due to excessive anticoagulation induced by combination of warfarin and amiodarone..Adverse drug reactions journal.MAY-2024;26:318-320$49$YR$A$M$Y$$$20240730$$HP$CN$CN
241521531$24152153$1$I$20240725$20240729$20240730$20240730$EXP$$US-INCYTE CORPORATION-2024IN007918$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241521541$24152154$1$I$$20240725$20240730$20240730$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137936$DAIICHI$$75$YR$$F$Y$$$20240730$$CN$US$US
241521551$24152155$1$I$$20240725$20240730$20240730$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137939$DAIICHI$$54$YR$$F$Y$$$20240730$$CN$US$US
241521561$24152156$1$I$20240510$20240527$20240730$20240730$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-011130$JAZZ$$16$YR$$$Y$$$20240730$$HP$JP$JP
241521571$24152157$1$I$20231123$20240723$20240730$20240730$EXP$$US-VERTEX PHARMACEUTICALS-2024-012193$VERTEX$$5$YR$$$Y$$$20240730$$HP$US$US
241521581$24152158$1$I$$20240724$20240730$20240730$EXP$$US-VERTEX PHARMACEUTICALS-2024-012309$VERTEX$$19$YR$$F$Y$$$20240730$$CN$US$US
241521591$24152159$1$I$20240616$20240723$20240730$20240730$EXP$$BR-VERTEX PHARMACEUTICALS-2024-012350$VERTEX$$31$YR$$F$Y$52$KG$20240730$$MD$BR$BR
241521601$24152160$1$I$$20240725$20240730$20240730$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012315$VERTEX$$$$A$M$Y$$$20240730$$CN$GB$GB
241521611$24152161$1$I$$20240723$20240730$20240730$EXP$$US-VERTEX PHARMACEUTICALS-2024-012259$VERTEX$$$$$M$Y$$$20240730$$CN$US$US
241521621$24152162$1$I$$20240723$20240730$20240730$EXP$$US-VERTEX PHARMACEUTICALS-2024-012257$VERTEX$$$$$M$Y$$$20240730$$CN$US$US
241521633$24152163$3$F$$20240905$20240730$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-012181$VERTEX$$43$YR$$$Y$$$20240912$$CN$US$US
241521641$24152164$1$I$$20240725$20240730$20240730$EXP$$NZ-VERTEX PHARMACEUTICALS-2024-012346$VERTEX$$$$C$M$Y$$$20240730$$MD$NZ$NZ
241521651$24152165$1$I$20240101$20240722$20240730$20240730$EXP$$CN-SA-2024SA203709$SANOFI AVENTIS$$65$YR$E$F$Y$50$KG$20240730$$CN$CN$CN
241521661$24152166$1$I$20240708$20240729$20240730$20240730$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040537$BOEHRINGER INGELHEIM$$10$DEC$E$M$Y$$$20240730$$PH$JP$JP
241521671$24152167$1$I$20230801$20240723$20240730$20240730$EXP$$MX-SANDOZ INC.-SDZ2023MX062337$SANDOZ$$70$YR$$F$Y$$$20240730$$CN$MX$MX
241521681$24152168$1$I$$20240715$20240730$20240730$EXP$$US-EPICPHARMA-US-2024EPCLIT00889$EPIC PHARM$S. Venkat Ramanan.Thyroid Tempest: Unravelling a Rare Case of Amiodarone-Induced Thyroid Storm.American Journal of Respiratory and Critical Care Medicine.2024;209:A3400$74$YR$E$F$Y$$$20240730$$HP$US$US
241521692$24152169$2$F$$20240814$20240730$20240822$30DAY$$KR-JNJFOC-20240759038$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$KR$KR
241521704$24152170$4$F$20240906$20240910$20240730$20240912$EXP$$US-GILEAD-2024-0682278$GILEAD$$81$YR$E$F$Y$$$20240912$$HP$US$US
241521711$24152171$1$I$20240424$20240722$20240730$20240730$EXP$$BE-AstraZeneca-2024A166231$ASTRAZENECA$$86$YR$$M$Y$54.1$KG$20240730$$MD$BE$
241521721$24152172$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120563$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240730$$CN$US$US
241521731$24152173$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120275$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240730$$CN$US$US
241521741$24152174$1$I$$20240726$20240730$20240730$EXP$$US-BAYER-2024A108963$BAYER$$69$YR$E$F$Y$$$20240730$$CN$US$US
241521752$24152175$2$F$$20240829$20240730$20240829$PER$$US-PFIZER INC-PV202400097563$PFIZER$$7$YR$$M$Y$21.6$KG$20240829$$HP$US$US
241521761$24152176$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52033$$FDA-CTU$$58$YR$$F$N$116.12$KG$20240729$N$$US$
241521771$24152177$1$I$$20240729$20240729$20240729$DIR$711971$$FDA-CTU$$$$$UNK$N$$$20240729$$CN$US$
241521782$24152178$2$F$$20240830$20240730$20240903$PER$$US-PFIZER INC-202400223294$PFIZER$$12$YR$$F$Y$$$20240903$$CN$US$US
241521792$24152179$2$F$$20240830$20240730$20240903$PER$$US-PFIZER INC-202400224308$PFIZER$$45$YR$$M$Y$$$20240903$$CN$US$US
241521802$24152180$2$F$$20240830$20240730$20240903$PER$$US-PFIZER INC-202400224203$PFIZER$$17$YR$$F$Y$$$20240903$$CN$US$US
241521812$24152181$2$F$$20240806$20240730$20240809$PER$$US-PFIZER INC-202400224700$PFIZER$$$$$$Y$$$20240809$$CN$US$US
241521823$24152182$3$F$20221021$20240904$20240730$20240905$PER$$US-PFIZER INC-PV202400097311$PFIZER$$13$YR$$M$Y$46.259$KG$20240905$$MD$US$US
241521831$24152183$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018557$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241521841$24152184$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52040$$FDA-CTU$$69$YR$$F$N$$$20240729$N$$US$
241521851$24152185$1$I$20240701$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52049$$FDA-CTU$$60$YR$$F$N$$$20240729$N$HP$US$
241521861$24152186$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52059$$FDA-CTU$$35$YR$$F$N$$$20240729$N$$US$
241521871$24152187$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018777$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240730$$CN$US$US
241521881$24152188$1$I$20170101$20240729$20240730$20240730$EXP$$FR-ABBVIE-5857768$ABBVIE$$58$YR$$F$Y$$$20240730$$MD$FR$FR
241521891$24152189$1$I$20240719$20240724$20240730$20240730$EXP$$CN-SA-2024SA220568$SANOFI AVENTIS$$53$YR$A$M$Y$75$KG$20240730$$HP$CN$CN
241521901$24152190$1$I$20240623$20240720$20240730$20240730$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-07043$HIKMA$$$$$$Y$$$20240730$$HP$EG$EG
241521921$24152192$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407014061$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240730$$CN$US$US
241521931$24152193$1$I$$20240722$20240730$20240730$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005479$BIOCON$$$$$$Y$$$20240730$$MD$CA$CA
241521951$24152195$1$I$$20240628$20240730$20240730$PER$$US-LUNDBECK-DKLU4001472$LUNDBECK$$$$$$Y$$$20240730$$CN$US$US
241521961$24152196$1$I$20240401$20240723$20240730$20240730$EXP$DK-DKMA-30733838$DK-ROCHE-10000033971$ROCHE$$32$YR$A$M$Y$$$20240730$$MD$DK$DK
241521971$24152197$1$I$20240720$20240724$20240730$20240730$PER$$US-EMD Serono-2024040271$EMD SERONO INC$$33$YR$A$F$Y$$$20240730$$HP$US$US
241521981$24152198$1$I$20240101$20240725$20240730$20240730$EXP$$US-SA-2024SA222434$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240730$$MD$US$US
241521991$24152199$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52106$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241522001$24152200$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52153$$FDA-CTU$$79$YR$$M$N$$$20240729$N$$US$
241522011$24152201$1$I$20240719$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52090$$FDA-CTU$$50$YR$$M$N$120.2$KG$20240729$N$PH$US$
241522051$24152205$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024150323$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241522062$24152206$2$F$$20240909$20240730$20240916$EXP$$JP-AMGEN-JPNSP2024149984$AMGEN$Unknown. Myositis Ossificans of the Psoas Major Muscle After i XLIF With Preoperative Administration of Romosozumab: A Case Report. JBJS Case Connector. 2024;14(3):1-6$62$YR$A$F$Y$$$20240916$$MD$JP$JP
241522071$24152207$1$I$20240726$20240730$20240730$20240730$EXP$$CN-ROCHE-10000041778$ROCHE$$45$YR$A$F$Y$66$KG$20240730$$HP$CN$CN
241522081$24152208$1$I$20240713$20240724$20240730$20240730$EXP$ES-AEMPS-1551538$ES-ABBVIE-5856444$ABBVIE$$81$YR$$M$Y$64$KG$20240730$$PH$ES$ES
241522092$24152209$2$F$$20240823$20240730$20240827$EXP$$FR-INCYTE CORPORATION-2024IN007916$INCYTE$$$$$$Y$$$20240827$$PH$FR$FR
241522103$24152210$3$F$$20240924$20240730$20240926$EXP$$US-BAYER-2024A106993$BAYER$$70$YR$E$M$Y$$$20240926$$CN$US$US
241522111$24152211$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225288$TEVA$$10$YR$$F$Y$27$KG$20240730$$PH$CA$CA
241522121$24152212$1$I$$20240715$20240730$20240730$EXP$$JP-EPICPHARMA-JP-2024EPCLIT00894$EPIC PHARM$Shingo Masuda.Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine.Internal Medicine.2024;63:1829-1835$72$YR$E$F$Y$$$20240730$$HP$JP$JP
241522132$24152213$2$F$$20240903$20240730$20240906$EXP$$GB-TAKEDA-2021TUS068348$TAKEDA$$$$$F$Y$$$20240906$$MD$GB$GB
241522143$24152214$3$F$20240725$20240812$20240730$20240814$PER$$US-AMGEN-USASP2024148495$AMGEN$$92$YR$E$F$Y$$$20240814$$MD$US$US
241522151$24152215$1$I$$20240723$20240730$20240730$EXP$$GB-JNJFOC-20240765385$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$GB$GB
241522162$24152216$2$F$$20240722$20240730$20240801$EXP$$US-TEVA-VS-3225875$TEVA$$72$YR$$F$Y$$$20240801$$PH$US$US
241522171$24152217$1$I$$20240722$20240730$20240730$EXP$$CN-AstraZeneca-2024A169452$ASTRAZENECA$$$$$F$Y$$$20240730$$MD$CN$
241522181$24152218$1$I$$20240726$20240730$20240730$EXP$$PL-AstraZeneca-2024A172287$ASTRAZENECA$$$$$F$Y$$$20240730$$MD$PL$
241522191$24152219$1$I$20240101$20240724$20240730$20240730$EXP$$US-009507513-2407USA014598$MERCK$$$$$F$Y$$$20240730$$CN$US$US
241522202$24152220$2$F$20211115$20240801$20240730$20240802$EXP$IT-MINISAL02-996792$IT-GILEAD-2024-0682232$GILEAD$$48$YR$A$F$Y$65$KG$20240802$$MD$IT$IT
241522214$24152221$4$F$20240724$20240829$20240730$20240904$PER$$US-PFIZER INC-PV202400097904$PFIZER$$71$YR$$F$Y$$$20240904$$HP$US$US
241522221$24152222$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224771$PFIZER$$$$A$$Y$$$20240730$$MD$US$US
241522231$24152223$1$I$20240701$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224717$PFIZER$$42$YR$$F$Y$$$20240730$$CN$US$US
241522241$24152224$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224787$PFIZER$$$$T$$Y$$$20240730$$MD$US$US
241522251$24152225$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52116$$FDA-CTU$$65$YR$$F$N$$$20240729$N$$US$
241522261$24152226$1$I$$20240715$20240730$20240730$EXP$$HU-TEVA-VS-3224120$TEVA$Irsai G, Tampu-Kiss T, Dezso B, Miltenyi Z, Illes A, Mehes G. Complications of systemic cytomegalovirus infection in therapy refracter Hodgkin^s lymphoma. [Hungarian]. Orv-Hetil 2012; 153 (19): 751-755.$$$$F$Y$$$20240730$$HP$HU$HU
241522271$24152227$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224783$PFIZER$$$$T$$Y$$$20240730$$MD$US$US
241522281$24152228$1$I$20240724$20240726$20240730$20240730$PER$$US-PFIZER INC-202400225660$PFIZER$$68$YR$$F$Y$$$20240730$$CN$US$US
241522291$24152229$1$I$20240701$20240726$20240730$20240730$PER$$US-PFIZER INC-202400225119$PFIZER$$32$YR$$F$Y$$$20240730$$MD$US$US
241522301$24152230$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52095$$FDA-CTU$$38$YR$$F$N$$$20240729$N$$US$
241522311$24152231$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52087$$FDA-CTU$$82$YR$$M$N$$$20240729$N$$US$
241522321$24152232$1$I$$20240725$20240730$20240730$PER$$US-PFIZER INC-202400105599$PFIZER$$73$YR$$F$Y$$$20240730$$CN$US$US
241522331$24152233$1$I$20240726$20240726$20240730$20240730$PER$$US-PFIZER INC-202400225041$PFIZER$$32$YR$$F$Y$$$20240730$$CN$US$US
241522342$24152234$2$F$20240501$20240822$20240730$20240828$EXP$$US-PFIZER INC-202400224185$PFIZER$$82$YR$$F$Y$$$20240828$$HP$US$US
241522351$24152235$1$I$20240715$20240723$20240730$20240730$PER$$US-PFIZER INC-202400223019$PFIZER$$43$YR$$M$Y$112.04$KG$20240730$$CN$US$US
241522361$24152236$1$I$20240101$20240725$20240730$20240730$PER$$US-PFIZER INC-202400223743$PFIZER$$37$YR$$F$Y$$$20240730$$CN$US$US
241522371$24152237$1$I$20240721$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224995$PFIZER$$63$YR$$F$Y$$$20240730$$CN$US$US
241522381$24152238$1$I$20240724$20240724$20240730$20240730$PER$$US-PFIZER INC-202400059389$PFIZER$$26$YR$$F$Y$$$20240730$$HP$US$US
241522391$24152239$1$I$20240727$20240729$20240729$20240729$DIR$712005$$FDA-CTU$$39$YR$$F$N$$$20240729$N$PH$US$
241522401$24152240$1$I$20240701$20240725$20240730$20240730$PER$$US-PFIZER INC-PV202400097595$PFIZER$$57$YR$$F$Y$$$20240730$$HP$US$US
241522411$24152241$1$I$$20240729$20240730$20240730$PER$$US-PFIZER INC-202400226029$PFIZER$$69$YR$$F$Y$$$20240730$$CN$US$US
241522421$24152242$1$I$20240401$20240726$20240730$20240730$PER$$US-PFIZER INC-202400225604$PFIZER$$85$YR$$F$Y$$$20240730$$HP$US$US
241522432$24152243$2$F$20240701$20240809$20240730$20240814$PER$$US-PFIZER INC-202400224676$PFIZER$$$$A$F$Y$$$20240814$$HP$US$US
241522441$24152244$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52043$$FDA-CTU$$57$YR$$F$N$$$20240729$N$$US$
241522452$24152245$2$F$$20240822$20240730$20240827$PER$$US-PFIZER INC-202400218924$PFIZER$$59$YR$$F$Y$$$20240827$$HP$US$US
241522461$24152246$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224777$PFIZER$$$$A$$Y$$$20240730$$MD$US$US
241522471$24152247$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224769$PFIZER$$$$A$$Y$$$20240730$$MD$US$US
241522481$24152248$1$I$$20240725$20240730$20240730$PER$$US-PFIZER INC-PV202400097549$PFIZER$$$$$F$Y$$$20240730$$CN$US$US
241522493$24152249$3$F$$20240829$20240730$20240829$PER$$US-PFIZER INC-202400225231$PFIZER$$62$YR$$F$Y$$$20240829$$CN$US$US
241522501$24152250$1$I$20240719$20240729$20240729$20240729$DIR$712001$$FDA-CTU$$79$YR$$M$N$96.75$KG$20240729$N$CN$US$
241522511$24152251$1$I$$20240725$20240730$20240730$PER$$US-PFIZER INC-PV202400097378$PFIZER$$65$YR$$M$Y$$$20240730$$CN$US$US
241522522$24152252$2$F$$20240802$20240730$20240806$PER$$US-PFIZER INC-PV202400095242$PFIZER$$61$YR$$M$Y$$$20240806$$CN$US$US
241522531$24152253$1$I$$20240724$20240730$20240730$PER$$US-PFIZER INC-PV202400097877$PFIZER$$58$YR$$F$Y$$$20240730$$CN$US$US
241522543$24152254$3$F$$20240905$20240730$20240909$PER$$US-PFIZER INC-PV202400080874$PFIZER$$71$YR$$F$Y$$$20240909$$CN$US$US
241522551$24152255$1$I$$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52058$$FDA-CTU$$88$YR$$F$N$$$20240729$N$$US$
241522563$24152256$3$F$$20240908$20240730$20240909$PER$$US-PFIZER INC-202400224987$PFIZER$$$$$$Y$$$20240909$$HP$US$US
241522571$24152257$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224782$PFIZER$$$$T$$Y$$$20240730$$MD$US$US
241522582$24152258$2$F$$20240731$20240730$20240805$PER$$US-PFIZER INC-202400219797$PFIZER$$30$YR$$F$Y$58.97$KG$20240805$$CN$US$US
241522591$24152259$1$I$20240720$20240729$20240730$20240730$EXP$$CN-GILEAD-2024-0682303$GILEAD$$50$YR$A$F$Y$59.2$KG$20240730$$HP$CN$CN
241522601$24152260$1$I$$20240730$20240730$20240730$EXP$FR-AFSSAPS-MA2024001260$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042621$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240730$$MD$FR$FR
241522611$24152261$1$I$$20240724$20240730$20240730$EXP$$GB-TAKEDA-2023TUS039499$TAKEDA$$$$$M$Y$$$20240730$$CN$GB$GB
241522621$24152262$1$I$$20240716$20240730$20240730$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700041$UPSHER SMITH LABORATORIES$$$$$M$Y$$$20240730$$MD$US$US
241522632$24152263$2$F$20240701$20240806$20240730$20240821$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700037$UPSHER SMITH LABORATORIES$$13$YR$$F$Y$48$KG$20240821$$MD$US$US
241522641$24152264$1$I$$20240723$20240730$20240730$PER$$US-ABBVIE-5853379$ABBVIE$$$$$$Y$$$20240730$$MD$US$US
241522651$24152265$1$I$$20240729$20240730$20240730$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137960$DAIICHI$$$$$F$Y$$$20240730$$CN$US$US
241522661$24152266$1$I$$20240716$20240730$20240730$EXP$$JP-UCBSA-2024036784$UCB$$$$$F$Y$$$20240730$$CN$JP$JP
241522671$24152267$1$I$$20240715$20240730$20240730$EXP$$ES-EPICPHARMA-ES-2024EPCLIT00890$EPIC PHARM$Izaskun Rubio.Green neutrophilic inclusions in patient with drug intoxication: a  case report.Journal of Laboratory and Precision Medicine.20-NOV-2023;9:1-4$54$YR$A$F$Y$$$20240730$$HP$ES$ES
241522681$24152268$1$I$$20240722$20240730$20240730$EXP$$US-ALXN-202407USA001595US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$PH$US$US
241522691$24152269$1$I$20240625$20240724$20240730$20240730$PER$$US-BAYER-2024A107647$BAYER$$30$YR$A$F$Y$$$20240730$$HP$US$US
241522702$24152270$2$F$$20240801$20240730$20240809$EXP$$DK-TEVA-VS-3224205$TEVA$Fage S, Johansen C. Severe and therapeutic challenging oral erosive lichen planus treated with oral roflumilast. Clin-Exp-Dermatol 2023; 48 (5): 556-557.; Fage S, Johansen C. Severe and therapeutic challenging oral erosive lichen planus treated with oral roflumilast. Clin-Exp-Dermatol 2023; 48 (5): 556-557.$24$YR$$F$Y$$$20240809$$HP$DK$DK
241522711$24152271$1$I$20240103$20240729$20240729$20240729$DIR$712004$$FDA-CTU$$65$YR$$F$N$63$KG$20240729$Y$CN$US$
241522721$24152272$1$I$$20240723$20240730$20240730$EXP$$US-ROCHE-10000034490$ROCHE$$79$YR$E$M$Y$$$20240730$$CN$US$US
241522731$24152273$1$I$$20240727$20240730$20240730$PER$$US-PFIZER INC-202400225083$PFIZER$$$$$$Y$$$20240730$$CN$US$US
241522741$24152274$1$I$$20240708$20240730$20240730$PER$$US-PFIZER INC-202400209197$PFIZER$$85$YR$$F$Y$$$20240730$$MD$US$US
241522751$24152275$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400225230$PFIZER$$75$YR$$M$Y$$$20240730$$CN$US$US
241522761$24152276$1$I$20240727$20240729$20240730$20240730$PER$$US-AMGEN-USASP2024151005$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241522771$24152277$1$I$$20240725$20240730$20240730$PER$$US-PFIZER INC-202400224087$PFIZER$$76$YR$$F$Y$86.64$KG$20240730$$CN$US$US
241522782$24152278$2$F$$20240822$20240730$20240828$PER$$US-PFIZER INC-PV202400097674$PFIZER$$82$YR$$F$Y$$$20240828$$CN$US$US
241522791$24152279$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400226133$PFIZER$$78$YR$$F$Y$$$20240730$$HP$US$US
241522801$24152280$1$I$$20240727$20240730$20240730$PER$$US-PFIZER INC-202400225477$PFIZER$$70$YR$$F$Y$$$20240730$$CN$US$US
241522811$24152281$1$I$20240701$20240727$20240730$20240730$PER$$US-PFIZER INC-202400225140$PFIZER$$64$YR$$F$Y$$$20240730$$CN$US$US
241522821$24152282$1$I$$20240729$20240730$20240730$PER$$US-PFIZER INC-202400225959$PFIZER$$40$YR$$F$Y$$$20240730$$MD$US$US
241522831$24152283$1$I$$20240725$20240730$20240730$PER$$US-PFIZER INC-PV202400097711$PFIZER$$$$$$Y$$$20240730$$CN$US$US
241522841$24152284$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224784$PFIZER$$$$T$$Y$$$20240730$$MD$US$US
241522851$24152285$1$I$20240725$20240726$20240730$20240730$PER$$US-PFIZER INC-202400225669$PFIZER$$32$YR$$F$Y$$$20240730$$CN$US$US
241522861$24152286$1$I$$20240725$20240730$20240730$PER$$US-PFIZER INC-202400224174$PFIZER$$26$YR$$F$Y$$$20240730$$CN$US$US
241522871$24152287$1$I$$20240725$20240730$20240730$PER$$US-PFIZER INC-202400224239$PFIZER$$38$YR$$M$Y$$$20240730$$HP$US$US
241522881$24152288$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224907$PFIZER$$16$YR$$M$Y$$$20240730$$HP$US$US
241522891$24152289$1$I$20240726$20240727$20240730$20240730$PER$$US-PFIZER INC-202400225241$PFIZER$$66$YR$$M$Y$$$20240730$$CN$US$US
241522902$24152290$2$F$20240724$20240819$20240730$20240822$PER$$US-PFIZER INC-202400224985$PFIZER$$74$YR$$M$Y$56.689$KG$20240822$$CN$US$US
241522911$24152291$1$I$20240721$20240725$20240730$20240730$PER$$US-PFIZER INC-202400225098$PFIZER$$23$YR$$F$Y$$$20240730$$HP$US$US
241522921$24152292$1$I$20240723$20240726$20240730$20240730$PER$$US-PFIZER INC-202400226088$PFIZER$$76$YR$$F$Y$$$20240730$$HP$US$US
241522931$24152293$1$I$$20240726$20240730$20240730$PER$$JP-PFIZER INC-202400224440$PFIZER$$$$$$Y$$$20240730$$PH$JP$JP
241522941$24152294$1$I$$20240726$20240730$20240730$PER$$KR-PFIZER INC-PV202400097832$PFIZER$$$$$F$Y$$$20240730$$CN$KR$KR
241522951$24152295$1$I$20240726$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224906$PFIZER$$45$YR$$M$Y$$$20240730$$CN$US$US
241522961$24152296$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224990$PFIZER$$77$YR$$F$Y$$$20240730$$CN$US$US
241522971$24152297$1$I$$20240725$20240730$20240730$PER$$US-PFIZER INC-PV202400097714$PFIZER$$68$YR$$F$Y$$$20240730$$PH$US$US
241522982$24152298$2$F$$20240726$20240730$20240731$PER$$US-PFIZER INC-PV202400098501$PFIZER$$62$YR$$F$Y$$$20240731$$MD$US$US
241522991$24152299$1$I$$20240724$20240730$20240730$PER$$US-PFIZER INC-202400224102$PFIZER$$73$YR$$F$Y$$$20240730$$HP$US$US
241523001$24152300$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-PV202400098219$PFIZER$$60$YR$$F$Y$$$20240730$$HP$US$US
241523011$24152301$1$I$20240725$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224908$PFIZER$$48$YR$$F$Y$$$20240730$$HP$US$US
241523021$24152302$1$I$20240701$20240729$20240730$20240730$PER$$US-PFIZER INC-202400226047$PFIZER$$60$YR$$F$Y$$$20240730$$CN$US$US
241523031$24152303$1$I$$20240725$20240730$20240730$PER$$US-PFIZER INC-202400223956$PFIZER$$$$$F$Y$$$20240730$$CN$US$US
241523041$24152304$1$I$$20240729$20240730$20240730$PER$$US-PFIZER INC-202400226227$PFIZER$$49$YR$$F$Y$$$20240730$$CN$US$US
241523051$24152305$1$I$20240723$20240726$20240730$20240730$PER$$US-PFIZER INC-202400225003$PFIZER$$78$YR$$F$Y$$$20240730$$CN$US$US
241523061$24152306$1$I$20240627$20240726$20240730$20240730$PER$$US-PFIZER INC-202400226000$PFIZER$$53$YR$$F$Y$$$20240730$$HP$US$US
241523071$24152307$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224781$PFIZER$$$$A$$Y$$$20240730$$MD$US$US
241523081$24152308$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400226028$PFIZER$$$$$$Y$$$20240730$$HP$US$US
241523101$24152310$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400226030$PFIZER$$54$YR$$F$Y$$$20240730$$HP$US$US
241523112$24152311$2$F$20240701$20240730$20240730$20240731$PER$$US-PFIZER INC-202400225078$PFIZER$$58$YR$$M$Y$111.13$KG$20240731$$CN$US$US
241523122$24152312$2$F$$20240916$20240730$20240919$PER$$US-PFIZER INC-PV202400098537$PFIZER$$55$YR$$F$Y$$$20240919$$HP$US$US
241523131$24152313$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400225242$PFIZER$$66$YR$$F$Y$$$20240730$$MD$US$US
241523141$24152314$1$I$20240701$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224619$PFIZER$$59$YR$$M$Y$$$20240730$$CN$US$US
241523151$24152315$1$I$$20240729$20240730$20240730$PER$$JP-PFIZER INC-202400225054$PFIZER$$$$$F$Y$$$20240730$$CN$JP$JP
241523162$24152316$2$F$20240401$20240816$20240730$20240821$PER$$US-PFIZER INC-202400224140$PFIZER$$$$$F$Y$$$20240821$$CN$US$US
241523171$24152317$1$I$20240701$20240727$20240730$20240730$PER$$US-PFIZER INC-202400225248$PFIZER$$67$YR$$M$Y$$$20240730$$CN$US$US
241523181$24152318$1$I$20240722$20240726$20240730$20240730$PER$$US-PFIZER INC-202400224909$PFIZER$$43$YR$$M$Y$$$20240730$$CN$US$US
241523191$24152319$1$I$20240727$20240727$20240730$20240730$PER$$US-PFIZER INC-202400225069$PFIZER$$$$$$Y$$$20240730$$CN$US$US
241523201$24152320$1$I$$20240725$20240730$20240730$PER$$US-PFIZER INC-PV202300065990$PFIZER$$59$YR$$F$Y$$$20240730$$CN$US$US
241523211$24152321$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400225963$PFIZER$$73$YR$$F$Y$$$20240730$$HP$US$US
241523222$24152322$2$F$$20240830$20240730$20240830$PER$$US-PFIZER INC-202400222975$PFIZER$$7$DEC$$F$Y$$$20240830$$PH$US$US
241523231$24152323$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-202400225007$PFIZER$$$$$F$Y$$$20240730$$CN$US$US
241523241$24152324$1$I$$20240724$20240730$20240730$PER$$US-BAYER-2024A107826$BAYER$$41$YR$A$F$Y$$$20240730$$MD$US$US
241523253$24152325$3$F$20240101$20240802$20240730$20240814$EXP$$US-INSMED, INC.-2024-02979-US$INSMED$$$$$M$Y$$$20240814$$CN$US$US
241523283$24152328$3$F$20240717$20240829$20240730$20240906$PER$$US-ROCHE-10000031331$ROCHE$$50$YR$A$F$Y$158.76$KG$20240906$$CN$US$US
241523291$24152329$1$I$$20240723$20240730$20240730$PER$US-MLMSERVICE-20240718-PI133705-00082-2$US-RDY-SPO/USA/24/0010973$DR REDDYS$Stewart MA, Rives TA, Blanton K, Baldwin L. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecologic Oncology Reports. 2024;54:101452. DOI:10.1016/j.gore.2024.101452.$33$YR$A$F$Y$$$20240730$$MD$US$US
241523301$24152330$1$I$$20240718$20240730$20240730$EXP$$US-RDY-LIT/USA/24/0010802$DR REDDYS$Applegarth J, Finn D, Tolkacz M. Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome. ASAIO Journal. 2024 May;70:$18$YR$A$F$Y$$$20240730$$HP$US$US
241523311$24152331$1$I$$20240715$20240730$20240730$EXP$$TR-EPICPHARMA-TR-2024EPCLIT00880$EPIC PHARM$Ugur Arslan.Causation or Coincidence? A Case of Coexisting  Spontaneous Coronary Artery Dissection and Coronary  Thrombosis in a Patient with Kounis Syndrome.International Journal of the Cardiovascular Academy.07-JUL-2023;9:48-51$39$YR$A$M$Y$$$20240730$$HP$TR$TR
241523321$24152332$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS076032$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241523331$24152333$1$I$$20240724$20240730$20240730$PER$$US-BAYER-2024A108366$BAYER$$42$YR$A$F$Y$$$20240730$$MD$US$US
241523342$24152334$2$F$20240727$20240729$20240730$20240801$PER$$US-HALEON-2189563$Haleon PLC$$80$YR$$F$Y$$$20240801$$CN$US$US
241523351$24152335$1$I$$20240725$20240730$20240730$PER$$US-BAYER-2024A108389$BAYER$$$$$F$Y$$$20240730$$CN$US$US
241523361$24152336$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120071$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240730$$CN$US$US
241523371$24152337$1$I$$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120530$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$55.79$KG$20240730$$CN$US$US
241523381$24152338$1$I$$20240723$20240730$20240730$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005512$BIOCON$$$$$$Y$$$20240730$$HP$CA$CA
241523392$24152339$2$F$$20240730$20240730$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407011533$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240802$$CN$US$US
241523402$24152340$2$F$20240723$20240807$20240730$20240815$PER$$US-BAYER-2024A108617$BAYER$$38$YR$A$F$Y$$$20240815$$HP$US$US
241523411$24152341$1$I$20221116$20230510$20240730$20240730$EXP$$CA-CELLTRION INC.-2021CA019555$CELLTRION$$$$$$Y$$$20240730$$CN$CA$CA
241523421$24152342$1$I$$20240715$20240730$20240730$EXP$$US-PURACAP-US-2024EPCLIT00877$PURACAP$P Simmer.Hot and Bothered: A Rare Case of Dyskinesia Hyperpyrexia Syndrome .Critical Care Medicine.JAN-2024;52:632$53$YR$A$F$Y$$$20240730$$HP$US$US
241523433$24152343$3$F$$20240909$20240730$20240911$EXP$$US-TAKEDA-2022TUS004580$TAKEDA$$$$$F$Y$49$KG$20240911$$HP$US$US
241523442$24152344$2$F$$20240812$20240730$20240813$EXP$$JP-UCBSA-2024036817$UCB$Ebihara M, Murano Y, Sato K, Tanaka N, Naito Y, Nakazawa T, et al. A Case of Multiple Malformations Born from a Mother with Dissociative Disorder. Journal of Japan Society of Perinatal and Neonatal Medicine. 2024;60(S1):P20-5$$$N$M$Y$2.885$KG$20240813$$MD$JP$JP
241523451$24152345$1$I$20240729$20240729$20240730$20240730$PER$$US-HALEON-2189480$Haleon PLC$$$$$F$Y$$$20240730$$CN$US$US
241523463$24152346$3$F$$20240801$20240730$20240812$EXP$$PT-TEVA-VS-3222588$TEVA$Vasconcelos AL, Serotonin syndrome: a long list of causal agents. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts [CNMI]. 2024 May; 279.; Vasconcelos AL, Serotonin syndrome: a long list of causal agents. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts [CNMI]. 2024 May; 279.$80$YR$$F$Y$$$20240812$$MD$PT$PT
241523471$24152347$1$I$$20240723$20240730$20240730$EXP$$BR-BAYER-2024A108182$BAYER$$$$$M$Y$$$20240730$$MD$BR$BR
241523483$24152348$3$F$$20240830$20240730$20240906$30DAY$$BR-JNJFOC-20240753190$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240906$$CN$BR$BR
241523494$24152349$4$F$20240725$20240905$20240730$20240919$PER$$US-JNJFOC-20240773516$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$CN$US$US
241523501$24152350$1$I$20240626$20240724$20240730$20240730$EXP$$US-JNJFOC-20240764856$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$US$US
241523511$24152351$1$I$$20240729$20240730$20240730$PER$$US-AMGEN-USASP2024150235$AMGEN$$62$YR$A$$Y$$$20240730$$CN$US$US
241523521$24152352$1$I$$20240723$20240730$20240730$EXP$$US-AMGEN-USASP2024146515$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241523532$24152353$2$F$20240705$20240807$20240730$20240813$EXP$$JP-SMPA-2024SMP010981$SUNOVION$$$$$$Y$$$20240813$$CN$JP$JP
241523541$24152354$1$I$$20240715$20240730$20240730$PER$$US-GRANULES-US-2024GRASPO00292$GRANULES INDIA$$$$$$Y$$$20240730$$CN$US$US
241523553$24152355$3$F$20240815$20240827$20240730$20240903$EXP$$CA-TAKEDA-2024TUS064777$TAKEDA$$79$YR$$M$Y$$$20240903$$MD$CA$CA
241523561$24152356$1$I$20240601$20240718$20240730$20240730$EXP$$JP-SMPA-2024SMP011090$SUNOVION$$$$$$Y$$$20240730$$CN$JP$JP
241523571$24152357$1$I$20240626$20240727$20240730$20240730$EXP$$IN-AstraZeneca-2024A172560$ASTRAZENECA$$22092$DY$$F$Y$$$20240730$$CN$IN$
241523581$24152358$1$I$$20240722$20240730$20240730$EXP$$ES-AstraZeneca-2024A167875$ASTRAZENECA$$70$YR$$F$Y$$$20240730$$MD$ES$
241523591$24152359$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A167608$ASTRAZENECA$$$$$F$Y$58$KG$20240730$$CN$US$
241523601$24152360$1$I$20240626$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A170003$ASTRAZENECA$$30394$DY$$M$Y$$$20240730$$CN$US$
241523611$24152361$1$I$20210710$20210830$20240730$20240730$EXP$$US-AstraZeneca-2021A704850$ASTRAZENECA$$32356$DY$$F$Y$$$20240730$$CN$US$
241523621$24152362$1$I$$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A170255$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241523631$24152363$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-PV202400098467$PFIZER$$85$YR$$F$Y$$$20240730$$HP$US$US
241523641$24152364$1$I$$20240726$20240730$20240730$PER$$JP-PFIZER INC-202400224195$PFIZER$$$$$$Y$$$20240730$$PH$JP$JP
241523651$24152365$1$I$20240729$20240729$20240730$20240730$PER$$GB-PFIZER INC-202400225769$PFIZER$$$$$$Y$$$20240730$$CN$GB$US
241523661$24152366$1$I$20240727$20240729$20240730$20240730$PER$$US-PFIZER INC-202400226284$PFIZER$$68$YR$$F$Y$$$20240730$$CN$US$US
241523671$24152367$1$I$20240601$20240729$20240730$20240730$PER$$US-PFIZER INC-202400225995$PFIZER$$87$YR$$F$Y$90.72$KG$20240730$$CN$US$US
241523681$24152368$1$I$$20240729$20240730$20240730$PER$$US-PFIZER INC-PV202400098948$PFIZER$$68$YR$$F$Y$$$20240730$$HP$US$US
241523692$24152369$2$F$$20240807$20240730$20240809$PER$$US-PFIZER INC-PV202400098138$PFIZER$$51$YR$$F$Y$$$20240809$$HP$US$US
241523702$24152370$2$F$20240101$20240801$20240730$20240801$PER$$US-PFIZER INC-202400225198$PFIZER$$73$YR$$F$Y$$$20240801$$HP$US$US
241523711$24152371$1$I$$20240726$20240730$20240730$PER$$US-PFIZER INC-PV202400098465$PFIZER$$74$YR$$F$Y$$$20240730$$CN$US$US
241523721$24152372$1$I$20240726$20240727$20240730$20240730$PER$$US-PFIZER INC-202400225508$PFIZER$$71$YR$$F$Y$$$20240730$$CN$US$US
241523741$24152374$1$I$$20240729$20240730$20240730$PER$$US-BAUSCH-BL-2024-011569$BAUSCH AND LOMB$$$$$M$Y$$$20240730$$CN$US$US
241523751$24152375$1$I$20240718$20240725$20240730$20240730$PER$$US-BAUSCH-BL-2024-011426$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240730$$CN$US$US
241523762$24152376$2$F$20240531$20240805$20240730$20240807$EXP$$DE-BAUSCH-BL-2024-011546$BAUSCH AND LOMB$$17$YR$$F$Y$63.9$KG$20240807$$MD$DE$DE
241523771$24152377$1$I$20240723$20240726$20240730$20240730$PER$$US-BAYER-2024A109094$BAYER$$17$YR$T$F$Y$$$20240730$$MD$US$US
241523781$24152378$1$I$20240128$20240728$20240730$20240730$EXP$$US-BAYER-2024A109091$BAYER$$$$$M$Y$$$20240730$$MD$US$US
241523791$24152379$1$I$20220101$20240723$20240730$20240730$EXP$$PH-009507513-2407PHL014702$MERCK$Jacinto E. Chemo-resistant Gestational Trophoblastic Neoplasia and the Use of Immunotherapy: A Case Report and Review of Literature.. Acta Med Philipp.. 2024;58 (11):90-8$41$YR$$F$Y$$$20240730$$MD$PH$PH
241523801$24152380$1$I$20240525$20240722$20240730$20240730$EXP$GB-MHRA-MED-202407221511173750-RLZNJ$GB-TEVA-VS-3224176$TEVA$$$$$F$Y$$$20240730$$HP$GB$GB
241523811$24152381$1$I$$20240715$20240730$20240730$EXP$$IR-EPICPHARMA-IR-2024EPCLIT00887$EPIC PHARM$F Shahbazi .Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases..Current Drug Safety.MAY-2024$52$YR$A$F$Y$$$20240730$$HP$IR$IR
241523821$24152382$1$I$$20240704$20240730$20240730$PER$$JP-Eisai-EC-2024-167940$EISAI$$65$YR$E$M$Y$$$20240730$$MD$JP$JP
241523831$24152383$1$I$20240101$20240723$20240730$20240730$PER$$JP-Eisai-EC-2024-170849$EISAI$$$$$F$Y$$$20240730$$MD$JP$JP
241523841$24152384$1$I$20240711$20240715$20240730$20240730$EXP$$US-SERVIER-S24008995$SERVIER$$$$$$Y$$$20240730$$CN$US$US
241523851$24152385$1$I$$20240724$20240730$20240730$PER$$US-ABBVIE-5855830$ABBVIE$$$$$$Y$$$20240730$$MD$US$US
241523861$24152386$1$I$20231030$20240715$20240730$20240730$EXP$$US-TEVA-VS-3141011$TEVA$$24$YR$$F$Y$$$20240730$$HP$US$US
241523871$24152387$1$I$20230817$20240729$20240730$20240730$EXP$FR-AFSSAPS-TS2024000854$FR-GILEAD-2024-0682239$GILEAD$$67$YR$E$F$Y$55$KG$20240730$$MD$FR$FR
241523881$24152388$1$I$20240401$20240728$20240730$20240730$EXP$FR-AFSSAPS-AN2024000959$FR-BAUSCH-BL-2024-011555$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240730$$MD$FR$FR
241523891$24152389$1$I$20211101$20240722$20240730$20240730$EXP$$CN-ASTELLAS-2024US021133$ASTELLAS$$39$YR$$F$Y$$$20240730$$HP$CN$CN
241523901$24152390$1$I$20240719$20240723$20240730$20240730$EXP$$MX-JNJFOC-20240765288$JOHNSON AND JOHNSON$$68$YR$E$$Y$$$20240730$$MD$MX$MX
241523912$24152391$2$F$20240101$20240729$20240730$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119985$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240731$$CN$US$US
241523921$24152392$1$I$20240718$20240723$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117750$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240730$$CN$US$US
241523931$24152393$1$I$$20240726$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120038$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240730$$CN$US$US
241523941$24152394$1$I$$20240729$20240730$20240730$PER$$US-GILEAD-2024-0682301$GILEAD$$$$A$F$Y$72.109$KG$20240730$$MD$US$US
241523961$24152396$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225222$TEVA$$6$YR$$M$Y$$$20240730$$PH$CA$CA
241523973$24152397$3$F$20240501$20240808$20240730$20240809$PER$$US-AMGEN-USASP2024150155$AMGEN$$27$YR$A$F$Y$$$20240809$$CN$US$US
241523984$24152398$4$F$20240101$20240909$20240730$20240912$30DAY$$AR-PFIZER INC-202400222921$PFIZER$$46$YR$$F$Y$$$20240912$$CN$AR$AR
241523994$24152399$4$F$20240101$20240909$20240730$20240913$30DAY$$AR-PFIZER INC-202400224591$PFIZER$$46$YR$$F$Y$$$20240913$$CN$AR$AR
241524001$24152400$1$I$20190101$20240729$20240730$20240730$EXP$FR-AFSSAPS-AN2024000948$FR-GILEAD-2024-0682238$GILEAD$$51$YR$A$M$Y$98$KG$20240730$$PH$FR$FR
241524011$24152401$1$I$20240704$20240715$20240730$20240730$PER$$US-EPICPHARMA-US-2024EPCSPO00878$EPIC PHARM$$68$YR$E$M$Y$240$KG$20240730$$CN$US$US
241524021$24152402$1$I$$20240719$20240730$20240730$PER$$US-ROCHE-10000031099$ROCHE$$$$T$M$Y$$$20240730$$CN$US$US
241524031$24152403$1$I$$20240726$20240730$20240730$PER$$US-TAKEDA-2024TUS076064$TAKEDA$$$$$M$Y$$$20240730$$CN$US$US
241524051$24152405$1$I$20230701$20240729$20240730$20240730$EXP$FR-AFSSAPS-TS2024000855$FR-GILEAD-2024-0682244$GILEAD$$57$YR$A$M$Y$68$KG$20240730$$MD$FR$FR
241524062$24152406$2$F$$20240926$20240730$20240927$PER$$NVSC2024US150091$NOVARTIS$$15$YR$$F$Y$$$20240927$$MD$US$US
241524071$24152407$1$I$20240703$20240719$20240730$20240730$PER$$US-ROCHE-10000033579$ROCHE$$37$YR$A$M$Y$$$20240730$$CN$US$US
241524081$24152408$1$I$$20240724$20240730$20240730$PER$$US-ROCHE-10000035560$ROCHE$$$$$M$Y$$$20240730$$CN$US$US
241524102$24152410$2$F$$20240729$20240730$20240803$PER$$US-AMGEN-USASP2024150658$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241524111$24152411$1$I$$20240715$20240730$20240730$EXP$$PT-TEVA-VS-3222155$TEVA$L M Pereira; R Tinoco; S Mendes; E Amaro; N Fernandes; D Cruz. IMI-073 - (2668) - AN UNCOMMON CAUSE OF SYNCOPE. Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024; 1357$34$YR$$M$Y$$$20240730$$MD$PT$PT
241524121$24152412$1$I$$20240718$20240730$20240730$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-07004$HIKMA$Gault KS.. Gault KS. The role of physical therapy with a multidisciplinary pancreatic cancer clinic to optimize case. Rehabilitation Oncology. 2024;42(2):119$78$YR$$F$Y$$$20240730$$MD$US$US
241524132$24152413$2$F$$20240821$20240730$20240826$PER$$US-ROCHE-10000034680$ROCHE$$$$I$M$Y$$$20240826$$HP$US$US
241524151$24152415$1$I$20240722$20240729$20240730$20240730$PER$$US-ROCHE-10000041141$ROCHE$$68$YR$E$M$Y$52.16$KG$20240730$$CN$US$US
241524161$24152416$1$I$$20240716$20240730$20240730$EXP$$US-GLANDPHARMA-US-2024GLNLIT00553$GLAND PHARMA$Pien I.Osteonecrosis of Trapezium Occurring in Patient with History of Recurrent Carpometacarpal Corticosteroid Injection.The Journal of Hand Surgery Asian-Pacific.FEB-2023;28:129-133$59$YR$A$F$Y$$$20240730$$HP$US$US
241524173$24152417$3$F$20240101$20240801$20240730$20240831$PER$$US-TEVA-VS-3221339$TEVA$$48$YR$$F$Y$61.23$KG$20240831$$CN$US$US
241524181$24152418$1$I$$20240724$20240730$20240730$EXP$$AU-TAKEDA-2024TUS075721$TAKEDA$$54$YR$$M$Y$$$20240730$$CN$AU$AU
241524202$24152420$2$F$$20240729$20240730$20240801$PER$$US-ROCHE-10000041008$ROCHE$$$$A$M$Y$$$20240801$$CN$US$US
241524211$24152421$1$I$20240729$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52160$$FDA-CTU$$54$YR$$F$N$39$KG$20240729$N$$US$
241524231$24152423$1$I$20240716$20240719$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010755$DR REDDYS$$26$YR$A$F$Y$96$KG$20240730$$CN$US$US
241524241$24152424$1$I$20240716$20240722$20240730$20240730$EXP$GB-MHRA-31250470$GB-RDY-SPO/GBR/24/0010870$DR REDDYS$$$$$M$Y$$$20240730$$HP$GB$GB
241524251$24152425$1$I$$20240408$20240730$20240730$PER$$US-Eisai-EC-2024-163390$EISAI$$$$$F$Y$$$20240730$$HP$US$US
241524262$24152426$2$F$20210101$20240815$20240730$20240816$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-097010$REGENERON$Maruyama K, Hara C, Sayanagi K, Nishida K. P-4 Changes in swept-source optical coherence tomography angiography images before and  after the development of retinal pigment epithelial tear.. Abstracts of the 40th Annual Meeting of Japanese Society for Ocular circulation. 2024;88$86$YR$$M$Y$$$20240816$$HP$JP$JP
241524272$24152427$2$F$20240722$20240807$20240730$20240808$PER$$US-ROCHE-10000037780$ROCHE$$$$$$Y$$$20240808$$CN$US$US
241524282$24152428$2$F$$20240729$20240730$20240807$EXP$$CA-JNJFOC-20240767699$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$60$KG$20240807$$HP$CA$CA
241524291$24152429$1$I$20240716$20240722$20240730$20240730$EXP$GB-MHRA-31250470$GB-TEVA-VS-3224680$TEVA$$$$$M$Y$$$20240730$$HP$GB$GB
241524304$24152430$4$F$20240413$20240813$20240730$20240819$EXP$$BR-JNJFOC-20240678186$JOHNSON AND JOHNSON$$59$YR$A$F$Y$71$KG$20240819$$CN$BR$BR
241524311$24152431$1$I$$20240716$20240730$20240730$EXP$$MA-GLANDPHARMA-MA-2024GLNLIT00540$GLAND PHARMA$S Nedday.Une toxicite cerebelleuse au metronidazole : a propos d^un cas.Revue Neurologique.APR-2024;180 (Suppl.):S77$17$YR$T$M$Y$$$20240730$$HP$MA$MA
241524321$24152432$1$I$20110301$20240718$20240730$20240730$EXP$$US-OTSUKA-BMS-2017-028477$OTSUKA$$31$YR$$F$Y$$$20240730$$CN$US$US
241524331$24152433$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A166471$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241524341$24152434$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A168134$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241524351$24152435$1$I$$20240722$20240730$20240730$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005429$BIOCON$$$$$$Y$$$20240730$$HP$CA$CA
241524361$24152436$1$I$20240726$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120558$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240730$$CN$US$US
241524371$24152437$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120307$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240730$$CN$US$US
241524382$24152438$2$F$$20240806$20240730$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119880$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240810$$CN$US$US
241524391$24152439$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119828$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240730$$MD$US$US
241524401$24152440$1$I$20220801$20240719$20240730$20240730$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202407012715$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240730$$CN$NL$TW
241524411$24152441$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018799$ELI LILLY AND CO$$16$YR$T$F$Y$$$20240730$$CN$US$US
241524432$24152443$2$F$$20240729$20240730$20240731$30DAY$$US-ELI_LILLY_AND_COMPANY-US202407019247$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240731$$CN$US$US
241524451$24152445$1$I$20240101$20240723$20240730$20240730$EXP$$US-UCBSA-2024013712$UCB$$$$$F$Y$$$20240730$$CN$US$US
241524461$24152446$1$I$$20240715$20240730$20240730$EXP$$PT-TEVA-VS-3223214$TEVA$Literature Reference:  Salgueiro D, Oliveira AR, Pardal N, Mota RV, Matos AS, Guerra D. PO-0318 - (4320) - Anamnesis: The Main Diagnostic Weapon. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts [CNMI].2024 May; 682.$65$YR$$F$Y$$$20240730$$MD$PT$PT
241524471$24152447$1$I$$20240726$20240730$20240730$EXP$$LT-ABBVIE-5856160$ABBVIE$$$$A$F$Y$$$20240730$$MD$LT$LT
241524481$24152448$1$I$$20240723$20240730$20240730$EXP$$US-AMGEN-USASP2024147664$AMGEN$$$$$M$Y$$$20240730$$HP$US$US
241524491$24152449$1$I$$20240723$20240730$20240730$EXP$$TW-GILEAD-2024-0681614$GILEAD$$41$YR$A$F$Y$$$20240730$$HP$TW$TW
241524501$24152450$1$I$$20240718$20240730$20240730$EXP$$AU-Atnahs Limited-ATNAHS20240702086$Atnahs Healthcare$$$$$$Y$$$20240730$$HP$AU$AU
241524511$24152451$1$I$20240727$20240727$20240730$20240730$PER$$US-AMGEN-USASP2024150203$AMGEN$$68$YR$E$F$Y$$$20240730$$CN$US$US
241524521$24152452$1$I$20240724$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148947$AMGEN$$69$YR$E$F$Y$$$20240730$$CN$US$US
241524531$24152453$1$I$$20240723$20240730$20240730$EXP$$CA-JNJFOC-20240770799$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240730$$HP$CA$CA
241524541$24152454$1$I$20240101$20240726$20240730$20240730$EXP$$US-PUMA BIOTECHNOLOGY, INC.-2024-PUM-US000640$PUMA$$$$$$Y$$$20240730$$HP$US$US
241524551$24152455$1$I$$20240716$20240730$20240730$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00537$GLAND PHARMA$S Furukawa.A Case of Consciousness Disorder Due to Hyperammonemia Induced by Modified FOLFOX6 for Multiple Liver Metastasis from Rectal Cancer.Gan to Kagaku Ryoho.MAY-2024;51 No.5:567-570$74$YR$E$M$Y$$$20240730$$HP$JP$JP
241524561$24152456$1$I$20240724$20240725$20240730$20240730$EXP$$US-AMGEN-USASP2024148538$AMGEN$$61$YR$A$F$Y$$$20240730$$PH$US$US
241524572$24152457$2$F$20240101$20240826$20240730$20240903$EXP$$US-ABBVIE-5854844$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
241524581$24152458$1$I$$20240724$20240730$20240730$EXP$$US-ABBVIE-5853553$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241524592$24152459$2$F$$20240726$20240730$20240801$PER$$NVSC2024US155074$NOVARTIS$$$$$M$Y$$$20240801$$HP$US$US
241524601$24152460$1$I$20231201$20240729$20240730$20240730$EXP$DE-CADRBFARM-2024329481$NVSC2024DE154694$NOVARTIS$$79$YR$$M$Y$80$KG$20240730$$CN$DE$DE
241524611$24152461$1$I$$20240718$20240730$20240730$EXP$$AU-Atnahs Limited-ATNAHS20240702115$Atnahs Healthcare$$$$$$Y$$$20240730$$HP$AU$AU
241524621$24152462$1$I$20240701$20240725$20240730$20240730$EXP$$US-ABBVIE-5854727$ABBVIE$$45$YR$$M$Y$$$20240730$$CN$US$US
241524631$24152463$1$I$20240701$20240726$20240730$20240730$EXP$$US-ABBVIE-5856796$ABBVIE$$67$YR$$M$Y$$$20240730$$CN$US$US
241524641$24152464$1$I$$20191111$20240730$20240730$EXP$$PL-REGENERON PHARMACEUTICALS, INC.-2024-103114$REGENERON$Nowosielska A. Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept~.. Case Reports in Ophthalmology. 2019;10(3):369?373$72$YR$$M$Y$$$20240730$$HP$PL$PL
241524651$24152465$1$I$$20240717$20240730$20240730$PER$$US-RDY-LIT/USA/24/0010903$DR REDDYS$Haynes TM, Kukuc L, Proute M, Fishberg R. A PCSK9 and APOB Double Heterozygote Presenting Phenotypically Similar to Homozygous Familial Hypercholesterolemia. Circulation. 2023 Nov;148: doi:10.1161/circ.148.suppl_1.18931.$73$YR$E$F$Y$$$20240730$$HP$US$US
241524682$24152468$2$F$20220701$20240730$20240730$20240802$EXP$$US-ABBVIE-5855744$ABBVIE$$48$YR$$F$Y$103$KG$20240802$$CN$US$US
241524691$24152469$1$I$$20240725$20240730$20240730$EXP$$US-ABBVIE-5856421$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241524701$24152470$1$I$20240101$20240726$20240730$20240730$EXP$$US-ABBVIE-5857041$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241524713$24152471$3$F$20240101$20240813$20240730$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-023315$UNITED THERAPEUTICS$$$$$M$Y$87.528$KG$20240821$$$US$US
241524721$24152472$1$I$$20240716$20240730$20240730$EXP$$US-GLANDPHARMA-US-2024GLNLIT00545$GLAND PHARMA$J Xie.Acute Myeloid Leukemia Secondary to Treatment with Oxaliplatin Combined with Capecitabine for Colorectal Cancer.Clinical Laboratory: Journal for Clinical Laboratories and Laboratories Related to Blood Transfusion.MAR-2024;70 (No.3):622-625$73$YR$E$F$Y$$$20240730$$HP$US$US
241524733$24152473$3$F$20240101$20240827$20240730$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022559$UNITED THERAPEUTICS$$$$$M$Y$113.38$KG$20240905$$$US$US
241524741$24152474$1$I$20240724$20240724$20240730$20240730$EXP$$US-JNJFOC-20240765386$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240730$$HP$US$US
241524753$24152475$3$F$$20240902$20240730$20240905$30DAY$$AU-JNJFOC-20240752680$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$PH$AU$AU
241524761$24152476$1$I$20240603$20240715$20240730$20240730$EXP$$US-COSETTE-CP2024US000181$COSETTE PHARMACEUTICALS$$36$YR$$F$Y$61.23$KG$20240730$$HP$US$US
241524771$24152477$1$I$20040213$20240716$20240730$20240730$EXP$$US-009507513-0405USA00949$MERCK$$$$$M$Y$71$KG$20240730$$HP$US$US
241524781$24152478$1$I$20231201$20240722$20240730$20240730$EXP$FR-AFSSAPS-TS2024000805$FR-TEVA-VS-3225080$TEVA$$7$YR$$M$Y$$$20240730$$MD$FR$FR
241524791$24152479$1$I$20240606$20240729$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120208$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$55.34$KG$20240730$$HP$US$US
241524801$24152480$1$I$20220617$20240723$20240730$20240730$EXP$$JP-ARGENX-2022-ARGX-JP002841$ARGENX BVBA$$$$$$Y$$$20240730$$CN$JP$JP
241524811$24152481$1$I$$20231124$20240730$20240730$EXP$$CA-CELLTRION INC.-2022CA022654$CELLTRION$$$$$$Y$$$20240730$$CN$CA$CA
241524821$24152482$1$I$$20240725$20240730$20240730$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137928$DAIICHI$$75$YR$$F$Y$$$20240730$$CN$US$US
241524831$24152483$1$I$$20240716$20240730$20240730$EXP$$TR-GLANDPHARMA-TR-2024GLNLIT00539$GLAND PHARMA$Ali Osman Saatci.Endogenous Endophthalmitis Caused by Aspergillus lentulus in an  Immunocompromised Patient with Lung Cancer.Turkish Journal of Ophthalmology.2024;54(3):175-179$78$YR$E$M$Y$$$20240730$$HP$TR$TR
241524841$24152484$1$I$$20240726$20240730$20240730$EXP$$JP-AMGEN-JPNSP2024150003$AMGEN$Karakawa S.; Shimomura M.; Tanaka M. et al.. A Pediatric Case of B Cell Precursor ALL With Blinatumomab-associated Encephalopathy. Journal of Pediatric Hematology/Oncology. 2024;1-6$14$YR$T$M$Y$$$20240730$$MD$JP$JP
241524871$24152487$1$I$$20240723$20240730$20240730$EXP$$US-SA-2024SA219416$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
241524881$24152488$1$I$20240714$20240715$20240730$20240730$PER$$US-COSETTE-CP2024US000182$COSETTE PHARMACEUTICALS$$53$YR$A$F$Y$$$20240730$$HP$US$US
241524891$24152489$1$I$$20240727$20240730$20240730$EXP$$US-INCYTE CORPORATION-2024IN007876$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241524902$24152490$2$F$20240101$20240724$20240730$20240731$EXP$$US-SA-2024SA219845$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240731$$MD$US$US
241524913$24152491$3$F$20240727$20240812$20240730$20240814$PER$$US-AMGEN-USASP2024150944$AMGEN$$73$YR$E$F$Y$$$20240814$$CN$US$US
241524921$24152492$1$I$$20240722$20240730$20240730$EXP$$US-AMGEN-USASP2024146832$AMGEN$Li X.; Fung B.; Kumar R.. Successful Treatment of Rituximab-Induced Crohn^s Disease with Ustekinumab. ACG Case Reports Journal. 2024;11 (7):1-3$51$YR$A$M$Y$$$20240730$$MD$US$US
241524932$24152493$2$F$$20240801$20240730$20240810$EXP$$DE-TEVA-VS-3224107$TEVA$Hans FP, Benning L, Pooth J-S, Busch H-J. A potentially lifesaving error: unintentional high-dose adrenaline administration in anaphylaxis-induced cardiac arrest; a case report. Int-J-Emerg-Med 2024; 17 (1):.; Hans FP, Benning L, Pooth J-S, Busch H-J. A potentially lifesaving error: unintentional high-dose adrenaline administration in anaphylaxis-induced cardiac arrest; a case report. Int-J-Emerg-Med 2024; 17 (1):.$66$YR$$F$Y$$$20240810$$HP$DE$DE
241524962$24152496$2$F$$20240918$20240730$20240918$EXP$$US-PFIZER INC-202400221477$PFIZER$$8$YR$$M$Y$$$20240918$$CN$US$US
241524972$24152497$2$F$$20240829$20240730$20240829$30DAY$$US-PFIZER INC-202400220016$PFIZER$$9$YR$$F$Y$$$20240829$$CN$US$US
241524981$24152498$1$I$$20240726$20240730$20240730$EXP$$PT-PFIZER INC-202400224404$PFIZER$Costa, A.. PO-0184 - (2479) - HEMOPHAGOCYTIC SYNDROME - WHEN SHOULD THIS ENTITY BE CONSIDERED? ABOUT A CLINICAL CASE. 30th National Congress of Internal Medicine (CNMI). 2024;552$50$YR$$F$Y$$$20240730$$MD$PT$PT
241524991$24152499$1$I$$20240725$20240730$20240730$EXP$$US-INCYTE CORPORATION-2024IN007828$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241525001$24152500$1$I$20230101$20240724$20240730$20240730$EXP$$US-SA-2023SA108993$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240730$$MD$US$US
241525011$24152501$1$I$$20240716$20240730$20240730$EXP$$US-GLANDPHARMA-US-2024GLNLIT00514$GLAND PHARMA$Janet Fan.Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers.Case Reports in Oncology.28-MAR-2024;17(1):517-523$56$YR$A$M$Y$$$20240730$$HP$US$US
241525021$24152502$1$I$$20240724$20240730$20240730$EXP$$CA-TAKEDA-2024TUS076075$TAKEDA$$$$$F$Y$$$20240730$$CN$CA$CA
241525031$24152503$1$I$$20240725$20240730$20240730$EXP$$CA-SA-2024SA218012$SANOFI AVENTIS$UNK. UNK. UNK. UNK;UNK:UNK$85$YR$E$F$Y$$$20240730$$HP$CA$CA
241525041$24152504$1$I$20240710$20240725$20240730$20240730$EXP$HR-HALMED-300086200$HR-TAKEDA-2024TUS075377$TAKEDA$$61$YR$$M$Y$$$20240730$$HP$HR$HR
241525051$24152505$1$I$$20240725$20240730$20240730$EXP$$US-SA-2024SA221132$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240730$$MD$US$US
241525061$24152506$1$I$20230626$20240720$20240730$20240730$EXP$$IN-INCYTE CORPORATION-2024IN007766$INCYTE$$$$$$Y$$$20240730$$CN$IN$IN
241525071$24152507$1$I$20240725$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149691$AMGEN$$59$YR$A$F$Y$$$20240730$$CN$US$US
241525081$24152508$1$I$$20240716$20240730$20240730$EXP$$IT-GLANDPHARMA-IT-2024GLNLIT00538$GLAND PHARMA$Elisabetta Schiavello.Ultra Short Course Chemotherapy for Early-Stage Non-Hodgkin^s Lymphoma in Children.Children.JAN-2022;9 No.9:1-10$$$$$Y$$$20240730$$HP$IT$IT
241525091$24152509$1$I$20240612$20240715$20240730$20240730$PER$$US-COSETTE-CP2024US000183$COSETTE PHARMACEUTICALS$$37$YR$A$F$Y$125$KG$20240730$$CN$US$US
241525101$24152510$1$I$$20240725$20240730$20240730$EXP$$CA-SA-2024SA218091$SANOFI AVENTIS$Unknown. Unknown. Unknown. unk;unk:unk$88$YR$E$M$Y$$$20240730$$HP$CA$CA
241525111$24152511$1$I$20240717$20240723$20240730$20240730$EXP$$CA-GSK-CA2024092805$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$CA$CA
241525121$24152512$1$I$$20240723$20240730$20240730$EXP$$CA-GSK-CA2024092337$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$CA$CA
241525131$24152513$1$I$20240718$20240725$20240730$20240730$EXP$$US-SA-2024SA221148$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240730$$MD$US$US
241525141$24152514$1$I$$20240725$20240730$20240730$EXP$$CA-SA-2024SA217959$SANOFI AVENTIS$unknown. unknown. unknown. unkn;unknown:unknown$73$YR$E$F$Y$$$20240730$$HP$CA$CA
241525161$24152516$1$I$$20240725$20240730$20240730$EXP$$US-AMGEN-USASP2024148741$AMGEN$$$$$M$Y$$$20240730$$CN$US$US
241525172$24152517$2$F$$20240730$20240730$20240802$PER$$US-AMGEN-USASP2024150620$AMGEN$$80$YR$E$M$Y$$$20240802$$CN$US$US
241525181$24152518$1$I$$20240724$20240730$20240730$PER$$US-JNJFOC-20240764739$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$PH$US$US
241525191$24152519$1$I$$20240716$20240730$20240730$EXP$$BR-JNJFOC-20240776465$JOHNSON AND JOHNSON$$13$YR$T$F$Y$63$KG$20240730$$PH$BR$BR
241525201$24152520$1$I$$20240718$20240730$20240730$EXP$$JP-TRIGEN LABORATORIES-2024ALO00344$Unknown Manufacturer$Nagaoka M, Murata T, Nagamine T, et al. Methylphenidate-Associated Creatine Kinase Level Elevation. American Journal of Therapeutics. 2024;31:4$25$YR$$M$Y$$$20240730$$HP$JP$JP
241525211$24152521$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120300$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240730$$CN$US$US
241525221$24152522$1$I$20240722$20240722$20240730$20240730$DIR$FDA-CDER-CTU-2024-52180$$FDA-CTU$$73$YR$$M$N$68.6$KG$20240722$N$$US$
241525231$24152523$1$I$20220701$20240717$20240730$20240730$EXP$$TW-MEDEXUS PHARMA, INC.-2024MED00321$MEDEXUS PHARMA$Hsieh C.-Y, Yu S.-C, Lee J.-A, Tsai T.-F. Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosed in a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Association?. Indian J. Dermatol. 2024;69(3):264-267$66$YR$$M$Y$$$20240730$$HP$TW$TW
241525241$24152524$1$I$$20240723$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007755$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241525251$24152525$1$I$$20240717$20240730$20240730$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00627$Phathom Pharmaceuticals$$$$$$Y$$$20240730$$MD$JP$JP
241525262$24152526$2$F$$20240829$20240730$20240829$30DAY$$US-PFIZER INC-202400219950$PFIZER$$6$YR$$F$Y$16.78$KG$20240829$$CN$US$US
241525281$24152528$1$I$$20240718$20240730$20240730$PER$$US-PHARMING-PHAUS2024000613$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
241525292$24152529$2$F$$20240913$20240730$20240918$EXP$$US-PHARMING-PHAUS2024000616$PHARMING GROUP$$$$$$Y$$$20240918$$CN$US$US
241525301$24152530$1$I$$20240722$20240730$20240730$PER$$US-PHARMING-PHAUS2024000620$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
241525311$24152531$1$I$$20240718$20240730$20240730$EXP$$US-PHARMING-PHAUS2024000614$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
241525321$24152532$1$I$$20240724$20240730$20240730$PER$$US-PHARMING-PHAUS2024000626$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
241525331$24152533$1$I$$20240724$20240730$20240730$PER$$US-PHARMING-PHAUS2024000633$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
241525351$24152535$1$I$$20240722$20240730$20240730$PER$$US-PHARMING-PHAUS2024000618$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
241525361$24152536$1$I$20240101$20240724$20240730$20240730$EXP$$US-ABBVIE-5853464$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241525371$24152537$1$I$20240729$20240729$20240730$20240730$PER$$US-HALEON-2189519$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241525381$24152538$1$I$$20240725$20240730$20240730$PER$$US-PHARMING-PHAUS2024000636$PHARMING GROUP$$$$$$Y$$$20240730$$CN$US$US
241525391$24152539$1$I$$20240723$20240730$20240730$EXP$$NVSC2024DE153716$NOVARTIS$$$$$F$Y$$$20240730$$MD$DE$DE
241525402$24152540$2$F$20240101$20240912$20240730$20240927$EXP$$US-TILDE SCIENCES LLC-2024TIL00014$Tilde Sciences$$$$$M$Y$136.8$KG$20240927$$PH$US$US
241525411$24152541$1$I$$20240723$20240730$20240730$EXP$$GB-009507513-2407GBR013997$MERCK$Naing S.. Immunotherapy related acute kidney injury. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24(Supplement)$46$YR$$M$Y$$$20240730$$HP$GB$GB
241525421$24152542$1$I$$20240716$20240730$20240730$EXP$$IT-GLANDPHARMA-IT-2024GLNLIT00560$GLAND PHARMA$S Samperi.A STRANGE CASE OF CARDIOTOXICITY FROM ANTIBLASTIC TREATMENT: A HIGH PRICE TO PAY.European Heart Journal.APR-2024;26 (Suppl.):ii178-ii179$58$YR$A$F$Y$$$20240730$$HP$IT$IT
241525431$24152543$1$I$20240723$20240723$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007748$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241525441$24152544$1$I$$20240716$20240730$20240730$EXP$$AU-TEVA-VS-3223638$TEVA$$20$YR$$F$Y$$$20240730$$HP$AU$AU
241525451$24152545$1$I$$20240716$20240730$20240730$EXP$$AU-TEVA-VS-3222477$TEVA$$58$YR$$M$Y$$$20240730$$HP$AU$AU
241525462$24152546$2$F$20240101$20240728$20240730$20240801$EXP$$IL-ABBVIE-5853597$ABBVIE$$$$$M$Y$$$20240801$$CN$IL$IL
241525471$24152547$1$I$$20240716$20240730$20240730$EXP$$AU-TEVA-VS-3223763$TEVA$$$$$F$Y$$$20240730$$HP$AU$AU
241525481$24152548$1$I$$20240718$20240730$20240730$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01193$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240730$$HP$US$US
241525491$24152549$1$I$$20240718$20240730$20240730$EXP$$GB-TEVA-VS-3223585$TEVA$$$$$F$Y$$$20240730$$CN$GB$GB
241525502$24152550$2$F$20240726$20240730$20240730$20240801$PER$$US-AMGEN-USASP2024150859$AMGEN$$49$YR$A$F$Y$$$20240731$$CN$US$US
241525511$24152551$1$I$20240701$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149422$AMGEN$$$$$M$Y$$$20240730$$CN$US$US
241525521$24152552$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3224848$TEVA$$72$YR$$F$Y$$$20240730$$HP$CA$CA
241525531$24152553$1$I$$20240723$20240730$20240730$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06609$VIFOR$$$$A$M$Y$$$20240730$$HP$ZA$ZA
241525543$24152554$3$F$$20240820$20240730$20240829$PER$$US-INCYTE CORPORATION-2024IN007739$INCYTE$$$$$$Y$$$20240829$$CN$US$US
241525551$24152555$1$I$20240715$20240722$20240730$20240730$DIR$FDA-CDER-CTU-2024-52163$$FDA-CTU$$69$YR$$F$N$89.1$KG$20240722$N$$US$
241525561$24152556$1$I$20240729$20240729$20240729$20240729$DIR$711991$$FDA-CTU$$51$YR$$M$N$$$20240729$N$$US$
241525571$24152557$1$I$20140211$20240729$20240729$20240729$DIR$711994$$FDA-CTU$$49$YR$$F$N$73.35$KG$20240729$N$CN$US$
241525581$24152558$1$I$20240715$20240722$20240730$20240730$DIR$FDA-CDER-CTU-2024-52121$$FDA-CTU$$$$$M$N$28.4$KG$20240722$N$$US$
241525611$24152561$1$I$20220101$20240725$20240730$20240730$EXP$$FR-TAKEDA-2024TUS075894$TAKEDA$$30$YR$$F$Y$$$20240730$$HP$FR$FR
241525621$24152562$1$I$$20240726$20240730$20240730$EXP$$NVSC2024US154745$NOVARTIS$$$$$M$Y$$$20240730$$CN$US$US
241525631$24152563$1$I$$20240726$20240730$20240730$EXP$$NVSC2024CA154885$NOVARTIS$$$$$$Y$$$20240730$$CN$CA$CA
241525641$24152564$1$I$$20240716$20240730$20240730$EXP$$GR-GLANDPHARMA-GR-2024GLNLIT00555$GLAND PHARMA$E Karmiris.An Atypical Case of Severe Toxicity, Anterior Chamber Inflammation, and Transient Subretinal Fluid Formation Induced by the Subconjunctival Injection of 5-FU.Ocular Immunology and Inflammation.JAN-2024$40$YR$A$M$Y$$$20240730$$HP$GR$GR
241525651$24152565$1$I$20240726$20240729$20240729$20240729$DIR$712010$$FDA-CTU$$61$YR$$F$N$66.6$KG$20240729$N$CN$US$
241525662$24152566$2$F$$20240723$20240730$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117625$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240801$$HP$US$US
241525681$24152568$1$I$20240301$20240726$20240730$20240730$EXP$$US-ABBVIE-5856896$ABBVIE$$53$YR$$F$Y$$$20240730$$CN$US$US
241525691$24152569$1$I$$20240723$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007736$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241525701$24152570$1$I$20240625$20240626$20240730$20240730$DIR$FDA-CDER-CTU-2024-52126$$FDA-CTU$$$$$M$N$75.9$KG$20240626$N$$US$
241525721$24152572$1$I$20240709$20240709$20240730$20240730$PER$$US-TOLMAR, INC.-24US050895$TOLMAR$$13$YR$$F$Y$$$20240729$$HP$US$US
241525732$24152573$2$F$20240709$20240822$20240730$20240911$PER$$US-TOLMAR, INC.-24US050924$TOLMAR$$56$YR$$M$Y$$$20240911$$PH$US$US
241525741$24152574$1$I$20240627$20240709$20240730$20240730$PER$$US-TOLMAR, INC.-24US050884$TOLMAR$$34$YR$$F$Y$$$20240729$$PH$US$US
241525751$24152575$1$I$20240708$20240709$20240730$20240730$PER$$US-TOLMAR, INC.-24US050875$TOLMAR$$53$YR$$F$Y$$$20240726$$HP$US$US
241525762$24152576$2$F$20231201$20240827$20240730$20240913$PER$$CO-TOLMAR, INC.-21CO030767$TOLMAR$$83$YR$$M$Y$$$20240913$$CN$CO$CO
241525771$24152577$1$I$$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024148086$AMGEN$$$$$F$Y$$$20240730$$HP$US$US
241525791$24152579$1$I$$20240723$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007733$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241525805$24152580$5$F$$20240829$20240730$20240904$EXP$$CA-AstraZeneca-2024A171751$ASTRAZENECA$$$$$M$Y$$$20240904$$MD$CA$
241525811$24152581$1$I$$20240722$20240730$20240730$EXP$$BR-AstraZeneca-2024A171132$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$BR$
241525831$24152583$1$I$$20240722$20240730$20240730$EXP$$ES-AstraZeneca-2024A167763$ASTRAZENECA$$84$YR$$M$Y$$$20240730$$MD$ES$
241525841$24152584$1$I$$20240725$20240730$20240730$EXP$$ZA-AstraZeneca-2024A170055$ASTRAZENECA$$71$YR$$M$Y$$$20240730$$CN$ZA$
241525851$24152585$1$I$$20240724$20240730$20240730$PER$$US-ROCHE-10000036504$ROCHE$$$$A$F$Y$$$20240730$$CN$US$US
241525861$24152586$1$I$20240525$20240603$20240730$20240730$PER$$US-LUNDBECK-DKLU4000161$LUNDBECK$$$$$$Y$$$20240730$$CN$US$US
241525871$24152587$1$I$20240711$20240725$20240730$20240730$EXP$$CA-ABBVIE-5856535$ABBVIE$$63$YR$$M$Y$$$20240730$$CN$CA$CA
241525882$24152588$2$F$20240511$20240823$20240730$20240904$PER$$US-INCYTE CORPORATION-2024IN007690$INCYTE$$$$$$Y$$$20240904$$CN$US$US
241525891$24152589$1$I$$20240716$20240730$20240730$EXP$$PL-GLANDPHARMA-PL-2024GLNLIT00559$GLAND PHARMA$Sylwia Slawek Szmyt.Intracranial hemorrhage in a patient with pulmonary embolism: how to overcome 2 problems?.Polskie Archiwum Medycyny Wewnetrznej.07-FEB-2023;133(3):16422 (1-3)$69$YR$E$M$Y$$$20240730$$MD$PL$PL
241525913$24152591$3$F$20240721$20240904$20240730$20240911$EXP$$BR-GSK-BR2024AMR036340$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$BR$BR
241525922$24152592$2$F$20240701$20240729$20240730$20240803$EXP$$US-ABBVIE-5856618$ABBVIE$$55$YR$$F$Y$$$20240803$$CN$US$US
241525931$24152593$1$I$$20240725$20240730$20240730$PER$$US-ROCHE-3548804$ROCHE$$48$YR$A$F$Y$$$20240730$$CN$US$US
241525941$24152594$1$I$$20240724$20240730$20240730$PER$$US-ABBVIE-5859038$ABBVIE$$$$A$F$Y$$$20240730$$MD$US$US
241525951$24152595$1$I$$20240725$20240730$20240730$EXP$$BG-ABBVIE-5856176$ABBVIE$$29$YR$$M$Y$$$20240730$$CN$BG$BG
241525962$24152596$2$F$$20240906$20240730$20240911$EXP$$US-AstraZeneca-2024A166816$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
241525971$24152597$1$I$20230101$20240722$20240730$20240730$EXP$$TW-AstraZeneca-2024A168185$ASTRAZENECA$$67$YR$$M$Y$$$20240730$$HP$TW$
241525981$24152598$1$I$20230101$20240724$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118422$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240730$$CN$US$US
241525991$24152599$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120572$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240730$$CN$US$US
241526011$24152601$1$I$20240701$20240729$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119976$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240730$$CN$US$US
241526022$24152602$2$F$$20240809$20240730$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119699$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240816$$CN$US$US
241526031$24152603$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119840$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240730$$CN$US$US
241526042$24152604$2$F$$20240820$20240730$20240821$PER$$NVSC2024US155490$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
241526051$24152605$1$I$$20240726$20240730$20240730$EXP$$US-ABBVIE-5856678$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241526061$24152606$1$I$20240503$20240729$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119990$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240730$$CN$US$US
241526072$24152607$2$F$$20240820$20240730$20240820$EXP$$US-ALXN-202407USA001665US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
241526081$24152608$1$I$$20240724$20240730$20240730$EXP$$US-ABBVIE-5853882$ABBVIE$$50$YR$$F$Y$$$20240730$$MD$US$US
241526091$24152609$1$I$$20240719$20240730$20240730$EXP$$US-ABBVIE-5846082$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241526101$24152610$1$I$$20240711$20240730$20240730$EXP$$DE-ACRAF SpA-2024-035192$SK LIFE SCIENCE$$$$$$Y$$$20240730$$HP$DE$DE
241526111$24152611$1$I$$20240711$20240730$20240730$EXP$$DE-ACRAF SpA-2024-035189$SK LIFE SCIENCE$$$$$$Y$$$20240730$$HP$DE$DE
241526121$24152612$1$I$$20240711$20240730$20240730$EXP$$DE-ACRAF SpA-2024-035193$SK LIFE SCIENCE$$$$$$Y$$$20240730$$HP$DE$DE
241526131$24152613$1$I$20240101$20240725$20240730$20240730$PER$$US-ORGANON-O2407USA001571$ORGANON$$$$$F$Y$121.54$KG$20240730$$HP$US$US
241526141$24152614$1$I$$20240729$20240730$20240730$PER$$US-ROCHE-10000041838$ROCHE$$$$$$Y$$$20240730$$PH$US$US
241526161$24152616$1$I$$20240716$20240730$20240730$PER$$US-COSETTE-CP2024US000187$COSETTE PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241526173$24152617$3$F$20230101$20240904$20240730$20240910$PER$$US-ABBVIE-5858181$ABBVIE$$$$$F$Y$86$KG$20240910$$CN$US$US
241526181$24152618$1$I$20240730$20240730$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042723$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240730$$CN$US$US
241526191$24152619$1$I$20240701$20240728$20240730$20240730$EXP$$SA-ABBVIE-5858972$ABBVIE$$80$YR$$F$Y$$$20240730$$CN$SA$SA
241526202$24152620$2$F$$20240722$20240730$20240731$EXP$$NVSC2024DE154997$NOVARTIS$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD OPEN. 2024;10(3):e004381$$$$M$Y$$$20240731$$HP$DE$DE
241526231$24152623$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA216728$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240730$$MD$US$US
241526241$24152624$1$I$20240101$20240718$20240730$20240730$PER$$US-SA-2024SA215124$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240730$$PH$US$US
241526251$24152625$1$I$$20240718$20240730$20240730$PER$$US-SA-2024SA214908$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240730$$MD$US$US
241526261$24152626$1$I$$20240718$20240730$20240730$PER$$US-SA-2024SA215143$SANOFI AVENTIS$$$$$$Y$$$20240730$$CN$US$US
241526271$24152627$1$I$$20240718$20240730$20240730$PER$$US-SA-2024SA216688$SANOFI AVENTIS$$55$YR$A$M$Y$101$KG$20240730$$MD$US$US
241526281$24152628$1$I$$20240718$20240730$20240730$PER$$US-SA-2024SA214928$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240730$$MD$US$US
241526291$24152629$1$I$$20240718$20240730$20240730$PER$$US-SA-2024SA216497$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240730$$MD$US$US
241526312$24152631$2$F$20240101$20240819$20240730$20240828$PER$$US-SA-2024SA219715$SANOFI AVENTIS$$56$YR$A$F$Y$80$KG$20240828$$MD$US$US
241526323$24152632$3$F$$20240909$20240730$20240918$PER$$US-SA-2024SA221197$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$MD$US$US
241526331$24152633$1$I$$20240718$20240730$20240730$PER$$US-SA-2024SA216699$SANOFI AVENTIS$$$$C$M$Y$$$20240730$$MD$US$US
241526341$24152634$1$I$20240718$20240718$20240730$20240730$PER$$US-SA-2024SA162852$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240730$$HP$US$US
241526351$24152635$1$I$20240101$20240718$20240730$20240730$PER$$US-SA-2024SA214741$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240730$$MD$US$US
241526361$24152636$1$I$20240101$20240718$20240730$20240730$PER$$US-SA-2024SA214855$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240730$$CN$US$US
241526371$24152637$1$I$20240701$20240718$20240730$20240730$PER$$US-SA-2024SA217426$SANOFI AVENTIS$$$$A$F$Y$63.95$KG$20240730$$MD$US$US
241526381$24152638$1$I$20240101$20240718$20240730$20240730$PER$$US-SA-2024SA214791$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240730$$MD$US$US
241526391$24152639$1$I$20240101$20240718$20240730$20240730$PER$$US-SA-2024SA216704$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240730$$MD$US$US
241526401$24152640$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA218434$SANOFI AVENTIS$$$$E$M$Y$91$KG$20240730$$MD$US$US
241526411$24152641$1$I$20240707$20240719$20240730$20240730$PER$$US-SA-2024SA217906$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240730$$MD$US$US
241526421$24152642$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA213513$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240730$$CN$US$US
241526431$24152643$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA217929$SANOFI AVENTIS$$$$E$F$Y$92.9$KG$20240730$$MD$US$US
241526441$24152644$1$I$20240701$20240719$20240730$20240730$PER$$US-SA-2024SA216811$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240730$$MD$US$US
241526451$24152645$1$I$20240714$20240718$20240730$20240730$PER$$US-SA-2024SA216693$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240730$$MD$US$US
241526461$24152646$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA219223$SANOFI AVENTIS$$$$A$F$Y$$$20240730$$MD$US$US
241526471$24152647$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA219800$SANOFI AVENTIS$$$$A$M$Y$83$KG$20240730$$MD$US$US
241526481$24152648$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA214725$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240730$$MD$US$US
241526492$24152649$2$F$20240101$20240819$20240730$20240830$PER$$US-SA-2024SA218016$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240830$$MD$US$US
241526501$24152650$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA217674$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240730$$MD$US$US
241526515$24152651$5$F$20240720$20240913$20240730$20240921$EXP$$CA-CELLTRION INC.-2024CA018048$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
241526522$24152652$2$F$20240101$20240904$20240730$20240930$PER$$US-SA-2024SA218052$SANOFI AVENTIS$$88$YR$E$F$Y$82$KG$20240930$$MD$US$US
241526531$24152653$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA217885$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240730$$CN$US$US
241526541$24152654$1$I$20240709$20240719$20240730$20240730$PER$$US-SA-2024SA108429$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240730$$MD$US$US
241526551$24152655$1$I$20240614$20240719$20240730$20240730$PER$$US-SA-2024SA215426$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240730$$MD$US$US
241526561$24152656$1$I$20240101$20240719$20240730$20240730$PER$$US-SA-2024SA216729$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240730$$MD$US$US
241526571$24152657$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA217700$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240730$$MD$US$US
241526581$24152658$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA219795$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
241526591$24152659$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA217999$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240730$$MD$US$US
241526601$24152660$1$I$20240701$20240719$20240730$20240730$PER$$US-SA-2024SA144082$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240730$$MD$US$US
241526621$24152662$1$I$$20240717$20240730$20240730$EXP$$US-RDY-LIT/USA/24/0010854$DR REDDYS$Sharayah S, Agner SC, Shinawi M, Rudnick D, Mar S. Neurological Improvement in a Patient with Cerebroretinal Microangiopathy with Calcifications and Cysts-1 Treated with Bevacizumab. Annals of Child Neurology. 2023 Jan 01;31(1): 52-55. doi:10.26815/acn.2022.00248.$16$YR$T$M$Y$$$20240730$$MD$US$US
241526631$24152663$1$I$20240518$20240729$20240729$20240729$DIR$711977$$FDA-CTU$$54$YR$$M$N$79$KG$20240729$N$HP$US$
241526641$24152664$1$I$20240727$20240729$20240729$20240729$DIR$711988$$FDA-CTU$$60$YR$$F$N$77.4$KG$20240729$Y$CN$US$
241526651$24152665$1$I$20240418$20240729$20240729$20240729$DIR$712029$$FDA-CTU$$27$YR$$M$N$99$KG$20240729$N$CN$US$
241526661$24152666$1$I$$20240715$20240730$20240730$EXP$$AT-TEVA-VS-3222571$TEVA$$47$YR$$F$Y$$$20240730$$MD$AT$AT
241526672$24152667$2$F$20240101$20240724$20240730$20240802$PER$$US-SA-2024SA216872$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240802$$CN$US$US
241526681$24152668$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA218976$SANOFI AVENTIS$$$$E$M$Y$$$20240730$$MD$US$US
241526691$24152669$1$I$20240101$20240719$20240730$20240730$PER$$US-SA-2024SA218084$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240730$$MD$US$US
241526701$24152670$1$I$20240601$20240719$20240730$20240730$PER$$US-SA-2024SA216158$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240730$$CN$US$US
241526711$24152671$1$I$20240101$20240719$20240730$20240730$PER$$US-SA-2024SA216427$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240730$$MD$US$US
241526721$24152672$1$I$20240101$20240719$20240730$20240730$PER$$US-SA-2024SA168705$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240730$$MD$US$US
241526731$24152673$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA217052$SANOFI AVENTIS$$$$A$M$Y$104$KG$20240730$$MD$US$US
241526741$24152674$1$I$20240701$20240719$20240730$20240730$PER$$US-SA-2024SA219350$SANOFI AVENTIS$$45$YR$A$M$Y$129.25$KG$20240730$$MD$US$US
241526751$24152675$1$I$20240701$20240719$20240730$20240730$PER$$US-SA-2024SA216724$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240730$$CN$US$US
241526762$24152676$2$F$$20240917$20240730$20240925$PER$$US-SA-2024SA216801$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240925$$MD$US$US
241526781$24152678$1$I$20240719$20240719$20240730$20240730$PER$$US-SA-2024SA216781$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240730$$PH$US$US
241526791$24152679$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA216607$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
241526802$24152680$2$F$20240101$20240906$20240730$20240918$PER$$US-SA-2024SA221011$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240918$$MD$US$US
241526821$24152682$1$I$20240101$20240719$20240730$20240730$PER$$US-SA-2024SA204244$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240730$$MD$US$US
241526831$24152683$1$I$20240101$20240719$20240730$20240730$PER$$US-SA-2024SA215827$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240730$$MD$US$US
241526841$24152684$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA217770$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240730$$MD$US$US
241526852$24152685$2$F$20240101$20240726$20240730$20240808$PER$$US-SA-2024SA216980$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240808$$MD$US$US
241526861$24152686$1$I$20231101$20240723$20240730$20240730$PER$$US-SA-2024SA221358$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240730$$MD$US$US
241526872$24152687$2$F$20240101$20240814$20240730$20240828$PER$$US-SA-2024SA218007$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240828$$MD$US$US
241526881$24152688$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218027$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240730$$MD$US$US
241526891$24152689$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218178$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240730$$MD$US$US
241526901$24152690$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA218293$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240730$$MD$US$US
241526921$24152692$1$I$20240614$20240729$20240729$20240729$DIR$711996$$FDA-CTU$$39$YR$$F$N$90.2$KG$20240729$N$PH$US$
241526931$24152693$1$I$20220601$20240719$20240730$20240730$PER$$US-SA-2024SA217406$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240730$$MD$US$US
241526941$24152694$1$I$20240228$20240729$20240729$20240729$DIR$712020$$FDA-CTU$$65$YR$$F$N$$$20240729$N$CN$US$
241526951$24152695$1$I$20240723$20240724$20240730$20240730$PER$$US-SA-2024SA221146$SANOFI AVENTIS$$22$YR$A$F$Y$76$KG$20240730$$MD$US$US
241526971$24152697$1$I$20240622$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52130$$FDA-CTU$$$$$F$N$64.3$KG$20240729$N$$US$
241526981$24152698$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA219168$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240730$$CN$US$US
241526991$24152699$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA216832$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240730$$MD$US$US
241527001$24152700$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218800$SANOFI AVENTIS$$$$A$F$Y$$$20240730$$MD$US$US
241527011$24152701$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA218187$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240730$$MD$US$US
241527031$24152703$1$I$20240601$20240719$20240730$20240730$PER$$US-SA-2024SA216634$SANOFI AVENTIS$$$$A$F$Y$$$20240730$$MD$US$US
241527041$24152704$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA217983$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240730$$MD$US$US
241527051$24152705$1$I$20240101$20240719$20240730$20240730$PER$$US-SA-2024SA216769$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240730$$MD$US$US
241527061$24152706$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218332$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240730$$MD$US$US
241527071$24152707$1$I$$20240723$20240730$20240730$EXP$$JP-Eisai-EC-2024-170932$EISAI$$$$$F$Y$$$20240730$$MD$JP$JP
241527081$24152708$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA219377$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240730$$MD$US$US
241527091$24152709$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221606$SANOFI AVENTIS$$$$C$M$Y$$$20240730$$MD$US$US
241527101$24152710$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA221185$SANOFI AVENTIS$$$$E$F$Y$$$20240730$$MD$US$US
241527111$24152711$1$I$20240101$20240723$20240730$20240730$PER$$US-SA-2024SA219155$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240730$$MD$US$US
241527121$24152712$1$I$$20240726$20240730$20240730$EXP$$US-ABBVIE-5856867$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241527131$24152713$1$I$$20240724$20240730$20240730$EXP$$JP-AMGEN-JPNSP2024148079$AMGEN$$$$$$Y$$$20240730$$PH$JP$JP
241527141$24152714$1$I$$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024148574$AMGEN$$$$A$$Y$$$20240730$$CN$US$US
241527151$24152715$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149046$AMGEN$$$$A$$Y$$$20240730$$CN$US$US
241527161$24152716$1$I$20240726$20240729$20240730$20240730$PER$$US-AMGEN-USASP2024150563$AMGEN$$78$YR$E$M$Y$$$20240730$$CN$US$US
241527171$24152717$1$I$20240601$20240723$20240730$20240730$PER$$US-SA-2024SA219149$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240730$$MD$US$US
241527181$24152718$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA217867$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240730$$MD$US$US
241527191$24152719$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219104$SANOFI AVENTIS$$$$$M$Y$$$20240730$$CN$US$US
241527201$24152720$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217198$SANOFI AVENTIS$$15$YR$T$F$Y$54$KG$20240730$$MD$US$US
241527211$24152721$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA014734$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240730$$MD$US$US
241527221$24152722$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA221568$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240730$$MD$US$US
241527231$24152723$1$I$20240101$20240723$20240730$20240730$PER$$US-SA-2024SA219806$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240730$$CN$US$US
241527241$24152724$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA219164$SANOFI AVENTIS$$$$A$F$Y$58.96$KG$20240730$$MD$US$US
241527251$24152725$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218543$SANOFI AVENTIS$$27$YR$A$M$Y$108$KG$20240730$$MD$US$US
241527261$24152726$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221420$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240730$$MD$US$US
241527271$24152727$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA221361$SANOFI AVENTIS$$$$T$F$Y$68$KG$20240730$$MD$US$US
241527281$24152728$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221514$SANOFI AVENTIS$$$$C$M$Y$$$20240730$$MD$US$US
241527291$24152729$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218955$SANOFI AVENTIS$$$$E$F$Y$$$20240730$$MD$US$US
241527301$24152730$1$I$20240701$20240724$20240730$20240730$PER$$US-SA-2024SA221601$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240730$$MD$US$US
241527311$24152731$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221232$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240730$$MD$US$US
241527321$24152732$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA217762$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240730$$MD$US$US
241527331$24152733$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA219351$SANOFI AVENTIS$$$$$$Y$$$20240730$$CN$US$US
241527341$24152734$1$I$20240708$20240723$20240730$20240730$PER$$US-SA-2024SA217290$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240730$$MD$US$US
241527351$24152735$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA218045$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240730$$MD$US$US
241527361$24152736$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA220559$SANOFI AVENTIS$$$$$M$Y$$$20240730$$MD$US$US
241527381$24152738$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217776$SANOFI AVENTIS$$$$E$F$Y$$$20240730$$MD$US$US
241527391$24152739$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA219438$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240730$$MD$US$US
241527401$24152740$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA219183$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240730$$CN$US$US
241527411$24152741$1$I$20240101$20240723$20240730$20240730$PER$$US-SA-2024SA220610$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240730$$MD$US$US
241527421$24152742$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA220776$SANOFI AVENTIS$$$$E$M$Y$72$KG$20240730$$MD$US$US
241527431$24152743$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA217540$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240730$$MD$US$US
241527441$24152744$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA218913$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240730$$MD$US$US
241527451$24152745$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA217151$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240730$$MD$US$US
241527461$24152746$1$I$20240719$20240722$20240730$20240730$PER$$US-SA-2024SA218872$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240730$$MD$US$US
241527472$24152747$2$F$20240101$20240816$20240730$20240827$PER$$US-SA-2024SA219804$SANOFI AVENTIS$$41$YR$A$M$Y$96.6$KG$20240827$$CN$US$US
241527481$24152748$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217946$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240730$$MD$US$US
241527491$24152749$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA216995$SANOFI AVENTIS$$$$C$M$Y$$$20240730$$MD$US$US
241527502$24152750$2$F$$20240724$20240730$20240802$PER$$US-SA-2024SA216860$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240802$$CN$US$US
241527511$24152751$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA219625$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240730$$MD$US$US
241527521$24152752$1$I$20220101$20240729$20240730$20240730$EXP$DE-BFARM-24005279$NVSC2024DE154695$NOVARTIS$$54$YR$$M$Y$91$KG$20240730$$MD$DE$DE
241527531$24152753$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA221307$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240730$$MD$US$US
241527541$24152754$1$I$20240522$20240724$20240730$20240730$PER$$US-SA-2024SA221111$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240730$$MD$US$US
241527551$24152755$1$I$20240101$20240723$20240730$20240730$PER$$US-SA-2024SA221214$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240730$$MD$US$US
241527561$24152756$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA219397$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240730$$MD$US$US
241527571$24152757$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA217341$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240730$$MD$US$US
241527581$24152758$1$I$20240622$20240729$20240729$20240729$DIR$712026$$FDA-CTU$$26$YR$$F$N$$$20240729$Y$MD$US$
241527591$24152759$1$I$20240714$20240722$20240730$20240730$PER$$US-SA-2024SA221312$SANOFI AVENTIS$$6$YR$C$F$Y$18.4$KG$20240730$$MD$US$US
241527601$24152760$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA218611$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240730$$MD$US$US
241527611$24152761$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA218663$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240730$$MD$US$US
241527623$24152762$3$F$20240101$20240813$20240730$20240821$PER$$US-SA-2024SA189630$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240821$$CN$US$US
241527631$24152763$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA215708$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240730$$PH$US$US
241527641$24152764$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA220985$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240730$$CN$US$US
241527651$24152765$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217551$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240730$$MD$US$US
241527661$24152766$1$I$20200701$20240724$20240730$20240730$PER$$US-SA-2024SA221441$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240730$$CN$US$US
241527681$24152768$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA217725$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240730$$MD$US$US
241527691$24152769$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218013$SANOFI AVENTIS$$$$E$F$Y$$$20240730$$MD$US$US
241527701$24152770$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52174$$FDA-CTU$$$$$F$N$$$20240729$N$HP$US$
241527711$24152771$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA219098$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240730$$MD$US$US
241527721$24152772$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA218421$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240730$$MD$US$US
241527731$24152773$1$I$20240101$20240723$20240730$20240730$PER$$US-SA-2024SA221218$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240730$$MD$US$US
241527741$24152774$1$I$20240719$20240722$20240730$20240730$PER$$US-SA-2024SA217992$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240730$$CN$US$US
241527751$24152775$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52195$$FDA-CTU$$75$YR$$M$N$$$20240730$N$$US$
241527761$24152776$1$I$20240309$20240729$20240729$20240729$DIR$712015$$FDA-CTU$$68$YR$$M$N$81$KG$20240729$N$CN$US$
241527771$24152777$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219769$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240730$$MD$US$US
241527782$24152778$2$F$20240818$20240822$20240730$20240903$PER$$US-SA-2024SA219632$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240903$$MD$US$US
241527791$24152779$1$I$20240721$20240722$20240730$20240730$PER$$US-SA-2024SA217162$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240730$$MD$US$US
241527803$24152780$3$F$20230101$20240730$20240730$20240806$PER$$US-SA-2024SA218125$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240806$$MD$US$US
241527811$24152781$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52193$$FDA-CTU$$57$YR$$F$N$$$20240730$N$$US$
241527821$24152782$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA218179$SANOFI AVENTIS$$23$YR$A$F$Y$54.4$KG$20240730$$MD$US$US
241527831$24152783$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA219173$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240730$$MD$US$US
241527841$24152784$1$I$20240704$20240722$20240730$20240730$PER$$US-SA-2024SA221329$SANOFI AVENTIS$$70$YR$E$M$Y$71.2$KG$20240730$$MD$US$US
241527851$24152785$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221412$SANOFI AVENTIS$$$$A$F$Y$49.44$KG$20240730$$MD$US$US
241527861$24152786$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221125$SANOFI AVENTIS$$$$A$M$Y$130$KG$20240730$$MD$US$US
241527871$24152787$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA221470$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240730$$PH$US$US
241527881$24152788$1$I$20240715$20240724$20240730$20240730$PER$$US-SA-2024SA221022$SANOFI AVENTIS$$$$A$F$Y$$$20240730$$MD$US$US
241527891$24152789$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218519$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240730$$MD$US$US
241527902$24152790$2$F$$20240819$20240730$20240829$PER$$US-SA-2024SA221594$SANOFI AVENTIS$$$$A$F$Y$$$20240829$$MD$US$US
241527911$24152791$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA218141$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240730$$MD$US$US
241527922$24152792$2$F$20240716$20240910$20240730$20240917$PER$$US-SA-2024SA221668$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240918$$MD$US$US
241527932$24152793$2$F$$20240814$20240730$20240828$PER$$US-SA-2024SA217661$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240828$$MD$US$US
241527951$24152795$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA218826$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240730$$MD$US$US
241527961$24152796$1$I$20240701$20240723$20240730$20240730$PER$$US-SA-2024SA218073$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240730$$MD$US$US
241527971$24152797$1$I$20240722$20240723$20240730$20240730$PER$$US-SA-2024SA221403$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240730$$MD$US$US
241527981$24152798$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA217677$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240730$$MD$US$US
241527991$24152799$1$I$20240715$20240729$20240730$20240730$EXP$$CN-PFIZER INC-PV202400098811$PFIZER$$35$YR$$F$Y$$$20240730$$HP$CN$CN
241528001$24152800$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA217931$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240730$$MD$US$US
241528011$24152801$1$I$$20240725$20240730$20240730$EXP$$IN-PFIZER INC-PV202300085239$PFIZER$$65$YR$$F$Y$$$20240730$$CN$IN$IN
241528021$24152802$1$I$20240605$20240725$20240730$20240730$EXP$FR-AFSSAPS-BS2024000459$FR-PFIZER INC-202400223497$PFIZER$$72$YR$$F$Y$62$KG$20240730$$MD$FR$FR
241528041$24152804$1$I$20231205$20240725$20240730$20240730$EXP$FR-AFSSAPS-NY2024000829$FR-PFIZER INC-202400223469$PFIZER$$58$YR$$F$Y$77$KG$20240730$$HP$FR$FR
241528055$24152805$5$F$20240101$20240826$20240730$20240829$EXP$$CA-PFIZER INC-202300419092$PFIZER$$86$YR$$F$Y$$$20240829$$HP$CA$CA
241528062$24152806$2$F$$20240904$20240730$20240904$30DAY$$HN-PFIZER INC-PV202400096998$PFIZER$$11$YR$$M$Y$$$20240904$$HP$HN$HN
241528071$24152807$1$I$20240613$20240725$20240730$20240730$EXP$FR-AFSSAPS-TO2024001123$FR-PFIZER INC-202400223499$PFIZER$$58$YR$$M$Y$100$KG$20240730$$PH$FR$FR
241528081$24152808$1$I$$20240726$20240730$20240730$EXP$$CA-PFIZER INC-202400225857$PFIZER$$33$YR$$M$Y$$$20240730$$MD$CA$CA
241528091$24152809$1$I$20230101$20240726$20240730$20240730$EXP$$US-PFIZER INC-202400226022$PFIZER$$68$YR$$F$Y$$$20240730$$HP$US$US
241528101$24152810$1$I$20240614$20240726$20240730$20240730$EXP$CH-SM-2024-14209$CH-PFIZER INC-202400224538$PFIZER$$59$YR$$M$Y$$$20240730$$MD$CH$CH
241528112$24152811$2$F$$20240812$20240730$20240815$EXP$$US-PFIZER INC-202400224176$PFIZER$$67$YR$$F$Y$$$20240815$$CN$US$US
241528123$24152812$3$F$$20240822$20240730$20240822$PER$$US-ALXN-202407USA001448US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
241528131$24152813$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA217645$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240730$$CN$US$US
241528141$24152814$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA221460$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240730$$MD$US$US
241528152$24152815$2$F$20240101$20240729$20240730$20240807$PER$$US-SA-2024SA221315$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240807$$MD$US$US
241528161$24152816$1$I$20221002$20240723$20240730$20240730$PER$$US-SA-2022SA410689$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240730$$MD$US$US
241528171$24152817$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA200339$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240730$$CN$US$US
241528181$24152818$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA218061$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240730$$MD$US$US
241528192$24152819$2$F$20240101$20240823$20240730$20240914$PER$$US-SA-2024SA218501$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240914$$MD$US$US
241528201$24152820$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218056$SANOFI AVENTIS$$$$C$F$Y$$$20240730$$MD$US$US
241528212$24152821$2$F$20240101$20240817$20240730$20240829$PER$$US-SA-2024SA221475$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240829$$MD$US$US
241528221$24152822$1$I$20240722$20240723$20240730$20240730$PER$$US-SA-2024SA219225$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240730$$HP$US$US
241528231$24152823$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217291$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240730$$MD$US$US
241528241$24152824$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA208534$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240730$$MD$US$US
241528252$24152825$2$F$20240101$20240828$20240730$20240919$PER$$US-SA-2024SA221669$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240919$$MD$US$US
241528261$24152826$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217707$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240730$$MD$US$US
241528271$24152827$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218275$SANOFI AVENTIS$$$$A$M$Y$73.93$KG$20240730$$MD$US$US
241528281$24152828$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA217558$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240730$$CN$US$US
241528291$24152829$1$I$20240501$20240723$20240730$20240730$PER$$US-SA-2024SA219109$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240730$$MD$US$US
241528302$24152830$2$F$20240101$20240812$20240730$20240821$PER$$US-SA-2024SA217814$SANOFI AVENTIS$$72$YR$E$F$Y$81$KG$20240821$$MD$US$US
241528311$24152831$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA218102$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240730$$MD$US$US
241528321$24152832$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA220630$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240730$$HP$US$US
241528331$24152833$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218425$SANOFI AVENTIS$$$$A$F$Y$79$KG$20240730$$MD$US$US
241528341$24152834$1$I$20240101$20240723$20240730$20240730$PER$$US-SA-2024SA218920$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240730$$CN$US$US
241528351$24152835$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA219127$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240730$$MD$US$US
241528361$24152836$1$I$20230411$20240719$20240730$20240730$EXP$$JP-AKEBIA EUROPE LIMITED-JP-AKEB-24-000195$AKEBIA THERAPEUTICS$$$$$$Y$$$20240730$$MD$JP$JP
241528371$24152837$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017795$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240730$$CN$US$US
241528381$24152838$1$I$$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119989$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240730$$HP$US$US
241528391$24152839$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018739$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240730$$CN$US$US
241528401$24152840$1$I$20240101$20240725$20240730$20240730$PER$$US-SA-2024SA221389$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240730$$MD$US$US
241528411$24152841$1$I$20240729$20240729$20240729$20240729$DIR$712028$$FDA-CTU$$33$YR$$F$N$94.5$KG$20240729$N$CN$US$
241528421$24152842$1$I$$20240726$20240730$20240730$PER$$US-SA-2024SA221508$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240730$$CN$US$US
241528431$24152843$1$I$20240101$20240723$20240730$20240730$PER$$US-SA-2024SA218583$SANOFI AVENTIS$$$$T$F$Y$$$20240730$$MD$US$US
241528441$24152844$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52199$$FDA-CTU$$72$YR$$F$N$70.76$KG$20240730$N$$US$
241528451$24152845$1$I$20240622$20240729$20240729$20240729$DIR$712027$$FDA-CTU$$41$YR$$M$N$$$20240729$Y$MD$US$
241528461$24152846$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52198$$FDA-CTU$$75$YR$$M$N$$$20240730$N$$US$
241528471$24152847$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA218836$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240730$$MD$US$US
241528481$24152848$1$I$20240729$20240729$20240729$20240729$DIR$712024$$FDA-CTU$$68$YR$$F$N$60.75$KG$20240729$N$CN$US$
241528491$24152849$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52197$$FDA-CTU$$54$YR$$F$N$$$20240730$N$$US$
241528504$24152850$4$F$20240101$20240815$20240730$20240828$PER$$US-SA-2024SA221506$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240828$$CN$US$US
241528511$24152851$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52182$$FDA-CTU$$62$YR$$M$N$$$20240730$N$$US$
241528531$24152853$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221242$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240730$$MD$US$US
241528541$24152854$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52196$$FDA-CTU$$91$YR$$F$N$$$20240730$N$$US$
241528551$24152855$1$I$20240724$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52183$$FDA-CTU$$91$YR$$F$N$48.98$KG$20240729$N$PH$US$
241528571$24152857$1$I$$20240725$20240730$20240730$PER$$US-SA-2024SA221492$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240730$$CN$US$US
241528581$24152858$1$I$20230101$20240723$20240730$20240730$PER$$US-SA-2024SA221173$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$HP$US$US
241528591$24152859$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219236$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240730$$HP$US$US
241528602$24152860$2$F$$20240826$20240730$20240910$PER$$US-SA-2024SA221365$SANOFI AVENTIS$$$$E$M$Y$$$20240910$$MD$US$US
241528611$24152861$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA218882$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240730$$CN$US$US
241528621$24152862$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA218925$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240730$$MD$US$US
241528631$24152863$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221273$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
241528641$24152864$1$I$$20240725$20240730$20240730$PER$$US-SA-2024SA219462$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240730$$PH$US$US
241528651$24152865$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219858$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240730$$MD$US$US
241528661$24152866$1$I$20240301$20240723$20240730$20240730$PER$$US-SA-2024SA219892$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240730$$MD$US$US
241528671$24152867$1$I$20240301$20240725$20240730$20240730$PER$$US-SA-2024SA221484$SANOFI AVENTIS$$83$YR$E$$Y$$$20240730$$HP$US$US
241528681$24152868$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219823$SANOFI AVENTIS$$$$C$F$Y$$$20240730$$MD$US$US
241528691$24152869$1$I$20240701$20240725$20240730$20240730$PER$$US-SA-2024SA220858$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240730$$MD$US$US
241528701$24152870$1$I$$20240725$20240730$20240730$PER$$US-SA-2024SA221216$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
241528711$24152871$1$I$20240101$20240725$20240730$20240730$PER$$US-SA-2024SA222042$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240730$$MD$US$US
241528731$24152873$1$I$20230101$20240725$20240730$20240730$PER$$US-ORGANON-O2407USA002689$ORGANON$$$$$F$Y$$$20240730$$CN$US$US
241528751$24152875$1$I$20240701$20240717$20240730$20240730$30DAY$$UY-JNJFOC-20240750373$JOHNSON AND JOHNSON$$4$YR$C$M$Y$15$KG$20240730$$CN$UY$UY
241528763$24152876$3$F$20240101$20240924$20240730$20240930$30DAY$$US-PFIZER INC-202400220991$PFIZER$$7$YR$$M$Y$23.129$KG$20240930$$CN$US$US
241528772$24152877$2$F$$20240918$20240730$20240920$30DAY$$CO-PFIZER INC-202400220637$PFIZER$$14$YR$$M$Y$$$20240920$$CN$CO$CO
241528782$24152878$2$F$$20240802$20240730$20240810$PER$$US-ABBVIE-5851159$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241528792$24152879$2$F$$20240904$20240730$20240910$EXP$$JP-009507513-2407JPN004507J$MERCK$$$$$M$Y$$$20240910$$MD$JP$JP
241528801$24152880$1$I$$20240726$20240730$20240730$PER$$US-009507513-2407USA015228$MERCK$$$$$M$Y$$$20240730$$CN$US$US
241528811$24152881$1$I$$20240723$20240730$20240730$EXP$$GB-TORRENT-00037345$TORRENT$$48$YR$A$F$Y$$$20240730$$MD$GB$GB
241528831$24152883$1$I$$20240725$20240730$20240730$EXP$$US-SA-2024SA221362$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240730$$MD$US$US
241528841$24152884$1$I$$20240726$20240730$20240730$PER$$US-BIOVITRUM-2024-US-010308$BIOVITRUM$$7$YR$$F$Y$$$20240730$$CN$US$US
241528851$24152885$1$I$$20240722$20240730$20240730$EXP$$SI-AstraZeneca-2024A171441$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$SI$
241528861$24152886$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A167180$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241528871$24152887$1$I$$20240722$20240730$20240730$EXP$$VN-AstraZeneca-2024A168861$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$VN$
241528881$24152888$1$I$$20240723$20240730$20240730$EXP$$US-JNJFOC-20240764696$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240730$$HP$US$US
241528891$24152889$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A167628$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241528901$24152890$1$I$20240101$20240723$20240730$20240730$PER$$US-ABBVIE-5852827$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241528911$24152891$1$I$$20240722$20240730$20240730$PER$$US-AstraZeneca-2024A166909$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241528922$24152892$2$F$$20240918$20240730$20240920$30DAY$$CO-PFIZER INC-202400220640$PFIZER$$9$YR$$M$Y$$$20240920$$CN$CO$CO
241528931$24152893$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA221300$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240730$$CN$US$US
241528941$24152894$1$I$20230101$20240727$20240730$20240730$PER$$US-SA-2024SA222333$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240730$$MD$US$US
241528951$24152895$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A166753$ASTRAZENECA$$$$$F$Y$68$KG$20240730$$CN$US$
241528961$24152896$1$I$20240722$20240722$20240730$20240730$PER$$US-SA-2024SA218186$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240730$$HP$US$US
241528971$24152897$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA221628$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
241528981$24152898$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA218970$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240730$$MD$US$US
241528991$24152899$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA218805$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240730$$MD$US$US
241529001$24152900$1$I$20240101$20240725$20240730$20240730$PER$$US-SA-2024SA221231$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240730$$HP$US$US
241529011$24152901$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA220580$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240730$$CN$US$US
241529021$24152902$1$I$20240716$20240729$20240729$20240729$DIR$711995$$FDA-CTU$$41$YR$$F$N$116.1$KG$20240729$N$PH$US$
241529031$24152903$1$I$20240724$20240729$20240729$20240729$DIR$712021$$FDA-CTU$$22$YR$$F$N$53.1$KG$20240729$N$CN$US$
241529041$24152904$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221170$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240730$$HP$US$US
241529061$24152906$1$I$$20240717$20240730$20240730$PER$$US-TEVA-VS-3224900$TEVA$$$$$$Y$$$20240730$$CN$US$US
241529071$24152907$1$I$$20240724$20240730$20240730$PER$$US-ABBVIE-5854657$ABBVIE$$$$$$Y$$$20240730$$HP$US$US
241529091$24152909$1$I$20240101$20240718$20240730$20240730$PER$$US-SA-2024SA214580$SANOFI AVENTIS$$62$YR$A$M$Y$80.2$KG$20240730$$MD$US$US
241529101$24152910$1$I$20240723$20240723$20240730$20240730$EXP$$NVSC2024RU151172$NOVARTIS$$66$YR$$F$Y$$$20240730$$CN$RU$RU
241529121$24152912$1$I$$20240724$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041867$BOEHRINGER INGELHEIM$$37$YR$A$M$Y$79.3$KG$20240730$$CN$US$US
241529131$24152913$1$I$20240131$20240715$20240730$20240730$EXP$$FR-HQ SPECIALTY-FR-2024INT000080$INTERCHEM$$64$YR$$M$Y$$$20240730$$HP$FR$FR
241529141$24152914$1$I$$20240729$20240730$20240730$EXP$$US-GILEAD-2024-0682295$GILEAD$$$$A$M$Y$$$20240730$$CN$US$US
241529151$24152915$1$I$$20240725$20240730$20240730$EXP$$NVSC2024ZA153562$NOVARTIS$$35$YR$$F$Y$78$KG$20240730$$HP$ZA$ZA
241529161$24152916$1$I$20240607$20240722$20240730$20240730$EXP$$MX-BIOVITRUM-2024-MX-010352$BIOVITRUM$$74$DY$$M$Y$4.6$KG$20240730$$CN$MX$MX
241529171$24152917$1$I$$20240719$20240730$20240730$EXP$$US-RDY-LIT/USA/24/0010990$DR REDDYS$Glicksman M, Parkash A, Srinivasan S, Farrell ME, Chauhan G. Spinal Cord Stimulation and Intrathecal Drug Delivery System Therapy in a Pregnant Patient with Complex Regional Pain Syndrome Type II: A Case Report. Pain Medicine Case Reports. 2024 Apr;8(3): 81-90.$24$YR$A$F$Y$$$20240730$$MD$US$US
241529181$24152918$1$I$20240101$20240725$20240730$20240730$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004142$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240730$$CN$US$US
241529192$24152919$2$F$20240708$20240730$20240730$20240805$EXP$$BR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004160$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240805$$LW$BR$BR
241529202$24152920$2$F$$20240821$20240730$20240821$PER$$US-ALXN-202407USA001646US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
241529211$24152921$1$I$20240301$20240725$20240730$20240730$EXP$$JP-ABBVIE-5701737$ABBVIE$$69$YR$$M$Y$$$20240730$$MD$JP$JP
241529221$24152922$1$I$20240101$20240722$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116988$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240730$$CN$US$US
241529231$24152923$1$I$$20240722$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116448$BRISTOL MYERS SQUIBB$$16$YR$T$M$Y$$$20240730$$HP$US$US
241529241$24152924$1$I$$20240724$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118322$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240730$$HP$US$US
241529251$24152925$1$I$$20240725$20240730$20240730$EXP$$IE-TAKEDA-2024TUS075387$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241529261$24152926$1$I$$20240718$20240730$20240730$EXP$$US-TEVA-VS-3225878$TEVA$$76$YR$$M$Y$$$20240730$$PH$US$US
241529271$24152927$1$I$20240708$20240723$20240730$20240730$PER$$US-BAYER-2024A106929$BAYER$$15$YR$T$F$Y$$$20240730$$HP$US$US
241529281$24152928$1$I$$20240723$20240730$20240730$EXP$$JP-ABBVIE-5796227$ABBVIE$Wanami Y, et al. A case of autoimmune hepatitis that was triggered by reactivation of hepatitis B. Acta Hepatologica Japonica. Proceedings of the 60th Annual Meeting of the Japan Society of Hepatology; Kumamoto-shi, Kumamoto: 2024;65(S1):A290.$71$YR$$M$Y$$$20240730$$MD$JP$JP
241529291$24152929$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024148440$AMGEN$Dubey D.; Kherbek H.; Itoh C.Y. et al.. Clinical and serological insights into paraneoplastic brachial amyotrophic diplegia.. Journal of Neurology. 2024;271:4620-4627$65$YR$E$M$Y$$$20240730$$HP$US$US
241529301$24152930$1$I$$20240717$20240730$20240730$PER$$US-TEVA-VS-3227095$TEVA$$$$$$Y$$$20240730$$CN$US$US
241529311$24152931$1$I$$20240719$20240730$20240730$EXP$$FR-AUROBINDO-AUR-APL-2024-036787$AUROBINDO$Furst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R, et al.. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLAimmunized adults with sickle cell disease.. Bone Marrow Transplantation.. 2024;59 (7):918-27.$46$YR$$F$Y$$$20240730$$HP$FR$FR
241529331$24152933$1$I$$20240725$20240730$20240730$EXP$$CA-PFIZER INC-202400223931$PFIZER$$70$YR$$F$Y$74$KG$20240730$$CN$CA$CA
241529341$24152934$1$I$20240514$20240725$20240730$20240730$EXP$$DE-PFIZER INC-202400223433$PFIZER$$53$YR$$F$Y$$$20240730$$MD$DE$DE
241529351$24152935$1$I$20240627$20240729$20240730$20240730$EXP$FR-AFSSAPS-LM2024000415$FR-GILEAD-2024-0682220$GILEAD$$79$YR$E$F$Y$$$20240730$$MD$FR$FR
241529361$24152936$1$I$$20240724$20240730$20240730$PER$$US-ROCHE-10000037337$ROCHE$$$$E$M$Y$$$20240730$$CN$US$US
241529371$24152937$1$I$$20240724$20240730$20240730$PER$$US-ROCHE-10000035628$ROCHE$$$$A$F$Y$$$20240730$$CN$US$US
241529391$24152939$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA218661$SANOFI AVENTIS$$8$YR$C$F$Y$29.8$KG$20240730$$MD$US$US
241529401$24152940$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA218842$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240730$$MD$US$US
241529411$24152941$1$I$20240723$20240725$20240730$20240730$EXP$$US-BAYER-2024A108792$BAYER$$41$YR$A$M$Y$$$20240730$$HP$US$US
241529421$24152942$1$I$$20240719$20240730$20240730$EXP$$US-AUROBINDO-AUR-APL-2024-036142$AUROBINDO$Xia J, Ahmed R.. Rapidly progressive locked-in syndrome secondary to atypical herpes simplex virus-1 rhombencephalitis in an immunocompromised individual. IDCases. 2024;:. DOI:. IDCases. 2024;37:e02027$61$YR$$M$Y$$$20240730$$MD$US$US
241529431$24152943$1$I$20221204$20240719$20240730$20240730$EXP$$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-06934$HIKMA$$76$YR$$F$Y$48$KG$20240730$$PH$FR$FR
241529441$24152944$1$I$20240711$20240724$20240730$20240730$PER$$US-BAYER-2024A107820$BAYER$$44$YR$A$F$Y$$$20240730$$MD$US$US
241529451$24152945$1$I$$20240729$20240730$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA068926$SANDOZ$$72$YR$$M$Y$90$KG$20240730$$HP$CA$CA
241529461$24152946$1$I$$20240724$20240730$20240730$PER$$US-BEH-2024176357$CSL BEHRING$$$$$M$Y$$$20240730$$CN$US$US
241529473$24152947$3$F$$20240901$20240730$20240903$30DAY$$US-PFIZER INC-PV202400095690$PFIZER$$$$$M$Y$$$20240903$$CN$US$US
241529483$24152948$3$F$$20240925$20240730$20240930$30DAY$$US-PFIZER INC-202400221679$PFIZER$$$$$$Y$$$20240930$$HP$US$US
241529492$24152949$2$F$$20240830$20240730$20240830$30DAY$$US-PFIZER INC-202400219729$PFIZER$$$$$$Y$$$20240830$$CN$US$US
241529501$24152950$1$I$$20240717$20240730$20240730$30DAY$$US-PFIZER INC-202400217804$PFIZER$$$$$$Y$$$20240730$$PH$US$US
241529511$24152951$1$I$$20240725$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119094$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240730$$CN$US$US
241529531$24152953$1$I$20240711$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018075$ELI LILLY AND CO$$$$$M$Y$$$20240730$$CN$US$US
241529541$24152954$1$I$$20240724$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018242$ELI LILLY AND CO$$$$$F$Y$$$20240730$$CN$US$US
241529551$24152955$1$I$20240721$20240722$20240730$20240730$PER$$US-ABBVIE-5852468$ABBVIE$$43$YR$$F$Y$$$20240730$$CN$US$US
241529561$24152956$1$I$20240101$20240715$20240730$20240730$EXP$CH-SM-2024-12814$CH-ELI_LILLY_AND_COMPANY-CH202407010111$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240730$$CN$CH$CH
241529571$24152957$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225325$TEVA$$78$YR$$F$Y$$$20240730$$HP$CA$CA
241529581$24152958$1$I$$20240725$20240730$20240730$PER$$US-SA-2024SA221237$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240730$$CN$US$US
241529591$24152959$1$I$$20240722$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117273$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240730$$CN$US$US
241529601$24152960$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221672$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240730$$MD$US$US
241529611$24152961$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-10000041118$ROCHE$$76$YR$E$F$Y$$$20240730$$CN$US$US
241529621$24152962$1$I$$20240718$20240730$20240730$PER$$US-SA-2024SA218586$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240730$$MD$US$US
241529631$24152963$1$I$20240501$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149487$AMGEN$$58$YR$A$F$Y$$$20240730$$PH$US$US
241529641$24152964$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52202$$FDA-CTU$$81$YR$$F$N$79.38$KG$20240730$N$$US$
241529652$24152965$2$F$20240701$20240730$20240730$20240802$EXP$$US-ABBVIE-5856795$ABBVIE$$49$YR$$F$Y$$$20240802$$CN$US$US
241529661$24152966$1$I$20240607$20240729$20240730$20240730$EXP$ES-AEMPS-1553165$NVSC2024ES154741$NOVARTIS$$57$YR$$F$Y$$$20240730$$MD$ES$ES
241529671$24152967$1$I$20240707$20240720$20240730$20240730$EXP$$FR-BAYER-2024A100453$BAYER$$34$YR$A$F$Y$67$KG$20240730$$HP$FR$FR
241529681$24152968$1$I$20240720$20240722$20240730$20240730$30DAY$$US-PFIZER INC-202400221221$PFIZER$$6$YR$$F$Y$$$20240730$$CN$US$US
241529704$24152970$4$F$20240701$20240923$20240730$20240926$30DAY$$CO-PFIZER INC-202400222022$PFIZER$$7$YR$$M$Y$$$20240926$$CN$CO$CO
241529712$24152971$2$F$$20240830$20240730$20240830$30DAY$$PR-PFIZER INC-202400221567$PFIZER$$14$YR$$M$Y$$$20240830$$CN$PR$PR
241529722$24152972$2$F$$20240805$20240730$20240808$30DAY$$CO-PFIZER INC-PV202400096584$PFIZER$$9$YR$$M$Y$$$20240808$$CN$CO$CO
241529741$24152974$1$I$$20240723$20240730$20240730$30DAY$$CO-PFIZER INC-PV202400096614$PFIZER$$$$$$Y$$$20240730$$CN$CO$CO
241529751$24152975$1$I$20240719$20240723$20240730$20240730$PER$$US-AMGEN-USASP2024146770$AMGEN$$58$YR$A$M$Y$102$KG$20240730$$PH$US$US
241529761$24152976$1$I$$20240723$20240730$20240730$EXP$$US-BAYER-2024A110073$BAYER$$$$$F$Y$$$20240730$$HP$US$US
241529771$24152977$1$I$20240720$20240723$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010920$DR REDDYS$$25$YR$A$F$Y$$$20240730$$CN$US$US
241529781$24152978$1$I$20240701$20240722$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010924$DR REDDYS$$32$YR$A$F$Y$$$20240730$$CN$US$US
241529791$24152979$1$I$$20240722$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010856$DR REDDYS$$$$$F$Y$$$20240730$$CN$US$US
241529801$24152980$1$I$20240101$20240723$20240730$20240730$PER$$US-ABBVIE-5854518$ABBVIE$$$$$$Y$$$20240730$$HP$US$US
241529811$24152981$1$I$$20240722$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010868$DR REDDYS$$25$YR$A$F$Y$$$20240730$$HP$US$US
241529821$24152982$1$I$$20240722$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010864$DR REDDYS$$23$YR$A$$Y$$$20240730$$CN$US$US
241529831$24152983$1$I$$20240722$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010867$DR REDDYS$$26$YR$A$F$Y$$$20240730$$MD$US$US
241529841$24152984$1$I$$20240617$20240730$20240730$PER$$US-YILING-2024YPSPO0014$YILING PHARMACEUTICAL$$$$$$Y$$$20240730$$PH$US$US
241529851$24152985$1$I$$20240723$20240730$20240730$PER$$US-ALXN-202407USA001645US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240730$$CN$US$US
241529861$24152986$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-07162$HIKMA$Lagarteira J, Ferreira CA, S? S, Pera R, Carrascal A.. Lagarteira J, Ferreira CA, S? S, Pera R, Carrascal A. PO-0091 - (4099) - Um caso de cardiotoxicidade por quimioterapia. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI. 2024;463$66$YR$$M$Y$$$20240730$$MD$PT$PT
241529871$24152987$1$I$20240627$20240722$20240730$20240730$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06588$VIFOR$$26$YR$$M$Y$$$20240730$$HP$ZA$ZA
241529881$24152988$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119697$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240730$$CN$US$US
241529891$24152989$1$I$$20240726$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-119491$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240730$$HP$CA$CA
241529901$24152990$1$I$$20240729$20240730$20240730$PER$$US-PFIZER INC-202400226509$PFIZER$$$$$$Y$$$20240730$$CN$US$US
241529911$24152991$1$I$20231016$20240722$20240730$20240730$EXP$FR-AFSSAPS-MA2024001065$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-116931$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$54$KG$20240730$$PH$FR$FR
241529921$24152992$1$I$20240601$20240724$20240730$20240730$PER$$US-PFIZER INC-202400224053$PFIZER$$51$YR$$F$Y$$$20240730$$HP$US$US
241529931$24152993$1$I$20240301$20240729$20240730$20240730$PER$$US-PFIZER INC-202400225908$PFIZER$$$$$M$Y$$$20240730$$MD$US$US
241529941$24152994$1$I$$20240724$20240730$20240730$EXP$$US-JNJFOC-20240771586$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$CN$US$US
241529952$24152995$2$F$20240721$20240807$20240730$20240815$PER$$US-ROCHE-10000036706$ROCHE$$$$$F$Y$$$20240815$$CN$US$US
241529961$24152996$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189637$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241529981$24152998$1$I$$20240723$20240730$20240730$EXP$$FR-AMGEN-FRASP2024147468$AMGEN$Cancel M.; Aubert M.; Mathiot L. et al.. Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature. The Oncologist. 2024;29 (7):e910-e917$$$$$Y$$$20240730$$HP$FR$FR
241529991$24152999$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52200$$FDA-CTU$$64$YR$$M$N$$$20240730$N$$US$
241530001$24153000$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52201$$FDA-CTU$$12$YR$$F$N$$$20240730$N$$US$
241530011$24153001$1$I$$20240726$20240730$20240730$EXP$$CA-ABBVIE-5857262$ABBVIE$$$$E$M$Y$$$20240730$$PH$CA$CA
241530021$24153002$1$I$20240726$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149415$AMGEN$$86$YR$E$F$Y$$$20240730$$PH$US$US
241530031$24153003$1$I$20240724$20240726$20240730$20240730$EXP$$US-ABBVIE-5856862$ABBVIE$$76$YR$$M$Y$$$20240730$$CN$US$US
241530041$24153004$1$I$$20240726$20240730$20240730$EXP$$AT-GILEAD-2024-0682062$GILEAD$$70$YR$E$F$Y$$$20240730$$MD$AT$AT
241530051$24153005$1$I$20231201$20240724$20240730$20240730$EXP$$CA-GSK-CA2023153523$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$CA$CA
241530061$24153006$1$I$$20240726$20240730$20240730$EXP$$US-ABBVIE-5856830$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241530071$24153007$1$I$20240709$20240726$20240730$20240730$EXP$$US-ABBVIE-5856952$ABBVIE$$66$YR$$F$Y$$$20240730$$CN$US$US
241530084$24153008$4$F$$20240814$20240730$20240820$30DAY$$DE-UCBSA-2024037648$UCB$$$$$M$Y$$$20240820$$CN$DE$DE
241530101$24153010$1$I$$20240718$20240730$20240730$PER$$US-PFIZER INC-202400219930$PFIZER$$27$YR$$F$Y$$$20240730$$MD$US$US
241530111$24153011$1$I$$20240723$20240730$20240730$30DAY$$US-PFIZER INC-PV202400096508$PFIZER$$$$$$Y$$$20240730$$PH$US$US
241530122$24153012$2$F$$20240829$20240730$20240829$30DAY$$US-PFIZER INC-202400222406$PFIZER$$9$YR$$M$Y$$$20240829$$CN$US$US
241530131$24153013$1$I$$20240723$20240730$20240730$30DAY$$US-PFIZER INC-202400222422$PFIZER$$53$YR$$F$Y$82.1$KG$20240730$$CN$US$US
241530142$24153014$2$F$20240706$20240731$20240730$20240805$PER$$US-PFIZER INC-PV202400097734$PFIZER$$58$YR$$F$Y$$$20240805$$HP$US$US
241530152$24153015$2$F$$20240830$20240730$20240830$30DAY$$US-PFIZER INC-202400222410$PFIZER$$11$MON$$F$Y$$$20240830$$CN$US$US
241530166$24153016$6$F$$20240929$20240730$20240930$30DAY$$US-PFIZER INC-202400222153$PFIZER$$11$YR$$M$Y$45.81$KG$20240930$$CN$US$US
241530174$24153017$4$F$20240101$20240909$20240730$20240913$30DAY$$AR-PFIZER INC-202400222950$PFIZER$$46$YR$$F$Y$$$20240913$$CN$AR$AR
241530182$24153018$2$F$20240701$20240801$20240730$20240805$30DAY$$US-PFIZER INC-PV202400096384$PFIZER$$$$$M$Y$$$20240805$$CN$US$US
241530191$24153019$1$I$$20240723$20240730$20240730$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005516$BIOCON$$$$$$Y$$$20240730$$CN$CA$CA
241530201$24153020$1$I$$20240716$20240730$20240730$EXP$$US-FreseniusKabi-FK202411445$FRESENIUS KABI$Kretovics E, Keegan K, Burg G, von Allmen D, Chima R, Benscoter D. Prolonged High-Dose Steroid Use in an Infant With Surfactant Protein-C Deficiency and Multiple Complications. American Journal of Respiratory and Critical Care Medicine. 2024 May;doi:https://www.atsjournals.org/doi/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2307.$3$MON$I$M$Y$$$20240730$$HP$US$US
241530212$24153021$2$F$20240716$20240828$20240730$20240902$EXP$$US-JNJFOC-20240771513$JOHNSON AND JOHNSON$$31$YR$A$F$Y$51.302$KG$20240902$$HP$US$US
241530222$24153022$2$F$20240724$20240829$20240730$20240830$EXP$$JP-Eisai-EC-2024-171026$EISAI$$80$YR$E$F$Y$$$20240830$$PH$JP$JP
241530231$24153023$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150925$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241530241$24153024$1$I$20240718$20240718$20240730$20240730$EXP$$US-ABBVIE-5852801$ABBVIE$$80$YR$$M$Y$$$20240730$$MD$US$US
241530251$24153025$1$I$$20240726$20240730$20240730$PER$$US-ROCHE-10000040470$ROCHE$$59$YR$A$M$Y$$$20240730$$CN$US$US
241530261$24153026$1$I$20240701$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52203$$FDA-CTU$$56$YR$$M$N$$$20240729$N$HP$US$
241530271$24153027$1$I$$20240725$20240730$20240730$EXP$GB-MHRA-FAKE-202407080853418920-FDLTV$GB-MYLANLABS-2024M1069833$MYLAN$$$$$$Y$$$20240730$$CN$GB$GB
241530282$24153028$2$F$$20240731$20240730$20240802$EXP$$GB-MYLANLABS-2024M1069711$MYLAN$$$$$M$Y$$$20240802$$PH$GB$GB
241530291$24153029$1$I$$20240724$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007790$INCYTE$$$$$$Y$$$20240730$$MD$US$US
241530301$24153030$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52204$$FDA-CTU$$$$$F$N$$$20240729$N$HP$US$
241530311$24153031$1$I$$20240723$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117084$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240730$$HP$US$US
241530321$24153032$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018117$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241530331$24153033$1$I$20240701$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018104$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240730$$CN$US$US
241530343$24153034$3$F$$20240826$20240730$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119756$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$50.35$KG$20240827$$CN$US$US
241530351$24153035$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018109$ELI LILLY AND CO$$$$A$F$Y$$$20240730$$CN$US$US
241530361$24153036$1$I$20240704$20240723$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407015768$ELI LILLY AND CO$$32$YR$A$M$Y$$$20240730$$CN$US$US
241530372$24153037$2$F$20230713$20240819$20240730$20240822$30DAY$$JP-JNJFOC-20240743841$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$CN$JP$JP
241530381$24153038$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407019254$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240730$$CN$US$US
241530391$24153039$1$I$20240704$20240724$20240730$20240730$EXP$$US-SA-2024SA191426$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240730$$MD$US$US
241530411$24153041$1$I$$20240725$20240730$20240730$EXP$$US-ABBVIE-5855645$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241530421$24153042$1$I$$20240724$20240730$20240730$PER$$US-ABBVIE-5855965$ABBVIE$$$$$$Y$$$20240730$$CN$US$US
241530431$24153043$1$I$20240712$20240725$20240730$20240730$EXP$$US-SA-2024SA221271$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240730$$MD$US$US
241530441$24153044$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA215412$SANOFI AVENTIS$$60$YR$A$M$Y$136$KG$20240730$$MD$US$US
241530451$24153045$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221540$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
241530481$24153048$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52205$$FDA-CTU$$59$YR$$F$N$$$20240730$N$$US$
241530491$24153049$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52206$$FDA-CTU$$61$YR$$F$N$$$20240730$N$$US$
241530521$24153052$1$I$$20240709$20240730$20240730$PER$$US-Covis Pharma GmbH-2024COV00866$COVIS PHARMA$$$$$M$Y$$$20240730$$CN$US$US
241530531$24153053$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS076164$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241530542$24153054$2$F$20240501$20240731$20240730$20240827$EXP$$FR-GILEAD-2024-0682218$GILEAD$$69$YR$E$M$Y$$$20240827$$MD$FR$FR
241530552$24153055$2$F$20240701$20240805$20240730$20240809$30DAY$$CL-PFIZER INC-PV202400097246$PFIZER$$11$YR$$M$Y$$$20240809$$CN$CL$CL
241530571$24153057$1$I$$20240724$20240730$20240730$EXP$$US-PFIZER INC-PV202400096683$PFIZER$Brisson, R.. Long-term outcomes following proton therapy for non-metastatic central nervous system germinoma in children and adolescents. Radiotherapy and Oncology. 2024;198:10.1016/j.radonc.2024.110371$$$T$$Y$$$20240730$$HP$US$US
241530582$24153058$2$F$$20240829$20240730$20240829$30DAY$$US-PFIZER INC-202400222897$PFIZER$$13$YR$$M$Y$$$20240829$$CN$US$US
241530591$24153059$1$I$20240101$20240712$20240730$20240730$PER$$US-009507513-2407USA008552$MERCK$$65$YR$$M$Y$$$20240730$$MD$US$US
241530601$24153060$1$I$20240722$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52208$$FDA-CTU$$69$YR$$M$N$$$20240730$Y$PH$US$
241530611$24153061$1$I$20240725$20240725$20240730$20240730$EXP$$US-JNJFOC-20240772457$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$HP$US$US
241530621$24153062$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52209$$FDA-CTU$$65$YR$$F$N$$$20240730$N$$US$
241530632$24153063$2$F$20240726$20240904$20240730$20240910$PER$$US-JNJFOC-20240774044$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240910$$CN$US$US
241530642$24153064$2$F$20240608$20240731$20240730$20240807$PER$$US-FreseniusKabi-FK202411304$FRESENIUS KABI$$29$YR$A$M$Y$88.7$KG$20240807$$PH$US$US
241530651$24153065$1$I$$20240719$20240730$20240730$EXP$$US-FreseniusKabi-FK202411661$FRESENIUS KABI$Alam RM, Espinoza J, Coches K. Steroid Induced Diabetic Ketoacidosis in End Stage Renal Disease with Suspected Vasculitis Induced Stroke. Southern Medical Journal. 2022 Jul;115: 443-44. doi:10.1080/17512433.2019.1555468.$71$YR$E$F$Y$$$20240730$$MD$US$US
241530661$24153066$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52210$$FDA-CTU$$42$YR$$M$N$$$20240730$N$$US$
241530671$24153067$1$I$$20240730$20240730$20240730$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042684$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240730$$MD$PL$PL
241530681$24153068$1$I$$20240729$20240730$20240730$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042622$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240730$$PH$US$US
241530694$24153069$4$F$20240701$20240823$20240730$20240823$PER$$US-ALXN-202407USA001452US$ALEXION PHARMACEUTICALS$$73$YR$$M$Y$$$20240823$$CN$US$US
241530701$24153070$1$I$$20240722$20240730$20240730$PER$$US-BAYER-2024A106921$BAYER$$37$YR$A$F$Y$$$20240730$$HP$US$US
241530712$24153071$2$F$$20240730$20240730$20240731$PER$$NVSC2024US155362$NOVARTIS$$$$$M$Y$$$20240731$$HP$US$US
241530722$24153072$2$F$20240701$20240729$20240730$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120347$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$86.18$KG$20240813$$CN$US$US
241530731$24153073$1$I$$20240726$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119894$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240730$$CN$US$US
241530741$24153074$1$I$$20240724$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117902$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240730$$CN$US$US
241530751$24153075$1$I$$20240716$20240730$20240730$PER$$US-TEVA-VS-3222502$TEVA$$75$YR$$F$Y$$$20240730$$CN$US$US
241530761$24153076$1$I$$20240720$20240730$20240730$EXP$$US-ABBVIE-5849504$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241530772$24153077$2$F$20240201$20240730$20240730$20240805$EXP$$US-ABBVIE-5668434$ABBVIE$$64$YR$$F$Y$$$20240805$$CN$US$US
241530782$24153078$2$F$$20240830$20240730$20240830$30DAY$$US-PFIZER INC-202400223145$PFIZER$$4$YR$$F$Y$$$20240830$$CN$US$US
241530793$24153079$3$F$$20240807$20240730$20240812$30DAY$$IL-PFIZER INC-PV202400097103$PFIZER$$10$YR$$M$Y$$$20240812$$CN$IL$IL
241530822$24153082$2$F$20240201$20240904$20240730$20240904$30DAY$$CO-PFIZER INC-PV202400096680$PFIZER$$13$YR$$M$Y$$$20240904$$CN$CO$CO
241530831$24153083$1$I$20240722$20240724$20240730$20240730$30DAY$$US-PFIZER INC-202400223100$PFIZER$$52$YR$$F$Y$58.97$KG$20240730$$CN$US$US
241530841$24153084$1$I$$20240724$20240730$20240730$30DAY$$CO-PFIZER INC-PV202400096652$PFIZER$$$$$M$Y$$$20240730$$CN$CO$CO
241530861$24153086$1$I$$20240729$20240730$20240730$PER$$US-BIOVITRUM-2024-US-010354$BIOVITRUM$$59$YR$$M$Y$$$20240730$$CN$US$US
241530871$24153087$1$I$20240623$20240705$20240730$20240730$30DAY$$CL-PFIZER INC-202400215085$PFIZER$$$$$$Y$$$20240730$$CN$CL$CL
241530883$24153088$3$F$20240722$20240815$20240730$20240815$30DAY$$CR-PFIZER INC-PV202400097551$PFIZER$$13$YR$$F$Y$$$20240815$$HP$CR$CR
241530892$24153089$2$F$20240721$20240829$20240730$20240829$30DAY$$US-PFIZER INC-202400223165$PFIZER$$49$YR$$F$Y$90.72$KG$20240829$$CN$US$US
241530906$24153090$6$F$20240701$20240926$20240730$20240927$30DAY$$CL-PFIZER INC-PV202400097249$PFIZER$$13$YR$$F$Y$$$20240927$$CN$CL$CL
241530912$24153091$2$F$20240101$20240802$20240730$20240805$30DAY$$US-PFIZER INC-202400222900$PFIZER$$$$$M$Y$$$20240805$$CN$US$US
241530921$24153092$1$I$$20240726$20240730$20240730$30DAY$$US-PFIZER INC-202400224794$PFIZER$$$$$F$Y$$$20240730$$HP$US$US
241530941$24153094$1$I$$20240722$20240730$20240730$EXP$$VN-AstraZeneca-2024A171538$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$VN$
241530951$24153095$1$I$$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A169947$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241530962$24153096$2$F$$20240801$20240730$20240810$EXP$$PT-TEVA-VS-3222789$TEVA$J B Leite, T S Costa, B B Laczkovits, M Sousa,  J R Morais. POSA - (2929) - PULMONARY TOXICITY DUE TO EVEROLIMUS - EXPLORING A FEVER OF UNKNOWN ORIGIN National Congress of  Internal Medicine - Book of abstracts. 2024 May: 1165.; Literature Reference:  J B Leite, T S Costa, B B Laczkovits, M Sousa,  J R Morais. POSA - (2929) - PULMONARY TOXICITY DUE TO EVEROLIMUS - EXPLORING A FEVER OF UNKNOWN ORIGIN National Congress of  Internal Medicine - Book of abstracts. 2024 May: 1165.$72$YR$$M$Y$$$20240810$$MD$PT$PT
241530971$24153097$1$I$$20240719$20240730$20240730$EXP$$US-SA-2024SA219361$SANOFI AVENTIS$$$$A$F$Y$89.81$KG$20240730$$MD$US$US
241530981$24153098$1$I$$20240723$20240730$20240730$EXP$$GB-MYLANLABS-2024M1070332$MYLAN$Anand A, Brown L, Smith R, Nouri B, Powell F, Mabrok M, et al. Donor Derived Myelodysplastic Syndrome after Sex Matched Haploidentical Allograft for AML with Monosomy 7 in Both Diseases: Importance of Donor Chimerism Assessment By Two Independent Techniques. Blood 2022; 140 (Suppl.) 13029-13030.$39$YR$$M$Y$$$20240730$$HP$GB$GB
241530991$24153099$1$I$$20240723$20240730$20240730$EXP$$US-MYLANLABS-2024M1070308$MYLAN$Mikhail E, Alexander D, Jankowski M, Pandya D, Kunadi A. Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature. Am-J-Respir-Crit-Care-Med 2024; 209.$72$YR$$F$Y$$$20240730$$HP$US$US
241531001$24153100$1$I$$20240722$20240730$20240730$EXP$$US-MYLANLABS-2024M1069892$MYLAN$Rosenfeld C, Kana T, Beizaeipour Z, Gafitanu S, Kandula S. 1708338 worsening ted, pretibial myxedema and development of acropachy post thyroidectomy for graves^ disease. Endocr-Pract 2024; 30 (Suppl.) (5): S171-S172 abstr. 1708338.$68$YR$$F$Y$$$20240730$$MD$US$US
241531011$24153101$1$I$$20240723$20240730$20240730$EXP$$IN-MYLANLABS-2024M1070374$MYLAN$Singh A, Gupta D, Bhanja R L, Agarwal A. An unusual case of acute dyspnea in current smoker: Thinking out of the box. IJSDR. 2024;9 (7):857-860$30$YR$$M$Y$$$20240730$$HP$IN$IN
241531021$24153102$1$I$$20240715$20240730$20240730$EXP$$PT-TEVA-VS-3223610$TEVA$Literature: Pereira I, Ferreira IM, Barbosa FR, Pereira D, Gabriel DF. CARBAMAZEPINE POISONING: CAUSE AND/OR CONSEQUENCE. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 1199.$66$YR$$M$Y$$$20240730$$MD$PT$PT
241531031$24153103$1$I$$20240723$20240730$20240730$EXP$$IN-MYLANLABS-2024M1070309$MYLAN$Ancilla LC, Sundaram B, Pathak N, Raj A. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. J-Nephropharmacol 2024; 13 (2): 1-5.$55$YR$$M$Y$$$20240730$$HP$IN$IN
241531041$24153104$1$I$$20240717$20240730$20240730$EXP$$GB-MYLANLABS-2024M1070528$MYLAN$$$$$M$Y$$$20240730$$CN$GB$US
241531051$24153105$1$I$$20240723$20240730$20240730$EXP$$US-MYLANLABS-2024M1070310$MYLAN$Churchill AB, Nguyen AD, Xia J, Nguyen VD, Agrawal N, Durant CE, et al. To Bite or Not to Bite: A Case of Non-bite Pasteurella Multicoda Resulting in Severe Septic Shock. Am-J-Respir-Crit-Care-Med 2024; 209 A1679.$68$YR$$M$Y$$$20240730$$HP$US$US
241531061$24153106$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3224863$TEVA$$49$YR$$$Y$$$20240730$$MD$CA$CA
241531071$24153107$1$I$20240101$20240725$20240730$20240730$EXP$$US-JNJFOC-20240770758$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240730$$HP$US$US
241531081$24153108$1$I$20230101$20230110$20240730$20240730$EXP$$KW-BIOVITRUM-2023KW00817$BIOVITRUM$$8$MON$$M$Y$$$20240730$$CN$KW$KW
241531091$24153109$1$I$$20240722$20240730$20240730$EXP$$RU-BAUSCH-BL-2024-011242$BAUSCH AND LOMB$Somov D, Chernyaeva A, Mazua V, Nurieva L, Bobrov M, Anichkov D. Valproic acid induced Stevens-Johnson syndrome. Vestnik Dermatologii i Venerologii. 2024;100(3):74-79. doi:10.25208/vdv10515$27$YR$$F$Y$$$20240730$$HP$RU$RU
241531101$24153110$1$I$$20240724$20240730$20240730$EXP$$JP-JNJFOC-20240779448$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240730$$MD$JP$JP
241531111$24153111$1$I$$20240725$20240730$20240730$EXP$$NVSC2024CA154521$NOVARTIS$$40$YR$$F$Y$96$KG$20240730$$HP$CA$CA
241531121$24153112$1$I$$20240729$20240730$20240730$EXP$$UY-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042718$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240730$$MD$UY$UY
241531131$24153113$1$I$20240101$20240726$20240730$20240730$PER$$US-BAUSCH-BL-2024-011479$BAUSCH AND LOMB$$76$YR$$F$Y$74.84$KG$20240730$$CN$US$US
241531141$24153114$1$I$20240705$20240725$20240730$20240730$EXP$$TR-AMERICAN REGENT INC-2024002873$AMERICAN REGENT$$28$YR$$F$Y$42$KG$20240730$$HP$TR$TR
241531154$24153115$4$F$20240503$20240912$20240730$20240919$EXP$$FR-BAUSCH-BL-2024-011496$BAUSCH AND LOMB$$69$YR$$F$Y$55.2$KG$20240919$$HP$FR$FR
241531161$24153116$1$I$$20240726$20240730$20240730$PER$$NVSC2024US155486$NOVARTIS$$$$$$Y$$$20240730$$HP$US$US
241531171$24153117$1$I$$20240727$20240730$20240730$PER$$NVSC2024US154618$NOVARTIS$$$$$F$Y$$$20240730$$HP$US$US
241531181$24153118$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150185$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241531191$24153119$1$I$20240101$20240726$20240730$20240730$EXP$$US-AMGEN-USASP2024149505$AMGEN$$$$$F$Y$$$20240730$$MD$US$US
241531202$24153120$2$F$$20240725$20240730$20240801$EXP$$BR-TAKEDA-2024TUS075287$TAKEDA$$23$YR$$M$Y$$$20240801$$MD$BR$BR
241531224$24153122$4$F$20240101$20240813$20240730$20240822$EXP$$US-BAUSCH-BL-2024-011521$BAUSCH AND LOMB$$85$YR$$F$Y$$$20240822$$CN$US$US
241531231$24153123$1$I$$20240729$20240730$20240730$EXP$$CA-BAUSCH-BL-2024-011591$BAUSCH AND LOMB$$22$YR$$F$Y$$$20240730$$HP$CA$CA
241531241$24153124$1$I$$20240715$20240730$20240730$EXP$$GB-VERTICAL PHARMACEUTICALS-2024ALO00337$VALOR COMPOUNDING PHARMACY - No Location Specified$$$$$F$Y$$$20240730$$CN$GB$GB
241531254$24153125$4$F$20240723$20240902$20240730$20240913$30DAY$$US-JNJFOC-20240769047$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240913$$CN$US$US
241531272$24153127$2$F$20240701$20240820$20240730$20240824$EXP$$US-ABBVIE-5838251$ABBVIE$$58$YR$$M$Y$$$20240824$$CN$US$US
241531281$24153128$1$I$20240101$20240725$20240730$20240730$EXP$$CA-ABBVIE-5857359$ABBVIE$$50$YR$$M$Y$$$20240730$$CN$CA$CA
241531291$24153129$1$I$$20240722$20240730$20240730$PER$$US-ABBVIE-5853325$ABBVIE$$$$$$Y$$$20240730$$HP$US$US
241531301$24153130$1$I$$20240725$20240730$20240730$EXP$$US-ALXN-202407USA001815US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$MD$US$US
241531311$24153131$1$I$$20240726$20240730$20240730$PER$$US-TAKEDA-2024TUS076347$TAKEDA$$$$$F$Y$$$20240730$$CN$US$US
241531324$24153132$4$F$$20240911$20240730$20240918$EXP$$CA-TEVA-VS-3224807$TEVA$$17$YR$$F$Y$$$20240918$$MD$CA$CA
241531331$24153133$1$I$20230823$20240715$20240730$20240730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113619$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$72$KG$20240719$$MD$JP$JP
241531351$24153135$1$I$20240515$20240729$20240730$20240730$EXP$GB-MHRA-MED-202407291354201210-ZYVDH$GB-BIOVITRUM-2024-GB-010350$BIOVITRUM$$68$YR$$F$Y$$$20240730$$MD$GB$GB
241531361$24153136$1$I$20240101$20240726$20240730$20240730$EXP$$AU-AMERICAN REGENT INC-2024002900$AMERICAN REGENT$$$$$F$Y$$$20240730$$MD$AU$AU
241531373$24153137$3$F$20240301$20240822$20240730$20240828$EXP$$US-TAKEDA-2024TUS065481$TAKEDA$$59$YR$$F$Y$$$20240828$$CN$US$US
241531382$24153138$2$F$$20240801$20240730$20240810$EXP$$US-TEVA-VS-3222656$TEVA$Cabot RC, Rosenberg ES, Dudzinski DM, Baggett MV, Tran KM, Sgroi DC, et al. Case 11-2023: A 67-Year-Old Man with Mantle-Cell Lymphoma and Hypoxemia. N-Engl-J-Med 2023; 388 (15): 1416-1423.; Cabot RC, Rosenberg ES, Dudzinski DM, Baggett MV, Tran KM, Sgroi DC, et al. Case 11-2023: A 67-Year-Old Man with Mantle-Cell Lymphoma and Hypoxemia. N-Engl-J-Med 2023; 388 (15): 1416-1423.$67$YR$$M$Y$$$20240810$$MD$US$US
241531391$24153139$1$I$$20240725$20240730$20240730$EXP$$US-KYOWAKIRIN-2024KK018053$KYOWA$$$$$$Y$$$20240730$$HP$US$US
241531401$24153140$1$I$20240725$20240725$20240730$20240730$EXP$$NVSC2024US153833$NOVARTIS$$74$YR$$F$Y$$$20240730$$CN$US$US
241531411$24153141$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017899$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240730$$CN$US$US
241531431$24153143$1$I$$20240718$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115223$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240730$$HP$CA$CA
241531441$24153144$1$I$$20240723$20240730$20240730$PER$$US-BIOGEN-2024BI01275133$BIOGEN$$$$$F$Y$67.7$KG$20240730$$MD$US$US
241531451$24153145$1$I$20240101$20240723$20240730$20240730$EXP$$US-ABBVIE-5853124$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241531461$24153146$1$I$20240606$20240724$20240730$20240730$EXP$ES-AEMPS-1549718$ES-MYLANLABS-2024M1069601$MYLAN$$83$YR$$F$Y$$$20240730$$MD$ES$ES
241531472$24153147$2$F$20240728$20240920$20240730$20240923$EXP$$NZ-MYLANLABS-2024M1070378$MYLAN$$78$YR$$M$Y$$$20240923$$CN$NZ$NZ
241531482$24153148$2$F$20240501$20240923$20240730$20240924$EXP$FR-AFSSAPS-AN2024000917$FR-MYLANLABS-2024M1069945$MYLAN$$63$YR$$$Y$$$20240924$$MD$FR$FR
241531492$24153149$2$F$20240720$20240731$20240730$20240731$EXP$$NZ-MYLANLABS-2024M1070756$MYLAN$$84$YR$$F$Y$$$20240731$$CN$NZ$NZ
241531501$24153150$1$I$20240715$20240726$20240730$20240730$EXP$$GB-MYLANLABS-2024M1070140$MYLAN$$54$YR$$M$Y$92$KG$20240730$$MD$GB$GB
241531511$24153151$1$I$20240101$20240725$20240730$20240730$EXP$$US-ABBVIE-5854799$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241531531$24153153$1$I$20231215$20240723$20240730$20240730$EXP$$GB-ABBVIE-5853858$ABBVIE$$0$YR$$F$Y$4$KG$20240730$$CN$GB$GB
241531541$24153154$1$I$20210601$20240725$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007850$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241531551$24153155$1$I$$20240724$20240730$20240730$EXP$$US-009507513-2407USA013819$MERCK$$$$$F$Y$$$20240730$$CN$US$US
241531561$24153156$1$I$20240101$20240726$20240730$20240730$EXP$$US-ABBVIE-5832413$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241531571$24153157$1$I$20240101$20240726$20240730$20240730$EXP$$US-ABBVIE-5857522$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241531581$24153158$1$I$20240101$20240723$20240730$20240730$EXP$$US-ABBVIE-5855325$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241531591$24153159$1$I$20240720$20240725$20240730$20240730$EXP$$US-ABBVIE-5854866$ABBVIE$$35$YR$$M$Y$$$20240730$$CN$US$US
241531601$24153160$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119947$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240730$$CN$US$US
241531611$24153161$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120339$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240730$$HP$US$US
241531621$24153162$1$I$20240201$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120054$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$74.84$KG$20240730$$CN$US$US
241531633$24153163$3$F$20240710$20240902$20240730$20240909$EXP$DE-AMK-278612$NVSC2024DE154811$NOVARTIS$$74$YR$$F$Y$$$20240909$$PH$DE$DE
241531644$24153164$4$F$$20240904$20240730$20240907$EXP$$NVSC2024PT154392$NOVARTIS$Valente CT, Tenreiro P, Figueiredo RS. A case of toxidermia to imatinib. CONGRESSES OF THE PORTUGUESE SOCIETY OF INTERNAL MEDICINE. 2024;1470$76$YR$$F$Y$$$20240907$$HP$PT$PT
241531651$24153165$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A171407$ASTRAZENECA$$2293$WK$$M$Y$$$20240730$$CN$US$
241531661$24153166$1$I$$20240723$20240730$20240730$EXP$$US-GSK-US2024092283$GLAXOSMITHKLINE$$$$$M$Y$$$20240730$$MD$US$US
241531672$24153167$2$F$$20240715$20240730$20240812$EXP$$PT-TEVA-VS-3222375$TEVA$Literature Reference: Mariana Moura Portugal; Ana Carolina Martins; Carla Serodio I: PO-0118 - (4088) - ACUTE METHOTREXATE POISONING, Emergency, intermediate care and critically ill patients | Clinical case; Literature Reference: Mariana Moura Portugal; Ana Carolina Martins; Carla Serodio I: PO-0118 - (4088) - ACUTE METHOTREXATE POISONING, Emergency, intermediate care and critically ill patients | Clinical case$85$YR$$F$Y$$$20240812$$MD$PT$PT
241531681$24153168$1$I$$20240724$20240730$20240730$PER$$US-ABBVIE-5856883$ABBVIE$$$$$$Y$$$20240730$$CN$US$US
241531701$24153170$1$I$$20240723$20240730$20240730$PER$$US-FreseniusKabi-FK202411569$FRESENIUS KABI$$42$YR$A$F$Y$$$20240730$$CN$US$US
241531711$24153171$1$I$20240627$20240722$20240730$20240730$EXP$BE-FAMHP-DHH-N2024-122337$BE-FreseniusKabi-FK202411575$FRESENIUS KABI$$63$YR$A$M$Y$106$KG$20240730$$PH$BE$BE
241531722$24153172$2$F$20240627$20240909$20240730$20240920$EXP$IT-MINISAL02-995815$IT-FreseniusKabi-FK202411659$FRESENIUS KABI$$60$YR$A$M$Y$70$KG$20240920$$MD$IT$IT
241531742$24153174$2$F$$20240826$20240730$20240828$EXP$$NZ-MYLANLABS-2024M1070618$MYLAN$$$$$F$Y$$$20240828$$PH$NZ$NZ
241531753$24153175$3$F$20240720$20240805$20240730$20240815$EXP$$GB-MYLANLABS-2024M1052733$MYLAN$$$$$M$Y$$$20240815$$PH$GB$GB
241531761$24153176$1$I$$20240719$20240730$20240730$PER$$US-RDY-LIT/USA/24/0010994$DR REDDYS$Chai AL, Rakocevic R, El-Baba FM, Killu K. Transient Diabetes Insipidus After Vasopressin Discontinuation. American Journal of Respiratory and Critical Care Medicine. 2023 May;207: A5282. doi:10.1164/ajrccm-conference.2023.C52.$59$YR$A$M$Y$$$20240730$$HP$US$US
241531782$24153178$2$F$20240726$20240808$20240730$20240812$PER$$US-AMGEN-USASP2024149414$AMGEN$$77$YR$E$F$Y$$$20240811$$MD$US$US
241531791$24153179$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120144$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$CN$US$US
241531801$24153180$1$I$$20240722$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116775$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$73.94$KG$20240730$$CN$US$US
241531811$24153181$1$I$20240101$20240725$20240730$20240730$PER$$US-ABBVIE-5859108$ABBVIE$$$$$M$Y$$$20240730$$HP$US$US
241531821$24153182$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189644$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241531832$24153183$2$F$20240101$20240729$20240730$20240801$PER$$US-AMGEN-USASP2024150947$AMGEN$$60$YR$A$F$Y$$$20240801$$HP$US$US
241531841$24153184$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225318$TEVA$$16$YR$$F$Y$52$KG$20240730$$HP$CA$CA
241531851$24153185$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150188$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241531861$24153186$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219289$SANOFI AVENTIS$$$$A$F$Y$$$20240730$$MD$US$US
241531871$24153187$1$I$20230601$20240716$20240730$20240730$DIR$FDA-CDER-CTU-2024-52176$$FDA-CTU$$$$$$N$$$20240716$N$CN$US$
241531881$24153188$1$I$20240626$20240717$20240730$20240730$DIR$FDA-CDER-CTU-2024-52177$$FDA-CTU$$74$YR$$F$N$154$LBS$20240717$N$CN$US$
241531891$24153189$1$I$20231105$20240718$20240730$20240730$PER$$US-SA-2024SA216198$SANOFI AVENTIS$$53$YR$A$F$Y$72.57$KG$20240730$$MD$US$US
241531901$24153190$1$I$20240118$20240722$20240730$20240730$PER$$US-SA-2024SA216465$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240730$$CN$US$US
241531911$24153191$1$I$20240709$20240724$20240730$20240730$EXP$FR-AFSSAPS-PB2024000803$FR-MYLANLABS-2024M1069360$MYLAN$$67$YR$$F$Y$83.7$KG$20240730$$PH$FR$FR
241531921$24153192$1$I$20240614$20240724$20240730$20240730$EXP$FR-AFSSAPS-TO2024001321$FR-MYLANLABS-2024M1069860$MYLAN$$94$YR$$M$Y$67.5$KG$20240730$$MD$FR$FR
241531931$24153193$1$I$20240501$20240724$20240730$20240730$EXP$FR-AFSSAPS-RN2024000761$FR-MYLANLABS-2024M1069559$MYLAN$$57$YR$$M$Y$$$20240730$$MD$FR$FR
241531941$24153194$1$I$20240409$20240724$20240730$20240730$EXP$IT-MINISAL02-995430$IT-MYLANLABS-2024M1069093$MYLAN$$78$YR$$M$Y$$$20240730$$MD$IT$IT
241531951$24153195$1$I$20240611$20240724$20240730$20240730$EXP$ES-AEMPS-1549721$ES-MYLANLABS-2024M1069258$MYLAN$$84$YR$$F$Y$49$KG$20240730$$MD$ES$ES
241531961$24153196$1$I$20240608$20240729$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120465$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240730$$CN$US$US
241531971$24153197$1$I$$20240715$20240730$20240730$EXP$$US-HLS-202400397$HLS THERAPEUTICS$$58$YR$A$F$Y$$$20240730$$MD$US$US
241531981$24153198$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120518$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240730$$CN$US$US
241531991$24153199$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120073$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240730$$CN$US$US
241532002$24153200$2$F$20180101$20240905$20240730$20240909$EXP$$CL-ORGANON-O2407CHL002692$ORGANON$$25$YR$$F$Y$$$20240909$$MD$CL$CL
241532011$24153201$1$I$$20240712$20240730$20240730$PER$$US-TEVA-VS-3221451$TEVA$$$$$F$Y$$$20240730$$CN$US$US
241532021$24153202$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA216941$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240730$$MD$US$US
241532031$24153203$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA217956$SANOFI AVENTIS$$50$YR$A$M$Y$116.1$KG$20240730$$MD$US$US
241532041$24153204$1$I$20240627$20240725$20240730$20240730$PER$$US-SA-2024SA221305$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240730$$HP$US$US
241532052$24153205$2$F$20240313$20240821$20240730$20240827$EXP$$CZ-MYLANLABS-2024M1069084$MYLAN$$75$YR$$M$Y$65$KG$20240827$$MD$CZ$CZ
241532062$24153206$2$F$20220617$20240918$20240730$20240925$EXP$AT-EMA-DD-20240712-7482661-082834$AT-TEVA-VS-3225263$TEVA$$29$YR$$M$Y$88.2$KG$20240925$$HP$AT$AT
241532071$24153207$1$I$20240618$20240723$20240730$20240730$EXP$$CA-JNJFOC-20240764440$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240730$$HP$CA$CA
241532081$24153208$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155173$NOVARTIS$$$$$$Y$$$20240730$$CN$US$US
241532091$24153209$1$I$$20240726$20240730$20240730$EXP$$US-ABBVIE-5857015$ABBVIE$$$$$F$Y$$$20240730$$HP$US$US
241532101$24153210$1$I$$20240719$20240730$20240730$PER$$US-RDY-LIT/USA/24/0010987$DR REDDYS$Viswanath P, Zhao H, Wayland J, Dean J, Heynekamp TR. Decoding the Enigma of Eosinophils in Pleural Fluid. American Journal of Respiratory and Critical Care Medicine. 2024 May;209(0): A1945. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1945.$34$YR$A$M$Y$$$20240730$$HP$US$US
241532111$24153211$1$I$$20240727$20240730$20240730$EXP$$IT-ABBVIE-5858974$ABBVIE$$$$E$M$Y$$$20240730$$CN$IT$IT
241532121$24153212$1$I$20240601$20240727$20240730$20240730$EXP$$ZA-ABBVIE-5858904$ABBVIE$$25$YR$$M$Y$$$20240730$$CN$ZA$ZA
241532131$24153213$1$I$20240101$20240725$20240730$20240730$EXP$$NL-ABBVIE-5520569$ABBVIE$$$$E$F$Y$$$20240730$$CN$NL$NL
241532141$24153214$1$I$20240424$20240725$20240730$20240730$EXP$$US-APELLIS-2024-APL-0000570$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240730$$CN$US$US
241532153$24153215$3$F$$20240822$20240730$20240828$30DAY$$US-JNJFOC-20240741873$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240828$$CN$US$US
241532161$24153216$1$I$$20240716$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114065$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$95.25$KG$20240730$$CN$US$US
241532171$24153217$1$I$20240201$20240727$20240730$20240730$EXP$$MX-AstraZeneca-2024A172338$ASTRAZENECA$$835$MON$$M$Y$$$20240730$$CN$MX$
241532181$24153218$1$I$20240621$20240722$20240730$20240730$EXP$$CO-ABBVIE-5822951$ABBVIE$$65$YR$$M$Y$78$KG$20240730$$HP$CO$CO
241532191$24153219$1$I$$20220531$20240730$20240730$EXP$$US-AstraZeneca-2022A204350$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241532201$24153220$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A167061$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241532212$24153221$2$F$20230105$20240913$20240730$20240918$EXP$$US-AstraZeneca-2024A166848$ASTRAZENECA$$26755$DY$$F$Y$93.4$KG$20240918$$MD$US$
241532221$24153222$1$I$20240101$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024147561$AMGEN$$$$$M$Y$58.957$KG$20240730$$CN$US$US
241532233$24153223$3$F$$20240911$20240730$20240919$EXP$$PL-MYLANLABS-2024M1069672$MYLAN$Zakrzewski, D., Zawadzka, M., Mazurkiewicz-Beldziiska, M.. A Boy with Severe Refractory Epileptic Seizures with Onset at Six Months of Age and Psychomotor Retardation. Practical Medicine-Neurology. 2024;87(3):57-60$6$MON$$M$Y$$$20240919$$MD$PL$PL
241532242$24153224$2$F$$20240830$20240730$20240906$EXP$$JP-OTSUKA-2024_018232$OTSUKA$$10$DEC$$M$Y$$$20240906$$PH$JP$JP
241532252$24153225$2$F$20231211$20240814$20240730$20240819$EXP$$JP-OTSUKA-2024_013128$OTSUKA$$81$YR$$F$Y$47$KG$20240819$$MD$JP$JP
241532281$24153228$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018876$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240730$$CN$US$US
241532291$24153229$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017897$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240730$$CN$US$US
241532301$24153230$1$I$20240724$20240724$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016423$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240730$$CN$US$US
241532313$24153231$3$F$$20240829$20240730$20240829$30DAY$$US-PFIZER INC-202400220979$PFIZER$$17$YR$$F$Y$$$20240829$$CN$US$US
241532321$24153232$1$I$$20240719$20240730$20240730$30DAY$$US-PFIZER INC-202400220447$PFIZER$$16$YR$$M$Y$$$20240730$$CN$US$US
241532332$24153233$2$F$$20240830$20240730$20240830$30DAY$$US-PFIZER INC-202400221172$PFIZER$$38$YR$$F$Y$$$20240830$$CN$US$US
241532342$24153234$2$F$$20240830$20240730$20240830$30DAY$$US-PFIZER INC-202400221403$PFIZER$$16$YR$$M$Y$$$20240830$$CN$US$US
241532351$24153235$1$I$$20240719$20240730$20240730$30DAY$$US-PFIZER INC-202400220303$PFIZER$$60$YR$$F$Y$$$20240730$$CN$US$US
241532363$24153236$3$F$$20240831$20240730$20240903$30DAY$$US-PFIZER INC-202400219641$PFIZER$$11$YR$$M$Y$$$20240903$$CN$US$US
241532371$24153237$1$I$20240701$20240719$20240730$20240730$PER$$US-SA-2024SA218945$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240730$$MD$US$US
241532381$24153238$1$I$20240701$20240723$20240730$20240730$EXP$$US-OTSUKA-2024_020593$OTSUKA$$$$$F$Y$$$20240730$$MD$US$US
241532392$24153239$2$F$20240101$20240816$20240730$20240821$EXP$$US-ABBVIE-5731082$ABBVIE$$$$$F$Y$102$KG$20240821$$CN$US$US
241532401$24153240$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189531$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241532411$24153241$1$I$20240619$20240725$20240730$20240730$EXP$$DE-ABBVIE-5811823$ABBVIE$$33$YR$$M$Y$$$20240730$$CN$DE$DE
241532421$24153242$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150169$AMGEN$$$$$$Y$$$20240730$$HP$US$US
241532431$24153243$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150173$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241532441$24153244$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150257$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241532452$24153245$2$F$$20240918$20240730$20240923$EXP$$US-BAYER-2024A109129$BAYER$$32$YR$A$M$Y$89$KG$20240923$$CN$US$US
241532461$24153246$1$I$$20240726$20240730$20240730$PER$$US-HALEON-2189633$Haleon PLC$$$$$F$Y$$$20240730$$CN$US$US
241532472$24153247$2$F$20230520$20240822$20240730$20240829$EXP$$CA-GSK-CA2023062933$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$HP$CA$CA
241532481$24153248$1$I$$20211102$20240730$20240730$EXP$$NL-BIOVITRUM-2021NL1011$BIOVITRUM$$$$I$M$Y$8.8$KG$20240730$$HP$NL$NL
241532491$24153249$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225221$TEVA$$11$YR$$M$Y$53$KG$20240730$$PH$CA$CA
241532511$24153251$1$I$$20240729$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US069073$SANDOZ$$$$$M$Y$$$20240730$$CN$US$US
241532521$24153252$1$I$$20240722$20240730$20240730$EXP$$GB-TEVA-VS-3224684$TEVA$$43$YR$$F$Y$82$KG$20240730$$MD$GB$GB
241532531$24153253$1$I$$20240726$20240730$20240730$PER$$NVSC2024US155431$NOVARTIS$$19$YR$$F$Y$$$20240730$$CN$US$US
241532541$24153254$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120168$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240730$$HP$US$US
241532551$24153255$1$I$$20240722$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120692$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$71.21$KG$20240730$$CN$US$US
241532561$24153256$1$I$$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119945$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240730$$CN$US$US
241532571$24153257$1$I$$20240402$20240730$20240730$30DAY$$US-SANDOZ INC.-SDZ2024US069074$SANDOZ$$10$YR$$M$Y$$$20240730$$CN$US$US
241532581$24153258$1$I$20240728$20240729$20240730$20240730$PER$$US-AMGEN-USASP2024150271$AMGEN$$47$YR$A$F$Y$$$20240730$$CN$US$US
241532591$24153259$1$I$20180301$20240723$20240730$20240730$EXP$$ES-JNJFOC-20240767597$JOHNSON AND JOHNSON$$96$YR$E$F$Y$75.3$KG$20240730$$MD$ES$ES
241532602$24153260$2$F$20240717$20240807$20240730$20240812$EXP$$GB-MYLANLABS-2024M1069293$MYLAN$$$$$F$Y$$$20240812$$CN$GB$GB
241532611$24153261$1$I$$20240723$20240730$20240730$EXP$$US-MYLANLABS-2024M1069895$MYLAN$Nguyen BM, Do CL, Boydstun IP, Wall PB. Iris atrophy following intracameral dexamethasone injection: a report of two pediatric cases. J-AAPOS 2024; 28 (3):.$10$YR$$F$Y$$$20240730$$MD$US$US
241532621$24153262$1$I$20240621$20240723$20240730$20240730$EXP$IT-MINISAL02-995205$IT-MYLANLABS-2024M1069079$MYLAN$$8$DY$$M$Y$1.61$KG$20240730$$MD$IT$IT
241532631$24153263$1$I$$20240723$20240730$20240730$EXP$$US-MYLANLABS-2024M1070267$MYLAN$Cypro A, Odish MF, Yi C, Pollema TL, Owens RL. Incidental Deep Venous Thromboses Found Post-decannulation of Large Extracorporeal Membrane Oxygenation Cannulas. Am-J-Respir-Crit-Care-Med 2023; 207 A5221.$45$YR$$M$Y$$$20240730$$HP$US$US
241532642$24153264$2$F$$20240805$20240730$20240814$EXP$$GR-MYLANLABS-2024M1070117$MYLAN$A. Iliaki, P. Pastras, C. Moisis, E. Koullias, A. Kyritsis, H. Mariolis, D. Vasilopoulos. Case of immunocompromised woman with fever and mucositis while taking methotrexate, who was eventually diagnosed with endocarditis with negative blood cultures. 50th annual panhellenic medical congress. 2024;198$60$YR$$F$Y$$$20240814$$MD$GR$GR
241532651$24153265$1$I$$20240723$20240730$20240730$EXP$$US-MYLANLABS-2024M1069789$MYLAN$Kulkarni R, Abdelrahman A, Ghesani M, Ghesani N, Wolin E, Oh W, et al. Management Of Concomitant Prostate Cancer and Pancreatic Neuroendocrine Tumour: Role of Nuclear Medicine in therapeutic decision making. J-Nucl-Med 2023; 64 (Suppl. 1) 1440.$71$YR$$M$Y$$$20240730$$HP$US$US
241532661$24153266$1$I$$20240723$20240730$20240730$EXP$$PT-MYLANLABS-2024M1069326$MYLAN$Pic?o de Carvalho C, Carmo F, Martins R, Matos E, Torres E, Rebelo M. Pic?o de Carvalho C, Carmo F, Martins R, Matos E, Torres E, Rebelo M.. When vitamin supplementation would make all the difference.. Birth and Growth Medical Journal. 2024;33(2):127-132$6$MON$$F$Y$$$20240730$$MD$PT$PT
241532671$24153267$1$I$$20240723$20240730$20240730$EXP$$US-MYLANLABS-2024M1069846$MYLAN$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$38$YR$$M$Y$$$20240730$$HP$US$US
241532681$24153268$1$I$20240401$20240723$20240730$20240730$EXP$$FR-MYLANLABS-2024M1069582$MYLAN$$61$YR$$F$Y$$$20240730$$CN$FR$FR
241532691$24153269$1$I$$20240723$20240730$20240730$EXP$$US-MYLANLABS-2024M1069793$MYLAN$Majid M, Arockiam AD, Yaker ZS, Kumar A, Agrawal A, Bhalla JS, et al. A case of longstanding chronic recurrent pericarditis managed with advanced diagnostic and therapeutic methods . J-Am-Coll-Cardiol 2024; 83 (13): 3496.$65$YR$$F$Y$$$20240730$$HP$US$US
241532702$24153270$2$F$20240710$20240813$20240730$20240820$EXP$$US-ALXN-202407USA001562US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
241532711$24153271$1$I$$20240723$20240730$20240730$EXP$$IT-MYLANLABS-2024M1069873$MYLAN$Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al. Pickering Syndrome: An Overlooked Renovascular Cause of Recurrent Heart Failure. J-Am-Heart-Assoc 2023; 12 (19):.$75$YR$$M$Y$$$20240730$$MD$IT$IT
241532721$24153272$1$I$20240101$20240723$20240730$20240730$PER$$US-ABBVIE-5854532$ABBVIE$$$$$$Y$$$20240730$$HP$US$US
241532731$24153273$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-07142$HIKMA$Dias F, Santos e Silva A, Alvarenga L, Sobral S, Gamito Lopes J, Nzwalo H, Rita H. Dias F, Santos e Silva A, Alvarenga L, Sobral S, Gamito Lopes J, Nzwalo H, Rita H. Atr?s do drag?o, a encefalopatia - relato de caso cl?nico. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI. 2024;1003$33$YR$$M$Y$$$20240730$$MD$PT$PT
241532741$24153274$1$I$20240729$20240730$20240730$20240730$DIR$712040$$FDA-CTU$$87$YR$$M$N$$$20240730$N$$US$
241532761$24153276$1$I$20240729$20240730$20240730$20240730$DIR$712041$$FDA-CTU$$69$YR$$M$N$$$20240730$N$$US$
241532791$24153279$1$I$20240727$20240730$20240730$20240730$DIR$712046$$FDA-CTU$$30$YR$$M$N$$$20240730$N$PH$US$
241532801$24153280$1$I$20240725$20240730$20240730$20240730$DIR$712033$$FDA-CTU$$32$YR$$M$N$83.7$KG$20240730$N$CN$US$
241532834$24153283$4$F$20240719$20240826$20240730$20240829$PER$$US-AMGEN-USASP2024148343$AMGEN$$69$YR$E$F$Y$$$20240828$$CN$US$US
241532841$24153284$1$I$$20240722$20240730$20240730$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001487$BLUEPRINT MEDICINES$$$$$M$Y$$$20240730$$PH$US$US
241532852$24153285$2$F$$20240808$20240730$20240813$EXP$$US-TAKEDA-2024TUS032778$TAKEDA$$$$$F$Y$60.59$KG$20240813$$CN$US$US
241532862$24153286$2$F$20240701$20240805$20240730$20240809$EXP$$US-AMGEN-USASP2024148970$AMGEN$$62$YR$A$F$Y$$$20240809$$MD$US$US
241532871$24153287$1$I$$20240723$20240730$20240730$EXP$$FR-OTSUKA-2024_020580$OTSUKA$$22$YR$$F$Y$$$20240730$$MD$FR$FR
241532881$24153288$1$I$$20240726$20240730$20240730$EXP$$US-TAKEDA-2024TUS076132$TAKEDA$$$$$M$Y$133.79$KG$20240730$$HP$US$US
241532891$24153289$1$I$$20240716$20240730$20240730$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06972$HIKMA$Shah D.. Shah D. Diagnostic Challenges of Psoriasis: A Multifaceted Case of Triple-Drug Interaction and Literature Review.. Consultant. 2024;64(6):e3:6$37$YR$$F$Y$$$20240730$$MD$US$US
241532901$24153290$1$I$20240719$20240725$20240730$20240730$EXP$$NVSC2024CN154246$NOVARTIS$$74$YR$$M$Y$$$20240730$$HP$CN$CN
241532912$24153291$2$F$$20240829$20240730$20240829$30DAY$$US-PFIZER INC-202400222037$PFIZER$$14$YR$$M$Y$$$20240829$$CN$US$US
241532922$24153292$2$F$$20240829$20240730$20240829$30DAY$$US-PFIZER INC-202400221162$PFIZER$$17$YR$$M$Y$$$20240829$$CN$US$US
241532942$24153294$2$F$$20240829$20240730$20240829$30DAY$$US-PFIZER INC-202400222939$PFIZER$$14$YR$$M$Y$$$20240829$$CN$US$US
241532953$24153295$3$F$20240721$20240903$20240730$20240905$30DAY$$US-PFIZER INC-202400221082$PFIZER$$8$YR$$M$Y$22.77$KG$20240905$$CN$US$US
241532973$24153297$3$F$$20240904$20240730$20240904$30DAY$$US-PFIZER INC-202400223322$PFIZER$$14$YR$$M$Y$$$20240904$$CN$US$US
241533003$24153300$3$F$$20240912$20240730$20240918$30DAY$$US-PFIZER INC-202400222294$PFIZER$$9$YR$$M$Y$$$20240918$$CN$US$US
241533012$24153301$2$F$20240101$20240823$20240730$20240828$30DAY$$US-PFIZER INC-202400222626$PFIZER$$14$YR$$M$Y$$$20240828$$HP$US$US
241533022$24153302$2$F$$20240830$20240730$20240830$30DAY$$US-PFIZER INC-202400220918$PFIZER$$9$YR$$F$Y$$$20240830$$HP$US$US
241533032$24153303$2$F$20240101$20240823$20240730$20240828$30DAY$$US-PFIZER INC-202400223324$PFIZER$$12$YR$$F$Y$43.09$KG$20240828$$MD$US$US
241533051$24153305$1$I$20240626$20240722$20240730$20240730$EXP$ES-AEMPS-1549106$ES-TEVA-VS-3225145$TEVA$$83$YR$$M$Y$$$20240730$$PH$ES$ES
241533061$24153306$1$I$20210301$20240723$20240730$20240730$EXP$$NVSC2024PL151896$NOVARTIS$$59$YR$$M$Y$90$KG$20240730$$MD$PL$PL
241533071$24153307$1$I$$20240726$20240730$20240730$30DAY$$US-SANDOZ INC.-SDZ2024US069023$SANDOZ$$$$$F$Y$$$20240730$$MD$US$US
241533081$24153308$1$I$$20240723$20240730$20240730$EXP$$NVSC2024CA111853$NOVARTIS$$48$YR$$F$Y$$$20240730$$CN$CA$CA
241533101$24153310$1$I$20240617$20240722$20240730$20240730$EXP$FR-AFSSAPS-BX2024001447$FR-TEVA-VS-3223443$TEVA$$79$YR$$M$Y$65$KG$20240730$$MD$FR$FR
241533111$24153311$1$I$20010101$20240727$20240730$20240730$30DAY$$US-SANDOZ INC.-SDZ2024US068729$SANDOZ$$$$$F$Y$$$20240730$$HP$US$US
241533122$24153312$2$F$$20240806$20240730$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120459$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240808$$CN$US$US
241533131$24153313$1$I$$20240724$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016428$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240730$$CN$US$US
241533141$24153314$1$I$$20240722$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018811$ELI LILLY AND CO$$$$$F$Y$$$20240730$$PH$US$US
241533152$24153315$2$F$$20240802$20240730$20240808$EXP$$US-TAKEDA-2024TUS076225$TAKEDA$$$$$F$Y$$$20240808$$CN$US$US
241533162$24153316$2$F$20240704$20240902$20240730$20240904$30DAY$$FR-JNJFOC-20240739429$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20240905$$PH$FR$FR
241533171$24153317$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA217251$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240730$$MD$US$US
241533182$24153318$2$F$20240601$20240816$20240730$20240819$PER$$US-ALXN-202407USA001584US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
241533191$24153319$1$I$20240711$20240725$20240730$20240730$EXP$$CN-TAKEDA-2024TUS075705$TAKEDA$$61$YR$$M$Y$65$KG$20240730$$HP$CN$CN
241533202$24153320$2$F$20240610$20240729$20240730$20240812$EXP$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457230$DE-UCBSA-2024038044$UCB$$27$YR$$M$Y$70$KG$20240812$$CN$DE$DE
241533211$24153321$1$I$20240715$20240730$20240730$20240730$DIR$712051$$FDA-CTU$$61$YR$$F$N$$$20240730$N$PH$US$
241533221$24153322$1$I$20240618$20240730$20240730$20240730$DIR$712052$$FDA-CTU$$52$YR$$M$N$105$KG$20240730$N$HP$US$
241533231$24153323$1$I$$20240725$20240730$20240730$EXP$$CA-MYLANLABS-2024M1069901$MYLAN$$$$$$Y$$$20240730$$CN$CA$CA
241533241$24153324$1$I$20240729$20240730$20240730$20240730$DIR$712032$$FDA-CTU$$32$YR$$M$N$83.7$KG$20240730$N$CN$US$
241533251$24153325$1$I$20240619$20240730$20240730$20240730$DIR$712054$$FDA-CTU$$52$YR$$M$N$104$KG$20240730$N$HP$US$
241533261$24153326$1$I$20240722$20240730$20240730$20240730$DIR$712049$$FDA-CTU$$65$YR$$F$N$$$20240730$Y$PH$US$
241533271$24153327$1$I$20240726$20240730$20240730$20240730$DIR$712042$$FDA-CTU$$72$YR$$F$N$$$20240730$N$PH$US$
241533291$24153329$1$I$$20240725$20240730$20240730$EXP$$JP-ABBVIE-5853819$ABBVIE$$47$YR$$F$Y$$$20240730$$MD$JP$JP
241533302$24153330$2$F$$20240801$20240730$20240810$EXP$$PL-TEVA-VS-3224206$TEVA$Kuc A, Stachura A, Jazdzyk P, Grzelinska J, Swiecicki L. Adjunctive electroconvulsive therapy in the treatment of a patient with comorbid major depressive disorder, posttraumatic stress disorder, and anorexia nervosa - a case report. Postepy-Psychiatrii-i-Neurologii 2024; 33 (1): 43-48.; Kuc A, Stachura A, Jazdzyk P, Grzelinska J, Swiecicki L. Adjunctive electroconvulsive therapy in the treatment of a patient with comorbid major depressive disorder, posttraumatic stress disorder, and anorexia...$28$YR$$F$Y$$$20240810$$HP$PL$PL
241533311$24153331$1$I$20240719$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149859$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241533322$24153332$2$F$$20240823$20240730$20240828$EXP$NL-LRB-00993628$NL-BAYER-2024A109886$BAYER$$30$YR$A$F$Y$88$KG$20240828$$CN$NL$NL
241533332$24153333$2$F$20231201$20240806$20240730$20240812$PER$$US-ABBVIE-5859812$ABBVIE$$75$YR$$F$Y$$$20240812$$CN$US$US
241533341$24153334$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-07144$HIKMA$Valente CT, Figueiredo RS, Santos CS, Gon?alves FR, Coelho S, Correia J. Valente CT, Figueiredo RS, Santos CS, Gon?alves FR, Coelho S, Correia J. POSA-135 - (4425) - Vasculite de pequenos vasos - um caso de vasculite leucocitocl?stica medicamentosa. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI. 2024;1210$70$YR$$F$Y$$$20240730$$MD$PT$PT
241533351$24153335$1$I$$20240719$20240730$20240730$EXP$$IN-ROCHE-10000036789$ROCHE$$73$YR$E$M$Y$$$20240730$$MD$IN$IN
241533361$24153336$1$I$$20240614$20240730$20240730$PER$$US-TRAVERE-2024TVT00610$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240730$$CN$US$US
241533371$24153337$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219224$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240730$$MD$US$US
241533381$24153338$1$I$20240629$20240730$20240730$20240730$DIR$712066$$FDA-CTU$$74$YR$$F$N$70$KG$20240730$N$HP$US$
241533391$24153339$1$I$20240101$20240723$20240730$20240730$PER$$US-SA-2024SA219166$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240730$$MD$US$US
241533401$24153340$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217394$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240730$$MD$US$US
241533411$24153341$1$I$$20240725$20240730$20240730$EXP$$CA-MYLANLABS-2024M1069911$MYLAN$$$$$F$Y$$$20240730$$HP$CA$CA
241533421$24153342$1$I$20210225$20210827$20240730$20240730$EXP$$CA-AstraZeneca-2021A112094$ASTRAZENECA$$25896$DY$$F$Y$$$20240730$$MD$CA$
241533431$24153343$1$I$$20240730$20240730$20240730$DIR$712061$$FDA-CTU$$$$$UNK$N$$$20240730$$CN$US$
241533441$24153344$1$I$$20230110$20240730$20240730$EXP$$US-AstraZeneca-2023A006975$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241533451$24153345$1$I$$20210730$20240730$20240730$EXP$$US-AstraZeneca-2021A660464$ASTRAZENECA$$$$$$Y$$$20240730$$CN$US$
241533461$24153346$1$I$$20240723$20240730$20240730$PER$$US-ABBVIE-5852984$ABBVIE$$$$$$Y$$$20240730$$CN$US$US
241533472$24153347$2$F$20240301$20240906$20240730$20240913$EXP$$DE-AstraZeneca-2024A170355$ASTRAZENECA$$72$YR$$M$Y$$$20240913$$MD$DE$
241533491$24153349$1$I$$20200424$20240730$20240730$EXP$$US-AstraZeneca-2020SE50116$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241533501$24153350$1$I$20240615$20240724$20240730$20240730$EXP$$CA-JNJFOC-20240776697$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$MD$CA$CA
241533511$24153351$1$I$$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A170735$ASTRAZENECA$$$$$M$Y$$$20240730$$HP$US$
241533531$24153353$1$I$$20240721$20240730$20240730$EXP$$BR-JNJFOC-20240761992$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$BR$BR
241533541$24153354$1$I$20240531$20240702$20240730$20240730$DIR$FDA-CDER-CTU-2024-52178$$FDA-CTU$$75$YR$$F$N$117$LBS$20240702$N$CN$US$
241533551$24153355$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149412$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241533561$24153356$1$I$20240620$20240730$20240730$20240730$DIR$712059$$FDA-CTU$$65$YR$$M$N$71.6$KG$20240730$N$HP$US$
241533581$24153358$1$I$20240729$20240730$20240730$20240730$DIR$712063$$FDA-CTU$$58$YR$$M$N$$$20240730$N$$US$
241533591$24153359$1$I$$20201221$20240730$20240730$EXP$$US-AstraZeneca-2020SF73099$ASTRAZENECA$$71$YR$$F$Y$$$20240730$$CN$US$
241533601$24153360$1$I$$20230110$20240730$20240730$EXP$$US-AstraZeneca-2023A008427$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241533611$24153361$1$I$20240101$20240724$20240730$20240730$EXP$$US-009507513-2407USA014897$MERCK$$76$YR$$M$Y$$$20240730$$CN$US$US
241533621$24153362$1$I$20240719$20240722$20240730$20240730$EXP$GB-MHRA-MED-202407222214251530-LHRDY$GB-TEVA-VS-3224523$TEVA$$70$YR$$F$Y$52$KG$20240730$$CN$GB$GB
241533631$24153363$1$I$$20240722$20240730$20240730$EXP$$MT-AstraZeneca-2024A172537$ASTRAZENECA$$69$YR$$F$Y$$$20240730$$MD$MT$
241533641$24153364$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-07139$HIKMA$Cruz D, Silva CP, Sevivas R, Pereira FM, Abreu JP, Ribeiro M.. Cruz D, Silva CP, Sevivas R, Pereira FM, Abreu JP, Ribeiro M. PO-0599 - (4122) - Doen?a de Whipple: Do envolvimento neurol?gico ? rea??o de Jarisch-Herxheime. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI. 2024;/:945$70$YR$$F$Y$$$20240730$$MD$PT$PT
241533651$24153365$1$I$$20221014$20240730$20240730$EXP$$US-AstraZeneca-2022A348330$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241533661$24153366$1$I$$20240722$20240730$20240730$EXP$$ZA-AstraZeneca-2024A166847$ASTRAZENECA$$67$YR$$M$Y$$$20240730$$CN$ZA$
241533671$24153367$1$I$20240705$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A170131$ASTRAZENECA$$29498$DY$$M$Y$$$20240730$$CN$US$
241533682$24153368$2$F$20230828$20240722$20240730$20240731$EXP$$FR-AstraZeneca-2024A172965$ASTRAZENECA$$37$YR$$M$Y$$$20240731$$HP$FR$
241533691$24153369$1$I$20240430$20240729$20240730$20240730$EXP$$CN-ROCHE-10000040268$ROCHE$$52$YR$A$F$Y$$$20240730$$HP$CN$CN
241533701$24153370$1$I$$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A169970$ASTRAZENECA$$$$$F$Y$$$20240730$$MD$US$
241533711$24153371$1$I$20240615$20240727$20240730$20240730$EXP$$IN-AstraZeneca-2024A172135$ASTRAZENECA$$26097$DY$$F$Y$$$20240730$$CN$IN$
241533721$24153372$1$I$$20240722$20240730$20240730$EXP$$IE-AstraZeneca-2024A165973$ASTRAZENECA$$$$A$F$Y$$$20240730$$MD$IE$
241533731$24153373$1$I$20240526$20240722$20240730$20240730$EXP$$CN-AstraZeneca-2024A168980$ASTRAZENECA$$2237$WK$$M$Y$$$20240730$$MD$CN$
241533741$24153374$1$I$20210901$20240722$20240730$20240730$EXP$$RO-AstraZeneca-2024A166338$ASTRAZENECA$$69$YR$$F$Y$$$20240730$$MD$RO$
241533751$24153375$1$I$20240515$20240724$20240730$20240730$EXP$$ID-AstraZeneca-2024A171279$ASTRAZENECA$$20468$DY$$F$Y$$$20240730$$CN$ID$
241533771$24153377$1$I$$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A170521$ASTRAZENECA$$$$$M$Y$74.8$KG$20240730$$CN$US$
241533781$24153378$1$I$$20240722$20240730$20240730$EXP$$JP-AstraZeneca-2024A169891$ASTRAZENECA$$80$YR$$F$Y$$$20240730$$MD$JP$
241533791$24153379$1$I$$20240725$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007849$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241533801$24153380$1$I$20240724$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A169999$ASTRAZENECA$$28065$DY$$F$Y$$$20240730$$HP$US$
241533811$24153381$1$I$$20240725$20240730$20240730$EXP$$IQ-JNJFOC-20240775740$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$MD$IQ$IQ
241533821$24153382$1$I$20240502$20240724$20240730$20240730$EXP$FR-AFSSAPS-LL2024001318$FR-MYLANLABS-2024M1069336$MYLAN$$58$YR$$M$Y$81$KG$20240730$$CN$FR$FR
241533831$24153383$1$I$20240401$20240711$20240730$20240730$PER$$US-009507513-2407USA008399$MERCK$$$$$F$Y$$$20240730$$CN$US$US
241533841$24153384$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA221547$SANOFI AVENTIS$$74$YR$E$F$Y$60.3$KG$20240730$$MD$US$US
241533852$24153385$2$F$20240725$20240827$20240730$20240829$PER$$US-JNJFOC-20240773896$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240829$$CN$US$US
241533862$24153386$2$F$$20240823$20240730$20240830$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-115595$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240830$$PH$FR$FR
241533872$24153387$2$F$$20240725$20240730$20240806$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-120299$BRISTOL MYERS SQUIBB$$6$DEC$A$$Y$$$20240806$$CN$TR$TR
241533881$24153388$1$I$20240725$20240726$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119993$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$58.06$KG$20240730$$HP$US$US
241533893$24153389$3$F$$20240808$20240730$20240816$PER$$NVSC2024US154700$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
241533901$24153390$1$I$$20240724$20240730$20240730$EXP$ES-AGUETTANT-2024000961$ES-MYLANLABS-2024M1069428$MYLAN$Greciano Calero P, Galmss Rossello Ll, Gil Ssnchez JA, Escriba Bori S.. Girl with acute coronary syndrome of allergic cause (Kounis Syndrome): a case report. Academic Journal of Health Sciences. 2024;39(4):154-156$14$YR$$F$Y$$$20240730$$MD$ES$ES
241533911$24153391$1$I$$20240726$20240730$20240730$EXP$$US-TAKEDA-2024TUS027928$TAKEDA$$$$$M$Y$$$20240730$$CN$US$US
241533921$24153392$1$I$$20240723$20240730$20240730$EXP$$IE-TAKEDA-2024TUS074876$TAKEDA$$$$$$Y$$$20240730$$MD$IE$IE
241533932$24153393$2$F$$20240726$20240730$20240731$EXP$$US-SA-2024SA222329$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240731$$MD$US$US
241533942$24153394$2$F$$20240808$20240730$20240812$EXP$$CA-TAKEDA-2023TUS096366$TAKEDA$$$$$F$Y$$$20240812$$CN$CA$CA
241533951$24153395$1$I$20220501$20240724$20240730$20240730$PER$$US-BIOGEN-2022BI01125786$BIOGEN$$50$YR$$F$Y$$$20240730$$CN$US$US
241533961$24153396$1$I$$20240723$20240730$20240730$PER$$US-AGIOS-2407US03845$AGIOS PHARMACEUTICALS$$$$$M$Y$177$KG$20240730$$CN$US$US
241533971$24153397$1$I$$20240723$20240730$20240730$EXP$$CA-GSK-CA2024092802$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$CA$CA
241533982$24153398$2$F$20240722$20240801$20240730$20240808$EXP$$US-ARGENX-2024-ARGX-US005876$ARGENX BVBA$$$$$$Y$$$20240808$$HP$US$US
241533991$24153399$1$I$$20240729$20240730$20240730$PER$$US-ROCHE-10000041638$ROCHE$$$$$$Y$$$20240730$$PH$US$US
241534001$24153400$1$I$$20240721$20240730$20240730$EXP$$US-JNJFOC-20240776936$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$HP$US$US
241534021$24153402$1$I$20240716$20240730$20240730$20240730$DIR$712055$$FDA-CTU$$32$YR$$F$N$69.75$KG$20240730$N$CN$US$
241534031$24153403$1$I$20130214$20240711$20240730$20240730$DIR$FDA-CDER-CTU-2024-52175$$FDA-CTU$$54$YR$$F$N$115$LBS$20240711$N$CN$US$
241534041$24153404$1$I$20240720$20240730$20240730$20240730$DIR$712070$$FDA-CTU$$58$YR$$F$N$58.5$KG$20240730$N$CN$US$
241534051$24153405$1$I$20240510$20240721$20240721$20240721$DIR$710941$$FDA-CTU$$$$$F$N$$$20240721$N$CN$US$
241534061$24153406$1$I$20240726$20240730$20240730$20240730$DIR$712068$$FDA-CTU$$67$YR$$F$N$61.65$KG$20240730$N$$US$
241534112$24153411$2$F$$20240701$20240730$20240815$PER$$US-TRAVERE-2024TVT00611$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$CN$US$US
241534121$24153412$1$I$20240101$20240718$20240730$20240730$EXP$$US-TEVA-VS-3226122$TEVA$$70$YR$$F$Y$74.84$KG$20240730$$CN$US$US
241534131$24153413$1$I$$20240717$20240730$20240730$EXP$$IN-Unichem Pharmaceuticals (USA) Inc-UCM202407-000927$UNICHEM$$55$YR$A$M$Y$$$20240730$$HP$IN$
241534143$24153414$3$F$$20240801$20240730$20240814$EXP$$JP-Unichem Pharmaceuticals (USA) Inc-UCM202407-000930$UNICHEM$$72$YR$E$M$Y$71.4$KG$20240815$$HP$JP$
241534151$24153415$1$I$$20240717$20240730$20240730$EXP$$TR-Unichem Pharmaceuticals (USA) Inc-UCM202407-000943$UNICHEM$$$$I$$Y$$$20240730$$$COUNTRY NOT SPECIFIED$
241534161$24153416$1$I$$20240719$20240730$20240730$EXP$$AU-Unichem Pharmaceuticals (USA) Inc-UCM202407-000934$UNICHEM$$$$$$Y$$$20240730$$$COUNTRY NOT SPECIFIED$
241534171$24153417$1$I$$20240717$20240730$20240730$EXP$$TR-Unichem Pharmaceuticals (USA) Inc-UCM202407-000942$UNICHEM$$$$I$$Y$$$20240730$$$COUNTRY NOT SPECIFIED$
241534181$24153418$1$I$$20240717$20240730$20240730$EXP$$TR-Unichem Pharmaceuticals (USA) Inc-UCM202407-000941$UNICHEM$$$$I$$Y$$$20240730$$$COUNTRY NOT SPECIFIED$
241534191$24153419$1$I$$20240717$20240730$20240730$EXP$$TR-Unichem Pharmaceuticals (USA) Inc-UCM202407-000944$UNICHEM$$$$I$$Y$$$20240730$$$COUNTRY NOT SPECIFIED$
241534202$24153420$2$F$$20240826$20240730$20240829$EXP$DE-EMA-DD-20240718-7482643-075622$DE-RDY-SPO/DEU/24/0010742$DR REDDYS$Isabel Brueckner, Jessica Welter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313. doi:https://doi.org/10.1093/jat/bkae011$44$YR$A$M$Y$$$20240829$$HP$DE$DE
241534212$24153421$2$F$$20240903$20240730$20240909$EXP$$CA-TAKEDA-2024TUS074795$TAKEDA$$$$$F$Y$$$20240909$$CN$CA$CA
241534221$24153422$1$I$$20240723$20240730$20240730$EXP$$CH-SANDOZ INC.-SDZ2024CH067827$SANDOZ$$$$$M$Y$66$KG$20240730$$HP$CH$CH
241534231$24153423$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120485$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240730$$CN$US$US
241534241$24153424$1$I$20150621$20240722$20240730$20240730$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-117737$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240730$$MD$IL$IL
241534253$24153425$3$F$$20240829$20240730$20240904$EXP$$IL-TAKEDA-2024TUS075362$TAKEDA$$41$YR$$F$Y$$$20240904$$HP$IL$IL
241534261$24153426$1$I$20240723$20240723$20240730$20240730$EXP$$US-GSK-US2024092237$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$US$US
241534271$24153427$1$I$$20240724$20240730$20240730$EXP$NO-NOMAADVRE-PASRAPP-2024-Vp37ne$NO-MYLANLABS-2024M1069304$MYLAN$$38$YR$$F$Y$$$20240730$$CN$NO$NO
241534281$24153428$1$I$$20240723$20240730$20240730$EXP$$US-GSK-US2024092323$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$US$US
241534291$24153429$1$I$20240603$20240729$20240730$20240730$EXP$$FR-SANDOZ INC.-SDZ2024FR068803$SANDOZ$$81$YR$$F$Y$67.2$KG$20240730$$PH$FR$FR
241534301$24153430$1$I$20240708$20240722$20240730$20240730$EXP$$CN-ALCON LABORATORIES-ALC2024CN003519$ALCON$$43$YR$$M$Y$58$KG$20240730$$HP$CN$CN
241534311$24153431$1$I$20240701$20240726$20240730$20240730$PER$$US-ORGANON-O2407USA002666$ORGANON$$20$YR$$F$Y$76.19$KG$20240730$$CN$US$US
241534321$24153432$1$I$$20240724$20240730$20240730$EXP$$NVSC2024AU152998$NOVARTIS$$40$YR$$F$Y$$$20240730$$MD$AU$AU
241534331$24153433$1$I$$20240722$20240730$20240730$EXP$GB-MHRA-MED-202407221123544330-SZRNY$GB-TEVA-VS-3224080$TEVA$$71$YR$$F$Y$$$20240730$$HP$GB$GB
241534341$24153434$1$I$$20240729$20240730$20240730$EXP$$NVSC2024PT154613$NOVARTIS$Caladol D, Esteves F, Roias C, Miranda S. Po-0265 - (4693) - predisposicoes precipitantesa flor da pele - um caso de pres (precipitanto predispositions to floor of the skin- a case of prescription). URGENCIA, CUIDADOS INTERMEDIOS E DOENTE CRITICO/CASO CLINICO (EMERGENCY, INTERME. 630$60$YR$$M$Y$$$20240730$$HP$PT$PT
241534351$24153435$1$I$$20240725$20240730$20240730$EXP$$RU-AstraZeneca-2024A171424$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$RU$
241534361$24153436$1$I$20240629$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A170124$ASTRAZENECA$$$$$M$Y$$$20240730$$MD$US$
241534371$24153437$1$I$20240629$20240725$20240730$20240730$EXP$$US-AstraZeneca-2024A170210$ASTRAZENECA$$$$$M$Y$$$20240730$$MD$US$
241534381$24153438$1$I$20240712$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A171577$ASTRAZENECA$$3322$WK$$F$Y$$$20240730$$CN$US$
241534391$24153439$1$I$20240604$20240722$20240730$20240730$EXP$$JP-AstraZeneca-2024A169784$ASTRAZENECA$$65$YR$$M$Y$76$KG$20240730$$MD$JP$
241534404$24153440$4$F$$20240906$20240730$20240919$EXP$$CA-DSJP-DSJ-2024-137604$DAIICHI$$$$$F$Y$$$20240919$$HP$CA$CA
241534411$24153441$1$I$$20240723$20240730$20240730$EXP$$GB-OTSUKA-2024_014295$OTSUKA$$21$YR$$M$Y$$$20240730$$CN$GB$GB
241534421$24153442$1$I$$20240729$20240730$20240730$PER$$US-ABBVIE-5859138$ABBVIE$$$$$$Y$$$20240730$$HP$US$US
241534431$24153443$1$I$20240729$20240730$20240730$20240730$DIR$712076$$FDA-CTU$$61$YR$$M$N$63$KG$20240730$N$CN$US$
241534441$24153444$1$I$$20240730$20240730$20240730$PER$$US-GILEAD-2024-0682330$GILEAD$$33$YR$A$F$Y$$$20240730$$CN$US$US
241534453$24153445$3$F$20240724$20240805$20240730$20240821$PER$$US-AMGEN-USASP2024147898$AMGEN$$61$YR$A$M$Y$99$KG$20240821$$HP$US$US
241534461$24153446$1$I$$20240726$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US068760$SANDOZ$$$$$F$Y$$$20240730$$MD$US$US
241534471$24153447$1$I$$20240726$20240730$20240730$30DAY$$US-SANDOZ INC.-SDZ2024US039925$SANDOZ$$$$$M$Y$$$20240730$$CN$US$US
241534481$24153448$1$I$$20240730$20240730$20240730$DIR$712083$$FDA-CTU$$$$$UNK$N$$$20240730$N$CN$US$
241534492$24153449$2$F$20240403$20240919$20240730$20240924$EXP$IT-MINISAL02-995336$IT-MYLANLABS-2024M1069436$MYLAN$$29$YR$$F$Y$$$20240924$$MD$IT$IT
241534501$24153450$1$I$$20240724$20240730$20240730$EXP$$ES-MYLANLABS-2024M1070036$MYLAN$$$$$F$Y$$$20240730$$CN$ES$ES
241534521$24153452$1$I$$20240614$20240730$20240730$PER$$US-TRAVERE-2024TVT00612$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240730$$HP$US$US
241534531$24153453$1$I$$20240724$20240730$20240730$EXP$$FR-MYLANLABS-2024M1069607$MYLAN$$$$$F$Y$75$KG$20240730$$MD$FR$FR
241534544$24153454$4$F$20240711$20240823$20240730$20240904$30DAY$$UM-JNJFOC-20240730065$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240904$$CN$UM$UM
241534551$24153455$1$I$$20240723$20240730$20240730$EXP$$AR-TAKEDA-2024TUS075877$TAKEDA$$$$$F$Y$$$20240730$$CN$AR$AR
241534571$24153457$1$I$20240705$20240730$20240730$20240730$DIR$712084$$FDA-CTU$$75$YR$$M$N$78.7$KG$20240730$Y$PH$US$
241534581$24153458$1$I$20240701$20240730$20240730$20240730$DIR$712072$$FDA-CTU$$70$YR$$F$N$83.6$KG$20240730$N$HP$US$
241534591$24153459$1$I$20240719$20240722$20240722$20240722$DIR$711047$$FDA-CTU$$$$$UNK$N$$$20240722$N$CN$US$
241534601$24153460$1$I$20240701$20240730$20240730$20240730$DIR$712071$$FDA-CTU$$70$YR$$F$N$83.6$KG$20240730$N$HP$US$
241534611$24153461$1$I$20240715$20240730$20240730$20240730$DIR$712081$$FDA-CTU$$78$YR$$M$N$116.1$KG$20240730$Y$CN$US$
241534621$24153462$1$I$20240729$20240730$20240730$20240730$DIR$712077$$FDA-CTU$$81$YR$$F$N$69.75$KG$20240730$N$$US$
241534631$24153463$1$I$20240711$20240730$20240730$20240730$DIR$712088$$FDA-CTU$$27$YR$$F$N$73$KG$20240730$N$HP$US$
241534641$24153464$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52212$$FDA-CTU$$79$YR$$M$N$$$20240730$N$$US$
241534661$24153466$1$I$20240726$20240730$20240730$20240730$DIR$712045$$FDA-CTU$$64$YR$$F$N$$$20240730$N$PH$US$
241534671$24153467$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52217$$FDA-CTU$$61$YR$$F$N$79.83$KG$20240730$N$$US$
241534681$24153468$1$I$20240705$20240730$20240730$20240730$DIR$712078$$FDA-CTU$$27$YR$$F$N$$$20240730$Y$PH$US$
241534691$24153469$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52219$$FDA-CTU$$$$$F$N$$$20240729$N$HP$US$
241534701$24153470$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52264$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241534711$24153471$1$I$20240529$20240722$20240730$20240730$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001492$BLUEPRINT MEDICINES$$46$YR$A$F$Y$$$20240730$$CN$US$US
241534721$24153472$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52263$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241534731$24153473$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120327$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$60.33$KG$20240730$$CN$US$US
241534741$24153474$1$I$20240122$20240724$20240730$20240730$EXP$FR-AFSSAPS-ST2024001179$FR-MYLANLABS-2024M1069438$MYLAN$$79$YR$$M$Y$75$KG$20240730$$HP$FR$FR
241534751$24153475$1$I$$20240724$20240730$20240730$EXP$$DE-MYLANLABS-2024M1069333$MYLAN$$64$YR$$F$Y$$$20240730$$CN$DE$DE
241534761$24153476$1$I$$20240722$20240730$20240730$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001509$BLUEPRINT MEDICINES$$$$$F$Y$$$20240730$$CN$US$US
241534771$24153477$1$I$20240620$20240722$20240730$20240730$EXP$FR-AFSSAPS-LL2024001308$FR-TEVA-VS-3223664$TEVA$$76$YR$$F$Y$$$20240730$$MD$FR$FR
241534781$24153478$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219154$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240730$$MD$US$US
241534791$24153479$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219171$SANOFI AVENTIS$$$$C$M$Y$$$20240730$$MD$US$US
241534801$24153480$1$I$$20240723$20240730$20240730$EXP$GB-MHRA-MED-202407231052238850-FZQPD$GB-TEVA-VS-3225161$TEVA$$$$$F$Y$$$20240730$$HP$GB$GB
241534811$24153481$1$I$$20240723$20240730$20240730$EXP$GB-MHRA-MED-202407231406193540-WSZVF$GB-TEVA-VS-3225167$TEVA$$$$$F$Y$$$20240730$$HP$GB$GB
241534821$24153482$1$I$$20240724$20240730$20240730$EXP$$US-ABBVIE-5854125$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241534831$24153483$1$I$20240715$20240723$20240730$20240730$EXP$GB-MHRA-MED-202407161503495630-WLTRZ$GB-TEVA-VS-3224711$TEVA$$50$YR$$F$Y$$$20240730$$HP$GB$GB
241534841$24153484$1$I$$20240716$20240730$20240730$EXP$$US-ASTELLAS-2024US020846$ASTELLAS$$56$YR$$M$Y$$$20240730$$CN$HK$US
241534851$24153485$1$I$20230831$20240719$20240730$20240730$EXP$$TR-ASTELLAS-2024US020985$ASTELLAS$$66$YR$$M$Y$$$20240730$$CN$TR$TR
241534861$24153486$1$I$20240501$20240726$20240730$20240730$EXP$$US-ABBVIE-5857007$ABBVIE$$57$YR$$M$Y$$$20240730$$CN$US$US
241534873$24153487$3$F$20240715$20240807$20240730$20240815$PER$$US-APELLIS-2024-APL-0000549$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240815$$CN$US$US
241534881$24153488$1$I$20240611$20240725$20240730$20240730$PER$$US-BAYER-2024A108404$BAYER$$33$YR$A$F$Y$$$20240730$$HP$US$US
241534891$24153489$1$I$$20240727$20240730$20240730$PER$$NVSC2024US154872$NOVARTIS$$$$$$Y$$$20240730$$CN$US$US
241534901$24153490$1$I$20240701$20240725$20240730$20240730$EXP$$US-ABBVIE-5856058$ABBVIE$$45$YR$$M$Y$$$20240730$$CN$US$US
241534911$24153491$1$I$20240301$20240726$20240730$20240730$EXP$$US-ABBVIE-5856872$ABBVIE$$72$YR$$M$Y$$$20240730$$CN$US$US
241534921$24153492$1$I$20240307$20240729$20240730$20240730$EXP$FR-AFSSAPS-LL2024001100$FR-LUNDBECK-DKLU4002220$LUNDBECK$$$$$$Y$$$20240730$$CN$FR$FR
241534931$24153493$1$I$$20240729$20240730$20240730$EXP$GB-MHRA-TPP43049929C4050647YC1721827772628$GB-SANDOZ INC.-SDZ2024GB068881$SANDOZ$$61$YR$$M$Y$80$KG$20240730$$HP$GB$GB
241534941$24153494$1$I$20240416$20240725$20240730$20240730$EXP$ES-AEMPS-1550302$ES-MYLANLABS-2024M1069476$MYLAN$$59$YR$$F$Y$$$20240730$$MD$ES$ES
241534951$24153495$1$I$$20240729$20240730$20240730$EXP$$CA-BAUSCH-BL-2024-011603$BAUSCH AND LOMB$$$$$$Y$$$20240730$$HP$CA$CA
241534961$24153496$1$I$$20240722$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US069010$SANDOZ$$$$$$Y$$$20240730$$HP$US$US
241534971$24153497$1$I$20230828$20240715$20240730$20240730$EXP$EU-AFSSAPS-AVCN2024000524$EU-ETHYPHARM-2024001905$ETHYPHARM$$$$$$Y$$$20240729$$MD$EU$EU
241534981$24153498$1$I$20240726$20240726$20240730$20240730$EXP$$CA-ABBVIE-5857032$ABBVIE$$64$YR$$M$Y$$$20240730$$CN$CA$CA
241534991$24153499$1$I$20240601$20240715$20240730$20240730$EXP$EU-AFSSAPS-AVNT2024000506$EU-ETHYPHARM-2024001906$ETHYPHARM$$$$$$Y$$$20240729$$PH$EU$EU
241535001$24153500$1$I$$20240729$20240730$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA069090$SANDOZ$$$$$M$Y$$$20240730$$CN$CA$CA
241535011$24153501$1$I$20240709$20240725$20240730$20240730$PER$$US-BAYER-2024A108676$BAYER$$27$YR$A$F$Y$$$20240730$$CN$US$US
241535021$24153502$1$I$$20240726$20240730$20240730$EXP$$US-BAUSCH-BL-2024-011494$BAUSCH AND LOMB$$88$YR$$F$Y$$$20240730$$CN$US$US
241535031$24153503$1$I$20240101$20240715$20240730$20240730$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01223$AVADEL CNS PHARMA$$$$$F$Y$$$20240730$$CN$US$US
241535043$24153504$3$F$$20240823$20240730$20240827$EXP$$US-SANDOZ INC.-SDZ2024US068742$SANDOZ$$60$YR$$F$Y$$$20240827$$CN$US$US
241535061$24153506$1$I$$20240725$20240730$20240730$EXP$GB-MHRA-MED-202407251011475310-VZQYH$GB-MYLANLABS-2024M1069703$MYLAN$$$$$M$Y$$$20240730$$CN$GB$GB
241535071$24153507$1$I$$20240725$20240730$20240730$EXP$GB-MHRA-MED-202407251012454120-CJPMW$GB-MYLANLABS-2024M1069597$MYLAN$$$$$M$Y$$$20240730$$CN$GB$GB
241535081$24153508$1$I$$20240725$20240730$20240730$EXP$GB-MHRA-31010652$GB-MYLANLABS-2024M1069681$MYLAN$$$$$M$Y$$$20240730$$CN$GB$GB
241535091$24153509$1$I$20220601$20240722$20240730$20240730$EXP$$CN-BAUSCH-BL-2024-011292$BAUSCH AND LOMB$Huang J, Chen Y, Zhong M, Tan R. Case report: Dose-dependent interaction between dexamethasone and voriconazole in severely ill patients with non-Hodgkin^s lymphoma being treated for invasive pulmonary aspergillosis.. Frontiers in pharmacology. 2024 JUN 27;15:1-8. doi:10.3389/fphar.2024.1403966$64$YR$$M$Y$70$KG$20240730$$HP$CN$CN
241535101$24153510$1$I$$20240716$20240730$20240730$EXP$CA-NOVARTIS PHARMA S.A.-NVSC2024CA147004$CA-ROCHE-10000034389$ROCHE$$35$YR$A$F$Y$$$20240730$$CN$CA$CA
241535111$24153511$1$I$20240727$20240727$20240730$20240730$EXP$GB-MHRA-MED-202407270917104810-QPYZV$GB-ABBVIE-5859733$ABBVIE$$$$$$Y$$$20240730$$MD$GB$GB
241535121$24153512$1$I$$20240726$20240730$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA068769$SANDOZ$$14$YR$$F$Y$$$20240730$$HP$CA$CA
241535132$24153513$2$F$20240601$20240816$20240730$20240823$EXP$$US-GSK-US2024092433$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$US$US
241535141$24153514$1$I$$20240729$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US068989$SANDOZ$$$$$F$Y$$$20240730$$CN$US$US
241535161$24153516$1$I$$20240725$20240730$20240730$EXP$$CA-SANDOZ INC.-NVSC2020CA231681$SANDOZ$$45$YR$$F$Y$$$20240730$$CN$CA$CA
241535171$24153517$1$I$20240101$20240726$20240730$20240730$PER$$US-TAKEDA-2024TUS076186$TAKEDA$$62$YR$$F$Y$100$KG$20240730$$MD$US$US
241535181$24153518$1$I$$20240719$20240730$20240730$EXP$$FR-JNJFOC-20240752216$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$MD$FR$FR
241535201$24153520$1$I$$20240730$20240730$20240730$DIR$712074$$FDA-CTU$$$$$UNK$N$$$20240730$$CN$US$
241535212$24153521$2$F$20230101$20240724$20240730$20240801$EXP$$US-009507513-2407USA014988$MERCK$$55$YR$$F$Y$$$20240801$$CN$US$US
241535221$24153522$1$I$20170101$20240725$20240730$20240730$EXP$$BR-MYLANLABS-2024M1069984$MYLAN$$$$$M$Y$68$KG$20240730$$CN$BR$BR
241535231$24153523$1$I$20240714$20240715$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113539$BRISTOL MYERS SQUIBB$$31$YR$A$F$Y$110$KG$20240730$$PH$US$US
241535241$24153524$1$I$$20240726$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120086$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240730$$CN$US$US
241535251$24153525$1$I$20240719$20240725$20240730$20240730$EXP$GB-MHRA-MED-202407251753217850-DHMKB$GB-MYLANLABS-2024M1069980$MYLAN$$81$YR$$M$Y$84$KG$20240730$$CN$GB$GB
241535261$24153526$1$I$$20240726$20240730$20240730$EXP$$JP-SANDOZ INC.-SDZ2024JP069048$SANDOZ$$78$YR$$F$Y$$$20240730$$CN$JP$JP
241535271$24153527$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A171832$ASTRAZENECA$$$$$M$Y$91.5$KG$20240730$$MD$US$
241535281$24153528$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52211$$FDA-CTU$$71$YR$$F$N$165$LBS$20240730$N$$US$
241535291$24153529$1$I$20240201$20240726$20240730$20240730$EXP$$DE-SANDOZ INC.-SDZ2024DE068574$SANDOZ$$1$DY$$M$Y$3.91$KG$20240730$$MD$DE$DE
241535301$24153530$1$I$$20240726$20240730$20240730$EXP$$CA-AstraZeneca-2020SF26723$ASTRAZENECA$$50$YR$$M$Y$$$20240730$$MD$CA$
241535311$24153531$1$I$20240101$20240717$20240730$20240730$PER$$US-BIOMARINAP-US-2024-159445$BIOMARIN$$$$$$Y$$$20240730$$CN$US$US
241535321$24153532$1$I$20240717$20240724$20240730$20240730$EXP$$CN-AstraZeneca-2024A170868$ASTRAZENECA$$23548$DY$$F$Y$46$KG$20240730$$MD$CN$
241535331$24153533$1$I$$20220117$20240730$20240730$EXP$$US-AstraZeneca-2022A028184$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241535341$24153534$1$I$$20240715$20240730$20240730$EXP$$CA-AstraZeneca-2024A172475$ASTRAZENECA$$65$YR$$F$Y$$$20240730$$MD$CA$
241535351$24153535$1$I$$20240724$20240730$20240730$EXP$$US-ARGENX-2024-ARGX-US005908$ARGENX BVBA$$$$$$Y$$$20240730$$CN$US$US
241535361$24153536$1$I$$20230922$20240730$20240730$EXP$$TW-AstraZeneca-2023A218272$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$TW$
241535371$24153537$1$I$$20240722$20240730$20240730$EXP$$US-AstraZeneca-2024A166688$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$US$
241535381$24153538$1$I$$20240722$20240730$20240730$EXP$$VN-AstraZeneca-2024A172033$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$VN$
241535391$24153539$1$I$$20240726$20240730$20240730$EXP$$RU-BAYER-2024A109570$BAYER$$49$YR$A$F$Y$$$20240730$$MD$RU$RU
241535401$24153540$1$I$$20240719$20240730$20240730$PER$$US-SA-2024SA218099$SANOFI AVENTIS$$$$C$M$Y$14$KG$20240730$$MD$US$US
241535411$24153541$1$I$20240718$20240730$20240730$20240730$DIR$712047$$FDA-CTU$$57$YR$$F$N$46.35$KG$20240730$N$CN$US$
241535421$24153542$1$I$20221101$20240719$20240730$20240730$PER$$US-SA-2024SA217943$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240730$$MD$US$US
241535431$24153543$1$I$$20240723$20240730$20240730$PER$$US-BIOGEN-2024BI01275158$BIOGEN$$$$$M$Y$$$20240730$$CN$US$US
241535441$24153544$1$I$$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017549$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240730$$CN$US$US
241535451$24153545$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018623$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240730$$CN$US$US
241535461$24153546$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018488$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241535471$24153547$1$I$20240720$20240730$20240730$20240730$DIR$712034$$FDA-CTU$$29$YR$$F$N$101.25$KG$20240730$N$CN$US$
241535491$24153549$1$I$20240715$20240728$20240730$20240730$DIR$FDA-CDER-CTU-2024-52213$$FDA-CTU$$38$YR$$F$N$$$20240728$N$HP$US$
241535501$24153550$1$I$20240528$20240730$20240730$20240730$DIR$712085$$FDA-CTU$$73$YR$$F$N$53.1$KG$20240730$N$CN$US$
241535511$24153551$1$I$20240726$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52216$$FDA-CTU$$63$YR$$M$N$$$20240729$N$HP$US$
241535521$24153552$1$I$20240720$20240730$20240730$20240730$DIR$712080$$FDA-CTU$$68$YR$$F$N$50$KG$20240730$N$PH$US$
241535531$24153553$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52215$$FDA-CTU$$47$YR$$F$N$67.13$KG$20240730$N$$US$
241535541$24153554$1$I$20240610$20240730$20240730$20240730$DIR$712082$$FDA-CTU$$38$YR$$F$N$54.8$KG$20240730$N$MD$US$
241535551$24153555$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52221$$FDA-CTU$$48$YR$$F$N$83.46$KG$20240730$N$$US$
241535561$24153556$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA219752$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
241535571$24153557$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA219068$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240730$$MD$US$US
241535582$24153558$2$F$20240109$20240812$20240730$20240819$30DAY$$EG-SANDOZ INC.-SDZ2023EG014570$SANDOZ$$11$YR$$M$Y$23$KG$20240819$$CN$EG$EG
241535592$24153559$2$F$20200101$20240827$20240730$20240829$EXP$$SE-SANDOZ INC.-SDZ2024SE069008$SANDOZ$$$$$F$Y$16.7$KG$20240829$$MD$SE$SE
241535601$24153560$1$I$$20240726$20240730$20240730$EXP$$CA-JNJFOC-20240774861$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$HP$CA$CA
241535613$24153561$3$F$$20240811$20240730$20240813$EXP$$AU-SANDOZ INC.-SDZ2024AU068476$SANDOZ$$$$A$F$Y$$$20240813$$HP$AU$AU
241535621$24153562$1$I$$20240722$20240730$20240730$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-102117$REGENERON$$$$$M$Y$$$20240730$$MD$CA$CA
241535631$24153563$1$I$20211101$20211109$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-452922$RANBAXY$$78$YR$$M$Y$$$20240730$$MD$CN$CN
241535641$24153564$1$I$20220815$20220815$20240730$20240730$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-452702$RANBAXY$$86$YR$$F$Y$$$20240730$$HP$CN$CN
241535651$24153565$1$I$20240717$20240722$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US069017$SANDOZ$$$$$$Y$$$20240730$$HP$US$US
241535661$24153566$1$I$$20240712$20240730$20240730$PER$$US-009507513-2407USA008991$MERCK$$$$$F$Y$$$20240730$$PH$US$US
241535672$24153567$2$F$$20240812$20240730$20240816$EXP$$CZ-MYLANLABS-2024M1070172$MYLAN$New horizons of biological treatment in dermatology. MEDICAL TRIBUNE. 2024;20(10):D4-D5$42$YR$$M$Y$$$20240816$$MD$CZ$CZ
241535681$24153568$1$I$20240702$20240724$20240730$20240730$EXP$FR-AFSSAPS-RS2024000701$FR-MYLANLABS-2024M1069564$MYLAN$$60$YR$$M$Y$81$KG$20240730$$PH$FR$FR
241535691$24153569$1$I$20200701$20240727$20240730$20240730$EXP$PL-URPL-2-1302-2020$PL-BAUSCH-BL-2024-011501$BAUSCH AND LOMB$$56$YR$$M$Y$$$20240730$$CN$PL$PL
241535702$24153570$2$F$$20240731$20240730$20240802$PER$$US-BAUSCH-BL-2024-011106$BAUSCH AND LOMB$$$$$F$Y$$$20240802$$CN$US$US
241535711$24153571$1$I$$20240725$20240730$20240730$EXP$$FR-MYLANLABS-2024M1070265$MYLAN$Lacampagne T, Guillotin V, Peuchant O, Belloir A, Sibon I, Bebear C, et al. Current Mycoplasma pneumoniae outbreak: Don^t forget its role in Bickerstaff encephalitis. Diagn-Microbiol-Infect-Dis 2024; 110 (1).$16$YR$$M$Y$$$20240730$$HP$FR$FR
241535722$24153572$2$F$$20240909$20240730$20240918$EXP$$CA-LUNDBECK-DKLU4002295$LUNDBECK$$$$$$Y$$$20240918$$CN$CA$CA
241535731$24153573$1$I$$20240727$20240730$20240730$PER$$US-BAUSCH-BL-2024-011519$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240730$$MD$US$US
241535741$24153574$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA218989$SANOFI AVENTIS$$6$YR$C$M$Y$18.1$KG$20240730$$MD$US$US
241535751$24153575$1$I$$20240723$20240730$20240730$EXP$$US-SA-2024SA218642$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240730$$MD$US$US
241535761$24153576$1$I$$20240729$20240730$20240730$EXP$$US-BAUSCH-BL-2024-011607$BAUSCH AND LOMB$$51$YR$$F$Y$$$20240730$$CN$US$US
241535771$24153577$1$I$20231201$20240727$20240730$20240730$EXP$$RO-BAUSCH-BL-2024-011504$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240730$$MD$RO$RO
241535781$24153578$1$I$20240723$20240723$20240730$20240730$EXP$GB-MHRA-MED-202407231338045280-DCLFW$GB-TEVA-VS-3225156$TEVA$$41$YR$$F$Y$$$20240730$$HP$GB$GB
241535791$24153579$1$I$20240101$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150692$AMGEN$$64$YR$A$F$Y$$$20240730$$CN$US$US
241535801$24153580$1$I$$20240729$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042607$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240730$$CN$US$US
241535812$24153581$2$F$20240601$20240821$20240730$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120391$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240830$$CN$US$US
241535825$24153582$5$F$20240721$20240908$20240730$20240912$EXP$$CA-TAKEDA-2024TUS067554$TAKEDA$$61$YR$$F$Y$$$20240912$$CN$CA$CA
241535841$24153584$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-07137$HIKMA$Ferreira Da Costa RM, Lopes C, Ferreira Lopes D, Conde PV, Pereira JM, Mayor JS, et al.. Ferreira Da Costa RM, Lopes C, Ferreira Lopes D, Conde PV, Pereira JM, Mayor JS, Ferreira Da Costa M, Tribuna C. POSA-194 - (4967) - POSA -194 - (4967) - Pneumonite eosinof?lica secund?ria ? amiodarona: um alerta sobre efeitos adversos farmacol?gicos. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional. 2024;/:1270$78$YR$$F$Y$$$20240730$$MD$PT$PT
241535853$24153585$3$F$20240601$20240911$20240730$20240913$PER$$US-ROCHE-10000040557$ROCHE$$70$YR$E$F$Y$60.33$KG$20240913$$CN$US$US
241535861$24153586$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA219371$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
241535872$24153587$2$F$20240701$20240723$20240730$20240803$PER$$US-SA-2024SA218931$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240803$$MD$US$US
241535881$24153588$1$I$$20240722$20240730$20240730$PER$$US-ROCHE-10000034039$ROCHE$$38$YR$A$F$Y$$$20240730$$CN$US$US
241535891$24153589$1$I$$20240718$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-120432$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240730$$HP$CA$CA
241535901$24153590$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52261$$FDA-CTU$$73$YR$$F$N$$$20240730$N$$US$
241535911$24153591$1$I$20240610$20240730$20240730$20240730$DIR$712089$$FDA-CTU$$62$YR$$F$N$82.8$KG$20240730$N$CN$US$
241535921$24153592$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52266$$FDA-CTU$$77$YR$$F$N$158$LBS$20240730$Y$PH$US$
241535931$24153593$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52265$$FDA-CTU$$64$YR$$M$N$$$20240730$N$$US$
241535951$24153595$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52267$$FDA-CTU$$53$YR$$M$N$$$20240730$N$$US$
241535961$24153596$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52214$$FDA-CTU$$$$$F$N$$$20240730$N$$US$
241535971$24153597$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52260$$FDA-CTU$$72$YR$$M$N$$$20240730$N$$US$
241535981$24153598$1$I$20240729$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52218$$FDA-CTU$$86$YR$$F$N$$$20240730$N$$US$
241536001$24153600$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52268$$FDA-CTU$$74$YR$$F$N$$$20240730$N$$US$
241536011$24153601$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52220$$FDA-CTU$$88$YR$$F$N$$$20240730$N$$US$
241536021$24153602$1$I$$20240729$20240730$20240730$PER$$US-HALEON-2189649$Haleon PLC$$$$$$Y$$$20240730$$CN$US$US
241536032$24153603$2$F$20240101$20240729$20240730$20240801$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011281$JAZZ$$$$$F$Y$$$20240801$$CN$US$US
241536041$24153604$1$I$20190424$20240716$20240730$20240730$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-06728$HIKMA$$13$YR$$M$Y$47.4$KG$20240730$$MD$US$US
241536051$24153605$1$I$$20240726$20240730$20240730$EXP$GB-MHRA-MED-202407262147142410-THDNB$GB-MYLANLABS-2024M1070124$MYLAN$$39$YR$$M$Y$59$KG$20240730$$CN$GB$GB
241536061$24153606$1$I$$20240726$20240730$20240730$EXP$$FR-MYLANLABS-2024M1070034$MYLAN$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N and al... Chemsex in France: a national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).. Toxicologie Analytique + Clinique.. 2023;35:376-394$46$YR$$M$Y$$$20240730$$MD$FR$FR
241536071$24153607$1$I$20240606$20240726$20240730$20240730$EXP$FR-AFSSAPS-GR2024000738$FR-MYLANLABS-2024M1056726$MYLAN$$54$YR$$M$Y$80$KG$20240730$$PH$FR$FR
241536082$24153608$2$F$20240701$20240724$20240730$20240801$EXP$$DE-INCYTE CORPORATION-2024IN007917$INCYTE$$$$$$Y$$$20240801$$CN$DE$DE
241536092$24153609$2$F$$20240726$20240730$20240801$EXP$$US-BIOMARINAP-US-2024-159481$BIOMARIN$$$$$$Y$$$20240801$$CN$US$US
241536102$24153610$2$F$20240423$20240730$20240730$20240801$EXP$$US-BIOMARINAP-US-2024-159473$BIOMARIN$$$$$$Y$$$20240801$$CN$US$US
241536111$24153611$1$I$$20240723$20240730$20240730$PER$$US-BIOGEN-2024BI01263125$BIOGEN$$$$$F$Y$$$20240730$$CN$US$US
241536121$24153612$1$I$20240101$20240723$20240730$20240730$PER$$US-BIOGEN-2024BI01275014$BIOGEN$$$$$F$Y$$$20240730$$CN$US$US
241536131$24153613$1$I$$20221121$20240730$20240730$EXP$$US-AstraZeneca-2022A385155$ASTRAZENECA$$$$$$Y$$$20240730$$MD$US$
241536151$24153615$1$I$$20240722$20240730$20240730$EXP$$ES-AstraZeneca-2024A169055$ASTRAZENECA$$78$YR$$F$Y$$$20240730$$MD$ES$
241536172$24153617$2$F$20240601$20240806$20240730$20240808$EXP$$NVSC2024GR153727$NOVARTIS$$$$A$F$Y$$$20240808$$MD$GR$GR
241536181$24153618$1$I$20240725$20240725$20240730$20240730$PER$$US-RDY-SPO/USA/24/0011061$DR REDDYS$$23$YR$A$F$Y$$$20240730$$HP$US$US
241536191$24153619$1$I$20180321$20240722$20240730$20240730$PER$$US-SA-2018SA093476$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240730$$MD$US$US
241536202$24153620$2$F$20220101$20240919$20240730$20240925$PER$$NVSC2024US152188$NOVARTIS$$78$YR$$F$Y$$$20240925$$HP$US$US
241536212$24153621$2$F$20240508$20240806$20240730$20240817$PER$$US-RDY-SPO/USA/24/0010968$DR REDDYS$$18$YR$A$F$Y$$$20240817$$CN$US$US
241536221$24153622$1$I$20240723$20240723$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010967$DR REDDYS$$23$YR$A$F$Y$$$20240730$$MD$US$US
241536231$24153623$1$I$$20240722$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010923$DR REDDYS$$40$YR$A$F$Y$$$20240730$$MD$US$US
241536241$24153624$1$I$$20240722$20240730$20240730$EXP$US-MLMSERVICE-20240718-PI133351-00306-2$US-RDY-SPO/USA/24/0010915$DR REDDYS$Joly L, Virgilio R, Yother C. Posttransplant Lymphoproliferative Disorder in a Patient With Alpha-1 Antitrypsin Deficiency: A Case Report. Cureus. 2024;16(6):e62107. DOI: 10.7759/cureus.62107.$13$YR$T$M$Y$$$20240730$$MD$US$US
241536251$24153625$1$I$$20240722$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010922$DR REDDYS$$17$YR$T$F$Y$$$20240730$$MD$US$US
241536263$24153626$3$F$$20240809$20240730$20240812$EXP$$NZ-MYLANLABS-2024M1070617$MYLAN$$$$$M$Y$$$20240812$$PH$NZ$NZ
241536271$24153627$1$I$20231103$20240729$20240730$20240730$EXP$$GB-MYLANLABS-2023M1122756$MYLAN$$$$$M$Y$$$20240730$$PH$GB$GB
241536281$24153628$1$I$20201115$20240723$20240730$20240730$EXP$$DE-SANDOZ INC.-SDZ2024DE069066$SANDOZ$$81$YR$$M$Y$70$KG$20240730$$PH$DE$DE
241536291$24153629$1$I$$20240729$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120515$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240730$$CN$US$US
241536301$24153630$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52256$$FDA-CTU$$70$YR$$M$N$$$20240730$N$$US$
241536311$24153631$1$I$20231212$20240723$20240730$20240730$EXP$$GB-009507513-2407GBR013193$MERCK$$60$YR$$$Y$$$20240730$$HP$GB$GB
241536321$24153632$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120285$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240730$$HP$US$US
241536331$24153633$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120264$BRISTOL MYERS SQUIBB$$22$YR$A$F$Y$$$20240730$$HP$US$US
241536342$24153634$2$F$20240601$20240806$20240730$20240815$EXP$$CA-LUNDBECK-DKLU4002148$LUNDBECK$$$$$$Y$$$20240815$$HP$CA$CA
241536351$24153635$1$I$$20240725$20240730$20240730$PER$$US-009507513-2407USA014357$MERCK$$$$$F$Y$$$20240730$$CN$US$US
241536361$24153636$1$I$$20240727$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007894$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241536371$24153637$1$I$$20240729$20240730$20240730$PER$$US-PFIZER INC-202400226343$PFIZER$$77$YR$$M$Y$$$20240730$$CN$US$US
241536381$24153638$1$I$$20240725$20240730$20240730$PER$$US-PFIZER INC-PV202400041599$PFIZER$$72$YR$$F$Y$$$20240730$$CN$US$US
241536391$24153639$1$I$$20240729$20240730$20240730$PER$$US-PFIZER INC-PV202400098867$PFIZER$$20$YR$$F$Y$$$20240730$$HP$US$US
241536401$24153640$1$I$$20240729$20240730$20240730$PER$$US-PFIZER INC-PV202400098766$PFIZER$$43$YR$$F$Y$$$20240730$$HP$US$US
241536411$24153641$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018295$ELI LILLY AND CO$$$$$F$Y$$$20240730$$CN$US$US
241536421$24153642$1$I$20240723$20240724$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016542$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240730$$CN$US$US
241536431$24153643$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018826$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240730$$CN$US$US
241536441$24153644$1$I$20230101$20240723$20240730$20240730$EXP$$AU-ABBVIE-5859877$ABBVIE$$$$$$Y$$$20240730$$CN$AU$AU
241536451$24153645$1$I$$20240726$20240730$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA069104$SANDOZ$$$$$M$Y$$$20240730$$MD$CA$CA
241536461$24153646$1$I$$20240722$20240730$20240730$EXP$GB-MHRA-31195147$GB-TEVA-VS-3224621$TEVA$$$$$$Y$$$20240730$$CN$GB$GB
241536471$24153647$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-07045$HIKMA$Costa Monteiro S, Vieira R, Bravo S, Nogueira J, Paracana B, Henriques J. Costa Monteiro S, Vieira R, Bravo S, Nogueira J, Paracana B, Henriques J. CO-0089 - (2048) - Hipersensibilidade coron?ria: a prop?sito de um caso cl?nico / Coronary hypersensitivity: About a clinical case. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI$77$YR$$F$Y$$$20240730$$MD$PT$PT
241536482$24153648$2$F$$20240715$20240730$20240812$EXP$$PT-TEVA-VS-3222374$TEVA$Literature Reference: Sevivas R, Cruz D, Paulo GC, Coelho I, Oliveira C, Veiga C. CO-0116 - (2299) - Toxic epidermal necrolysis induced by co-trimoxazole: a clinical case. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts [CNMI]. 2024 May; 217.$53$YR$$$Y$$$20240812$$MD$PT$PT
241536491$24153649$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51619$$FDA-CTU$$61$YR$$F$N$$$20240725$N$$US$
241536501$24153650$1$I$20240625$20240724$20240725$20240725$DIR$FDA-CDER-CTU-2024-51620$$FDA-CTU$$75$YR$$M$N$$$20240724$N$HP$US$
241536511$24153651$1$I$20240704$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51621$$FDA-CTU$$78$YR$$M$N$$$20240725$Y$PH$US$
241536521$24153652$1$I$20240708$20240725$20240725$20240725$DIR$711535$$FDA-CTU$$74$YR$$M$N$82.35$KG$20240725$Y$CN$US$
241536531$24153653$1$I$20240704$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51622$$FDA-CTU$$78$YR$$M$N$$$20240725$Y$PH$US$
241536542$24153654$2$F$20240718$20240813$20240730$20240820$PER$$US-AMGEN-USASP2024144240$AMGEN$$61$YR$A$M$Y$$$20240820$$HP$US$US
241536552$24153655$2$F$20240701$20240822$20240730$20240828$30DAY$$US-AMGEN-USASP2024145862$AMGEN$$53$YR$A$F$Y$63.039$KG$20240827$$PH$US$US
241536562$24153656$2$F$20240718$20240815$20240730$20240821$30DAY$$US-AMGEN-USASP2024146746$AMGEN$$$$$F$Y$$$20240821$$HP$US$US
241536573$24153657$3$F$20240101$20240823$20240730$20240828$30DAY$$US-AMGEN-USASP2024144635$AMGEN$$62$YR$A$F$Y$$$20240828$$CN$US$US
241536581$24153658$1$I$20240725$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51623$$FDA-CTU$$54$YR$$F$N$$$20240725$Y$PH$US$
241536591$24153659$1$I$20240722$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51624$$FDA-CTU$$49$YR$$M$N$$$20240725$N$$US$
241536603$24153660$3$F$20000101$20240812$20240730$20240816$EXP$$CO-LUNDBECK-DKLU4002149$LUNDBECK$$$$$$Y$$$20240816$$CN$CO$CO
241536611$24153661$1$I$$20240725$20240730$20240730$30DAY$$US-SANDOZ INC.-SDZ2024US068791$SANDOZ$$$$$F$Y$$$20240730$$CN$US$US
241536621$24153662$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51625$$FDA-CTU$$87$YR$$F$N$$$20240725$N$$US$
241536631$24153663$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51626$$FDA-CTU$$81$YR$$F$N$$$20240725$N$$US$
241536651$24153665$1$I$20240709$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51627$$FDA-CTU$$42$YR$$F$N$$$20240725$Y$PH$US$
241536661$24153666$1$I$$20240725$20240725$20240725$DIR$FDA-CDER-CTU-2024-51628$$FDA-CTU$$73$YR$$F$N$$$20240725$N$$US$
241536672$24153667$2$F$$20240918$20240730$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115979$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240920$$CN$US$US
241536681$24153668$1$I$20240101$20240727$20240730$20240730$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137951$DAIICHI$$46$YR$$F$Y$$$20240730$$CN$US$US
241536691$24153669$1$I$$20240720$20240730$20240730$PER$$US-TAKEDA-2024TUS074747$TAKEDA$$$$$$Y$$$20240730$$CN$US$US
241536701$24153670$1$I$20240715$20240724$20240730$20240730$EXP$$CN-TAKEDA-2024TUS075361$TAKEDA$$86$YR$$F$Y$$$20240730$$HP$CN$CN
241536712$24153671$2$F$$20240729$20240730$20240802$EXP$$US-AstraZeneca-2024A172252$ASTRAZENECA$$$$$$Y$$$20240802$$HP$US$
241536721$24153672$1$I$20231130$20240722$20240730$20240730$EXP$$JP-AstraZeneca-2024A022085$ASTRAZENECA$$78$YR$$M$Y$64$KG$20240730$$MD$JP$
241536731$24153673$1$I$20240721$20240725$20240730$20240730$EXP$$ID-AstraZeneca-2024A160222$ASTRAZENECA$$27216$DY$$F$Y$$$20240730$$CN$ID$
241536741$24153674$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155627$NOVARTIS$$$$$$Y$$$20240730$$HP$US$US
241536751$24153675$1$I$$20240728$20240730$20240730$PER$$NVSC2024US154881$NOVARTIS$$$$$$Y$$$20240730$$CN$US$US
241536761$24153676$1$I$$20240606$20240730$20240730$PER$$US-LUNDBECK-DKLU4000214$LUNDBECK$$$$$$Y$$$20240730$$CN$US$US
241536771$24153677$1$I$20240712$20240715$20240730$20240730$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01235$AVADEL CNS PHARMA$$40$YR$$F$Y$55.329$KG$20240730$$CN$US$US
241536781$24153678$1$I$20240101$20240715$20240730$20240730$PER$$US-009507513-2407USA009850$MERCK$$75$YR$$F$Y$$$20240730$$CN$US$US
241536801$24153680$1$I$20240102$20240305$20240725$20240725$DIR$FDA-CDER-CTU-2024-51514$$FDA-CTU$$45$YR$$F$N$$$20240305$N$CN$US$
241536821$24153682$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150591$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241536831$24153683$1$I$$20240722$20240730$20240730$EXP$$US-AMGEN-USASP2024147885$AMGEN$Parraga S. P.; Hrin M. L.; Jorizzo J. L.. Management of brunsting-perry pemphigoid (OPP): A single-center retrospective case series. Journal of Investigative Dermatology. 2024;144 (8):S42$$$$$Y$$$20240730$$HP$US$US
241536841$24153684$1$I$20240704$20240727$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US069142$SANDOZ$$$$$$Y$$$20240730$$CN$US$US
241536851$24153685$1$I$$20240728$20240730$20240730$30DAY$$US-SANDOZ INC.-SDZ2024US069214$SANDOZ$$$$$M$Y$$$20240730$$CN$US$US
241536861$24153686$1$I$20240701$20240729$20240730$20240730$EXP$$NVSC2024US155397$NOVARTIS$$60$YR$$M$Y$$$20240730$$CN$US$US
241536873$24153687$3$F$20240101$20240917$20240730$20240930$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-05963$IPSEN$$40$YR$A$F$Y$83$KG$20240930$$HP$US$US
241536881$24153688$1$I$20240702$20240722$20240730$20240730$EXP$$PE-JNJFOC-20240719775$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240730$$CN$PE$PE
241536891$24153689$1$I$$20240717$20240730$20240730$PER$$US-TEVA-VS-3225873$TEVA$$$$$$Y$$$20240730$$CN$US$US
241536901$24153690$1$I$$20240725$20240730$20240730$PER$$US-ABBVIE-5855032$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241536911$24153691$1$I$$20240729$20240730$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA069095$SANDOZ$$75$YR$$M$Y$84.09$KG$20240730$$HP$CA$CA
241536921$24153692$1$I$$20240729$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US069003$SANDOZ$$$$$F$Y$$$20240730$$CN$US$US
241536931$24153693$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-07057$HIKMA$Mort?gua Velho R, Maia M, P?scoa F, Paix?o J, Silva F, Teixeira AS, Fortuna J, Santos L. Mort?gua Velho R, Maia M, P?scoa F, Paix?o J, Silva F, Teixeira AS, Fortuna J, Santos L. PO-0097 - (4625) - Hiponatr?mia grave secund?ria ? ciprofloxacina. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI. 469$84$YR$$M$Y$$$20240730$$MD$PT$PT
241536941$24153694$1$I$$20240722$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116744$BRISTOL MYERS SQUIBB$$20$YR$A$F$Y$$$20240730$$HP$US$US
241536951$24153695$1$I$$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118975$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240730$$CN$US$US
241536962$24153696$2$F$$20240816$20240730$20240819$EXP$$BR-ALXN-202407SAM001413BR$ALEXION PHARMACEUTICALS$$7$YR$$F$Y$$$20240819$$CN$BR$BR
241536971$24153697$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017835$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240730$$CN$US$US
241536981$24153698$1$I$20240725$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016639$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240730$$CN$US$US
241536991$24153699$1$I$20240728$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407019088$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240730$$CN$US$US
241537001$24153700$1$I$20240709$20240723$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407015961$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241537021$24153702$1$I$20240724$20240724$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016637$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241537031$24153703$1$I$$20240723$20240730$20240730$EXP$$US-GSK-US2024AMR093018$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$MD$US$US
241537041$24153704$1$I$$20240725$20240730$20240730$PER$$US-DSJP-DSU-2024-137930$DAIICHI$$40$YR$$F$Y$$$20240730$$MD$US$US
241537051$24153705$1$I$20240727$20240727$20240730$20240730$EXP$GB-MHRA-MED-202407272131139770-THDFV$GB-JNJFOC-20240780384$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240730$$CN$GB$GB
241537061$24153706$1$I$20240625$20240729$20240730$20240730$EXP$FR-AFSSAPS-NC2024000884$FR-JNJFOC-20240779569$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240730$$PH$FR$FR
241537071$24153707$1$I$$20240723$20240730$20240730$EXP$$IT-MYLANLABS-2024M1069842$MYLAN$Borotti E, Ronda E, Guidotti S, Scarpa A, Schiro A, Cortellazzi P, et al. Genetic molecular profile in Chronic Myelomonocytic Leukemia (CMML) patient from onset to post-transplant relapse a case report. Haematologica 2024; 109 (Suppl.) 90 abstr. P067.$57$YR$$F$Y$$$20240730$$HP$IT$IT
241537081$24153708$1$I$$20240723$20240730$20240730$EXP$$IT-MYLANLABS-2024M1069818$MYLAN$Merz V, Maines F, Marcucci S, Sartori C, Frisinghelli M, Trentin C, et al. Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma. J-Cancer-Res-Clin-Oncol 2024; 150 (7):.$69$YR$$M$Y$$$20240730$$HP$IT$IT
241537091$24153709$1$I$$20240723$20240730$20240730$EXP$$PT-MYLANLABS-2024M1069777$MYLAN$Real LL, Rodrigues AC, Araujo PS, Iashchuk M, Silva D, Quelhas M, et al. Fever in covid-19 times. Eur-J-Case-Rep-Intern-Med 2022; 9 (Suppl.) 378.$68$YR$$F$Y$$$20240730$$HP$PT$PT
241537101$24153710$1$I$$20240723$20240730$20240730$EXP$$US-RIGEL-20240700093$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240730$$CN$US$US
241537111$24153711$1$I$$20240722$20240730$20240730$PER$$US-AMGEN-USASP2024145759$AMGEN$Shaikh A:. Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 Cases. Kidney Medicine. 2024;6 (8):1-5$50$YR$A$F$Y$$$20240730$$MD$US$US
241537121$24153712$1$I$$20240722$20240730$20240730$EXP$$US-AMGEN-USASP2024145682$AMGEN$Men C.J.. Successful Treatment of Refractory Orbital Plasmacytoma with Chimeric Antigen Receptor T Cell Therapy: A Case Report and Review of the Literature. Ophthalmic Plastic and Reconstructive Surgery. 2024;40 (4):e142-e145$69$YR$E$F$Y$$$20240730$$MD$US$US
241537131$24153713$1$I$$20240715$20240730$20240730$EXP$$US-CMP PHARMA-2024CMP00042$CMP PHARMA$Applegarth J, Finn D, Tolkacz M, Iacco A. Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome. ASAIO J. 2024;70:151$18$YR$$F$Y$$$20240730$$HP$US$US
241537141$24153714$1$I$20240625$20240722$20240730$20240730$EXP$FR-AFSSAPS-LY2024000964$FR-TEVA-VS-3225284$TEVA$$81$YR$$F$Y$87.8$KG$20240730$$PH$FR$FR
241537151$24153715$1$I$20090101$20240716$20240730$20240730$EXP$$DE-GLENMARK PHARMACEUTICALS-2024GMK092421$GLENMARK$$$$$$Y$$$20240730$$MD$DE$DE
241537161$24153716$1$I$$20240715$20240730$20240730$EXP$$VN-CMP PHARMA-2024CMP00043$CMP PHARMA$Nguyen C.T, Bui V.C, Do N.S, et al.. Effective Management of Severe Amlodipine/ Atenolol Overdose with Intravenous Calcium, Hyperinsulinemic Euglycemia Therapy, and Continuous Veno-Venous Hemodialysis: A Case Report. Am. J. Case Rep. 2024;25$64$YR$$M$Y$$$20240730$$HP$VN$VN
241537171$24153717$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221343$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
241537181$24153718$1$I$$20240729$20240730$20240730$PER$$US-DSJP-DSU-2024-137954$DAIICHI$$$$$M$Y$$$20240730$$HP$US$US
241537191$24153719$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA218891$SANOFI AVENTIS$$$$A$M$Y$102$KG$20240730$$MD$US$US
241537201$24153720$1$I$$20240725$20240730$20240730$EXP$$CA-SA-2024SA217972$SANOFI AVENTIS$unknown. unknown. unknown. unkn;unknown:unknown$75$YR$E$M$Y$$$20240730$$HP$CA$CA
241537211$24153721$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA223338$SANOFI AVENTIS$$$$A$F$Y$97$KG$20240730$$MD$US$US
241537221$24153722$1$I$$20240722$20240730$20240730$EXP$$US-AMGEN-USASP2024145802$AMGEN$Shaikh A. Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 Cases. Kidney Medicine. 2024;6 (8):1-5$70$YR$E$M$Y$$$20240730$$MD$US$US
241537231$24153723$1$I$$20240725$20240730$20240730$EXP$$US-AMGEN-USASP2024148295$AMGEN$Sharu H.B.; Jain P.; Singer B. et.al.. A rare case of pericardial sarcoidosis presenting as chest pain. Clin Case Rep. 2024;1-6$52$YR$A$F$Y$120$KG$20240730$$HP$US$US
241537241$24153724$1$I$$20240723$20240730$20240730$EXP$CA-HEALTHCANVIG-E2B_07173320$CA-PURDUE-USA-2024-0310988$PURDUE$$43$YR$$F$Y$96$KG$20240730$$HP$CA$CA
241537271$24153727$1$I$20200101$20240723$20240730$20240730$PER$$US-ABBVIE-5852514$ABBVIE$$$$$$Y$$$20240730$$CN$US$US
241537281$24153728$1$I$20240101$20240729$20240730$20240730$PER$$US-JNJFOC-20240777383$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240730$$CN$US$US
241537291$24153729$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-07219$HIKMA$Sevivas R, Silva CP, Ramos FF, Veiga C, Goncalves E, Oliveira CS.. Sevivas R, Silva CP, Ramos FF, Veiga C, Goncalves E, Oliveira CS. PO-0601 - (2110) - Desfecho fatal do  diagn?stico tardio  de Rickettsiose. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI - Livro de res. 2024;/:947$80$YR$$M$Y$$$20240730$$MD$PT$PT
241537301$24153730$1$I$$20240722$20240730$20240730$EXP$$ES-ASTELLAS-2024US021032$ASTELLAS$Cabanillas-Cabral AA, Terron AS, Rodriguez-Conde S, Canueto-Alvarez J, Conde-Ferreiros A. Severe cutaneous drug reaction associated with enfortumab vedotin. Dermatology Online Journal. 2024;30(3):1-3$74$YR$$M$Y$$$20240730$$HP$ES$ES
241537312$24153731$2$F$$20240726$20240730$20240806$PER$$US-SA-2024SA219190$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240806$$CN$US$US
241537321$24153732$1$I$$20240716$20240730$20240730$EXP$$FR-009507513-0703FRA00100$MERCK$J.P DURAND, B GOURMEL, O MIR, F GOLDWASSER. Antiemetic neurokinin-1 antagonist aprepitant and ifosfamide-induced encephalopathy. ANNALS OF ONCOLOGY. 2007;18(4):Pg:808-809$57$YR$$F$Y$$$20240730$$MD$FR$FR
241537331$24153733$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-07138$HIKMA$Carvalhinha C, Henriques C, Barreto F, Fernandes R, Loja JT, Freitas JM, et al.. Carvalhinha C, Henriques C, Barreto F, Fernandes R, Loja JT, Freitas JM, Faria T. PO-0487 - (4622) - Uma manifesta??o  comum, uma  entidade rara. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI. 2024;/:847$$$$$Y$$$20240730$$MD$PT$PT
241537341$24153734$1$I$20240430$20240722$20240730$20240730$EXP$$CO-VANTIVE-2024VAN018442$Vantive US Healthcare$$74$YR$$F$Y$51$KG$20240730$$HP$CO$CO
241537351$24153735$1$I$20230601$20240724$20240730$20240730$EXP$$BR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004167$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240730$$LW$BR$BR
241537361$24153736$1$I$20240413$20240724$20240730$20240730$EXP$FR-AFSSAPS-LL2024001335$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004159$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240730$$MD$FR$FR
241537371$24153737$1$I$20230711$20240724$20240730$20240730$EXP$$HU-MYLANLABS-2024M1069199$MYLAN$$1$MON$$F$Y$$$20240730$$CN$HU$HU
241537381$24153738$1$I$20240701$20240726$20240730$20240730$PER$$US-JNJFOC-20240773568$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240730$$PH$US$US
241537401$24153740$1$I$20240701$20240702$20240730$20240730$PER$$US-LEX-000373$LEXICON PHARMACEUTICALS$$76$YR$$F$Y$$$20240730$$CN$US$US
241537411$24153741$1$I$20240723$20240725$20240729$20240729$DIR$FDA-CDER-CTU-2024-51888$$FDA-CTU$$24$YR$$M$N$111.13$KG$20240725$N$CN$US$
241537423$24153742$3$F$$20240731$20240730$20240807$EXP$$MY-EXELIXIS-CABO-24079886$EXELIXIS$$65$YR$$M$Y$66$KG$20240807$$CN$MY$MY
241537431$24153743$1$I$20240607$20240724$20240730$20240730$EXP$$JP-EXELIXIS-CABO-24079988$EXELIXIS$$8$DEC$$M$Y$$$20240730$$PH$JP$JP
241537441$24153744$1$I$20231128$20240729$20240730$20240730$EXP$$JP-EXELIXIS-CABO-24079996$EXELIXIS$$64$YR$$M$Y$53$KG$20240730$$MD$JP$JP
241537451$24153745$1$I$$20240725$20240730$20240730$EXP$$US-EXELIXIS-CABO-24079844$EXELIXIS$$$$$M$Y$$$20240730$$CN$US$US
241537461$24153746$1$I$20240201$20240724$20240730$20240730$EXP$$JP-EXELIXIS-CABO-24079932$EXELIXIS$$9$DEC$$M$Y$$$20240730$$PH$JP$JP
241537471$24153747$1$I$$20240724$20240730$20240730$EXP$$JP-EXELIXIS-CABO-24079946$EXELIXIS$$$$$$Y$$$20240730$$MD$JP$JP
241537481$24153748$1$I$$20240724$20240730$20240730$EXP$$JP-EXELIXIS-CABO-24079942$EXELIXIS$$7$DEC$$M$Y$$$20240730$$MD$JP$JP
241537491$24153749$1$I$20240720$20240725$20240730$20240730$EXP$$US-PFIZER INC-PV202400057717$PFIZER$$87$YR$$M$Y$$$20240730$$HP$US$US
241537501$24153750$1$I$$20240726$20240730$20240730$EXP$$US-EXELIXIS-CABO-24079891$EXELIXIS$$$$$M$Y$$$20240729$$HP$US$US
241537523$24153752$3$F$$20240913$20240730$20240920$EXP$$JP-EXELIXIS-CABO-24079931$EXELIXIS$$7$DEC$$M$Y$$$20240920$$MD$JP$JP
241537531$24153753$1$I$20220520$20240723$20240730$20240730$EXP$$JP-EXELIXIS-CABO-24079877$EXELIXIS$$63$YR$$M$Y$52$KG$20240730$$MD$JP$JP
241537542$24153754$2$F$20240723$20240801$20240730$20240806$EXP$$JP-EXELIXIS-CABO-24079938$EXELIXIS$$$$$F$Y$$$20240806$$MD$JP$JP
241537551$24153755$1$I$$20240725$20240730$20240730$EXP$$US-EXELIXIS-CABO-24079848$EXELIXIS$$$$$M$Y$$$20240729$$HP$US$US
241537572$24153757$2$F$20240701$20240801$20240730$20240813$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-14655$IPSEN$$35$YR$A$M$Y$103$KG$20240813$$HP$GB$GB
241537581$24153758$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120361$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240730$$HP$US$US
241537591$24153759$1$I$$20240722$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116787$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$73.94$KG$20240730$$CN$US$US
241537601$24153760$1$I$$20240725$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119832$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240730$$CN$US$US
241537612$24153761$2$F$$20240729$20240730$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119037$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240802$$HP$US$US
241537621$24153762$1$I$20240510$20240715$20240730$20240730$EXP$$PT-FOUNDATIONCONSUMERHC-2024-PT-000069$FOUNDATION CONSUMER HEALTHCARE$$47$YR$A$F$Y$$$20240730$$PH$PT$PT
241537631$24153763$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120049$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240730$$CN$US$US
241537641$24153764$1$I$20240503$20240724$20240730$20240730$EXP$FR-AFSSAPS-RE2024000725$FR-MYLANLABS-2024M1070136$MYLAN$$47$YR$$F$Y$63$KG$20240730$$MD$FR$FR
241537651$24153765$1$I$20230901$20240724$20240730$20240730$EXP$$PT-MYLANLABS-2024M1069637$MYLAN$$45$YR$$F$Y$$$20240730$$MD$PT$PT
241537661$24153766$1$I$$20240724$20240730$20240730$EXP$$MT-MYLANLABS-2024M1069533$MYLAN$Debrincat, M., Pullicino, R., + Pace, A.. An unusual case of adult-onset acute disseminated encephalomyelitis. 2024$57$YR$$M$Y$$$20240730$$CN$MT$MT
241537673$24153767$3$F$20240704$20240916$20240730$20240917$EXP$$US-INCYTE CORPORATION-2024IN007893$INCYTE$$$$$$Y$$$20240917$$HP$US$US
241537681$24153768$1$I$$20240725$20240730$20240730$EXP$$CA-MYLANLABS-2024M1070038$MYLAN$$46$YR$$M$Y$$$20240730$$CN$CA$CA
241537692$24153769$2$F$20240708$20240902$20240730$20240909$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-14627$IPSEN$$77$YR$E$F$Y$$$20240909$$MD$US$US
241537701$24153770$1$I$20240601$20240729$20240730$20240730$EXP$$AU-ABBVIE-5858791$ABBVIE$$57$YR$$M$Y$$$20240730$$CN$AU$AU
241537711$24153771$1$I$$20240724$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118761$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$HP$US$US
241537721$24153772$1$I$20240101$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120470$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240730$$HP$US$US
241537731$24153773$1$I$$20240722$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117746$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240730$$MD$US$US
241537741$24153774$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120366$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240730$$CN$US$US
241537751$24153775$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120419$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240730$$CN$US$US
241537762$24153776$2$F$$20240906$20240730$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119720$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240910$$MD$US$US
241537772$24153777$2$F$$20240729$20240730$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120532$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240801$$HP$US$US
241537781$24153778$1$I$$20240722$20240730$20240730$EXP$$RU-AstraZeneca-2024A171913$ASTRAZENECA$Obrazcova, L.A; Zlobina, I.S. ANTIPHOSPHOLIPID SYNDROME MASKED BY ACUTE CORONARY. Russian Journal of Cardiology 2024;29(5S):$32$YR$$M$Y$$$20240730$$HP$RU$
241537791$24153779$1$I$$20240721$20240730$20240730$EXP$GB-MHRA-MED-202407210124074600-ZFWGB$GB-TEVA-VS-3223784$TEVA$$25$YR$$$Y$$$20240730$$CN$GB$GB
241537801$24153780$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225301$TEVA$$57$YR$$F$Y$101$KG$20240730$$HP$CA$CA
241537811$24153781$1$I$20240719$20240721$20240730$20240730$EXP$GB-MHRA-MED-202407211929351360-NJSTM$GB-TEVA-VS-3223909$TEVA$$86$YR$$F$Y$$$20240730$$CN$GB$GB
241537821$24153782$1$I$20240715$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016674$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240730$$CN$US$US
241537832$24153783$2$F$$20240801$20240730$20240809$EXP$$PL-TEVA-VS-3224121$TEVA$Wach A, Kosalka-Wegiel J, Korkosz M. Double trouble: a case of DRESS syndrome induced by lamotrigine and subsequent skin reaction to levetiracetam. Pol-Arch-Med-Wewn 2024; 134 (6):.; Wach A, Kosalka-Wegiel J, Korkosz M. Double trouble: a case of DRESS syndrome induced by lamotrigine and subsequent skin reaction to levetiracetam. Pol-Arch-Med-Wewn 2024; 134 (6):.$21$YR$$F$Y$$$20240809$$MD$PL$PL
241537841$24153784$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018733$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240730$$CN$US$US
241537852$24153785$2$F$20240701$20240724$20240730$20240802$EXP$$EG-ELI_LILLY_AND_COMPANY-EG202407016478$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240802$$CN$EG$EG
241537861$24153786$1$I$$20240716$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-116473$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$MD$CA$CA
241537882$24153788$2$F$$20240726$20240730$20240805$EXP$$TH-INCYTE CORPORATION-2024IN007915$INCYTE$$$$$$Y$$$20240805$$MD$TH$TH
241537891$24153789$1$I$$20240705$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007158$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241537901$24153790$1$I$20240721$20240721$20240730$20240730$EXP$GB-MHRA-MED-202407211006196690-CFHYB$GB-TEVA-VS-3223824$TEVA$$56$YR$$M$Y$80$KG$20240730$$CN$GB$GB
241537911$24153791$1$I$20240101$20240724$20240730$20240730$EXP$$US-ABBVIE-5855813$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241537921$24153792$1$I$20210101$20240723$20240730$20240730$EXP$$GB-MYLANLABS-2024M1019627$MYLAN$$$$A$M$Y$$$20240730$$MD$GB$GB
241537931$24153793$1$I$$20240718$20240730$20240730$EXP$$CA-TEVA-VS-3225235$TEVA$$60$YR$$F$Y$$$20240730$$PH$CA$CA
241537941$24153794$1$I$$20240719$20240730$20240730$PER$$US-MYLANLABS-2024M1068217$MYLAN$$$$$M$Y$68.04$KG$20240730$$CN$US$US
241537951$24153795$1$I$20240713$20240721$20240730$20240730$EXP$$GB-TEVA-VS-3224565$TEVA$$69$YR$$F$Y$$$20240730$$CN$GB$GB
241537962$24153796$2$F$20220101$20240725$20240730$20240805$EXP$$US-ABBVIE-5831001$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241537971$24153797$1$I$20190918$20240723$20240730$20240730$EXP$$PL-PFIZER INC-2021851848$MYLAN$$62$YR$$M$Y$98$KG$20240730$$MD$PL$PL
241537981$24153798$1$I$20240101$20240719$20240730$20240730$PER$$GR-KARYOPHARM-2024KPT001371$KARYOPHARM THERAPEUTICS$$75$YR$$F$Y$50$KG$20240730$$MD$GR$GR
241537992$24153799$2$F$$20240803$20240730$20240805$EXP$$CL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042696$BOEHRINGER INGELHEIM$$59$YR$A$M$Y$$$20240805$$MD$CL$CL
241538001$24153800$1$I$$20240726$20240730$20240730$EXP$$AU-MYLANLABS-2024M1070142$MYLAN$$$$$M$Y$$$20240730$$HP$AU$AU
241538011$24153801$1$I$$20240725$20240730$20240730$EXP$$US-MYLANLABS-2024M1070504$MYLAN$$$$$$Y$$$20240730$$CN$US$US
241538021$24153802$1$I$$20240725$20240730$20240730$EXP$$US-MYLANLABS-2024M1070835$MYLAN$$$$$F$Y$$$20240730$$HP$US$US
241538031$24153803$1$I$20230901$20240729$20240730$20240730$EXP$FR-AFSSAPS-MP2024001191$FR-PFIZER INC-202400225529$PFIZER$$90$YR$$M$Y$101$KG$20240730$$PH$FR$FR
241538041$24153804$1$I$$20240726$20240730$20240730$EXP$$CA-PFIZER INC-202400224749$PFIZER$$74$YR$$F$Y$67$KG$20240730$$HP$CA$CA
241538051$24153805$1$I$$20240730$20240730$20240730$EXP$$CN-PFIZER INC-202400226034$PFIZER$$$$$$Y$$$20240730$$MD$CN$CN
241538061$24153806$1$I$20240101$20240725$20240730$20240730$EXP$$CA-PFIZER INC-202400226180$PFIZER$$75$YR$$F$Y$$$20240730$$PH$CA$CA
241538071$24153807$1$I$20240701$20240725$20240730$20240730$EXP$FR-AFSSAPS-GR2024000930$FR-PFIZER INC-202400223467$PFIZER$$74$YR$$F$Y$$$20240730$$PH$FR$FR
241538081$24153808$1$I$$20240718$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115566$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240730$$HP$CA$CA
241538091$24153809$1$I$$20240725$20240730$20240730$EXP$$CA-PFIZER INC-202400224718$PFIZER$$41$YR$$F$Y$$$20240730$$HP$CA$CA
241538101$24153810$1$I$20200101$20240724$20240730$20240730$EXP$$CA-PFIZER INC-202400224408$PFIZER$$53$YR$$M$Y$$$20240730$$MD$CA$CA
241538111$24153811$1$I$$20240726$20240730$20240730$EXP$$US-PFIZER INC-202400224925$PFIZER$$24$YR$$M$Y$$$20240730$$MD$US$US
241538121$24153812$1$I$20221209$20240725$20240730$20240730$EXP$FR-AFSSAPS-PC2024000593$FR-PFIZER INC-202400223498$PFIZER$$45$YR$$F$Y$$$20240730$$PH$FR$FR
241538131$24153813$1$I$20240601$20240725$20240730$20240730$EXP$FR-AFSSAPS-GR2024000931$FR-PFIZER INC-202400223493$PFIZER$$74$YR$$M$Y$105$KG$20240730$$PH$FR$FR
241538141$24153814$1$I$$20240726$20240730$20240730$EXP$$CA-PFIZER INC-202400224753$PFIZER$$69$YR$$F$Y$75$KG$20240730$$HP$CA$CA
241538151$24153815$1$I$20240724$20240725$20240730$20240730$EXP$$CA-PFIZER INC-202400224344$PFIZER$$65$YR$$M$Y$$$20240730$$HP$CA$CA
241538161$24153816$1$I$20240701$20240726$20240730$20240730$EXP$$JP-PFIZER INC-202400224460$PFIZER$$90$YR$$M$Y$$$20240730$$PH$JP$JP
241538171$24153817$1$I$20240101$20240726$20240730$20240730$EXP$$CA-PFIZER INC-202400022712$PFIZER$$49$YR$$M$Y$$$20240730$$HP$CA$CA
241538181$24153818$1$I$$20240724$20240730$20240730$EXP$$US-PFIZER INC-202400223006$PFIZER$$37$YR$$F$Y$$$20240730$$CN$US$US
241538191$24153819$1$I$20240624$20240724$20240730$20240730$EXP$$IN-PFIZER INC-PV202400097217$PFIZER$$65$YR$$F$Y$$$20240730$$CN$IN$IN
241538201$24153820$1$I$$20240725$20240730$20240730$EXP$$IN-PFIZER INC-PV202400097953$PFIZER$$71$YR$$M$Y$$$20240730$$CN$IN$IN
241538211$24153821$1$I$20221106$20240726$20240730$20240730$EXP$IT-MINISAL02-996380$IT-DSJP-DSE-2024-137636$DAIICHI$$90$YR$$F$Y$$$20240730$$MD$IT$IT
241538221$24153822$1$I$$20240723$20240730$20240730$EXP$$DE-009507513-2407DEU014439$MERCK$$$$$F$Y$$$20240730$$MD$DE$DE
241538232$24153823$2$F$$20240717$20240730$20240925$PER$$US-INCYTE CORPORATION-2024IN007545$INCYTE$$$$$$Y$$$20240925$$CN$US$US
241538242$24153824$2$F$20240625$20240827$20240730$20240830$EXP$FR-AFSSAPS-TO2024001356$FR-MYLANLABS-2024M1069820$MYLAN$$67$YR$$M$Y$68$KG$20240830$$PH$FR$FR
241538251$24153825$1$I$20240708$20240724$20240730$20240730$EXP$IT-MINISAL02-996370$IT-ABBVIE-5851686$ABBVIE$$82$YR$$F$Y$$$20240730$$MD$IT$IT
241538261$24153826$1$I$$20240724$20240730$20240730$PER$$US-JNJFOC-20240766165$JOHNSON AND JOHNSON$$9$DEC$E$M$Y$$$20240730$$CN$US$US
241538271$24153827$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120087$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240730$$CN$US$US
241538281$24153828$1$I$$20240726$20240730$20240730$EXP$GB-MHRA-MED-202407260940522970-MBTYF$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-120599$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240730$$HP$GB$GB
241538292$24153829$2$F$$20240805$20240730$20240809$30DAY$$CL-PFIZER INC-PV202400097244$PFIZER$$10$YR$$F$Y$$$20240809$$CN$CL$CL
241538311$24153831$1$I$$20240729$20240730$20240730$EXP$$US-TAKEDA-2024TUS076344$TAKEDA$$$$$F$Y$$$20240730$$CN$US$US
241538321$24153832$1$I$$20240722$20240730$20240730$EXP$$CA-DSJP-DSJ-2024-137653$DAIICHI$$$$$F$Y$$$20240730$$MD$CA$CA
241538331$24153833$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155602$NOVARTIS$$$$$F$Y$$$20240730$$MD$US$US
241538341$24153834$1$I$$20240722$20240730$20240730$EXP$$CA-DSJP-DSJ-2024-137650$DAIICHI$$$$$F$Y$$$20240730$$HP$CA$CA
241538351$24153835$1$I$$20240726$20240730$20240730$EXP$$JP-ABBVIE-5858578$ABBVIE$$$$$$Y$$$20240730$$MD$JP$JP
241538362$24153836$2$F$$20240902$20240730$20240906$EXP$$BR-TAKEDA-2024TUS074691$TAKEDA$$$$$M$Y$82$KG$20240906$$CN$BR$BR
241538371$24153837$1$I$20240620$20240724$20240730$20240730$EXP$FR-AFSSAPS-RN2024000778$FR-MYLANLABS-2024M1069554$MYLAN$$38$YR$$F$Y$$$20240730$$HP$FR$FR
241538382$24153838$2$F$$20240717$20240730$20240812$PER$$US-INCYTE CORPORATION-2024IN007551$INCYTE$$$$$$Y$$$20240813$$MD$US$US
241538391$24153839$1$I$20240101$20240724$20240730$20240730$EXP$$IL-AMERICAN REGENT INC-2024002869$AMERICAN REGENT$$23$YR$$F$Y$$$20240730$$PH$IL$IL
241538402$24153840$2$F$$20240823$20240730$20240823$EXP$$GR-ALXN-202407EEA001933GR$ALEXION PHARMACEUTICALS$$$$E$F$Y$75$KG$20240823$$MD$GR$GR
241538411$24153841$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120479$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240730$$CN$US$US
241538421$24153842$1$I$20190101$20240729$20240730$20240730$EXP$FR-AFSSAPS-AN2024000948$NVSC2024FR154742$NOVARTIS$$51$YR$$M$Y$98$KG$20240730$$PH$FR$FR
241538431$24153843$1$I$20240529$20240724$20240730$20240730$EXP$FR-AFSSAPS-BS2024000431$FR-MYLANLABS-2024M1069667$MYLAN$$85$YR$$F$Y$$$20240730$$PH$FR$FR
241538443$24153844$3$F$$20240918$20240730$20240930$PER$$US-INCYTE CORPORATION-2024IN007554$INCYTE$$$$$$Y$$$20240930$$MD$US$US
241538451$24153845$1$I$$20240726$20240730$20240730$PER$$US-JNJFOC-20240773665$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$US$US
241538461$24153846$1$I$20240701$20240723$20240730$20240730$PER$$US-SA-2024SA218857$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240730$$MD$US$US
241538471$24153847$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA221680$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240730$$MD$US$US
241538481$24153848$1$I$20240101$20240724$20240730$20240730$PER$$US-SA-2024SA223380$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240730$$MD$US$US
241538491$24153849$1$I$20220216$20240723$20240730$20240730$EXP$$CO-TAKEDA-CO201907234$TAKEDA$$51$YR$$M$Y$82$KG$20240730$$CN$CO$CO
241538501$24153850$1$I$$20240719$20240730$20240730$PER$$US-RDY-LIT/USA/24/0010992$DR REDDYS$Murphy A, Cordisco A, Khan AH, Craft CA. AN UNCOMMON CUASE OF COMPLETE HEART BLOCK IN A PATIENT WITH A HISTORY OF SEIZURES. Journal of the American College of Cardiology. 2024 Apr 02;83(13): 2881. doi:10.1016/S0735-1097%2824%2904871-X.$64$YR$A$M$Y$$$20240730$$HP$US$US
241538511$24153851$1$I$20230701$20240729$20240730$20240730$EXP$FR-AFSSAPS-TS2024000855$FR-SANDOZ INC.-SDZ2024FR069044$SANDOZ$$57$YR$$M$Y$68$KG$20240730$$MD$FR$FR
241538521$24153852$1$I$20240725$20240725$20240730$20240730$EXP$$US-BAYER-2024A109562$BAYER$$27$YR$A$M$Y$$$20240730$$CN$US$US
241538541$24153854$1$I$$20240726$20240730$20240730$EXP$GB-MHRA-MED-202407261046426710-STWQJ$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-120625$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240730$$HP$GB$GB
241538561$24153856$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120764$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$138.35$KG$20240730$$CN$US$US
241538571$24153857$1$I$20240210$20240726$20240730$20240730$EXP$$DE-MYLANLABS-2024M1069955$MYLAN$$$$E$F$Y$$$20240730$$HP$DE$DE
241538583$24153858$3$F$20240715$20240816$20240730$20240820$EXP$$IT-AMERICAN REGENT INC-2024002908$AMERICAN REGENT$$39$YR$$F$Y$85$KG$20240820$$MD$IT$IT
241538591$24153859$1$I$20240601$20240723$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US069247$SANDOZ$$46$YR$$F$Y$65.76$KG$20240730$$HP$US$US
241538601$24153860$1$I$20240709$20240723$20240730$20240730$EXP$GB-MHRA-MED-202407231210550910-LSYKQ$GB-TEVA-VS-3224906$TEVA$$$$$M$Y$$$20240730$$PH$GB$GB
241538611$24153861$1$I$$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018626$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241538622$24153862$2$F$20230101$20240910$20240730$20240923$EXP$$US-UCBSA-2024037229$UCB$$$$$M$Y$92.971$KG$20240923$$HP$US$US
241538634$24153863$4$F$20240703$20240726$20240730$20240802$PER$$US-BIOGEN-2024BI01275518$BIOGEN$$69$YR$$M$Y$$$20240802$$CN$US$US
241538641$24153864$1$I$20240722$20240723$20240730$20240730$PER$$US-HETERO-HET2024US02472$HETERO$$54$YR$$M$Y$$$20240730$$HP$US$US
241538651$24153865$1$I$$20240729$20240730$20240730$EXP$$GB-SANDOZ INC.-NVSC2020GB325799$SANDOZ$$$$$F$Y$$$20240730$$HP$GB$GB
241538661$24153866$1$I$$20240703$20240730$20240730$PER$$US-JNJFOC-20240712102$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240730$$CN$US$US
241538672$24153867$2$F$$20240726$20240730$20240801$PER$$US-JNJFOC-20240761883$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
241538681$24153868$1$I$20240625$20240725$20240730$20240730$PER$$US-JNJFOC-20240769559$JOHNSON AND JOHNSON$$25$YR$A$$Y$$$20240730$$HP$US$US
241538691$24153869$1$I$$20230823$20240730$20240730$EXP$$CA-AstraZeneca-2023A194170$ASTRAZENECA$$$$$F$Y$$$20240730$$CN$CA$
241538701$24153870$1$I$20231214$20240729$20240730$20240730$EXP$FR-AFSSAPS-LY2024000209$FR-SANDOZ INC.-SDZ2024FR023885$SANDOZ$$62$YR$$F$Y$57$KG$20240730$$HP$FR$FR
241538711$24153871$1$I$$20240718$20240730$20240730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-119999$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240730$$HP$CA$CA
241538731$24153873$1$I$20231201$20240729$20240730$20240730$EXP$FR-AFSSAPS-MP2024001191$NVSC2024FR154734$NOVARTIS$$90$YR$$M$Y$101$KG$20240730$$PH$FR$FR
241538741$24153874$1$I$20240401$20240726$20240730$20240730$EXP$$JP-009507513-2404JPN003543J$MERCK$$74$YR$$F$Y$$$20240730$$PH$JP$JP
241538751$24153875$1$I$$20240726$20240730$20240730$EXP$$IE-MYLANLABS-2024M1070147$MYLAN$$$$$F$Y$$$20240730$$PH$IE$IE
241538761$24153876$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225287$TEVA$$5$YR$$M$Y$18$KG$20240730$$PH$CA$CA
241538771$24153877$1$I$20240101$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119299$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240730$$HP$US$US
241538783$24153878$3$F$$20240913$20240730$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119378$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240925$$MD$JP$JP
241538791$24153879$1$I$20240601$20240724$20240730$20240730$PER$$US-SA-2024SA218696$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240730$$CN$US$US
241538801$24153880$1$I$$20240709$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007234$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241538811$24153881$1$I$20240128$20240723$20240730$20240730$EXP$GB-MHRA-30722942$GB-TEVA-VS-3224997$TEVA$$85$YR$$M$Y$80$KG$20240730$$CN$GB$GB
241538821$24153882$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150593$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241538831$24153883$1$I$20240701$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120551$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$65.77$KG$20240730$$CN$US$US
241538841$24153884$1$I$$20240710$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007290$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241538861$24153886$1$I$$20240726$20240730$20240730$PER$$NVSC2024US155079$NOVARTIS$$$$$F$Y$$$20240730$$CN$US$US
241538881$24153888$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225283$TEVA$$13$YR$$F$Y$42$KG$20240730$$PH$CA$CA
241538891$24153889$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120495$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240730$$CN$US$US
241538901$24153890$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120748$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240730$$MD$US$US
241538911$24153891$1$I$$20240722$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116769$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240730$$HP$US$US
241538921$24153892$1$I$$20240724$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118225$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240730$$CN$US$US
241538933$24153893$3$F$20240726$20240913$20240730$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120628$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240917$$CN$US$US
241538943$24153894$3$F$$20240909$20240730$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120675$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$66.22$KG$20240911$$CN$US$US
241538951$24153895$1$I$$20240719$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007635$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241538961$24153896$1$I$$20240723$20240730$20240730$PER$$US-MYLANLABS-2024M1069568$MYLAN$$$$$F$Y$$$20240730$$CN$US$US
241538971$24153897$1$I$20240724$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018107$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240730$$CN$US$US
241538983$24153898$3$F$$20240718$20240730$20240925$PER$$US-INCYTE CORPORATION-2024IN007630$INCYTE$$$$$$Y$$$20240925$$CN$US$US
241538991$24153899$1$I$$20240715$20240730$20240730$EXP$$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-07157$HIKMA$I. De Albuquerque Monteiro, J. Correira Cardoso, F. Guedes, S. Festa, P. Macedo Neves, J. Salomao, M. Esteves. I.De Albuquerque Monteiro, J.Correira Cardoso, F.Guedes, S.Festa, P.Macedo Neves, J.Salomao, M.Esteves. An infection never comes alone - about a clinical case. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional$$$$$Y$$$20240730$$MD$PT$PT
241539001$24153900$1$I$20240717$20240718$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007592$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241539013$24153901$3$F$20240718$20240801$20240730$20240813$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02691$AMNEAL$$29$YR$$F$Y$70.295$KG$20240813$$HP$US$US
241539021$24153902$1$I$$20240730$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042776$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240730$$CN$US$US
241539031$24153903$1$I$20240616$20240729$20240730$20240730$EXP$PT-INFARMED-T202407-431$PT-SANDOZ INC.-SDZ2024PT069019$SANDOZ$$47$YR$$F$Y$60$KG$20240730$$PH$PT$PT
241539041$24153904$1$I$$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150588$AMGEN$$$$$$Y$$$20240730$$CN$US$US
241539051$24153905$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217891$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240730$$MD$US$US
241539062$24153906$2$F$$20240715$20240730$20240810$EXP$$CH-TEVA-VS-3223532$TEVA$Thurner A, Delco-Volonte C, Zanolari M, Simonetti GD, Prader S, Pachlopnik Schmid J, et al. Think atypical!. Swiss-Med-Wkly 2024; 154 (Suppl.) 25S abstr. P 19.; Thurner A, Delco-Volonte C, Zanolari M, Simonetti GD, Prader S, Pachlopnik Schmid J, et al. Think atypical!. Swiss-Med-Wkly 2024; 154 (Suppl.) 25S abstr. P 19.$7$YR$$M$Y$$$20240810$$HP$CH$CH
241539081$24153908$1$I$20240701$20240726$20240730$20240730$EXP$$US-KYOWAKIRIN-2024KK018127$KYOWA$$$$$$Y$$$20240730$$HP$US$US
241539091$24153909$1$I$$20240724$20240730$20240730$PER$$US-MYLANLABS-2024M1069948$MYLAN$$82$YR$$M$Y$$$20240730$$CN$US$US
241539101$24153910$1$I$20240309$20240724$20240730$20240730$PER$$US-Eisai-EC-2024-171044$EISAI$$69$YR$E$M$Y$$$20240730$$CN$US$US
241539113$24153911$3$F$20240715$20240906$20240730$20240913$PER$$US-ROCHE-10000031836$ROCHE$$49$YR$A$F$Y$$$20240913$$CN$US$US
241539131$24153913$1$I$20240720$20240724$20240730$20240730$EXP$$CN-009507513-2407CHN014923$MERCK$$62$YR$$F$Y$65$KG$20240730$$HP$CN$CN
241539141$24153914$1$I$$20240729$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120504$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240730$$MD$US$US
241539151$24153915$1$I$$20240722$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116789$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240730$$CN$US$US
241539162$24153916$2$F$20240227$20240923$20240730$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115846$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$68.66$KG$20240926$$HP$US$US
241539171$24153917$1$I$20240430$20240716$20240730$20240730$EXP$GB-MHRA-MED-202405111547264380-ZDQLF$GB-GLENMARK PHARMACEUTICALS-2024GMK092542$GLENMARK$$$$$$Y$$$20240730$$CN$GB$GB
241539181$24153918$1$I$$20240725$20240730$20240730$EXP$$US-KYOWAKIRIN-2024KK018146$KYOWA$$$$$$Y$$$20240730$$CN$US$US
241539192$24153919$2$F$$20240905$20240730$20240911$EXP$$JP-009507513-2407JPN005031J$MERCK$$48$YR$$F$Y$$$20240911$$MD$JP$JP
241539201$24153920$1$I$20240101$20240727$20240730$20240730$EXP$$US-009507513-2406USA005526$MERCK$$$$$F$Y$$$20240730$$HP$US$US
241539211$24153921$1$I$$20240725$20240730$20240730$EXP$$US-KYOWAKIRIN-2024KK018131$KYOWA$$$$$$Y$$$20240730$$HP$US$US
241539221$24153922$1$I$20240513$20240726$20240730$20240730$EXP$FR-AFSSAPS-LY2024000793$FR-MYLANLABS-2024M1070019$MYLAN$$89$YR$$M$Y$55$KG$20240730$$PH$FR$FR
241539231$24153923$1$I$20240109$20240726$20240730$20240730$EXP$FR-AFSSAPS-NY2024000843$FR-MYLANLABS-2024M1069808$MYLAN$$41$YR$$M$Y$92$KG$20240730$$PH$FR$FR
241539241$24153924$1$I$20231023$20240726$20240730$20240730$EXP$FR-AFSSAPS-NY2024000834$FR-MYLANLABS-2024M1069946$MYLAN$$64$YR$$F$Y$75$KG$20240730$$PH$FR$FR
241539251$24153925$1$I$20240403$20240726$20240730$20240730$EXP$FR-AFSSAPS-NY2024000438$FR-MYLANLABS-2024M1040391$MYLAN$$60$YR$$F$Y$75.8$KG$20240730$$PH$FR$FR
241539262$24153926$2$F$$20240814$20240730$20240819$EXP$$GB-MYLANLABS-2024M1070353$MYLAN$$$$$M$Y$$$20240819$$CN$GB$GB
241539271$24153927$1$I$20240601$20240721$20240730$20240730$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-06950$HIKMA$$$$$$Y$$$20240730$$HP$EG$EG
241539281$24153928$1$I$20240705$20240726$20240730$20240730$EXP$FR-AFSSAPS-PB2024000801$FR-MYLANLABS-2024M1069961$MYLAN$$60$YR$$F$Y$72$KG$20240730$$MD$FR$FR
241539291$24153929$1$I$20200101$20230607$20240730$20240730$PER$$US-Genus_Lifesciences-USA-POI0580202300190$GENUS LIFESCIENCES$$$$A$F$Y$$$20240724$$$US$US
241539301$24153930$1$I$$20240718$20240730$20240730$EXP$$GB-SMPA-2024SPA000169$SUNOVION$$$$$$Y$$$20240730$$HP$RU$RU
241539311$24153931$1$I$20240723$20240726$20240730$20240730$EXP$$NVSC2024CN155307$NOVARTIS$$87$YR$$M$Y$51.2$KG$20240730$$HP$CN$CN
241539321$24153932$1$I$$20240722$20240730$20240730$PER$$US-MYLANLABS-2024M1069832$MYLAN$$$$$F$Y$83.01$KG$20240730$$CN$US$US
241539331$24153933$1$I$20240701$20240719$20240730$20240730$PER$$US-SA-2024SA214364$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240730$$MD$US$US
241539341$24153934$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA221089$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240730$$MD$US$US
241539351$24153935$1$I$$20240729$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042773$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240730$$CN$US$US
241539361$24153936$1$I$20240701$20240729$20240730$20240730$EXP$$US-KYOWAKIRIN-2024KK018189$KYOWA$$$$$$Y$$$20240730$$HP$US$US
241539371$24153937$1$I$20240730$20240730$20240730$20240730$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042725$BOEHRINGER INGELHEIM$$$$$$Y$$$20240730$$CN$US$US
241539382$24153938$2$F$20231108$20240829$20240730$20240903$EXP$IT-MINISAL02-995646$IT-MYLANLABS-2024M1069645$MYLAN$$54$YR$$F$Y$$$20240903$$MD$IT$IT
241539391$24153939$1$I$20240702$20240724$20240730$20240730$EXP$FR-AFSSAPS-NT2024000877$FR-MYLANLABS-2024M1069142$MYLAN$$51$YR$$F$Y$63$KG$20240730$$MD$FR$FR
241539401$24153940$1$I$20240626$20240724$20240730$20240730$EXP$$DE-MYLANLABS-2024M1069585$MYLAN$$91$YR$$M$Y$79$KG$20240730$$MD$DE$DE
241539411$24153941$1$I$20230901$20240724$20240730$20240730$EXP$$PT-MYLANLABS-2024M1069354$MYLAN$$39$YR$$F$Y$$$20240730$$MD$PT$PT
241539421$24153942$1$I$$20240730$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120656$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240730$$HP$US$US
241539442$24153944$2$F$$20240730$20240730$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120582$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$72.57$KG$20240731$$CN$US$US
241539451$24153945$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120119$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240730$$HP$US$US
241539461$24153946$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120035$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240730$$CN$US$US
241539471$24153947$1$I$$20240729$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042596$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240730$$CN$US$US
241539481$24153948$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3224769$TEVA$$46$YR$$M$Y$$$20240730$$CN$CA$CA
241539492$24153949$2$F$$20240801$20240730$20240810$EXP$$US-TEVA-VS-3222773$TEVA$Raza HS, Love JS, Mikolajczyk AE. Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding. ACG-Case-Rep-J 2024; 11 (6):.; Raza HS, Love JS, Mikolajczyk AE. Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding. ACG-Case-Rep-J 2024; 11 (6):.$38$YR$$M$Y$$$20240810$$MD$US$US
241539501$24153950$1$I$20240101$20240719$20240730$20240730$EXP$$US-ALKERMES INC.-ALK-2024-001947$ALKERMES$$$$$M$Y$$$20240730$$CN$US$US
241539511$24153951$1$I$20240711$20240722$20240730$20240730$EXP$$US-ALKERMES INC.-ALK-2024-001943$ALKERMES$$23$YR$$M$Y$181.41$KG$20240730$$HP$US$US
241539521$24153952$1$I$20240101$20240718$20240730$20240730$EXP$$US-ALKERMES INC.-ALK-2024-001932$ALKERMES$$$$$F$Y$94.785$KG$20240730$$CN$US$US
241539531$24153953$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225280$TEVA$$7$YR$$F$Y$33$KG$20240730$$HP$CA$CA
241539541$24153954$1$I$$20240729$20240730$20240730$PER$$US-JNJFOC-20240776788$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$PH$US$US
241539551$24153955$1$I$$20240729$20240730$20240730$PER$$US-JNJFOC-20240778263$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$US$US
241539571$24153957$1$I$$20210130$20240730$20240730$EXP$$DE-DSJP-DSJ-2021-104712$DAIICHI$$$$E$F$Y$$$20240730$$MD$DE$DE
241539582$24153958$2$F$$20240729$20240730$20240814$EXP$$CA-GILEAD-2024-0681718$GILEAD$Kordy F, Nashid N, Khan S, Read S, Macdougall G,Bitnun A, et al.. Video directly observed therapy to improve adherence of human immunodeficiency virus infected adolescents to combination antiretroviral therapy a proof of concept study. AIDS Care Psychol Socio Medical aspects of HIV AIDS. 2023;35(3):417-424. doi:10.1080/09540121.2022.2104794$16$YR$T$M$Y$$$20240814$$HP$CA$CA
241539591$24153959$1$I$20240101$20240729$20240730$20240730$PER$$US-ABBVIE-5860188$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241539601$24153960$1$I$$20240727$20240730$20240730$EXP$$US-ASTELLAS-2024EU007513$ASTELLAS$$$$$M$Y$$$20240730$$CN$US$US
241539611$24153961$1$I$20240701$20240724$20240730$20240730$PER$$US-SA-2024SA221682$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240730$$MD$US$US
241539621$24153962$1$I$$20240724$20240730$20240730$EXP$GB-MHRA-MIDB-b0ac154e-0835-4945-b18d-d0ea9223a0c0$GB-SA-2024SA218164$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240730$$PH$GB$GB
241539631$24153963$1$I$$20240723$20240730$20240730$EXP$$NVSC2024CA154504$NOVARTIS$$44$YR$$F$Y$$$20240730$$HP$CA$CA
241539641$24153964$1$I$20240726$20240729$20240730$20240730$EXP$$US-BAYER-2024A110197$BAYER$$71$YR$E$M$Y$$$20240730$$HP$US$US
241539663$24153966$3$F$$20240805$20240730$20240808$EXP$$NVSC2024DE155599$NOVARTIS$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD OPEN. 2024;10(3):e004381$29$YR$$F$Y$$$20240808$$HP$DE$DE
241539671$24153967$1$I$20240721$20240722$20240730$20240730$PER$$US-MYLANLABS-2024M1068669$MYLAN$$79$YR$$M$Y$58.97$KG$20240730$$CN$US$US
241539681$24153968$1$I$$20240730$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120652$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240730$$CN$US$US
241539692$24153969$2$F$20240517$20240813$20240730$20240816$EXP$$US-PFIZER INC-202400225620$PFIZER$$77$YR$$M$Y$$$20240816$$HP$US$US
241539701$24153970$1$I$$20240605$20240730$20240730$PER$$US-LUNDBECK-DKLU4000357$LUNDBECK$$$$$$Y$$$20240730$$CN$US$US
241539712$24153971$2$F$$20240801$20240730$20240809$EXP$$UA-TEVA-VS-3223269$TEVA$Chernyshova L, Lysytsia O, Stryha N, Beglaryan S, Shadrin O. Bone Marrow Transplantation as a Method of Choice in Treatment of Gain-of-Function Mutations in STAT1. Case Report. Paediatr-East-Eur 2021; 9 (3): 414-423.; Chernyshova L, Lysytsia O, Stryha N, Beglaryan S, Shadrin O. Bone Marrow Transplantation as a Method of Choice in Treatment of Gain-of-Function Mutations in STAT1. Case Report. Paediatr-East-Eur 2021; 9 (3): 414-423.$22$MON$$M$Y$$$20240809$$HP$UA$UA
241539731$24153973$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3225295$TEVA$$14$YR$$M$Y$41$KG$20240730$$PH$CA$CA
241539741$24153974$1$I$$20240729$20240730$20240730$PER$$US-ABBVIE-5860574$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241539751$24153975$1$I$$20240722$20240730$20240730$EXP$$CA-TEVA-VS-3224738$TEVA$$61$YR$$F$Y$$$20240730$$HP$CA$CA
241539761$24153976$1$I$$20240726$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US068736$SANDOZ$$$$$F$Y$$$20240730$$MD$US$US
241539771$24153977$1$I$20240101$20240714$20240730$20240730$PER$$US-KARYOPHARM-2024KPT001191$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240730$$CN$US$US
241539781$24153978$1$I$$20240723$20240730$20240730$PER$$US-AMGEN-USASP2024147042$AMGEN$$$$$$Y$$$20240730$$PH$US$US
241539791$24153979$1$I$20240301$20240724$20240730$20240730$EXP$$US-MYLANLABS-2024M1069593$MYLAN$$84$YR$$F$Y$68.95$KG$20240730$$CN$US$US
241539801$24153980$1$I$20240720$20240730$20240730$20240730$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042754$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240730$$CN$US$US
241539812$24153981$2$F$20240503$20240828$20240730$20240904$EXP$FR-AFSSAPS-LL2024001380$FR-009507513-2407FRA014226$MERCK$$54$YR$$F$Y$71$KG$20240904$$MD$FR$FR
241539821$24153982$1$I$20240701$20240724$20240730$20240730$EXP$$US-AMGEN-USASP2024148864$AMGEN$$$$A$F$Y$$$20240730$$PH$US$US
241539831$24153983$1$I$$20240726$20240730$20240730$EXP$$FR-PURDUE-USA-2024-0311033$PURDUE$Larabi I-A, Ghishb A, Kintzc P, Marillier M, Fabresse N and al.. Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA). Toxicologie Analytique + Clinique. 2023;35:376-394$55$YR$$M$Y$$$20240730$$MD$FR$FR
241539842$24153984$2$F$20240701$20240827$20240730$20240902$EXP$FR-AFSSAPS-LL2024001385$FR-009507513-2407FRA014044$MERCK$$49$YR$$F$Y$52.5$KG$20240902$$MD$FR$FR
241539851$24153985$1$I$20190507$20240724$20240730$20240730$EXP$$US-PURDUE PHARMA-USA-2024-0311009$PURDUE$$$$A$F$Y$$$20240730$$CN$US$US
241539861$24153986$1$I$20240625$20240726$20240730$20240730$EXP$$FR-PURDUE-USA-2024-0311041$PURDUE$$83$YR$$M$Y$60$KG$20240730$$MD$FR$FR
241539871$24153987$1$I$20170101$20240726$20240730$20240730$EXP$$FR-PURDUE-USA-2024-0311040$PURDUE$$46$YR$$F$Y$$$20240730$$MD$FR$FR
241539881$24153988$1$I$20191106$20240725$20240730$20240730$EXP$$PH-PFIZER INC-PV202400097295$PFIZER$Jacinto, E.. Chemo-resistant Gestational Trophoblastic Neoplasia and the Use of Immunotherapy: A Case Report and Review of Literature. Acta medica Philippina. 2024;58 (11):10.47895/ amp.v58i11.8008$$$A$F$Y$$$20240730$$MD$PH$PH
241539891$24153989$1$I$20240725$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018229$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240730$$CN$US$US
241539901$24153990$1$I$20240726$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018013$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240730$$CN$US$US
241539911$24153991$1$I$20240725$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018159$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240730$$CN$US$US
241539934$24153993$4$F$20240726$20240821$20240730$20240822$PER$$US-JNJFOC-20240774091$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$PH$US$US
241539941$24153994$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA221683$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240730$$CN$US$US
241539951$24153995$1$I$$20210204$20240730$20240730$EXP$$FR-DSJP-DSJ-2021-104529AA$DAIICHI$$$$$F$Y$$$20240730$$MD$FR$FR
241539961$24153996$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA217488$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240730$$MD$US$US
241539971$24153997$1$I$20230101$20240725$20240730$20240730$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2023-07019$IPSEN$$58$YR$A$F$Y$$$20240730$$HP$GB$GB
241539982$24153998$2$F$$20240830$20240730$20240830$30DAY$$US-PFIZER INC-202400220883$PFIZER$$14$YR$$M$Y$$$20240830$$CN$US$US
241539991$24153999$1$I$$20240726$20240730$20240730$PER$$US-BAUSCH-BL-2024-011491$BAUSCH AND LOMB$$80$YR$$F$Y$62.652$KG$20240730$$CN$US$US
241540001$24154000$1$I$20240701$20240724$20240730$20240730$PER$$US-SA-2024SA221203$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240730$$MD$US$US
241540011$24154001$1$I$$20240718$20240730$20240730$PER$$US-SA-2024SA214922$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240730$$MD$US$US
241540022$24154002$2$F$20240724$20240724$20240730$20240807$PER$$US-SA-2024SA221252$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240807$$MD$US$US
241540031$24154003$1$I$20240701$20240718$20240730$20240730$PER$$US-SA-2024SA214933$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240730$$MD$US$US
241540041$24154004$1$I$$20240728$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US069081$SANDOZ$$$$$$Y$$$20240730$$CN$US$US
241540051$24154005$1$I$$20240723$20240730$20240730$EXP$$DE-009507513-2407DEU014232$MERCK$$$$$F$Y$$$20240730$$MD$DE$DE
241540062$24154006$2$F$$20240830$20240730$20240830$30DAY$$US-PFIZER INC-202400221216$PFIZER$$13$YR$$M$Y$$$20240830$$CN$US$US
241540074$24154007$4$F$$20240807$20240730$20240809$PER$$NVSC2024US155011$NOVARTIS$$$$$$Y$$$20240809$$CN$US$US
241540081$24154008$1$I$$20240726$20240730$20240730$EXP$GB-MHRA-MED-202407261520428400-HWMCJ$GB-MYLANLABS-2024M1070192$MYLAN$$60$YR$$F$Y$$$20240730$$HP$GB$GB
241540101$24154010$1$I$$20240725$20240730$20240730$EXP$$US-OTSUKA-2024_020812$OTSUKA$$4$DEC$$M$Y$$$20240730$$HP$US$US
241540112$24154011$2$F$$20240722$20240730$20240814$EXP$$ID-MYLANLABS-2024M1069406$MYLAN$$61$YR$$F$Y$63$KG$20240814$$MD$ID$ID
241540121$24154012$1$I$20240226$20240724$20240730$20240730$EXP$$US-OTSUKA-2023_021438$OTSUKA$$25$YR$$F$Y$159.6$KG$20240730$$MD$US$US
241540131$24154013$1$I$$20240718$20240730$20240730$PER$$US-JNJFOC-20240755920$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$CN$US$US
241540141$24154014$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217672$SANOFI AVENTIS$$$$A$M$Y$$$20240730$$MD$US$US
241540152$24154015$2$F$$20240801$20240730$20240810$EXP$$IT-TEVA-VS-3197616$TEVA$Tansella D, Pittorru R, Perazzolo Marra M VENTRICULAR ARRHYTHMIAS IN A UNEXPECTED CARDIAC MAGNETIC RESONANCE. European Heart Journal, Supplement 26 (Suppl.): ii52-ii53, Apr 2024; Pittorru R, Tansella D, Cipriani A, Giorgio DC, Lazzari MD, Rizzo S, et al. Ventricular Arrhythmias in a Unexpected Cardiac Magnetic Resonance. J-Cardiovasc-Magn-Resonance 2024; 26 (Suppl. 1) 447-448 abstr. Kiosk 6Q-FA-07.; Pittorru R, Tansella D, Cipriani A, Giorgio DC, Lazzari MD, Rizzo S, et al. Ventricular Arrhyt...$59$YR$$M$Y$$$20240810$$MD$IT$IT
241540162$24154016$2$F$20240706$20240814$20240730$20240820$PER$$US-BIOMARINAP-US-2024-159411$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
241540171$24154017$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155607$NOVARTIS$$$$$$Y$$$20240730$$MD$US$US
241540186$24154018$6$F$$20240826$20240730$20240905$PER$$US-GILEAD-2024-0682296$GILEAD$$$$A$F$Y$$$20240905$$HP$US$US
241540191$24154019$1$I$20240702$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017851$ELI LILLY AND CO$$9$YR$C$M$Y$$$20240730$$CN$US$US
241540201$24154020$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017931$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240730$$CN$US$US
241540212$24154021$2$F$$20240818$20240730$20240906$PER$$US-INCYTE CORPORATION-2024IN007546$INCYTE$$$$$$Y$$$20240906$$CN$US$US
241540222$24154022$2$F$$20240717$20240730$20240812$PER$$US-INCYTE CORPORATION-2024IN007544$INCYTE$$$$$$Y$$$20240813$$CN$US$US
241540231$24154023$1$I$$20230808$20240730$20240730$EXP$$US-AstraZeneca-2023A182233$ASTRAZENECA$$$$$M$Y$$$20240730$$CN$US$
241540241$24154024$1$I$20240601$20240723$20240730$20240730$PER$$US-SA-2024SA221213$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240730$$MD$US$US
241540251$24154025$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217738$SANOFI AVENTIS$$$$C$F$Y$$$20240730$$MD$US$US
241540261$24154026$1$I$20240101$20240720$20240730$20240730$EXP$$JP-RADIUS HEALTH, INC.-2024JP005581$RADIUS PHARM$$87$YR$$F$Y$$$20240730$$CN$JP$JP
241540272$24154027$2$F$$20240815$20240730$20240816$PER$$US-PURDUE PHARMA-USA-2024-0311010$PURDUE$$$$$M$Y$$$20240816$$CN$US$US
241540281$24154028$1$I$$20240729$20240730$20240730$PER$$US-PURDUE-USA-2024-0311017$PURDUE$$$$$$Y$$$20240730$$CN$US$US
241540291$24154029$1$I$$20240730$20240730$20240730$PER$$US-PURDUE-USA-2024-0311025$PURDUE$$$$$F$Y$$$20240730$$CN$US$US
241540301$24154030$1$I$$20240729$20240730$20240730$PER$$US-PURDUE-USA-2024-0311030$PURDUE$$$$$M$Y$$$20240730$$CN$US$US
241540311$24154031$1$I$20240629$20240722$20240730$20240730$EXP$$CN-GE HEALTHCARE-2024CSU008348$GE HEALTHCARE$$64$YR$$M$Y$55$KG$20240730$$HP$CN$CN
241540323$24154032$3$F$20240729$20240731$20240730$20240801$PER$$US-PURDUE PHARMA-USA-2024-0311035$PURDUE$$63$YR$$F$Y$122.47$KG$20240801$$CN$US$US
241540341$24154034$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120481$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240730$$CN$US$US
241540352$24154035$2$F$$20240805$20240730$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120517$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240806$$CN$US$US
241540362$24154036$2$F$$20240905$20240730$20240918$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI07459$NEUROCRINE BIOSCIENCES$$69$YR$$M$Y$$$20240918$$PH$JP$JP
241540371$24154037$1$I$$20240719$20240730$20240730$EXP$$KR-TAKEDA-2024TUS075031$TAKEDA$$$$E$$Y$$$20240730$$HP$KR$KR
241540381$24154038$1$I$20240711$20240715$20240730$20240730$PER$$US-JNJFOC-20240779330$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240730$$MD$US$US
241540391$24154039$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA217819$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240730$$MD$US$US
241540401$24154040$1$I$$20240715$20240730$20240730$EXP$$US-FMCRTG-FMC-2407-000872$FRESENIUS MEDICAL CARE$$59$YR$A$$Y$72$KG$20240730$$HP$US$US
241540421$24154042$1$I$20231025$20240718$20240730$20240730$PER$$US-SA-2024SA217925$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240730$$MD$US$US
241540431$24154043$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120271$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$64.41$KG$20240730$$CN$US$US
241540441$24154044$1$I$$20240726$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120480$BRISTOL MYERS SQUIBB$$37$YR$A$M$Y$$$20240730$$CN$US$US
241540451$24154045$1$I$$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120150$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240730$$CN$US$US
241540461$24154046$1$I$20240701$20240717$20240730$20240730$PER$$US-JNJFOC-20240780230$JOHNSON AND JOHNSON$$$$$M$Y$$$20240730$$PH$US$US
241540471$24154047$1$I$20240725$20240725$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407017344$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$US$US
241540481$24154048$1$I$20240601$20240723$20240730$20240730$EXP$$NVSC2024MX146604$NOVARTIS$$19$YR$$F$Y$$$20240730$$CN$MX$MX
241540491$24154049$1$I$$20240715$20240730$20240730$EXP$$US-HLS-202400396$HLS THERAPEUTICS$$58$YR$A$F$Y$$$20240730$$MD$US$US
241540501$24154050$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA218047$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240730$$MD$US$US
241540512$24154051$2$F$20240723$20240731$20240730$20240807$PER$$US-ALXN-202407USA001934US$ALEXION PHARMACEUTICALS$$77$YR$$F$Y$$$20240807$$CN$US$US
241540521$24154052$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155558$NOVARTIS$$$$$$Y$$$20240730$$MD$US$US
241540531$24154053$1$I$$20240724$20240730$20240730$PER$$AU-Eisai-EC-2024-170791$EISAI$$46$YR$A$F$Y$$$20240730$$MD$AU$AU
241540541$24154054$1$I$$20240716$20240730$20240730$PER$$US-TEVA-VS-3225798$TEVA$$91$YR$$F$Y$$$20240730$$CN$US$US
241540551$24154055$1$I$20230101$20240723$20240730$20240730$PER$$US-ABBVIE-5854330$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241540564$24154056$4$F$$20240815$20240730$20240821$EXP$PL-URPL-1-1720-2020$PL-BAUSCH-BL-2024-011575$BAUSCH AND LOMB$$21$YR$$M$Y$75$KG$20240821$$MD$PL$PL
241540571$24154057$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120290$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240730$$CN$US$US
241540581$24154058$1$I$20240629$20240725$20240730$20240730$EXP$FR-AFSSAPS-NC2024000888$FR-BAUSCH-BL-2024-011452$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240730$$MD$FR$FR
241540591$24154059$1$I$20240605$20240725$20240730$20240730$EXP$FR-AFSSAPS-ST2024001180$FR-009507513-2407FRA014023$MERCK$$70$YR$$M$Y$63$KG$20240730$$HP$FR$FR
241540631$24154063$1$I$$20240722$20240730$20240730$PER$$US-INCYTE CORPORATION-2024IN007683$INCYTE$$$$$$Y$$$20240730$$CN$US$US
241540641$24154064$1$I$$20240728$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119602$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$73.48$KG$20240730$$CN$US$US
241540651$24154065$1$I$20240601$20240726$20240730$20240730$PER$$US-BAUSCH-BL-2024-011537$BAUSCH AND LOMB$$$$$F$Y$$$20240730$$HP$US$US
241540681$24154068$1$I$$20240725$20240730$20240730$PER$$US-SA-2024SA221239$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240730$$MD$US$US
241540701$24154070$1$I$$20240729$20240730$20240730$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042580$BOEHRINGER INGELHEIM$$$$$$Y$$$20240730$$CN$US$US
241540711$24154071$1$I$$20240723$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117755$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240730$$MD$US$US
241540721$24154072$1$I$$20240729$20240730$20240730$EXP$$CL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042498$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240730$$MD$CL$CL
241540731$24154073$1$I$$20240721$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119714$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$56.7$KG$20240730$$HP$US$US
241540742$24154074$2$F$$20240715$20240730$20240812$EXP$$PT-TEVA-VS-3223154$TEVA$Literature Reference:  Albuquerque P, Regateiro D, Velho R, Paix?o J, Santos L. NEUROLEPTIC MALIGNANT SYNDROME: REPORT OF A CLINICAL CASE. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 1071.$70$YR$$F$Y$$$20240812$$MD$PT$PT
241540751$24154075$1$I$$20240715$20240730$20240730$PER$$US-TEVA-VS-3225438$TEVA$$55$YR$$F$Y$$$20240730$$CN$US$US
241540761$24154076$1$I$20221104$20240722$20240730$20240730$PER$$US-SA-2024SA218491$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240730$$MD$US$US
241540771$24154077$1$I$20190501$20240721$20240730$20240730$EXP$$EU-BAUSCHBL-BL-2020-013345$BAUSCH AND LOMB$$42$YR$$F$Y$80$KG$20240730$$CN$EU$EU
241540783$24154078$3$F$$20240801$20240730$20240812$EXP$$TR-TEVA-VS-3224264$TEVA$Gul EE, Bektasoglu G, Dogan Z. Brugada phenocopy associated with multiple psychotic drugs. J-Electrocardiol 2023; 81 156-158.; Gul EE, Bektasoglu G, Dogan Z. Brugada phenocopy associated with multiple psychotic drugs. J-Electrocardiol 2023; 81 156-158.$17$YR$$F$Y$$$20240812$$MD$TR$TR
241540792$24154079$2$F$20240617$20240725$20240730$20240801$EXP$IT-MINISAL02-995896$IT-009507513-2407ITA014466$MERCK$$74$YR$$M$Y$70$KG$20240801$$MD$IT$IT
241540801$24154080$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA218342$SANOFI AVENTIS$$$$$$Y$$$20240730$$MD$US$US
241540811$24154081$1$I$20240619$20240730$20240730$20240730$EXP$FR-AFSSAPS-PP2024000838$FR-GILEAD-2024-0682366$GILEAD$$75$YR$E$F$Y$$$20240730$$PH$FR$FR
241540822$24154082$2$F$20231222$20240828$20240730$20240903$EXP$FR-AFSSAPS-RE2024000736$FR-009507513-2407FRA014241$MERCK$$74$YR$$F$Y$$$20240903$$HP$FR$FR
241540831$24154083$1$I$$20240725$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119056$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240730$$PH$US$US
241540841$24154084$1$I$$20240729$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120430$BRISTOL MYERS SQUIBB$$69$YR$A$M$Y$74.39$KG$20240730$$PH$US$US
241540852$24154085$2$F$$20240820$20240730$20240913$PER$$US-SA-2024SA218568$SANOFI AVENTIS$$$$A$F$Y$52.16$KG$20240913$$MD$US$US
241540861$24154086$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155174$NOVARTIS$$$$$F$Y$$$20240730$$MD$US$US
241540871$24154087$1$I$20240701$20240722$20240730$20240730$EXP$$JP-009507513-2407JPN004136J$MERCK$$7$DEC$$M$Y$$$20240730$$MD$JP$JP
241540881$24154088$1$I$$20240726$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119696$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240730$$CN$US$US
241540891$24154089$1$I$$20240730$20240730$20240730$PER$$US-GILEAD-2024-0682371$GILEAD$$$$A$M$Y$$$20240730$$HP$US$US
241540902$24154090$2$F$$20240801$20240730$20240810$EXP$$US-TEVA-VS-3224071$TEVA$Music S, Suvar T, Tan M, Amin S. Severe Bilateral Glossopharyngeal Neuralgia Managed With Nerve Blocks Following Plasmodium falciparum Malaria Infection Treated With Mefloquine. Pain-Med-Case-Rep 2024; 8 (3): 119-126.; Music S, Suvar T, Tan M, Amin S. Severe Bilateral Glossopharyngeal Neuralgia Managed With Nerve Blocks Following Plasmodium falciparum Malaria Infection Treated With Mefloquine. Pain-Med-Case-Rep 2024; 8 (3): 119-126.$38$YR$$F$Y$$$20240810$$HP$US$US
241540921$24154092$1$I$20240723$20240723$20240730$20240730$EXP$$IT-GILEAD-2024-0681622$GILEAD$$75$YR$E$F$Y$$$20240730$$MD$IT$IT
241540932$24154093$2$F$20240720$20240820$20240730$20240828$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011502$JAZZ$$50$YR$$M$Y$$$20240828$$MD$JP$JP
241540941$24154094$1$I$$20240723$20240730$20240730$PER$$US-GILEAD-2024-0681901$GILEAD$$35$YR$A$F$Y$$$20240730$$HP$US$US
241540951$24154095$1$I$$20240730$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042799$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240730$$CN$US$US
241540961$24154096$1$I$$20240715$20240730$20240730$EXP$$ES-TEVA-VS-3223997$TEVA$Vazquez-Revuelta P, Ruffinelli Rodriguez JC, Casanovas-Lopez E, Alvarez-Sala P, Molina-Molina G, Molina-Mata K, et al. Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts). Ann-Oncol 2024; 35 (Suppl. 1) S60-S61 abstr. 130P.$60$YR$$M$Y$$$20240730$$HP$ES$ES
241540981$24154098$1$I$20240101$20240725$20240730$20240730$PER$$US-DSJP-DSU-2024-137919$DAIICHI$$$$$F$Y$$$20240730$$MD$US$US
241540991$24154099$1$I$$20240723$20240730$20240730$EXP$$US-ALXN-202407USA001581US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240730$$MD$US$US
241541001$24154100$1$I$$20240709$20240730$20240730$PER$$US-009507513-2407USA005278$MERCK$$76$YR$$$Y$$$20240730$$CN$US$US
241541011$24154101$1$I$$20240728$20240730$20240730$PER$$NVSC2024US154985$NOVARTIS$$$$$$Y$$$20240730$$CN$US$US
241541022$24154102$2$F$20240719$20240808$20240730$20240828$EXP$$US-PHARMING-PHAUS2024000631$PHARMING GROUP$$$$$$Y$$$20240815$$CN$US$US
241541041$24154104$1$I$20240702$20240718$20240730$20240730$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407011469$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240730$$CN$JP$JP
241541051$24154105$1$I$$20240702$20240730$20240730$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00709$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240730$$CN$US$US
241541061$24154106$1$I$20240719$20240724$20240730$20240730$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017504$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240730$$CN$US$US
241541072$24154107$2$F$$20240906$20240730$20240911$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407013420$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240911$$CN$JP$JP
241541081$24154108$1$I$20240710$20240718$20240730$20240730$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407015552$ELI LILLY AND CO$$70$YR$E$M$Y$67$KG$20240730$$CN$DE$CN
241541091$24154109$1$I$$20240718$20240730$20240730$EXP$$EC-ELI_LILLY_AND_COMPANY-EC202407017220$ELI LILLY AND CO$$$$$M$Y$$$20240730$$CN$DE$EC
241541102$24154110$2$F$$20240727$20240730$20240808$EXP$$MY-ELI_LILLY_AND_COMPANY-MY202407015536$ELI LILLY AND CO$$70$YR$E$F$Y$67$KG$20240808$$CN$MY$MY
241541112$24154111$2$F$20240401$20240909$20240730$20240919$EXP$$EG-ELI_LILLY_AND_COMPANY-EG202407013571$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240919$$CN$EG$EG
241541121$24154112$1$I$20220415$20240718$20240730$20240730$EXP$FR-AFSSAPS-PP2024000812$FR-ELI_LILLY_AND_COMPANY-FR202407012653$ELI LILLY AND CO$$60$YR$A$F$Y$75$KG$20240730$$CN$FR$FR
241541131$24154113$1$I$20240614$20240724$20240730$20240730$EXP$FR-AFSSAPS-NC2024000893$FR-ELI_LILLY_AND_COMPANY-FR202407016424$ELI LILLY AND CO$$69$YR$E$M$Y$60$KG$20240730$$CN$FR$FR
241541141$24154114$1$I$$20240724$20240730$20240730$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015950$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240730$$CN$US$US
241541151$24154115$1$I$$20240718$20240730$20240730$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407013437$ELI LILLY AND CO$$$$$$Y$$$20240730$$CN$CN$CN
241541161$24154116$1$I$20240717$20240719$20240730$20240730$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407015444$ELI LILLY AND CO$$57$YR$A$M$Y$71$KG$20240730$$CN$DE$CN
241541181$24154118$1$I$$20240717$20240730$20240730$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202407018017$ELI LILLY AND CO$$$$$M$Y$$$20240730$$HP$IN$IN
241541191$24154119$1$I$$20240726$20240730$20240730$PER$$NVSC2024US155069$NOVARTIS$$$$$$Y$$$20240730$$CN$US$US
241541201$24154120$1$I$$20240715$20240730$20240730$EXP$$US-HLS-202400398$HLS THERAPEUTICS$$33$YR$A$M$Y$$$20240730$$HP$CN$US
241541211$24154121$1$I$20240619$20240723$20240730$20240730$EXP$$SE-ANIPHARMA-2024-SE-000018$ANI$$85$YR$$F$Y$$$20240730$$MD$SE$SE
241541221$24154122$1$I$20240101$20240724$20240730$20240730$EXP$$US-009507513-2407USA015001$MERCK$$74$YR$$F$Y$$$20240730$$MD$US$US
241541231$24154123$1$I$$20240722$20240730$20240730$EXP$$CA-AstraZeneca-2024A070997$ASTRAZENECA$$$$$F$Y$$$20240730$$MD$CA$
241541241$24154124$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155630$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
241541254$24154125$4$F$$20240924$20240730$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120475$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240926$$CN$US$US
241541261$24154126$1$I$$20240717$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407013867$ELI LILLY AND CO$$$$$F$Y$$$20240730$$CN$US$US
241541271$24154127$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA221303$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240731$$MD$US$US
241541282$24154128$2$F$20240701$20240809$20240730$20240814$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011272$JAZZ$$58$YR$$F$Y$$$20240814$$CN$US$US
241541291$24154129$1$I$$20240723$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407016679$ELI LILLY AND CO$$$$$M$Y$$$20240730$$CN$US$US
241541301$24154130$1$I$$20240726$20240730$20240730$EXP$$US-TAKEDA-2024TUS067311$TAKEDA$$$$$M$Y$77.11$KG$20240730$$MD$US$US
241541311$24154131$1$I$$20240723$20240730$20240730$EXP$$DK-ANIPHARMA-2024-DK-000006$ANI$Knudsen GH, Kermanian N, Kock-Jensen CH, Antulov R.Opioid-induced leukoencephalopathies: a report of two cases..Case Reports in Neurology.2022;14(1):25-30.$24$YR$$M$Y$$$20240730$$HP$DK$DK
241541321$24154132$1$I$$20240722$20240730$20240730$EXP$$MA-AstraZeneca-2024A168359$ASTRAZENECA$$$$$F$Y$$$20240730$$HP$MA$
241541331$24154133$1$I$$20240715$20240730$20240730$EXP$$CA-HLS-202401766$HLS THERAPEUTICS$$$$E$M$Y$$$20240730$$MD$CA$CA
241541341$24154134$1$I$$20240729$20240730$20240730$PER$$NVSC2024US155574$NOVARTIS$$$$$F$Y$$$20240731$$HP$US$US
241541352$24154135$2$F$$20240719$20240730$20240730$PER$$US-ROCHE-10000033514$ROCHE$$67$YR$E$F$Y$$$20240730$$CN$US$US
241541361$24154136$1$I$$20240724$20240730$20240730$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011235$JAZZ$$$$$F$Y$$$20240730$$HP$US$US
241541371$24154137$1$I$20240530$20240726$20240730$20240730$PER$$US-TAKEDA-2024TUS076441$TAKEDA$$$$$M$Y$$$20240730$$CN$US$US
241541382$24154138$2$F$20240701$20240813$20240730$20240827$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07181$NEUROCRINE BIOSCIENCES$$40$YR$$F$Y$$$20240828$$HP$US$US
241541391$24154139$1$I$$20240716$20240730$20240730$EXP$$CA-HLS-202401768$HLS THERAPEUTICS$$$$A$M$Y$$$20240730$$PH$CA$CA
241541402$24154140$2$F$$20240912$20240730$20240912$PER$$NVSC2024US155605$NOVARTIS$$$$$M$Y$$$20240912$$MD$US$US
241541411$24154141$1$I$$20240711$20240730$20240730$PER$$US-JNJFOC-20240737283$JOHNSON AND JOHNSON$$$$$$Y$$$20240730$$CN$US$US
241541421$24154142$1$I$$20240709$20240730$20240730$PER$$US-JNJFOC-20240725158$JOHNSON AND JOHNSON$$$$$F$Y$$$20240730$$CN$US$US
241541431$24154143$1$I$$20240723$20240730$20240730$PER$$US-ABBVIE-5852700$ABBVIE$$$$$$Y$$$20240730$$CN$US$US
241541442$24154144$2$F$$20240816$20240730$20240830$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07226$NEUROCRINE BIOSCIENCES$$68$YR$$F$Y$$$20240831$$HP$US$US
241541451$24154145$1$I$$20240717$20240730$20240730$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07225$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240730$$HP$US$US
241541461$24154146$1$I$20240701$20240717$20240730$20240730$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07233$NEUROCRINE BIOSCIENCES$$38$YR$$F$Y$$$20240730$$HP$US$US
241541471$24154147$1$I$$20240722$20240730$20240730$EXP$$PH-APELLIS-2024-APL-0000537$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$PH$PH
241541482$24154148$2$F$$20240912$20240730$20240912$PER$$NVSC2024US155532$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
241541502$24154150$2$F$20240728$20240730$20240730$20240802$PER$$US-BIOMARINAP-US-2024-159490$BIOMARIN$$$$$$Y$$$20240802$$CN$US$US
241541511$24154151$1$I$$20240728$20240730$20240730$PER$$US-BIOMARINAP-US-2024-159485$BIOMARIN$$$$$$Y$$$20240730$$CN$US$US
241541521$24154152$1$I$$20240725$20240730$20240730$PER$$US-BIOMARINAP-US-2024-159437$BIOMARIN$$$$$$Y$$$20240730$$CN$US$US
241541531$24154153$1$I$$20240716$20240730$20240730$EXP$$US-HLS-202400501$HLS THERAPEUTICS$$$$A$$Y$$$20240730$$MD$US$US
241541541$24154154$1$I$$20240726$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407018238$ELI LILLY AND CO$$$$$$Y$$$20240730$$HP$US$US
241541551$24154155$1$I$$20240716$20240730$20240730$EXP$$US-HLS-202400407$HLS THERAPEUTICS$$$$A$$Y$$$20240730$$PH$US$US
241541561$24154156$1$I$$20240717$20240730$20240730$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07289$NEUROCRINE BIOSCIENCES$$64$YR$$F$Y$$$20240730$$HP$US$US
241541571$24154157$1$I$$20240717$20240730$20240730$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07401$NEUROCRINE BIOSCIENCES$$46$YR$$F$Y$$$20240730$$MD$US$US
241541581$24154158$1$I$$20240718$20240730$20240730$EXP$$US-ROCHE-10000030847$ROCHE$Engen R, Keyser M, Jiang Z, Kizilbash S. Norovirus Management and Outcomes in a Multicenter Pediatric Kidney Transplant Population. Pediatric Transplantation. 2024-Aug;28 (5):1-8. doi:10.1111/petr.14821.$$$$$Y$$$20240730$$HP$US$US
241541591$24154159$1$I$$20240725$20240730$20240730$PER$$US-BIOMARINAP-US-2024-159475$BIOMARIN$$$$$$Y$$$20240730$$CN$US$US
241541601$24154160$1$I$20240101$20240729$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042815$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240730$$CN$US$US
241541621$24154162$1$I$$20240716$20240730$20240730$EXP$$US-HLS-202400389$HLS THERAPEUTICS$$59$YR$A$M$Y$$$20240730$$PH$US$US
241541631$24154163$1$I$$20240716$20240730$20240730$EXP$$US-HLS-202400421$HLS THERAPEUTICS$$70$YR$E$F$Y$$$20240730$$HP$US$US
241541641$24154164$1$I$20240227$20240724$20240730$20240730$EXP$$US-009507513-2407USA015005$MERCK$$24$YR$$M$Y$$$20240730$$MD$US$US
241541652$24154165$2$F$$20240729$20240730$20240730$EXP$$US-ROCHE-10000041890$ROCHE$$76$YR$E$M$Y$$$20240730$$HP$US$US
241541661$24154166$1$I$20240624$20240716$20240730$20240730$EXP$$US-HLS-202400408$HLS THERAPEUTICS$$35$YR$A$$Y$$$20240730$$HP$US$US
241541672$24154167$2$F$$20240812$20240730$20240822$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07202$NEUROCRINE BIOSCIENCES$$74$YR$$M$Y$$$20240822$$HP$US$US
241541681$24154168$1$I$$20240710$20240730$20240730$PER$$US-009507513-2407USA005203$MERCK$$$$$M$Y$$$20240730$$MD$US$US
241541691$24154169$1$I$$20240710$20240730$20240730$PER$$US-009507513-2407USA010739$MERCK$$$$$F$Y$$$20240730$$MD$US$US
241541712$24154171$2$F$$20240807$20240730$20240808$PER$$NVSC2024US155047$NOVARTIS$$$$$$Y$$$20240808$$MD$US$US
241541721$24154172$1$I$20240712$20240712$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407008855$ELI LILLY AND CO$$$$$M$Y$$$20240730$$CN$US$US
241541734$24154173$4$F$20240201$20240822$20240730$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-029406$JAZZ$$48$YR$$F$Y$$$20240827$$CN$US$US
241541742$24154174$2$F$20220101$20240723$20240730$20240801$PER$$US-009507513-2407USA013282$MERCK$Aldarayseh M, Sodhi S.S, Musleh G, Kumar D, Cholankeril M.. UNFORESEEN COMPLICATIONS OF PEMBROLIZUMAB IN BREAST RECONSTRUCTION POST-MASTECTOMY. European Journal of Case Reports in Internal Medicine. 2024;7$53$YR$$F$Y$$$20240801$$HP$US$US
241541751$24154175$1$I$20240606$20240703$20240730$20240730$PER$$US-AstraZeneca-2024A152968$ASTRAZENECA$$21990$DY$$F$Y$100.2$KG$20240731$$MD$US$
241541761$24154176$1$I$20240701$20240719$20240730$20240730$EXP$$US-GSK-US2024091230$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$US$US
241541771$24154177$1$I$20240720$20240726$20240730$20240730$EXP$$US-GSK-US2024094262$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$US$US
241541781$24154178$1$I$$20240726$20240730$20240730$EXP$$US-GSK-US2024AMR094579$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$CN$US$US
241541791$24154179$1$I$$20240723$20240730$20240730$EXP$$JP-009507513-2407JPN004541J$MERCK$$5$DEC$$M$Y$$$20240730$$MD$JP$JP
241541801$24154180$1$I$$20240730$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042823$BOEHRINGER INGELHEIM$$$$$$Y$$$20240731$$CN$US$US
241541812$24154181$2$F$$20240903$20240730$20240911$PER$$US-AstraZeneca-2024A170243$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
241541822$24154182$2$F$20240319$20240913$20240730$20240917$EXP$$NVSJ2024JP009199$NOVARTIS$$73$YR$$F$Y$46.3$KG$20240918$$PH$JP$JP
241541831$24154183$1$I$20240617$20240618$20240730$20240730$PER$$US-GALDERMA-US2024010105$GALDERMA$$$$$$Y$$$20240731$$CN$US$US
241541842$24154184$2$F$20240401$20240807$20240730$20240814$EXP$$EG-BIOGEN-2024BI01275509$BIOGEN$$36$YR$$F$Y$$$20240814$$CN$EG$EG
241541854$24154185$4$F$20240101$20240809$20240730$20240815$EXP$$US-ABBVIE-5852202$ABBVIE$$54$YR$$M$Y$92$KG$20240815$$CN$US$US
241541871$24154187$1$I$20220328$20240724$20240730$20240730$EXP$$TR-BIOGEN-2024BI01275441$BIOGEN$$0$YR$$M$Y$$$20240730$$MD$TR$TR
241541882$24154188$2$F$20191129$20240730$20240730$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-120286$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240808$$MD$JP$JP
241541901$24154190$1$I$20240723$20240723$20240730$20240730$EXP$$US-JNJFOC-20240768273$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240731$$HP$US$US
241541911$24154191$1$I$20080407$20240722$20240730$20240730$EXP$$US-BIOGEN-2008BI009471$BIOGEN$$43$YR$$F$Y$$$20240730$$CN$US$US
241541921$24154192$1$I$20240708$20240724$20240730$20240730$PER$$US-ABBVIE-5855088$ABBVIE$$38$YR$$F$Y$$$20240730$$MD$US$US
241541932$24154193$2$F$$20240726$20240730$20240731$EXP$$CA-BIOGEN-2024BI01275612$BIOGEN$$$$$F$Y$$$20240731$$HP$CA$CA
241541941$24154194$1$I$20240101$20240726$20240730$20240730$EXP$DK-DKMA-30735520$DK-009507513-2407DNK014689$MERCK$$76$YR$$F$Y$$$20240730$$MD$DK$DK
241541961$24154196$1$I$20240729$20240729$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042813$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240731$$CN$US$US
241541972$24154197$2$F$20240701$20240801$20240730$20240805$PER$$US-AMGEN-USASP2024148503$AMGEN$$21$YR$A$M$Y$$$20240805$$MD$US$US
241541982$24154198$2$F$$20240820$20240730$20240823$EXP$$US-BIOGEN-2024BI01275547$BIOGEN$$$$$F$Y$$$20240823$$MD$US$US
241541992$24154199$2$F$$20240730$20240730$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069125$SANDOZ$$$$$F$Y$$$20240801$$CN$US$US
241542002$24154200$2$F$20240703$20240805$20240730$20240809$EXP$IT-MINISAL02-996344$IT-SANDOZ INC.-SDZ2024IT069037$SANDOZ$$53$YR$$F$Y$$$20240809$$MD$IT$IT
241542011$24154201$1$I$20240601$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024150104$AMGEN$$80$YR$E$F$Y$$$20240730$$CN$US$US
241542021$24154202$1$I$$20240725$20240730$20240730$PER$$US-AMGEN-USASP2024149191$AMGEN$$63$YR$A$M$Y$$$20240730$$HP$US$US
241542031$24154203$1$I$$20240727$20240730$20240730$EXP$$GB-SANDOZ INC.-NVSC2020GB231853$SANDOZ$$$$$M$Y$$$20240730$$CN$GB$GB
241542041$24154204$1$I$$20240729$20240730$20240730$EXP$$FR-SANDOZ INC.-SDZ2024FR061780$SANDOZ$$52$YR$$F$Y$$$20240730$$HP$FR$FR
241542051$24154205$1$I$$20240724$20240730$20240730$EXP$$US-JNJFOC-20240766514$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241542063$24154206$3$F$$20240828$20240730$20240904$30DAY$$CH-JNJFOC-20240772481$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$CH$CH
241542071$24154207$1$I$$20240725$20240730$20240730$PER$$US-JNJFOC-20240770677$JOHNSON AND JOHNSON$$$$$M$Y$$$20240731$$CN$US$US
241542082$24154208$2$F$$20240802$20240730$20240808$EXP$$JP-GSK-JP2024JPN093056$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$PH$JP$JP
241542091$24154209$1$I$$20240724$20240730$20240730$EXP$$US-JNJFOC-20240766505$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$HP$US$US
241542101$24154210$1$I$$20240723$20240730$20240730$PER$$US-BAUSCHBL-2024BNL030573$BAUSCH AND LOMB$$$$$M$Y$$$20240731$$CN$US$US
241542111$24154211$1$I$$20240722$20240730$20240730$PER$$US-BAUSCHBL-2024BNL030529$BAUSCH AND LOMB$$$$$F$Y$$$20240731$$CN$US$US
241542121$24154212$1$I$20240415$20240721$20240730$20240730$EXP$$CN-BEIGENE-BGN-2024-011296$BEIGENE$$$$$$Y$$$20240730$$HP$CN$CN
241542132$24154213$2$F$20191023$20240730$20240730$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-120258$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240808$$MD$JP$JP
241542142$24154214$2$F$$20240806$20240730$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407015458$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240809$$CN$US$US
241542151$24154215$1$I$20210301$20240730$20240730$20240730$EXP$PL-URPL-DML-MLP.4401.1.4919.2021$PL-JNJFOC-20240781130$JOHNSON AND JOHNSON$$40$YR$A$F$Y$100$KG$20240731$$MD$PL$PL
241542161$24154216$1$I$$20240719$20240730$20240730$EXP$$FR-JNJFOC-20240752220$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$MD$FR$FR
241542171$24154217$1$I$20161201$20240723$20240730$20240730$EXP$$ES-JNJFOC-20240767645$JOHNSON AND JOHNSON$$94$YR$E$F$Y$75.3$KG$20240731$$MD$ES$ES
241542181$24154218$1$I$$20240711$20240730$20240730$EXP$$JP-JNJFOC-20240777060$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$HP$JP$JP
241542191$24154219$1$I$20240725$20240726$20240730$20240730$EXP$$FR-JNJFOC-20240776824$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240731$$PH$FR$FR
241542211$24154221$1$I$$20240727$20240730$20240730$EXP$$EU-BAUSCHBL-2024BNL030701$BAUSCH AND LOMB$$8$DEC$$M$Y$$$20240731$$PH$EU$EU
241542221$24154222$1$I$20240701$20240726$20240730$20240730$PER$$US-AMGEN-USASP2024149592$AMGEN$$$$$M$Y$$$20240730$$HP$US$US
241542231$24154223$1$I$20240101$20240718$20240730$20240730$PER$$US-SA-2024SA216719$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240731$$MD$US$US
241542241$24154224$1$I$20240501$20240724$20240730$20240730$PER$$US-SA-2024SA221286$SANOFI AVENTIS$$$$A$F$Y$$$20240731$$MD$US$US
241542251$24154225$1$I$20230101$20240725$20240730$20240730$EXP$$US-ABBVIE-5454634$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241542262$24154226$2$F$$20240828$20240730$20240904$30DAY$$EC-JNJFOC-20240746288$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$MD$EC$EC
241542271$24154227$1$I$20240724$20240724$20240730$20240730$EXP$$KR-BIOGEN-2024BI01275429$BIOGEN$$2$YR$$M$Y$$$20240730$$MD$KR$KR
241542282$24154228$2$F$20240701$20240731$20240730$20240807$EXP$$CA-JNJFOC-20240763913$JOHNSON AND JOHNSON$$69$YR$E$M$Y$84$KG$20240807$$HP$CA$CA
241542291$24154229$1$I$20240728$20240729$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407019151$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240730$$CN$US$US
241542301$24154230$1$I$20240717$20240722$20240730$20240730$PER$$US-ABBVIE-5851509$ABBVIE$$$$$$Y$$$20240730$$CN$US$US
241542311$24154231$1$I$$20240724$20240730$20240730$EXP$$US-BEIGENE-BGN-2024-011569$BEIGENE$$$$$$Y$$$20240730$$PH$US$US
241542323$24154232$3$F$20240504$20240806$20240730$20240808$EXP$$US-BIOGEN-2024BI01275596$BIOGEN$$65$YR$$F$Y$$$20240808$$MD$US$US
241542331$24154233$1$I$$20240725$20240730$20240730$PER$$US-SA-2024SA221299$SANOFI AVENTIS$$$$T$$Y$$$20240731$$MD$US$US
241542341$24154234$1$I$$20240729$20240730$20240730$EXP$$PL-BAUSCH-BL-2024-011571$BAUSCH AND LOMB$$58$YR$$F$Y$$$20240731$$PH$PL$PL
241542351$24154235$1$I$$20240724$20240730$20240730$PER$$US-AMGEN-USASP2024147731$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241542362$24154236$2$F$20240710$20240812$20240730$20240820$30DAY$$US-AMGEN-USASL2024147780$AMGEN$$70$YR$E$F$Y$$$20240820$$MD$US$US
241542371$24154237$1$I$$20240724$20240730$20240730$EXP$$US-AMGEN-USASP2024148215$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241542381$24154238$1$I$20240101$20240729$20240730$20240730$EXP$SE-SEMPA-2024-005668$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-120574$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240731$$MD$SE$SE
241542391$24154239$1$I$20240430$20240723$20240730$20240730$EXP$$CA-CELLTRION INC.-2024CA011826$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
241542403$24154240$3$F$$20240913$20240730$20240917$PER$$NVSC2024US155606$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
241542421$24154242$1$I$20230728$20240723$20240730$20240730$EXP$$CA-CELLTRION INC.-2023CA015857$CELLTRION$$$$$$Y$$$20240731$$CN$CA$CA
241542431$24154243$1$I$20240101$20240718$20240730$20240730$PER$$US-SA-2024SA217978$SANOFI AVENTIS$$$$A$F$Y$$$20240731$$MD$US$US
241542441$24154244$1$I$20240711$20240719$20240730$20240730$PER$$US-SA-2024SA219344$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240731$$MD$US$US
241542451$24154245$1$I$20240501$20240722$20240730$20240730$PER$$US-SA-2024SA218927$SANOFI AVENTIS$$$$E$M$Y$$$20240731$$MD$US$US
241542462$24154246$2$F$20230808$20240809$20240730$20240818$EXP$$JP-SA-2024SA183191$SANOFI AVENTIS$$65$YR$E$F$Y$63$KG$20240819$$MD$JP$JP
241542471$24154247$1$I$20240101$20240723$20240730$20240730$PER$$US-SA-2024SA219152$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240731$$MD$US$US
241542481$24154248$1$I$20230301$20240722$20240730$20240730$PER$$US-SA-2024SA219623$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240731$$MD$US$US
241542491$24154249$1$I$20240101$20240723$20240730$20240730$EXP$$CA-CELLTRION INC.-2024CA012553$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
241542501$24154250$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA220620$SANOFI AVENTIS$$$$E$M$Y$$$20240731$$MD$US$US
241542511$24154251$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA216207$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240731$$MD$US$US
241542521$24154252$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA216290$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240731$$MD$US$US
241542531$24154253$1$I$$20240729$20240730$20240730$EXP$$US-ABBVIE-5859704$ABBVIE$$$$$M$Y$$$20240730$$HP$US$US
241542541$24154254$1$I$$20240724$20240730$20240730$PER$$US-ABBVIE-5855666$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241542552$24154255$2$F$20230401$20240805$20240730$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-117425$BRISTOL MYERS SQUIBB$$10$DEC$E$M$Y$$$20240809$$PH$JP$JP
241542563$24154256$3$F$20240701$20240815$20240730$20240827$PER$$US-SA-2024SA216915$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240827$$MD$US$US
241542571$24154257$1$I$$20240722$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120819$BRISTOL MYERS SQUIBB$Hochman MJ, Gerber GF, Imus PH, Ali SA, DeZern AE. Management of patients with concurrent clonal plasma cell and myeloid disorders: a single center descriptive case series. Leukemia Research Reports. 2024 Jan 01;22:1-5. doi:10.1016/j.lrr.2024.100469.$78$YR$E$M$Y$$$20240731$$MD$US$US
241542582$24154258$2$F$20240621$20240725$20240730$20240802$PER$$US-SA-2024SA221308$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240802$$MD$US$US
241542591$24154259$1$I$20240501$20240722$20240730$20240730$PER$$US-SA-2024SA219811$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240731$$MD$US$US
241542601$24154260$1$I$$20240725$20240730$20240730$PER$$US-SA-2024SA221130$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240731$$MD$US$US
241542611$24154261$1$I$$20240722$20240730$20240730$PER$$US-ABBVIE-5851622$ABBVIE$$$$$$Y$$$20240730$$HP$US$US
241542621$24154262$1$I$$20240725$20240730$20240730$EXP$$CA-SANDOZ INC.-SDZ2024CA068346$SANDOZ$$70$YR$$M$Y$$$20240730$$CN$CA$CA
241542631$24154263$1$I$$20240726$20240730$20240730$EXP$$US-ABBVIE-5857130$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241542641$24154264$1$I$20240701$20240730$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407019467$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240730$$CN$US$US
241542651$24154265$1$I$20240725$20240729$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120452$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240731$$MD$US$US
241542661$24154266$1$I$$20240723$20240730$20240730$EXP$$CA-BEIGENE-BGN-2024-011461$BEIGENE$$$$$$Y$$$20240730$$MD$CA$CA
241542671$24154267$1$I$$20240722$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117284$BRISTOL MYERS SQUIBB$Hochman MJ, Gerber GF, Imus PH, Ali SA, DeZern AE. Management of patients with concurrent clonal plasma cell and myeloid disorders: a single center descriptive case series. Leukemia Research Reports. 2024 Jan 01;22:1-5. doi:10.1016/j.lrr.2024.100469.$59$YR$A$F$Y$$$20240731$$MD$US$US
241542682$24154268$2$F$20240710$20240730$20240730$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120085$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240806$$PH$US$US
241542691$24154269$1$I$20240623$20240729$20240730$20240730$EXP$$US-ABBVIE-5860231$ABBVIE$$63$YR$$F$Y$$$20240730$$CN$US$US
241542701$24154270$1$I$20240101$20240725$20240730$20240730$EXP$$US-ABBVIE-5856035$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241542711$24154271$1$I$$20240725$20240730$20240730$EXP$$CA-ABBVIE-5857382$ABBVIE$$$$E$M$Y$$$20240730$$CN$CA$CA
241542721$24154272$1$I$20240328$20240729$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120034$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240731$$HP$US$US
241542731$24154273$1$I$20240627$20240726$20240730$20240730$EXP$$AU-TAKEDA-2024TUS065356$TAKEDA$$49$YR$$M$Y$$$20240730$$CN$AU$AU
241542742$24154274$2$F$$20240828$20240730$20240902$EXP$$NVSC2024FR155619$NOVARTIS$$$$$$Y$$$20240902$$PH$FR$FR
241542751$24154275$1$I$$20240729$20240730$20240730$EXP$$NVSC2024NP155565$NOVARTIS$$$$$M$Y$$$20240731$$MD$NP$NP
241542761$24154276$1$I$$20240724$20240730$20240730$EXP$$CN-Bion-013542$BIONPHARMA$$1$YR$I$F$Y$$$20240731$$HP$CN$CN
241542771$24154277$1$I$$20240724$20240730$20240730$EXP$$CN-Bion-013544$BIONPHARMA$$8$YR$C$F$Y$$$20240731$$HP$CN$CN
241542781$24154278$1$I$$20240724$20240730$20240730$EXP$$IT-Bion-013541$BIONPHARMA$$15$YR$T$M$Y$$$20240731$$HP$IT$IT
241542791$24154279$1$I$$20240724$20240730$20240730$EXP$$IT-Bion-013557$BIONPHARMA$$13$YR$T$M$Y$$$20240731$$HP$IT$IT
241542802$24154280$2$F$$20240828$20240730$20240912$PER$$US-SA-2024SA220942$SANOFI AVENTIS$$$$E$F$Y$$$20240912$$MD$US$US
241542811$24154281$1$I$$20240724$20240730$20240730$EXP$$US-Bion-013538$BIONPHARMA$$80$YR$E$M$Y$$$20240731$$HP$US$US
241542821$24154282$1$I$20240724$20240724$20240730$20240730$PER$$US-RDY-SPO/USA/24/0011006$DR REDDYS$$18$YR$A$F$Y$$$20240731$$CN$US$US
241542831$24154283$1$I$20240617$20240725$20240730$20240730$PER$$CN-Eisai-EC-2024-170959$EISAI$$39$YR$A$F$Y$55$KG$20240731$$CN$CN$CN
241542842$24154284$2$F$$20240723$20240730$20240731$EXP$$JP-Eisai-EC-2023-136957$EISAI$$80$YR$E$M$Y$$$20240731$$MD$JP$JP
241542852$24154285$2$F$20240719$20240829$20240730$20240905$PER$$JP-Eisai-EC-2024-170776$EISAI$$$$E$M$Y$$$20240905$$MD$JP$JP
241542863$24154286$3$F$$20240920$20240730$20240926$EXP$$JP-GSK-JP2024JPN093587$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$JP$JP
241542871$24154287$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217403$SANOFI AVENTIS$$$$E$F$Y$71.9$KG$20240731$$MD$US$US
241542881$24154288$1$I$20240101$20240717$20240730$20240730$PER$$US-SA-2024SA217421$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240731$$MD$US$US
241542891$24154289$1$I$$20240722$20240730$20240730$EXP$$CA-JNJFOC-20240757678$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$MD$CA$CA
241542901$24154290$1$I$$20240730$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407019474$ELI LILLY AND CO$$$$$M$Y$$$20240730$$PH$US$US
241542913$24154291$3$F$$20240801$20240730$20240808$EXP$$JP-JNJFOC-20240773498$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240808$$PH$JP$JP
241542921$24154292$1$I$20230401$20240724$20240730$20240730$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-102800$REGENERON$$$$$F$Y$$$20240731$$CN$US$US
241542931$24154293$1$I$$20240724$20240730$20240730$PER$$US-ABBVIE-5855209$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241542941$24154294$1$I$$20240715$20240730$20240730$EXP$$GR-ABBVIE-5860476$ABBVIE$$$$$$Y$$$20240730$$MD$GR$GR
241542953$24154295$3$F$20240101$20240826$20240730$20240903$EXP$$CA-CELLTRION INC.-2024CA013265$CELLTRION$$$$$$Y$$$20240903$$MD$CA$CA
241542962$24154296$2$F$20240515$20240731$20240730$20240805$EXP$$NVSJ2024JP006804$NOVARTIS$$81$YR$$M$Y$$$20240805$$MD$JP$JP
241542971$24154297$1$I$$20240718$20240730$20240730$PER$$US-RDY-SPO/USA/24/0010716$DR REDDYS$$19$YR$A$F$Y$$$20240731$$HP$US$US
241542981$24154298$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221165$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240731$$MD$US$US
241542991$24154299$1$I$$20240723$20240730$20240730$EXP$$AU-CELLTRION INC.-2024AU018017$CELLTRION$$$$$$Y$$$20240731$$HP$AU$AU
241543001$24154300$1$I$$20240723$20240730$20240730$PER$$US-SA-2024SA221209$SANOFI AVENTIS$$$$$M$Y$$$20240731$$CN$US$US
241543011$24154301$1$I$20240101$20240724$20240730$20240730$PER$$US-SA-2024SA221350$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240731$$MD$US$US
241543022$24154302$2$F$20240101$20240913$20240730$20240924$PER$$US-SA-2024SA221373$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240924$$MD$US$US
241543031$24154303$1$I$$20240724$20240730$20240730$PER$$US-SA-2024SA221220$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240731$$MD$US$US
241543041$24154304$1$I$20240701$20240724$20240730$20240730$EXP$$US-ABBVIE-5854918$ABBVIE$$51$YR$$F$Y$$$20240730$$CN$US$US
241543051$24154305$1$I$$20240722$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117449$BRISTOL MYERS SQUIBB$Elhusseiny AM, Smiddy WE, Flynn HW, Schwartz SG. Case series of recurring spontaneous closure of macular hole. Case Reports in Ophthalmological Medicine. 2019 Jun 16;2019: 1-4. doi:10.1155/2019/2398342.$80$YR$E$M$Y$$$20240731$$HP$US$US
241543062$24154306$2$F$$20240812$20240730$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120346$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240814$$CN$US$US
241543072$24154307$2$F$20240708$20240812$20240730$20240813$EXP$GB-MHRA-MED-202407300949016260-LGWCY$GB-ABBVIE-5860506$ABBVIE$$56$YR$$M$Y$$$20240813$$HP$GB$GB
241543081$24154308$1$I$$20240724$20240730$20240730$EXP$$US-ABBVIE-5855050$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241543091$24154309$1$I$$20240725$20240730$20240730$EXP$$US-ABBVIE-5856104$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241543101$24154310$1$I$$20240726$20240730$20240730$EXP$$IT-ABBVIE-5858975$ABBVIE$$82$YR$$F$Y$$$20240730$$CN$IT$IT
241543111$24154311$1$I$$20240722$20240730$20240730$EXP$$US-ASTELLAS-2024US020967$ASTELLAS$$$$$F$Y$$$20240731$$CN$US$US
241543121$24154312$1$I$20240501$20240725$20240730$20240730$EXP$$US-ABBVIE-5854900$ABBVIE$$72$YR$$M$Y$$$20240730$$CN$US$US
241543131$24154313$1$I$$20240724$20240730$20240730$EXP$$JP-ASTELLAS-2024JP005391$ASTELLAS$Sogabe M, Tokimasa S, Suezawa R, Jwa S, Okamoto S, Hamazaki T. A case of nephrotic syndrome after cord blood transplantation for Mucopolysaccharidosis Type II.. The 46th JSTCT Annual Meeting (JSTCT2024) Japanese Society for Transplantation a. 2024;P-033$4$YR$$M$Y$$$20240731$$MD$JP$JP
241543142$24154314$2$F$20240701$20240822$20240730$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042872$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240826$$CN$US$US
241543153$24154315$3$F$$20240816$20240730$20240822$30DAY$$JM-JNJFOC-20240749341$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$PH$JM$JM
241543161$24154316$1$I$20240603$20240730$20240730$20240730$EXP$$AU-ABBVIE-5860064$ABBVIE$$75$YR$$M$Y$$$20240730$$HP$AU$AU
241543171$24154317$1$I$20240713$20240726$20240730$20240730$EXP$$NVSJ2024JP009168$NOVARTIS$$70$YR$$M$Y$$$20240731$$MD$JP$JP
241543181$24154318$1$I$20240721$20240722$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US069259$SANDOZ$$$$$$Y$$$20240730$$HP$US$US
241543191$24154319$1$I$$20240725$20240730$20240730$PER$$US-JNJFOC-20240771920$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240731$$CN$US$US
241543201$24154320$1$I$$20240724$20240730$20240730$EXP$$CA-JNJFOC-20240768033$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240731$$HP$CA$CA
241543211$24154321$1$I$20240101$20240725$20240730$20240730$EXP$$US-ABBVIE-5856310$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241543221$24154322$1$I$20221101$20240725$20240730$20240730$EXP$$BR-009507513-2304BRA008619$MERCK$$44$YR$$F$Y$100$KG$20240730$$PH$BR$BR
241543231$24154323$1$I$$20240725$20240730$20240730$EXP$$US-ABBVIE-5855704$ABBVIE$$$$$F$Y$$$20240730$$CN$US$US
241543241$24154324$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA218915$SANOFI AVENTIS$$$$A$F$Y$85.73$KG$20240731$$MD$US$US
241543251$24154325$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217689$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240731$$MD$US$US
241543261$24154326$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA217639$SANOFI AVENTIS$$29$YR$A$F$Y$73.93$KG$20240731$$MD$US$US
241543272$24154327$2$F$20240723$20240726$20240730$20240801$PER$$US-SA-2024SA222105$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240801$$MD$US$US
241543281$24154328$1$I$$20240726$20240730$20240730$EXP$$GB-AMGEN-GBRSP2024150184$AMGEN$$$$$M$Y$$$20240730$$HP$GB$GB
241543291$24154329$1$I$$20240730$20240730$20240730$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120776$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240731$$HP$US$US
241543301$24154330$1$I$$20240723$20240730$20240730$EXP$$JP-009507513-2407JPN004341J$MERCK$$$$$F$Y$$$20240730$$MD$JP$JP
241543312$24154331$2$F$20240101$20240912$20240730$20240920$PER$$US-SA-2024SA217955$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240920$$MD$US$US
241543321$24154332$1$I$$20240722$20240730$20240730$PER$$US-SA-2024SA217784$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240731$$MD$US$US
241543331$24154333$1$I$20240201$20240722$20240730$20240730$PER$$US-SA-2024SA219776$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240731$$MD$US$US
241543341$24154334$1$I$20220126$20240729$20240730$20240730$30DAY$$EG-SANDOZ INC.-NVSC2023EG132632$SANDOZ$$10$YR$$F$Y$$$20240730$$CN$EG$EG
241543352$24154335$2$F$$20240806$20240730$20240808$EXP$$US-BIOGEN-2024BI01275130$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241543361$24154336$1$I$$20240726$20240730$20240730$EXP$$US-SANDOZ INC.-SDZ2024US068726$SANDOZ$$$$$F$Y$$$20240730$$CN$US$US
241543371$24154337$1$I$20240720$20240725$20240730$20240730$EXP$$CN-GSK-CN2024APC093618$GLAXOSMITHKLINE$$$$$$Y$$$20240730$$HP$CN$CN
241543381$24154338$1$I$$20240719$20240730$20240730$PER$$US-ELI_LILLY_AND_COMPANY-US202407013210$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240730$$CN$US$US
241543391$24154339$1$I$20240101$20240730$20240730$20240730$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042873$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240731$$CN$US$US
241543401$24154340$1$I$20240101$20240723$20240730$20240730$PER$$US-SA-2024SA220604$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240731$$MD$US$US
241543411$24154341$1$I$20240101$20240722$20240730$20240730$PER$$US-SA-2024SA221394$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240731$$MD$US$US
241543421$24154342$1$I$20231216$20240723$20240730$20240730$EXP$$GB-ABBVIE-5850299$ABBVIE$$60$YR$$$Y$$$20240730$$PH$GB$GB
241543432$24154343$2$F$$20240815$20240730$20240820$30DAY$$US-SANDOZ INC.-NVSC2020US031484$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
241543441$24154344$1$I$20240611$20240724$20240730$20240730$EXP$IT-MINISAL02-996072$IT-BIOGEN-2024BI01275623$BIOGEN$$31$YR$$F$Y$$$20240730$$MD$IT$IT
241543452$24154345$2$F$20240716$20240724$20240730$20240806$EXP$$JP-JNJFOC-20240755889$JOHNSON AND JOHNSON$$2$DEC$A$F$Y$$$20240806$$PH$JP$JP
241543461$24154346$1$I$20240617$20240722$20240730$20240730$PER$$US-JNJFOC-20240760677$JOHNSON AND JOHNSON$$67$YR$E$F$Y$73$KG$20240731$$HP$US$US
241543471$24154347$1$I$20240723$20240725$20240730$20240730$EXP$$GB-PFIZER INC-202400223686$PFIZER$$38$YR$$F$Y$$$20240730$$CN$GB$GB
241543483$24154348$3$F$20240724$20240909$20240730$20240917$EXP$$JP-PFIZER INC-202400225158$PFIZER$$6$DEC$$M$Y$$$20240917$$PH$JP$JP
241543491$24154349$1$I$20231218$20240723$20240730$20240730$EXP$$CN-PFIZER INC-2024SGN02809$PFIZER$$71$YR$$M$Y$67.2$KG$20240730$$MD$CN$CN
241543511$24154351$1$I$$20240726$20240730$20240730$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-120240$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240731$$CN$TW$TW
241543522$24154352$2$F$$20240830$20240730$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-120267$BRISTOL MYERS SQUIBB$Ohyagi H, Matano S, Matsuura E, Kurokawa K, Yamashita T, Sugimori n, et al. VD-VZV infection developing in a patient under treatment of LCH, myelodysplastic neoplasms (MDS) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) and regrettably running a rapid and fatal course. The 42nd Meeting of the Japanese Society of Hematology Hokuriku Association (Programs and Abstracts). 2024;21.$8$DEC$E$M$Y$$$20240909$$MD$JP$JP
241543531$24154353$1$I$$20240721$20240730$20240730$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119715$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$56.7$KG$20240731$$HP$US$US
241543541$24154354$1$I$$20240724$20240730$20240730$EXP$$US-ABBVIE-5855660$ABBVIE$$$$$M$Y$$$20240730$$CN$US$US
241543551$24154355$1$I$20240101$20240723$20240730$20240730$EXP$$DE-ABBVIE-5853329$ABBVIE$$$$$F$Y$$$20240730$$CN$DE$DE
241543563$24154356$3$F$$20240819$20240730$20240824$PER$$US-AMGEN-USASP2024150559$AMGEN$$$$$M$Y$$$20240824$$CN$US$US
241543571$24154357$1$I$20240701$20240722$20240730$20240730$PER$$US-SA-2024SA219864$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240731$$MD$US$US
241543581$24154358$1$I$20240201$20240723$20240730$20240730$EXP$$GB-ABBVIE-5852925$ABBVIE$$78$YR$$F$Y$$$20240730$$HP$GB$GB
241543591$24154359$1$I$20231201$20240730$20240730$20240730$EXP$GB-MHRA-MED-202407301423383740-BSZFL$GB-JNJFOC-20240781797$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240731$$HP$GB$GB
241543611$24154361$1$I$$20240726$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119539$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240731$$CN$US$US
241543621$24154362$1$I$$20240723$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117744$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240731$$HP$US$US
241543631$24154363$1$I$20201101$20240726$20240731$20240731$EXP$CZ-CZSUKL-21000317$CZ-TAKEDA-2021TUS011883$TAKEDA$$50$YR$$F$Y$70$KG$20240730$$MD$CZ$CZ
241543641$24154364$1$I$$20240723$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118331$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240731$$CN$US$US
241543661$24154366$1$I$20240101$20240725$20240731$20240731$EXP$$US-ABBVIE-5856059$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241543671$24154367$1$I$20180101$20240724$20240731$20240731$EXP$$DE-ABBVIE-5858935$ABBVIE$$$$$F$Y$$$20240731$$CN$DE$DE
241543681$24154368$1$I$20240101$20240726$20240731$20240731$EXP$$US-ABBVIE-5857039$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241543691$24154369$1$I$20240101$20240725$20240731$20240731$EXP$$BE-ABBVIE-5855973$ABBVIE$$$$E$F$Y$56$KG$20240731$$HP$BE$BE
241543701$24154370$1$I$$20240725$20240731$20240731$EXP$$US-ABBVIE-5857434$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241543712$24154371$2$F$$20240910$20240731$20240923$EXP$$GB-UCBSA-2024038235$UCB$$$$$F$Y$$$20240923$$CN$GB$GB
241543721$24154372$1$I$20230101$20240727$20240731$20240731$EXP$$EG-ABBVIE-5669404$ABBVIE$$68$YR$$M$Y$$$20240731$$CN$EG$EG
241543731$24154373$1$I$20231125$20240727$20240731$20240731$EXP$$GR-ABBVIE-5858811$ABBVIE$$72$YR$$M$Y$70$KG$20240731$$MD$GR$GR
241543741$24154374$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5858918$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241543751$24154375$1$I$$20240726$20240731$20240731$EXP$$CA-ABBVIE-5859537$ABBVIE$$$$$M$Y$$$20240731$$PH$CA$CA
241543761$24154376$1$I$$20240723$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117538$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240731$$CN$US$US
241543772$24154377$2$F$$20240826$20240731$20240827$PER$$NVSC2024US155770$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
241543792$24154379$2$F$20240101$20240819$20240731$20240826$EXP$$US-ABBVIE-5748830$ABBVIE$$64$YR$$F$Y$$$20240826$$CN$US$US
241543803$24154380$3$F$20240729$20240812$20240731$20240814$PER$$US-AMGEN-USASP2024150601$AMGEN$$70$YR$E$F$Y$$$20240814$$CN$US$US
241543811$24154381$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA221143$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240731$$MD$US$US
241543822$24154382$2$F$$20240731$20240731$20240802$EXP$$US-ABBVIE-5820821$ABBVIE$$$$$F$Y$82$KG$20240802$$CN$US$US
241543831$24154383$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221254$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240731$$CN$US$US
241543842$24154384$2$F$$20240726$20240731$20240731$EXP$$US-JNJFOC-20240776115$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241543851$24154385$1$I$$20240725$20240731$20240731$EXP$$US-GSK-US2024AMR094492$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$US$US
241543861$24154386$1$I$20240701$20240724$20240731$20240731$EXP$$IT-ABBVIE-5853939$ABBVIE$$77$YR$$F$Y$$$20240731$$HP$IT$IT
241543871$24154387$1$I$20240618$20240723$20240731$20240731$EXP$$US-ABBVIE-5851677$ABBVIE$$60$YR$$F$Y$56.7$KG$20240731$$CN$US$US
241543882$24154388$2$F$$20240904$20240731$20240907$EXP$$US-TAKEDA-2024TUS076057$TAKEDA$$$$$M$Y$156$KG$20240907$$HP$US$US
241543891$24154389$1$I$$20240722$20240731$20240731$EXP$$US-TEYRO-2024-TY-000331$Teyro Labs$Suvilesh KN, Manjunath Y, Nussbaum YI, Gadelkarim M, Raju M, Srivastava A, Kaif J T, et al..Targeting AKR1B10 by drug repurposing with epalrestat overcomes chemoresistance in non-small cell lung cancer patient-derived tumor organoids..Clin Cancer Res.2024$64$YR$A$M$Y$$$20240731$$HP$US$US
241543902$24154390$2$F$$20240813$20240731$20240823$PER$$ZA-REGENERON PHARMACEUTICALS, INC.-2024-104172$REGENERON$$$$$M$Y$$$20240823$$MD$ZA$ZA
241543911$24154391$1$I$$20240715$20240731$20240731$EXP$$GR-ABBVIE-5860649$ABBVIE$$$$$$Y$$$20240731$$MD$GR$GR
241543921$24154392$1$I$20240729$20240722$20240731$20240731$EXP$$US-TAKEDA-2024TUS074316$TAKEDA$$72$YR$$F$Y$$$20240731$$CN$US$US
241543933$24154393$3$F$20240101$20240903$20240731$20240913$PER$$US-SA-2024SA219476$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240913$$MD$US$US
241543941$24154394$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221678$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240731$$MD$US$US
241543951$24154395$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221439$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240731$$MD$US$US
241543961$24154396$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA220692$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240731$$MD$US$US
241543971$24154397$1$I$20220101$20240723$20240731$20240731$PER$$US-SA-2024SA221321$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240731$$MD$US$US
241543982$24154398$2$F$20240709$20240917$20240731$20240925$EXP$$DE-JNJFOC-20240774909$JOHNSON AND JOHNSON$$49$YR$A$F$Y$85$KG$20240925$$MD$DE$DE
241543991$24154399$1$I$20231201$20240724$20240731$20240731$EXP$$BR-BIOGEN-2024BI01275594$BIOGEN$$33$YR$$F$Y$65$KG$20240731$$CN$BR$BR
241544001$24154400$1$I$20240601$20240726$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119504$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$216.68$KG$20240731$$PH$US$US
241544011$24154401$1$I$$20240724$20240731$20240731$EXP$$US-JNJFOC-20240765589$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$HP$US$US
241544022$24154402$2$F$20240401$20240802$20240731$20240809$EXP$$JP-AMGEN-JPNSP2024150058$AMGEN$$$$E$F$Y$$$20240809$$MD$JP$JP
241544031$24154403$1$I$$20240726$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119933$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240731$$CN$US$US
241544041$24154404$1$I$$20240722$20240731$20240731$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009405$STRIDES$Fatima M, Gandhi ZJ, Simonetti G, Saladi L, Naik S.. Fatal Case of Cryptococcal Arthritis.. Am-J-Respir-Crit-Care-Med. 2023;207$57$YR$$F$Y$$$20240731$$HP$US$US
241544051$24154405$1$I$$20240719$20240731$20240731$PER$$US-AstraZeneca-2024A165600$ASTRAZENECA$$$$$$Y$$$20240731$$CN$US$
241544061$24154406$1$I$$20240724$20240731$20240731$EXP$$ZA-AstraZeneca-2024A168809$ASTRAZENECA$$69$YR$$F$Y$$$20240731$$CN$ZA$
241544071$24154407$1$I$$20240723$20240731$20240731$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009395$STRIDES$Shultz J, Antar-Shultz M, Taha M, Zervogiannis P, Lazcano G, Lamarche J.. SEVELAMER-ASSOCIATED COLITIS: A TRIGGER TO CHANGE TREATMENT APPROACH.. Am-J-Kidney-Dis. 2024;83 (Suppl.) (4):S74 abstr. 242.$63$YR$$F$Y$$$20240731$$HP$US$US
241544081$24154408$1$I$20240401$20240720$20240731$20240731$PER$$US-SA-2024SA219908$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240731$$MD$US$US
241544091$24154409$1$I$$20240730$20240731$20240731$EXP$GB-MHRA-MED-202407260753521180-LKRTB$GB-SANDOZ INC.-SDZ2024GB069213$SANDOZ$$60$YR$$F$Y$$$20240731$$MD$GB$GB
241544101$24154410$1$I$20240101$20240719$20240731$20240731$PER$$US-SA-2024SA217694$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240731$$MD$US$US
241544123$24154412$3$F$$20240820$20240731$20240827$EXP$$US-JNJFOC-20240720150$JOHNSON AND JOHNSON$$46$YR$A$F$Y$136.4$KG$20240827$$CN$US$US
241544133$24154413$3$F$20240713$20240805$20240731$20240810$EXP$$CO-ABBVIE-5859494$ABBVIE$$77$YR$$M$Y$84$KG$20240810$$HP$CO$CO
241544141$24154414$1$I$$20240722$20240731$20240731$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002084$Alvotech$$59$YR$$F$Y$$$20240731$$CN$CA$CA
241544152$24154415$2$F$$20240731$20240731$20240808$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002085$Alvotech$$$$$F$Y$$$20240808$$CN$CA$CA
241544161$24154416$1$I$$20240729$20240731$20240731$EXP$$NVSC2024NP155566$NOVARTIS$$$$$M$Y$$$20240731$$MD$NP$NP
241544171$24154417$1$I$$20240723$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069294$SANDOZ$$$$$$Y$$$20240731$$HP$US$US
241544181$24154418$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5857753$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241544191$24154419$1$I$$20240726$20240731$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119633$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240731$$MD$JP$JP
241544212$24154421$2$F$20231001$20240814$20240731$20240821$EXP$$US-ABBVIE-5650034$ABBVIE$$55$YR$$F$Y$54$KG$20240821$$CN$US$US
241544221$24154422$1$I$20230701$20240724$20240731$20240731$EXP$$US-ABBVIE-5734376$ABBVIE$$66$YR$$F$Y$$$20240731$$CN$US$US
241544231$24154423$1$I$$20240722$20240731$20240731$EXP$$US-ABBVIE-5856441$ABBVIE$$$$$M$Y$$$20240731$$HP$US$US
241544243$24154424$3$F$20240601$20240819$20240731$20240826$EXP$$GR-ABBVIE-5856067$ABBVIE$$69$YR$$F$Y$$$20240826$$HP$GR$GR
241544251$24154425$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000041318$ROCHE$$92$YR$E$F$Y$$$20240731$$MD$US$US
241544261$24154426$1$I$$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149769$AMGEN$$$$A$F$Y$$$20240730$$HP$US$US
241544272$24154427$2$F$20240101$20240912$20240731$20240918$EXP$$GR-ABBVIE-5844637$ABBVIE$$$$$F$Y$67$KG$20240918$$CN$GR$GR
241544281$24154428$1$I$$20240724$20240731$20240731$EXP$$AU-AstraZeneca-2024A168979$ASTRAZENECA$$$$$F$Y$$$20240731$$MD$AU$
241544291$24154429$1$I$$20240724$20240731$20240731$PER$$US-ABBVIE-5855798$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241544301$24154430$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018867$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240731$$CN$US$US
241544311$24154431$1$I$$20240723$20240731$20240731$EXP$$IE-TAKEDA-2024TUS076127$TAKEDA$$$$$$Y$$$20240731$$MD$IE$IE
241544321$24154432$1$I$20240725$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018593$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240731$$CN$US$US
241544333$24154433$3$F$$20240808$20240731$20240820$30DAY$$CH-JNJFOC-20240727007$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$MD$CH$CH
241544341$24154434$1$I$$20240730$20240731$20240731$EXP$$GB-SANDOZ INC.-SDZ2024GB069255$SANDOZ$$69$YR$$M$Y$64$KG$20240731$$MD$GB$GB
241544351$24154435$1$I$20240101$20240723$20240731$20240731$EXP$$US-ABBVIE-5853762$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241544362$24154436$2$F$20240101$20240815$20240731$20240822$EXP$$US-ABBVIE-5853912$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
241544371$24154437$1$I$$20240724$20240731$20240731$EXP$$UY-ABBVIE-5853275$ABBVIE$$$$$F$Y$$$20240731$$CN$UY$UY
241544381$24154438$1$I$20240725$20240725$20240731$20240731$PER$$US-SA-2024SA221453$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240731$$HP$US$US
241544391$24154439$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221580$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240731$$MD$US$US
241544401$24154440$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA221364$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240731$$MD$US$US
241544411$24154441$1$I$$20240724$20240731$20240731$EXP$$US-ABBVIE-5854939$ABBVIE$$$$$M$Y$$$20240731$$HP$US$US
241544421$24154442$1$I$20240101$20240724$20240731$20240731$EXP$$US-ABBVIE-5824821$ABBVIE$$78$YR$$M$Y$$$20240731$$CN$US$US
241544431$24154443$1$I$20240617$20240724$20240731$20240731$EXP$$CA-ABBVIE-5856949$ABBVIE$$62$YR$$M$Y$$$20240731$$CN$CA$CA
241544442$24154444$2$F$20240625$20240906$20240731$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019651$UNITED THERAPEUTICS$$23$YR$$M$Y$103.4$KG$20240913$$PH$US$US
241544451$24154445$1$I$20231201$20240724$20240731$20240731$EXP$$US-ABBVIE-5819302$ABBVIE$$46$YR$$F$Y$$$20240731$$CN$US$US
241544462$24154446$2$F$$20240826$20240731$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120314$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240830$$HP$US$US
241544471$24154447$1$I$20240718$20240723$20240731$20240731$EXP$$HR-BRISTOL-MYERS SQUIBB COMPANY-2024-120567$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240731$$HP$HR$HR
241544481$24154448$1$I$20240722$20240724$20240731$20240731$EXP$$US-ABBVIE-5858376$ABBVIE$$79$YR$$M$Y$$$20240731$$MD$US$US
241544494$24154449$4$F$20240101$20240826$20240731$20240909$PER$$US-SA-2024SA221546$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240909$$MD$US$US
241544501$24154450$1$I$$20240723$20240731$20240731$EXP$$BE-ABBVIE-5853824$ABBVIE$$$$E$M$Y$70$KG$20240731$$HP$BE$BE
241544521$24154452$1$I$$20240725$20240731$20240731$EXP$$CA-ABBVIE-5856595$ABBVIE$$$$A$F$Y$$$20240731$$CN$CA$CA
241544532$24154453$2$F$20240101$20240730$20240731$20240805$EXP$$US-ABBVIE-5854956$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241544542$24154454$2$F$20210101$20240729$20240731$20240802$EXP$$US-ABBVIE-5853380$ABBVIE$$$$$F$Y$113.39$KG$20240802$$CN$US$US
241544551$24154455$1$I$$20240725$20240731$20240731$EXP$$CA-ABBVIE-5855767$ABBVIE$$$$A$M$Y$$$20240731$$CN$CA$CA
241544561$24154456$1$I$20240516$20240726$20240731$20240731$EXP$$DE-ABBVIE-5859046$ABBVIE$$62$YR$$F$Y$$$20240731$$MD$DE$DE
241544571$24154457$1$I$$20240624$20240731$20240731$PER$$US-CHATTEMPRD-2024OHG022293$CHATTEM$$26$YR$A$F$Y$$$20240731$$CN$US$US
241544581$24154458$1$I$$20240725$20240731$20240731$EXP$$CA-ABBVIE-5856305$ABBVIE$$$$E$M$Y$$$20240731$$CN$CA$CA
241544591$24154459$1$I$$20240725$20240731$20240731$PER$$US-CHATTEMPRD-2024OHG025463$CHATTEM$$$$$M$Y$$$20240731$$CN$US$US
241544602$24154460$2$F$$20240731$20240731$20240803$EXP$$US-ABBVIE-5857229$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241544611$24154461$1$I$20240607$20240711$20240731$20240731$PER$$AR-TOLMAR, INC.-24AR050914$TOLMAR$$71$YR$$M$Y$$$20240731$$CN$AR$AR
241544622$24154462$2$F$20230901$20240826$20240731$20240919$PER$$AR-TOLMAR, INC.-24AR051008$TOLMAR$$8$YR$$M$Y$$$20240919$$CN$AR$AR
241544631$24154463$1$I$$20240711$20240731$20240731$PER$$AU-TOLMAR, INC.-24AU050916$TOLMAR$$$$$M$Y$$$20240731$$CN$AU$AU
241544641$24154464$1$I$$20240710$20240731$20240731$PER$$AU-TOLMAR, INC.-24AU050919$TOLMAR$$$$$M$Y$$$20240731$$CN$AU$AU
241544652$24154465$2$F$20240709$20240823$20240731$20240911$PER$$AU-TOLMAR, INC.-24AU050928$TOLMAR$$84$YR$$M$Y$$$20240911$$HP$AU$AU
241544661$24154466$1$I$$20240711$20240731$20240731$PER$$AU-TOLMAR, INC.-24AU050961$TOLMAR$$$$$M$Y$$$20240731$$CN$AU$AU
241544671$24154467$1$I$$20240710$20240731$20240731$PER$$AU-TOLMAR, INC.-24AU050980$TOLMAR$$$$$M$Y$$$20240731$$CN$AU$AU
241544682$24154468$2$F$20240710$20240822$20240731$20240911$PER$$AU-TOLMAR, INC.-24AU050968$TOLMAR$$$$$$Y$$$20240911$$HP$AU$AU
241544692$24154469$2$F$20240712$20240826$20240731$20240919$PER$$AU-TOLMAR, INC.-24AU050993$TOLMAR$$88$YR$$M$Y$$$20240919$$PH$AU$AU
241544702$24154470$2$F$$20240815$20240731$20240902$PER$$AU-TOLMAR, INC.-24AU051034$TOLMAR$$$$$M$Y$$$20240902$$CN$AU$AU
241544721$24154472$1$I$$20240722$20240731$20240731$30DAY$$US-GSK-US2024091814$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$CN$US$US
241544731$24154473$1$I$20240713$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150330$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241544741$24154474$1$I$20240713$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149423$AMGEN$$82$YR$E$M$Y$$$20240730$$HP$US$US
241544751$24154475$1$I$$20230808$20240731$20240731$EXP$$PH-BEH-2024176323$CSL BEHRING$$$$$$Y$$$20240731$$HP$PH$PH
241544761$24154476$1$I$$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024149130$AMGEN$$$$$M$Y$$$20240730$$CN$US$US
241544782$24154478$2$F$20240911$20240917$20240731$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003371$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240927$$CN$US$US
241544793$24154479$3$F$$20240913$20240731$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003367$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241544811$24154481$1$I$$20240728$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120378$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$84.37$KG$20240731$$CN$US$US
241544821$24154482$1$I$$20240730$20240731$20240731$PER$$US-ABBVIE-5860831$ABBVIE$$$$$$Y$$$20240731$$MD$US$US
241544831$24154483$1$I$$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003389$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241544841$24154484$1$I$$20240729$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042861$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240731$$HP$US$US
241544852$24154485$2$F$$20240729$20240731$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011468$JAZZ$$$$$F$Y$$$20240807$$CN$US$US
241544861$24154486$1$I$20240201$20240717$20240731$20240731$EXP$$US-CIPLA LTD.-2024US07922$CIPLA$Zieneldien T, Kim J, Greene J.. Breakthrough pneumocystis jirovecii pneumonia in an allogeneic hematopoietic stem cell transplant recipient.. Cureus. 2024;16(6):e61890$$$$$Y$$$20240731$$HP$US$US
241544871$24154487$1$I$$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003372$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241544881$24154488$1$I$$20240723$20240731$20240731$EXP$$CA-TOLMAR, INC.-24CA051244$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241544893$24154489$3$F$20240701$20240815$20240731$20240830$PER$$CA-TOLMAR, INC.-24CA051264$TOLMAR$$93$YR$$M$Y$$$20240830$$CN$CA$CA
241544901$24154490$1$I$$20240723$20240731$20240731$EXP$$CA-TOLMAR, INC.-24CA051261$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241544911$24154491$1$I$$20240724$20240731$20240731$EXP$$CA-TOLMAR, INC.-24CA051305$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241544922$24154492$2$F$$20240816$20240731$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003388$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
241544931$24154493$1$I$$20240724$20240731$20240731$EXP$$CA-TOLMAR, INC.-24CA051309$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241544941$24154494$1$I$$20240724$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA051307$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241544951$24154495$1$I$$20240723$20240731$20240731$EXP$$NL-TOLMAR, INC.-24NL051250$TOLMAR$$$$$M$Y$$$20240731$$CN$NL$NL
241544961$24154496$1$I$$20240723$20240731$20240731$EXP$$NL-TOLMAR, INC.-24NL051245$TOLMAR$$$$$M$Y$$$20240731$$HP$NL$NL
241544971$24154497$1$I$20240619$20240709$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003366$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240731$$CN$US$US
241544991$24154499$1$I$$20240719$20240731$20240731$PER$$US-AMGEN-USANI2024150020$AMGEN$Dranitsaris, G. et al.. Fostamatinib or Thrombopoietin Receptor Agonists for the Treatment of Chronic Immune Thrombocytopenia in Adult Patients: A Real-World Assessment of Safety, Effectiveness and Cost. Acta Haematol.. 2024;147:333-343$$$A$$Y$$$20240730$$MD$US$US
241545001$24154500$1$I$20240716$20240719$20240731$20240731$EXP$GB-MHRA-MED-202407191648322520-RHGLP$GB-Accord-437118$ACCORD$$52$YR$A$F$Y$75$KG$20240730$$MD$GB$GB
241545011$24154501$1$I$20190101$20240717$20240731$20240731$PER$$US-TEVA-VS-3225445$TEVA$$60$YR$$F$Y$$$20240731$$CN$US$US
241545021$24154502$1$I$20240704$20240722$20240731$20240731$EXP$$US-BIOGEN-2024BI01274957$BIOGEN$$46$YR$$F$Y$$$20240731$$HP$US$US
241545031$24154503$1$I$$20240725$20240731$20240731$EXP$$CA-GSK-CA2023076537$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$CA$CA
241545041$24154504$1$I$20240725$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149444$AMGEN$$54$YR$A$F$Y$$$20240730$$CN$US$US
241545051$24154505$1$I$$20240727$20240731$20240731$PER$$US-AMGEN-USASP2024151034$AMGEN$$$$$M$Y$$$20240730$$PH$US$US
241545081$24154508$1$I$20240724$20240725$20240731$20240731$PER$$US-SA-2024SA221109$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240731$$CN$US$US
241545101$24154510$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018502$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$US$US
241545112$24154511$2$F$$20240819$20240731$20240828$30DAY$$US-GSK-US2024091815$GLAXOSMITHKLINE$$$$$M$Y$$$20240828$$CN$US$US
241545121$24154512$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018692$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240731$$CN$US$US
241545131$24154513$1$I$$20240726$20240731$20240731$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010192$JAZZ$$$$$M$Y$$$20240730$$CN$US$US
241545151$24154515$1$I$$20240723$20240731$20240731$PER$$US-AMGEN-USASP2024147074$AMGEN$$44$YR$A$F$Y$$$20240730$$MD$US$US
241545162$24154516$2$F$$20240729$20240731$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003378$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
241545172$24154517$2$F$$20240821$20240731$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003392$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
241545181$24154518$1$I$$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003339$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241545192$24154519$2$F$$20240731$20240731$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003380$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$HP$US$US
241545201$24154520$1$I$$20240729$20240731$20240731$PER$$US-HALEON-2189678$Haleon PLC$$$$$M$Y$$$20240731$$CN$US$US
241545211$24154521$1$I$$20240723$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117728$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240731$$CN$US$US
241545221$24154522$1$I$$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024151427$AMGEN$$$$$F$Y$$$20240730$$HP$US$US
241545231$24154523$1$I$20230101$20240726$20240731$20240731$EXP$$AU-AMGEN-AUSSP2024150133$AMGEN$$$$$F$Y$$$20240730$$CN$AU$AU
241545241$24154524$1$I$20231201$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024146937$AMGEN$$92$YR$E$F$Y$$$20240730$$CN$US$US
241545252$24154525$2$F$20240707$20240906$20240731$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003384$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240927$$HP$US$US
241545261$24154526$1$I$20240601$20240717$20240731$20240731$PER$$US-TEVA-VS-3225862$TEVA$$76$YR$$M$Y$94.8$KG$20240731$$CN$US$US
241545272$24154527$2$F$20240628$20240729$20240731$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003382$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240821$$CN$US$US
241545282$24154528$2$F$20230801$20240820$20240731$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042864$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240821$$CN$US$US
241545292$24154529$2$F$$20240809$20240731$20240813$PER$$NVSC2024US154444$NOVARTIS$$47$YR$$F$Y$$$20240813$$CN$US$US
241545311$24154531$1$I$$20240720$20240731$20240731$EXP$$US-NOVOPROD-1260436$NOVO NORDISK$$$$A$M$Y$$$20240731$$CN$US$US
241545321$24154532$1$I$$20240721$20240731$20240731$EXP$$IL-NOVOPROD-1259807$NOVO NORDISK$$$$$F$Y$$$20240731$$MD$IL$IL
241545332$24154533$2$F$$20240726$20240731$20240806$EXP$$EG-NOVOPROD-1259191$NOVO NORDISK$$$$$F$Y$$$20240806$$CN$EG$EG
241545341$24154534$1$I$$20240721$20240731$20240731$EXP$$US-NOVOPROD-1260208$NOVO NORDISK$$$$A$F$Y$$$20240731$$CN$US$US
241545351$24154535$1$I$$20240719$20240731$20240731$EXP$$TR-NOVOPROD-1261712$NOVO NORDISK$$$$$M$Y$$$20240731$$CN$TR$TR
241545361$24154536$1$I$$20240723$20240731$20240731$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP009358$STRIDES$Muller PR, Coelho ADC, da Cruz VIF, Barros DDO, Bertolini DV.. PERFIL DO AMBULATORIO DE PRE NATAL (CIS E TRANS) DE PESSOAS GESTANTES QUE VIVEM COM HIV (PGVHIV) OU PESSOAS GESTANTES DE PARCERIAS SORODIFERENTES (PGPSD), INCLUINDO HOMENS TRANSEXUAIS NO CRT DST-AIDS SP E SEU IMPACTO SOBRE A TRANSMISSAO VERTICAL.. Brazil-J-Infect-Dis. 2023;27 (Suppl.):no pagination$$$$F$Y$$$20240731$$HP$BR$BR
241545371$24154537$1$I$$20240723$20240731$20240731$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP009361$STRIDES$Muller PR, Coelho ADC, da Cruz VIF, Barros DDO, Bertolini DV.. PERFIL DO AMBULATORIO DE PRE NATAL (CIS E TRANS) DE PESSOAS GESTANTES QUE VIVEM COM HIV (PGVHIV) OU PESSOAS GESTANTES DE PARCERIAS SORODIFERENTES (PGPSD), INCLUINDO HOMENS TRANSEXUAIS NO CRT DST-AIDS SP E SEU IMPACTO SOBRE A TRANSMISSAO VERTICAL.. Brazil-J-Infect-Dis. 2023;27 (Suppl.):no pagination$$$$F$Y$$$20240731$$HP$BR$BR
241545391$24154539$1$I$$20240723$20240731$20240731$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP009362$STRIDES$Muller PR, Coelho ADC, da Cruz VIF, Barros DDO, Bertolini DV.. PERFIL DO AMBULATORIO DE PRE NATAL (CIS E TRANS) DE PESSOAS GESTANTES QUE VIVEM COM HIV (PGVHIV) OU PESSOAS GESTANTES DE PARCERIAS SORODIFERENTES (PGPSD), INCLUINDO HOMENS TRANSEXUAIS NO CRT DST-AIDS SP E SEU IMPACTO SOBRE A TRANSMISSAO VERTICAL.. Brazil-J-Infect-Dis. 2023;27 (Suppl.):no pagination$$$$F$Y$$$20240731$$HP$BR$BR
241545401$24154540$1$I$$20240725$20240731$20240731$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP009391$STRIDES$Javed A, Fatima A.. An unexpected case of cryoglobulinaemia vasculitis that presented as respiratory failure.. Clin-Med-London. 2024;24 (Suppl.).$66$YR$$F$Y$$$20240731$$HP$GB$GB
241545413$24154541$3$F$$20240916$20240731$20240924$EXP$$US-ROCHE-10000032543$ROCHE$$82$YR$E$M$Y$$$20240924$$CN$US$US
241545421$24154542$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA220696$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240731$$CN$US$US
241545431$24154543$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA217219$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240731$$MD$US$US
241545441$24154544$1$I$$20240729$20240731$20240731$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011454$JAZZ$$$$$M$Y$$$20240730$$HP$US$US
241545451$24154545$1$I$$20240725$20240731$20240731$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009392$STRIDES$Beesley S, Lanspa MJ.. Calcium Channel Overdose and Insulin Therapy Dosing.. Am-J-Respir-Crit-Care-Med. 2024;209$28$YR$$M$Y$$$20240731$$HP$US$US
241545461$24154546$1$I$$20240723$20240731$20240731$PER$$US-ABBVIE-5856365$ABBVIE$$$$$$Y$$$20240731$$MD$US$US
241545472$24154547$2$F$$20240730$20240731$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA069237$SANDOZ$$70$YR$$M$Y$$$20240731$$CN$CA$CA
241545481$24154548$1$I$20240719$20240722$20240731$20240731$EXP$CN-NMPA-3203211030469202400284$CN-NOVOPROD-1259866$NOVO NORDISK$$74$YR$$F$Y$64$KG$20240731$$HP$CN$CN
241545491$24154549$1$I$20240713$20240722$20240731$20240731$EXP$DK-DKMA-30736129$DK-NOVOPROD-1260050$NOVO NORDISK$$62$YR$$F$Y$85$KG$20240731$$MD$DK$DK
241545503$24154550$3$F$20240608$20240826$20240731$20240905$EXP$$US-NOVOPROD-1260200$NOVO NORDISK$$74$YR$$F$Y$$$20240905$$CN$US$US
241545513$24154551$3$F$20230117$20240826$20240731$20240905$EXP$$US-NOVOPROD-1260212$NOVO NORDISK$$70$YR$$M$Y$$$20240905$$CN$US$US
241545521$24154552$1$I$20240419$20240722$20240731$20240731$EXP$IT-MINISAL02-995948$IT-NOVOPROD-1260046$NOVO NORDISK$$54$YR$$M$Y$$$20240731$$MD$IT$IT
241545531$24154553$1$I$20240101$20240722$20240731$20240731$EXP$DK-DKMA-30736186$DK-NOVOPROD-1260158$NOVO NORDISK$$77$YR$$F$Y$$$20240731$$MD$DK$DK
241545542$24154554$2$F$20240701$20240821$20240731$20240904$EXP$$US-NOVOPROD-1260253$NOVO NORDISK$$27$YR$$F$Y$50.34$KG$20240904$$CN$US$US
241545553$24154555$3$F$$20240809$20240731$20240820$EXP$$EG-NOVOPROD-1259832$NOVO NORDISK$$75$YR$$F$Y$130$KG$20240820$$CN$EG$EG
241545561$24154556$1$I$$20240722$20240731$20240731$EXP$$GB-NOVOPROD-1259711$NOVO NORDISK$$$$$F$Y$$$20240731$$CN$GB$GB
241545571$24154557$1$I$20240101$20240722$20240731$20240731$EXP$DK-DKMA-30736189$DK-NOVOPROD-1260161$NOVO NORDISK$$42$YR$$M$Y$$$20240731$$MD$DK$DK
241545581$24154558$1$I$20240503$20240722$20240731$20240731$EXP$IS-IMA-8758$IS-NOVOPROD-1260169$NOVO NORDISK$$67$YR$$F$Y$$$20240731$$MD$IS$IS
241545591$24154559$1$I$$20240722$20240731$20240731$EXP$$GB-NOVOPROD-1259811$NOVO NORDISK$$41$YR$$F$Y$$$20240731$$CN$GB$GB
241545601$24154560$1$I$20240710$20240722$20240731$20240731$EXP$DK-DKMA-30735523$DK-NOVOPROD-1260172$NOVO NORDISK$$80$YR$$M$Y$125$KG$20240731$$MD$DK$DK
241545611$24154561$1$I$$20240722$20240731$20240731$EXP$$CO-NOVOPROD-1259830$NOVO NORDISK$$67$YR$$F$Y$$$20240731$$CN$CO$CO
241545621$24154562$1$I$$20240722$20240731$20240731$EXP$US-FDA-ADR 23668301$US-NOVOPROD-1260231$NOVO NORDISK$$$$$$Y$$$20240731$$CN$US$US
241545633$24154563$3$F$$20240904$20240731$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003397$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241545641$24154564$1$I$20240201$20240724$20240731$20240731$EXP$$IN-SANDOZ INC.-SDZ2024IN069171$SANDOZ$$$$$M$Y$$$20240731$$CN$IN$IN
241545651$24154565$1$I$$20240724$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118988$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240731$$HP$US$US
241545661$24154566$1$I$$20240723$20240731$20240731$EXP$$US-RDY-LIT/USA/24/0011067$DR REDDYS$Kulkarni R, Abdelrahman A, Ghesani M, Ghesani N, Wolin E, Oh W, et al. Management Of Concomitant Prostate Cancer and Pancreatic Neuroendocrine Tumour: Role of Nuclear Medicine in therapeutic decision making. Journal of Nuclear Medicine. 2023 Jun 01;64: 1440.$71$YR$E$M$Y$$$20240731$$HP$US$US
241545672$24154567$2$F$20240701$20240807$20240731$20240819$EXP$$CN-NOVOPROD-1259206$NOVO NORDISK$$71$YR$$M$Y$85$KG$20240819$$CN$CN$CN
241545681$24154568$1$I$20240630$20240722$20240731$20240731$EXP$$US-NOVOPROD-1260653$NOVO NORDISK$$72$YR$$M$Y$$$20240731$$CN$US$US
241545691$24154569$1$I$$20240722$20240731$20240731$EXP$$US-NOVOPROD-1260763$NOVO NORDISK$$$$A$F$Y$$$20240731$$CN$US$US
241545702$24154570$2$F$$20240910$20240731$20240919$30DAY$$SE-NOVOPROD-1259000$NOVO NORDISK$$$$$$Y$$$20240919$$CN$SE$SE
241545711$24154571$1$I$$20240722$20240731$20240731$EXP$$US-NOVOPROD-1260748$NOVO NORDISK$$40$YR$$F$Y$$$20240731$$CN$US$US
241545721$24154572$1$I$$20240725$20240731$20240731$EXP$$US-JNJFOC-20240771612$JOHNSON AND JOHNSON$$$$$M$Y$$$20240731$$CN$US$US
241545732$24154573$2$F$$20240904$20240731$20240916$EXP$$CN-NOVOPROD-1256116$NOVO NORDISK$$75$YR$$M$Y$67$KG$20240916$$CN$CN$CN
241545751$24154575$1$I$20240704$20240709$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001818$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240731$$CN$US$US
241545761$24154576$1$I$20240701$20240723$20240731$20240731$EXP$$CN-ROCHE-10000034620$ROCHE$$19$YR$A$F$Y$$$20240731$$HP$CN$CN
241545771$24154577$1$I$20240728$20240729$20240731$20240731$EXP$$US-AstraZeneca-2024A172410$ASTRAZENECA$$29534$DY$$M$Y$$$20240731$$CN$US$
241545782$24154578$2$F$20240701$20240814$20240731$20240820$30DAY$$US-AMGEN-USASP2024147787$AMGEN$$83$YR$E$M$Y$$$20240819$$HP$US$US
241545791$24154579$1$I$20230814$20240723$20240731$20240731$EXP$$CA-NOVOPROD-1240967$NOVO NORDISK$$54$YR$$M$Y$109$KG$20240731$$MD$CA$CA
241545801$24154580$1$I$$20240716$20240731$20240731$EXP$$US-DEXPHARM-2024-2479$DEXCEL$Pien, I.; Mudgal, C. S.  Osteonecrosis of Trapezium Occurring in  Patient with History of Recurrent Carpometacarpal Corticosteroid Injection. The Journal of Hand Surgery Asian-Pacific Volume 2023, V28, P129-133$59$YR$A$F$Y$$$20240731$$HP$US$US
241545811$24154581$1$I$$20240729$20240731$20240731$EXP$$US-ORGANON-O2407USA002763$ORGANON$$$$$F$Y$$$20240731$$CN$US$US
241545831$24154583$1$I$20240719$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017858$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240731$$CN$US$US
241545841$24154584$1$I$20240729$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018785$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240731$$CN$US$US
241545851$24154585$1$I$$20240729$20240731$20240731$PER$$US-HALEON-2189669$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241545862$24154586$2$F$20240727$20240808$20240731$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023254$UNITED THERAPEUTICS$$58$YR$$F$Y$53.515$KG$20240817$$$US$US
241545871$24154587$1$I$20240723$20240723$20240731$20240731$EXP$$US-VIIV HEALTHCARE LIMITED-US2024092256$VIIV$$63$YR$$F$Y$$$20240731$$CN$US$US
241545882$24154588$2$F$$20240819$20240731$20240829$30DAY$$US-GSK-US2024091837$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
241545891$24154589$1$I$$20240723$20240731$20240731$EXP$$GB-CELLTRION INC.-2024GB006551$CELLTRION$$$$$$Y$$$20240731$$CN$GB$GB
241545902$24154590$2$F$20230403$20240806$20240731$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-037766$AUROBINDO$$1$DY$$F$Y$2.63$KG$20240809$$HP$FR$FR
241545911$24154591$1$I$$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003405$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241545922$24154592$2$F$20240621$20240731$20240731$20240803$EXP$IT-MINISAL02-993592$IT-ROCHE-10000031421$ROCHE$$58$YR$A$M$Y$$$20240803$$MD$IT$IT
241545931$24154593$1$I$20230901$20240717$20240731$20240731$EXP$$DO-ROCHE-3455297$ROCHE$$43$YR$A$F$Y$$$20240731$$CN$DO$DO
241545941$24154594$1$I$$20240719$20240731$20240731$EXP$$BR-CHEPLA-2024009539$CHEPLAPHARM$$75$YR$$F$Y$$$20240730$$CN$COUNTRY NOT SPECIFIED$BR
241545951$24154595$1$I$$20240723$20240731$20240731$EXP$$US-AMGEN-USASP2024147873$AMGEN$Lee G.; Li R.; Ei-sherief A. et al.. Immunotherapy causing pneumonitis in a patient with pneumonitis in a patient with (NSCLC). BMJ Case Reports. 2019;12 (3):1-4$72$YR$E$M$Y$$$20240730$$MD$US$US
241545961$24154596$1$I$$20240726$20240731$20240731$EXP$$ES-CHEPLA-1200129220$CHEPLAPHARM$$$$$F$Y$$$20240730$$MD$COUNTRY NOT SPECIFIED$ES
241545981$24154598$1$I$$20240723$20240731$20240731$EXP$NO-NOMAADVRE-PASRAPP-2024-Vp37ne$NO-CHEPLA-2024009502$CHEPLAPHARM$$38$YR$$F$Y$$$20240730$$CN$COUNTRY NOT SPECIFIED$NO
241545991$24154599$1$I$20220823$20240723$20240731$20240731$EXP$$JP-CHEPLA-2024009384$CHEPLAPHARM$$66$YR$$F$Y$56.099$KG$20240730$$MD$COUNTRY NOT SPECIFIED$JP
241546001$24154600$1$I$$20240723$20240731$20240731$EXP$$JP-CHEPLA-2024009523$CHEPLAPHARM$Harada Y, Makino M, Nakao R, Shimura Y, Ogata T, Hayakawa M et al. An Autopsy Case of Severe COVID-19 Pneumonia Complicated by Intrapulmonary Thrombosis in Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis. Cureus. 2024;16(6):e62790. doi: 10.7759/cureus.62790.$$$E$M$Y$$$20240730$$HP$COUNTRY NOT SPECIFIED$JP
241546011$24154601$1$I$$20240726$20240731$20240731$30DAY$$US-SANDOZ INC.-SDZ2024US069284$SANDOZ$$55$YR$$F$Y$$$20240731$$CN$US$US
241546023$24154602$3$F$20240508$20240827$20240731$20240903$EXP$$JP-GENMAB-2024-02668$GENMAB$$7$DEC$$M$Y$$$20240903$$MD$JP$JP
241546031$24154603$1$I$$20240729$20240731$20240731$EXP$$US-AstraZeneca-2024A172218$ASTRAZENECA$$$$$M$Y$$$20240731$$HP$US$
241546041$24154604$1$I$20240720$20240722$20240731$20240731$PER$$US-ABBVIE-5851390$ABBVIE$$13$YR$$F$Y$$$20240731$$CN$US$US
241546051$24154605$1$I$20240720$20240729$20240731$20240731$EXP$FR-AFSSAPS-LL2024001493$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-120644$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$81$KG$20240731$$PH$FR$FR
241546081$24154608$1$I$$20240722$20240731$20240731$PER$$US-ROCHE-10000033680$ROCHE$$$$$M$Y$$$20240731$$CN$US$US
241546092$24154609$2$F$20240723$20240812$20240731$20240814$PER$$US-AMGEN-USASP2024147713$AMGEN$$43$YR$A$F$Y$$$20240813$$CN$US$US
241546102$24154610$2$F$$20240715$20240731$20240816$EXP$$US-AUROBINDO-AUR-APL-2024-035967$AUROBINDO$Ogundare T, Ologun OA.. Feeling blue to seeing red: A case of escitalopram-induced epistaxis. Clin-Case-Rep. Clinical case reports. 2024;12(7):e9128$33$YR$$F$Y$$$20240816$$MD$US$US
241546111$24154611$1$I$20240709$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003443$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240731$$CN$US$US
241546124$24154612$4$F$20240101$20240827$20240731$20240905$EXP$$KR-UNITED THERAPEUTICS-UNT-2024-023064$UNITED THERAPEUTICS$$$$$M$Y$56.009$KG$20240905$$$KR$KR
241546132$24154613$2$F$$20240827$20240731$20240828$EXP$GB-MHRA-DEFECT-202407021824451430-QFCZK$GB-ORGANON-O2407GBR002719$ORGANON$$$$$F$Y$$$20240828$$HP$GB$GB
241546141$24154614$1$I$$20240722$20240731$20240731$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009409$STRIDES$Zubair N, Isaac S, Westerman J.. Drug-induced Euglycemic Diabetic Ketoacidosis in a Patient with Systemic Sarcoidosis. South-Med-J. 2022;116:93$$$$$Y$$$20240731$$MD$US$US
241546162$24154616$2$F$20230801$20240910$20240731$20240917$EXP$$CO-AMGEN-COLSL2024007019$AMGEN$$75$YR$E$M$Y$$$20240916$$CN$CO$CO
241546171$24154617$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019077$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240731$$CN$US$US
241546181$24154618$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018652$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240731$$CN$US$US
241546191$24154619$1$I$$20240723$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407016158$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240731$$CN$US$US
241546201$24154620$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019117$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240731$$CN$US$US
241546212$24154621$2$F$$20240805$20240731$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202407018754$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240811$$CN$US$US
241546221$24154622$1$I$20240725$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018863$ELI LILLY AND CO$$23$YR$A$M$Y$$$20240731$$CN$US$US
241546231$24154623$1$I$20240701$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018654$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240731$$CN$US$US
241546241$24154624$1$I$20240628$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018910$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240731$$CN$US$US
241546251$24154625$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019039$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240731$$CN$US$US
241546262$24154626$2$F$20240728$20240730$20240731$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202407018761$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240813$$CN$US$US
241546271$24154627$1$I$$20240719$20240731$20240731$PER$$US-SA-2024SA153979$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240731$$MD$US$US
241546281$24154628$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA220767$SANOFI AVENTIS$$$$$$Y$$$20240731$$HP$US$US
241546291$24154629$1$I$20230101$20240719$20240731$20240731$PER$$US-SA-2024SA216828$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240731$$MD$US$US
241546301$24154630$1$I$$20240723$20240731$20240731$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009365$STRIDES$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al.. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$$$$$Y$$$20240731$$HP$US$US
241546311$24154631$1$I$20210901$20240718$20240731$20240731$EXP$$DE-ROCHE-3006067$ROCHE$$54$YR$A$F$Y$68$KG$20240731$$MD$DE$DE
241546323$24154632$3$F$20240716$20240924$20240731$20240930$PER$$US-BIOVITRUM-2024-US-010365$BIOVITRUM$$77$YR$$F$Y$$$20240930$$CN$US$US
241546331$24154633$1$I$20240601$20240722$20240731$20240731$PER$$US-SA-2024SA221079$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240731$$MD$US$US
241546341$24154634$1$I$$20240725$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119927$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240731$$CN$US$US
241546351$24154635$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221630$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240731$$MD$US$US
241546361$24154636$1$I$$20240726$20240731$20240731$PER$$US-ROCHE-10000040582$ROCHE$$$$$$Y$$$20240731$$CN$US$US
241546371$24154637$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000042177$ROCHE$$52$YR$A$F$Y$$$20240731$$HP$US$US
241546381$24154638$1$I$20240601$20240723$20240731$20240731$EXP$$US-GSK-US2024092358$GLAXOSMITHKLINE$$38$YR$$M$Y$$$20240731$$HP$US$US
241546391$24154639$1$I$$20240730$20240731$20240731$EXP$$NVSC2024US155677$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
241546401$24154640$1$I$$20240729$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069102$SANDOZ$$81$YR$$F$Y$$$20240731$$CN$US$US
241546414$24154641$4$F$20240701$20240814$20240731$20240904$EXP$$PY-UNITED THERAPEUTICS-UNT-2024-023179$UNITED THERAPEUTICS$$51$YR$$F$Y$95$KG$20240904$$$PY$PY
241546421$24154642$1$I$$20240726$20240731$20240731$EXP$$US-ROCHE-10000041876$ROCHE$$71$YR$E$M$Y$$$20240731$$MD$US$US
241546431$24154643$1$I$$20240726$20240731$20240731$EXP$$US-ROCHE-10000040013$ROCHE$$56$YR$A$F$Y$$$20240731$$CN$US$US
241546442$24154644$2$F$20240722$20240723$20240731$20240731$EXP$$US-ROCHE-10000034461$ROCHE$$51$YR$A$F$Y$128.36$KG$20240731$$CN$US$US
241546451$24154645$1$I$$20240722$20240731$20240731$EXP$$CZ-UCBSA-2024036517$UCB$Krysl D, Krijtova H, Marusia P. Non-convulsive status epilepticus. Neurology for Practice. 2024;25(3):182-91$66$YR$$F$Y$$$20240731$$MD$CZ$CZ
241546461$24154646$1$I$20240601$20240723$20240731$20240731$PER$$US-SA-2024SA220403$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240731$$CN$US$US
241546472$24154647$2$F$$20240729$20240731$20240731$EXP$$IE-ROCHE-10000041163$ROCHE$$$$$M$Y$$$20240731$$CN$IE$IE
241546482$24154648$2$F$$20240819$20240731$20240828$30DAY$$US-GSK-US2024091842$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$CN$US$US
241546491$24154649$1$I$20240516$20240526$20240731$20240731$PER$$US-CSL-2024-004877$CSL Plasma$$28$YR$$F$Y$$$20240731$$HP$US$US
241546503$24154650$3$F$20240727$20240808$20240731$20240810$PER$$US-AMGEN-USASP2024150762$AMGEN$$68$YR$E$F$Y$$$20240810$$CN$US$US
241546513$24154651$3$F$$20240725$20240731$20240809$PER$$NVSC2024US153944$NOVARTIS$$$$$$Y$$$20240809$$CN$US$US
241546522$24154652$2$F$$20240808$20240731$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003444$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
241546532$24154653$2$F$20240723$20240724$20240731$20240731$EXP$$US-AMGEN-USASP2024147794$AMGEN$$$$$F$Y$$$20240731$$HP$US$US
241546541$24154654$1$I$$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003421$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241546551$24154655$1$I$20240405$20240722$20240731$20240731$PER$$US-JNJFOC-20240764205$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240731$$CN$US$US
241546561$24154656$1$I$$20240713$20240731$20240731$PER$$US-JNJFOC-20240737944$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241546575$24154657$5$F$$20240821$20240731$20240823$EXP$$CA-ROCHE-10000041260$ROCHE$$$$A$F$Y$$$20240823$$HP$CA$CA
241546581$24154658$1$I$20240716$20240726$20240731$20240731$EXP$$US-JNJFOC-20240744045$JOHNSON AND JOHNSON$$59$YR$A$F$Y$83.2$KG$20240731$$HP$US$US
241546601$24154660$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000042210$ROCHE$$82$YR$E$M$Y$$$20240731$$MD$US$US
241546611$24154661$1$I$20240101$20240729$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042868$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240731$$CN$US$US
241546621$24154662$1$I$$20240710$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003423$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241546631$24154663$1$I$$20240710$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003424$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241546642$24154664$2$F$20240101$20240820$20240731$20240906$PER$$US-SA-2024SA222556$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240906$$MD$US$US
241546651$24154665$1$I$$20240724$20240731$20240731$EXP$$GB-SA-2024SA218244$SANOFI AVENTIS$Sohail A, Hare J, Ibrahim A.. Cavitating pulmonary lesion secondary to mycobacterium szulgai infection-ase report of a rare pathogenic organism. Oxford Medical Case Reports. 2024;7:291-4$74$YR$E$M$Y$$$20240731$$HP$GB$GB
241546661$24154666$1$I$20240701$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150294$AMGEN$$19$YR$A$F$Y$$$20240730$$CN$US$US
241546671$24154667$1$I$20240101$20240722$20240731$20240731$EXP$$RU-SA-2024SA217812$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240731$$CN$RU$RU
241546683$24154668$3$F$$20240809$20240731$20240813$30DAY$$US-AMGEN-USASP2024147676$AMGEN$$$$$$Y$$$20240813$$HP$US$US
241546691$24154669$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120621$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240731$$HP$US$US
241546703$24154670$3$F$$20240801$20240731$20240815$EXP$$US-ROCHE-10000032344$ROCHE$$74$YR$E$F$Y$$$20240815$$CN$US$US
241546711$24154671$1$I$$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003426$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241546721$24154672$1$I$20240719$20240730$20240731$20240731$EXP$GB-MHRA-MED-202407301008578330-RQFNS$GB-BIOVITRUM-2024-GB-010386$BIOVITRUM$$70$YR$$M$Y$$$20240731$$PH$GB$GB
241546731$24154673$1$I$20240606$20240723$20240731$20240731$EXP$$CN-ROCHE-10000034546$ROCHE$$3$YR$C$F$Y$15.5$KG$20240731$$HP$CN$CN
241546743$24154674$3$F$$20240819$20240731$20240924$EXP$$ES-BIOVITRUM-2024-ES-010340$BIOVITRUM$$$$$$Y$$$20240924$$CN$ES$ES
241546753$24154675$3$F$20220309$20240919$20240731$20240928$EXP$$CA-CELLTRION INC.-2022CA005660$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
241546761$24154676$1$I$$20240719$20240731$20240731$EXP$$US-TWI PHARMACEUTICAL, INC-20240700051$TWI PHARMACEUTICALS$Sorabella RA, Gray WH, Dabal RJ, Padilla LA, Hock K, Clark MG et al.. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO J... 2024;70(7):E92-96$17$YR$$M$Y$85$KG$20240729$$MD$US$US
241546771$24154677$1$I$$20240710$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003394$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$MD$US$US
241546781$24154678$1$I$$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003429$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241546791$24154679$1$I$$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003445$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241546801$24154680$1$I$$20240721$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-108104$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240731$$CN$US$US
241546811$24154681$1$I$$20240718$20240731$20240731$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07052$LUPIN$Vincent J, Greenberg J, Sanghani S, Finneran K, Nguyen N et.al. Profound lactic acidosis and shock in a patient taking Metformin. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5702$52$YR$$F$Y$$$20240731$$HP$US$US
241546821$24154682$1$I$20240703$20240729$20240731$20240731$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-116995$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240731$$MD$IT$IT
241546832$24154683$2$F$20220103$20240717$20240731$20240801$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460110$RANBAXY$$71$YR$$F$Y$51.5$KG$20240801$$MD$IT$IT
241546841$24154684$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000042159$ROCHE$$48$YR$A$M$Y$$$20240731$$MD$US$US
241546851$24154685$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221107$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240731$$MD$US$US
241546863$24154686$3$F$20231029$20240816$20240731$20240829$EXP$$FR-CIPLA LTD.-2024FR07869$CIPLA$$$$$$Y$$$20240829$$MD$FR$FR
241546871$24154687$1$I$$20240717$20240731$20240731$EXP$$OM-ROCHE-10000037136$ROCHE$$62$YR$A$M$Y$$$20240731$$CN$OM$OM
241546881$24154688$1$I$20240714$20240717$20240731$20240731$EXP$$IT-CIPLA LTD.-2024IT07875$CIPLA$$$$$$Y$$$20240731$$MD$IT$IT
241546891$24154689$1$I$$20240725$20240731$20240731$EXP$$US-GSK-US2024AMR094504$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$US$US
241546901$24154690$1$I$20240709$20240710$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003432$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240731$$CN$US$US
241546912$24154691$2$F$$20240822$20240731$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-023199$UNITED THERAPEUTICS$$$$$F$Y$50.794$KG$20240831$$$US$US
241546921$24154692$1$I$$20240723$20240731$20240731$EXP$$AU-CELLTRION INC.-2024AU018020$CELLTRION$$$$$$Y$$$20240731$$HP$AU$AU
241546931$24154693$1$I$$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003437$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241546941$24154694$1$I$$20240726$20240731$20240731$PER$$US-ROCHE-10000040625$ROCHE$$58$YR$A$F$Y$$$20240731$$CN$US$US
241546952$24154695$2$F$20240801$20240910$20240731$20240917$PER$$US-BIOGEN-2024BI01275358$BIOGEN$$58$YR$$F$Y$$$20240917$$CN$US$US
241546962$24154696$2$F$20240619$20240723$20240731$20240731$EXP$$US-JNJFOC-20240768286$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$HP$US$US
241546972$24154697$2$F$$20240720$20240731$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459428$RANBAXY$Anderson M, Brozzi N, Rosenthal R, Hernandez-Montfort J, Reddy R, Gopalan R. Panel Discussion: Non-cardiac Surgery Interventions on Patients Receiving Impella Support. Interven Cardiol (London). 2024;19 (Suppl):31-34$66$YR$$F$Y$$$20240802$$MD$US$US
241546981$24154698$1$I$20240717$20240717$20240731$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458957$RANBAXY$$86$YR$E$M$Y$$$20240731$$CN$US$US
241546991$24154699$1$I$$20240627$20240731$20240731$EXP$GB-MHRA-31008345$GB-DEXPHARM-2024-2442$DEXCEL$$62$YR$A$F$Y$62$KG$20240731$$CN$GB$GB
241547001$24154700$1$I$$20240730$20240731$20240731$PER$$US-HALEON-2189726$Haleon PLC$$$$$F$Y$$$20240731$$CN$US$US
241547011$24154701$1$I$20240614$20240729$20240731$20240731$EXP$FR-AFSSAPS-BR2024000593$NVSC2024FR154740$NOVARTIS$$68$YR$$M$Y$$$20240731$$MD$FR$FR
241547021$24154702$1$I$20240701$20240730$20240731$20240731$PER$$US-AMGEN-USASP2024151325$AMGEN$$$$$F$Y$$$20240730$$CN$US$US
241547032$24154703$2$F$$20240820$20240731$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003441$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
241547041$24154704$1$I$$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003439$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241547051$24154705$1$I$$20240726$20240731$20240731$EXP$$US-JNJFOC-20240775780$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240731$$HP$US$US
241547061$24154706$1$I$$20240730$20240731$20240731$EXP$$GB-JNJFOC-20240780911$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240731$$PH$GB$GB
241547072$24154707$2$F$20240717$20240725$20240731$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459165$RANBAXY$$15$YR$T$M$Y$$$20240809$$MD$US$US
241547081$24154708$1$I$$20240717$20240731$20240731$PER$$US-ABBVIE-5853615$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241547094$24154709$4$F$20240717$20240909$20240731$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003534$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240927$$CN$US$US
241547102$24154710$2$F$$20240820$20240731$20240827$PER$$US-RDY-SPO/USA/24/0010869$DR REDDYS$$$$$M$Y$$$20240827$$CN$US$US
241547111$24154711$1$I$$20240708$20240731$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06977$LUPIN$$$$$$Y$$$20240731$$HP$US$US
241547122$24154712$2$F$20240620$20240822$20240731$20240903$EXP$$JP-AMGEN-JPNSP2024138883$AMGEN$$5$DEC$A$F$Y$$$20240902$$MD$JP$JP
241547131$24154713$1$I$$20240711$20240731$20240731$PER$$US-APOTEX-2024AP008303$APOTEX$$$$$F$Y$$$20240731$$CN$US$US
241547141$24154714$1$I$20240701$20240729$20240731$20240731$EXP$DK-DKMA-30736286$DK-BRISTOL-MYERS SQUIBB COMPANY-2024-120678$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240731$$MD$DK$DK
241547151$24154715$1$I$$20240729$20240731$20240731$EXP$$IT-SNT-000403$SINOTHERAPEUTICS$(Citation: Dicorato M.M., Caretto P., Colucci C., Ciaccia M., Rella M., Muscogiuri E. et.al., Cardiac magnetic resonance in a rare case of recurrent mesalazine-induced myocarditis. Future Cardiol. 2024; 20(4):183-9. Doi:10.1080/14796678.2024.2373558)$25$YR$A$M$Y$$$20240731$$HP$IT$IT
241547161$24154716$1$I$$20240720$20240731$20240731$EXP$$IT-AUROBINDO-AUR-APL-2024-037130$AUROBINDO$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$83$YR$$M$Y$$$20240731$$MD$IT$IT
241547171$24154717$1$I$$20240723$20240731$20240731$PER$$US-BIOGEN-2024BI01275157$BIOGEN$$$$$M$Y$$$20240731$$CN$US$US
241547181$24154718$1$I$$20240723$20240731$20240731$PER$$US-BIOGEN-2024BI01275016$BIOGEN$$$$$M$Y$$$20240731$$CN$US$US
241547191$24154719$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018989$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240731$$CN$US$US
241547201$24154720$1$I$$20240724$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407016697$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240731$$CN$US$US
241547211$24154721$1$I$20240729$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019134$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240731$$CN$US$US
241547222$24154722$2$F$$20240729$20240731$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407018792$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240808$$CN$US$US
241547231$24154723$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019406$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240731$$CN$US$US
241547241$24154724$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019007$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240731$$CN$US$US
241547252$24154725$2$F$20240729$20240801$20240731$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407018900$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240802$$CN$US$US
241547262$24154726$2$F$$20240830$20240731$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202407018495$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240905$$CN$US$US
241547271$24154727$1$I$20240501$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019141$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240731$$CN$US$US
241547281$24154728$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018987$ELI LILLY AND CO$$$$$M$Y$$$20240731$$CN$US$US
241547291$24154729$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA219827$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240731$$CN$US$US
241547301$24154730$1$I$$20240719$20240731$20240731$PER$$US-SA-2024SA158111$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240731$$MD$US$US
241547311$24154731$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA220895$SANOFI AVENTIS$$63$YR$A$F$Y$68.04$KG$20240731$$MD$US$US
241547321$24154732$1$I$20240101$20240723$20240731$20240731$PER$$US-SA-2024SA221471$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240731$$MD$US$US
241547331$24154733$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA219724$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240731$$MD$US$US
241547341$24154734$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221681$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240731$$MD$US$US
241547351$24154735$1$I$20240701$20240724$20240731$20240731$PER$$US-SA-2024SA221175$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240731$$MD$US$US
241547361$24154736$1$I$$20240725$20240731$20240731$EXP$$US-JNJFOC-20240772863$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240731$$CN$US$US
241547371$24154737$1$I$$20240710$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003447$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241547381$24154738$1$I$20110101$20240720$20240731$20240731$EXP$$BG-AUROBINDO-AUR-APL-2024-036893$AUROBINDO$Nikolova M, Grashnov E. ripiprazole in the therapy of patients diagnosed with schizophrenia and bipolar affective disorder. Medic Plus. 2024;2:56-58$50$YR$$F$Y$$$20240731$$HP$BG$BG
241547392$24154739$2$F$$20240812$20240731$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003335$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
241547401$24154740$1$I$20240710$20240710$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003450$ACADIA PHARMACEUTICALS$$86$YR$$F$Y$$$20240731$$CN$US$US
241547411$24154741$1$I$20240722$20240722$20240731$20240731$30DAY$$US-GSK-US2024091870$GLAXOSMITHKLINE$$26$YR$$F$Y$$$20240731$$CN$US$US
241547442$24154744$2$F$20231201$20240715$20240731$20240821$EXP$$CA-CELLTRION INC.-2023CA025227$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
241547451$24154745$1$I$20200422$20240722$20240731$20240731$EXP$PL-URPL-1-3287-2020$PL-BIOCON BIOLOGICS LIMITED-BBL2020000016$BIOCON$$$$$$Y$$$20240731$$MD$PL$PL
241547461$24154746$1$I$$20240729$20240731$20240731$PER$$US-ABBVIE-5860450$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241547471$24154747$1$I$20240720$20240730$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120765$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240731$$CN$US$US
241547481$24154748$1$I$20240718$20240724$20240731$20240731$EXP$$BR-CELLTRION INC.-2024BR018176$CELLTRION$$$$$$Y$$$20240731$$CN$BR$BR
241547492$24154749$2$F$20240725$20240801$20240731$20240806$EXP$$US-JNJFOC-20240775813$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240806$$HP$US$US
241547502$24154750$2$F$20240701$20240823$20240731$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003452$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240916$$CN$US$US
241547512$24154751$2$F$$20240730$20240731$20240731$PER$$US-ROCHE-10000041879$ROCHE$$60$YR$A$F$Y$$$20240731$$CN$US$US
241547521$24154752$1$I$$20240725$20240731$20240731$EXP$$IE-ROCHE-10000037273$ROCHE$$$$$M$Y$$$20240731$$HP$IE$IE
241547531$24154753$1$I$20240701$20240717$20240731$20240731$EXP$$CN-OCTA-ALB11524$OCTAPHARMA$$$$A$F$Y$51$KG$20240730$$HP$CN$CN
241547541$24154754$1$I$$20240722$20240731$20240731$30DAY$$US-GSK-US2024091829$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$CN$US$US
241547551$24154755$1$I$20240627$20240717$20240731$20240731$EXP$$US-OCTA-GAM21624$OCTAPHARMA$$$$A$F$Y$81$KG$20240730$$HP$US$US
241547561$24154756$1$I$$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003342$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241547571$24154757$1$I$20240701$20240717$20240731$20240731$PER$$US-TEVA-VS-3222561$TEVA$$19$YR$$F$Y$$$20240731$$CN$US$US
241547583$24154758$3$F$$20240907$20240731$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003343$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241547591$24154759$1$I$$20240710$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003453$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241547601$24154760$1$I$$20240627$20240731$20240731$PER$$US-CHATTEMPRD-2024OHG022517$CHATTEM$$$$$F$Y$$$20240731$$CN$US$US
241547611$24154761$1$I$20240101$20240729$20240731$20240731$EXP$$US-ABBVIE-5860161$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241547621$24154762$1$I$$20240723$20240731$20240731$EXP$$AU-CELLTRION INC.-2024AU018049$CELLTRION$$$$$$Y$$$20240731$$HP$AU$AU
241547641$24154764$1$I$$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024149630$AMGEN$Wang P.; Dimitrion P.; Young A. et al.. CyTOF immune profiling uncovers sex- and race-specific differences and cellular biomarkers for biologic response in Hidradenitis suppurativa. Journal of Investigative Dermatology. 2024;144 (8):S161$$$$$Y$$$20240731$$HP$US$US
241547652$24154765$2$F$$20240810$20240731$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003349$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
241547661$24154766$1$I$20240408$20240730$20240731$20240731$EXP$FR-AFSSAPS-NT2024000948$FR-JNJFOC-20240780652$JOHNSON AND JOHNSON$$56$YR$A$F$Y$94$KG$20240731$$MD$FR$FR
241547671$24154767$1$I$$20240729$20240731$20240731$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011444$JAZZ$$$$$F$Y$$$20240731$$CN$US$US
241547681$24154768$1$I$20240630$20240726$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119444$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240731$$CN$US$US
241547691$24154769$1$I$$20240710$20240731$20240731$PER$$US-ROCHE-10000025337$ROCHE$$43$YR$A$F$Y$$$20240731$$MD$US$US
241547702$24154770$2$F$20240703$20240909$20240731$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003354$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240919$$CN$US$US
241547711$24154771$1$I$$20240729$20240731$20240731$PER$$NVSC2024US155855$NOVARTIS$$$$$F$Y$$$20240731$$CN$US$US
241547721$24154772$1$I$$20240722$20240731$20240731$EXP$$JP-EMD Serono-2024037391$EMD SERONO INC$$9$DEC$E$F$Y$$$20240731$$PH$JP$JP
241547733$24154773$3$F$$20240916$20240731$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003356$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241547741$24154774$1$I$20240713$20240713$20240731$20240731$PER$$US-CSL-2024-006609$CSL Plasma$$45$YR$$F$Y$$$20240731$$HP$US$US
241547751$24154775$1$I$20240726$20240730$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120726$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240731$$CN$US$US
241547771$24154777$1$I$20240621$20240716$20240731$20240731$PER$$US-JNJFOC-20240748105$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240731$$CN$US$US
241547781$24154778$1$I$$20240723$20240731$20240731$EXP$$US-JNJFOC-20240762601$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240731$$HP$US$US
241547791$24154779$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018760$ELI LILLY AND CO$$17$YR$T$F$Y$$$20240731$$CN$US$US
241547801$24154780$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018658$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$US$US
241547811$24154781$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019124$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240731$$CN$US$US
241547821$24154782$1$I$20240727$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018842$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240731$$CN$US$US
241547831$24154783$1$I$$20240719$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407013737$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240731$$CN$US$US
241547841$24154784$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018474$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240731$$CN$US$US
241547851$24154785$1$I$$20240727$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018718$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240731$$CN$US$US
241547861$24154786$1$I$20240728$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018840$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240731$$CN$US$US
241547871$24154787$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019058$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$US$US
241547881$24154788$1$I$20240701$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018847$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240731$$CN$US$US
241547891$24154789$1$I$20240722$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018660$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$US$US
241547902$24154790$2$F$$20240731$20240731$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003357$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
241547921$24154792$1$I$$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149411$AMGEN$$$$$F$Y$$$20240731$$HP$US$US
241547932$24154793$2$F$20240703$20240815$20240731$20240821$30DAY$$US-AMGEN-USASP2024146780$AMGEN$$65$YR$E$F$Y$77.098$KG$20240821$$HP$US$US
241547941$24154794$1$I$20240201$20240710$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003454$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240731$$CN$US$US
241547951$24154795$1$I$20240222$20240722$20240731$20240731$EXP$$AR-ROCHE-10000034091$ROCHE$$50$YR$A$M$Y$$$20240731$$MD$AR$AR
241547961$24154796$1$I$20240101$20240710$20240731$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000612$DECIPHERA PHARMACEUTICALS$$71$YR$E$M$Y$$$20240731$$CN$US$US
241547991$24154799$1$I$$20240716$20240731$20240731$EXP$$IN-RISINGPHARMA-IN-2024RISLIT00256$RISING PHARMACEUTICALS$Avadhesh Oli.Unusual clinical features and histopathological findings in a case of Pseudo-endophthalmitis in neovascular glaucoma.Romanian Journal of Ophthalmology.19-MAY-2024;68:1-5$56$YR$A$M$Y$$$20240731$$HP$IN$IN
241548011$24154801$1$I$$20240730$20240731$20240731$PER$$US-HALEON-2189729$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241548022$24154802$2$F$20240707$20240906$20240731$20240914$EXP$$JP-ROCHE-10000035609$ROCHE$$56$YR$A$M$Y$$$20240914$$MD$JP$JP
241548031$24154803$1$I$$20240711$20240731$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000614$DECIPHERA PHARMACEUTICALS$$73$YR$E$M$Y$$$20240731$$CN$US$US
241548041$24154804$1$I$20230925$20240726$20240731$20240731$EXP$GB-MHRA-MED-202407261253026970-GRYWK$GB-ABBVIE-5859719$ABBVIE$$69$YR$$F$Y$$$20240731$$PH$GB$GB
241548052$24154805$2$F$$20240724$20240731$20240812$PER$$US-AMGEN-USASP2024147359$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241548061$24154806$1$I$$20240722$20240731$20240731$PER$$US-ABBVIE-5851650$ABBVIE$$$$$$Y$$$20240731$$MD$US$US
241548071$24154807$1$I$$20240723$20240731$20240731$EXP$$GB-NOVITIUMPHARMA-2024GBNVP01420$NOVITIUM PHARMA$Alison M. Cook.One mechanism of sudden sensorineural hearing loss after sildenafil and sexual activity.International Journal of Audiology.01-JUL-2024;NA:1-4$$$A$M$Y$$$20240731$$HP$GB$GB
241548081$24154808$1$I$$20240722$20240731$20240731$PER$$US-ABBVIE-5854353$ABBVIE$$$$$$Y$$$20240731$$HP$US$US
241548091$24154809$1$I$$20240723$20240731$20240731$EXP$$IN-ROCHE-10000038261$ROCHE$$$$$M$Y$$$20240731$$CN$IN$IN
241548101$24154810$1$I$$20210426$20240731$20240731$EXP$$CA-AstraZeneca-2021A366969$ASTRAZENECA$$$$$F$Y$$$20240731$$MD$CA$
241548111$24154811$1$I$$20230216$20240731$20240731$EXP$$US-AstraZeneca-2023A041150$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241548121$24154812$1$I$20240603$20240725$20240731$20240731$EXP$$US-JNJFOC-20240770036$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241548131$24154813$1$I$$20240725$20240731$20240731$EXP$$CA-JNJFOC-20240774972$JOHNSON AND JOHNSON$$4$DY$N$F$Y$$$20240731$$HP$CA$CA
241548141$24154814$1$I$$20240724$20240731$20240731$PER$$US-BIOGEN-2024BI01275593$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
241548151$24154815$1$I$20240708$20240717$20240731$20240731$EXP$$FR-CIPLA LTD.-2024FR07870$CIPLA$$$$$$Y$$$20240731$$MD$FR$FR
241548172$24154817$2$F$20240101$20240814$20240731$20240819$PER$$US-AMGEN-USASP2024151069$AMGEN$$60$YR$A$F$Y$$$20240819$$CN$US$US
241548181$24154818$1$I$20240101$20240723$20240731$20240731$EXP$$JP-ROCHE-10000037734$ROCHE$$78$YR$E$M$Y$$$20240731$$MD$JP$JP
241548192$24154819$2$F$$20240819$20240731$20240829$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07470$LUPIN$$$$$$Y$$$20240829$$PH$US$US
241548201$24154820$1$I$20221101$20240717$20240731$20240731$EXP$$US-CIPLA LTD.-2024US07924$CIPLA$Krause PJ, Rogers R, Shah MK, Kang H, Parsonnet J, Kodama R, et al.. Tafenoquine for Relapsing Babesiosis: A Case Series.. Clinical infectious diseases. 2024$$$$$Y$$$20240731$$MD$US$US
241548221$24154822$1$I$20240723$20240723$20240731$20240731$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024092366$VIIV$$33$YR$$M$Y$$$20240731$$HP$US$US
241548232$24154823$2$F$$20240722$20240731$20240802$PER$$NVSC2024US153473$NOVARTIS$$$$E$F$Y$$$20240802$$MD$US$US
241548241$24154824$1$I$$20240725$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118683$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240731$$HP$US$US
241548251$24154825$1$I$$20240726$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120332$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240731$$CN$US$US
241548261$24154826$1$I$$20240722$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116948$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240731$$HP$US$US
241548271$24154827$1$I$$20240729$20240731$20240731$EXP$$CA-UCBSA-2024038264$UCB$$72$YR$$F$Y$$$20240731$$MD$CA$CA
241548291$24154829$1$I$$20240725$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407016974$ELI LILLY AND CO$$$$$M$Y$$$20240731$$CN$US$US
241548302$24154830$2$F$20240727$20240729$20240731$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407018904$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241548311$24154831$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018899$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240731$$CN$US$US
241548321$24154832$1$I$20240727$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018645$ELI LILLY AND CO$$59$YR$A$$Y$$$20240731$$CN$US$US
241548331$24154833$1$I$20240729$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018473$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240731$$CN$US$US
241548341$24154834$1$I$20240726$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150920$AMGEN$$61$YR$A$M$Y$$$20240731$$CN$US$US
241548353$24154835$3$F$20240722$20240809$20240731$20240816$30DAY$$US-AMGEN-USASP2024147961$AMGEN$$58$YR$A$F$Y$52.4$KG$20240816$$PH$US$US
241548361$24154836$1$I$$20240725$20240731$20240731$EXP$$US-AMGEN-USASP2024149836$AMGEN$$$$A$F$Y$$$20240731$$HP$US$US
241548371$24154837$1$I$$20240709$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003409$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241548381$24154838$1$I$20240701$20240722$20240731$20240731$EXP$$CA-009507513-2407CAN015031$MERCK$$$$$F$Y$$$20240731$$MD$CA$CA
241548391$24154839$1$I$$20240723$20240731$20240731$EXP$$JP-ROCHE-10000037739$ROCHE$$7$DEC$E$$Y$$$20240731$$MD$JP$JP
241548401$24154840$1$I$20230108$20240725$20240731$20240731$EXP$CH-SM-2024-13947$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-118917$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$48$KG$20240731$$MD$CH$CH
241548413$24154841$3$F$$20240911$20240731$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003359$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241548421$24154842$1$I$20240601$20240726$20240731$20240731$EXP$$BR-JNJFOC-20240777232$JOHNSON AND JOHNSON$$70$YR$E$F$Y$83$KG$20240731$$PH$BR$BR
241548432$24154843$2$F$$20240801$20240731$20240808$EXP$$BR-CELLTRION INC.-2023BR001059$CELLTRION$$$$$$Y$$$20240808$$CN$BR$BR
241548441$24154844$1$I$$20240725$20240731$20240731$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2024093431$VIIV$$$$$$Y$$$20240731$$PH$JP$JP
241548451$24154845$1$I$$20240725$20240731$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-023098$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240731$$$US$US
241548461$24154846$1$I$$20240723$20240731$20240731$EXP$$US-NOVITIUMPHARMA-2024USNVP01421$NOVITIUM PHARMA$Kyle T. O Meara.Acute hypoxic respiratory failure due to Lenalidomide-induced interstitial pneumonitis in a patient with multiple myeloma.BMC Pulmonary Medicine.04-JUL-2024;24(1):321$80$YR$E$M$Y$$$20240731$$HP$US$US
241548471$24154847$1$I$20240101$20240723$20240731$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-022836$UNITED THERAPEUTICS$$$$$M$Y$82.993$KG$20240731$$$US$US
241548481$24154848$1$I$$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003410$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241548491$24154849$1$I$$20240724$20240731$20240731$PER$$US-JNJFOC-20240766309$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$MD$US$US
241548501$24154850$1$I$20240719$20240719$20240731$20240731$PER$$US-CSL-2024-006904$CSL Plasma$$29$YR$$M$Y$$$20240731$$HP$US$US
241548511$24154851$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA219708$SANOFI AVENTIS$$$$A$F$Y$90.7$KG$20240731$$MD$US$US
241548521$24154852$1$I$$20240725$20240731$20240731$PER$$US-SA-2024SA221137$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240731$$HP$US$US
241548531$24154853$1$I$20240101$20240723$20240731$20240731$PER$$US-SA-2024SA221192$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240731$$MD$US$US
241548541$24154854$1$I$20240701$20240723$20240731$20240731$PER$$US-SA-2024SA219854$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240731$$MD$US$US
241548551$24154855$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA218301$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240731$$MD$US$US
241548561$24154856$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA219732$SANOFI AVENTIS$$$$A$F$Y$$$20240731$$MD$US$US
241548571$24154857$1$I$$20240729$20240731$20240731$PER$$US-HALEON-2189783$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241548582$24154858$2$F$20240601$20240814$20240731$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003361$ACADIA PHARMACEUTICALS$$17$YR$$F$Y$$$20240906$$CN$US$US
241548592$24154859$2$F$$20240809$20240731$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003362$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
241548603$24154860$3$F$20240101$20240809$20240731$20240821$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000623$DECIPHERA PHARMACEUTICALS$$56$YR$A$M$Y$62.5$KG$20240821$$CN$US$US
241548611$24154861$1$I$20240701$20240724$20240731$20240731$EXP$$IL-ALXN-202407EEA001627IL$ALEXION PHARMACEUTICALS$$4$YR$$M$Y$$$20240731$$HP$IL$IL
241548623$24154862$3$F$$20240911$20240731$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003411$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241548632$24154863$2$F$20240601$20240913$20240731$20240927$EXP$$US-RECORDATI RARE DISEASES-2024005632$RECORDATI$$$$$$Y$$$20240927$$CN$US$US
241548644$24154864$4$F$20240301$20240904$20240731$20240912$EXP$$US-INTERCEPT-PM2024001468$INTERCEPT PHARMACEUTICALS$$72$YR$$F$Y$$$20240912$$CN$US$US
241548661$24154866$1$I$$20240709$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003414$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241548671$24154867$1$I$$20240709$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003363$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241548682$24154868$2$F$$20240925$20240731$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118956$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240926$$CN$US$US
241548691$24154869$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120695$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240731$$CN$US$US
241548701$24154870$1$I$$20211001$20240731$20240731$EXP$$US-AstraZeneca-2021A757342$ASTRAZENECA$$$$$$Y$81.6$KG$20240731$$CN$US$
241548711$24154871$1$I$$20240725$20240731$20240731$EXP$$US-ORG100016242-2024000494$PACIRA$Lorentz S, Levin JM, Warren E Jr, Hurley ET, Mills FB, Crook BS, Poehlein E, Green CL, Bullock WM, Gadsden JC, Klifto CS, Anakwenze O. Single Shot Interscalene Block with Liposomal Bupivacaine versus Non-Liposomal Bupivacaine in Shoulder Arthroplasty. J Shoulder Elbow Surg. 2024 Jul 19;S1058-2746(24)00499-3: doi:10.1016/j.jse.2024.05.046$$$$$Y$$$20240731$$MD$US$US
241548723$24154872$3$F$20240101$20240820$20240731$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022708$UNITED THERAPEUTICS$$$$$M$Y$56.689$KG$20240829$$$US$US
241548731$24154873$1$I$20240729$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018665$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240731$$CN$US$US
241548741$24154874$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019503$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240731$$CN$US$US
241548752$24154875$2$F$20240701$20240731$20240731$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202407018672$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240812$$CN$US$US
241548761$24154876$1$I$20240701$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017840$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240731$$CN$US$US
241548771$24154877$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018971$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240731$$CN$US$US
241548781$24154878$1$I$20230101$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018898$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240731$$CN$US$US
241548791$24154879$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018711$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240731$$CN$US$US
241548801$24154880$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018599$ELI LILLY AND CO$$$$E$F$Y$$$20240731$$HP$US$US
241548811$24154881$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018477$ELI LILLY AND CO$$$$$M$Y$$$20240731$$CN$US$US
241548821$24154882$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019146$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240731$$CN$US$US
241548831$24154883$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017683$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240731$$CN$US$US
241548842$24154884$2$F$$20240819$20240731$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003365$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
241548851$24154885$1$I$$20240724$20240731$20240731$PER$$US-AMGEN-USASP2024151077$AMGEN$$$$$$Y$$$20240731$$MD$US$US
241548863$24154886$3$F$$20240828$20240731$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003954$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
241548871$24154887$1$I$$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003395$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241548881$24154888$1$I$$20240703$20240731$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06953$LUPIN$$$$$$Y$$$20240731$$CN$US$US
241548891$24154889$1$I$$20240729$20240731$20240731$PER$$US-HALEON-2189658$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241548901$24154890$1$I$$20240726$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119792$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240731$$CN$US$US
241548912$24154891$2$F$$20240829$20240731$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003416$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
241548921$24154892$1$I$$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003458$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241548931$24154893$1$I$20200401$20240722$20240731$20240731$EXP$$PT-AMGEN-PRTSP2024147226$AMGEN$Baptista:M.. Applied immunotherapy to multiple myeloma. HEMATOLOGY. 32$46$YR$A$F$Y$$$20240731$$MD$PT$PT
241548941$24154894$1$I$$20240730$20240731$20240731$PER$$US-HALEON-2189739$Haleon PLC$$70$YR$$F$Y$$$20240731$$CN$US$US
241548951$24154895$1$I$$20240723$20240731$20240731$PER$$US-ALXN-A202301567$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240731$$CN$US$US
241548961$24154896$1$I$$20240715$20240731$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000639$DECIPHERA PHARMACEUTICALS$$76$YR$E$M$Y$$$20240731$$CN$US$US
241548972$24154897$2$F$20240702$20240806$20240731$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-022884$UNITED THERAPEUTICS$$62$YR$$F$Y$$$20240814$$$US$US
241548981$24154898$1$I$$20240729$20240731$20240731$PER$$NVSC2024US156001$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
241548991$24154899$1$I$$20240724$20240731$20240731$EXP$$BR-JNJFOC-20240769814$JOHNSON AND JOHNSON$$59$YR$A$F$Y$71$KG$20240731$$CN$BR$BR
241549001$24154900$1$I$$20240719$20240731$20240731$PER$$US-JNJFOC-20240756792$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240731$$CN$US$US
241549011$24154901$1$I$$20240729$20240731$20240731$EXP$$CA-UCBSA-2024038320$UCB$$$$$F$Y$$$20240731$$CN$CA$CA
241549021$24154902$1$I$$20240715$20240731$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000620$DECIPHERA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241549032$24154903$2$F$$20240911$20240731$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003684$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
241549041$24154904$1$I$$20240725$20240731$20240731$EXP$$JP-GSK-JP2024093412$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$JP$JP
241549051$24154905$1$I$20240726$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150903$AMGEN$$94$YR$E$F$Y$$$20240731$$CN$US$US
241549061$24154906$1$I$$20240718$20240731$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-120589$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240731$$HP$CA$CA
241549071$24154907$1$I$20240501$20240726$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120310$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$86.18$KG$20240731$$CN$US$US
241549081$24154908$1$I$20240709$20240719$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115947$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240731$$CN$US$US
241549092$24154909$2$F$20240101$20240815$20240731$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-022387$UNITED THERAPEUTICS$$$$$M$Y$104.31$KG$20240824$$$US$US
241549111$24154911$1$I$20240711$20240723$20240731$20240731$EXP$$CN-ROCHE-10000034613$ROCHE$$76$YR$E$F$Y$60$KG$20240731$$HP$CN$CN
241549121$24154912$1$I$$20240722$20240731$20240731$PER$$US-ABBVIE-5853811$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241549131$24154913$1$I$$20240729$20240731$20240731$PER$$US-HALEON-2189728$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241549142$24154914$2$F$$20240828$20240731$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003702$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
241549152$24154915$2$F$$20240910$20240731$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000648$DECIPHERA PHARMACEUTICALS$$69$YR$E$F$Y$$$20240927$$HP$US$US
241549161$24154916$1$I$$20240717$20240731$20240731$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090108$VIIV$$29$YR$$M$Y$$$20240731$$HP$US$US
241549171$24154917$1$I$$20240726$20240731$20240731$EXP$$BE-ABBVIE-5860723$ABBVIE$$72$YR$$F$Y$$$20240731$$HP$BE$BE
241549181$24154918$1$I$$20240723$20240731$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000646$DECIPHERA PHARMACEUTICALS$$55$YR$A$M$Y$63.4$KG$20240731$$CN$US$US
241549191$24154919$1$I$20210829$20210917$20240731$20240731$EXP$$US-AstraZeneca-2021A733328$ASTRAZENECA$$22533$DY$$F$Y$$$20240731$$CN$US$
241549204$24154920$4$F$20240701$20240913$20240731$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003276$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240930$$CN$US$US
241549212$24154921$2$F$$20240725$20240731$20240805$PER$$US-ROCHE-10000036727$ROCHE$Elimam A, Elimam A, Khalil K. Hereditary TTP in pregnant saudi lady with family history of TTP. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024-Apr;24:23-4. doi:10.1016/j.clinme.2024.100081.$26$YR$A$F$Y$$$20240805$$HP$US$US
241549222$24154922$2$F$$20240829$20240731$20240905$PER$$US-TAKEDA-2024TUS075603$TAKEDA$$$$A$F$Y$$$20240905$$PH$US$US
241549231$24154923$1$I$$20240716$20240731$20240731$EXP$$TR-IMP-2024000548$Harrow Health$Kasal K, Canli MK, Karahan E. The effect of topical antibiotic use on the incidence of endophthalmitis after intravitreal injection. JOURNAL OF RETINA-VITREOUS. 2023;32:46-51. doi:10.37845/ret.vit.2023.32.8$58$YR$A$M$Y$$$20240731$$MD$TR$TR
241549241$24154924$1$I$20240101$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150785$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241549251$24154925$1$I$20240701$20240725$20240731$20240731$EXP$$CO-JNJFOC-20240773438$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$65$KG$20240731$$HP$CO$CO
241549261$24154926$1$I$$20240719$20240731$20240731$PER$$US-JNJFOC-20240756799$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241549271$24154927$1$I$$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003289$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241549281$24154928$1$I$$20240702$20240731$20240731$PER$$US-JNJFOC-20240712978$JOHNSON AND JOHNSON$$$$$M$Y$$$20240731$$CN$US$US
241549291$24154929$1$I$$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003288$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241549302$24154930$2$F$20240701$20240729$20240731$20240803$EXP$$GB-JNJFOC-20240754773$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240803$$CN$GB$GB
241549311$24154931$1$I$20170101$20240729$20240731$20240731$EXP$$FR-BAUSCH-BL-2024-011626$BAUSCH AND LOMB$$58$YR$$F$Y$$$20240731$$MD$FR$FR
241549321$24154932$1$I$$20240724$20240731$20240731$PER$$US-ALXN-202407USA001666US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241549332$24154933$2$F$20240625$20240802$20240731$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003285$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240827$$CN$US$US
241549341$24154934$1$I$$20240730$20240731$20240731$PER$$NVSC2024US155986$NOVARTIS$$$$$F$Y$$$20240731$$MD$US$US
241549354$24154935$4$F$20231023$20240906$20240731$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003312$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240927$$CN$US$US
241549362$24154936$2$F$$20240812$20240731$20240902$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003311$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
241549371$24154937$1$I$$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003297$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241549381$24154938$1$I$$20240726$20240731$20240731$EXP$$US-AMGEN-USASP2024150711$AMGEN$$$$$$Y$$$20240731$$PH$US$US
241549391$24154939$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150877$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241549401$24154940$1$I$20240705$20240709$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003296$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240731$$CN$US$US
241549411$24154941$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120962$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240731$$CN$US$US
241549421$24154942$1$I$20240101$20240717$20240731$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000632$DECIPHERA PHARMACEUTICALS$$35$YR$A$M$Y$$$20240731$$MD$US$US
241549431$24154943$1$I$$20240717$20240731$20240731$EXP$GB-MHRA-MED-202407161710424160-TSGMF$GB-ROCHE-10000029563$ROCHE$$67$YR$E$F$Y$$$20240731$$HP$GB$GB
241549441$24154944$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018872$ELI LILLY AND CO$$43$YR$A$$Y$$$20240731$$CN$US$US
241549452$24154945$2$F$$20240816$20240731$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202407018857$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240822$$CN$US$US
241549461$24154946$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019043$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$US$US
241549471$24154947$1$I$20240727$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018891$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240731$$CN$US$US
241549481$24154948$1$I$19970101$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019618$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240731$$CN$US$US
241549491$24154949$1$I$20240601$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019295$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240731$$CN$US$US
241549502$24154950$2$F$$20240909$20240731$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003316$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241549512$24154951$2$F$$20240729$20240731$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019029$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240804$$CN$US$US
241549521$24154952$1$I$20240719$20240719$20240731$20240731$EXP$$HK-ROCHE-3419423$ROCHE$$67$YR$E$F$Y$$$20240731$$MD$HK$HK
241549531$24154953$1$I$$20240725$20240731$20240731$EXP$$BR-JNJFOC-20240773521$JOHNSON AND JOHNSON$$23$YR$A$F$Y$80$KG$20240731$$CN$BR$BR
241549543$24154954$3$F$$20240826$20240731$20240904$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009176$STRIDES$Xia J, Ahmed R. Rapidly progressive locked-in syndrome secondary to atypical herpes simplex virus-1 rhombencephalitis in an immunocompromised individual.. IDCases. 2024;37:e02027$$$$$Y$$$20240904$$MD$US$US
241549551$24154955$1$I$20240530$20240724$20240731$20240731$EXP$FR-AFSSAPS-PB2024000771$FR-ROCHE-10000035379$ROCHE$$61$YR$A$F$Y$$$20240731$$MD$FR$FR
241549561$24154956$1$I$20240718$20240725$20240731$20240731$EXP$$US-ABBVIE-5854933$ABBVIE$$64$YR$$M$Y$$$20240731$$CN$US$US
241549572$24154957$2$F$$20240913$20240731$20240920$PER$$NVSC2024US150600$NOVARTIS$$29$YR$$F$Y$$$20240920$$CN$US$US
241549582$24154958$2$F$20240827$20240828$20240731$20240829$PER$$US-AMGEN-USASP2024150241$AMGEN$$$$$F$Y$$$20240829$$CN$US$US
241549592$24154959$2$F$$20240731$20240731$20240805$PER$$US-AMGEN-USASP2024149624$AMGEN$$$$$$Y$$$20240805$$CN$US$US
241549601$24154960$1$I$$20240723$20240731$20240731$PER$$US-AMGEN-USASP2024147592$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241549611$24154961$1$I$$20240723$20240731$20240731$EXP$$TR-NOVITIUMPHARMA-2024TRNVP01425$NOVITIUM PHARMA$Emin Fatih Visneci.A Case of Pulmonary Embolism after Receiving a Dose of Sildenafil.Akademik Acil Tip Olgu Sunumlari Dergisi.28-JUN-2024;15:53-55$81$YR$E$M$Y$$$20240731$$HP$TR$TR
241549623$24154962$3$F$20240914$20240916$20240731$20240920$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000637$DECIPHERA PHARMACEUTICALS$$87$YR$E$M$Y$$$20240920$$CN$US$US
241549631$24154963$1$I$20240723$20240724$20240731$20240731$EXP$GB-MHRA-MED-202407241113464250-NKMQV$GB-RDY-SPO/GBR/24/0011004$DR REDDYS$$70$YR$E$F$Y$$$20240731$$CN$GB$GB
241549643$24154964$3$F$20240717$20240807$20240731$20240813$EXP$$CA-JNJFOC-20240771665$JOHNSON AND JOHNSON$$56$YR$A$F$Y$72$KG$20240813$$HP$CA$CA
241549651$24154965$1$I$$20240729$20240731$20240731$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042608$BOEHRINGER INGELHEIM$$$$$$Y$$$20240731$$MD$JP$JP
241549664$24154966$4$F$20240701$20240801$20240731$20240808$PER$$US-UNITED THERAPEUTICS-UNT-2024-022502$UNITED THERAPEUTICS$$84$YR$$F$Y$40.816$KG$20240808$$$US$US
241549671$24154967$1$I$20240723$20240723$20240731$20240731$PER$$US-ALXN-202407USA001339US$ALEXION PHARMACEUTICALS$$80$YR$$M$Y$$$20240731$$CN$US$US
241549681$24154968$1$I$$20240726$20240731$20240731$EXP$$NVSJ2024JP009150$NOVARTIS$$$$$$Y$$$20240731$$PH$JP$JP
241549691$24154969$1$I$20240607$20240720$20240731$20240731$EXP$$ES-AUROBINDO-AUR-APL-2024-036707$AUROBINDO$$66$YR$$M$Y$$$20240731$$PH$ES$ES
241549701$24154970$1$I$20240711$20240712$20240731$20240731$PER$$US-TEVA-VS-3225774$TEVA$$60$YR$$F$Y$$$20240731$$CN$US$US
241549711$24154971$1$I$$20240722$20240731$20240731$EXP$$GB-ROCHE-10000031995$ROCHE$Celsa C, Cabibbo G, Maria C, Enea B, Scheiner B, Alessio A, et al. Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment. Hepatology. 2024; doi:10.1097/HEP.0000000000001026.$$$$$Y$$$20240731$$HP$GB$GB
241549721$24154972$1$I$$20240718$20240731$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000640$DECIPHERA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241549731$24154973$1$I$20240415$20240723$20240731$20240731$PER$$US-ABBVIE-5853558$ABBVIE$$26$YR$$F$Y$$$20240731$$MD$US$US
241549741$24154974$1$I$$20240719$20240731$20240731$EXP$$JP-ROCHE-10000035662$ROCHE$$8$DEC$E$F$Y$$$20240731$$MD$JP$JP
241549751$24154975$1$I$20240722$20240722$20240731$20240731$PER$$US-CSL-2024-007015$CSL Plasma$$40$YR$$F$Y$$$20240731$$HP$US$US
241549761$24154976$1$I$20240101$20240722$20240731$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000645$DECIPHERA PHARMACEUTICALS$$83$YR$E$M$Y$100.2$KG$20240731$$CN$US$US
241549771$24154977$1$I$20240619$20240710$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003455$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240731$$CN$US$US
241549781$24154978$1$I$$20240715$20240731$20240731$PER$$US-JNJFOC-20240747870$JOHNSON AND JOHNSON$$$$$M$Y$$$20240731$$CN$US$US
241549791$24154979$1$I$$20240725$20240731$20240731$PER$$US-JNJFOC-20240776324$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$HP$US$US
241549801$24154980$1$I$20240604$20240729$20240731$20240731$EXP$$US-ABBVIE-5853506$ABBVIE$$49$YR$$M$Y$107$KG$20240731$$CN$US$US
241549811$24154981$1$I$$20240725$20240731$20240731$PER$$US-JNJFOC-20240775806$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241549821$24154982$1$I$20240601$20240628$20240731$20240731$PER$$US-AJANTA-2024AJA00124$AJANTA PHARMA$$72$YR$E$F$Y$172$KG$20240731$$CN$US$US
241549831$24154983$1$I$20240101$20240719$20240731$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000643$DECIPHERA PHARMACEUTICALS$$57$YR$A$M$Y$$$20240731$$CN$US$US
241549841$24154984$1$I$$20240730$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120792$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240731$$CN$US$US
241549851$24154985$1$I$20240709$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003456$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240731$$CN$US$US
241549861$24154986$1$I$20240417$20240418$20240731$20240731$PER$$US-AJANTA-2024AJA00080$AJANTA PHARMA$$73$YR$E$F$Y$145$KG$20240731$$CN$US$US
241549871$24154987$1$I$$20240724$20240731$20240731$EXP$$US-ROCHE-10000036243$ROCHE$$66$YR$E$F$Y$$$20240731$$CN$US$US
241549881$24154988$1$I$$20240710$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003457$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241549901$24154990$1$I$20240709$20240722$20240731$20240731$EXP$$CN-ROCHE-10000033071$ROCHE$$42$YR$A$F$Y$50$KG$20240731$$HP$CN$CN
241549911$24154991$1$I$$20240724$20240731$20240731$PER$$US-ABBVIE-5855837$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241549921$24154992$1$I$20240726$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019181$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240731$$CN$US$US
241549931$24154993$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018907$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240731$$CN$US$US
241549941$24154994$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019551$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240731$$CN$US$US
241549961$24154996$1$I$20240401$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019047$ELI LILLY AND CO$$70$YR$E$$Y$$$20240731$$CN$US$US
241549971$24154997$1$I$20240729$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019069$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240731$$CN$US$US
241549981$24154998$1$I$$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003460$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241549992$24154999$2$F$20240605$20240829$20240731$20240905$EXP$$ZA-TAKEDA-2024TUS058475$TAKEDA$$64$YR$$F$Y$$$20240905$$CN$ZA$ZA
241550011$24155001$1$I$20231128$20231129$20240731$20240731$EXP$$US-KHC-000061$Kilitch Healthcare$$$$$F$Y$$$20240731$$CN$US$US
241550021$24155002$1$I$20230101$20231115$20240731$20240731$EXP$$US-KHC-000059$Kilitch Healthcare$$$$$$Y$$$20240731$$CN$US$US
241550031$24155003$1$I$20230718$20231114$20240731$20240731$EXP$$US-KHC-000056$Kilitch Healthcare$$63$YR$A$F$Y$$$20240731$$CN$US$US
241550042$24155004$2$F$$20240827$20240731$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06893$LUPIN$$$$$$Y$$$20240918$$CN$US$US
241550052$24155005$2$F$$20240805$20240731$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003459$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
241550061$24155006$1$I$20240719$20240720$20240731$20240731$EXP$$GB-AUROBINDO-AUR-APL-2024-036612$AUROBINDO$$48$YR$$M$Y$77$KG$20240731$$HP$GB$GB
241550071$24155007$1$I$20240626$20240703$20240731$20240731$EXP$$US-NEBO-663190$PHARMACOSMOS$$73$YR$$M$Y$$$20240731$$HP$US$US
241550082$24155008$2$F$$20240813$20240731$20240814$PER$$NVSC2024US156014$NOVARTIS$$$$$$Y$$$20240815$$MD$US$US
241550101$24155010$1$I$20240725$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149714$AMGEN$$71$YR$E$F$Y$$$20240731$$CN$US$US
241550111$24155011$1$I$$20240718$20240731$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-120660$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240731$$HP$CA$CA
241550121$24155012$1$I$$20201120$20240731$20240731$EXP$$US-AstraZeneca-2020SF57205$ASTRAZENECA$$81$YR$$M$Y$$$20240731$$CN$US$
241550131$24155013$1$I$$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171639$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241550142$24155014$2$F$20240722$20240826$20240731$20240904$EXP$$JP-ROCHE-10000037685$ROCHE$$$$$M$Y$$$20240904$$MD$JP$JP
241550151$24155015$1$I$$20240704$20240731$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06960$LUPIN$$$$$$Y$$$20240731$$CN$US$US
241550161$24155016$1$I$$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003468$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241550171$24155017$1$I$$20240717$20240731$20240731$EXP$$US-RDY-LIT/USA/24/0010857$DR REDDYS$McQuinn D, Hyun M, Kim K, Kenkre VP, Fletcher CD, Rajguru SA, et al. Minimal Residual Disease (MRD) Testing By Next Generation Sequencing (NGS) after Two Cycles (CY) of Non-Intensive Chemoimmunotherapy Is Predictive of Remission Duration and Need for Maintenance Therapy (MT) in Previously Untreated Mantle Cell Lymphoma (MCL): A Wisconsin Oncology Network Study. Blood. 2023 Nov 28;142: 4407-4408. doi:10.1182/blood-2023-173871.$$$$$Y$$$20240731$$MD$US$US
241550181$24155018$1$I$$20240730$20240731$20240731$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042841$BOEHRINGER INGELHEIM$$$$$$Y$$$20240731$$PH$JP$JP
241550192$24155019$2$F$20240730$20240731$20240731$20240801$PER$$US-AMGEN-USASP2024151331$AMGEN$$75$YR$E$M$Y$$$20240801$$CN$US$US
241550201$24155020$1$I$$20240730$20240731$20240731$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042897$BOEHRINGER INGELHEIM$$82$YR$E$M$Y$$$20240731$$MD$DE$DE
241550211$24155021$1$I$$20240723$20240731$20240731$EXP$$JP-ROCHE-10000040759$ROCHE$$77$YR$E$F$Y$$$20240731$$MD$JP$JP
241550221$24155022$1$I$$20240720$20240731$20240731$EXP$$PL-AUROBINDO-AUR-APL-2024-036901$AUROBINDO$$76$YR$$F$Y$95$KG$20240731$$MD$PL$PL
241550232$24155023$2$F$$20240830$20240731$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06869$LUPIN$$$$$$Y$$$20240919$$CN$US$US
241550242$24155024$2$F$$20240803$20240731$20240806$PER$$NVSC2024US154851$NOVARTIS$$$$$$Y$$$20240807$$CN$US$US
241550251$24155025$1$I$$20240729$20240731$20240731$PER$$NVSC2024US155864$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
241550261$24155026$1$I$20240630$20240723$20240731$20240731$EXP$$CN-ROCHE-10000034394$ROCHE$$67$YR$E$F$Y$68.9$KG$20240731$$HP$CN$CN
241550273$24155027$3$F$$20240823$20240731$20240828$EXP$$NVSC2024US155787$NOVARTIS$$60$YR$$F$Y$$$20240828$$CN$US$US
241550281$24155028$1$I$20240402$20240703$20240731$20240731$EXP$$US-NEBO-663188$PHARMACOSMOS$$55$YR$$M$Y$$$20240731$$HP$US$US
241550291$24155029$1$I$$20240725$20240731$20240731$PER$$US-JNJFOC-20240773496$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241550303$24155030$3$F$$20240729$20240731$20240808$EXP$$RO-AUROBINDO-AUR-APL-2024-037346$AUROBINDO$Cighir A, Budin C. E, Cighir T, Mare A. D, Man A.. Beyond the gut - Atypical presentation of Salmonella spp. infection.. Acta Medica.. 2024;70(2):87-94$61$YR$$M$Y$$$20240808$$HP$RO$RO
241550312$24155031$2$F$20240728$20240805$20240731$20240806$PER$$US-HALEON-2189655$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241550321$24155032$1$I$$20240726$20240731$20240731$PER$$NVSC2024US154688$NOVARTIS$$$$$$Y$$$20240731$$CN$US$US
241550331$24155033$1$I$$20240729$20240731$20240731$PER$$US-HALEON-2189554$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241550342$24155034$2$F$$20240807$20240731$20240814$EXP$$CH-IMMUNOCORE, LTD-2024-IMC-002893$IMMUNOCORE$$$$$$Y$$$20240814$$MD$CH$CH
241550351$24155035$1$I$$20240723$20240731$20240731$EXP$$US-TEVA-VS-3225967$TEVA$$$$$$Y$$$20240731$$LW$US$US
241550361$24155036$1$I$$20240726$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120627$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240731$$MD$US$US
241550373$24155037$3$F$$20240913$20240731$20240923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-120444$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240923$$MD$JP$JP
241550381$24155038$1$I$20231201$20240722$20240731$20240731$EXP$$US-ROCHE-10000033273$ROCHE$$63$YR$A$F$Y$50.8$KG$20240731$$CN$US$US
241550391$24155039$1$I$$20240704$20240731$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06970$LUPIN$$$$$$Y$$$20240731$$CN$US$US
241550401$24155040$1$I$$20240723$20240731$20240731$EXP$$US-LUOXIN-LUX-2024-US-LIT-00041$LUOXIN AUROVITAS PHARMA(CHENGDU)$$12$YR$C$M$Y$$$20240731$$HP$US$US
241550411$24155041$1$I$$20240718$20240731$20240731$EXP$$US-ROCHE-10000035498$ROCHE$$$$T$M$Y$$$20240731$$CN$US$US
241550421$24155042$1$I$$20240723$20240731$20240731$EXP$$US-LUOXIN-LUX-2024-US-LIT-00040$LUOXIN AUROVITAS PHARMA(CHENGDU)$Bollam RR, Reddy VK.Persistent Pseudomonas Aeruginosa Pneumonia Due to Antimicrobial Resistance Development Requiring Lobectomy.Am-J-Respir-Crit-Care-Med.2024;209:A2400$56$YR$A$F$Y$$$20240731$$HP$US$US
241550431$24155043$1$I$20240101$20240730$20240731$20240731$EXP$FR-AFSSAPS-NT2024000941$FR-JNJFOC-20240782188$JOHNSON AND JOHNSON$$69$YR$E$M$Y$90$KG$20240731$$MD$FR$FR
241550441$24155044$1$I$20240601$20240729$20240731$20240731$EXP$$US-GILEAD-2024-0682341$GILEAD$$64$YR$A$F$Y$$$20240731$$CN$US$US
241550451$24155045$1$I$$20240720$20240731$20240731$EXP$$GB-AUROBINDO-AUR-APL-2024-036615$AUROBINDO$$60$YR$$F$Y$89$KG$20240731$$CN$GB$GB
241550463$24155046$3$F$20240101$20240917$20240731$20240926$EXP$$CA-CELLTRION INC.-2024CA002646$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
241550471$24155047$1$I$$20240723$20240731$20240731$EXP$$ZA-AstraZeneca-2024A167607$ASTRAZENECA$$72$YR$$M$Y$$$20240731$$CN$ZA$
241550482$24155048$2$F$$20240906$20240731$20240911$EXP$$US-AstraZeneca-2024A167935$ASTRAZENECA$$$$$F$Y$$$20240911$$HP$US$
241550491$24155049$1$I$20240727$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018471$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240731$$CN$US$US
241550501$24155050$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018804$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240731$$CN$US$US
241550511$24155051$1$I$20240701$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019016$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240731$$CN$US$US
241550521$24155052$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019149$ELI LILLY AND CO$$$$$M$Y$$$20240731$$CN$US$US
241550531$24155053$1$I$20240729$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018744$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240731$$CN$US$US
241550541$24155054$1$I$$20240717$20240731$20240731$PER$$US-TEVA-VS-3222726$TEVA$$$$A$F$Y$$$20240731$$CN$US$US
241550551$24155055$1$I$$20240725$20240731$20240731$EXP$$US-TAKEDA-2024TUS063094$TAKEDA$$$$$M$Y$$$20240731$$HP$US$US
241550571$24155057$1$I$20230731$20240726$20240731$20240731$EXP$$ES-AUROBINDO-AUR-APL-2024-037731$AUROBINDO$$76$YR$$F$Y$$$20240731$$MD$ES$ES
241550581$24155058$1$I$$20240724$20240731$20240731$EXP$$US-GSK-US2024AMR094342$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$US$US
241550591$24155059$1$I$20240615$20240719$20240731$20240731$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024091099$VIIV$$24$YR$$M$Y$$$20240731$$HP$US$US
241550601$24155060$1$I$$20240726$20240731$20240731$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02769$AMNEAL$$$$$F$Y$65$KG$20240731$$CN$US$US
241550625$24155062$5$F$$20240828$20240731$20240903$EXP$$US-AMGEN-USASP2024150949$AMGEN$$$$$F$Y$$$20240903$$CN$US$US
241550631$24155063$1$I$$20240725$20240731$20240731$EXP$$IT-AMGEN-ITASP2024150004$AMGEN$Tovoli F.; Franceschini E.; Vivaldi C. et al.. Management of portal hypertension in patients receiving atezolizumab-bevacizumab for hepatocellular carcinoma. Digestive and Liver Disease. 2024;56:p.S87$$$$$Y$$$20240731$$HP$IT$IT
241550641$24155064$1$I$$20240725$20240731$20240731$EXP$$IT-AMGEN-ITASP2024150009$AMGEN$Tovoli F.; Franceschini E.; Vivaldi C. et al.. Management of portal hypertension in patients receiving atezolizumab-bevacizumab for hepatocellular carcinoma. Digestive and Liver Disease. 2024;56:p.S87$$$$$Y$$$20240731$$HP$IT$IT
241550662$24155066$2$F$$20240805$20240731$20240819$EXP$$JP-ROCHE-10000040736$ROCHE$$8$DEC$E$$Y$$$20240819$$MD$JP$JP
241550671$24155067$1$I$$20240722$20240731$20240731$EXP$$PL-ROCHE-10000034086$ROCHE$$41$YR$A$M$Y$$$20240731$$CN$PL$PL
241550681$24155068$1$I$20240701$20240725$20240731$20240731$EXP$$US-JNJFOC-20240769828$JOHNSON AND JOHNSON$$13$YR$T$F$Y$$$20240731$$CN$US$US
241550695$24155069$5$F$$20240829$20240731$20240910$EXP$$FR-ROCHE-10000039646$ROCHE$$74$YR$E$F$Y$$$20240910$$MD$FR$FR
241550701$24155070$1$I$20240707$20240722$20240731$20240731$EXP$$US-VIIV HEALTHCARE LIMITED-US2024091631$VIIV$$57$YR$$M$Y$$$20240731$$CN$US$US
241550712$24155071$2$F$20240731$20240731$20240731$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003401$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240823$$CN$US$US
241550721$24155072$1$I$$20240125$20240731$20240731$EXP$$US-HALEON-2182072$Haleon PLC$$$$$M$Y$$$20240726$$CN$US$US
241550731$24155073$1$I$$20240719$20240731$20240731$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-07248$LUPIN$Spalgais S, Safwan MA, Mrigpuri P, Kumar R. Exfoliated dermatitis and hepatitis to first line anti-tubercular therapy with treatment of drug-sensitive tuberculosis with second line anti-tubercular therapy: A roller coaster ride. Chest Disease Reports$31$YR$$M$Y$$$20240731$$HP$IN$IN
241550741$24155074$1$I$20240510$20240703$20240731$20240731$EXP$$US-NEBO-663186$PHARMACOSMOS$$84$YR$$F$Y$$$20240731$$HP$US$US
241550751$24155075$1$I$$20240723$20240731$20240731$EXP$$AU-CELLTRION INC.-2024AU018046$CELLTRION$$$$$$Y$$$20240731$$HP$AU$AU
241550761$24155076$1$I$20231211$20240724$20240731$20240731$EXP$DE-DCGMA-24203583$DE-ROCHE-10000035045$ROCHE$$60$YR$A$F$Y$$$20240731$$MD$DE$DE
241550771$24155077$1$I$$20240725$20240731$20240731$EXP$$CA-UCBSA-2024038113$UCB$$5$YR$$M$Y$17$KG$20240731$$HP$CA$CA
241550781$24155078$1$I$$20240722$20240731$20240731$EXP$$ES-SA-2024SA214547$SANOFI AVENTIS$Rabaneda-Lombarte N, Teniente-Serra A, Massuet-Vilamajo A, Ramo-Tello C, Presas-Rodriguez S.. Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers. Front Immunol.. 2024;15:1-6$30$YR$A$F$Y$$$20240731$$HP$ES$ES
241550791$24155079$1$I$20240111$20240730$20240731$20240731$EXP$FR-AFSSAPS-MP2024001185$FR-ORGANON-O2407FRA002784$ORGANON$$35$YR$$F$Y$$$20240731$$MD$FR$FR
241550802$24155080$2$F$$20240731$20240731$20240806$EXP$$US-BIOGEN-2024BI01275831$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241550815$24155081$5$F$$20240813$20240731$20240822$EXP$$PL-ORGANON-O2407POL002637$ORGANON$$55$YR$$F$Y$$$20240822$$PH$PL$PL
241550821$24155082$1$I$20240601$20240729$20240731$20240731$EXP$$US-UCBSA-2024038288$UCB$$33$YR$$F$Y$$$20240731$$HP$US$US
241550831$24155083$1$I$$20240722$20240731$20240731$EXP$$RU-SA-2024SA217380$SANOFI AVENTIS$$$$A$F$Y$$$20240731$$HP$RU$RU
241550841$24155084$1$I$20240725$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149619$AMGEN$$59$YR$A$F$Y$$$20240731$$CN$US$US
241550851$24155085$1$I$$20240726$20240731$20240731$EXP$GB-MHRA-MIDB-8ee5f812-cf71-451c-b64b-976b486f0895$GB-ABBVIE-5856466$ABBVIE$$35$YR$$M$Y$$$20240731$$PH$GB$GB
241550861$24155086$1$I$$20240723$20240731$20240731$EXP$$US-ROCHE-10000035120$ROCHE$$83$YR$E$F$Y$$$20240731$$CN$US$US
241550871$24155087$1$I$$20240725$20240731$20240731$EXP$$AT-BIOGEN-2024BI01275814$BIOGEN$$$$A$F$Y$$$20240731$$MD$AT$AT
241550881$24155088$1$I$$20240716$20240731$20240731$EXP$$US-HLS-202400413$HLS THERAPEUTICS$$$$A$F$Y$$$20240731$$PH$US$US
241550891$24155089$1$I$20240722$20240723$20240731$20240731$EXP$$US-SA-2024SA220999$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240731$$MD$US$US
241550902$24155090$2$F$$20240801$20240731$20240815$EXP$$US-HLS-202400415$HLS THERAPEUTICS$$75$YR$E$M$Y$$$20240815$$PH$US$US
241550921$24155092$1$I$$20240725$20240731$20240731$EXP$CA-MALLINCKRODT-MNK202404786$CA-MALLINCKRODT-MNK202404786$MALLINCKRODT$$$$$$Y$$$20240731$$HP$CA$CA
241550932$24155093$2$F$$20240731$20240731$20240802$PER$$US-AMGEN-USASP2024150812$AMGEN$$$$$F$Y$$$20240802$$HP$US$US
241550941$24155094$1$I$$20240725$20240731$20240731$EXP$CA-MALLINCKRODT-MNK202404785$CA-MALLINCKRODT-MNK202404785$MALLINCKRODT$$$$$F$Y$$$20240731$$HP$CA$CA
241550951$24155095$1$I$20240725$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149792$AMGEN$$77$YR$E$M$Y$$$20240731$$CN$US$US
241550961$24155096$1$I$20240721$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150950$AMGEN$$87$YR$E$M$Y$$$20240731$$CN$US$US
241550971$24155097$1$I$20240101$20240723$20240731$20240731$EXP$$KR-MALLINCKRODT-MNK202404743$MALLINCKRODT$$$$N$F$Y$0.635$KG$20240731$$HP$KR$KR
241550981$24155098$1$I$20240513$20240703$20240731$20240731$EXP$$US-NEBO-663184$PHARMACOSMOS$$27$YR$$F$Y$$$20240731$$HP$US$US
241550991$24155099$1$I$$20240702$20240731$20240731$PER$$US-JNJFOC-20240712767$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240731$$CN$US$US
241551002$24155100$2$F$$20240730$20240731$20240802$PER$$PR-JNJFOC-20240780383$JOHNSON AND JOHNSON$$$$$M$Y$105.33$KG$20240802$$CN$PR$PR
241551013$24155101$3$F$$20240913$20240731$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003386$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241551021$24155102$1$I$20240723$20240723$20240731$20240731$EXP$$CO-ABBVIE-5860639$ABBVIE$$63$YR$$M$Y$68$KG$20240731$$HP$CO$CO
241551031$24155103$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018991$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240731$$CN$US$US
241551041$24155104$1$I$20240727$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019159$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240731$$CN$US$US
241551051$24155105$1$I$20240701$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018772$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240731$$CN$US$US
241551061$24155106$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018679$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240731$$CN$US$US
241551081$24155108$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018750$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240731$$CN$US$US
241551091$24155109$1$I$$20240721$20240731$20240731$EXP$$JP-CARNEGIE-000015$Carnegie Pharmaceuticals$$79$YR$E$F$Y$$$20240724$$MD$JP$JP
241551101$24155110$1$I$$20240724$20240731$20240731$EXP$$CN-MEDLEY-000015$MEDLEY PHARMACEUTICALS$$2$YR$C$F$Y$$$20240726$$MD$CN$CN
241551113$24155111$3$F$$20240910$20240731$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003376$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241551122$24155112$2$F$$20240828$20240731$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003374$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
241551132$24155113$2$F$$20240805$20240731$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003375$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241551141$24155114$1$I$$20240721$20240731$20240731$EXP$$CN-GTI-000257$Granulation Technology, INC$$46$YR$A$M$Y$$$20240724$$MD$CN$CN
241551151$24155115$1$I$$20240728$20240731$20240731$EXP$$US-ABBVIE-5857594$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241551161$24155116$1$I$$20240725$20240731$20240731$EXP$$US-ABBVIE-5855963$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241551171$24155117$1$I$$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171861$ASTRAZENECA$$$$$F$Y$$$20240731$$MD$US$
241551181$24155118$1$I$$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171867$ASTRAZENECA$$$$$F$Y$$$20240731$$MD$US$
241551191$24155119$1$I$$20240726$20240731$20240731$EXP$$US-CHATTEMPRD-2024OHG025586$CHATTEM$$$$$F$Y$$$20240731$$CN$US$US
241551201$24155120$1$I$20240617$20240723$20240731$20240731$EXP$$FR-AstraZeneca-2024A167076$ASTRAZENECA$$55$YR$$F$Y$83$KG$20240731$$MD$FR$
241551211$24155121$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5860087$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241551221$24155122$1$I$20240101$20240723$20240731$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-022907$UNITED THERAPEUTICS$$$$$F$Y$17.3$KG$20240731$$$US$US
241551233$24155123$3$F$20240201$20240809$20240731$20240813$EXP$$US-ABBVIE-5856824$ABBVIE$$59$YR$$M$Y$74.84$KG$20240813$$CN$US$US
241551241$24155124$1$I$20240305$20240723$20240731$20240731$EXP$$GB-AstraZeneca-2024A167525$ASTRAZENECA$$65$YR$$F$Y$77$KG$20240731$$MD$GB$
241551253$24155125$3$F$20240724$20240826$20240731$20240830$30DAY$$US-AMGEN-USASL2024148875$AMGEN$$67$YR$E$F$Y$$$20240830$$HP$US$US
241551262$24155126$2$F$20240720$20240807$20240731$20240808$PER$$US-AMGEN-USASP2024150535$AMGEN$$57$YR$A$M$Y$$$20240808$$CN$US$US
241551271$24155127$1$I$$20240725$20240731$20240731$PER$$US-009507513-2407USA015789$MERCK$$$$$F$Y$$$20240731$$CN$US$US
241551283$24155128$3$F$20240101$20240816$20240731$20240821$EXP$$US-ABBVIE-5856958$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
241551303$24155130$3$F$$20240830$20240731$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003391$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
241551313$24155131$3$F$20240731$20240821$20240731$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003399$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240913$$CN$US$US
241551321$24155132$1$I$$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003390$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241551331$24155133$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5857022$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241551341$24155134$1$I$$20240725$20240731$20240731$EXP$$US-BIOGEN-2024BI01275522$BIOGEN$$$$$M$Y$$$20240731$$CN$US$US
241551351$24155135$1$I$20240709$20240729$20240731$20240731$EXP$$US-TAKEDA-2024TUS038521$TAKEDA$$42$YR$$F$Y$$$20240731$$HP$US$US
241551362$24155136$2$F$20240101$20240820$20240731$20240827$EXP$$US-ABBVIE-5856957$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
241551372$24155137$2$F$$20240910$20240731$20240916$EXP$$AR-IPCA LABORATORIES LIMITED-IPC-2024-AR-001853$IPCA$Jose G. Cervantes ,Rodrigo A. Gasque , Marcelo E. Lenz, et.al. Trasplante hep?tico como tratamiento de intoxicaci?n por paracetamol. MEDICINA (Buenos Aires). 2024;84:588-591$$$$$Y$$$20240916$$HP$AR$AR
241551391$24155139$1$I$20240718$20240726$20240731$20240731$EXP$$US-ABBVIE-5856826$ABBVIE$$76$YR$$F$Y$$$20240731$$CN$US$US
241551402$24155140$2$F$$20240829$20240731$20240916$PER$$US-APOTEX-2024AP008566$APOTEX$$$$$M$Y$$$20240916$$CN$US$US
241551411$24155141$1$I$20220101$20240729$20240731$20240731$EXP$$US-TAKEDA-2024TUS063740$TAKEDA$$82$YR$$M$Y$$$20240731$$MD$US$US
241551432$24155143$2$F$20240728$20240826$20240731$20240828$PER$$US-AMGEN-USASP2024150660$AMGEN$$77$YR$E$M$Y$$$20240828$$HP$US$US
241551442$24155144$2$F$$20240826$20240731$20240827$EXP$$AT-SANDOZ INC.-SDZ2024AT068963$SANDOZ$$66$YR$$F$Y$$$20240827$$MD$AT$AT
241551451$24155145$1$I$20240719$20240720$20240731$20240731$EXP$$GB-AUROBINDO-AUR-APL-2024-036614$AUROBINDO$$12$YR$$F$Y$31$KG$20240731$$CN$GB$GB
241551461$24155146$1$I$$20240716$20240731$20240731$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109955$ZYDUS PHARM$Gondek S, Ogledzinski M, Lin W, Milejczyk K, Juengel B, Potter L, et al.. Persistence of long-term insulin independence after islet transplantation and two subsequent pregnancies. European journal of translational and clinical medicine. 2023;6(1):9-13$$$$$Y$$$20240731$$HP$US$US
241551471$24155147$1$I$$20240717$20240731$20240731$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110141$ZYDUS PHARM$Raza HS, Love JS, Mikolajczyk AE. Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding. ACG Case Reports Journal. 2024;11:1-3$$$$$Y$$$20240731$$MD$US$US
241551482$24155148$2$F$20140101$20240729$20240731$20240917$EXP$$DE-SANDOZ INC.-SDZ2024DE069046$SANDOZ$$48$YR$$M$Y$$$20240917$$HP$DE$DE
241551491$24155149$1$I$$20240717$20240731$20240731$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110133$ZYDUS PHARM$Xu E, Thomas S, Habibi B. Intrathecal Methotrexate-Induced Lumbosacral Polyradiculopathy: A Case Report. Pain-Med-Case-Rep. 2024;8 (1):31-35$$$$$Y$$$20240731$$HP$US$US
241551501$24155150$1$I$$20240723$20240731$20240731$EXP$$CA-APOTEX-2023AP010833$APOTEX$$6$DEC$$F$Y$$$20240731$$HP$CA$CA
241551511$24155151$1$I$$20240726$20240731$20240731$EXP$$US-JNJFOC-20240773679$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$MD$US$US
241551523$24155152$3$F$20240507$20240831$20240731$20240906$EXP$$BR-TAKEDA-2024TUS049203$TAKEDA$$22$YR$$M$Y$$$20240906$$CN$BR$BR
241551531$24155153$1$I$20240724$20240729$20240731$20240731$EXP$$NVSC2024US155579$NOVARTIS$$61$YR$$M$Y$$$20240731$$CN$US$US
241551541$24155154$1$I$$20240717$20240731$20240731$PER$$US-TEVA-VS-3223979$TEVA$$$$$M$Y$$$20240731$$CN$US$US
241551553$24155155$3$F$$20240813$20240731$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-023311$UNITED THERAPEUTICS$$$$$F$Y$63.946$KG$20240821$$$US$US
241551561$24155156$1$I$$20240724$20240731$20240731$EXP$$US-UCBSA-2024037649$UCB$Lee J, Kumar N, Kabeto M, Galecki A, Chang C-H, Singh N, et al.. Prevalence and Factors Associated with De?escalation of Anti?TNFs in Older Adults with Rheumatoid Arthritis: A Medicare Claims?Based Observational Study. Drugs and Aging. 2024;41(7):601-13$$$E$$Y$$$20240731$$HP$US$US
241551573$24155157$3$F$$20240912$20240731$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003412$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241551581$24155158$1$I$20240713$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150567$AMGEN$$62$YR$A$F$Y$$$20240731$$HP$US$US
241551591$24155159$1$I$$20220322$20240731$20240731$EXP$$US-AstraZeneca-2022A124508$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241551601$24155160$1$I$$20221219$20240731$20240731$EXP$$US-AstraZeneca-2022A412840$ASTRAZENECA$$$$$$Y$$$20240731$$CN$US$
241551611$24155161$1$I$$20220506$20240731$20240731$EXP$$US-AstraZeneca-2022A178652$ASTRAZENECA$$$$$F$Y$$$20240731$$HP$US$
241551621$24155162$1$I$$20230628$20240731$20240731$EXP$$US-AstraZeneca-2023A149610$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241551632$24155163$2$F$20210101$20240822$20240731$20240826$EXP$$US-ROCHE-3544930$ROCHE$$29$YR$A$F$Y$61.69$KG$20240826$$MD$US$US
241551641$24155164$1$I$20240701$20240730$20240731$20240731$PER$$US-JNJFOC-20240781589$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240731$$CN$US$US
241551651$24155165$1$I$$20240729$20240731$20240731$PER$$US-HALEON-2189604$Haleon PLC$$$$$F$Y$$$20240731$$CN$US$US
241551661$24155166$1$I$$20240725$20240731$20240731$EXP$$NVSC2024BR155078$NOVARTIS$$$$$F$Y$$$20240731$$CN$BR$BR
241551671$24155167$1$I$20240615$20240725$20240731$20240731$EXP$FR-AFSSAPS-PB2024000800$FR-CHEPLA-2024009548$CHEPLAPHARM$$39$YR$$F$Y$59$KG$20240731$$MD$COUNTRY NOT SPECIFIED$FR
241551681$24155168$1$I$$20240723$20240731$20240731$EXP$$AU-CHEPLA-2024009716$CHEPLAPHARM$$$$$$Y$$$20240731$$CN$COUNTRY NOT SPECIFIED$AU
241551692$24155169$2$F$$20240903$20240731$20240909$EXP$$JP-CHEPLA-2024009530$CHEPLAPHARM$$$$C$M$Y$$$20240909$$PH$COUNTRY NOT SPECIFIED$JP
241551701$24155170$1$I$20240601$20240724$20240731$20240731$EXP$$US-CHEPLA-2024009690$CHEPLAPHARM$$$$$F$Y$$$20240731$$CN$COUNTRY NOT SPECIFIED$US
241551711$24155171$1$I$$20240723$20240731$20240731$EXP$$GB-TAKEDA-2023TUS055779$TAKEDA$$$$$F$Y$$$20240731$$CN$GB$GB
241551721$24155172$1$I$20240707$20240725$20240731$20240731$EXP$FR-AFSSAPS-MP2024001141$FR-CHEPLA-2024009589$CHEPLAPHARM$$79$YR$$F$Y$$$20240731$$PH$COUNTRY NOT SPECIFIED$FR
241551731$24155173$1$I$20240708$20240722$20240731$20240731$EXP$$CN-ROCHE-10000041587$ROCHE$$65$YR$E$M$Y$61$KG$20240731$$HP$CN$CN
241551741$24155174$1$I$$20240730$20240731$20240731$PER$$NVSC2024US156052$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
241551751$24155175$1$I$$20240716$20240731$20240731$EXP$$FR-INSMED, INC.-2024-02916-FR$INSMED$$$$$$Y$$$20240731$$HP$FR$FR
241551761$24155176$1$I$20240415$20240726$20240731$20240731$EXP$PT-INFARMED-B202407-415$PT-009507513-2407PRT014767$MERCK$$66$YR$$M$Y$72$KG$20240731$$MD$PT$PT
241551772$24155177$2$F$20240721$20240724$20240731$20240731$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041937$BOEHRINGER INGELHEIM$$24$YR$A$F$Y$50$KG$20240731$$MD$BR$BR
241551781$24155178$1$I$$20240717$20240731$20240731$EXP$$SG-ROCHE-10000031355$ROCHE$$44$YR$A$F$Y$$$20240731$$CN$SG$SG
241551791$24155179$1$I$$20240724$20240731$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001518$BLUEPRINT MEDICINES$$$$$M$Y$$$20240731$$CN$US$US
241551801$24155180$1$I$20240101$20240723$20240731$20240731$EXP$$CA-CELLTRION INC.-2024CA002621$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
241551811$24155181$1$I$20240101$20240726$20240731$20240731$EXP$$US-ABBVIE-5856854$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241551821$24155182$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150958$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241551832$24155183$2$F$20240719$20240828$20240731$20240903$PER$$US-AMGEN-USASP2024147874$AMGEN$$54$YR$A$F$Y$160.54$KG$20240903$$HP$US$US
241551841$24155184$1$I$20240715$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149782$AMGEN$$77$YR$E$F$Y$$$20240731$$CN$US$US
241551851$24155185$1$I$$20240724$20240731$20240731$EXP$ES-SANDOZ-SDZ2024ES062898$ES-ROCHE-10000035633$ROCHE$Ruiz-Nieto N, Aparicio-Collado H, Segura-Cerda A, Barea-Moya L, Zahonero-Ferriz A, Campillo-Alpera M, et al. Primary central nervous system vasculitis: A diagnostic and therapeutic challenge. A series of 7 patients. Neurolgia. 2024;39 (6):486-95. doi:10.1016/j.nrleng.2023.04.004.$72$YR$E$M$Y$$$20240731$$HP$ES$ES
241551861$24155186$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5856973$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241551871$24155187$1$I$$20240710$20240731$20240731$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003415$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$MD$US$US
241551881$24155188$1$I$20240101$20240726$20240731$20240731$EXP$$US-ABBVIE-5857017$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241551891$24155189$1$I$$20240725$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120738$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240731$$MD$US$US
241551902$24155190$2$F$$20240911$20240731$20240921$EXP$$US-GSK-US2024AMR093297$GLAXOSMITHKLINE$$$$$F$Y$68.027$KG$20240921$$CN$US$US
241551913$24155191$3$F$20240101$20240831$20240731$20240904$EXP$$CA-ABBVIE-5857062$ABBVIE$$37$YR$$F$Y$$$20240904$$HP$CA$CA
241551923$24155192$3$F$$20240806$20240731$20240812$EXP$$US-ABBVIE-5857171$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241551931$24155193$1$I$20240613$20240724$20240731$20240731$EXP$$CN-EMD Serono-2024040538$EMD SERONO INC$$58$YR$A$F$Y$85$KG$20240731$$HP$CN$CN
241551941$24155194$1$I$20240101$20240726$20240731$20240731$EXP$$US-ABBVIE-5857079$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241551951$24155195$1$I$20240729$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018833$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240731$$CN$US$US
241551962$24155196$2$F$$20240827$20240731$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202407017850$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240830$$CN$US$US
241551971$24155197$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019144$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$US$US
241551981$24155198$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018885$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240731$$CN$US$US
241551991$24155199$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018823$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240731$$CN$US$US
241552001$24155200$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5858325$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241552011$24155201$1$I$20240703$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003417$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240731$$CN$US$US
241552021$24155202$1$I$$20240725$20240731$20240731$EXP$$US-ABBVIE-5856467$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241552031$24155203$1$I$20231017$20240720$20240731$20240731$EXP$$IT-AUROBINDO-AUR-APL-2024-036677$AUROBINDO$$54$YR$$F$Y$$$20240731$$MD$IT$IT
241552052$24155205$2$F$20240606$20240831$20240731$20240902$EXP$$NVSC2024EG154437$NOVARTIS$$50$YR$$M$Y$80$KG$20240902$$CN$EG$EG
241552061$24155206$1$I$$20240730$20240731$20240731$PER$$US-HALEON-2189750$Haleon PLC$$25$YR$$F$Y$$$20240731$$CN$US$US
241552074$24155207$4$F$20240101$20240826$20240731$20240906$EXP$$US-UCBSA-2024033474$UCB$$$$$M$Y$99.7$KG$20240906$$CN$US$US
241552081$24155208$1$I$$20240710$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003420$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241552092$24155209$2$F$20240710$20240801$20240731$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003419$ACADIA PHARMACEUTICALS$$13$YR$$F$Y$$$20240827$$CN$US$US
241552103$24155210$3$F$20240101$20240831$20240731$20240905$EXP$$US-ABBVIE-5856814$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
241552112$24155211$2$F$$20240722$20240731$20240806$PER$$US-SECURA BIO, INC.-2024-SECUR-US000052$PAREXEL$$$$$$Y$$$20240806$$HP$US$US
241552121$24155212$1$I$20210618$20210713$20240731$20240731$EXP$$TW-AstraZeneca-2021A622555$ASTRAZENECA$$68$YR$$M$Y$$$20240731$$CN$TW$
241552131$24155213$1$I$$20210902$20240731$20240731$EXP$$US-AstraZeneca-2021A712015$ASTRAZENECA$$$$$$Y$77.2$KG$20240731$$CN$US$
241552141$24155214$1$I$$20240725$20240731$20240731$PER$$US-ABBVIE-5857742$ABBVIE$$$$$$Y$$$20240731$$HP$US$US
241552151$24155215$1$I$$20230502$20240731$20240731$EXP$$US-AstraZeneca-2023A104025$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241552163$24155216$3$F$$20240801$20240731$20240810$PER$$US-AstraZeneca-2024A166728$ASTRAZENECA$$87$YR$$M$Y$$$20240810$$CN$US$
241552171$24155217$1$I$20220601$20230306$20240731$20240731$EXP$$CA-AstraZeneca-2023A055819$ASTRAZENECA$$394$MON$$F$Y$$$20240731$$CN$CA$
241552181$24155218$1$I$$20230425$20240731$20240731$EXP$$US-AstraZeneca-2023A096837$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241552191$24155219$1$I$20210101$20210928$20240731$20240731$EXP$$US-AstraZeneca-2021A689359$ASTRAZENECA$$73$YR$$M$Y$84.4$KG$20240731$$CN$US$
241552201$24155220$1$I$20240408$20240729$20240731$20240731$EXP$FR-AFSSAPS-DJ2024000844$NVSC2024FR155223$NOVARTIS$$51$YR$$M$Y$108$KG$20240731$$MD$FR$FR
241552212$24155221$2$F$$20240821$20240731$20240821$PER$$US-ALXN-202407USA001794US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
241552222$24155222$2$F$$20240821$20240731$20240827$EXP$$GB-SANDOZ INC.-PHHY2019GB196307$SANDOZ$$$$$F$Y$$$20240827$$CN$GB$GB
241552232$24155223$2$F$$20240806$20240731$20240808$EXP$$IL-ABBVIE-5860134$ABBVIE$$$$$M$Y$$$20240808$$CN$IL$IL
241552241$24155224$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5859143$ABBVIE$$$$$F$Y$$$20240731$$MD$US$US
241552251$24155225$1$I$20240716$20240718$20240731$20240731$EXP$$CN-ROCHE-10000030981$ROCHE$$53$YR$A$M$Y$55$KG$20240731$$HP$CN$CN
241552262$24155226$2$F$$20240827$20240731$20240829$PER$$US-JNJFOC-20240777077$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$HP$US$US
241552273$24155227$3$F$20240705$20240909$20240731$20240912$30DAY$$US-JNJFOC-20240773884$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240912$$CN$US$US
241552281$24155228$1$I$20240711$20240723$20240731$20240731$EXP$$CN-SANDOZ INC.-SDZ2024CN068942$SANDOZ$$75$YR$$M$Y$52.5$KG$20240731$$HP$CN$CN
241552291$24155229$1$I$$20240724$20240731$20240731$EXP$$US-GSK-US2024AMR093279$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$US$US
241552301$24155230$1$I$$20240718$20240731$20240731$PER$$US-APOTEX-2024AP008769$APOTEX$Becker DA.. The Positive Assistance of Assisted Reproductive Technology. Epilepsy Currents (English-Edition). 2024;24 (3):180-181$$$$F$Y$$$20240731$$MD$US$US
241552312$24155231$2$F$20240101$20240816$20240731$20240824$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022635$UNITED THERAPEUTICS$$$$$F$Y$43.537$KG$20240824$$$US$US
241552322$24155232$2$F$20230626$20240731$20240731$20240805$EXP$$JP-EXELIXIS-CABO-24080016$EXELIXIS$$80$YR$$M$Y$59$KG$20240804$$MD$JP$JP
241552331$24155233$1$I$20240625$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-037331$AUROBINDO$$$$E$F$Y$$$20240731$$PH$FR$FR
241552341$24155234$1$I$20230813$20240720$20240731$20240731$EXP$$IT-AUROBINDO-AUR-APL-2024-036655$AUROBINDO$$78$YR$$F$Y$$$20240731$$MD$IT$IT
241552351$24155235$1$I$$20240725$20240731$20240731$PER$$US-MTPC-MTDA2024-0015623$Unknown Manufacturer$$$$A$$Y$$$20240731$$HP$US$US
241552361$24155236$1$I$20240719$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149334$AMGEN$$67$YR$E$F$Y$$$20240731$$HP$US$US
241552371$24155237$1$I$$20240708$20240731$20240731$EXP$$US-SINTETICA US LLC-US-SIN-2024-00009$Sintetica$Camila N. Fontane Hoyos, MD, Chad J. Jessup, MD, and Ari  M. Goldminz, MD. Allergic Contact Dermatitis to Lidocaine and Sodium Metabisulfite.. American Contact Dermatitis Society. 2024$57$YR$$F$Y$$$20240731$$MD$US$US
241552381$24155238$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5856873$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241552394$24155239$4$F$20240101$20240920$20240731$20240930$EXP$$CA-CELLTRION INC.-2024CA018203$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
241552401$24155240$1$I$20240601$20240723$20240731$20240731$EXP$$JP-ROCHE-10000036733$ROCHE$$8$DEC$E$M$Y$$$20240731$$MD$JP$JP
241552411$24155241$1$I$$20240723$20240731$20240731$EXP$$US-MTPC-MTDA2024-0015411$Unknown Manufacturer$$$$A$M$Y$$$20240731$$CN$US$US
241552421$24155242$1$I$20240702$20240729$20240731$20240731$EXP$FR-AFSSAPS-PA2024001389$FR-SANDOZ INC.-SDZ2024FR069126$SANDOZ$$21$YR$$M$Y$71.4$KG$20240731$$MD$FR$FR
241552431$24155243$1$I$20240702$20240723$20240731$20240731$EXP$FR-AFSSAPS-PC2024000583$FR-SANDOZ INC.-SDZ2024FR067583$SANDOZ$$42$YR$$M$Y$110$KG$20240731$$MD$FR$FR
241552441$24155244$1$I$$20240724$20240731$20240731$PER$$US-ALXN-202407USA001699US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
241552452$24155245$2$F$20230101$20240827$20240731$20240831$EXP$$US-ABBVIE-5458177$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
241552461$24155246$1$I$20170101$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003338$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241552471$24155247$1$I$$20240724$20240731$20240731$EXP$$JP-SANDOZ INC.-SDZ2024JP069105$SANDOZ$$89$YR$$F$Y$$$20240731$$CN$JP$JP
241552481$24155248$1$I$$20240723$20240731$20240731$EXP$$US-ABBVIE-5853021$ABBVIE$$$$$F$Y$$$20240731$$HP$US$US
241552501$24155250$1$I$$20240729$20240731$20240731$EXP$$NVSC2023NP084267$NOVARTIS$$$$$M$Y$$$20240731$$MD$NP$NP
241552511$24155251$1$I$$20240722$20240731$20240731$EXP$$BE-ROCHE-10000034043$ROCHE$De T, Van S J, D^hooghe M B, Peeters G, Nagels G, D^haeseleer M.. Clinical effectiveness of coronavirus disease 2019 vaccination in patients with multiple sclerosis stratified by disease-modifying treatment.. European journal of neurology. 2024-Mar-28;31 (7):1-8. doi:10.1111/ene.16300.$$$$$Y$$$20240731$$HP$BE$BE
241552521$24155252$1$I$20140206$20221117$20240731$20240731$EXP$$US-AstraZeneca-2022A382433$ASTRAZENECA$$21296$DY$$M$Y$$$20240731$$CN$US$
241552531$24155253$1$I$$20210915$20240731$20240731$EXP$$US-AstraZeneca-2021A728430$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241552542$24155254$2$F$$20240724$20240731$20240808$30DAY$$US-UCBSA-2024036818$UCB$$$$$M$Y$$$20240808$$CN$US$US
241552551$24155255$1$I$20240403$20240715$20240731$20240731$PER$$US-TEVA-VS-3222073$TEVA$$89$YR$$F$Y$$$20240731$$HP$US$US
241552561$24155256$1$I$$20210402$20240731$20240731$EXP$$US-AstraZeneca-2021A273550$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241552571$24155257$1$I$$20240724$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069270$SANDOZ$$$$$$Y$$$20240731$$PH$US$US
241552581$24155258$1$I$$20240724$20240731$20240731$PER$$US-BEH-2024176364$CSL BEHRING$$$$T$F$Y$$$20240731$$HP$US$US
241552591$24155259$1$I$$20240722$20240731$20240731$EXP$$US-GSK-US2024AMR092287$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$MD$US$US
241552601$24155260$1$I$$20240730$20240731$20240731$EXP$$US-ADIENNEP-2024AD000565$ADIENNE PHARMA + BIOTECH$Gullickson C, Kersun L, Reilly A, Seif A, Chehab L. Isolated central nervous system relapse in two adolescents with primary mediastinal large B-cell lymphoma after treatment with R-DA-EPOCH. Pediatr Blood Cancer. 2024;71(8):e31065. DOI: 10.1002/pbc.31065$$$T$F$Y$$$20240730$$MD$US$
241552611$24155261$1$I$20240701$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019498$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240731$$CN$US$US
241552621$24155262$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018717$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240731$$CN$US$US
241552631$24155263$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018708$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$US$US
241552643$24155264$3$F$20240424$20240903$20240731$20240904$EXP$$US-KYOWAKIRIN-2024KK018192$KYOWA$$$$$$Y$$$20240904$$CN$US$US
241552651$24155265$1$I$$20240723$20240731$20240731$EXP$$BR-JNJFOC-20240765689$JOHNSON AND JOHNSON$$57$YR$A$M$Y$86$KG$20240731$$CN$BR$BR
241552661$24155266$1$I$20240729$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150821$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241552681$24155268$1$I$$20240717$20240731$20240731$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15478$ALKEM$Ojha N, Riaz S, Eranki A.. Cefepime neurotoxicity in a patient with acute tubular necrosis. Cureus. 2020;12(8):e9911$67$YR$$M$Y$$$20240731$$HP$US$US
241552692$24155269$2$F$$20240725$20240731$20240808$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16302$ALKEM$Lan J, Lahoti A, Lew DB.. A severe case of minocycline-induced DRESS resulting in liver transplantation and autoimmune sequelae. Ann Allergy Asthma Immunol. 2016;116(4):367-368$13$YR$$F$Y$$$20240808$$MD$US$US
241552701$24155270$1$I$$20240717$20240731$20240731$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-16329$ALKEM$Mahe E, Bodemer C, Dupic L, Hubert P, Lacaille F, Goulet O, et al. Drug-induced hypersensitivity syndrome associated with primary Epstein-Barr virus and human herpesvirus 6 infections in a child intestinal transplant recipient. Transplantation. 2004;77(3):479-80$6$YR$$M$Y$$$20240731$$HP$FR$FR
241552711$24155271$1$I$$20240717$20240731$20240731$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-16706$ALKEM$Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol. 2009;145(1):67-72$15$YR$$F$Y$$$20240731$$HP$FR$FR
241552722$24155272$2$F$$20240725$20240731$20240808$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2024-16260$ALKEM$Frank Wolf M, Sloma R, Akria L, Rimon E, Wiener Y, Carmiel Haggai M, Lowenstein L.. Azathioprine and 6-mercaptopurine-induced intrahepatic cholestasis of pregnancy: Case report and review of the literature. Taiwanese Journal of Obstetrics + Gynecology. 2023;62 (5):761-764$33$YR$$F$Y$$$20240808$$HP$IL$IL
241552731$24155273$1$I$$20240717$20240731$20240731$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-16519$ALKEM$Yamasaki K, Ishikawa S, Suzuki T, Tanaka Y, Oi K. Refractory Peritonitis Related to Peritoneal Dialysis Caused by Enterococcus gallinarum. Internal Medicine. 2024;63:1907-1912$65$YR$$F$Y$$$20240731$$HP$JP$JP
241552741$24155274$1$I$$20240717$20240731$20240731$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16407$ALKEM$Frisaldi E, Ferrero B, Di Liberto A, Barbiani D, Camerone EM, Piedimonte A, Vollert J, Cavallo R, Zibetti M, Lopiano L, Shaibani A, Benedetti F. The impact of patients^ pre-treatment expectations on immunosuppressive treatment outcomes in myasthenia gravis: A pilot correlational study. Muscle + Nerve. 2024;Unk:1-7$51$YR$$M$Y$$$20240731$$HP$IT$IT
241552751$24155275$1$I$$20240717$20240731$20240731$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16403$ALKEM$Frisaldi E, Ferrero B, Di Liberto A, Barbiani D, Camerone EM, Piedimonte A, Vollert J, Cavallo R, Zibetti M, Lopiano L, Shaibani A, Benedetti F.. The impact of patients^ pre-treatment expectations on immunosuppressive treatment outcomes in myasthenia gravis: A pilot correlational study. Muscle + Nerve. 2024;unk:1-7$62$YR$$M$Y$$$20240731$$HP$IT$IT
241552763$24155276$3$F$20240501$20240912$20240731$20240912$PER$$NVSC2024US154666$NOVARTIS$$63$YR$$M$Y$$$20240912$$CN$US$US
241552771$24155277$1$I$$20240717$20240731$20240731$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-15922$ALKEM$Frisaldi E, Ferrero B, Di Liberto A, Barbiani D, Camerone EM, Piedimonte A, Vollert J, Cavallo R, Zibetti M, Lopiano L, Shaibani A, Benedetti F. The impact of patients^ pre-treatment expectations on immunosuppressive treatment outcomes in myasthenia gravis: A pilot correlational study. Muscle + Nerve. 2024;unk:1-7$32$YR$$F$Y$$$20240731$$HP$IT$IT
241552781$24155278$1$I$$20240717$20240731$20240731$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16548$ALKEM$Naik S, Li Y, Talleur AC, Selukar S, Ashcraft E et al.. Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial. Journal of Hematology + Oncology. 2024;17(1):50$$$$$Y$$$20240731$$HP$US$US
241552791$24155279$1$I$$20240717$20240731$20240731$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16550$ALKEM$Naik S, Li Y, Talleur AC, Selukar S, Ashcraft E et al.. Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial. Journal of Hematology + Oncology. 2024;17(1):50$$$$$Y$$$20240731$$HP$US$US
241552801$24155280$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5860378$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241552812$24155281$2$F$$20240725$20240731$20240808$EXP$US-MLMSERVICE-20181210-1527721-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16389$ALKEM$Ghaly RF, Plesca A, Rana S, Candido KD, Knezevic NN. Gabapentin-related suicide: Myth or fact. Surgical Neurology International. 2018;9:210$28$YR$$M$Y$$$20240808$$MD$US$US
241552821$24155282$1$I$$20240717$20240731$20240731$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16374$ALKEM$Ruiz de Villa A, Charles K, Bassi R, Spencer S, Bazikian Y. Approach to cefepime-induced neurotoxicity in the setting of chronic kidney disease: a case report and review of literature. Cureus. 2022;14(6):e26005$52$YR$$F$Y$$$20240731$$HP$US$US
241552831$24155283$1$I$$20240717$20240731$20240731$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-15926$ALKEM$Frisaldi E, Ferrero B, Di Liberto A, Barbiani D, Camerone EM, Piedimonte A, Vollert J, Cavallo R, Zibetti M, Lopiano L, Shaibani A, Benedetti F.. The impact of patients^ pre-treatment expectations on immunosuppressive treatment outcomes in myasthenia gravis: A pilot correlational study. Muscle + Nerve. 2024;unk:1-7$82$YR$$M$Y$$$20240731$$HP$IT$IT
241552841$24155284$1$I$$20240717$20240731$20240731$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16423$ALKEM$Frisaldi E, Ferrero B, Di Liberto A, Barbiani D, Camerone EM, Piedimonte A, Vollert J, Cavallo R, Zibetti M, Lopiano L, Shaibani A, Benedetti F.. The impact of patients^ pre-treatment expectations on immunosuppressive treatment outcomes in myasthenia gravis: A pilot correlational study. Muscle + Nerve. 2024;unk:1-7$34$YR$$F$Y$$$20240731$$HP$IT$IT
241552852$24155285$2$F$20240101$20240802$20240731$20240808$EXP$$CA-CELLTRION INC.-2024CA018183$CELLTRION$$$$$$Y$$$20240808$$HP$CA$CA
241552861$24155286$1$I$$20240723$20240731$20240731$EXP$$IE-TAKEDA-2024TUS074730$TAKEDA$$$$$$Y$$$20240731$$MD$IE$IE
241552871$24155287$1$I$$20240725$20240731$20240731$EXP$$US-Stemline Therapeutics, Inc.-2024ST004565$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240726$$CN$US$US
241552881$24155288$1$I$$20240725$20240731$20240731$EXP$$US-ROCHE-10000038118$ROCHE$$$$A$F$Y$$$20240731$$MD$US$US
241552891$24155289$1$I$$20240725$20240731$20240731$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06724$VIFOR$$$$A$F$Y$$$20240731$$CN$ZA$ZA
241552901$24155290$1$I$$20240725$20240731$20240731$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06723$VIFOR$$$$A$F$Y$$$20240731$$HP$ZA$ZA
241552911$24155291$1$I$20240301$20240723$20240731$20240731$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06638$VIFOR$$42$YR$$M$Y$$$20240731$$HP$ZA$ZA
241552921$24155292$1$I$20240209$20240723$20240731$20240731$EXP$$BR-CELLTRION INC.-2024BR017401$CELLTRION$$$$$$Y$$$20240731$$CN$BR$BR
241552931$24155293$1$I$$20240724$20240731$20240731$EXP$$US-Stemline Therapeutics, Inc.-2024ST004520$STEMLINE THERAPEUTICS$$42$YR$A$F$Y$$$20240726$$CN$US$US
241552941$24155294$1$I$$20240724$20240731$20240731$EXP$ES-SANDOZ-SDZ2024ES062895$ES-ROCHE-10000035908$ROCHE$Ruiz-Nieto N, Aparicio-Collado H, Segura-Cerda A, Barea-Moya L, Zahonero-Ferriz A, Campillo-Alpera MS et.al. Primary central nervous system vasculitis: A diagnostic and therapeutic challenge. A series of 7 patients.. Neurologia. 2024;39(6):486-495. doi:10.1016/j.nrleng.2023.04.004$81$YR$E$M$Y$$$20240731$$HP$ES$ES
241552951$24155295$1$I$20240722$20240722$20240731$20240731$EXP$$US-Stemline Therapeutics, Inc.-2024ST004448$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240726$$CN$US$US
241552961$24155296$1$I$$20240727$20240731$20240731$PER$$US-JNJFOC-20240777275$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241552971$24155297$1$I$20240716$20240724$20240731$20240731$EXP$$CN-JNJFOC-20240768267$JOHNSON AND JOHNSON$$78$YR$E$F$Y$63$KG$20240731$$HP$CN$CN
241552981$24155298$1$I$$20240702$20240731$20240731$PER$$US-JNJFOC-20240718036$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240731$$CN$US$US
241552991$24155299$1$I$$20240724$20240731$20240731$EXP$$US-Stemline Therapeutics, Inc.-2024ST004512$STEMLINE THERAPEUTICS$$84$YR$E$F$Y$$$20240726$$CN$US$US
241553001$24155300$1$I$$20240729$20240731$20240731$PER$$US-ABBVIE-5859308$ABBVIE$$$$A$F$Y$$$20240731$$MD$US$US
241553012$24155301$2$F$$20240724$20240731$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST004533$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240801$$CN$US$US
241553021$24155302$1$I$$20240723$20240731$20240731$PER$$US-Stemline Therapeutics, Inc.-2024ST004475$STEMLINE THERAPEUTICS$$$$E$F$Y$$$20240729$$HP$US$US
241553031$24155303$1$I$$20240725$20240731$20240731$EXP$$BR-TAKEDA-2024TUS076151$TAKEDA$$17$YR$$$Y$$$20240731$$CN$BR$BR
241553042$24155304$2$F$20240503$20240916$20240731$20240923$EXP$$CA-TAKEDA-2024TUS039711$TAKEDA$$40$YR$$F$Y$$$20240923$$CN$CA$CA
241553052$24155305$2$F$20240725$20240813$20240731$20240819$EXP$$CA-TAKEDA-2024TUS076489$TAKEDA$$45$YR$$F$Y$$$20240819$$CN$CA$CA
241553061$24155306$1$I$20240101$20240726$20240731$20240731$EXP$$US-ABBVIE-5857025$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241553071$24155307$1$I$$20240730$20240731$20240731$EXP$$DE-ORGANON-O2407DEU002839$ORGANON$Schott-Seidenschwanz I, Muehlbauer B, Wille H.. Metamizole - a death trap?.. Bremen Medical Journal.. 2011;64(20)$25$YR$$F$Y$$$20240731$$MD$DE$DE
241553084$24155308$4$F$20240101$20240726$20240731$20240812$EXP$$US-ABBVIE-5825465$ABBVIE$$$$$F$Y$70$KG$20240812$$CN$US$US
241553091$24155309$1$I$$20240723$20240731$20240731$EXP$$US-ADC THERAPEUTICS SA-ADC-2024-000252$ADC THERAPEUTICS$$$$$M$Y$$$20240731$$MD$US$US
241553101$24155310$1$I$20220501$20240726$20240731$20240731$EXP$$US-INCYTE CORPORATION-2024IN007896$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241553111$24155311$1$I$$20240724$20240731$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001513$BLUEPRINT MEDICINES$$$$$$Y$$$20240731$$MD$US$US
241553121$24155312$1$I$20230101$20240724$20240731$20240731$EXP$$US-ABBVIE-5743020$ABBVIE$$$$$F$Y$111$KG$20240731$$CN$US$US
241553131$24155313$1$I$$20240730$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069453$SANDOZ$$$$$F$Y$$$20240731$$CN$US$US
241553141$24155314$1$I$20240101$20240723$20240731$20240731$EXP$$US-SA-2024SA223204$SANOFI AVENTIS$$66$YR$E$F$Y$94.347$KG$20240731$$MD$US$US
241553151$24155315$1$I$20240720$20240726$20240731$20240731$EXP$$US-INCYTE CORPORATION-2024IN007871$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241553161$24155316$1$I$20240727$20240729$20240731$20240731$EXP$$US-ABBVIE-5859043$ABBVIE$$92$YR$$F$Y$$$20240731$$HP$US$US
241553172$24155317$2$F$$20240727$20240731$20240802$EXP$$NVSC2024US154738$NOVARTIS$$$$$F$Y$$$20240802$$MD$US$US
241553181$24155318$1$I$$20240730$20240731$20240731$PER$$NVSC2024US156100$NOVARTIS$$$$$F$Y$$$20240731$$HP$US$US
241553191$24155319$1$I$20240712$20240730$20240731$20240731$EXP$$US-TAKEDA-2024TUS076556$TAKEDA$$43$YR$$M$Y$$$20240731$$CN$US$US
241553201$24155320$1$I$$20240723$20240731$20240731$EXP$$ZA-AstraZeneca-2024A167757$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$ZA$
241553211$24155321$1$I$$20240723$20240731$20240731$EXP$$VN-AstraZeneca-2024A171482$ASTRAZENECA$$71$YR$$M$Y$$$20240731$$HP$VN$
241553221$24155322$1$I$$20230502$20240731$20240731$EXP$$US-AstraZeneca-2023A102923$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241553231$24155323$1$I$20240717$20240729$20240731$20240731$EXP$$US-KYOWAKIRIN-2024KK018207$KYOWA$$$$$$Y$$$20240731$$HP$US$US
241553241$24155324$1$I$$20240730$20240731$20240731$EXP$$US-ABBVIE-5860644$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241553252$24155325$2$F$20240712$20240807$20240731$20240812$30DAY$$US-AMGEN-USASP2024149666$AMGEN$$67$YR$E$F$Y$$$20240812$$PH$US$US
241553261$24155326$1$I$20240101$20240724$20240731$20240731$EXP$$US-SA-2024SA221366$SANOFI AVENTIS$$$$$$Y$$$20240731$$HP$US$US
241553271$24155327$1$I$20240524$20240703$20240731$20240731$EXP$$US-NEBO-663182$PHARMACOSMOS$$39$YR$$F$Y$$$20240731$$HP$US$US
241553283$24155328$3$F$20230101$20240815$20240731$20240820$EXP$$US-ABBVIE-5382920$ABBVIE$$$$$M$Y$113.4$KG$20240820$$CN$US$US
241553293$24155329$3$F$$20240826$20240731$20240902$EXP$$US-ABBVIE-5855026$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
241553302$24155330$2$F$$20240730$20240731$20240806$EXP$$CA-TAKEDA-2024TUS074424$TAKEDA$$$$$F$Y$$$20240806$$CN$CA$CA
241553311$24155331$1$I$20240101$20240726$20240731$20240731$EXP$$US-ABBVIE-5858147$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241553321$24155332$1$I$20190101$20240725$20240731$20240731$EXP$FR-AFSSAPS-AN2024000948$FR-RDY-SPO/FRA/24/0011026$DR REDDYS$$51$YR$A$M$Y$98$KG$20240731$$PH$FR$FR
241553332$24155333$2$F$20240701$20240919$20240731$20240928$EXP$$CA-CELLTRION INC.-2024CA018191$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
241553341$24155334$1$I$20240101$20240717$20240731$20240731$EXP$$US-UCBSA-2024036564$UCB$$8$YR$$M$Y$$$20240731$$CN$US$US
241553351$24155335$1$I$20231201$20240729$20240731$20240731$EXP$$JP-ABBVIE-5859802$ABBVIE$$74$YR$$M$Y$72$KG$20240731$$MD$JP$JP
241553361$24155336$1$I$$20240723$20240731$20240731$EXP$$US-TAKEDA-2024TUS075272$TAKEDA$$$$$M$Y$$$20240731$$MD$US$US
241553382$24155338$2$F$$20240819$20240731$20240830$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07468$LUPIN$$$$$$Y$$$20240830$$MD$US$US
241553391$24155339$1$I$$20240726$20240731$20240731$EXP$$US-SA-2024SA222020$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240731$$MD$US$US
241553402$24155340$2$F$$20240730$20240731$20240805$EXP$$DE-JNJFOC-20240779951$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240804$$MD$DE$DE
241553432$24155343$2$F$20230309$20240919$20240731$20240923$EXP$$AU-TAKEDA-2023TUS025887$TAKEDA$$71$YR$$M$Y$$$20240923$$CN$AU$AU
241553441$24155344$1$I$$20240725$20240731$20240731$EXP$$US-TAKEDA-2024TUS075561$TAKEDA$$$$$F$Y$$$20240731$$CN$US$US
241553452$24155345$2$F$$20240730$20240731$20240803$PER$$US-ELI_LILLY_AND_COMPANY-US202407018775$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240803$$CN$US$US
241553461$24155346$1$I$20240401$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018895$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240731$$CN$US$US
241553471$24155347$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019125$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240731$$CN$US$US
241553481$24155348$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018973$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240731$$CN$US$US
241553491$24155349$1$I$20240718$20240718$20240731$20240731$PER$$US-ALVOTECHPMS-2024-ALVOTECHPMS-002053$Alvotech$$42$YR$$F$Y$77.11$KG$20240731$$CN$US$
241553501$24155350$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019049$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240731$$CN$US$US
241553512$24155351$2$F$20240708$20240918$20240731$20240920$EXP$$US-KYOWAKIRIN-2024KK018124$KYOWA$$$$$$Y$$$20240920$$HP$US$US
241553521$24155352$1$I$20230912$20240726$20240731$20240731$EXP$$CZ-ABBVIE-5856011$ABBVIE$$73$YR$$F$Y$$$20240731$$HP$CZ$CZ
241553531$24155353$1$I$$20240729$20240731$20240731$EXP$$US-TAKEDA-2024TUS076233$TAKEDA$$$$$F$Y$$$20240731$$CN$US$US
241553551$24155355$1$I$$20240726$20240731$20240731$EXP$$US-INCYTE CORPORATION-2024IN007866$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241553571$24155357$1$I$20240101$20240726$20240731$20240731$EXP$$US-SA-2024SA222449$SANOFI AVENTIS$$$$$$Y$$$20240731$$MD$US$US
241553581$24155358$1$I$20240730$20240730$20240731$20240731$PER$$NVSC2024US156112$NOVARTIS$$61$YR$$F$Y$$$20240731$$CN$US$US
241553592$24155359$2$F$$20240726$20240731$20240805$PER$$NVSC2024US154865$NOVARTIS$$$$$F$Y$$$20240805$$CN$US$US
241553602$24155360$2$F$$20240722$20240731$20240820$EXP$$US-TEVA-VS-3226019$TEVA$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J-Ophthalmic-Inflamm-Infect 2024; 14.; Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J-Ophthalmic-Inflamm-Infect 2024; 14.; Karaca I, Tra...$50$YR$$M$Y$$$20240820$$HP$US$US
241553611$24155361$1$I$20240718$20240720$20240731$20240731$EXP$$DE-AUROBINDO-AUR-APL-2024-036963$AUROBINDO$$63$YR$$F$Y$$$20240731$$MD$DE$DE
241553622$24155362$2$F$20240405$20240920$20240731$20240923$EXP$$AU-ROCHE-10000035088$ROCHE$$26$YR$A$F$Y$$$20240923$$MD$AU$AU
241553631$24155363$1$I$20240723$20240723$20240731$20240731$PER$$US-CSL-2024-006948$CSL Plasma$$38$YR$$M$Y$$$20240731$$HP$US$US
241553641$24155364$1$I$$20240731$20240731$20240731$PER$$US-ROCHE-10000043150$ROCHE$$$$$F$Y$$$20240731$$CN$US$US
241553651$24155365$1$I$20240614$20240703$20240731$20240731$EXP$$US-NEBO-663180$PHARMACOSMOS$$25$YR$$F$Y$$$20240731$$HP$US$US
241553661$24155366$1$I$20240629$20240724$20240731$20240731$EXP$$CN-ABBVIE-5858278$ABBVIE$$73$YR$$F$Y$55$KG$20240731$$HP$CN$CN
241553671$24155367$1$I$20240610$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-037017$AUROBINDO$$15$YR$$F$Y$$$20240731$$MD$FR$FR
241553681$24155368$1$I$20240203$20240726$20240731$20240731$EXP$$US-TAKEDA-2023TUS082418$TAKEDA$$27$YR$$M$Y$$$20240731$$CN$US$US
241553701$24155370$1$I$20240713$20240726$20240731$20240731$EXP$$US-KYOWAKIRIN-2024KK018142$KYOWA$$$$$$Y$$$20240731$$HP$US$US
241553711$24155371$1$I$$20240723$20240731$20240731$EXP$$NVSC2024MX153995$NOVARTIS$$$$$F$Y$74$KG$20240731$$CN$MX$MX
241553721$24155372$1$I$20240101$20240726$20240731$20240731$EXP$$CA-ABBVIE-5857544$ABBVIE$$19$YR$$F$Y$45.3$KG$20240731$$CN$CA$CA
241553731$24155373$1$I$20240101$20240715$20240731$20240731$PER$$US-TEVA-VS-3221742$TEVA$$$$$F$Y$$$20240731$$PH$US$US
241553741$24155374$1$I$$20240724$20240731$20240731$PER$$US-BIOGEN-2024BI01275297$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
241553751$24155375$1$I$20240601$20240726$20240731$20240731$EXP$$US-ABBVIE-5856959$ABBVIE$$74$YR$$M$Y$$$20240731$$CN$US$US
241553761$24155376$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5856580$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241553771$24155377$1$I$20240101$20240730$20240731$20240731$EXP$$US-GILEAD-2024-0682357$GILEAD$$64$YR$A$M$Y$$$20240731$$CN$US$US
241553781$24155378$1$I$$20240727$20240731$20240731$EXP$$US-ABBVIE-5858215$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241553792$24155379$2$F$20240101$20240807$20240731$20240809$EXP$$US-ABBVIE-5858263$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241553801$24155380$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5859648$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241553812$24155381$2$F$$20240827$20240731$20240828$PER$$US-JNJFOC-20240773067$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
241553821$24155382$1$I$$20240712$20240731$20240731$PER$$US-JNJFOC-20240737196$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241553831$24155383$1$I$$20240723$20240731$20240731$EXP$$JP-AstraZeneca-2024A168801$ASTRAZENECA$$$$$$Y$$$20240731$$PH$JP$
241553841$24155384$1$I$20240301$20240717$20240731$20240731$EXP$$RU-ROCHE-10000030471$ROCHE$$$$$F$Y$$$20240731$$CN$RU$RU
241553851$24155385$1$I$20240713$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171534$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241553862$24155386$2$F$20240728$20240812$20240731$20240814$PER$$US-AMGEN-USASP2024150907$AMGEN$$74$YR$E$F$Y$$$20240814$$CN$US$US
241553872$24155387$2$F$20240729$20240801$20240731$20240806$PER$$US-AMGEN-USASP2024150667$AMGEN$$76$YR$E$F$Y$$$20240806$$HP$US$US
241553881$24155388$1$I$$20210709$20240731$20240731$EXP$$US-AstraZeneca-2021A614054$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241553891$24155389$1$I$20211209$20220216$20240731$20240731$EXP$$US-AstraZeneca-2022A077855$ASTRAZENECA$$23857$DY$$$Y$$$20240731$$CN$US$
241553901$24155390$1$I$$20210408$20240731$20240731$EXP$$US-AstraZeneca-2021A301765$ASTRAZENECA$$$$$F$Y$$$20240731$$MD$US$
241553911$24155391$1$I$$20230920$20240731$20240731$EXP$$US-AstraZeneca-2023A215423$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241553921$24155392$1$I$$20240723$20240731$20240731$EXP$$IN-AstraZeneca-2024A168794$ASTRAZENECA$$62$YR$$M$Y$$$20240731$$CN$IN$
241553934$24155393$4$F$$20240809$20240731$20240819$EXP$$CA-TAKEDA-2024TUS076549$TAKEDA$$$$$M$Y$$$20240819$$CN$CA$CA
241553941$24155394$1$I$$20240723$20240731$20240731$EXP$$JP-TAKEDA-2024TUS067259$TAKEDA$$8$DEC$$M$Y$$$20240731$$MD$JP$JP
241553951$24155395$1$I$$20240729$20240731$20240731$EXP$$US-TAKEDA-2024TUS076466$TAKEDA$$$$$M$Y$$$20240731$$CN$US$US
241553961$24155396$1$I$20240708$20240715$20240731$20240731$PER$$US-ALMUS-US-2024-1717$ALMUS$$58$YR$A$M$Y$95.25$KG$20240731$$CN$US$US
241553971$24155397$1$I$$20240723$20240731$20240731$EXP$$GB-CELLTRION INC.-2024GB018150$CELLTRION$$$$$$Y$$$20240731$$CN$GB$GB
241553982$24155398$2$F$$20240822$20240731$20240831$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202407-000180$AZURITY PHARMACEUTICALS$$$$$F$Y$$$20240831$$CN$US$US
241553991$24155399$1$I$20240701$20240730$20240731$20240731$EXP$$AU-ABBVIE-5860031$ABBVIE$$72$YR$$M$Y$$$20240731$$CN$AU$AU
241554002$24155400$2$F$$20240731$20240731$20240806$EXP$$CA-TAKEDA-2024TUS074887$TAKEDA$$$$$F$Y$$$20240806$$CN$CA$CA
241554017$24155401$7$F$20240101$20240919$20240731$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022688$UNITED THERAPEUTICS$$$$$F$Y$68.481$KG$20240925$$$US$US
241554021$24155402$1$I$20240307$20240722$20240731$20240731$EXP$IT-MINISAL02-994906$IT-TEVA-VS-3224597$TEVA$$65$YR$$M$Y$$$20240731$$MD$IT$IT
241554031$24155403$1$I$20240701$20240725$20240731$20240731$EXP$$CA-TAKEDA-2024TUS075875$TAKEDA$$60$YR$$F$Y$$$20240731$$CN$CA$CA
241554042$24155404$2$F$20230302$20240918$20240731$20240924$EXP$$CA-TAKEDA-2022TUS003108$TAKEDA$$58$YR$$F$Y$$$20240924$$CN$CA$CA
241554052$24155405$2$F$20230923$20240731$20240731$20240802$EXP$$NO-TAKEDA-2024TUS076495$TAKEDA$$52$YR$$F$Y$$$20240802$$HP$NO$NO
241554061$24155406$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5859510$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241554072$24155407$2$F$$20240730$20240731$20240802$PER$$US-JNJFOC-20240771259$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$CN$US$US
241554082$24155408$2$F$20240728$20240823$20240731$20240827$PER$$US-AMGEN-USASP2024150659$AMGEN$$89$YR$E$F$Y$$$20240827$$CN$US$US
241554091$24155409$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150666$AMGEN$$$$$F$Y$$$20240731$$PH$US$US
241554112$24155411$2$F$$20240726$20240731$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-036517$AUROBINDO$Sahloul O, Louapre C, Beigneux Y, Lubetzki C, Maillart E, Roux T.. Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapies.. Mult-SclerRelat-Dis. 2024;85:1-8$$$A$F$Y$$$20240807$$MD$FR$FR
241554121$24155412$1$I$$20240724$20240731$20240731$EXP$$CA-VANTIVE-2024VAN018621$Vantive US Healthcare$$$$$F$Y$$$20240731$$CN$CA$CA
241554131$24155413$1$I$20220726$20240722$20240731$20240731$EXP$$US-VANTIVE-2024VAN018585$Vantive US Healthcare$$$$$M$Y$$$20240731$$HP$US$US
241554143$24155414$3$F$20240704$20240828$20240731$20240904$EXP$$GB-VANTIVE-2024VAN018364$Vantive US Healthcare$$41$YR$$F$Y$$$20240904$$HP$GB$GB
241554152$24155415$2$F$$20240719$20240731$20240802$EXP$$US-SUNPHARMA-2024R1-459599AA$RANBAXY$Gault KS. The Role of Physical Therapy Within A Multidisciplinary Pancreatic Cancer Clinic to Optimize Care. Rehabil Oncol. 2024;42 (2):119$78$YR$$F$Y$$$20240802$$HP$US$US
241554161$24155416$1$I$$20240718$20240731$20240731$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001032$ALEMBIC$Kirven R.M, Fisher K, Kaffenberger B.H, Chung C.G, Korman A.M.. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024;316 (6) 279:1-5$$$$$Y$$$20240731$$HP$US$US
241554171$24155417$1$I$20240610$20240729$20240731$20240731$EXP$$US-ABBVIE-5859474$ABBVIE$$23$YR$$M$Y$$$20240731$$CN$US$US
241554182$24155418$2$F$20240101$20240821$20240731$20240826$EXP$$US-ABBVIE-5859956$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
241554191$24155419$1$I$20240501$20240726$20240731$20240731$EXP$$US-KYOWAKIRIN-2024KK018144$KYOWA$$$$$$Y$$$20240731$$HP$US$US
241554201$24155420$1$I$$20240718$20240731$20240731$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001042$ALEMBIC$Preskorn S.H, Masolak D.D.. Cerebral Anoxia in an 18-year-old Patient Being Treated for Major Depressive Disorder: How Forensic Detective Work Uses Medical Knowledge Including Clinical Pharmacology to Solve Cases. Journal of Psychiatric Practice. 2024;30 (3):212-219$$$$$Y$$$20240731$$MD$US$US
241554211$24155421$1$I$20240718$20240729$20240731$20240731$EXP$$US-TAKEDA-2024TUS076541$TAKEDA$$85$YR$$F$Y$$$20240731$$CN$US$US
241554222$24155422$2$F$20240629$20240730$20240731$20240806$EXP$$US-TAKEDA-2024TUS068554$TAKEDA$$44$YR$$M$Y$87.07$KG$20240806$$CN$US$US
241554231$24155423$1$I$20240623$20240729$20240731$20240731$EXP$$US-TAKEDA-2024TUS008433$TAKEDA$$62$YR$$F$Y$$$20240731$$MD$US$US
241554241$24155424$1$I$$20240729$20240731$20240731$EXP$$CA-ABBVIE-5859436$ABBVIE$$$$E$F$Y$$$20240731$$HP$CA$CA
241554251$24155425$1$I$$20240729$20240731$20240731$PER$$US-JNJFOC-20240778554$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241554262$24155426$2$F$$20240807$20240731$20240928$PER$$US-JNJFOC-20240764030$JOHNSON AND JOHNSON$$$$$M$Y$$$20240928$$CN$US$US
241554271$24155427$1$I$20240716$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150974$AMGEN$$70$YR$E$F$Y$$$20240731$$CN$US$US
241554281$24155428$1$I$$20240726$20240731$20240731$EXP$$US-AMGEN-USASP2024149176$AMGEN$Mainero C.; Herranz E.; Treaba C.A. et al.. Characterization of cortico-meningeal translocator protein expression in multiple sclerosis. Brain. 2024;147:2566-2578$$$$$Y$$$20240731$$MD$US$US
241554291$24155429$1$I$$20240725$20240731$20240731$EXP$$JP-EXELIXIS-CABO-24079987$EXELIXIS$$6$DEC$$M$Y$$$20240731$$MD$JP$JP
241554302$24155430$2$F$20240414$20240909$20240731$20240912$EXP$$JP-EXELIXIS-CABO-24079995$EXELIXIS$$79$YR$$M$Y$64$KG$20240912$$MD$JP$JP
241554311$24155431$1$I$20210101$20240724$20240731$20240731$EXP$$NVSC2024US152951$NOVARTIS$$$$$$Y$$$20240731$$CN$US$US
241554322$24155432$2$F$$20240820$20240731$20240823$EXP$$IT-TAKEDA-2024TUS076545$TAKEDA$$$$$M$Y$$$20240823$$CN$IT$IT
241554331$24155433$1$I$$20240729$20240731$20240731$EXP$$US-TAKEDA-2024TUS076574$TAKEDA$$$$$M$Y$$$20240731$$CN$US$US
241554344$24155434$4$F$20240502$20240821$20240731$20240828$EXP$$BE-EXELIXIS-XL18424077703$EXELIXIS$$$$$$Y$$$20240828$$MD$BE$BE
241554353$24155435$3$F$20240710$20240711$20240731$20240802$30DAY$$US-UCBSA-2024035970$UCB$$64$YR$$F$Y$$$20240802$$CN$US$US
241554361$24155436$1$I$20240729$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019607$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240731$$CN$US$US
241554371$24155437$1$I$20240708$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018985$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240731$$CN$US$US
241554381$24155438$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017645$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$US$US
241554392$24155439$2$F$$20240827$20240731$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202407019506$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240829$$HP$US$US
241554401$24155440$1$I$20240701$20240725$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017842$ELI LILLY AND CO$$$$A$F$Y$$$20240731$$CN$US$US
241554411$24155441$1$I$20240729$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019331$ELI LILLY AND CO$$44$YR$A$$Y$$$20240731$$CN$US$US
241554421$24155442$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019544$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240731$$CN$US$US
241554431$24155443$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019517$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240731$$HP$US$US
241554441$24155444$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019031$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240731$$CN$US$US
241554451$24155445$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019625$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240731$$CN$US$US
241554461$24155446$1$I$20240717$20240726$20240731$20240731$EXP$$US-TAKEDA-2024TUS035740$TAKEDA$$32$YR$$M$Y$$$20240731$$CN$US$US
241554471$24155447$1$I$$20240730$20240731$20240731$PER$$NVSC2024US156092$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
241554481$24155448$1$I$$20240725$20240731$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-023181$UNITED THERAPEUTICS$$$$$F$Y$81.633$KG$20240731$$$US$US
241554492$24155449$2$F$20240701$20240902$20240731$20240909$EXP$$PK-ROCHE-10000042230$ROCHE$$49$YR$A$F$Y$55$KG$20240909$$CN$PK$PK
241554504$24155450$4$F$20240703$20240905$20240731$20240908$EXP$$US-ROCHE-10000035226$ROCHE$$56$YR$A$M$Y$86.5$KG$20240908$$MD$US$US
241554511$24155451$1$I$20230709$20240723$20240731$20240731$EXP$$CO-SANDOZ INC.-SDZ2024CO069004$SANDOZ$$39$YR$$F$Y$60$KG$20240731$$CN$CO$CO
241554521$24155452$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A168260$ASTRAZENECA$$$$$F$Y$$$20240731$$MD$US$
241554531$24155453$1$I$$20210924$20240731$20240731$EXP$$US-AstraZeneca-2021A747820$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241554541$24155454$1$I$$20240717$20240731$20240731$EXP$$JP-UCBSA-2024036872$UCB$$2$YR$$$Y$$$20240731$$MD$JP$JP
241554551$24155455$1$I$$20210713$20240731$20240731$EXP$$US-AstraZeneca-2021A620307$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241554561$24155456$1$I$20230911$20230920$20240731$20240731$EXP$$US-AstraZeneca-2023A215019$ASTRAZENECA$$60$YR$$F$Y$$$20240731$$CN$US$
241554571$24155457$1$I$$20221220$20240731$20240731$EXP$$US-AstraZeneca-2022A414134$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241554581$24155458$1$I$$20230914$20240731$20240731$EXP$$US-AstraZeneca-2023A210715$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241554591$24155459$1$I$$20210915$20240731$20240731$EXP$$US-AstraZeneca-2021A733579$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241554601$24155460$1$I$20240715$20240723$20240731$20240731$EXP$$TW-AstraZeneca-2024A167945$ASTRAZENECA$$14453$DY$$F$Y$$$20240731$$CN$TW$
241554611$24155461$1$I$$20230130$20240731$20240731$EXP$$US-AstraZeneca-2023A025949$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241554621$24155462$1$I$$20220216$20240731$20240731$EXP$$US-AstraZeneca-2022A076658$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241554641$24155464$1$I$20240301$20240724$20240731$20240731$EXP$$CA-CELLTRION INC.-2024CA009578$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
241554651$24155465$1$I$$20240722$20240731$20240731$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-22754$SAMSUNG BIOEPIS$$81$YR$E$F$Y$$$20240731$$CN$GB$GB
241554661$24155466$1$I$$20240719$20240731$20240731$EXP$$US-SAMSUNG BIOEPIS-SB-2024-22481$SAMSUNG BIOEPIS$Urquhart S. Use of Upadacitinib as Salvage Therapy for Ulcerative Colitis in Pregnancy: A Case Report. Infammatory Bowel Diseases. 2024 JUL 05;1-2. doi:https://doi.org/10.1093/ibd/izae146$33$YR$A$F$Y$$$20240731$$MD$US$US
241554671$24155467$1$I$20240712$20240723$20240731$20240731$EXP$$KR-SAMSUNG BIOEPIS-SB-2024-22779$SAMSUNG BIOEPIS$$84$YR$E$M$Y$$$20240731$$HP$KR$KR
241554681$24155468$1$I$$20240725$20240731$20240731$EXP$US-MLMSERVICE-20240718-PI136191-00099-1$US-RDY-SPO/USA/24/0011089$DR REDDYS$Krishnamoorthy S, Kaur R, Ameer N, Uzoma AA, Enemuo NR, Gopal S, et al. Type I Kounis Syndrome: Allergic Myocardial Infarction Triggered by Ciprofloxacin. Cureus. 2024;16(6):e62460. DOI: 10.7759/cureus.62460.$35$YR$A$F$Y$$$20240731$$MD$US$US
241554701$24155470$1$I$$20240726$20240731$20240731$EXP$$US-KYOWAKIRIN-2024KK018224$KYOWA$$$$$$Y$$$20240731$$HP$US$US
241554712$24155471$2$F$$20240816$20240731$20240827$EXP$$US-ROCHE-RCA5176768$ROCHE$$80$YR$E$M$Y$110.22$KG$20240827$$CN$US$US
241554721$24155472$1$I$$20240725$20240731$20240731$EXP$$CA-AMGEN-CANSP2024149142$AMGEN$$44$YR$A$F$Y$$$20240731$$CN$CA$CA
241554731$24155473$1$I$20240327$20240718$20240731$20240731$EXP$FR-AFSSAPS-TO2024001134$FR-ROCHE-10000030636$ROCHE$$77$YR$E$M$Y$88$KG$20240731$$PH$FR$FR
241554741$24155474$1$I$20240601$20240722$20240731$20240731$PER$$US-TAKEDA-2024TUS074546$TAKEDA$$$$A$M$Y$$$20240731$$HP$US$US
241554751$24155475$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151513$AMGEN$$$$$$Y$$$20240731$$PH$US$US
241554761$24155476$1$I$$20240722$20240731$20240731$EXP$$US-TEVA-VS-3223219$TEVA$$73$YR$$F$Y$$$20240731$$PH$US$US
241554772$24155477$2$F$$20240730$20240731$20240731$PER$$US-GILEAD-2024-0682380$GILEAD$$24$YR$A$M$Y$$$20240731$$HP$US$US
241554781$24155478$1$I$20200304$20240726$20240731$20240731$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-15012$IPSEN$$68$YR$E$M$Y$$$20240731$$MD$CA$CA
241554791$24155479$1$I$$20240723$20240731$20240731$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009419$STRIDES$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al.. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$$$$$Y$$$20240731$$HP$US$US
241554801$24155480$1$I$$20240719$20240731$20240731$EXP$$CA-ROCHE-10000037682$ROCHE$$31$YR$A$F$Y$$$20240731$$CN$CA$CA
241554811$24155481$1$I$20220701$20240726$20240731$20240731$EXP$$ES-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00392$VELOXIS PHARMACEUTICALS$Jimenez Alvaro S, Galeano ?lvarez C, Elias Trevino S, Ferreria Bermejo M, Fernandez Lucas M.. Safe immunosuppression. New tool for personalized immunosuppressant treatment in renal transplantation. A case report.. Archives of Organ Transplantation.. 2024;9(1):5-8$$$E$M$Y$$$20240731$$HP$ES$ES
241554821$24155482$1$I$$20240728$20240731$20240731$PER$$US-AMGEN-USASP2024150126$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241554843$24155484$3$F$20240701$20240820$20240731$20240825$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-117002$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240826$$PH$DE$DE
241554851$24155485$1$I$20231114$20240730$20240731$20240731$EXP$FR-AFSSAPS-NY2024000787$FR-ROCHE-10000042393$ROCHE$$$$A$F$Y$$$20240731$$MD$FR$FR
241554861$24155486$1$I$$20240717$20240731$20240731$PER$$US-JNJFOC-20240748764$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241554875$24155487$5$F$20130101$20240904$20240731$20240906$EXP$$FR-SANDOZ INC.-PHHY2017FR202265$SANDOZ$$78$YR$$F$Y$$$20240906$$CN$FR$FR
241554881$24155488$1$I$20240601$20240717$20240731$20240731$EXP$$US-UCBSA-2024036571$UCB$$45$YR$$M$Y$$$20240731$$HP$US$US
241554891$24155489$1$I$$20240725$20240731$20240731$PER$$US-ABBVIE-5857301$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241554911$24155491$1$I$$20240730$20240731$20240731$PER$$US-HALEON-2189743$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241554921$24155492$1$I$$20240730$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069437$SANDOZ$$$$$F$Y$$$20240731$$CN$US$US
241554931$24155493$1$I$$20240729$20240731$20240731$EXP$$CA-ORGANON-O2407CAN002678$ORGANON$$$$$F$Y$$$20240731$$HP$CA$CA
241554941$24155494$1$I$$20240718$20240731$20240731$PER$$US-TAKEDA-2024TUS075367$TAKEDA$$75$YR$$M$Y$$$20240731$$CN$US$US
241554951$24155495$1$I$$20240702$20240731$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06808$LUPIN$$$$$$Y$$$20240731$$CN$US$US
241554961$24155496$1$I$20240101$20240729$20240731$20240731$EXP$$US-ABBVIE-5859295$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241554971$24155497$1$I$$20240725$20240731$20240731$EXP$$IN-ROCHE-10000036457$ROCHE$Kapoor M, Sundriyal D, Sehrawat A, Khanna M. Carcinoma en Cuirasse as the heralding sign of underlying HER-2 positive male breast cancer. BMJ Case Reports. 2024-Jul-08;17 (7):1-4. doi:10.1136/bcr-2023-259535.$$$A$M$Y$$$20240731$$MD$IN$IN
241554981$24155498$1$I$$20240730$20240731$20240731$EXP$$KR-GILEAD-2024-0682401$GILEAD$$$$$F$Y$$$20240731$$CN$KR$KR
241554991$24155499$1$I$$20240725$20240731$20240731$EXP$$NVSC2024GR154721$NOVARTIS$$$$$M$Y$$$20240731$$MD$GR$GR
241555012$24155501$2$F$20240101$20240806$20240731$20240809$EXP$$US-ABBVIE-5809203$ABBVIE$$$$$F$Y$48$KG$20240809$$CN$US$US
241555022$24155502$2$F$$20240820$20240731$20240831$EXP$$CA-UCBSA-2024038111$UCB$$$$$M$Y$$$20240831$$CN$CA$CA
241555031$24155503$1$I$20240608$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171183$ASTRAZENECA$$26627$DY$$$Y$$$20240731$$HP$US$
241555041$24155504$1$I$$20210908$20240731$20240731$EXP$$US-AstraZeneca-2021A721490$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241555051$24155505$1$I$20240701$20240723$20240731$20240731$EXP$$FR-AstraZeneca-2024A167134$ASTRAZENECA$$69$YR$$M$Y$$$20240731$$MD$FR$
241555061$24155506$1$I$$20230404$20240731$20240731$EXP$$US-AstraZeneca-2023A079606$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241555071$24155507$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A168220$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241555081$24155508$1$I$20210317$20210617$20240731$20240731$EXP$$US-AstraZeneca-2021A540016$ASTRAZENECA$$83$YR$$F$Y$54.4$KG$20240731$$CN$US$
241555091$24155509$1$I$$20230608$20240731$20240731$EXP$$US-AstraZeneca-2023A134335$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241555101$24155510$1$I$20240729$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150669$AMGEN$$74$YR$E$M$Y$$$20240731$$CN$US$US
241555111$24155511$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150610$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241555121$24155512$1$I$20240101$20240724$20240731$20240731$PER$$US-AMGEN-USASP2024150449$AMGEN$$$$A$$Y$$$20240731$$CN$US$US
241555131$24155513$1$I$20240725$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024148375$AMGEN$$43$YR$A$F$Y$$$20240731$$PH$US$US
241555141$24155514$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019629$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240731$$CN$US$US
241555151$24155515$1$I$$20240728$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019365$ELI LILLY AND CO$$$$$M$Y$$$20240731$$CN$US$US
241555161$24155516$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018871$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240731$$CN$US$US
241555171$24155517$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019598$ELI LILLY AND CO$$77$YR$E$$Y$$$20240731$$CN$US$US
241555181$24155518$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019619$ELI LILLY AND CO$$46$YR$A$$Y$$$20240731$$CN$US$US
241555191$24155519$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019611$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240731$$CN$US$US
241555201$24155520$1$I$20240524$20240722$20240731$20240731$EXP$IT-MINISAL02-995763$IT-SERVIER-S24009268$SERVIER$$$$$$Y$$$20240731$$PH$IT$IT
241555211$24155521$1$I$$20240726$20240731$20240731$PER$$US-LEO Pharma-372366$LEO PHARM$$62$YR$$F$Y$$$20240731$$PH$US$US
241555221$24155522$1$I$$20240723$20240731$20240731$EXP$$VE-ROCHE-10000037327$ROCHE$$61$YR$A$F$Y$56$KG$20240731$$MD$VE$VE
241555232$24155523$2$F$20240720$20240731$20240731$20240808$PER$$FR-Blueprint Medicines Corporation-SP-FR-2024-001522$BLUEPRINT MEDICINES$$45$YR$A$F$Y$$$20240809$$PH$FR$FR
241555241$24155524$1$I$20240705$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-037069$AUROBINDO$$60$YR$$F$Y$72$KG$20240731$$MD$FR$FR
241555252$24155525$2$F$20240728$20240730$20240731$20240801$PER$$US-AMGEN-USASP2024150905$AMGEN$$77$YR$E$F$Y$$$20240731$$CN$US$US
241555271$24155527$1$I$$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024148047$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et. al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$65$YR$E$$Y$$$20240731$$HP$US$US
241555281$24155528$1$I$$20240725$20240731$20240731$PER$$US-ABBVIE-5856641$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241555291$24155529$1$I$20210210$20240724$20240731$20240731$EXP$$KR-GSK-KR2024GSK094655$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$KR$KR
241555301$24155530$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812330$AU-Accord-437260$ACCORD$$$$$F$Y$$$20240731$$HP$AU$AU
241555311$24155531$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812331$AU-Accord-437259$ACCORD$$$$$F$Y$$$20240731$$HP$AU$AU
241555321$24155532$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812683$AU-Accord-437243$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241555331$24155533$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812262$AU-Accord-437278$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241555341$24155534$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812255$AU-Accord-437284$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241555351$24155535$1$I$$20240719$20240731$20240731$EXP$$BE-ASPEN-GLO2024BE005044$ASPEN$Dekock T, Taelman T, Vanhaverbeke G, Derijcke S, Ghysen K.. Immunotherapy-induced diabetes mellitus: A case study.. Tijdschrift voor Geneeskunde en Gezondheidszorg. 2024;80(7):585-93$$$$$Y$$$20240731$$MD$BE$BE
241555361$24155536$1$I$$20240726$20240731$20240731$EXP$$BE-ROCHE-10000040802$ROCHE$$$$$F$Y$$$20240731$$MD$BE$BE
241555371$24155537$1$I$$20240720$20240731$20240731$EXP$CA-MHPD-E2B_07152587$CA-Accord-437449$ACCORD$$$$E$M$Y$$$20240731$$HP$CA$CA
241555381$24155538$1$I$$20240722$20240731$20240731$EXP$$US-Accord-438251$ACCORD$$29$YR$A$M$Y$$$20240731$$PH$US$US
241555391$24155539$1$I$20240603$20240720$20240731$20240731$EXP$$US-Accord-437687$ACCORD$$64$YR$A$M$Y$$$20240731$$HP$US$US
241555402$24155540$2$F$$20240807$20240731$20240902$EXP$$JP-Accord-436155$ACCORD$Naganawa H, Katada Y, Nakagawa S, Umemura K, Ishimura H, Kajiwara M, et al. Influence of ensitrelvir or nirmatrelvir/ritonavir on tacrolimus clearance in kidney transplant recipients: a single-center case series. J Pharm Health Care Sci. 2024 Jul 10;10(1):37.$8$DEC$E$M$Y$59.2$KG$20240902$$HP$JP$JP
241555411$24155541$1$I$$20240722$20240731$20240731$EXP$AU-TGA-813096$AU-Accord-437360$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241555421$24155542$1$I$$20240722$20240731$20240731$EXP$AU-TGA-812434$AU-Accord-437375$ACCORD$$32$YR$$F$Y$$$20240731$$HP$AU$AU
241555431$24155543$1$I$$20240720$20240731$20240731$EXP$CA-MHPD-E2B_07130002$CA-Accord-437443$ACCORD$$83$YR$E$M$Y$$$20240731$$CN$CA$CA
241555441$24155544$1$I$20240606$20240720$20240731$20240731$EXP$ES-AEMPS-1549718$ES-Accord-438048$ACCORD$$83$YR$E$F$Y$$$20240731$$MD$ES$ES
241555451$24155545$1$I$20230101$20240719$20240731$20240731$EXP$$ES-Accord-437378$ACCORD$Posado-Dominguez L, Figuero-Perez L, Olivares-Hernandez A, Chinchilla-Tabora L, Antunez-Plaza P, Rivas-Hernandez R, et al. Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review. Chinese Clinical Oncology. 2024;13(3): DOI:10.21037/cco-23-146.$65$YR$E$M$Y$$$20240731$$MD$ES$ES
241555462$24155546$2$F$20240723$20240918$20240731$20240928$EXP$$CA-CELLTRION INC.-2024CA017974$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
241555471$24155547$1$I$20240705$20240718$20240731$20240731$EXP$$CN-ROCHE-10000031001$ROCHE$$54$YR$A$F$Y$$$20240731$$HP$CN$CN
241555481$24155548$1$I$20240516$20240719$20240731$20240731$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-096028$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240731$$MD$JP$JP
241555491$24155549$1$I$$20240715$20240731$20240731$PER$$US-JNJFOC-20240741414$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241555501$24155550$1$I$20240415$20240718$20240731$20240731$PER$$US-JNJFOC-20240752380$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240731$$CN$US$US
241555511$24155551$1$I$$20240725$20240731$20240731$EXP$$US-JNJFOC-20240768971$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$MD$US$US
241555522$24155552$2$F$20240712$20240722$20240731$20240803$EXP$$DE-AUROBINDO-AUR-APL-2024-036488$AUROBINDO$$68$YR$$M$Y$70$KG$20240803$$MD$DE$DE
241555531$24155553$1$I$$20240717$20240731$20240731$PER$$US-TEVA-VS-3222727$TEVA$$$$E$M$Y$$$20240731$$CN$US$US
241555541$24155554$1$I$20240726$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150302$AMGEN$$56$YR$A$F$Y$$$20240731$$HP$US$US
241555552$24155555$2$F$$20240815$20240731$20240820$PER$$US-AMGEN-USASP2024151095$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
241555561$24155556$1$I$$20240730$20240731$20240731$PER$$US-AMGEN-USASP2024150915$AMGEN$Azarcon C.P.; Raralio C.A.; Williams R. et al.. nm laser for sub-internal limiting membrane hemorrhage associated with retinal macroaneurysms. Canadian Journal of Ophthalmology. 2024;59 (4):e411-e415$90$YR$E$F$Y$$$20240731$$MD$US$US
241555571$24155557$1$I$20240708$20240722$20240731$20240731$30DAY$$US-GSK-US2024091599$GLAXOSMITHKLINE$$73$YR$$M$Y$$$20240731$$CN$US$US
241555591$24155559$1$I$20240721$20240722$20240731$20240731$EXP$$AE-ROCHE-10000037372$ROCHE$$34$YR$A$F$Y$$$20240731$$CN$AE$AE
241555601$24155560$1$I$$20240722$20240731$20240731$EXP$$CA-TEVA-VS-3225292$TEVA$$7$YR$$M$Y$23$KG$20240731$$PH$CA$CA
241555611$24155561$1$I$$20240723$20240731$20240731$EXP$$US-SA-2024SA220638$SANOFI AVENTIS$$84$YR$E$M$Y$78.47$KG$20240731$$MD$US$US
241555621$24155562$1$I$$20240720$20240731$20240731$EXP$$PL-AUROBINDO-AUR-APL-2024-037091$AUROBINDO$Kukla P. U. wave - what electrolyte disorders can it suggest.. Med Prakt.. 2024;6:76-78$78$YR$$M$Y$$$20240731$$HP$PL$PL
241555631$24155563$1$I$$20240717$20240731$20240731$PER$$US-AMGEN-USASP2024150598$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241555641$24155564$1$I$20240601$20240724$20240731$20240731$EXP$$US-SA-2024SA221448$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240731$$MD$US$US
241555651$24155565$1$I$$20240729$20240731$20240731$EXP$$NVSC2024US155555$NOVARTIS$$$$$F$Y$$$20240731$$CN$US$US
241555662$24155566$2$F$$20240827$20240731$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06649$LUPIN$$$$$$Y$$$20240919$$CN$US$US
241555672$24155567$2$F$$20240821$20240731$20240830$EXP$$PL-TAKEDA-2024TUS076155$TAKEDA$$5$YR$$M$Y$$$20240830$$CN$PL$PL
241555681$24155568$1$I$20240718$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150263$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241555691$24155569$1$I$$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024148041$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et. al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$67$YR$E$$Y$$$20240731$$HP$US$US
241555702$24155570$2$F$$20240821$20240731$20240821$PER$$US-ALXN-202407USA001576US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
241555711$24155571$1$I$20240511$20240724$20240731$20240731$EXP$SE-SEMPA-2024-005592$SE-AMGEN-SWESP2024147488$AMGEN$$50$YR$A$F$Y$85$KG$20240731$$MD$SE$SE
241555721$24155572$1$I$20240101$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036929$AUROBINDO$$55$YR$$M$Y$$$20240731$$PH$FR$FR
241555732$24155573$2$F$20201123$20240720$20240731$20240801$EXP$$PL-AUROBINDO-AUR-APL-2024-036845$AUROBINDO$$19$YR$$F$Y$70$KG$20240801$$MD$PL$PL
241555741$24155574$1$I$$20240720$20240731$20240731$EXP$$IT-AUROBINDO-AUR-APL-2024-037133$AUROBINDO$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al.. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting.. Clinical Therapeutics.. 2024;e1-5.$87$YR$$F$Y$$$20240731$$MD$IT$IT
241555751$24155575$1$I$$20240617$20240731$20240731$PER$$US-TRAVERE-2024TVT00613$TRAVERE THERAPEUTICS$$40$YR$A$M$Y$$$20240731$$CN$US$US
241555761$24155576$1$I$$20240724$20240731$20240731$EXP$$US-PADAGIS-2024PAD01255$PADAGIS$$$$$$Y$$$20240731$$CN$US$US
241555771$24155577$1$I$$20240723$20240731$20240731$EXP$$US-PADAGIS-2024PAD01252$PADAGIS$$$$$$Y$$$20240731$$CN$US$US
241555781$24155578$1$I$$20240724$20240731$20240731$EXP$$US-PADAGIS-2024PAD01243$PADAGIS$Hodson E.L., Kranyak A., Salem I., Buckey J.C.. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases. Journal of Tissue Viability. 2024;33(3):449-451$$$$$Y$$$20240731$$HP$US$US
241555792$24155579$2$F$$20240815$20240731$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120341$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240818$$CN$US$US
241555801$24155580$1$I$20240721$20240723$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117702$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240731$$MD$US$US
241555811$24155581$1$I$$20240725$20240731$20240731$EXP$$NVSC2023IN280044$NOVARTIS$$$$$M$Y$$$20240731$$CN$IN$IN
241555821$24155582$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018882$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240731$$CN$US$US
241555831$24155583$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019905$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240731$$CN$US$US
241555841$24155584$1$I$20240729$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019648$ELI LILLY AND CO$$53$YR$A$$Y$$$20240731$$HP$US$US
241555851$24155585$1$I$20240729$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019718$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240731$$CN$US$US
241555861$24155586$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018595$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240731$$CN$US$US
241555871$24155587$1$I$20240727$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018850$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240731$$CN$US$US
241555882$24155588$2$F$20240729$20240815$20240731$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202407019119$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240820$$CN$US$US
241555903$24155590$3$F$20240101$20240904$20240731$20240912$EXP$$CA-JNJFOC-20240521148$JOHNSON AND JOHNSON$$36$YR$A$M$Y$70.31$KG$20240912$$HP$CA$CA
241555911$24155591$1$I$$20240726$20240731$20240731$EXP$$CA-Orion Corporation ORION PHARMA-24_00031087$ORION$$75$YR$E$M$Y$$$20240731$$MD$CA$
241555921$24155592$1$I$20240717$20240724$20240731$20240731$EXP$$CN-ORGANON-O2407CHN002556$ORGANON$$81$YR$$M$Y$80$KG$20240731$$HP$CN$CN
241555941$24155594$1$I$$20240722$20240731$20240731$EXP$$CA-TEVA-VS-3225310$TEVA$$8$YR$$M$Y$30$KG$20240731$$HP$CA$CA
241555951$24155595$1$I$$20240723$20240731$20240731$EXP$$AT-VIIV HEALTHCARE LIMITED-AT2024EME093045$VIIV$$$$$$Y$$$20240731$$MD$AT$AT
241555961$24155596$1$I$$20240704$20240731$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06875$LUPIN$$$$$$Y$$$20240731$$CN$US$US
241555971$24155597$1$I$$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149707$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241555982$24155598$2$F$20220101$20240724$20240731$20240806$EXP$$US-AMGEN-USASP2024147719$AMGEN$$43$YR$A$F$Y$$$20240806$$CN$US$US
241555991$24155599$1$I$$20240726$20240731$20240731$EXP$$TH-AstraZeneca-2024A171206$ASTRAZENECA$$$$$$Y$$$20240731$$HP$TH$
241556001$24155600$1$I$$20230707$20240731$20240731$EXP$$US-AstraZeneca-2023A120655$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241556011$24155601$1$I$$20211207$20240731$20240731$EXP$$US-AstraZeneca-2021A731255$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241556021$24155602$1$I$$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171380$ASTRAZENECA$$$$$$Y$$$20240731$$MD$US$
241556031$24155603$1$I$$20230905$20240731$20240731$EXP$$CA-AstraZeneca-2023A204199$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$CA$
241556041$24155604$1$I$$20221020$20240731$20240731$EXP$$US-AstraZeneca-2022A352419$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241556051$24155605$1$I$$20230320$20240731$20240731$EXP$$US-AstraZeneca-2023A067091$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241556061$24155606$1$I$$20240718$20240731$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-120743$BRISTOL MYERS SQUIBB$Literature citation unavailable.$$$$$Y$$$20240731$$HP$CA$CA
241556071$24155607$1$I$$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171488$ASTRAZENECA$$$$$F$Y$114$KG$20240731$$CN$US$
241556081$24155608$1$I$$20240723$20240731$20240731$EXP$$ZA-AstraZeneca-2024A167705$ASTRAZENECA$$69$YR$$F$Y$$$20240731$$CN$ZA$
241556091$24155609$1$I$$20210503$20240731$20240731$EXP$$US-AstraZeneca-2021A399595$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241556101$24155610$1$I$20230101$20240717$20240731$20240731$EXP$$JP-UCBSA-2024036844$UCB$$$$C$F$Y$$$20240731$$PH$JP$JP
241556111$24155611$1$I$$20240722$20240731$20240731$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005432$BIOCON$$$$$$Y$$$20240731$$HP$CA$CA
241556121$24155612$1$I$20221101$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036760$AUROBINDO$$63$YR$$F$Y$70$KG$20240731$$CN$FR$FR
241556141$24155614$1$I$$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024147813$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et. al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$32$YR$A$$Y$$$20240731$$HP$US$US
241556151$24155615$1$I$20240621$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-037011$AUROBINDO$$51$YR$$F$Y$$$20240731$$PH$FR$FR
241556161$24155616$1$I$20240101$20240727$20240731$20240731$PER$$US-ABBVIE-5859392$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241556173$24155617$3$F$$20240813$20240731$20240814$EXP$CZ-002147023-NVSC2024CZ121942$CZ-ROCHE-10000037760$ROCHE$Bloomfield M, Klocperk A, Schneiderova H, Hlavackova E, Turnovec M, Tichy L et. al.. The expansion of national newborn screening marks an advancement in diagnosing patients with severe inborn errors of immunity. CESKO-SLOVENSKA PEDIATRIE.. 2024;79(3):136-41$7$WK$I$M$Y$$$20240814$$HP$CZ$CZ
241556181$24155618$1$I$$20240724$20240731$20240731$EXP$GB-MHRA-31010651$GB-RDY-SPO/GBR/24/0010953$DR REDDYS$$$$$M$Y$$$20240731$$CN$GB$GB
241556191$24155619$1$I$$20240726$20240731$20240731$EXP$$US-UCBSA-2024038344$UCB$$$$$M$Y$$$20240731$$HP$US$US
241556201$24155620$1$I$$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024148032$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):1-12$57$YR$A$$Y$$$20240731$$HP$US$US
241556211$24155621$1$I$20240701$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151045$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241556221$24155622$1$I$$20240716$20240731$20240731$EXP$$PS-GLANDPHARMA-PS-2024GLNLIT00551$GLAND PHARMA$Ahmed AwadGhanem.Atraumatic splenic rupture after administering aspirin, clopidogrel, and heparin to a patient with unstable angina: A case report..SAGE Open Medical Case Reports.10-JUN-2024;12:1-5$49$YR$A$M$Y$$$20240731$$HP$PS$PS
241556231$24155623$1$I$20240612$20240715$20240731$20240731$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024088760$VIIV$$22$YR$$F$Y$$$20240731$$MD$US$US
241556241$24155624$1$I$20240622$20240722$20240731$20240731$EXP$$GB-ROCHE-10000032941$ROCHE$$44$YR$A$F$Y$$$20240731$$HP$GB$GB
241556261$24155626$1$I$$20210624$20240731$20240731$EXP$$PT-AstraZeneca-2021A565806$ASTRAZENECA$$$$$$Y$$$20240731$$MD$PT$
241556271$24155627$1$I$$20240718$20240731$20240731$PER$$US-JNJFOC-20240760290$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241556281$24155628$1$I$$20210426$20240731$20240731$EXP$$CA-AstraZeneca-2021A366853$ASTRAZENECA$$$$$M$Y$$$20240731$$MD$CA$
241556292$24155629$2$F$20240614$20240906$20240731$20240923$PER$$US-JNJFOC-20240777722$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$HP$US$US
241556311$24155631$1$I$$20240730$20240731$20240731$EXP$$US-TAKEDA-2024TUS066158$TAKEDA$$$$$F$Y$$$20240731$$CN$US$US
241556321$24155632$1$I$$20240725$20240731$20240731$EXP$$BR-TAKEDA-2024TUS076262$TAKEDA$$23$YR$$$Y$$$20240731$$CN$BR$BR
241556342$24155634$2$F$$20240829$20240731$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US069349$SANDOZ$$$$$M$Y$$$20240902$$CN$US$US
241556351$24155635$1$I$$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024148052$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):1-12$48$YR$A$$Y$$$20240731$$HP$US$US
241556361$24155636$1$I$$20240723$20240731$20240731$EXP$$CN-ORGANON-O2407CHN002579$ORGANON$$57$YR$$M$Y$$$20240731$$MD$CN$CN
241556381$24155638$1$I$20240723$20240723$20240731$20240731$PER$$US-CSL-2024-007016$CSL Plasma$$24$YR$$M$Y$$$20240731$$HP$US$US
241556391$24155639$1$I$20240501$20240605$20240731$20240731$EXP$$DE-TEVA-VS-3223344$TEVA$$12$YR$$M$Y$35$KG$20240731$$MD$DE$DE
241556401$24155640$1$I$20230101$20240213$20240731$20240731$EXP$$ZA-TEVA-VS-3198861$TEVA$$54$YR$$F$Y$$$20240731$$CN$ZA$ZA
241556411$24155641$1$I$20240715$20240718$20240731$20240731$EXP$GB-MHRA-MED-202407161003047020-YVRCW$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001839$IPCA$$$$$$Y$$$20240731$$MD$GB$GB
241556421$24155642$1$I$$20240725$20240731$20240731$EXP$$US-ABBVIE-5854847$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241556431$24155643$1$I$20240531$20240729$20240731$20240731$EXP$$FR-SANDOZ INC.-SDZ2024FR069326$SANDOZ$$3$YR$$F$Y$$$20240731$$PH$FR$FR
241556441$24155644$1$I$20231001$20240716$20240731$20240731$EXP$$US-ASTELLAS-2024US021217$ASTELLAS$$71$YR$$F$Y$$$20240731$$CN$HK$US
241556471$24155647$1$I$$20240726$20240731$20240731$EXP$$BR-TAKEDA-2024TUS076532$TAKEDA$$10$YR$$$Y$$$20240731$$CN$BR$BR
241556481$24155648$1$I$$20240716$20240731$20240731$EXP$$IT-GLANDPHARMA-IT-2024GLNLIT00541$GLAND PHARMA$G. Sorvillo.A very complex clinical case of acute coronary syndrome complicated by thrombosis and intracranial haemorrhage.European Heart Journal .APR-2024;26 (Suppl. 2):ii127$62$YR$A$F$Y$$$20240731$$HP$IT$IT
241556492$24155649$2$F$$20240731$20240731$20240808$EXP$$US-MSNLABS-2024MSNLIT01640$MSN LABORATORIES$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D.Rhabdomyolysis Risk: The Dangers of Tribulus Terrestris, an Over-the-Counter Supplement.American Journal of Case Reports.16-JUL-2024;25:e943492-3$$$$$Y$$$20240808$$MD$US$US
241556502$24155650$2$F$$20240730$20240731$20240803$EXP$$US-ABBVIE-5856766$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241556514$24155651$4$F$20240711$20240906$20240731$20240913$30DAY$$US-JNJFOC-20240766141$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240913$$CN$US$US
241556521$24155652$1$I$$20240717$20240731$20240731$PER$$US-JNJFOC-20240748508$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241556534$24155653$4$F$20240101$20240919$20240731$20240928$EXP$$CA-CELLTRION INC.-2024CA018333$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
241556541$24155654$1$I$$20240723$20240731$20240731$EXP$$ZA-AMGEN-ZAFSP2024148827$AMGEN$$57$YR$A$F$Y$$$20240731$$CN$ZA$ZA
241556551$24155655$1$I$$20240717$20240731$20240731$PER$$US-TEVA-VS-3224640$TEVA$$$$A$F$Y$$$20240731$$CN$US$US
241556571$24155657$1$I$20240715$20240726$20240731$20240731$EXP$$US-ABBVIE-5857020$ABBVIE$$75$YR$$M$Y$$$20240731$$CN$US$US
241556581$24155658$1$I$20240501$20240722$20240731$20240731$EXP$$CN-ASTELLAS-2024US021314$ASTELLAS$$$$$M$Y$$$20240731$$CN$CN$CN
241556602$24155660$2$F$$20240730$20240731$20240801$EXP$$US-ROCHE-10000042144$ROCHE$$$$$F$Y$$$20240801$$CN$US$US
241556611$24155661$1$I$20240706$20240717$20240731$20240731$EXP$$CN-ASTELLAS-2024US021407$ASTELLAS$$79$YR$$M$Y$$$20240731$$CN$CN$CN
241556631$24155663$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018918$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240731$$CN$US$US
241556641$24155664$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019660$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240731$$CN$US$US
241556651$24155665$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018828$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240731$$CN$US$US
241556661$24155666$1$I$20240625$20240726$20240731$20240731$EXP$$CA-ABBVIE-5857065$ABBVIE$$$$A$F$Y$$$20240731$$CN$CA$CA
241556671$24155667$1$I$$20240716$20240731$20240731$EXP$$US-GLANDPHARMA-US-2024GLNLIT00567$GLAND PHARMA$Caitlin A. Contag.Q fever presenting as splenic infarct without endocarditis. IDCases.01-MAY-2024;37:1-3$44$YR$A$M$Y$$$20240731$$HP$US$US
241556682$24155668$2$F$20240716$20240801$20240731$20240806$EXP$$BE-ROCHE-10000033474$ROCHE$$28$YR$A$F$Y$107$KG$20240806$$MD$BE$BE
241556691$24155669$1$I$20240701$20240717$20240731$20240731$PER$$US-JNJFOC-20240748487$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241556701$24155670$1$I$20240720$20240722$20240731$20240731$EXP$$US-TEVA-VS-3224242$TEVA$$59$YR$$M$Y$$$20240731$$PH$US$US
241556711$24155671$1$I$$20240726$20240731$20240731$PER$$US-ABBVIE-5859214$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241556721$24155672$1$I$$20240725$20240731$20240731$EXP$$GT-JNJFOC-20240772990$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$MD$GT$GT
241556732$24155673$2$F$20240721$20240814$20240731$20240822$30DAY$$US-GSK-US2024091788$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240822$$CN$US$US
241556741$24155674$1$I$$20240715$20240731$20240731$PER$$US-TEVA-VS-3222331$TEVA$$67$YR$$F$Y$$$20240731$$CN$US$US
241556762$24155676$2$F$$20240804$20240731$20240805$EXP$$US-BAYER-2024A106168$BAYER$$53$YR$A$F$Y$$$20240805$$CN$US$US
241556771$24155677$1$I$$20240716$20240731$20240731$EXP$$BR-GLANDPHARMA-BR-2024GLNLIT00542$GLAND PHARMA$Arnildo Linck Junior.Malignant hyperthermia without fever in a burned child after bandaging: A case report.Journal of Pediatric Surgery Case Reports.15-MAR-2023;92:1-3$16$MON$I$F$Y$$$20240731$$HP$BR$BR
241556781$24155678$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A170377$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241556791$24155679$1$I$20240702$20240729$20240731$20240731$EXP$$US-AstraZeneca-2024A172724$ASTRAZENECA$$32829$DY$$F$Y$$$20240731$$CN$US$
241556801$24155680$1$I$$20240729$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069175$SANDOZ$Laxman Wagle. Metformin Toxicity Leading to Severe RefractoryHyperkalemia and Metabolic Acidosis: A CaseReport$74$YR$$M$Y$$$20240731$$HP$US$US
241556811$24155681$1$I$$20240729$20240731$20240731$EXP$$US-AstraZeneca-2024A172399$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241556821$24155682$1$I$20220929$20221207$20240731$20240731$EXP$$US-AstraZeneca-2022A401527$ASTRAZENECA$$22493$DY$$F$Y$65.3$KG$20240731$$CN$US$
241556831$24155683$1$I$$20230725$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004523$ARBOR$$$$$$Y$$$20240731$$HP$US$US
241556841$24155684$1$I$$20230725$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004410$ARBOR$$$$$F$Y$$$20240731$$HP$US$US
241556851$24155685$1$I$$20230718$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004498$ARBOR$$$$$F$Y$$$20240731$$HP$US$US
241556861$24155686$1$I$$20230712$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004455$ARBOR$$$$$F$Y$$$20240731$$HP$US$US
241556871$24155687$1$I$$20230726$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004530$ARBOR$$$$$F$Y$$$20240731$$MD$US$US
241556881$24155688$1$I$$20210928$20240731$20240731$EXP$$US-AstraZeneca-2021A752235$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241556891$24155689$1$I$$20230718$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004492$ARBOR$$8$YR$$F$Y$48$KG$20240731$$MD$US$US
241556901$24155690$1$I$20230714$20230714$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004471$ARBOR$$10$YR$$F$Y$$$20240731$$HP$US$US
241556911$24155691$1$I$20230630$20230630$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004392$ARBOR$$10$YR$$F$Y$$$20240731$$PH$US$US
241556921$24155692$1$I$20230101$20230713$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004459$ARBOR$$$$$M$Y$$$20240731$$HP$US$US
241556931$24155693$1$I$$20230713$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004466$ARBOR$$$$$F$Y$$$20240731$$HP$US$US
241556941$24155694$1$I$20230706$20230710$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004433$ARBOR$$21$YR$$F$Y$$$20240731$$PH$US$US
241556951$24155695$1$I$$20230705$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004405$ARBOR$$$$$F$Y$$$20240731$$HP$US$US
241556961$24155696$1$I$20230101$20240501$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004529$ARBOR$$$$$F$Y$$$20240731$$CN$US$US
241556971$24155697$1$I$$20220720$20240731$20240731$EXP$$US-AstraZeneca-2022A176972$ASTRAZENECA$$45$YR$$F$Y$$$20240731$$CN$US$
241556981$24155698$1$I$20240101$20240725$20240731$20240731$EXP$$US-DSJP-DSU-2024-135980$DAIICHI$$$$$F$Y$$$20240731$$CN$TR$TR
241556991$24155699$1$I$20230101$20240514$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004504$ARBOR$$$$$F$Y$$$20240731$$CN$US$US
241557002$24155700$2$F$20240719$20240805$20240731$20240809$EXP$$US-BAYER-2024A107334$BAYER$$30$YR$A$F$Y$$$20240809$$HP$US$US
241557011$24155701$1$I$$20240724$20240731$20240731$EXP$$US-JNJFOC-20240766504$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240731$$CN$US$US
241557021$24155702$1$I$20230826$20240729$20240731$20240731$EXP$FR-AFSSAPS-PV2023000873$NVSC2023FR196477$NOVARTIS$$49$YR$$F$Y$87.3$KG$20240731$$MD$FR$FR
241557031$24155703$1$I$$20240724$20240731$20240731$30DAY$$US-GSK-US2024092955$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$CN$US$US
241557041$24155704$1$I$20230101$20240719$20240731$20240731$EXP$$US-INSMED-2023-04912-USAA$INSMED$$$$$M$Y$$$20240731$$CN$US$US
241557051$24155705$1$I$$20240716$20240731$20240731$EXP$$IN-GLANDPHARMA-IN-2024GLNLIT00562$GLAND PHARMA$Anubhuti Sood.Post-COVID steroid induced avascular necrosis of the jaw: Emerging challenge in India.Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.APR-2023;135 (No.4):e89-e93$28$YR$A$M$Y$$$20240731$$MD$IN$IN
241557082$24155708$2$F$20240726$20240730$20240731$20240802$PER$$US-AMGEN-USASP2024149848$AMGEN$$76$YR$E$M$Y$$$20240802$$CN$US$US
241557091$24155709$1$I$$20240729$20240731$20240731$EXP$$US-AMGEN-USASP2024150539$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241557101$24155710$1$I$$20240724$20240731$20240731$PER$$US-AMGEN-USASP2024148883$AMGEN$$$$$$Y$$$20240731$$PH$US$US
241557111$24155711$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812332$AU-Accord-437258$ACCORD$$$$$F$Y$$$20240731$$HP$AU$AU
241557121$24155712$1$I$20240717$20240720$20240731$20240731$EXP$$US-Accord-438349$ACCORD$$37$YR$A$F$Y$$$20240731$$HP$US$US
241557131$24155713$1$I$$20240722$20240731$20240731$EXP$AU-TGA-812217$AU-Accord-437382$ACCORD$$64$YR$A$F$Y$$$20240731$$HP$AU$AU
241557141$24155714$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812263$AU-Accord-437276$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241557151$24155715$1$I$$20240722$20240731$20240731$EXP$$US-Accord-437770$ACCORD$Laches R, Hall RJ, Chaffin J, Hahn P. Omission of etoposide in the treatment of haemophagocytic lymphohistiocytosis secondary to primary central nervous system lymphoma with satisfactory response. BMJ case reports. 2024;17(7):e258559$7$DEC$E$F$Y$$$20240731$$MD$US$US
241557161$24155716$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812405$AU-Accord-437246$ACCORD$$$$$F$Y$$$20240731$$HP$AU$AU
241557171$24155717$1$I$$20240721$20240731$20240731$EXP$$MG-Accord-438268$ACCORD$Randrianarisoa RMF, Raulin O, Merlin A, Tonnelier M, Lecapitaine AL. A Case of Confusion in an Obese Patient Treated With Daptomycin: Neurotoxicity. Cureus. 2024 Jun 12;16(6):e62254.$73$YR$E$M$Y$150$KG$20240731$$HP$MG$MG
241557181$24155718$1$I$20240415$20240720$20240731$20240731$EXP$IT-MINISAL02-995433$IT-Accord-437694$ACCORD$$17$YR$T$F$Y$$$20240731$$MD$IT$IT
241557191$24155719$1$I$$20240721$20240731$20240731$EXP$AU-TGA-807681$AU-Accord-437268$ACCORD$$68$YR$E$M$Y$$$20240731$$HP$AU$AU
241557201$24155720$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812341$AU-Accord-437253$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241557211$24155721$1$I$20240717$20240720$20240731$20240731$EXP$$US-Accord-437922$ACCORD$$16$YR$T$M$Y$$$20240731$$PH$US$US
241557221$24155722$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812684$AU-Accord-437242$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241557231$24155723$1$I$20240721$20240721$20240731$20240731$EXP$GB-MHRA-MED-202407211006196690-CFHYB$GB-Accord-437580$ACCORD$$56$YR$A$M$Y$80$KG$20240731$$CN$GB$GB
241557242$24155724$2$F$$20240725$20240731$20240828$EXP$$US-Accord-437925$ACCORD$$49$YR$A$F$Y$$$20240828$$MD$US$US
241557251$24155725$1$I$$20240721$20240731$20240731$EXP$AU-TGA-804517$AU-Accord-437235$ACCORD$$73$YR$E$M$Y$$$20240731$$HP$AU$AU
241557261$24155726$1$I$$20240721$20240731$20240731$EXP$AU-TGA-803835$AU-Accord-437237$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241557272$24155727$2$F$20180316$20240827$20240731$20240830$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009335$STRIDES$$50$YR$$F$Y$$$20240830$$MD$US$US
241557281$24155728$1$I$$20240719$20240731$20240731$EXP$$NL-HIKMA PHARMACEUTICALS USA INC.-NL-H14001-24-07016$HIKMA$Sylva M, Abdulla A, Koch BC, Mulder J.. Sylva M, Abdulla A, Koch BC, Mulder J. Cephalosporin-Related Neurotoxicity in a Ceftriaxone-Treated Critically Ill Child: A Case Report.. Case rep. acute med. 2023;6(1):19-24$4$YR$$F$Y$$$20240731$$MD$NL$NL
241557311$24155731$1$I$$20240725$20240731$20240731$EXP$$BR-TAKEDA-2024TUS076010$TAKEDA$$44$YR$$$Y$$$20240731$$CN$BR$BR
241557331$24155733$1$I$$20240712$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050585$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241557341$24155734$1$I$20240601$20240710$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050566$TOLMAR$$$$$M$Y$$$20240731$$HP$CA$CA
241557351$24155735$1$I$20240601$20240712$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050569$TOLMAR$$81$YR$$M$Y$$$20240731$$CN$CA$CA
241557362$24155736$2$F$20240702$20240815$20240731$20240903$PER$$CA-TOLMAR, INC.-24CA050777$TOLMAR$$75$YR$$M$Y$$$20240902$$HP$CA$CA
241557371$24155737$1$I$20240626$20240712$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050713$TOLMAR$$80$YR$$M$Y$$$20240731$$CN$CA$CA
241557381$24155738$1$I$20240703$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050814$TOLMAR$$82$YR$$M$Y$$$20240731$$CN$CA$CA
241557391$24155739$1$I$$20240712$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050847$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241557401$24155740$1$I$$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050821$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241557421$24155742$1$I$$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050947$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241557431$24155743$1$I$$20240728$20240731$20240731$EXP$$US-HALEON-2189500$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241557441$24155744$1$I$20240718$20240723$20240731$20240731$EXP$$CN-JNJFOC-20240771861$JOHNSON AND JOHNSON$$13$YR$T$M$Y$46$KG$20240731$$HP$CN$CN
241557453$24155745$3$F$20240101$20240808$20240731$20240812$EXP$$CA-UCBSA-2024030225$UCB$$$$$F$Y$$$20240812$$CN$CA$CA
241557462$24155746$2$F$20230801$20240904$20240731$20240910$EXP$$NVSC2024IT153090$NOVARTIS$$53$YR$$M$Y$98$KG$20240910$$MD$IT$IT
241557471$24155747$1$I$20240701$20240725$20240731$20240731$EXP$$US-ASTELLAS-2024US020200$ASTELLAS$$75$YR$$M$Y$$$20240731$$CN$US$US
241557482$24155748$2$F$20240714$20240906$20240731$20240912$EXP$$CA-BEH-2024175801$CSL BEHRING$$66$YR$E$F$Y$56.689$KG$20240912$$HP$CA$CA
241557491$24155749$1$I$20240101$20240724$20240731$20240731$PER$$US-ABBVIE-5854464$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241557501$24155750$1$I$20240601$20240724$20240731$20240731$EXP$$AU-GSK-AU2024APC093251$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$AU$AU
241557511$24155751$1$I$$20240729$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069499$SANDOZ$$$$$F$Y$$$20240731$$MD$US$US
241557534$24155753$4$F$$20240730$20240731$20240801$EXP$$US-ROCHE-10000040534$ROCHE$$$$E$F$Y$$$20240801$$CN$US$US
241557541$24155754$1$I$20220301$20240722$20240731$20240731$EXP$$SE-PIRAMAL PHARMA LIMITED-2024-PPL-000550$PIRAMAL$$$$$$Y$$$20240731$$CN$SE$SE
241557551$24155755$1$I$20230920$20230920$20240731$20240731$PER$$US-SOMERSET-2023-US-001376$ODIN PHARMACEUTICALS$$97$YR$E$F$Y$$$20240731$$CN$US$US
241557561$24155756$1$I$$20240716$20240731$20240731$EXP$$IN-GLANDPHARMA-IN-2024GLNLIT00563$GLAND PHARMA$Anubhuti Sood.Post-COVID steroid induced avascular necrosis of the jaw: Emerging challenge in India.Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.APR-2023;135 (No.4):e89-e93$49$YR$A$M$Y$$$20240731$$MD$IN$IN
241557571$24155757$1$I$$20240725$20240731$20240731$PER$$US-ABBVIE-5857343$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241557591$24155759$1$I$20240627$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036759$AUROBINDO$$81$YR$$F$Y$63.5$KG$20240731$$PH$FR$FR
241557602$24155760$2$F$$20240911$20240731$20240914$EXP$$SG-ROCHE-10000034103$ROCHE$$66$YR$E$M$Y$$$20240914$$CN$SG$SG
241557611$24155761$1$I$$20240723$20240731$20240731$EXP$$US-MYLANLABS-2024M1070315$MYLAN$Alsabbagh Alchirazi K, Bhavsar-Burke I, Syed H, Alkhayyat M, Bass S, Kapoor A, et al. Molecular Adsorbent Recirculating System in Acute Liver Failure. ACG-Case-Rep-J 2024; 11 (7):.$44$YR$$M$Y$$$20240731$$MD$US$US
241557621$24155762$1$I$$20240722$20240731$20240731$EXP$$JP-MYLANLABS-2024M1069620$MYLAN$Tanaka H, Sakakibara M, Hiratsuka M, Sugiura Y, Hiruta N. [Improved QOL in a Case of Breast Cancer with Meningeal Carcinomatosis Treated with Radiation Therapy and Intrathecal Chemotherapy]. [Japanese]. Gan-To-Kagaku-Ryoho 2022; 49 (13): 1938-1940.. 2022;49 (13):1938-1940$6$DEC$$F$Y$$$20240731$$HP$JP$JP
241557631$24155763$1$I$$20240723$20240731$20240731$EXP$$US-MYLANLABS-2024M1070277$MYLAN$Lopez A, Chen KP, Gundogdu B, Orr JE, Joshua J. Shrinking Lung Syndrome With Diaphragm Myopathy and Phrenic Neuropathy. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$43$YR$$M$Y$$$20240731$$HP$US$US
241557641$24155764$1$I$$20240723$20240731$20240731$EXP$$US-MYLANLABS-2024M1070263$MYLAN$Ocasio V, Kapoor S, Atteih S, Sadreameli SC, Mogayzel PJ. A Case of Trimethoprim-sulfamethoxazole Associated Fulminant Respiratory Failure in a 15- year-old Male. Am-J-Respir-Crit-Care-Med 2024; 209 (0).$15$YR$$M$Y$$$20240731$$HP$US$US
241557651$24155765$1$I$$20240723$20240731$20240731$EXP$$IN-MYLANLABS-2024M1070270$MYLAN$Ancilla LC, Sundaram B, Pathak N, Raj A. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. J-Nephropharmacol 2024; 13 (2): 1-5.$58$YR$$M$Y$$$20240731$$HP$IN$IN
241557661$24155766$1$I$$20240722$20240731$20240731$EXP$$BY-MYLANLABS-2024M1070747$MYLAN$Yatskevich N.V, Sinha A, Alvarez J.L, Lachenal N, Solodovnikova V.V, Gurevich G.L, Skryagina E.M. Preliminary Assessment of Safety of Six Month BPaLM/C Regimens in Patients with Rifampicin- Resistant Tuberculosis in the  Republic of Belarus. Clinical infectology and parasitology. 2024;13:2$46$YR$$$Y$$$20240731$$HP$BY$BY
241557671$24155767$1$I$$20240723$20240731$20240731$EXP$$US-MYLANLABS-2024M1070724$MYLAN$Ortiz Velez I, Gener E, Quiles-Cruz C, Roman-Velez N, Rodriguez KP, Rosado-Jimenez M, et al. The Challenge of multi-organism lung infection with human immunodeficiency virus. Am-J-Med-Sci 2023;365 (Suppl. 1):S160-S161 abstr. 300.$57$YR$$M$Y$$$20240731$$HP$US$US
241557682$24155768$2$F$$20240828$20240731$20240830$30DAY$$DE-UCBSA-2024038218$UCB$$$$$$Y$$$20240830$$CN$DE$DE
241557691$24155769$1$I$20240207$20240730$20240731$20240731$EXP$FR-AFSSAPS-RE2024000769$FR-SANDOZ INC.-SDZ2024FR069245$SANDOZ$$53$YR$$F$Y$59$KG$20240731$$MD$FR$FR
241557701$24155770$1$I$20240726$20240729$20240731$20240731$EXP$$NVSC2024CA156025$NOVARTIS$$33$YR$$M$Y$85$KG$20240731$$CN$CA$CA
241557711$24155771$1$I$20240615$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036868$AUROBINDO$$39$YR$$F$Y$59$KG$20240731$$MD$FR$FR
241557721$24155772$1$I$$20240724$20240731$20240731$EXP$$TR-GILEAD-2024-0681779$GILEAD$$$$$M$Y$$$20240731$$CN$TR$TR
241557731$24155773$1$I$$20240722$20240731$20240731$EXP$$JP-MYLANLABS-2024M1069623$MYLAN$Matsuki S, Taniuchi N, Okada N, Sato J, Nishijima N, Kamio K, et al. A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung Cancer. J-Nippon-Med-Sch 2024; 91 (3): 339-346.. 2024;91 (3):339-346$67$YR$$M$Y$$$20240731$$HP$JP$JP
241557742$24155774$2$F$$20240807$20240731$20240816$EXP$$TN-MSNLABS-2024MSNLIT01685$MSN LABORATORIES$Ouni B, Mansour K, Sassi M, Sriha B, Bensayed N, Fathallah N.Silodosin-induced leukocytoclastic vasculitis: a first case report.European Journal of Dermatology.2024;34(1):92-93$$$$$Y$$$20240816$$HP$TN$TN
241557751$24155775$1$I$20240510$20240725$20240731$20240731$EXP$CH-SM-2024-14110$CH-BAYER-2024A108194$BAYER$$38$YR$A$F$Y$63$KG$20240731$$MD$CH$CH
241557761$24155776$1$I$20210819$20210827$20240731$20240731$EXP$$US-AstraZeneca-2021A706412$ASTRAZENECA$$20946$DY$$F$Y$$$20240731$$CN$US$
241557773$24155777$3$F$20240301$20240807$20240731$20240813$EXP$$IE-ROCHE-10000042357$ROCHE$$$$$F$Y$$$20240813$$CN$IE$IE
241557781$24155778$1$I$20240709$20240724$20240731$20240731$EXP$GB-MHRA-MED-202407241128358700-RYMLG$GB-NEBO-665156$PHARMACOSMOS$$61$YR$$F$Y$$$20240731$$PH$GB$GB
241557791$24155779$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019171$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240731$$CN$US$US
241557801$24155780$1$I$20240725$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019685$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240731$$CN$US$US
241557811$24155781$1$I$$20240723$20240731$20240731$EXP$$ZA-AstraZeneca-2024A167901$ASTRAZENECA$$62$YR$$M$Y$$$20240731$$CN$ZA$
241557821$24155782$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019728$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240731$$CN$US$US
241557832$24155783$2$F$20240714$20240730$20240731$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019319$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240802$$PH$US$US
241557841$24155784$1$I$20240722$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019044$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$US$US
241557852$24155785$2$F$$20240729$20240731$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407017701$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240802$$CN$US$US
241557861$24155786$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018561$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240731$$CN$US$US
241557871$24155787$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019770$ELI LILLY AND CO$$65$YR$E$$Y$$$20240731$$CN$US$US
241557881$24155788$1$I$20240725$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019584$ELI LILLY AND CO$$$$$M$Y$$$20240731$$CN$US$US
241557891$24155789$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019797$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240731$$CN$US$US
241557901$24155790$1$I$$20240716$20240731$20240731$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459866$RANBAXY$Jang SY, Byun JM, Yoon S-S, Paeng JC, Lee S-P, Koh Y. Lenalidomide as a treatment for patients with AL amyloidosis and cardiac involvement. Blood Res. 2023;58:221-245$56$YR$$F$Y$$$20240731$$HP$KR$KR
241557911$24155791$1$I$20240617$20240724$20240731$20240731$PER$$US-BIOGEN-2024BI01274043$BIOGEN$$56$YR$$F$Y$$$20240731$$CN$US$US
241557921$24155792$1$I$$20240716$20240731$20240731$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459824$RANBAXY$Wang Y, An Y, Hou X, Xu Y, Li Z, Liu X, et al. Cushing^s Syndrome in Pregnancy Secondary to Adrenocortical Adenoma: A Case Series and Review. Endocrinol Diabetes Metab. 2024;7 (2):e00474;1-10$$$N$$Y$$$20240731$$HP$CN$CN
241557931$24155793$1$I$20150201$20240724$20240731$20240731$PER$$US-BIOGEN-2024BI01275279$BIOGEN$$43$YR$$F$Y$$$20240731$$CN$US$US
241557941$24155794$1$I$$20240716$20240731$20240731$EXP$$IN-GLANDPHARMA-IN-2024GLNLIT00557$GLAND PHARMA$Aaliya Khanam.CYPROHEPTADINE AND DEXAMETHASONE INDUCED SUICIDALITY AND OBSESSIONS PRESENTING TO LIASON PSYCHIATRY- A CASE REPORT.Indian Journal of Psychiatry.JAN-2024;66 (Suppl. 1):S177$20$YR$A$M$Y$$$20240731$$HP$IN$IN
241557951$24155795$1$I$$20240716$20240731$20240731$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459491$RANBAXY$Stone C, Bertolotti A, Davey L, Murrell DF. Atypical fixed drug eruption in confetti due to paracetamo. Dermatol in. 2024;42 (2):160-161$45$YR$$M$Y$$$20240731$$HP$AU$AU
241557961$24155796$1$I$$20240730$20240731$20240731$EXP$$IT-SANDOZ INC.-SDZ2024IT069289$SANDOZ$$64$YR$$F$Y$$$20240731$$HP$IT$IT
241557971$24155797$1$I$$20240716$20240731$20240731$EXP$$ZA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459443$RANBAXY$Davies A, Hofmeyr R. Anaesthesia for caesarean section in a patient with uncorrected Tetralogy of Fallot complicated by eclampsia.. South Afr J Anaesth Analg. 2024;30 (3):90-93$$$$$Y$$$20240731$$HP$ZA$ZA
241557991$24155799$1$I$$20240716$20240731$20240731$EXP$$ZA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459440$RANBAXY$Davies A, Hofmeyr R. Anaesthesia for caesarean section in a patient with uncorrected Tetralogy of Fallot complicated by eclampsia.. South Afr J Anaesth Analg. 2024;30 (3):90-93$29$YR$$F$Y$$$20240731$$HP$ZA$ZA
241558001$24155800$1$I$$20240716$20240731$20240731$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459656$RANBAXY$Kaur B, Kundu K, Singh P, Saini LK, Gupta R. Positive airway pressure (PAP) as a remedy for treatment-resistant migraine - A case report. Lung India. 2024;Jul-Aug; 41 (4):322-324$33$YR$$F$Y$$$20240731$$HP$IN$IN
241558011$24155801$1$I$$20240716$20240731$20240731$EXP$$BT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460068$RANBAXY$Chhetri B, Gyeltshen D. Treatment of tardive dyskinesia with clonazepam: A case report. Clin Case Rep. 2024;12 (5):1-5$50$YR$$M$Y$$$20240731$$HP$BT$BT
241558021$24155802$1$I$$20240716$20240731$20240731$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459996$RANBAXY$Di Rauso G, Orlandi N, Jacopetti M, Bigliardi G, Antonelli F, Meletti S. Botulinum neurotoxin as early treatment in acute-onset lesional hemiballism. Neurol Sci. 2024;45(7):3509-3511$78$YR$$M$Y$$$20240731$$HP$IT$IT
241558031$24155803$1$I$$20240716$20240731$20240731$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459667$RANBAXY$Ramos MM, Oliveira AL, Velame ML, Monteiro AM, de Cassia Andrade R, da Conceicao Freitas M. Gingival enlargement induced by anticonvulsant drugs in children with microcephaly-Case Report. J Pre Clin Clin Res. 2024;18 (2):135-8$$$C$M$Y$$$20240731$$HP$BR$BR
241558041$24155804$1$I$$20240716$20240731$20240731$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459661$RANBAXY$Raduna O, Oprescu B, Mihaicuta S, Frent S. Relapsing Eosinophilia in a Severe Allergic Asthma Patient on Biological Therapy. J Clin Med. 2024;13 (12):3402/1-10$63$YR$$F$Y$$$20240731$$HP$RO$RO
241558051$24155805$1$I$$20240716$20240731$20240731$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460081$RANBAXY$Polgarova K. Glofitamab - experience from the study NP30179. Current topics in oncology. 2024;2:137-42$59$YR$$F$Y$$$20240731$$HP$CZ$CZ
241558061$24155806$1$I$$20240716$20240731$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459446$RANBAXY$Al-Shokri S, Shimizu S, Warren EL, Kourouni I. Pneumocystis Jirovecii Pneumonia in an Immunocompetent Patient With Inhalation Injury, A Case Report With Literature Review. Am J Respir Crit Care Med. 2024;May 20;209 (0):A3559;B43$57$YR$$M$Y$$$20240731$$HP$US$US
241558071$24155807$1$I$$20240716$20240731$20240731$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460099$RANBAXY$Daifu T, Umeda K, Yokoyama A, Yoshida T, Saida S, Kato I, et al.. Juvenile xanthogranuloma manifesting with LCH-associated neurodegenerative disease-like radiological findings. Pediatr Blood Cancer. 2024;71 (7)$1$YR$$M$Y$$$20240731$$HP$JP$JP
241558081$24155808$1$I$$20240716$20240731$20240731$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459686$RANBAXY$Scordato F, Giunta N, Peritore G, Zambelli G, Smecca I. Vasospastic Infarction Started with Pulseless Electrical Activity Cardiac Arrest. Eur Heart J Suppl. 2024;26(Suppl.):ii129-ii130$48$YR$$F$Y$$$20240731$$HP$IT$IT
241558092$24155809$2$F$$20240731$20240731$20240814$EXP$$ID-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459510$RANBAXY$Indrajanu IN, Marhana IA, Indrawanto DW. A rare case of a young man with mediastinal synovial sarcoma. Respirat Med Case Report. 2024;51 (0):102079$23$YR$$M$Y$$$20240814$$HP$ID$ID
241558101$24155810$1$I$$20240716$20240731$20240731$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459614$RANBAXY$Babaoglu K, Basar EZ, Usta E, Y?lmaz EH, Gunlemez A. Effect of different dose regimens of everolimus in a series of neonates with giant cardiac rhabdomyomas. Cardiol Young. 2023;33 (11):2291-2296$$$N$M$Y$$$20240731$$HP$TR$TR
241558111$24155811$1$I$$20240716$20240731$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459431$RANBAXY$Ogundare T, Ologun OA. Feeling blue to seeing red: A case of escitalopram-induced epistaxis. Clin Case Rep. 2024;12 (7):1-4$33$YR$$F$Y$$$20240731$$HP$US$US
241558121$24155812$1$I$20240703$20240716$20240731$20240731$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459194$RANBAXY$$56$YR$$M$Y$98$KG$20240731$$HP$ES$ES
241558131$24155813$1$I$$20240716$20240731$20240731$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460040$RANBAXY$Dasdar S, Kianfar N,  Tavakolpour S, Balighi  K, Mahmoudi H Daneshpazhooh M. Rituximab for the treatment of epidermolysis bullosa acquisita: A large case series of 15 patients. J Dtsch Dermatol Ges. 2023;21 (7):779-784$58$YR$$F$Y$$$20240731$$HP$IR$IR
241558141$24155814$1$I$$20240716$20240731$20240731$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460036$RANBAXY$Dasdar S, Kianfar N,  Tavakolpour S, Balighi  K, Mahmoudi H Daneshpazhooh M. Rituximab for the treatment of epidermolysis bullosa acquisita: A large case series of 15 patients. J Dtsch Dermatol Ges. 2023;21 (7):779-784$54$YR$$M$Y$$$20240731$$HP$IR$IR
241558151$24155815$1$I$$20240716$20240731$20240731$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460023$RANBAXY$Dolfi A, Tudose C. Obsessive-compulsive disorder in a woman with high-functioning autism. Dusunen Adam. 2024;37 (2):114-116$24$YR$$F$Y$$$20240731$$MD$RO$RO
241558172$24155817$2$F$$20240731$20240731$20240814$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459553$RANBAXY$Dunn A, Wu N, Cordaro F. Management of loperamide-related opioid use disorder with buprenorphine within an Australian context: A case report. Drug Alcohol Rev. 2024;0(0):1-4$28$YR$$M$Y$$$20240814$$HP$AU$AU
241558181$24155818$1$I$$20240716$20240731$20240731$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459663$RANBAXY$Ramos MM, Oliveira AL, Velame ML, Monteiro AM, de Cassia Andrade R, da Conceicao Freitas M. Gingival enlargement induced by anticonvulsant drugs in children with microcephaly-Case Report. J Pre Clin Clin Res. 2024;(18)2:135-8$$$C$F$Y$$$20240731$$HP$BR$BR
241558191$24155819$1$I$$20240716$20240731$20240731$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459622$RANBAXY$Evaluationofsafetyoffluoxetineforcerebellarmutismsyndromeinchildrenafterposteriorfossasurgery. Evaluation of safety of fluoxetine for cerebellar mutism syndrome in children after posterior fossa surgery. Arch Pediatr. 2024;31(4):231-237$$$C$$Y$$$20240731$$HP$FR$FR
241558201$24155820$1$I$$20240716$20240731$20240731$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460033$RANBAXY$Dasdar S, Kianfar N,  Tavakolpour S, Balighi  K, Mahmoudi H Daneshpazhooh M. Rituximab for the treatment of epidermolysis bullosa acquisita: A large case series of 15 patients. J Dtsch Dermatol Ges. 2023;21 (7):779-784$45$YR$$F$Y$$$20240731$$HP$IR$IR
241558211$24155821$1$I$$20240716$20240731$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459463$RANBAXY$Kuczmarski TM, Lynch RC. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma. Br J Haematol. 2024;205:100-108$58$YR$$M$Y$$$20240731$$HP$US$US
241558221$24155822$1$I$$20240716$20240731$20240731$EXP$$TH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459595$RANBAXY$Triwatcharikorn J, Pholmoo N, Ratanasutiranont N, Rerknimitr P, Klaewsongkram J. Skin testing might have a diagnostic role in immune complex-mediated hypersensitivity reactions. Clin Exp Dermatol. 2023;48(1):27-30$37$YR$$F$Y$$$20240731$$HP$TH$TH
241558231$24155823$1$I$$20240716$20240731$20240731$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446020$RANBAXY$Lundby C, Farrell B, Wilson A. Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects. Br J Clin Pharmacol. 2024;May 2; 0 (0);90:1741-1744$76$YR$$F$Y$$$20240731$$HP$CA$CA
241558242$24155824$2$F$$20240722$20240731$20240806$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459575$RANBAXY$Yang W, Hu D, Zheng B, Han B, Feng P, Zhou Y, et al. Rash caused by lurasidone in old chinese patient with bipolar disorder: case-based review. BMC Psychiatry. 2024;24 (1):491; 1-7$63$YR$$M$Y$60$KG$20240806$$HP$CN$CN
241558252$24155825$2$F$$20240802$20240731$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459157$RANBAXY$$$$A$F$Y$$$20240816$$MD$US$US
241558261$24155826$1$I$$20240716$20240731$20240731$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459526$RANBAXY$Saad M, Flament J. Paracetamol overdose causing acute kidney injury without hepatotoxicity: a case report. Int J Emerg Med. 2024;17 (1):81 (1-4)$15$YR$$F$Y$57$KG$20240731$$HP$BE$BE
241558271$24155827$1$I$$20240716$20240731$20240731$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460087$RANBAXY$Daifu T, Umeda K, Yokoyama A, Yoshida T, Saida S, Kato I, et al.. Juvenile xanthogranuloma manifesting with LCH-associated neurodegenerative disease-like radiological findings. Pediatr Blood Cancer. 2024;71 (7):1-4$7$YR$$M$Y$$$20240731$$HP$JP$JP
241558281$24155828$1$I$20220214$20240716$20240731$20240731$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-458982$RANBAXY$$59$YR$$F$Y$$$20240731$$HP$DE$DE
241558291$24155829$1$I$$20240716$20240731$20240731$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459621$RANBAXY$Evaluationofsafetyoffluoxetineforcerebellarmutismsyndromeinchildrenafterposteriorfossasurgery. Evaluation of safety of fluoxetine for cerebellar mutism syndrome in children after posterior fossa surgery. Arch Pediatr. 2024;31(4):231-237$$$C$$Y$$$20240731$$HP$FR$FR
241558301$24155830$1$I$$20240716$20240731$20240731$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459677$RANBAXY$Yeh JW, Yang CC.. Upadacitinib for the treatment of alopecia areata-A case report. Dermatologica Sinica. 2024;42(2):150-151$21$YR$$F$Y$$$20240731$$HP$TW$TW
241558321$24155832$1$I$$20240716$20240731$20240731$EXP$$VN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459596$RANBAXY$Duc NM, Thu NTM, Bui C-B, Hoa G, Le Trung Hieu N. Genotype and phenotype characteristics of west syndrome in 20 Vietnamese children: Two novel variants detected by next-generation sequencing. Epilepsy Res. 2023;190:107094; 1-6$$$C$M$Y$$$20240731$$HP$VN$VN
241558331$24155833$1$I$$20240716$20240731$20240731$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459822$RANBAXY$Wang Y, An Y, Hou X, Xu Y, Li Z, Liu X, et al. Cushing^s Syndrome in Pregnancy Secondary to Adrenocortical Adenoma: A Case Series and Review. Endocrinol Diabetes Metab. 2024;7 (2):e00474;1-10$30$YR$$F$Y$$$20240731$$HP$CN$CN
241558341$24155834$1$I$$20240716$20240731$20240731$EXP$$PE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459684$RANBAXY$Cerna-Lopez JA, Tejada-Llacsa PJ, Valle- Farfan FADJ, Alarcon GS, Ugarte-Gil MF, Pimentel-Quiroz VR. Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review. Revista Colombian Rheumatol. 2023;3 0(3):277-282$47$YR$$M$Y$$$20240731$$HP$PE$PE
241558351$24155835$1$I$$20240716$20240731$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459454$RANBAXY$Hua A, Igel C, Fridman D, Ngai I. Direct Visualization of a Cesarean Scar Ectopic Pregnancy After Medical Management. Am J Case Rep. 2024;25 (0):e944396$44$YR$$F$Y$$$20240731$$HP$US$US
241558361$24155836$1$I$$20240716$20240731$20240731$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459676$RANBAXY$Kenar SG, Leba LK, Genc BO, Genc E. ^Tweeting^ Seizures in a Patient with Tuberous Sclerosis with Refractory Epilepsy. Neurol Sci Neurophysiol. 2024;Apr-Jun;41 (2):112-114$34$YR$$M$Y$$$20240731$$HP$TR$TR
241558371$24155837$1$I$$20240716$20240731$20240731$EXP$$PE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459688$RANBAXY$Cerna-Lopez JA, Tejada-Llacsa PJ, Valle- Farfan FADJ, Alarcon GS, Ugarte-Gil MF, Pimentel-Quiroz VR. Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review. Revista Colombian Rheumatol. 2023;3 0(3):277-282$61$YR$$F$Y$$$20240731$$HP$PE$PE
241558381$24155838$1$I$$20240716$20240731$20240731$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459498$RANBAXY$Yoshida H, Iwata Y, Fuchigami T, Katagiri J. Acute onset of ornithine transcarbamylase deficiency after total anomalous pulmonary venous connection repair to a 2-day-old neonate. Cardiol Young. 33;Apr;33(9):1775-1776$2$DY$$M$Y$$$20240731$$MD$JP$JP
241558391$24155839$1$I$$20240716$20240731$20240731$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459639$RANBAXY$Isabel Ribeiro Carvalho C, Miguel Rocha Carvalho P, Ines Costa Silveira M, Isabel Santos Baptista A. A Case of Tumoral Acute Coronary Syndrome - Case Report and Literature Review. J Cardiovasc Echogr. 2024;Apr-Jun; 34 (2):93-95$59$YR$$M$Y$$$20240731$$HP$PT$PT
241558401$24155840$1$I$$20240716$20240731$20240731$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459504$RANBAXY$Tanomogi N, Ota T, Sato D, Itagaki S, Shimada K. Fatal cerebral venous sinus thrombosis with preceding thrombocytopenia in a patient with new-onset eosinophilic granulomatosis with polyangiitis. Mod Rheumatol Case Rep. 2023;7(2):435-439$44$YR$$F$Y$$$20240731$$HP$JP$JP
241558411$24155841$1$I$$20240716$20240731$20240731$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459593$RANBAXY$Jablonska A, Chmiel M, Chwarscianek N, Czyzewski K, Richert- Przygonska M. Thromboembolic complications associated with COVID-19 infection in children. Acta Haematologica Polonica. 2023;54(1):43-45$4$MON$$M$Y$$$20240731$$HP$PL$PL
241558421$24155842$1$I$$20240716$20240731$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459495$RANBAXY$Weichold A, Bowers K. Is Therapeutic Plasma Exchange an Underused Treatment for Antimelanoma Differentiation-Associated Gene 5 (MDA 5) Amyopathic Dermatomyositis. Am J Respir Crit Care Med. 2024;209 (0):A5556$50$YR$$F$Y$$$20240731$$HP$US$US
241558431$24155843$1$I$$20240716$20240731$20240731$EXP$$VN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459597$RANBAXY$Duc NM, Thu NTM, Bui C-B, Hoa G, Le Trung Hieu N. Genotype and phenotype characteristics of west syndrome in 20 Vietnamese children: Two novel variants detected by next-generation sequencing. Epilepsy Res. 2023;190:107094; 1-6$$$C$F$Y$$$20240731$$HP$VN$VN
241558451$24155845$1$I$$20240716$20240731$20240731$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460030$RANBAXY$Dasdar S, Kianfar N,  Tavakolpour S, Balighi  K, Mahmoudi H Daneshpazhooh M. Rituximab for the treatment of epidermolysis bullosa acquisita: A large case series of 15 patients. J Dtsch Dermatol Ges. 2023;21 (7):779-784$88$YR$$M$Y$$$20240731$$HP$IR$IR
241558461$24155846$1$I$$20240716$20240731$20240731$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459624$RANBAXY$Evaluationofsafetyoffluoxetineforcerebellarmutismsyndromeinchildrenafterposteriorfossasurgery. Evaluation of safety of fluoxetine for cerebellar mutism syndrome in children after posterior fossa surgery. Arch Pediatr. 2024;31(4):231-237$$$C$$Y$$$20240731$$HP$FR$FR
241558471$24155847$1$I$$20240716$20240731$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459421$RANBAXY$Frankel ES, Hajduczok AG, Rajapreyar IN, Brailovsky Y. Recurrent giant cell myocarditis after heart transplant: a case report. Eur Heart J Case Rep. 2022;6 (9):1-5$33$YR$$M$Y$$$20240731$$HP$US$US
241558484$24155848$4$F$20240101$20240911$20240731$20240919$EXP$$US-BAYER-2024A108309$BAYER$$44$YR$A$F$Y$58.75$KG$20240919$$MD$US$US
241558491$24155849$1$I$$20240726$20240731$20240731$PER$$US-LEO Pharma-372378$LEO PHARM$$70$YR$$F$Y$$$20240731$$CN$US$US
241558501$24155850$1$I$$20240722$20240731$20240731$30DAY$$US-GSK-US2024091797$GLAXOSMITHKLINE$$$$$M$Y$$$20240731$$CN$US$US
241558511$24155851$1$I$$20240726$20240731$20240731$EXP$$JP-GSK-JP2024094911$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$MD$JP$JP
241558521$24155852$1$I$20200301$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036942$AUROBINDO$$32$YR$$M$Y$81$KG$20240731$$PH$FR$FR
241558541$24155854$1$I$20240509$20240724$20240731$20240731$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000692$PAREXEL$$$$$$Y$$$20240731$$HP$CN$CN
241558551$24155855$1$I$20240516$20240724$20240731$20240731$EXP$$US-009507513-2407USA015009$MERCK$$67$YR$$M$Y$69.66$KG$20240731$$MD$US$US
241558561$24155856$1$I$$20240726$20240731$20240731$PER$$NVSC2024US154898$NOVARTIS$$$$$M$Y$$$20240731$$CN$US$US
241558571$24155857$1$I$$20240725$20240731$20240731$EXP$$US-DSJP-DSU-2024-137935$DAIICHI$$75$YR$$F$Y$$$20240731$$CN$US$US
241558581$24155858$1$I$$20240703$20240731$20240731$EXP$$SG-ROCHE-10000015961$ROCHE$$64$YR$A$F$Y$$$20240731$$CN$SG$SG
241558601$24155860$1$I$$20240716$20240731$20240731$EXP$$TR-GLANDPHARMA-TR-2024GLNLIT00566$GLAND PHARMA$Gozde Koycu Buhari.Evaluation of the basophil activation in immediate type hypersensitivity reactions to chemotherapeutic agents.Alergologia Polska-Polish Journal of Allergology.20-FEB-2024;11:48-55$60$YR$A$M$Y$$$20240731$$HP$TR$TR
241558611$24155861$1$I$20240715$20240722$20240731$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-022613$UNITED THERAPEUTICS$$56$YR$$M$Y$54.422$KG$20240731$$$US$US
241558621$24155862$1$I$20231201$20240725$20240731$20240731$EXP$FR-AFSSAPS-PV2023001296$FR-RDY-SPO/FRA/24/0011030$DR REDDYS$$12$YR$C$M$Y$31$KG$20240731$$MD$FR$FR
241558633$24155863$3$F$20240101$20240821$20240731$20240828$EXP$$CA-UCBSA-2024038346$UCB$$$$$F$Y$$$20240829$$CN$CA$CA
241558642$24155864$2$F$$20240804$20240731$20240807$EXP$$DE-BAYER-2024A109823$BAYER$$$$$F$Y$$$20240807$$MD$DE$DE
241558651$24155865$1$I$$20240728$20240731$20240731$PER$$US-JNJFOC-20240780592$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241558661$24155866$1$I$$20240725$20240731$20240731$EXP$$BR-JNJFOC-20240773957$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$BR$BR
241558681$24155868$1$I$$20240716$20240731$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459485$RANBAXY$Kretovics E, Keegan K, Burg G, Von Allmen D, Chima R, Benscoter D, et al. Prolonged High-Dose Steroid Use in an Infant With Surfactant Protein-C Deficiency and Multiple Complications. Am J Respir Crit Care Med. 2024;May 19;209 (0):A2307;A63$36$MON$$M$Y$$$20240731$$HP$US$US
241558693$24155869$3$F$20240101$20240813$20240731$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022998$UNITED THERAPEUTICS$$$$$F$Y$82.54$KG$20240823$$$US$US
241558701$24155870$1$I$$20240716$20240731$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458182$RANBAXY$Van Noord B, Samaan C, Flamm A. A Case of Delayed and Immediate Hypersensitivity Reactions Induced by Corticosteroids. Dermatitis. 2024;35 (2):191-192$71$YR$$M$Y$$$20240731$$HP$US$US
241558712$24155871$2$F$$20240827$20240731$20240911$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459563$RANBAXY$Wastrom M, Pfammatter J-P. Ten-year-old boy with congenital long QT syndrome type 2 (LQTS2) and life-threatening electrical storm : a case report of successful treatment with mexiletine. Cardiol Young. 2022;32 (11):1871-1872$$$$F$Y$$$20240911$$MD$CH$CH
241558721$24155872$1$I$$20240716$20240731$20240731$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459606$RANBAXY$Babaoglu K, Basar EZ, Usta E, Y?lmaz EH, Gunlemez A. Effect of different dose regimens of everolimus in a series of neonates with giant cardiac rhabdomyomas. Cardiol Young. 2023;33 (11):2291-2296$$$N$M$Y$$$20240731$$HP$TR$TR
241558731$24155873$1$I$$20240716$20240731$20240731$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459678$RANBAXY$Hsu CJ, Tsai TF. Adult?onset Still?s disease following severe acute respiratory syndrome coronavirus 2 vaccination presenting with persistent psoriasis?like dermatitis: A case report. Dermatol Sin. 2024;42(2):164-165$43$YR$$M$Y$$$20240731$$HP$TW$TW
241558741$24155874$1$I$$20240716$20240731$20240731$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459666$RANBAXY$Ramos MM, Oliveira AL, Velame ML, Monteiro AM, de Cassia Andrade R, da Conceicao Freitas M. Gingival enlargement induced by anticonvulsant drugs in children with microcephaly-Case Report. J Pre Clin Clin Res. 2024;18 (2):135-8$$$C$F$Y$$$20240731$$HP$BR$BR
241558751$24155875$1$I$$20240716$20240731$20240731$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459623$RANBAXY$Evaluationofsafetyoffluoxetineforcerebellarmutismsyndromeinchildrenafterposteriorfossasurgery. Evaluation of safety of fluoxetine for cerebellar mutism syndrome in children after posterior fossa surgery. Arch Pediatr. 2024;31(4):231-237$$$C$$Y$$$20240731$$HP$FR$FR
241558761$24155876$1$I$20140101$20240716$20240731$20240731$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460160$RANBAXY$$$$A$M$Y$73$KG$20240731$$MD$GB$GB
241558771$24155877$1$I$$20240716$20240731$20240731$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459858$RANBAXY$Jang SY, Byun JM, Yoon S-S, Paeng JC, Lee S-P, Koh Y. Lenalidomide as a treatment for patients with AL amyloidosis and cardiac involvement. Blood Res. 2023;58:221-245$61$YR$$M$Y$$$20240731$$HP$KR$KR
241558781$24155878$1$I$$20240716$20240731$20240731$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457831$RANBAXY$Ranjan A, Hussain NH, Alam K. Assessment of outcomes of peritoneal lavage using normal saline versus metronidazole in operated perforation peritonitis patients at a tertiary centre. J Cardiovasc Dis Res. 2024;15 (3):800-804$$$$$Y$$$20240731$$MD$IN$IN
241558791$24155879$1$I$$20240716$20240731$20240731$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459465$RANBAXY$Kuczmarski TM, Lynch RC. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma. Br J Haematol. 2024;205:100-108$24$YR$$M$Y$$$20240731$$HP$US$US
241558801$24155880$1$I$$20240716$20240731$20240731$EXP$$VN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459591$RANBAXY$Duc NM, Thu NTM, Bui C-B, Hoa G, Le Trung Hieu N. Genotype and phenotype characteristics of west syndrome in 20 Vietnamese children: Two novel variants detected by next-generation sequencing. Epilepsy Res. 2023;190:107094; 1-6$$$C$F$Y$$$20240731$$HP$VN$VN
241558811$24155881$1$I$$20240716$20240731$20240731$EXP$$VN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459544$RANBAXY$Nguyen CT, Bui VC, Do NS, Giang Bui TH, Pham T T, Hoang TP, et al. Effective Management of Severe Amlodipine/Atenolol Overdose with Intravenous Calcium, Hyperinsulinemic Euglycemia Therapy, and Continuous Veno-Venous Hemodialysis. Am J Case Rep. 2024;25:e943777$64$YR$$M$Y$$$20240731$$HP$VN$VN
241558821$24155882$1$I$$20240716$20240731$20240731$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459629$RANBAXY$Cohen ME, Shechter Y, Eichel R, Yahalom G. A benign course of Parkinson^s disease associated with different mutations in the glucocerebrosidase gene - A case series. Parkinson Relat Dis. 2024;124 (0):106990; 1-7$47$YR$$M$Y$$$20240731$$HP$IL$IL
241558831$24155883$1$I$$20240716$20240731$20240731$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459620$RANBAXY$Evaluationofsafetyoffluoxetineforcerebellarmutismsyndromeinchildrenafterposteriorfossasurgery. Evaluation of safety of fluoxetine for cerebellar mutism syndrome in children after posterior fossa surgery. Arch Pediatr. 2024;31(4):231-237$$$C$$Y$$$20240731$$HP$FR$FR
241558841$24155884$1$I$$20240716$20240731$20240731$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459626$RANBAXY$Cohen ME, Shechter Y, Eichel R, Yahalom G. A benign course of Parkinson^s disease associated with different mutations in the glucocerebrosidase gene - A case series. Parkinson Relat Dis. 2024;124 (0):106990; 1-7$71$YR$$F$Y$$$20240731$$HP$IL$IL
241558851$24155885$1$I$$20240723$20240731$20240731$EXP$$DK-ELITEPHARMA-2024ELLIT00195$ELITE$Knudsen GHo, et al..Opioid-Induced Leukoencephalopathies: A Report of Two Cases.Case Reports in Neurology.01-FEB-2022;14(1):25-30$24$YR$A$M$Y$$$20240731$$HP$DK$DK
241558861$24155886$1$I$$20240716$20240731$20240731$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459659$RANBAXY$Ramos MM, Oliveira AL, Velame ML, Monteiro AM, de Cassia Andrade R, da Conceicao Freitas M. Gingival enlargement induced by anticonvulsant drugs in children with microcephaly-Case Report. J Pre Clin Clin Res. 2024;18(2):135-8$$$C$F$Y$$$20240731$$HP$BR$BR
241558871$24155887$1$I$$20240729$20240731$20240731$EXP$$GB-MYLANLABS-2024M1070677$MYLAN$$$$$F$Y$$$20240731$$HP$GB$GB
241558881$24155888$1$I$20240703$20240729$20240731$20240731$EXP$$CA-MYLANLABS-2024M1070953$MYLAN$$83$YR$$F$Y$$$20240731$$CN$CA$CA
241558891$24155889$1$I$20240620$20240730$20240731$20240731$EXP$$GB-MYLANLABS-2024M1071028$MYLAN$$$$$M$Y$$$20240731$$PH$GB$GB
241558902$24155890$2$F$$20240724$20240731$20240807$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-16607$ALKEM$Takahashi Y, Nakano H, Motoki M, Wakimoto Y, Ikechi D, Koyama Y, Hashimoto H.. Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review. Acute Medine + Surgery. 2024;11(1):e981$45$YR$$F$Y$90$KG$20240807$$HP$JP$JP
241558911$24155891$1$I$20210201$20240718$20240731$20240731$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-11304$ALKEM$$$$$F$Y$$$20240731$$HP$DE$DE
241558921$24155892$1$I$20240715$20240718$20240731$20240731$EXP$GB-MHRA-TPP28718033C22543987YC1721048475207$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-16199$ALKEM$$80$YR$$F$Y$77$KG$20240731$$HP$GB$GB
241558931$24155893$1$I$20240721$20240728$20240731$20240731$EXP$$US-BAYER-2024A110133$BAYER$$78$YR$E$M$Y$124.72$KG$20240731$$CN$US$US
241558961$24155896$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151004$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241558971$24155897$1$I$$20240722$20240731$20240731$EXP$$KR-SA-2024SA219115$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240731$$CN$KR$KR
241558991$24155899$1$I$$20240720$20240731$20240731$EXP$$US-AUROBINDO PHARMA GMBH-AUR-APL-2014-05905$AUROBINDO$803103150$12$YR$$M$Y$$$20240731$$HP$US$US
241559001$24155900$1$I$$20240724$20240731$20240731$EXP$$US-TAKEDA-2024TUS037822$TAKEDA$$$$$M$Y$$$20240731$$CN$US$US
241559011$24155901$1$I$20240725$20240729$20240731$20240731$PER$$US-HALEON-2189676$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241559021$24155902$1$I$$20240723$20240731$20240731$EXP$$US-BIOGEN-2024BI01275438$BIOGEN$$$$$M$Y$$$20240731$$CN$US$US
241559032$24155903$2$F$20240101$20240802$20240731$20240807$EXP$$CA-UCBSA-2024034144$UCB$$$$$M$Y$$$20240807$$CN$CA$CA
241559041$24155904$1$I$$20240716$20240731$20240731$EXP$$TR-GLANDPHARMA-TR-2024GLNLIT00549$GLAND PHARMA$Gozde Koycu Buhari.Evaluation of the basophil activation in immediate type hypersensitivity reactions to chemotherapeutic agents.Alergologia Polska.JAN-2024;11 (No.1):48-55$59$YR$A$M$Y$$$20240731$$HP$TR$TR
241559051$24155905$1$I$$20240723$20240731$20240731$EXP$$TR-ASCENT-2024ASLIT00016$ASCENT$Kaya Akca U, et al.Drug-induced lupus erythematosus in childhood: Case-based review.Lupus.2024;0 (0):1-12$11$YR$C$F$Y$$$20240731$$HP$TR$TR
241559071$24155907$1$I$$20240725$20240731$20240731$EXP$$NVSJ2024JP009143$NOVARTIS$$75$YR$$F$Y$$$20240731$$MD$JP$JP
241559081$24155908$1$I$$20240725$20240731$20240731$EXP$$NVSC2024US153007$NOVARTIS$$$$$F$Y$$$20240731$$CN$US$US
241559091$24155909$1$I$20240528$20240729$20240731$20240731$EXP$FR-AFSSAPS-TO2024001407$NVSC2024FR154735$NOVARTIS$$21$YR$$M$Y$$$20240731$$PH$FR$FR
241559101$24155910$1$I$$20240725$20240731$20240731$EXP$$NVSC2024GR155348$NOVARTIS$Tsotridou E. Encephalopathy Syndrome in an adolescent with Systemic Lupus Nephritis. 62ND PANHELLENIC PEDIATRIC CONGRESS. 2024$10$YR$$F$Y$$$20240731$$HP$GR$GR
241559111$24155911$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151040$AMGEN$$$$$$Y$$$20240731$$PH$US$US
241559121$24155912$1$I$$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024150641$AMGEN$$$$$$Y$$$20240731$$MD$US$US
241559132$24155913$2$F$20220101$20240822$20240731$20240828$EXP$$NVSC2024CN154624$NOVARTIS$Zhang Q, Xie P, Hou X, Zhao C, Duan L, Qiao H. Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report. JOURNAL OF CHEMOTHERAPY. 2024;36 (4):334-42$52$YR$$M$Y$$$20240828$$HP$CN$CN
241559151$24155915$1$I$$20240724$20240731$20240731$EXP$$AU-BEH-2024176385$CSL BEHRING$$82$YR$E$F$Y$80$KG$20240731$$CN$AU$AU
241559161$24155916$1$I$20231130$20231204$20240731$20240731$PER$$US-BAYER-2024A091458$BAYER$$33$YR$A$F$Y$$$20240731$$MD$US$US
241559171$24155917$1$I$$20240726$20240731$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA068767$SANDOZ$$79$YR$$M$Y$$$20240731$$HP$CA$CA
241559181$24155918$1$I$20240726$20240729$20240731$20240731$EXP$$US-009507513-2407USA015188$MERCK$$$$$M$Y$$$20240731$$CN$US$US
241559191$24155919$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A168371$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241559201$24155920$1$I$20240101$20240725$20240731$20240731$EXP$DE-CADRBFARM-2024329426$DE-DEXPHARM-2024-2431$DEXCEL$$25$YR$A$F$Y$80$KG$20240731$$CN$DE$DE
241559222$24155922$2$F$$20240829$20240731$20240906$EXP$$JP-AstraZeneca-2024A169981$ASTRAZENECA$$$$$$Y$$$20240906$$PH$JP$
241559231$24155923$1$I$$20240724$20240731$20240731$EXP$$US-AstraZeneca-2024A170802$ASTRAZENECA$$$$$M$Y$$$20240731$$HP$US$
241559241$24155924$1$I$20240613$20240726$20240731$20240731$EXP$$GB-AstraZeneca-2024A170789$ASTRAZENECA$$$$$M$Y$$$20240731$$MD$GB$
241559251$24155925$1$I$$20211202$20240731$20240731$EXP$$GB-AstraZeneca-2021A852031$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$GB$
241559261$24155926$1$I$20230101$20240726$20240731$20240731$EXP$$US-SA-2024SA224460$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240731$$MD$US$US
241559271$24155927$1$I$$20240726$20240731$20240731$EXP$GB-MHRA-MED-202407261307507540-CDNYM$GB-SA-2024SA224398$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240731$$CN$GB$GB
241559291$24155929$1$I$20240719$20240725$20240731$20240731$EXP$$CA-TAKEDA-2024TUS017605$TAKEDA$$44$YR$$F$Y$$$20240731$$CN$CA$CA
241559301$24155930$1$I$20240207$20240208$20240731$20240731$PER$$US-BAYER-2024A091380$BAYER$$30$YR$A$F$Y$$$20240731$$MD$US$US
241559311$24155931$1$I$$20240726$20240731$20240731$EXP$GB-MHRA-MED-202407261255204420-PRWGY$GB-SA-2024SA220883$SANOFI AVENTIS$$$$$$Y$$$20240731$$CN$GB$GB
241559321$24155932$1$I$20240725$20240725$20240731$20240731$PER$$US-RDY-SPO/USA/24/0011063$DR REDDYS$$16$YR$T$$Y$$$20240731$$CN$US$US
241559332$24155933$2$F$$20240813$20240731$20240823$30DAY$$IT-JNJFOC-20240774708$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$IT$IT
241559341$24155934$1$I$20240401$20240722$20240731$20240731$30DAY$$US-GSK-US2024091678$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240731$$CN$US$US
241559351$24155935$1$I$20231121$20240214$20240731$20240731$PER$$US-BAYER-2024A091424$BAYER$$34$YR$A$F$Y$$$20240731$$MD$US$US
241559362$24155936$2$F$$20240807$20240731$20240809$EXP$$GB-MYLANLABS-2024M1070144$MYLAN$$$$$F$Y$$$20240809$$CN$GB$GB
241559371$24155937$1$I$$20240717$20240731$20240731$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110009$ZYDUS PHARM$Patel K, McQuaid S, Ketterl T, Benedetti DJ, Sokol E.. Two cases of hepatoblastoma in Bohring-Opitz syndrome: An emerging association.. Pediatr-Blood-Cancer. 2024;71:e31010$$$$$Y$$$20240731$$HP$US$US
241559382$24155938$2$F$$20240726$20240731$20240802$EXP$$US-SANDOZ INC.-SDZ2024US068951$SANDOZ$$$$$$Y$$$20240802$$CN$US$US
241559391$24155939$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812343$AU-Accord-437250$ACCORD$$$$$F$Y$$$20240731$$HP$AU$AU
241559401$24155940$1$I$$20240721$20240731$20240731$EXP$AU-TGA-805205$AU-Accord-437233$ACCORD$$68$YR$E$M$Y$$$20240731$$HP$AU$AU
241559411$24155941$1$I$$20240721$20240731$20240731$EXP$$US-Accord-438296$ACCORD$Kwon L. Portable Percussive Massage Device-Related Rectus Sheath Hematoma and Obstructive Uropathy: A Case Report. Biomed Hub. 2024 May 27;9(1):89-93.$6$DEC$A$M$Y$$$20240731$$HP$US$US
241559421$24155942$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812265$AU-Accord-437274$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241559431$24155943$1$I$$20240721$20240731$20240731$EXP$$PH-Accord-437945$ACCORD$Jacinto EK. Chemo-resistant Gestational Trophoblastic Neoplasia and the Use of Immunotherapy: A Case Report and Review of Literature. Acta medica Philippina. 2024;58(11):90-98.$$$A$F$Y$$$20240731$$MD$PH$PH
241559441$24155944$1$I$20240711$20240720$20240731$20240731$EXP$$US-Accord-437916$ACCORD$$37$YR$A$$Y$$$20240731$$HP$US$US
241559451$24155945$1$I$20240515$20240720$20240731$20240731$EXP$$US-Accord-437720$ACCORD$$69$YR$E$M$Y$$$20240731$$MD$US$US
241559471$24155947$1$I$$20240717$20240731$20240731$EXP$$US-RDY-SPO/USA/24/0010826$DR REDDYS$$79$YR$E$M$Y$82$KG$20240731$$CN$US$US
241559481$24155948$1$I$$20240719$20240731$20240731$EXP$$US-Accord-437780$ACCORD$$70$YR$E$M$Y$80.74$KG$20240731$$CN$US$US
241559493$24155949$3$F$20240501$20240915$20240731$20240923$EXP$$NVSC2024GB155856$NOVARTIS$$77$YR$$M$Y$$$20240923$$MD$GB$GB
241559501$24155950$1$I$20240717$20240724$20240731$20240731$EXP$$PK-ROCHE-10000038034$ROCHE$$41$YR$A$F$Y$$$20240731$$CN$PK$PK
241559511$24155951$1$I$20200825$20240725$20240731$20240731$EXP$$CA-TAKEDA-2020TUS038228$TAKEDA$$17$YR$$M$Y$$$20240731$$MD$CA$CA
241559522$24155952$2$F$20230101$20240808$20240731$20240822$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06992$HIKMA$$$$$$Y$$$20240822$$MD$US$US
241559531$24155953$1$I$$20240719$20240731$20240731$EXP$$BR-BAYER-2024A106718$BAYER$$$$C$$Y$$$20240731$$HP$BR$BR
241559542$24155954$2$F$20240725$20240805$20240731$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202407019564$ELI LILLY AND CO$$24$YR$A$$Y$$$20240813$$CN$US$US
241559551$24155955$1$I$20240619$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036862$AUROBINDO$$36$YR$$F$Y$$$20240731$$PH$FR$FR
241559561$24155956$1$I$$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036930$AUROBINDO$$$$$F$Y$$$20240731$$CN$FR$FR
241559571$24155957$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018813$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240731$$CN$US$US
241559581$24155958$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019663$ELI LILLY AND CO$$$$$M$Y$$$20240731$$CN$US$US
241559591$24155959$1$I$20240729$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018606$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240731$$CN$US$US
241559601$24155960$1$I$20240728$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018659$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240731$$CN$US$US
241559611$24155961$1$I$20240711$20240725$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017091$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240731$$CN$US$US
241559621$24155962$1$I$20230101$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019621$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240731$$CN$US$US
241559632$24155963$2$F$$20240822$20240731$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202407006556$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240828$$CN$US$US
241559641$24155964$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019056$ELI LILLY AND CO$$48$YR$A$$Y$$$20240731$$PH$US$US
241559651$24155965$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018829$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240731$$CN$US$US
241559661$24155966$1$I$20240214$20240214$20240731$20240731$PER$$US-BAYER-2024A093366$BAYER$$$$$F$Y$$$20240731$$MD$US$US
241559672$24155967$2$F$$20240802$20240731$20240812$EXP$$GB-TEVA-VS-3207497$TEVA$Hadjivassiliou, M., Blackburn, D., O^Malley, R. et al. IgG4 Disease-Related Ataxia. Cerebellum 23, 1231-1234 (2024). https://doi.org/10.1007/s12311-023-01592-8$67$YR$$M$Y$$$20240812$$HP$GB$GB
241559681$24155968$1$I$20240725$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024151770$AMGEN$$70$YR$E$M$Y$$$20240731$$CN$US$US
241559691$24155969$1$I$$20240723$20240731$20240731$EXP$$JP-AMGEN-JPNSP2024146933$AMGEN$$89$YR$E$F$Y$$$20240731$$PH$JP$JP
241559711$24155971$1$I$$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024148210$AMGEN$Kamali A.; Khalaj K.; Jacobs M.A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$72$YR$E$$Y$$$20240731$$HP$US$US
241559721$24155972$1$I$$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024148218$AMGEN$Kamali A.; Khalaj K.; Jacobs M.A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$52$YR$A$$Y$$$20240731$$HP$US$US
241559731$24155973$1$I$$20240724$20240731$20240731$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011500$JAZZ$$$$$$Y$$$20240731$$HP$JP$JP
241559741$24155974$1$I$$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024148207$AMGEN$Kamali A.; Khalaj K.; Jacobs M.A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$51$YR$A$$Y$$$20240731$$HP$US$US
241559751$24155975$1$I$$20240720$20240731$20240731$EXP$$PT-AUROBINDO-AUR-APL-2024-036905$AUROBINDO$Ara?jo M, Santos S, Viana J, Marques S. Metformin-associated lactic acidosis (MALA) - 4-year series at a university hospital. Congresses of the Portuguese Society of Internal Medicine. 2024;212$$$$F$Y$$$20240731$$MD$PT$PT
241559761$24155976$1$I$$20240729$20240731$20240731$PER$$NVSC2024US155342$NOVARTIS$$$$$F$Y$$$20240731$$CN$US$US
241559771$24155977$1$I$$20240722$20240731$20240731$EXP$$UA-TEVA-VS-3213772$TEVA$$12$YR$$M$Y$55$KG$20240731$$MD$UA$UA
241559783$24155978$3$F$20240725$20240905$20240731$20240911$EXP$$US-BIOGEN-2024BI01275868$BIOGEN$$29$YR$$F$Y$$$20240911$$CN$US$US
241559794$24155979$4$F$20240721$20240918$20240731$20240925$EXP$$MX-BIOGEN-2024BI01275930$BIOGEN$$27$YR$$F$Y$$$20240925$$CN$MX$MX
241559801$24155980$1$I$$20240729$20240731$20240731$EXP$$FR-ABBVIE-5859039$ABBVIE$$65$YR$$F$Y$$$20240731$$MD$FR$FR
241559812$24155981$2$F$$20240820$20240731$20240820$PER$$US-ALXN-202407USA001715US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
241559821$24155982$1$I$20240721$20240721$20240731$20240731$EXP$GB-MHRA-MED-202407211006196690-CFHYB$GB-MACLEODS PHARMA-MAC2024048513$MACLEODS$$$$$$Y$$$20240731$$CN$GB$GB
241559831$24155983$1$I$20240101$20240722$20240731$20240731$EXP$GB-MHRA-MED-202407221850381580-RYPNJ$GB-MACLEODS PHARMA-MAC2024048542$MACLEODS$$$$$$Y$$$20240731$$CN$GB$GB
241559841$24155984$1$I$20240710$20240722$20240731$20240731$EXP$GB-MHRA-MED-202407221710403620-ZPDQF$GB-MACLEODS PHARMA-MAC2024048540$MACLEODS$$$$$$Y$$$20240731$$HP$GB$GB
241559851$24155985$1$I$$20240130$20240731$20240731$PER$$US-BAYER-2024A108248$BAYER$$26$YR$A$F$Y$$$20240731$$CN$US$US
241559861$24155986$1$I$$20240722$20240731$20240731$EXP$$IN-MACLEODS PHARMA-MAC2024048528$MACLEODS$Pradhan A, Bhandari M, Vishwakarma P, Sethi R.Clopidogrel resistance and its relevance: Current concepts.Journal of Family Medicine and Primary Care.2024;13:2187-99$$$$$Y$$$20240731$$HP$IN$IN
241559871$24155987$1$I$$20240722$20240731$20240731$EXP$$CN-MACLEODS PHARMA-MAC2024048527$MACLEODS$Wang C, Qiu J, Huang X, Xu J, Pan L..Hemophagocytic lymphohistiocytosis secondary to rifampin treatment A case report.Medicine (Baltimore).19-JUL-2024;103(29):e39011:1-6$$$$$Y$$$20240731$$MD$CN$CN
241559881$24155988$1$I$$20231221$20240731$20240731$PER$US-MLMSERVICE-20231215-4728880-1$US-STRIDES ARCOLAB LIMITED-2023SP019078$STRIDES$Hansen AC, Piranavan P, Kundu A, El-Dalati SA, Ahmed T.. Embolic myocardial infarction with cardiac arrest as an initial manifestation of non-bacterial thrombotic endocarditis.. BMJ Case Reports. 2023;16(11):e257466$7$DEC$$M$Y$$$20240731$$MD$US$US
241559892$24155989$2$F$$20240809$20240731$20240822$30DAY$$CN-JNJFOC-20240774555$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$CN$CN
241559901$24155990$1$I$20240704$20240725$20240731$20240731$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000687$PAREXEL$$$$$$Y$$$20240731$$HP$CN$CN
241559911$24155991$1$I$20240727$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150654$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241559921$24155992$1$I$$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024148426$AMGEN$Andrade-Bucknor S.; Vasquez M. A.. Isolated cardiac sarcoidosis presenting as transient ischemic attack. Clinical Case Reports. 2024;12 (7):1-5$54$YR$A$F$Y$$$20240731$$HP$US$US
241559931$24155993$1$I$$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024148226$AMGEN$Kamali A.; Khalaj K.; Jacobs M.A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$54$YR$A$$Y$$$20240731$$HP$US$US
241559941$24155994$1$I$$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024148245$AMGEN$Kamali A.; Khalaj K.; Jacobs M.A. et al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (13):2440$57$YR$A$$Y$$$20240731$$HP$US$US
241559953$24155995$3$F$$20240830$20240731$20240910$EXP$$PT-AUROBINDO-AUR-APL-2024-036853$AUROBINDO$Silva P, Ferreira M, Grilo A, Gon?alves F... Serotonin syndrome: the purpose of a clinical case... Congresses of the Portuguese Society of Internal Medicine.. 2024;30:481$79$YR$$F$Y$$$20240910$$MD$PT$PT
241559961$24155996$1$I$20230301$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036735$AUROBINDO$$$$$F$Y$$$20240731$$CN$FR$FR
241559971$24155997$1$I$$20230811$20240731$20240731$PER$US-MLMSERVICE-20230731-4449466-1$US-STRIDES ARCOLAB LIMITED-2023SP013291$STRIDES$Dsouza KG, Alexander AS, Watts JR, Kulkarni T.. Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease.. Multidisciplinary Respiratory Medicine.. 2023;18:890$62$YR$$M$Y$$$20240731$$MD$US$US
241559981$24155998$1$I$20221128$20240219$20240731$20240731$PER$$US-BAYER-2024A091453$BAYER$$22$YR$A$F$Y$$$20240731$$MD$US$US
241559991$24155999$1$I$$20231121$20240731$20240731$PER$$US-SOMERSET-2023-US-001594$ODIN PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241560001$24156000$1$I$$20240720$20240731$20240731$EXP$$IT-AUROBINDO-AUR-APL-2024-036897$AUROBINDO$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al.. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$49$YR$$M$Y$$$20240731$$MD$IT$IT
241560011$24156001$1$I$20240101$20240723$20240731$20240731$EXP$$SG-ROCHE-10000034677$ROCHE$$60$YR$A$F$Y$$$20240731$$CN$SG$SG
241560022$24156002$2$F$$20240719$20240731$20240913$EXP$$US-BAYER-2024A108128$BAYER$Krishnamoorthy S; Kaur R; Ameer N; Uzoma AA; Enemuo NR; Gopal S et al. Type I Kounis Syndrome: Allergic Myocardial Infarction Triggered by Ciprofloxacin. Cureus 2024 Jun 16;16(6):e62460. 2024;16;16(6):e62460$35$YR$A$F$Y$$$20240913$$HP$US$US
241560031$24156003$1$I$$20240716$20240731$20240731$EXP$$TR-GLANDPHARMA-TR-2024GLNLIT00550$GLAND PHARMA$Gozde Koycu Buhari.Evaluation of the basophil activation in immediate type hypersensitivity reactions to chemotherapeutic agents.Alergologia Polska.JAN-2024;11 (No.1):48-55$67$YR$E$M$Y$$$20240731$$HP$TR$TR
241560042$24156004$2$F$$20240805$20240731$20240807$EXP$$US-GILEAD-2024-0682345$GILEAD$$$$E$M$Y$$$20240807$$CN$US$US
241560051$24156005$1$I$20080101$20240726$20240731$20240731$EXP$$CA-Orion Corporation ORION PHARMA-24_00031057$ORION$$59$YR$A$F$Y$$$20240731$$MD$CA$
241560061$24156006$1$I$20230728$20240219$20240731$20240731$PER$$US-BAYER-2024A091457$BAYER$$21$YR$A$F$Y$$$20240731$$HP$US$US
241560072$24156007$2$F$$20240802$20240731$20240807$EXP$$GB-MYLANLABS-2024M1070320$MYLAN$$$$$F$Y$$$20240807$$HP$GB$GB
241560091$24156009$1$I$$20240227$20240731$20240731$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002689$STRIDES$Evbayiro U, Delmas T, Lat T. Non-traumatic Acute Subdural Hematoma in a Patient With Scleroderma Complicated by Pulmonary Arterial Hypertension: A Case Report. Cureus. 2023;15(5):e38769$64$YR$$F$Y$$$20240731$$HP$US$US
241560102$24156010$2$F$20240721$20240904$20240731$20240909$EXP$$GB-MYLANLABS-2024M1070307$MYLAN$$34$YR$$M$Y$$$20240909$$MD$GB$GB
241560111$24156011$1$I$$20240726$20240731$20240731$EXP$$GB-MYLANLABS-2024M1070314$MYLAN$$$$$F$Y$$$20240731$$HP$GB$GB
241560123$24156012$3$F$20240827$20240902$20240731$20240905$EXP$$GB-MYLANLABS-2024M1070371$MYLAN$$$$$M$Y$$$20240905$$PH$GB$GB
241560131$24156013$1$I$$20240726$20240731$20240731$EXP$$IE-MYLANLABS-2024M1070424$MYLAN$$$$$M$Y$$$20240731$$HP$IE$IE
241560151$24156015$1$I$$20240730$20240731$20240731$PER$$US-HALEON-2189796$Haleon PLC$$$$$F$Y$$$20240731$$CN$US$US
241560162$24156016$2$F$20240610$20240724$20240731$20240827$EXP$$NVSC2024CZ145794$NOVARTIS$$$$$F$Y$$$20240827$$MD$CZ$CZ
241560171$24156017$1$I$20240207$20240207$20240731$20240731$PER$$US-BAYER-2024A091372$BAYER$$36$YR$A$F$Y$$$20240731$$HP$US$US
241560181$24156018$1$I$$20240729$20240731$20240731$EXP$$US-GILEAD-2024-0682359$GILEAD$$19$YR$A$M$Y$$$20240731$$CN$US$US
241560192$24156019$2$F$20240620$20240806$20240731$20240814$EXP$$JP-AstraZeneca-2024A169396$ASTRAZENECA$$70$YR$$F$Y$61$KG$20240814$$MD$JP$
241560201$24156020$1$I$$20240604$20240731$20240731$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006640$STRIDES$Carletti P, Shah A, Bair C, Curran C, Mai A, Patel R, et al.. The spectrum of COVID-19-associated chorioretinal vasculopathy.. Am-J-Ophthalmol-Case-Rep. 2023;31$39$YR$$M$Y$$$20240731$$HP$US$US
241560211$24156021$1$I$$20240725$20240731$20240731$EXP$$US-AstraZeneca-2024A170533$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241560221$24156022$1$I$$20240709$20240731$20240731$EXP$$ID-ROCHE-10000038498$ROCHE$$$$$F$Y$$$20240731$$MD$ID$ID
241560231$24156023$1$I$$20240618$20240731$20240731$PER$$US-AstraZeneca-2024A173777$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241560241$24156024$1$I$20160701$20240729$20240731$20240731$EXP$$FR-SANDOZ INC.-SDZ2024FR069186$SANDOZ$$76$YR$$F$Y$$$20240731$$MD$FR$FR
241560251$24156025$1$I$20240216$20240223$20240731$20240731$PER$$US-BAYER-2024A091479$BAYER$$41$YR$A$F$Y$$$20240731$$MD$US$US
241560261$24156026$1$I$$20240729$20240731$20240731$EXP$$CA-TAKEDA-2024TUS076727$TAKEDA$$$$$M$Y$$$20240731$$CN$CA$CA
241560271$24156027$1$I$$20240725$20240731$20240731$EXP$$JP-VIATRISJAPAN-2024M1069197AA$MYLAN$Saito K and Taguchi D. A case of drug-induced lung injury presumably due to celecoxib. The Journal of Japanese Society for Emergency Medicine. 2024;27(3):421$7$DEC$$F$Y$$$20240731$$MD$JP$JP
241560291$24156029$1$I$20240415$20240723$20240731$20240731$EXP$$SG-ROCHE-10000034594$ROCHE$$64$YR$A$M$Y$$$20240731$$CN$SG$SG
241560301$24156030$1$I$$20240723$20240731$20240731$PER$$US-ROCHE-10000034798$ROCHE$$$$$$Y$$$20240731$$CN$US$US
241560311$24156031$1$I$$20240330$20240731$20240731$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004034$STRIDES$Grewal US, Pande A.. Rituximab Rescue in Treatment Refractory Hypersensitivity Pneumonitis. Am-J-Ther. 2023;30 (6):E576-E578$59$YR$$F$Y$$$20240731$$MD$US$US
241560321$24156032$1$I$20240222$20240222$20240731$20240731$PER$$US-BAYER-2024A091494$BAYER$$52$YR$A$F$Y$$$20240731$$MD$US$US
241560331$24156033$1$I$20240208$20240212$20240731$20240731$PER$$US-BAYER-2024A091401$BAYER$$44$YR$A$F$Y$$$20240731$$MD$US$US
241560341$24156034$1$I$$20240725$20240731$20240731$EXP$$CZ-MYLANLABS-2024M1070168$MYLAN$New horizons of biological treatment in dermatology. MEDICAL TRIBUNE. 2024;20(10):D4-D5$26$YR$$F$Y$$$20240731$$MD$CZ$CZ
241560351$24156035$1$I$20240701$20240722$20240731$20240731$EXP$$US-GSK-US2024091713$GLAXOSMITHKLINE$$40$YR$$F$Y$$$20240731$$HP$US$US
241560361$24156036$1$I$$20240730$20240731$20240731$EXP$NL-LRB-00993729$NL-JNJFOC-20240781158$JOHNSON AND JOHNSON$$60$YR$A$M$Y$92$KG$20240731$$CN$NL$NL
241560381$24156038$1$I$$20240724$20240731$20240731$EXP$$CN-ROCHE-10000034919$ROCHE$Liu P, Hang X, Li J, Zhao L, Liu W, Ji J, et al. Chidamide represses MYC expression and might improve survival for patients with double expressor lymphoma. American Journal of Cancer Research. 2024-Jun-30;14 (6):2921-33. doi:10.62347/GLLR3351.$$$$$Y$$$20240731$$HP$CN$CN
241560392$24156039$2$F$20240601$20240906$20240731$20240924$PER$$CA-TOLMAR, INC.-24CA050247$TOLMAR$$67$YR$$M$Y$$$20240924$$CN$CA$CA
241560401$24156040$1$I$$20240725$20240731$20240731$EXP$$CZ-JNJFOC-20240774427$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240731$$MD$CZ$CZ
241560411$24156041$1$I$20240101$20240703$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050274$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241560421$24156042$1$I$20240611$20240717$20240731$20240731$EXP$$CN-ROCHE-10000029734$ROCHE$$8$YR$C$M$Y$29$KG$20240731$$HP$CN$CN
241560431$24156043$1$I$$20240703$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050317$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241560441$24156044$1$I$20240617$20240703$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050350$TOLMAR$$77$YR$$M$Y$$$20240731$$CN$CA$CA
241560451$24156045$1$I$$20240705$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050389$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241560461$24156046$1$I$$20240704$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050423$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241560481$24156048$1$I$$20240703$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050787$TOLMAR$$$$$M$Y$$$20240731$$CN$CA$CA
241560492$24156049$2$F$20240703$20240815$20240731$20240903$PER$$CA-TOLMAR, INC.-24CA050773$TOLMAR$$77$YR$$M$Y$$$20240902$$HP$CA$CA
241560501$24156050$1$I$$20240705$20240731$20240731$PER$$US-TOLMAR, INC.-24US050288$TOLMAR$$$$$M$Y$$$20240731$$HP$US$US
241560511$24156051$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52308$$FDA-CTU$$$$$UNK$N$$$20240730$N$HP$US$
241560521$24156052$1$I$20240101$20240705$20240731$20240731$PER$$US-TOLMAR, INC.-24US050839$TOLMAR$$$$$M$Y$$$20240731$$CN$US$US
241560532$24156053$2$F$20240601$20240815$20240731$20240905$PER$$US-TOLMAR, INC.-24US050775$TOLMAR$$$$$M$Y$$$20240905$$HP$US$US
241560541$24156054$1$I$20240202$20240722$20240731$20240731$EXP$$AU-ITALFARMACO SPA-2159767$ITALFARMACO$$79$YR$$F$Y$$$20240731$$$AU$AU
241560551$24156055$1$I$$20240717$20240731$20240731$EXP$$US-Dolgencorp-2159787$DOLGENCORP$$$$$F$Y$$$20240731$$$US$US
241560561$24156056$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52322$$FDA-CTU$$$$$M$N$$$20240730$N$HP$US$
241560571$24156057$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52347$$FDA-CTU$$$$$F$N$$$20240730$N$$US$
241560581$24156058$1$I$$20240717$20240731$20240731$EXP$$ZA-B.Braun Medical Inc.-2159790$B BRAUN$Literature Article$71$YR$$M$Y$$$20240731$$$ZA$ZA
241560591$24156059$1$I$$20240728$20240731$20240731$PER$$US-HALEON-2189665$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241560601$24156060$1$I$$20240717$20240731$20240731$EXP$$US-B.Braun Medical Inc.-2159775$B BRAUN$Literature Article$18$YR$$F$Y$$$20240731$$$US$US
241560611$24156061$1$I$$20240724$20240731$20240731$PER$$US-ALXN-202407USA001696US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241560621$24156062$1$I$20240601$20240725$20240731$20240731$EXP$$BR-AMGEN-BRASP2024123763$AMGEN$$$$A$M$Y$$$20240731$$MD$BR$BR
241560631$24156063$1$I$$20240717$20240731$20240731$EXP$$ES-B.Braun Medical Inc.-2159795$B BRAUN$Literature Article$27$YR$$F$Y$$$20240731$$$ES$ES
241560641$24156064$1$I$20240711$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036940$AUROBINDO$$26$YR$$F$Y$$$20240731$$MD$FR$FR
241560662$24156066$2$F$$20240723$20240731$20240809$PER$$US-TEVA-VS-3223819$TEVA$$69$YR$$$Y$$$20240809$$CN$US$US
241560671$24156067$1$I$20231228$20240212$20240731$20240731$PER$$US-BAYER-2024A091590$BAYER$$31$YR$A$F$Y$$$20240731$$MD$US$US
241560682$24156068$2$F$20240701$20240829$20240731$20240902$PER$$US-AMGEN-USASP2024151705$AMGEN$$77$YR$E$F$Y$$$20240901$$PH$US$US
241560691$24156069$1$I$20240109$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036863$AUROBINDO$$41$YR$$M$Y$92$KG$20240731$$PH$FR$FR
241560701$24156070$1$I$$20240715$20240731$20240731$EXP$$IN-CorePharma LLC-2159771$COREPHARMA$Source document (Abstract)$74$YR$$F$Y$$$20240731$$$IN$IN
241560711$24156071$1$I$$20240723$20240731$20240731$EXP$$US-MYLANLABS-2024M1070278$MYLAN$Bajwa M. A Giant Complication: A Case of Pituitary Apoplexy of a Giant Adenoma in a Patient on Anticoagulation Therapy. South-Med-J 2023; 116 (1): 71-72.$80$YR$$F$Y$$$20240731$$MD$US$US
241560721$24156072$1$I$$20240723$20240731$20240731$EXP$$US-MYLANLABS-2024M1069790$MYLAN$Rahman O, Javed F, Iqbal M, Fulkerson Z, Chaudhry A, Pasha N, et al. Progressive Refractory Interstitial Lung Disease Due to Recurrent Aspiration in Bulimia Nervosa. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$44$YR$$F$Y$$$20240731$$HP$US$US
241560731$24156073$1$I$$20240723$20240731$20240731$EXP$$US-MYLANLABS-2024M1070364$MYLAN$Pepin A, Lee V, O^Brien S, Mulugeta P, Taunk NK. Management of Dry Eye Toxicity After Treatment With 177Lu-PSMA-617 Radioligand Therapy. Prac-Radiat-Oncol 2024; 14 (4): 301-304.$82$YR$$M$Y$$$20240731$$MD$US$US
241560741$24156074$1$I$$20240723$20240731$20240731$EXP$$US-MYLANLABS-2024M1069875$MYLAN$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$33$YR$$M$Y$$$20240731$$HP$US$US
241560751$24156075$1$I$$20240725$20240731$20240731$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-102964$REGENERON$$$$$F$Y$$$20240731$$CN$US$US
241560761$24156076$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52343$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241560771$24156077$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52318$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241560791$24156079$1$I$20240722$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52362$$FDA-CTU$$43$YR$$F$N$$$20240730$Y$PH$US$
241560811$24156081$1$I$$20240730$20240731$20240731$PER$$US-HALEON-2189740$Haleon PLC$$$$$M$Y$$$20240731$$CN$US$US
241560821$24156082$1$I$20240628$20240725$20240731$20240731$EXP$FR-AFSSAPS-RN2024000830$FR-RDY-SPO/FRA/24/0011027$DR REDDYS$$71$YR$E$F$Y$$$20240731$$MD$FR$FR
241560831$24156083$1$I$20240213$20240213$20240731$20240731$PER$$US-BAYER-2024A091383$BAYER$$49$YR$A$F$Y$$$20240731$$MD$US$US
241560842$24156084$2$F$20240709$20240827$20240731$20240919$PER$$US-GLK-002365$GLAUKOS$$30$YR$$F$Y$$$20240919$$CN$US$US
241560851$24156085$1$I$$20240726$20240731$20240731$EXP$$US-JNJFOC-20240775972$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241560862$24156086$2$F$$20240813$20240731$20240822$30DAY$$US-JNJFOC-20240773138$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$PH$US$US
241560871$24156087$1$I$$20240704$20240731$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06937$LUPIN$$$$$$Y$$$20240731$$CN$US$US
241560881$24156088$1$I$$20240716$20240731$20240731$EXP$$TR-GLANDPHARMA-TR-2024GLNLIT00554$GLAND PHARMA$Gozde Koycu Buhari.Evaluation of the basophil activation in immediate type hypersensitivity reactions to chemotherapeutic agents.Alergologia Polska.20-FEB-2024;11:48-55$57$YR$A$M$Y$$$20240731$$HP$TR$TR
241560891$24156089$1$I$20240701$20240723$20240731$20240731$PER$$US-ABBVIE-5852998$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241560901$24156090$1$I$20240715$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149801$AMGEN$$77$YR$E$F$Y$$$20240731$$CN$US$US
241560912$24156091$2$F$$20240729$20240731$20240806$EXP$$BR-AMGEN-BRASP2024148658$AMGEN$$6$YR$C$F$Y$$$20240806$$PH$BR$BR
241560921$24156092$1$I$20240715$20240715$20240731$20240731$PER$$US-P+L Developments of Newyork Corporation-2159820$PL DEVELOPMENTS$$$$$F$Y$$$20240731$$$US$US
241560931$24156093$1$I$$20240724$20240731$20240731$EXP$$US-009507513-2407USA014762$MERCK$$34$YR$$F$Y$$$20240731$$HP$US$US
241560941$24156094$1$I$20240213$20240213$20240731$20240731$PER$$US-BAYER-2024A091390$BAYER$$43$YR$A$F$Y$$$20240731$$MD$US$US
241560951$24156095$1$I$$20240718$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115197$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240731$$CN$US$US
241560962$24156096$2$F$$20240807$20240731$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202407019658$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240814$$CN$US$US
241560971$24156097$1$I$20240401$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202405015370$ELI LILLY AND CO$$$$A$M$Y$$$20240731$$CN$US$US
241560981$24156098$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019579$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240731$$CN$US$US
241560991$24156099$1$I$20240701$20240724$20240731$20240731$EXP$$US-GSK-US2024092905$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$US$US
241561007$24156100$7$F$$20240913$20240731$20240925$EXP$$PT-AUROBINDO-AUR-APL-2024-037096$AUROBINDO$Salgueiro D, Oliveira AR, Pardal N, Mota RV, Matos AS, Guerra D.. PO-0318 - (4320) - ANAMNESE: A PRINCIPAL ARMA DIAGN?STICA^Anamnesis: the primary diagnosis weapon. Congresses of the Portuguese Society of Internal Medicine. 2024;30:682$65$YR$$F$Y$$$20240925$$MD$PT$PT
241561011$24156101$1$I$$20240729$20240731$20240731$PER$$US-ABBVIE-5860395$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241561021$24156102$1$I$20240624$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-037015$AUROBINDO$$51$YR$$F$Y$57$KG$20240731$$MD$FR$FR
241561031$24156103$1$I$$20240726$20240731$20240731$PER$$US-ROCHE-10000041225$ROCHE$$57$YR$A$F$Y$$$20240731$$CN$US$US
241561041$24156104$1$I$20240722$20240723$20240731$20240731$PER$$US-ROCHE-10000040903$ROCHE$$$$$F$Y$$$20240731$$PH$US$US
241561052$24156105$2$F$20240601$20240726$20240731$20240731$PER$$US-ROCHE-10000040618$ROCHE$$60$YR$A$M$Y$$$20240731$$MD$US$US
241561065$24156106$5$F$20240726$20240910$20240731$20240918$PER$$US-ROCHE-10000040052$ROCHE$$23$YR$A$F$Y$$$20240918$$PH$US$US
241561071$24156107$1$I$$20240720$20240731$20240731$EXP$$PT-AUROBINDO-AUR-APL-2024-037097$AUROBINDO$Ara?jo M, Santos S, Viana J, Marques S. Metformin-associated lactic acidosis (MALA) - 4-year series at a university hospital. Congresses of the Portuguese Society of Internal Medicine. 2024;212$$$$F$Y$$$20240731$$MD$PT$PT
241561081$24156108$1$I$20240212$20240214$20240731$20240731$PER$$US-BAYER-2024A091346$BAYER$$30$YR$A$F$Y$$$20240731$$HP$US$US
241561091$24156109$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52317$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241561111$24156111$1$I$20240711$20240729$20240729$20240729$DIR$FDA-CDER-CTU-2024-52293$$FDA-CTU$$36$YR$$F$N$112.49$KG$20240729$N$$US$
241561121$24156112$1$I$20240727$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52307$$FDA-CTU$$26$YR$$M$N$$$20240729$N$HP$US$
241561131$24156113$1$I$20240710$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52331$$FDA-CTU$$67$YR$$M$N$$$20240730$Y$HP$US$
241561141$24156114$1$I$$20240724$20240731$20240731$EXP$$US-ROCHE-10000036710$ROCHE$$81$YR$E$F$Y$$$20240731$$CN$US$US
241561151$24156115$1$I$$20240730$20240731$20240731$EXP$$US-GILEAD-2024-0682390$GILEAD$$$$A$M$Y$$$20240731$$CN$US$US
241561161$24156116$1$I$$20240716$20240731$20240731$EXP$$TR-GLANDPHARMA-TR-2024GLNLIT00556$GLAND PHARMA$Gozde Koycu Buhari.Evaluation of the basophil activation in immediate type hypersensitivity reactions to chemotherapeutic agents.Alergologia Polska.20-FEB-2024;11:48-55$56$YR$A$M$Y$$$20240731$$HP$TR$TR
241561171$24156117$1$I$20230414$20240725$20240731$20240731$EXP$$CA-TAKEDA-2020TUS052689$TAKEDA$$36$YR$$F$Y$$$20240731$$HP$CA$CA
241561181$24156118$1$I$20240628$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52342$$FDA-CTU$$76$YR$$M$N$$$20240730$Y$PH$US$
241561191$24156119$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120709$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240731$$CN$US$US
241561201$24156120$1$I$20240717$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120224$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240731$$CN$US$US
241561211$24156121$1$I$20240601$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120560$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240731$$HP$US$US
241561222$24156122$2$F$$20240917$20240731$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120571$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240923$$CN$US$US
241561231$24156123$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120725$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240731$$HP$US$US
241561251$24156125$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120906$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240731$$HP$US$US
241561261$24156126$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120376$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240731$$CN$US$US
241561271$24156127$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120681$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240731$$HP$US$US
241561281$24156128$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120672$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240731$$CN$US$US
241561291$24156129$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120397$BRISTOL MYERS SQUIBB$$37$YR$A$M$Y$$$20240731$$HP$US$US
241561311$24156131$1$I$$20240718$20240731$20240731$30DAY$$CA-UCBSA-2024037195$UCB$$$$$M$Y$$$20240731$$CN$CA$CA
241561322$24156132$2$F$$20240719$20240731$20240731$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP009187$STRIDES$Khurana K, Mahajan S, Acharya S, PantbaleKundri N. Bridging immune realms: A striking case report on autoimmune thyroiditis co-existing with immune thrombocytopenic purpura internal medicine section. Journal of Clinical and Diagnostic Research. 2024;18(7):OD01-4$60$YR$$F$Y$$$20240731$$MD$IN$IN
241561331$24156133$1$I$20240725$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024148819$AMGEN$$35$YR$A$F$Y$$$20240731$$PH$US$US
241561341$24156134$1$I$$20240724$20240731$20240731$EXP$$US-EMD Serono-2024040513$EMD SERONO INC$$$$A$F$Y$$$20240731$$CN$US$US
241561351$24156135$1$I$20240701$20240726$20240731$20240731$EXP$$US-ABBVIE-5856940$ABBVIE$$71$YR$$M$Y$$$20240731$$CN$US$US
241561361$24156136$1$I$20220604$20240720$20240731$20240731$EXP$$DE-AUROBINDO-AUR-APL-2024-036713$AUROBINDO$$$$A$F$Y$92$KG$20240731$$MD$DE$DE
241561371$24156137$1$I$20240214$20240214$20240731$20240731$PER$$US-BAYER-2024A091407$BAYER$$18$YR$A$F$Y$$$20240731$$MD$US$US
241561402$24156140$2$F$$20240722$20240731$20240801$EXP$$US-TEVA-VS-3224948$TEVA$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.$$$A$$Y$$$20240801$$PH$US$US
241561413$24156141$3$F$20240725$20240831$20240731$20240903$EXP$$GB-MYLANLABS-2024M1069719$MYLAN$$64$YR$$M$Y$111.2$KG$20240903$$CN$GB$GB
241561422$24156142$2$F$$20240812$20240731$20240813$EXP$$GB-MYLANLABS-2024M1070158$MYLAN$$$$$M$Y$$$20240813$$MD$GB$GB
241561431$24156143$1$I$$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024149476$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241561441$24156144$1$I$$20240722$20240731$20240731$30DAY$$US-GSK-US2024091724$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$CN$US$US
241561451$24156145$1$I$20240724$20240724$20240731$20240731$EXP$$IL-EMD Serono-2024040455$EMD SERONO INC$$32$YR$A$F$Y$63$KG$20240731$$CN$IL$IL
241561461$24156146$1$I$$20240725$20240731$20240731$EXP$$US-TAKEDA-2024TUS075773$TAKEDA$Lin R.Z., Lu T., Homer N., Men C.J., et.al.. Successful treatment of refractory orbital plasmacytoma with chimeric antigen receptor t cell therapy: a case report and review of the literature. Ophthalmic Plastic and Reconstructive Surgery. 2024;40(4)$69$YR$$F$Y$$$20240731$$MD$US$US
241561471$24156147$1$I$20240101$20240726$20240731$20240731$EXP$$US-ABBVIE-5860186$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241561481$24156148$1$I$$20240730$20240731$20240731$PER$$US-ROCHE-10000043478$ROCHE$$6$YR$C$F$Y$$$20240731$$MD$US$US
241561492$24156149$2$F$20240711$20240830$20240731$20240909$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000688$PAREXEL$$$$$$Y$$$20240909$$HP$CN$CN
241561501$24156150$1$I$20240102$20240215$20240731$20240731$PER$$US-BAYER-2024A091430$BAYER$$21$YR$A$F$Y$$$20240731$$MD$US$US
241561512$24156151$2$F$20240101$20240905$20240731$20240912$EXP$$US-ABBVIE-5860377$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
241561521$24156152$1$I$$20240728$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120554$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240731$$CN$US$US
241561531$24156153$1$I$20240725$20240726$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119418$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$91.19$KG$20240731$$PH$US$US
241561541$24156154$1$I$20240620$20240725$20240731$20240731$EXP$FR-AFSSAPS-MP2024001172$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-119186$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$74$KG$20240731$$MD$FR$FR
241561551$24156155$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120736$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240731$$HP$US$US
241561561$24156156$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120703$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$83.9$KG$20240731$$CN$US$US
241561571$24156157$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120601$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240731$$HP$US$US
241561581$24156158$1$I$$20240722$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119210$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240731$$HP$US$US
241561591$24156159$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52301$$FDA-CTU$$39$YR$$F$N$$$20240730$N$$US$
241561611$24156161$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120912$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240731$$HP$US$US
241561621$24156162$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120434$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240731$$HP$US$US
241561631$24156163$1$I$20240710$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52310$$FDA-CTU$$32$YR$$M$N$$$20240730$N$HP$US$
241561641$24156164$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52346$$FDA-CTU$$71$YR$$F$N$$$20240730$N$$US$
241561651$24156165$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52327$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241561661$24156166$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120405$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240731$$HP$US$US
241561672$24156167$2$F$$20240830$20240731$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120509$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240902$$CN$US$US
241561691$24156169$1$I$$20240722$20240731$20240731$EXP$AU-TGA-812553$AU-Accord-437367$ACCORD$$67$YR$E$F$Y$$$20240731$$HP$AU$AU
241561701$24156170$1$I$$20240720$20240731$20240731$EXP$FR-EMA-2024715-AUTODUP-1721071958260$FR-Accord-437326$ACCORD$$$$A$M$Y$78$KG$20240731$$MD$FR$FR
241561711$24156171$1$I$$20240725$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120928$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$115.89$KG$20240731$$CN$US$US
241561721$24156172$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812326$AU-Accord-437263$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241561731$24156173$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812325$AU-Accord-437264$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241561741$24156174$1$I$$20240721$20240731$20240731$EXP$$CA-Accord-438599$ACCORD$Reyes NG, Bendahan N, Swinkin E, Lang AE, Bassett AS. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2024$$$A$F$Y$$$20240731$$HP$CA$CA
241561751$24156175$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812333$AU-Accord-437256$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241561762$24156176$2$F$20240422$20240724$20240731$20240805$EXP$$US-Accord-437779$ACCORD$$29$YR$A$M$Y$$$20240805$$HP$US$US
241561771$24156177$1$I$$20240722$20240731$20240731$EXP$AU-TGA-807288$AU-Accord-437432$ACCORD$$55$YR$A$F$Y$$$20240731$$HP$AU$AU
241561781$24156178$1$I$$20240719$20240731$20240731$EXP$AU-TGA-810787$AU-Accord-436827$ACCORD$$53$YR$A$F$Y$$$20240731$$HP$AU$AU
241561791$24156179$1$I$20240122$20240720$20240731$20240731$EXP$FR-AFSSAPS-ST2024001179$FR-Accord-437581$ACCORD$$79$YR$E$M$Y$75$KG$20240731$$HP$FR$FR
241561801$24156180$1$I$20240624$20240720$20240731$20240731$EXP$FR-AFSSAPS-TS2024000826$FR-Accord-437585$ACCORD$$68$YR$E$M$Y$61$KG$20240731$$MD$FR$FR
241561811$24156181$1$I$20240710$20240722$20240731$20240731$EXP$$US-Accord-438263$ACCORD$$43$YR$A$M$Y$$$20240731$$HP$US$US
241561821$24156182$1$I$20240702$20240720$20240731$20240731$EXP$FR-AFSSAPS-RS2024000701$FR-Accord-437564$ACCORD$$60$YR$A$M$Y$81$KG$20240731$$PH$FR$FR
241561831$24156183$1$I$$20240722$20240731$20240731$EXP$AU-TGA-812557$AU-Accord-437362$ACCORD$$64$YR$A$F$Y$$$20240731$$HP$AU$AU
241561841$24156184$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812735$AU-Accord-437238$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241561851$24156185$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812335$AU-Accord-437254$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241561861$24156186$1$I$20240718$20240720$20240731$20240731$EXP$CN-HENLIUS-24CN015998$CN-Accord-438495$ACCORD$$53$YR$A$F$Y$71$KG$20240731$$MD$CN$CN
241561871$24156187$1$I$$20240722$20240731$20240731$EXP$$US-BAYER-2024A107226$BAYER$$$$E$F$Y$$$20240731$$CN$US$US
241561881$24156188$1$I$$20240729$20240731$20240731$PER$$US-HALEON-2189829$Haleon PLC$$$$$F$Y$$$20240731$$HP$US$US
241561892$24156189$2$F$20240227$20240808$20240731$20240817$PER$$US-BAYER-2024A091484$BAYER$$36$YR$A$F$Y$59$KG$20240817$$MD$US$US
241561901$24156190$1$I$$20240716$20240731$20240731$EXP$$OM-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460100$RANBAXY$Nejah F. Ellouze, Darpanarayan Hazra, Suad Al Abri. Baclofen-induced neurotoxicity in a dialysis patient managed with continuous venovenous hemodialysis: A case report and literature review. Turk J Emerg Med. 2024;24 (3):176-179$73$YR$$F$Y$$$20240731$$HP$OM$OM
241561911$24156191$1$I$$20240716$20240731$20240731$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460150$RANBAXY$Studentova H. The experience with PADCEV in the Czech Republic. Current topics in oncology. 2024;2:161-7$73$YR$$F$Y$$$20240731$$HP$CZ$CZ
241561921$24156192$1$I$$20240716$20240731$20240731$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460178$RANBAXY$Brezeanu AM, Brezeanu D, Tica VI. An unexpected case of an adnexal hydatid cyst in a pregnant woman: a case report. J Med Case Rep. 2024;18 (1):312$15$YR$$F$Y$$$20240731$$HP$RO$RO
241561933$24156193$3$F$20240725$20240909$20240731$20240912$EXP$$NVSC2024CN155541$NOVARTIS$$$$$M$Y$$$20240912$$CN$CN$CN
241561942$24156194$2$F$$20240723$20240731$20240731$EXP$$US-ROCHE-10000034848$ROCHE$$$$$$Y$$$20240731$$CN$US$US
241561951$24156195$1$I$$20240716$20240731$20240731$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459808$RANBAXY$Krawczyk M, Chajec J, Paluch Z, et al. Pneumothorax as a complication of respiratory failure - two case reports and literature review. Pre Clin Clin Res. 2024;Vol 18, No 2:139-146$28$YR$$M$Y$$$20240731$$HP$PL$PL
241561961$24156196$1$I$20240322$20240716$20240731$20240731$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460125$RANBAXY$$112$YR$$F$Y$64$KG$20240731$$MD$GB$GB
241561971$24156197$1$I$20240715$20240726$20240731$20240731$EXP$$CN-ORGANON-O2407CHN002635$ORGANON$$90$YR$$M$Y$35$KG$20240731$$HP$CN$CN
241561981$24156198$1$I$20240101$20240724$20240731$20240731$EXP$$CA-APOTEX-2024AP008803$APOTEX$$$$E$F$Y$$$20240731$$PH$CA$CA
241561991$24156199$1$I$$20240722$20240731$20240731$30DAY$$US-GSK-US2024091737$GLAXOSMITHKLINE$$$$$M$Y$$$20240731$$CN$US$US
241562001$24156200$1$I$20240721$20240726$20240731$20240731$EXP$$NVSC2024GB155563$NOVARTIS$$18$YR$$M$Y$$$20240731$$CN$GB$GB
241562011$24156201$1$I$20240722$20240723$20240731$20240731$PER$$US-BAYER-2024A106925$BAYER$$39$YR$A$F$Y$$$20240731$$MD$US$US
241562021$24156202$1$I$$20240723$20240731$20240731$EXP$$GB-BAYER-2024A106965$BAYER$$$$$$Y$$$20240731$$CN$GB$GB
241562031$24156203$1$I$20240712$20240717$20240731$20240731$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000683$PAREXEL$$$$$$Y$$$20240731$$HP$CN$CN
241562041$24156204$1$I$20240101$20240723$20240731$20240731$EXP$$HR-BRISTOL-MYERS SQUIBB COMPANY-2024-117500$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240731$$HP$HR$HR
241562052$24156205$2$F$20240615$20240827$20240731$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120863$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240902$$HP$US$US
241562061$24156206$1$I$20240601$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120734$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240731$$HP$US$US
241562071$24156207$1$I$20240601$20240724$20240731$20240731$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-118271$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$81.65$KG$20240731$$CN$PR$PR
241562081$24156208$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120463$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$88.45$KG$20240731$$CN$US$US
241562091$24156209$1$I$20240705$20240722$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116474$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240731$$HP$US$US
241562101$24156210$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120842$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$59.87$KG$20240731$$CN$US$US
241562111$24156211$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120410$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240731$$CN$US$US
241562121$24156212$1$I$20240720$20240726$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119972$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240731$$CN$US$US
241562131$24156213$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120564$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240731$$CN$US$US
241562142$24156214$2$F$$20240926$20240731$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120668$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240927$$CN$US$US
241562151$24156215$1$I$20200601$20240726$20240731$20240731$EXP$$AU-TAKEDA-2024TUS076250$TAKEDA$$76$YR$$F$Y$$$20240731$$MD$AU$AU
241562161$24156216$1$I$$20240725$20240731$20240731$PER$$US-BAYER-2024A108997$BAYER$$18$YR$A$F$Y$$$20240731$$HP$US$US
241562172$24156217$2$F$$20240926$20240731$20240927$EXP$$NVSC2024US153872$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
241562181$24156218$1$I$$20240718$20240731$20240731$EXP$$PL-ROCHE-10000032749$ROCHE$$$$$M$Y$$$20240731$$CN$PL$PL
241562201$24156220$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5859045$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241562211$24156221$1$I$$20240723$20240731$20240731$EXP$$PT-STERISCIENCE B.V.-2024-ST-001116$Steriscience PTE$Tavares M, Pereira I, Nicolau M, Mendes AC, Ferreira C.. BURKHOLDERIA CEPACIA COMPLEX: A RARE PERITONITIS CASE REPORT.. Clin-Chem-Lab-Med. 2024;62 (6):eA175-eA176 abstr. PO39$87$YR$$F$Y$$$20240731$$HP$PT$PT
241562221$24156222$1$I$$20240722$20240731$20240731$EXP$$PT-STERISCIENCE B.V.-2024-ST-001106$Steriscience PTE$Mosca AM, Garcia D, Martins JJ, Araujo R, E Silva AO.. A CASE REPORT OF A COMPLICATED INFECTIVE ENDOCARDITIS.. Eur-J-Case-Rep-Intern-Med. 2019;6 (Suppl. 1):461 abstr. 1042.$65$YR$$M$Y$$$20240731$$HP$PT$PT
241562232$24156223$2$F$$20240807$20240731$20240821$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06837$HIKMA$$$$$F$Y$$$20240821$$HP$US$US
241562241$24156224$1$I$$20240723$20240731$20240731$EXP$$US-STERISCIENCE B.V.-2024-ST-001114$Steriscience PTE$Churchill AB, Nguyen AD, Xia J, Nguyen VD, Agrawal N, Durant CE, et al.. To Bite or Not to Bite: A Case of Non-bite Pasteurella Multicoda Resulting in Severe Septic Shock.. Am-J-Respir-Crit-Care-Med. 2024;209:A1679.$68$YR$$M$Y$$$20240731$$HP$US$US
241562251$24156225$1$I$$20240726$20240731$20240731$EXP$$NL-JNJFOC-20240781128$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$NL$NL
241562261$24156226$1$I$20240628$20240725$20240731$20240731$PER$$US-RDY-SPO/USA/24/0011054$DR REDDYS$$13$YR$T$F$Y$$$20240731$$PH$US$US
241562271$24156227$1$I$$20240718$20240731$20240731$EXP$$US-Indoco-000590$INDOCO$Boleyn J, McLaury M, Wieman S. Suspected Pseudocholinesterase Deficiency During Left Thyroid Lobectomy and Isthmusectomy: A Case Report. S D Med. 2024 Jun;77(6):266-269. PMID: 39013099.$59$YR$A$F$Y$$$20240731$$HP$US$US
241562281$24156228$1$I$20240730$20240730$20240730$20240730$DIR$712099$$FDA-CTU$$$$$UNK$N$$$20240730$N$CN$US$
241562291$24156229$1$I$$20240725$20240731$20240731$PER$$US-BAYER-2024A108999$BAYER$$33$YR$A$F$Y$$$20240731$$MD$US$US
241562301$24156230$1$I$20240701$20240730$20240731$20240731$PER$$US-AMGEN-USASP2024151624$AMGEN$$$$$M$Y$$$20240731$$CN$US$US
241562321$24156232$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120866$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240731$$HP$US$US
241562331$24156233$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120712$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240731$$CN$US$US
241562341$24156234$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120778$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240731$$HP$US$US
241562351$24156235$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120438$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240731$$CN$US$US
241562371$24156237$1$I$20240725$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120620$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$89.4$KG$20240731$$PH$US$US
241562381$24156238$1$I$20240726$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019022$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240731$$CN$US$US
241562391$24156239$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019578$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240731$$CN$US$US
241562401$24156240$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018676$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240731$$CN$US$US
241562411$24156241$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019591$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240731$$CN$US$US
241562421$24156242$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018740$ELI LILLY AND CO$$48$YR$A$$Y$$$20240731$$CN$US$US
241562431$24156243$1$I$20240718$20240729$20240731$20240731$EXP$FR-AFSSAPS-LL2024001419$FR-PFIZER INC-202400225526$PFIZER$$73$YR$$F$Y$65$KG$20240731$$PH$FR$FR
241562441$24156244$1$I$20240428$20240503$20240731$20240731$PER$$US-AMGEN-USASP2024151017$AMGEN$$50$YR$A$M$Y$$$20240731$$CN$US$US
241562451$24156245$1$I$20240725$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150975$AMGEN$$83$YR$E$M$Y$$$20240731$$CN$US$US
241562464$24156246$4$F$20240506$20240918$20240731$20240926$30DAY$$CO-AMGEN-COLSP2024144287$AMGEN$$$$$$Y$$$20240926$$CN$CO$CO
241562471$24156247$1$I$$20240722$20240731$20240731$EXP$$ID-TEYRO-2024-TY-000327$Teyro Labs$Darmawan F, Fauzi AR, Pratignyo RB, Kumaladewi P, Rahmadanty AE, Gunadi, et al..Challenges in the diagnosis and treatment of pure non-gestational uterine choriocarcinoma in a child: a case report.J Med Case Rep.2024;18:323$4$YR$C$F$Y$$$20240731$$HP$ID$ID
241562482$24156248$2$F$20240701$20240807$20240731$20240821$EXP$$JP-AMGEN-JPNSP2024148549$AMGEN$$5$DEC$A$F$Y$$$20240820$$PH$JP$JP
241562491$24156249$1$I$$20240724$20240731$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-120677$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240731$$HP$CA$CA
241562511$24156251$1$I$20240730$20240730$20240730$20240730$DIR$712106$$FDA-CTU$$$$$UNK$N$$$20240730$N$CN$US$
241562521$24156252$1$I$20240726$20240730$20240730$20240730$DIR$712109$$FDA-CTU$$77$YR$$M$N$86.4$KG$20240730$Y$PH$US$
241562532$24156253$2$F$$20240805$20240731$20240814$EXP$$PT-SSPHARMA-2024PTSSP00071$SS PHARMA$David G. FERREIRA.Drug-induced liver injury with bromocriptine.Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2024.MAY-2024;183(4):367-369$40$YR$A$F$Y$$$20240814$$HP$PT$PT
241562541$24156254$1$I$20240727$20240730$20240731$20240731$PER$$US-GILEAD-2024-0682387$GILEAD$$38$YR$A$M$Y$$$20240731$$MD$US$US
241562552$24156255$2$F$$20240827$20240731$20240829$EXP$$GB-SANDOZ INC.-SDZ2024GB069319$SANDOZ$$$$$M$Y$$$20240829$$CN$GB$GB
241562561$24156256$1$I$$20240725$20240731$20240731$PER$$US-BAYER-2024A109080$BAYER$$46$YR$A$F$Y$$$20240731$$MD$US$US
241562571$24156257$1$I$20240601$20240715$20240731$20240731$EXP$$US-ETON PHARMACEUTICALS, INC-2024ETO000162$ETON PHARMACEUTICALS$$$$$$Y$$$20240729$$CN$US$US
241562581$24156258$1$I$$20240722$20240731$20240731$EXP$$JP-PERRIGO-17JP034447$PERRIGO$Chiba M, Tsuji T, Takahashi K, Komatsu M, Sugawara T, Ono I. Onset of Ulcerative Colitis after Helicobacter pylori Eradication Therapy: A Case Report. The Permanente journal. 2016;20(2): e115-e118$63$YR$$M$Y$55$KG$20240731$$MD$JP$JP
241562591$24156259$1$I$$20240730$20240731$20240731$EXP$DE-EMA-20110318-raevhumanwt-113838138$DE-ORGANON-O2407DEU002813$ORGANON$Lange-Asschenfeldt C, Blaeser I, Supprian T.. Bipolar switching after carbamazepine withdrawal.. Pharmacopsychiatry. 2007;40(2):86-7$74$YR$$M$Y$$$20240731$$HP$DE$DE
241562601$24156260$1$I$20240724$20240726$20240731$20240731$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159821$JIANGSU HANSOH PHARMACEUTICAL$$81$YR$$M$Y$51$KG$20240731$$MD$CN$CN
241562611$24156261$1$I$20230801$20240724$20240731$20240731$EXP$$CA-GSK-CA2023126687$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$CA$CA
241562631$24156263$1$I$20240711$20240726$20240731$20240731$EXP$FR-AFSSAPS-PB2024000805$FR-MYLANLABS-2024M1069940$MYLAN$$26$YR$$F$Y$$$20240731$$MD$FR$FR
241562641$24156264$1$I$20231201$20240726$20240731$20240731$EXP$FR-AFSSAPS-AN2024000916$FR-MYLANLABS-2024M1069807$MYLAN$$74$YR$$$Y$$$20240731$$MD$FR$FR
241562651$24156265$1$I$20240624$20240726$20240731$20240731$EXP$FR-AFSSAPS-PC2024000574$FR-MYLANLABS-2024M1070047$MYLAN$$51$YR$$F$Y$57$KG$20240731$$MD$FR$FR
241562661$24156266$1$I$$20240726$20240731$20240731$EXP$GB-MHRA-MED-202407260010004620-VJKDB$GB-MYLANLABS-2024M1069748$MYLAN$$$$$F$Y$$$20240731$$CN$GB$GB
241562673$24156267$3$F$20240626$20240805$20240731$20240812$EXP$$AR-MYLANLABS-2024M1061804$MYLAN$$47$YR$$F$Y$$$20240812$$CN$AR$AR
241562681$24156268$1$I$20240723$20240726$20240731$20240731$EXP$$GB-MYLANLABS-2024M1070045$MYLAN$$42$YR$$M$Y$82$KG$20240731$$HP$GB$GB
241562691$24156269$1$I$$20240708$20240731$20240731$PER$$US-B.Braun Medical Inc.-2159822$B BRAUN$$$$$F$Y$$$20240731$$$US$US
241562701$24156270$1$I$$20240718$20240731$20240731$PER$$US-P+L Developments of Newyork Corporation-2159823$PL DEVELOPMENTS$$$$$F$Y$$$20240731$$$US$US
241562711$24156271$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151009$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241562721$24156272$1$I$$20240730$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042896$BOEHRINGER INGELHEIM$$58$YR$A$F$Y$$$20240731$$CN$US$US
241562731$24156273$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5860142$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241562742$24156274$2$F$20190101$20240806$20240731$20240817$EXP$$IT-AUROBINDO-AUR-APL-2024-035597$AUROBINDO$Rosati G, Annunziata L, Scarano E, Dapoto F, Bilancia D.. Clinical outcomes of intermittent panitumumab based-therapy for previously treated older patient with metastatic colorectal cancer: A case report and review of literature.. Frontiers in Oncology. 2024;14:6:1369952$84$YR$$M$Y$78$KG$20240817$$MD$IT$IT
241562751$24156275$1$I$20240206$20240216$20240731$20240731$PER$$US-BAYER-2024A092397$BAYER$$48$YR$A$F$Y$$$20240731$$MD$US$US
241562762$24156276$2$F$20240606$20240813$20240731$20240819$EXP$$NVSC2024FR154814$NOVARTIS$$$$A$F$Y$$$20240819$$MD$FR$FR
241562771$24156277$1$I$$20240729$20240731$20240731$EXP$$CA-ROCHE-2861481$ROCHE$$$$A$M$Y$$$20240731$$CN$CA$CA
241562781$24156278$1$I$20240719$20240724$20240731$20240731$EXP$$CN-BAYER-2024A107969$BAYER$$94$YR$E$M$Y$$$20240731$$HP$CN$CN
241562791$24156279$1$I$$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149824$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241562801$24156280$1$I$$20240723$20240731$20240731$EXP$$US-ROCHE-10000034696$ROCHE$$79$YR$E$F$Y$$$20240731$$CN$US$US
241562811$24156281$1$I$$20240722$20240731$20240731$30DAY$$US-GSK-US2024091755$GLAXOSMITHKLINE$$68$YR$$M$Y$$$20240731$$CN$US$US
241562825$24156282$5$F$20230201$20240819$20240731$20240826$EXP$$BR-SANDOZ INC.-SDZ2024BR069169$SANDOZ$$46$YR$$M$Y$$$20240826$$CN$BR$BR
241562833$24156283$3$F$$20240805$20240731$20240814$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-06703$LUPIN$$$$$$Y$$$20240814$$MD$US$US
241562841$24156284$1$I$20240701$20240701$20240731$20240731$PER$$US-009507513-2407USA000851$MERCK$$21$YR$$$Y$$$20240731$$HP$US$US
241562851$24156285$1$I$20240717$20240730$20240730$20240730$DIR$712095$$FDA-CTU$$55$YR$$F$N$74.7$KG$20240730$N$MD$US$
241562891$24156289$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52314$$FDA-CTU$$75$YR$$F$N$$$20240730$N$$US$
241562901$24156290$1$I$$20240730$20240730$20240730$DIR$712132$$FDA-CTU$$$$$UNK$N$$$20240730$N$CN$US$
241562911$24156291$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52364$$FDA-CTU$$50$YR$$F$N$$$20240730$N$$US$
241562921$24156292$1$I$20240726$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52302$$FDA-CTU$$61$YR$$F$N$$$20240730$N$$US$
241562942$24156294$2$F$20240717$20240828$20240731$20240913$EXP$$JP-SA-2024SA221425$SANOFI AVENTIS$$$$$M$Y$$$20240913$$PH$JP$JP
241562951$24156295$1$I$20240714$20240726$20240731$20240731$EXP$$NVSC2024US154821$NOVARTIS$$33$YR$$F$Y$$$20240731$$CN$US$US
241562961$24156296$1$I$$20240725$20240731$20240731$PER$$US-ROCHE-10000038352$ROCHE$$$$$$Y$$$20240731$$PH$US$US
241562973$24156297$3$F$$20240913$20240731$20240919$EXP$$GB-SA-2024SA217165$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240919$$MD$GB$GB
241562981$24156298$1$I$20240311$20240304$20240731$20240731$PER$$US-BAYER-2024A091524$BAYER$$30$YR$A$F$Y$$$20240731$$HP$US$US
241562991$24156299$1$I$$20240723$20240731$20240731$EXP$$GB-RDY-LIT/GBR/24/0011109$DR REDDYS$Anand A, Brown L, Smith R, Nouri B, Powell F, Mabrok M, et al. Donor Derived Myelodysplastic Syndrome after Sex Matched Haploidentical Allograft for AML with Monosomy 7 in Both Diseases: Importance of Donor Chimerism Assessment By Two Independent Techniques. Blood. 2022 Nov 15;140: 13029-13030. doi:10.1182/blood-2022-167114.$39$YR$A$M$Y$$$20240731$$HP$GB$GB
241563001$24156300$1$I$20240208$20240219$20240731$20240731$PER$$US-BAYER-2024A091413$BAYER$$18$YR$A$F$Y$$$20240731$$MD$US$US
241563011$24156301$1$I$$20230908$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004705$ARBOR$$$$$M$Y$$$20240731$$HP$US$US
241563021$24156302$1$I$20230801$20230803$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004550$ARBOR$$10$YR$$F$Y$$$20240731$$HP$US$US
241563031$24156303$1$I$$20230817$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004608$ARBOR$$$$$M$Y$$$20240731$$MD$US$US
241563041$24156304$1$I$20230817$20230911$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004657$ARBOR$$7$YR$$F$Y$21.315$KG$20240731$$HP$US$US
241563051$24156305$1$I$20230101$20230905$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004675$ARBOR$$$$$F$Y$$$20240731$$CN$US$US
241563061$24156306$1$I$$20230810$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004569$ARBOR$$$$$$Y$$$20240731$$HP$US$US
241563071$24156307$1$I$20230101$20240223$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004711$ARBOR$$$$$F$Y$$$20240731$$CN$US$US
241563081$24156308$1$I$$20230728$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004532$ARBOR$$$$$M$Y$$$20240731$$CN$US$US
241563091$24156309$1$I$20230101$20231108$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004561$ARBOR$$$$$F$Y$$$20240731$$HP$US$US
241563101$24156310$1$I$20230606$20230822$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004613$ARBOR$$17$YR$$M$Y$$$20240731$$HP$US$US
241563111$24156311$1$I$20230728$20231227$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004533$ARBOR$$9$YR$$F$Y$48.1$KG$20240731$$PH$US$US
241563121$24156312$1$I$$20230905$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004684$ARBOR$$$$$F$Y$$$20240731$$MD$US$US
241563131$24156313$1$I$20230807$20230807$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004558$ARBOR$$7$YR$$M$Y$$$20240731$$HP$US$US
241563141$24156314$1$I$20230101$20230913$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004646$ARBOR$$$$$F$Y$$$20240731$$CN$US$US
241563151$24156315$1$I$20230101$20230901$20240731$20240731$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004672$ARBOR$$$$$F$Y$$$20240731$$CN$US$US
241563161$24156316$1$I$20210701$20240725$20240731$20240731$EXP$$US-CHEPLA-2024009511$CHEPLAPHARM$$58$YR$A$M$Y$86.18$KG$20240731$$CN$COUNTRY NOT SPECIFIED$US
241563171$24156317$1$I$20240715$20240725$20240731$20240731$EXP$GB-MHRA-MED-202407240808085920-WDRBP$GB-CHEPLA-2024009568$CHEPLAPHARM$$60$YR$$M$Y$68$KG$20240731$$CN$COUNTRY NOT SPECIFIED$GB
241563181$24156318$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52315$$FDA-CTU$$75$YR$$F$N$$$20240730$N$$US$
241563191$24156319$1$I$$20240723$20240731$20240731$EXP$$AU-CHEPLA-2024009639$CHEPLAPHARM$$$$$$Y$$$20240731$$CN$COUNTRY NOT SPECIFIED$AU
241563211$24156321$1$I$20240315$20240725$20240731$20240731$EXP$FR-AFSSAPS-PP2024000772$FR-CHEPLA-2024009562$CHEPLAPHARM$$74$YR$$F$Y$45.2$KG$20240731$$MD$COUNTRY NOT SPECIFIED$FR
241563221$24156322$1$I$$20240725$20240731$20240731$EXP$PL-URPL-1-3856-2020$PL-CHEPLA-2024009677$CHEPLAPHARM$$33$YR$$M$Y$100$KG$20240731$$MD$COUNTRY NOT SPECIFIED$PL
241563231$24156323$1$I$$20240723$20240731$20240731$EXP$$CA-TAKEDA-2024TUS074826$TAKEDA$$$$$F$Y$$$20240731$$CN$CA$CA
241563241$24156324$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52299$$FDA-CTU$$67$YR$$F$N$$$20240730$N$$US$
241563261$24156326$1$I$$20240723$20240731$20240731$EXP$$AU-CHEPLA-2024009712$CHEPLAPHARM$$25$YR$$F$Y$$$20240731$$CN$COUNTRY NOT SPECIFIED$AU
241563272$24156327$2$F$$20240815$20240731$20240820$EXP$$IE-MYLANLABS-2024M1070702$MYLAN$$$$$F$Y$$$20240820$$HP$IE$IE
241563284$24156328$4$F$$20240905$20240731$20240906$EXP$$GB-MYLANLABS-2024M1069836$MYLAN$$$$$F$Y$$$20240906$$HP$GB$GB
241563293$24156329$3$F$20211201$20240731$20240731$20240812$EXP$$US-MYLANLABS-2024M1069374$MYLAN$Allami N , O?Connor K and Bagley SM. A case of severe opioid and methamphetamine use disorder in a 14 year old. Addiction Science and Clinical Practice. 2024;19(54)$14$YR$$F$Y$$$20240812$$HP$US$US
241563301$24156330$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52330$$FDA-CTU$$75$YR$$F$N$$$20240730$N$$US$
241563314$24156331$4$F$20240726$20240909$20240731$20240915$PER$$US-ROCHE-10000040727$ROCHE$$77$YR$E$M$Y$86.18$KG$20240915$$CN$US$US
241563321$24156332$1$I$20240723$20240730$20240730$20240730$DIR$712160$$FDA-CTU$$5$YR$$M$N$19.2$KG$20240730$Y$$US$
241563331$24156333$1$I$$20240724$20240731$20240731$EXP$$PT-MYLANLABS-2024M1070391$MYLAN$Gaspar CF, Greenfield H, Carneiro L. Donepezil as a cause of cardiogenic syncope - elderly heaven or hell ?. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl. 1) 116-117.$80$YR$$F$Y$$$20240731$$HP$PT$PT
241563341$24156334$1$I$20240723$20240724$20240731$20240731$EXP$$GB-MYLANLABS-2024M1069338$MYLAN$$$$$F$Y$$$20240731$$MD$GB$GB
241563351$24156335$1$I$20240705$20240730$20240730$20240730$DIR$712148$$FDA-CTU$$69$YR$$F$N$$$20240730$N$CN$US$
241563372$24156337$2$F$$20240730$20240731$20240805$EXP$$FR-MYLANLABS-2024M1069359$MYLAN$Archer E, Bosdure L, Lejeune J, Faucheux L, Guery EA, Sillamy N et al.. Hypofibrinogenemia induced by corticosteroids alone during treatment of acute  lymphoblastic leukemia: a case report from Tours University Hospital. REVUE FRANCOPHONE O^HEMOSTASE ET THROMBOSE.. 2024;6(2):67-70$14$YR$$M$Y$$$20240805$$HP$FR$FR
241563381$24156338$1$I$20240415$20240724$20240731$20240731$EXP$IT-MINISAL02-995433$IT-MYLANLABS-2024M1069417$MYLAN$$17$YR$$F$Y$$$20240731$$MD$IT$IT
241563391$24156339$1$I$20220301$20240724$20240731$20240731$EXP$SE-SEMPA-2024-005445$SE-MYLANLABS-2024M1069383$MYLAN$$25$YR$$M$Y$77$KG$20240731$$CN$SE$SE
241563401$24156340$1$I$20240101$20240722$20240731$20240731$EXP$$JP-TEVA-VS-3227001$TEVA$$88$YR$$M$Y$$$20240731$$PH$JP$JP
241563413$24156341$3$F$$20240829$20240731$20240904$EXP$DE-EMA-DD-20240717-7482689-074104$DE-MYLANLABS-2024M1069265$MYLAN$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul.. Alpha-Pyrrolidinohexanophenone (alpha-PHP) vs. alpha-pyrrolidinoisohexanophenone (alpha-PiHP): A toxicological  investigation about plasma concentrations and behavior in  forensic routine cases.. Journal of Analytical Toxicology.. 2024;48(5):299?313$40$YR$$M$Y$$$20240904$$HP$DE$DE
241563421$24156342$1$I$20180727$20240727$20240731$20240731$EXP$GB-MHRA-WEBRADR-202407271514074320-MDRFC$GB-MYLANLABS-2024M1070326$MYLAN$$31$YR$$M$Y$79$KG$20240731$$CN$GB$GB
241563431$24156343$1$I$20240212$20240219$20240731$20240731$PER$$US-BAYER-2024A091445$BAYER$$$$$F$Y$$$20240731$$HP$US$US
241563441$24156344$1$I$$20240727$20240731$20240731$PER$$US-ROCHE-10000042108$ROCHE$$$$$$Y$$$20240731$$CN$US$US
241563451$24156345$1$I$$20240730$20240731$20240731$PER$$US-ROCHE-10000043174$ROCHE$$$$$F$Y$$$20240731$$HP$US$US
241563461$24156346$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000041704$ROCHE$$$$$F$Y$$$20240731$$HP$US$US
241563471$24156347$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000042194$ROCHE$$$$E$F$Y$$$20240731$$CN$US$US
241563481$24156348$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000041547$ROCHE$$$$$$Y$$$20240731$$HP$US$US
241563491$24156349$1$I$20240701$20240730$20240731$20240731$PER$$US-ROCHE-10000043061$ROCHE$$38$YR$A$F$Y$$$20240731$$CN$US$US
241563502$24156350$2$F$$20240821$20240731$20240823$PER$$US-ROCHE-10000035850$ROCHE$$40$YR$A$F$Y$$$20240823$$CN$US$US
241563511$24156351$1$I$$20240725$20240731$20240731$EXP$$US-SA-2024SA222278$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240731$$MD$US$US
241563521$24156352$1$I$20240504$20240726$20240731$20240731$EXP$FR-AFSSAPS-PP2024000810$FR-SA-2024SA221122$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240731$$MD$FR$FR
241563531$24156353$1$I$20200422$20240725$20240731$20240731$EXP$PL-URPL-1-3287-2020$PL-SA-2024SA221155$SANOFI AVENTIS$$35$YR$A$F$Y$60$KG$20240731$$MD$PL$PL
241563552$24156355$2$F$20240201$20240828$20240731$20240830$PER$$US-BAYER-2024A091574$BAYER$$28$YR$A$F$Y$$$20240830$$MD$US$US
241563561$24156356$1$I$$20240722$20240731$20240731$PER$$US-PFM-2024-04212$PIERRE FABRE MEDICAMENT$Nourbakhsh S, Ferrando SJ. Primary versus secondary psychosis in a patient with congenital liver disease. BMJ Case Rep. 2024;17$$$A$M$Y$$$20240731$$HP$US$US
241563571$24156357$1$I$20240706$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149921$AMGEN$$52$YR$A$F$Y$$$20240731$$CN$US$US
241563581$24156358$1$I$$20240726$20240731$20240731$PER$$US-ROCHE-10000041954$ROCHE$$$$$$Y$$$20240731$$CN$US$US
241563591$24156359$1$I$$20240725$20240731$20240731$PER$$US-ROCHE-10000037471$ROCHE$$$$$M$Y$$$20240731$$MD$US$US
241563601$24156360$1$I$$20240730$20240731$20240731$PER$$US-ROCHE-10000044219$ROCHE$$$$A$F$Y$$$20240731$$CN$US$US
241563611$24156361$1$I$$20240726$20240731$20240731$PER$$US-ROCHE-10000040575$ROCHE$$$$$$Y$$$20240731$$PH$US$US
241563621$24156362$1$I$$20240716$20240731$20240731$EXP$$CN-ROCHE-3346104$ROCHE$$72$YR$E$F$Y$$$20240731$$MD$CN$CN
241563631$24156363$1$I$$20240725$20240731$20240731$PER$$US-JNJFOC-20240776912$JOHNSON AND JOHNSON$$$$A$M$Y$74.7$KG$20240731$$MD$US$US
241563644$24156364$4$F$20240719$20240918$20240731$20240926$PER$$US-ROCHE-10000040435$ROCHE$$59$YR$A$F$Y$$$20240926$$CN$US$US
241563651$24156365$1$I$$20240724$20240731$20240731$EXP$$US-GSK-US2024092938$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$US$US
241563661$24156366$1$I$20240531$20240719$20240731$20240731$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000676$PAREXEL$$$$$$Y$$$20240731$$HP$CN$CN
241563672$24156367$2$F$20240507$20240812$20240731$20240816$EXP$$ES-SA-2024SA224438$SANOFI AVENTIS$$52$YR$A$F$Y$44.7$KG$20240816$$MD$ES$ES
241563681$24156368$1$I$20240228$20240723$20240731$20240731$EXP$$DE-ROCHE-10000035370$ROCHE$$64$YR$A$F$Y$81$KG$20240731$$MD$DE$DE
241563691$24156369$1$I$20240601$20240725$20240731$20240731$EXP$GB-MHRA-MED-202407250739342500-QMYNB$GB-MYLANLABS-2024M1069425$MYLAN$$63$YR$$F$Y$$$20240731$$CN$GB$GB
241563701$24156370$1$I$20240718$20240726$20240731$20240731$EXP$$US-BAYER-2024A109619$BAYER$$72$YR$E$M$Y$95.238$KG$20240731$$CN$US$US
241563721$24156372$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52309$$FDA-CTU$$55$YR$$M$N$$$20240730$N$$US$
241563741$24156374$1$I$20240719$20240730$20240730$20240730$DIR$712123$$FDA-CTU$$29$YR$$M$N$63.9$KG$20240730$N$CN$US$
241563761$24156376$1$I$$20240730$20240730$20240730$DIR$712130$$FDA-CTU$$$$$UNK$N$$$20240730$N$CN$US$
241563771$24156377$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52306$$FDA-CTU$$$$$F$N$$$20240729$N$HP$US$
241563813$24156381$3$F$$20240829$20240731$20240903$PER$$US-AMGEN-USASP2024151263$AMGEN$$62$YR$A$F$Y$$$20240903$$CN$US$US
241563821$24156382$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120448$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240731$$CN$US$US
241563831$24156383$1$I$20240723$20240723$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120406$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240731$$PH$US$US
241563841$24156384$1$I$$20240722$20240731$20240731$EXP$$CA-TEVA-VS-3225311$TEVA$$57$YR$$F$Y$97$KG$20240731$$HP$CA$CA
241563852$24156385$2$F$20240716$20240816$20240731$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117697$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240828$$PH$US$US
241563862$24156386$2$F$20240501$20240731$20240731$20240802$EXP$$US-PFIZER INC-PV202400099628$PFIZER$$81$YR$$F$Y$$$20240802$$HP$US$US
241563874$24156387$4$F$$20240924$20240731$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117526$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240926$$CN$US$US
241563881$24156388$1$I$$20240729$20240731$20240731$EXP$$US-PFIZER INC-202400226901$PFIZER$$58$YR$$F$Y$$$20240731$$MD$US$US
241563893$24156389$3$F$$20240913$20240731$20240916$30DAY$$BR-PFIZER INC-202400225690$PFIZER$$$$$$Y$$$20240916$$CN$BR$BR
241563901$24156390$1$I$$20240729$20240731$20240731$EXP$$US-PFIZER INC-202400225960$PFIZER$$89$YR$$M$Y$$$20240731$$HP$US$US
241563911$24156391$1$I$20240614$20240726$20240731$20240731$EXP$FR-AFSSAPS-NC2024000893$FR-PFIZER INC-202400224333$PFIZER$$69$YR$$M$Y$60$KG$20240731$$MD$FR$FR
241563932$24156393$2$F$$20240923$20240731$20240925$EXP$$US-PFIZER INC-202400225976$PFIZER$$91$YR$$M$Y$79.38$KG$20240925$$CN$US$US
241563942$24156394$2$F$$20240730$20240731$20240805$EXP$$CA-PFIZER INC-202400226345$PFIZER$Bassett, A.. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurological sciences : official journal of the Italian Neurological Society and. 2024;10.1007/s10072-024-07705-3$$$A$F$Y$$$20240805$$MD$CA$CA
241563951$24156395$1$I$$20240725$20240731$20240731$EXP$$IN-PFIZER INC-PV202400072464$PFIZER$$74$YR$$F$Y$$$20240731$$CN$IN$IN
241563961$24156396$1$I$20240530$20240730$20240731$20240731$EXP$ES-AEMPS-1554643$ES-PFIZER INC-202400226302$PFIZER$$52$YR$$F$Y$$$20240731$$PH$ES$ES
241563971$24156397$1$I$$20240726$20240731$20240731$EXP$$CN-PFIZER INC-PV202400097730$PFIZER$$$$A$F$Y$$$20240731$$CN$CN$CN
241563983$24156398$3$F$$20240813$20240731$20240815$EXP$$US-PFIZER INC-202400224968$PFIZER$$76$YR$$F$Y$102.06$KG$20240815$$CN$US$US
241563991$24156399$1$I$$20240726$20240731$20240731$EXP$$JP-PFIZER INC-202400225249$PFIZER$$25$YR$$$Y$$$20240731$$CN$JP$JP
241564001$24156400$1$I$20240701$20240728$20240731$20240731$EXP$$CN-PFIZER INC-202400224042$PFIZER$$$$E$M$Y$$$20240731$$PH$CN$CN
241564011$24156401$1$I$20240625$20240726$20240731$20240731$EXP$$PT-PFIZER INC-202400224389$PFIZER$$37$YR$$M$Y$$$20240731$$PH$PT$PT
241564021$24156402$1$I$$20240729$20240731$20240731$EXP$$AR-PFIZER INC-202400226678$PFIZER$$74$YR$$F$Y$$$20240731$$CN$AR$AR
241564031$24156403$1$I$20240625$20240726$20240731$20240731$EXP$$CN-PFIZER INC-PV202400098020$PFIZER$$60$YR$$M$Y$69$KG$20240731$$HP$CN$CN
241564051$24156405$1$I$20240719$20240729$20240731$20240731$EXP$GB-MHRA-MED-202407290940570280-YFVPD$GB-PFIZER INC-202400225651$PFIZER$$30$YR$$F$Y$66$KG$20240731$$HP$GB$GB
241564061$24156406$1$I$20240528$20240729$20240731$20240731$EXP$PT-INFARMED-R202407-578$PT-PFIZER INC-202400225417$PFIZER$$33$YR$$F$Y$$$20240731$$MD$PT$PT
241564072$24156407$2$F$20240530$20240812$20240731$20240815$EXP$$IT-PFIZER INC-202400224278$PFIZER$$57$YR$$F$Y$70$KG$20240815$$MD$IT$IT
241564081$24156408$1$I$$20240726$20240731$20240731$EXP$FR-AFSSAPS-RE2024000752$FR-PFIZER INC-202400224312$PFIZER$$74$YR$$F$Y$$$20240731$$HP$FR$FR
241564092$24156409$2$F$$20240730$20240731$20240805$EXP$$CA-PFIZER INC-202400225969$PFIZER$Bassett, A.. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurological sciences : official journal of the Italian Neurological Society and. 2024;10.1007/s10072-024-07705-3$$$A$F$Y$$$20240805$$MD$CA$CA
241564104$24156410$4$F$$20240807$20240731$20240812$EXP$$US-PFIZER INC-202400224900$PFIZER$$65$YR$$M$Y$$$20240812$$CN$US$US
241564113$24156411$3$F$20240702$20240830$20240731$20240905$30DAY$$DE-PFIZER INC-202400224695$PFIZER$$10$YR$$M$Y$$$20240905$$HP$DE$DE
241564121$24156412$1$I$20240702$20240729$20240731$20240731$EXP$HR-HALMED-300086199$HR-PFIZER INC-202400225359$PFIZER$$38$YR$$M$Y$$$20240731$$MD$HR$HR
241564131$24156413$1$I$$20240729$20240731$20240731$EXP$$US-PFIZER INC-202400226448$PFIZER$$$$$$Y$$$20240731$$MD$US$US
241564141$24156414$1$I$20240709$20240729$20240731$20240731$EXP$FR-AFSSAPS-GR2024000958$FR-PFIZER INC-202400225393$PFIZER$$79$YR$$F$Y$$$20240731$$MD$FR$FR
241564151$24156415$1$I$20231201$20240726$20240731$20240731$EXP$FR-AFSSAPS-PB2024000818$FR-PFIZER INC-202400224324$PFIZER$$71$YR$$F$Y$54$KG$20240731$$MD$FR$FR
241564161$24156416$1$I$20240601$20240725$20240731$20240731$EXP$$US-PFIZER INC-202400225033$PFIZER$$56$YR$$F$Y$$$20240731$$HP$US$US
241564172$24156417$2$F$20240101$20240813$20240731$20240815$EXP$$US-PFIZER INC-202400225934$PFIZER$$77$YR$$M$Y$58.97$KG$20240815$$CN$US$US
241564182$24156418$2$F$$20240805$20240731$20240806$EXP$$US-PFIZER INC-202400224999$PFIZER$$$$$F$Y$$$20240806$$HP$US$US
241564191$24156419$1$I$20240614$20240730$20240730$20240730$DIR$712131$$FDA-CTU$$66$YR$$M$N$$$20240730$N$PH$US$
241564211$24156421$1$I$$20240730$20240731$20240731$EXP$$CA-PFIZER INC-202400226771$PFIZER$$37$YR$$F$Y$$$20240731$$PH$CA$CA
241564221$24156422$1$I$$20240729$20240731$20240731$EXP$$PK-PFIZER INC-PV202300190475$PFIZER$$56$YR$$F$Y$$$20240731$$CN$PK$PK
241564231$24156423$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52300$$FDA-CTU$$59$YR$$F$N$78.93$KG$20240730$N$$US$
241564252$24156425$2$F$$20240731$20240731$20240801$EXP$$TR-PFIZER INC-PV202400099118$PFIZER$$26$YR$$M$Y$$$20240801$$MD$TR$TR
241564261$24156426$1$I$$20240729$20240731$20240731$EXP$$US-PFIZER INC-PV202400098674$PFIZER$$95$YR$$M$Y$$$20240731$$CN$US$US
241564271$24156427$1$I$20240501$20240730$20240731$20240731$EXP$GB-MHRA-MED-202407292333319350-NVPFD$GB-PFIZER INC-202400225952$PFIZER$$18$YR$$F$Y$52$KG$20240731$$CN$GB$GB
241564291$24156429$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52334$$FDA-CTU$$74$YR$$M$N$$$20240730$N$PH$US$
241564302$24156430$2$F$$20240805$20240731$20240805$EXP$$US-PFIZER INC-202400225188$PFIZER$$$$$M$Y$$$20240805$$CN$US$US
241564311$24156431$1$I$$20240729$20240731$20240731$EXP$$AR-PFIZER INC-202400226679$PFIZER$$84$YR$$M$Y$$$20240731$$CN$AR$AR
241564321$24156432$1$I$20240730$20240730$20240730$20240730$DIR$712114$$FDA-CTU$$33$YR$$F$N$49.95$KG$20240730$N$$US$
241564341$24156434$1$I$$20240724$20240731$20240731$EXP$$IN-PFIZER INC-202400225261$PFIZER$Ravi, D.. PULMONARY NOCARDIOSIS: CASE REPORT OF A RARE OPPORTUNISTIC INFECTION COMPLICATING PEMPHIGUS VULGARIS. Chest. 2023;164(4 Suppleme):1167A-1168A$71$YR$$M$Y$$$20240731$$HP$IN$IN
241564351$24156435$1$I$20240621$20240729$20240731$20240731$EXP$$BE-PFIZER INC-202400198495$PFIZER$$83$YR$$F$Y$66$KG$20240731$$MD$BE$BE
241564372$24156437$2$F$20240610$20240902$20240731$20240905$EXP$FR-AFSSAPS-LY2024001136$FR-PFIZER INC-202400225537$PFIZER$$53$YR$$F$Y$62$KG$20240905$$PH$FR$FR
241564381$24156438$1$I$$20240730$20240730$20240730$DIR$712138$$FDA-CTU$$$$$UNK$N$$$20240730$$CN$US$
241564391$24156439$1$I$$20240730$20240730$20240730$DIR$712159$$FDA-CTU$$$$$UNK$N$$$20240730$N$HP$US$
241564401$24156440$1$I$20240701$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52390$$FDA-CTU$$61$YR$$M$N$$$20240729$N$PH$US$
241564411$24156441$1$I$20240123$20240724$20240731$20240731$EXP$$US-PFIZER INC-202400223151$PFIZER$$61$YR$$F$Y$$$20240731$$HP$US$US
241564431$24156443$1$I$20230501$20240729$20240731$20240731$EXP$$PE-PFIZER INC-PV202300109342$PFIZER$$$$A$F$Y$$$20240731$$CN$PE$PE
241564441$24156444$1$I$20240723$20240726$20240731$20240731$EXP$$CN-PFIZER INC-PV202400097965$PFIZER$$50$YR$$F$Y$44$KG$20240731$$HP$CN$CN
241564451$24156445$1$I$20240721$20240729$20240731$20240731$EXP$$CN-PFIZER INC-PV202400098803$PFIZER$$85$YR$$M$Y$$$20240731$$HP$CN$CN
241564464$24156446$4$F$20240724$20240814$20240731$20240816$EXP$$CA-PFIZER INC-PV202400076524$PFIZER$$54$YR$$F$Y$128$KG$20240816$$MD$CA$CA
241564472$24156447$2$F$20240724$20240726$20240731$20240802$EXP$$CA-PFIZER INC-202400018248$PFIZER$$65$YR$$M$Y$$$20240802$$MD$CA$CA
241564481$24156448$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52321$$FDA-CTU$$54$YR$$F$N$$$20240730$N$HP$US$
241564491$24156449$1$I$$20240729$20240731$20240731$EXP$$IL-PFIZER INC-PV202400099196$PFIZER$$$$$F$Y$$$20240731$$MD$IL$IL
241564501$24156450$1$I$20210622$20240730$20240730$20240730$DIR$712171$$FDA-CTU$$25$YR$$F$N$67.5$KG$20240730$N$CN$CA$
241564511$24156451$1$I$20240727$20240729$20240731$20240731$EXP$GB-MHRA-MED-202407291223444680-QRWYD$GB-PFIZER INC-202400225724$PFIZER$$43$YR$$F$Y$$$20240731$$PH$GB$GB
241564531$24156453$1$I$20240101$20240725$20240731$20240731$EXP$$CN-PFIZER INC-PV202400097625$PFIZER$$$$A$F$Y$$$20240731$$CN$CN$CN
241564541$24156454$1$I$20240103$20240726$20240731$20240731$EXP$$CN-PFIZER INC-PV202400097978$PFIZER$$53$YR$$M$Y$$$20240731$$HP$CN$CN
241564551$24156455$1$I$20240622$20240725$20240731$20240731$EXP$$CN-PFIZER INC-PV202400097506$PFIZER$$4$YR$$F$Y$14.3$KG$20240731$$HP$CN$CN
241564562$24156456$2$F$20220101$20240830$20240731$20240910$EXP$$CA-PFIZER INC-202201208427$PFIZER$$13$YR$$M$Y$63$KG$20240910$$MD$CA$CA
241564581$24156458$1$I$20240201$20240726$20240731$20240731$EXP$DE-EMBRYOTOX-202306428$DE-TORRENT-00027076$TORRENT$$1$DY$N$M$Y$3$KG$20240731$$MD$DE$DE
241564592$24156459$2$F$20240719$20240802$20240731$20240807$EXP$DE-CADRBFARM-2024329519$DE-TORRENT-00027088$TORRENT$$71$YR$E$F$Y$70$KG$20240807$$MD$DE$DE
241564601$24156460$1$I$20240723$20240726$20240731$20240731$EXP$GB-MHRA-TPP5103845C13177302YC1721732778348$GB-PFIZER INC-202400224618$PFIZER$$42$YR$$M$Y$82$KG$20240731$$HP$GB$GB
241564612$24156461$2$F$20240715$20240802$20240731$20240808$EXP$DE-AMK-278462$DE-TORRENT-00027075$TORRENT$$80$YR$E$F$Y$$$20240808$$PH$DE$DE
241564621$24156462$1$I$20230101$20240729$20240731$20240731$EXP$DE-AMK-278042$DE-TORRENT-00027086$TORRENT$$64$YR$A$F$Y$150$KG$20240731$$PH$DE$DE
241564631$24156463$1$I$$20240730$20240730$20240730$DIR$712118$$FDA-CTU$$$$$M$N$$$20240730$Y$HP$US$
241564641$24156464$1$I$20240715$20240724$20240731$20240731$EXP$GB-MHRA-MED-202407241446599570-YNRCZ$GB-TORRENT-00037359$TORRENT$$95$YR$E$F$Y$$$20240731$$MD$GB$GB
241564651$24156465$1$I$$20240724$20240731$20240731$EXP$GB-MHRA-31081389$GB-TORRENT-00037346$TORRENT$$$$$F$Y$$$20240731$$CN$GB$GB
241564661$24156466$1$I$20240723$20240724$20240731$20240731$EXP$GB-MHRA-MED-202407241113464250-NKMQV$GB-TORRENT-00037363$TORRENT$$70$YR$E$F$Y$$$20240731$$CN$GB$GB
241564671$24156467$1$I$20240723$20240723$20240731$20240731$EXP$GB-MHRA-MED-202407230647463120-ZYNKC$GB-TORRENT-00037365$TORRENT$$54$YR$A$M$Y$69$KG$20240731$$CN$GB$GB
241564681$24156468$1$I$$20240723$20240731$20240731$EXP$GB-MHRA-30742974$GB-TORRENT-00037361$TORRENT$$79$YR$E$F$Y$$$20240731$$PH$GB$GB
241564691$24156469$1$I$20240501$20240724$20240731$20240731$EXP$GB-MHRA-31122984$GB-TORRENT-00037353$TORRENT$$69$YR$E$F$Y$61$KG$20240731$$MD$GB$GB
241564701$24156470$1$I$20240709$20240723$20240731$20240731$EXP$GB-MHRA-MED-202407231210550910-LSYKQ$GB-TORRENT-00037373$TORRENT$$$$$M$Y$$$20240731$$PH$GB$GB
241564711$24156471$1$I$$20240725$20240731$20240731$EXP$$US-TORRENT-00013692$TORRENT$$28$YR$A$F$Y$$$20240731$$CN$US$US
241564723$24156472$3$F$20240721$20240730$20240731$20240822$PER$$US-ROCHE-10000038501$ROCHE$$$$$F$Y$$$20240822$$CN$US$US
241564731$24156473$1$I$$20240723$20240731$20240731$EXP$$US-BEH-2024176324$CSL BEHRING$$65$YR$E$F$Y$$$20240731$$CN$US$US
241564741$24156474$1$I$$20240723$20240731$20240731$EXP$GB-MHRA-30693806$GB-TORRENT-00037367$TORRENT$$65$YR$E$F$Y$$$20240731$$PH$GB$GB
241564752$24156475$2$F$20240716$20240722$20240731$20240803$EXP$$DE-AUROBINDO-AUR-APL-2024-036468$AUROBINDO$$48$YR$$F$Y$68$KG$20240803$$MD$DE$DE
241564761$24156476$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000042201$ROCHE$$57$YR$A$F$Y$$$20240731$$CN$US$US
241564771$24156477$1$I$$20240730$20240731$20240731$PER$$US-ROCHE-10000043436$ROCHE$$$$A$F$Y$$$20240731$$CN$US$US
241564781$24156478$1$I$$20240722$20240731$20240731$PER$$US-Appco Pharma LLC-2159824$APPCO PHARMA$$$$$M$Y$$$20240731$$$US$US
241564791$24156479$1$I$20240720$20240729$20240731$20240731$PER$$AU-REGENERON PHARMACEUTICALS, INC.-2024-104611$REGENERON$$$$$F$Y$$$20240731$$CN$AU$AU
241564801$24156480$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120810$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$78.93$KG$20240731$$CN$US$US
241564811$24156481$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120453$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$71.21$KG$20240731$$HP$US$US
241564821$24156482$1$I$$20240723$20240731$20240731$EXP$$IR-AstraZeneca-2024A168686$ASTRAZENECA$Bozorgi A, Farzaei A, Nasab EM, Jenab Y, Amirzadegan A, Javazm AK. An interesting case series of ticagrelor induced long QTc. International Journal of Cardiology Cardiovascular Risk and Prevention 2024;22:200311-.$72$YR$$M$Y$$$20240731$$HP$IR$
241564831$24156483$1$I$20240611$20240722$20240731$20240731$EXP$FR-AFSSAPS-AM2024000577$FR-TEVA-VS-3225138$TEVA$$45$YR$$F$Y$54$KG$20240731$$MD$FR$FR
241564841$24156484$1$I$20240701$20240723$20240731$20240731$EXP$$US-VIIV HEALTHCARE LIMITED-US2024092299$VIIV$$29$YR$$F$Y$$$20240731$$HP$US$US
241564851$24156485$1$I$$20240729$20240731$20240731$PER$$NVSC2024US156220$NOVARTIS$$$$$F$Y$$$20240731$$HP$US$US
241564871$24156487$1$I$20240611$20240730$20240731$20240731$EXP$FR-AFSSAPS-LL2024001483$FR-SANDOZ INC.-SDZ2024FR069297$SANDOZ$$46$YR$$F$Y$$$20240731$$CN$FR$FR
241564882$24156488$2$F$$20240730$20240731$20240806$PER$$NVSC2024US156256$NOVARTIS$$$$$$Y$$$20240806$$MD$US$US
241564891$24156489$1$I$20240701$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036739$AUROBINDO$$49$YR$$F$Y$52.5$KG$20240731$$MD$FR$FR
241564901$24156490$1$I$20230602$20240720$20240731$20240731$EXP$$ES-AUROBINDO-AUR-APL-2023-047844$AUROBINDO$$64$YR$$M$Y$64$KG$20240731$$MD$ES$ES
241564912$24156491$2$F$$20240722$20240731$20240821$PER$$US-IMP-2024000502$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
241564922$24156492$2$F$20230222$20240826$20240731$20240904$EXP$$TN-HIKMA PHARMACEUTICALS-TN-H14001-24-06996$HIKMA$Ayadi S, Monastiri S, Safta AB, Hammami M, Samaali I, Kammoun M, et al.. Ayadi S, Monastiri S, Safta AB, Hammami M, Samaali I, Kammoun M, et al. Gastric metastasis and peritoneal carcinosis revealing primary breast cancer: An unusual presentation.. Future Science OA.. 2024;17;10(1)$$$$$Y$$$20240904$$MD$TN$TN
241564931$24156493$1$I$20240727$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150980$AMGEN$$75$YR$E$M$Y$$$20240731$$CN$US$US
241564941$24156494$1$I$$20240727$20240731$20240731$EXP$$US-AMGEN-USASP2024150629$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241564951$24156495$1$I$$20240722$20240731$20240731$EXP$$JP-TAKEDA-2024TUS076253$TAKEDA$$88$YR$$F$Y$$$20240731$$MD$JP$JP
241564961$24156496$1$I$20240718$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149987$AMGEN$$69$YR$E$M$Y$$$20240731$$CN$US$US
241564971$24156497$1$I$$20240727$20240731$20240731$EXP$$US-AMGEN-USASP2024150123$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241564981$24156498$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151415$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241564991$24156499$1$I$$20240724$20240731$20240731$PER$$US-BIOGEN-2024BI01275440$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
241565001$24156500$1$I$$20240725$20240731$20240731$PER$$US-BIOGEN-2024BI01275515$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
241565011$24156501$1$I$20240723$20240723$20240731$20240731$PER$$US-BIOGEN-2024BI01275182$BIOGEN$$51$YR$$F$Y$$$20240731$$PH$US$US
241565021$24156502$1$I$20240101$20240725$20240731$20240731$PER$$US-BIOGEN-2024BI01273506$BIOGEN$$$$$M$Y$$$20240731$$CN$US$US
241565041$24156504$1$I$20231201$20240724$20240731$20240731$EXP$$US-009507513-2407USA015273$MERCK$$64$YR$$M$Y$$$20240731$$CN$US$US
241565053$24156505$3$F$20200505$20240904$20240731$20240917$EXP$$DE-AUROBINDO-AUR-APL-2022-025467$AUROBINDO$$64$YR$$F$Y$64$KG$20240917$$MD$DE$DE
241565061$24156506$1$I$20210420$20240725$20240731$20240731$EXP$$US-JNJFOC-20240770980$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240731$$HP$US$US
241565071$24156507$1$I$20240719$20240722$20240731$20240731$30DAY$$CA-JNJFOC-20240762975$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240731$$HP$CA$CA
241565081$24156508$1$I$$20240727$20240731$20240731$EXP$$GB-GSK-GB2023EME102590$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$GB$GB
241565091$24156509$1$I$$20240730$20240731$20240731$PER$$US-BAYER-2024A110376$BAYER$$52$YR$A$F$Y$$$20240731$$HP$US$US
241565101$24156510$1$I$$20240723$20240731$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001506$BLUEPRINT MEDICINES$$$$$F$Y$$$20240731$$CN$US$US
241565111$24156511$1$I$20240718$20240720$20240731$20240731$EXP$$US-Accord-437888$ACCORD$$37$YR$A$F$Y$$$20240731$$HP$US$US
241565121$24156512$1$I$$20240720$20240731$20240731$EXP$PL-URPL-DML-MLP.4401.1.4939.2021$PL-Accord-437561$ACCORD$$53$YR$A$F$Y$62$KG$20240731$$MD$PL$PL
241565131$24156513$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812324$AU-Accord-437272$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241565141$24156514$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812345$AU-Accord-437248$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241565151$24156515$1$I$20240625$20240720$20240731$20240731$EXP$ES-AEMPS-1548432$ES-Accord-437555$ACCORD$$47$YR$A$F$Y$$$20240731$$MD$ES$ES
241565161$24156516$1$I$20240711$20240720$20240731$20240731$EXP$$US-Accord-437782$ACCORD$$43$YR$A$F$Y$$$20240731$$PH$US$US
241565171$24156517$1$I$20240708$20240720$20240731$20240731$EXP$$US-Accord-437777$ACCORD$$37$YR$A$$Y$$$20240731$$HP$US$US
241565181$24156518$1$I$20240718$20240719$20240731$20240731$EXP$$US-Accord-437781$ACCORD$$70$YR$E$M$Y$80.74$KG$20240731$$CN$US$US
241565191$24156519$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812261$AU-Accord-437280$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241565203$24156520$3$F$$20240730$20240731$20240809$EXP$GB-MHRA-TPP19250208C9433810YC1721401292676$GB-Accord-437884$ACCORD$$69$YR$E$M$Y$64$KG$20240809$$MD$GB$GB
241565211$24156521$1$I$20240614$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036757$AUROBINDO$$76$YR$$F$Y$$$20240731$$MD$FR$FR
241565221$24156522$1$I$$20240720$20240731$20240731$EXP$AU-TGA-812256$AU-Accord-437282$ACCORD$$$$$$Y$$$20240731$$HP$AU$AU
241565241$24156524$1$I$$20240724$20240731$20240731$EXP$$US-BEH-2024176360$CSL BEHRING$$56$YR$A$F$Y$$$20240731$$CN$US$US
241565252$24156525$2$F$$20240826$20240731$20240903$EXP$$JP-BAUSCH-BL-2024-011653$BAUSCH AND LOMB$$$$$M$Y$$$20240903$$MD$JP$JP
241565271$24156527$1$I$$20240722$20240731$20240731$EXP$$JP-BAUSCH-BL-2024-011642$BAUSCH AND LOMB$$$$$$Y$$$20240731$$MD$JP$JP
241565281$24156528$1$I$20240701$20240729$20240731$20240731$EXP$$US-BAUSCH-BL-2024-011601$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240731$$PH$US$US
241565291$24156529$1$I$20240101$20240729$20240731$20240731$PER$$US-BAUSCH-BL-2024-011191$BAUSCH AND LOMB$$$$$F$Y$$$20240731$$CN$US$US
241565301$24156530$1$I$$20240729$20240731$20240731$EXP$$US-BAUSCH-BL-2024-011617$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240731$$CN$US$US
241565311$24156531$1$I$$20240728$20240731$20240731$PER$$US-BAUSCH-BL-2024-011641$BAUSCH AND LOMB$$$$$F$Y$$$20240731$$CN$US$US
241565321$24156532$1$I$20240701$20240725$20240731$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001526$BLUEPRINT MEDICINES$$62$YR$A$F$Y$$$20240731$$CN$US$US
241565331$24156533$1$I$20240604$20240722$20240731$20240731$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22876$SAMSUNG BIOEPIS$$53$YR$A$F$Y$$$20240731$$HP$CA$CA
241565341$24156534$1$I$$20240727$20240731$20240731$EXP$$US-AMGEN-USASP2024150631$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241565351$24156535$1$I$20240722$20240723$20240731$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001515$BLUEPRINT MEDICINES$$82$YR$E$F$Y$$$20240731$$CN$US$US
241565361$24156536$1$I$20240409$20240729$20240731$20240731$EXP$FR-AFSSAPS-NT2024000908$FR-SANDOZ INC.-SDZ2024FR069149$SANDOZ$$14$YR$$F$Y$53$KG$20240731$$MD$FR$FR
241565371$24156537$1$I$20211201$20240724$20240731$20240731$EXP$$CN-BAUSCH-BL-2024-011397$BAUSCH AND LOMB$Yuf J, Xu F, Zhang Y, Wen J, Zhou Q. Diagnosis of light-chain deposition disease after renal  transplantation: A case report and literature review. Experimental and therapeutic medicine. 2024;28:339:1-7. doi:10.3892/etm.2024.12628$6$DEC$$M$Y$$$20240731$$HP$CN$CN
241565381$24156538$1$I$$20240722$20240731$20240731$EXP$$JP-Vifor (International) Inc.-VIT-2024-06590$VIFOR$Tanaka Y, Tezuka S, Hashimoto A, Hosobe Y, Saeki A, Fukae K. Pregnancy with overt diabetic nephropathy: A case report.. Modern Trends in Obstetrics + Gynecology. 2024;72 (2):255-60.$37$YR$$F$Y$83.5$KG$20240731$$MD$JP$JP
241565392$24156539$2$F$20201201$20240919$20240731$20240924$EXP$$PL-BAUSCH-BL-2024-011624$BAUSCH AND LOMB$$49$YR$$M$Y$$$20240924$$HP$PL$PL
241565401$24156540$1$I$20230721$20240724$20240731$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001521$BLUEPRINT MEDICINES$$57$YR$A$F$Y$$$20240731$$CN$US$US
241565411$24156541$1$I$$20240724$20240731$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001514$BLUEPRINT MEDICINES$$$$$$Y$$$20240731$$MD$US$US
241565421$24156542$1$I$20240730$20240730$20240730$20240730$DIR$712163$$FDA-CTU$$57$YR$$F$N$112.5$KG$20240730$N$CN$US$
241565431$24156543$1$I$$20240724$20240731$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001520$BLUEPRINT MEDICINES$$$$$M$Y$$$20240731$$CN$US$US
241565451$24156545$1$I$20240530$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036948$AUROBINDO$$16$YR$$M$Y$$$20240731$$MD$FR$FR
241565461$24156546$1$I$20240725$20240730$20240730$20240730$DIR$712155$$FDA-CTU$$26$YR$$F$N$72$KG$20240730$N$CN$US$
241565471$24156547$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52366$$FDA-CTU$$79$YR$$M$N$$$20240729$N$HP$US$
241565481$24156548$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52391$$FDA-CTU$$42$YR$$M$N$$$20240730$N$$US$
241565501$24156550$1$I$20221208$20240728$20240731$20240731$EXP$$IT-BAUSCH-BL-2024-011553$BAUSCH AND LOMB$$74$YR$$M$Y$73$KG$20240731$$HP$IT$IT
241565511$24156551$1$I$20240717$20240722$20240731$20240731$EXP$$CN-BEIGENE-BGN-2024-011336$BEIGENE$$$$$$Y$$$20240731$$HP$CN$CN
241565521$24156552$1$I$$20240727$20240731$20240731$EXP$$US-AMGEN-USASP2024150635$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241565531$24156553$1$I$20240327$20240726$20240731$20240731$PER$$FR-BRACCO-2024FR04627$BRACCO$$$$$M$Y$$$20240731$$PH$FR$FR
241565542$24156554$2$F$20240625$20240822$20240731$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-036748$AUROBINDO$$67$YR$$M$Y$68$KG$20240902$$PH$FR$FR
241565561$24156556$1$I$$20240726$20240731$20240731$PER$$US-ABBVIE-5857847$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241565572$24156557$2$F$20240727$20240816$20240731$20240826$EXP$$US-BAYER-2024A109656$BAYER$$49$YR$A$M$Y$$$20240826$$CN$US$US
241565582$24156558$2$F$20240628$20240821$20240731$20240831$EXP$$DE-AUROBINDO-AUR-APL-2024-037009$AUROBINDO$$75$YR$$M$Y$76$KG$20240831$$MD$DE$DE
241565591$24156559$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52396$$FDA-CTU$$42$YR$$M$N$$$20240730$N$$US$
241565601$24156560$1$I$$20240717$20240731$20240731$30DAY$$US-UCBSA-2024033936$UCB$$$$$F$Y$$$20240731$$CN$US$US
241565611$24156561$1$I$$20240720$20240731$20240731$EXP$$NL-AUROBINDO-AUR-APL-2024-037179$AUROBINDO$$62$YR$$F$Y$76$KG$20240731$$CN$NL$NL
241565621$24156562$1$I$$20240725$20240731$20240731$PER$$US-BAYER-2024A108383$BAYER$$$$$F$Y$$$20240731$$CN$US$US
241565631$24156563$1$I$$20240730$20240731$20240731$PER$$US-HALEON-2189817$Haleon PLC$$$$$M$Y$$$20240731$$CN$US$US
241565641$24156564$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52387$$FDA-CTU$$49$YR$$F$N$$$20240730$N$$US$
241565651$24156565$1$I$$20240710$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN007301$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241565661$24156566$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018702$ELI LILLY AND CO$$16$YR$T$F$Y$$$20240731$$CN$US$US
241565671$24156567$1$I$$20240719$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407013752$ELI LILLY AND CO$$51$YR$A$$Y$$$20240731$$CN$US$US
241565681$24156568$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018993$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$US$US
241565691$24156569$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019606$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240731$$CN$US$US
241565701$24156570$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019248$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240731$$CN$US$US
241565711$24156571$1$I$20240726$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018745$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240731$$HP$US$US
241565721$24156572$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018949$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240731$$CN$US$US
241565731$24156573$1$I$20240405$20240722$20240731$20240731$EXP$$CN-BEIGENE-BGN-2024-011339$BEIGENE$$$$$$Y$$$20240731$$HP$CN$CN
241565743$24156574$3$F$20240723$20240726$20240731$20240808$EXP$$NVSC2024CN155717$NOVARTIS$$35$YR$$M$Y$55$KG$20240808$$HP$CN$CN
241565761$24156576$1$I$$20240725$20240731$20240731$PER$$US-BAYER-2024A108613$BAYER$$$$$$Y$$$20240731$$CN$US$US
241565771$24156577$1$I$$20240724$20240731$20240731$PER$$US-ALXN-202407USA001768US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241565783$24156578$3$F$$20240823$20240731$20240823$EXP$$US-ALXN-202407USA001959US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$PH$US$US
241565792$24156579$2$F$$20240820$20240731$20240820$PER$$US-ALXN-202407USA001767US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
241565801$24156580$1$I$$20240718$20240731$20240731$EXP$$US-SPECGX-T202401587$SPECGX$Ho T, Vrabec JT, Burton AW. Hydrocodone use and sensorineural hearing loss. Pain Physician. 2007;10(3):467-72$48$YR$$F$Y$$$20240731$$MD$US$US
241565811$24156581$1$I$$20240718$20240731$20240731$EXP$$US-SPECGX-T202401588$SPECGX$Ho T, Vrabec JT, Burton AW. Hydrocodone use and sensorineural hearing loss. Pain Physician. 2007;10(3):467-72$57$YR$$M$Y$$$20240731$$MD$US$US
241565821$24156582$1$I$$20240718$20240731$20240731$EXP$$US-SPECGX-T202401586$SPECGX$Ho T, Vrabec JT, Burton AW. Hydrocodone use and sensorineural hearing loss. Pain Physician. 2007;10(3):467-72$49$YR$$M$Y$$$20240731$$MD$US$US
241565831$24156583$1$I$$20240718$20240731$20240731$EXP$$US-SPECGX-T202401584$SPECGX$Ho T, Vrabec JT, Burton AW. Hydrocodone use and sensorineural hearing loss. Pain Physician. 2007;10(3):467-72$28$YR$$F$Y$$$20240731$$MD$US$US
241565841$24156584$1$I$$20240718$20240731$20240731$EXP$$US-SPECGX-T202401585$SPECGX$Ho T, Vrabec JT, Burton AW. Hydrocodone use and sensorineural hearing loss. Pain Physician. 2007;10(3):467-72$47$YR$$M$Y$$$20240731$$MD$US$US
241565851$24156585$1$I$20240111$20240220$20240731$20240731$PER$$US-BAYER-2024A091235$BAYER$$31$YR$A$F$Y$$$20240731$$MD$US$US
241565861$24156586$1$I$$20240723$20240731$20240731$EXP$$IT-AMGEN-ITASP2024149037$AMGEN$Camma C.; Celsa C.; Cabibbo G. et al.. Hepatic decompensation is the major driver of mortality in Hepatocellular Carcinoma patients treated with Atezolizumab plus Bevacizumab: the impact of successful antiviral treatment.. Hepatology. 2024$$$$$Y$$$20240731$$MD$IT$IT
241565871$24156587$1$I$$20240715$20240731$20240731$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000619$DECIPHERA PHARMACEUTICALS$$$$E$M$Y$$$20240731$$PH$US$US
241565881$24156588$1$I$20240612$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150756$AMGEN$$$$$$Y$$$20240731$$PH$US$US
241565892$24156589$2$F$20240724$20240801$20240731$20240805$PER$$US-AMGEN-USASP2024149664$AMGEN$$$$$$Y$$$20240805$$HP$US$US
241565902$24156590$2$F$$20240729$20240731$20240806$EXP$US-MLMSERVICE-20240715-PI133231-00232-1$US-STRIDES ARCOLAB LIMITED-2024SP009343$STRIDES$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al.. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy.. Experimental and Clinical Transplantation. 2024;22(5):392-395$$$$$Y$$$20240806$$MD$US$US
241565911$24156591$1$I$20240709$20240722$20240731$20240731$EXP$$CN-BEIGENE-BGN-2024-011343$BEIGENE$$$$$$Y$$$20240731$$HP$CN$CN
241565921$24156592$1$I$$20240726$20240731$20240731$PER$$NVSC2024US155092$NOVARTIS$$$$$$Y$$$20240731$$CN$US$US
241565932$24156593$2$F$20231127$20240802$20240731$20240806$EXP$$CA-JNJFOC-20240776105$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$HP$CA$CA
241565941$24156594$1$I$$20240725$20240731$20240731$EXP$$US-JNJFOC-20240768948$JOHNSON AND JOHNSON$$$$$M$Y$$$20240731$$CN$US$US
241565951$24156595$1$I$$20240718$20240731$20240731$EXP$$BR-UCBSA-2024036986$UCB$$$$$F$Y$$$20240731$$CN$BR$BR
241565961$24156596$1$I$20240716$20240725$20240731$20240731$EXP$$US-Vifor (International) Inc.-VIT-2024-06686$VIFOR$$60$YR$$M$Y$69$KG$20240731$$HP$US$US
241565971$24156597$1$I$20240724$20240729$20240731$20240731$EXP$$CN-BAYER-2024A109922$BAYER$$51$YR$A$M$Y$65$KG$20240731$$HP$CN$CN
241565981$24156598$1$I$20240721$20240726$20240731$20240731$EXP$$CN-MYLANLABS-2024M1070519$MYLAN$$30$YR$$F$Y$42$KG$20240731$$HP$CN$CN
241565992$24156599$2$F$20240722$20240729$20240731$20240806$EXP$$US-MYLANLABS-2024M1070924$MYLAN$$63$YR$$F$Y$73.6$KG$20240806$$CN$US$US
241566001$24156600$1$I$$20240730$20240730$20240730$DIR$712096$$FDA-CTU$$$$$F$N$63$KG$20240730$$CN$US$
241566011$24156601$1$I$$20240726$20240731$20240731$EXP$GB-MHRA-MIDB-2febd9d7-3b66-453e-bebb-fba455297ab9$GB-MYLANLABS-2024M1070197$MYLAN$$85$YR$$F$Y$$$20240731$$PH$GB$GB
241566021$24156602$1$I$20240414$20240726$20240731$20240731$EXP$GB-MHRA-31124029$GB-MYLANLABS-2024M1070107$MYLAN$$73$YR$$M$Y$99$KG$20240731$$PH$GB$GB
241566031$24156603$1$I$$20240722$20240731$20240731$EXP$$BY-MYLANLABS-2024M1070753$MYLAN$Yatskevich, NV., Sinha, A., Alvarez, JL., Lachenal, N., Solodovnikova, VV., Gurevich,GL., et al. Preliminary Assessment of Safety of Six Month BPaLM/C Regimens in Patients with Rifampicin- Resistant Tuberculosis in the  Republic of Belarus. Clinical infectology and parasitology. 2024;13:2$52$YR$$$Y$$$20240731$$HP$BY$BY
241566041$24156604$1$I$$20240722$20240731$20240731$EXP$$BY-MYLANLABS-2024M1070749$MYLAN$Yatskevich N, Sinha A, Alvarez J.L, Lachenal N, Solodovnikova V, Hurevich H, et.al.,. Preliminary Assessment of Safety of Six Month BPaLM/C Regimens in Patients with Rifampicin- Resistant Tuberculosis in the  Republic of Belarus. Clinical infectology and parasitology. 2024;13:2$46$YR$$$Y$$$20240731$$HP$BY$BY
241566051$24156605$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52337$$FDA-CTU$$77$YR$$F$N$71.67$KG$20240730$N$$US$
241566061$24156606$1$I$$20240726$20240731$20240731$EXP$GB-MHRA-MIDB-538cdba0-a553-4ecf-a7dd-5b17618f3e21$GB-MYLANLABS-2024M1070103$MYLAN$$44$YR$$F$Y$$$20240731$$PH$GB$GB
241566071$24156607$1$I$$20240719$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN007634$INCYTE$$$$$$Y$$$20240731$$MD$US$US
241566081$24156608$1$I$20240718$20240721$20240731$20240731$EXP$$GB-AUROBINDO-AUR-APL-2024-036630$AUROBINDO$$50$YR$$F$Y$$$20240731$$CN$GB$GB
241566091$24156609$1$I$20240501$20240726$20240731$20240731$EXP$FR-AFSSAPS-LY2024001097$FR-MYLANLABS-2024M1070300$MYLAN$$63$YR$$F$Y$$$20240731$$PH$FR$FR
241566101$24156610$1$I$$20240726$20240731$20240731$EXP$GB-MHRA-MED-202407262113594890-VKHFP$GB-MYLANLABS-2024M1070122$MYLAN$$63$YR$$M$Y$78$KG$20240731$$CN$GB$GB
241566111$24156611$1$I$$20240723$20240731$20240731$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005517$BIOCON$$$$$$Y$$$20240731$$HP$CA$CA
241566121$24156612$1$I$20240730$20240730$20240730$20240730$DIR$712112$$FDA-CTU$$55$YR$$F$N$$$20240730$Y$HP$US$
241566131$24156613$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52319$$FDA-CTU$$61$YR$$M$N$$$20240730$N$$US$
241566141$24156614$1$I$20240727$20240727$20240731$20240731$PER$$US-AMGEN-USASP2024151049$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241566151$24156615$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151277$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241566161$24156616$1$I$$20240721$20240731$20240731$EXP$$GB-AUROBINDO-AUR-APL-2024-036636$AUROBINDO$$47$YR$$M$Y$$$20240731$$CN$GB$GB
241566171$24156617$1$I$20240717$20240730$20240730$20240730$DIR$712115$$FDA-CTU$$76$YR$$F$N$101.7$KG$20240730$N$PH$US$
241566181$24156618$1$I$20240729$20240730$20240730$20240730$DIR$712110$$FDA-CTU$$65$YR$$M$N$$$20240730$N$$US$
241566201$24156620$1$I$20231025$20240719$20240731$20240731$PER$$US-INCYTE CORPORATION-2023IN011225$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241566211$24156621$1$I$20201123$20240720$20240731$20240731$EXP$$PL-AUROBINDO-AUR-APL-2024-036846$AUROBINDO$$84$YR$$M$Y$$$20240731$$PH$PL$PL
241566221$24156622$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52352$$FDA-CTU$$52$YR$$F$N$82.1$KG$20240730$N$$US$
241566231$24156623$1$I$20240730$20240730$20240730$20240730$DIR$712154$$FDA-CTU$$44$YR$$M$N$98.1$KG$20240730$N$$US$
241566241$24156624$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52304$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241566251$24156625$1$I$20240709$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52333$$FDA-CTU$$56$YR$$F$N$$$20240730$N$HP$US$
241566261$24156626$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52379$$FDA-CTU$$62$YR$$M$N$$$20240730$N$$US$
241566271$24156627$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52312$$FDA-CTU$$68$YR$$F$N$$$20240730$N$$US$
241566281$24156628$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52326$$FDA-CTU$$81$YR$$F$N$$$20240730$N$$US$
241566291$24156629$1$I$20240611$20240729$20240731$20240731$EXP$ES-AEMPS-1550749$ES-UCBSA-2024038057$UCB$$90$YR$$M$Y$53$KG$20240731$$MD$ES$ES
241566301$24156630$1$I$20240722$20240729$20240731$20240731$EXP$$US-GILEAD-2024-0682289$GILEAD$$75$YR$E$F$Y$$$20240731$$CN$US$US
241566313$24156631$3$F$20240101$20240914$20240731$20240923$EXP$$CA-CELLTRION INC.-2024CA018090$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
241566321$24156632$1$I$20240212$20240220$20240731$20240731$PER$$US-BAYER-2024A091422$BAYER$$21$YR$A$F$Y$$$20240731$$MD$US$US
241566331$24156633$1$I$$20240723$20240731$20240731$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR093924$VIIV$$$$$M$Y$$$20240731$$PH$US$US
241566341$24156634$1$I$20240725$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149992$AMGEN$$85$YR$E$$Y$$$20240731$$CN$US$US
241566352$24156635$2$F$20240701$20240918$20240731$20240923$30DAY$$JP-PFIZER INC-PV202400097076$PFIZER$$$$$$Y$$$20240923$$MD$JP$JP
241566362$24156636$2$F$20230615$20240917$20240731$20240926$30DAY$$JP-PFIZER INC-PV202400096741$PFIZER$$$$$M$Y$$$20240926$$MD$JP$JP
241566373$24156637$3$F$$20240921$20240731$20240923$EXP$$US-PFIZER INC-PV202400098593$PFIZER$$67$YR$$M$Y$136$KG$20240923$$MD$US$US
241566393$24156639$3$F$$20240925$20240731$20240927$30DAY$$US-PFIZER INC-202400219179$PFIZER$$$$$$Y$$$20240927$$PH$US$US
241566402$24156640$2$F$$20240813$20240731$20240816$PER$$US-ROCHE-10000041480$ROCHE$$$$$F$Y$$$20240816$$CN$US$US
241566411$24156641$1$I$$20240724$20240731$20240731$PER$$US-ROCHE-10000036865$ROCHE$$$$$F$Y$$$20240731$$CN$US$US
241566422$24156642$2$F$$20240910$20240731$20240916$PER$$US-ROCHE-10000034292$ROCHE$$$$A$M$Y$$$20240916$$PH$US$US
241566431$24156643$1$I$$20240726$20240731$20240731$PER$$US-ROCHE-10000039668$ROCHE$$$$$$Y$$$20240731$$CN$US$US
241566451$24156645$1$I$$20240722$20240731$20240731$EXP$$CA-BLUEPRINT MEDICINES CORPORATION-2024BUS004447$Unknown Manufacturer$$$$$$Y$$$20240731$$MD$CA$CA
241566462$24156646$2$F$$20240905$20240731$20240909$30DAY$$FR-PFIZER INC-202400219347$PFIZER$$68$YR$$F$Y$$$20240909$$PH$FR$FR
241566471$24156647$1$I$20240220$20240220$20240731$20240731$PER$$US-BAYER-2024A091449$BAYER$$26$YR$A$F$Y$$$20240731$$MD$US$US
241566481$24156648$1$I$20240724$20240724$20240731$20240731$PER$$US-ALXN-202407USA001664US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241566491$24156649$1$I$20240703$20240724$20240731$20240731$EXP$$US-Stemline Therapeutics, Inc.-2024ST004510$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240730$$HP$US$US
241566501$24156650$1$I$$20240730$20240731$20240731$PER$$US-ROCHE-10000043337$ROCHE$$$$E$F$Y$$$20240731$$CN$US$US
241566511$24156651$1$I$$20240725$20240731$20240731$PER$$US-ROCHE-10000037982$ROCHE$$$$E$F$Y$$$20240731$$CN$US$US
241566521$24156652$1$I$$20240625$20240731$20240731$PER$$US-ROCHE-10000013336$ROCHE$$$$$$Y$$$20240731$$PH$US$US
241566531$24156653$1$I$$20240722$20240731$20240731$EXP$$US-AMGEN-USASP2024146871$AMGEN$Bandali T.; Kim Y.; Khodadoust M. et al.. Polatuzumab vedotin-piiq for treatment of primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCL-LT) in older adults. Journal of Investigative Dermatology. 2024;144 (8):S49$83$YR$E$F$Y$$$20240731$$HP$US$US
241566541$24156654$1$I$20240728$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151021$AMGEN$$77$YR$E$F$Y$$$20240731$$PH$US$US
241566551$24156655$1$I$$20240709$20240731$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-023411$UNITED THERAPEUTICS$$$$A$F$Y$$$20240731$$$US$US
241566561$24156656$1$I$20240727$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150927$AMGEN$$76$YR$E$F$Y$$$20240731$$CN$US$US
241566571$24156657$1$I$$20240725$20240731$20240731$PER$$US-PHARMING-PHAUS2024000639$PHARMING GROUP$$$$$$Y$$$20240731$$CN$US$US
241566581$24156658$1$I$20240131$20240223$20240731$20240731$PER$$US-BAYER-2024A022556$BAYER$$33$YR$A$F$Y$96.145$KG$20240731$$HP$US$US
241566591$24156659$1$I$$20240723$20240731$20240731$30DAY$$US-GSK-US2024092392$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$HP$US$US
241566601$24156660$1$I$$20240716$20240731$20240731$EXP$$IT-LEADINGPHARMA-IT-2024LEALIT00324$LEADING PHARMA$M Conti.Severe hypoglycemia caused by hydroxyurea interference on continuous glucose sensor integrated with advanced hybrid closed-loop system: a case report.Acta Diabetologica.DEC-2023;60:1749-1752$62$YR$A$M$Y$$$20240731$$HP$IT$IT
241566614$24156661$4$F$20240101$20240916$20240731$20240925$EXP$$CA-CELLTRION INC.-2024CA018171$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
241566622$24156662$2$F$$20240917$20240731$20240920$30DAY$$JP-PFIZER INC-202400224245$PFIZER$$$$$M$Y$$$20240920$$MD$JP$JP
241566631$24156663$1$I$20230411$20240729$20240731$20240731$EXP$$JP-EXELIXIS-CABO-23070238$EXELIXIS$$74$YR$$F$Y$56$KG$20240731$$MD$JP$JP
241566641$24156664$1$I$$20240726$20240731$20240731$PER$$US-PHARMING-PHAUS2024000640$PHARMING GROUP$$$$$$Y$$$20240731$$CN$US$US
241566651$24156665$1$I$$20240730$20240730$20240730$DIR$712100$$FDA-CTU$$$$$UNK$N$$$20240730$$CN$US$
241566663$24156666$3$F$20231001$20240730$20240731$20240808$PER$$US-AMGEN-USASP2024149704$AMGEN$$64$YR$A$F$Y$$$20240807$$PH$US$US
241566671$24156667$1$I$$20240724$20240731$20240731$EXP$$JP-AMGEN-JPNSP2024148778$AMGEN$$$$$$Y$$$20240731$$PH$JP$JP
241566681$24156668$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151252$AMGEN$$$$$$Y$$$20240731$$PH$US$US
241566691$24156669$1$I$$20240725$20240731$20240731$EXP$GB-MYLANLABS-2024M1062176$GB-RDY-SPO/GBR/24/0011059$DR REDDYS$$$$$F$Y$$$20240731$$PH$GB$GB
241566701$24156670$1$I$20240708$20240730$20240730$20240730$DIR$712166$$FDA-CTU$$74$YR$$F$N$78$KG$20240730$N$HP$US$
241566711$24156671$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52323$$FDA-CTU$$$$$M$N$$$20240730$N$HP$US$
241566721$24156672$1$I$20220301$20240721$20240731$20240731$PER$$NVSC2024US121832$NOVARTIS$$$$$$Y$$$20240731$$CN$US$US
241566731$24156673$1$I$$20240729$20240731$20240731$30DAY$$US-SANDOZ INC.-SDZ2024US069442$SANDOZ$$$$$M$Y$$$20240731$$CN$US$US
241566741$24156674$1$I$$20240722$20240731$20240731$PER$$US-BAYER-2024A106220$BAYER$$$$$$Y$$$20240731$$CN$US$US
241566751$24156675$1$I$20240709$20240722$20240731$20240731$EXP$$CN-BEIGENE-BGN-2024-011349$BEIGENE$$$$$$Y$$$20240731$$HP$CN$CN
241566761$24156676$1$I$20240701$20240721$20240731$20240731$PER$$US-BAYER-2024A106068$BAYER$$$$$$Y$$$20240731$$CN$US$US
241566771$24156677$1$I$20240625$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036478$AUROBINDO$$57$YR$$M$Y$$$20240731$$PH$FR$FR
241566781$24156678$1$I$20240307$20240313$20240731$20240731$PER$$US-BAYER-2024A091865$BAYER$$21$YR$A$F$Y$$$20240731$$CN$US$US
241566791$24156679$1$I$20240101$20240730$20240731$20240731$PER$$US-ROCHE-10000042718$ROCHE$$$$$$Y$$$20240731$$HP$US$US
241566801$24156680$1$I$20240108$20240723$20240731$20240731$EXP$$FR-AstraZeneca-2024A167860$ASTRAZENECA$$75$YR$$F$Y$57$KG$20240731$$MD$FR$
241566811$24156681$1$I$20240705$20240722$20240731$20240731$EXP$GB-MHRA-MED-202407110926498710-WMLNK$GB-HALEON-2188732$Haleon PLC$$72$YR$$F$Y$$$20240731$$CN$GB$GB
241566821$24156682$1$I$20240418$20240725$20240731$20240731$EXP$$US-JNJFOC-20240774904$JOHNSON AND JOHNSON$$$$$M$Y$$$20240731$$CN$US$US
241566831$24156683$1$I$$20240719$20240731$20240731$30DAY$$US-JNJFOC-20240752519$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$HP$US$US
241566841$24156684$1$I$20240702$20240722$20240731$20240731$PER$$US-JNJFOC-20240763908$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240731$$CN$US$US
241566851$24156685$1$I$$20240709$20240731$20240731$PER$$US-MYLANLABS-2024M1070778$MYLAN$$$$$F$Y$27$KG$20240731$$HP$US$US
241566861$24156686$1$I$20141028$20240722$20240731$20240731$PER$$US-MYLANLABS-2024M1069539$MYLAN$$81$YR$$M$Y$$$20240731$$MD$US$US
241566871$24156687$1$I$20240622$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-037131$AUROBINDO$$70$YR$$M$Y$79$KG$20240731$$PH$FR$FR
241566881$24156688$1$I$20240711$20240720$20240731$20240731$EXP$$FR-AUROBINDO-AUR-APL-2024-036522$AUROBINDO$$88$YR$$F$Y$40$KG$20240731$$MD$FR$FR
241566891$24156689$1$I$20240720$20240723$20240731$20240731$EXP$$US-009507513-2407USA012962$MERCK$$77$YR$$M$Y$$$20240731$$CN$US$US
241566912$24156691$2$F$$20240802$20240731$20240812$EXP$$TR-TEVA-VS-3225375$TEVA$Kaya Akca U, Sener S, Batu ED, Balik Z, Basaran O, Bilginer Y, et al. Drug-induced lupus erythematosus in childhood: Case-based review. Lupus 2024; 33 (7): 737-748.; Kaya Akca U, Sener S, Batu ED, Balik Z, Basaran O, Bilginer Y, et al. Drug-induced lupus erythematosus in childhood: Case-based review. Lupus 2024; 33 (7): 737-748.$$$C$F$Y$$$20240812$$HP$TR$TR
241566921$24156692$1$I$$20240721$20240731$20240731$PER$$US-BAYER-2024A106080$BAYER$$$$$M$Y$$$20240731$$CN$US$US
241566931$24156693$1$I$20240227$20240227$20240731$20240731$PER$$US-BAYER-2024A092393$BAYER$$48$YR$A$F$Y$$$20240731$$MD$US$US
241566941$24156694$1$I$20240725$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024151043$AMGEN$$$$$F$Y$$$20240731$$HP$US$US
241566951$24156695$1$I$20240430$20240718$20240731$20240731$EXP$FR-AFSSAPS-TO2024001230$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06909$HIKMA$$$$$$Y$$$20240731$$PH$FR$FR
241566961$24156696$1$I$20240101$20240730$20240731$20240731$EXP$$US-UCBSA-2024020485$UCB$$$$$F$Y$$$20240731$$CN$US$US
241566971$24156697$1$I$20240727$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150822$AMGEN$$59$YR$A$F$Y$$$20240731$$CN$US$US
241566982$24156698$2$F$20240718$20240914$20240731$20240923$EXP$$CA-CELLTRION INC.-2024CA018172$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
241566991$24156699$1$I$$20240722$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN004055$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241567001$24156700$1$I$$20240723$20240731$20240731$EXP$$BR-AKCEA THERAPEUTICS, INC.-2024IS006105$AKCEA THERAPEUTICS$$$$$$Y$$$20240730$$CN$BR$BR
241567011$24156701$1$I$20240425$20240722$20240731$20240731$EXP$$CN-BEIGENE-BGN-2024-011350$BEIGENE$$$$$$Y$$$20240731$$HP$CN$CN
241567021$24156702$1$I$$20240722$20240731$20240731$EXP$$CA-TEVA-VS-3225302$TEVA$$7$YR$$F$Y$33$KG$20240731$$HP$CA$CA
241567031$24156703$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52335$$FDA-CTU$$71$YR$$F$N$$$20240730$N$$US$
241567042$24156704$2$F$$20240805$20240731$20240812$EXP$$JP-BEH-2024175958$CSL BEHRING$$4$YR$C$F$Y$$$20240812$$HP$JP$JP
241567051$24156705$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52305$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241567061$24156706$1$I$$20240719$20240731$20240731$PER$$US-BAYER-2024A106086$BAYER$$2$YR$C$$Y$$$20240731$$CN$US$US
241567071$24156707$1$I$20240724$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52328$$FDA-CTU$$35$YR$$F$N$$$20240730$Y$PH$US$
241567081$24156708$1$I$$20240730$20240730$20240730$DIR$712129$$FDA-CTU$$42$YR$$F$N$96.3$KG$20240730$N$$US$
241567091$24156709$1$I$$20240726$20240731$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001537$BLUEPRINT MEDICINES$$$$$F$Y$$$20240731$$CN$US$US
241567101$24156710$1$I$$20240725$20240731$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001533$BLUEPRINT MEDICINES$$$$$F$Y$$$20240731$$CN$US$US
241567111$24156711$1$I$$20240725$20240731$20240731$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001530$BLUEPRINT MEDICINES$$$$$F$Y$$$20240731$$CN$US$US
241567131$24156713$1$I$20240704$20240722$20240731$20240731$EXP$$CN-BEIGENE-BGN-2024-011351$BEIGENE$$$$$$Y$$$20240731$$HP$CN$CN
241567141$24156714$1$I$$20240729$20240731$20240731$PER$$US-HALEON-2189841$Haleon PLC$$44$YR$$F$Y$$$20240731$$HP$US$US
241567152$24156715$2$F$20240722$20240728$20240731$20240805$EXP$$BG-AKCEA THERAPEUTICS, INC.-2024IS006090$AKCEA THERAPEUTICS$$$$$$Y$$$20240802$$CN$BG$BG
241567163$24156716$3$F$20240101$20240725$20240731$20240807$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004250$BLUEPRINT MEDICINES$$$$$$Y$$$20240802$$CN$CN$CN
241567171$24156717$1$I$$20240722$20240731$20240731$PER$$US-TEVA-VS-3225897$TEVA$$$$A$F$Y$$$20240731$$MD$US$US
241567181$24156718$1$I$$20240726$20240731$20240731$PER$$NVSC2024US154368$NOVARTIS$$$$$$Y$$$20240731$$CN$US$US
241567191$24156719$1$I$$20240708$20240731$20240731$EXP$$US-TEVA-VS-3218811$TEVA$$68$YR$$F$Y$$$20240731$$PH$US$US
241567202$24156720$2$F$$20240731$20240731$20240805$PER$$US-AMGEN-USASP2024151129$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
241567211$24156721$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151219$AMGEN$$$$$$Y$$$20240731$$MD$US$US
241567221$24156722$1$I$$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149789$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241567231$24156723$1$I$20240726$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149973$AMGEN$$60$YR$A$F$Y$$$20240731$$CN$US$US
241567241$24156724$1$I$20240716$20240722$20240731$20240731$EXP$$CN-BEIGENE-BGN-2024-011353$BEIGENE$$$$$$Y$$$20240731$$HP$CN$CN
241567251$24156725$1$I$$20240723$20240731$20240731$EXP$$VE-ROCHE-10000037177$ROCHE$$33$YR$A$M$Y$91$KG$20240731$$MD$VE$VE
241567271$24156727$1$I$$20240722$20240731$20240731$EXP$$US-APOTEX-2024AP008768$APOTEX$Beavin S, Ahmed S. Mind the Gap: Pyroglutamic Acidosis as a Not-so-Rare Cause of High Anion Gap Metabolic Acidosis (HAGMA). Journal of the American Society of Nephrology. 2023;34:202$39$YR$$M$Y$$$20240731$$HP$US$US
241567283$24156728$3$F$20240718$20240823$20240731$20240830$EXP$$DE-JNJFOC-20240768810$JOHNSON AND JOHNSON$$73$YR$E$M$Y$65$KG$20240830$$MD$DE$DE
241567291$24156729$1$I$$20240722$20240731$20240731$EXP$$CA-TEVA-VS-3225230$TEVA$$27$YR$$M$Y$$$20240731$$MD$CA$CA
241567301$24156730$1$I$20240703$20240730$20240731$20240731$EXP$$CN-BAYER-2024A110371$BAYER$$80$YR$E$F$Y$40$KG$20240731$$HP$CN$CN
241567311$24156731$1$I$$20240730$20240731$20240731$PER$$US-GILEAD-2024-0682403$GILEAD$$$$$F$Y$$$20240731$$PH$US$US
241567321$24156732$1$I$20240622$20240729$20240731$20240731$EXP$$US-BAYER-2024A110272$BAYER$$76$YR$E$F$Y$74.83$KG$20240731$$CN$US$US
241567331$24156733$1$I$$20240722$20240731$20240731$EXP$$US-TAKEDA-2024TUS074544$TAKEDA$$$$$M$Y$$$20240731$$CN$US$US
241567341$24156734$1$I$$20240730$20240731$20240731$EXP$$US-INCYTE CORPORATION-2024IN007960$INCYTE$$$$$$Y$$$20240731$$HP$US$US
241567351$24156735$1$I$$20240721$20240731$20240731$EXP$$GB-AUROBINDO-AUR-APL-2024-036633$AUROBINDO$$25$YR$$$Y$$$20240731$$CN$GB$GB
241567361$24156736$1$I$$20240726$20240731$20240731$EXP$$US-UCBSA-2024038015$UCB$Surineni K, Le V, Jones D. A Case of Oral-Buccal-Lingual Dyskinesia and Neuropsychiatric Symptoms After Prolonged Levetiracetam Exposure. Cureus. 2024;16(6):1-5$86$YR$$F$Y$$$20240731$$HP$US$US
241567371$24156737$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52338$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241567381$24156738$1$I$20240726$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52339$$FDA-CTU$$45$YR$$F$N$$$20240730$N$HP$US$
241567391$24156739$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52393$$FDA-CTU$$72$YR$$F$N$$$20240730$Y$HP$US$
241567411$24156741$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52324$$FDA-CTU$$81$YR$$M$N$$$20240730$N$$US$
241567421$24156742$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52351$$FDA-CTU$$46$YR$$F$N$54.43$KG$20240730$N$$US$
241567431$24156743$1$I$20240710$20240730$20240730$20240730$DIR$712152$$FDA-CTU$$59$YR$$F$N$$$20240730$Y$$US$
241567441$24156744$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52316$$FDA-CTU$$61$YR$$F$N$$$20240730$N$$US$
241567451$24156745$1$I$$20240730$20240730$20240730$DIR$712134$$FDA-CTU$$$$$UNK$N$$$20240730$$CN$US$
241567461$24156746$1$I$20240727$20240730$20240730$20240730$DIR$712140$$FDA-CTU$$83$YR$$F$N$48.6$KG$20240730$N$CN$US$
241567471$24156747$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52385$$FDA-CTU$$62$YR$$M$N$$$20240730$N$$US$
241567481$24156748$1$I$20240319$20240730$20240730$20240730$DIR$712167$$FDA-CTU$$46$YR$$F$N$80.55$KG$20240730$N$CN$US$
241567501$24156750$1$I$20240730$20240730$20240730$20240730$DIR$712136$$FDA-CTU$$80$YR$$M$N$83.25$KG$20240730$Y$PH$US$
241567511$24156751$1$I$20240730$20240730$20240730$20240730$DIR$712105$$FDA-CTU$$76$YR$$F$N$$$20240730$N$$US$
241567521$24156752$1$I$20240710$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52336$$FDA-CTU$$67$YR$$M$N$$$20240730$Y$PH$US$
241567531$24156753$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52332$$FDA-CTU$$53$YR$$M$N$$$20240730$N$$US$
241567541$24156754$1$I$20240703$20240724$20240731$20240731$PER$$US-EMD Serono-2024040353$EMD SERONO INC$$52$YR$A$F$Y$$$20240731$$CN$US$US
241567551$24156755$1$I$20240725$20240725$20240731$20240731$EXP$$BE-EMD Serono-2024040458$EMD SERONO INC$$53$YR$A$F$Y$$$20240731$$CN$BE$BE
241567561$24156756$1$I$20240725$20240730$20240730$20240730$DIR$712157$$FDA-CTU$$54$YR$$F$N$81$KG$20240730$Y$CN$US$
241567571$24156757$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52303$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241567591$24156759$1$I$$20240724$20240731$20240731$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00789$CATALYST PHARMA$$$$$M$Y$$$20240731$$HP$US$US
241567601$24156760$1$I$20240717$20240730$20240730$20240730$DIR$712125$$FDA-CTU$$70$YR$$M$N$$$20240730$Y$HP$US$
241567611$24156761$1$I$20240730$20240730$20240730$20240730$DIR$712103$$FDA-CTU$$68$YR$$F$N$67.5$KG$20240730$N$CN$US$
241567631$24156763$1$I$$20240724$20240731$20240731$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00803$CATALYST PHARMA$$$$$M$Y$68.027$KG$20240731$$CN$US$US
241567641$24156764$1$I$20240716$20240717$20240731$20240731$EXP$$US-PHARMAAND GMBH-2024PHR00436$pharmaAND$$69$YR$$F$Y$$$20240731$$CN$US$US
241567651$24156765$1$I$$20240726$20240731$20240731$EXP$$US-INCYTE CORPORATION-2024IN007869$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241567661$24156766$1$I$20240727$20240730$20240730$20240730$DIR$712122$$FDA-CTU$$34$YR$$F$N$72.45$KG$20240730$N$CN$US$
241567671$24156767$1$I$$20240730$20240730$20240730$DIR$712146$$FDA-CTU$$$$$F$N$$$20240730$Y$HP$US$
241567681$24156768$1$I$20240713$20240724$20240731$20240731$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00786$CATALYST PHARMA$$11$YR$$M$Y$31.746$KG$20240731$$CN$US$US
241567691$24156769$1$I$$20240717$20240731$20240731$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01182$INTRA-CELLULAR THERAPIES$$7$DEC$$M$Y$$$20240731$$MD$US$US
241567701$24156770$1$I$20240720$20240729$20240731$20240731$EXP$$BE-ABBVIE-5861455$ABBVIE$$25$YR$$F$Y$65$KG$20240731$$HP$BE$BE
241567711$24156771$1$I$20240729$20240730$20240731$20240731$EXP$$CN-BAYER-2024A110452$BAYER$$66$YR$E$F$Y$73.3$KG$20240731$$HP$CN$CN
241567721$24156772$1$I$20240712$20240725$20240731$20240731$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00808$CATALYST PHARMA$$65$YR$$F$Y$113.38$KG$20240731$$CN$US$US
241567731$24156773$1$I$20240721$20240721$20240731$20240731$EXP$$GB-AUROBINDO-AUR-APL-2024-036632$AUROBINDO$$56$YR$$M$Y$80$KG$20240731$$CN$GB$GB
241567741$24156774$1$I$20240629$20240722$20240731$20240731$EXP$$CN-BEIGENE-BGN-2024-011354$BEIGENE$$$$$$Y$$$20240731$$HP$CN$CN
241567752$24156775$2$F$20240620$20240717$20240731$20240731$PER$$US-ROCHE-10000033437$ROCHE$$10$YR$C$F$Y$$$20240731$$HP$US$US
241567761$24156776$1$I$20240707$20240718$20240731$20240731$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00631$Phathom Pharmaceuticals$$83$YR$$M$Y$$$20240731$$PH$JP$JP
241567771$24156777$1$I$$20240718$20240731$20240731$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00635$Phathom Pharmaceuticals$$48$YR$$M$Y$$$20240731$$HP$JP$JP
241567781$24156778$1$I$$20240730$20240731$20240731$PER$$US-GILEAD-2024-0682405$GILEAD$$$$$F$Y$$$20240731$$PH$US$US
241567791$24156779$1$I$20240601$20240726$20240731$20240731$EXP$$US-ABBVIE-5856522$ABBVIE$$62$YR$$F$Y$$$20240731$$CN$US$US
241567801$24156780$1$I$$20240725$20240731$20240731$EXP$$US-INCYTE CORPORATION-2024IN007837$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241567811$24156781$1$I$$20240725$20240731$20240731$EXP$$US-INCYTE CORPORATION-2024IN007830$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241567831$24156783$1$I$$20240729$20240731$20240731$EXP$$GB-MYLANLABS-2024M1070734$MYLAN$$$$$F$Y$$$20240731$$MD$GB$GB
241567851$24156785$1$I$$20240729$20240731$20240731$EXP$$US-MYLANLABS-2024M1070498$MYLAN$$$$$M$Y$$$20240731$$CN$US$US
241567862$24156786$2$F$$20240807$20240731$20240809$EXP$$NZ-MYLANLABS-2024M1070694$MYLAN$$$$$F$Y$$$20240809$$HP$NZ$NZ
241567872$24156787$2$F$$20240819$20240731$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121266$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240823$$CN$US$US
241567882$24156788$2$F$20240716$20240718$20240731$20240731$EXP$$US-ROCHE-10000031002$ROCHE$$$$$F$Y$$$20240731$$HP$US$US
241567891$24156789$1$I$20240319$20240723$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015456$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$US$US
241567901$24156790$1$I$$20240722$20240731$20240731$EXP$$TR-TEVA-VS-3225377$TEVA$Kaya Akca U, Sener S, Batu ED, Balik Z, Basaran O, Bilginer Y, et al. Drug-induced lupus erythematosus in childhood: Case-based review. Lupus 2024; 33 (7): 737-748.$$$C$F$Y$$$20240731$$HP$TR$TR
241567911$24156791$1$I$$20240718$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013015$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$US$US
241567921$24156792$1$I$$20240718$20240731$20240731$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202407014111$ELI LILLY AND CO$$$$$F$Y$$$20240731$$MD$AE$AE
241567931$24156793$1$I$$20240719$20240731$20240731$EXP$GB-MHRA-MED-202407191220432400-FBCMG$GB-ELI_LILLY_AND_COMPANY-GB202407012581$ELI LILLY AND CO$$53$YR$A$F$Y$78$KG$20240731$$CN$GB$GB
241567941$24156794$1$I$$20240722$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015228$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240731$$CN$US$US
241567951$24156795$1$I$$20240719$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407014655$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240731$$CN$US$US
241567961$24156796$1$I$$20240718$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407012587$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240731$$HP$US$US
241567971$24156797$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019027$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240731$$CN$US$US
241567991$24156799$1$I$20240713$20240717$20240731$20240731$EXP$GB-MHRA-MED-202407171645542450-QHMTZ$GB-ELI_LILLY_AND_COMPANY-GB202407011837$ELI LILLY AND CO$$33$YR$A$F$Y$82$KG$20240731$$CN$GB$GB
241568001$24156800$1$I$$20240718$20240731$20240731$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407011760$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$DE$DE
241568011$24156801$1$I$$20240718$20240731$20240731$EXP$$KW-ELI_LILLY_AND_COMPANY-KW202407013570$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$KW$KW
241568021$24156802$1$I$20240709$20240717$20240731$20240731$EXP$GB-MHRA-MED-202407172155370600-NGCMS$GB-ELI_LILLY_AND_COMPANY-GB202407011845$ELI LILLY AND CO$$44$YR$A$F$Y$111$KG$20240731$$CN$GB$GB
241568031$24156803$1$I$20240701$20240723$20240731$20240731$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407013080$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$JP$JP
241568041$24156804$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018969$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240731$$CN$US$US
241568051$24156805$1$I$$20240718$20240731$20240731$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407012590$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240731$$CN$DE$DE
241568062$24156806$2$F$$20240730$20240731$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202407019585$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240812$$CN$US$US
241568071$24156807$1$I$$20240719$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016763$ELI LILLY AND CO$$57$YR$A$$Y$$$20240731$$LW$US$US
241568081$24156808$1$I$20240604$20240719$20240731$20240731$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407013203$ELI LILLY AND CO$$40$YR$A$M$Y$130$KG$20240731$$CN$JP$JP
241568091$24156809$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019674$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240731$$CN$US$US
241568101$24156810$1$I$20240523$20240723$20240731$20240731$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407018084$ELI LILLY AND CO$$2$MON$I$$Y$$$20240731$$CN$BR$BR
241568111$24156811$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019348$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240731$$CN$US$US
241568121$24156812$1$I$$20240719$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407014739$ELI LILLY AND CO$$25$YR$A$$Y$$$20240731$$LW$US$US
241568131$24156813$1$I$20240601$20240723$20240731$20240731$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407004033$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240731$$CN$JP$JP
241568141$24156814$1$I$20240701$20240718$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407012566$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$US$US
241568151$24156815$1$I$20200101$20240729$20240731$20240731$EXP$$PT-PFIZER INC-202400225542$PFIZER$Ambrosio, A. IMI-152 - (4246) - AVIUM COMPLEX.. 30.? Congresso Nacional de Medicina Interna. 2024;1435$81$YR$$F$Y$$$20240731$$MD$PT$PT
241568161$24156816$1$I$20240718$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52329$$FDA-CTU$$77$YR$$F$N$$$20240730$N$HP$US$
241568181$24156818$1$I$20240711$20240726$20240731$20240731$EXP$$CN-PFIZER INC-PV202400097992$PFIZER$$62$YR$$M$Y$62$KG$20240731$$HP$CN$CN
241568191$24156819$1$I$20240719$20240726$20240731$20240731$EXP$$CN-PFIZER INC-PV202400098007$PFIZER$$68$YR$$F$Y$65$KG$20240731$$HP$CN$CN
241568201$24156820$1$I$$20240730$20240730$20240730$DIR$712142$$FDA-CTU$$$$$UNK$N$$$20240730$$CN$US$
241568211$24156821$1$I$$20240729$20240730$20240730$DIR$FDA-CDER-CTU-2024-52368$$FDA-CTU$$80$YR$$M$N$$$20240729$N$$US$
241568221$24156822$1$I$$20240730$20240731$20240731$EXP$$TW-PFIZER INC-PV202400099405$PFIZER$$$$E$F$Y$$$20240731$$HP$TW$TW
241568231$24156823$1$I$20240728$20240730$20240730$20240730$DIR$712127$$FDA-CTU$$49$YR$$F$N$100.8$KG$20240730$Y$CN$US$
241568241$24156824$1$I$20240722$20240730$20240730$20240730$DIR$712147$$FDA-CTU$$5$YR$$F$N$16.8$KG$20240730$N$HP$US$
241568251$24156825$1$I$20240726$20240730$20240730$20240730$DIR$712126$$FDA-CTU$$58$YR$$M$N$69.4$KG$20240730$N$HP$US$
241568261$24156826$1$I$20240715$20240730$20240730$20240730$DIR$712139$$FDA-CTU$$68$YR$$M$N$87.3$KG$20240730$Y$MD$US$
241568271$24156827$1$I$$20240729$20240731$20240731$EXP$$PT-PFIZER INC-202400225550$PFIZER$Veiga, C. PO-0645 - (2824) - SAE1 DERMATOMYOSITIS - A CASE REPORT. 30th National Congress of Internal Medicine. 2024;980$62$YR$$F$Y$$$20240731$$MD$PT$PT
241568282$24156828$2$F$$20240829$20240731$20240906$EXP$$PT-PFIZER INC-202400225547$PFIZER$Almeida, R.. PO-0611 - (2544) - Azithromycin-induced thrombocytopenia - about a clinical case.. 30 Congresso Nacional de Medicina Interna. 2024;957$79$YR$$F$Y$$$20240906$$MD$PT$PT
241568291$24156829$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52354$$FDA-CTU$$75$YR$$M$N$$$20240730$N$$US$
241568301$24156830$1$I$20240729$20240730$20240730$20240730$DIR$712113$$FDA-CTU$$67$YR$$M$N$64.35$KG$20240730$Y$HP$US$
241568321$24156832$1$I$$20240723$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN007746$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241568332$24156833$2$F$$20240807$20240731$20240807$30DAY$$US-PFIZER INC-PV202400095851$PFIZER$$$$$F$Y$$$20240807$$CN$US$US
241568353$24156835$3$F$20240101$20240912$20240731$20240918$30DAY$$GR-PFIZER INC-PV202400096069$PFIZER$$3$YR$$M$Y$13$KG$20240918$$CN$GR$GR
241568362$24156836$2$F$$20240914$20240731$20240920$30DAY$$KR-PFIZER INC-202400225191$PFIZER$$13$YR$$$Y$$$20240920$$CN$KR$KR
241568381$24156838$1$I$20240724$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149446$AMGEN$$19$YR$A$M$Y$$$20240731$$CN$US$US
241568391$24156839$1$I$20240729$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151159$AMGEN$$54$YR$A$F$Y$$$20240731$$CN$US$US
241568411$24156841$1$I$$20240723$20240731$20240731$EXP$$IR-AstraZeneca-2024A168687$ASTRAZENECA$Bozorgi A, Farzaei A, Nasab EM, Jenab Y, Amirzadegan A, Javazm AK. An interesting case series of ticagrelor induced long QTc. International Journal of Cardiology Cardiovascular Risk and Prevention 2024;22:200311-.$64$YR$$F$Y$$$20240731$$HP$IR$
241568421$24156842$1$I$$20240724$20240731$20240731$PER$$US-ALXN-202407USA001825US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241568432$24156843$2$F$20240101$20240905$20240731$20240912$EXP$$US-ABBVIE-5855685$ABBVIE$$$$$M$Y$88$KG$20240912$$CN$US$US
241568441$24156844$1$I$$20240724$20240731$20240731$EXP$$SK-BAYER-2024A109765$BAYER$?ubom?r Lachv??1 , Monika ??k2 , Vladim?ra Sobolov?1 ,  Peter Bohu?3 , Franti?ek Gmitter3 , Katar?na Bel?nov?2. Complete regression of clear cell renal cell carcinoma following therapy with sunitinib Klin urol 2024. 31st ANNUAL CONFERENCE OF THE SLOVAK UROLOGICAL SOCIETY. 2024;20 (2):80-81$58$YR$A$M$Y$$$20240731$$MD$SK$SK
241568452$24156845$2$F$20240701$20240806$20240731$20240812$EXP$$US-PUMA BIOTECHNOLOGY, INC.-2024-PUM-US001004$PUMA$$$$$$Y$$$20240812$$PH$US$US
241568461$24156846$1$I$20240722$20240724$20240731$20240731$30DAY$$GR-PFIZER INC-PV202400097192$PFIZER$$8$YR$$F$Y$19$KG$20240731$$CN$GR$GR
241568471$24156847$1$I$$20240723$20240731$20240731$30DAY$$GB-PFIZER INC-202400223792$PFIZER$$56$YR$$F$Y$$$20240731$$CN$GB$GB
241568481$24156848$1$I$20240301$20240724$20240731$20240731$EXP$$US-TAKEDA-2024TUS064047$TAKEDA$$54$YR$$F$Y$69.841$KG$20240731$$MD$US$US
241568492$24156849$2$F$$20240926$20240731$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120981$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240926$$HP$US$US
241568521$24156852$1$I$20240728$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52313$$FDA-CTU$$56$YR$$F$N$$$20240730$N$HP$US$
241568531$24156853$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52320$$FDA-CTU$$70$YR$$F$N$49.9$KG$20240730$N$$US$
241568541$24156854$1$I$$20240718$20240731$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-117644$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240731$$HP$CA$CA
241568551$24156855$1$I$20240723$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52400$$FDA-CTU$$65$YR$$F$N$$$20240730$N$HP$US$
241568571$24156857$1$I$$20240731$20240731$20240731$EXP$$NVSC2024TH156039$NOVARTIS$$$$$$Y$$$20240731$$MD$TH$TH
241568581$24156858$1$I$$20240717$20240731$20240731$PER$$US-Kindeva Drug Delivery L.P.-2159827$KINDEVA DRUG DELIVERY$$$$$M$Y$$$20240731$$$US$US
241568591$24156859$1$I$20240228$20240229$20240731$20240731$PER$$US-BAYER-2024A091477$BAYER$$25$YR$A$F$Y$$$20240731$$CN$US$US
241568601$24156860$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A167934$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241568611$24156861$1$I$$20240726$20240731$20240731$EXP$$ES-AstraZeneca-2024A171094$ASTRAZENECA$$80$YR$$F$Y$$$20240731$$CN$ES$
241568621$24156862$1$I$$20240730$20240731$20240731$PER$$US-TAKEDA-2024TUS076821$TAKEDA$$$$$$Y$$$20240731$$CN$US$US
241568631$24156863$1$I$$20240725$20240731$20240731$EXP$$HU-JNJFOC-20240775803$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$MD$HU$HU
241568642$24156864$2$F$20240712$20240815$20240731$20240821$30DAY$$US-JNJFOC-20240739560$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240822$$CN$US$US
241568651$24156865$1$I$$20240719$20240731$20240731$PER$$US-JNJFOC-20240756214$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241568661$24156866$1$I$$20240725$20240731$20240731$EXP$$BR-AMGEN-BRASP2024149632$AMGEN$$84$YR$E$F$Y$$$20240731$$CN$BR$BR
241568672$24156867$2$F$20240720$20240826$20240731$20240830$PER$$US-AMGEN-USASP2024148846$AMGEN$$54$YR$A$F$Y$66$KG$20240830$$HP$US$US
241568681$24156868$1$I$$20240725$20240731$20240731$EXP$$CO-AMGEN-COLSL2024149681$AMGEN$$66$YR$E$F$Y$$$20240731$$CN$CO$CO
241568691$24156869$1$I$20240701$20240725$20240731$20240731$EXP$$US-AMGEN-USASP2024148804$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241568701$24156870$1$I$20240612$20240724$20240731$20240731$EXP$$CN-AMGEN-CHNSP2024147894$AMGEN$$67$YR$E$F$Y$55$KG$20240731$$HP$CN$CN
241568711$24156871$1$I$20240529$20240529$20240731$20240731$PER$$US-BAYER-2024A090657$BAYER$$36$YR$A$F$Y$$$20240731$$MD$US$US
241568721$24156872$1$I$20240627$20240724$20240731$20240731$EXP$$CN-AMGEN-CHNSP2024147850$AMGEN$$50$YR$A$M$Y$39$KG$20240731$$HP$CN$CN
241568732$24156873$2$F$$20240819$20240731$20240821$EXP$$KR-SAMSUNG BIOEPIS-SB-2024-23263$SAMSUNG BIOEPIS$$$$$F$Y$$$20240821$$MD$KR$KR
241568741$24156874$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150788$AMGEN$$$$$$Y$$$20240731$$PH$US$US
241568751$24156875$1$I$$20240722$20240731$20240731$EXP$$IL-TEVA-VS-3208131$TEVA$$43$YR$$M$Y$$$20240731$$CN$IL$IL
241568762$24156876$2$F$$20240725$20240731$20240805$PER$$US-BEH-2024176425$CSL BEHRING$$$$A$M$Y$$$20240805$$HP$US$US
241568772$24156877$2$F$$20240730$20240731$20240801$EXP$$US-BAYER-2024A110480$BAYER$$73$YR$E$F$Y$$$20240801$$HP$US$US
241568781$24156878$1$I$20240522$20240529$20240731$20240731$PER$$US-BAYER-2024A090661$BAYER$$24$YR$A$F$Y$$$20240731$$MD$US$US
241568791$24156879$1$I$20240701$20240729$20240731$20240731$EXP$$US-ABBVIE-5859944$ABBVIE$$72$YR$$F$Y$$$20240731$$CN$US$US
241568811$24156881$1$I$$20240725$20240731$20240731$EXP$$NVSC2024DE155050$NOVARTIS$$$$A$M$Y$$$20240731$$PH$DE$DE
241568821$24156882$1$I$$20240729$20240731$20240731$EXP$$US-GILEAD-2024-0682395$GILEAD$$42$YR$A$F$Y$$$20240731$$CN$US$US
241568832$24156883$2$F$$20240729$20240731$20240809$EXP$$GR-ROCHE-3359621$ROCHE$$$$$F$Y$$$20240809$$MD$GR$GR
241568842$24156884$2$F$20240601$20240802$20240731$20240809$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012331$VERTEX$$$$A$M$Y$$$20240809$$CN$GB$GB
241568851$24156885$1$I$$20240726$20240731$20240731$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012447$VERTEX$$$$A$M$Y$$$20240731$$CN$GB$GB
241568871$24156887$1$I$$20240731$20240731$20240731$DIR$712178$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241568902$24156890$2$F$20240722$20240823$20240731$20240830$EXP$$US-VERTEX PHARMACEUTICALS-2024-012353$VERTEX$$16$YR$$M$Y$$$20240830$$HP$US$US
241568911$24156891$1$I$20240410$20240515$20240731$20240731$PER$$US-BAYER-2024A091201$BAYER$$44$YR$A$F$Y$$$20240731$$MD$US$US
241568922$24156892$2$F$20240101$20240802$20240731$20240806$EXP$$US-ABBVIE-5857183$ABBVIE$$65$YR$$M$Y$$$20240806$$CN$US$US
241568931$24156893$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150290$AMGEN$$$$$M$Y$$$20240731$$CN$US$US
241568942$24156894$2$F$20240708$20240809$20240731$20240813$EXP$$US-ABBVIE-5857592$ABBVIE$$56$YR$$M$Y$$$20240813$$CN$US$US
241568951$24156895$1$I$$20240724$20240731$20240731$EXP$$IN-ROCHE-10000039959$ROCHE$$65$YR$E$M$Y$$$20240731$$CN$IN$IN
241568962$24156896$2$F$20240101$20240807$20240731$20240812$EXP$$NVSC2024CN155547$NOVARTIS$$81$YR$$F$Y$$$20240812$$CN$CN$CN
241568971$24156897$1$I$20240209$20240723$20240731$20240731$PER$$US-ROCHE-3512397$ROCHE$$$$$F$Y$$$20240731$$MD$US$US
241568981$24156898$1$I$20240508$20240516$20240731$20240731$PER$$US-BAYER-2024A093753$BAYER$$36$YR$A$F$Y$$$20240731$$CN$US$US
241568991$24156899$1$I$20240101$20240730$20240731$20240731$EXP$$AU-UCBSA-2024013780$UCB$$$$$F$Y$$$20240731$$CN$AU$AU
241569002$24156900$2$F$20240509$20240806$20240731$20240813$PER$$US-BAYER-2024A090637$BAYER$$37$YR$A$F$Y$79.365$KG$20240813$$MD$US$US
241569011$24156901$1$I$$20240731$20240731$20240731$DIR$712182$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241569021$24156902$1$I$$20240730$20240731$20240731$EXP$$GB-MYLANLABS-2024M1071037$MYLAN$$$$$M$Y$$$20240731$$CN$GB$GB
241569031$24156903$1$I$$20240722$20240731$20240731$EXP$$US-MYLANLABS-2024M1069413$MYLAN$Woods HB, Bharathidasan K, Yang M, Nichols J, Nugent K. Delayed onset graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency virus: a case series. Am-J-Med-Sci 2024; 367 (Suppl. 1) S9-S10.$51$YR$$F$Y$$$20240731$$HP$US$US
241569041$24156904$1$I$$20240723$20240731$20240731$EXP$$US-MYLANLABS-2024M1069841$MYLAN$Anwar A, Chahine Z, Piecoro D, Kesler M, Qasrawi A. Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia. Hum-Pathol-Rep 2023; 33 300713.$68$YR$$F$Y$$$20240731$$HP$US$US
241569051$24156905$1$I$20240714$20240722$20240731$20240731$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000686$PAREXEL$$$$$$Y$$$20240731$$HP$CN$CN
241569061$24156906$1$I$$20240723$20240731$20240731$PER$$US-VERTEX PHARMACEUTICALS-2024-012202$VERTEX$$$$$F$Y$$$20240731$$CN$US$US
241569071$24156907$1$I$$20240723$20240731$20240731$EXP$$US-VERTEX PHARMACEUTICALS-2024-012256$VERTEX$$$$$M$Y$$$20240731$$CN$US$US
241569091$24156909$1$I$$20240725$20240731$20240731$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012299$VERTEX$$$$$M$Y$$$20240731$$CN$GB$GB
241569101$24156910$1$I$$20240731$20240731$20240731$DIR$712181$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241569111$24156911$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018965$ELI LILLY AND CO$$28$YR$A$M$Y$$$20240731$$CN$US$US
241569121$24156912$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019126$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240731$$CN$US$US
241569131$24156913$1$I$$20240719$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407013209$ELI LILLY AND CO$$62$YR$A$$Y$$$20240731$$LW$US$US
241569141$24156914$1$I$20240729$20240730$20240731$20240731$PER$$US-JNJFOC-20240781648$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240731$$MD$US$US
241569151$24156915$1$I$$20240731$20240731$20240731$DIR$712176$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241569162$24156916$2$F$20221006$20240813$20240731$20240817$EXP$$JP-AMGEN-JPNSP2022193949$AMGEN$$67$YR$E$M$Y$$$20240817$$MD$JP$JP
241569171$24156917$1$I$20240601$20240724$20240731$20240731$EXP$$BR-AMGEN-BRASP2024147845$AMGEN$$70$YR$E$F$Y$$$20240731$$CN$BR$BR
241569181$24156918$1$I$20240506$20240520$20240731$20240731$PER$$US-BAYER-2024A091219$BAYER$$25$YR$A$F$Y$$$20240731$$HP$US$US
241569191$24156919$1$I$20240727$20240731$20240731$20240731$DIR$712172$$FDA-CTU$$63$YR$$F$N$103.5$KG$20240731$N$CN$US$
241569201$24156920$1$I$$20240731$20240731$20240731$DIR$712179$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241569231$24156923$1$I$$20240610$20240731$20240731$PER$$US-LUNDBECK-DKLU4000345$LUNDBECK$$$$$$Y$$$20240731$$CN$US$US
241569241$24156924$1$I$$20240731$20240731$20240731$DIR$712180$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241569251$24156925$1$I$20240701$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150693$AMGEN$$55$YR$A$M$Y$$$20240731$$CN$US$US
241569261$24156926$1$I$20240727$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150678$AMGEN$$80$YR$E$M$Y$$$20240731$$CN$US$US
241569271$24156927$1$I$20240101$20240725$20240731$20240731$EXP$$US-009507513-2407USA013963$MERCK$$56$YR$$M$Y$$$20240731$$CN$US$US
241569281$24156928$1$I$20240721$20240730$20240731$20240731$EXP$$US-INCYTE CORPORATION-2024IN007216$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241569291$24156929$1$I$20240520$20240523$20240731$20240731$PER$$US-BAYER-2024A090590$BAYER$$39$YR$A$F$Y$$$20240731$$MD$US$US
241569301$24156930$1$I$$20240728$20240731$20240731$EXP$$BR-TAKEDA-2024TUS076653$TAKEDA$$21$YR$$$Y$$$20240731$$CN$BR$BR
241569311$24156931$1$I$20240705$20240719$20240731$20240731$EXP$$US-INFO-20240220$INFORLIFE$$$$$$Y$$$20240723$$HP$US$
241569321$24156932$1$I$20240520$20240522$20240731$20240731$PER$$US-BAYER-2024A090647$BAYER$$24$YR$A$F$Y$$$20240731$$MD$US$US
241569331$24156933$1$I$$20240607$20240731$20240731$PER$$US-LUNDBECK-DKLU4000222$LUNDBECK$$$$$$Y$$$20240731$$HP$US$US
241569341$24156934$1$I$$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024150031$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241569351$24156935$1$I$$20240725$20240731$20240731$EXP$$BR-AMGEN-BRASP2024148780$AMGEN$$83$YR$E$F$Y$$$20240731$$CN$BR$BR
241569361$24156936$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A167972$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241569372$24156937$2$F$$20240724$20240731$20240808$EXP$$FR-JNJFOC-20240768418$JOHNSON AND JOHNSON$$73$YR$E$M$Y$75$KG$20240808$$MD$FR$FR
241569381$24156938$1$I$$20240724$20240731$20240731$PER$$US-JNJFOC-20240771032$JOHNSON AND JOHNSON$$$$$M$Y$$$20240731$$MD$US$US
241569391$24156939$1$I$20240119$20240221$20240731$20240731$EXP$$NVSC2024CN038266$NOVARTIS$$68$YR$$M$Y$63$KG$20240731$$HP$CN$CN
241569402$24156940$2$F$20240701$20240729$20240731$20240802$EXP$$NVSC2024FR155060$NOVARTIS$$60$YR$$F$Y$65$KG$20240802$$MD$FR$FR
241569411$24156941$1$I$$20240723$20240731$20240731$EXP$$FR-Merck Healthcare KGaA-2024040038$MERCK KGAA$$$$$F$Y$$$20240729$$MD$FR$FR
241569422$24156942$2$F$$20240806$20240731$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-023105$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240810$$$US$US
241569431$24156943$1$I$$20240723$20240731$20240731$EXP$$US-BAYER-2024A019579$BAYER$$57$YR$A$M$Y$$$20240731$$CN$US$US
241569441$24156944$1$I$$20240723$20240731$20240731$PER$$US-BAYER-2024A106995$BAYER$$$$$$Y$$$20240731$$MD$US$US
241569451$24156945$1$I$$20240729$20240731$20240731$EXP$$US-Karo Pharma-2159828$Karo Pharma$$44$YR$$F$Y$$$20240731$$$US$US
241569461$24156946$1$I$20240613$20240726$20240731$20240731$EXP$$JP-DSJP-DSJ-2024-137615$DAIICHI$$8$DEC$$F$Y$45$KG$20240731$$MD$JP$JP
241569481$24156948$1$I$$20240722$20240731$20240731$EXP$$TR-TEVA-VS-3225381$TEVA$Kaya Akca U, Sener S, Batu ED, Balik Z, Basaran O, Bilginer Y, et al. Drug-induced lupus erythematosus in childhood: Case-based review. Lupus 2024; 33 (7): 737-748.$$$C$F$Y$$$20240731$$HP$TR$TR
241569491$24156949$1$I$20240606$20240606$20240731$20240731$PER$$US-BAYER-2024A090669$BAYER$$39$YR$A$F$Y$$$20240731$$HP$US$US
241569501$24156950$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150839$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241569511$24156951$1$I$20240729$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151131$AMGEN$$78$YR$E$M$Y$$$20240731$$CN$US$US
241569522$24156952$2$F$20240724$20240731$20240731$20240802$PER$$US-AMGEN-USASP2024147513$AMGEN$$68$YR$E$F$Y$$$20240802$$CN$US$US
241569531$24156953$1$I$20240429$20240430$20240731$20240731$PER$$US-BAYER-2024A092779$BAYER$$23$YR$A$F$Y$$$20240731$$CN$US$US
241569541$24156954$1$I$$20240724$20240731$20240731$PER$$US-Merck Healthcare KGaA-2024040191$MERCK KGAA$Chimatapu SN, Schachter JL, Batra AS, Sirignano R, Okawa ER. A Pediatric Case of Refractory Torsades de Pointes in Autoimmune Hypothyroidism.. JCEM case reports.. 2024 Jul 01;2(7): 1-4. doi:https://doi.org/10.1210/jcemcr/luae124.$15$YR$T$F$Y$$$20240731$$MD$US$US
241569551$24156955$1$I$$20240718$20240731$20240731$EXP$$IT-ASTELLAS-2024US021334$ASTELLAS$$$$$M$Y$$$20240731$$CN$IT$IT
241569571$24156957$1$I$20240625$20240725$20240731$20240731$PER$$US-ABBVIE-5856481$ABBVIE$$32$YR$$F$Y$$$20240731$$MD$US$US
241569581$24156958$1$I$20240614$20240730$20240731$20240731$EXP$FR-AFSSAPS-AM2024000610$FR-JNJFOC-20240782217$JOHNSON AND JOHNSON$$48$YR$A$F$Y$72$KG$20240731$$PH$FR$FR
241569591$24156959$1$I$$20240724$20240731$20240731$PER$$US-JNJFOC-20240765817$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$HP$US$US
241569601$24156960$1$I$20240511$20240724$20240731$20240731$EXP$$US-JNJFOC-20240715421$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240731$$CN$US$US
241569613$24156961$3$F$20240226$20240822$20240731$20240830$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001149$AKEBIA THERAPEUTICS$$79$YR$$F$Y$53.8$KG$20240830$$MD$JP$JP
241569621$24156962$1$I$$20240723$20240731$20240731$EXP$$US-MYLANLABS-2024M1069893$MYLAN$Thompson C, Barrett K, Scott D, Lofters J, Rastogi N. Oh, what a storm: A case of blinatumomab-induced cytokine release syndrome. J-Invest-Med 2023; 71 (7): 140-141.$72$YR$$F$Y$$$20240731$$HP$US$US
241569631$24156963$1$I$20240430$20240520$20240731$20240731$PER$$US-BAYER-2024A090573$BAYER$$39$YR$A$F$Y$$$20240731$$MD$US$US
241569641$24156964$1$I$$20240724$20240731$20240731$EXP$$US-PFIZER INC-202400223812$PFIZER$Brisson, R.. Long-term outcomes following proton therapy for non-metastatic central nervous system germinoma in children and adolescents. Radiotherapy and Oncology. 2024;198:10.1016/j.radonc.2024.110371$$$T$$Y$$$20240731$$HP$US$US
241569651$24156965$1$I$$20240724$20240731$20240731$EXP$$US-PFIZER INC-202400223811$PFIZER$Brisson, R.. Long-term outcomes following proton therapy for non-metastatic central nervous system germinoma in children and adolescents. Radiotherapy and Oncology. 2024;198:10.1016/j.radonc.2024.110371$$$T$$Y$$$20240731$$HP$US$US
241569661$24156966$1$I$$20240726$20240731$20240731$EXP$$CN-PFIZER INC-202400224400$PFIZER$Min, W.. Efficacy of dupilumab in the treatment of severe vulvar pruritus associated with lichen sclerosus et atrophicus: a case report.. Frontiers in Medicine. 2024;11:10.3389/fmed.2024.1422389$60$YR$$F$Y$45$KG$20240731$$MD$CN$CN
241569671$24156967$1$I$20240709$20240716$20240731$20240731$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00362$MELINTA THERAPEUTICS$$$$$$Y$$$20240731$$MD$CN$CN
241569681$24156968$1$I$20240101$20240730$20240731$20240731$EXP$$US-UCBSA-2024038403$UCB$$$$$M$Y$$$20240731$$CN$US$US
241569691$24156969$1$I$20240430$20240506$20240731$20240731$PER$$US-BAYER-2024A091134$BAYER$$40$YR$A$F$Y$$$20240731$$MD$US$US
241569702$24156970$2$F$20240706$20240726$20240731$20240807$EXP$$GB-MYLANLABS-2024M1070118$MYLAN$$75$YR$$M$Y$84$KG$20240807$$MD$GB$GB
241569711$24156971$1$I$20240411$20240507$20240731$20240731$PER$$US-BAYER-2024A091062$BAYER$$32$YR$A$F$Y$$$20240731$$CN$US$US
241569721$24156972$1$I$$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149722$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241569734$24156973$4$F$$20240829$20240731$20240904$PER$$US-AMGEN-USASP2024150305$AMGEN$$$$$F$Y$$$20240904$$PH$US$US
241569741$24156974$1$I$20240725$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150896$AMGEN$$79$YR$E$F$Y$$$20240731$$CN$US$US
241569753$24156975$3$F$$20240916$20240731$20240918$30DAY$$JP-PFIZER INC-202400218286$PFIZER$$$$$M$Y$$$20240918$$PH$JP$JP
241569762$24156976$2$F$20240723$20240912$20240731$20240918$30DAY$$US-PFIZER INC-202400223156$PFIZER$$3$YR$$F$Y$16.6$KG$20240918$$CN$US$US
241569771$24156977$1$I$20240713$20240721$20240731$20240731$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-06991$HIKMA$$$$$$Y$$$20240731$$PH$EG$EG
241569781$24156978$1$I$20240601$20240723$20240731$20240731$EXP$$US-TEVA-VS-3226213$TEVA$$78$YR$$F$Y$$$20240731$$PH$US$US
241569791$24156979$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5860144$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241569801$24156980$1$I$$20240607$20240731$20240731$PER$$US-LUNDBECK-DKLU4000293$LUNDBECK$$$$$$Y$$$20240731$$HP$US$US
241569831$24156983$1$I$20240101$20240725$20240731$20240731$EXP$$CA-ABBVIE-5857231$ABBVIE$$82$YR$$F$Y$$$20240731$$CN$CA$CA
241569841$24156984$1$I$20240426$20240524$20240731$20240731$PER$$US-BAYER-2024A090572$BAYER$$$$$F$Y$$$20240731$$MD$US$US
241569851$24156985$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5859280$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241569862$24156986$2$F$20240825$20240829$20240731$20240904$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006350$AURINIA PHARMACEUTICALS$$66$YR$$F$Y$$$20240904$$CN$US$US
241569871$24156987$1$I$20240711$20240724$20240731$20240731$EXP$$CN-EMD Serono-2024040354$EMD SERONO INC$$72$YR$E$F$Y$68$KG$20240731$$HP$CN$CN
241569881$24156988$1$I$20240516$20240723$20240731$20240731$EXP$$FR-AstraZeneca-2024A167112$ASTRAZENECA$$76$YR$$M$Y$74.6$KG$20240731$$MD$FR$
241569891$24156989$1$I$$20240718$20240731$20240731$EXP$$GB-AMICUS THERAPEUTICS, INC.-AMI_3264$AMICUS THERAPEUTICS$Kugan M, D^amore S, Mitra-Royhurst U, Patel S, Burke D, Heales S, et al.. Fabry disease Enzyme Enhancement on migalastat Study: FEES. Clinica Chimica Acta. 2024;561:119843$$$$$Y$$$20240731$$HP$GB$GB
241569901$24156990$1$I$20240426$20240723$20240731$20240731$EXP$$CN-AstraZeneca-2024A169747$ASTRAZENECA$$71$YR$$M$Y$58$KG$20240731$$MD$CN$
241569911$24156991$1$I$$20240723$20240731$20240731$EXP$$ZA-AstraZeneca-2024A171201$ASTRAZENECA$$26663$DY$$F$Y$$$20240731$$CN$ZA$
241569921$24156992$1$I$$20240607$20240731$20240731$PER$$US-LUNDBECK-DKLU4000278$LUNDBECK$$$$$$Y$$$20240731$$HP$US$US
241569934$24156993$4$F$20240201$20240814$20240731$20240821$30DAY$$US-PFIZER INC-202400224085$PFIZER$$17$YR$$F$Y$41.4$KG$20240821$$MD$US$US
241569941$24156994$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019326$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240731$$CN$US$US
241569951$24156995$1$I$20240718$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018790$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240731$$CN$US$US
241569961$24156996$1$I$20240712$20240729$20240731$20240731$EXP$$US-INCYTE CORPORATION-2024IN007920$INCYTE$$$$$$Y$$$20240731$$HP$US$US
241569971$24156997$1$I$20240605$20240725$20240731$20240731$EXP$FR-AFSSAPS-GR2024000909$FR-MYLANLABS-2024M1069694$MYLAN$$75$YR$$M$Y$$$20240731$$PH$FR$FR
241569981$24156998$1$I$20240729$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019791$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240731$$CN$US$US
241570001$24157000$1$I$20240701$20240726$20240731$20240731$EXP$$GB-ABBVIE-5860387$ABBVIE$$26$YR$$F$Y$$$20240731$$CN$GB$GB
241570011$24157001$1$I$20240404$20240508$20240731$20240731$PER$$US-BAYER-2024A090988$BAYER$$38$YR$A$F$Y$$$20240731$$MD$US$US
241570021$24157002$1$I$20240101$20240723$20240731$20240731$EXP$$CA-CELLTRION INC.-2024CA018197$CELLTRION$$$$$$Y$$$20240731$$HP$CA$CA
241570031$24157003$1$I$20240725$20240726$20240731$20240731$EXP$$CO-BIOVITRUM-2024-CO-010406$BIOVITRUM$$100$DY$$F$Y$4.2$KG$20240731$$CN$CO$CO
241570041$24157004$1$I$$20240725$20240731$20240731$EXP$$US-JNJFOC-20240769135$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240731$$HP$US$US
241570051$24157005$1$I$$20240729$20240731$20240731$EXP$$US-INCYTE CORPORATION-2024IN007919$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241570061$24157006$1$I$$20240725$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN007826$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241570071$24157007$1$I$$20240730$20240731$20240731$EXP$$US-BAYER-2024A110426$BAYER$$81$YR$E$F$Y$$$20240731$$CN$US$US
241570081$24157008$1$I$$20240722$20240731$20240731$EXP$$TR-TEVA-VS-3225382$TEVA$Kaya Akca U, Sener S, Batu ED, Balik Z, Basaran O, Bilginer Y, et al. Drug-induced lupus erythematosus in childhood: Case-based review. Lupus 2024; 33 (7): 737-748.$$$C$M$Y$$$20240731$$HP$TR$TR
241570093$24157009$3$F$20240629$20240805$20240731$20240814$EXP$$DE-BAXTER-2024BAX021093$BAXTER$$47$YR$$M$Y$$$20240814$$HP$DE$DE
241570103$24157010$3$F$20240601$20240913$20240731$20240927$PER$$US-RISINGPHARMA-US-2024RISSPO00251$RISING PHARMACEUTICALS$$68$YR$E$F$Y$65.77$KG$20240927$$CN$US$US
241570111$24157011$1$I$$20240722$20240731$20240731$EXP$$US-TEVA-VS-3225470$TEVA$Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.; Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.$51$YR$$F$Y$$$20240731$$HP$US$US
241570121$24157012$1$I$$20240731$20240731$20240731$DIR$712184$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241570131$24157013$1$I$20240729$20240729$20240731$20240731$30DAY$$US-GSK-US2024094883$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240731$$CN$US$US
241570141$24157014$1$I$20240304$20240419$20240731$20240731$PER$$US-BAYER-2024A092444$BAYER$$44$YR$A$F$Y$$$20240731$$MD$US$US
241570151$24157015$1$I$$20240717$20240731$20240731$EXP$$PT-AZURITY PHARMACEUTICALS, INC.-AZR202407-000193$AZURITY PHARMACEUTICALS$Varela JS. Caca a hipertensao resistente: seguir as pistas para o diagnostico corret. Portuguese Society of Hypertension. 2024$70$YR$$F$Y$$$20240731$$HP$PT$PT
241570171$24157017$1$I$$20240729$20240731$20240731$EXP$$US-TAKEDA-2024TUS076293$TAKEDA$$$$$F$Y$$$20240731$$CN$US$US
241570181$24157018$1$I$$20240726$20240731$20240731$EXP$$GB-TAKEDA-2024TUS076421$TAKEDA$$$$A$M$Y$$$20240731$$CN$GB$GB
241570201$24157020$1$I$$20240729$20240731$20240731$EXP$$US-Karo Pharma-2159830$Karo Pharma$$$$$F$Y$$$20240731$$$US$US
241570211$24157021$1$I$$20240719$20240731$20240731$EXP$$BR-UCBSA-2024037235$UCB$$$$$F$Y$$$20240731$$MD$BR$BR
241570221$24157022$1$I$$20240726$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN007892$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241570231$24157023$1$I$20240727$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150781$AMGEN$$31$YR$A$F$Y$$$20240731$$CN$US$US
241570241$24157024$1$I$20240701$20240728$20240731$20240731$PER$$US-PFIZER INC-202400224880$PFIZER$$90$YR$$F$Y$$$20240731$$CN$US$US
241570251$24157025$1$I$20240721$20240726$20240731$20240731$PER$$US-PFIZER INC-202400225047$PFIZER$$64$YR$$F$Y$$$20240731$$CN$US$US
241570262$24157026$2$F$$20240813$20240731$20240828$EXP$$NL-ASTELLAS-2024EU007478$ASTELLAS$Ghambari K, de Jong DM, Bruno MJ, Polak WG, van Driel LMJW, den Hoed CM. Risks of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis After Liver Transplantation. Clinical Transplantation 2024;38(7):1-9.$60$YR$A$F$Y$$$20240821$$HP$NL$NL
241570271$24157027$1$I$20240122$20240722$20240731$20240731$EXP$FR-AFSSAPS-ST2024001179$FR-BAXTER-2024BAX022032$BAXTER$$79$YR$$M$Y$75$KG$20240731$$HP$FR$FR
241570281$24157028$1$I$$20240605$20240731$20240731$PER$$US-LUNDBECK-DKLU4000151$LUNDBECK$$$$$$Y$$$20240731$$HP$US$US
241570291$24157029$1$I$20240701$20240726$20240731$20240731$PER$$US-PFIZER INC-202400225023$PFIZER$$35$YR$$M$Y$$$20240731$$HP$US$US
241570301$24157030$1$I$$20240730$20240731$20240731$PER$$US-PFIZER INC-202400226943$PFIZER$$$$$M$Y$$$20240731$$HP$US$US
241570311$24157031$1$I$20240701$20240726$20240731$20240731$PER$$US-PFIZER INC-202400224902$PFIZER$$52$YR$$M$Y$$$20240731$$CN$US$US
241570321$24157032$1$I$20240728$20240728$20240731$20240731$PER$$US-PFIZER INC-202400225989$PFIZER$$70$YR$$F$Y$$$20240731$$CN$US$US
241570331$24157033$1$I$20240725$20240726$20240731$20240731$PER$$US-PFIZER INC-202400226486$PFIZER$$60$YR$$F$Y$$$20240731$$HP$US$US
241570341$24157034$1$I$$20240727$20240731$20240731$PER$$US-PFIZER INC-202400225077$PFIZER$$$$$$Y$$$20240731$$CN$US$US
241570351$24157035$1$I$20240729$20240730$20240731$20240731$PER$$US-PFIZER INC-202400227272$PFIZER$$64$YR$$F$Y$$$20240731$$CN$US$US
241570361$24157036$1$I$$20240725$20240731$20240731$PER$$US-PFIZER INC-PV202400097589$PFIZER$$47$YR$$F$Y$$$20240731$$CN$US$US
241570371$24157037$1$I$20240725$20240728$20240731$20240731$PER$$US-PFIZER INC-202400224901$PFIZER$$53$YR$$F$Y$$$20240731$$CN$US$US
241570381$24157038$1$I$20240626$20240726$20240731$20240731$PER$$US-PFIZER INC-PV202400099271$PFIZER$$83$YR$$M$Y$$$20240731$$MD$US$US
241570391$24157039$1$I$20240728$20240728$20240731$20240731$PER$$US-PFIZER INC-202400225020$PFIZER$$50$YR$$M$Y$$$20240731$$CN$US$US
241570411$24157041$1$I$20240601$20240729$20240731$20240731$PER$$US-PFIZER INC-202400226884$PFIZER$$65$YR$$F$Y$$$20240731$$HP$US$US
241570421$24157042$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-202400225985$PFIZER$$$$$F$Y$$$20240731$$CN$US$US
241570431$24157043$1$I$$20240725$20240731$20240731$PER$$JP-PFIZER INC-202400223536$PFIZER$$$$$$Y$$$20240731$$PH$JP$JP
241570441$24157044$1$I$20240726$20240728$20240731$20240731$PER$$US-PFIZER INC-202400225206$PFIZER$$53$YR$$F$Y$$$20240731$$CN$US$US
241570451$24157045$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-202400090938$PFIZER$$61$YR$$F$Y$$$20240731$$CN$US$US
241570471$24157047$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-202400226344$PFIZER$$68$YR$$F$Y$$$20240731$$CN$US$US
241570482$24157048$2$F$$20240804$20240731$20240806$PER$$FR-PFIZER INC-202400225471$PFIZER$$$$$M$Y$$$20240806$$CN$FR$FR
241570491$24157049$1$I$$20240727$20240731$20240731$PER$$US-PFIZER INC-202400225089$PFIZER$$$$$$Y$$$20240731$$CN$US$US
241570501$24157050$1$I$20240719$20240727$20240731$20240731$PER$$US-PFIZER INC-202400225255$PFIZER$$75$YR$$M$Y$$$20240731$$CN$US$US
241570511$24157051$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-202400226341$PFIZER$$59$YR$$F$Y$$$20240731$$PH$US$US
241570521$24157052$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-PV202400099113$PFIZER$$52$YR$$F$Y$$$20240731$$HP$US$US
241570531$24157053$1$I$$20240725$20240731$20240731$PER$$US-PFIZER INC-202400223883$PFIZER$$$$$F$Y$$$20240731$$CN$US$US
241570541$24157054$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-PV202400098990$PFIZER$$61$YR$$F$Y$$$20240731$$HP$US$US
241570551$24157055$1$I$20240728$20240730$20240731$20240731$PER$$US-PFIZER INC-202400227250$PFIZER$$59$YR$$M$Y$$$20240731$$CN$US$US
241570561$24157056$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-202400226023$PFIZER$$64$YR$$F$Y$$$20240731$$HP$US$US
241570581$24157058$1$I$20240101$20240729$20240731$20240731$PER$$US-PFIZER INC-PV202400045782$PFIZER$$67$YR$$F$Y$$$20240731$$HP$US$US
241570591$24157059$1$I$20240727$20240728$20240731$20240731$PER$$US-PFIZER INC-202400225029$PFIZER$$72$YR$$F$Y$$$20240731$$CN$US$US
241570601$24157060$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-PV202400099353$PFIZER$$57$YR$$F$Y$$$20240731$$HP$US$US
241570612$24157061$2$F$$20240805$20240731$20240808$PER$$US-PFIZER INC-PV202400097947$PFIZER$$$$$M$Y$$$20240808$$CN$US$US
241570621$24157062$1$I$20230101$20240728$20240731$20240731$PER$$US-PFIZER INC-202400225582$PFIZER$$80$YR$$M$Y$72.57$KG$20240731$$CN$US$US
241570631$24157063$1$I$20240726$20240726$20240731$20240731$PER$$US-PFIZER INC-202400224984$PFIZER$$50$YR$$F$Y$99.79$KG$20240731$$CN$US$US
241570641$24157064$1$I$20240729$20240730$20240731$20240731$PER$$US-PFIZER INC-202400227234$PFIZER$$30$YR$$F$Y$$$20240731$$CN$US$US
241570651$24157065$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-PV202400098392$PFIZER$$43$YR$$F$Y$$$20240731$$CN$US$US
241570661$24157066$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-202400226911$PFIZER$$39$YR$$F$Y$$$20240731$$HP$US$US
241570671$24157067$1$I$20240601$20240726$20240731$20240731$PER$$US-PFIZER INC-202400225679$PFIZER$$81$YR$$F$Y$$$20240731$$PH$US$US
241570681$24157068$1$I$20240728$20240729$20240731$20240731$PER$$US-PFIZER INC-202400225664$PFIZER$$71$YR$$F$Y$$$20240731$$CN$US$US
241570691$24157069$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-PV202400098267$PFIZER$$72$YR$$F$Y$$$20240731$$HP$US$US
241570702$24157070$2$F$20240726$20240731$20240731$20240731$PER$$US-PFIZER INC-202400226138$PFIZER$$73$YR$$F$Y$$$20240731$$HP$US$US
241570711$24157071$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-202400226055$PFIZER$$42$YR$$F$Y$$$20240731$$HP$US$US
241570721$24157072$1$I$20240701$20240728$20240731$20240731$PER$$US-PFIZER INC-202400224946$PFIZER$$$$$$Y$$$20240731$$CN$US$US
241570732$24157073$2$F$20240101$20240919$20240731$20240919$PER$$US-PFIZER INC-PV202400098984$PFIZER$$$$A$$Y$$$20240919$$CN$US$US
241570741$24157074$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-202400226257$PFIZER$$60$YR$$F$Y$$$20240731$$HP$US$US
241570751$24157075$1$I$20240728$20240728$20240731$20240731$PER$$US-PFIZER INC-202400224941$PFIZER$$$$$$Y$$$20240731$$CN$US$US
241570761$24157076$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-PV202400099597$PFIZER$$55$YR$$M$Y$$$20240731$$HP$US$US
241570771$24157077$1$I$20240331$20240729$20240731$20240731$PER$$US-PFIZER INC-PV202400098896$PFIZER$$73$YR$$F$Y$$$20240731$$PH$US$US
241570781$24157078$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-202400225252$PFIZER$$43$YR$$F$Y$$$20240731$$MD$US$US
241570792$24157079$2$F$20240101$20240802$20240731$20240805$PER$$US-PFIZER INC-PV202400099155$PFIZER$$73$YR$$M$Y$66.667$KG$20240805$$CN$US$US
241570801$24157080$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-202400226039$PFIZER$$47$YR$$F$Y$$$20240731$$HP$US$US
241570812$24157081$2$F$20240725$20240822$20240731$20240829$PER$$US-PFIZER INC-PV202400099165$PFIZER$$47$YR$$M$Y$$$20240829$$HP$US$US
241570821$24157082$1$I$20240501$20240729$20240731$20240731$PER$$US-PFIZER INC-202400226998$PFIZER$$54$YR$$F$Y$$$20240731$$HP$US$US
241570831$24157083$1$I$$20240730$20240731$20240731$PER$$US-PFIZER INC-202400227043$PFIZER$$84$YR$$F$Y$$$20240731$$HP$US$US
241570843$24157084$3$F$$20240826$20240731$20240828$PER$$US-PFIZER INC-PV202400099111$PFIZER$$73$YR$$F$Y$$$20240828$$HP$US$US
241570851$24157085$1$I$$20240730$20240731$20240731$PER$$US-PFIZER INC-202400227110$PFIZER$$19$YR$$F$Y$$$20240731$$MD$US$US
241570861$24157086$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-202400225942$PFIZER$$$$$M$Y$$$20240731$$MD$US$US
241570872$24157087$2$F$20240701$20240807$20240731$20240807$EXP$$TW-BAYER-2024A110287$BAYER$$81$YR$E$M$Y$$$20240807$$MD$TW$TW
241570881$24157088$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-PV202400099050$PFIZER$$23$YR$$F$Y$$$20240731$$HP$US$US
241570891$24157089$1$I$20240429$20240506$20240731$20240731$PER$$US-BAYER-2024A091103$BAYER$$32$YR$A$F$Y$$$20240731$$HP$US$US
241570902$24157090$2$F$$20240731$20240731$20240801$PER$$US-PFIZER INC-202400227334$PFIZER$$$$$$Y$$$20240801$$MD$US$US
241570911$24157091$1$I$20240716$20240727$20240731$20240731$PER$$US-PFIZER INC-202400225250$PFIZER$$66$YR$$F$Y$$$20240731$$CN$US$US
241570921$24157092$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-PV202400098652$PFIZER$$49$YR$$F$Y$$$20240731$$CN$US$US
241570943$24157094$3$F$20240801$20240825$20240731$20240830$PER$$US-PFIZER INC-PV202400098919$PFIZER$$75$YR$$F$Y$79.38$KG$20240830$$CN$US$US
241570951$24157095$1$I$20240729$20240729$20240731$20240731$PER$$US-PFIZER INC-202400226228$PFIZER$$48$YR$$F$Y$$$20240731$$CN$US$US
241570961$24157096$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-PV202300078079$PFIZER$$50$YR$$F$Y$$$20240731$$HP$US$US
241570971$24157097$1$I$$20240725$20240731$20240731$PER$$US-PFIZER INC-202400224361$PFIZER$$$$$F$Y$$$20240731$$CN$US$US
241570981$24157098$1$I$20240726$20240729$20240731$20240731$PER$$JP-PFIZER INC-202400225210$PFIZER$$$$$$Y$$$20240731$$PH$JP$JP
241570991$24157099$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-202400225986$PFIZER$$$$$$Y$$$20240731$$CN$US$US
241571002$24157100$2$F$$20240823$20240731$20240830$PER$$US-PFIZER INC-PV202400098466$PFIZER$$50$YR$$F$Y$$$20240830$$HP$US$US
241571012$24157101$2$F$$20240807$20240731$20240812$PER$$US-PFIZER INC-PV202400098576$PFIZER$$$$$$Y$$$20240812$$CN$US$US
241571022$24157102$2$F$$20240730$20240731$20240801$PER$$US-PFIZER INC-PV202400099635$PFIZER$$50$YR$$F$Y$$$20240801$$HP$US$US
241571031$24157103$1$I$20240726$20240727$20240731$20240731$PER$$US-PFIZER INC-202400225486$PFIZER$$88$YR$$F$Y$$$20240731$$CN$US$US
241571042$24157104$2$F$$20240919$20240731$20240924$PER$$US-PFIZER INC-202400226999$PFIZER$$65$YR$$F$Y$$$20240924$$HP$US$US
241571051$24157105$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-202400226161$PFIZER$$28$YR$$F$Y$$$20240731$$HP$US$US
241571061$24157106$1$I$20240728$20240728$20240731$20240731$PER$$US-PFIZER INC-202400225517$PFIZER$$58$YR$$M$Y$$$20240731$$CN$US$US
241571071$24157107$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-202400226271$PFIZER$$66$YR$$F$Y$$$20240731$$MD$US$US
241571082$24157108$2$F$$20240911$20240731$20240913$PER$$US-PFIZER INC-PV202400098179$PFIZER$$67$YR$$F$Y$$$20240913$$CN$US$US
241571091$24157109$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-PV202400099218$PFIZER$$70$YR$$F$Y$$$20240731$$HP$US$US
241571101$24157110$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-202400225094$PFIZER$$9$DEC$$F$Y$$$20240731$$CN$US$US
241571111$24157111$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-PV202400098512$PFIZER$$70$YR$$M$Y$$$20240731$$CN$US$US
241571121$24157112$1$I$20240728$20240728$20240731$20240731$PER$$US-PFIZER INC-202400225028$PFIZER$$64$YR$$F$Y$$$20240731$$CN$US$US
241571131$24157113$1$I$$20240724$20240731$20240731$PER$$US-ROCHE-10000038278$ROCHE$$$$$$Y$$$20240731$$CN$US$US
241571141$24157114$1$I$$20240725$20240731$20240731$PER$$US-ROCHE-10000037384$ROCHE$$$$$$Y$$$20240731$$CN$US$US
241571151$24157115$1$I$$20240724$20240731$20240731$PER$$US-ROCHE-10000036411$ROCHE$$$$A$M$Y$$$20240731$$CN$US$US
241571162$24157116$2$F$20230919$20240802$20240731$20240802$EXP$$JP-ABBVIE-5861073$ABBVIE$$71$YR$$F$Y$62$KG$20240802$$MD$JP$JP
241571182$24157118$2$F$20240722$20240805$20240731$20240812$PER$$US-BAYER-2024A109114$BAYER$$68$YR$E$F$Y$$$20240812$$CN$US$US
241571191$24157119$1$I$20230101$20240717$20240731$20240731$PER$$US-TEVA-VS-3222567$TEVA$$73$YR$$M$Y$$$20240731$$CN$US$US
241571202$24157120$2$F$20240301$20240819$20240731$20240821$EXP$$JP-JNJFOC-20240782743$JOHNSON AND JOHNSON$Okamura T. A case of multiple myeloma with frailty from the initial visit to our facility: What would you do.$74$YR$E$M$Y$$$20240821$$MD$JP$JP
241571221$24157122$1$I$$20240722$20240731$20240731$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005480$BIOCON$$$$$$Y$$$20240731$$MD$CA$CA
241571231$24157123$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000041671$ROCHE$$$$I$M$Y$$$20240731$$CN$US$US
241571241$24157124$1$I$$20240725$20240731$20240731$PER$$US-ROCHE-10000037502$ROCHE$$7$MON$I$M$Y$$$20240731$$CN$US$US
241571251$24157125$1$I$$20240722$20240731$20240731$EXP$$US-ROCHE-10000033557$ROCHE$$$$E$M$Y$$$20240731$$CN$US$US
241571261$24157126$1$I$$20240726$20240731$20240731$PER$$US-HALEON-2189849$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241571281$24157128$1$I$20240701$20240730$20240731$20240731$PER$$US-ROCHE-10000042320$ROCHE$$19$YR$A$M$Y$$$20240731$$CN$US$US
241571291$24157129$1$I$20240708$20240730$20240731$20240731$PER$$US-ROCHE-10000042234$ROCHE$$45$YR$A$M$Y$$$20240731$$CN$US$US
241571301$24157130$1$I$$20240708$20240731$20240731$EXP$$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-07294$HIKMA$Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al. Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, Santoro N. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports. Journal of pediatric hematology/oncology. 2024$15$YR$$M$Y$$$20240731$$MD$IT$IT
241571311$24157131$1$I$$20240726$20240731$20240731$EXP$$FR-ROCHE-10000042437$ROCHE$$$$$F$Y$$$20240731$$HP$FR$FR
241571321$24157132$1$I$20240411$20240507$20240731$20240731$PER$$US-BAYER-2024A091098$BAYER$$24$YR$A$F$Y$$$20240731$$MD$US$US
241571333$24157133$3$F$20240709$20240829$20240731$20240830$PER$$US-ROCHE-10000042280$ROCHE$$27$YR$A$M$Y$$$20240830$$CN$US$US
241571341$24157134$1$I$$20240605$20240731$20240731$PER$$US-LUNDBECK-DKLU4000304$LUNDBECK$$$$$$Y$$$20240731$$HP$US$US
241571351$24157135$1$I$20240701$20240730$20240731$20240731$PER$$US-ROCHE-10000042319$ROCHE$$23$YR$A$M$Y$79.38$KG$20240731$$CN$US$US
241571361$24157136$1$I$20240701$20240730$20240731$20240731$PER$$US-ROCHE-10000043102$ROCHE$$19$YR$A$M$Y$$$20240731$$CN$US$US
241571371$24157137$1$I$$20240722$20240731$20240731$PER$$US-ABBVIE-5853481$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241571384$24157138$4$F$$20240904$20240731$20240905$30DAY$$US-PFIZER INC-202400221072$PFIZER$$13$YR$$M$Y$$$20240905$$CN$US$US
241571391$24157139$1$I$$20240716$20240731$20240731$EXP$$BR-LEADINGPHARMA-BR-2024LEALIT00322$LEADING PHARMA$Arnildo Linck Junior.Malignant hyperthermia without fever in a burned child after bandaging: A case report.Journal of Pediatric Surgery Case Reports.21-MAR-2023;92:1-4$16$MON$I$F$Y$$$20240731$$HP$BR$BR
241571403$24157140$3$F$$20240904$20240731$20240904$30DAY$$US-PFIZER INC-202400219759$PFIZER$$12$YR$$F$Y$$$20240904$$CN$US$US
241571413$24157141$3$F$$20240830$20240731$20240830$30DAY$$US-PFIZER INC-202400225071$PFIZER$$10$YR$$F$Y$$$20240830$$CN$US$US
241571421$24157142$1$I$$20240725$20240731$20240731$EXP$$NVSC2024DE154925$NOVARTIS$$58$YR$$M$Y$$$20240731$$PH$DE$DE
241571431$24157143$1$I$$20240730$20240731$20240731$EXP$$NVSC2024ET155671$NOVARTIS$$$$$F$Y$$$20240731$$MD$ET$ET
241571441$24157144$1$I$$20240729$20240731$20240731$EXP$$US-OTSUKA-2024_021097$OTSUKA$$$$$M$Y$$$20240731$$CN$US$US
241571451$24157145$1$I$$20240724$20240731$20240731$PER$$US-ABBVIE-5857305$ABBVIE$$$$$$Y$$$20240731$$HP$US$US
241571461$24157146$1$I$20240716$20240727$20240731$20240731$EXP$$NVSC2024CN155817$NOVARTIS$$71$YR$$M$Y$86$KG$20240731$$HP$CN$CN
241571471$24157147$1$I$$20240724$20240731$20240731$EXP$$CA-GSK-CA2024AMR093080$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$CA$CA
241571481$24157148$1$I$20240101$20240723$20240731$20240731$EXP$$JP-AMGEN-JPNSP2024147384$AMGEN$$79$YR$E$F$Y$$$20240731$$CN$JP$JP
241571491$24157149$1$I$20240725$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150632$AMGEN$$43$YR$A$M$Y$$$20240731$$CN$US$US
241571501$24157150$1$I$$20240726$20240731$20240731$EXP$$BR-TAKEDA-2024TUS076259$TAKEDA$$44$YR$$$Y$$$20240731$$CN$BR$BR
241571511$24157151$1$I$$20240728$20240731$20240731$EXP$$BR-TAKEDA-2024TUS076660$TAKEDA$$7$YR$$$Y$$$20240731$$CN$BR$BR
241571521$24157152$1$I$$20240729$20240731$20240731$EXP$$FR-ROCHE-10000042347$ROCHE$$$$T$M$Y$$$20240731$$PH$FR$FR
241571531$24157153$1$I$$20240717$20240731$20240731$PER$$US-Calliditas-2024CAL01346$CALLIDITAS THERAPEUTICS$$32$YR$A$F$Y$59.8$KG$20240731$$CN$US$US
241571543$24157154$3$F$20230801$20240919$20240731$20240925$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-012411$JAZZ$$49$YR$$F$Y$$$20240925$$CN$US$US
241571552$24157155$2$F$20240101$20240822$20240731$20240905$EXP$$GB-Ascend Therapeutics US, LLC-2159831$ASCEND$$48$YR$$F$Y$$$20240905$$$GB$GB
241571562$24157156$2$F$20240503$20240905$20240731$20240906$PER$$US-BAYER-2024A093766$BAYER$$23$YR$A$F$Y$46.259$KG$20240906$$CN$US$US
241571581$24157158$1$I$$20240716$20240731$20240731$EXP$$TW-LEADINGPHARMA-TW-2024LEALIT00320$LEADING PHARMA$Jen-Jen Su.Case Report: Lacosamide unmasking SCN5A-associated Brugada syndrome in a young female with epilepsy.Frontiers in Cardiovascular Medicine .31-MAY-2024;11:1-6$33$YR$A$F$Y$$$20240731$$HP$TW$TW
241571591$24157159$1$I$$20240604$20240731$20240731$PER$$US-LUNDBECK-DKLU4000165$LUNDBECK$$$$$$Y$$$20240731$$PH$US$US
241571601$24157160$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150363$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241571621$24157162$1$I$20240101$20240723$20240731$20240731$EXP$$US-TEVA-VS-3226920$TEVA$$16$YR$$M$Y$$$20240731$$HP$US$US
241571631$24157163$1$I$20240201$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018046$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240731$$CN$US$US
241571642$24157164$2$F$20240501$20240813$20240731$20240821$PER$$US-BAYER-2024A091003$BAYER$$25$YR$A$F$Y$$$20240821$$MD$US$US
241571651$24157165$1$I$$20240717$20240731$20240731$PER$$US-SA-2024SA215075$SANOFI AVENTIS$$60$YR$A$M$Y$97.522$KG$20240731$$MD$US$US
241571661$24157166$1$I$$20240719$20240731$20240731$PER$$US-SA-2024SA219426$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240731$$MD$US$US
241571681$24157168$1$I$20240101$20240718$20240731$20240731$PER$$US-SA-2024SA215033$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240731$$MD$US$US
241571691$24157169$1$I$20240101$20240719$20240731$20240731$PER$$US-SA-2024SA217053$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240731$$MD$US$US
241571701$24157170$1$I$$20240719$20240731$20240731$PER$$US-SA-2024SA060441$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240731$$MD$US$US
241571711$24157171$1$I$20240101$20240719$20240731$20240731$PER$$US-SA-2024SA217667$SANOFI AVENTIS$$45$YR$A$F$Y$120$KG$20240731$$MD$US$US
241571721$24157172$1$I$20240101$20240719$20240731$20240731$PER$$US-SA-2024SA217687$SANOFI AVENTIS$$76$YR$E$M$Y$99.7$KG$20240731$$MD$US$US
241571731$24157173$1$I$20240101$20240719$20240731$20240731$PER$$US-SA-2024SA201228$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240731$$MD$US$US
241571741$24157174$1$I$20240101$20240719$20240731$20240731$PER$$US-SA-2024SA221387$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240731$$HP$US$US
241571751$24157175$1$I$$20240719$20240731$20240731$PER$$US-SA-2024SA217300$SANOFI AVENTIS$$$$A$M$Y$$$20240731$$MD$US$US
241571761$24157176$1$I$$20240719$20240731$20240731$PER$$US-SA-2024SA221646$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240731$$MD$US$US
241571771$24157177$1$I$20231201$20240720$20240731$20240731$PER$$US-SA-2024SA216931$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240731$$MD$US$US
241571781$24157178$1$I$$20240606$20240731$20240731$PER$$US-LUNDBECK-DKLU4000206$LUNDBECK$$$$$$Y$$$20240731$$HP$US$US
241571791$24157179$1$I$20240101$20240720$20240731$20240731$PER$$US-SA-2024SA217091$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240731$$MD$US$US
241571801$24157180$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA220404$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240731$$CN$US$US
241571811$24157181$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA219718$SANOFI AVENTIS$$32$YR$A$F$Y$122$KG$20240731$$MD$US$US
241571821$24157182$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA220581$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240731$$MD$US$US
241571841$24157184$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221610$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240731$$MD$US$US
241571851$24157185$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221716$SANOFI AVENTIS$$$$A$M$Y$69$KG$20240731$$MD$US$US
241571861$24157186$1$I$20230101$20240724$20240731$20240731$PER$$US-SA-2024SA219175$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240731$$CN$US$US
241571871$24157187$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA221262$SANOFI AVENTIS$$25$YR$A$M$Y$72.57$KG$20240731$$MD$US$US
241571881$24157188$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA217813$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240731$$MD$US$US
241571891$24157189$1$I$$20240723$20240731$20240731$EXP$$IE-TAKEDA-2024TUS074875$TAKEDA$$$$$$Y$$$20240731$$MD$IE$IE
241571901$24157190$1$I$20240701$20240723$20240731$20240731$PER$$US-SA-2024SA221108$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240731$$MD$US$US
241571911$24157191$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA219609$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240731$$MD$US$US
241571921$24157192$1$I$20240701$20240723$20240731$20240731$PER$$US-SA-2024SA221404$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240731$$MD$US$US
241571931$24157193$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA222656$SANOFI AVENTIS$$25$YR$A$M$Y$37.03$KG$20240731$$CN$US$US
241571941$24157194$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA219764$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240731$$MD$US$US
241571952$24157195$2$F$$20240815$20240731$20240829$PER$$US-SA-2024SA222490$SANOFI AVENTIS$$$$A$M$Y$$$20240829$$MD$US$US
241571961$24157196$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA223472$SANOFI AVENTIS$$$$A$F$Y$58.96$KG$20240731$$MD$US$US
241571971$24157197$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA216951$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240731$$MD$US$US
241571981$24157198$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA222512$SANOFI AVENTIS$$$$A$M$Y$97$KG$20240731$$MD$US$US
241571991$24157199$1$I$20240101$20240723$20240731$20240731$PER$$US-SA-2024SA220969$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240731$$MD$US$US
241572001$24157200$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA217918$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240731$$MD$US$US
241572011$24157201$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA223563$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240731$$MD$US$US
241572022$24157202$2$F$20240101$20240724$20240731$20240802$PER$$US-SA-2024SA219138$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240802$$MD$US$US
241572031$24157203$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA221809$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240731$$MD$US$US
241572041$24157204$1$I$20240401$20240724$20240731$20240731$PER$$US-SA-2024SA222516$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240731$$MD$US$US
241572051$24157205$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA223487$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240731$$MD$US$US
241572061$24157206$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA223316$SANOFI AVENTIS$$$$A$M$Y$104$KG$20240731$$MD$US$US
241572071$24157207$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA222594$SANOFI AVENTIS$$44$YR$A$F$Y$80$KG$20240731$$MD$US$US
241572081$24157208$1$I$20240506$20240508$20240731$20240731$PER$$US-BAYER-2024A091042$BAYER$$32$YR$A$F$Y$$$20240731$$MD$US$US
241572091$24157209$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA224561$SANOFI AVENTIS$$$$E$M$Y$64$KG$20240731$$CN$US$US
241572101$24157210$1$I$$20240605$20240731$20240731$PER$$US-LUNDBECK-DKLU4000355$LUNDBECK$$$$$$Y$$$20240731$$HP$US$US
241572111$24157211$1$I$20240501$20240723$20240731$20240731$PER$$US-SA-2024SA221283$SANOFI AVENTIS$$40$YR$A$F$Y$61.23$KG$20240731$$MD$US$US
241572121$24157212$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA140993$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240731$$MD$US$US
241572132$24157213$2$F$$20240801$20240731$20240810$PER$$US-SA-2024SA221339$SANOFI AVENTIS$$$$C$F$Y$30.84$KG$20240810$$MD$US$US
241572141$24157214$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA060529$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240731$$MD$US$US
241572151$24157215$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA222814$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240731$$CN$US$US
241572161$24157216$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA221688$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240731$$MD$US$US
241572171$24157217$1$I$20240701$20240723$20240731$20240731$PER$$US-SA-2024SA222666$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240731$$MD$US$US
241572181$24157218$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221632$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240731$$CN$US$US
241572191$24157219$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221556$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240731$$HP$US$US
241572201$24157220$1$I$20240711$20240724$20240731$20240731$PER$$US-SA-2024SA223539$SANOFI AVENTIS$$59$YR$A$F$Y$79.8$KG$20240731$$MD$US$US
241572211$24157221$1$I$20240701$20240722$20240731$20240731$PER$$US-SA-2024SA221327$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240731$$MD$US$US
241572221$24157222$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221728$SANOFI AVENTIS$$23$YR$A$F$Y$83.91$KG$20240731$$MD$US$US
241572231$24157223$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA223395$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240731$$MD$US$US
241572241$24157224$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA221349$SANOFI AVENTIS$$19$YR$A$F$Y$46$KG$20240731$$MD$US$US
241572251$24157225$1$I$20230101$20240724$20240731$20240731$PER$$US-SA-2024SA222128$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240731$$MD$US$US
241572261$24157226$1$I$20240601$20240724$20240731$20240731$PER$$US-SA-2024SA221684$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240731$$MD$US$US
241572271$24157227$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA219417$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240731$$MD$US$US
241572281$24157228$1$I$20230101$20240722$20240731$20240731$PER$$US-SA-2024SA218558$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240731$$MD$US$US
241572291$24157229$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA221542$SANOFI AVENTIS$$$$A$M$Y$$$20240731$$MD$US$US
241572301$24157230$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221296$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240731$$MD$US$US
241572311$24157231$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221817$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240731$$MD$US$US
241572321$24157232$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA218549$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240731$$MD$US$US
241572331$24157233$1$I$20220813$20240722$20240731$20240731$PER$$US-SA-2024SA218895$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240731$$MD$US$US
241572351$24157235$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA219791$SANOFI AVENTIS$$$$A$F$Y$92.5$KG$20240731$$MD$US$US
241572361$24157236$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA223463$SANOFI AVENTIS$$$$$M$Y$$$20240731$$CN$US$US
241572371$24157237$1$I$20240516$20240724$20240731$20240731$PER$$US-SA-2024SA223488$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240731$$MD$US$US
241572381$24157238$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA221437$SANOFI AVENTIS$$$$A$M$Y$$$20240731$$MD$US$US
241572391$24157239$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA220841$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240731$$MD$US$US
241572402$24157240$2$F$$20240729$20240731$20240801$EXP$$US-ROCHE-10000041630$ROCHE$$26$YR$A$F$Y$46.9$KG$20240801$$CN$US$US
241572411$24157241$1$I$$20240722$20240731$20240731$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005472$BIOCON$$$$$$Y$$$20240731$$MD$CA$CA
241572421$24157242$1$I$20240201$20240722$20240731$20240731$PER$$US-SA-2024SA221200$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240731$$MD$US$US
241572431$24157243$1$I$20240526$20240722$20240731$20240731$EXP$FR-AFSSAPS-PB2024000790$FR-TEVA-VS-3225203$TEVA$$19$YR$$F$Y$$$20240731$$MD$FR$FR
241572441$24157244$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221747$SANOFI AVENTIS$$$$A$M$Y$78.005$KG$20240731$$MD$US$US
241572451$24157245$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221844$SANOFI AVENTIS$$$$T$F$Y$64.8$KG$20240731$$MD$US$US
241572461$24157246$1$I$20230601$20240723$20240731$20240731$EXP$$EU-SEPTODONT-2024018831$SEPTODONT$$$$C$$Y$$$20240731$$HP$EU$EU
241572471$24157247$1$I$$20240716$20240731$20240731$EXP$$JP-LEADINGPHARMA-JP-2024LEALIT00323$LEADING PHARMA$Shunsuke Nakamura.Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine.Internal Medicine.JUN-2024;63:1829-1835$72$YR$E$F$Y$$$20240731$$HP$JP$JP
241572481$24157248$1$I$20240618$20240719$20240731$20240731$EXP$FR-AFSSAPS-LL2024001298$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06928$HIKMA$$59$YR$$F$Y$50$KG$20240731$$MD$FR$FR
241572491$24157249$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221039$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240731$$HP$US$US
241572501$24157250$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA221685$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240731$$HP$US$US
241572511$24157251$1$I$$20240722$20240731$20240731$PER$$US-SA-2022SA262857$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240731$$MD$US$US
241572521$24157252$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA223411$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240731$$MD$US$US
241572531$24157253$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA218170$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240731$$MD$US$US
241572541$24157254$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221306$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240731$$MD$US$US
241572551$24157255$1$I$20240723$20240724$20240731$20240731$PER$$US-SA-2024SA223160$SANOFI AVENTIS$$11$YR$C$M$Y$38.555$KG$20240731$$MD$US$US
241572561$24157256$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA085574$SANOFI AVENTIS$$$$A$F$Y$129$KG$20240731$$MD$US$US
241572571$24157257$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA219878$SANOFI AVENTIS$$$$C$M$Y$27.28$KG$20240731$$MD$US$US
241572581$24157258$1$I$20240101$20240723$20240731$20240731$PER$$US-SA-2024SA222176$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240731$$MD$US$US
241572591$24157259$1$I$20240723$20240723$20240731$20240731$PER$$US-SA-2024SA221571$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240731$$HP$US$US
241572602$24157260$2$F$20240101$20240826$20240731$20240910$PER$$US-SA-2024SA221625$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240910$$MD$US$US
241572611$24157261$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221517$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240731$$MD$US$US
241572621$24157262$1$I$20240721$20240724$20240731$20240731$PER$$US-SA-2024SA221648$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240731$$MD$US$US
241572631$24157263$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA221311$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240731$$MD$US$US
241572641$24157264$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA218652$SANOFI AVENTIS$$11$YR$C$F$Y$43$KG$20240731$$MD$US$US
241572653$24157265$3$F$$20240726$20240731$20240806$PER$$US-SA-2024SA219819$SANOFI AVENTIS$$11$YR$C$M$Y$36.5$KG$20240806$$MD$US$US
241572661$24157266$1$I$20240723$20240724$20240731$20240731$PER$$US-SA-2024SA223308$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240731$$MD$US$US
241572671$24157267$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA217767$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240731$$MD$US$US
241572682$24157268$2$F$$20240806$20240731$20240813$PER$$US-SA-2024SA223592$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240814$$MD$US$US
241572691$24157269$1$I$$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52356$$FDA-CTU$$36$YR$$F$N$$$20240730$N$$US$
241572701$24157270$1$I$20240701$20240722$20240731$20240731$EXP$$JP-009507513-2407JPN004168J$MERCK$$7$DEC$$M$Y$$$20240731$$MD$JP$JP
241572711$24157271$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA218618$SANOFI AVENTIS$$$$A$F$Y$$$20240731$$CN$US$US
241572722$24157272$2$F$20240101$20240816$20240731$20240830$PER$$US-SA-2024SA171617$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240830$$MD$US$US
241572731$24157273$1$I$20210501$20240724$20240731$20240731$PER$$US-SA-2024SA221598$SANOFI AVENTIS$$$$E$F$Y$$$20240731$$MD$US$US
241572742$24157274$2$F$20240101$20240722$20240731$20240805$PER$$US-SA-2024SA221163$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240805$$MD$US$US
241572751$24157275$1$I$20240401$20240722$20240731$20240731$PER$$US-SA-2024SA218517$SANOFI AVENTIS$$52$YR$A$F$Y$78$KG$20240731$$MD$US$US
241572761$24157276$1$I$20240701$20240723$20240731$20240731$PER$$US-SA-2024SA222298$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240731$$MD$US$US
241572771$24157277$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA221661$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240731$$MD$US$US
241572781$24157278$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA223352$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240731$$MD$US$US
241572791$24157279$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA219244$SANOFI AVENTIS$$$$$$Y$$$20240731$$HP$US$US
241572801$24157280$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA220859$SANOFI AVENTIS$$$$A$M$Y$$$20240731$$MD$US$US
241572811$24157281$1$I$20240716$20240724$20240731$20240731$PER$$US-SA-2024SA222851$SANOFI AVENTIS$$49$YR$A$F$Y$97.5$KG$20240731$$MD$US$US
241572821$24157282$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA217253$SANOFI AVENTIS$$$$E$M$Y$$$20240731$$MD$US$US
241572831$24157283$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221687$SANOFI AVENTIS$$$$T$F$Y$$$20240731$$MD$US$US
241572841$24157284$1$I$20240101$20240723$20240731$20240731$PER$$US-SA-2024SA219598$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240731$$MD$US$US
241572851$24157285$1$I$$20240731$20240731$20240731$DIR$712183$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241572861$24157286$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA012471$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240731$$MD$US$US
241572871$24157287$1$I$20240701$20240722$20240731$20240731$PER$$US-SA-2024SA166123$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240731$$MD$US$US
241572881$24157288$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221638$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240731$$CN$US$US
241572891$24157289$1$I$20240507$20240724$20240731$20240731$PER$$US-SA-2024SA222440$SANOFI AVENTIS$$$$$F$Y$$$20240731$$CN$US$US
241572901$24157290$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA219395$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240731$$CN$US$US
241572911$24157291$1$I$20240101$20240723$20240731$20240731$PER$$US-SA-2024SA221346$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240731$$MD$US$US
241572921$24157292$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221245$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240731$$MD$US$US
241572931$24157293$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA220689$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240731$$MD$US$US
241572942$24157294$2$F$$20240722$20240731$20240801$PER$$US-SA-2024SA221282$SANOFI AVENTIS$$31$YR$A$M$Y$105$KG$20240801$$MD$US$US
241572951$24157295$1$I$20240506$20240722$20240731$20240731$PER$$US-SA-2024SA220574$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240731$$CN$US$US
241572962$24157296$2$F$20240101$20240710$20240731$20240801$PER$$US-SA-2024SA207725$SANOFI AVENTIS$$56$YR$A$F$Y$83.9$KG$20240719$$MD$US$US
241572971$24157297$1$I$20240601$20240724$20240731$20240731$PER$$US-SA-2024SA222451$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240731$$MD$US$US
241572981$24157298$1$I$$20240725$20240731$20240731$EXP$$RO-AstraZeneca-2024A173310$ASTRAZENECA$$$$$F$Y$$$20240731$$MD$RO$
241572991$24157299$1$I$20240422$20240423$20240731$20240731$PER$$US-BAYER-2024A092450$BAYER$$21$YR$A$F$Y$$$20240731$$MD$US$US
241573001$24157300$1$I$$20240723$20240731$20240731$EXP$$PH-PFIZER INC-202400225653$PFIZER$$35$YR$$F$Y$$$20240731$$CN$PH$PH
241573012$24157301$2$F$$20240910$20240731$20240915$EXP$$GR-AstraZeneca-2024A170035$ASTRAZENECA$$$$E$M$Y$$$20240915$$MD$GR$
241573022$24157302$2$F$$20240828$20240731$20240902$EXP$$CA-PFIZER INC-202400025881$PFIZER$$58$YR$$M$Y$$$20240902$$HP$CA$CA
241573033$24157303$3$F$20230519$20240801$20240731$20240809$EXP$$CN-PFIZER INC-2023SGN08423$PFIZER$$35$YR$$M$Y$77$KG$20240809$$MD$CN$CN
241573041$24157304$1$I$$20240729$20240731$20240731$EXP$$CA-PFIZER INC-202400226629$PFIZER$$66$YR$$M$Y$$$20240731$$HP$CA$CA
241573061$24157306$1$I$$20240723$20240731$20240731$EXP$$AR-AstraZeneca-2024A168190$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$AR$
241573071$24157307$1$I$20240707$20240726$20240731$20240731$EXP$$ZA-AstraZeneca-2024A171220$ASTRAZENECA$$31776$DY$$F$Y$$$20240731$$CN$ZA$
241573081$24157308$1$I$$20240728$20240731$20240731$PER$$US-HALEON-2189612$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241573092$24157309$2$F$20240101$20240808$20240731$20240815$EXP$$US-ABBVIE-5857655$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
241573101$24157310$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA217183$SANOFI AVENTIS$$$$T$M$Y$$$20240731$$MD$US$US
241573111$24157311$1$I$20240709$20240722$20240731$20240731$PER$$US-SA-2024SA219363$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240731$$MD$US$US
241573121$24157312$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221310$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240731$$MD$US$US
241573141$24157314$1$I$20240619$20240722$20240731$20240731$PER$$US-SA-2024SA221157$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240731$$MD$US$US
241573151$24157315$1$I$20240601$20240722$20240731$20240731$PER$$US-SA-2024SA219860$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240731$$MD$US$US
241573161$24157316$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA219145$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240731$$MD$US$US
241573171$24157317$1$I$20240722$20240722$20240731$20240731$PER$$US-SA-2024SA220614$SANOFI AVENTIS$$26$YR$A$F$Y$58$KG$20240731$$MD$US$US
241573181$24157318$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA222226$SANOFI AVENTIS$$$$A$F$Y$$$20240731$$MD$US$US
241573192$24157319$2$F$20221214$20240808$20240731$20240816$PER$$US-SA-2024SA219470$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240816$$CN$US$US
241573201$24157320$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA222672$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240731$$MD$US$US
241573221$24157322$1$I$20240702$20240723$20240731$20240731$EXP$$CN-AstraZeneca-2024A169763$ASTRAZENECA$$51$YR$$F$Y$62$KG$20240731$$MD$CN$
241573231$24157323$1$I$$20240702$20240731$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06494$LUPIN$$$$$$Y$$$20240731$$CN$US$US
241573243$24157324$3$F$20240101$20240808$20240731$20240911$30DAY$$DE-UCBSA-2024034626$UCB$$$$$F$Y$$$20240911$$CN$DE$DE
241573251$24157325$1$I$20210324$20240724$20240731$20240731$EXP$$HU-UCBSA-2023058939$UCB$$32$YR$$F$Y$$$20240731$$MD$HU$HU
241573261$24157326$1$I$20200201$20240725$20240731$20240731$EXP$$US-TAKEDA-US202009733$TAKEDA$$48$YR$$F$Y$$$20240731$$MD$US$US
241573271$24157327$1$I$$20240716$20240731$20240731$EXP$$TR-AZURITY PHARMACEUTICALS, INC.-AZR202407-000131$AZURITY PHARMACEUTICALS$Cetinkaya OA, Demirkan NA, Keskin Y, Sevinc H.. Surgical treatment of a rare brachial artery aneurysm postarteriovenous fistula closure after kidney transplant: A case report. World J Clin Cases. 2024;12 (21):4755-61$61$YR$$M$Y$$$20240731$$MD$TR$TR
241573281$24157328$1$I$20240101$20240723$20240731$20240731$PER$$US-SA-2024SA143199$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240731$$MD$US$US
241573291$24157329$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221671$SANOFI AVENTIS$$$$A$M$Y$$$20240731$$MD$US$US
241573301$24157330$1$I$20240101$20240723$20240731$20240731$PER$$US-SA-2024SA221169$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240731$$MD$US$US
241573311$24157331$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221836$SANOFI AVENTIS$$$$A$F$Y$73.8$KG$20240731$$MD$US$US
241573321$24157332$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA222831$SANOFI AVENTIS$$$$A$M$Y$113.39$KG$20240731$$MD$US$US
241573331$24157333$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA225139$SANOFI AVENTIS$$$$E$F$Y$$$20240731$$MD$US$US
241573341$24157334$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA221662$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240731$$MD$US$US
241573351$24157335$1$I$20240701$20240724$20240731$20240731$PER$$US-SA-2024SA222521$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240731$$CN$US$US
241573362$24157336$2$F$$20240802$20240731$20240813$PER$$US-SA-2024SA222056$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240814$$MD$US$US
241573371$24157337$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA221963$SANOFI AVENTIS$$$$A$M$Y$$$20240731$$MD$US$US
241573382$24157338$2$F$$20240724$20240731$20240805$PER$$US-SA-2024SA219781$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240805$$MD$US$US
241573391$24157339$1$I$20231214$20240109$20240731$20240731$PER$$US-BAYER-2024A091410$BAYER$$49$YR$A$F$Y$$$20240731$$HP$US$US
241573402$24157340$2$F$$20240830$20240731$20240830$30DAY$$US-PFIZER INC-202400223299$PFIZER$$9$YR$$F$Y$$$20240830$$CN$US$US
241573411$24157341$1$I$20240613$20240727$20240731$20240731$EXP$$CN-JNJFOC-20240776253$JOHNSON AND JOHNSON$$24$YR$A$M$Y$67$KG$20240731$$HP$CN$CN
241573421$24157342$1$I$20240701$20240717$20240731$20240731$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001618$SK LIFE SCIENCE$$$$$$Y$$$20240731$$CN$US$US
241573432$24157343$2$F$$20240831$20240731$20240903$30DAY$$US-PFIZER INC-202400223214$PFIZER$$12$YR$$M$Y$42.177$KG$20240903$$CN$US$US
241573452$24157345$2$F$20240601$20240813$20240731$20240821$PER$$US-SA-2024SA222395$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240822$$CN$US$US
241573461$24157346$1$I$$20240725$20240731$20240731$PER$$US-SA-2024SA219898$SANOFI AVENTIS$$$$A$$Y$64.4$KG$20240731$$HP$US$US
241573471$24157347$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA222922$SANOFI AVENTIS$$$$E$F$Y$86.18$KG$20240731$$MD$US$US
241573481$24157348$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA222638$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240731$$MD$US$US
241573491$24157349$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA221184$SANOFI AVENTIS$$$$A$F$Y$95.2$KG$20240731$$MD$US$US
241573502$24157350$2$F$20240724$20240809$20240731$20240821$PER$$US-SA-2024SA221337$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240822$$MD$US$US
241573512$24157351$2$F$20240724$20240725$20240731$20240806$PER$$US-SA-2024SA221288$SANOFI AVENTIS$$28$YR$A$F$Y$184$KG$20240806$$MD$US$US
241573521$24157352$1$I$$20240731$20240731$20240731$DIR$712185$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241573531$24157353$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA223468$SANOFI AVENTIS$$$$$$Y$$$20240731$$MD$US$US
241573541$24157354$1$I$20240725$20240725$20240731$20240731$PER$$US-SA-2024SA223629$SANOFI AVENTIS$$$$E$F$Y$$$20240731$$MD$US$US
241573551$24157355$1$I$$20240725$20240731$20240731$PER$$US-SA-2024SA222110$SANOFI AVENTIS$$$$A$$Y$$$20240731$$HP$US$US
241573561$24157356$1$I$20240201$20240725$20240731$20240731$PER$$US-SA-2024SA221743$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240731$$MD$US$US
241573571$24157357$1$I$$20240725$20240731$20240731$PER$$US-SA-2024SA223423$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240731$$CN$US$US
241573581$24157358$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA221692$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240731$$MD$US$US
241573591$24157359$1$I$$20240725$20240731$20240731$PER$$US-SA-2024SA221746$SANOFI AVENTIS$$$$$$Y$$$20240731$$HP$US$US
241573601$24157360$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA182860$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240731$$MD$US$US
241573611$24157361$1$I$$20240731$20240731$20240731$DIR$712192$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241573621$24157362$1$I$20240725$20240725$20240731$20240731$PER$$US-SA-2024SA221959$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240731$$MD$US$US
241573631$24157363$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221395$SANOFI AVENTIS$$$$C$M$Y$$$20240731$$MD$US$US
241573641$24157364$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221212$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240731$$MD$US$US
241573651$24157365$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA221118$SANOFI AVENTIS$$1$YR$I$F$Y$9.5$KG$20240731$$MD$US$US
241573661$24157366$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA223620$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240731$$MD$US$US
241573671$24157367$1$I$$20240725$20240731$20240731$PER$$US-SA-2024SA221121$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240731$$MD$US$US
241573681$24157368$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA219861$SANOFI AVENTIS$$14$YR$T$M$Y$42.086$KG$20240731$$MD$US$US
241573692$24157369$2$F$20240725$20240827$20240731$20240903$PER$$US-SA-2024SA223789$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240903$$MD$US$US
241573702$24157370$2$F$20240728$20240729$20240731$20240807$PER$$US-SA-2024SA224854$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240807$$MD$US$US
241573713$24157371$3$F$20240101$20240820$20240731$20240902$PER$$US-SA-2024SA223118$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240902$$CN$US$US
241573721$24157372$1$I$$20240726$20240731$20240731$PER$$US-SA-2024SA126136$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240731$$MD$US$US
241573731$24157373$1$I$20240722$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52410$$FDA-CTU$$73$YR$$M$N$68.6$KG$20240730$N$$US$
241573742$24157374$2$F$20240101$20240726$20240731$20240807$PER$$US-SA-2024SA222192$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240807$$MD$US$US
241573751$24157375$1$I$$20240726$20240731$20240731$PER$$US-SA-2024SA224270$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240731$$MD$US$US
241573761$24157376$1$I$$20240726$20240731$20240731$PER$$US-SA-2024SA223461$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240731$$CN$US$US
241573771$24157377$1$I$$20240726$20240731$20240731$PER$$US-SA-2024SA222101$SANOFI AVENTIS$$$$A$F$Y$$$20240731$$HP$US$US
241573782$24157378$2$F$20240725$20240815$20240731$20240827$PER$$US-SA-2024SA219000$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240827$$HP$US$US
241573793$24157379$3$F$20240101$20240730$20240731$20240808$PER$$US-SA-2024SA219047$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240808$$CN$US$US
241573801$24157380$1$I$$20240731$20240731$20240731$DIR$712186$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241573811$24157381$1$I$20240707$20240729$20240731$20240731$DIR$FDA-CDER-CTU-2024-52439$$FDA-CTU$$76$YR$$F$N$$$20240729$N$HP$US$
241573821$24157382$1$I$20240424$20240425$20240731$20240731$PER$$US-BAYER-2024A092483$BAYER$$$$$F$Y$$$20240731$$MD$US$US
241573832$24157383$2$F$$20240724$20240731$20240805$EXP$$US-BIOGEN-2024BI01275941$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
241573841$24157384$1$I$$20240722$20240731$20240731$EXP$$AR-SA-2024SA222467$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240731$$MD$AR$AR
241573861$24157386$1$I$20230301$20240212$20240731$20240731$PER$$US-BAYER-2024A091393$BAYER$$16$YR$T$F$Y$$$20240731$$MD$US$US
241573871$24157387$1$I$20240714$20240729$20240731$20240731$EXP$$US-ABBVIE-5860337$ABBVIE$$41$YR$$M$Y$$$20240731$$CN$US$US
241573881$24157388$1$I$$20240725$20240731$20240731$PER$$NVSC2024US153911$NOVARTIS$$43$YR$$$Y$$$20240731$$CN$US$US
241573895$24157389$5$F$$20240919$20240731$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023024$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240927$$$US$US
241573901$24157390$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA223509$SANOFI AVENTIS$$$$A$F$Y$79.365$KG$20240731$$MD$US$US
241573911$24157391$1$I$$20240725$20240731$20240731$PER$$US-SA-2024SA222432$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240731$$MD$US$US
241573921$24157392$1$I$$20240726$20240731$20240731$EXP$$CA-AstraZeneca-2024A172481$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$CA$
241573932$24157393$2$F$$20240726$20240731$20240802$EXP$$US-AstraZeneca-2024A171641$ASTRAZENECA$$51$YR$$M$Y$83.5$KG$20240802$$MD$US$
241573942$24157394$2$F$20240101$20240724$20240731$20240802$PER$$US-SA-2024SA219281$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240802$$MD$US$US
241573952$24157395$2$F$20240404$20240819$20240731$20240820$EXP$PT-INFARMED-J202407-152$PT-ROCHE-10000041573$ROCHE$$37$YR$A$M$Y$$$20240820$$MD$PT$PT
241573962$24157396$2$F$$20240830$20240731$20240830$30DAY$$US-PFIZER INC-202400223617$PFIZER$$13$YR$$M$Y$45.36$KG$20240830$$CN$US$US
241573971$24157397$1$I$20240213$20240213$20240731$20240731$PER$$US-BAYER-2024A091406$BAYER$$$$$F$Y$$$20240731$$MD$US$US
241573981$24157398$1$I$20240101$20240723$20240731$20240731$EXP$$US-SA-2024SA221131$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240731$$CN$US$US
241573991$24157399$1$I$$20240702$20240731$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06351$LUPIN$$$$$$Y$$$20240731$$CN$US$US
241574001$24157400$1$I$$20240729$20240731$20240731$PER$$NVSC2024US156074$NOVARTIS$$81$YR$$F$Y$$$20240731$$CN$US$US
241574011$24157401$1$I$20240723$20240724$20240731$20240731$EXP$GB-MHRA-MED-202407241113464250-NKMQV$GB-PERRIGO-24GB007020$PERRIGO$$70$YR$$F$Y$$$20240731$$CN$GB$GB
241574022$24157402$2$F$20240719$20240801$20240731$20240809$EXP$GB-MHRA-TPP54847959C10408146YC1721386483902$GB-PERRIGO-24GB006832$PERRIGO$$41$YR$$M$Y$100$KG$20240809$$MD$GB$GB
241574032$24157403$2$F$$20240801$20240731$20240809$EXP$GB-MHRA-MED-202407232209444480-NGZPL$GB-PERRIGO-24GB006968$PERRIGO$$32$YR$$F$Y$$$20240809$$MD$GB$GB
241574041$24157404$1$I$$20240722$20240731$20240731$EXP$GB-MHRA-MED-202407221100182840-MSGHK$GB-PERRIGO-24GB006898$PERRIGO$$$$$F$Y$$$20240731$$HP$GB$GB
241574051$24157405$1$I$20240209$20240213$20240731$20240731$PER$$US-BAYER-2024A091442$BAYER$$27$YR$A$F$Y$$$20240731$$CN$US$US
241574061$24157406$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA222590$SANOFI AVENTIS$$$$A$M$Y$60.3$KG$20240731$$MD$US$US
241574071$24157407$1$I$$20240724$20240731$20240731$EXP$$US-SA-2024SA221257$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240731$$MD$US$US
241574082$24157408$2$F$$20240807$20240731$20240821$EXP$$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2024-019335$VALIDUS$$$$$$Y$$$20240821$$HP$CA$CA
241574091$24157409$1$I$20240720$20240724$20240731$20240731$PER$$US-SA-2024SA221251$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240731$$MD$US$US
241574101$24157410$1$I$$20240716$20240731$20240731$EXP$$ES-GLANDPHARMA-ES-2024GLNLIT00570$GLAND PHARMA$Rosa Alvarez.Prolonged survival of a patient with  desmoplastic small round cell tumor.Cancer and Chemotherapy Reviews.2022;17(3):41-46$34$YR$A$M$Y$$$20240731$$HP$ES$ES
241574111$24157411$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221991$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240731$$MD$US$US
241574122$24157412$2$F$$20240817$20240731$20240822$EXP$$US-SA-2024SA225199$SANOFI AVENTIS$$$$A$F$Y$$$20240822$$MD$US$US
241574131$24157413$1$I$20240518$20240723$20240731$20240731$EXP$GB-MHRA-30896361$GB-ROCHE-10000034221$ROCHE$$79$YR$E$$Y$83$KG$20240731$$CN$GB$GB
241574141$24157414$1$I$$20240730$20240731$20240731$PER$$US-GILEAD-2024-0682349$GILEAD$$$$A$$Y$$$20240731$$CN$US$US
241574151$24157415$1$I$20240519$20240620$20240731$20240731$EXP$$CO-GILEAD-2024-0682115$GILEAD$$73$YR$E$M$Y$65$KG$20240731$$HP$CO$CO
241574161$24157416$1$I$$20240723$20240731$20240731$PER$$US-ABBVIE-5852803$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241574171$24157417$1$I$$20240724$20240731$20240731$PER$$US-ABBVIE-5854433$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241574181$24157418$1$I$$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024149049$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241574191$24157419$1$I$$20240725$20240731$20240731$EXP$$CA-AMGEN-CANSP2024149155$AMGEN$$78$YR$E$M$Y$$$20240731$$CN$CA$CA
241574202$24157420$2$F$20240728$20240801$20240731$20240806$PER$$US-AMGEN-USASP2024150865$AMGEN$$82$YR$E$F$Y$$$20240806$$HP$US$US
241574211$24157421$1$I$$20240717$20240731$20240731$PER$$US-Calliditas-2024CAL01347$CALLIDITAS THERAPEUTICS$$35$YR$A$F$Y$62.59$KG$20240731$$CN$US$US
241574221$24157422$1$I$20240212$20240214$20240731$20240731$PER$$US-BAYER-2024A091405$BAYER$$22$YR$A$F$Y$$$20240731$$MD$US$US
241574231$24157423$1$I$$20240702$20240731$20240731$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06641$LUPIN$$51$YR$$$Y$$$20240731$$CN$US$US
241574241$24157424$1$I$20240101$20240722$20240731$20240731$EXP$FR-AFSSAPS-PB2024000777$FR-TEVA-VS-3224907$TEVA$$42$YR$$F$Y$57$KG$20240731$$PH$FR$FR
241574251$24157425$1$I$$20240730$20240731$20240731$EXP$$PL-ORGANON-O2407POL002855$ORGANON$$58$YR$$F$Y$$$20240731$$PH$PL$PL
241574261$24157426$1$I$20240214$20240215$20240731$20240731$PER$$US-BAYER-2024A091435$BAYER$$23$YR$A$F$Y$$$20240731$$MD$US$US
241574271$24157427$1$I$20240727$20240728$20240731$20240731$PER$$US-PFIZER INC-202400225469$PFIZER$$71$YR$$M$Y$$$20240731$$CN$US$US
241574281$24157428$1$I$$20240731$20240731$20240731$DIR$712188$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241574291$24157429$1$I$$20240731$20240731$20240731$DIR$712193$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241574301$24157430$1$I$20240722$20240727$20240731$20240731$PER$$US-PFIZER INC-202400225483$PFIZER$$77$YR$$F$Y$$$20240731$$CN$US$US
241574311$24157431$1$I$$20240731$20240731$20240731$DIR$712187$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241574321$24157432$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-PV202400098227$PFIZER$$41$YR$$F$Y$$$20240731$$CN$US$US
241574341$24157434$1$I$$20240731$20240731$20240731$DIR$712189$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241574351$24157435$1$I$20240601$20240726$20240731$20240731$PER$$US-PFIZER INC-202400225586$PFIZER$$51$YR$$F$Y$$$20240731$$CN$US$US
241574362$24157436$2$F$20240626$20240730$20240731$20240731$EXP$$US-JNJFOC-20240772958$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241574372$24157437$2$F$$20240805$20240731$20240813$EXP$$IT-JNJFOC-20240763560$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$IT$IT
241574381$24157438$1$I$$20240716$20240731$20240731$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00571$GLAND PHARMA$S Furukawa.A Case of Consciousness Disorder Due to Hyperammonemia Induced by Modified FOLFOX6 for Multiple Liver Metastasis from Rectal Cancer.Gan to Kagaku Ryoho.MAY-2024;51 No.5:567-570$74$YR$E$M$Y$$$20240731$$HP$JP$JP
241574391$24157439$1$I$$20240724$20240731$20240731$EXP$$IT-GSK-IT2024EME093309$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$IT$IT
241574401$24157440$1$I$20240214$20240220$20240731$20240731$PER$$US-BAYER-2024A091418$BAYER$$35$YR$A$F$Y$$$20240731$$MD$US$US
241574411$24157441$1$I$$20240726$20240731$20240731$EXP$$US-SA-2024SA224865$SANOFI AVENTIS$$22$MON$I$M$Y$$$20240731$$CN$US$US
241574421$24157442$1$I$$20240726$20240731$20240731$EXP$$US-SA-2024SA224783$SANOFI AVENTIS$$75$YR$E$F$Y$60.7$KG$20240731$$MD$US$US
241574433$24157443$3$F$20240719$20240821$20240731$20240826$EXP$$ES-CHIESI-2024CHF04584$CHIESI$$0$YR$$F$Y$$$20240826$$PH$ES$ES
241574441$24157444$1$I$$20240725$20240731$20240731$PER$$US-RDY-SPO/USA/24/0011125$DR REDDYS$$19$YR$A$M$Y$$$20240731$$MD$US$US
241574451$24157445$1$I$$20240724$20240731$20240731$PER$$US-RDY-SPO/USA/24/0011052$DR REDDYS$$29$YR$A$$Y$$$20240731$$MD$US$US
241574461$24157446$1$I$20240501$20240724$20240731$20240731$PER$$US-SA-2024SA221874$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240731$$MD$US$US
241574471$24157447$1$I$20190124$20240722$20240731$20240731$EXP$$CN-RDY-LIT/CHN/24/0010996$DR REDDYS$Sun L, Gao Y, Bin S, Li M. Atypical antipsychotic drugs with strong alpha 1 receptor antagonism resulting in self-perceived hot in patients with schizophrenia:a case report. Sichuan Mental Health. 37(3): doi:10.1186/s12348-023-00372-z.$31$YR$A$M$Y$$$20240731$$HP$CN$CN
241574481$24157448$1$I$20240726$20240726$20240731$20240731$EXP$$US-OTSUKA-2024_020945$OTSUKA$$$$$F$Y$$$20240731$$HP$US$US
241574491$24157449$1$I$$20240725$20240731$20240731$EXP$GB-MHRA-MIDB-79dd5f53-180a-4b96-bf8d-5d7b52b82726$GB-LABORATORIOS LICONSA S.A.-2407GB05959$INSUD PHARMA$$56$YR$$$Y$$$20240731$$PH$GB$GB
241574501$24157450$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5857014$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241574511$24157451$1$I$20240219$20240221$20240731$20240731$PER$$US-BAYER-2024A091464$BAYER$$$$$F$Y$$$20240731$$MD$US$US
241574521$24157452$1$I$20240101$20240725$20240731$20240731$EXP$$CA-ABBVIE-5857368$ABBVIE$$54$YR$$F$Y$$$20240731$$CN$CA$CA
241574541$24157454$1$I$$20240716$20240731$20240731$PER$$US-GLANDPHARMA-US-2024GLNSPO00525$GLAND PHARMA$$$$$M$Y$$$20240731$$HP$US$US
241574551$24157455$1$I$20230803$20240723$20240731$20240731$EXP$$DE-ROCHE-3544448$ROCHE$$39$YR$A$F$Y$$$20240731$$MD$DE$DE
241574562$24157456$2$F$20231230$20240812$20240731$20240819$EXP$$CN-ABBVIE-5857645$ABBVIE$$61$YR$$M$Y$75$KG$20240819$$MD$CN$CN
241574572$24157457$2$F$$20240722$20240731$20240906$EXP$$PT-BAYER-2024A107424$BAYER$$15$YR$T$F$Y$$$20240906$$MD$PT$PT
241574582$24157458$2$F$$20240801$20240731$20240809$PER$$US-ROCHE-10000041390$ROCHE$$$$A$M$Y$$$20240809$$CN$US$US
241574591$24157459$1$I$20240101$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018090$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240731$$CN$US$US
241574601$24157460$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151461$AMGEN$$59$YR$A$M$Y$93.9$KG$20240731$$MD$US$US
241574611$24157461$1$I$$20240716$20240731$20240731$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00572$GLAND PHARMA$K Tanimura.Surgical site infection caused by Rhizopus caespitosus after metastasectomy for osteosarcoma: First report of infection in humans.Pediatric Blood and Cancer.APR-2023;70: No. 4$11$YR$C$M$Y$$$20240731$$HP$JP$JP
241574622$24157462$2$F$20240326$20240809$20240731$20240814$EXP$$CA-JNJFOC-20240478026$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240814$$HP$CA$CA
241574641$24157464$1$I$20240113$20240221$20240731$20240731$PER$$US-BAYER-2024A091468$BAYER$$29$YR$A$F$Y$$$20240731$$MD$US$US
241574651$24157465$1$I$20240628$20240731$20240731$20240731$DIR$712202$$FDA-CTU$$73$YR$$M$N$53.3$KG$20240731$N$HP$US$
241574661$24157466$1$I$$20240730$20240731$20240731$PER$$US-GILEAD-2024-0682411$GILEAD$$$$$F$Y$$$20240731$$CN$US$US
241574671$24157467$1$I$$20240725$20240731$20240731$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15055$IPSEN$$$$$$Y$$$20240731$$MD$US$US
241574681$24157468$1$I$$20240731$20240731$20240731$DIR$712203$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241574691$24157469$1$I$20240703$20240731$20240731$20240731$DIR$712205$$FDA-CTU$$72$YR$$F$N$56.8$KG$20240731$N$HP$US$
241574701$24157470$1$I$20240730$20240731$20240731$20240731$DIR$712204$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241574711$24157471$1$I$20240228$20240229$20240731$20240731$PER$$US-BAYER-2024A091500$BAYER$$21$YR$A$F$Y$$$20240731$$MD$US$US
241574731$24157473$1$I$20240703$20240731$20240731$20240731$DIR$712208$$FDA-CTU$$72$YR$$F$N$56.8$KG$20240731$N$HP$US$
241574741$24157474$1$I$20240725$20240731$20240731$20240731$DIR$712209$$FDA-CTU$$74$YR$$F$N$$$20240731$Y$HP$US$
241574751$24157475$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A169696$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241574761$24157476$1$I$$20240607$20240731$20240731$PER$$US-AstraZeneca-2024A173901$ASTRAZENECA$$$$$$Y$$$20240731$$MD$US$
241574771$24157477$1$I$20240601$20240723$20240731$20240731$EXP$$FR-AstraZeneca-2024A169765$ASTRAZENECA$$33317$DY$$F$Y$$$20240731$$CN$FR$
241574781$24157478$1$I$$20240723$20240731$20240731$EXP$$GB-AstraZeneca-2024A167482$ASTRAZENECA$$65$YR$$F$Y$$$20240731$$MD$GB$
241574791$24157479$1$I$20240223$20240301$20240731$20240731$PER$$US-BAYER-2024A091520$BAYER$$39$YR$A$F$Y$$$20240731$$CN$US$US
241574801$24157480$1$I$20240305$20240730$20240731$20240731$EXP$GR-GREOF-202400829$GR-ORGANON-O2407GRC002869$ORGANON$$40$YR$$M$Y$85$KG$20240731$$MD$GR$GR
241574811$24157481$1$I$20240329$20240416$20240731$20240731$PER$$US-BAYER-2024A092409$BAYER$$$$$F$Y$$$20240731$$MD$US$US
241574821$24157482$1$I$20240611$20240716$20240731$20240731$PER$$US-COSETTE-CP2024US000185$COSETTE PHARMACEUTICALS$$44$YR$A$F$Y$142$KG$20240731$$PH$US$US
241574831$24157483$1$I$20240701$20240730$20240731$20240731$PER$$PR-JNJFOC-20240782923$JOHNSON AND JOHNSON$$78$YR$E$M$Y$73.03$KG$20240731$$CN$PR$PR
241574841$24157484$1$I$20240624$20240724$20240731$20240731$EXP$$JP-ARGENX-2024-ARGX-JP005061$ARGENX BVBA$$$$$$Y$$$20240731$$MD$JP$JP
241574851$24157485$1$I$20240213$20240301$20240731$20240731$PER$$US-BAYER-2024A091534$BAYER$$29$YR$A$F$Y$$$20240731$$MD$US$US
241574861$24157486$1$I$$20240724$20240731$20240731$EXP$$CA-GSK-CA2024AMR093155$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$CA$CA
241574871$24157487$1$I$20240504$20240729$20240731$20240731$EXP$FR-AFSSAPS-PP2024000810$FR-FreseniusKabi-FK202411826$FRESENIUS KABI$$80$YR$E$M$Y$$$20240731$$MD$FR$FR
241574881$24157488$1$I$20240701$20240729$20240731$20240731$EXP$FR-AFSSAPS-GR2024000930$FR-FreseniusKabi-FK202411821$FRESENIUS KABI$$74$YR$E$F$Y$$$20240731$$PH$FR$FR
241574891$24157489$1$I$$20240729$20240731$20240731$EXP$FR-AFSSAPS-RE2024000752$FR-FreseniusKabi-FK202411865$FRESENIUS KABI$$74$YR$E$F$Y$$$20240731$$HP$FR$FR
241574901$24157490$1$I$$20240716$20240731$20240731$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00558$GLAND PHARMA$$72$YR$E$F$Y$$$20240731$$MD$JP$JP
241574911$24157491$1$I$20231227$20240729$20240731$20240731$EXP$FR-AFSSAPS-NY2024000829$FR-FreseniusKabi-FK202411824$FRESENIUS KABI$$58$YR$A$F$Y$77$KG$20240731$$HP$FR$FR
241574921$24157492$1$I$$20240723$20240731$20240731$PER$$US-FreseniusKabi-FK202411643$FRESENIUS KABI$$73$YR$E$M$Y$$$20240731$$MD$US$US
241574931$24157493$1$I$20240428$20240723$20240731$20240731$EXP$$CN-FreseniusKabi-FK202411688$FRESENIUS KABI$$85$YR$E$M$Y$54$KG$20240731$$HP$CN$CN
241574941$24157494$1$I$20240614$20240729$20240731$20240731$EXP$FR-AFSSAPS-NC2024000893$FR-FreseniusKabi-FK202411864$FRESENIUS KABI$$69$YR$E$M$Y$60$KG$20240731$$MD$FR$FR
241574951$24157495$1$I$$20240729$20240731$20240731$EXP$$PT-FreseniusKabi-FK202411894$FRESENIUS KABI$$71$YR$E$M$Y$$$20240731$$MD$PT$PT
241574961$24157496$1$I$$20240719$20240731$20240731$EXP$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01114$TARO$Khalil H, Cota D. MULTIORGAN FAILURE FROM IVERMECTIN AND DEET TOXICITY CONCEALED BEHIND ALCOHOL WITHDRAWAL. Crit Care Med. 2024;52 (Suppl.) (1):S440$$$$$Y$$$20240731$$HP$US$US
241574971$24157497$1$I$$20240725$20240731$20240731$EXP$$CA-TAKEDA-2023TUS063868$TAKEDA$$$$$M$Y$$$20240731$$CN$CA$CA
241574982$24157498$2$F$20240206$20240806$20240731$20240809$EXP$$CA-ROCHE-3506603$ROCHE$$41$YR$A$F$Y$$$20240809$$HP$CA$CA
241574991$24157499$1$I$$20240729$20240731$20240731$EXP$$CA-ROCHE-10000042451$ROCHE$$$$A$F$Y$$$20240731$$CN$CA$CA
241575001$24157500$1$I$$20240611$20240731$20240731$EXP$$US-NOVOPROD-1260663$NOVO NORDISK$$$$$F$Y$$$20240731$$MD$US$US
241575011$24157501$1$I$$20240717$20240731$20240731$EXP$$CO-NOVOPROD-1258773$NOVO NORDISK$$$$$M$Y$83$KG$20240731$$CN$CO$CO
241575021$24157502$1$I$20240715$20240716$20240731$20240731$PER$$US-COSETTE-CP2024US000186$COSETTE PHARMACEUTICALS$$55$YR$A$F$Y$125$KG$20240731$$CN$US$US
241575032$24157503$2$F$20240501$20240726$20240731$20240806$PER$$US-SA-2024SA221969$SANOFI AVENTIS$$18$YR$A$M$Y$99$KG$20240806$$MD$US$US
241575041$24157504$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA218578$SANOFI AVENTIS$$$$C$F$Y$49.71$KG$20240731$$MD$US$US
241575051$24157505$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA219813$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240731$$CN$US$US
241575061$24157506$1$I$20240723$20240723$20240731$20240731$PER$$US-SA-2024SA220831$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240731$$MD$US$US
241575071$24157507$1$I$20240701$20240722$20240731$20240731$EXP$$JP-009507513-2407JPN004005J$MERCK$$87$YR$$M$Y$$$20240731$$MD$JP$JP
241575081$24157508$1$I$$20240723$20240731$20240731$EXP$$DE-009507513-2407DEU014429$MERCK$$$$$F$Y$$$20240731$$MD$DE$DE
241575092$24157509$2$F$$20240821$20240731$20240822$PER$$US-ALXN-202407USA001950US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$HP$US$US
241575101$24157510$1$I$20240706$20240731$20240731$20240731$DIR$712211$$FDA-CTU$$60$YR$$M$N$$$20240731$Y$HP$US$
241575111$24157511$1$I$$20240731$20240731$20240731$DIR$712212$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241575121$24157512$1$I$20240727$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52473$$FDA-CTU$$92$YR$$M$N$$$20240730$N$HP$US$
241575131$24157513$1$I$20240729$20240731$20240731$20240731$DIR$712190$$FDA-CTU$$86$YR$$F$N$$$20240731$N$$US$
241575141$24157514$1$I$$20240731$20240731$20240731$DIR$712213$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241575153$24157515$3$F$20240301$20240904$20240731$20240906$PER$$US-BAYER-2024A091888$BAYER$$28$YR$A$F$Y$$$20240906$$MD$US$US
241575162$24157516$2$F$20240531$20240821$20240731$20240830$EXP$FR-AFSSAPS-LL2024001297$FR-TEVA-VS-3223390$TEVA$$73$YR$$F$Y$58$KG$20240830$$MD$FR$FR
241575171$24157517$1$I$20240723$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52406$$FDA-CTU$$29$MON$$F$N$18.5$KG$20240730$N$$US$
241575181$24157518$1$I$20240417$20240417$20240731$20240731$PER$$US-BAYER-2024A092410$BAYER$$45$YR$A$F$Y$$$20240731$$MD$US$US
241575191$24157519$1$I$$20240728$20240731$20240731$PER$$NVSC2024US155571$NOVARTIS$$$$$$Y$$$20240731$$CN$US$US
241575201$24157520$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5860358$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241575212$24157521$2$F$20240314$20240816$20240731$20240823$PER$$US-BAYER-2024A091974$BAYER$$20$YR$A$F$Y$48.526$KG$20240823$$CN$US$US
241575221$24157522$1$I$20240712$20240725$20240731$20240731$EXP$$US-BAYER-2024A104268$BAYER$$75$YR$E$M$Y$75.283$KG$20240731$$CN$US$US
241575231$24157523$1$I$$20240716$20240731$20240731$EXP$$IN-GLANDPHARMA-IN-2024GLNLIT00561$GLAND PHARMA$Anitha Ramkumar.Unraveling the link between severe  bradycardia and paraquat poisoning .Clinical and Experimental Emergency Medicine.2024;11(1):117-119$32$YR$A$M$Y$$$20240731$$HP$IN$IN
241575241$24157524$1$I$20240716$20240726$20240731$20240731$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006362$AURINIA PHARMACEUTICALS$$45$YR$$M$Y$$$20240731$$CN$US$US
241575251$24157525$1$I$20240719$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024151774$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241575261$24157526$1$I$20240223$20240724$20240731$20240731$EXP$FR-AFSSAPS-AVMA2024000329$FR-Waylis Therapeutics LLC-ATNAHS20240702139$Waylis$$63$YR$A$M$Y$$$20240730$$PH$FR$FR
241575273$24157527$3$F$20240701$20240814$20240731$20240819$PER$$US-AMGEN-USASP2024151394$AMGEN$$63$YR$A$F$Y$$$20240819$$PH$US$US
241575281$24157528$1$I$20240101$20240729$20240731$20240731$EXP$$US-ABBVIE-5765241$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241575291$24157529$1$I$20240523$20240722$20240731$20240731$EXP$FR-AFSSAPS-NT2024000800$FR-TEVA-VS-3224826$TEVA$$79$YR$$F$Y$$$20240731$$MD$FR$FR
241575301$24157530$1$I$20240701$20240726$20240731$20240731$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006363$AURINIA PHARMACEUTICALS$$46$YR$$F$Y$$$20240731$$CN$US$US
241575311$24157531$1$I$$20240730$20240731$20240731$PER$$NVSC2024US156378$NOVARTIS$$$$$$Y$$$20240731$$MD$US$US
241575321$24157532$1$I$20240110$20240315$20240731$20240731$PER$$US-BAYER-2024A092002$BAYER$$22$YR$A$F$Y$$$20240731$$MD$US$US
241575331$24157533$1$I$20240313$20240417$20240731$20240731$PER$$US-BAYER-2024A092413$BAYER$$47$YR$A$F$Y$$$20240731$$HP$US$US
241575342$24157534$2$F$20240222$20240923$20240731$20240927$PER$$US-BAYER-2024A092014$BAYER$$30$YR$A$F$Y$121$KG$20240927$$HP$US$US
241575352$24157535$2$F$$20240809$20240731$20240815$EXP$$FR-Waylis Therapeutics LLC-ATNAHS20240702112$Waylis$$$$$F$Y$$$20240815$$MD$FR$FR
241575361$24157536$1$I$$20240729$20240731$20240731$PER$$US-ABBVIE-5859462$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241575373$24157537$3$F$20240727$20240919$20240731$20240920$PER$$US-AMGEN-USASP2024150825$AMGEN$$74$YR$E$F$Y$$$20240920$$MD$US$US
241575381$24157538$1$I$$20240726$20240731$20240731$EXP$$NVSC2024BE155014$NOVARTIS$$$$A$F$Y$$$20240731$$MD$BE$BE
241575391$24157539$1$I$20240101$20240723$20240731$20240731$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003567$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$CA$CA
241575402$24157540$2$F$20210401$20240822$20240731$20240829$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003572$CURRAX PHARMACEUTICALS$$67$YR$$F$Y$85.714$KG$20240829$$CN$CA$CA
241575411$24157541$1$I$20240313$20240318$20240731$20240731$PER$$US-BAYER-2024A092108$BAYER$$32$YR$A$F$Y$$$20240731$$MD$US$US
241575421$24157542$1$I$20240417$20240418$20240731$20240731$PER$$US-BAYER-2024A092419$BAYER$$35$YR$A$F$Y$$$20240731$$MD$US$US
241575431$24157543$1$I$$20240716$20240731$20240731$EXP$$CA-GLANDPHARMA-CA-2024GLNLIT00564$GLAND PHARMA$Brittany Salter.Concurrent BCR-ABL1 and core binding factor beta rearrangement in de novo acute myeloid leukemia: A case report and review of literature.eJHaem.JUN-2024;5:607-615$62$YR$A$M$Y$$$20240731$$HP$CA$CA
241575441$24157544$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5859894$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241575451$24157545$1$I$$20210804$20240731$20240731$EXP$$US-AstraZeneca-2021A668353$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241575461$24157546$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A171696$ASTRAZENECA$$$$$M$Y$$$20240731$$HP$US$
241575471$24157547$1$I$20240722$20240726$20240731$20240731$EXP$$RO-AstraZeneca-2024A172450$ASTRAZENECA$$89$YR$$M$Y$$$20240731$$MD$RO$
241575481$24157548$1$I$20240716$20240729$20240731$20240731$EXP$$US-ABBVIE-5860105$ABBVIE$$77$YR$$F$Y$$$20240731$$CN$US$US
241575491$24157549$1$I$$20220720$20240731$20240731$EXP$$US-AstraZeneca-2022A228591$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241575501$24157550$1$I$20240608$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150442$AMGEN$$60$YR$A$M$Y$$$20240731$$PH$US$US
241575511$24157551$1$I$$20230331$20240731$20240731$EXP$$US-NOVOPROD-1245695$NOVO NORDISK$$75$YR$$$Y$$$20240731$$CN$US$US
241575521$24157552$1$I$$20230526$20240731$20240731$EXP$$US-NOVOPROD-1245451$NOVO NORDISK$$72$YR$$$Y$$$20240731$$CN$US$US
241575531$24157553$1$I$20240316$20240417$20240731$20240731$PER$$US-BAYER-2024A092423$BAYER$$17$YR$T$F$Y$$$20240731$$HP$US$US
241575542$24157554$2$F$20240313$20240812$20240731$20240822$PER$$US-BAYER-2024A092113$BAYER$$39$YR$A$F$Y$79.49$KG$20240822$$CN$US$US
241575551$24157555$1$I$20240201$20240726$20240731$20240731$EXP$$CN-009507513-2407CHN015728$MERCK$$$$A$F$Y$$$20240731$$MD$CN$CN
241575561$24157556$1$I$20221201$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019290$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240731$$CN$US$US
241575571$24157557$1$I$20240603$20240722$20240731$20240731$EXP$FR-AFSSAPS-LL2024001307$FR-TEVA-VS-3224730$TEVA$$75$YR$$M$Y$$$20240731$$MD$FR$FR
241575581$24157558$1$I$20240502$20240723$20240731$20240731$EXP$FR-AFSSAPS-AVLY2024000109$FR-Waylis Therapeutics LLC-ATNAHS20240702113$Waylis$$25$YR$A$M$Y$59$KG$20240730$$MD$FR$FR
241575591$24157559$1$I$$20240725$20240731$20240731$PER$$US-SA-2024SA221637$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240731$$CN$US$US
241575602$24157560$2$F$$20240813$20240731$20240820$EXP$$AT-TAKEDA-2024TUS076054$TAKEDA$$66$YR$$F$Y$$$20240820$$MD$AT$AT
241575622$24157562$2$F$20240721$20240730$20240731$20240821$EXP$$ES-TEVA-VS-3225007$TEVA$$54$YR$$F$Y$$$20240821$$CN$ES$ES
241575632$24157563$2$F$20240320$20240929$20240731$20240930$EXP$$US-BAYER-2024A092140$BAYER$$47$YR$A$F$Y$$$20240930$$CN$US$US
241575641$24157564$1$I$$20240726$20240731$20240731$EXP$$US-SA-2024SA224807$SANOFI AVENTIS$$$$A$F$Y$89.35$KG$20240731$$MD$US$US
241575651$24157565$1$I$20240324$20240418$20240731$20240731$PER$$US-BAYER-2024A092430$BAYER$$22$YR$A$F$Y$$$20240731$$MD$US$US
241575661$24157566$1$I$20240101$20240729$20240731$20240731$PER$$US-ABBVIE-5860433$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241575671$24157567$1$I$$20240729$20240731$20240731$PER$$US-ORGANON-O2407USA002858$ORGANON$$$$$F$Y$$$20240731$$CN$US$US
241575681$24157568$1$I$$20240716$20240731$20240731$EXP$$IT-GLANDPHARMA-IT-2024GLNLIT00543$GLAND PHARMA$F Fabozzi.Prolonged neutropenia in patients with lymphoma treated with antiretroviral therapy: Raltegravir too? A single-case report.Pediatric Blood and Cancer.APR-2023;70 (No.4)$6$YR$C$F$Y$$$20240731$$HP$IT$IT
241575691$24157569$1$I$20230627$20240726$20240731$20240731$EXP$GB-MHRA-MED-202407261409248220-KTYLD$GB-Atnahs Limited-ATNAHS20240702178$Atnahs Healthcare$$61$YR$A$F$Y$61$KG$20240731$$PH$GB$GB
241575701$24157570$1$I$20240306$20240308$20240731$20240731$PER$$US-BAYER-2024A091719$BAYER$$40$YR$A$F$Y$$$20240731$$HP$US$US
241575711$24157571$1$I$20240722$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150240$AMGEN$$78$YR$E$F$Y$$$20240731$$CN$US$US
241575721$24157572$1$I$20240101$20240726$20240731$20240731$EXP$$US-SA-2024SA224878$SANOFI AVENTIS$$$$$M$Y$$$20240731$$MD$US$US
241575732$24157573$2$F$20221130$20240813$20240731$20240814$EXP$IE-HPRA-2024-114389$IE-ORGANON-O2407IRL002872$ORGANON$$5$YR$$F$Y$$$20240814$$CN$IE$IE
241575741$24157574$1$I$$20240718$20240731$20240731$EXP$$US-RDY-LIT/USA/24/0010939$DR REDDYS$Walgamage M, Cuello LN, Walgamage T. Can MRSA Really Do That? A Rare Case of Acute Cholecystitis With MRSA Bacteremia. American Journal of Respiratory and Critical Care Medicine. 2024 May;209:$70$YR$E$F$Y$$$20240731$$HP$US$US
241575761$24157576$1$I$20240718$20240727$20240731$20240731$EXP$$NVSC2024CN156000$NOVARTIS$$73$YR$$F$Y$48$KG$20240731$$HP$CN$CN
241575771$24157577$1$I$$20240726$20240731$20240731$EXP$$BR-TAKEDA-2024TUS076551$TAKEDA$$10$YR$$$Y$$$20240731$$CN$BR$BR
241575781$24157578$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA221658$SANOFI AVENTIS$$$$A$M$Y$$$20240731$$MD$US$US
241575791$24157579$1$I$$20240722$20240731$20240731$EXP$GB-MHRA-MED-202407221123544330-SZRNY$GB-Atnahs Limited-ATNAHS20240702151$Atnahs Healthcare$$71$YR$E$F$Y$$$20240731$$HP$GB$GB
241575801$24157580$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA218852$SANOFI AVENTIS$$$$$$Y$$$20240731$$MD$US$US
241575813$24157581$3$F$$20240901$20240731$20240903$PER$$US-ALXN-202407USA001721US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
241575821$24157582$1$I$$20240716$20240731$20240731$EXP$$US-GLANDPHARMA-US-2024GLNLIT00546$GLAND PHARMA$Kimberly Levinson.Postmenopausal mixed gestational trophoblastic neoplasia with complete  response to immunotherapy A case report.Gynecologic Oncology Reports.APR-2023;46:1-4$66$YR$A$F$Y$$$20240731$$HP$US$US
241575831$24157583$1$I$20240301$20240306$20240731$20240731$PER$$US-BAYER-2024A091827$BAYER$$34$YR$A$F$Y$$$20240731$$HP$US$US
241575841$24157584$1$I$20240412$20240412$20240731$20240731$PER$$US-BAYER-2024A092408$BAYER$$41$YR$A$F$Y$$$20240731$$MD$US$US
241575851$24157585$1$I$20221026$20240724$20240731$20240731$EXP$$KR-GSK-KR2024GSK094550$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$KR$KR
241575861$24157586$1$I$20240728$20240729$20240731$20240731$PER$$US-HALEON-2189493$Haleon PLC$$20$YR$$F$Y$$$20240731$$CN$US$US
241575871$24157587$1$I$20240711$20240730$20240731$20240731$EXP$$CN-BAYER-2024A110542$BAYER$$56$YR$A$M$Y$$$20240731$$HP$CN$CN
241575881$24157588$1$I$$20240723$20240731$20240731$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07105$HIKMA$$$$$M$Y$$$20240731$$CN$US$US
241575891$24157589$1$I$$20240725$20240731$20240731$EXP$$NVSC2024DE155293$NOVARTIS$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S et al. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. BRITISH JOURNAL OF CANCER. 2023;128:1134-47.$$$$$Y$$$20240731$$HP$DE$DE
241575901$24157590$1$I$$20240716$20240731$20240731$EXP$$JP-AZURITY PHARMACEUTICALS, INC.-AZR202407-000132$AZURITY PHARMACEUTICALS$Fukumoto K, Watanabe R, Tsutsumi M, Takakuwa T, Miyamoto M, Hayashi N et al.. Lymphoproliferative disorder progressing after partial remission following immunosuppressive drugs withdrawal in a patient with rheumatoid arthritis. Mod Rheumatol Case Rep.. 2024;8:243-8$73$YR$$F$Y$$$20240731$$HP$JP$JP
241575911$24157591$1$I$$20240722$20240731$20240731$EXP$$KR-MEITHEAL-2024MPLIT00226$MEITHEAL PHARMACEUTICALS$Kim J, et al.Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report..Medicina.17-JUN-2024;60 (6):1-5$79$YR$E$M$Y$$$20240731$$HP$KR$KR
241575921$24157592$1$I$20240226$20240415$20240731$20240731$PER$$US-BAYER-2024A092385$BAYER$$39$YR$A$F$Y$$$20240731$$MD$US$US
241575931$24157593$1$I$20240412$20240415$20240731$20240731$PER$$US-BAYER-2024A092389$BAYER$$40$YR$A$F$Y$$$20240731$$HP$US$US
241575941$24157594$1$I$20220826$20240724$20240731$20240731$EXP$$KR-GSK-KR2024GSK094956$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$KR$KR
241575951$24157595$1$I$$20240722$20240731$20240731$EXP$$US-MEITHEAL-2024MPLIT00227$MEITHEAL PHARMACEUTICALS$Kuraitis D, et al..Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis.JAAD Case Reports.2024;50 (1):33-6$68$YR$A$M$Y$$$20240731$$MD$US$US
241575961$24157596$1$I$$20240731$20240731$20240731$DIR$712191$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241575971$24157597$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52464$$FDA-CTU$$78$YR$$F$N$76.66$KG$20240731$N$$US$
241575981$24157598$1$I$20231020$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52409$$FDA-CTU$$$$$M$N$109$KG$20240730$N$$US$
241575991$24157599$1$I$20240725$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52415$$FDA-CTU$$83$YR$$M$N$103$KG$20240730$N$$US$
241576001$24157600$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52460$$FDA-CTU$$$$$M$N$$$20240730$N$HP$US$
241576011$24157601$1$I$20240711$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52539$$FDA-CTU$$62$YR$$F$N$$$20240731$Y$HP$US$
241576022$24157602$2$F$20240318$20240806$20240731$20240816$PER$$US-BAYER-2024A092204$BAYER$$30$YR$A$F$Y$$$20240816$$MD$US$US
241576031$24157603$1$I$20230101$20240723$20240731$20240731$EXP$$BR-BIOGEN-2024BI01275840$BIOGEN$$$$$F$Y$85$KG$20240731$$CN$BR$BR
241576041$24157604$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA223619$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240731$$MD$US$US
241576051$24157605$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221840$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240731$$MD$US$US
241576061$24157606$1$I$$20240716$20240731$20240731$EXP$$RU-GLANDPHARMA-RU-2024GLNLIT00552$GLAND PHARMA$Dmitrii S. Bug.Safety, Feasibility, and Advantages of Oral Microbiota Transplantation: The First Clinical Case.Journal of Pediatric Hematology/Oncology.2024;00:1-10$6$MON$N$F$Y$9.3$KG$20240731$$MD$RU$RU
241576071$24157607$1$I$$20240729$20240731$20240731$EXP$GB-MHRA-MED-202407291047274410-QGHYD$GB-ABBVIE-5860240$ABBVIE$$$$$$Y$$$20240731$$MD$GB$GB
241576081$24157608$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A168211$ASTRAZENECA$$$$$$Y$$$20240731$$CN$US$
241576091$24157609$1$I$$20240722$20240731$20240731$EXP$$US-TEVA-VS-3225471$TEVA$Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.; Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.$13$YR$$M$Y$$$20240731$$HP$US$US
241576101$24157610$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52479$$FDA-CTU$$60$YR$$F$N$97.07$KG$20240731$N$$US$
241576111$24157611$1$I$20240726$20240730$20240731$20240731$PER$$US-PFIZER INC-202400227222$PFIZER$$70$YR$$F$Y$$$20240731$$HP$US$US
241576122$24157612$2$F$20240722$20240822$20240731$20240827$PER$$US-PFIZER INC-202400225882$PFIZER$$59$YR$$F$Y$60.04$KG$20240827$$CN$US$US
241576131$24157613$1$I$20240701$20240729$20240731$20240731$PER$$US-PFIZER INC-202400225877$PFIZER$$83$YR$$M$Y$$$20240731$$CN$US$US
241576141$24157614$1$I$$20240730$20240731$20240731$PER$$US-PFIZER INC-202400226844$PFIZER$$$$$M$Y$$$20240731$$MD$US$US
241576151$24157615$1$I$20240701$20240730$20240731$20240731$PER$$US-PFIZER INC-202400226798$PFIZER$$69$YR$$F$Y$$$20240731$$CN$US$US
241576161$24157616$1$I$20240720$20240729$20240731$20240731$PER$$US-PFIZER INC-202400225743$PFIZER$$59$YR$$F$Y$$$20240731$$CN$US$US
241576171$24157617$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-PV202400098988$PFIZER$$$$$$Y$$$20240731$$CN$US$US
241576182$24157618$2$F$20240101$20240807$20240731$20240812$PER$$US-PFIZER INC-PV202400099566$PFIZER$$61$YR$$F$Y$$$20240812$$HP$US$US
241576192$24157619$2$F$$20240729$20240731$20240802$PER$$US-PFIZER INC-202400225812$PFIZER$$51$YR$$F$Y$$$20240802$$CN$US$US
241576202$24157620$2$F$20240704$20240730$20240731$20240805$EXP$FI-FIMEA-202402668$FI-OTSUKA-2024_020762$OTSUKA$$31$YR$$F$Y$$$20240805$$CN$FI$FI
241576211$24157621$1$I$20240415$20240415$20240731$20240731$PER$$US-BAYER-2024A092392$BAYER$$30$YR$A$F$Y$$$20240731$$CN$US$US
241576221$24157622$1$I$20240415$20240415$20240731$20240731$PER$$US-BAYER-2024A092400$BAYER$$46$YR$A$F$Y$$$20240731$$CN$US$US
241576231$24157623$1$I$$20240724$20240731$20240731$PER$$US-AMGEN-USASP2024147674$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241576241$24157624$1$I$$20240722$20240731$20240731$EXP$$US-RDY-LIT/USA/24/0011022$DR REDDYS$Usman S, Ashraf A, Badar F, Iftikhar A. Evidence Based Management of Right Heart Failure in Intensive Care Unit: A Case Report. American Journal of Respiratory and Critical Care Medicine. 2023;207: A1785. doi:10.1164/ajrccm-conference.2023.A49.$93$YR$E$F$Y$$$20240731$$HP$US$US
241576251$24157625$1$I$$20240716$20240731$20240731$EXP$$DE-GLANDPHARMA-DE-2024GLNLIT00569$GLAND PHARMA$Samir Abu-Rumeileh.Posterior reversible encephalopathy syndrome associated with antibiotic therapy: a case report and systematic review.Neurological Sciences.29-APR-2024;1-10$55$YR$A$F$Y$$$20240731$$HP$DE$DE
241576264$24157626$4$F$20240815$20240904$20240731$20240909$EXP$$US-ALXN-202407USA001932US$ALEXION PHARMACEUTICALS$$21$YR$$F$Y$65.76$KG$20240909$$CN$US$US
241576271$24157627$1$I$$20240730$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042888$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240731$$CN$US$US
241576281$24157628$1$I$$20240730$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042940$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240731$$CN$US$US
241576291$24157629$1$I$$20240730$20240731$20240731$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042905$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240731$$MD$RU$RU
241576301$24157630$1$I$20240227$20240415$20240731$20240731$PER$$US-BAYER-2024A092402$BAYER$$28$YR$A$F$Y$$$20240731$$MD$US$US
241576311$24157631$1$I$20240309$20240311$20240731$20240731$PER$$US-BAYER-2024A091613$BAYER$$29$YR$A$F$Y$$$20240731$$MD$US$US
241576321$24157632$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221633$SANOFI AVENTIS$$$$E$F$Y$$$20240731$$MD$US$US
241576342$24157634$2$F$$20240905$20240731$20240912$EXP$$JP-009507513-2407JPN005035J$MERCK$$72$YR$$F$Y$$$20240912$$MD$JP$JP
241576351$24157635$1$I$$20240727$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018307$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$US$US
241576364$24157636$4$F$20240712$20240915$20240731$20240923$EXP$$ES-CHIESI-2024CHF04586$CHIESI$$0$YR$$F$Y$$$20240923$$PH$ES$ES
241576371$24157637$1$I$$20240721$20240731$20240731$EXP$$CH-TAKEDA-2024TUS076535$TAKEDA$$72$YR$$F$Y$$$20240731$$HP$CH$CH
241576381$24157638$1$I$$20240716$20240731$20240731$EXP$$IT-GLANDPHARMA-IT-2024GLNLIT00544$GLAND PHARMA$M. Malavasi.The Conundrum of Drug Interactions and Holter Monitoring: Lamin Gene Mutation Discovered by A Torsade De Pointes Episode Followed by Out-Of-The-Hospital Resuscitation.European Heart Journal Supplements.APR-2024;26(2):ii55-ii56$57$YR$A$F$Y$$$20240731$$HP$IT$IT
241576391$24157639$1$I$$20240730$20240731$20240731$PER$$US-AMGEN-USASP2024151881$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241576401$24157640$1$I$20240101$20240726$20240731$20240731$EXP$$US-AMGEN-USASP2024149452$AMGEN$$63$YR$A$M$Y$$$20240731$$HP$US$US
241576411$24157641$1$I$20240727$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150798$AMGEN$$60$YR$A$F$Y$$$20240731$$CN$US$US
241576421$24157642$1$I$$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024149027$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241576431$24157643$1$I$20240224$20240725$20240731$20240731$EXP$FR-AFSSAPS-NT2024000849$FR-MYLANLABS-2024M1069722$MYLAN$$15$YR$$M$Y$57$KG$20240731$$PH$FR$FR
241576443$24157644$3$F$20240506$20240822$20240731$20240828$EXP$DE-CADRBFARM-2024329376$DE-MYLANLABS-2024M1069743$MYLAN$$88$YR$$M$Y$68$KG$20240828$$MD$DE$DE
241576451$24157645$1$I$20240229$20240311$20240731$20240731$PER$$US-BAYER-2024A091746$BAYER$$25$YR$A$F$Y$$$20240731$$MD$US$US
241576471$24157647$1$I$$20240723$20240731$20240731$PER$$US-ABBVIE-5852378$ABBVIE$$$$$$Y$$$20240731$$HP$US$US
241576481$24157648$1$I$20240709$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050949$TOLMAR$$70$YR$$M$Y$$$20240730$$CN$CA$CA
241576491$24157649$1$I$$20240710$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050952$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
241576501$24157650$1$I$20240711$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050948$TOLMAR$$77$YR$$M$Y$$$20240730$$CN$CA$CA
241576511$24157651$1$I$20240710$20240710$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050954$TOLMAR$$74$YR$$M$Y$$$20240730$$CN$CA$CA
241576521$24157652$1$I$20240710$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050953$TOLMAR$$66$YR$$M$Y$$$20240730$$CN$CA$CA
241576531$24157653$1$I$20240711$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050974$TOLMAR$$85$YR$$M$Y$$$20240730$$CN$CA$CA
241576541$24157654$1$I$20240710$20240710$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050973$TOLMAR$$95$YR$$M$Y$$$20240730$$CN$CA$CA
241576551$24157655$1$I$$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050975$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
241576561$24157656$1$I$20240710$20240710$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050970$TOLMAR$$73$YR$$M$Y$$$20240730$$CN$CA$CA
241576571$24157657$1$I$$20240729$20240731$20240731$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042599$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240731$$CN$US$US
241576581$24157658$1$I$20240711$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050976$TOLMAR$$82$YR$$M$Y$$$20240730$$CN$CA$CA
241576591$24157659$1$I$$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050978$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
241576601$24157660$1$I$$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050988$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
241576611$24157661$1$I$$20240730$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042863$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240731$$MD$US$US
241576621$24157662$1$I$20240101$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050979$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
241576631$24157663$1$I$$20240711$20240731$20240731$PER$$CA-TOLMAR, INC.-24CA050985$TOLMAR$$$$$M$Y$$$20240730$$CN$CA$CA
241576642$24157664$2$F$$20240725$20240731$20240819$PER$$CA-TOLMAR, INC.-24CA050982$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
241576651$24157665$1$I$20240130$20240415$20240731$20240731$PER$$US-BAYER-2024A092403$BAYER$$37$YR$A$F$Y$$$20240731$$MD$US$US
241576664$24157666$4$F$20240727$20240731$20240731$20240807$EXP$$US-GSK-US2024093510$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
241576671$24157667$1$I$$20240716$20240731$20240731$EXP$$US-GLANDPHARMA-US-2024GLNLIT00565$GLAND PHARMA$Yao JM.A Case of Adult Acute B-Cell Lymphoblastic Leukemia with Hypercalcemia and Osteolytic Bone Lesions. Clinical Laboratory.Journal for Clinical Laboratories and Laboratories Related to Blood Transfusion.JAN-2023;69(7): 1534-1536$53$YR$A$M$Y$$$20240731$$HP$US$US
241576681$24157668$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52481$$FDA-CTU$$53$YR$$F$N$$$20240731$N$$US$
241576692$24157669$2$F$20240723$20240831$20240731$20240903$30DAY$$US-PFIZER INC-202400223136$PFIZER$$12$YR$$M$Y$35.38$KG$20240903$$CN$US$US
241576701$24157670$1$I$20240408$20240416$20240731$20240731$PER$$US-BAYER-2024A092407$BAYER$$36$YR$A$F$Y$$$20240731$$MD$US$US
241576711$24157671$1$I$$20240725$20240731$20240731$EXP$$US-BAYER-2024A108581$BAYER$$86$YR$E$M$Y$$$20240731$$CN$US$US
241576721$24157672$1$I$20240131$20240312$20240731$20240731$PER$$US-BAYER-2024A091855$BAYER$$35$YR$A$F$Y$$$20240731$$MD$US$US
241576732$24157673$2$F$20220101$20240728$20240731$20240826$EXP$$NVSC2024CZ155680$NOVARTIS$$57$YR$$F$Y$$$20240826$$MD$CZ$CZ
241576751$24157675$1$I$$20240722$20240731$20240731$EXP$$GB-TEVA-VS-3224076$TEVA$$86$YR$$F$Y$54$KG$20240731$$MD$GB$GB
241576761$24157676$1$I$$20240719$20240731$20240731$EXP$$JP-009507513-2407JPN003974J$MERCK$$7$DEC$$F$Y$$$20240731$$MD$JP$JP
241576771$24157677$1$I$20240723$20240723$20240731$20240731$EXP$$JP-009507513-2407JPN004336J$MERCK$$93$YR$$M$Y$$$20240731$$MD$JP$JP
241576781$24157678$1$I$20240712$20240722$20240731$20240731$EXP$$US-RVL_Pharmaceuticals-USA-POI1255202400170$RVL PHARMACEUTICALS$$86$YR$E$M$Y$$$20240731$$CN$US$US
241576791$24157679$1$I$20210101$20240724$20240731$20240731$PER$$US-SA-2024SA221689$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240731$$MD$US$US
241576802$24157680$2$F$$20240820$20240731$20240820$PER$$US-ALXN-202407USA001755US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
241576813$24157681$3$F$$20240904$20240731$20240904$30DAY$$US-PFIZER INC-202400225026$PFIZER$$8$YR$$M$Y$$$20240904$$HP$US$US
241576822$24157682$2$F$$20240729$20240731$20240802$30DAY$$US-PFIZER INC-202400225137$PFIZER$$14$YR$$F$Y$$$20240802$$CN$US$US
241576831$24157683$1$I$$20240729$20240731$20240731$EXP$$CA-BAYER-2024A110520$BAYER$$$$$$Y$$$20240731$$MD$CA$CA
241576841$24157684$1$I$20240606$20240725$20240731$20240731$EXP$FR-AFSSAPS-TS2024000829$FR-MYLANLABS-2024M1070146$MYLAN$$33$WK$$F$Y$2.7$KG$20240731$$MD$FR$FR
241576851$24157685$1$I$20240326$20240326$20240731$20240731$PER$$US-BAYER-2024A092197$BAYER$$33$YR$A$F$Y$$$20240731$$HP$US$US
241576861$24157686$1$I$20240701$20240723$20240731$20240731$EXP$$US-AMGEN-USASP2024146445$AMGEN$$73$YR$E$$Y$$$20240731$$CN$US$US
241576873$24157687$3$F$20240101$20240807$20240731$20240812$PER$$US-AMGEN-USASP2024150402$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241576882$24157688$2$F$20240601$20240807$20240731$20240813$EXP$$US-BAYER-2024A106926$BAYER$$32$YR$A$F$Y$$$20240813$$MD$US$US
241576892$24157689$2$F$20240201$20240828$20240731$20240903$PER$$US-BAYER-2024A091398$BAYER$$22$YR$A$F$Y$$$20240903$$MD$US$US
241576901$24157690$1$I$20240527$20240722$20240731$20240731$EXP$FR-AFSSAPS-LL2024001305$FR-TEVA-VS-3223378$TEVA$$55$YR$$F$Y$88$KG$20240731$$PH$FR$FR
241576921$24157692$1$I$$20240725$20240731$20240731$EXP$$US-GSK-US2024AMR094502$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$US$US
241576931$24157693$1$I$$20240723$20240731$20240731$EXP$$DE-AstraZeneca-2024A171692$ASTRAZENECA$$$$$$Y$$$20240731$$MD$DE$
241576941$24157694$1$I$$20210727$20240731$20240731$EXP$$CA-AstraZeneca-2021A008841$ASTRAZENECA$$68$YR$$F$Y$$$20240731$$MD$CA$
241576951$24157695$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120808$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$62.6$KG$20240731$$CN$US$US
241576962$24157696$2$F$20190601$20240730$20240731$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-120146$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240808$$MD$JP$JP
241576971$24157697$1$I$20240721$20240729$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120193$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240731$$CN$US$US
241576981$24157698$1$I$20240601$20240730$20240731$20240731$EXP$$US-UCBSA-2024038495$UCB$$62$YR$$F$Y$$$20240731$$CN$US$US
241576991$24157699$1$I$20231210$20240723$20240731$20240731$EXP$$JP-AstraZeneca-2024A037666$ASTRAZENECA$$46$YR$$M$Y$$$20240731$$MD$JP$
241577001$24157700$1$I$20240526$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121167$BRISTOL MYERS SQUIBB$$73$YR$E$$Y$91.63$KG$20240731$$CN$US$US
241577013$24157701$3$F$20240701$20240918$20240731$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119136$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240920$$CN$US$US
241577021$24157702$1$I$$20240729$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120662$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240731$$CN$US$US
241577033$24157703$3$F$20240701$20240822$20240731$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119771$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240902$$CN$US$US
241577042$24157704$2$F$$20240819$20240731$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117542$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$96.62$KG$20240821$$CN$US$US
241577051$24157705$1$I$20240701$20240726$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119818$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240731$$CN$US$US
241577061$24157706$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120910$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$70.76$KG$20240731$$CN$US$US
241577082$24157708$2$F$$20220713$20240731$20240819$EXP$$CA-AstraZeneca-2020SF36404$ASTRAZENECA$$53$YR$$F$Y$$$20240819$$MD$CA$
241577095$24157709$5$F$$20240905$20240731$20240913$EXP$DE-EMA-DD-20240718-7482643-075622$DE-MYLANLABS-2024M1070204$MYLAN$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology.. 2024;48 (5):299-313$44$YR$$M$Y$$$20240913$$HP$DE$DE
241577101$24157710$1$I$$20240725$20240731$20240731$EXP$$JP-AMGEN-JPNSP2024148931$AMGEN$$$$E$M$Y$$$20240731$$MD$JP$JP
241577111$24157711$1$I$20240222$20240301$20240731$20240731$PER$$US-BAYER-2024A091531$BAYER$$18$YR$A$F$Y$$$20240731$$MD$US$US
241577121$24157712$1$I$$20240729$20240731$20240731$PER$$NVSC2024US156343$NOVARTIS$$$$$M$Y$$$20240731$$HP$US$US
241577133$24157713$3$F$$20240802$20240731$20240923$EXP$ES-EMA-DD-20240327-7482645-063651$ES-TEVA-VS-3182430$TEVA$Pena M, Montane C, Paviglianiti A, Hurtado L, Gonzalez S, Carro I, Maluquer C, Domingo-Domenech E, Gonzalez-Barca E, Sureda A and Mussetti A. Outcomes of allogeneic hematopoietic cell transplantation after bispecific antibodies in non-Hodgkin lymphomas. DOI: 10.1038/s41409-023-02069-2. Bone Marrow Transplantation 2023 Nov;58 (11):1282-5.; Pena M, Montane C, Paviglianiti A, Hurtado L, Gonzalez S, Carro I, Maluquer C, Domingo-Domenech E, Gonzalez-Barca E, Sureda A and Mussetti A. Outcomes of al...$48$YR$$M$Y$$$20240923$$HP$ES$ES
241577141$24157714$1$I$20240506$20240506$20240731$20240731$PER$$US-BAYER-2024A090917$BAYER$$51$YR$A$F$Y$$$20240731$$HP$US$US
241577152$24157715$2$F$$20240816$20240731$20240822$EXP$$NVSC2024DE155535$NOVARTIS$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S et al.. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. BRITISH JOURNAL OF CANCER. 2023;128(6):1134-47$$$$$Y$$$20240822$$HP$DE$DE
241577162$24157716$2$F$$20240802$20240731$20240812$EXP$$US-TEVA-VS-3225977$TEVA$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch-Dermatol-Res 2024; 316 (5):.; Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch-Dermatol-Res 2024; 316 (5):.; Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch-Dermatol-Res 2...$$$$$Y$$$20240812$$HP$US$US
241577171$24157717$1$I$20231212$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52404$$FDA-CTU$$$$$M$N$75.3$KG$20240730$N$$US$
241577183$24157718$3$F$20240725$20240808$20240731$20240813$EXP$$CN-DSJP-DSJ-2024-137610$DAIICHI$$$$A$F$Y$38.6$KG$20240813$$MD$CN$CN
241577192$24157719$2$F$20240227$20240806$20240731$20240812$PER$$US-BAYER-2024A091870$BAYER$$38$YR$A$F$Y$118.2$KG$20240812$$MD$US$US
241577201$24157720$1$I$20230101$20240730$20240731$20240731$EXP$$US-UCBSA-2024038485$UCB$$$$$F$Y$$$20240731$$CN$US$US
241577211$24157721$1$I$20240301$20240313$20240731$20240731$PER$$US-BAYER-2024A091910$BAYER$$29$YR$A$F$Y$$$20240731$$HP$US$US
241577221$24157722$1$I$20240503$20240507$20240731$20240731$PER$$US-BAYER-2024A091066$BAYER$$32$YR$A$F$Y$$$20240731$$CN$US$US
241577231$24157723$1$I$20240603$20240725$20240731$20240731$EXP$$CN-009507513-2407CHN015359$MERCK$$25$YR$$F$Y$55$KG$20240731$$HP$CN$CN
241577241$24157724$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52563$$FDA-CTU$$67$YR$$M$N$$$20240731$N$$US$
241577251$24157725$1$I$$20240722$20240731$20240731$EXP$$US-TEVA-VS-3225978$TEVA$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch-Dermatol-Res 2024; 316 (5):.; Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch-Dermatol-Res 2024; 316 (5):.$$$$$Y$$$20240731$$HP$US$US
241577262$24157726$2$F$20240607$20240905$20240731$20240910$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004186$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240910$$CN$US$US
241577273$24157727$3$F$20240725$20240812$20240731$20240814$EXP$$US-BAYER-2024A108591$BAYER$$47$YR$A$F$Y$$$20240814$$MD$US$US
241577281$24157728$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000041973$ROCHE$$69$YR$E$F$Y$$$20240731$$CN$US$US
241577291$24157729$1$I$$20240722$20240731$20240731$EXP$$US-TEVA-VS-3225472$TEVA$Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.; Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.$59$YR$$F$Y$$$20240731$$HP$US$US
241577301$24157730$1$I$20240722$20240729$20240731$20240731$PER$$US-ROCHE-10000041675$ROCHE$$$$$F$Y$$$20240731$$CN$US$US
241577321$24157732$1$I$20240523$20240717$20240731$20240731$PER$$US-Vifor (International) Inc.-VIT-2024-06468$VIFOR$$21$YR$$M$Y$69$KG$20240731$$HP$US$US
241577332$24157733$2$F$20230816$20240809$20240731$20240814$PER$$US-Vifor (International) Inc.-VIT-2024-06467$VIFOR$$46$YR$$F$Y$83$KG$20240814$$HP$US$US
241577341$24157734$1$I$20230520$20240717$20240731$20240731$PER$$US-Vifor (International) Inc.-VIT-2024-06465$VIFOR$$64$YR$$M$Y$44$KG$20240731$$HP$US$US
241577351$24157735$1$I$20240601$20240717$20240731$20240731$PER$$US-Vifor (International) Inc.-VIT-2024-06470$VIFOR$$30$YR$$F$Y$115.7$KG$20240731$$HP$US$US
241577361$24157736$1$I$$20240729$20240731$20240731$DIR$FDA-CDER-CTU-2024-52465$$FDA-CTU$$$$$F$N$$$20240729$N$HP$US$
241577373$24157737$3$F$20240724$20240820$20240731$20240820$PER$$US-ALXN-202407USA001711US$ALEXION PHARMACEUTICALS$$28$YR$$F$Y$$$20240820$$CN$US$US
241577381$24157738$1$I$20230101$20240723$20240731$20240731$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001517$BLUEPRINT MEDICINES$$77$YR$E$M$Y$$$20240731$$CN$US$US
241577391$24157739$1$I$20240311$20240314$20240731$20240731$PER$$US-BAYER-2024A091948$BAYER$$37$YR$A$F$Y$$$20240731$$MD$US$US
241577403$24157740$3$F$$20240729$20240731$20240807$EXP$$AU-ABBVIE-5860183$ABBVIE$$64$YR$$M$Y$$$20240807$$MD$AU$AU
241577411$24157741$1$I$20240620$20240724$20240731$20240731$EXP$IT-MINISAL02-995864$IT-EMD Serono-2024040210$EMD SERONO INC$$28$YR$A$F$Y$$$20240731$$MD$IT$IT
241577421$24157742$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52484$$FDA-CTU$$66$YR$$F$N$74.84$KG$20240731$N$$US$
241577431$24157743$1$I$20240701$20240726$20240731$20240731$EXP$$CN-PURDUE-USA-2024-0311057$PURDUE$$65$YR$$F$Y$64$KG$20240731$$HP$CN$CN
241577441$24157744$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52554$$FDA-CTU$$39$YR$$F$N$$$20240731$N$$US$
241577452$24157745$2$F$$20240801$20240731$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118399$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$96$KG$20240813$$HP$CA$CA
241577461$24157746$1$I$$20240725$20240731$20240731$EXP$$CA-PURDUE-USA-2024-0311031$PURDUE$$50$YR$$F$Y$68$KG$20240731$$HP$CA$CA
241577471$24157747$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52483$$FDA-CTU$$55$YR$$F$N$91.63$KG$20240731$N$$US$
241577481$24157748$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52482$$FDA-CTU$$70$YR$$F$N$$$20240731$N$$US$
241577491$24157749$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52485$$FDA-CTU$$70$YR$$M$N$85.73$KG$20240731$N$$US$
241577501$24157750$1$I$20240101$20240726$20240731$20240731$EXP$$CA-UCBSA-2024038252$UCB$$$$$M$Y$$$20240731$$PH$CA$CA
241577511$24157751$1$I$$20240730$20240731$20240731$PER$$US-ROCHE-10000043869$ROCHE$$$$E$F$Y$$$20240731$$CN$US$US
241577521$24157752$1$I$$20240730$20240731$20240731$PER$$US-ROCHE-10000043272$ROCHE$$$$E$F$Y$$$20240731$$CN$US$US
241577531$24157753$1$I$20240317$20240319$20240731$20240731$PER$$US-BAYER-2024A092060$BAYER$$20$YR$A$F$Y$$$20240731$$MD$US$US
241577541$24157754$1$I$$20240723$20240731$20240731$PER$$US-RDY-SPO/USA/24/0010921$DR REDDYS$$70$YR$E$$Y$$$20240731$$PH$US$US
241577552$24157755$2$F$$20240822$20240731$20240826$PER$$US-RDY-SPO/USA/24/0010884$DR REDDYS$$53$YR$A$M$Y$$$20240826$$CN$US$US
241577561$24157756$1$I$$20240716$20240731$20240731$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202407-000134$AZURITY PHARMACEUTICALS$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al.. Collapsing glomerulopathy leading to rapidly progressive allograft failure from cytomegalovirus and sars-cov-2 infection with concomitant bk virus nephropathy. Exp Clin Transplant. 2024;5:392-5$68$YR$$F$Y$$$20240731$$HP$US$US
241577571$24157757$1$I$$20240723$20240731$20240731$PER$$US-BAYER-2024A107229$BAYER$$48$YR$A$F$Y$$$20240731$$MD$US$US
241577581$24157758$1$I$20240718$20240722$20240731$20240731$30DAY$$US-GSK-US2024091767$GLAXOSMITHKLINE$$42$YR$$F$Y$55.34$KG$20240731$$CN$US$US
241577593$24157759$3$F$20240701$20240830$20240731$20240905$EXP$$JP-009507513-2407JPN001914J$MERCK$$9$DEC$$F$Y$$$20240905$$MD$JP$JP
241577601$24157760$1$I$$20240724$20240731$20240731$EXP$$CA-GSK-CA2024AMR093485$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$CA$CA
241577611$24157761$1$I$20240601$20240628$20240731$20240731$EXP$$ES-TEVA-VS-3217147$TEVA$$68$YR$$F$Y$$$20240731$$CN$ES$ES
241577621$24157762$1$I$$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024151445$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241577631$24157763$1$I$20240319$20240320$20240731$20240731$PER$$US-BAYER-2024A092109$BAYER$$26$YR$A$F$Y$$$20240731$$HP$US$US
241577641$24157764$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120762$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240731$$HP$US$US
241577652$24157765$2$F$$20240731$20240731$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119279$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240807$$HP$US$US
241577671$24157767$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120707$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240731$$HP$US$US
241577681$24157768$1$I$$20240729$20240731$20240731$EXP$$PK-TAKEDA-2024TUS076463$TAKEDA$$$$$$Y$$$20240731$$PH$PK$PK
241577691$24157769$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52478$$FDA-CTU$$48$YR$$F$N$$$20240731$N$$US$
241577701$24157770$1$I$$20240729$20240731$20240731$DIR$FDA-CDER-CTU-2024-52446$$FDA-CTU$$$$$F$N$$$20240729$N$HP$US$
241577711$24157771$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120579$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$96.16$KG$20240731$$HP$US$US
241577721$24157772$1$I$20240123$20240320$20240731$20240731$PER$$US-BAYER-2024A092126$BAYER$$40$YR$A$F$Y$$$20240731$$MD$US$US
241577731$24157773$1$I$$20240723$20240731$20240731$PER$$US-BAYER-2024A107655$BAYER$$48$YR$A$F$Y$$$20240731$$CN$US$US
241577741$24157774$1$I$$20240729$20240731$20240731$DIR$FDA-CDER-CTU-2024-52438$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241577751$24157775$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52467$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241577761$24157776$1$I$$20240724$20240731$20240731$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-102241$REGENERON$$$$$F$Y$$$20240731$$CN$US$US
241577771$24157777$1$I$20230101$20240723$20240731$20240731$PER$$US-SA-2024SA221674$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240731$$MD$US$US
241577783$24157778$3$F$20240101$20240822$20240731$20240906$PER$$US-SA-2024SA219663$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240906$$MD$US$US
241577791$24157779$1$I$20240731$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52553$$FDA-CTU$$69$YR$$F$N$$$20240731$Y$HP$US$
241577801$24157780$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52561$$FDA-CTU$$$$$M$N$$$20240731$N$HP$US$
241577821$24157782$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA222681$SANOFI AVENTIS$$$$E$M$Y$127$KG$20240731$$MD$US$US
241577832$24157783$2$F$$20240725$20240731$20240805$PER$$US-AMGEN-USASP2024151027$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241577841$24157784$1$I$$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024151444$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241577851$24157785$1$I$$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024151451$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241577861$24157786$1$I$$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024151460$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241577871$24157787$1$I$$20240724$20240731$20240731$PER$$US-BAYER-2024A108064$BAYER$$34$YR$A$F$Y$$$20240731$$HP$US$US
241577881$24157788$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA222153$SANOFI AVENTIS$$46$YR$A$F$Y$97$KG$20240731$$MD$US$US
241577891$24157789$1$I$20240320$20240403$20240731$20240731$PER$$US-BAYER-2024A092295$BAYER$$41$YR$A$F$Y$$$20240731$$MD$US$US
241577901$24157790$1$I$20240712$20240725$20240731$20240731$EXP$$CA-JNJFOC-20240772821$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240731$$PH$CA$CA
241577912$24157791$2$F$$20240917$20240731$20240925$EXP$$AU-JNJFOC-20240765108$JOHNSON AND JOHNSON$$$$$M$Y$65$KG$20240925$$CN$AU$AU
241577923$24157792$3$F$20240418$20240813$20240731$20240820$EXP$$IE-GSK-IE2024EME093247$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$HP$IE$IE
241577931$24157793$1$I$$20240722$20240731$20240731$EXP$GB-MHRA-MED-202407220402126200-KTDHZ$GB-TEVA-VS-3224204$TEVA$$$$$F$Y$$$20240731$$CN$GB$GB
241577941$24157794$1$I$$20240722$20240731$20240731$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001494$BLUEPRINT MEDICINES$$$$$F$Y$$$20240731$$CN$US$US
241577951$24157795$1$I$20240101$20240725$20240731$20240731$PER$$US-BAYER-2024A108682$BAYER$$31$YR$A$F$Y$$$20240731$$HP$US$US
241577961$24157796$1$I$$20240722$20240731$20240731$EXP$$US-TEVA-VS-3225979$TEVA$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch-Dermatol-Res 2024; 316 (5):.; Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Arch-Dermatol-Res 2024; 316 (5):.$$$$$Y$$$20240731$$HP$US$US
241577971$24157797$1$I$20231202$20240723$20240731$20240731$EXP$$HR-AstraZeneca-2024A167182$ASTRAZENECA$$49$YR$$F$Y$70$KG$20240731$$MD$HR$
241577981$24157798$1$I$$20210901$20240731$20240731$EXP$$AU-AstraZeneca-2021A672186$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$AU$
241577991$24157799$1$I$20230515$20230515$20240731$20240731$EXP$$US-AstraZeneca-2023A113665$ASTRAZENECA$$28903$DY$$M$Y$$$20240731$$CN$US$
241578001$24157800$1$I$$20231020$20240731$20240731$EXP$$IN-AstraZeneca-2023A218525$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$IN$
241578011$24157801$1$I$$20201116$20240731$20240731$EXP$$US-AstraZeneca-2020SF52638$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241578021$24157802$1$I$20240723$20240725$20240731$20240731$EXP$$US-RIGEL-20240700107$RIGEL PHARMACEUTICALS$$94$YR$$F$Y$63.503$KG$20240731$$CN$US$US
241578031$24157803$1$I$$20240718$20240731$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-120583$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240731$$HP$CA$CA
241578041$24157804$1$I$20240726$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121252$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$101.6$KG$20240731$$HP$US$US
241578061$24157806$1$I$$20240730$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121173$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240731$$CN$US$US
241578072$24157807$2$F$$20240903$20240731$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120857$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$93.44$KG$20240905$$CN$US$US
241578082$24157808$2$F$$20240918$20240731$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120937$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$75.75$KG$20240930$$CN$US$US
241578091$24157809$1$I$$20240729$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120721$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240731$$CN$US$US
241578101$24157810$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120990$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240731$$MD$US$US
241578111$24157811$1$I$20240101$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121169$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240731$$CN$US$US
241578121$24157812$1$I$20240401$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120895$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240731$$CN$US$US
241578141$24157814$1$I$20240717$20240717$20240731$20240731$PER$$US-ROCHE-10000033985$ROCHE$$70$YR$E$M$Y$$$20240731$$CN$US$US
241578151$24157815$1$I$20240601$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120901$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240731$$HP$US$US
241578161$24157816$1$I$$20240724$20240731$20240731$EXP$$US-ROCHE-10000035529$ROCHE$$6$YR$C$M$Y$$$20240731$$CN$US$US
241578171$24157817$1$I$20240306$20240308$20240731$20240731$PER$$US-BAYER-2024A098373$BAYER$$40$YR$A$F$Y$$$20240731$$HP$US$US
241578181$24157818$1$I$$20240722$20240731$20240731$PER$$US-TEVA-VS-3225550$TEVA$Mak J, Gandhi R, Zaidan MF, Murthy V. Rituximab for Rapidly Progressive MDA5 Dermatomyositis-Associated Interstitial Lung Disease. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$47$YR$$M$Y$$$20240731$$HP$US$US
241578191$24157819$1$I$$20240727$20240731$20240731$PER$$US-JNJFOC-20240779061$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241578201$24157820$1$I$$20240722$20240731$20240731$EXP$$US-GSK-US2024091876$GLAXOSMITHKLINE$$87$YR$$F$Y$$$20240731$$HP$US$US
241578211$24157821$1$I$20240718$20240723$20240731$20240731$PER$$US-ABBVIE-5854221$ABBVIE$$27$YR$$M$Y$$$20240731$$CN$US$US
241578222$24157822$2$F$20240723$20240801$20240731$20240808$PER$$US-ALXN-202407USA001710US$ALEXION PHARMACEUTICALS$$31$YR$$F$Y$$$20240808$$CN$US$US
241578232$24157823$2$F$20240709$20240812$20240731$20240812$PER$$US-ALXN-202407USA001668US$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240812$$HP$US$US
241578241$24157824$1$I$$20240729$20240731$20240731$EXP$$CA-TAKEDA-2024TUS076597$TAKEDA$$$$$F$Y$51$KG$20240731$$CN$CA$CA
241578251$24157825$1$I$$20240718$20240731$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-114766$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$70$KG$20240731$$HP$CA$CA
241578261$24157826$1$I$20240720$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52512$$FDA-CTU$$56$YR$$F$N$91.6$KG$20240731$N$$US$
241578271$24157827$1$I$20240722$20240729$20240731$20240731$DIR$FDA-CDER-CTU-2024-52437$$FDA-CTU$$75$YR$$F$N$$$20240729$N$HP$US$
241578281$24157828$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52469$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241578291$24157829$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52472$$FDA-CTU$$60$YR$$F$N$74.39$KG$20240731$N$$US$
241578301$24157830$1$I$$20240729$20240731$20240731$PER$$NVSC2024US156435$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
241578311$24157831$1$I$20240712$20240729$20240731$20240731$EXP$$DE-ABBVIE-5860642$ABBVIE$$79$YR$$$Y$$$20240731$$HP$DE$DE
241578322$24157832$2$F$20240101$20240815$20240731$20240830$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00908$AVADEL CNS PHARMA$$$$$F$Y$72.562$KG$20240830$$CN$US$US
241578341$24157834$1$I$20240201$20240318$20240731$20240731$PER$$US-BAYER-2024A092023$BAYER$$39$YR$A$F$Y$$$20240731$$CN$US$US
241578351$24157835$1$I$$20240722$20240731$20240731$EXP$$JP-009507513-2407JPN003983J$MERCK$$8$DEC$$M$Y$$$20240731$$MD$JP$JP
241578364$24157836$4$F$20240101$20240916$20240731$20240924$PER$$US-AMGEN-USASP2024151318$AMGEN$$75$YR$E$F$Y$$$20240924$$HP$US$US
241578371$24157837$1$I$20240312$20240321$20240731$20240731$PER$$US-BAYER-2024A092158$BAYER$$19$YR$A$F$Y$$$20240731$$MD$US$US
241578381$24157838$1$I$$20240723$20240731$20240731$PER$$US-EMD Serono-2024040438$EMD SERONO INC$$$$A$F$Y$73$KG$20240731$$CN$US$US
241578391$24157839$1$I$$20240729$20240731$20240731$PER$$NVSC2024US155349$NOVARTIS$$$$$M$Y$$$20240731$$HP$US$US
241578401$24157840$1$I$$20240726$20240731$20240731$EXP$GB-MHRA-MED-202407260940522970-MBTYF$GB-MYLANLABS-2024M1069919$MYLAN$$$$$F$Y$$$20240731$$HP$GB$GB
241578411$24157841$1$I$20240320$20240321$20240731$20240731$PER$$US-BAYER-2024A092165$BAYER$$30$YR$A$F$Y$$$20240731$$MD$US$US
241578421$24157842$1$I$20240101$20240724$20240731$20240731$EXP$$CA-JNJFOC-20240772898$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$HP$CA$CA
241578434$24157843$4$F$20240724$20240809$20240731$20240813$EXP$$US-AMGEN-USASP2024149542$AMGEN$$$$A$M$Y$$$20240813$$PH$US$US
241578441$24157844$1$I$20240623$20240722$20240731$20240731$EXP$GB-MHRA-MED-202407211526198410-SRDLP$GB-TEVA-VS-3224403$TEVA$$62$YR$$F$Y$56$KG$20240731$$CN$GB$GB
241578452$24157845$2$F$20240601$20240813$20240731$20240821$EXP$$JP-BAYER-2024A110477$BAYER$$73$YR$E$M$Y$$$20240821$$MD$JP$JP
241578471$24157847$1$I$$20240723$20240731$20240731$EXP$$US-MYLANLABS-2024M1069854$MYLAN$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$31$YR$$F$Y$$$20240731$$HP$US$US
241578481$24157848$1$I$20240320$20240325$20240731$20240731$PER$$US-BAYER-2024A092181$BAYER$$34$YR$A$F$Y$$$20240731$$MD$US$US
241578491$24157849$1$I$$20240722$20240731$20240731$EXP$$BY-MYLANLABS-2024M1070742$MYLAN$Yatskevich N. Preliminary Assessment of Safety of Six Month BPaLM/C Regimens in Patients with Rifampicin- Resistant Tuberculosis in the Republic of Belarus. Clinical infectology and parasitology. 2024;13:2$63$YR$$$Y$$$20240731$$HP$BY$BY
241578501$24157850$1$I$20240327$20240412$20240731$20240731$PER$$US-BAYER-2024A101127$BAYER$$17$YR$T$F$Y$$$20240731$$MD$US$US
241578511$24157851$1$I$20240716$20240722$20240731$20240731$EXP$$JP-009507513-2407JPN003975J$MERCK$$8$DEC$$$Y$$$20240731$$MD$JP$JP
241578525$24157852$5$F$20240101$20240902$20240731$20240905$EXP$$CN-SA-2024SA224259$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240905$$MD$CN$CN
241578532$24157853$2$F$$20240731$20240731$20240803$PER$$US-ABBVIE-5853550$ABBVIE$$30$YR$$F$Y$$$20240803$$MD$US$US
241578541$24157854$1$I$$20240729$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121256$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240731$$CN$US$US
241578553$24157855$3$F$20240722$20240829$20240731$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119490$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240830$$CN$JP$JP
241578561$24157856$1$I$20240724$20240730$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120733$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240731$$CN$US$US
241578571$24157857$1$I$$20240730$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120791$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240731$$CN$US$US
241578581$24157858$1$I$20240318$20240416$20240731$20240731$PER$$US-BAYER-2024A092399$BAYER$$49$YR$A$F$Y$$$20240731$$HP$US$US
241578591$24157859$1$I$20240729$20240729$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121214$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240731$$HP$US$US
241578601$24157860$1$I$$20240729$20240731$20240731$EXP$$MT-ANIPHARMA-2024-MT-000003$ANI$$69$YR$$F$Y$$$20240731$$PH$MT$MT
241578611$24157861$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52480$$FDA-CTU$$60$YR$$F$N$$$20240731$N$$US$
241578621$24157862$1$I$20240501$20240724$20240731$20240731$PER$$US-SA-2024SA222846$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240731$$MD$US$US
241578631$24157863$1$I$20240601$20240722$20240731$20240731$PER$$US-SA-2024SA220827$SANOFI AVENTIS$$25$YR$A$F$Y$70.3$KG$20240731$$MD$US$US
241578641$24157864$1$I$20240701$20240726$20240731$20240731$EXP$$US-SA-2024SA224262$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240731$$MD$US$US
241578651$24157865$1$I$20240705$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52470$$FDA-CTU$$67$YR$$F$N$$$20240730$N$HP$US$
241578661$24157866$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221953$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240731$$MD$US$US
241578671$24157867$1$I$20240101$20240723$20240731$20240731$PER$$US-SA-2024SA222315$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240731$$MD$US$US
241578681$24157868$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52486$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241578691$24157869$1$I$20240101$20240719$20240731$20240731$PER$$US-SA-2024SA221161$SANOFI AVENTIS$$65$YR$E$F$Y$59.8$KG$20240731$$MD$US$US
241578701$24157870$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA223064$SANOFI AVENTIS$$$$A$M$Y$$$20240731$$MD$US$US
241578712$24157871$2$F$$20240729$20240731$20240731$EXP$$US-GILEAD-2024-0682353$GILEAD$$5$DEC$A$F$Y$$$20240731$$HP$US$US
241578721$24157872$1$I$20240325$20240326$20240731$20240731$PER$$US-BAYER-2024A092198$BAYER$$27$YR$A$F$Y$$$20240731$$MD$US$US
241578731$24157873$1$I$20240320$20240325$20240731$20240731$PER$$US-BAYER-2024A092200$BAYER$$41$YR$A$F$Y$$$20240731$$MD$US$US
241578742$24157874$2$F$$20240807$20240731$20240816$EXP$$JP-AMGEN-JPNSP2024150071$AMGEN$$$$$$Y$$$20240815$$PH$JP$JP
241578752$24157875$2$F$20230201$20240724$20240731$20240731$EXP$$US-ROCHE-10000035685$ROCHE$$70$YR$E$F$Y$$$20240731$$HP$US$US
241578761$24157876$1$I$$20240727$20240731$20240731$PER$$US-JNJFOC-20240776103$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241578772$24157877$2$F$$20240821$20240731$20240827$EXP$$FR-MYLANLABS-2024M1069844$MYLAN$$29$YR$$F$Y$$$20240827$$MD$FR$FR
241578782$24157878$2$F$20240726$20240805$20240731$20240808$EXP$$DE-JNJFOC-20240784120$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240808$$CN$DE$DE
241578791$24157879$1$I$20240723$20240723$20240731$20240731$PER$$US-SA-2024SA222252$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240731$$MD$US$US
241578801$24157880$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA222862$SANOFI AVENTIS$$62$YR$A$M$Y$99.773$KG$20240731$$MD$US$US
241578821$24157882$1$I$20240101$20240723$20240731$20240731$PER$$US-SA-2024SA220485$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240731$$MD$US$US
241578831$24157883$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA223456$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240731$$MD$US$US
241578842$24157884$2$F$20240802$20240803$20240731$20240813$PER$$US-APELLIS-2024-APL-0000566$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240813$$CN$US$US
241578851$24157885$1$I$20240326$20240326$20240731$20240731$PER$$US-BAYER-2024A092205$BAYER$$20$YR$A$F$Y$$$20240731$$MD$US$US
241578861$24157886$1$I$$20240724$20240731$20240731$PER$$US-ALXN-202407USA001706US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241578871$24157887$1$I$$20240722$20240731$20240731$EXP$FR-AFSSAPS-AVNT2024000540$FR-TEVA-VS-3224897$TEVA$$35$YR$$F$Y$$$20240731$$MD$FR$FR
241578881$24157888$1$I$20240408$20240416$20240731$20240731$PER$$US-BAYER-2024A092405$BAYER$$47$YR$A$F$Y$$$20240731$$MD$US$US
241578891$24157889$1$I$$20230302$20240731$20240731$EXP$$US-AstraZeneca-2023A053807$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241578901$24157890$1$I$$20230210$20240731$20240731$EXP$$US-AstraZeneca-2023A035686$ASTRAZENECA$$$$$$Y$$$20240731$$CN$US$
241578911$24157891$1$I$$20190816$20240731$20240731$EXP$$US-AstraZeneca-2019SE99722$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241578921$24157892$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A169136$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241578931$24157893$1$I$$20240723$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118101$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240731$$MD$US$US
241578941$24157894$1$I$20200914$20240722$20240731$20240731$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117145$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$59$KG$20240731$$MD$KR$KR
241578951$24157895$1$I$20240729$20240730$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120929$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240731$$HP$US$US
241578961$24157896$1$I$20240320$20240416$20240731$20240731$PER$$US-BAYER-2024A092421$BAYER$$32$YR$A$F$Y$$$20240731$$HP$US$US
241578971$24157897$1$I$20240305$20240326$20240731$20240731$PER$$US-BAYER-2024A092194$BAYER$$41$YR$A$F$Y$$$20240731$$MD$US$US
241578981$24157898$1$I$$20240730$20240731$20240731$EXP$$DE-GILEAD-2024-0682456$GILEAD$$76$YR$E$F$Y$$$20240731$$MD$DE$DE
241578991$24157899$1$I$20240321$20240322$20240731$20240731$PER$$US-BAYER-2024A092179$BAYER$$23$YR$A$F$Y$$$20240731$$MD$US$US
241579001$24157900$1$I$20240223$20240325$20240731$20240731$PER$$US-BAYER-2024A092230$BAYER$$44$YR$A$F$Y$$$20240731$$HP$US$US
241579011$24157901$1$I$$20240722$20240731$20240731$EXP$$GB-TEVA-VS-3224629$TEVA$$69$YR$$M$Y$64$KG$20240731$$MD$GB$GB
241579021$24157902$1$I$$20240723$20240731$20240731$PER$$US-JNJFOC-20240774919$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241579031$24157903$1$I$20240729$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150653$AMGEN$$86$YR$E$F$Y$$$20240731$$HP$US$US
241579041$24157904$1$I$$20240723$20240731$20240731$EXP$$ES-AMGEN-ESPSP2024146811$AMGEN$Mateos M.. A research center^s experience of T-cell- redirecting therapies in triple-class refractory multiple myeloma. Blood Advances. 2024;8 (13):3478-3487$$$$$Y$$$20240731$$HP$ES$ES
241579051$24157905$1$I$20240417$20240418$20240731$20240731$PER$$US-BAYER-2024A092415$BAYER$$$$$F$Y$$$20240731$$HP$US$US
241579061$24157906$1$I$20240404$20240408$20240731$20240731$PER$$US-BAYER-2024A092343$BAYER$$26$YR$A$F$Y$$$20240731$$MD$US$US
241579071$24157907$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52516$$FDA-CTU$$30$YR$$F$N$$$20240731$N$$US$
241579081$24157908$1$I$$20240724$20240731$20240731$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-137656$DAIICHI$$50$YR$$F$Y$$$20240731$$CN$US$US
241579091$24157909$1$I$20240322$20240327$20240731$20240731$PER$$US-BAYER-2024A092224$BAYER$$32$YR$A$F$Y$$$20240731$$MD$US$US
241579101$24157910$1$I$20240105$20240408$20240731$20240731$PER$$US-BAYER-2024A092353$BAYER$$$$$F$Y$$$20240731$$MD$US$US
241579111$24157911$1$I$20240223$20240327$20240731$20240731$PER$$US-BAYER-2024A092233$BAYER$$19$YR$A$F$Y$$$20240731$$MD$US$US
241579122$24157912$2$F$20240701$20240806$20240731$20240809$PER$$US-009507513-2407USA013320$MERCK$$87$YR$$M$Y$130$KG$20240809$$MD$US$US
241579131$24157913$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52534$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241579142$24157914$2$F$$20240802$20240731$20240812$EXP$$JP-TEVA-VS-3224789$TEVA$Sawamura H, Koyasu S, Sugimoto A, Fujimura S, Nakamoto Y. Gingival Hyperplasia Masquerading as Tumor Lesion, Possibly Linked to Amlodipine Use. Clin-Nucl-Med 2024; 0 (0):.; Sawamura H, Koyasu S, Sugimoto A, Fujimura S, Nakamoto Y. Gingival Hyperplasia Masquerading as Tumor Lesion, Possibly Linked to Amlodipine Use. Clin-Nucl-Med 2024; 0 (0):.; Sawamura H, Koyasu S, Sugimoto A, Fujimura S, Nakamoto Y. Gingival Hyperplasia Masquerading as Tumor Lesion, Possibly Linked to Amlodipine Use. Clin-Nu...$70$YR$$F$Y$$$20240812$$MD$JP$JP
241579152$24157915$2$F$20240726$20240909$20240731$20240910$PER$$US-AMGEN-USASP2024150717$AMGEN$$55$YR$A$M$Y$$$20240909$$CN$US$US
241579171$24157917$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52550$$FDA-CTU$$$$$M$N$$$20240730$N$HP$US$
241579181$24157918$1$I$20240409$20240409$20240731$20240731$PER$$US-BAYER-2024A092742$BAYER$$27$YR$A$F$Y$$$20240731$$CN$US$US
241579191$24157919$1$I$20240418$20240419$20240731$20240731$PER$$US-BAYER-2024A092425$BAYER$$27$YR$A$F$Y$$$20240731$$MD$US$US
241579201$24157920$1$I$$20240730$20240731$20240731$EXP$$FR-JNJFOC-20240783369$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240731$$MD$FR$FR
241579211$24157921$1$I$20220201$20240724$20240731$20240731$EXP$$KR-GSK-KR2024GSK094662$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$KR$KR
241579222$24157922$2$F$$20240822$20240731$20240829$EXP$$US-GSK-US2024AMR093316$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$US$US
241579231$24157923$1$I$20240606$20240731$20240731$20240731$DIR$712232$$FDA-CTU$$63$YR$$M$N$$$20240731$N$PH$US$
241579243$24157924$3$F$20240719$20240911$20240731$20240920$EXP$$FI-Blueprint Medicines Corporation-SO-FI-2024-001485$BLUEPRINT MEDICINES$$58$YR$A$M$Y$91.6$KG$20240920$$HP$FI$FI
241579251$24157925$1$I$20240723$20240724$20240731$20240731$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001531$BLUEPRINT MEDICINES$$82$YR$E$F$Y$$$20240731$$CN$US$US
241579261$24157926$1$I$20240101$20240328$20240731$20240731$PER$$US-BAYER-2024A092239$BAYER$$18$YR$A$F$Y$$$20240731$$HP$US$US
241579271$24157927$1$I$20240405$20240417$20240731$20240731$PER$$US-BAYER-2024A092422$BAYER$$40$YR$A$F$Y$$$20240731$$CN$US$US
241579281$24157928$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52520$$FDA-CTU$$41$YR$$F$N$$$20240731$N$$US$
241579291$24157929$1$I$$20240723$20240731$20240731$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202407-000178$AZURITY PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
241579301$24157930$1$I$$20240729$20240731$20240731$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138167$DAIICHI$$33$YR$$F$Y$$$20240731$$CN$US$US
241579311$24157931$1$I$$20240729$20240731$20240731$PER$$US-DSJP-DSU-2024-138159$DAIICHI$$56$YR$$F$Y$$$20240731$$CN$US$US
241579321$24157932$1$I$20240419$20240422$20240731$20240731$PER$$US-BAYER-2024A092456$BAYER$$36$YR$A$F$Y$$$20240731$$HP$US$US
241579331$24157933$1$I$20240209$20240403$20240731$20240731$PER$$US-BAYER-2024A092288$BAYER$$16$YR$T$F$Y$$$20240731$$HP$US$US
241579341$24157934$1$I$20240627$20240722$20240731$20240731$EXP$FR-AFSSAPS-PP2024000780$FR-TEVA-VS-3223449$TEVA$$86$YR$$F$Y$50$KG$20240731$$PH$FR$FR
241579351$24157935$1$I$$20240730$20240731$20240731$EXP$$NVSC2024GB155777$NOVARTIS$$$$$F$Y$$$20240731$$HP$GB$GB
241579361$24157936$1$I$20240322$20240424$20240731$20240731$PER$$US-BAYER-2024A092447$BAYER$$17$YR$T$F$Y$$$20240731$$MD$US$US
241579371$24157937$1$I$20240731$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52569$$FDA-CTU$$73$YR$$F$N$$$20240731$N$$US$
241579391$24157939$1$I$20240726$20240729$20240731$20240731$DIR$FDA-CDER-CTU-2024-52435$$FDA-CTU$$17$MON$$F$N$$$20240729$N$HP$US$
241579401$24157940$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52570$$FDA-CTU$$47$YR$$F$N$$$20240731$N$$US$
241579421$24157942$1$I$20240405$20240730$20240730$20240730$DIR$FDA-CDER-CTU-2024-52515$$FDA-CTU$$77$YR$$F$N$55.3$KG$20240730$N$HP$US$
241579431$24157943$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52436$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241579441$24157944$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52441$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241579451$24157945$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA222462$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240731$$MD$US$US
241579461$24157946$1$I$20240328$20240329$20240731$20240731$PER$$US-BAYER-2024A092297$BAYER$$38$YR$A$F$Y$$$20240731$$MD$US$US
241579472$24157947$2$F$20240101$20240820$20240731$20240830$EXP$$JP-IMP-2024000553$Harrow Health$$$$$$Y$$$20240830$$MD$JP$JP
241579481$24157948$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA218600$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240731$$MD$US$US
241579491$24157949$1$I$$20240722$20240731$20240731$PER$$US-SA-2023SA337512$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240731$$MD$US$US
241579501$24157950$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA033237$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240731$$MD$US$US
241579511$24157951$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA223136$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240731$$MD$US$US
241579521$24157952$1$I$$20240730$20240731$20240731$PER$$US-DSJP-DSU-2024-138169$DAIICHI$$$$$F$Y$$$20240731$$HP$US$US
241579532$24157953$2$F$20240425$20240910$20240731$20240917$EXP$$US-OTSUKA-2024_012172$OTSUKA$$59$YR$$F$Y$81.2$KG$20240917$$MD$US$US
241579541$24157954$1$I$20240701$20240730$20240731$20240731$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138162$DAIICHI$$$$A$F$Y$$$20240731$$HP$US$US
241579551$24157955$1$I$$20240729$20240731$20240731$PER$$US-DSJP-DSU-2024-138332$DAIICHI$$41$YR$$F$Y$$$20240731$$CN$US$US
241579561$24157956$1$I$20240403$20240410$20240731$20240731$PER$$US-BAYER-2024A092361$BAYER$$28$YR$A$F$Y$$$20240731$$MD$US$US
241579571$24157957$1$I$20240408$20240409$20240731$20240731$PER$$US-BAYER-2024A092386$BAYER$$32$YR$A$F$Y$$$20240731$$MD$US$US
241579581$24157958$1$I$20240103$20240403$20240731$20240731$PER$$US-BAYER-2024A092314$BAYER$$28$YR$A$F$Y$$$20240731$$MD$US$US
241579592$24157959$2$F$20230205$20240814$20240731$20240823$EXP$$IL-JNJFOC-20240764025$JOHNSON AND JOHNSON$$68$YR$E$F$Y$58.5$KG$20240823$$MD$IL$IL
241579601$24157960$1$I$20240401$20240424$20240731$20240731$PER$$US-BAYER-2024A092458$BAYER$$35$YR$A$F$Y$$$20240731$$MD$US$US
241579611$24157961$1$I$20240325$20240329$20240731$20240731$PER$$US-BAYER-2024A092328$BAYER$$39$YR$A$F$Y$$$20240731$$MD$US$US
241579621$24157962$1$I$20240402$20240403$20240731$20240731$PER$$US-BAYER-2024A092322$BAYER$$25$YR$A$F$Y$$$20240731$$MD$US$US
241579631$24157963$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5859415$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241579643$24157964$3$F$20240601$20240820$20240731$20240821$PER$$US-GRUNENTHAL-2024-123473$AVERITAS$$66$YR$$F$Y$$$20240821$$HP$US$US
241579651$24157965$1$I$20240312$20240417$20240731$20240731$PER$$US-BAYER-2024A092420$BAYER$$32$YR$A$F$Y$$$20240731$$MD$US$US
241579661$24157966$1$I$20240322$20240410$20240731$20240731$PER$$US-BAYER-2024A092356$BAYER$$22$YR$A$F$Y$$$20240731$$MD$US$US
241579671$24157967$1$I$20230504$20240725$20240731$20240731$PER$$US-ORGANON-O2407USA002481$ORGANON$$19$YR$$F$Y$65.77$KG$20240731$$CN$US$US
241579681$24157968$1$I$20240208$20240410$20240731$20240731$PER$$US-BAYER-2024A092357$BAYER$$41$YR$A$F$Y$$$20240731$$MD$US$US
241579692$24157969$2$F$$20240724$20240731$20240827$PER$$US-APELLIS-2024-APL-0000572$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240827$$CN$US$US
241579701$24157970$1$I$20240602$20240725$20240731$20240731$EXP$PT-INFARMED-R202407-238$PT-MYLANLABS-2024M1069905$MYLAN$$79$YR$$M$Y$$$20240731$$PH$PT$PT
241579711$24157971$1$I$20240402$20240410$20240731$20240731$PER$$US-BAYER-2024A092388$BAYER$$44$YR$A$F$Y$$$20240731$$MD$US$US
241579722$24157972$2$F$$20240827$20240731$20240903$EXP$$US-OTSUKA-2024_020816$OTSUKA$$$$$M$Y$$$20240903$$CN$US$US
241579731$24157973$1$I$$20240725$20240731$20240731$EXP$$HU-MYLANLABS-2024M1069891$MYLAN$$$$$M$Y$60$KG$20240731$$CN$HU$HU
241579741$24157974$1$I$20240326$20240410$20240731$20240731$PER$$US-BAYER-2024A092371$BAYER$$30$YR$A$F$Y$$$20240731$$MD$US$US
241579752$24157975$2$F$$20240801$20240731$20240807$EXP$$US-ABBVIE-5859527$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241579761$24157976$1$I$20240101$20240726$20240731$20240731$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004165$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
241579771$24157977$1$I$20220901$20240722$20240731$20240731$EXP$FR-AFSSAPS-AVPO2024000133$FR-TEVA-VS-3224941$TEVA$$36$YR$$F$Y$$$20240731$$PH$FR$FR
241579781$24157978$1$I$$20240726$20240731$20240731$EXP$$NVSC2024CA155471$NOVARTIS$$$$A$F$Y$$$20240731$$MD$CA$CA
241579791$24157979$1$I$20240722$20240725$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407016678$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$US$US
241579801$24157980$1$I$$20240722$20240731$20240731$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005440$BIOCON$$$$$$Y$$$20240731$$HP$CA$CA
241579811$24157981$1$I$20240325$20240405$20240731$20240731$PER$$US-BAYER-2024A092346$BAYER$$48$YR$A$F$Y$$$20240731$$MD$US$US
241579821$24157982$1$I$20240321$20240410$20240731$20240731$PER$$US-BAYER-2024A092379$BAYER$$41$YR$A$F$Y$$$20240731$$HP$US$US
241579831$24157983$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000042205$ROCHE$$7$YR$C$F$Y$$$20240731$$CN$US$US
241579841$24157984$1$I$$20240730$20240731$20240731$PER$$US-ROCHE-10000043154$ROCHE$$$$E$F$Y$$$20240731$$CN$US$US
241579852$24157985$2$F$$20240802$20240731$20240812$EXP$$JP-TEVA-VS-3224814$TEVA$Tanomogi N, Ota T, Sato D, Itagaki S, Shimada K. Fatal cerebral venous sinus thrombosis with preceding thrombocytopenia in a patient with new-onset eosinophilic granulomatosis with polyangiitis. Mod-Rheumatol-Case-Rep 2023; 7 (2): 410-415.; Tanomogi N, Ota T, Sato D, Itagaki S, Shimada K. Fatal cerebral venous sinus thrombosis with preceding thrombocytopenia in a patient with new-onset eosinophilic granulomatosis with polyangiitis. Mod-Rheumatol-Case-Rep 2023; 7 (2): 410-415.$44$YR$$F$Y$$$20240812$$HP$JP$JP
241579861$24157986$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000042068$ROCHE$$$$A$M$Y$$$20240731$$CN$US$US
241579871$24157987$1$I$$20240729$20240731$20240731$PER$$US-ROCHE-10000042147$ROCHE$$$$$M$Y$$$20240731$$CN$US$US
241579881$24157988$1$I$20240327$20240412$20240731$20240731$PER$$US-BAYER-2024A092384$BAYER$$17$YR$T$F$Y$$$20240731$$MD$US$US
241579891$24157989$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52466$$FDA-CTU$$$$$M$N$$$20240730$N$HP$US$
241579911$24157991$1$I$20240616$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52525$$FDA-CTU$$88$YR$$M$N$$$20240731$N$HP$US$
241579931$24157993$1$I$20240618$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52566$$FDA-CTU$$32$YR$$F$N$$$20240730$N$HP$US$
241579952$24157995$2$F$$20240727$20240731$20240802$EXP$$AU-AstraZeneca-2024A171079$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$AU$
241579961$24157996$1$I$20240713$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171979$ASTRAZENECA$$30497$DY$$F$Y$$$20240731$$CN$US$
241579971$24157997$1$I$$20240723$20240731$20240731$EXP$$NL-AstraZeneca-2024A160680$ASTRAZENECA$$82$YR$$F$Y$$$20240731$$MD$NL$
241579981$24157998$1$I$$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171662$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241579991$24157999$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A169022$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241580001$24158000$1$I$20230501$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A171336$ASTRAZENECA$$59$YR$$M$Y$$$20240731$$CN$US$
241580011$24158001$1$I$20230705$20230814$20240731$20240731$EXP$$US-AstraZeneca-2023A187050$ASTRAZENECA$$28050$DY$$$Y$$$20240731$$CN$US$
241580021$24158002$1$I$$20240722$20240731$20240731$EXP$$IN-AstraZeneca-2024A172348$ASTRAZENECA$$70$YR$$F$Y$$$20240731$$CN$IN$
241580031$24158003$1$I$$20240723$20240731$20240731$EXP$$US-AMERICAN REGENT INC-2024002833$AMERICAN REGENT$Anderson M, Brozzi N, Rosenthal R, Hernandez-Montfort J, Reddy R, Gopalan R.. Panel Discussion: Non-cardiac Surgery Interventions on Patients Receiving Impella Support. Interventional Cardiology (London). 2024;19 (Suppl.):31-34 - [abstract]$66$YR$$F$Y$$$20240731$$MD$US$US
241580041$24158004$1$I$$20240724$20240731$20240731$EXP$$US-MYLANLABS-2024M1070608$MYLAN$Bandali T, Kim Y, Khodadoust M, Rieger K, Fernandez-Pol S, Saleem A, et al. Polatuzumab vedotin-piiq for treatment of primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCL-LT) in older adults. J-Invest-Dermatol 2024; 144 (Suppl.) (8): S49 abstr. 282.$92$YR$$M$Y$$$20240731$$HP$US$US
241580052$24158005$2$F$20240527$20240723$20240731$20240805$EXP$$ES-AstraZeneca-2024A173648$ASTRAZENECA$$38$YR$$F$Y$$$20240805$$MD$ES$
241580061$24158006$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52572$$FDA-CTU$$67$YR$$F$N$67.13$KG$20240731$N$$US$
241580071$24158007$1$I$20240410$20240411$20240731$20240731$PER$$US-BAYER-2024A092387$BAYER$$$$$F$Y$$$20240731$$HP$US$US
241580081$24158008$1$I$20210602$20240730$20240731$20240731$EXP$PL-URPL-DML-MLP.4401.1.4918.2021$PL-BAYER-2024A109856$BAYER$$47$YR$A$M$Y$80$KG$20240731$$MD$PL$PL
241580091$24158009$1$I$$20240726$20240731$20240731$PER$$US-ROCHE-10000041220$ROCHE$$25$YR$A$F$Y$$$20240731$$MD$US$US
241580102$24158010$2$F$$20240724$20240731$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07018$LUPIN$$$$$$Y$$$20240818$$CN$US$US
241580111$24158011$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52573$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
241580132$24158013$2$F$20240729$20240805$20240731$20240807$EXP$$US-ABBVIE-5860949$ABBVIE$$80$YR$$M$Y$$$20240807$$CN$US$US
241580141$24158014$1$I$$20240725$20240731$20240731$EXP$$JP-009507513-2407JPN004747J$MERCK$$$$$F$Y$$$20240731$$MD$JP$JP
241580151$24158015$1$I$20240124$20240722$20240731$20240731$EXP$FR-AFSSAPS-PO2024000772$FR-TEVA-VS-3224860$TEVA$$74$YR$$M$Y$67$KG$20240731$$MD$FR$FR
241580161$24158016$1$I$20240712$20240724$20240731$20240731$DIR$FDA-CDER-CTU-2024-52574$$FDA-CTU$$$$$M$N$$$20240724$N$HP$US$
241580171$24158017$1$I$$20240730$20240731$20240731$PER$$NVSC2024US156450$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
241580181$24158018$1$I$20240304$20240418$20240731$20240731$PER$$US-BAYER-2024A092414$BAYER$$32$YR$A$F$Y$$$20240731$$MD$US$US
241580191$24158019$1$I$$20240722$20240731$20240731$PER$$US-ABBVIE-5851514$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241580201$24158020$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA213743$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240731$$CN$US$US
241580211$24158021$1$I$20230101$20240726$20240731$20240731$PER$$US-SA-2024SA222876$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240731$$CN$US$US
241580221$24158022$1$I$$20240725$20240731$20240731$EXP$$JP-009507513-2407JPN004519J$MERCK$$56$YR$$F$Y$$$20240731$$PH$JP$JP
241580231$24158023$1$I$$20240726$20240731$20240731$PER$$US-ROCHE-10000041224$ROCHE$$79$YR$E$F$Y$$$20240731$$CN$US$US
241580242$24158024$2$F$20240403$20240923$20240731$20240927$PER$$US-BAYER-2024A092429$BAYER$$27$YR$A$F$Y$59.864$KG$20240927$$HP$US$US
241580251$24158025$1$I$19750708$20240730$20240731$20240731$EXP$GB-MHRA-TPP22396720C12504289YC1721979504265$GB-SANDOZ INC.-SDZ2024GB069347$SANDOZ$$59$YR$$F$Y$54$KG$20240731$$PH$GB$GB
241580261$24158026$1$I$20240626$20240726$20240731$20240731$EXP$$GB-AstraZeneca-2024A170820$ASTRAZENECA$$80$YR$$F$Y$64$KG$20240731$$MD$GB$
241580271$24158027$1$I$$20240723$20240731$20240731$EXP$$ZA-AstraZeneca-2024A171784$ASTRAZENECA$$84$YR$$F$Y$$$20240731$$CN$ZA$
241580281$24158028$1$I$20240715$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171445$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241580291$24158029$1$I$$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171121$ASTRAZENECA$$$$$M$Y$89$KG$20240731$$CN$US$
241580303$24158030$3$F$20240201$20240821$20240731$20240826$EXP$$MX-AstraZeneca-2024A170096$ASTRAZENECA$$711$MON$$F$Y$$$20240826$$CN$MX$
241580311$24158031$1$I$20110201$20240723$20240731$20240731$EXP$$NL-AstraZeneca-2024A173656$ASTRAZENECA$$52$YR$$F$Y$95$KG$20240731$$MD$NL$
241580321$24158032$1$I$$20240723$20240731$20240731$EXP$$JP-AstraZeneca-2024A169790$ASTRAZENECA$$70$YR$$F$Y$$$20240731$$MD$JP$
241580331$24158033$1$I$20240729$20240730$20240731$20240731$EXP$$US-BAYER-2024A110751$BAYER$$72$YR$E$F$Y$$$20240731$$CN$US$US
241580341$24158034$1$I$$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171225$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241580351$24158035$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A168179$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241580361$24158036$1$I$$20240726$20240731$20240731$EXP$$VN-AstraZeneca-2024A171542$ASTRAZENECA$$$$$F$Y$$$20240731$$MD$VN$
241580371$24158037$1$I$20240722$20240723$20240731$20240731$EXP$$CO-AstraZeneca-2024A168977$ASTRAZENECA$$10890$DY$$F$Y$$$20240731$$CN$CO$
241580381$24158038$1$I$$20230620$20240731$20240731$EXP$$US-AstraZeneca-2023A142971$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241580393$24158039$3$F$$20240814$20240731$20240820$EXP$$CA-TAKEDA-2024TUS076661$TAKEDA$$$$$F$Y$$$20240820$$CN$CA$CA
241580401$24158040$1$I$20240325$20240404$20240731$20240731$PER$$US-BAYER-2024A092336$BAYER$$16$YR$T$F$Y$$$20240731$$CN$US$US
241580412$24158041$2$F$$20240816$20240731$20240826$PER$$US-APELLIS-2024-APL-0000575$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
241580424$24158042$4$F$20240719$20240730$20240731$20240821$PER$$US-ROCHE-10000038376$ROCHE$$37$YR$A$M$Y$93.89$KG$20240821$$CN$US$US
241580431$24158043$1$I$20200701$20240724$20240731$20240731$PER$$US-SA-2024SA221921$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240731$$MD$US$US
241580441$24158044$1$I$$20240726$20240731$20240731$PER$$US-ROCHE-10000040550$ROCHE$$$$A$F$Y$$$20240731$$CN$US$US
241580451$24158045$1$I$20240614$20240723$20240731$20240731$EXP$FR-AFSSAPS-PV2024000587$FR-ROCHE-10000033950$ROCHE$$76$YR$E$F$Y$$$20240731$$MD$FR$FR
241580464$24158046$4$F$20240723$20240905$20240731$20240910$PER$$US-ROCHE-10000036659$ROCHE$$54$YR$A$M$Y$90.71$KG$20240910$$CN$US$US
241580473$24158047$3$F$20240724$20240912$20240731$20240923$PER$$US-ROCHE-10000040017$ROCHE$$8$YR$C$M$Y$$$20240923$$CN$US$US
241580481$24158048$1$I$20240110$20240404$20240731$20240731$PER$$US-BAYER-2024A092351$BAYER$$42$YR$A$F$Y$$$20240731$$HP$US$US
241580491$24158049$1$I$20240724$20240724$20240731$20240731$PER$$US-BIOGEN-2024BI01275604$BIOGEN$$27$YR$$M$Y$$$20240731$$CN$US$US
241580501$24158050$1$I$$20240722$20240731$20240731$EXP$$US-JNJFOC-20240764125$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241580511$24158051$1$I$$20240724$20240731$20240731$PER$$US-ROCHE-10000035802$ROCHE$$69$YR$E$M$Y$$$20240731$$CN$US$US
241580521$24158052$1$I$20240401$20240404$20240731$20240731$PER$$US-BAYER-2024A093993$BAYER$$34$YR$A$F$Y$$$20240731$$CN$US$US
241580531$24158053$1$I$$20240723$20240731$20240731$PER$$US-ABBVIE-5852798$ABBVIE$$$$$$Y$$$20240731$$HP$US$US
241580541$24158054$1$I$$20240726$20240731$20240731$PER$$US-ROCHE-10000040585$ROCHE$$48$YR$A$F$Y$$$20240731$$CN$US$US
241580551$24158055$1$I$20240101$20240408$20240731$20240731$PER$$US-BAYER-2024A092376$BAYER$$22$YR$A$F$Y$$$20240731$$MD$US$US
241580561$24158056$1$I$20240603$20240722$20240731$20240731$EXP$FR-AFSSAPS-NY2024000753$FR-TEVA-VS-3224914$TEVA$$97$YR$$F$Y$58$KG$20240731$$PH$FR$FR
241580572$24158057$2$F$$20240722$20240731$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07047$LUPIN$$$$$$Y$$$20240813$$CN$US$US
241580591$24158059$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52577$$FDA-CTU$$27$YR$$F$N$43.09$KG$20240731$N$$US$
241580611$24158061$1$I$20240412$20240422$20240731$20240731$EXP$$US-BAYER-2024A092438$BAYER$$27$YR$A$F$Y$$$20240731$$CN$US$US
241580621$24158062$1$I$$20240725$20240731$20240731$EXP$$NVSC2024IN151325$NOVARTIS$$$$$F$Y$$$20240731$$CN$IN$IN
241580632$24158063$2$F$$20240807$20240731$20240808$EXP$$NVSC2024ET155670$NOVARTIS$$$$$M$Y$$$20240808$$MD$ET$ET
241580641$24158064$1$I$20240618$20240617$20240731$20240731$PER$$US-TRAVERE-2024TVT00615$TRAVERE THERAPEUTICS$$75$YR$E$F$Y$$$20240731$$CN$US$US
241580651$24158065$1$I$$20240617$20240731$20240731$PER$$US-TRAVERE-2024TVT00614$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240731$$CN$US$US
241580661$24158066$1$I$20240401$20240409$20240731$20240731$PER$$US-BAYER-2024A092380$BAYER$$30$YR$A$F$Y$$$20240731$$CN$US$US
241580672$24158067$2$F$$20240903$20240731$20240906$PER$$US-ROCHE-10000036807$ROCHE$$$$A$F$Y$$$20240906$$CN$US$US
241580681$24158068$1$I$$20240718$20240731$20240731$PER$$US-ROCHE-10000042836$ROCHE$$$$A$F$Y$$$20240731$$CN$US$US
241580691$24158069$1$I$20240322$20240409$20240731$20240731$PER$$US-BAYER-2024A092364$BAYER$$49$YR$A$F$Y$$$20240731$$MD$US$US
241580701$24158070$1$I$20240411$20240411$20240731$20240731$PER$$US-BAYER-2024A092395$BAYER$$35$YR$A$F$Y$$$20240731$$MD$US$US
241580711$24158071$1$I$20240301$20240719$20240731$20240731$EXP$$AR-EMD Serono-2024039607$EMD SERONO INC$$17$YR$T$M$Y$$$20240731$$CN$AR$AR
241580721$24158072$1$I$$20240725$20240731$20240731$EXP$$GB-MYLANLABS-2024M1070120$MYLAN$$$$$M$Y$$$20240731$$MD$GB$GB
241580731$24158073$1$I$$20240723$20240731$20240731$EXP$$KR-BAYER-2024A107642$BAYER$$$$$$Y$$$20240731$$HP$KR$KR
241580741$24158074$1$I$20240722$20240722$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407014909$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240731$$CN$US$US
241580751$24158075$1$I$20240725$20240725$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018322$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240731$$CN$US$US
241580761$24158076$1$I$20240126$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018308$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$US$US
241580771$24158077$1$I$20240629$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019038$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240731$$CN$US$US
241580781$24158078$1$I$20230101$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019164$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240731$$CN$US$US
241580791$24158079$1$I$20240701$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019089$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240731$$CN$US$US
241580802$24158080$2$F$20240722$20240729$20240731$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407017644$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240802$$CN$US$US
241580811$24158081$1$I$$20240725$20240731$20240731$EXP$$CA-TAKEDA-2024TUS063378$TAKEDA$$$$$M$Y$$$20240731$$CN$CA$CA
241580821$24158082$1$I$$20240730$20240731$20240731$PER$$US-GILEAD-2024-0682434$GILEAD$$71$YR$E$F$Y$$$20240731$$CN$US$US
241580831$24158083$1$I$$20240730$20240731$20240731$EXP$$US-BAYER-2024A110120$BAYER$$67$YR$E$M$Y$$$20240731$$MD$US$US
241580841$24158084$1$I$20231201$20240724$20240731$20240731$EXP$$US-009507513-2407USA015020$MERCK$$48$YR$$M$Y$$$20240731$$MD$US$US
241580852$24158085$2$F$$20240802$20240731$20240812$EXP$$US-TEVA-VS-3225918$TEVA$Talon A, Gao YA, Murray C, Shamsid-Deen N, Puebla Neira DA. Factitious Elevation of Plasma Free Hemoglobin in a Patient Undergoing VV-ECMO With Hypertriglyceridemia. Am-J-Respir-Crit-Care-Med 2024; 209 A1700 (plus Poster).; Talon A, Gao YA, Murray C, Shamsid-Deen N, Puebla Neira DA. Factitious Elevation of Plasma Free Hemoglobin in a Patient Undergoing VV-ECMO With Hypertriglyceridemia. Am-J-Respir-Crit-Care-Med 2024; 209 A1700 (plus Poster).$49$YR$$M$Y$$$20240812$$HP$US$US
241580861$24158086$1$I$$20240709$20240731$20240731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003314$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241580871$24158087$1$I$$20240618$20240731$20240731$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091077$GLENMARK$$$$$$Y$$$20240731$$CN$US$US
241580881$24158088$1$I$$20240730$20240731$20240731$EXP$$US-ORGANON-O2407USA002933$ORGANON$$$$$F$Y$$$20240731$$CN$US$US
241580891$24158089$1$I$$20240726$20240731$20240731$PER$$US-ABBVIE-5858854$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241580904$24158090$4$F$20240701$20240911$20240731$20240920$EXP$$JP-009507513-2407JPN003731J$MERCK$$66$YR$$M$Y$$$20240920$$MD$JP$JP
241580911$24158091$1$I$$20240729$20240731$20240731$EXP$$CA-MYLANLABS-2023M1037562$MYLAN$$$$$M$Y$75$KG$20240731$$HP$CA$CA
241580921$24158092$1$I$20240616$20240617$20240731$20240731$PER$$US-TRAVERE-2024TVT00618$TRAVERE THERAPEUTICS$$57$YR$A$F$Y$$$20240731$$CN$US$US
241580933$24158093$3$F$$20240710$20240731$20240815$PER$$US-TRAVERE-2024TVT00620$TRAVERE THERAPEUTICS$$50$YR$A$M$Y$$$20240815$$CN$US$US
241580941$24158094$1$I$$20240730$20240731$20240731$EXP$$CA-MYLANLABS-2024M1070977$MYLAN$$$$$M$Y$2$KG$20240731$$HP$CA$CA
241580951$24158095$1$I$20240626$20240726$20240731$20240731$EXP$$NVSC2024CN155551$NOVARTIS$$72$YR$$F$Y$53$KG$20240731$$HP$CN$CN
241580961$24158096$1$I$$20240617$20240731$20240731$PER$$US-TRAVERE-2024TVT00616$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240731$$CN$US$US
241580971$24158097$1$I$20240628$20240722$20240731$20240731$EXP$FR-AFSSAPS-AM2024000579$FR-TEVA-VS-3225208$TEVA$$36$YR$$F$Y$65$KG$20240731$$MD$FR$FR
241580984$24158098$4$F$$20240726$20240731$20240815$PER$$US-TRAVERE-2024TVT00617$TRAVERE THERAPEUTICS$$55$YR$A$M$Y$$$20240815$$CN$US$US
241580991$24158099$1$I$$20240722$20240731$20240731$EXP$$CA-APOTEX-2024AP008696$APOTEX$$81$YR$$F$Y$$$20240731$$PH$CA$CA
241581001$24158100$1$I$20240329$20240722$20240731$20240731$EXP$FR-AFSSAPS-LL2024001296$FR-TEVA-VS-3224735$TEVA$$69$YR$$F$Y$100$KG$20240731$$MD$FR$FR
241581011$24158101$1$I$20240311$20240725$20240731$20240731$EXP$$BR-BIOGEN-2024BI01275807$BIOGEN$$32$YR$$F$Y$53$KG$20240731$$CN$BR$BR
241581021$24158102$1$I$20220101$20240726$20240731$20240731$EXP$$CL-ABBVIE-5856291$ABBVIE$$$$$M$Y$$$20240731$$CN$CL$CL
241581031$24158103$1$I$20240601$20240726$20240731$20240731$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-15098$IPSEN$$4$YR$C$F$Y$21.7$KG$20240731$$CN$US$US
241581041$24158104$1$I$20240729$20240731$20240731$20240731$DIR$712194$$FDA-CTU$$76$YR$$F$N$69.75$KG$20240731$N$CN$US$
241581051$24158105$1$I$$20240318$20240731$20240731$EXP$$CA-TEVA-202303_00014058$TEVA$$43$YR$$F$Y$96$KG$20240731$$HP$CA$CA
241581061$24158106$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5859526$ABBVIE$$$$$M$Y$$$20240731$$HP$US$US
241581071$24158107$1$I$20240626$20240729$20240731$20240731$EXP$$US-GSK-US2024094791$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$US$US
241581081$24158108$1$I$20240615$20240725$20240731$20240731$EXP$FR-AFSSAPS-NC2024000837$FR-MYLANLABS-2024M1069950$MYLAN$$89$YR$$F$Y$$$20240731$$MD$FR$FR
241581091$24158109$1$I$$20240730$20240731$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA069358$SANDOZ$$23$MON$$M$Y$11$KG$20240731$$PH$CA$CA
241581101$24158110$1$I$$20240730$20240731$20240731$PER$$US-HALEON-2189751$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241581111$24158111$1$I$20240628$20240724$20240731$20240731$EXP$$US-AMERICAN REGENT INC-2024002886$AMERICAN REGENT$$35$YR$$F$Y$64$KG$20240731$$HP$US$US
241581121$24158112$1$I$$20240722$20240731$20240731$EXP$$IR-MAYNE PHARMA-2024MYN000325$MAYNE$Homina Saffar, Leili Abdan, Zahra Abdan, Hamidreza Hekmat, Alireza Amirzadegan, Negar Omidi. Spontaneous coronary artery dissection in the context of tamoxifen; Is there any correlation?. Clinical case reports. 2024;12:e9140$$$$$Y$$$20240731$$MD$IR$IR
241581132$24158113$2$F$20180613$20240729$20240731$20240820$EXP$$DE-SANDOZ INC.-SDZ2024DE069191$SANDOZ$$50$YR$$F$Y$49$KG$20240820$$CN$DE$DE
241581141$24158114$1$I$20230515$20240729$20240731$20240731$EXP$FR-AFSSAPS-AM2024000584$FR-SANDOZ INC.-SDZ2024FR069164$SANDOZ$$63$YR$$M$Y$113$KG$20240731$$MD$FR$FR
241581151$24158115$1$I$$20240730$20240731$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA069404$SANDOZ$$59$YR$$M$Y$$$20240731$$CN$CA$CA
241581161$24158116$1$I$$20240724$20240731$20240731$EXP$$US-APELLIS-2024-APL-0000565$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240731$$HP$US$US
241581171$24158117$1$I$$20240727$20240731$20240731$EXP$$TW-AMGEN-TWNSP2024150195$AMGEN$Lai E. C.; Huang H.; Chuang A. T. et al.. Denosumab and the Risk of Diabetes in Patients Treated for Osteoporosis. JAMA Network Open I Pharmacy and Clinical Pharmacology. 2024;7 (2):1-13$$$$$Y$$$20240731$$MD$TW$TW
241581181$24158118$1$I$20240724$20240725$20240731$20240731$EXP$$US-JNJFOC-20240773440$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240731$$CN$US$US
241581193$24158119$3$F$$20240808$20240731$20240809$PER$$US-PFIZER INC-PV202400097576$PFIZER$$10$YR$$M$Y$32.205$KG$20240809$$MD$US$US
241581202$24158120$2$F$$20240830$20240731$20240903$PER$$US-PFIZER INC-202400225105$PFIZER$$54$YR$$F$Y$$$20240903$$CN$US$US
241581212$24158121$2$F$$20240830$20240731$20240903$PER$$US-PFIZER INC-PV202400096628$PFIZER$$14$YR$$M$Y$53.1$KG$20240903$$MD$US$US
241581232$24158123$2$F$$20240831$20240731$20240903$PER$$US-PFIZER INC-202400225379$PFIZER$$67$YR$$F$Y$$$20240903$$CN$US$US
241581241$24158124$1$I$$20240725$20240731$20240731$PER$$US-PFIZER INC-202400224453$PFIZER$$$$$$Y$$$20240731$$CN$US$US
241581252$24158125$2$F$$20240801$20240731$20240806$PER$$US-PFIZER INC-PV202400099124$PFIZER$$63$YR$$F$Y$$$20240806$$CN$US$US
241581261$24158126$1$I$$20240725$20240731$20240731$PER$$US-BAYER-2024A108941$BAYER$$37$YR$A$F$Y$$$20240731$$MD$US$US
241581281$24158128$1$I$$20240730$20240731$20240731$EXP$GB-MHRA-TPP22108890C20896881YC1721916123024$GB-ORGANON-O2407GBR002853$ORGANON$$79$YR$$F$Y$77$KG$20240731$$MD$GB$GB
241581291$24158129$1$I$$20240726$20240731$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA068629$SANDOZ$$$$$F$Y$$$20240731$$MD$CA$CA
241581301$24158130$1$I$$20240405$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005616$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241581311$24158131$1$I$$20240710$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006237$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241581321$24158132$1$I$$20240515$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005866$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241581331$24158133$1$I$20240501$20240530$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005981$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241581341$24158134$1$I$$20240605$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006025$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241581351$24158135$1$I$$20240403$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005566$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241581361$24158136$1$I$$20240513$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005850$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241581381$24158138$1$I$$20240731$20240731$20240731$DIR$712219$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241581391$24158139$1$I$20240730$20240731$20240731$20240731$DIR$712200$$FDA-CTU$$63$YR$$M$N$123.2$KG$20240731$N$HP$US$
241581401$24158140$1$I$20240704$20240708$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006217$AURINIA PHARMACEUTICALS$$38$YR$$F$Y$$$20240731$$CN$US$US
241581411$24158141$1$I$$20240624$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006148$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241581421$24158142$1$I$20240501$20240521$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005813$AURINIA PHARMACEUTICALS$$57$YR$$M$Y$$$20240731$$CN$US$US
241581431$24158143$1$I$$20240617$20240731$20240731$PER$$US-TRAVERE-2024TVT00621$TRAVERE THERAPEUTICS$$55$YR$A$F$Y$$$20240731$$CN$US$US
241581441$24158144$1$I$20240728$20240731$20240731$20240731$DIR$712197$$FDA-CTU$$48$YR$$F$N$54.6$KG$20240731$N$$US$
241581451$24158145$1$I$$20240730$20240731$20240731$EXP$GB-MHRA-MED-202407251205574320-RQCGB$GB-ORGANON-O2407GBR002856$ORGANON$$$$$$Y$$$20240731$$CN$GB$GB
241581461$24158146$1$I$20240730$20240731$20240731$20240731$DIR$712201$$FDA-CTU$$70$YR$$M$N$75.3$KG$20240731$N$HP$US$
241581471$24158147$1$I$$20240729$20240731$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA069030$SANDOZ$$16$YR$$M$Y$$$20240731$$CN$CA$CA
241581481$24158148$1$I$20240718$20240731$20240731$20240731$DIR$712225$$FDA-CTU$$$$$F$N$109$KG$20240731$N$$US$
241581491$24158149$1$I$$20240730$20240731$20240731$EXP$$US-TAKEDA-2024TUS062722$TAKEDA$$$$$F$Y$$$20240731$$CN$US$US
241581502$24158150$2$F$20240729$20240730$20240731$20240802$EXP$$US-BIOVITRUM-2024-US-010412$BIOVITRUM$$54$YR$$F$Y$$$20240802$$PH$US$US
241581511$24158151$1$I$20240723$20240723$20240731$20240731$PER$$US-BIOGEN-2024BI01275262$BIOGEN$$39$YR$$F$Y$$$20240731$$CN$US$US
241581521$24158152$1$I$20240516$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52580$$FDA-CTU$$74$YR$$M$N$72.57$KG$20240731$N$CN$US$
241581531$24158153$1$I$$20240729$20240731$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA069054$SANDOZ$$81$YR$$F$Y$$$20240731$$HP$CA$CA
241581541$24158154$1$I$20240529$20240722$20240731$20240731$EXP$FR-AFSSAPS-BS2024000431$FR-TAKEDA-2024TUS076459$TAKEDA$$85$YR$$F$Y$$$20240731$$HP$FR$FR
241581551$24158155$1$I$$20240721$20240731$20240731$EXP$$CH-TAKEDA-2024TUS076523$TAKEDA$$61$YR$$M$Y$$$20240731$$HP$CH$CH
241581561$24158156$1$I$20240603$20240731$20240731$20240731$DIR$712227$$FDA-CTU$$51$YR$$F$N$72$KG$20240731$N$HP$US$
241581571$24158157$1$I$$20240725$20240731$20240731$EXP$$US-BIOGEN-2024BI01275619$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
241581582$24158158$2$F$$20240815$20240731$20240819$EXP$$US-SANDOZ INC.-SDZ2024US069228$SANDOZ$$$$$F$Y$$$20240819$$CN$US$US
241581591$24158159$1$I$20240605$20240726$20240731$20240731$EXP$FR-AFSSAPS-AVCN2024000571$FR-JNJFOC-20240776139$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240731$$HP$FR$FR
241581603$24158160$3$F$20230101$20240917$20240731$20240924$EXP$$CA-GSK-CA2023123165$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$CA$CA
241581611$24158161$1$I$20240606$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171085$ASTRAZENECA$$$$$$Y$$$20240731$$MD$US$
241581621$24158162$1$I$$20240723$20240731$20240731$EXP$$IR-AstraZeneca-2024A168689$ASTRAZENECA$Bozorgi A, Farzaei A, Nasab EM, Jenab Y, Amirzadegan A, Javazm AK. An interesting case series of ticagrelor induced long QTc. International Journal of Cardiology Cardiovascular Risk and Prevention 2024;22:200311-.$70$YR$$M$Y$$$20240731$$HP$IR$
241581631$24158163$1$I$$20240523$20240731$20240731$EXP$$US-AstraZeneca-2024A121869$ASTRAZENECA$$$$$$Y$$$20240731$$CN$US$
241581641$24158164$1$I$20230508$20240725$20240731$20240731$EXP$$CA-GSK-CA2022AMR153723$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$HP$CA$CA
241581652$24158165$2$F$20230528$20240913$20240731$20240917$EXP$$JP-AstraZeneca-2023A225239$ASTRAZENECA$$79$YR$$M$Y$58$KG$20240917$$MD$JP$
241581661$24158166$1$I$$20240731$20240731$20240731$DIR$712228$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241581671$24158167$1$I$$20240731$20240731$20240731$DIR$712229$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241581681$24158168$1$I$$20240731$20240731$20240731$DIR$712230$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241581691$24158169$1$I$20240724$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52582$$FDA-CTU$$55$YR$$M$N$101$KG$20240731$N$$US$
241581701$24158170$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52581$$FDA-CTU$$56$YR$$F$N$$$20240731$N$$US$
241581711$24158171$1$I$20240709$20240730$20240731$20240731$PER$$US-ABBVIE-5861041$ABBVIE$$51$YR$$M$Y$$$20240731$$CN$US$US
241581721$24158172$1$I$$20240718$20240731$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-120636$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240731$$HP$CA$CA
241581731$24158173$1$I$20240601$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121227$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240731$$CN$US$US
241581741$24158174$1$I$$20240619$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006113$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241581751$24158175$1$I$20240603$20240603$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005995$AURINIA PHARMACEUTICALS$$17$YR$$F$Y$$$20240731$$CN$US$US
241581761$24158176$1$I$$20240530$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005998$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241581771$24158177$1$I$$20240702$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006196$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241581781$24158178$1$I$20240101$20240329$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005537$AURINIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240731$$CN$US$US
241581791$24158179$1$I$$20240426$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005746$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241581801$24158180$1$I$$20240411$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005635$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241581811$24158181$1$I$20240601$20240719$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006298$AURINIA PHARMACEUTICALS$$26$YR$$F$Y$$$20240731$$CN$US$US
241581821$24158182$1$I$$20240606$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006036$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241581831$24158183$1$I$20240412$20240415$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005645$AURINIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240731$$CN$US$US
241581841$24158184$1$I$20240501$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121402$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240731$$HP$US$US
241581851$24158185$1$I$20200102$20240722$20240731$20240731$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117432$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$59.4$KG$20240731$$MD$KR$KR
241581861$24158186$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121174$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240731$$HP$US$US
241581871$24158187$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120948$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240731$$CN$US$US
241581881$24158188$1$I$$20240729$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069336$SANDOZ$Preskorn SH, Masolak DD.. Life-threatening Rash Due to Lamotrigine and a Failure to Understand Its Pharmacology: How Forensic Detective Work Uses Medical Knowledge and Clinical Pharmacology to Solve Cases.. Journal of Psychiatric Practice. 2024;30(4):273-8$13$YR$$M$Y$$$20240731$$HP$US$US
241581891$24158189$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121072$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240731$$CN$US$US
241581901$24158190$1$I$20180320$20240722$20240731$20240731$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117343$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$72$KG$20240731$$MD$KR$KR
241581911$24158191$1$I$20240711$20240731$20240731$20240731$EXP$$CN-GILEAD-2024-0682446$GILEAD$$51$YR$A$F$Y$77$KG$20240731$$HP$CN$CN
241581921$24158192$1$I$20240709$20240719$20240731$20240731$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407018049$ELI LILLY AND CO$$87$YR$E$F$Y$75$KG$20240731$$CN$DE$CN
241581932$24158193$2$F$$20240906$20240731$20240910$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407016715$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240910$$CN$JP$JP
241581941$24158194$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018853$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240731$$CN$US$US
241581951$24158195$1$I$20240703$20240723$20240731$20240731$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407017654$ELI LILLY AND CO$$43$YR$A$M$Y$61$KG$20240731$$CN$DE$CN
241581961$24158196$1$I$$20240719$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013317$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240731$$CN$US$US
241581971$24158197$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018311$ELI LILLY AND CO$$$$E$$Y$$$20240731$$CN$US$US
241581981$24158198$1$I$20240304$20240718$20240731$20240731$EXP$ES-AEMPS-1546629$ES-ELI_LILLY_AND_COMPANY-ES202407012833$ELI LILLY AND CO$$40$YR$A$F$Y$65$KG$20240731$$CN$ES$ES
241581992$24158199$2$F$20240721$20240726$20240731$20240805$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407017514$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240805$$CN$JP$JP
241582002$24158200$2$F$20240703$20240808$20240731$20240819$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407016021AA$ELI LILLY AND CO$$25$YR$A$M$Y$$$20240819$$CN$JP$JP
241582022$24158202$2$F$20240701$20240715$20240731$20240815$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0726$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240814$$CN$US$US
241582031$24158203$1$I$$20240726$20240731$20240731$PER$$US-AMGEN-USASL2024149831$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241582041$24158204$1$I$$20240709$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006123$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582051$24158205$1$I$$20240607$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005547$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241582061$24158206$1$I$$20240429$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005762$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241582071$24158207$1$I$$20240718$20240731$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-121052$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$70$KG$20240731$$HP$CA$CA
241582081$24158208$1$I$$20240611$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005920$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582091$24158209$1$I$20240301$20240418$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005676$AURINIA PHARMACEUTICALS$$47$YR$$M$Y$$$20240731$$CN$US$US
241582101$24158210$1$I$$20240328$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005523$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241582111$24158211$1$I$$20240405$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005594$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582121$24158212$1$I$$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006137$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582131$24158213$1$I$$20240424$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005714$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241582141$24158214$1$I$$20240731$20240731$20240731$DIR$712206$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241582151$24158215$1$I$20240724$20240726$20240731$20240731$EXP$$CN-SANDOZ INC.-SDZ2024CN068744$SANDOZ$$38$YR$$F$Y$49$KG$20240731$$HP$CN$CN
241582161$24158216$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52583$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241582171$24158217$1$I$$20240711$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006118$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582181$24158218$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52585$$FDA-CTU$$64$YR$$F$N$88$KG$20240731$N$$US$
241582191$24158219$1$I$$20240524$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005940$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582201$24158220$1$I$$20240604$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006024$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582211$24158221$1$I$20240101$20240724$20240731$20240731$PER$$US-BIOGEN-2024BI01273401$BIOGEN$$$$$F$Y$$$20240731$$MD$US$US
241582221$24158222$1$I$$20240429$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005759$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582231$24158223$1$I$20240731$20240731$20240731$20240731$DIR$712217$$FDA-CTU$$44$YR$$M$N$$$20240731$Y$HP$US$
241582241$24158224$1$I$$20240430$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005769$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241582251$24158225$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52584$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241582261$24158226$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52590$$FDA-CTU$$66$YR$$M$N$$$20240731$N$$US$
241582271$24158227$1$I$20240621$20240621$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006139$AURINIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240731$$CN$US$US
241582281$24158228$1$I$$20240617$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006102$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582291$24158229$1$I$$20240410$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005621$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582301$24158230$1$I$20240710$20240731$20240731$20240731$DIR$712235$$FDA-CTU$$53$YR$$F$N$80.1$KG$20240731$N$CN$US$
241582311$24158231$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52591$$FDA-CTU$$65$YR$$M$N$$$20240731$N$$US$
241582321$24158232$1$I$20240723$20240731$20240731$20240731$DIR$712236$$FDA-CTU$$58$YR$$M$N$77.5$KG$20240731$N$CN$US$
241582331$24158233$1$I$$20240604$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005617$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582341$24158234$1$I$$20240417$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005674$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582351$24158235$1$I$$20240613$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005576$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241582361$24158236$1$I$$20240725$20240731$20240731$EXP$$AR-INCYTE CORPORATION-2024IN007936$INCYTE$$$$$$Y$$$20240731$$MD$AR$AR
241582371$24158237$1$I$20240201$20240725$20240731$20240731$EXP$$DE-MYLANLABS-2024M1069973$MYLAN$$36$YR$$F$Y$89$KG$20240731$$MD$DE$DE
241582381$24158238$1$I$$20240722$20240731$20240731$EXP$$CH-AMGEN-CHESP2024147001$AMGEN$Schmid G.. Unknown. Unknown. 2024;30-33$83$YR$E$F$Y$$$20240731$$MD$CH$CH
241582392$24158239$2$F$20210910$20240822$20240731$20240829$EXP$$CA-GSK-CA2021AMR199544$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$CA$CA
241582403$24158240$3$F$20240101$20240824$20240731$20240827$EXP$$KR-JNJFOC-20240159606$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240827$$HP$KR$KR
241582411$24158241$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121435$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240731$$CN$US$US
241582421$24158242$1$I$20240101$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120031$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240731$$HP$US$US
241582432$24158243$2$F$20240701$20240821$20240731$20240823$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-119099$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240823$$PH$CH$CH
241582441$24158244$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120284$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240731$$HP$US$US
241582451$24158245$1$I$$20240723$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118560$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240731$$HP$US$US
241582461$24158246$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120404$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240731$$CN$US$US
241582471$24158247$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121092$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240731$$CN$US$US
241582491$24158249$1$I$20240601$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120039$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240731$$HP$US$US
241582501$24158250$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120090$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240731$$CN$US$US
241582511$24158251$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121383$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240731$$CN$US$US
241582521$24158252$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120467$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240731$$CN$US$US
241582531$24158253$1$I$$20240701$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120950$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240731$$CN$US$US
241582541$24158254$1$I$20231023$20240724$20240731$20240731$EXP$FR-AFSSAPS-NY2024000834$FR-EMD Serono-2024040219$EMD SERONO INC$$64$YR$A$F$Y$75$KG$20240731$$PH$FR$FR
241582551$24158255$1$I$20240618$20240722$20240731$20240731$EXP$FR-AFSSAPS-LL2024001298$FR-TEVA-VS-3224837$TEVA$$59$YR$$F$Y$50$KG$20240731$$MD$FR$FR
241582561$24158256$1$I$20240621$20240624$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006143$AURINIA PHARMACEUTICALS$$23$YR$$F$Y$$$20240731$$CN$US$US
241582571$24158257$1$I$$20240417$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005680$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582581$24158258$1$I$$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005965$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582592$24158259$2$F$$20240830$20240731$20240904$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006227$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
241582601$24158260$1$I$20240621$20240624$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006149$AURINIA PHARMACEUTICALS$$46$YR$$F$Y$$$20240731$$MD$US$US
241582611$24158261$1$I$$20240717$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006281$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241582621$24158262$1$I$$20240508$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005809$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582631$24158263$1$I$$20240529$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005968$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582641$24158264$1$I$$20240620$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005816$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241582651$24158265$1$I$$20240712$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006264$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582671$24158267$1$I$$20240725$20240731$20240731$EXP$$MY-AMERICAN REGENT INC-2024002876$AMERICAN REGENT$Mohd Shukri MF, Badrin S, Abdul Kadir A, Hasan NA, Chung TS. The pregnancy journey of a patient with end-stage renal disease on hemodialysis: A case study. Electronic Journal of General Medicine. 2024;21(2):em575 (1-4)$37$YR$$F$Y$$$20240731$$HP$MY$MY
241582681$24158268$1$I$$20240724$20240731$20240731$PER$$US-RDY-SPO/USA/24/0011051$DR REDDYS$$25$YR$A$F$Y$$$20240731$$MD$US$US
241582691$24158269$1$I$$20240619$20240731$20240731$PER$$US-TRAVERE-2024TVT00627$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240731$$HP$US$US
241582701$24158270$1$I$20240601$20240725$20240731$20240731$EXP$SE-SEMPA-2024-005422$SE-MYLANLABS-2024M1070175$MYLAN$$73$YR$$M$Y$$$20240731$$MD$SE$SE
241582711$24158271$1$I$$20240620$20240731$20240731$PER$$US-TRAVERE-2024TVT00626$TRAVERE THERAPEUTICS$$$$$F$Y$61.69$KG$20240731$$CN$US$US
241582721$24158272$1$I$20240710$20240731$20240731$20240731$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042986$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$55$KG$20240731$$HP$CN$CN
241582731$24158273$1$I$20200101$20240730$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042816$BOEHRINGER INGELHEIM$$$$$$Y$$$20240731$$HP$US$US
241582741$24158274$1$I$$20240723$20240731$20240731$EXP$$CH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041422$BOEHRINGER INGELHEIM$Hugli O, Matbouli R, Pantet O, Castioni J, Vakilzadeh N, Alberio L. Dabigatran accumulation in acute kidney injury: is more better than less to prevent bleeding? A case report. International Journal of Emergency Medicine. 2024;17:1: 91. doi:10.1186/s12245-024-00677-3.$71$YR$E$F$Y$$$20240731$$HP$CH$CH
241582751$24158275$1$I$$20240725$20240731$20240731$PER$$US-BIOGEN-2024BI01275586$BIOGEN$$$$$F$Y$$$20240731$$HP$US$US
241582761$24158276$1$I$$20240725$20240731$20240731$PER$$US-BIOGEN-2024BI01275525$BIOGEN$$$$$F$Y$$$20240731$$MD$US$US
241582771$24158277$1$I$$20240724$20240731$20240731$EXP$$CA-GSK-CA2024AMR093282$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$CA$CA
241582791$24158279$1$I$$20240728$20240731$20240731$DIR$FDA-CDER-CTU-2024-52592$$FDA-CTU$$$$$M$N$$$20240728$N$HP$US$
241582801$24158280$1$I$20240711$20240731$20240731$20240731$DIR$712234$$FDA-CTU$$80$YR$$M$N$87.5$KG$20240731$N$PH$US$
241582851$24158285$1$I$20240727$20240731$20240731$20240731$DIR$712240$$FDA-CTU$$54$YR$$F$N$93.9$KG$20240731$N$HP$US$
241582861$24158286$1$I$20240517$20240731$20240731$20240731$DIR$712218$$FDA-CTU$$70$YR$$M$N$78.75$KG$20240731$N$CN$US$
241582871$24158287$1$I$20240601$20240722$20240731$20240731$PER$$US-SA-2024SA218639$SANOFI AVENTIS$$3$YR$C$M$Y$11.8$KG$20240731$$MD$US$US
241582881$24158288$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA219052$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240731$$MD$US$US
241582891$24158289$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA222255$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240731$$MD$US$US
241582902$24158290$2$F$$20240731$20240731$20240731$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043011$BOEHRINGER INGELHEIM$$$$$$Y$$$20240731$$MD$US$US
241582912$24158291$2$F$$20240731$20240731$20240731$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043009$BOEHRINGER INGELHEIM$$$$$$Y$$$20240731$$MD$US$US
241582921$24158292$1$I$$20240429$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005749$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582931$24158293$1$I$$20240719$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006302$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582941$24158294$1$I$20230202$20240612$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006083$AURINIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240731$$CN$US$US
241582951$24158295$1$I$$20240502$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005779$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582961$24158296$1$I$20240704$20240709$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006240$AURINIA PHARMACEUTICALS$$38$YR$$F$Y$$$20240731$$CN$US$US
241582971$24158297$1$I$$20240717$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006297$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582981$24158298$1$I$$20240416$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005667$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241582991$24158299$1$I$$20240624$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006146$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583001$24158300$1$I$$20240627$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006168$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583011$24158301$1$I$$20240603$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005997$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583021$24158302$1$I$$20240716$20240731$20240731$PER$$US-JNJFOC-20240776111$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241583031$24158303$1$I$$20240729$20240731$20240731$PER$$US-TAKEDA-2024TUS076457$TAKEDA$$$$$F$Y$$$20240731$$CN$US$US
241583041$24158304$1$I$$20240607$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006048$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241583051$24158305$1$I$20240615$20240718$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006299$AURINIA PHARMACEUTICALS$$53$YR$$F$Y$$$20240731$$CN$US$US
241583061$24158306$1$I$$20240409$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005604$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583071$24158307$1$I$$20240717$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006290$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583081$24158308$1$I$$20240716$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006280$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583091$24158309$1$I$$20240425$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005737$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241583101$24158310$1$I$$20240708$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006222$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583111$24158311$1$I$$20240711$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006243$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583121$24158312$1$I$$20240710$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006242$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241583131$24158313$1$I$$20240723$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120416$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240731$$HP$US$US
241583141$24158314$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120494$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240731$$CN$US$US
241583151$24158315$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121033$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240731$$CN$US$US
241583161$24158316$1$I$$20240729$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120037$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240731$$CN$US$US
241583171$24158317$1$I$20240731$20240731$20240731$20240731$DIR$712221$$FDA-CTU$$49$YR$$F$N$$$20240731$N$PH$US$
241583181$24158318$1$I$$20240730$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120888$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$103.87$KG$20240731$$CN$US$US
241583191$24158319$1$I$20240703$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52593$$FDA-CTU$$81$YR$$M$N$$$20240731$Y$PH$US$
241583213$24158321$3$F$20240701$20240827$20240731$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121450$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240903$$CN$US$US
241583221$24158322$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120292$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240731$$CN$US$US
241583231$24158323$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121175$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240731$$CN$US$US
241583241$24158324$1$I$$20240730$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121082$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$72.12$KG$20240731$$CN$US$US
241583251$24158325$1$I$20240101$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121247$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240731$$CN$US$US
241583261$24158326$1$I$$20240731$20240731$20240731$DIR$712242$$FDA-CTU$$61$YR$$F$N$$$20240731$N$PH$US$
241583271$24158327$1$I$20240706$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120278$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240731$$CN$US$US
241583281$24158328$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120169$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240731$$HP$US$US
241583301$24158330$1$I$20240329$20240722$20240731$20240731$EXP$FR-AFSSAPS-AM2024000570$FR-TEVA-VS-3225214$TEVA$$72$YR$$F$Y$60$KG$20240731$$MD$FR$FR
241583311$24158331$1$I$20240711$20240711$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006251$AURINIA PHARMACEUTICALS$$29$YR$$F$Y$$$20240731$$MD$US$US
241583331$24158333$1$I$$20240730$20240731$20240731$EXP$$ES-SANDOZ INC.-SDZ2024ES069243$SANDOZ$$$$$M$Y$$$20240731$$CN$ES$ES
241583341$24158334$1$I$$20240624$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006144$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583351$24158335$1$I$$20240708$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006216$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241583361$24158336$1$I$$20240716$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006283$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583371$24158337$1$I$20240401$20240423$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005709$AURINIA PHARMACEUTICALS$$41$YR$$F$Y$$$20240731$$CN$US$US
241583381$24158338$1$I$$20240422$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005619$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241583391$24158339$1$I$$20240724$20240731$20240731$EXP$$US-BAYER-2024A110065$BAYER$$76$YR$E$M$Y$$$20240731$$CN$US$US
241583401$24158340$1$I$$20240711$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006252$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583411$24158341$1$I$$20240424$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005725$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583421$24158342$1$I$$20240626$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005967$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583431$24158343$1$I$$20240708$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006225$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583441$24158344$1$I$20240401$20240418$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005684$AURINIA PHARMACEUTICALS$$23$YR$$F$Y$$$20240731$$CN$US$US
241583451$24158345$1$I$$20240729$20240731$20240731$EXP$$JP-ABBVIE-5859855$ABBVIE$$72$YR$$F$Y$$$20240731$$MD$JP$JP
241583462$24158346$2$F$20240701$20240806$20240731$20240809$PER$$US-ABBVIE-5860895$ABBVIE$$40$YR$$F$Y$74$KG$20240809$$CN$US$US
241583471$24158347$1$I$20240706$20240730$20240731$20240731$EXP$$GB-MYLANLABS-2024M1070893$MYLAN$$50$YR$$F$Y$65$KG$20240731$$MD$GB$GB
241583481$24158348$1$I$$20240729$20240731$20240731$EXP$$CA-MYLANLABS-2023M1031153$MYLAN$$$$$F$Y$$$20240731$$HP$CA$CA
241583492$24158349$2$F$20240703$20240904$20240731$20240905$EXP$FR-AFSSAPS-TS2024000863$FR-SANDOZ INC.-SDZ2024FR069252$SANDOZ$$89$YR$$M$Y$103$KG$20240905$$MD$FR$FR
241583501$24158350$1$I$20240113$20240722$20240731$20240731$EXP$ES-AEMPS-1550895$ES-BAXTER-2024BAX022095$BAXTER$$75$YR$$M$Y$$$20240731$$MD$ES$ES
241583511$24158351$1$I$20240705$20240729$20240731$20240731$EXP$$DE-SANDOZ INC.-SDZ2024DE069009$SANDOZ$$78$YR$$F$Y$$$20240731$$MD$DE$DE
241583521$24158352$1$I$$20240722$20240731$20240731$EXP$$US-BAXTER-2024BAX022079$BAXTER$$$$$$Y$$$20240731$$PH$US$US
241583532$24158353$2$F$20240720$20240801$20240731$20240811$EXP$$DE-BAXTER-2024BAX022059$BAXTER$$77$YR$$M$Y$$$20240811$$HP$DE$DE
241583541$24158354$1$I$$20240722$20240731$20240731$EXP$NL-LRB-00990425$NL-BAXTER-2024BAX022094$BAXTER$$57$YR$$M$Y$80$KG$20240731$$MD$NL$NL
241583552$24158355$2$F$$20240812$20240731$20240822$EXP$$ES-BAXTER-2024BAX022172$BAXTER$$73$YR$$M$Y$$$20240822$$HP$ES$ES
241583561$24158356$1$I$$20240723$20240731$20240731$PER$$US-BIOGEN-2024BI01275436$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
241583571$24158357$1$I$20240601$20240724$20240731$20240731$EXP$$US-ABBVIE-5819248$ABBVIE$$52$YR$$M$Y$$$20240731$$CN$US$US
241583581$24158358$1$I$$20240702$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006195$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583591$24158359$1$I$$20240328$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005532$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241583601$24158360$1$I$$20240718$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006294$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241583611$24158361$1$I$$20240403$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005557$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583621$24158362$1$I$$20240507$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005791$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241583631$24158363$1$I$$20240405$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005584$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241583641$24158364$1$I$$20240716$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006288$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583651$24158365$1$I$20240502$20240502$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005793$AURINIA PHARMACEUTICALS$$44$YR$$F$Y$$$20240731$$CN$US$US
241583661$24158366$1$I$$20240614$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006099$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583671$24158367$1$I$20240101$20240711$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006256$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583681$24158368$1$I$$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119970$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240731$$HP$US$US
241583692$24158369$2$F$20240701$20240723$20240731$20240802$EXP$$AE-AstraZeneca-2024A170196$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$AE$
241583701$24158370$1$I$$20240723$20240731$20240731$EXP$$JP-AstraZeneca-2024A169390$ASTRAZENECA$$74$YR$$M$Y$$$20240731$$MD$JP$
241583711$24158371$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A168215$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241583721$24158372$1$I$20230101$20240724$20240731$20240731$EXP$$US-AMGEN-USASP2024147459$AMGEN$$68$YR$E$M$Y$$$20240731$$CN$US$US
241583731$24158373$1$I$20240624$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150303$AMGEN$$90$YR$E$F$Y$$$20240731$$CN$US$US
241583741$24158374$1$I$$20240730$20240731$20240731$EXP$$DE-SANDOZ INC.-SDZ2024DE069287$SANDOZ$$63$YR$$M$Y$$$20240731$$MD$DE$DE
241583761$24158376$1$I$$20240701$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006191$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583771$24158377$1$I$$20240716$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006289$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583782$24158378$2$F$20240318$20240918$20240731$20240927$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-005587$AURINIA PHARMACEUTICALS$$31$YR$$F$Y$$$20240927$$CN$US$US
241583791$24158379$1$I$20240522$20240604$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006021$AURINIA PHARMACEUTICALS$$54$YR$$F$Y$$$20240731$$CN$US$US
241583801$24158380$1$I$$20240717$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006286$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583811$24158381$1$I$$20240717$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006291$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241583821$24158382$1$I$$20240705$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006210$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583831$24158383$1$I$$20240531$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005991$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241583841$24158384$1$I$$20240705$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006215$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583851$24158385$1$I$20240301$20240730$20240731$20240731$EXP$FR-AFSSAPS-TS2024000869$FR-ABBVIE-5859936$ABBVIE$$41$YR$$F$Y$88$KG$20240731$$MD$FR$FR
241583861$24158386$1$I$$20240711$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006253$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583871$24158387$1$I$$20240716$20240731$20240731$PER$$US-RDY-SPO/USA/24/0010556$DR REDDYS$$$$$F$Y$$$20240731$$CN$US$US
241583882$24158388$2$F$20240106$20240725$20240731$20240806$EXP$FR-AFSSAPS-NY2024000841$FR-009507513-2407FRA014194$MERCK$$76$YR$$M$Y$75$KG$20240806$$PH$FR$FR
241583891$24158389$1$I$20240601$20240730$20240731$20240731$EXP$FR-AFSSAPS-NT2024000942$FR-ORGANON-O2407FRA002818$ORGANON$$84$YR$$M$Y$65.7$KG$20240731$$MD$FR$FR
241583901$24158390$1$I$20240716$20240716$20240731$20240731$PER$$US-RDY-SPO/USA/24/0010681$DR REDDYS$$38$YR$A$$Y$$$20240731$$CN$US$US
241583912$24158391$2$F$20240622$20240731$20240731$20240805$EXP$$US-Eisai-EC-2024-171085$EISAI$$67$YR$E$M$Y$103.2$KG$20240804$$HP$US$US
241583921$24158392$1$I$20240713$20240730$20240731$20240731$EXP$DE-BFARM-24005219$DE-ORGANON-O2407DEU002803$ORGANON$$35$YR$$F$Y$$$20240731$$MD$DE$DE
241583931$24158393$1$I$$20240620$20240731$20240731$PER$$US-TRAVERE-2024TVT00630$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240731$$CN$US$US
241583942$24158394$2$F$20240611$20240702$20240731$20240815$PER$$US-TRAVERE-2024TVT00629$TRAVERE THERAPEUTICS$$44$YR$A$M$Y$$$20240815$$CN$US$US
241583953$24158395$3$F$20190316$20240808$20240731$20240813$EXP$$CA-TAKEDA-2024TUS076620$TAKEDA$$21$YR$$F$Y$$$20240813$$CN$CA$CA
241583962$24158396$2$F$$20240905$20240731$20240913$EXP$$JP-009507513-2407JPN004517J$MERCK$$$$$F$Y$$$20240913$$MD$JP$JP
241583971$24158397$1$I$$20240408$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005595$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241583981$24158398$1$I$$20240709$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006231$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241583993$24158399$3$F$20240617$20240729$20240731$20240806$EXP$GB-MHRA-MED-202407231401250430-NKYWP$GB-009507513-2407GBR015452$MERCK$$60$YR$$M$Y$$$20240806$$MD$GB$GB
241584001$24158400$1$I$20240701$20240722$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006138$AURINIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240731$$CN$US$US
241584011$24158401$1$I$20240321$20240621$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006134$AURINIA PHARMACEUTICALS$$26$YR$$F$Y$$$20240731$$MD$US$US
241584021$24158402$1$I$$20240530$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005984$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584031$24158403$1$I$$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006272$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584041$24158404$1$I$$20240712$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006266$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584051$24158405$1$I$$20240717$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006295$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584061$24158406$1$I$$20240710$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006244$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584071$24158407$1$I$$20240708$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006221$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584081$24158408$1$I$20240706$20240716$20240731$20240731$PER$$US-MYLANLABS-2024M1067340$MYLAN$$43$YR$$F$Y$$$20240731$$CN$US$US
241584091$24158409$1$I$20240601$20240725$20240731$20240731$EXP$$FR-MYLANLABS-2024M1070086$MYLAN$$34$YR$$M$Y$$$20240731$$MD$FR$FR
241584102$24158410$2$F$20240101$20240802$20240731$20240802$PER$$US-BAYER-2024A107944$BAYER$$$$$F$Y$$$20240802$$CN$US$US
241584111$24158411$1$I$20240101$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024148433$AMGEN$$$$$M$Y$$$20240731$$CN$US$US
241584121$24158412$1$I$$20240724$20240731$20240731$EXP$$US-AMGEN-USASP2024147976$AMGEN$$$$$F$Y$73.878$KG$20240731$$CN$US$US
241584132$24158413$2$F$$20240724$20240731$20240806$EXP$$CA-BEH-2024176550$CSL BEHRING$$$$$M$Y$$$20240806$$CN$CA$CA
241584141$24158414$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018628$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$US$US
241584151$24158415$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019798$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240731$$CN$US$US
241584161$24158416$1$I$20240726$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017922$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240731$$CN$US$US
241584171$24158417$1$I$20240101$20240703$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006204$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584181$24158418$1$I$$20240607$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006042$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584191$24158419$1$I$$20240410$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005623$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241584201$24158420$1$I$20231001$20240522$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005919$AURINIA PHARMACEUTICALS$$18$YR$$F$Y$$$20240731$$MD$US$US
241584211$24158421$1$I$20240519$20240530$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005910$AURINIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240731$$CN$US$US
241584221$24158422$1$I$$20240710$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006247$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584231$24158423$1$I$$20240626$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006164$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584241$24158424$1$I$$20240620$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006126$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241584251$24158425$1$I$$20240510$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005833$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584261$24158426$1$I$$20240614$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006089$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584271$24158427$1$I$20240626$20240722$20240731$20240731$EXP$FR-AFSSAPS-CN2024000699$FR-TEVA-VS-3224873$TEVA$$91$YR$$F$Y$$$20240731$$MD$FR$FR
241584281$24158428$1$I$$20240723$20240731$20240731$EXP$GB-MHRA-MED-202407232209444480-NGZPL$GB-TEVA-VS-3225250$TEVA$$32$YR$$F$Y$$$20240731$$MD$GB$GB
241584291$24158429$1$I$20240603$20240725$20240731$20240731$EXP$$EU-SEPTODONT-2024018709$SEPTODONT$$$$A$$Y$$$20240731$$HP$EU$EU
241584301$24158430$1$I$$20240730$20240731$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA069368$SANDOZ$$35$YR$$M$Y$$$20240731$$MD$CA$CA
241584311$24158431$1$I$$20240401$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005542$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584321$24158432$1$I$$20240514$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005855$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584331$24158433$1$I$20240701$20240711$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006255$AURINIA PHARMACEUTICALS$$52$YR$$M$Y$$$20240731$$CN$US$US
241584341$24158434$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006063$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584351$24158435$1$I$$20240516$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005869$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584361$24158436$1$I$$20240701$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006187$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584371$24158437$1$I$20240421$20240515$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005695$AURINIA PHARMACEUTICALS$$29$YR$$F$Y$$$20240731$$CN$US$US
241584383$24158438$3$F$$20240815$20240731$20240823$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000642$DECIPHERA PHARMACEUTICALS$$59$YR$A$F$Y$57.9$KG$20240823$$CN$US$US
241584391$24158439$1$I$$20240725$20240731$20240731$EXP$$BR-TAKEDA-2024TUS076550$TAKEDA$$24$YR$$$Y$$$20240731$$CN$BR$BR
241584401$24158440$1$I$$20240515$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005575$AURINIA PHARMACEUTICALS$$$$$F$Y$104.8$KG$20240731$$CN$US$US
241584411$24158441$1$I$$20240724$20240731$20240731$EXP$$KR-GSK-KR2024APC095037$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$MD$KR$KR
241584421$24158442$1$I$20240101$20240723$20240731$20240731$EXP$$CA-APOTEX-2024AP008817$APOTEX$$$$E$M$Y$$$20240731$$PH$CA$CA
241584431$24158443$1$I$20240728$20240728$20240731$20240731$EXP$GB-MHRA-MED-202407280259568670-CYMKB$GB-ABBVIE-5860227$ABBVIE$$$$$$Y$$$20240731$$CN$GB$GB
241584441$24158444$1$I$$20240705$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006213$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584451$24158445$1$I$$20240619$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005716$AURINIA PHARMACEUTICALS$$$$$F$Y$87.075$KG$20240731$$CN$US$US
241584461$24158446$1$I$$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006262$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584471$24158447$1$I$$20240415$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005658$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584481$24158448$1$I$$20240425$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005736$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584491$24158449$1$I$$20240409$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005612$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241584501$24158450$1$I$$20240423$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005715$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584511$24158451$1$I$$20240605$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006022$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584521$24158452$1$I$$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006269$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584531$24158453$1$I$$20240614$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005780$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$PH$US$US
241584551$24158455$1$I$$20240723$20240731$20240731$PER$$US-JNJFOC-20240764290$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241584561$24158456$1$I$$20240412$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005646$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241584571$24158457$1$I$$20240415$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005657$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584581$24158458$1$I$$20240619$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006116$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241584591$24158459$1$I$20240419$20240422$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005696$AURINIA PHARMACEUTICALS$$39$YR$$F$Y$$$20240731$$CN$US$US
241584601$24158460$1$I$$20240717$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005841$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241584611$24158461$1$I$20240301$20240506$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005794$AURINIA PHARMACEUTICALS$$34$YR$$F$Y$$$20240731$$CN$US$US
241584621$24158462$1$I$20240501$20240718$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005912$AURINIA PHARMACEUTICALS$$69$YR$$F$Y$72.109$KG$20240731$$CN$US$US
241584631$24158463$1$I$$20240718$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006249$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584651$24158465$1$I$$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024149090$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241584661$24158466$1$I$$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024149028$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241584671$24158467$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221322$SANOFI AVENTIS$$$$A$F$Y$52.16$KG$20240731$$MD$US$US
241584681$24158468$1$I$$20240419$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005683$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584691$24158469$1$I$$20240426$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005745$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584711$24158471$1$I$20240621$20240622$20240731$20240731$PER$$US-TRAVERE-2024TVT00633$TRAVERE THERAPEUTICS$$23$YR$A$M$Y$$$20240731$$CN$US$US
241584722$24158472$2$F$$20240806$20240731$20240822$PER$$US-TRAVERE-2024TVT00632$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
241584731$24158473$1$I$$20240726$20240731$20240731$EXP$CA-SEPTODONT-2024018845$CA-SEPTODONT-2024018845$SEPTODONT$$$$$$Y$$$20240731$$HP$CA$CA
241584741$24158474$1$I$$20240730$20240731$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA069492$SANDOZ$$$$$F$Y$$$20240731$$CN$CA$CA
241584752$24158475$2$F$$20240802$20240731$20240812$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700056$UPSHER SMITH LABORATORIES$$$$$F$Y$$$20240812$$MD$US$US
241584761$24158476$1$I$$20240415$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005653$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584771$24158477$1$I$$20240517$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005890$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241584781$24158478$1$I$$20240711$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005586$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584791$24158479$1$I$$20240404$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005579$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584801$24158480$1$I$$20240717$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005948$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241584811$24158481$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006070$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241584821$24158482$1$I$$20240424$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005723$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241584831$24158483$1$I$$20240412$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005637$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241584841$24158484$1$I$$20240426$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005554$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584851$24158485$1$I$20240321$20240401$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005544$AURINIA PHARMACEUTICALS$$39$YR$$F$Y$$$20240731$$HP$US$US
241584871$24158487$1$I$$20240727$20240731$20240731$EXP$$US-ABBVIE-5859328$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241584891$24158489$1$I$20240725$20240725$20240731$20240731$PER$$US-AMGEN-USASP2024148802$AMGEN$$82$YR$E$F$Y$$$20240731$$CN$US$US
241584901$24158490$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A168136$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241584911$24158491$1$I$20230101$20231025$20240731$20240731$EXP$$CA-PFIZER INC-202300151957$PFIZER$$81$YR$$M$Y$$$20240731$$PH$CA$CA
241584922$24158492$2$F$$20240917$20240731$20240920$30DAY$$US-PFIZER INC-202400219910$PFIZER$$14$YR$$F$Y$$$20240920$$CN$US$US
241584934$24158493$4$F$$20240923$20240731$20240926$30DAY$$CL-PFIZER INC-202400222761$PFIZER$$$$$M$Y$$$20240926$$CN$CL$CL
241584941$24158494$1$I$20240718$20240725$20240731$20240731$EXP$$SG-VANTIVE-2024VAN018601$Vantive US Healthcare$$73$YR$$M$Y$$$20240731$$CN$SG$SG
241584951$24158495$1$I$20240720$20240726$20240731$20240731$EXP$$SG-VANTIVE-2024VAN018648$Vantive US Healthcare$$60$YR$$M$Y$$$20240731$$CN$SG$SG
241584961$24158496$1$I$$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024150783$AMGEN$$$$$$Y$$$20240731$$HP$US$US
241584971$24158497$1$I$20240401$20240411$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005651$AURINIA PHARMACEUTICALS$$35$YR$$F$Y$$$20240731$$CN$US$US
241584981$24158498$1$I$$20240426$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005735$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241584991$24158499$1$I$$20240604$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005941$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585001$24158500$1$I$$20240425$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005740$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585011$24158501$1$I$20230928$20240701$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006183$AURINIA PHARMACEUTICALS$$35$YR$$F$Y$$$20240731$$MD$US$US
241585021$24158502$1$I$20240611$20240625$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006154$AURINIA PHARMACEUTICALS$$44$YR$$M$Y$$$20240731$$CN$US$US
241585031$24158503$1$I$$20240702$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006031$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585041$24158504$1$I$20240428$20240501$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005767$AURINIA PHARMACEUTICALS$$21$YR$$F$Y$$$20240731$$CN$US$US
241585061$24158506$1$I$$20240429$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005760$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241585073$24158507$3$F$20240623$20240826$20240731$20240903$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006177$AURINIA PHARMACEUTICALS$$35$YR$$F$Y$51.5$KG$20240903$$CN$US$US
241585081$24158508$1$I$20210929$20240726$20240731$20240731$PER$$US-DSJP-DSU-2024-137938$DAIICHI$$64$YR$$F$Y$89.5$KG$20240731$$MD$US$US
241585092$24158509$2$F$$20240831$20240731$20240903$30DAY$$US-PFIZER INC-202400224122$PFIZER$$14$YR$$M$Y$41.28$KG$20240903$$CN$US$US
241585114$24158511$4$F$20240725$20240917$20240731$20240920$30DAY$$US-PFIZER INC-202400224047$PFIZER$$47$YR$$F$Y$$$20240920$$CN$US$US
241585131$24158513$1$I$20240721$20240722$20240731$20240731$30DAY$$CL-PFIZER INC-202400222025$PFIZER$$9$YR$$$Y$$$20240731$$CN$CL$CL
241585142$24158514$2$F$$20240921$20240731$20240923$30DAY$$CO-PFIZER INC-202400220720$PFIZER$$13$YR$$M$Y$$$20240923$$CN$CO$CO
241585151$24158515$1$I$$20240728$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069076$SANDOZ$$63$YR$$F$Y$$$20240731$$CN$US$US
241585161$24158516$1$I$20240601$20240722$20240731$20240731$PER$$US-SA-2024SA217285$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240731$$MD$US$US
241585171$24158517$1$I$20240723$20240724$20240731$20240731$PER$$US-SA-2024SA222860$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240731$$MD$US$US
241585181$24158518$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA217760$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240731$$MD$US$US
241585201$24158520$1$I$20240101$20240722$20240731$20240731$EXP$$DE-TEVA-VS-3225856$TEVA$$78$YR$$F$Y$$$20240731$$PH$DE$DE
241585211$24158521$1$I$$20240730$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069504$SANDOZ$$$$$M$Y$$$20240731$$HP$US$US
241585221$24158522$1$I$20240101$20240723$20240731$20240731$PER$$US-SA-2024SA222237$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240731$$MD$US$US
241585231$24158523$1$I$$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005949$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585241$24158524$1$I$$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005966$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585251$24158525$1$I$$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005957$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585261$24158526$1$I$$20240509$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005804$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585271$24158527$1$I$$20240618$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005892$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585281$24158528$1$I$$20240522$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005698$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585291$24158529$1$I$$20240612$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005812$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585301$24158530$1$I$$20240415$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005665$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585311$24158531$1$I$$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005955$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$MD$US$US
241585321$24158532$1$I$$20240530$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005535$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585341$24158534$1$I$$20240724$20240731$20240731$EXP$$CA-GSK-CA2024092949$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$CA$CA
241585361$24158536$1$I$$20240720$20240731$20240731$PER$$US-BAYER-2024A105995$BAYER$$$$$$Y$$$20240731$$CN$US$US
241585371$24158537$1$I$$20240717$20240731$20240731$PER$$US-INSUD PHARMA-2407US05747$INSUD PHARMA$$$$$$Y$$$20240731$$HP$US$US
241585381$24158538$1$I$$20240715$20240731$20240731$PER$$US-INSUD PHARMA-2407US05593$INSUD PHARMA$$$$$$Y$$$20240731$$MD$US$US
241585391$24158539$1$I$20240101$20240718$20240731$20240731$PER$$US-INSUD PHARMA-2407US05794$INSUD PHARMA$$$$$$Y$$$20240731$$CN$US$US
241585401$24158540$1$I$20240301$20240710$20240731$20240731$PER$$US-INSUD PHARMA-2407US05542$INSUD PHARMA$$$$$$Y$$$20240731$$CN$US$US
241585411$24158541$1$I$20240331$20240405$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005588$AURINIA PHARMACEUTICALS$$44$YR$$F$Y$$$20240731$$CN$US$US
241585421$24158542$1$I$$20240503$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005782$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241585431$24158543$1$I$$20240412$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005640$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585441$24158544$1$I$$20240423$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005707$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241585461$24158546$1$I$$20240726$20240731$20240731$EXP$$CA-TAKEDA-2024TUS076425$TAKEDA$$$$$M$Y$$$20240731$$CN$CA$CA
241585472$24158547$2$F$20240722$20240809$20240731$20240816$EXP$$AU-GE HEALTHCARE-2024CSU008280$GE HEALTHCARE$$59$YR$$F$Y$85$KG$20240816$$HP$AU$AU
241585481$24158548$1$I$20231226$20240725$20240731$20240731$EXP$FR-AFSSAPS-TO2024000378$FR-SANDOZ INC.-SDZ2024FR026510$SANDOZ$$77$YR$$F$Y$$$20240731$$PH$FR$FR
241585491$24158549$1$I$$20240429$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005751$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585501$24158550$1$I$$20240611$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005610$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585511$24158551$1$I$$20240613$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006084$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241585521$24158552$1$I$$20240523$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005883$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585531$24158553$1$I$20240415$20240605$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005663$AURINIA PHARMACEUTICALS$$23$YR$$F$Y$$$20240731$$CN$US$US
241585541$24158554$1$I$20240417$20240417$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005553$AURINIA PHARMACEUTICALS$$34$YR$$F$Y$$$20240731$$CN$US$US
241585551$24158555$1$I$$20240724$20240731$20240731$PER$$US-RDY-SPO/USA/24/0011010$DR REDDYS$$76$YR$E$M$Y$$$20240731$$CN$US$US
241585562$24158556$2$F$20240301$20240905$20240731$20240905$30DAY$$CO-PFIZER INC-PV202400096582$PFIZER$$7$YR$$M$Y$$$20240905$$CN$CO$CO
241585571$24158557$1$I$20240101$20240729$20240731$20240731$EXP$$GB-SANDOZ INC.-SDZ2024GB043470$SANDOZ$$$$$F$Y$$$20240731$$CN$GB$GB
241585581$24158558$1$I$$20240517$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005897$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241585592$24158559$2$F$$20240731$20240731$20240808$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006090$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
241585601$24158560$1$I$$20240507$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005814$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585611$24158561$1$I$$20240624$20240731$20240731$PER$$US-TRAVERE-2024TVT00638$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240731$$CN$US$US
241585621$24158562$1$I$$20240624$20240731$20240731$PER$$US-TRAVERE-2024TVT00648$TRAVERE THERAPEUTICS$$$$$$Y$$$20240731$$MD$US$US
241585631$24158563$1$I$20240327$20240726$20240731$20240731$PER$$US-AMGEN-USASP2024149562$AMGEN$$49$YR$A$F$Y$$$20240731$$CN$US$US
241585641$24158564$1$I$$20240513$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005844$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241585651$24158565$1$I$$20240514$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005853$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585661$24158566$1$I$$20240709$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006101$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585671$24158567$1$I$$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005969$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585681$24158568$1$I$$20240517$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005886$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585691$24158569$1$I$$20240618$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006076$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585701$24158570$1$I$20240501$20240719$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005983$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$65.76$KG$20240731$$CN$US$US
241585711$24158571$1$I$20240618$20240722$20240731$20240731$EXP$FR-AFSSAPS-LY2024001045$FR-TEVA-VS-3224861$TEVA$$83$YR$$F$Y$51$KG$20240731$$PH$FR$FR
241585721$24158572$1$I$$20240725$20240731$20240731$EXP$$NVSC2024CN116029$NOVARTIS$$$$$$Y$$$20240731$$CN$CN$CN
241585731$24158573$1$I$20240707$20240722$20240731$20240731$EXP$FR-AFSSAPS-MP2024001141$FR-TEVA-VS-3224763$TEVA$$79$YR$$F$Y$$$20240731$$PH$FR$FR
241585751$24158575$1$I$$20240725$20240731$20240731$PER$$US-ROCHE-10000036414$ROCHE$Greenman M, Bellone S D. Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer. Gynecologic Oncology Reports. 2024-Aug;54:1-4. doi:10.1016/j.gore.2024.101459.$69$YR$E$F$Y$$$20240731$$HP$US$US
241585761$24158576$1$I$$20240411$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005625$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585771$24158577$1$I$$20240419$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005699$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241585781$24158578$1$I$20240627$20240724$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005731$AURINIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240731$$CN$US$US
241585791$24158579$1$I$$20240531$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005589$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585801$24158580$1$I$$20240603$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006011$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585811$24158581$1$I$$20240530$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005980$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241585821$24158582$1$I$$20240410$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005633$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585831$24158583$1$I$$20240424$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005732$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585841$24158584$1$I$$20240528$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005748$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241585851$24158585$1$I$$20240604$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006013$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241585861$24158586$1$I$20230222$20240724$20240731$20240731$EXP$$CZ-GSK-CZ2024EME093078$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$MD$CZ$CZ
241585872$24158587$2$F$20240101$20240826$20240731$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120373$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240828$$CN$US$US
241585881$24158588$1$I$20240722$20240730$20240731$20240731$EXP$$CN-PFIZER INC-PV202400099481$PFIZER$$30$YR$$F$Y$48$KG$20240731$$HP$CN$CN
241585892$24158589$2$F$20240718$20240906$20240731$20240906$EXP$$CA-PFIZER INC-202200582090$PFIZER$$61$YR$$M$Y$$$20240906$$HP$CA$CA
241585913$24158591$3$F$20240725$20240905$20240731$20240909$EXP$$US-PFIZER INC-202400225244$PFIZER$$63$YR$$M$Y$72.562$KG$20240909$$HP$US$US
241585921$24158592$1$I$20200312$20240722$20240731$20240731$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117389$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$57$KG$20240731$$MD$KR$KR
241585931$24158593$1$I$$20240725$20240731$20240731$EXP$$US-PFIZER INC-202400225018$PFIZER$$72$YR$$M$Y$$$20240731$$HP$US$US
241585941$24158594$1$I$20240515$20240729$20240731$20240731$EXP$FR-AFSSAPS-LM2024000425$FR-PFIZER INC-202400225545$PFIZER$$30$YR$$M$Y$73$KG$20240731$$MD$FR$FR
241585951$24158595$1$I$20240703$20240728$20240731$20240731$EXP$$CN-PFIZER INC-PV202400098095$PFIZER$$76$YR$$M$Y$30$KG$20240731$$HP$CN$CN
241585963$24158596$3$F$20240713$20240829$20240731$20240902$EXP$$BR-PFIZER INC-PV202400098506$PFIZER$$71$YR$$F$Y$53.1$KG$20240902$$MD$BR$BR
241585973$24158597$3$F$20240101$20240814$20240731$20240820$EXP$$US-PFIZER INC-PV202400099716$PFIZER$$82$YR$$F$Y$63.492$KG$20240820$$CN$US$US
241585981$24158598$1$I$20240727$20240729$20240731$20240731$EXP$$US-PFIZER INC-202400226879$PFIZER$$92$YR$$F$Y$$$20240731$$HP$US$US
241585991$24158599$1$I$20240710$20240729$20240731$20240731$EXP$NL-LRB-00990768$NL-PFIZER INC-202400225460$PFIZER$$58$YR$$F$Y$66$KG$20240731$$CN$NL$NL
241586001$24158600$1$I$$20240730$20240731$20240731$EXP$$CN-PFIZER INC-PV202400099096$PFIZER$$$$A$M$Y$$$20240731$$CN$CN$CN
241586011$24158601$1$I$20230523$20240725$20240731$20240731$EXP$$CA-PFIZER INC-202300173823$PFIZER$$43$YR$$M$Y$$$20240731$$MD$CA$CA
241586021$24158602$1$I$$20240730$20240731$20240731$EXP$$US-PFIZER INC-PV202400099709$PFIZER$$84$YR$$F$Y$$$20240731$$HP$US$US
241586031$24158603$1$I$20240101$20240725$20240731$20240731$EXP$$CA-PFIZER INC-202400205254$PFIZER$$85$YR$$M$Y$$$20240731$$HP$CA$CA
241586042$24158604$2$F$20240306$20240923$20240731$20240925$EXP$$PL-PFIZER INC-202400224291$PFIZER$$71$YR$$F$Y$$$20240925$$MD$PL$PL
241586051$24158605$1$I$20220601$20240730$20240731$20240731$EXP$GB-MHRA-MED-202407302116285600-FNPGT$GB-PFIZER INC-202400226866$PFIZER$$31$YR$$F$Y$75$KG$20240731$$CN$GB$GB
241586061$24158606$1$I$$20240729$20240731$20240731$EXP$$DZ-PFIZER INC-202400225844$PFIZER$$$$$F$Y$$$20240731$$MD$DZ$DZ
241586071$24158607$1$I$20240722$20240729$20240731$20240731$EXP$$CN-PFIZER INC-PV202400098849$PFIZER$$72$YR$$M$Y$70$KG$20240731$$HP$CN$CN
241586081$24158608$1$I$20240713$20240726$20240731$20240731$EXP$$CN-PFIZER INC-PV202400097963$PFIZER$$37$YR$$F$Y$61.5$KG$20240731$$HP$CN$CN
241586102$24158610$2$F$20240101$20240813$20240731$20240819$EXP$$CA-PFIZER INC-202400224664$PFIZER$$81$YR$$M$Y$$$20240819$$HP$CA$CA
241586111$24158611$1$I$$20240730$20240731$20240731$30DAY$$US-SANDOZ INC.-SDZ2024US069528$SANDOZ$$$$$F$Y$$$20240731$$HP$US$US
241586121$24158612$1$I$20220701$20240724$20240731$20240731$EXP$$EG-SANDOZ INC.-NVSC2022EG263235$SANDOZ$$68$YR$$M$Y$$$20240731$$CN$EG$EG
241586131$24158613$1$I$20240101$20240724$20240731$20240731$EXP$$CN-PFIZER INC-2024SGN01417$PFIZER$$64$YR$$F$Y$46$KG$20240731$$MD$CN$CN
241586142$24158614$2$F$20240718$20240904$20240731$20240909$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-102723$REGENERON$$$$$M$Y$$$20240909$$PH$US$US
241586151$24158615$1$I$$20240719$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407013745$ELI LILLY AND CO$$57$YR$A$$Y$$$20240731$$HP$US$US
241586161$24158616$1$I$20240730$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019769$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$US$US
241586171$24158617$1$I$20240301$20240717$20240731$20240731$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202407018033$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240731$$CN$IN$IN
241586181$24158618$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019559$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240731$$CN$US$US
241586191$24158619$1$I$20240710$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019849$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240731$$CN$US$US
241586201$24158620$1$I$20240726$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018334$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240731$$CN$US$US
241586211$24158621$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017640$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240731$$CN$US$US
241586221$24158622$1$I$20240729$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019871$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240731$$CN$US$US
241586231$24158623$1$I$$20240730$20240731$20240731$EXP$$PL-SANDOZ INC.-SDZ2024PL069275$SANDOZ$$55$YR$$F$Y$$$20240731$$MD$PL$PL
241586241$24158624$1$I$$20240614$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006098$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586251$24158625$1$I$$20240401$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005541$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586261$24158626$1$I$20240301$20240611$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006069$AURINIA PHARMACEUTICALS$$44$YR$$F$Y$$$20240731$$CN$US$US
241586271$24158627$1$I$$20240410$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005626$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586281$24158628$1$I$20240201$20240424$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005543$AURINIA PHARMACEUTICALS$$33$YR$$F$Y$$$20240731$$CN$US$US
241586291$24158629$1$I$$20240402$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005549$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241586301$24158630$1$I$$20240509$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005832$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241586311$24158631$1$I$$20240717$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006037$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586321$24158632$1$I$$20240516$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005727$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586331$24158633$1$I$$20240516$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005790$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586341$24158634$1$I$$20240726$20240731$20240731$PER$$US-GILEAD-2024-0682159$GILEAD$$$$E$M$Y$$$20240731$$HP$US$US
241586351$24158635$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150306$AMGEN$$$$$$Y$$$20240731$$CN$US$US
241586361$24158636$1$I$$20240730$20240731$20240731$EXP$$CA-SANDOZ INC.-SDZ2024CA069369$SANDOZ$$35$YR$$M$Y$$$20240731$$MD$CA$CA
241586371$24158637$1$I$20240604$20240605$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006030$AURINIA PHARMACEUTICALS$$40$YR$$F$Y$$$20240731$$CN$US$US
241586381$24158638$1$I$$20240401$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005539$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586391$24158639$1$I$20240326$20240405$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005580$AURINIA PHARMACEUTICALS$$39$YR$$F$Y$$$20240731$$CN$US$US
241586401$24158640$1$I$$20240523$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005924$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586411$24158641$1$I$$20240411$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005641$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586421$24158642$1$I$20240604$20240606$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005718$AURINIA PHARMACEUTICALS$$30$YR$$F$Y$$$20240731$$CN$US$US
241586431$24158643$1$I$20240101$20240402$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005550$AURINIA PHARMACEUTICALS$$25$YR$$M$Y$$$20240731$$CN$US$US
241586441$24158644$1$I$$20240402$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005551$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586451$24158645$1$I$$20240612$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006079$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586461$24158646$1$I$$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006074$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586472$24158647$2$F$20240717$20240819$20240731$20240827$EXP$GB-MHRA-MED-202407251204342300-HMTGD$GB-TEVA-VS-3227386$TEVA$$25$YR$$M$Y$85$KG$20240827$$CN$GB$GB
241586481$24158648$1$I$$20240625$20240731$20240731$EXP$$DE-BIOVITRUM-2024-DE-010293$BIOVITRUM$$17$YR$$F$Y$52$KG$20240731$$MD$DE$DE
241586492$24158649$2$F$$20240807$20240731$20240815$EXP$$DE-AstraZeneca-2024A172773$ASTRAZENECA$Schork A, Eberbach M-L, Artunc F, Bohnert BN, Eisinger F, Heister DJ, et al.. SGLT2 Inhibitors Correct Fluid Overload in Adult Kidney Transplant Recipients-A Prospective Observational Study. Transpl-Int 2024;37:$$$$M$Y$$$20240815$$HP$DE$
241586501$24158650$1$I$$20240425$20240731$20240731$EXP$$US-AstraZeneca-2024A173322$ASTRAZENECA$$2$MON$$F$Y$2.7$KG$20240731$$MD$US$
241586521$24158652$1$I$$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171875$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241586531$24158653$1$I$20240510$20240723$20240731$20240731$EXP$$CN-AstraZeneca-2024A171240$ASTRAZENECA$$19557$DY$$F$Y$50$KG$20240731$$MD$CN$
241586541$24158654$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A168469$ASTRAZENECA$$$$$M$Y$$$20240731$$CN$US$
241586551$24158655$1$I$$20240723$20240731$20240731$EXP$$US-AstraZeneca-2024A167891$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241586561$24158656$1$I$$20240723$20240731$20240731$EXP$$SG-AstraZeneca-2024A168398$ASTRAZENECA$$$$$$Y$$$20240731$$MD$SG$
241586571$24158657$1$I$$20240729$20240731$20240731$EXP$$DE-AstraZeneca-2024A171652$ASTRAZENECA$Schork A, Eberbach M-L, Artunc F, Bohnert BN, Eisinger F, Heister DJ, et al. SGLT2 Inhibitors Correct Fluid Overload in Adult Kidney Transplant Recipients-A Prospective Observational Study. Transpl-Int 2024;37((0)):$$$$M$Y$$$20240731$$MD$DE$
241586582$24158658$2$F$$20240801$20240731$20240802$EXP$$US-SANDOZ INC.-SDZ2024US069579$SANDOZ$$$$$$Y$$$20240802$$CN$US$US
241586601$24158660$1$I$$20240723$20240731$20240731$PER$$US-ROCHE-10000034496$ROCHE$$$$$$Y$$$20240731$$CN$US$US
241586611$24158661$1$I$$20240723$20240731$20240731$PER$$US-ROCHE-10000034959$ROCHE$$$$$$Y$$$20240731$$CN$US$US
241586621$24158662$1$I$20240122$20240722$20240731$20240731$EXP$FR-AFSSAPS-TO2024001303$FR-TEVA-VS-3224732$TEVA$$76$YR$$M$Y$$$20240731$$MD$FR$FR
241586631$24158663$1$I$$20240506$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005797$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586641$24158664$1$I$$20240424$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005721$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241586651$24158665$1$I$$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005950$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241586661$24158666$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006019$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241586671$24158667$1$I$$20240403$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005567$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586681$24158668$1$I$$20240429$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005750$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241586691$24158669$1$I$$20240723$20240731$20240731$EXP$$US-APOTEX-2024AP008821$APOTEX$Mikhail E, Alexander D, Jankowski M, Pandya D, Kunadi A.. Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature. American Journal of Respiratory and Critical Care Medicine. 2024;209:96-99$70$YR$$F$Y$$$20240731$$HP$US$US
241586701$24158670$1$I$$20240424$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005717$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586711$24158671$1$I$$20240411$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005624$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586721$24158672$1$I$$20240524$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005933$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586731$24158673$1$I$$20240507$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005815$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586741$24158674$1$I$$20240725$20240731$20240731$EXP$GB-MHRA-MED-202407251011475310-VZQYH$GB-RDY-SPO/GBR/24/0011075$DR REDDYS$$$$$M$Y$$$20240731$$CN$GB$GB
241586751$24158675$1$I$20240710$20240723$20240731$20240731$EXP$$CN-BEIGENE-BGN-2024-011423$BEIGENE$$$$$$Y$$$20240731$$HP$CN$CN
241586764$24158676$4$F$20240717$20240911$20240731$20240919$PER$$CN-Eisai-EC-2024-170807$EISAI$$57$YR$A$M$Y$58$KG$20240919$$MD$CN$CN
241586782$24158678$2$F$20240418$20240722$20240731$20240815$PER$$US-TRAVERE-2024TVT00640$TRAVERE THERAPEUTICS$$56$YR$A$F$Y$$$20240815$$CN$US$US
241586791$24158679$1$I$$20240730$20240731$20240731$EXP$$FR-SANDOZ INC.-SDZ2024FR069441$SANDOZ$$37$YR$$F$Y$$$20240731$$HP$FR$FR
241586802$24158680$2$F$$20240807$20240731$20240808$EXP$$AU-GILEAD-2024-0682394$GILEAD$$$$$F$Y$$$20240808$$MD$AU$AU
241586812$24158681$2$F$20240704$20240821$20240731$20240828$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011581$JAZZ$$71$YR$$M$Y$$$20240828$$PH$JP$JP
241586821$24158682$1$I$20240101$20240724$20240731$20240731$EXP$$ES-ABBVIE-5853661$ABBVIE$$$$$M$Y$$$20240731$$CN$ES$ES
241586832$24158683$2$F$20240331$20240822$20240731$20240827$EXP$$JP-Taiho Oncology Inc-2024-003362$TAIHO ONCOLOGY INC$$82$YR$E$M$Y$$$20240827$$PH$JP$JP
241586842$24158684$2$F$20240101$20240722$20240731$20240802$EXP$$US-ARDELYX-2024ARDX005575$ARDELYX$$69$YR$$F$Y$$$20240802$$HP$US$US
241586851$24158685$1$I$20240721$20240725$20240731$20240731$PER$$US-Eisai-EC-2024-170943$EISAI$$67$YR$E$M$Y$100.2$KG$20240731$$HP$US$US
241586861$24158686$1$I$20220312$20240729$20240731$20240731$EXP$PL-URPL-DML-MLP.4401.1.757.2022$PL-BAUSCH-BL-2024-011625$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240731$$PH$PL$PL
241586871$24158687$1$I$$20240726$20240731$20240731$EXP$$US-BAUSCH-BL-2024-011492$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240731$$CN$US$US
241586881$24158688$1$I$20240709$20240723$20240731$20240731$EXP$$CN-BEIGENE-BGN-2024-011427$BEIGENE$$$$$$Y$$$20240731$$HP$CN$CN
241586891$24158689$1$I$$20240129$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005138$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586901$24158690$1$I$$20240711$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006056$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241586911$24158691$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006065$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586921$24158692$1$I$20240529$20240611$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006066$AURINIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240731$$HP$US$US
241586931$24158693$1$I$$20240510$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005830$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241586941$24158694$1$I$$20240528$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005887$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586951$24158695$1$I$$20240607$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006051$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586961$24158696$1$I$$20240404$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005582$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586971$24158697$1$I$$20240129$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005134$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241586981$24158698$1$I$20240301$20240722$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006119$AURINIA PHARMACEUTICALS$$21$YR$$F$Y$$$20240731$$CN$US$US
241586991$24158699$1$I$$20240724$20240731$20240731$EXP$$NVSC2024BR155857$NOVARTIS$$$$$F$Y$$$20240731$$CN$BR$BR
241587001$24158700$1$I$20240601$20240725$20240731$20240731$EXP$$GB-ABBVIE-5856195$ABBVIE$$$$$F$Y$$$20240731$$CN$GB$GB
241587022$24158702$2$F$20240501$20240823$20240731$20240828$EXP$$US-ABBVIE-5856970$ABBVIE$$69$YR$$F$Y$$$20240828$$CN$US$US
241587031$24158703$1$I$$20240131$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005146$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587041$24158704$1$I$$20240730$20240731$20240731$PER$$US-GILEAD-2024-0682479$GILEAD$$$$E$M$Y$$$20240731$$CN$US$US
241587051$24158705$1$I$$20240201$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005160$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241587061$24158706$1$I$$20240202$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005166$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587071$24158707$1$I$20231030$20240201$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005124$AURINIA PHARMACEUTICALS$$52$YR$$F$Y$$$20240731$$MD$US$US
241587081$24158708$1$I$$20240131$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005150$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587091$24158709$1$I$20231213$20240205$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005186$AURINIA PHARMACEUTICALS$$29$YR$$F$Y$$$20240731$$MD$US$US
241587101$24158710$1$I$$20240205$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005185$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587111$24158711$1$I$$20240205$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005178$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587121$24158712$1$I$$20240206$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005187$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587131$24158713$1$I$$20240202$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005171$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587141$24158714$1$I$$20240723$20240731$20240731$EXP$$US-TEVA-VS-3225921$TEVA$$$$A$M$Y$$$20240731$$CN$US$US
241587151$24158715$1$I$$20240729$20240731$20240731$EXP$$US-GILEAD-2024-0682423$GILEAD$$53$YR$A$M$Y$$$20240731$$CN$US$US
241587163$24158716$3$F$20240728$20240731$20240731$20240808$PER$$US-AMGEN-USASP2024150295$AMGEN$$87$YR$E$F$Y$$$20240808$$CN$US$US
241587171$24158717$1$I$20200801$20240729$20240731$20240731$EXP$$JP-ABBVIE-4723091$ABBVIE$$77$YR$$F$Y$54$KG$20240731$$MD$JP$JP
241587181$24158718$1$I$$20240208$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005206$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587191$24158719$1$I$$20240206$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005190$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587201$24158720$1$I$$20240209$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005223$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587211$24158721$1$I$$20240208$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005203$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587221$24158722$1$I$$20240207$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005196$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241587231$24158723$1$I$$20240208$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005207$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241587241$24158724$1$I$$20240206$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005191$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587251$24158725$1$I$20240202$20240209$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005211$AURINIA PHARMACEUTICALS$$38$YR$$M$Y$$$20240731$$CN$US$US
241587261$24158726$1$I$$20240209$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005216$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241587271$24158727$1$I$$20240209$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005222$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587281$24158728$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5856842$ABBVIE$$$$A$F$Y$$$20240731$$MD$US$US
241587301$24158730$1$I$$20240725$20240731$20240731$EXP$$NVSC2024DE155536$NOVARTIS$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S, et al.. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. BRITISH JOURNAL OF CANCER. 2023;128 (6):1134-47$$$$$Y$$$20240731$$HP$DE$DE
241587311$24158731$1$I$20240729$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150312$AMGEN$$81$YR$E$F$Y$$$20240731$$CN$US$US
241587321$24158732$1$I$$20240716$20240731$20240731$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2024JUB00059$JUBILANT$Martino J, Elfessi Z, Szaflarska K, Suh M, Antonishina K. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use. Journal of Pharmacy Practice. 2024;1-4$25$YR$$M$Y$$$20240731$$MD$US$US
241587331$24158733$1$I$20240701$20240725$20240731$20240731$EXP$$US-SA-2024SA219053$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240731$$CN$US$US
241587341$24158734$1$I$$20240209$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005219$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587351$24158735$1$I$$20240211$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005230$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587361$24158736$1$I$20240101$20240209$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005218$AURINIA PHARMACEUTICALS$$43$YR$$F$Y$$$20240731$$CN$US$US
241587371$24158737$1$I$$20240729$20240731$20240731$PER$$US-HALEON-2189746$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241587382$24158738$2$F$20240101$20240902$20240731$20240916$PER$$US-SA-2024SA219177$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240916$$MD$US$US
241587391$24158739$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA218834$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240731$$MD$US$US
241587401$24158740$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA219114$SANOFI AVENTIS$$$$C$F$Y$$$20240731$$MD$US$US
241587411$24158741$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221739$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240731$$MD$US$US
241587421$24158742$1$I$20240724$20240725$20240731$20240731$PER$$US-SA-2024SA221502$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240731$$MD$US$US
241587431$24158743$1$I$20240601$20240724$20240731$20240731$PER$$US-SA-2024SA218880$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240731$$MD$US$US
241587441$24158744$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA222359$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240731$$MD$US$US
241587451$24158745$1$I$20240601$20240726$20240731$20240731$PER$$US-SA-2024SA195155$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240731$$MD$US$US
241587461$24158746$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA218126$SANOFI AVENTIS$$$$A$F$Y$76.2$KG$20240731$$MD$US$US
241587471$24158747$1$I$$20240722$20240731$20240731$PER$$US-TEVA-VS-3225003$TEVA$$$$$F$Y$$$20240731$$CN$US$US
241587481$24158748$1$I$$20240212$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005238$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241587491$24158749$1$I$20240710$20240723$20240731$20240731$EXP$$CN-BEIGENE-BGN-2024-011432$BEIGENE$$$$$$Y$$$20240731$$HP$CN$CN
241587501$24158750$1$I$$20240214$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005260$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587511$24158751$1$I$$20240212$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005240$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587521$24158752$1$I$$20240214$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005262$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587531$24158753$1$I$$20240215$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005274$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241587541$24158754$1$I$$20240211$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005232$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587551$24158755$1$I$$20240214$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005263$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587561$24158756$1$I$20240728$20240729$20240731$20240731$EXP$$NL-ABBVIE-5860638$ABBVIE$$84$YR$$F$Y$$$20240731$$CN$NL$NL
241587571$24158757$1$I$$20210426$20240731$20240731$EXP$$CA-Covis Pharma GmbH-2021COV22370$COVIS PHARMA$$50$YR$A$F$Y$$$20240731$$MD$CA$CA
241587581$24158758$1$I$$20240524$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005939$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587591$24158759$1$I$$20240516$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005873$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241587601$24158760$1$I$$20240520$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005896$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587611$24158761$1$I$20240301$20240408$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005605$AURINIA PHARMACEUTICALS$$36$YR$$F$Y$$$20240731$$CN$US$US
241587621$24158762$1$I$$20240524$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005932$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241587631$24158763$1$I$$20240523$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005923$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241587641$24158764$1$I$$20240523$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005863$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241587651$24158765$1$I$$20240726$20240731$20240731$EXP$$US-SA-2024SA222015$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240731$$MD$US$US
241587661$24158766$1$I$$20240724$20240731$20240731$EXP$$US-SA-2024SA218420$SANOFI AVENTIS$$$$$M$Y$$$20240731$$CN$US$US
241587671$24158767$1$I$20181004$20240722$20240731$20240731$EXP$FR-AFSSAPS-AM2024000569$FR-TEVA-VS-3225216$TEVA$$67$YR$$F$Y$60$KG$20240731$$MD$FR$FR
241587681$24158768$1$I$$20240729$20240731$20240731$PER$$US-JNJFOC-20240778039$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241587691$24158769$1$I$$20240731$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043025$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240731$$CN$US$US
241587701$24158770$1$I$20240530$20240531$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005992$AURINIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240731$$CN$US$US
241587711$24158771$1$I$20240618$20240729$20240731$20240731$EXP$FR-AFSSAPS-AN2024000972$FR-BAUSCH-BL-2024-011638$BAUSCH AND LOMB$$52$YR$$F$Y$73.5$KG$20240731$$PH$FR$FR
241587721$24158772$1$I$$20240530$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005976$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241587731$24158773$1$I$20240319$20240328$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005525$AURINIA PHARMACEUTICALS$$33$YR$$F$Y$$$20240731$$CN$US$US
241587741$24158774$1$I$20240712$20240723$20240731$20240731$EXP$$CN-BEIGENE-BGN-2024-011430$BEIGENE$$$$$$Y$$$20240731$$HP$CN$CN
241587751$24158775$1$I$20240625$20240725$20240731$20240731$PER$$US-BIOMARINAP-US-2024-159466$BIOMARIN$$$$$$Y$$$20240731$$CN$US$US
241587762$24158776$2$F$$20240731$20240731$20240802$PER$$US-BIOMARINAP-US-2024-159456$BIOMARIN$$$$$$Y$$$20240802$$CN$US$US
241587771$24158777$1$I$20240725$20240725$20240731$20240731$PER$$US-BIOMARINAP-US-2024-159480$BIOMARIN$$$$$$Y$$$20240731$$CN$US$US
241587782$24158778$2$F$$20240820$20240731$20240829$PER$$US-BIOMARINAP-US-2024-159465$BIOMARIN$$$$$$Y$$$20240829$$CN$US$US
241587792$24158779$2$F$$20240724$20240731$20240925$PER$$US-ROCHE-10000040051$ROCHE$$$$$$Y$$$20240925$$HP$US$US
241587801$24158780$1$I$20240215$20240219$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005290$AURINIA PHARMACEUTICALS$$38$YR$$M$Y$$$20240731$$MD$US$US
241587811$24158781$1$I$20240101$20240220$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005301$AURINIA PHARMACEUTICALS$$37$YR$$M$Y$$$20240731$$CN$US$US
241587821$24158782$1$I$$20240219$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005276$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241587831$24158783$1$I$20240219$20240219$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005287$AURINIA PHARMACEUTICALS$$10$YR$$M$Y$$$20240731$$HP$US$US
241587841$24158784$1$I$$20240219$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005293$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587852$24158785$2$F$20240806$20240807$20240731$20240812$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-005288$AURINIA PHARMACEUTICALS$$55$YR$$F$Y$$$20240812$$CN$US$US
241587861$24158786$1$I$$20240216$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005273$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587871$24158787$1$I$$20240216$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005277$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241587881$24158788$1$I$20231201$20240219$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005291$AURINIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240731$$CN$US$US
241587891$24158789$1$I$$20231212$20240731$20240731$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410425$RANBAXY$$$$A$F$Y$72$KG$20240801$$CN$US$US
241587901$24158790$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121296$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240731$$MD$US$US
241587911$24158791$1$I$$20240220$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005299$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241587921$24158792$1$I$20240723$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121112$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$77.11$KG$20240731$$CN$US$US
241587931$24158793$1$I$$20240724$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118455$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240731$$CN$US$US
241587941$24158794$1$I$$20240730$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121344$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240731$$CN$US$US
241587951$24158795$1$I$$20240730$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121292$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240731$$CN$US$US
241587961$24158796$1$I$$20230613$20240731$20240731$EXP$$US-AstraZeneca-2023A137623$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241587971$24158797$1$I$$20240729$20240731$20240731$30DAY$$US-GSK-US2024094857$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240731$$CN$US$US
241587985$24158798$5$F$20240701$20240821$20240731$20240830$EXP$FR-AFSSAPS-AN2024000928$FR-TEVA-VS-3223835$TEVA$$86$YR$$M$Y$$$20240830$$MD$FR$FR
241587991$24158799$1$I$$20240730$20240731$20240731$PER$$US-ROCHE-10000043191$ROCHE$$$$E$F$Y$$$20240731$$MD$US$US
241588003$24158800$3$F$$20240905$20240731$20240910$PER$$US-ROCHE-10000040155$ROCHE$$$$A$F$Y$$$20240910$$CN$US$US
241588011$24158801$1$I$$20240222$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005333$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$MD$US$US
241588021$24158802$1$I$$20240222$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005325$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588031$24158803$1$I$$20240226$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005241$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588041$24158804$1$I$$20240228$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005357$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588051$24158805$1$I$$20240226$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005294$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588061$24158806$1$I$20240131$20240221$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005155$AURINIA PHARMACEUTICALS$$19$YR$$F$Y$$$20240731$$CN$US$US
241588071$24158807$1$I$$20240228$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005379$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588081$24158808$1$I$$20240226$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005297$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588091$24158809$1$I$$20240221$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005302$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588101$24158810$1$I$$20240223$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005332$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588111$24158811$1$I$20240101$20240702$20240731$20240731$PER$$US-JNJFOC-20240711868$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240731$$CN$US$US
241588131$24158813$1$I$$20240724$20240731$20240731$PER$$US-APELLIS-2024-APL-0000555$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
241588141$24158814$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019364$ELI LILLY AND CO$$$$$F$Y$$$20240731$$MD$US$US
241588151$24158815$1$I$$20240722$20240731$20240731$EXP$$ES-TEVA-VS-3225259$TEVA$$$$$F$Y$$$20240731$$MD$ES$ES
241588161$24158816$1$I$20231001$20240730$20240731$20240731$EXP$$RO-TAKEDA-2024TUS076874$TAKEDA$$$$$F$Y$$$20240731$$CN$RO$RO
241588171$24158817$1$I$$20240730$20240731$20240731$PER$$US-ABBVIE-5861163$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241588181$24158818$1$I$$20240301$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005373$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588191$24158819$1$I$$20240228$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005349$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241588201$24158820$1$I$20240301$20240304$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005388$AURINIA PHARMACEUTICALS$$38$YR$$F$Y$$$20240731$$CN$US$US
241588211$24158821$1$I$20230419$20240304$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005380$AURINIA PHARMACEUTICALS$$54$YR$$F$Y$$$20240731$$MD$US$US
241588221$24158822$1$I$$20240229$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005367$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588231$24158823$1$I$$20240301$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005368$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588241$24158824$1$I$$20240229$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005362$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588251$24158825$1$I$$20240301$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005374$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588261$24158826$1$I$$20240729$20240731$20240731$EXP$$US-TAKEDA-2024TUS076875$TAKEDA$$$$$F$Y$$$20240731$$MD$US$US
241588271$24158827$1$I$$20240305$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005324$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241588281$24158828$1$I$20240223$20240726$20240731$20240731$EXP$FR-AFSSAPS-AVMA2024000329$FR-BAUSCH-BL-2024-011476$BAUSCH AND LOMB$$63$YR$$M$Y$$$20240731$$PH$FR$FR
241588291$24158829$1$I$$20240727$20240731$20240731$EXP$$BR-TAKEDA-2024TUS076461$TAKEDA$$$$$F$Y$$$20240731$$CN$BR$BR
241588301$24158830$1$I$$20240305$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005394$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588311$24158831$1$I$$20240306$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005410$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588321$24158832$1$I$20240101$20240305$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005399$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241588331$24158833$1$I$20230101$20240305$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005391$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588341$24158834$1$I$$20240305$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005397$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588351$24158835$1$I$$20240306$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005436$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588361$24158836$1$I$$20240307$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005404$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241588371$24158837$1$I$$20240305$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005398$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588381$24158838$1$I$$20240307$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005413$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588391$24158839$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121224$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240731$$CN$US$US
241588403$24158840$3$F$20240728$20240905$20240731$20240906$PER$$US-AMGEN-USASP2024150273$AMGEN$$89$YR$E$M$Y$$$20240906$$HP$US$US
241588412$24158841$2$F$20240729$20240801$20240731$20240806$PER$$US-AMGEN-USASP2024150362$AMGEN$$78$YR$E$F$Y$99.7$KG$20240806$$HP$US$US
241588422$24158842$2$F$$20240620$20240731$20240906$PER$$US-FARMAPROD-202403-0842$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$US
241588432$24158843$2$F$20240101$20240821$20240731$20240829$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-025648$BOEHRINGER INGELHEIM$$88$YR$E$M$Y$$$20240829$$CN$US$US
241588441$24158844$1$I$$20240318$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005460$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588451$24158845$1$I$20240115$20240308$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005110$AURINIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240731$$CN$US$US
241588461$24158846$1$I$$20240311$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005428$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588471$24158847$1$I$$20240308$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005224$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241588481$24158848$1$I$$20240315$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005464$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588491$24158849$1$I$20240101$20240308$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005278$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241588501$24158850$1$I$20240116$20240312$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005429$AURINIA PHARMACEUTICALS$$29$YR$$F$Y$$$20240731$$CN$US$US
241588511$24158851$1$I$20240309$20240313$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005437$AURINIA PHARMACEUTICALS$$62$YR$$F$Y$$$20240731$$CN$US$US
241588521$24158852$1$I$$20240314$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005450$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588531$24158853$1$I$$20240625$20240731$20240731$PER$$US-TRAVERE-2024TVT00645$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240731$$CN$US$US
241588541$24158854$1$I$$20240729$20240731$20240731$PER$$NVSC2024US156436$NOVARTIS$$$$$F$Y$$$20240731$$HP$US$US
241588551$24158855$1$I$$20240312$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005435$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588561$24158856$1$I$20240319$20240319$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005468$AURINIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240731$$CN$US$US
241588571$24158857$1$I$$20240319$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005469$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588581$24158858$1$I$$20240320$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005475$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588591$24158859$1$I$$20240320$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005486$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241588601$24158860$1$I$$20240321$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005281$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588611$24158861$1$I$$20240319$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005470$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588621$24158862$1$I$$20240321$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005477$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241588631$24158863$1$I$$20240319$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005204$AURINIA PHARMACEUTICALS$$$$$F$Y$82.993$KG$20240731$$CN$US$US
241588641$24158864$1$I$20240601$20240619$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006120$AURINIA PHARMACEUTICALS$$23$YR$$F$Y$$$20240731$$CN$US$US
241588651$24158865$1$I$20230601$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121076$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240731$$HP$US$US
241588662$24158866$2$F$$20240730$20240731$20240731$EXP$$US-GILEAD-2024-0682460$GILEAD$$$$$M$Y$$$20240731$$HP$US$US
241588681$24158868$1$I$$20240328$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005530$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588691$24158869$1$I$20240514$20240524$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005935$AURINIA PHARMACEUTICALS$$44$YR$$F$Y$$$20240731$$MD$US$US
241588701$24158870$1$I$$20240422$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005702$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241588711$24158871$1$I$20240301$20240403$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005565$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240731$$CN$US$US
241588721$24158872$1$I$$20240606$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006034$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588731$24158873$1$I$$20240605$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006035$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588741$24158874$1$I$$20240701$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005592$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588751$24158875$1$I$$20240404$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005581$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588761$24158876$1$I$20240727$20240729$20240731$20240731$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011537$JAZZ$$29$YR$$F$Y$33.8$KG$20240731$$CN$US$US
241588771$24158877$1$I$$20240712$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN007376$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241588781$24158878$1$I$20240209$20240607$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006052$AURINIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240731$$CN$US$US
241588791$24158879$1$I$20220826$20240722$20240731$20240731$EXP$$CA-TAKEDA-2024TUS074655$TAKEDA$$61$YR$$F$Y$$$20240731$$MD$CA$CA
241588801$24158880$1$I$20240705$20240724$20240731$20240731$PER$$US-BAYER-2024A108405$BAYER$$53$YR$A$M$Y$$$20240731$$CN$US$US
241588831$24158883$1$I$20240101$20240722$20240731$20240731$PER$$US-SA-2024SA219628$SANOFI AVENTIS$$22$YR$A$F$Y$90.718$KG$20240731$$MD$US$US
241588841$24158884$1$I$$20240722$20240731$20240731$PER$$US-SA-2024SA219719$SANOFI AVENTIS$$52$YR$A$F$Y$72.575$KG$20240731$$MD$US$US
241588851$24158885$1$I$$20240724$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN007803$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241588861$24158886$1$I$$20240725$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN007839$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241588871$24158887$1$I$20240503$20240507$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005800$AURINIA PHARMACEUTICALS$$51$YR$$M$Y$$$20240731$$CN$US$US
241588881$24158888$1$I$$20240416$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005662$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588891$24158889$1$I$$20240620$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006131$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588901$24158890$1$I$$20240708$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006141$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241588911$24158891$1$I$$20240620$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006132$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588921$24158892$1$I$$20240619$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006121$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241588931$24158893$1$I$$20240402$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005552$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241588941$24158894$1$I$20240601$20240624$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006151$AURINIA PHARMACEUTICALS$$29$YR$$M$Y$$$20240731$$CN$US$US
241588951$24158895$1$I$$20240516$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005871$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588961$24158896$1$I$$20240415$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005571$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241588971$24158897$1$I$$20240724$20240731$20240731$PER$$US-ALXN-202405USA000383US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241588981$24158898$1$I$20231225$20240722$20240731$20240731$EXP$FR-AFSSAPS-NY2024000790$FR-TEVA-VS-3225291$TEVA$$61$YR$$M$Y$108$KG$20240731$$MD$FR$FR
241588992$24158899$2$F$20240501$20240725$20240731$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241016$IRONSHORE PHARMA$$32$YR$A$M$Y$113.6$KG$20240810$$CN$US$US
241589011$24158901$1$I$$20240731$20240731$20240731$EXP$$US-GILEAD-2024-0682447$GILEAD$$$$A$F$Y$87.528$KG$20240731$$HP$US$US
241589024$24158902$4$F$$20240815$20240731$20240822$PER$$US-ROCHE-10000035771$ROCHE$$$$A$F$Y$72.12$KG$20240822$$CN$US$US
241589031$24158903$1$I$$20240401$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005538$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589041$24158904$1$I$20231001$20240322$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005491$AURINIA PHARMACEUTICALS$$20$YR$$M$Y$$$20240731$$CN$US$US
241589051$24158905$1$I$$20240325$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005497$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589061$24158906$1$I$20240210$20240325$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005337$AURINIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240731$$CN$US$US
241589071$24158907$1$I$$20240325$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005495$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589081$24158908$1$I$20231020$20240328$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005522$AURINIA PHARMACEUTICALS$$54$YR$$F$Y$$$20240731$$MD$US$US
241589091$24158909$1$I$20240124$20240326$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005512$AURINIA PHARMACEUTICALS$$17$YR$$M$Y$$$20240731$$CN$US$US
241589101$24158910$1$I$$20240327$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005387$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589111$24158911$1$I$$20240326$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005392$AURINIA PHARMACEUTICALS$$$$$F$Y$73.7$KG$20240731$$CN$US$US
241589121$24158912$1$I$20240331$20240401$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005462$AURINIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240731$$CN$US$US
241589151$24158915$1$I$$20240722$20240731$20240731$PER$$US-MYLANLABS-2024M1069890$MYLAN$$$$$F$Y$83.01$KG$20240731$$CN$US$US
241589173$24158917$3$F$20240101$20240827$20240731$20240911$PER$$US-SA-2024SA221751$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240911$$MD$US$US
241589181$24158918$1$I$20240101$20240723$20240731$20240731$PER$$US-SA-2024SA219157$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240731$$CN$US$US
241589191$24158919$1$I$20221001$20240722$20240731$20240731$EXP$FR-AFSSAPS-NT2024000865$FR-TEVA-VS-3225076$TEVA$$65$YR$$F$Y$80$KG$20240731$$MD$FR$FR
241589201$24158920$1$I$20240301$20240403$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005572$AURINIA PHARMACEUTICALS$$38$YR$$F$Y$$$20240731$$CN$US$US
241589211$24158921$1$I$$20240405$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005583$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589222$24158922$2$F$$20240813$20240731$20240816$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-005360$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
241589231$24158923$1$I$20240201$20240415$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005439$AURINIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240731$$CN$US$US
241589241$24158924$1$I$$20240411$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005630$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589251$24158925$1$I$$20240411$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005636$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589261$24158926$1$I$20240201$20240403$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005569$AURINIA PHARMACEUTICALS$$30$YR$$M$Y$$$20240731$$CN$US$US
241589271$24158927$1$I$20240103$20240416$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005670$AURINIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240731$$CN$US$US
241589281$24158928$1$I$$20240402$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005558$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589291$24158929$1$I$$20240415$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005655$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589301$24158930$1$I$$20240625$20240731$20240731$PER$$US-TRAVERE-2024TVT00646$TRAVERE THERAPEUTICS$$52$YR$A$M$Y$$$20240731$$CN$US$US
241589321$24158932$1$I$$20240417$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005679$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241589331$24158933$1$I$$20240417$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005183$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589341$24158934$1$I$$20240419$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005459$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589351$24158935$1$I$$20240419$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005328$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589361$24158936$1$I$20240201$20240419$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005694$AURINIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240731$$CN$US$US
241589371$24158937$1$I$$20240419$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005691$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241589381$24158938$1$I$$20240419$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005693$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589391$24158939$1$I$$20240417$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005257$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589401$24158940$1$I$$20240417$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005678$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241589411$24158941$1$I$20240701$20240724$20240731$20240731$PER$$US-BIOGEN-2024BI01275311$BIOGEN$$68$YR$$F$Y$$$20240731$$CN$US$US
241589422$24158942$2$F$$20240722$20240731$20240807$EXP$$JP-TAKEDA-2024TUS076373$TAKEDA$Yokofuji H. A case of midodrine hydrochloride intoxication with suicidal intent. The Japanese Journal of Clinical Toxicology. The 46th Annual Meeting of Japanese. 2024;37(2):193$15$YR$$F$Y$$$20240807$$HP$JP$JP
241589431$24158943$1$I$$20240725$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017065$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$US$US
241589441$24158944$1$I$$20240725$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017350$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$US$US
241589451$24158945$1$I$$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018325$ELI LILLY AND CO$$$$A$F$Y$$$20240731$$CN$US$US
241589461$24158946$1$I$20240601$20240723$20240731$20240731$EXP$$JP-009507513-2407JPN004376J$MERCK$$$$$F$Y$$$20240731$$MD$JP$JP
241589471$24158947$1$I$$20240423$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005710$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241589481$24158948$1$I$20231201$20240425$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005311$AURINIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240731$$CN$US$US
241589491$24158949$1$I$$20240425$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005733$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589501$24158950$1$I$$20240426$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005742$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589511$24158951$1$I$$20240426$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005739$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589521$24158952$1$I$20240406$20240426$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005614$AURINIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240731$$CN$US$US
241589531$24158953$1$I$$20240424$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005170$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589541$24158954$1$I$$20240423$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005711$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589551$24158955$1$I$$20240424$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005719$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589561$24158956$1$I$20240601$20240727$20240731$20240731$EXP$$NVSC2024CA155695$NOVARTIS$$$$$F$Y$$$20240731$$CN$CA$CA
241589571$24158957$1$I$$20240718$20240731$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115601$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240731$$HP$CA$CA
241589582$24158958$2$F$$20240731$20240731$20240801$PER$$US-PURDUE PHARMA-USA-2024-0311044$PURDUE$$56$YR$$F$Y$63.5$KG$20240801$$CN$US$US
241589591$24158959$1$I$$20240730$20240731$20240731$PER$$US-PURDUE PHARMA-USA-2024-0311059$PURDUE$$$$$$Y$$$20240731$$CN$US$US
241589601$24158960$1$I$$20240729$20240731$20240731$PER$$US-PURDUE PHARMA-USA-2024-0311011$PURDUE$$39$YR$$F$Y$$$20240731$$CN$US$US
241589611$24158961$1$I$$20240503$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005786$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241589621$24158962$1$I$$20240429$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005249$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589632$24158963$2$F$$20240807$20240731$20240814$EXP$$CA-TAKEDA-2024TUS076218$TAKEDA$$$$$F$Y$$$20240814$$CN$CA$CA
241589641$24158964$1$I$$20240506$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005627$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589651$24158965$1$I$$20240503$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005783$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589661$24158966$1$I$20240329$20240508$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005548$AURINIA PHARMACEUTICALS$$28$YR$$M$Y$$$20240731$$CN$US$US
241589671$24158967$1$I$$20240508$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005803$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589681$24158968$1$I$$20240501$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005768$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589691$24158969$1$I$20240301$20240429$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005761$AURINIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240731$$CN$US$US
241589701$24158970$1$I$$20240429$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005758$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589711$24158971$1$I$$20240724$20240731$20240731$PER$$US-ALXN-202407USA001651US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240731$$HP$US$US
241589721$24158972$1$I$$20240508$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005162$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589731$24158973$1$I$$20240726$20240731$20240731$EXP$$CA-PURDUE-USA-2024-0311050$PURDUE$$$$$F$Y$$$20240731$$HP$CA$CA
241589751$24158975$1$I$$20240729$20240731$20240731$EXP$$CA-APOTEX-2024AP008990$APOTEX$$51$YR$$M$Y$$$20240731$$CN$CA$CA
241589761$24158976$1$I$20240716$20240729$20240731$20240731$EXP$$US-AstraZeneca-2024A172679$ASTRAZENECA$$32894$DY$$F$Y$$$20240731$$CN$US$
241589771$24158977$1$I$$20230203$20240731$20240731$EXP$$US-AstraZeneca-2023A030170$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241589781$24158978$1$I$$20240726$20240731$20240731$30DAY$$US-GSK-US2024094224$GLAXOSMITHKLINE$$$$$F$Y$$$20240731$$CN$US$US
241589791$24158979$1$I$20211001$20211026$20240731$20240731$EXP$$US-AstraZeneca-2021A788791$ASTRAZENECA$$892$MON$$F$Y$$$20240731$$CN$US$
241589801$24158980$1$I$$20240722$20240731$20240731$PER$$US-ROCHE-10000040444$ROCHE$Bandali T, Kim Y, Khodadoust M, Rieger K, Fernandez-Pol S, Saleem A, et al. Polatuzumab vedotin-piiq for treatment of primary cutaneous diffuse large Bcell lymphoma, leg-type (PCDLBCL-LT) in older adults (Abstract number: 282). Journal of Investigative Dermatology. 2024-Aug;144 (8):S49. doi:10.1016/j.jid.2024.06.298.$83$YR$E$F$Y$$$20240731$$HP$US$US
241589811$24158981$1$I$$20240515$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005864$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589821$24158982$1$I$20230201$20240517$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005675$AURINIA PHARMACEUTICALS$$46$YR$$F$Y$87.9$KG$20240731$$CN$US$US
241589831$24158983$1$I$$20240521$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005904$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589841$24158984$1$I$$20240523$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005922$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241589851$24158985$1$I$$20240516$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005867$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241589871$24158987$1$I$20240512$20240514$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005858$AURINIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240731$$CN$US$US
241589881$24158988$1$I$$20240515$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005868$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589891$24158989$1$I$20240501$20240517$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005882$AURINIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240731$$CN$US$US
241589901$24158990$1$I$$20240523$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005104$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589911$24158991$1$I$$20240508$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005808$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241589921$24158992$1$I$$20240729$20240731$20240731$PER$$US-ABBVIE-5860872$ABBVIE$$70$YR$$M$Y$$$20240731$$MD$US$US
241589931$24158993$1$I$20240531$20240729$20240731$20240731$EXP$FR-AFSSAPS-BR2024000612$FR-009507513-2407FRA015347$MERCK$$61$YR$$F$Y$$$20240731$$MD$FR$FR
241589941$24158994$1$I$$20240530$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005973$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589951$24158995$1$I$20240527$20240530$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005975$AURINIA PHARMACEUTICALS$$21$YR$$F$Y$$$20240731$$CN$US$US
241589961$24158996$1$I$20240501$20240603$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005225$AURINIA PHARMACEUTICALS$$21$YR$$F$Y$$$20240731$$CN$US$US
241589971$24158997$1$I$$20240606$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005977$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589981$24158998$1$I$$20240523$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005928$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241589991$24158999$1$I$20240601$20240604$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006009$AURINIA PHARMACEUTICALS$$52$YR$$F$Y$$$20240731$$CN$US$US
241590002$24159000$2$F$20240201$20240912$20240731$20240920$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-005384$AURINIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240920$$CN$US$US
241590011$24159001$1$I$$20240606$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006029$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590021$24159002$1$I$$20240604$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006007$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590031$24159003$1$I$$20240606$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006032$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590042$24159004$2$F$$20240816$20240731$20240819$PER$$NVSC2024US156448$NOVARTIS$$$$$F$Y$$$20240819$$MD$US$US
241590052$24159005$2$F$$20240725$20240731$20240808$PER$$US-SA-2024SA195126$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240808$$CN$US$US
241590061$24159006$1$I$$20240717$20240731$20240731$PER$$US-KARYOPHARM-2024KPT001326$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240731$$CN$US$US
241590072$24159007$2$F$$20240722$20240731$20240802$EXP$$CH-MYLANLABS-2024M1069189$MYLAN$Umbrichta F, Aerztin D, Szajeka K, Fehra T. When ions run amok, Unclear status epilepticus. Schweizerische ?rztezeitung und Swissmedcal Forum$8$DEC$$F$Y$$$20240802$$MD$CH$CH
241590083$24159008$3$F$20240101$20240807$20240731$20240809$PER$$US-KARYOPHARM-2024KPT001377$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240809$$CN$US$US
241590091$24159009$1$I$$20240729$20240731$20240731$EXP$GB-MHRA-MED-202407291015035270-CFZVJ$GB-MYLANLABS-2024M1070545$MYLAN$$$$$F$Y$$$20240731$$CN$GB$GB
241590101$24159010$1$I$$20240724$20240731$20240731$EXP$$US-MYLANLABS-2024M1070454$MYLAN$Wolf AB, Corboy JR. Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. Neurol-Clin-Pract 2024; 14 (5).$36$YR$$F$Y$$$20240731$$MD$US$US
241590113$24159011$3$F$$20240820$20240731$20240826$EXP$$US-MYLANLABS-2024M1067624$MYLAN$$$$$F$Y$81.65$KG$20240826$$CN$US$US
241590121$24159012$1$I$20240617$20240726$20240731$20240731$EXP$FR-AFSSAPS-MA2024001078$FR-009507513-2407FRA014663$MERCK$$82$YR$$M$Y$$$20240731$$MD$FR$FR
241590131$24159013$1$I$$20240724$20240731$20240731$EXP$$IT-009507513-2407ITA014435$MERCK$$81$YR$$F$Y$$$20240731$$MD$IT$IT
241590141$24159014$1$I$20210401$20210512$20240731$20240731$EXP$$US-AstraZeneca-2021A428662$ASTRAZENECA$$212$MON$$F$Y$$$20240731$$CN$US$
241590151$24159015$1$I$$20230501$20240731$20240731$EXP$$US-AstraZeneca-2023A101950$ASTRAZENECA$$$$$$Y$$$20240731$$CN$US$
241590161$24159016$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006054$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590171$24159017$1$I$$20240612$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005891$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590181$24159018$1$I$$20240729$20240731$20240731$PER$$US-ABBVIE-5860379$ABBVIE$$$$$$Y$$$20240731$$MD$US$US
241590191$24159019$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006060$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590201$24159020$1$I$20240606$20240606$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006038$AURINIA PHARMACEUTICALS$$34$YR$$F$Y$$$20240731$$CN$US$US
241590211$24159021$1$I$$20240611$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006072$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590221$24159022$1$I$20231226$20240610$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005339$AURINIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240731$$CN$US$US
241590231$24159023$1$I$$20240724$20240731$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-023049$UNITED THERAPEUTICS$$$$$M$Y$90.703$KG$20240731$$$US$US
241590241$24159024$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005956$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590251$24159025$1$I$$20240611$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005859$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590261$24159026$1$I$20240201$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005476$AURINIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240731$$CN$US$US
241590271$24159027$1$I$20240214$20240607$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005921$AURINIA PHARMACEUTICALS$$25$YR$$F$Y$79.819$KG$20240731$$CN$US$US
241590281$24159028$1$I$20240101$20240724$20240731$20240731$PER$$US-UNITED THERAPEUTICS-UNT-2024-023015$UNITED THERAPEUTICS$$$$$F$Y$89.342$KG$20240731$$$US$US
241590292$24159029$2$F$20240723$20240819$20240731$20240821$EXP$$US-KARYOPHARM-2024KPT001363$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240821$$CN$US$US
241590301$24159030$1$I$$20240730$20240731$20240731$PER$$NVSC2024US156498$NOVARTIS$$$$$F$Y$$$20240731$$HP$US$US
241590311$24159031$1$I$$20240612$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005354$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590321$24159032$1$I$20240618$20240615$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006128$AURINIA PHARMACEUTICALS$$39$YR$$F$Y$$$20240731$$CN$US$US
241590331$24159033$1$I$$20240614$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006088$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590341$24159034$1$I$20240501$20240617$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006097$AURINIA PHARMACEUTICALS$$48$YR$$F$Y$$$20240731$$CN$US$US
241590351$24159035$1$I$$20240614$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006094$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590361$24159036$1$I$$20240614$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006092$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590371$24159037$1$I$20240612$20240613$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006081$AURINIA PHARMACEUTICALS$$42$YR$$F$Y$$$20240731$$CN$US$US
241590381$24159038$1$I$$20240612$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006080$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241590392$24159039$2$F$20240101$20240801$20240731$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023188$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240806$$$US$US
241590411$24159041$1$I$$20240613$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006086$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590421$24159042$1$I$$20240613$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006087$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590431$24159043$1$I$20230105$20240726$20240731$20240731$EXP$$BE-AMERICAN REGENT INC-2024002893$AMERICAN REGENT$$$$A$F$Y$$$20240731$$HP$BE$BE
241590441$24159044$1$I$20240705$20240729$20240731$20240731$EXP$FR-AFSSAPS-LY2024001085$FR-009507513-2407FRA015255$MERCK$$72$YR$$M$Y$97.6$KG$20240731$$PH$FR$FR
241590451$24159045$1$I$$20240619$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006117$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590461$24159046$1$I$$20240620$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006130$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241590471$24159047$1$I$$20240621$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006140$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590481$24159048$1$I$$20240618$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006108$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590491$24159049$1$I$$20240620$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006127$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590501$24159050$1$I$$20240625$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006153$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590511$24159051$1$I$$20240626$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006129$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590521$24159052$1$I$20240502$20240622$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006014$AURINIA PHARMACEUTICALS$$18$YR$$F$Y$60.8$KG$20240731$$CN$US$US
241590531$24159053$1$I$20240401$20240618$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005785$AURINIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240731$$CN$US$US
241590541$24159054$1$I$$20240729$20240731$20240731$PER$$NVSC2024US155639$NOVARTIS$$$$$$Y$$$20240731$$CN$US$US
241590551$24159055$1$I$20240314$20240730$20240731$20240731$EXP$$FR-WAYLIS-2024-FR-000120$Waylis$$92$YR$$M$Y$$$20240730$$PH$FR$FR
241590561$24159056$1$I$20240301$20240620$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005908$AURINIA PHARMACEUTICALS$$20$YR$$F$Y$85.78$KG$20240731$$CN$US$US
241590572$24159057$2$F$$20240816$20240731$20240822$EXP$$US-ABBVIE-5859755$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
241590583$24159058$3$F$20240701$20240823$20240731$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023406$UNITED THERAPEUTICS$$27$YR$$M$Y$82.993$KG$20240831$$$US$US
241590601$24159060$1$I$$20240724$20240731$20240731$PER$$US-Covis Pharma GmbH-2024COV00923$COVIS PHARMA$$85$YR$E$F$Y$$$20240731$$CN$US$US
241590611$24159061$1$I$20240501$20240730$20240731$20240731$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-138168$DAIICHI$$32$YR$$F$Y$$$20240731$$HP$US$US
241590621$24159062$1$I$$20240627$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006174$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590631$24159063$1$I$20240222$20240627$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005471$AURINIA PHARMACEUTICALS$$47$YR$$F$Y$$$20240731$$CN$US$US
241590641$24159064$1$I$$20240702$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006192$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590651$24159065$1$I$$20240628$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006178$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241590661$24159066$1$I$$20240701$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006186$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590671$24159067$1$I$$20191202$20240731$20240731$EXP$$CA-Covis Pharma GmbH-2021COV22200$COVIS PHARMA$$58$YR$A$M$Y$$$20240731$$$COUNTRY NOT SPECIFIED$CA
241590681$24159068$1$I$$20240627$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006173$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590691$24159069$1$I$20240625$20240626$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006158$AURINIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240731$$CN$US$US
241590701$24159070$1$I$$20240702$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006203$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590711$24159071$1$I$$20240628$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006172$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590722$24159072$2$F$$20240802$20240731$20240812$EXP$$JP-TEVA-VS-3224786$TEVA$Ono M, Okabe T, Isomura N, Ochiai M. Successful treatment of vasospastic angina refractory to various therapies using stenting: A case report. J-Cardiol-Cases 2024; 0 (0):.; Ono M, Okabe T, Isomura N, Ochiai M. Successful treatment of vasospastic angina refractory to various therapies using stenting: A case report. J-Cardiol-Cases 2024; 0 (0):.$47$YR$$F$Y$$$20240812$$HP$JP$JP
241590732$24159073$2$F$20240101$20240808$20240731$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-023399$UNITED THERAPEUTICS$$$$$F$Y$104.31$KG$20240817$$$US$US
241590741$24159074$1$I$20240127$20240702$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006077$AURINIA PHARMACEUTICALS$$67$YR$$F$Y$$$20240731$$CN$US$US
241590771$24159077$1$I$$20240729$20240731$20240731$PER$$US-ABBVIE-5861063$ABBVIE$$14$YR$$M$Y$$$20240731$$CN$US$US
241590781$24159078$1$I$20240701$20240724$20240731$20240731$PER$$US-SA-2024SA222824$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240731$$MD$US$US
241590791$24159079$1$I$20240723$20240723$20240731$20240731$PER$$US-ABBVIE-5854225$ABBVIE$$68$YR$$F$Y$$$20240731$$CN$US$US
241590801$24159080$1$I$20210101$20240729$20240731$20240731$EXP$$ES-SANDOZ INC.-SDZ2024ES069146$SANDOZ$$57$YR$$F$Y$$$20240731$$MD$ES$ES
241590811$24159081$1$I$$20240626$20240731$20240731$PER$$US-TRAVERE-2024TVT00652$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240731$$CN$US$US
241590821$24159082$1$I$$20240626$20240731$20240731$PER$$US-TRAVERE-2024TVT00651$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240731$$CN$US$US
241590832$24159083$2$F$$20240820$20240731$20240917$PER$$US-TRAVERE-2024TVT00650$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
241590841$24159084$1$I$$20240625$20240731$20240731$PER$$US-TRAVERE-2024TVT00647$TRAVERE THERAPEUTICS$$57$YR$A$F$Y$$$20240731$$CN$US$US
241590851$24159085$1$I$20240601$20240705$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006212$AURINIA PHARMACEUTICALS$$33$YR$$F$Y$$$20240731$$CN$US$US
241590861$24159086$1$I$20240702$20240702$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006198$AURINIA PHARMACEUTICALS$$36$YR$$M$Y$$$20240731$$CN$US$US
241590871$24159087$1$I$$20240710$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006211$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590881$24159088$1$I$$20240705$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006218$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590891$24159089$1$I$$20240710$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005574$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590901$24159090$1$I$20240702$20240708$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006229$AURINIA PHARMACEUTICALS$$29$YR$$F$Y$$$20240731$$MD$US$US
241590911$24159091$1$I$20240530$20240702$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005996$AURINIA PHARMACEUTICALS$$26$YR$$M$Y$65.8$KG$20240731$$CN$US$US
241590921$24159092$1$I$$20240709$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006238$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590931$24159093$1$I$$20240704$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006208$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590941$24159094$1$I$$20240703$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006170$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241590951$24159095$1$I$$20240729$20240731$20240731$PER$$US-ABBVIE-5859478$ABBVIE$$$$$$Y$$$20240731$$MD$US$US
241590961$24159096$1$I$20240704$20240725$20240731$20240731$EXP$GR-GREOF-202400793$GR-009507513-2407GRC014212$MERCK$$51$YR$$F$Y$75$KG$20240731$$MD$GR$GR
241590971$24159097$1$I$$20240723$20240731$20240731$PER$$US-ABBVIE-5853924$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241590981$24159098$1$I$$20240725$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017627$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240731$$CN$US$US
241590991$24159099$1$I$$20240724$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017346$ELI LILLY AND CO$$$$$M$Y$$$20240731$$CN$US$US
241591001$24159100$1$I$20240401$20240712$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006112$AURINIA PHARMACEUTICALS$$60$YR$$F$Y$$$20240731$$CN$US$US
241591011$24159101$1$I$$20240712$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006265$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591021$24159102$1$I$20240701$20240725$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407017419$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240731$$CN$US$US
241591041$24159104$1$I$20240601$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006273$AURINIA PHARMACEUTICALS$$61$YR$$F$Y$$$20240731$$CN$US$US
241591051$24159105$1$I$$20240711$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006257$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591061$24159106$1$I$$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006091$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591071$24159107$1$I$$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006275$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591081$24159108$1$I$$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006049$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591091$24159109$1$I$$20240710$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005139$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591101$24159110$1$I$$20240712$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006260$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241591111$24159111$1$I$$20240710$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006246$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241591122$24159112$2$F$$20240806$20240731$20240812$EXP$$BR-009507513-2407BRA014907$MERCK$$$$A$F$Y$$$20240812$$MD$BR$BR
241591131$24159113$1$I$$20240716$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006284$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591141$24159114$1$I$$20240716$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006053$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591151$24159115$1$I$$20240718$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006309$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591161$24159116$1$I$$20240716$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006274$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591171$24159117$1$I$20240719$20240719$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006300$AURINIA PHARMACEUTICALS$$38$YR$$F$Y$$$20240731$$CN$US$US
241591181$24159118$1$I$20240209$20240718$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006307$AURINIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240731$$CN$US$US
241591191$24159119$1$I$$20240723$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006234$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591201$24159120$1$I$$20240722$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005787$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241591211$24159121$1$I$20240701$20240719$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006258$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240731$$CN$US$US
241591221$24159122$1$I$20231001$20240123$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005108$AURINIA PHARMACEUTICALS$$47$YR$$F$Y$$$20240731$$HP$US$US
241591231$24159123$1$I$$20240125$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005123$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591241$24159124$1$I$20240115$20240122$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005103$AURINIA PHARMACEUTICALS$$42$YR$$F$Y$$$20240731$$CN$US$US
241591251$24159125$1$I$$20240723$20240731$20240731$EXP$$NVSC2024MX154001$NOVARTIS$$$$$F$Y$60$KG$20240731$$CN$MX$MX
241591261$24159126$1$I$20240607$20240729$20240731$20240731$EXP$FR-AFSSAPS-NT2024000943$FR-SANDOZ INC.-SDZ2024FR069345$SANDOZ$$76$YR$$F$Y$$$20240731$$MD$FR$FR
241591271$24159127$1$I$20240324$20240729$20240731$20240731$EXP$FR-AFSSAPS-LM2024000199$FR-SANDOZ INC.-SDZ2024FR038434$SANDOZ$$22$YR$$F$Y$58.7$KG$20240731$$MD$FR$FR
241591281$24159128$1$I$20240109$20240125$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005113$AURINIA PHARMACEUTICALS$$50$YR$$F$Y$$$20240731$$CN$US$US
241591291$24159129$1$I$$20240125$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005116$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241591301$24159130$1$I$$20240125$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005127$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241591311$24159131$1$I$$20240125$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005120$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591321$24159132$1$I$$20230508$20240731$20240731$EXP$$US-AstraZeneca-2023A107259$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241591331$24159133$1$I$20240706$20240730$20240731$20240731$EXP$$CN-PFIZER INC-PV202400099491$PFIZER$$69$YR$$M$Y$62$KG$20240731$$HP$CN$CN
241591341$24159134$1$I$$20240730$20240731$20240731$EXP$$CA-PFIZER INC-202400226758$PFIZER$$77$YR$$F$Y$$$20240731$$HP$CA$CA
241591352$24159135$2$F$20240701$20240802$20240731$20240808$EXP$$DE-PFIZER INC-202400225601$PFIZER$$58$YR$$M$Y$$$20240808$$MD$DE$DE
241591361$24159136$1$I$$20240126$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005152$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241591371$24159137$1$I$$20240129$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005132$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591381$24159138$1$I$$20240126$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005126$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241591391$24159139$1$I$$20240129$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005137$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241591401$24159140$1$I$$20240126$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005125$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241591411$24159141$1$I$20240128$20240129$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005129$AURINIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240731$$CN$US$US
241591421$24159142$1$I$$20240126$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005122$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591431$24159143$1$I$$20240730$20240731$20240731$PER$$NVSC2024US156503$NOVARTIS$$$$$M$Y$$$20240731$$HP$US$US
241591443$24159144$3$F$$20240920$20240731$20240920$PER$$US-BAYER-2024A110026$BAYER$$$$$F$Y$$$20240920$$HP$US$US
241591454$24159145$4$F$20240622$20240913$20240731$20240930$PER$$US-TRAVERE-2024TVT00653$TRAVERE THERAPEUTICS$$59$YR$A$M$Y$$$20240930$$CN$US$US
241591461$24159146$1$I$$20240626$20240731$20240731$PER$$US-TRAVERE-2024TVT00654$TRAVERE THERAPEUTICS$$$$$$Y$$$20240731$$MD$US$US
241591471$24159147$1$I$$20240626$20240731$20240731$PER$$US-TRAVERE-2024TVT00655$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240731$$CN$US$US
241591481$24159148$1$I$$20240626$20240731$20240731$PER$$US-TRAVERE-2024TVT00658$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240731$$CN$US$US
241591491$24159149$1$I$$20240722$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN007705$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241591511$24159151$1$I$$20240130$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005153$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591521$24159152$1$I$$20240130$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005144$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241591531$24159153$1$I$$20240130$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005147$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591541$24159154$1$I$$20240130$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005140$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591551$24159155$1$I$20240126$20240129$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005128$AURINIA PHARMACEUTICALS$$41$YR$$F$Y$$$20240731$$CN$US$US
241591561$24159156$1$I$$20240129$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005142$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591571$24159157$1$I$$20240129$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005133$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241591581$24159158$1$I$20240101$20240130$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005148$AURINIA PHARMACEUTICALS$$50$YR$$F$Y$$$20240731$$CN$US$US
241591592$24159159$2$F$20240701$20240819$20240731$20240826$PER$$US-KARYOPHARM-2024KPT001368$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240826$$CN$US$US
241591601$24159160$1$I$20220101$20240729$20240731$20240731$EXP$$JP-DSJP-DSJ-2024-112803$DAIICHI$$$$$F$Y$56$KG$20240731$$MD$JP$JP
241591611$24159161$1$I$$20240729$20240731$20240731$PER$$NVSC2024US156324$NOVARTIS$$$$$F$Y$$$20240731$$MD$US$US
241591621$24159162$1$I$20240101$20240730$20240731$20240731$EXP$$RU-ABBVIE-5861781$ABBVIE$$38$YR$$M$Y$$$20240731$$MD$RU$RU
241591631$24159163$1$I$$20240730$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069533$SANDOZ$Manuel, Sebastian L, Sapone, et al. Tacrolimus-Induced Recurrent Acute Coronary Syndrome Due to an Unknown Mechanism. Cureus. 16(6)$74$YR$$F$Y$$$20240731$$HP$US$US
241591641$24159164$1$I$$20240131$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005149$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241591651$24159165$1$I$$20240201$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005157$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591662$24159166$2$F$20231205$20240828$20240731$20240904$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005174$AURINIA PHARMACEUTICALS$$30$YR$$F$Y$$$20240904$$MD$US$US
241591671$24159167$1$I$$20240131$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005107$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241591691$24159169$1$I$$20240131$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005151$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591701$24159170$1$I$$20240201$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005167$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591711$24159171$1$I$20240101$20240730$20240731$20240731$EXP$$US-ABBVIE-5861438$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241591722$24159172$2$F$20240701$20240819$20240731$20240826$PER$$US-IGSA-BIG0030039$GRIFOLS$$83$YR$$F$Y$56.699$KG$20240826$$CN$US$US
241591731$24159173$1$I$$20240726$20240731$20240731$EXP$$FR-INCYTE CORPORATION-2024IN007962$INCYTE$$$$$$Y$$$20240731$$MD$FR$FR
241591741$24159174$1$I$20240206$20240202$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005168$AURINIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240731$$CN$US$US
241591751$24159175$1$I$20240130$20240201$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005161$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240731$$CN$US$US
241591761$24159176$1$I$$20240202$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005164$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591771$24159177$1$I$20240101$20240205$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005177$AURINIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240731$$CN$US$US
241591781$24159178$1$I$$20240205$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005180$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591791$24159179$1$I$20240101$20240725$20240731$20240731$EXP$$IT-009507513-2407ITA014440$MERCK$$79$YR$$F$Y$$$20240731$$MD$IT$IT
241591801$24159180$1$I$$20240207$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005197$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241591811$24159181$1$I$$20240207$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005189$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$PH$US$US
241591821$24159182$1$I$$20240206$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005184$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591841$24159184$1$I$$20240207$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005131$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591851$24159185$1$I$$20240207$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005192$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591871$24159187$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5859961$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241591881$24159188$1$I$$20240722$20240731$20240731$EXP$$CA-DSJP-DSJ-2024-137896$DAIICHI$$$$$F$Y$$$20240731$$CN$CA$CA
241591891$24159189$1$I$$20240722$20240731$20240731$EXP$$CA-DSJP-DSJ-2024-137909$DAIICHI$$41$YR$$F$Y$$$20240731$$MD$CA$CA
241591901$24159190$1$I$$20240722$20240731$20240731$EXP$$CA-DSJP-DSJ-2024-137910$DAIICHI$$$$$F$Y$64$KG$20240731$$CN$CA$CA
241591911$24159191$1$I$$20240722$20240731$20240731$EXP$$CA-DSJP-DSJ-2024-137871$DAIICHI$$$$$F$Y$$$20240731$$MD$CA$CA
241591921$24159192$1$I$20240208$20240208$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005200$AURINIA PHARMACEUTICALS$$36$YR$$M$Y$$$20240731$$CN$US$US
241591931$24159193$1$I$20240203$20240208$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005208$AURINIA PHARMACEUTICALS$$29$YR$$M$Y$$$20240731$$CN$US$US
241591941$24159194$1$I$$20240208$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005199$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241591951$24159195$1$I$$20240208$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005198$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241591961$24159196$1$I$$20240208$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005202$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241591971$24159197$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA222674$SANOFI AVENTIS$$$$A$M$Y$$$20240731$$MD$US$US
241591981$24159198$1$I$$20240722$20240731$20240731$EXP$$CA-DSJP-DSJ-2024-137872$DAIICHI$$$$$F$Y$$$20240731$$MD$CA$CA
241591991$24159199$1$I$20240114$20240208$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005195$AURINIA PHARMACEUTICALS$$29$YR$$F$Y$$$20240731$$CN$US$US
241592001$24159200$1$I$$20240209$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005221$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592011$24159201$1$I$20220609$20240208$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005209$AURINIA PHARMACEUTICALS$$16$YR$$F$Y$$$20240731$$CN$US$US
241592021$24159202$1$I$$20240207$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005193$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592032$24159203$2$F$$20240819$20240731$20240823$PER$$US-ALXN-202407USA001730US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
241592041$24159204$1$I$20220415$20240725$20240731$20240731$EXP$FR-AFSSAPS-PP2024000812$FR-MYLANLABS-2024M1069954$MYLAN$$60$YR$$F$Y$75$KG$20240731$$MD$FR$FR
241592051$24159205$1$I$$20240725$20240731$20240731$EXP$$FR-MYLANLABS-2024M1069697$MYLAN$$87$YR$$F$Y$$$20240731$$PH$FR$FR
241592061$24159206$1$I$$20240211$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005229$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592071$24159207$1$I$$20240209$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005212$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241592081$24159208$1$I$20240201$20240211$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005227$AURINIA PHARMACEUTICALS$$38$YR$$F$Y$$$20240731$$CN$US$US
241592091$24159209$1$I$$20240211$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005231$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592101$24159210$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018335$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240731$$CN$US$US
241592111$24159211$1$I$20240514$20240717$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006043$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$64.9$KG$20240731$$CN$US$US
241592122$24159212$2$F$$20240726$20240731$20240801$PER$$US-ABBVIE-5854424$ABBVIE$$$$$M$Y$$$20240801$$HP$US$US
241592131$24159213$1$I$$20240725$20240731$20240731$EXP$NL-LRB-00992949$NL-MYLANLABS-2024M1069887$MYLAN$$66$YR$$F$Y$69$KG$20240731$$CN$NL$NL
241592141$24159214$1$I$20240115$20240725$20240731$20240731$EXP$FR-AFSSAPS-PC2024000580$FR-MYLANLABS-2024M1069963$MYLAN$$70$YR$$F$Y$60$KG$20240731$$PH$FR$FR
241592151$24159215$1$I$20240501$20240725$20240731$20240731$EXP$FR-AFSSAPS-GR2024000908$FR-MYLANLABS-2024M1069696$MYLAN$$41$YR$$M$Y$76$KG$20240731$$PH$FR$FR
241592161$24159216$1$I$20240119$20240725$20240731$20240731$EXP$FR-AFSSAPS-TO2024001320$FR-MYLANLABS-2024M1069791$MYLAN$$55$YR$$M$Y$69$KG$20240731$$MD$FR$FR
241592171$24159217$1$I$20231206$20240725$20240731$20240731$EXP$IT-MINISAL02-995672$IT-MYLANLABS-2024M1069710$MYLAN$$94$YR$$M$Y$$$20240731$$MD$IT$IT
241592181$24159218$1$I$$20240730$20240731$20240731$PER$$US-JNJFOC-20240781436$JOHNSON AND JOHNSON$$$$$$Y$$$20240731$$CN$US$US
241592191$24159219$1$I$20240210$20240212$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005228$AURINIA PHARMACEUTICALS$$58$YR$$F$Y$$$20240731$$CN$US$US
241592201$24159220$1$I$$20240212$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005245$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592211$24159221$1$I$$20240212$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005242$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592221$24159222$1$I$20240206$20240212$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005243$AURINIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240731$$CN$US$US
241592231$24159223$1$I$$20240213$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005251$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592241$24159224$1$I$20240208$20240212$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005244$AURINIA PHARMACEUTICALS$$26$YR$$M$Y$$$20240731$$CN$US$US
241592251$24159225$1$I$$20240722$20240731$20240731$EXP$$CA-TEVA-VS-3225789$TEVA$$43$YR$$F$Y$$$20240731$$HP$CA$CA
241592261$24159226$1$I$$20240729$20240731$20240731$EXP$NL-LRB-00993570$NL-009507513-2407NLD015311$MERCK$$23$YR$$F$Y$$$20240731$$HP$NL$NL
241592271$24159227$1$I$20240522$20240725$20240731$20240731$EXP$GB-MHRA-MED-202407251558370590-WYBFG$GB-009507513-2407GBR014281$MERCK$$21$YR$$M$Y$102$KG$20240731$$PH$GB$GB
241592281$24159228$1$I$20240116$20240721$20240731$20240731$EXP$$AU-TEVA-VS-3224210$TEVA$$74$YR$$M$Y$$$20240731$$MD$AU$AU
241592291$24159229$1$I$$20240730$20240731$20240731$PER$$US-AMGEN-USASP2024151961$AMGEN$$$$$$Y$$$20240731$$MD$US$US
241592301$24159230$1$I$$20240213$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005115$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241592311$24159231$1$I$$20240213$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005254$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592321$24159232$1$I$$20240213$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005253$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241592331$24159233$1$I$$20240214$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005182$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241592341$24159234$1$I$$20240214$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005252$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592351$24159235$1$I$$20240214$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005248$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241592361$24159236$1$I$20231201$20240214$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005106$AURINIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240731$$CN$US$US
241592371$24159237$1$I$$20240214$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005261$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241592381$24159238$1$I$$20240214$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005259$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592391$24159239$1$I$$20240214$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005266$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592401$24159240$1$I$$20240213$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005255$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592411$24159241$1$I$$20240725$20240731$20240731$EXP$$GR-MYLANLABS-2024M1069880$MYLAN$Tsotsorou O, Kalogeropoulos P, Lionaki S. Lactic Acidosis and Acute Kidney Injury in patients receiving metformin: Description of 2 clinical cases. Poster no: P06. 25th Panhellenic Congress of Nephrology. 2024;19-21$74$YR$$F$Y$$$20240731$$MD$GR$GR
241592421$24159242$1$I$$20240725$20240731$20240731$EXP$$GR-MYLANLABS-2024M1069884$MYLAN$Tsotsorou O, Kalogeropoulos P, Lionaki S.. Euglycaemic Ketoacidosis, Lactic Acidosis and Acute Kidney Injury in patients receiving metformin: Description of 2 clinical cases.. 25th Panhellenic Congress of Nephrology.$71$YR$$F$Y$$$20240731$$MD$GR$GR
241592432$24159243$2$F$20240605$20240723$20240731$20240802$EXP$$NVSC2024GE152007$NOVARTIS$$69$YR$$F$Y$67$KG$20240802$$MD$GE$GE
241592441$24159244$1$I$20200905$20240722$20240731$20240731$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-116918$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$63$KG$20240731$$MD$KR$KR
241592452$24159245$2$F$$20240829$20240731$20240904$EXP$DE-EMA-DD-20240718-7482645-080313$DE-MYLANLABS-2024M1069972$MYLAN$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology.. 2024;48 (5):299?313$35$YR$$M$Y$$$20240904$$HP$DE$DE
241592461$24159246$1$I$$20240219$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005283$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592471$24159247$1$I$20240219$20240219$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005282$AURINIA PHARMACEUTICALS$$45$YR$$M$Y$$$20240731$$CN$US$US
241592484$24159248$4$F$20240101$20240820$20240731$20240823$EXP$$JP-Eisai-EC-2024-171025$EISAI$$$$A$F$Y$53$KG$20240823$$MD$JP$JP
241592491$24159249$1$I$$20240219$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005159$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592501$24159250$1$I$$20240215$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005270$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592511$24159251$1$I$20240202$20240214$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005217$AURINIA PHARMACEUTICALS$$28$YR$$M$Y$$$20240731$$CN$US$US
241592521$24159252$1$I$$20240219$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005296$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592531$24159253$1$I$$20240722$20240731$20240731$EXP$$CA-TEVA-VS-3225391$TEVA$$43$YR$$F$Y$$$20240731$$HP$CA$CA
241592541$24159254$1$I$$20240221$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005300$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592551$24159255$1$I$$20240221$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005313$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592561$24159256$1$I$20240221$20240221$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005314$AURINIA PHARMACEUTICALS$$54$YR$$F$Y$$$20240731$$CN$US$US
241592571$24159257$1$I$$20240221$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005319$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592581$24159258$1$I$20240508$20240509$20240731$20240731$PER$$US-GE HEALTHCARE-2024CSU004980$GE HEALTHCARE$$$$$M$Y$$$20240731$$MD$US$US
241592591$24159259$1$I$$20240729$20240731$20240731$PER$$US-ABBVIE-5860515$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241592602$24159260$2$F$$20240801$20240731$20240801$EXP$$PT-ABBVIE-5861880$ABBVIE$Danny C, Catarina Pinto S, Rita S, Francisca M. P, Joao Pedro A, Marcia R. ENVOLVIMENTO NEUROLOGICO A REACAO DE JARISCH (WHIPPLE^S DISEASE: FROM NEUROLOGICAL INVOLVEMENT TO THE JARISCH- HERXHEIMER REACTION). Infectious and parasitic diseases. Clinical case. 945.$70$YR$$F$Y$$$20240801$$HP$PT$PT
241592611$24159261$1$I$$20240731$20240731$20240731$EXP$$US-PAIPHARMA-2024-US-041357$PHARMACEUTICAL ASSOC$Kretovics E, Keegan K, Burg G, et al.Prolonged high-dose steroid use in an infant with surfactant protein-C deficiency and multiple complications..American Journal of Respiratory and Critical Care Medicine.2024;209A2307.$3$MON$$M$Y$$$20240731$$HP$US$US
241592621$24159262$1$I$$20240726$20240731$20240731$PER$$US-ABBVIE-5857516$ABBVIE$$$$$F$Y$$$20240731$$MD$US$US
241592631$24159263$1$I$20240101$20240724$20240731$20240731$EXP$$US-ALKERMES INC.-ALK-2024-001958$ALKERMES$$$$$F$Y$$$20240731$$HP$US$US
241592641$24159264$1$I$20240201$20240222$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005320$AURINIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240731$$CN$US$US
241592651$24159265$1$I$$20240222$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005310$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241592661$24159266$1$I$20240101$20240223$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005321$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592671$24159267$1$I$$20240222$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005323$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592681$24159268$1$I$20240220$20240221$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005307$AURINIA PHARMACEUTICALS$$66$YR$$F$Y$$$20240731$$CN$US$US
241592691$24159269$1$I$$20240223$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005279$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241592701$24159270$1$I$$20240222$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005322$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592711$24159271$1$I$$20240226$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005336$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592721$24159272$1$I$$20240724$20240731$20240731$PER$$US-ALKERMES INC.-ALK-2024-001964$ALKERMES$$$$$F$Y$136.05$KG$20240731$$HP$US$US
241592731$24159273$1$I$$20240724$20240731$20240731$PER$$US-ABBVIE-5854515$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241592741$24159274$1$I$$20240226$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005334$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592751$24159275$1$I$$20240725$20240731$20240731$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15051$IPSEN$$$$$$Y$$$20240731$$MD$US$US
241592761$24159276$1$I$20240313$20240726$20240731$20240731$EXP$$US-MYLANLABS-2024M1026508$MYLAN$$57$YR$$F$Y$86.18$KG$20240731$$CN$US$US
241592771$24159277$1$I$20240223$20240228$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005341$AURINIA PHARMACEUTICALS$$23$YR$$F$Y$$$20240731$$CN$US$US
241592781$24159278$1$I$$20240228$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005356$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592791$24159279$1$I$20240726$20240730$20240731$20240731$PER$$US-BAUSCH-BL-2024-011651$BAUSCH AND LOMB$$24$YR$$F$Y$$$20240731$$CN$US$US
241592802$24159280$2$F$20240701$20240830$20240731$20240904$PER$$US-BAUSCH-BL-2024-011577$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240904$$CN$US$US
241592811$24159281$1$I$$20240729$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN007945$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241592821$24159282$1$I$$20240229$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005370$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592831$24159283$1$I$20240201$20240301$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005366$AURINIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240731$$CN$US$US
241592841$24159284$1$I$$20240301$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005369$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241592852$24159285$2$F$20230525$20240729$20240731$20240805$EXP$$DE-BAUSCH-BL-2024-011572$BAUSCH AND LOMB$$78$YR$$M$Y$92$KG$20240805$$MD$DE$DE
241592861$24159286$1$I$$20240703$20240731$20240731$PER$$US-JNJFOC-20240714152$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$HP$US$US
241592871$24159287$1$I$$20240723$20240731$20240731$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011379$JAZZ$$$$$$Y$$$20240731$$CN$US$US
241592881$24159288$1$I$20240404$20240722$20240731$20240731$EXP$FR-AFSSAPS-BX2024001441$FR-TEVA-VS-3224599$TEVA$$78$YR$$M$Y$97$KG$20240731$$PH$FR$FR
241592891$24159289$1$I$20180201$20240729$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN007922$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241592901$24159290$1$I$$20240304$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005378$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241592911$24159291$1$I$20230101$20240301$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005347$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241592922$24159292$2$F$20240731$20240731$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043043$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240731$$CN$US$US
241592931$24159293$1$I$$20240726$20240731$20240731$EXP$GB-MHRA-31082675$GB-MYLANLABS-2024M1070298$MYLAN$$23$YR$$M$Y$$$20240731$$CN$GB$GB
241592941$24159294$1$I$20240313$20240726$20240731$20240731$EXP$FR-AFSSAPS-NT2024000875$FR-MYLANLABS-2024M1070078$MYLAN$$23$YR$$M$Y$51$KG$20240731$$MD$FR$FR
241592951$24159295$1$I$$20240304$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005109$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592962$24159296$2$F$20240319$20240822$20240731$20240829$EXP$$JP-Eisai-EC-2024-170944$EISAI$$6$YR$C$F$Y$20$KG$20240829$$MD$JP$JP
241592971$24159297$1$I$20240311$20240304$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005419$AURINIA PHARMACEUTICALS$$17$YR$$F$Y$$$20240731$$HP$US$US
241592981$24159298$1$I$$20240304$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005386$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241592991$24159299$1$I$20240131$20240305$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005158$AURINIA PHARMACEUTICALS$$43$YR$$F$Y$$$20240731$$CN$US$US
241593001$24159300$1$I$20240302$20240304$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005402$AURINIA PHARMACEUTICALS$$65$YR$$F$Y$$$20240731$$CN$US$US
241593011$24159301$1$I$$20240723$20240731$20240731$EXP$GB-MHRA-31183392$GB-TEVA-VS-3224700$TEVA$$$$$F$Y$$$20240731$$PH$GB$GB
241593022$24159302$2$F$$20240802$20240731$20240812$EXP$$JP-TEVA-VS-3224739$TEVA$Yamada H, Toko M, Nakamori M, Ueno H, Aoki S, Sugimoto T, et al. Progressive multifocal leukoencephalopathy associated with systemic lupus erythematosus: longitudinal observation of lymphocytes, JC virus in cerebrospinal fluid, and brain magnetic resonance imaging. J-Neurovirol 2024;.; Yamada H, Toko M, Nakamori M, Ueno H, Aoki S, Sugimoto T, et al. Progressive multifocal leukoencephalopathy associated with systemic lupus erythematosus: longitudinal observation of lymphocytes, JC virus in cer...$60$YR$$F$Y$$$20240812$$HP$JP$JP
241593031$24159303$1$I$20240201$20240723$20240731$20240731$EXP$GB-MHRA-30722627$GB-TEVA-VS-3225097$TEVA$$51$YR$$M$Y$$$20240731$$CN$GB$GB
241593041$24159304$1$I$20231125$20240723$20240731$20240731$EXP$GB-MHRA-MIDB-6ea4b56c-514b-48c2-8bd9-99d40b5163f6$GB-TEVA-VS-3224889$TEVA$$68$YR$$F$Y$$$20240731$$PH$GB$GB
241593051$24159305$1$I$$20240729$20240731$20240731$EXP$$US-GILEAD-2024-0682253$GILEAD$$$$A$M$Y$$$20240731$$CN$US$US
241593061$24159306$1$I$$20240725$20240731$20240731$EXP$$US-Covis Pharma GmbH-2024COV00930$COVIS PHARMA$$$$$F$Y$$$20240731$$HP$US$US
241593071$24159307$1$I$$20240307$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005408$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241593081$24159308$1$I$20240209$20240306$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005403$AURINIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240731$$CN$US$US
241593091$24159309$1$I$$20240306$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005400$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593101$24159310$1$I$20240201$20240307$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005407$AURINIA PHARMACEUTICALS$$40$YR$$M$Y$$$20240731$$CN$US$US
241593111$24159311$1$I$$20240305$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005389$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593121$24159312$1$I$$20240307$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005411$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593131$24159313$1$I$20231201$20240307$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005213$AURINIA PHARMACEUTICALS$$38$YR$$F$Y$88.9$KG$20240731$$CN$US$US
241593141$24159314$1$I$$20240726$20240731$20240731$EXP$$US-MYLANLABS-2024M1069991$MYLAN$$$$$$Y$$$20240731$$LW$US$US
241593151$24159315$1$I$20240202$20240307$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005318$AURINIA PHARMACEUTICALS$$40$YR$$F$Y$$$20240731$$CN$US$US
241593161$24159316$1$I$20240705$20240726$20240731$20240731$EXP$$GB-MYLANLABS-2024M1063550$MYLAN$$$$$F$Y$$$20240731$$MD$GB$GB
241593171$24159317$1$I$$20240729$20240731$20240731$EXP$$NVSC2024US155796$NOVARTIS$$$$$M$Y$$$20240731$$HP$US$US
241593181$24159318$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018875$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240731$$CN$US$US
241593191$24159319$1$I$20240728$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018966$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240731$$CN$US$US
241593201$24159320$1$I$20230323$20240726$20240731$20240731$EXP$FR-AFSSAPS-PC2024000591$FR-009507513-2407FRA014895$MERCK$$53$YR$$F$Y$$$20240731$$PH$FR$FR
241593211$24159321$1$I$20111021$20240722$20240731$20240731$EXP$DK-EMA-20170323-neetievhp-143749013$DK-TEVA-VS-3225738$TEVA$$72$YR$$F$Y$103$KG$20240731$$MD$DK$DK
241593221$24159322$1$I$$20240719$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013611$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240731$$CN$US$US
241593231$24159323$1$I$20240623$20240724$20240731$20240731$EXP$$JP-009507513-2407JPN004430J$MERCK$$67$YR$$F$Y$$$20240731$$MD$JP$JP
241593241$24159324$1$I$20240201$20240723$20240731$20240731$EXP$$JP-009507513-2407JPN004346J$MERCK$$79$YR$$F$Y$$$20240731$$MD$JP$JP
241593251$24159325$1$I$20240311$20240311$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005423$AURINIA PHARMACEUTICALS$$29$YR$$M$Y$$$20240731$$CN$US$US
241593261$24159326$1$I$$20240311$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005268$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593271$24159327$1$I$$20240308$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004151$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593281$24159328$1$I$$20240307$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005415$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$HP$US$US
241593291$24159329$1$I$$20240311$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005267$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593301$24159330$1$I$$20240308$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005258$AURINIA PHARMACEUTICALS$$$$$M$Y$64.399$KG$20240731$$CN$US$US
241593312$24159331$2$F$20240722$20240725$20240731$20240801$EXP$$CA-JNJFOC-20240772132$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240801$$HP$CA$CA
241593321$24159332$1$I$20240501$20240726$20240731$20240731$EXP$$UY-JNJFOC-20240773945$JOHNSON AND JOHNSON$$72$YR$E$M$Y$83$KG$20240731$$CN$UY$UY
241593331$24159333$1$I$20240612$20240715$20240731$20240731$PER$$US-JNJFOC-20240783805$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240731$$MD$US$US
241593341$24159334$1$I$$20240723$20240731$20240731$PER$$US-JNJFOC-20240784181$JOHNSON AND JOHNSON$$$$$M$Y$$$20240731$$PH$US$US
241593351$24159335$1$I$20240723$20240723$20240731$20240731$PER$$US-JNJFOC-20240783193$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240731$$HP$US$US
241593361$24159336$1$I$20240221$20240312$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005327$AURINIA PHARMACEUTICALS$$78$YR$$F$Y$72.562$KG$20240731$$CN$US$US
241593371$24159337$1$I$$20240728$20240731$20240731$EXP$$US-OTSUKA-2024_021087$OTSUKA$$$$$$Y$$$20240731$$MD$US$US
241593381$24159338$1$I$$20240724$20240731$20240731$EXP$$US-MYLANLABS-2024M1070599$MYLAN$Gandhi I, Dean O, Lenhart K, Gaddis K, Maher E, Schultz B. A novel association of ichthyosis with the GJP2 mutation p.Ser139Asn responsive to ixekizumab therapy. J-Invest-Dermatol 2024; 144 (Suppl.) S69 abstr. 399.$37$YR$$M$Y$$$20240731$$HP$US$US
241593391$24159339$1$I$20240121$20240313$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005350$AURINIA PHARMACEUTICALS$$21$YR$$F$Y$103.5$KG$20240731$$HP$US$US
241593401$24159340$1$I$$20240731$20240731$20240731$EXP$$CA-MYLANLABS-2024M1071404$MYLAN$$50$YR$$F$Y$63$KG$20240731$$CN$CA$CA
241593411$24159341$1$I$20240118$20240730$20240731$20240731$EXP$$US-BIOVITRUM-2024-US-010416$BIOVITRUM$$61$YR$$M$Y$$$20240731$$HP$US$US
241593422$24159342$2$F$$20240920$20240731$20240923$PER$$US-PHARMING-PHAUS2024000642$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
241593431$24159343$1$I$20240313$20240314$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005440$AURINIA PHARMACEUTICALS$$33$YR$$F$Y$$$20240731$$CN$US$US
241593441$24159344$1$I$$20240314$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005442$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$MD$US$US
241593451$24159345$1$I$20240208$20240314$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005286$AURINIA PHARMACEUTICALS$$59$YR$$F$Y$$$20240731$$CN$US$US
241593461$24159346$1$I$$20240315$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005457$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593471$24159347$1$I$$20240314$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005441$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593481$24159348$1$I$$20240726$20240731$20240731$PER$$US-PHARMING-PHAUS2024000641$PHARMING GROUP$$$$$$Y$$$20240731$$CN$US$US
241593491$24159349$1$I$$20240313$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005438$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593501$24159350$1$I$20231201$20240315$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005456$AURINIA PHARMACEUTICALS$$35$YR$$F$Y$$$20240731$$MD$US$US
241593511$24159351$1$I$20240130$20240313$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005448$AURINIA PHARMACEUTICALS$$61$YR$$F$Y$$$20240731$$CN$US$US
241593521$24159352$1$I$$20240718$20240731$20240731$EXP$$CA-TEVA-VS-3225218$TEVA$$69$YR$$F$Y$$$20240731$$CN$CA$CA
241593531$24159353$1$I$20240101$20240723$20240731$20240731$PER$$US-ABBVIE-5852678$ABBVIE$$$$$M$Y$64$KG$20240731$$CN$US$US
241593541$24159354$1$I$$20240319$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005474$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241593551$24159355$1$I$20240223$20240315$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005452$AURINIA PHARMACEUTICALS$$29$YR$$F$Y$$$20240731$$CN$US$US
241593561$24159356$1$I$$20240315$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005060$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241593571$24159357$1$I$20240222$20240321$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005331$AURINIA PHARMACEUTICALS$$49$YR$$F$Y$$$20240731$$CN$US$US
241593581$24159358$1$I$20240301$20240320$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005484$AURINIA PHARMACEUTICALS$$34$YR$$F$Y$$$20240731$$CN$US$US
241593591$24159359$1$I$$20240319$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005247$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241593601$24159360$1$I$$20240315$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005454$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593611$24159361$1$I$$20240315$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005455$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593621$24159362$1$I$20240701$20240722$20240731$20240731$PER$$US-009507513-2407USA012846$MERCK$$$$$M$Y$$$20240731$$CN$US$US
241593641$24159364$1$I$20230118$20240730$20240731$20240731$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-214182$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240731$$CN$CA$CA
241593651$24159365$1$I$20240611$20240724$20240731$20240731$PER$$CN-Eisai-EC-2024-170956$EISAI$$50$YR$A$F$Y$57$KG$20240731$$HP$CN$CN
241593661$24159366$1$I$$20240321$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005488$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593671$24159367$1$I$$20240321$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005483$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593681$24159368$1$I$20231111$20240322$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005304$AURINIA PHARMACEUTICALS$$55$YR$$F$Y$$$20240731$$CN$US$US
241593691$24159369$1$I$$20240322$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005490$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593701$24159370$1$I$20240301$20240321$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005487$AURINIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240731$$CN$US$US
241593711$24159371$1$I$20240321$20240321$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005478$AURINIA PHARMACEUTICALS$$27$YR$$M$Y$$$20240731$$CN$US$US
241593721$24159372$1$I$20231115$20240322$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004579$AURINIA PHARMACEUTICALS$$52$YR$$F$Y$$$20240731$$CN$US$US
241593731$24159373$1$I$$20240723$20240731$20240731$PER$$US-MYLANLABS-2024M1069457$MYLAN$$$$$F$Y$$$20240731$$CN$US$US
241593741$24159374$1$I$20240319$20240321$20240731$20240731$PER$1000036280$US-AURINIA PHARMACEUTICALS INC.-AUR-005482$AURINIA PHARMACEUTICALS$$33$YR$$F$Y$$$20240731$$CN$US$US
241593752$24159375$2$F$$20240720$20240731$20240802$EXP$$NVSC2024IN109110$NOVARTIS$$$$$M$Y$$$20240802$$CN$IN$IN
241593761$24159376$1$I$20230501$20240722$20240731$20240731$EXP$FR-AFSSAPS-TS2024000811$FR-TEVA-VS-3224898$TEVA$$47$YR$$M$Y$$$20240731$$MD$FR$FR
241593771$24159377$1$I$$20240325$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005494$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241593781$24159378$1$I$$20240325$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005514$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241593791$24159379$1$I$$20240325$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005498$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241593801$24159380$1$I$$20240325$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005496$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$MD$US$US
241593811$24159381$1$I$$20240325$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005529$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241593821$24159382$1$I$$20240325$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005509$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593831$24159383$1$I$$20210125$20240731$20240731$EXP$$US-AstraZeneca-2021A000127$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241593841$24159384$1$I$20240112$20240325$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005306$AURINIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240731$$MD$US$US
241593852$24159385$2$F$$20240821$20240731$20240821$PER$$US-ALXN-202407USA001816US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240821$$CN$US$US
241593861$24159386$1$I$20240723$20240723$20240731$20240731$PER$$US-MYLANLABS-2024M1069102$MYLAN$$14$YR$$M$Y$53.98$KG$20240731$$CN$US$US
241593871$24159387$1$I$20240301$20240326$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005510$AURINIA PHARMACEUTICALS$$59$YR$$F$Y$$$20240731$$CN$US$US
241593881$24159388$1$I$$20240326$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005513$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593891$24159389$1$I$$20240327$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005521$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241593901$24159390$1$I$$20240326$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005409$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593911$24159391$1$I$$20240326$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005515$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241593921$24159392$1$I$$20240327$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005528$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$MD$US$US
241593931$24159393$1$I$$20240325$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005506$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593942$24159394$2$F$20240321$20240910$20240731$20240916$EXP$$JP-009507513-2407JPN004680J$MERCK$$75$YR$$M$Y$$$20240916$$MD$JP$JP
241593951$24159395$1$I$20221209$20240726$20240731$20240731$EXP$FR-AFSSAPS-PC2024000593$FR-009507513-2407FRA014738$MERCK$$45$YR$$F$Y$$$20240731$$PH$FR$FR
241593962$24159396$2$F$$20240802$20240731$20240812$EXP$$JP-TEVA-VS-3224746$TEVA$: Tsukui D, Haga T, Abe K. Discordance Between Mucosal Appearances and Pathologic Findings in Intestinal Mycobacterial Infection in an Immunocompromised Patient. Mayo-Clin-Proc 2024; 99 (7): 1112-1113; Tsukui D, Haga T, Abe K. Discordance Between Mucosal Appearances and Pathologic Findings in Intestinal Mycobacterial Infection in an Immunocompromised Patient. Mayo-Clin-Proc 2024; 99 (7): 1112-1113.$$$A$M$Y$$$20240812$$MD$JP$JP
241593971$24159397$1$I$$20240724$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118678$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240731$$HP$US$US
241593981$24159398$1$I$$20240329$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005534$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241593991$24159399$1$I$$20240729$20240731$20240731$EXP$$GB-MYLANLABS-2024M1070419$MYLAN$$72$YR$$M$Y$$$20240731$$HP$GB$GB
241594001$24159400$1$I$20220101$20240725$20240731$20240731$EXP$$GB-MYLANLABS-2024M1071075$MYLAN$Hyde K, Rashed K. A case of embolic stroke and failed treatment with anticoagulation with papillary fibroelastoma. Clin-Med-London 2024; 24 (Suppl.) 44 abstr. 6336073.$38$YR$$F$Y$$$20240731$$HP$GB$GB
241594011$24159401$1$I$$20240327$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005520$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594021$24159402$1$I$$20240328$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005344$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594031$24159403$1$I$$20240327$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005518$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594041$24159404$1$I$$20240328$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005181$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594051$24159405$1$I$20240131$20240326$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005434$AURINIA PHARMACEUTICALS$$40$YR$$M$Y$86.8$KG$20240731$$HP$US$US
241594061$24159406$1$I$$20240724$20240731$20240731$EXP$$NVSC2024US153154$NOVARTIS$$$$$M$Y$$$20240731$$CN$US$US
241594071$24159407$1$I$$20240715$20240731$20240731$PER$$US-INCYTE CORPORATION-2024IN007448$INCYTE$$$$$$Y$$$20240731$$CN$US$US
241594081$24159408$1$I$$20240730$20240731$20240731$30DAY$$US-SANDOZ INC.-SDZ2024US069383$SANDOZ$$$$$F$Y$$$20240731$$CN$US$US
241594091$24159409$1$I$$20240728$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069507$SANDOZ$$63$YR$$F$Y$$$20240731$$CN$US$US
241594111$24159411$1$I$$20240726$20240731$20240731$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012435$VERTEX$$$$$M$Y$$$20240731$$CN$GB$GB
241594121$24159412$1$I$$20240408$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005504$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594131$24159413$1$I$20240326$20240405$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005585$AURINIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240731$$CN$US$US
241594141$24159414$1$I$20240112$20240403$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005156$AURINIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240731$$CN$US$US
241594151$24159415$1$I$$20240404$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005473$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594161$24159416$1$I$$20240405$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005591$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241594171$24159417$1$I$$20240401$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005432$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594181$24159418$1$I$$20240403$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005564$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594191$24159419$1$I$$20240401$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005364$AURINIA PHARMACEUTICALS$$$$$F$Y$184.4$KG$20240731$$CN$US$US
241594201$24159420$1$I$20230101$20240401$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005555$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241594211$24159421$1$I$$20240408$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005526$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594221$24159422$1$I$$20240725$20240731$20240731$EXP$$US-GILEAD-2024-0682021$GILEAD$$$$A$M$Y$$$20240731$$CN$US$US
241594231$24159423$1$I$$20240722$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116484$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240731$$HP$US$US
241594241$24159424$1$I$20240325$20240409$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005540$AURINIA PHARMACEUTICALS$$41$YR$$F$Y$$$20240731$$CN$US$US
241594251$24159425$1$I$$20240409$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005598$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594261$24159426$1$I$20240408$20240409$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005603$AURINIA PHARMACEUTICALS$$44$YR$$F$Y$$$20240731$$CN$US$US
241594271$24159427$1$I$$20240410$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005622$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594281$24159428$1$I$20230829$20240409$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005606$AURINIA PHARMACEUTICALS$$13$YR$$F$Y$$$20240731$$CN$US$US
241594291$24159429$1$I$20240101$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019315$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240731$$CN$US$US
241594302$24159430$2$F$20240727$20240730$20240731$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407018339$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240801$$CN$US$US
241594311$24159431$1$I$$20240411$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005628$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594321$24159432$1$I$$20240725$20240731$20240731$EXP$$SE-MYLANLABS-2024M1069839$MYLAN$Grundberg O, Skribek M, Swerkersson S, Skorpil M, K?lbeck K, Grozman V, et al.. Diffusion weighted MRI and apparent diffusion coefficient as a prognostic biomarker in evaluating chemotherapy-antiangiogenic treated stage IV non-small cell lung cancer: A prospective, single-arm, open-label, clinical trial (BevMar). European Journal of Radiology. 2024;177$77$YR$$M$Y$$$20240731$$HP$SE$SE
241594331$24159433$1$I$20240315$20240411$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005472$AURINIA PHARMACEUTICALS$$49$YR$$F$Y$$$20240731$$CN$US$US
241594341$24159434$1$I$20240410$20240410$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005615$AURINIA PHARMACEUTICALS$$21$YR$$M$Y$$$20240731$$CN$US$US
241594351$24159435$1$I$20240401$20240410$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005239$AURINIA PHARMACEUTICALS$$50$YR$$F$Y$$$20240731$$CN$US$US
241594361$24159436$1$I$20240101$20240410$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005511$AURINIA PHARMACEUTICALS$$25$YR$$F$Y$70.748$KG$20240731$$HP$US$US
241594371$24159437$1$I$20240501$20240722$20240731$20240731$EXP$FR-AFSSAPS-BR2024000540$FR-TEVA-VS-3224932$TEVA$$68$YR$$F$Y$$$20240731$$MD$FR$FR
241594381$24159438$1$I$$20240412$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005629$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594391$24159439$1$I$$20240416$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005666$AURINIA PHARMACEUTICALS$$$$A$F$Y$$$20240731$$CN$US$US
241594401$24159440$1$I$$20240416$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005664$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594412$24159441$2$F$$20240821$20240731$20240821$PER$$US-ALXN-202407USA001813US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240821$$MD$US$US
241594421$24159442$1$I$20240418$20240418$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005685$AURINIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240731$$CN$US$US
241594431$24159443$1$I$20240418$20240422$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005692$AURINIA PHARMACEUTICALS$$41$YR$$F$Y$$$20240731$$CN$US$US
241594441$24159444$1$I$$20240418$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005237$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594451$24159445$1$I$$20240417$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005264$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594461$24159446$1$I$20240326$20240523$20240731$20240731$PER$ES-MEN-2024-096638$ES-MEN-2024-096638$MENARINI$$65$YR$$M$Y$$$20240731$$MD$ES$ES
241594471$24159447$1$I$$20240417$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005395$AURINIA PHARMACEUTICALS$$$$$F$Y$65.6$KG$20240731$$HP$US$US
241594481$24159448$1$I$$20240425$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005729$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594491$24159449$1$I$20240319$20240424$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005568$AURINIA PHARMACEUTICALS$$37$YR$$M$Y$$$20240731$$CN$US$US
241594501$24159450$1$I$$20240426$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005738$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594511$24159451$1$I$$20240426$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005668$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594521$24159452$1$I$20240401$20240423$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005708$AURINIA PHARMACEUTICALS$$44$YR$$F$Y$$$20240731$$CN$US$US
241594531$24159453$1$I$$20240423$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005338$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594541$24159454$1$I$$20240424$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005712$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241594551$24159455$1$I$20231228$20240501$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005771$AURINIA PHARMACEUTICALS$$48$YR$$F$Y$$$20240731$$MD$US$US
241594561$24159456$1$I$$20240427$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005772$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240731$$CN$US$US
241594573$24159457$3$F$20240615$20240816$20240731$20240820$EXP$$DE-JAZZ PHARMACEUTICALS-2024-DE-011506$JAZZ$$$$$$Y$$$20240820$$MD$DE$DE
241594581$24159458$1$I$$20240430$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005754$AURINIA PHARMACEUTICALS$$31$YR$$F$Y$$$20240731$$CN$US$US
241594591$24159459$1$I$$20240430$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005757$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594601$24159460$1$I$20240301$20240430$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005481$AURINIA PHARMACEUTICALS$$31$YR$$F$Y$$$20240731$$CN$US$US
241594611$24159461$1$I$20240428$20240429$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005753$AURINIA PHARMACEUTICALS$$35$YR$$F$Y$$$20240731$$CN$US$US
241594621$24159462$1$I$20231109$20240430$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-004192$AURINIA PHARMACEUTICALS$$70$YR$$F$Y$$$20240731$$CN$US$US
241594641$24159464$1$I$$20240430$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005764$AURINIA PHARMACEUTICALS$$68$YR$$F$Y$$$20240731$$CN$US$US
241594651$24159465$1$I$20220301$20240715$20240731$20240731$PER$$US-SA-2024SA224504$SANOFI AVENTIS$$6$YR$C$F$Y$22.67$KG$20240731$$MD$US$US
241594662$24159466$2$F$20240101$20240901$20240731$20240916$PER$$US-SA-2024SA221828$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240916$$MD$US$US
241594671$24159467$1$I$$20240728$20240731$20240731$EXP$$EU-BAUSCHBL-2024BNL030713$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240731$$MD$EU$EU
241594681$24159468$1$I$$20240724$20240731$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118201$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240731$$HP$CA$CA
241594721$24159472$1$I$20240212$20240501$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005445$AURINIA PHARMACEUTICALS$$39$YR$$F$Y$$$20240731$$CN$US$US
241594741$24159474$1$I$20240503$20240506$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005796$AURINIA PHARMACEUTICALS$$23$YR$$F$Y$$$20240731$$CN$US$US
241594751$24159475$1$I$$20240503$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005801$AURINIA PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
241594761$24159476$1$I$$20240502$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005775$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594771$24159477$1$I$20240409$20240507$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005590$AURINIA PHARMACEUTICALS$$50$YR$$F$Y$$$20240731$$MD$US$US
241594781$24159478$1$I$$20240507$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005169$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241594791$24159479$1$I$$20240507$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005461$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594801$24159480$1$I$20240406$20240506$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005609$AURINIA PHARMACEUTICALS$$60$YR$$F$Y$72.109$KG$20240731$$HP$US$US
241594811$24159481$1$I$$20240730$20240731$20240731$PER$$US-PFIZER INC-PV202400099742$PFIZER$$57$YR$$F$Y$$$20240731$$CN$US$US
241594823$24159482$3$F$20240720$20240822$20240731$20240823$PER$$US-PFIZER INC-PV202400095403$PFIZER$$71$YR$$F$Y$51.3$KG$20240823$$PH$US$US
241594831$24159483$1$I$$20240730$20240731$20240731$PER$$US-PFIZER INC-202400226838$PFIZER$$56$YR$$F$Y$$$20240731$$HP$US$US
241594841$24159484$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-202400226908$PFIZER$$75$YR$$F$Y$$$20240731$$HP$US$US
241594851$24159485$1$I$$20240726$20240731$20240731$PER$$US-PFIZER INC-PV202400098218$PFIZER$$67$YR$$F$Y$$$20240731$$HP$US$US
241594862$24159486$2$F$$20240729$20240731$20240801$PER$$US-PFIZER INC-202400227138$PFIZER$$47$YR$$F$Y$$$20240801$$HP$US$US
241594871$24159487$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-PV202400099158$PFIZER$$46$YR$$F$Y$$$20240731$$HP$US$US
241594881$24159488$1$I$20240508$20240508$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005811$AURINIA PHARMACEUTICALS$$39$YR$$F$Y$$$20240731$$CN$US$US
241594891$24159489$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-202400225947$PFIZER$$48$YR$$F$Y$68.04$KG$20240731$$CN$US$US
241594911$24159491$1$I$$20240507$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005799$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241594921$24159492$1$I$20240126$20240508$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005817$AURINIA PHARMACEUTICALS$$19$YR$$F$Y$$$20240731$$MD$US$US
241594931$24159493$1$I$$20240508$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005810$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594941$24159494$1$I$20240508$20240508$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005805$AURINIA PHARMACEUTICALS$$23$YR$$F$Y$$$20240731$$CN$US$US
241594951$24159495$1$I$$20240509$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005825$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594961$24159496$1$I$$20240509$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005824$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594971$24159497$1$I$$20240510$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005827$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594981$24159498$1$I$$20240508$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005821$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241594991$24159499$1$I$$20240721$20240731$20240731$EXP$$US-JNJFOC-20240767277$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240731$$HP$US$US
241595002$24159500$2$F$20240706$20240806$20240731$20240815$EXP$$JP-FERRINGPH-2024FE04076$FERRING$$$$$$Y$$$20240815$$PH$JP$JP
241595012$24159501$2$F$$20240821$20240731$20240822$PER$$US-ALXN-202407USA001961US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240822$$MD$US$US
241595021$24159502$1$I$20240513$20240513$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005870$AURINIA PHARMACEUTICALS$$$$A$M$Y$90.703$KG$20240731$$CN$US$US
241595033$24159503$3$F$20240101$20240814$20240731$20240821$EXP$$CA-FERRINGPH-2024FE03616$FERRING$$$$$$Y$$$20240821$$HP$CA$CA
241595041$24159504$1$I$$20240510$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005829$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240731$$CN$US$US
241595051$24159505$1$I$$20240513$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005836$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241595061$24159506$1$I$$20240510$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005355$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595071$24159507$1$I$$20240513$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005846$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241595081$24159508$1$I$$20240513$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005840$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595091$24159509$1$I$20240511$20240513$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005843$AURINIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240731$$CN$US$US
241595101$24159510$1$I$$20240513$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005834$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241595111$24159511$1$I$$20240510$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005265$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241595121$24159512$1$I$$20240729$20240731$20240731$PER$$NVSC2024US156523$NOVARTIS$$$$$$Y$$$20240731$$HP$US$US
241595131$24159513$1$I$20240723$20240729$20240731$20240731$EXP$$CN-ABBVIE-5857647$ABBVIE$$69$YR$$F$Y$66$KG$20240731$$MD$CN$CN
241595141$24159514$1$I$20240701$20240726$20240731$20240731$EXP$$US-ABBVIE-5857118$ABBVIE$$88$YR$$F$Y$$$20240731$$CN$US$US
241595151$24159515$1$I$20231106$20240514$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005852$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240731$$HP$US$US
241595161$24159516$1$I$20231228$20240722$20240731$20240731$EXP$FR-AFSSAPS-NY2024000792$FR-TEVA-VS-3224901$TEVA$$41$YR$$F$Y$80$KG$20240731$$MD$FR$FR
241595171$24159517$1$I$$20240724$20240731$20240731$EXP$GB-MHRA-MIDB-ce3d3c75-d2bb-42f2-b7de-6f0f7460db08$GB-009507513-2407GBR014418$MERCK$$84$YR$$F$Y$$$20240731$$PH$GB$GB
241595181$24159518$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5860014$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241595191$24159519$1$I$$20240516$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005673$AURINIA PHARMACEUTICALS$$$$A$F$Y$$$20240731$$CN$US$US
241595201$24159520$1$I$$20240514$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005485$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595211$24159521$1$I$20240701$20240729$20240731$20240731$EXP$$US-KYOWAKIRIN-2024KK018270$KYOWA$$$$$$Y$$$20240731$$HP$US$US
241595221$24159522$1$I$20240425$20240515$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005773$AURINIA PHARMACEUTICALS$$58$YR$$F$Y$$$20240731$$CN$US$US
241595231$24159523$1$I$20240101$20240515$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005451$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241595241$24159524$1$I$$20240516$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005888$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241595251$24159525$1$I$$20240515$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005860$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595261$24159526$1$I$$20240516$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005874$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595271$24159527$1$I$$20240517$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005880$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595281$24159528$1$I$20231101$20240517$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005634$AURINIA PHARMACEUTICALS$$23$YR$$F$Y$$$20240731$$CN$US$US
241595291$24159529$1$I$$20240517$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005784$AURINIA PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
241595301$24159530$1$I$20240501$20240517$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005878$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240731$$CN$US$US
241595311$24159531$1$I$20240418$20240517$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005687$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$56.689$KG$20240731$$CN$US$US
241595321$24159532$1$I$$20240730$20240731$20240731$PER$SE-SEMPA-2024-005707$SE-Eisai-EC-2024-171120$EISAI$$86$YR$E$M$Y$$$20240731$$MD$SE$SE
241595331$24159533$1$I$20240601$20240725$20240731$20240731$PER$$JP-Eisai-EC-2024-170926$EISAI$$$$$$Y$$$20240731$$MD$JP$JP
241595341$24159534$1$I$20240501$20240517$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005881$AURINIA PHARMACEUTICALS$$29$YR$$M$Y$$$20240731$$CN$US$US
241595352$24159535$2$F$$20240921$20240731$20240930$EXP$$CA-OTSUKA-2024_020777$OTSUKA$$$$$F$Y$$$20240930$$HP$CA$CA
241595361$24159536$1$I$$20240520$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005911$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241595371$24159537$1$I$$20240520$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005899$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595381$24159538$1$I$20240519$20240521$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005508$AURINIA PHARMACEUTICALS$$20$YR$$M$Y$$$20240731$$CN$US$US
241595391$24159539$1$I$$20240520$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005901$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595401$24159540$1$I$$20240521$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005903$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595411$24159541$1$I$$20240522$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005649$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595421$24159542$1$I$20240501$20240521$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005925$AURINIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240731$$CN$US$US
241595431$24159543$1$I$20230930$20240522$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005854$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240731$$HP$US$US
241595441$24159544$1$I$20240714$20240723$20240731$20240731$EXP$$CN-AstraZeneca-2024A169704$ASTRAZENECA$$19384$DY$$M$Y$70$KG$20240731$$MD$CN$
241595451$24159545$1$I$20240707$20240719$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013621$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240731$$CN$US$US
241595462$24159546$2$F$$20240916$20240731$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013670$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240923$$CN$US$US
241595471$24159547$1$I$$20240718$20240731$20240731$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407012609$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$BR$BR
241595481$24159548$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018781$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240731$$CN$US$US
241595491$24159549$1$I$20240301$20240718$20240731$20240731$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407013384$ELI LILLY AND CO$$76$YR$E$M$Y$70$KG$20240731$$CN$CN$CN
241595501$24159550$1$I$$20240718$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407012607$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240731$$CN$US$US
241595511$24159551$1$I$$20240719$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013254$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240731$$CN$US$US
241595521$24159552$1$I$$20240718$20240731$20240731$EXP$GB-MHRA-MED-202407181426300180-ZYLQW$GB-ELI_LILLY_AND_COMPANY-GB202407011888$ELI LILLY AND CO$$25$YR$A$F$Y$105$KG$20240731$$CN$GB$GB
241595531$24159553$1$I$20240701$20240726$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018080$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240731$$CN$US$US
241595541$24159554$1$I$$20240718$20240731$20240731$EXP$GB-MHRA-MED-202407181504560600-BFVNH$GB-ELI_LILLY_AND_COMPANY-GB202407012502$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$GB$GB
241595551$24159555$1$I$$20240522$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005914$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595561$24159556$1$I$$20240522$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005916$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241595571$24159557$1$I$$20240522$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005917$AURINIA PHARMACEUTICALS$$27$YR$$M$Y$$$20240731$$MD$US$US
241595581$24159558$1$I$20240406$20240524$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005741$AURINIA PHARMACEUTICALS$$39$YR$$F$Y$63.2$KG$20240731$$CN$US$US
241595591$24159559$1$I$$20240528$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005944$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595601$24159560$1$I$20240501$20240528$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005945$AURINIA PHARMACEUTICALS$$28$YR$$M$Y$$$20240731$$CN$US$US
241595611$24159561$1$I$$20240528$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005272$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595621$24159562$1$I$$20240524$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005837$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595631$24159563$1$I$20240528$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005952$AURINIA PHARMACEUTICALS$$26$YR$$F$Y$$$20240731$$CN$US$US
241595641$24159564$1$I$$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005947$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241595651$24159565$1$I$20240301$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005559$AURINIA PHARMACEUTICALS$$22$YR$$F$Y$78$KG$20240731$$CN$US$US
241595661$24159566$1$I$$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005959$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595671$24159567$1$I$$20240530$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005978$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595681$24159568$1$I$20240529$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005951$AURINIA PHARMACEUTICALS$$13$YR$$F$Y$$$20240731$$MD$US$US
241595691$24159569$1$I$$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005954$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241595701$24159570$1$I$20240410$20240529$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005620$AURINIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240731$$CN$US$US
241595711$24159571$1$I$$20240529$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005958$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595722$24159572$2$F$20231024$20240805$20240731$20240808$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-119017$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240808$$MD$FR$FR
241595731$24159573$1$I$20240312$20240531$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005985$AURINIA PHARMACEUTICALS$$16$YR$$F$Y$$$20240731$$MD$US$US
241595741$24159574$1$I$$20240726$20240731$20240731$PER$$US-ALXN-202407USA001949US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595751$24159575$1$I$$20240531$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005493$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241595761$24159576$1$I$$20240531$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005990$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595771$24159577$1$I$$20240603$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006010$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241595781$24159578$1$I$$20240531$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005317$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595791$24159579$1$I$$20240603$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005233$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595801$24159580$1$I$$20240605$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006023$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241595811$24159581$1$I$20240301$20240604$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006004$AURINIA PHARMACEUTICALS$$33$YR$$F$Y$$$20240731$$MD$US$US
241595821$24159582$1$I$20240528$20240603$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005993$AURINIA PHARMACEUTICALS$$24$YR$$M$Y$$$20240731$$CN$US$US
241595831$24159583$1$I$20240101$20240531$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005143$AURINIA PHARMACEUTICALS$$65$YR$$F$Y$97.61$KG$20240731$$CN$US$US
241595841$24159584$1$I$$20240604$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006006$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241595851$24159585$1$I$$20240605$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006026$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241595862$24159586$2$F$20221201$20240726$20240731$20240801$EXP$FR-AFSSAPS-PC2024000586$FR-009507513-2407FRA014608$MERCK$$62$YR$$M$Y$62$KG$20240801$$MD$FR$FR
241595871$24159587$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006059$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241595881$24159588$1$I$$20240606$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-002918$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595891$24159589$1$I$20240601$20240607$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006050$AURINIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240731$$CN$US$US
241595901$24159590$1$I$20240710$20240729$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120369$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240731$$PH$US$US
241595911$24159591$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006055$AURINIA PHARMACEUTICALS$$39$YR$$F$Y$$$20240731$$CN$US$US
241595921$24159592$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006061$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595931$24159593$1$I$$20240611$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005713$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595941$24159594$1$I$20240411$20240611$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005792$AURINIA PHARMACEUTICALS$$47$YR$$F$Y$54.9$KG$20240731$$CN$US$US
241595951$24159595$1$I$$20240611$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006071$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595961$24159596$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006058$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595971$24159597$1$I$$20240611$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006067$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$PH$US$US
241595981$24159598$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006064$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241595991$24159599$1$I$20240201$20240611$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005422$AURINIA PHARMACEUTICALS$$27$YR$$F$Y$$$20240731$$CN$US$US
241596001$24159600$1$I$$20240610$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006057$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596012$24159601$2$F$$20240924$20240731$20240924$PER$$US-PFIZER INC-PV202400098200$PFIZER$$71$YR$$F$Y$$$20240924$$CN$US$US
241596021$24159602$1$I$$20240726$20240731$20240731$EXP$$CA-ANIPHARMA-2024-CA-003400$ANI$$$$$F$Y$$$20240731$$MD$CA$CA
241596031$24159603$1$I$$20240613$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006044$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241596041$24159604$1$I$20240614$20240614$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006085$AURINIA PHARMACEUTICALS$$36$YR$$M$Y$$$20240731$$CN$US$US
241596051$24159605$1$I$20240302$20240617$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005963$AURINIA PHARMACEUTICALS$$30$YR$$F$Y$$$20240731$$HP$US$US
241596061$24159606$1$I$$20240614$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005420$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596071$24159607$1$I$20231020$20240617$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005960$AURINIA PHARMACEUTICALS$$30$YR$$F$Y$$$20240731$$HP$US$US
241596081$24159608$1$I$$20240613$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005372$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596091$24159609$1$I$$20240614$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006100$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241596101$24159610$1$I$20240301$20240613$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005545$AURINIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240731$$CN$US$US
241596112$24159611$2$F$$20240716$20240731$20240731$EXP$$US-HLS-202400410$HLS THERAPEUTICS$$$$A$M$Y$$$20240731$$HP$US$US
241596121$24159612$1$I$20240430$20240614$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005788$AURINIA PHARMACEUTICALS$$54$YR$$F$Y$78.005$KG$20240731$$CN$US$US
241596131$24159613$1$I$$20240725$20240731$20240731$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07464$NEUROCRINE BIOSCIENCES$$6$DEC$$M$Y$$$20240731$$HP$US$US
241596151$24159615$1$I$$20240619$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006110$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596161$24159616$1$I$20240603$20240625$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006001$AURINIA PHARMACEUTICALS$$16$YR$$F$Y$$$20240731$$MD$US$US
241596171$24159617$1$I$20231106$20240617$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005964$AURINIA PHARMACEUTICALS$$30$YR$$F$Y$97.1$KG$20240731$$HP$US$US
241596181$24159618$1$I$20240401$20240624$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005856$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240731$$CN$US$US
241596191$24159619$1$I$$20240618$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006104$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596201$24159620$1$I$20231202$20240617$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005961$AURINIA PHARMACEUTICALS$$30$YR$$F$Y$96.6$KG$20240731$$HP$US$US
241596211$24159621$1$I$$20240626$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005377$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596221$24159622$1$I$$20240618$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006105$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596231$24159623$1$I$$20240628$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005755$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241596241$24159624$1$I$20240106$20240626$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005953$AURINIA PHARMACEUTICALS$$46$YR$$F$Y$$$20240731$$CN$US$US
241596251$24159625$1$I$$20240627$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006169$AURINIA PHARMACEUTICALS$$31$YR$$F$Y$$$20240731$$CN$US$US
241596261$24159626$1$I$20240425$20240628$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005734$AURINIA PHARMACEUTICALS$$63$YR$$F$Y$$$20240731$$CN$US$US
241596271$24159627$1$I$$20240626$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006162$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241596281$24159628$1$I$$20240626$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006157$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596291$24159629$1$I$$20240701$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006182$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596301$24159630$1$I$20240604$20240605$20240731$20240731$PER$$US-LUNDBECK-DKLU4000307$LUNDBECK$$$$$$Y$$$20240731$$HP$US$US
241596311$24159631$1$I$$20240701$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006016$AURINIA PHARMACEUTICALS$$$$A$M$Y$$$20240731$$HP$US$US
241596321$24159632$1$I$20240615$20240702$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006190$AURINIA PHARMACEUTICALS$$22$YR$$F$Y$$$20240731$$HP$US$US
241596331$24159633$1$I$20240301$20240701$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005111$AURINIA PHARMACEUTICALS$$55$YR$$F$Y$$$20240731$$CN$US$US
241596341$24159634$1$I$20240701$20240702$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006194$AURINIA PHARMACEUTICALS$$22$YR$$F$Y$$$20240731$$CN$US$US
241596351$24159635$1$I$$20240705$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006206$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241596361$24159636$1$I$20240619$20240703$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006199$AURINIA PHARMACEUTICALS$$38$YR$$M$Y$$$20240731$$CN$US$US
241596371$24159637$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019130$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$US$US
241596381$24159638$1$I$20230101$20240723$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407016010$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240731$$CN$US$US
241596391$24159639$1$I$$20240709$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006233$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241596401$24159640$1$I$$20240709$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006232$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596411$24159641$1$I$$20240709$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006223$AURINIA PHARMACEUTICALS$$57$YR$$F$Y$$$20240731$$HP$US$US
241596421$24159642$1$I$20240624$20240708$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006219$AURINIA PHARMACEUTICALS$$31$YR$$F$Y$$$20240731$$CN$US$US
241596431$24159643$1$I$20240701$20240708$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006220$AURINIA PHARMACEUTICALS$$48$YR$$F$Y$$$20240731$$HP$US$US
241596441$24159644$1$I$$20240709$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006226$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241596451$24159645$1$I$20240516$20240708$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006068$AURINIA PHARMACEUTICALS$$50$YR$$M$Y$$$20240731$$CN$US$US
241596461$24159646$1$I$$20240705$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006207$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596471$24159647$1$I$$20240710$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006239$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596481$24159648$1$I$20240608$20240710$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-005926$AURINIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240731$$CN$US$US
241596491$24159649$1$I$20240621$20240711$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006159$AURINIA PHARMACEUTICALS$$56$YR$$F$Y$$$20240731$$CN$US$US
241596501$24159650$1$I$$20240712$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006188$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596511$24159651$1$I$20240627$20240712$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006259$AURINIA PHARMACEUTICALS$$38$YR$$F$Y$$$20240731$$CN$US$US
241596521$24159652$1$I$20230527$20240712$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005705$AURINIA PHARMACEUTICALS$$61$YR$$M$Y$$$20240731$$CN$US$US
241596531$24159653$1$I$$20240711$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006250$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596541$24159654$1$I$$20240711$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006236$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596551$24159655$1$I$$20240715$20240731$20240731$PER$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006277$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241596561$24159656$1$I$$20240712$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006254$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596571$24159657$1$I$20240713$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006270$AURINIA PHARMACEUTICALS$$49$YR$$F$Y$$$20240731$$CN$US$US
241596581$24159658$1$I$$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006263$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$HP$US$US
241596591$24159659$1$I$20240529$20240712$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006047$AURINIA PHARMACEUTICALS$$23$YR$$F$Y$79.8$KG$20240731$$CN$US$US
241596601$24159660$1$I$20240713$20240713$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006267$AURINIA PHARMACEUTICALS$$31$YR$$F$Y$$$20240731$$CN$US$US
241596611$24159661$1$I$$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006271$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$MD$US$US
241596622$24159662$2$F$$20240912$20240731$20240923$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006109$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
241596631$24159663$1$I$20240712$20240715$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006268$AURINIA PHARMACEUTICALS$$45$YR$$F$Y$$$20240731$$CN$US$US
241596641$24159664$1$I$20240501$20240717$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006282$AURINIA PHARMACEUTICALS$$33$YR$$F$Y$$$20240731$$CN$US$US
241596651$24159665$1$I$$20240717$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006287$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596661$24159666$1$I$$20240718$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006241$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596672$24159667$2$F$20231201$20240730$20240731$20240806$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006045$AURINIA PHARMACEUTICALS$$26$YR$$F$Y$$$20240806$$CN$US$US
241596681$24159668$1$I$$20240718$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006296$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241596691$24159669$1$I$20240701$20240719$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006312$AURINIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240731$$CN$US$US
241596701$24159670$1$I$$20240719$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006311$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241596711$24159671$1$I$20240503$20240719$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-005938$AURINIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240731$$CN$US$US
241596721$24159672$1$I$$20240722$20240731$20240731$PER$$US-AURINIA PHARMACEUTICALS INC.-AUR-006145$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240731$$CN$US$US
241596731$24159673$1$I$$20240726$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119741$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$58.06$KG$20240731$$HP$US$US
241596742$24159674$2$F$$20240820$20240731$20240820$PER$$US-ALXN-202407USA001775US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
241596751$24159675$1$I$$20240716$20240731$20240731$EXP$$US-HLS-202400411$HLS THERAPEUTICS$$$$A$$Y$$$20240731$$HP$US$US
241596762$24159676$2$F$$20240802$20240731$20240812$EXP$$US-TEVA-VS-3225914$TEVA$Kirmaier A, Blackshear L, Lee MSL, Kirby JE. Cellulitis and bacteremia caused by the fish pathogen, Streptococcus iniae, in an immunocompromised patient: Case report and mini-review of zoonotic disease, lab identification, and antimicrobial susceptibility. Diagn-Microbiol-Infect-Dis 2024; 108 (4):.; Kirmaier A, Blackshear L, Lee MSL, Kirby JE. Cellulitis and bacteremia caused by the fish pathogen, Streptococcus iniae, in an immunocompromised patient: Case report and mini-review of zoonotic di...$49$YR$$F$Y$$$20240812$$HP$US$US
241596781$24159678$1$I$$20240716$20240731$20240731$EXP$$US-HLS-202400412$HLS THERAPEUTICS$$$$E$$Y$$$20240731$$PH$US$US
241596791$24159679$1$I$$20240719$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013243$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240731$$CN$US$US
241596801$24159680$1$I$$20240724$20240731$20240731$EXP$GB-MHRA-MED-202407242133392220-GTZYS$GB-ELI_LILLY_AND_COMPANY-GB202407016510$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240731$$CN$GB$GB
241596812$24159681$2$F$20180101$20240912$20240731$20240920$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407012784$ELI LILLY AND CO$$$$$M$Y$$$20240920$$CN$BR$BR
241596821$24159682$1$I$$20240719$20240731$20240731$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407013436$ELI LILLY AND CO$$$$$F$Y$$$20240731$$PH$KR$KR
241596831$24159683$1$I$$20240719$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407012969$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240731$$CN$US$US
241596842$24159684$2$F$$20240807$20240731$20240813$30DAY$$BR-ELI_LILLY_AND_COMPANY-BR202407013576$ELI LILLY AND CO$$$$$M$Y$$$20240813$$CN$BR$BR
241596851$24159685$1$I$$20240724$20240731$20240731$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407015902$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240731$$CN$JP$JP
241596861$24159686$1$I$$20240719$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013792$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240731$$CN$US$US
241596871$24159687$1$I$$20240719$20240731$20240731$EXP$GB-MHRA-MED-202407101308047970-RQDSB$GB-ELI_LILLY_AND_COMPANY-GB202407012548$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240731$$CN$GB$GB
241596881$24159688$1$I$$20240515$20240731$20240731$PER$$US-GALDERMA-US2024008445$GALDERMA$$$$$$Y$$$20240731$$CN$US$US
241596891$24159689$1$I$20240717$20240719$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013157$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$US$US
241596902$24159690$2$F$20240101$20240904$20240731$20240913$EXP$$JP-RADIUS HEALTH, INC.-2024JP003264$RADIUS PHARM$$84$YR$$F$Y$$$20240913$$MD$JP$JP
241596911$24159691$1$I$20240730$20240730$20240731$20240731$PER$$NVSC2024US156494$NOVARTIS$$$$$F$Y$$$20240731$$HP$US$US
241596921$24159692$1$I$20240321$20240725$20240731$20240731$PER$$JP-Eisai-EC-2024-170994$EISAI$$$$E$M$Y$$$20240731$$MD$JP$JP
241596931$24159693$1$I$20240715$20240716$20240731$20240731$EXP$$CA-HLS-202401686$HLS THERAPEUTICS$$28$YR$A$M$Y$$$20240731$$PH$CA$CA
241596951$24159695$1$I$$20240718$20240731$20240731$EXP$$US-AstraZeneca-2024A170836$ASTRAZENECA$$$$$F$Y$$$20240731$$CN$US$
241596961$24159696$1$I$20240101$20240725$20240731$20240731$EXP$$US-Eisai-EC-2024-170745$EISAI$$69$YR$E$M$Y$$$20240731$$CN$US$US
241596971$24159697$1$I$20240724$20240725$20240731$20240731$PER$$JP-Eisai-EC-2024-171079$EISAI$$$$A$F$Y$$$20240731$$MD$JP$JP
241596982$24159698$2$F$$20240802$20240731$20240812$EXP$$US-TEVA-VS-3225916$TEVA$Acosta C, Zhang C, Deutsch G, Graw-Panzer K. A Case of Persistent Tachypnea in a Two-month-old Infant. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A2330.; Acosta C, Zhang C, Deutsch G, Graw-Panzer K. A Case of Persistent Tachypnea in a Two-month-old Infant. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A2330.$2$MON$$M$Y$$$20240812$$HP$US$US
241596991$24159699$1$I$20240701$20240726$20240731$20240731$EXP$$US-Eisai-EC-2024-171037$EISAI$$$$$M$Y$$$20240731$$HP$US$US
241597001$24159700$1$I$20240708$20240724$20240731$20240731$EXP$$CN-Eisai-EC-2024-170953$EISAI$$73$YR$E$M$Y$$$20240731$$HP$CN$CN
241597011$24159701$1$I$$20240727$20240731$20240731$PER$$US-AMGEN-USASP2024150037$AMGEN$$$$A$F$Y$$$20240731$$CN$US$US
241597023$24159702$3$F$20240701$20240806$20240731$20240809$PER$$US-AMGEN-USASP2024151190$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241597031$24159703$1$I$$20240716$20240731$20240731$EXP$$US-HLS-202400420$HLS THERAPEUTICS$$77$YR$E$$Y$$$20240731$$PH$US$US
241597041$24159704$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018340$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240731$$CN$US$US
241597051$24159705$1$I$$20240723$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069310$SANDOZ$$$$$F$Y$$$20240731$$CN$US$US
241597061$24159706$1$I$$20240724$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069295$SANDOZ$$$$$$Y$$$20240731$$HP$US$US
241597071$24159707$1$I$$20240729$20240731$20240731$PER$$US-PFIZER INC-202400225974$PFIZER$$$$$$Y$$$20240731$$CN$US$US
241597081$24159708$1$I$$20240718$20240731$20240731$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07236$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240731$$HP$US$US
241597091$24159709$1$I$20240604$20240724$20240731$20240731$PER$$CN-Eisai-EC-2024-170955$EISAI$$20$YR$A$M$Y$43$KG$20240731$$HP$CN$CN
241597101$24159710$1$I$20240722$20240726$20240731$20240731$EXP$$VN-Eisai-EC-2024-170910$EISAI$$55$YR$A$M$Y$$$20240731$$MD$VN$VN
241597112$24159711$2$F$$20240802$20240731$20240812$EXP$$US-TEVA-VS-3225547$TEVA$Maurya A, Sivanandham R, Bagheri S, Moshtahedian K. Immune-mediated Myositis With Bulbar Involvement Leading to Respiratory Failure: A Rare Adverse Effect of Pembrolizumab. Am-J-Respir-Crit-Care-Med 2024; 209.; Maurya A, Sivanandham R, Bagheri S, Moshtahedian K. Immune-mediated Myositis With Bulbar Involvement Leading to Respiratory Failure: A Rare Adverse Effect of Pembrolizumab. Am-J-Respir-Crit-Care-Med 2024; 209.$72$YR$$M$Y$$$20240812$$HP$US$US
241597121$24159712$1$I$20240618$20240724$20240731$20240731$PER$$CN-Eisai-EC-2024-170957$EISAI$$58$YR$A$F$Y$55$KG$20240731$$HP$CN$CN
241597131$24159713$1$I$$20240729$20240731$20240731$30DAY$$HR-SANDOZ INC.-SDZ2024HR069132$SANDOZ$$$$C$$Y$$$20240731$$CN$HR$HR
241597142$24159714$2$F$20240101$20240801$20240731$20240808$PER$$US-009507513-2407USA013179$MERCK$$$$$M$Y$96.16$KG$20240808$$CN$US$US
241597152$24159715$2$F$20240726$20240731$20240731$20240802$EXP$$ZA-ABBVIE-5860559$ABBVIE$$34$YR$$F$Y$$$20240802$$MD$ZA$ZA
241597161$24159716$1$I$$20240716$20240731$20240731$EXP$$US-HLS-202400419$HLS THERAPEUTICS$$76$YR$E$M$Y$$$20240731$$HP$US$US
241597172$24159717$2$F$20240327$20240829$20240731$20240912$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07299$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240912$$MD$US$US
241597181$24159718$1$I$20240201$20240729$20240731$20240731$EXP$$CN-009507513-2407CHN015425$MERCK$$61$YR$$M$Y$60$KG$20240731$$MD$CN$CN
241597191$24159719$1$I$20240717$20240726$20240731$20240731$PER$$CN-Eisai-EC-2024-171069$EISAI$$61$YR$A$M$Y$68$KG$20240731$$HP$CN$CN
241597201$24159720$1$I$$20240724$20240731$20240731$EXP$$JP-Eisai-EC-2024-170934$EISAI$Kishino Daizo. Our Experience and Consideration of Lenvatinib for Thymic Carcinoma.$$$E$M$Y$$$20240731$$MD$JP$JP
241597212$24159721$2$F$20240728$20240821$20240731$20240823$PER$$US-AMGEN-USASP2024151101$AMGEN$$69$YR$E$M$Y$$$20240823$$HP$US$US
241597221$24159722$1$I$$20240730$20240731$20240731$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043064$BOEHRINGER INGELHEIM$$$$$$Y$$$20240731$$MD$US$US
241597231$24159723$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019447$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240731$$CN$US$US
241597241$24159724$1$I$20240728$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019450$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240731$$PH$US$US
241597251$24159725$1$I$$20240725$20240731$20240731$EXP$$US-009507513-2407USA014208$MERCK$$$$$F$Y$$$20240731$$MD$US$US
241597261$24159726$1$I$$20240718$20240731$20240731$PER$$US-JNJFOC-20240756143$JOHNSON AND JOHNSON$$$$$F$Y$$$20240731$$CN$US$US
241597271$24159727$1$I$20240101$20240724$20240731$20240731$EXP$$US-009507513-2407USA014968$MERCK$$34$YR$$F$Y$$$20240731$$CN$US$US
241597281$24159728$1$I$20230601$20240724$20240731$20240731$EXP$$NL-009507513-2407NLD013572$MERCK$$54$YR$$M$Y$67$KG$20240731$$CN$NL$NL
241597291$24159729$1$I$20240731$20240731$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043077$BOEHRINGER INGELHEIM$$73$YR$E$$Y$$$20240731$$HP$US$US
241597301$24159730$1$I$$20240731$20240731$20240731$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043094$BOEHRINGER INGELHEIM$$$$$$Y$$$20240731$$CN$US$US
241597311$24159731$1$I$$20240726$20240731$20240731$EXP$$US-AstraZeneca-2024A171391$ASTRAZENECA$$$$$$Y$$$20240731$$MD$US$
241597322$24159732$2$F$$20240726$20240731$20240807$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017535$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240807$$CN$US$US
241597331$24159733$1$I$$20240726$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017532$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240731$$CN$US$US
241597341$24159734$1$I$20240706$20240725$20240731$20240731$EXP$FR-AFSSAPS-PO2024000787$FR-ELI_LILLY_AND_COMPANY-FR202407017276$ELI LILLY AND CO$$58$YR$A$F$Y$43.8$KG$20240731$$CN$FR$FR
241597351$24159735$1$I$$20240726$20240731$20240731$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407017328$ELI LILLY AND CO$$91$YR$E$F$Y$$$20240731$$CN$DE$DE
241597362$24159736$2$F$$20240726$20240731$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017634$ELI LILLY AND CO$$90$YR$E$M$Y$$$20240802$$CN$US$US
241597371$24159737$1$I$$20240725$20240731$20240731$EXP$$US-BIOMARINAP-US-2024-159428$BIOMARIN$$$$$$Y$$$20240731$$CN$US$US
241597381$24159738$1$I$$20240724$20240731$20240731$PER$$US-BIOMARINAP-US-2024-159425$BIOMARIN$$$$$$Y$$$20240731$$CN$US$US
241597391$24159739$1$I$$20240724$20240731$20240731$PER$$US-BIOMARINAP-US-2024-159408$BIOMARIN$$$$$$Y$$$20240731$$CN$US$US
241597401$24159740$1$I$$20240724$20240731$20240731$PER$$US-BIOMARINAP-US-2024-159414$BIOMARIN$$$$$$Y$$$20240731$$CN$US$US
241597411$24159741$1$I$$20240723$20240731$20240731$PER$$US-BIOMARINAP-US-2024-159409$BIOMARIN$$$$$$Y$$$20240731$$CN$US$US
241597422$24159742$2$F$$20240801$20240731$20240802$PER$$US-BIOMARINAP-US-2024-159410$BIOMARIN$$$$$$Y$$$20240802$$CN$US$US
241597431$24159743$1$I$20240705$20240717$20240731$20240731$EXP$$CA-HLS-202401687$HLS THERAPEUTICS$$66$YR$E$M$Y$$$20240731$$CN$CA$CA
241597441$24159744$1$I$$20240731$20240731$20240731$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043052$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240731$$CN$US$US
241597452$24159745$2$F$20240718$20240829$20240731$20240905$EXP$$CO-BIOMARINAP-CO-2024-159374$BIOMARIN$$$$$$Y$$$20240905$$CN$CO$CO
241597461$24159746$1$I$$20240731$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043080$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240731$$CN$US$US
241597472$24159747$2$F$$20240806$20240731$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121136$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240807$$CN$US$US
241597481$24159748$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150292$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241597491$24159749$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121157$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240731$$CN$US$US
241597502$24159750$2$F$$20240821$20240731$20240830$EXP$$JP-009507513-2407JPN004725J$MERCK$$90$YR$$F$Y$$$20240830$$MD$JP$JP
241597511$24159751$1$I$20240208$20240725$20240731$20240731$EXP$FR-AFSSAPS-AN2024000952$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-121471$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$82$KG$20240731$$PH$FR$FR
241597521$24159752$1$I$$20240731$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043069$BOEHRINGER INGELHEIM$$$$$$Y$$$20240731$$CN$US$US
241597531$24159753$1$I$$20240731$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042992$BOEHRINGER INGELHEIM$$$$$$Y$$$20240731$$CN$US$US
241597541$24159754$1$I$$20240719$20240731$20240731$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013797$ELI LILLY AND CO$$$$$$Y$$$20240731$$CN$US$US
241597551$24159755$1$I$20231001$20240725$20240731$20240731$EXP$$JP-009507513-2311JPN001382J$MERCK$$6$DEC$$F$Y$$$20240731$$MD$JP$JP
241597571$24159757$1$I$20240711$20240729$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121158$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240731$$CN$US$US
241597581$24159758$1$I$$20240729$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120973$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240731$$CN$US$US
241597591$24159759$1$I$$20240731$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043103$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240731$$MD$US$US
241597601$24159760$1$I$$20240729$20240731$20240731$EXP$$NVSC2024US155716$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
241597613$24159761$3$F$20240701$20240925$20240731$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121415$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240926$$HP$US$US
241597621$24159762$1$I$$20240730$20240731$20240731$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121259$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$$$20240731$$CN$US$US
241597631$24159763$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120848$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240731$$HP$US$US
241597641$24159764$1$I$$20240719$20240731$20240731$EXP$GB-MHRA-MED-202407191403335200-TRVBS$GB-ELI_LILLY_AND_COMPANY-GB202407012809$ELI LILLY AND CO$$$$$F$Y$$$20240731$$CN$GB$GB
241597651$24159765$1$I$$20240719$20240731$20240731$EXP$GB-MHRA-MED-202407192108597790-PDKFY$GB-ELI_LILLY_AND_COMPANY-GB202407013702$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240731$$CN$GB$GB
241597661$24159766$1$I$$20240729$20240731$20240731$EXP$$NVSC2024US155757$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
241597671$24159767$1$I$$20240731$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043106$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240731$$CN$US$US
241597681$24159768$1$I$$20240729$20240731$20240731$EXP$$NVSC2024US155776$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
241597691$24159769$1$I$$20240728$20240731$20240731$EXP$$US-SANDOZ INC.-SDZ2024US069122$SANDOZ$$$$$$Y$$$20240731$$CN$US$US
241597701$24159770$1$I$20240728$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150608$AMGEN$$78$YR$E$M$Y$$$20240731$$CN$US$US
241597712$24159771$2$F$20240826$20240827$20240731$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121056$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240829$$CN$US$US
241597721$24159772$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019610$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240731$$CN$US$US
241597731$24159773$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150383$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241597742$24159774$2$F$20240701$20240828$20240731$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121097$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240829$$HP$US$US
241597751$24159775$1$I$$20240730$20240731$20240731$EXP$$NVSC2024US156171$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
241597761$24159776$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121011$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240731$$HP$US$US
241597771$24159777$1$I$$20240724$20240731$20240731$PER$$US-AMGEN-USASP2024147541$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241597781$24159778$1$I$20240601$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121275$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240731$$HP$US$US
241597791$24159779$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120991$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$75.3$KG$20240731$$CN$US$US
241597801$24159780$1$I$$20240730$20240731$20240731$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121276$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$81.19$KG$20240731$$CN$US$US
241597811$24159781$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019706$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240731$$CN$US$US
241597821$24159782$1$I$$20240718$20240731$20240731$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-120162$BRISTOL MYERS SQUIBB$Literature citation unavailable.$$$$$Y$$$20240801$$HP$CA$CA
241597832$24159783$2$F$20230719$20240830$20240731$20240903$EXP$$NVSJ2024JP006774$NOVARTIS$$49$YR$$M$Y$53$KG$20240904$$MD$JP$JP
241597841$24159784$1$I$$20240731$20240731$20240731$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043022$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240801$$CN$US$US
241597851$24159785$1$I$$20240730$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019825$ELI LILLY AND CO$$72$YR$E$$Y$$$20240731$$CN$US$US
241597861$24159786$1$I$20240712$20240712$20240731$20240731$PER$$US-009507513-2407USA009104$MERCK$$$$$M$Y$$$20240731$$CN$US$US
241597871$24159787$1$I$20240726$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151276$AMGEN$$61$YR$A$M$Y$$$20240731$$CN$US$US
241597881$24159788$1$I$20240601$20240730$20240731$20240731$EXP$$NVSJ2024JP008230$NOVARTIS$$$$A$F$Y$$$20240801$$MD$JP$JP
241597891$24159789$1$I$20240729$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150350$AMGEN$$53$YR$A$F$Y$$$20240731$$CN$US$US
241597901$24159790$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019037$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240731$$CN$US$US
241597913$24159791$3$F$20240718$20240910$20240731$20240919$EXP$$JP-SMPA-2024SMP011340$SUNOVION$$$$$$Y$$$20240919$$CN$JP$JP
241597921$24159792$1$I$$20240722$20240731$20240731$EXP$$US-GSK-US2024091615$GLAXOSMITHKLINE$$$$$M$Y$$$20240731$$MD$US$US
241597941$24159794$1$I$20240701$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150321$AMGEN$$$$$M$Y$$$20240731$$CN$US$US
241597951$24159795$1$I$$20240730$20240731$20240731$PER$$NVSC2024US156528$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241597961$24159796$1$I$20240701$20240719$20240731$20240731$PER$$US-SA-2024SA216989$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240801$$MD$US$US
241597971$24159797$1$I$20240629$20240729$20240731$20240731$EXP$$GB-ABBVIE-5860870$ABBVIE$$71$YR$$F$Y$$$20240731$$CN$GB$GB
241597981$24159798$1$I$$20240730$20240731$20240731$PER$$NVSC2024US156529$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241597991$24159799$1$I$20240101$20240725$20240731$20240731$EXP$$US-BIOGEN-2024BI01275609$BIOGEN$$68$YR$$M$Y$$$20240731$$CN$US$US
241598003$24159800$3$F$$20240814$20240731$20240823$EXP$$US-JNJFOC-20240766486$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$CN$US$US
241598011$24159801$1$I$$20240722$20240731$20240731$EXP$$JP-PRINSTON PHARMACEUTICAL INC.-2024PRN00285$PRINSTON PHARMACEUTICAL$Nagaoka M, Murata T, Nagamine T, Fujise N.,. Methylphenidate-Associated Creatine Kinase Level Elevation. American Journal of Therapeutics. 2024;31(4)$25$YR$$M$Y$$$20240731$$MD$JP$JP
241598021$24159802$1$I$$20240725$20240731$20240731$EXP$$US-BIOGEN-2024BI01275937$BIOGEN$$$$$F$Y$$$20240731$$CN$US$US
241598031$24159803$1$I$$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407018817$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240731$$CN$US$US
241598052$24159805$2$F$$20240802$20240731$20240805$PER$$NVSC2024US156526$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241598061$24159806$1$I$$20240708$20240731$20240731$PER$$US-AstraZeneca-2024A156388$ASTRAZENECA$$$$$F$Y$$$20240801$$HP$US$
241598071$24159807$1$I$$20240724$20240731$20240731$EXP$$DE-JNJFOC-20240768132$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240801$$MD$DE$DE
241598083$24159808$3$F$20240727$20240808$20240731$20240814$PER$$US-AMGEN-USASP2024150651$AMGEN$$9$YR$C$M$Y$$$20240814$$HP$US$US
241598092$24159809$2$F$20240101$20240830$20240731$20240910$EXP$$US-JNJFOC-20240769568$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240910$$CN$US$US
241598102$24159810$2$F$20240629$20240730$20240731$20240806$EXP$$US-JNJFOC-20240724911$JOHNSON AND JOHNSON$$44$YR$A$M$Y$87.07$KG$20240807$$CN$US$US
241598111$24159811$1$I$20240724$20240725$20240731$20240731$PER$$US-ALXN-202407USA001796US$ALEXION PHARMACEUTICALS$$63$YR$$M$Y$$$20240801$$CN$US$US
241598121$24159812$1$I$$20240730$20240731$20240731$EXP$$AU-ABBVIE-5861888$ABBVIE$$$$$F$Y$$$20240731$$CN$AU$AU
241598131$24159813$1$I$20240727$20240729$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407019361$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240731$$CN$US$US
241598151$24159815$1$I$20240601$20240724$20240731$20240731$EXP$$US-ABBVIE-5852427$ABBVIE$$48$YR$$F$Y$$$20240731$$CN$US$US
241598161$24159816$1$I$$20240723$20240731$20240731$EXP$$US-AMGEN-USASP2024148078$AMGEN$Sivaram CA. Successful management of myocardial infarction during pregnancy in a renal transplant recipient. Clin. Cardiol. 1998;21:447-450$30$YR$A$F$Y$$$20240731$$MD$US$US
241598171$24159817$1$I$$20240721$20240731$20240731$EXP$$RO-JNJFOC-20240756507$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$HP$RO$RO
241598181$24159818$1$I$$20240724$20240731$20240731$EXP$$US-ABBVIE-5852618$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241598192$24159819$2$F$20240726$20240926$20240731$20240930$EXP$$NVSJ2024JP009156$NOVARTIS$$$$E$F$Y$$$20240930$$PH$JP$JP
241598201$24159820$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221407$SANOFI AVENTIS$$43$YR$A$F$Y$63$KG$20240801$$MD$US$US
241598211$24159821$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA222143$SANOFI AVENTIS$$$$A$F$Y$$$20240801$$MD$US$US
241598221$24159822$1$I$$20240723$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407016706$ELI LILLY AND CO$$12$YR$C$M$Y$$$20240731$$CN$US$US
241598231$24159823$1$I$$20240725$20240731$20240731$EXP$$US-BEIGENE-BGN-2023-015087$BEIGENE$$$$$$Y$$$20240731$$MD$US$US
241598241$24159824$1$I$$20240725$20240731$20240731$PER$$US-ABBVIE-5859801$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241598251$24159825$1$I$20240701$20240723$20240731$20240731$PER$$US-ABBVIE-5856378$ABBVIE$$62$YR$$$Y$$$20240731$$MD$US$US
241598261$24159826$1$I$20231122$20240725$20240731$20240731$EXP$$US-ABBVIE-5816122$ABBVIE$$51$YR$$M$Y$125$KG$20240731$$CN$US$US
241598272$24159827$2$F$20221220$20240801$20240731$20240806$EXP$$US-AstraZeneca-2024A173127$ASTRAZENECA$$27170$DY$$F$Y$86.2$KG$20240806$$CN$US$
241598291$24159829$1$I$$20240730$20240731$20240731$EXP$$FR-JNJFOC-20240784235$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240801$$HP$FR$FR
241598301$24159830$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA221643$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240801$$HP$US$US
241598311$24159831$1$I$20240701$20240723$20240731$20240731$PER$$US-SA-2024SA221835$SANOFI AVENTIS$$41$YR$A$F$Y$84.82$KG$20240801$$MD$US$US
241598321$24159832$1$I$$20240730$20240731$20240731$PER$$NVSC2024US156402$NOVARTIS$$44$YR$$F$Y$$$20240801$$HP$US$US
241598331$24159833$1$I$$20240729$20240731$20240731$PER$$NVSC2024US155809$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
241598342$24159834$2$F$$20240819$20240731$20240828$PER$$US-BAUSCHBL-2024BNL030564$BAUSCH AND LOMB$$$$$F$Y$$$20240828$$CN$US$US
241598351$24159835$1$I$$20240724$20240731$20240731$PER$$US-ALXN-202407USA001687US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
241598362$24159836$2$F$$20240822$20240731$20240830$EXP$$ZA-ABBVIE-5858330$ABBVIE$$48$YR$$M$Y$$$20240830$$CN$ZA$ZA
241598372$24159837$2$F$20240711$20240731$20240731$20240805$PER$$US-AMGEN-USASP2024141728$AMGEN$$77$YR$E$F$Y$62.7$KG$20240805$$PH$US$US
241598381$24159838$1$I$$20240725$20240731$20240731$EXP$$US-ABBVIE-5856024$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241598392$24159839$2$F$$20240807$20240731$20240816$PER$$US-ABBVIE-5852983$ABBVIE$$$$$F$Y$47.17$KG$20240816$$CN$US$US
241598402$24159840$2$F$20230101$20240903$20240731$20240906$EXP$$US-ABBVIE-5859083$ABBVIE$$$$$F$Y$65$KG$20240906$$CN$US$US
241598421$24159842$1$I$$20240724$20240731$20240731$PER$$US-RDY-SPO/USA/24/0011009$DR REDDYS$$$$$M$Y$$$20240801$$CN$US$US
241598431$24159843$1$I$$20240729$20240731$20240731$EXP$$CA-ABBVIE-5860667$ABBVIE$$$$E$M$Y$$$20240731$$HP$CA$CA
241598441$24159844$1$I$$20240726$20240731$20240731$EXP$$US-JNJFOC-20240775077$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$MD$US$US
241598453$24159845$3$F$$20240911$20240731$20240913$PER$$US-ALXN-202407USA001722US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
241598461$24159846$1$I$$20240724$20240731$20240731$PER$$US-ALXN-202407USA001759US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
241598471$24159847$1$I$$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024151107$AMGEN$$$$$$Y$$$20240731$$MD$US$US
241598481$24159848$1$I$20231201$20240724$20240731$20240731$PER$$US-SA-2024SA221679$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240801$$MD$US$US
241598491$24159849$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221766$SANOFI AVENTIS$$37$YR$A$M$Y$89.35$KG$20240801$$MD$US$US
241598502$24159850$2$F$$20240726$20240731$20240806$PER$$US-AMGEN-USASP2024149759$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241598511$24159851$1$I$20240402$20240726$20240731$20240731$EXP$$CA-TAKEDA-2024TUS076320$TAKEDA$$31$YR$$F$Y$$$20240731$$CN$CA$CA
241598522$24159852$2$F$20240729$20240904$20240731$20240905$EXP$$JP-TAKEDA-2024TJP011400$TAKEDA$$3$DEC$$F$Y$$$20240905$$MD$JP$JP
241598531$24159853$1$I$$20240723$20240731$20240731$EXP$$BR-JNJFOC-20240765649$JOHNSON AND JOHNSON$$$$$M$Y$72$KG$20240801$$PH$BR$BR
241598541$24159854$1$I$$20240726$20240731$20240731$EXP$$US-JNJFOC-20240777493$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$HP$US$US
241598552$24159855$2$F$20240101$20240813$20240731$20240821$PER$$US-SA-2024SA219668$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240822$$MD$US$US
241598561$24159856$1$I$$20240719$20240731$20240731$PER$$US-SA-2024SA219850$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240801$$MD$US$US
241598572$24159857$2$F$$20240819$20240731$20240829$PER$$US-SA-2024SA221331$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240829$$MD$US$US
241598581$24159858$1$I$20240701$20240725$20240731$20240731$PER$$US-ALXN-202407USA001788US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
241598591$24159859$1$I$$20240724$20240731$20240731$PER$$US-ALXN-202407USA001781US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
241598602$24159860$2$F$$20240828$20240731$20240902$30DAY$$AU-JNJFOC-20240766496$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$PH$AU$AU
241598611$24159861$1$I$$20240725$20240731$20240731$EXP$$US-ABBVIE-5855447$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241598621$24159862$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221210$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240801$$MD$US$US
241598631$24159863$1$I$20240725$20240726$20240731$20240731$PER$$US-SA-2024SA221443$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240801$$CN$US$US
241598641$24159864$1$I$20240101$20240729$20240731$20240731$EXP$$US-ABBVIE-5860431$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241598651$24159865$1$I$$20240726$20240731$20240731$EXP$$US-ABBVIE-5859677$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241598661$24159866$1$I$$20240725$20240731$20240731$PER$$US-ALXN-202407USA001782US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
241598671$24159867$1$I$20240606$20240722$20240731$20240731$PER$$US-ABBVIE-5852935$ABBVIE$$65$YR$$F$Y$$$20240731$$CN$US$US
241598681$24159868$1$I$20240101$20240729$20240731$20240731$EXP$$US-JNJFOC-20240780261$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240801$$HP$US$US
241598691$24159869$1$I$20240701$20240725$20240731$20240731$EXP$$CA-JNJFOC-20240771420$JOHNSON AND JOHNSON$$39$YR$A$M$Y$114$KG$20240801$$HP$CA$CA
241598701$24159870$1$I$$20240725$20240731$20240731$EXP$$US-JNJFOC-20240772456$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$HP$US$US
241598711$24159871$1$I$20240728$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150347$AMGEN$$70$YR$E$F$Y$$$20240731$$CN$US$US
241598721$24159872$1$I$$20240723$20240731$20240731$PER$$US-ABBVIE-5852391$ABBVIE$$$$$M$Y$$$20240731$$MD$US$US
241598731$24159873$1$I$$20240722$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407016705$ELI LILLY AND CO$$16$YR$T$M$Y$$$20240731$$CN$US$US
241598741$24159874$1$I$$20240709$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407006561$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240731$$CN$US$US
241598751$24159875$1$I$$20240710$20240731$20240731$PER$$US-ELI_LILLY_AND_COMPANY-US202407007199$ELI LILLY AND CO$$$$$M$Y$$$20240731$$CN$US$US
241598761$24159876$1$I$$20240723$20240731$20240731$PER$$US-ABBVIE-5852959$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241598771$24159877$1$I$20230101$20240724$20240731$20240731$EXP$$US-ABBVIE-5656231$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241598783$24159878$3$F$20240724$20240820$20240731$20240820$PER$$US-ALXN-202407USA001790US$ALEXION PHARMACEUTICALS$$43$YR$$F$Y$$$20240820$$CN$US$US
241598792$24159879$2$F$$20240820$20240731$20240820$PER$$US-ALXN-202407USA001777US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
241598803$24159880$3$F$$20240820$20240731$20240820$PER$$US-ALXN-202407USA001791US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
241598811$24159881$1$I$20240501$20240726$20240731$20240731$EXP$$US-ABBVIE-5856301$ABBVIE$$50$YR$$F$Y$$$20240731$$CN$US$US
241598821$24159882$1$I$20240101$20240725$20240731$20240731$EXP$$US-ABBVIE-5855958$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241598831$24159883$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5860674$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241598841$24159884$1$I$$20240730$20240731$20240731$EXP$$US-ABBVIE-5861181$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241598851$24159885$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5859735$ABBVIE$$$$$F$Y$$$20240731$$HP$US$US
241598861$24159886$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA221133$SANOFI AVENTIS$$$$A$M$Y$$$20240801$$MD$US$US
241598873$24159887$3$F$20240101$20240822$20240731$20240916$EXP$$US-SA-2024SA221605$SANOFI AVENTIS$$76$YR$E$M$Y$84$KG$20240916$$PH$US$US
241598882$24159888$2$F$$20240821$20240731$20240821$PER$$US-ALXN-202407USA001814US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
241598891$24159889$1$I$20240601$20240725$20240731$20240731$EXP$$US-JNJFOC-20240768973$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$US$US
241598901$24159890$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA220835$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240801$$MD$US$US
241598911$24159891$1$I$20240701$20240723$20240731$20240731$PER$$US-SA-2024SA221139$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240801$$MD$US$US
241598921$24159892$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA221753$SANOFI AVENTIS$$66$YR$E$M$Y$90.7$KG$20240801$$MD$US$US
241598931$24159893$1$I$$20240723$20240731$20240731$PER$$US-ABBVIE-5853182$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241598941$24159894$1$I$$20240724$20240731$20240731$EXP$$CA-JNJFOC-20240767484$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240801$$HP$CA$CA
241598951$24159895$1$I$20240101$20240720$20240731$20240731$PER$$US-SA-2024SA216085$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240801$$MD$US$US
241598962$24159896$2$F$$20240728$20240731$20240806$PER$$US-SA-2024SA222108$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240806$$MD$US$US
241598971$24159897$1$I$20240725$20240725$20240731$20240731$EXP$$GH-PFIZER INC-202400224526$PFIZER$$34$YR$$M$Y$$$20240731$$MD$GH$GH
241598981$24159898$1$I$$20240725$20240731$20240731$PER$$US-SA-2024SA223729$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240801$$CN$US$US
241598991$24159899$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA218746$SANOFI AVENTIS$$$$E$F$Y$$$20240801$$MD$US$US
241599001$24159900$1$I$20240527$20240729$20240731$20240731$EXP$FR-AFSSAPS-MA2024001231$FR-PFIZER INC-202400225371$PFIZER$$81$YR$$M$Y$$$20240731$$MD$FR$FR
241599012$24159901$2$F$20240712$20240805$20240731$20240812$EXP$$US-PFIZER INC-202400226040$PFIZER$$72$YR$$M$Y$83.9$KG$20240812$$HP$US$US
241599021$24159902$1$I$$20240730$20240731$20240731$EXP$$ES-SANDOZ INC.-SDZ2024ES069394$SANDOZ$$52$YR$$F$Y$$$20240731$$HP$ES$ES
241599032$24159903$2$F$20200101$20240916$20240731$20240917$EXP$$FR-SANDOZ INC.-SDZ2024FR069390$SANDOZ$$4$YR$$M$Y$$$20240917$$HP$FR$FR
241599041$24159904$1$I$$20240725$20240731$20240731$PER$$US-ALXN-202407USA001797US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
241599051$24159905$1$I$$20240726$20240731$20240731$PER$$US-ABBVIE-5857484$ABBVIE$$$$$$Y$$$20240731$$CN$US$US
241599061$24159906$1$I$$20240723$20240731$20240731$EXP$$US-ASTELLAS-2024EU007514$ASTELLAS$$$$$M$Y$1.73$KG$20240801$$HP$US$US
241599071$24159907$1$I$$20240724$20240731$20240731$EXP$$US-GSK-US2024AMR093048$GLAXOSMITHKLINE$$40$YR$$F$Y$59.87$KG$20240731$$CN$US$US
241599082$24159908$2$F$20240726$20240802$20240731$20240807$EXP$$JP-ASTELLAS-2024JP005422$ASTELLAS$$6$DEC$$M$Y$$$20240807$$MD$JP$JP
241599091$24159909$1$I$20240101$20240724$20240731$20240731$PER$$US-SA-2024SA221863$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240801$$MD$US$US
241599102$24159910$2$F$20240723$20240729$20240731$20240807$PER$$US-SA-2024SA223916$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240807$$MD$US$US
241599112$24159911$2$F$20240101$20240801$20240731$20240803$EXP$$US-ABBVIE-5860496$ABBVIE$$$$$F$Y$61$KG$20240803$$CN$US$US
241599121$24159912$1$I$20240728$20240729$20240731$20240731$PER$$US-AMGEN-USASP2024150611$AMGEN$$79$YR$E$F$Y$$$20240731$$CN$US$US
241599131$24159913$1$I$$20240725$20240731$20240731$EXP$$US-ABBVIE-5856057$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241599151$24159915$1$I$$20240729$20240731$20240731$EXP$$US-ABBVIE-5859517$ABBVIE$$$$$F$Y$$$20240731$$HP$US$US
241599162$24159916$2$F$$20240812$20240731$20240814$PER$$US-AMGEN-USASP2024151321$AMGEN$$56$YR$A$M$Y$$$20240814$$HP$US$US
241599181$24159918$1$I$$20240724$20240731$20240731$PER$$US-SA-2024SA222051$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240801$$MD$US$US
241599191$24159919$1$I$20240601$20240725$20240731$20240731$PER$$US-SA-2024SA221040$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240801$$MD$US$US
241599204$24159920$4$F$$20240812$20240731$20240814$PER$$US-AMGEN-USASP2024150201$AMGEN$$$$$F$Y$$$20240814$$PH$US$US
241599211$24159921$1$I$$20240723$20240731$20240731$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202407017138$ELI LILLY AND CO$$$$$M$Y$$$20240731$$CN$BE$BE
241599221$24159922$1$I$20240101$20240725$20240731$20240731$EXP$FI-FIMEA-202402681$FI-ELI_LILLY_AND_COMPANY-FI202407017444$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240731$$CN$FI$FI
241599232$24159923$2$F$20240721$20240822$20240731$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017448$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240826$$MD$US$US
241599241$24159924$1$I$$20240727$20240731$20240731$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407018136$ELI LILLY AND CO$$49$YR$A$F$Y$42$KG$20240731$$CN$CN$CN
241599253$24159925$3$F$20240601$20240805$20240731$20240808$PER$$US-AMGEN-USASP2024152367$AMGEN$$57$YR$A$F$Y$$$20240808$$CN$US$US
241599261$24159926$1$I$$20240729$20240731$20240731$EXP$GB-MHRA-MED-202407290946084720-KBZVW$GB-GSK-GB2024094500$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$GB$GB
241599272$24159927$2$F$20240701$20240918$20240731$20240923$EXP$$US-ABBVIE-5856018$ABBVIE$$58$YR$$F$Y$$$20240923$$CN$US$US
241599281$24159928$1$I$20240101$20240725$20240731$20240731$EXP$$US-ABBVIE-5856424$ABBVIE$$$$$F$Y$$$20240731$$CN$US$US
241599292$24159929$2$F$20240725$20240827$20240731$20240830$EXP$$US-ABBVIE-5803686$ABBVIE$$84$YR$$F$Y$$$20240830$$CN$US$US
241599301$24159930$1$I$20240701$20240729$20240731$20240731$EXP$$PR-ABBVIE-5860208$ABBVIE$$74$YR$$F$Y$$$20240731$$CN$PR$PR
241599312$24159931$2$F$$20240730$20240731$20240813$PER$$US-HLS-202400498$HLS THERAPEUTICS$$$$$F$Y$$$20240813$$CN$US$US
241599321$24159932$1$I$$20240723$20240731$20240731$PER$$US-SA-2024SA220951$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240801$$CN$US$US
241599331$24159933$1$I$20240610$20240711$20240731$20240731$PER$$US-APOTEX-2024AP008351$APOTEX$$$$$F$Y$$$20240731$$CN$US$US
241599341$24159934$1$I$$20240730$20240731$20240731$PER$$NVSC2024US156510$NOVARTIS$$$$$M$Y$102$KG$20240801$$CN$US$US
241599351$24159935$1$I$20240724$20240725$20240731$20240731$EXP$$GB-ABBVIE-5855929$ABBVIE$$67$YR$$F$Y$$$20240731$$CN$GB$GB
241599361$24159936$1$I$20240703$20240729$20240731$20240731$EXP$GB-MHRA-MED-202407032204148930-MRGNP$GB-GSK-GB2024GSK095518$GLAXOSMITHKLINE$$$$$$Y$$$20240731$$CN$GB$GB
241599371$24159937$1$I$20240725$20240729$20240731$20240731$EXP$$NVSC2024CN156187$NOVARTIS$$69$YR$$M$Y$$$20240801$$HP$CN$CN
241599381$24159938$1$I$$20240725$20240731$20240731$EXP$$DE-JNJFOC-20240770993$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$MD$DE$DE
241599391$24159939$1$I$$20240722$20240731$20240731$EXP$$FR-JNJFOC-20240763863$JOHNSON AND JOHNSON$$63$YR$A$F$Y$42$KG$20240801$$MD$FR$FR
241599401$24159940$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5860396$ABBVIE$$$$$M$Y$$$20240731$$CN$US$US
241599411$24159941$1$I$20240403$20240715$20240801$20240801$PER$$PR-TEVA-VS-3227118$TEVA$$89$YR$$F$Y$$$20240801$$CN$PR$PR
241599421$24159942$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA222566$SANOFI AVENTIS$$$$E$F$Y$$$20240801$$MD$US$US
241599431$24159943$1$I$20240101$20240729$20240801$20240801$EXP$$DE-ABBVIE-5860620$ABBVIE$$$$$$Y$$$20240731$$CN$DE$DE
241599441$24159944$1$I$20240701$20240729$20240801$20240801$EXP$$CA-ABBVIE-5860721$ABBVIE$$50$YR$$F$Y$$$20240801$$CN$CA$CA
241599451$24159945$1$I$20231201$20231214$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20230368$IRONSHORE PHARMA$$9$YR$C$M$Y$$$20240801$$MD$US$US
241599461$24159946$1$I$20240601$20240724$20240801$20240801$PER$$US-ABBVIE-5854825$ABBVIE$$65$YR$$M$Y$$$20240801$$CN$US$US
241599471$24159947$1$I$$20240207$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240048$IRONSHORE PHARMA$$$$$$Y$$$20240801$$HP$US$US
241599481$24159948$1$I$20240729$20240730$20240801$20240801$EXP$$US-ABBVIE-5861995$ABBVIE$$76$YR$$M$Y$$$20240801$$CN$US$US
241599491$24159949$1$I$$20240207$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240049$IRONSHORE PHARMA$$$$$$Y$$$20240801$$HP$US$US
241599501$24159950$1$I$20220101$20240730$20240801$20240801$EXP$$US-ABBVIE-5842603$ABBVIE$$43$YR$$F$Y$$$20240801$$CN$US$US
241599511$24159951$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA219859$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240801$$CN$US$US
241599521$24159952$1$I$20240101$20240727$20240801$20240801$EXP$$EG-ABBVIE-5859054$ABBVIE$$65$YR$$F$Y$$$20240801$$CN$EG$EG
241599531$24159953$1$I$$20240729$20240801$20240801$EXP$$FR-JNJFOC-20240776391$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$FR$FR
241599542$24159954$2$F$20240101$20240828$20240801$20240909$PER$$US-SA-2024SA221530$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240909$$MD$US$US
241599551$24159955$1$I$$20240724$20240801$20240801$PER$$US-ABBVIE-5857304$ABBVIE$$$$$F$Y$$$20240801$$MD$US$US
241599561$24159956$1$I$20240723$20240725$20240801$20240801$EXP$$US-ALXN-202407USA001793US$ALEXION PHARMACEUTICALS$$50$YR$$F$Y$$$20240801$$MD$US$US
241599571$24159957$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5860472$ABBVIE$$$$$$Y$$$20240801$$CN$US$US
241599581$24159958$1$I$20240101$20240722$20240801$20240801$EXP$$JP-TAKEDA-2024TUS076869$TAKEDA$$88$YR$$M$Y$$$20240801$$PH$JP$JP
241599591$24159959$1$I$$20240729$20240801$20240801$PER$$US-ABBVIE-5860363$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241599603$24159960$3$F$20240101$20240808$20240801$20240813$EXP$$US-ABBVIE-5857322$ABBVIE$$$$$M$Y$3.629$KG$20240813$$CN$US$US
241599612$24159961$2$F$20240701$20240727$20240801$20240802$EXP$$GB-ABBVIE-5859099$ABBVIE$$$$E$M$Y$$$20240802$$CN$GB$GB
241599621$24159962$1$I$$20240724$20240801$20240801$EXP$$US-NOVITIUMPHARMA-2024USNVP01431$NOVITIUM PHARMA$A. Gupta.Mucormycosis - A Rare Etiology of Empyema Nessisitans.American Journal of Respiratory and Critical Care Medicine.19-MAY-2024;NA:A2386 - A2386$55$YR$A$M$Y$$$20240801$$HP$US$US
241599631$24159963$1$I$20240725$20240725$20240801$20240801$EXP$$US-ABBVIE-5856054$ABBVIE$$76$YR$$M$Y$$$20240801$$CN$US$US
241599641$24159964$1$I$$20240321$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240805$IRONSHORE PHARMA$$$$$F$Y$$$20240801$$CN$US$US
241599651$24159965$1$I$20240101$20240322$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240795$IRONSHORE PHARMA$$$$A$F$Y$$$20240801$$HP$US$US
241599661$24159966$1$I$$20240229$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240749$IRONSHORE PHARMA$$$$C$$Y$$$20240801$$MD$US$US
241599671$24159967$1$I$$20240322$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240793$IRONSHORE PHARMA$$11$YR$C$M$Y$$$20240801$$MD$US$US
241599681$24159968$1$I$$20240229$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240875$IRONSHORE PHARMA$$$$C$$Y$$$20240801$$MD$US$US
241599691$24159969$1$I$20240201$20240325$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240804$IRONSHORE PHARMA$$15$YR$T$F$Y$$$20240801$$CN$COUNTRY NOT SPECIFIED$US
241599701$24159970$1$I$$20240726$20240801$20240801$EXP$$US-ABBVIE-5857089$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241599711$24159971$1$I$$20240723$20240801$20240801$PER$$US-ABBVIE-5853674$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241599721$24159972$1$I$20240714$20240729$20240801$20240801$EXP$$US-AstraZeneca-2024A172353$ASTRAZENECA$$27208$DY$$M$Y$$$20240801$$CN$US$
241599731$24159973$1$I$20240722$20240728$20240801$20240801$EXP$$NVSC2024CN156131$NOVARTIS$$70$YR$$M$Y$45$KG$20240801$$HP$CN$CN
241599742$24159974$2$F$$20240729$20240801$20240805$PER$$US-009507513-2407USA016026$MERCK$$64$YR$$F$Y$$$20240805$$CN$US$US
241599751$24159975$1$I$20240723$20240729$20240801$20240801$EXP$$CO-ABBVIE-5860861$ABBVIE$$77$YR$$F$Y$$$20240801$$CN$CO$CO
241599762$24159976$2$F$$20240905$20240801$20240911$EXP$$JP-009507513-2407JPN005038J$MERCK$$49$YR$$M$Y$$$20240911$$MD$JP$JP
241599771$24159977$1$I$20240710$20240730$20240801$20240801$EXP$$US-ABBVIE-5862072$ABBVIE$$86$YR$$M$Y$$$20240801$$CN$US$US
241599781$24159978$1$I$$20240723$20240801$20240801$PER$$US-APOTEX-2024AP008773$APOTEX$$$$$F$Y$$$20240801$$CN$US$US
241599791$24159979$1$I$$20240724$20240801$20240801$EXP$$US-VIIV HEALTHCARE LIMITED-US2024092903$VIIV$$$$$M$Y$$$20240801$$HP$US$US
241599803$24159980$3$F$$20240805$20240801$20240828$30DAY$$US-GSK-US2024091750$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$CN$US$US
241599811$24159981$1$I$$20240406$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240825$IRONSHORE PHARMA$$$$A$M$Y$$$20240801$$CN$US$US
241599821$24159982$1$I$20240301$20240321$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240807$IRONSHORE PHARMA$$$$$$Y$$$20240801$$HP$US$US
241599831$24159983$1$I$$20240718$20240801$20240801$PER$$US-APOTEX-2024AP008650$APOTEX$$$$E$F$Y$$$20240801$$CN$US$US
241599841$24159984$1$I$$20240327$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240809$IRONSHORE PHARMA$$$$$$Y$$$20240801$$HP$US$US
241599851$24159985$1$I$$20240321$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240808$IRONSHORE PHARMA$$$$$$Y$$$20240801$$HP$US$US
241599861$24159986$1$I$$20240726$20240801$20240801$EXP$$JP-AMGEN-JPNSP2024152111$AMGEN$$$$$$Y$$$20240731$$PH$JP$JP
241599871$24159987$1$I$$20240403$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240821$IRONSHORE PHARMA$$19$YR$A$F$Y$$$20240801$$MD$US$US
241599881$24159988$1$I$$20240620$20240801$20240801$PER$$US-ROCHE-10000041415$ROCHE$$$$A$F$Y$$$20240801$$CN$US$US
241599891$24159989$1$I$20240101$20240724$20240801$20240801$EXP$$CN-ABBVIE-5853416$ABBVIE$$$$$$Y$$$20240801$$MD$CN$CN
241599903$24159990$3$F$20240101$20240725$20240801$20240808$PER$$US-SA-2024SA221478$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240808$$CN$US$US
241599912$24159991$2$F$$20240826$20240801$20240830$EXP$$CA-ABBVIE-5861078$ABBVIE$$$$A$M$Y$$$20240829$$MD$CA$CA
241599921$24159992$1$I$$20240417$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240849$IRONSHORE PHARMA$$17$YR$T$$Y$$$20240801$$HP$US$US
241599931$24159993$1$I$20240411$20240412$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240836$IRONSHORE PHARMA$$$$$M$Y$$$20240801$$CN$COUNTRY NOT SPECIFIED$US
241599941$24159994$1$I$$20240417$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240850$IRONSHORE PHARMA$$10$YR$C$$Y$$$20240801$$HP$US$US
241599951$24159995$1$I$20240701$20240724$20240801$20240801$PER$$US-ALXN-202407USA001828US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
241599961$24159996$1$I$$20240417$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240851$IRONSHORE PHARMA$$12$YR$T$$Y$$$20240801$$HP$US$US
241599971$24159997$1$I$$20240729$20240801$20240801$EXP$$US-JNJFOC-20240780344$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$HP$US$US
241599981$24159998$1$I$$20240729$20240801$20240801$EXP$$PH-AstraZeneca-2024A172214$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$PH$
241599991$24159999$1$I$$20240724$20240801$20240801$EXP$$AT-ABBVIE-5854872$ABBVIE$$$$A$F$Y$$$20240801$$CN$AT$AT
241600001$24160000$1$I$20240101$20240725$20240801$20240801$EXP$$US-ABBVIE-5784998$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241600011$24160001$1$I$20240725$20240725$20240801$20240801$EXP$$CO-ABBVIE-5862254$ABBVIE$$69$YR$$F$Y$73$KG$20240801$$HP$CO$CO
241600021$24160002$1$I$$20240724$20240801$20240801$EXP$$US-ABBVIE-5855672$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241600031$24160003$1$I$$20240725$20240801$20240801$EXP$$BR-TAKEDA-2024TUS076605$TAKEDA$$41$YR$$$Y$$$20240801$$CN$BR$BR
241600041$24160004$1$I$20240512$20240729$20240801$20240801$EXP$$US-ABBVIE-5860241$ABBVIE$$81$YR$$M$Y$$$20240801$$CN$US$US
241600052$24160005$2$F$$20240806$20240801$20240816$EXP$$TW-TEVA-VS-3226198$TEVA$Chen R-L, Ip PP, Shaw J-J, Wang Y-H, Fan L-H, Shen Y-L, et al. Anti-Thymocyte Globulin (ATG)-Free Nonmyeloablative Haploidentical PBSCT Plus Post-Transplantation Cyclophosphamide Is a Safe and Efficient Treatment Approach for Pediatric Acquired Aplastic Anemia. Int-J-Molecular-Sci 2022; 23 (23):.; Chen R-L, Ip PP, Shaw J-J, Wang Y-H, Fan L-H, Shen Y-L, et al. Anti-Thymocyte Globulin (ATG)-Free Nonmyeloablative Haploidentical PBSCT Plus Post-Transplantation Cyclophosphamide Is a Safe and Effic...$10$YR$$M$Y$$$20240816$$HP$TW$TW
241600061$24160006$1$I$20240727$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151145$AMGEN$$72$YR$E$F$Y$$$20240731$$CN$US$US
241600071$24160007$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA222425$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240801$$MD$US$US
241600082$24160008$2$F$$20240806$20240801$20240816$EXP$$ES-TEVA-VS-3226262$TEVA$Casado E, Costa E, Mezquita-Raya P, Andujar-Espinosa R, Neyro JL. Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases. Drugs-Cont 2023; 12.; Casado E, Costa E, Mezquita-Raya P, Andujar-Espinosa R, Neyro JL. Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases. Drugs-Cont 2023; 12.$$$E$M$Y$$$20240816$$HP$ES$ES
241600092$24160009$2$F$20240101$20240819$20240801$20240828$PER$$US-SA-2024SA219855$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240828$$CN$US$US
241600101$24160010$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA219143$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240801$$CN$US$US
241600111$24160011$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA222243$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240801$$CN$US$US
241600121$24160012$1$I$$20240723$20240801$20240801$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009396$STRIDES$Shultz J, Antar-Shultz M, Taha M, Zervogiannis P, Lazcano G, Lamarche J.. SEVELAMER-ASSOCIATED COLITIS: A TRIGGER TO CHANGE TREATMENT APPROACH.. Am-J-Kidney-Dis. 2024;83 (Suppl.) (4):S74 abstr. 242.$63$YR$$M$Y$$$20240801$$HP$US$US
241600131$24160013$1$I$$20240723$20240801$20240801$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009413$STRIDES$Anwar A, Chahine Z, Piecoro D, Kesler M, Qasrawi A.. Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia. Hum-Pathol-Rep. 2023;33:300713$68$YR$$F$Y$$$20240801$$HP$US$US
241600141$24160014$1$I$$20240723$20240801$20240801$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP009383$STRIDES$Medeiros T, Sequeira S, Mendes M, Hierro F, Duarte S.. PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA COMPLICATED BY CEREBRAL VENOUS SINUS THROMBOSIS: A CASE REPORT.. Eur-J-Case-Rep-Intern-Med. 2023;10 (8):1-5$64$YR$$F$Y$$$20240801$$HP$PT$PT
241600151$24160015$1$I$20240101$20240503$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240889$IRONSHORE PHARMA$$11$YR$C$M$Y$$$20240801$$MD$US$US
241600161$24160016$1$I$20240101$20240503$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240890$IRONSHORE PHARMA$$$$$$Y$$$20240801$$MD$US$US
241600171$24160017$1$I$$20240507$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240893$IRONSHORE PHARMA$$22$YR$A$F$Y$$$20240801$$HP$US$US
241600181$24160018$1$I$$20240508$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240898$IRONSHORE PHARMA$$8$YR$C$M$Y$$$20240801$$MD$US$US
241600191$24160019$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221225$SANOFI AVENTIS$$$$A$F$Y$86.18$KG$20240801$$MD$US$US
241600201$24160020$1$I$$20240723$20240801$20240801$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009420$STRIDES$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al.. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$38$YR$$M$Y$$$20240801$$HP$US$US
241600211$24160021$1$I$$20240719$20240801$20240801$PER$$US-APOTEX-2024AP008704$APOTEX$Allahyar A, Munoz EP, Molina A, Hsu J, Abbas A.. (133) Aplastic Anemia After Long-Acting Injectable Paliperidone: A Case Report.. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64:S66$62$YR$$M$Y$$$20240801$$HP$US$US
241600222$24160022$2$F$20240701$20240806$20240801$20240816$PER$$US-SA-2024SA222535$SANOFI AVENTIS$$60$YR$A$M$Y$158.76$KG$20240816$$MD$US$US
241600233$24160023$3$F$20240718$20240826$20240801$20240902$30DAY$$BR-JNJFOC-20240765790$JOHNSON AND JOHNSON$$50$YR$A$F$Y$51$KG$20240902$$CN$BR$BR
241600241$24160024$1$I$$20240722$20240801$20240801$30DAY$$US-GSK-US2024091819$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$MD$US$US
241600251$24160025$1$I$20200916$20240723$20240801$20240801$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009374$STRIDES$Wang C-L, Zhang Q, Huang X-M.. Electrocardiographic manifestations of a fatal case of oral propafenone poisoning.. Acad-J-Nav-Med-Univ. 2023;44 (3):382-384$10$YR$$F$Y$$$20240801$$HP$CN$CN
241600261$24160026$1$I$$20240723$20240801$20240801$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000261$EMCURE$Price A, File C, Call-Orellana F, Andrade de Almeida RA, North RY. Surgical decompression in spinal Paget^s disease: illustrative case. J Neurosurg Case Lessons.. 2024;8(4):CASE24203$52$YR$$M$Y$$$20240801$$HP$US$US
241600271$24160027$1$I$20240101$20240724$20240801$20240801$PER$$US-SA-2024SA222662$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240801$$MD$US$US
241600281$24160028$1$I$$20240724$20240801$20240801$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009483$STRIDES$Abedrabo S, Rodriguez TE, Klein LM, Bitran J.. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142 (Suppl. 1)$$$$$Y$$$20240801$$MD$US$US
241600291$24160029$1$I$$20240724$20240801$20240801$EXP$$US-NOVITIUMPHARMA-2024USNVP01434$NOVITIUM PHARMA$Eitan S Frankel .Recurrent giant cell myocarditis after heart transplant: a case report.European Heart Journal - Case Reports.05-SEP-2022;6:1-4$33$YR$A$M$Y$$$20240801$$HP$US$US
241600301$24160030$1$I$$20240508$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240901$IRONSHORE PHARMA$$15$YR$T$F$Y$$$20240801$$MD$US$US
241600311$24160031$1$I$20240101$20240509$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240903$IRONSHORE PHARMA$$70$YR$E$F$Y$$$20240801$$HP$US$US
241600321$24160032$1$I$20210101$20240723$20240801$20240801$EXP$ID-MLMSERVICE-20240712-PI131612-00306-3$ID-STRIDES ARCOLAB LIMITED-2024SP009175$STRIDES$Rohmah SN, Puspitasari M, Wardhani Y, Ananda NR, Khotijah AA. Diagnostic and therapeutic challenges of tuberculosis in kidney transplant recipients; a case series study.. Journal of Nephropharmacology. 2024;13(2):e11679$42$YR$$M$Y$$$20240801$$MD$ID$ID
241600331$24160033$1$I$$20240508$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240900$IRONSHORE PHARMA$$11$YR$C$M$Y$$$20240801$$MD$US$US
241600341$24160034$1$I$20190101$20240513$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240912$IRONSHORE PHARMA$$$$$$Y$$$20240801$$CN$COUNTRY NOT SPECIFIED$US
241600351$24160035$1$I$$20240508$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240904$IRONSHORE PHARMA$$$$T$$Y$$$20240801$$MD$COUNTRY NOT SPECIFIED$US
241600361$24160036$1$I$$20240730$20240801$20240801$EXP$$US-ABBVIE-5861124$ABBVIE$$70$YR$$M$Y$$$20240801$$MD$US$US
241600372$24160037$2$F$20240201$20240905$20240801$20240912$EXP$$US-ABBVIE-5852652$ABBVIE$$81$YR$$F$Y$41$KG$20240912$$CN$US$US
241600381$24160038$1$I$$20240722$20240801$20240801$EXP$$US-GSK-US2024AMR092108$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
241600391$24160039$1$I$20240723$20240729$20240801$20240801$EXP$$ES-ABBVIE-5860835$ABBVIE$$81$YR$$F$Y$$$20240801$$CN$ES$ES
241600402$24160040$2$F$20200327$20240827$20240801$20240911$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009333$STRIDES$$55$YR$$F$Y$$$20240911$$CN$US$US
241600411$24160041$1$I$$20240720$20240801$20240801$EXP$$NL-AUROBINDO-AUR-APL-2024-036947$AUROBINDO$$74$YR$$F$Y$79$KG$20240801$$CN$NL$NL
241600421$24160042$1$I$$20240723$20240801$20240801$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP009387$STRIDES$Holla UP, Patil A.. SSA mediated endocardial fibroelastosis treated with dexamethasone and IVIG.. Indian-J-Rheumatol. 2023;18 (Suppl. 2):S358-S359 abstr. CAS124$$$$F$Y$$$20240801$$HP$IN$IN
241600432$24160043$2$F$20240719$20240809$20240801$20240819$EXP$$IN-ROCHE-10000034291$ROCHE$$67$YR$E$M$Y$$$20240819$$CN$IN$IN
241600441$24160044$1$I$$20240723$20240801$20240801$EXP$$ID-STRIDES ARCOLAB LIMITED-2024SP009398$STRIDES$Rohmah SN, Puspitasari M, Wardhani Y, Ananda NR, Khotijah AA.. Diagnostic and therapeutic challenges of tuberculosis in kidney transplant recipients; a case series study.. J-Nephropharmacol. 2024;13 (2)$29$YR$$M$Y$$$20240801$$HP$ID$ID
241600451$24160045$1$I$20240701$20240729$20240801$20240801$EXP$$US-ABBVIE-5860287$ABBVIE$$75$YR$$F$Y$$$20240801$$HP$US$US
241600471$24160047$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156613$NOVARTIS$$$$$F$Y$$$20240801$$MD$US$US
241600482$24160048$2$F$20240710$20240808$20240801$20240813$PER$$US-AMGEN-USASP2024149739$AMGEN$$$$$$Y$$$20240813$$PH$US$US
241600491$24160049$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA221402$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240801$$MD$US$US
241600501$24160050$1$I$$20240726$20240801$20240801$PER$$US-SA-2024SA222835$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240801$$CN$US$US
241600511$24160051$1$I$20240601$20240719$20240801$20240801$PER$$US-SA-2024SA219327$SANOFI AVENTIS$$22$YR$A$M$Y$64.41$KG$20240801$$MD$US$US
241600521$24160052$1$I$20240101$20240725$20240801$20240801$EXP$$US-ABBVIE-5855661$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241600531$24160053$1$I$20240726$20240726$20240801$20240801$EXP$$CO-ABBVIE-5862382$ABBVIE$$70$YR$$M$Y$60$KG$20240801$$HP$CO$CO
241600541$24160054$1$I$$20240723$20240801$20240801$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP009416$STRIDES$Mohan V, Jain S, Naithani R.. Low-dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe-BIRD) in a child with relapsed/refractory B-cell acute lymphoblastic leukemia with TP53 mutation. Pediatr-Blood-Cancer. 2024;71 (9)$11$YR$$M$Y$$$20240801$$HP$IN$IN
241600551$24160055$1$I$20240101$20240513$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240916$IRONSHORE PHARMA$$$$$F$Y$$$20240801$$HP$US$US
241600561$24160056$1$I$$20240514$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240918$IRONSHORE PHARMA$$$$$M$Y$$$20240801$$HP$US$US
241600571$24160057$1$I$20240725$20240731$20240801$20240801$EXP$$CN-ABBVIE-5861915$ABBVIE$$58$YR$$M$Y$$$20240801$$MD$CN$CN
241600581$24160058$1$I$$20240520$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240926$IRONSHORE PHARMA$$$$A$F$Y$$$20240801$$MD$US$US
241600591$24160059$1$I$$20240523$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240941$IRONSHORE PHARMA$$$$$$Y$$$20240801$$MD$US$US
241600601$24160060$1$I$20240401$20240531$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240957$IRONSHORE PHARMA$$11$YR$C$F$Y$$$20240801$$HP$US$US
241600611$24160061$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5859297$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241600621$24160062$1$I$$20240723$20240801$20240801$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP009417$STRIDES$Fuessl L, Kreuzer L, Nierychlewski K, Seibt T, Stangl MJ, Koliogiannis D, et al.. The use of extended-release tacrolimus twice a day might be beneficial for selected kidney transplant recipients: a case report.. Front-Med. 2024;11$47$YR$$F$Y$$$20240801$$HP$DE$DE
241600631$24160063$1$I$20240624$20240719$20240801$20240801$PER$$US-JNJFOC-20240756145$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240801$$CN$US$US
241600641$24160064$1$I$$20240724$20240801$20240801$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009481$STRIDES$Gorbonos A, Kamat A, Williams B, Rodriguez G, Bahtiyar G.. Pheochromocytoma in a Pregnant Woman with VHL leading to First Trimester Fetal Demise.. J-Endocr-Soc. 2022;6 (Suppl. 1):A93$39$YR$$F$Y$$$20240801$$HP$US$US
241600654$24160065$4$F$20240506$20240905$20240801$20240917$EXP$$US-NOVOPROD-1260240$NOVO NORDISK$$77$YR$$F$Y$$$20240917$$CN$US$US
241600661$24160066$1$I$$20240728$20240801$20240801$EXP$GB-MHRA-MIDB-79dd5f53-180a-4b96-bf8d-5d7b52b82726$GB-DEXPHARM-2024-2472$DEXCEL$$56$YR$A$$Y$$$20240801$$PH$GB$GB
241600671$24160067$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221044$SANOFI AVENTIS$$$$A$F$Y$74.84$KG$20240801$$MD$US$US
241600681$24160068$1$I$20240701$20240723$20240801$20240801$PER$$US-SA-2024SA223549$SANOFI AVENTIS$$$$$F$Y$$$20240801$$MD$US$US
241600691$24160069$1$I$20240726$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150381$AMGEN$$79$YR$E$F$Y$$$20240731$$CN$US$US
241600701$24160070$1$I$$20240723$20240801$20240801$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01423$NOVITIUM PHARMA$Liang, Juan MD.Combined Use of Emapalumab With Ruxolitinib and Dexamethasone as an Effective Treatment for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Complicated With Multiorgan Damage and Severe Infection.Journal of Pediatric Hematology/Oncology.JUL-2024;46:e360-e362$8$YR$C$F$Y$$$20240801$$HP$CN$CN
241600711$24160071$1$I$20190101$20240724$20240801$20240801$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009493$STRIDES$Imani-Musimwa P, Grant E, Feza-Malira M, Mbala-Kingebeni P, Buhoro-Baabo G, Zawadi-Endanda E, et al.. A premature newborn born to an adolescent girl with acute Ebola virus disease and malaria survives in a resource-limited setting in an Ebola treatment unit in DR Congo: ^A case report^.. Clin-Case-Rep. 2023;11 (11)$17$YR$$F$Y$45$KG$20240801$$HP$US$US
241600721$24160072$1$I$20190101$20240724$20240801$20240801$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009494$STRIDES$Imani-Musimwa P, Grant E, Feza-Malira M, Mbala-Kingebeni P, Buhoro-Baabo G, Zawadi-Endanda E, et al.. A premature newborn born to an adolescent girl with acute Ebola virus disease and malaria survives in a resource-limited setting in an Ebola treatment unit in DR Congo: ^A case report^.. Clin-Case-Rep. 2023;11 (11)$$$N$F$Y$$$20240801$$HP$US$US
241600731$24160073$1$I$$20240723$20240801$20240801$PER$$US-AMGEN-USASP2024146950$AMGEN$$$$A$$Y$$$20240731$$PH$US$US
241600741$24160074$1$I$$20240722$20240801$20240801$PER$$US-AMGEN-USASP2024151741$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et. Al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (3):2440$$$$$Y$$$20240731$$HP$US$US
241600752$24160075$2$F$20240701$20240730$20240801$20240805$PER$$US-AMGEN-USASP2024152104$AMGEN$$59$YR$A$F$Y$$$20240803$$HP$US$US
241600761$24160076$1$I$20240701$20240726$20240801$20240801$EXP$$US-ABBVIE-5858763$ABBVIE$$80$YR$$F$Y$$$20240801$$CN$US$US
241600771$24160077$1$I$20240101$20240618$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240990$IRONSHORE PHARMA$$$$$$Y$$$20240801$$CN$US$US
241600781$24160078$1$I$$20240616$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240988$IRONSHORE PHARMA$$16$YR$T$M$Y$$$20240801$$$US$US
241600791$24160079$1$I$$20240614$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240982$IRONSHORE PHARMA$$$$$M$Y$$$20240801$$MD$US$US
241600802$24160080$2$F$20240101$20240821$20240801$20240824$EXP$$CA-ABBVIE-5857063$ABBVIE$$$$E$M$Y$$$20240824$$CN$CA$CA
241600811$24160081$1$I$$20240603$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240959$IRONSHORE PHARMA$$$$$M$Y$$$20240801$$MD$US$US
241600821$24160082$1$I$$20240626$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241002$IRONSHORE PHARMA$$$$$$Y$$$20240801$$HP$US$US
241600831$24160083$1$I$20240101$20240711$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241030$IRONSHORE PHARMA$$8$YR$C$M$Y$$$20240801$$HP$US$US
241600841$24160084$1$I$20240101$20240720$20240801$20240801$EXP$$DE-AUROBINDO-AUR-APL-2024-036835$AUROBINDO$$25$YR$$F$Y$80$KG$20240801$$CN$DE$DE
241600851$24160085$1$I$20200422$20240720$20240801$20240801$EXP$$PL-AUROBINDO-AUR-APL-2024-036911$AUROBINDO$$18$YR$$F$Y$70$KG$20240801$$MD$PL$PL
241600861$24160086$1$I$$20240730$20240801$20240801$EXP$$US-TAKEDA-2024TUS076888$TAKEDA$$$$$F$Y$$$20240801$$CN$US$US
241600871$24160087$1$I$20240710$20240725$20240801$20240801$EXP$$NVSC2024US154088$NOVARTIS$$54$YR$$M$Y$$$20240801$$CN$US$US
241600881$24160088$1$I$20240726$20240728$20240801$20240801$EXP$$US-TAKEDA-2024TUS076252$TAKEDA$$36$YR$$F$Y$$$20240801$$MD$US$US
241600891$24160089$1$I$$20240724$20240801$20240801$EXP$$US-NOVITIUMPHARMA-2024USNVP01444$NOVITIUM PHARMA$Evan J Patel.Invasive Fungal Sinusitis in an Immunocompetent Patient After Sinus Surgery for Chronic Rhinosinusitis with Nasal Polyps and a Mycetoma.The Laryngoscope.23-APR-2024;NA:1-6$38$YR$A$F$Y$$$20240801$$HP$US$US
241600911$24160091$1$I$20240101$20240725$20240801$20240801$PER$$US-ABBVIE-5858931$ABBVIE$$$$$$Y$$$20240801$$CN$US$US
241600921$24160092$1$I$20240701$20240724$20240801$20240801$PER$$US-SA-2024SA219829$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240801$$MD$US$US
241600931$24160093$1$I$$20240726$20240801$20240801$PER$$US-SA-2024SA223224$SANOFI AVENTIS$$$$$M$Y$$$20240801$$CN$US$US
241600943$24160094$3$F$20240729$20240801$20240801$20240829$PER$$US-AMGEN-USASP2024151117$AMGEN$$80$YR$E$M$Y$$$20240829$$CN$US$US
241600951$24160095$1$I$20220601$20240723$20240801$20240801$EXP$$CA-ROCHE-3241569$ROCHE$$40$YR$A$F$Y$$$20240801$$CN$CA$CA
241600961$24160096$1$I$$20240729$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043108$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240801$$CN$US$US
241600971$24160097$1$I$20240722$20240723$20240801$20240801$PER$$US-ROCHE-10000034452$ROCHE$$$$$F$Y$$$20240801$$CN$US$US
241600981$24160098$1$I$$20240725$20240801$20240801$PER$$US-BIOGEN-2024BI01274951$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
241600992$24160099$2$F$$20240820$20240801$20240820$PER$$US-ALXN-202407USA001765US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
241601001$24160100$1$I$$20240722$20240801$20240801$EXP$$US-STERISCIENCE B.V.-2024-ST-001109$Steriscience PTE$Shih J, Hamera L.. Multiorgan Failure in the Aftermath of Pre-eclampsia With Intracerebral Hemorrhage and HELLP Syndrome.. Am-J-Respir-Crit-Care-Med. 2023;207$18$YR$$F$Y$$$20240801$$HP$US$US
241601011$24160101$1$I$20220213$20240718$20240801$20240801$EXP$$JP-ROCHE-3101562$ROCHE$$82$YR$E$M$Y$$$20240801$$MD$JP$JP
241601021$24160102$1$I$20240101$20240723$20240801$20240801$PER$$US-SA-2024SA221855$SANOFI AVENTIS$$7$YR$C$M$Y$22$KG$20240801$$MD$US$US
241601031$24160103$1$I$$20240729$20240801$20240801$EXP$$US-AstraZeneca-2024A172456$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241601042$24160104$2$F$$20240724$20240801$20240821$EXP$$US-AstraZeneca-2024A169218$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
241601051$24160105$1$I$20240101$20240729$20240801$20240801$EXP$$PH-AstraZeneca-2024A172219$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$PH$
241601061$24160106$1$I$20240714$20240729$20240801$20240801$EXP$$US-AstraZeneca-2024A172343$ASTRAZENECA$$27681$DY$$M$Y$$$20240801$$CN$US$
241601071$24160107$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156446$NOVARTIS$$$$$$Y$$$20240801$$MD$US$US
241601081$24160108$1$I$$20240722$20240801$20240801$EXP$$JP-STERISCIENCE B.V.-2024-ST-001111$Steriscience PTE$Isoshima Y, Kondo E, Uchiyama S, Iio K, Tajiri R, Amimoto S, et al.. A case of chorioamnionitis preceded by sudden intrauterine fetal death at 25 weeks 5 days gestation.. Placenta. 2023;141 (0):104$36$YR$$F$Y$$$20240801$$HP$JP$JP
241601092$24160109$2$F$20230327$20240813$20240801$20240822$EXP$$FR-CHATTEMPRD-2024OHG025717$CHATTEM$$39$YR$A$F$Y$110$KG$20240822$$MD$FR$FR
241601111$24160111$1$I$$20240723$20240801$20240801$EXP$$US-AMGEN-USASP2024146880$AMGEN$$38$YR$A$F$Y$$$20240731$$CN$US$US
241601122$24160112$2$F$$20240812$20240801$20240822$30DAY$$BE-JNJFOC-20240774548$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$BE$BE
241601131$24160113$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156710$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241601141$24160114$1$I$20240525$20240725$20240801$20240801$EXP$GB-MHRA-MED-202406031427307740-BVMKD$GB-DEXPHARM-2024-2446$DEXCEL$$72$YR$E$F$Y$75$KG$20240801$$CN$GB$GB
241601152$24160115$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225406$TEVA$Brenneman E, Keil E, Advani SD, Campbell KB, Wrenn R. A Turtle Disaster: Salmonella enteritidis Cardiovascular Implantable Electronic Device Infection. Open-Forum-Infect-Dis 2022; 9 (12):.; Brenneman E, Keil E, Advani SD, Campbell KB, Wrenn R. A Turtle Disaster: Salmonella enteritidis Cardiovascular Implantable Electronic Device Infection. Open-Forum-Infect-Dis 2022; 9 (12):.$60$YR$$M$Y$$$20240816$$PH$US$US
241601161$24160116$1$I$20240717$20240724$20240801$20240801$PER$$CN-Eisai-EC-2024-170954$EISAI$$62$YR$A$F$Y$64$KG$20240801$$HP$CN$CN
241601171$24160117$1$I$$20240724$20240801$20240801$EXP$$AU-GSK-AU2024APC092596$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$HP$AU$AU
241601181$24160118$1$I$$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151503$AMGEN$$$$$$Y$$$20240731$$PH$US$US
241601191$24160119$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156707$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241601201$24160120$1$I$$20240729$20240801$20240801$PER$$US-ROCHE-10000041931$ROCHE$$33$YR$A$M$Y$$$20240801$$CN$US$US
241601211$24160121$1$I$$20240719$20240801$20240801$EXP$$TR-NOVOPROD-1261934$NOVO NORDISK$$$$$$Y$103$KG$20240801$$CN$TR$TR
241601224$24160122$4$F$20240301$20240816$20240801$20240823$EXP$$JP-ARGENX-2024-ARGX-JP005731$ARGENX BVBA$$$$$$Y$$$20240823$$HP$JP$JP
241601231$24160123$1$I$20110101$20240724$20240801$20240801$PER$$US-JNJFOC-20240769309$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240801$$HP$US$US
241601241$24160124$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156720$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241601251$24160125$1$I$$20240722$20240801$20240801$30DAY$$US-GSK-US2024091835$GLAXOSMITHKLINE$$$$$M$Y$$$20240801$$CN$US$US
241601261$24160126$1$I$$20240721$20240801$20240801$EXP$$CN-NOVOPROD-1259277$NOVO NORDISK$$$$$M$Y$$$20240801$$CN$CN$CN
241601271$24160127$1$I$20231201$20240725$20240801$20240801$EXP$$CA-GSK-CA2024094168$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$CA$CA
241601282$24160128$2$F$20240607$20240731$20240801$20240809$EXP$$DK-NOVOPROD-1243336$NOVO NORDISK$$$$$F$Y$105$KG$20240809$$HP$DK$DK
241601291$24160129$1$I$20240201$20240723$20240801$20240801$EXP$$DE-NOVOPROD-1258453$NOVO NORDISK$$780$MON$$F$Y$72$KG$20240801$$MD$DE$DE
241601311$24160131$1$I$$20240721$20240801$20240801$EXP$$EG-NOVOPROD-1233939$NOVO NORDISK$$619$MON$$F$Y$90$KG$20240801$$CN$EG$EG
241601322$24160132$2$F$$20240823$20240801$20240904$EXP$$US-NOVOPROD-1260770$NOVO NORDISK$$$$$F$Y$$$20240904$$CN$US$US
241601331$24160133$1$I$$20240725$20240801$20240801$PER$$US-BIOGEN-2024BI01275629$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
241601341$24160134$1$I$$20240728$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069563$SANDOZ$$$$$$Y$$$20240801$$CN$US$US
241601353$24160135$3$F$$20240813$20240801$20240823$EXP$$IL-NOVOPROD-1259785$NOVO NORDISK$$51$YR$$M$Y$86$KG$20240823$$MD$IL$IL
241601361$24160136$1$I$20240601$20240722$20240801$20240801$EXP$$US-NOVOPROD-1260233$NOVO NORDISK$$65$YR$$F$Y$$$20240801$$HP$US$US
241601381$24160138$1$I$20240701$20240724$20240801$20240801$PER$$US-AstraZeneca-2024A173388$ASTRAZENECA$$$$$$Y$$$20240801$$CN$US$
241601391$24160139$1$I$20240726$20240730$20240801$20240801$EXP$$GB-HALEON-2189695$Haleon PLC$$29$YR$$F$Y$78$KG$20240801$$MD$GB$GB
241601401$24160140$1$I$$20240724$20240801$20240801$PER$$US-SA-2023SA284004$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240801$$MD$US$US
241601411$24160141$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA223470$SANOFI AVENTIS$$$$E$F$Y$90$KG$20240801$$MD$US$US
241601421$24160142$1$I$20240201$20240723$20240801$20240801$PER$$US-SA-2024SA222481$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240801$$MD$US$US
241601431$24160143$1$I$20240101$20240508$20240801$20240801$PER$$AP-2024-US-5910$AILEX PHARMACEUTICALS$$26$YR$$F$Y$$$20240801$$CN$US$US
241601441$24160144$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156721$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241601451$24160145$1$I$20240228$20240725$20240801$20240801$EXP$CA-MMM-PQC85XHU$CA-GSK-CA2023154338$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$HP$CA$CA
241601463$24160146$3$F$$20240729$20240801$20240828$EXP$GB-MHRA-30827191$GB-LEO Pharma-372373$LEO PHARM$$$$$M$Y$$$20240828$$CN$GB$GB
241601471$24160147$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024152087$AMGEN$$$$$$Y$$$20240731$$MD$US$US
241601481$24160148$1$I$$20240724$20240801$20240801$PER$$US-CHATTEMPRD-2024OHG025349$CHATTEM$$$$$F$Y$$$20240801$$CN$US$US
241601491$24160149$1$I$$20240725$20240801$20240801$PER$$US-CHATTEMPRD-2024OHG025572$CHATTEM$$$$A$F$Y$$$20240801$$HP$US$US
241601501$24160150$1$I$$20240715$20240801$20240801$PER$$US-CHATTEMPRD-2024OHG025495$CHATTEM$$$$A$F$Y$$$20240801$$CN$US$US
241601511$24160151$1$I$$20240726$20240801$20240801$PER$$US-CHATTEMPRD-2024OHG025528$CHATTEM$$$$A$F$Y$$$20240801$$CN$US$US
241601531$24160153$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156733$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241601541$24160154$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156737$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241601551$24160155$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156740$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241601561$24160156$1$I$$20240717$20240801$20240801$EXP$$MX-009507513-2407MEX015021$MERCK$$85$YR$$F$Y$60$KG$20240801$$MD$MX$MX
241601571$24160157$1$I$$20240729$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069292$SANDOZ$$$$$F$Y$$$20240801$$CN$US$US
241601582$24160158$2$F$20240701$20240912$20240801$20240919$EXP$$US-SANDOZ INC.-SDZ2024US069467$SANDOZ$$$$$F$Y$$$20240919$$CN$US$US
241601592$24160159$2$F$$20240729$20240801$20240801$30DAY$$US-SANDOZ INC.-SDZ2024US039297$SANDOZ$$$$$$Y$$$20240801$$CN$US$US
241601601$24160160$1$I$$20240728$20240801$20240801$EXP$GB-MHRA-31113737$GB-DEXPHARM-2024-2473$DEXCEL$$89$YR$E$$Y$$$20240801$$PH$GB$GB
241601611$24160161$1$I$$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024152542$AMGEN$$$$$$Y$$$20240731$$PH$US$US
241601621$24160162$1$I$$20240730$20240801$20240801$EXP$$US-UCBSA-2024038523$UCB$$$$$F$Y$$$20240801$$CN$US$US
241601631$24160163$1$I$20240101$20240723$20240801$20240801$PER$$US-SA-2024SA220955$SANOFI AVENTIS$$$$A$M$Y$$$20240801$$MD$US$US
241601641$24160164$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221789$SANOFI AVENTIS$$$$A$F$Y$49$KG$20240801$$MD$US$US
241601651$24160165$1$I$20240601$20240724$20240801$20240801$PER$$US-SA-2024SA221832$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240801$$MD$US$US
241601661$24160166$1$I$$20240717$20240801$20240801$PER$$US-AstraZeneca-2024A167117$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241601671$24160167$1$I$20240601$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024149360$AMGEN$$$$$F$Y$$$20240731$$CN$US$US
241601681$24160168$1$I$20240701$20240725$20240801$20240801$EXP$$US-JNJFOC-20240775082$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240801$$HP$US$US
241601691$24160169$1$I$$20240722$20240801$20240801$30DAY$$US-GSK-US2024091846$GLAXOSMITHKLINE$$$$$M$Y$$$20240801$$CN$US$US
241601701$24160170$1$I$20240601$20240722$20240801$20240801$30DAY$$US-GSK-US2024091669$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240801$$CN$US$US
241601711$24160171$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019708$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240801$$CN$US$US
241601725$24160172$5$F$20240210$20240911$20240801$20240913$EXP$$JP-GSK-JP2024JPN081680$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$JP$JP
241601741$24160174$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156748$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241601752$24160175$2$F$20240724$20240904$20240801$20240906$PER$$US-AMGEN-USASP2024150113$AMGEN$$73$YR$E$F$Y$$$20240906$$CN$US$US
241601761$24160176$1$I$$20240729$20240801$20240801$PER$$US-LEO Pharma-372396$LEO PHARM$$44$YR$$M$Y$$$20240801$$PH$US$US
241601771$24160177$1$I$20230101$20240729$20240801$20240801$EXP$$CN-JNJFOC-20240800500$JOHNSON AND JOHNSON$Ke YJ; Zhu SH; Zhang HY; Liang XT; Chen JS.; Huang HL; Chen ZR. A rare tamponade after percutaneous ablation operation. JTCVS Techniques. 2024;26:76-78$54$YR$A$F$Y$65$KG$20240801$$HP$CN$CN
241601781$24160178$1$I$20240719$20240721$20240801$20240801$EXP$CN-NMPACDR-3307811759242202400019$CN-BAXTER-2024BAX022125$BAXTER$$68$YR$$F$Y$51$KG$20240801$$MD$CN$CN
241601791$24160179$1$I$$20240721$20240801$20240801$EXP$$IT-SKF-000136$ESKAYEF PHARMACEUTICALS$$15$YR$T$F$Y$48$KG$20240724$$MD$IT$IT
241601801$24160180$1$I$$20240724$20240801$20240801$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01435$NOVITIUM PHARMA$Heng Liu.Chidamide in combination with azacitidine for an elderly patient with peripheral T cell lymphoma-not otherwise specified: A case report.Oncology Letters.28-MAY-2024;28:1-6$71$YR$E$M$Y$$$20240801$$HP$CN$CN
241601811$24160181$1$I$20240719$20240722$20240801$20240801$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02727$AMNEAL$$55$YR$$F$Y$44.898$KG$20240801$$MD$US$US
241601821$24160182$1$I$$20240717$20240801$20240801$EXP$$CH-MDD US Operations-MDD202407-002636$MDD OPERATIONS$$54$YR$$M$Y$$$20240801$$HP$CH$
241601831$24160183$1$I$$20240726$20240801$20240801$EXP$$US-HALEON-2189271$Haleon PLC$$$$$$Y$$$20240731$$CN$US$US
241601841$24160184$1$I$$20240724$20240801$20240801$EXP$$CA-APOTEX-2024AP008792$APOTEX$$33$YR$$F$Y$$$20240801$$HP$CA$CA
241601852$24160185$2$F$$20240730$20240801$20240808$PER$$US-SA-2024SA222579$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240808$$CN$US$US
241601861$24160186$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA223626$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240801$$MD$US$US
241601871$24160187$1$I$$20240726$20240801$20240801$PER$$US-SA-2024SA223289$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240801$$MD$US$US
241601881$24160188$1$I$20240501$20240725$20240801$20240801$PER$$US-SA-2024SA223553$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240801$$MD$US$US
241601891$24160189$1$I$$20240729$20240801$20240801$PER$$NVSC2024US156377$NOVARTIS$$74$YR$$M$Y$$$20240801$$HP$US$US
241601901$24160190$1$I$20240728$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150874$AMGEN$$$$$M$Y$$$20240731$$CN$US$US
241601912$24160191$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3226030$TEVA$Vincent J, Greenberg J, Sanghani S, Finneran K, Nguyen N. Profound Lactic Acidosis and Shock in a Patient Taking Metformin. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Vincent J, Greenberg J, Sanghani S, Finneran K, Nguyen N. Profound Lactic Acidosis and Shock in a Patient Taking Metformin. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$52$YR$$F$Y$$$20240816$$HP$US$US
241601921$24160192$1$I$20240707$20240726$20240801$20240801$EXP$$CN-JNJFOC-20240782853$JOHNSON AND JOHNSON$$8$YR$C$M$Y$22.1$KG$20240801$$HP$CN$CN
241601931$24160193$1$I$20240710$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151802$AMGEN$$$$$$Y$$$20240731$$PH$US$US
241601951$24160195$1$I$20240701$20240730$20240801$20240801$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011542$JAZZ$$25$YR$$F$Y$$$20240731$$CN$US$US
241601962$24160196$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3226005$TEVA$Frankel ES, Hajduczok AG, Rajapreyar IN, Brailovsky Y. Recurrent giant cell myocarditis after heart transplant: a case report. Eur-Heart-J-Case-Rep 2022; 6 (9): no pagination.; Frankel ES, Hajduczok AG, Rajapreyar IN, Brailovsky Y. Recurrent giant cell myocarditis after heart transplant: a case report. Eur-Heart-J-Case-Rep 2022; 6 (9): no pagination.; Frankel ES, Hajduczok AG, Rajapreyar IN, Brailovsky Y. Recurrent giant cell myocarditis after heart transplant: a case report. Eur-Heart-J-Case...$33$YR$$M$Y$$$20240816$$HP$US$US
241601971$24160197$1$I$$20240723$20240801$20240801$PER$$US-AstraZeneca-2024A167867$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241601981$24160198$1$I$$20240724$20240801$20240801$EXP$$PT-AMGEN-PRTSP2024148690$AMGEN$$$$$F$Y$$$20240731$$MD$PT$PT
241601991$24160199$1$I$20240701$20240724$20240801$20240801$PER$$US-AMGEN-USASP2024147868$AMGEN$$65$YR$E$F$Y$$$20240731$$HP$US$US
241602002$24160200$2$F$$20240731$20240801$20240802$PER$$NVSC2024US156250$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
241602011$24160201$1$I$$20240730$20240801$20240801$PER$$US-ROCHE-10000044401$ROCHE$$33$YR$A$F$Y$$$20240801$$HP$US$US
241602031$24160203$1$I$20240702$20240722$20240801$20240801$EXP$FR-AFSSAPS-LL2024001290$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110220$ZYDUS PHARM$$$$$$Y$$$20240801$$PH$FR$FR
241602041$24160204$1$I$20240101$20240722$20240801$20240801$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110173$ZYDUS PHARM$$$$$$Y$$$20240801$$CN$US$US
241602052$24160205$2$F$20240701$20240725$20240801$20240801$EXP$$US-AMGEN-USASP2024149541$AMGEN$$$$A$M$Y$$$20240801$$PH$US$US
241602065$24160206$5$F$20240101$20240821$20240801$20240905$PER$$US-SA-2024SA222819$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240905$$HP$US$US
241602071$24160207$1$I$$20240725$20240801$20240801$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001527$BLUEPRINT MEDICINES$$$$$F$Y$$$20240801$$CN$US$US
241602081$24160208$1$I$$20240722$20240801$20240801$30DAY$$US-GSK-US2024091872$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
241602091$24160209$1$I$$20240724$20240801$20240801$EXP$$BR-JNJFOC-20240770072$JOHNSON AND JOHNSON$$16$YR$T$M$Y$80$KG$20240801$$CN$BR$BR
241602102$24160210$2$F$$20240905$20240801$20240910$EXP$$JP-GSK-JP2023148758$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$JP$JP
241602111$24160211$1$I$20211001$20240722$20240801$20240801$EXP$$US-ROCHE-10000033398$ROCHE$$49$YR$A$F$Y$64.41$KG$20240801$$CN$US$US
241602121$24160212$1$I$20240710$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151745$AMGEN$$$$$$Y$$$20240731$$PH$US$US
241602131$24160213$1$I$$20240725$20240801$20240801$EXP$$NVSC2024US153988$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
241602141$24160214$1$I$$20240730$20240801$20240801$EXP$$NVSC2024US156408$NOVARTIS$$$$$M$Y$$$20240801$$MD$US$US
241602151$24160215$1$I$20240101$20240723$20240801$20240801$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000654$DECIPHERA PHARMACEUTICALS$$64$YR$A$F$Y$$$20240801$$CN$US$US
241602161$24160216$1$I$$20240725$20240801$20240801$EXP$$JP-AMGEN-JPNSP2024151958$AMGEN$$$$$F$Y$$$20240731$$PH$JP$JP
241602171$24160217$1$I$20230205$20230224$20240801$20240801$EXP$$TH-AstraZeneca-2023A045481$ASTRAZENECA$$32452$DY$$M$Y$$$20240801$$CN$TH$
241602181$24160218$1$I$20240724$20240726$20240801$20240801$PER$$US-AMGEN-USASP2024149968$AMGEN$$55$YR$A$F$Y$$$20240731$$CN$US$US
241602191$24160219$1$I$$20211129$20240801$20240801$EXP$$GB-AstraZeneca-2021A851974$ASTRAZENECA$$$$$$Y$$$20240801$$MD$GB$
241602202$24160220$2$F$$20240802$20240801$20240806$EXP$$US-ROCHE-10000038061$ROCHE$Wang Y, Kaj-Carbaidwala B, Lane A, Agarwal S, Beier F, Bertuch A, et al. Liver disease and transplantation in telomere biology disorders: An international multicenter cohort. Hepatology Communications. 2024-Jun;8 (7):1-12. doi:10.1097/HC9.0000000000000462.$39$YR$A$$Y$$$20240806$$HP$US$US
241602211$24160221$1$I$$20240730$20240801$20240801$EXP$$US-HALEON-2189774$Haleon PLC$$$$$M$Y$$$20240731$$CN$US$US
241602221$24160222$1$I$$20240727$20240801$20240801$EXP$$US-BEIGENE-BGN-2024-011814$BEIGENE$$$$$$Y$$$20240801$$CN$US$US
241602231$24160223$1$I$$20240725$20240801$20240801$PER$$US-ALXN-202407USA001829US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
241602242$24160224$2$F$$20240802$20240801$20240802$PER$$US-HALEON-2189727$Haleon PLC$$37$YR$$F$Y$$$20240802$$CN$US$US
241602251$24160225$1$I$$20240726$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011642$BEIGENE$$$$$$Y$$$20240801$$MD$CN$CN
241602261$24160226$1$I$20231228$20240730$20240801$20240801$EXP$FR-AFSSAPS-NY2024000792$FR-HALEON-2189721$Haleon PLC$$41$YR$$F$Y$80$KG$20240801$$MD$FR$FR
241602271$24160227$1$I$20240401$20240731$20240801$20240801$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042966$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240801$$HP$SG$SG
241602281$24160228$1$I$20240627$20240731$20240801$20240801$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042959$BOEHRINGER INGELHEIM$$84$YR$E$M$Y$$$20240801$$HP$SG$SG
241602292$24160229$2$F$$20240813$20240801$20240814$PER$$NVSC2024US156790$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
241602312$24160231$2$F$$20240807$20240801$20240814$EXP$$GB-CELLTRION INC.-2024GB018168$CELLTRION$$$$$$Y$$$20240814$$CN$GB$GB
241602321$24160232$1$I$20240101$20240724$20240801$20240801$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000659$DECIPHERA PHARMACEUTICALS$$69$YR$E$M$Y$$$20240801$$CN$US$US
241602333$24160233$3$F$20240601$20240823$20240801$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-001696$JAZZ$$38$YR$$F$Y$$$20240828$$CN$US$US
241602341$24160234$1$I$20240727$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151251$AMGEN$$61$YR$A$F$Y$$$20240731$$CN$US$US
241602351$24160235$1$I$20240729$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020032$ELI LILLY AND CO$$$$$$Y$$$20240801$$CN$US$US
241602361$24160236$1$I$20240719$20240726$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407017996$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240801$$MD$US$US
241602371$24160237$1$I$20240727$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407018475$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240801$$CN$US$US
241602381$24160238$1$I$20240723$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019773$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240801$$CN$US$US
241602391$24160239$1$I$$20240722$20240801$20240801$PER$$US-ROCHE-3562751$ROCHE$$$$$F$Y$$$20240801$$CN$US$US
241602401$24160240$1$I$20240501$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019078$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240801$$CN$US$US
241602411$24160241$1$I$$20240726$20240801$20240801$EXP$$CA-BEIGENE-BGN-2024-011640$BEIGENE$$$$$$Y$$$20240801$$HP$CA$CA
241602421$24160242$1$I$$20240725$20240801$20240801$PER$$US-JNJFOC-20240772264$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
241602442$24160244$2$F$20240220$20240814$20240801$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-003314$JAZZ$$68$YR$$F$Y$$$20240820$$MD$US$US
241602451$24160245$1$I$20240601$20240703$20240801$20240801$PER$$AP-2024-US-6001$AILEX PHARMACEUTICALS$$67$YR$$F$Y$$$20240801$$CN$US$US
241602461$24160246$1$I$$20240730$20240801$20240801$PER$$US-HALEON-2189738$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241602472$24160247$2$F$$20240911$20240801$20240921$30DAY$$US-GSK-US2024091877$GLAXOSMITHKLINE$$$$$M$Y$$$20240921$$CN$US$US
241602482$24160248$2$F$20190101$20240807$20240801$20240813$EXP$$JP-EMD Serono-2024040585$EMD SERONO INC$$85$YR$E$M$Y$$$20240813$$MD$JP$JP
241602491$24160249$1$I$20240707$20240710$20240801$20240801$PER$$AP-2024-US-6009$AILEX PHARMACEUTICALS$$46$YR$$F$Y$$$20240801$$CN$US$US
241602501$24160250$1$I$$20210702$20240801$20240801$EXP$$US-AstraZeneca-2021A600848$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241602512$24160251$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225537$TEVA$Baez Gonzalez J, Clark MD, Bruera E. Fluoroquinolone-Induced Seizure in a Patient Receiving End-of-Life Care: A Case Report. J-Palliat-Med 2023; 26 (11): 1590-1592.; Baez Gonzalez J, Clark MD, Bruera E. Fluoroquinolone-Induced Seizure in a Patient Receiving End-of-Life Care: A Case Report. J-Palliat-Med 2023; 26 (11): 1590-1592.$$$A$F$Y$$$20240816$$MD$US$US
241602521$24160252$1$I$20240101$20240729$20240801$20240801$PER$$US-LEO Pharma-372415$LEO PHARM$$22$YR$$F$Y$$$20240801$$PH$US$US
241602534$24160253$4$F$$20240827$20240801$20240905$EXP$$JP-ABBVIE-5859228$ABBVIE$Ito H, Noda K, Saruta M, Kurosaka D. Case report: Peristomal pyoderma gangrenosum complicated by rheumatoid arthritis and Behcet^s disease successfully treated with baricitinib. Int J of Rheum Dis. 2024;27(7):e15275.$63$YR$$F$Y$$$20240905$$HP$JP$JP
241602541$24160254$1$I$20240601$20240730$20240801$20240801$EXP$$US-UCBSA-2024038526$UCB$$57$YR$$F$Y$$$20240801$$CN$US$US
241602552$24160255$2$F$$20240731$20240801$20240813$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092559$GLENMARK$Sahyouni MJ, Acevedo LA, Rodriguez SC, Chiles JA, Pennings NJ.. Neuropathy of diabetes following initiation of a low-carbohydrate diet:. Case report. Obesity pillars. 2024;11:100115$$$$$Y$$$20240813$$MD$US$US
241602562$24160256$2$F$$20240822$20240801$20240823$PER$$NVSC2024US156802$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
241602571$24160257$1$I$$20240724$20240801$20240801$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000656$DECIPHERA PHARMACEUTICALS$$67$YR$A$M$Y$$$20240801$$CN$US$US
241602581$24160258$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151879$AMGEN$$64$YR$A$M$Y$$$20240731$$CN$US$US
241602591$24160259$1$I$20240702$20240708$20240801$20240801$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003294$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240801$$CN$US$US
241602601$24160260$1$I$$20240726$20240801$20240801$EXP$$US-JNJFOC-20240773746$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$US$US
241602611$24160261$1$I$20240501$20240725$20240801$20240801$EXP$$CL-JNJFOC-20240773598$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$HP$CL$CL
241602621$24160262$1$I$$20240724$20240801$20240801$PER$$US-ROCHE-10000039005$ROCHE$$50$YR$A$F$Y$$$20240801$$CN$US$US
241602632$24160263$2$F$$20240819$20240801$20240827$PER$$US-BIOGEN-2024BI01274988$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
241602641$24160264$1$I$20240624$20240721$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-036635$AUROBINDO$$64$YR$$M$Y$74$KG$20240801$$CN$GB$GB
241602651$24160265$1$I$$20240724$20240801$20240801$PER$$US-ABBVIE-5855733$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241602663$24160266$3$F$20240701$20240805$20240801$20240822$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000622$DECIPHERA PHARMACEUTICALS$$88$YR$E$F$Y$$$20240822$$CN$US$US
241602671$24160267$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156800$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241602691$24160269$1$I$20240727$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150432$AMGEN$$77$YR$E$F$Y$$$20240731$$CN$US$US
241602712$24160271$2$F$$20240814$20240801$20240819$PER$$US-AMGEN-USASP2024151714$AMGEN$$$$$F$Y$$$20240819$$CN$US$US
241602721$24160272$1$I$$20240729$20240801$20240801$PER$$US-JNJFOC-20240785084$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$HP$US$US
241602731$24160273$1$I$20240731$20240731$20240801$20240801$EXP$GB-MHRA-MED-202407312012257010-SCYBD$GB-JNJFOC-20240785351$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$GB$GB
241602741$24160274$1$I$20240101$20240729$20240801$20240801$EXP$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000625$PAREXEL$$$$$$Y$$$20240801$$HP$US$US
241602751$24160275$1$I$20240101$20240723$20240801$20240801$PER$$US-UNITED THERAPEUTICS-UNT-2024-022903$UNITED THERAPEUTICS$$$$$F$Y$$$20240801$$$US$US
241602761$24160276$1$I$$20240724$20240801$20240801$PER$$US-ABBVIE-5855150$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241602771$24160277$1$I$$20240725$20240801$20240801$PER$$US-ABBVIE-5857094$ABBVIE$$66$YR$$F$Y$$$20240801$$MD$US$US
241602781$24160278$1$I$$20230515$20240801$20240801$EXP$$US-AstraZeneca-2023A113574$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241602792$24160279$2$F$$20240910$20240801$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06849$LUPIN$$$$$$Y$$$20240926$$CN$US$US
241602801$24160280$1$I$20190714$20240722$20240801$20240801$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117313$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$68.6$KG$20240801$$MD$KR$KR
241602811$24160281$1$I$20240601$20240724$20240801$20240801$PER$$US-ABBVIE-5855270$ABBVIE$$$$$$Y$$$20240801$$CN$US$US
241602821$24160282$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019636$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240801$$CN$US$US
241602831$24160283$1$I$$20240718$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407013022$ELI LILLY AND CO$$$$$F$Y$$$20240801$$CN$US$US
241602841$24160284$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019750$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240801$$HP$US$US
241602851$24160285$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019888$ELI LILLY AND CO$$$$$$Y$$$20240801$$CN$US$US
241602861$24160286$1$I$20240501$20240731$20240801$20240801$EXP$SE-SEMPA-2024-005701$SE-JNJFOC-20240800801$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240801$$MD$SE$SE
241602871$24160287$1$I$$20240709$20240801$20240801$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003407$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
241602881$24160288$1$I$$20240725$20240801$20240801$PER$$US-ROCHE-10000040436$ROCHE$$39$YR$A$F$Y$$$20240801$$MD$US$US
241602891$24160289$1$I$$20240726$20240801$20240801$PER$$US-ROCHE-10000041860$ROCHE$$$$$$Y$$$20240801$$CN$US$US
241602901$24160290$1$I$20240101$20240724$20240801$20240801$PER$$US-UNITED THERAPEUTICS-UNT-2024-022994$UNITED THERAPEUTICS$$$$$F$Y$63.946$KG$20240801$$$US$US
241602911$24160291$1$I$$20240717$20240801$20240801$PER$$US-ROCHE-10000042209$ROCHE$$60$YR$A$M$Y$$$20240801$$CN$US$US
241602921$24160292$1$I$$20240723$20240801$20240801$PER$$US-ROCHE-10000035501$ROCHE$$54$YR$A$M$Y$$$20240801$$CN$US$US
241602932$24160293$2$F$20240101$20240820$20240801$20240909$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000626$DECIPHERA PHARMACEUTICALS$$57$YR$A$M$Y$71.7$KG$20240909$$CN$US$US
241602941$24160294$1$I$$20240724$20240801$20240801$EXP$$NL-TOLMAR, INC.-24NL051272$TOLMAR$$$$$M$Y$$$20240801$$CN$NL$NL
241602951$24160295$1$I$$20240727$20240801$20240801$PER$$US-ROCHE-10000040449$ROCHE$$37$YR$A$F$Y$$$20240801$$CN$US$US
241602963$24160296$3$F$20240502$20240821$20240801$20240831$EXP$$JP-ROCHE-10000037611$ROCHE$$65$YR$E$F$Y$62.7$KG$20240831$$MD$JP$JP
241602971$24160297$1$I$20240521$20240723$20240801$20240801$EXP$$FR-AUROBINDO-AUR-APL-2024-037432$AUROBINDO$$17$YR$$F$Y$49$KG$20240801$$MD$FR$FR
241602981$24160298$1$I$$20240731$20240801$20240801$PER$$US-ROCHE-10000044529$ROCHE$$$$$M$Y$$$20240801$$CN$US$US
241602991$24160299$1$I$$20240723$20240801$20240801$EXP$$NL-AUROBINDO-AUR-APL-2024-037214$AUROBINDO$$58$YR$$F$Y$80$KG$20240801$$CN$NL$NL
241603002$24160300$2$F$$20240827$20240801$20240830$PER$$US-BIOGEN-2024BI01275784$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
241603011$24160301$1$I$$20240730$20240801$20240801$PER$$US-BIOGEN-2024BI01272071$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
241603021$24160302$1$I$$20240723$20240801$20240801$EXP$$US-ENDO USA, INC.-2024-003044$ENDO$$$$$M$Y$$$20240801$$CN$US$US
241603031$24160303$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156821$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241603042$24160304$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3224829$TEVA$Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.; Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.; Uluc K, Ambad...$39$YR$$M$Y$$$20240816$$HP$US$US
241603052$24160305$2$F$$20240919$20240801$20240930$PER$$US-ALXN-202407USA001841US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
241603061$24160306$1$I$$20240724$20240801$20240801$PER$$US-ALXN-A202301210$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
241603071$24160307$1$I$$20240723$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-032498$AUROBINDO$$$$$F$Y$$$20240801$$CN$GB$GB
241603081$24160308$1$I$$20240724$20240801$20240801$EXP$$CA-CELLTRION INC.-2024CA018196$CELLTRION$$$$$$Y$$$20240801$$MD$CA$CA
241603091$24160309$1$I$20240723$20240725$20240801$20240801$EXP$$NVSJ2024JP009124$NOVARTIS$$$$$F$Y$$$20240801$$HP$JP$JP
241603102$24160310$2$F$20240507$20240828$20240801$20240902$EXP$ES-AEMPS-1550562$ES-BEH-2024176025$CSL BEHRING$$61$YR$A$M$Y$$$20240902$$HP$ES$ES
241603112$24160311$2$F$$20240910$20240801$20240918$EXP$$CA-BIOGEN-2024BI01275869$BIOGEN$$$$$M$Y$$$20240918$$CN$CA$CA
241603124$24160312$4$F$20240726$20240822$20240801$20240828$EXP$$CA-ROCHE-10000045839$ROCHE$$48$YR$A$F$Y$$$20240828$$CN$CA$CA
241603141$24160314$1$I$$20240726$20240801$20240801$EXP$$US-BIOGEN-2024BI01275878$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
241603152$24160315$2$F$$20240808$20240801$20240813$EXP$$JP-JNJFOC-20240800054$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$PH$JP$JP
241603162$24160316$2$F$$20240911$20240801$20240919$30DAY$$US-GSK-US2024094304$GLAXOSMITHKLINE$$$$$F$Y$46.712$KG$20240919$$MD$US$US
241603171$24160317$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3224831$TEVA$Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.; Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.$58$YR$$M$Y$$$20240801$$HP$US$US
241603181$24160318$1$I$20240101$20240726$20240801$20240801$PER$$US-HETERO-HET2024US02501$HETERO$$85$YR$$F$Y$50.8$KG$20240801$$CN$US$US
241603191$24160319$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3225477$TEVA$Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.; Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.$43$YR$$M$Y$$$20240801$$HP$US$US
241603201$24160320$1$I$20240412$20240722$20240801$20240801$EXP$$IT-AUROBINDO-AUR-APL-2024-037023$AUROBINDO$$56$YR$$M$Y$$$20240801$$MD$IT$IT
241603211$24160321$1$I$20240513$20240726$20240801$20240801$EXP$PT-INFARMED-F202407-298$PT-BIOGEN-2024BI01275791$BIOGEN$$29$YR$$F$Y$67$KG$20240801$$PH$PT$PT
241603221$24160322$1$I$$20240730$20240801$20240801$PER$$US-ROCHE-10000042828$ROCHE$$$$A$M$Y$$$20240801$$HP$US$US
241603232$24160323$2$F$$20240809$20240801$20240818$EXP$$JP-AMGEN-JPNSP2024150278$AMGEN$Masuda T, Kanazashi S, Satou H, Katou A, Yoshida K, Horiguchi N, et al.. O-179 A case of gastrointestinal symptoms due to hypercalcemia thought to be caused by Graves^ disease and osteoporosis treatment drugs, Journal of the Japanese General Medical Association, 28th Annual Meeting of the Japanese General Medical Association. See Journal Title following Article Title. 2024;20:216$67$YR$E$F$Y$$$20240818$$MD$JP$JP
241603241$24160324$1$I$$20240726$20240801$20240801$EXP$$US-BIOGEN-2024BI01275951$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
241603251$24160325$1$I$20240628$20240722$20240801$20240801$EXP$$ES-AUROBINDO-AUR-APL-2024-037061$AUROBINDO$$67$YR$$M$Y$65.5$KG$20240801$$HP$ES$ES
241603262$24160326$2$F$$20240902$20240801$20240911$EXP$$US-APOTEX-2024AP008900$APOTEX$Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwari A.. OVERWHELMING CYTOCHROME P450 ISOENZYME ACTIVITY GENERATING DRUGINDUCED LIVER INJURY RESULTING IN FULMINANT LIVER FAILURE. Hepatology. 2023;78:S643-S644.$40$YR$$F$Y$$$20240911$$HP$US$US
241603272$24160327$2$F$20240721$20240910$20240801$20240912$EXP$$CA-ROCHE-10000023712$ROCHE$$45$YR$A$F$Y$$$20240912$$CN$CA$CA
241603281$24160328$1$I$$20240726$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407018102$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240801$$CN$US$US
241603291$24160329$1$I$$20240719$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407014783$ELI LILLY AND CO$$$$$F$Y$$$20240801$$HP$US$US
241603301$24160330$1$I$$20240725$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019819$ELI LILLY AND CO$$$$A$F$Y$$$20240801$$CN$US$US
241603311$24160331$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407018598$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240801$$CN$US$US
241603321$24160332$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019552$ELI LILLY AND CO$$33$YR$A$$Y$$$20240801$$CN$US$US
241603331$24160333$1$I$20240723$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020308$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240801$$CN$US$US
241603341$24160334$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020189$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240801$$CN$US$US
241603352$24160335$2$F$20240906$20240914$20240801$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202407019543$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240920$$CN$US$US
241603361$24160336$1$I$$20240726$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407017875$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240801$$CN$US$US
241603371$24160337$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019513$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240801$$CN$US$US
241603381$24160338$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000051$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240801$$CN$US$US
241603391$24160339$1$I$$20240726$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019296$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240801$$CN$US$US
241603401$24160340$1$I$20231201$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019938$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240801$$CN$US$US
241603411$24160341$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019740$ELI LILLY AND CO$$$$$F$Y$$$20240801$$CN$US$US
241603421$24160342$1$I$20240722$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151052$AMGEN$$67$YR$E$F$Y$$$20240801$$CN$US$US
241603431$24160343$1$I$20240726$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150260$AMGEN$$46$YR$A$M$Y$$$20240801$$CN$US$US
241603441$24160344$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3225478$TEVA$Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.; Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.$$$$$Y$$$20240801$$HP$US$US
241603451$24160345$1$I$$20240726$20240801$20240801$PER$$US-JNJFOC-20240777057$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$LW$US$US
241603461$24160346$1$I$$20221209$20240801$20240801$EXP$$US-AstraZeneca-2022A404126$ASTRAZENECA$$$$$$Y$$$20240801$$CN$US$
241603471$24160347$1$I$$20221101$20240801$20240801$EXP$$US-AstraZeneca-2022A363456$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241603481$24160348$1$I$$20230413$20240801$20240801$EXP$$US-AstraZeneca-2023A087103$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241603492$24160349$2$F$$20240828$20240801$20240906$30DAY$$US-GSK-US2024AMR092736$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$HP$US$US
241603501$24160350$1$I$20220929$20221005$20240801$20240801$EXP$$US-AstraZeneca-2022A341377$ASTRAZENECA$$22465$DY$$M$Y$79.4$KG$20240801$$CN$US$
241603511$24160351$1$I$20210923$20210924$20240801$20240801$EXP$$US-AstraZeneca-2021A748753$ASTRAZENECA$$25622$DY$$F$Y$$$20240801$$CN$US$
241603521$24160352$1$I$20240711$20240729$20240801$20240801$EXP$$CN-ROCHE-10000041262$ROCHE$$73$YR$E$M$Y$$$20240801$$HP$CN$CN
241603532$24160353$2$F$20240701$20240805$20240801$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-019500$UNITED THERAPEUTICS$$72$YR$$F$Y$53.968$KG$20240809$$$US$US
241603542$24160354$2$F$20240711$20240826$20240801$20240828$PER$$US-AMGEN-USASP2024151763$AMGEN$$65$YR$E$M$Y$$$20240828$$CN$US$US
241603551$24160355$1$I$20240726$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024152006$AMGEN$$45$YR$A$M$Y$$$20240801$$PH$US$US
241603561$24160356$1$I$$20240729$20240801$20240801$EXP$$CA-AMGEN-CANSP2024151035$AMGEN$$$$$F$Y$54$KG$20240801$$MD$CA$CA
241603571$24160357$1$I$$20240723$20240801$20240801$EXP$GB-MHRA-MED-202407232209444480-NGZPL$GB-JNJFOC-20240763101$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240801$$MD$GB$GB
241603582$24160358$2$F$20240101$20240913$20240801$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-022459$UNITED THERAPEUTICS$$$$$F$Y$86.621$KG$20240919$$$US$US
241603593$24160359$3$F$20240716$20240801$20240801$20240813$EXP$$IT-AUROBINDO-AUR-APL-2024-037234$AUROBINDO$$77$YR$$M$Y$$$20240813$$MD$IT$IT
241603601$24160360$1$I$20240618$20240725$20240801$20240801$EXP$$JP-ROCHE-10000040694$ROCHE$$72$YR$E$F$Y$$$20240801$$MD$JP$JP
241603611$24160361$1$I$20240719$20240723$20240801$20240801$EXP$SE-SEMPA-2024-005672$SE-JUBILANT PHARMA LTD-2024SE001070$JUBILANT - No Location Specified$$76$YR$$F$Y$80$KG$20240801$$MD$SE$SE
241603621$24160362$1$I$$20240725$20240801$20240801$EXP$$JP-ROCHE-10000041841$ROCHE$$$$E$$Y$$$20240801$$MD$JP$JP
241603631$24160363$1$I$$20240727$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US068987$SANDOZ$$$$$$Y$$$20240801$$CN$US$US
241603641$24160364$1$I$20240725$20240725$20240801$20240801$EXP$$US-VIIV HEALTHCARE LIMITED-US2024093724$VIIV$$29$YR$$F$Y$$$20240801$$CN$US$US
241603651$24160365$1$I$$20240729$20240801$20240801$EXP$$PH-AstraZeneca-2024A172238$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$PH$
241603661$24160366$1$I$$20240728$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069424$SANDOZ$$$$$$Y$$$20240801$$CN$US$US
241603671$24160367$1$I$$20240723$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-037320$AUROBINDO$$$$$F$Y$$$20240801$$CN$GB$GB
241603681$24160368$1$I$20240725$20240725$20240801$20240801$EXP$$US-ALXN-202407USA001774US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
241603691$24160369$1$I$$20240731$20240801$20240801$PER$$US-ROCHE-10000044977$ROCHE$$72$YR$E$F$Y$$$20240801$$MD$US$US
241603701$24160370$1$I$$20211216$20240801$20240801$EXP$$US-AstraZeneca-2021A882648$ASTRAZENECA$$$$$F$Y$86.2$KG$20240801$$CN$US$
241603733$24160373$3$F$$20240903$20240801$20240912$EXP$$JP-ROCHE-10000009423$ROCHE$$5$DEC$A$F$Y$$$20240912$$MD$JP$JP
241603742$24160374$2$F$20240729$20240814$20240801$20240816$PER$$US-AMGEN-USASP2024150936$AMGEN$$67$YR$E$F$Y$$$20240816$$CN$US$US
241603751$24160375$1$I$20240710$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151797$AMGEN$$$$$$Y$$$20240801$$PH$US$US
241603763$24160376$3$F$20240101$20240909$20240801$20240920$EXP$$AR-AMGEN-ARGSP2024151488$AMGEN$$46$YR$A$F$Y$$$20240919$$CN$AR$AR
241603771$24160377$1$I$20240710$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024152023$AMGEN$$$$$$Y$$$20240801$$PH$US$US
241603781$24160378$1$I$$20240730$20240801$20240801$EXP$$US-JNJFOC-20240783666$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$US$US
241603791$24160379$1$I$$20240730$20240801$20240801$PER$$US-JNJFOC-20240782522$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$MD$US$US
241603801$24160380$1$I$20240709$20240723$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-037036$AUROBINDO$$$$$M$Y$$$20240801$$PH$GB$GB
241603811$24160381$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5859854$ABBVIE$$$$$F$Y$$$20240801$$MD$US$US
241603831$24160383$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3225482$TEVA$Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.; Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors. Neurooncol-Adv 2022; 4 (1):.$$$$$Y$$$20240801$$HP$US$US
241603851$24160385$1$I$20240306$20240730$20240801$20240801$EXP$$NVSC2024IN156601$NOVARTIS$$84$YR$$F$Y$$$20240801$$CN$IN$IN
241603861$24160386$1$I$20240624$20240726$20240801$20240801$EXP$$CN-JNJFOC-20240774808$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240801$$HP$CN$CN
241603871$24160387$1$I$20240730$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151634$AMGEN$$65$YR$E$M$Y$$$20240801$$CN$US$US
241603881$24160388$1$I$$20240730$20240801$20240801$PER$$US-AstraZeneca-2024A174095$ASTRAZENECA$$$$$F$Y$$$20240801$$MD$US$
241603891$24160389$1$I$$20230309$20240801$20240801$EXP$$US-AstraZeneca-2023A061314$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241603901$24160390$1$I$$20240723$20240801$20240801$EXP$$CZ-AUROBINDO-AUR-APL-2024-037416$AUROBINDO$$39$YR$$F$Y$71$KG$20240801$$CN$CZ$CZ
241603911$24160391$1$I$20240627$20240719$20240801$20240801$EXP$$EG-ROCHE-10000033741$ROCHE$$62$YR$A$F$Y$$$20240801$$HP$EG$EG
241603921$24160392$1$I$20240101$20240725$20240801$20240801$PER$$US-AMGEN-USASP2024149180$AMGEN$$77$YR$E$M$Y$$$20240801$$CN$US$US
241603932$24160393$2$F$$20240807$20240801$20240820$30DAY$$BR-JNJFOC-20240776166$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$BR$BR
241603941$24160394$1$I$$20240729$20240801$20240801$EXP$$JP-JNJFOC-20240800057$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$PH$JP$JP
241603951$24160395$1$I$$20240723$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-035466$AUROBINDO$$32$YR$$F$Y$$$20240801$$HP$GB$GB
241603961$24160396$1$I$$20240729$20240801$20240801$EXP$$CA-AMGEN-CANSP2024151093$AMGEN$$73$YR$E$F$Y$$$20240801$$MD$CA$CA
241603971$24160397$1$I$$20240726$20240801$20240801$EXP$$AU-AMGEN-AUSSP2024149602$AMGEN$Ta B.; Bennett M. J.. Refractory Hypercalcemia Secondary to Metastatic Parathyroid Carcinoma Treated With Immunotherapy. JCEM case reports. 2024;2 (7):1-7$64$YR$A$F$Y$$$20240801$$MD$AU$AU
241603982$24160398$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225495$TEVA$Jackson DL, Coke L, Zhang SX, Steenbergen C, Khan G, Gorfu G, et al. Myocarditis and brain abscess caused by disseminated Scedosporium boydii infection. J-Natl-Med-Assoc 2024; 116 (3): 238-246.; Jackson DL, Coke L, Zhang SX, Steenbergen C, Khan G, Gorfu G, et al. Myocarditis and brain abscess caused by disseminated Scedosporium boydii infection. J-Natl-Med-Assoc 2024; 116 (3): 238-246.$52$YR$$M$Y$$$20240816$$HP$US$US
241603991$24160399$1$I$$20240726$20240801$20240801$EXP$$CA-APOTEX-2024AP008907$APOTEX$$73$YR$$F$Y$47$KG$20240801$$HP$CA$CA
241604001$24160400$1$I$20240717$20240724$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-037498$AUROBINDO$$55$YR$$M$Y$91$KG$20240801$$PH$GB$GB
241604011$24160401$1$I$$20240718$20240801$20240801$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000636$DECIPHERA PHARMACEUTICALS$$75$YR$E$F$Y$$$20240801$$CN$US$US
241604022$24160402$2$F$$20240827$20240801$20240906$EXP$$JP-SPECGX-T202401592$SPECGX$$8$DEC$$M$Y$$$20240906$$MD$JP$JP
241604031$24160403$1$I$20240516$20240724$20240801$20240801$EXP$$CA-CELLTRION INC.-2024CA018178$CELLTRION$$$$$$Y$$$20240801$$CN$CA$CA
241604041$24160404$1$I$20240722$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150685$AMGEN$$61$YR$A$F$Y$$$20240801$$HP$US$US
241604051$24160405$1$I$20240101$20240719$20240801$20240801$EXP$$JP-AMGEN-JPNSP2024133158$AMGEN$$8$DEC$E$M$Y$$$20240801$$MD$JP$JP
241604061$24160406$1$I$$20240725$20240801$20240801$EXP$$US-AMGEN-USASP2024148677$AMGEN$Yeh J.E..; Maloney N.; Novoa. R. Chronic ulcer in a patient with essential thrombocythemia taking hydroxyurea. Dermatology OnlineJournal. 2024;30 (3):1-3$82$YR$E$F$Y$$$20240801$$MD$US$US
241604071$24160407$1$I$20240727$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150899$AMGEN$$76$YR$E$F$Y$$$20240801$$CN$US$US
241604081$24160408$1$I$$20240724$20240801$20240801$EXP$$US-APOTEX-2024AP008897$APOTEX$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D.. Rhabdomyolysis Risk: The Dangers of Tribulus terrestris, an Over-the-Counter Supplement. American Journal of Case Reports. 2024;25:e943492(1-3)$71$YR$$M$Y$$$20240801$$HP$US$US
241604092$24160409$2$F$20200923$20240807$20240801$20240815$EXP$$CA-CELLTRION INC.-2020CA028251$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
241604112$24160411$2$F$20240710$20240801$20240801$20240808$EXP$$ZA-EMD Serono-2024040934$EMD SERONO INC$$26$YR$A$F$Y$$$20240808$$CN$ZA$ZA
241604121$24160412$1$I$$20240726$20240801$20240801$EXP$$US-BEIGENE-BGN-2024-009926$BEIGENE$$$$$$Y$$$20240801$$CN$US$US
241604131$24160413$1$I$$20240725$20240801$20240801$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001528$BLUEPRINT MEDICINES$$$$$F$Y$$$20240801$$CN$US$US
241604142$24160414$2$F$20240416$20240731$20240801$20240802$PER$$US-ABBVIE-5861056$ABBVIE$$19$YR$$F$Y$$$20240802$$HP$US$US
241604151$24160415$1$I$$20211015$20240801$20240801$EXP$$US-AstraZeneca-2021A777706$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241604162$24160416$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3224999$TEVA$Rodriguez H, Tan J, Reddy S. A Missed Mass: An Exceedingly Rare Round Cell Sarcoma Leading to Respiratory Failure in a 19-year-old. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.; Rodriguez H, Tan J, Reddy S. A Missed Mass: An Exceedingly Rare Round Cell Sarcoma Leading to Respiratory Failure in a 19-year-old. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.$19$YR$$F$Y$$$20240816$$HP$US$US
241604171$24160417$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5860500$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241604181$24160418$1$I$20240727$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019961$ELI LILLY AND CO$$$$$$Y$$$20240801$$HP$US$US
241604191$24160419$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019748$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240801$$CN$US$US
241604201$24160420$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020016$ELI LILLY AND CO$$$$$M$Y$$$20240801$$CN$US$US
241604211$24160421$1$I$20240721$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020024$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240801$$CN$US$US
241604221$24160422$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020021$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240801$$CN$US$US
241604231$24160423$1$I$20240727$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020202$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240801$$CN$US$US
241604241$24160424$1$I$20240722$20240726$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019502$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240801$$CN$US$US
241604251$24160425$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019786$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240801$$CN$US$US
241604261$24160426$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407018803$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240801$$CN$US$US
241604271$24160427$1$I$20240501$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019917$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240801$$CN$US$US
241604281$24160428$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5860234$ABBVIE$$$$$$Y$$$20240801$$MD$US$US
241604292$24160429$2$F$20210101$20240826$20240801$20240830$EXP$$JP-EMD Serono-2024040714$EMD SERONO INC$$52$YR$A$F$Y$$$20240830$$MD$JP$JP
241604302$24160430$2$F$20240617$20240731$20240801$20240806$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15001$IPSEN$$44$YR$A$F$Y$69.5$KG$20240806$$HP$US$US
241604311$24160431$1$I$$20240725$20240801$20240801$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15053$IPSEN$$$$$$Y$$$20240801$$MD$US$US
241604321$24160432$1$I$$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151240$AMGEN$$$$$$Y$$$20240801$$PH$US$US
241604331$24160433$1$I$$20240731$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043135$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240801$$MD$US$US
241604341$24160434$1$I$$20240725$20240801$20240801$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024093578$VIIV$$6$DEC$$F$Y$$$20240801$$CN$US$US
241604364$24160436$4$F$20240101$20240909$20240801$20240919$EXP$$AR-AMGEN-ARGSP2024151492$AMGEN$$46$YR$A$F$Y$$$20240919$$CN$AR$AR
241604371$24160437$1$I$$20240718$20240801$20240801$EXP$$US-RDY-LIT/USA/24/0010943$DR REDDYS$Samuelson Bannow BT. Management of abnormal uterine bleeding on anticoagulation: the patient-clinician perspective. Journal of Thrombosis and Haemostasis. 2024 Jul;22(7): 1819-1825. doi:10.1016/j.jtha.2024.04.002.$27$YR$A$F$Y$$$20240801$$HP$US$US
241604381$24160438$1$I$20240618$20240718$20240801$20240801$EXP$$US-INSMED, INC.-2024-02566-US$INSMED$$61$YR$$M$Y$$$20240801$$CN$US$US
241604391$24160439$1$I$20190401$20240722$20240801$20240801$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117033$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$51$KG$20240801$$MD$KR$KR
241604401$24160440$1$I$$20240725$20240801$20240801$PER$$NVSC2024US153952$NOVARTIS$$$$$$Y$$$20240801$$CN$US$US
241604411$24160441$1$I$$20240723$20240801$20240801$EXP$$AU-SA-2024SA217501$SANOFI AVENTIS$$$$$F$Y$$$20240801$$PH$AU$AU
241604421$24160442$1$I$20240621$20240624$20240801$20240801$EXP$$US-INFO-20240229$INFORLIFE$$$$$$Y$$$20240731$$HP$US$US
241604433$24160443$3$F$20231201$20240906$20240801$20240913$EXP$$CA-GSK-CA2024003175$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$CA$CA
241604441$24160444$1$I$$20240727$20240801$20240801$EXP$$SG-AstraZeneca-2024A172580$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$SG$
241604451$24160445$1$I$$20240723$20240801$20240801$EXP$$KR-SA-2024SA222127$SANOFI AVENTIS$$$$E$M$Y$$$20240801$$CN$KR$KR
241604463$24160446$3$F$20240701$20240906$20240801$20240909$EXP$$JP-TAKEDA-2024TJP010590AA$TAKEDA$$6$DEC$$M$Y$$$20240909$$MD$JP$JP
241604471$24160447$1$I$$20240723$20240801$20240801$EXP$$LB-BEH-2024176321$CSL BEHRING$$95$MON$C$F$Y$$$20240801$$HP$LB$LB
241604481$24160448$1$I$$20240724$20240801$20240801$EXP$ES-AEMPS-1551187$ES-SA-2024SA222088$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240801$$PH$ES$ES
241604492$24160449$2$F$20240101$20240829$20240801$20240917$EXP$$US-SA-2024SA223028$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240917$$MD$US$US
241604501$24160450$1$I$$20240730$20240801$20240801$PER$$US-ROCHE-10000045951$ROCHE$$$$$$Y$$$20240801$$CN$US$US
241604511$24160451$1$I$$20240724$20240801$20240801$EXP$$US-ROCHE-10000036666$ROCHE$$$$$$Y$$$20240801$$CN$US$US
241604521$24160452$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019916$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240801$$CN$US$US
241604531$24160453$1$I$$20240726$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407018119$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240801$$CN$US$US
241604541$24160454$1$I$20240728$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020073$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240801$$CN$US$US
241604551$24160455$1$I$20240716$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019655$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240801$$CN$US$US
241604561$24160456$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019757$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240801$$CN$US$US
241604571$24160457$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000169$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240801$$CN$US$US
241604581$24160458$1$I$$20240724$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118185$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$64.41$KG$20240801$$CN$US$US
241604591$24160459$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019967$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240801$$CN$US$US
241604602$24160460$2$F$$20240724$20240801$20240801$EXP$$US-AMGEN-USASP2024147823$AMGEN$$$$A$$Y$$$20240801$$PH$US$US
241604611$24160461$1$I$$20240722$20240801$20240801$EXP$$JP-ROCHE-10000040787$ROCHE$$$$E$$Y$$$20240801$$MD$JP$JP
241604621$24160462$1$I$$20240725$20240801$20240801$EXP$$US-SA-2024SA221487$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240801$$MD$US$US
241604632$24160463$2$F$$20240830$20240801$20240909$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000653$DECIPHERA PHARMACEUTICALS$$79$YR$E$M$Y$99.1$KG$20240909$$CN$US$US
241604643$24160464$3$F$20240724$20240805$20240801$20240827$EXP$$CN-BEH-2024176457$CSL BEHRING$$74$YR$E$F$Y$42$KG$20240827$$HP$CN$CN
241604651$24160465$1$I$20211111$20240724$20240801$20240801$EXP$$US-JNJFOC-20240771022$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240801$$HP$US$US
241604661$24160466$1$I$20240701$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151357$AMGEN$$73$YR$E$F$Y$$$20240801$$CN$US$US
241604671$24160467$1$I$20240101$20240726$20240801$20240801$PER$$US-ABBVIE-5860821$ABBVIE$$$$$M$Y$$$20240801$$MD$US$US
241604681$24160468$1$I$20210301$20240729$20240801$20240801$EXP$$FR-AMGEN-FRANI2024150767$AMGEN$$58$YR$A$M$Y$$$20240801$$HP$FR$FR
241604692$24160469$2$F$20210416$20240918$20240801$20240926$EXP$$CA-ROCHE-2835850$ROCHE$$37$YR$A$F$Y$163$KG$20240926$$HP$CA$CA
241604701$24160470$1$I$20240731$20240731$20240801$20240801$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043048$BOEHRINGER INGELHEIM$$85$YR$E$$Y$$$20240801$$CN$US$US
241604711$24160471$1$I$20240724$20240725$20240801$20240801$PER$$US-ALXN-202407USA001818US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240801$$CN$US$US
241604721$24160472$1$I$$20240730$20240801$20240801$EXP$$US-ABBVIE-5860938$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241604731$24160473$1$I$20240714$20240729$20240801$20240801$EXP$$US-ABBVIE-5740977$ABBVIE$$40$YR$$F$Y$$$20240801$$CN$US$US
241604741$24160474$1$I$20240101$20240729$20240801$20240801$PER$$US-JNJFOC-20240780290$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$US$US
241604751$24160475$1$I$20240722$20240726$20240801$20240801$PER$$US-AMGEN-USASP2024151011$AMGEN$$61$YR$A$F$Y$$$20240801$$CN$US$US
241604761$24160476$1$I$20240728$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150968$AMGEN$$69$YR$E$F$Y$$$20240801$$CN$US$US
241604771$24160477$1$I$20240101$20240718$20240801$20240801$EXP$$CA-ADVANZ PHARMA-202407006251$ADVANZ PHARMA$$$$$$Y$$$20240801$$HP$CA$CA
241604781$24160478$1$I$$20230816$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240645$IRONSHORE PHARMA$$$$$M$Y$$$20240801$$MD$US$US
241604791$24160479$1$I$$20230829$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240636$IRONSHORE PHARMA$$$$$F$Y$$$20240801$$HP$US$US
241604801$24160480$1$I$$20230822$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240650$IRONSHORE PHARMA$$9$YR$C$M$Y$36.281$KG$20240801$$MD$US$US
241604811$24160481$1$I$$20230815$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240644$IRONSHORE PHARMA$$$$$$Y$$$20240801$$CN$US$US
241604821$24160482$1$I$$20230825$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240652$IRONSHORE PHARMA$$$$$F$Y$$$20240801$$HP$US$US
241604831$24160483$1$I$$20230816$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240646$IRONSHORE PHARMA$$$$$M$Y$$$20240801$$HP$US$US
241604841$24160484$1$I$$20230822$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240631$IRONSHORE PHARMA$$$$$M$Y$$$20240801$$MD$US$US
241604851$24160485$1$I$$20230823$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240669$IRONSHORE PHARMA$$$$$$Y$$$20240801$$MD$US$US
241604861$24160486$1$I$$20240722$20240801$20240801$EXP$$JP-ROCHE-10000040705$ROCHE$Chifu Y. P-006 A case of rheumatoid arthritis on treatment with tocilizumab in which gastric cellulitis developed. Japanese Journal of Hospital General Medicine / The 28th Annual Meeting of Japan. 2024;20(S1):220$73$YR$E$F$Y$$$20240801$$MD$JP$JP
241604871$24160487$1$I$20160501$20240730$20240801$20240801$EXP$PL-URPL-2-986-2020$PL-JNJFOC-20240800588$JOHNSON AND JOHNSON$$65$YR$E$F$Y$29.025$KG$20240801$$CN$PL$PL
241604881$24160488$1$I$20180917$20240726$20240801$20240801$EXP$FR-AFSSAPS-SE2024000602$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-119883$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$88$KG$20240801$$MD$FR$FR
241604892$24160489$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3226003$TEVA$Senchyna F, Murugesan K, Rotunno W, Nadimpalli SS, Deresinski S, Banaei N. Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-beta-lactamase-Producing Escherichia coli Causing Fatal Bloodstream Infection. Clin-Infect-Dis 2024; 78 (6): 1425-1428.; Senchyna F, Murugesan K, Rotunno W, Nadimpalli SS, Deresinski S, Banaei N. Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Foll...$12$YR$$M$Y$$$20240816$$HP$US$US
241604901$24160490$1$I$20240327$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120108$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$102$KG$20240801$$CN$US$US
241604911$24160491$1$I$$20240730$20240801$20240801$PER$$US-HALEON-2189931$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241604922$24160492$2$F$$20240912$20240801$20240918$EXP$$GB-TAKEDA-2024TUS076428$TAKEDA$$$$$F$Y$$$20240918$$MD$GB$GB
241604931$24160493$1$I$$20240718$20240801$20240801$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07055$LUPIN$Abdelmajid HA, Mustafa GMA, Fernandez A, Franco SD, Esquibies AE, Valencia GB, et al. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring. Case Reports in Perinatal Medicine. 2024;13 (1):1-5$$$$$Y$$$20240801$$MD$US$US
241604942$24160494$2$F$20240726$20240801$20240801$20240803$EXP$$US-ABBVIE-5859602$ABBVIE$$72$YR$$M$Y$$$20240803$$CN$US$US
241604952$24160495$2$F$20240101$20240626$20240801$20240924$PER$$US-FDC-2024USSPO00462$FDC LIMITED$$$$$M$Y$$$20240924$$CN$US$US
241604961$24160496$1$I$$20230901$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240691$IRONSHORE PHARMA$$10$YR$C$F$Y$$$20240801$$MD$US$US
241604971$24160497$1$I$20230815$20230907$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240692$IRONSHORE PHARMA$$6$YR$C$M$Y$$$20240801$$CN$US$US
241604981$24160498$1$I$$20230908$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240694$IRONSHORE PHARMA$$$$$M$Y$$$20240801$$MD$US$US
241604991$24160499$1$I$$20240722$20240801$20240801$EXP$$GB-ESPERIONTHERAPEUTICS-2024GBR01196$ESPERION THERAPEUTICS$$$$$$Y$$$20240801$$MD$GB$GB
241605001$24160500$1$I$20240520$20240719$20240801$20240801$EXP$GB-MHRA-EMIS-1657-ee3d0086-3ef6-4b56-abe9-52490303244c$GB-ESPERIONTHERAPEUTICS-2024GBR01191$ESPERION THERAPEUTICS$$73$YR$$F$Y$109$KG$20240801$$PH$GB$GB
241605011$24160501$1$I$$20240723$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407000264$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240801$$CN$US$US
241605021$24160502$1$I$$20240726$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407017763$ELI LILLY AND CO$$$$$$Y$$$20240801$$CN$US$US
241605031$24160503$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019501$ELI LILLY AND CO$$$$$$Y$$$20240801$$CN$US$US
241605042$24160504$2$F$20240729$20240823$20240801$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202407018693$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240904$$MD$US$US
241605051$24160505$1$I$20240601$20240719$20240801$20240801$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-015980$JAZZ$$35$YR$$F$Y$$$20240801$$CN$US$US
241605061$24160506$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019700$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240801$$CN$US$US
241605071$24160507$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019857$ELI LILLY AND CO$$29$YR$A$M$Y$$$20240801$$CN$US$US
241605081$24160508$1$I$20240501$20240722$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407014540$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240801$$CN$US$US
241605091$24160509$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019764$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240801$$CN$US$US
241605101$24160510$1$I$$20240729$20240801$20240801$EXP$$US-JNJFOC-20240778336$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240801$$HP$US$US
241605111$24160511$1$I$20240612$20240723$20240801$20240801$EXP$FR-AFSSAPS-NC2024000819$FR-ROCHE-10000033421$ROCHE$$76$YR$E$M$Y$$$20240801$$MD$FR$FR
241605122$24160512$2$F$20240101$20240730$20240801$20240806$PER$$US-AMGEN-USASP2024151769$AMGEN$$$$A$F$Y$$$20240805$$HP$US$US
241605132$24160513$2$F$$20240801$20240801$20240805$EXP$$AU-BEIGENE-BGN-2024-011821$BEIGENE$$$$$$Y$$$20240805$$MD$AU$AU
241605141$24160514$1$I$$20230913$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240696$IRONSHORE PHARMA$$$$$$Y$$$20240801$$MD$US$US
241605151$24160515$1$I$$20240724$20240801$20240801$PER$$NVSC2024US152963$NOVARTIS$$$$$$Y$$$20240801$$CN$US$US
241605161$24160516$1$I$$20230911$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240695$IRONSHORE PHARMA$$$$$M$Y$$$20240801$$HP$US$US
241605171$24160517$1$I$20240705$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121064$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240801$$CN$US$US
241605191$24160519$1$I$20240729$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150581$AMGEN$$64$YR$A$F$Y$$$20240801$$CN$US$US
241605201$24160520$1$I$20240729$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151704$AMGEN$$$$$F$Y$$$20240801$$HP$US$US
241605221$24160522$1$I$20240101$20240728$20240801$20240801$EXP$$MY-ORGANON-O2407MYS002720$ORGANON$$36$YR$$F$Y$$$20240801$$MD$MY$MY
241605231$24160523$1$I$20240101$20240730$20240801$20240801$EXP$$US-ABBVIE-5862390$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241605241$24160524$1$I$$20240730$20240801$20240801$EXP$$NVSC2024GR156226$NOVARTIS$$65$YR$$$Y$$$20240801$$MD$GR$GR
241605251$24160525$1$I$20230915$20230915$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240592$IRONSHORE PHARMA$$10$YR$C$M$Y$$$20240801$$CN$US$US
241605261$24160526$1$I$20230906$20230915$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240608$IRONSHORE PHARMA$$7$YR$C$M$Y$$$20240801$$HP$US$US
241605271$24160527$1$I$20240701$20240722$20240801$20240801$PER$$US-ABBVIE-5855546$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241605284$24160528$4$F$20240709$20240919$20240801$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021107$UNITED THERAPEUTICS$$70$YR$$F$Y$81.179$KG$20240927$$$US$US
241605321$24160532$1$I$20240101$20240609$20240801$20240801$30DAY$$US-UCBSA-2024030446$UCB$$$$$M$Y$$$20240801$$CN$US$US
241605331$24160533$1$I$20230701$20240724$20240801$20240801$EXP$$IT-AMGEN-ITASP2024147944$AMGEN$$86$YR$E$F$Y$$$20240801$$CN$IT$IT
241605341$24160534$1$I$20240729$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151511$AMGEN$$86$YR$E$F$Y$$$20240801$$CN$US$US
241605351$24160535$1$I$20240716$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121170$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$127.01$KG$20240801$$PH$US$US
241605371$24160537$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121201$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240801$$CN$US$US
241605381$24160538$1$I$20240727$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121393$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240801$$CN$US$US
241605391$24160539$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121283$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240801$$CN$US$US
241605401$24160540$1$I$$20240724$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119204$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240801$$CN$US$US
241605411$24160541$1$I$20231101$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120794$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240801$$CN$US$US
241605422$24160542$2$F$20240716$20240903$20240801$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120462$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$85.9$KG$20240913$$PH$US$US
241605431$24160543$1$I$20240610$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120996$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240801$$PH$US$US
241605441$24160544$1$I$20240622$20240724$20240801$20240801$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-104897$REGENERON$$64$YR$$F$Y$$$20240801$$HP$CO$CO
241605451$24160545$1$I$20240725$20240730$20240801$20240801$PER$$US-JNJFOC-20240783789$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240801$$CN$US$US
241605461$24160546$1$I$$20240704$20240801$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06728$LUPIN$$$$$$Y$$$20240801$$CN$US$US
241605471$24160547$1$I$$20240724$20240801$20240801$EXP$$CA-APOTEX-2024AP008802$APOTEX$$75$YR$$F$Y$$$20240801$$HP$CA$CA
241605481$24160548$1$I$20240101$20240726$20240801$20240801$EXP$$US-ABBVIE-5859327$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241605491$24160549$1$I$$20240723$20240801$20240801$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005515$BIOCON$$$$$$Y$$$20240801$$CN$CA$CA
241605501$24160550$1$I$$20230926$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240623$IRONSHORE PHARMA$$6$YR$C$F$Y$$$20240801$$MD$US$US
241605511$24160551$1$I$$20231002$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240624$IRONSHORE PHARMA$$29$YR$A$F$Y$$$20240801$$HP$US$US
241605521$24160552$1$I$20230101$20231002$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240625$IRONSHORE PHARMA$$$$$$Y$$$20240801$$MD$US$US
241605531$24160553$1$I$20230919$20230921$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240622$IRONSHORE PHARMA$$8$YR$C$M$Y$$$20240801$$CN$US$US
241605541$24160554$1$I$$20231001$20240801$20240801$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240626$IRONSHORE PHARMA$$$$$$Y$$$20240801$$MD$US$US
241605572$24160557$2$F$20240716$20240801$20240801$20240807$EXP$$US-EMD Serono-2024039292$EMD SERONO INC$$61$YR$A$F$Y$$$20240807$$CN$US$US
241605581$24160558$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121226$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240801$$CN$US$US
241605591$24160559$1$I$20240701$20240729$20240801$20240801$EXP$FR-AFSSAPS-RS2024000743$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-120588$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240801$$MD$FR$FR
241605601$24160560$1$I$$20240723$20240801$20240801$PER$$US-ROCHE-10000034401$ROCHE$$$$$$Y$$$20240801$$CN$US$US
241605611$24160561$1$I$$20240722$20240801$20240801$PER$$US-ROCHE-10000033497$ROCHE$$$$$M$Y$$$20240801$$CN$US$US
241605622$24160562$2$F$$20240807$20240801$20240808$PER$$US-ALXN-202407USA000960US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241605631$24160563$1$I$$20240704$20240801$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06688$LUPIN$$$$$$Y$$$20240801$$CN$US$US
241605641$24160564$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3223220$TEVA$$81$YR$$F$Y$$$20240801$$PH$US$US
241605651$24160565$1$I$$20240727$20240801$20240801$EXP$$US-GILEAD-2024-0682280$GILEAD$$$$A$F$Y$$$20240801$$CN$US$US
241605661$24160566$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156341$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
241605681$24160568$1$I$$20240729$20240801$20240801$EXP$$CA-TAKEDA-2023TUS101586$TAKEDA$$$$$F$Y$$$20240801$$MD$CA$CA
241605691$24160569$1$I$20240601$20240724$20240801$20240801$EXP$$BR-AstraZeneca-2024A172292$ASTRAZENECA$$20546$DY$$F$Y$$$20240801$$CN$BR$
241605701$24160570$1$I$$20240725$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121234$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240801$$CN$US$US
241605711$24160571$1$I$$20240726$20240801$20240801$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-121500$BRISTOL MYERS SQUIBB$Literature citation unavailable$63$YR$A$F$Y$$$20240801$$HP$CA$CA
241605722$24160572$2$F$20240724$20240726$20240801$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407017705$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240802$$CN$US$US
241605731$24160573$1$I$20240730$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019562$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240801$$CN$US$US
241605741$24160574$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019883$ELI LILLY AND CO$$51$YR$A$$Y$$$20240801$$CN$US$US
241605751$24160575$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019633$ELI LILLY AND CO$$$$A$F$Y$$$20240801$$CN$US$US
241605761$24160576$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019907$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240801$$CN$US$US
241605771$24160577$1$I$20240701$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019804$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240801$$CN$US$US
241605781$24160578$1$I$20240605$20240722$20240801$20240801$EXP$ES-AEMPS-1549990$ES-ESPERIONTHERAPEUTICS-2024ESP01200$ESPERION THERAPEUTICS$$56$YR$$M$Y$77$KG$20240801$$MD$ES$ES
241605791$24160579$1$I$$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150502$AMGEN$$$$$M$Y$$$20240801$$MD$US$US
241605802$24160580$2$F$20230417$20240805$20240801$20240819$EXP$$JP-AMGEN-JPNSP2024151399$AMGEN$Shirai K, Ichikawa D, Yoshitome A, Takayama S, Han W, Kiyomi O. A study of avacopan combination therapy in ANCA-associated vasculitis. Journal of Japanese Society of Nephrology. 2024 JUN 28;66(4):606.$79$YR$E$F$Y$51.8$KG$20240818$$MD$JP$JP
241605811$24160581$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019885$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240801$$CN$US$US
241605821$24160582$1$I$20240101$20240717$20240801$20240801$PER$$US-AMGEN-USASP2024143270$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241605841$24160584$1$I$$20240515$20240801$20240801$EXP$$CA-AUROBINDO-AUR-APL-2024-025621$AUROBINDO$$14$YR$$F$Y$$$20240801$$HP$CA$CA
241605861$24160586$1$I$20240101$20240724$20240801$20240801$EXP$$CA-GSK-CA2024034379$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$CA$CA
241605871$24160587$1$I$20240702$20240725$20240801$20240801$PER$$US-ALXN-202407USA001812US$ALEXION PHARMACEUTICALS$$43$YR$$M$Y$$$20240801$$CN$US$US
241605883$24160588$3$F$20240724$20240808$20240801$20240819$EXP$$JP-ALXN-202407JPN001635JP$ALEXION PHARMACEUTICALS$$74$YR$$F$Y$$$20240819$$MD$JP$JP
241605891$24160589$1$I$20240623$20240722$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-036811$AUROBINDO$$62$YR$$F$Y$56$KG$20240801$$CN$GB$GB
241605901$24160590$1$I$$20240726$20240801$20240801$EXP$$CA-APOTEX-2024AP008914$APOTEX$$64$YR$$F$Y$$$20240801$$HP$CA$CA
241605912$24160591$2$F$20240531$20240805$20240801$20240820$EXP$DE-BAXTER-2024BAX021324$DE-SERVIER-S24009072$SERVIER$$$$$$Y$$$20240820$$MD$DE$DE
241605921$24160592$1$I$$20240722$20240801$20240801$EXP$$JP-ROCHE-10000040757$ROCHE$Nakagawa N, Mori R, Kotari S, Tanaka K, Kitaoka M, Wakatsuki Y et al.. P-6 A case in which retinal pigment epithelial tear and endophthalmitis occurred after intravitreal injection of faricimab for age-related macular degeneration. The 40th Annual Meeting of Japanese Society for Ocular Circulation. 2024;89$79$YR$E$M$Y$$$20240801$$MD$JP$JP
241605931$24160593$1$I$$20240723$20240801$20240801$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01418$NOVITIUM PHARMA$Lorenzo Lazzari.Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura.Current Research in Translational Medicine.05-MAR-2024;72(1):103441$65$YR$A$M$Y$$$20240801$$HP$IT$IT
241605941$24160594$1$I$$20240722$20240801$20240801$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07007$HIKMA$Laches R, Hall RJ, Chaffin J, Hahn P.. Laches R, Hall RJ, Chaffin J, Hahn P. Omission of etoposide in the treatment of haemophagocytic lymphohistiocytosis secondary to primary central nervous system lymphoma with satisfactory response.. BMJ case reports. 2024;17(7):e258559$7$DEC$$F$Y$$$20240801$$MD$US$US
241605952$24160595$2$F$20230804$20240907$20240801$20240916$EXP$$CA-TAKEDA-2024TUS076237$TAKEDA$$32$YR$$F$Y$58$KG$20240916$$MD$CA$CA
241605961$24160596$1$I$$20240720$20240801$20240801$EXP$$BE-AUROBINDO-AUR-APL-2017-15122$AUROBINDO$Devresse A, Maldague P, Coulier B, Pierard F, Gielen I... Focal parietal necrosis of the sigmoid due to atypical neuroleptics: A case report... Acta Gastro-Enterologica Belgica.. 2012;75 (2):263-265$26$YR$$M$Y$$$20240801$$MD$BE$BE
241605971$24160597$1$I$$20240719$20240801$20240801$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07320$LUPIN$Khachatryan A, Isseh I, Vavilin I, Saeed IM, Harutyunyan H, Bansro V, et al. Recurrent perimyocarditis associated with long-term methylphenidate use. Journal of the American College of Cardiology. 2024;83 (13) A:3543$19$YR$$M$Y$$$20240801$$HP$US$US
241605991$24160599$1$I$$20240722$20240801$20240801$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-07125$HIKMA$Oliveira C, Queiroz L, Almeida M, Fernandes R, Caeiro C.. Oliveira C, Queiroz L, Almeida M, Fernandes R, Caeiro C. Challenging case of severe hepatotoxicity with ribociclib. REVISTA PORTUGUESA DE ONCOLOGIA. 2024;7:46-48$$$$$Y$$$20240801$$MD$PT$PT
241606001$24160600$1$I$$20240722$20240801$20240801$EXP$$CN-Encube-000846$ENCUBE ETHICALS$Yiu MK, Ho M, Ho ACH, Chan WKY, Yung W, Yip WWK, Young AL. Paediatric Uveitis - the uniqueness in clinical presentation and the efficacy of biologics treatment. J Ophthalmic Inflamm Infect. 2024 Jul 17;14(1):34. doi: 10.1186/s12348-024-00415-z. PMID: 39017721; PMCID: PMC11254883.$17$YR$T$F$Y$$$20240731$$MD$CN$
241606011$24160601$1$I$$20240722$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-036894$AUROBINDO$$$$$$Y$$$20240801$$CN$GB$GB
241606021$24160602$1$I$$20240724$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121278$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$79.38$KG$20240801$$CN$US$US
241606031$24160603$1$I$$20240729$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121454$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240801$$CN$US$US
241606041$24160604$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119980$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$84.82$KG$20240801$$HP$US$US
241606051$24160605$1$I$$20240727$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120050$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$78.47$KG$20240801$$CN$US$US
241606061$24160606$1$I$20240722$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120992$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$71.67$KG$20240801$$HP$US$US
241606083$24160608$3$F$$20240924$20240801$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120827$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240925$$HP$US$US
241606091$24160609$1$I$$20240722$20240801$20240801$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR095769$VIIV$$$$$$Y$$$20240801$$HP$US$US
241606101$24160610$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121548$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$69.4$KG$20240801$$CN$US$US
241606111$24160611$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121090$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240801$$CN$US$US
241606121$24160612$1$I$$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121084$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240801$$CN$US$US
241606131$24160613$1$I$$20240731$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121534$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240801$$HP$US$US
241606141$24160614$1$I$$20240722$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-036925$AUROBINDO$$$$$F$Y$$$20240801$$HP$GB$GB
241606152$24160615$2$F$20240601$20240815$20240801$20240826$EXP$$US-RDY-CLI/USA/24/0011048$DR REDDYS$$23$YR$A$F$Y$$$20240826$$CN$US$US
241606161$24160616$1$I$20230101$20240327$20240801$20240801$EXP$$CA-CELLTRION INC.-2022CA022672$CELLTRION$$$$$$Y$$$20240801$$CN$CA$CA
241606173$24160617$3$F$20240727$20240822$20240801$20240829$30DAY$$US-JNJFOC-20240778751$JOHNSON AND JOHNSON$$56$YR$A$$Y$$$20240829$$PH$US$US
241606181$24160618$1$I$$20240729$20240801$20240801$EXP$$GB-JNJFOC-20240784253$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240801$$CN$GB$GB
241606192$24160619$2$F$$20240808$20240801$20240815$EXP$$JP-JNJFOC-20240800866$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$PH$JP$JP
241606201$24160620$1$I$$20240722$20240801$20240801$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07082$HIKMA$$$$$$Y$$$20240801$$CN$US$US
241606212$24160621$2$F$20240501$20240909$20240801$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-019230$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240918$$MD$JP$JP
241606221$24160622$1$I$20240702$20240705$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-107174$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$96.16$KG$20240801$$PH$US$US
241606231$24160623$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121490$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240801$$CN$US$US
241606241$24160624$1$I$20200101$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121483$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240801$$CN$US$US
241606251$24160625$1$I$$20240725$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119102$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240801$$HP$US$US
241606261$24160626$1$I$$20240726$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121153$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240801$$HP$US$US
241606271$24160627$1$I$$20240716$20240801$20240801$PER$$US-ROCHE-10000029101$ROCHE$$$$A$F$Y$$$20240801$$CN$US$US
241606283$24160628$3$F$$20240801$20240801$20240816$PER$$US-AMGEN-USASP2024151825$AMGEN$$$$$F$Y$$$20240816$$CN$US$US
241606293$24160629$3$F$20240701$20240805$20240801$20240815$30DAY$$US-AMGEN-USASL2024149447$AMGEN$$56$YR$A$F$Y$$$20240815$$PH$US$US
241606301$24160630$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151557$AMGEN$$$$$M$Y$$$20240801$$CN$US$US
241606311$24160631$1$I$20240726$20240726$20240801$20240801$PER$$US-AMGEN-USASP2024149961$AMGEN$$62$YR$A$F$Y$$$20240801$$CN$US$US
241606323$24160632$3$F$20240711$20240807$20240801$20240812$30DAY$$BR-AMGEN-BRASP2024147998$AMGEN$$$$$$Y$$$20240812$$CN$BR$BR
241606332$24160633$2$F$$20240815$20240801$20240820$PER$$US-AMGEN-USASP2024151621$AMGEN$$$$$M$Y$$$20240820$$CN$US$US
241606341$24160634$1$I$20240101$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151279$AMGEN$$67$YR$E$F$Y$$$20240801$$CN$US$US
241606351$24160635$1$I$$20240105$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-17267$ALKEM$$$$$M$Y$$$20240801$$CN$US$US
241606361$24160636$1$I$$20240313$20240801$20240801$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-05563$ALKEM$Fukuoka H, Yokoi N, Komori A, Makimura K, Sotozono C.. Dematiaceous fungal keratitis caused by Cladophialophora boppii - A case report. American Journal of Ophthalmology Case Reports. 2024;33:102006$83$YR$$M$Y$$$20240801$$HP$JP$JP
241606371$24160637$1$I$$20240403$20240801$20240801$EXP$$RO-ALKEM LABORATORIES LIMITED-RO-ALKEM-2024-06855$ALKEM$Colosi IA, Crisan M, Toc DA, Colosi HA, Georgiu C, Sabou M, Costache C. First Reported Case of a Clinically Nonresponsive-to-Itraconazole Alternaria alternata Isolated from a Skin Infection of a Nonimmunocompromised Patient from Romania. Journal of fungi. 2023;9:839$75$YR$$M$Y$$$20240801$$HP$RO$RO
241606381$24160638$1$I$$20240605$20240801$20240801$EXP$$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-12617$ALKEM$Lou HY, Fang CL, Fang SU, et al.. Hepatic failure related to itraconazole use successfully treated by corticosteroids. Hepat Mon. 2011;11:843-846$46$YR$$F$Y$$$20240801$$HP$TW$TW
241606391$24160639$1$I$$20240605$20240801$20240801$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2024-12718$ALKEM$Srebrnik A, Levtov S, Ben-Ami R, et al.. Itraconazole treatment for toenail onychomycosis. J Eur Acad Dermatol Venereol. 2005;19:205-207$25$YR$$F$Y$$$20240801$$HP$IL$IL
241606401$24160640$1$I$$20240605$20240801$20240801$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-12605$ALKEM$Laverijsen AP, Balmus KJ, Nugteren-Huying WM, et al.. Hepatic injury associated with itraconazole. Lancet. 1992;340:251-252$62$YR$$F$Y$$$20240801$$HP$NL$NL
241606411$24160641$1$I$$20240605$20240801$20240801$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-12608$ALKEM$Laverijsen AP, Balmus KJ, Nugteren-Huying WM, et al. Hepatic injury associated with itraconazole. Lancet. 1992;340:251-252$75$YR$$M$Y$$$20240801$$HP$NL$NL
241606421$24160642$1$I$$20240605$20240801$20240801$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-12609$ALKEM$Laverijsen AP, Balmus KJ, Nugteren-Huying WM, et al.. Hepatic injury associated with itraconazole. Lancet. 1992;340:251-252$57$YR$$F$Y$$$20240801$$HP$NL$NL
241606431$24160643$1$I$$20240605$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12616$ALKEM$Talwalkar JN, Soetikno RE, Carr-Locke DL, et.al.. Severe cholestasis related to itraconazole for the treatment of onychomycosis. Am J Gastroenterol. 1999;94:3632-3633$74$YR$$F$Y$$$20240801$$HP$US$US
241606441$24160644$1$I$$20240605$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-13130$ALKEM$Gallardo-Queseda S, Luelmo-Aguilar J, Guanyabens-Calvet C.. Hepatotoxicity associated with itraconazole. Int J Dermatol.. 1995;34:589$$$$M$Y$$$20240801$$HP$ES$ES
241606451$24160645$1$I$$20240605$20240801$20240801$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-12964$ALKEM$Hann SK, Kim JB, Im S, et al.. Itraconazole-induced acute hepatitis. Br J Dermatol. 1993;129:500-501$51$YR$$F$Y$$$20240801$$HP$KR$KR
241606461$24160646$1$I$$20240605$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-12614$ALKEM$Collazos J, Mayo J, Martinez E, Diaz F. Unusual liver toxicity due to the new antifungal agents fluconazole and itraconazole. Int Hepatol Commun. 1995;3:112-5$$$$$Y$$$20240801$$HP$ES$ES
241606471$24160647$1$I$$20230925$20240801$20240801$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2023-11966$ALKEM$Benko LMP, Vieira da Silva MES, Falcao EMM, Freitas DFS, Calvet GA, Almeida MdA, Almeida-Paes R, Zancope-Oliveira RM, do Valle ACF, de Macedo PM. Paracoccidioidomycosis and pregnancy: A 40-year single-center cohort study in the endemic area of Rio de Janeiro, Brazil. PLOS Neglected Tropical Diseases. 2023;17(9):e0011645$25$YR$$F$Y$$$20240801$$HP$BR$BR
241606481$24160648$1$I$$20230915$20240801$20240801$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2023-11062$ALKEM$Dhabal A, Das NK, Sil A.. Symmetric drug-related intertriginous and flexural exanthema: case report. Indian-J-Pharmacol. 2023;55(3):192-193$13$YR$$M$Y$$$20240801$$HP$IN$IN
241606491$24160649$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13150$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$34$YR$$F$Y$$$20240801$$HP$MX$MX
241606501$24160650$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13147$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$61$YR$$F$Y$$$20240801$$HP$MX$MX
241606511$24160651$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13149$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$37$YR$$F$Y$$$20240801$$HP$MX$MX
241606521$24160652$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13135$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$61$YR$$M$Y$$$20240801$$HP$MX$MX
241606531$24160653$1$I$$20231214$20240801$20240801$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2023-16294$ALKEM$Oliveira VF, Funari AP, Taborda M, Magri ASGK, Levin AS, Magri MMC.. Cutaneous Naganishia albida (Cryptococcus albidus) infection: a case report and literature review. Revista do Instituto de Medicina Tropical de Sao Paulo. 2023;65:e60$72$YR$$M$Y$$$20240801$$HP$BR$BR
241606541$24160654$1$I$$20240403$20240801$20240801$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-07488$ALKEM$Hu Y, Qi X, Sun H, Lu Y, Hu Y, Chen X, Liu K, Yang Y, Mao Z, Wu Z, Zhou X.. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro. PLOS Neglected Tropical Diseases. 2019;13 (10):e0007849$50$YR$$M$Y$$$20240801$$HP$CN$CN
241606551$24160655$1$I$$20240209$20240801$20240801$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-02377$ALKEM$Pourcher V, Young J, Le Pimpec-Barthes F, Maillart E, Gibault L, Boussouar S. Chronic necrotizing aspergillosis: a new risk with teriflunomide in multiple sclerosis patients?. Revue Neurologique. 2022;178:261-284$56$YR$$F$Y$$$20240801$$HP$FR$FR
241606561$24160656$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13152$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose Venetoclax plus Itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$33$YR$$F$Y$$$20240801$$HP$MX$MX
241606571$24160657$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13148$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose Venetoclax plus Itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$55$YR$$F$Y$$$20240801$$HP$MX$MX
241606581$24160658$1$I$$20230925$20240801$20240801$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2023-11968$ALKEM$Benko LMP, Vieira da Silva MES, Falcao EMM, Freitas DFS, Calvet GA, Almeida MA, Almeida-Paes R, Zancope-Oliveira RM, do Valle ACF, de Macedo PM. Paracoccidioidomycosis and pregnancy: A 40-year single-center cohort study in the endemic area of Rio de Janeiro, Brazil. PLOS Neglected Tropical Diseases. 2023;17(9):e0011645$16$YR$$F$Y$$$20240801$$HP$BR$BR
241606591$24160659$1$I$$20230925$20240801$20240801$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2023-11969$ALKEM$Benko LMP, Vieira da Silva MES, Falcao EMM, Freitas DFS, Calvet GA, Almeida MA, Almeida-Paes R, Zancope-Oliveira RM, do Valle ACF, de Macedo PM. Paracoccidioidomycosis and pregnancy: A 40-year single-center cohort study in the endemic area of Rio de Janeiro, Brazil. PLOS Neglected Tropical Diseases. 2023;17(9):e0011645$$$$M$Y$$$20240801$$HP$BR$BR
241606601$24160660$1$I$$20230925$20240801$20240801$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2023-11965$ALKEM$Benko LMP, Vieira da Silva MES, Falcao EMM, Freitas DFS, Calvet GA, Almeida MdA, Almeida-Paes R, Zancope-Oliveira RM, do Valle ACF, de Macedo PM. Paracoccidioidomycosis and pregnancy: A 40-year single-center cohort study in the endemic area of Rio de Janeiro, Brazil. PLOS Neglected Tropical Diseases. 2023;17(9):e0011645$28$YR$$F$Y$$$20240801$$HP$BR$BR
241606611$24160661$1$I$$20240327$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-06911$ALKEM$Gil-Pallares P, Gracia-Cazana T, Alvarez-Salafranca M, Gorgojo MA, Garcia-Garcia M, Beltran-Rosel A, Almenara-Blasco M, Navarro-Bielsa A, Gilaberte Y.. Cutaneous Alternariosis in Immunosuppressed Patients Treated with Photodynamic Therapy and Oral Antifungals, a Synergistic Strategy. Pharmaceuticals. 2024;17(2):245$70$YR$$M$Y$$$20240801$$HP$ES$ES
241606621$24160662$1$I$$20240322$20240801$20240801$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-06518$ALKEM$Capone D, Gentile A, Imperatore P, Palmiero G, Basile V.. Effects of itraconazole on tacrolimus blood concentrations in a renal transplant recipient. Ann Pharmacother. 1999;33(10):1124-5$$$$$Y$$$20240801$$HP$IT$IT
241606631$24160663$1$I$$20240403$20240801$20240801$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-07486$ALKEM$Yang Y, Hu Y, Zhang J, Li X, Lu C, Liang Y, Xi L.. A refractory case of chromoblastomycosis due  to Fonsecaea monophora with improvement by  photodynamic therapy. Medical Mycology. 2012;50:649-653$55$YR$$M$Y$$$20240801$$HP$CN$CN
241606641$24160664$1$I$$20231219$20240801$20240801$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2023-16581$ALKEM$Li F, He J, Yang T, Li S, Liu L, Huang Q, Duan X. 5-aminolevulinic acid-photodynamic therapy for a refractory severe kerion: A case report. Photodiagnosis and Photodynamic Therapy. 2023;44:103888$6$YR$$F$Y$$$20240801$$HP$CN$CN
241606651$24160665$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13154$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$73$YR$$F$Y$$$20240801$$HP$MX$MX
241606661$24160666$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13155$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose Venetoclax plus Itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$89$YR$$F$Y$$$20240801$$HP$MX$MX
241606671$24160667$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13145$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$30$YR$$M$Y$$$20240801$$HP$MX$MX
241606681$24160668$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13137$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$59$YR$$M$Y$$$20240801$$HP$MX$MX
241606691$24160669$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13139$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$53$YR$$M$Y$$$20240801$$HP$MX$MX
241606701$24160670$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13153$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$25$YR$$F$Y$$$20240801$$HP$MX$MX
241606711$24160671$1$I$$20240403$20240801$20240801$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-07489$ALKEM$Hu Y, Qi X, Sun H, Lu Y, Hu Y, Chen X, Liu K, Yang Y, Mao Z, Wu Z, Zhou X.. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro. PLOS Neglected Tropical Diseases. 2019;13(10):e0007849$50$YR$$F$Y$$$20240801$$HP$CN$CN
241606721$24160672$1$I$$20230925$20240801$20240801$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2023-11961$ALKEM$Benko LMP, Vieira da Silva MES, Falcao EMM, Freitas DFS, Calvet GA, Almeida MdA, Almeida-Paes R, Zancope-Oliveira RM, do Valle ACF, de Macedo PM. Paracoccidioidomycosis and pregnancy: A 40-year single-center cohort study in the endemic area of Rio de Janeiro, Brazil. PLOS Neglected Tropical Diseases. 2023;17(9):e0011645$17$YR$$F$Y$$$20240801$$HP$BR$BR
241606731$24160673$1$I$$20231016$20240801$20240801$EXP$$MX-ALKEM LABORATORIES LIMITED-MX-ALKEM-2023-13142$ALKEM$De la Garza-Salazar F, Colunga-Pedraza PR, Gomez-Almaguer D, Garcia-Zarate VA, Gomez-De Leon A. Low dose Venetoclax plus Itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study. Leukemia Research. 2023;133:107373$34$YR$$M$Y$$$20240801$$HP$MX$MX
241606741$24160674$1$I$$20230925$20240801$20240801$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2023-11963$ALKEM$Benko LMP, Vieira da Silva MES, Falcao EMM, Freitas DFS, Calvet GA, Almeida MdA, Almeida-Paes R, Zancope-Oliveira RM, do Valle ACF, de Macedo PM. Paracoccidioidomycosis and pregnancy: A 40-year single-center cohort study in the endemic area of Rio de Janeiro, Brazil. PLOS Neglected Tropical Diseases. 2023;17(9):e0011645$24$YR$$F$Y$$$20240801$$HP$BR$BR
241606751$24160675$1$I$$20231108$20240801$20240801$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2023-14175$ALKEM$Liu YY, Song Y, Guan MQ, Yang L, Chen RL, Shi Y, Cui Y, Li SS.. Hyperthermia is a Promising Potential Adjunct to Treating Sporotrichosis: A Refractory Case of HIV Sporotrichosis and In Vitro Experiments on Sporothrix spp. Mycoses. 2023;unk:unk$44$YR$$M$Y$$$20240801$$MD$CN$CN
241606761$24160676$1$I$$20231102$20240801$20240801$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-12886$ALKEM$Nenoff P, Stahl M, Schaller M, Burmester A, Monod M, Ebert A, Uhrlas S. Recurrent tinea corporis generalisata due to Terbinafine-resistant Trichophyton rubrum strain : Long-term treatment with super bioavailability itraconazole. Dermatology. 2023;74(11):864-873$82$YR$$M$Y$$$20240801$$HP$DE$DE
241606771$24160677$1$I$20150101$20240723$20240801$20240801$EXP$$FR-AUROBINDO-AUR-APL-2024-037389$AUROBINDO$$18$YR$$F$Y$55$KG$20240801$$MD$FR$FR
241606781$24160678$1$I$$20240723$20240801$20240801$EXP$$US-APOTEX-2024AP008816$APOTEX$Sendil S, Yarlagadda K, Lawal H, Nookala V, Shingala H.. Metformin Associated Lactic Acidosis in the Intensive Care Unit: A Rare Condition Mimicking Sepsis. Cureus. 2020;12(7):e9119 (1-8)$63$YR$$M$Y$$$20240801$$HP$US$US
241606791$24160679$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121148$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240801$$CN$US$US
241606801$24160680$1$I$$20240730$20240801$20240801$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-121075$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$96.16$KG$20240801$$CN$PR$PR
241606811$24160681$1$I$$20240729$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120565$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240801$$CN$US$US
241606831$24160683$1$I$$20240723$20240801$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-120363$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$MD$JP$JP
241606842$24160684$2$F$$20240821$20240801$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118158$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240830$$CN$US$US
241606852$24160685$2$F$20240714$20240802$20240801$20240809$EXP$$DE-BAXTER-2024BAX021901$BAXTER$$71$YR$$M$Y$$$20240809$$HP$DE$DE
241606861$24160686$1$I$20200629$20240730$20240801$20240801$EXP$FR-AFSSAPS-PC2024000614$FR-ORGANON-O2407FRA002801$ORGANON$$95$YR$$F$Y$$$20240801$$PH$FR$FR
241606871$24160687$1$I$$20240730$20240801$20240801$PER$$US-HALEON-2189934$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241606881$24160688$1$I$$20240724$20240801$20240801$EXP$$CA-APOTEX-2024AP008789$APOTEX$$25$YR$$F$Y$64$KG$20240801$$HP$CA$CA
241606892$24160689$2$F$$20240814$20240801$20240820$EXP$$IN-ROCHE-10000044548$ROCHE$$73$YR$E$M$Y$$$20240820$$CN$IN$IN
241606901$24160690$1$I$$20240723$20240801$20240801$EXP$$GB-ROCHE-10000037844$ROCHE$$$$A$F$Y$$$20240801$$CN$GB$GB
241606911$24160691$1$I$$20240726$20240801$20240801$EXP$$AU-RDY-SPO/AUS/24/0011149$DR REDDYS$$18$YR$A$$Y$$$20240801$$CN$AU$AU
241606921$24160692$1$I$$20240730$20240801$20240801$EXP$$US-GILEAD-2024-0682406$GILEAD$$$$E$F$Y$$$20240801$$CN$US$US
241606934$24160693$4$F$$20240905$20240801$20240918$30DAY$$US-JNJFOC-20240778237$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$HP$US$US
241606941$24160694$1$I$$20240719$20240801$20240801$EXP$$AU-MACLEODS PHARMA-MAC2024048588$MACLEODS$$$$$$Y$$$20240801$$MD$AU$AU
241606951$24160695$1$I$$20240717$20240801$20240801$EXP$$US-MACLEODS PHARMA-MAC2024048554$MACLEODS$$$$$$Y$$$20240801$$CN$US$US
241606961$24160696$1$I$20240602$20240724$20240801$20240801$EXP$$DE-ROCHE-10000040517$ROCHE$$61$YR$A$M$Y$78$KG$20240801$$MD$DE$DE
241606971$24160697$1$I$$20240719$20240801$20240801$EXP$$CN-ROCHE-10000038690$ROCHE$Wang H, Li H S. Clinical characteristic and treatment of breast cancer patients with interstitial lung disease. Oncology Progress. 2024-Feb;22 (3):257-61.$66$YR$E$F$Y$$$20240801$$HP$CN$CN
241606983$24160698$3$F$$20240822$20240801$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121273$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240826$$CN$US$US
241606991$24160699$1$I$20240101$20240725$20240801$20240801$EXP$FI-FIMEA-202402681$FI-BRISTOL-MYERS SQUIBB COMPANY-2024-121404$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240801$$HP$FI$FI
241607001$24160700$1$I$20240729$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121245$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240801$$CN$US$US
241607011$24160701$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121522$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$135.62$KG$20240801$$CN$US$US
241607021$24160702$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019761$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240801$$CN$US$US
241607031$24160703$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000107$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240801$$CN$US$US
241607041$24160704$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019920$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240801$$CN$US$US
241607051$24160705$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019640$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240801$$CN$US$US
241607061$24160706$1$I$20240724$20240729$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121295$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240801$$CN$US$US
241607071$24160707$1$I$20240626$20240725$20240801$20240801$EXP$$CL-UCBSA-2024038590$UCB$$76$YR$$M$Y$$$20240801$$CN$CL$CL
241607081$24160708$1$I$20220701$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121307$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$104.33$KG$20240801$$CN$US$US
241607091$24160709$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121313$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240801$$PH$US$US
241607101$24160710$1$I$20240701$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121412$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240801$$CN$US$US
241607111$24160711$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121333$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240801$$CN$US$US
241607131$24160713$1$I$$20240726$20240801$20240801$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-120873$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240801$$MD$DE$DE
241607141$24160714$1$I$$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121199$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240801$$CN$US$US
241607152$24160715$2$F$20240701$20240812$20240801$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120492$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240815$$CN$US$US
241607161$24160716$1$I$$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121343$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$$$20240801$$HP$US$US
241607171$24160717$1$I$20240701$20240730$20240801$20240801$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-121328$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240801$$CN$PR$PR
241607181$24160718$1$I$20190904$20240722$20240801$20240801$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117172$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$52.5$KG$20240801$$MD$KR$KR
241607191$24160719$1$I$$20240725$20240801$20240801$EXP$$MX-BRISTOL-MYERS SQUIBB COMPANY-2024-120796$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$CN$MX$MX
241607201$24160720$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121160$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240801$$CN$US$US
241607211$24160721$1$I$20240725$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121380$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240801$$HP$US$US
241607221$24160722$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121010$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240801$$CN$US$US
241607231$24160723$1$I$$20240724$20240801$20240801$EXP$E2B_03403713$CA-APOTEX-2021AP013226$APOTEX$$$$$M$Y$$$20240801$$HP$CA$CA
241607241$24160724$1$I$20180320$20240722$20240801$20240801$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117862$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$72$KG$20240801$$MD$KR$KR
241607251$24160725$1$I$$20240725$20240801$20240801$EXP$$GB-TAKEDA-2024TUS076141$TAKEDA$$$$A$F$Y$$$20240801$$CN$GB$GB
241607263$24160726$3$F$20240524$20240908$20240801$20240917$30DAY$$US-AMGEN-USASP2024150435$AMGEN$$62$YR$A$M$Y$94.785$KG$20240917$$PH$US$US
241607272$24160727$2$F$20240520$20240820$20240801$20240826$30DAY$$US-AMGEN-USASP2024150445$AMGEN$$51$YR$A$F$Y$67.574$KG$20240826$$PH$US$US
241607281$24160728$1$I$$20240722$20240801$20240801$EXP$$US-AMGEN-USASP2024149121$AMGEN$Maalouf N.M.; Foster E.. Use of Cinacalcet for the Management of Primary Hyperparathyroidism in Pregnancy. JCEM Case Reports. 2024;2 (7):1-5$28$YR$A$F$Y$$$20240801$$HP$US$US
241607291$24160729$1$I$20240729$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151519$AMGEN$$74$YR$E$M$Y$$$20240801$$CN$US$US
241607301$24160730$1$I$$20240717$20240801$20240801$PER$$US-TEVA-VS-3223607$TEVA$$$$$F$Y$$$20240801$$HP$US$US
241607311$24160731$1$I$$20240726$20240801$20240801$EXP$$CA-APOTEX-2024AP008916$APOTEX$$58$YR$$F$Y$58.503$KG$20240801$$HP$CA$CA
241607322$24160732$2$F$$20240821$20240801$20240822$PER$$US-ALXN-202407USA001913US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
241607331$24160733$1$I$20240616$20240730$20240801$20240801$EXP$$IN-ROCHE-10000044915$ROCHE$$68$YR$E$M$Y$$$20240801$$CN$IN$IN
241607341$24160734$1$I$$20240308$20240801$20240801$PER$$US-SAGENT PHARMACEUTICALS-2024SAG000081$SAGENT$$$$$M$Y$$$20240731$$PH$US$US
241607351$24160735$1$I$$20240730$20240801$20240801$PER$$US-AstraZeneca-2024A173995$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241607361$24160736$1$I$$20240724$20240801$20240801$EXP$$DK-AstraZeneca-2024A171359$ASTRAZENECA$$75$YR$$M$Y$88.7$KG$20240801$$MD$NL$
241607371$24160737$1$I$$20240724$20240801$20240801$EXP$$ZA-AstraZeneca-2024A169098$ASTRAZENECA$$51$YR$$F$Y$$$20240801$$CN$ZA$
241607381$24160738$1$I$20240730$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120988$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240801$$HP$US$US
241607391$24160739$1$I$$20240728$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121480$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$50.35$KG$20240801$$CN$US$US
241607401$24160740$1$I$$20240730$20240801$20240801$PER$$US-ROCHE-10000045983$ROCHE$$$$$$Y$$$20240801$$CN$US$US
241607411$24160741$1$I$20240111$20240722$20240801$20240801$EXP$FR-AFSSAPS-NC2024000838$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110253$ZYDUS PHARM$$$$$$Y$$$20240801$$MD$FR$FR
241607431$24160743$1$I$20240702$20240722$20240801$20240801$EXP$FR-AFSSAPS-PC2024000583$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110267$ZYDUS PHARM$$$$$$Y$$$20240801$$MD$FR$FR
241607441$24160744$1$I$20230101$20240722$20240801$20240801$EXP$FR-AFSSAPS-GR2024000892$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110193$ZYDUS PHARM$$$$$$Y$$$20240801$$MD$FR$FR
241607451$24160745$1$I$$20240731$20240801$20240801$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043137$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240801$$CN$US$US
241607461$24160746$1$I$20240725$20240730$20240801$20240801$EXP$$CN-ROCHE-10000043384$ROCHE$$44$YR$A$F$Y$68$KG$20240801$$HP$CN$CN
241607472$24160747$2$F$$20240814$20240801$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121576$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240816$$CN$US$US
241607481$24160748$1$I$$20240724$20240801$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119544$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$MD$JP$JP
241607491$24160749$1$I$$20240729$20240801$20240801$EXP$$FR-AMGEN-FRASP2021149384$AMGEN$$$$$F$Y$$$20240801$$HP$FR$FR
241607501$24160750$1$I$$20240725$20240801$20240801$EXP$$CN-VANTIVE-2024VAN018652$Vantive US Healthcare$$$$$F$Y$$$20240801$$CN$CN$CN
241607512$24160751$2$F$$20240801$20240801$20240806$EXP$$CH-JNJFOC-20240778407$JOHNSON AND JOHNSON$$9$DEC$E$$Y$$$20240806$$MD$CH$CH
241607521$24160752$1$I$$20240730$20240801$20240801$PER$$US-JNJFOC-20240783577$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$US$US
241607531$24160753$1$I$$20240722$20240801$20240801$EXP$$GB-JNJFOC-20240759737$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$HP$GB$GB
241607542$24160754$2$F$20240701$20240726$20240801$20240801$EXP$$CA-APOTEX-2024AP008614$APOTEX$$80$YR$E$M$Y$$$20240801$$HP$CA$CA
241607551$24160755$1$I$$20240719$20240801$20240801$PER$$US-AstraZeneca-2024A165949$ASTRAZENECA$$$$$$Y$$$20240801$$CN$US$
241607561$24160756$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A169964$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241607571$24160757$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A169772$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241607581$24160758$1$I$$20240724$20240801$20240801$PER$$US-AstraZeneca-2024A169273$ASTRAZENECA$$$$$F$Y$$$20240801$$HP$US$
241607591$24160759$1$I$$20240722$20240801$20240801$EXP$$BR-TAKEDA-2024TUS073556$TAKEDA$$$$$F$Y$63$KG$20240801$$CN$BR$BR
241607602$24160760$2$F$$20240723$20240801$20240801$EXP$$US-AMGEN-USASP2024148019$AMGEN$$$$$$Y$$$20240801$$HP$US$US
241607611$24160761$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156814$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241607621$24160762$1$I$$20240718$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115711$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240801$$MD$US$US
241607631$24160763$1$I$20240619$20240729$20240801$20240801$EXP$FR-AFSSAPS-MP2024001224$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-120498$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$85.5$KG$20240801$$MD$FR$FR
241607641$24160764$1$I$$20240730$20240801$20240801$EXP$$GB-ABBVIE-5862283$ABBVIE$$$$$M$Y$$$20240801$$HP$GB$GB
241607653$24160765$3$F$20240523$20240720$20240801$20240805$EXP$$NL-AUROBINDO-AUR-APL-2024-036967$AUROBINDO$$52$YR$$F$Y$$$20240805$$CN$NL$NL
241607662$24160766$2$F$20240719$20240814$20240801$20240822$EXP$$JP-ROCHE-10000037676$ROCHE$$8$DEC$E$F$Y$$$20240822$$MD$JP$JP
241607671$24160767$1$I$20240701$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151510$AMGEN$$$$$$Y$$$20240801$$CN$US$US
241607681$24160768$1$I$$20240727$20240801$20240801$EXP$$US-BEIGENE-BGN-2024-011817$BEIGENE$$$$$$Y$$$20240801$$CN$US$US
241607691$24160769$1$I$20240601$20240723$20240801$20240801$EXP$$US-HBP-2024US030956$HELSINN HEALTHCARE$$70$YR$$M$Y$$$20240801$$CN$US$US
241607702$24160770$2$F$$20240813$20240801$20240821$EXP$$CA-APOTEX-2024AP008927$APOTEX$$67$YR$$F$Y$$$20240821$$CN$CA$CA
241607712$24160771$2$F$$20240801$20240801$20240807$EXP$$BG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042105$BOEHRINGER INGELHEIM$Bocheva A, Konova L, Shalamanov P. Metastases to the spine, pelvic bones, and scapula in a patient with breast carcinoma (Clinical case report). InSpiro. 2024 Jul 23;73(5, 2023):$52$YR$A$F$Y$$$20240807$$MD$BG$BG
241607721$24160772$1$I$$20240720$20240801$20240801$EXP$$FR-AUROBINDO-AUR-APL-2024-038066$AUROBINDO$Kamel ME, Marzullo C, Maguet H, Checkouri A, Pointurier V, Oudeville P. Metabolic acidosis in a context of  chronic paracetamol intoxication (Acidose m?tabolique dans un contexte d?intoxication chronique au parac?tamol). Summaries. 2024$18$YR$$F$Y$$$20240801$$HP$FR$FR
241607731$24160773$1$I$20240715$20240720$20240801$20240801$EXP$$DE-AUROBINDO-AUR-APL-2024-037112$AUROBINDO$$80$YR$$F$Y$$$20240801$$PH$DE$DE
241607742$24160774$2$F$20240415$20240919$20240801$20240928$EXP$$AU-CELLTRION INC.-2024AU018330$CELLTRION$$$$$$Y$$$20240928$$MD$AU$AU
241607753$24160775$3$F$$20240816$20240801$20240827$EXP$$CA-ROCHE-10000037271$ROCHE$$$$A$F$Y$$$20240827$$HP$CA$CA
241607761$24160776$1$I$20240729$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150932$AMGEN$$73$YR$E$M$Y$$$20240801$$CN$US$US
241607771$24160777$1$I$20240703$20240725$20240801$20240801$EXP$$JP-AMGEN-JPNSP2024148811$AMGEN$$$$E$M$Y$$$20240801$$MD$JP$JP
241607791$24160779$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020014$ELI LILLY AND CO$$$$$F$Y$$$20240801$$CN$US$US
241607801$24160780$1$I$20240730$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020303$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240801$$CN$US$US
241607811$24160781$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019780$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240801$$CN$US$US
241607821$24160782$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019507$ELI LILLY AND CO$$$$$$Y$$$20240801$$HP$US$US
241607831$24160783$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000151$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240801$$HP$US$US
241607841$24160784$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407018894$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240801$$CN$US$US
241607851$24160785$1$I$$20240723$20240801$20240801$EXP$$US-APOTEX-2024AP008820$APOTEX$Santoli J, Aldakkour JL, Tohidi H, Lin Y.. Metformin-Associated Lactic Acidosis: A Case Report. HCA Healthcare Journal of Medicine. 2023;4: 2:215-218$62$YR$$M$Y$$$20240801$$MD$US$US
241607871$24160787$1$I$20230103$20240725$20240801$20240801$EXP$$US-GSK-US2024093576$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
241607881$24160788$1$I$20240712$20240725$20240801$20240801$EXP$$CN-ROCHE-10000038128$ROCHE$$45$YR$A$F$Y$49$KG$20240801$$HP$CN$CN
241607891$24160789$1$I$$20240725$20240801$20240801$PER$$US-ABBVIE-5856584$ABBVIE$$30$YR$$F$Y$$$20240801$$HP$US$US
241607901$24160790$1$I$20240101$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151322$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241607911$24160791$1$I$20240101$20240730$20240801$20240801$EXP$$CA-ABBVIE-5862335$ABBVIE$$$$$$Y$$$20240801$$HP$CA$CA
241607921$24160792$1$I$$20240729$20240801$20240801$PER$$US-ABBVIE-5860010$ABBVIE$$$$$$Y$$$20240801$$CN$US$US
241607931$24160793$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5861133$ABBVIE$$$$$$Y$$$20240801$$HP$US$US
241607941$24160794$1$I$$20240730$20240801$20240801$EXP$FR-AFSSAPS-NT2024000950$FR-ORGANON-O2407FRA002774$ORGANON$$86$YR$$F$Y$$$20240801$$MD$FR$FR
241607951$24160795$1$I$$20211019$20240801$20240801$EXP$$US-AstraZeneca-2021A781723$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241607961$24160796$1$I$$20240724$20240801$20240801$EXP$$ZA-AstraZeneca-2024A168850$ASTRAZENECA$$93$YR$$F$Y$$$20240801$$CN$ZA$
241607971$24160797$1$I$$20220426$20240801$20240801$EXP$$US-AstraZeneca-2022A111032$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241607981$24160798$1$I$20240611$20240722$20240801$20240801$EXP$IT-MINISAL02-990806$IT-TEVA-VS-3215140$TEVA$$75$YR$$M$Y$$$20240801$$MD$IT$IT
241607993$24160799$3$F$$20240822$20240801$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120460$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$83.46$KG$20240824$$CN$US$US
241608001$24160800$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121496$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240801$$CN$US$US
241608011$24160801$1$I$$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121538$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240801$$CN$US$US
241608022$24160802$2$F$$20240819$20240801$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-120279$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240826$$PH$JP$JP
241608031$24160803$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121337$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240801$$CN$US$US
241608041$24160804$1$I$$20240725$20240801$20240801$PER$$US-EMD Serono-2024040769$EMD SERONO INC$$31$YR$A$F$Y$$$20240801$$CN$US$US
241608051$24160805$1$I$$20240722$20240801$20240801$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005428$BIOCON$$$$$$Y$$$20240801$$HP$CA$CA
241608061$24160806$1$I$20240710$20240724$20240801$20240801$PER$$US-ABBVIE-5856937$ABBVIE$$34$YR$$F$Y$$$20240801$$MD$US$US
241608071$24160807$1$I$$20240726$20240801$20240801$PER$$US-ABBVIE-5857087$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241608081$24160808$1$I$$20240709$20240801$20240801$PER$$US-JNJFOC-20240724506$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240801$$CN$US$US
241608101$24160810$1$I$20240701$20240728$20240801$20240801$EXP$$IR-EMD Serono-2024040874$EMD SERONO INC$$24$YR$A$F$Y$$$20240801$$CN$IR$IR
241608111$24160811$1$I$20240723$20240729$20240801$20240801$EXP$$US-JNJFOC-20240778656$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240801$$HP$US$US
241608121$24160812$1$I$$20240723$20240801$20240801$EXP$$GB-CELLTRION INC.-2024GB018153$CELLTRION$$$$$$Y$$$20240801$$CN$GB$GB
241608131$24160813$1$I$$20240719$20240801$20240801$EXP$$EG-ROCHE-10000033367$ROCHE$$61$YR$A$F$Y$80$KG$20240801$$HP$EG$EG
241608144$24160814$4$F$20240723$20240819$20240801$20240824$EXP$$US-ABBVIE-5858503$ABBVIE$$69$YR$$M$Y$58.966$KG$20240824$$CN$US$US
241608152$24160815$2$F$20210204$20240910$20240801$20240917$EXP$$CA-ROCHE-2303799$ROCHE$$25$YR$A$M$Y$$$20240917$$CN$CA$CA
241608162$24160816$2$F$20240723$20240822$20240801$20240829$EXP$$JP-GENMAB-2024-02675$GENMAB$$9$DEC$$M$Y$$$20240829$$PH$JP$JP
241608171$24160817$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121433$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240801$$CN$US$US
241608182$24160818$2$F$$20240730$20240801$20240802$PER$$NVSC2024US156941$NOVARTIS$$$$$F$Y$$$20240802$$HP$US$US
241608191$24160819$1$I$20180718$20240722$20240801$20240801$EXP$$AU-TEVA-VS-3226318$TEVA$$56$YR$$F$Y$$$20240801$$MD$AU$AU
241608201$24160820$1$I$$20240730$20240801$20240801$PER$$US-BIOVITRUM-2024-US-010445$BIOVITRUM$$62$YR$$F$Y$$$20240801$$MD$US$US
241608221$24160822$1$I$$20240730$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069352$SANDOZ$Drew Kuraitis. Relapse or recall? Docetaxel-associatedre-emergence of paraneoplasticdermatomyositis. JAAD CASE REPORTS. 2024;50:33-6$68$YR$$M$Y$$$20240801$$MD$US$US
241608234$24160823$4$F$$20240919$20240801$20240923$PER$$US-ROCHE-10000031775$ROCHE$$$$$F$Y$$$20240923$$MD$US$US
241608241$24160824$1$I$20210201$20240730$20240801$20240801$EXP$FR-AFSSAPS-NY2024000798$FR-ROCHE-10000041917$ROCHE$$52$YR$A$F$Y$78$KG$20240801$$MD$FR$FR
241608252$24160825$2$F$20240725$20240807$20240801$20240812$PER$$US-AMGEN-USASP2024149589$AMGEN$$$$$F$Y$$$20240812$$PH$US$US
241608262$24160826$2$F$$20240821$20240801$20240831$EXP$$CA-APOTEX-2024AP008939$APOTEX$$70$YR$$F$Y$66$KG$20240831$$MD$CA$CA
241608282$24160828$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225403$TEVA$Gupta A, Wojnowski K, Gurung P. Mucormycosis - A Rare Etiology of Empyema Nessisitans. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).; Gupta A, Wojnowski K, Gurung P. Mucormycosis - A Rare Etiology of Empyema Nessisitans. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$55$YR$$M$Y$$$20240816$$HP$US$US
241608292$24160829$2$F$20240731$20240731$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043134$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240802$$CN$US$US
241608301$24160830$1$I$$20220526$20240801$20240801$EXP$$US-AstraZeneca-2022A201990$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241608313$24160831$3$F$$20240905$20240801$20240910$PER$$US-AstraZeneca-2024A173474$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
241608321$24160832$1$I$20240730$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020079$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240801$$CN$US$US
241608331$24160833$1$I$20240601$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407018936$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240801$$CN$US$US
241608341$24160834$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019592$ELI LILLY AND CO$$$$$F$Y$$$20240801$$CN$US$US
241608351$24160835$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000181$ELI LILLY AND CO$$$$$M$Y$$$20240801$$MD$US$US
241608361$24160836$1$I$20240730$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019630$ELI LILLY AND CO$$$$$$Y$$$20240801$$CN$US$US
241608371$24160837$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5859609$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241608381$24160838$1$I$$20240725$20240801$20240801$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-23367$SAMSUNG BIOEPIS$$$$A$F$Y$$$20240801$$CN$CA$CA
241608391$24160839$1$I$$20240719$20240801$20240801$EXP$GB-MHRA-MED-202407190926201320-QNYGS$GB-ADVANZ PHARMA-202407006154$ADVANZ PHARMA$$$$$$Y$$$20240801$$HP$GB$GB
241608401$24160840$1$I$$20240730$20240801$20240801$EXP$$US-TAKEDA-2024TUS076765$TAKEDA$$$$$F$Y$$$20240801$$CN$US$US
241608411$24160841$1$I$$20240719$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115841$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240722$$CN$US$US
241608421$24160842$1$I$$20240703$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106653$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240704$$HP$US$US
241608432$24160843$2$F$$20240722$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116555$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240723$$CN$US$US
241608441$24160844$1$I$$20240723$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117377$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240724$$CN$US$US
241608451$24160845$1$I$20240101$20240723$20240801$20240801$EXP$$US-ABBVIE-5852094$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241608461$24160846$1$I$$20240730$20240801$20240801$PER$$US-HALEON-2189947$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241608471$24160847$1$I$$20240726$20240801$20240801$EXP$$US-TAKEDA-2024TUS075873$TAKEDA$$$$$M$Y$$$20240801$$MD$US$US
241608481$24160848$1$I$$20240722$20240801$20240801$30DAY$$US-GSK-US2024AMR092134$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
241608494$24160849$4$F$20240702$20240918$20240801$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022366$UNITED THERAPEUTICS$$79$YR$$F$Y$45.351$KG$20240926$$$US$US
241608501$24160850$1$I$20240529$20240730$20240801$20240801$EXP$$CN-HALEON-2189765$Haleon PLC$$45$YR$$F$Y$65$KG$20240801$$HP$CN$CN
241608512$24160851$2$F$$20240828$20240801$20240903$EXP$IT-GERMAN-LIT/ITA/24/0011106$IT-RDY-LIT/ITA/24/0011106$DR REDDYS$Borotti E, Ronda E, Guidotti S, Scarpa A, Schiro A, Cortellazzi P, et al. GENETIC MOLECULAR PROFILE IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENT FROM ONSET TO POST-TRANSPLANT RELAPSE A CASE REPORT. Haematologica. 2024 Mar;109(90): P067.$57$YR$A$F$Y$$$20240903$$HP$IT$IT
241608521$24160852$1$I$$20240726$20240801$20240801$EXP$$AU-RDY-SPO/AUS/24/0011176$DR REDDYS$$58$YR$A$M$Y$$$20240801$$CN$AU$AU
241608531$24160853$1$I$20240701$20240703$20240801$20240801$PER$$US-009507513-2407USA001943$MERCK$$$$$F$Y$$$20240801$$HP$US$US
241608541$24160854$1$I$$20240731$20240801$20240801$PER$$US-ROCHE-10000046285$ROCHE$$20$YR$A$M$Y$$$20240801$$HP$US$US
241608551$24160855$1$I$20240720$20240722$20240801$20240801$30DAY$$US-GSK-US2024091810$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240801$$CN$US$US
241608571$24160857$1$I$$20240722$20240801$20240801$EXP$$US-GSK-US2024AMR092612$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
241608592$24160859$2$F$$20240729$20240801$20240808$PER$$US-ABBVIE-5859828$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241608602$24160860$2$F$$20240820$20240801$20240820$PER$$US-ALXN-202407USA001802US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
241608613$24160861$3$F$20220101$20240902$20240801$20240910$PER$$US-ROCHE-10000034809$ROCHE$$40$YR$A$F$Y$61.23$KG$20240910$$CN$US$US
241608621$24160862$1$I$20240601$20240730$20240801$20240801$EXP$$NVSC2024SK156570$NOVARTIS$$$$E$M$Y$$$20240801$$HP$SK$SK
241608631$24160863$1$I$20240711$20240717$20240801$20240801$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00361$MELINTA THERAPEUTICS$$$$$$Y$$$20240801$$MD$CN$CN
241608641$24160864$1$I$$20240724$20240801$20240801$PER$$US-ROCHE-3556790$ROCHE$$86$YR$E$F$Y$$$20240801$$CN$US$US
241608651$24160865$1$I$$20240729$20240801$20240801$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-23404$SAMSUNG BIOEPIS$$33$YR$A$F$Y$$$20240801$$CN$GB$GB
241608661$24160866$1$I$20240101$20240724$20240801$20240801$EXP$$JP-GENMAB-2024-02679$GENMAB$$$$$$Y$$$20240801$$MD$JP$JP
241608671$24160867$1$I$$20240722$20240801$20240801$EXP$$US-GSK-US2024091823$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$HP$US$US
241608681$24160868$1$I$20240118$20240722$20240801$20240801$EXP$FR-AFSSAPS-DJ2024000846$FR-Accord-438403$ACCORD$$44$YR$A$F$Y$63$KG$20240801$$MD$FR$FR
241608691$24160869$1$I$$20240722$20240801$20240801$EXP$NL-LRB-00992949$NL-Accord-438373$ACCORD$$66$YR$E$F$Y$69$KG$20240801$$CN$NL$NL
241608701$24160870$1$I$20240708$20240723$20240801$20240801$EXP$$US-Accord-437297$ACCORD$$21$YR$A$M$Y$$$20240801$$HP$US$US
241608711$24160871$1$I$20220415$20240722$20240801$20240801$EXP$FR-AFSSAPS-PP2024000812$FR-Accord-437955$ACCORD$$60$YR$A$F$Y$75$KG$20240801$$MD$FR$FR
241608721$24160872$1$I$20240515$20240722$20240801$20240801$EXP$SE-SEMPA-2024-005426$SE-Accord-437853$ACCORD$$41$YR$A$F$Y$76$KG$20240801$$MD$SE$SE
241608732$24160873$2$F$$20240801$20240801$20240813$EXP$$US-Accord-437977$ACCORD$Stewart MA, Rives TA, Blanton K, Baldwin L. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecologic Oncology Reports. 2024; 54:101452.$33$YR$A$F$Y$$$20240813$$MD$US$US
241608741$24160874$1$I$$20240723$20240801$20240801$EXP$CA-MHPD-E2B_07121316$CA-Accord-437868$ACCORD$$70$YR$E$F$Y$$$20240801$$CN$CA$CA
241608751$24160875$1$I$20240601$20240725$20240801$20240801$EXP$SE-SEMPA-2024-005474$SE-SA-2024SA221351$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240801$$MD$SE$SE
241608761$24160876$1$I$$20240727$20240801$20240801$EXP$$US-TAKEDA-2024TUS076468$TAKEDA$$$$$F$Y$$$20240801$$MD$US$US
241608771$24160877$1$I$20240710$20240722$20240801$20240801$EXP$$CA-TAKEDA-2024TUS074684$TAKEDA$$73$YR$$F$Y$$$20240801$$CN$CA$CA
241608781$24160878$1$I$$20240731$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069752$SANDOZ$$$$$F$Y$$$20240801$$CN$US$US
241608791$24160879$1$I$$20240722$20240801$20240801$EXP$CA-MHPD-001088091$CA-Accord-437696$ACCORD$$71$YR$E$M$Y$$$20240801$$HP$CA$CA
241608801$24160880$1$I$$20240730$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069719$SANDOZ$$$$$M$Y$$$20240801$$CN$US$US
241608812$24160881$2$F$20220101$20240724$20240801$20240813$EXP$$BR-SANDOZ INC.-SDZ2024BR069537$SANDOZ$$$$$F$Y$$$20240813$$CN$BR$BR
241608821$24160882$1$I$$20240731$20240801$20240801$EXP$GB-MHRA-MED-202407311157498130-FKZLG$GB-SANDOZ INC.-SDZ2024GB069588$SANDOZ$$$$$$Y$$$20240801$$PH$GB$GB
241608841$24160884$1$I$$20240725$20240801$20240801$EXP$$US-SA-2024SA221461$SANOFI AVENTIS$$54$YR$A$F$Y$67.13$KG$20240801$$CN$US$US
241608851$24160885$1$I$20240313$20240726$20240801$20240801$EXP$FR-AFSSAPS-NT2024000875$FR-SA-2024SA222369$SANOFI AVENTIS$$23$YR$A$M$Y$51$KG$20240801$$MD$FR$FR
241608861$24160886$1$I$$20240729$20240801$20240801$EXP$$AU-ROCHE-10000043455$ROCHE$Lorger S, McClintock G, Watson G, Liu K, Jeffery N. Hepatocellular carcinoma metastasis presenting as a pedunculated bladder mass. Urology Case Reports. 2024-Sep;56:1-3. doi:10.1016/j.eucr.2024.102801.$66$YR$E$M$Y$$$20240801$$HP$AU$AU
241608883$24160888$3$F$$20240913$20240801$20240923$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-23291$SAMSUNG BIOEPIS$$72$YR$E$F$Y$$$20240923$$CN$GB$GB
241608901$24160890$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121045$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240801$$CN$US$US
241608912$24160891$2$F$$20240821$20240801$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06889$LUPIN$$$$$$Y$$$20240909$$CN$US$US
241608921$24160892$1$I$20240707$20240729$20240801$20240801$EXP$FR-AFSSAPS-PO2024000834$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-119994$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$66$KG$20240801$$MD$FR$FR
241608933$24160893$3$F$20240327$20240806$20240801$20240813$EXP$$US-TAKEDA-2024TUS030066$TAKEDA$$65$YR$$M$Y$69.84$KG$20240813$$MD$US$US
241608941$24160894$1$I$$20230802$20240801$20240801$EXP$$CA-AstraZeneca-2023A155900$ASTRAZENECA$$$$$M$Y$$$20240801$$MD$CA$
241608951$24160895$1$I$20210427$20210616$20240801$20240801$EXP$$US-AstraZeneca-2021A366602$ASTRAZENECA$$22560$DY$$M$Y$320$KG$20240801$$CN$US$
241608961$24160896$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A169211$ASTRAZENECA$$$$$F$Y$46$KG$20240801$$CN$US$
241608971$24160897$1$I$$20240726$20240801$20240801$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001539$BLUEPRINT MEDICINES$$$$$F$Y$$$20240801$$CN$US$US
241608981$24160898$1$I$20240617$20240717$20240801$20240801$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00364$UNKNOWN$$$$$$Y$$$20240801$$MD$CN$CN
241608991$24160899$1$I$20240727$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151237$AMGEN$$65$YR$E$F$Y$$$20240801$$CN$US$US
241609002$24160900$2$F$20240712$20240903$20240801$20240906$PER$$US-AMGEN-USASP2024148149$AMGEN$$$$$$Y$$$20240906$$PH$US$US
241609012$24160901$2$F$$20240815$20240801$20240817$PER$$US-JNJFOC-20240776957$JOHNSON AND JOHNSON$$$$$$Y$$$20240817$$HP$US$US
241609021$24160902$1$I$20220701$20240719$20240801$20240801$PER$$US-JNJFOC-20240756348$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240801$$CN$US$US
241609031$24160903$1$I$$20240730$20240801$20240801$EXP$$US-ABBVIE-5861452$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241609042$24160904$2$F$$20240927$20240801$20240930$EXP$$NVSC2024US154846$NOVARTIS$$$$$M$Y$$$20240930$$MD$US$US
241609051$24160905$1$I$$20240722$20240801$20240801$30DAY$$US-GSK-US2024091857$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
241609061$24160906$1$I$20240723$20240726$20240801$20240801$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-23262$SAMSUNG BIOEPIS$$35$YR$A$M$Y$$$20240801$$HP$CA$CA
241609071$24160907$1$I$$20240725$20240801$20240801$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-23101$SAMSUNG BIOEPIS$$74$YR$E$M$Y$$$20240801$$PH$GB$GB
241609081$24160908$1$I$$20240723$20240801$20240801$PER$$US-EMD Serono-2024040267$EMD SERONO INC$$71$YR$E$F$Y$$$20240801$$CN$US$US
241609091$24160909$1$I$20240320$20240420$20240801$20240801$PER$$US-AJANTA-2024AJA00082$AJANTA PHARMA$$64$YR$A$$Y$$$20240801$$CN$US$US
241609102$24160910$2$F$$20240819$20240801$20240823$EXP$$JP-AMGEN-JPNSP2024150163$AMGEN$$93$YR$E$F$Y$$$20240823$$MD$JP$JP
241609111$24160911$1$I$$20240726$20240801$20240801$EXP$$JP-AMGEN-JPNSP2024078652$AMGEN$$83$YR$E$F$Y$$$20240801$$MD$JP$JP
241609121$24160912$1$I$20240101$20240729$20240801$20240801$EXP$$US-ABBVIE-5860069$ABBVIE$$60$YR$$M$Y$$$20240801$$CN$US$US
241609131$24160913$1$I$$20240731$20240801$20240801$EXP$$MW-BRISTOL-MYERS SQUIBB COMPANY-2024-121356$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240801$$MD$MW$MW
241609141$24160914$1$I$$20240722$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116652$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240801$$HP$US$US
241609151$24160915$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121123$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240801$$CN$US$US
241609161$24160916$1$I$20240729$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121069$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$89.81$KG$20240801$$CN$US$US
241609171$24160917$1$I$20240701$20240729$20240801$20240801$EXP$$US-ABBVIE-5860281$ABBVIE$$66$YR$$F$Y$$$20240801$$CN$US$US
241609182$24160918$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225321$TEVA$Osei KM, Wuni G, Mehta N, Gupta SK. Comparative Analysis of Right Ventricular (RV) Apical Pacing versus Physiologic Left Bundle Branch Area Pacing (LBBAP) in Hypertrophic Cardiomyopathy With Left Ventricular Outflow Tract Obstruction (LVOTO): A Case Study. Circulation 2023; 148 (Suppl.).; Osei KM, Wuni G, Mehta N, Gupta SK. Comparative Analysis of Right Ventricular (RV) Apical Pacing versus Physiologic Left Bundle Branch Area Pacing (LBBAP) in Hypertrophic Cardiomyopathy With Left Ventricular...$69$YR$$F$Y$$$20240816$$HP$US$US
241609192$24160919$2$F$$20240826$20240801$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06891$LUPIN$$$$$$Y$$$20240916$$CN$US$US
241609203$24160920$3$F$20240723$20240905$20240801$20240913$EXP$$CA-CELLTRION INC.-2024CA018284$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
241609221$24160922$1$I$20240728$20240729$20240801$20240801$EXP$$NVSC2024DE155935$NOVARTIS$$$$E$F$Y$$$20240801$$CN$DE$DE
241609231$24160923$1$I$$20240624$20240801$20240801$PER$$US-CHATTEMPRD-2024OHG025406$CHATTEM$$43$YR$A$F$Y$$$20240801$$CN$US$US
241609242$24160924$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225946$TEVA$Warus J, Hidalgo MA, Belzer M, Olson-Kennedy J. Acute HIV Diagnosis After Initiation of Pre-exposure Prophylaxis in a Young Adult Patient: A Case Report. J-Adolesc-Health 2024; 74 (1): 205-207.; Warus J, Hidalgo MA, Belzer M, Olson-Kennedy J. Acute HIV Diagnosis After Initiation of Pre-exposure Prophylaxis in a Young Adult Patient: A Case Report. J-Adolesc-Health 2024; 74 (1): 205-207.$18$YR$$M$Y$$$20240816$$MD$US$US
241609251$24160925$1$I$$20240702$20240801$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06888$LUPIN$$$$$$Y$$$20240801$$CN$US$US
241609261$24160926$1$I$$20240722$20240801$20240801$EXP$$US-GSK-US2024091825$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
241609271$24160927$1$I$$20240722$20240801$20240801$30DAY$$US-GSK-US2024AMR092534$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
241609281$24160928$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5859823$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241609293$24160929$3$F$20240101$20240819$20240801$20240822$EXP$$CH-ABBVIE-5860135$ABBVIE$$$$$F$Y$$$20240822$$CN$CH$CH
241609303$24160930$3$F$20240727$20240924$20240801$20240926$PER$$US-AMGEN-USASP2024151155$AMGEN$$73$YR$E$F$Y$$$20240926$$CN$US$US
241609312$24160931$2$F$20240730$20240806$20240801$20240808$PER$$US-AMGEN-USASP2024151840$AMGEN$$76$YR$E$F$Y$$$20240808$$CN$US$US
241609322$24160932$2$F$20221201$20240808$20240801$20240809$EXP$$US-CIPLA LTD.-2024US07959$CIPLA$Khan S, Yetiskul E, Khattar G, Ghada A, Afif S, Khan MWZ, et al.. Failure of the PD-1 blocking agent Pembrolizumab to benefit a patient with renal squamous cell cancer. European journal of case reports in internal medicine. 2024;11$$$$$Y$$$20240809$$MD$US$US
241609331$24160933$1$I$$20240726$20240801$20240801$EXP$$SG-ROCHE-10000037567$ROCHE$$68$YR$E$M$Y$$$20240801$$CN$SG$SG
241609341$24160934$1$I$20240724$20240726$20240801$20240801$EXP$$US-APOTEX-2024AP008943$APOTEX$$$$$F$Y$$$20240801$$CN$US$US
241609351$24160935$1$I$$20240726$20240801$20240801$EXP$$CA-APOTEX-2024AP008930$APOTEX$$67$YR$$F$Y$$$20240801$$CN$CA$CA
241609361$24160936$1$I$$20240607$20240801$20240801$30DAY$$CL-UCBSA-2024029977$UCB$$$$$F$Y$$$20240801$$CN$CL$CL
241609371$24160937$1$I$20230701$20240729$20240801$20240801$EXP$ES-AEMPS-1549766$ES-TAKEDA-2024TUS075992$TAKEDA$$57$YR$$M$Y$$$20240801$$HP$ES$ES
241609381$24160938$1$I$$20240722$20240801$20240801$EXP$$CN-MSNLABS-2024MSNLIT01652$MSN LABORATORIES$$$$$$Y$$$20240801$$HP$CN$CN
241609391$24160939$1$I$$20240724$20240801$20240801$EXP$$JP-ROCHE-10000041792$ROCHE$$5$DEC$A$M$Y$$$20240801$$MD$JP$JP
241609404$24160940$4$F$20240727$20240910$20240801$20240912$EXP$$FR-ABBVIE-5861243$ABBVIE$$43$YR$$F$Y$61$KG$20240912$$MD$FR$FR
241609411$24160941$1$I$20240705$20240730$20240801$20240801$PER$$US-JNJFOC-20240781281$JOHNSON AND JOHNSON$$59$YR$A$$Y$$$20240801$$PH$US$US
241609421$24160942$1$I$$20240725$20240801$20240801$EXP$$US-JNJFOC-20240769441$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$US$US
241609432$24160943$2$F$20240726$20240809$20240801$20240812$EXP$$GR-ABBVIE-5861287$ABBVIE$$51$YR$$F$Y$99$KG$20240812$$MD$GR$GR
241609441$24160944$1$I$$20240731$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-029907$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240801$$CN$US$US
241609451$24160945$1$I$20240731$20240731$20240801$20240801$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043066$BOEHRINGER INGELHEIM$$$$$$Y$$$20240801$$HP$US$US
241609461$24160946$1$I$$20240731$20240801$20240801$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042968$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240801$$HP$SG$SG
241609473$24160947$3$F$20240301$20240807$20240801$20240819$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043185$BOEHRINGER INGELHEIM$$6$DEC$A$M$Y$$$20240819$$MD$JP$JP
241609481$24160948$1$I$$20240718$20240801$20240801$EXP$$JP-RICONPHARMA, LLC-2024RIC000052$RICONPHARMA$Naganuma J, Suzumura H, Koyama S, Yaginuma M, Fujita Y, Kagami M, et al.. Pseudohypoparathyroidism type 1B with involuntary movements: a case report and literature review.. Clinical Pediatric Endocrinology. 2024;33(3):151-156$7$YR$$F$Y$19.8$KG$20240801$$MD$JP$JP
241609491$24160949$1$I$$20240724$20240801$20240801$EXP$$GR-TEVA-VS-3226027$TEVA$$$$$F$Y$$$20240801$$MD$GR$GR
241609501$24160950$1$I$$20240725$20240801$20240801$EXP$$CA-CELLTRION INC.-2024CA018005$CELLTRION$$$$$$Y$$$20240801$$HP$CA$CA
241609511$24160951$1$I$$20240718$20240801$20240801$EXP$$JP-UCBSA-2024005828$UCB$$4$YR$$F$Y$$$20240801$$MD$JP$JP
241609521$24160952$1$I$$20240702$20240801$20240801$PER$$US-009507513-2407USA001863$MERCK$$$$$M$Y$63.5$KG$20240801$$MD$US$US
241609531$24160953$1$I$$20240729$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121330$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240801$$CN$US$US
241609541$24160954$1$I$20240501$20240726$20240801$20240801$EXP$ES-AEMPS-1553074$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-119935$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240801$$PH$ES$ES
241609551$24160955$1$I$$20240723$20240801$20240801$PER$$US-ABBVIE-5853403$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241609561$24160956$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121529$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$84.82$KG$20240801$$CN$US$US
241609571$24160957$1$I$20230101$20240724$20240801$20240801$EXP$FR-AFSSAPS-GR2024000892$FR-TEVA-VS-3225636$TEVA$$68$YR$$M$Y$$$20240801$$MD$FR$FR
241609581$24160958$1$I$$20220414$20240801$20240801$EXP$$US-AstraZeneca-2022A152125$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241609591$24160959$1$I$20240622$20240724$20240801$20240801$EXP$$FR-AstraZeneca-2024A168541$ASTRAZENECA$$70$YR$$M$Y$79$KG$20240801$$MD$FR$
241609601$24160960$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A170237$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241609611$24160961$1$I$20240523$20240729$20240801$20240801$EXP$IT-JNJFOC-20240720833$IT-ROCHE-10000040551$ROCHE$$72$YR$E$M$Y$70$KG$20240801$$MD$IT$IT
241609622$24160962$2$F$$20240801$20240801$20240802$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043160$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240802$$CN$US$US
241609631$24160963$1$I$20240728$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150831$AMGEN$$80$YR$E$M$Y$$$20240801$$CN$US$US
241609641$24160964$1$I$$20240726$20240801$20240801$PER$$US-AMGEN-USASP2024149723$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241609651$24160965$1$I$20240101$20240729$20240801$20240801$PER$$US-ABBVIE-5859939$ABBVIE$$$$$$Y$$$20240801$$CN$US$US
241609661$24160966$1$I$20240701$20240724$20240801$20240801$EXP$$JP-ROCHE-10000041775$ROCHE$$7$DEC$E$F$Y$$$20240801$$MD$JP$JP
241609673$24160967$3$F$20230101$20240910$20240801$20240910$EXP$$SG-ROCHE-10000033246$ROCHE$$71$YR$E$F$Y$$$20240910$$CN$SG$SG
241609681$24160968$1$I$20240626$20240725$20240801$20240801$EXP$$CA-APOTEX-2024AP008893$APOTEX$$49$YR$A$F$Y$$$20240801$$HP$CA$CA
241609691$24160969$1$I$20240724$20240730$20240801$20240801$EXP$GB-MHRA-MED-202407271652431410-JMDGK$GB-TEVA-VS-3227924$TEVA$$31$YR$$F$Y$56$KG$20240801$$CN$GB$GB
241609711$24160971$1$I$$20240730$20240801$20240801$EXP$$NVSC2024MY155525$NOVARTIS$$$$$$Y$$$20240801$$MD$MY$MY
241609722$24160972$2$F$20240704$20240809$20240801$20240817$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006192$JAZZ$$22$YR$$F$Y$$$20240817$$CN$US$US
241609731$24160973$1$I$20240724$20240731$20240801$20240801$EXP$$CN-ROCHE-10000046208$ROCHE$$69$YR$E$F$Y$48$KG$20240801$$HP$CN$CN
241609743$24160974$3$F$20230101$20240919$20240801$20240928$EXP$$CA-CELLTRION INC.-2023CA020449$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
241609753$24160975$3$F$20240101$20240821$20240801$20240902$EXP$$JP-ADVANZ PHARMA-202407006254$ADVANZ PHARMA$$$$$$Y$$$20240902$$PH$JP$JP
241609761$24160976$1$I$20240705$20240723$20240801$20240801$EXP$$JP-ROCHE-10000041791$ROCHE$$5$DEC$A$F$Y$$$20240801$$MD$JP$JP
241609781$24160978$1$I$$20240729$20240801$20240801$PER$$US-ABBVIE-5859378$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241609791$24160979$1$I$20240701$20240722$20240801$20240801$30DAY$$US-GSK-US2024092218$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240801$$CN$US$US
241609802$24160980$2$F$$20240816$20240801$20240820$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001536$BLUEPRINT MEDICINES$$$$$F$Y$$$20240820$$MD$US$US
241609811$24160981$1$I$20240725$20240726$20240801$20240801$PER$$US-TAKEDA-2024TUS076080$TAKEDA$$52$YR$$F$Y$120$KG$20240801$$MD$US$US
241609821$24160982$1$I$$20240723$20240801$20240801$EXP$$US-BEH-2024176339$CSL BEHRING$$88$YR$E$F$Y$63.492$KG$20240801$$MD$US$US
241609831$24160983$1$I$$20240724$20240801$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121081$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$MD$JP$JP
241609841$24160984$1$I$20240101$20240725$20240801$20240801$EXP$$US-ABBVIE-5855876$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241609851$24160985$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121179$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240801$$CN$US$US
241609861$24160986$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121589$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$51.26$KG$20240801$$CN$US$US
241609871$24160987$1$I$20240716$20240719$20240801$20240801$EXP$GB-MHRA-MED-202407191119188980-VBRWP$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-110101$ZYDUS PHARM$$$$$$Y$$$20240801$$PH$GB$GB
241609881$24160988$1$I$20240501$20240722$20240801$20240801$EXP$FR-AFSSAPS-GR2024000908$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110250$ZYDUS PHARM$$$$$$Y$$$20240801$$PH$FR$FR
241609891$24160989$1$I$20240721$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150364$AMGEN$$53$YR$A$M$Y$$$20240801$$CN$US$US
241609901$24160990$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000083$ELI LILLY AND CO$$$$$$Y$$$20240801$$CN$US$US
241609911$24160991$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000016$ELI LILLY AND CO$$$$$F$Y$$$20240801$$CN$US$US
241609921$24160992$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000250$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240801$$CN$US$US
241609931$24160993$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020083$ELI LILLY AND CO$$48$YR$A$$Y$$$20240801$$CN$US$US
241609941$24160994$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020051$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240801$$CN$US$US
241609951$24160995$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000009$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240801$$CN$US$US
241609962$24160996$2$F$$20240813$20240801$20240822$EXP$$BR-TAKEDA-2024TUS076646$TAKEDA$$3$YR$$$Y$$$20240822$$CN$BR$BR
241609971$24160997$1$I$$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150823$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241609982$24160998$2$F$$20240829$20240801$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009671$JAZZ$$$$$F$Y$$$20240902$$MD$US$US
241609992$24160999$2$F$$20240806$20240801$20240812$PER$$NVSC2024US156513$NOVARTIS$$$$$M$Y$$$20240812$$HP$US$US
241610001$24161000$1$I$$20240730$20240801$20240801$EXP$$NVSC2024US156049$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
241610011$24161001$1$I$$20240722$20240801$20240801$30DAY$$US-GSK-US2024091801$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
241610031$24161003$1$I$20230104$20240726$20240801$20240801$EXP$$CO-UCBSA-2024038646$UCB$$85$YR$$M$Y$$$20240801$$CN$CO$CO
241610041$24161004$1$I$20220701$20240717$20240801$20240801$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06838$HIKMA$$59$YR$$F$Y$$$20240801$$CN$US$US
241610051$24161005$1$I$$20211228$20240801$20240801$EXP$$US-AstraZeneca-2021A821207$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241610061$24161006$1$I$$20240730$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043238$BOEHRINGER INGELHEIM$$$$$$Y$$$20240801$$CN$US$US
241610071$24161007$1$I$20240420$20240729$20240801$20240801$EXP$$FR-HALEON-2189856$Haleon PLC$$43$YR$$F$Y$$$20240801$$MD$FR$FR
241610081$24161008$1$I$20240216$20240724$20240801$20240801$EXP$$ZA-AstraZeneca-2024A168982$ASTRAZENECA$$59$YR$$M$Y$$$20240801$$CN$ZA$
241610091$24161009$1$I$20240723$20240724$20240801$20240801$EXP$$GB-AstraZeneca-2024A168699$ASTRAZENECA$$68$YR$$M$Y$$$20240801$$MD$GB$
241610101$24161010$1$I$$20240403$20240801$20240801$EXP$$CA-CELLTRION INC.-2022CA022690$CELLTRION$$$$$$Y$$$20240801$$CN$CA$CA
241610113$24161011$3$F$$20240905$20240801$20240911$EXP$$JP-ABBVIE-5859898$ABBVIE$$39$YR$$M$Y$$$20240911$$MD$JP$JP
241610123$24161012$3$F$20240731$20240801$20240801$20240807$PER$$US-AMGEN-USASP2024152430$AMGEN$$79$YR$E$M$Y$$$20240806$$CN$US$US
241610131$24161013$1$I$$20220525$20240801$20240801$EXP$$US-AstraZeneca-2022A200700$ASTRAZENECA$$$$$F$Y$61.2$KG$20240801$$CN$US$
241610141$24161014$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151542$AMGEN$$$$$M$Y$$$20240801$$CN$US$US
241610152$24161015$2$F$$20240808$20240801$20240812$PER$$US-AMGEN-USASP2024150351$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
241610161$24161016$1$I$20240101$20240726$20240801$20240801$EXP$$US-BIOGEN-2024BI01261591$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
241610172$24161017$2$F$20240601$20240906$20240801$20240912$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040779$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240912$$MD$JP$JP
241610181$24161018$1$I$20240701$20240723$20240801$20240801$30DAY$$US-GSK-US2024092316$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240801$$CN$US$US
241610192$24161019$2$F$$20240731$20240801$20240808$EXP$$JP-ALK-ABELLO A/S-2024AA002984$ALK-ABELLO$$$$$$Y$$$20240808$$HP$JP$JP
241610201$24161020$1$I$$20240723$20240801$20240801$EXP$$US-ROCHE-10000035298$ROCHE$$76$YR$E$F$Y$$$20240801$$CN$US$US
241610221$24161022$1$I$$20240722$20240801$20240801$EXP$$JP-ALVOGEN-2024095219$ALVOGEN$Takahata, H. A case of struggle in selecting antibacterial drugs for surgical site infection after mandibular bone articular process fracture  surgery. The 55th Annual Meeting of the Japanese Society of Oral and Maxillofacial. 2024;55th:30.$32$YR$$F$Y$$$20240801$$HP$JP$JP
241610231$24161023$1$I$20240112$20240725$20240801$20240801$EXP$$JP-009507513-2403JPN000269J$MERCK$$76$YR$$M$Y$57$KG$20240801$$PH$JP$JP
241610241$24161024$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121236$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240801$$CN$US$US
241610251$24161025$1$I$20240716$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120983$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240801$$CN$US$US
241610262$24161026$2$F$20240725$20240730$20240801$20240807$EXP$$IN-VANTIVE-2024VAN018660$Vantive US Healthcare$$1$YR$$M$Y$$$20240807$$CN$IN$IN
241610272$24161027$2$F$$20240911$20240801$20240917$EXP$$BR-TAKEDA-BR202023671$TAKEDA$$$$$M$Y$45$KG$20240917$$CN$BR$BR
241610281$24161028$1$I$$20240725$20240801$20240801$EXP$$IN-AMGEN-INDSP2024149353$AMGEN$Gupta N. Improved Outcome of Primary Plasma Cell Leukemia in the Current Era with the Use of Novel Agents and Autologous Bone Marrow Transplants-A Single Centre Experience. Indian Journal of Hematology and Blood Transfusion. 2024;40 (3):400-406$65$YR$E$M$Y$$$20240801$$HP$IN$IN
241610291$24161029$1$I$20240727$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150656$AMGEN$$61$YR$A$M$Y$$$20240801$$CN$US$US
241610301$24161030$1$I$20230101$20240719$20240801$20240801$EXP$$ES-HIKMA PHARMACEUTICALS-ES-H14001-24-07005$HIKMA$Posado-Dominguez L, Figuero-Perez L, Olivares-Hernandez A, Chinchilla-Tabora L, Antunez-Plaza P, Rivas-Hernandez R, et al. Posado-Dominguez L, Figuero-Perez L, Olivares-Hernandez A, Chinchilla-Tabora L, Antunez-Plaza P, Rivas-Hernandez R, Martin-Galache M, Redondo Gonzalez JC, Fonseca Sanchez E. Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review.. Chinese Clinical Oncology. 2024;13(3)$65$YR$$M$Y$$$20240801$$MD$ES$ES
241610311$24161031$1$I$$20240725$20240801$20240801$EXP$$US-TAKEDA-2024TUS075357$TAKEDA$$63$YR$$M$Y$$$20240801$$CN$US$US
241610321$24161032$1$I$20231204$20240724$20240801$20240801$EXP$$US-ALXN-202407GLO001712US$ALEXION PHARMACEUTICALS$$81$YR$$M$Y$$$20240801$$MD$US$US
241610331$24161033$1$I$20240727$20240731$20240801$20240801$EXP$$US-ROCHE-10000046089$ROCHE$$73$YR$E$M$Y$$$20240801$$CN$US$US
241610342$24161034$2$F$20240731$20240812$20240801$20240819$PER$$US-AMGEN-USASP2024152388$AMGEN$$35$YR$A$F$Y$$$20240819$$MD$US$US
241610351$24161035$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024152204$AMGEN$$$$E$F$Y$$$20240801$$CN$US$US
241610361$24161036$1$I$$20240729$20240801$20240801$PER$$US-ROCHE-10000041384$ROCHE$$$$$F$Y$43.09$KG$20240801$$CN$US$US
241610372$24161037$2$F$$20240802$20240801$20240809$PER$$US-ABBVIE-5853938$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241610381$24161038$1$I$20231025$20240729$20240801$20240801$EXP$$GB-UCBSA-2024036212$UCB$$40$YR$$F$Y$$$20240801$$CN$GB$GB
241610392$24161039$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225332$TEVA$Hamill G, Burchard T, Khan EK. Gazing into the Crystal Ball: Correlating ATP-binding Cassette Protein A3 (ABCA3) Pathogenic Variant Genotypes and Phenotypes. Am-J-Respir-Crit-Care-Med 2024; 209 A2326.; Hamill G, Burchard T, Khan EK. Gazing into the Crystal Ball: Correlating ATP-binding Cassette Protein A3 (ABCA3) Pathogenic Variant Genotypes and Phenotypes. Am-J-Respir-Crit-Care-Med 2024; 209 A2326.$3$WK$$F$Y$$$20240816$$HP$US$US
241610403$24161040$3$F$20240101$20240829$20240801$20240905$EXP$$US-Eisai-EC-2024-171215$EISAI$$62$YR$A$F$Y$$$20240905$$CN$US$US
241610411$24161041$1$I$20240713$20240729$20240801$20240801$EXP$$SG-ROCHE-10000035131$ROCHE$$59$YR$A$F$Y$$$20240801$$CN$SG$SG
241610421$24161042$1$I$20240601$20240718$20240801$20240801$EXP$$US-UCBSA-2024016381$UCB$$38$YR$$F$Y$$$20240801$$HP$US$US
241610431$24161043$1$I$$20240705$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15480$ALKEM$Baciewicz AM, Chandra R. Cefprozil-induced rash in infectious mononucleosis. Ann Pharmacother .. 2005;39:974-975$18$YR$$F$Y$$$20240801$$HP$US$US
241610441$24161044$1$I$$20240730$20240801$20240801$EXP$$US-AMGEN-USASP2024151738$AMGEN$$$$$M$Y$$$20240801$$CN$US$US
241610453$24161045$3$F$20240729$20240822$20240801$20240824$PER$$US-AMGEN-USASP2024151566$AMGEN$$72$YR$E$F$Y$$$20240824$$HP$US$US
241610461$24161046$1$I$20230501$20240729$20240801$20240801$EXP$$BR-ROCHE-10000042465$ROCHE$$$$$F$Y$$$20240801$$MD$BR$BR
241610471$24161047$1$I$20240701$20240722$20240801$20240801$EXP$$JP-ROCHE-10000040681$ROCHE$$9$DEC$E$F$Y$$$20240801$$MD$JP$JP
241610481$24161048$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156952$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241610491$24161049$1$I$20240610$20240726$20240801$20240801$EXP$$NVSC2024RU155756$NOVARTIS$$17$YR$$F$Y$57$KG$20240801$$HP$RU$RU
241610501$24161050$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120993$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240801$$CN$US$US
241610512$24161051$2$F$20240220$20240731$20240801$20240809$EXP$$PT-AstraZeneca-2024A168574$ASTRAZENECA$$64$YR$$F$Y$68$KG$20240809$$MD$PT$
241610521$24161052$1$I$$20210604$20240801$20240801$EXP$$CA-AstraZeneca-2021A509235$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$CA$
241610531$24161053$1$I$$20220331$20240801$20240801$EXP$$US-AstraZeneca-2022A137451$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241610541$24161054$1$I$$20230317$20240801$20240801$EXP$$US-AstraZeneca-2023A067947$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241610551$24161055$1$I$$20210614$20240801$20240801$EXP$$US-AstraZeneca-2021A527049$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241610561$24161056$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A168857$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241610571$24161057$1$I$$20240724$20240801$20240801$EXP$$BR-AstraZeneca-2024A172061$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$BR$
241610581$24161058$1$I$20240731$20240731$20240801$20240801$PER$$US-HALEON-2189945$Haleon PLC$$84$YR$$$Y$$$20240801$$CN$US$US
241610591$24161059$1$I$$20240724$20240801$20240801$EXP$$ZA-AstraZeneca-2024A169963$ASTRAZENECA$$27759$DY$$F$Y$$$20240801$$CN$ZA$
241610601$24161060$1$I$$20240726$20240801$20240801$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001534$BLUEPRINT MEDICINES$$$$$M$Y$$$20240801$$CN$US$US
241610611$24161061$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000071$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240801$$CN$US$US
241610621$24161062$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000122$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240801$$CN$US$US
241610631$24161063$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020064$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240801$$CN$US$US
241610641$24161064$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407018893$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240801$$CN$US$US
241610651$24161065$1$I$20240730$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019994$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240801$$CN$US$US
241610662$24161066$2$F$20240507$20240814$20240801$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017443$UNITED THERAPEUTICS$$81$YR$$F$Y$72.109$KG$20240823$$$US$US
241610671$24161067$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020043$ELI LILLY AND CO$$$$$$Y$$$20240801$$CN$US$US
241610681$24161068$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020286$ELI LILLY AND CO$$$$$$Y$$$20240801$$CN$US$US
241610691$24161069$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019731$ELI LILLY AND CO$$$$$F$Y$$$20240801$$CN$US$US
241610701$24161070$1$I$$20240710$20240801$20240801$PER$$US-SA-2024SA207433$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240719$$MD$US$US
241610711$24161071$1$I$20240601$20240710$20240801$20240801$PER$$US-SA-2024SA206617$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240719$$MD$US$US
241610721$24161072$1$I$$20240722$20240801$20240801$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005510$BIOCON$$$$$$Y$$$20240801$$HP$CA$CA
241610731$24161073$1$I$$20240710$20240801$20240801$PER$$US-SA-2024SA140896$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240719$$MD$US$US
241610741$24161074$1$I$$20240712$20240801$20240801$EXP$$US-SA-2024SA210491$SANOFI AVENTIS$$$$A$M$Y$72.574$KG$20240719$$MD$US$US
241610754$24161075$4$F$20240101$20240812$20240801$20240821$PER$$US-SA-2024SA209859$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240821$$MD$US$US
241610761$24161076$1$I$20240601$20240712$20240801$20240801$PER$$US-SA-2024SA208346$SANOFI AVENTIS$$78$YR$E$M$Y$83.9$KG$20240719$$MD$US$US
241610771$24161077$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA208832$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240719$$MD$US$US
241610781$24161078$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA208369$SANOFI AVENTIS$$$$E$M$Y$$$20240719$$CN$US$US
241610791$24161079$1$I$20240708$20240711$20240801$20240801$PER$$US-SA-2024SA208510$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240719$$MD$US$US
241610801$24161080$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA211350$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240719$$CN$US$US
241610811$24161081$1$I$20240701$20240710$20240801$20240801$PER$$US-SA-2024SA207311$SANOFI AVENTIS$$35$YR$A$M$Y$92.9$KG$20240719$$MD$US$US
241610821$24161082$1$I$20240606$20240712$20240801$20240801$PER$$US-SA-2024SA210570$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240719$$MD$US$US
241610831$24161083$1$I$20240101$20240711$20240801$20240801$PER$$US-SA-2024SA207851$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240719$$MD$US$US
241610841$24161084$1$I$$20240712$20240801$20240801$PER$$US-SA-2023SA304986$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240719$$MD$US$US
241610851$24161085$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA208578$SANOFI AVENTIS$$$$A$M$Y$74$KG$20240719$$MD$US$US
241610861$24161086$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA209187$SANOFI AVENTIS$$$$A$F$Y$$$20240719$$HP$US$US
241610881$24161088$1$I$$20240729$20240801$20240801$EXP$$CA-APOTEX-2024AP009001$APOTEX$$62$YR$$F$Y$$$20240801$$CN$CA$CA
241610891$24161089$1$I$20210127$20240725$20240801$20240801$EXP$$FR-ROCHE-2850882$ROCHE$$51$YR$A$F$Y$$$20240801$$HP$FR$FR
241610901$24161090$1$I$20240619$20240722$20240801$20240801$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00620$PARATEK PHARMACEUTICALS$$87$YR$$F$Y$$$20240801$$HP$CN$CN
241610912$24161091$2$F$20240729$20240903$20240801$20240905$PER$$US-AMGEN-USASP2024150919$AMGEN$$74$YR$E$F$Y$$$20240905$$CN$US$US
241610922$24161092$2$F$20240724$20240830$20240801$20240904$PER$$US-AMGEN-USASP2024148563$AMGEN$$55$YR$A$F$Y$84.807$KG$20240904$$PH$US$US
241610931$24161093$1$I$20220601$20240722$20240801$20240801$EXP$$JP-ROCHE-10000040975$ROCHE$$$$$F$Y$$$20240801$$MD$JP$JP
241610941$24161094$1$I$$20240727$20240801$20240801$EXP$GB-MHRA-MED-202407270735169410-MQLDJ$GB-AMAROX PHARMA-AMR2024GB02492$HETERO$$67$YR$$F$Y$66$KG$20240801$$CN$GB$GB
241610951$24161095$1$I$20220101$20220516$20240801$20240801$EXP$$CA-CELLTRION INC.-2022CA022516$CELLTRION$$$$$$Y$$$20240801$$MD$CA$CA
241610961$24161096$1$I$$20240714$20240801$20240801$PER$$US-SA-2024SA211113$SANOFI AVENTIS$$$$A$F$Y$$$20240719$$MD$US$US
241610971$24161097$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA208361$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240719$$MD$US$US
241610981$24161098$1$I$20240701$20240714$20240801$20240801$PER$$US-SA-2024SA208529$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240719$$MD$US$US
241610991$24161099$1$I$20240101$20240711$20240801$20240801$PER$$US-SA-2024SA208624$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240719$$MD$US$US
241611001$24161100$1$I$$20240710$20240801$20240801$PER$$US-SA-2024SA206105$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240719$$MD$US$US
241611011$24161101$1$I$20240101$20240713$20240801$20240801$PER$$US-SA-2024SA208141$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240719$$MD$US$US
241611021$24161102$1$I$20240101$20240710$20240801$20240801$PER$$US-SA-2024SA206204$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240719$$MD$US$US
241611031$24161103$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA209302$SANOFI AVENTIS$$19$YR$A$F$Y$55.79$KG$20240719$$MD$US$US
241611043$24161104$3$F$$20240917$20240801$20240919$EXP$$GB-Orion Corporation ORION PHARMA-24_00031073$ORION$Kopernicka G, Chew J. Acute urinary retention and constipation caused by multi-dermatomal herpes zoster in an immunosuppressed patient. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24 (SUPPL.):9.$71$YR$E$F$Y$$$20240919$$MD$GB$
241611051$24161105$1$I$$20240716$20240801$20240801$PER$$US-JNJFOC-20240747985$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$US$US
241611061$24161106$1$I$20240101$20240730$20240801$20240801$EXP$$BG-ABBVIE-5862404$ABBVIE$$70$YR$$F$Y$$$20240801$$CN$BG$BG
241611071$24161107$1$I$20240726$20240729$20240801$20240801$PER$$US-HALEON-2189667$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241611081$24161108$1$I$20240701$20240731$20240801$20240801$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043107$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240801$$CN$US$US
241611091$24161109$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA207783$SANOFI AVENTIS$$$$T$F$Y$52$KG$20240719$$MD$US$US
241611101$24161110$1$I$$20240722$20240801$20240801$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024091847$VIIV$$$$$M$Y$$$20240801$$HP$US$US
241611112$24161111$2$F$20240705$20240819$20240801$20240828$PER$$US-SA-2024SA209087$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240828$$MD$US$US
241611121$24161112$1$I$20240601$20240712$20240801$20240801$EXP$$US-SA-2024SA209575$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240719$$MD$US$US
241611131$24161113$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA209260$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240719$$PH$US$US
241611141$24161114$1$I$$20240710$20240801$20240801$PER$$US-SA-2024SA209785$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240719$$MD$US$US
241611151$24161115$1$I$$20240715$20240801$20240801$EXP$NL-LRB-00978987$NL-SA-2024SA208276$SANOFI AVENTIS$$46$YR$A$F$Y$133$KG$20240719$$HP$NL$NL
241611163$24161116$3$F$20240101$20240826$20240801$20240905$PER$$US-SA-2024SA211150$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240905$$MD$US$US
241611171$24161117$1$I$20240420$20240715$20240801$20240801$PER$$US-SA-2024SA211163$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240719$$MD$US$US
241611181$24161118$1$I$20240601$20240712$20240801$20240801$EXP$$US-SA-2024SA210511$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240719$$MD$US$US
241611191$24161119$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA208617$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240719$$CN$US$US
241611201$24161120$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA209816$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240719$$CN$US$US
241611211$24161121$1$I$$20240715$20240801$20240801$EXP$NL-LRB-00978990$NL-SA-2024SA208264$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240719$$HP$NL$NL
241611221$24161122$1$I$$20240713$20240801$20240801$PER$$US-SA-2024SA211121$SANOFI AVENTIS$$$$A$M$Y$74.978$KG$20240719$$MD$US$US
241611233$24161123$3$F$20240101$20240912$20240801$20240917$EXP$$US-SA-2024SA211375$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240917$$MD$US$US
241611241$24161124$1$I$$20240716$20240801$20240801$PER$$US-SA-2024SA211756$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240719$$CN$US$US
241611252$24161125$2$F$20231001$20240820$20240801$20240830$PER$$US-SA-2023SA389975$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240830$$MD$US$US
241611262$24161126$2$F$20240701$20240816$20240801$20240830$PER$$US-SA-2024SA208541$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240830$$MD$US$US
241611271$24161127$1$I$20231101$20240712$20240801$20240801$EXP$$US-SA-2024SA211229$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240719$$MD$US$US
241611281$24161128$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA210384$SANOFI AVENTIS$$$$A$F$Y$$$20240719$$MD$US$US
241611291$24161129$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA209359$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240719$$MD$US$US
241611301$24161130$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA209264$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240719$$CN$US$US
241611311$24161131$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA209316$SANOFI AVENTIS$$$$A$F$Y$$$20240719$$MD$US$US
241611321$24161132$1$I$20220603$20240715$20240801$20240801$EXP$NL-LRB-00979018$NL-SA-2024SA208196$SANOFI AVENTIS$$77$YR$E$M$Y$144.5$KG$20240719$$HP$NL$NL
241611331$24161133$1$I$20240523$20240711$20240801$20240801$PER$$US-SA-2024SA209049$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240719$$MD$US$US
241611341$24161134$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA208868$SANOFI AVENTIS$$50$YR$A$F$Y$72$KG$20240719$$MD$US$US
241611351$24161135$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA207837$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240719$$MD$US$US
241611362$24161136$2$F$$20240731$20240801$20240807$EXP$$IN-ROCHE-10000041714$ROCHE$$$$A$F$Y$$$20240807$$CN$IN$IN
241611371$24161137$1$I$20240719$20240729$20240801$20240801$EXP$$US-ABBVIE-5860070$ABBVIE$$66$YR$$F$Y$$$20240801$$CN$US$US
241611381$24161138$1$I$$20240723$20240801$20240801$EXP$$JP-AMGEN-JPNSP2024151540$AMGEN$Kubota K, Tsuyama Y, Miyamoto Y, Abe M, Suenaga H, Tomiduka K, et al.. 1-P3-10 Five cases of wisdom teeth periodontitis that developed during drug therapy in patients with recurrent metastatic. The 78th Annual Meeting of the Japanese Society of Oral Sciences. 2024;285$$$$$Y$$$20240801$$MD$JP$JP
241611391$24161139$1$I$$20240726$20240801$20240801$PER$$US-AMGEN-USASP2024150792$AMGEN$$$$$$Y$$$20240801$$HP$US$US
241611402$24161140$2$F$20240701$20240725$20240801$20240812$PER$$US-AMGEN-USASP2024147984$AMGEN$$51$YR$A$M$Y$$$20240812$$CN$US$US
241611411$24161141$1$I$20240701$20240715$20240801$20240801$PER$$US-SA-2023SA215570$SANOFI AVENTIS$$$$A$F$Y$$$20240719$$MD$US$US
241611421$24161142$1$I$$20240726$20240801$20240801$PER$$FR-PFM-2024-04251$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240801$$CN$FR$FR
241611431$24161143$1$I$20231011$20240726$20240801$20240801$EXP$$CO-UCBSA-2024038660$UCB$$39$YR$$F$Y$$$20240801$$CN$CO$CO
241611441$24161144$1$I$$20240719$20240801$20240801$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07316$LUPIN$Glicksman M, Parkash A, Srinivasan S, Farrell ME, Chauhan G. Spinal cord stimulation and intrathecal drug delivery system therapy in a pregnant patient with complex regional pain syndrome type II: A Case Report. Pain Medicine Case Reports. 2024;8 (3):81-90$24$YR$$F$Y$$$20240801$$MD$US$US
241611451$24161145$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156921$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
241611462$24161146$2$F$20240302$20240809$20240801$20240814$EXP$$NVSC2024US052785$NOVARTIS$$35$YR$$F$Y$$$20240814$$CN$US$US
241611471$24161147$1$I$20230101$20240722$20240801$20240801$EXP$$US-Encube-000843$ENCUBE ETHICALS$Cheng JJ, Shen J, Suresh Y, Akopyan NA, Kapoor NS. Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy: Case report. Int J Surg Case Rep. 2024 Jul 18;122:110050. doi: 10.1016/j.ijscr.2024.110050.$72$YR$E$M$Y$$$20240731$$MD$US$
241611481$24161148$1$I$20090429$20240716$20240801$20240801$EXP$$US-009507513-0906USA00573$MERCK$$$$$M$Y$$$20240801$$HP$US$US
241611492$24161149$2$F$$20240831$20240801$20240904$EXP$$TW-009507513-2407TWN015195$MERCK$$52$YR$$F$Y$$$20240904$$MD$TW$TW
241611501$24161150$1$I$$20240729$20240801$20240801$EXP$$US-GILEAD-2024-0682365$GILEAD$$$$E$F$Y$$$20240801$$CN$US$US
241611511$24161151$1$I$$20240729$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121416$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240801$$CN$US$US
241611522$24161152$2$F$$20240828$20240801$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121453$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240830$$CN$US$US
241611531$24161153$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121903$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240801$$CN$US$US
241611541$24161154$1$I$20240601$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-093339$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240801$$HP$US$US
241611551$24161155$1$I$$20240724$20240801$20240801$PER$$US-ALXN-202407USA001676US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
241611561$24161156$1$I$20240708$20240729$20240801$20240801$EXP$FR-AFSSAPS-MA2024001251$FR-TAKEDA-2024TUS076408$TAKEDA$$58$YR$$M$Y$$$20240801$$HP$FR$FR
241611571$24161157$1$I$$20240728$20240801$20240801$PER$$NVSC2024US156796$NOVARTIS$$63$YR$$F$Y$$$20240801$$CN$US$US
241611581$24161158$1$I$$20240726$20240801$20240801$EXP$$US-SA-2024SA215960$SANOFI AVENTIS$$92$YR$E$M$Y$55.7$KG$20240801$$MD$US$US
241611591$24161159$1$I$20240320$20240726$20240801$20240801$EXP$FR-AFSSAPS-PP2024000820$FR-SA-2024SA222166$SANOFI AVENTIS$$56$YR$A$F$Y$45.5$KG$20240801$$MD$FR$FR
241611601$24161160$1$I$20230925$20240725$20240801$20240801$EXP$$US-TAKEDA-2022TUS067767$TAKEDA$$69$YR$$F$Y$74$KG$20240801$$HP$US$US
241611611$24161161$1$I$$20240723$20240801$20240801$EXP$GB-RDY-SPO/GBR/24/0011142$GB-RDY-SPO/GBR/24/0011142$DR REDDYS$Timmons P, Williamson A, Gibbs V, Torgersen A. Weak legs. Acute medicine. 2022;21(3):153-6. DOI: 10.52964/AMJA.0917.$48$YR$A$F$Y$$$20240801$$MD$GB$GB
241611621$24161162$1$I$$20240726$20240801$20240801$EXP$$AU-RDY-SPO/AUS/24/0011150$DR REDDYS$$20$YR$A$F$Y$$$20240801$$CN$AU$AU
241611631$24161163$1$I$$20240726$20240801$20240801$PER$$US-AMGEN-USASP2024150153$AMGEN$$$$$$Y$$$20240801$$MD$US$US
241611641$24161164$1$I$20240701$20240724$20240801$20240801$EXP$$AR-AMGEN-ARGSP2024147685$AMGEN$$76$YR$E$F$Y$54$KG$20240801$$MD$AR$AR
241611651$24161165$1$I$20240731$20240731$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043151$BOEHRINGER INGELHEIM$$76$YR$E$$Y$$$20240801$$CN$US$US
241611671$24161167$1$I$$20240721$20240801$20240801$EXP$$CH-TAKEDA-2024TUS076454$TAKEDA$$66$YR$$F$Y$$$20240801$$HP$CH$CH
241611681$24161168$1$I$$20240722$20240801$20240801$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005508$BIOCON$$$$$$Y$$$20240801$$HP$CA$CA
241611691$24161169$1$I$20240712$20240730$20240801$20240801$EXP$$CA-TAKEDA-2024TUS077016$TAKEDA$$40$YR$$M$Y$$$20240801$$CN$CA$CA
241611711$24161171$1$I$$20240730$20240801$20240801$EXP$FR-AFSSAPS-PC2024000623$FR-SA-2024SA223328$SANOFI AVENTIS$$25$YR$A$F$Y$85$KG$20240801$$HP$FR$FR
241611723$24161172$3$F$20240101$20240903$20240801$20240911$EXP$$CA-JNJFOC-20240345643$JOHNSON AND JOHNSON$$19$YR$A$M$Y$49.486$KG$20240911$$PH$CA$CA
241611731$24161173$1$I$$20240726$20240801$20240801$PER$$US-AMGEN-USASP2024152774$AMGEN$$$$$F$Y$$$20240801$$HP$US$US
241611742$24161174$2$F$20240612$20240730$20240801$20240806$PER$$US-AMGEN-USASP2024152159$AMGEN$$32$YR$A$F$Y$$$20240805$$HP$US$US
241611751$24161175$1$I$$20240725$20240801$20240801$EXP$$US-AMGEN-USASP2024150060$AMGEN$$$$E$F$Y$$$20240801$$HP$US$US
241611761$24161176$1$I$20240629$20240726$20240801$20240801$EXP$$US-BIOGEN-2024BI01272801$BIOGEN$$78$YR$$F$Y$$$20240801$$CN$US$US
241611771$24161177$1$I$20230101$20240729$20240801$20240801$EXP$$US-ABBVIE-5859275$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241611783$24161178$3$F$$20240815$20240801$20240910$EXP$$CA-BEH-2024175188$CSL BEHRING$$45$YR$A$F$Y$61.3$KG$20240910$$CN$CA$CA
241611791$24161179$1$I$20240501$20240730$20240801$20240801$EXP$$CA-ABBVIE-5861733$ABBVIE$$44$YR$$F$Y$$$20240801$$CN$CA$CA
241611801$24161180$1$I$$20240711$20240801$20240801$PER$$US-JNJFOC-20240731870$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$US$US
241611811$24161181$1$I$20240719$20240723$20240801$20240801$EXP$$CH-Merz Pharmaceuticals GmbH-2024070000149$MERZ$$52$YR$$F$Y$$$20240801$$MD$CH$CH
241611821$24161182$1$I$$20211020$20240801$20240801$EXP$$US-AstraZeneca-2021A781912$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241611833$24161183$3$F$$20240826$20240801$20240904$PER$$US-AstraZeneca-2024A173321$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
241611841$24161184$1$I$20240726$20240730$20240801$20240801$EXP$$US-AstraZeneca-2024A173483$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241611851$24161185$1$I$$20240724$20240801$20240801$EXP$$ZA-AstraZeneca-2024A169936$ASTRAZENECA$$21549$DY$$M$Y$$$20240801$$CN$ZA$
241611861$24161186$1$I$$20211109$20240801$20240801$EXP$$US-AstraZeneca-2021A803545$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241611871$24161187$1$I$$20240710$20240801$20240801$PER$$US-AstraZeneca-2024A173785$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241611881$24161188$1$I$20240625$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121436$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240801$$CN$US$US
241611891$24161189$1$I$$20240724$20240801$20240801$EXP$$BR-AstraZeneca-2024A171444$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$BR$
241611901$24161190$1$I$$20240725$20240801$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121023$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240801$$PH$JP$JP
241611911$24161191$1$I$$20240724$20240801$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-120324$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$CN$JP$JP
241611921$24161192$1$I$20240301$20240723$20240801$20240801$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07078$HIKMA$$61$YR$$F$Y$$$20240801$$HP$US$US
241611931$24161193$1$I$$20240731$20240801$20240801$EXP$$US-GILEAD-2024-0682488$GILEAD$$56$YR$A$F$Y$$$20240801$$CN$US$US
241611941$24161194$1$I$20240101$20240729$20240801$20240801$PER$$US-ABBVIE-5860815$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241611951$24161195$1$I$$20240723$20240801$20240801$PER$$US-RDY-LIT/USA/24/0011100$DR REDDYS$Shultz J, Antar-Shultz M, Taha M, Zervogiannis P, Lazcano G, Lamarche J. SEVELAMER-ASSOCIATED COLITIS: A TRIGGER TO CHANGE TREATMENT APPROACH. American Journal of Kidney Diseases. 2024 Apr;83(4): S74. doi:10.1053/j.ajkd.2024.01.245.$63$YR$A$F$Y$$$20240801$$HP$US$US
241611971$24161197$1$I$20240719$20240723$20240801$20240801$EXP$$CH-Merz Pharmaceuticals GmbH-2024070000150$MERZ$$35$YR$$F$Y$$$20240801$$MD$CH$CH
241611981$24161198$1$I$20240703$20240722$20240801$20240801$30DAY$$US-GSK-US2024091778$GLAXOSMITHKLINE$$80$YR$$M$Y$$$20240801$$HP$US$US
241611992$24161199$2$F$$20240802$20240801$20240808$30DAY$$US-GSK-US2024AMR092626$GLAXOSMITHKLINE$$73$YR$$$Y$$$20240808$$CN$US$US
241612001$24161200$1$I$$20240723$20240801$20240801$EXP$$JP-ROCHE-10000041829$ROCHE$$8$DEC$E$F$Y$$$20240801$$MD$JP$JP
241612011$24161201$1$I$20210101$20240725$20240801$20240801$EXP$NO-NOMAADVRE-PASRAPP-2024-V7rgxj$NO-TEVA-VS-3226296$TEVA$$49$YR$$F$Y$72$KG$20240801$$CN$NO$NO
241612021$24161202$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121221$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240801$$CN$US$US
241612031$24161203$1$I$20231201$20240401$20240801$20240801$EXP$$US-MYLANLABS-2024M1030081$MYLAN$$36$YR$$F$Y$$$20240801$$MD$US$US
241612041$24161204$1$I$20240731$20240731$20240801$20240801$EXP$GB-MHRA-MED-202407311413458760-CJTWP$GB-TEVA-VS-3227917$TEVA$$35$YR$$F$Y$85$KG$20240801$$CN$GB$GB
241612053$24161205$3$F$20240719$20240812$20240801$20240816$EXP$$FR-BIOGEN-2024BI01275879$BIOGEN$$38$YR$$M$Y$48$KG$20240816$$MD$FR$FR
241612061$24161206$1$I$20231102$20240125$20240801$20240801$EXP$IT-MINISAL02-957834$IT-TEVA-VS-3226378$TEVA$$63$YR$$M$Y$$$20240801$$MD$IT$IT
241612071$24161207$1$I$20240718$20240724$20240801$20240801$EXP$$CN-AstraZeneca-2024A171638$ASTRAZENECA$$66$YR$$F$Y$83$KG$20240801$$MD$CN$
241612081$24161208$1$I$$20230201$20240801$20240801$EXP$$US-AstraZeneca-2023A027947$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241612091$24161209$1$I$$20240727$20240801$20240801$EXP$$VN-AstraZeneca-2024A171105$ASTRAZENECA$$$$$F$Y$$$20240801$$MD$VN$
241612101$24161210$1$I$20220426$20240729$20240801$20240801$EXP$$FR-AstraZeneca-2022A170416$ASTRAZENECA$$1024$MON$$F$Y$71$KG$20240801$$MD$FR$
241612111$24161211$1$I$$20240724$20240801$20240801$EXP$$CN-AstraZeneca-2024A170119$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$CN$
241612121$24161212$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A169397$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241612131$24161213$1$I$20240701$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151872$AMGEN$$78$YR$E$F$Y$$$20240801$$CN$US$US
241612143$24161214$3$F$20240101$20240909$20240801$20240919$EXP$$AR-AMGEN-ARGSP2024151514$AMGEN$$46$YR$A$F$Y$$$20240919$$CN$AR$AR
241612153$24161215$3$F$20240618$20240731$20240801$20240810$EXP$$ES-TEVA-VS-3227137$TEVA$$79$YR$$M$Y$82$KG$20240810$$HP$ES$ES
241612161$24161216$1$I$$20240724$20240801$20240801$PER$$US-UNITED THERAPEUTICS-UNT-2024-022864$UNITED THERAPEUTICS$$$$$F$Y$$$20240801$$PH$US$US
241612171$24161217$1$I$20240315$20240717$20240801$20240801$PER$$US-Vifor (International) Inc.-VIT-2024-06472$VIFOR$$51$YR$$M$Y$123.7$KG$20240801$$HP$US$US
241612181$24161218$1$I$$20240725$20240801$20240801$EXP$$IL-JNJFOC-20240770318$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$MD$IL$IL
241612191$24161219$1$I$$20240722$20240801$20240801$EXP$$NO-ROCHE-10000038302$ROCHE$Torgauten H, Onyango T, Ljostveit S, Hallin E, Serkland T, Skrede S, et al. Hospitalisations and humoral COVID-19 vaccine response in vaccinated rituximab-treated multiple sclerosis patients. Multiple sclerosis and related disorders. 2024;89:1-7. doi:10.1016/j.msard.2024.105770.$$$$$Y$$$20240801$$HP$NO$NO
241612201$24161220$1$I$20240101$20240723$20240801$20240801$PER$$US-ABBVIE-5853066$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241612211$24161221$1$I$$20240726$20240801$20240801$PER$$US-AMGEN-USASP2024152745$AMGEN$$$$$F$Y$$$20240801$$HP$US$US
241612221$24161222$1$I$20240701$20240729$20240801$20240801$EXP$$CA-ABBVIE-5860386$ABBVIE$$58$YR$$M$Y$$$20240801$$CN$CA$CA
241612231$24161223$1$I$$20240729$20240801$20240801$EXP$$US-BIOGEN-2024BI01275913$BIOGEN$$$$C$$Y$$$20240801$$MD$US$US
241612241$24161224$1$I$$20240726$20240801$20240801$PER$$US-BIOGEN-2020BI00939152$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
241612251$24161225$1$I$$20240729$20240801$20240801$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011547$JAZZ$$$$$M$Y$$$20240801$$CN$US$US
241612262$24161226$2$F$20240101$20240826$20240801$20240902$EXP$$US-ABBVIE-5860438$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
241612271$24161227$1$I$20240710$20240729$20240801$20240801$EXP$$US-ABBVIE-5861038$ABBVIE$$44$YR$$F$Y$$$20240801$$CN$US$US
241612281$24161228$1$I$20240729$20240730$20240801$20240801$EXP$$US-ABBVIE-5861572$ABBVIE$$64$YR$$$Y$$$20240801$$CN$US$US
241612292$24161229$2$F$$20240913$20240801$20240913$PER$$NVSC2024US156246$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
241612301$24161230$1$I$$20240728$20240801$20240801$PER$$NVSC2024US154940$NOVARTIS$$63$YR$$F$Y$191.2$KG$20240801$$CN$US$US
241612311$24161231$1$I$20240201$20240717$20240801$20240801$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07018$HIKMA$Zieneldien T, Kim J, Greene J.. Zieneldien T, Kim J, Greene J. Breakthrough pneumocystis jirovecii pneumonia in an allogeneic hematopoietic stem cell transplant recipient.. Cureus. 2024;16(6):e61890$50$YR$$F$Y$$$20240801$$MD$US$US
241612332$24161233$2$F$$20240906$20240801$20240906$PER$$US-ALXN-202407USA001640US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
241612341$24161234$1$I$20231025$20240730$20240801$20240801$EXP$FR-AFSSAPS-DJ2024000861$FR-ORGANON-O2407FRA002772$ORGANON$$72$YR$$M$Y$$$20240801$$MD$FR$FR
241612351$24161235$1$I$20240714$20240728$20240801$20240801$EXP$$GB-JNJFOC-20240779664$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$GB$GB
241612362$24161236$2$F$20240701$20240801$20240801$20240802$PER$$US-JNJFOC-20240800766$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241612381$24161238$1$I$$20240729$20240801$20240801$EXP$$CA-ORGANON-O2407CAN002679$ORGANON$$$$$F$Y$$$20240801$$HP$CA$CA
241612391$24161239$1$I$$20240717$20240801$20240801$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459579$RANBAXY$Soni R, Mandal B, Negi SL, Singh H, Mandal M, Singh N. A Rare Case of Early?Onset Postpneumonectomy Syndrome. Ann Card Anaesth. 2024;Jul-Sep; 27(3):266-269$55$YR$$F$Y$$$20240801$$HP$IN$IN
241612401$24161240$1$I$$20240717$20240801$20240801$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460426$RANBAXY$$23$YR$$F$Y$56$KG$20240801$$CN$GB$GB
241612411$24161241$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459571$RANBAXY$Voelz K, Miller G, Lee-Miller C. 6-Mercaptopurine-associated Sinusoidal Obstructive Syndrome During Interim Maintenance I: A Case Report. J Pediatr Hematol Oncol. 2024;Jul 46(5):e317?e321$14$YR$$M$Y$$$20240801$$MD$US$US
241612423$24161242$3$F$20210801$20240813$20240801$20240827$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459637$RANBAXY$Dowle H, Unger S, Khalid S, Brown C, Urquhart DS. Reversible deafness related to long-term daily Azithromycin treatment in a child with cystic fibrosis. Pediatr Pulmonol. 2024;0:1-3$12$YR$$M$Y$$$20240827$$HP$GB$GB
241612431$24161243$1$I$20231006$20240717$20240801$20240801$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457871$RANBAXY$$69$YR$$M$Y$$$20240801$$MD$JP$JP
241612441$24161244$1$I$20230825$20240717$20240801$20240801$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460075$RANBAXY$$30$YR$$M$Y$70$KG$20240801$$PH$DE$DE
241612451$24161245$1$I$20240129$20240717$20240801$20240801$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459502$RANBAXY$$36$YR$$M$Y$$$20240801$$MD$ES$ES
241612461$24161246$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459543$RANBAXY$Ghalayni R, Al Kalaji B, Malik K. From Friend to Foe: A Case of Naloxone-Induced Pulmonary Edema. Hosp Pharm. 2024;59 (4):407-410$66$YR$$F$Y$$$20240801$$HP$US$US
241612471$24161247$1$I$20220529$20240717$20240801$20240801$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460422$RANBAXY$$74$YR$$M$Y$$$20240801$$PH$ES$ES
241612482$24161248$2$F$$20240731$20240801$20240814$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459603$RANBAXY$Wakankar R, Bal J, Sharma K, Dougall P. A Rare Case of Renal Malakoplakia Incidentally Detected on 18F-FDG PET/CT in a Patient With Concomitant Breast Cancer and Lymphoma. Clin Nucl Med. 2024;Jun 3; 0 (0):no pagination$68$YR$$F$Y$$$20240814$$MD$IN$IN
241612491$24161249$1$I$$20240717$20240801$20240801$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457193$RANBAXY$Zhiryakova AS, Denisenko NP, Kryukov AV, Akmalova K.A, Tuchkova SN, Mirzaev K.B, Sychev DA. Patients? pharmacogenetic characteristics and the risk of adverse reactions to non-steroidal anti-inflammatory drugs: case reports. Safety and Risk of Pharmacotherapy. 2024;12(2):178-189$75$YR$$F$Y$$$20240801$$HP$RU$RU
241612501$24161250$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459589$RANBAXY$Golob S, Ting P, Pires K, Soetanto V, Pagano B, Wan KL, et al. Bupropion Overdose Requiring Veno-Arterial Extracorporeal Membrane Oxygenation. Circulation. 2023;148(Suppl.):no pagination$32$YR$$M$Y$$$20240801$$HP$US$US
241612511$24161251$1$I$$20240717$20240801$20240801$EXP$$MX-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459660$RANBAXY$de La Torre-Ortiz MA, Garcia-Esparza RA, Perez-Yanez JJ, Reyna-Lopez BG, Arguelles-Muniz RE. Urachal adenocarcinoma. A case report.. Gac Mex Oncol. 2024;23(Supl):92-96$30$YR$$M$Y$$$20240801$$HP$MX$MX
241612521$24161252$1$I$20240503$20240717$20240801$20240801$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460077$RANBAXY$$62$YR$$F$Y$$$20240801$$PH$IT$IT
241612531$24161253$1$I$20240414$20240717$20240801$20240801$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460104$RANBAXY$$85$YR$$M$Y$57$KG$20240801$$MD$ES$ES
241612541$24161254$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459588$RANBAXY$Chhabra K, Gudipati S, Bloomingdale R. Opioid Withdrawal Causing a Broken Heart. Circulation. 2023;148 (Suppl):no pagination(17123)$26$YR$$M$Y$$$20240801$$HP$US$US
241612551$24161255$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459540$RANBAXY$Bollam RR, Reddy VK. Persistent Pseudomonas Aeruginosa Pneumonia Due to Antimicrobial Resistance Development Requiring Lobectomy. Am J Respir Crit Care Med. 2024;209 (0):A2400$56$YR$$F$Y$$$20240801$$HP$US$US
241612561$24161256$1$I$$20240717$20240801$20240801$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460423$RANBAXY$Duburcq T, Goutay J, Preau S, Mugnier A, Rousse N, Moussa MD, et al. Venoarterial Extracorporeal Membrane Oxygenation in Severe Drug Intoxication: A Retrospective Comparison of Survivors and Nonsurvivors. ASAIO. 2022;68(7):907-913$$$$$Y$$$20240801$$HP$FR$FR
241612571$24161257$1$I$$20240717$20240801$20240801$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459557$RANBAXY$Chen C-P. Recurrent neural tube defect and craniorachischisis detected in the first trimester and associated with maternal smoking. Taiwan J Obstet Gynecol. 2024;63(2):260-262$25$YR$$F$Y$79$KG$20240801$$HP$TW$TW
241612581$24161258$1$I$$20240717$20240801$20240801$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459632$RANBAXY$Qi L, Ma B, Fan H, Qi S, Yang F, An H. Case report: Time response of plasma clozapine concentrations on cessation of heavy smoking. Front Pharmacol. 2024;15(0):1408915$33$YR$$M$Y$$$20240801$$HP$CN$CN
241612591$24161259$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459573$RANBAXY$Jackson DL, Coke L, Zhang SX, Steenbergen C, Khan G, Gorfu G et al. Myocarditis and brain abscess caused by disseminated Scedosporium boydii infection. J Natl Med Assoc. 2024;Jun; 116(3):238-246$52$YR$$M$Y$$$20240801$$HP$US$US
241612601$24161260$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459548$RANBAXY$Bonar S, Schneider III HL, Cook K, Samala RV, F.F.Poole M. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J Pain Symptom Manage. 2023;Oct; 66(4):e455-e459$$$$$Y$$$20240801$$PH$US$US
241612611$24161261$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458821$RANBAXY$Noe G, Shah K, Cinderella M, Munjal S. Multiple medication use resulting in serotonin syndrome with deprescribing resulting in acute dystonia. J Clin Psychopharmacol. 2024;May/Jun; 44 (3):326-328$42$YR$$F$Y$$$20240801$$HP$US$US
241612621$24161262$1$I$20240422$20240717$20240801$20240801$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459503$RANBAXY$$87$YR$$M$Y$$$20240801$$PH$ES$ES
241612631$24161263$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459545$RANBAXY$Bonar S, Schneider III HL, Cook K, Samala RV, F.F.Poole M. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J Pain Symptom Manage. 2023;Oct; 66(4):e455-e459$$$$$Y$$$20240801$$PH$US$US
241612641$24161264$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459547$RANBAXY$Bonar S, Schneider III HL, Cook K, Samala RV, F.F.Poole M. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J Pain Symptom Manage. 2023;Oct; 66(4):e455-e459$$$$$Y$$$20240801$$PH$US$US
241612651$24161265$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459549$RANBAXY$Bonar S, Schneider III HL, Cook K, Samala RV, F.F.Poole M. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J Pain Symptom Manage. 2023;Oct; 66(4):e455-e459$$$$$Y$$$20240801$$PH$US$US
241612661$24161266$1$I$$20240717$20240801$20240801$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459556$RANBAXY$Yilmaz GR, Kaya O, INkaya AC, Unal O, Nurlu Temel E, Akcam FZ, et al. Treatment of Pneumocystis jirovecii Pneumonia with Caspofungin and Clindamycin: An HIV Patient and Literature Review. Flora. 2024;29 (1):139-144$54$YR$$M$Y$$$20240801$$HP$TR$TR
241612671$24161267$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459539$RANBAXY$Mcgourty M, Adams EW, Lyons J, Ayyaswami V, Holdorf JD. MDA-5 Associated Dermatomyositis: A Case of Delayed Care and Dire Consequences. Am J Respir Crit Care Med. 2024;May;209 (0):A1994 (A51)$43$YR$$M$Y$$$20240801$$HP$US$US
241612681$24161268$1$I$$20240717$20240801$20240801$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459601$RANBAXY$Nakai T, Seki H, Makino A, Kadota Y, Kaburagi T, Okumura T, et al. Development of neuro-Behcet^s disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy: A case report. Breast Disease. 2024;43 (1):223-229$40$YR$$F$Y$$$20240801$$HP$JP$JP
241612692$24161269$2$F$20240709$20240822$20240801$20240903$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458878$RANBAXY$-. -. -. -;-:-$50$YR$$M$Y$70$KG$20240903$$MD$CN$CN
241612701$24161270$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459550$RANBAXY$Bonar S, Schneider III HL, Cook K, Samala RV, F.F.Poole M. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J Pain Symptom Manage. 2023;Oct; 66(4):e455-e459$$$$$Y$$$20240801$$PH$US$US
241612711$24161271$1$I$20210418$20240717$20240801$20240801$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460238$RANBAXY$$59$YR$$F$Y$42$KG$20240801$$MD$ES$ES
241612721$24161272$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459587$RANBAXY$Haynes TM, Kukuc L, Proute M, Fishberg R. A PCSK9 and APOB Double Heterozygote Presenting Phenotypically Similar to Homozygous Familial Hypercholesterolemia. Circulation. 2023;148 (Suppl.):no pagination$73$YR$$F$Y$$$20240801$$HP$US$US
241612731$24161273$1$I$20221130$20240717$20240801$20240801$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460154$RANBAXY$$91$YR$$F$Y$$$20240801$$PH$ES$ES
241612741$24161274$1$I$20240730$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000191$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240801$$CN$US$US
241612751$24161275$1$I$20240412$20240717$20240801$20240801$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460171$RANBAXY$$68$YR$$M$Y$79$KG$20240801$$CN$DE$DE
241612761$24161276$1$I$$20240717$20240801$20240801$EXP$$ZA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460159$RANBAXY$Nkoane MA, Adefolalu AO. Rapid onset diarrhoea in HIV patient The importance of suspecting cholera in non endemic areas. Southern African Journal of Infectious Diseases. 2024;39 (1):1-5$48$YR$$M$Y$$$20240801$$HP$ZA$ZA
241612771$24161277$1$I$20240428$20240717$20240801$20240801$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460341$RANBAXY$$69$YR$$M$Y$75$KG$20240801$$CN$DE$DE
241612781$24161278$1$I$$20240717$20240801$20240801$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460275$RANBAXY$Scala M, Martinez Trapote P, Rodriguez-Jimenez R, Pecorino B, Serretti A. Managing a treatmentresistant schizophrenia spectrum disorder with a hormonal twist in a female patient: a case report of a progestin-only pill. J Clin Psychopharmacol. 2024;44(3):323-326$41$YR$$F$Y$$$20240801$$HP$IT$IT
241612791$24161279$1$I$20230911$20240717$20240801$20240801$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460155$RANBAXY$$65$YR$$F$Y$$$20240801$$MD$IT$IT
241612801$24161280$1$I$20240223$20240717$20240801$20240801$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460269$RANBAXY$$58$YR$$F$Y$$$20240801$$MD$IT$IT
241612811$24161281$1$I$$20240717$20240801$20240801$EXP$$QA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460158$RANBAXY$Kannappilly N, Peediyakkal MZ, Khatib MY, Ananthegowda DC, Elshafei MS, El Zeer H, et al. Ibuprofen-Induced Toxic Epidermal Necrolysis: A Case Report. Int J Dermatol Venereol. 2023;7 (2):108-110$41$YR$$M$Y$$$20240801$$HP$QA$QA
241612821$24161282$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458806$RANBAXY$Baez Gonzalez J, Clark MD, Bruera E. Fluoroquinolone-Induced Seizure in a Patient Receiving End-of-Life Care: A Case Report. J Palliat Med. 2023;26(11):1590-1592$$$$F$Y$$$20240801$$MD$US$US
241612831$24161283$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020065$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240801$$CN$US$US
241612841$24161284$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000043$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240801$$CN$US$US
241612851$24161285$1$I$20240108$20240717$20240801$20240801$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460278$RANBAXY$$73$YR$$M$Y$71$KG$20240801$$PH$IT$IT
241612862$24161286$2$F$$20240809$20240801$20240823$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460301$RANBAXY$Kufa J, Novotna J, Lukasova M, et al.. Rare granulomatous processes. Transfusion and Hematology today. 2024;30(2):122-30$48$YR$$M$Y$$$20240823$$HP$CZ$CZ
241612871$24161287$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000055$ELI LILLY AND CO$$$$$F$Y$$$20240801$$PH$US$US
241612881$24161288$1$I$20240503$20240717$20240801$20240801$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460318$RANBAXY$$46$YR$$F$Y$64$KG$20240801$$MD$IT$IT
241612891$24161289$1$I$$20240729$20240801$20240801$EXP$$US-ROCHE-10000042112$ROCHE$$85$YR$E$F$Y$$$20240801$$CN$US$US
241612901$24161290$1$I$$20240717$20240801$20240801$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460349$RANBAXY$$62$YR$$M$Y$94$KG$20240801$$MD$NL$NL
241612911$24161291$1$I$20240422$20240717$20240801$20240801$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460156$RANBAXY$$85$YR$$M$Y$$$20240801$$PH$IT$IT
241612921$24161292$1$I$$20240717$20240801$20240801$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460131$RANBAXY$$60$YR$$F$Y$$$20240801$$PH$GB$GB
241612931$24161293$1$I$$20240717$20240801$20240801$EXP$$CO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460253$RANBAXY$Tabares B, Sarmiento-Suarez AD, Gil O, Hernandez-Pabon JC, Firacative C. Fatal co-infection by multiple pathogens in an indigenous woman with autoimmune hemolytic anemia and tuberculosis: a case report. BMC Infect Dis. 2024;24 (1):6 pages$28$YR$$F$Y$$$20240801$$HP$CO$CO
241612941$24161294$1$I$$20240725$20240801$20240801$EXP$$JP-AMGEN-JPNSP2024147964$AMGEN$$$$$$Y$$$20240801$$MD$JP$JP
241612951$24161295$1$I$20230101$20240712$20240801$20240801$PER$$US-SA-2024SA211247$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240719$$MD$US$US
241612961$24161296$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA211128$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240719$$MD$US$US
241612972$24161297$2$F$$20240815$20240801$20240828$PER$$US-SA-2024SA211169$SANOFI AVENTIS$$$$A$F$Y$87.982$KG$20240828$$MD$US$US
241612981$24161298$1$I$20240601$20240712$20240801$20240801$PER$$US-SA-2024SA209148$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240719$$MD$US$US
241612991$24161299$1$I$20230501$20240710$20240801$20240801$PER$$US-SA-2024SA206289$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240719$$MD$US$US
241613001$24161300$1$I$20240501$20240712$20240801$20240801$PER$$US-SA-2024SA210053$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240719$$MD$US$US
241613011$24161301$1$I$20230101$20240710$20240801$20240801$PER$$US-SA-2024SA206510$SANOFI AVENTIS$$29$YR$A$F$Y$65.77$KG$20240719$$MD$US$US
241613022$24161302$2$F$20240101$20240816$20240801$20240822$EXP$$US-SA-2024SA211218$SANOFI AVENTIS$$59$YR$A$M$Y$85.7$KG$20240822$$MD$US$US
241613031$24161303$1$I$20240101$20240715$20240801$20240801$PER$$US-SA-2024SA209398$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240719$$MD$US$US
241613041$24161304$1$I$20240601$20240712$20240801$20240801$PER$$US-SA-2024SA210176$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240719$$MD$US$US
241613051$24161305$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA209364$SANOFI AVENTIS$$$$$F$Y$16.3$KG$20240719$$CN$US$US
241613061$24161306$1$I$20240701$20240715$20240801$20240801$PER$$US-SA-2024SA209666$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240719$$MD$US$US
241613071$24161307$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA209385$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240719$$MD$US$US
241613081$24161308$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA211166$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240719$$MD$US$US
241613101$24161310$1$I$20240101$20240724$20240801$20240801$EXP$$US-ROCHE-10000035842$ROCHE$$52$YR$A$F$Y$99.33$KG$20240801$$CN$US$US
241613111$24161311$1$I$$20240729$20240801$20240801$EXP$$ZA-ABBVIE-5861782$ABBVIE$$88$YR$$M$Y$$$20240801$$HP$ZA$ZA
241613122$24161312$2$F$$20240728$20240801$20240806$EXP$$NVSC2024US153498$NOVARTIS$$$$$F$Y$$$20240806$$HP$US$US
241613131$24161313$1$I$$20240725$20240801$20240801$EXP$$NVSC2024CA154714$NOVARTIS$$32$YR$$F$Y$$$20240801$$HP$CA$CA
241613141$24161314$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA208204$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240719$$HP$US$US
241613151$24161315$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA209246$SANOFI AVENTIS$$$$A$M$Y$$$20240719$$CN$US$US
241613161$24161316$1$I$20240715$20240716$20240801$20240801$PER$$US-SA-2024SA209468$SANOFI AVENTIS$$92$YR$E$M$Y$$$20240719$$CN$US$US
241613171$24161317$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA208408$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240719$$MD$US$US
241613181$24161318$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA208087$SANOFI AVENTIS$$98$YR$E$F$Y$$$20240719$$CN$US$US
241613191$24161319$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA208230$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240719$$CN$US$US
241613201$24161320$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA209677$SANOFI AVENTIS$$$$$M$Y$$$20240719$$HP$US$US
241613211$24161321$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA208207$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240719$$CN$US$US
241613221$24161322$1$I$$20240713$20240801$20240801$PER$$US-SA-2024SA208962$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240719$$MD$US$US
241613231$24161323$1$I$20170101$20240715$20240801$20240801$PER$$US-SA-2024SA208152$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240719$$CN$US$US
241613241$24161324$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA208097$SANOFI AVENTIS$$$$A$F$Y$$$20240719$$CN$US$US
241613251$24161325$1$I$$20240716$20240801$20240801$PER$$US-SA-2024SA209350$SANOFI AVENTIS$$$$$$Y$$$20240719$$HP$US$US
241613262$24161326$2$F$20240509$20240731$20240801$20240809$PER$$US-SA-2024SA209750$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240809$$MD$US$US
241613271$24161327$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA207075$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240719$$CN$US$US
241613281$24161328$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA209753$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240719$$MD$US$US
241613301$24161330$1$I$20240601$20240712$20240801$20240801$PER$$US-SA-2024SA209479$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240719$$MD$US$US
241613311$24161331$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA208805$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240719$$CN$US$US
241613321$24161332$1$I$20240701$20240712$20240801$20240801$PER$$US-SA-2024SA207823$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240719$$HP$US$US
241613331$24161333$1$I$20240715$20240716$20240801$20240801$PER$$US-SA-2024SA210892$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240719$$CN$US$US
241613341$24161334$1$I$$20240729$20240801$20240801$EXP$$US-ROCHE-10000041746$ROCHE$$76$YR$E$F$Y$$$20240801$$CN$US$US
241613352$24161335$2$F$20240723$20240806$20240801$20240816$EXP$$TW-ROCHE-10000044334$ROCHE$$83$YR$E$F$Y$$$20240816$$MD$TW$TW
241613361$24161336$1$I$$20240727$20240801$20240801$EXP$GB-MHRA-MED-202407271036139910-PFJBY$GB-AMAROX PHARMA-AMR2024GB02495$HETERO$$68$YR$$$Y$68$KG$20240801$$CN$GB$GB
241613371$24161337$1$I$$20240724$20240801$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121102$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240801$$MD$JP$JP
241613381$24161338$1$I$$20240717$20240801$20240801$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459706$RANBAXY$Yang Y, Yan J, Yang J, Wang P, Liu Y, Wang X. Janus kinase inhibitor Abrocitinib as an Off-Label treatment for tattoo granuloma with uveitis (TAGU). Australas J Dermatol. 2024;65:297-299$41$YR$$M$Y$$$20240801$$MD$CN$CN
241613391$24161339$1$I$20240401$20240724$20240801$20240801$EXP$$GB-AstraZeneca-2024A168668$ASTRAZENECA$$68$YR$$F$Y$$$20240801$$MD$GB$
241613401$24161340$1$I$$20211102$20240801$20240801$EXP$$AU-AstraZeneca-2021A796075$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$AU$
241613411$24161341$1$I$20240305$20240717$20240801$20240801$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460355$RANBAXY$$75$YR$$M$Y$$$20240801$$MD$ES$ES
241613421$24161342$1$I$$20240717$20240801$20240801$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459559$RANBAXY$Shinohara RC, Oshima T, Otsubo T, Ariga K Ono T, Muneoka K, et al. Successful utilization of clozapine for a patient with treatment resistant schizophrenia after recurrent violent behavior. Neuropsychopharmacol Rep. 2024;00:1-5$38$YR$$M$Y$$$20240801$$HP$JP$JP
241613431$24161343$1$I$20240718$20240724$20240801$20240801$PER$$US-AstraZeneca-2024A168949$ASTRAZENECA$$27385$DY$$F$Y$$$20240801$$CN$US$
241613441$24161344$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA207828$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240719$$MD$US$US
241613451$24161345$1$I$$20240717$20240801$20240801$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459546$RANBAXY$Bonar S, Schneider III HL, Cook K, Samala RV, F.F.Poole M. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J Pain Symptom Manage. 2023;Oct; 66(4):e455-e459$$$$$Y$$$20240801$$PH$US$US
241613461$24161346$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA207779$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240719$$HP$US$US
241613471$24161347$1$I$20240712$20240715$20240801$20240801$PER$$US-SA-2024SA209706$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240719$$CN$US$US
241613481$24161348$1$I$20240101$20240715$20240801$20240801$PER$$US-SA-2024SA208402$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240719$$CN$US$US
241613492$24161349$2$F$20240709$20240809$20240801$20240819$PER$$US-SA-2024SA210944$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240819$$MD$US$US
241613501$24161350$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA208647$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240719$$HP$US$US
241613512$24161351$2$F$$20240913$20240801$20240923$PER$$US-SA-2024SA209555$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240923$$MD$US$US
241613521$24161352$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA208107$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240719$$HP$US$US
241613531$24161353$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA209029$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240719$$MD$US$US
241613542$24161354$2$F$20240709$20240905$20240801$20240920$PER$$US-SA-2024SA185083$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240920$$MD$US$US
241613551$24161355$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA209476$SANOFI AVENTIS$$$$C$M$Y$$$20240719$$MD$US$US
241613561$24161356$1$I$20240710$20240715$20240801$20240801$PER$$US-SA-2024SA209711$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240719$$CN$US$US
241613571$24161357$1$I$20240714$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A170175$ASTRAZENECA$$13994$DY$$F$Y$68.5$KG$20240801$$CN$US$
241613581$24161358$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA209757$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240719$$MD$US$US
241613591$24161359$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA208952$SANOFI AVENTIS$$$$A$M$Y$$$20240719$$MD$US$US
241613601$24161360$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA208650$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240719$$MD$US$US
241613611$24161361$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA208284$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240719$$MD$US$US
241613621$24161362$1$I$20240710$20240712$20240801$20240801$PER$$US-SA-2024SA209466$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240719$$MD$US$US
241613631$24161363$1$I$20240708$20240712$20240801$20240801$PER$$US-SA-2024SA209588$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240719$$MD$US$US
241613641$24161364$1$I$$20240715$20240801$20240801$PER$$US-SA-2024SA208483$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240719$$MD$US$US
241613651$24161365$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA209537$SANOFI AVENTIS$$43$YR$A$M$Y$97.52$KG$20240719$$MD$US$US
241613661$24161366$1$I$20240701$20240712$20240801$20240801$PER$$US-SA-2024SA209377$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240719$$MD$US$US
241613672$24161367$2$F$20240628$20240812$20240801$20240821$PER$$US-SA-2024SA207777$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240821$$MD$US$US
241613681$24161368$1$I$$20240726$20240801$20240801$PER$$US-AstraZeneca-2024A171547$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241613691$24161369$1$I$$20210824$20240801$20240801$EXP$$US-AstraZeneca-2021A615112$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241613702$24161370$2$F$$20240801$20240801$20240806$PER$$US-AMGEN-USASP2024150881$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241613711$24161371$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA208476$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240719$$MD$US$US
241613721$24161372$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA206817$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240719$$CN$US$US
241613731$24161373$1$I$20240307$20240712$20240801$20240801$PER$$US-SA-2024SA123545$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240719$$MD$US$US
241613741$24161374$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA207820$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240719$$MD$US$US
241613751$24161375$1$I$20240711$20240712$20240801$20240801$PER$$US-SA-2024SA209386$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240719$$MD$US$US
241613761$24161376$1$I$20240701$20240712$20240801$20240801$PER$$US-SA-2024SA209153$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240719$$MD$US$US
241613771$24161377$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA209735$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240719$$MD$US$US
241613781$24161378$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA208863$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240719$$MD$US$US
241613791$24161379$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA209021$SANOFI AVENTIS$$$$A$F$Y$54.4$KG$20240719$$MD$US$US
241613801$24161380$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA208512$SANOFI AVENTIS$$$$A$F$Y$101.1$KG$20240719$$MD$US$US
241613811$24161381$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA209583$SANOFI AVENTIS$$$$A$F$Y$93.8$KG$20240719$$MD$US$US
241613821$24161382$1$I$20220827$20240712$20240801$20240801$PER$$US-SA-2024SA210428$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240719$$MD$US$US
241613831$24161383$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA209524$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240719$$MD$US$US
241613841$24161384$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA209574$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240719$$MD$US$US
241613851$24161385$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA210782$SANOFI AVENTIS$$49$YR$A$F$Y$188$KG$20240719$$MD$US$US
241613861$24161386$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA209433$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240719$$MD$US$US
241613871$24161387$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA208911$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240719$$MD$US$US
241613881$24161388$1$I$20240601$20240711$20240801$20240801$PER$$US-SA-2024SA170114$SANOFI AVENTIS$$50$YR$A$F$Y$117.9$KG$20240719$$MD$US$US
241613891$24161389$1$I$20240705$20240712$20240801$20240801$PER$$US-SA-2024SA209319$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240719$$MD$US$US
241613901$24161390$1$I$$20240711$20240801$20240801$PER$$US-SA-2022SA135195$SANOFI AVENTIS$$$$A$F$Y$82.5$KG$20240719$$MD$US$US
241613911$24161391$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA208969$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240719$$MD$US$US
241613922$24161392$2$F$$20240819$20240801$20240821$PER$$US-SA-2024SA209394$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240821$$MD$US$US
241613931$24161393$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA208961$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240719$$MD$US$US
241613941$24161394$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA206850$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240719$$MD$US$US
241613951$24161395$1$I$20230101$20240711$20240801$20240801$PER$$US-SA-2024SA207757$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240719$$MD$US$US
241613961$24161396$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA209576$SANOFI AVENTIS$$$$E$F$Y$$$20240719$$MD$US$US
241613971$24161397$1$I$20240702$20240712$20240801$20240801$PER$$US-SA-2024SA209052$SANOFI AVENTIS$$65$YR$E$F$Y$87.9$KG$20240719$$MD$US$US
241613981$24161398$1$I$20240401$20240712$20240801$20240801$PER$$US-SA-2024SA208620$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240719$$MD$US$US
241613991$24161399$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA207771$SANOFI AVENTIS$$$$$M$Y$$$20240719$$CN$US$US
241614001$24161400$1$I$20240101$20240711$20240801$20240801$PER$$US-SA-2024SA206270$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240719$$CN$US$US
241614011$24161401$1$I$20240101$20240712$20240801$20240801$PER$$US-SA-2024SA207540$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240719$$CN$US$US
241614021$24161402$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA207057$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240719$$CN$US$US
241614031$24161403$1$I$20180901$20240712$20240801$20240801$PER$$US-SA-2024SA209579$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240719$$MD$US$US
241614041$24161404$1$I$20240101$20240711$20240801$20240801$PER$$US-SA-2024SA208957$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240719$$MD$US$US
241614051$24161405$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA202265$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240719$$MD$US$US
241614061$24161406$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA207251$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240719$$MD$US$US
241614072$24161407$2$F$20240708$20240812$20240801$20240820$PER$$US-SA-2024SA207918$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240820$$CN$US$US
241614081$24161408$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA207363$SANOFI AVENTIS$$$$A$F$Y$$$20240719$$MD$US$US
241614091$24161409$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA207368$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240719$$MD$US$US
241614101$24161410$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA209379$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240719$$CN$US$US
241614111$24161411$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA210417$SANOFI AVENTIS$$$$A$F$Y$77$KG$20240719$$MD$US$US
241614121$24161412$1$I$20240101$20240711$20240801$20240801$PER$$US-SA-2024SA210327$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240719$$MD$US$US
241614131$24161413$1$I$20240101$20240711$20240801$20240801$PER$$US-SA-2024SA208977$SANOFI AVENTIS$$34$YR$A$F$Y$58.967$KG$20240719$$MD$US$US
241614141$24161414$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA209809$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240719$$MD$US$US
241614151$24161415$1$I$20240101$20240711$20240801$20240801$PER$$US-SA-2024SA209486$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240719$$MD$US$US
241614161$24161416$1$I$20240101$20240711$20240801$20240801$PER$$US-SA-2024SA207727$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240719$$MD$US$US
241614171$24161417$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA210311$SANOFI AVENTIS$$42$YR$A$F$Y$79.8$KG$20240719$$HP$US$US
241614182$24161418$2$F$20240601$20240830$20240801$20240916$PER$$US-SA-2024SA209196$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240916$$MD$US$US
241614193$24161419$3$F$$20240812$20240801$20240821$PER$$US-SA-2024SA207901$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240821$$MD$US$US
241614201$24161420$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA209762$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240719$$MD$US$US
241614211$24161421$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA207569$SANOFI AVENTIS$$$$E$F$Y$$$20240719$$HP$US$US
241614221$24161422$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA206038$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240719$$MD$US$US
241614231$24161423$1$I$$20240723$20240801$20240801$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005459$BIOCON$$$$$$Y$$$20240801$$HP$CA$CA
241614241$24161424$1$I$20240101$20240711$20240801$20240801$PER$$US-SA-2024SA209544$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240719$$MD$US$US
241614251$24161425$1$I$20240101$20240711$20240801$20240801$PER$$US-SA-2024SA209700$SANOFI AVENTIS$$60$YR$A$M$Y$113.3$KG$20240719$$MD$US$US
241614261$24161426$1$I$20240101$20240711$20240801$20240801$PER$$US-SA-2024SA206952$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240719$$MD$US$US
241614271$24161427$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA207319$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240719$$MD$US$US
241614281$24161428$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA207139$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240719$$MD$US$US
241614292$24161429$2$F$20230201$20240801$20240801$20240809$PER$$US-SA-2024SA209786$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240809$$HP$US$US
241614301$24161430$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA207846$SANOFI AVENTIS$$$$E$F$Y$$$20240719$$MD$US$US
241614311$24161431$1$I$20240101$20240711$20240801$20240801$PER$$US-SA-2024SA207903$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240719$$MD$US$US
241614321$24161432$1$I$20240709$20240711$20240801$20240801$PER$$US-SA-2024SA209704$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240719$$MD$US$US
241614331$24161433$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA207206$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240719$$MD$US$US
241614341$24161434$1$I$20240601$20240711$20240801$20240801$PER$$US-SA-2024SA207148$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240719$$MD$US$US
241614351$24161435$1$I$20240601$20240725$20240801$20240801$EXP$$JP-CHEPLA-2024009483$CHEPLAPHARM$$$$$$Y$$$20240801$$CN$COUNTRY NOT SPECIFIED$JP
241614361$24161436$1$I$20240610$20240725$20240801$20240801$EXP$HR-HALMED-300086079$HR-CHEPLA-2024009632$CHEPLAPHARM$$24$YR$$M$Y$$$20240801$$MD$COUNTRY NOT SPECIFIED$HR
241614371$24161437$1$I$20221201$20240725$20240801$20240801$EXP$MT-SEATTLE GENETICS-2023SGN05182$MT-CHEPLA-2024009803$CHEPLAPHARM$$3$DEC$$F$Y$$$20240801$$MD$COUNTRY NOT SPECIFIED$MT
241614381$24161438$1$I$$20240726$20240801$20240801$EXP$GB-MHRA-MIDB-a188337a-c9a8-425a-8150-f53719a6f451$GB-CHEPLA-2024009627$CHEPLAPHARM$$38$YR$$$Y$$$20240801$$PH$COUNTRY NOT SPECIFIED$GB
241614391$24161439$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA206839$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240719$$CN$US$US
241614402$24161440$2$F$20240701$20240913$20240801$20240923$PER$$US-SA-2024SA208963$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240923$$MD$US$US
241614411$24161441$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA208530$SANOFI AVENTIS$$$$A$F$Y$86$KG$20240719$$MD$US$US
241614421$24161442$1$I$20240701$20240709$20240801$20240801$PER$$US-SA-2024SA210318$SANOFI AVENTIS$$$$E$F$Y$$$20240719$$MD$US$US
241614431$24161443$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA209814$SANOFI AVENTIS$$$$C$F$Y$$$20240719$$MD$US$US
241614441$24161444$1$I$20240601$20240711$20240801$20240801$PER$$US-SA-2024SA209003$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240719$$MD$US$US
241614452$24161445$2$F$20240101$20240918$20240801$20240925$PER$$US-SA-2024SA206992$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240925$$MD$US$US
241614462$24161446$2$F$$20240729$20240801$20240807$PER$$US-SA-2024SA206625$SANOFI AVENTIS$$$$A$M$Y$$$20240807$$MD$US$US
241614471$24161447$1$I$20240601$20240710$20240801$20240801$PER$$US-SA-2024SA207872$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240719$$MD$US$US
241614481$24161448$1$I$20190101$20240711$20240801$20240801$PER$$US-SA-2024SA208990$SANOFI AVENTIS$$17$YR$T$M$Y$61$KG$20240719$$MD$US$US
241614492$24161449$2$F$20240101$20240819$20240801$20240830$PER$$US-SA-2024SA207403$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240830$$CN$US$US
241614501$24161450$1$I$20240201$20240710$20240801$20240801$PER$$US-SA-2024SA208561$SANOFI AVENTIS$$69$YR$E$M$Y$95$KG$20240719$$MD$US$US
241614512$24161451$2$F$20240101$20240807$20240801$20240816$PER$$US-SA-2024SA209511$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240816$$MD$US$US
241614532$24161453$2$F$20240713$20240719$20240801$20240802$PER$$US-TEVA-VS-3221705$TEVA$$$$$F$Y$$$20240802$$CN$US$US
241614541$24161454$1$I$20240701$20240710$20240801$20240801$PER$$US-SA-2024SA209780$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240719$$MD$US$US
241614552$24161455$2$F$20240701$20240802$20240801$20240812$PER$$US-SA-2024SA209788$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240812$$MD$US$US
241614561$24161456$1$I$$20240710$20240801$20240801$PER$$US-SA-2024SA209813$SANOFI AVENTIS$$$$A$F$Y$68.9$KG$20240719$$MD$US$US
241614571$24161457$1$I$20240101$20240710$20240801$20240801$PER$$US-SA-2024SA206559$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240719$$MD$US$US
241614581$24161458$1$I$20240101$20240710$20240801$20240801$PER$$US-SA-2024SA206703$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240719$$CN$US$US
241614591$24161459$1$I$20240101$20240710$20240801$20240801$PER$$US-SA-2024SA209599$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240719$$MD$US$US
241614601$24161460$1$I$20220101$20240710$20240801$20240801$PER$$US-SA-2024SA209603$SANOFI AVENTIS$$66$YR$E$F$Y$56$KG$20240719$$MD$US$US
241614611$24161461$1$I$$20240710$20240801$20240801$PER$$US-SA-2024SA211127$SANOFI AVENTIS$$$$E$F$Y$74$KG$20240719$$MD$US$US
241614621$24161462$1$I$20240101$20240710$20240801$20240801$PER$$US-SA-2024SA208579$SANOFI AVENTIS$$$$E$F$Y$$$20240719$$MD$US$US
241614631$24161463$1$I$$20240710$20240801$20240801$PER$$US-SA-2024SA206814$SANOFI AVENTIS$$$$A$F$Y$$$20240719$$MD$US$US
241614642$24161464$2$F$20231011$20240730$20240801$20240802$EXP$$IT-009507513-2407ITA014320$MERCK$$51$YR$$F$Y$$$20240802$$PH$IT$IT
241614651$24161465$1$I$$20240710$20240801$20240801$PER$$US-SA-2024SA206550$SANOFI AVENTIS$$$$A$F$Y$54$KG$20240719$$MD$US$US
241614661$24161466$1$I$$20240710$20240801$20240801$PER$$US-SA-2024SA207609$SANOFI AVENTIS$$48$YR$A$F$Y$58.9$KG$20240719$$MD$US$US
241614671$24161467$1$I$$20240710$20240801$20240801$PER$$US-SA-2024SA206451$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240719$$MD$US$US
241614681$24161468$1$I$20120101$20240716$20240801$20240801$EXP$FR-AFSSAPS-AVLL2024000166$FR-SA-2024SA207657$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240719$$MD$FR$FR
241614691$24161469$1$I$$20240723$20240801$20240801$PER$$US-ABBVIE-5855317$ABBVIE$$$$$$Y$$$20240801$$HP$US$US
241614711$24161471$1$I$$20240716$20240801$20240801$EXP$NL-LRB-00982464$NL-SA-2024SA210346$SANOFI AVENTIS$$52$YR$A$F$Y$74.8$KG$20240719$$MD$NL$NL
241614731$24161473$1$I$$20240419$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-08926$ALKEM$Ramirez E, Bellon T, Tong HY, Borobia AM, et.al.. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/ TEN are different from those found for the same AED-induced DRESS in  the Spanish population. Pharmacological Research. 2016;unk:unk$3$YR$$M$Y$$$20240801$$HP$ES$ES
241614741$24161474$1$I$$20240419$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-08928$ALKEM$Ramirez E, Bellon T, Tong HY, Borobia AM, et.al.. Significant HLA class I type associations with aromatic antiepileptic drug  (AED)-induced SJS/ TEN are different from those found for the same AED-induced DRESS in the Spanish population. Pharmacological Research. 2017;unk:unk$16$YR$$F$Y$$$20240801$$HP$ES$ES
241614751$24161475$1$I$$20240419$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-08930$ALKEM$Ramirez E, Bellon T, Tong HY, Borobia AM, et.al.. Significant HLA class I type associations with aromatic antiepileptic drug  (AED)-induced SJS/ TEN are different from those found for the same AED-induced DRESS in  the Spanish population. Pharmacological Research. 2016;unk:unk$16$YR$$F$Y$$$20240801$$HP$ES$ES
241614761$24161476$1$I$$20240419$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-08925$ALKEM$Ramirez E, Bellon T, Tong HY, Borobia AM, et.al.. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/ TEN are different from those found for the same AED-induced DRESS in  the Spanish population. Pharmacological Research. 2016;unk:unk$34$YR$$F$Y$$$20240801$$HP$ES$ES
241614771$24161477$1$I$$20240419$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-08929$ALKEM$Ramirez E, Bellon T, Tong HY, Borobia AM, et.al.. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/ TEN are different from those found for the same AED-induced DRESS in the Spanish population. Pharmacological Research. 2016;unk:unk$91$YR$$F$Y$$$20240801$$HP$ES$ES
241614781$24161478$1$I$$20231219$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2023-16663$ALKEM$Fernandez-Galan M, Martin-Nunez G, Castellanos F, Lopez-Lopez M. Lamotrigine-induced agranulocytosis. Med Cl?n (Barc. 2000;115:759$17$YR$$F$Y$$$20240801$$HP$ES$ES
241614791$24161479$1$I$$20240115$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-00993$ALKEM$Medina-Caliz I, Sanabria-Cabrera J, Villanueva-Paz M, Aukstikalne L, et.al.. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries. Archives of Toxicology. 2024;98:303-325$51$YR$$M$Y$$$20240801$$HP$ES$ES
241614801$24161480$1$I$$20240115$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-00995$ALKEM$Medina-Caliz I, Sanabria-Cabrera J, Villanueva-Paz M, Aukstikalne L, et.al.. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries. Archives of Toxicology. 2024;98:303-325$19$YR$$F$Y$$$20240801$$HP$ES$ES
241614811$24161481$1$I$$20240419$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-08927$ALKEM$Ramirez E, Bellon T, Tong HY, Borobia AM, et.al.. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/ TEN are different from those found for the same AED-induced DRESS in the Spanish population. Pharmacological Research. 2017;unk:unk$5$YR$$M$Y$$$20240801$$HP$ES$ES
241614821$24161482$1$I$$20240322$20240801$20240801$EXP$$CN-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-06574$ALKEM$Chen YC, Chiu HC, Chu CY,. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Dermatol. 2010;146:1373-1379$21$YR$$M$Y$$$20240801$$HP$CN$CN
241614831$24161483$1$I$$20231219$20240801$20240801$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2023-16788$ALKEM$Kilbas S. Lamotrigine-induced leucopenia. Epileptic Disord. 2006;8:317$24$YR$$F$Y$$$20240801$$HP$TR$TR
241614841$24161484$1$I$$20231219$20240801$20240801$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2023-16679$ALKEM$Okur M, Kaya A, Caksen H, Taskin G.. Lamotrigine-associated thrombocytopenia and leukopenia. J Emerg Med. 2012;42:584-585$10$YR$$M$Y$$$20240801$$HP$TR$TR
241614851$24161485$1$I$$20240322$20240801$20240801$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-06558$ALKEM$Ozaydin E, Cayir A, Gurler T, Cengizlier R, Kose G, Vidinlisan S. Lamotrigine-induced hypersensitivity syndrome: case report. Gazi Med J. 2009;20:135-138$11$YR$$F$Y$$$20240801$$HP$TR$TR
241614861$24161486$1$I$$20240115$20240801$20240801$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-00989$ALKEM$Medina-Caliz I, Sanabria-Cabrera J, Villanueva-Paz M, Aukstikalne L, et.al.. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries. Archives of Toxicology. 2024;98:303-325$16$YR$$M$Y$$$20240801$$HP$ES$ES
241614871$24161487$1$I$$20231219$20240801$20240801$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2023-16699$ALKEM$Ural AU, Avcu F, Gokcil Z, Nevruz O, Cetin T.. Leucopenia and thrombocytopenia possibly associated with lamotrigine use in a patient. Epileptic Disord. 2005;7:33-35$25$YR$$F$Y$$$20240801$$HP$TR$TR
241614881$24161488$1$I$$20240109$20240801$20240801$EXP$$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-00470$ALKEM$Chang CF, Chung KH. Lamotrigine-induced pancytopenia in bipolar disorder. Journal of the Formosan Medical Association. 2018;117:1128-1129$55$YR$$F$Y$$$20240801$$HP$TW$TW
241614891$24161489$1$I$$20240403$20240801$20240801$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-06560$ALKEM$Kocaoglu C, Cilasun C, Solak ES, Kurtipek GS, Arslan S. Successful Treatment of Antiepileptic Drug-Induced DRESS Syndrome with Pulse Methylprednisolone. Case Reports in Pediatrics. 2013;2013:928910$6$YR$$M$Y$$$20240801$$HP$TR$TR
241614901$24161490$1$I$$20240322$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-06629$ALKEM$Chang CC, Shiah IS, Yeh CB, Wang TS, Chang HA. Lamotrigine-associated anticonvulant hypersensitivity syndrome in bipolar disorder. Prog. Neuropsy-chopharmacol. Biol. 2006;30:741-744$48$YR$$F$Y$$$20240801$$HP$US$US
241614911$24161491$1$I$$20240322$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06690$ALKEM$Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et.al.. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19:661-665$16$YR$$F$Y$$$20240801$$HP$GB$GB
241614921$24161492$1$I$$20240322$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06692$ALKEM$Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et.al.. Lamotrigine induced DIHS/DRESS: manifestations, treatment, and outcome in 57 patients. Clinical Neurology and Neurosurgery. 2009;19:661-665$39$YR$$M$Y$$$20240801$$HP$GB$GB
241614931$24161493$1$I$$20240621$20240801$20240801$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-13293$ALKEM$Bozca BC, Unal B, Alpsoy E.. Lamotrigine-induced DRESS with purpuric lesions in the oral mucosa. JAAD Case Reports. 2020;6(5):383-385$31$YR$$F$Y$$$20240801$$MD$TR$TR
241614941$24161494$1$I$$20240221$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03684$ALKEM$Bromley RL, Mawer GE, Briggs M, et al.. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84:637-643$27$YR$$F$Y$$$20240801$$MD$GB$GB
241614951$24161495$1$I$$20240322$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06691$ALKEM$Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et.al.. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19:661-665$50$YR$$M$Y$$$20240801$$HP$GB$GB
241614961$24161496$1$I$$20240221$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03680$ALKEM$Bromley RL, Mawer GE, Briggs M, et al.. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2023;84:637-643$30$YR$$F$Y$$$20240801$$MD$GB$GB
241614971$24161497$1$I$$20240322$20240801$20240801$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-06588$ALKEM$Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol. 2009;145:67-72$25$YR$$F$Y$$$20240801$$HP$FR$FR
241614981$24161498$1$I$$20240322$20240801$20240801$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-06596$ALKEM$Jeandel PY, Traissac T, Rainfray M, Bourdel-Marchasson I.. Drug hypersensitivity syndrome with lamotrigine two cases in elderly. Presse Med. 2005;34:516-518$85$YR$$F$Y$$$20240801$$HP$FR$FR
241614991$24161499$1$I$$20231119$20240801$20240801$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-14178$ALKEM$Kerkemeyer KLS, Lee S, Lai FYX, Mar A. Drug rash with eosinophilia and systemic symptoms syndrome without eosinophilia managed with intravenous immunoglobulin. Internal Medicine Journal. 2020;50(9):1156-1157$39$YR$$M$Y$$$20240801$$HP$AU$AU
241615001$24161500$1$I$$20240322$20240801$20240801$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-06593$ALKEM$Jeandel PY, Traissac T, Rainfray M, Bourdel-Marchasson I.. Drug hypersensitivity syndrome with lamotrigine two cases in elderly. Presse Med. 2005;34:516-518$91$YR$$M$Y$$$20240801$$HP$FR$FR
241615011$24161501$1$I$$20240322$20240801$20240801$EXP$$CH-ALKEM LABORATORIES LIMITED-CH-ALKEM-2024-06634$ALKEM$Caubet JC, Pichler WJ, Eigenmann PA.. Educational case series: Mechanisms of drug allergy. Pediatr Allergy Immunol. 2011;22:559-567$8$YR$$M$Y$$$20240801$$HP$CH$CH
241615021$24161502$1$I$$20231219$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-16740$ALKEM$Nicholson RJ, Kelly KP, Grant IS. Leucopenia associated with lamotrigine. BMJ. 1995;310:504$35$YR$$F$Y$$$20240801$$HP$GB$GB
241615031$24161503$1$I$$20240221$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03677$ALKEM$Bromley RL, Mawer GE, Briggs M, et al.. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84:637-643$26$YR$$F$Y$$$20240801$$MD$GB$GB
241615041$24161504$1$I$$20240322$20240801$20240801$EXP$$AR-ALKEM LABORATORIES LIMITED-AR-ALKEM-2024-06753$ALKEM$Pereira de Silva N, Piquioni P, Kochen S, Saidon P. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. Eur. J. Clin. Pharmacol. 2011;67:463-470$21$YR$$F$Y$$$20240801$$HP$AR$AR
241615051$24161505$1$I$$20240403$20240801$20240801$EXP$$CN-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-06564$ALKEM$Chow JC, Huang CW, Fang CW, Wu YJ, Tsai JJ.. Lamotrigine-induced hypersensitivity syndrome in a Han Chinese patient with the HLA-B 5801 genotype. Neurol. Sci. 2013;34:117-119$32$YR$$F$Y$$$20240801$$HP$CN$CN
241615061$24161506$1$I$$20240221$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03692$ALKEM$Bromley RL, Mawer GE, Briggs M, et al.. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84:637-643$24$YR$$F$Y$$$20240801$$MD$GB$GB
241615071$24161507$1$I$$20240322$20240801$20240801$EXP$$AR-ALKEM LABORATORIES LIMITED-AR-ALKEM-2024-06755$ALKEM$N. Pereira de Silva, P. Piquioni, S. Kochen, P. Saidon. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. Eur. J. Clin. Pharmacol. 2011;67:463-470$15$YR$$F$Y$$$20240801$$HP$AR$AR
241615081$24161508$1$I$$20240322$20240801$20240801$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06625$ALKEM$Marriott DJ, Periyasamy P. Anticonvulsant hypersensitivity syndrome secondary to lamotrigine mimicking a septic episode. Ann. Acad. Med. Singap. 2011;40:422-423$49$YR$$F$Y$$$20240801$$HP$AU$AU
241615091$24161509$1$I$$20240322$20240801$20240801$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2023-12745$ALKEM$Fervenza FC, Kanakiriya S, Kunau RT, Gibney R, Lager DJ.. Acute granulomatous interstitial nephritis and colitis in anticonvulsant hypersensitivity syndrome associated with lamotrigine treatment. Am J Kidney Dis. 2000;36:1034-40$17$YR$$F$Y$$$20240801$$HP$CN$CN
241615101$24161510$1$I$$20231219$20240801$20240801$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-16660$ALKEM$De Camargo OA, Bode H. Agranulocytosis associated with lamotrigine. BMJ. 1999;318:1179$11$YR$$F$Y$$$20240801$$HP$DE$DE
241615111$24161511$1$I$$20231219$20240801$20240801$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2023-16668$ALKEM$Siniscalchi A, Gallelli L, Calabro G, Tolotta GA, De Sarro G.. Phenobarbital/Lamotrigine coadministration- induced blood dyscrasia in a patient with epilepsy. Ann Pharmacother. 2010;44:2031-2034$45$YR$$F$Y$$$20240801$$HP$IT$IT
241615121$24161512$1$I$$20240403$20240801$20240801$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-06575$ALKEM$Ogawa K, Morito H, Hasegawa A, Daikoku N, Miyagawa F, Okazaki A, Fukumoto T, Kobayashi N, Kasai T, Watanabe H, Sueki H, Iijima M, Tohyama M, Hashimoto K, Asada H. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS). Journal of Dermatological Science. 2013;69:38-43$36$YR$$F$Y$$$20240801$$HP$JP$JP
241615131$24161513$1$I$$20240322$20240801$20240801$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-06581$ALKEM$Gentile I, Talamo M, Borgia G. Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review. BMC Infect. 2010;10:49$26$YR$$F$Y$$$20240801$$HP$IT$IT
241615141$24161514$1$I$$20240403$20240801$20240801$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-06578$ALKEM$Ogawa K, Morito H, Hasegawa A, Daikoku N, Miyagawa F, Okazaki A, Fukumoto T, Kobayashi N, Kasai T, Watanabe H, Sueki H, Iijima M, Tohyama M, Hashimoto K, Asada H. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS). Journal of Dermatological Science. 2013;69:38-43$60$YR$$M$Y$$$20240801$$HP$JP$JP
241615151$24161515$1$I$$20240322$20240801$20240801$EXP$$AR-ALKEM LABORATORIES LIMITED-AR-ALKEM-2024-06752$ALKEM$Pereira de Silva N, Piquioni P, Kochen S, Saidon P.. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs,. Eur. J. Clin. Pharmacol. 2011;67:463-470$32$YR$$F$Y$$$20240801$$HP$AR$AR
241615161$24161516$1$I$$20240403$20240801$20240801$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-06577$ALKEM$Ogawa K, Morito H, Hasegawa A, Daikoku N, Miyagawa F, Okazaki A, Fukumoto T, Kobayashi N, Kasai T, Watanabe H, Sueki H, Iijima M, Tohyama M, Hashimoto K, Asada H. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS). Journal of Dermatological Science. 2013;69:38-43$16$YR$$M$Y$$$20240801$$HP$JP$JP
241615171$24161517$1$I$$20240322$20240801$20240801$EXP$$TR-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-06557$ALKEM$Bakker CV, Hegt VN, Praag MC.. Lamotrigine hypersensitivity syndrome and spiking Fever. Indian J. Dermatol. 2012;57:504$24$YR$$F$Y$$$20240801$$HP$TR$TR
241615181$24161518$1$I$$20240430$20240801$20240801$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-09751$ALKEM$Srivastava S, Ramanujam B, Ihtisham K, Tripathi M. Cutaneous adverse drug reactions to lamotrigine and human leukocyte antigen typing in North Indian patients: a case series. Annals of Indian Academy of Neurology. 2017;20:408-10$16$YR$$M$Y$$$20240801$$HP$IN$IN
241615191$24161519$1$I$$20240502$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-09887$ALKEM$A. L. Lofton, W. Klein-Schwartz.. Evaluation of lamotrigine toxicity reported to poison centers. Annals of Pharmacotherapy. 2004;38(11):1811-1815$3$YR$$F$Y$$$20240801$$HP$US$US
241615201$24161520$1$I$$20240322$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06743$ALKEM$Newell BD, Moinfa M, Mancini AJ, Nopper AJ.. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS). Pediatr. Dermatol.. 2009;26:536-546$2$YR$$F$Y$$$20240801$$HP$US$US
241615211$24161521$1$I$$20240322$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06744$ALKEM$Newell BD, Moinfar M, Mancini AJ, Nopper AJ.. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS). Pediatr. Dermatol.. 2009;26:536-546$3$YR$$M$Y$$$20240801$$HP$US$US
241615221$24161522$1$I$$20240322$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06745$ALKEM$Newell BD, Moinfa M, Mancini AJ, Nopper AJ.. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS). Pediatr. Dermatol.. 2009;26:536-546$7$YR$$M$Y$$$20240801$$HP$US$US
241615231$24161523$1$I$$20240322$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06748$ALKEM$B.D. Newell, M. Moinfa, A.J. Mancini, A.J. Nopper.. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS). Pediatr. Dermatol. 2009;26:536-546$12$YR$$M$Y$$$20240801$$HP$US$US
241615241$24161524$1$I$$20240502$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-09023$ALKEM$Griswold A, Tully B, Katz K, Beauchamp G, Cook M, Cannon R.. Lamotrigine ODT-Induced Seizure in a 3-Year-Old Child after Accidental Ingestion. Case Reports in Emergency Medicine. 2019;2019:1-3$3$YR$$M$Y$14.5$KG$20240801$$HP$US$US
241615251$24161525$1$I$$20240621$20240801$20240801$EXP$$TN-ALKEM LABORATORIES LIMITED-TN-ALKEM-2024-13290$ALKEM$Salah NB, Soua Y, Trimeche K, Lahouel I, Fathel NB, Korbi M, Belhadjali H, Youssef M, Zili J. Atypical presentation of lamotrigine-induced drug reaction with eosinophilia and systemic symptoms. Dermatologic Therapy. 2021;34(2):e14875$49$YR$$M$Y$$$20240801$$HP$TN$TN
241615261$24161526$1$I$$20231229$20240801$20240801$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2023-16689$ALKEM$Zhu X, Xiao T, Huang S, Liu S, Li X, Shang D, Wen Y.. Case Report: Predicting the Range of Lamotrigine Concentration Using Pharmacokinetic Models Based on Monte Carlo Simulation: A Case Study of Antiepileptic Drug-Related Leukopenia. Frontiers in Pharmacology. 2021;12:706329$15$YR$$F$Y$60$KG$20240801$$HP$CN$CN
241615271$24161527$1$I$$20240322$20240801$20240801$EXP$$CA-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06624$ALKEM$Comfere NI, Sartori-Valinotti JC, Bruce AJ, Drage LA. Successful treatment of lamotrigine-associated drug hypersensitivity syndrome with intravenous IgG. J.  Am. Acad. Dermatol. 2012;66:e249-e250$30$YR$$F$Y$$$20240801$$HP$CA$CA
241615291$24161529$1$I$$20231212$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-15080$ALKEM$Shlager G, Nakhla MN, Pritchett D, Brocks D.. Case report: Concomitant use of nightly vitamin A ointment with daily PROSE wear for ocular surface disease associated with chronic Stevens-Johnson syndrome. American Journal of Ophthalmology Case Reports. 2023;32:101943$51$YR$$F$Y$$$20240801$$HP$US$US
241615301$24161530$1$I$$20240430$20240801$20240801$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-09750$ALKEM$Srivastava S, Ramanujam B, Ihtisham K, Tripathi M. Cutaneous adverse drug reactions to lamotrigine and human leukocyte antigen typing in North Indian patients: a case series. Annals of Indian Academy of Neurology. 2017;20(4):408-410$54$YR$$F$Y$$$20240801$$HP$IN$IN
241615311$24161531$1$I$$20240322$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06636$ALKEM$Sarris BM, Wong JG. Multisystem hypersensitivity reaction to lamotrigine. Neurology. 1999;53:1367$27$YR$$F$Y$$$20240801$$HP$US$US
241615321$24161532$1$I$$20240322$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06623$ALKEM$Brown TS, Appel JE, Kasteler JS, Callen JP. Hypersensitivity reaction in a child due to lamotrigine. Pediatr. Dermatol. 1999;16:46-49$6$YR$$M$Y$$$20240801$$HP$US$US
241615331$24161533$1$I$$20240322$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06621$ALKEM$Bicknell LT, Sanches M, Schatte DJ. Erythema multiforme vs. DRESS syndrome associated with the combined use of lamotrigine and cyclobenzaprine: a case report. Int. J. Psychiatry Med. 2012;44:305-314$50$YR$$F$Y$$$20240801$$HP$US$US
241615341$24161534$1$I$$20240322$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06742$ALKEM$Newell BD, Moinfar M, Mancini AJ, Nopper AJ. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS). Pediatr. Dermatol.. 2009;26:536-546$4$YR$$F$Y$$$20240801$$HP$US$US
241615351$24161535$1$I$$20231219$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-16659$ALKEM$Das P, Ramaswamy S, Arora M, Samuels I, Gabel TL. Lamotrigine-induced neutropenia in a woman with schizoaffective disorder. Prim Care Companion J Clin Psychiatry. 2007;9:471-472$50$YR$$F$Y$$$20240801$$HP$US$US
241615361$24161536$1$I$$20240322$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06628$ALKEM$Calabrese JR, Sullivan JR, Bowden CL, Suppes T, Goldberg JF, Sachs GS, et.al.. Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J. Clin. Psychiatry. 2002;63:1012-1019$50$YR$$F$Y$$$20240801$$HP$US$US
241615371$24161537$1$I$$20240322$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06698$ALKEM$Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et.al.. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19:661-665$9$YR$$F$Y$$$20240801$$HP$GB$GB
241615381$24161538$1$I$$20240408$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08176$ALKEM$Silva E, Higgins M, Hammer B, Stephenson P.. Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital. Therapeutic Advances in Psychopharmacology. 2021;11:1-16$$$$M$Y$$$20240801$$HP$GB$GB
241615391$24161539$1$I$$20240322$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06694$ALKEM$Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et.al.. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19:661-665$41$YR$$F$Y$$$20240801$$HP$GB$GB
241615411$24161541$1$I$$20240322$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06627$ALKEM$Beller TC, Boyce JA. Prolonged anticonvulsant hypersensitivity syndrome related to lamotrigine in a patient withhumanimmunodeficiency virus. Allergy Asthma Proc.. 2002;23:415-419$32$YR$$F$Y$$$20240801$$HP$US$US
241615421$24161542$1$I$$20240322$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06699$ALKEM$Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et.al.. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19:661-665$38$YR$$F$Y$$$20240801$$HP$GB$GB
241615431$24161543$1$I$$20240322$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06700$ALKEM$Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et.al.. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19:661-665$20$YR$$M$Y$$$20240801$$HP$GB$GB
241615441$24161544$1$I$$20240322$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06702$ALKEM$Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et.al.. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19:661-665$25$YR$$F$Y$$$20240801$$HP$GB$GB
241615451$24161545$1$I$$20240322$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06695$ALKEM$Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et.al.. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19:661-665$44$YR$$F$Y$$$20240801$$HP$GB$GB
241615461$24161546$1$I$$20240322$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06696$ALKEM$Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et.al.. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19:661-665$24$YR$$F$Y$$$20240801$$HP$GB$GB
241615471$24161547$1$I$$20240322$20240801$20240801$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06697$ALKEM$Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et.al.. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19:661-665$30$YR$$F$Y$$$20240801$$HP$GB$GB
241615481$24161548$1$I$$20240508$20240801$20240801$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-09727$ALKEM$Kashyapa H, Verma L, Jadhav RB. Lamotrigine-induced Stevens-Johnson syndrome in a 25 year old lady. Int J Basic Clin Pharmacol. 2016;5:2694-6$25$YR$$F$Y$$$20240801$$HP$IN$IN
241615491$24161549$1$I$20240528$20240711$20240801$20240801$EXP$FR-AFSSAPS-CN2024000544$FR-SA-2024SA206859$SANOFI AVENTIS$$79$YR$E$F$Y$97.5$KG$20240719$$PH$FR$FR
241615501$24161550$1$I$$20240430$20240801$20240801$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-08835$ALKEM$Srivastava S, Ramanujam B, Ihtisham K, Tripathi M.. Cutaneous adverse drug reactions to lamotrigine and human leukocyte antigen typing in North Indian patients: a case series. Annals of Indian Academy of Neurology. 2017;20(4):408-410$16$YR$$F$Y$$$20240801$$HP$IN$IN
241615511$24161551$1$I$$20240322$20240801$20240801$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06626$ALKEM$Mylonakis E, Vittorio CC, Hollik DA, Rounds S. Lamotrigine overdose pre-senting as anticonvulsant hypersensitivity syndrome. Ann Pharmacother. 1999;33:557-559$49$YR$$F$Y$$$20240801$$HP$US$US
241615521$24161552$1$I$$20240717$20240801$20240801$EXP$$CA-SA-2024SA210295$SANOFI AVENTIS$$12$YR$T$F$Y$32$KG$20240719$$HP$CA$CA
241615531$24161553$1$I$20240601$20240715$20240801$20240801$EXP$$US-SA-2024SA198671$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240719$$MD$US$US
241615541$24161554$1$I$$20240716$20240801$20240801$EXP$$US-SA-2024SA210258$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240719$$MD$US$US
241615551$24161555$1$I$$20240715$20240801$20240801$EXP$$US-SA-2024SA208697$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240719$$CN$US$US
241615561$24161556$1$I$$20240711$20240801$20240801$EXP$$RU-SA-2024SA204728$SANOFI AVENTIS$Koksharova E, Drai R, Noskov S, Dorotenko A, Protsenko E, Radaeva K et al.. Clinical Pharmacology of GP40321 (Insulin Glulisine Biosimilar): Pharmacokinetic and Pharmacodynamic Comparability in a Hyperinsulinemic-Euglycemic Clamp Procedure. Clinical Pharmacology in Drug Development. 2024;13(7):828-36$$$A$M$Y$$$20240719$$MD$RU$RU
241615571$24161557$1$I$20210302$20240730$20240801$20240801$EXP$GR-GREOF-202400830$GR-ORGANON-O2407GRC002777$ORGANON$$61$YR$$F$Y$78$KG$20240801$$MD$GR$GR
241615581$24161558$1$I$20240101$20240711$20240801$20240801$EXP$$US-SA-2024SA208194$SANOFI AVENTIS$$56$YR$A$F$Y$92.998$KG$20240719$$MD$US$US
241615591$24161559$1$I$20240624$20240715$20240801$20240801$EXP$FR-AFSSAPS-SE2024000564$FR-SA-2024SA206462$SANOFI AVENTIS$$78$YR$E$M$Y$79$KG$20240719$$MD$FR$FR
241615601$24161560$1$I$20240701$20240715$20240801$20240801$PER$$US-SA-2024SA209899$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240719$$CN$US$US
241615611$24161561$1$I$$20240712$20240801$20240801$PER$$US-SA-2024SA209452$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240719$$MD$US$US
241615631$24161563$1$I$20240101$20240715$20240801$20240801$PER$$US-SA-2024SA208498$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240719$$MD$US$US
241615641$24161564$1$I$$20240711$20240801$20240801$PER$$US-SA-2024SA207338$SANOFI AVENTIS$$$$A$F$Y$$$20240719$$MD$US$US
241615651$24161565$1$I$$20240705$20240801$20240801$PER$$US-SA-2024SA208643$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240719$$CN$US$US
241615661$24161566$1$I$20240101$20240710$20240801$20240801$PER$$US-SA-2024SA209778$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240719$$MD$US$US
241615671$24161567$1$I$20220101$20240712$20240801$20240801$PER$$US-SA-2024SA209563$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240719$$MD$US$US
241615682$24161568$2$F$$20240729$20240801$20240806$EXP$$IT-JNJFOC-20240775960$JOHNSON AND JOHNSON$$$$T$F$Y$$$20240806$$MD$IT$IT
241615691$24161569$1$I$$20240718$20240801$20240801$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06987$HIKMA$Bosley A, Abdou C, Ahmad S, Barssoum K, Chatila K.. Bosley A, Abdou C, Ahmad S, Barssoum K, Chatila K. Successful long-term percutaneous transvalvular mechanical circulatory support without anticoagulation as a bridge to heart transplant: a case report.. ASAIO Journal. 2024;70(Supplement3):119-20$62$YR$$M$Y$$$20240801$$MD$US$US
241615711$24161571$1$I$20240715$20240726$20240801$20240801$PER$$CN-HBP-2024CN031034$HELSINN HEALTHCARE$$34$YR$$F$Y$$$20240801$$HP$CN$CN
241615721$24161572$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121937$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240801$$CN$US$US
241615731$24161573$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121193$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240801$$CN$US$US
241615741$24161574$1$I$20240630$20240724$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118361$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240801$$CN$US$US
241615752$24161575$2$F$$20240812$20240801$20240815$EXP$$US-ABBVIE-5861192$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
241615761$24161576$1$I$20240618$20240725$20240801$20240801$EXP$$CN-ROCHE-10000038131$ROCHE$$61$YR$A$F$Y$55$KG$20240801$$HP$CN$CN
241615772$24161577$2$F$20240101$20240903$20240801$20240905$PER$$US-JAZZ-2022-US-017019$JAZZ$$$$$F$Y$$$20240905$$HP$US$US
241615781$24161578$1$I$20240216$20240724$20240801$20240801$EXP$$JP-EMD Serono-2024040729$EMD SERONO INC$$86$YR$E$M$Y$$$20240801$$PH$JP$JP
241615792$24161579$2$F$20240716$20240807$20240801$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-023053$UNITED THERAPEUTICS$$83$YR$$F$Y$63.492$KG$20240814$$$US$US
241615801$24161580$1$I$20240101$20240729$20240801$20240801$EXP$$US-ABBVIE-5860840$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241615811$24161581$1$I$$20240726$20240801$20240801$PER$$US-AMGEN-USASP2024150120$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241615822$24161582$2$F$20240717$20240821$20240801$20240830$30DAY$$US-AMGEN-USASP2024149006$AMGEN$$59$YR$A$F$Y$97.39$KG$20240830$$HP$US$US
241615831$24161583$1$I$$20240717$20240801$20240801$PER$$US-JNJFOC-20240748659$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
241615841$24161584$1$I$20240701$20240730$20240801$20240801$EXP$$US-UCBSA-2024038572$UCB$$37$YR$$F$Y$$$20240801$$HP$US$US
241615852$24161585$2$F$20240718$20240816$20240801$20240823$30DAY$$US-GSK-US2024093773$GLAXOSMITHKLINE$$25$YR$$F$Y$$$20240823$$CN$US$US
241615861$24161586$1$I$$20240730$20240801$20240801$EXP$$JP-ASTELLAS-2024JP005495$ASTELLAS$$8$DEC$$F$Y$$$20240801$$MD$JP$JP
241615871$24161587$1$I$$20240723$20240801$20240801$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01415$NOVITIUM PHARMA$Federica Troisi.Zero-Fluoroscopy Catheter Ablation of Right Appendage Focal Atrial Tachycardia in a Pregnant Woman.Clinics and practice.21-MAY-2024;14(3):946-953$34$YR$A$F$Y$$$20240801$$HP$IT$IT
241615881$24161588$1$I$$20240728$20240801$20240801$PER$$US-JNJFOC-20240779568$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$US$US
241615891$24161589$1$I$$20240729$20240801$20240801$EXP$$JP-JNJFOC-20240800849$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240801$$PH$JP$JP
241615901$24161590$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121392$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240801$$HP$US$US
241615911$24161591$1$I$20240627$20240726$20240801$20240801$EXP$ES-AEMPS-1547363$ES-TEVA-VS-3226856$TEVA$$15$YR$$F$Y$103$KG$20240801$$MD$ES$ES
241615922$24161592$2$F$20210301$20240724$20240801$20240807$EXP$IN-MLMSERVICE-20240711-PI128919-00232-1$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-16327$ALKEM$Giri K, Sahay M, Ismal KM, Kavadi A. A Rare Malignancy Postrenal Transplantation-The Dark Side of Success. Indian Journal of Transplantation. 2024;18(2):171-73$32$YR$$M$Y$$$20240807$$MD$IN$IN
241615932$24161593$2$F$$20240724$20240801$20240807$EXP$IN-MLMSERVICE-20240711-PI127771-00218-1$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-16322$ALKEM$Kapoor R, Sadda S, Tyagi M. Suspected Retinal Toxicity After Multiple Intravitreal Ganciclovir Injections in a Patient of CMV Retinitis. Ocular Immunology and Inflammation. 2024;32(5):525-28$69$YR$$M$Y$$$20240807$$MD$IN$IN
241615941$24161594$1$I$$20240722$20240801$20240801$EXP$$DE-ROCHE-10000032506$ROCHE$Morath O, Hoffmann J, Schilling K, Hochhaus A, Rachow T, Lang S. Venous and Arterial Thromboembolism in Lung Cancer Patients: A Retrospective Analysis. Journal of Clinical Medicine. 2024-Jul;13 (13):1-12. doi:10.3390/jcm13133773.$$$$$Y$$$20240801$$HP$DE$DE
241615952$24161595$2$F$$20240804$20240801$20240805$EXP$$NVSC2024UZ156606$NOVARTIS$$$$$M$Y$$$20240805$$MD$UZ$UZ
241615961$24161596$1$I$$20240730$20240801$20240801$EXP$$US-AMGEN-USASP2024151521$AMGEN$Parikh R. B.; Lin J. K.; Hearn C. M. et al.. Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer. European Urology Oncology. 2024;7 (4):794-803$$$$$Y$$$20240801$$HP$US$US
241615971$24161597$1$I$$20240724$20240801$20240801$EXP$$GR-AMGEN-GRCSP2024148770$AMGEN$Laskari K.; Papatheodorou V.; Gerodimos C. et al.. TNFRSF11A variants contribute to systemic autoinflammatory disease: A case series of 12 patients. Seminars in Arthritis and Rheumatism. 2024;68:1-7$$$$$Y$$$20240801$$HP$GR$GR
241615981$24161598$1$I$$20240730$20240801$20240801$EXP$$US-GILEAD-2024-0682541$GILEAD$$55$YR$A$F$Y$$$20240801$$CN$US$US
241615992$24161599$2$F$20240701$20240730$20240801$20240812$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-16315$ALKEM$$58$YR$$M$Y$$$20240812$$MD$DE$DE
241616001$24161600$1$I$20190326$20240722$20240801$20240801$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117070$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$51$KG$20240801$$MD$KR$KR
241616011$24161601$1$I$$20240703$20240801$20240801$PER$$US-RDY-SPO/USA/24/0009791$DR REDDYS$$58$YR$A$F$Y$$$20240801$$CN$US$US
241616021$24161602$1$I$20240609$20240725$20240801$20240801$EXP$$CN-ROCHE-10000037861$ROCHE$$48$YR$A$F$Y$68.5$KG$20240801$$HP$CN$CN
241616031$24161603$1$I$$20240726$20240801$20240801$EXP$$AU-RDY-SPO/AUS/24/0011177$DR REDDYS$$43$YR$A$F$Y$$$20240801$$CN$AU$AU
241616041$24161604$1$I$$20240725$20240801$20240801$EXP$$US-GSK-US2024AMR094343$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
241616053$24161605$3$F$20240101$20240806$20240801$20240813$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023421$UNITED THERAPEUTICS$$$$$F$Y$58.503$KG$20240813$$$US$US
241616061$24161606$1$I$$20240729$20240801$20240801$PER$$US-JNJFOC-20240776806$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$PH$US$US
241616072$24161607$2$F$$20240821$20240801$20240822$PER$$US-ALXN-202407USA001876US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
241616081$24161608$1$I$20240727$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121321$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240801$$CN$US$US
241616091$24161609$1$I$$20240726$20240801$20240801$EXP$$NVSC2024US154831$NOVARTIS$$$$$F$Y$$$20240801$$HP$US$US
241616101$24161610$1$I$$20240729$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121389$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240801$$CN$US$US
241616113$24161611$3$F$20240723$20240905$20240801$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121028$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240909$$CN$US$US
241616121$24161612$1$I$$20211222$20240801$20240801$EXP$$US-AstraZeneca-2021A900035$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241616131$24161613$1$I$$20220105$20240801$20240801$EXP$$US-AstraZeneca-2021A848094$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241616141$24161614$1$I$$20240729$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120613$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240801$$CN$US$US
241616151$24161615$1$I$$20240724$20240801$20240801$EXP$$CR-AstraZeneca-2024A170229$ASTRAZENECA$$$$$F$Y$$$20240801$$PH$CR$
241616161$24161616$1$I$$20211028$20240801$20240801$EXP$$US-AstraZeneca-2021A790681$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241616171$24161617$1$I$$20240729$20240801$20240801$EXP$$US-AstraZeneca-2024A172412$ASTRAZENECA$$$$$F$Y$$$20240801$$MD$US$
241616181$24161618$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000270$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240801$$CN$US$US
241616191$24161619$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019956$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240801$$CN$US$US
241616201$24161620$1$I$20240730$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000272$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240801$$CN$US$US
241616211$24161621$1$I$20240728$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019991$ELI LILLY AND CO$$42$YR$A$$Y$$$20240801$$CN$US$US
241616221$24161622$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019745$ELI LILLY AND CO$$$$$F$Y$$$20240801$$CN$US$US
241616231$24161623$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019565$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240801$$CN$US$US
241616241$24161624$1$I$$20240726$20240801$20240801$EXP$$US-ABBVIE-5856615$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241616251$24161625$1$I$20240101$20240727$20240801$20240801$EXP$$CA-ABBVIE-5860660$ABBVIE$$64$YR$$M$Y$$$20240801$$CN$CA$CA
241616262$24161626$2$F$$20240814$20240801$20240819$EXP$$US-ABBVIE-5860198$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
241616271$24161627$1$I$$20240730$20240801$20240801$EXP$$AT-GILEAD-2024-0682356$GILEAD$$$$$M$Y$$$20240801$$MD$AT$AT
241616281$24161628$1$I$20240715$20240719$20240801$20240801$PER$$US-SA-2024SA222486$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240801$$MD$US$US
241616291$24161629$1$I$$20240410$20240801$20240801$PER$$US-SA-2024SA221730$SANOFI AVENTIS$$$$A$M$Y$$$20240801$$MD$US$US
241616301$24161630$1$I$20240701$20240719$20240801$20240801$PER$$US-SA-2024SA204408$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240801$$CN$US$US
241616311$24161631$1$I$20240723$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52624$$FDA-CTU$$90$YR$$M$N$$$20240730$N$HP$US$
241616321$24161632$1$I$$20240727$20240731$20240731$DIR$FDA-CDER-CTU-2024-52607$$FDA-CTU$$$$$M$N$$$20240727$N$HP$US$
241616331$24161633$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225793$TEVA$$44$YR$$F$Y$$$20240801$$HP$CA$CA
241616341$24161634$1$I$$20240719$20240801$20240801$PER$$US-SA-2024SA221020$SANOFI AVENTIS$$77$YR$E$F$Y$79$KG$20240801$$MD$US$US
241616351$24161635$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52627$$FDA-CTU$$70$YR$$M$N$$$20240731$N$$US$
241616361$24161636$1$I$20240703$20240724$20240801$20240801$EXP$FR-AFSSAPS-LM2024000403$FR-TEVA-VS-3225454$TEVA$$35$YR$$F$Y$$$20240801$$PH$FR$FR
241616371$24161637$1$I$$20240730$20240801$20240801$EXP$GB-MHRA-MED-202407300742060690-TMPNY$GB-ABBVIE-5860238$ABBVIE$$$$$M$Y$$$20240801$$HP$GB$GB
241616381$24161638$1$I$20240731$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52610$$FDA-CTU$$62$YR$$M$N$103.87$KG$20240731$N$$US$
241616391$24161639$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52645$$FDA-CTU$$63$YR$$F$N$$$20240731$N$HP$US$
241616401$24161640$1$I$$20240726$20240801$20240801$EXP$GB-MHRA-MIDB-2febd9d7-3b66-453e-bebb-fba455297ab9$GB-AMAROX PHARMA-AMR2024GB02498$HETERO$$85$YR$$F$Y$$$20240801$$PH$GB$GB
241616414$24161641$4$F$20240723$20240819$20240801$20240828$PER$$US-SA-2024SA221639$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240828$$CN$US$US
241616421$24161642$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA221805$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240801$$MD$US$US
241616431$24161643$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221850$SANOFI AVENTIS$$30$YR$A$M$Y$61$KG$20240801$$MD$US$US
241616451$24161645$1$I$20230501$20240724$20240801$20240801$PER$$US-SA-2024SA222290$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240801$$CN$US$US
241616462$24161646$2$F$20240205$20240805$20240801$20240813$PER$$US-SA-2024SA048418$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240814$$MD$US$US
241616471$24161647$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221234$SANOFI AVENTIS$$80$YR$E$F$Y$68.9$KG$20240801$$MD$US$US
241616481$24161648$1$I$20240101$20240724$20240801$20240801$PER$$US-SA-2024SA222436$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240801$$MD$US$US
241616491$24161649$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA223641$SANOFI AVENTIS$$$$E$F$Y$$$20240801$$MD$US$US
241616501$24161650$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA222249$SANOFI AVENTIS$$$$A$F$Y$$$20240801$$MD$US$US
241616521$24161652$1$I$20240101$20240724$20240801$20240801$PER$$US-SA-2024SA221973$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240801$$MD$US$US
241616531$24161653$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221741$SANOFI AVENTIS$$$$$F$Y$$$20240801$$HP$US$US
241616541$24161654$1$I$20240201$20240724$20240801$20240801$PER$$US-SA-2024SA220570$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240801$$MD$US$US
241616551$24161655$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221010$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240801$$MD$US$US
241616561$24161656$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA221881$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240801$$MD$US$US
241616571$24161657$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221406$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240801$$MD$US$US
241616581$24161658$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA221811$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240801$$MD$US$US
241616591$24161659$1$I$$20240729$20240801$20240801$PER$$NVSC2024US156106$NOVARTIS$$$$$$Y$$$20240801$$CN$US$US
241616601$24161660$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA222043$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240801$$MD$US$US
241616611$24161661$1$I$20240401$20240724$20240801$20240801$PER$$US-SA-2024SA223639$SANOFI AVENTIS$$$$A$M$Y$$$20240801$$MD$US$US
241616621$24161662$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA222941$SANOFI AVENTIS$$$$A$F$Y$106.5$KG$20240801$$MD$US$US
241616633$24161663$3$F$20240101$20240822$20240801$20240912$PER$$US-SA-2024SA189565$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240912$$MD$US$US
241616641$24161664$1$I$20240101$20240724$20240801$20240801$PER$$US-SA-2024SA137246$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240801$$MD$US$US
241616651$24161665$1$I$20240715$20240723$20240801$20240801$PER$$US-SA-2024SA219775$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240801$$MD$US$US
241616661$24161666$1$I$20240719$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024150288$AMGEN$$80$YR$E$F$Y$$$20240801$$CN$US$US
241616673$24161667$3$F$20240708$20240816$20240801$20240823$PER$$US-AMGEN-USASP2024151175$AMGEN$$66$YR$E$F$Y$$$20240823$$MD$US$US
241616681$24161668$1$I$20240708$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024152235$AMGEN$$83$YR$E$M$Y$$$20240801$$CN$US$US
241616691$24161669$1$I$20240101$20240723$20240801$20240801$PER$$US-SA-2024SA131644$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240801$$CN$US$US
241616701$24161670$1$I$20240101$20240723$20240801$20240801$PER$$US-SA-2024SA219191$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240801$$CN$US$US
241616711$24161671$1$I$$20240722$20240801$20240801$EXP$CA-MHPD-E2B_07181943$CA-Accord-437586$ACCORD$$89$YR$E$M$Y$$$20240801$$HP$CA$CA
241616721$24161672$1$I$$20240720$20240801$20240801$EXP$AU-TGA-812322$AU-Accord-437273$ACCORD$$$$$$Y$$$20240801$$HP$AU$AU
241616731$24161673$1$I$$20240722$20240801$20240801$EXP$AU-TGA-812198$AU-Accord-437385$ACCORD$$58$YR$A$M$Y$$$20240801$$HP$AU$AU
241616741$24161674$1$I$$20240723$20240801$20240801$EXP$CA-MHPD-E2B_07117630$CA-Accord-437865$ACCORD$$67$YR$E$M$Y$$$20240801$$HP$CA$CA
241616751$24161675$1$I$$20240722$20240801$20240801$EXP$CA-MHPD-E2B_07172672$CA-Accord-437597$ACCORD$$$$E$M$Y$$$20240801$$CN$CA$CA
241616761$24161676$1$I$20190628$20240724$20240801$20240801$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-07074$HIKMA$$$$$F$Y$$$20240801$$MD$US$US
241616771$24161677$1$I$$20240720$20240801$20240801$EXP$AU-TGA-812328$AU-Accord-437261$ACCORD$$$$$$Y$$$20240801$$HP$AU$AU
241616781$24161678$1$I$$20240723$20240801$20240801$EXP$CA-MHPD-E2B_07124111$CA-Accord-437852$ACCORD$$45$YR$A$M$Y$$$20240801$$MD$CA$CA
241616791$24161679$1$I$$20240731$20240801$20240801$PER$$US-HALEON-2189985$Haleon PLC$$$$$F$Y$$$20240801$$CN$US$US
241616801$24161680$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA223571$SANOFI AVENTIS$$$$E$F$Y$51.2$KG$20240801$$MD$US$US
241616811$24161681$1$I$20240101$20240724$20240801$20240801$PER$$US-SA-2024SA222465$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240801$$MD$US$US
241616821$24161682$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA135614$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240801$$MD$US$US
241616833$24161683$3$F$20240101$20240911$20240801$20240919$PER$$US-SA-2024SA223611$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240919$$MD$US$US
241616842$24161684$2$F$20240601$20240904$20240801$20240930$PER$$US-SA-2024SA222444$SANOFI AVENTIS$$73$YR$E$F$Y$91$KG$20240930$$MD$US$US
241616851$24161685$1$I$20240101$20240723$20240801$20240801$PER$$US-SA-2024SA221673$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240801$$MD$US$US
241616861$24161686$1$I$20240515$20240723$20240801$20240801$PER$$US-SA-2024SA221665$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240801$$MD$US$US
241616872$24161687$2$F$20240101$20240826$20240801$20240909$PER$$US-SA-2024SA221526$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240909$$MD$US$US
241616881$24161688$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA222532$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240801$$MD$US$US
241616891$24161689$1$I$20240701$20240724$20240801$20240801$PER$$US-SA-2024SA223090$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240801$$MD$US$US
241616901$24161690$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA221978$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240801$$MD$US$US
241616911$24161691$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA222477$SANOFI AVENTIS$$$$T$M$Y$77$KG$20240801$$MD$US$US
241616921$24161692$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA222231$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240801$$MD$US$US
241616931$24161693$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA222600$SANOFI AVENTIS$$$$A$M$Y$$$20240801$$MD$US$US
241616941$24161694$1$I$20240701$20240724$20240801$20240801$PER$$US-SA-2024SA222439$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240801$$MD$US$US
241616952$24161695$2$F$20240722$20240802$20240801$20240812$PER$$US-SA-2024SA221097$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240812$$MD$US$US
241616961$24161696$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA222025$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240801$$MD$US$US
241616971$24161697$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA111831$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240801$$MD$US$US
241616981$24161698$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA222187$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240801$$MD$US$US
241616991$24161699$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5860300$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241617001$24161700$1$I$20240101$20240730$20240801$20240801$EXP$$US-ABBVIE-5861290$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241617011$24161701$1$I$20240101$20240724$20240801$20240801$PER$$US-SA-2024SA221984$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240801$$MD$US$US
241617031$24161703$1$I$20231101$20240724$20240801$20240801$PER$$US-SA-2024SA223038$SANOFI AVENTIS$$36$YR$A$F$Y$107$KG$20240801$$MD$US$US
241617042$24161704$2$F$20240101$20240801$20240801$20240810$PER$$US-SA-2024SA222596$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240810$$MD$US$US
241617051$24161705$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52633$$FDA-CTU$$56$YR$$F$N$78.47$KG$20240731$N$CN$US$
241617061$24161706$1$I$20240101$20240724$20240801$20240801$PER$$US-SA-2024SA153483$SANOFI AVENTIS$$63$YR$A$F$Y$82.4$KG$20240801$$MD$US$US
241617071$24161707$1$I$$20240724$20240801$20240801$EXP$$AU-NOVITIUMPHARMA-2024AUNVP01440$NOVITIUM PHARMA$Krupa Shah.Adrenal insufficiency in hemodialysis patients-An under-recognized problem: A case series.Hemodialysis International.07-FEB-2024;28(2):229-232$17$YR$T$F$Y$$$20240801$$HP$AU$AU
241617081$24161708$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA173241$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240801$$MD$US$US
241617091$24161709$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA219058$SANOFI AVENTIS$$$$A$M$Y$74.38$KG$20240801$$MD$US$US
241617101$24161710$1$I$20240601$20240727$20240801$20240801$EXP$$CA-JNJFOC-20240623435$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240801$$HP$CA$CA
241617111$24161711$1$I$20240515$20240722$20240801$20240801$EXP$GB-MHRA-MED-202407221746523650-VSWNY$GB-Accord-437874$ACCORD$$31$YR$A$F$Y$90$KG$20240801$$CN$GB$GB
241617121$24161712$1$I$$20240722$20240801$20240801$EXP$GB-MHRA-TPP24635513C8992204YC1721409354561$GB-Accord-437741$ACCORD$$86$YR$E$F$Y$54$KG$20240801$$MD$GB$GB
241617131$24161713$1$I$20220101$20240722$20240801$20240801$EXP$SK-TEVA-VS-3135125$SK-Accord-438672$ACCORD$$62$YR$A$F$Y$$$20240801$$MD$SK$SK
241617141$24161714$1$I$$20240723$20240801$20240801$EXP$CA-MHPD-E2B_07117645$CA-Accord-437867$ACCORD$$67$YR$E$M$Y$$$20240801$$MD$CA$CA
241617151$24161715$1$I$20240701$20240726$20240801$20240801$PER$$US-SA-2024SA223344$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240801$$MD$US$US
241617162$24161716$2$F$20240101$20240829$20240801$20240912$PER$$US-SA-2024SA223324$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240912$$MD$US$US
241617171$24161717$1$I$20240515$20240726$20240801$20240801$PER$$US-SA-2024SA223319$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240801$$MD$US$US
241617181$24161718$1$I$20240101$20240725$20240801$20240801$PER$$US-SA-2024SA222098$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240801$$MD$US$US
241617191$24161719$1$I$20240726$20240726$20240801$20240801$PER$$US-SA-2024SA223933$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240801$$CN$US$US
241617201$24161720$1$I$20240701$20240726$20240801$20240801$PER$$US-SA-2024SA222850$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240801$$CN$US$US
241617211$24161721$1$I$$20240729$20240801$20240801$PER$$US-SA-2024SA221950$SANOFI AVENTIS$$67$YR$E$M$Y$96.6$KG$20240801$$CN$US$US
241617221$24161722$1$I$20240723$20240726$20240801$20240801$PER$$US-SA-2024SA223525$SANOFI AVENTIS$$$$$F$Y$$$20240801$$CN$US$US
241617231$24161723$1$I$20240101$20240726$20240801$20240801$PER$$US-SA-2024SA223267$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240801$$MD$US$US
241617241$24161724$1$I$20240724$20240726$20240801$20240801$PER$$US-SA-2024SA222496$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240801$$MD$US$US
241617251$24161725$1$I$$20240729$20240801$20240801$PER$$US-SA-2024SA224428$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240801$$CN$US$US
241617261$24161726$1$I$20240701$20240725$20240801$20240801$PER$$US-SA-2024SA222908$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240801$$MD$US$US
241617271$24161727$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA222230$SANOFI AVENTIS$$$$$F$Y$$$20240801$$CN$US$US
241617282$24161728$2$F$20240101$20240802$20240801$20240813$PER$$US-SA-2024SA223363$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240814$$MD$US$US
241617292$24161729$2$F$20240101$20240726$20240801$20240808$PER$$US-SA-2024SA221457$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240808$$CN$US$US
241617301$24161730$1$I$20240201$20240726$20240801$20240801$PER$$US-SA-2024SA223489$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240801$$MD$US$US
241617311$24161731$1$I$$20240726$20240801$20240801$PER$$US-SA-2024SA223557$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240801$$MD$US$US
241617321$24161732$1$I$$20240726$20240801$20240801$PER$$US-SA-2024SA223166$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240801$$MD$US$US
241617331$24161733$1$I$20240101$20240725$20240801$20240801$PER$$US-SA-2024SA221008$SANOFI AVENTIS$$$$$F$Y$$$20240801$$MD$US$US
241617341$24161734$1$I$20230101$20240725$20240801$20240801$PER$$US-SA-2023SA405802$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240801$$MD$US$US
241617351$24161735$1$I$20240725$20240726$20240801$20240801$PER$$US-SA-2024SA223381$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240801$$CN$US$US
241617361$24161736$1$I$$20240730$20240801$20240801$PER$$US-HALEON-2189997$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241617371$24161737$1$I$20240606$20240730$20240801$20240801$EXP$$TW-TAKEDA-2024TUS077127$TAKEDA$$60$YR$$M$Y$$$20240801$$CN$TW$TW
241617381$24161738$1$I$20240729$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151739$AMGEN$$83$YR$E$F$Y$$$20240801$$CN$US$US
241617391$24161739$1$I$20240501$20240730$20240801$20240801$EXP$$US-ABBVIE-5861130$ABBVIE$$47$YR$$M$Y$$$20240801$$CN$US$US
241617401$24161740$1$I$$20240725$20240801$20240801$EXP$NL-LRB-00992748$NL-TEVA-VS-3226202$TEVA$$29$YR$$F$Y$80$KG$20240801$$CN$NL$NL
241617411$24161741$1$I$$20240731$20240801$20240801$EXP$$NVSC2024US156868$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241617421$24161742$1$I$20240725$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151482$AMGEN$$65$YR$E$F$Y$$$20240801$$CN$US$US
241617431$24161743$1$I$$20240722$20240801$20240801$EXP$$US-ROCHE-10000033182$ROCHE$$$$$F$Y$$$20240801$$CN$US$US
241617441$24161744$1$I$$20240731$20240801$20240801$EXP$GB-MHRA-MED-202407311157498130-FKZLG$GB-ORGANON-O2407GBR003011$ORGANON$$$$$$Y$$$20240801$$PH$GB$GB
241617452$24161745$2$F$20240609$20240725$20240801$20240806$EXP$$DE-AUROBINDO-AUR-APL-2024-037117$AUROBINDO$$34$YR$$M$Y$117$KG$20240806$$CN$DE$DE
241617461$24161746$1$I$$20240730$20240801$20240801$PER$$US-ROCHE-10000045994$ROCHE$$$$$$Y$$$20240801$$CN$US$US
241617471$24161747$1$I$20240404$20240724$20240801$20240801$EXP$$CA-JNJFOC-20240510896$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240801$$HP$CA$CA
241617481$24161748$1$I$$20240724$20240801$20240801$EXP$$CA-ABBVIE-5861233$ABBVIE$$63$YR$$F$Y$$$20240801$$PH$CA$CA
241617491$24161749$1$I$$20240724$20240801$20240801$EXP$NL-LRB-00990425$NL-TEVA-VS-3225621$TEVA$$57$YR$$M$Y$80$KG$20240801$$MD$NL$NL
241617501$24161750$1$I$$20240731$20240801$20240801$EXP$$CN-TAKEDA-2024TUS077118$TAKEDA$$$$$F$Y$$$20240801$$CN$CN$CN
241617523$24161752$3$F$$20240812$20240801$20240819$EXP$$CA-TAKEDA-2024TUS075739$TAKEDA$$$$$M$Y$$$20240819$$CN$CA$CA
241617531$24161753$1$I$20240723$20240725$20240801$20240801$EXP$$US-VANTIVE-2024VAN018590$Vantive US Healthcare$$69$YR$$M$Y$$$20240801$$CN$US$US
241617542$24161754$2$F$$20240821$20240801$20240829$EXP$$NL-VANTIVE-2024VAN018566$Vantive US Healthcare$$$$$M$Y$$$20240829$$HP$NL$NL
241617551$24161755$1$I$$20240730$20240801$20240801$EXP$$NVSC2024US156397$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
241617561$24161756$1$I$20221103$20240726$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120243$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$80.74$KG$20240801$$CN$US$US
241617571$24161757$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121360$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240801$$CN$US$US
241617581$24161758$1$I$$20240730$20240801$20240801$PER$$US-HALEON-2189977$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241617601$24161760$1$I$20240729$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52643$$FDA-CTU$$43$YR$$M$N$$$20240731$Y$PH$US$
241617631$24161763$1$I$$20240703$20240801$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06502$LUPIN$$$$$$Y$$$20240801$$CN$US$US
241617641$24161764$1$I$$20240724$20240801$20240801$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01436$NOVITIUM PHARMA$Cedric Sztejkowski.Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event.Rheumatology.09-DEC-2023;63(6):e185-e187$52$YR$A$F$Y$$$20240801$$HP$FR$FR
241617651$24161765$1$I$$20240722$20240801$20240801$30DAY$$US-GSK-US2024091817$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
241617671$24161767$1$I$$20240722$20240801$20240801$30DAY$$US-GSK-US2024091834$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
241617682$24161768$2$F$$20240730$20240801$20240802$PER$$US-AMGEN-USASP2024150269$AMGEN$$$$$F$Y$$$20240802$$CN$US$US
241617691$24161769$1$I$$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150983$AMGEN$$$$$$Y$$$20240801$$CN$US$US
241617701$24161770$1$I$$20240718$20240801$20240801$EXP$$JP-AMGEN-JPNSP2024151420$AMGEN$Kinoshita N. A case of Sjogren^s syndrome during maintenance therapy with bevacizumab and atezolizumab for H-05 lung adenocarcinoma. Chinese Shikoku Regional Association of the Lung Cancer Society$$$$$Y$$$20240801$$MD$JP$JP
241617711$24161771$1$I$$20230606$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2484$AMICUS THERAPEUTICS$$$$$M$Y$$$20240801$$CN$US$US
241617721$24161772$1$I$20220117$20231013$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_1686$AMICUS THERAPEUTICS$$56$YR$$M$Y$$$20240801$$CN$US$US
241617731$24161773$1$I$20230101$20230803$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2585$AMICUS THERAPEUTICS$$$$$F$Y$97.506$KG$20240801$$CN$US$US
241617741$24161774$1$I$20230715$20231002$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2648$AMICUS THERAPEUTICS$$20$YR$$M$Y$76.19$KG$20240801$$CN$US$US
241617751$24161775$1$I$20220713$20240419$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_1920$AMICUS THERAPEUTICS$$39$YR$$M$Y$$$20240801$$CN$US$US
241617761$24161776$1$I$20230928$20230930$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2682$AMICUS THERAPEUTICS$$53$YR$$M$Y$$$20240801$$CN$US$US
241617771$24161777$1$I$20230601$20230927$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2673$AMICUS THERAPEUTICS$$42$YR$$F$Y$$$20240801$$CN$US$US
241617781$24161778$1$I$$20231220$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_1985$AMICUS THERAPEUTICS$$$$$F$Y$76.19$KG$20240801$$CN$US$US
241617791$24161779$1$I$$20240129$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_1205$AMICUS THERAPEUTICS$$$$$M$Y$72.562$KG$20240801$$CN$US$US
241617801$24161780$1$I$$20231126$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2690$AMICUS THERAPEUTICS$$$$$M$Y$76$KG$20240801$$MD$US$US
241617811$24161781$1$I$20230401$20230607$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2485$AMICUS THERAPEUTICS$$19$YR$$F$Y$$$20240801$$HP$US$US
241617821$24161782$1$I$$20230714$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2491$AMICUS THERAPEUTICS$$$$$F$Y$$$20240801$$HP$US$US
241617831$24161783$1$I$20230915$20230919$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2654$AMICUS THERAPEUTICS$$67$YR$$M$Y$$$20240801$$CN$US$US
241617841$24161784$1$I$20230726$20230809$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2595$AMICUS THERAPEUTICS$$53$YR$$M$Y$$$20240801$$CN$US$US
241617851$24161785$1$I$20230101$20230804$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2537$AMICUS THERAPEUTICS$$$$$F$Y$$$20240801$$CN$US$US
241617861$24161786$1$I$$20230726$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2566$AMICUS THERAPEUTICS$$$$$F$Y$$$20240801$$MD$US$US
241617871$24161787$1$I$$20230607$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2488$AMICUS THERAPEUTICS$$$$$M$Y$79.365$KG$20240801$$CN$US$US
241617881$24161788$1$I$$20230913$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2649$AMICUS THERAPEUTICS$$$$$F$Y$$$20240801$$CN$US$US
241617891$24161789$1$I$$20230720$20240801$20240801$EXP$$US-AstraZeneca-2023A167463$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241617901$24161790$1$I$20230407$20231214$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2346$AMICUS THERAPEUTICS$$28$YR$$F$Y$$$20240801$$CN$US$US
241617911$24161791$1$I$$20231016$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2714$AMICUS THERAPEUTICS$$$$A$M$Y$$$20240801$$MD$US$US
241617921$24161792$1$I$$20240725$20240801$20240801$PER$$US-AstraZeneca-2024A172038$ASTRAZENECA$$$$$$Y$$$20240801$$CN$US$
241617931$24161793$1$I$20240520$20240522$20240801$20240801$PER$$US-BAYER-2024A091072$BAYER$$39$YR$A$F$Y$$$20240801$$MD$US$US
241617941$24161794$1$I$$20240730$20240801$20240801$PER$$US-TAKEDA-2024TUS077129$TAKEDA$$$$$$Y$$$20240801$$CN$US$US
241617951$24161795$1$I$$20230529$20240801$20240801$EXP$$US-BAYER-2024A110589$BAYER$Brenneman E; Keil E; Advani SD; Campbell KB; Wrenn R. A Turtle Disaster: Salmonella enteritidis Cardiovascular Implantable Electronic Device Infection. Open Forum Infectious Diseases. 2022;9:12:668$60$YR$A$M$Y$$$20240801$$HP$US$US
241617961$24161796$1$I$20240501$20240723$20240801$20240801$EXP$$CA-862174955-ML2024-04146$Unknown Manufacturer$$61$YR$A$M$Y$$$20240801$$HP$CA$CA
241617971$24161797$1$I$$20240723$20240801$20240801$EXP$$US-862174955-ML2023-05820$Unknown Manufacturer$Pires KD, Bloom J, Sahagun BE, Yang J, Ting P, Greco AA, et al. The interval before the storm: veno-arterial extracorporeal membrane oxygenation initiation for confirmed severe bupropion cardiotoxicity. CLINICAL TOXICOLOGY. 2023;61 (SUPPL. 2): 78-79.$32$YR$A$F$Y$$$20240801$$HP$US$US
241617981$24161798$1$I$$20240724$20240801$20240801$EXP$GB-MHRA-MED-202407232053358180-ZLGPY$GB-862174955-ML2024-04166$Unknown Manufacturer$$29$YR$A$F$Y$$$20240801$$CN$GB$GB
241617991$24161799$1$I$$20240730$20240801$20240801$EXP$$AT-SANDOZ INC.-SDZ2024AT069314$SANDOZ$$76$YR$$F$Y$$$20240801$$HP$AT$AT
241618001$24161800$1$I$20240717$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151609$AMGEN$$58$YR$A$M$Y$$$20240801$$CN$US$US
241618011$24161801$1$I$20200602$20240723$20240801$20240801$EXP$$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-07075$HIKMA$$$$$$Y$$$20240801$$MD$DE$DE
241618021$24161802$1$I$$20240723$20240801$20240801$EXP$$CA-862174955-ML2024-04216$Unknown Manufacturer$Lundby C, Farrell B, Wilson A. Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects. British Journal of Clinical Pharmacology. 2024;90: 1741-1744. doi:10.1111/bcp.16078.$76$YR$E$F$Y$$$20240801$$HP$CA$CA
241618031$24161803$1$I$$20240719$20240801$20240801$PER$$US-RDY-LIT/USA/24/0010991$DR REDDYS$Redmond MA, Begnaud A. Dressler^s Syndrome Is Making a Comeback: Massive Pleural Effusion After Atrial Fibrillation Ablation. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: A1925. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1925.$73$YR$E$F$Y$$$20240801$$HP$US$US
241618041$24161804$1$I$$20240724$20240801$20240801$EXP$GB-MHRA-MIDB-: 3c2cfb19-2f66-4d41-8848-95bff55a184d$GB-TEVA-VS-3225309$TEVA$$74$YR$$F$Y$$$20240801$$PH$GB$GB
241618051$24161805$1$I$20240727$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151571$AMGEN$$47$YR$A$F$Y$$$20240801$$CN$US$US
241618061$24161806$1$I$20240320$20240522$20240801$20240801$PER$$US-BAYER-2024A091086$BAYER$$36$YR$A$F$Y$$$20240801$$MD$US$US
241618071$24161807$1$I$$20240731$20240801$20240801$PER$$US-HALEON-2189933$Haleon PLC$$$$$M$Y$$$20240801$$CN$US$US
241618082$24161808$2$F$20240727$20240817$20240801$20240821$PER$$US-AMGEN-USASP2024151623$AMGEN$$83$YR$E$M$Y$$$20240821$$CN$US$US
241618091$24161809$1$I$20240730$20240731$20240801$20240801$PER$$US-JNJFOC-20240785439$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240801$$CN$US$US
241618101$24161810$1$I$20240507$20240730$20240801$20240801$EXP$FR-AFSSAPS-ST2024001223$FR-GSK-FR2024095617$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$HP$FR$FR
241618111$24161811$1$I$20240418$20240522$20240801$20240801$PER$$US-BAYER-2024A091100$BAYER$$25$YR$A$F$Y$$$20240801$$MD$US$US
241618122$24161812$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3226072$TEVA$Rozenbaum Lerner G, Villamizar JP, Pelaez A, Salgado JC. Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).; Rozenbaum Lerner G, Villamizar JP, Pelaez A, Salgado JC. Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$68$YR$$M$Y$$$20240816$$HP$US$US
241618134$24161813$4$F$20240720$20240726$20240801$20240805$EXP$$ES-AUROBINDO-AUR-APL-2024-037729$AUROBINDO$$90$YR$$F$Y$$$20240805$$HP$ES$ES
241618151$24161815$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151402$AMGEN$$$$$$Y$$$20240801$$CN$US$US
241618161$24161816$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000076$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240801$$CN$US$US
241618171$24161817$1$I$20240730$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000123$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240801$$CN$US$US
241618181$24161818$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000282$ELI LILLY AND CO$$$$$$Y$$$20240801$$CN$US$US
241618191$24161819$1$I$20240501$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019921$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240801$$CN$US$US
241618201$24161820$1$I$20240728$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019845$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240801$$CN$US$US
241618211$24161821$1$I$$20240724$20240801$20240801$EXP$$CA-TAKEDA-2024TUS075450$TAKEDA$$$$$M$Y$$$20240801$$CN$CA$CA
241618222$24161822$2$F$$20240730$20240801$20240806$EXP$$NVSC2024BR156690$NOVARTIS$$$$$F$Y$$$20240806$$CN$BR$BR
241618233$24161823$3$F$$20240822$20240801$20240822$EXP$$BR-BAYER-2024A111433$BAYER$$$$$F$Y$$$20240822$$HP$BR$BR
241618242$24161824$2$F$$20240730$20240801$20240807$EXP$$NVSC2024RU154305$NOVARTIS$Sergeenko KA, Kirgizov KI, Machreva EB, Burlakal NA, Potemkinal TI , Mitrakov KV et al.. ?????????? ?????????????? ??????????????? ????????? ?????? ???  ?????????/???????????? ??????? ????????????? ???????? [Allogeneic hematopoietic stem cell transplantation for relapsed/refractory non-hodgkin lymphomas]. PEDIATRIC HEMATOLOGY/ONCOLOGY AND IMMUNOPATHOLOGY. 2024;23(2):152-7$7$YR$$$Y$$$20240807$$HP$RU$RU
241618251$24161825$1$I$$20240723$20240801$20240801$EXP$$US-BELUSA-2024BELLIT0087$BIOLOGICAL E.$Torelli VA, Ernest Jean R, Tran E.Acute Hypoxic Respiratory Failure Secondary to Daptomycin-induced Eosinophilic Pneumonia.American Journal of Respiratory and Critical Care Medicine.2024;209:A2019$$$$$Y$$$20240801$$HP$US$US
241618261$24161826$1$I$$20240723$20240801$20240801$EXP$$US-MYLANLABS-2024M1070287$MYLAN$Cypro A, Odish MF, Yi C, Pollema TL, Owens RL. Incidental Deep Venous Thromboses Found Post-decannulation of Large Extracorporeal Membrane Oxygenation Cannulas. Am-J-Respir-Crit-Care-Med 2023; 207 A5221.$53$YR$$M$Y$$$20240801$$HP$US$US
241618271$24161827$1$I$$20240724$20240801$20240801$EXP$$US-MYLANLABS-2024M1070645$MYLAN$Bandali T, Kim Y, Khodadoust M, Rieger K, Fernandez-Pol S, Saleem A, et al. Polatuzumab vedotin-piiq for treatment of primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCL-LT) in older adults. J-Invest-Dermatol 2024; 144 (Suppl.) (8): S49 abstr. 282.$83$YR$$F$Y$$$20240801$$HP$US$US
241618281$24161828$1$I$$20240723$20240801$20240801$30DAY$$US-GSK-US2024AMR092777$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
241618291$24161829$1$I$$20240723$20240801$20240801$30DAY$$US-GSK-US2024092384$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
241618301$24161830$1$I$$20240723$20240801$20240801$30DAY$$US-GSK-US2024092426$GLAXOSMITHKLINE$$$$E$F$Y$$$20240801$$CN$US$US
241618311$24161831$1$I$$20240726$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120631$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240801$$CN$US$US
241618331$24161833$1$I$$20240722$20240801$20240801$EXP$$DK-MYLANLABS-2024M1069658$MYLAN$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic-Sci-Int 2009; 184 (1-3): 74-79.$40$YR$$M$Y$$$20240801$$HP$DK$DK
241618341$24161834$1$I$$20240724$20240801$20240801$EXP$$US-MYLANLABS-2024M1070621$MYLAN$George MN, Seervai RNH, Chon SY. Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series. JAAD-Case-Rep 2024; 47 72-79.$62$YR$$F$Y$$$20240801$$MD$US$US
241618351$24161835$1$I$$20240723$20240801$20240801$EXP$$IT-MYLANLABS-2024M1069862$MYLAN$Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al. Pickering Syndrome: An Overlooked Renovascular Cause of Recurrent Heart Failure. J-Am-Heart-Assoc 2023; 12 (19):.$79$YR$$M$Y$$$20240801$$MD$IT$IT
241618361$24161836$1$I$20190101$20240724$20240801$20240801$EXP$$IT-MYLANLABS-2024M1070659$MYLAN$Coletti Moja M, Cravero E, Logozzo I, Mairano C, Labate C. Unilateral Poststroke Periodic Limb Movements: A Case Series. Case-Rep-Neurol 2022; 14 (1): 162-166.$79$YR$$M$Y$$$20240801$$HP$IT$IT
241618371$24161837$1$I$20240101$20240723$20240801$20240801$PER$$US-ROCHE-10000034999$ROCHE$$38$YR$A$F$Y$63.5$KG$20240801$$CN$US$US
241618381$24161838$1$I$$20240726$20240801$20240801$PER$$US-ROCHE-10000040457$ROCHE$$$$A$F$Y$54.43$KG$20240801$$CN$US$US
241618391$24161839$1$I$$20240627$20240801$20240801$PER$$US-Ascend Therapeutics US, LLC-2159840$ASCEND$$$$$F$Y$$$20240801$$$US$US
241618401$24161840$1$I$$20240123$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2888$AMICUS THERAPEUTICS$$$$$F$Y$$$20240801$$HP$US$US
241618411$24161841$1$I$$20240313$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_3024$AMICUS THERAPEUTICS$$$$$$Y$$$20240801$$MD$US$US
241618421$24161842$1$I$20230101$20230817$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2422$AMICUS THERAPEUTICS$$$$$M$Y$$$20240801$$HP$US$US
241618431$24161843$1$I$20240111$20240116$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2874$AMICUS THERAPEUTICS$$72$YR$$M$Y$$$20240801$$CN$US$US
241618441$24161844$1$I$$20240724$20240801$20240801$EXP$$US-MYLANLABS-2024M1070607$MYLAN$George MN, Seervai RNH, Chon SY. Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series. JAAD-Case-Rep 2024; 47 72-79.$73$YR$$F$Y$$$20240801$$MD$US$US
241618451$24161845$1$I$20240401$20240430$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_3094$AMICUS THERAPEUTICS$$$$$F$Y$$$20240801$$MD$US$US
241618461$24161846$1$I$$20231219$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2815$AMICUS THERAPEUTICS$$$$$F$Y$$$20240801$$MD$US$US
241618471$24161847$1$I$20240317$20240320$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_3017$AMICUS THERAPEUTICS$$60$YR$$F$Y$$$20240801$$CN$US$US
241618481$24161848$1$I$20240112$20240115$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2869$AMICUS THERAPEUTICS$$66$YR$$M$Y$$$20240801$$CN$US$US
241618491$24161849$1$I$$20240423$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_3078$AMICUS THERAPEUTICS$$$$$F$Y$$$20240801$$CN$US$US
241618501$24161850$1$I$$20240724$20240801$20240801$EXP$$US-MYLANLABS-2024M1070595$MYLAN$Baczynski A, Waterman C, Haber R. Recurrent erythema multiforme induced by contact dermatitis to nickel. Int-J-Dermatol 2023; 62 e615-e616.$17$YR$$F$Y$$$20240801$$MD$US$US
241618511$24161851$1$I$$20230926$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2668$AMICUS THERAPEUTICS$$$$$F$Y$$$20240801$$CN$US$US
241618521$24161852$1$I$$20240321$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_3019$AMICUS THERAPEUTICS$$$$$F$Y$56.689$KG$20240801$$CN$US$US
241618531$24161853$1$I$$20240313$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_3023$AMICUS THERAPEUTICS$$$$$$Y$$$20240801$$MD$US$US
241618541$24161854$1$I$$20231030$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2736$AMICUS THERAPEUTICS$$$$$M$Y$95.238$KG$20240801$$CN$US$US
241618551$24161855$1$I$20230727$20230810$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2596$AMICUS THERAPEUTICS$$48$YR$$F$Y$$$20240801$$CN$US$US
241618561$24161856$1$I$$20231222$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2879$AMICUS THERAPEUTICS$$$$$M$Y$$$20240801$$MD$US$US
241618571$24161857$1$I$20240325$20240708$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_3029$AMICUS THERAPEUTICS$$38$YR$$F$Y$71.655$KG$20240801$$CN$US$US
241618581$24161858$1$I$20240120$20240123$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2884$AMICUS THERAPEUTICS$$27$YR$$F$Y$58.957$KG$20240801$$CN$US$US
241618591$24161859$1$I$$20240731$20240801$20240801$PER$$US-ROCHE-10000046663$ROCHE$$$$$$Y$$$20240801$$MD$US$US
241618601$24161860$1$I$20240409$20240420$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_3075$AMICUS THERAPEUTICS$$73$YR$$F$Y$49.887$KG$20240801$$CN$US$US
241618611$24161861$1$I$$20240728$20240801$20240801$EXP$$ES-UCBSA-2024038584$UCB$$$$$F$Y$$$20240801$$CN$ES$ES
241618621$24161862$1$I$$20240731$20240731$20240731$DIR$712244$$FDA-CTU$$69$YR$$M$N$$$20240731$N$PH$US$
241618631$24161863$1$I$$20240726$20240801$20240801$PER$$US-ROCHE-10000021494$ROCHE$$52$YR$A$M$Y$$$20240801$$CN$US$US
241618641$24161864$1$I$$20240726$20240801$20240801$PER$$US-ROCHE-10000041223$ROCHE$$$$E$M$Y$$$20240801$$CN$US$US
241618651$24161865$1$I$$20240724$20240801$20240801$PER$$US-ROCHE-10000035549$ROCHE$$64$YR$A$M$Y$$$20240801$$CN$US$US
241618661$24161866$1$I$20231101$20231127$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2775$AMICUS THERAPEUTICS$$55$YR$$M$Y$99.773$KG$20240801$$CN$US$US
241618671$24161867$1$I$$20240719$20240801$20240801$EXP$$US-MYLANLABS-2024M1068381$MYLAN$Martin G, Narvaez-Guerra O, Aurigemma G, Kovell L. Peripartum ventricular tachycardia and PVC-induced cardiomyopathy: delivering optimal care when it^s time to deliver. BMJ-Case-Rep 2024; 17.$3$DEC$$F$Y$$$20240801$$HP$US$US
241618681$24161868$1$I$$20240730$20240801$20240801$PER$$US-ROCHE-10000045906$ROCHE$$$$E$F$Y$$$20240801$$CN$US$US
241618692$24161869$2$F$$20240806$20240801$20240816$EXP$$TR-TEVA-VS-3224777$TEVA$Visneci EF, Aydin T, Tekin FC, Acar D. A Case of Pulmonary Embolism after Receiving a Dose of Sildenafil. Akad-Acil-Tip-Olgu-Sunum-Dergisi 2024; 15 (2): 53-55.; Visneci EF, Aydin T, Tekin FC, Acar D. A Case of Pulmonary Embolism after Receiving a Dose of Sildenafil. Akad-Acil-Tip-Olgu-Sunum-Dergisi 2024; 15 (2): 53-55.; Visneci EF, Aydin T, Tekin FC, Acar D. A Case of Pulmonary Embolism after Receiving a Dose of Sildenafil. Akad-Acil-Tip-Olgu-Sunum-Dergisi 2024; 15 (2): 53-55.$81$YR$$M$Y$$$20240816$$HP$TR$TR
241618701$24161870$1$I$$20240731$20240801$20240801$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042981$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240801$$MD$DE$DE
241618711$24161871$1$I$$20240731$20240801$20240801$EXP$$GB-SANDOZ INC.-SDZ2024GB069603$SANDOZ$$$$$M$Y$$$20240801$$CN$GB$GB
241618721$24161872$1$I$$20240730$20240801$20240801$EXP$GB-MHRA-TPP19250208C9433810YC1721401292676$GB-ORGANON-O2407GBR002890$ORGANON$$69$YR$$M$Y$64$KG$20240801$$MD$GB$GB
241618731$24161873$1$I$$20240723$20240801$20240801$EXP$$GB-TAKEDA-2024TUS074936$TAKEDA$$$$A$F$Y$$$20240801$$CN$GB$GB
241618741$24161874$1$I$$20240730$20240801$20240801$PER$$US-JNJFOC-20240781908$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$US$US
241618762$24161876$2$F$$20240813$20240801$20240905$30DAY$$BE-JNJFOC-20240779683$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$PH$BE$BE
241618771$24161877$1$I$20230101$20240606$20240801$20240801$PER$$US-Ascend Therapeutics US, LLC-2159834$ASCEND$$$$$F$Y$$$20240801$$$US$US
241618781$24161878$1$I$$20240717$20240801$20240801$EXP$$US-GRANULES-US-2024GRALIT00298$GRANULES INDIA$S C Oomrigar.The Highest Form of Flattery: Bupropion Overdose Mimicking Brain Death.American Journal of Respiratory and Critical Care Medicine.2024;209:A5653$$$A$F$Y$$$20240801$$HP$US$US
241618791$24161879$1$I$$20240722$20240801$20240801$EXP$$DE-Knight Therapeutics (USA) Inc.-2159843$KNIGHT THERAPEUTICS$Literature article$26$YR$$M$Y$$$20240801$$$DE$DE
241618801$24161880$1$I$$20240624$20240801$20240801$PER$$US-Ascend Therapeutics US, LLC-2159835$ASCEND$$$$$F$Y$$$20240801$$$US$US
241618811$24161881$1$I$20200301$20240727$20240801$20240801$EXP$$US-SA-2024SA224803$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240801$$CN$US$US
241618821$24161882$1$I$$20240731$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069792$SANDOZ$$$$$F$Y$$$20240801$$CN$US$US
241618831$24161883$1$I$$20240725$20240801$20240801$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15049$IPSEN$$$$$$Y$$$20240801$$MD$US$US
241618841$24161884$1$I$20240405$20240726$20240801$20240801$EXP$HR-HALMED-300086142$HR-BAYER-2024A108618$BAYER$$44$YR$A$F$Y$58$KG$20240801$$CN$HR$HR
241618851$24161885$1$I$$20240729$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069304$SANDOZ$Munsef Barakat , Salem Vilayet , Genta Uehara , Abubakr Adala , Ahmed I. Kamal , Karim Soliman 1. When Medications Backfire: A Case Report ofRifaximin-Induced Rhabdomyolysis in a KidneyTransplant Patient. Cureus$56$YR$$M$Y$$$20240801$$HP$US$US
241618861$24161886$1$I$$20240719$20240801$20240801$EXP$$US-CIPLA LTD.-2024US08080$CIPLA$Louis M, Cawthon M, Gibson B, Kuhn B.. Management of NSAID-induced penetrating gastric ulcer complicated by hemorrhagic cholecystitis: The role of percutaneous transhepatic biliary drainage. Radiology Case Reports. 2024;19:4059 to 4065$$$$$Y$$$20240801$$MD$US$US
241618871$24161887$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151396$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241618883$24161888$3$F$20240728$20240924$20240801$20240928$PER$$US-AMGEN-USASP2024151191$AMGEN$$63$YR$A$M$Y$$$20240927$$CN$US$US
241618892$24161889$2$F$20240715$20240807$20240801$20240815$30DAY$$US-AMGEN-USASP2024150942$AMGEN$$53$YR$A$F$Y$48.98$KG$20240815$$HP$US$US
241618901$24161890$1$I$$20240730$20240801$20240801$PER$$US-ROCHE-10000043631$ROCHE$$58$YR$A$F$Y$$$20240801$$CN$US$US
241618911$24161891$1$I$$20240719$20240801$20240801$EXP$$ES-AUROBINDO-AUR-APL-2024-036581$AUROBINDO$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, IglesiasBaena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. International Journal of Molecular Sciences. 2023;24:1-17$3$YR$$F$Y$$$20240801$$HP$ES$ES
241618922$24161892$2$F$20240101$20240822$20240801$20240905$EXP$$GB-Ascend Therapeutics US, LLC-2159833$ASCEND$$48$YR$$F$Y$$$20240905$$$GB$GB
241618932$24161893$2$F$20220201$20240804$20240801$20240808$EXP$$CA-SANDOZ INC.-NVSC2021CA219751$SANDOZ$$74$YR$$F$Y$$$20240808$$CN$CA$CA
241618942$24161894$2$F$20240101$20240904$20240801$20240915$30DAY$$US-UCBSA-2024019148$UCB$$$$$F$Y$92.6$KG$20240915$$CN$US$US
241618951$24161895$1$I$$20240409$20240801$20240801$PER$$US-Allermed Laboratories, Inc.-2159847$ALLERMED LABORATORIES$$33$YR$$F$Y$$$20240801$$$US$US
241618961$24161896$1$I$$20240726$20240801$20240801$PER$$US-Xttrium Laboratories, Inc-2159848$XTTRIUM$$$$$F$Y$$$20240801$$$US$US
241618972$24161897$2$F$$20240808$20240801$20240812$EXP$$NVSC2024AR155802$NOVARTIS$$$$A$M$Y$$$20240812$$CN$AR$AR
241618981$24161898$1$I$20240101$20240730$20240801$20240801$EXP$$DE-SANDOZ INC.-SDZ2024DE069316$SANDOZ$$63$YR$$M$Y$$$20240801$$MD$DE$DE
241618991$24161899$1$I$$20240627$20240801$20240801$PER$$US-Ascend Therapeutics US, LLC-2159837$ASCEND$$$$$F$Y$$$20240801$$$US$US
241619001$24161900$1$I$20210901$20240726$20240801$20240801$EXP$$NVSC2024CA130529$NOVARTIS$$76$YR$$F$Y$65.76$KG$20240801$$MD$CA$CA
241619011$24161901$1$I$20240701$20240726$20240801$20240801$EXP$$NVSC2024AU153994$NOVARTIS$$69$YR$$M$Y$$$20240801$$MD$AU$AU
241619021$24161902$1$I$$20240723$20240801$20240801$PER$$US-P+L Developments of Newyork Corporation-2159871$PL DEVELOPMENTS$$$$$$Y$$$20240801$$$US$US
241619031$24161903$1$I$20240712$20240722$20240801$20240801$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00612$PARATEK PHARMACEUTICALS$$56$YR$$F$Y$70$KG$20240801$$HP$CN$CN
241619041$24161904$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225828$TEVA$$$$$F$Y$$$20240801$$HP$CA$CA
241619051$24161905$1$I$$20240722$20240801$20240801$PER$$US-P+L Developments of Newyork Corporation-2159870$PL DEVELOPMENTS$$$$$$Y$$$20240801$$$US$US
241619061$24161906$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA223597$SANOFI AVENTIS$$$$A$F$Y$58.96$KG$20240801$$MD$US$US
241619072$24161907$2$F$$20240828$20240801$20240904$30DAY$$AU-JNJFOC-20240774322$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$PH$AU$AU
241619081$24161908$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121394$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240801$$CN$US$US
241619092$24161909$2$F$20240101$20240917$20240801$20240923$PER$$US-SA-2024SA224058$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240923$$MD$US$US
241619101$24161910$1$I$$20240717$20240801$20240801$EXP$$CH-GRANULES-CH-2024GRALIT00299$GRANULES INDIA$Bujana Batusha Sopi.Unhappy Hearts with The Antidepressant Venlafaxine.Swiss Medical Weekly.JAN-2024;154 (Suppl.):63S-64S$82$YR$E$M$Y$$$20240801$$HP$CH$CH
241619112$24161911$2$F$20220601$20240724$20240801$20240802$PER$$US-SA-2024SA221677$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240802$$MD$US$US
241619121$24161912$1$I$20240101$20240723$20240801$20240801$PER$$US-SA-2024SA122242$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240801$$MD$US$US
241619131$24161913$1$I$20240601$20240724$20240801$20240801$PER$$US-SA-2024SA222679$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240801$$MD$US$US
241619141$24161914$1$I$20220101$20240724$20240801$20240801$PER$$US-SA-2024SA221187$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240801$$CN$US$US
241619151$24161915$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA221719$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240801$$MD$US$US
241619161$24161916$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225829$TEVA$$65$YR$$F$Y$$$20240801$$HP$CA$CA
241619171$24161917$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA223640$SANOFI AVENTIS$$$$C$F$Y$30$KG$20240801$$MD$US$US
241619181$24161918$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA221248$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240801$$MD$US$US
241619191$24161919$1$I$20240501$20240724$20240801$20240801$PER$$US-SA-2024SA223659$SANOFI AVENTIS$$23$YR$A$M$Y$93.8$KG$20240801$$MD$US$US
241619201$24161920$1$I$20220101$20240723$20240801$20240801$PER$$US-SA-2024SA223654$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240801$$MD$US$US
241619211$24161921$1$I$20240701$20240725$20240801$20240801$PER$$US-SA-2024SA221127$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240801$$MD$US$US
241619221$24161922$1$I$20240101$20240725$20240801$20240801$EXP$$BR-EMD Serono-2024040772$EMD SERONO INC$$55$YR$A$F$Y$$$20240801$$CN$BR$BR
241619231$24161923$1$I$20240518$20240702$20240801$20240801$EXP$$US-The Mentholatum Company-2159863$MENTHOLATUM$$71$YR$$M$Y$$$20240801$$$US$US
241619241$24161924$1$I$20240724$20240725$20240801$20240801$PER$$US-SA-2024SA223681$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240801$$MD$US$US
241619251$24161925$1$I$$20240726$20240801$20240801$PER$$US-SA-2024SA224951$SANOFI AVENTIS$$$$T$M$Y$45$KG$20240801$$MD$US$US
241619261$24161926$1$I$20240101$20240726$20240801$20240801$PER$$US-SA-2024SA223084$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240801$$HP$US$US
241619271$24161927$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA221031$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240801$$HP$US$US
241619281$24161928$1$I$$20240722$20240801$20240801$PER$$US-P+L Developments of Newyork Corporation-2159868$PL DEVELOPMENTS$$$$$$Y$$$20240801$$$US$US
241619291$24161929$1$I$20240701$20240725$20240801$20240801$PER$$US-SA-2024SA222420$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240801$$MD$US$US
241619301$24161930$1$I$$20240207$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2921$AMICUS THERAPEUTICS$$6$DEC$$F$Y$$$20240801$$MD$US$US
241619311$24161931$1$I$$20240206$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2909$AMICUS THERAPEUTICS$$$$$M$Y$$$20240801$$CN$US$US
241619321$24161932$1$I$$20240213$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2928$AMICUS THERAPEUTICS$$$$$F$Y$$$20240801$$CN$US$US
241619331$24161933$1$I$$20240207$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2922$AMICUS THERAPEUTICS$$6$DEC$$F$Y$$$20240801$$MD$US$US
241619341$24161934$1$I$20220708$20240219$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2945$AMICUS THERAPEUTICS$$47$YR$$F$Y$97.506$KG$20240801$$CN$US$US
241619351$24161935$1$I$$20231229$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2833$AMICUS THERAPEUTICS$$$$$M$Y$$$20240801$$CN$US$US
241619361$24161936$1$I$$20240516$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_3125$AMICUS THERAPEUTICS$$$$$M$Y$$$20240801$$MD$US$US
241619371$24161937$1$I$20240130$20240206$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2912$AMICUS THERAPEUTICS$$50$YR$$M$Y$$$20240801$$CN$US$US
241619381$24161938$1$I$$20240718$20240801$20240801$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-121473$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240801$$HP$CA$CA
241619391$24161939$1$I$$20240206$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2915$AMICUS THERAPEUTICS$$6$DEC$$F$Y$$$20240801$$MD$US$US
241619401$24161940$1$I$20240221$20240228$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2965$AMICUS THERAPEUTICS$$47$YR$$F$Y$$$20240801$$CN$US$US
241619411$24161941$1$I$$20240206$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2914$AMICUS THERAPEUTICS$$5$DEC$$F$Y$$$20240801$$MD$US$US
241619421$24161942$1$I$$20240207$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2920$AMICUS THERAPEUTICS$$$$A$M$Y$$$20240801$$MD$US$US
241619432$24161943$2$F$20240717$20240814$20240801$20240827$EXP$$DE-AUROBINDO-AUR-APL-2024-037063$AUROBINDO$$57$YR$$F$Y$$$20240827$$MD$DE$DE
241619441$24161944$1$I$$20240722$20240801$20240801$EXP$$US-Oxford Pharmaceuticals, LLC-2159881$OXFORD PHARMACEUTICALS$Source document$62$YR$$M$Y$$$20240801$$$US$US
241619451$24161945$1$I$20240715$20240726$20240801$20240801$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159875$JIANGSU HANSOH PHARMACEUTICAL$$74$YR$$M$Y$70$KG$20240801$$MD$CN$CN
241619461$24161946$1$I$$20240723$20240801$20240801$EXP$$GB-Bion-013576$BIONPHARMA$$28$YR$A$M$Y$$$20240801$$HP$GB$GB
241619471$24161947$1$I$20240712$20240718$20240801$20240801$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159879$JIANGSU HANSOH PHARMACEUTICAL$$50$YR$$M$Y$50$KG$20240801$$MD$CN$CN
241619481$24161948$1$I$$20240725$20240801$20240801$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2159869$Chengdu Suncadia Medicine$Clinical analysis of 14 pregnancies in women with renal transplant.$$$$$Y$1.94$KG$20240801$$MD$CN$CN
241619491$24161949$1$I$$20240725$20240801$20240801$EXP$$IN-Bion-013556$BIONPHARMA$$36$YR$A$M$Y$$$20240801$$HP$IN$IN
241619501$24161950$1$I$$20240724$20240801$20240801$PER$$US-ABBVIE-5854729$ABBVIE$$$$$M$Y$$$20240801$$HP$US$US
241619511$24161951$1$I$$20240725$20240801$20240801$EXP$$IN-Bion-013563$BIONPHARMA$$63$YR$A$M$Y$$$20240801$$HP$IN$IN
241619521$24161952$1$I$20240722$20240729$20240801$20240801$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159878$JIANGSU HANSOH PHARMACEUTICAL$$70$YR$$M$Y$65$KG$20240801$$MD$CN$CN
241619531$24161953$1$I$$20240717$20240801$20240801$EXP$$DE-Innogenix, LLC-2159877$INNOGENIX$Full text$55$YR$$F$Y$$$20240801$$$DE$DE
241619541$24161954$1$I$20221229$20240718$20240801$20240801$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159883$JIANGSU HANSOH PHARMACEUTICAL$$$$$M$Y$$$20240801$$MD$CN$CN
241619551$24161955$1$I$$20240725$20240801$20240801$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2159872$Chengdu Suncadia Medicine$Literature title: Clinical analysis of 14 pregnancies in women with renal transplant.?Journal of publication: Journal of Reproductive Medicine, 2024, 33 (7): 878-884.?Authors: Bing Liang, Liyun Gong, Zhiwei Zhang, Hang Liu, Junli Lu.$33$YR$$F$Y$$$20240801$$MD$CN$CN
241619561$24161956$1$I$$20240709$20240801$20240801$PER$$US-Marksans Pharma Limited-2159864$MARKSANS$$$$$$Y$$$20240801$$$US$US
241619571$24161957$1$I$$20230301$20240801$20240801$EXP$$NP-Appco Pharma LLC-2159885$APPCO PHARMA$Initial$45$YR$$F$Y$$$20240801$$$NP$NP
241619581$24161958$1$I$20240716$20240722$20240801$20240801$PER$$US-Appco Pharma LLC-2159873$APPCO PHARMA$$63$YR$$F$Y$$$20240801$$$US$US
241619591$24161959$1$I$$20240725$20240801$20240801$EXP$$US-Bion-013558$BIONPHARMA$$54$YR$A$M$Y$$$20240801$$CN$US$US
241619601$24161960$1$I$$20240717$20240801$20240801$PER$$-TOLMAR, INC.-24051060$TOLMAR$$$$$$Y$$$20240801$$CN$COUNTRY NOT SPECIFIED$
241619611$24161961$1$I$$20230301$20240801$20240801$EXP$$IT-Appco Pharma LLC-2159884$APPCO PHARMA$Initial$50$YR$$F$Y$$$20240801$$$IT$IT
241619621$24161962$1$I$$20240716$20240801$20240801$PER$$US-TOLMAR, INC.-24US050666$TOLMAR$$$$$F$Y$$$20240801$$HP$US$US
241619632$24161963$2$F$$20240815$20240801$20240906$PER$$US-TOLMAR, INC.-24US050743$TOLMAR$$$$$$Y$$$20240906$$MD$US$US
241619642$24161964$2$F$$20240815$20240801$20240906$PER$$US-TOLMAR, INC.-24US050742$TOLMAR$$$$C$$Y$$$20240906$$MD$US$US
241619652$24161965$2$F$$20240821$20240801$20240906$PER$$US-TOLMAR, INC.-24US051044$TOLMAR$$$$$$Y$$$20240906$$HP$US$US
241619661$24161966$1$I$$20240724$20240801$20240801$EXP$$US-Bion-013559$BIONPHARMA$$86$YR$E$F$Y$$$20240801$$CN$US$US
241619671$24161967$1$I$20240716$20240719$20240801$20240801$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2159876$JIANGSU HENGRUI MEDICINE$$39$YR$$F$Y$48$KG$20240801$$MD$CN$CN
241619682$24161968$2$F$$20240805$20240801$20240827$PER$$US-TOLMAR, INC.-24US051122$TOLMAR$$$$$M$Y$$$20240823$$HP$US$US
241619691$24161969$1$I$$20240716$20240801$20240801$PER$$US-TOLMAR, INC.-24US051052$TOLMAR$$$$$$Y$$$20240801$$MD$US$US
241619701$24161970$1$I$$20240717$20240801$20240801$PER$$US-TOLMAR, INC.-24US051070$TOLMAR$$$$$$Y$$$20240801$$MD$US$US
241619711$24161971$1$I$$20240724$20240801$20240801$EXP$$US-Oxford Pharmaceuticals, LLC-2159880$OXFORD PHARMACEUTICALS$Source document$26$YR$$M$Y$$$20240801$$$US$US
241619721$24161972$1$I$$20240717$20240801$20240801$EXP$$MA-Innogenix, LLC-2159874$INNOGENIX$Abstract$17$YR$$M$Y$$$20240801$$$MA$MA
241619731$24161973$1$I$20240717$20240719$20240801$20240801$EXP$$GB-CIPLA LTD.-2024GB07925$CIPLA$$$$$$Y$$$20240801$$MD$GB$GB
241619741$24161974$1$I$$20240725$20240801$20240801$EXP$$NVSC2024DE155493$NOVARTIS$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S et al.. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. BRITISH JOURNAL OF CANCER. 2023;128:1134-47$$$$$Y$$$20240801$$HP$DE$DE
241619751$24161975$1$I$$20240726$20240801$20240801$PER$$US-GILEAD-2024-0682111$GILEAD$$$$$$Y$$$20240801$$CN$US$US
241619761$24161976$1$I$$20240726$20240801$20240801$EXP$$US-Bion-013562$BIONPHARMA$$$$$M$Y$$$20240801$$HP$US$US
241619771$24161977$1$I$$20240730$20240801$20240801$PER$$US-ROCHE-10000046097$ROCHE$$$$$$Y$$$20240801$$CN$US$US
241619791$24161979$1$I$20240629$20240719$20240801$20240801$EXP$$FR-CIPLA LTD.-2024FR07931$CIPLA$$$$$$Y$$$20240801$$PH$FR$FR
241619801$24161980$1$I$20211105$20240719$20240801$20240801$EXP$$ES-CIPLA (EU) LIMITED-2024ES07947$CIPLA$$$$$$Y$$$20240801$$MD$ES$ES
241619811$24161981$1$I$20230412$20240724$20240801$20240801$EXP$FR-AFSSAPS-PC2024000565$FR-TEVA-VS-3225384$TEVA$$72$YR$$F$Y$80$KG$20240801$$MD$FR$FR
241619821$24161982$1$I$$20240722$20240801$20240801$EXP$$US-MYLANLABS-2024M1070279$MYLAN$Abdelrahim B, Alam M, Horani MH. Iatrogenic Thyroid Storm Treated with Plasmapheresis. J-Endocr-Soc 2022; 6 (Suppl.) A768-A769 abstr. ODP487.$32$YR$$M$Y$$$20240801$$HP$US$US
241619831$24161983$1$I$20240101$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151619$AMGEN$$$$A$M$Y$$$20240801$$CN$US$US
241619841$24161984$1$I$$20240731$20240731$20240731$DIR$712258$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241619852$24161985$2$F$20240725$20240805$20240801$20240807$PER$$US-AMGEN-USASP2024149654$AMGEN$$34$YR$A$F$Y$90.7$KG$20240807$$MD$US$US
241619861$24161986$1$I$20240725$20240725$20240801$20240801$PER$$US-AMGEN-USASP2024149876$AMGEN$$54$YR$A$F$Y$$$20240801$$CN$US$US
241619871$24161987$1$I$$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151754$AMGEN$$70$YR$E$F$Y$$$20240801$$HP$US$US
241619882$24161988$2$F$$20240808$20240801$20240822$EXP$$GB-UCBSA-2024038337$UCB$$$$$M$Y$$$20240822$$PH$GB$GB
241619891$24161989$1$I$$20240724$20240801$20240801$EXP$$HN-BAYER-2024A108240$BAYER$$$$$F$Y$$$20240801$$CN$HN$HN
241619901$24161990$1$I$$20240722$20240801$20240801$30DAY$$US-GSK-US2024091827$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
241619911$24161991$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121405$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240801$$CN$US$US
241619922$24161992$2$F$20240701$20240801$20240801$20240806$EXP$$PR-ABBVIE-5837375$ABBVIE$$74$YR$$F$Y$$$20240806$$CN$PR$PR
241619931$24161993$1$I$20240713$20240722$20240801$20240801$EXP$$IT-AUROBINDO-AUR-APL-2024-037026$AUROBINDO$$71$YR$$F$Y$$$20240801$$PH$IT$IT
241619941$24161994$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000364$ELI LILLY AND CO$$$$$M$Y$$$20240801$$CN$US$US
241619951$24161995$1$I$20240730$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019931$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240801$$CN$US$US
241619961$24161996$1$I$20240730$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000297$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240801$$CN$US$US
241619973$24161997$3$F$20240426$20240822$20240801$20240827$EXP$$NVSJ2024JP009155$NOVARTIS$$6$YR$$M$Y$$$20240827$$MD$JP$JP
241619981$24161998$1$I$$20240215$20240801$20240801$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00622$AMNEAL$$$$$F$Y$$$20240801$$MD$US$US
241619991$24161999$1$I$$20240722$20240801$20240801$EXP$$FR-AUROBINDO-AUR-APL-2024-037504$AUROBINDO$Hay M, Leguy S, Cahagne V, Lassalle N, Le Page E, Michel L.. Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient.. Rev-Neurol-Paris.. 2024;180 (6):565-567.$62$YR$$F$Y$$$20240801$$HP$FR$FR
241620001$24162000$1$I$$20240718$20240801$20240801$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05710$HIKMA$$$$$F$Y$$$20240801$$CN$US$US
241620011$24162001$1$I$20211225$20240729$20240801$20240801$EXP$$AU-ASTELLAS-2024US021732$ASTELLAS$$$$$M$Y$$$20240801$$CN$AU$AU
241620021$24162002$1$I$$20240722$20240801$20240801$EXP$$JP-ROCHE-10000040718$ROCHE$Ayabe K, Koga R. MT03-1 An experience of a rheumatoid arthritis case in which IL-6 inhibitor improved the symptoms of late periprosthetic knee joint infection that recurred seven years and seven months after the patient contracted the infection during administration of biological agent. The 47th Annual Meeting of Japanese Society for Study of Bones and Joint Infecti. 2024;74$64$YR$A$F$Y$$$20240801$$MD$JP$JP
241620041$24162004$1$I$$20240725$20240801$20240801$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001532$BLUEPRINT MEDICINES$$$$$F$Y$$$20240801$$CN$US$US
241620051$24162005$1$I$20240717$20240724$20240801$20240801$EXP$GB-MHRA-MED-202407241020397610-KDWHG$GB-MSNLABS-2024MSNSPO01684$MSN LABORATORIES$$$$$$Y$$$20240801$$PH$GB$GB
241620061$24162006$1$I$20240101$20240729$20240801$20240801$EXP$$US-ABBVIE-5859959$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241620072$24162007$2$F$20240725$20240729$20240801$20240808$EXP$$JP-AMGEN-JPNSP2024151841$AMGEN$$$$E$F$Y$$$20240807$$PH$JP$JP
241620081$24162008$1$I$20240729$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151736$AMGEN$$63$YR$A$$Y$$$20240801$$CN$US$US
241620091$24162009$1$I$$20240730$20240801$20240801$PER$$US-HALEON-2189794$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241620101$24162010$1$I$$20240724$20240801$20240801$EXP$$CA-APOTEX-2024AP008795$APOTEX$$$$$F$Y$$$20240801$$CN$CA$CA
241620111$24162011$1$I$20240525$20240726$20240801$20240801$EXP$$CH-AMERICAN REGENT INC-2024002896$AMERICAN REGENT$$74$YR$$F$Y$$$20240801$$MD$CH$CH
241620132$24162013$2$F$$20240830$20240801$20240909$EXP$$CA-TEVA-VS-3225801$TEVA$$6$MON$$F$Y$$$20240909$$HP$CA$CA
241620141$24162014$1$I$$20240722$20240801$20240801$EXP$$PL-AUROBINDO-AUR-APL-2024-037463$AUROBINDO$Skwarek-Dziekanowska A, Klaja B, Olajossy B, Miszczak M, Szewczuk R, Wojtowicz-Scislak A, et al.. A stuck CSP lead: Should everyone have tools for TLE?. Kardiol-Pol. 2024;82(Suppl. 1):55$54$YR$$M$Y$$$20240801$$HP$PL$PL
241620151$24162015$1$I$$20240725$20240801$20240801$EXP$$US-GSK-US2024093779$GLAXOSMITHKLINE$$$$A$F$Y$$$20240801$$CN$US$US
241620161$24162016$1$I$$20240717$20240801$20240801$EXP$$CH-GRANULES-CH-2024GRALIT00300$GRANULES INDIA$Bujana Batusha Sopi.Unhappy Hearts with The Antidepressant Venlafaxine.Swiss Medical Weekly.JAN-2024;154 (Suppl.):63S-64S$77$YR$E$F$Y$$$20240801$$HP$CH$CH
241620171$24162017$1$I$$20240731$20240801$20240801$PER$$US-ROCHE-10000046005$ROCHE$$70$YR$E$F$Y$$$20240801$$MD$US$US
241620182$24162018$2$F$20200420$20240827$20240801$20240831$EXP$$UY-SHIRE-UY202014231$TAKEDA$$47$YR$$M$Y$80$KG$20240831$$HP$UY$UY
241620191$24162019$1$I$20231201$20240723$20240801$20240801$PER$$US-SA-2024SA220926$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240801$$CN$US$US
241620201$24162020$1$I$20240701$20240724$20240801$20240801$PER$$US-SA-2024SA221419$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240801$$CN$US$US
241620211$24162021$1$I$20240704$20240726$20240801$20240801$EXP$$DE-SA-2024SA222203$SANOFI AVENTIS$$37$YR$A$F$Y$96$KG$20240801$$MD$DE$DE
241620221$24162022$1$I$$20240513$20240801$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090839$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241620231$24162023$1$I$$20231220$20240801$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087848$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241620242$24162024$2$F$$20240813$20240801$20240823$EXP$$CA-JNJFOC-20240776837$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240823$$PH$CA$CA
241620251$24162025$1$I$$20231214$20240801$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087692$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241620261$24162026$1$I$$20240304$20240801$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089273$GLENMARK$$$$$$Y$$$20240801$$HP$US$US
241620271$24162027$1$I$20240603$20240629$20240801$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091431$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241620281$24162028$1$I$$20240409$20240801$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089617$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241620291$24162029$1$I$$20240419$20240801$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090407$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241620301$24162030$1$I$$20240501$20240801$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090668$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241620311$24162031$1$I$$20240405$20240801$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090014$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241620321$24162032$1$I$$20240314$20240801$20240801$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089501$GLENMARK$$$$$$Y$$$20240801$$CN$US$US
241620331$24162033$1$I$$20240722$20240801$20240801$EXP$$JP-ROCHE-10000040761$ROCHE$Fujinaka K, Kakiwaki A, Fujita R, Yoneima R, Kitano T, Uenishi Y et al.. P-009 Adult Still^s disease complicated by TCZ-induced haemophagocytic syndrome which remitted with reintroduction of lipo-steroids and tocilizumab (TCZ). Japanese Journal of Hospital General Medicine/The 28th Annual Meeting of Japanes. 2024;20(S1):222$39$YR$A$M$Y$$$20240801$$MD$JP$JP
241620341$24162034$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA223398$SANOFI AVENTIS$$$$A$F$Y$$$20240801$$MD$US$US
241620351$24162035$1$I$20240101$20240730$20240801$20240801$PER$$US-SA-2024SA226156$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240801$$MD$US$US
241620362$24162036$2$F$$20240807$20240801$20240817$EXP$GB-MHRA-MIDB-fadd5e0d-e13f-46d0-b5ec-a270925b4c91$GB-TEVA-VS-3225320$TEVA$$41$YR$$M$Y$$$20240817$$PH$GB$GB
241620371$24162037$1$I$$20240729$20240801$20240801$EXP$$JP-BAYER-2024A105738$BAYER$$32$YR$A$F$Y$$$20240801$$PH$JP$JP
241620381$24162038$1$I$20240410$20240729$20240801$20240801$EXP$PL-URPL-DML-MLP.4401.1.161.2024$PL-TAKEDA-2024TUS075983$TAKEDA$$15$YR$$M$Y$47.8$KG$20240801$$HP$PL$PL
241620391$24162039$1$I$$20240725$20240801$20240801$EXP$$GB-MYLANLABS-2024M1070814$MYLAN$Kyaw O, Morris R, Leibowitz M. Hashimoto^s encephalitis - A case report. Clin-Med-London 2024; 24 (Suppl.).$50$YR$$F$Y$$$20240801$$HP$GB$GB
241620401$24162040$1$I$20240110$20240725$20240801$20240801$EXP$$US-TG THERAPEUTICS INC.-TGT003844$TG THERAPEUTICS$$$$$$Y$$$20240801$$CN$US$US
241620411$24162041$1$I$20240730$20240731$20240731$20240731$DIR$712257$$FDA-CTU$$73$YR$$F$N$$$20240731$N$HP$US$
241620421$24162042$1$I$$20240722$20240801$20240801$EXP$$US-RDY-LIT/USA/24/0011096$DR REDDYS$Fortich M, Reddy N, Bellinghausen A. Meth, PCP or Both? A Case of Diffuse Alveolar Hemorrhage in the Setting of Combined Amphetamine and Phencyclidine Use. American Journal of Respiratory and Critical Care Medicine. 2024 May;209:$37$YR$A$M$Y$$$20240801$$HP$US$US
241620431$24162043$1$I$$20240731$20240731$20240731$DIR$712259$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241620443$24162044$3$F$20200101$20240902$20240801$20240909$EXP$ES-ASTELLAS-2022US026364$ES-SA-2024SA226363$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240909$$HP$ES$ES
241620451$24162045$1$I$20240701$20240724$20240801$20240801$PER$$US-SA-2024SA222326$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240801$$MD$US$US
241620461$24162046$1$I$20240401$20240726$20240801$20240801$PER$$US-UNITED THERAPEUTICS-UNT-2024-010397$UNITED THERAPEUTICS$$45$YR$$F$Y$97.506$KG$20240801$$$US$US
241620471$24162047$1$I$20240601$20240726$20240801$20240801$PER$$US-SA-2024SA223618$SANOFI AVENTIS$$58$YR$A$F$Y$79.37$KG$20240801$$MD$US$US
241620481$24162048$1$I$$20240730$20240801$20240801$PER$$US-HALEON-2189963$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241620491$24162049$1$I$$20240718$20240801$20240801$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07060$LUPIN$Applegarth J, Finn D, Tolkacz M, Iacco A. Calcium channel blocker overdose and ECMO: A unique presentation of harlequin syndrome. ASAIO Journal. 2024;70 (3):151$18$YR$$F$Y$$$20240801$$HP$US$US
241620501$24162050$1$I$20240522$20240722$20240801$20240801$EXP$$NL-AUROBINDO-AUR-APL-2024-028320$AUROBINDO$$52$YR$$F$Y$$$20240801$$HP$NL$NL
241620514$24162051$4$F$$20240820$20240801$20240830$30DAY$$AU-JNJFOC-20240764162$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$PH$AU$AU
241620521$24162052$1$I$$20231017$20240801$20240801$EXP$$NVSC2023TW280920$NOVARTIS$Chai PY, Lin C, Kao CC, Lin LM, Chen YH, Sun CY. Use of everolimus following kidney transplantation during pregnancy: A case report and systematic review. TAIWANESE JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2023;62:774-8$29$YR$$F$Y$$$20240801$$HP$TW$TW
241620543$24162054$3$F$20240101$20240801$20240801$20240807$PER$$US-AMGEN-USASP2024152284$AMGEN$$66$YR$E$M$Y$$$20240807$$CN$US$US
241620551$24162055$1$I$20240729$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151436$AMGEN$$35$YR$A$F$Y$$$20240801$$CN$US$US
241620561$24162056$1$I$$20240724$20240801$20240801$EXP$$TW-MYLANLABS-2024M1071604$MYLAN$Peng T-R, Wu T-W, Chen H-F, Kao W-Y, Chan C-H. Gemcitabine-Associated Hyperammonemia in a Patient With Cholangiocarcinoma. Am-J-Ther 2024; 31 (4): e439-e440.$57$YR$$F$Y$$$20240801$$MD$TW$TW
241620571$24162057$1$I$$20240724$20240801$20240801$EXP$$US-MYLANLABS-2024M1070609$MYLAN$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D. Rhabdomyolysis Risk: The Dangers of Tribulus Terrestris, an Over-the-Counter Supplement. Am-J-Case-Rep 2024; 25 (0): e943492.$71$YR$$M$Y$$$20240801$$HP$US$US
241620581$24162058$1$I$$20240724$20240801$20240801$EXP$$JP-009507513-2407JPN004427J$MERCK$$79$YR$$M$Y$$$20240801$$MD$JP$JP
241620591$24162059$1$I$$20240722$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-036892$AUROBINDO$$34$YR$$M$Y$83$KG$20240801$$CN$GB$GB
241620602$24162060$2$F$20240101$20240813$20240801$20240826$PER$$US-SA-2024SA223010$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240826$$MD$US$US
241620612$24162061$2$F$20240529$20240722$20240801$20240801$EXP$FR-AFSSAPS-LY2024001070$FR-TEVA-VS-3224852$TEVA$$0$DY$$M$Y$4.135$KG$20240801$$HP$FR$FR
241620621$24162062$1$I$$20240722$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-036885$AUROBINDO$$71$YR$$F$Y$$$20240801$$HP$GB$GB
241620631$24162063$1$I$$20240722$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-036785$AUROBINDO$$$$$M$Y$$$20240801$$CN$GB$GB
241620641$24162064$1$I$$20240729$20240801$20240801$PER$$US-ROCHE-10000043398$ROCHE$$23$DY$N$F$Y$$$20240801$$CN$US$US
241620651$24162065$1$I$$20240731$20240731$20240731$DIR$712252$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241620671$24162067$1$I$20240601$20240724$20240801$20240801$EXP$FR-AFSSAPS-LM2024000391$FR-TEVA-VS-3225682$TEVA$$68$YR$$F$Y$54$KG$20240801$$MD$FR$FR
241620682$24162068$2$F$20231219$20240724$20240801$20240805$EXP$AT-CELLTRION INC.-2024AT015775$AT-ROCHE-10000034155$ROCHE$$60$YR$A$F$Y$80$KG$20240805$$MD$AT$AT
241620691$24162069$1$I$20220530$20240724$20240801$20240801$EXP$FR-AFSSAPS-PC2024000564$FR-TEVA-VS-3225451$TEVA$$40$YR$$F$Y$70$KG$20240801$$MD$FR$FR
241620701$24162070$1$I$$20240731$20240731$20240731$DIR$712263$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241620711$24162071$1$I$$20240722$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-036834$AUROBINDO$$$$$F$Y$$$20240801$$HP$GB$GB
241620723$24162072$3$F$20240701$20240823$20240801$20240827$30DAY$$US-AMGEN-USASP2024148693$AMGEN$$$$$M$Y$$$20240827$$HP$US$US
241620731$24162073$1$I$20240724$20240731$20240731$20240731$DIR$712260$$FDA-CTU$$71$YR$$M$N$$$20240731$Y$HP$US$
241620741$24162074$1$I$20240622$20240729$20240801$20240801$EXP$HR-HALMED-300086113$HR-HALEON-2189838$Haleon PLC$$32$YR$$F$Y$$$20240801$$MD$HR$HR
241620751$24162075$1$I$20240707$20240722$20240801$20240801$EXP$$IT-AUROBINDO-AUR-APL-2024-037365$AUROBINDO$$79$YR$$F$Y$$$20240801$$MD$IT$IT
241620762$24162076$2$F$20240724$20240815$20240801$20240821$EXP$$US-Vifor (International) Inc.-VIT-2024-06693$VIFOR$$60$YR$$F$Y$86.4$KG$20240821$$HP$US$US
241620771$24162077$1$I$$20240726$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120770$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$HP$US$US
241620783$24162078$3$F$20240728$20240822$20240801$20240827$PER$$US-HALEON-2189791$Haleon PLC$$41$YR$$F$Y$$$20240827$$MD$US$US
241620791$24162079$1$I$$20240723$20240801$20240801$EXP$$DE-AUROBINDO-AUR-APL-2024-037188$AUROBINDO$$61$YR$$M$Y$$$20240801$$CN$DE$DE
241620801$24162080$1$I$$20240723$20240801$20240801$EXP$$US-SAMSUNG BIOEPIS-SB-2024-22866$SAMSUNG BIOEPIS$Mueller S. Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug- Resistant Pseudomonas aeruginosa. Journal of Burn Care and Research. 2024 FEB 29;45 (3):808-810. doi:https://doi.org/10.1093/jbcr/irae026$48$YR$A$M$Y$$$20240801$$HP$US$US
241620821$24162082$1$I$$20240723$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-037038$AUROBINDO$$65$YR$$F$Y$$$20240801$$PH$GB$GB
241620831$24162083$1$I$$20240725$20240801$20240801$EXP$$US-MYLANLABS-2024M1070791$MYLAN$Spitz A, Shi H, Panjawatanan P, Skarda C, Shahsavari S, Welch T, et al. Late-onset amiodarone-induced thyrotoxicosis (ait) causing recurrent heart failure with reduced ejection fraction. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3182.$58$YR$$M$Y$$$20240801$$HP$US$US
241620841$24162084$1$I$$20240725$20240801$20240801$EXP$$IN-MYLANLABS-2024M1071013$MYLAN$Chowdhury S, Das D, Sarkar P, Karmakar S, Nayak PS, Gharami RC. Non langerhans cell histiocytoses in genitalia: A rare entity. J-Pak-Assoc-Dermatol 2024; 34 (3): 749-751.$35$YR$$M$Y$$$20240801$$MD$IN$IN
241620851$24162085$1$I$$20240725$20240801$20240801$EXP$$US-MYLANLABS-2024M1071103$MYLAN$Gaur D, Michalopulos MG, Drake KA, Gattineni J. Acetaminophen induced high anion gap metabolic acidosis: a potentially under-recognized consequence from a common medication. Pediatr-Nephrol 2024;.$12$YR$$F$Y$$$20240801$$HP$US$US
241620861$24162086$1$I$20200222$20240730$20240801$20240801$EXP$PL-URPL-2-455-2020$PL-ORGANON-O2407POL002883$ORGANON$$$$$F$Y$$$20240801$$CN$PL$PL
241620871$24162087$1$I$$20240725$20240801$20240801$EXP$$LT-MYLANLABS-2024M1069934$MYLAN$Kristina R, Jolita B. Vitamin K Antagonists Versus Direct Oral Anticoagulants For The Treatment of Left Ventricular Thrombus: A Case Report and Literature Review.. Laboratorin? Medicina. 2024;2 (98):78-84$48$YR$$M$Y$$$20240801$$HP$LT$LT
241620881$24162088$1$I$20240514$20240723$20240801$20240801$EXP$$FR-AUROBINDO-AUR-APL-2024-037345$AUROBINDO$$59$YR$$F$Y$$$20240801$$MD$FR$FR
241620894$24162089$4$F$$20240822$20240801$20240827$EXP$$NVSC2024US071908$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
241620901$24162090$1$I$$20240726$20240801$20240801$EXP$$CA-APOTEX-2024AP008902$APOTEX$$$$$F$Y$$$20240801$$CN$CA$CA
241620911$24162091$1$I$$20240722$20240801$20240801$EXP$AU-TGA-812555$AU-Accord-437364$ACCORD$$58$YR$A$M$Y$$$20240801$$HP$AU$AU
241620921$24162092$1$I$$20240722$20240801$20240801$EXP$CA-MHPD-E2B_07174776$CA-Accord-437601$ACCORD$$$$E$M$Y$$$20240801$$MD$CA$CA
241620931$24162093$1$I$$20240722$20240801$20240801$EXP$AU-TGA-814108$AU-Accord-437355$ACCORD$$68$YR$E$M$Y$$$20240801$$HP$AU$AU
241620942$24162094$2$F$20240716$20240808$20240801$20240820$EXP$$US-Accord-438474$ACCORD$$59$YR$A$M$Y$$$20240820$$HP$US$US
241620951$24162095$1$I$$20240720$20240801$20240801$EXP$AU-TGA-812327$AU-Accord-437262$ACCORD$$$$$$Y$$$20240801$$HP$AU$AU
241620961$24162096$1$I$20240719$20240723$20240801$20240801$EXP$$US-Accord-438470$ACCORD$$40$YR$A$F$Y$$$20240801$$HP$US$US
241620971$24162097$1$I$$20240723$20240801$20240801$EXP$GB-MHRA-MIDB- 5057ded2-761c-436e-a4ba-7b90a13f04e7$GB-Accord-438107$ACCORD$$59$YR$A$$Y$$$20240801$$PH$GB$GB
241620981$24162098$1$I$20240413$20240722$20240801$20240801$EXP$ES-AEMPS-1550301$ES-Accord-438562$ACCORD$$57$YR$A$M$Y$$$20240801$$MD$ES$ES
241620991$24162099$1$I$$20240722$20240801$20240801$EXP$GB-MHRA-MED-202407221836467660-FLBWV$GB-Accord-437876$ACCORD$$34$YR$A$M$Y$83$KG$20240801$$CN$GB$GB
241621001$24162100$1$I$$20240722$20240801$20240801$EXP$GB-MHRA-31195147$GB-Accord-437701$ACCORD$$$$$$Y$$$20240801$$CN$GB$GB
241621011$24162101$1$I$$20240709$20240801$20240801$PER$$US-Vifor (International) Inc.-VIT-2024-06245$VIFOR$$$$$$Y$$$20240801$$PH$US$US
241621021$24162102$1$I$20240701$20240717$20240801$20240801$PER$$US-Vifor (International) Inc.-VIT-2024-06466$VIFOR$$65$YR$$M$Y$67$KG$20240801$$HP$US$US
241621041$24162104$1$I$20211101$20240722$20240801$20240801$EXP$AU-TGA-0000809960$AU-Accord-437949$ACCORD$$$$$M$Y$$$20240801$$MD$AU$AU
241621051$24162105$1$I$20240604$20240728$20240801$20240801$EXP$$GB-TAKEDA-2024TUS076664$TAKEDA$$63$YR$$M$Y$$$20240801$$CN$GB$GB
241621061$24162106$1$I$$20240726$20240801$20240801$EXP$$GB-TAKEDA-2023TUS114666$TAKEDA$$$$$F$Y$$$20240801$$CN$GB$GB
241621071$24162107$1$I$$20240723$20240801$20240801$EXP$$IT-AUROBINDO-AUR-APL-2024-037503$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology.. Eur-J-Haematol. 2024;113 (1):90-98$3$YR$$F$Y$$$20240801$$HP$IT$IT
241621081$24162108$1$I$20240201$20240723$20240801$20240801$EXP$$FR-AUROBINDO-AUR-APL-2024-037075$AUROBINDO$$26$YR$$F$Y$$$20240801$$MD$FR$FR
241621091$24162109$1$I$$20240724$20240801$20240801$EXP$$MA-BIOVITRUM-2024-MA-010210$BIOVITRUM$$59$YR$$$Y$47$KG$20240801$$MD$MA$MA
241621101$24162110$1$I$$20230825$20240801$20240801$EXP$$US-AstraZeneca-2023A195157$ASTRAZENECA$$$$$$Y$$$20240801$$CN$US$
241621111$24162111$1$I$20230401$20230518$20240801$20240801$EXP$$TW-AstraZeneca-2023A118051$ASTRAZENECA$$73$YR$$M$Y$$$20240801$$CN$TW$
241621121$24162112$1$I$$20220315$20240801$20240801$EXP$$US-AstraZeneca-2022A052575$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241621131$24162113$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225821$TEVA$$77$YR$$F$Y$$$20240801$$CN$CA$CA
241621141$24162114$1$I$$20240723$20240801$20240801$PER$$US-AstraZeneca-2024A171971$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241621151$24162115$1$I$$20220705$20240801$20240801$EXP$$US-AstraZeneca-2022A246670$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241621161$24162116$1$I$20240730$20240731$20240731$20240731$DIR$712264$$FDA-CTU$$57$YR$$F$N$80.55$KG$20240731$N$$US$
241621171$24162117$1$I$20240730$20240731$20240731$20240731$DIR$712247$$FDA-CTU$$70$YR$$F$N$84.15$KG$20240731$N$PH$US$
241621181$24162118$1$I$$20240731$20240731$20240731$DIR$712269$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241621191$24162119$1$I$20240625$20240731$20240731$20240731$DIR$712268$$FDA-CTU$$75$YR$$M$N$135$KG$20240731$Y$CN$US$
241621211$24162121$1$I$$20240731$20240731$20240731$DIR$712272$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241621221$24162122$1$I$$20240731$20240731$20240731$DIR$712248$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241621231$24162123$1$I$20240731$20240731$20240731$20240731$DIR$712271$$FDA-CTU$$69$YR$$M$N$$$20240731$N$PH$US$
241621241$24162124$1$I$20240721$20240722$20240801$20240801$30DAY$$US-GSK-US2024091849$GLAXOSMITHKLINE$$61$YR$$M$Y$$$20240801$$CN$US$US
241621251$24162125$1$I$$20240723$20240801$20240801$EXP$$NL-AUROBINDO-AUR-APL-2024-037169$AUROBINDO$$23$YR$$M$Y$70$KG$20240801$$MD$NL$NL
241621261$24162126$1$I$20200501$20240723$20240801$20240801$EXP$$PL-AUROBINDO-AUR-APL-2024-037204$AUROBINDO$$57$YR$$F$Y$75$KG$20240801$$MD$PL$PL
241621271$24162127$1$I$$20240730$20240801$20240801$PER$$US-JNJFOC-20240783564$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$HP$US$US
241621281$24162128$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000084$ELI LILLY AND CO$$15$YR$T$F$Y$$$20240801$$PH$US$US
241621291$24162129$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000288$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240801$$CN$US$US
241621301$24162130$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020297$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240801$$CN$US$US
241621311$24162131$1$I$20240726$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019784$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240801$$CN$US$US
241621321$24162132$1$I$$20240722$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407015648$ELI LILLY AND CO$$45$YR$A$$Y$$$20240801$$LW$US$US
241621331$24162133$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000028$ELI LILLY AND CO$$$$$F$Y$$$20240801$$CN$US$US
241621341$24162134$1$I$20240726$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000326$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240801$$CN$US$US
241621351$24162135$1$I$$20240726$20240801$20240801$EXP$$US-AMGEN-USASP2024149964$AMGEN$$73$YR$E$F$Y$$$20240801$$MD$US$US
241621362$24162136$2$F$$20240815$20240801$20240820$EXP$$CA-JNJFOC-20240772002$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240820$$HP$CA$CA
241621371$24162137$1$I$20240727$20240729$20240801$20240801$EXP$$JP-SA-2024SA222337$SANOFI AVENTIS$$$$$$Y$$$20240801$$HP$JP$JP
241621381$24162138$1$I$20240202$20240726$20240801$20240801$EXP$$CO-UCBSA-2024038652$UCB$$54$YR$$F$Y$$$20240801$$CN$CO$CO
241621391$24162139$1$I$$20240724$20240801$20240801$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-23093$SAMSUNG BIOEPIS$$47$YR$A$F$Y$$$20240801$$CN$CA$CA
241621401$24162140$1$I$20240722$20240724$20240801$20240801$PER$$US-BAYER-2024A107811$BAYER$$$$$F$Y$$$20240801$$HP$US$US
241621411$24162141$1$I$$20240724$20240801$20240801$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-23118$SAMSUNG BIOEPIS$$35$YR$A$F$Y$$$20240801$$CN$CA$CA
241621421$24162142$1$I$$20240731$20240801$20240801$EXP$$US-ROCHE-10000046195$ROCHE$$$$A$$Y$$$20240801$$CN$US$US
241621436$24162143$6$F$$20240822$20240801$20240902$PER$$US-ROCHE-10000033149$ROCHE$$78$YR$E$M$Y$$$20240902$$MD$US$US
241621442$24162144$2$F$20240622$20240911$20240801$20240919$EXP$$JP-ROCHE-10000041942$ROCHE$$50$YR$A$F$Y$46$KG$20240919$$MD$JP$JP
241621451$24162145$1$I$20240723$20240725$20240801$20240801$PER$$US-BAYER-2024A108439$BAYER$$41$YR$A$F$Y$$$20240801$$MD$US$US
241621461$24162146$1$I$20240608$20240717$20240801$20240801$PER$$US-Vifor (International) Inc.-VIT-2024-06471$VIFOR$$77$YR$$F$Y$62.8$KG$20240801$$HP$US$US
241621471$24162147$1$I$$20240724$20240801$20240801$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-23144$SAMSUNG BIOEPIS$$64$YR$A$M$Y$$$20240801$$CN$GB$GB
241621481$24162148$1$I$20230901$20240724$20240801$20240801$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-23208$SAMSUNG BIOEPIS$$19$YR$A$F$Y$77$KG$20240801$$MD$AU$AU
241621491$24162149$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121814$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$MD$US$US
241621502$24162150$2$F$$20240810$20240801$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120946$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$86.18$KG$20240815$$CN$US$US
241621511$24162151$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121413$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$PH$US$US
241621521$24162152$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121544$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$84.82$KG$20240801$$CN$US$US
241621532$24162153$2$F$$20240908$20240801$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121039$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$69.4$KG$20240918$$CN$US$US
241621541$24162154$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121164$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240801$$CN$US$US
241621551$24162155$1$I$$20240729$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120473$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240801$$CN$US$US
241621561$24162156$1$I$20240430$20240723$20240801$20240801$EXP$GB-MHRA-30702653$GB-TEVA-VS-3225188$TEVA$$40$YR$$F$Y$$$20240801$$MD$GB$GB
241621584$24162158$4$F$$20240829$20240801$20240905$EXP$$GB-ROCHE-10000043009$ROCHE$$42$YR$A$F$Y$$$20240905$$HP$GB$GB
241621601$24162160$1$I$$20240729$20240801$20240801$PER$$US-BIOVITRUM-2024-US-010429$BIOVITRUM$Long C, Helm M, Foulke G. Seronegative cutaneous rheumatoid nodules with positive response to tofacitinib. JAAD Case Reports. 2024;50: 88-90. doi:10.1016/j.jdcr.2024.05.033.$29$YR$$F$Y$$$20240801$$HP$US$US
241621611$24162161$1$I$$20240722$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-036804$AUROBINDO$$69$YR$$M$Y$64$KG$20240801$$MD$GB$GB
241621621$24162162$1$I$20240701$20240724$20240801$20240801$30DAY$$US-GSK-US2024092906$GLAXOSMITHKLINE$$28$YR$$M$Y$$$20240801$$CN$US$US
241621631$24162163$1$I$$20240725$20240801$20240801$PER$$US-BAYER-2024A108598$BAYER$$$$$F$Y$$$20240801$$CN$US$US
241621642$24162164$2$F$$20240819$20240801$20240826$EXP$$BR-TAKEDA-2024TUS077221$TAKEDA$$5$YR$$$Y$$$20240826$$CN$BR$BR
241621662$24162166$2$F$20181027$20240808$20240801$20240814$EXP$$BR-TAKEDA-2019TUS049030$TAKEDA$$41$YR$$F$Y$$$20240814$$CN$BR$BR
241621671$24162167$1$I$20240719$20240725$20240801$20240801$EXP$$CA-TAKEDA-2024TUS074525$TAKEDA$$60$YR$$F$Y$$$20240801$$CN$CA$CA
241621682$24162168$2$F$$20240821$20240801$20240827$30DAY$$JP-MYLANLABS-2024M1068492$MYLAN$$$$$M$Y$$$20240827$$CN$JP$JP
241621691$24162169$1$I$20230131$20240731$20240731$20240731$DIR$712298$$FDA-CTU$$51$YR$$F$N$69.75$KG$20240731$N$CN$US$
241621703$24162170$3$F$$20240826$20240801$20240829$EXP$$FI-MYLANLABS-2024M1068750$MYLAN$$83$YR$$F$Y$$$20240829$$PH$FI$FI
241621712$24162171$2$F$$20240829$20240801$20240905$30DAY$$US-MYLANLABS-2024M1069385$MYLAN$$$$$F$Y$$$20240905$$CN$US$US
241621721$24162172$1$I$$20240725$20240801$20240801$EXP$$AT-MYLANLABS-2024M1070149$MYLAN$$85$YR$$F$Y$$$20240801$$MD$AT$AT
241621731$24162173$1$I$20210201$20240725$20240801$20240801$EXP$$DE-MYLANLABS-2024M1070081$MYLAN$$$$$F$Y$$$20240801$$HP$DE$DE
241621741$24162174$1$I$20240101$20240723$20240801$20240801$PER$$US-SA-2024SA222211$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240801$$MD$US$US
241621751$24162175$1$I$20240714$20240725$20240801$20240801$EXP$IT-MINISAL02-995817$IT-MYLANLABS-2024M1070049$MYLAN$$81$YR$$M$Y$74$KG$20240801$$MD$IT$IT
241621761$24162176$1$I$20240101$20240723$20240801$20240801$PER$$US-SA-2024SA196488$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240801$$CN$US$US
241621771$24162177$1$I$20240722$20240723$20240801$20240801$PER$$US-SA-2024SA223515$SANOFI AVENTIS$$54$YR$A$F$Y$127$KG$20240801$$MD$US$US
241621781$24162178$1$I$20240101$20240724$20240801$20240801$PER$$US-SA-2024SA224199$SANOFI AVENTIS$$75$YR$E$F$Y$54.4$KG$20240801$$MD$US$US
241621792$24162179$2$F$20240724$20240729$20240801$20240812$PER$$US-SA-2024SA219466$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240812$$CN$US$US
241621801$24162180$1$I$$20240725$20240801$20240801$PER$$US-BAYER-2024A108890$BAYER$$36$YR$A$F$Y$$$20240801$$HP$US$US
241621811$24162181$1$I$$20240723$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-037082$AUROBINDO$$$$$F$Y$$$20240801$$HP$GB$GB
241621821$24162182$1$I$20230501$20240725$20240801$20240801$EXP$$SG-ROCHE-10000037679$ROCHE$$59$YR$A$M$Y$$$20240801$$CN$SG$SG
241621832$24162183$2$F$20240101$20240917$20240801$20240919$PER$$US-AMGEN-USASP2024150317$AMGEN$$70$YR$E$F$Y$$$20240919$$CN$US$US
241621851$24162185$1$I$20240413$20240724$20240801$20240801$EXP$FR-AFSSAPS-DJ2024000840$FR-TEVA-VS-3225689$TEVA$$72$YR$$M$Y$90$KG$20240801$$PH$FR$FR
241621861$24162186$1$I$$20240722$20240801$20240801$EXP$$GB-AUROBINDO-AUR-APL-2024-036890$AUROBINDO$$$$$F$Y$$$20240801$$CN$GB$GB
241621871$24162187$1$I$20240603$20240726$20240801$20240801$PER$$US-BAYER-2024A109078$BAYER$$39$YR$A$F$Y$$$20240801$$HP$US$US
241621881$24162188$1$I$20240522$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52640$$FDA-CTU$$68$YR$$F$N$$$20240731$Y$PH$US$
241621901$24162190$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52630$$FDA-CTU$$59$YR$$M$N$$$20240731$N$$US$
241621921$24162192$1$I$20240726$20240731$20240731$20240731$DIR$712285$$FDA-CTU$$37$YR$$M$N$96.75$KG$20240731$N$CN$US$
241621941$24162194$1$I$20240727$20240731$20240731$20240731$DIR$712290$$FDA-CTU$$55$YR$$F$N$108$KG$20240731$N$CN$US$
241621951$24162195$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52648$$FDA-CTU$$47$YR$$F$N$$$20240731$N$$US$
241621961$24162196$1$I$20240731$20240731$20240731$20240731$DIR$712295$$FDA-CTU$$40$YR$$F$N$110.7$KG$20240731$Y$HP$US$
241621971$24162197$1$I$$20240728$20240801$20240801$EXP$GB-MHRA-MED-202407280834110720-LGBZW$GB-MYLANLABS-2024M1070385$MYLAN$$48$YR$$F$Y$85$KG$20240801$$CN$GB$GB
241621982$24162198$2$F$$20240801$20240801$20240802$PER$$US-HALEON-2189982$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241621993$24162199$3$F$20240731$20240820$20240801$20240827$EXP$$CA-TAKEDA-2024TUS076642$TAKEDA$$59$YR$$F$Y$$$20240827$$CN$CA$CA
241622002$24162200$2$F$20240101$20240918$20240801$20240927$EXP$$CA-CELLTRION INC.-2024CA018370$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
241622013$24162201$3$F$20240722$20240904$20240801$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-023191$UNITED THERAPEUTICS$$53$YR$$F$Y$45.805$KG$20240912$$PH$US$US
241622022$24162202$2$F$20221201$20240724$20240801$20240803$EXP$FR-AFSSAPS-PP2024000799$FR-TEVA-VS-3225696$TEVA$$77$YR$$M$Y$82$KG$20240803$$MD$FR$FR
241622041$24162204$1$I$20240709$20240726$20240801$20240801$PER$$US-BAYER-2024A109096$BAYER$$42$YR$A$F$Y$$$20240801$$MD$US$US
241622051$24162205$1$I$$20240729$20240801$20240801$EXP$$MX-BAYER-2024A110395$BAYER$$29$YR$A$M$Y$$$20240801$$CN$MX$MX
241622061$24162206$1$I$$20240723$20240801$20240801$EXP$$CA-JNJFOC-20240775846$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240801$$MD$CA$CA
241622071$24162207$1$I$20240713$20240715$20240801$20240801$PER$$US-JNJFOC-20240741153$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240801$$CN$US$US
241622082$24162208$2$F$$20240724$20240801$20240808$EXP$$SA-JNJFOC-20240773218$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240808$$MD$SA$SA
241622091$24162209$1$I$20240717$20240717$20240801$20240801$PER$$US-JNJFOC-20240752424$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
241622103$24162210$3$F$20240101$20240826$20240801$20240905$PER$$US-009507513-2407USA014207$MERCK$$$$$M$Y$$$20240905$$CN$US$US
241622114$24162211$4$F$$20240910$20240801$20240912$PER$$US-ROCHE-10000046161$ROCHE$$$$A$F$Y$$$20240912$$CN$US$US
241622121$24162212$1$I$$20240726$20240801$20240801$PER$$US-TAKEDA-2024TUS075910$TAKEDA$$40$YR$$F$Y$59$KG$20240801$$CN$US$US
241622131$24162213$1$I$20240712$20240724$20240801$20240801$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22999$SAMSUNG BIOEPIS$$69$YR$E$F$Y$$$20240801$$CN$CA$CA
241622141$24162214$1$I$$20240725$20240801$20240801$PER$$US-BAYER-2024A109194$BAYER$$40$YR$A$F$Y$$$20240801$$HP$US$US
241622153$24162215$3$F$20240625$20240723$20240801$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-037453$AUROBINDO$$73$YR$$M$Y$$$20240805$$PH$FR$FR
241622161$24162216$1$I$$20240726$20240801$20240801$PER$$US-ROCHE-10000042440$ROCHE$$$$A$F$Y$$$20240801$$CN$US$US
241622171$24162217$1$I$20240711$20240724$20240801$20240801$EXP$ES-AEMPS-1549431$ES-TEVA-VS-3225462$TEVA$$80$YR$$F$Y$$$20240801$$PH$ES$ES
241622183$24162218$3$F$20240430$20240910$20240801$20240917$EXP$$BE-EXELIXIS-XL18424077213$EXELIXIS$$$$$$Y$$$20240917$$MD$BE$BE
241622191$24162219$1$I$$20240722$20240801$20240801$EXP$$US-GSK-US2024091853$GLAXOSMITHKLINE$$$$$F$Y$$$20240801$$CN$US$US
241622201$24162220$1$I$$20240724$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119010$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240801$$CN$US$US
241622211$24162221$1$I$$20240729$20240801$20240801$PER$$NVSC2024US155947$NOVARTIS$$$$$F$Y$87.09$KG$20240801$$HP$US$US
241622221$24162222$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121677$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240801$$HP$US$NO
241622231$24162223$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121373$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240801$$CN$US$US
241622241$24162224$1$I$20240116$20240726$20240801$20240801$EXP$$FR-EXELIXIS-XL18424077513$EXELIXIS$$$$$$Y$$$20240801$$MD$FR$FR
241622251$24162225$1$I$$20240726$20240801$20240801$PER$$US-BAYER-2024A109450$BAYER$$38$YR$A$F$Y$$$20240801$$MD$US$US
241622261$24162226$1$I$$20240730$20240801$20240801$EXP$FR-AFSSAPS-AN2024000972$FR-SANDOZ INC.-SDZ2024FR069282$SANDOZ$$52$YR$$F$Y$73.5$KG$20240801$$PH$FR$FR
241622272$24162227$2$F$20240601$20240726$20240801$20240802$EXP$$US-AMGEN-USASP2024149956$AMGEN$$73$YR$E$F$Y$$$20240802$$CN$US$US
241622281$24162228$1$I$$20240725$20240801$20240801$PER$$US-BAYER-2024A109487$BAYER$$43$YR$A$F$Y$$$20240801$$MD$US$US
241622292$24162229$2$F$20240728$20240821$20240801$20240826$PER$$US-AMGEN-USASP2024151047$AMGEN$$81$YR$E$F$Y$$$20240826$$CN$US$US
241622311$24162231$1$I$$20240724$20240801$20240801$EXP$$CA-APOTEX-2024AP008800$APOTEX$$61$YR$$F$Y$$$20240801$$MD$CA$CA
241622321$24162232$1$I$20240729$20240729$20240801$20240801$PER$$US-TAKEDA-2024TUS076910$TAKEDA$$30$YR$$F$Y$$$20240801$$CN$US$US
241622331$24162233$1$I$20240614$20240711$20240801$20240801$EXP$$IN-ROCHE-10000027682$ROCHE$$56$YR$A$F$Y$73$KG$20240801$$CN$IN$IN
241622341$24162234$1$I$20240714$20240723$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011417$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241622351$24162235$1$I$$20240725$20240801$20240801$PER$$US-AMGEN-USASP2024148847$AMGEN$$70$YR$E$F$Y$$$20240801$$HP$US$US
241622362$24162236$2$F$20240729$20240819$20240801$20240826$PER$$US-AMGEN-USASP2024151384$AMGEN$$25$YR$A$F$Y$$$20240826$$MD$US$US
241622371$24162237$1$I$$20240724$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118235$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240801$$CN$US$US
241622381$24162238$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121440$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$PH$US$US
241622391$24162239$1$I$$20240723$20240801$20240801$EXP$$US-VIVUS, Inc.-2024V1000934$VIVUS$$$$A$F$Y$$$20240730$$CN$US$US
241622401$24162240$1$I$$20240724$20240801$20240801$EXP$$US-VIVUS LLC-2024V1000940$VIVUS$$$$E$F$Y$$$20240731$$CN$US$US
241622411$24162241$1$I$$20240731$20240801$20240801$PER$$US-ROCHE-10000046400$ROCHE$$45$YR$A$F$Y$$$20240801$$CN$US$US
241622421$24162242$1$I$20220601$20240730$20240801$20240801$EXP$FR-AFSSAPS-BR2024000589$FR-ROCHE-10000043107$ROCHE$$60$YR$A$F$Y$58$KG$20240801$$MD$FR$FR
241622432$24162243$2$F$$20240725$20240801$20240807$EXP$$JP-ASTELLAS-2024EU007445$ASTELLAS$$6$DEC$$F$Y$$$20240807$$CN$US$JP
241622442$24162244$2$F$20240731$20240808$20240801$20240812$EXP$$AU-ROCHE-10000046029$ROCHE$$41$YR$A$F$Y$$$20240812$$HP$AU$AU
241622451$24162245$1$I$$20240729$20240801$20240801$EXP$$US-PFIZER INC-PV202400098983$PFIZER$$$$$$Y$$$20240801$$CN$US$US
241622462$24162246$2$F$$20240731$20240801$20240807$EXP$$IN-PFIZER INC-PV202400098718$PFIZER$$56$YR$$M$Y$$$20240807$$CN$IN$IN
241622471$24162247$1$I$$20240730$20240801$20240801$EXP$$US-PFIZER INC-PV202400099631$PFIZER$$66$YR$$F$Y$$$20240801$$CN$US$US
241622482$24162248$2$F$20240417$20240921$20240801$20240926$EXP$$IN-PFIZER INC-PV202400065504$PFIZER$$44$YR$$M$Y$67$KG$20240926$$CN$IN$IN
241622491$24162249$1$I$$20240731$20240801$20240801$EXP$$AR-PFIZER INC-202400227458$PFIZER$$51$YR$$F$Y$$$20240801$$CN$AR$AR
241622501$24162250$1$I$$20240729$20240801$20240801$EXP$$JP-PFIZER INC-PV202400098878$PFIZER$Watanabe, J.. An autopsy case of atrioventricular block complete due to a cardiac tumour associated with lung cancer. The 301st Hokkaido Regional Meeting of the Japanese Society of Internal Medicine. 2024;301st$70$YR$$M$Y$$$20240801$$HP$JP$JP
241622511$24162251$1$I$$20240730$20240801$20240801$EXP$$US-PFIZER INC-202400227008$PFIZER$$72$YR$$F$Y$86.64$KG$20240801$$CN$US$US
241622521$24162252$1$I$$20240731$20240731$20240731$DIR$712284$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241622531$24162253$1$I$20240722$20240729$20240801$20240801$EXP$$CN-PFIZER INC-PV202400098860$PFIZER$$49$YR$$F$Y$$$20240801$$HP$CN$CN
241622541$24162254$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3225642$TEVA$$$$$F$Y$$$20240801$$CN$US$US
241622552$24162255$2$F$$20240731$20240801$20240805$EXP$$IR-PFIZER INC-202400221566$PFIZER$Ghazavi, M.. Levofloxacin-Induced Oromandibular Dystonia in a 9-Year-Old Patient. Iranian journal of child neurology. 2024;18(3):151-157$9$YR$$M$Y$$$20240805$$MD$IR$IR
241622562$24162256$2$F$20240325$20240726$20240801$20240807$EXP$FR-AFSSAPS-ST2024001218$FR-PFIZER INC-202400224332$PFIZER$$69$YR$$F$Y$54.6$KG$20240807$$HP$FR$FR
241622572$24162257$2$F$20210928$20240826$20240801$20240828$EXP$$FR-PFIZER INC-202400226458$PFIZER$$77$YR$$M$Y$54$KG$20240828$$MD$FR$FR
241622581$24162258$1$I$20240413$20240729$20240801$20240801$EXP$$JP-PFIZER INC-PV202400097943$PFIZER$$71$YR$$M$Y$59.9$KG$20240801$$PH$JP$JP
241622591$24162259$1$I$$20240731$20240801$20240801$EXP$$CA-PFIZER INC-202400227509$PFIZER$$4$MON$$F$Y$$$20240801$$HP$CA$CA
241622601$24162260$1$I$20240718$20240729$20240801$20240801$EXP$IT-MINISAL02-996859$IT-PFIZER INC-202400225346$PFIZER$$79$YR$$F$Y$60$KG$20240801$$MD$IT$IT
241622612$24162261$2$F$20240725$20240819$20240801$20240821$EXP$$CA-PFIZER INC-202400199754$PFIZER$$45$YR$$F$Y$$$20240821$$MD$CA$CA
241622621$24162262$1$I$$20240731$20240801$20240801$EXP$$US-PFIZER INC-PV202400100026$PFIZER$$68$YR$$F$Y$$$20240801$$HP$US$US
241622632$24162263$2$F$$20240805$20240801$20240805$EXP$$AU-PFIZER INC-PV202400099679$PFIZER$$84$YR$$M$Y$$$20240805$$PH$AU$AU
241622641$24162264$1$I$20240601$20240731$20240731$20240731$DIR$712253$$FDA-CTU$$$$$UNK$N$$$20240731$N$CN$US$
241622651$24162265$1$I$$20240731$20240801$20240801$EXP$$CA-PFIZER INC-202400227502$PFIZER$$5$YR$$F$Y$19$KG$20240801$$HP$CA$CA
241622661$24162266$1$I$20240724$20240730$20240801$20240801$EXP$$CN-PFIZER INC-PV202400099490$PFIZER$$30$YR$$F$Y$62$KG$20240801$$HP$CN$CN
241622671$24162267$1$I$20240426$20240726$20240801$20240801$EXP$$IE-PFIZER INC-PV202400098474$PFIZER$$53$YR$$F$Y$69$KG$20240801$$MD$IE$IE
241622681$24162268$1$I$20231002$20240729$20240801$20240801$EXP$FR-AFSSAPS-AM2024000583$FR-PFIZER INC-202400225493$PFIZER$$78$YR$$M$Y$80$KG$20240801$$MD$FR$FR
241622691$24162269$1$I$20240720$20240729$20240801$20240801$EXP$$CN-PFIZER INC-PV202400098862$PFIZER$$44$YR$$F$Y$49.7$KG$20240801$$HP$CN$CN
241622701$24162270$1$I$20210831$20240729$20240801$20240801$EXP$FR-AFSSAPS-TO2024000667$FR-PFIZER INC-202400088519$PFIZER$$78$YR$$M$Y$$$20240801$$MD$FR$FR
241622711$24162271$1$I$20240613$20240729$20240801$20240801$EXP$FR-AFSSAPS-NY2024000808$FR-PFIZER INC-202400225347$PFIZER$$54$YR$$F$Y$125$KG$20240801$$MD$FR$FR
241622722$24162272$2$F$$20240921$20240801$20240923$EXP$$CA-PFIZER INC-202400226626$PFIZER$$62$YR$$F$Y$$$20240923$$PH$CA$CA
241622732$24162273$2$F$$20240920$20240801$20240920$EXP$$CA-PFIZER INC-PV202400057960$PFIZER$$56$YR$$M$Y$$$20240920$$HP$CA$CA
241622741$24162274$1$I$20140101$20240730$20240801$20240801$EXP$$US-PFIZER INC-PV202400099646$PFIZER$$67$YR$$F$Y$$$20240801$$HP$US$US
241622751$24162275$1$I$20240713$20240731$20240731$20240731$DIR$712286$$FDA-CTU$$61$YR$$F$N$56.25$KG$20240731$N$CN$US$
241622762$24162276$2$F$$20240823$20240801$20240826$EXP$$BE-PFIZER INC-PV202400098559$PFIZER$Meganck, S.. Recurrent rejections after liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient. Acta Clinica Belgica. 2024;1-8$32$YR$$F$Y$$$20240826$$HP$BE$BE
241622771$24162277$1$I$$20240730$20240801$20240801$EXP$$AR-PFIZER INC-202400227643$PFIZER$$75$YR$$M$Y$$$20240801$$CN$AR$AR
241622781$24162278$1$I$20231001$20240729$20240801$20240801$EXP$$CA-PFIZER INC-202400226139$PFIZER$$81$YR$$M$Y$$$20240801$$MD$CA$CA
241622791$24162279$1$I$20240521$20240729$20240801$20240801$EXP$$CN-PFIZER INC-PV202400098843$PFIZER$$82$YR$$F$Y$$$20240801$$HP$CN$CN
241622802$24162280$2$F$$20240806$20240801$20240808$EXP$$CN-PFIZER INC-PV202400099168$PFIZER$Chen, X.. Juvenile dermatomyositis complications: navigating gastrointestinal perforations and treatment challenges, a case report. Frontiers in Pediatrics. 2024;18:10.3389/fped.2024.1419355$12$YR$$F$Y$30$KG$20240808$$HP$CN$CN
241622821$24162282$1$I$20230901$20240731$20240801$20240801$EXP$$NP-PFIZER INC-PV202400099798$PFIZER$$65$YR$$M$Y$$$20240801$$MD$NP$NP
241622831$24162283$1$I$20200629$20240729$20240801$20240801$EXP$FR-AFSSAPS-AN2024000960$FR-PFIZER INC-202400225539$PFIZER$$66$YR$$M$Y$$$20240801$$MD$FR$FR
241622843$24162284$3$F$20240629$20240913$20240801$20240916$30DAY$$US-PFIZER INC-202400224971$PFIZER$$26$YR$$F$Y$$$20240916$$CN$US$US
241622852$24162285$2$F$20240621$20240823$20240801$20240827$EXP$$US-PFIZER INC-202400225967$PFIZER$$78$YR$$M$Y$68.04$KG$20240827$$CN$US$US
241622862$24162286$2$F$20240701$20240922$20240801$20240923$EXP$$CA-PFIZER INC-202400227166$PFIZER$$66$YR$$F$Y$$$20240923$$HP$CA$CA
241622872$24162287$2$F$20240620$20240902$20240801$20240904$EXP$FR-AFSSAPS-LL2024001456$FR-PFIZER INC-202400226464$PFIZER$$73$YR$$M$Y$$$20240904$$MD$FR$FR
241622881$24162288$1$I$20240629$20240729$20240801$20240801$EXP$$US-PFIZER INC-202400226169$PFIZER$$92$YR$$F$Y$$$20240801$$PH$US$US
241622891$24162289$1$I$20240125$20240731$20240731$20240731$DIR$712322$$FDA-CTU$$43$YR$$F$N$57.6$KG$20240731$N$CN$US$
241622901$24162290$1$I$20230801$20240729$20240801$20240801$EXP$$IN-PFIZER INC-PV202300074315$PFIZER$$69$YR$$F$Y$62.9$KG$20240801$$CN$IN$IN
241622911$24162291$1$I$$20240726$20240801$20240801$EXP$$IT-PFIZER INC-202400225674$PFIZER$Testi, A.. Hodgkin Lymphoma in Children: A 16-year Experience at the Children^s Welfare Teaching Hospital of Baghdad, Iraq.. Mediterranean Journal of Hematology and Infectious Diseases. 2024;16(1):10.4084/MJHID.2024.053$$$C$$Y$$$20240801$$HP$IT$IQ
241622921$24162292$1$I$20240101$20240730$20240801$20240801$EXP$$CN-PFIZER INC-PV202400099204$PFIZER$$$$A$F$Y$$$20240801$$CN$CN$CN
241622931$24162293$1$I$20240717$20240729$20240801$20240801$EXP$$CN-PFIZER INC-PV202400098782$PFIZER$$54$YR$$F$Y$48$KG$20240801$$HP$CN$CN
241622941$24162294$1$I$20230101$20240729$20240801$20240801$EXP$FR-AFSSAPS-RN2024000815$FR-PFIZER INC-202400225538$PFIZER$$74$YR$$F$Y$$$20240801$$MD$FR$FR
241622962$24162296$2$F$20240101$20240731$20240801$20240805$EXP$$GB-PFIZER INC-202400224697$PFIZER$$34$YR$$F$Y$$$20240805$$CN$GB$GB
241622971$24162297$1$I$20220201$20240729$20240801$20240801$EXP$FR-AFSSAPS-TS2024000855$FR-PFIZER INC-202400225510$PFIZER$$57$YR$$M$Y$68$KG$20240801$$MD$FR$FR
241622981$24162298$1$I$20240610$20240731$20240731$20240731$DIR$712335$$FDA-CTU$$41$YR$$F$N$54$KG$20240731$N$CN$US$
241622991$24162299$1$I$$20240726$20240801$20240801$PER$$US-BAYER-2024A109789$BAYER$$$$$F$Y$$$20240801$$CN$US$US
241623001$24162300$1$I$$20240731$20240801$20240801$EXP$$US-PFIZER INC-202400227776$PFIZER$$$$$M$Y$$$20240801$$CN$US$US
241623011$24162301$1$I$$20240730$20240801$20240801$EXP$$US-PFIZER INC-202400227244$PFIZER$$57$YR$$F$Y$$$20240801$$CN$US$US
241623022$24162302$2$F$$20240805$20240801$20240807$EXP$$US-PFIZER INC-PV202400099913$PFIZER$$67$YR$$F$Y$$$20240807$$CN$US$US
241623031$24162303$1$I$20240501$20240729$20240801$20240801$EXP$$CA-PFIZER INC-202400190491$PFIZER$$21$YR$$M$Y$83.9$KG$20240801$$HP$CA$CA
241623041$24162304$1$I$$20240729$20240801$20240801$EXP$$CA-PFIZER INC-202400226637$PFIZER$$$$$F$Y$$$20240801$$CN$CA$CA
241623051$24162305$1$I$$20240729$20240801$20240801$EXP$$US-PFIZER INC-PV202400034032$PFIZER$$88$YR$$F$Y$$$20240801$$MD$US$US
241623061$24162306$1$I$20240704$20240729$20240801$20240801$EXP$$CN-PFIZER INC-PV202400098812$PFIZER$$60$YR$$M$Y$49$KG$20240801$$HP$CN$CN
241623071$24162307$1$I$$20240731$20240801$20240801$EXP$$US-PFIZER INC-202400227806$PFIZER$$62$YR$$F$Y$$$20240801$$CN$US$US
241623081$24162308$1$I$20190729$20240725$20240801$20240801$EXP$$GB-PFIZER INC-202400226487$PFIZER$$73$YR$$M$Y$$$20240801$$MD$GB$GB
241623091$24162309$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000347$ELI LILLY AND CO$$$$$$Y$$$20240801$$PH$US$US
241623102$24162310$2$F$$20240730$20240801$20240805$EXP$$US-PFIZER INC-2016170216$PFIZER$Lin, S.. Subdural spread of local anesthetic mimicking cerebrovascular accident: A case report. Regional Anesthesia and Pain Medicine. 2015;40 (5)$53$YR$$F$Y$$$20240805$$HP$US$US
241623111$24162311$1$I$$20240729$20240801$20240801$EXP$$CA-PFIZER INC-202400200651$PFIZER$$60$YR$$F$Y$$$20240801$$HP$CA$CA
241623121$24162312$1$I$20240717$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000089$ELI LILLY AND CO$$$$A$F$Y$$$20240801$$CN$US$US
241623131$24162313$1$I$$20240730$20240801$20240801$EXP$$CA-PFIZER INC-202400226762$PFIZER$$51$YR$$F$Y$$$20240801$$CN$CA$CA
241623141$24162314$1$I$20240515$20240729$20240801$20240801$EXP$FR-AFSSAPS-TS2024000856$FR-PFIZER INC-202400225516$PFIZER$$64$YR$$M$Y$82$KG$20240801$$MD$FR$FR
241623151$24162315$1$I$$20240729$20240801$20240801$EXP$$DE-ABBVIE-5860926$ABBVIE$$$$$M$Y$$$20240801$$MD$DE$DE
241623161$24162316$1$I$$20240726$20240801$20240801$EXP$GB-MHRA-MED-202407261611297380-YCDKF$GB-MYLANLABS-2024M1070116$MYLAN$$$$$F$Y$$$20240801$$MD$GB$GB
241623171$24162317$1$I$$20240701$20240801$20240801$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004451$BLUEPRINT MEDICINES$$$$$$Y$$$20240731$$CN$US$US
241623181$24162318$1$I$$20240730$20240801$20240801$EXP$$AU-ROCHE-3097173$ROCHE$$$$A$F$Y$125$KG$20240801$$HP$AU$AU
241623191$24162319$1$I$$20240726$20240801$20240801$PER$$US-BAYER-2024A111052$BAYER$$$$$$Y$$$20240801$$CN$US$US
241623201$24162320$1$I$$20240730$20240801$20240801$PER$$US-TAKEDA-2024TUS076973$TAKEDA$$25$YR$$M$Y$74$KG$20240801$$MD$US$US
241623211$24162321$1$I$20240729$20240730$20240801$20240801$EXP$$US-GILEAD-2024-0682458$GILEAD$$53$YR$A$M$Y$$$20240801$$HP$US$US
241623221$24162322$1$I$20240614$20240723$20240801$20240801$EXP$$FR-AUROBINDO-AUR-APL-2024-037423$AUROBINDO$$58$YR$$M$Y$100$KG$20240801$$PH$FR$FR
241623231$24162323$1$I$20240707$20240723$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011419$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241623241$24162324$1$I$$20240725$20240801$20240801$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024093769$VIIV$$$$$$Y$$$20240801$$HP$US$US
241623251$24162325$1$I$$20240722$20240801$20240801$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR095583$VIIV$$$$$$Y$$$20240801$$HP$US$US
241623261$24162326$1$I$20240722$20240731$20240801$20240801$EXP$$US-INCYTE CORPORATION-2024IN008013$INCYTE$$$$$$Y$$$20240801$$CN$US$US
241623271$24162327$1$I$$20230503$20240801$20240801$EXP$$US-AstraZeneca-2023A104045$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241623281$24162328$1$I$20240115$20240722$20240801$20240801$EXP$FR-AFSSAPS-PC2024000580$FR-Accord-438281$ACCORD$$70$YR$E$F$Y$60$KG$20240801$$PH$FR$FR
241623291$24162329$1$I$$20240722$20240801$20240801$EXP$AU-TGA-812554$AU-Accord-437365$ACCORD$$54$YR$A$M$Y$$$20240801$$HP$AU$AU
241623301$24162330$1$I$$20240722$20240801$20240801$EXP$AU-TGA-807009$AU-Accord-437446$ACCORD$$55$YR$A$F$Y$$$20240801$$HP$AU$AU
241623311$24162331$1$I$20240712$20240722$20240801$20240801$EXP$$US-Accord-438293$ACCORD$$66$YR$E$M$Y$$$20240801$$PH$US$US
241623321$24162332$1$I$$20240722$20240801$20240801$EXP$GB-MHRA-31137098$GB-Accord-437668$ACCORD$$$$$M$Y$$$20240801$$CN$GB$GB
241623332$24162333$2$F$20240628$20240823$20240801$20240904$EXP$$US-Accord-438206$ACCORD$$34$YR$A$M$Y$$$20240904$$HP$US$US
241623341$24162334$1$I$20240717$20240722$20240801$20240801$EXP$$US-Accord-438302$ACCORD$$34$YR$A$F$Y$$$20240801$$HP$US$US
241623351$24162335$1$I$$20240721$20240801$20240801$EXP$$US-Accord-437996$ACCORD$Jones DT, Srinivasmurthy R, Pandit M, Tovar R, Ho L, Wairimu K. Raoultella ornithinolytica Urinary Tract Infection in a Patient With Triple-Negative Breast Cancer. Cureus. 2024 Jul 17;16(7):e64742. doi: 10.7759/cureus.64742.$81$YR$E$F$Y$$$20240801$$HP$US$US
241623361$24162336$1$I$$20240722$20240801$20240801$EXP$AU-TGA-812319$AU-Accord-437379$ACCORD$$85$YR$E$M$Y$$$20240801$$HP$AU$AU
241623371$24162337$1$I$20210810$20211102$20240801$20240801$EXP$$US-AstraZeneca-2021A799562$ASTRAZENECA$$13801$DY$$F$Y$$$20240801$$CN$US$
241623381$24162338$1$I$$20230912$20240801$20240801$EXP$$US-AstraZeneca-2023A208283$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241623391$24162339$1$I$$20240721$20240801$20240801$EXP$$CA-Accord-438597$ACCORD$Reyes NG, Bendahan N, Swinkin E, Lang AE, Bassett AS. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2024.$4$DEC$A$F$Y$$$20240801$$HP$CA$CA
241623401$24162340$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225824$TEVA$$60$YR$$M$Y$$$20240801$$HP$CA$CA
241623411$24162341$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52664$$FDA-CTU$$49$YR$$F$N$$$20240731$N$$US$
241623421$24162342$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225826$TEVA$$$$$M$Y$$$20240801$$HP$CA$CA
241623431$24162343$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52622$$FDA-CTU$$69$YR$$M$N$99.34$KG$20240731$N$$US$
241623452$24162345$2$F$20240701$20240816$20240801$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116394$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240827$$HP$US$US
241623461$24162346$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52660$$FDA-CTU$$20$YR$$F$N$$$20240731$N$$US$
241623471$24162347$1$I$20201230$20240722$20240801$20240801$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-116902$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240801$$MD$KR$KR
241623482$24162348$2$F$$20240819$20240801$20240827$EXP$NL-LRB-00990265$NL-TEVA-VS-3225728$TEVA$$72$YR$$F$Y$$$20240827$$MD$NL$NL
241623491$24162349$1$I$20240720$20240731$20240731$20240731$DIR$712288$$FDA-CTU$$22$YR$$M$N$62.1$KG$20240731$N$CN$US$
241623501$24162350$1$I$$20240726$20240801$20240801$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-120578$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240801$$MD$AU$AU
241623511$24162351$1$I$20240101$20240726$20240801$20240801$PER$$US-JNJFOC-20240780320$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240801$$CN$US$US
241623521$24162352$1$I$20211101$20240724$20240801$20240801$EXP$$US-JNJFOC-20240771110$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240801$$CN$US$US
241623541$24162354$1$I$$20240723$20240801$20240801$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005514$BIOCON$$$$$$Y$$$20240801$$HP$CA$CA
241623551$24162355$1$I$20240722$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52661$$FDA-CTU$$59$YR$$F$N$$$20240731$N$$US$
241623562$24162356$2$F$20240701$20240921$20240801$20240923$EXP$$CA-PFIZER INC-202400206915$PFIZER$$46$YR$$M$Y$77.2$KG$20240923$$MD$CA$CA
241623581$24162358$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52662$$FDA-CTU$$80$YR$$F$N$$$20240731$N$$US$
241623591$24162359$1$I$20240727$20240729$20240801$20240801$PER$$US-BAYER-2024A111021$BAYER$$77$YR$E$F$Y$$$20240801$$CN$US$US
241623601$24162360$1$I$20240703$20240723$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011421$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241623611$24162361$1$I$20240101$20240719$20240801$20240801$EXP$$US-CIPLA LTD.-2024US07986$CIPLA$$$$$$Y$$$20240801$$CN$US$US
241623621$24162362$1$I$20240728$20240731$20240731$20240731$DIR$712276$$FDA-CTU$$$$$F$N$$$20240731$N$CN$US$
241623631$24162363$1$I$$20240719$20240801$20240801$EXP$$CA-LUPIN HEALTHCARE (UK) LIMITED-2024-07429$LUPIN$$$$$$Y$$$20240801$$CN$CA$CA
241623641$24162364$1$I$$20240729$20240801$20240801$EXP$$CA-APOTEX-2024AP008965$APOTEX$$65$YR$$M$Y$$$20240801$$CN$CA$CA
241623651$24162365$1$I$20240705$20240731$20240731$20240731$DIR$712317$$FDA-CTU$$36$YR$$F$N$54$KG$20240731$N$CN$US$
241623661$24162366$1$I$$20240723$20240801$20240801$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-22957$SAMSUNG BIOEPIS$$62$YR$A$F$Y$$$20240801$$CN$GB$GB
241623671$24162367$1$I$20240701$20240726$20240801$20240801$PER$$US-BIOGEN-2024BI01275815$BIOGEN$$20$YR$$F$Y$$$20240801$$CN$US$US
241623681$24162368$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151134$AMGEN$$$$$$Y$$$20240801$$CN$US$US
241623701$24162370$1$I$20240301$20240731$20240801$20240801$EXP$$US-INCYTE CORPORATION-2024IN008011$INCYTE$$$$$$Y$$$20240801$$MD$US$US
241623712$24162371$2$F$20240705$20240807$20240801$20240813$EXP$$JP-Eisai-EC-2024-170936$EISAI$$72$YR$E$M$Y$73.8$KG$20240813$$MD$JP$JP
241623721$24162372$1$I$$20240729$20240801$20240801$EXP$$TR-ROCHE-10000042036$ROCHE$Aygunes U, Karagun B, Sasmaz H, Antmen A, Tumgor G. The Treatment of Steroid-Refractory Severe Gastrointestinal Acute Graft-Versus-Host Disease in Children after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience. Osmangazi Journal of Medicine. 2024-Apr-22;46 (3):394-403. doi:10.20515/otd.1420314.$15$YR$T$M$Y$$$20240801$$HP$TR$TR
241623731$24162373$1$I$$20240730$20240801$20240801$PER$$US-BAUSCH-BL-2024-011663$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240801$$CN$US$US
241623742$24162374$2$F$20240101$20240906$20240801$20240918$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-23188$SAMSUNG BIOEPIS$$55$YR$A$F$Y$75$KG$20240918$$CN$CA$CA
241623751$24162375$1$I$$20240723$20240801$20240801$PER$$US-BAYER-2024A107812$BAYER$$24$YR$A$F$Y$$$20240801$$CN$US$US
241623761$24162376$1$I$$20240722$20240801$20240801$EXP$$JP-Vifor (International) Inc.-VIT-2024-06592$VIFOR$Tanaka Y, Tezuka S, Hashimoto A, Hosobe Y, Saeki A, Fukae K. Pregnancy with overt diabetic nephropathy: A case report. Modern Trends in Obstetrics + Gynecology. 2024;72(2):255-260.$$$$F$Y$0.991$KG$20240801$$MD$JP$JP
241623771$24162377$1$I$20240701$20240729$20240801$20240801$EXP$$US-AMGEN-USASP2024150430$AMGEN$$49$YR$A$F$Y$$$20240801$$CN$US$US
241623781$24162378$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASL2024151727$AMGEN$$$$$$Y$$$20240801$$CN$US$US
241623791$24162379$1$I$20240101$20240729$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043184$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$$$20240801$$CN$US$US
241623801$24162380$1$I$20240601$20240729$20240801$20240801$PER$$US-009507513-2407USA015653$MERCK$$72$YR$$M$Y$$$20240801$$CN$US$US
241623812$24162381$2$F$20240730$20240821$20240801$20240823$PER$$US-AMGEN-USASP2024151919$AMGEN$$80$YR$E$F$Y$$$20240823$$CN$US$US
241623822$24162382$2$F$$20240806$20240801$20240816$EXP$$JP-TEVA-VS-3227376$TEVA$Maeshima K, Abe T, Imada C, Ozaki T, Shibata H. Anifrolumab for refractory lupus erythematosus panniculitis in systemic lupus erythematosus. Rheumatology 2024; 63 (3): E115-E117.; Maeshima K, Abe T, Imada C, Ozaki T, Shibata H. Anifrolumab for refractory lupus erythematosus panniculitis in systemic lupus erythematosus. Rheumatology 2024; 63 (3): E115-E117.$36$YR$$F$Y$$$20240816$$HP$JP$JP
241623831$24162383$1$I$$20240724$20240801$20240801$EXP$$US-VANTIVE-2024VAN018595$Vantive US Healthcare$$$$$F$Y$$$20240801$$HP$US$US
241623842$24162384$2$F$$20240725$20240801$20240806$EXP$$US-SAMSUNG BIOEPIS-SB-2024-23084$SAMSUNG BIOEPIS$Khan A, Ghali N. Paradoxical keratitis and dermatitis following adalimumab treatment. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024 JUL 11;. doi:https://doi.org/10.1016/j.jaapos.2024.103970$6$YR$C$F$Y$$$20240806$$MD$US$US
241623851$24162385$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A171677$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$US$
241623861$24162386$1$I$20210701$20210712$20240801$20240801$EXP$$US-AstraZeneca-2021A617629$ASTRAZENECA$$26791$DY$$M$Y$$$20240801$$CN$US$
241623871$24162387$1$I$$20240724$20240801$20240801$PER$$US-ABBVIE-5855260$ABBVIE$$$$$$Y$$$20240801$$HP$US$US
241623881$24162388$1$I$20240704$20240723$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011422$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241623891$24162389$1$I$$20221005$20240801$20240801$EXP$$US-AstraZeneca-2022A339822$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241623901$24162390$1$I$20211027$20211106$20240801$20240801$EXP$$US-AstraZeneca-2021A801123$ASTRAZENECA$$27531$DY$$M$Y$$$20240801$$CN$US$
241623911$24162391$1$I$$20240709$20240801$20240801$PER$$US-JNJFOC-20240727375$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
241623921$24162392$1$I$$20240726$20240801$20240801$PER$$US-JNJFOC-20240773845$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$HP$US$US
241623931$24162393$1$I$$20240717$20240801$20240801$EXP$$ES-GRANULES-ES-2024GRALIT00303$GRANULES INDIA$Flor M Fernandez-Gordon Sanchez.Active microscopic colitis precipitated by fluoxetine.Revista Espanola de Enfermedades Digestivas: The spanish journal of Gastroenterology.2024$41$YR$A$F$Y$$$20240801$$HP$ES$ES
241623941$24162394$1$I$20240301$20240723$20240801$20240801$PER$$US-SA-2024SA221670$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240801$$MD$US$US
241623951$24162395$1$I$$20240719$20240801$20240801$EXP$$US-IBIGEN-2024-015608$ISTITUTO BICHIMICO ITALIANO GIOVANNI LORENZINI (IBIGEN)$Xia J, Ahmed R. Rapidly progressive locked-in syndrome secondary to atypical herpes simplex virus-1 rhombencephalitis in an immunocompromised individual. IDCases. 2024;37:e02027. DOI:10.1016/j.idcr.2024.e02027.$61$YR$$M$Y$$$20240723$$MD$US$
241623961$24162396$1$I$20240101$20240723$20240801$20240801$PER$$US-SA-2024SA223647$SANOFI AVENTIS$$44$YR$A$F$Y$65$KG$20240801$$MD$US$US
241623971$24162397$1$I$20240722$20240724$20240801$20240801$PER$$US-SA-2024SA221851$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240801$$MD$US$US
241623981$24162398$1$I$20240521$20240521$20240801$20240801$PER$$US-BAYER-2024A091052$BAYER$$41$YR$A$F$Y$$$20240801$$MD$US$US
241623991$24162399$1$I$20240722$20240730$20240801$20240801$EXP$$CN-ROCHE-10000043050$ROCHE$$56$YR$A$F$Y$50$KG$20240801$$HP$CN$CN
241624001$24162400$1$I$$20240612$20240801$20240801$EXP$$CA-ROCHE-10000041525$ROCHE$$62$YR$A$M$Y$$$20240801$$HP$CA$CA
241624011$24162401$1$I$20240612$20240717$20240801$20240801$PER$$US-Vifor (International) Inc.-VIT-2024-06461$VIFOR$$55$YR$$M$Y$99$KG$20240801$$HP$US$US
241624021$24162402$1$I$20240517$20240521$20240801$20240801$PER$$US-BAYER-2024A091115$BAYER$$21$YR$A$F$Y$$$20240801$$MD$US$US
241624031$24162403$1$I$20240701$20240730$20240801$20240801$EXP$$JP-BAYER-2024A106996$BAYER$$80$YR$E$M$Y$$$20240801$$MD$JP$JP
241624041$24162404$1$I$20240617$20240723$20240801$20240801$EXP$$FR-AUROBINDO-AUR-APL-2024-037145$AUROBINDO$$42$YR$$M$Y$58.5$KG$20240801$$MD$FR$FR
241624051$24162405$1$I$20240101$20240722$20240801$20240801$PER$$US-ABBVIE-5851993$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241624061$24162406$1$I$20240622$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121507$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$61.23$KG$20240801$$HP$US$US
241624071$24162407$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121760$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240801$$HP$US$US
241624081$24162408$1$I$$20240731$20240731$20240731$DIR$712277$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241624091$24162409$1$I$$20240730$20240801$20240801$PER$$US-ABBVIE-5861209$ABBVIE$$$$$$Y$$$20240801$$HP$US$US
241624101$24162410$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52647$$FDA-CTU$$$$$M$N$$$20240730$N$HP$US$
241624111$24162411$1$I$20240501$20240725$20240801$20240801$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003163$CURRAX PHARMACEUTICALS$$63$YR$$F$Y$$$20240801$$CN$CA$CA
241624121$24162412$1$I$20240718$20240729$20240731$20240731$DIR$FDA-CDER-CTU-2024-52596$$FDA-CTU$$80$YR$$M$N$$$20240729$N$HP$US$
241624132$24162413$2$F$$20240909$20240801$20240911$30DAY$$US-PFIZER INC-PV202400098183$PFIZER$$$$$F$Y$$$20240911$$CN$US$US
241624142$24162414$2$F$$20240823$20240801$20240829$30DAY$$DE-PFIZER INC-202400219358$PFIZER$$$$$F$Y$$$20240829$$CN$DE$DE
241624151$24162415$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52602$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241624163$24162416$3$F$20240101$20240924$20240801$20240927$EXP$$US-PFIZER INC-202400224701$PFIZER$$72$YR$$F$Y$55.79$KG$20240927$$HP$US$US
241624171$24162417$1$I$20240726$20240731$20240731$20240731$DIR$712266$$FDA-CTU$$$$$UNK$N$$$20240731$N$PH$US$
241624184$24162418$4$F$$20240904$20240801$20240906$EXP$$CA-PFIZER INC-202400223975$PFIZER$$$$$F$Y$$$20240906$$HP$CA$CA
241624191$24162419$1$I$$20240726$20240801$20240801$EXP$$BR-ZAMBON SWITZERLAND LTD.-2024-ZAM-BR000042$PAREXEL$$$$$$Y$$$20240801$$CN$BR$BR
241624201$24162420$1$I$20240719$20240725$20240801$20240801$EXP$$GB-ZAMBON SWITZERLAND LTD.-2024-ZAM-GB000041$PAREXEL$$$$$$Y$$$20240801$$CN$GB$GB
241624211$24162421$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52598$$FDA-CTU$$62$YR$$F$N$$$20240731$N$$US$
241624221$24162422$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52599$$FDA-CTU$$80$YR$$F$N$$$20240731$N$$US$
241624251$24162425$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52606$$FDA-CTU$$84$YR$$F$N$$$20240731$N$$US$
241624261$24162426$1$I$20240705$20240731$20240731$20240731$DIR$712336$$FDA-CTU$$76$YR$$F$N$87$KG$20240731$N$CN$US$
241624271$24162427$1$I$20190410$20240724$20240801$20240801$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-07087$HIKMA$$36$YR$$F$Y$92.4$KG$20240801$$HP$US$US
241624291$24162429$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151418$AMGEN$$$$A$F$Y$$$20240801$$CN$US$US
241624302$24162430$2$F$20240729$20240729$20240801$20240805$PER$$US-AMGEN-USASP2024150434$AMGEN$$56$YR$A$F$Y$$$20240805$$CN$US$US
241624311$24162431$1$I$20240521$20240521$20240801$20240801$PER$$US-BAYER-2024A091127$BAYER$$31$YR$A$F$Y$$$20240801$$MD$US$US
241624321$24162432$1$I$$20240704$20240801$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06974$LUPIN$$$$$$Y$$$20240801$$CN$US$US
241624331$24162433$1$I$$20240716$20240801$20240801$PER$$US-INCYTE CORPORATION-2024IN007494$INCYTE$$$$$$Y$$$20240801$$CN$US$US
241624341$24162434$1$I$20240623$20240730$20240801$20240801$EXP$DE-BFARM-24005300$DE-ORGANON-O2407DEU002752$ORGANON$$33$YR$$F$Y$$$20240801$$MD$DE$DE
241624351$24162435$1$I$$20240725$20240801$20240801$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-07319$HIKMA$Krishnamoorthy S, Kaur R, Ameer N, Uzoma AA, Enemuo NR, Gopal S, et al.. Krishnamoorthy S, Kaur R, Ameer N, Uzoma AA, Enemuo NR, Gopal S, et al. Type I Kounis Syndrome: Allergic Myocardial Infarction Triggered by Ciprofloxacin.. Cureus.. 2024;16(6):e62460$35$YR$$F$Y$$$20240801$$MD$US$US
241624361$24162436$1$I$$20220812$20240801$20240801$EXP$$AU-ABBVIE-2227444US$ABBVIE$$$$$M$Y$$$20240801$$MD$AU$AU
241624371$24162437$1$I$$20240717$20240801$20240801$EXP$$IT-GRANULES-IT-2024GRALIT00297$GRANULES INDIA$C. Scollo.CARDIOVASCULAR CONSIDERATIONS IN ANTIDEPRESSANT THERAPY: SINUS ARREST DUE TO SERTRALINE.European Heart Journal Supplements.APR-2024;26 (Suppl. 2):ii78$39$YR$A$F$Y$$$20240801$$HP$IT$IT
241624381$24162438$1$I$$20240726$20240801$20240801$EXP$$US-MYLANLABS-2024M1070963$MYLAN$$$$$M$Y$$$20240801$$CN$US$US
241624391$24162439$1$I$$20240724$20240801$20240801$PER$$US-ABBVIE-5855256$ABBVIE$$$$$$Y$$$20240801$$MD$US$US
241624401$24162440$1$I$20240711$20240717$20240801$20240801$PER$$US-INCYTE CORPORATION-2024IN007561$INCYTE$$$$$$Y$$$20240801$$CN$US$US
241624411$24162441$1$I$$20240726$20240801$20240801$PER$$US-ABBVIE-5857751$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241624422$24162442$2$F$$20240911$20240801$20240912$PER$$NVSC2024US157138$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
241624431$24162443$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121647$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240801$$CN$US$US
241624441$24162444$1$I$$20240729$20240801$20240801$EXP$$US-GILEAD-2024-0682421$GILEAD$$$$E$F$Y$$$20240801$$CN$US$US
241624451$24162445$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121705$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240801$$CN$US$US
241624461$24162446$1$I$20240703$20240725$20240801$20240801$EXP$$CN-TEVA-VS-3226996$TEVA$$71$YR$$M$Y$56$KG$20240801$$CN$CN$CN
241624471$24162447$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000108$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240801$$CN$US$US
241624481$24162448$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019553$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240801$$CN$US$US
241624491$24162449$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000050$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240801$$CN$US$US
241624501$24162450$1$I$$20240725$20240801$20240801$EXP$$GB-JNJFOC-20240771931$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240801$$CN$GB$GB
241624512$24162451$2$F$20240718$20240731$20240801$20240805$EXP$$PK-ROCHE-10000043392$ROCHE$$40$YR$A$M$Y$$$20240805$$CN$PK$PK
241624521$24162452$1$I$20240731$20240731$20240731$20240731$DIR$712254$$FDA-CTU$$61$YR$$F$N$$$20240731$Y$$US$
241624531$24162453$1$I$$20240722$20240801$20240801$EXP$AU-TGA-807141$AU-Accord-437442$ACCORD$$55$YR$A$F$Y$$$20240801$$HP$AU$AU
241624542$24162454$2$F$$20240722$20240801$20240803$EXP$AU-TGA-806090$AU-Accord-437425$ACCORD$$60$YR$A$M$Y$$$20240803$$HP$AU$AU
241624551$24162455$1$I$20240722$20240723$20240801$20240801$EXP$$US-Accord-438422$ACCORD$$44$YR$A$F$Y$$$20240801$$PH$US$US
241624561$24162456$1$I$$20240722$20240801$20240801$EXP$CA-MHPD-E2B_07172403$CA-Accord-437591$ACCORD$$$$E$M$Y$$$20240801$$CN$CA$CA
241624571$24162457$1$I$$20240722$20240801$20240801$EXP$AU-TGA-812314$AU-Accord-437411$ACCORD$$67$YR$E$F$Y$$$20240801$$HP$AU$AU
241624581$24162458$1$I$$20240722$20240801$20240801$EXP$$PT-Accord-437769$ACCORD$Morao B, Ramos LR, Oliveira MH, Gloria L. Malignancy and mass-forming phenotypes of IgG4-related disease: A challenging diagnosis. BMJ Case Reports. 2024;17(7):e257372$8$DEC$E$F$Y$60$KG$20240801$$MD$PT$PT
241624591$24162459$1$I$$20240725$20240801$20240801$PER$$NVSC2024US154315$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241624601$24162460$1$I$$20240730$20240801$20240801$EXP$GB-MHRA-MED-202407260753521180-LKRTB$GB-MYLANLABS-2024M1071114$MYLAN$$60$YR$$F$Y$$$20240801$$MD$GB$GB
241624611$24162461$1$I$20231101$20240730$20240801$20240801$EXP$GB-MHRA-MED-202407301909068180-JCTHZ$GB-MYLANLABS-2024M1071102$MYLAN$$19$YR$$F$Y$63$KG$20240801$$CN$GB$GB
241624621$24162462$1$I$$20240729$20240801$20240801$EXP$$JP-JNJFOC-20240800869$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240801$$PH$JP$JP
241624631$24162463$1$I$20240516$20240521$20240801$20240801$PER$$US-BAYER-2024A104709$BAYER$$56$YR$A$F$Y$$$20240801$$CN$US$US
241624641$24162464$1$I$20240520$20240521$20240801$20240801$PER$$US-BAYER-2024A091139$BAYER$$24$YR$A$F$Y$$$20240801$$MD$US$US
241624652$24162465$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3226483$TEVA$Shayegh NA, Aggarwal M, Simonetto D. CLINICAL AND HISTOPATHOLOGICAL SPECTRUM OF OXALIPLATININDUCED SINUSOIDAL OBSTRUCTION SYNDROME: A CASE SERIES. Gastroenterology 2024; 166 (Suppl.) (5): S-1759-S-1760 abstr. Tu1643.; Shayegh NA, Aggarwal M, Simonetto D. CLINICAL AND HISTOPATHOLOGICAL SPECTRUM OF OXALIPLATININDUCED SINUSOIDAL OBSTRUCTION SYNDROME: A CASE SERIES. Gastroenterology 2024; 166 (Suppl.) (5): S-1759-S-1760 abstr. Tu1643.$$$$$Y$$$20240816$$HP$US$US
241624672$24162467$2$F$$20240802$20240801$20240813$EXP$US-MLMSERVICE-20240722-PI134774-00145-1$US-RDY-SPO/USA/24/0011141$DR REDDYS$Venkatraman S, Mehta T, Deng F. A Rare Neurotoxicity Syndrome Following Opioid Intoxication. Annals of Neurology. 2024;96(2):412-5. DOI: 10.1002/ana.26953.$55$YR$A$F$Y$$$20240813$$MD$US$US
241624681$24162468$1$I$$20240725$20240801$20240801$EXP$GB-MHRA-MED-202407251004357380-PQSYK$GB-RDY-SPO/GBR/24/0011073$DR REDDYS$$$$$M$Y$$$20240801$$CN$GB$GB
241624691$24162469$1$I$20240720$20240723$20240801$20240801$EXP$$IL-RECORDATI-2024005651$RECORDATI$$$$$$Y$$$20240801$$CN$IL$IL
241624711$24162471$1$I$20240523$20240524$20240801$20240801$PER$$US-BAYER-2024A090617$BAYER$$52$YR$A$F$Y$$$20240801$$MD$US$US
241624721$24162472$1$I$$20240726$20240801$20240801$EXP$$NVSC2024US154710$NOVARTIS$$10$MON$$$Y$$$20240801$$PH$US$US
241624731$24162473$1$I$20240301$20240718$20240801$20240801$EXP$$US-UCBSA-2024011127$UCB$$14$YR$$F$Y$31.75$KG$20240801$$CN$US$US
241624741$24162474$1$I$20240717$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52651$$FDA-CTU$$23$YR$$M$N$$$20240731$Y$PH$US$
241624761$24162476$1$I$$20240724$20240801$20240801$EXP$$US-AMGEN-USASP2024148686$AMGEN$Mani H.; Safo P.; Onitilo A.A. Linagliptin-associated bullous pemphigoid treated with rituximab. BMJ Case Reports. 2019;12 (9):1-3$73$YR$E$M$Y$$$20240801$$MD$US$US
241624771$24162477$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52635$$FDA-CTU$$59$YR$$F$N$$$20240731$N$$US$
241624801$24162480$1$I$20240618$20240731$20240731$20240731$DIR$712293$$FDA-CTU$$58$YR$$F$N$49.5$KG$20240731$N$CN$US$
241624823$24162482$3$F$20240722$20240903$20240801$20240905$EXP$$US-ABBVIE-5860985$ABBVIE$$91$YR$$M$Y$$$20240905$$CN$US$US
241624831$24162483$1$I$20220722$20240731$20240731$20240731$DIR$712320$$FDA-CTU$$29$YR$$F$N$60.75$KG$20240731$N$CN$US$
241624841$24162484$1$I$20240516$20240726$20240801$20240801$EXP$GB-MHRA-MED-202407261542221570-DBJYP$GB-ASTELLAS-2024US021435$ASTELLAS$$82$YR$$F$Y$55$KG$20240801$$CN$GB$GB
241624861$24162486$1$I$$20240718$20240801$20240801$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004445$Unknown Manufacturer$$$$$$Y$$$20240731$$CN$US$US
241624873$24162487$3$F$20240708$20240913$20240801$20240923$30DAY$$FR-PFIZER INC-202400218570$PFIZER$$12$MON$$M$Y$9$KG$20240923$$HP$FR$FR
241624882$24162488$2$F$20240101$20240922$20240801$20240923$EXP$$CA-PFIZER INC-202400226390$PFIZER$$58$YR$$M$Y$$$20240923$$CN$CA$CA
241624901$24162490$1$I$20240722$20240731$20240731$20240731$DIR$712312$$FDA-CTU$$69$YR$$F$N$63.54$KG$20240731$N$CN$US$
241624921$24162492$1$I$$20240731$20240731$20240731$DIR$712281$$FDA-CTU$$$$$UNK$N$$$20240731$$CN$US$
241624931$24162493$1$I$$20240722$20240801$20240801$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024091868$VIIV$$$$$M$Y$$$20240801$$HP$US$US
241624941$24162494$1$I$20240702$20240719$20240801$20240801$EXP$$CN-GSK-CN2024APC095506$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$MD$CN$CN
241624951$24162495$1$I$20240523$20240523$20240801$20240801$PER$$US-BAYER-2024A090658$BAYER$$$$$F$Y$$$20240801$$CN$US$US
241624971$24162497$1$I$20240726$20240726$20240801$20240801$PER$$US-AMGEN-USASP2024149689$AMGEN$$62$YR$A$M$Y$$$20240801$$CN$US$US
241624981$24162498$1$I$20240730$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151583$AMGEN$$82$YR$E$M$Y$$$20240801$$HP$US$US
241624991$24162499$1$I$$20240725$20240801$20240801$PER$$US-AMGEN-USASP2024149100$AMGEN$$$$$F$Y$$$20240801$$HP$US$US
241625001$24162500$1$I$$20240726$20240801$20240801$PER$$US-SA-2024SA223263$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240801$$MD$US$US
241625011$24162501$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA072906$SANOFI AVENTIS$$$$A$F$Y$59.41$KG$20240801$$MD$US$US
241625021$24162502$1$I$20240101$20240725$20240801$20240801$PER$$US-SA-2024SA223747$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240801$$MD$US$US
241625031$24162503$1$I$20240627$20240724$20240801$20240801$PER$$US-SA-2024SA217811$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240801$$CN$US$US
241625041$24162504$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA223864$SANOFI AVENTIS$$$$E$F$Y$$$20240801$$CN$US$US
241625061$24162506$1$I$$20240723$20240801$20240801$EXP$PL-URPL-1-4242-2020$PL-JNJFOC-20240763225$JOHNSON AND JOHNSON$$24$YR$A$F$Y$76$KG$20240801$$MD$PL$PL
241625071$24162507$1$I$20220501$20240723$20240801$20240801$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004448$PPD DEVELOPMENT LP$$$$$$Y$$$20240731$$CN$CN$CN
241625081$24162508$1$I$$20240731$20240801$20240801$PER$$US-HALEON-2189967$Haleon PLC$$$$$M$Y$$$20240801$$CN$US$US
241625091$24162509$1$I$20240711$20240730$20240801$20240801$EXP$$UA-MYLANLABS-2024M1071410$MYLAN$$60$YR$$M$Y$$$20240801$$HP$UA$UA
241625101$24162510$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151315$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241625111$24162511$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024152599$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241625121$24162512$1$I$$20240726$20240801$20240801$EXP$$BE-GILEAD-2024-0682097$GILEAD$$$$A$$Y$$$20240801$$MD$BE$BE
241625131$24162513$1$I$20240507$20240523$20240801$20240801$PER$$US-BAYER-2024A091038$BAYER$$33$YR$A$F$Y$$$20240801$$MD$US$US
241625141$24162514$1$I$20240402$20240730$20240801$20240801$EXP$$GB-MYLANLABS-2024M1070905$MYLAN$$81$YR$$F$Y$77$KG$20240801$$PH$GB$GB
241625151$24162515$1$I$$20240719$20240801$20240801$EXP$$CA-LUPIN HEALTHCARE (UK) LIMITED-2024-07430$LUPIN$$57$YR$$F$Y$$$20240801$$CN$CA$CA
241625161$24162516$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120884$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240801$$CN$US$US
241625192$24162519$2$F$$20240831$20240801$20240903$30DAY$$US-PFIZER INC-202400224124$PFIZER$$8$YR$$F$Y$$$20240903$$HP$US$US
241625201$24162520$1$I$$20240715$20240801$20240801$PER$$US-009507513-2407USA010354$MERCK$$$$$F$Y$$$20240801$$CN$US$US
241625213$24162521$3$F$20240701$20240815$20240801$20240822$30DAY$$FR-JNJFOC-20240755024$JOHNSON AND JOHNSON$$39$YR$A$M$Y$96$KG$20240822$$CN$FR$FR
241625221$24162522$1$I$$20240724$20240801$20240801$PER$$US-GILEAD-2024-0681953$GILEAD$$$$$F$Y$$$20240801$$MD$US$US
241625231$24162523$1$I$20240730$20240731$20240801$20240801$EXP$GB-MHRA-MED-202407310931596210-CTQWP$GB-BAYER-2024A110720$BAYER$$61$YR$A$M$Y$$$20240801$$HP$GB$GB
241625242$24162524$2$F$20190101$20240806$20240801$20240816$EXP$$JP-TEVA-VS-3227375$TEVA$Oka H, Sumitomo S, Nishikubo M, Yamashita D, Maruoka H, Shiroishi Y, et al. VEXAS syndrome with granulomatosis with polyangiitis manifestation: retained in remission using methotrexate and infliximab. Rheumatology 2024; 63 (3): E110-E112.; Oka H, Sumitomo S, Nishikubo M, Yamashita D, Maruoka H, Shiroishi Y, et al. VEXAS syndrome with granulomatosis with polyangiitis manifestation: retained in remission using methotrexate and infliximab. Rheumatology 2024; 63 (3): E110-E112.; Oka H, Sumitomo S...$76$YR$$M$Y$$$20240816$$HP$JP$JP
241625251$24162525$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225825$TEVA$$81$YR$$F$Y$$$20240801$$HP$CA$CA
241625261$24162526$1$I$$20240724$20240801$20240801$EXP$$IT-TEVA-VS-3225744$TEVA$$22$YR$$F$Y$$$20240801$$MD$IT$IT
241625271$24162527$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225818$TEVA$$43$YR$$F$Y$96$KG$20240801$$HP$CA$CA
241625281$24162528$1$I$$20240730$20240801$20240801$EXP$GB-MHRA-MED-202407251205574320-RQCGB$GB-MYLANLABS-2024M1071079$MYLAN$$$$$$Y$$$20240801$$CN$GB$GB
241625291$24162529$1$I$20240601$20240724$20240801$20240801$EXP$FR-AFSSAPS-TS2024000813$FR-TEVA-VS-3225693$TEVA$$54$YR$$M$Y$72$KG$20240801$$MD$FR$FR
241625301$24162530$1$I$$20240730$20240801$20240801$EXP$$US-OTSUKA-2024_021216$OTSUKA$$81$YR$$M$Y$$$20240801$$MD$US$US
241625311$24162531$1$I$20240701$20240731$20240801$20240801$EXP$$US-GILEAD-2024-0682549$GILEAD$$60$YR$A$F$Y$$$20240801$$CN$US$US
241625321$24162532$1$I$20240101$20240522$20240801$20240801$PER$$US-BAYER-2024A091060$BAYER$$44$YR$A$F$Y$$$20240801$$HP$US$US
241625331$24162533$1$I$20240629$20240729$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043240$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$$$20240801$$CN$US$US
241625341$24162534$1$I$$20240723$20240801$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST004489$STEMLINE THERAPEUTICS$$81$YR$E$F$Y$$$20240731$$CN$US$US
241625351$24162535$1$I$20240629$20240724$20240801$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST004515$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240731$$HP$US$US
241625371$24162537$1$I$$20240727$20240801$20240801$EXP$$US-PFIZER INC-PV202400098263$PFIZER$Jackson, D.. Myocarditis and brain abscess caused by disseminated Scedosporium boydii infection. J-Natl-Med-Assoc. 2024;116(3):238-246$52$YR$$M$Y$$$20240801$$HP$US$US
241625381$24162538$1$I$20240725$20240731$20240731$20240731$DIR$712256$$FDA-CTU$$78$YR$$M$N$50.3$KG$20240731$Y$HP$US$
241625391$24162539$1$I$20240727$20240731$20240731$20240731$DIR$712249$$FDA-CTU$$41$YR$$M$N$106$KG$20240731$N$PH$US$
241625411$24162541$1$I$20240715$20240731$20240731$20240731$DIR$712291$$FDA-CTU$$68$YR$$F$N$104.4$KG$20240731$N$CN$US$
241625421$24162542$1$I$20240401$20240729$20240801$20240801$EXP$GB-MHRA-MED-202407290946084720-KBZVW$GB-MYLANLABS-2024M1070510$MYLAN$$34$YR$$F$Y$$$20240801$$CN$GB$GB
241625431$24162543$1$I$$20240729$20240801$20240801$EXP$$GB-MYLANLABS-2024M1070414$MYLAN$$72$YR$$M$Y$91$KG$20240801$$PH$GB$GB
241625441$24162544$1$I$$20240729$20240801$20240801$EXP$$GB-MYLANLABS-2024M1071350$MYLAN$$$$$M$Y$$$20240801$$MD$GB$GB
241625451$24162545$1$I$$20240729$20240801$20240801$EXP$$GB-MYLANLABS-2024M1070759$MYLAN$$$$$M$Y$$$20240801$$PH$GB$GB
241625461$24162546$1$I$20240728$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020074$ELI LILLY AND CO$$87$YR$E$F$Y$$$20240801$$HP$US$US
241625471$24162547$1$I$20240701$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000315$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240801$$CN$US$US
241625481$24162548$1$I$20240716$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019877$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240801$$CN$US$US
241625491$24162549$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407002172$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240801$$CN$US$US
241625501$24162550$1$I$$20240723$20240801$20240801$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407015689$ELI LILLY AND CO$Cha S.,Shin B.-S.,Shin J.-O.,Lee J.,Shin K.,Kim H.,Ko H.,Kim M.-B.,Kim B..Demographic characteristics of elderly Korean patients with plaque psoriasis, and effectiveness and safety of biological agents..European Journal of Dermatology 2024;34(2):211-212.DOI:10.1684/ejd.2024.4644$$$E$$Y$$$20240801$$HP$KR$KR
241625511$24162551$1$I$$20240728$20240801$20240801$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407019359$ELI LILLY AND CO$Baudriller A.,Abbara C.,Briet M.,Jousset N.,Malbranque S.,Zabet D.,Rossi L.-H.,Durfort C.,Ferec S.,Drevin G..Deaths related to pharmacobezoars: A report on two cases..Analytical + Clinical Toxicology 2024;:.DOI:10.1016/j.toxac.2024.07.001$63$YR$A$M$Y$$$20240801$$HP$FR$FR
241625521$24162552$1$I$20240729$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019887$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240801$$CN$US$US
241625531$24162553$1$I$$20240729$20240801$20240801$PER$$US-009507513-2407USA015476$MERCK$$$$$F$Y$$$20240801$$CN$US$US
241625541$24162554$1$I$20240615$20240729$20240801$20240801$EXP$$US-JNJFOC-20240776896$JOHNSON AND JOHNSON$$51$YR$$M$Y$$$20240801$$PH$US$US
241625561$24162556$1$I$$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151235$AMGEN$$$$$$Y$$$20240801$$HP$US$US
241625571$24162557$1$I$$20240725$20240801$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST004556$STEMLINE THERAPEUTICS$$51$YR$A$F$Y$$$20240731$$CN$US$US
241625581$24162558$1$I$20240509$20240516$20240801$20240801$PER$$US-BAYER-2024A091019$BAYER$$35$YR$A$F$Y$$$20240801$$MD$US$US
241625591$24162559$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156713$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
241625602$24162560$2$F$$20240819$20240801$20240823$EXP$$JP-GENMAB-2024-02693$GENMAB$$63$YR$$M$Y$$$20240823$$MD$JP$JP
241625611$24162561$1$I$20230925$20240729$20240801$20240801$EXP$$US-OTSUKA-2023_025272$OTSUKA$$$$$M$Y$$$20240801$$CN$US$US
241625621$24162562$1$I$$20240729$20240801$20240801$PER$$US-DSJP-DSU-2024-138158$DAIICHI$$41$YR$$F$Y$$$20240801$$CN$US$US
241625631$24162563$1$I$20230131$20240722$20240801$20240801$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001540$BLUEPRINT MEDICINES$$44$YR$A$F$Y$$$20240801$$MD$CN$CN
241625641$24162564$1$I$$20240725$20240801$20240801$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07310$HIKMA$Attieh RM, Brumble L, Elwasila SM, Wadei HM.. Attieh RM, Brumble L, Elwasila SM, Wadei HM. Disseminated Monkeypox Infection in a Kidney Transplant Recipient A Case Report.. Transplantation Proceedings. 2023;55(3):667-71$$$$$Y$$$20240801$$MD$US$US
241625653$24162565$3$F$$20240826$20240801$20240829$EXP$$US-TAKEDA-2024TUS077231$TAKEDA$$$$$F$Y$$$20240829$$CN$US$US
241625661$24162566$1$I$20200601$20240724$20240801$20240801$EXP$PL-URPL-1-1635-2020$PL-TEVA-VS-3225460$TEVA$$68$YR$$F$Y$78.8$KG$20240801$$MD$PL$PL
241625671$24162567$1$I$$20240724$20240801$20240801$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-001415$JAZZ$$$$$F$Y$$$20240801$$CN$US$US
241625681$24162568$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA222630$SANOFI AVENTIS$$$$$F$Y$$$20240801$$CN$US$US
241625691$24162569$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA223805$SANOFI AVENTIS$$$$$$Y$$$20240801$$HP$US$US
241625701$24162570$1$I$20240319$20240516$20240801$20240801$PER$$US-BAYER-2024A091057$BAYER$$44$YR$A$F$Y$$$20240801$$MD$US$US
241625711$24162571$1$I$$20240722$20240801$20240801$30DAY$$CL-PFIZER INC-202400222766$PFIZER$$$$$F$Y$$$20240801$$CN$CL$CL
241625722$24162572$2$F$$20240905$20240801$20240905$30DAY$$CO-PFIZER INC-PV202400098589$PFIZER$$9$YR$$M$Y$$$20240905$$CN$CO$CO
241625731$24162573$1$I$20240626$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52657$$FDA-CTU$$77$YR$$F$N$$$20240731$Y$HP$US$
241625741$24162574$1$I$$20240725$20240801$20240801$30DAY$$GB-PFIZER INC-PV202400097203$PFIZER$$12$YR$$F$Y$$$20240801$$CN$GB$GB
241625751$24162575$1$I$$20240729$20240801$20240801$EXP$$US-AMGEN-USASP2024150867$AMGEN$$$$$$Y$$$20240801$$MD$US$US
241625761$24162576$1$I$20240502$20240516$20240801$20240801$PER$$US-BAYER-2024A091073$BAYER$$46$YR$A$F$Y$$$20240801$$CN$US$US
241625781$24162578$1$I$$20240725$20240801$20240801$EXP$$GB-Stemline Therapeutics, Inc.-2024ST004548$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240731$$PH$GB$GB
241625791$24162579$1$I$$20240724$20240801$20240801$EXP$$GR-TEVA-VS-3225745$TEVA$$$$$F$Y$$$20240801$$MD$GR$GR
241625801$24162580$1$I$20240726$20240731$20240801$20240801$EXP$$CN-BAYER-2024A111081$BAYER$$30$YR$A$M$Y$72$KG$20240801$$HP$CN$CN
241625811$24162581$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52600$$FDA-CTU$$36$YR$$F$N$$$20240731$N$$US$
241625822$24162582$2$F$20040201$20240820$20240801$20240903$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07003$HIKMA$$37$YR$$F$Y$69.4$KG$20240903$$HP$US$US
241625831$24162583$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52605$$FDA-CTU$$57$YR$$F$N$63.5$KG$20240731$N$$US$
241625841$24162584$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52594$$FDA-CTU$$59$YR$$F$N$128.82$KG$20240731$N$$US$
241625851$24162585$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52613$$FDA-CTU$$66$YR$$F$N$$$20240731$N$HP$US$
241625861$24162586$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52608$$FDA-CTU$$54$YR$$F$N$$$20240731$N$$US$
241625901$24162590$1$I$20240726$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52676$$FDA-CTU$$60$YR$$F$N$$$20240731$N$$US$
241625911$24162591$1$I$$20240725$20240801$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST004547$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240731$$CN$US$US
241625921$24162592$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52637$$FDA-CTU$$79$YR$$F$N$$$20240731$N$$US$
241625931$24162593$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52672$$FDA-CTU$$70$YR$$M$N$$$20240731$N$$US$
241625941$24162594$1$I$20240701$20240725$20240801$20240801$EXP$$US-Eisai-EC-2024-171230$EISAI$$64$YR$A$F$Y$$$20240801$$CN$US$US
241625951$24162595$1$I$20240509$20240515$20240801$20240801$PER$$US-BAYER-2024A091141$BAYER$$$$$F$Y$$$20240801$$HP$US$US
241625961$24162596$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52611$$FDA-CTU$$77$YR$$F$N$$$20240731$N$$US$
241625971$24162597$1$I$20240101$20240719$20240801$20240801$EXP$GB-MHRA-EMIS-990-f33fa3d0-bf23-4cc3-813d-5b1ca8633412$GB-SHIELD THERAPEUTICS-GB-STX-24-00182$IRON THERAPEUTICS$$52$YR$$F$Y$89$KG$20240801$$MD$GB$GB
241625981$24162598$1$I$$20240725$20240801$20240801$EXP$$GB-MYLANLABS-2024M1070789$MYLAN$Tatarinova OS, Furness CL, Borman AM, Barber J, Muthialu N, Ferreras-Antolin L. Neosartorya udagawae pulmonary infection requiring a surgical treatment in a paediatric haematopoietic progenitor cell recipient. Med-Mycol-Case-Reports 2024; 44 1-4.$3$YR$$M$Y$$$20240801$$HP$GB$GB
241625992$24162599$2$F$20240701$20240911$20240801$20240925$PER$$US-MYLANLABS-2024M1066478$MYLAN$$95$YR$$F$Y$$$20240925$$CN$US$US
241626002$24162600$2$F$20240101$20240920$20240801$20240927$PER$$US-MYLANLABS-2024M1068677$MYLAN$$$$$M$Y$119.74$KG$20240927$$CN$US$US
241626011$24162601$1$I$$20240723$20240801$20240801$EXP$GB-MHRA-MED-202407232038068870-BFWGY$GB-TEVA-VS-3225239$TEVA$$40$YR$$F$Y$$$20240801$$CN$GB$GB
241626022$24162602$2$F$$20240831$20240801$20240903$30DAY$$US-PFIZER INC-202400225609$PFIZER$$15$YR$$F$Y$$$20240903$$CN$US$US
241626032$24162603$2$F$$20240901$20240801$20240903$30DAY$$US-PFIZER INC-202400223115$PFIZER$$6$YR$$F$Y$14.51$KG$20240903$$CN$US$US
241626051$24162605$1$I$20240724$20240725$20240801$20240801$30DAY$$US-PFIZER INC-PV202400047799$PFIZER$$53$YR$$F$Y$72.57$KG$20240801$$CN$US$US
241626063$24162606$3$F$$20240831$20240801$20240903$30DAY$$US-PFIZER INC-202400224021$PFIZER$$10$YR$$M$Y$25.896$KG$20240903$$CN$US$US
241626071$24162607$1$I$$20240725$20240801$20240801$EXP$$CA-EMD Serono-2024040800$EMD SERONO INC$$$$E$M$Y$$$20240801$$CN$CA$CA
241626081$24162608$1$I$$20240730$20240801$20240801$EXP$$AT-PFIZER INC-202400226652$PFIZER$Thonhofer, R.. Rheumatoid arthritis patients with therapy-induced myelodysplastic syndrome present with long-termremission after recovery. Scand J Rheumatol. 2007;36;2:149-151$76$YR$$F$Y$$$20240801$$HP$AT$AT
241626091$24162609$1$I$$20240730$20240801$20240801$EXP$$PT-PFIZER INC-202400226394$PFIZER$Mesquita, P. CO-0074-(2871) -UM DIAGNOSTICO RARO E UM EFEITO ADVERSO INESPERADO. 30 Congresso Nacional de Medicina Interna. 2024;174$55$YR$$F$Y$$$20240801$$MD$PT$PT
241626101$24162610$1$I$20240721$20240729$20240801$20240801$EXP$$CN-ROCHE-10000043031$ROCHE$$63$YR$A$M$Y$50$KG$20240801$$HP$CN$CN
241626111$24162611$1$I$$20240721$20240801$20240801$PER$$US-MYLANLABS-2024M1068618$MYLAN$$$$$F$Y$$$20240801$$CN$US$US
241626122$24162612$2$F$$20240826$20240801$20240829$PER$$US-LEO Pharma-372413$LEO PHARM$$31$YR$$M$Y$$$20240829$$PH$US$US
241626131$24162613$1$I$20240416$20240731$20240801$20240801$EXP$$CN-BAYER-2024A111114$BAYER$$26$YR$A$F$Y$43$KG$20240801$$HP$CN$CN
241626142$24162614$2$F$$20240809$20240801$20240823$EXP$$JP-ROCHE-10000033163$ROCHE$$38$YR$A$F$Y$$$20240823$$MD$JP$JP
241626152$24162615$2$F$20240719$20240823$20240801$20240902$EXP$$FI-TEVA-VS-3225101$TEVA$$77$YR$$F$Y$$$20240902$$CN$FI$FI
241626161$24162616$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024152297$AMGEN$$$$$$Y$$$20240801$$CN$US$US
241626171$24162617$1$I$20190725$20240724$20240801$20240801$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-07099$HIKMA$$25$YR$$M$Y$87.3$KG$20240801$$MD$US$US
241626181$24162618$1$I$20231101$20240729$20240801$20240801$EXP$$US-ABBVIE-5860196$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241626191$24162619$1$I$20240701$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121803$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240801$$CN$US$US
241626202$24162620$2$F$20240701$20240826$20240801$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121531$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$82.55$KG$20240829$$CN$US$US
241626211$24162621$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121818$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240801$$CN$US$US
241626222$24162622$2$F$20210301$20240918$20240801$20240927$EXP$$CA-TAKEDA-2024TUS042239$TAKEDA$$74$YR$$F$Y$$$20240927$$CN$CA$CA
241626231$24162623$1$I$20240608$20240724$20240801$20240801$EXP$FR-AFSSAPS-NY2024000839$FR-Waylis Therapeutics LLC-ATNAHS20240702138$Waylis$$37$YR$A$M$Y$70$KG$20240801$$MD$FR$FR
241626241$24162624$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA223439$SANOFI AVENTIS$$$$A$M$Y$79.365$KG$20240801$$MD$US$US
241626251$24162625$1$I$20240508$20240515$20240801$20240801$PER$$US-BAYER-2024A091270$BAYER$$44$YR$A$F$Y$$$20240801$$MD$US$US
241626262$24162626$2$F$$20240821$20240801$20240827$30DAY$$US-GSK-US2024AMR093257$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
241626271$24162627$1$I$20240710$20240726$20240801$20240801$EXP$$CN-SA-2024SA226322$SANOFI AVENTIS$$90$YR$E$M$Y$35$KG$20240801$$CN$CN$CN
241626281$24162628$1$I$$20240731$20240801$20240801$EXP$$AU-ABBVIE-5863177$ABBVIE$Arzivian A, Jones B, Joshua F, Paul M, Lynch T, Brown M, et al. Fever and increased gastrointestinal uptake on positron emission tomography after anti-tumour necrosis factor therapy: a case report of whipple^s disease. Case Rep Gastroenterol. 2024;18(1):221-30.$40$YR$$M$Y$$$20240801$$HP$AU$AU
241626291$24162629$1$I$$20240725$20240801$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST004540$STEMLINE THERAPEUTICS$$$$A$F$Y$$$20240731$$MD$US$US
241626301$24162630$1$I$$20240724$20240801$20240801$PER$$ES-Blueprint Medicines Corporation-SP-ES-2024-001511$BLUEPRINT MEDICINES$$$$$$Y$$$20240801$$MD$ES$ES
241626311$24162631$1$I$20230301$20240725$20240801$20240801$EXP$$US-SERVIER-S23002565$SERVIER$$$$$$Y$$$20240801$$CN$US$US
241626321$24162632$1$I$$20240723$20240801$20240801$EXP$$US-MYLANLABS-2024M1070311$MYLAN$Thomas R. New Onset Severe Asthma in a College Student?. Am-J-Respir-Crit-Care-Med 2024; 209 A5998.$18$YR$$F$Y$$$20240801$$HP$US$US
241626331$24162633$1$I$$20240729$20240801$20240801$EXP$GB-MHRA-MED-202407172145168960-ZSWDL$GB-MYLANLABS-2024M1070489$MYLAN$$25$YR$$F$Y$$$20240801$$CN$GB$GB
241626341$24162634$1$I$$20240730$20240801$20240801$PER$$US-GILEAD-2024-0682572$GILEAD$$$$E$M$Y$$$20240801$$HP$US$US
241626351$24162635$1$I$20240607$20240724$20240801$20240801$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS003863$TERSERA THERAPEUTICS$$$$$$Y$$$20240801$$MD$CN$CN
241626361$24162636$1$I$20240725$20240726$20240801$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST004583$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240731$$CN$US$US
241626372$24162637$2$F$20240528$20240813$20240801$20240821$PER$$US-BAYER-2024A090663$BAYER$$39$YR$A$F$Y$127.89$KG$20240821$$MD$US$US
241626381$24162638$1$I$$20240726$20240801$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST004582$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$$$20240731$$CN$US$US
241626391$24162639$1$I$$20240723$20240801$20240801$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003867$TERSERA THERAPEUTICS$$$$$$Y$$$20240801$$CN$AU$AU
241626411$24162641$1$I$20230101$20240730$20240801$20240801$EXP$$CA-UCBSA-2023005946$UCB$$19$YR$$F$Y$$$20240801$$CN$CA$CA
241626421$24162642$1$I$20240401$20240728$20240801$20240801$PER$$US-DSJP-DSU-2024-138175$DAIICHI$$$$$M$Y$$$20240801$$CN$US$US
241626431$24162643$1$I$$20240729$20240801$20240801$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138160$DAIICHI$$56$YR$$F$Y$$$20240801$$CN$US$US
241626442$24162644$2$F$$20240729$20240801$20240806$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138152$DAIICHI$$41$YR$$F$Y$$$20240806$$CN$US$US
241626451$24162645$1$I$$20240729$20240801$20240801$PER$$US-ROCHE-10000041718$ROCHE$$$$A$M$Y$$$20240801$$CN$US$US
241626462$24162646$2$F$20240701$20240731$20240801$20240805$PER$$US-ROCHE-10000041817$ROCHE$$$$C$F$Y$$$20240805$$CN$US$US
241626471$24162647$1$I$20240724$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52656$$FDA-CTU$$20$YR$$M$N$94$KG$20240731$Y$PH$US$
241626481$24162648$1$I$$20240729$20240731$20240731$DIR$FDA-CDER-CTU-2024-52595$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241626491$24162649$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52609$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241626501$24162650$1$I$20240730$20240731$20240801$20240801$PER$$US-ROCHE-10000046113$ROCHE$$30$YR$A$M$Y$$$20240801$$CN$US$US
241626511$24162651$1$I$20240701$20240726$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407018068$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240801$$CN$US$US
241626521$24162652$1$I$20240315$20240520$20240801$20240801$PER$$US-BAYER-2024A091185$BAYER$$50$YR$A$F$Y$$$20240801$$MD$US$US
241626531$24162653$1$I$$20240729$20240801$20240801$EXP$$US-INCYTE CORPORATION-2024IN007939$INCYTE$$$$$$Y$$$20240801$$CN$US$US
241626541$24162654$1$I$20240601$20240718$20240801$20240801$EXP$$US-UCBSA-2024036795$UCB$$73$YR$$M$Y$121.1$KG$20240801$$HP$US$US
241626551$24162655$1$I$20240609$20240724$20240801$20240801$PER$$US-AstraZeneca-2024A169395$ASTRAZENECA$$28307$DY$$M$Y$83.5$KG$20240801$$CN$US$
241626561$24162656$1$I$20240726$20240726$20240801$20240801$PER$$US-AMGEN-USASP2024152783$AMGEN$$56$YR$A$F$Y$$$20240801$$CN$US$US
241626571$24162657$1$I$$20240726$20240801$20240801$PER$$US-ROCHE-10000040605$ROCHE$$$$$F$Y$$$20240801$$HP$US$US
241626581$24162658$1$I$20240415$20240520$20240801$20240801$PER$$US-BAYER-2024A091210$BAYER$$21$YR$A$F$Y$$$20240801$$MD$US$US
241626591$24162659$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225843$TEVA$$72$YR$$F$Y$$$20240801$$HP$CA$CA
241626601$24162660$1$I$$20240730$20240801$20240801$EXP$$NVSC2024US156572$NOVARTIS$$$$$M$Y$$$20240801$$MD$US$US
241626611$24162661$1$I$$20240729$20240801$20240801$PER$$NVSC2024US156586$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
241626621$24162662$1$I$20240701$20240725$20240801$20240801$PER$$US-ALXN-202407USA001906US$ALEXION PHARMACEUTICALS$$62$YR$$M$Y$$$20240801$$CN$US$US
241626631$24162663$1$I$20240730$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121997$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240801$$CN$US$US
241626641$24162664$1$I$$20240723$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117182$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240801$$HP$US$US
241626651$24162665$1$I$$20240724$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119584$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240801$$CN$US$US
241626661$24162666$1$I$20190227$20240722$20240801$20240801$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117018$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$51$KG$20240801$$MD$KR$KR
241626671$24162667$1$I$20240627$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52655$$FDA-CTU$$64$YR$$F$N$$$20240731$Y$PH$US$
241626681$24162668$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52603$$FDA-CTU$$62$YR$$F$N$61.69$KG$20240731$N$$US$
241626691$24162669$1$I$20240101$20240729$20240801$20240801$EXP$$US-ABBVIE-5861264$ABBVIE$$$$$M$Y$$$20240801$$HP$US$US
241626701$24162670$1$I$20230920$20240724$20240801$20240801$EXP$$US-JNJFOC-20240775921$JOHNSON AND JOHNSON$$0$YR$$F$Y$5.4$KG$20240801$$HP$US$US
241626711$24162671$1$I$$20240725$20240801$20240801$EXP$$US-GSK-US2024AMR094501$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
241626721$24162672$1$I$$20240726$20240801$20240801$EXP$$CA-APOTEX-2024AP008905$APOTEX$$84$YR$$F$Y$29.025$KG$20240801$$HP$CA$CA
241626731$24162673$1$I$20240517$20240520$20240801$20240801$PER$$US-BAYER-2024A090996$BAYER$$41$YR$A$F$Y$$$20240801$$MD$US$US
241626742$24162674$2$F$20240725$20240731$20240801$20240807$EXP$$CN-BAYER-2024A111311$BAYER$$69$YR$E$M$Y$56$KG$20240807$$HP$CN$CN
241626751$24162675$1$I$$20240729$20240801$20240801$PER$$US-ABBVIE-5860040$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241626761$24162676$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA222751$SANOFI AVENTIS$$$$T$M$Y$95.254$KG$20240801$$MD$US$US
241626772$24162677$2$F$20240722$20240729$20240801$20240805$PER$$US-SA-2024SA224005$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240805$$MD$US$US
241626781$24162678$1$I$20240318$20240725$20240801$20240801$EXP$FR-AFSSAPS-PP2024000820$FR-AMGEN-FRASP2024151171$AMGEN$$56$YR$A$F$Y$45.5$KG$20240801$$MD$FR$FR
241626792$24162679$2$F$20240723$20240808$20240801$20240810$PER$$US-AMGEN-USASP2024149853$AMGEN$$74$YR$E$F$Y$$$20240810$$HP$US$US
241626801$24162680$1$I$20240610$20240724$20240801$20240801$EXP$FR-AFSSAPS-RS2024000695$FR-TEVA-VS-3225713$TEVA$$81$YR$$F$Y$70$KG$20240801$$MD$FR$FR
241626811$24162681$1$I$$20240726$20240801$20240801$EXP$$AU-RDY-SPO/AUS/24/0011143$DR REDDYS$$86$YR$E$M$Y$$$20240801$$CN$AU$AU
241626821$24162682$1$I$20230101$20240723$20240801$20240801$EXP$$NVSC2024BR154134$NOVARTIS$$$$$M$Y$98$KG$20240801$$CN$BR$BR
241626831$24162683$1$I$20240101$20240717$20240801$20240801$EXP$$US-EAGLE PHARMACEUTICALS, INC.-US-2024EAG000179$EAGLE$$$$$M$Y$$$20240801$$HP$US$US
241626841$24162684$1$I$20231001$20240729$20240801$20240801$EXP$$CA-JNJFOC-20240779796$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240801$$HP$CA$CA
241626851$24162685$1$I$$20240731$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043153$BOEHRINGER INGELHEIM$$$$$$Y$$$20240801$$CN$US$US
241626861$24162686$1$I$20240621$20240724$20240801$20240801$EXP$FR-AFSSAPS-GR2024000890$FR-TEVA-VS-3225639$TEVA$$19$YR$$M$Y$84$KG$20240801$$PH$FR$FR
241626871$24162687$1$I$$20240718$20240801$20240801$EXP$$US-UCBSA-2024037031$UCB$$$$$$Y$$$20240801$$MD$US$US
241626881$24162688$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52652$$FDA-CTU$$78$YR$$F$N$115.21$KG$20240731$N$$US$
241626891$24162689$1$I$20240508$20240510$20240801$20240801$PER$$US-BAYER-2024A090940$BAYER$$43$YR$A$F$Y$$$20240801$$MD$US$US
241626901$24162690$1$I$20240731$20240801$20240801$20240801$DIR$712337$$FDA-CTU$$52$YR$$F$N$67.5$KG$20240801$N$CN$US$
241626911$24162691$1$I$20240619$20240724$20240801$20240801$EXP$IT-MINISAL02-995250$IT-TEVA-VS-3225562$TEVA$$61$YR$$F$Y$$$20240801$$PH$IT$IT
241626921$24162692$1$I$$20240726$20240731$20240731$DIR$FDA-CDER-CTU-2024-52604$$FDA-CTU$$$$$F$N$$$20240726$N$HP$US$
241626931$24162693$1$I$20240727$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52649$$FDA-CTU$$31$YR$$F$N$$$20240730$N$HP$US$
241626951$24162695$1$I$20210517$20240727$20240801$20240801$EXP$$CA-TAKEDA-2021TUS039200$TAKEDA$$32$YR$$F$Y$$$20240801$$CN$CA$CA
241626961$24162696$1$I$20240404$20240508$20240801$20240801$PER$$US-BAYER-2024A091017$BAYER$$29$YR$A$F$Y$$$20240801$$CN$US$US
241626971$24162697$1$I$$20240729$20240801$20240801$PER$$NVSC2024US155962$NOVARTIS$$$$$F$Y$$$20240801$$MD$US$US
241626981$24162698$1$I$$20240730$20240801$20240801$PER$$US-HALEON-2189992$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241626991$24162699$1$I$20240719$20240725$20240801$20240801$EXP$$CN-ROCHE-10000038130$ROCHE$$63$YR$A$F$Y$76$KG$20240801$$HP$CN$CN
241627002$24162700$2$F$20240717$20240829$20240801$20240830$PER$$US-JNJFOC-20240781781$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240830$$PH$US$US
241627011$24162701$1$I$20200101$20240725$20240801$20240801$EXP$$US-ABBVIE-5854387$ABBVIE$$55$YR$$F$Y$61$KG$20240801$$CN$US$US
241627022$24162702$2$F$$20240806$20240801$20240816$EXP$$IN-TEVA-VS-3219496$TEVA$Arora K, Singh AS, Bedi R, Dang K, Kaur A. Navigating the Uncharted: A Rare Case of Ocular Flutter and Intermittent Jaw Movements in a Case of Chronic Lymphoid Leukemia. Ann-Indian-Acad-Neurol 2024; 27 (3): 313-315.; Arora K, Singh AS, Bedi R, Dang K, Kaur A. Navigating the Uncharted: A Rare Case of Ocular Flutter and Intermittent Jaw Movements in a Case of Chronic Lymphoid Leukemia. Ann-Indian-Acad-Neurol 2024; 27 (3): 313-315.; Arora K, Singh AS, Bedi R, Dang K, Kaur A. Navigating the uncha...$63$YR$$F$Y$$$20240816$$MD$IN$IN
241627031$24162703$1$I$20240719$20240731$20240801$20240801$EXP$$CN-GILEAD-2024-0682444$GILEAD$$48$YR$A$F$Y$84$KG$20240801$$HP$CN$CN
241627041$24162704$1$I$20240512$20240513$20240801$20240801$PER$$US-BAYER-2024A090908$BAYER$$34$YR$A$F$Y$$$20240801$$HP$US$US
241627051$24162705$1$I$20240401$20240725$20240801$20240801$PER$$US-SA-2024SA223445$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240801$$MD$US$US
241627061$24162706$1$I$$20240726$20240801$20240801$EXP$$CA-APOTEX-2024AP008911$APOTEX$$$$$F$Y$1$KG$20240801$$HP$CA$CA
241627071$24162707$1$I$$20240724$20240801$20240801$PER$$US-ALXN-202407USA001703US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
241627081$24162708$1$I$20240724$20240725$20240801$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST004554$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240731$$CN$US$US
241627091$24162709$1$I$20240507$20240513$20240801$20240801$PER$$US-BAYER-2024A090916$BAYER$$38$YR$A$F$Y$$$20240801$$HP$US$US
241627101$24162710$1$I$$20240723$20240801$20240801$EXP$$CA-APOTEX-2024AP008751$APOTEX$$61$YR$$M$Y$$$20240801$$CN$CA$CA
241627111$24162711$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA224187$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240801$$CN$US$US
241627122$24162712$2$F$$20240726$20240801$20240820$PER$$US-SA-2024SA223017$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240820$$CN$US$US
241627131$24162713$1$I$20240101$20240725$20240801$20240801$PER$$US-SA-2024SA223547$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240801$$MD$US$US
241627141$24162714$1$I$20230701$20240723$20240801$20240801$PER$$US-SA-2024SA222411$SANOFI AVENTIS$$5$YR$C$F$Y$19.955$KG$20240801$$MD$US$US
241627152$24162715$2$F$$20240822$20240801$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121811$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$92.1$KG$20240830$$CN$US$US
241627161$24162716$1$I$$20240725$20240801$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST004542$STEMLINE THERAPEUTICS$$64$YR$A$F$Y$$$20240731$$HP$US$US
241627171$24162717$1$I$$20240801$20240801$20240801$DIR$712351$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241627181$24162718$1$I$20240728$20240729$20240731$20240731$DIR$FDA-CDER-CTU-2024-52671$$FDA-CTU$$6$YR$$F$N$$$20240729$N$HP$US$
241627191$24162719$1$I$$20240801$20240801$20240801$DIR$712352$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241627201$24162720$1$I$20240731$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52658$$FDA-CTU$$70$YR$$F$N$$$20240731$Y$HP$US$
241627211$24162721$1$I$$20240801$20240801$20240801$DIR$712353$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241627221$24162722$1$I$20240729$20240801$20240801$20240801$DIR$712347$$FDA-CTU$$68$YR$$F$N$85.5$KG$20240801$N$CN$US$
241627231$24162723$1$I$20240530$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52654$$FDA-CTU$$77$YR$$M$N$$$20240731$Y$HP$US$
241627241$24162724$1$I$20240729$20240801$20240801$20240801$DIR$712346$$FDA-CTU$$56$YR$$M$N$83.25$KG$20240801$N$CN$US$
241627251$24162725$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52638$$FDA-CTU$$37$YR$$M$N$$$20240731$N$$US$
241627261$24162726$1$I$20240703$20240725$20240801$20240801$EXP$$EC-VANTIVE-2024VAN018179$Vantive US Healthcare$$94$YR$$M$Y$60.2$KG$20240801$$HP$EC$EC
241627271$24162727$1$I$20240415$20240724$20240801$20240801$EXP$FR-AFSSAPS-AN2024000807$FR-TEVA-VS-3226443$TEVA$$76$YR$$M$Y$$$20240801$$PH$FR$FR
241627281$24162728$1$I$$20240725$20240801$20240801$PER$$US-JNJFOC-20240769658$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$HP$US$US
241627291$24162729$1$I$20240301$20240724$20240801$20240801$EXP$$CA-BEH-2024170573$CSL BEHRING$$55$YR$A$M$Y$72$KG$20240801$$HP$CA$CA
241627301$24162730$1$I$20240513$20240513$20240801$20240801$PER$$US-BAYER-2024A091277$BAYER$$36$YR$A$F$Y$$$20240801$$MD$US$US
241627311$24162731$1$I$20240701$20240717$20240801$20240801$PER$$US-EPICPHARMA-US-2024EPCSPO00902$EPIC PHARM$$44$YR$A$F$Y$200$KG$20240801$$CN$US$US
241627322$24162732$2$F$20240720$20240828$20240801$20240829$PER$$US-AMGEN-USASP2024151817$AMGEN$$76$YR$E$F$Y$$$20240829$$CN$US$US
241627331$24162733$1$I$$20240726$20240801$20240801$EXP$GB-MHRA-MED-202407261046426710-STWQJ$GB-TORRENT-00037389$TORRENT$$$$$F$Y$$$20240801$$HP$GB$GB
241627342$24162734$2$F$20240708$20240802$20240801$20240806$EXP$DE-AMK-278251$DE-TORRENT-00027087$TORRENT$$39$YR$A$M$Y$80$KG$20240806$$PH$DE$DE
241627351$24162735$1$I$$20240726$20240801$20240801$EXP$GB-MHRA-MED-202407260940522970-MBTYF$GB-TORRENT-00037393$TORRENT$$$$$F$Y$$$20240801$$HP$GB$GB
241627361$24162736$1$I$20240724$20240725$20240801$20240801$EXP$GB-MHRA-TPP51263210C8263963YC1721839010950$GB-TORRENT-00037385$TORRENT$$10$YR$C$M$Y$50$KG$20240801$$HP$GB$GB
241627371$24162737$1$I$$20240726$20240801$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST003909$STEMLINE THERAPEUTICS$$73$YR$E$F$Y$$$20240731$$CN$US$US
241627381$24162738$1$I$$20240513$20240801$20240801$PER$$US-BAYER-2024A091295$BAYER$$19$YR$A$F$Y$$$20240801$$MD$US$US
241627391$24162739$1$I$$20240725$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118772$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240801$$HP$US$US
241627401$24162740$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020003$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240801$$CN$US$US
241627411$24162741$1$I$$20240722$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407014515$ELI LILLY AND CO$$60$YR$A$$Y$$$20240801$$CN$US$US
241627422$24162742$2$F$$20240731$20240801$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120977$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$89.3$KG$20240806$$PH$US$US
241627432$24162743$2$F$$20240730$20240801$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120329$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$67$KG$20240805$$HP$US$US
241627441$24162744$1$I$20240728$20240730$20240801$20240801$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-121184$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240801$$CN$TW$TW
241627452$24162745$2$F$$20240926$20240801$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121110$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240928$$CN$US$US
241627461$24162746$1$I$$20240724$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118372$BRISTOL MYERS SQUIBB$$33$YR$A$M$Y$$$20240801$$HP$US$US
241627471$24162747$1$I$$20240724$20240801$20240801$PER$$US-BAYER-2024A108199$BAYER$$9$YR$C$F$Y$$$20240801$$CN$US$US
241627481$24162748$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024152164$AMGEN$$$$$$Y$$$20240801$$HP$US$US
241627493$24162749$3$F$$20240829$20240801$20240904$PER$$US-JNJFOC-20240781509$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
241627503$24162750$3$F$20230910$20240823$20240801$20240827$EXP$FR-AFSSAPS-BS2024000467$FR-JNJFOC-20240800604$JOHNSON AND JOHNSON$$61$YR$A$F$Y$80$KG$20240827$$MD$FR$FR
241627511$24162751$1$I$20240722$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121562$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$108$KG$20240801$$PH$US$US
241627521$24162752$1$I$20240509$20240514$20240801$20240801$PER$$US-BAYER-2024A091119$BAYER$$42$YR$A$F$Y$$$20240801$$CN$US$US
241627532$24162753$2$F$$20240821$20240801$20240821$PER$$US-ALXN-202407USA001851US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$MD$US$US
241627541$24162754$1$I$$20240730$20240801$20240801$PER$$US-PHARMING-PHAUS2024000647$PHARMING GROUP$$$$$$Y$$$20240801$$CN$US$US
241627551$24162755$1$I$$20240724$20240801$20240801$EXP$$GR-TEVA-VS-3225742$TEVA$$$$$F$Y$$$20240801$$MD$GR$GR
241627562$24162756$2$F$20230401$20240903$20240801$20240911$EXP$$GR-TEVA-VS-3226367$TEVA$$49$YR$$F$Y$$$20240911$$MD$GR$GR
241627571$24162757$1$I$20221026$20240731$20240801$20240801$EXP$$NVSC2023RU020822$NOVARTIS$$66$YR$$F$Y$85$KG$20240801$$MD$RU$RU
241627581$24162758$1$I$$20240721$20240801$20240801$EXP$$CH-TAKEDA-2024TUS076520$TAKEDA$$61$YR$$M$Y$$$20240801$$HP$CH$CH
241627591$24162759$1$I$20240101$20240730$20240801$20240801$EXP$$US-UCBSA-2024027681$UCB$$$$$M$Y$$$20240801$$HP$US$US
241627601$24162760$1$I$20240119$20240212$20240801$20240801$PER$$US-BAYER-2024A091399$BAYER$$18$YR$A$F$Y$$$20240801$$MD$US$US
241627621$24162762$1$I$$20240725$20240801$20240801$PER$$US-BAYER-2024A108599$BAYER$$74$YR$E$F$Y$$$20240801$$MD$US$US
241627631$24162763$1$I$20240515$20240516$20240801$20240801$PER$$US-BAYER-2024A090963$BAYER$$71$YR$E$F$Y$$$20240801$$MD$US$US
241627642$24162764$2$F$20240705$20240821$20240801$20240911$PER$$US-TOLMAR, INC.-24US050856$TOLMAR$$79$YR$$M$Y$$$20240911$$HP$US$US
241627652$24162765$2$F$20240708$20240821$20240801$20240911$PER$$US-TOLMAR, INC.-24US050899$TOLMAR$$$$$$Y$$$20240911$$HP$US$US
241627662$24162766$2$F$20240710$20240823$20240801$20240911$PER$$US-TOLMAR, INC.-24US050913$TOLMAR$$65$YR$$M$Y$$$20240911$$HP$US$US
241627671$24162767$1$I$$20240710$20240801$20240801$PER$$US-TOLMAR, INC.-24US050936$TOLMAR$$$$$F$Y$$$20240801$$MD$US$US
241627681$24162768$1$I$20231001$20240711$20240801$20240801$PER$$US-TOLMAR, INC.-24US050943$TOLMAR$$18$YR$$M$Y$$$20240801$$HP$US$US
241627692$24162769$2$F$20240710$20240823$20240801$20240910$PER$$US-TOLMAR, INC.-24US050939$TOLMAR$$71$YR$$M$Y$$$20240909$$HP$US$US
241627702$24162770$2$F$20240708$20240820$20240801$20240910$PER$$US-TOLMAR, INC.-24US050945$TOLMAR$$75$YR$$M$Y$$$20240909$$HP$US$US
241627711$24162771$1$I$20240618$20240711$20240801$20240801$PER$$US-TOLMAR, INC.-24US050942$TOLMAR$$78$YR$$M$Y$$$20240801$$HP$US$US
241627721$24162772$1$I$20210101$20240726$20240801$20240801$EXP$$CA-ROCHE-10000041255$ROCHE$$15$YR$T$M$Y$$$20240801$$HP$CA$CA
241627731$24162773$1$I$20240708$20240712$20240801$20240801$PER$$US-TOLMAR, INC.-24US050984$TOLMAR$$71$YR$$M$Y$$$20240801$$HP$US$US
241627741$24162774$1$I$20240711$20240711$20240801$20240801$PER$$US-TOLMAR, INC.-24US050971$TOLMAR$$39$YR$$F$Y$$$20240801$$PH$US$US
241627751$24162775$1$I$$20240712$20240801$20240801$PER$$US-TOLMAR, INC.-24US051001$TOLMAR$$$$$M$Y$$$20240801$$CN$US$US
241627761$24162776$1$I$20240712$20240712$20240801$20240801$PER$$US-TOLMAR, INC.-24US051006$TOLMAR$$88$YR$$M$Y$$$20240801$$HP$US$US
241627771$24162777$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A168834$ASTRAZENECA$$$$$M$Y$$$20240801$$HP$US$
241627781$24162778$1$I$$20240724$20240801$20240801$EXP$$ZA-AstraZeneca-2024A168865$ASTRAZENECA$$77$YR$$M$Y$$$20240801$$CN$ZA$
241627791$24162779$1$I$20240516$20240517$20240801$20240801$PER$$US-BAYER-2024A090999$BAYER$$$$$F$Y$$$20240801$$MD$US$US
241627802$24162780$2$F$20240722$20240812$20240801$20240815$PER$$US-PFIZER INC-202400227136$PFIZER$$91$YR$$F$Y$$$20240815$$CN$US$US
241627811$24162781$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121137$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240801$$CN$US$US
241627821$24162782$1$I$$20240726$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122004$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240801$$CN$US$US
241627831$24162783$1$I$20240725$20240729$20240801$20240801$PER$$US-PFIZER INC-202400226231$PFIZER$$50$YR$$F$Y$$$20240801$$CN$US$US
241627841$24162784$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-PV202400040186$PFIZER$$76$YR$$F$Y$$$20240801$$CN$US$US
241627853$24162785$3$F$20240701$20240730$20240801$20240809$EXP$$US-PFIZER INC-202400226894$PFIZER$$79$YR$$F$Y$$$20240809$$HP$US$US
241627862$24162786$2$F$$20240926$20240801$20240930$PER$$US-PFIZER INC-PV202400058354$PFIZER$$74$YR$$F$Y$$$20240930$$MD$US$US
241627871$24162787$1$I$20240727$20240727$20240801$20240801$PER$$US-PFIZER INC-202400225147$PFIZER$$84$YR$$F$Y$$$20240801$$CN$US$US
241627881$24162788$1$I$$20240728$20240801$20240801$PER$$US-PFIZER INC-202400224934$PFIZER$$47$YR$$F$Y$79.83$KG$20240801$$CN$US$US
241627891$24162789$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-202400227681$PFIZER$$6$DEC$$M$Y$$$20240801$$HP$US$US
241627901$24162790$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-PV202400099102$PFIZER$$48$YR$$F$Y$$$20240801$$CN$US$US
241627911$24162791$1$I$$20240730$20240801$20240801$PER$$US-PFIZER INC-PV202400011873$PFIZER$$53$YR$$F$Y$$$20240801$$HP$US$US
241627931$24162793$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-202400178602$PFIZER$$43$YR$$F$Y$$$20240801$$CN$US$US
241627941$24162794$1$I$20240729$20240729$20240801$20240801$PER$$US-PFIZER INC-202400226309$PFIZER$$61$YR$$F$Y$72.48$KG$20240801$$HP$US$US
241627951$24162795$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-202400226251$PFIZER$$59$YR$$F$Y$$$20240801$$PH$US$US
241627971$24162797$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-PV202400098981$PFIZER$$41$YR$$F$Y$$$20240801$$HP$US$US
241627981$24162798$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-202400226444$PFIZER$$66$YR$$F$Y$$$20240801$$PH$US$US
241627992$24162799$2$F$$20240807$20240801$20240812$PER$$US-PFIZER INC-PV202400098577$PFIZER$$$$$$Y$$$20240812$$CN$US$US
241628001$24162800$1$I$20240701$20240729$20240801$20240801$PER$$US-PFIZER INC-202400225922$PFIZER$$54$YR$$M$Y$83.91$KG$20240801$$CN$US$US
241628011$24162801$1$I$$20240730$20240801$20240801$PER$$US-PFIZER INC-202400227216$PFIZER$$54$YR$$F$Y$$$20240801$$CN$US$US
241628022$24162802$2$F$$20240822$20240801$20240828$PER$$US-PFIZER INC-PV202400099650$PFIZER$$69$YR$$F$Y$$$20240828$$HP$US$US
241628031$24162803$1$I$$20240730$20240801$20240801$PER$$US-PFIZER INC-202400227035$PFIZER$$21$YR$$F$Y$$$20240801$$MD$US$US
241628041$24162804$1$I$20240101$20240730$20240801$20240801$PER$$US-PFIZER INC-PV202400100013$PFIZER$$49$YR$$F$Y$$$20240801$$HP$US$US
241628052$24162805$2$F$20240718$20240802$20240801$20240806$PER$$US-PFIZER INC-PV202400094257$PFIZER$$53$YR$$F$Y$$$20240806$$MD$US$US
241628061$24162806$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-PV202400098870$PFIZER$$76$YR$$F$Y$$$20240801$$CN$US$US
241628072$24162807$2$F$$20240924$20240801$20240926$PER$$US-PFIZER INC-PV202400099697$PFIZER$$54$YR$$F$Y$$$20240926$$HP$US$US
241628081$24162808$1$I$$20240726$20240801$20240801$PER$$US-PFIZER INC-202400224996$PFIZER$$$$$$Y$$$20240801$$CN$US$US
241628092$24162809$2$F$$20240917$20240801$20240919$PER$$US-PFIZER INC-PV202400099039$PFIZER$$43$YR$$F$Y$$$20240919$$HP$US$US
241628101$24162810$1$I$20240730$20240730$20240801$20240801$PER$$US-PFIZER INC-202400227235$PFIZER$$55$YR$$M$Y$$$20240801$$MD$US$US
241628111$24162811$1$I$$20240726$20240801$20240801$PER$$US-PFIZER INC-202400224775$PFIZER$$$$A$$Y$$$20240801$$MD$US$US
241628121$24162812$1$I$$20240730$20240801$20240801$PER$$US-PFIZER INC-PV202400099768$PFIZER$$58$YR$$F$Y$$$20240801$$HP$US$US
241628131$24162813$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-202400227140$PFIZER$$47$YR$$F$Y$$$20240801$$CN$US$US
241628141$24162814$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-PV202400084599$PFIZER$$71$YR$$F$Y$$$20240801$$CN$US$US
241628151$24162815$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-PV202400072268$PFIZER$$$$$$Y$$$20240801$$CN$US$US
241628162$24162816$2$F$20240730$20240730$20240801$20240802$PER$$US-PFIZER INC-202400227282$PFIZER$$$$$F$Y$$$20240802$$HP$US$US
241628171$24162817$1$I$$20240727$20240801$20240801$PER$$US-PFIZER INC-PV202400098247$PFIZER$$68$YR$$$Y$$$20240801$$CN$US$US
241628182$24162818$2$F$20240719$20240807$20240801$20240808$PER$$US-PFIZER INC-PV202400098868$PFIZER$$$$$$Y$$$20240808$$HP$US$US
241628193$24162819$3$F$20240701$20240903$20240801$20240905$PER$$US-PFIZER INC-202400226955$PFIZER$$55$YR$$F$Y$$$20240905$$HP$US$US
241628201$24162820$1$I$20240722$20240729$20240801$20240801$PER$$US-PFIZER INC-202400226134$PFIZER$$76$YR$$F$Y$$$20240801$$CN$US$US
241628211$24162821$1$I$$20240726$20240801$20240801$PER$$US-PFIZER INC-PV202400097926$PFIZER$$71$YR$$F$Y$$$20240801$$HP$US$US
241628222$24162822$2$F$$20240730$20240801$20240802$PER$$US-PFIZER INC-202400227534$PFIZER$$72$YR$$F$Y$$$20240802$$MD$US$US
241628231$24162823$1$I$$20240730$20240801$20240801$PER$$US-PFIZER INC-202400226726$PFIZER$$83$YR$$F$Y$$$20240801$$CN$US$US
241628251$24162825$1$I$20240718$20240730$20240801$20240801$PER$$US-PFIZER INC-202400227009$PFIZER$$64$YR$$F$Y$$$20240801$$CN$US$US
241628261$24162826$1$I$20240729$20240729$20240801$20240801$PER$$US-PFIZER INC-202400225992$PFIZER$$40$YR$$M$Y$$$20240801$$CN$US$US
241628271$24162827$1$I$20240730$20240731$20240801$20240801$PER$$US-PFIZER INC-202400227707$PFIZER$$62$YR$$M$Y$$$20240801$$CN$US$US
241628281$24162828$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-PV202400100389$PFIZER$$67$YR$$F$Y$$$20240801$$CN$US$US
241628295$24162829$5$F$20240101$20240906$20240801$20240910$PER$$US-PFIZER INC-PV202400099685$PFIZER$$56$YR$$F$Y$$$20240910$$HP$US$US
241628302$24162830$2$F$$20240924$20240801$20240926$PER$$US-PFIZER INC-2021725372$PFIZER$$72$YR$$F$Y$$$20240926$$HP$US$US
241628311$24162831$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-PV202400100212$PFIZER$$46$YR$$F$Y$$$20240801$$HP$US$US
241628321$24162832$1$I$20240101$20240729$20240801$20240801$PER$$US-PFIZER INC-PV202400099909$PFIZER$$80$YR$$F$Y$56$KG$20240801$$CN$US$US
241628331$24162833$1$I$20240729$20240729$20240801$20240801$PER$$US-PFIZER INC-202400225994$PFIZER$$$$E$F$Y$$$20240801$$CN$US$US
241628342$24162834$2$F$$20240730$20240801$20240802$EXP$$US-PFIZER INC-PV202400099935$PFIZER$$69$YR$$F$Y$$$20240802$$CN$US$US
241628351$24162835$1$I$20240101$20240730$20240801$20240801$PER$$US-PFIZER INC-PV202300164166$PFIZER$$60$YR$$F$Y$$$20240801$$HP$US$US
241628361$24162836$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-202400226975$PFIZER$$36$YR$$F$Y$$$20240801$$HP$US$US
241628372$24162837$2$F$20240728$20240828$20240801$20240904$PER$$US-PFIZER INC-202400226310$PFIZER$$56$YR$$F$Y$52.608$KG$20240904$$MD$US$US
241628381$24162838$1$I$20240101$20240729$20240801$20240801$PER$$US-PFIZER INC-202400173265$PFIZER$$64$YR$$F$Y$74.84$KG$20240801$$CN$US$US
241628391$24162839$1$I$20240701$20240729$20240801$20240801$PER$$US-PFIZER INC-PV202400099610$PFIZER$$41$YR$$F$Y$$$20240801$$CN$US$US
241628401$24162840$1$I$$20240725$20240801$20240801$PER$$US-PFIZER INC-202400224983$PFIZER$$88$YR$$F$Y$$$20240801$$HP$US$US
241628411$24162841$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-202400227586$PFIZER$$$$$F$Y$$$20240801$$CN$US$US
241628421$24162842$1$I$20240729$20240729$20240801$20240801$PER$$US-PFIZER INC-202400226313$PFIZER$$44$YR$$F$Y$55.88$KG$20240801$$HP$US$US
241628441$24162844$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-PV202400098899$PFIZER$$$$$$Y$$$20240801$$CN$US$US
241628451$24162845$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-202400227689$PFIZER$$19$YR$$F$Y$$$20240801$$CN$US$US
241628461$24162846$1$I$$20240726$20240801$20240801$PER$$US-PFIZER INC-PV202400098173$PFIZER$$90$YR$$F$Y$$$20240801$$HP$US$US
241628471$24162847$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-PV202400064853$PFIZER$$26$YR$$F$Y$$$20240801$$HP$US$US
241628482$24162848$2$F$20240720$20240802$20240801$20240806$PER$$US-PFIZER INC-PV202400099327$PFIZER$$$$$$Y$$$20240806$$HP$US$US
241628491$24162849$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-PV202400100316$PFIZER$$59$YR$$F$Y$$$20240801$$HP$US$US
241628501$24162850$1$I$20240731$20240801$20240801$20240801$DIR$712343$$FDA-CTU$$25$YR$$UNK$N$64.35$KG$20240801$N$CN$US$
241628511$24162851$1$I$20240713$20240801$20240801$20240801$DIR$712339$$FDA-CTU$$86$YR$$M$N$101.25$KG$20240801$N$CN$US$
241628521$24162852$1$I$20240710$20240727$20240801$20240801$PER$$US-PFIZER INC-202400225484$PFIZER$$60$YR$$M$Y$$$20240801$$CN$US$US
241628531$24162853$1$I$20240601$20240729$20240801$20240801$PER$$US-PFIZER INC-PV202400099657$PFIZER$$27$YR$$F$Y$$$20240801$$CN$US$US
241628541$24162854$1$I$20240729$20240729$20240801$20240801$PER$$US-PFIZER INC-202400226287$PFIZER$$76$YR$$F$Y$$$20240801$$CN$US$US
241628552$24162855$2$F$$20240807$20240801$20240812$EXP$$JP-OTSUKA-2024_020860$OTSUKA$$5$DEC$$F$Y$$$20240812$$MD$JP$JP
241628561$24162856$1$I$$20240729$20240801$20240801$PER$$US-BAYER-2024A111143$BAYER$$$$$F$Y$$$20240801$$CN$US$US
241628571$24162857$1$I$20240727$20240729$20240801$20240801$PER$$US-PFIZER INC-202400225706$PFIZER$$68$YR$$F$Y$$$20240801$$HP$US$US
241628581$24162858$1$I$$20240729$20240731$20240731$DIR$FDA-CDER-CTU-2024-52612$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241628591$24162859$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA223939$SANOFI AVENTIS$$$$A$F$Y$66$KG$20240801$$MD$US$US
241628601$24162860$1$I$20230101$20240724$20240801$20240801$PER$$US-SA-2024SA223634$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240801$$MD$US$US
241628612$24162861$2$F$20240503$20240826$20240801$20240919$PER$$US-SA-2024SA222087$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240919$$MD$US$US
241628621$24162862$1$I$20220130$20240801$20240801$20240801$DIR$712341$$FDA-CTU$$37$YR$$M$N$67.5$KG$20240801$N$CN$US$
241628631$24162863$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA224749$SANOFI AVENTIS$$$$$F$Y$63$KG$20240801$$MD$US$US
241628641$24162864$1$I$20240101$20240724$20240801$20240801$PER$$US-SA-2024SA223633$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240801$$MD$US$US
241628651$24162865$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA223657$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240801$$MD$US$US
241628661$24162866$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA223650$SANOFI AVENTIS$$$$A$F$Y$61.23$KG$20240801$$MD$US$US
241628671$24162867$1$I$20231101$20240723$20240801$20240801$PER$$US-SA-2024SA221015$SANOFI AVENTIS$$48$YR$A$F$Y$83.9$KG$20240801$$MD$US$US
241628681$24162868$1$I$20200101$20240718$20240801$20240801$PER$$US-SA-2024SA216572$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240801$$MD$US$US
241628692$24162869$2$F$20240101$20240821$20240801$20240902$EXP$$US-SA-2024SA224466$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240902$$MD$US$US
241628701$24162870$1$I$$20240731$20240801$20240801$PER$$US-HALEON-2189952$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241628711$24162871$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA223607$SANOFI AVENTIS$$$$A$M$Y$$$20240801$$CN$US$US
241628721$24162872$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA224080$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240801$$MD$US$US
241628731$24162873$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA221258$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240801$$MD$US$US
241628741$24162874$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA224194$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240801$$MD$US$US
241628761$24162876$1$I$$20240726$20240801$20240801$EXP$$US-ABBVIE-5856847$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241628771$24162877$1$I$20240718$20240727$20240801$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST004600$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240731$$CN$US$US
241628781$24162878$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225842$TEVA$$52$YR$$M$Y$$$20240801$$HP$CA$CA
241628791$24162879$1$I$$20240726$20240801$20240801$PER$$US-SA-2024SA224016$SANOFI AVENTIS$$$$$$Y$$$20240801$$MD$US$US
241628821$24162882$1$I$$20240725$20240801$20240801$EXP$$US-ABBVIE-5856327$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241628833$24162883$3$F$$20240807$20240801$20240812$EXP$$JP-OTSUKA-2024_020873$OTSUKA$$6$DEC$$F$Y$$$20240812$$MD$JP$JP
241628841$24162884$1$I$$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52668$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241628851$24162885$1$I$$20240728$20240801$20240801$EXP$$US-Stemline Therapeutics, Inc.-2024ST004603$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240731$$CN$US$US
241628861$24162886$1$I$$20240730$20240801$20240801$PER$$US-BAYER-2024A110951$BAYER$$$$$F$Y$$$20240801$$CN$US$US
241628871$24162887$1$I$$20240726$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119955$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240801$$HP$US$US
241628881$24162888$1$I$$20240717$20240801$20240801$PER$$US-TEVA-VS-3222704$TEVA$$$$A$F$Y$$$20240801$$CN$US$US
241628892$24162889$2$F$$20240831$20240801$20240903$30DAY$$US-PFIZER INC-202400223355$PFIZER$$14$YR$$M$Y$$$20240903$$CN$US$US
241628902$24162890$2$F$$20240831$20240801$20240903$30DAY$$US-PFIZER INC-202400224153$PFIZER$$8$YR$$M$Y$$$20240903$$CN$US$US
241628913$24162891$3$F$20240723$20240906$20240801$20240909$30DAY$$US-PFIZER INC-202400224036$PFIZER$$15$YR$$M$Y$$$20240909$$CN$US$US
241628922$24162892$2$F$20240701$20240831$20240801$20240903$30DAY$$US-PFIZER INC-202400224187$PFIZER$$15$YR$$M$Y$58.97$KG$20240903$$CN$US$US
241628945$24162894$5$F$20240701$20240927$20240801$20240927$30DAY$$US-PFIZER INC-202400224938$PFIZER$$11$YR$$F$Y$$$20240927$$HP$US$US
241628952$24162895$2$F$$20240831$20240801$20240903$30DAY$$US-PFIZER INC-202400224075$PFIZER$$15$YR$$M$Y$$$20240903$$CN$US$US
241628961$24162896$1$I$20240701$20240726$20240801$20240801$PER$$US-SA-2024SA223952$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240801$$MD$US$US
241628971$24162897$1$I$20240523$20240801$20240801$20240801$DIR$712342$$FDA-CTU$$49$YR$$F$N$117.9$KG$20240801$N$CN$US$
241628991$24162899$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225840$TEVA$$5$YR$$F$Y$$$20240801$$HP$CA$CA
241629001$24162900$1$I$20240703$20240730$20240731$20240731$DIR$FDA-CDER-CTU-2024-52636$$FDA-CTU$$21$YR$$F$N$$$20240730$N$HP$US$
241629011$24162901$1$I$$20240724$20240801$20240801$EXP$$US-ROCHE-2855359$ROCHE$$$$E$M$Y$$$20240801$$HP$US$US
241629021$24162902$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52679$$FDA-CTU$$67$YR$$F$N$68.04$KG$20240731$N$$US$
241629041$24162904$1$I$20240730$20240730$20240801$20240801$PER$$US-BAYER-2024A110982$BAYER$$52$YR$A$F$Y$$$20240801$$CN$US$US
241629051$24162905$1$I$20240723$20240723$20240801$20240801$EXP$GB-MHRA-MED-202407230647463120-ZYNKC$GB-TEVA-VS-3224943$TEVA$$54$YR$$M$Y$69$KG$20240801$$CN$GB$GB
241629061$24162906$1$I$$20240726$20240801$20240801$PER$$US-EMD Serono-2024041069$EMD SERONO INC$$$$A$F$Y$$$20240801$$MD$US$US
241629071$24162907$1$I$20240511$20240718$20240801$20240801$EXP$$GB-TEVA-VS-3227940$TEVA$$64$YR$$M$Y$78$KG$20240801$$MD$GB$GB
241629082$24162908$2$F$$20240901$20240801$20240903$30DAY$$US-PFIZER INC-202400223857$PFIZER$$$$$$Y$$$20240903$$CN$US$US
241629091$24162909$1$I$20240722$20240729$20240801$20240801$EXP$$CN-PFIZER INC-PV202400098859$PFIZER$$4$YR$$M$Y$15$KG$20240801$$HP$CN$CN
241629101$24162910$1$I$20240801$20240801$20240801$20240801$DIR$712344$$FDA-CTU$$41$YR$$M$N$110.25$KG$20240801$N$CN$US$
241629111$24162911$1$I$$20240801$20240801$20240801$DIR$712356$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241629121$24162912$1$I$20240701$20240727$20240801$20240801$EXP$$US-SA-2024SA224451$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240801$$CN$US$US
241629131$24162913$1$I$$20240801$20240801$20240801$DIR$712357$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241629151$24162915$1$I$20240801$20240801$20240801$20240801$DIR$712354$$FDA-CTU$$72$YR$$F$N$56.7$KG$20240801$Y$CN$US$
241629161$24162916$1$I$20240501$20240724$20240801$20240801$EXP$SE-SEMPA-2024-005419$SE-TEVA-VS-3225431$TEVA$$72$YR$$M$Y$$$20240801$$MD$SE$SE
241629171$24162917$1$I$20240501$20240729$20240801$20240801$EXP$DK-DKMA-30734501$DK-SA-2024SA223159$SANOFI AVENTIS$$78$YR$E$F$Y$55$KG$20240801$$MD$DK$DK
241629182$24162918$2$F$20240725$20240805$20240801$20240809$EXP$$US-BAYER-2024A101154$BAYER$$67$YR$E$M$Y$$$20240809$$CN$US$US
241629191$24162919$1$I$20240726$20240731$20240801$20240801$EXP$$NVSC2024US157097$NOVARTIS$$71$YR$$M$Y$$$20240801$$HP$US$US
241629201$24162920$1$I$$20240729$20240801$20240801$EXP$$CA-PFIZER INC-PV202400098701$PFIZER$Aboguddah, A.. Herpes simplex hepatitis in a patient with psoriatic arthritis taking prednisone and methotrexate. Report and review of the literature. The Journal of Rheumatology. 1991;18(9):1406-12$43$YR$$F$Y$$$20240801$$HP$CA$CA
241629211$24162921$1$I$20240725$20240729$20240801$20240801$EXP$$CN-PFIZER INC-PV202400098802$PFIZER$$26$YR$$F$Y$50$KG$20240801$$HP$CN$CN
241629221$24162922$1$I$$20240724$20240801$20240801$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118238$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240801$$HP$CA$CA
241629232$24162923$2$F$20240728$20240901$20240801$20240903$30DAY$$US-PFIZER INC-202400225946$PFIZER$$12$YR$$M$Y$$$20240903$$CN$US$US
241629241$24162924$1$I$$20240724$20240801$20240801$EXP$$US-JNJFOC-20240770810$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$US$US
241629251$24162925$1$I$$20240730$20240801$20240801$PER$$US-JNJFOC-20240784579$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$MD$US$US
241629261$24162926$1$I$$20240729$20240801$20240801$EXP$$CA-JNJFOC-20240801552$JOHNSON AND JOHNSON$$82$YR$E$M$Y$61$KG$20240801$$PH$CA$CA
241629271$24162927$1$I$$20240723$20240801$20240801$30DAY$$US-PFIZER INC-202400222396$PFIZER$$13$YR$$M$Y$$$20240801$$CN$US$US
241629281$24162928$1$I$20230329$20240724$20240801$20240801$EXP$FR-AFSSAPS-PO2024000785$FR-TEVA-VS-3225667$TEVA$$33$YR$$F$Y$116$KG$20240801$$MD$FR$FR
241629292$24162929$2$F$$20240901$20240801$20240903$30DAY$$US-PFIZER INC-PV202400095709$PFIZER$$17$YR$$M$Y$$$20240903$$CN$US$US
241629301$24162930$1$I$20240709$20240729$20240801$20240801$EXP$$CN-PFIZER INC-PV202400098842$PFIZER$$64$YR$$M$Y$65$KG$20240801$$HP$CN$CN
241629311$24162931$1$I$$20240729$20240801$20240801$EXP$$US-PFIZER INC-202400225880$PFIZER$$79$YR$$F$Y$$$20240801$$CN$US$US
241629321$24162932$1$I$$20240730$20240801$20240801$EXP$$US-PFIZER INC-PV202400100291$PFIZER$$85$YR$$M$Y$$$20240801$$CN$US$US
241629334$24162933$4$F$$20240923$20240801$20240925$PER$$NVSC2024US156235$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
241629341$24162934$1$I$20200101$20240711$20240801$20240801$PER$$US-ROCHE-10000037730$ROCHE$$70$YR$E$F$Y$$$20240801$$MD$US$US
241629351$24162935$1$I$20240201$20240729$20240801$20240801$EXP$FR-AFSSAPS-TO2024001155$FR-PFIZER INC-202400225519$PFIZER$$59$YR$$M$Y$$$20240801$$PH$FR$FR
241629371$24162937$1$I$20240724$20240724$20240801$20240801$EXP$$GT-AstraZeneca-2024A170798$ASTRAZENECA$$22900$DY$$M$Y$$$20240801$$CN$GT$
241629383$24162938$3$F$20240612$20240821$20240801$20240918$PER$$US-SA-2024SA224200$SANOFI AVENTIS$$76$YR$E$F$Y$79.55$KG$20240918$$MD$US$US
241629391$24162939$1$I$$20240729$20240801$20240801$EXP$$PT-PFIZER INC-202400225551$PFIZER$Buruian, N.. POSA-070 - (2704) - A RARE CAUSE OF SYNDROME OF INAPPROPRIATE SECRETION OF ANTIDIURETIC HORMONE, DESPITE WIDELY USED IN CLINICAL PRACTICE. 30th National Congress of Internal Medicine. 2024;1142$64$YR$$F$Y$$$20240801$$MD$PT$PT
241629401$24162940$1$I$$20240731$20240801$20240801$EXP$$TW-PFIZER INC-PV202400100237$PFIZER$$$$A$F$Y$$$20240801$$HP$TW$TW
241629411$24162941$1$I$$20240731$20240801$20240801$EXP$$CA-PFIZER INC-202400227612$PFIZER$$$$$M$Y$$$20240801$$MD$CA$CA
241629421$24162942$1$I$20240701$20240726$20240801$20240801$EXP$$CA-AMGEN-CANSL2024150492$AMGEN$$66$YR$E$M$Y$$$20240801$$CN$CA$CA
241629431$24162943$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A170094$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241629441$24162944$1$I$20240429$20240726$20240801$20240801$EXP$$GB-AMGEN-GBRSP2024149139$AMGEN$$$$$F$Y$$$20240801$$HP$GB$GB
241629452$24162945$2$F$20240701$20240901$20240801$20240903$30DAY$$US-PFIZER INC-202400225396$PFIZER$$12$YR$$M$Y$$$20240903$$CN$US$US
241629461$24162946$1$I$$20240730$20240801$20240801$EXP$$US-PFIZER INC-PV202400099692$PFIZER$$56$YR$$F$Y$$$20240801$$CN$US$US
241629472$24162947$2$F$20240710$20240904$20240801$20240904$30DAY$$US-PFIZER INC-PV202400083613$PFIZER$$12$YR$$M$Y$31.3$KG$20240904$$MD$US$US
241629484$24162948$4$F$20240724$20240915$20240801$20240916$30DAY$$US-PFIZER INC-202400223771$PFIZER$$12$YR$$M$Y$$$20240916$$CN$US$US
241629491$24162949$1$I$$20240729$20240801$20240801$EXP$$TW-PFIZER INC-12264$PFIZER$Chao A.. Hysteroscopic management of cesarean scar pregnancy after unsuccessful methotrexate treatment.. Journal of Minimally Invasive Gynecology. 2005;12(4):374-376$33$YR$$F$Y$$$20240801$$MD$TW$TW
241629501$24162950$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407018878$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240801$$CN$US$US
241629511$24162951$1$I$20240718$20240725$20240801$20240801$PER$$US-ABBVIE-5856773$ABBVIE$$$$$$Y$$$20240801$$HP$US$US
241629522$24162952$2$F$$20240813$20240801$20240816$PER$$US-BIOVITRUM-2024-US-010463$BIOVITRUM$$72$YR$$M$Y$$$20240816$$CN$US$US
241629561$24162956$1$I$20230918$20240730$20240801$20240801$PER$$US-BIOVITRUM-2024-US-010446$BIOVITRUM$$84$YR$$M$Y$$$20240801$$CN$US$US
241629573$24162957$3$F$20240409$20240916$20240801$20240920$EXP$$US-OTSUKA-2024_011985$OTSUKA$$$$$F$Y$$$20240920$$CN$US$US
241629581$24162958$1$I$$20240729$20240801$20240801$EXP$$PK-TAKEDA-2024TUS076453$TAKEDA$$$$$$Y$$$20240801$$CN$PK$PK
241629591$24162959$1$I$$20240725$20240801$20240801$EXP$$US-ASTELLAS-2024US021501$ASTELLAS$$$$$M$Y$$$20240801$$CN$US$US
241629601$24162960$1$I$$20240726$20240801$20240801$EXP$$US-AMGEN-USASP2024149834$AMGEN$$$$$F$Y$$$20240801$$PH$US$US
241629611$24162961$1$I$$20240724$20240801$20240801$EXP$$CA-MYLANLABS-2024M1069482$MYLAN$$52$YR$$M$Y$$$20240801$$CN$CA$CA
241629621$24162962$1$I$20231201$20240722$20240801$20240801$EXP$$DE-NORDICGR-057010$NORDIC PHARMA$$63$YR$$F$Y$$$20240730$$MD$DE$DE
241629631$24162963$1$I$20240515$20240722$20240801$20240801$EXP$PT-INFARMED-F202407-304$PT-NORDICGR-057018$NORDIC PHARMA$$53$YR$$M$Y$$$20240730$$MD$PT$PT
241629641$24162964$1$I$20230309$20240722$20240801$20240801$EXP$$DE-NORDICGR-057013$NORDIC PHARMA$$$$E$M$Y$$$20240730$$MD$DE$DE
241629651$24162965$1$I$20231101$20240722$20240801$20240801$EXP$FR-AFSSAPS-TS2024000765$FR-NORDICGR-056984$NORDIC PHARMA$$78$YR$$F$Y$$$20240801$$MD$FR$FR
241629662$24162966$2$F$20240711$20240821$20240801$20240904$EXP$$US-RADIUS HEALTH, INC.-2024US005628$RADIUS PHARM$$49$YR$$F$Y$$$20240904$$MD$US$US
241629671$24162967$1$I$20240413$20240724$20240801$20240801$EXP$FR-AFSSAPS-DJ2024000842$FR-TEVA-VS-3225657$TEVA$$46$YR$$M$Y$53$KG$20240801$$MD$FR$FR
241629681$24162968$1$I$$20240703$20240801$20240801$30DAY$$US-VEROBIOTECH-2024USVEROSPO00158$VERO BIOTECH$$$$$$Y$$$20240801$$HP$US$US
241629691$24162969$1$I$20240701$20240725$20240801$20240801$EXP$$AU-NALPROPION PHARMACEUTICALS INC.-AU-2024CUR003610$CURRAX PHARMACEUTICALS$$36$YR$$M$Y$$$20240801$$CN$AU$AU
241629701$24162970$1$I$$20240731$20240801$20240801$EXP$$US-TAKEDA-2024TUS062281$TAKEDA$$$$$F$Y$$$20240801$$CN$US$US
241629711$24162971$1$I$20240415$20240726$20240801$20240801$EXP$$US-OTSUKA-2024_012472$OTSUKA$$22$YR$$M$Y$70.4$KG$20240801$$MD$US$US
241629722$24162972$2$F$20240101$20240729$20240801$20240802$EXP$GB-MHRA-MED-202407101828241330-CHMLS$GB-INDIVIOR EUROPE LIMITED-INDV-145942-2024$RECKITT BENCKISER$$$$$$Y$$$20240802$$CN$GB$GB
241629731$24162973$1$I$20240123$20240712$20240801$20240801$PER$$US-TEVA-VS-3222557$TEVA$$80$YR$$M$Y$$$20240801$$CN$US$US
241629741$24162974$1$I$$20240729$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043195$BOEHRINGER INGELHEIM$$$$$$Y$$$20240801$$PH$US$US
241629751$24162975$1$I$20201123$20240724$20240801$20240801$EXP$PL-URPL-1-4248-2020$PL-JNJFOC-20240767443$JOHNSON AND JOHNSON$$19$YR$A$F$Y$70$KG$20240801$$MD$PL$PL
241629761$24162976$1$I$$20240703$20240801$20240801$30DAY$$US-VEROBIOTECH-2024USVEROSPO00156$VERO BIOTECH$$$$$$Y$$$20240801$$HP$US$US
241629771$24162977$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156727$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
241629781$24162978$1$I$20200101$20240730$20240801$20240801$EXP$GB-MHRA-30862230$GB-MYLANLABS-2024M1071202$MYLAN$$$$$F$Y$$$20240801$$CN$GB$GB
241629791$24162979$1$I$$20240730$20240801$20240801$EXP$$US-TAKEDA-2024TUS076733$TAKEDA$$$$$F$Y$$$20240801$$HP$US$US
241629801$24162980$1$I$20240716$20240723$20240801$20240801$EXP$$CN-ROCHE-10000034585$ROCHE$$65$YR$E$M$Y$$$20240801$$HP$CN$CN
241629812$24162981$2$F$20240401$20240806$20240801$20240813$EXP$$NVSC2024BR155913$NOVARTIS$$76$YR$$F$Y$64$KG$20240813$$CN$BR$BR
241629821$24162982$1$I$$20240730$20240801$20240801$EXP$GB-MHRA-MIDB-8a1610a6-646a-4dc8-9455-6f3510bb9e9e$GB-MYLANLABS-2024M1071185$MYLAN$$79$YR$$$Y$$$20240801$$PH$GB$GB
241629831$24162983$1$I$20231201$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121866$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240801$$HP$US$US
241629841$24162984$1$I$$20240703$20240801$20240801$30DAY$$US-VEROBIOTECH-2024USVEROSPO00157$VERO BIOTECH$$$$$$Y$$$20240801$$HP$US$US
241629851$24162985$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121409$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240801$$CN$US$US
241629861$24162986$1$I$20240730$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151807$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241629872$24162987$2$F$20240715$20240730$20240801$20240815$PER$$US-AMGEN-USASP2024150384$AMGEN$$85$YR$E$F$Y$$$20240815$$CN$US$US
241629881$24162988$1$I$20240101$20240722$20240801$20240801$EXP$$CA-TEVA-VS-3219919$TEVA$$49$YR$$F$Y$$$20240801$$CN$CA$CA
241629891$24162989$1$I$20240701$20240731$20240801$20240801$PER$$US-AMGEN-USASP2024152671$AMGEN$$59$YR$A$F$Y$$$20240801$$HP$US$US
241629902$24162990$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3226835$TEVA$Golob S, Ting P, Pires K, Soetanto V, Pagano B, Wan K-L, et al. Bupropion Overdose Requiring Veno-Arterial Extracorporeal Membrane Oxygenation. Circulation 2023; 148 (Suppl.) no pagination abstr. 15659.; Golob S, Ting P, Pires K, Soetanto V, Pagano B, Wan K-L, et al. Bupropion Overdose Requiring Veno-Arterial Extracorporeal Membrane Oxygenation. Circulation 2023; 148 (Suppl.) no pagination abstr. 15659.$32$YR$$F$Y$$$20240816$$HP$US$US
241629911$24162991$1$I$$20240722$20240801$20240801$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005436$BIOCON$$$$$$Y$$$20240801$$MD$CA$CA
241629921$24162992$1$I$$20240718$20240801$20240801$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-121957$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$70$KG$20240801$$HP$CA$CA
241629931$24162993$1$I$$20240801$20240801$20240801$DIR$712358$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241629941$24162994$1$I$20240701$20240801$20240801$20240801$DIR$712355$$FDA-CTU$$44$YR$$F$N$102.24$KG$20240801$Y$HP$US$
241629951$24162995$1$I$$20240801$20240801$20240801$DIR$712359$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241629961$24162996$1$I$$20240801$20240801$20240801$DIR$712360$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241629971$24162997$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52626$$FDA-CTU$$34$YR$$F$N$$$20240731$N$$US$
241629981$24162998$1$I$$20240730$20240801$20240801$EXP$$NVSC2023MW192166$NOVARTIS$$$$$F$Y$$$20240801$$MD$MW$MW
241629991$24162999$1$I$$20240723$20240801$20240801$EXP$GB-MHRA-31008345$GB-TEVA-VS-3225176$TEVA$$62$YR$$F$Y$62$KG$20240801$$CN$GB$GB
241630001$24163000$1$I$$20240726$20240801$20240801$EXP$$US-MYLANLABS-2024M1071563$MYLAN$Wang EJ, Berninger LE, Smith TJ, Pantelyat AY. Scrambler Therapy for the Treatment of Pain and Sensory Symptoms in Corticobasal Syndrome: A Case Series. Pain-Med-Case-Rep 2023; 7 (3): 151-155.$70$YR$$M$Y$$$20240801$$MD$US$US
241630011$24163001$1$I$$20240801$20240801$20240801$DIR$712364$$FDA-CTU$$$$$UNK$N$$$20240801$$CN$US$
241630022$24163002$2$F$20170101$20240801$20240801$20240806$EXP$$US-INDIVIOR US-INDV-146035-2024$RECKITT BENCKISER$$$$$$Y$$$20240806$$CN$US$US
241630031$24163003$1$I$$20240730$20240801$20240801$EXP$$US-GILEAD-2024-0682528$GILEAD$$$$A$F$Y$$$20240801$$CN$US$US
241630042$24163004$2$F$$20240801$20240801$20240802$PER$$US-JNJFOC-20240800822$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241630051$24163005$1$I$$20240718$20240801$20240801$30DAY$$CA-JNJFOC-20240751970$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$HP$CA$CA
241630061$24163006$1$I$$20240801$20240801$20240801$DIR$712366$$FDA-CTU$$$$$UNK$N$$$20240801$$CN$US$
241630071$24163007$1$I$20240101$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024152084$AMGEN$$72$YR$E$F$Y$$$20240801$$CN$US$US
241630081$24163008$1$I$$20240724$20240801$20240801$EXP$$US-EMD Serono-2024040452$EMD SERONO INC$$$$A$M$Y$108$KG$20240801$$CN$US$US
241630091$24163009$1$I$20180924$20240729$20240801$20240801$EXP$$CA-TAKEDA-2018TUS024644$TAKEDA$$31$YR$$F$Y$$$20240801$$CN$CA$CA
241630101$24163010$1$I$20240416$20240724$20240801$20240801$EXP$FR-AFSSAPS-AVPO2024000104$FR-TEVA-VS-3225690$TEVA$$37$YR$$M$Y$$$20240801$$PH$FR$FR
241630111$24163011$1$I$20240701$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151060$AMGEN$$66$YR$E$M$Y$$$20240801$$CN$US$US
241630121$24163012$1$I$$20240801$20240801$20240801$DIR$712363$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241630131$24163013$1$I$$20240726$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119441$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$73.48$KG$20240801$$HP$US$US
241630141$24163014$1$I$$20240723$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117279$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240801$$HP$US$US
241630152$24163015$2$F$20240726$20240730$20240801$20240808$EXP$$ES-ROCHE-10000042425$ROCHE$$79$YR$E$F$Y$$$20240808$$MD$ES$ES
241630161$24163016$1$I$20240404$20240507$20240801$20240801$PER$$US-BAYER-2024A090904$BAYER$$21$YR$A$F$Y$$$20240801$$MD$US$US
241630171$24163017$1$I$$20240725$20240801$20240801$EXP$$US-MYLANLABS-2024M1071016$MYLAN$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. J-Allergy-Clin-Immunol-Pract 2024; 12 (6): 1663-1665.$49$YR$$F$Y$$$20240801$$MD$US$US
241630181$24163018$1$I$$20240730$20240801$20240801$EXP$$NVSC2024US156425$NOVARTIS$$$$$M$Y$$$20240801$$MD$US$US
241630191$24163019$1$I$$20240801$20240801$20240801$DIR$712362$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241630201$24163020$1$I$20240601$20240718$20240801$20240801$EXP$$US-UCBSA-2024036797$UCB$$51$YR$$M$Y$$$20240801$$HP$US$US
241630211$24163021$1$I$20240423$20240507$20240801$20240801$PER$$US-BAYER-2024A090947$BAYER$$17$YR$T$F$Y$$$20240801$$MD$US$US
241630221$24163022$1$I$20240626$20240729$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043203$BOEHRINGER INGELHEIM$$86$YR$E$M$Y$$$20240801$$CN$US$US
241630241$24163024$1$I$$20240723$20240801$20240801$EXP$GB-MHRA-MED-202407232053358180-ZLGPY$GB-TEVA-VS-3225240$TEVA$$29$YR$$F$Y$$$20240801$$CN$GB$GB
241630255$24163025$5$F$20230101$20240824$20240801$20240924$30DAY$$US-ROCHE-10000034506$ROCHE$$70$YR$E$F$Y$$$20240924$$CN$US$US
241630261$24163026$1$I$20240709$20240725$20240801$20240801$EXP$$GB-TEVA-VS-3226276$TEVA$$35$YR$$M$Y$72$KG$20240801$$CN$GB$GB
241630271$24163027$1$I$$20240730$20240801$20240801$PER$$US-TAKEDA-2024TUS077199$TAKEDA$$$$$M$Y$$$20240801$$CN$US$US
241630291$24163029$1$I$20240628$20240724$20240801$20240801$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00621$PARATEK PHARMACEUTICALS$$70$YR$$M$Y$70$KG$20240801$$HP$CN$CN
241630301$24163030$1$I$20240424$20240725$20240801$20240801$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00513$PARATEK PHARMACEUTICALS$$57$YR$$M$Y$126.98$KG$20240801$$CN$US$US
241630311$24163031$1$I$$20240729$20240801$20240801$EXP$$MX-JNJFOC-20240781485$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$MD$MX$MX
241630321$24163032$1$I$20240501$20240507$20240801$20240801$PER$$US-BAYER-2024A091029$BAYER$$17$YR$T$F$Y$$$20240801$$CN$US$US
241630331$24163033$1$I$$20240731$20240801$20240801$EXP$$US-BAUSCH-BL-2024-009625$BAUSCH AND LOMB$$55$YR$$F$Y$$$20240801$$CN$US$US
241630341$24163034$1$I$$20240729$20240801$20240801$EXP$$CA-BAYER-2024A110781$BAYER$$72$YR$E$F$Y$$$20240801$$HP$CA$CA
241630351$24163035$1$I$$20240718$20240801$20240801$EXP$$CN-Rubicon research Pvt ltd-2024000038$RUBICON RESEARCH$Wenjing zhai, Hao liu, Jinrui li and Haili xin. Pregabalin-induced rhabdomyolysis: a case series and literature analysis.$90$YR$$F$Y$$$20240724$$MD$CN$CN
241630362$24163036$2$F$$20240731$20240801$20240814$PER$$US-LEADINGPHARMA-US-2024LEASPO00327$LEADING PHARMA$$$$$F$Y$$$20240814$$CN$US$US
241630371$24163037$1$I$$20240725$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120192$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240801$$MD$US$US
241630382$24163038$2$F$$20240731$20240801$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120540$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240806$$PH$US$US
241630401$24163040$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52631$$FDA-CTU$$64$YR$$F$N$$$20240731$N$$US$
241630411$24163041$1$I$20240101$20240730$20240801$20240801$EXP$$US-SA-2024SA217706$SANOFI AVENTIS$$101$YR$E$F$Y$$$20240801$$MD$US$US
241630422$24163042$2$F$$20240819$20240801$20240822$EXP$$US-PFIZER INC-PV202400099092$PFIZER$$75$YR$$F$Y$$$20240822$$HP$US$US
241630442$24163044$2$F$20240717$20240905$20240801$20240909$EXP$$US-PFIZER INC-202400227799$PFIZER$$73$YR$$F$Y$72.562$KG$20240909$$CN$US$US
241630451$24163045$1$I$20240228$20240507$20240801$20240801$PER$$US-BAYER-2024A091051$BAYER$$25$YR$A$F$Y$$$20240801$$CN$US$US
241630461$24163046$1$I$$20240725$20240801$20240801$EXP$$AU-AMGEN-AUSSP2024149016$AMGEN$$79$YR$E$F$Y$$$20240801$$CN$AU$AU
241630473$24163047$3$F$20240101$20240802$20240801$20240812$PER$$US-AMGEN-USASP2024152079$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241630491$24163049$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA224067$SANOFI AVENTIS$$$$T$M$Y$97.9$KG$20240801$$MD$US$US
241630501$24163050$1$I$20240101$20240724$20240801$20240801$PER$$US-SA-2024SA223844$SANOFI AVENTIS$$$$C$M$Y$$$20240801$$MD$US$US
241630511$24163051$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA222548$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240801$$MD$US$US
241630521$24163052$1$I$20240723$20240723$20240801$20240801$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2024-001669$SK LIFE SCIENCE$$$$$$Y$$$20240801$$CN$US$US
241630531$24163053$1$I$20240619$20240729$20240801$20240801$EXP$$CN-PFIZER INC-PV202400098841$PFIZER$$61$YR$$F$Y$49.4$KG$20240801$$HP$CN$CN
241630541$24163054$1$I$20240214$20240507$20240801$20240801$PER$$US-BAYER-2024A091055$BAYER$$17$YR$T$F$Y$$$20240801$$MD$US$US
241630551$24163055$1$I$20240713$20240729$20240801$20240801$EXP$$AT-AMERICAN REGENT INC-2024002910$AMERICAN REGENT$$46$YR$$F$Y$$$20240801$$MD$AT$AT
241630561$24163056$1$I$20231206$20240723$20240801$20240801$EXP$GB-MHRA-30734100$GB-TEVA-VS-3225199$TEVA$$70$YR$$F$Y$60$KG$20240801$$MD$GB$GB
241630571$24163057$1$I$$20240705$20240801$20240801$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04974$LUPIN$$$$$$Y$$$20240801$$CN$US$US
241630581$24163058$1$I$$20240724$20240801$20240801$EXP$$US-ROCHE-10000035796$ROCHE$$$$I$M$Y$$$20240801$$CN$US$US
241630591$24163059$1$I$$20240724$20240801$20240801$EXP$$TN-AstraZeneca-2024A169732$ASTRAZENECA$Sahnoun D.;  Ghardallou H.;  Agrebi M.;  Ben Rejeb M.;  Ghariani N.;  Sriha B.; Denguezli M.;  Ben Salem C.. Dapagliflozin-induced leukocytoclastic vasculitis. Therapie 2024;$47$YR$$M$Y$$$20240801$$HP$TN$
241630611$24163061$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122054$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240801$$CN$US$US
241630621$24163062$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52601$$FDA-CTU$$22$YR$$M$N$$$20240731$N$$US$
241630631$24163063$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121365$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240801$$HP$US$US
241630641$24163064$1$I$$20240729$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121452$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240801$$CN$US$US
241630652$24163065$2$F$20230101$20240823$20240801$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118384$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240902$$CN$US$US
241630661$24163066$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121567$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240801$$CN$US$US
241630671$24163067$1$I$20190306$20240722$20240801$20240801$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117015$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$51$KG$20240801$$MD$KR$KR
241630681$24163068$1$I$$20231222$20240801$20240801$PER$$US-AMICUS THERAPEUTICS, INC.-AMI_2878$AMICUS THERAPEUTICS$$$$$M$Y$$$20240801$$MD$US$US
241630691$24163069$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225835$TEVA$$38$YR$$M$Y$$$20240801$$HP$CA$CA
241630701$24163070$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225833$TEVA$$33$YR$$M$Y$$$20240801$$MD$CA$CA
241630711$24163071$1$I$20240701$20240723$20240801$20240801$PER$$US-SA-2024SA223666$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240801$$MD$US$US
241630721$24163072$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52669$$FDA-CTU$$53$YR$$F$N$108.86$KG$20240731$N$$US$
241630731$24163073$1$I$20240430$20240507$20240801$20240801$PER$$US-BAYER-2024A091084$BAYER$$$$$F$Y$$$20240801$$CN$US$US
241630741$24163074$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA223861$SANOFI AVENTIS$$$$A$M$Y$81.2$KG$20240801$$MD$US$US
241630751$24163075$1$I$20200101$20240725$20240801$20240801$EXP$$CA-Orion Corporation ORION PHARMA-24_00031093$ORION$$53$YR$A$M$Y$$$20240801$$MD$CA$
241630761$24163076$1$I$20240101$20240718$20240801$20240801$EXP$$CA-TEVA-VS-3225732$TEVA$$$$A$F$Y$$$20240801$$CN$CA$CA
241630771$24163077$1$I$20240201$20240726$20240801$20240801$EXP$$US-OTSUKA-2024_020946$OTSUKA$$66$YR$$F$Y$108.86$KG$20240801$$CN$US$US
241630781$24163078$1$I$20240509$20240509$20240801$20240801$PER$$US-BAYER-2024A090856$BAYER$$30$YR$A$F$Y$$$20240801$$MD$US$US
241630793$24163079$3$F$$20240813$20240801$20240815$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043201$BOEHRINGER INGELHEIM$$$$$$Y$$$20240815$$CN$US$US
241630801$24163080$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52616$$FDA-CTU$$46$YR$$F$N$$$20240731$N$$US$
241630812$24163081$2$F$$20240718$20240801$20240831$PER$$US-TEVA-VS-3224661$TEVA$$66$YR$$M$Y$$$20240831$$CN$US$US
241630822$24163082$2$F$20240101$20240729$20240801$20240802$PER$$US-ABBVIE-5859052$ABBVIE$$$$$F$Y$86.183$KG$20240802$$CN$US$US
241630831$24163083$1$I$$20240726$20240801$20240801$EXP$$US-OTSUKA-2024_021040$OTSUKA$$$$$F$Y$$$20240801$$CN$US$US
241630841$24163084$1$I$$20240717$20240801$20240801$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090484$VIIV$$5$DEC$$M$Y$$$20240801$$HP$US$US
241630851$24163085$1$I$20240716$20240724$20240801$20240801$EXP$$CN-TAKEDA-2024TUS076830$TAKEDA$$78$YR$$F$Y$63$KG$20240801$$HP$CN$CN
241630861$24163086$1$I$$20240801$20240801$20240801$EXP$$NZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043177$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240801$$HP$NZ$NZ
241630871$24163087$1$I$$20240726$20240801$20240801$PER$$US-AMGEN-USASP2024149663$AMGEN$Long C.; Helm M.; Foulke G.. Seronegative cutaneous rheumatoid nodules with positive response to tofacitinib. JAAD Case Reports. 2024;50:88-90$29$YR$A$F$Y$$$20240801$$HP$US$US
241630881$24163088$1$I$$20240723$20240801$20240801$PER$$US-ABBVIE-5855783$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241630891$24163089$1$I$20240728$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024152228$AMGEN$$57$YR$A$F$Y$$$20240801$$CN$US$US
241630901$24163090$1$I$$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151174$AMGEN$$$$$M$Y$$$20240801$$CN$US$US
241630911$24163091$1$I$20240501$20240726$20240731$20240731$DIR$FDA-CDER-CTU-2024-52642$$FDA-CTU$$79$YR$$M$N$$$20240726$N$HP$US$
241630921$24163092$1$I$20240729$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151692$AMGEN$$63$YR$A$M$Y$$$20240801$$CN$US$US
241630931$24163093$1$I$20230828$20230912$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004718$ARBOR$$$$$F$Y$$$20240801$$HP$US$US
241630941$24163094$1$I$20230101$20230915$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004729$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241630951$24163095$1$I$20231003$20231012$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004740$ARBOR$$6$YR$$F$Y$42$KG$20240801$$HP$US$US
241630961$24163096$1$I$$20240223$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000213$ARBOR$$$$$F$Y$$$20240801$$HP$US$US
241630971$24163097$1$I$$20231006$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004800$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241630981$24163098$1$I$20221201$20231103$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004881$ARBOR$$14$YR$$M$Y$$$20240801$$CN$US$US
241630991$24163099$1$I$20231031$20231127$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004888$ARBOR$$8$YR$$F$Y$$$20240801$$HP$US$US
241631001$24163100$1$I$20230101$20230925$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004754$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241631011$24163101$1$I$20240530$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52634$$FDA-CTU$$80$YR$$M$N$$$20240731$N$$US$
241631021$24163102$1$I$20230922$20231011$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004813$ARBOR$$15$YR$$M$Y$$$20240801$$HP$US$US
241631031$24163103$1$I$20230101$20240320$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004767$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241631041$24163104$1$I$$20230915$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004730$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241631051$24163105$1$I$$20231024$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004840$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241631061$24163106$1$I$20230930$20240501$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004784$ARBOR$$8$YR$$F$Y$$$20240801$$CN$US$US
241631071$24163107$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A170297$ASTRAZENECA$Giustini N.P.;  Pritchard C.C.;  Kamat N.V.;  Menon M.P.. EGFR V834L and L858R Comutation Is Associated with Response to Osimertinib in Non-Small-Cell Lung Cancer.. JCO Precision Oncology 2024;8:e2300215.$77$YR$$F$Y$$$20240801$$MD$US$
241631081$24163108$1$I$20240528$20240725$20240801$20240801$EXP$$CO-AstraZeneca-2024A171325$ASTRAZENECA$$27382$DY$$F$Y$$$20240801$$CN$CO$
241631091$24163109$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A170064$ASTRAZENECA$$$$$F$Y$61.2$KG$20240801$$CN$US$
241631101$24163110$1$I$20240515$20240724$20240801$20240801$EXP$$GB-AstraZeneca-2024A173527$ASTRAZENECA$$31$YR$$F$Y$90$KG$20240801$$MD$GB$
241631111$24163111$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121745$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240801$$CN$US$US
241631121$24163112$1$I$$20240729$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121492$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240801$$CN$US$US
241631132$24163113$2$F$$20240920$20240801$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121467$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240925$$HP$US$US
241631141$24163114$1$I$$20240719$20240801$20240801$PER$$US-AstraZeneca-2024A165527$ASTRAZENECA$$$$$$Y$$$20240801$$CN$US$
241631151$24163115$1$I$$20240724$20240801$20240801$EXP$$ZA-AstraZeneca-2024A168772$ASTRAZENECA$$72$YR$$F$Y$$$20240801$$CN$ZA$
241631161$24163116$1$I$20240110$20240724$20240801$20240801$EXP$$JP-ABBVIE-5862738$ABBVIE$$70$YR$$M$Y$$$20240801$$HP$JP$JP
241631171$24163117$1$I$20240415$20240503$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000465$ARBOR$$10$YR$$F$Y$$$20240801$$HP$US$US
241631181$24163118$1$I$$20240305$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004934$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241631191$24163119$1$I$20230101$20231213$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB005028$ARBOR$$$$$F$Y$$$20240801$$HP$US$US
241631201$24163120$1$I$20240101$20240315$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000304$ARBOR$$$$$F$Y$$$20240801$$HP$US$US
241631211$24163121$1$I$$20240209$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000168$ARBOR$$$$$$Y$$$20240801$$HP$US$US
241631221$24163122$1$I$20240321$20240418$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000323$ARBOR$$12$YR$$M$Y$$$20240801$$HP$US$US
241631231$24163123$1$I$$20240206$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000144$ARBOR$$$$$F$Y$$$20240801$$MD$US$US
241631241$24163124$1$I$$20231108$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004897$ARBOR$$9$YR$$F$Y$$$20240801$$HP$US$US
241631251$24163125$1$I$20231107$20231107$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004892$ARBOR$$10$YR$$F$Y$$$20240801$$CN$US$US
241631261$24163126$1$I$20210101$20240313$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000174$ARBOR$$8$YR$$F$Y$$$20240801$$MD$US$US
241631271$24163127$1$I$20240101$20240314$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000273$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241631281$24163128$1$I$20240118$20240503$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000543$ARBOR$$18$YR$$M$Y$$$20240801$$MD$US$US
241631291$24163129$1$I$$20240315$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000308$ARBOR$$$$$F$Y$$$20240801$$HP$US$US
241631301$24163130$1$I$$20231215$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB005045$ARBOR$$$$$F$Y$$$20240801$$HP$US$US
241631311$24163131$1$I$20240618$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52659$$FDA-CTU$$93$YR$$M$N$$$20240731$Y$PH$US$
241631321$24163132$1$I$20240506$20240506$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000548$ARBOR$$11$YR$$F$Y$$$20240801$$HP$US$US
241631331$24163133$1$I$20231023$20240513$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000458$ARBOR$$7$YR$$F$Y$27.5$KG$20240801$$HP$US$US
241631341$24163134$1$I$$20240320$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000317$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241631351$24163135$1$I$$20240129$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000111$ARBOR$$17$YR$$F$Y$$$20240801$$PH$US$US
241631361$24163136$1$I$20240101$20240406$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000418$ARBOR$$$$$F$Y$$$20240801$$MD$US$US
241631371$24163137$1$I$20231210$20240417$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB005023$ARBOR$$11$YR$$M$Y$32.4$KG$20240801$$MD$US$US
241631381$24163138$1$I$$20240418$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000476$ARBOR$$$$T$F$Y$$$20240801$$HP$US$US
241631391$24163139$1$I$20240201$20240503$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000228$ARBOR$$10$YR$$F$Y$$$20240801$$CN$US$US
241631401$24163140$1$I$20231115$20231222$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004982$ARBOR$$4$YR$$F$Y$$$20240801$$HP$US$US
241631411$24163141$1$I$$20240304$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000240$ARBOR$$$$$M$Y$$$20240801$$MD$US$US
241631421$24163142$1$I$20240101$20240506$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000340$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241631431$24163143$1$I$$20240415$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000457$ARBOR$$$$$F$Y$$$20240801$$HP$US$US
241631441$24163144$1$I$20240129$20240206$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000117$ARBOR$$8$YR$$F$Y$29.6$KG$20240801$$MD$US$US
241631451$24163145$1$I$20240129$20240329$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000355$ARBOR$$$$$$Y$$$20240801$$HP$US$US
241631461$24163146$1$I$$20240506$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000547$ARBOR$$$$$F$Y$$$20240801$$HP$US$US
241631471$24163147$1$I$$20240506$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000551$ARBOR$$$$$F$Y$$$20240801$$MD$US$US
241631481$24163148$1$I$$20240509$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000569$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241631491$24163149$1$I$$20231116$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004930$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241631501$24163150$1$I$20240119$20240119$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000078$ARBOR$$8$YR$$F$Y$$$20240801$$HP$US$US
241631511$24163151$1$I$20240101$20240430$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000488$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241631521$24163152$1$I$$20240315$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000305$ARBOR$$$$$F$Y$$$20240801$$CN$US$US
241631531$24163153$1$I$20240401$20240430$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000524$ARBOR$$10$YR$$M$Y$$$20240801$$PH$US$US
241631541$24163154$1$I$$20240717$20240801$20240801$PER$$US-GRANULES-US-2024GRASPO00301$GRANULES INDIA$$26$YR$A$F$Y$230$KG$20240801$$CN$US$US
241631551$24163155$1$I$$20240517$20240801$20240801$EXP$$US-SERB S.A.S.-2159889$LABORATOIRES SERB$$$$$$Y$$$20240801$$PH$US$US
241631563$24163156$3$F$20240417$20240927$20240801$20240930$EXP$$NVSC2024US092873$NOVARTIS$$55$YR$$F$Y$$$20240930$$CN$US$US
241631571$24163157$1$I$20231102$20231214$20240801$20240801$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004889$ARBOR$$10$YR$$M$Y$34.2$KG$20240801$$HP$US$US
241631581$24163158$1$I$20240725$20240726$20240801$20240801$EXP$$US-OTSUKA-2024_021068$OTSUKA$$33$YR$$F$Y$$$20240801$$HP$US$US
241631591$24163159$1$I$$20240730$20240801$20240801$EXP$$US-LUNDBECK-DKLU4002359$LUNDBECK$$$$$$Y$$$20240801$$CN$US$US
241631602$24163160$2$F$$20240806$20240801$20240816$EXP$$NZ-TEVA-VS-3226553$TEVA$Lee HK, Reiche L. Lamotrigine-induced generalised pustular psoriasis. N-Z-Med-J 2023; 136 99-101.; Lee HK, Reiche L. Lamotrigine-induced generalised pustular psoriasis. N-Z-Med-J 2023; 136 99-101.$23$YR$$F$Y$$$20240816$$HP$NZ$NZ
241631612$24163161$2$F$20240101$20240814$20240801$20240816$EXP$$CA-UCBSA-2024038676$UCB$$$$$F$Y$$$20240816$$CN$CA$CA
241631622$24163162$2$F$20231101$20240813$20240801$20240820$EXP$$US-AMERICAN REGENT INC-2024002854$AMERICAN REGENT$$67$YR$$F$Y$$$20240820$$CN$US$US
241631631$24163163$1$I$$20240723$20240801$20240801$EXP$$RO-ROCHE-10000035033$ROCHE$$$$A$M$Y$$$20240801$$MD$RO$RO
241631641$24163164$1$I$20240601$20240711$20240801$20240801$PER$$CO-TOLMAR, INC.-24CO051057$TOLMAR$$82$YR$$M$Y$$$20240801$$CN$CO$CO
241631651$24163165$1$I$20240714$20240717$20240801$20240801$EXP$$CA-HLS-202401775$HLS THERAPEUTICS$$75$YR$E$F$Y$$$20240801$$PH$CA$CA
241631661$24163166$1$I$$20240711$20240801$20240801$PER$$US-TOLMAR, INC.-24US050024$TOLMAR$$$$$M$Y$$$20240731$$HP$US$US
241631672$24163167$2$F$20240626$20240808$20240801$20240903$PER$$US-TOLMAR, INC.-24US050562$TOLMAR$$78$YR$$M$Y$$$20240903$$HP$US$US
241631681$24163168$1$I$$20240710$20240801$20240801$PER$$US-TOLMAR, INC.-24US050588$TOLMAR$$$$$$Y$$$20240731$$HP$US$US
241631692$24163169$2$F$$20240812$20240801$20240904$PER$$US-TOLMAR, INC.-24US050597$TOLMAR$$$$$M$Y$$$20240904$$PH$US$US
241631702$24163170$2$F$$20240813$20240801$20240830$PER$$US-TOLMAR, INC.-24US050665$TOLMAR$$$$$$Y$$$20240829$$HP$US$US
241631711$24163171$1$I$20240611$20240711$20240801$20240801$PER$$US-TOLMAR, INC.-24US050761$TOLMAR$$69$YR$$M$Y$$$20240731$$HP$US$US
241631722$24163172$2$F$20240702$20240815$20240801$20240905$PER$$US-TOLMAR, INC.-24US050772$TOLMAR$$64$YR$$M$Y$$$20240905$$HP$US$US
241631731$24163173$1$I$20240729$20240729$20240801$20240801$EXP$$US-OTSUKA-2024_021134$OTSUKA$$$$$$Y$$$20240801$$CN$US$US
241631741$24163174$1$I$20240507$20240509$20240801$20240801$PER$$US-BAYER-2024A090890$BAYER$$28$YR$A$F$Y$$$20240801$$MD$US$US
241631751$24163175$1$I$$20240730$20240801$20240801$EXP$$NVSC2024GR156420$NOVARTIS$$$$$$Y$$$20240801$$MD$GR$GR
241631762$24163176$2$F$$20240911$20240801$20240916$PER$$NVSC2024US156433$NOVARTIS$$$$$F$Y$59.2$KG$20240916$$HP$US$US
241631772$24163177$2$F$20221001$20240820$20240801$20240827$EXP$$GR-TEVA-VS-3225990$TEVA$$47$YR$$F$Y$$$20240827$$MD$GR$GR
241631781$24163178$1$I$20240723$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52702$$FDA-CTU$$69$YR$$F$N$89.1$KG$20240731$N$$US$
241631791$24163179$1$I$20240730$20240730$20240801$20240801$DIR$FDA-CDER-CTU-2024-52665$$FDA-CTU$$54$YR$$F$N$83.1$KG$20240730$N$$US$
241631801$24163180$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52750$$FDA-CTU$$59$YR$$F$N$92.53$KG$20240801$N$$US$
241631811$24163181$1$I$$20240610$20240801$20240801$PER$$US-LUNDBECK-DKLU4000414$LUNDBECK$$$$$$Y$$$20240801$$CN$US$US
241631821$24163182$1$I$20230101$20240723$20240801$20240801$EXP$$BR-TEVA-VS-3227072$TEVA$$68$YR$$F$Y$$$20240801$$CN$BR$BR
241631832$24163183$2$F$$20240829$20240801$20240912$PER$$US-GRANULES-US-2024GRASPO00302$GRANULES INDIA$$30$YR$A$M$Y$$$20240912$$PH$US$US
241631841$24163184$1$I$$20240723$20240801$20240801$EXP$$US-TEVA-VS-3227016$TEVA$$$$A$F$Y$$$20240801$$HP$US$US
241631851$24163185$1$I$$20240724$20240801$20240801$EXP$$GR-TEVA-VS-3225907$TEVA$$$$$F$Y$$$20240801$$MD$GR$GR
241631861$24163186$1$I$20240410$20240510$20240801$20240801$PER$$US-BAYER-2024A090923$BAYER$$29$YR$A$F$Y$$$20240801$$HP$US$US
241631873$24163187$3$F$20240729$20240805$20240801$20240807$PER$$US-AMGEN-USASP2024151048$AMGEN$$82$YR$E$F$Y$$$20240807$$CN$US$US
241631882$24163188$2$F$20240101$20240828$20240801$20240906$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00394$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
241631901$24163190$1$I$20180718$20240722$20240801$20240801$EXP$$AU-TEVA-VS-3226350$TEVA$$56$YR$$F$Y$$$20240801$$MD$AU$AU
241631911$24163191$1$I$20240501$20240501$20240801$20240801$PER$$US-BAYER-2024A091280$BAYER$$49$YR$A$F$Y$$$20240801$$MD$US$US
241631921$24163192$1$I$$20240717$20240801$20240801$EXP$$DE-TEVA-VS-3222527$TEVA$$$$$F$Y$$$20240801$$CN$DE$DE
241631931$24163193$1$I$$20240726$20240801$20240801$EXP$$DE-INCYTE CORPORATION-2024IN008010$INCYTE$$$$$$Y$$$20240801$$MD$DE$DE
241631942$24163194$2$F$$20240731$20240801$20240906$PER$$US-LUNDBECK-DKLU4001857$LUNDBECK$$$$$$Y$$$20240906$$CN$US$US
241631951$24163195$1$I$20240416$20240501$20240801$20240801$PER$$US-BAYER-2024A091286$BAYER$$33$YR$A$F$Y$$$20240801$$MD$US$US
241631961$24163196$1$I$$20240730$20240801$20240801$PER$$NVSC2024US157244$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241631971$24163197$1$I$$20240726$20240801$20240801$PER$$NVSC2024US154845$NOVARTIS$$$$$$Y$$$20240801$$CN$US$US
241631981$24163198$1$I$20240729$20240730$20240801$20240801$PER$$US-HALEON-2189870$Haleon PLC$$$$$F$Y$$$20240801$$CN$US$US
241631991$24163199$1$I$20240319$20240501$20240801$20240801$PER$$US-BAYER-2024A091291$BAYER$$24$YR$A$F$Y$$$20240801$$MD$US$US
241632001$24163200$1$I$20240110$20240222$20240801$20240801$PER$$US-BAYER-2024A091495$BAYER$$36$YR$A$F$Y$$$20240801$$MD$US$US
241632021$24163202$1$I$$20240610$20240801$20240801$PER$$US-LUNDBECK-DKLU4000344$LUNDBECK$$$$$$Y$$$20240801$$CN$US$US
241632041$24163204$1$I$20240716$20240729$20240801$20240801$EXP$$IN-AstraZeneca-2024A173154$ASTRAZENECA$$18673$DY$$M$Y$$$20240801$$CN$IN$
241632051$24163205$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A169656$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241632061$24163206$1$I$20240801$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52822$$FDA-CTU$$80$YR$$M$N$$$20240801$N$$US$
241632071$24163207$1$I$$20240726$20240801$20240801$EXP$$IT-PFIZER INC-PV202400097905$PFIZER$Testi, A.. Hodgkin Lymphoma in Children: A 16-year Experience at the Children^s Welfare Teaching Hospital of Baghdad, Iraq.. Mediterranean Journal of Hematology and Infectious Diseases. 2024;16(1):10.4084/MJHID.2024.053$$$C$$Y$$$20240801$$HP$IT$IQ
241632081$24163208$1$I$$20240724$20240801$20240801$EXP$$GB-MYLANLABS-2024M1070684$MYLAN$Del Mundo JS, Khan H. A rare presentation of geriatric non-epileptic seizures due to carotid artery encasement of a diffuse large B-cell lymphoma: A case report. Clin-Med-London 2024; 24 (Suppl.) 100095.$75$YR$$M$Y$$$20240801$$HP$GB$GB
241632111$24163211$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA221748$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240801$$MD$US$US
241632132$24163213$2$F$20240101$20240826$20240801$20240909$EXP$$EE-NOVOPROD-1262382$NOVO NORDISK$$43$YR$$M$Y$$$20240909$$HP$EE$EE
241632141$24163214$1$I$20240723$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52710$$FDA-CTU$$62$YR$$M$N$86.5$KG$20240731$N$$US$
241632151$24163215$1$I$20240708$20240719$20240801$20240801$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000685$PAREXEL$$$$$$Y$$$20240801$$HP$CN$CN
241632161$24163216$1$I$20240209$20240212$20240801$20240801$PER$$US-BAYER-2024A091396$BAYER$$39$YR$A$F$Y$$$20240801$$MD$US$US
241632171$24163217$1$I$20221027$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52663$$FDA-CTU$$71$YR$$M$N$101.3$KG$20240731$N$$US$
241632181$24163218$1$I$20240329$20240501$20240801$20240801$PER$$US-BAYER-2024A091314$BAYER$$30$YR$A$F$Y$$$20240801$$HP$US$US
241632191$24163219$1$I$$20240729$20240801$20240801$EXP$$NVSC2024US155769$NOVARTIS$$$$$M$Y$$$20240801$$HP$US$US
241632201$24163220$1$I$20240124$20240725$20240801$20240801$EXP$FR-AFSSAPS-TO2024001284$FR-009507513-2407FRA014315$MERCK$$73$YR$$F$Y$$$20240801$$PH$FR$FR
241632211$24163221$1$I$20240430$20240520$20240801$20240801$PER$$US-BAYER-2024A090946$BAYER$$24$YR$A$F$Y$$$20240801$$MD$US$US
241632222$24163222$2$F$$20240921$20240801$20240930$EXP$$IN-INCYTE CORPORATION-2024IN007966$INCYTE$$$$$$Y$$$20240930$$CN$IN$IN
241632231$24163223$1$I$20230920$20240212$20240801$20240801$PER$$US-BAYER-2024A091400$BAYER$$24$YR$A$F$Y$$$20240801$$MD$US$US
241632251$24163225$1$I$20240728$20240730$20240801$20240801$DIR$FDA-CDER-CTU-2024-52782$$FDA-CTU$$45$YR$$F$N$$$20240730$N$HP$US$
241632271$24163227$1$I$20240727$20240729$20240801$20240801$DIR$FDA-CDER-CTU-2024-52670$$FDA-CTU$$$$$M$N$36.6$KG$20240729$N$$US$
241632281$24163228$1$I$$20240722$20240801$20240801$EXP$$CA-BEH-2024176693$CSL BEHRING$$$$$M$Y$$$20240801$$CN$CA$CA
241632291$24163229$1$I$20240121$20240213$20240801$20240801$PER$$US-BAYER-2024A091387$BAYER$$47$YR$A$F$Y$$$20240801$$MD$US$US
241632301$24163230$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121044$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240801$$CN$US$US
241632311$24163231$1$I$20240627$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121495$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240801$$CN$US$US
241632321$24163232$1$I$$20240726$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122052$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$114.31$KG$20240801$$CN$US$US
241632331$24163233$1$I$20240711$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121493$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$$$20240801$$CN$US$US
241632341$24163234$1$I$$20240724$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118362$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240801$$CN$US$US
241632351$24163235$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA223247$SANOFI AVENTIS$$$$C$M$Y$$$20240801$$MD$US$US
241632361$24163236$1$I$20240730$20240730$20240801$20240801$DIR$FDA-CDER-CTU-2024-52667$$FDA-CTU$$17$YR$$M$N$69.2$KG$20240730$N$$US$
241632371$24163237$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA223680$SANOFI AVENTIS$$$$E$M$Y$$$20240801$$CN$US$US
241632381$24163238$1$I$20240209$20240213$20240801$20240801$PER$$US-BAYER-2024A091455$BAYER$$27$YR$A$F$Y$$$20240801$$MD$US$US
241632391$24163239$1$I$$20240723$20240801$20240801$PER$$US-BAYER-2024A107264$BAYER$$$$$M$Y$$$20240801$$CN$US$US
241632401$24163240$1$I$$20240730$20240801$20240801$PER$$US-BAYER-2024A111068$BAYER$$$$$$Y$$$20240801$$CN$US$US
241632411$24163241$1$I$20240503$20240506$20240801$20240801$PER$$US-BAYER-2024A090925$BAYER$$31$YR$A$F$Y$$$20240801$$MD$US$US
241632421$24163242$1$I$20240710$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52714$$FDA-CTU$$35$YR$$M$N$87$KG$20240731$N$$US$
241632431$24163243$1$I$20240531$20240725$20240801$20240801$EXP$FR-AFSSAPS-DJ2024000848$FR-009507513-2407FRA014432$MERCK$$61$YR$$M$Y$62$KG$20240801$$MD$FR$FR
241632441$24163244$1$I$20240212$20240215$20240801$20240801$PER$$US-BAYER-2024A091352$BAYER$$34$YR$A$F$Y$$$20240801$$MD$US$US
241632451$24163245$1$I$$20240712$20240801$20240801$PER$$US-MYLANLABS-2024M1070961$MYLAN$$$$$F$Y$$$20240801$$CN$US$US
241632461$24163246$1$I$$20240730$20240801$20240801$PER$$NVSC2024US157273$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241632471$24163247$1$I$20240215$20240216$20240801$20240801$PER$$US-BAYER-2024A091499$BAYER$$$$$F$Y$$$20240801$$MD$US$US
241632482$24163248$2$F$$20240730$20240801$20240809$PER$$US-BAYER-2024A111139$BAYER$$$$$$Y$$$20240809$$CN$US$US
241632491$24163249$1$I$20240426$20240506$20240801$20240801$PER$$US-BAYER-2024A091011$BAYER$$42$YR$A$F$Y$$$20240801$$MD$US$US
241632502$24163250$2$F$$20240731$20240801$20240814$EXP$$US-HLS-202400521$HLS THERAPEUTICS$$$$A$F$Y$$$20240814$$PH$US$US
241632511$24163251$1$I$20240213$20240216$20240801$20240801$PER$$US-BAYER-2024A092412$BAYER$$41$YR$A$F$Y$$$20240801$$MD$US$US
241632521$24163252$1$I$$20240722$20240801$20240801$PER$$US-AMGEN-USASP2024151758$AMGEN$Kamali A.; Khalaj K.; Jacobs M. A. et. Al.. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma. Cancers. 2024;16 (3):2440$$$$$Y$$$20240801$$HP$US$US
241632531$24163253$1$I$$20240725$20240801$20240801$EXP$GB-MHRA-MIDB-79dd5f53-180a-4b96-bf8d-5d7b52b82726$GB-RDY-SPO/GBR/24/0011056$DR REDDYS$$56$YR$A$$Y$$$20240801$$PH$GB$GB
241632541$24163254$1$I$20240627$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151264$AMGEN$$50$YR$A$M$Y$$$20240801$$CN$US$US
241632551$24163255$1$I$$20240726$20240801$20240801$EXP$$NVSC2024CZ145259$NOVARTIS$Citation B K. Lecba oboustrannych objemnych angiomyolipomu ledviny everolimem [Everolimus in treatment of bilateral giant angiomyolipomas]. CESKA UROLOGIE.. 2024;28(2):113-6$37$YR$$F$Y$$$20240801$$HP$CZ$CZ
241632561$24163256$1$I$$20240729$20240801$20240801$PER$$US-ROCHE-3554346$ROCHE$$$$$F$Y$$$20240801$$MD$US$US
241632571$24163257$1$I$20240429$20240506$20240801$20240801$PER$$US-BAYER-2024A091118$BAYER$$26$YR$A$F$Y$$$20240801$$MD$US$US
241632581$24163258$1$I$20240101$20240729$20240801$20240801$EXP$$RO-FreseniusKabi-FK202411787$FRESENIUS KABI$$74$YR$E$M$Y$$$20240801$$MD$RO$RO
241632591$24163259$1$I$$20240731$20240801$20240801$EXP$GB-MHRA-TPP12479291C576475YC1722346102666$GB-ORGANON-O2407GBR003022$ORGANON$$34$YR$$M$Y$69$KG$20240801$$HP$GB$GB
241632601$24163260$1$I$20240109$20240220$20240801$20240801$PER$$US-BAYER-2024A091415$BAYER$$33$YR$A$F$Y$$$20240801$$MD$US$US
241632622$24163262$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225490$TEVA$Allonce J, Patel V. New-onset Refractory Status Epilepticus Induced by Synthetic Marijuana: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 A2117.; Allonce J, Patel V. New-onset Refractory Status Epilepticus Induced by Synthetic Marijuana: A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 A2117.$26$YR$$M$Y$$$20240816$$HP$US$US
241632631$24163263$1$I$20240219$20240222$20240801$20240801$PER$$US-BAYER-2024A091460$BAYER$$36$YR$A$F$Y$$$20240801$$MD$US$US
241632641$24163264$1$I$20240504$20240506$20240801$20240801$PER$$US-BAYER-2024A091126$BAYER$$23$YR$A$F$Y$$$20240801$$MD$US$US
241632651$24163265$1$I$20231025$20240725$20240801$20240801$EXP$IT-MINISAL02-996661$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-121963$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$62$KG$20240801$$MD$IT$IT
241632661$24163266$1$I$20240707$20240725$20240801$20240801$EXP$ES-AEMPS-1551648$ES-SA-2024SA218799$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240801$$MD$ES$ES
241632671$24163267$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407018414$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240801$$CN$US$US
241632681$24163268$1$I$20240701$20240723$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011436$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241632691$24163269$1$I$$20240115$20240801$20240801$EXP$$NVSC2024CA155503$NOVARTIS$$44$YR$$F$Y$97$KG$20240801$$HP$CA$CA
241632701$24163270$1$I$20240730$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000372$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240801$$CN$US$US
241632711$24163271$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000124$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240801$$CN$US$US
241632731$24163273$1$I$20240723$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52749$$FDA-CTU$$73$YR$$F$N$$$20240731$N$HP$US$
241632761$24163276$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52752$$FDA-CTU$$53$YR$$F$N$139.71$KG$20240801$N$$US$
241632771$24163277$1$I$20240615$20240729$20240801$20240801$EXP$$RU-009507513-2407RUS015946$MERCK$$47$YR$$F$Y$99$KG$20240801$$HP$RU$RU
241632781$24163278$1$I$20231217$20240223$20240801$20240801$PER$$US-BAYER-2024A091482$BAYER$$32$YR$A$F$Y$$$20240801$$MD$US$US
241632791$24163279$1$I$20240430$20240501$20240801$20240801$PER$$US-BAYER-2024A090973$BAYER$$34$YR$A$F$Y$$$20240801$$MD$US$US
241632802$24163280$2$F$20240723$20240816$20240801$20240820$PER$$NVSC2024US157274$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
241632811$24163281$1$I$$20240612$20240801$20240801$PER$$US-LUNDBECK-DKLU4000442$LUNDBECK$$$$$$Y$$$20240801$$HP$US$US
241632821$24163282$1$I$20240727$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024151110$AMGEN$$$$$$Y$$$20240801$$HP$US$US
241632831$24163283$1$I$20240206$20240223$20240801$20240801$PER$$US-BAYER-2024A091486$BAYER$$37$YR$A$F$Y$$$20240801$$MD$US$US
241632841$24163284$1$I$$20240705$20240801$20240801$PER$$US-JNJFOC-20240717981$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
241632852$24163285$2$F$20240701$20240814$20240801$20240823$EXP$$KR-UNITED THERAPEUTICS-UNT-2024-023289$UNITED THERAPEUTICS$$59$YR$$M$Y$50$KG$20240823$$$KR$KR
241632861$24163286$1$I$20240217$20240226$20240801$20240801$PER$$US-BAYER-2024A091506$BAYER$$26$YR$A$F$Y$$$20240801$$MD$US$US
241632871$24163287$1$I$20240403$20240501$20240801$20240801$PER$$US-BAYER-2024A090985$BAYER$$36$YR$A$F$Y$$$20240801$$MD$US$US
241632882$24163288$2$F$$20240821$20240801$20240829$EXP$$GR-TEVA-VS-3226037$TEVA$$$$$F$Y$$$20240829$$MD$GR$GR
241632891$24163289$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121896$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$61.6$KG$20240801$$HP$US$US
241632901$24163290$1$I$$20240723$20240801$20240801$EXP$$JP-009507513-2407JPN004340J$MERCK$$$$$F$Y$$$20240801$$MD$JP$JP
241632911$24163291$1$I$$20240610$20240801$20240801$PER$$US-LUNDBECK-DKLU4000351$LUNDBECK$$$$$$Y$$$20240801$$HP$US$US
241632921$24163292$1$I$$20240725$20240801$20240801$EXP$$AU-ALSI-2024000209$AIRGAS$$3$YR$$M$Y$$$20240801$$MD$AU$AU
241632931$24163293$1$I$20240613$20240719$20240801$20240801$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000677$PAREXEL$$$$$$Y$$$20240801$$HP$CN$CN
241632941$24163294$1$I$20240701$20240724$20240801$20240801$EXP$FR-AFSSAPS-RS2024000707$FR-TEVA-VS-3225707$TEVA$$85$YR$$F$Y$48.8$KG$20240801$$MD$FR$FR
241632951$24163295$1$I$20240101$20240724$20240801$20240801$EXP$AT-BASGAGES-2024-005291$AT-TEVA-VS-3225437$TEVA$$87$YR$$F$Y$63$KG$20240801$$MD$AT$AT
241632961$24163296$1$I$20240101$20240731$20240801$20240801$EXP$$US-UCBSA-2024038669$UCB$$$$$$Y$$$20240801$$CN$US$US
241632971$24163297$1$I$20240729$20240729$20240801$20240801$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2024-105300$REGENERON$$61$YR$$F$Y$$$20240801$$CN$GB$GB
241632981$24163298$1$I$20240606$20240722$20240801$20240801$EXP$$US-ADMA BIOLOGICS INC.-US-2024ADM000097$ADMA BIOLOGICS$$72$YR$$M$Y$$$20240801$$PH$US$US
241632991$24163299$1$I$20240223$20240226$20240801$20240801$PER$$US-BAYER-2024A091513$BAYER$$38$YR$A$F$Y$$$20240801$$MD$US$US
241633002$24163300$2$F$20240209$20240905$20240801$20240912$EXP$FR-AFSSAPS-NY2024000826$FR-009507513-2407FRA014610$MERCK$$34$YR$$F$Y$62$KG$20240912$$PH$FR$FR
241633011$24163301$1$I$$20240607$20240801$20240801$PER$$US-LUNDBECK-DKLU4000295$LUNDBECK$$$$$$Y$$$20240801$$CN$US$US
241633021$24163302$1$I$$20240723$20240801$20240801$PER$$US-ROCHE-10000034656$ROCHE$$$$$$Y$$$20240801$$CN$US$US
241633031$24163303$1$I$20230603$20240729$20240801$20240801$EXP$DK-DKMA-30736598$DK-FreseniusKabi-FK202411791$FRESENIUS KABI$$35$YR$A$F$Y$75$KG$20240801$$CN$DK$DK
241633041$24163304$1$I$20240625$20240729$20240801$20240801$EXP$DE-CADRBFARM-2024329530$DE-FreseniusKabi-FK202411853$FRESENIUS KABI$$68$YR$E$F$Y$44$KG$20240801$$MD$DE$DE
241633051$24163305$1$I$20240603$20240729$20240801$20240801$EXP$DE-CADRBFARM-2024329529$DE-FreseniusKabi-FK202411852$FRESENIUS KABI$$50$YR$A$F$Y$78$KG$20240801$$MD$DE$DE
241633061$24163306$1$I$20240503$20240729$20240801$20240801$EXP$$ES-FreseniusKabi-FK202411800$FRESENIUS KABI$$2$YR$C$M$Y$$$20240801$$PH$ES$ES
241633071$24163307$1$I$$20240722$20240801$20240801$EXP$$BE-JNJFOC-20240761211$JOHNSON AND JOHNSON$$$$E$$Y$$$20240801$$MD$BE$BE
241633081$24163308$1$I$20240221$20240614$20240801$20240801$PER$$JP-Eisai-EC-2024-157987$EISAI$$$$A$F$Y$$$20240801$$MD$JP$JP
241633091$24163309$1$I$20240101$20240523$20240801$20240801$PER$$US-BAYER-2024A091023$BAYER$$39$YR$A$F$Y$$$20240801$$CN$US$US
241633101$24163310$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52760$$FDA-CTU$$53$YR$$F$N$106.14$KG$20240801$N$$US$
241633121$24163312$1$I$$20240724$20240801$20240801$PER$$US-ABBVIE-5854980$ABBVIE$$$$$M$Y$$$20240801$$HP$US$US
241633141$24163314$1$I$$20240724$20240801$20240801$PER$$US-ROCHE-10000038744$ROCHE$$59$YR$A$M$Y$$$20240801$$CN$US$US
241633151$24163315$1$I$20240112$20240229$20240801$20240801$PER$$US-BAYER-2024A091490$BAYER$$25$YR$A$F$Y$$$20240801$$HP$US$US
241633161$24163316$1$I$20240608$20240730$20240801$20240801$EXP$FR-AFSSAPS-NY2024000839$FR-ORGANON-O2407FRA002810$ORGANON$$37$YR$$M$Y$70$KG$20240801$$MD$FR$FR
241633171$24163317$1$I$$20240717$20240801$20240801$EXP$$CA-HLS-202401781$HLS THERAPEUTICS$$$$E$F$Y$$$20240801$$CN$CA$CA
241633181$24163318$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121884$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$HP$US$US
241633192$24163319$2$F$$20240916$20240801$20240917$PER$$NVSC2024US157247$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
241633201$24163320$1$I$20240414$20240722$20240801$20240801$PER$$US-INCYTE CORPORATION-2024IN004444$INCYTE$$$$$$Y$$$20240801$$MD$US$US
241633211$24163321$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221667$SANOFI AVENTIS$$$$T$M$Y$53.9$KG$20240801$$MD$US$US
241633221$24163322$1$I$20240507$20240516$20240801$20240801$PER$$US-BAYER-2024A091046$BAYER$$31$YR$A$F$Y$$$20240801$$MD$US$US
241633231$24163323$1$I$$20240725$20240801$20240801$PER$$US-ABBVIE-5856323$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241633241$24163324$1$I$20240701$20240724$20240801$20240801$PER$$US-ABBVIE-5855528$ABBVIE$$$$$M$Y$$$20240801$$HP$US$US
241633251$24163325$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221745$SANOFI AVENTIS$$$$$$Y$$$20240801$$CN$US$US
241633261$24163326$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA223177$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240801$$MD$US$US
241633274$24163327$4$F$$20240923$20240801$20240925$EXP$$CZ-UCBSA-2024038334$UCB$Klocperk A, Bloomfield AM, Schneiderova H, Hlavackova E, Turno-Vec M, Tichy L, et al. Neonatal Screening of Severe Combined Immunodeficiency (SCID) in the Czech Republic. Allergies. 2024;-:85-90$$$N$$Y$$$20240925$$MD$CZ$CZ
241633281$24163328$1$I$20240601$20240725$20240801$20240801$PER$$US-SA-2024SA223393$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240801$$MD$US$US
241633291$24163329$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA224184$SANOFI AVENTIS$$$$A$F$Y$58.96$KG$20240801$$MD$US$US
241633301$24163330$1$I$20240503$20240503$20240801$20240801$PER$$US-BAYER-2024A091140$BAYER$$22$YR$A$F$Y$$$20240801$$MD$US$US
241633312$24163331$2$F$$20240730$20240801$20240809$EXP$$BG-BIOCON BIOLOGICS LIMITED-BBL2024005586$BIOCON$V. Petrusheva, M. Samardzhieva, I. Simova, N. Chilingirova, T. Vekov.. Cardiotoxicity in patient with breast cancer treated with HER-2 targeted therapy-A case report. Cardiovascular Diseases. 2024;2:14-23$$$$$Y$$$20240809$$HP$BG$BG
241633321$24163332$1$I$20240226$20240229$20240801$20240801$PER$$US-BAYER-2024A091505$BAYER$$44$YR$A$F$Y$$$20240801$$MD$US$US
241633331$24163333$1$I$$20240722$20240801$20240801$PER$$US-INCYTE CORPORATION-2024IN006713$INCYTE$$$$$$Y$$$20240801$$CN$US$US
241633342$24163334$2$F$$20240806$20240801$20240816$EXP$$DE-TEVA-VS-3226606$TEVA$Austein T, Sommer MM, Morche M, Finck A. Uncommon diagnosis of malignant Melanoma by bone marrow smear. Oncol-Res-Treat 2023; 46 (Suppl. 5) 175 abstr. P327.; Austein T, Sommer MM, Morche M, Finck A. Uncommon diagnosis of malignant Melanoma by bone marrow smear. Oncol-Res-Treat 2023; 46 (Suppl. 5) 175 abstr. P327.$62$YR$$M$Y$$$20240816$$HP$DE$DE
241633351$24163335$1$I$20240719$20240730$20240801$20240801$EXP$$US-TAKEDA-2024TUS060269$TAKEDA$$47$YR$$M$Y$50$KG$20240801$$HP$US$US
241633361$24163336$1$I$20240419$20240723$20240801$20240801$EXP$$US-GSK-US2024092266$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
241633371$24163337$1$I$20240227$20240229$20240801$20240801$PER$$US-BAYER-2024A091510$BAYER$$$$$F$Y$$$20240801$$MD$US$US
241633381$24163338$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52765$$FDA-CTU$$58$YR$$F$N$$$20240801$N$$US$
241633391$24163339$1$I$20240710$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52826$$FDA-CTU$$62$YR$$F$N$81.65$KG$20240801$N$PH$US$
241633411$24163341$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52767$$FDA-CTU$$87$YR$$F$N$99.79$KG$20240801$N$$US$
241633421$24163342$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52799$$FDA-CTU$$69$YR$$F$N$78.02$KG$20240801$N$$US$
241633432$24163343$2$F$20240724$20240917$20240801$20240919$PER$$US-ROCHE-10000046209$ROCHE$$6$YR$C$M$Y$$$20240919$$CN$US$US
241633441$24163344$1$I$20240628$20240731$20240801$20240801$EXP$$CN-ROCHE-10000045933$ROCHE$$77$YR$E$F$Y$$$20240801$$HP$CN$CN
241633451$24163345$1$I$20240703$20240731$20240801$20240801$PER$$US-ROCHE-10000046197$ROCHE$$11$YR$C$M$Y$$$20240801$$CN$US$US
241633462$24163346$2$F$20220601$20240731$20240801$20240802$PER$$US-ROCHE-10000046102$ROCHE$$53$YR$A$M$Y$$$20240802$$CN$US$US
241633472$24163347$2$F$20240713$20240730$20240801$20240806$PER$$US-ROCHE-10000043774$ROCHE$$67$YR$E$F$Y$$$20240806$$CN$US$US
241633482$24163348$2$F$20240629$20240726$20240801$20240805$EXP$FR-AFSSAPS-LM2024000407$FR-EMD Serono-2024040216$EMD SERONO INC$$57$YR$A$M$Y$90$KG$20240805$$MD$FR$FR
241633491$24163349$1$I$20240430$20240501$20240801$20240801$PER$$US-BAYER-2024A091151$BAYER$$46$YR$A$F$Y$$$20240801$$MD$US$US
241633501$24163350$1$I$$20240607$20240801$20240801$PER$$US-LUNDBECK-DKLU4000212$LUNDBECK$$$$$$Y$$$20240801$$HP$US$US
241633511$24163351$1$I$20240501$20240723$20240801$20240801$PER$$US-INCYTE CORPORATION-2024IN007749$INCYTE$$$$$$Y$$$20240801$$CN$US$US
241633521$24163352$1$I$20240701$20240729$20240801$20240801$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004219$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
241633531$24163353$1$I$$20240729$20240801$20240801$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004209$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
241633541$24163354$1$I$$20240729$20240801$20240801$EXP$$DE-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004203$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240801$$MD$DE$DE
241633554$24163355$4$F$20240727$20240912$20240801$20240917$PER$$US-ROCHE-10000046001$ROCHE$$27$YR$A$M$Y$58.97$KG$20240917$$CN$US$US
241633561$24163356$1$I$$20240730$20240801$20240801$PER$$US-ROCHE-10000043700$ROCHE$$62$YR$A$M$Y$$$20240801$$HP$US$US
241633572$24163357$2$F$20240720$20240918$20240801$20240919$PER$$US-ROCHE-10000046246$ROCHE$$16$YR$T$M$Y$$$20240919$$CN$US$US
241633581$24163358$1$I$$20240730$20240801$20240801$PER$$US-ROCHE-10000044620$ROCHE$$84$YR$E$F$Y$$$20240801$$CN$US$US
241633593$24163359$3$F$$20240815$20240801$20240816$PER$$US-ROCHE-10000046242$ROCHE$$26$YR$A$M$Y$$$20240816$$CN$US$US
241633601$24163360$1$I$20240708$20240729$20240801$20240801$EXP$$CN-AstraZeneca-2024A173607$ASTRAZENECA$$838$MON$$M$Y$$$20240801$$MD$CN$
241633611$24163361$1$I$20240715$20240729$20240801$20240801$EXP$$CN-SA-2024SA224255$SANOFI AVENTIS$$60$YR$A$M$Y$80$KG$20240801$$HP$CN$CN
241633622$24163362$2$F$20240730$20240806$20240801$20240807$EXP$$CA-BAYER-2024A111290$BAYER$$75$YR$E$F$Y$$$20240807$$HP$CA$CA
241633631$24163363$1$I$20240228$20240229$20240801$20240801$PER$$US-BAYER-2024A091526$BAYER$$$$$F$Y$$$20240801$$MD$US$US
241633641$24163364$1$I$20240430$20240502$20240801$20240801$PER$$US-BAYER-2024A091165$BAYER$$27$YR$A$F$Y$$$20240801$$HP$US$US
241633651$24163365$1$I$20230101$20240722$20240801$20240801$EXP$$US-ROCHE-10000033678$ROCHE$$46$YR$A$F$Y$106.59$KG$20240801$$CN$US$US
241633671$24163367$1$I$20240101$20240723$20240801$20240801$EXP$$JP-009507513-2407JPN004518J$MERCK$$4$DEC$$F$Y$$$20240801$$MD$JP$JP
241633681$24163368$1$I$20240101$20240726$20240801$20240801$EXP$$US-Eisai-EC-2024-171314$EISAI$$66$YR$E$F$Y$59$KG$20240801$$CN$US$US
241633691$24163369$1$I$20240711$20240717$20240801$20240801$PER$$US-FreseniusKabi-FK202411429$FRESENIUS KABI$$84$YR$E$F$Y$58.97$KG$20240801$$CN$US$US
241633701$24163370$1$I$20240421$20240729$20240801$20240801$EXP$FR-AFSSAPS-BR2024000611$FR-FreseniusKabi-FK202411866$FRESENIUS KABI$$33$YR$A$F$Y$54$KG$20240801$$MD$FR$FR
241633711$24163371$1$I$20240529$20240729$20240801$20240801$EXP$FR-AFSSAPS-PP2024000830$FR-FreseniusKabi-FK202411873$FRESENIUS KABI$$86$YR$E$F$Y$57$KG$20240801$$PH$FR$FR
241633721$24163372$1$I$20240229$20240301$20240801$20240801$PER$$US-BAYER-2024A091530$BAYER$$17$YR$T$F$Y$$$20240801$$CN$US$US
241633732$24163373$2$F$$20240911$20240801$20240912$EXP$$US-TAKEDA-2024TUS064596$TAKEDA$$$$$F$Y$$$20240912$$CN$US$US
241633741$24163374$1$I$$20240726$20240801$20240801$EXP$$CA-TAKEDA-2024TUS076435$TAKEDA$$$$$M$Y$$$20240801$$MD$CA$CA
241633751$24163375$1$I$20240728$20240801$20240801$20240801$DIR$712371$$FDA-CTU$$84$YR$$M$N$77.85$KG$20240801$N$$US$
241633761$24163376$1$I$20240406$20240502$20240801$20240801$PER$$US-BAYER-2024A091184$BAYER$$17$YR$T$F$Y$$$20240801$$MD$US$US
241633771$24163377$1$I$20240723$20240726$20240801$20240801$EXP$$US-G1 THERAPEUTICS-2024G1US0000097$G1 THERAPEUTICS$$$$$$Y$$$20240801$$CN$US$US
241633782$24163378$2$F$20240101$20240911$20240801$20240916$PER$$US-ORGANON-O2407USA002845$ORGANON$$$$$F$Y$52.698$KG$20240916$$HP$US$US
241633791$24163379$1$I$$20240730$20240801$20240801$EXP$$US-PURDUE PHARMA-USA-2024-0311067$PURDUE$$$$$F$Y$$$20240801$$CN$US$US
241633801$24163380$1$I$20240719$20240726$20240801$20240801$EXP$$CN-PURDUE-USA-2024-0311084$PURDUE$$69$YR$$M$Y$$$20240801$$HP$CN$CN
241633811$24163381$1$I$20240717$20240726$20240801$20240801$EXP$$CN-PURDUE-USA-2024-0311070$PURDUE$$69$YR$$M$Y$60$KG$20240801$$HP$CN$CN
241633821$24163382$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019717$ELI LILLY AND CO$$63$YR$A$$Y$$$20240801$$CN$US$US
241633831$24163383$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019160$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240801$$CN$US$US
241633841$24163384$1$I$20240728$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019162$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240801$$CN$US$US
241633851$24163385$1$I$$20240722$20240801$20240801$EXP$$CA-TEVA-VS-3224822$TEVA$$43$YR$$M$Y$$$20240801$$MD$CA$CA
241633861$24163386$1$I$20240731$20240801$20240801$20240801$DIR$712373$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241633881$24163388$1$I$20240617$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000379$ELI LILLY AND CO$$68$YR$E$$Y$$$20240801$$CN$US$US
241633891$24163389$1$I$20240328$20240426$20240801$20240801$PER$$US-BAYER-2024A092725$BAYER$$40$YR$A$F$Y$$$20240801$$MD$US$US
241633901$24163390$1$I$20240502$20240502$20240801$20240801$PER$$US-BAYER-2024A091191$BAYER$$31$YR$A$F$Y$$$20240801$$MD$US$US
241633911$24163391$1$I$20240424$20240725$20240801$20240801$EXP$$DE-BAYER-2024A108816$BAYER$$74$YR$E$M$Y$$$20240801$$MD$DE$DE
241633921$24163392$1$I$20230101$20240724$20240801$20240801$EXP$FR-AFSSAPS-LY2024001077$FR-TEVA-VS-3225692$TEVA$$34$YR$$M$Y$$$20240801$$MD$FR$FR
241633931$24163393$1$I$20240216$20240301$20240801$20240801$PER$$US-BAYER-2024A091533$BAYER$$42$YR$A$F$Y$$$20240801$$MD$US$US
241633941$24163394$1$I$20230830$20240722$20240801$20240801$EXP$GB-MHRA-31184211$GB-MYLANLABS-2024M1068410$MYLAN$$74$YR$$M$Y$87$KG$20240801$$MD$GB$GB
241633951$24163395$1$I$20240604$20240724$20240801$20240801$EXP$FR-AFSSAPS-GR2024000888$FR-TEVA-VS-3225684$TEVA$$58$YR$$M$Y$$$20240801$$PH$FR$FR
241633961$24163396$1$I$$20240726$20240801$20240801$EXP$GB-MHRA-31082675$GB-ABBVIE-5861094$ABBVIE$$23$YR$$M$Y$$$20240801$$CN$GB$GB
241633971$24163397$1$I$$20240729$20240801$20240801$EXP$$US-VERTEX PHARMACEUTICALS-2024-012481$VERTEX$$$$$M$Y$$$20240801$$HP$US$US
241633981$24163398$1$I$$20240726$20240801$20240801$PER$$US-VERTEX PHARMACEUTICALS-2024-012414$VERTEX$$27$YR$$F$Y$$$20240801$$CN$US$US
241633992$24163399$2$F$$20240809$20240801$20240813$PER$$US-VERTEX PHARMACEUTICALS-2024-012360$VERTEX$$35$YR$$M$Y$$$20240813$$CN$US$US
241634002$24163400$2$F$20240610$20240805$20240801$20240813$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017757$UNITED THERAPEUTICS$$61$YR$$F$Y$48.299$KG$20240813$$PH$US$US
241634011$24163401$1$I$$20240729$20240801$20240801$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012473$VERTEX$$$$A$F$Y$$$20240801$$CN$GB$GB
241634021$24163402$1$I$$20240723$20240801$20240801$PER$$US-VERTEX PHARMACEUTICALS-2024-012207$VERTEX$$$$$M$Y$$$20240801$$CN$US$US
241634031$24163403$1$I$$20240726$20240801$20240801$PER$$US-VERTEX PHARMACEUTICALS-2024-012404$VERTEX$$60$YR$$F$Y$$$20240801$$CN$US$US
241634042$24163404$2$F$$20240905$20240801$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-012515$VERTEX$$$$$$Y$$$20240912$$CN$US$US
241634052$24163405$2$F$$20240809$20240801$20240814$PER$$US-AMGEN-USASP2024151259$AMGEN$$$$$M$Y$$$20240814$$CN$US$US
241634061$24163406$1$I$$20240731$20240801$20240801$EXP$$CN-GILEAD-2024-0682606$GILEAD$$58$YR$A$F$Y$57$KG$20240801$$HP$CN$CN
241634071$24163407$1$I$20240101$20240726$20240801$20240801$PER$$US-ABBVIE-5857103$ABBVIE$$55$YR$$F$Y$$$20240801$$CN$US$US
241634082$24163408$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225956$TEVA$Rhoads S, Maloney J, Mantha A, Van Hook R, Henao-Martinez AF. Pneumocystis jirovecii Pneumonia in HIV-Negative, Non-transplant Patients: Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention. Curr-Fungal-Infect-Rep 2024; 18 (2): 125-135; Rhoads S, Maloney J, Mantha A, Van Hook R, Henao-Martinez AF. Pneumocystis jirovecii Pneumonia in HIV-Negative, Non-transplant Patients: Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention. Curr-Fungal-Infect-Rep ...$34$YR$$F$Y$$$20240816$$HP$US$US
241634091$24163409$1$I$20240423$20240424$20240801$20240801$PER$$US-BAYER-2024A092472$BAYER$$38$YR$A$F$Y$$$20240801$$MD$US$US
241634101$24163410$1$I$20240220$20240304$20240801$20240801$PER$$US-BAYER-2024A091548$BAYER$$19$YR$A$F$Y$$$20240801$$MD$US$US
241634112$24163411$2$F$20240422$20240805$20240801$20240806$PER$$US-BAYER-2024A091161$BAYER$$44$YR$A$F$Y$$$20240806$$MD$US$US
241634121$24163412$1$I$20240731$20240801$20240801$20240801$DIR$712375$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241634131$24163413$1$I$20240731$20240801$20240801$20240801$DIR$712380$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241634141$24163414$1$I$20240801$20240801$20240801$20240801$DIR$712382$$FDA-CTU$$30$YR$$M$N$$$20240801$N$$US$
241634171$24163417$1$I$$20240731$20240801$20240801$PER$$US-JNJFOC-20240801106$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
241634181$24163418$1$I$20240601$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121856$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240801$$HP$US$US
241634191$24163419$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA223108$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240801$$MD$US$US
241634201$24163420$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA221290$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240801$$MD$US$US
241634211$24163421$1$I$20240226$20240304$20240801$20240801$PER$$US-BAYER-2024A092084$BAYER$$21$YR$A$F$Y$$$20240801$$MD$US$US
241634232$24163423$2$F$20200917$20240812$20240801$20240814$EXP$$CA-TAKEDA-2024TUS076685$TAKEDA$$81$YR$$F$Y$$$20240814$$CN$CA$CA
241634241$24163424$1$I$$20240731$20240801$20240801$PER$$NVSC2024US157289$NOVARTIS$$$$$M$Y$$$20240801$$MD$US$US
241634251$24163425$1$I$20240720$20240801$20240801$20240801$DIR$712381$$FDA-CTU$$41$YR$$M$N$100.9$KG$20240801$N$PH$US$
241634261$24163426$1$I$20240418$20240726$20240801$20240801$EXP$IT-MINISAL02-996040$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004223$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240801$$MD$IT$IT
241634271$24163427$1$I$$20240726$20240801$20240801$EXP$$US-MYLANLABS-2024M1071225$MYLAN$Martinez A, Hernandez S, Montreuil N, Quiroz T, Kaur D, Ayoade F, et al. Multi-drug resistant gluteal abscesses due to Mycobacterium abscessus following medical tourism for cosmetic purposes to Mexico. J-Travel-Med 2023; 30 (8).$34$YR$$F$Y$$$20240801$$MD$US$US
241634281$24163428$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52792$$FDA-CTU$$63$YR$$F$N$69$KG$20240731$N$$US$
241634291$24163429$1$I$20201221$20240726$20240801$20240801$EXP$$DE-MYLANLABS-2021M1054128$MYLAN$$$$A$F$Y$100$KG$20240801$$MD$DE$DE
241634301$24163430$1$I$$20240725$20240801$20240801$EXP$$US-MYLANLABS-2024M1071088$MYLAN$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. J-Allergy-Clin-Immunol-Pract 2024; 12 (6): 1663-1665.$36$YR$$F$Y$$$20240801$$MD$US$US
241634311$24163431$1$I$20240212$20240305$20240801$20240801$PER$$US-BAYER-2024A091542$BAYER$$37$YR$A$F$Y$$$20240801$$MD$US$US
241634321$24163432$1$I$20240304$20240305$20240801$20240801$PER$$US-BAYER-2024A091583$BAYER$$41$YR$A$F$Y$$$20240801$$MD$US$US
241634331$24163433$1$I$20240418$20240424$20240801$20240801$PER$$US-BAYER-2024A091324$BAYER$$42$YR$A$F$Y$$$20240801$$MD$US$US
241634341$24163434$1$I$20240306$20240307$20240801$20240801$PER$$US-BAYER-2024A091599$BAYER$$20$YR$A$F$Y$$$20240801$$MD$US$US
241634351$24163435$1$I$20240425$20240425$20240801$20240801$PER$$US-BAYER-2024A091733$BAYER$$43$YR$A$F$Y$$$20240801$$HP$US$US
241634362$24163436$2$F$20240725$20240911$20240801$20240916$PER$$US-JNJFOC-20240776941$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$US$US
241634371$24163437$1$I$$20240731$20240801$20240801$PER$$US-HALEON-2190033$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241634381$24163438$1$I$20240101$20240725$20240801$20240801$PER$$US-SA-2024SA223208$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240801$$MD$US$US
241634391$24163439$1$I$20240723$20240725$20240801$20240801$PER$$US-SA-2024SA222173$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240801$$MD$US$US
241634401$24163440$1$I$20240101$20240725$20240801$20240801$PER$$US-SA-2024SA223168$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240801$$MD$US$US
241634411$24163441$1$I$20240707$20240731$20240801$20240801$EXP$$US-BAUSCH-BL-2024-001141$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240801$$HP$US$US
241634421$24163442$1$I$20240729$20240731$20240801$20240801$EXP$$US-BAUSCH-BL-2024-011715$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240801$$CN$US$US
241634431$24163443$1$I$20240228$20240306$20240801$20240801$PER$$US-BAYER-2024A091602$BAYER$$42$YR$A$F$Y$$$20240801$$MD$US$US
241634441$24163444$1$I$20240216$20240419$20240801$20240801$PER$$US-BAYER-2024A090910$BAYER$$31$YR$A$F$Y$$$20240801$$MD$US$US
241634451$24163445$1$I$20240419$20240422$20240801$20240801$PER$$US-BAYER-2024A092455$BAYER$$$$$F$Y$$$20240801$$MD$US$US
241634461$24163446$1$I$$20240729$20240801$20240801$EXP$$JP-ABBVIE-5835600$ABBVIE$$71$YR$$$Y$$$20240801$$MD$JP$JP
241634481$24163448$1$I$20240416$20240422$20240801$20240801$PER$$US-BAYER-2024A092454$BAYER$$43$YR$A$F$Y$$$20240801$$MD$US$US
241634491$24163449$1$I$20240305$20240307$20240801$20240801$PER$$US-BAYER-2024A091604$BAYER$$25$YR$A$F$Y$$$20240801$$CN$US$US
241634501$24163450$1$I$20240417$20240418$20240801$20240801$PER$$US-BAYER-2024A092432$BAYER$$$$$F$Y$$$20240801$$MD$US$US
241634511$24163451$1$I$20240101$20240730$20240801$20240801$EXP$$CA-UCBSA-2024038585$UCB$$$$$M$Y$$$20240801$$CN$CA$CA
241634523$24163452$3$F$20240101$20240919$20240801$20240930$EXP$$US-UCBSA-2024030261$UCB$$$$$F$Y$$$20241001$$CN$US$US
241634531$24163453$1$I$20240226$20240308$20240801$20240801$PER$$US-BAYER-2024A091606$BAYER$$28$YR$A$F$Y$$$20240801$$MD$US$US
241634541$24163454$1$I$20240408$20240418$20240801$20240801$PER$$US-BAYER-2024A092434$BAYER$$45$YR$A$F$Y$$$20240801$$MD$US$US
241634551$24163455$1$I$20240307$20240308$20240801$20240801$PER$$US-BAYER-2024A091791$BAYER$$36$YR$A$F$Y$$$20240801$$HP$US$US
241634561$24163456$1$I$20240422$20240423$20240801$20240801$PER$$US-BAYER-2024A092471$BAYER$$17$YR$T$F$Y$$$20240801$$MD$US$US
241634571$24163457$1$I$20240401$20240404$20240801$20240801$PER$$US-BAYER-2024A092317$BAYER$$21$YR$A$F$Y$$$20240801$$MD$US$US
241634581$24163458$1$I$20240522$20240722$20240801$20240801$EXP$FR-AFSSAPS-GR2024000856$FR-NORDICGR-056986$NORDIC PHARMA$$88$YR$$F$Y$$$20240801$$PH$FR$FR
241634591$24163459$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225831$TEVA$$63$YR$$M$Y$$$20240801$$HP$CA$CA
241634601$24163460$1$I$20240701$20240722$20240801$20240801$EXP$CN-NMPACDR-4401131007711202400221$CN-BAXTER-2024BAX022235$BAXTER$$47$YR$$M$Y$75$KG$20240801$$MD$CN$CN
241634611$24163461$1$I$20231223$20240722$20240801$20240801$EXP$FR-AFSSAPS-NY2024000761$FR-NORDICGR-056981$NORDIC PHARMA$$30$YR$$F$Y$50$KG$20240801$$MD$FR$FR
241634621$24163462$1$I$20240105$20240724$20240801$20240801$EXP$FR-AFSSAPS-TS2024000818$FR-TEVA-VS-3225665$TEVA$$75$YR$$F$Y$60$KG$20240801$$MD$FR$FR
241634631$24163463$1$I$20240101$20240717$20240801$20240801$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0739$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
241634641$24163464$1$I$$20240722$20240801$20240801$EXP$NL-LRB-00985651$NL-BAXTER-2024BAX022072$BAXTER$$54$YR$$M$Y$90$KG$20240801$$MD$NL$NL
241634651$24163465$1$I$20240505$20240722$20240801$20240801$EXP$CN-NMPACDR-3401011514314202400440$CN-BAXTER-2024BAX022231$BAXTER$$21$YR$$M$Y$77$KG$20240801$$MD$CN$CN
241634661$24163466$1$I$$20240722$20240801$20240801$EXP$$IT-BAXTER-2024BAX022179$BAXTER$$22$YR$$F$Y$$$20240801$$CN$IT$IT
241634671$24163467$1$I$20240611$20240729$20240801$20240801$EXP$FR-AFSSAPS-NC2024000900$FR-FreseniusKabi-FK202411904$FRESENIUS KABI$$88$YR$E$F$Y$52$KG$20240801$$MD$FR$FR
241634681$24163468$1$I$$20240723$20240801$20240801$PER$$US-RDY-LIT/USA/24/0011101$DR REDDYS$Shultz J, Antar-Shultz M, Taha M, Zervogiannis P, Lazcano G, Lamarche J. SEVELAMER-ASSOCIATED COLITIS: A TRIGGER TO CHANGE TREATMENT APPROACH. American Journal of Kidney Diseases. 2024 Apr;83(4): S74. doi:10.1053/j.ajkd.2024.01.245.$63$YR$A$M$Y$$$20240801$$HP$US$US
241634691$24163469$1$I$$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52800$$FDA-CTU$$18$YR$$M$N$70.31$KG$20240731$Y$CN$US$
241634701$24163470$1$I$20220328$20240722$20240801$20240801$EXP$SE-SEMPA-2024-005445$SE-BAXTER-2024BAX022031$BAXTER$$25$YR$$M$Y$77$KG$20240801$$CN$SE$SE
241634711$24163471$1$I$20240721$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52797$$FDA-CTU$$31$YR$$F$N$$$20240731$N$$US$
241634721$24163472$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52872$$FDA-CTU$$64$YR$$F$N$$$20240801$N$HP$US$
241634731$24163473$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52894$$FDA-CTU$$57$YR$$F$N$113.4$KG$20240801$N$$US$
241634741$24163474$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52875$$FDA-CTU$$49$YR$$F$N$$$20240801$N$$US$
241634751$24163475$1$I$$20240730$20240801$20240801$DIR$FDA-CDER-CTU-2024-52879$$FDA-CTU$$$$$M$N$$$20240730$N$HP$US$
241634761$24163476$1$I$20240601$20240702$20240801$20240801$PER$$US-009507513-2407USA001934$MERCK$$67$YR$$F$Y$$$20240801$$CN$US$US
241634772$24163477$2$F$20240701$20240806$20240801$20240821$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0766$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240821$$MD$US$US
241634781$24163478$1$I$20240601$20240726$20240801$20240801$EXP$$JP-MALLINCKRODT-MNK202404817$MALLINCKRODT$$65$YR$A$F$Y$$$20240801$$PH$JP$JP
241634791$24163479$1$I$20240701$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151401$AMGEN$$87$YR$E$F$Y$$$20240801$$CN$US$US
241634802$24163480$2$F$20240727$20240801$20240801$20240806$PER$$US-AMGEN-USASP2024152570$AMGEN$$70$YR$E$F$Y$$$20240806$$CN$US$US
241634811$24163481$1$I$20240506$20240508$20240801$20240801$PER$$US-BAYER-2024A101217$BAYER$$32$YR$A$F$Y$$$20240801$$MD$US$US
241634821$24163482$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52877$$FDA-CTU$$45$YR$$F$N$104.33$KG$20240801$N$$US$
241634831$24163483$1$I$20231103$20240723$20240801$20240801$EXP$$US-Taiho Oncology Inc-2024-004398$TAIHO ONCOLOGY INC$$72$YR$E$F$Y$$$20240801$$MD$US$US
241634841$24163484$1$I$20240101$20240308$20240801$20240801$PER$$US-BAYER-2024A091797$BAYER$$16$YR$T$F$Y$$$20240801$$MD$US$US
241634851$24163485$1$I$$20240729$20240801$20240801$PER$$US-HALEON-2190009$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241634881$24163488$1$I$20240403$20240403$20240801$20240801$PER$$US-BAYER-2024A092320$BAYER$$36$YR$A$F$Y$$$20240801$$MD$US$US
241634901$24163490$1$I$$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52788$$FDA-CTU$$$$$M$N$$$20240731$N$HP$US$
241634911$24163491$1$I$$20240730$20240801$20240801$PER$$US-JNJFOC-20240783520$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$US$US
241634921$24163492$1$I$20240618$20240729$20240801$20240801$EXP$$BR-JNJFOC-20240781250$JOHNSON AND JOHNSON$$56$YR$A$F$Y$83$KG$20240801$$CN$BR$BR
241634931$24163493$1$I$$20240725$20240801$20240801$EXP$$US-JNJFOC-20240769132$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$US$US
241634951$24163495$1$I$20240425$20240726$20240801$20240801$EXP$$CA-TAKEDA-2024TUS076366$TAKEDA$$42$YR$$F$Y$$$20240801$$CN$CA$CA
241634961$24163496$1$I$20240306$20240306$20240801$20240801$PER$$US-BAYER-2024A093937$BAYER$$25$YR$A$F$Y$$$20240801$$MD$US$US
241634971$24163497$1$I$20240403$20240403$20240801$20240801$PER$$US-BAYER-2024A092350$BAYER$$28$YR$A$F$Y$$$20240801$$MD$US$US
241634981$24163498$1$I$20240728$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019749$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240801$$CN$US$US
241634991$24163499$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019975$ELI LILLY AND CO$$$$$F$Y$$$20240801$$CN$US$US
241635001$24163500$1$I$$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407017770$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240801$$CN$US$US
241635012$24163501$2$F$20240202$20240808$20240801$20240813$PER$$US-BAYER-2024A092212$BAYER$$31$YR$A$F$Y$67.12$KG$20240813$$CN$US$US
241635021$24163502$1$I$20240401$20240405$20240801$20240801$PER$$US-BAYER-2024A092738$BAYER$$45$YR$A$F$Y$$$20240801$$CN$US$US
241635031$24163503$1$I$20240215$20240312$20240801$20240801$PER$$US-BAYER-2024A091755$BAYER$$33$YR$A$F$Y$$$20240801$$MD$US$US
241635042$24163504$2$F$20240101$20240829$20240801$20240830$EXP$DE-BFARM-24004638$DE-ABBVIE-5822397$ABBVIE$$57$YR$$M$Y$80$KG$20240830$$MD$DE$DE
241635051$24163505$1$I$20240715$20240726$20240801$20240801$EXP$$CN-009507513-2407CHN015742$MERCK$$61$YR$$M$Y$80$KG$20240801$$HP$CN$CN
241635061$24163506$1$I$$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52783$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
241635071$24163507$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52776$$FDA-CTU$$76$YR$$M$N$$$20240801$N$$US$
241635081$24163508$1$I$$20240724$20240801$20240801$EXP$$NVSC2024RU155546$NOVARTIS$Bobylova MY, Abramov MO, Mukhini KY. Pontocerebellar hypoplasia caused by the tsen54 mutation: clinical and electroencephalographic characteristics based on 3 cases [?????????????????? ??????????, ????????????? ???????? tsen54: ???????????  ? ?????????????????????????? ?????????????? ?? ??????? 3 ???????]. RUSSIAN JOURNAL OF CHILD NEUROLOGY. 2024;19(2):49-63$6$YR$$F$Y$$$20240801$$HP$RU$RU
241635102$24163510$2$F$$20240726$20240801$20240807$EXP$$NZ-EMD Serono-2024040761$EMD SERONO INC$$58$YR$A$M$Y$$$20240807$$MD$NZ$NZ
241635121$24163512$1$I$20240611$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011494$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241635131$24163513$1$I$20240410$20240411$20240801$20240801$PER$$US-BAYER-2024A092383$BAYER$$25$YR$A$F$Y$$$20240801$$CN$US$US
241635141$24163514$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52884$$FDA-CTU$$95$YR$$M$N$$$20240801$N$$US$
241635151$24163515$1$I$20240725$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52691$$FDA-CTU$$76$YR$$F$N$42.4$KG$20240731$N$$US$
241635171$24163517$1$I$$20240724$20240801$20240801$EXP$$IT-GSK-IT2024EME093310$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$IT$IT
241635181$24163518$1$I$20240619$20240724$20240801$20240801$EXP$$CN-AstraZeneca-2024A171616$ASTRAZENECA$$26568$DY$$F$Y$$$20240801$$MD$CN$
241635191$24163519$1$I$$20240724$20240801$20240801$EXP$$ZA-AstraZeneca-2024A169781$ASTRAZENECA$$59$YR$$M$Y$$$20240801$$CN$ZA$
241635201$24163520$1$I$20240727$20240730$20240801$20240801$EXP$$US-AstraZeneca-2024A174057$ASTRAZENECA$$25585$DY$$F$Y$$$20240801$$CN$US$
241635212$24163521$2$F$$20240731$20240801$20240808$EXP$$NL-AstraZeneca-2024A173629$ASTRAZENECA$Dekker, MJHJ.; Herdink, G.C.; Plattel, CHM.. Vitamin B12 Deficiency-Induced Neuropathy and Cognitive and Motor Impairment in the Elderly: A Case Study. Food and nutrition bulletin 2024;45(1):S53-7.$71$YR$$M$Y$$$20240808$$MD$NL$
241635221$24163522$1$I$20240311$20240312$20240801$20240801$PER$$US-BAYER-2024A091832$BAYER$$15$YR$T$F$Y$$$20240801$$CN$US$US
241635231$24163523$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121439$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240801$$HP$US$US
241635241$24163524$1$I$20240101$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121932$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240801$$MD$US$US
241635251$24163525$1$I$$20240725$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118574$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240801$$HP$US$US
241635261$24163526$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121779$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240801$$CN$US$US
241635271$24163527$1$I$$20240729$20240801$20240801$PER$$US-JNJFOC-20240781018$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240801$$CN$US$US
241635281$24163528$1$I$20240101$20240722$20240801$20240801$PER$$US-UNITED THERAPEUTICS-UNT-2024-019108$UNITED THERAPEUTICS$$$$$M$Y$109.3$KG$20240801$$$US$US
241635291$24163529$1$I$20240405$20240416$20240801$20240801$PER$$US-BAYER-2024A092416$BAYER$$40$YR$A$F$Y$$$20240801$$CN$US$US
241635301$24163530$1$I$20240401$20240416$20240801$20240801$PER$$US-BAYER-2024A092398$BAYER$$28$YR$A$F$Y$$$20240801$$MD$US$US
241635311$24163531$1$I$$20240727$20240801$20240801$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-023671$UNITED THERAPEUTICS$$80$YR$$M$Y$$$20240801$$MD$JP$JP
241635321$24163532$1$I$$20240722$20240801$20240801$EXP$$US-BIOCON BIOLOGICS LIMITED-BBL2024005548$BIOCON$Hui M, Gunzenhauser R, Dillon A, Tsui I.. Unexpected Vision Loss following Six Intravitreal Injections for Neovascular Age-Related Macular Degeneration.. Case Reports in Ophthalmology.. 2024;15(1):518-524$$$$$Y$$$20240801$$HP$US$US
241635332$24163533$2$F$$20240830$20240801$20240904$EXP$$RU-TAKEDA-2024TUS072211$TAKEDA$$$$A$M$Y$$$20240904$$CN$RU$RU
241635342$24163534$2$F$20240717$20240812$20240801$20240820$EXP$FR-AFSSAPS-SE2024000593$FR-FreseniusKabi-FK202411862$FRESENIUS KABI$$52$YR$A$M$Y$103$KG$20240820$$MD$FR$FR
241635351$24163535$1$I$$20240723$20240801$20240801$EXP$$US-FreseniusKabi-FK202411796$FRESENIUS KABI$Patel S, Tsai C. When in Doubt, Examine the Medication List: A Rare Case of Daptomycin-Induced Lung Injury. American Journal of Respiratory and Critical Care Medicine. 2024 May;(0): 209. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2025.$75$YR$E$F$Y$$$20240801$$HP$US$US
241635361$24163536$1$I$20240719$20240725$20240801$20240801$EXP$$CN-FreseniusKabi-FK202411728$FRESENIUS KABI$$79$YR$E$F$Y$55$KG$20240801$$HP$CN$CN
241635371$24163537$1$I$20240611$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011493$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241635381$24163538$1$I$20190409$20240724$20240801$20240801$EXP$$US-FreseniusKabi-FK202411679$FRESENIUS KABI$$27$YR$A$F$Y$69.5$KG$20240801$$HP$US$US
241635391$24163539$1$I$20230101$20240729$20240801$20240801$EXP$$NL-FreseniusKabi-FK202411885$FRESENIUS KABI$$46$YR$A$F$Y$$$20240801$$HP$NL$NL
241635401$24163540$1$I$20231226$20240328$20240801$20240801$PER$$US-BAYER-2024A092219$BAYER$$18$YR$A$F$Y$$$20240801$$HP$US$US
241635411$24163541$1$I$20240223$20240312$20240801$20240801$PER$$US-BAYER-2024A091839$BAYER$$33$YR$A$F$Y$$$20240801$$CN$US$US
241635421$24163542$1$I$$20240726$20240801$20240801$EXP$$TH-BAYER-2024A109221$BAYER$$$$$$Y$$$20240801$$CN$TH$TH
241635431$24163543$1$I$20240329$20240329$20240801$20240801$PER$$US-BAYER-2024A092301$BAYER$$22$YR$A$F$Y$$$20240801$$MD$US$US
241635441$24163544$1$I$20240722$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52897$$FDA-CTU$$12$MON$$F$N$9$KG$20240801$N$$US$
241635462$24163546$2$F$20240101$20240731$20240801$20240805$EXP$$US-JNJFOC-20240780023$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240805$$HP$US$US
241635471$24163547$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121620$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240801$$CN$US$US
241635491$24163549$1$I$20240720$20240730$20240801$20240801$EXP$FR-AFSSAPS-RS2024000749$FR-ORGANON-O2407FRA002919$ORGANON$$68$YR$$F$Y$45$KG$20240801$$MD$FR$FR
241635501$24163550$1$I$20240723$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52867$$FDA-CTU$$64$YR$$F$N$$$20240731$N$HP$US$
241635511$24163551$1$I$20240722$20240731$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121945$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240801$$HP$US$US
241635521$24163552$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52819$$FDA-CTU$$74$YR$$M$N$$$20240801$N$$US$
241635531$24163553$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52899$$FDA-CTU$$65$YR$$F$N$$$20240801$N$$US$
241635554$24163555$4$F$20230612$20240909$20240801$20240909$EXP$$TR-PFIZER INC-PV202400099729$PFIZER$$60$YR$$M$Y$90$KG$20240909$$MD$TR$TR
241635561$24163556$1$I$20240508$20240724$20240801$20240801$EXP$FR-AFSSAPS-PP2024000797$FR-TEVA-VS-3226406$TEVA$$58$YR$$M$Y$$$20240801$$MD$FR$FR
241635571$24163557$1$I$$20240725$20240801$20240801$EXP$$JP-GENMAB-2024-02691$GENMAB$$73$YR$$F$Y$$$20240801$$MD$JP$JP
241635581$24163558$1$I$20240101$20240726$20240801$20240801$PER$$US-SA-2024SA223391$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240801$$MD$US$US
241635594$24163559$4$F$20240101$20240827$20240801$20240909$PER$$US-AMGEN-USASP2024149524$AMGEN$$78$YR$E$M$Y$$$20240909$$CN$US$US
241635601$24163560$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA222803$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240801$$MD$US$US
241635611$24163561$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA222372$SANOFI AVENTIS$$$$A$F$Y$$$20240801$$MD$US$US
241635621$24163562$1$I$20240131$20240312$20240801$20240801$PER$$US-BAYER-2024A091890$BAYER$$35$YR$A$F$Y$$$20240801$$MD$US$US
241635631$24163563$1$I$20240223$20240729$20240801$20240801$EXP$FR-AFSSAPS-AVMA2024000329$FR-SA-2024SA224787$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240801$$PH$FR$FR
241635641$24163564$1$I$$20240730$20240801$20240801$PER$$US-HALEON-2189768$Haleon PLC$$$$$F$Y$$$20240801$$CN$US$US
241635652$24163565$2$F$$20240806$20240801$20240816$EXP$$IT-TEVA-VS-3226234$TEVA$Linardos G, Coltella L, Ranno S, Di Maio VC, Colagrossi L, Pandolfi E, et al. Whooping Cough Cases Increase in Central Italy after COVID-19 Pandemic. Antibiotics-(Basel) 2024; 13 (5):.; Linardos G, Coltella L, Ranno S, Di Maio VC, Colagrossi L, Pandolfi E, et al. Whooping Cough Cases Increase in Central Italy after COVID-19 Pandemic. Antibiotics-(Basel) 2024; 13 (5):.; Linardos G, Coltella L, Ranno S, Di Maio VC, Colagrossi L, Pandolfi E, et al. Whooping Cough Cases Increase in Central Italy ...$$$N$F$Y$$$20240816$$HP$IT$IT
241635661$24163566$1$I$$20240730$20240801$20240801$PER$$US-ABBVIE-5862511$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241635671$24163567$1$I$20240307$20240315$20240801$20240801$PER$$US-BAYER-2024A091983$BAYER$$49$YR$A$F$Y$$$20240801$$MD$US$US
241635681$24163568$1$I$20240305$20240318$20240801$20240801$PER$$US-BAYER-2024A092065$BAYER$$35$YR$A$F$Y$$$20240801$$MD$US$US
241635691$24163569$1$I$20240130$20240318$20240801$20240801$PER$$US-BAYER-2024A092069$BAYER$$20$YR$A$F$Y$$$20240801$$CN$US$US
241635701$24163570$1$I$20240308$20240315$20240801$20240801$PER$$US-BAYER-2024A092050$BAYER$$32$YR$A$F$Y$$$20240801$$MD$US$US
241635711$24163571$1$I$$20240524$20240801$20240801$30DAY$$DE-UCBSA-2024028288$UCB$$$$$F$Y$$$20240801$$PH$DE$DE
241635721$24163572$1$I$$20240709$20240801$20240801$EXP$$US-Vifor (International) Inc.-VIT-2024-06171$VIFOR$$$$$F$Y$$$20240801$$CN$US$US
241635731$24163573$1$I$20240503$20240717$20240801$20240801$PER$$US-Vifor (International) Inc.-VIT-2024-06474$VIFOR$$80$YR$$F$Y$$$20240801$$HP$US$US
241635741$24163574$1$I$20240605$20240717$20240801$20240801$EXP$$US-Vifor (International) Inc.-VIT-2024-06475$VIFOR$$90$YR$$F$Y$78$KG$20240801$$HP$US$US
241635752$24163575$2$F$20230101$20240804$20240801$20240806$PER$$US-PFIZER INC-PV202400098277$PFIZER$$43$YR$$F$Y$$$20240806$$CN$US$US
241635761$24163576$1$I$$20240728$20240801$20240801$PER$$US-PFIZER INC-PV202400098103$PFIZER$$71$YR$$$Y$$$20240801$$CN$US$US
241635773$24163577$3$F$20240101$20240906$20240801$20240910$PER$$US-PFIZER INC-202400225164$PFIZER$$80$YR$$M$Y$77.098$KG$20240910$$CN$US$US
241635781$24163578$1$I$20240101$20240725$20240801$20240801$PER$$US-PFIZER INC-202400228226$PFIZER$$60$YR$$F$Y$$$20240801$$CN$US$US
241635791$24163579$1$I$20231215$20240319$20240801$20240801$PER$$US-BAYER-2024A092048$BAYER$$23$YR$A$F$Y$$$20240801$$HP$US$US
241635801$24163580$1$I$20240704$20240724$20240801$20240801$EXP$$GR-FreseniusKabi-FK202411732$FRESENIUS KABI$$51$YR$A$F$Y$75$KG$20240801$$MD$GR$GR
241635811$24163581$1$I$20240318$20240318$20240801$20240801$PER$$US-BAYER-2024A092041$BAYER$$40$YR$A$F$Y$$$20240801$$MD$US$US
241635821$24163582$1$I$20240318$20240319$20240801$20240801$PER$$US-BAYER-2024A092052$BAYER$$43$YR$A$F$Y$$$20240801$$MD$US$US
241635833$24163583$3$F$20240620$20240912$20240801$20240918$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004897$SAREPTA THERAPEUTICS$$20$YR$$M$Y$83.5$KG$20240918$$CN$US$US
241635841$24163584$1$I$$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52784$$FDA-CTU$$$$$M$N$$$20240731$N$HP$US$
241635851$24163585$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52761$$FDA-CTU$$78$YR$$F$N$$$20240801$N$$US$
241635861$24163586$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52742$$FDA-CTU$$67$YR$$F$N$$$20240801$N$$US$
241635871$24163587$1$I$20240510$20240724$20240801$20240801$EXP$$NVSC2024MX139806$NOVARTIS$$29$YR$$F$Y$59$KG$20240801$$CN$MX$MX
241635881$24163588$1$I$20230707$20230707$20240801$20240801$PER$$US-SEBELA IRELAND LIMITED-2023SEB00052$SEBELA$$$$$F$Y$$$20240801$$CN$US$US
241635893$24163589$3$F$$20240705$20240801$20240906$PER$$US-FARMAPROD-202406-2334$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$US
241635901$24163590$1$I$$20240717$20240801$20240801$PER$$US-JNJFOC-20240751703$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$US$US
241635912$24163591$2$F$$20240901$20240801$20240903$30DAY$$US-PFIZER INC-202400224180$PFIZER$$15$YR$$M$Y$$$20240903$$CN$US$US
241635922$24163592$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3224902$TEVA$Lee R, Gonsalves Z, Wang S, Hussain A, Herrera K. Case study: Autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks^ gestation. Case-Rep-Perinat-Med 2024; 13 (1):.; Lee R, Gonsalves Z, Wang S, Hussain A, Herrera K. Case study: Autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks^ gestation. Case-Rep-Perinat-Med 2024; 13 (1):.$29$YR$$F$Y$$$20240816$$MD$US$US
241635932$24163593$2$F$20240101$20240906$20240801$20240926$PER$$US-SA-2024SA222235$SANOFI AVENTIS$$37$YR$A$M$Y$88$KG$20240926$$MD$US$US
241635941$24163594$1$I$20240707$20240801$20240801$20240801$EXP$AT-BASGAGES-2024-005477$AT-BAYER-2024A111475$BAYER$$57$YR$A$M$Y$87$KG$20240801$$PH$AT$AT
241635951$24163595$1$I$20240227$20240322$20240801$20240801$PER$$US-BAYER-2024A092216$BAYER$$31$YR$A$F$Y$$$20240801$$MD$US$US
241635961$24163596$1$I$$20240724$20240801$20240801$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001512$BLUEPRINT MEDICINES$$$$$M$Y$$$20240801$$CN$US$US
241635971$24163597$1$I$$20240724$20240801$20240801$EXP$$JP-TEVA-VS-3226535$TEVA$$$$$F$Y$$$20240801$$CN$JP$JP
241635981$24163598$1$I$$20240731$20240801$20240801$EXP$$NVSC2024FR156117$NOVARTIS$Sahloul O, Louapre C, Beigneux Y, Lubetzki C, Maillart E, Roux T et al. Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapies.. MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2024;85:1-8 (105557)$$$N$$Y$$$20240801$$HP$FR$FR
241635991$24163599$1$I$20210101$20240724$20240801$20240801$EXP$$FR-TEVA-VS-3225099$TEVA$$2$YR$$M$Y$23$KG$20240801$$MD$FR$FR
241636001$24163600$1$I$20240101$20240325$20240801$20240801$PER$$US-BAYER-2024A092202$BAYER$$48$YR$A$F$Y$$$20240801$$HP$US$US
241636021$24163602$1$I$20240101$20240730$20240801$20240801$EXP$$US-BAUSCH-BL-2024-011678$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240801$$CN$US$US
241636031$24163603$1$I$20240223$20240326$20240801$20240801$PER$$US-BAYER-2024A092210$BAYER$$36$YR$A$F$Y$$$20240801$$CN$US$US
241636043$24163604$3$F$20240721$20240829$20240801$20240911$PER$$US-JNJFOC-20240778925$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240911$$CN$US$US
241636051$24163605$1$I$$20240729$20240801$20240801$EXP$$BR-JNJFOC-20240781333$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$MD$BR$BR
241636062$24163606$2$F$$20240913$20240801$20240923$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000081$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240923$$HP$US$US
241636072$24163607$2$F$$20240719$20240801$20240829$EXP$$ES-BAUSCH-BL-2024-011144$BAUSCH AND LOMB$Calero P, Rossello L, Sanchez J, Bori S. Nina con sindrome coronario agudo de causa alergica (Sindrome de Kounis): a proposito de un caso. Academic Journal of Health Sciences. 2024;39(4):154-156. doi:10.3306/AJHS.2024.39.04.154$14$YR$$F$Y$$$20240829$$HP$ES$ES
241636081$24163608$1$I$20240429$20240501$20240801$20240801$PER$$US-BAYER-2024A091332$BAYER$$18$YR$A$F$Y$$$20240801$$CN$US$US
241636092$24163609$2$F$20240326$20240821$20240801$20240823$PER$$US-BAYER-2024A092218$BAYER$$28$YR$A$F$Y$$$20240823$$MD$US$US
241636101$24163610$1$I$20240101$20240730$20240801$20240801$EXP$$ZA-SA-2024SA226146$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240801$$MD$ZA$ZA
241636111$24163611$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52758$$FDA-CTU$$48$YR$$M$N$$$20240801$N$$US$
241636121$24163612$1$I$20240601$20240726$20240801$20240801$PER$$US-BAUSCH-BL-2024-011484$BAUSCH AND LOMB$$14$YR$$F$Y$46.762$KG$20240801$$CN$US$US
241636131$24163613$1$I$20240601$20240724$20240801$20240801$PER$$US-SA-2024SA210481$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240801$$CN$US$US
241636141$24163614$1$I$$20240729$20240801$20240801$EXP$$US-BAUSCH-BL-2024-011660$BAUSCH AND LOMB$$$$$$Y$$$20240801$$CN$US$US
241636152$24163615$2$F$$20240826$20240801$20240902$EXP$$JP-ROCHE-10000041721$ROCHE$Imataki O, Fujita H, Uemura M. Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus. International Journal of Hematology. 2024-Jul;120 (1):1-2. doi:10.1007/s12185-024-03798-w.$58$YR$A$M$Y$$$20240902$$HP$JP$JP
241636161$24163616$1$I$$20240731$20240801$20240801$EXP$$US-BAUSCH-BL-2024-011701$BAUSCH AND LOMB$$81$YR$$F$Y$$$20240801$$CN$US$US
241636171$24163617$1$I$20240727$20240731$20240801$20240801$EXP$$US-BAUSCH-BL-2024-011694$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240801$$CN$US$US
241636181$24163618$1$I$$20240715$20240801$20240801$30DAY$$US-VEROBIOTECH-2024USVEROSPO00154$VERO BIOTECH$$$$$M$Y$$$20240801$$HP$US$US
241636201$24163620$1$I$20240312$20240328$20240801$20240801$PER$$US-BAYER-2024A092229$BAYER$$30$YR$A$F$Y$$$20240801$$MD$US$US
241636211$24163621$1$I$20240326$20240327$20240801$20240801$PER$$US-BAYER-2024A092226$BAYER$$43$YR$A$F$Y$$$20240801$$MD$US$US
241636221$24163622$1$I$$20240731$20240801$20240801$EXP$$US-GILEAD-2024-0682530$GILEAD$$$$A$M$Y$$$20240801$$CN$US$US
241636231$24163623$1$I$20240325$20240329$20240801$20240801$PER$$US-BAYER-2024A092323$BAYER$$22$YR$A$F$Y$$$20240801$$MD$US$US
241636242$24163624$2$F$20230801$20240819$20240801$20240830$PER$$US-SA-2024SA224482$SANOFI AVENTIS$$65$YR$E$F$Y$63.503$KG$20240830$$MD$US$US
241636251$24163625$1$I$$20240726$20240801$20240801$EXP$$JP-009507513-2408JPN000173$MERCK$$73$YR$$M$Y$$$20240801$$CN$JP$JP
241636261$24163626$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA222797$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240801$$CN$US$US
241636271$24163627$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA223585$SANOFI AVENTIS$$$$T$M$Y$$$20240801$$MD$US$US
241636281$24163628$1$I$20240724$20240729$20240801$20240801$EXP$$CN-ORGANON-O2407CHN002868$ORGANON$$60$YR$$F$Y$60$KG$20240801$$HP$CN$CN
241636291$24163629$1$I$$20240731$20240801$20240801$EXP$$CA-BAUSCH-BL-2024-011704$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240801$$HP$CA$CA
241636301$24163630$1$I$20240722$20240723$20240801$20240801$PER$$US-SA-2024SA222605$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240801$$HP$US$US
241636311$24163631$1$I$20240501$20240501$20240801$20240801$PER$$US-BAYER-2024A090965$BAYER$$33$YR$A$F$Y$$$20240801$$MD$US$US
241636321$24163632$1$I$20240401$20240401$20240801$20240801$PER$$US-BAYER-2024A092287$BAYER$$36$YR$A$F$Y$$$20240801$$MD$US$US
241636331$24163633$1$I$20240701$20240729$20240801$20240801$EXP$$US-JNJFOC-20240780200$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240801$$HP$US$US
241636341$24163634$1$I$20240701$20240724$20240801$20240801$PER$$US-ABBVIE-5856185$ABBVIE$$50$YR$$F$Y$$$20240801$$MD$US$US
241636361$24163636$1$I$20240422$20240501$20240801$20240801$PER$$US-BAYER-2024A091276$BAYER$$48$YR$A$F$Y$$$20240801$$MD$US$US
241636381$24163638$1$I$20240401$20240402$20240801$20240801$PER$$US-BAYER-2024A092293$BAYER$$41$YR$A$F$Y$$$20240801$$MD$US$US
241636391$24163639$1$I$20240718$20240720$20240801$20240801$EXP$$US-Accord-438350$ACCORD$$35$YR$A$F$Y$$$20240801$$MD$US$US
241636401$24163640$1$I$20240703$20240719$20240801$20240801$EXP$$US-Accord-438189$ACCORD$$37$YR$A$M$Y$$$20240801$$MD$US$US
241636411$24163641$1$I$20240326$20240402$20240801$20240801$PER$$US-BAYER-2024A092318$BAYER$$41$YR$A$F$Y$$$20240801$$MD$US$US
241636421$24163642$1$I$20240412$20240430$20240801$20240801$PER$$US-BAYER-2024A092760$BAYER$$41$YR$A$F$Y$$$20240801$$MD$US$US
241636431$24163643$1$I$$20240726$20240801$20240801$EXP$$US-TAKEDA-2024TUS076905$TAKEDA$$$$$M$Y$$$20240801$$CN$US$US
241636441$24163644$1$I$20240731$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52798$$FDA-CTU$$74$YR$$F$N$$$20240731$N$HP$US$
241636461$24163646$1$I$20240510$20240731$20240731$20240731$DIR$FDA-CDER-CTU-2024-52805$$FDA-CTU$$$$$F$N$$$20240731$N$CN$US$
241636471$24163647$1$I$$20240731$20240801$20240801$PER$$US-HALEON-2189929$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241636481$24163648$1$I$$20240726$20240801$20240801$EXP$$US-TAKEDA-2024TUS075923$TAKEDA$$$$$M$Y$$$20240801$$CN$US$US
241636491$24163649$1$I$20240701$20240729$20240801$20240801$EXP$$CA-TAKEDA-2024TUS076602$TAKEDA$$37$YR$$F$Y$$$20240801$$CN$CA$CA
241636501$24163650$1$I$$20240725$20240801$20240801$EXP$$US-GSK-US2024AMR094503$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
241636512$24163651$2$F$$20240814$20240801$20240822$30DAY$$US-GSK-US2024091826$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
241636533$24163653$3$F$20240705$20240807$20240801$20240813$EXP$$US-ABBVIE-5857013$ABBVIE$$75$YR$$F$Y$$$20240813$$CN$US$US
241636541$24163654$1$I$$20240724$20240801$20240801$EXP$$US-ARGENX-2024-ARGX-US005910$ARGENX BVBA$$$$$$Y$$$20240801$$CN$US$US
241636551$24163655$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3224945$TEVA$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.$$$A$$Y$$$20240801$$PH$US$US
241636562$24163656$2$F$$20240807$20240801$20240813$EXP$$DE-JNJFOC-20240776859$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240813$$MD$DE$DE
241636571$24163657$1$I$$20240725$20240801$20240801$EXP$$JP-GENMAB-2024-02692$GENMAB$$66$YR$$F$Y$$$20240801$$MD$JP$JP
241636581$24163658$1$I$$20240726$20240801$20240801$EXP$$CA-EXELIXIS-CABO-24079821$EXELIXIS$$$$$M$Y$$$20240801$$MD$CA$CA
241636591$24163659$1$I$20240306$20240403$20240801$20240801$PER$$US-BAYER-2024A092290$BAYER$$32$YR$A$F$Y$$$20240801$$MD$US$US
241636611$24163661$1$I$20240727$20240729$20240801$20240801$PER$$US-PFIZER INC-202400227131$PFIZER$$$$$F$Y$$$20240801$$CN$US$US
241636621$24163662$1$I$$20240726$20240801$20240801$EXP$$FR-DSJP-DSE-2024-138151$DAIICHI$$$$E$F$Y$$$20240801$$MD$FR$FR
241636631$24163663$1$I$20240601$20240730$20240801$20240801$EXP$$CA-TAKEDA-2024TUS077110$TAKEDA$$41$YR$$M$Y$$$20240801$$MD$CA$CA
241636641$24163664$1$I$$20240725$20240801$20240801$EXP$$US-ARGENX-2024-ARGX-US006001$ARGENX BVBA$$$$$$Y$$$20240801$$CN$US$US
241636651$24163665$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA223257$SANOFI AVENTIS$$$$T$M$Y$$$20240801$$MD$US$US
241636661$24163666$1$I$20240423$20240725$20240801$20240801$PER$$US-BAYER-2024A108396$BAYER$$50$YR$A$F$Y$$$20240801$$MD$US$US
241636671$24163667$1$I$20240510$20240725$20240801$20240801$EXP$$NVSC2024FR108355$NOVARTIS$$66$YR$$M$Y$80$KG$20240801$$MD$FR$FR
241636681$24163668$1$I$20240723$20240726$20240801$20240801$EXP$$US-BAYER-2024A109686$BAYER$$69$YR$E$F$Y$$$20240801$$CN$US$US
241636691$24163669$1$I$20220808$20240723$20240801$20240801$EXP$$AU-ABBVIE-5864007$ABBVIE$$$$$M$Y$$$20240801$$CN$AU$AU
241636701$24163670$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3224947$TEVA$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.$$$A$$Y$$$20240801$$PH$US$US
241636711$24163671$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52806$$FDA-CTU$$62$YR$$F$N$76.66$KG$20240801$N$$US$
241636721$24163672$1$I$$20240726$20240801$20240801$PER$$US-BAYER-2024A109930$BAYER$$$$$F$Y$$$20240801$$CN$US$US
241636731$24163673$1$I$$20240730$20240801$20240801$PER$$US-ROCHE-10000043992$ROCHE$$$$A$F$Y$$$20240801$$CN$US$US
241636741$24163674$1$I$$20240730$20240801$20240801$30DAY$$US-SANDOZ INC.-SDZ2024US069606$SANDOZ$$$$$F$Y$$$20240801$$CN$US$US
241636751$24163675$1$I$$20240726$20240801$20240801$PER$$US-BAYER-2024A110968$BAYER$$$$$$Y$$$20240801$$CN$US$US
241636763$24163676$3$F$$20240806$20240801$20240806$EXP$$DK-BAYER-2024A109309$BAYER$$$$$F$Y$$$20240806$$CN$DK$DK
241636771$24163677$1$I$20240730$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000211$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240801$$CN$US$US
241636781$24163678$1$I$20240723$20240723$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019250$ELI LILLY AND CO$$65$YR$E$$Y$$$20240801$$CN$US$US
241636793$24163679$3$F$20240729$20240923$20240801$20240925$PER$$US-PFIZER INC-202400227011$PFIZER$$44$YR$$F$Y$58.957$KG$20240925$$CN$US$US
241636802$24163680$2$F$20240101$20240903$20240801$20240905$PER$$US-PFIZER INC-PV202400100208$PFIZER$$67$YR$$M$Y$$$20240905$$HP$US$US
241636811$24163681$1$I$$20240729$20240801$20240801$PER$$JP-PFIZER INC-202400225503$PFIZER$$$$$$Y$$$20240801$$PH$JP$JP
241636821$24163682$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-PV202400100323$PFIZER$$62$YR$$F$Y$$$20240801$$CN$US$US
241636831$24163683$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-202400227065$PFIZER$$9$YR$$F$Y$40.37$KG$20240801$$CN$US$US
241636842$24163684$2$F$20240610$20240816$20240801$20240821$PER$$US-PFIZER INC-PV202400098917$PFIZER$$59$YR$$F$Y$$$20240821$$HP$US$US
241636851$24163685$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-PV202400100409$PFIZER$$69$YR$$F$Y$$$20240801$$HP$US$US
241636861$24163686$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-PV202400100202$PFIZER$$78$YR$$F$Y$$$20240801$$HP$US$US
241636872$24163687$2$F$$20240802$20240801$20240806$PER$$US-PFIZER INC-202400227715$PFIZER$$57$YR$$F$Y$$$20240806$$MD$US$US
241636881$24163688$1$I$$20240730$20240801$20240801$PER$$US-PFIZER INC-PV202400099575$PFIZER$$$$$$Y$$$20240801$$CN$US$US
241636891$24163689$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-202400227785$PFIZER$$61$YR$$F$Y$$$20240801$$CN$US$US
241636911$24163691$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-202400227711$PFIZER$$72$YR$$M$Y$$$20240801$$CN$US$US
241636921$24163692$1$I$$20240730$20240801$20240801$PER$$US-PFIZER INC-PV202400100188$PFIZER$$$$$$Y$$$20240801$$CN$US$US
241636931$24163693$1$I$$20240730$20240801$20240801$PER$$US-PFIZER INC-202400227632$PFIZER$$35$YR$$F$Y$$$20240801$$CN$US$US
241636961$24163696$1$I$$20240730$20240801$20240801$EXP$$DE-ALXN-202407GLO002027DE$ALEXION PHARMACEUTICALS$$41$YR$$F$Y$64$KG$20240801$$CN$DE$DE
241636971$24163697$1$I$20220101$20240730$20240801$20240801$PER$$US-PFIZER INC-202400227362$PFIZER$$52$YR$$M$Y$102.06$KG$20240801$$CN$US$US
241636981$24163698$1$I$$20240730$20240801$20240801$PER$$US-PFIZER INC-202400226834$PFIZER$$70$YR$$M$Y$$$20240801$$PH$US$US
241636992$24163699$2$F$20240722$20240920$20240801$20240925$PER$$US-PFIZER INC-202400225997$PFIZER$$34$YR$$F$Y$53.52$KG$20240925$$CN$US$US
241637002$24163700$2$F$20240731$20240828$20240801$20240830$PER$$US-PFIZER INC-202400227676$PFIZER$$44$YR$$M$Y$163.27$KG$20240830$$CN$US$US
241637012$24163701$2$F$$20240730$20240801$20240809$EXP$$CN-ORGANON-O2407CHN002008$ORGANON$$18$YR$$F$Y$$$20240809$$CN$CN$CN
241637021$24163702$1$I$$20240731$20240801$20240801$PER$$NVSC2024US157307$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241637031$24163703$1$I$$20240730$20240801$20240801$PER$$US-BAYER-2024A111041$BAYER$$$$$$Y$$$20240801$$CN$US$US
241637042$24163704$2$F$$20240806$20240801$20240816$EXP$$IT-TEVA-VS-3226244$TEVA$Carta A, Cavassa V, Puci MV, Averna R, Sotgiu G, Valeri G, et al. Treatment of Aggressive Behavior and Agitation in an 11-Year-Old Boy with Co-Occurring Autism and ADHD: A Case Report and Literature Review on the Use of Intravenous Valproate in Emergency Psychiatry. J-Clin-Med 2024; 13 (12): 1-22.; Carta A, Cavassa V, Puci MV, Averna R, Sotgiu G, Valeri G, et al. Treatment of Aggressive Behavior and Agitation in an 11-Year-Old Boy with Co-Occurring Autism and ADHD: A Case Report and Literatur...$11$YR$$M$Y$$$20240816$$HP$IT$IT
241637052$24163705$2$F$$20240806$20240801$20240816$EXP$$SI-TEVA-VS-3226163$TEVA$Mlinsek G, Blagus T, Vrecko MM, Rigler AA, Dolzan V. Genetic variability in rosuvastatin metabolism explains rhabdomyolysis and consequent acute renal failure. Nephrol-Dial-Transplant 2024; 39 (Suppl.) i2823-i2824.; Mlinsek G, Blagus T, Vrecko MM, Rigler AA, Dolzan V. Genetic variability in rosuvastatin metabolism explains rhabdomyolysis and consequent acute renal failure. Nephrol-Dial-Transplant 2024; 39 (Suppl.) i2823-i2824.$79$YR$$F$Y$$$20240816$$HP$SI$SI
241637061$24163706$1$I$20231121$20240725$20240801$20240801$PER$$US-BAYER-2024A107961$BAYER$$19$YR$A$F$Y$$$20240801$$CN$US$US
241637072$24163707$2$F$20240717$20240819$20240801$20240828$EXP$GB-MHRA-MED-202407251204342300-HMTGD$GB-ABBVIE-5863537$ABBVIE$$25$YR$$M$Y$85$KG$20240828$$CN$GB$GB
241637081$24163708$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52906$$FDA-CTU$$$$$F$N$$$20240801$N$HP$US$
241637091$24163709$1$I$20240718$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52903$$FDA-CTU$$79$YR$$F$N$$$20240801$N$HP$US$
241637101$24163710$1$I$20210806$20240801$20240801$20240801$DIR$712388$$FDA-CTU$$18$YR$$M$N$63$KG$20240801$N$CN$US$
241637111$24163711$1$I$20240801$20240801$20240801$20240801$DIR$712386$$FDA-CTU$$79$YR$$F$N$$$20240801$N$$US$
241637121$24163712$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52751$$FDA-CTU$$56$YR$$F$N$$$20240801$N$$US$
241637131$24163713$1$I$$20240726$20240801$20240801$EXP$$AU-SA-2024SA221379$SANOFI AVENTIS$$$$A$$Y$$$20240801$$HP$AU$AU
241637141$24163714$1$I$$20240724$20240801$20240801$PER$$US-AstraZeneca-2024A169569$ASTRAZENECA$$$$$F$Y$$$20240801$$MD$US$
241637161$24163716$1$I$20240628$20240724$20240801$20240801$EXP$$PT-AstraZeneca-2024A168518$ASTRAZENECA$$95$YR$$F$Y$$$20240801$$MD$PT$
241637171$24163717$1$I$$20240724$20240801$20240801$EXP$$AU-AstraZeneca-2024A142506$ASTRAZENECA$$$$$M$Y$78$KG$20240801$$CN$AU$
241637181$24163718$1$I$$20240724$20240801$20240801$EXP$$IN-AstraZeneca-2024A168953$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$IN$
241637192$24163719$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3226006$TEVA$Singanallur P, Schrader K, Chiravuri S, Abdulfattah O. Multifactorial Shock: Managing a Patient With Septic Shock and Left Ventricular Outflow Tract Obstruction. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Singanallur P, Schrader K, Chiravuri S, Abdulfattah O. Multifactorial Shock: Managing a Patient With Septic Shock and Left Ventricular Outflow Tract Obstruction. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$80$YR$$F$Y$$$20240816$$HP$US$US
241637201$24163720$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA221317$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240801$$CN$US$US
241637211$24163721$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA221900$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240801$$MD$US$US
241637221$24163722$1$I$20240621$20240725$20240801$20240801$EXP$$JP-AstraZeneca-2024A151013$ASTRAZENECA$$94$YR$$F$Y$45$KG$20240801$$PH$JP$
241637231$24163723$1$I$20240723$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A170194$ASTRAZENECA$$29$YR$$F$Y$$$20240801$$CN$US$
241637241$24163724$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A170488$ASTRAZENECA$$$$$$Y$$$20240801$$HP$US$
241637251$24163725$1$I$20240501$20240724$20240801$20240801$EXP$$GB-AstraZeneca-2024A168698$ASTRAZENECA$$69$YR$$F$Y$61$KG$20240801$$MD$GB$
241637261$24163726$1$I$20190130$20240722$20240801$20240801$EXP$$CN-GALDERMA-CN2024011787$GALDERMA$$$$$$Y$$$20240801$$HP$CN$CN
241637271$24163727$1$I$20240701$20240725$20240801$20240801$EXP$$JP-ROCHE-10000043581$ROCHE$$6$DEC$A$M$Y$$$20240801$$MD$JP$JP
241637282$24163728$2$F$$20240806$20240801$20240816$EXP$$CA-TEVA-VS-3225912$TEVA$Bodor TLW, Webber JC, Scheske JA. Primary Cardiac Lymphoma in an 85-Year-Old Man, With Highly Suggestive Features on Imaging. CJC-Open 2023; 5 (2): 167-169.; Bodor TLW, Webber JC, Scheske JA. Primary Cardiac Lymphoma in an 85-Year-Old Man, With Highly Suggestive Features on Imaging. CJC-Open 2023; 5 (2): 167-169.; Bodor TLW, Webber JC, Scheske JA. Primary Cardiac Lymphoma in an 85-Year-Old Man, With Highly Suggestive Features on Imaging. CJC-Open 2023; 5 (2): 167-169.$85$YR$$M$Y$$$20240816$$HP$CA$CA
241637293$24163729$3$F$20240101$20240912$20240801$20240925$PER$$US-SA-2024SA222115$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240925$$CN$US$US
241637302$24163730$2$F$$20240806$20240801$20240816$EXP$$HR-TEVA-VS-3226177$TEVA$Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children-(Basel) 2022; 9 (7):.; Giljevic JS, Rajacic N, Mikulic D, Batos AT. Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia. Children-(Basel) 2022; 9 (7):.$3$MON$$F$Y$$$20240816$$HP$HR$HR
241637312$24163731$2$F$20240725$20240730$20240801$20240808$PER$$US-SA-2024SA222809$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240808$$CN$US$US
241637321$24163732$1$I$$20240725$20240801$20240801$EXP$$DE-AstraZeneca-2024A172415$ASTRAZENECA$$54$YR$$M$Y$$$20240801$$HP$DE$
241637341$24163734$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52898$$FDA-CTU$$60$YR$$F$N$$$20240801$N$$US$
241637351$24163735$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A170256$ASTRAZENECA$Giustini N.P.;  Pritchard C.C.;  Kamat N.V.;  Menon M.P.. EGFR V834L and L858R Comutation Is Associated with Response to Osimertinib in Non-Small-Cell Lung Cancer.. [In Process] JCO Precision Oncology Article Number e2300215 2024;8:$49$YR$$M$Y$$$20240801$$MD$US$
241637361$24163736$1$I$$20240724$20240801$20240801$EXP$$CN-AstraZeneca-2024A169871$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$CN$
241637371$24163737$1$I$20231201$20240801$20240801$20240801$DIR$712385$$FDA-CTU$$52$YR$$M$N$72$KG$20240801$N$CN$US$
241637381$24163738$1$I$20240627$20240801$20240801$20240801$DIR$712387$$FDA-CTU$$70$YR$$F$N$76.5$KG$20240801$N$CN$US$
241637401$24163740$1$I$$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52741$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
241637411$24163741$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A171539$ASTRAZENECA$$$$$M$Y$78.9$KG$20240801$$HP$US$
241637421$24163742$1$I$$20240724$20240801$20240801$EXP$$BR-AstraZeneca-2024A172057$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$BR$
241637431$24163743$1$I$$20240724$20240801$20240801$EXP$$CA-AstraZeneca-2024A170722$ASTRAZENECA$$53$YR$$M$Y$$$20240801$$MD$CA$
241637443$24163744$3$F$20240725$20240808$20240801$20240813$PER$$US-AMGEN-USASP2024149595$AMGEN$$50$YR$A$M$Y$82.1$KG$20240813$$HP$US$US
241637451$24163745$1$I$$20240731$20240801$20240801$EXP$FR-AFSSAPS-MA2024001266$FR-JNJFOC-20240800780$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240801$$MD$FR$FR
241637462$24163746$2$F$$20240726$20240801$20240808$PER$$US-JNJFOC-20240776534$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241637471$24163747$1$I$20240801$20240801$20240801$20240801$DIR$712389$$FDA-CTU$$54$YR$$M$N$103.5$KG$20240801$Y$CN$US$
241637501$24163750$1$I$20230605$20240722$20240801$20240801$EXP$$CN-GALDERMA-CN2024011790$GALDERMA$$$$$$Y$$$20240801$$HP$CN$CN
241637512$24163751$2$F$20240701$20240821$20240801$20240823$EXP$$TW-BAYER-2024A109980$BAYER$$81$YR$E$M$Y$$$20240823$$HP$TW$TW
241637541$24163754$1$I$20211109$20240722$20240801$20240801$EXP$$CN-GALDERMA-CN2024011804$GALDERMA$$$$$$Y$$$20240801$$HP$CN$CN
241637551$24163755$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3224934$TEVA$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.$$$A$$Y$$$20240801$$PH$US$US
241637562$24163756$2$F$20240301$20240801$20240801$20240808$EXP$$US-GSK-US2024093725$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
241637571$24163757$1$I$20240101$20240717$20240801$20240801$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0740$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
241637581$24163758$1$I$20240701$20240725$20240801$20240801$EXP$FR-AFSSAPS-LL2024001389$FR-SA-2024SA220709$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240801$$MD$FR$FR
241637594$24163759$4$F$20240726$20240903$20240801$20240913$30DAY$$US-JNJFOC-20240776813$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240913$$PH$US$US
241637601$24163760$1$I$$20240726$20240801$20240801$EXP$$CA-JNJFOC-20240735129$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240801$$CN$CA$CA
241637611$24163761$1$I$$20240722$20240801$20240801$EXP$$US-JNJFOC-20240762990$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$HP$US$US
241637631$24163763$1$I$$20240722$20240801$20240801$EXP$$US-BAYER-2024A106217$BAYER$$$$$M$Y$$$20240801$$HP$US$US
241637641$24163764$1$I$20211231$20240722$20240801$20240801$EXP$$CN-GALDERMA-CN2024011806$GALDERMA$$$$$$Y$$$20240801$$HP$CN$CN
241637651$24163765$1$I$20240601$20240730$20240801$20240801$EXP$$TW-INCYTE CORPORATION-2024IN008020$INCYTE$$$$$$Y$$$20240801$$MD$TW$TW
241637661$24163766$1$I$$20240723$20240801$20240801$EXP$$CA-TEVA-VS-3225832$TEVA$$33$YR$$F$Y$$$20240801$$MD$CA$CA
241637681$24163768$1$I$$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52781$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
241637691$24163769$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52764$$FDA-CTU$$69$YR$$M$N$$$20240801$N$$US$
241637701$24163770$1$I$20240304$20240717$20240801$20240801$EXP$$GB-TEVA-VS-3222126$TEVA$$1$DY$$M$Y$185$KG$20240801$$CN$GB$GB
241637711$24163771$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3226190$TEVA$$59$YR$$M$Y$$$20240801$$CN$US$US
241637721$24163772$1$I$$20240725$20240801$20240801$EXP$$JP-GENMAB-2024-02695$GENMAB$$83$YR$$M$Y$$$20240801$$MD$JP$JP
241637731$24163773$1$I$$20240723$20240801$20240801$30DAY$$US-GSK-US2024AMR093963$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
241637741$24163774$1$I$$20240722$20240801$20240801$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR095668$VIIV$$$$$$Y$$$20240801$$HP$US$US
241637751$24163775$1$I$$20240726$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407017913$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240801$$CN$US$US
241637763$24163776$3$F$20240501$20240829$20240801$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202407019817$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240904$$CN$US$US
241637771$24163777$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019577$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240801$$CN$US$US
241637781$24163778$1$I$20240701$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000224$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240801$$CN$US$US
241637791$24163779$1$I$$20240725$20240801$20240801$PER$$US-ABBVIE-5856008$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241637801$24163780$1$I$20180903$20221102$20240801$20240801$EXP$$AU-ABBVIE-5864068$ABBVIE$$77$YR$$M$Y$$$20240801$$CN$AU$AU
241637812$24163781$2$F$$20240813$20240801$20240819$EXP$$US-JNJFOC-20240780916$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240820$$HP$US$US
241637821$24163782$1$I$20240101$20240729$20240801$20240801$EXP$$US-JNJFOC-20240783037$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
241637831$24163783$1$I$$20240717$20240801$20240801$EXP$$IN-CMP PHARMA-2024CMP00044$CMP PHARMA$Sarvepalli T, Alagappan S.P, Nair K.S, Dhas C.J, Partheeban S, Murali A. Isoniazid-Induced Cerebellitis in a Chronic Kidney Disease Patient. Dis. Clin. Pract. 2024;32 (4):e1361$54$YR$$M$Y$$$20240801$$HP$IN$IN
241637841$24163784$1$I$$20240723$20240801$20240801$EXP$$GB-TEVA-VS-3225182$TEVA$$33$YR$$M$Y$$$20240801$$PH$GB$GB
241637856$24163785$6$F$20240201$20240917$20240801$20240926$EXP$$NVSC2024DE142743$NOVARTIS$$$$A$F$Y$78$KG$20240926$$MD$DE$DE
241637862$24163786$2$F$20240508$20240802$20240801$20240806$EXP$HR-HALMED-300086268$HR-INCYTE CORPORATION-2024IN008005$INCYTE$$$$$$Y$$$20240806$$HP$HR$HR
241637872$24163787$2$F$$20240821$20240801$20240823$PER$$US-ALXN-202407USA002132US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241637883$24163788$3$F$$20240916$20240801$20240930$EXP$$DE-APELLIS-2024-APL-0000599$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240930$$CN$DE$DE
241637891$24163789$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52790$$FDA-CTU$$31$YR$$M$N$$$20240801$N$$US$
241637901$24163790$1$I$$20240730$20240801$20240801$EXP$$US-Karo Pharma-2159895$Karo Pharma$$$$$F$Y$$$20240801$$$US$US
241637911$24163791$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52900$$FDA-CTU$$60$YR$$F$N$$$20240801$N$$US$
241637931$24163793$1$I$$20240723$20240801$20240801$EXP$$GB-TEVA-VS-3226226$TEVA$$$$A$F$Y$$$20240801$$CN$GB$GB
241637941$24163794$1$I$$20240724$20240801$20240801$EXP$$KR-AstraZeneca-2024A160062$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$KR$
241637951$24163795$1$I$20240717$20240724$20240801$20240801$EXP$$CN-AstraZeneca-2024A171349$ASTRAZENECA$$2791$WK$$F$Y$46$KG$20240801$$MD$CN$
241637961$24163796$1$I$$20240724$20240801$20240801$EXP$$US-ALCON LABORATORIES-ALC2024US003547$ALCON$Avery Zhou, M.A., Anja Rabljenovic, B.S., and Thomas L. Steinemann, M.D.. Proparacaine Overuse in Corneal Abrasions at the Emergency Department: A Case Series. Proparacaine Overuse in Corneal Abrasions. 2024;50 (6):274 - 275$58$YR$$M$Y$$$20240801$$HP$US$US
241637971$24163797$1$I$20181004$20240725$20240801$20240801$EXP$$FR-AstraZeneca-2024A173549$ASTRAZENECA$$67$YR$$F$Y$60$KG$20240801$$MD$FR$
241637981$24163798$1$I$$20240724$20240801$20240801$EXP$$BR-AstraZeneca-2024A172051$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$BR$
241637991$24163799$1$I$20231115$20240726$20240801$20240801$EXP$$FR-AstraZeneca-2024A173803$ASTRAZENECA$$6$DY$$F$Y$$$20240801$$MD$FR$
241638001$24163800$1$I$20240501$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A147123$ASTRAZENECA$$22706$DY$$F$Y$67$KG$20240801$$CN$US$
241638011$24163801$1$I$$20240731$20240801$20240801$PER$$NVSC2024US157278$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
241638022$24163802$2$F$$20240814$20240801$20240822$EXP$$PT-AstraZeneca-2024A168603$ASTRAZENECA$$80$YR$$M$Y$$$20240822$$MD$PT$
241638041$24163804$1$I$$20240724$20240801$20240801$EXP$$ZA-AstraZeneca-2024A168851$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$ZA$
241638051$24163805$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A170468$ASTRAZENECA$$$$$$Y$$$20240801$$HP$US$
241638061$24163806$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA222647$SANOFI AVENTIS$$$$E$F$Y$$$20240801$$MD$US$US
241638072$24163807$2$F$$20240912$20240801$20240916$EXP$$JP-AstraZeneca-2024A169393$ASTRAZENECA$$76$YR$$F$Y$$$20240916$$PH$JP$
241638082$24163808$2$F$20240701$20240903$20240801$20240909$EXP$$JP-AstraZeneca-2024A169894$ASTRAZENECA$$$$$F$Y$$$20240909$$MD$JP$
241638091$24163809$1$I$$20240722$20240801$20240801$EXP$$BE-DSJP-DSJ-2024-137889$DAIICHI$$$$E$F$Y$$$20240801$$MD$BE$BE
241638101$24163810$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A168950$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241638111$24163811$1$I$$20240724$20240801$20240801$EXP$$AU-AstraZeneca-2024A170067$ASTRAZENECA$$$$$M$Y$$$20240801$$HP$AU$
241638121$24163812$1$I$$20240729$20240801$20240801$EXP$$KR-AstraZeneca-2024A174674$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$KR$
241638131$24163813$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A170318$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241638142$24163814$2$F$20240606$20240730$20240801$20240807$EXP$$CA-AstraZeneca-2024A153742$ASTRAZENECA$$16256$DY$$M$Y$63$KG$20240807$$CN$CA$
241638151$24163815$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A169298$ASTRAZENECA$$$$$$Y$$$20240801$$MD$US$
241638161$24163816$1$I$$20240729$20240801$20240801$EXP$$CA-ABBVIE-5797281$ABBVIE$$$$A$F$Y$$$20240801$$CN$CA$CA
241638171$24163817$1$I$$20240731$20240801$20240801$EXP$$US-GILEAD-2024-0682632$GILEAD$$38$YR$A$M$Y$$$20240801$$CN$US$US
241638181$24163818$1$I$20240601$20240725$20240801$20240801$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000703$PAREXEL$$$$$$Y$$$20240801$$MD$CN$CN
241638192$24163819$2$F$20240101$20240805$20240801$20240816$EXP$$ES-VALIDUS PHARMACEUTICALS LLC-ES-VDP-2024-019337$VALIDUS$$$$$$Y$$$20240816$$MD$ES$ES
241638201$24163820$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3224936$TEVA$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.$$$A$$Y$$$20240801$$PH$US$US
241638211$24163821$1$I$$20240730$20240801$20240801$EXP$$IN-VANTIVE-2024VAN018786$Vantive US Healthcare$$67$YR$$M$Y$$$20240801$$CN$IN$IN
241638221$24163822$1$I$$20240726$20240801$20240801$EXP$$US-VANTIVE-2024VAN018682$Vantive US Healthcare$$$$$M$Y$$$20240801$$HP$US$US
241638231$24163823$1$I$20240701$20240724$20240801$20240801$EXP$$CN-009507513-2407CHN014718$MERCK$$85$YR$$F$Y$$$20240801$$HP$CN$CN
241638241$24163824$1$I$$20240724$20240801$20240801$EXP$$US-VANTIVE-2024VAN018646$Vantive US Healthcare$$$$$F$Y$$$20240801$$CN$US$US
241638251$24163825$1$I$20201123$20240725$20240801$20240801$EXP$$PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2024-019339$VALIDUS$$$$$$Y$$$20240801$$PH$PL$PL
241638263$24163826$3$F$$20240725$20240801$20240805$EXP$$PT-009507513-2407PRT015369$MERCK$$$$$F$Y$$$20240805$$MD$PT$PT
241638271$24163827$1$I$$20240729$20240801$20240801$EXP$$CA-009507513-2407CAN015838$MERCK$$$$$$Y$$$20240801$$HP$CA$CA
241638281$24163828$1$I$20240715$20240729$20240801$20240801$EXP$$AR-TAKEDA-2024TUS076820$TAKEDA$$63$YR$$F$Y$$$20240801$$CN$AR$AR
241638291$24163829$1$I$20240701$20240725$20240801$20240801$EXP$$CN-009507513-2407CHN015072$MERCK$$66$YR$$M$Y$50$KG$20240801$$HP$CN$CN
241638301$24163830$1$I$$20240731$20240801$20240801$EXP$$NVSC2024VN156876$NOVARTIS$$47$YR$$F$Y$$$20240801$$MD$VN$VN
241638311$24163831$1$I$20200101$20240729$20240801$20240801$EXP$$NVSC2021SE133450$NOVARTIS$Einberg AP, Casswall TH, Arnell H, Nowak G, Mirazimi A, Sundin M et al.. Iatrogenic immunosuppression can lead to prolonged viral shedding and absent immune response to COVID-19. ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2021;00:1-2$$$$F$Y$16.7$KG$20240801$$HP$SE$SE
241638321$24163832$1$I$$20240729$20240801$20240801$EXP$$NVSC2024US156999$NOVARTIS$$$$$$Y$$$20240801$$MD$US$US
241638331$24163833$1$I$$20240730$20240801$20240801$PER$$US-JNJFOC-20240783162$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$HP$US$US
241638341$24163834$1$I$$20240730$20240801$20240801$PER$$US-JNJFOC-20240781282$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$HP$US$US
241638351$24163835$1$I$20220103$20240729$20240801$20240801$EXP$$AR-JNJFOC-20240780776$JOHNSON AND JOHNSON$$13$YR$T$F$Y$53$KG$20240801$$CN$AR$AR
241638361$24163836$1$I$20240709$20240725$20240801$20240801$EXP$$CN-JNJFOC-20240775800$JOHNSON AND JOHNSON$$7$YR$C$M$Y$31$KG$20240801$$HP$CN$CN
241638371$24163837$1$I$$20240723$20240801$20240801$EXP$$JP-BAYER-2024A107995$BAYER$Urabe F, Imai Y, Goto Y, Tashiro K, Hashimoto M, Yoshihara K, et al. Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter study. Japanese Journal of Clinical Oncology. 2024;1-5$$$$M$Y$$$20240801$$HP$JP$JP
241638382$24163838$2$F$$20240821$20240801$20240822$PER$$US-ALXN-202407USA001929US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
241638391$24163839$1$I$20240729$20240730$20240801$20240801$EXP$$US-INDIVIOR US-INDV-146202-2024$RECKITT BENCKISER$$$$$$Y$$$20240801$$HP$US$US
241638401$24163840$1$I$$20240723$20240801$20240801$EXP$$JP-BAYER-2024A107998$BAYER$Urabe F, Imai Y, Goto Y, Tashiro K, Hashimoto M, Yoshihara K, et al. Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter study. Japanese Journal of Clinical Oncology. 2024;1-5$$$$M$Y$$$20240801$$HP$JP$JP
241638411$24163841$1$I$$20240722$20240801$20240801$PER$$US-TEVA-VS-3225911$TEVA$Nichols MM, Pozdnyakova O. Snapper-Schneid bodies (coarse cytoplasmic granules) in a patient with multiply relapsed multiple myeloma. Blood 2024; 143 (24): 2559.$66$YR$$M$Y$$$20240801$$HP$US$US
241638421$24163842$1$I$$20240731$20240801$20240801$PER$$US-HALEON-2190052$Haleon PLC$$$$A$F$Y$$$20240801$$CN$US$US
241638431$24163843$1$I$20240101$20240718$20240801$20240801$EXP$$CA-Amarin Pharma, Inc-2024AMR000364$AMARIN$$69$YR$E$M$Y$$$20240730$$CN$CA$CA
241638442$24163844$2$F$20240101$20240807$20240801$20240814$EXP$$CA-AMGEN-CANSL2024147452$AMGEN$$49$YR$A$F$Y$$$20240813$$HP$CA$CA
241638452$24163845$2$F$20221218$20240819$20240801$20240826$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-105291$REGENERON$$80$YR$$F$Y$$$20240826$$HP$CH$CH
241638462$24163846$2$F$20240625$20240902$20240801$20240909$EXP$IT-MINISAL02-995248$IT-TEVA-VS-3225518$TEVA$$92$YR$$F$Y$$$20240909$$MD$IT$IT
241638471$24163847$1$I$20240716$20240722$20240801$20240801$EXP$$US-APELLIS-2024-APL-0000536$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$MD$US$US
241638481$24163848$1$I$20240726$20240729$20240801$20240801$PER$$US-ABBVIE-5859107$ABBVIE$$26$YR$$F$Y$38.555$KG$20240801$$CN$US$US
241638491$24163849$1$I$$20240720$20240801$20240801$EXP$AU-TGA-812344$AU-Accord-437249$ACCORD$$$$$F$Y$$$20240801$$HP$AU$AU
241638502$24163850$2$F$$20240814$20240801$20240823$EXP$$GR-TEVA-VS-3225733$TEVA$$$$$F$Y$$$20240823$$MD$GR$GR
241638511$24163851$1$I$20220722$20240725$20240801$20240801$EXP$$CH-ABBVIE-5857456$ABBVIE$$81$YR$$M$Y$61$KG$20240801$$MD$CH$CH
241638521$24163852$1$I$$20240723$20240801$20240801$EXP$$CA-Amarin Pharma, Inc-2024AMR000371$AMARIN$$$$$$Y$$$20240731$$HP$CA$CA
241638531$24163853$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A169586$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241638541$24163854$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A170516$ASTRAZENECA$$$$$$Y$$$20240801$$HP$US$
241638551$24163855$1$I$20240724$20240729$20240801$20240801$EXP$$US-ABBVIE-5861055$ABBVIE$$69$YR$$M$Y$$$20240801$$HP$US$US
241638562$24163856$2$F$$20240830$20240801$20240906$EXP$$US-AstraZeneca-2024A169012$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
241638571$24163857$1$I$$20240729$20240801$20240801$EXP$$US-AstraZeneca-2024A172144$ASTRAZENECA$Gikandi A, Connors JM, Zenati MA. Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest. Perfusion 2024;0(0):$$$$M$Y$$$20240801$$HP$US$
241638581$24163858$1$I$20240707$20240724$20240801$20240801$EXP$SE-SEMPA-2024-005516$SE-TEVA-VS-3225724$TEVA$$44$YR$$M$Y$$$20240801$$MD$SE$SE
241638591$24163859$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52912$$FDA-CTU$$74$YR$$F$N$$$20240801$N$$US$
241638611$24163861$1$I$20230401$20240728$20240801$20240801$EXP$$IL-ABBVIE-5860652$ABBVIE$$74$YR$$M$Y$$$20240801$$CN$IL$IL
241638621$24163862$1$I$$20240723$20240801$20240801$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407015688$ELI LILLY AND CO$Cha S.,Shin B.-S.,Shin J.-O.,Lee J.,Shin K.,Kim H.,Ko H.,Kim M.-B.,Kim B..Demographic characteristics of elderly Korean patients with plaque psoriasis, and effectiveness and safety of biological agents..European Journal of Dermatology 2024;34(2):211-212.DOI:10.1684/ejd.2024.4644$$$E$$Y$$$20240801$$HP$KR$KR
241638631$24163863$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000085$ELI LILLY AND CO$$$$$$Y$$$20240801$$CN$US$US
241638641$24163864$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52913$$FDA-CTU$$27$YR$$F$N$73.03$KG$20240801$N$$US$
241638651$24163865$1$I$$20240725$20240801$20240801$EXP$$CA-Amarin Pharma, Inc-2024AMR000377$AMARIN$$74$YR$E$F$Y$$$20240731$$CN$CA$CA
241638661$24163866$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52914$$FDA-CTU$$72$YR$$M$N$$$20240801$N$$US$
241638672$24163867$2$F$$20240805$20240801$20240809$EXP$$CO-ABBVIE-5860915$ABBVIE$$$$$F$Y$90$KG$20240809$$CN$CO$CO
241638682$24163868$2$F$$20240925$20240801$20240930$EXP$$US-SANDOZ INC.-SDZ2024US069765$SANDOZ$$$$$F$Y$$$20240929$$CN$US$US
241638691$24163869$1$I$$20240729$20240801$20240801$EXP$$GB-SANDOZ INC.-SDZ2024GB066517$SANDOZ$$$$$M$Y$$$20240801$$CN$GB$GB
241638711$24163871$1$I$$20240731$20240801$20240801$PER$$NVSC2024US157010$NOVARTIS$$$$$F$Y$$$20240801$$MD$US$US
241638721$24163872$1$I$$20240723$20240801$20240801$EXP$GB-MHRA-MIDB- 473528ff-49cf-4345-b3b9-c807cb9192dc$GB-TEVA-VS-3225212$TEVA$$41$YR$$M$Y$$$20240801$$PH$GB$GB
241638731$24163873$1$I$$20240727$20240801$20240801$PER$$US-SA-2024SA223474$SANOFI AVENTIS$$$$A$$Y$$$20240801$$MD$US$US
241638741$24163874$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA221957$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240801$$MD$US$US
241638751$24163875$1$I$20240129$20240729$20240801$20240801$EXP$$FR-SA-2024SA224970$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240801$$PH$FR$FR
241638761$24163876$1$I$20240101$20240724$20240801$20240801$PER$$US-SA-2024SA224213$SANOFI AVENTIS$$$$A$F$Y$$$20240801$$MD$US$US
241638771$24163877$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA221962$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240801$$MD$US$US
241638781$24163878$1$I$20240711$20240729$20240801$20240801$EXP$$CA-JNJFOC-20240780120$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240801$$HP$CA$CA
241638792$24163879$2$F$20240731$20240731$20240801$20240802$PER$$US-JNJFOC-20240800203$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240802$$HP$US$US
241638802$24163880$2$F$20240601$20240827$20240801$20240902$EXP$$US-TAKEDA-2022TUS017721$TAKEDA$$62$YR$$M$Y$$$20240902$$HP$US$US
241638812$24163881$2$F$$20240831$20240801$20240903$PER$$US-AMGEN-USASP2024152810$AMGEN$$32$YR$A$F$Y$$$20240903$$MD$US$US
241638822$24163882$2$F$20240717$20240809$20240801$20240815$PER$$US-AMGEN-USASP2024142461$AMGEN$$77$YR$E$M$Y$50$KG$20240814$$PH$US$US
241638841$24163884$1$I$$20240730$20240801$20240801$PER$$US-APELLIS-2024-APL-0000601$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
241638852$24163885$2$F$$20240730$20240801$20240807$EXP$$JP-GUERBET / LLC-JP-20240100$GUERBET$Shimizu S. A case of fetal goiter due to pregnancy after hysterography. Journal of the Japanese Society of Perinatal and Neonatal Medicine. 60: 368.$35$YR$A$F$Y$$$20240807$$MD$JP$JP
241638862$24163886$2$F$$20240822$20240801$20240826$EXP$$US-TAKEDA-2024TUS076509$TAKEDA$$$$$M$Y$$$20240826$$CN$US$US
241638871$24163887$1$I$$20240730$20240801$20240801$EXP$GB-MHRA-MED-202407301345582370-YRLZB$GB-MYLANLABS-2024M1071070$MYLAN$$$$$F$Y$$$20240801$$MD$GB$GB
241638891$24163889$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52911$$FDA-CTU$$41$YR$$M$N$$$20240801$N$$US$
241638901$24163890$1$I$$20240611$20240801$20240801$PER$$US-LUNDBECK-DKLU4000395$LUNDBECK$$$$$$Y$$$20240801$$CN$US$US
241638911$24163891$1$I$20240216$20240730$20240801$20240801$EXP$SE-SEMPA-2024-005681$SE-TAKEDA-2024TUS076393$TAKEDA$$32$YR$$F$Y$82$KG$20240801$$HP$SE$SE
241638921$24163892$1$I$20240601$20240729$20240801$20240801$EXP$$US-ABBVIE-5862256$ABBVIE$$70$YR$$M$Y$$$20240801$$CN$US$US
241638931$24163893$1$I$$20240731$20240801$20240801$PER$$NVSC2024US157104$NOVARTIS$$$$$F$Y$$$20240801$$CN$US$US
241638952$24163895$2$F$$20240730$20240801$20240805$EXP$$US-TAKEDA-2024TUS077282$TAKEDA$$$$$M$Y$$$20240805$$MD$US$US
241638961$24163896$1$I$$20240729$20240801$20240801$30DAY$$DE-UCBSA-2024032057$UCB$$$$A$F$Y$$$20240801$$HP$DE$DE
241638971$24163897$1$I$$20240401$20240801$20240801$EXP$$GB-SANDOZ INC.-SDZ2024GB069681$SANDOZ$$$$$$Y$$$20240801$$CN$GB$GB
241639001$24163900$1$I$$20240731$20240801$20240801$EXP$$GB-SANDOZ INC.-NVSC2022GB078531$SANDOZ$$54$YR$$F$Y$$$20240801$$MD$GB$GB
241639011$24163901$1$I$$20240730$20240801$20240801$EXP$$CA-SA-2024SA225803$SANOFI AVENTIS$$$$$M$Y$$$20240801$$CN$CA$CA
241639021$24163902$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA210683$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240801$$MD$US$US
241639031$24163903$1$I$$20240611$20240801$20240801$PER$$US-LUNDBECK-DKLU4000413$LUNDBECK$$$$$$Y$$$20240801$$HP$US$US
241639041$24163904$1$I$20240628$20240728$20240801$20240801$DIR$FDA-CDER-CTU-2024-52810$$FDA-CTU$$38$YR$$F$N$$$20240728$N$HP$US$
241639051$24163905$1$I$$20240729$20240801$20240801$PER$$US-ABBVIE-5860963$ABBVIE$$$$$$Y$$$20240801$$HP$US$US
241639071$24163907$1$I$20240717$20240724$20240801$20240801$EXP$GB-MHRA-MED-202407241020397610-KDWHG$GB-TEVA-VS-3225248$TEVA$$55$YR$$M$Y$91$KG$20240801$$PH$GB$GB
241639081$24163908$1$I$$20240731$20240801$20240801$30DAY$$US-SANDOZ INC.-SDZ2024US069755$SANDOZ$$$$$$Y$$$20240801$$CN$US$US
241639111$24163911$1$I$$20240730$20240801$20240801$DIR$FDA-CDER-CTU-2024-52896$$FDA-CTU$$$$$F$N$$$20240730$N$HP$US$
241639121$24163912$1$I$20240727$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52910$$FDA-CTU$$51$YR$$F$N$$$20240801$N$HP$US$
241639131$24163913$1$I$20240729$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52916$$FDA-CTU$$73$YR$$F$N$$$20240731$N$HP$US$
241639151$24163915$1$I$20240701$20240726$20240801$20240801$PER$$US-BIOGEN-2024BI01275730$BIOGEN$$63$YR$$F$Y$$$20240801$$CN$US$US
241639161$24163916$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52909$$FDA-CTU$$64$YR$$F$N$136.08$KG$20240801$N$$US$
241639171$24163917$1$I$20240722$20240726$20240801$20240801$PER$$US-BIOGEN-2024BI01275029$BIOGEN$$58$YR$$F$Y$$$20240801$$CN$US$US
241639192$24163919$2$F$$20240731$20240801$20240807$PER$$US-BIOGEN-2024BI01276205$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
241639202$24163920$2$F$$20240923$20240801$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA069780$SANDOZ$$$$$F$Y$$$20240925$$MD$CA$CA
241639211$24163921$1$I$$20240727$20240801$20240801$EXP$$US-BEH-2024176568$CSL BEHRING$$$$A$F$Y$$$20240801$$HP$US$US
241639221$24163922$1$I$$20240730$20240801$20240801$PER$$US-HALEON-2190065$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241639231$24163923$1$I$20240124$20240724$20240801$20240801$EXP$$DE-TEVA-VS-3225927$TEVA$$$$$F$Y$$$20240801$$MD$DE$DE
241639241$24163924$1$I$$20240730$20240801$20240801$EXP$$CA-SANDOZ INC.-SDZ2024CA069386$SANDOZ$$$$$M$Y$$$20240801$$MD$CA$CA
241639251$24163925$1$I$$20240729$20240801$20240801$EXP$$TW-AstraZeneca-2024A174628$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$TW$
241639262$24163926$2$F$$20240805$20240801$20240812$EXP$$KW-JNJFOC-20240775608$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240812$$HP$KW$KW
241639272$24163927$2$F$20240729$20240806$20240801$20240808$EXP$$JP-JNJFOC-20240801152$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240809$$PH$JP$JP
241639281$24163928$1$I$20230219$20240726$20240801$20240801$EXP$$KR-AstraZeneca-2024A170949$ASTRAZENECA$$829$MON$$F$Y$$$20240801$$MD$KR$
241639291$24163929$1$I$20240722$20240724$20240801$20240801$EXP$$CN-AstraZeneca-2024A170858$ASTRAZENECA$$19702$DY$$F$Y$51.8$KG$20240801$$MD$CN$
241639301$24163930$1$I$$20220124$20240801$20240801$EXP$$CA-AstraZeneca-2020SF37379$ASTRAZENECA$$$$$F$Y$$$20240801$$MD$CA$
241639311$24163931$1$I$$20240725$20240801$20240801$PER$$US-BAYER-2024A108742$BAYER$$$$$F$Y$$$20240801$$CN$US$US
241639321$24163932$1$I$20240712$20240724$20240801$20240801$EXP$$BR-TAKEDA-2021TUS068987$TAKEDA$$30$YR$$F$Y$72$KG$20240801$$CN$BR$BR
241639331$24163933$1$I$20240724$20240724$20240801$20240801$EXP$GB-MHRA-TPP39696913C9087993YC1721827399331$GB-RDY-SPO/GBR/24/0011002$DR REDDYS$$27$YR$A$F$Y$70$KG$20240801$$MD$GB$GB
241639341$24163934$1$I$$20240703$20240801$20240801$PER$$US-Eisai-EC-2024-169501$EISAI$$$$$F$Y$$$20240801$$HP$US$US
241639351$24163935$1$I$20210710$20240729$20240801$20240801$EXP$PL-URPL-DML-MLP.4401.1.4958.2021$PL-SANDOZ INC.-SDZ2024PL069280$SANDOZ$$14$YR$$F$Y$43$KG$20240801$$MD$PL$PL
241639372$24163937$2$F$20230101$20240820$20240801$20240823$EXP$$JP-DSJP-DSJ-2024-138132$DAIICHI$Seki T, Shimizu T, Yamagata T, Shimada T, Komabayashi D, Satou H, et al.. W2-02 An autopsy case of gastric cancer in which metastatic lesions invading the inferior vena cava became necrotic due to anti-HER2 therapy and the patient died of acute thrombosis, Journal of Regular Meeting of the Tohoku Branch of the Japanese Society of Gastroenterology/ The 217th Regular Meeting of the Tohoku Branch of the Japanese Society of Gastroenterology. See Journal Title following Article Title. 2024;45$68$YR$$M$Y$$$20240823$$MD$JP$JP
241639381$24163938$1$I$$20240731$20240801$20240801$PER$$US-HALEON-2190031$Haleon PLC$$$$$$Y$$$20240801$$CN$US$US
241639391$24163939$1$I$$20240725$20240801$20240801$EXP$$US-MYLANLABS-2024M1071015$MYLAN$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. J-Allergy-Clin-Immunol-Pract 2024; 12 (6): 1663-1665.$46$YR$$F$Y$$$20240801$$MD$US$US
241639401$24163940$1$I$$20240725$20240801$20240801$PER$$US-ABBVIE-5856510$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241639411$24163941$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137882$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241639422$24163942$2$F$$20240819$20240801$20240826$EXP$$CA-DSJP-DSJ-2024-137885$DAIICHI$$$$$F$Y$$$20240826$$MD$CA$CA
241639431$24163943$1$I$20240401$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121858$BRISTOL MYERS SQUIBB$$20$YR$A$F$Y$$$20240801$$HP$US$US
241639441$24163944$1$I$20230701$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121805$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240801$$CN$US$US
241639451$24163945$1$I$20240730$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121442$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240801$$HP$US$US
241639462$24163946$2$F$$20240827$20240801$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121900$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240830$$CN$US$US
241639472$24163947$2$F$20240101$20240626$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00480$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639481$24163948$1$I$20230412$20231102$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00931$UPSHER-SMITH$$1$YR$$$Y$$$20240801$$CN$US$US
241639491$24163949$1$I$$20231106$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00932$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639501$24163950$1$I$20231005$20231107$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00933$UPSHER-SMITH$$1$YR$$$Y$$$20240801$$CN$US$US
241639511$24163951$1$I$$20231109$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00939$UPSHER-SMITH$$$$$M$Y$$$20240801$$CN$US$US
241639521$24163952$1$I$20231031$20231109$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00940$UPSHER-SMITH$$1$YR$$$Y$$$20240801$$CN$US$US
241639531$24163953$1$I$$20240215$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00183$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639541$24163954$1$I$20240213$20240215$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00193$UPSHER-SMITH$$0$YR$$$Y$$$20240801$$CN$US$US
241639551$24163955$1$I$20240221$20240221$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00197$UPSHER-SMITH$$0$YR$$$Y$$$20240801$$CN$US$US
241639561$24163956$1$I$20240222$20240223$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00207$UPSHER-SMITH$$3$YR$$$Y$$$20240801$$CN$US$US
241639571$24163957$1$I$20240301$20240308$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00245$UPSHER-SMITH$$0$YR$$F$Y$$$20240801$$CN$US$US
241639581$24163958$1$I$20240301$20240315$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00264$UPSHER-SMITH$$2$YR$$$Y$$$20240801$$CN$US$US
241639591$24163959$1$I$20240311$20240320$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00281$UPSHER-SMITH$$0$YR$$$Y$$$20240801$$CN$US$US
241639601$24163960$1$I$20240321$20240321$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00288$UPSHER-SMITH$$0$YR$$$Y$$$20240801$$CN$US$US
241639611$24163961$1$I$$20240321$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00290$UPSHER-SMITH$$$$$F$Y$$$20240801$$CN$US$US
241639621$24163962$1$I$20240301$20240331$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00309$UPSHER-SMITH$$0$YR$$M$Y$$$20240801$$CN$US$US
241639631$24163963$1$I$20230909$20231113$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00947$UPSHER-SMITH$$0$YR$$$Y$$$20240801$$HP$US$US
241639641$24163964$1$I$$20231113$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00948$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639651$24163965$1$I$$20231113$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00949$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639661$24163966$1$I$20231101$20231120$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00965$UPSHER-SMITH$$0$YR$$$Y$$$20240801$$CN$US$US
241639671$24163967$1$I$20230901$20231124$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00985$UPSHER-SMITH$$0$YR$$$Y$$$20240801$$CN$US$US
241639681$24163968$1$I$20231205$20231205$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL01008$UPSHER-SMITH$$2$YR$$$Y$$$20240801$$CN$US$US
241639691$24163969$1$I$20230101$20231207$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL01013$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639701$24163970$1$I$20230101$20231214$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL01027$UPSHER-SMITH$$$$$F$Y$$$20240801$$CN$US$US
241639711$24163971$1$I$$20240119$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00084$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639721$24163972$1$I$20240123$20240123$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00110$UPSHER-SMITH$$1$YR$$M$Y$$$20240801$$CN$US$US
241639731$24163973$1$I$$20240206$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00159$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639741$24163974$1$I$$20240206$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00160$UPSHER-SMITH$$$$$$Y$$$20240801$$MD$US$US
241639751$24163975$1$I$$20240214$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00182$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639761$24163976$1$I$20240101$20240402$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00320$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639771$24163977$1$I$$20240402$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00322$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639781$24163978$1$I$20240101$20240402$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00326$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639791$24163979$1$I$20240402$20240405$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00336$UPSHER-SMITH$$1$YR$$F$Y$$$20240801$$CN$US$US
241639801$24163980$1$I$20240410$20240411$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00349$UPSHER-SMITH$$2$YR$$$Y$$$20240801$$CN$US$US
241639811$24163981$1$I$$20240412$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00351$UPSHER-SMITH$$$$$$Y$$$20240801$$HP$US$US
241639821$24163982$1$I$20240401$20240419$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00365$UPSHER-SMITH$$0$YR$$$Y$$$20240801$$CN$US$US
241639831$24163983$1$I$20240401$20240429$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00380$UPSHER-SMITH$$0$YR$$$Y$$$20240801$$CN$US$US
241639841$24163984$1$I$$20240430$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00388$UPSHER-SMITH$$$$$M$Y$$$20240801$$CN$US$US
241639851$24163985$1$I$$20240503$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00396$UPSHER-SMITH$$$$$$Y$$$20240801$$CN$US$US
241639861$24163986$1$I$$20240513$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00408$UPSHER-SMITH$$$$$M$Y$$$20240801$$CN$US$US
241639871$24163987$1$I$20240510$20240510$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00414$UPSHER-SMITH$$1$YR$$F$Y$$$20240801$$CN$US$US
241639881$24163988$1$I$20230721$20240522$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00424$UPSHER-SMITH$$0$YR$$$Y$$$20240801$$HP$US$US
241639891$24163989$1$I$20240523$20240529$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00449$UPSHER-SMITH$$1$YR$$$Y$$$20240801$$CN$US$US
241639901$24163990$1$I$20240607$20240607$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00483$UPSHER-SMITH$$0$YR$$M$Y$$$20240801$$CN$US$US
241639911$24163991$1$I$$20240607$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00484$UPSHER-SMITH$$$$$F$Y$$$20240801$$CN$US$US
241639921$24163992$1$I$20240614$20240614$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00494$UPSHER-SMITH$$2$YR$$$Y$$$20240801$$CN$US$US
241639931$24163993$1$I$20231028$20231122$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2023USL00983$UPSHER-SMITH$$0$YR$$M$Y$$$20240801$$CN$US$US
241639941$24163994$1$I$20240611$20240614$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00496$UPSHER-SMITH$$1$YR$$$Y$$$20240801$$CN$US$US
241639951$24163995$1$I$20240101$20240410$20240801$20240801$PER$$US-UPSHER-SMITH LABORATORIES, LLC-2024USL00339$UPSHER-SMITH$$$$$M$Y$$$20240801$$CN$US$US
241639961$24163996$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000078$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240801$$CN$US$US
241639971$24163997$1$I$20240731$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000293$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240801$$CN$US$US
241639981$24163998$1$I$20240730$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407017847$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240801$$CN$US$US
241639991$24163999$1$I$$20240726$20240801$20240801$EXP$$CZ-MYLANLABS-2024M1070654$MYLAN$Flanderov? I.. Canagliflozin ? the right  treatment for a rock band drummer  with type 2 diabetes. DIABETOLOGY.. 2024;22(2):10-11$46$YR$$M$Y$$$20240801$$HP$CZ$CZ
241640001$24164000$1$I$$20240726$20240801$20240801$EXP$$GB-MYLANLABS-2024M1071282$MYLAN$Mistry A, Parry D, Chisman R, Mark W, Doffinger R, Savic S. A Mutation In The G6PC3 Associated With A Periodic-fever Like Syndrome. Clin-Exp-Immunol 2015; 182 (Suppl. 1) 25 abstr. P53.$7$YR$$M$Y$$$20240801$$HP$GB$GB
241640011$24164001$1$I$20200101$20240726$20240801$20240801$EXP$PT-INFARMED-R202407-420$PT-MYLANLABS-2024M1071042$MYLAN$$65$YR$$M$Y$70$KG$20240801$$MD$PT$PT
241640021$24164002$1$I$20240601$20240726$20240801$20240801$EXP$FR-AFSSAPS-LL2024001360$FR-MYLANLABS-2024M1070844$MYLAN$$61$YR$$F$Y$$$20240801$$MD$FR$FR
241640033$24164003$3$F$20240701$20240805$20240801$20240815$EXP$$DE-MYLANLABS-2024M1070717$MYLAN$$58$YR$$M$Y$$$20240815$$MD$DE$DE
241640043$24164004$3$F$20240718$20240820$20240801$20240827$PER$$US-Calliditas-2024CAL01370$CALLIDITAS THERAPEUTICS$$47$YR$A$F$Y$78.65$KG$20240827$$CN$US$US
241640051$24164005$1$I$20230309$20240726$20240801$20240801$EXP$$DE-MYLANLABS-2024M1070810$MYLAN$$$$E$M$Y$$$20240801$$MD$DE$DE
241640061$24164006$1$I$20230301$20240726$20240801$20240801$EXP$$FR-MYLANLABS-2024M1070561$MYLAN$$$$$F$Y$$$20240801$$CN$FR$FR
241640071$24164007$1$I$$20240726$20240801$20240801$EXP$$CA-MYLANLABS-2024M1071322$MYLAN$$$$$F$Y$$$20240801$$HP$CA$CA
241640081$24164008$1$I$$20240722$20240801$20240801$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-137886$DAIICHI$$47$YR$$F$Y$101$KG$20240801$$CN$CA$CA
241640091$24164009$1$I$$20240716$20240801$20240801$PER$$US-JNJFOC-20240747816$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$US$US
241640102$24164010$2$F$$20240806$20240801$20240816$EXP$$TR-TEVA-VS-3226175$TEVA$Karhan O, Sezgin Y, Ileri S, Tunc S. Mesenteric Panniculitis as a Side Effect of Nivolumab in a Patient with Larnyngeal Cancer. Niger-J-Clin-Pract 2024; 27 (6): 800-803.; Karhan O, Sezgin Y, Ileri S, Tunc S. Mesenteric Panniculitis as a Side Effect of Nivolumab in a Patient with Larnyngeal Cancer. Niger-J-Clin-Pract 2024; 27 (6): 800-803.$57$YR$$M$Y$$$20240816$$MD$TR$TR
241640111$24164011$1$I$20240717$20240717$20240801$20240801$PER$$US-JNJFOC-20240748492$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20240801$$CN$US$US
241640121$24164012$1$I$$20240730$20240801$20240801$EXP$$DE-PURDUE-USA-2024-0311089$PURDUE$Heinz P, Wolf B, Schuldes S.. Locked-in Syndrome After Pontine Hemorrhage in an Amphetamine Abuser. Deutsches Arzteblatt International. 2024;121(10):330$37$YR$$F$Y$$$20240801$$MD$DE$DE
241640132$24164013$2$F$$20240806$20240801$20240816$EXP$$ES-TEVA-VS-3226100$TEVA$Garcia IC, Pedroza JB, Rodriguez IM, Rincon I. Trabectedin and Radiotherapy in Endometrial Stromal Sarcoma: A Case Report. Case-Rep-Oncol 2024; 17 (1): 82-90.; Garcia IC, Pedroza JB, Rodriguez IM, Rincon I. Trabectedin and Radiotherapy in Endometrial Stromal Sarcoma: A Case Report. Case-Rep-Oncol 2024; 17 (1): 82-90.$47$YR$$F$Y$$$20240816$$HP$ES$ES
241640141$24164014$1$I$$20240730$20240801$20240801$EXP$$DE-PURDUE-USA-2024-0311083$PURDUE$Hans FP, Benning L, Pooth J, Busch H.. A potentially lifesaving error: unintentional high-dose adrenaline administration in anaphylaxis-induced cardiac arrest; a case report.. International Journal of Emergency Medicine. 17(1)$66$YR$$F$Y$$$20240801$$HP$DE$DE
241640151$24164015$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137887$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241640161$24164016$1$I$$20240508$20240801$20240801$DIR$FDA-CDER-CTU-2024-52853$$FDA-CTU$$$$$$N$$$20240508$N$$US$
241640171$24164017$1$I$$20240729$20240801$20240801$EXP$$IT-BIOVITRUM-2024-IT-010383$BIOVITRUM$$$$$$Y$85$KG$20240801$$MD$IT$IT
241640181$24164018$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221666$SANOFI AVENTIS$$22$YR$A$F$Y$61$KG$20240801$$MD$US$US
241640191$24164019$1$I$20240503$20240722$20240801$20240801$EXP$$BR-SANDOZ INC.-SDZ2024BR063077$SANDOZ$$61$YR$$F$Y$85.6$KG$20240801$$PH$BR$BR
241640201$24164020$1$I$20240728$20240731$20240801$20240801$EXP$$CN-SANDOZ INC.-SDZ2024CN069748$SANDOZ$$67$YR$$M$Y$66$KG$20240801$$HP$CN$CN
241640211$24164021$1$I$$20240730$20240801$20240801$EXP$$CA-SANDOZ INC.-SDZ2024CA069446$SANDOZ$$$$$F$Y$$$20240801$$MD$CA$CA
241640231$24164023$1$I$$20240725$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118597$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240801$$MD$US$US
241640241$24164024$1$I$20240722$20240725$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118793$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$73.03$KG$20240801$$HP$US$US
241640251$24164025$1$I$20240723$20240724$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118993$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240801$$CN$US$US
241640261$24164026$1$I$20240701$20240725$20240801$20240801$EXP$$AR-GSK-AR2024AMR093764$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$AR$AR
241640271$24164027$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137901$DAIICHI$$$$$F$Y$$$20240801$$HP$CA$CA
241640281$24164028$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137888$DAIICHI$$$$$F$Y$36$KG$20240801$$CN$CA$CA
241640292$24164029$2$F$20201223$20240819$20240801$20240826$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-116984$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240826$$MD$KR$KR
241640301$24164030$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137897$DAIICHI$$$$$F$Y$56$KG$20240801$$HP$CA$CA
241640311$24164031$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137900$DAIICHI$$$$$F$Y$63$KG$20240801$$CN$CA$CA
241640321$24164032$1$I$20210701$20240724$20240801$20240801$EXP$$GE-SANDOZ INC.-SDZ2024GE069710$SANDOZ$$$$A$F$Y$65$KG$20240801$$MD$GE$GE
241640331$24164033$1$I$20231001$20240725$20240801$20240801$EXP$$CO-SANDOZ INC.-PHHY2018CO092219$SANDOZ$$48$YR$$F$Y$62$KG$20240801$$CN$CO$CO
241640341$24164034$1$I$$20240725$20240801$20240801$EXP$US-MLMSERVICE-20240718-PI136477-00057-1$US-RDY-SPO/USA/24/0011090$DR REDDYS$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D. Rhabdomyolysis Risk: The Dangers of Tribulus terrestris, an Over-the-Counter Supplement. Am J Case Rep. 2024;25:e943492. DOI: 10.12659/AJCR.943492.$71$YR$E$M$Y$$$20240801$$MD$US$US
241640352$24164035$2$F$20240614$20240729$20240801$20240805$EXP$FR-AFSSAPS-NC2024000893$FR-009507513-2407FRA015068$MERCK$$69$YR$$M$Y$60$KG$20240805$$MD$FR$FR
241640361$24164036$1$I$$20240718$20240801$20240801$EXP$$JP-GUERBET / LLC-JP-20240101$GUERBET$?? ???. ???????????????????????????. ?????????????.60(S1)P39-1(2024)$$$N$F$Y$3.236$KG$20240801$$MD$JP$JP
241640371$24164037$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138091$DAIICHI$$$$$F$Y$$$20240801$$CN$CA$CA
241640381$24164038$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138065$DAIICHI$$75$YR$$F$Y$$$20240801$$MD$CA$CA
241640391$24164039$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137906$DAIICHI$$$$$F$Y$80$KG$20240801$$MD$CA$CA
241640401$24164040$1$I$20240614$20240726$20240801$20240801$EXP$$DE-SA-2024SA222130$SANOFI AVENTIS$$39$YR$A$F$Y$96$KG$20240801$$MD$DE$DE
241640411$24164041$1$I$$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120446$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240801$$CN$US$US
241640421$24164042$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120723$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240801$$HP$US$US
241640432$24164043$2$F$$20240806$20240801$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121096$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$93.2$KG$20240807$$CN$US$US
241640441$24164044$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121899$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240801$$HP$US$US
241640451$24164045$1$I$$20240508$20240801$20240801$DIR$FDA-CDER-CTU-2024-52845$$FDA-CTU$$$$$$N$$$20240508$N$$US$
241640461$24164046$1$I$20240701$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121371$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240801$$CN$US$US
241640471$24164047$1$I$20240201$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121015$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240801$$PH$US$US
241640481$24164048$1$I$$20240507$20240801$20240801$DIR$FDA-CDER-CTU-2024-52842$$FDA-CTU$$$$$$N$$$20240507$N$$US$
241640492$24164049$2$F$20240101$20240730$20240801$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120942$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240821$$HP$US$US
241640502$24164050$2$F$20240922$20240926$20240801$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120615$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240927$$HP$US$US
241640511$24164051$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120646$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240801$$CN$US$US
241640521$24164052$1$I$20240725$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A171552$ASTRAZENECA$$88$YR$$F$Y$86.2$KG$20240801$$HP$US$
241640531$24164053$1$I$$20240722$20240801$20240801$PER$$US-TEVA-VS-3225421$TEVA$Lafleur JL. Peripheral Nerve Stimulation with High-Frequency Electromagnetic Coupling (HF-EMC) at the Ilioinguinal and the Superior Gluteal Nerve in the Treatment of Mononeuropathy. Pain-Med-Case-Rep 2023; 7 (1): 7-10.$62$YR$$F$Y$$$20240801$$MD$US$US
241640541$24164054$1$I$$20240724$20240801$20240801$EXP$$BR-AstraZeneca-2024A172056$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$BR$
241640551$24164055$1$I$20240401$20240726$20240801$20240801$EXP$$US-ORGANON-O2407USA002820$ORGANON$$$$$F$Y$$$20240801$$CN$US$US
241640571$24164057$1$I$20240601$20240726$20240801$20240801$EXP$$US-GENMAB-2024-02711$GENMAB$$82$YR$$M$Y$68.934$KG$20240801$$PH$US$US
241640581$24164058$1$I$$20240715$20240801$20240801$PER$$US-JNJFOC-20240740774$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
241640591$24164059$1$I$$20240724$20240801$20240801$EXP$$GR-TEVA-VS-3225737$TEVA$$63$YR$$F$Y$$$20240801$$MD$GR$GR
241640601$24164060$1$I$$20240724$20240801$20240801$EXP$$ES-TEVA-VS-3225936$TEVA$$$$$F$Y$$$20240801$$HP$ES$ES
241640611$24164061$1$I$$20240718$20240801$20240801$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-121793$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$70$KG$20240801$$HP$CA$CA
241640623$24164062$3$F$20240705$20240911$20240801$20240913$EXP$$JP-BAYER-2024A111122$BAYER$$70$YR$E$M$Y$$$20240913$$MD$JP$JP
241640631$24164063$1$I$$20240702$20240801$20240801$PER$$US-009507513-2407ITA002752$MERCK$Petri F, Gemayel F, El ZS, Tande AJ, Thoendel MJ, Berbari EF.. Tiny but Nasty: A case report and a review of the literature on Ureaplasma parvum peritonitis. IDCases. 2024;37(e02015)$36$YR$$F$Y$$$20240801$$HP$US$US
241640641$24164064$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121710$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240801$$CN$US$US
241640651$24164065$1$I$20201001$20240731$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121999$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240801$$CN$US$US
241640661$24164066$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122018$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240801$$CN$US$US
241640672$24164067$2$F$$20240815$20240801$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120871$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240823$$CN$US$US
241640691$24164069$1$I$$20240722$20240801$20240801$EXP$$US-GSK-US2024091862$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
241640701$24164070$1$I$$20240724$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121976$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$92.1$KG$20240801$$CN$US$US
241640712$24164071$2$F$$20240801$20240801$20240810$PER$$US-SA-2024SA223402$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240810$$MD$US$US
241640722$24164072$2$F$20240701$20240730$20240801$20240808$PER$$US-SA-2024SA223274$SANOFI AVENTIS$$52$YR$A$M$Y$129.27$KG$20240808$$MD$US$US
241640731$24164073$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA222376$SANOFI AVENTIS$$$$E$M$Y$$$20240801$$MD$US$US
241640741$24164074$1$I$20240101$20240730$20240801$20240801$EXP$$US-ABBVIE-5860855$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241640751$24164075$1$I$$20240715$20240801$20240801$PER$$US-JNJFOC-20240741242$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$US$US
241640761$24164076$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA223494$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240801$$MD$US$US
241640771$24164077$1$I$20181220$20240722$20240801$20240801$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117007$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240801$$MD$KR$KR
241640781$24164078$1$I$20240704$20240717$20240801$20240801$EXP$$CN-Bio-Thera Solutions, Ltd.-2159774$BIO-THERA SOLUTIONS$$61$YR$$F$Y$58$KG$20240801$$$CN$CN
241640801$24164080$1$I$20230712$20240726$20240801$20240801$EXP$ES-AEMPS-1550896$ES-MYLANLABS-2024M1070556$MYLAN$$60$YR$$F$Y$$$20240801$$MD$ES$ES
241640811$24164081$1$I$20230907$20240726$20240801$20240801$EXP$IT-MINISAL02-996018$IT-MYLANLABS-2024M1070531$MYLAN$$92$YR$$M$Y$$$20240801$$MD$IT$IT
241640821$24164082$1$I$20200301$20240726$20240801$20240801$EXP$FR-AFSSAPS-PC2024000587$FR-MYLANLABS-2024M1070560$MYLAN$$32$YR$$M$Y$81$KG$20240801$$PH$FR$FR
241640831$24164083$1$I$$20240726$20240801$20240801$EXP$$RO-MYLANLABS-2024M1070516$MYLAN$Cighir A.,Budin C. E.,Cighir T., Mare A. D., Man A. Beyond the gut - Atypical presentation of Salmonella spp. infection.. Acta Medica. 2024;70(2):87-94$61$YR$$M$Y$$$20240801$$HP$RO$RO
241640841$24164084$1$I$$20240726$20240801$20240801$EXP$$FR-MYLANLABS-2024M1070559$MYLAN$$$$$F$Y$$$20240801$$CN$FR$FR
241640851$24164085$1$I$$20240726$20240801$20240801$EXP$$GR-MYLANLABS-2024M1070496$MYLAN$Lathiri E. et al.,. Patient with possible Dress Syndrome, 50th Annual Panhellenic Congress of Medicine. Athens, Greece. 2024;249:25-27$96$YR$$M$Y$$$20240801$$MD$GR$GR
241640861$24164086$1$I$20240629$20240726$20240801$20240801$EXP$FR-AFSSAPS-LM2024000407$FR-MYLANLABS-2024M1070493$MYLAN$$57$YR$$M$Y$90$KG$20240801$$MD$FR$FR
241640871$24164087$1$I$$20240726$20240801$20240801$EXP$$IT-MYLANLABS-2024M1070647$MYLAN$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al.. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting.. Clinical Therapeutics. 2024;e1-5$49$YR$$M$Y$$$20240801$$MD$IT$IT
241640891$24164089$1$I$20240711$20240726$20240801$20240801$EXP$FR-AFSSAPS-RE2024000751$FR-MYLANLABS-2024M1070538$MYLAN$$88$YR$$F$Y$40$KG$20240801$$MD$FR$FR
241640901$24164090$1$I$20201031$20240722$20240801$20240801$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-116914$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$67$KG$20240801$$MD$KR$KR
241640911$24164091$1$I$$20240506$20240801$20240801$DIR$FDA-CDER-CTU-2024-52869$$FDA-CTU$$$$$$N$$$20240506$N$$US$
241640932$24164093$2$F$20240717$20240726$20240801$20240801$EXP$$ES-GUERBET / LLC-ES-20240031$GUERBET$$20$YR$A$F$Y$50$KG$20240801$$HP$ES$ES
241640942$24164094$2$F$$20240903$20240801$20240904$EXP$$NVSC2024US156718$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
241640951$24164095$1$I$20230414$20240725$20240801$20240801$EXP$IT-MINISAL02-995348$IT-TEVA-VS-3225938$TEVA$$75$YR$$F$Y$$$20240801$$MD$IT$IT
241640961$24164096$1$I$20240801$20240801$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043311$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240801$$CN$US$US
241640971$24164097$1$I$$20240729$20240801$20240801$EXP$$US-PFIZER INC-PV202400098933$PFIZER$$$$$F$Y$$$20240801$$HP$US$US
241640981$24164098$1$I$20200101$20240725$20240801$20240801$EXP$$HN-PFIZER INC-202400227082$PFIZER$$75$YR$$M$Y$81.64$KG$20240801$$CN$HN$HN
241640992$24164099$2$F$20200508$20240812$20240801$20240819$EXP$$IT-PFIZER INC-202400225457$PFIZER$$55$YR$$F$Y$$$20240819$$MD$IT$IT
241641001$24164100$1$I$$20240508$20240801$20240801$DIR$FDA-CDER-CTU-2024-52851$$FDA-CTU$$$$$$N$$$20240508$N$$US$
241641011$24164101$1$I$$20240729$20240801$20240801$EXP$$US-PFIZER INC-202400225966$PFIZER$$80$YR$$F$Y$$$20240801$$HP$US$US
241641022$24164102$2$F$20240518$20240812$20240801$20240816$EXP$$US-PFIZER INC-PV202400099654$PFIZER$$52$YR$$M$Y$95.4$KG$20240816$$MD$US$US
241641031$24164103$1$I$$20240729$20240801$20240801$EXP$$CA-PFIZER INC-202400225808$PFIZER$$64$YR$$F$Y$$$20240801$$CN$CA$CA
241641046$24164104$6$F$$20240904$20240801$20240920$EXP$$MY-TAKEDA-2024TUS076979$TAKEDA$$$$$F$Y$$$20240920$$CN$MY$MY
241641061$24164106$1$I$$20240722$20240801$20240801$EXP$$RU-TEVA-VS-3226165$TEVA$Sergeeva NS, Karmakova TA, Savchina VV, Deshkina TI, Karpenko EYu, Bolotina LV, et al. DYNAMICS OF URINARY KIM-1 AS A BIOMARKER OF ACUTE KIDNEY INJURY IN CANCER PATIENTS UNDERGOING CISPLATIN-BASED CHEMOTHERAPY. [Russian]. Sib-Onkol-Zhur 2023; 22 (4): 44-54.; Sergeeva NS, Karmakova TA, Savchina VV, Deshkina TI, Karpenko EYu, Bolotina LV, et al. DYNAMICS OF URINARY KIM-1 AS A BIOMARKER OF ACUTE KIDNEY INJURY IN CANCER PATIENTS UNDERGOING CISPLATIN-BASED CHEMOTHERAPY. [Russian]. Sib-Onkol-Zhur 2...$60$YR$$M$Y$$$20240801$$HP$RU$RU
241641071$24164107$1$I$$20240724$20240801$20240801$EXP$GB-MHRA-MIDB-b0ac154e-0835-4945-b18d-d0ea9223a0c0$GB-TEVA-VS-3225290$TEVA$$83$YR$$F$Y$$$20240801$$PH$GB$GB
241641081$24164108$1$I$$20240722$20240801$20240801$EXP$$DE-TEVA-VS-3226543$TEVA$Walle N, Dorr AA, Potente S, Schmidt PH, Schafer N. The last resort-Suicide by taking pentobarbital. [German]. Rechtsmedizin 2023; 33 (4): 301-306.$53$YR$$F$Y$$$20240801$$HP$DE$DE
241641091$24164109$1$I$$20240724$20240801$20240801$EXP$$IL-TAKEDA-2023TUS112965$TAKEDA$$$$$M$Y$$$20240801$$CN$IL$IL
241641111$24164111$1$I$20240730$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121235$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240801$$CN$US$US
241641122$24164112$2$F$$20240827$20240801$20240828$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-121774$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240829$$HP$CH$CH
241641131$24164113$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122132$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240801$$CN$US$US
241641141$24164114$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122102$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240801$$CN$US$US
241641151$24164115$1$I$$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020393$ELI LILLY AND CO$$$$$M$Y$$$20240801$$CN$US$US
241641162$24164116$2$F$$20240731$20240801$20240807$PER$$US-ABBVIE-5853362$ABBVIE$$60$YR$$$Y$$$20240807$$CN$US$US
241641172$24164117$2$F$20240101$20240730$20240801$20240805$EXP$$JP-009507513-2407JPN004738J$MERCK$$71$YR$$M$Y$$$20240805$$PH$JP$JP
241641199$24164119$9$F$20240626$20240916$20240801$20240924$EXP$$CA-BEH-2024175463$CSL BEHRING$$75$YR$E$F$Y$56.689$KG$20240924$$HP$CA$CA
241641201$24164120$1$I$20240723$20240724$20240801$20240801$EXP$$US-ABBVIE-5315594$ABBVIE$$73$YR$$F$Y$54.431$KG$20240801$$CN$US$US
241641211$24164121$1$I$20240701$20240729$20240801$20240801$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-138324$DAIICHI$$60$YR$$F$Y$$$20240801$$MD$CA$CA
241641221$24164122$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137912$DAIICHI$$50$YR$$F$Y$$$20240801$$HP$CA$CA
241641231$24164123$1$I$20240730$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122110$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240801$$CN$US$US
241641241$24164124$1$I$20240301$20240724$20240801$20240801$EXP$FR-AFSSAPS-BX2024001457$FR-TEVA-VS-3225722$TEVA$$65$YR$$M$Y$$$20240801$$MD$FR$FR
241641251$24164125$1$I$20240601$20240731$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121987$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240801$$CN$US$US
241641261$24164126$1$I$$20240628$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-105961$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240801$$MD$US$US
241641271$24164127$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A169637$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241641281$24164128$1$I$$20240730$20240801$20240801$EXP$$US-Karo Pharma-2159897$Karo Pharma$$77$YR$$F$Y$$$20240801$$MD$US$US
241641292$24164129$2$F$20240725$20240822$20240801$20240904$PER$$US-AstraZeneca-2024A171124$ASTRAZENECA$$27860$DY$$$Y$$$20240904$$CN$US$
241641311$24164131$1$I$$20240724$20240801$20240801$EXP$$US-AstraZeneca-2024A170278$ASTRAZENECA$$$$$F$Y$68$KG$20240801$$CN$US$
241641321$24164132$1$I$20240501$20240726$20240801$20240801$EXP$$US-SA-2024SA181642$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240801$$MD$US$US
241641331$24164133$1$I$20240423$20240724$20240801$20240801$EXP$FR-AFSSAPS-ST2024001178$FR-TEVA-VS-3225400$TEVA$$45$YR$$M$Y$$$20240801$$CN$FR$FR
241641341$24164134$1$I$20240712$20240719$20240801$20240801$EXP$$CN-GE HEALTHCARE-2024CSU008265$GE HEALTHCARE$$58$YR$$F$Y$60$KG$20240801$$HP$CN$CN
241641351$24164135$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137918$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241641361$24164136$1$I$20240412$20240507$20240801$20240801$PER$$US-GE HEALTHCARE-2024CSU004888$GE HEALTHCARE$$18$YR$$M$Y$$$20240801$$HP$US$US
241641371$24164137$1$I$20231222$20240507$20240801$20240801$PER$$US-GE HEALTHCARE-2024CSU004887$GE HEALTHCARE$$18$YR$$M$Y$65.76$KG$20240801$$HP$US$US
241641381$24164138$1$I$$20240729$20240801$20240801$EXP$$US-009507513-2407USA015463$MERCK$$$$$F$Y$$$20240801$$CN$US$US
241641391$24164139$1$I$$20240702$20240801$20240801$PER$$US-009507513-2407USA001804$MERCK$$$$$M$Y$$$20240801$$CN$US$US
241641405$24164140$5$F$20240522$20240812$20240801$20240814$EXP$$DE-BAXTER-2024BAX022161$BAXTER$$19$YR$$F$Y$$$20240814$$HP$DE$DE
241641411$24164141$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137976$DAIICHI$$$$$F$Y$76$KG$20240801$$CN$CA$CA
241641421$24164142$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137972$DAIICHI$$$$$F$Y$$$20240801$$CN$CA$CA
241641431$24164143$1$I$20230517$20240722$20240801$20240801$EXP$$ES-BAXTER-2024BAX022182$BAXTER$$69$YR$$M$Y$$$20240801$$PH$ES$ES
241641441$24164144$1$I$$20240724$20240801$20240801$EXP$GB-MHRA-31026485$GB-TEVA-VS-3225769$TEVA$$$$$$Y$$$20240801$$CN$GB$GB
241641452$24164145$2$F$20240628$20240726$20240801$20240805$EXP$$CN-BAXTER-2024BAX022167$BAXTER$$63$YR$$F$Y$39$KG$20240805$$MD$CN$CN
241641461$24164146$1$I$20210712$20240722$20240801$20240801$EXP$$US-BAXTER-2024BAX021917$BAXTER$$74$YR$$F$Y$62.6$KG$20240801$$MD$US$US
241641472$24164147$2$F$20240712$20240911$20240801$20240917$PER$$US-ABBVIE-5855223$ABBVIE$$20$YR$$M$Y$74.8$KG$20240917$$HP$US$US
241641481$24164148$1$I$$20240724$20240801$20240801$EXP$$US-ALKERMES INC.-ALK-2024-001962$ALKERMES$$33$YR$$F$Y$$$20240801$$HP$US$US
241641491$24164149$1$I$20240801$20240801$20240801$20240801$DIR$712390$$FDA-CTU$$71$YR$$F$N$$$20240801$N$PH$US$
241641501$24164150$1$I$20240728$20240801$20240801$20240801$DIR$712392$$FDA-CTU$$73$YR$$M$N$$$20240801$N$PH$US$
241641511$24164151$1$I$20240724$20240801$20240801$20240801$DIR$712397$$FDA-CTU$$68$YR$$M$N$$$20240801$N$PH$US$
241641521$24164152$1$I$$20240724$20240801$20240801$EXP$$US-ALKERMES INC.-ALK-2024-001981$ALKERMES$$$$$M$Y$$$20240801$$CN$US$US
241641531$24164153$1$I$20240701$20240724$20240801$20240801$EXP$$US-ALKERMES INC.-ALK-2024-001963$ALKERMES$$44$YR$$M$Y$$$20240801$$HP$US$US
241641541$24164154$1$I$$20240731$20240801$20240801$PER$$US-BIOMARINAP-US-2024-159546$BIOMARIN$$$$$$Y$$$20240801$$CN$US$US
241641551$24164155$1$I$20240622$20240722$20240801$20240801$EXP$$CA-BIOMARINAP-CA-2024-159543$BIOMARIN$$$$$$Y$$$20240801$$CN$CA$CA
241641561$24164156$1$I$20240411$20240724$20240801$20240801$EXP$NO-NOMAADVRE-RELISSO-2024-Vake68$NO-TEVA-VS-3225389$TEVA$$59$YR$$M$Y$$$20240801$$MD$NO$NO
241641571$24164157$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137988$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241641581$24164158$1$I$20240725$20240725$20240801$20240801$PER$$US-ALXN-202407USA002097US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240801$$CN$US$US
241641591$24164159$1$I$$20240726$20240801$20240801$PER$$US-SA-2024SA223282$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240801$$HP$US$US
241641601$24164160$1$I$20240101$20240725$20240801$20240801$PER$$US-SA-2024SA223139$SANOFI AVENTIS$$$$A$M$Y$$$20240801$$MD$US$US
241641611$24164161$1$I$20240625$20240723$20240801$20240801$EXP$$CN-TAKEDA-2024TUS076706$TAKEDA$$61$YR$$M$Y$48$KG$20240801$$HP$CN$CN
241641621$24164162$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137989$DAIICHI$$$$$F$Y$$$20240801$$CN$CA$CA
241641631$24164163$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138000$DAIICHI$$47$YR$$F$Y$60$KG$20240801$$HP$CA$CA
241641641$24164164$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137993$DAIICHI$$$$$F$Y$73$KG$20240801$$CN$CA$CA
241641651$24164165$1$I$$20240726$20240801$20240801$EXP$$BR-TAKEDA-2024TUS076612$TAKEDA$$18$YR$$$Y$$$20240801$$CN$BR$BR
241641661$24164166$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138019$DAIICHI$$51$YR$$F$Y$$$20240801$$MD$CA$CA
241641671$24164167$1$I$$20240726$20240801$20240801$PER$$US-ABBVIE-5857482$ABBVIE$$$$$$Y$$$20240801$$CN$US$US
241641681$24164168$1$I$$20240724$20240801$20240801$EXP$$IT-TEVA-VS-3225947$TEVA$$$$$F$Y$$$20240801$$MD$IT$IT
241641692$24164169$2$F$$20240806$20240801$20240816$EXP$$NL-TEVA-VS-3226204$TEVA$Ten Brinck MFM, Verheijen IWH, van de Wardt J, van Dijk GW, Nijhuis FAP, Verrips A. Dilated fixed pupils and respiratory failure: a rare clinical course of Lambert-Eaton myasthenic syndrome. BMJ-Neurol-Open 2023; 5 (2): 1-4.; Ten Brinck MFM, Verheijen IWH, van de Wardt J, van Dijk GW, Nijhuis FAP, Verrips A. Dilated fixed pupils and respiratory failure: a rare clinical course of Lambert-Eaton myasthenic syndrome. BMJ-Neurol-Open 2023; 5 (2): 1-4.$62$YR$$F$Y$$$20240816$$HP$NL$NL
241641701$24164170$1$I$20240722$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151932$AMGEN$$80$YR$E$M$Y$$$20240801$$CN$US$US
241641711$24164171$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138020$DAIICHI$$58$YR$$F$Y$76$KG$20240801$$CN$CA$CA
241641731$24164173$1$I$20240701$20240730$20240801$20240801$EXP$$US-JNJFOC-20240780308$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$CN$US$US
241641741$24164174$1$I$20100310$20100318$20240801$20240801$EXP$$JP-009507513-2408JPN000201$MERCK$$65$YR$$M$Y$67$KG$20240801$$MD$JP$JP
241641751$24164175$1$I$20240522$20240729$20240801$20240801$PER$$US-ABBVIE-5862715$ABBVIE$$22$YR$$F$Y$$$20240801$$MD$US$US
241641761$24164176$1$I$$20240724$20240801$20240801$EXP$GB-MHRA-MED-202407240905003350-VBCJN$GB-TEVA-VS-3225242$TEVA$$74$YR$$F$Y$58$KG$20240801$$CN$GB$GB
241641771$24164177$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138044$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241641781$24164178$1$I$$20240726$20240801$20240801$PER$$US-BAYER-2024A110929$BAYER$$$$$$Y$$$20240801$$CN$US$US
241641791$24164179$1$I$$20240724$20240801$20240801$PER$$US-009507513-2407USA013706$MERCK$$$$$M$Y$$$20240801$$CN$US$US
241641801$24164180$1$I$$20240729$20240801$20240801$EXP$$CA-009507513-2407CAN015935$MERCK$$68$YR$$F$Y$$$20240801$$HP$CA$CA
241641811$24164181$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121812$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240801$$CN$US$US
241641821$24164182$1$I$20240701$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121766$BRISTOL MYERS SQUIBB$$72$YR$E$$Y$$$20240801$$PH$US$US
241641831$24164183$1$I$$20240705$20240801$20240801$PER$$US-IMP-2024000466$Harrow Health$$$$E$F$Y$$$20240801$$CN$US$US
241641841$24164184$1$I$20240710$20240724$20240801$20240801$EXP$$CN-AstraZeneca-2024A171238$ASTRAZENECA$$28333$DY$$M$Y$64$KG$20240801$$MD$CN$
241641851$24164185$1$I$$20230612$20240801$20240801$EXP$$US-AstraZeneca-2023A139146$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$US$
241641861$24164186$1$I$20240607$20240705$20240801$20240801$PER$$US-IMP-2024000468$Harrow Health$$69$YR$E$F$Y$$$20240801$$CN$US$US
241641871$24164187$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019816$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240801$$CN$US$US
241641881$24164188$1$I$$20240705$20240801$20240801$PER$$US-IMP-2024000469$Harrow Health$$$$E$F$Y$$$20240801$$CN$US$US
241641892$24164189$2$F$20240101$20240730$20240801$20240802$EXP$$US-UCBSA-2024025885$UCB$$$$$F$Y$$$20240802$$HP$US$US
241641901$24164190$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138038$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241641911$24164191$1$I$$20240725$20240801$20240801$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR094512$VIIV$$$$$M$Y$$$20240801$$MD$US$US
241641921$24164192$1$I$$20240707$20240801$20240801$PER$$US-IMP-2024000481$Harrow Health$$$$A$M$Y$$$20240801$$CN$US$US
241641931$24164193$1$I$20240701$20240708$20240801$20240801$PER$$US-IMP-2024000477$Harrow Health$$81$YR$E$F$Y$$$20240801$$CN$US$US
241641941$24164194$1$I$$20240711$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01095$AIMMUNE$$$$$$Y$$$20240801$$MD$US$US
241641951$24164195$1$I$20240709$20240709$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01085$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241641961$24164196$1$I$$20240722$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01141$AIMMUNE$$$$$$Y$$$20240801$$HP$US$US
241641971$24164197$1$I$$20240711$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01096$AIMMUNE$$$$$$Y$$$20240801$$MD$US$US
241641981$24164198$1$I$20240527$20240709$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01084$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241641992$24164199$2$F$$20240926$20240801$20240930$PER$$US-JNJFOC-20240767448$JOHNSON AND JOHNSON$$31$YR$A$$Y$$$20240930$$CN$US$US
241642001$24164200$1$I$$20240724$20240801$20240801$PER$$US-MYLANLABS-2024M1069610$MYLAN$$$$$F$Y$81.65$KG$20240801$$CN$US$US
241642011$24164201$1$I$20240701$20240708$20240801$20240801$PER$$US-IMP-2024000478$Harrow Health$$$$E$F$Y$$$20240801$$CN$US$US
241642021$24164202$1$I$$20240731$20240801$20240801$PER$$NVSC2024US157141$NOVARTIS$$$$$$Y$$$20240801$$HP$US$US
241642031$24164203$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138057$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241642041$24164204$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138045$DAIICHI$$$$$F$Y$$$20240801$$HP$CA$CA
241642051$24164205$1$I$20240101$20240708$20240801$20240801$PER$$US-IMP-2024000476$Harrow Health$$72$YR$E$F$Y$$$20240801$$CN$US$US
241642061$24164206$1$I$$20240730$20240801$20240801$EXP$$US-Karo Pharma-2159898$Karo Pharma$$76$YR$$F$Y$$$20240801$$MD$US$US
241642071$24164207$1$I$$20240725$20240801$20240801$EXP$GB-MHRA-MED-202407251356400930-ZGKRJ$GB-TEVA-VS-3226469$TEVA$$65$YR$$M$Y$83$KG$20240801$$CN$GB$GB
241642081$24164208$1$I$20240101$20240730$20240801$20240801$PER$$US-ABBVIE-5861423$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241642091$24164209$1$I$$20240719$20240801$20240801$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK092636$GLENMARK$$$$$$Y$$$20240801$$MD$GB$GB
241642103$24164210$3$F$20240729$20240812$20240801$20240820$EXP$$AU-TAKEDA-2024TUS076601$TAKEDA$$75$YR$$F$Y$46$KG$20240820$$CN$AU$AU
241642111$24164211$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-202400225801$PFIZER$$$$$M$Y$$$20240801$$HP$US$US
241642121$24164212$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-202400227724$PFIZER$$61$YR$$F$Y$$$20240801$$HP$US$US
241642132$24164213$2$F$20240101$20240909$20240801$20240911$EXP$$US-PFIZER INC-PV202400100238$PFIZER$$42$YR$$F$Y$$$20240911$$HP$US$US
241642141$24164214$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138049$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241642151$24164215$1$I$$20240722$20240801$20240801$PER$$US-VERTEX PHARMACEUTICALS-2024-012184$VERTEX$$$$$$Y$$$20240801$$CN$US$US
241642163$24164216$3$F$20240606$20240821$20240801$20240827$EXP$FR-AFSSAPS-TS2024000829$FR-VERTEX PHARMACEUTICALS-2024-012243$VERTEX$$22$YR$$F$Y$94$KG$20240827$$MD$FR$FR
241642171$24164217$1$I$$20240730$20240801$20240801$EXP$$IN-EMD Serono-2024041481$EMD SERONO INC$$$$E$F$Y$$$20240801$$CN$IN$IN
241642181$24164218$1$I$$20240725$20240801$20240801$EXP$$NVSC2023GB140273$NOVARTIS$$$$$M$Y$$$20240801$$CN$GB$GB
241642191$24164219$1$I$20240229$20240730$20240801$20240801$EXP$FR-AFSSAPS-PV2024000231$FR-GUERBET / LLC-FR-20240128$GUERBET$$68$YR$E$F$Y$75$KG$20240801$$HP$FR$FR
241642212$24164221$2$F$$20240724$20240801$20240828$PER$$US-ABBVIE-5855892$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
241642221$24164222$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138016$DAIICHI$$66$YR$$F$Y$68$KG$20240801$$MD$CA$CA
241642231$24164223$1$I$$20240724$20240801$20240801$EXP$$ES-TEVA-VS-3225976$TEVA$$$$$F$Y$$$20240801$$MD$ES$ES
241642252$24164225$2$F$$20240829$20240801$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121934$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240903$$CN$US$US
241642261$24164226$1$I$$20240731$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121914$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240801$$CN$US$US
241642271$24164227$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121460$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240801$$PH$US$US
241642281$24164228$1$I$20240731$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122047$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240801$$CN$US$US
241642292$24164229$2$F$20240715$20240805$20240801$20240806$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-119874$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$70.5$KG$20240807$$CN$CN$CN
241642301$24164230$1$I$$20240730$20240801$20240801$EXP$$US-APELLIS-2024-APL-0000602$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
241642322$24164232$2$F$20240201$20240805$20240801$20240807$EXP$$US-ABBVIE-5862570$ABBVIE$$72$YR$$F$Y$58$KG$20240807$$CN$US$US
241642331$24164233$1$I$$20240726$20240801$20240801$PER$$US-SA-2024SA223058$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240801$$MD$US$US
241642341$24164234$1$I$20231001$20240723$20240801$20240801$PER$$US-SA-2024SA223572$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240801$$MD$US$US
241642351$24164235$1$I$20240101$20240725$20240801$20240801$PER$$US-SA-2024SA223351$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240801$$MD$US$US
241642361$24164236$1$I$20240601$20240725$20240801$20240801$PER$$US-SA-2024SA224196$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240801$$MD$US$US
241642371$24164237$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA223537$SANOFI AVENTIS$$$$E$F$Y$$$20240801$$MD$US$US
241642381$24164238$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221948$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240801$$MD$US$US
241642391$24164239$1$I$20240601$20240709$20240801$20240801$PER$$US-IMP-2024000485$Harrow Health$$$$E$F$Y$$$20240801$$CN$US$US
241642401$24164240$1$I$20240101$20240709$20240801$20240801$PER$$US-IMP-2024000486$Harrow Health$$$$E$F$Y$$$20240801$$CN$US$US
241642411$24164241$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138010$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241642421$24164242$1$I$$20240731$20240801$20240801$PER$$NVSC2024US157176$NOVARTIS$$$$$M$Y$$$20240801$$MD$US$US
241642431$24164243$1$I$$20240729$20240801$20240801$PER$$NVSC2024US156659$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
241642441$24164244$1$I$$20240723$20240801$20240801$EXP$GB-MHRA-31081282$GB-TEVA-VS-3225017$TEVA$$26$YR$$F$Y$$$20240801$$CN$GB$GB
241642451$24164245$1$I$$20240726$20240801$20240801$EXP$$CA-TAKEDA-2024TUS009042$TAKEDA$$$$$M$Y$$$20240801$$MD$CA$CA
241642461$24164246$1$I$20240501$20240709$20240801$20240801$PER$$US-IMP-2024000487$Harrow Health$$$$E$F$Y$$$20240801$$CN$US$US
241642471$24164247$1$I$$20240725$20240801$20240801$EXP$$GB-TEVA-VS-3225888$TEVA$$$$$F$Y$$$20240801$$PH$GB$GB
241642481$24164248$1$I$20240101$20240710$20240801$20240801$PER$$US-IMP-2024000488$Harrow Health$$$$A$F$Y$$$20240801$$CN$US$US
241642492$24164249$2$F$20240101$20240801$20240801$20240821$PER$$US-IMP-2024000489$Harrow Health$$94$YR$E$F$Y$$$20240821$$CN$US$US
241642501$24164250$1$I$20110101$20240726$20240801$20240801$EXP$$BG-MYLANLABS-2024M1070455$MYLAN$Nikolova M, Grashnov E.. Aripiprazole in the therapy of patients diagnosed with schizophrenia and bipolar affective disorder. Medic Plus. 2024;2:56-58$50$YR$$F$Y$$$20240801$$HP$BG$BG
241642511$24164251$1$I$20240702$20240726$20240801$20240801$EXP$FR-AFSSAPS-PC2024000583$FR-MYLANLABS-2024M1070453$MYLAN$$42$YR$$M$Y$110$KG$20240801$$MD$FR$FR
241642521$24164252$1$I$20240709$20240726$20240801$20240801$EXP$FR-AFSSAPS-RE2024000739$FR-MYLANLABS-2024M1070539$MYLAN$$60$YR$$F$Y$80$KG$20240801$$PH$FR$FR
241642531$24164253$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-138008$DAIICHI$$69$YR$$F$Y$$$20240801$$CN$CA$CA
241642541$24164254$1$I$$20240726$20240801$20240801$EXP$$IT-MYLANLABS-2024M1070459$MYLAN$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al.. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$87$YR$$F$Y$$$20240801$$MD$IT$IT
241642551$24164255$1$I$20240701$20240726$20240801$20240801$EXP$FR-AFSSAPS-AVCN2024000555$FR-MYLANLABS-2024M1070460$MYLAN$$27$YR$$M$Y$$$20240801$$MD$FR$FR
241642561$24164256$1$I$20211105$20240726$20240801$20240801$EXP$ES-AEMPS-1549197$ES-MYLANLABS-2024M1070471$MYLAN$$62$YR$$F$Y$48$KG$20240801$$MD$ES$ES
241642571$24164257$1$I$20230510$20240726$20240801$20240801$EXP$IT-MINISAL02-995777$IT-MYLANLABS-2024M1070494$MYLAN$$95$YR$$F$Y$$$20240801$$MD$IT$IT
241642581$24164258$1$I$20240129$20240726$20240801$20240801$EXP$DE-CADRBFARM-2024329426$DE-MYLANLABS-2024M1070461$MYLAN$$25$YR$$F$Y$80$KG$20240801$$CN$DE$DE
241642591$24164259$1$I$$20240711$20240801$20240801$PER$$US-IMP-2024000490$Harrow Health$$$$E$F$Y$$$20240801$$CN$US$US
241642601$24164260$1$I$$20240730$20240801$20240801$EXP$$UG-PFIZER INC-PV202400099918$PFIZER$$83$YR$$F$Y$$$20240801$$HP$UG$UG
241642621$24164262$1$I$20240708$20240726$20240801$20240801$EXP$$CN-009507513-2407CHN015738$MERCK$$66$YR$$M$Y$69$KG$20240801$$HP$CN$CN
241642631$24164263$1$I$20240708$20240730$20240801$20240801$EXP$FR-AFSSAPS-LM2024000422$FR-PFIZER INC-202400226456$PFIZER$$54$YR$$F$Y$46.8$KG$20240801$$MD$FR$FR
241642641$24164264$1$I$20240724$20240730$20240801$20240801$EXP$LU-ALMPS-202404286$LU-PFIZER INC-202400226224$PFIZER$$57$YR$$M$Y$81$KG$20240801$$PH$LU$LU
241642651$24164265$1$I$20240611$20240731$20240801$20240801$EXP$$CN-PFIZER INC-PV202400100171$PFIZER$$58$YR$$F$Y$83$KG$20240801$$HP$CN$CN
241642661$24164266$1$I$$20240730$20240801$20240801$EXP$$FR-PFIZER INC-202400226459$PFIZER$$75$YR$$F$Y$$$20240801$$MD$FR$FR
241642671$24164267$1$I$20240101$20240730$20240801$20240801$EXP$$CA-PFIZER INC-202400184289$PFIZER$$79$YR$$F$Y$$$20240801$$CN$CA$CA
241642681$24164268$1$I$20240726$20240730$20240801$20240801$EXP$$GB-PFIZER INC-202400226577$PFIZER$$66$YR$$M$Y$71$KG$20240801$$CN$GB$GB
241642694$24164269$4$F$20240101$20240915$20240801$20240916$EXP$$CA-PFIZER INC-202400226739$PFIZER$$69$YR$$F$Y$$$20240916$$MD$CA$CA
241642701$24164270$1$I$20240601$20240731$20240801$20240801$EXP$$IT-PFIZER INC-PV202400099915$PFIZER$$78$YR$$F$Y$$$20240801$$CN$IT$IT
241642711$24164271$1$I$20240505$20240730$20240801$20240801$EXP$$CN-PFIZER INC-PV202400099499$PFIZER$$73$YR$$M$Y$$$20240801$$HP$CN$CN
241642721$24164272$1$I$20240603$20240729$20240801$20240801$EXP$FR-AFSSAPS-NC2024000900$FR-PFIZER INC-202400225536$PFIZER$$88$YR$$F$Y$52$KG$20240801$$MD$FR$FR
241642741$24164274$1$I$$20240730$20240801$20240801$EXP$$IN-PFIZER INC-PV202400099813$PFIZER$$50$YR$$F$Y$$$20240801$$CN$IN$IN
241642751$24164275$1$I$$20240730$20240801$20240801$EXP$$US-PFIZER INC-PV202400099636$PFIZER$$69$YR$$$Y$$$20240801$$CN$US$US
241642762$24164276$2$F$$20240805$20240801$20240809$EXP$$JP-PFIZER INC-202400194728$PFIZER$$$$A$$Y$$$20240809$$MD$JP$JP
241642772$24164277$2$F$20240218$20240805$20240801$20240807$EXP$$CH-ASTELLAS-2024US021475$ASTELLAS$$16$YR$$F$Y$38.5$KG$20240807$$CN$CH$CH
241642781$24164278$1$I$20240101$20240731$20240801$20240801$EXP$$US-PFIZER INC-202400228115$PFIZER$$65$YR$$M$Y$$$20240801$$CN$US$US
241642791$24164279$1$I$20240714$20240729$20240801$20240801$EXP$$NVSC2024CN157075$NOVARTIS$$3$MON$$M$Y$5.9$KG$20240801$$HP$CN$CN
241642801$24164280$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137990$DAIICHI$$$$$F$Y$$$20240801$$HP$CA$CA
241642821$24164282$1$I$20240401$20240729$20240801$20240801$EXP$$US-PFIZER INC-PV202400099115$PFIZER$$34$YR$$M$Y$$$20240801$$HP$US$US
241642832$24164283$2$F$20240101$20240925$20240801$20240930$EXP$$US-UCBSA-2024026262$UCB$$$$$M$Y$84.19$KG$20240930$$HP$US$US
241642841$24164284$1$I$$20240729$20240801$20240801$EXP$$US-GSK-US2024094751$GLAXOSMITHKLINE$$$$$$Y$$$20240801$$CN$US$US
241642851$24164285$1$I$$20240711$20240801$20240801$PER$$US-IMP-2024000491$Harrow Health$$$$E$F$Y$$$20240801$$CN$US$US
241642861$24164286$1$I$$20240711$20240801$20240801$PER$$US-IMP-2024000495$Harrow Health$$$$E$F$Y$$$20240801$$CN$US$US
241642871$24164287$1$I$$20240724$20240801$20240801$EXP$$IT-Eisai-EC-2024-170872$EISAI$$81$YR$E$F$Y$$$20240801$$MD$IT$IT
241642882$24164288$2$F$$20240820$20240801$20240902$EXP$IE-GE HEALTHCARE-2024CSU007801$IE-GUERBET / LLC-IE-20240022$GUERBET$$$$$M$Y$$$20240902$$MD$IE$IE
241642891$24164289$1$I$$20240729$20240801$20240801$PER$$US-ROCHE-10000042477$ROCHE$$60$YR$A$F$Y$$$20240801$$HP$US$US
241642901$24164290$1$I$$20240711$20240801$20240801$PER$$US-IMP-2024000496$Harrow Health$$$$E$F$Y$$$20240801$$CN$US$US
241642911$24164291$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137974$DAIICHI$$$$$F$Y$$$20240801$$HP$CA$CA
241642921$24164292$1$I$20240101$20240726$20240801$20240801$PER$$US-Eisai-EC-2024-170997$EISAI$$64$YR$A$M$Y$$$20240801$$CN$US$US
241642931$24164293$1$I$$20240715$20240801$20240801$PER$$US-IMP-2024000504$Harrow Health$$$$E$F$Y$$$20240801$$CN$US$US
241642941$24164294$1$I$$20240730$20240801$20240801$PER$$US-PHARMING-PHAUS2024000644$PHARMING GROUP$$$$$$Y$$$20240801$$CN$US$US
241642951$24164295$1$I$$20240729$20240801$20240801$PER$$US-PHARMING-PHAUS2024000645$PHARMING GROUP$$$$$$Y$$$20240801$$CN$US$US
241642971$24164297$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137908$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241642991$24164299$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137921$DAIICHI$$$$$F$Y$84$KG$20240801$$HP$CA$CA
241643002$24164300$2$F$20240424$20240823$20240801$20240830$EXP$$CA-TAKEDA-2024TUS074535$TAKEDA$$60$YR$$M$Y$$$20240830$$HP$CA$CA
241643011$24164301$1$I$20240101$20240726$20240801$20240801$PER$$US-ORGANON-O2407USA002622$ORGANON$$$$$F$Y$$$20240801$$HP$US$US
241643022$24164302$2$F$$20240730$20240801$20240820$EXP$$CA-MYLANLABS-2024M1070941$MYLAN$$$$$M$Y$$$20240820$$PH$CA$CA
241643031$24164303$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137905$DAIICHI$$$$$F$Y$69$KG$20240801$$MD$CA$CA
241643041$24164304$1$I$$20240729$20240801$20240801$EXP$$US-PHARMING-PHAUS2024000646$PHARMING GROUP$$$$$$Y$$$20240801$$CN$US$US
241643051$24164305$1$I$20240710$20240724$20240801$20240801$PER$$US-BRACCO-2024US04317$BRACCO$$47$YR$$F$Y$$$20240801$$CN$US$US
241643061$24164306$1$I$20240725$20240730$20240801$20240801$EXP$$US-KYOWAKIRIN-2024KK018391$KYOWA$$$$$$Y$$$20240801$$HP$US$US
241643072$24164307$2$F$$20240812$20240801$20240821$EXP$$IT-TEVA-VS-3225957$TEVA$$61$YR$$M$Y$$$20240821$$MD$IT$IT
241643082$24164308$2$F$20240726$20240902$20240801$20240905$EXP$$CA-BAUSCH-BL-2024-011583$BAUSCH AND LOMB$$36$YR$$F$Y$$$20240905$$CN$CA$CA
241643091$24164309$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137881$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241643101$24164310$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137879$DAIICHI$$$$$F$Y$77$KG$20240801$$CN$CA$CA
241643111$24164311$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137902$DAIICHI$$66$YR$$F$Y$67$KG$20240801$$CN$CA$CA
241643121$24164312$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121700$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240801$$HP$US$US
241643131$24164313$1$I$20240730$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121428$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240801$$HP$US$US
241643141$24164314$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA221917$SANOFI AVENTIS$$28$YR$A$F$Y$52.154$KG$20240801$$MD$US$US
241643151$24164315$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137877$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241643161$24164316$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA222049$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240801$$HP$US$US
241643181$24164318$1$I$$20240505$20240801$20240801$DIR$FDA-CDER-CTU-2024-52864$$FDA-CTU$$$$$$N$$$20240505$N$PH$US$
241643191$24164319$1$I$20240701$20240723$20240801$20240801$EXP$$CL-BIOMARINAP-CL-2024-159462$BIOMARIN$$$$$$Y$$$20240801$$CN$CL$CL
241643201$24164320$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137876$DAIICHI$$$$$F$Y$$$20240801$$CN$CA$CA
241643211$24164321$1$I$20240101$20240726$20240801$20240801$EXP$$DE-MYLANLABS-2024M1062375$MYLAN$$$$E$M$Y$$$20240801$$MD$DE$DE
241643221$24164322$1$I$$20240720$20240801$20240801$PER$$US-JNJFOC-20240767994$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$CN$US$US
241643231$24164323$1$I$20240601$20240801$20240801$20240801$EXP$CZ-CZSUKL-24002160$CZ-ABBVIE-5863034$ABBVIE$$63$YR$$F$Y$76$KG$20240801$$MD$CZ$CZ
241643251$24164325$1$I$20220101$20240725$20240801$20240801$EXP$$CN-009507513-2407CHN014012$MERCK$Di C, Yu T, Ni L. Non-bacterial cystitis caused by pembrolizumab therapy for adenocarcinoma of the lung: a case report. Frontiers in immunology. 2024;15:1423123$27$YR$$F$Y$$$20240801$$HP$CN$CN
241643261$24164326$1$I$20240501$20240724$20240801$20240801$EXP$GB-MHRA-31122984$GB-TEVA-VS-3225632$TEVA$$69$YR$$F$Y$61$KG$20240801$$MD$GB$GB
241643271$24164327$1$I$20240601$20240731$20240801$20240801$PER$$US-ABBVIE-5862680$ABBVIE$$47$YR$$F$Y$63$KG$20240801$$CN$US$US
241643282$24164328$2$F$20120403$20240828$20240801$20240907$EXP$GB-MHRA-MED-202407241045585120-DRSWJ$GB-TEVA-VS-3225705$TEVA$$0$DY$$M$Y$$$20240907$$MD$GB$GB
241643291$24164329$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137875$DAIICHI$$$$$F$Y$$$20240801$$PH$CA$CA
241643301$24164330$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137874$DAIICHI$$$$$F$Y$$$20240801$$CN$CA$CA
241643311$24164331$1$I$20240715$20240724$20240801$20240801$EXP$GB-MHRA-MED-202407241446599570-YNRCZ$GB-TEVA-VS-3225706$TEVA$$95$YR$$F$Y$$$20240801$$MD$GB$GB
241643321$24164332$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121744$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$90.26$KG$20240801$$CN$US$US
241643331$24164333$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121910$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240801$$CN$US$US
241643341$24164334$1$I$20210913$20210915$20240801$20240801$EXP$$US-AstraZeneca-2021A729131$ASTRAZENECA$$$$$$Y$$$20240801$$CN$US$
241643361$24164336$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137870$DAIICHI$$$$$F$Y$64$KG$20240801$$MD$CA$CA
241643371$24164337$1$I$$20240724$20240801$20240801$EXP$$GB-AstraZeneca-2024A175111$ASTRAZENECA$$62$YR$$F$Y$62$KG$20240801$$MD$GB$
241643381$24164338$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137873$DAIICHI$$$$$F$Y$$$20240801$$CN$CA$CA
241643391$24164339$1$I$$20240726$20240801$20240801$EXP$IS-IMA-8762$IS-MYLANLABS-2024M1070446$MYLAN$$16$YR$$M$Y$$$20240801$$MD$IS$IS
241643401$24164340$1$I$$20240726$20240801$20240801$EXP$$HR-MYLANLABS-2024M1070357$MYLAN$$65$YR$$M$Y$96$KG$20240801$$MD$HR$HR
241643411$24164341$1$I$$20240503$20240801$20240801$DIR$FDA-CDER-CTU-2024-52893$$FDA-CTU$$$$$$N$$$20240503$N$PH$US$
241643421$24164342$1$I$20240615$20240726$20240801$20240801$EXP$FR-AFSSAPS-PB2024000800$FR-MYLANLABS-2024M1070383$MYLAN$$39$YR$$F$Y$59$KG$20240801$$MD$FR$FR
241643431$24164343$1$I$20221101$20240726$20240801$20240801$EXP$DK-DKMA-30735696$DK-MYLANLABS-2024M1070439$MYLAN$$53$YR$$F$Y$92$KG$20240801$$MD$DK$DK
241643441$24164344$1$I$20240625$20240726$20240801$20240801$EXP$FR-AFSSAPS-GR2024000926$FR-MYLANLABS-2024M1070434$MYLAN$$74$YR$$F$Y$$$20240801$$PH$FR$FR
241643451$24164345$1$I$$20240726$20240801$20240801$EXP$$FR-MYLANLABS-2024M1070435$MYLAN$Furst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R et al.. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease. Bone Marrow Transplant. 2024;59(7):918-27$$$A$M$Y$$$20240801$$MD$FR$FR
241643461$24164346$1$I$20240605$20240726$20240801$20240801$EXP$IT-MINISAL02-995859$IT-MYLANLABS-2024M1070429$MYLAN$$79$YR$$F$Y$$$20240801$$MD$IT$IT
241643471$24164347$1$I$20240713$20240726$20240801$20240801$EXP$FR-AFSSAPS-SE2024000588$FR-MYLANLABS-2024M1070445$MYLAN$$68$YR$$F$Y$74.7$KG$20240801$$MD$FR$FR
241643481$24164348$1$I$$20240723$20240801$20240801$PER$$US-JNJFOC-20240762330$JOHNSON AND JOHNSON$$$$$F$Y$$$20240801$$CN$US$US
241643492$24164349$2$F$20240601$20240922$20240801$20240925$EXP$$IL-ABBVIE-5859093$ABBVIE$$45$YR$$F$Y$$$20240925$$PH$IL$IL
241643501$24164350$1$I$20220101$20240718$20240801$20240801$EXP$$US-UCBSA-2024037740$UCB$$48$YR$$F$Y$$$20240801$$HP$US$US
241643511$24164351$1$I$$20240730$20240801$20240801$EXP$$IE-MYLANLABS-2024M1071556$MYLAN$$$$$M$Y$$$20240801$$HP$IE$IE
241643521$24164352$1$I$$20240728$20240801$20240801$PER$$US-ABBVIE-5858880$ABBVIE$$$$$$Y$$$20240801$$CN$US$US
241643531$24164353$1$I$20240319$20240730$20240801$20240801$PER$FR-AFSSAPS-ST2024001247$FR-Eisai-EC-2024-171137$EISAI$$74$YR$E$F$Y$45$KG$20240801$$HP$FR$FR
241643541$24164354$1$I$$20240507$20240801$20240801$DIR$FDA-CDER-CTU-2024-52871$$FDA-CTU$$$$$$N$$$20240507$N$PH$US$
241643551$24164355$1$I$$20240503$20240801$20240801$DIR$FDA-CDER-CTU-2024-52890$$FDA-CTU$$$$$$N$$$20240503$N$PH$US$
241643561$24164356$1$I$$20240508$20240801$20240801$DIR$FDA-CDER-CTU-2024-52844$$FDA-CTU$$$$$$N$$$20240508$N$PH$US$
241643573$24164357$3$F$20240723$20240730$20240801$20240812$EXP$$US-GUERBET / LLC-US-20240119$GUERBET$$29$YR$A$F$Y$79.37$KG$20240812$$HP$US$US
241643581$24164358$1$I$20240723$20240723$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407015672$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240801$$CN$US$US
241643591$24164359$1$I$20220101$20240722$20240801$20240801$EXP$$EG-ELI_LILLY_AND_COMPANY-EG202407014684$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240801$$CN$EG$EG
241643601$24164360$1$I$$20240719$20240801$20240801$EXP$GB-MHRA-MED-202407191310321430-SZWBF$GB-ELI_LILLY_AND_COMPANY-GB202407012686$ELI LILLY AND CO$$35$YR$A$F$Y$87$KG$20240801$$CN$GB$GB
241643611$24164361$1$I$$20240722$20240801$20240801$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016498$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240801$$CN$US$US
241643622$24164362$2$F$$20240731$20240801$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015409$ELI LILLY AND CO$$88$YR$E$M$Y$$$20240813$$CN$US$US
241643631$24164363$1$I$$20240706$20240801$20240801$PER$$US-JNJFOC-20240722232$JOHNSON AND JOHNSON$$64$YR$A$F$Y$59$KG$20240801$$CN$US$US
241643641$24164364$1$I$$20240729$20240801$20240801$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407019001$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240801$$CN$DE$DE
241643662$24164366$2$F$$20240802$20240801$20240814$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407013643$ELI LILLY AND CO$$$$$M$Y$105$KG$20240814$$CN$DE$DE
241643671$24164367$1$I$20200101$20240722$20240801$20240801$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015377$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240801$$CN$US$US
241643682$24164368$2$F$20240708$20240730$20240801$20240807$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407012012$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240807$$CN$JP$JP
241643691$24164369$1$I$$20240503$20240801$20240801$DIR$FDA-CDER-CTU-2024-52858$$FDA-CTU$$$$$$N$7.68$KG$20240503$N$PH$US$
241643701$24164370$1$I$$20240503$20240801$20240801$DIR$FDA-CDER-CTU-2024-52855$$FDA-CTU$$$$$$N$$$20240503$N$PH$US$
241643722$24164372$2$F$$20240806$20240801$20240816$EXP$$FR-TEVA-VS-3226555$TEVA$Hay M, Leguy S, Cahagne V, Lassalle N, Le Page E, Michel L. Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient. Rev-Neurol-Paris 2024; 180 (6): 565-567.; Hay M, Leguy S, Cahagne V, Lassalle N, Le Page E, Michel L. Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient. Rev-Neurol-Paris 2024; 180 (6): 565-567.; Hay M, Legu...$62$YR$$F$Y$$$20240816$$HP$FR$FR
241643731$24164373$1$I$20240709$20240726$20240801$20240801$PER$$US-GILEAD-2024-0682171$GILEAD$$30$YR$A$M$Y$$$20240801$$MD$US$US
241643741$24164374$1$I$$20240730$20240801$20240801$PER$$US-ABBVIE-5861660$ABBVIE$$$$$$Y$$$20240801$$HP$US$US
241643752$24164375$2$F$20240717$20240809$20240801$20240821$PER$$CA-GREER Laboratories, Inc.-2159901$GREER$$37$YR$$F$Y$$$20240821$$$CA$CA
241643761$24164376$1$I$$20240726$20240801$20240801$EXP$AU-TGA-0000811845$AU-PERRIGO-24AU007107$PERRIGO$$$$$M$Y$$$20240801$$CN$AU$AU
241643781$24164378$1$I$20240701$20240731$20240801$20240801$EXP$$US-ASTELLAS-2024EU007629$ASTELLAS$$70$YR$$M$Y$$$20240801$$CN$US$US
241643792$24164379$2$F$$20240801$20240801$20240814$PER$$US-SA-2024SA223627$SANOFI AVENTIS$$52$YR$A$M$Y$88.45$KG$20240814$$MD$US$US
241643801$24164380$1$I$20240613$20240723$20240801$20240801$PER$$US-Eisai-EC-2024-170859$EISAI$$78$YR$E$F$Y$$$20240801$$MD$US$US
241643811$24164381$1$I$$20240726$20240801$20240801$EXP$$US-TAKEDA-2024TUS076170$TAKEDA$$$$$F$Y$$$20240801$$MD$US$US
241643821$24164382$1$I$20230101$20240727$20240801$20240801$EXP$$US-BEH-2024176535$CSL BEHRING$$3$DEC$A$F$Y$$$20240801$$HP$US$US
241643831$24164383$1$I$$20240731$20240801$20240801$PER$$NVSC2024US157058$NOVARTIS$$$$$$Y$$$20240801$$MD$US$US
241643842$24164384$2$F$20230401$20240725$20240801$20240807$EXP$$JP-Eisai-EC-2024-171151$EISAI$$48$YR$A$F$Y$65$KG$20240807$$MD$JP$JP
241643851$24164385$1$I$$20240731$20240801$20240801$PER$$NVSC2024US157078$NOVARTIS$$$$$M$Y$$$20240801$$CN$US$US
241643861$24164386$1$I$$20240508$20240801$20240801$DIR$FDA-CDER-CTU-2024-52847$$FDA-CTU$$$$$$N$$$20240508$N$PH$US$
241643872$24164387$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3224942$TEVA$Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.; Bonar S, Schneider HL3rd, Cook K, Samala RV, Poole MFF. Olanzapine for Non-Chemotherapy Related Nausea and Emesis in Patients with a Palliative Care Consult. J-Pain-Symptom-Manage 2023; 66 (4): e455-e459.$$$A$$Y$$$20240816$$PH$US$US
241643881$24164388$1$I$20240704$20240730$20240801$20240801$EXP$FR-AFSSAPS-NC2024000904$FR-ASTELLAS-2024EU007549$ASTELLAS$$52$YR$$M$Y$48.4$KG$20240801$$CN$FR$FR
241643891$24164389$1$I$20240612$20240726$20240801$20240801$EXP$FR-AFSSAPS-NC2024000864$FR-MYLANLABS-2024M1070349$MYLAN$$46$YR$$M$Y$98$KG$20240801$$MD$FR$FR
241643901$24164390$1$I$20240709$20240726$20240801$20240801$EXP$IT-MINISAL02-995781$IT-MYLANLABS-2024M1070360$MYLAN$$14$YR$$F$Y$$$20240801$$PH$IT$IT
241643911$24164391$1$I$20240610$20240726$20240801$20240801$EXP$$DE-MYLANLABS-2024M1070692$MYLAN$$27$YR$$M$Y$70$KG$20240801$$CN$DE$DE
241643921$24164392$1$I$20240514$20240726$20240801$20240801$EXP$FR-AFSSAPS-LY2024001076$FR-MYLANLABS-2024M1070303$MYLAN$$51$YR$$F$Y$68$KG$20240801$$PH$FR$FR
241643931$24164393$1$I$20190919$20240726$20240801$20240801$EXP$PT-INFARMED-T202407-276$PT-MYLANLABS-2024M1070337$MYLAN$$36$YR$$M$Y$69$KG$20240801$$CN$PT$PT
241643941$24164394$1$I$20221101$20240726$20240801$20240801$EXP$FR-AFSSAPS-LY2024001083$FR-MYLANLABS-2024M1070313$MYLAN$$63$YR$$F$Y$70$KG$20240801$$CN$FR$FR
241643952$24164395$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225422$TEVA$Bangash H, Marwat A, Mahmoud A, Le C. A Case of Non-cardiogenic Pulmonary Edema Secondary to Fentanyl Overdose. Am-J-Respir-Crit-Care-Med 2024; 209.; Bangash H, Marwat A, Mahmoud A, Le C. A Case of Non-cardiogenic Pulmonary Edema Secondary to Fentanyl Overdose. Am-J-Respir-Crit-Care-Med 2024; 209.$33$YR$$M$Y$$$20240816$$HP$US$US
241643961$24164396$1$I$$20240729$20240801$20240801$EXP$$CA-MYLANLABS-2024M1070514$MYLAN$$$$$F$Y$65$KG$20240801$$MD$CA$CA
241643971$24164397$1$I$$20240729$20240801$20240801$EXP$$CA-MYLANLABS-2024M1071259$MYLAN$$70$YR$$M$Y$$$20240801$$CN$CA$CA
241643981$24164398$1$I$$20240729$20240801$20240801$EXP$$CA-MYLANLABS-2024M1070501$MYLAN$$71$YR$$$Y$79.37$KG$20240801$$PH$CA$CA
241643991$24164399$1$I$$20240730$20240801$20240801$30DAY$$IT-SANDOZ INC.-SDZ2023IT021302$SANDOZ$$$$$M$Y$$$20240801$$CN$IT$IT
241644001$24164400$1$I$20240718$20240725$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121758$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$73.03$KG$20240801$$HP$US$US
241644011$24164401$1$I$$20240726$20240801$20240801$EXP$$SK-MYLANLABS-2024M1057441$MYLAN$Repkova Z. Therapeutic menu in the labyrinth of depression. PSYCHIATRIA PRE PRAX. 2024;25(2):68-71$85$YR$$F$Y$$$20240801$$MD$SK$SK
241644022$24164402$2$F$$20240806$20240801$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121787$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240808$$CN$US$US
241644032$24164403$2$F$$20240912$20240801$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117142$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$76.66$KG$20240913$$CN$US$US
241644042$24164404$2$F$20240101$20240809$20240801$20240820$PER$$US-SA-2024SA188369$SANOFI AVENTIS$$68$YR$E$F$Y$64.4$KG$20240820$$MD$US$US
241644052$24164405$2$F$20240726$20240918$20240801$20240920$30DAY$$CA-PFIZER INC-202400225627$PFIZER$$50$YR$$F$Y$$$20240920$$HP$CA$CA
241644061$24164406$1$I$$20240722$20240801$20240801$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2024-081921$REGENERON$$71$YR$$M$Y$$$20240801$$MD$GB$GB
241644071$24164407$1$I$$20240730$20240801$20240801$PER$$NVSC2024US157135$NOVARTIS$$$$$$Y$$$20240801$$MD$US$US
241644081$24164408$1$I$$20210130$20240801$20240801$EXP$$DE-DSJP-DSJ-2021-104714$DAIICHI$$$$E$F$Y$$$20240801$$MD$DE$DE
241644091$24164409$1$I$$20240726$20240801$20240801$EXP$$AU-RDY-SPO/AUS/24/0011180$DR REDDYS$$61$YR$A$$Y$$$20240801$$CN$AU$AU
241644101$24164410$1$I$20240110$20240726$20240801$20240801$EXP$FR-AFSSAPS-TO2024001275$FR-MYLANLABS-2024M1070260$MYLAN$$86$YR$$F$Y$$$20240801$$PH$FR$FR
241644111$24164411$1$I$20240615$20240726$20240801$20240801$EXP$FR-AFSSAPS-TO2024001186$FR-MYLANLABS-2024M1070285$MYLAN$$52$YR$$F$Y$$$20240801$$PH$FR$FR
241644121$24164412$1$I$20240201$20240726$20240801$20240801$EXP$FR-AFSSAPS-LM2024000399$FR-MYLANLABS-2024M1069953$MYLAN$$77$YR$$M$Y$58$KG$20240801$$MD$FR$FR
241644132$24164413$2$F$20240711$20240808$20240801$20240816$EXP$$JP-ALXN-202407JPN001630JP$ALEXION PHARMACEUTICALS$$69$YR$$M$Y$$$20240816$$MD$JP$JP
241644142$24164414$2$F$20240723$20240801$20240801$20240807$EXP$$AU-GUERBET / LLC-AU-20240044$GUERBET$$37$YR$A$F$Y$55$KG$20240807$$HP$AU$AU
241644151$24164415$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137869AA$DAIICHI$$$$$F$Y$56$KG$20240801$$CN$CA$CA
241644161$24164416$1$I$$20240729$20240801$20240801$EXP$$KR-009507513-2407KOR015747$MERCK$$$$$F$Y$$$20240801$$CN$KR$KR
241644171$24164417$1$I$$20240729$20240801$20240801$PER$$US-ABBVIE-5860846$ABBVIE$$$$$$Y$$$20240801$$MD$US$US
241644182$24164418$2$F$$20240729$20240801$20240805$EXP$$DE-SANDOZ INC.-SDZ2024DE069232$SANDOZ$$86$YR$$F$Y$$$20240805$$CN$DE$DE
241644191$24164419$1$I$$20240729$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121666$BRISTOL MYERS SQUIBB$$$$A$M$Y$$$20240801$$MD$US$US
241644201$24164420$1$I$$20240729$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121258$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240801$$CN$US$US
241644211$24164421$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121887$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240801$$CN$US$US
241644221$24164422$1$I$$20240726$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119628$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240801$$CN$US$US
241644231$24164423$1$I$20191115$20240722$20240801$20240801$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117139$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$51.5$KG$20240801$$MD$KR$KR
241644241$24164424$1$I$20240601$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019635$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240801$$CN$US$US
241644251$24164425$1$I$20240729$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019366$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240801$$CN$US$US
241644261$24164426$1$I$20240727$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019168$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240801$$CN$US$US
241644271$24164427$1$I$20180101$20240722$20240801$20240801$EXP$$RU-TEVA-VS-3226176$TEVA$Lyadova MA, Gerus AY, Lyadov VK. Development of finger bone necrosis after administration of immune checkpoint inhibitors in a patient with Hodgkin^s lymphoma. [Russian]. Onkol-Zhur-Imen-Gerc 2021; 10 (2): 50-54.$36$YR$$M$Y$$$20240801$$HP$RU$RU
241644281$24164428$1$I$$20240731$20240801$20240801$EXP$$GB-SANDOZ INC.-SDZ2024GB068586$SANDOZ$$$$$F$Y$$$20240801$$CN$GB$GB
241644291$24164429$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137867$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241644303$24164430$3$F$20240403$20240821$20240801$20240828$EXP$$SA-SANDOZ INC.-SDZ2024SA036493$SANDOZ$$40$YR$$F$Y$$$20240828$$CN$SA$SA
241644312$24164431$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225506$TEVA$Chen F, Boominathan P. Aortoesophageal Fistula Following a Cervical Epidural Steroid Injection: Case Report. Pain-Med-Case-Rep 2023; 7 (8): 345-347.; Chen F, Boominathan P. Aortoesophageal Fistula Following a Cervical Epidural Steroid Injection: Case Report. Pain-Med-Case-Rep 2023; 7 (8): 345-347.$$$A$M$Y$$$20240816$$MD$US$US
241644321$24164432$1$I$$20240723$20240801$20240801$EXP$$GB-TEVA-VS-3224853$TEVA$$65$YR$$F$Y$$$20240801$$PH$GB$GB
241644331$24164433$1$I$20240708$20240722$20240801$20240801$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14692$IPSEN$$43$YR$A$F$Y$$$20240801$$HP$US$US
241644341$24164434$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137866$DAIICHI$$$$$F$Y$$$20240801$$CN$CA$CA
241644351$24164435$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137865$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241644361$24164436$1$I$$20240731$20240801$20240801$EXP$$GB-SANDOZ INC.-SDZ2024GB069550$SANDOZ$$16$YR$$F$Y$$$20240801$$HP$GB$GB
241644371$24164437$1$I$20240519$20240725$20240801$20240801$EXP$FR-AFSSAPS-CN2024000605$FR-TEVA-VS-3226403$TEVA$$58$YR$$F$Y$58$KG$20240801$$MD$FR$FR
241644381$24164438$1$I$$20240729$20240801$20240801$PER$$US-MYLANLABS-2024M1070875$MYLAN$$$$$F$Y$$$20240801$$HP$US$US
241644392$24164439$2$F$20240720$20240801$20240801$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116481$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240812$$CN$US$US
241644403$24164440$3$F$$20240826$20240801$20240902$EXP$$GR-TEVA-VS-3226393$TEVA$$$$$F$Y$$$20240902$$MD$GR$GR
241644411$24164441$1$I$20240101$20240722$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116342$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240801$$HP$US$US
241644421$24164442$1$I$$20240722$20240801$20240801$EXP$$CA-DSJP-DSJ-2024-137863$DAIICHI$$$$$F$Y$$$20240801$$CN$CA$CA
241644431$24164443$1$I$20240608$20240729$20240801$20240801$EXP$FR-AFSSAPS-NY2024000839$FR-SANDOZ INC.-SDZ2024FR069155$SANDOZ$$37$YR$$M$Y$70$KG$20240801$$MD$FR$FR
241644441$24164444$1$I$20240724$20240724$20240801$20240801$EXP$$GB-TEVA-VS-3225500$TEVA$$27$YR$$F$Y$65$KG$20240801$$MD$GB$GB
241644451$24164445$1$I$20230627$20240726$20240801$20240801$EXP$GB-MHRA-MED-202407261409248220-KTYLD$GB-TEVA-VS-3226501$TEVA$$61$YR$$F$Y$61$KG$20240801$$PH$GB$GB
241644461$24164446$1$I$20240726$20240731$20240801$20240801$EXP$$CN-SANDOZ INC.-SDZ2024CN069796$SANDOZ$$85$YR$$M$Y$65$KG$20240801$$HP$CN$CN
241644472$24164447$2$F$20231201$20240805$20240801$20240812$EXP$$CA-SANDOZ INC.-SDZ2023CA053785$SANDOZ$$66$YR$$F$Y$$$20240812$$MD$CA$CA
241644481$24164448$1$I$$20240611$20240801$20240801$PER$$US-LUNDBECK-DKLU4000337$LUNDBECK$$$$$$Y$$$20240801$$CN$US$US
241644491$24164449$1$I$$20240725$20240801$20240801$EXP$$CA-EMD Serono-2024041140$EMD SERONO INC$$$$E$M$Y$$$20240801$$CN$CA$CA
241644502$24164450$2$F$$20240830$20240801$20240906$EXP$$GB-PHARMING-PHAGB2024000650$PHARMING GROUP$$$$$$Y$$$20240906$$CN$GB$GB
241644522$24164452$2$F$20220101$20240726$20240801$20240808$EXP$$NVSC2024MX126489$NOVARTIS$$$$$M$Y$23$KG$20240808$$CN$MX$MX
241644531$24164453$1$I$$20240730$20240801$20240801$EXP$$US-009507513-2407USA016001$MERCK$$$$$F$Y$$$20240801$$CN$US$US
241644541$24164454$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121596$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240801$$HP$US$US
241644552$24164455$2$F$20240729$20240731$20240801$20240805$EXP$$US-KYOWAKIRIN-2024KK018368$KYOWA$$$$$$Y$$$20240805$$HP$US$US
241644561$24164456$1$I$$20240725$20240801$20240801$PER$$US-JNJFOC-20240769709$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$HP$US$US
241644571$24164457$1$I$$20240730$20240801$20240801$EXP$$DE-SANDOZ INC.-SDZ2024DE069660$SANDOZ$$$$$F$Y$$$20240801$$CN$DE$DE
241644582$24164458$2$F$20240725$20240826$20240801$20240903$EXP$$US-JNJFOC-20240778055$JOHNSON AND JOHNSON$$61$YR$A$$Y$$$20240904$$HP$US$US
241644592$24164459$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225491$TEVA$Mahmoud A, Amir A, Bangash H, Ayaz S. Pasteurella Multocida-induced Empyema in an Immunocompromised Patient - A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Mahmoud A, Amir A, Bangash H, Ayaz S. Pasteurella Multocida-induced Empyema in an Immunocompromised Patient - A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$70$YR$$M$Y$$$20240816$$HP$US$US
241644601$24164460$1$I$20240101$20240730$20240801$20240801$EXP$$NVSC2024DE157159$NOVARTIS$$$$A$M$Y$$$20240801$$PH$DE$DE
241644611$24164461$1$I$20240101$20240729$20240801$20240801$EXP$$GB-SANDOZ INC.-SDZ2024GB069250$SANDOZ$$$$$F$Y$$$20240801$$CN$GB$GB
241644621$24164462$1$I$$20240730$20240801$20240801$30DAY$$US-SANDOZ INC.-SDZ2024US069784$SANDOZ$$$$$F$Y$$$20240801$$CN$US$US
241644632$24164463$2$F$$20240806$20240801$20240816$EXP$$FR-TEVA-VS-3226179$TEVA$Sztejkowski C, Sibilia J, Danion F, Mertz P, Elodie F, Kassegne L, et al. Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event. Rheumatology 2024; 63 (6): e185-e187.; Sztejkowski C, Sibilia J, Danion F, Mertz P, Elodie F, Kassegne L, et al. Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event. Rheumatology 2024; 63 (6): e185-e187.; Sztejkowski C, Sibilia J, Danion F, Mertz P, Elodie F, Kassegne L, et al. Combining ts- and a...$52$YR$$F$Y$$$20240816$$HP$FR$FR
241644641$24164464$1$I$$20240731$20240801$20240801$EXP$$CA-BAUSCH-BL-2024-011706$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240801$$PH$CA$CA
241644651$24164465$1$I$20240615$20240726$20240801$20240801$EXP$FR-AFSSAPS-MP2024001128$FR-MYLANLABS-2024M1070297$MYLAN$$41$YR$$M$Y$$$20240801$$MD$FR$FR
241644661$24164466$1$I$20210316$20240729$20240801$20240801$EXP$$FR-AMGEN-FRANI2024150829$AMGEN$$82$YR$E$F$Y$$$20240801$$MD$FR$FR
241644671$24164467$1$I$$20240731$20240801$20240801$EXP$$CA-SANDOZ INC.-SDZ2023CA067175$SANDOZ$$$$$F$Y$$$20240801$$CN$CA$CA
241644681$24164468$1$I$$20240726$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069313$SANDOZ$$$$$F$Y$$$20240801$$CN$US$US
241644692$24164469$2$F$$20240911$20240801$20240917$PER$$US-JNJFOC-20240781377$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$US$US
241644701$24164470$1$I$$20240730$20240801$20240801$EXP$$CA-SANDOZ INC.-NVSC2020CA091786$SANDOZ$$$$A$F$Y$$$20240801$$HP$CA$CA
241644711$24164471$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121616$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240801$$CN$US$US
241644722$24164472$2$F$20240727$20240801$20240801$20240806$EXP$$US-KYOWAKIRIN-2024KK018423$KYOWA$$$$$$Y$$$20240806$$HP$US$US
241644741$24164474$1$I$20240729$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019779$ELI LILLY AND CO$$$$$M$Y$$$20240801$$CN$US$US
241644751$24164475$1$I$20240601$20240729$20240801$20240801$EXP$$CN-PFIZER INC-PV202400085182$PFIZER$$49$YR$$M$Y$$$20240801$$CN$CN$CN
241644761$24164476$1$I$20240701$20240729$20240801$20240801$30DAY$$KR-PFIZER INC-202400225470$PFIZER$$19$YR$$F$Y$$$20240801$$HP$KR$KR
241644771$24164477$1$I$$20240729$20240801$20240801$EXP$$NVSC2024US155465$NOVARTIS$$$$$$Y$$$20240801$$CN$US$US
241644781$24164478$1$I$$20240730$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069851$SANDOZ$$$$$$Y$$$20240801$$CN$US$US
241644793$24164479$3$F$20240729$20240909$20240801$20240910$PER$$US-JNJFOC-20240776905$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240910$$CN$US$US
241644801$24164480$1$I$20230124$20240730$20240801$20240801$EXP$$TR-SANDOZ INC.-SDZ2024TR069538$SANDOZ$Sibel?Suzen?Ozbayrak ,Nilgun?Mesci, Merve?Ozdemir?Sezgin, Duygu?Geler?Kulcu. A patient with?axial spondylarthritis who experienced pancytopenia while?receiving anti-TNF therapy. Clinical Rheumatology. 2024;43:2701-2705$38$YR$$F$Y$$$20240801$$HP$TR$TR
241644811$24164481$1$I$$20240722$20240801$20240801$EXP$$DE-TEVA-VS-3226180$TEVA$Rupprecht H. Accidental intoxication by fentanyl patch. MMW-Fortschr-Med 2023; 165 (4): 50-51.$80$YR$$F$Y$$$20240801$$MD$DE$DE
241644831$24164483$1$I$$20240801$20240801$20240801$EXP$$NL-SANDOZ INC.-SDZ2024NL069815$SANDOZ$$$$$F$Y$$$20240801$$MD$NL$NL
241644841$24164484$1$I$$20240725$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US068261$SANDOZ$$9$YR$$F$Y$$$20240801$$CN$US$US
241644851$24164485$1$I$20240422$20240724$20240801$20240801$EXP$FR-AFSSAPS-DJ2024000838$FR-TEVA-VS-3226439$TEVA$$86$YR$$F$Y$60$KG$20240801$$MD$FR$FR
241644862$24164486$2$F$20230101$20240822$20240801$20240828$EXP$$BR-SANDOZ INC.-SDZ2024BR069818$SANDOZ$$$$$F$Y$$$20240828$$CN$BR$BR
241644871$24164487$1$I$$20240726$20240801$20240801$EXP$$CA-SANDOZ INC.-SDZ2024CA069750$SANDOZ$$16$YR$$M$Y$$$20240801$$CN$CA$CA
241644892$24164489$2$F$$20240805$20240801$20240806$EXP$$FR-SANDOZ INC.-SDZ2024FR069371$SANDOZ$$34$YR$$F$Y$$$20240806$$HP$FR$FR
241644901$24164490$1$I$20240725$20240729$20240801$20240801$30DAY$$IT-SANDOZ INC.-SDZ2024IT069644$SANDOZ$$15$YR$$M$Y$55$KG$20240801$$CN$IT$IT
241644913$24164491$3$F$20230101$20240920$20240801$20240927$EXP$$FR-PURDUE PHARMA-USA-2024-0311078$PURDUE$Baudriller A., Abbara C., Briet M., Jousset N., Malbranque S., Zabet D., Rossi L., Durfort C.,  Ferec S., Drevin G.. Deaths related to pharmacobezoars: A report on two cases. Toxicologie Analytique et Clinique. 2024$55$YR$$F$Y$$$20240927$$HP$FR$FR
241644921$24164492$1$I$$20240730$20240801$20240801$EXP$$NL-PURDUE-USA-2024-0311080$PURDUE$$58$YR$$F$Y$80$KG$20240801$$CN$NL$NL
241644932$24164493$2$F$20240702$20240731$20240801$20240807$EXP$DE-GUERBET / GUERBET GMBH-DE-20240032$DE-GUERBET / LLC-DE-20240032$GUERBET$$52$YR$A$M$Y$79$KG$20240807$$HP$DE$DE
241644941$24164494$1$I$20211201$20240729$20240801$20240801$EXP$$US-PURDUE-USA-2024-0311081$PURDUE$Allami N, O^Connor K, Bagley SM.. A case of severe opioid and methamphetamine use disorder in a 14 year old.. Addiction Science + Clinical Practice. 2024;19:54$14$YR$$F$Y$$$20240801$$HP$US$US
241644965$24164496$5$F$20240724$20240905$20240801$20240905$30DAY$$US-PFIZER INC-202400224630$PFIZER$$13$YR$$M$Y$$$20240905$$CN$US$US
241644971$24164497$1$I$20240715$20240717$20240801$20240801$30DAY$$AR-PFIZER INC-202400219328$PFIZER$$$$$$Y$$$20240801$$CN$AR$AR
241644982$24164498$2$F$$20240813$20240801$20240816$EXP$$GB-MYLANLABS-2024M1071048$MYLAN$$$$$M$Y$$$20240816$$HP$GB$GB
241645002$24164500$2$F$$20240910$20240801$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-119797$BRISTOL MYERS SQUIBB$Minami S, Kawashima Y, Munakata Y, Matsuno M, Hara S, Yamazaki Y, et al. Successful application of tocilizumab in a patient with neoadjuvant immunochemotherapy-induced cytokine release syndrome. Cancer Reports. 2024 Jul 01;7(7):1-5. doi:10.1002/cnr2.2145.$69$YR$E$M$Y$$$20240917$$MD$JP$JP
241645012$24164501$2$F$20240701$20240926$20240801$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120876$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240927$$HP$US$US
241645023$24164502$3$F$20231201$20240808$20240801$20240815$EXP$$JP-KYOWAKIRIN-2024KK000369$KYOWA$$$$$$Y$$$20240815$$MD$JP$JP
241645032$24164503$2$F$$20240921$20240801$20240923$30DAY$$CO-PFIZER INC-202400226685$PFIZER$$14$YR$$M$Y$$$20240923$$CN$CO$CO
241645042$24164504$2$F$20240701$20240802$20240801$20240812$30DAY$$AR-PFIZER INC-202400225933$PFIZER$$12$YR$$F$Y$$$20240812$$HP$AR$AR
241645051$24164505$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA223935$SANOFI AVENTIS$$$$T$M$Y$$$20240801$$MD$US$US
241645061$24164506$1$I$$20240723$20240801$20240801$PER$$US-SA-2024SA217124$SANOFI AVENTIS$$$$A$M$Y$84.82$KG$20240801$$MD$US$US
241645071$24164507$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121815$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240801$$CN$US$US
241645082$24164508$2$F$$20240802$20240801$20240806$PER$$US-PFIZER INC-202400227490$PFIZER$$26$YR$$F$Y$$$20240806$$CN$US$US
241645091$24164509$1$I$$20220825$20240801$20240801$EXP$$CA-DSJP-DSJ-2022-131938$DAIICHI$$$$$F$Y$$$20240801$$MD$CA$CA
241645101$24164510$1$I$$20240729$20240801$20240801$EXP$$GB-MYLANLABS-2024M1071180$MYLAN$$$$$M$Y$$$20240801$$MD$GB$GB
241645112$24164511$2$F$$20240730$20240801$20240806$PER$$US-PFIZER INC-202400227047$PFIZER$$39$YR$$M$Y$$$20240806$$MD$US$US
241645121$24164512$1$I$$20240729$20240801$20240801$PER$$US-PFIZER INC-202400226082$PFIZER$$43$YR$$F$Y$$$20240801$$HP$US$US
241645131$24164513$1$I$20240701$20240729$20240801$20240801$PER$$US-PFIZER INC-PV202400099120$PFIZER$$78$YR$$F$Y$$$20240801$$HP$US$US
241645141$24164514$1$I$$20240731$20240801$20240801$PER$$US-PFIZER INC-202400227930$PFIZER$$65$YR$$M$Y$$$20240801$$MD$US$US
241645151$24164515$1$I$20190417$20240722$20240801$20240801$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117025$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$51$KG$20240801$$MD$KR$KR
241645162$24164516$2$F$20240713$20240905$20240801$20240910$EXP$$CN-AMERICAN REGENT INC-2024002926$AMERICAN REGENT$$16$YR$$F$Y$46$KG$20240910$$HP$CN$CN
241645171$24164517$1$I$$20240729$20240801$20240801$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138335$DAIICHI$$56$YR$$F$Y$$$20240801$$CN$US$US
241645181$24164518$1$I$$20240718$20240801$20240801$PER$$US-INCYTE CORPORATION-2024IN007586$INCYTE$$$$$$Y$$$20240801$$CN$US$US
241645193$24164519$3$F$20240701$20240903$20240801$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120854$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240910$$PH$US$US
241645202$24164520$2$F$$20240729$20240801$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019198$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240802$$CN$US$US
241645211$24164521$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121130$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240801$$CN$US$US
241645221$24164522$1$I$$20240731$20240801$20240801$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138373$DAIICHI$$$$$F$Y$$$20240801$$HP$US$US
241645231$24164523$1$I$$20240730$20240801$20240801$PER$$US-DSJP-DSU-2024-138434$DAIICHI$$$$$F$Y$$$20240801$$CN$US$US
241645241$24164524$1$I$20240601$20240727$20240801$20240801$EXP$$EG-ABBVIE-5858914$ABBVIE$$9$YR$$M$Y$$$20240801$$CN$EG$EG
241645251$24164525$1$I$$20240725$20240801$20240801$EXP$GB-MHRA-MIDB-6a4fbfaa-917f-48da-9304-8081b2c97bf7$GB-TEVA-VS-3225883$TEVA$$32$YR$$M$Y$$$20240801$$PH$GB$GB
241645261$24164526$1$I$20240606$20240729$20240801$20240801$EXP$$JP-009507513-2407JPN005292J$MERCK$$71$YR$$F$Y$$$20240801$$MD$JP$JP
241645281$24164528$1$I$20240101$20240725$20240801$20240801$EXP$BG-BDA-27893$BG-TEVA-VS-3226305$TEVA$$78$YR$$F$Y$$$20240801$$CN$BG$BG
241645302$24164530$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225266$TEVA$Torelli VA, Ernest Jean R, Tran E. Acute Hypoxic Respiratory Failure Secondary to Daptomycin-induced Eosinophilic Pneumonia. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A2019.; Torelli VA, Ernest Jean R, Tran E. Acute Hypoxic Respiratory Failure Secondary to Daptomycin-induced Eosinophilic Pneumonia. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A2019.$86$YR$$F$Y$$$20240816$$HP$US$US
241645321$24164532$1$I$$20240724$20240801$20240801$EXP$$IT-SCIEGENP-2024SCLIT00345$SCIEGEN$Marano M, et al..Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars.Toxicology Reports.21-JUN-2024;13 (1):101683$15$YR$T$F$Y$48$KG$20240801$$HP$IT$IT
241645341$24164534$1$I$20240101$20240702$20240801$20240801$PER$$US-009507513-2407USA001482$MERCK$$$$$$Y$$$20240801$$HP$US$US
241645351$24164535$1$I$$20240726$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119554$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240801$$CN$US$US
241645361$24164536$1$I$$20240724$20240801$20240801$EXP$$US-APELLIS-2024-APL-0000503$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
241645371$24164537$1$I$$20240725$20240801$20240801$PER$$US-SA-2024SA224124$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240801$$MD$US$US
241645381$24164538$1$I$$20240729$20240801$20240801$EXP$$EU-BAUSCHBL-2023BNL006162$BAUSCH AND LOMB$$71$YR$$M$Y$70$KG$20240801$$MD$EU$EU
241645401$24164540$1$I$$20240724$20240801$20240801$PER$$US-ABBVIE-5857986$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241645411$24164541$1$I$20240709$20240729$20240801$20240801$EXP$PT-INFARMED-F202407-301$PT-FreseniusKabi-FK202411881$FRESENIUS KABI$$66$YR$E$F$Y$50$KG$20240801$$HP$PT$PT
241645421$24164542$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122035$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$109.3$KG$20240801$$CN$US$US
241645431$24164543$1$I$20240725$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019367$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240801$$CN$US$US
241645451$24164545$1$I$20240101$20240719$20240801$20240801$EXP$$US-009507513-2407USA012200$MERCK$$$$$F$Y$$$20240801$$CN$US$US
241645462$24164546$2$F$$20240828$20240801$20240906$EXP$$US-RADIUS HEALTH, INC.-2024US005712$RADIUS PHARM$$$$$F$Y$$$20240906$$CN$US$US
241645471$24164547$1$I$$20240726$20240801$20240801$PER$$US-ABBVIE-5857632$ABBVIE$$$$$$Y$$$20240801$$CN$US$US
241645482$24164548$2$F$20240617$20240805$20240801$20240813$EXP$$US-LUNDBECK-DKLU4002439$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
241645492$24164549$2$F$20240701$20240904$20240801$20240910$EXP$$BG-ABBVIE-5862410$ABBVIE$$66$YR$$M$Y$$$20240910$$CN$BG$BG
241645511$24164551$1$I$20240715$20240729$20240801$20240801$EXP$FR-AFSSAPS-PV2024000692$FR-FreseniusKabi-FK202411874$FRESENIUS KABI$$21$YR$A$F$Y$96$KG$20240801$$HP$FR$FR
241645521$24164552$1$I$$20240723$20240801$20240801$EXP$$DK-ASCENT-2024ASLIT00017$ASCENT$Knudsen GH, Kermanian N, Kock-Jensen CH, Antulov R.Opioid-Induced Leukoencephalopathies: A Report of Two Cases.Case Reports in Neurology.FEB-2022;14(1):25-30$24$YR$A$M$Y$$$20240801$$HP$DK$DK
241645531$24164553$1$I$$20240723$20240801$20240801$EXP$$US-ASCENT-2024ASLIT00018$ASCENT$Cardona Quinones RA, et al. .A neuropsychiatric case of delayed post-hypoxic leukoencephalopathy from opioid intoxication resulting in Anton-Babinski syndrome and quadriplegia.Neurocase.07-MAY-2023;29 (5):160-6$26$YR$A$M$Y$$$20240801$$HP$US$US
241645541$24164554$1$I$20240626$20240724$20240801$20240801$EXP$EE-SAM-1982407022$EE-TEVA-VS-3225709$TEVA$$85$YR$$F$Y$87$KG$20240801$$MD$EE$EE
241645551$24164555$1$I$$20240722$20240801$20240801$EXP$$DK-WINDERLABS-2024WILIT00003$WINDER LABORATORY$$24$YR$A$M$Y$$$20240801$$HP$DK$DK
241645561$24164556$1$I$$20240730$20240801$20240801$PER$$US-JNJFOC-20240785391$JOHNSON AND JOHNSON$$$$$$Y$$$20240801$$HP$US$US
241645571$24164557$1$I$$20240723$20240801$20240801$EXP$$US-PRAXGEN-2024PPLIT00045$PRAXGEN PHARMACEUTICALS$Darnell et al.Sevelamer-Induced Ischemic Enteritis.ACG CASE REPORTS JOURNAL.17-JUL-2024;11 (7):e01451$35$YR$A$M$Y$$$20240801$$MD$US$US
241645581$24164558$1$I$20240704$20240726$20240801$20240801$EXP$FR-AFSSAPS-LL2024001386$FR-MYLANLABS-2024M1070425$MYLAN$$46$YR$$F$Y$63$KG$20240801$$MD$FR$FR
241645591$24164559$1$I$$20240725$20240801$20240801$EXP$$GR-TEVA-VS-3226370$TEVA$$$$$F$Y$$$20240801$$MD$GR$GR
241645611$24164561$1$I$$20240723$20240801$20240801$EXP$$US-GENEYORK-2024PPLIT00046$GENEYORK PHARMA$Lee, Rachel, et al..Case study: Autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks gestation.Case Reports in Perinatal Medicine.APR-2024;13 (1):1-3$$$N$$Y$$$20240801$$MD$US$US
241645632$24164563$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3224975$TEVA$Sanjeevi A, Clark BL, Aguirre A, Verghese BG. Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature. Clin-Immunol-Commun 2024; 6.; Sanjeevi A, Clark BL, Aguirre A, Verghese BG. Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature. Clin-Immunol-Commun 2024; 6.$65$YR$$F$Y$$$20240816$$HP$US$US
241645641$24164564$1$I$$20240729$20240801$20240801$PER$$US-BIOMARINAP-US-2024-159506$BIOMARIN$$$$$$Y$$$20240801$$CN$US$US
241645651$24164565$1$I$20240601$20240729$20240801$20240801$PER$$US-BIOMARINAP-US-2024-159498$BIOMARIN$$$$$$Y$$$20240801$$CN$US$US
241645661$24164566$1$I$20240701$20240729$20240801$20240801$PER$$US-BIOMARINAP-US-2024-159497$BIOMARIN$$$$$$Y$$$20240801$$CN$US$US
241645671$24164567$1$I$20231001$20240725$20240801$20240801$EXP$DE-BFARM-24004242$DE-ABBVIE-5862860$ABBVIE$$$$$M$Y$$$20240801$$CN$DE$DE
241645681$24164568$1$I$$20240724$20240801$20240801$EXP$$ZA-AstraZeneca-2024A169729$ASTRAZENECA$$69$YR$$M$Y$$$20240801$$CN$ZA$
241645691$24164569$1$I$$20240724$20240801$20240801$EXP$$CN-AstraZeneca-2024A169710$ASTRAZENECA$$$$$F$Y$$$20240801$$CN$CN$
241645721$24164572$1$I$20240101$20240730$20240801$20240801$PER$$US-JNJFOC-20240781466$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240801$$CN$US$US
241645731$24164573$1$I$$20240729$20240801$20240801$PER$$NVSC2024US156855$NOVARTIS$$$$$$Y$$$20240801$$CN$US$US
241645741$24164574$1$I$20240730$20240730$20240801$20240801$PER$$US-JNJFOC-20240781974$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240801$$HP$US$US
241645751$24164575$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122017$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$97.07$KG$20240801$$CN$US$US
241645761$24164576$1$I$$20240724$20240801$20240801$EXP$$IN-AstraZeneca-2024A169025$ASTRAZENECA$$$$$M$Y$$$20240801$$CN$IN$
241645771$24164577$1$I$$20240731$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121810$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$93.89$KG$20240801$$CN$US$US
241645781$24164578$1$I$20240701$20240729$20240801$20240801$EXP$$CA-009507513-2407CAN015378$MERCK$$$$$F$Y$$$20240801$$CN$CA$CA
241645792$24164579$2$F$20240513$20240725$20240801$20240805$EXP$CH-SM-2024-13639$CH-009507513-2407CHE014387$MERCK$$64$YR$$M$Y$$$20240805$$PH$CH$CH
241645805$24164580$5$F$20240718$20240917$20240801$20240920$EXP$$NVSC2024GB154052$NOVARTIS$$$$$F$Y$$$20240920$$CN$GB$GB
241645811$24164581$1$I$20240701$20240725$20240801$20240801$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011643$JAZZ$$3$YR$$M$Y$$$20240801$$MD$JP$JP
241645822$24164582$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225344$TEVA$Gravenmier C, Shah B, Hussaini M, Zhang L. Chimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment. Leuk-Lymphoma 2024; 65 (5): 674-678.; Gravenmier C, Shah B, Hussaini M, Zhang L. Chimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment. Leuk-Lymphoma 2024; 65 (5): 674-678.; Gravenmier C, Shah B, Hussaini M, Zhang L. Chimeric antigen recep...$58$YR$$M$Y$$$20240816$$HP$US$US
241645831$24164583$1$I$20240619$20240717$20240801$20240801$EXP$EU-AFSSAPS-AVCN2024000517$EU-ETHYPHARM-2024001932$ETHYPHARM$$$$$$Y$$$20240801$$MD$EU$EU
241645852$24164585$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3224978$TEVA$Noe G, Shah K, Cinderella M, Munjal S. Multiple Medication Use Resulting in Serotonin Syndrome with Deprescribing Resulting in Acute Dystonia. J-Clin-Psychopharmacol 2024; 44 (3): 326-328.; Noe G, Shah K, Cinderella M, Munjal S. Multiple Medication Use Resulting in Serotonin Syndrome with Deprescribing Resulting in Acute Dystonia. J-Clin-Psychopharmacol 2024; 44 (3): 326-328.$42$YR$$F$Y$$$20240816$$HP$US$US
241645862$24164586$2$F$20240621$20240823$20240801$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119524$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$77.61$KG$20240902$$PH$US$US
241645871$24164587$1$I$$20240728$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121481$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$50.35$KG$20240801$$CN$US$US
241645891$24164589$1$I$20240719$20240724$20240801$20240801$PER$$US-ABBVIE-5854837$ABBVIE$$19$YR$$M$Y$$$20240801$$CN$US$US
241645901$24164590$1$I$20240611$20240725$20240801$20240801$EXP$$AU-GE HEALTHCARE-2024CSU008485$GE HEALTHCARE$$63$YR$$F$Y$64$KG$20240801$$HP$AU$AU
241645911$24164591$1$I$$20240724$20240801$20240801$EXP$$GR-TEVA-VS-3225743$TEVA$$$$$F$Y$$$20240801$$MD$GR$GR
241645921$24164592$1$I$20240412$20240507$20240801$20240801$PER$$US-GE HEALTHCARE-2024CSU004889$GE HEALTHCARE$$$$$$Y$$$20240801$$HP$US$US
241645931$24164593$1$I$20240507$20240507$20240801$20240801$PER$$US-GE HEALTHCARE-2024CSU004890$GE HEALTHCARE$$71$YR$$M$Y$63$KG$20240801$$HP$US$US
241645952$24164595$2$F$20240724$20240805$20240801$20240813$PER$$US-ALXN-202407USA001832US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
241645961$24164596$1$I$$20240725$20240801$20240801$PER$$US-JNJFOC-20240801455$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240801$$CN$US$US
241645971$24164597$1$I$$20240722$20240801$20240801$PER$$US-JNJFOC-20240802171$JOHNSON AND JOHNSON$$$$$M$Y$$$20240801$$HP$US$US
241645982$24164598$2$F$$20240903$20240801$20240918$PER$$US-JNJFOC-20240801868$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$HP$US$US
241646001$24164600$1$I$20240701$20240730$20240801$20240801$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-121438$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240801$$CN$PR$PR
241646011$24164601$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3225392$TEVA$Patel K, McQuaid S, Ketterl T, Benedetti DJ, Sokol E. Two cases of hepatoblastoma in Bohring-Opitz syndrome: An emerging association. Pediatr-Blood-Cancer 2024; 71 (7):.$2$YR$$M$Y$$$20240801$$HP$US$US
241646021$24164602$1$I$$20240731$20240801$20240801$PER$$US-DSJP-DSU-2024-138372$DAIICHI$$$$$F$Y$$$20240801$$HP$US$US
241646031$24164603$1$I$$20240717$20240801$20240801$PER$$US-JNJFOC-20240802382$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240801$$HP$US$US
241646042$24164604$2$F$20240725$20240809$20240801$20240819$PER$$US-APELLIS-2024-APL-0000576$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
241646052$24164605$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225393$TEVA$Patel K, McQuaid S, Ketterl T, Benedetti DJ, Sokol E. Two cases of hepatoblastoma in Bohring-Opitz syndrome: An emerging association. Pediatr-Blood-Cancer 2024; 71 (7):.; Patel K, McQuaid S, Ketterl T, Benedetti DJ, Sokol E. Two cases of hepatoblastoma in Bohring-Opitz syndrome: An emerging association. Pediatr-Blood-Cancer 2024; 71 (7):.$15$MON$$F$Y$$$20240816$$HP$US$US
241646061$24164606$1$I$20230601$20240719$20240801$20240801$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-018983$JAZZ$$49$YR$$F$Y$$$20240801$$CN$US$US
241646071$24164607$1$I$20240501$20240718$20240801$20240801$EXP$$CA-VER-202400358$VERITY PHARMACEUTICALS$$79$YR$E$M$Y$$$20240801$$CN$CA$CA
241646102$24164610$2$F$$20240731$20240801$20240807$EXP$$JP-ANIPHARMA-2024-JP-000205$ANI$$89$YR$$M$Y$$$20240807$$PH$JP$JP
241646111$24164611$1$I$20240531$20240722$20240801$20240801$EXP$$CN-009507513-2407CHN013776$MERCK$$79$YR$$F$Y$$$20240801$$HP$CN$CN
241646122$24164612$2$F$$20240806$20240801$20240816$EXP$$JP-TEVA-VS-3224745$TEVA$Yamamoto A, Nishimori H, Shirai T, Takano K, Komura A, Kambara Y, et al. Recurrent Cerebral Hemorrhaging with Platelet Dysfunction Accompanied by Anti-glycoprotein VI Autoantibodies in a Patient with TAFRO Syndrome. Intern-Med 2024; 63 (13): 1917-1922.; Yamamoto A, Nishimori H, Shirai T, Takano K, Komura A, Kambara Y, et al. Recurrent Cerebral Hemorrhaging with Platelet Dysfunction Accompanied by Anti-glycoprotein VI Autoantibodies in a Patient with TAFRO Syndrome. Intern-Med 2024; 63 (13): 1...$55$YR$$M$Y$$$20240816$$HP$JP$JP
241646131$24164613$1$I$$20240730$20240801$20240801$EXP$$CA-TAKEDA-2024TUS077122$TAKEDA$$$$$M$Y$$$20240801$$MD$CA$CA
241646141$24164614$1$I$20220101$20240729$20240801$20240801$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407019249$ELI LILLY AND CO$$$$$F$Y$$$20240801$$CN$BR$BR
241646151$24164615$1$I$$20240725$20240801$20240801$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407018027$ELI LILLY AND CO$$$$A$M$Y$$$20240801$$MD$DE$DE
241646161$24164616$1$I$$20240729$20240801$20240801$EXP$$US-ELI_LILLY_AND_COMPANY-US202407018956$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240801$$CN$US$US
241646171$24164617$1$I$20240724$20240726$20240801$20240801$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407018057$ELI LILLY AND CO$$62$YR$A$F$Y$52$KG$20240801$$CN$CN$CN
241646191$24164619$1$I$20240710$20240729$20240801$20240801$EXP$SE-SEMPA-2024-005598$SE-ELI_LILLY_AND_COMPANY-SE202407018175$ELI LILLY AND CO$$54$YR$A$F$Y$58$KG$20240801$$CN$SE$SE
241646202$24164620$2$F$20230815$20240729$20240801$20240812$EXP$$CH-ELI_LILLY_AND_COMPANY-CH202407019305$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240812$$MD$CH$CH
241646211$24164621$1$I$20240708$20240723$20240801$20240801$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407019796$ELI LILLY AND CO$$59$YR$A$F$Y$51$KG$20240801$$CN$DE$CN
241646221$24164622$1$I$20231219$20240729$20240801$20240801$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407017487$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240801$$CN$AU$AU
241646232$24164623$2$F$20230101$20240731$20240801$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000320$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240813$$CN$US$US
241646241$24164624$1$I$20240711$20240723$20240801$20240801$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407019957$ELI LILLY AND CO$$54$YR$A$M$Y$66$KG$20240801$$CN$DE$CN
241646254$24164625$4$F$$20240827$20240801$20240830$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407016721$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240830$$PH$JP$JP
241646261$24164626$1$I$20240710$20240723$20240801$20240801$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407018089$ELI LILLY AND CO$$62$YR$A$F$Y$50$KG$20240801$$CN$DE$CN
241646282$24164628$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3224970$TEVA$Kretovics E, Keegan K, Burg G, Von Allmen D, Chima R, Benscoter D, et al. Prolonged High-Dose Steroid Use in an Infant With Surfactant Protein-C Deficiency and Multiple Complications. Am-J-Respir-Crit-Care-Med 2024; 209 A2307.; Kretovics E, Keegan K, Burg G, Von Allmen D, Chima R, Benscoter D, et al. Prolonged High-Dose Steroid Use in an Infant With Surfactant Protein-C Deficiency and Multiple Complications. Am-J-Respir-Crit-Care-Med 2024; 209 A2307.$$$I$M$Y$$$20240816$$HP$US$US
241646291$24164629$1$I$$20240726$20240801$20240801$EXP$$US-ELI_LILLY_AND_COMPANY-US202407020448$ELI LILLY AND CO$$67$YR$E$M$Y$105.22$KG$20240801$$CN$US$US
241646302$24164630$2$F$20240229$20240813$20240801$20240822$EXP$PT-INFARMED-R202407-362$PT-TEVA-VS-3225581$TEVA$$62$YR$$M$Y$$$20240822$$MD$PT$PT
241646311$24164631$1$I$20240701$20240730$20240801$20240801$EXP$$MY-JNJFOC-20240779609$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240801$$MD$MY$MY
241646322$24164632$2$F$20240504$20240815$20240801$20240822$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034176$BOEHRINGER INGELHEIM$$84$YR$E$F$Y$$$20240822$$PH$DE$DE
241646332$24164633$2$F$$20240825$20240801$20240903$PER$$US-APELLIS-2024-APL-0000580$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240903$$CN$US$US
241646341$24164634$1$I$$20240731$20240801$20240801$PER$$US-BIOMARINAP-US-2024-159539$BIOMARIN$$$$$$Y$$$20240801$$CN$US$US
241646351$24164635$1$I$20240101$20240717$20240801$20240801$PER$$US-JNJFOC-20240748727$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240801$$CN$US$US
241646361$24164636$1$I$20240701$20240730$20240801$20240801$PER$$US-BIOMARINAP-US-2024-159538$BIOMARIN$$$$$$Y$$$20240801$$CN$US$US
241646371$24164637$1$I$$20240730$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069674$SANDOZ$$$$$$Y$$$20240801$$HP$US$US
241646381$24164638$1$I$$20240730$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069389$SANDOZ$$$$$M$Y$$$20240801$$MD$US$US
241646392$24164639$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3225064$TEVA$Fenton GA, Dean EA. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case-Rep-Oncol 2024; 17 (1): 75-81.; Fenton GA, Dean EA. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case-Rep-Oncol 2024; 17 (1): 75-81.; Fenton GA, Dean EA. Exacerbations of Persistent Neurotoxicity f...$64$YR$$F$Y$$$20240816$$HP$US$US
241646401$24164640$1$I$20240101$20240731$20240801$20240801$EXP$$US-ABBVIE-5862779$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241646411$24164641$1$I$$20240426$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00729$AIMMUNE$$$$$$Y$$$20240801$$HP$US$US
241646422$24164642$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3224988$TEVA$Ghalayni R, Al Kalaji B, Malik K. From Friend to Foe: A Case of Naloxone-Induced Pulmonary Edema. Hosp-Pharm 2024; 59 (4): 407-410.; Ghalayni R, Al Kalaji B, Malik K. From Friend to Foe: A Case of Naloxone-Induced Pulmonary Edema. Hosp-Pharm 2024; 59 (4): 407-410.$66$YR$$F$Y$$$20240816$$HP$US$US
241646431$24164643$1$I$$20240725$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01150$AIMMUNE$$$$$$Y$$$20240801$$PH$US$US
241646441$24164644$1$I$$20240508$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00786$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646451$24164645$1$I$20240508$20240529$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00777$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646461$24164646$1$I$20240501$20240503$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00763$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646471$24164647$1$I$$20240606$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00827$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646481$24164648$1$I$20240401$20240531$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00757$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646491$24164649$1$I$$20240605$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00804$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646501$24164650$1$I$20240506$20240506$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00776$AIMMUNE$$$$$$Y$$$20240801$$PH$US$US
241646511$24164651$1$I$$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121734$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240801$$HP$US$US
241646521$24164652$1$I$20240527$20240528$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00861$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646531$24164653$1$I$20240428$20240523$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00735$AIMMUNE$$$$$$Y$$$20240801$$HP$US$US
241646541$24164654$1$I$20240726$20240729$20240801$20240801$EXP$$AR-SANDOZ INC.-SDZ2024AR069333$SANDOZ$$11$YR$$M$Y$31.5$KG$20240801$$CN$AR$AR
241646551$24164655$1$I$$20240531$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00890$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646561$24164656$1$I$20240517$20240614$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00841$AIMMUNE$$$$$$Y$$$20240801$$HP$US$US
241646571$24164657$1$I$$20240724$20240801$20240801$EXP$$GR-BRISTOL-MYERS SQUIBB COMPANY-GRC-20191102933$BRISTOL MYERS SQUIBB$Kastritis E, Dialoupi I, Gavriatopoulou M, Roussou M, Kanellias N, Fotiou D, et al. Primary treatment of light-chain amyloidosis with bortezomib,lenalidomide, and dexamethasone. Blood Advances. 2019 Oct 22;3(20):3002-9. doi:10.1182/bloodadvances.2019000147.$$$$$Y$$$20240801$$HP$GR$GR
241646581$24164658$1$I$20240513$20240517$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00834$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646591$24164659$1$I$20240520$20240522$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00848$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646601$24164660$1$I$$20240529$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00887$AIMMUNE$$$$$$Y$$$20240801$$MD$US$US
241646611$24164661$1$I$20240602$20240603$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00916$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646621$24164662$1$I$$20240626$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00859$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646631$24164663$1$I$$20240617$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00864$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646641$24164664$1$I$$20240730$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069571$SANDOZ$$$$$$Y$$$20240801$$CN$US$US
241646651$24164665$1$I$20240730$20240731$20240801$20240801$30DAY$$US-SANDOZ INC.-SDZ2024US069740$SANDOZ$$$$$F$Y$$$20240801$$CN$US$US
241646661$24164666$1$I$20240612$20240612$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00957$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646671$24164667$1$I$20240101$20240612$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00959$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646681$24164668$1$I$$20240729$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069568$SANDOZ$$$$$M$Y$$$20240801$$CN$US$US
241646691$24164669$1$I$20240617$20240618$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00973$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646701$24164670$1$I$20240624$20240624$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01009$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646711$24164671$1$I$$20240624$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01011$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646721$24164672$1$I$$20240617$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00979$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646731$24164673$1$I$20240614$20240710$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00974$AIMMUNE$$$$$$Y$$$20240801$$HP$US$US
241646741$24164674$1$I$20240611$20240612$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00954$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646751$24164675$1$I$20240609$20240620$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00996$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646761$24164676$1$I$20240101$20240622$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01000$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646771$24164677$1$I$$20240620$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00988$AIMMUNE$$$$$$Y$$$20240801$$HP$US$US
241646781$24164678$1$I$20240501$20240606$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00932$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646791$24164679$1$I$$20240627$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01032$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646801$24164680$1$I$20240628$20240722$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01033$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646811$24164681$1$I$$20240626$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01023$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646821$24164682$1$I$20240601$20240722$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01044$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646831$24164683$1$I$20240601$20240627$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01030$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646841$24164684$1$I$$20240701$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01043$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646851$24164685$1$I$$20240710$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01091$AIMMUNE$$$$$$Y$$$20240801$$HP$US$US
241646861$24164686$1$I$20240628$20240701$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01051$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646871$24164687$1$I$20240703$20240703$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01058$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646881$24164688$1$I$20240101$20240724$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01137$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646891$24164689$1$I$20240601$20240701$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01045$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646901$24164690$1$I$$20240712$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01099$AIMMUNE$$$$$$Y$$$20240801$$HP$US$US
241646911$24164691$1$I$20240718$20240718$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01123$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646921$24164692$1$I$20240709$20240718$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01129$AIMMUNE$$$$$$Y$$$20240801$$CN$US$US
241646932$24164693$2$F$20231001$20240828$20240801$20240903$EXP$$GR-TEVA-VS-3225729$TEVA$$67$YR$$F$Y$$$20240903$$MD$GR$GR
241646941$24164694$1$I$20180917$20240730$20240801$20240801$EXP$FR-AFSSAPS-SE2024000602$FR-TAKEDA-2024TUS076742$TAKEDA$$66$YR$$M$Y$88$KG$20240801$$HP$FR$FR
241646951$24164695$1$I$$20240722$20240801$20240801$EXP$$CA-APELLIS-2024-APL-0000581$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$MD$CA$CA
241646961$24164696$1$I$$20240729$20240801$20240801$EXP$$ES-HALOZYME THERAPEUTICS, INC.-2024-ES-HYL-06770$HALOZYME$E Gracia Rovira, S Natividad Andreu, N Montalt Barrachina, E Navarro Hern?ndez, J Agust? Mart?nez, A Lanuza Garc?a. Ocular ischemia syndrome after aesthetic treatment with hyaluronic acid. Sociedad Espa?ola de Oftalmolog?a. 2024;20:S2173$$$$$Y$$$20240801$$HP$ES$ES
241646972$24164697$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3224993$TEVA$Naumann J, Naumann T. Acute Precipitated Opioid Withdrawal With Akathisia, Delirium, and Lactic Acidosis from Low-Dose Naltrexone for Chronic Pain: Case Report. Pain-Med-Case-Rep 2023; 7 (8): 353-356.; Naumann J, Naumann T. Acute Precipitated Opioid Withdrawal With Akathisia, Delirium, and Lactic Acidosis from Low-Dose Naltrexone for Chronic Pain: Case Report. Pain-Med-Case-Rep 2023; 7 (8): 353-356.$66$YR$$M$Y$$$20240816$$HP$US$US
241646982$24164698$2$F$$20240722$20240801$20240820$EXP$$US-TEVA-VS-3224955$TEVA$Moussa MJ, Khandelwal J, Wilson NR, Naik SA, Subbiah V, Campbell MT, et al. Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Curr-Oncol 2024; 31 (6): 3342-3349.; Moussa MJ, Khandelwal J, Wilson NR, Naik SA, Subbiah V, Campbell MT, et al. Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Curr-Oncol 2024; 31 (6): 3342-3349.; Moussa MJ, Khandelwal J...$71$YR$$F$Y$$$20240820$$HP$US$US
241646991$24164699$1$I$20240801$20240801$20240801$20240801$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043357$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240801$$CN$US$US
241647001$24164700$1$I$$20240729$20240801$20240801$PER$$US-APELLIS-2024-APL-0000587$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$CN$US$US
241647012$24164701$2$F$$20240729$20240801$20240802$EXP$$CA-SANDOZ INC.-SDZ2024CA049209$SANDOZ$$$$$F$Y$$$20240802$$CN$CA$CA
241647021$24164702$1$I$$20240719$20240801$20240801$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07296$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240801$$HP$US$US
241647031$24164703$1$I$20230101$20240724$20240801$20240801$EXP$$US-009507513-2407USA014879$MERCK$$55$YR$$F$Y$$$20240801$$CN$US$US
241647041$24164704$1$I$20240101$20240729$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020291$ELI LILLY AND CO$$76$YR$E$$Y$$$20240801$$CN$US$US
241647051$24164705$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3224903$TEVA$Lee R, Gonsalves Z, Wang S, Hussain A, Herrera K. Case study: Autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks^ gestation. Case-Rep-Perinat-Med 2024; 13 (1):.$1$DY$$$Y$$$20240801$$MD$US$US
241647061$24164706$1$I$$20240729$20240801$20240801$PER$$US-APELLIS-2024-APL-0000588$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240801$$HP$US$US
241647072$24164707$2$F$$20240724$20240801$20240805$PER$$US-009507513-2408USA000231$MERCK$$57$YR$$M$Y$94.39$KG$20240805$$CN$US$US
241647081$24164708$1$I$$20240722$20240801$20240801$EXP$$US-TEVA-VS-3226058$TEVA$Abdelmajid HA, Mustafa GMA, Fernandez A, Franco SD, Esquibies AE, Valencia GB, et al. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring. Case-Rep-Perinat-Med 2024; 13 (1): 1-5.$45$DY$$M$Y$2.155$KG$20240801$$MD$US$US
241647091$24164709$1$I$$20240731$20240801$20240801$EXP$$JP-ABBVIE-5862251$ABBVIE$$$$$$Y$$$20240801$$MD$JP$JP
241647101$24164710$1$I$$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150556$AMGEN$$$$$M$Y$$$20240801$$CN$US$US
241647111$24164711$1$I$$20240717$20240801$20240801$EXP$$US-HLS-202400439$HLS THERAPEUTICS$$$$A$$Y$$$20240801$$PH$US$US
241647121$24164712$1$I$20240501$20240731$20240801$20240801$EXP$FR-AFSSAPS-PV2024000687$FR-JNJFOC-20240801967$JOHNSON AND JOHNSON$$43$YR$A$F$Y$93$KG$20240801$$MD$FR$FR
241647142$24164714$2$F$$20240802$20240801$20240813$EXP$$JP-ROCHE-10000040778$ROCHE$Mizuki S.. MT01-2 Clinical course of disseminated nontuberculous mycobacteriosis that developed in a patient with systemic lupus erythematosus. The 47th Annual Meeting of Japanese Society for Study of Bone and Joint Infectio. 2024;66$52$YR$A$F$Y$$$20240813$$MD$JP$JP
241647152$24164715$2$F$$20240805$20240801$20240808$EXP$$FR-JNJFOC-20240801863$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240809$$CN$FR$FR
241647162$24164716$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3226059$TEVA$Abdelmajid HA, Mustafa GMA, Fernandez A, Franco SD, Esquibies AE, Valencia GB, et al. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring. Case-Rep-Perinat-Med 2024; 13 (1): 1-5.; Abdelmajid HA, Mustafa GMA, Fernandez A, Franco SD, Esquibies AE, Valencia GB, et al. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring. Case-Rep-Perinat-Med 2024; 13 (1): 1-5.$33$YR$$F$Y$$$20240816$$MD$US$US
241647171$24164717$1$I$$20240515$20240801$20240801$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00815$AIMMUNE$$$$$$Y$$$20240801$$MD$US$US
241647183$24164718$3$F$$20240729$20240801$20240811$EXP$$PL-JNJFOC-20240802513$JOHNSON AND JOHNSON$Windyga J. Prevention and treatment of venous thromboembolic disease. Medycyna Praktyczna (English Practical Medicine). 2024;4:116-119$$$$F$Y$$$20240812$$HP$PL$PL
241647192$24164719$2$F$$20240806$20240801$20240816$EXP$$CA-TEVA-VS-3224952$TEVA$Domain G, Strube C, Plourde B, Steinberg C, Sarrazin J-F, Roy K, et al. Acute transvenous pacemaker lead thrombosis early after implantation: A rare clinical scenario. Pacing-Clin-Electrophysiol 2023; 46 (8): 934-938.; Domain G, Strube C, Plourde B, Steinberg C, Sarrazin J-F, Roy K, et al. Acute transvenous pacemaker lead thrombosis early after implantation: A rare clinical scenario. Pacing-Clin-Electrophysiol 2023; 46 (8): 934-938.$84$YR$$M$Y$$$20240816$$MD$CA$CA
241647201$24164720$1$I$$20240722$20240801$20240801$EXP$$JP-ROCHE-10000040663$ROCHE$Yamazaki Y, Hishiki H, Nagasawa K, Hamada H, Ishiwada N. Managing a challenging case of invasive pulmonary Aspergillosis following hematopoietic stem cell transplantation in a paediatric patient with acute lymphoblastic leukemia. Japanese Journal of Pediatric Pulmonology. 2024;35 (2):106-12.$15$YR$T$M$Y$$$20240801$$MD$JP$JP
241647212$24164721$2$F$$20240806$20240801$20240816$EXP$$IT-TEVA-VS-3226228$TEVA$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et al. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicol-Rep 2024; 13 101683.; Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et al. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicol-Rep 2024; 13 101683.$15$YR$$F$Y$48$KG$20240816$$HP$IT$IT
241647222$24164722$2$F$$20240806$20240801$20240816$EXP$$US-TEVA-VS-3224865$TEVA$O^Meara KT, Fansiwala K, Kathuria-Prakash N, El-Masry M, Oh S. Acute hypoxic respiratory failure due to Lenalidomide-induced interstitial pneumonitis in a patient with multiple myeloma. BMC-Pulm-Med 2024; 24 (1): 321.; O^Meara KT, Fansiwala K, Kathuria-Prakash N, El-Masry M, Oh S. Acute hypoxic respiratory failure due to Lenalidomide-induced interstitial pneumonitis in a patient with multiple myeloma. BMC-Pulm-Med 2024; 24 (1): 321.$80$YR$$M$Y$$$20240816$$HP$US$US
241647231$24164723$1$I$20240718$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407020298$ELI LILLY AND CO$$72$YR$E$$Y$$$20240801$$CN$US$US
241647242$24164724$2$F$$20240806$20240801$20240816$EXP$$CA-TEVA-VS-3225945$TEVA$Lundby C, Farrell B, Wilson A. Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects. Br-J-Clin-Pharmacol 2024; 90 (7): no pagination.; Lundby C, Farrell B, Wilson A. Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects. Br-J-Clin-Pharmacol 2024; 90 (7): no pagination.$76$YR$$F$Y$$$20240816$$HP$CA$CA
241647261$24164726$1$I$20240716$20240729$20240801$20240801$EXP$$CN-ROCHE-10000043020$ROCHE$$62$YR$A$M$Y$50$KG$20240802$$HP$CN$CN
241647271$24164727$1$I$20240728$20240729$20240801$20240801$EXP$$JP-009507513-2407JPN004924J$MERCK$$75$YR$$M$Y$$$20240801$$PH$JP$JP
241647281$24164728$1$I$$20240731$20240801$20240801$EXP$$US-SANDOZ INC.-SDZ2024US069795$SANDOZ$$$$$F$Y$$$20240801$$CN$US$US
241647291$24164729$1$I$$20240621$20240801$20240801$PER$$US-JNJFOC-20240752732$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240802$$CN$US$US
241647301$24164730$1$I$$20240730$20240801$20240801$EXP$$JP-009507513-2407JPN005277J$MERCK$$17$YR$$M$Y$$$20240801$$PH$JP$JP
241647311$24164731$1$I$20240725$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150388$AMGEN$$79$YR$E$F$Y$$$20240801$$HP$US$US
241647321$24164732$1$I$20240701$20240723$20240801$20240801$PER$$US-AMGEN-USASP2024146530$AMGEN$$66$YR$E$F$Y$$$20240801$$CN$US$US
241647331$24164733$1$I$$20240725$20240801$20240801$EXP$$US-JNJFOC-20240770699$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240802$$HP$US$US
241647341$24164734$1$I$20240703$20240725$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120802$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240802$$PH$US$US
241647351$24164735$1$I$20240725$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150361$AMGEN$$$$$M$Y$$$20240801$$HP$US$US
241647361$24164736$1$I$$20240730$20240801$20240801$PER$$NVSC2024US157351$NOVARTIS$$$$$$Y$$$20240802$$MD$US$US
241647371$24164737$1$I$20240101$20240724$20240801$20240801$PER$$US-ABBVIE-5854609$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241647381$24164738$1$I$20240601$20240731$20240801$20240801$EXP$$NVSJ2024JP007602$NOVARTIS$$$$E$F$Y$$$20240802$$MD$JP$JP
241647391$24164739$1$I$$20240731$20240801$20240801$PER$$NVSC2024US157405$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241647401$24164740$1$I$$20240731$20240801$20240801$PER$$NVSC2024US157406$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241647411$24164741$1$I$20240728$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150267$AMGEN$$61$YR$A$F$Y$$$20240801$$CN$US$US
241647422$24164742$2$F$$20240813$20240801$20240814$PER$$NVSC2024US157407$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
241647432$24164743$2$F$20240701$20240820$20240801$20240821$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043378$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240821$$CN$US$US
241647441$24164744$1$I$$20240726$20240801$20240801$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121682$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240802$$PH$JP$JP
241647452$24164745$2$F$20240716$20240729$20240801$20240803$EXP$$CA-ABBVIE-5860668$ABBVIE$$72$YR$$M$Y$$$20240803$$CN$CA$CA
241647461$24164746$1$I$$20240801$20240801$20240801$PER$$NVSC2024US157408$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241647471$24164747$1$I$$20240722$20240801$20240801$EXP$$JP-PRINSTON PHARMACEUTICAL INC.-2024PRN00286$PRINSTON PHARMACEUTICAL$Takahashi Y, Nakano H, Motoki M. et.al. Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review. Acute Medicine + Surgery. 2024;11:1-5$45$YR$$F$Y$90$KG$20240801$$HP$JP$JP
241647482$24164748$2$F$20220902$20240809$20240801$20240815$EXP$$US-009507513-2407USA014681$MERCK$$75$YR$$F$Y$52.5$KG$20240815$$CN$US$US
241647494$24164749$4$F$$20240816$20240801$20240829$EXP$$BR-JNJFOC-20240777263$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$MD$BR$BR
241647501$24164750$1$I$20210101$20240725$20240801$20240801$EXP$$GI-009507513-2407GIB015489$MERCK$Lopez EC, Flores A, Haider W, Zagurova M, Quandil N, Roman AJ, et al.. Unexpected effect of anti-PD-1 immune checkpoint inhibitor on a 61-year-old female with stage III non-small cell lung cancer on progression to chemo-radiotherapy. Clinical Medicine. 2024;24:100041$61$YR$$F$Y$$$20240801$$HP$GI$GI
241647513$24164751$3$F$20240715$20240821$20240801$20240823$PER$$US-AMGEN-USASP2024150929$AMGEN$$80$YR$E$F$Y$$$20240823$$CN$US$US
241647522$24164752$2$F$$20240730$20240801$20240807$PER$$US-AMGEN-USASP2024151953$AMGEN$$$$$M$Y$$$20240806$$CN$US$US
241647531$24164753$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024152022$AMGEN$$$$$F$Y$$$20240801$$HP$US$US
241647542$24164754$2$F$$20240826$20240801$20240830$30DAY$$RU-JNJFOC-20240782340$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$RU$RU
241647551$24164755$1$I$$20240725$20240801$20240801$EXP$$US-JNJFOC-20240774622$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$LW$US$US
241647561$24164756$1$I$20240714$20240724$20240801$20240801$PER$$US-JNJFOC-20240767270$JOHNSON AND JOHNSON$$65$YR$E$$Y$$$20240802$$MD$US$US
241647571$24164757$1$I$20240709$20240725$20240801$20240801$PER$$US-ABBVIE-5856523$ABBVIE$$30$YR$$F$Y$$$20240801$$MD$US$US
241647582$24164758$2$F$$20240905$20240801$20240910$30DAY$$FR-JNJFOC-20240782306$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$FR$FR
241647592$24164759$2$F$$20240909$20240801$20240915$PER$$US-JNJFOC-20240780350$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$CN$US$US
241647602$24164760$2$F$$20240926$20240801$20240930$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043314$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$$$20240930$$CN$CA$CA
241647612$24164761$2$F$20240730$20240911$20240801$20240916$PER$$US-AMGEN-USASP2024153049$AMGEN$$42$YR$A$F$Y$$$20240916$$CN$US$US
241647621$24164762$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151672$AMGEN$$$$$F$Y$$$20240801$$HP$US$US
241647631$24164763$1$I$$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151936$AMGEN$$65$YR$E$F$Y$$$20240801$$MD$US$US
241647641$24164764$1$I$$20240730$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202407019980$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240801$$CN$US$US
241647651$24164765$1$I$$20240731$20240801$20240801$PER$$US-JNJFOC-20240785326$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$MD$US$US
241647661$24164766$1$I$20230101$20240730$20240801$20240801$30DAY$$US-SANDOZ INC.-SDZ2024US069768$SANDOZ$$$$$$Y$65.91$KG$20240801$$CN$US$US
241647672$24164767$2$F$20240701$20240802$20240801$20240806$EXP$$US-ABBVIE-5856516$ABBVIE$$49$YR$$M$Y$$$20240806$$CN$US$US
241647682$24164768$2$F$20240601$20240731$20240801$20240809$PER$$US-AMGEN-USASP2024150274$AMGEN$$69$YR$E$F$Y$$$20240809$$CN$US$US
241647691$24164769$1$I$$20240730$20240801$20240801$EXP$$DE-SANDOZ INC.-SDZ2024DE069296$SANDOZ$$$$$M$Y$$$20240801$$MD$DE$DE
241647711$24164771$1$I$20240701$20240730$20240801$20240801$EXP$$US-ORGANON-O2407USA002952$ORGANON$$$$$F$Y$$$20240801$$CN$US$US
241647722$24164772$2$F$$20240820$20240801$20240829$PER$$US-BAUSCHBL-2024BNL030516$BAUSCH AND LOMB$$85$YR$$F$Y$$$20240830$$CN$US$US
241647731$24164773$1$I$$20240730$20240801$20240801$PER$$NVSC2024US156492$NOVARTIS$$$$$$Y$$$20240802$$CN$US$US
241647741$24164774$1$I$20240201$20240731$20240801$20240801$EXP$$NVSC2024US156595$NOVARTIS$$41$YR$$F$Y$$$20240802$$HP$US$US
241647751$24164775$1$I$20240720$20240722$20240801$20240801$PER$$US-BAUSCHBL-2024BNL030533$BAUSCH AND LOMB$$80$YR$$M$Y$$$20240802$$CN$US$US
241647761$24164776$1$I$$20240730$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121357$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240802$$MD$US$US
241647771$24164777$1$I$20240730$20240731$20240801$20240801$PER$$US-ELI_LILLY_AND_COMPANY-US202408000346$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240801$$CN$US$US
241647783$24164778$3$F$20240701$20240730$20240801$20240810$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121697$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240810$$MD$US$US
241647791$24164779$1$I$$20240723$20240801$20240801$PER$US-MLMSERVICE-20240716-PI133709-00082-1$US-RDY-SPO/USA/24/0010972$DR REDDYS$Jiang H, Cartwright S, Wagner DG, Krishnamurthy J, Santamaria-Barria JA. Pathologic Complete Response to Neoadjuvant Chemotherapy and Pembrolizumab in Postpartum High-Risk Basal-Type Breast Cancer. Cureus. 2024;16(6):e62338. DOI: 10.7759/cureus.62338.$39$YR$A$F$Y$$$20240802$$MD$US$US
241647801$24164780$1$I$20240728$20240729$20240801$20240801$PER$$US-AMGEN-USASP2024150286$AMGEN$$76$YR$E$M$Y$$$20240801$$CN$US$US
241647811$24164781$1$I$20240723$20240723$20240801$20240801$PER$$US-BAUSCHBL-2024BNL030603$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240802$$CN$US$US
241647821$24164782$1$I$20240713$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011516$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241647831$24164783$1$I$20240701$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011532$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241647841$24164784$1$I$20240101$20240729$20240801$20240801$EXP$$US-ABBVIE-5861079$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241647851$24164785$1$I$20240708$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011534$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241647861$24164786$1$I$$20240722$20240801$20240801$EXP$$US-RDY-LIT/USA/24/0011113$DR REDDYS$Zhang Y, Chakraborti C. REFINING PAIN MANAGEMENT IN CRYPTOCOCCAL IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME. Southern Medical Journal. 2022 Jul;115: 560.$28$YR$A$M$Y$$$20240802$$HP$US$US
241647871$24164787$1$I$20240612$20240722$20240801$20240801$PER$$US-JNJFOC-20240758890$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240802$$CN$US$US
241647881$24164788$1$I$$20240723$20240801$20240801$PER$$US-ABBVIE-5855038$ABBVIE$$$$A$M$Y$$$20240801$$MD$US$US
241647892$24164789$2$F$20240728$20240808$20240801$20240810$PER$$US-AMGEN-USASP2024151204$AMGEN$$65$YR$E$F$Y$$$20240810$$CN$US$US
241647911$24164791$1$I$20240712$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011536$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241647922$24164792$2$F$20231101$20240801$20240801$20240808$EXP$$US-BIOGEN-2024BI01275835$BIOGEN$$61$YR$$F$Y$$$20240808$$HP$US$US
241647931$24164793$1$I$$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011581$BEIGENE$$$$$$Y$$$20240801$$CN$CN$CN
241647941$24164794$1$I$20240628$20240801$20240801$20240801$EXP$FR-AFSSAPS-AM2024000622$NVSC2024FR157238$NOVARTIS$$22$MON$$F$Y$9.6$KG$20240802$$CN$FR$FR
241647951$24164795$1$I$20240705$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011515$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241647961$24164796$1$I$$20240729$20240801$20240801$EXP$$NVSJ2024JP009173$NOVARTIS$$$$$$Y$$$20240802$$MD$JP$JP
241647971$24164797$1$I$$20240730$20240801$20240801$PER$$US-JNJFOC-20240783059$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$MD$US$US
241647981$24164798$1$I$20240607$20240724$20240801$20240801$EXP$$CN-JNJFOC-20240768589$JOHNSON AND JOHNSON$$68$YR$E$F$Y$52$KG$20240802$$HP$CN$CN
241647992$24164799$2$F$20200313$20240902$20240801$20240903$EXP$$JP-TAKEDA-2024TJP011468$TAKEDA$$26$YR$$M$Y$$$20240903$$MD$JP$JP
241648001$24164800$1$I$20240702$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011489$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648011$24164801$1$I$$20240725$20240801$20240801$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2159907$Chengdu Suncadia Medicine$Clinical analysis of 14 pregnancies in women with renal transplant.$33$YR$$F$Y$$$20240801$$MD$CN$CN
241648022$24164802$2$F$$20240813$20240801$20240904$30DAY$$DE-JNJFOC-20240779264$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$PH$DE$DE
241648031$24164803$1$I$20240703$20240725$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011587$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648041$24164804$1$I$20240625$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011492$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648051$24164805$1$I$20240723$20240724$20240801$20240801$PER$$US-009507513-2407USA013369$MERCK$$63$YR$$F$Y$$$20240801$$CN$US$US
241648061$24164806$1$I$20240630$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011495$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648071$24164807$1$I$$20240726$20240801$20240801$EXP$$US-BIOGEN-2024BI01274818$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
241648081$24164808$1$I$$20240726$20240801$20240801$EXP$GB-MHRA-MED-202407261520428400-HWMCJ$GB-BIOGEN-2024BI01275796$BIOGEN$$60$YR$$F$Y$$$20240801$$HP$GB$GB
241648092$24164809$2$F$20240420$20240815$20240801$20240823$EXP$$US-BIOGEN-2024BI01275877$BIOGEN$$24$YR$$F$Y$104$KG$20240823$$HP$US$US
241648101$24164810$1$I$$20240731$20240801$20240801$EXP$$FR-JNJFOC-20240801540$JOHNSON AND JOHNSON$$7$YR$C$F$Y$$$20240802$$HP$FR$FR
241648111$24164811$1$I$$20240726$20240801$20240801$EXP$$US-BIOGEN-2024BI01276045$BIOGEN$$$$$F$Y$$$20240801$$CN$US$US
241648124$24164812$4$F$$20240821$20240801$20240829$EXP$$US-ALXN-202407USA001849US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
241648131$24164813$1$I$20240718$20240724$20240801$20240801$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2159908$JIANGSU HENGRUI MEDICINE$$70$YR$$F$Y$54$KG$20240801$$MD$CN$CN
241648141$24164814$1$I$20240721$20240725$20240801$20240801$EXP$$CA-JNJFOC-20240773049$JOHNSON AND JOHNSON$$38$YR$A$F$Y$59$KG$20240802$$HP$CA$CA
241648151$24164815$1$I$20240609$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011497$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648161$24164816$1$I$20240501$20240725$20240801$20240801$EXP$$CO-JNJFOC-20240663181$JOHNSON AND JOHNSON$$47$YR$A$M$Y$67$KG$20240802$$HP$CO$CO
241648171$24164817$1$I$20240603$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011496$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648181$24164818$1$I$$20240726$20240801$20240801$EXP$$US-BIOGEN-2024BI01276055$BIOGEN$$$$$M$Y$$$20240801$$CN$US$US
241648192$24164819$2$F$20240703$20240913$20240801$20240918$30DAY$$US-AMGEN-USASP2024148158$AMGEN$$$$$M$Y$58$KG$20240918$$PH$US$US
241648202$24164820$2$F$20240725$20240805$20240801$20240813$PER$$US-ABBVIE-5854324$ABBVIE$$68$YR$$M$Y$83$KG$20240813$$CN$US$US
241648211$24164821$1$I$20240710$20240730$20240801$20240801$PER$$US-AMGEN-USASP2024151391$AMGEN$$$$$F$Y$$$20240801$$PH$US$US
241648221$24164822$1$I$20240617$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011498$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648232$24164823$2$F$20240726$20240806$20240801$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120535$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240814$$PH$US$US
241648242$24164824$2$F$$20240830$20240801$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118806$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$78.02$KG$20240902$$CN$US$US
241648261$24164826$1$I$20240618$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011519$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648272$24164827$2$F$$20240822$20240801$20240826$EXP$$JP-TAKEDA-2023TJP016136$TAKEDA$$79$YR$$F$Y$$$20240826$$PH$JP$JP
241648281$24164828$1$I$20240701$20240725$20240801$20240801$EXP$$US-ABBVIE-5855964$ABBVIE$$63$YR$$M$Y$$$20240801$$CN$US$US
241648291$24164829$1$I$$20240725$20240801$20240801$EXP$$US-Jiangsu Hengrui Medicine Co., Ltd.-2159909$JIANGSU HENGRUI MEDICINE$Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis$68$YR$$M$Y$$$20240801$$MD$US$US
241648301$24164830$1$I$20240714$20240729$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011783$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648312$24164831$2$F$$20240726$20240801$20240821$PER$$US-BIOGEN-2024BI01275786$BIOGEN$$26$YR$$F$Y$$$20240821$$CN$US$US
241648321$24164832$1$I$20240714$20240725$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011591$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648331$24164833$1$I$20240605$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011502$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648341$24164834$1$I$20240327$20240730$20240801$20240801$EXP$$MX-ABBVIE-5862403$ABBVIE$$82$YR$$F$Y$$$20240801$$CN$MX$MX
241648351$24164835$1$I$$20240730$20240801$20240801$EXP$$CA-ABBVIE-5863823$ABBVIE$$$$$M$Y$$$20240801$$HP$CA$CA
241648361$24164836$1$I$20240717$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011533$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648371$24164837$1$I$$20240724$20240801$20240801$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024092847$VIIV$$$$$M$Y$$$20240801$$MD$US$US
241648381$24164838$1$I$20240718$20240729$20240801$20240801$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120744$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$99.34$KG$20240802$$HP$US$US
241648391$24164839$1$I$20240702$20240725$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011586$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648404$24164840$4$F$20220228$20240913$20240801$20240919$EXP$$JP-009507513-2203JPN001227J$MERCK$$63$YR$$F$Y$$$20240919$$MD$JP$JP
241648411$24164841$1$I$20240716$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011527$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648421$24164842$1$I$20240611$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011503$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648431$24164843$1$I$$20240801$20240801$20240801$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043365$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$$$20240802$$CN$US$US
241648441$24164844$1$I$20240628$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011530$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648451$24164845$1$I$20240722$20240725$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011588$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648462$24164846$2$F$20240803$20240828$20240801$20240830$EXP$$US-TAKEDA-2024TUS077019$TAKEDA$$16$YR$$M$Y$$$20240830$$PH$US$US
241648471$24164847$1$I$20231105$20240725$20240801$20240801$EXP$$US-ABBVIE-5856040$ABBVIE$$57$YR$$F$Y$$$20240801$$CN$US$US
241648483$24164848$3$F$$20240813$20240801$20240814$PER$$US-AMGEN-USASP2024151081$AMGEN$$$$$M$Y$$$20240814$$CN$US$US
241648491$24164849$1$I$$20240726$20240801$20240801$EXP$$BR-TAKEDA-2024TUS076615$TAKEDA$$$$$M$Y$$$20240801$$CN$BR$BR
241648504$24164850$4$F$20190201$20240827$20240801$20240906$EXP$$JP-TAKEDA-2024TUS030478$TAKEDA$$21$YR$$M$Y$50$KG$20240906$$PH$JP$JP
241648511$24164851$1$I$20220101$20240729$20240801$20240801$EXP$$US-ABBVIE-5860656$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241648522$24164852$2$F$20240727$20240802$20240801$20240806$EXP$$US-ABBVIE-5859683$ABBVIE$$54$YR$$F$Y$68.03$KG$20240806$$CN$US$US
241648531$24164853$1$I$20240724$20240729$20240801$20240801$EXP$$US-ABBVIE-5859414$ABBVIE$$52$YR$$M$Y$$$20240801$$CN$US$US
241648541$24164854$1$I$$20240730$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122015$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240802$$CN$US$US
241648551$24164855$1$I$20240727$20240729$20240801$20240801$EXP$$AT-ABBVIE-5860665$ABBVIE$$84$YR$$M$Y$$$20240801$$MD$AT$AT
241648561$24164856$1$I$20240701$20240729$20240801$20240801$EXP$$US-ABBVIE-5860352$ABBVIE$$45$YR$$M$Y$$$20240801$$CN$US$US
241648572$24164857$2$F$20240731$20240821$20240801$20240827$EXP$$US-ABBVIE-5860291$ABBVIE$$65$YR$$F$Y$80$KG$20240827$$CN$US$US
241648581$24164858$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5860292$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241648592$24164859$2$F$$20240722$20240801$20240805$EXP$$JP-Unichem Pharmaceuticals (USA) Inc-UCM202407-000936$UNICHEM$$45$YR$A$F$Y$90$KG$20240805$$HP$JP$
241648601$24164860$1$I$$20240730$20240801$20240801$EXP$$CO-SANDOZ INC.-SDZ2024CO069679$SANDOZ$$$$$F$Y$70$KG$20240801$$CN$CO$CO
241648612$24164861$2$F$$20240805$20240801$20240806$EXP$$TR-ABBVIE-5863754$ABBVIE$$$$$M$Y$$$20240806$$CN$TR$TR
241648621$24164862$1$I$20230907$20240722$20240801$20240801$PER$$US-ABBVIE-5852948$ABBVIE$$47$YR$$F$Y$74$KG$20240801$$HP$US$US
241648631$24164863$1$I$20240323$20240725$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011589$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241648642$24164864$2$F$$20240821$20240801$20240823$PER$$US-ALXN-202407USA001895US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
241648654$24164865$4$F$20240201$20240905$20240801$20240914$EXP$$US-ABBVIE-5861127$ABBVIE$$68$YR$$M$Y$99.79$KG$20240914$$CN$US$US
241648661$24164866$1$I$20240509$20240717$20240801$20240801$PER$$US-RDY-SPO/USA/24/0010760$DR REDDYS$$73$YR$E$M$Y$$$20240802$$CN$US$US
241648671$24164867$1$I$20240101$20240730$20240801$20240801$EXP$$US-ABBVIE-5861568$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241648681$24164868$1$I$$20240730$20240801$20240801$EXP$$US-ABBVIE-5862126$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241648691$24164869$1$I$$20240730$20240801$20240801$EXP$$US-ABBVIE-5861586$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241648701$24164870$1$I$20240101$20240730$20240801$20240801$EXP$$US-ABBVIE-5862038$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241648711$24164871$1$I$$20240731$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121542$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240802$$HP$US$US
241648721$24164872$1$I$20150101$20240726$20240801$20240801$EXP$$US-ABBVIE-5364152$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241648732$24164873$2$F$$20240731$20240801$20240806$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-121549$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$92$KG$20240806$$PH$CA$CA
241648744$24164874$4$F$$20240902$20240801$20240912$30DAY$$KR-JNJFOC-20240778641$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$KR$KR
241648751$24164875$1$I$$20240730$20240801$20240801$EXP$$SE-ABBVIE-5862313$ABBVIE$$$$A$F$Y$$$20240801$$HP$SE$SE
241648761$24164876$1$I$20100101$20240731$20240801$20240801$EXP$$US-ABBVIE-5862766$ABBVIE$$$$$M$Y$$$20240801$$HP$US$US
241648781$24164878$1$I$20240601$20240724$20240801$20240801$PER$$US-SA-2024SA222147$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240802$$MD$US$US
241648791$24164879$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA221618$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240802$$MD$US$US
241648801$24164880$1$I$$20240724$20240801$20240801$PER$$US-SA-2024SA220861$SANOFI AVENTIS$$$$A$F$Y$$$20240802$$HP$US$US
241648811$24164881$1$I$$20240725$20240801$20240801$PER$$US-ALXN-202407USA001866US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241648821$24164882$1$I$20240101$20240724$20240801$20240801$PER$$US-SA-2024SA223041$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240802$$MD$US$US
241648831$24164883$1$I$20240101$20240730$20240801$20240801$EXP$$US-ABBVIE-5822983$ABBVIE$$$$$F$Y$77.564$KG$20240801$$CN$US$US
241648841$24164884$1$I$$20240725$20240801$20240801$EXP$$US-ABBVIE-5855785$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241648851$24164885$1$I$$20240718$20240801$20240801$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-115570$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240802$$HP$CA$CA
241648861$24164886$1$I$20240525$20240726$20240801$20240801$EXP$$DE-ABBVIE-5857064$ABBVIE$$62$YR$$F$Y$$$20240801$$MD$DE$DE
241648871$24164887$1$I$20240725$20240722$20240801$20240801$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120777$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240802$$CN$US$US
241648881$24164888$1$I$20230510$20240729$20240801$20240801$EXP$$US-ABBVIE-5859411$ABBVIE$$68$YR$$F$Y$$$20240801$$CN$US$US
241648891$24164889$1$I$$20240701$20240801$20240801$PER$$US-009507513-2407USA001170$MERCK$$$$$F$Y$$$20240801$$CN$US$US
241648901$24164890$1$I$20240601$20240729$20240801$20240801$EXP$$MX-ABBVIE-5862739$ABBVIE$$49$YR$$F$Y$98$KG$20240801$$CN$MX$MX
241648911$24164891$1$I$20240101$20240730$20240801$20240801$EXP$$US-ABBVIE-5862728$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241648921$24164892$1$I$$20240731$20240801$20240801$EXP$$US-ABBVIE-5863863$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241648931$24164893$1$I$$20240730$20240801$20240801$EXP$$US-ABBVIE-5770783$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241648941$24164894$1$I$$20240730$20240801$20240801$EXP$$CA-ABBVIE-5862546$ABBVIE$$$$A$F$Y$$$20240801$$CN$CA$CA
241648951$24164895$1$I$20231001$20240729$20240801$20240801$EXP$$US-ABBVIE-5859671$ABBVIE$$65$YR$$F$Y$$$20240801$$CN$US$US
241648961$24164896$1$I$20240702$20240730$20240801$20240801$EXP$$JP-ASTELLAS-2024JP005515$ASTELLAS$$10$DEC$$M$Y$$$20240802$$MD$JP$JP
241648971$24164897$1$I$20240730$20240730$20240801$20240801$EXP$$PR-ABBVIE-5861532$ABBVIE$$78$YR$$F$Y$$$20240801$$HP$PR$PR
241648981$24164898$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5859751$ABBVIE$$$$$F$Y$$$20240801$$CN$US$US
241648991$24164899$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5862285$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241649001$24164900$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5862112$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241649013$24164901$3$F$$20240911$20240801$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003433$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241649021$24164902$1$I$$20240711$20240801$20240801$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003436$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$HP$US$US
241649041$24164904$1$I$20240612$20240711$20240801$20240801$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003438$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240802$$CN$US$US
241649054$24164905$4$F$$20240916$20240801$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003434$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241649061$24164906$1$I$$20240729$20240801$20240801$EXP$$US-ABBVIE-5860511$ABBVIE$$$$$M$Y$$$20240801$$CN$US$US
241649071$24164907$1$I$20240701$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011505$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241649081$24164908$1$I$20240506$20240729$20240801$20240801$EXP$IT-MINISAL02-994921$IT-ROCHE-10000040779$ROCHE$$69$YR$E$F$Y$$$20240802$$MD$IT$IT
241649101$24164910$1$I$20240708$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011507$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241649111$24164911$1$I$$20240730$20240801$20240801$PER$$US-ROCHE-10000045873$ROCHE$$77$YR$E$F$Y$$$20240802$$CN$US$US
241649121$24164912$1$I$20240730$20240730$20240801$20240801$PER$$US-JNJFOC-20240782565$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$HP$US$US
241649131$24164913$1$I$20230101$20240722$20240801$20240801$EXP$$US-Emmaus Medical, Inc.-EMM202407-000362$EMMAUS LIFE SCIENCES$$33$YR$A$M$Y$$$20240802$$CN$US$
241649142$24164914$2$F$20240701$20240821$20240801$20240822$PER$$US-ALXN-202407USA001864US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
241649152$24164915$2$F$$20240821$20240801$20240822$PER$$US-ALXN-202407USA001857US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
241649161$24164916$1$I$20240611$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011508$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241649171$24164917$1$I$$20240724$20240801$20240801$EXP$$US-NOVITIUMPHARMA-2024USNVP01461$NOVITIUM PHARMA$$$$$F$Y$51$KG$20240802$$PH$US$US
241649181$24164918$1$I$20240620$20240724$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011509$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241649191$24164919$1$I$20240711$20240725$20240801$20240801$EXP$$CN-BEIGENE-BGN-2024-011590$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241649201$24164920$1$I$20240201$20240729$20240801$20240801$EXP$$US-ABBVIE-5860268$ABBVIE$$91$YR$$F$Y$$$20240801$$CN$US$US
241649212$24164921$2$F$$20240805$20240802$20240807$EXP$$US-ABBVIE-5862810$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241649221$24164922$1$I$$20240723$20240802$20240802$PER$$US-AstraZeneca-2024A171452$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241649231$24164923$1$I$$20240726$20240802$20240802$EXP$$ZA-AstraZeneca-2024A171355$ASTRAZENECA$$65$YR$$M$Y$$$20240802$$CN$ZA$
241649241$24164924$1$I$20240607$20240731$20240802$20240802$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043398$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240802$$CN$US$US
241649251$24164925$1$I$$20240731$20240802$20240802$EXP$$US-ABBVIE-5863442$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241649261$24164926$1$I$20230505$20240724$20240802$20240802$EXP$$CN-BEIGENE-BGN-2024-011510$BEIGENE$$$$$$Y$$$20240801$$HP$CN$CN
241649272$24164927$2$F$$20240827$20240802$20240829$EXP$$JP-TAKEDA-2024TJP009760$TAKEDA$$6$DEC$$F$Y$$$20240829$$MD$JP$JP
241649283$24164928$3$F$20240715$20240826$20240802$20240902$EXP$$US-ABBVIE-5859787$ABBVIE$$77$YR$$F$Y$$$20240902$$CN$US$US
241649291$24164929$1$I$20240101$20240731$20240802$20240802$EXP$$US-ABBVIE-5863454$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241649301$24164930$1$I$20240101$20240726$20240802$20240802$EXP$$US-ABBVIE-5856885$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241649312$24164931$2$F$$20240816$20240802$20240821$EXP$$US-ABBVIE-5856798$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
241649322$24164932$2$F$$20240910$20240802$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003466$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241649331$24164933$1$I$20240620$20240724$20240802$20240802$EXP$$CN-BEIGENE-BGN-2024-011513$BEIGENE$$$$$$Y$$$20240802$$HP$CN$CN
241649341$24164934$1$I$$20240711$20240802$20240802$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003465$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241649351$24164935$1$I$20240627$20240724$20240802$20240802$EXP$$CN-BEIGENE-BGN-2024-011511$BEIGENE$$$$$$Y$$$20240802$$HP$CN$CN
241649361$24164936$1$I$$20240723$20240802$20240802$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024092236$VIIV$$3$DEC$$F$Y$$$20240802$$MD$US$US
241649372$24164937$2$F$$20240808$20240802$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003467$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
241649381$24164938$1$I$$20240724$20240802$20240802$EXP$$CA-JNJFOC-20240767673$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$HP$CA$CA
241649391$24164939$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223655$SANOFI AVENTIS$$$$A$M$Y$$$20240802$$MD$US$US
241649401$24164940$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA224685$SANOFI AVENTIS$$$$C$M$Y$$$20240802$$CN$US$US
241649412$24164941$2$F$20240701$20240923$20240802$20240930$EXP$$UY-ABBVIE-5860841$ABBVIE$$67$YR$$M$Y$$$20240930$$CN$UY$UY
241649421$24164942$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223709$SANOFI AVENTIS$$$$A$F$Y$74.8$KG$20240802$$MD$US$US
241649431$24164943$1$I$20240708$20240729$20240802$20240802$EXP$$ZA-ABBVIE-5858912$ABBVIE$$71$YR$$M$Y$$$20240802$$CN$ZA$ZA
241649441$24164944$1$I$20240306$20240726$20240802$20240802$PER$$US-ABBVIE-5857466$ABBVIE$$37$YR$$F$Y$$$20240802$$MD$US$US
241649461$24164946$1$I$$20240711$20240802$20240802$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003469$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241649472$24164947$2$F$$20240821$20240802$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003470$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
241649482$24164948$2$F$$20240819$20240802$20240822$EXP$$US-ABBVIE-5860509$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
241649492$24164949$2$F$20240724$20240830$20240802$20240902$EXP$$JP-TAKEDA-2024TJP011390$TAKEDA$$79$YR$$F$Y$$$20240902$$PH$JP$JP
241649501$24164950$1$I$20240101$20240729$20240802$20240802$EXP$$US-ABBVIE-5860303$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241649511$24164951$1$I$20240722$20240730$20240802$20240802$EXP$CZ-CZSUKL-24002143$CZ-AMGEN-CZESP2024151355$AMGEN$$75$YR$E$F$Y$60$KG$20240801$$MD$CZ$CZ
241649521$24164952$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA222035$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240802$$MD$US$US
241649531$24164953$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA221952$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240802$$MD$US$US
241649541$24164954$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224155$SANOFI AVENTIS$$$$E$F$Y$90.718$KG$20240802$$MD$US$US
241649551$24164955$1$I$20240201$20240725$20240802$20240802$PER$$US-SA-2024SA221955$SANOFI AVENTIS$$32$YR$A$$Y$$$20240802$$HP$US$US
241649561$24164956$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224365$SANOFI AVENTIS$$$$A$M$Y$65.317$KG$20240802$$MD$US$US
241649571$24164957$1$I$20240705$20240724$20240802$20240802$PER$$US-SA-2024SA223893$SANOFI AVENTIS$$16$YR$T$F$Y$86$KG$20240802$$MD$US$US
241649581$24164958$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA221858$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240802$$MD$US$US
241649591$24164959$1$I$20240601$20240724$20240802$20240802$PER$$US-SA-2024SA221758$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240802$$MD$US$US
241649601$24164960$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003471$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241649612$24164961$2$F$20240604$20240806$20240802$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003472$ACADIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240829$$CN$US$US
241649621$24164962$1$I$$20240731$20240802$20240802$EXP$$US-ABBVIE-5863390$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241649631$24164963$1$I$20240428$20240729$20240802$20240802$EXP$$IT-ABBVIE-5861806$ABBVIE$$76$YR$$F$Y$$$20240802$$CN$IT$IT
241649642$24164964$2$F$$20240813$20240802$20240821$EXP$$TW-AstraZeneca-2024A173545$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$TW$
241649651$24164965$1$I$$20240724$20240802$20240802$EXP$$US-AstraZeneca-2024A169775$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241649661$24164966$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA222335$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240802$$CN$US$US
241649672$24164967$2$F$20231111$20240729$20240802$20240806$EXP$$JP-SA-2024SA220529$SANOFI AVENTIS$$84$YR$E$M$Y$56.5$KG$20240807$$MD$JP$JP
241649682$24164968$2$F$20240701$20240820$20240802$20240827$EXP$$US-ABBVIE-5861136$ABBVIE$$73$YR$$M$Y$$$20240827$$CN$US$US
241649692$24164969$2$F$20240101$20240904$20240802$20240913$PER$$US-SA-2024SA222459$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240913$$MD$US$US
241649702$24164970$2$F$20240401$20240918$20240802$20240925$EXP$$US-ABBVIE-5861522$ABBVIE$$78$YR$$$Y$$$20240925$$CN$US$US
241649711$24164971$1$I$20240401$20240726$20240802$20240802$EXP$$US-ABBVIE-5856880$ABBVIE$$61$YR$$F$Y$$$20240802$$CN$US$US
241649721$24164972$1$I$20240509$20240730$20240802$20240802$EXP$$FR-ABBVIE-5864086$ABBVIE$$82$YR$$M$Y$$$20240802$$HP$FR$FR
241649731$24164973$1$I$20240731$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152395$AMGEN$$$$$M$Y$$$20240801$$CN$US$US
241649741$24164974$1$I$20240731$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153053$AMGEN$$67$YR$E$F$Y$$$20240801$$CN$US$US
241649751$24164975$1$I$$20240725$20240802$20240802$EXP$$IN-AMGEN-INDSP2024149365$AMGEN$Gupta N;. Improved Outcome of Primary Plasma Cell Leukemia in the Current Era with the Use of Novel Agents and Autologous Bone Marrow Transplants-A Single Centre Experience. Indian Journal of Hematology and Blood Transfusion. 2024;40 (3):400-406$59$YR$A$M$Y$$$20240801$$HP$IN$IN
241649762$24164976$2$F$$20240821$20240802$20240821$PER$$US-ALXN-202407USA001845US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
241649771$24164977$1$I$20240101$20240725$20240802$20240802$PER$$US-ABBVIE-5857194$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241649781$24164978$1$I$$20240726$20240802$20240802$PER$$US-AMGEN-USASP2024149690$AMGEN$$$$$$Y$$$20240801$$MD$US$US
241649791$24164979$1$I$$20240723$20240802$20240802$EXP$$JP-STERISCIENCE B.V.-2024-ST-001125$Steriscience PTE$Nashimoto S, Miyamae M, Higuchi I, Kono M, Tada M, Atsumi T, et al.. Decrease in Mycophenolic Acid Plasma Level by Sacubitril/Valsartan in a Lupus Nephritis Patient: A Case Report.. Case-Rep-Nephrol-Dial. 2024;14(1):30-35$5$DEC$$M$Y$$$20240802$$HP$JP$JP
241649801$24164980$1$I$20240101$20240729$20240802$20240802$EXP$$DE-ABBVIE-5859927$ABBVIE$$$$$F$Y$$$20240802$$CN$DE$DE
241649811$24164981$1$I$20240723$20240729$20240802$20240802$EXP$GB-MHRA-MED-202407241620080620-HGWJR$GB-GSK-GB2024094699$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$GB$GB
241649821$24164982$1$I$$20240724$20240802$20240802$EXP$$JP-STERISCIENCE B.V.-2024-ST-001126$Steriscience PTE$Azuma S, Kawasuji H, Nakai R, Yamada H, Yoshida Y, Kawahara H, et al.. The fatal case of ^Pigmentibacter^ bacteremia following aspiration pneumonia in elderly patient.. J-Infect-Chemother. 2024;30 (8):806-811$95$YR$$M$Y$60.3$KG$20240802$$HP$JP$JP
241649831$24164983$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000238$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240802$$CN$US$US
241649841$24164984$1$I$20240601$20240724$20240802$20240802$PER$$US-SA-2024SA223957$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240802$$CN$US$US
241649851$24164985$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA223096$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240802$$MD$US$US
241649861$24164986$1$I$$20240723$20240802$20240802$EXP$$US-STERISCIENCE B.V.-2024-ST-001113$Steriscience PTE$Rahman O, Javed F, Iqbal M, Fulkerson Z, Chaudhry A, Pasha N, et al.. Progressive Refractory Interstitial Lung Disease Due to Recurrent Aspiration in Bulimia Nervosa.. Am-J-Respir-Crit-Care-Med. 2024;209:(plus Poster)$44$YR$$F$Y$$$20240802$$HP$US$US
241649871$24164987$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223370$SANOFI AVENTIS$$$$$$Y$$$20240802$$MD$US$US
241649881$24164988$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA221771$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240802$$MD$US$US
241649891$24164989$1$I$$20240729$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120903$BRISTOL MYERS SQUIBB$Nicpon J. Keratoacanthoma: treatment options. Journal of the Dermatology Nurses^ Association. 2024 Jul 01;16(4):128-33. doi:10.1097/JDN.0000000000000797.$88$YR$E$M$Y$$$20240802$$HP$US$US
241649901$24164990$1$I$20240101$20240724$20240802$20240802$PER$$US-ABBVIE-5855458$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241649911$24164991$1$I$20240401$20240730$20240802$20240802$EXP$FR-AFSSAPS-MP2024000827$FR-GSK-FR2024095605$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$FR$FR
241649931$24164993$1$I$20240701$20240729$20240802$20240802$EXP$$US-ABBVIE-5862159$ABBVIE$$80$YR$$M$Y$$$20240802$$CN$US$US
241649941$24164994$1$I$$20240726$20240802$20240802$EXP$$US-AMGEN-USASP2024149427$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241649951$24164995$1$I$20210301$20210919$20240802$20240802$EXP$$AU-AstraZeneca-2021A734072$ASTRAZENECA$$262$MON$$F$Y$$$20240802$$CN$AU$
241649961$24164996$1$I$$20240801$20240802$20240802$30DAY$$US-SANDOZ INC.-SDZ2024US069911$SANDOZ$$54$YR$$M$Y$$$20240802$$HP$US$US
241649971$24164997$1$I$$20240723$20240802$20240802$EXP$$IN-STERISCIENCE B.V.-2024-ST-001119$Steriscience PTE$Mohan V, Jain S, Naithani R.. Low-dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe-BIRD) in a child with relapsed/refractory B-cell acute lymphoblastic leukemia with TP53 mutation.. Pediatr-Blood-Cancer. 2024;71(9)$11$YR$$M$Y$$$20240802$$HP$IN$IN
241649982$24164998$2$F$$20240901$20240802$20240908$EXP$$CN-JNJFOC-20240769401$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$CN$CN
241649993$24164999$3$F$$20240924$20240802$20240930$EXP$$US-GSK-US2024AMR091966$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
241650001$24165000$1$I$$20240730$20240802$20240802$EXP$$US-ABBVIE-5861485$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241650011$24165001$1$I$20240101$20240730$20240802$20240802$EXP$$CN-ABBVIE-5859656$ABBVIE$$57$YR$$M$Y$60$KG$20240802$$MD$CN$CN
241650021$24165002$1$I$$20240723$20240802$20240802$EXP$$US-STERISCIENCE B.V.-2024-ST-001120$Steriscience PTE$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al.. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$38$YR$$M$Y$$$20240802$$HP$US$US
241650031$24165003$1$I$20240702$20240730$20240802$20240802$EXP$$US-ABBVIE-5862085$ABBVIE$$44$YR$$M$Y$$$20240802$$CN$US$US
241650041$24165004$1$I$$20240726$20240802$20240802$PER$$US-JNJFOC-20240777134$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$HP$US$US
241650051$24165005$1$I$20220101$20240725$20240802$20240802$EXP$$CA-ABBVIE-5856403$ABBVIE$$79$YR$$F$Y$$$20240802$$CN$CA$CA
241650061$24165006$1$I$$20240725$20240802$20240802$EXP$$US-ABBVIE-5855523$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241650071$24165007$1$I$20210101$20240730$20240802$20240802$EXP$$US-ABBVIE-5862409$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241650081$24165008$1$I$20240729$20240729$20240802$20240802$EXP$$US-ABBVIE-5860919$ABBVIE$$45$YR$$F$Y$$$20240802$$CN$US$US
241650091$24165009$1$I$20240701$20240718$20240802$20240802$PER$$US-Encube-000841$ENCUBE ETHICALS$$$$$M$Y$$$20240730$$CN$US$
241650101$24165010$1$I$$20240731$20240802$20240802$PER$$NVSC2024US157266$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
241650111$24165011$1$I$20240528$20240725$20240802$20240802$PER$$US-ABBVIE-5856284$ABBVIE$$29$YR$$F$Y$$$20240802$$MD$US$US
241650121$24165012$1$I$20240730$20240730$20240802$20240802$PER$$US-ABBVIE-5861641$ABBVIE$$59$YR$$F$Y$$$20240802$$CN$US$US
241650131$24165013$1$I$$20240719$20240802$20240802$EXP$$US-HLS-202400481$HLS THERAPEUTICS$$50$YR$A$M$Y$$$20240802$$PH$US$US
241650142$24165014$2$F$20240101$20240730$20240802$20240803$EXP$$CA-ABBVIE-5861367$ABBVIE$$$$E$F$Y$$$20240803$$CN$CA$CA
241650152$24165015$2$F$$20240807$20240802$20240813$EXP$$CA-ROCHE-10000042996$ROCHE$$29$YR$A$M$Y$$$20240813$$MD$CA$CA
241650162$24165016$2$F$$20240828$20240802$20240905$EXP$$US-ROCHE-10000043421$ROCHE$$$$E$F$Y$58.97$KG$20240905$$CN$US$US
241650171$24165017$1$I$$20240729$20240802$20240802$EXP$JP-MMM-IHL8JDSK$JP-GSK-JP2024094733$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$JP$JP
241650181$24165018$1$I$$20240718$20240802$20240802$EXP$$IE-TAKEDA-2024TUS076911$TAKEDA$$$$$M$Y$$$20240802$$MD$IE$IE
241650193$24165019$3$F$20240101$20240819$20240802$20240823$PER$$US-AMGEN-USASP2024152477$AMGEN$$64$YR$A$M$Y$$$20240822$$CN$US$US
241650211$24165021$1$I$20230901$20240725$20240802$20240802$PER$$US-SA-2024SA223567$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240802$$CN$US$US
241650221$24165022$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223514$SANOFI AVENTIS$$$$C$F$Y$15.87$KG$20240802$$MD$US$US
241650231$24165023$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223670$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240802$$MD$US$US
241650241$24165024$1$I$$20240726$20240802$20240802$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-119255$BRISTOL MYERS SQUIBB$Literature citation unavailable$63$YR$A$F$Y$$$20240802$$HP$CA$CA
241650256$24165025$6$F$20240101$20240911$20240802$20240918$EXP$$CA-ABBVIE-5860633$ABBVIE$$48$YR$$M$Y$$$20240918$$CN$CA$CA
241650263$24165026$3$F$20240722$20240903$20240802$20240916$EXP$$JP-ROCHE-10000043777$ROCHE$$8$DEC$E$M$Y$56.6$KG$20240916$$MD$JP$JP
241650271$24165027$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024092304$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241650281$24165028$1$I$$20240727$20240802$20240802$EXP$$BR-TAKEDA-2024TUS076647$TAKEDA$$$$$$Y$$$20240802$$CN$BR$BR
241650291$24165029$1$I$$20240726$20240802$20240802$EXP$$US-AMGEN-USASP2024149715$AMGEN$Bock A.M.; Nowakowsk. G.S.; Mwangi. R. et.al. Defining primary refractory large B cell lymphoma. Blood Advances. 2024;8 (13):3402-3415$$$$$Y$$$20240801$$HP$US$US
241650301$24165030$1$I$$20240729$20240802$20240802$EXP$$US-ABBVIE-5862908$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241650321$24165032$1$I$20240712$20240730$20240802$20240802$EXP$$CN-HALEON-2189766$Haleon PLC$$73$YR$$M$Y$65$KG$20240802$$HP$CN$CN
241650333$24165033$3$F$$20240807$20240802$20240809$PER$$US-AMGEN-USASP2024152784$AMGEN$$$$$M$Y$$$20240809$$CN$US$US
241650341$24165034$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003484$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241650351$24165035$1$I$20240101$20240725$20240802$20240802$EXP$$US-ABBVIE-5854375$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241650361$24165036$1$I$$20240717$20240802$20240802$PER$$US-TEVA-VS-3224220$TEVA$$64$YR$$F$Y$54.88$KG$20240802$$PH$US$US
241650371$24165037$1$I$$20240731$20240802$20240802$EXP$GB-MHRA-MED-202407311601387660-MNDWB$GB-GSK-GB2024095824$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$GB$GB
241650381$24165038$1$I$$20240722$20240802$20240802$EXP$$US-SPC-000466$SOLARIS PHARMA$Jacques L, Kelly B, Soehl J, Wagar M, Rhoades J, Cowley ES, et al. Peripartum Uterine Clostridial Myonecrosis: A Report of Two Fatal Cases. WMJ. 2024 Jul;123(3):213-217.$$$T$F$Y$$$20240801$$MD$US$US
241650392$24165039$2$F$$20240826$20240802$20240829$PER$$US-ROCHE-10000038748$ROCHE$$$$T$M$Y$$$20240829$$HP$US$US
241650401$24165040$1$I$20230918$20230920$20240802$20240802$EXP$$US-AstraZeneca-2023A215152$ASTRAZENECA$$24965$DY$$F$Y$$$20240802$$CN$US$
241650411$24165041$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224374$SANOFI AVENTIS$$$$T$F$Y$61.6$KG$20240802$$MD$US$US
241650421$24165042$1$I$20230315$20230316$20240802$20240802$EXP$$US-AstraZeneca-2023A064171$ASTRAZENECA$$26719$DY$$F$Y$$$20240802$$CN$US$
241650431$24165043$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A171976$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241650441$24165044$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A172204$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241650451$24165045$1$I$20240714$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173332$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241650461$24165046$1$I$$20220719$20240802$20240802$EXP$$AU-AstraZeneca-2022A262224$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$AU$
241650471$24165047$1$I$20240714$20240731$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121665$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$44$KG$20240802$$CN$US$US
241650481$24165048$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003513$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241650491$24165049$1$I$$20240725$20240802$20240802$EXP$$US-ROCHE-10000038298$ROCHE$$64$YR$A$F$Y$$$20240802$$CN$US$US
241650501$24165050$1$I$$20240730$20240802$20240802$EXP$$CA-ABBVIE-5862298$ABBVIE$$$$A$F$Y$$$20240802$$MD$CA$CA
241650511$24165051$1$I$$20240725$20240802$20240802$PER$$US-ALXN-202407USA001748US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240802$$HP$US$US
241650521$24165052$1$I$$20240730$20240802$20240802$EXP$$US-ABBVIE-5862264$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241650531$24165053$1$I$$20240725$20240802$20240802$EXP$$JP-VANTIVE-2024VAN018202$Vantive US Healthcare$$$$$M$Y$$$20240802$$HP$JP$JP
241650541$24165054$1$I$20190604$20240731$20240802$20240802$EXP$$US-TAKEDA-US201918261$TAKEDA$$66$YR$$F$Y$$$20240802$$MD$US$US
241650551$24165055$1$I$20240705$20240726$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407017860$ELI LILLY AND CO$$$$$$Y$$$20240802$$CN$US$US
241650561$24165056$1$I$20240701$20240726$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407018321$ELI LILLY AND CO$$$$$M$Y$$$20240802$$CN$US$US
241650572$24165057$2$F$$20240731$20240802$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202407019035$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240812$$CN$US$US
241650581$24165058$1$I$20070101$20240729$20240802$20240802$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407020027$ELI LILLY AND CO$$59$YR$A$F$Y$62.5$KG$20240802$$CN$CN$CN
241650591$24165059$1$I$20240717$20240727$20240802$20240802$EXP$GB-MHRA-MED-202407271748259760-MWCVR$GB-ELI_LILLY_AND_COMPANY-GB202407018193$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240802$$CN$GB$GB
241650601$24165060$1$I$20240615$20240720$20240802$20240802$EXP$GB-MHRA-MED-202407201835583080-NMCRD$GB-ELI_LILLY_AND_COMPANY-GB202407013678$ELI LILLY AND CO$$31$YR$A$F$Y$97$KG$20240802$$CN$GB$GB
241650611$24165061$1$I$20240101$20240726$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017976$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240802$$CN$US$US
241650621$24165062$1$I$$20240723$20240802$20240802$EXP$$GB-JUBILANT CADISTA PHARMACEUTICALS-2024GB001074$JUBILANT$Timmons P, Williamson A, Gibbs V, Torgersen A. Weak legs. Acute medicine. 2022;21(3):153-6$48$YR$$F$Y$$$20240802$$MD$GB$GB
241650631$24165063$1$I$20240710$20240722$20240802$20240802$EXP$GB-MHRA-MED-202407221710403620-ZPDQF$GB-JUBILANT PHARMA LTD-2024GB001078$JUBILANT$$$$A$M$Y$$$20240802$$HP$GB$GB
241650641$24165064$1$I$20230223$20240730$20240802$20240802$EXP$$ZA-SANDOZ INC.-NVSC2023ZA042992$SANDOZ$$68$YR$$F$Y$102.2$KG$20240802$$MD$ZA$ZA
241650651$24165065$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152021$AMGEN$$$$A$F$Y$$$20240801$$CN$US$US
241650661$24165066$1$I$20240628$20240722$20240802$20240802$EXP$$US-ROCHE-10000033976$ROCHE$$77$YR$E$F$Y$$$20240802$$HP$US$US
241650672$24165067$2$F$$20240906$20240802$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003473$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241650681$24165068$1$I$20240729$20240729$20240802$20240802$EXP$$US-ABBVIE-5862128$ABBVIE$$75$YR$$F$Y$$$20240802$$CN$US$US
241650692$24165069$2$F$$20240911$20240802$20240917$EXP$$CA-ABBVIE-5862777$ABBVIE$$$$A$F$Y$$$20240917$$MD$CA$CA
241650701$24165070$1$I$20240723$20240726$20240802$20240802$30DAY$$US-GSK-US2024094272$GLAXOSMITHKLINE$$$$E$F$Y$$$20240802$$CN$US$US
241650713$24165071$3$F$$20240826$20240802$20240826$PER$$US-ALXN-202407USA001960US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241650721$24165072$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152175$AMGEN$$$$A$F$Y$$$20240801$$HP$US$US
241650731$24165073$1$I$$20240730$20240802$20240802$30DAY$$US-SANDOZ INC.-NVSC2021US042019$SANDOZ$$$$$M$Y$$$20240802$$CN$US$US
241650741$24165074$1$I$20240706$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152275$AMGEN$$79$YR$E$M$Y$$$20240801$$CN$US$US
241650751$24165075$1$I$$20240726$20240802$20240802$PER$$US-AMGEN-USASP2024151631$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241650761$24165076$1$I$20240101$20240730$20240802$20240802$EXP$$US-JNJFOC-20240782586$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240802$$CN$US$US
241650772$24165077$2$F$$20240830$20240802$20240905$EXP$$US-JNJFOC-20240773007$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$US$US
241650781$24165078$1$I$$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173667$ASTRAZENECA$$$$$$Y$$$20240802$$MD$US$
241650792$24165079$2$F$20240730$20240823$20240802$20240831$PER$$US-AstraZeneca-2024A175161$ASTRAZENECA$$20209$DY$$F$Y$$$20240831$$CN$US$
241650801$24165080$1$I$20240703$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A174533$ASTRAZENECA$$26127$DY$$M$Y$$$20240802$$CN$US$
241650811$24165081$1$I$$20210922$20240802$20240802$EXP$$GB-AstraZeneca-2021A736414$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$GB$
241650821$24165082$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003475$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241650831$24165083$1$I$$20240725$20240802$20240802$EXP$$JP-ROCHE-10000046518$ROCHE$$8$DEC$E$F$Y$$$20240802$$MD$JP$JP
241650841$24165084$1$I$$20240731$20240802$20240802$PER$$NVSC2024US157067$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241650852$24165085$2$F$$20240731$20240802$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003693$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
241650871$24165087$1$I$$20220512$20240802$20240802$EXP$$US-AstraZeneca-2022A184861$ASTRAZENECA$$$$$M$Y$61.9$KG$20240802$$HP$US$
241650881$24165088$1$I$$20240722$20240802$20240802$EXP$$US-NOVOPROD-1261080$NOVO NORDISK$$$$$M$Y$$$20240802$$CN$US$US
241650891$24165089$1$I$20240716$20240722$20240802$20240802$EXP$$US-NOVOPROD-1260651$NOVO NORDISK$$72$YR$$M$Y$$$20240802$$CN$US$US
241650901$24165090$1$I$20240201$20240722$20240802$20240802$EXP$$US-NOVOPROD-1260681$NOVO NORDISK$$69$YR$$F$Y$$$20240802$$CN$US$US
241650911$24165091$1$I$20230117$20240722$20240802$20240802$EXP$$US-NOVOPROD-1260615$NOVO NORDISK$$71$YR$$M$Y$$$20240802$$CN$US$US
241650921$24165092$1$I$20240101$20240722$20240802$20240802$EXP$$US-NOVOPROD-1260976$NOVO NORDISK$$77$YR$$F$Y$$$20240802$$CN$US$US
241650931$24165093$1$I$20200101$20240722$20240802$20240802$EXP$$US-NOVOPROD-1260761$NOVO NORDISK$$40$YR$$F$Y$$$20240802$$CN$US$US
241650941$24165094$1$I$$20240722$20240802$20240802$EXP$$US-NOVOPROD-1260700$NOVO NORDISK$$59$YR$$M$Y$$$20240802$$PH$US$US
241650952$24165095$2$F$20230801$20240806$20240802$20240910$EXP$$US-NOVOPROD-1260654$NOVO NORDISK$$73$YR$$F$Y$$$20240910$$CN$US$US
241650961$24165096$1$I$20240401$20240722$20240802$20240802$EXP$$US-NOVOPROD-1260645$NOVO NORDISK$$49$YR$$F$Y$$$20240802$$CN$US$US
241650971$24165097$1$I$$20240722$20240802$20240802$EXP$$US-NOVOPROD-1260703$NOVO NORDISK$$$$$F$Y$$$20240802$$HP$US$US
241650981$24165098$1$I$20240713$20240722$20240802$20240802$EXP$ES-AEMPS-1552322$ES-NOVOPROD-1260177$NOVO NORDISK$$58$YR$$F$Y$95$KG$20240802$$MD$ES$ES
241650991$24165099$1$I$$20240722$20240802$20240802$EXP$$US-NOVOPROD-1260996$NOVO NORDISK$$$$$F$Y$$$20240802$$CN$US$US
241651001$24165100$1$I$$20240722$20240802$20240802$EXP$$US-NOVOPROD-1260975$NOVO NORDISK$$$$$$Y$$$20240802$$CN$US$US
241651011$24165101$1$I$$20240722$20240802$20240802$EXP$$JP-NOVOPROD-1246382$NOVO NORDISK$$$$$M$Y$$$20240802$$HP$JP$JP
241651023$24165102$3$F$20240616$20240816$20240802$20240828$EXP$$DE-NOVOPROD-1246990$NOVO NORDISK$$75$YR$$M$Y$81.5$KG$20240828$$CN$DE$DE
241651031$24165103$1$I$20240722$20240722$20240802$20240802$EXP$$GB-NOVOPROD-1259243$NOVO NORDISK$$48$YR$$M$Y$115$KG$20240802$$MD$GB$GB
241651041$24165104$1$I$$20240722$20240802$20240802$EXP$$JP-NOVOPROD-1260784$NOVO NORDISK$$78$YR$$M$Y$$$20240802$$PH$JP$JP
241651051$24165105$1$I$20240717$20240722$20240802$20240802$EXP$GB-MHRA-MED-202407221636404560-DNLVZ$GB-NOVOPROD-1259246$NOVO NORDISK$$64$YR$$F$Y$$$20240802$$PH$GB$GB
241651061$24165106$1$I$$20240722$20240802$20240802$EXP$$US-NOVOPROD-1260729$NOVO NORDISK$$$$$M$Y$$$20240802$$CN$US$US
241651071$24165107$1$I$$20240724$20240802$20240802$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024092792$VIIV$$$$$M$Y$$$20240802$$MD$US$US
241651081$24165108$1$I$20240711$20240725$20240802$20240802$EXP$$CN-BEIGENE-BGN-2024-011599$BEIGENE$$$$$$Y$$$20240802$$HP$CN$CN
241651091$24165109$1$I$20240529$20240724$20240802$20240802$EXP$$JP-ROCHE-10000003692$ROCHE$$66$YR$E$F$Y$44.8$KG$20240802$$MD$JP$JP
241651101$24165110$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003476$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241651111$24165111$1$I$20240708$20240724$20240802$20240802$EXP$$CN-BEIGENE-BGN-2024-011514$BEIGENE$$$$$$Y$$$20240802$$HP$CN$CN
241651121$24165112$1$I$$20240723$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407015994$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240802$$CN$US$US
241651131$24165113$1$I$20240731$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000166$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240802$$CN$US$US
241651141$24165114$1$I$$20240721$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407015060$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240802$$CN$US$US
241651152$24165115$2$F$$20240725$20240802$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407009155$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240808$$CN$US$US
241651161$24165116$1$I$$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024150729$AMGEN$$$$$F$Y$$$20240801$$CN$US$US
241651171$24165117$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003478$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241651181$24165118$1$I$$20240730$20240802$20240802$EXP$$CA-ABBVIE-5862317$ABBVIE$$$$A$F$Y$$$20240802$$CN$CA$CA
241651191$24165119$1$I$20240722$20240724$20240802$20240802$EXP$$GB-TEVA-VS-3225771$TEVA$$58$YR$$F$Y$81$KG$20240802$$HP$GB$GB
241651202$24165120$2$F$20240629$20240729$20240802$20240805$PER$$US-SA-2024SA223936$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240805$$MD$US$US
241651211$24165121$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223949$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240802$$MD$US$US
241651221$24165122$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223714$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240802$$CN$US$US
241651231$24165123$1$I$20200101$20240724$20240802$20240802$PER$$US-SA-2024SA224185$SANOFI AVENTIS$$14$YR$T$F$Y$58.96$KG$20240802$$MD$US$US
241651242$24165124$2$F$20240724$20240903$20240802$20240912$PER$$US-SA-2024SA224049$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240912$$MD$US$US
241651251$24165125$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA221676$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240802$$HP$US$US
241651261$24165126$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223821$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240802$$MD$US$US
241651272$24165127$2$F$20240101$20240809$20240802$20240820$PER$$US-SA-2024SA223761$SANOFI AVENTIS$$40$YR$A$F$Y$109.76$KG$20240820$$MD$US$US
241651282$24165128$2$F$$20240904$20240802$20240911$EXP$$US-GSK-US2024094185$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$US$US
241651292$24165129$2$F$20240801$20240823$20240802$20240917$PER$$US-SA-2024SA224389$SANOFI AVENTIS$$$$A$F$Y$66.67$KG$20240918$$MD$US$US
241651301$24165130$1$I$20230101$20240730$20240802$20240802$EXP$$CA-ABBVIE-5861799$ABBVIE$$$$E$F$Y$$$20240802$$CN$CA$CA
241651311$24165131$1$I$20240624$20240730$20240802$20240802$EXP$$CO-AstraZeneca-2024A174336$ASTRAZENECA$$27705$DY$$M$Y$$$20240802$$CN$CO$
241651322$24165132$2$F$$20240725$20240802$20240927$PER$$US-TEVA-VS-3225324$TEVA$$61$YR$$$Y$$$20240927$$HP$US$US
241651332$24165133$2$F$20240621$20240916$20240802$20240918$EXP$$US-AstraZeneca-2024A173440$ASTRAZENECA$$27311$DY$$M$Y$$$20240918$$CN$US$
241651341$24165134$1$I$$20240731$20240802$20240802$EXP$$NVSJ2024JP009317$NOVARTIS$$$$$$Y$$$20240802$$MD$JP$JP
241651353$24165135$3$F$20240101$20240904$20240802$20240908$EXP$$CA-ABBVIE-5862621$ABBVIE$$76$YR$$M$Y$$$20240908$$CN$CA$CA
241651361$24165136$1$I$$20240730$20240802$20240802$EXP$$US-GSK-US2024095372$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$US$US
241651371$24165137$1$I$$20240726$20240802$20240802$EXP$$US-ROCHE-10000040442$ROCHE$$$$A$F$Y$$$20240802$$CN$US$US
241651382$24165138$2$F$20240516$20240827$20240802$20240830$EXP$$CA-ABBVIE-5862923$ABBVIE$$70$YR$$M$Y$$$20240830$$HP$CA$CA
241651391$24165139$1$I$20240701$20240725$20240802$20240802$EXP$$US-009507513-2407USA013896$MERCK$$96$YR$$F$Y$$$20240802$$CN$US$US
241651401$24165140$1$I$$20240726$20240802$20240802$EXP$$NVSC2024US154492$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
241651412$24165141$2$F$$20240803$20240802$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003480$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241651421$24165142$1$I$$20240722$20240802$20240802$EXP$$IT-Encube-000844$ENCUBE ETHICALS$Pigni S, Cristofolini G, Jaafar S, Maida G, Grossrubatscher E, Dalino P, Carioni E, Mazziotti G, Lania A, Zampetti B, Chiodini I. Late-onset Schmidt^s Syndrome Presenting with Severe Hyponatremia: A Case Report. Endocr Metab Immune Disord Drug Targets. 2024 Jul 15. doi: 10.2174/0118715303323053240611075428. Epub ahead of print. PMID: 39021176.$73$YR$E$F$Y$$$20240730$$MD$IT$
241651431$24165143$1$I$$20240725$20240802$20240802$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2159911$Chengdu Suncadia Medicine$Clinical analysis of 14 pregnancies in women with renal transplant.$35$YR$$F$Y$$$20240802$$MD$CN$CN
241651441$24165144$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003425$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$HP$US$US
241651451$24165145$1$I$$20240730$20240802$20240802$EXP$$US-JNJFOC-20240800261$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$CN$US$US
241651462$24165146$2$F$20240201$20240805$20240802$20240812$PER$$US-ABBVIE-5855463$ABBVIE$$19$YR$$F$Y$77$KG$20240812$$CN$US$US
241651475$24165147$5$F$20240719$20240813$20240802$20240822$30DAY$$JP-JNJFOC-20240759547$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$41.5$KG$20240822$$PH$JP$JP
241651481$24165148$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024092402$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$CN$US$US
241651492$24165149$2$F$$20240815$20240802$20240829$EXP$$US-VIIV HEALTHCARE LIMITED-US2024092945$VIIV$$$$$M$Y$74.84$KG$20240829$$HP$US$US
241651501$24165150$1$I$$20240726$20240802$20240802$PER$$US-JNJFOC-20240776188$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$CN$US$US
241651511$24165151$1$I$20240502$20240711$20240802$20240802$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003481$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240802$$CN$US$US
241651521$24165152$1$I$$20240723$20240802$20240802$EXP$$US-TWI PHARMACEUTICAL, INC-20240700048$TWI PHARMACEUTICALS$Bajwa N.A.; Bajwa A.A.; Ghazala S.; Masood U.. Dimethyl Fumarate-Associated Enterocolitis. Am. J. Ther.. 2024;31:4:e448-e450$38$YR$$F$Y$$$20240731$$$US$US
241651531$24165153$1$I$20210101$20240726$20240802$20240802$EXP$$US-ABBVIE-5856754$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241651542$24165154$2$F$20240701$20240808$20240802$20240813$EXP$$US-GSK-US2024AMR093043$GLAXOSMITHKLINE$$40$YR$$F$Y$$$20240813$$CN$US$US
241651551$24165155$1$I$20240701$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151628$AMGEN$$$$$$Y$$$20240801$$CN$US$US
241651571$24165157$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003485$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241651581$24165158$1$I$$20240723$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407015721$ELI LILLY AND CO$$55$YR$A$$Y$$$20240802$$LW$US$US
241651591$24165159$1$I$$20240729$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407018757$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241651601$24165160$1$I$20240515$20240722$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-036891$AUROBINDO$$31$YR$$F$Y$90$KG$20240802$$CN$GB$GB
241651611$24165161$1$I$20240712$20240801$20240802$20240802$EXP$FR-AFSSAPS-LY2024001115$NVSC2024FR157126$NOVARTIS$$69$YR$$M$Y$73$KG$20240802$$PH$FR$FR
241651621$24165162$1$I$20240729$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019596$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240802$$CN$US$US
241651631$24165163$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000449$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240802$$CN$US$US
241651642$24165164$2$F$$20240821$20240802$20240821$PER$$US-ALXN-202407USA001875US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240821$$MD$US$US
241651652$24165165$2$F$20240615$20240813$20240802$20240817$PER$$US-AMGEN-USASP2024152188$AMGEN$$50$YR$A$F$Y$$$20240816$$CN$US$US
241651661$24165166$1$I$$20240722$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407015038$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240802$$HP$US$US
241651671$24165167$1$I$$20240725$20240802$20240802$PER$$US-AMGEN-USASP2024152773$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240801$$MD$US$US
241651681$24165168$1$I$20240717$20240726$20240802$20240802$EXP$$CO-UCBSA-2024038649$UCB$$90$YR$$F$Y$$$20240802$$CN$CO$CO
241651691$24165169$1$I$20240725$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024150956$AMGEN$$80$YR$E$M$Y$$$20240801$$PH$US$US
241651701$24165170$1$I$20150901$20231120$20240802$20240802$EXP$$CA-GLAXOSMITHKLINE-JNJFOC-20150923105$Haleon PLC$$44$YR$$F$Y$68$KG$20240801$$CN$CA$CA
241651711$24165171$1$I$$20240722$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-036560$AUROBINDO$Al?s-palmer ML, And?jar-vera F, Mu?oz-de-rueda P, Iglesias-baena I, Ocete-hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. International Journal of Molecular Sciences. 2023;24:1-17$5$YR$$M$Y$$$20240802$$HP$ES$ES
241651721$24165172$1$I$$20240728$20240802$20240802$EXP$$DE-JNJFOC-20240777226$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$PH$DE$DE
241651731$24165173$1$I$$20240724$20240802$20240802$EXP$$US-JNJFOC-20240770323$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240802$$MD$US$US
241651741$24165174$1$I$$20240725$20240802$20240802$EXP$$CA-SA-2024SA220659$SANOFI AVENTIS$$$$$F$Y$$$20240802$$HP$CA$CA
241651751$24165175$1$I$20240101$20240731$20240802$20240802$EXP$$US-ABBVIE-5862824$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241651761$24165176$1$I$$20240730$20240802$20240802$EXP$$AU-ROCHE-10000042750$ROCHE$$22$YR$A$F$Y$$$20240802$$MD$AU$AU
241651771$24165177$1$I$20240523$20240729$20240802$20240802$PER$$NVSC2024US157507$NOVARTIS$$$$$M$Y$$$20240802$$CN$US$US
241651782$24165178$2$F$20240201$20240730$20240802$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011619$JAZZ$$39$YR$$F$Y$$$20240808$$CN$US$US
241651791$24165179$1$I$$20240723$20240802$20240802$PER$$US-ROCHE-10000034834$ROCHE$$68$YR$E$F$Y$$$20240802$$CN$US$US
241651801$24165180$1$I$20240719$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A174493$ASTRAZENECA$$32999$DY$$M$Y$$$20240802$$CN$US$
241651811$24165181$1$I$$20240728$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120474$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240802$$CN$US$US
241651821$24165182$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151620$AMGEN$$$$$M$Y$$$20240801$$CN$US$US
241651833$24165183$3$F$20240724$20240830$20240802$20240906$PER$$US-ROCHE-10000037077$ROCHE$$54$YR$A$F$Y$$$20240906$$CN$US$US
241651851$24165185$1$I$20240727$20240730$20240802$20240802$EXP$$CA-ABBVIE-5862306$ABBVIE$$52$YR$$$Y$$$20240802$$HP$CA$CA
241651861$24165186$1$I$$20240731$20240802$20240802$PER$$NVSC2024US157429$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
241651871$24165187$1$I$$20240725$20240802$20240802$PER$$US-AMGEN-USASP2024152735$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240801$$MD$US$US
241651891$24165189$1$I$$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037034$AUROBINDO$$87$YR$$F$Y$$$20240802$$PH$GB$GB
241651901$24165190$1$I$20240726$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000104$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240802$$CN$US$US
241651911$24165191$1$I$20240731$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000172$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240802$$CN$US$US
241651921$24165192$1$I$20240622$20240729$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120298$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240802$$HP$US$US
241651931$24165193$1$I$$20240726$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119158$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240802$$HP$US$US
241651941$24165194$1$I$20240727$20240729$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019472$ELI LILLY AND CO$$64$YR$E$F$Y$$$20240802$$CN$US$US
241651951$24165195$1$I$20240711$20240729$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120720$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240802$$CN$US$US
241651962$24165196$2$F$20240601$20240916$20240802$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116940$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240920$$HP$US$US
241651971$24165197$1$I$20240712$20240729$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120362$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$67.13$KG$20240802$$PH$US$US
241651982$24165198$2$F$20240729$20240819$20240802$20240823$PER$$US-ROCHE-10000041916$ROCHE$$63$YR$A$F$Y$$$20240823$$CN$US$US
241651991$24165199$1$I$20240723$20240723$20240802$20240802$30DAY$$US-GSK-US2024092405$GLAXOSMITHKLINE$$24$YR$$F$Y$$$20240802$$CN$US$US
241652001$24165200$1$I$$20240724$20240802$20240802$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01437$NOVITIUM PHARMA$Muggeo Paola.Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports.Journal of Pediatric Hematology/Oncology.AUG 2024;46(6):e439-e442$15$YR$T$M$Y$$$20240802$$HP$IT$IT
241652012$24165201$2$F$20240724$20240813$20240802$20240819$PER$$US-ALXN-202407USA001963US$ALEXION PHARMACEUTICALS$$54$YR$$F$Y$53.07$KG$20240819$$CN$US$US
241652021$24165202$1$I$$20240729$20240802$20240802$EXP$$CA-JNJFOC-20240784565$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240802$$HP$CA$CA
241652031$24165203$1$I$$20240726$20240802$20240802$EXP$$NVSC2024HK134456$NOVARTIS$$63$YR$$$Y$$$20240802$$MD$HK$HK
241652041$24165204$1$I$$20240725$20240802$20240802$PER$$US-AMGEN-USASP2024153035$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240801$$MD$US$US
241652051$24165205$1$I$$20240726$20240802$20240802$EXP$$DE-EMD Serono-2024040992$EMD SERONO INC$$$$E$F$Y$$$20240802$$CN$DE$DE
241652061$24165206$1$I$20231214$20240726$20240802$20240802$EXP$FR-AFSSAPS-LY2024000209$FR-RDY-SPO/FRA/24/0002617$DR REDDYS$$62$YR$A$F$Y$57$KG$20240802$$HP$FR$FR
241652071$24165207$1$I$$20240724$20240802$20240802$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023014$UNITED THERAPEUTICS$$$$$F$Y$70.295$KG$20240802$$$US$US
241652081$24165208$1$I$$20240724$20240802$20240802$30DAY$$US-GSK-US2024AMR093941$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$CN$US$US
241652101$24165210$1$I$$20240726$20240802$20240802$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004055$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241652111$24165211$1$I$20240101$20240730$20240802$20240802$EXP$$US-ABBVIE-5862895$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241652121$24165212$1$I$$20240731$20240802$20240802$EXP$$US-AstraZeneca-2024A174443$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241652131$24165213$1$I$$20220412$20240802$20240802$EXP$$US-AstraZeneca-2022A149419$ASTRAZENECA$$$$$M$Y$$$20240802$$HP$US$
241652141$24165214$1$I$20240323$20240724$20240802$20240802$EXP$IT-MINISAL02-994382$IT-ROCHE-10000036418$ROCHE$$62$YR$A$F$Y$$$20240802$$MD$IT$IT
241652153$24165215$3$F$20240716$20240815$20240802$20240827$PER$$US-SA-2024SA222527$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240827$$MD$US$US
241652161$24165216$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA221885$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240802$$MD$US$US
241652173$24165217$3$F$20240101$20240812$20240802$20240819$PER$$US-SA-2024SA224514$SANOFI AVENTIS$$73$YR$E$M$Y$95.61$KG$20240819$$MD$US$US
241652182$24165218$2$F$$20240729$20240802$20240807$PER$$US-SA-2024SA223783$SANOFI AVENTIS$$$$$F$Y$$$20240807$$CN$US$US
241652191$24165219$1$I$$20240723$20240802$20240802$EXP$$US-BSC-2024000078$BOSTON SCIENTIFIC$$$$$F$Y$$$20240802$$MD$US$US
241652201$24165220$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA222770$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240802$$MD$US$US
241652211$24165221$1$I$20240730$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151630$AMGEN$$75$YR$E$F$Y$$$20240801$$CN$US$US
241652221$24165222$1$I$$20240726$20240802$20240802$PER$$US-ALXN-202407USA001944US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241652231$24165223$1$I$$20240724$20240802$20240802$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01455$NOVITIUM PHARMA$Muggeo Paola.Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports.Journal of Pediatric Hematology/Oncology.AUG 2024;46(6):e439-e442$13$YR$T$M$Y$$$20240802$$HP$IT$IT
241652241$24165224$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122197$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240802$$CN$US$US
241652251$24165225$1$I$$20240724$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20191201392$BRISTOL MYERS SQUIBB$Sinit RB, Hwang DG, Vishnu P, Peterson JF, Aboulafia DM. B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review. BMC Cancer. 2019 Nov 27;19(1): 1-9. doi:10.1186/s12885-019-6286-9.$67$YR$E$M$Y$$$20240802$$HP$US$US
241652273$24165227$3$F$$20240909$20240802$20240927$PER$$US-TEVA-VS-3226410$TEVA$$85$YR$$F$Y$158$KG$20240927$$CN$US$US
241652281$24165228$1$I$$20240718$20240802$20240802$EXP$$IN-Nuvo Pharmaceuticals Inc-2159912$NUVO PHARMACEUTICALS$Source document (Abstract)$74$YR$$F$Y$$$20240802$$$IN$IN
241652291$24165229$1$I$20240729$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024150287$AMGEN$$64$YR$A$M$Y$$$20240801$$CN$US$US
241652301$24165230$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152194$AMGEN$$$$$$Y$$$20240801$$CN$US$US
241652311$24165231$1$I$$20240726$20240802$20240802$PER$$US-EMD Serono-2024040771$EMD SERONO INC$$67$YR$E$F$Y$$$20240802$$CN$US$US
241652321$24165232$1$I$20240730$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000575$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240802$$CN$US$US
241652331$24165233$1$I$20240731$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000547$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240802$$CN$US$US
241652341$24165234$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000105$ELI LILLY AND CO$$47$YR$A$$Y$$$20240802$$CN$US$US
241652351$24165235$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000467$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241652361$24165236$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000517$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240802$$CN$US$US
241652371$24165237$1$I$20240730$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000225$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240802$$CN$US$US
241652381$24165238$1$I$$20240725$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119666$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240802$$CN$US$US
241652391$24165239$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003463$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241652401$24165240$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003451$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241652412$24165241$2$F$$20240808$20240802$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003462$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
241652421$24165242$1$I$$20240711$20240802$20240802$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003461$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$HP$US$US
241652431$24165243$1$I$20240708$20240711$20240802$20240802$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003448$ACADIA PHARMACEUTICALS$$18$YR$$F$Y$$$20240802$$CN$US$US
241652443$24165244$3$F$20240905$20240906$20240802$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003449$ACADIA PHARMACEUTICALS$$5$YR$$F$Y$$$20240927$$CN$US$US
241652453$24165245$3$F$$20240829$20240802$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003464$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
241652463$24165246$3$F$20240701$20240918$20240802$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003446$ACADIA PHARMACEUTICALS$$42$YR$$F$Y$$$20240927$$CN$US$US
241652471$24165247$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003440$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$HP$US$US
241652481$24165248$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152049$AMGEN$$$$$$Y$$$20240801$$PH$US$US
241652491$24165249$1$I$20240101$20240725$20240802$20240802$EXP$$BR-EMD Serono-2024040913$EMD SERONO INC$$75$YR$E$F$Y$$$20240802$$CN$BR$BR
241652501$24165250$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003518$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241652512$24165251$2$F$$20240718$20240802$20240831$PER$$US-TEVA-VS-3222780$TEVA$$$$$$Y$$$20240831$$HP$US$US
241652522$24165252$2$F$$20240819$20240802$20240821$30DAY$$US-UCBSA-2024037191$UCB$$$$$F$Y$$$20240821$$CN$US$US
241652531$24165253$1$I$$20240724$20240802$20240802$30DAY$$US-GSK-US2024092976$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241652541$24165254$1$I$$20240724$20240802$20240802$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01438$NOVITIUM PHARMA$Osamu Imataki.Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus.International Journal of Hematology.26-MAY-2024;120:1-2$58$YR$A$M$Y$$$20240802$$HP$JP$JP
241652551$24165255$1$I$20240601$20240731$20240802$20240802$EXP$GB-MHRA-MED-202407311036069820-JWVBQ$GB-GSK-GB2024095635$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$GB$GB
241652562$24165256$2$F$20240701$20240731$20240802$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023644$UNITED THERAPEUTICS$$53$YR$$F$Y$72.562$KG$20240809$$$US$US
241652571$24165257$1$I$$20240730$20240802$20240802$EXP$$GB-ABBVIE-5862249$ABBVIE$$40$YR$$M$Y$$$20240802$$CN$GB$GB
241652581$24165258$1$I$$20211210$20240802$20240802$EXP$$US-AstraZeneca-2021A872645$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241652591$24165259$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A137020$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241652601$24165260$1$I$$20220415$20240802$20240802$EXP$$US-AstraZeneca-2022A153700$ASTRAZENECA$$$$$F$Y$71.2$KG$20240802$$CN$US$
241652611$24165261$1$I$20231128$20240729$20240802$20240802$EXP$$US-SA-2024SA226555$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240802$$MD$US$US
241652622$24165262$2$F$$20240822$20240802$20240828$30DAY$$AU-JNJFOC-20240726952$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$CN$AU$AU
241652631$24165263$1$I$$20240725$20240802$20240802$PER$$US-ALXN-202407USA001848US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241652643$24165264$3$F$20240701$20240827$20240802$20240830$PER$$US-ALXN-202407USA001941US$ALEXION PHARMACEUTICALS$$49$YR$$F$Y$$$20240830$$CN$US$US
241652651$24165265$1$I$$20240711$20240802$20240802$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003519$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241652671$24165267$1$I$$20240731$20240802$20240802$PER$$US-TAKEDA-2024TUS077315$TAKEDA$$$$$F$Y$63$KG$20240802$$MD$US$US
241652681$24165268$1$I$20240708$20240723$20240802$20240802$EXP$$CN-ROCHE-10000034547$ROCHE$$51$YR$A$F$Y$60$KG$20240802$$HP$CN$CN
241652691$24165269$1$I$$20240731$20240802$20240802$EXP$$CA-SANDOZ INC.-SDZ2023CA076650$SANDOZ$$$$$F$Y$$$20240802$$HP$CA$CA
241652701$24165270$1$I$20240729$20240730$20240802$20240802$PER$$US-HALEON-2189755$Haleon PLC$$$$$F$Y$$$20240802$$CN$US$US
241652712$24165271$2$F$$20240805$20240802$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003520$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
241652721$24165272$1$I$20240723$20240729$20240802$20240802$30DAY$$US-GSK-US2024094783$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240802$$CN$US$US
241652732$24165273$2$F$$20240808$20240802$20240822$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16457$ALKEM$$$$$M$Y$$$20240822$$CN$US$US
241652741$24165274$1$I$20220601$20240719$20240802$20240802$EXP$CN-MLMSERVICE-20240628-PI115738-00232-1$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-15282$ALKEM$Luo S, Yan P, Wang X, Ren X, Sun K, Guo L, Lv J, Su X, Zhao K, Chen J, Wang R.. Talaromyces marneffei: A challenging diagnosis in a kidney transplant patient. Clinical Case Reports. 2024;12(7):e9028$68$YR$$M$Y$$$20240802$$MD$CN$CN
241652751$24165275$1$I$20240705$20240721$20240802$20240802$EXP$GB-MHRA-MED-202407181411456990-GQPDN$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17051$ALKEM$$77$YR$$M$Y$71$KG$20240802$$CN$GB$GB
241652761$24165276$1$I$20240710$20240721$20240802$20240802$EXP$GB-MHRA-TPP27416045C6161826YC1720603307953$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-16703$ALKEM$$39$YR$$F$Y$111$KG$20240802$$MD$GB$GB
241652772$24165277$2$F$$20240806$20240802$20240821$PER$$US-GRANULES-US-2024GRASPO00305$GRANULES INDIA$$$$$M$Y$$$20240821$$CN$US$US
241652781$24165278$1$I$20240201$20240721$20240802$20240802$EXP$GB-MHRA-MED-202407181443113020-RYQDH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-16700$ALKEM$$70$YR$$M$Y$89$KG$20240802$$CN$GB$GB
241652792$24165279$2$F$20240717$20240812$20240802$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-037475$AUROBINDO$$47$YR$$M$Y$117.93$KG$20240823$$CN$US$US
241652801$24165280$1$I$20240401$20240726$20240802$20240802$EXP$$GT-JNJFOC-20240773940$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$HP$GT$GT
241652812$24165281$2$F$20240201$20240902$20240802$20240906$EXP$$SK-JNJFOC-20240773270$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240906$$MD$SK$SK
241652823$24165282$3$F$$20240802$20240802$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122082$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240807$$CN$US$US
241652833$24165283$3$F$$20240813$20240802$20240819$PER$$US-LEO Pharma-372414$LEO PHARM$$81$YR$$F$Y$$$20240819$$HP$US$US
241652841$24165284$1$I$$20240718$20240802$20240802$PER$$US-TEVA-VS-3225094$TEVA$$74$YR$$F$Y$45.4$KG$20240802$$PH$US$US
241652851$24165285$1$I$$20240729$20240802$20240802$EXP$$DE-009507513-2407DEU016132$MERCK$$$$$F$Y$$$20240802$$MD$DE$DE
241652861$24165286$1$I$20240729$20240729$20240802$20240802$EXP$$US-BIOGEN-2024BI01276019$BIOGEN$$46$YR$$F$Y$$$20240802$$MD$US$US
241652871$24165287$1$I$$20240729$20240802$20240802$EXP$$US-BIOGEN-2024BI01275914$BIOGEN$$$$C$$Y$$$20240802$$MD$US$US
241652881$24165288$1$I$$20240729$20240802$20240802$EXP$$US-BIOGEN-2024BI01274725$BIOGEN$$$$$F$Y$$$20240802$$HP$US$US
241652891$24165289$1$I$20240419$20240722$20240802$20240802$EXP$$US-BAXTER-2024BAX017920$BAXTER$$63$YR$$F$Y$$$20240802$$PH$US$US
241652901$24165290$1$I$20200602$20240722$20240802$20240802$EXP$$DE-BAXTER-2024BAX022193$BAXTER$$$$$$Y$$$20240802$$MD$DE$DE
241652911$24165291$1$I$$20240723$20240802$20240802$EXP$GB-MHRA-30755771$GB-BAXTER-2024BAX022173$BAXTER$$87$YR$$F$Y$$$20240802$$PH$GB$GB
241652921$24165292$1$I$20240508$20240722$20240802$20240802$EXP$FR-AFSSAPS-PP2024000797$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110210$ZYDUS PHARM$$$$$$Y$$$20240802$$MD$FR$FR
241652931$24165293$1$I$$20240725$20240802$20240802$EXP$$BR-TAKEDA-BR202031613$TAKEDA$$$$$$Y$$$20240802$$CN$BR$BR
241652943$24165294$3$F$20180815$20240827$20240802$20240905$EXP$$AT-BAXTER-2024BAX022181$BAXTER$$37$YR$$F$Y$$$20240905$$MD$AT$AT
241652952$24165295$2$F$$20240816$20240802$20240826$30DAY$$US-GSK-US2024093760$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
241652961$24165296$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024092396$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$CN$US$US
241652971$24165297$1$I$$20240726$20240802$20240802$30DAY$$US-GSK-US2024094286$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241652981$24165298$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003522$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241652991$24165299$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152240$AMGEN$$$$$$Y$$$20240801$$HP$US$US
241653001$24165300$1$I$$20240730$20240802$20240802$PER$$US-LEO Pharma-372426$LEO PHARM$$21$YR$$F$Y$$$20240802$$CN$US$US
241653012$24165301$2$F$$20240905$20240802$20240916$30DAY$$KR-JNJFOC-20240784767$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$KR$KR
241653022$24165302$2$F$$20240802$20240802$20240807$EXP$$US-BIOGEN-2024BI01275324$BIOGEN$$$$$M$Y$$$20240807$$CN$US$US
241653031$24165303$1$I$$20240729$20240802$20240802$EXP$$US-BIOGEN-2024BI01275909$BIOGEN$$$$T$$Y$$$20240802$$MD$US$US
241653041$24165304$1$I$$20240729$20240802$20240802$EXP$$US-BIOGEN-2024BI01275907$BIOGEN$$$$C$$Y$$$20240802$$MD$US$US
241653052$24165305$2$F$$20240801$20240802$20240806$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043424$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240806$$CN$US$US
241653061$24165306$1$I$$20240726$20240802$20240802$PER$$US-ALXN-202407USA001997US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241653081$24165308$1$I$20240721$20240723$20240802$20240802$30DAY$$US-GSK-US2024091964$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240802$$CN$US$US
241653092$24165309$2$F$20240701$20240730$20240802$20240819$PER$$US-TEVA-VS-3228248$TEVA$$74$YR$$M$Y$$$20240819$$CN$US$US
241653101$24165310$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037755$AUROBINDO$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clin-Toxicol-(Phila). 2024;62(5):296-302$18$YR$$F$Y$$$20240802$$HP$US$US
241653111$24165311$1$I$20240731$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000479$ELI LILLY AND CO$$26$YR$A$M$Y$$$20240802$$CN$US$US
241653121$24165312$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122147$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240802$$HP$US$US
241653131$24165313$1$I$$20240729$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120543$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240802$$HP$US$US
241653141$24165314$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122163$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240802$$CN$US$US
241653151$24165315$1$I$$20240718$20240802$20240802$PER$$US-JNJFOC-20240755924$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241653162$24165316$2$F$$20240819$20240802$20240910$30DAY$$CA-JNJFOC-20240747150$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$CA$CA
241653171$24165317$1$I$20240703$20240722$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-036803$AUROBINDO$$36$YR$$F$Y$73$KG$20240802$$CN$GB$GB
241653181$24165318$1$I$20240313$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037157$AUROBINDO$$80$YR$$F$Y$$$20240802$$PH$FR$FR
241653192$24165319$2$F$20240101$20240808$20240802$20240810$PER$$US-ABBVIE-5862886$ABBVIE$$$$$F$Y$49$KG$20240810$$CN$US$US
241653201$24165320$1$I$20231001$20240723$20240802$20240802$EXP$$DE-AUROBINDO-AUR-APL-2024-037237$AUROBINDO$$1$DY$$M$Y$2.13$KG$20240802$$MD$DE$DE
241653211$24165321$1$I$20240723$20240723$20240802$20240802$EXP$$US-GSK-US2024092393$GLAXOSMITHKLINE$$54$YR$$$Y$$$20240802$$PH$US$US
241653221$24165322$1$I$$20240722$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-036566$AUROBINDO$Al?s-palmer ML, And?jar-vera F, Mu?oz-de-rueda P, Iglesias-baena I, Ocete-hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int. J. Mol. Sci. 2023;24:1-17$6$MON$$M$Y$$$20240802$$HP$ES$ES
241653231$24165323$1$I$$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037322$AUROBINDO$$$$$$Y$$$20240802$$CN$GB$GB
241653241$24165324$1$I$$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037319$AUROBINDO$$28$YR$$$Y$$$20240802$$CN$GB$GB
241653251$24165325$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046079$ROCHE$$$$$$Y$$$20240802$$MD$US$US
241653261$24165326$1$I$20240723$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037053$AUROBINDO$$54$YR$$M$Y$69$KG$20240802$$CN$GB$GB
241653281$24165328$1$I$$20240725$20240802$20240802$EXP$$US-NOVITIUMPHARMA-2024USNVP01469$NOVITIUM PHARMA$Haram A. Abdelmajid.Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring.Case Reports in Perinatal Medicine.31-MAY-2024;13:1-5$45$DY$$M$Y$$$20240802$$HP$US$US
241653291$24165329$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037741$AUROBINDO$Grable S, Houchard G, Rossfeld Z. Alpha Alert: Utilization of Transdermal Clonidine for Refractory Agitation. J-Pain-Pall-Care-Pharmacother. 2024;38(2):149-152$79$YR$$M$Y$$$20240802$$HP$US$US
241653301$24165330$1$I$20240101$20240727$20240802$20240802$PER$$US-UNITED THERAPEUTICS-UNT-2024-023280$UNITED THERAPEUTICS$$$$$F$Y$40.816$KG$20240802$$$US$US
241653311$24165331$1$I$20200101$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037104$AUROBINDO$$$$$$Y$$$20240802$$CN$GB$GB
241653322$24165332$2$F$$20240808$20240802$20240822$EXP$$GB-SA-2024SA209509$SANOFI AVENTIS$$$$$M$Y$$$20240822$$CN$GB$GB
241653332$24165333$2$F$$20240807$20240802$20240809$EXP$$NVSJ2024JP009260$NOVARTIS$$$$A$F$Y$$$20240809$$MD$JP$JP
241653342$24165334$2$F$20240101$20240826$20240802$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-018517$UNITED THERAPEUTICS$$$$$M$Y$59.864$KG$20240831$$$US$US
241653352$24165335$2$F$$20240828$20240802$20240902$30DAY$$KR-JNJFOC-20240779109$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$KR$KR
241653361$24165336$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037790$AUROBINDO$Senchyna F, Murugesan K, Rotunno W, Nadimpalli SS, Deresinski S, Banaei N.. Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-beta-lactamase-Producing Escherichia coli Causing Fatal Bloodstream Infection. Clin-Infect-Dis. 2024;78(6):1425-1428$12$YR$$M$Y$$$20240802$$HP$US$US
241653371$24165337$1$I$20220101$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037496$AUROBINDO$Furst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R, et al. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLAimmunized adults with sickle cell disease. Bone Marrow Transplantation. 2024;59 (7):918-27$30$YR$$F$Y$$$20240802$$HP$FR$FR
241653381$24165338$1$I$$20240731$20240802$20240802$EXP$$TH-ROCHE-10000043877$ROCHE$$61$YR$A$M$Y$$$20240802$$HP$TH$TH
241653401$24165340$1$I$20221209$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037481$AUROBINDO$$45$YR$$F$Y$$$20240802$$PH$FR$FR
241653411$24165341$1$I$20240727$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151804$AMGEN$$88$YR$E$F$Y$$$20240801$$CN$US$US
241653421$24165342$1$I$20240730$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152009$AMGEN$$77$YR$E$F$Y$$$20240801$$PH$US$US
241653431$24165343$1$I$$20240725$20240802$20240802$30DAY$$US-GSK-US2024093757$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$CN$US$US
241653442$24165344$2$F$$20240802$20240802$20240812$EXP$$US-GSK-US2024AMR093044$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
241653451$24165345$1$I$20240727$20240729$20240802$20240802$PER$$US-JNJFOC-20240777427$JOHNSON AND JOHNSON$$66$YR$E$$Y$$$20240802$$HP$US$US
241653461$24165346$1$I$20240705$20240725$20240802$20240802$EXP$$US-JNJFOC-20240769317$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240802$$HP$US$US
241653472$24165347$2$F$$20240822$20240802$20240828$EXP$$GB-JNJFOC-20240776000$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240828$$CN$GB$GB
241653482$24165348$2$F$20230101$20240808$20240802$20240813$EXP$$BG-JNJFOC-20240803953$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240813$$CN$BG$BG
241653493$24165349$3$F$20240101$20240823$20240802$20240926$PER$$US-009507513-2407USA003474$MERCK$$$$$F$Y$$$20240926$$CN$US$US
241653502$24165350$2$F$20240101$20240822$20240802$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012496$UNITED THERAPEUTICS$$$$$F$Y$100.23$KG$20240830$$$US$US
241653521$24165352$1$I$$20240801$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122138$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$89.36$KG$20240802$$CN$US$US
241653531$24165353$1$I$20220101$20240722$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116855$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240802$$CN$US$US
241653542$24165354$2$F$20240822$20240822$20240802$20240829$PER$$CA-TOLMAR, INC.-24CA051327$TOLMAR$$91$YR$$M$Y$$$20240829$$CN$CA$CA
241653551$24165355$1$I$$20240729$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019024$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240802$$CN$US$US
241653561$24165356$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019744$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240802$$CN$US$US
241653572$24165357$2$F$20240701$20240801$20240802$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000259$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240805$$CN$US$US
241653581$24165358$1$I$20240705$20240710$20240802$20240802$PER$$FR-TOLMAR, INC.-24FR050836$TOLMAR$$80$YR$$M$Y$$$20240802$$PH$FR$FR
241653591$24165359$1$I$20240730$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019684$ELI LILLY AND CO$$65$YR$E$$Y$$$20240802$$CN$US$US
241653601$24165360$1$I$20240701$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000137$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240802$$CN$US$US
241653611$24165361$1$I$20240719$20240724$20240802$20240802$PER$$US-ABBVIE-5854891$ABBVIE$$23$YR$$F$Y$$$20240802$$CN$US$US
241653632$24165363$2$F$$20240910$20240802$20240920$EXP$$ES-AUROBINDO-AUR-APL-2024-037168$AUROBINDO$Fern?ndez-Concha I, Pose K, de las Vecillas L, Lluch-Bernal M, Tom?s-P?rez M, Soto T, et al. Successful desensitization to lenalidomide in leukocytoclastic vasculitis. Journal of Investigational Allergology + Clinical Immunology. 2024;34(5):1-2$82$YR$$F$Y$$$20240920$$PH$ES$ES
241653641$24165364$1$I$20240710$20240710$20240802$20240802$PER$$FR-TOLMAR, INC.-24FR050962$TOLMAR$$50$YR$$M$Y$$$20240802$$PH$FR$FR
241653652$24165365$2$F$$20240828$20240802$20240924$PER$$FR-TOLMAR, INC.-24FR051004$TOLMAR$$82$YR$$M$Y$$$20240923$$PH$FR$FR
241653661$24165366$1$I$20240711$20240712$20240802$20240802$PER$$FR-TOLMAR, INC.-24FR050965$TOLMAR$$87$YR$$M$Y$$$20240802$$PH$FR$FR
241653671$24165367$1$I$20240401$20240712$20240802$20240802$PER$$NL-TOLMAR, INC.-24NL050996$TOLMAR$$68$YR$$M$Y$$$20240802$$CN$NL$NL
241653681$24165368$1$I$$20240711$20240802$20240802$PER$$TR-TOLMAR, INC.-24TR050999$TOLMAR$$66$YR$$M$Y$$$20240802$$MD$TR$TR
241653691$24165369$1$I$20240710$20240710$20240802$20240802$PER$$TR-TOLMAR, INC.-24TR050964$TOLMAR$$91$YR$$$Y$$$20240802$$MD$TR$TR
241653701$24165370$1$I$20240701$20240712$20240802$20240802$PER$$PA-TOLMAR, INC.-24PA051020$TOLMAR$$72$YR$$M$Y$$$20240802$$CN$PA$PA
241653711$24165371$1$I$20240712$20240712$20240802$20240802$PER$$TR-TOLMAR, INC.-24TR051007$TOLMAR$$82$YR$$M$Y$$$20240802$$MD$TR$TR
241653741$24165374$1$I$$20240730$20240802$20240802$PER$$US-ROCHE-10000044974$ROCHE$$57$YR$A$F$Y$$$20240802$$CN$US$US
241653751$24165375$1$I$20240101$20240729$20240802$20240802$EXP$$US-ABBVIE-5859623$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241653761$24165376$1$I$20240723$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037065$AUROBINDO$$83$YR$$M$Y$83$KG$20240802$$MD$GB$GB
241653771$24165377$1$I$$20240725$20240802$20240802$EXP$$US-GSK-US2024093726$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$MD$US$US
241653781$24165378$1$I$$20200925$20240802$20240802$EXP$$GB-AstraZeneca-2020SF26080$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$GB$
241653791$24165379$1$I$$20240722$20240802$20240802$PER$$US-AstraZeneca-2024A166566$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241653801$24165380$1$I$20240201$20240731$20240802$20240802$EXP$$US-ROCHE-10000046683$ROCHE$$40$YR$A$M$Y$134.72$KG$20240802$$MD$US$US
241653811$24165381$1$I$$20240731$20240802$20240802$EXP$$KR-JAZZ PHARMACEUTICALS-2024-KR-011614$JAZZ$$65$YR$$M$Y$$$20240802$$CN$KR$KR
241653821$24165382$1$I$20240731$20240731$20240802$20240802$PER$$US-JNJFOC-20240784895$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$CN$US$US
241653831$24165383$1$I$$20240722$20240802$20240802$EXP$$DE-AMGEN-DEUSP2024152398$AMGEN$$$$$M$Y$$$20240802$$CN$DE$DE
241653841$24165384$1$I$$20240730$20240802$20240802$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011536$JAZZ$$5$YR$$F$Y$$$20240802$$MD$US$US
241653851$24165385$1$I$$20240726$20240802$20240802$EXP$$CA-APOTEX-2024AP008904$APOTEX$$84$YR$$F$Y$$$20240802$$PH$CA$CA
241653861$24165386$1$I$$20240722$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-036567$AUROBINDO$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, IglesiasBaena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. International Journal of Molecular Sciences. 2023;24:1-17$2$YR$$F$Y$$$20240802$$HP$ES$ES
241653871$24165387$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024092344$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$HP$US$US
241653881$24165388$1$I$20240731$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122193$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240802$$HP$US$US
241653891$24165389$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122090$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240802$$HP$US$US
241653901$24165390$1$I$$20240725$20240802$20240802$PER$$US-JNJFOC-20240783653$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$HP$US$US
241653911$24165391$1$I$20240206$20240724$20240802$20240802$EXP$$CN-JNJFOC-20240769336$JOHNSON AND JOHNSON$$29$YR$A$M$Y$63$KG$20240802$$HP$CN$CN
241653921$24165392$1$I$20240724$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024150955$AMGEN$$$$$M$Y$$$20240802$$CN$US$US
241653932$24165393$2$F$20240729$20240828$20240802$20240901$PER$$US-AMGEN-USASP2024151896$AMGEN$$55$YR$A$F$Y$$$20240901$$CN$US$US
241653952$24165395$2$F$20240625$20240801$20240802$20240805$PER$$US-AMGEN-USASP2024152932$AMGEN$$$$$$Y$$$20240805$$PH$US$US
241653962$24165396$2$F$20240701$20240801$20240802$20240805$PER$$US-AMGEN-USASP2024153238$AMGEN$$62$YR$A$F$Y$$$20240805$$HP$US$US
241653971$24165397$1$I$20240701$20240730$20240802$20240802$EXP$$US-ABBVIE-5848583$ABBVIE$$71$YR$$M$Y$$$20240802$$CN$US$US
241653981$24165398$1$I$$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037728$AUROBINDO$$62$YR$$F$Y$62$KG$20240802$$CN$GB$GB
241653991$24165399$1$I$$20240726$20240802$20240802$EXP$$NVSC2024US155081$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
241654001$24165400$1$I$$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037060$AUROBINDO$$29$YR$$F$Y$$$20240802$$CN$GB$GB
241654011$24165401$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024AMR093674$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241654021$24165402$1$I$$20240730$20240802$20240802$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019342$VALIDUS$$$$$$Y$$$20240802$$CN$US$US
241654031$24165403$1$I$$20240723$20240802$20240802$EXP$$CA-AUROBINDO-AUR-APL-2024-037330$AUROBINDO$$19$YR$$M$Y$$$20240802$$HP$CA$CA
241654041$24165404$1$I$20240714$20240731$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122121$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240802$$CN$US$US
241654051$24165405$1$I$$20240725$20240802$20240802$EXP$$US-GSK-US2024093509$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241654061$24165406$1$I$19981108$20240719$20240802$20240802$EXP$$DE-VALIDUS PHARMACEUTICALS LLC-DE-VDP-2024-019340$VALIDUS$$$$$$Y$$$20240802$$MD$DE$DE
241654071$24165407$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046253$ROCHE$$$$$F$Y$$$20240802$$MD$US$US
241654081$24165408$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046493$ROCHE$$57$YR$A$F$Y$$$20240802$$MD$US$US
241654091$24165409$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046803$ROCHE$$$$$M$Y$$$20240802$$MD$US$US
241654111$24165411$1$I$$20240725$20240802$20240802$EXP$$IN-AMGEN-INDSP2024149347$AMGEN$Gupta N. Improved Outcome of Primary Plasma Cell Leukemia in the Current Era with the Use of Novel Agents and Autologous Bone Marrow Transplants-A Single Centre Experience. Indian Journal of Hematology and Blood Transfusion. 2024;40 (3):400-406$36$YR$A$F$Y$$$20240802$$HP$IN$IN
241654121$24165412$1$I$$20240725$20240802$20240802$EXP$$GB-TEVA-VS-3226423$TEVA$$$$$F$Y$$$20240802$$CN$GB$GB
241654131$24165413$1$I$$20240723$20240802$20240802$EXP$$IT-AUROBINDO-AUR-APL-2024-037360$AUROBINDO$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al.. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case-Control Study in a Real-World Setting.. Clinical Therapeutics. 2024;e1:5$80$YR$$F$Y$$$20240802$$MD$IT$IT
241654141$24165414$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122150$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$69.4$KG$20240802$$CN$US$US
241654152$24165415$2$F$$20240801$20240802$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000195$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240805$$CN$US$US
241654161$24165416$1$I$20240601$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000266$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240802$$CN$US$US
241654171$24165417$1$I$20240724$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000226$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240802$$CN$US$US
241654191$24165419$1$I$$20240725$20240802$20240802$PER$$US-ABBVIE-5857167$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241654202$24165420$2$F$20240716$20240828$20240802$20240906$EXP$$CA-JNJFOC-20240771811$JOHNSON AND JOHNSON$$66$YR$E$F$Y$53$KG$20240906$$CN$CA$CA
241654211$24165421$1$I$20240101$20240730$20240802$20240802$EXP$$US-ABBVIE-5861473$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241654221$24165422$1$I$20220801$20240730$20240802$20240802$EXP$$US-ABBVIE-5861283$ABBVIE$$59$YR$$M$Y$$$20240802$$CN$US$US
241654232$24165423$2$F$20240727$20240807$20240802$20240809$PER$$US-AMGEN-USASP2024152470$AMGEN$$66$YR$E$M$Y$$$20240809$$CN$US$US
241654241$24165424$1$I$20240724$20240730$20240802$20240802$EXP$$US-ABBVIE-5861933$ABBVIE$$60$YR$$F$Y$$$20240802$$CN$US$US
241654252$24165425$2$F$20240712$20240807$20240802$20240812$EXP$$US-EMD Serono-2024041450$EMD SERONO INC$$78$YR$E$F$Y$$$20240812$$CN$US$US
241654261$24165426$1$I$20240601$20240719$20240802$20240802$EXP$$US-UCBSA-2024037060$UCB$$53$YR$$F$Y$$$20240802$$HP$US$US
241654272$24165427$2$F$20240731$20240807$20240802$20240808$PER$$US-ABBVIE-5863481$ABBVIE$$85$YR$$F$Y$$$20240808$$CN$US$US
241654281$24165428$1$I$$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037140$AUROBINDO$$$$$$Y$$$20240802$$CN$GB$GB
241654293$24165429$3$F$20240508$20240813$20240802$20240820$EXP$$PR-ABBVIE-5861803$ABBVIE$$26$YR$$F$Y$71$KG$20240820$$CN$PR$PR
241654301$24165430$1$I$$20240722$20240802$20240802$EXP$$US-ROCHE-10000034871$ROCHE$$$$T$M$Y$$$20240802$$HP$US$US
241654311$24165431$1$I$$20211005$20240802$20240802$EXP$$GB-AstraZeneca-2021A760238$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$GB$
241654321$24165432$1$I$20240718$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173404$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241654331$24165433$1$I$$20210624$20240802$20240802$EXP$$MX-AstraZeneca-2021A568777$ASTRAZENECA$$53$YR$$F$Y$64$KG$20240802$$CN$MX$
241654341$24165434$1$I$$20210401$20240802$20240802$EXP$$BE-AstraZeneca-2021A262218$ASTRAZENECA$$$$$M$Y$$$20240802$$HP$BE$
241654351$24165435$1$I$$20220718$20240802$20240802$EXP$$US-AstraZeneca-2022A260619$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241654361$24165436$1$I$20221101$20230104$20240802$20240802$EXP$$US-AstraZeneca-2023A003446$ASTRAZENECA$$20109$DY$$M$Y$$$20240802$$CN$US$
241654371$24165437$1$I$$20220323$20240802$20240802$EXP$$CA-AstraZeneca-2022A115794$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$CA$
241654381$24165438$1$I$$20230927$20240802$20240802$EXP$$US-AstraZeneca-2023A221265$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241654401$24165440$1$I$$20240723$20240802$20240802$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR095670$VIIV$$$$$$Y$$$20240802$$HP$US$US
241654411$24165441$1$I$20240320$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037146$AUROBINDO$$82$YR$$M$Y$$$20240802$$PH$FR$FR
241654421$24165442$1$I$20240731$20240731$20240802$20240802$EXP$$JP-TAKEDA-2024TJP011449$TAKEDA$$$$$$Y$$$20240802$$HP$JP$JP
241654434$24165443$4$F$$20240905$20240802$20240916$30DAY$$US-JNJFOC-20240778274$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$US$US
241654441$24165444$1$I$$20240731$20240802$20240802$EXP$$JP-JNJFOC-20240804588$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240802$$MD$JP$JP
241654451$24165445$1$I$20220826$20220831$20240802$20240802$EXP$$US-AstraZeneca-2022A269660$ASTRAZENECA$$27841$DY$$M$Y$$$20240802$$CN$US$
241654461$24165446$1$I$$20240724$20240802$20240802$EXP$$ES-TEVA-VS-3225939$TEVA$$$$$F$Y$$$20240802$$MD$ES$ES
241654471$24165447$1$I$20240728$20240729$20240802$20240802$EXP$$FR-ABBVIE-5862301$ABBVIE$$63$YR$$M$Y$$$20240802$$HP$FR$FR
241654481$24165448$1$I$20240617$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037337$AUROBINDO$$71$YR$$F$Y$50$KG$20240802$$PH$FR$FR
241654491$24165449$1$I$$20240723$20240802$20240802$EXP$$NL-AUROBINDO-AUR-APL-2024-037072$AUROBINDO$$30$YR$$F$Y$$$20240802$$MD$NL$NL
241654501$24165450$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190122$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241654511$24165451$1$I$$20240730$20240802$20240802$EXP$$ES-ABBVIE-5862436$ABBVIE$$$$$M$Y$$$20240802$$CN$ES$ES
241654521$24165452$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190163$Haleon PLC$$27$YR$$M$Y$$$20240802$$CN$US$US
241654531$24165453$1$I$$20240729$20240802$20240802$EXP$$US-BIOGEN-2024BI01275916$BIOGEN$$$$C$$Y$$$20240802$$MD$US$US
241654542$24165454$2$F$20240501$20240905$20240802$20240909$EXP$$DE-JNJFOC-20240803960$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240909$$PH$DE$DE
241654551$24165455$1$I$$20240725$20240802$20240802$PER$$US-JNJFOC-20240771086$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241654563$24165456$3$F$20240701$20240807$20240802$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022106$UNITED THERAPEUTICS$$76$YR$$M$Y$$$20240816$$$US$US
241654571$24165457$1$I$20240701$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152721$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241654581$24165458$1$I$20240401$20240730$20240802$20240802$EXP$$US-UCBSA-2024029853$UCB$$52$YR$$F$Y$175$KG$20240802$$CN$US$US
241654591$24165459$1$I$$20240729$20240802$20240802$EXP$GB-MHRA-30707975$GB-LEO Pharma-372369$LEO PHARM$$38$YR$$$Y$$$20240802$$PH$GB$GB
241654601$24165460$1$I$20240710$20240731$20240802$20240802$EXP$$US-ABBVIE-5862780$ABBVIE$$62$YR$$F$Y$$$20240802$$CN$US$US
241654611$24165461$1$I$$20240730$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120741$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240802$$HP$US$US
241654621$24165462$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122164$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240802$$CN$US$US
241654631$24165463$1$I$20240101$20240730$20240802$20240802$EXP$$US-ABBVIE-5861858$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241654651$24165465$1$I$$20240730$20240802$20240802$EXP$$US-ABBVIE-5861960$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241654661$24165466$1$I$20230819$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037458$AUROBINDO$$11$YR$$M$Y$22.5$KG$20240802$$PH$FR$FR
241654672$24165467$2$F$$20240802$20240802$20240814$EXP$$JP-AMGEN-JPNSP2024152521$AMGEN$$$$$$Y$$$20240813$$PH$JP$JP
241654681$24165468$1$I$$20240731$20240802$20240802$EXP$$FI-JNJFOC-20240800307$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20240802$$PH$FI$FI
241654691$24165469$1$I$$20230301$20240802$20240802$EXP$$US-Appco Pharma LLC-2159913$APPCO PHARMA$Initial$27$YR$$M$Y$$$20240802$$MD$US$US
241654701$24165470$1$I$20240726$20240731$20240802$20240802$PER$$NVSC2024US157547$NOVARTIS$$64$YR$$$Y$$$20240802$$MD$US$US
241654711$24165471$1$I$$20230907$20240802$20240802$EXP$$US-AstraZeneca-2023A205154$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241654721$24165472$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153284$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241654731$24165473$1$I$$20240723$20240802$20240802$EXP$$PT-AUROBINDO-AUR-APL-2024-037436$AUROBINDO$$71$YR$$M$Y$$$20240802$$MD$PT$PT
241654741$24165474$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153030$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241654751$24165475$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000489$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240802$$PH$US$US
241654761$24165476$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000178$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240802$$HP$US$US
241654771$24165477$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000495$ELI LILLY AND CO$$$$A$F$Y$$$20240802$$CN$US$US
241654781$24165478$1$I$$20240726$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407017696$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240802$$CN$US$US
241654791$24165479$1$I$20240723$20240726$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407017900$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240802$$CN$US$US
241654801$24165480$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000319$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240802$$CN$US$US
241654811$24165481$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000464$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240802$$CN$US$US
241654821$24165482$1$I$20240501$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000673$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240802$$CN$US$US
241654831$24165483$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000542$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240802$$CN$US$US
241654841$24165484$1$I$$20240724$20240802$20240802$30DAY$$US-GSK-US2024092973$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241654852$24165485$2$F$20240513$20240830$20240802$20240926$EXP$$CA-ABBVIE-5864014$ABBVIE$$68$YR$$$Y$$$20240926$$MD$CA$CA
241654861$24165486$1$I$20240101$20240730$20240802$20240802$EXP$$CA-UCBSA-2024033761$UCB$$$$$F$Y$$$20240802$$CN$CA$CA
241654871$24165487$1$I$$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037151$AUROBINDO$$$$$F$Y$$$20240802$$PH$GB$GB
241654881$24165488$1$I$$20240731$20240802$20240802$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037134$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240802$$MD$US$US
241654891$24165489$1$I$20240101$20240730$20240802$20240802$EXP$$US-ABBVIE-5861249$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241654901$24165490$1$I$$20240726$20240802$20240802$PER$$US-HALEON-2189438$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241654911$24165491$1$I$$20240726$20240802$20240802$EXP$$US-GSK-US2024AMR095484$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241654921$24165492$1$I$20240101$20240730$20240802$20240802$EXP$$US-ABBVIE-5862147$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241654931$24165493$1$I$20240715$20240719$20240802$20240802$EXP$$DE-UCBSA-2024036987$UCB$$36$YR$$F$Y$$$20240802$$CN$DE$DE
241654941$24165494$1$I$20240727$20240730$20240802$20240802$EXP$$US-ABBVIE-5862184$ABBVIE$$80$YR$$F$Y$$$20240802$$CN$US$US
241654951$24165495$1$I$20240701$20240729$20240802$20240802$EXP$$CA-JNJFOC-20240782371$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240802$$PH$CA$CA
241654961$24165496$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153113$AMGEN$$$$$F$Y$$$20240802$$CN$US$US
241654971$24165497$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152775$AMGEN$$$$$M$Y$$$20240802$$CN$US$US
241655001$24165500$1$I$20240101$20240730$20240802$20240802$EXP$$US-ABBVIE-5862762$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241655011$24165501$1$I$20240501$20240725$20240802$20240802$EXP$IT-MINISAL02-995424$IT-TEVA-VS-3225908$TEVA$$16$YR$$M$Y$50$KG$20240802$$PH$IT$IT
241655021$24165502$1$I$20240724$20240723$20240802$20240802$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024092364$VIIV$$56$YR$$M$Y$$$20240802$$HP$US$US
241655031$24165503$1$I$20240716$20240723$20240802$20240802$30DAY$$US-GSK-US2024092284$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240802$$CN$US$US
241655041$24165504$1$I$20240628$20240729$20240802$20240802$EXP$FR-AFSSAPS-AM2024000599$FR-PFIZER INC-202400225352$PFIZER$$92$YR$$M$Y$62$KG$20240802$$MD$FR$FR
241655051$24165505$1$I$20240703$20240726$20240802$20240802$EXP$ES-AEMPS-1552875$ES-PFIZER INC-202400224301$PFIZER$$79$YR$$M$Y$$$20240802$$MD$ES$ES
241655061$24165506$1$I$20231205$20240726$20240802$20240802$EXP$$CN-PFIZER INC-2024SGN02888$PFIZER$$29$YR$$M$Y$55$KG$20240802$$MD$CN$CN
241655071$24165507$1$I$20240701$20240729$20240802$20240802$EXP$$CL-PFIZER INC-PV202400099279$PFIZER$$$$$F$Y$$$20240802$$CN$CL$CL
241655081$24165508$1$I$20240101$20240723$20240802$20240802$EXP$$US-SA-2024SA226236$SANOFI AVENTIS$$$$$F$Y$$$20240802$$HP$US$US
241655091$24165509$1$I$20240710$20240725$20240802$20240802$EXP$$ZA-ABBVIE-5863958$ABBVIE$$53$YR$$M$Y$$$20240802$$CN$ZA$ZA
241655102$24165510$2$F$20240726$20240812$20240802$20240815$EXP$$CA-PFIZER INC-202400042665$PFIZER$$32$YR$$F$Y$72.7$KG$20240815$$MD$CA$CA
241655111$24165511$1$I$$20240725$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121503$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240802$$MD$US$US
241655122$24165512$2$F$$20240814$20240802$20240913$PER$$US-009507513-2407USA010891$MERCK$$$$$M$Y$$$20240913$$CN$US$US
241655131$24165513$1$I$$20240724$20240802$20240802$PER$$US-ABBVIE-5854449$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241655142$24165514$2$F$20240701$20240806$20240802$20240808$30DAY$$US-AMGEN-USASP2024149567$AMGEN$$63$YR$A$F$Y$$$20240808$$HP$US$US
241655151$24165515$1$I$20170101$20240726$20240802$20240802$EXP$$US-SA-2024SA223074$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240802$$MD$US$US
241655164$24165516$4$F$20230816$20240819$20240802$20240912$EXP$$TR-SA-2024SA222034$SANOFI AVENTIS$$6$MON$I$M$Y$9.6$KG$20240912$$MD$TR$TR
241655171$24165517$1$I$$20240703$20240802$20240802$PER$$US-AstraZeneca-2024A162150$ASTRAZENECA$$68$YR$$F$Y$$$20240802$$CN$US$
241655181$24165518$1$I$20240715$20240716$20240802$20240802$PER$$US-AstraZeneca-2024A173552$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241655191$24165519$1$I$$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173515$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241655201$24165520$1$I$$20240724$20240802$20240802$EXP$$US-GSK-US2024092876$GLAXOSMITHKLINE$$2$DEC$$F$Y$$$20240802$$HP$US$US
241655212$24165521$2$F$$20240822$20240802$20240901$30DAY$$US-GSK-US2024092406$GLAXOSMITHKLINE$$93$YR$$F$Y$$$20240901$$CN$US$US
241655221$24165522$1$I$20240707$20240724$20240802$20240802$EXP$$IT-AUROBINDO-AUR-APL-2024-037530$AUROBINDO$$76$YR$$F$Y$71$KG$20240802$$MD$IT$IT
241655251$24165525$1$I$20240530$20240724$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037685$AUROBINDO$$71$YR$$M$Y$73.1$KG$20240802$$MD$FR$FR
241655261$24165526$1$I$$20240721$20240802$20240802$EXP$$JP-JNJFOC-20240771166$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240802$$HP$JP$JP
241655271$24165527$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152626$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241655281$24165528$1$I$20240701$20240730$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120968$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240802$$HP$US$US
241655295$24165529$5$F$20240622$20240823$20240802$20240904$EXP$$US-BANNER LIFE SCIENCES-USBAN24000120$BANNER$$$$$$Y$$$20240904$$MD$US$US
241655301$24165530$1$I$20240708$20240723$20240802$20240802$PER$$TW-IGSA-BIG0030023$GRIFOLS$$38$YR$$F$Y$$$20240802$$HP$TW$TW
241655311$24165531$1$I$20240730$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000097$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240802$$CN$US$US
241655321$24165532$1$I$20240101$20240725$20240802$20240802$PER$$US-UNITED THERAPEUTICS-UNT-2024-005440$UNITED THERAPEUTICS$$$$$M$Y$79.365$KG$20240802$$$US$US
241655331$24165533$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000426$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240802$$CN$US$US
241655341$24165534$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000058$ELI LILLY AND CO$$$$$F$Y$$$20240802$$MD$US$US
241655351$24165535$1$I$20240801$20240801$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000984$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240802$$CN$US$US
241655361$24165536$1$I$20240731$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000113$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240802$$CN$US$US
241655371$24165537$1$I$$20240725$20240802$20240802$EXP$$US-GSK-US2024AMR096095$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$US$US
241655381$24165538$1$I$20240501$20240730$20240802$20240802$EXP$$CA-UCBSA-2024038663$UCB$$37$YR$$F$Y$$$20240802$$CN$CA$CA
241655411$24165541$1$I$20240506$20240718$20240802$20240802$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2159914$JIANGSU HANSOH PHARMACEUTICAL$$54$YR$$F$Y$46$KG$20240802$$MD$CN$CN
241655421$24165542$1$I$$20240618$20240802$20240802$EXP$$US-CHEPLA-2024009641$CHEPLAPHARM$$$$$F$Y$$$20240801$$HP$COUNTRY NOT SPECIFIED$US
241655432$24165543$2$F$$20240826$20240802$20240903$EXP$$CA-APOTEX-2024AP008805$APOTEX$$75$YR$$F$Y$$$20240903$$HP$CA$CA
241655441$24165544$1$I$$20240729$20240802$20240802$EXP$GR-SEATTLE GENETICS-2023SGN13222$GR-CHEPLA-2024009764$CHEPLAPHARM$$$$$F$Y$$$20240802$$MD$COUNTRY NOT SPECIFIED$GR
241655451$24165545$1$I$$20240724$20240802$20240802$EXP$$US-JNJFOC-20240765544$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$MD$US$US
241655461$24165546$1$I$$20240731$20240802$20240802$PER$$US-TAKEDA-2024TUS077358$TAKEDA$$$$$$Y$$$20240802$$CN$US$US
241655471$24165547$1$I$20240614$20240725$20240802$20240802$EXP$HR-HALMED-300086093$HR-CHEPLA-2024009485$CHEPLAPHARM$$13$YR$$F$Y$50$KG$20240801$$MD$COUNTRY NOT SPECIFIED$HR
241655481$24165548$1$I$$20240724$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037424$AUROBINDO$$85$YR$$$Y$$$20240802$$CN$GB$GB
241655491$24165549$1$I$20240401$20240628$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000033$VERRICA PHARMACEUTICALS$$$$$$Y$$$20240731$$HP$US$US
241655501$24165550$1$I$20240701$20240710$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000034$VERRICA PHARMACEUTICALS$$$$$$Y$$$20240731$$CN$US$US
241655511$24165551$1$I$$20240708$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000035$VERRICA PHARMACEUTICALS$$$$C$$Y$$$20240731$$MD$US$US
241655521$24165552$1$I$20240620$20240620$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000029$VERRICA PHARMACEUTICALS$$$$$$Y$$$20240731$$MD$US$US
241655531$24165553$1$I$20240613$20240619$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000030$VERRICA PHARMACEUTICALS$$7$YR$$F$Y$$$20240731$$HP$US$US
241655541$24165554$1$I$20240601$20240625$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000032$VERRICA PHARMACEUTICALS$$7$YR$$M$Y$$$20240731$$HP$US$US
241655551$24165555$1$I$$20240515$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000020$VERRICA PHARMACEUTICALS$$$$$$Y$$$20240731$$PH$US$US
241655561$24165556$1$I$20240528$20240529$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000025$VERRICA PHARMACEUTICALS$$4$YR$$M$Y$$$20240731$$MD$US$US
241655571$24165557$1$I$$20240603$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000027$VERRICA PHARMACEUTICALS$$4$YR$$F$Y$$$20240731$$CN$US$US
241655581$24165558$1$I$$20240423$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000018$VERRICA PHARMACEUTICALS$$$$$F$Y$$$20240731$$CN$US$US
241655591$24165559$1$I$20240430$20240501$20240802$20240802$PER$$GE-VERRICA PHARMACEUTICALS INC.-2024VER000019$VERRICA PHARMACEUTICALS$$2$YR$$$Y$$$20240731$$MD$GE$US
241655601$24165560$1$I$$20240521$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000022$VERRICA PHARMACEUTICALS$$$$$$Y$$$20240731$$MD$US$US
241655611$24165561$1$I$$20240605$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000023$VERRICA PHARMACEUTICALS$$$$$$Y$$$20240731$$HP$US$US
241655621$24165562$1$I$$20240708$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000036$VERRICA PHARMACEUTICALS$$$$C$F$Y$$$20240731$$MD$US$US
241655631$24165563$1$I$20240601$20240712$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000031$VERRICA PHARMACEUTICALS$$$$$$Y$$$20240731$$MD$US$US
241655641$24165564$1$I$20240401$20240604$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000026$VERRICA PHARMACEUTICALS$$$$$$Y$$$20240731$$MD$US$US
241655651$24165565$1$I$20240601$20240620$20240802$20240802$PER$$US-VERRICA PHARMACEUTICALS INC.-2024VER000028$VERRICA PHARMACEUTICALS$$$$$$Y$$$20240731$$MD$US$US
241655671$24165567$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152167$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241655681$24165568$1$I$$20240723$20240802$20240802$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR092643$VIIV$$3$DEC$$F$Y$$$20240802$$MD$US$US
241655691$24165569$1$I$20240711$20240730$20240802$20240802$EXP$$DE-EMD Serono-2024041282$EMD SERONO INC$$49$YR$A$F$Y$$$20240802$$CN$DE$DE
241655702$24165570$2$F$$20240822$20240802$20240823$PER$$US-ALXN-202407USA002133US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241655711$24165571$1$I$20240716$20240726$20240802$20240802$PER$$US-UNITED THERAPEUTICS-UNT-2024-023275$UNITED THERAPEUTICS$$58$YR$$F$Y$66.667$KG$20240802$$$US$US
241655721$24165572$1$I$$20240731$20240802$20240802$PER$$US-JNJFOC-20240801112$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$HP$US$US
241655731$24165573$1$I$$20240731$20240802$20240802$EXP$$US-JNJFOC-20240802119$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240802$$CN$US$US
241655742$24165574$2$F$$20240814$20240802$20240815$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043387$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$61$KG$20240815$$CN$CN$CN
241655761$24165576$1$I$20240726$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024150272$AMGEN$$$$$F$Y$$$20240802$$HP$US$US
241655771$24165577$1$I$20240701$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151581$AMGEN$$67$YR$E$M$Y$$$20240802$$CN$US$US
241655781$24165578$1$I$$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024150676$AMGEN$$71$YR$E$F$Y$$$20240802$$PH$US$US
241655791$24165579$1$I$$20240715$20240802$20240802$PER$$US-TEVA-VS-3225596$TEVA$$63$YR$$F$Y$$$20240802$$PH$US$US
241655801$24165580$1$I$$20240730$20240802$20240802$EXP$$CN-AstraZeneca-2024A174252$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$CN$
241655811$24165581$1$I$$20211207$20240802$20240802$EXP$$US-AstraZeneca-2021A866488$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241655821$24165582$1$I$$20240723$20240802$20240802$EXP$$TH-ROCHE-10000035148$ROCHE$$36$YR$A$F$Y$$$20240802$$CN$TH$TH
241655831$24165583$1$I$20210513$20211019$20240802$20240802$EXP$$US-AstraZeneca-2021A780475$ASTRAZENECA$$24037$DY$$F$Y$$$20240802$$CN$US$
241655841$24165584$1$I$20230501$20231018$20240802$20240802$EXP$$US-AstraZeneca-2023A238182$ASTRAZENECA$$736$MON$$F$Y$$$20240802$$CN$US$
241655851$24165585$1$I$$20230720$20240802$20240802$EXP$$US-AstraZeneca-2023A166901$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241655861$24165586$1$I$$20220809$20240802$20240802$EXP$$US-AstraZeneca-2022A235569$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241655871$24165587$1$I$$20210916$20240802$20240802$EXP$$US-AstraZeneca-2021A731847$ASTRAZENECA$$$$$$Y$64.4$KG$20240802$$CN$US$
241655881$24165588$1$I$$20211209$20240802$20240802$EXP$$US-AstraZeneca-2021A869110$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241655891$24165589$1$I$$20210928$20240802$20240802$EXP$$US-AstraZeneca-2021A753752$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241655901$24165590$1$I$$20230131$20240802$20240802$EXP$$IN-AstraZeneca-2023A027865$ASTRAZENECA$$61$YR$$F$Y$$$20240802$$CN$IN$
241655911$24165591$1$I$$20240730$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121912$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240802$$CN$US$US
241655921$24165592$1$I$$20240724$20240802$20240802$EXP$$US-GSK-US2024AMR093614$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$MD$US$US
241655932$24165593$2$F$$20240725$20240802$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118875$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240805$$PH$US$US
241655942$24165594$2$F$20240701$20240903$20240802$20240912$EXP$$JP-ROCHE-10000041787$ROCHE$$8$DEC$E$M$Y$$$20240912$$MD$JP$JP
241655951$24165595$1$I$$20240729$20240802$20240802$EXP$$CA-JNJFOC-20240781339$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$HP$CA$CA
241655961$24165596$1$I$20230101$20240801$20240802$20240802$EXP$$US-ROCHE-10000047264$ROCHE$$67$YR$E$M$Y$$$20240802$$HP$US$US
241655972$24165597$2$F$20230201$20240731$20240802$20240806$30DAY$$US-UCBSA-2023033388$UCB$$49$YR$$F$Y$$$20240806$$CN$US$US
241655981$24165598$1$I$$20240731$20240802$20240802$PER$$NVSC2024US157775$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241655991$24165599$1$I$20240725$20240725$20240802$20240802$EXP$$US-ORG100016242-2024000499$PACIRA$$58$YR$A$F$Y$$$20240802$$HP$US$US
241656003$24165600$3$F$20240701$20240812$20240802$20240814$30DAY$$US-AMGEN-USASP2024150671$AMGEN$$65$YR$E$M$Y$$$20240814$$CN$US$US
241656011$24165601$1$I$20180727$20240727$20240802$20240802$EXP$GB-MHRA-WEBRADR-202407271514074320-MDRFC$GB-RDY-SPO/GBR/24/0011148$DR REDDYS$$31$YR$A$M$Y$79$KG$20240802$$CN$GB$GB
241656022$24165602$2$F$$20240821$20240802$20240822$PER$$US-ALXN-202407USA001873US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
241656031$24165603$1$I$$20240725$20240802$20240802$EXP$$CZ-UCBSA-2024038332$UCB$Klocperk A, Bloomfield AM, Schneiderova H, Hlavackova E, Turno-Vec M, Tichy L, et al. Neonatal Screening of Severe Combined Immunodeficienc (SCID) in the Czech Republic. Allergies. 2024;85-90$$$$F$Y$$$20240802$$MD$CZ$CZ
241656041$24165604$1$I$20240101$20240726$20240802$20240802$PER$$US-AMGEN-USASP2024149409$AMGEN$$82$YR$E$F$Y$$$20240802$$HP$US$US
241656051$24165605$1$I$$20240731$20240802$20240802$EXP$$US-JNJFOC-20240784321$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$HP$US$US
241656061$24165606$1$I$20220601$20240730$20240802$20240802$EXP$ES-AEMPS-1553975$ES-ORGANON-O2407ESP002814$ORGANON$$27$YR$$F$Y$59$KG$20240802$$CN$ES$ES
241656071$24165607$1$I$20240101$20240730$20240802$20240802$PER$$US-ROCHE-10000046435$ROCHE$$17$YR$T$F$Y$$$20240802$$HP$US$US
241656081$24165608$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046310$ROCHE$$15$YR$T$M$Y$$$20240802$$CN$US$US
241656092$24165609$2$F$20240226$20240813$20240802$20240815$EXP$$US-ROCHE-10000030669$ROCHE$$46$YR$A$F$Y$$$20240815$$MD$US$US
241656101$24165610$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121738$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$80.74$KG$20240802$$CN$US$US
241656111$24165611$1$I$20240101$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122122$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240802$$HP$US$US
241656121$24165612$1$I$20240722$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000958$ELI LILLY AND CO$$$$$$Y$$$20240802$$CN$US$US
241656131$24165613$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019922$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240802$$CN$US$US
241656141$24165614$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000348$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240802$$HP$US$US
241656151$24165615$1$I$$20240726$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407018975$ELI LILLY AND CO$$14$YR$T$F$Y$$$20240802$$CN$US$US
241656161$24165616$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003488$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241656171$24165617$1$I$20240318$20240724$20240802$20240802$EXP$$JP-RIGEL PHARMACEUTICALS, INC.-2024FOS000517$RIGEL PHARMACEUTICALS$$66$YR$$M$Y$84.8$KG$20240802$$MD$JP$JP
241656181$24165618$1$I$20230214$20240725$20240802$20240802$EXP$$KR-GSK-KR2024096287$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$KR$KR
241656201$24165620$1$I$$20240801$20240802$20240802$PER$$NVSC2024US157435$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241656221$24165622$1$I$$20240729$20240802$20240802$PER$$US-ROCHE-10000044230$ROCHE$$$$$$Y$$$20240802$$HP$US$US
241656232$24165623$2$F$$20240723$20240802$20240803$EXP$$PL-AUROBINDO-AUR-APL-2024-037444$AUROBINDO$$36$YR$$F$Y$49$KG$20240803$$MD$PL$PL
241656241$24165624$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003487$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241656251$24165625$1$I$$20240726$20240802$20240802$EXP$$FR-EMD Serono-2023478580$EMD SERONO INC$$52$YR$A$F$Y$73$KG$20240802$$CN$FR$FR
241656271$24165627$1$I$$20240730$20240802$20240802$PER$$US-ROCHE-10000046141$ROCHE$$75$YR$E$F$Y$$$20240802$$CN$US$US
241656281$24165628$1$I$$20231011$20240802$20240802$EXP$$US-AstraZeneca-2023A232560$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241656294$24165629$4$F$$20240906$20240802$20240911$PER$$US-ROCHE-10000045854$ROCHE$$$$A$F$Y$$$20240911$$CN$US$US
241656301$24165630$1$I$$20240730$20240802$20240802$PER$$US-ROCHE-10000046179$ROCHE$$$$A$F$Y$$$20240802$$CN$US$US
241656312$24165631$2$F$$20240729$20240802$20240902$PER$$US-ROCHE-10000042385$ROCHE$$59$YR$A$F$Y$$$20240902$$CN$US$US
241656322$24165632$2$F$$20240717$20240802$20240806$PER$$US-TEVA-VS-3225871$TEVA$$57$YR$$F$Y$$$20240806$$PH$US$US
241656331$24165633$1$I$$20240731$20240802$20240802$PER$$NVSC2024US157788$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241656341$24165634$1$I$20240620$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037464$AUROBINDO$$65$YR$$F$Y$55$KG$20240802$$MD$FR$FR
241656352$24165635$2$F$20240716$20240812$20240802$20240813$EXP$$KR-ABBVIE-5861175$ABBVIE$$77$YR$$M$Y$56$KG$20240813$$MD$KR$KR
241656361$24165636$1$I$20240701$20240719$20240802$20240802$PER$$US-TEVA-VS-3224171$TEVA$$$$$F$Y$$$20240802$$CN$US$US
241656371$24165637$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152657$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241656381$24165638$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151403$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241656391$24165639$1$I$$20240729$20240802$20240802$EXP$$CA-APOTEX-2024AP008989$APOTEX$$17$YR$$F$Y$$$20240802$$PH$CA$CA
241656401$24165640$1$I$$20240724$20240802$20240802$PER$$US-ROCHE-10000037295$ROCHE$$$$$$Y$$$20240802$$CN$US$US
241656411$24165641$1$I$$20240729$20240802$20240802$PER$$US-ROCHE-10000041734$ROCHE$$68$YR$E$F$Y$$$20240802$$CN$US$US
241656423$24165642$3$F$$20240731$20240802$20240807$PER$$US-ROCHE-10000041670$ROCHE$$$$A$F$Y$$$20240807$$CN$US$US
241656431$24165643$1$I$$20240729$20240802$20240802$PER$$US-ROCHE-10000041616$ROCHE$$21$YR$A$M$Y$$$20240802$$CN$US$US
241656441$24165644$1$I$$20240729$20240802$20240802$PER$$US-ROCHE-10000041610$ROCHE$$69$YR$E$F$Y$$$20240802$$CN$US$US
241656451$24165645$1$I$$20240730$20240802$20240802$EXP$$CA-UCBSA-2024038681$UCB$$$$$F$Y$$$20240802$$HP$CA$CA
241656461$24165646$1$I$20240712$20240717$20240802$20240802$PER$$US-TEVA-VS-3225869$TEVA$$74$YR$$F$Y$$$20240802$$PH$US$US
241656471$24165647$1$I$$20240726$20240802$20240802$30DAY$$US-GSK-US2024AMR094532$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$US$US
241656481$24165648$1$I$$20240730$20240802$20240802$PER$$US-ROCHE-10000043197$ROCHE$$76$YR$E$F$Y$$$20240802$$CN$US$US
241656491$24165649$1$I$20211003$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2023-011471$AUROBINDO$$15$YR$$F$Y$80$KG$20240802$$MD$FR$FR
241656501$24165650$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003489$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241656512$24165651$2$F$20240726$20240821$20240802$20240822$PER$$US-ALXN-202407USA001877US$ALEXION PHARMACEUTICALS$$44$YR$$$Y$$$20240822$$CN$US$US
241656521$24165652$1$I$20240703$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121894$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$64.41$KG$20240802$$HP$US$US
241656535$24165653$5$F$$20240917$20240802$20240924$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001553$BLUEPRINT MEDICINES$$$$$M$Y$$$20240924$$CN$US$US
241656541$24165654$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046372$ROCHE$$55$YR$A$F$Y$$$20240802$$CN$US$US
241656551$24165655$1$I$20240618$20240621$20240802$20240802$PER$$US-ROCHE-10000009616$ROCHE$$$$$$Y$$$20240802$$PH$US$US
241656571$24165657$1$I$20240706$20240730$20240802$20240802$EXP$FR-AFSSAPS-PO2024000787$FR-EMD Serono-2024041164$EMD SERONO INC$$58$YR$A$F$Y$44$KG$20240802$$MD$FR$FR
241656601$24165660$1$I$$20240729$20240802$20240802$EXP$$CA-ORGANON-O2407CAN002662$ORGANON$$43$YR$$F$Y$68$KG$20240802$$HP$CA$CA
241656611$24165661$1$I$$20240729$20240802$20240802$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001547$BLUEPRINT MEDICINES$$$$$F$Y$$$20240802$$CN$US$US
241656621$24165662$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003491$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241656631$24165663$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046202$ROCHE$$$$E$M$Y$$$20240802$$CN$US$US
241656651$24165665$1$I$$20240708$20240802$20240802$PER$$US-JNJFOC-20240720036$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$CN$US$US
241656661$24165666$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152230$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241656671$24165667$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152211$AMGEN$$$$$$Y$$$20240802$$HP$US$US
241656681$24165668$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046023$ROCHE$$$$$$Y$$$20240802$$CN$US$US
241656691$24165669$1$I$20240111$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037158$AUROBINDO$$90$YR$$F$Y$$$20240802$$PH$FR$FR
241656701$24165670$1$I$$20240711$20240802$20240802$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003492$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241656711$24165671$1$I$$20240412$20240802$20240802$PER$$US-AUROBINDO-AUR-APL-2024-016791$AUROBINDO$$$$$$Y$$$20240802$$HP$US$US
241656721$24165672$1$I$$20240725$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118870$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$75.75$KG$20240802$$CN$US$US
241656741$24165674$1$I$$20240729$20240802$20240802$EXP$$PH-AstraZeneca-2024A172228$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$PH$
241656751$24165675$1$I$20240725$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A172678$ASTRAZENECA$$28055$DY$$F$Y$$$20240802$$CN$US$
241656761$24165676$1$I$$20240722$20240802$20240802$EXP$$CN-AUROBINDO-AUR-APL-2024-037788$AUROBINDO$Xingyu C, Yuxia J, Tongxin S, Caijie Q. Two cases of amlodipine-induced interstitial granulomatous drug reaction. [Chinese]. Chin-J-Dermatol. 2021;54(11):1005-1006$68$YR$$F$Y$$$20240802$$HP$CN$CN
241656771$24165677$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170463$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241656782$24165678$2$F$$20240801$20240802$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118403$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240813$$HP$CA$CA
241656791$24165679$1$I$$20240429$20240802$20240802$PER$$US-AUROBINDO-AUR-APL-2024-016831$AUROBINDO$$$$$$Y$$$20240802$$HP$US$US
241656801$24165680$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003496$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241656811$24165681$1$I$$20240730$20240802$20240802$EXP$$US-JNJFOC-20240782141$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$HP$US$US
241656821$24165682$1$I$20240101$20240729$20240802$20240802$PER$$US-BIOGEN-2024BI01274022$BIOGEN$$$$$M$Y$$$20240802$$CN$US$US
241656831$24165683$1$I$$20240725$20240802$20240802$PER$$US-ABBVIE-5855702$ABBVIE$$42$YR$$F$Y$$$20240802$$MD$US$US
241656841$24165684$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153209$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241656851$24165685$1$I$$20240722$20240802$20240802$EXP$$ZA-AUROBINDO-AUR-APL-2024-037403$AUROBINDO$Frigati LJ, Rabie H.. Third-Line Antiretroviral Therapy: What Do We Do When the Appropriate Formulations Are Not Available?. Children. 2022;9(4):1-6$2$YR$$M$Y$10.9$KG$20240802$$HP$ZA$ZA
241656861$24165686$1$I$20230410$20240726$20240802$20240802$EXP$$GR-TAKEDA-2023TUS059069$TAKEDA$$39$YR$$F$Y$$$20240802$$CN$GR$GR
241656871$24165687$1$I$20240304$20240306$20240802$20240802$PER$$US-AUROBINDO-AUR-APL-2024-011966$AUROBINDO$$80$YR$$F$Y$47$KG$20240802$$CN$US$US
241656881$24165688$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046603$ROCHE$$$$$$Y$$$20240802$$PH$US$US
241656891$24165689$1$I$$20240725$20240802$20240802$PER$$US-ROCHE-10000037670$ROCHE$$$$$$Y$$$20240802$$CN$US$US
241656901$24165690$1$I$$20240722$20240802$20240802$EXP$$JP-PBT-009561$PANACEA BIOTEC$Yokoyama T, Inoue N, Sakumura N, Tasaki Y, Wada T. An Adolescent Case of Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis With Interstitial Lung Disease Successfully Treated by Multitarget Therapy Avoiding Cyclophosphamide: A Case Report and Literature Review. Cureus. 2024 Jun 15;16(6):e62425. doi: 10.7759/cureus.62425.$13$YR$T$F$Y$$$20240802$$HP$JP$JP
241656911$24165691$1$I$$20240729$20240802$20240802$EXP$$CA-JNJFOC-20240783803$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240802$$HP$CA$CA
241656921$24165692$1$I$$20240712$20240802$20240802$PER$$US-WT-2024-000184$Waylis$$81$YR$$M$Y$$$20240802$$CN$US$US
241656932$24165693$2$F$20240101$20240808$20240802$20240813$EXP$$US-JNJFOC-20240782649$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240813$$HP$US$US
241656941$24165694$1$I$20240725$20240725$20240802$20240802$EXP$$US-TAKEDA-US202014594$TAKEDA$$71$YR$$F$Y$$$20240802$$HP$US$US
241656951$24165695$1$I$20181101$20240722$20240802$20240802$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009334$STRIDES$$67$YR$$F$Y$$$20240802$$CN$US$US
241656961$24165696$1$I$20240528$20240801$20240802$20240802$EXP$$GB-SANDOZ INC.-SDZ2024GB069932$SANDOZ$$63$YR$$F$Y$74$KG$20240802$$HP$GB$GB
241656971$24165697$1$I$20211001$20240319$20240802$20240802$PER$$US-Accord-404895$ACCORD$$59$YR$A$F$Y$$$20240802$$LW$US$US
241656981$24165698$1$I$20210201$20240509$20240802$20240802$PER$$US-Accord-412750$ACCORD$$77$YR$E$F$Y$$$20240802$$LW$US$US
241656991$24165699$1$I$20150201$20240410$20240802$20240802$EXP$$US-Accord-419148$ACCORD$$52$YR$A$F$Y$64.86$KG$20240802$$LW$US$US
241657001$24165700$1$I$20190614$20230811$20240802$20240802$PER$$US-Accord-364448$ACCORD$$41$YR$$F$Y$$$20240802$$LW$US$US
241657012$24165701$2$F$$20240808$20240802$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-036645$AUROBINDO$Laches R, Hall RJ, Chaffin J, Hahn P.. Omission of etoposide in the treatment of haemophagocytic lymphohistiocytosis secondary to primary central nervous system lymphoma with satisfactory response.. BMJ case reports.. 2024;17(7):e258559$7$DEC$$F$Y$$$20240821$$MD$US$US
241657021$24165702$1$I$20240401$20240517$20240802$20240802$PER$$US-Accord-416338$ACCORD$$45$YR$A$M$Y$$$20240802$$CN$US$US
241657031$24165703$1$I$$20240318$20240802$20240802$PER$$US-Accord-413471$ACCORD$$74$YR$E$M$Y$$$20240802$$CN$US$US
241657041$24165704$1$I$20230901$20231002$20240802$20240802$PER$$US-Accord-387911$ACCORD$$61$YR$A$M$Y$$$20240802$$CN$US$US
241657051$24165705$1$I$20190501$20231228$20240802$20240802$PER$$US-Accord-390973$ACCORD$$59$YR$A$F$Y$$$20240802$$LW$US$US
241657061$24165706$1$I$20240201$20240216$20240802$20240802$PER$$US-Accord-414289$ACCORD$$70$YR$E$M$Y$$$20240802$$CN$US$US
241657071$24165707$1$I$$20240426$20240802$20240802$PER$$US-Accord-422333$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
241657081$24165708$1$I$20180209$20230731$20240802$20240802$PER$$US-Accord-371681$ACCORD$$50$YR$A$F$Y$$$20240802$$LW$US$US
241657091$24165709$1$I$20200201$20231201$20240802$20240802$PER$$US-Accord-384365$ACCORD$$45$YR$A$F$Y$$$20240802$$LW$US$US
241657101$24165710$1$I$20150901$20240514$20240802$20240802$EXP$$US-Accord-419147$ACCORD$$54$YR$A$F$Y$81.65$KG$20240802$$LW$US$US
241657111$24165711$1$I$20171001$20231024$20240802$20240802$PER$$US-Accord-370402$ACCORD$$45$YR$A$F$Y$$$20240802$$LW$US$US
241657121$24165712$1$I$20211001$20240529$20240802$20240802$EXP$$US-Accord-417692$ACCORD$$48$YR$A$F$Y$$$20240802$$LW$US$US
241657131$24165713$1$I$20190301$20240501$20240802$20240802$PER$$US-Accord-412752$ACCORD$$50$YR$A$F$Y$$$20240802$$LW$US$US
241657141$24165714$1$I$20210517$20240116$20240802$20240802$PER$$US-Accord-402836$ACCORD$$54$YR$A$F$Y$$$20240802$$LW$US$US
241657151$24165715$1$I$20220401$20240423$20240802$20240802$PER$$US-Accord-417693$ACCORD$$49$YR$$F$Y$$$20240802$$LW$US$US
241657161$24165716$1$I$20111001$20230728$20240802$20240802$PER$$US-Accord-372715$ACCORD$$68$YR$E$F$Y$104.33$KG$20240802$$LW$US$US
241657171$24165717$1$I$$20240501$20240802$20240802$PER$$US-Accord-412873$ACCORD$$58$YR$$M$Y$$$20240802$$CN$US$US
241657181$24165718$1$I$20140101$20230719$20240802$20240802$EXP$$US-Accord-370406$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
241657191$24165719$1$I$20160101$20230823$20240802$20240802$PER$$US-Accord-370404$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
241657203$24165720$3$F$$20240823$20240802$20240823$PER$$US-ALXN-202407USA001878US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241657211$24165721$1$I$20210304$20231113$20240802$20240802$PER$$US-Accord-364446$ACCORD$$47$YR$$F$Y$$$20240802$$LW$US$US
241657221$24165722$1$I$$20240723$20240802$20240802$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009384$STRIDES$Churchill AB, Nguyen AD, Xia J, Nguyen VD, Agrawal N, Durant CE, et al.. To Bite or Not to Bite: A Case of Non-bite Pasteurella Multicoda Resulting in Severe Septic Shock.. Am-J-Respir-Crit-Care-Med. 2024;209:A1679$68$YR$$M$Y$$$20240802$$HP$US$US
241657232$24165723$2$F$20240731$20240916$20240802$20240917$PER$$US-AMGEN-USASP2024152979$AMGEN$$81$YR$E$M$Y$$$20240917$$CN$US$US
241657241$24165724$1$I$$20240729$20240802$20240802$EXP$$US-JAZZ-2020-US-015805$JAZZ$$$$$F$Y$$$20240802$$CN$US$US
241657251$24165725$1$I$$20240724$20240802$20240802$PER$$US-JNJFOC-20240766470$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$HP$US$US
241657262$24165726$2$F$20240225$20240823$20240802$20240827$EXP$$US-GILEAD-2024-0682544$GILEAD$$59$YR$A$F$Y$$$20240827$$CN$US$US
241657271$24165727$1$I$20230827$20240220$20240802$20240802$PER$$US-Accord-380866$ACCORD$$69$YR$E$M$Y$$$20240802$$CN$US$US
241657281$24165728$1$I$$20240722$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-036563$AUROBINDO$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, IglesiasBaena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. International Journal of Molecular Sciences. 2023;24:1-17$1$YR$$M$Y$$$20240802$$HP$ES$ES
241657292$24165729$2$F$20240729$20240903$20240802$20240904$PER$$US-AMGEN-USASP2024151575$AMGEN$$70$YR$E$F$Y$$$20240904$$CN$US$US
241657301$24165730$1$I$$20240722$20240802$20240802$EXP$$CA-RECORDATI-2024005754$RECORDATI$Unspecified$$$$$Y$$$20240802$$HP$CA$CA
241657311$24165731$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037546$AUROBINDO$Patel K, McQuaid S, Ketterl T, Benedetti DJ, Sokol E. Two cases of hepatoblastoma in BohringOpitz syndrome: An emerging association. Pediatr-Blood-Cancer. 2024;71(7)$15$MON$$F$Y$$$20240802$$HP$US$US
241657321$24165732$1$I$20240719$20240724$20240802$20240802$EXP$$CN-SA-2024SA222053$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240802$$HP$CN$CN
241657333$24165733$3$F$20240718$20240913$20240802$20240926$EXP$$CA-HLS-202401799$HLS THERAPEUTICS$$58$YR$A$M$Y$$$20240926$$HP$CA$CA
241657341$24165734$1$I$$20240722$20240802$20240802$EXP$$CA-HLS-202401832$HLS THERAPEUTICS$$$$$M$Y$$$20240802$$HP$CA$CA
241657351$24165735$1$I$$20240722$20240802$20240802$EXP$$US-HLS-202400492$HLS THERAPEUTICS$$54$YR$A$M$Y$$$20240802$$HP$US$US
241657361$24165736$1$I$$20240722$20240802$20240802$EXP$$CA-HLS-202401834$HLS THERAPEUTICS$$70$YR$E$M$Y$$$20240802$$HP$CA$CA
241657371$24165737$1$I$$20240722$20240802$20240802$EXP$$CA-HLS-202401837$HLS THERAPEUTICS$$76$YR$E$M$Y$$$20240802$$HP$CA$CA
241657381$24165738$1$I$$20240724$20240802$20240802$EXP$$US-HLS-202400529$HLS THERAPEUTICS$$29$YR$A$M$Y$$$20240802$$PH$US$US
241657392$24165739$2$F$$20240813$20240802$20240815$PER$$CA-HLS-202401831$HLS THERAPEUTICS$$34$YR$A$F$Y$$$20240815$$HP$CA$CA
241657402$24165740$2$F$$20240813$20240802$20240815$PER$$CA-HLS-202401836$HLS THERAPEUTICS$$66$YR$E$M$Y$$$20240815$$HP$CA$CA
241657411$24165741$1$I$20240301$20240724$20240802$20240802$EXP$$CA-HLS-202401861$HLS THERAPEUTICS$$87$YR$E$M$Y$$$20240802$$PH$CA$CA
241657421$24165742$1$I$$20240722$20240802$20240802$EXP$$CA-HLS-202401838$HLS THERAPEUTICS$$$$$F$Y$$$20240802$$HP$CA$CA
241657431$24165743$1$I$$20240722$20240802$20240802$EXP$$CA-HLS-202401833$HLS THERAPEUTICS$$62$YR$A$F$Y$$$20240802$$HP$CA$CA
241657442$24165744$2$F$20240701$20240826$20240802$20240828$EXP$$US-JAZZ-2022-US-027877$JAZZ$$88$YR$$F$Y$$$20240828$$MD$US$US
241657451$24165745$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046882$ROCHE$$20$YR$A$M$Y$$$20240802$$CN$US$US
241657461$24165746$1$I$$20240723$20240802$20240802$EXP$$US-RDY-LIT/USA/24/0011112$DR REDDYS$Anwar A, Chahine Z, Piecoro D, Kesler M, Qasrawi A. Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia. Human Pathology Reports. 2023 Sep;33: doi:10.1016/j.hpr.2023.300713.$68$YR$E$F$Y$$$20240802$$HP$US$US
241657471$24165747$1$I$20240710$20240725$20240802$20240802$EXP$$BR-BIOVITRUM-2024-BR-010480$BIOVITRUM$$$$$M$Y$$$20240802$$CN$BR$BR
241657481$24165748$1$I$$20240726$20240802$20240802$EXP$$CA-ABBVIE-5846459$ABBVIE$$$$A$F$Y$$$20240802$$CN$CA$CA
241657501$24165750$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037549$AUROBINDO$Jackson DL, Coke L, Zhang SX, Steenbergen C, Khan G, Gorfu G, et al.. Myocarditis and brain abscess caused by disseminated Scedosporium boydii infection. J-Natl-Med-Assoc. 2024;116(3):238-246$52$YR$$M$Y$$$20240802$$HP$US$US
241657511$24165751$1$I$$20240719$20240802$20240802$PER$$US-TEVA-VS-3225021$TEVA$$$$$F$Y$$$20240802$$HP$US$US
241657522$24165752$2$F$20240101$20240904$20240802$20240916$EXP$$US-SA-2024SA221266$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240916$$MD$US$US
241657531$24165753$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000485$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241657541$24165754$1$I$20240725$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000216$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240802$$CN$US$US
241657551$24165755$1$I$$20240801$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408001066$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241657561$24165756$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000341$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240802$$CN$US$US
241657571$24165757$1$I$$20240729$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407020063$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240802$$CN$US$US
241657581$24165758$1$I$20240718$20240726$20240802$20240802$EXP$$JP-ROCHE-10000046355$ROCHE$$6$DEC$A$M$Y$$$20240802$$MD$JP$JP
241657592$24165759$2$F$$20240801$20240802$20240808$PER$$NVSC2024US157344$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241657601$24165760$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190151$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241657611$24165761$1$I$20240723$20240725$20240802$20240802$EXP$GB-MHRA-MED-202407252156382080-YFJKP$GB-TEVA-VS-3226473$TEVA$$$$$$Y$93$KG$20240802$$CN$GB$GB
241657631$24165763$1$I$20091211$20240621$20240802$20240802$EXP$$NZ-ROCHE-10000044400$ROCHE$$58$YR$A$M$Y$120$KG$20240802$$HP$NZ$NZ
241657641$24165764$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-036649$AUROBINDO$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al.. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy.. Experimental and Clinical Transplantation.. 2024;22(5):392-5$68$YR$$F$Y$$$20240802$$MD$US$US
241657651$24165765$1$I$$20240722$20240802$20240802$EXP$$IT-AUROBINDO-AUR-APL-2024-033240$AUROBINDO$Daus F, Maloberti A, Pavanello C, Toscani G, Riccio A, Fabbri S, et al.. MULTIDRUG RESISTANT DYSLIPIDEMIA: A CASE REPORT.. European Heart Journal Supplements.. 2024;26(Supplement 2:155$71$YR$$F$Y$$$20240802$$MD$IT$IT
241657661$24165766$1$I$$20240801$20240802$20240802$PER$$US-ROCHE-10000047104$ROCHE$$$$$$Y$$$20240802$$MD$US$US
241657671$24165767$1$I$20240730$20240730$20240802$20240802$PER$$US-ROCHE-10000044760$ROCHE$$74$YR$E$F$Y$$$20240802$$CN$US$US
241657681$24165768$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A171408$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241657691$24165769$1$I$$20240725$20240802$20240802$EXP$$UG-NOVITIUMPHARMA-2024UGNVP01452$NOVITIUM PHARMA$Mariam Nambuya. A case report: recurrent anemia related to long term acyclovir use in a pregnant HIV infected Ugandan.African Health Sciences.01-APR-2024;24(1):91-93$19$YR$A$F$Y$$$20240802$$HP$UG$UG
241657701$24165770$1$I$$20240726$20240802$20240802$EXP$$FR-AstraZeneca-2024A173577$ASTRAZENECA$$$$$F$Y$$$20240802$$MD$FR$
241657711$24165771$1$I$$20220104$20240802$20240802$EXP$$US-AstraZeneca-2022A008764$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241657721$24165772$1$I$$20230915$20240802$20240802$EXP$$US-AstraZeneca-2023A212175$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241657732$24165773$2$F$20240501$20240806$20240802$20240814$EXP$$JP-AstraZeneca-2024A172753$ASTRAZENECA$$70$YR$$F$Y$$$20240814$$MD$JP$
241657741$24165774$1$I$20211021$20211117$20240802$20240802$EXP$$IN-AstraZeneca-2021A821105$ASTRAZENECA$$27$YR$$F$Y$$$20240802$$CN$IN$
241657752$24165775$2$F$$20240723$20240802$20240802$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP009414$STRIDES$Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al.. Pickering Syndrome: An Overlooked Renovascular Cause of Recurrent Heart Failure.. J-Am-Heart-Assoc. 2023;12 (19)$75$YR$$M$Y$$$20240802$$MD$IT$IT
241657761$24165776$1$I$$20240801$20240802$20240802$PER$$US-ROCHE-10000047365$ROCHE$$54$YR$A$F$Y$$$20240802$$CN$US$US
241657781$24165778$1$I$$20240724$20240802$20240802$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP009467$STRIDES$Gaspar CF, Greenfield H, Carneiro L.. DONEPEZIL AS A CAUSE OF CARDIOGENIC SYNCOPE - ELDERLY HEAVEN OR HELL.. Eur-J-Case-Rep-Intern-Med. 2019;6 (Suppl. 1):116-117.$80$YR$$F$Y$$$20240802$$HP$PT$PT
241657791$24165779$1$I$20051201$20240621$20240802$20240802$EXP$$FR-ROCHE-10000029742$ROCHE$$43$YR$A$F$Y$$$20240802$$CN$FR$FR
241657803$24165780$3$F$20240730$20240830$20240802$20240902$PER$$US-AMGEN-USASP2024151829$AMGEN$$68$YR$E$F$Y$$$20240902$$CN$US$US
241657811$24165781$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152557$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241657821$24165782$1$I$$20240722$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-036571$AUROBINDO$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E.. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. International Journal of Molecular Sciences. 2023;24(17)$10$YR$$F$Y$$$20240802$$HP$ES$ES
241657841$24165784$1$I$$20240725$20240802$20240802$EXP$GB-MHRA-31008345$GB-STRIDES ARCOLAB LIMITED-2024SP009506$STRIDES$$62$YR$$F$Y$62$KG$20240802$$CN$GB$GB
241657853$24165785$3$F$20240101$20240902$20240802$20240912$30DAY$$US-UCBSA-2024007123$UCB$$$$$M$Y$180$KG$20240912$$HP$US$US
241657861$24165786$1$I$$20240729$20240802$20240802$PER$$US-BIOGEN-2024BI01276095$BIOGEN$$$$$F$Y$$$20240802$$CN$US$US
241657871$24165787$1$I$$20240726$20240802$20240802$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP009444$STRIDES$Akin G, Avci C, Akarsu S.. The Significance of Eosinophil-to-Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series.. Indian-J-Dermatol. 2024;69 (1):81-85$72$YR$$M$Y$$$20240802$$MD$TR$TR
241657892$24165789$2$F$20240701$20240808$20240802$20240814$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011574$JAZZ$$46$YR$$F$Y$$$20240814$$CN$US$US
241657901$24165790$1$I$20240304$20240725$20240802$20240802$EXP$$JP-ARDELYX-2024ARDX004290$ARDELYX$$78$YR$$M$Y$$$20240802$$MD$JP$JP
241657911$24165791$1$I$20240701$20240725$20240802$20240802$EXP$$US-ARDELYX-2024ARDX005700$ARDELYX$$44$YR$$F$Y$$$20240802$$HP$US$US
241657922$24165792$2$F$$20240830$20240802$20240907$EXP$$JP-ARDELYX-2024ARDX005780$ARDELYX$$6$DEC$$M$Y$$$20240907$$MD$JP$JP
241657931$24165793$1$I$20240101$20240730$20240802$20240802$EXP$$US-ABBVIE-5862607$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241657941$24165794$1$I$20240517$20240726$20240802$20240802$PER$$US-ABBVIE-5857328$ABBVIE$$29$YR$$F$Y$$$20240802$$MD$US$US
241657951$24165795$1$I$$20240719$20240802$20240802$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK092594$GLENMARK$Ancilla LC, Sundaram B, Pathak N, Raj A.. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy.. Journal of Nephropharmacology.. 2024;13 (2):e11681$$$$$Y$$$20240802$$MD$IN$IN
241657961$24165796$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-035572$AUROBINDO$O?meara KT, Fansiwala K, Kathuria-prakash N, El-masry M, Oh S. Acute hypoxic respiratory failure due to Lenalidomide-induced interstitial pneumonitis in a patient with multiple myeloma.. BMC Pulmonary Medicine. 2024;24:321:1 to 5$80$YR$$M$Y$$$20240802$$HP$US$US
241657971$24165797$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152123$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241657981$24165798$1$I$$20240728$20240802$20240802$EXP$$VN-AstraZeneca-2024A173698$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$VN$
241657991$24165799$1$I$$20240717$20240802$20240802$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-07001$HIKMA$$$$A$F$Y$$$20240802$$CN$US$US
241658001$24165800$1$I$20211029$20221018$20240802$20240802$EXP$$US-AstraZeneca-2021A857006$ASTRAZENECA$$26936$DY$$M$Y$$$20240802$$CN$US$
241658011$24165801$1$I$$20221205$20240802$20240802$EXP$$US-AstraZeneca-2022A403265$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241658021$24165802$1$I$20240606$20240725$20240802$20240802$EXP$ES-AEMPS-1549718$ES-TEVA-VS-3226278$TEVA$$83$YR$$F$Y$$$20240802$$MD$ES$ES
241658031$24165803$1$I$20230310$20230609$20240802$20240802$EXP$$US-AstraZeneca-2023A136011$ASTRAZENECA$$26698$DY$$F$Y$$$20240802$$CN$US$
241658041$24165804$1$I$$20230929$20240802$20240802$EXP$$US-AstraZeneca-2023A223133$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241658051$24165805$1$I$20211202$20211202$20240802$20240802$EXP$$US-AstraZeneca-2021A853980$ASTRAZENECA$$25212$DY$$F$Y$$$20240802$$CN$US$
241658061$24165806$1$I$20210828$20211007$20240802$20240802$EXP$$TW-AstraZeneca-2021A764411$ASTRAZENECA$$69$YR$$M$Y$$$20240802$$HP$TW$
241658071$24165807$1$I$$20240801$20240802$20240802$PER$$US-BIOVITRUM-2024-US-010501$BIOVITRUM$$16$YR$$M$Y$$$20240802$$MD$US$US
241658081$24165808$1$I$$20240724$20240802$20240802$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR095770$VIIV$$$$$$Y$$$20240802$$HP$US$US
241658092$24165809$2$F$20210901$20240924$20240802$20240927$EXP$$JP-GSK-JP2024JPN085341$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$JP$JP
241658101$24165810$1$I$$20240729$20240802$20240802$EXP$GB-MHRA-MED-202407272224566460-HYGZR$GB-STRIDES ARCOLAB LIMITED-2024SP009455$STRIDES$$29$YR$$F$Y$$$20240802$$CN$GB$GB
241658113$24165811$3$F$$20240906$20240802$20240906$PER$$US-ALXN-202407USA001827US$ALEXION PHARMACEUTICALS$$$$$F$Y$45.351$KG$20240906$$CN$US$US
241658122$24165812$2$F$20240729$20240904$20240802$20240904$EXP$$US-ALXN-202407USA002155US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$HP$US$US
241658131$24165813$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037625$AUROBINDO$Fitzsimons J, Phelan K, Dhanarajan A.. Hearing Loss in a Patient with Waldenstrom Macroglobulinemia Receiving Bortezomib.. Case-Rep-Oncol. 2024;17(1):653-657$67$YR$$M$Y$$$20240802$$HP$US$US
241658141$24165814$1$I$$20240730$20240802$20240802$EXP$$NVSC2024US157174$NOVARTIS$$$$$$Y$$$20240802$$CN$US$US
241658154$24165815$4$F$20240430$20240916$20240802$20240920$EXP$$US-ABBVIE-5860471$ABBVIE$$67$YR$$F$Y$73$KG$20240920$$HP$US$US
241658161$24165816$1$I$$20240725$20240802$20240802$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009544$STRIDES$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al.. Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.. Ann-Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240802$$HP$CN$CN
241658171$24165817$1$I$$20240725$20240802$20240802$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009529$STRIDES$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al.. Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.. Ann-Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240802$$HP$CN$CN
241658181$24165818$1$I$20240501$20240725$20240802$20240802$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013891$UNITED THERAPEUTICS$$43$YR$$F$Y$72.109$KG$20240802$$$US$US
241658191$24165819$1$I$$20240729$20240802$20240802$PER$$US-HETERO-HET2024US02181$HETERO$$$$$F$Y$$$20240802$$CN$US$US
241658201$24165820$1$I$$20240728$20240802$20240802$EXP$$BR-TAKEDA-2024TUS076831$TAKEDA$$43$YR$$$Y$$$20240802$$CN$BR$BR
241658211$24165821$1$I$20240101$20240726$20240802$20240802$PER$$US-UNITED THERAPEUTICS-UNT-2024-023666$UNITED THERAPEUTICS$$$$$F$Y$63.946$KG$20240802$$$US$US
241658221$24165822$1$I$$20240719$20240802$20240802$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092596$GLENMARK$Sorabekka RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al.. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children.. ASAIO Journal.. 2024;70(7):e92-6$$$$$Y$$$20240802$$MD$US$US
241658231$24165823$1$I$$20240725$20240802$20240802$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009530$STRIDES$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al.. Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.. Ann-Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240802$$HP$CN$CN
241658241$24165824$1$I$$20240726$20240802$20240802$EXP$$CA-APOTEX-2024AP008932$APOTEX$$69$YR$$F$Y$$$20240802$$PH$CA$CA
241658251$24165825$1$I$$20240723$20240802$20240802$EXP$$CA-AUROBINDO-AUR-APL-2024-037364$AUROBINDO$$54$YR$$F$Y$$$20240802$$HP$CA$CA
241658261$24165826$1$I$$20240719$20240802$20240802$PER$$US-APOTEX-2024AP008775$APOTEX$Glicksman M, Parkash A, Srinivasan S, Farrell ME, Chauhan G.. Spinal Cord Stimulation and Intrathecal Drug Delivery System Therapy in a Pregnant Patient with Complex Regional Pain Syndrome Type II: A Case Report. Pain Medicine Case Reports. 2024;8 (3):81-90$24$YR$$F$Y$$$20240802$$MD$US$US
241658281$24165828$1$I$$20240725$20240802$20240802$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009554$STRIDES$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al.. Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.. Ann-Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240802$$HP$CN$CN
241658291$24165829$1$I$$20240725$20240802$20240802$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009555$STRIDES$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al.. Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.. Ann-Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240802$$HP$CN$CN
241658301$24165830$1$I$$20240725$20240802$20240802$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009556$STRIDES$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al.. Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.. Ann-Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240802$$HP$CN$CN
241658311$24165831$1$I$$20240722$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-036565$AUROBINDO$Al?s-palmer ML, And?jar-vera F, Mu?oz-de-rueda P, Iglesias-baena I, Ocete-hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int. J. Mol. Sci. 2023;24:1-17$5$YR$$M$Y$$$20240802$$HP$ES$ES
241658321$24165832$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037430$AUROBINDO$Nichols MM, Pozdnyakova O. Snapper-Schneid bodies (coarse cytoplasmic granules) in a patient with multiply relapsed multiple myeloma.. Blood. 2024;143(24):2559$66$YR$$M$Y$$$20240802$$HP$US$US
241658331$24165833$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037448$AUROBINDO$Gul MH, Taylor K, Bailey KL, Adickes E. An Unexpected Cause of Acute Liver Failure. Am-JRespir-Crit-Care-Med. 2024;209:A1723$81$YR$$M$Y$$$20240802$$HP$US$US
241658341$24165834$1$I$$20240717$20240802$20240802$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000317$Tarsus Pharmaceuticals$$$$$F$Y$$$20240802$$MD$US$US
241658351$24165835$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019689$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241658361$24165836$1$I$20240731$20240801$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408001299$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240802$$CN$US$US
241658371$24165837$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000424$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240802$$CN$US$US
241658381$24165838$1$I$20240728$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000117$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240802$$CN$US$US
241658391$24165839$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000138$ELI LILLY AND CO$$$$$$Y$$$20240802$$CN$US$US
241658401$24165840$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000968$ELI LILLY AND CO$$$$A$F$Y$$$20240802$$CN$US$US
241658411$24165841$1$I$$20240729$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019679$ELI LILLY AND CO$$16$YR$T$M$Y$$$20240802$$CN$US$US
241658421$24165842$1$I$$20240722$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407014513$ELI LILLY AND CO$$41$YR$A$$Y$$$20240802$$CN$US$US
241658431$24165843$1$I$20240726$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152887$AMGEN$$48$YR$A$F$Y$$$20240802$$CN$US$US
241658441$24165844$1$I$$20240723$20240802$20240802$EXP$$IT-AUROBINDO-AUR-APL-2024-037382$AUROBINDO$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al.. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$83$YR$$F$Y$$$20240802$$MD$IT$IT
241658451$24165845$1$I$$20240725$20240802$20240802$EXP$$CO-NOVITIUMPHARMA-2024CONVP01453$NOVITIUM PHARMA$Bryan Tabares.Fatal co-infection by multiple pathogens in an indigenous woman with autoimmune hemolytic anemia and tuberculosis: a case report.BMC Infectious Diseases.27-JUN-2024;24:1-6$28$YR$A$F$Y$$$20240802$$HP$CO$CO
241658462$24165846$2$F$$20240723$20240802$20240805$EXP$$IT-AUROBINDO-AUR-APL-2024-037772$AUROBINDO$Mannini E, Misirocchi F, Lazzari S, Balella G, Bottignole D, Frapporti M, et al.. Off-label use of cannabidiol in genetic epileptic and developmental encephalopathies: A case report. Epilepsy + Behavior Reports. 2024;27:1-4$30$YR$$F$Y$$$20240805$$HP$IT$IT
241658471$24165847$1$I$$20240723$20240802$20240802$EXP$$IT-AUROBINDO-AUR-APL-2024-038126$AUROBINDO$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al.. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting.. Clinical Therapeutics.. 2024;e1-5.$88$YR$$M$Y$$$20240802$$MD$IT$IT
241658491$24165849$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037733$AUROBINDO$Golob S, Ting P, Pires K, Soetanto V, Pagano B, Wan K-L, et al. Bupropion Overdose Requiring Veno-Arterial Extracorporeal Membrane Oxygenation. Circulation. 2023;148 (Suppl.)no:abstr. 15659$32$YR$$$Y$$$20240802$$HP$US$US
241658501$24165850$1$I$$20240722$20240802$20240802$PER$$US-AstraZeneca-2024A166574$ASTRAZENECA$$$$$F$Y$$$20240802$$HP$US$
241658511$24165851$1$I$$20211124$20240802$20240802$EXP$$PH-AstraZeneca-2021A832943$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$PH$
241658521$24165852$1$I$$20210920$20240802$20240802$EXP$$US-AstraZeneca-2021A737494$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241658531$24165853$1$I$20210601$20211231$20240802$20240802$EXP$$US-AstraZeneca-2022A001383$ASTRAZENECA$$760$MON$$F$Y$$$20240802$$CN$US$
241658541$24165854$1$I$$20221227$20240802$20240802$EXP$$US-AstraZeneca-2022A419645$ASTRAZENECA$$$$$$Y$$$20240802$$HP$US$
241658551$24165855$1$I$$20211013$20240802$20240802$EXP$$US-AstraZeneca-2021A775679$ASTRAZENECA$$$$$F$Y$127$KG$20240802$$CN$US$
241658561$24165856$1$I$20231023$20231025$20240802$20240802$EXP$$CO-AstraZeneca-2023A244263$ASTRAZENECA$$23722$DY$$M$Y$65$KG$20240802$$CN$CO$
241658571$24165857$1$I$20240101$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173722$ASTRAZENECA$$70$YR$$F$Y$$$20240802$$CN$US$
241658581$24165858$1$I$20240723$20240723$20240802$20240802$EXP$$US-JNJFOC-20240765907$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$MD$US$US
241658591$24165859$1$I$$20240726$20240802$20240802$EXP$$JP-JNJFOC-20240803683$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$MD$JP$JP
241658601$24165860$1$I$20230901$20230927$20240802$20240802$EXP$$CA-AstraZeneca-2023A219519$ASTRAZENECA$$1055$MON$$F$Y$$$20240802$$MD$CA$
241658611$24165861$1$I$$20230706$20240802$20240802$EXP$$US-AstraZeneca-2023A156169$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241658621$24165862$1$I$$20230505$20240802$20240802$EXP$$US-AstraZeneca-2023A106251$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241658631$24165863$1$I$$20240727$20240802$20240802$EXP$GB-MHRA-MED-202407271036139910-PFJBY$GB-RDY-SPO/GBR/24/0011147$DR REDDYS$$68$YR$E$$Y$68$KG$20240802$$CN$GB$GB
241658641$24165864$1$I$20240618$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037440$AUROBINDO$$21$YR$$F$Y$55$KG$20240802$$PH$FR$FR
241658652$24165865$2$F$20240601$20240802$20240802$20240809$EXP$FR-AFSSAPS-NT2024000953$NVSC2024FR157239$NOVARTIS$$$$A$M$Y$$$20240809$$MD$FR$FR
241658661$24165866$1$I$20240626$20240725$20240802$20240802$EXP$$DE-TEVA-VS-3225922$TEVA$$91$YR$$M$Y$79$KG$20240802$$MD$DE$DE
241658671$24165867$1$I$20240701$20240729$20240802$20240802$PER$$US-BIOGEN-2024BI01276004$BIOGEN$$24$YR$$F$Y$$$20240802$$CN$US$US
241658683$24165868$3$F$$20240819$20240802$20240827$EXP$$US-BIOGEN-2024BI01276058$BIOGEN$$$$$M$Y$$$20240827$$CN$US$US
241658692$24165869$2$F$20240617$20240731$20240802$20240802$PER$$US-ROCHE-RCA5171928$ROCHE$$36$YR$A$M$Y$$$20240802$$CN$US$US
241658701$24165870$1$I$20240101$20240724$20240802$20240802$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014057$UNITED THERAPEUTICS$$$$$M$Y$98.413$KG$20240802$$$US$US
241658711$24165871$1$I$20240501$20240801$20240802$20240802$EXP$$US-UCBSA-2024038749$UCB$$74$YR$$M$Y$$$20240802$$CN$US$US
241658721$24165872$1$I$$20240723$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-037418$AUROBINDO$$$$I$F$Y$$$20240802$$MD$ES$ES
241658731$24165873$1$I$20240501$20240729$20240802$20240802$EXP$$US-ABBVIE-5860197$ABBVIE$$60$YR$$F$Y$$$20240802$$CN$US$US
241658741$24165874$1$I$20240723$20240725$20240802$20240802$EXP$$GB-ESPERIONTHERAPEUTICS-2024GBR01203$ESPERION THERAPEUTICS$$73$YR$$F$Y$64$KG$20240802$$PH$GB$GB
241658751$24165875$1$I$$20240719$20240802$20240802$EXP$$US-UCBSA-2024036983$UCB$$$$$F$Y$$$20240802$$HP$US$US
241658771$24165877$1$I$20240601$20240725$20240802$20240802$EXP$GB-MHRA-MED-202407250739342500-QMYNB$GB-TEVA-VS-3226060$TEVA$$63$YR$$F$Y$$$20240802$$CN$GB$GB
241658781$24165878$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152544$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241658791$24165879$1$I$20240730$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152994$AMGEN$$74$YR$E$F$Y$$$20240802$$CN$US$US
241658801$24165880$1$I$20240420$20240724$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-037519$AUROBINDO$$75$YR$$M$Y$$$20240802$$MD$ES$ES
241658811$24165881$1$I$$20240729$20240802$20240802$EXP$$US-ABBVIE-5847960$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241658821$24165882$1$I$20240601$20240722$20240802$20240802$EXP$FR-AFSSAPS-TS2024000813$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110206$ZYDUS PHARM$$$$$$Y$$$20240802$$MD$FR$FR
241658831$24165883$1$I$20240614$20240722$20240802$20240802$EXP$FR-AFSSAPS-TO2024001321$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110219$ZYDUS PHARM$$$$$$Y$$$20240802$$MD$FR$FR
241658841$24165884$1$I$20240119$20240722$20240802$20240802$EXP$FR-AFSSAPS-TO2024001320$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110236$ZYDUS PHARM$$$$$$Y$$$20240802$$MD$FR$FR
241658851$24165885$1$I$20240201$20240725$20240802$20240802$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110323$ZYDUS PHARM$$$$$$Y$$$20240802$$CN$US$US
241658861$24165886$1$I$$20240719$20240802$20240802$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110216$ZYDUS PHARM$Kraus MJ, Nguyen J.. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report.. Case-Rep-Neurol. 2024;16 (1):142-147$$$$$Y$$$20240802$$HP$US$US
241658871$24165887$1$I$$20240725$20240802$20240802$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110515$ZYDUS PHARM$$$$$$Y$$$20240802$$CN$US$US
241658881$24165888$1$I$$20240730$20240802$20240802$PER$$US-JNJFOC-20240782176$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240802$$HP$US$US
241658891$24165889$1$I$$20240726$20240802$20240802$PER$$US-ALXN-202407USA001948US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241658901$24165890$1$I$20240501$20240730$20240802$20240802$EXP$$US-ABBVIE-5862003$ABBVIE$$80$YR$$F$Y$$$20240802$$CN$US$US
241658911$24165891$1$I$20240601$20240731$20240802$20240802$EXP$$DE-ABBVIE-5863934$ABBVIE$$46$YR$$M$Y$$$20240802$$CN$DE$DE
241658921$24165892$1$I$20240701$20240731$20240802$20240802$EXP$$US-ABBVIE-5863152$ABBVIE$$41$YR$$F$Y$$$20240802$$CN$US$US
241658941$24165894$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122135$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240802$$CN$US$US
241658951$24165895$1$I$20231001$20240731$20240802$20240802$EXP$$US-GILEAD-2024-0682587$GILEAD$$39$YR$A$F$Y$$$20240802$$CN$US$US
241658961$24165896$1$I$$20240729$20240802$20240802$EXP$$EU-BAUSCHBL-2024BNL030764$BAUSCH AND LOMB$$$$$M$Y$$$20240802$$MD$EU$EU
241658971$24165897$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170112$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241658981$24165898$1$I$20200101$20211228$20240802$20240802$EXP$$US-AstraZeneca-2021A907142$ASTRAZENECA$$76$YR$$F$Y$$$20240802$$CN$US$
241658991$24165899$1$I$20240625$20240726$20240802$20240802$EXP$ES-AEMPS-1548520$ES-TEVA-VS-3226607$TEVA$$58$YR$$M$Y$$$20240802$$MD$ES$ES
241659001$24165900$1$I$20211228$20220111$20240802$20240802$EXP$$US-AstraZeneca-2022A021580$ASTRAZENECA$$26797$DY$$F$Y$$$20240802$$CN$US$
241659011$24165901$1$I$20240702$20240725$20240802$20240802$EXP$FR-AFSSAPS-CN2024000696$FR-TEVA-VS-3226341$TEVA$$61$YR$$M$Y$57$KG$20240802$$MD$FR$FR
241659021$24165902$1$I$$20211227$20240802$20240802$EXP$$US-AstraZeneca-2021A905006$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241659031$24165903$1$I$$20230707$20240802$20240802$EXP$$US-AstraZeneca-2023A157075$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241659041$24165904$1$I$$20240728$20240802$20240802$EXP$$VN-AstraZeneca-2024A173711$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$VN$
241659051$24165905$1$I$$20240726$20240802$20240802$EXP$$RU-AstraZeneca-2024A172371$ASTRAZENECA$$3$YR$$M$Y$$$20240802$$HP$RU$
241659061$24165906$1$I$20231201$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A173557$ASTRAZENECA$$68$YR$$M$Y$84$KG$20240802$$HP$US$
241659071$24165907$1$I$$20230531$20240802$20240802$EXP$$US-AstraZeneca-2023A127106$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241659081$24165908$1$I$$20231115$20240802$20240802$EXP$$US-AstraZeneca-2023A261537$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241659091$24165909$1$I$20240101$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000682$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240802$$CN$US$US
241659101$24165910$1$I$20240701$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000080$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240802$$HP$US$US
241659121$24165912$1$I$$20240729$20240802$20240802$EXP$$CA-APOTEX-2024AP008995$APOTEX$$23$YR$$F$Y$$$20240802$$HP$CA$CA
241659141$24165914$1$I$20240220$20240724$20240802$20240802$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-023342$UNITED THERAPEUTICS$$64$YR$$F$Y$$$20240802$$$JP$JP
241659152$24165915$2$F$20210101$20240912$20240802$20240920$EXP$$DE-AMGEN-DEUSP2024148621$AMGEN$$61$YR$A$F$Y$$$20240920$$PH$DE$DE
241659161$24165916$1$I$$20230301$20240802$20240802$EXP$$US-Appco Pharma LLC-2159915$APPCO PHARMA$Initial$$$$F$Y$2.115$KG$20240802$$$US$US
241659172$24165917$2$F$20240701$20240826$20240802$20240902$EXP$$JP-AMGEN-JPNSP2024134714$AMGEN$$73$YR$E$F$Y$$$20240902$$MD$JP$JP
241659181$24165918$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024092427$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241659201$24165920$1$I$20240601$20240729$20240802$20240802$EXP$$US-TAKEDA-2024TUS076315$TAKEDA$$63$YR$$M$Y$$$20240802$$CN$US$US
241659211$24165921$1$I$20240701$20240731$20240802$20240802$PER$$US-JNJFOC-20240801067$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240802$$CN$US$US
241659222$24165922$2$F$$20240911$20240802$20240914$EXP$$US-TAKEDA-2024TUS076725$TAKEDA$$$$$F$Y$$$20240914$$CN$US$US
241659231$24165923$1$I$$20240726$20240802$20240802$EXP$$US-TAKEDA-2024TUS075809$TAKEDA$$$$$M$Y$$$20240802$$CN$US$US
241659241$24165924$1$I$20240530$20240725$20240802$20240802$EXP$$CN-ROCHE-10000038026$ROCHE$$42$YR$A$F$Y$65$KG$20240802$$HP$CN$CN
241659251$24165925$1$I$$20240708$20240802$20240802$PER$$US-BEIGENE-BGN-2024-010730$BEIGENE$$$$$$Y$$$20240802$$CN$US$US
241659261$24165926$1$I$20240101$20240725$20240802$20240802$PER$$US-APOTEX-2024AP008886$APOTEX$$$$E$F$Y$$$20240802$$MD$US$US
241659271$24165927$1$I$$20240719$20240802$20240802$EXP$$US-UCBSA-2024037024$UCB$$$$$$Y$$$20240802$$CN$US$US
241659281$24165928$1$I$$20240725$20240802$20240802$EXP$$TR-NOVITIUMPHARMA-2024TRNVP01454$NOVITIUM PHARMA$Safiye Gul Kenar.^Tweeting^ Seizures in a Patient with Tuberous Sclerosis with Refractory Epilepsy.Neurological Sciences and Neurophysiology.2024;41:112-114$34$YR$A$M$Y$$$20240802$$HP$TR$TR
241659291$24165929$1$I$$20240729$20240802$20240802$EXP$$CA-TAKEDA-2024TUS076779$TAKEDA$$$$$F$Y$$$20240802$$CN$CA$CA
241659301$24165930$1$I$20190809$20240724$20240802$20240802$EXP$$CA-TAKEDA-2020TUS005765$TAKEDA$$39$YR$$F$Y$$$20240802$$CN$CA$CA
241659311$24165931$1$I$$20240730$20240802$20240802$EXP$$US-ORGANON-O2408USA000107$ORGANON$$$$$F$Y$$$20240802$$CN$US$US
241659321$24165932$1$I$20240101$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152659$AMGEN$$20$YR$A$M$Y$$$20240802$$HP$US$US
241659332$24165933$2$F$20240101$20240826$20240802$20240902$EXP$$US-RECORDATI RARE DISEASE INC.-2024005767$RECORDATI$$$$$$Y$$$20240902$$CN$US$US
241659341$24165934$1$I$20240719$20240726$20240802$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121694$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240802$$PH$JP$JP
241659351$24165935$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122165$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240802$$HP$US$US
241659361$24165936$1$I$$20240731$20240802$20240802$PER$$NVSC2024US157374$NOVARTIS$$$$$F$Y$78$KG$20240802$$CN$US$US
241659377$24165937$7$F$$20240920$20240802$20240921$PER$$NVSC2024US156798$NOVARTIS$$$$$$Y$$$20240921$$CN$US$US
241659381$24165938$1$I$20240725$20240729$20240802$20240802$30DAY$$IT-SANDOZ INC.-SDZ2024IT069693$SANDOZ$$10$YR$$F$Y$36$KG$20240802$$CN$IT$IT
241659391$24165939$1$I$$20240731$20240802$20240802$EXP$$GB-SANDOZ INC.-SDZ2024GB069888$SANDOZ$$$$$F$Y$$$20240802$$CN$GB$GB
241659412$24165941$2$F$$20240927$20240802$20240930$EXP$$US-SANDOZ INC.-SDZ2024US069706$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
241659421$24165942$1$I$$20240729$20240802$20240802$EXP$$DE-JNJFOC-20240780690$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$MD$DE$DE
241659431$24165943$1$I$$20240731$20240802$20240802$PER$$US-JNJFOC-20240800103$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240802$$HP$US$US
241659442$24165944$2$F$20240723$20240826$20240802$20240905$PER$$US-JNJFOC-20240801964$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240905$$PH$US$US
241659452$24165945$2$F$$20240829$20240802$20240901$PER$$US-JNJFOC-20240780910$JOHNSON AND JOHNSON$$$$$M$Y$$$20240901$$HP$US$US
241659462$24165946$2$F$$20240830$20240802$20240901$PER$$US-JNJFOC-20240781116$JOHNSON AND JOHNSON$$$$$M$Y$$$20240901$$HP$US$US
241659473$24165947$3$F$20240706$20240911$20240802$20240927$PER$$US-JNJFOC-20240780189$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
241659481$24165948$1$I$$20240725$20240802$20240802$EXP$FR-AFSSAPS-LM2023000077$FR-SA-2024SA220742$SANOFI AVENTIS$$$$$$Y$$$20240802$$MD$FR$FR
241659491$24165949$1$I$20240624$20240725$20240802$20240802$EXP$FR-AFSSAPS-PC2024000574$FR-SA-2024SA220717$SANOFI AVENTIS$$51$YR$A$F$Y$57$KG$20240802$$MD$FR$FR
241659501$24165950$1$I$20240729$20240801$20240802$20240802$PER$$US-HALEON-2190131$Haleon PLC$$66$YR$$F$Y$$$20240802$$CN$US$US
241659511$24165951$1$I$20240710$20240724$20240802$20240802$EXP$$CN-ROCHE-10000035615$ROCHE$$59$YR$A$F$Y$65$KG$20240802$$HP$CN$CN
241659521$24165952$1$I$$20240725$20240802$20240802$PER$$US-MTPC-MTDA2024-0015631$MITSUBISHI TANABE PHARMA$$$$A$$Y$$$20240802$$HP$US$US
241659531$24165953$1$I$20240101$20240725$20240802$20240802$EXP$$US-SA-2024SA225332$SANOFI AVENTIS$$3$YR$C$M$Y$15.4$KG$20240802$$MD$US$US
241659542$24165954$2$F$20240101$20240731$20240802$20240806$PER$$US-AMGEN-USASP2024152067$AMGEN$$73$YR$E$F$Y$$$20240805$$CN$US$US
241659551$24165955$1$I$$20240725$20240802$20240802$EXP$$JP-MTPC-MTPC2024-0014732$MITSUBISHI TANABE PHARMA$$71$YR$$F$Y$$$20240802$$PH$JP$JP
241659562$24165956$2$F$20240725$20240819$20240802$20240822$EXP$$JP-MTPC-MTPC2024-0015777$Unknown Manufacturer$$8$DEC$$F$Y$$$20240822$$PH$JP$JP
241659571$24165957$1$I$$20240723$20240802$20240802$EXP$LB-JNJFOC-20240767984$LB-TAKEDA-2024TUS077130$TAKEDA$$72$YR$$F$Y$$$20240802$$HP$LB$LB
241659581$24165958$1$I$$20240605$20240802$20240802$PER$$US-CIPLA LTD.-2024US05879$CIPLA$$$$$$Y$$$20240802$$CN$US$US
241659591$24165959$1$I$$20220606$20240802$20240802$EXP$$US-AstraZeneca-2022A211373$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241659602$24165960$2$F$$20240905$20240802$20240912$PER$$US-AstraZeneca-2024A173775$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
241659611$24165961$1$I$$20220629$20240802$20240802$EXP$$US-AstraZeneca-2022A240032$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241659621$24165962$1$I$20200101$20220301$20240802$20240802$EXP$$GT-AstraZeneca-2022A095102$ASTRAZENECA$$23097$DY$$M$Y$$$20240802$$CN$GT$
241659632$24165963$2$F$$20221129$20240802$20240911$EXP$$BE-AstraZeneca-2022A395977$ASTRAZENECA$$$$$M$Y$$$20240911$$MD$BE$
241659641$24165964$1$I$$20211117$20240802$20240802$EXP$$US-AstraZeneca-2021A811171$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241659651$24165965$1$I$$20230314$20240802$20240802$EXP$$US-AstraZeneca-2023A062206$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241659661$24165966$1$I$20200101$20230106$20240802$20240802$EXP$$US-AstraZeneca-2023A006729$ASTRAZENECA$$60$YR$$F$Y$61.2$KG$20240802$$CN$US$
241659671$24165967$1$I$$20220224$20240802$20240802$EXP$$US-AstraZeneca-2022A089390$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241659681$24165968$1$I$$20221024$20240802$20240802$EXP$$US-AstraZeneca-2022A356517$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241659691$24165969$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A169788$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241659701$24165970$1$I$$20210920$20240802$20240802$EXP$$US-AstraZeneca-2021A748208$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241659712$24165971$2$F$$20240912$20240802$20240923$PER$$US-JNJFOC-20240781575$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$US$US
241659721$24165972$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A171095$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241659741$24165974$1$I$20240729$20240729$20240802$20240802$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700116$RIGEL PHARMACEUTICALS$$66$YR$$M$Y$207.75$KG$20240802$$CN$US$US
241659751$24165975$1$I$$20240718$20240802$20240802$PER$$US-TEVA-VS-3222940$TEVA$$$$$F$Y$$$20240802$$CN$US$US
241659761$24165976$1$I$$20240724$20240802$20240802$EXP$$GB-MSNLABS-2024MSNSPO01679$MSN LABORATORIES$$$$$$Y$$$20240802$$PH$GB$GB
241659771$24165977$1$I$$20240730$20240802$20240802$PER$$US-GILEAD-2024-0682472$GILEAD$$$$T$F$Y$$$20240802$$CN$US$US
241659781$24165978$1$I$$20240731$20240802$20240802$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043359$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240802$$PH$US$US
241659792$24165979$2$F$20240717$20240819$20240802$20240902$PER$$US-APOTEX-2024AP008569$APOTEX$$$$$F$Y$$$20240902$$CN$US$US
241659801$24165980$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122094$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240802$$HP$US$US
241659811$24165981$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122168$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240802$$HP$US$US
241659821$24165982$1$I$$20240731$20240802$20240802$EXP$$US-TAKEDA-2024TUS077165$TAKEDA$$$$$F$Y$$$20240802$$CN$US$US
241659831$24165983$1$I$20240729$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000922$ELI LILLY AND CO$$9$YR$C$F$Y$$$20240802$$CN$US$US
241659841$24165984$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019662$ELI LILLY AND CO$$$$$M$Y$$$20240802$$CN$US$US
241659851$24165985$1$I$20240501$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000217$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240802$$CN$US$US
241659861$24165986$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000180$ELI LILLY AND CO$$17$YR$T$F$Y$$$20240802$$CN$US$US
241659871$24165987$1$I$$20240721$20240802$20240802$EXP$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000178-2024$QILU PHARMACEUTICAL$Fitzsimons J Phelan K Dhanarajan A.Hearing Loss in a Patient with Waldenstrom Macroglobulinemia Receiving Bortezomib..Case Reports in Oncology.18-JUN-2024;17 (1):653-657$67$YR$E$M$Y$$$20240802$$HP$US$US
241659882$24165988$2$F$$20240731$20240802$20240809$EXP$$JP-ROCHE-10000041805$ROCHE$$$$A$M$Y$$$20240809$$MD$JP$JP
241659891$24165989$1$I$20240704$20240730$20240802$20240802$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095365$VIIV$$$$$$Y$$$20240802$$CN$US$US
241659902$24165990$2$F$$20240812$20240802$20240823$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092650$GLENMARK$$$$$$Y$$$20240823$$CN$US$US
241659911$24165991$1$I$$20240725$20240802$20240802$EXP$$RO-JNJFOC-20240756086$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240802$$HP$RO$RO
241659922$24165992$2$F$20240725$20240805$20240802$20240809$PER$$US-AMGEN-USASP2024149008$AMGEN$$70$YR$E$F$Y$82.2$KG$20240808$$PH$US$US
241659931$24165993$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151757$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241659941$24165994$1$I$$20240724$20240802$20240802$EXP$$CA-ALVOGEN-2024095206$ALVOGEN$Adamo A, Marshall K, Woodall KL. Fentanyl-Related Deaths in Ontario, Canada: Toxicological Findings and Circumstances of  Death in 4395 Cases (2020-2022). Journal of Analytical Toxicology. 2024; doi:https://doi.org/10.1093/jat/bkae061$21$YR$$F$Y$$$20240802$$HP$CA$CA
241659953$24165995$3$F$20240101$20240822$20240802$20240827$PER$$US-AMGEN-USASP2024151788$AMGEN$$48$YR$A$F$Y$$$20240827$$HP$US$US
241659961$24165996$1$I$$20240608$20240802$20240802$PER$$US-Accord-429946$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
241659972$24165997$2$F$20210101$20240815$20240802$20240827$EXP$$US-Accord-429925$ACCORD$$72$YR$E$F$Y$$$20240827$$LW$US$US
241659981$24165998$1$I$20201201$20240426$20240802$20240802$PER$$US-Accord-422336$ACCORD$$48$YR$A$F$Y$$$20240802$$LW$US$US
241659991$24165999$1$I$20220512$20240510$20240802$20240802$EXP$$US-Accord-424914$ACCORD$$70$YR$E$F$Y$$$20240802$$LW$US$US
241660001$24166000$1$I$$20240513$20240802$20240802$PER$$US-Accord-425182$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
241660011$24166001$1$I$$20240608$20240802$20240802$PER$$US-Accord-429926$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
241660021$24166002$1$I$$20240510$20240802$20240802$PER$$US-Accord-424759$ACCORD$$$$$F$Y$$$20240802$$LW$US$US
241660031$24166003$1$I$$20240416$20240802$20240802$PER$$US-Accord-422629$ACCORD$$70$YR$E$M$Y$$$20240802$$CN$US$US
241660041$24166004$1$I$20170101$20240426$20240802$20240802$PER$$US-Accord-422337$ACCORD$$60$YR$A$F$Y$$$20240802$$LW$US$US
241660054$24166005$4$F$20240314$20240919$20240802$20240928$EXP$$CA-CELLTRION INC.-2024CA007288$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
241660061$24166006$1$I$$20240711$20240802$20240802$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003495$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241660071$24166007$1$I$20230601$20240726$20240802$20240802$EXP$$US-SA-2024SA226988$SANOFI AVENTIS$$22$YR$A$F$Y$56$KG$20240802$$MD$US$US
241660081$24166008$1$I$$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037385$AUROBINDO$$50$YR$$F$Y$$$20240802$$PH$FR$FR
241660091$24166009$1$I$$20240725$20240802$20240802$30DAY$$US-JNJFOC-20240784040$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241660102$24166010$2$F$20240724$20240819$20240802$20240826$PER$$US-AMGEN-USASP2024149569$AMGEN$$67$YR$E$F$Y$54.6$KG$20240826$$PH$US$US
241660111$24166011$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152035$AMGEN$$73$YR$E$F$Y$$$20240802$$MD$US$US
241660121$24166012$1$I$20240424$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152332$AMGEN$$53$YR$A$F$Y$$$20240802$$CN$US$US
241660131$24166013$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151378$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241660141$24166014$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151731$AMGEN$$$$$F$Y$$$20240802$$CN$US$US
241660151$24166015$1$I$$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024152289$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241660161$24166016$1$I$20240301$20240801$20240802$20240802$EXP$FR-AFSSAPS-RS2024000768$FR-ABBVIE-5863055$ABBVIE$$69$YR$$F$Y$$$20240802$$MD$FR$FR
241660171$24166017$1$I$20240723$20240724$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037391$AUROBINDO$$70$YR$$F$Y$$$20240802$$CN$GB$GB
241660182$24166018$2$F$20240722$20240808$20240802$20240815$EXP$$JP-ROCHE-10000040698$ROCHE$$$$E$M$Y$$$20240815$$MD$JP$JP
241660191$24166019$1$I$$20240724$20240802$20240802$30DAY$$US-GSK-US2024092989$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$CN$US$US
241660201$24166020$1$I$20240715$20240724$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037479$AUROBINDO$$95$YR$$F$Y$$$20240802$$MD$GB$GB
241660211$24166021$1$I$$20240726$20240802$20240802$EXP$$JP-ALXN-202407JPN001839JP$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$MD$JP$JP
241660221$24166022$1$I$$20220422$20240802$20240802$EXP$$US-AstraZeneca-2022A163515$ASTRAZENECA$$$$$M$Y$73$KG$20240802$$CN$US$
241660232$24166023$2$F$$20240821$20240802$20240822$PER$$US-ALXN-202407USA001892US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
241660241$24166024$1$I$$20240730$20240802$20240802$EXP$$AR-AstraZeneca-2024A173462$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$AR$
241660251$24166025$1$I$20210301$20211207$20240802$20240802$EXP$$US-AstraZeneca-2021A864039$ASTRAZENECA$$30904$DY$$F$Y$$$20240802$$CN$US$
241660261$24166026$1$I$$20240722$20240802$20240802$PER$$US-AstraZeneca-2024A171964$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241660271$24166027$1$I$20240719$20240731$20240802$20240802$EXP$$GR-ABBVIE-5850331$ABBVIE$$79$YR$$F$Y$$$20240802$$MD$GR$GR
241660281$24166028$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170353$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241660291$24166029$1$I$$20210817$20240802$20240802$EXP$$US-AstraZeneca-2021A687409$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241660301$24166030$1$I$$20211228$20240802$20240802$EXP$$US-AstraZeneca-2021A824657$ASTRAZENECA$$$$$F$Y$48.1$KG$20240802$$CN$US$
241660311$24166031$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A172345$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241660322$24166032$2$F$20240721$20240820$20240802$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042561$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240821$$CN$US$US
241660331$24166033$1$I$$20240726$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119987$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240802$$HP$US$US
241660341$24166034$1$I$20230809$20240726$20240802$20240802$EXP$$CN-EMD Serono-2024040939$EMD SERONO INC$$61$YR$A$F$Y$64$KG$20240802$$HP$CN$CN
241660351$24166035$1$I$$20240724$20240802$20240802$EXP$$DE-ALVOGEN-2024095162$ALVOGEN$Heinz P,  Schuldes S, Wolf B. Locked-in Syndrome After Pontine Hemorrhage in an Amphetamine Abuser. Deutsches Arzteblatt International. 2024 May 17;121(10):330. doi:https://dx.doi.org/10.3238/arztebl.m2023.0330$37$YR$$F$Y$$$20240802$$MD$DE$DE
241660361$24166036$1$I$20240601$20240725$20240802$20240802$EXP$DE-CADRBFARM-2024329351$DE-TEVA-VS-3226143$TEVA$$46$YR$$F$Y$78$KG$20240802$$CN$DE$DE
241660372$24166037$2$F$$20240816$20240802$20240828$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092651$GLENMARK$$$$$$Y$$$20240828$$CN$US$US
241660381$24166038$1$I$$20240722$20240802$20240802$EXP$$JP-ROCHE-10000042257$ROCHE$Hosoi M, Ueno K, Kikuchi J, Miyauchi J, Ooka R, Takikawa K. An unfavorable and a successful pregnancy outcome during and after treatment of gamma heavy chain disease. International Journal of Hematology. 2024-Jul;120 (1):135-141. doi:10.1007/s12185-024-03769-1.$165$DY$I$M$Y$0.268$KG$20240802$$HP$JP$JP
241660391$24166039$1$I$$20240730$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US069646$SANDOZ$$$$$$Y$$$20240802$$CN$US$US
241660401$24166040$1$I$20240501$20240725$20240802$20240802$EXP$GB-MHRA-31122984$GB-MSNLABS-2024MSNSPO01687$MSN LABORATORIES$$$$$$Y$$$20240802$$MD$GB$GB
241660411$24166041$1$I$$20240730$20240802$20240802$PER$$NVSC2024US156930$NOVARTIS$$$$$M$Y$$$20240802$$MD$US$US
241660421$24166042$1$I$20240501$20240724$20240802$20240802$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014587$UNITED THERAPEUTICS$$64$YR$$F$Y$$$20240802$$$US$US
241660431$24166043$1$I$$20240730$20240802$20240802$EXP$$US-TAKEDA-2024TUS076923$TAKEDA$$$$$M$Y$$$20240802$$CN$US$US
241660441$24166044$1$I$$20240725$20240802$20240802$EXP$$US-TAKEDA-2024TUS075675$TAKEDA$$$$$F$Y$$$20240802$$CN$US$US
241660451$24166045$1$I$20240706$20240726$20240802$20240802$EXP$$HR-TAKEDA-2024TUS076983$TAKEDA$$59$YR$$M$Y$$$20240802$$HP$HR$HR
241660471$24166047$1$I$20240726$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024150236$AMGEN$$74$YR$E$M$Y$$$20240802$$CN$US$US
241660481$24166048$1$I$$20240730$20240802$20240802$PER$$US-HALEON-2190057$Haleon PLC$$$$$M$Y$$$20240802$$CN$US$US
241660491$24166049$1$I$$20240719$20240802$20240802$EXP$$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001870$IPCA$$$$$$Y$$$20240802$$HP$GB$GB
241660501$24166050$1$I$20190919$20240729$20240802$20240802$EXP$PT-INFARMED-T202407-276$PT-TEVA-VS-3227522$TEVA$$36$YR$$M$Y$69$KG$20240802$$CN$PT$PT
241660511$24166051$1$I$$20240709$20240802$20240802$PER$$US-JNJFOC-20240728610$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241660521$24166052$1$I$$20240731$20240802$20240802$PER$$US-JNJFOC-20240800070$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240802$$HP$US$US
241660531$24166053$1$I$$20240723$20240802$20240802$EXP$$US-RDY-LIT/USA/24/0011108$DR REDDYS$Velez IO, Huertas EG, Velez NR, Ramirez J, Perez Mitchell MC, Torrech C, et al. The Challenge of Multi-organism Lung Infection With Human Immunodeficiency Virus. American Journal of Respiratory and Critical Medicine. 2023;207: doi:10.1164/conference.2023.B63.$57$YR$A$M$Y$$$20240802$$HP$US$US
241660541$24166054$1$I$$20240723$20240802$20240802$EXP$$US-RDY-LIT/USA/24/0011111$DR REDDYS$Anwar A, Chahine Z, Piecoro D, Kesler M, Qasrawi A. Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia. Human Pathology Reports. 2023 Sep;33: doi:10.1016/j.hpr.2023.300713.$51$YR$A$F$Y$$$20240802$$HP$US$US
241660551$24166055$1$I$$20240723$20240802$20240802$EXP$$US-RDY-LIT/USA/24/0011107$DR REDDYS$Majid M, Arockiam AD, Yaker ZS, Kumar A, Agrawal, A, Bhalla JS, et al. A CASE OF LONGSTANDING CHRONIC RECURRENT PERICARDITIS MANAGED WITH ADVANCED DIAGNOSTIC AND THERAPEUTIC METHODS. Journal of the American College of Cardiology. 2024 Apr 02;83(13): 3496. doi:10.1016/S0735-1097%2824%2905486-X.$65$YR$E$F$Y$$$20240802$$HP$US$US
241660561$24166056$1$I$$20240724$20240802$20240802$EXP$$US-ROCHE-10000037775$ROCHE$$$$$F$Y$$$20240802$$MD$US$US
241660572$24166057$2$F$20240805$20240808$20240802$20240816$EXP$$US-GSK-US2024AMR092659$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240816$$CN$US$US
241660581$24166058$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190125$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241660591$24166059$1$I$$20240729$20240802$20240802$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011565$JAZZ$$$$$F$Y$$$20240802$$CN$US$US
241660601$24166060$1$I$20240101$20240723$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117752$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240802$$CN$US$US
241660611$24166061$1$I$20230101$20240729$20240802$20240802$PER$$US-BIOGEN-2023BI01228522$BIOGEN$$$$$M$Y$$$20240802$$CN$US$US
241660621$24166062$1$I$$20240721$20240802$20240802$EXP$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000177-2024$QILU PHARMACEUTICAL$Rafee Y Ghanim N Kamal M Elsheikh W Al Nahar M Onwuzurike N Schnepp A.Primary Cutaneous Mucormycosis Confirmed by Molecular Testing in a Child With Acute Lymphoblastic Leukemia on Daily Imatinib.The Pediatric Infectious Disease Journal.15-JUL-2024;1-2$5$YR$C$F$Y$$$20240802$$MD$US$US
241660631$24166063$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000295$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240802$$CN$US$US
241660642$24166064$2$F$20240708$20240813$20240802$20240906$PER$$US-BEIGENE-BGN-2024-010646$BEIGENE$$$$$$Y$$$20240906$$MD$US$US
241660651$24166065$1$I$20240101$20240731$20240802$20240802$EXP$$US-TAKEDA-2024TUS032855$TAKEDA$$53$YR$$F$Y$$$20240802$$HP$US$US
241660661$24166066$1$I$$20240729$20240802$20240802$EXP$$CA-TEVA-VS-3227847$TEVA$$78$YR$$F$Y$$$20240802$$HP$CA$CA
241660671$24166067$1$I$$20240726$20240802$20240802$PER$$US-ALXN-202407USA001894US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241660681$24166068$1$I$$20240727$20240802$20240802$EXP$GB-MHRA-MED-202407262147142410-THDNB$GB-MSNLABS-2024MSNSPO01694$MSN LABORATORIES$$$$$$Y$$$20240802$$CN$GB$GB
241660692$24166069$2$F$20240730$20240902$20240802$20240903$PER$$US-JNJFOC-20240785277$JOHNSON AND JOHNSON$$43$YR$A$$Y$$$20240903$$PH$US$US
241660701$24166070$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024092327$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241660711$24166071$1$I$20240720$20240731$20240802$20240802$EXP$$CN-GSK-CN2024GSK096147$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$CN$CN
241660721$24166072$1$I$20240701$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-036931$AUROBINDO$$63$YR$$M$Y$77$KG$20240802$$PH$FR$FR
241660731$24166073$1$I$20240301$20240723$20240802$20240802$EXP$$CO-CIPLA (EU) LIMITED-2024CO02895$CIPLA$$$$$$Y$$$20240802$$CN$CO$CO
241660741$24166074$1$I$20240701$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A172634$ASTRAZENECA$$757$MON$$F$Y$84.4$KG$20240802$$CN$US$
241660751$24166075$1$I$$20240725$20240802$20240802$EXP$$JP-AstraZeneca-2024A172310$ASTRAZENECA$$$$$$Y$$$20240802$$MD$JP$
241660761$24166076$1$I$$20230621$20240802$20240802$EXP$$US-AstraZeneca-2023A144150$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241660771$24166077$1$I$$20230816$20240802$20240802$EXP$$US-AstraZeneca-2023A144988$ASTRAZENECA$$76$YR$$F$Y$53.5$KG$20240802$$CN$US$
241660781$24166078$1$I$$20230412$20240802$20240802$EXP$$US-AstraZeneca-2023A087063$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241660791$24166079$1$I$$20230922$20240802$20240802$EXP$$US-AstraZeneca-2023A217720$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241660801$24166080$1$I$$20230302$20240802$20240802$EXP$$US-AstraZeneca-2023A052515$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241660811$24166081$1$I$$20230921$20240802$20240802$EXP$$US-AstraZeneca-2023A217319$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241660821$24166082$1$I$$20240729$20240802$20240802$EXP$$US-AstraZeneca-2024A172207$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241660831$24166083$1$I$20240726$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024151207$AMGEN$$76$YR$E$F$Y$$$20240802$$CN$US$US
241660841$24166084$1$I$$20240730$20240802$20240802$EXP$$US-AMGEN-USASP2024151818$AMGEN$$$$A$F$Y$$$20240802$$HP$US$US
241660851$24166085$1$I$$20211014$20240802$20240802$EXP$$US-AstraZeneca-2021A775031$ASTRAZENECA$$$$$F$Y$53.1$KG$20240802$$CN$US$
241660862$24166086$2$F$20240101$20240827$20240802$20240829$EXP$$US-ABBVIE-5829641$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
241660871$24166087$1$I$$20240728$20240802$20240802$EXP$$NL-ABBVIE-5860726$ABBVIE$$$$$$Y$$$20240802$$CN$NL$NL
241660882$24166088$2$F$$20240903$20240802$20240910$30DAY$$FR-JNJFOC-20240783668$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$PH$FR$FR
241660891$24166089$1$I$20240613$20240730$20240802$20240802$EXP$$AU-TAKEDA-2024TUS077094$TAKEDA$$67$YR$$M$Y$$$20240802$$CN$AU$AU
241660912$24166091$2$F$$20240904$20240802$20240924$PER$$US-TEVA-VS-3224568$TEVA$$57$YR$$M$Y$$$20240924$$CN$US$US
241660921$24166092$1$I$20240607$20240726$20240802$20240802$EXP$ES-AEMPS-1551742$ES-HIKMA PHARMACEUTICALS-ES-H14001-24-07202$HIKMA$$$$$$Y$$$20240802$$PH$ES$ES
241660931$24166093$1$I$20100101$20240726$20240802$20240802$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040375$BOEHRINGER INGELHEIM$$88$YR$E$F$Y$$$20240802$$CN$BR$BR
241660941$24166094$1$I$$20230802$20240802$20240802$EXP$$CA-CELLTRION INC.-2023CA025706$CELLTRION$$$$$$Y$$$20240802$$CN$CA$CA
241660952$24166095$2$F$20230606$20240801$20240802$20240811$EXP$$XI-TEVA-VS-3226380$TEVA$$52$YR$$M$Y$$$20240811$$MD$GB$GB
241660961$24166096$1$I$$20240701$20240802$20240802$PER$$US-ROCHE-10000047297$ROCHE$$$$$$Y$$$20240802$$CN$US$US
241660971$24166097$1$I$$20240722$20240802$20240802$EXP$$SG-ROCHE-10000036354$ROCHE$$58$YR$A$F$Y$$$20240802$$CN$SG$SG
241660981$24166098$1$I$$20240617$20240802$20240802$EXP$$VN-ROCHE-10000043459$ROCHE$$19$YR$A$M$Y$$$20240802$$MD$VN$VN
241660991$24166099$1$I$$20240724$20240802$20240802$EXP$GB-MHRA-MIDB-3e0b2222-b1da-4514-8e7d-db4030fecfee$GB-TEVA-VS-3225697$TEVA$$95$YR$$F$Y$$$20240802$$PH$GB$GB
241661001$24166100$1$I$$20240719$20240802$20240802$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092673$GLENMARK$Bowen MB, Melendez B, Zhang Q, Yang RK, Fellman BM, Lawson BC, et. al.. Long-term follow-up of levonorgestrel intrauterine device for atypical hyperplasia and early endometrial cancer reveals relapse characterized by immune exhaustion.. Clinical cancer research: an official journal of the American Association for Ca. 2024$$$$$Y$$$20240802$$HP$US$US
241661011$24166101$1$I$$20240731$20240802$20240802$EXP$$US-TAKEDA-2024TUS077182$TAKEDA$$$$$F$Y$$$20240802$$CN$US$US
241661021$24166102$1$I$$20240725$20240802$20240802$EXP$$US-RIGEL-20240700110$RIGEL PHARMACEUTICALS$$$$$F$Y$60.781$KG$20240802$$CN$US$US
241661031$24166103$1$I$$20240726$20240802$20240802$PER$$US-TAKEDA-2024TUS076184$TAKEDA$$72$YR$$M$Y$112$KG$20240802$$MD$US$US
241661041$24166104$1$I$20240601$20240731$20240802$20240802$EXP$$US-ABBVIE-5863305$ABBVIE$$55$YR$$M$Y$$$20240802$$CN$US$US
241661051$24166105$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153066$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241661062$24166106$2$F$20240801$20240802$20240802$20240806$PER$$US-AMGEN-USASP2024153499$AMGEN$$46$YR$A$$Y$$$20240805$$CN$US$US
241661071$24166107$1$I$$20240726$20240802$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121707$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240802$$MD$JP$JP
241661081$24166108$1$I$20230403$20240721$20240802$20240802$EXP$$CN-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000174-2024$QILU PHARMACEUTICAL$Ju Y Zhu Y Zhu G Wang M Wu R.Lower-extremity deep vein thrombosis induced by oxaliplatin and capecitabine chemotherapy: A case report.Asia-Pacific Journal of Oncology Nursing.14-MAY-2024;11(7):1-4$64$YR$A$M$Y$76$KG$20240730$$HP$CN$CN
241661092$24166109$2$F$20120403$20240828$20240802$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-037406$AUROBINDO$$$DY$$M$Y$$$20240906$$MD$GB$GB
241661102$24166110$2$F$$20240904$20240802$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07465$LUPIN$$$$$$Y$$$20240913$$CN$US$US
241661111$24166111$1$I$$20240725$20240802$20240802$EXP$GB-MHRA-FAKE-202407080853418920-FDLTV$GB-TEVA-VS-3226085$TEVA$$$$$$Y$$$20240802$$CN$GB$GB
241661121$24166112$1$I$20230328$20231116$20240802$20240802$EXP$$CA-CELLTRION INC.-2022CA022686$CELLTRION$$$$$$Y$$$20240802$$MD$CA$CA
241661131$24166113$1$I$$20240719$20240802$20240802$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092674$GLENMARK$Bowen MB, Melendez B, Zhang Q, Yang RK, Fellman BM, Lawson BC, et. al.. Long-term follow-up of levonorgestrel intrauterine device for atypical hyperplasia and early endometrial cancer reveals relapse characterized by immune exhaustion.. Clinical cancer research: an official journal of the American Association for Ca. 2024$$$$$Y$$$20240802$$HP$US$US
241661141$24166114$1$I$20240715$20240724$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037483$AUROBINDO$$95$YR$$F$Y$$$20240802$$MD$GB$GB
241661151$24166115$1$I$20230624$20240725$20240802$20240802$EXP$FR-AFSSAPS-BS2024000448$FR-TEVA-VS-3226343$TEVA$$50$YR$$M$Y$$$20240802$$MD$FR$FR
241661162$24166116$2$F$$20240821$20240802$20240822$PER$$US-ALXN-202407USA001903US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
241661171$24166117$1$I$$20240725$20240802$20240802$EXP$GB-MYLANLABS-2024M1062176$GB-JUBILANT PHARMA LTD-2024GB001093$JUBILANT$$$$A$F$Y$$$20240802$$PH$GB$GB
241661182$24166118$2$F$20240715$20240802$20240802$20240814$EXP$GB-MHRA-MED-202407240808085920-WDRBP$GB-JUBILANT PHARMA LTD-2024GB001084$JUBILANT$$60$YR$$M$Y$68$KG$20240814$$CN$GB$GB
241661191$24166119$1$I$$20240730$20240802$20240802$PER$$US-TAKEDA-2024TUS076783$TAKEDA$$$$$F$Y$$$20240802$$CN$US$US
241661211$24166121$1$I$$20240730$20240802$20240802$PER$$US-ROCHE-10000043454$ROCHE$$51$YR$A$F$Y$$$20240802$$CN$US$US
241661221$24166122$1$I$$20240719$20240802$20240802$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092675$GLENMARK$Bowen M.B., Melendez B., Zhang Q., Yang R.K., Fellman B.M., Lawson B.C., et. al. Long-term follow-up of levonorgestrel intrauterine device for atypical hyperplasia and early endometrial cancer reveals relapse characterized by immune exhaustion. Clinical cancer research : an official journal of the American Association for C. 2024$$$$$Y$$$20240802$$HP$US$US
241661231$24166123$1$I$$20240718$20240802$20240802$EXP$$US-LUPIN HEALTHCARE (UK) LIMITED-2024-07230$LUPIN$Samuelson Bannow BT. Management of abnormal uterine bleeding on anticoagulation: The patient-clinician perspective. Journal of Thrombosis and Haemostasis. 2024;22 (7):1819-1825$27$YR$$F$Y$$$20240802$$HP$US$US
241661241$24166124$1$I$20240221$20240722$20240802$20240802$EXP$FR-AFSSAPS-NC2024000869$FR-BEH-2024176027$CSL BEHRING$$73$YR$E$M$Y$$$20240802$$MD$FR$FR
241661251$24166125$1$I$$20240723$20240802$20240802$PER$$US-JNJFOC-20240772760$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241661261$24166126$1$I$$20240719$20240802$20240802$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092676$GLENMARK$Bowen MB, Melendez B, Zhang Q, Yang RK, Fellman BM, Lawson BC, et. al.. Long-term follow-up of levonorgestrel intrauterine device for atypical hyperplasia and early endometrial cancer reveals relapse characterized by immune exhaustion.. Clinical cancer research: an official journal of the American Association for Ca. 2024$$$$$Y$$$20240802$$HP$US$US
241661271$24166127$1$I$$20240725$20240802$20240802$PER$$US-ABBVIE-5857233$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241661281$24166128$1$I$20240201$20240724$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037595$AUROBINDO$$80$YR$$M$Y$$$20240802$$PH$FR$FR
241661291$24166129$1$I$20200103$20240725$20240802$20240802$PER$$US-RDY-SPO/USA/24/0011211$DR REDDYS$$24$YR$T$M$Y$$$20240802$$CN$US$US
241661301$24166130$1$I$$20240723$20240802$20240802$EXP$$US-RDY-LIT/USA/24/0011105$DR REDDYS$Patel S, Tsai C, Slampak-Cindric A. When in Doubt, Examine the Medication List: A Rare Case of Daptomycin-Induced Lung Injury. American Journal of Respiratory and Critical Care Medicine. 2024 May;209(0): A2025. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2025.$75$YR$E$F$Y$$$20240802$$HP$US$US
241661311$24166131$1$I$$20240724$20240802$20240802$30DAY$$US-GSK-US2024092979$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241661322$24166132$2$F$20240720$20240819$20240802$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119571$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240827$$CN$US$US
241661331$24166133$1$I$$20210730$20240802$20240802$EXP$$AU-AstraZeneca-2021A653757$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$AU$
241661341$24166134$1$I$$20240725$20240802$20240802$EXP$$IN-AstraZeneca-2024A170177$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$IN$
241661351$24166135$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153294$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241661361$24166136$1$I$20240101$20240726$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120012$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$68.86$KG$20240802$$PH$US$US
241661371$24166137$1$I$20240701$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152907$AMGEN$$34$YR$$F$Y$$$20240802$$HP$US$US
241661381$24166138$1$I$$20240729$20240802$20240802$EXP$$DE-AstraZeneca-2024A172708$ASTRAZENECA$$95$YR$$F$Y$$$20240802$$HP$DE$
241661392$24166139$2$F$20240715$20240802$20240802$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-037487$AUROBINDO$$60$YR$$M$Y$68$KG$20240814$$CN$GB$GB
241661401$24166140$1$I$$20210712$20240802$20240802$EXP$$ZA-AstraZeneca-2021A625323$ASTRAZENECA$$55$YR$$M$Y$$$20240802$$CN$ZA$
241661411$24166141$1$I$$20210913$20240802$20240802$EXP$$US-AstraZeneca-2021A725002$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241661421$24166142$1$I$$20220414$20240802$20240802$EXP$$US-AstraZeneca-2022A152350$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241661431$24166143$1$I$$20231114$20240802$20240802$EXP$$US-AstraZeneca-2023A215962$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241661441$24166144$1$I$20240712$20240729$20240802$20240802$EXP$$US-AstraZeneca-2024A172421$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241661451$24166145$1$I$$20240726$20240802$20240802$EXP$$AU-AstraZeneca-2024A172376$ASTRAZENECA$$$$$$Y$$$20240802$$MD$AU$
241661461$24166146$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170432$ASTRAZENECA$$$$$M$Y$$$20240802$$HP$US$
241661471$24166147$1$I$$20240731$20240802$20240802$PER$$US-JNJFOC-20240784076$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$HP$US$US
241661481$24166148$1$I$20240702$20240724$20240802$20240802$EXP$$US-JNJFOC-20240767269$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240802$$MD$US$US
241661491$24166149$1$I$$20240723$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407015861$ELI LILLY AND CO$$57$YR$A$$Y$$$20240802$$LW$US$US
241661511$24166151$1$I$20240731$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000784$ELI LILLY AND CO$$$$$$Y$$$20240802$$CN$US$US
241661522$24166152$2$F$$20240909$20240802$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202408001058$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240911$$CN$US$US
241661531$24166153$1$I$$20240729$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407020259$ELI LILLY AND CO$$$$$$Y$$$20240802$$CN$US$US
241661541$24166154$1$I$$20240719$20240802$20240802$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092677$GLENMARK$Bowen M.B., Melendez B., Zhang Q., Yang R.K., Fellman B.M., Lawson B.C., et al. Long-term follow-up of levonorgestrel intrauterine device for atypical hyperplasia and early endometrial cancer reveals relapse characterized by immune exhaustion. Clinical cancer research : an official journal of the American Association for C. 2024$$$$$Y$$$20240802$$HP$US$US
241661551$24166155$1$I$20240503$20240729$20240802$20240802$EXP$IT-MINISAL02-996088$IT-REGENERON PHARMACEUTICALS, INC.-2024-105547$REGENERON$$86$YR$$F$Y$$$20240802$$MD$IT$IT
241661561$24166156$1$I$20240209$20240724$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-037517$AUROBINDO$$46$YR$$F$Y$$$20240802$$MD$ES$ES
241661573$24166157$3$F$20240101$20240824$20240802$20240831$EXP$$JP-GENMAB-2024-02690$GENMAB$$67$YR$$M$Y$$$20240831$$MD$JP$JP
241661582$24166158$2$F$20240101$20240916$20240802$20240925$EXP$$DE-TEVA-VS-3226842$TEVA$$38$YR$$M$Y$$$20240925$$PH$DE$DE
241661593$24166159$3$F$20240101$20240909$20240802$20240913$EXP$$GB-ABBVIE-5792024$ABBVIE$$$$A$F$Y$$$20240913$$CN$GB$GB
241661601$24166160$1$I$20200901$20240722$20240802$20240802$EXP$$US-ROCHE-3160992$ROCHE$$59$YR$A$F$Y$54.43$KG$20240802$$CN$US$US
241661611$24166161$1$I$20230820$20240730$20240802$20240802$EXP$$US-ABBVIE-5861369$ABBVIE$$39$YR$$F$Y$$$20240802$$CN$US$US
241661622$24166162$2$F$20220325$20221102$20240802$20240815$EXP$$CA-CELLTRION INC.-2022CA022687$CELLTRION$$$$$$Y$$$20240815$$MD$CA$CA
241661641$24166164$1$I$20170101$20240725$20240802$20240802$EXP$PL-URPL-2-533-2020$PL-TEVA-VS-3226390$TEVA$$33$YR$$M$Y$$$20240802$$CN$PL$PL
241661652$24166165$2$F$$20240904$20240802$20240909$EXP$$US-862174955-ML2024-04060$MICRO LABS$$91$YR$E$F$Y$$$20240909$$CN$US$US
241661663$24166166$3$F$$20240914$20240802$20240919$EXP$$US-862174955-ML2024-04111$Unknown Manufacturer$$$$$F$Y$$$20240919$$PH$US$US
241661671$24166167$1$I$20240519$20240726$20240802$20240802$EXP$$GB-862174955-ML2024-04211$MICRO LABS$$47$YR$A$M$Y$89$KG$20240802$$PH$GB$GB
241661681$24166168$1$I$$20240725$20240802$20240802$EXP$GB-MHRA-MED-202407251356400930-ZGKRJ$GB-862174955-ML2024-04186$MICRO LABS$$65$YR$E$M$Y$83$KG$20240802$$CN$GB$GB
241661691$24166169$1$I$$20240719$20240802$20240802$EXP$$US-862174955-ML2024-04145$MICRO LABS$$$$$M$Y$$$20240802$$CN$US$US
241661701$24166170$1$I$$20240726$20240802$20240802$EXP$GB-MHRA-MED-202407262147142410-THDNB$GB-862174955-ML2024-04207$MICRO LABS$$39$YR$A$M$Y$59$KG$20240802$$CN$GB$GB
241661711$24166171$1$I$$20240725$20240802$20240802$EXP$$US-862174955-ML2024-04233$MICRO LABS$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D. Rhabdomyolysis Risk: The Dangers of Tribulus terrestris, an Over-the-Counter Supplement. Am J Case Rep. 2024;25:e943492. DOI: 10.12659/AJCR.943492.$71$YR$E$M$Y$$$20240802$$MD$US$US
241661722$24166172$2$F$20230101$20240828$20240802$20240830$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043413$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240829$$CN$US$US
241661732$24166173$2$F$$20240805$20240802$20240807$EXP$$JP-SPECGX-T202401596$SPECGX$$6$DEC$$F$Y$$$20240807$$MD$JP$JP
241661741$24166174$1$I$20230101$20240729$20240802$20240802$PER$$US-ABBVIE-5859569$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241661751$24166175$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121455$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241661761$24166176$1$I$20240801$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122229$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$66.13$KG$20240802$$CN$US$US
241661771$24166177$1$I$$20240726$20240802$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121773$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240802$$MD$JP$JP
241661781$24166178$1$I$20160101$20240730$20240802$20240802$EXP$$US-ABBVIE-5861618$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241661791$24166179$1$I$20240701$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151272$AMGEN$$79$YR$E$M$Y$$$20240802$$CN$US$US
241661801$24166180$1$I$$20240718$20240802$20240802$PER$$US-JNJFOC-20240752244$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$CN$US$US
241661812$24166181$2$F$20240711$20240815$20240802$20240821$EXP$$CA-ABBVIE-5862263$ABBVIE$$77$YR$$F$Y$$$20240821$$CN$CA$CA
241661821$24166182$1$I$$20240729$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US069097$SANDOZ$$$$$F$Y$$$20240802$$CN$US$US
241661831$24166183$1$I$$20240731$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US069836$SANDOZ$$$$$F$Y$$$20240802$$MD$US$US
241661841$24166184$1$I$$20240731$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US069928$SANDOZ$$$$$M$Y$$$20240802$$HP$US$US
241661851$24166185$1$I$20230508$20240718$20240802$20240802$EXP$$JP-SA-2024SA220852$SANOFI AVENTIS$$79$YR$E$M$Y$59.7$KG$20240802$$HP$JP$JP
241661861$24166186$1$I$20220101$20240725$20240802$20240802$EXP$$CN-EMD Serono-9303806$EMD SERONO INC$$$$$M$Y$$$20240802$$CN$CN$CN
241661871$24166187$1$I$$20240729$20240802$20240802$PER$$US-ROCHE-10000042966$ROCHE$$$$$$Y$$$20240802$$CN$US$US
241661881$24166188$1$I$20240729$20240731$20240802$20240802$EXP$$US-UCBSA-2024038722$UCB$$28$YR$$M$Y$$$20240802$$CN$US$US
241661891$24166189$1$I$$20240722$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-036573$AUROBINDO$Andujar-Vera F, Ales-Palmer ML, Munoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E.. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. International Journal of Molecular Sciences. 2023;24(17)$3$YR$$F$Y$$$20240802$$HP$ES$ES
241661902$24166190$2$F$20240730$20240808$20240802$20240813$EXP$$JP-ABBVIE-5860879$ABBVIE$$50$YR$$M$Y$$$20240813$$MD$JP$JP
241661911$24166191$1$I$$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037077$AUROBINDO$Timmons P, Williamson A, Gibbs V, Torgersen A.. Weak legs.. Acute medicine. 2022;21(3):153-6$48$YR$$F$Y$$$20240802$$MD$GB$GB
241661921$24166192$1$I$$20240801$20240802$20240802$EXP$$US-SANDOZ INC.-NVSC2020US022982$SANDOZ$$$$$F$Y$$$20240802$$CN$US$US
241661932$24166193$2$F$$20240826$20240802$20240830$EXP$$US-ABBVIE-5819425$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
241661941$24166194$1$I$$20240729$20240802$20240802$EXP$$US-ABBVIE-5861965$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241661951$24166195$1$I$20240710$20240723$20240802$20240802$EXP$IT-MINISAL02-995328$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-07031$HIKMA$$78$YR$$M$Y$$$20240802$$MD$IT$IT
241661961$24166196$1$I$$20240726$20240802$20240802$EXP$$US-NOVITIUMPHARMA-2024USNVP01459$NOVITIUM PHARMA$J. W. Torres.Crisis in the Lungs: EVALI Unveiled in a Young Male Patient.American Journal of Respiratory and Critical Care Medicine.19-MAY-2024;209:A2122 - A2122$23$YR$A$M$Y$$$20240802$$HP$US$US
241661971$24166197$1$I$20230228$20231103$20240802$20240802$EXP$$CA-CELLTRION INC.-2022CA022699$CELLTRION$$$$$$Y$$$20240802$$CN$CA$CA
241661981$24166198$1$I$$20240731$20240802$20240802$PER$$US-ABBVIE-5864239$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241661991$24166199$1$I$20240601$20240730$20240802$20240802$EXP$$US-ABBVIE-5861776$ABBVIE$$88$YR$$F$Y$$$20240802$$CN$US$US
241662011$24166201$1$I$$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037045$AUROBINDO$$79$YR$$F$Y$$$20240802$$PH$GB$GB
241662022$24166202$2$F$$20240816$20240802$20240826$EXP$$BG-CELLTRION INC.-2024BG018433$CELLTRION$Petrusheva V, Samardzhieva M, Simova I, Chilingirova N, Vekov T. Cardiotoxicity in patients with Breast Cancer treated with HER-2 targeted therapy - A case report. Cardiovascular Diseases. 2024;2:14-23$$$$$Y$$$20240826$$HP$BG$BG
241662031$24166203$1$I$$20240729$20240802$20240802$EXP$$BR-JNJFOC-20240785194$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$MD$BR$BR
241662041$24166204$1$I$20230101$20240726$20240802$20240802$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042246$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$$$20240802$$CN$US$US
241662051$24166205$1$I$20240721$20240724$20240802$20240802$EXP$$CN-ROCHE-10000036412$ROCHE$$70$YR$E$F$Y$62$KG$20240802$$HP$CN$CN
241662062$24166206$2$F$$20240823$20240802$20240831$EXP$$JP-ROCHE-10000040691$ROCHE$$$$E$$Y$$$20240831$$MD$JP$JP
241662071$24166207$1$I$20240616$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037467$AUROBINDO$$22$YR$$F$Y$59$KG$20240802$$MD$FR$FR
241662081$24166208$1$I$$20240722$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-036575$AUROBINDO$Al?s-palmer ML, And?jar-vera F, Mu?oz-de-rueda P, Iglesias-baena I, Ocete-hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int. J. Mol. Sci. 2023;24(17):1-17$9$YR$$M$Y$$$20240802$$HP$ES$ES
241662091$24166209$1$I$$20240719$20240802$20240802$EXP$$US-UCBSA-2024037217$UCB$$$$$F$Y$144.4$KG$20240802$$CN$US$US
241662101$24166210$1$I$$20240729$20240802$20240802$EXP$$TR-ROCHE-10000042134$ROCHE$Aygunes U, Karagin B, Sasmaz H, Antmen A, Tumgor G. The Treatment of Steroid-Refractory Severe Gastrointestinal Acute Graft-Versus-Host Disease in Children after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience.. Osmangazi Journal of Medicine. 2024;46 (3):394-403. doi:10.20515/otd.1420314.$1$YR$I$M$Y$$$20240802$$HP$TR$TR
241662111$24166211$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122084$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240802$$HP$US$US
241662123$24166212$3$F$20240715$20240826$20240802$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121053$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$46.72$KG$20240827$$HP$US$US
241662131$24166213$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037667$AUROBINDO$Brenneman E, Keil E, Advani SD, Campbell KB, Wrenn R. A Turtle Disaster: Salmonella enteritidis Cardiovascular Implantable Electronic Device Infection. Open-Forum-Infect-Dis. 2022;9:12$60$YR$$M$Y$$$20240802$$MD$US$US
241662141$24166214$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122617$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241662151$24166215$1$I$$20240724$20240802$20240802$PER$$US-ABBVIE-5857303$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241662161$24166216$1$I$$20240731$20240802$20240802$EXP$$CA-BAUSCH-BL-2024-011708$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240802$$CN$CA$CA
241662171$24166217$1$I$$20240731$20240802$20240802$EXP$$CA-BAUSCH-BL-2024-011707$BAUSCH AND LOMB$$41$YR$$M$Y$$$20240802$$CN$CA$CA
241662181$24166218$1$I$20130418$20240731$20240802$20240802$EXP$$FR-BAUSCH-BL-2024-011727$BAUSCH AND LOMB$$65$YR$$F$Y$58$KG$20240802$$MD$FR$FR
241662191$24166219$1$I$$20240730$20240802$20240802$PER$$US-ABBVIE-5861949$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241662203$24166220$3$F$20231101$20240829$20240802$20240910$EXP$$US-UCBSA-2023056664$UCB$$6$YR$$M$Y$$$20240910$$CN$US$US
241662211$24166221$1$I$20240703$20240723$20240802$20240802$EXP$$CN-ROCHE-10000034589$ROCHE$$72$YR$E$F$Y$$$20240802$$HP$CN$CN
241662221$24166222$1$I$$20240729$20240802$20240802$EXP$$US-009507513-2407USA015041$MERCK$$$$$M$Y$$$20240802$$CN$US$US
241662231$24166223$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000079$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240802$$CN$US$US
241662241$24166224$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000149$ELI LILLY AND CO$$$$A$F$Y$$$20240802$$CN$US$US
241662251$24166225$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000711$ELI LILLY AND CO$$$$A$F$Y$$$20240802$$CN$US$US
241662261$24166226$1$I$$20240712$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407008866$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240802$$CN$US$US
241662273$24166227$3$F$20240729$20240812$20240802$20240816$EXP$$US-ABBVIE-5863011$ABBVIE$$83$YR$$M$Y$92$KG$20240816$$CN$US$US
241662281$24166228$1$I$$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024150815$AMGEN$$$$$$Y$$$20240802$$MD$US$US
241662291$24166229$1$I$$20240726$20240802$20240802$EXP$$MX-BAUSCH-BL-2024-011498$BAUSCH AND LOMB$Lopez-Vidal W, Enriquez-Montes M, Meza-Martinez D, Gallardo-Cantua L, Hernandez-Guedea M. Anaphylaxis as an Unusual Cause of Shock in the Trauma Setting: A Case Report. Cureus. 2024 JUL 16;16(7):1-5. doi:10.7759/cureus.64696$51$YR$$M$Y$$$20240802$$HP$MX$MX
241662302$24166230$2$F$$20240906$20240802$20240916$30DAY$$VN-JNJFOC-20240783511$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$VN$VN
241662311$24166231$1$I$20200501$20240725$20240802$20240802$EXP$SE-SEMPA-2024-005495$SE-BAUSCH-BL-2024-011736$BAUSCH AND LOMB$$24$YR$$F$Y$60$KG$20240802$$CN$SE$SE
241662321$24166232$1$I$$20240731$20240802$20240802$EXP$$CA-SANDOZ INC.-SDZ2023CA076643$SANDOZ$$$$$F$Y$$$20240802$$HP$CA$CA
241662331$24166233$1$I$$20240729$20240802$20240802$EXP$$US-UCBSA-2024038479$UCB$Siddiqui AS.. Certolizumab pegol-Associated Acute Interstitial Pneumonitis. Archivos de Bronconeumolog?a. 2024;1-2$76$YR$$M$Y$$$20240802$$HP$US$US
241662341$24166234$1$I$20230824$20231011$20240802$20240802$EXP$$CA-CELLTRION INC.-2022CA022710$CELLTRION$$$$$$Y$$$20240802$$MD$CA$CA
241662364$24166236$4$F$20240725$20240809$20240802$20240819$30DAY$$US-GSK-US2024094163$GLAXOSMITHKLINE$$64$YR$$M$Y$$$20240819$$MD$US$US
241662371$24166237$1$I$$20240801$20240802$20240802$PER$$NVSC2024US157772$NOVARTIS$$59$YR$$F$Y$$$20240802$$CN$US$US
241662381$24166238$1$I$$20240731$20240802$20240802$EXP$$CA-SANDOZ INC.-SDZ2023CA076647$SANDOZ$$$$$F$Y$$$20240802$$HP$CA$CA
241662391$24166239$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A172977$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241662401$24166240$1$I$$20220317$20240802$20240802$EXP$$ZA-AstraZeneca-2022A120416$ASTRAZENECA$$64$YR$$F$Y$$$20240802$$CN$ZA$
241662411$24166241$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170093$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241662421$24166242$1$I$20210901$20230614$20240802$20240802$EXP$$TH-AstraZeneca-2021A791722$ASTRAZENECA$$839$MON$$F$Y$$$20240802$$PH$TH$
241662431$24166243$1$I$$20240729$20240802$20240802$EXP$$PH-AstraZeneca-2024A172227$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$PH$
241662451$24166245$1$I$20240201$20240730$20240802$20240802$EXP$$US-UCBSA-2024009960$UCB$$60$YR$$M$Y$97.778$KG$20240802$$CN$US$US
241662461$24166246$1$I$20230101$20240725$20240802$20240802$EXP$FR-AFSSAPS-TS2024000842$FR-SA-2024SA224579$SANOFI AVENTIS$$79$YR$E$M$Y$74$KG$20240802$$CN$FR$FR
241662471$24166247$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190138$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241662481$24166248$1$I$20240731$20240801$20240802$20240802$PER$$US-ROCHE-10000047213$ROCHE$$46$YR$A$F$Y$$$20240802$$CN$US$US
241662491$24166249$1$I$$20240801$20240802$20240802$PER$$US-ROCHE-10000047158$ROCHE$$$$$$Y$$$20240802$$CN$US$US
241662501$24166250$1$I$$20240801$20240802$20240802$PER$$US-ROCHE-10000020494$ROCHE$$4$YR$C$F$Y$$$20240802$$CN$US$US
241662511$24166251$1$I$$20221007$20240802$20240802$EXP$$US-SERB S.A.S.-2159916$LABORATOIRES SERB$$4$YR$$M$Y$$$20240802$$$US$US
241662521$24166252$1$I$20240422$20240722$20240802$20240802$EXP$FR-AFSSAPS-DJ2024000838$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110205$ZYDUS PHARM$$$$$$Y$$$20240802$$MD$FR$FR
241662541$24166254$1$I$$20240719$20240802$20240802$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110209$ZYDUS PHARM$Noe G, Shah K, Cinderella M, Munjal S.. Multiple Medication Use Resulting in Serotonin Syndrome with Deprescribing Resulting in Acute Dystonia.. J-Clin-Psychopharmacol. 2024;44(3):326-328$$$$$Y$$$20240802$$HP$US$US
241662553$24166255$3$F$20240609$20240802$20240802$20240807$EXP$DE-CADRBFARM-2024329453$DE-TORRENT-00027092$TORRENT$$34$YR$A$M$Y$117$KG$20240807$$CN$DE$DE
241662561$24166256$1$I$$20240725$20240802$20240802$EXP$GB-MHRA-MED-202407251356400930-ZGKRJ$GB-TORRENT-00037387$TORRENT$$65$YR$E$M$Y$83$KG$20240802$$CN$GB$GB
241662571$24166257$1$I$$20240726$20240802$20240802$EXP$GB-MHRA-MIDB-538cdba0-a553-4ecf-a7dd-5b17618f3e21$GB-TORRENT-00037398$TORRENT$$44$YR$A$F$Y$$$20240802$$PH$GB$GB
241662581$24166258$1$I$20240727$20240727$20240802$20240802$EXP$GB-MHRA-MED-202407270917104810-QPYZV$GB-TORRENT-00037401$TORRENT$$60$YR$A$M$Y$78$KG$20240802$$MD$GB$GB
241662591$24166259$1$I$$20240729$20240802$20240802$EXP$GB-MHRA-MED-202407251154413950-VRTCD$GB-TORRENT-00037406$TORRENT$$$$$M$Y$$$20240802$$MD$GB$GB
241662601$24166260$1$I$20240519$20240726$20240802$20240802$EXP$GB-MHRA-TPP19516521C7216619YC1721413742543$GB-TORRENT-00037407$TORRENT$$47$YR$A$M$Y$89$KG$20240802$$PH$GB$GB
241662612$24166261$2$F$$20240731$20240802$20240805$EXP$$GB-JNJFOC-20240802293$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240805$$HP$GB$GB
241662621$24166262$1$I$$20240724$20240802$20240802$EXP$$US-TEVA-VS-3227615$TEVA$$$$E$M$Y$$$20240802$$HP$US$US
241662632$24166263$2$F$$20240802$20240802$20240814$EXP$$CA-AUROBINDO-AUR-APL-2023-081709$AUROBINDO$Kordy F, Nashid N, Khan S, Read S, Macdougall G, Louch D, et al.. Video directly observed therapy to improve adherence of human immunodeficiency virus infected adolescents to combination antiretroviral therapy: a proof-of-concept study. AIDS-Care Psychological and Socio-medical Aspects of AIDS/HIV. 2023;35(3):417-424$19$YR$$M$Y$$$20240814$$HP$CA$CA
241662641$24166264$1$I$$20240730$20240802$20240802$EXP$$EG-UCBSA-2024038568$UCB$Tharwat S, Nassar MK, Salem KM, Nassar MK. Extraarticular manifestations of juvenile idiopathic arthritis and their impact on health?related quality of life. Clinical Rheumatology. 2024;43(7):2295-305$$$$$Y$$$20240802$$HP$EG$EG
241662651$24166265$1$I$$20240729$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120542$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240802$$CN$US$US
241662661$24166266$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122618$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241662672$24166267$2$F$20240728$20240801$20240802$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121847$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240807$$PH$US$US
241662682$24166268$2$F$$20240731$20240802$20240808$PER$$US-ABBVIE-5864143$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241662691$24166269$1$I$$20240726$20240802$20240802$EXP$$MY-EMD Serono-2024040775$EMD SERONO INC$$13$YR$T$M$Y$$$20240802$$CN$MY$MY
241662701$24166270$1$I$20240701$20240730$20240802$20240802$PER$$US-ABBVIE-5862693$ABBVIE$$25$YR$$F$Y$$$20240802$$HP$US$US
241662711$24166271$1$I$$20240725$20240802$20240802$PER$$US-AstraZeneca-2024A170046$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241662721$24166272$1$I$$20240724$20240802$20240802$EXP$$CA-AUROBINDO-AUR-APL-2024-038561$AUROBINDO$$72$YR$$F$Y$$$20240802$$MD$CA$CA
241662741$24166274$1$I$20240601$20240730$20240802$20240802$PER$$US-ROCHE-10000047059$ROCHE$$47$YR$A$F$Y$$$20240802$$CN$US$US
241662751$24166275$1$I$$20231201$20240802$20240802$EXP$$CA-CELLTRION INC.-2022CA022701$CELLTRION$$$$$$Y$$$20240802$$CN$CA$CA
241662761$24166276$1$I$$20240724$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037461$AUROBINDO$$$$$F$Y$$$20240802$$CN$GB$GB
241662771$24166277$1$I$$20240730$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US069620$SANDOZ$$$$$M$Y$$$20240802$$HP$US$US
241662781$24166278$1$I$$20240725$20240802$20240802$PER$$US-ABBVIE-5854688$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241662791$24166279$1$I$20240101$20240725$20240802$20240802$EXP$$CA-CELLTRION INC.-2023CA017114$CELLTRION$$$$$$Y$$$20240802$$MD$CA$CA
241662801$24166280$1$I$$20240724$20240802$20240802$EXP$$CA-AUROBINDO-AUR-APL-2024-037829$AUROBINDO$$70$YR$$M$Y$$$20240802$$HP$CA$CA
241662812$24166281$2$F$20240616$20240806$20240802$20240808$30DAY$$US-AMGEN-USASP2024146778$AMGEN$$80$YR$E$M$Y$60$KG$20240808$$PH$US$US
241662821$24166282$1$I$20240101$20240730$20240802$20240802$EXP$$US-ABBVIE-5862156$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241662831$24166283$1$I$20240602$20240726$20240802$20240802$EXP$PT-INFARMED-R202407-238$PT-TEVA-VS-3226845$TEVA$$79$YR$$M$Y$$$20240802$$PH$PT$PT
241662841$24166284$1$I$$20240715$20240802$20240802$PER$$US-TEVA-VS-3222373$TEVA$$$$A$F$Y$$$20240802$$CN$US$US
241662851$24166285$1$I$$20240730$20240802$20240802$EXP$$US-ABBVIE-5860788$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241662861$24166286$1$I$20240614$20240725$20240802$20240802$EXP$FR-AFSSAPS-TO2024001321$FR-TEVA-VS-3226330$TEVA$$94$YR$$M$Y$67.5$KG$20240802$$MD$FR$FR
241662872$24166287$2$F$$20240826$20240802$20240830$EXP$$IN-ROCHE-10000044485$ROCHE$$94$YR$E$F$Y$$$20240830$$CN$IN$IN
241662881$24166288$1$I$20240628$20240727$20240802$20240802$EXP$$CN-ROCHE-10000046118$ROCHE$$70$YR$E$M$Y$70$KG$20240802$$HP$CN$CN
241662891$24166289$1$I$20240722$20240723$20240802$20240802$EXP$$US-009507513-2407USA014018$MERCK$$69$YR$$M$Y$$$20240802$$CN$US$US
241662901$24166290$1$I$$20240729$20240802$20240802$EXP$$DE-AMGEN-DEUSP2024150122$AMGEN$$$$$M$Y$$$20240802$$CN$DE$DE
241662931$24166293$1$I$$20240725$20240802$20240802$PER$$US-ALXN-202407USA001749US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$HP$US$US
241662941$24166294$1$I$$20240726$20240802$20240802$PER$$US-ALXN-202407USA001921US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241662951$24166295$1$I$20240101$20240731$20240802$20240802$EXP$$US-ABBVIE-5863932$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241662961$24166296$1$I$$20240727$20240802$20240802$EXP$GB-MHRA-MED-202407271856178380-TYNJZ$GB-RDY-SPO/GBR/24/0011146$DR REDDYS$$$$$M$Y$$$20240802$$CN$GB$GB
241662971$24166297$1$I$$20240728$20240802$20240802$PER$$US-JNJFOC-20240782626$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241662981$24166298$1$I$20190101$20240730$20240802$20240802$EXP$$BR-SANDOZ INC.-SDZ2024BR055322$SANDOZ$$$$$F$Y$$$20240802$$CN$BR$BR
241662991$24166299$1$I$20240507$20240723$20240802$20240802$EXP$$DE-009507513-2407DEU014636$MERCK$$3$MON$$M$Y$5.3$KG$20240802$$MD$DE$DE
241663011$24166301$1$I$20240723$20240726$20240802$20240802$EXP$$AU-GSK-AU2024093801$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$AU$AU
241663021$24166302$1$I$20240101$20240729$20240802$20240802$EXP$$US-ABBVIE-5862023$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241663031$24166303$1$I$20240726$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024151734$AMGEN$$58$YR$A$M$Y$$$20240802$$CN$US$US
241663041$24166304$1$I$20240727$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024151732$AMGEN$$62$YR$A$F$Y$$$20240802$$HP$US$US
241663051$24166305$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122043$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240802$$CN$US$US
241663061$24166306$1$I$20240724$20240724$20240802$20240802$PER$$US-TEVA-VS-3225453$TEVA$$63$YR$$F$Y$$$20240802$$CN$US$US
241663071$24166307$1$I$20240720$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151559$AMGEN$$44$YR$A$F$Y$$$20240802$$CN$US$US
241663081$24166308$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151880$AMGEN$$$$$M$Y$$$20240802$$HP$US$US
241663091$24166309$1$I$$20240722$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407014761$ELI LILLY AND CO$$46$YR$A$$Y$$$20240802$$CN$US$US
241663101$24166310$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408001093$ELI LILLY AND CO$$$$A$F$Y$$$20240802$$CN$US$US
241663112$24166311$2$F$20240101$20240730$20240802$20240808$PER$$US-ORGANON-O2407USA003035$ORGANON$$$$$F$Y$$$20240808$$HP$US$US
241663121$24166312$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-036631$AUROBINDO$Seltzer J, Schneir A. Case Files from the University of California San Diego Medical Toxicology Fellowship: Neonatal Flecainide Toxicity from an Accidental Dosing Error. Journal of medical toxicology. 2024;20:314?323$22$DY$$M$Y$3.65$KG$20240802$$MD$US$US
241663132$24166313$2$F$$20240730$20240802$20240809$EXP$$US-MACLEODS PHARMA-MAC2024048549$MACLEODS$Jain S, Sekhon S, Chandran AS, Gummadi J, Patel P, Nakka R, et.al..Metformin-Associated Lactic Acidosis in an Older Adult: A Case Report and Review.Cureus.19-JUN-2024;16(6):e62729:1-6$$$$$Y$$$20240809$$MD$US$US
241663141$24166314$1$I$$20240723$20240802$20240802$EXP$$US-MACLEODS PHARMA-MAC2024048553$MACLEODS$Shenoy C.Metformin-associated lactic acidosis precipitated by acute renal failure.The American journal of the medical sciences.2006;331(1):55-7$$$$$Y$$$20240802$$HP$US$US
241663151$24166315$1$I$20240709$20240723$20240802$20240802$EXP$GB-MHRA-MED-202407231210550910-LSYKQ$GB-MACLEODS PHARMA-MAC2024048567$MACLEODS$$$$$$Y$$$20240802$$PH$GB$GB
241663161$24166316$1$I$20240716$20240725$20240802$20240802$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00629$PARATEK PHARMACEUTICALS$$75$YR$$F$Y$48$KG$20240802$$HP$CN$CN
241663171$24166317$1$I$20240723$20240723$20240802$20240802$EXP$GB-MHRA-MED-202407230647463120-ZYNKC$GB-MACLEODS PHARMA-MAC2024048564$MACLEODS$$$$$$Y$$$20240802$$CN$GB$GB
241663181$24166318$1$I$$20240723$20240802$20240802$EXP$$GB-MACLEODS PHARMA-MAC2024048570$MACLEODS$$$$$$Y$$$20240802$$PH$GB$GB
241663192$24166319$2$F$20240729$20240808$20240802$20240813$PER$$US-ABBVIE-5861000$ABBVIE$$50$YR$$F$Y$$$20240813$$HP$US$US
241663201$24166320$1$I$$20231219$20240802$20240802$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-16792$ALKEM$Biehl A, Taube M, Kotloski RJ, Kopacek K, Jones J, Gidal BE.. Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a Veteran population. Epilepsy and Behavior. 2023;149 (109496):1-5$56$YR$$M$Y$$$20240802$$HP$US$US
241663211$24166321$1$I$$20240322$20240802$20240802$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06693$ALKEM$Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et.al.. High-resolution HLA genotyping and severe cutaneous adverse reac-tions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19:661-665$74$YR$$F$Y$$$20240802$$HP$GB$GB
241663221$24166322$1$I$$20230911$20240802$20240802$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2023-10805$ALKEM$Parravicini S, Pasca L, Zanaboni MP, Varesio C, Rognone E, Totaro M, Gana S, Rossi E, De Giorgis V. Electroclinical Improvement in a Patient with Ring Chromosome 20 Syndrome Treated with Zonisamide: A Case Report. Journal of Pediatric Genetics. 2023;12:219-223$13$YR$$F$Y$24.7$KG$20240802$$HP$IT$IT
241663231$24166323$1$I$$20240109$20240802$20240802$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-00471$ALKEM$Sawant NS, Parkar SR, Singh RV, Nachane HB.. Lamotrigine-induced agranulocytosis in a case of schizoaffective disorder. Annals of Indian Psychiatry. 2017;1:49$30$YR$$M$Y$$$20240802$$HP$IN$IN
241663241$24166324$1$I$$20230627$20240802$20240802$EXP$$CZ-ALKEM LABORATORIES LIMITED-CZ-ALKEM-2023-07787$ALKEM$Kacirova I, Grundmann M, Brozmanova H. Umbilical cord, maternal milk, and breastfed infant levetiracetam concentrations monitoring at delivery and during early postpartum period. Pharmaceutics. 2021;13:398$$$$F$Y$$$20240802$$HP$CZ$CZ
241663251$24166325$1$I$$20231219$20240802$20240802$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-16798$ALKEM$Biehl A, Taube M, Kotloski RJ, Kopacek K, Jones J, Gidal BE.. Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a Veteran population. Epilepsy and Behavior. 2023;149 (109496):1-5$74$YR$$M$Y$$$20240802$$HP$US$US
241663261$24166326$1$I$$20240509$20240802$20240802$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-09888$ALKEM$Presley JD, Chyka PA.. Intravenous lipid emulsion to reverse acute drug toxicity in pediatric patients. Annals of Pharmacotherapy. 2013;47(5):735-743$$$$$Y$$$20240802$$HP$US$US
241663271$24166327$1$I$$20240419$20240802$20240802$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-09206$ALKEM$Wood KE, Palmer KL, Krasowski MD.. Correlation of elevated lamotrigine and levetiracetam serum/plasma levels with toxicity: A long-term retrospective review at an academic medical center. Toxicology Reports. 2021;8:1592-1598$76$YR$$M$Y$$$20240802$$HP$US$US
241663281$24166328$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-07116$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding Medicine. 2022;17(4):341-348$$$$F$Y$$$20240802$$HP$IL$IL
241663291$24166329$1$I$$20231219$20240802$20240802$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-16797$ALKEM$Biehl A, Taube M, Kotloski RJ, Kopacek K, Jones J, Gidal BE. Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a Veteran population. Epilepsy and Behavior. 2023;149 (109496):1-5$58$YR$$M$Y$$$20240802$$HP$US$US
241663301$24166330$1$I$$20240221$20240802$20240802$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03690$ALKEM$Bromley RL, Mawer GE, Briggs M, Cheyne C, Clayton-Smith J, Garcia-Finana M, Kneen R, Lucas SB, Shallcross R, Baker GA. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84:637-643$$$C$M$Y$$$20240802$$HP$GB$GB
241663311$24166331$1$I$$20230719$20240802$20240802$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2023-08517$ALKEM$Khalkhali M, Aram S, Zarrabi H, Kafie M, Heidarzadeh A.. Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial. Iranian J Psychiatry. 2016;11(2):104-114$$$$F$Y$$$20240802$$MD$IR$IR
241663321$24166332$1$I$$20240221$20240802$20240802$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03689$ALKEM$Bromley RL, Mawer GE, Briggs M, et al.. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84:637-643$22$YR$$F$Y$$$20240802$$MD$GB$GB
241663331$24166333$1$I$$20231211$20240802$20240802$EXP$$CZ-ALKEM LABORATORIES LIMITED-CZ-ALKEM-2023-16127$ALKEM$Kacirova I, Urinovska R, Grundmann M.. Therapeutic monitoring of lacosamide, perampanel, and zonisamide during breastfeeding. Epilepsy Research. 2023;199:107264$29$YR$$F$Y$$$20240802$$HP$CZ$CZ
241663341$24166334$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07492$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding Medicine. 2022;17 (4):341-348$$$$F$Y$55$KG$20240802$$HP$IL$IL
241663351$24166335$1$I$$20230719$20240802$20240802$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2023-08518$ALKEM$Khalkhali M, Aram S, Zarrabi H, Kafie M, Heidarzadeh A. Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial. Iran J Psychiatry. 2016;11(2):104-114$$$$$Y$$$20240802$$MD$IR$IR
241663361$24166336$1$I$$20240221$20240802$20240802$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03687$ALKEM$Bromley RL, Mawer GE, Briggs M, et al.. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84:637-643$18$YR$$F$Y$$$20240802$$MD$GB$GB
241663371$24166337$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07491$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding medicine. 2022;17(4):341-348$$$$F$Y$58$KG$20240802$$HP$IL$IL
241663381$24166338$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07493$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding medicine. 2022;17(4):341-348$$$$F$Y$66$KG$20240802$$HP$IL$IL
241663391$24166339$1$I$$20230719$20240802$20240802$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2023-08520$ALKEM$Khalkhali M, Aram S, Zarrabi H, Kafie M, Heidarzadeh A. Lamotrigine Augmentation Versus Placebo in Serotonin  Reuptake Inhibitors-Resistant Obsessive-Compulsive  Disorder: A Randomized Controlled Trial. Iran J Psychiatry. 2016;11(2):104-114$$$$$Y$$$20240802$$MD$IR$IR
241663401$24166340$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07494$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding Medicine. 2022;17 (4):341-348$$$$F$Y$73.7$KG$20240802$$HP$IL$IL
241663411$24166341$1$I$$20240502$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2024-09889$ALKEM$Daana M, Nevo Y, Tenenbaum A, Taustein I, Berger I.. Lamotrigine overdose in a child. Journal of Child Neurology. 2007;22 (5):642-644$$$C$$Y$$$20240802$$HP$IL$IL
241663421$24166342$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07489$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding medicine. 2022;17(4):341-348$$$$F$Y$100$KG$20240802$$HP$IL$IL
241663431$24166343$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07490$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding Medicine. 2022;17 (4):341-348$$$$F$Y$59$KG$20240802$$HP$IL$IL
241663441$24166344$1$I$$20231219$20240802$20240802$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-16796$ALKEM$Biehl A, Taube M, Kotloski RJ, Kopacek K, Jones J, Gidal BE. Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a Veteran population. Epilepsy and Behavior. 2023;149 (109496):1-5$61$YR$$M$Y$$$20240802$$HP$US$US
241663451$24166345$1$I$$20240221$20240802$20240802$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03688$ALKEM$Bromley RL, Mawer GE, Briggs M, et al.. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84:637-643$$$$M$Y$$$20240802$$MD$GB$GB
241663461$24166346$1$I$$20231219$20240802$20240802$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-16793$ALKEM$Biehl A, Taube M, Kotloski RJ, Kopacek K, Jones J, Gidal BE.. Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a Veteran population. Epilepsy and Behavior. 2023;149 (109496):1-5$77$YR$$M$Y$$$20240802$$HP$US$US
241663471$24166347$1$I$$20231219$20240802$20240802$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-16794$ALKEM$Biehl A, Taube M, Kotloski RJ, Kopacek K, Jones J, Gidal BE.. Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a Veteran population. Epilepsy and Behavior. 2023;149 (109496):1-5$94$YR$$M$Y$$$20240802$$HP$US$US
241663481$24166348$1$I$$20231012$20240802$20240802$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2023-12298$ALKEM$Mogami Y, Takahashi Y, Takayama R, Ohtani H, Ikeda H, Imai K, Shigematu H, Inoue Y.. Cutaneous adverse drug reaction in patients with epilepsy after acute encephalitis. Brain + Development. 2012;34(6):496-503$$$$$Y$$$20240802$$HP$JP$JP
241663491$24166349$1$I$$20231219$20240802$20240802$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-16795$ALKEM$Biehl A, Taube M, Kotloski RJ, Kopacek K, Jones J, Gidal BE. Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a Veteran population. Epilepsy and Behavior. 2023;149 (109496):1-5$43$YR$$M$Y$$$20240802$$HP$US$US
241663501$24166350$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07485$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding medicine. 2022;17(4):341-348$$$$F$Y$81$KG$20240802$$HP$IL$IL
241663511$24166351$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07481$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding medicine. 2022;17(4):341-348$$$$F$Y$78$KG$20240802$$HP$IL$IL
241663521$24166352$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07480$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M.. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding Medicine. 2022;17(4):341-348$$$$F$Y$67.5$KG$20240802$$HP$IL$IL
241663531$24166353$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07479$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M.. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding Medicine. 2022;17(4):341-348$$$$F$Y$57$KG$20240802$$HP$IL$IL
241663541$24166354$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07488$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding Medicine. 2022;17 (4):341-348$$$$F$Y$59$KG$20240802$$HP$IL$IL
241663551$24166355$1$I$$20231229$20240802$20240802$EXP$$PL-ALKEM LABORATORIES LIMITED-PL-ALKEM-2023-17178$ALKEM$Grabowska-Grzyb A, Naganska E, Wolanczyk T. Hypersexuality in two patients with epilepsy treated with Lamotrigine. Epilepsy Behav. 2006;8:663-665$55$YR$$M$Y$$$20240802$$HP$PL$PL
241663561$24166356$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07486$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding Medicine. 2022;17 (4):341-348$$$$F$Y$63$KG$20240802$$HP$IL$IL
241663571$24166357$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07483$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding medicine. 2022;17(4):341-348$$$$F$Y$66$KG$20240802$$HP$IL$IL
241663581$24166358$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07484$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding Medicine. 2022;17 (4):341-348$$$$F$Y$58$KG$20240802$$HP$IL$IL
241663591$24166359$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07487$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding medicine. 2022;17(4):341-348$$$$F$Y$58.7$KG$20240802$$HP$IL$IL
241663601$24166360$1$I$$20230627$20240802$20240802$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2023-07482$ALKEM$Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I, Keidar R, Livne A, Stepensky D, Berkovitch M, Masarwi M.. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeeding Medicine. 2022;17(4):341-348$$$$F$Y$47.5$KG$20240802$$HP$IL$IL
241663611$24166361$1$I$20211201$20240417$20240802$20240802$EXP$DE-CADRBFARM-2024327387$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-08324$ALKEM$$39$YR$$F$Y$52$KG$20240802$$CN$DE$DE
241663622$24166362$2$F$20240704$20240913$20240802$20240923$EXP$$US-TAKEDA-2024TUS075022$TAKEDA$$26$YR$$M$Y$$$20240923$$CN$US$US
241663631$24166363$1$I$20240721$20240725$20240802$20240802$EXP$$CN-TAKEDA-2024TUS076717$TAKEDA$$52$YR$$F$Y$45.4$KG$20240802$$HP$CN$CN
241663641$24166364$1$I$$20231229$20240802$20240802$EXP$$PL-ALKEM LABORATORIES LIMITED-PL-ALKEM-2023-17179$ALKEM$Grabowska-Grzyb A, Naganska E, Wolanczyk T. Hypersexuality in two patients with epilepsy treated with lamotrigine. Epilepsy Behav. 2006;8:663-665$50$YR$$M$Y$$$20240802$$HP$PL$PL
241663651$24166365$1$I$20240719$20240725$20240802$20240802$EXP$$IL-AstraZeneca-2024A172263$ASTRAZENECA$$80$YR$$M$Y$$$20240802$$MD$IL$
241663661$24166366$1$I$20240728$20240729$20240802$20240802$EXP$$US-AstraZeneca-2024A172488$ASTRAZENECA$$35440$DY$$F$Y$$$20240802$$CN$US$
241663671$24166367$1$I$$20240725$20240802$20240802$EXP$$CN-AstraZeneca-2024A171157$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$CN$
241663681$24166368$1$I$$20231229$20240802$20240802$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2023-16564$ALKEM$Ge J, Cao SS, Cao XY, Tang M, Mu F, Qiao Y, Guan Y, Wang JW. Lamotrigine induced priapism in children: case analysis and literature review. Journal of International Medical Research. 2022;50 (11):1-7$11$YR$$M$Y$$$20240802$$HP$CN$CN
241663692$24166369$2$F$$20240812$20240802$20240814$EXP$$GB-MYLANLABS-2024M1071100$MYLAN$$$$$F$Y$$$20240814$$HP$GB$GB
241663701$24166370$1$I$$20240730$20240802$20240802$EXP$$AR-MYLANLABS-2024M1071696$MYLAN$$$$$F$Y$$$20240802$$MD$AR$AR
241663711$24166371$1$I$20240731$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152920$AMGEN$$54$YR$A$F$Y$$$20240802$$CN$US$US
241663722$24166372$2$F$$20240828$20240802$20240830$PER$$US-HALEON-2190134$Haleon PLC$$$$$F$Y$$$20240830$$CN$US$US
241663731$24166373$1$I$$20240729$20240802$20240802$EXP$GB-MHRA-MED-202407251154413950-VRTCD$GB-MYLANLABS-2024M1071542$MYLAN$$12$MON$$M$Y$$$20240802$$MD$GB$GB
241663741$24166374$1$I$$20231101$20240802$20240802$EXP$$UZ-MYLANLABS-2024M1071525$MYLAN$$$$$M$Y$87$KG$20240802$$CN$UZ$UZ
241663751$24166375$1$I$20240101$20240719$20240802$20240802$PER$$US-COSETTE-CP2024US000188$COSETTE PHARMACEUTICALS$$52$YR$A$F$Y$56.69$KG$20240802$$CN$US$US
241663761$24166376$1$I$$20240727$20240802$20240802$EXP$GB-MHRA-MED-202407272225156400-FJKLZ$GB-RDY-SPO/GBR/24/0011145$DR REDDYS$$30$YR$A$M$Y$$$20240802$$CN$GB$GB
241663771$24166377$1$I$$20240729$20240802$20240802$EXP$$CA-JNJFOC-20240782464$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$HP$CA$CA
241663782$24166378$2$F$20240708$20240820$20240802$20240826$EXP$$CA-JNJFOC-20240676675$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240826$$HP$CA$CA
241663791$24166379$1$I$20240521$20240801$20240802$20240802$EXP$FR-AFSSAPS-NC2024000916$FR-JNJFOC-20240804590$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240802$$MD$FR$FR
241663803$24166380$3$F$20240701$20240814$20240802$20240823$30DAY$$CL-JNJFOC-20240760580$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240823$$CN$CL$CL
241663811$24166381$1$I$20240409$20240731$20240802$20240802$EXP$$US-TAKEDA-2024TUS076965$TAKEDA$$66$YR$$M$Y$$$20240802$$HP$US$US
241663831$24166383$1$I$20240611$20240725$20240802$20240802$EXP$ES-AEMPS-1549721$ES-TEVA-VS-3226283$TEVA$$84$YR$$F$Y$49$KG$20240802$$MD$ES$ES
241663843$24166384$3$F$20240321$20240916$20240802$20240924$EXP$$US-ALKERMES INC.-ALK-2024-001971$ALKERMES$$51$YR$$M$Y$139$KG$20240925$$HP$US$US
241663851$24166385$1$I$20240325$20240725$20240802$20240802$EXP$$ES-TAKEDA-2024TUS077351$TAKEDA$$78$YR$$F$Y$$$20240802$$MD$ES$ES
241663861$24166386$1$I$$20240801$20240802$20240802$EXP$$US-TAKEDA-2024TUS077621$TAKEDA$$$$$$Y$$$20240802$$MD$US$US
241663871$24166387$1$I$20240705$20240725$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119013$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240802$$CN$US$US
241663881$24166388$1$I$$20240726$20240802$20240802$EXP$$CA-GSK-CA2023170971$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$CA$CA
241663901$24166390$1$I$20240701$20240725$20240802$20240802$EXP$$US-ALKERMES INC.-ALK-2024-001972$ALKERMES$$32$YR$$F$Y$56.689$KG$20240802$$HP$US$US
241663911$24166391$1$I$$20240729$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US069458$SANDOZ$$$$E$F$Y$$$20240802$$MD$US$US
241663933$24166393$3$F$20240501$20240820$20240802$20240826$PER$$US-AMGEN-USASP2024151102$AMGEN$$68$YR$E$F$Y$$$20240825$$CN$US$US
241663941$24166394$1$I$20230201$20240725$20240802$20240802$EXP$$FR-AMGEN-FRASP2024148344$AMGEN$$58$YR$A$F$Y$$$20240802$$MD$FR$FR
241663951$24166395$1$I$$20240730$20240802$20240802$PER$$US-HALEON-2190207$Haleon PLC$$$$$F$Y$$$20240802$$CN$US$US
241663961$24166396$1$I$$20240729$20240802$20240802$PER$$US-BEH-2024176532$CSL BEHRING$$$$E$M$Y$$$20240802$$PH$US$US
241663971$24166397$1$I$$20240705$20240802$20240802$EXP$GB-MHRA-MED-202405121027032300-HPZVD$GB-MYLANLABS-2024M1071795$MYLAN$$$$$F$Y$$$20240802$$CN$GB$GB
241663981$24166398$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024092378$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$US$US
241663991$24166399$1$I$$20240729$20240802$20240802$EXP$$US-TAKEDA-2023TUS111009$TAKEDA$$$$$F$Y$$$20240802$$CN$US$US
241664002$24166400$2$F$$20240905$20240802$20240912$EXP$$CA-TAKEDA-2024TUS074926$TAKEDA$$$$$M$Y$$$20240912$$MD$CA$CA
241664011$24166401$1$I$$20240731$20240802$20240802$EXP$$CA-TAKEDA-2024TUS077628$TAKEDA$$$$$M$Y$$$20240802$$MD$CA$CA
241664032$24166403$2$F$20240422$20240905$20240802$20240909$EXP$$AU-MYLANLABS-2024M1071601$MYLAN$$53$YR$$M$Y$$$20240909$$PH$AU$AU
241664041$24166404$1$I$$20240731$20240802$20240802$EXP$$AU-MYLANLABS-2024M1071589$MYLAN$$$$$M$Y$$$20240802$$HP$AU$AU
241664071$24166407$1$I$$20240731$20240802$20240802$EXP$$NVSC2024BO157427$NOVARTIS$$$$$F$Y$$$20240802$$MD$BO$BO
241664081$24166408$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152436$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241664092$24166409$2$F$20240101$20240812$20240802$20240815$PER$$US-AMGEN-USASP2024151967$AMGEN$$54$YR$A$F$Y$$$20240815$$CN$US$US
241664101$24166410$1$I$20230909$20240727$20240802$20240802$EXP$$CA-JNJFOC-20240776053$JOHNSON AND JOHNSON$$42$YR$A$F$Y$66$KG$20240802$$HP$CA$CA
241664111$24166411$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151385$AMGEN$$$$$$Y$$$20240802$$HP$US$US
241664121$24166412$1$I$$20240725$20240802$20240802$EXP$$CA-TAKEDA-2023TUS083940$TAKEDA$$$$$F$Y$$$20240802$$CN$CA$CA
241664131$24166413$1$I$20240513$20240731$20240802$20240802$EXP$FR-AFSSAPS-GR2024000962$FR-TAKEDA-2024TUS076868$TAKEDA$$62$YR$$M$Y$42$KG$20240802$$HP$FR$FR
241664141$24166414$1$I$$20240729$20240802$20240802$PER$$US-UNITED THERAPEUTICS-UNT-2024-023582$UNITED THERAPEUTICS$$$$$F$Y$59.864$KG$20240802$$$US$US
241664151$24166415$1$I$$20240709$20240802$20240802$EXP$$CA-MYLANLABS-2024M1071880$MYLAN$$7$YR$$F$Y$$$20240802$$HP$CA$CA
241664161$24166416$1$I$$20240722$20240802$20240802$PER$$US-TEVA-VS-3224980$TEVA$$$$A$F$Y$$$20240802$$CN$US$US
241664171$24166417$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121862$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240802$$HP$US$US
241664181$24166418$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122191$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$48.53$KG$20240802$$CN$US$US
241664191$24166419$1$I$$20230524$20240802$20240802$EXP$$US-AstraZeneca-2023A121327$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241664201$24166420$1$I$$20240730$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121670$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$71.67$KG$20240802$$PH$US$US
241664211$24166421$1$I$20240305$20240731$20240802$20240802$EXP$$GR-AstraZeneca-2024A175417$ASTRAZENECA$$40$YR$$M$Y$85$KG$20240802$$MD$GR$
241664221$24166422$1$I$20221224$20221229$20240802$20240802$EXP$$AE-AstraZeneca-2023A000560$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$AE$
241664232$24166423$2$F$20240501$20240726$20240802$20240809$EXP$$US-BEH-2024176494$CSL BEHRING$$$$$M$Y$$$20240809$$HP$US$US
241664241$24166424$1$I$$20240729$20240802$20240802$EXP$$US-ROCHE-10000041941$ROCHE$$$$$$Y$$$20240802$$CN$US$US
241664251$24166425$1$I$$20240725$20240802$20240802$EXP$$US-GSK-US2024090137$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$HP$US$US
241664261$24166426$1$I$$20240726$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407018099$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240802$$CN$US$US
241664271$24166427$1$I$$20240722$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407014772$ELI LILLY AND CO$$34$YR$A$$Y$$$20240802$$LW$US$US
241664281$24166428$1$I$$20240723$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407016521$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241664291$24166429$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019884$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240802$$CN$US$US
241664301$24166430$1$I$$20240801$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408001106$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240802$$CN$US$US
241664311$24166431$1$I$20240730$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000161$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240802$$CN$US$US
241664331$24166433$1$I$$20240730$20240802$20240802$PER$$NVSC2024US156115$NOVARTIS$$$$$F$Y$$$20240802$$HP$US$US
241664341$24166434$1$I$20240708$20240729$20240802$20240802$EXP$$FR-ABBVIE-5862052$ABBVIE$$56$YR$$M$Y$$$20240802$$HP$FR$FR
241664353$24166435$3$F$20240101$20240920$20240802$20240930$EXP$$CA-CELLTRION INC.-2024CA015504$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
241664361$24166436$1$I$$20240729$20240802$20240802$EXP$$PK-ROCHE-10000040824$ROCHE$$47$YR$A$M$Y$$$20240802$$CN$PK$PK
241664381$24166438$1$I$$20240730$20240802$20240802$EXP$$US-ABBVIE-5860844$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241664391$24166439$1$I$$20240729$20240802$20240802$EXP$$US-ABBVIE-5861837$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241664401$24166440$1$I$$20240722$20240802$20240802$EXP$$IT-AUROBINDO-AUR-APL-2024-037613$AUROBINDO$Troisi F, Valenti N, Quadrini F, Vitulano N, Di Monaco A, Romanazzi I, et al.. Zero-Fluoroscopy Catheter Ablation of Right Appendage Focal Atrial Tachycardia in a Pregnant Woman. ClinicsPractice. 2024;14(3):946-953$34$YR$$F$Y$$$20240802$$HP$IT$IT
241664411$24166441$1$I$20240101$20240725$20240802$20240802$PER$$CA-TOLMAR, INC.-24CA051039$TOLMAR$$$$$M$Y$$$20240802$$CN$CA$CA
241664421$24166442$1$I$$20240725$20240802$20240802$PER$$CA-TOLMAR, INC.-24CA050990$TOLMAR$$$$$M$Y$$$20240802$$CN$CA$CA
241664431$24166443$1$I$20240701$20240724$20240802$20240802$PER$$US-TOLMAR, INC.-24US051375$TOLMAR$$58$YR$$M$Y$$$20240802$$CN$US$US
241664441$24166444$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046973$ROCHE$$51$YR$A$F$Y$$$20240802$$CN$US$US
241664451$24166445$1$I$20231001$20240723$20240802$20240802$EXP$$US-ROCHE-10000034442$ROCHE$$41$YR$A$F$Y$$$20240802$$CN$US$US
241664473$24166447$3$F$$20240906$20240802$20240910$EXP$$CZ-GSK-CZ2024EME093690$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$CZ$CZ
241664481$24166448$1$I$$20240725$20240802$20240802$EXP$$GB-TEVA-VS-3227681$TEVA$$$$A$M$Y$$$20240802$$CN$GB$GB
241664491$24166449$1$I$$20240723$20240802$20240802$EXP$$JP-MYLANLABS-2024M1070243$MYLAN$Takahashi Y, Nakano H, Motoki M, Wakimoto Y, Ikechi D, Koyama Y, et al. Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review. Acute-Med-Surg 2024; 11 (1): 1-5.. 2024;11 (1):1-5$45$YR$$F$Y$$$20240802$$HP$JP$JP
241664501$24166450$1$I$$20240722$20240802$20240802$EXP$$GB-MYLANLABS-2024M1069653$MYLAN$Jacobs B, Vidoni A, Mughal MZ. Two Year follow-up of Children treated for Aneurysmal Bone Cyst (ABC) with Denosumab combined with Zoledronate. JBMR-Plus 2023; 7 (Suppl. 3) abstr. P298.$$$C$$Y$$$20240802$$HP$GB$GB
241664511$24166451$1$I$$20240724$20240802$20240802$EXP$$MX-GSK-MX2024GSK095275$GLAXOSMITHKLINE$Carrillo-Esper R, Pineda AAV. Anestesicos inhalados en estado asmatico experiencia de dos casos. Med Crit.. 2024;38 (2):134-143$$$$$Y$$$20240802$$MD$MX$MX
241664521$24166452$1$I$20240101$20240730$20240802$20240802$EXP$$GB-ABBVIE-5862255$ABBVIE$$76$YR$$F$Y$$$20240802$$HP$GB$GB
241664531$24166453$1$I$20240701$20240730$20240802$20240802$EXP$$US-ABBVIE-5862304$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241664541$24166454$1$I$$20240719$20240802$20240802$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17342$ALKEM$$$$$F$Y$56.689$KG$20240802$$CN$US$US
241664551$24166455$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037902$AUROBINDO$Neuwelt EA , Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al.. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors.. Neurooncol-Adv. 2022;4:No. 1$39$YR$$M$Y$$$20240802$$HP$US$US
241664562$24166456$2$F$$20240726$20240802$20240805$EXP$$US-JNJFOC-20240778924$JOHNSON AND JOHNSON$$3$YR$C$M$Y$$$20240805$$CN$US$US
241664571$24166457$1$I$$20240725$20240802$20240802$EXP$$US-CORIUM, LLC-2024COR000147$CORIUM$$$$$$Y$$$20240802$$CN$US$US
241664581$24166458$1$I$$20240727$20240802$20240802$EXP$GB-MHRA-MED-202407271036139910-PFJBY$GB-CHATTEMPRD-2024OHG025547$CHATTEM$$68$YR$E$$Y$68$KG$20240802$$CN$GB$GB
241664591$24166459$1$I$$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024151863$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241664601$24166460$1$I$$20240725$20240802$20240802$EXP$$US-AMGEN-USASP2024148681$AMGEN$Chen J.J.; Tajfirouz D.; Madhavan A. et.al. Frequency of Asymptomatic Optic Nerve Enhancement in 203 Patients With MOG Antibody-Associated Disease. Neurology Neuroimmunology + Neuroinflammation. 2024;11 (5):e200277(1)-(5)$$$$$Y$$$20240802$$MD$US$US
241664611$24166461$1$I$20240729$20240729$20240802$20240802$EXP$$PK-ROCHE-10000040985$ROCHE$$40$YR$A$M$Y$$$20240802$$CN$PK$PK
241664621$24166462$1$I$20240616$20240725$20240802$20240802$EXP$$US-SAMSUNG BIOEPIS-SB-2024-23157$SAMSUNG BIOEPIS$$62$YR$A$F$Y$$$20240802$$CN$US$US
241664631$24166463$1$I$20200822$20240729$20240802$20240802$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011607$JAZZ$$49$YR$$F$Y$$$20240802$$HP$US$US
241664641$24166464$1$I$$20240726$20240802$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121725$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240802$$MD$JP$JP
241664661$24166466$1$I$$20240730$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121229$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$61$KG$20240802$$PH$US$US
241664671$24166467$1$I$$20240725$20240802$20240802$EXP$$CA-TEVA-VS-3226679$TEVA$$53$YR$$F$Y$$$20240802$$HP$CA$CA
241664691$24166469$1$I$$20240725$20240802$20240802$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02735$AMNEAL$$$$$M$Y$$$20240802$$CN$US$US
241664702$24166470$2$F$$20240821$20240802$20240822$PER$$US-ALXN-202407USA001905US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
241664711$24166471$1$I$$20240726$20240802$20240802$PER$$US-ALXN-202407USA001898US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241664721$24166472$1$I$$20240801$20240802$20240802$EXP$GB-MHRA-31377037$GB-SANDOZ INC.-SDZ2024GB069914$SANDOZ$$38$YR$$M$Y$$$20240802$$PH$GB$GB
241664741$24166474$1$I$$20240727$20240802$20240802$EXP$GB-MHRA-MED-202407270735169410-MQLDJ$GB-MSNLABS-2024MSNSPO01695$MSN LABORATORIES$$$$$$Y$$$20240802$$CN$GB$GB
241664751$24166475$1$I$20240526$20240724$20240802$20240802$EXP$GB-MHRA-MIDB-0a67027d-cd82-466b-8331-8f69dc4c7ddf$GB-TEVA-VS-3225507$TEVA$$63$YR$$M$Y$$$20240802$$PH$GB$GB
241664761$24166476$1$I$$20240111$20240802$20240802$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000667$STRIDES$Peeples J, Shu S, Romo KG, Tereul J, Grissett BB.. New Onset Heart Failure In A Patient With Rapidly Progressive Adrenocortical Carcinoma.. J-Endocr-Soc. 2023;7 (Suppl. 1):A133-A134 abstr. FRI249.$20$YR$$M$Y$$$20240802$$MD$US$US
241664771$24166477$1$I$$20231228$20240802$20240802$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000110$STRIDES$Mittal A, Beidoun MH, Valdes JL, Peleman A, Reddy S, Patel AK.. Hypercalcemia as a Rare Manifestation of Pneumocystis jirovecii Pneumonia.. J-Am-Soc-Nephrol. 2023;34 (Suppl.):329 (plus Po) abstr. TH-PO85$63$YR$$M$Y$$$20240802$$HP$US$US
241664781$24166478$1$I$$20231219$20240802$20240802$PER$$US-STRIDES ARCOLAB LIMITED-2023SP018910$STRIDES$De Ferrari A, Pywell C, Bahl D.. ACTH-Producing Pheochromocytoma, a Challenging Disease to Diagnose and Manage.. J-Endocr-Soc. 2020;4 (Suppl.):A432-A433 abstr. SAT-204.$41$YR$$F$Y$$$20240802$$MD$US$US
241664791$24166479$1$I$$20231219$20240802$20240802$PER$$US-STRIDES ARCOLAB LIMITED-2023SP018930$STRIDES$Motazedi B, Cowen LE, Jonklaas J.. A Case of Acute Psychosis as Manifestation of Ectopic ACTH Producing Pancreatic Neuroendocrine Tumor.. J-Endocr-Soc. 2021;5 (Suppl. 1):A558-A559.$31$YR$$F$Y$$$20240802$$MD$US$US
241664801$24166480$1$I$$20230705$20240802$20240802$PER$$US-STRIDES ARCOLAB LIMITED-2023SP011134$STRIDES$Cameron K, Venegas C, Fahad I, Mathew S.. Cushing +amp;apos; s Syndrome Presenting as Nonconvulsive Status Epilepticus: A Case Report and Literature Review.. Neurology.. 2023;100 (2):17.$6$DEC$$M$Y$$$20240802$$HP$US$US
241664811$24166481$1$I$$20240213$20240802$20240802$PER$US-MLMSERVICE-20231121-4676095-1$US-STRIDES ARCOLAB LIMITED-2024SP001968$STRIDES$Gopinath C, Pagadala P, Choudhary C, Tilden DR. A Case Of Cushing^ s Disease Due To T-pit Positive, ACTH Negative Aggressive Corticotroph Pituitary Adenoma. J-Endocr-Soc. 2023;7(1):A582 abstr. THU010$56$YR$$M$Y$$$20240802$$MD$US$US
241664821$24166482$1$I$20230802$20240730$20240802$20240802$EXP$$SG-CHATTEMPRD-2024OHG025724$CHATTEM$$74$YR$E$F$Y$$$20240802$$CN$SG$SG
241664831$24166483$1$I$$20240111$20240802$20240802$PER$US-MLMSERVICE-20231116-4664310-1$US-STRIDES ARCOLAB LIMITED-2023SP018004$STRIDES$Henry R, Mamilly L, Baron K.. Liraglutide Ameliorates Symptoms of Cushing Syndrome in a Pediatric Patient.. Journal of the Endocrine Society.. 2022;6(Supplement 1):A106-A107 abstr. PSAT043$13$YR$$F$Y$$$20240802$$MD$US$US
241664841$24166484$1$I$$20240304$20240802$20240802$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002802$STRIDES$Schwartz A, Zemkova Y, Bowmaster S, Doerschug KC.. Pneumocystis Jirovecii Pneumonia Secondary to ACTH-secreting Neuroendocrine Tumors.. Am-J-Respir-Crit-Care-Med. 2023;207:no pagination$45$YR$$F$Y$$$20240802$$HP$US$US
241664851$24166485$1$I$$20240724$20240802$20240802$EXP$GB-MHRA-MED-202407240927293430-QGYBT$GB-TEVA-VS-3225700$TEVA$$$$$F$Y$$$20240802$$CN$GB$GB
241664862$24166486$2$F$$20240812$20240802$20240813$PER$$US-TAKEDA-2024TUS077459$TAKEDA$$$$$M$Y$$$20240813$$CN$US$US
241664872$24166487$2$F$$20240826$20240802$20240906$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2024-07682$LUPIN$Brueckner I, Welter-Luedeke J, Z Anna, Graw M, Paul LD. Alpha-Pyrrolidinohexanophenone (alpha-PHP) vs. alpha-pyrrolidinoisohexanophenone (alpha-PiHP): A toxicological  investigation about plasma concentrations and behavior in  forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$39$YR$$F$Y$$$20240906$$HP$DE$DE
241664881$24166488$1$I$$20240731$20240802$20240802$EXP$$CA-SANDOZ INC.-SDZ2023CA076651$SANDOZ$$$$$F$Y$$$20240802$$HP$CA$CA
241664911$24166491$1$I$20240801$20240801$20240802$20240802$30DAY$$US-SANDOZ INC.-SDZ2024US026350$SANDOZ$$32$YR$$F$Y$$$20240802$$HP$US$US
241664921$24166492$1$I$20240702$20240725$20240802$20240802$EXP$$CA-CELLTRION INC.-2024CA018431$CELLTRION$$$$$$Y$$$20240802$$HP$CA$CA
241664941$24166494$1$I$$20240719$20240802$20240802$PER$$US-ROCHE-10000032052$ROCHE$$$$$$Y$$$20240802$$PH$US$US
241664952$24166495$2$F$20220201$20240828$20240802$20240831$EXP$$US-GSK-US2024095206$GLAXOSMITHKLINE$$$$$$Y$$$20240831$$MD$US$US
241664963$24166496$3$F$20240725$20240814$20240802$20240820$EXP$$JP-ARGENX-2024-ARGX-JP005950AA$ARGENX BVBA$$$$$$Y$$$20240820$$MD$JP$JP
241664981$24166498$1$I$$20240723$20240802$20240802$EXP$$JP-BEH-2024176253$CSL BEHRING$$30$YR$A$F$Y$$$20240802$$HP$JP$JP
241664991$24166499$1$I$$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460589$RANBAXY$$$$$M$Y$$$20240802$$CN$GB$GB
241665001$24166500$1$I$$20230830$20240802$20240802$EXP$$US-AstraZeneca-2023A200124$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241665012$24166501$2$F$$20240918$20240802$20240926$EXP$$US-HETERO-HET2024US02435$HETERO$$$$$$Y$$$20240926$$CN$US$US
241665022$24166502$2$F$$20240812$20240802$20240815$EXP$$CA-TAKEDA-2024TUS063550$TAKEDA$$$$$F$Y$$$20240815$$CN$CA$CA
241665031$24166503$1$I$20210722$20210728$20240802$20240802$EXP$$US-AstraZeneca-2021A652956$ASTRAZENECA$$23578$DY$$M$Y$$$20240802$$CN$US$
241665041$24166504$1$I$20240708$20240725$20240802$20240802$PER$$US-ABBVIE-5857165$ABBVIE$$42$YR$$F$Y$$$20240802$$MD$US$US
241665051$24166505$1$I$$20240725$20240802$20240802$EXP$$ZA-AstraZeneca-2024A170978$ASTRAZENECA$$75$YR$$M$Y$$$20240802$$CN$ZA$
241665061$24166506$1$I$$20240723$20240802$20240802$EXP$$US-GSK-US2024AMR093936$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241665071$24166507$1$I$$20240723$20240802$20240802$EXP$$CA-AUROBINDO-AUR-APL-2024-037386$AUROBINDO$Kordy F, Nashid N, Khan S, Read S, Macdougall G, Louch D et al.. Video directly observed therapy to improve adherence of human immunodeficiency virus infected adolescents to combination antiretroviral therapy:a proof-of-concept study.. AIDS Care Psychological and Socio-medical Aspects of AIDS/HIV.. 2023;35(3):417???424$16$YR$$M$Y$$$20240802$$HP$CA$CA
241665081$24166508$1$I$$20240724$20240802$20240802$30DAY$$US-GSK-US2024AMR093964$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$US$US
241665092$24166509$2$F$$20240921$20240802$20240923$PER$$US-PFIZER INC-202400226438$PFIZER$$27$YR$$M$Y$$$20240923$$MD$US$US
241665101$24166510$1$I$$20240724$20240802$20240802$PER$$US-PFIZER INC-PV202400097014$PFIZER$$2$YR$$F$Y$7.2$KG$20240802$$MD$US$US
241665111$24166511$1$I$20240101$20240729$20240802$20240802$PER$$US-PFIZER INC-202400226289$PFIZER$$15$YR$$M$Y$49.9$KG$20240802$$CN$US$US
241665122$24166512$2$F$$20240904$20240802$20240904$PER$$US-PFIZER INC-202400227013$PFIZER$$26$YR$$F$Y$$$20240904$$CN$US$US
241665131$24166513$1$I$$20240726$20240802$20240802$EXP$GB-MHRA-MED-202407260940522970-MBTYF$GB-AMAROX PHARMA-AMR2024GB02496$HETERO$$$$$F$Y$$$20240802$$HP$GB$GB
241665141$24166514$1$I$$20240801$20240802$20240802$EXP$GB-MHRA-31354159$GB-SANDOZ INC.-SDZ2024GB069927$SANDOZ$$75$YR$$M$Y$$$20240802$$CN$GB$GB
241665161$24166516$1$I$20230101$20240723$20240802$20240802$EXP$$BR-SANDOZ INC.-SDZ2024BR069946$SANDOZ$$$$$M$Y$98$KG$20240802$$CN$BR$BR
241665171$24166517$1$I$$20240719$20240802$20240802$EXP$$SA-QUAGEN-2024QUALIT00231$QUAGEN PHARMACEUTICALS$Gomaa Mostafa-Hedeab.Levetiracetam-Induced Acute Hypersensitivity Reaction in a Previously Undiagnosed Epilepsy Elderly Woman: A Case Report.International Journal of Pharmacology.JAN-2024;20:912-915$71$YR$E$F$Y$$$20240802$$HP$SA$SA
241665181$24166518$1$I$$20240726$20240802$20240802$PER$$US-ROCHE-10000040063$ROCHE$$$$$F$Y$$$20240802$$HP$US$US
241665191$24166519$1$I$$20240725$20240802$20240802$EXP$$KZ-EMD Serono-2024040555$EMD SERONO INC$$$$$M$Y$$$20240802$$MD$KZ$KZ
241665211$24166521$1$I$$20240725$20240802$20240802$EXP$$US-CHATTEMPRD-2024OHG025471$CHATTEM$$$$$M$Y$$$20240802$$LW$US$US
241665221$24166522$1$I$20240101$20240719$20240802$20240802$EXP$$US-Axsome Therapeutics, Inc.-AXS202406-000883$AXSOME THERAPEUTICS$$18$YR$A$F$Y$$$20240802$$$US$
241665241$24166524$1$I$20240730$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152293$AMGEN$$70$YR$E$F$Y$$$20240802$$PH$US$US
241665251$24166525$1$I$$20240724$20240802$20240802$PER$$US-BEH-2024176417$CSL BEHRING$$$$A$F$Y$$$20240802$$CN$US$US
241665261$24166526$1$I$$20240731$20240802$20240802$EXP$$TW-SANDOZ INC.-SDZ2024TW069505$SANDOZ$$74$YR$$F$Y$$$20240802$$CN$TW$TW
241665272$24166527$2$F$20240101$20240812$20240802$20240814$PER$$US-AMGEN-USASP2024151830$AMGEN$$52$YR$A$F$Y$$$20240814$$MD$US$US
241665281$24166528$1$I$20240730$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151678$AMGEN$$78$YR$E$F$Y$$$20240802$$CN$US$US
241665301$24166530$1$I$20200106$20240722$20240802$20240802$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009664$STRIDES$$54$YR$$F$Y$$$20240802$$CN$US$US
241665311$24166531$1$I$20190801$20240722$20240802$20240802$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009332$STRIDES$$60$YR$$F$Y$$$20240802$$CN$US$US
241665321$24166532$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151359$AMGEN$$$$$F$Y$$$20240802$$CN$US$US
241665331$24166533$1$I$20240701$20240725$20240802$20240802$EXP$$US-ASTELLAS-2024US021489$ASTELLAS$$$$$M$Y$$$20240802$$CN$US$US
241665341$24166534$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122261$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240802$$HP$US$US
241665351$24166535$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122258$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240802$$HP$US$US
241665361$24166536$1$I$$20240729$20240802$20240802$EXP$$CA-SANDOZ INC.-SDZ2024CA069118$SANDOZ$$6$YR$$M$Y$21$KG$20240802$$HP$CA$CA
241665371$24166537$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122598$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241665381$24166538$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122124$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240802$$CN$US$US
241665391$24166539$1$I$$20240719$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116169$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$66.68$KG$20240802$$HP$US$US
241665401$24166540$1$I$$20240730$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121510$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240802$$CN$US$US
241665411$24166541$1$I$$20240725$20240802$20240802$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-15016$IPSEN$TORRES RM, NASEREDDIN T, DAHIYA D, ZELT C, PERISETTI A, et al. EFFICACY AND SAFETY OF A NOVEL TECHNIQUE UTILIZING EUS-GUIDED FNI OF BOTOX AND BALLOON DILATION (EGBBD) FOR THE TREATMENT OF BOTOX IN ACHALASIA. GASTROINTESTINAL ENDOSCOPY. 2024;99(6S): AB802-AB803.$$$$$Y$$$20240802$$HP$US$US
241665422$24166542$2$F$20240320$20240729$20240802$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460508$RANBAXY$$68$YR$$M$Y$$$20240813$$HP$FR$FR
241665431$24166543$1$I$$20240725$20240802$20240802$PER$$US-JNJFOC-20240802864$JOHNSON AND JOHNSON$$66$YR$E$F$Y$67.4$KG$20240802$$MD$US$US
241665451$24166545$1$I$$20240719$20240802$20240802$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460421$RANBAXY$Demir B, Bickici O, Kaya O. Case report: Sickle cell anemia avascular necrosis mimicking chronic sacroiliitis in a patient with a pre-diagnosis spondyloarthropathy. Int J Rheum Dis. 2024;27(6):e15230$43$YR$$M$Y$$$20240802$$HP$TR$TR
241665461$24166546$1$I$$20240719$20240802$20240802$EXP$$US-QUAGEN-2024QUALIT00230$QUAGEN PHARMACEUTICALS$I Pien.Osteonecrosis of Trapezium Occurring in Patient with History of Recurrent Carpometacarpal Corticosteroid Injection.The Journal of Hand Surgery Asian-Pacific.FEB-2023;28:129-133$59$YR$A$F$Y$$$20240802$$HP$US$US
241665471$24166547$1$I$20240620$20240726$20240802$20240802$EXP$$CO-JNJFOC-20240777703$JOHNSON AND JOHNSON$$62$YR$A$F$Y$68$KG$20240802$$HP$CO$CO
241665481$24166548$1$I$$20240719$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460234$RANBAXY$Nnadi E, Khatun N, Abdulfattah A. A Case of Progressive Post-covid-19 Interstitial Lung Disease Requiring Prolonged Hospitalization. Am J Respir Crit Care Med. 204;209(0):A2081$45$YR$$F$Y$$$20240802$$HP$US$US
241665491$24166549$1$I$20240401$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-459984$RANBAXY$$58$YR$$F$Y$$$20240802$$MD$FR$FR
241665502$24166550$2$F$$20240730$20240802$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460089$RANBAXY$Rossi NP, Sathyanarayanan G, Mahmood M, Shakespeare D. Toxic leukoencephalopathy versus delayed post-hypoxic leukoencephalopathy after oral morphine sulphate overdose. BMJ Case Rep. 2023;16:e255291(1-7)$5$DEC$$M$Y$$$20240814$$HP$GB$GB
241665512$24166551$2$F$$20240821$20240802$20240821$EXP$$NL-ABBVIE-5863057$ABBVIE$$58$YR$$F$Y$$$20240821$$CN$NL$NL
241665521$24166552$1$I$$20240719$20240802$20240802$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460113$RANBAXY$Wacker J, Joye R, McLin V, Wildhaber B, Toso C, Genecand L, et al. Liver transplantation for pediatric portopulmonary hypertension. Cardiol Young. 2023;33:S290-S291; P-597$$$T$$Y$$$20240802$$HP$CH$CH
241665531$24166553$1$I$$20240719$20240802$20240802$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460114$RANBAXY$Wacker J, Joye R, McLin V, Wildhaber B, Toso C, Genecand L, et al. Liver transplantation for pediatric portopulmonary hypertension. Cardiol Young. 2023;33:S290-S291; P-597$$$T$$Y$$$20240802$$HP$CH$CH
241665541$24166554$1$I$$20240719$20240802$20240802$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460205$RANBAXY$GaUr U, Gadkari C, PUndkar A. Hypokalaemic Periodic Paralysis in a Patient with Rheumatoid Arthritis:A Case Report. J Clin Diagnostic Res. 2024;Jul; 18 (7):OD01-OD03$37$YR$$F$Y$$$20240802$$MD$IN$IN
241665551$24166555$1$I$20240707$20240719$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460435$RANBAXY$$61$YR$$M$Y$85$KG$20240802$$CN$GB$GB
241665561$24166556$1$I$$20240719$20240802$20240802$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460263$RANBAXY$Campos-Lopes S, Monteiro AM, Marques O. Pulmonary Embolism in Adipsic DI: Can Desmopressin Be a Contributing Factor?. J Endocr Soc. 2021;5:A605-A606$51$YR$$F$Y$$$20240802$$MD$PT$PT
241665571$24166557$1$I$$20240719$20240802$20240802$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460477$RANBAXY$Shah K, Wong J, Mac K, Lau NS, Wong VM, Makris A. Adrenal insufficiency in hemodialysis patients-An under-recognized problem: A case series. Hemodial Int. 2024;28(2):229-232$21$YR$$F$Y$$$20240802$$HP$AU$AU
241665581$24166558$1$I$$20240719$20240802$20240802$EXP$$EC-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460528$RANBAXY$Eduardo Gomez L, Lenin Velez N, Peralta RDC, Nancy Villegas V, Elsy Pinela M, Edison Torres R. Severe Inflammatory and Disseminated Cutaneous Leishmaniasis in a Pregnant Woman: A Case Report from Portoviejo, Ecuador. Am J Case Rep. 2024;25(0):e944422$25$YR$$F$Y$$$20240802$$HP$EC$EC
241665591$24166559$1$I$$20240719$20240802$20240802$EXP$$QA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460298$RANBAXY$Saud A, Abuhaliqa WM. Euglycemic Diabetic Ketoacidosis in a Patient With Gestational Diabetes Mellitus and COVID-19 Infection. J Enodcr Soc. 2021;Apr-May;5 S1:A780-A781$30$YR$$F$Y$$$20240802$$MD$QA$QA
241665601$24166560$1$I$$20240719$20240802$20240802$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460491$RANBAXY$Ayadi M, Khemakhem R, Bahloul N, Gargouri R, Kallel N, Yangui I. Palmar-plantar erythrodysesthesia secondary to Docetaxel: 2 case reports. French Journal of Allergology. 2024;64:103923 (Medi -40)$52$YR$$M$Y$$$20240802$$HP$TN$TN
241665611$24166561$1$I$$20240719$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460235$RANBAXY$Redmond MA, Begnaud A. Dressler^s Syndrome Is Making a Comeback: Massive Pleural Effusion After Atrial Fibrillation Ablation. Am J Respir Crit Care Med. 2024;209 (0):A1925$73$YR$$F$Y$$$20240802$$HP$US$US
241665621$24166562$1$I$$20240719$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460380$RANBAXY$Hagan AJ, Verity SJ. Key Questions on the Long-Term Utility of Methylphenidate in Paediatric Brain Tumour Survivorship: A Retrospective Clinical Case Series. Children (Base). 2024;11 (2):187 (1-13)$$$C$M$Y$$$20240802$$HP$GB$GB
241665631$24166563$1$I$20211015$20240719$20240802$20240802$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460071$RANBAXY$Zhong^an L, Yeshan C, Ai H, Guiling L. Pneumocystis jirovecii infection during immune checkpoint inhibitor therapy: a report of two cases and review of literature. Anti tumor Pharmacy. 2023;Feb;13(1):127-132$46$YR$$M$Y$$$20240802$$HP$CN$CN
241665641$24166564$1$I$$20240719$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460382$RANBAXY$Hagan AJ, Verity SJ. Key Questions on the Long-Term Utility of Methylphenidate in Paediatric Brain Tumour Survivorship: A Retrospective Clinical Case Series. Children (Base). 2024;11 (2):187 (1-13)$$$C$F$Y$$$20240802$$HP$GB$GB
241665651$24166565$1$I$$20240719$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460257$RANBAXY$Pollack ED, Richardson C, Powell B, Patel K. Meningoencephalitis With Transverse Myelitis in a Patient With West Nile Virus - Clinical Insights and Awareness. Am J Respir Crit Care Med. 2024;May 21;209 (0):A5619;C43$42$YR$$M$Y$$$20240802$$HP$US$US
241665662$24166566$2$F$$20240726$20240802$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460486$RANBAXY$Herrera AF, Chen L, Crombie JL, Cohen JB, Advani RH, LaCasce AS, et al.. Polatuzumab vedotin combined with R-ICE (PolaR-ICE) as second-line therapy in relapsed/refractory diffuse large B-cell lymphoma.. Blood. 2022;140(Sup1)nov:1065-1067$$$A$$Y$$$20240809$$MD$US$US
241665671$24166567$1$I$$20240719$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460142$RANBAXY$$86$YR$$F$Y$68$KG$20240802$$HP$GB$GB
241665681$24166568$1$I$20231023$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460433$RANBAXY$$38$YR$$M$Y$90$KG$20240802$$PH$FR$FR
241665691$24166569$1$I$$20240719$20240802$20240802$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460424$RANBAXY$Gazouni E, Betsikos A, Zisis C, Paschou E, Patrikalou E, Zorbas A, et al. LIGHT-CHAIN MULTIPLE MYELOMA IN A PATIENT WITH IGDA MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS): A PUZZLING DIAGNOSIS. Eur J Case Rep Intern Med. 2023;10 (Suppl.):393$76$YR$$F$Y$$$20240802$$HP$GR$GR
241665702$24166570$2$F$$20240726$20240802$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460390$RANBAXY$Belnavis G, Goyal A, Boudoulas KD, Breckenridge MB. A CASE OF MYOCARDIAL INFARCTION IN A YOUNG BODYBUILDER ON TESTOSTERONE. J Am Coll Cardiol. 2024;APR; 83 (S)(13):3294$33$YR$$M$Y$$$20240809$$HP$US$US
241665711$24166571$1$I$$20240719$20240802$20240802$EXP$$AR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460258$RANBAXY$Smiles S, Stante C, Ruda M, Magnanelli V, Palmieri FI, Cheistwer A, et al. Abdominal tuberculosis in pediatrics: A case report. Arch Argent Pediatr. 2023;122(2):e202310049; 1-5$15$YR$$M$Y$49.4$KG$20240802$$HP$AR$AR
241665721$24166572$1$I$$20240719$20240802$20240802$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460436$RANBAXY$Onder H, Comoglu S. Levodopa-Induced Jaw and Facial Dystonia in a Case of Progressive Supranuclear Palsy with Blepharospasm. Mov Disord Clin Pract. 2023;10(12):1806-1808$64$YR$$M$Y$$$20240802$$MD$TR$TR
241665731$24166573$1$I$$20240719$20240802$20240802$EXP$$EG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460428$RANBAXY$El-Tooney A, Kasem A. A Case Report of COVID-19 With an Uncommon Presentation and an Unfavorable Outcome. Am J Respir Crit Care Med. 2023;207:A5277$40$YR$$M$Y$$$20240802$$HP$EG$EG
241665742$24166574$2$F$$20240726$20240802$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460479$RANBAXY$Khachatryan A, Isseh I, Vavilin I, Saeed IM, Harutyunyan H, Bansro V, et al. RECURRENT PERIMYOCARDITIS ASSOCIATED WITH LONG-TERM METHYLPHENIDATE USE. J Am Coll Cardiol. 2024;APR; 83(S)(13):3543$19$YR$$M$Y$$$20240809$$HP$US$US
241665751$24166575$1$I$$20240719$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460489$RANBAXY$Murphy A, Cordisco A, Khan AH, Craft CA.. An uncommon cause of complete heart block in a patient with a history of seizures. J-Am-Coll-Cardiol. 2024;2APR 83 (S)13:2881$64$YR$$M$Y$$$20240802$$HP$US$US
241665761$24166576$1$I$20220314$20240719$20240802$20240802$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460507$RANBAXY$$59$YR$$F$Y$$$20240802$$PH$ES$ES
241665771$24166577$1$I$$20240719$20240802$20240802$EXP$$QA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460300$RANBAXY$Saud A, Abuhaliqa WM. Euglycemic Diabetic Ketoacidosis in a Patient With Gestational Diabetes Mellitus and COVID-19 Infection. J Enodcr Soc. 2021;5 (Suppl.):A780-A781$$$$F$Y$$$20240802$$MD$QA$QA
241665781$24166578$1$I$20240502$20240719$20240802$20240802$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460439$RANBAXY$$83$YR$$F$Y$$$20240802$$PH$ES$ES
241665791$24166579$1$I$20240430$20240719$20240802$20240802$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460388$RANBAXY$$92$YR$$M$Y$$$20240802$$MD$SE$SE
241665801$24166580$1$I$$20240719$20240802$20240802$EXP$$MX-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460460$RANBAXY$Venegas-gomez VA, Ruiz-Manriquez J, Falcon-Antonio OE, Zamora-Nava LE. Protein-losing enteropathy secondary to graft-versus-host disease. Rev Esp Enferm Dig. 2024;116(4):238-239$23$YR$$M$Y$$$20240802$$HP$MX$MX
241665811$24166581$1$I$20240229$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460181$RANBAXY$$45$YR$$F$Y$95$KG$20240802$$PH$FR$FR
241665821$24166582$1$I$$20240719$20240802$20240802$EXP$$US-UCBSA-2024037025$UCB$$$$$$Y$$$20240802$$CN$US$US
241665842$24166584$2$F$20200711$20240723$20240802$20240803$EXP$$PL-AUROBINDO-AUR-APL-2024-037315$AUROBINDO$$48$YR$$F$Y$70$KG$20240803$$MD$PL$PL
241665851$24166585$1$I$$20240725$20240802$20240802$EXP$GB-MHRA-MIDB-f07c6790-3404-4bea-9c77-902bded173a9$GB-TEVA-VS-3226239$TEVA$$87$YR$$$Y$$$20240802$$PH$GB$GB
241665861$24166586$1$I$$20240719$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460144$RANBAXY$$79$YR$$F$Y$$$20240802$$HP$GB$GB
241665871$24166587$1$I$$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460366$RANBAXY$$$$$F$Y$$$20240802$$CN$GB$GB
241665882$24166588$2$F$$20240808$20240802$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459903$RANBAXY$Rhoads S, Maloney J, Mantha A, Hook RV, Henao?Martinez AF. Pneumocystis jirovecii Pneumonia in HIV-Negative, Non-transplant Patients: Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention. Curr Fungal Infect Rep. 2024;18:125-135$34$YR$$F$Y$$$20240823$$HP$US$US
241665891$24166589$1$I$$20240729$20240802$20240802$EXP$$NVSC2024ZA155712$NOVARTIS$$51$YR$$F$Y$$$20240802$$HP$ZA$ZA
241665901$24166590$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459909$RANBAXY$Tissavirasingham F, Singh S, Calvo Ayala E. Where Are the Antibodies? A Case of Prolonged COVID19 Infection in an Immunocompromised Patient Status Post Rituximab Therapy. Am J Respir Crit Care Med. 2024;209(0):A1348/A33$34$YR$$M$Y$$$20240802$$HP$US$US
241665911$24166591$1$I$$20240718$20240802$20240802$EXP$$MY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460228$RANBAXY$Zainudin MF, Yee CM, Yin KN. Morbid hunger and hyperphagia post-traumatic brain injury in a young male : good prognosis with escitalopram and multidisciplinary rehabilitation. Brain Inj. 2024;Jul 17:1-5$$$$M$Y$$$20240802$$HP$MY$MY
241665921$24166592$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459860$RANBAXY$Crowley A, Desai B, Waldron S. Vague Presentation of Cat Scratch Disease in a Child. Ochsner J. 2024;24 (2):131-134$10$YR$$F$Y$$$20240802$$MD$US$US
241665931$24166593$1$I$20240327$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460593$RANBAXY$$31$YR$$M$Y$$$20240802$$PH$FR$FR
241665941$24166594$1$I$$20240801$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408001238$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240802$$CN$US$US
241665951$24166595$1$I$20240601$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000174$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240802$$CN$US$US
241665961$24166596$1$I$$20240720$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459784$RANBAXY$$64$YR$$M$Y$$$20240802$$CN$US$US
241665972$24166597$2$F$20240727$20240731$20240802$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407019693$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240807$$CN$US$US
241665981$24166598$1$I$$20240718$20240802$20240802$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460184$RANBAXY$Wei J, Ning J. Successful treatment of penicillin-resistant pneumococcal meningitis following ventriculo-peritoneal shunt for congenital hydrocephalus: A case report on the efficacy of linezolid. Asian J Surg. 2024;47:3389$12$MON$$F$Y$$$20240802$$HP$CN$CN
241665991$24166599$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459854$RANBAXY$Marvin JE, McSweeney T, Cohen E, Davis MW, Belfield K, Do V, et al. Nocardiosis in Kidney Transplant Recipients and Possible Association With Decreased Utilization of Trimethoprim/Sulfamethoxazole During COVID-19. Transplantation. 2024;Jul;108 (7):e150-e151$$$$$Y$$$20240802$$PH$US$US
241666001$24166600$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459844$RANBAXY$Cheng TW, Colakovic RN, Pearson DR, Sio TT, Fiessinger LA. Treatment of sclerotic chronic graft-versus host disease with injections of hyaluronidase. JAAD Case Rep. 2023;38:55-58$35$YR$$M$Y$$$20240802$$HP$US$US
241666011$24166601$1$I$$20240718$20240802$20240802$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460333$RANBAXY$Winkler A, Buczek K, Krzyzanowski K, Orski Z, Krzesinski P, Kiliszek M.. Ventricular tachycardia in patient with chronic atrial fibrillation and cardiac resynchronization therapy. Kardiol Pol. 2024;82(Suppl.):78$67$YR$$M$Y$$$20240802$$HP$PL$PL
241666021$24166602$1$I$20240718$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460290$RANBAXY$$84$YR$$M$Y$75$KG$20240802$$MD$GB$GB
241666031$24166603$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460209$RANBAXY$Abdelmajid HA, Mustafa GMA, Fernandez A, Franco SD, Esquibies AE, Valencia GB, et al. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring. Case Rep Perinat Med. 2024;13(1):20220019/1-5$$$I$M$Y$$$20240802$$MD$US$US
241666041$24166604$1$I$$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460687$RANBAXY$ay M, Leguy S, Cahagne V, Lassalle N, Le Page E, Michel L. Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient. Rev Neurol Paris. 2024;180 (6):565-567$62$YR$$F$Y$$$20240802$$HP$FR$FR
241666061$24166606$1$I$20240112$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460649$RANBAXY$$60$YR$$F$Y$50.4$KG$20240802$$MD$FR$FR
241666071$24166607$1$I$$20240719$20240802$20240802$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460645$RANBAXY$$34$YR$$M$Y$87$KG$20240802$$CN$NL$NL
241666081$24166608$1$I$20240501$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460427$RANBAXY$$62$YR$$F$Y$82$KG$20240802$$MD$GB$GB
241666091$24166609$1$I$$20240730$20240802$20240802$EXP$$GB-ABBVIE-5862632$ABBVIE$$$$A$F$Y$$$20240802$$MD$GB$GB
241666101$24166610$1$I$$20240719$20240802$20240802$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460695$RANBAXY$$34$YR$$M$Y$$$20240802$$CN$SE$SE
241666111$24166611$1$I$20240411$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460577$RANBAXY$$45$YR$$F$Y$37$KG$20240802$$HP$FR$FR
241666121$24166612$1$I$$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460454$RANBAXY$$$$$M$Y$$$20240802$$CN$GB$GB
241666131$24166613$1$I$20240329$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460722$RANBAXY$$36$YR$$F$Y$54$KG$20240802$$MD$FR$FR
241666141$24166614$1$I$20240709$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460299$RANBAXY$$78$YR$$M$Y$$$20240802$$HP$GB$GB
241666151$24166615$1$I$$20240719$20240802$20240802$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460680$RANBAXY$$32$YR$$M$Y$76$KG$20240802$$MD$NL$NL
241666161$24166616$1$I$$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460596$RANBAXY$$66$YR$$F$Y$$$20240802$$PH$FR$FR
241666171$24166617$1$I$20240621$20240719$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459177$RANBAXY$$25$YR$A$F$Y$$$20240802$$HP$US$US
241666181$24166618$1$I$20240401$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460556$RANBAXY$$77$YR$$M$Y$80$KG$20240802$$MD$FR$FR
241666191$24166619$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460195$RANBAXY$Lawson CT, Portz BJ. A Case of Steroid Refractory Lupus Podocytopathy: Is Glucocorticoid Monotherapy Sufficient?. J Am Soc Nephrol. 2023;Nov; 34(11S):1013/ SA-PO1015$38$YR$$F$Y$$$20240802$$HP$US$US
241666201$24166620$1$I$20240129$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460600$RANBAXY$$94$YR$$M$Y$$$20240802$$PH$FR$FR
241666211$24166621$1$I$$20240718$20240802$20240802$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403439$RANBAXY$Suzuki N, Okuyama M, Kamiya K. Effects and Limitations of Naldemedine for Opioid-Induced Urinary Retention: A Case Report. J Palliat Med. 2023;26(11):1593-1595$78$YR$$M$Y$$$20240802$$MD$JP$JP
241666221$24166622$1$I$$20240718$20240802$20240802$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459965$RANBAXY$Torrente Segarra V. Oligoarticular enthesitis-related arthritis and tofacitinib suitability: A case-based literature review. Int J Rheum Dis. 2024;27:e15038$$$$M$Y$$$20240802$$HP$ES$ES
241666231$24166623$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459818$RANBAXY$Adesina J, Patel A, Khan S. MANY REASONS FOR RESTLESS LEGS, NOT TO REST. Sleep. 2024;47(suppl.1):A494(1153)$52$YR$$M$Y$$$20240802$$HP$US$US
241666241$24166624$1$I$$20240718$20240802$20240802$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460029$RANBAXY$Xue H, Wang L, Ma Y, Hou C. Pharmacotherapy and cardiovascular challenges: a case report of olverembatinib-induced myocardial infarction with non-obstructive coronary arteries. BMC Cardiovasc Discord. 2024;24 (1):332$61$YR$$M$Y$$$20240802$$HP$CN$CN
241666251$24166625$1$I$$20240718$20240802$20240802$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460070$RANBAXY$Lei M, Cao Y, Yuan M,Xiong J, He H. Case report: A case of bradycardia triggered by diarrhea. Front Med. 2024;May; 11:1405494(1-5)$92$YR$$M$Y$$$20240802$$HP$CN$CN
241666261$24166626$1$I$$20240719$20240802$20240802$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458534$RANBAXY$Pigni S, Cristofolini G, Jaafar S, Maida G, Grossrubatscher E, Dalino P, et al.. Late-onset schmidts syndrome presenting with severe hyponatremia: A case report. Endocr Metab Immune Disord Drug Targets. 2024;Jul 15$73$YR$$F$Y$$$20240802$$HP$IT$IT
241666272$24166627$2$F$$20240726$20240802$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459748$RANBAXY$Abdelal Q, Isern S, Najjar N. Azith and the Myth. Am J Respir Crit Care Med. 2024;May 19;209 (0):A2032;A52$73$YR$$F$Y$$$20240809$$HP$US$US
241666281$24166628$1$I$20240601$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460455$RANBAXY$$23$YR$$F$Y$254$KG$20240802$$HP$GB$GB
241666291$24166629$1$I$$20240718$20240802$20240802$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460230$RANBAXY$Miyakawa Y, Ihara S, Ishii S, Rui Y, Yajima S, Hayakawa Y et al. First case report of intestinal lymphangiectasia with refractory bleeding from the duodenum, successfully treated by intra-abdominal lymphaticovenous anastomosis with venous ligation. Clin J Gastroenterol. 2024;Jul 17:Online ahead of print(22)$41$YR$$F$Y$$$20240802$$HP$JP$JP
241666301$24166630$1$I$$20240719$20240802$20240802$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458828$RANBAXY$Lyadova MA, Gerus AY, Lyadov VK. Development of finger bone necrosis after administration of immune checkpoint inhibitors in a patient with Hodgkin^s lymphoma. PA Herzen J Oncol. 2021;10 (2):50-54$36$YR$$M$Y$$$20240802$$HP$RU$RU
241666311$24166631$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460208$RANBAXY$Abdelmajid HA, Mustafa GMA, Fernandez A, Franco SD, Esquibies AE, Valencia GB, et al. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring. Case Rep Perinat Med. 2024;13(1):20220019/1-5$33$YR$$F$Y$$$20240802$$MD$US$US
241666321$24166632$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460200$RANBAXY$Shakir M, Mohamed N, Vietor N, Mai V, Hoang T. Acute Cardiovascular Complications From Testosterone Therapy. J Endocr Soc. 2019;Apr-May;3(S1):SUN-206$48$YR$$M$Y$$$20240802$$MD$US$US
241666331$24166633$1$I$20240603$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460440$RANBAXY$$21$YR$$F$Y$52$KG$20240802$$CN$GB$GB
241666342$24166634$2$F$$20240725$20240802$20240809$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460017$RANBAXY$Terasawa R, Takashima Y, Hirata A, Kimura K, Morita S, Hayash M. A Case Study of Successful Breast Cancer Treatment after Recovery from Drug-Induced Interstitial Lung Disease. Jpn J Cancer Chemother. 2023;May; 50(5):635-637$5$DEC$$F$Y$$$20240809$$HP$JP$JP
241666351$24166635$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459780$RANBAXY$Hamill G, Burchard T, Khan EK. Gazing into the Crystal Ball: Correlating ATP-binding Cassette Protein A3 (ABCA3) Pathogenic Variant Genotypes and Phenotypes. Am J Respir Crit Care Med. 2024;209:A2326$3$WK$$F$Y$$$20240802$$HP$US$US
241666361$24166636$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459852$RANBAXY$Marvin JE, McSweeney T, Cohen E, Davis MW, Belfield K, Do V, et al. Nocardiosis in Kidney Transplant Recipients and Possible Association With Decreased Utilization of Trimethoprim/Sulfamethoxazole During COVID-19. Transplantation. 2024;Jul;108 (7):e150-e151$$$$$Y$$$20240802$$PH$US$US
241666372$24166637$2$F$$20240730$20240802$20240814$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459105$RANBAXY$Mavris N, Jaouni T, Amer R. Subretinal Fibrosis Developing 10 Years After First Presentation with Chronic Ocular Sarcoidosis in a Child. Ocular Immunol Inflamm. 2024;209 (0):1-1$$$$F$Y$$$20240814$$MD$IL$IL
241666381$24166638$1$I$20240609$20240719$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459145$RANBAXY$$72$YR$E$F$Y$$$20240802$$CN$US$US
241666392$24166639$2$F$$20240725$20240802$20240809$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460019$RANBAXY$Terasawa R, Takashima Y, Hirata A, Kimura K, Morita S, Hayash M. A Case Study of Successful Breast Cancer Treatment after Recovery from Drug-Induced Interstitial Lung Disease. Jpn J Cancer Chemother. 2023;May; 50(5):635-637$6$DEC$$F$Y$$$20240809$$HP$JP$JP
241666401$24166640$1$I$$20240718$20240802$20240802$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460180$RANBAXY$Sheng J, Pan H, Han W. Immunochemotherapy achieved a complete response for metastatic adenocarcinoma of unknown primary based on gene expression profiling: a case report and review of the literature. Front Immunol. 2023;14:1181444$52$YR$$F$Y$$$20240802$$HP$CN$CN
241666411$24166641$1$I$20240221$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460699$RANBAXY$$63$YR$$F$Y$73$KG$20240802$$MD$FR$FR
241666421$24166642$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459859$RANBAXY$Torres JW, Collazo Santiago HO, Torrens Olan J, QuilesCruz CV, Ortiz Velez I,Gonzalez Santiago G, et al. Crisis in the Lungs: EVALI Unveiled in a Young Male Patient. Am J Respir Crit Care Med. 2024;209:A2122$23$YR$$M$Y$$$20240802$$HP$US$US
241666431$24166643$1$I$$20240718$20240802$20240802$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458753$RANBAXY$Cao L, Zhang W. Tumor lysis syndrome in a patient with advanced lung squamous cell carcinoma undergoing combined therapy with a programmed cell death protein 1 inhibitor and firstline chemotherapy: A case report. Oncol Lett. 2024;28 (2):no pagination$61$YR$$M$Y$$$20240802$$HP$CN$CN
241666441$24166644$1$I$20240410$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460552$RANBAXY$$68$YR$$F$Y$70$KG$20240802$$MD$FR$FR
241666451$24166645$1$I$$20240718$20240802$20240802$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460052$RANBAXY$Mrabet S, Jaziri A, Aroud M, Zellama D, Naija S, Amor SB, et al. Coronavirus disease-19 encephalitis as a differential diagnosis of a cyclosporine related posterior leukoencephalopathy syndrome: A case report. Tunis Med. 2024;102(7):429-432$16$YR$$M$Y$75$KG$20240802$$HP$TN$TN
241666461$24166646$1$I$20240725$20240726$20240802$20240802$PER$$US-ALXN-202407USA001946US$ALEXION PHARMACEUTICALS$$43$YR$$F$Y$$$20240802$$CN$US$US
241666472$24166647$2$F$$20240922$20240802$20240925$EXP$$TR-AMGEN-TURSP2024152428$AMGEN$$46$YR$A$M$Y$$$20240925$$CN$TR$TR
241666481$24166648$1$I$20240730$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152282$AMGEN$$70$YR$E$F$Y$$$20240802$$CN$US$US
241666491$24166649$1$I$$20240728$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US069502$SANDOZ$$$$$$Y$$$20240802$$CN$US$US
241666501$24166650$1$I$$20240801$20240802$20240802$PER$$US-GILEAD-2024-0682673$GILEAD$$$$$M$Y$$$20240802$$CN$US$US
241666531$24166653$1$I$20230901$20240722$20240802$20240802$EXP$$PE-UCBSA-2023061097$UCB$$32$YR$$F$Y$57$KG$20240802$$CN$PE$PE
241666541$24166654$1$I$20231206$20240723$20240802$20240802$EXP$GB-MHRA-30734100$GB-Accord-437958$ACCORD$$70$YR$E$F$Y$60$KG$20240802$$MD$GB$GB
241666551$24166655$1$I$$20240724$20240802$20240802$EXP$$CA-AUROBINDO-AUR-APL-2024-038209$AUROBINDO$$40$YR$$F$Y$104.32$KG$20240802$$CN$CA$CA
241666561$24166656$1$I$$20240723$20240802$20240802$EXP$CA-MHPD-E2B_07121350$CA-Accord-438265$ACCORD$$83$YR$E$M$Y$$$20240802$$HP$CA$CA
241666571$24166657$1$I$$20240723$20240802$20240802$EXP$CA-MHPD-E2B_07121336$CA-Accord-437859$ACCORD$$57$YR$A$M$Y$$$20240802$$HP$CA$CA
241666581$24166658$1$I$20190919$20240723$20240802$20240802$EXP$PT-INFARMED-T202407-276$PT-Accord-438504$ACCORD$$36$YR$A$M$Y$69$KG$20240802$$CN$PT$PT
241666591$24166659$1$I$20240718$20240722$20240802$20240802$EXP$$BR-Accord-438273$ACCORD$$7$YR$C$F$Y$22.9$KG$20240802$$PH$BR$BR
241666601$24166660$1$I$20230419$20240722$20240802$20240802$EXP$AU-TGA-0000810595$AU-Accord-437953$ACCORD$$85$YR$E$F$Y$$$20240802$$MD$AU$AU
241666612$24166661$2$F$20240319$20240827$20240802$20240906$EXP$$US-JNJFOC-20240780205$JOHNSON AND JOHNSON$$69$YR$E$M$Y$97$KG$20240906$$PH$US$US
241666621$24166662$1$I$$20240726$20240802$20240802$EXP$$US-JNJFOC-20240778841$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241666632$24166663$2$F$$20240803$20240802$20240806$EXP$$US-SANDOZ INC.-SDZ2024US069954$SANDOZ$$$$$$Y$$$20240806$$CN$US$US
241666641$24166664$1$I$$20240731$20240802$20240802$EXP$$NVSC2024US157180$NOVARTIS$$$$$M$Y$$$20240802$$HP$US$US
241666651$24166665$1$I$$20240724$20240802$20240802$EXP$$RU-STRIDES ARCOLAB LIMITED-2024SP009562$STRIDES$Olisova OY, Teplyuk NP, Ignatiev DV, Dunaeva ER.. Development of scalded skin syndrome in an adult patient with acquired epidermolysis bullosa after long-term treatment with methotrexate. [Russian].. Russ-J-Skin-Vener-Dis. 2023;26 (1):41-49$47$YR$$M$Y$$$20240802$$HP$RU$RU
241666671$24166667$1$I$$20240508$20240801$20240801$DIR$FDA-CDER-CTU-2024-52849$$FDA-CTU$$$$$$N$$$20240508$N$PH$US$
241666682$24166668$2$F$20240330$20240802$20240802$20240807$EXP$$GB-SANDOZ INC.-SDZ2023GB053012$SANDOZ$$54$YR$$F$Y$71$KG$20240807$$MD$GB$GB
241666711$24166671$1$I$$20240725$20240802$20240802$EXP$$GR-STRIDES ARCOLAB LIMITED-2024SP009552$STRIDES$Asimakopoulos JV, Dolkiras F, Lakiotaki E, Rondogianni P, Tsourouflis G, Siakantaris MP, et al.. Prolonged 3-year spontaneous remission of diffuse large B-cell lymphoma upon withdrawal of infliximab and late relapse in a patient with psoriasis: a case report and review of the literature. [Review].. Leuk-Lymphoma. 2023;64 (10):1695-1700.$6$DEC$$M$Y$$$20240802$$HP$GR$GR
241666721$24166672$1$I$20240716$20240724$20240802$20240802$EXP$$IT-AUROBINDO-AUR-APL-2024-037515$AUROBINDO$$70$YR$$F$Y$$$20240802$$MD$IT$IT
241666732$24166673$2$F$20240709$20240911$20240802$20240918$EXP$$IL-ASTELLAS PHARMA EUROPE B.V.-2024US020103$ASTELLAS$$67$YR$E$M$Y$$$20240918$$CN$IL$IL
241666751$24166675$1$I$$20240726$20240802$20240802$EXP$$FR-MYLANLABS-2024M1071509$MYLAN$Lescarbotte F, Romano G, Balleyguier C, Arfi Rouche J, Ilenko A, Leymarie N. Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases. . Ann-Chir-Plast-Esthet 2024; 69 27-33.$65$YR$$F$Y$$$20240802$$HP$FR$FR
241666761$24166676$1$I$$20240726$20240802$20240802$EXP$$FR-MYLANLABS-2024M1071681$MYLAN$Lescarbotte F, Romano G, Balleyguier C, Arfi Rouche J, Ilenko A, Leymarie N. Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases. . Ann-Chir-Plast-Esthet 2024; 69 27-33.$76$YR$$F$Y$$$20240802$$HP$FR$FR
241666771$24166677$1$I$$20240726$20240802$20240802$EXP$$FR-MYLANLABS-2024M1071516$MYLAN$Lescarbotte F, Romano G, Balleyguier C, Arfi Rouche J, Ilenko A, Leymarie N. Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases. . Ann-Chir-Plast-Esthet 2024; 69 27-33.$60$YR$$F$Y$$$20240802$$HP$FR$FR
241666791$24166679$1$I$$20240725$20240802$20240802$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009542$STRIDES$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al.. Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.. Ann-Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240802$$HP$CN$CN
241666801$24166680$1$I$$20240725$20240802$20240802$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009543$STRIDES$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al.. Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.. Ann-Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240802$$HP$CN$CN
241666811$24166681$1$I$$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460459$RANBAXY$$$$$$Y$$$20240802$$CN$GB$GB
241666821$24166682$1$I$$20240718$20240802$20240802$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460109$RANBAXY$Shafiepour M, Najafzadeh MJ, Hashemi Bajgani SM, Dalfardi B. Pneumoscrotum, a Rare Presentation of Barotrauma Following Noninvasive Positive Pressure Ventilation in Patients with Severe COVID-19 Pneumonia. GMJ. 2022;11:e2372;1-5$40$YR$$M$Y$$$20240802$$HP$IR$IR
241666831$24166683$1$I$$20240718$20240802$20240802$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460105$RANBAXY$Shafiepour M, Najafzadeh MJ, Hashemi Bajgani SM, Dalfardi B. Pneumoscrotum, a Rare Presentation of Barotrauma Following Noninvasive Positive Pressure Ventilation in Patients with Severe COVID-19 Pneumonia. GMJ. 2022;11:e2372;1-5$43$YR$$M$Y$$$20240802$$HP$IR$IR
241666841$24166684$1$I$20240401$20240719$20240802$20240802$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460701$RANBAXY$$78$YR$$M$Y$61$KG$20240802$$PH$IT$IT
241666851$24166685$1$I$$20240719$20240802$20240802$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460683$RANBAXY$Tolino E, Proietti I, Skroza N, Di Guardo A, Di Fraia M, Dybala A, et al.. Atopic Dermatitis Onset in a Melanoma Patient Under Pembrolizumab Therapy: A Case of Successful Treatment with Dupilumab.. Indian J Dermatol. 2024;69 (3):268-269$82$YR$$M$Y$$$20240802$$HP$IT$IT
241666861$24166686$1$I$$20240718$20240802$20240802$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459966$RANBAXY$Sachdev G, Yadav S, Patil P, Patankar A, Balakrishnan C. Evolving clinical spectrum of vasculitis in systemic lupus erythematosus: a rare case of polyarteritis nodosa like manifestation. Indian J Rheumatol. 2023;18:S363-S364/CAS131$40$YR$$M$Y$$$20240802$$HP$IN$IN
241666881$24166688$1$I$20240503$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460282$RANBAXY$$36$YR$$F$Y$62$KG$20240802$$CN$GB$GB
241666891$24166689$1$I$$20240725$20240802$20240802$PER$$US-ABBVIE-5855124$ABBVIE$$$$$F$Y$$$20240802$$HP$US$US
241666901$24166690$1$I$20240422$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460691$RANBAXY$$87$YR$$M$Y$83$KG$20240802$$MD$FR$FR
241666912$24166691$2$F$$20240726$20240802$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459755$RANBAXY$Singanallur P, Schrader K, Chiravuri S, Abdulfattah O. Multifactorial Shock: Managing a Patient With Septic Shock and Left Ventricular Outflow Tract Obstruction. Am J Respir Crit Care Med. 2024;May;209 (0):A1622 (A43)$80$YR$$F$Y$$$20240809$$HP$US$US
241666921$24166692$1$I$$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460456$RANBAXY$$$$$$Y$$$20240802$$CN$GB$GB
241666931$24166693$1$I$20230921$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460608$RANBAXY$$40$YR$$F$Y$90$KG$20240802$$MD$FR$FR
241666941$24166694$1$I$$20240718$20240802$20240802$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460517$RANBAXY$Shigeyasu K, Yamamoto H, Takahashi T, Moriwake K, Kayano M, Takeda S. BRAF-mutant microsatellite-stable rectal cancer with acquired KRAS mutation leading to drug resistance in liver metastasis. Int Canc Conf J. 2024;13:189?192$74$YR$$F$Y$$$20240802$$HP$JP$JP
241666951$24166695$1$I$20240424$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460689$RANBAXY$$67$YR$$M$Y$85$KG$20240802$$MD$FR$FR
241666961$24166696$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459736$RANBAXY$Chittal A, Disilvio BE, Dumont T. Amiodarone Not the Only Anti-arrhythmic Wreaking Havoc on the Lung: A Case of Flecainide Induced Pneumonitis. Am J Respir Crit Care Med. 2024;209:A2028$69$YR$$F$Y$$$20240802$$HP$US$US
241666971$24166697$1$I$$20240718$20240802$20240802$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460170$RANBAXY$Nakamoto K, Horimasu Y, Yamaguchi K, Sakamoto S, Masuda T, Miyamoto S, et al. Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases. Intern Me. 2024;63 (12):1783-1787$88$YR$$M$Y$$$20240802$$HP$JP$JP
241666981$24166698$1$I$$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460708$RANBAXY$$52$YR$$M$Y$101$KG$20240802$$MD$FR$FR
241666991$24166699$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459732$RANBAXY$S. Arjun, J. Kang, J. Otero, J. Tsai, J. Iqbal. Whippet Too Hard: Nitrous Inhalant Abuse Leading to Acute Lung Injury. Am J Respir Crit Care Med. 2024;209 (0):A2035$22$YR$$F$Y$$$20240802$$HP$US$US
241667002$24166700$2$F$$20240730$20240802$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459982$RANBAXY$Li J, He L, Wu Q, Zhou J, Zhou L, Li T. et. al. Undifferentiated embryonal sarcoma of the liver in pediatric patients: a single-institution retrospective case series. Transl Pediatr. 2024;13 (5):784-790$11$YR$$M$Y$$$20240814$$HP$CN$CN
241667011$24166701$1$I$$20240718$20240802$20240802$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460185$RANBAXY$Faria MS, Zinterl C, Campanilho-Marques R, Esteves IC, Marques JG, Reis PC, et al. Clinical characteristics of a portuguese cohort with undefined autoinflammatory disease. Pediatr Rheumatol. 2023;21 (S2):122 (102)/P061$$$$$Y$$$20240802$$HP$PT$PT
241667021$24166702$1$I$20240717$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460431$RANBAXY$$94$YR$$F$Y$53$KG$20240802$$MD$GB$GB
241667031$24166703$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459744$RANBAXY$Finkelshteyn A. Myxedema Coma: An Atypical Presentation. South Med J. 2022;115:482-484$52$YR$$$Y$$$20240802$$MD$US$US
241667041$24166704$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459991$RANBAXY$Vincent J, Greenberg J, Sanghani S, Finneran K, Nguyen N. Profound Lactic Acidosis and Shock in a Patient Taking Metformin. Am J Respir Crit Care Med. 2024;209(0):A5702/C44$52$YR$$F$Y$$$20240802$$HP$US$US
241667051$24166705$1$I$$20240718$20240802$20240802$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460168$RANBAXY$Nakamoto K, Horimasu Y, Yamaguchi K, Sakamoto S, Masuda T, Miyamoto S, et al. Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases. Intern Med. 2024;63 (12):1783-1787$63$YR$$M$Y$$$20240802$$HP$JP$JP
241667071$24166707$1$I$$20240718$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460457$RANBAXY$$28$YR$$M$Y$$$20240802$$CN$GB$GB
241667081$24166708$1$I$$20240718$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460179$RANBAXY$Quo SW, Mederos N, Parianos M, Idrisov E. Significant Esophageal And Intestiinal Ulcerations In The Setting Of Recent Chemotherapy For Pancreatic Adenocarcinoma. Gastroenterology. 2023;164 (Suppl.)(6):S-1209-S-1210 (EP84)$72$YR$$M$Y$$$20240802$$HP$US$US
241667091$24166709$1$I$20240701$20240725$20240802$20240802$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001049$ALEMBIC$$$$$$Y$$$20240802$$CN$US$US
241667102$24166710$2$F$$20240809$20240802$20240814$PER$$US-HETERO-HET2024US02504$HETERO$$$$$F$Y$56.6$KG$20240814$$CN$US$US
241667111$24166711$1$I$20240726$20240726$20240802$20240802$PER$$US-RDY-SPO/USA/24/0011060$DR REDDYS$$$$$F$Y$$$20240802$$CN$US$US
241667121$24166712$1$I$20230617$20240722$20240802$20240802$EXP$$CN-RDY-LIT/CHN/24/0011300$DR REDDYS$Keling P, Yuqian W, Li Z, shushu L, tao Z. Amisulpride-induced sinus arrest. Journal of Adverse Drug Reactions. 2024;26(6): 379-381. doi:10.3760/cma.j.cn114015-20230714-00525.$65$YR$E$F$Y$$$20240802$$HP$CN$CN
241667131$24166713$1$I$$20240724$20240802$20240802$EXP$$CA-AUROBINDO-AUR-APL-2024-037967$AUROBINDO$$$$$M$Y$$$20240802$$CN$CA$CA
241667141$24166714$1$I$$20240724$20240802$20240802$EXP$$JP-MYLANLABS-2024M1070573$MYLAN$Azuma S, Kawasuji H, Nakai R, Yamada H, Yoshida Y, Kawahara H, et al. The fatal case of ^Pigmentibacter^ bacteremia following aspiration pneumonia in elderly patient. J-Infect-Chemother 2024; 30 (8): 806-811.. 2024;30 (8):806-811$95$YR$$M$Y$60.3$KG$20240802$$HP$JP$JP
241667151$24166715$1$I$$20240724$20240802$20240802$EXP$$GB-MYLANLABS-2024M1070166$MYLAN$$$$$M$Y$$$20240802$$CN$GB$GB
241667161$24166716$1$I$$20240724$20240802$20240802$EXP$$JP-MYLANLABS-2024M1070575$MYLAN$Iwasaki S, Takahashi K, Katano H, Suzuki T, Sasaki H, Harada H, et al. BK Polyomavirus-Associated Urothelial Carcinoma of the Bladder with a Background of BK Polyomavirus Nephropathy in a Kidney Transplant Recipient. [Review]. Nephron 2023; 147 (1) 1-17.. 2023;147 (1):1-17$65$YR$$F$Y$$$20240802$$HP$JP$JP
241667172$24166717$2$F$$20240814$20240802$20240820$EXP$$US-TAKEDA-2022TUS022929$TAKEDA$$$$$F$Y$$$20240820$$MD$US$US
241667182$24166718$2$F$$20240918$20240802$20240924$EXP$$JP-ASTELLAS-2024JP005573$ASTELLAS$$8$DEC$E$M$Y$$$20240924$$MD$JP$JP
241667191$24166719$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122599$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241667201$24166720$1$I$$20240729$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120412$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$103.87$KG$20240802$$HP$US$US
241667221$24166722$1$I$$20211115$20240802$20240802$EXP$$US-AstraZeneca-2021A808701$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241667231$24166723$1$I$$20230822$20240802$20240802$EXP$$US-AstraZeneca-2023A191777$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241667241$24166724$1$I$20240715$20240726$20240802$20240802$EXP$$JP-AstraZeneca-2024A172309$ASTRAZENECA$$$$E$F$Y$$$20240802$$MD$JP$
241667251$24166725$1$I$$20240725$20240802$20240802$EXP$$DO-AstraZeneca-2024A171196$ASTRAZENECA$$$$$M$Y$$$20240802$$MD$DO$
241667261$24166726$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A173567$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241667272$24166727$2$F$20240729$20240820$20240802$20240905$PER$$US-AstraZeneca-2024A173555$ASTRAZENECA$$26963$DY$$F$Y$$$20240905$$CN$US$
241667281$24166728$1$I$$20240725$20240802$20240802$EXP$$ZA-AstraZeneca-2024A170980$ASTRAZENECA$$28124$DY$$F$Y$$$20240802$$CN$ZA$
241667291$24166729$1$I$$20230427$20240802$20240802$EXP$$US-AstraZeneca-2023A099533$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241667301$24166730$1$I$$20240725$20240802$20240802$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009531$STRIDES$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al.. Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.. Ann-Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240802$$HP$CN$CN
241667311$24166731$1$I$20240207$20240723$20240802$20240802$EXP$$JP-ROCHE-10000040700$ROCHE$$45$YR$A$F$Y$62$KG$20240802$$PH$JP$JP
241667321$24166732$1$I$20220801$20240724$20240802$20240802$EXP$$DO-BAYER-2024A109211$BAYER$$$$$F$Y$$$20240802$$CN$DO$DO
241667331$24166733$1$I$$20240730$20240802$20240802$EXP$$US-ORGANON-O2407USA002941$ORGANON$$$$$F$Y$$$20240802$$CN$US$US
241667341$24166734$1$I$$20240725$20240802$20240802$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009532$STRIDES$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al.. Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.. Ann-Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240802$$HP$CN$CN
241667351$24166735$1$I$20240730$20240730$20240802$20240802$EXP$GB-MHRA-MED-202407300854552090-QKZCR$GB-ABBVIE-5862834$ABBVIE$$$$$$Y$$$20240802$$MD$GB$GB
241667362$24166736$2$F$20240328$20240808$20240802$20240816$EXP$FR-AFSSAPS-AN2024000959$FR-TAKEDA-2024TUS076676$TAKEDA$$66$YR$$M$Y$$$20240816$$HP$FR$FR
241667371$24166737$1$I$$20240729$20240802$20240802$EXP$GB-MHRA-MED-202407272225156400-FJKLZ$GB-STRIDES ARCOLAB LIMITED-2024SP009456$STRIDES$$30$YR$$M$Y$$$20240802$$CN$GB$GB
241667382$24166738$2$F$$20240726$20240802$20240823$PER$$US-BEH-2024176496$CSL BEHRING$$33$YR$A$F$Y$$$20240823$$PH$US$US
241667401$24166740$1$I$20240731$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153165$AMGEN$$51$YR$A$F$Y$$$20240802$$CN$US$US
241667411$24166741$1$I$20240101$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152420$AMGEN$$$$$M$Y$$$20240802$$CN$US$US
241667421$24166742$1$I$$20240712$20240802$20240802$PER$$US-JNJFOC-20240740848$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$CN$US$US
241667431$24166743$1$I$$20240726$20240802$20240802$EXP$$NVSC2023CO143164$NOVARTIS$$$$$F$Y$59$KG$20240802$$CN$CO$CO
241667443$24166744$3$F$20240101$20240805$20240802$20240807$EXP$$NVSC2024GB157426$NOVARTIS$$$$E$M$Y$$$20240807$$HP$GB$GB
241667452$24166745$2$F$$20240906$20240802$20240916$30DAY$$US-GSK-US2024AMR094569$GLAXOSMITHKLINE$$$$$M$Y$$$20240916$$CN$US$US
241667461$24166746$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024AMR093615$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$CN$US$US
241667471$24166747$1$I$$20240731$20240802$20240802$EXP$$GR-EMD Serono-2024041581$EMD SERONO INC$$50$YR$A$F$Y$$$20240802$$HP$GR$GR
241667482$24166748$2$F$20240701$20240813$20240802$20240813$EXP$$AU-BAYER-2024A108103$BAYER$$28$YR$A$F$Y$$$20240813$$MD$AU$AU
241667492$24166749$2$F$20240603$20240829$20240802$20240909$EXP$$IT-AUROBINDO-AUR-APL-2024-037547$AUROBINDO$$76$YR$$F$Y$$$20240909$$HP$IT$IT
241667501$24166750$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190139$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241667513$24166751$3$F$20240728$20240820$20240802$20240829$EXP$$JP-009507513-2407JPN005280J$MERCK$$7$DEC$$F$Y$$$20240829$$HP$JP$JP
241667521$24166752$1$I$20240627$20240801$20240802$20240802$EXP$$US-UCBSA-2024038754$UCB$$73$YR$$F$Y$$$20240802$$CN$US$US
241667531$24166753$1$I$$20240723$20240802$20240802$EXP$$US-STERISCIENCE B.V.-2024-ST-001117$Steriscience PTE$Sahni T, Vessal A, Mayo-Olano S, Silverman B.. Catastrophic Antiphospholipid Syndrome as a Unique Trigger for Rapidly Progressive Interstitial Lung Disease.. Am-J-Respir-Crit-Care-Med. 2024;209:A1974$46$YR$$F$Y$$$20240802$$HP$US$US
241667541$24166754$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151615$AMGEN$$$$$M$Y$$$20240802$$CN$US$US
241667551$24166755$1$I$20191101$20240719$20240802$20240802$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-07015$HIKMA$Platteter E, Wulf G.. Platteter E, Wulf G. Durable Response to Programmed Death 1-Directed Antibodies in a Hypermutated Triple-Negative Breast Cancer: A Case Report.. Case Reports in Oncology. 2024;17(1):392-98$65$YR$$F$Y$$$20240802$$MD$US$US
241667563$24166756$3$F$20240801$20240808$20240802$20240811$PER$$US-AMGEN-USASP2024153900$AMGEN$$76$YR$E$F$Y$$$20240810$$CN$US$US
241667571$24166757$1$I$$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024150743$AMGEN$$$$$$Y$$$20240802$$HP$US$US
241667591$24166759$1$I$20240731$20240801$20240802$20240802$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043375$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240802$$MD$US$US
241667611$24166761$1$I$$20240722$20240802$20240802$EXP$$NL-STERISCIENCE B.V.-2024-ST-001121$Steriscience PTE$Dorsthorst-Maas MT, Vissers YLJ, Grupa NM, Deben DS, Boselie TFM.. Bupivacaine pleural effusion mimicking a hemothorax after a thoracoscopic microdiscectomy with epidural anesthesia.. Acta-Neurochir-Wien. 2024;166$42$YR$$F$Y$$$20240802$$HP$NL$NL
241667621$24166762$1$I$$20240724$20240802$20240802$EXP$$US-Alcon Laboratories-ALC2024US003549$ALCON$Avery Zhou, M.A., Anja Rabljenovic, B.S., and Thomas L. Steinemann, M.D.. Proparacaine Overuse in Corneal Abrasions at the Emergency Department: A Case Series. Proparacaine Overuse in Corneal Abrasions. 2024;50 (6):274-275$29$YR$$F$Y$$$20240802$$HP$US$US
241667631$24166763$1$I$20220926$20231218$20240802$20240802$EXP$$CA-CELLTRION INC.-2022CA022698$CELLTRION$$$$$$Y$$$20240802$$MD$CA$CA
241667641$24166764$1$I$$20240726$20240802$20240802$PER$$US-APOTEX-2024AP009030$APOTEX$Wang EJ, Berninger LE, Smith TJ, Pantelyat AY.. Scrambler Therapy for the Treatment of Pain and Sensory Symptoms in Corticobasal Syndrome: A Case Series. Pain Medicine Case Reports. 2023;7 (3):151-155$70$YR$$M$Y$$$20240802$$MD$US$US
241667651$24166765$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122578$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241667672$24166767$2$F$20240701$20240821$20240802$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122264$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240829$$PH$US$US
241667681$24166768$1$I$$20240728$20240802$20240802$EXP$$AU-JNJFOC-20240777356$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240802$$MD$AU$AU
241667691$24166769$1$I$$20240716$20240802$20240802$PER$$US-JNJFOC-20240748934$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241667701$24166770$1$I$$20240723$20240802$20240802$PER$$US-CHATTEMPRD-2024OHG025178$CHATTEM$$$$$F$Y$$$20240802$$CN$US$US
241667722$24166772$2$F$$20240911$20240802$20240916$PER$$US-GILEAD-2024-0682287$GILEAD$$77$YR$E$M$Y$$$20240915$$CN$US$US
241667731$24166773$1$I$$20240726$20240802$20240802$EXP$$ZA-ORGANON-O2407ZAF002695$ORGANON$$$$A$F$Y$$$20240802$$MD$ZA$ZA
241667741$24166774$1$I$$20240726$20240802$20240802$EXP$$PH-ROCHE-10000038407$ROCHE$$57$YR$A$$Y$$$20240802$$MD$PH$PH
241667761$24166776$1$I$$20240723$20240802$20240802$EXP$$US-CHEPLA-1400057668$CHEPLAPHARM$$$$E$$Y$$$20240802$$CN$COUNTRY NOT SPECIFIED$US
241667771$24166777$1$I$$20240520$20240802$20240802$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005960$STRIDES$$$$$F$Y$$$20240802$$CN$US$US
241667781$24166778$1$I$$20240729$20240802$20240802$EXP$GR-SEATTLE GENETICS-2023SGN11095$GR-CHEPLA-2024009843$CHEPLAPHARM$$$$$F$Y$$$20240802$$MD$COUNTRY NOT SPECIFIED$GR
241667791$24166779$1$I$$20240726$20240802$20240802$EXP$$BR-CHEPLA-2024009900$CHEPLAPHARM$$$$A$M$Y$$$20240802$$CN$COUNTRY NOT SPECIFIED$BR
241667801$24166780$1$I$$20240729$20240802$20240802$EXP$DE-SEATTLE GENETICS-2024SGN00172$DE-CHEPLA-2024009868$CHEPLAPHARM$$34$YR$$F$Y$$$20240802$$MD$COUNTRY NOT SPECIFIED$DE
241667811$24166781$1$I$$20240729$20240802$20240802$EXP$$IN-ROCHE-10000043418$ROCHE$$$$$M$Y$$$20240802$$MD$IN$IN
241667821$24166782$1$I$20240509$20240726$20240802$20240802$EXP$$ZA-CELLTRION INC.-2024ZA011008$CELLTRION$$$$$$Y$$$20240802$$CN$ZA$ZA
241667831$24166783$1$I$$20240726$20240802$20240802$EXP$$US-MYLANLABS-2024M1071227$MYLAN$Bharucha K. Multisystemic Sarcoidosis Culminating in Asymptomatic Complete Heart Block. Am-J-Respir-Crit-Care-Med 2024; 209.$$$$M$Y$$$20240802$$HP$US$US
241667841$24166784$1$I$$20240726$20240802$20240802$EXP$$FR-MYLANLABS-2024M1071301$MYLAN$Beigneux Y, Louapre C, Bihan K, Roux T, de Paz R, Lubetzki C, et al. Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab. Mult-Scler-J 2024; 30 (1): 131-133.$38$YR$$F$Y$$$20240802$$HP$FR$FR
241667851$24166785$1$I$$20240726$20240802$20240802$EXP$$IN-MYLANLABS-2024M1071566$MYLAN$Agarwal A, Saha SC, Kaur A, Naganur S. Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum. BMJ-Case-Rep 2023; 16.$40$HR$$M$Y$$$20240802$$MD$IN$IN
241667861$24166786$1$I$$20240726$20240802$20240802$EXP$$IT-MYLANLABS-2024M1070787$MYLAN$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al.. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting.. Clinical Therapeutics.. 2024;e1-5$69$YR$$F$Y$$$20240802$$MD$IT$IT
241667871$24166787$1$I$$20240730$20240802$20240802$PER$$US-JNJFOC-20240782733$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241667881$24166788$1$I$20240701$20240724$20240802$20240802$EXP$$US-JNJFOC-20240776606$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$CN$US$US
241667891$24166789$1$I$$20240726$20240802$20240802$EXP$$US-MYLANLABS-2024M1071584$MYLAN$Lam L, Bansal V, Chai T, Driver LC. Recurrent Pain From Chemotherapy-Induced Peripheral Neuropathy After COVID-19 Infection - A Case Report. Pain-Med-Case-Rep 2023; 7 (8): 357-359.$59$YR$$M$Y$$$20240802$$HP$US$US
241667901$24166790$1$I$20240701$20240727$20240802$20240802$PER$$US-CHATTEMPRD-2024OHG025782$CHATTEM$$$$$M$Y$$$20240802$$CN$US$US
241667911$24166791$1$I$$20240624$20240802$20240802$PER$$US-CHATTEMPRD-2024OHG022303$CHATTEM$$43$YR$A$F$Y$$$20240802$$CN$US$US
241667942$24166794$2$F$20240101$20240919$20240802$20240928$EXP$$CA-CELLTRION INC.-2024CA018450$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
241667952$24166795$2$F$$20240725$20240802$20240828$EXP$$US-CHIESI-2024CHF04672$CHIESI$$51$YR$$M$Y$$$20240828$$CN$US$US
241667962$24166796$2$F$20230101$20240725$20240802$20240828$EXP$$US-CHIESI-2024CHF04615$CHIESI$$70$YR$$F$Y$$$20240828$$CN$US$US
241667971$24166797$1$I$$20221116$20240802$20240802$EXP$$US-AstraZeneca-2022A381401$ASTRAZENECA$$$$$M$Y$108.9$KG$20240802$$CN$US$
241667981$24166798$1$I$$20240729$20240802$20240802$EXP$$VN-AstraZeneca-2024A174125$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$VN$
241667992$24166799$2$F$20240728$20240805$20240802$20240807$PER$$US-AMGEN-USASP2024151886$AMGEN$$74$YR$E$M$Y$$$20240807$$CN$US$US
241668002$24166800$2$F$$20240909$20240802$20240919$30DAY$$US-GSK-US2024092421$GLAXOSMITHKLINE$$$$$M$Y$$$20240919$$CN$US$US
241668011$24166801$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024092438$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$HP$US$US
241668021$24166802$1$I$20240709$20240725$20240802$20240802$EXP$FR-AFSSAPS-PB2024000803$FR-TEVA-VS-3226338$TEVA$$67$YR$$F$Y$83.7$KG$20240802$$PH$FR$FR
241668031$24166803$1$I$$20240730$20240802$20240802$PER$$US-ROCHE-10000045862$ROCHE$Jamison K, Medepalli L, Ye S. Isolated Pericardial Effusion Without Associated Myocarditis in a Small-Cell Lung Cancer Patient Undergoing Atezolizumab Therapy. Cureus. 2024-May-13;16 (5):e60184. doi:10.7759/cureus.60184.$67$YR$E$M$Y$$$20240802$$HP$US$US
241668041$24166804$1$I$$20240726$20240802$20240802$EXP$GB-MHRA-31113737$GB-RDY-SPO/GBR/24/0011117$DR REDDYS$$89$YR$E$$Y$$$20240802$$PH$GB$GB
241668051$24166805$1$I$$20240731$20240802$20240802$EXP$$US-TAKEDA-2024TUS041177$TAKEDA$$$$$M$Y$$$20240802$$CN$US$US
241668071$24166807$1$I$20240520$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52786$$FDA-CTU$$76$YR$$M$N$168$LBS$20240802$$CN$US$
241668081$24166808$1$I$$20240503$20240801$20240801$DIR$FDA-CDER-CTU-2024-52891$$FDA-CTU$$$$$$N$$$20240503$N$PH$US$
241668101$24166810$1$I$$20240507$20240801$20240801$DIR$FDA-CDER-CTU-2024-52840$$FDA-CTU$$$$$$N$$$20240507$N$PH$US$
241668111$24166811$1$I$20180815$20240725$20240802$20240802$EXP$$AU-TAKEDA-2024TUS077424$TAKEDA$$65$YR$$F$Y$$$20240802$$MD$AU$AU
241668121$24166812$1$I$$20240719$20240802$20240802$EXP$$GB-Allegis Pharmaceuticals, LLC-APL202407-000083$ALLEGIS PHARMACEUTICALS$$32$YR$A$F$Y$$$20240802$$HP$GB$
241668131$24166813$1$I$20131201$20240726$20240802$20240802$EXP$FR-EMA-20150326-AUTODUP-434508$FR-TEVA-VS-3226841$TEVA$$58$YR$$M$Y$66$KG$20240802$$MD$FR$FR
241668141$24166814$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-038438$AUROBINDO$Neuwelt EA , Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al.. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors.. Neurooncol-Adv. 2022;4:No. 1$51$YR$$F$Y$$$20240802$$HP$US$US
241668151$24166815$1$I$$20240507$20240801$20240801$DIR$FDA-CDER-CTU-2024-52873$$FDA-CTU$$$$$$N$$$20240507$N$$US$
241668161$24166816$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122579$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241668171$24166817$1$I$$20240726$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119975$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240802$$HP$US$US
241668181$24166818$1$I$$20240726$20240802$20240802$EXP$$FR-MYLANLABS-2024M1071643$MYLAN$Lescarbotte F, Romano G, Balleyguier C, Arfi Rouche J, Ilenko A, Leymarie N. Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases. . Ann-Chir-Plast-Esthet 2024; 69 27-33.$55$YR$$F$Y$$$20240802$$HP$FR$FR
241668191$24166819$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190211$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241668201$24166820$1$I$20240613$20240801$20240802$20240802$EXP$$US-TAKEDA-2024TUS076975$TAKEDA$$39$YR$$F$Y$$$20240802$$CN$US$US
241668211$24166821$1$I$20240201$20240724$20240802$20240802$EXP$$CA-TAKEDA-2024TUS075471$TAKEDA$$59$YR$$F$Y$$$20240802$$CN$CA$CA
241668221$24166822$1$I$20240601$20240731$20240802$20240802$EXP$$US-ROCHE-10000045993$ROCHE$$71$YR$E$F$Y$52.62$KG$20240802$$CN$US$US
241668231$24166823$1$I$$20240724$20240802$20240802$30DAY$$US-GSK-US2024AMR093931$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241668241$24166824$1$I$$20210813$20240802$20240802$EXP$$NVSC2020DE142262$NOVARTIS$$$$A$F$Y$$$20240802$$MD$DE$DE
241668251$24166825$1$I$20210603$20210915$20240802$20240802$EXP$GB-MHRA-EYC 00260629$NVSC2021GB209870$NOVARTIS$$$$$F$Y$$$20240802$$PH$GB$GB
241668261$24166826$1$I$$20240725$20240802$20240802$EXP$NL-LRB-00985303$NL-ROCHE-10000036598$ROCHE$$70$YR$E$F$Y$101$KG$20240802$$CN$NL$NL
241668271$24166827$1$I$$20240728$20240802$20240802$EXP$$US-BAYER-2024A109766$BAYER$$$$$M$Y$$$20240802$$CN$US$US
241668281$24166828$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-038439$AUROBINDO$Neuwelt EA , Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al.. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors.. Neurooncol-Adv. 2022;4:No. 1$13$YR$$M$Y$$$20240802$$HP$US$US
241668291$24166829$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-038441$AUROBINDO$Neuwelt EA , Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al.. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors.. Neurooncol-Adv. 2022;4:No. 1$43$YR$$M$Y$$$20240802$$HP$US$US
241668301$24166830$1$I$$20240726$20240802$20240802$EXP$$CA-TEVA-VS-3228757$TEVA$$72$YR$$F$Y$$$20240802$$CN$CA$CA
241668311$24166831$1$I$20240708$20240725$20240802$20240802$EXP$SE-SEMPA-2024-005572$SE-TEVA-VS-3226386$TEVA$$69$YR$$M$Y$$$20240802$$MD$SE$SE
241668321$24166832$1$I$$20240611$20240802$20240802$PER$$US-LUNDBECK-DKLU4000401$LUNDBECK$$$$$$Y$$$20240802$$CN$US$US
241668331$24166833$1$I$20240714$20240724$20240802$20240802$EXP$$CN-JNJFOC-20240775947$JOHNSON AND JOHNSON$$26$YR$A$M$Y$75$KG$20240802$$HP$CN$CN
241668341$24166834$1$I$$20230510$20240802$20240802$PER$$US-SERB S.A.S.-2159918$LABORATOIRES SERB$$$$$F$Y$$$20240802$$$US$US
241668351$24166835$1$I$$20240724$20240802$20240802$EXP$$FR-JNJFOC-20240804839$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240802$$HP$FR$FR
241668361$24166836$1$I$$20240722$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-036583$AUROBINDO$Al?s-palmer ML, And?jar-vera F, Mu?oz-de-rueda P, Iglesias-baena I, Ocete-hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. Int. J. Mol. Sci. 2023;24:1-17$3$YR$$F$Y$$$20240802$$HP$ES$ES
241668371$24166837$1$I$$20240729$20240802$20240802$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-105574$REGENERON$$$$$F$Y$$$20240802$$CN$CA$CA
241668381$24166838$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037752$AUROBINDO$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose.. Clin-Toxicol-(Phila). 2024;62(5):296-302$44$YR$$F$Y$$$20240802$$HP$US$US
241668391$24166839$1$I$20240625$20240719$20240802$20240802$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00649$Phathom Pharmaceuticals$$9$DEC$$F$Y$$$20240802$$HP$JP$JP
241668401$24166840$1$I$20220701$20240723$20240802$20240802$EXP$$ES-AUROBINDO-AUR-APL-2024-037417$AUROBINDO$Jimenez Alvaro S, Galeano ?lvarez C, Elias Trevino S, Ferreria Bermejo M, Fernandez Lucas M. Safe immunosuppression. New tool for personalized immunosuppressant treatment in renal transplantation. A case report. Archives of Organ Transplantation. 2024;9(1):5-8$$$E$M$Y$$$20240802$$HP$ES$ES
241668411$24166841$1$I$20240731$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152969$AMGEN$$64$YR$A$M$Y$$$20240802$$CN$US$US
241668421$24166842$1$I$20240320$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-036850$AUROBINDO$$56$YR$$F$Y$45.5$KG$20240802$$MD$FR$FR
241668441$24166844$1$I$20240723$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037332$AUROBINDO$$76$YR$$F$Y$90$KG$20240802$$MD$GB$GB
241668451$24166845$1$I$$20240723$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037816$AUROBINDO$Kirmaier A, Blackshear L, Lee MSL, Kirby JE.. Cellulitis and bacteremia caused by the fish pathogen, Streptococcus iniae, in an immunocompromised patient: Case report and mini-review of zoonotic disease, lab identification, and antimicrobial susceptibility. Diagn-Microbiol-Infect-Dis. 2024;108:No. 4$49$YR$$F$Y$$$20240802$$HP$US$US
241668461$24166846$1$I$20240614$20240723$20240802$20240802$EXP$FR-AFSSAPS-AVCN2024000554$FR-Accord-438124$ACCORD$$21$YR$A$M$Y$$$20240802$$MD$FR$FR
241668471$24166847$1$I$$20240723$20240802$20240802$EXP$AU-TGA-811396$AU-Accord-437795$ACCORD$$76$YR$E$F$Y$$$20240802$$HP$AU$AU
241668481$24166848$1$I$20231227$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037459$AUROBINDO$$58$YR$$F$Y$77$KG$20240802$$HP$FR$FR
241668491$24166849$1$I$$20240723$20240802$20240802$EXP$GB-MHRA-30693806$GB-Accord-437921$ACCORD$$65$YR$E$F$Y$$$20240802$$PH$GB$GB
241668501$24166850$1$I$20240709$20240725$20240802$20240802$EXP$$JP-ROCHE-10000043588$ROCHE$$$$$F$Y$$$20240802$$MD$JP$JP
241668511$24166851$1$I$$20240723$20240802$20240802$EXP$CA-MHPD-E2B_07123876$CA-Accord-437864$ACCORD$$65$YR$E$F$Y$95$KG$20240802$$HP$CA$CA
241668521$24166852$1$I$20190101$20240722$20240802$20240802$EXP$RO-EMA-DD-20240717-7482661-101258$RO-Accord-438172$ACCORD$$64$YR$A$F$Y$$$20240802$$MD$RO$RO
241668531$24166853$1$I$$20240723$20240802$20240802$EXP$CA-MHPD-E2B_07121338$CA-Accord-437957$ACCORD$$85$YR$E$F$Y$$$20240802$$HP$CA$CA
241668541$24166854$1$I$20240516$20240723$20240802$20240802$EXP$PL-URPL-DML-MLP.4401.1.159.2024$PL-Accord-438503$ACCORD$$38$YR$A$F$Y$84$KG$20240802$$MD$PL$PL
241668551$24166855$1$I$$20240723$20240802$20240802$EXP$AU-TGA-807873$AU-Accord-437724$ACCORD$$$$$$Y$$$20240802$$HP$AU$AU
241668561$24166856$1$I$$20240723$20240802$20240802$EXP$$TR-Accord-437975$ACCORD$Kaynar K, Ertekin T, Ureyener GE, Mungan S, Abuhadwan H. Hodgkin lymphoma in a patient with kidney transplantation. Nefrologia. 2024;44(4):601-3. DOI:10.1016/j.nefro.2023.03.006.$35$YR$$M$Y$$$20240802$$MD$TR$TR
241668571$24166857$1$I$$20240731$20240802$20240802$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043423$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240802$$CN$US$US
241668581$24166858$1$I$$20240705$20240802$20240802$PER$$US-009507513-2407USA003546$MERCK$Khosla H, Bhatt S, Wang MJ, Gignac G, Mittal K, Patel J. Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis. Journal of Oncology Pharmacy Practice. 2024;30(5):941-4$$$$M$Y$$$20240802$$HP$US$US
241668592$24166859$2$F$20240731$20240904$20240802$20240905$EXP$$NVSC2024US157291$NOVARTIS$$$$$M$Y$$$20240905$$HP$US$US
241668601$24166860$1$I$$20240722$20240802$20240802$EXP$$IT-Accord-437767$ACCORD$Acerbis A, Orofino G, Campodonico E, Del Poggio A, Xue E, di Matteo F, et al. Pre-engraftment neurological impairment in allogeneic stem cell transplant: A case report of atypical posterior reversible encephalopathy syndrome with pontine involvement. Frontiers in transplantation. 2023;1:1089995$59$YR$A$F$Y$$$20240802$$MD$IT$IT
241668611$24166861$1$I$$20240726$20240802$20240802$EXP$GR-GREOF-202400761$GR-MYLANLABS-2024M1070372$MYLAN$$74$YR$$M$Y$90$KG$20240802$$MD$GR$GR
241668621$24166862$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121771$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240802$$HP$US$US
241668632$24166863$2$F$$20240809$20240802$20240821$EXP$$EC-Accord-437974$ACCORD$Llerena-Rengel PA, Basantes-Borja EE, Alvear-Matailo CS. Organic failure secondary to methotrexate poisoning, Is dialysis an alternative? Case report. Gac Mex Oncol. 2024;23(Supplement):31-5. DOI: 10.24875/j.gamo.23000045.$45$YR$A$M$Y$67$KG$20240821$$MD$EC$EC
241668641$24166864$1$I$20240111$20240726$20240802$20240802$EXP$FR-AFSSAPS-ST2024001188$FR-MYLANLABS-2024M1070272$MYLAN$$59$YR$$M$Y$$$20240802$$HP$FR$FR
241668651$24166865$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122614$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241668661$24166866$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122613$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241668671$24166867$1$I$$20210728$20240802$20240802$EXP$$US-AstraZeneca-2021A650976$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241668681$24166868$1$I$20231101$20240726$20240802$20240802$EXP$FR-AFSSAPS-LM2024000417$FR-LUNDBECK-DKLU4002460$LUNDBECK$$$$$$Y$$$20240802$$MD$FR$FR
241668691$24166869$1$I$$20240723$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-037002$AUROBINDO$Bayless SL, Walker NV, Scott MM, Leo RJ.. Clozapine-Related Cecal Volvulus.. The primary care companion for CNS. 2024;26(4):24cr03729$58$YR$$F$Y$$$20240802$$MD$US$US
241668701$24166870$1$I$20240701$20240725$20240802$20240802$EXP$$JP-AstraZeneca-2024A171014$ASTRAZENECA$$$$E$M$Y$$$20240802$$MD$JP$
241668711$24166871$1$I$20220825$20221207$20240802$20240802$EXP$$US-AstraZeneca-2022A364025$ASTRAZENECA$$25547$DY$$M$Y$131.8$KG$20240802$$HP$US$
241668721$24166872$1$I$$20240507$20240801$20240801$DIR$FDA-CDER-CTU-2024-52874$$FDA-CTU$$$$$$N$$$20240507$N$PH$US$
241668731$24166873$1$I$$20220815$20240802$20240802$EXP$$US-AstraZeneca-2022A288051$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241668741$24166874$1$I$$20230428$20240802$20240802$EXP$$US-AstraZeneca-2023A100504$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241668751$24166875$1$I$20220401$20220613$20240802$20240802$EXP$$US-AstraZeneca-2022A222188$ASTRAZENECA$$827$MON$$F$Y$122.5$KG$20240802$$CN$US$
241668761$24166876$1$I$$20240729$20240802$20240802$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042834$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240802$$CN$US$US
241668771$24166877$1$I$20231206$20240723$20240802$20240802$EXP$$GB-AUROBINDO-AUR-APL-2024-037081$AUROBINDO$$70$YR$$F$Y$60$KG$20240802$$MD$GB$GB
241668781$24166878$1$I$$20240730$20240802$20240802$PER$$US-ABBVIE-5862813$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241668791$24166879$1$I$20240731$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000134$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240802$$CN$US$US
241668801$24166880$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000626$ELI LILLY AND CO$$$$$M$Y$$$20240802$$CN$US$US
241668811$24166881$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408001039$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240802$$CN$US$US
241668821$24166882$1$I$$20240801$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000985$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241668831$24166883$1$I$20240201$20240718$20240802$20240802$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202403016240$ELI LILLY AND CO$$80$YR$E$M$Y$60.3$KG$20240802$$CN$JP$JP
241668851$24166885$1$I$$20240502$20240801$20240801$DIR$FDA-CDER-CTU-2024-52880$$FDA-CTU$$$$$$N$$$20240502$N$PH$US$
241668861$24166886$1$I$$20240801$20240802$20240802$EXP$$GB-SANDOZ INC.-SDZ2024GB069937$SANDOZ$$$$$F$Y$$$20240802$$CN$GB$GB
241668871$24166887$1$I$20240717$20240722$20240802$20240802$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00365$MELINTA THERAPEUTICS$$$$$$Y$$$20240802$$MD$CN$CN
241668881$24166888$1$I$$20240726$20240802$20240802$EXP$$CA-GSK-CA2023167070$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$CA$CA
241668891$24166889$1$I$$20240507$20240801$20240801$DIR$FDA-CDER-CTU-2024-52838$$FDA-CTU$$$$$$N$$$20240507$N$PH$US$
241668901$24166890$1$I$20180101$20240729$20240802$20240802$EXP$$US-CHATTEMPRD-2024OHG025825$CHATTEM$$$$$F$Y$$$20240802$$CN$US$US
241668912$24166891$2$F$20240601$20240911$20240802$20240912$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-005171$BOEHRINGER INGELHEIM$$25$YR$A$F$Y$$$20240912$$CN$JP$JP
241668921$24166892$1$I$$20240722$20240802$20240802$EXP$$US-Oxford Pharmaceuticals, LLC-2159919$OXFORD PHARMACEUTICALS$Source document$86$YR$$F$Y$$$20240802$$$US$US
241668941$24166894$1$I$$20240721$20240802$20240802$EXP$$TR-NATCOUSA-2024-NATCOUSA-000216$NATCO PHARMA$Celen Arabaci I, Nurozler Tabakci B, Onal I, Yildirim Y. Erlotinib-induced blepharitis: Management of two challenging cases. J Fr Ophtalmol. 2024 Jul 16:104247. doi: 10.1016/j.jfo.2024.104247. Epub ahead of print. PMID: 39019717.$70$YR$$M$Y$$$20240802$$HP$TR$
241668951$24166895$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122198$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240802$$CN$US$US
241668961$24166896$1$I$$20240725$20240802$20240802$EXP$$US-MYLANLABS-2024M1071083$MYLAN$Moody R, Tinker D, Hurley MY, Heinecke G. Rapid-onset DRESS syndrome secondary to iopamidol contrast media with subsequent syndrome of inappropriate antidiuretic hormone secretion. JAAD-Case-Rep 2024; 50 (0): 85-87.$65$YR$$F$Y$$$20240802$$MD$US$US
241668971$24166897$1$I$20240301$20240730$20240802$20240802$EXP$$NVSC2021CA284259$NOVARTIS$$60$YR$$F$Y$$$20240802$$CN$CA$CA
241668981$24166898$1$I$$20240721$20240802$20240802$EXP$$TR-NATCOUSA-2024-NATCOUSA-000217$NATCO PHARMA$Celen Arabaci I, Nurozler Tabakci B, Onal I, Yildirim Y. Erlotinib-induced blepharitis: Management of two challenging cases. J Fr Ophtalmol. 2024 Jul 16:104247. doi: 10.1016/j.jfo.2024.104247. Epub ahead of print. PMID: 39019717.$40$YR$$F$Y$$$20240802$$HP$TR$
241668991$24166899$1$I$20240703$20240723$20240802$20240802$EXP$$FR-AUROBINDO-AUR-APL-2024-037480$AUROBINDO$$14$YR$$M$Y$32$KG$20240802$$MD$FR$FR
241669001$24166900$1$I$$20240729$20240802$20240802$EXP$$CA-BAYER-2024A110798$BAYER$$67$YR$E$F$Y$$$20240802$$HP$CA$CA
241669011$24166901$1$I$20220208$20240722$20240802$20240802$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00587$MIRUM PHARMACEUTICALS$$18$YR$$F$Y$53.98$KG$20240802$$MD$US$US
241669021$24166902$1$I$20240101$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024152990$AMGEN$$$$A$F$Y$$$20240802$$HP$US$US
241669031$24166903$1$I$$20240730$20240802$20240802$EXP$$US-GSK-US2024095400$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$US$US
241669041$24166904$1$I$$20240724$20240802$20240802$EXP$$US-GSK-US2024092875$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$HP$US$US
241669051$24166905$1$I$$20240724$20240802$20240802$30DAY$$US-GSK-US2024AMR093479$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241669071$24166907$1$I$$20240611$20240802$20240802$PER$$US-LUNDBECK-DKLU4000459$LUNDBECK$$$$$$Y$$$20240802$$HP$US$US
241669081$24166908$1$I$20240601$20240611$20240802$20240802$PER$$US-LUNDBECK-DKLU4000334$LUNDBECK$$$$$$Y$$$20240802$$CN$US$US
241669091$24166909$1$I$$20230803$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-004595$ENDO$$$$$M$Y$$$20240802$$CN$US$US
241669101$24166910$1$I$$20230911$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-004494$ENDO$$$$$M$Y$$$20240802$$CN$US$US
241669111$24166911$1$I$20230401$20230919$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-003499$ENDO$$$$$M$Y$$$20240802$$CN$US$US
241669121$24166912$1$I$20230901$20240125$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-006000$ENDO$$81$YR$$M$Y$$$20240802$$CN$US$US
241669131$24166913$1$I$20230101$20231110$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-005005$ENDO$$$$$M$Y$81.633$KG$20240802$$CN$US$US
241669141$24166914$1$I$$20240802$20240802$20240802$EXP$PL-URPL-1-3868-2020$NVSC2024PL157747$NOVARTIS$$16$YR$$M$Y$100$KG$20240802$$MD$PL$PL
241669151$24166915$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-038437$AUROBINDO$Neuwelt EA , Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al.. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors.. Neurooncol-Adv. 2022;4:No. 1$58$YR$$M$Y$$$20240802$$HP$US$US
241669201$24166920$1$I$20240714$20240801$20240801$20240801$DIR$712395$$FDA-CTU$$67$YR$$M$N$66.6$KG$20240801$N$$US$
241669211$24166921$1$I$$20240801$20240801$20240801$DIR$712406$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241669221$24166922$1$I$$20240801$20240801$20240801$DIR$712417$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241669231$24166923$1$I$$20240801$20240801$20240801$DIR$712410$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241669251$24166925$1$I$20240801$20240801$20240801$20240801$DIR$712407$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241669261$24166926$1$I$20240728$20240801$20240801$20240801$DIR$712396$$FDA-CTU$$73$YR$$M$N$$$20240801$N$PH$US$
241669271$24166927$1$I$$20240801$20240801$20240801$DIR$712401$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241669291$24166929$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52934$$FDA-CTU$$54$YR$$M$N$$$20240801$N$$US$
241669301$24166930$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52956$$FDA-CTU$$81$YR$$M$N$$$20240801$N$$US$
241669311$24166931$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52944$$FDA-CTU$$72$YR$$F$N$190$LBS$20240801$N$$US$
241669332$24166933$2$F$$20240807$20240802$20240808$EXP$$US-TAKEDA-2024TUS073348$TAKEDA$$$$$M$Y$$$20240808$$CN$US$US
241669341$24166934$1$I$$20240721$20240802$20240802$EXP$$US-MankindUS-000224$MANKIND PHARMA$Boleyn J, McLaury M, Wieman S. Suspected Pseudocholinesterase Deficiency During Left Thyroid Lobectomy and Isthmusectomy: A Case Report. S D Med. 2024 Jun;77(6):266-269. PMID: 39013099.$59$YR$A$F$Y$$$20240802$$HP$US$US
241669351$24166935$1$I$$20240729$20240802$20240802$EXP$$US-TAKEDA-2024TUS072698$TAKEDA$$$$$F$Y$$$20240802$$CN$US$US
241669361$24166936$1$I$$20240721$20240802$20240802$EXP$$JP-Accord-438539$ACCORD$Sumi T, Suzuki K, Arioka K, Chiba H. Methotrexate-associated lymphoproliferative disorder of the heart. Jpn J Clin Oncol. 2024 Jul 18:hyae091.$70$YR$E$M$Y$$$20240802$$HP$JP$JP
241669371$24166937$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121824$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240802$$CN$US$US
241669381$24166938$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122616$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241669391$24166939$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121845$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240802$$CN$US$US
241669401$24166940$1$I$20240724$20240730$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121594$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240802$$HP$US$US
241669411$24166941$1$I$$20230530$20240802$20240802$PER$$US-SERB S.A.S.-2159920$LABORATOIRES SERB$$$$$M$Y$$$20240802$$$US$US
241669421$24166942$1$I$$20240723$20240802$20240802$30DAY$$US-JNJFOC-20240783506$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241669431$24166943$1$I$$20240729$20240802$20240802$EXP$$GB-MYLANLABS-2024M1067013$MYLAN$$$$$F$Y$$$20240802$$PH$GB$GB
241669441$24166944$1$I$$20240723$20240802$20240802$EXP$GB-MHRA-30767071$GB-Accord-438319$ACCORD$$$$$$Y$$$20240802$$CN$GB$GB
241669451$24166945$1$I$$20240723$20240802$20240802$EXP$GB-MHRA-MED-202407232038068870-BFWGY$GB-Accord-438085$ACCORD$$40$YR$A$F$Y$$$20240802$$CN$GB$GB
241669461$24166946$1$I$$20240723$20240802$20240802$EXP$GB-MHRA-30755771$GB-Accord-438294$ACCORD$$87$YR$E$F$Y$$$20240802$$PH$GB$GB
241669471$24166947$1$I$$20240722$20240802$20240802$EXP$AU-TGA-812197$AU-Accord-437389$ACCORD$$54$YR$A$M$Y$$$20240802$$HP$AU$AU
241669481$24166948$1$I$$20240723$20240802$20240802$EXP$CA-MHPD-E2B_07121326$CA-Accord-437862$ACCORD$$63$YR$A$M$Y$$$20240802$$HP$CA$CA
241669501$24166950$1$I$20240717$20240723$20240802$20240802$EXP$$US-Accord-438932$ACCORD$$42$YR$A$F$Y$$$20240802$$HP$US$US
241669511$24166951$1$I$$20240724$20240802$20240802$PER$$US-BAYER-2024A107835$BAYER$$42$YR$A$F$Y$$$20240802$$MD$US$US
241669521$24166952$1$I$$20240723$20240802$20240802$EXP$GB-MHRA-MED-202407232053358180-ZLGPY$GB-Accord-438074$ACCORD$$29$YR$A$F$Y$$$20240802$$CN$GB$GB
241669531$24166953$1$I$$20240723$20240802$20240802$EXP$CN-HENLIUS-24CN016045$CN-Accord-439208$ACCORD$$$$$F$Y$50$KG$20240802$$MD$CN$CN
241669541$24166954$1$I$20240615$20240726$20240802$20240802$EXP$FR-AFSSAPS-NC2024000837$FR-TEVA-VS-3227213$TEVA$$89$YR$$F$Y$$$20240802$$MD$FR$FR
241669551$24166955$1$I$$20240725$20240802$20240802$PER$$US-BAYER-2024A108885$BAYER$$36$YR$A$F$Y$$$20240802$$CN$US$US
241669561$24166956$1$I$$20231023$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-005557$ENDO$$$$$M$Y$$$20240802$$CN$US$US
241669571$24166957$1$I$$20240306$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2024-000028$ENDO$$$$$M$Y$95.238$KG$20240802$$CN$US$US
241669581$24166958$1$I$20240530$20240719$20240802$20240802$PER$$US-ENDO USA, INC.-2024-002481$ENDO$$69$YR$$M$Y$99.773$KG$20240802$$CN$US$US
241669591$24166959$1$I$20230801$20231016$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-004872$ENDO$$35$YR$$M$Y$63.946$KG$20240802$$CN$US$US
241669611$24166961$1$I$20230101$20231207$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-005357$ENDO$$$$$M$Y$$$20240802$$CN$US$US
241669621$24166962$1$I$20220101$20231108$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-004854$ENDO$$$$$M$Y$$$20240802$$CN$US$US
241669631$24166963$1$I$20240528$20240719$20240802$20240802$PER$$US-ENDO USA, INC.-2024-002430$ENDO$$79$YR$$M$Y$$$20240802$$CN$US$US
241669641$24166964$1$I$$20230908$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-004315$ENDO$$$$$M$Y$$$20240802$$HP$US$US
241669652$24166965$2$F$20170101$20240813$20240802$20240821$EXP$$IT-OTSUKA-2024_020112$OTSUKA$$$$$M$Y$$$20240821$$CN$IT$IT
241669661$24166966$1$I$$20231205$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-006087$ENDO$$$$$M$Y$$$20240802$$CN$US$US
241669671$24166967$1$I$20231114$20240430$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2024-001245$ENDO$$83$YR$$M$Y$$$20240802$$HP$US$US
241669681$24166968$1$I$20231123$20240125$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-006054$ENDO$$79$YR$$M$Y$69.388$KG$20240802$$HP$US$US
241669691$24166969$1$I$$20230905$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-004462$ENDO$$$$$M$Y$95.238$KG$20240802$$CN$US$US
241669701$24166970$1$I$$20240727$20240802$20240802$PER$$US-ABBVIE-5858871$ABBVIE$$$$$$Y$$$20240802$$HP$US$US
241669711$24166971$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153017$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241669722$24166972$2$F$20240412$20240730$20240802$20240816$EXP$$IN-BAYER-2024A110498$BAYER$$63$YR$A$M$Y$$$20240816$$HP$IN$IN
241669732$24166973$2$F$20240725$20240815$20240802$20240820$PER$$US-AMGEN-USASP2024152292$AMGEN$$$$$$Y$$$20240820$$PH$US$US
241669741$24166974$1$I$$20240725$20240802$20240802$PER$$US-BAYER-2024A109432$BAYER$$$$$F$Y$$$20240802$$CN$US$US
241669751$24166975$1$I$$20240731$20240802$20240802$EXP$$CA-SANDOZ INC.-SDZ2023CA076653$SANDOZ$$$$$F$Y$$$20240802$$HP$CA$CA
241669761$24166976$1$I$20230908$20240115$20240802$20240802$PER$$US-ENDO PHARMACEUTICALS INC-2023-005009$ENDO$$76$YR$$M$Y$$$20240802$$CN$US$US
241669781$24166978$1$I$20240524$20240725$20240802$20240802$EXP$FR-AFSSAPS-BX2024001458$FR-TEVA-VS-3226354$TEVA$$87$YR$$M$Y$$$20240802$$MD$FR$FR
241669791$24166979$1$I$$20240724$20240802$20240802$EXP$$US-BAUSCHBL-2024BNL030709$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240802$$CN$US$US
241669801$24166980$1$I$$20240722$20240802$20240802$EXP$$PL-AUROBINDO-AUR-APL-2024-037457$AUROBINDO$Braksator M, Jachymek M, Rahmani A, Widecka K, Lewandowski M, Jodko L, et al.. Nonsurgical treatment of a patient with decompensated right ventricular failure due to chronic thromboembolic pulmonary hypertension with proximal clot location-A case report. Pulm-Circ. 2024;14(2):1-5$38$YR$$M$Y$$$20240802$$HP$PL$PL
241669811$24166981$1$I$$20240729$20240802$20240802$EXP$$CA-SANDOZ INC.-SDZ2024CA069072$SANDOZ$$74$YR$$F$Y$64$KG$20240802$$PH$CA$CA
241669821$24166982$1$I$20240722$20240729$20240802$20240802$EXP$$IE-MYLANLABS-2024M1071031$MYLAN$$$$$M$Y$$$20240802$$PH$IE$IE
241669833$24166983$3$F$20240725$20240905$20240802$20240916$30DAY$$US-JNJFOC-20240783107$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240916$$HP$US$US
241669841$24166984$1$I$20240423$20240729$20240802$20240802$EXP$$US-MYLANLABS-2024M1071424$MYLAN$$32$YR$$F$Y$$$20240802$$MD$US$US
241669851$24166985$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52961$$FDA-CTU$$5$YR$$F$N$$$20240801$N$$US$
241669861$24166986$1$I$20240710$20240725$20240802$20240802$EXP$ES-AEMPS-1549942$ES-TEVA-VS-3225925$TEVA$$57$YR$$F$Y$$$20240802$$MD$ES$ES
241669872$24166987$2$F$20220916$20240808$20240802$20240819$EXP$$FR-AMRYT PHARMACEUTICALS DAC-AEGR006983$AEGERION$$$$$$Y$$$20240819$$MD$FR$FR
241669881$24166988$1$I$20240801$20240801$20240801$20240801$DIR$712414$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241669891$24166989$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52952$$FDA-CTU$$81$YR$$F$N$$$20240801$N$$US$
241669911$24166991$1$I$$20240726$20240802$20240802$PER$$US-BAYER-2024A111086$BAYER$$$$$F$Y$$$20240802$$CN$US$US
241669921$24166992$1$I$$20230228$20240802$20240802$PER$$US-SERB S.A.S.-2159921$LABORATOIRES SERB$$30$YR$$F$Y$$$20240802$$PH$US$US
241669931$24166993$1$I$$20240719$20240802$20240802$PER$$US-TEVA-VS-3224577$TEVA$$$$E$F$Y$$$20240802$$CN$US$US
241669941$24166994$1$I$$20240730$20240802$20240802$PER$$US-ABBVIE-5863111$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241669951$24166995$1$I$20240101$20240801$20240802$20240802$EXP$$US-UCBSA-2024038732$UCB$$$$$F$Y$$$20240802$$CN$US$US
241669961$24166996$1$I$20240725$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151657$AMGEN$$69$YR$E$F$Y$$$20240802$$HP$US$US
241669971$24166997$1$I$$20240726$20240802$20240802$PER$$US-BAYER-2024A111189$BAYER$$$$$$Y$$$20240802$$CN$US$US
241669981$24166998$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122591$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241669991$24166999$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122590$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241670001$24167000$1$I$$20240725$20240802$20240802$EXP$$TW-MYLANLABS-2024M1071146$MYLAN$Chou M-Y, Wu W-C, Chu P-Y, Tai S-K, Chang PM-H, Lee T-L, et al. Paclitaxel-Ifosfamide-based Therapy as Salvage Treatment in Platinum-resistant Recurrent/Metastatic Head and Neck Cancer. In-Vivo 2024; 38 (4): 1891-1899.$71$YR$$M$Y$$$20240802$$MD$TW$TW
241670011$24167001$1$I$20200101$20240729$20240802$20240802$EXP$$FR-MYLANLABS-2022M1148455$MYLAN$Dufayet, L., Deveaux, M., Cheze, M., Charuel, L., Ludes, B., Fortel, I., et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the ?le-de-France Toxic Death Surveillance System (DCTOX-IdF).. Toxicologie Analytique et Clinique.. 2023;35 (1):54-59$18$YR$$M$Y$$$20240802$$HP$FR$FR
241670021$24167002$1$I$$20240725$20240802$20240802$EXP$$JP-MYLANLABS-2024M1070989$MYLAN$Terui H, Segawa Y, Otake E, Omori R, Tsuchiyama K, Kikuchi K, et al. Successful treatment of pustulotic arthro-osteitis with amoxicillin: A case report and review of the literature. [Review]. J-Dermatol 2023; 50 (11): 1478-1483.. 2023;50 (11):1478-1483$5$DEC$$F$Y$$$20240802$$HP$JP$JP
241670031$24167003$1$I$$20240725$20240802$20240802$EXP$$IN-MYLANLABS-2024M1070833$MYLAN$Kapoor R, Sadda S, Tyagi M. Suspected Retinal Toxicity After Multiple Intravitreal Ganciclovir Injections in a Patient of CMV Retinitis. Ocular-Immunol-Inflamm 2024; 32 (5): 525-528.$69$YR$$M$Y$$$20240802$$MD$IN$IN
241670041$24167004$1$I$$20240725$20240802$20240802$EXP$$US-MYLANLABS-2024M1071014$MYLAN$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. J-Allergy-Clin-Immunol-Pract 2024; 12 (6): 1663-1665.$32$YR$$F$Y$$$20240802$$MD$US$US
241670051$24167005$1$I$$20240725$20240802$20240802$EXP$$US-MYLANLABS-2024M1071098$MYLAN$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. J-Allergy-Clin-Immunol-Pract 2024; 12 (6): 1663-1665.$43$YR$$F$Y$$$20240802$$MD$US$US
241670061$24167006$1$I$$20240725$20240802$20240802$EXP$$US-MYLANLABS-2024M1071107$MYLAN$Shacker M, Braat JP, Arjuna A. Acute Hepatitis After Lung Transplant in a Recipient from Hep C Donor: The Chicken or the Egg Phenomenon?. J-Heart-Lung-Transplant 2024; 43 (Suppl.) (4): S480 abstr. 1029.$70$YR$$F$Y$$$20240802$$HP$US$US
241670071$24167007$1$I$20240624$20240730$20240802$20240802$EXP$FR-AFSSAPS-TS2024000826$FR-ROCHE-10000042942$ROCHE$$68$YR$E$M$Y$61$KG$20240802$$MD$FR$FR
241670081$24167008$1$I$20240501$20240731$20240802$20240802$EXP$$DE-ASTELLAS-2024EU007595$ASTELLAS$$76$YR$$M$Y$$$20240802$$CN$NL$DE
241670091$24167009$1$I$$20240728$20240802$20240802$EXP$$US-TEVA-VS-3227460$TEVA$$$$$$Y$$$20240802$$PH$US$US
241670101$24167010$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152234$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241670112$24167011$2$F$$20240913$20240802$20240913$PER$$NVSC2024US156241$NOVARTIS$$$$$F$Y$$$20240913$$HP$US$US
241670121$24167012$1$I$$20240725$20240802$20240802$EXP$$ZA-ROCHE-10000038735$ROCHE$$$$A$F$Y$$$20240802$$CN$ZA$ZA
241670131$24167013$1$I$20240401$20240731$20240802$20240802$EXP$$NVSC2024US157423$NOVARTIS$$54$YR$$F$Y$$$20240802$$CN$US$US
241670141$24167014$1$I$$20240728$20240802$20240802$PER$$US-BAYER-2024A109792$BAYER$$$$$F$Y$$$20240802$$CN$US$US
241670151$24167015$1$I$20240630$20240731$20240802$20240802$EXP$FR-AFSSAPS-LL2024001454$FR-ASTELLAS-2024EU007582$ASTELLAS$$56$YR$$M$Y$$$20240802$$CN$FR$FR
241670161$24167016$1$I$20230301$20240730$20240802$20240802$EXP$HR-HALMED-300085966$HR-ASTELLAS-2024EU007560$ASTELLAS$$85$YR$$F$Y$60$KG$20240802$$HP$GB$HR
241670171$24167017$1$I$$20240801$20240802$20240802$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043442$BOEHRINGER INGELHEIM$$$$$$Y$$$20240802$$MD$US$US
241670191$24167019$1$I$$20240723$20240802$20240802$EXP$$BR-ASTELLAS-2024US021578$ASTELLAS$$45$YR$$M$Y$$$20240802$$CN$BR$BR
241670201$24167020$1$I$$20240729$20240802$20240802$EXP$$RO-MYLANLABS-2024M1070379$MYLAN$$71$YR$$M$Y$$$20240802$$MD$RO$RO
241670211$24167021$1$I$$20240728$20240802$20240802$PER$$US-BAYER-2024A109974$BAYER$$$$$F$Y$$$20240802$$CN$US$US
241670221$24167022$1$I$$20240723$20240802$20240802$EXP$$US-BRAEBURN-US-BRA-24-000688$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240802$$HP$US$US
241670241$24167024$1$I$$20240722$20240802$20240802$EXP$$CN-TEYRO-2024-TY-000351$Teyro Labs$Zhang C, Sun YX, Yi DC, Jiang BY, Yan LX, Zhong WZ, et al..Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)..Cell Rep Med..2024;5:101615$$$$$Y$$$20240802$$HP$CN$CN
241670251$24167025$1$I$$20240726$20240802$20240802$EXP$$FR-EMD Serono-2024040762$EMD SERONO INC$$90$YR$E$F$Y$$$20240802$$MD$FR$FR
241670261$24167026$1$I$20240721$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52931$$FDA-CTU$$45$YR$$F$N$$$20240801$N$HP$US$
241670271$24167027$1$I$20230623$20240801$20240801$20240801$DIR$712404$$FDA-CTU$$33$YR$$M$N$$$20240801$N$CN$US$
241670283$24167028$3$F$$20240819$20240802$20240827$EXP$$US-ALIMERA SCIENCES INC.-US-A16013-24-000487$ALIMERA$$$$$F$Y$$$20240827$$MD$US$US
241670291$24167029$1$I$$20240729$20240802$20240802$EXP$$JP-EXELIXIS-CABO-24080114$EXELIXIS$$9$DEC$$M$Y$$$20240802$$MD$JP$JP
241670301$24167030$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024092401$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241670321$24167032$1$I$$20230109$20240802$20240802$EXP$$US-AstraZeneca-2023A006149$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241670331$24167033$1$I$$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173615$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241670341$24167034$1$I$$20240731$20240802$20240802$PER$$US-ABBVIE-5862984$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241670351$24167035$1$I$$20230427$20240802$20240802$EXP$$CA-AstraZeneca-2023A047444$ASTRAZENECA$$$$$F$Y$$$20240802$$MD$CA$
241670361$24167036$1$I$$20240725$20240802$20240802$EXP$$GB-AstraZeneca-2024A170241$ASTRAZENECA$$$$$F$Y$$$20240802$$MD$GB$
241670372$24167037$2$F$$20240916$20240802$20240917$PER$$US-AstraZeneca-2024A174180$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
241670381$24167038$1$I$$20231122$20240802$20240802$EXP$$US-AstraZeneca-2023A267227$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241670391$24167039$1$I$$20230726$20240802$20240802$EXP$$US-AstraZeneca-2023A171868$ASTRAZENECA$$$$$M$Y$75.7$KG$20240802$$CN$US$
241670411$24167041$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170578$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241670421$24167042$1$I$$20240725$20240802$20240802$EXP$$CA-AstraZeneca-2024A171420$ASTRAZENECA$$65$YR$$M$Y$$$20240802$$MD$CA$
241670432$24167043$2$F$20231217$20240825$20240802$20240830$EXP$$PH-AstraZeneca-2024A172212$ASTRAZENECA$$86$YR$$F$Y$31.8$KG$20240830$$MD$PH$
241670441$24167044$1$I$$20240730$20240802$20240802$PER$$US-BAYER-2024A111024$BAYER$$$$$$Y$$$20240802$$CN$US$US
241670451$24167045$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A171276$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241670471$24167047$1$I$20240730$20240801$20240801$20240801$DIR$712415$$FDA-CTU$$93$YR$$F$N$$$20240801$$CN$US$
241670481$24167048$1$I$20240801$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52966$$FDA-CTU$$39$YR$$F$N$$$20240801$N$HP$US$
241670491$24167049$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52949$$FDA-CTU$$72$YR$$M$N$100$LBS$20240801$N$$US$
241670501$24167050$1$I$20230813$20230815$20240802$20240802$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02907$AMNEAL$$$$$F$Y$$$20240802$$CN$US$US
241670511$24167051$1$I$20230601$20230628$20240802$20240802$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02452$AMNEAL$$66$YR$$F$Y$138.32$KG$20240802$$CN$US$US
241670521$24167052$1$I$20240708$20240708$20240802$20240802$PER$$US-Eisai-EC-2024-169804$EISAI$$85$YR$E$F$Y$$$20240802$$CN$US$US
241670531$24167053$1$I$$20240725$20240802$20240802$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14997$IPSEN$$$$$M$Y$$$20240802$$CN$US$US
241670542$24167054$2$F$$20240801$20240802$20240806$PER$$US-AstraZeneca-2024A169922$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241670561$24167056$1$I$$20240722$20240802$20240802$EXP$$HU-Oxford Pharmaceuticals, LLC-2159922$OXFORD PHARMACEUTICALS$Source document$4$YR$$F$Y$$$20240802$$$HU$HU
241670571$24167057$1$I$$20230620$20240802$20240802$EXP$$US-AstraZeneca-2023A143231$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241670581$24167058$1$I$$20240722$20240802$20240802$EXP$$JP-TEYRO-2024-TY-000328$Teyro Labs$Saitou A, Shioya M, Nagahisa Y, Haseyama A, Niwa R, Tsuchimoto J, et al..Small-cell Lung Carcinoma with Gastrointestinal Pseudo-obstruction as a Paraneoplastic Neurological Syndrome Elicited by an Immune Checkpoint Inhibitor..Intern Med.2024;63:2059-2062$75$YR$E$M$Y$$$20240802$$HP$JP$JP
241670601$24167060$1$I$20240501$20240729$20240802$20240802$PER$$US-BAYER-2024A109618$BAYER$$$$$F$Y$$$20240802$$CN$US$US
241670611$24167061$1$I$20240301$20240418$20240802$20240802$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01351$AMNEAL$$81$YR$$M$Y$$$20240802$$CN$US$US
241670622$24167062$2$F$20240101$20240824$20240802$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-023154$UNITED THERAPEUTICS$$$$$F$Y$71.202$KG$20240831$$$US$US
241670631$24167063$1$I$$20240620$20240802$20240802$EXP$$CA-TEVA-VS-3219727$TEVA$$67$YR$$F$Y$$$20240802$$MD$CA$CA
241670641$24167064$1$I$$20231012$20240802$20240802$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03764$AMNEAL$$$$$M$Y$$$20240802$$CN$US$US
241670651$24167065$1$I$20240601$20240610$20240802$20240802$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02155$AMNEAL$$62$YR$$F$Y$61.224$KG$20240802$$CN$US$US
241670661$24167066$1$I$$20240502$20240802$20240802$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01581$AMNEAL$$$$$$Y$$$20240802$$PH$US$US
241670671$24167067$1$I$$20231005$20240802$20240802$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03520$AMNEAL$$81$YR$$F$Y$$$20240802$$CN$US$US
241670681$24167068$1$I$$20240801$20240802$20240802$EXP$$US-GILEAD-2024-0682678$GILEAD$$67$YR$E$F$Y$$$20240802$$HP$US$US
241670694$24167069$4$F$$20240913$20240802$20240917$PER$$US-BIOVITRUM-2024-US-010496$BIOVITRUM$$78$YR$$F$Y$$$20240917$$CN$US$US
241670702$24167070$2$F$$20240905$20240802$20240910$30DAY$$US-MYLANLABS-2024M1069914$MYLAN$$$$$M$Y$$$20240910$$CN$US$US
241670713$24167071$3$F$$20240912$20240802$20240916$EXP$$AU-MYLANLABS-2024M1070725$MYLAN$$$$$M$Y$$$20240916$$CN$AU$AU
241670722$24167072$2$F$$20240909$20240802$20240912$30DAY$$US-MYLANLABS-2024M1070763$MYLAN$$$$$F$Y$$$20240912$$CN$US$US
241670732$24167073$2$F$$20240911$20240802$20240913$30DAY$$DE-MYLANLABS-2024M1070743$MYLAN$$3$YR$$M$Y$$$20240913$$PH$DE$DE
241670741$24167074$1$I$$20240719$20240802$20240802$EXP$$US-UCBSA-2024037021$UCB$$$$$$Y$$$20240802$$CN$US$US
241670752$24167075$2$F$20160530$20240807$20240802$20240812$EXP$$CA-TAKEDA-2015TUS013625$TAKEDA$$35$YR$$F$Y$$$20240812$$CN$CA$CA
241670761$24167076$1$I$20240722$20240729$20240802$20240802$PER$$US-BAYER-2024A109651$BAYER$$39$YR$A$F$Y$$$20240802$$MD$US$US
241670771$24167077$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122106$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240802$$HP$US$US
241670781$24167078$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122611$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241670791$24167079$1$I$20240705$20240712$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113027$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240802$$CN$US$US
241670801$24167080$1$I$$20240730$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121312$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240802$$HP$US$US
241670821$24167082$1$I$20240601$20240723$20240802$20240802$PER$$US-JNJFOC-20240776647$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$MD$US$US
241670831$24167083$1$I$$20240729$20240802$20240802$PER$$US-BIOGEN-2024BI01276170$BIOGEN$$$$$F$Y$$$20240802$$CN$US$US
241670841$24167084$1$I$20240722$20240728$20240802$20240802$EXP$$CN-EMD Serono-2024041172$EMD SERONO INC$$49$YR$A$F$Y$62$KG$20240802$$HP$CN$CN
241670851$24167085$1$I$20240101$20240726$20240802$20240802$PER$$US-UNITED THERAPEUTICS-UNT-2024-023370$UNITED THERAPEUTICS$$$$$F$Y$58.957$KG$20240802$$$US$US
241670861$24167086$1$I$$20240730$20240802$20240802$EXP$$US-BAYER-2024A111093$BAYER$$$$$$Y$$$20240802$$CN$US$US
241670871$24167087$1$I$20240715$20240729$20240802$20240802$PER$$US-BAYER-2024A109862$BAYER$$23$YR$A$F$Y$$$20240802$$MD$US$US
241670881$24167088$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A171746$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241670891$24167089$1$I$$20240725$20240802$20240802$EXP$$CA-TEVA-VS-3227315$TEVA$$45$YR$$M$Y$$$20240802$$HP$CA$CA
241670902$24167090$2$F$20240507$20240916$20240802$20240917$EXP$$US-AstraZeneca-2024A174325$ASTRAZENECA$$25474$DY$$F$Y$$$20240917$$CN$US$
241670911$24167091$1$I$$20240725$20240802$20240802$EXP$$AU-AstraZeneca-2024A174614$ASTRAZENECA$$20$YR$$F$Y$$$20240802$$MD$AU$
241670921$24167092$1$I$$20240719$20240802$20240802$PER$$US-ALKERMES INC.-ALK-2024-001941$ALKERMES$$$$$F$Y$$$20240802$$CN$US$US
241670931$24167093$1$I$$20240726$20240802$20240802$EXP$NL-LRB-00990053$NL-TEVA-VS-3227291$TEVA$$85$YR$$F$Y$$$20240802$$MD$NL$NL
241670941$24167094$1$I$$20240729$20240802$20240802$EXP$$US-ARGENX-2024-ARGX-US006033$ARGENX BVBA$$$$$$Y$$$20240802$$HP$US$US
241670951$24167095$1$I$20240601$20240729$20240802$20240802$PER$$US-BAYER-2024A110134$BAYER$$37$YR$A$F$Y$$$20240802$$MD$US$US
241670961$24167096$1$I$$20240722$20240802$20240802$EXP$$CN-TEYRO-2024-TY-000356$Teyro Labs$Zhang C, Sun YX, Yi DC, Jiang BY, Yan LX, Zhong WZ, et al..Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)..Cell Rep Med..2024;5:101615$$$$$Y$$$20240802$$HP$CN$CN
241670971$24167097$1$I$$20240717$20240802$20240802$PER$$US-EMD Serono-2024039144$EMD SERONO INC$$$$A$F$Y$$$20240802$$CN$US$US
241670991$24167099$1$I$$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024151303$AMGEN$$$$$M$Y$$$20240802$$PH$US$US
241671003$24167100$3$F$$20240918$20240802$20240925$EXP$$CA-OTSUKA-2024_018513$OTSUKA$$$$$F$Y$$$20240925$$HP$CA$CA
241671011$24167101$1$I$$20240729$20240802$20240802$EXP$$JP-PFIZER INC-PV202400098705$PFIZER$Nemoto, N.. Two cases of pseudocirrhosis caused by drug therapy for metastases to liver from breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:531$63$YR$$F$Y$$$20240802$$HP$JP$JP
241671021$24167102$1$I$20240601$20240725$20240802$20240802$EXP$FR-AFSSAPS-GR2024000910$FR-MYLANLABS-2024M1069979$MYLAN$$88$YR$$F$Y$$$20240802$$PH$FR$FR
241671031$24167103$1$I$20240626$20240719$20240802$20240802$EXP$PT-INFARMED-E202407-190$PT-TEVA-VS-3223603$TEVA$$90$YR$$M$Y$60$KG$20240802$$PH$PT$PT
241671042$24167104$2$F$$20240801$20240802$20240807$EXP$$IE-PFIZER INC-202400226421$PFIZER$Kelliher, J.. Severe atypical iliac wing fracture associated with long-term bisphosphonate use. Skeletal radiology. 2024;1-5$63$YR$$F$Y$$$20240807$$MD$IE$IE
241671051$24167105$1$I$20240721$20240801$20240802$20240802$PER$$US-BAYER-2024A111703$BAYER$$61$YR$A$M$Y$$$20240802$$CN$US$US
241671063$24167106$3$F$20220520$20240917$20240802$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011602$JAZZ$$58$YR$$F$Y$$$20240923$$MD$US$US
241671071$24167107$1$I$20240702$20240718$20240802$20240802$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202407-000152$AZURITY PHARMACEUTICALS$$10$YR$$M$Y$$$20240802$$HP$US$US
241671081$24167108$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52932$$FDA-CTU$$59$YR$$F$N$$$20240801$N$$US$
241671091$24167109$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52950$$FDA-CTU$$68$YR$$F$N$$$20240801$N$$US$
241671101$24167110$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52925$$FDA-CTU$$69$YR$$F$N$$$20240801$N$$US$
241671121$24167112$1$I$20240717$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52964$$FDA-CTU$$23$YR$$M$N$$$20240731$Y$PH$US$
241671131$24167113$1$I$$20240801$20240801$20240801$DIR$712421$$FDA-CTU$$33$YR$$F$N$82.35$KG$20240801$N$CN$US$
241671181$24167118$1$I$20240701$20240801$20240802$20240802$PER$$US-BAYER-2024A111715$BAYER$$102$YR$E$F$Y$$$20240802$$CN$US$US
241671191$24167119$1$I$$20240731$20240802$20240802$EXP$$US-GILEAD-2024-0682637$GILEAD$$$$A$M$Y$$$20240802$$CN$US$US
241671221$24167122$1$I$$20240724$20240802$20240802$30DAY$$US-GSK-US2024092980$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241671231$24167123$1$I$$20240729$20240802$20240802$EXP$$CA-TAKEDA-2023TUS040295$TAKEDA$$$$$F$Y$$$20240802$$CN$CA$CA
241671241$24167124$1$I$$20240722$20240802$20240802$EXP$$FR-RECORDATI RARE DISEASE INC.-2024005800$RECORDATI$Choderlos De Laclos X, Risbourg S, Marec-Berard P, Cecile Le Deley M, Tabone MD, Bertucci F, et al. Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials. European Journal of Cancer. 2024;208$$$$$Y$$$20240802$$HP$FR$FR
241671252$24167125$2$F$20240303$20240802$20240802$20240809$EXP$$NVSC2024IL049310$NOVARTIS$$77$YR$$F$Y$$$20240809$$HP$IL$IL
241671261$24167126$1$I$$20240801$20240802$20240802$PER$$US-BAYER-2024A111760$BAYER$$64$YR$A$M$Y$$$20240802$$CN$US$US
241671271$24167127$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52930$$FDA-CTU$$$$$M$N$$$20240801$N$HP$US$
241671291$24167129$1$I$20240707$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52940$$FDA-CTU$$82$YR$$F$N$$$20240801$N$$US$
241671301$24167130$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122592$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241671311$24167131$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122571$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241671321$24167132$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52941$$FDA-CTU$$65$YR$$F$N$143$LBS$20240801$N$$US$
241671341$24167134$1$I$20240321$20240801$20240801$20240801$DIR$712423$$FDA-CTU$$76$YR$$M$N$74.25$KG$20240801$N$CN$US$
241671351$24167135$1$I$20240620$20240718$20240802$20240802$EXP$$CN-EAGLE PHARMACEUTICALS, INC.-CN-2024EAG000186$EAGLE$$59$YR$$F$Y$54.7$KG$20240802$$HP$CN$CN
241671364$24167136$4$F$20240701$20240918$20240802$20240924$EXP$$PR-ABBVIE-5860356$ABBVIE$$48$YR$$F$Y$$$20240924$$CN$PR$PR
241671371$24167137$1$I$$20240730$20240802$20240802$EXP$GB-MHRA-MIDB-8a1610a6-646a-4dc8-9455-6f3510bb9e9e$GB-TEVA-VS-3228351$TEVA$$79$YR$$$Y$$$20240802$$PH$GB$GB
241671381$24167138$1$I$$20240724$20240802$20240802$EXP$$GR-TEVA-VS-3225739$TEVA$$$$$F$Y$$$20240802$$MD$GR$GR
241671391$24167139$1$I$20240612$20240719$20240802$20240802$EXP$$JP-EAGLE PHARMACEUTICALS, INC.-JP-2024EAG000187$EAGLE$$$$E$F$Y$63$KG$20240802$$MD$JP$JP
241671401$24167140$1$I$$20240801$20240801$20240801$DIR$712424$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241671412$24167141$2$F$$20240813$20240802$20240816$30DAY$$AU-PFIZER INC-202400104107$PFIZER$$60$YR$$F$Y$$$20240816$$CN$AU$AU
241671422$24167142$2$F$20240101$20240809$20240802$20240815$30DAY$$JP-PFIZER INC-202400182388$PFIZER$$$$$$Y$$$20240815$$HP$JP$JP
241671432$24167143$2$F$20240625$20240731$20240802$20240912$EXP$$US-PFIZER INC-202400226025$PFIZER$$66$YR$$F$Y$54.43$KG$20240912$$MD$US$US
241671441$24167144$1$I$20240707$20240730$20240802$20240802$EXP$ES-AEMPS-1551259$ES-PFIZER INC-202400226337$PFIZER$$17$YR$$M$Y$52.9$KG$20240802$$PH$ES$ES
241671451$24167145$1$I$$20240724$20240802$20240802$EXP$$US-ARGENX-2024-ARGX-US005909$ARGENX BVBA$$$$$$Y$$$20240802$$CN$US$US
241671461$24167146$1$I$20191231$20240719$20240802$20240802$EXP$$FR-SERVIER-S21010111$SERVIER$$$$$$Y$$$20240802$$MD$FR$FR
241671471$24167147$1$I$20240501$20240723$20240802$20240802$30DAY$$US-GSK-US2024092277$GLAXOSMITHKLINE$$63$YR$$M$Y$$$20240802$$HP$US$US
241671481$24167148$1$I$$20240725$20240802$20240802$30DAY$$US-GSK-US2024093774$GLAXOSMITHKLINE$$$$E$M$Y$$$20240802$$CN$US$US
241671491$24167149$1$I$20240601$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000423$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240802$$CN$US$US
241671501$24167150$1$I$$20240725$20240802$20240802$30DAY$$US-GSK-US2024AMR093911$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241671511$24167151$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408001303$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240802$$CN$US$US
241671521$24167152$1$I$$20240723$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202403009703$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240802$$CN$US$US
241671531$24167153$1$I$20240401$20240723$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407015478$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240802$$CN$US$US
241671541$24167154$1$I$20240614$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000973$ELI LILLY AND CO$$$$$$Y$$$20240802$$CN$US$US
241671552$24167155$2$F$20240729$20240730$20240802$20240805$EXP$$US-UCBSA-2024038358$UCB$$31$YR$$F$Y$$$20240805$$CN$US$US
241671561$24167156$1$I$$20240801$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US070063$SANDOZ$$$$$F$Y$$$20240802$$CN$US$US
241671571$24167157$1$I$20240728$20240729$20240802$20240802$PER$$US-BAYER-2024A111123$BAYER$$$$$$Y$$$20240802$$CN$US$US
241671581$24167158$1$I$$20240724$20240802$20240802$EXP$$CA-TEVA-VS-3226564$TEVA$$49$YR$$M$Y$$$20240802$$HP$CA$CA
241671592$24167159$2$F$$20240801$20240802$20240803$EXP$$GB-ABBVIE-5862531$ABBVIE$$$$E$F$Y$$$20240803$$CN$GB$GB
241671601$24167160$1$I$20240710$20240724$20240802$20240802$EXP$$US-VANTIVE-2024VAN018607$Vantive US Healthcare$$52$YR$$M$Y$$$20240802$$HP$US$US
241671611$24167161$1$I$20240730$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153082$AMGEN$$86$YR$E$F$Y$$$20240802$$CN$US$US
241671621$24167162$1$I$20240601$20240717$20240802$20240802$PER$$US-Vifor (International) Inc.-VIT-2024-06476$VIFOR$$44$YR$$F$Y$79$KG$20240802$$HP$US$US
241671632$24167163$2$F$20240604$20240911$20240802$20240918$EXP$$US-Vifor (International) Inc.-VIT-2024-06479$VIFOR$$71$YR$$M$Y$55$KG$20240918$$HP$US$US
241671641$24167164$1$I$20240429$20240717$20240802$20240802$PER$$US-Vifor (International) Inc.-VIT-2024-06477$VIFOR$$80$YR$$M$Y$89$KG$20240802$$HP$US$US
241671661$24167166$1$I$20240101$20240731$20240802$20240802$EXP$$US-ABBVIE-5863251$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241671671$24167167$1$I$$20240725$20240802$20240802$EXP$$CA-AMGEN-CANSP2024151988$AMGEN$$40$YR$A$F$Y$96$KG$20240802$$HP$CA$CA
241671681$24167168$1$I$20240613$20240717$20240802$20240802$PER$$US-Vifor (International) Inc.-VIT-2024-06478$VIFOR$$75$YR$$M$Y$95$KG$20240802$$HP$US$US
241671691$24167169$1$I$$20240705$20240802$20240802$PER$$US-009507513-2407USA004857$MERCK$$$$$F$Y$49.5$KG$20240802$$HP$US$US
241671701$24167170$1$I$$20240801$20240802$20240802$EXP$$US-UCBSA-2024038818$UCB$$$$$F$Y$$$20240802$$HP$US$US
241671713$24167171$3$F$20240701$20240812$20240802$20240816$EXP$$CO-BAYER-2024A107535$BAYER$$72$YR$E$F$Y$$$20240816$$CN$CO$CO
241671721$24167172$1$I$$20240730$20240802$20240802$EXP$$KR-AstraZeneca-2024A173504$ASTRAZENECA$$47$YR$$M$Y$$$20240802$$MD$KR$
241671731$24167173$1$I$$20240729$20240802$20240802$EXP$$NVSC2024KR157147$NOVARTIS$$$$$$Y$$$20240802$$CN$KR$KR
241671741$24167174$1$I$$20240730$20240802$20240802$PER$$US-BAYER-2024A110917$BAYER$$$$$$Y$$$20240802$$CN$US$US
241671751$24167175$1$I$$20240702$20240802$20240802$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07529$LUPIN$$$$$$Y$$$20240802$$CN$US$US
241671771$24167177$1$I$$20240725$20240802$20240802$EXP$$AU-MYLANLABS-2024M1071053$MYLAN$Yeoh K, Lass-Florl C, Lamoth F, Slavin MA, Williams E, Neofytos D. Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual. Transpl-Infect-Dis 2024;.$53$YR$$F$Y$$$20240802$$HP$AU$AU
241671781$24167178$1$I$$20240726$20240802$20240802$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001538$BLUEPRINT MEDICINES$$$$$M$Y$$$20240802$$CN$US$US
241671791$24167179$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52936$$FDA-CTU$$59$YR$$F$N$$$20240801$N$$US$
241671831$24167183$1$I$$20240731$20240802$20240802$PER$$US-ABBVIE-5862973$ABBVIE$$$$A$F$Y$$$20240802$$HP$US$US
241671841$24167184$1$I$20240101$20240729$20240802$20240802$EXP$$US-ABBVIE-5859484$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241671851$24167185$1$I$$20240730$20240802$20240802$EXP$$CO-ABBVIE-5863959$ABBVIE$$$$$M$Y$65$KG$20240802$$HP$CO$CO
241671862$24167186$2$F$20240801$20240813$20240802$20240816$EXP$$CA-UCBSA-2024038812$UCB$$43$YR$$F$Y$$$20240816$$CN$CA$CA
241671901$24167190$1$I$$20240801$20240801$20240801$DIR$712425$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241671911$24167191$1$I$$20240731$20240802$20240802$PER$$US-BAYER-2024A110942$BAYER$$$$$$Y$$$20240802$$CN$US$US
241671921$24167192$1$I$$20240730$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US069717$SANDOZ$$$$A$M$Y$$$20240802$$MD$US$US
241671931$24167193$1$I$$20240731$20240802$20240802$EXP$$GB-MYLANLABS-2024M1071569$MYLAN$$$$$M$Y$$$20240802$$CN$GB$GB
241671941$24167194$1$I$20240523$20240731$20240802$20240802$EXP$$GB-MYLANLABS-2024M1071642$MYLAN$$70$YR$$M$Y$87.1$KG$20240802$$MD$GB$GB
241671951$24167195$1$I$$20240731$20240802$20240802$EXP$$GB-MYLANLABS-2024M1071593$MYLAN$$$$$M$Y$$$20240802$$PH$GB$GB
241671961$24167196$1$I$$20240731$20240802$20240802$EXP$$CA-MYLANLABS-2024M1071463$MYLAN$$69$YR$$M$Y$$$20240802$$HP$CA$CA
241671971$24167197$1$I$20221129$20231204$20240802$20240802$EXP$$CA-CELLTRION INC.-2022CA022711$CELLTRION$$$$$$Y$$$20240802$$MD$CA$CA
241671981$24167198$1$I$$20240731$20240802$20240802$EXP$GB-MHRA-MIDB-2e957c43-01ee-4abe-8676-d258493bd95a$GB-MYLANLABS-2024M1071529$MYLAN$$72$YR$$M$Y$$$20240802$$PH$GB$GB
241671991$24167199$1$I$$20240731$20240802$20240802$EXP$GB-MHRA-MED-202407311157498130-FKZLG$GB-MYLANLABS-2024M1071748$MYLAN$$$$$$Y$$$20240802$$PH$GB$GB
241672002$24167200$2$F$$20240820$20240802$20240821$PER$$NVSC2024US158054$NOVARTIS$$$$$M$Y$$$20240822$$HP$US$US
241672012$24167201$2$F$20240101$20240805$20240802$20240808$EXP$$AU-ABBVIE-5864225$ABBVIE$$$$$M$Y$$$20240808$$CN$AU$AU
241672021$24167202$1$I$$20240730$20240802$20240802$PER$$US-HALEON-2190176$Haleon PLC$$$$$F$Y$$$20240802$$HP$US$US
241672041$24167204$1$I$$20240801$20240802$20240802$EXP$$FR-SANDOZ INC.-SDZ2024FR069847$SANDOZ$$57$YR$$F$Y$$$20240802$$HP$FR$FR
241672052$24167205$2$F$20240201$20240827$20240802$20240906$30DAY$$US-GSK-US2024092359$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240906$$HP$US$US
241672061$24167206$1$I$20240714$20240731$20240802$20240802$EXP$FR-AFSSAPS-LL2024001435$FR-GSK-FR2024095957$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$FR$FR
241672071$24167207$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190179$Haleon PLC$$77$YR$$M$Y$$$20240802$$CN$US$US
241672081$24167208$1$I$$20240801$20240802$20240802$PER$$US-BAYER-2024A111653$BAYER$$$$$$Y$$$20240802$$CN$US$US
241672091$24167209$1$I$$20240722$20240802$20240802$EXP$$US-AUROBINDO-AUR-APL-2024-038440$AUROBINDO$Neuwelt EA , Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al.. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors.. Neurooncol-Adv. 2022;4:No. 1$59$YR$$F$Y$$$20240802$$HP$US$US
241672102$24167210$2$F$$20240905$20240802$20240911$EXP$$JP-ABBVIE-5833961$ABBVIE$$70$YR$$F$Y$$$20240911$$PH$JP$JP
241672112$24167211$2$F$$20240821$20240802$20240821$PER$$US-ALXN-202407USA001954US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240821$$MD$US$US
241672121$24167212$1$I$20240701$20240731$20240802$20240802$EXP$FR-AFSSAPS-MA2024001219$FR-BAYER-2024A110637$BAYER$$46$YR$A$M$Y$$$20240802$$MD$FR$FR
241672131$24167213$1$I$$20240726$20240802$20240802$PER$$US-ABBVIE-5858268$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241672141$24167214$1$I$20240716$20240730$20240802$20240802$EXP$$US-ABBVIE-5861831$ABBVIE$$26$YR$$F$Y$$$20240802$$CN$US$US
241672151$24167215$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152161$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241672161$24167216$1$I$$20240730$20240802$20240802$EXP$$CN-AMGEN-CHNSP2024151553$AMGEN$Zeng H.; Wang Y.; Xue Y. et. al.. Treatment and outcomes of patients with B-ALL relapse after CD19 CAR-T therapy. Journal of Translational Medicine. 2024;22 (1):1-3$$$$$Y$$$20240802$$HP$CN$CN
241672182$24167218$2$F$20240901$20240910$20240802$20240913$EXP$$US-ABBVIE-5863591$ABBVIE$$64$YR$$M$Y$$$20240913$$CN$US$US
241672202$24167220$2$F$$20240727$20240802$20240806$PER$$US-ABBVIE-5859707$ABBVIE$$$$$$Y$$$20240806$$HP$US$US
241672211$24167221$1$I$$20240731$20240802$20240802$EXP$$CA-SANDOZ INC.-SDZ2023CA076645$SANDOZ$$$$$F$Y$$$20240802$$HP$CA$CA
241672221$24167222$1$I$20240420$20240726$20240802$20240802$EXP$$US-RECORDATI RARE DISEASE INC.-2024005785$RECORDATI$$$$$$Y$$$20240802$$CN$US$US
241672231$24167223$1$I$$20240725$20240802$20240802$EXP$$US-AMGEN-USASL2024151682$AMGEN$$73$YR$E$M$Y$$$20240802$$CN$US$US
241672241$24167224$1$I$$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024151158$AMGEN$$$$$$Y$$$20240802$$HP$US$US
241672261$24167226$1$I$20240801$20240801$20240801$20240801$DIR$712408$$FDA-CTU$$60$YR$$F$N$$$20240801$Y$$US$
241672271$24167227$1$I$$20240801$20240801$20240801$DIR$712433$$FDA-CTU$$$$$F$N$$$20240801$N$HP$US$
241672281$24167228$1$I$20240730$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152895$AMGEN$$73$YR$E$F$Y$$$20240802$$CN$US$US
241672291$24167229$1$I$$20240731$20240802$20240802$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004268$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240802$$CN$US$US
241672311$24167231$1$I$$20240729$20240802$20240802$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004236$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240802$$CN$US$US
241672321$24167232$1$I$$20240729$20240802$20240802$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004233$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240802$$CN$US$US
241672332$24167233$2$F$20240717$20240830$20240802$20240906$EXP$$IN-ROCHE-10000038431$ROCHE$$54$YR$A$M$Y$$$20240906$$MD$IN$IN
241672341$24167234$1$I$$20240726$20240802$20240802$PER$$US-ABBVIE-5857762$ABBVIE$$$$T$M$Y$$$20240802$$MD$US$US
241672351$24167235$1$I$20240612$20240614$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000763$ARBOR$$6$YR$$F$Y$$$20240802$$CN$US$US
241672361$24167236$1$I$20240425$20240515$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000576$ARBOR$$$$$$Y$$$20240802$$HP$US$US
241672371$24167237$1$I$20240412$20240627$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000824$ARBOR$$11$YR$$F$Y$$$20240802$$HP$US$US
241672381$24167238$1$I$20240530$20240530$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000687$ARBOR$$8$YR$$F$Y$$$20240802$$HP$US$US
241672391$24167239$1$I$20240522$20240522$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000647$ARBOR$$17$YR$$M$Y$$$20240802$$CN$US$US
241672401$24167240$1$I$20240514$20240514$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000605$ARBOR$$$$$$Y$$$20240802$$PH$US$US
241672411$24167241$1$I$$20240628$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000831$ARBOR$$$$$$Y$$$20240802$$HP$US$US
241672421$24167242$1$I$$20240611$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000727$ARBOR$$$$$F$Y$$$20240802$$HP$US$US
241672431$24167243$1$I$$20240510$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000579$ARBOR$$$$$$Y$$$20240802$$MD$US$US
241672441$24167244$1$I$$20240520$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000640$ARBOR$$$$$F$Y$$$20240802$$HP$US$US
241672451$24167245$1$I$20240614$20240614$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000770$ARBOR$$9$YR$$F$Y$$$20240802$$HP$US$US
241672461$24167246$1$I$20240425$20240515$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000577$ARBOR$$$$$$Y$$$20240802$$HP$US$US
241672471$24167247$1$I$20240612$20240618$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000782$ARBOR$$8$YR$$F$Y$$$20240802$$CN$US$US
241672481$24167248$1$I$20240513$20240516$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000606$ARBOR$$9$YR$$F$Y$$$20240802$$MD$US$US
241672491$24167249$1$I$20231211$20240522$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000616$ARBOR$$4$YR$$F$Y$$$20240802$$MD$US$US
241672501$24167250$1$I$20230101$20240530$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000686$ARBOR$$$$$F$Y$$$20240802$$CN$US$US
241672511$24167251$1$I$$20240517$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000631$ARBOR$$$$$M$Y$$$20240802$$HP$US$US
241672521$24167252$1$I$$20240528$20240802$20240802$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000670$ARBOR$$$$$M$Y$$$20240802$$CN$US$US
241672531$24167253$1$I$$20240731$20240802$20240802$EXP$$US-BAYER-2024A111570$BAYER$$$$$$Y$$$20240802$$CN$US$US
241672541$24167254$1$I$$20240731$20240802$20240802$PER$$US-DSJP-DSU-2024-138371$DAIICHI$$5$DEC$$F$Y$$$20240802$$HP$US$US
241672551$24167255$1$I$$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024151139$AMGEN$$67$YR$E$F$Y$$$20240802$$CN$US$US
241672561$24167256$1$I$20240730$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151612$AMGEN$$77$YR$E$F$Y$$$20240802$$CN$US$US
241672572$24167257$2$F$20240727$20240812$20240802$20240816$PER$$US-AMGEN-USASP2024151109$AMGEN$$29$YR$A$F$Y$77$KG$20240816$$PH$US$US
241672581$24167258$1$I$$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024151205$AMGEN$$$$$M$Y$$$20240802$$CN$US$US
241672592$24167259$2$F$20231026$20240726$20240802$20240809$EXP$$US-UCBSA-2023050628$UCB$$28$YR$$M$Y$$$20240809$$CN$US$US
241672601$24167260$1$I$$20240730$20240802$20240802$EXP$$NVSC2024US156728$NOVARTIS$$$$$$Y$$$20240802$$CN$US$US
241672611$24167261$1$I$$20240723$20240802$20240802$EXP$$CA-TEVA-VS-3225791$TEVA$$43$YR$$F$Y$68$KG$20240802$$HP$CA$CA
241672621$24167262$1$I$$20240726$20240802$20240802$EXP$$US-TAKEDA-2024TUS076857$TAKEDA$$67$YR$$M$Y$91$KG$20240802$$MD$US$US
241672631$24167263$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52945$$FDA-CTU$$57$YR$$F$N$125.65$KG$20240801$N$$US$
241672641$24167264$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52933$$FDA-CTU$$38$YR$$$N$$$20240801$N$$US$
241672653$24167265$3$F$20240628$20240724$20240802$20240805$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS003884$TERSERA THERAPEUTICS$$$$$$Y$$$20240805$$MD$CN$CN
241672661$24167266$1$I$$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460643$RANBAXY$$37$YR$$M$Y$$$20240802$$MD$FR$FR
241672671$24167267$1$I$20240718$20240719$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460959$RANBAXY$$34$YR$$F$Y$75$KG$20240802$$HP$GB$GB
241672681$24167268$1$I$20240422$20240719$20240802$20240802$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460641$RANBAXY$$54$YR$$M$Y$90$KG$20240802$$CN$FR$FR
241672691$24167269$1$I$$20240723$20240802$20240802$EXP$$TR-ELI_LILLY_AND_COMPANY-TR202407017441$ELI LILLY AND CO$Kubra Sezer Katar, Ayse Gokcen Gundogmus.Impulse Control Problems Following Bariatric Surgery and Extrapyramidal Adverse Effects with Fluoxetine: A Case Report.Sakarya Med J 2024;14(1):119-123.DOI:10.31832/smj.1218126$46$YR$A$F$Y$$$20240802$$HP$TR$TR
241672701$24167270$1$I$$20240719$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460729$RANBAXY$Greenfield MJ, Fobian AD, Fargason RE, Birur B. Optimizing outcomes when treating functional neurological disorder in acute care settings: case reports depicting the value of diagnostic precision and timely and appropriate psychological interventions using an interdisciplinary framework. Front Psychiatry. 2024;Jun 6; 15(0):1288828; 1-9$20$YR$$M$Y$$$20240802$$HP$US$US
241672711$24167271$1$I$$20240801$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408001105$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241672721$24167272$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000679$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240802$$CN$US$US
241672731$24167273$1$I$20240725$20240801$20240802$20240802$EXP$$US-BAUSCH-BL-2024-011757$BAUSCH AND LOMB$$58$YR$$M$Y$$$20240802$$CN$US$US
241672741$24167274$1$I$$20240729$20240802$20240802$EXP$$US-AGIOS-2407US03847$AGIOS PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241672751$24167275$1$I$$20240726$20240802$20240802$EXP$$JP-009507513-2407JPN016096$MERCK$$$$$F$Y$$$20240802$$CN$JP$JP
241672763$24167276$3$F$$20240813$20240802$20240823$EXP$HU-Merck Healthcare KGaA-2024040472$HU-EMD Serono-2024040472$EMD SERONO INC$Beres K, Ladanyi E. Metformin-associated lactic acidosis in our patient with chronic kidney disease. Hypertonia and Nephrology. 2024;28(3): 142-144. doi:https://doi.org/  10.33668/hn.28.$78$YR$E$M$Y$$$20240823$$MD$HU$HU
241672771$24167277$1$I$$20240728$20240802$20240802$EXP$$DE-TAKEDA-2024TUS064763$TAKEDA$$34$YR$$M$Y$$$20240802$$CN$DE$DE
241672783$24167278$3$F$20240626$20240906$20240802$20240911$30DAY$$US-AMGEN-USASP2024150552$AMGEN$$43$YR$A$F$Y$125.81$KG$20240911$$PH$US$US
241672793$24167279$3$F$20240717$20240924$20240802$20240930$EXP$$US-AMGEN-USASP2024150963$AMGEN$$67$YR$E$M$Y$$$20240930$$CN$US$US
241672806$24167280$6$F$20240724$20240820$20240802$20240826$30DAY$$US-AMGEN-USASP2024151637$AMGEN$$69$YR$E$M$Y$91.9$KG$20240826$$PH$US$US
241672811$24167281$1$I$$20240726$20240802$20240802$EXP$GB-MHRA-MIDB-88ccc8aa-0c4c-4276-81ff-b8ea67538fde$GB-TEVA-VS-3226478$TEVA$$79$YR$$$Y$$$20240802$$PH$GB$GB
241672821$24167282$1$I$20240101$20240731$20240802$20240802$EXP$$CA-UCBSA-2024038797$UCB$$$$$M$Y$$$20240802$$MD$CA$CA
241672833$24167283$3$F$20180201$20240813$20240802$20240827$EXP$$US-UCBSA-2024037012$UCB$$56$YR$$F$Y$$$20240827$$HP$US$US
241672841$24167284$1$I$20240101$20240726$20240802$20240802$PER$$US-UNITED THERAPEUTICS-UNT-2024-023208$UNITED THERAPEUTICS$$$$$$Y$$$20240802$$$US$US
241672863$24167286$3$F$20240916$20240916$20240802$20240923$EXP$$CA-TAKEDA-2024TUS077296$TAKEDA$$75$YR$$F$Y$73.3$KG$20240923$$CN$CA$CA
241672871$24167287$1$I$20240501$20240726$20240802$20240802$EXP$FR-AFSSAPS-GR2024000908$FR-TEVA-VS-3227207$TEVA$$41$YR$$M$Y$76$KG$20240802$$PH$FR$FR
241672881$24167288$1$I$20240723$20240730$20240802$20240802$EXP$GB-MHRA-MED-202407251256518390-GSFJZ$GB-BEH-2024176588$CSL BEHRING$$32$YR$A$F$Y$$$20240802$$HP$GB$GB
241672892$24167289$2$F$20240101$20240925$20240802$20240930$EXP$$CZ-REGENERON PHARMACEUTICALS, INC.-2024-105753$REGENERON$$70$YR$$M$Y$$$20240930$$CN$CZ$CZ
241672901$24167290$1$I$20240624$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A172461$ASTRAZENECA$$24924$DY$$F$Y$$$20240802$$CN$US$
241672911$24167291$1$I$$20240726$20240802$20240802$EXP$PL-URPL-1-3856-2020$PL-TEVA-VS-3227181$TEVA$$33$YR$$M$Y$100$KG$20240802$$MD$PL$PL
241672921$24167292$1$I$$20240801$20240802$20240802$PER$$NVSC2024US157947$NOVARTIS$$$$$$Y$$$20240802$$MD$US$US
241672931$24167293$1$I$$20240725$20240802$20240802$EXP$$JP-TAKEDA-2024TUS077152$TAKEDA$$$$$F$Y$$$20240802$$MD$JP$JP
241672942$24167294$2$F$$20240807$20240802$20240819$EXP$$JP-EMD Serono-2024040176$EMD SERONO INC$Takahashi Y, Nakano H, Motoki M, Wakimoto Y, Ikechi D, et al. Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review. Acute medicine and surgery. 2024 Jul 06;11(1): e981. doi:https://doi.org/10.1002/a ms2.981.$45$YR$A$F$Y$90$KG$20240819$$HP$JP$JP
241672951$24167295$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153134$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241672961$24167296$1$I$20240726$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024150412$AMGEN$$75$YR$E$F$Y$$$20240802$$CN$US$US
241672971$24167297$1$I$20240412$20240801$20240802$20240802$EXP$$FR-SANDOZ INC.-SDZ2024FR070018$SANDOZ$$68$YR$$F$Y$$$20240802$$PH$FR$FR
241672991$24167299$1$I$20240401$20240730$20240802$20240802$EXP$FR-AFSSAPS-SE2024000613$FR-RDY-SPO/FRA/24/0011222$DR REDDYS$$72$YR$E$M$Y$72$KG$20240802$$MD$FR$FR
241673002$24167300$2$F$$20240903$20240802$20240910$EXP$$CA-ROCHE-10000041236$ROCHE$$$$A$F$Y$$$20240910$$CN$CA$CA
241673013$24167301$3$F$20240713$20240902$20240802$20240904$EXP$$DK-BAYER-2024A112084$BAYER$$68$YR$E$$Y$$$20240904$$HP$DK$DK
241673021$24167302$1$I$$20240802$20240802$20240802$EXP$$AU-MYLANLABS-2024M1072038$MYLAN$$$$$M$Y$$$20240802$$PH$AU$AU
241673041$24167304$1$I$$20240724$20240802$20240802$EXP$$US-TEVA-VS-3225447$TEVA$$$$$$Y$$$20240802$$CN$US$US
241673051$24167305$1$I$20240722$20240731$20240802$20240802$EXP$$CA-UCBSA-2024037282$UCB$$84$YR$$F$Y$$$20240802$$CN$CA$CA
241673091$24167309$1$I$20240715$20240801$20240801$20240801$DIR$712416$$FDA-CTU$$46$YR$$F$N$68.9$KG$20240801$Y$PH$US$
241673101$24167310$1$I$20240730$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151379$AMGEN$$48$YR$A$M$Y$$$20240802$$CN$US$US
241673111$24167311$1$I$20240416$20240726$20240802$20240802$EXP$ES-AEMPS-1550302$ES-TEVA-VS-3226595$TEVA$$59$YR$$F$Y$$$20240802$$MD$ES$ES
241673131$24167313$1$I$20240606$20240730$20240802$20240802$EXP$FR-AFSSAPS-TO2024001133$FR-009507513-2406FRA010091$MERCK$$70$YR$$F$Y$$$20240802$$PH$FR$FR
241673141$24167314$1$I$20240101$20240726$20240802$20240802$EXP$$AR-JNJFOC-20240678909$JOHNSON AND JOHNSON$$77$YR$E$M$Y$80$KG$20240802$$CN$AR$AR
241673151$24167315$1$I$$20240726$20240802$20240802$EXP$$US-GILEAD-2024-0682196$GILEAD$$57$YR$A$F$Y$$$20240802$$HP$US$US
241673161$24167316$1$I$20240730$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152928$AMGEN$$33$YR$A$F$Y$$$20240802$$CN$US$US
241673171$24167317$1$I$$20240726$20240802$20240802$PER$$US-ABBVIE-5858252$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241673181$24167318$1$I$20231101$20231106$20240802$20240802$PER$$US-SOMERSET-2023-US-001540$ODIN PHARMACEUTICALS$$50$YR$$F$Y$$$20240802$$PH$US$US
241673191$24167319$1$I$20240701$20240726$20240802$20240802$PER$$US-ALXN-202407USA001922US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240802$$CN$US$US
241673201$24167320$1$I$$20240730$20240802$20240802$EXP$$CA-MYLANLABS-2024M1071339$MYLAN$$45$YR$$M$Y$150$KG$20240802$$PH$CA$CA
241673211$24167321$1$I$$20240727$20240802$20240802$EXP$GB-MHRA-MED-202407270735169410-MQLDJ$GB-TEVA-VS-3226967$TEVA$$67$YR$$F$Y$66$KG$20240802$$CN$GB$GB
241673222$24167322$2$F$$20240724$20240802$20240808$EXP$$US-APOTEX-2024AP008899$APOTEX$Abedrabo S, Rodriguez TE, Klein LM, Bitran J.. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142 (Suppl. 1):7078$$$A$$Y$$$20240808$$MD$US$US
241673231$24167323$1$I$$20240729$20240802$20240802$EXP$$US-ABBVIE-5860682$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241673241$24167324$1$I$$20240731$20240802$20240802$PER$$NVSC2024US158111$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241673251$24167325$1$I$$20240723$20240802$20240802$EXP$$US-EMD Serono-2024040139$EMD SERONO INC$Jain S, Sekhon S, Pradeep Chandran AL, Gummadi J, Patel P, Nakka R, et al. Metformin-Associated Lactic Acidosis in an Older Adult: A Case Report and Review. Cureus. 2024 Jun 19;16(6): 1-6. doi:10.7759/cureus.62729.$82$YR$E$M$Y$$$20240802$$HP$US$US
241673271$24167327$1$I$$20240726$20240802$20240802$PER$$US-BAYER-2024A109423$BAYER$$$$$M$Y$$$20240802$$HP$US$US
241673291$24167329$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122575$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241673301$24167330$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122596$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241673311$24167331$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122064$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240802$$CN$US$US
241673321$24167332$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122595$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241673331$24167333$1$I$$20240731$20240802$20240802$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012608$VERTEX$$$$A$F$Y$$$20240802$$CN$GB$GB
241673341$24167334$1$I$20240101$20240801$20240802$20240802$EXP$$CO-VERTEX PHARMACEUTICALS-2024-012658$VERTEX$$17$YR$$F$Y$$$20240802$$HP$CO$CO
241673355$24167335$5$F$20231101$20240916$20240802$20240920$PER$$US-VERTEX PHARMACEUTICALS-2024-012180$VERTEX$$$$$$Y$$$20240920$$CN$US$US
241673361$24167336$1$I$20240101$20240726$20240802$20240802$PER$$US-VERTEX PHARMACEUTICALS-2024-012405$VERTEX$$7$YR$$F$Y$$$20240802$$HP$US$US
241673371$24167337$1$I$$20240730$20240802$20240802$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012560$VERTEX$$$$$M$Y$$$20240802$$CN$GB$GB
241673381$24167338$1$I$$20240726$20240802$20240802$PER$$US-VERTEX PHARMACEUTICALS-2024-012406$VERTEX$$$$C$F$Y$$$20240802$$MD$US$US
241673391$24167339$1$I$20240701$20240726$20240802$20240802$EXP$$US-SA-2024SA227548$SANOFI AVENTIS$$73$YR$E$M$Y$108.84$KG$20240802$$MD$US$US
241673401$24167340$1$I$20240701$20240718$20240802$20240802$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0765$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240801$$HP$US$US
241673411$24167341$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190237$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241673421$24167342$1$I$20240601$20240719$20240802$20240802$EXP$$US-UCBSA-2024037225$UCB$$65$YR$$F$Y$$$20240802$$HP$US$US
241673431$24167343$1$I$20240101$20240730$20240802$20240802$EXP$$US-Indivior Limited-INDV-146226-2024$RECKITT BENCKISER$$$$$$Y$$$20240802$$HP$US$US
241673441$24167344$1$I$20240101$20240724$20240802$20240802$PER$$US-MYLANLABS-2024M1069889$MYLAN$$$$$F$Y$$$20240802$$CN$US$US
241673451$24167345$1$I$20240724$20240726$20240802$20240802$PER$$US-RDY-SPO/USA/24/0011138$DR REDDYS$$$$$F$Y$$$20240802$$CN$US$US
241673462$24167346$2$F$$20240819$20240802$20240826$30DAY$$BE-JNJFOC-20240779574$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$PH$BE$BE
241673471$24167347$1$I$20170501$20240723$20240802$20240802$EXP$$ES-JNJFOC-20240767614$JOHNSON AND JOHNSON$$98$YR$E$F$Y$75.3$KG$20240802$$MD$ES$ES
241673481$24167348$1$I$20240729$20240726$20240802$20240802$PER$$US-RDY-SPO/USA/24/0011139$DR REDDYS$$65$YR$E$F$Y$$$20240802$$HP$US$US
241673501$24167350$1$I$$20240722$20240802$20240802$EXP$$US-BAYER-2024A106903$BAYER$$53$YR$A$F$Y$$$20240802$$CN$US$US
241673511$24167351$1$I$20240730$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152237$AMGEN$$80$YR$E$F$Y$$$20240802$$CN$US$US
241673521$24167352$1$I$$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024151700$AMGEN$$$$A$$Y$$$20240802$$HP$US$US
241673531$24167353$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152827$AMGEN$$$$$F$Y$$$20240802$$CN$US$US
241673541$24167354$1$I$$20240722$20240802$20240802$PER$$AU-Eisai-EC-2023-154137$EISAI$Causer A, Tan X, Moseley P, Teoh S, Molotkov N. Deepspatial-omics analysis of Head  Neck carcinomas provides alternative therapeutic targets and rationale for treatment failure. NPJ-Precis-Oncol. 2023;(No 1):$60$YR$A$M$Y$$$20240802$$MD$AU$AU
241673554$24167355$4$F$$20240918$20240802$20240920$EXP$$US-TAKEDA-2024TUS076731$TAKEDA$$$$$M$Y$$$20240920$$CN$US$US
241673561$24167356$1$I$20240701$20240730$20240802$20240802$EXP$$CN-ABBVIE-5861080$ABBVIE$$48$YR$$F$Y$45$KG$20240802$$MD$CN$CN
241673571$24167357$1$I$$20240729$20240802$20240802$EXP$$ZA-ROCHE-10000041625$ROCHE$$44$YR$A$M$Y$$$20240802$$CN$ZA$ZA
241673583$24167358$3$F$$20240926$20240802$20240927$EXP$$NVSC2022TH284445$NOVARTIS$$$$$F$Y$$$20240927$$CN$TH$TH
241673591$24167359$1$I$$20240725$20240802$20240802$PER$$US-ABBVIE-5856233$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241673601$24167360$1$I$20240101$20240729$20240802$20240802$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-087867$REGENERON$$$$$F$Y$$$20240802$$CN$US$US
241673611$24167361$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122221$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240802$$HP$US$US
241673631$24167363$1$I$20240301$20240722$20240802$20240802$EXP$GB-MHRA-MED-202407191750325460-LJVQW$GB-LUPIN PHARMACEUTICALS INC.-2024-07072$LUPIN$$$$$M$Y$$$20240802$$MD$GB$GB
241673641$24167364$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122597$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240802$$HP$US$US
241673651$24167365$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122207$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240802$$CN$US$US
241673661$24167366$1$I$20230101$20240726$20240802$20240802$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-119907$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240802$$MD$CZ$CZ
241673671$24167367$1$I$20190821$20240722$20240802$20240802$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117105$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$23.36$KG$20240802$$MD$KR$KR
241673681$24167368$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122503$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240802$$HP$US$US
241673692$24167369$2$F$$20240801$20240802$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000546$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240805$$CN$US$US
241673701$24167370$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408001006$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240802$$CN$US$US
241673711$24167371$1$I$$20240727$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004602$STEMLINE THERAPEUTICS$$66$YR$E$F$Y$$$20240801$$CN$US$US
241673721$24167372$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122609$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$M$Y$$$20240802$$HP$US$US
241673731$24167373$1$I$20240701$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019723$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240802$$CN$US$US
241673741$24167374$1$I$$20240726$20240802$20240802$PER$$US-ALXN-202407USA001912US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240802$$CN$US$US
241673751$24167375$1$I$$20240729$20240802$20240802$EXP$$US-JNJFOC-20240777274$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$CN$US$US
241673762$24167376$2$F$$20240814$20240802$20240816$EXP$$US-UCBSA-2024038839$UCB$$$$$F$Y$$$20240816$$CN$US$US
241673771$24167377$1$I$20240511$20240801$20240801$20240801$DIR$712427$$FDA-CTU$$39$YR$$F$N$51.3$KG$20240801$N$CN$US$
241673782$24167378$2$F$20240725$20240730$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004615$STEMLINE THERAPEUTICS$$77$YR$E$F$Y$$$20240802$$HP$US$US
241673791$24167379$1$I$20190125$20240729$20240802$20240802$EXP$GB-MHRA-MED-202407291532105780-DYJFP$GB-SA-2024SA224940$SANOFI AVENTIS$$30$YR$A$F$Y$99$KG$20240802$$CN$GB$GB
241673801$24167380$1$I$$20240729$20240802$20240802$PER$$US-JNJFOC-20240779073$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241673811$24167381$1$I$$20240719$20240802$20240802$EXP$$PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460619$RANBAXY$Zulfiqar A, Irfan R, Hanif F, Usman J. Usual presentation of an unusual pathogen ? Cryptococcus laurentii meningitis: a case report. J Pak Med Assoc. 2023;73:2100-2102$40$YR$$M$Y$$$20240802$$HP$PK$PK
241673821$24167382$1$I$$20240729$20240802$20240802$EXP$$JP-GENMAB-2024-02732$GENMAB$$8$DEC$$F$Y$$$20240802$$MD$JP$JP
241673831$24167383$1$I$20240710$20240718$20240802$20240802$PER$$US-IMP-2024000522$Harrow Health$$80$YR$E$F$Y$$$20240802$$CN$US$US
241673842$24167384$2$F$$20240812$20240802$20240819$EXP$$US-BAYER-2024A107034$BAYER$$59$YR$A$M$Y$$$20240819$$CN$US$US
241673852$24167385$2$F$20240101$20240731$20240802$20240809$PER$$US-AMGEN-USASP2024152854$AMGEN$$81$YR$E$F$Y$$$20240809$$MD$US$US
241673861$24167386$1$I$20240729$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151312$AMGEN$$64$YR$A$F$Y$$$20240802$$CN$US$US
241673871$24167387$1$I$20240730$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151934$AMGEN$$78$YR$E$F$Y$$$20240802$$CN$US$US
241673881$24167388$1$I$$20240801$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US070116$SANDOZ$$$$$F$Y$$$20240802$$CN$US$US
241673891$24167389$1$I$$20240730$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004670$STEMLINE THERAPEUTICS$$60$YR$A$F$Y$$$20240801$$CN$US$US
241673902$24167390$2$F$20240708$20240828$20240802$20240923$30DAY$$US-Kaleo, Inc.-2024KL000020$KALEO$$7$YR$C$M$Y$$$20240920$$CN$US$US
241673911$24167391$1$I$$20240730$20240802$20240802$EXP$GB-MHRA-31193571$GB-MYLANLABS-2024M1071596$MYLAN$$$$$M$Y$$$20240802$$CN$GB$GB
241673921$24167392$1$I$$20240726$20240802$20240802$EXP$GB-MHRA-MIDB-2febd9d7-3b66-453e-bebb-fba455297ab9$GB-TORRENT-00037416$TORRENT$$85$YR$E$F$Y$$$20240802$$PH$GB$GB
241673931$24167393$1$I$$20240730$20240802$20240802$EXP$$US-SA-2024SA174332$SANOFI AVENTIS$$76$YR$E$F$Y$50.802$KG$20240802$$MD$US$US
241673941$24167394$1$I$$20240730$20240802$20240802$EXP$$FR-MYLANLABS-2024M1071665$MYLAN$$77$YR$$M$Y$$$20240802$$CN$FR$FR
241673951$24167395$1$I$$20240730$20240802$20240802$EXP$$FR-MYLANLABS-2024M1071482$MYLAN$$87$YR$$M$Y$$$20240802$$PH$FR$FR
241673961$24167396$1$I$20240514$20240730$20240802$20240802$EXP$$DE-MYLANLABS-2024M1070921$MYLAN$$53$YR$$F$Y$$$20240802$$MD$DE$DE
241673971$24167397$1$I$20240727$20240730$20240802$20240802$EXP$GB-MHRA-MED-202407302037241980-FZTHB$GB-MYLANLABS-2024M1071213$MYLAN$$15$YR$$F$Y$$$20240802$$CN$GB$GB
241673981$24167398$1$I$20240701$20240730$20240802$20240802$EXP$FR-AFSSAPS-GR2024000930$FR-MYLANLABS-2024M1070767$MYLAN$$74$YR$$F$Y$$$20240802$$PH$FR$FR
241674001$24167400$1$I$$20240730$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004650$STEMLINE THERAPEUTICS$$53$YR$A$F$Y$$$20240801$$CN$US$US
241674012$24167401$2$F$$20240725$20240802$20240802$EXP$$US-ORG100014127-2024000219$HRA PHARMA$$52$YR$$M$Y$$$20240802$$HP$US$US
241674022$24167402$2$F$20240525$20240722$20240802$20240807$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004438$BLUEPRINT MEDICINES$$$$$$Y$$$20240801$$MD$US$US
241674041$24167404$1$I$$20240801$20240801$20240801$DIR$712435$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241674071$24167407$1$I$$20240729$20240802$20240802$EXP$$US-ABBVIE-5862624$ABBVIE$$$$$F$Y$$$20240802$$HP$US$US
241674083$24167408$3$F$20240725$20240912$20240802$20240917$EXP$$IN-VANTIVE-2024VAN018670$Vantive US Healthcare$$16$YR$$M$Y$$$20240917$$CN$IN$IN
241674091$24167409$1$I$$20240726$20240802$20240802$EXP$$US-VANTIVE-2024VAN018698$Vantive US Healthcare$$$$$F$Y$$$20240802$$HP$US$US
241674101$24167410$1$I$$20240729$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004623$STEMLINE THERAPEUTICS$$79$YR$E$F$Y$$$20240801$$CN$US$US
241674111$24167411$1$I$$20240611$20240802$20240802$EXP$$AR-SANDOZ INC.-SDZ2024AR070022$SANDOZ$$11$YR$$M$Y$35$KG$20240802$$CN$AR$AR
241674132$24167413$2$F$20220101$20240922$20240802$20240923$EXP$$US-PFIZER INC-202400227159$PFIZER$$65$YR$$M$Y$$$20240923$$CN$US$US
241674146$24167414$6$F$20100101$20240829$20240802$20240903$EXP$$US-PFIZER INC-202400227729$PFIZER$$53$YR$$F$Y$99.79$KG$20240903$$HP$US$US
241674152$24167415$2$F$$20240922$20240802$20240923$EXP$$US-PFIZER INC-202400196590$PFIZER$$39$YR$$M$Y$$$20240923$$MD$US$US
241674171$24167417$1$I$20231101$20231106$20240802$20240802$PER$$US-SOMERSET-2023-US-001543$ODIN PHARMACEUTICALS$$54$YR$$M$Y$$$20240802$$PH$US$US
241674181$24167418$1$I$$20240729$20240802$20240802$PER$$US-Stemline Therapeutics, Inc.-2024ST004621$STEMLINE THERAPEUTICS$$71$YR$E$F$Y$$$20240801$$CN$US$US
241674191$24167419$1$I$$20240731$20240802$20240802$EXP$$US-GILEAD-2024-0682693$GILEAD$$$$A$F$Y$$$20240802$$CN$US$US
241674201$24167420$1$I$20240718$20240729$20240802$20240802$EXP$IT-MINISAL02-996104$IT-MYLANLABS-2024M1070699$MYLAN$$35$YR$$M$Y$$$20240802$$MD$IT$IT
241674211$24167421$1$I$$20240724$20240802$20240802$PER$$US-MYLANLABS-2024M1069121$MYLAN$$$$$$Y$$$20240802$$CN$US$US
241674221$24167422$1$I$20240610$20240730$20240802$20240802$EXP$HR-HALMED-300086078$HR-HALEON-2190018$Haleon PLC$$22$YR$$M$Y$$$20240802$$MD$HR$HR
241674231$24167423$1$I$20240401$20240729$20240802$20240802$EXP$$DE-ROCHE-10000044428$ROCHE$$53$YR$A$F$Y$73$KG$20240802$$MD$DE$DE
241674243$24167424$3$F$$20240806$20240802$20240807$EXP$$CA-ROCHE-10000041957$ROCHE$$$$A$M$Y$$$20240807$$CN$CA$CA
241674251$24167425$1$I$20240719$20240725$20240802$20240802$EXP$$IT-Stemline Therapeutics, Inc.-2024ST004567$STEMLINE THERAPEUTICS$$80$YR$E$F$Y$60$KG$20240801$$MD$IT$IT
241674261$24167426$1$I$$20240730$20240802$20240802$EXP$$US-ABBVIE-5862395$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241674271$24167427$1$I$$20240729$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004625$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240801$$CN$US$US
241674281$24167428$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52921$$FDA-CTU$$65$YR$$F$N$$$20240801$N$$US$
241674301$24167430$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52938$$FDA-CTU$$60$YR$$F$N$72.57$KG$20240801$N$$US$
241674311$24167431$1$I$20230214$20240731$20240802$20240802$EXP$$US-ROCHE-10000046042$ROCHE$$61$YR$A$F$Y$$$20240802$$CN$US$US
241674321$24167432$1$I$20240717$20240731$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004683$STEMLINE THERAPEUTICS$$75$YR$E$F$Y$$$20240801$$HP$US$US
241674333$24167433$3$F$20240724$20240924$20240802$20240926$PER$$US-AMGEN-USASP2024151148$AMGEN$$74$YR$E$F$Y$$$20240926$$CN$US$US
241674341$24167434$1$I$$20240801$20240802$20240802$PER$$US-AMGEN-USASP2024153579$AMGEN$$$$A$M$Y$$$20240802$$CN$US$US
241674351$24167435$1$I$$20240729$20240802$20240802$EXP$$JP-AMGEN-JPNSP2024150115$AMGEN$$$$$$Y$$$20240802$$PH$JP$JP
241674361$24167436$1$I$$20240730$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004669$STEMLINE THERAPEUTICS$$46$YR$A$F$Y$$$20240801$$CN$US$US
241674371$24167437$1$I$$20240728$20240802$20240802$EXP$$VN-AstraZeneca-2024A173710$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$VN$
241674385$24167438$5$F$20240311$20240910$20240802$20240911$EXP$$JP-PFIZER INC-PV202400099738$PFIZER$$8$YR$$M$Y$24$KG$20240911$$MD$JP$JP
241674391$24167439$1$I$20200101$20240423$20240802$20240802$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS006099$AKCEA THERAPEUTICS$$$$$$Y$$$20240801$$HP$US$US
241674401$24167440$1$I$$20240729$20240802$20240802$EXP$$JP-PFIZER INC-202400227084$PFIZER$Nemoto, N.. Two cases of pseudocirrhosis caused by drug therapy for metastases to liver from breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:531$59$YR$$F$Y$$$20240802$$HP$JP$JP
241674412$24167441$2$F$20240701$20240922$20240802$20240923$EXP$$CA-PFIZER INC-PV202400097326$PFIZER$$87$YR$$M$Y$$$20240923$$HP$CA$CA
241674421$24167442$1$I$$20240724$20240802$20240802$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05114$LUPIN$$$$$$Y$$$20240802$$CN$US$US
241674432$24167443$2$F$20240731$20240801$20240802$20240808$EXP$$US-EXELIXIS-CABO-24080109$EXELIXIS$$71$YR$$M$Y$89.81$KG$20240808$$CN$US$US
241674441$24167444$1$I$$20240729$20240802$20240802$EXP$$IT-PFIZER INC-202400225709$PFIZER$Musone, D.. Therapeutic plasmapheresis in idiopathic membranous nephropathy anti-PLA2R-related: A case series. J Clin Apher. 2024;39(3):e22134$69$YR$$M$Y$$$20240802$$HP$IT$IT
241674452$24167445$2$F$20240710$20240806$20240802$20240815$EXP$$GB-EXELIXIS-CABO-24080129$EXELIXIS$$10$YR$$F$Y$28.5$KG$20240815$$HP$GB$GB
241674461$24167446$1$I$$20240730$20240802$20240802$PER$$US-TAKEDA-2024TUS076972$TAKEDA$$$$$F$Y$91$KG$20240802$$MD$US$US
241674471$24167447$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152710$AMGEN$$$$$M$Y$$$20240802$$CN$US$US
241674481$24167448$1$I$20240611$20240730$20240802$20240802$EXP$FR-AFSSAPS-DJ2024000859$FR-MYLANLABS-2024M1071342$MYLAN$$23$YR$$M$Y$$$20240802$$PH$FR$FR
241674491$24167449$1$I$$20240730$20240802$20240802$PER$$US-ROCHE-10000044364$ROCHE$$41$YR$A$M$Y$$$20240802$$HP$US$US
241674501$24167450$1$I$$20240731$20240802$20240802$PER$$NVSC2024US157367$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241674511$24167451$1$I$$20240724$20240802$20240802$PER$$US-TAKEDA-2024TUS075459$TAKEDA$$$$$F$Y$$$20240802$$CN$US$US
241674521$24167452$1$I$20240610$20240726$20240802$20240802$EXP$ES-AEMPS-1550297$ES-TEVA-VS-3226870$TEVA$$82$YR$$F$Y$$$20240802$$MD$ES$ES
241674532$24167453$2$F$$20240719$20240802$20240902$PER$$US-TEVA-VS-3224974$TEVA$$49$YR$$F$Y$$$20240902$$HP$US$US
241674541$24167454$1$I$$20240703$20240802$20240802$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06644$LUPIN$$$$$$Y$$$20240802$$CN$US$US
241674561$24167456$1$I$20240701$20240731$20240802$20240802$PER$$US-GRUNENTHAL-2024-123220$AVERITAS$$$$A$F$Y$$$20240801$$HP$US$US
241674571$24167457$1$I$$20240801$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122673$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240802$$CN$US$US
241674583$24167458$3$F$20201201$20240919$20240802$20240923$EXP$$US-ROCHE-10000045834$ROCHE$$53$YR$A$F$Y$81.64$KG$20240923$$CN$US$US
241674591$24167459$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122566$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240802$$CN$US$US
241674601$24167460$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122587$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$M$Y$$$20240802$$HP$US$US
241674611$24167461$1$I$20240729$20240801$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122594$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240802$$CN$US$US
241674621$24167462$1$I$$20240725$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122257$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$75.3$KG$20240802$$HP$US$US
241674632$24167463$2$F$20240708$20240815$20240802$20240819$EXP$$US-UCBSA-2024035801$UCB$$66$YR$$M$Y$$$20240819$$CN$US$US
241674641$24167464$1$I$$20240731$20240802$20240802$PER$$NVSC2024US158122$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241674651$24167465$1$I$$20240719$20240802$20240802$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700042$UPSHER SMITH LABORATORIES$$$$$$Y$$$20240801$$MD$US$US
241674661$24167466$1$I$20240724$20240726$20240802$20240802$PER$$FR-BRACCO-2024FR04629$BRACCO$$$$$M$Y$$$20240802$$PH$FR$FR
241674671$24167467$1$I$20240701$20240725$20240802$20240802$EXP$$US-RECORDATI-2024005838$RECORDATI$$$$$$Y$$$20240802$$CN$US$US
241674681$24167468$1$I$20240619$20240726$20240802$20240802$EXP$FR-AFSSAPS-NT2024000854$FR-TEVA-VS-3226830$TEVA$$84$YR$$F$Y$57.9$KG$20240802$$MD$FR$FR
241674691$24167469$1$I$20240726$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52969$$FDA-CTU$$66$YR$$$N$$$20240801$N$$US$
241674701$24167470$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52954$$FDA-CTU$$80$YR$$F$N$$$20240801$N$$US$
241674721$24167472$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52973$$FDA-CTU$$78$YR$$M$N$$$20240801$N$$US$
241674741$24167474$1$I$20240601$20240726$20240802$20240802$EXP$FR-AFSSAPS-GR2024000910$FR-TEVA-VS-3226667$TEVA$$88$YR$$F$Y$$$20240802$$PH$FR$FR
241674751$24167475$1$I$$20240724$20240802$20240802$PER$$US-TAKEDA-2024TUS075452$TAKEDA$$$$$F$Y$$$20240802$$CN$US$US
241674761$24167476$1$I$$20240726$20240802$20240802$EXP$$CA-EMD Serono-2024040839$EMD SERONO INC$$9$DEC$E$M$Y$$$20240802$$HP$CA$CA
241674771$24167477$1$I$$20240729$20240802$20240802$EXP$$CO-JNJFOC-20240784260$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$MD$CO$CO
241674781$24167478$1$I$$20240723$20240802$20240802$PER$$US-ABBVIE-5857402$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241674791$24167479$1$I$$20240723$20240802$20240802$EXP$$JP-009507513-2401JPN005339J$MERCK$$65$YR$$F$Y$$$20240802$$MD$JP$JP
241674811$24167481$1$I$$20240703$20240802$20240802$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06932$LUPIN$$$$$$Y$$$20240802$$CN$US$US
241674831$24167483$1$I$20240101$20240725$20240802$20240802$PER$$US-AMGEN-USASP2024148990$AMGEN$$65$YR$E$F$Y$$$20240802$$CN$US$US
241674842$24167484$2$F$20240101$20240806$20240802$20240811$PER$$US-AMGEN-USASP2024152218$AMGEN$$78$YR$E$F$Y$$$20240811$$CN$US$US
241674851$24167485$1$I$$20240726$20240802$20240802$EXP$$US-BAYER-2024A111001$BAYER$$$$$$Y$$$20240802$$CN$US$US
241674861$24167486$1$I$$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52968$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
241674871$24167487$1$I$$20240726$20240802$20240802$PER$$US-ALXN-202407USA001910US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241674881$24167488$1$I$$20240731$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121536$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240802$$CN$US$US
241674891$24167489$1$I$$20240730$20240802$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121152$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240802$$MD$JP$JP
241674901$24167490$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52951$$FDA-CTU$$$$$F$N$$$20240801$N$HP$US$
241674911$24167491$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122222$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240802$$CN$US$US
241674921$24167492$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122320$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$64.41$KG$20240802$$CN$US$US
241674931$24167493$1$I$20230901$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52923$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
241674941$24167494$1$I$20240701$20240724$20240802$20240802$EXP$$US-TEVA-VS-3225394$TEVA$$97$YR$$F$Y$49.9$KG$20240802$$CN$US$US
241674951$24167495$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408001032$ELI LILLY AND CO$$90$YR$E$F$Y$$$20240802$$CN$US$US
241674961$24167496$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046607$ROCHE$$$$$F$Y$$$20240802$$CN$US$US
241674971$24167497$1$I$20231120$20231127$20240802$20240802$PER$$US-SOMERSET-2023-US-001603$ODIN PHARMACEUTICALS$$77$YR$$F$Y$$$20240802$$CN$US$US
241674981$24167498$1$I$$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52929$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
241674991$24167499$1$I$$20240724$20240802$20240802$EXP$$US-CIVICARX-2024-US-040303$CIVICA$Kraus M, Nguyen J.Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A case report.Case Reports in Neurology.2024;16(1):142-147.$38$YR$$F$Y$$$20240802$$HP$US$US
241675002$24167500$2$F$20220112$20240829$20240802$20240910$EXP$$JP-UCBSA-2024037296$UCB$$8$DEC$$M$Y$$$20240910$$MD$JP$JP
241675023$24167502$3$F$$20240913$20240802$20240927$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07507$LUPIN$$$$$$Y$$$20240927$$HP$US$US
241675031$24167503$1$I$20240101$20240722$20240802$20240802$PER$$US-AMGEN-USASP2024145419$AMGEN$$$$$F$Y$$$20240802$$HP$US$US
241675041$24167504$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046471$ROCHE$$$$$F$Y$$$20240802$$CN$US$US
241675051$24167505$1$I$$20240731$20240802$20240802$PER$$NVSC2024US158130$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241675061$24167506$1$I$20240702$20240801$20240802$20240802$EXP$$CN-BAYER-2024A111906$BAYER$$62$YR$A$M$Y$$$20240802$$HP$CN$CN
241675071$24167507$1$I$20240321$20240801$20240802$20240802$EXP$$GB-SANDOZ INC.-SDZ2024GB069950$SANDOZ$$70$YR$$F$Y$82$KG$20240802$$PH$GB$GB
241675081$24167508$1$I$$20240724$20240802$20240802$PER$$US-TAKEDA-2024TUS075349$TAKEDA$$$$$F$Y$84.4$KG$20240802$$MD$US$US
241675091$24167509$1$I$$20240730$20240802$20240802$EXP$$US-MYLANLABS-2024M1071780$MYLAN$Zhang X, Aoun B. A deadly form of delirium. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl.) 373 abstr. #34.$62$YR$$F$Y$$$20240802$$HP$US$US
241675101$24167510$1$I$$20240703$20240802$20240802$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06864$LUPIN$$$$$$Y$$$20240802$$CN$US$US
241675112$24167511$2$F$20240712$20240801$20240802$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121610$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240807$$PH$US$US
241675121$24167512$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A171076$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241675131$24167513$1$I$20240717$20240729$20240802$20240802$EXP$$US-AstraZeneca-2024A172419$ASTRAZENECA$$35415$DY$$M$Y$$$20240802$$CN$US$
241675141$24167514$1$I$$20240730$20240802$20240802$EXP$$AU-MYLANLABS-2024M1071637$MYLAN$Liang I, Berglund LJ, Brown DA, Suan D, Meybodi F, Lee AYS, et al. Granulomatous mastitis and immunosuppression: Case series at an Australian quaternary referral center. Int-J-Rheum-Diseases 2024; 27 (1):.$$$$F$Y$$$20240802$$HP$AU$AU
241675151$24167515$1$I$$20240724$20240802$20240802$EXP$$US-ORG100014127-2024000212$HRA PHARMA$Spaniol A, Mulla BM, Daily JG et al. Carney complex: a rare cause of Cushing syndrome in pregnancy. Obstetr Gynecol. 2014; 124: 426?428.$24$YR$$F$Y$$$20240802$$MD$US$US
241675161$24167516$1$I$$20240726$20240802$20240802$EXP$$VN-AstraZeneca-2024A173540$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$VN$
241675171$24167517$1$I$20240722$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173436$ASTRAZENECA$$28361$DY$$M$Y$$$20240802$$CN$US$
241675181$24167518$1$I$20240730$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152677$AMGEN$$67$YR$E$F$Y$$$20240802$$CN$US$US
241675191$24167519$1$I$20240503$20240717$20240802$20240802$PER$$US-Vifor (International) Inc.-VIT-2024-06473$VIFOR$$65$YR$$F$Y$57$KG$20240802$$HP$US$US
241675201$24167520$1$I$20240617$20240717$20240802$20240802$PER$$US-Vifor (International) Inc.-VIT-2024-06480$VIFOR$$62$YR$$F$Y$73$KG$20240802$$HP$US$US
241675211$24167521$1$I$20240601$20240725$20240802$20240802$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00276$PRINSTON PHARMACEUTICAL$$85$YR$$M$Y$62.132$KG$20240802$$CN$US$US
241675221$24167522$1$I$20240614$20240717$20240802$20240802$PER$$US-Vifor (International) Inc.-VIT-2024-06482$VIFOR$$72$YR$$M$Y$99$KG$20240802$$HP$US$US
241675232$24167523$2$F$20240625$20240813$20240802$20240911$PER$$US-Vifor (International) Inc.-VIT-2024-06481$VIFOR$$48$YR$$F$Y$103$KG$20240911$$HP$US$US
241675241$24167524$1$I$20240622$20240717$20240802$20240802$PER$$US-Vifor (International) Inc.-VIT-2024-06483$VIFOR$$75$YR$$F$Y$92.5$KG$20240802$$HP$US$US
241675251$24167525$1$I$20240729$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152090$AMGEN$$59$YR$A$F$Y$$$20240802$$CN$US$US
241675261$24167526$1$I$20240610$20240729$20240802$20240802$EXP$FR-AFSSAPS-AVLY2024000105$FR-MYLANLABS-2024M1070752$MYLAN$$15$YR$$F$Y$$$20240802$$MD$FR$FR
241675282$24167528$2$F$20240701$20240924$20240802$20240927$EXP$$JP-Eisai-EC-2024-171086$EISAI$$65$YR$E$F$Y$$$20240927$$MD$JP$JP
241675291$24167529$1$I$$20240715$20240802$20240802$PER$$US-Vifor (International) Inc.-VIT-2024-06316$VIFOR$$39$YR$$F$Y$$$20240802$$HP$US$US
241675301$24167530$1$I$20230429$20240731$20240802$20240802$EXP$$US-GILEAD-2024-0672300$GILEAD$$30$YR$A$F$Y$$$20240802$$HP$US$US
241675311$24167531$1$I$$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52947$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
241675321$24167532$1$I$20240716$20240801$20240801$20240801$DIR$712418$$FDA-CTU$$51$YR$$M$N$$$20240801$N$PH$US$
241675341$24167534$1$I$20240712$20240801$20240801$20240801$DIR$712402$$FDA-CTU$$47$YR$$F$N$52.2$KG$20240801$N$CN$US$
241675351$24167535$1$I$20240626$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52974$$FDA-CTU$$71$YR$$F$N$$$20240801$Y$PH$US$
241675361$24167536$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52958$$FDA-CTU$$61$YR$$F$N$$$20240801$N$$US$
241675381$24167538$1$I$$20240801$20240801$20240801$DIR$712439$$FDA-CTU$$$$$UNK$N$$$20240801$$CN$US$
241675391$24167539$1$I$$20240801$20240801$20240801$DIR$712440$$FDA-CTU$$$$$UNK$N$$$20240801$$CN$US$
241675411$24167541$1$I$20240729$20240731$20240802$20240802$EXP$$KR-VANTIVE-2024VAN018770$Vantive US Healthcare$$58$YR$$M$Y$$$20240802$$CN$KR$KR
241675421$24167542$1$I$20240725$20240730$20240802$20240802$PER$$US-TAKEDA-2024TUS077237$TAKEDA$$$$$F$Y$$$20240802$$MD$US$US
241675431$24167543$1$I$20240717$20240725$20240802$20240802$PER$$US-BAYER-2024A108615$BAYER$$49$YR$A$F$Y$$$20240802$$CN$US$US
241675441$24167544$1$I$$20240726$20240802$20240802$EXP$$US-OTSUKA-2024_020950$OTSUKA$$$$$M$Y$$$20240802$$CN$US$US
241675451$24167545$1$I$$20240725$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119918$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240802$$CN$US$US
241675461$24167546$1$I$20240721$20240723$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117393$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240802$$HP$US$US
241675471$24167547$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122588$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$M$Y$$$20240802$$HP$US$US
241675481$24167548$1$I$20240701$20240730$20240802$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121865$BRISTOL MYERS SQUIBB$$6$DEC$A$F$Y$$$20240802$$MD$JP$JP
241675491$24167549$1$I$$20240731$20240802$20240802$EXP$$US-ROCHE-10000047001$ROCHE$$48$YR$A$F$Y$$$20240802$$HP$US$US
241675501$24167550$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046213$ROCHE$$$$$$Y$$$20240802$$CN$US$US
241675511$24167551$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046495$ROCHE$$$$$$Y$$$20240802$$CN$US$US
241675521$24167552$1$I$$20240802$20240802$20240802$EXP$PL-URPL-1-1983-2020$NVSC2024PL157889$NOVARTIS$$31$YR$$F$Y$93$KG$20240802$$MD$PL$PL
241675531$24167553$1$I$$20240724$20240802$20240802$PER$$US-BAYER-2024A111205$BAYER$$$$$$Y$$$20240802$$CN$US$US
241675541$24167554$1$I$20240723$20240725$20240802$20240802$EXP$$DE-CISBIO-2024000490$CURIUM PHARMACEUTICALS$$61$YR$$F$Y$$$20240802$$MD$DE$DE
241675551$24167555$1$I$$20240801$20240802$20240802$PER$$US-ROCHE-10000046811$ROCHE$$$$$$Y$$$20240802$$CN$US$US
241675561$24167556$1$I$$20240728$20240802$20240802$PER$$US-BAYER-2024A111148$BAYER$$$$$$Y$$$20240802$$CN$US$US
241675571$24167557$1$I$$20240724$20240802$20240802$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024092967$VIIV$$38$YR$$M$Y$$$20240802$$HP$US$US
241675581$24167558$1$I$20240101$20240726$20240802$20240802$EXP$$US-ABBVIE-5856906$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241675592$24167559$2$F$$20240806$20240802$20240809$30DAY$$US-MYLANLABS-2024M1069534$MYLAN$$$$$F$Y$$$20240809$$PH$US$US
241675601$24167560$1$I$20240118$20240726$20240802$20240802$EXP$FR-AFSSAPS-DJ2024000846$FR-TEVA-VS-3226677$TEVA$$44$YR$$F$Y$63$KG$20240802$$MD$FR$FR
241675611$24167561$1$I$$20240729$20240802$20240802$EXP$$US-ABBVIE-5859701$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241675622$24167562$2$F$20240709$20240813$20240802$20240819$PER$$US-BAYER-2024A109620$BAYER$$36$YR$A$F$Y$$$20240819$$HP$US$US
241675643$24167564$3$F$$20240913$20240802$20240917$PER$$NVSC2024US157905$NOVARTIS$$$$$$Y$$$20240917$$HP$US$US
241675652$24167565$2$F$20240621$20240912$20240802$20240917$EXP$$JP-BEH-2024176717$CSL BEHRING$$26$YR$A$M$Y$62$KG$20240917$$MD$JP$JP
241675661$24167566$1$I$20240714$20240726$20240802$20240802$EXP$ES-AEMPS-1549978$ES-TEVA-VS-3226792$TEVA$$50$YR$$F$Y$65$KG$20240802$$PH$ES$ES
241675671$24167567$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151947$AMGEN$$$$$F$Y$$$20240802$$HP$US$US
241675681$24167568$1$I$$20240725$20240802$20240802$EXP$$FR-OTSUKA-2024_019484$OTSUKA$$$$$F$Y$$$20240802$$HP$FR$FR
241675691$24167569$1$I$20240701$20240730$20240802$20240802$EXP$$CA-ABBVIE-5862302$ABBVIE$$$$A$$Y$$$20240802$$CN$CA$CA
241675711$24167571$1$I$$20240724$20240802$20240802$EXP$$US-PFIZER INC-202400226676$PFIZER$$75$YR$$M$Y$$$20240802$$MD$US$US
241675731$24167573$1$I$20240726$20240730$20240802$20240802$EXP$$JP-009507513-2407JPN005278J$MERCK$$87$YR$$M$Y$$$20240802$$PH$JP$JP
241675741$24167574$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52957$$FDA-CTU$$73$YR$$M$N$$$20240801$N$$US$
241675751$24167575$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046825$ROCHE$$$$$$Y$$$20240802$$CN$US$US
241675761$24167576$1$I$20240601$20240726$20240802$20240802$EXP$SE-SEMPA-2024-005422$SE-TEVA-VS-3227121$TEVA$$73$YR$$M$Y$$$20240802$$MD$SE$SE
241675771$24167577$1$I$20240101$20240731$20240802$20240802$EXP$$US-ABBVIE-5863494$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241675781$24167578$1$I$$20240730$20240802$20240802$PER$$US-LEO Pharma-372408$LEO PHARM$$57$YR$$M$Y$$$20240802$$CN$US$US
241675801$24167580$1$I$$20240618$20240802$20240802$EXP$GB-MHRA-MED-202406171241304850-VSQWK$GB-MYLANLABS-2024M1072027$MYLAN$$$$$F$Y$$$20240802$$CN$GB$GB
241675811$24167581$1$I$20240801$20240801$20240801$20240801$DIR$712429$$FDA-CTU$$40$YR$$F$N$87$KG$20240801$N$$US$
241675821$24167582$1$I$20240101$20240730$20240802$20240802$EXP$$US-Eisai-EC-2024-171309$EISAI$$$$E$F$Y$$$20240802$$MD$US$US
241675831$24167583$1$I$$20240730$20240802$20240802$PER$$JP-Eisai-EC-2024-168698$EISAI$$67$YR$E$F$Y$$$20240802$$MD$JP$JP
241675841$24167584$1$I$20230101$20240729$20240802$20240802$EXP$$BR-JNJFOC-20240781394$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$CN$BR$BR
241675851$24167585$1$I$$20240724$20240802$20240802$EXP$$US-ORG100014127-2024000213$HRA PHARMA$Spaniol A, Mulla BM, Daily JG et al. Carney complex: a rare cause of Cushing syndrome in pregnancy. Obstetr Gynecol. 2014; 124: 426?428.$$$N$F$Y$0.65$KG$20240802$$MD$US$US
241675862$24167586$2$F$$20240902$20240802$20240913$30DAY$$BE-JNJFOC-20240779152$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$PH$BE$BE
241675871$24167587$1$I$$20240801$20240802$20240802$EXP$$NL-SANDOZ INC.-SDZ2024NL069840$SANDOZ$$44$YR$$M$Y$$$20240802$$HP$NL$NL
241675881$24167588$1$I$$20240726$20240802$20240802$EXP$$AU-MYLANLABS-2024M1071507$MYLAN$Hush JM, Steffens D, Solomon MJ. A patient-designed integrative oncology intervention for stage IV locally recurrent rectal cancer: A case report. Explore-NY 2024; 20 (5): 103004.$59$YR$$F$Y$$$20240802$$HP$AU$AU
241675891$24167589$1$I$$20240726$20240802$20240802$EXP$$US-MYLANLABS-2024M1071550$MYLAN$Martino J, Elfessi Z, Szaflarska K, Suh M, Antonishina K. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use. J-Pharm-Pract 2024; 0 (0):.$23$YR$$M$Y$$$20240802$$HP$US$US
241675901$24167590$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122751$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240802$$CN$US$US
241675911$24167591$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122621$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$M$Y$$$20240802$$HP$US$US
241675921$24167592$1$I$20240801$20240801$20240801$20240801$DIR$712445$$FDA-CTU$$53$YR$$F$N$$$20240801$N$$US$
241675931$24167593$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122601$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$M$Y$$$20240802$$HP$US$US
241675942$24167594$2$F$20240723$20240801$20240802$20240809$EXP$$CO-AstraZeneca-2024A173580$ASTRAZENECA$$31314$DY$$M$Y$43$KG$20240809$$CN$CO$
241675951$24167595$1$I$$20240726$20240802$20240802$EXP$$JP-AstraZeneca-2024A173357$ASTRAZENECA$$80$YR$$F$Y$$$20240802$$CN$JP$
241675961$24167596$1$I$$20240729$20240802$20240802$EXP$$GB-AstraZeneca-2024A173718$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$GB$
241675971$24167597$1$I$$20210709$20240802$20240802$EXP$$US-AstraZeneca-2021A614828$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241675981$24167598$1$I$$20240801$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408001067$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240802$$CN$US$US
241675991$24167599$1$I$20180201$20180220$20240802$20240802$EXP$$AU-ABBVIE-18K-008-2264415-00$ABBVIE$$52$YR$$F$Y$$$20240802$$CN$AU$AU
241676001$24167600$1$I$20240801$20240801$20240801$20240801$DIR$712447$$FDA-CTU$$40$YR$$M$N$$$20240801$N$$US$
241676011$24167601$1$I$$20240802$20240802$20240802$EXP$$CN-BAYER-2023A085472$BAYER$$49$YR$A$M$Y$$$20240802$$CN$CN$CN
241676021$24167602$1$I$$20240731$20240802$20240802$EXP$$NVSC2024IN157852$NOVARTIS$$$$$M$Y$$$20240802$$CN$IN$IN
241676041$24167604$1$I$$20240713$20240802$20240802$PER$$CA-TOLMAR, INC.-24CA051011$TOLMAR$$$$$M$Y$$$20240802$$CN$CA$CA
241676051$24167605$1$I$20240101$20240712$20240802$20240802$PER$$CA-TOLMAR, INC.-24CA051014$TOLMAR$$$$$M$Y$$$20240801$$CN$CA$CA
241676061$24167606$1$I$20240713$20240713$20240802$20240802$PER$$CA-TOLMAR, INC.-24CA051010$TOLMAR$$92$YR$$M$Y$$$20240802$$CN$CA$CA
241676071$24167607$1$I$$20240711$20240802$20240802$PER$$CA-TOLMAR, INC.-24CA051036$TOLMAR$$$$$M$Y$$$20240801$$CN$CA$CA
241676081$24167608$1$I$$20240714$20240802$20240802$PER$$CA-TOLMAR, INC.-24CA051015$TOLMAR$$$$$M$Y$$$20240802$$CN$CA$CA
241676091$24167609$1$I$20240401$20240711$20240802$20240802$PER$$CA-TOLMAR, INC.-24CA051033$TOLMAR$$60$YR$$M$Y$$$20240801$$CN$CA$CA
241676111$24167611$1$I$20240711$20240711$20240802$20240802$PER$$CA-TOLMAR, INC.-24CA051041$TOLMAR$$73$YR$$M$Y$$$20240801$$CN$CA$CA
241676122$24167612$2$F$$20240826$20240802$20240919$PER$$CA-TOLMAR, INC.-24CA051059$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
241676131$24167613$1$I$20240711$20240711$20240802$20240802$PER$$CA-TOLMAR, INC.-24CA051042$TOLMAR$$70$YR$$M$Y$$$20240801$$CN$CA$CA
241676141$24167614$1$I$$20240726$20240802$20240802$EXP$$US-MYLANLABS-2024M1071572$MYLAN$Rafeq R, Salzman M. Use of Concentrated Insulin in the Management of Calcium Channel Blocker Overdose: A Case Report. J-Pharm-Pract 2023; 36 (6): 1519-1522.$73$YR$$F$Y$69.9$KG$20240802$$PH$US$US
241676151$24167615$1$I$20240622$20240711$20240802$20240802$PER$$CO-TOLMAR, INC.-24CO050516$TOLMAR$$91$YR$$M$Y$$$20240801$$CN$CO$CO
241676161$24167616$1$I$20240712$20240712$20240802$20240802$PER$$CA-TOLMAR, INC.-24CA051068$TOLMAR$$63$YR$$M$Y$$$20240801$$CN$CA$CA
241676171$24167617$1$I$20240708$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52955$$FDA-CTU$$65$YR$$M$N$$$20240731$N$HP$US$
241676181$24167618$1$I$20240602$20240730$20240802$20240802$EXP$$CO-GSK-CO2024AMR096441$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$CO$CO
241676193$24167619$3$F$$20240813$20240802$20240815$EXP$$CA-LUNDBECK-DKLU4002457$LUNDBECK$$$$$$Y$$$20240815$$CN$CA$CA
241676202$24167620$2$F$20240730$20240830$20240802$20240902$PER$$US-AMGEN-USASP2024152651$AMGEN$$76$YR$E$F$Y$$$20240902$$CN$US$US
241676211$24167621$1$I$$20240801$20240802$20240802$EXP$$US-ROCHE-10000047295$ROCHE$$$$C$M$Y$36.29$KG$20240802$$CN$US$US
241676221$24167622$1$I$$20240709$20240802$20240802$EXP$$SG-ROCHE-10000032028$ROCHE$$56$YR$A$F$Y$$$20240802$$CN$SG$SG
241676231$24167623$1$I$$20240731$20240802$20240802$PER$$US-BAYER-2024A111079$BAYER$$$$$$Y$$$20240802$$CN$US$US
241676241$24167624$1$I$20240501$20240725$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119092$BRISTOL MYERS SQUIBB$$27$YR$A$F$Y$$$20240802$$HP$US$US
241676251$24167625$1$I$20240712$20240730$20240802$20240802$EXP$GB-MHRA-MED-202407251255323230-DYHJM$GB-MYLANLABS-2024M1071122$MYLAN$$70$YR$$F$Y$$$20240802$$HP$GB$GB
241676261$24167626$1$I$$20240727$20240802$20240802$PER$$US-BAYER-2024A111134$BAYER$$$$$$Y$$$20240802$$CN$US$US
241676273$24167627$3$F$20240720$20240731$20240802$20240809$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011080$JAZZ$$44$YR$$F$Y$$$20240809$$CN$US$US
241676281$24167628$1$I$$20240731$20240802$20240802$EXP$$US-ROCHE-10000046647$ROCHE$$$$T$M$Y$$$20240802$$CN$US$US
241676292$24167629$2$F$$20240913$20240802$20240916$30DAY$$MX-PFIZER INC-202400220925$PFIZER$$$$A$F$Y$$$20240916$$HP$MX$MX
241676301$24167630$1$I$$20240405$20240802$20240802$30DAY$$DE-PFIZER INC-PV202400045897$PFIZER$$40$YR$$F$Y$$$20240802$$PH$DE$DE
241676312$24167631$2$F$20240501$20240703$20240802$20240830$PER$$US-ROCHE-10000018450$ROCHE$$71$YR$E$F$Y$45.36$KG$20240830$$CN$US$US
241676322$24167632$2$F$$20240828$20240802$20240910$PER$$US-Calliditas-2024CAL01309$CALLIDITAS THERAPEUTICS$$47$YR$A$M$Y$70$KG$20240910$$CN$US$US
241676331$24167633$1$I$$20240722$20240802$20240802$EXP$GB-MHRA-MED-202407210639446900-SWDZM$GB-LUPIN PHARMACEUTICALS INC.-2024-07069$LUPIN$$$$$$Y$$$20240802$$CN$GB$GB
241676341$24167634$1$I$$20240801$20240802$20240802$EXP$$US-UCBSA-2024038906$UCB$$$$$M$Y$$$20240802$$CN$US$US
241676351$24167635$1$I$$20240728$20240802$20240802$PER$$US-BAYER-2024A111039$BAYER$$$$$$Y$$$20240802$$CN$US$US
241676371$24167637$1$I$$20240731$20240802$20240802$EXP$$CN-JNJFOC-20240801349$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$MD$CN$CN
241676381$24167638$1$I$20240101$20240726$20240802$20240802$PER$$US-Eisai-EC-2024-167132$EISAI$$73$YR$E$M$Y$$$20240802$$CN$US$US
241676402$24167640$2$F$$20240726$20240802$20240902$PER$$US-ASTELLAS-2024US020841$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241676411$24167641$1$I$$20240726$20240802$20240802$PER$$US-ALXN-202407USA001897US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241676421$24167642$1$I$$20240729$20240802$20240802$PER$$US-BAYER-2024A111049$BAYER$$$$$$Y$$$20240802$$CN$US$US
241676431$24167643$1$I$$20240725$20240802$20240802$PER$$US-BAYER-2024A108611$BAYER$$69$YR$E$M$Y$$$20240802$$CN$US$US
241676453$24167645$3$F$$20240815$20240802$20240819$PER$$US-BIOVITRUM-2024-US-010525$BIOVITRUM$$63$YR$$F$Y$$$20240819$$CN$US$US
241676461$24167646$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122582$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$M$Y$$$20240802$$HP$US$US
241676471$24167647$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122603$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$M$Y$$$20240802$$HP$US$US
241676481$24167648$1$I$$20240705$20240802$20240802$PER$$US-009507513-2408USA000599$MERCK$Khosla H, Bhatt S, Wang MJ, Gignac G, Mittal K, Patel J. Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis. Journal of Oncology Pharmacy Practice. 2024;30(5):941-4$59$YR$$M$Y$$$20240802$$HP$US$US
241676492$24167649$2$F$$20240820$20240802$20240823$PER$$US-BIOVITRUM-2024-US-010516$BIOVITRUM$$12$MON$$F$Y$$$20240823$$HP$US$US
241676511$24167651$1$I$$20240506$20240802$20240802$PER$$US-SOMERSET-2024-US-000339$ODIN PHARMACEUTICALS$$$$$F$Y$$$20240802$$PH$US$US
241676521$24167652$1$I$$20240730$20240802$20240802$PER$$US-HALEON-2190222$Haleon PLC$$37$YR$$F$Y$$$20240802$$HP$US$US
241676531$24167653$1$I$$20240731$20240802$20240802$PER$$US-BAYER-2024A111203$BAYER$$38$YR$A$F$Y$$$20240802$$MD$US$US
241676541$24167654$1$I$20201224$20240726$20240802$20240802$EXP$$US-PFIZER INC-2020SGN03836$PFIZER$$66$YR$$F$Y$$$20240802$$PH$US$US
241676551$24167655$1$I$$20240728$20240802$20240802$EXP$GB-MHRA-MED-202407280834110720-LGBZW$GB-LABORATORIOS LICONSA S.A.-2407GB06010$INSUD PHARMA$$48$YR$$F$Y$85$KG$20240802$$CN$GB$GB
241676561$24167656$1$I$$20240719$20240802$20240802$EXP$$NL-LABORATORIOS LICONSA S.A.-2407NL05938$INSUD PHARMA$Dekker MJHJ, Heerdink GC, Plattel CHM.. Vitamin B12 Deficiency-Induced Neuropathy and Cognitive and Motor Impairment in the Elderly: A Case Study. Food and nutrition bulletin. 2024;45(1_suppl):S53-7$71$YR$$M$Y$$$20240802$$MD$NL$NL
241676572$24167657$2$F$20240401$20240830$20240802$20240905$EXP$$JP-009507513-2406JPN003287J$MERCK$$8$DEC$$F$Y$$$20240905$$MD$JP$JP
241676593$24167659$3$F$$20240802$20240802$20240805$PER$$US-ROCHE-10000047174$ROCHE$$$$A$F$Y$$$20240805$$CN$US$US
241676601$24167660$1$I$20240725$20240801$20240802$20240802$PER$$US-ROCHE-10000047240$ROCHE$$48$YR$A$M$Y$$$20240802$$CN$US$US
241676611$24167661$1$I$$20240801$20240802$20240802$PER$$US-ROCHE-10000047336$ROCHE$$71$YR$E$F$Y$$$20240802$$CN$US$US
241676622$24167662$2$F$20240716$20240826$20240802$20240829$PER$$US-ROCHE-10000047555$ROCHE$$18$YR$A$M$Y$73.94$KG$20240829$$CN$US$US
241676631$24167663$1$I$$20240731$20240802$20240802$EXP$$US-ROCHE-10000046519$ROCHE$$$$N$$Y$$$20240802$$CN$US$US
241676641$24167664$1$I$20240721$20240724$20240802$20240802$PER$$US-ROCHE-10000040461$ROCHE$$$$$F$Y$$$20240802$$CN$US$US
241676651$24167665$1$I$$20240718$20240802$20240802$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07057$LUPIN$Abdelmajid HA, Mustafa GMA, Fernandez A, Franco SD, Esquibies AE, Valencia GB, et al. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring. Case Reports in Perinatal Medicine. 2024;13 (1):1-5$45$DY$$M$Y$$$20240802$$MD$US$US
241676661$24167666$1$I$$20240731$20240802$20240802$PER$$US-BAYER-2024A111565$BAYER$$$$$$Y$$$20240802$$CN$US$US
241676671$24167667$1$I$$20240729$20240802$20240802$EXP$$US-ABBVIE-5859945$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241676681$24167668$1$I$$20240723$20240802$20240802$EXP$$CA-TEVA-VS-3225792$TEVA$$44$YR$$F$Y$97$KG$20240802$$MD$CA$CA
241676691$24167669$1$I$20240708$20240801$20240801$20240801$DIR$712449$$FDA-CTU$$38$YR$$F$N$57.1$KG$20240801$N$PH$US$
241676701$24167670$1$I$20240725$20240801$20240801$20240801$DIR$712430$$FDA-CTU$$84$YR$$M$N$67.5$KG$20240801$N$CN$US$
241676711$24167671$1$I$$20240801$20240801$20240801$DIR$712452$$FDA-CTU$$70$YR$$F$N$93.4$KG$20240801$N$HP$US$
241676721$24167672$1$I$20240711$20240801$20240801$20240801$DIR$712451$$FDA-CTU$$48$YR$$F$N$62.1$KG$20240801$N$HP$US$
241676731$24167673$1$I$20240715$20240801$20240801$20240801$DIR$712411$$FDA-CTU$$85$YR$$M$N$78.75$KG$20240801$Y$HP$US$
241676743$24167674$3$F$$20240906$20240802$20240906$EXP$$JP-ABBVIE-5864500$ABBVIE$$67$YR$$$Y$$$20240906$$MD$JP$JP
241676752$24167675$2$F$20240711$20240829$20240802$20240902$PER$$US-ROCHE-10000047573$ROCHE$$49$YR$A$M$Y$$$20240902$$CN$US$US
241676761$24167676$1$I$$20240730$20240802$20240802$PER$$US-LEO Pharma-372420$LEO PHARM$$39$YR$$F$Y$$$20240802$$PH$US$US
241676771$24167677$1$I$20240201$20240731$20240802$20240802$EXP$$US-ROCHE-10000046441$ROCHE$$69$YR$E$F$Y$58.97$KG$20240802$$CN$US$US
241676781$24167678$1$I$20240329$20240719$20240802$20240802$EXP$FR-AFSSAPS-LL2024001296$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-06922$HIKMA$$69$YR$$F$Y$100$KG$20240802$$MD$FR$FR
241676791$24167679$1$I$$20240801$20240802$20240802$PER$$US-BAYER-2024A111754$BAYER$$$$$$Y$$$20240802$$CN$US$US
241676801$24167680$1$I$20240626$20240731$20240802$20240802$EXP$$JP-BAYER-2024A111687$BAYER$$89$YR$E$M$Y$$$20240802$$MD$JP$JP
241676811$24167681$1$I$$20240730$20240802$20240802$EXP$$NVSC2024ES157004$NOVARTIS$$65$YR$$M$Y$$$20240802$$MD$ES$ES
241676822$24167682$2$F$20240611$20240628$20240802$20240910$EXP$$IT-TAKEDA-2024TUS077678$TAKEDA$$72$YR$$F$Y$$$20240910$$MD$IT$IT
241676831$24167683$1$I$20240715$20240718$20240802$20240802$EXP$$CN-GALDERMA-CN2024011592$GALDERMA$$$$$$Y$$$20240802$$HP$CN$CN
241676841$24167684$1$I$$20240723$20240802$20240802$EXP$$US-BAYER-2024A110714$BAYER$Majid S; Hamzavi-Abedi Y. Correction to ^Dose Dependent: A Case report of NSAID-induced urticaria and angioedema in an otherwise asymptomatic individual [M058]^ (Ann Allergy Asthma Immunol. 2023; 131(5S1): S114) (Annals of Allergy, Asthma + Immunology (2023) 131(5S1) (S114), (S108112062300950X), (10.1016/j.anai.2023.08.339). Annals of Allergy, Asthma and Immunology (2024). 2024;131:1081-1206$71$YR$E$F$Y$$$20240802$$HP$US$US
241676851$24167685$1$I$20240601$20240726$20240802$20240802$EXP$$CN-SA-2024SA227073$SANOFI AVENTIS$$59$YR$A$F$Y$57$KG$20240802$$HP$CN$CN
241676861$24167686$1$I$20240717$20240726$20240802$20240802$PER$$US-ALXN-202407USA001911US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240802$$HP$US$US
241676871$24167687$1$I$20240601$20240730$20240802$20240802$EXP$$MX-ROCHE-10000046902$ROCHE$$47$YR$A$F$Y$65$KG$20240802$$CN$MX$MX
241676881$24167688$1$I$20240702$20240725$20240802$20240802$EXP$FR-AFSSAPS-AVMA2024000333$FR-Waylis Therapeutics LLC-ATNAHS20240702162$Waylis$$23$YR$A$F$Y$$$20240801$$CN$FR$FR
241676891$24167689$1$I$$20240801$20240802$20240802$PER$$US-ROCHE-10000047512$ROCHE$$$$A$M$Y$$$20240802$$CN$US$US
241676901$24167690$1$I$20210101$20240730$20240802$20240802$EXP$$US-AMGEN-USASP2024151811$AMGEN$$40$YR$A$F$Y$$$20240802$$CN$US$US
241676911$24167691$1$I$$20240727$20240802$20240802$EXP$$US-OTSUKA-2024_021013$OTSUKA$$$$$M$Y$85.73$KG$20240802$$CN$US$US
241676921$24167692$1$I$$20240725$20240802$20240802$EXP$$US-ARGENX-2024-ARGX-US005734$ARGENX BVBA$$$$$$Y$$$20240802$$CN$US$US
241676931$24167693$1$I$20240701$20240730$20240802$20240802$EXP$$GR-KARYOPHARM-2024KPT001385$KARYOPHARM THERAPEUTICS$$82$YR$$M$Y$$$20240802$$MD$GR$GR
241676942$24167694$2$F$20240708$20240805$20240802$20240806$EXP$HR-HALMED-300086184$HR-ROCHE-10000046496$ROCHE$$31$YR$A$F$Y$$$20240806$$MD$HR$HR
241676951$24167695$1$I$20240323$20240725$20240802$20240802$EXP$FR-AFSSAPS-NT2024000929$FR-Waylis Therapeutics LLC-ATNAHS20240702160$Waylis$$34$YR$A$F$Y$47$KG$20240801$$MD$FR$FR
241676962$24167696$2$F$$20240731$20240802$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407018755$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240807$$CN$US$US
241676973$24167697$3$F$20240705$20240807$20240802$20240813$EXP$$US-ROCHE-10000047489$ROCHE$$55$YR$A$F$Y$63.5$KG$20240813$$CN$US$US
241676981$24167698$1$I$$20240726$20240802$20240802$EXP$$US-EMD Serono-2024041074$EMD SERONO INC$$$$A$F$Y$$$20240802$$CN$US$US
241677012$24167701$2$F$20240701$20240903$20240802$20240906$30DAY$$AR-JNJFOC-20240769078$JOHNSON AND JOHNSON$$78$YR$E$F$Y$73$KG$20240906$$CN$AR$AR
241677031$24167703$1$I$$20240801$20240802$20240802$PER$$US-ROCHE-10000047294$ROCHE$$$$A$M$Y$$$20240802$$CN$US$US
241677041$24167704$1$I$$20240801$20240802$20240802$PER$$US-ROCHE-10000047222$ROCHE$$19$YR$A$M$Y$$$20240802$$CN$US$US
241677051$24167705$1$I$20240728$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152563$AMGEN$$63$YR$A$M$Y$$$20240802$$CN$US$US
241677064$24167706$4$F$20240101$20240905$20240802$20240909$EXP$$US-KARYOPHARM-2024KPT001387$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240909$$CN$US$US
241677071$24167707$1$I$$20240730$20240802$20240802$EXP$$US-AMERICAN REGENT INC-2024002943$AMERICAN REGENT$Dillon J, Bernik S, Zeizafoun N, Balija T.. Benign phyllodes tumour in a transgender woman receiving hormonal therapy. BMJ Case Reports. 2024;17(3):1-5$5$DEC$$M$Y$$$20240802$$MD$US$US
241677081$24167708$1$I$$20240801$20240802$20240802$PER$$US-ROCHE-10000047209$ROCHE$$$$A$M$Y$$$20240802$$CN$US$US
241677091$24167709$1$I$$20240730$20240802$20240802$PER$$US-ROCHE-10000045813$ROCHE$$8$MON$I$M$Y$$$20240802$$CN$US$US
241677101$24167710$1$I$20240529$20240722$20240802$20240802$EXP$$CH-OPKO PHARMACEUTICALS, LLC.-2024OPK00181$OPKO HEALTH$$86$YR$$F$Y$$$20240731$$PH$CH$US
241677111$24167711$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152514$AMGEN$$$$$F$Y$$$20240802$$HP$US$US
241677122$24167712$2$F$20231002$20240723$20240802$20240805$EXP$$JP-009507513-2310JPN002526J$MERCK$$79$YR$$F$Y$$$20240805$$MD$JP$JP
241677132$24167713$2$F$20240720$20240822$20240802$20240826$PER$$US-ROCHE-10000046288$ROCHE$$41$YR$A$M$Y$127.9$KG$20240826$$CN$US$US
241677141$24167714$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122585$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$M$Y$$$20240802$$HP$US$US
241677152$24167715$2$F$$20240911$20240802$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122477$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$73.94$KG$20240913$$CN$US$US
241677162$24167716$2$F$20240604$20240801$20240802$20240807$EXP$$CA-TAKEDA-2024TUS043205$TAKEDA$$41$YR$$M$Y$$$20240807$$CN$CA$CA
241677171$24167717$1$I$$20240731$20240802$20240802$EXP$$CA-TAKEDA-2024TUS077482$TAKEDA$$$$$M$Y$$$20240802$$CN$CA$CA
241677182$24167718$2$F$$20240805$20240802$20240809$EXP$$US-PFIZER INC-202400225182$PFIZER$Wadei, H.. Disseminated Monkeypox Infection in a Kidney Transplant Recipient A Case Report. Transplantation Proceedings. 2023;55(3):667-671$44$YR$$M$Y$$$20240809$$MD$US$US
241677191$24167719$1$I$$20240731$20240802$20240802$EXP$$IT-ABBVIE-5864381$ABBVIE$$$$$M$Y$$$20240802$$HP$IT$IT
241677201$24167720$1$I$$20240725$20240802$20240802$PER$$US-AstraZeneca-2024A170615$ASTRAZENECA$$85$YR$$$Y$$$20240802$$CN$US$
241677211$24167721$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A171516$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241677231$24167723$1$I$20240708$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170750$ASTRAZENECA$$22729$DY$$F$Y$81.6$KG$20240802$$HP$US$
241677251$24167725$1$I$$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024151941$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241677261$24167726$1$I$20240101$20240801$20240802$20240802$PER$$US-AMGEN-USASP2024153676$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241677271$24167727$1$I$$20240730$20240802$20240802$EXP$$US-AMGEN-USASP2024151794$AMGEN$$$$A$M$Y$$$20240802$$MD$US$US
241677281$24167728$1$I$$20240730$20240802$20240802$EXP$$CN-AstraZeneca-2024A174267$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$CN$
241677296$24167729$6$F$$20240924$20240802$20240927$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043266$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$76$KG$20240927$$CN$DE$DE
241677303$24167730$3$F$$20240816$20240802$20240829$EXP$$US-ACORDA-ACO_177679_2024$ACORDA$$$$$F$Y$96.961$KG$20240829$$CN$US$US
241677311$24167731$1$I$$20240726$20240802$20240802$EXP$$JP-JNJFOC-20240804183$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$MD$JP$JP
241677321$24167732$1$I$$20240726$20240802$20240802$PER$$US-RDY-SPO/USA/24/0011136$DR REDDYS$$24$YR$A$$Y$$$20240802$$MD$US$US
241677351$24167735$1$I$20240704$20240726$20240802$20240802$EXP$ES-AEMPS-1548350$ES-TEVA-VS-3226617$TEVA$$75$YR$$F$Y$$$20240802$$MD$ES$ES
241677361$24167736$1$I$20240301$20240726$20240802$20240802$EXP$$JP-TAKEDA-2024TUS076933$TAKEDA$$74$YR$$M$Y$$$20240802$$MD$JP$JP
241677371$24167737$1$I$$20240726$20240802$20240802$EXP$$US-AMGEN-USASP2024150116$AMGEN$$$$$F$Y$$$20240802$$CN$US$US
241677381$24167738$1$I$$20240729$20240802$20240802$EXP$$US-OTSUKA-2024_015351$OTSUKA$$$$$M$Y$$$20240802$$CN$US$US
241677391$24167739$1$I$20240401$20240726$20240802$20240802$EXP$$FR-AstraZeneca-2024A174941$ASTRAZENECA$$88$YR$$M$Y$$$20240802$$HP$FR$
241677401$24167740$1$I$$20240719$20240802$20240802$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07042$HIKMA$Xia J, Ahmed R.. Xia J, Ahmed R. Rapidly progressive locked-in syndrome secondary to atypical herpes simplex virus-1 rhombencephalitis in an immunocompromised individual.. IDCases. 2024;37:e02027$61$YR$$M$Y$$$20240802$$MD$US$US
241677411$24167741$1$I$20240723$20240725$20240802$20240802$EXP$$CN-AstraZeneca-2024A172136$ASTRAZENECA$$75$YR$$F$Y$50$KG$20240802$$MD$CN$
241677421$24167742$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122584$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$M$Y$$$20240802$$HP$US$US
241677431$24167743$1$I$$20240726$20240802$20240802$EXP$$US-BIOGEN-2024BI01275861$BIOGEN$$$$$F$Y$$$20240802$$HP$US$US
241677442$24167744$2$F$20230821$20240808$20240802$20240813$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-06992$IPSEN$$46$YR$A$F$Y$88$KG$20240813$$CN$CA$CA
241677451$24167745$1$I$20240624$20240723$20240802$20240802$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000689$PAREXEL$$$$$$Y$$$20240802$$HP$CN$CN
241677471$24167747$1$I$20240717$20240723$20240802$20240802$EXP$LU-ALMPS-202404281$LU-BAXTER-2024BAX022075$BAXTER$$53$YR$$F$Y$71$KG$20240802$$PH$LU$LU
241677481$24167748$1$I$20240615$20240723$20240802$20240802$EXP$CN-NMPACDR-3412221002221202400146$CN-BAXTER-2024BAX022290$BAXTER$$70$YR$$F$Y$50$KG$20240802$$MD$CN$CN
241677491$24167749$1$I$20221111$20240723$20240802$20240802$EXP$$ES-BAXTER-2024BAX022098$BAXTER$$65$YR$$M$Y$$$20240802$$MD$ES$ES
241677501$24167750$1$I$20240731$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153170$AMGEN$$46$YR$A$F$Y$$$20240802$$CN$US$US
241677511$24167751$1$I$20240216$20240726$20240802$20240802$EXP$$US-AMGEN-USASL2024039349$AMGEN$$55$YR$A$F$Y$81.92$KG$20240802$$MD$US$US
241677521$24167752$1$I$$20240722$20240802$20240802$PER$$US-TEVA-VS-3225587$TEVA$$$$$F$Y$$$20240802$$CN$US$US
241677531$24167753$1$I$20240415$20240725$20240802$20240802$EXP$IT-MINISAL02-995433$IT-TEVA-VS-3226451$TEVA$$17$YR$$F$Y$$$20240802$$MD$IT$IT
241677541$24167754$1$I$20240513$20240729$20240802$20240802$EXP$FR-AFSSAPS-AVPO2024000111$FR-OTSUKA-2024_021029$OTSUKA$$30$YR$$F$Y$$$20240802$$PH$FR$FR
241677551$24167755$1$I$20240604$20240730$20240802$20240802$EXP$$US-AMGEN-USANI2024112126$AMGEN$$77$YR$E$M$Y$$$20240802$$MD$US$US
241677563$24167756$3$F$20240709$20240807$20240802$20240821$PER$$US-Calliditas-2024CAL01378$CALLIDITAS THERAPEUTICS$$72$YR$E$M$Y$$$20240821$$CN$US$US
241677571$24167757$1$I$$20240725$20240802$20240802$EXP$$CA-CHATTEMPRD-2021SA122816$CHATTEM$$56$YR$A$M$Y$$$20240802$$PH$CA$CA
241677581$24167758$1$I$20240701$20240729$20240802$20240802$EXP$$CN-OTSUKA-2024_021128$OTSUKA$$65$YR$$M$Y$55.5$KG$20240802$$HP$CN$CN
241677591$24167759$1$I$$20240722$20240802$20240802$EXP$$MX-RK PHARMA, INC-20240700038$RK PHARMA$Williams Luciano L?pez-Vidal. Anaphylaxis as an Unusual Cause of Shock in the Trauma Setting: A Case Report. Cureus. 2024;16:16(7)$$$$$Y$$$20240802$$$MX$MX
241677611$24167761$1$I$20240730$20240801$20240801$20240801$DIR$712460$$FDA-CTU$$8$YR$$M$N$38.1$KG$20240801$Y$HP$US$
241677621$24167762$1$I$$20240722$20240802$20240802$EXP$$JP-RK PHARMA, INC-20240700037$RK PHARMA$Yuji Takahashi. Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review. Acute Med Surg. 2024;11(1):e981$$$$$Y$$$20240802$$HP$JP$JP
241677631$24167763$1$I$$20240718$20240802$20240802$PER$$US-GLANDPHARMA-US-2024GLNSPO00526$GLAND PHARMA$$$$$F$Y$$$20240802$$CN$US$US
241677641$24167764$1$I$20240731$20240801$20240801$20240801$DIR$712454$$FDA-CTU$$36$YR$$F$N$119.7$KG$20240801$N$HP$US$
241677651$24167765$1$I$$20240731$20240802$20240802$EXP$$US-GILEAD-2024-0682540$GILEAD$$51$YR$A$M$Y$$$20240802$$HP$US$US
241677661$24167766$1$I$20240729$20240730$20240802$20240802$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-15268$IPSEN$$58$YR$A$F$Y$$$20240802$$CN$GB$GB
241677671$24167767$1$I$20240801$20240801$20240801$20240801$DIR$712461$$FDA-CTU$$77$YR$$F$N$51.75$KG$20240801$N$HP$US$
241677681$24167768$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122248$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240802$$CN$US$US
241677691$24167769$1$I$20240101$20240730$20240802$20240802$EXP$$CA-PFIZER INC-PV202400094358$PFIZER$$67$YR$$M$Y$80.9$KG$20240802$$HP$CA$CA
241677701$24167770$1$I$20240413$20240729$20240802$20240802$EXP$$CN-PFIZER INC-PV202400098469$PFIZER$$64$YR$$M$Y$57.5$KG$20240802$$MD$CN$CN
241677711$24167771$1$I$$20240730$20240802$20240802$EXP$$US-PFIZER INC-202400226682$PFIZER$$$$$$Y$$$20240802$$HP$US$US
241677731$24167773$1$I$$20240725$20240802$20240802$EXP$$US-AMGEN-USASP2024148668$AMGEN$Zamvil S.S.; Virupakshaiah A.; Moseley C.E. et.al.. Life-Threatening MOG Antibody-Associated Hemorrhagic ADEM With Elevated CSF IL-6. Neurology Neuroimmunology + Neuroinflammation. 2024;11 (4):1-6$35$YR$A$M$Y$$$20240802$$MD$US$US
241677741$24167774$1$I$$20240729$20240802$20240802$EXP$$NL-PFIZER INC-202400225673$PFIZER$Ten Brinck, M.. Dilated fixed pupils and respiratory failure: a rare clinical course of Lambert-Eaton myasthenic syndrome.. BMJ-Neurol-Open. 2023;5(2):1-4$62$YR$$F$Y$$$20240802$$HP$NL$NL
241677753$24167775$3$F$20240101$20240830$20240802$20240904$EXP$$US-PFIZER INC-202400081345$PFIZER$$45$YR$$F$Y$76$KG$20240904$$CN$US$US
241677761$24167776$1$I$20240101$20240731$20240802$20240802$EXP$$TW-PFIZER INC-PV202400100216$PFIZER$$52$YR$$F$Y$$$20240802$$HP$TW$TW
241677771$24167777$1$I$$20240730$20240802$20240802$EXP$$US-PFIZER INC-PV202400082752$PFIZER$$59$YR$$F$Y$$$20240802$$CN$US$US
241677782$24167778$2$F$20240701$20240806$20240802$20240809$EXP$$CA-PFIZER INC-202400226717$PFIZER$$85$YR$$M$Y$$$20240809$$CN$CA$CA
241677791$24167779$1$I$20240201$20240730$20240802$20240802$EXP$$CO-PFIZER INC-202400226669$PFIZER$$70$YR$$F$Y$$$20240802$$CN$CO$CO
241677801$24167780$1$I$20240207$20240730$20240802$20240802$EXP$FR-AFSSAPS-RE2024000769$FR-PFIZER INC-202400226452$PFIZER$$53$YR$$F$Y$59$KG$20240802$$MD$FR$FR
241677811$24167781$1$I$20240606$20240730$20240802$20240802$EXP$FR-AFSSAPS-AN2024000972$FR-PFIZER INC-202400226218$PFIZER$$52$YR$$F$Y$73.5$KG$20240802$$PH$FR$FR
241677821$24167782$1$I$20240701$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53096$$FDA-CTU$$59$YR$$F$N$$$20240801$N$$US$
241677831$24167783$1$I$20240606$20240730$20240802$20240802$EXP$$CN-PFIZER INC-PV202400099525$PFIZER$$59$YR$$M$Y$$$20240802$$HP$CN$CN
241677843$24167784$3$F$20240712$20240821$20240802$20240826$EXP$$SK-PFIZER INC-PV202400099725$PFIZER$$66$YR$$M$Y$$$20240826$$MD$SK$SK
241677851$24167785$1$I$20240718$20240730$20240802$20240802$EXP$$US-PFIZER INC-202400226822$PFIZER$$$$$M$Y$$$20240802$$MD$US$US
241677861$24167786$1$I$$20240730$20240802$20240802$EXP$$TR-PFIZER INC-PV202400099359$PFIZER$Saribayev, M.. Corticosteroid treatment normalizes QTc prolongation and improves heart block in an elderly patient with anti-Ro-positive systemic lupus erythematosus. Aging Clinical and Experimental Research. 2014;26(3):337-339$77$YR$$M$Y$$$20240802$$HP$TR$TR
241677871$24167787$1$I$20240101$20240729$20240802$20240802$EXP$$US-PFIZER INC-202400225815$PFIZER$$76$YR$$F$Y$72.57$KG$20240802$$CN$US$US
241677882$24167788$2$F$20200201$20240830$20240802$20240904$EXP$$CA-PFIZER INC-2021815102$PFIZER$$77$YR$$M$Y$$$20240904$$HP$CA$CA
241677901$24167790$1$I$$20240730$20240802$20240802$EXP$$DE-PFIZER INC-202400226450$PFIZER$$$$$M$Y$$$20240802$$MD$DE$DE
241677911$24167791$1$I$$20240731$20240802$20240802$EXP$$TW-PFIZER INC-PV202400100186$PFIZER$$$$A$F$Y$$$20240802$$HP$TW$TW
241677921$24167792$1$I$20230620$20240730$20240802$20240802$EXP$IS-IMA-8713$IS-PFIZER INC-202400226388$PFIZER$$64$YR$$F$Y$80$KG$20240802$$CN$IS$IS
241677941$24167794$1$I$$20240731$20240802$20240802$EXP$$TW-PFIZER INC-PV202400100214$PFIZER$$$$A$F$Y$$$20240802$$HP$TW$TW
241677951$24167795$1$I$$20240729$20240802$20240802$EXP$$CA-PFIZER INC-202400226856$PFIZER$$58$YR$$M$Y$$$20240802$$CN$CA$CA
241677961$24167796$1$I$20240701$20240729$20240802$20240802$EXP$$CA-PFIZER INC-202400201525$PFIZER$$78$YR$$M$Y$$$20240802$$HP$CA$CA
241677971$24167797$1$I$$20240725$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122806$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$83.01$KG$20240802$$CN$US$US
241677991$24167799$1$I$$20240729$20240802$20240802$EXP$$JP-PFIZER INC-PV202400098965$PFIZER$Miyajima, N.. A case of a patient with metastases to bone from breast cancer who developed bone marrow carcinomatosis and experienced acute exacerbation although stable disease was determined during drug therapy. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:476$75$YR$$M$Y$$$20240802$$HP$JP$JP
241678001$24167800$1$I$$20240731$20240802$20240802$EXP$$CA-PFIZER INC-202400227624$PFIZER$$23$YR$$M$Y$$$20240802$$HP$CA$CA
241678011$24167801$1$I$20240517$20240728$20240802$20240802$EXP$$NP-PFIZER INC-PV202400098232$PFIZER$$63$YR$$F$Y$$$20240802$$MD$NP$NP
241678021$24167802$1$I$20240628$20240729$20240802$20240802$EXP$$CN-PFIZER INC-202400227540$PFIZER$$81$YR$$M$Y$66$KG$20240802$$HP$CN$CN
241678032$24167803$2$F$20240718$20240807$20240802$20240808$EXP$$CN-PFIZER INC-PV202400098829$PFIZER$$66$YR$$M$Y$61.9$KG$20240808$$HP$CN$CN
241678041$24167804$1$I$$20240730$20240802$20240802$EXP$$JP-PFIZER INC-202400226036$PFIZER$$84$YR$$M$Y$$$20240802$$PH$JP$JP
241678051$24167805$1$I$$20240730$20240802$20240802$PER$$US-ROCHE-10000044808$ROCHE$$57$YR$A$F$Y$$$20240802$$HP$US$US
241678061$24167806$1$I$$20240729$20240802$20240802$EXP$$US-OTSUKA-2024_021196$OTSUKA$$$$$F$Y$$$20240802$$CN$US$US
241678081$24167808$1$I$20240614$20240624$20240802$20240802$PER$$US-SOMERSET-2024-US-000486$ODIN PHARMACEUTICALS$$81$YR$$F$Y$$$20240802$$CN$US$US
241678091$24167809$1$I$$20240719$20240802$20240802$PER$$US-LEADINGPHARMA-US-2024LEASPO00331$LEADING PHARMA$$$$$F$Y$$$20240802$$CN$US$US
241678101$24167810$1$I$20240101$20240729$20240802$20240802$EXP$$EC-009507513-2405ECU006870$MERCK$$$$$F$Y$$$20240802$$MD$EC$EC
241678111$24167811$1$I$20240301$20240731$20240802$20240802$EXP$$FR-AstraZeneca-2024A173917$ASTRAZENECA$$66$YR$$M$Y$84$KG$20240802$$MD$FR$
241678122$24167812$2$F$20240625$20240813$20240802$20240827$EXP$$PL-UCBSA-2024038550$UCB$$29$YR$$F$Y$73$KG$20240827$$MD$PL$PL
241678131$24167813$1$I$20230908$20240725$20240802$20240802$EXP$$FR-AstraZeneca-2024A174472$ASTRAZENECA$$72$YR$$F$Y$60$KG$20240802$$MD$FR$
241678141$24167814$1$I$20240724$20240725$20240802$20240802$EXP$GB-MHRA-MED-202407250146116250-ZFYPC$GB-009507513-2407GBR013579$MERCK$$60$YR$$M$Y$$$20240802$$MD$GB$GB
241678152$24167815$2$F$20240701$20240809$20240802$20240815$EXP$$US-Eisai-EC-2024-171299$EISAI$$38$YR$A$M$Y$$$20240815$$CN$US$US
241678161$24167816$1$I$$20240723$20240802$20240802$EXP$$US-RDY-LIT/USA/24/0011104$DR REDDYS$Gomez RF, Lin G, Golts E, Lin VM, Kafi A, Yung G, et al. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024 May;209(0): doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A3706?role=tab.$38$YR$A$M$Y$$$20240802$$HP$US$US
241678171$24167817$1$I$20240722$20240801$20240802$20240802$EXP$SE-SEMPA-2024-005723$SE-BAYER-2024A111395$BAYER$$22$YR$A$M$Y$85$KG$20240802$$CN$SE$SE
241678181$24167818$1$I$20240205$20240801$20240801$20240801$DIR$712474$$FDA-CTU$$64$YR$$F$N$83.25$KG$20240801$N$CN$US$
241678201$24167820$1$I$20240801$20240801$20240801$20240801$DIR$712431$$FDA-CTU$$$$$UNK$N$$$20240801$N$CN$US$
241678211$24167821$1$I$20240522$20240801$20240801$20240801$DIR$712472$$FDA-CTU$$65$YR$$M$N$62.1$KG$20240801$N$CN$US$
241678231$24167823$1$I$20240626$20240801$20240801$20240801$DIR$712466$$FDA-CTU$$74$YR$$F$N$110.7$KG$20240801$N$CN$US$
241678241$24167824$1$I$$20240801$20240801$20240801$DIR$712444$$FDA-CTU$$$$$UNK$N$$$20240801$$CN$US$
241678251$24167825$1$I$$20240723$20240802$20240802$EXP$$CA-TEVA-VS-3225830$TEVA$$40$YR$$F$Y$96$KG$20240802$$HP$CA$CA
241678261$24167826$1$I$$20240731$20240801$20240801$DIR$FDA-CDER-CTU-2024-52924$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
241678271$24167827$1$I$20240730$20240801$20240801$20240801$DIR$712455$$FDA-CTU$$83$YR$$F$N$$$20240801$Y$PH$US$
241678281$24167828$1$I$$20240726$20240802$20240802$EXP$NL-LRB-00992949$NL-TEVA-VS-3227241$TEVA$$66$YR$$F$Y$69$KG$20240802$$CN$NL$NL
241678291$24167829$1$I$20240617$20240730$20240802$20240802$EXP$$US-OTSUKA-2024_018291$OTSUKA$$60$YR$$F$Y$84.35$KG$20240802$$MD$US$US
241678301$24167830$1$I$$20240723$20240802$20240802$EXP$$CA-TEVA-VS-3225810$TEVA$$27$YR$$F$Y$$$20240802$$CN$CA$CA
241678311$24167831$1$I$20240726$20240729$20240802$20240802$PER$$US-AMGEN-USASP2024150583$AMGEN$$$$$$Y$$$20240802$$HP$US$US
241678321$24167832$1$I$$20230404$20240802$20240802$EXP$$US-NOVOPROD-1245691$NOVO NORDISK$$$$$F$Y$$$20240802$$CN$US$US
241678331$24167833$1$I$20220301$20240725$20240802$20240802$EXP$SE-SEMPA-2024-005445$SE-TEVA-VS-3226383$TEVA$$25$YR$$M$Y$77$KG$20240802$$CN$SE$SE
241678341$24167834$1$I$$20240722$20240802$20240802$PER$$US-TEVA-VS-3228804$TEVA$$62$YR$$$Y$$$20240802$$CN$US$US
241678351$24167835$1$I$20230101$20240719$20240802$20240802$EXP$$US-NOVOPROD-1263311$NOVO NORDISK$$$$A$F$Y$106.58$KG$20240802$$CN$US$US
241678361$24167836$1$I$20230801$20240724$20240802$20240802$EXP$$US-TEVA-VS-3227022$TEVA$$$$$M$Y$$$20240802$$CN$US$US
241678381$24167838$1$I$20240721$20240730$20240802$20240802$EXP$$AR-BIOMARINAP-AR-2024-159403$BIOMARIN$$$$$$Y$$$20240802$$CN$AR$AR
241678393$24167839$3$F$$20240823$20240802$20240823$PER$$US-ALXN-202407USA001820US$ALEXION PHARMACEUTICALS$$$$$M$Y$190$KG$20240823$$CN$US$US
241678401$24167840$1$I$$20240704$20240802$20240802$PER$$US-009507513-2407USA014535$MERCK$Kerai A, Doshi S, Laleker A, Majumdar A. Fungal Foe and Mechanical Hearts: A Retrospective Case Series on Candida auris Bloodstream Infection With Left Ventricular Assist Devices. Open Forum Infectious Diseases. 2024;11 (6):1-5$65$YR$$F$Y$$$20240802$$MD$US$US
241678411$24167841$1$I$20240628$20240710$20240802$20240802$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000588$PAREXEL$$$$$$Y$$$20240802$$HP$US$US
241678421$24167842$1$I$20240703$20240708$20240802$20240802$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000614$PAREXEL$$$$$$Y$$$20240802$$HP$US$US
241678431$24167843$1$I$20240101$20240729$20240802$20240802$EXP$$US-ABBVIE-5859886$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241678442$24167844$2$F$$20240806$20240802$20240809$EXP$$DE-BIOMARINAP-DE-2024-159578$BIOMARIN$$$$$$Y$$$20240809$$HP$DE$DE
241678451$24167845$1$I$20240623$20240729$20240802$20240802$EXP$$US-ABBVIE-5862982$ABBVIE$$72$YR$$F$Y$$$20240802$$CN$US$US
241678461$24167846$1$I$20240704$20240729$20240802$20240802$EXP$FR-AFSSAPS-AM2024000602$FR-ABBVIE-5858770$ABBVIE$$63$YR$$F$Y$57$KG$20240802$$MD$FR$FR
241678471$24167847$1$I$$20240725$20240802$20240802$PER$$US-ABBVIE-5858319$ABBVIE$$$$$$Y$$$20240802$$HP$US$US
241678481$24167848$1$I$$20240730$20240802$20240802$EXP$$US-ABBVIE-5861193$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241678491$24167849$1$I$$20240724$20240802$20240802$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2024-001403$SK LIFE SCIENCE$$$$$$Y$$$20240802$$CN$US$US
241678501$24167850$1$I$20240101$20240722$20240802$20240802$EXP$SE-SEMPA-2024-005212$SE-SK LIFE SCIENCE, INC-SKPVG-2024-001759$SK LIFE SCIENCE$$$$$$Y$$$20240802$$MD$SE$SE
241678512$24167851$2$F$$20240730$20240802$20240812$PER$$US-HALEON-2190041$Haleon PLC$$$$$F$Y$$$20240812$$CN$US$US
241678521$24167852$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122349$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240802$$CN$US$US
241678531$24167853$1$I$20240721$20240725$20240802$20240802$EXP$$CN-AstraZeneca-2024A172138$ASTRAZENECA$$16426$DY$$F$Y$55$KG$20240802$$MD$CN$
241678541$24167854$1$I$20240703$20240726$20240802$20240802$EXP$$US-GSK-US2024AMR094593$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$US$US
241678551$24167855$1$I$$20240726$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121429$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240802$$CN$US$US
241678561$24167856$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A171868$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241678571$24167857$1$I$20240728$20240730$20240802$20240802$EXP$$US-ABBVIE-5861131$ABBVIE$$30$YR$$F$Y$$$20240802$$CN$US$US
241678581$24167858$1$I$20240720$20240729$20240802$20240802$EXP$$US-AstraZeneca-2024A173156$ASTRAZENECA$$28126$DY$$M$Y$$$20240802$$CN$US$
241678591$24167859$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407020344$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240802$$CN$US$US
241678601$24167860$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170327$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241678611$24167861$1$I$$20240723$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407016254$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241678622$24167862$2$F$$20240809$20240802$20240813$EXP$$CA-PFIZER INC-202400228339$PFIZER$$$$E$F$Y$$$20240813$$CN$CA$CA
241678631$24167863$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190145$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241678642$24167864$2$F$$20240801$20240802$20240802$EXP$$US-PFIZER INC-PV202400100311$PFIZER$$77$YR$$F$Y$$$20240802$$HP$US$US
241678651$24167865$1$I$20240729$20240730$20240802$20240802$EXP$$US-BIOMARINAP-US-2024-159507$BIOMARIN$$$$$$Y$$$20240802$$CN$US$US
241678662$24167866$2$F$20240101$20240823$20240802$20240902$EXP$$CA-CELLTRION INC.-2024CA007538$CELLTRION$$$$$$Y$$$20240902$$CN$CA$CA
241678671$24167867$1$I$20240801$20240801$20240801$20240801$DIR$712469$$FDA-CTU$$54$YR$$F$N$81.9$KG$20240801$N$CN$US$
241678681$24167868$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52935$$FDA-CTU$$32$YR$$M$N$$$20240801$N$$US$
241678701$24167870$1$I$20240625$20240801$20240801$20240801$DIR$712443$$FDA-CTU$$56$YR$$F$N$$$20240801$N$PH$US$
241678711$24167871$1$I$20240622$20240801$20240801$20240801$DIR$712459$$FDA-CTU$$52$YR$$M$N$81$KG$20240801$N$CN$US$
241678721$24167872$1$I$20191225$20240731$20240802$20240802$EXP$$IL-ABBVIE-20K-082-3221553-00$ABBVIE$$72$YR$$F$Y$62$KG$20240802$$MD$IL$IL
241678732$24167873$2$F$20240101$20240817$20240802$20240823$EXP$$JP-GENMAB-2024-02766$GENMAB$$59$YR$$M$Y$78$KG$20240823$$MD$JP$JP
241678741$24167874$1$I$$20240612$20240802$20240802$PER$$US-LUNDBECK-DKLU4000399$LUNDBECK$$$$$$Y$$$20240802$$CN$US$US
241678752$24167875$2$F$$20240826$20240802$20240904$30DAY$$AR-SA-2024SA223209$SANOFI AVENTIS$$$$A$$Y$$$20240904$$CN$AR$AR
241678761$24167876$1$I$$20240725$20240802$20240802$PER$$US-BAYER-2024A108960$BAYER$$16$YR$T$F$Y$$$20240802$$HP$US$US
241678781$24167878$1$I$20240501$20240726$20240802$20240802$EXP$$CO-ABBVIE-5864233$ABBVIE$$81$YR$$F$Y$61$KG$20240802$$HP$CO$CO
241678791$24167879$1$I$20240801$20240801$20240801$20240801$DIR$712470$$FDA-CTU$$43$YR$$F$N$67.5$KG$20240801$N$CN$US$
241678802$24167880$2$F$20240725$20240820$20240802$20240828$EXP$$US-VANTIVE-2024VAN018701$Vantive US Healthcare$$78$YR$$F$Y$$$20240828$$HP$US$US
241678811$24167881$1$I$$20240726$20240802$20240802$EXP$$GB-009507513-2407GBR015437$MERCK$$47$YR$$M$Y$$$20240802$$MD$GB$GB
241678832$24167883$2$F$$20240801$20240802$20240807$PER$$US-AMGEN-USASP2024153616$AMGEN$$$$$F$Y$$$20240806$$HP$US$US
241678841$24167884$1$I$$20240731$20240802$20240802$PER$$US-ABBVIE-5863774$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241678851$24167885$1$I$$20240610$20240802$20240802$PER$$US-LUNDBECK-DKLU4000350$LUNDBECK$$$$$$Y$$$20240802$$HP$US$US
241678861$24167886$1$I$$20240613$20240802$20240802$PER$$US-LUNDBECK-DKLU4000510$LUNDBECK$$$$$$Y$$$20240802$$CN$US$US
241678871$24167887$1$I$$20240729$20240802$20240802$EXP$$US-ABBVIE-5863022$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241678881$24167888$1$I$20240801$20240802$20240802$20240802$DIR$712323$$FDA-CTU$$89$YR$$M$N$64.8$KG$20240802$N$CN$US$
241678891$24167889$1$I$$20240723$20240802$20240802$EXP$$US-FARMAPROD-202407-2713$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240802$$CN$US$US
241678901$24167890$1$I$$20240612$20240802$20240802$PER$$US-LUNDBECK-DKLU4000385$LUNDBECK$$$$$$Y$$$20240802$$CN$US$US
241678911$24167891$1$I$$20240725$20240802$20240802$EXP$$JP-AMGEN-JPNNI2024149611$AMGEN$$$$$$Y$$$20240802$$MD$JP$JP
241678921$24167892$1$I$$20240802$20240802$20240802$DIR$712326$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241678931$24167893$1$I$20240723$20240802$20240802$20240802$DIR$712477$$FDA-CTU$$50$YR$$F$N$65.25$KG$20240802$N$CN$US$
241678941$24167894$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52917$$FDA-CTU$$66$YR$$M$N$$$20240801$N$$US$
241678951$24167895$1$I$20240730$20240730$20240802$20240802$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-15333$IPSEN$$68$YR$E$M$Y$$$20240802$$HP$US$US
241678961$24167896$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122778$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240802$$CN$US$US
241678971$24167897$1$I$20240501$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122813$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240802$$CN$US$US
241678981$24167898$1$I$$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52971$$FDA-CTU$$83$YR$$F$N$$$20240801$N$$US$
241678991$24167899$1$I$$20240730$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122153$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240802$$CN$US$US
241679001$24167900$1$I$$20240724$20240802$20240802$PER$$US-009507513-2407USA014911$MERCK$$72$YR$$M$Y$83.9$KG$20240802$$CN$US$US
241679011$24167901$1$I$$20240726$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122769$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240802$$CN$US$US
241679021$24167902$1$I$$20240723$20240802$20240802$EXP$$CA-TEVA-VS-3225795$TEVA$$44$YR$$F$Y$$$20240802$$HP$CA$CA
241679031$24167903$1$I$20240712$20240725$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119117$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240802$$PH$US$US
241679041$24167904$1$I$20220416$20240729$20240802$20240802$EXP$$FR-009507513-2407FRA015130$MERCK$$6$YR$$F$Y$21$KG$20240802$$MD$FR$FR
241679051$24167905$1$I$20240601$20240731$20240802$20240802$EXP$$CN-PFIZER INC-PV202400100169$PFIZER$$65$YR$$M$Y$77$KG$20240802$$HP$CN$CN
241679061$24167906$1$I$$20240731$20240802$20240802$EXP$$US-PFIZER INC-202300392477$PFIZER$$73$YR$$M$Y$$$20240802$$CN$US$US
241679074$24167907$4$F$$20240918$20240802$20240920$EXP$$US-PFIZER INC-202400223038$PFIZER$$63$YR$$F$Y$$$20240920$$CN$US$US
241679081$24167908$1$I$20240721$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52967$$FDA-CTU$$45$YR$$M$N$$$20240801$N$PH$US$
241679091$24167909$1$I$20240501$20240731$20240802$20240802$EXP$$US-PFIZER INC-202400228256$PFIZER$$94$YR$$M$Y$74.83$KG$20240802$$CN$US$US
241679101$24167910$1$I$20181001$20240724$20240802$20240802$EXP$$US-SA-2018SA302705$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240802$$MD$US$US
241679111$24167911$1$I$20210701$20240731$20240802$20240802$EXP$$ZA-PFIZER INC-PV202400099824$PFIZER$$37$YR$$F$Y$134$KG$20240802$$MD$ZA$ZA
241679121$24167912$1$I$$20240731$20240802$20240802$EXP$$US-PFIZER INC-202400227824$PFIZER$$54$YR$$F$Y$$$20240802$$HP$US$US
241679131$24167913$1$I$20240723$20240731$20240802$20240802$EXP$$CN-PFIZER INC-PV202400100064$PFIZER$$38$YR$$F$Y$60$KG$20240802$$HP$CN$CN
241679141$24167914$1$I$20240726$20240801$20240802$20240802$EXP$$US-PFIZER INC-PV202400100614$PFIZER$$84$YR$$M$Y$$$20240802$$CN$US$US
241679151$24167915$1$I$20240731$20240801$20240802$20240802$EXP$$IN-PFIZER INC-PV202300109593$PFIZER$$71$YR$$F$Y$$$20240802$$CN$IN$IN
241679162$24167916$2$F$$20240731$20240802$20240805$EXP$$US-PFIZER INC-202400228374$PFIZER$$80$YR$$M$Y$$$20240805$$HP$US$US
241679171$24167917$1$I$$20240731$20240802$20240802$EXP$GB-MHRA-MED-202407311342475800-VJWKT$GB-PFIZER INC-202400227519$PFIZER$$26$YR$$F$Y$$$20240802$$PH$GB$GB
241679182$24167918$2$F$$20240901$20240802$20240904$EXP$$MY-PFIZER INC-PV202400100625$PFIZER$$47$YR$$F$Y$$$20240904$$MD$MY$MY
241679191$24167919$1$I$$20240731$20240802$20240802$EXP$$CA-PFIZER INC-202400227654$PFIZER$$$$$$Y$$$20240802$$HP$CA$CA
241679201$24167920$1$I$$20240801$20240802$20240802$EXP$$US-PFIZER INC-202400228629$PFIZER$$89$YR$$F$Y$$$20240802$$CN$US$US
241679211$24167921$1$I$$20240801$20240802$20240802$EXP$$US-PFIZER INC-202400228363$PFIZER$$75$YR$$F$Y$$$20240802$$CN$US$US
241679221$24167922$1$I$20240101$20240802$20240802$20240802$EXP$$TH-PFIZER INC-PV202400100991$PFIZER$$60$YR$$F$Y$$$20240802$$HP$TH$TH
241679231$24167923$1$I$20240724$20240731$20240802$20240802$EXP$$CN-PFIZER INC-PV202400100173$PFIZER$$38$YR$$F$Y$54$KG$20240802$$HP$CN$CN
241679242$24167924$2$F$$20240825$20240802$20240827$EXP$$JP-PFIZER INC-PV202400099727$PFIZER$$$$$$Y$$$20240827$$MD$JP$JP
241679251$24167925$1$I$20230825$20240730$20240802$20240802$EXP$$JP-BIOVITRUM-2023-JP-014412$BIOVITRUM$$75$YR$$M$Y$95$KG$20240802$$MD$JP$JP
241679261$24167926$1$I$$20240612$20240802$20240802$PER$$US-LUNDBECK-DKLU4000455$LUNDBECK$$$$$$Y$$$20240802$$CN$US$US
241679271$24167927$1$I$$20240731$20240802$20240802$EXP$$CA-PFIZER INC-202400227650$PFIZER$$31$YR$$F$Y$$$20240802$$HP$CA$CA
241679281$24167928$1$I$$20240604$20240802$20240802$EXP$$HU-CELLTRION INC.-2024HU018451$CELLTRION$$$$$$Y$$$20240802$$MD$HU$HU
241679301$24167930$1$I$$20240726$20240802$20240802$PER$$US-BAYER-2024A109083$BAYER$$$$$F$Y$$$20240802$$CN$US$US
241679311$24167931$1$I$$20240729$20240802$20240802$EXP$$US-SA-2024SA223993$SANOFI AVENTIS$Darnell H, Brenner A, Kern C, Flomenhoft D, Lee E.. Sevelamer-Induced Ischemic Enteritis.. ACG Case Rep J.. 2024;11(7):unk$35$YR$A$M$Y$$$20240802$$MD$US$US
241679322$24167932$2$F$20240101$20240730$20240802$20240910$EXP$$PL-GENMAB-2024-02812$GENMAB$$$$$M$Y$$$20240910$$MD$PL$PL
241679331$24167933$1$I$$20240729$20240802$20240802$30DAY$$US-VEROBIOTECH-2024USVEROSPO00155$VERO BIOTECH$$$$$$Y$$$20240802$$HP$US$US
241679341$24167934$1$I$20240708$20240727$20240802$20240802$EXP$$CN-009507513-2407CHN016120$MERCK$$71$YR$$M$Y$75$KG$20240802$$HP$CN$CN
241679351$24167935$1$I$$20240730$20240802$20240802$EXP$$US-LUNDBECK-DKLU4002448$LUNDBECK$$$$$$Y$$$20240802$$CN$US$US
241679361$24167936$1$I$20240726$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-52960$$FDA-CTU$$68$YR$$F$N$56.7$KG$20240801$N$HP$US$
241679371$24167937$1$I$$20240722$20240802$20240802$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460626$RANBAXY$Erseven F. Combined Therapy in Severe Valproic Acid Intoxication. Anest Derg. 2023;31 (3):249-251$$$A$$Y$$$20240802$$HP$TR$TR
241679382$24167938$2$F$$20240802$20240802$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460991$RANBAXY$$$$$F$Y$$$20240816$$CN$GB$GB
241679392$24167939$2$F$$20240827$20240802$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459722$RANBAXY$$$$A$F$Y$$$20240911$$CN$US$US
241679401$24167940$1$I$20240624$20240721$20240802$20240802$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460717$RANBAXY$$64$YR$$M$Y$74$KG$20240802$$CN$GB$GB
241679411$24167941$1$I$$20240704$20240802$20240802$30DAY$$US-VEROBIOTECH-2024USVEROSPO00159$VERO BIOTECH$$$$N$$Y$$$20240802$$HP$US$US
241679431$24167943$1$I$$20240722$20240802$20240802$EXP$$PE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459305$RANBAXY$Ponce FL, Leiva-Goicochea J, Miranda-Damian M, Zuniga-Condor M, Hilario-Vargas J. Rituximab therapy in two pediatric patients with systemic lupus erythematosus. Acta Med Peru. 2023;40 (1):80-84$10$YR$$M$Y$$$20240802$$HP$PE$PE
241679441$24167944$1$I$$20240722$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460500$RANBAXY$Elwood KF, Warner EJ, Chang JS, Kopplin LJ. Aspergillus Endophthalmitis Secondary to Infectious Scleritis: Utility of Diagnostic PCR. Retin Cases Brief Rep. 2024;Jul 19:Online ahead of print(5)$76$YR$$M$Y$$$20240802$$HP$US$US
241679452$24167945$2$F$20181214$20240827$20240802$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459723$RANBAXY$$50$YR$A$M$Y$$$20240911$$CN$US$US
241679461$24167946$1$I$$20240722$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460378$RANBAXY$Simpson T, Aljareh A, Shah U, Yoon S, Petrovic Elbaz M, Khan Z, et al. Atypical Presentation of Rhinovirus Infection With Rapid Deterioration Requiring Mechanical Ventilation. Am J Respir Crit Care Med. 2023;207:A1369$45$YR$$M$Y$$$20240802$$HP$US$US
241679471$24167947$1$I$$20240722$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460399$RANBAXY$Fortich M, Reddy N, Bellinghausen A.. Meth, PCP or Both? A case of diffuse alveolar hemorrhage in the setting of combined amphetamine and phencyclidine use. Am J Respir Crit Care Med. 2024;209(0)$37$YR$$M$Y$$$20240802$$HP$US$US
241679481$24167948$1$I$20200327$20240722$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459734$RANBAXY$$55$YR$A$F$Y$$$20240802$$CN$US$US
241679491$24167949$1$I$20240724$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-52970$$FDA-CTU$$$$$M$N$86.2$KG$20240801$N$$US$
241679512$24167951$2$F$20211101$20240828$20240802$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459976$RANBAXY$$67$YR$E$M$Y$$$20240912$$CN$US$US
241679522$24167952$2$F$20181101$20240827$20240802$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459728$RANBAXY$$53$YR$A$M$Y$$$20240911$$CN$US$US
241679532$24167953$2$F$20190901$20240827$20240802$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459727$RANBAXY$$72$YR$E$F$Y$$$20240911$$CN$US$US
241679541$24167954$1$I$20190710$20240722$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459973$RANBAXY$$62$YR$A$M$Y$131.52$KG$20240802$$LW$US$US
241679551$24167955$1$I$$20240722$20240802$20240802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459731$RANBAXY$$$$A$F$Y$$$20240802$$CN$US$US
241679562$24167956$2$F$$20240828$20240802$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459739$RANBAXY$$$$E$F$Y$59$KG$20240912$$CN$US$US
241679571$24167957$1$I$$20240730$20240802$20240802$PER$$US-HALEON-2190224$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241679581$24167958$1$I$$20240722$20240802$20240802$EXP$$KE-HQ SPECIALTY-US-2024INT000079$INTERCHEM$Saleh M, Barve M, Subbiah V, Papadopoulos KP, Morgensztern D, Mettu NB, et al. Open-label, dose-escalation FIGHT-101 study of pemigatinib combined with targeted therapy, chemotherapy, or immunotherapy in patients with advanced malignancies. ESMO open. 2024;9(7)$$$$$Y$$$20240802$$HP$KE$US
241679591$24167959$1$I$$20240729$20240802$20240802$PER$$US-JNJFOC-20240776946$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$PH$US$US
241679612$24167961$2$F$20170201$20240827$20240802$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459733$RANBAXY$$57$YR$A$M$Y$$$20240911$$CN$US$US
241679623$24167962$3$F$20240101$20240912$20240802$20240916$EXP$$DE-TAKEDA-2024TUS077014$TAKEDA$$58$YR$$F$Y$71$KG$20240916$$MD$DE$DE
241679633$24167963$3$F$20240725$20240903$20240802$20240908$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121465$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240909$$CN$US$US
241679645$24167964$5$F$20230501$20240909$20240802$20240918$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-116886$BRISTOL MYERS SQUIBB$$1$DY$N$F$Y$4.04$KG$20240918$$HP$DE$DE
241679651$24167965$1$I$$20240730$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121094$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$51.26$KG$20240802$$CN$US$US
241679671$24167967$1$I$20240101$20240719$20240802$20240802$PER$$US-SA-2024SA221091$SANOFI AVENTIS$$59$YR$A$F$Y$76$KG$20240802$$MD$US$US
241679682$24167968$2$F$$20240826$20240802$20240828$EXP$$US-UCBSA-2024038852$UCB$$$$$M$Y$$$20240828$$CN$US$US
241679691$24167969$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223206$SANOFI AVENTIS$$71$YR$E$F$Y$89$KG$20240802$$MD$US$US
241679701$24167970$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA219091$SANOFI AVENTIS$$51$YR$A$M$Y$119$KG$20240802$$MD$US$US
241679711$24167971$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224420$SANOFI AVENTIS$$$$E$F$Y$$$20240802$$MD$US$US
241679721$24167972$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224011$SANOFI AVENTIS$$$$A$M$Y$76.4$KG$20240802$$MD$US$US
241679731$24167973$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223816$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240802$$MD$US$US
241679741$24167974$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223700$SANOFI AVENTIS$$10$YR$C$F$Y$26.98$KG$20240802$$MD$US$US
241679751$24167975$1$I$20220802$20240724$20240802$20240802$PER$$US-SA-2024SA224165$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240802$$MD$US$US
241679761$24167976$1$I$$20240722$20240802$20240802$PER$$US-SA-2024SA219693$SANOFI AVENTIS$$$$$M$Y$$$20240802$$CN$US$US
241679773$24167977$3$F$20240701$20240813$20240802$20240827$PER$$US-SA-2024SA221522$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240827$$CN$US$US
241679781$24167978$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223852$SANOFI AVENTIS$$$$A$M$Y$$$20240802$$MD$US$US
241679791$24167979$1$I$20240201$20240724$20240802$20240802$PER$$US-SA-2024SA224464$SANOFI AVENTIS$$50$YR$A$F$Y$72$KG$20240802$$MD$US$US
241679801$24167980$1$I$20220821$20240725$20240802$20240802$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2022-24221$IPSEN$$75$YR$E$F$Y$$$20240802$$CN$GB$GB
241679811$24167981$1$I$$20240729$20240802$20240802$EXP$$US-BIOVITRUM-2024-US-010413$BIOVITRUM$$75$YR$$M$Y$$$20240802$$CN$US$US
241679821$24167982$1$I$20240701$20240724$20240802$20240802$PER$$US-SA-2024SA222391$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240802$$HP$US$US
241679831$24167983$1$I$20240501$20240724$20240802$20240802$PER$$US-SA-2024SA223845$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240802$$MD$US$US
241679841$24167984$1$I$$20240723$20240802$20240802$PER$$US-SA-2024SA221622$SANOFI AVENTIS$$$$C$F$Y$$$20240802$$MD$US$US
241679851$24167985$1$I$20240709$20240724$20240802$20240802$PER$$US-SA-2024SA223922$SANOFI AVENTIS$$45$YR$A$F$Y$83.9$KG$20240802$$MD$US$US
241679861$24167986$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223044$SANOFI AVENTIS$$$$A$F$Y$56.689$KG$20240802$$MD$US$US
241679881$24167988$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224212$SANOFI AVENTIS$$$$C$M$Y$$$20240802$$MD$US$US
241679891$24167989$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223062$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240802$$MD$US$US
241679901$24167990$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224052$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240802$$CN$US$US
241679911$24167991$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA213176$SANOFI AVENTIS$$$$A$M$Y$$$20240802$$MD$US$US
241679921$24167992$1$I$20240101$20240723$20240802$20240802$PER$$US-SA-2024SA223141$SANOFI AVENTIS$$57$YR$A$F$Y$46.493$KG$20240802$$MD$US$US
241679931$24167993$1$I$20040101$20240724$20240802$20240802$PER$$US-SA-2024SA222812$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240802$$CN$US$US
241679941$24167994$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA221987$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240802$$MD$US$US
241679952$24167995$2$F$20240723$20240809$20240802$20240820$PER$$US-SA-2024SA222018$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240820$$MD$US$US
241679961$24167996$1$I$20240601$20240724$20240802$20240802$PER$$US-SA-2024SA138938$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240802$$MD$US$US
241679971$24167997$1$I$20231101$20240724$20240802$20240802$PER$$US-SA-2024SA224202$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240802$$MD$US$US
241679982$24167998$2$F$20240101$20240819$20240802$20240821$PER$$US-SA-2024SA224079$SANOFI AVENTIS$$73$YR$E$F$Y$83$KG$20240821$$HP$US$US
241679991$24167999$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA110823$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240802$$MD$US$US
241680001$24168000$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA223684$SANOFI AVENTIS$$69$YR$E$F$Y$111.13$KG$20240802$$MD$US$US
241680011$24168001$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223719$SANOFI AVENTIS$$$$A$F$Y$58.5$KG$20240802$$MD$US$US
241680021$24168002$1$I$20240626$20240724$20240802$20240802$PER$$US-SA-2024SA223540$SANOFI AVENTIS$$82$YR$E$F$Y$64.8$KG$20240802$$MD$US$US
241680032$24168003$2$F$20240101$20240805$20240802$20240813$PER$$US-SA-2024SA227235$SANOFI AVENTIS$$73$YR$E$F$Y$68.039$KG$20240814$$CN$US$US
241680041$24168004$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223651$SANOFI AVENTIS$$$$A$F$Y$63.5$KG$20240802$$MD$US$US
241680051$24168005$1$I$20240501$20240724$20240802$20240802$PER$$US-SA-2024SA224059$SANOFI AVENTIS$$40$YR$A$F$Y$90.78$KG$20240802$$MD$US$US
241680064$24168006$4$F$20240101$20240923$20240802$20240926$PER$$US-SA-2024SA221833$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240926$$MD$US$US
241680072$24168007$2$F$20240101$20240913$20240802$20240919$PER$$US-SA-2024SA223687$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240919$$MD$US$US
241680081$24168008$1$I$20240708$20240723$20240802$20240802$DIR$FDA-CDER-CTU-2024-52972$$FDA-CTU$$$$$F$N$62.5$KG$20240723$N$$US$
241680091$24168009$1$I$20240401$20240724$20240802$20240802$PER$$US-SA-2024SA224159$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240802$$CN$US$US
241680101$24168010$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA223944$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240802$$MD$US$US
241680111$24168011$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA223622$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240802$$MD$US$US
241680121$24168012$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA223554$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240802$$MD$US$US
241680131$24168013$1$I$20240722$20240724$20240802$20240802$PER$$US-SA-2024SA221806$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240802$$MD$US$US
241680141$24168014$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224210$SANOFI AVENTIS$$$$A$F$Y$88.4$KG$20240802$$MD$US$US
241680151$24168015$1$I$20240701$20240724$20240802$20240802$PER$$US-SA-2024SA223612$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240802$$MD$US$US
241680161$24168016$1$I$20240601$20240724$20240802$20240802$PER$$US-SA-2024SA223646$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240802$$MD$US$US
241680171$24168017$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA222024$SANOFI AVENTIS$$$$$$Y$$$20240802$$MD$US$US
241680182$24168018$2$F$$20240726$20240802$20240809$PER$$US-SA-2024SA223941$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240809$$CN$US$US
241680191$24168019$1$I$$20240730$20240802$20240802$EXP$$US-PHARMAESSENTIA-US-2024-PEC-004239$PHARMAESSENTIA$$$$$F$Y$$$20240802$$HP$US$US
241680201$24168020$1$I$20240201$20240724$20240802$20240802$PER$$US-SA-2024SA223668$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240802$$CN$US$US
241680212$24168021$2$F$20240701$20240809$20240802$20240820$PER$$US-SA-2024SA223309$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240820$$MD$US$US
241680222$24168022$2$F$20240701$20240913$20240802$20240923$PER$$US-SA-2024SA221960$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240923$$MD$US$US
241680231$24168023$1$I$20240601$20240724$20240802$20240802$PER$$US-SA-2024SA223069$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240802$$MD$US$US
241680241$24168024$1$I$20240701$20240725$20240802$20240802$PER$$US-SA-2024SA223516$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240802$$MD$US$US
241680251$24168025$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223858$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240802$$MD$US$US
241680271$24168027$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA221645$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240802$$CN$US$US
241680281$24168028$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA066615$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240802$$MD$US$US
241680291$24168029$1$I$20240701$20240725$20240802$20240802$PER$$US-SA-2024SA223479$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240802$$MD$US$US
241680301$24168030$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA223132$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240802$$MD$US$US
241680311$24168031$1$I$20240601$20240725$20240802$20240802$PER$$US-SA-2024SA223022$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240802$$MD$US$US
241680321$24168032$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA224418$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240802$$MD$US$US
241680331$24168033$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223455$SANOFI AVENTIS$$22$YR$A$M$Y$66.5$KG$20240802$$MD$US$US
241680342$24168034$2$F$$20240829$20240802$20240919$PER$$US-SA-2024SA225627$SANOFI AVENTIS$$9$YR$C$F$Y$23.1$KG$20240919$$MD$US$US
241680351$24168035$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA223570$SANOFI AVENTIS$$60$YR$A$F$Y$72.8$KG$20240802$$MD$US$US
241680361$24168036$1$I$20240601$20240724$20240802$20240802$PER$$US-SA-2023SA288188$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240802$$MD$US$US
241680371$24168037$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223815$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240802$$MD$US$US
241680381$24168038$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA222431$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240802$$MD$US$US
241680391$24168039$1$I$$20240724$20240802$20240802$EXP$$SK-DSJP-DSJ-2024-138486$DAIICHI$$$$$F$Y$$$20240802$$MD$SK$SK
241680403$24168040$3$F$$20240826$20240802$20240826$PER$$US-ALXN-202407USA001853US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241680411$24168041$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223500$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240802$$MD$US$US
241680421$24168042$1$I$20240701$20240725$20240802$20240802$PER$$US-SA-2024SA223335$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240802$$PH$US$US
241680431$24168043$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223054$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240802$$MD$US$US
241680441$24168044$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA223428$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240802$$CN$US$US
241680451$24168045$1$I$20240731$20240725$20240802$20240802$PER$$US-SA-2024SA223281$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240802$$HP$US$US
241680461$24168046$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223809$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240802$$HP$US$US
241680471$24168047$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223748$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240802$$CN$US$US
241680481$24168048$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223176$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240802$$MD$US$US
241680491$24168049$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA224603$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240802$$CN$US$US
241680501$24168050$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA222094$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240802$$MD$US$US
241680512$24168051$2$F$$20240801$20240802$20240808$EXP$$US-009507513-2407USA015411$MERCK$$$$$F$Y$$$20240808$$CN$US$US
241680531$24168053$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA225612$SANOFI AVENTIS$$$$A$M$Y$122$KG$20240802$$MD$US$US
241680541$24168054$1$I$20240524$20240531$20240802$20240802$DIR$FDA-CDER-CTU-2024-52978$$FDA-CTU$$23$MON$$M$N$14.3$KG$20240531$N$$US$
241680551$24168055$1$I$20240124$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-52979$$FDA-CTU$$62$YR$$F$N$88.8$KG$20240801$N$$US$
241680561$24168056$1$I$$20240730$20240802$20240802$EXP$$CA-TAKEDA-2024TUS067369$TAKEDA$$$$$F$Y$$$20240802$$CN$CA$CA
241680572$24168057$2$F$$20240725$20240802$20240808$PER$$US-SA-2024SA223448$SANOFI AVENTIS$$5$YR$C$$Y$$$20240808$$HP$US$US
241680581$24168058$1$I$20230605$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-52976$$FDA-CTU$$76$YR$$M$N$90.8$KG$20240801$N$MD$US$
241680591$24168059$1$I$20240725$20240725$20240802$20240802$PER$$US-SA-2024SA222584$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240802$$MD$US$US
241680601$24168060$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA225963$SANOFI AVENTIS$$47$YR$A$F$Y$58.96$KG$20240802$$MD$US$US
241680611$24168061$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA223591$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240802$$MD$US$US
241680621$24168062$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA222493$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240802$$MD$US$US
241680631$24168063$1$I$20240701$20240725$20240802$20240802$PER$$US-SA-2024SA223253$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240802$$MD$US$US
241680641$24168064$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223379$SANOFI AVENTIS$$20$YR$A$F$Y$81.55$KG$20240802$$MD$US$US
241680652$24168065$2$F$20240701$20240814$20240802$20240829$PER$$US-SA-2024SA222400$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240829$$MD$US$US
241680661$24168066$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA223804$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240802$$MD$US$US
241680671$24168067$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA224209$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240802$$MD$US$US
241680681$24168068$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA224073$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240802$$MD$US$US
241680691$24168069$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA203946$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240802$$CN$US$US
241680701$24168070$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA225114$SANOFI AVENTIS$$$$A$F$Y$$$20240802$$MD$US$US
241680712$24168071$2$F$20240101$20240820$20240802$20240903$PER$$US-SA-2024SA224203$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240903$$MD$US$US
241680722$24168072$2$F$20240601$20240822$20240802$20240830$PER$$US-SA-2024SA225878$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240830$$MD$US$US
241680731$24168073$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA225245$SANOFI AVENTIS$$$$A$M$Y$$$20240802$$CN$US$US
241680741$24168074$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA093555$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240802$$MD$US$US
241680751$24168075$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA223452$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240802$$MD$US$US
241680761$24168076$1$I$20240708$20240725$20240802$20240802$PER$$US-SA-2024SA223232$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240802$$MD$US$US
241680771$24168077$1$I$20240720$20240725$20240802$20240802$PER$$US-SA-2024SA224056$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240802$$MD$US$US
241680781$24168078$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA224163$SANOFI AVENTIS$$$$A$M$Y$$$20240802$$MD$US$US
241680792$24168079$2$F$20240601$20240826$20240802$20240918$PER$$US-SA-2024SA224538$SANOFI AVENTIS$$67$YR$E$F$Y$61.23$KG$20240918$$MD$US$US
241680801$24168080$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223578$SANOFI AVENTIS$$64$YR$A$M$Y$84$KG$20240802$$MD$US$US
241680811$24168081$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223018$SANOFI AVENTIS$$$$T$M$Y$70.3$KG$20240802$$MD$US$US
241680821$24168082$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA223199$SANOFI AVENTIS$$3$YR$C$F$Y$13$KG$20240802$$MD$US$US
241680831$24168083$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA224719$SANOFI AVENTIS$$$$A$M$Y$$$20240802$$MD$US$US
241680841$24168084$1$I$20240611$20240731$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122151$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240802$$CN$US$US
241680852$24168085$2$F$$20240905$20240802$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122559$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$67.59$KG$20240916$$CN$US$US
241680861$24168086$1$I$20240705$20240723$20240802$20240802$DIR$FDA-CDER-CTU-2024-52975$$FDA-CTU$$$$$F$N$105.6$KG$20240723$N$$US$
241680871$24168087$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223956$SANOFI AVENTIS$$$$I$F$Y$$$20240802$$MD$US$US
241680881$24168088$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA223076$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240802$$MD$US$US
241680891$24168089$1$I$20240726$20240726$20240802$20240802$PER$$US-SA-2024SA224247$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240802$$MD$US$US
241680901$24168090$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA227198$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240802$$MD$US$US
241680911$24168091$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA196205$SANOFI AVENTIS$$53$YR$A$F$Y$86.168$KG$20240802$$MD$US$US
241680921$24168092$1$I$20240101$20240726$20240802$20240802$PER$$US-SA-2024SA225834$SANOFI AVENTIS$$69$YR$E$M$Y$81.64$KG$20240802$$MD$US$US
241680931$24168093$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA225760$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240802$$MD$US$US
241680941$24168094$1$I$20240101$20240726$20240802$20240802$PER$$US-SA-2024SA225629$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240802$$MD$US$US
241680951$24168095$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA223165$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240802$$MD$US$US
241680961$24168096$1$I$20240101$20240726$20240802$20240802$PER$$US-SA-2024SA222118$SANOFI AVENTIS$$$$A$$Y$$$20240802$$PH$US$US
241680971$24168097$1$I$$20240725$20240802$20240802$PER$$US-SA-2022SA117077$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240802$$MD$US$US
241680981$24168098$1$I$$20240725$20240802$20240802$PER$$US-SA-2023SA198273$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240802$$CN$US$US
241680991$24168099$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA223786$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240802$$MD$US$US
241681001$24168100$1$I$20240701$20240726$20240802$20240802$PER$$US-SA-2024SA224730$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240802$$MD$US$US
241681011$24168101$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA225754$SANOFI AVENTIS$$$$C$M$Y$$$20240802$$MD$US$US
241681021$24168102$1$I$20240701$20240726$20240802$20240802$PER$$US-SA-2024SA222345$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240802$$MD$US$US
241681031$24168103$1$I$20240714$20240725$20240802$20240802$PER$$US-SA-2024SA221654$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240802$$MD$US$US
241681041$24168104$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223834$SANOFI AVENTIS$$$$T$F$Y$59.184$KG$20240802$$MD$US$US
241681051$24168105$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA223890$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240802$$MD$US$US
241681061$24168106$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA225870$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240802$$MD$US$US
241681072$24168107$2$F$$20240725$20240802$20240809$PER$$US-SA-2024SA224039$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$CN$US$US
241681081$24168108$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA222433$SANOFI AVENTIS$$11$YR$C$$Y$$$20240802$$MD$US$US
241681091$24168109$1$I$20240101$20240726$20240802$20240802$PER$$US-SA-2024SA224520$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240802$$MD$US$US
241681101$24168110$1$I$20240601$20240726$20240802$20240802$PER$$US-SA-2024SA224085$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240802$$MD$US$US
241681111$24168111$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA223676$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240802$$MD$US$US
241681121$24168112$1$I$20240101$20240726$20240802$20240802$PER$$US-SA-2024SA224353$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240802$$MD$US$US
241681131$24168113$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA223056$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240802$$MD$US$US
241681141$24168114$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA224845$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240802$$MD$US$US
241681161$24168116$1$I$20220101$20240726$20240802$20240802$PER$$US-SA-2024SA223180$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240802$$MD$US$US
241681171$24168117$1$I$20240101$20240726$20240802$20240802$PER$$US-SA-2024SA223429$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240802$$MD$US$US
241681181$24168118$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA224425$SANOFI AVENTIS$$$$A$F$Y$61.2$KG$20240802$$MD$US$US
241681191$24168119$1$I$20240729$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151363$AMGEN$$68$YR$E$M$Y$$$20240802$$CN$US$US
241681201$24168120$1$I$$20240802$20240802$20240802$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043516$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240802$$CN$US$US
241681211$24168121$1$I$20240101$20240726$20240802$20240802$PER$$US-SA-2024SA224089$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240802$$MD$US$US
241681221$24168122$1$I$20240101$20240729$20240802$20240802$EXP$ES-AEMPS-1544307$ES-FreseniusKabi-FK202411189$FRESENIUS KABI$$64$YR$A$M$Y$$$20240802$$MD$ES$ES
241681241$24168124$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA225165$SANOFI AVENTIS$$$$C$$Y$$$20240802$$PH$US$US
241681251$24168125$1$I$20240725$20240726$20240802$20240802$PER$$US-SA-2024SA224751$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240802$$MD$US$US
241681262$24168126$2$F$$20240812$20240802$20240821$PER$$US-SA-2024SA225487$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240821$$MD$US$US
241681271$24168127$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA225358$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240802$$MD$US$US
241681281$24168128$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA226276$SANOFI AVENTIS$$67$YR$E$M$Y$83$KG$20240802$$MD$US$US
241681291$24168129$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA224602$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240802$$MD$US$US
241681301$24168130$1$I$$20240727$20240802$20240802$PER$$US-SA-2024SA224419$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240802$$MD$US$US
241681311$24168131$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA226254$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240802$$MD$US$US
241681321$24168132$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA225081$SANOFI AVENTIS$$59$YR$A$F$Y$89$KG$20240802$$MD$US$US
241681331$24168133$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA224436$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240802$$HP$US$US
241681342$24168134$2$F$20240728$20240807$20240802$20240815$PER$$US-SA-2024SA225364$SANOFI AVENTIS$$77$YR$E$M$Y$75.2$KG$20240815$$CN$US$US
241681351$24168135$1$I$$20240731$20240802$20240802$PER$$US-SA-2024SA228703$SANOFI AVENTIS$$$$A$F$Y$$$20240802$$MD$US$US
241681361$24168136$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA225501$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240802$$CN$US$US
241681381$24168138$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA224545$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240802$$MD$US$US
241681391$24168139$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA224899$SANOFI AVENTIS$$$$A$$Y$$$20240802$$MD$US$US
241681401$24168140$1$I$20240701$20240729$20240802$20240802$PER$$US-SA-2024SA224370$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240802$$CN$US$US
241681411$24168141$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA224061$SANOFI AVENTIS$$$$C$M$Y$$$20240802$$MD$US$US
241681421$24168142$1$I$$20240727$20240802$20240802$PER$$US-SA-2024SA224869$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240802$$MD$US$US
241681431$24168143$1$I$20240101$20240729$20240802$20240802$PER$$US-SA-2024SA225717$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240802$$MD$US$US
241681441$24168144$1$I$20240701$20240729$20240802$20240802$PER$$US-SA-2024SA225375$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240802$$MD$US$US
241681451$24168145$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA224944$SANOFI AVENTIS$$$$A$F$Y$83$KG$20240802$$MD$US$US
241681461$24168146$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA225593$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240802$$MD$US$US
241681471$24168147$1$I$$20240727$20240802$20240802$PER$$US-SA-2024SA224344$SANOFI AVENTIS$$$$E$M$Y$$$20240802$$MD$US$US
241681481$24168148$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA225180$SANOFI AVENTIS$$$$A$F$Y$$$20240802$$MD$US$US
241681491$24168149$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA225382$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240802$$MD$US$US
241681501$24168150$1$I$20240704$20240729$20240802$20240802$EXP$$DE-FreseniusKabi-FK202411854$FRESENIUS KABI$$70$YR$E$M$Y$70$KG$20240802$$MD$DE$DE
241681511$24168151$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA224647$SANOFI AVENTIS$$$$A$F$Y$$$20240802$$MD$US$US
241681522$24168152$2$F$20240101$20240821$20240802$20240905$PER$$US-SA-2024SA225580$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240905$$MD$US$US
241681531$24168153$1$I$$20240727$20240802$20240802$PER$$US-SA-2024SA225578$SANOFI AVENTIS$$$$A$F$Y$$$20240802$$MD$US$US
241681541$24168154$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA225448$SANOFI AVENTIS$$$$A$M$Y$$$20240802$$CN$US$US
241681551$24168155$1$I$$20240727$20240802$20240802$PER$$US-SA-2024SA225751$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240802$$MD$US$US
241681561$24168156$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA225094$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240802$$MD$US$US
241681571$24168157$1$I$20201101$20240728$20240802$20240802$PER$$US-SA-2024SA225310$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240802$$MD$US$US
241681581$24168158$1$I$$20240730$20240802$20240802$PER$$US-SA-2024SA226452$SANOFI AVENTIS$$$$$$Y$$$20240802$$PH$US$US
241681591$24168159$1$I$20240430$20240729$20240802$20240802$PER$$US-SA-2024SA227152$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240802$$CN$US$US
241681601$24168160$1$I$20190101$20240729$20240802$20240802$PER$$US-SA-2024SA225129$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240802$$CN$US$US
241681611$24168161$1$I$20240101$20240729$20240802$20240802$PER$$US-SA-2024SA225455$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240802$$MD$US$US
241681621$24168162$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA225381$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240802$$CN$US$US
241681631$24168163$1$I$$20240724$20240802$20240802$EXP$$ES-RDY-LIT/ESP/24/0011197$DR REDDYS$Espinosa MC, Espinosa MC, Soler Campos JA, Rodriguez SH, Moreno Belmonte MJ, Gonzalez Pardo MC, et al. Unravelling Transplant Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain. Blood. 142(1): doi:10.1182/blood-2023-172708.$$$$$Y$$$20240802$$HP$ES$ES
241681641$24168164$1$I$$20240730$20240802$20240802$PER$$US-APELLIS-2024-APL-0000600$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240802$$CN$US$US
241681651$24168165$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA225126$SANOFI AVENTIS$$$$E$F$Y$$$20240802$$MD$US$US
241681661$24168166$1$I$20240703$20240729$20240802$20240802$PER$$US-SA-2024SA225439$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240802$$MD$US$US
241681671$24168167$1$I$20240501$20240729$20240802$20240802$PER$$US-SA-2024SA225596$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240802$$MD$US$US
241681681$24168168$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA224657$SANOFI AVENTIS$$$$$$Y$$$20240802$$MD$US$US
241681691$24168169$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA225208$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240802$$MD$US$US
241681701$24168170$1$I$20240727$20240729$20240802$20240802$PER$$US-SA-2024SA224651$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240802$$MD$US$US
241681711$24168171$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA224684$SANOFI AVENTIS$$$$$F$Y$$$20240802$$CN$US$US
241681721$24168172$1$I$20230501$20240729$20240802$20240802$PER$$US-SA-2024SA225588$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240802$$MD$US$US
241681731$24168173$1$I$$20240724$20240802$20240802$EXP$$JP-BIOCON BIOLOGICS LIMITED-BBL2024004818$BIOCON$$$$$$Y$$$20240802$$MD$JP$JP
241681741$24168174$1$I$$20240724$20240802$20240802$EXP$$RU-TEVA-VS-3227027$TEVA$$$$$M$Y$$$20240802$$MD$RU$RU
241681751$24168175$1$I$$20240703$20240802$20240802$PER$$US-009507513-2407USA002041$MERCK$$$$$F$Y$$$20240802$$CN$US$US
241681761$24168176$1$I$$20240727$20240802$20240802$EXP$$US-SA-2024SA224417$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240802$$CN$US$US
241681771$24168177$1$I$20240101$20240724$20240802$20240802$EXP$$BR-TAKEDA-BR202023155$TAKEDA$$57$YR$$F$Y$80$KG$20240802$$CN$BR$BR
241681781$24168178$1$I$$20240723$20240802$20240802$EXP$$CA-TEVA-VS-3225794$TEVA$$44$YR$$F$Y$$$20240802$$HP$CA$CA
241681791$24168179$1$I$20240629$20240730$20240802$20240802$EXP$FR-AFSSAPS-LY2024001142$FR-SA-2024SA223115$SANOFI AVENTIS$$76$YR$E$F$Y$76$KG$20240802$$PH$FR$FR
241681801$24168180$1$I$$20240612$20240802$20240802$PER$$US-LUNDBECK-DKLU4000450$LUNDBECK$$$$$$Y$$$20240802$$CN$US$US
241681811$24168181$1$I$20240101$20240725$20240802$20240802$PER$$US-SA-2024SA223836$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240802$$MD$US$US
241681821$24168182$1$I$20240101$20240726$20240802$20240802$PER$$US-SA-2024SA224473$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240802$$MD$US$US
241681831$24168183$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA221686$SANOFI AVENTIS$$$$C$M$Y$$$20240802$$MD$US$US
241681841$24168184$1$I$20230101$20240725$20240802$20240802$EXP$CH-SM-2024-13633$CH-SA-2024SA224169$SANOFI AVENTIS$$$$$M$Y$2.9$KG$20240802$$PH$CH$CH
241681851$24168185$1$I$20240722$20240729$20240802$20240802$PER$$US-BAYER-2024A109647$BAYER$$35$YR$A$F$Y$$$20240802$$MD$US$US
241681861$24168186$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024AMR094452$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$US$US
241681871$24168187$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122800$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240802$$CN$US$US
241681882$24168188$2$F$20240502$20240827$20240802$20240904$EXP$$US-GSK-US2024AMR094346$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$US$US
241681891$24168189$1$I$20240415$20240721$20240802$20240802$PER$$US-JNJFOC-20240763619$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240802$$CN$US$US
241681901$24168190$1$I$20221013$20221031$20240802$20240802$EXP$$ES-AstraZeneca-2022A364605$ASTRAZENECA$$70$YR$$F$Y$$$20240802$$CN$ES$
241681911$24168191$1$I$20240716$20240726$20240802$20240802$EXP$$CN-AstraZeneca-2024A173185$ASTRAZENECA$$24392$DY$$F$Y$34.5$KG$20240802$$MD$CN$
241681921$24168192$1$I$$20221114$20240802$20240802$EXP$$US-AstraZeneca-2022A373135$ASTRAZENECA$$$$$F$Y$$$20240802$$HP$US$
241681931$24168193$1$I$20240722$20240726$20240802$20240802$EXP$$GB-AstraZeneca-2024A170782$ASTRAZENECA$$63$YR$$M$Y$79$KG$20240802$$MD$GB$
241681941$24168194$1$I$$20240726$20240802$20240802$EXP$$CA-GSK-CA2024094210$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$CA$CA
241681951$24168195$1$I$$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A175763$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241681961$24168196$1$I$$20220105$20240802$20240802$EXP$$US-AstraZeneca-2021A848176$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241681971$24168197$1$I$$20211222$20240802$20240802$EXP$$US-AstraZeneca-2021A896190$ASTRAZENECA$$$$$F$Y$$$20240802$$HP$US$
241681982$24168198$2$F$$20240731$20240802$20240808$EXP$$CA-AstraZeneca-2024A172028$ASTRAZENECA$$$$$F$Y$$$20240808$$MD$CA$
241681992$24168199$2$F$20240201$20240902$20240802$20240909$EXP$$SK-TAKEDA-2024TUS077679$TAKEDA$$75$YR$$F$Y$$$20240909$$MD$SK$SK
241682001$24168200$1$I$20240711$20240726$20240802$20240802$PER$$US-BAYER-2024A109910$BAYER$$$$$F$Y$$$20240802$$CN$US$US
241682012$24168201$2$F$$20240827$20240802$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121830$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240830$$CN$US$US
241682022$24168202$2$F$$20240828$20240802$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122393$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$56.25$KG$20240830$$CN$US$US
241682031$24168203$1$I$20240617$20240729$20240802$20240802$EXP$$CN-MFDS-2021000061-2408CHN000461$MERCK$$61$YR$$M$Y$71$KG$20240802$$HP$CN$CN
241682042$24168204$2$F$$20240808$20240802$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122330$BRISTOL MYERS SQUIBB$$40$YR$A$M$Y$$$20240813$$HP$US$US
241682051$24168205$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122663$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240802$$CN$US$US
241682061$24168206$1$I$20240101$20240726$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122223$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$88$KG$20240802$$HP$US$US
241682071$24168207$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121821$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240802$$CN$US$US
241682081$24168208$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190202$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241682092$24168209$2$F$20240725$20240810$20240802$20240812$EXP$$CO-UCBSA-2024038918$UCB$$81$YR$$M$Y$$$20240812$$CN$CO$CO
241682111$24168211$1$I$$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53104$$FDA-CTU$$$$$F$N$$$20240801$N$HP$US$
241682131$24168213$1$I$$20240731$20240802$20240802$EXP$$IL-ROCHE-10000045812$ROCHE$$$$A$F$Y$$$20240802$$CN$IL$IL
241682141$24168214$1$I$20240502$20240725$20240802$20240802$EXP$$CN-FreseniusKabi-FK202411727$FRESENIUS KABI$$51$YR$A$M$Y$$$20240802$$HP$CN$CN
241682153$24168215$3$F$20240528$20240802$20240802$20240819$PER$$US-Calliditas-2024CAL01100$CALLIDITAS THERAPEUTICS$$23$YR$A$F$Y$107.5$KG$20240819$$CN$US$US
241682174$24168217$4$F$20240101$20240916$20240802$20240923$PER$$US-SA-2024SA223173$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240923$$MD$US$US
241682182$24168218$2$F$20240101$20240731$20240802$20240809$PER$$US-SA-2024SA223797$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240809$$MD$US$US
241682191$24168219$1$I$20240515$20240724$20240802$20240802$PER$$US-SA-2024SA223777$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240802$$MD$US$US
241682201$24168220$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53097$$FDA-CTU$$61$YR$$M$N$$$20240802$N$$US$
241682211$24168221$1$I$$20240724$20240802$20240802$EXP$$CA-TEVA-VS-3226580$TEVA$$74$YR$$F$Y$$$20240802$$MD$CA$CA
241682221$24168222$1$I$$20240726$20240802$20240802$EXP$$CA-GSK-CA2024094799$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$CA$CA
241682231$24168223$1$I$20240716$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121913$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240802$$CN$US$US
241682241$24168224$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53077$$FDA-CTU$$42$YR$$F$N$81.19$KG$20240802$N$$US$
241682251$24168225$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121514$BRISTOL MYERS SQUIBB$$73$YR$E$$Y$$$20240802$$CN$US$US
241682261$24168226$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121662$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240802$$HP$US$US
241682271$24168227$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121956$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$77$KG$20240802$$PH$US$US
241682281$24168228$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121799$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240802$$CN$US$US
241682291$24168229$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121828$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240802$$CN$US$US
241682362$24168236$2$F$$20240725$20240802$20240802$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-14912$IPSEN$$$$$F$Y$$$20240802$$HP$US$US
241682372$24168237$2$F$20240730$20240813$20240802$20240814$PER$$US-AMGEN-USASP2024151373$AMGEN$$76$YR$E$F$Y$$$20240814$$CN$US$US
241682381$24168238$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152154$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241682403$24168240$3$F$20240728$20240821$20240802$20240828$PER$$US-APELLIS-2024-APL-0000603$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$US$US
241682411$24168241$1$I$$20240613$20240802$20240802$PER$$US-LUNDBECK-DKLU4000512$LUNDBECK$$$$$$Y$$$20240802$$CN$US$US
241682421$24168242$1$I$$20240730$20240802$20240802$PER$$US-ROCHE-10000045006$ROCHE$$$$A$F$Y$$$20240802$$CN$US$US
241682431$24168243$1$I$$20240726$20240802$20240802$EXP$GB-MHRA-MED-202407261307507540-CDNYM$GB-TEVA-VS-3226977$TEVA$$71$YR$$M$Y$$$20240802$$PH$GB$GB
241682441$24168244$1$I$$20240724$20240802$20240802$EXP$$ALC2024US003548$ALCON$Avery Zhou, M.A., Anja Rabljenovic, B.S., and Thomas L. Steinemann, M.D.. Proparacaine Overuse in Corneal Abrasions at the Emergency Department: A Case Series. Proparacaine Overuse in Corneal Abrasions. 2024;50 (6):274-275$28$YR$$M$Y$$$20240802$$HP$US$US
241682451$24168245$1$I$20240717$20240726$20240802$20240802$EXP$$CN-AstraZeneca-2024A173261$ASTRAZENECA$$19995$DY$$M$Y$72$KG$20240802$$MD$CN$
241682461$24168246$1$I$$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173694$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241682471$24168247$1$I$$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173511$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241682481$24168248$1$I$$20240726$20240802$20240802$EXP$$IT-AstraZeneca-2024A173455$ASTRAZENECA$$$$$F$Y$$$20240802$$MD$IT$
241682492$24168249$2$F$$20240822$20240802$20240829$EXP$$CA-GSK-CA2024094782$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$CA$CA
241682501$24168250$1$I$20240604$20240729$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120199$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240802$$HP$US$US
241682511$24168251$1$I$$20240729$20240802$20240802$PER$$US-ROCHE-10000042056$ROCHE$$63$YR$A$M$Y$$$20240802$$CN$US$US
241682521$24168252$1$I$20240606$20240723$20240802$20240802$EXP$$FR-AstraZeneca-2024A175405$ASTRAZENECA$$22$YR$$F$Y$94$KG$20240802$$MD$FR$
241682531$24168253$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000046806$ROCHE$$$$$$Y$$$20240802$$CN$US$US
241682541$24168254$1$I$$20240731$20240802$20240802$PER$$US-ROCHE-10000047482$ROCHE$$$$$$Y$$$20240802$$PH$US$US
241682552$24168255$2$F$$20240801$20240802$20240809$EXP$$US-AstraZeneca-2024A170079$ASTRAZENECA$$56$YR$$M$Y$$$20240809$$CN$US$
241682561$24168256$1$I$20240729$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151737$AMGEN$$65$YR$E$M$Y$$$20240802$$CN$US$US
241682571$24168257$1$I$20240719$20240719$20240802$20240802$30DAY$$CA-PFIZER INC-202400219434$PFIZER$$$$$F$Y$$$20240802$$PH$CA$CA
241682581$24168258$1$I$20240620$20240725$20240802$20240802$EXP$$CN-FreseniusKabi-FK202411729$FRESENIUS KABI$$71$YR$E$M$Y$90$KG$20240802$$HP$CN$CN
241682591$24168259$1$I$20240710$20240730$20240802$20240802$EXP$SE-FreseniusKabi-FK202411909$SE-FreseniusKabi-FK202411909$FRESENIUS KABI$$54$YR$A$F$Y$58$KG$20240802$$MD$SE$SE
241682601$24168260$1$I$20240702$20240729$20240802$20240802$EXP$FR-AFSSAPS-BX2024001510$FR-FreseniusKabi-FK202411901$FRESENIUS KABI$$37$YR$A$F$Y$52$KG$20240802$$MD$FR$FR
241682611$24168261$1$I$$20240724$20240802$20240802$EXP$$CA-TEVA-VS-3225850$TEVA$$$$$$Y$$$20240802$$HP$CA$CA
241682621$24168262$1$I$20240101$20240729$20240802$20240802$EXP$$US-ABBVIE-5859536$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241682641$24168264$1$I$$20240723$20240802$20240802$EXP$$US-RDY-LIT/USA/24/0011046$DR REDDYS$Rahman O, Javed F, Iqbal M, Fulkerson Z, Chaudhry A, Pasha N, et al. Progressive Refractory Interstitial Lung Disease Due to Recurrent Aspiration in Bulimia Nervosa. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: A2048. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2048.$44$YR$A$F$Y$$$20240802$$HP$US$US
241682651$24168265$1$I$20240531$20240729$20240802$20240802$EXP$FR-AFSSAPS-LL2024001423$FR-009507513-2407FRA015170$MERCK$$66$YR$$F$Y$57$KG$20240802$$PH$FR$FR
241682671$24168267$1$I$20240525$20240731$20240802$20240802$EXP$$US-ABBVIE-5863449$ABBVIE$$62$YR$$F$Y$$$20240802$$CN$US$US
241682681$24168268$1$I$$20240614$20240802$20240802$PER$$US-LUNDBECK-DKLU4000569$LUNDBECK$$$$$$Y$$$20240802$$CN$US$US
241682691$24168269$1$I$$20240726$20240802$20240802$EXP$$CA-ABBVIE-5864324$ABBVIE$$$$A$M$Y$$$20240802$$CN$CA$CA
241682701$24168270$1$I$$20240726$20240802$20240802$PER$$US-009507513-2407USA015491$MERCK$$$$$M$Y$$$20240802$$CN$US$US
241682712$24168271$2$F$$20240830$20240802$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122437$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$43.54$KG$20240904$$CN$US$US
241682721$24168272$1$I$20240101$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122099$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240802$$HP$US$US
241682732$24168273$2$F$$20240827$20240802$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121558$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$119.75$KG$20240829$$CN$US$US
241682741$24168274$1$I$20240101$20240719$20240802$20240802$PER$$US-KARYOPHARM-2024KPT001340$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240802$$CN$US$US
241682751$24168275$1$I$$20240731$20240802$20240802$PER$$US-ABBVIE-5864084$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241682762$24168276$2$F$20240101$20240731$20240802$20240809$EXP$$CA-PFIZER INC-202400004549$PFIZER$$80$YR$$F$Y$$$20240809$$HP$CA$CA
241682771$24168277$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152736$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241682781$24168278$1$I$$20240723$20240802$20240802$EXP$$US-FARMAPROD-202407-2720$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240802$$CN$US$US
241682791$24168279$1$I$20240101$20240716$20240802$20240802$PER$$US-INSUD PHARMA-2407US05731$INSUD PHARMA$$$$$$Y$$$20240802$$CN$US$US
241682801$24168280$1$I$$20240715$20240802$20240802$PER$$US-INSUD PHARMA-2407US05696$INSUD PHARMA$$$$$$Y$$$20240802$$CN$US$US
241682811$24168281$1$I$20240101$20240715$20240802$20240802$PER$$US-INSUD PHARMA-2407US05699$INSUD PHARMA$$$$$$Y$$$20240802$$CN$US$US
241682821$24168282$1$I$20240501$20240715$20240802$20240802$PER$$US-INSUD PHARMA-2407US05697$INSUD PHARMA$$$$$$Y$$$20240802$$CN$US$US
241682831$24168283$1$I$$20240715$20240802$20240802$PER$$US-INSUD PHARMA-2407US05691$INSUD PHARMA$$$$$$Y$$$20240802$$CN$US$US
241682841$24168284$1$I$$20240725$20240802$20240802$EXP$$JP-ALXN-202404JPN001321JP$ALEXION PHARMACEUTICALS$$17$YR$$M$Y$58$KG$20240802$$MD$JP$JP
241682851$24168285$1$I$$20240724$20240802$20240802$EXP$$CA-TEVA-VS-3226539$TEVA$$76$YR$$F$Y$$$20240802$$MD$CA$CA
241682871$24168287$1$I$20240724$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122606$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240802$$CN$US$US
241682881$24168288$1$I$$20240722$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116905$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240802$$CN$US$US
241682891$24168289$1$I$$20240730$20240802$20240802$PER$$US-ABBVIE-5862316$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241682903$24168290$3$F$20240101$20240816$20240802$20240825$PER$$US-AMGEN-USASP2024150261$AMGEN$$68$YR$E$F$Y$$$20240825$$CN$US$US
241682911$24168291$1$I$20220701$20240729$20240802$20240802$EXP$ES-AEMPS-1549769$ES-FreseniusKabi-FK202411794$FRESENIUS KABI$$36$YR$A$F$Y$$$20240802$$MD$ES$ES
241682922$24168292$2$F$20240715$20240805$20240802$20240812$EXP$FR-AFSSAPS-PV2024000688$FR-FreseniusKabi-FK202411930$FRESENIUS KABI$$7$YR$C$M$Y$$$20240812$$MD$FR$FR
241682931$24168293$1$I$$20240722$20240802$20240802$PER$$US-RDY-LIT/USA/24/0011097$DR REDDYS$Field J, Shah ND, Memel ZD, Mahadevan UD, Beck KD. The Crohn^s Disease Exclusion Diet as Treatment for Medication- Refractory Disease. Digestive Diseases and Sciences. 2024 May;69: 1608-1612. doi:10.1007/s10620-024-08345-5.$32$YR$A$F$Y$$$20240802$$HP$US$US
241682941$24168294$1$I$20240101$20240730$20240802$20240802$EXP$FI-FIMEA-202402681$FI-FreseniusKabi-FK202411896$FRESENIUS KABI$$73$YR$E$F$Y$$$20240802$$HP$FI$FI
241682951$24168295$1$I$$20240726$20240802$20240802$EXP$$US-FreseniusKabi-FK202411991$FRESENIUS KABI$Abdelal Q, Isern S, Najjar N. Azith and the Myth. American Journal of Respiratory and Critical Care Medicine. 2024 May;209-A2032.$73$YR$E$F$Y$$$20240802$$HP$US$US
241682961$24168296$1$I$$20240723$20240802$20240802$EXP$$US-RDY-LIT/USA/24/0011103$DR REDDYS$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024 May;209(0): doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A3706?role=tab.$31$YR$A$F$Y$$$20240802$$HP$US$US
241682971$24168297$1$I$$20240724$20240802$20240802$EXP$$CA-TEVA-VS-3225849$TEVA$$$$$$Y$$$20240802$$HP$CA$CA
241682981$24168298$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA224198$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240802$$MD$US$US
241683001$24168300$1$I$$20240727$20240802$20240802$PER$$US-SA-2024SA224109$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240802$$HP$US$US
241683011$24168301$1$I$20240501$20240726$20240802$20240802$PER$$US-SA-2024SA225227$SANOFI AVENTIS$$74$YR$E$M$Y$98.3$KG$20240802$$MD$US$US
241683021$24168302$1$I$$20240726$20240802$20240802$EXP$$FR-AstraZeneca-2024A172533$ASTRAZENECA$$$$$M$Y$$$20240802$$MD$FR$
241683032$24168303$2$F$$20240731$20240802$20240808$EXP$$JP-AstraZeneca-2024A171262$ASTRAZENECA$$70$YR$$F$Y$$$20240808$$PH$JP$
241683041$24168304$1$I$$20240730$20240802$20240802$EXP$$SA-JNJFOC-20240784824$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$HP$SA$SA
241683051$24168305$1$I$$20240731$20240802$20240802$PER$$US-JNJFOC-20240802182$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240802$$CN$US$US
241683061$24168306$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53102$$FDA-CTU$$77$YR$$F$N$$$20240802$N$$US$
241683071$24168307$1$I$$20240730$20240802$20240802$EXP$$US-JNJFOC-20240783065$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$HP$US$US
241683081$24168308$1$I$20240701$20240726$20240802$20240802$EXP$$BR-JNJFOC-20240777801$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240802$$CN$BR$BR
241683091$24168309$1$I$20240711$20240801$20240802$20240802$EXP$FR-AFSSAPS-TS2024000868$FR-JNJFOC-20240805130$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240802$$MD$FR$FR
241683121$24168312$1$I$$20240728$20240802$20240802$EXP$$VN-AstraZeneca-2024A173686$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$VN$
241683141$24168314$1$I$20240713$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A175108$ASTRAZENECA$$17068$DY$$F$Y$$$20240802$$CN$US$
241683151$24168315$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118053$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$90.72$KG$20240802$$MD$US$US
241683161$24168316$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122853$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240802$$CN$US$US
241683171$24168317$1$I$$20240724$20240802$20240802$30DAY$$US-GSK-US2024AMR094086$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241683181$24168318$1$I$$20240730$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122050$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240802$$CN$US$US
241683201$24168320$1$I$$20240726$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120484$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$89.6$KG$20240802$$PH$US$US
241683211$24168321$1$I$$20240725$20240802$20240802$EXP$$CN-AstraZeneca-2024A171299$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$CN$
241683221$24168322$1$I$$20240723$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117260$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240802$$CN$US$US
241683231$24168323$1$I$20240101$20240727$20240802$20240802$EXP$$JP-AstraZeneca-2024A173372$ASTRAZENECA$$74$YR$$F$Y$$$20240802$$MD$JP$
241683241$24168324$1$I$$20240724$20240802$20240802$EXP$$CA-CHATTEMPRD-2024OHG025894$CHATTEM$$77$YR$E$F$Y$$$20240802$$HP$CA$CA
241683261$24168326$1$I$20231001$20240725$20240802$20240802$PER$$US-SA-2024SA224525$SANOFI AVENTIS$$68$YR$E$F$Y$79.8$KG$20240802$$MD$US$US
241683271$24168327$1$I$20230801$20240725$20240802$20240802$PER$$US-SA-2024SA223766$SANOFI AVENTIS$$1$YR$I$M$Y$10$KG$20240802$$MD$US$US
241683281$24168328$1$I$$20240725$20240802$20240802$EXP$$US-TEVA-VS-3225312$TEVA$$39$YR$$F$Y$$$20240802$$PH$US$US
241683291$24168329$1$I$$20240731$20240802$20240802$PER$$US-ABBVIE-5863512$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241683301$24168330$1$I$$20240721$20240802$20240802$EXP$$IN-Accord-438286$ACCORD$Pradhan A, Bhandari M, Vishwakarma P, Sethi R. Clopidogrel resistance and its relevance: Current concepts. J Family Med Prim Care 2024;13:2187-99.$53$YR$A$F$Y$$$20240802$$HP$IN$IN
241683311$24168331$1$I$$20240723$20240802$20240802$EXP$$CN-JNJFOC-20240772448$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$HP$CN$CN
241683321$24168332$1$I$$20240731$20240802$20240802$EXP$$CA-MYLANLABS-2024M1071398$MYLAN$$35$YR$$F$Y$$$20240802$$CN$CA$CA
241683331$24168333$1$I$19710822$20240802$20240802$20240802$DIR$712527$$FDA-CTU$$0$YR$$F$N$$$20240802$N$$US$
241683341$24168334$1$I$$20240726$20240802$20240802$EXP$$US-MYLANLABS-2024M1071277$MYLAN$Moon YM, Park SE, Smith-Hicks C, Hauptman A. Resolution of severe neurobehavioral difficulties in an individual with Primrose syndrome with sertraline. Am-J-Med-Genet-A 2024; 194 (8).$13$YR$$M$Y$$$20240802$$HP$US$US
241683351$24168335$1$I$20240501$20240731$20240802$20240802$EXP$$GB-MYLANLABS-2024M1071805$MYLAN$$56$YR$$M$Y$72$KG$20240802$$MD$GB$GB
241683362$24168336$2$F$20240724$20240826$20240802$20240904$30DAY$$US-GSK-US2024092981$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240904$$CN$US$US
241683371$24168337$1$I$$20240726$20240802$20240802$EXP$$ES-AMGEN-ESPSP2024149252$AMGEN$Danes I.; Bosch M.; Ballarin E. et al.. Effectiveness and safety of alirocumab and evolocumab for hypercholesterolemia in a population with high cardiovascular risk. Medicina Clinica. 2024;2024:1-6$$$$$Y$$$20240802$$HP$ES$ES
241683381$24168338$1$I$20240724$20240725$20240802$20240802$EXP$$GB-TEVA-VS-3225884$TEVA$$10$YR$$M$Y$50$KG$20240802$$HP$GB$GB
241683391$24168339$1$I$$20240729$20240802$20240802$EXP$$PT-FreseniusKabi-FK202411892$FRESENIUS KABI$$71$YR$E$F$Y$$$20240802$$MD$PT$PT
241683401$24168340$1$I$20240701$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53075$$FDA-CTU$$89$YR$$M$N$$$20240802$N$$US$
241683411$24168341$1$I$$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53141$$FDA-CTU$$$$$F$N$$$20240801$N$HP$US$
241683431$24168343$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53071$$FDA-CTU$$41$YR$$F$N$$$20240802$N$$US$
241683451$24168345$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122492$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240802$$HP$US$US
241683461$24168346$1$I$$20240730$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121093$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$82.55$KG$20240802$$HP$US$US
241683471$24168347$1$I$$20240725$20240802$20240802$PER$$US-ALXN-202407USA001842US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241683481$24168348$1$I$$20240724$20240802$20240802$EXP$$CA-TEVA-VS-3225851$TEVA$$$$$$Y$$$20240802$$HP$CA$CA
241683491$24168349$1$I$20240718$20240728$20240802$20240802$EXP$$CN-GSK-CN2024APC094525$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$HP$CN$CN
241683521$24168352$1$I$20240125$20240729$20240802$20240802$DIR$FDA-CDER-CTU-2024-53067$$FDA-CTU$$73$YR$$F$N$51.6$KG$20240729$N$HP$US$
241683531$24168353$1$I$20240802$20240802$20240802$20240802$DIR$712534$$FDA-CTU$$68$YR$$F$N$$$20240802$N$HP$US$
241683541$24168354$1$I$$20240802$20240802$20240802$DIR$712540$$FDA-CTU$$$$$UNK$N$$$20240802$$CN$US$
241683561$24168356$1$I$20240619$20240729$20240802$20240802$DIR$FDA-CDER-CTU-2024-53064$$FDA-CTU$$71$YR$$M$N$94.2$KG$20240729$N$HP$US$
241683581$24168358$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA222389$SANOFI AVENTIS$$$$A$F$Y$95.2$KG$20240802$$MD$US$US
241683591$24168359$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA221285$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240802$$MD$US$US
241683601$24168360$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA221691$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240802$$MD$US$US
241683611$24168361$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA221847$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240802$$MD$US$US
241683621$24168362$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223863$SANOFI AVENTIS$$$$T$M$Y$86.183$KG$20240802$$MD$US$US
241683631$24168363$1$I$20240717$20240722$20240802$20240802$EXP$$GB-CIPLA LTD.-2024GB07989$CIPLA$$$$$$Y$$$20240802$$MD$GB$GB
241683641$24168364$1$I$20231101$20240730$20240802$20240802$EXP$$DE-SHIONOGI, INC-2024001866$SHIONOGI$$$$$$Y$$$20240802$$MD$DE$DE
241683651$24168365$1$I$20231218$20240723$20240802$20240802$EXP$$DE-DSJP-DSJ-2024-116869$DAIICHI$$51$YR$$F$Y$61$KG$20240802$$MD$DE$DE
241683661$24168366$1$I$$20240730$20240802$20240802$EXP$$US-ORGANON-O2407USA002978$ORGANON$$$$$F$Y$$$20240802$$CN$US$US
241683671$24168367$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121908$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240802$$CN$US$US
241683683$24168368$3$F$$20240913$20240802$20240919$EXP$$JP-JNJFOC-20220319070$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240919$$MD$JP$JP
241683691$24168369$1$I$20240129$20240729$20240802$20240802$EXP$PT-INFARMED-R202401-770$PT-FreseniusKabi-FK202411891$FRESENIUS KABI$$43$YR$A$F$Y$$$20240802$$PH$PT$PT
241683711$24168371$1$I$$20240726$20240802$20240802$EXP$$US-BIOGEN-2024BI01273740$BIOGEN$$$$$F$Y$$$20240802$$HP$US$US
241683721$24168372$1$I$$20240723$20240802$20240802$EXP$$CA-APOTEX-2024AP008749$APOTEX$$61$YR$$M$Y$$$20240802$$PH$CA$CA
241683731$24168373$1$I$$20240723$20240802$20240802$EXP$$US-RDY-LIT/USA/24/0011102$DR REDDYS$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2024 May;209(0): doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A3706?role=tab.$33$YR$A$M$Y$$$20240802$$HP$US$US
241683742$24168374$2$F$$20240809$20240802$20240813$PER$$US-VERTEX PHARMACEUTICALS-2024-012492$VERTEX$$10$YR$$M$Y$$$20240813$$CN$US$US
241683751$24168375$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA224404$SANOFI AVENTIS$$$$E$M$Y$$$20240802$$CN$US$US
241683761$24168376$1$I$20240723$20240725$20240802$20240802$PER$$US-SA-2024SA226314$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240802$$MD$US$US
241683771$24168377$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA222585$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240802$$MD$US$US
241683781$24168378$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224051$SANOFI AVENTIS$$$$T$F$Y$$$20240802$$MD$US$US
241683791$24168379$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA221977$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240802$$MD$US$US
241683801$24168380$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224429$SANOFI AVENTIS$$$$C$M$Y$$$20240802$$MD$US$US
241683812$24168381$2$F$$20240722$20240802$20240806$EXP$$US-SIMILASAN-2024USSIMSPO00128$SIMILASAN$$$$$$Y$$$20240806$$CN$US$US
241683822$24168382$2$F$20231130$20240806$20240802$20240809$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-088303$REGENERON$$$$$F$Y$$$20240809$$MD$US$US
241683831$24168383$1$I$$20240729$20240802$20240802$EXP$$CA-JNJFOC-20240783727$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240802$$HP$CA$CA
241683842$24168384$2$F$20240601$20240916$20240802$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122269$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240918$$HP$US$US
241683851$24168385$1$I$$20240801$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122632$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240802$$CN$US$US
241683861$24168386$1$I$$20240729$20240802$20240802$EXP$NL-LRB-00992851$NL-MYLANLABS-2024M1071393$MYLAN$$71$YR$$F$Y$54$KG$20240802$$CN$NL$NL
241683881$24168388$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019889$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240802$$CN$US$US
241683901$24168390$1$I$20220101$20240730$20240802$20240802$EXP$$CA-JNJFOC-20221053629$JOHNSON AND JOHNSON$$71$YR$E$F$Y$58.112$KG$20240802$$PH$CA$CA
241683911$24168391$1$I$$20240613$20240802$20240802$PER$$US-LUNDBECK-DKLU4000496$LUNDBECK$$$$$$Y$$$20240802$$CN$US$US
241683922$24168392$2$F$20240611$20240813$20240802$20240820$EXP$$AR-GSK-AR2024AMR073976$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$AR$AR
241683931$24168393$1$I$20240712$20240725$20240802$20240802$EXP$GB-MHRA-MED-202407251503395980-STHPD$GB-TEVA-VS-3226426$TEVA$$57$YR$$M$Y$79$KG$20240802$$CN$GB$GB
241683941$24168394$1$I$$20240724$20240802$20240802$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-14909$IPSEN$$$$$$Y$$$20240802$$HP$US$US
241683951$24168395$1$I$$20240729$20240802$20240802$EXP$$CA-BAYER-2024A109863$BAYER$$62$YR$A$M$Y$$$20240802$$HP$CA$CA
241683971$24168397$1$I$20240709$20240801$20240802$20240802$EXP$$US-TAKEDA-2024TUS077472$TAKEDA$$53$YR$$M$Y$107$KG$20240802$$MD$US$US
241683981$24168398$1$I$20240731$20240731$20240802$20240802$EXP$GB-MHRA-MED-202407310712289880-LQJTH$GB-ABBVIE-5862841$ABBVIE$$$$$$Y$$$20240802$$CN$GB$GB
241683991$24168399$1$I$$20240731$20240802$20240802$EXP$$CA-TAKEDA-2024TUS077718$TAKEDA$$$$$M$Y$$$20240802$$CN$CA$CA
241684001$24168400$1$I$20240802$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53167$$FDA-CTU$$71$YR$$F$N$$$20240802$N$$US$
241684011$24168401$1$I$$20240711$20240802$20240802$PER$$US-JNJFOC-20240782986$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$CN$US$US
241684021$24168402$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190177$Haleon PLC$$$$$$Y$$$20240802$$CN$US$US
241684034$24168403$4$F$20240725$20240905$20240802$20240905$30DAY$$US-PFIZER INC-202400224722$PFIZER$$$$$F$Y$$$20240905$$CN$US$US
241684053$24168405$3$F$20240101$20240906$20240802$20240909$30DAY$$PR-PFIZER INC-202400227088$PFIZER$$10$YR$$M$Y$$$20240909$$CN$PR$PR
241684063$24168406$3$F$20240101$20240904$20240802$20240904$30DAY$$US-PFIZER INC-202400224046$PFIZER$$10$YR$$F$Y$54.422$KG$20240904$$CN$US$US
241684073$24168407$3$F$20240701$20240828$20240802$20240903$30DAY$$US-PFIZER INC-202400222169$PFIZER$$14$YR$$M$Y$52.154$KG$20240903$$CN$US$US
241684083$24168408$3$F$$20240903$20240802$20240905$30DAY$$US-PFIZER INC-202400223834$PFIZER$$11$YR$$F$Y$$$20240905$$CN$US$US
241684091$24168409$1$I$$20240730$20240802$20240802$EXP$$IN-AstraZeneca-2024A173692$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$IN$
241684101$24168410$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A173008$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241684111$24168411$1$I$$20240725$20240802$20240802$EXP$$ZA-AstraZeneca-2024A171005$ASTRAZENECA$$59$YR$$F$Y$$$20240802$$CN$ZA$
241684121$24168412$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A172409$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241684131$24168413$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170620$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241684141$24168414$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170467$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241684151$24168415$1$I$20221224$20240723$20240802$20240802$EXP$$KR-TAKEDA-2023TUS005770$TAKEDA$$50$YR$$F$Y$98.4$KG$20240802$$CN$KR$KR
241684161$24168416$1$I$$20240724$20240802$20240802$EXP$$ES-RDY-LIT/ESP/24/0011198$DR REDDYS$Espinosa MC, Hernandez Garcia MT, Soler Campos JA, Rodriguez SH, Moreno Belmonte MJ, Gonzalez Pardo MC, et al. Unravelling Transplant Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain. Blood. 142(1): 4694-4695. doi:10.1182/blood-2023-172708.$$$$$Y$$$20240802$$HP$ES$ES
241684171$24168417$1$I$$20240731$20240802$20240802$EXP$$ES-BAYER-2024A111480$BAYER$$$$$M$Y$$$20240802$$CN$ES$ES
241684183$24168418$3$F$20240630$20240904$20240802$20240905$PER$$US-AMGEN-USASP2024150210$AMGEN$$77$YR$E$F$Y$$$20240905$$CN$US$US
241684193$24168419$3$F$20240528$20240821$20240802$20240823$EXP$GR-GREOF-202400823$GR-MYLANLABS-2024M1071138$MYLAN$$45$YR$$F$Y$$$20240823$$MD$GR$GR
241684201$24168420$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA223962$SANOFI AVENTIS$$$$A$F$Y$113.3$KG$20240802$$MD$US$US
241684211$24168421$1$I$20240625$20240730$20240802$20240802$EXP$FR-AFSSAPS-NC2024000884$FR-MYLANLABS-2024M1070784$MYLAN$$73$YR$$M$Y$$$20240802$$PH$FR$FR
241684221$24168422$1$I$20240401$20240726$20240802$20240802$PER$$US-SA-2024SA226033$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240802$$MD$US$US
241684241$24168424$1$I$20230601$20240725$20240802$20240802$EXP$$RU-AstraZeneca-2024A172386$ASTRAZENECA$$142$MON$$M$Y$46$KG$20240802$$CN$RU$
241684251$24168425$1$I$20240313$20240725$20240802$20240802$EXP$$FR-AstraZeneca-2024A169290$ASTRAZENECA$$51$YR$$F$Y$155$KG$20240802$$MD$FR$
241684261$24168426$1$I$20240730$20240801$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122627$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240802$$CN$US$US
241684271$24168427$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A175007$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241684281$24168428$1$I$$20240730$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121859$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240802$$HP$US$US
241684291$24168429$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A171437$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241684301$24168430$1$I$20240604$20240625$20240802$20240802$EXP$$CN-AstraZeneca-2024A148434$ASTRAZENECA$$25441$DY$$M$Y$$$20240802$$MD$CN$
241684311$24168431$1$I$$20240726$20240802$20240802$EXP$$CA-GSK-CA2022133712$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$CA$CA
241684321$24168432$1$I$20240629$20240725$20240802$20240802$EXP$$HR-AstraZeneca-2024A174985$ASTRAZENECA$$42$YR$$F$Y$$$20240802$$MD$HR$
241684331$24168433$1$I$$20240719$20240802$20240802$PER$$US-AstraZeneca-2024A165548$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241684341$24168434$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170477$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241684351$24168435$1$I$20240715$20240802$20240802$20240802$DIR$712329$$FDA-CTU$$65$YR$$M$N$$$20240802$N$PH$US$
241684361$24168436$1$I$$20240730$20240802$20240802$EXP$$JP-AstraZeneca-2024A174377$ASTRAZENECA$Nemoto N, et al.. EP-1413 Two cases of pseudocirrhosis caused by chemotherapy for breast cancer with liver metastases. The 32nd Annual Meeting of the Japanese Breast Cancer Society 2024;531-.$63$YR$$F$Y$$$20240802$$MD$JP$
241684371$24168437$1$I$20240626$20240725$20240802$20240802$EXP$$ES-AstraZeneca-2024A174845$ASTRAZENECA$$83$YR$$M$Y$$$20240802$$MD$ES$
241684382$24168438$2$F$20240724$20240731$20240802$20240805$EXP$$JP-AstraZeneca-2024A174959$ASTRAZENECA$$$$$F$Y$$$20240805$$MD$JP$
241684401$24168440$1$I$$20240731$20240802$20240802$EXP$$IE-MYLANLABS-2024M1064483$MYLAN$$$$$M$Y$$$20240802$$MD$IE$IE
241684411$24168441$1$I$$20240725$20240802$20240802$EXP$$CZ-TEVA-VS-3227235$TEVA$$26$YR$$F$Y$$$20240802$$HP$CZ$CZ
241684421$24168442$1$I$20240706$20240710$20240802$20240802$PER$$US-Vifor (International) Inc.-VIT-2024-06169$VIFOR$$38$YR$$M$Y$146.1$KG$20240802$$HP$US$US
241684431$24168443$1$I$20240717$20240718$20240802$20240802$EXP$$US-HLS-202400450$HLS THERAPEUTICS$$63$YR$A$M$Y$$$20240802$$HP$US$US
241684441$24168444$1$I$20240718$20240715$20240802$20240802$PER$$US-TEVA-VS-3224471$TEVA$$68$YR$$F$Y$81.65$KG$20240802$$CN$US$US
241684451$24168445$1$I$20240717$20240718$20240802$20240802$PER$$US-JNJFOC-20240752701$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240802$$CN$US$US
241684481$24168448$1$I$20240101$20240720$20240802$20240802$EXP$GB-MHRA-MED-202407202224023780-RBJHW$GB-GLENMARK PHARMACEUTICALS-2024GMK092643$GLENMARK$$$$$$Y$$$20240802$$CN$GB$GB
241684493$24168449$3$F$20240101$20240905$20240802$20240905$30DAY$$US-PFIZER INC-202400227175$PFIZER$$12$YR$$M$Y$$$20240905$$CN$US$US
241684504$24168450$4$F$$20240912$20240802$20240916$30DAY$$US-PFIZER INC-202400226374$PFIZER$$14$YR$$M$Y$$$20240916$$CN$US$US
241684512$24168451$2$F$20231110$20240802$20240802$20240806$30DAY$$US-PFIZER INC-PV202400044276$PFIZER$$$$$$Y$$$20240806$$CN$US$US
241684521$24168452$1$I$$20240730$20240802$20240802$30DAY$$US-PFIZER INC-PV202400044479$PFIZER$$$$$$Y$$$20240802$$HP$US$US
241684532$24168453$2$F$$20240806$20240802$20240806$30DAY$$US-PFIZER INC-202400226159$PFIZER$$$$$F$Y$$$20240806$$CN$US$US
241684541$24168454$1$I$$20240729$20240802$20240802$30DAY$$US-PFIZER INC-202400225999$PFIZER$$14$YR$$M$Y$49.9$KG$20240802$$CN$US$US
241684553$24168455$3$F$20240729$20240906$20240802$20240909$30DAY$$US-PFIZER INC-202400226969$PFIZER$$11$YR$$M$Y$$$20240909$$CN$US$US
241684564$24168456$4$F$$20240907$20240802$20240909$30DAY$$US-PFIZER INC-202400226086$PFIZER$$12$YR$$M$Y$$$20240909$$CN$US$US
241684573$24168457$3$F$20240726$20240901$20240802$20240903$30DAY$$US-PFIZER INC-PV202400060031$PFIZER$$14$YR$$M$Y$$$20240903$$CN$US$US
241684582$24168458$2$F$$20240901$20240802$20240903$30DAY$$US-PFIZER INC-202400225063$PFIZER$$14$YR$$F$Y$$$20240903$$CN$US$US
241684593$24168459$3$F$$20240904$20240802$20240904$30DAY$$US-PFIZER INC-202400023133$PFIZER$$14$YR$$M$Y$$$20240904$$CN$US$US
241684602$24168460$2$F$$20240901$20240802$20240903$30DAY$$US-PFIZER INC-202400225090$PFIZER$$15$YR$$M$Y$$$20240903$$CN$US$US
241684621$24168462$1$I$20240724$20240725$20240802$20240802$PER$$US-009507513-2407USA014164$MERCK$$$$$$Y$$$20240802$$CN$US$US
241684631$24168463$1$I$$20240731$20240802$20240802$PER$$US-TAKEDA-2024TUS077362$TAKEDA$$41$YR$$F$Y$57$KG$20240802$$CN$US$US
241684641$24168464$1$I$$20240703$20240802$20240802$EXP$$FR-Axsome Therapeutics, Inc.-E2B_00000547$AXSOME THERAPEUTICS$$17$YR$T$M$Y$$$20240802$$MD$FR$FR
241684671$24168467$1$I$$20240722$20240802$20240802$EXP$$US-RDY-LIT/USA/24/0011044$DR REDDYS$Joshi A, Ghnaima H, Nader G, Alattal S. A Trifecta of Challenges: A Case Report of Triple Valve Endocarditis. American Journal of Respiratory and Critical Care Medicine. 2024;209(0): doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1661.$37$YR$A$M$Y$$$20240802$$HP$US$US
241684683$24168468$3$F$20240101$20240802$20240802$20240817$EXP$$HU-IMP-2024000053$Harrow Health$$39$YR$A$F$Y$59$KG$20240817$$CN$HU$HU
241684691$24168469$1$I$$20240731$20240802$20240802$PER$$US-ABBVIE-5863926$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241684701$24168470$1$I$20240603$20240726$20240802$20240802$EXP$FR-AFSSAPS-MA2024001091$FR-SA-2024SA221158$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240802$$MD$FR$FR
241684711$24168471$1$I$$20240725$20240802$20240802$PER$$US-MYLANLABS-2024M1069926$MYLAN$$$$$M$Y$$$20240802$$MD$US$US
241684721$24168472$1$I$$20240719$20240802$20240802$PER$$US-TEVA-VS-3222800$TEVA$$55$YR$$M$Y$$$20240802$$CN$US$US
241684741$24168474$1$I$$20240801$20240802$20240802$EXP$$US-TAKEDA-2024TUS077695$TAKEDA$$$$$M$Y$$$20240802$$CN$US$US
241684762$24168476$2$F$$20240827$20240802$20240910$PER$$US-Vifor (International) Inc.-VIT-2024-06412$VIFOR$$$$$M$Y$61.6$KG$20240910$$HP$US$US
241684771$24168477$1$I$20240710$20240731$20240802$20240802$PER$$US-JNJFOC-20240785626$JOHNSON AND JOHNSON$$33$YR$A$$Y$$$20240802$$PH$US$US
241684781$24168478$1$I$$20240724$20240802$20240802$EXP$$US-JNJFOC-20240769343$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$MD$US$US
241684791$24168479$1$I$20240723$20240801$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122718$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240802$$CN$US$US
241684801$24168480$1$I$20240801$20240802$20240802$20240802$DIR$712546$$FDA-CTU$$55$YR$$F$N$133.5$KG$20240802$N$HP$US$
241684811$24168481$1$I$20231222$20240729$20240802$20240802$EXP$FR-AFSSAPS-NY2024000853$FR-009507513-2407FRA015247$MERCK$$65$YR$$M$Y$70$KG$20240802$$MD$FR$FR
241684821$24168482$1$I$$20240725$20240802$20240802$PER$$US-ABBVIE-5858908$ABBVIE$$$$$$Y$$$20240802$$HP$US$US
241684831$24168483$1$I$20240722$20240729$20240802$20240802$EXP$$US-GSK-US2021263755$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$US$US
241684842$24168484$2$F$20231220$20240822$20240802$20240829$EXP$$US-BIOGEN-2024BI01275800$BIOGEN$$73$YR$$M$Y$$$20240829$$HP$US$US
241684861$24168486$1$I$$20240724$20240802$20240802$EXP$$US-BAYER-2024A110608$BAYER$Medina C.S.; Jijelava S.; Dancour E.; Wright P.. Middle Meningeal Artery Embolization in the Treatment of Acute Subdural Hematoma: A Case Series Featuring Access Through a Carotid Stent. Korean Journal of Neurotrauma. 2024;20:2:113-124$76$YR$E$M$Y$$$20240802$$HP$US$US
241684871$24168487$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53181$$FDA-CTU$$55$YR$$F$N$$$20240802$Y$$US$
241684882$24168488$2$F$$20240802$20240802$20240805$PER$$US-BAYER-2024A111521$BAYER$$$$$F$Y$$$20240805$$CN$US$US
241684892$24168489$2$F$$20240812$20240802$20240820$EXP$$RU-AstraZeneca-2024A174425$ASTRAZENECA$Shalaeva D. D., Pereverzeva K. G., Fomina O. A., Yakushin S. S.. BRASH-syndrome: ? clinical case.. Rational Pharmacotherapy in Cardiology 2024;20((3)):367-373.$$$$F$Y$$$20240820$$HP$RU$
241684901$24168490$1$I$20240801$20240802$20240802$20240802$DIR$712495$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241684911$24168491$1$I$20240627$20240726$20240802$20240802$EXP$$FR-AstraZeneca-2024A170585$ASTRAZENECA$$75$YR$$F$Y$54$KG$20240802$$MD$FR$
241684921$24168492$1$I$20240730$20240730$20240802$20240802$EXP$$IN-AstraZeneca-2024A175261$ASTRAZENECA$$67$YR$$M$Y$$$20240802$$CN$IN$
241684931$24168493$1$I$$20240730$20240802$20240802$EXP$$ZA-AstraZeneca-2024A174538$ASTRAZENECA$$72$YR$$M$Y$$$20240802$$CN$ZA$
241684941$24168494$1$I$20240517$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173463$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241684951$24168495$1$I$$20240726$20240802$20240802$EXP$$TR-AstraZeneca-2024A175307$ASTRAZENECA$Erdogan H, Velioglu Yakut O, Sen E, Senturk Cankorur V. Drug Induced Lung Disease Related To Lamotrigine/Quetiapine: A Case Report. Duygudurum Bozukluklari Kongresi - Bipolar Bozuklugu Olan Kisiler Dernegi / 1st Mood Disorders Congress - Association of People with Bipolar Disorders 2024;$68$YR$$F$Y$$$20240802$$HP$TR$
241684961$24168496$1$I$20211016$20211022$20240802$20240802$EXP$$AU-AstraZeneca-2021A785763$ASTRAZENECA$$22950$DY$$F$Y$$$20240802$$CN$AU$
241684972$24168497$2$F$20120403$20240830$20240802$20240906$EXP$$GB-AstraZeneca-2024A175101$ASTRAZENECA$$$$N$M$Y$$$20240906$$MD$GB$
241684982$24168498$2$F$$20240903$20240802$20240911$EXP$$JP-AstraZeneca-2024A171629$ASTRAZENECA$$74$YR$$M$Y$$$20240911$$MD$JP$
241684991$24168499$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A175156$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241685001$24168500$1$I$$20230913$20240802$20240802$EXP$$CA-AstraZeneca-2023A212442$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$CA$
241685011$24168501$1$I$20240801$20240802$20240802$20240802$DIR$712497$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241685021$24168502$1$I$20231001$20240729$20240802$20240802$EXP$$US-AstraZeneca-2024A110482$ASTRAZENECA$$25960$DY$$F$Y$$$20240802$$CN$US$
241685033$24168503$3$F$20240701$20240913$20240802$20240918$EXP$$JP-AstraZeneca-2024A173824$ASTRAZENECA$$81$YR$$M$Y$$$20240918$$MD$JP$
241685041$24168504$1$I$20240723$20240729$20240802$20240802$EXP$$CO-AstraZeneca-2024A173960$ASTRAZENECA$$23595$DY$$M$Y$87$KG$20240802$$CN$CO$
241685052$24168505$2$F$20240726$20240814$20240802$20240822$EXP$$US-AstraZeneca-2024A171524$ASTRAZENECA$$20778$DY$$F$Y$92.1$KG$20240822$$HP$US$
241685061$24168506$1$I$$20240730$20240802$20240802$EXP$$IN-AstraZeneca-2024A173506$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$IN$
241685072$24168507$2$F$$20240729$20240802$20240821$PER$$US-BEH-2024176583$CSL BEHRING$$$$$M$Y$$$20240821$$CN$US$US
241685081$24168508$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A171540$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241685091$24168509$1$I$20240601$20240725$20240802$20240802$EXP$$GB-AstraZeneca-2024A169727$ASTRAZENECA$$$$$M$Y$$$20240802$$MD$GB$
241685101$24168510$1$I$$20240725$20240802$20240802$EXP$$JP-AstraZeneca-2024A171259$ASTRAZENECA$$53$YR$$F$Y$$$20240802$$MD$JP$
241685112$24168511$2$F$20200801$20240910$20240802$20240915$EXP$$FR-AstraZeneca-2024A172814$ASTRAZENECA$$883$MON$$F$Y$$$20240915$$MD$FR$
241685121$24168512$1$I$$20240725$20240802$20240802$EXP$$JP-AstraZeneca-2024A172554$ASTRAZENECA$$73$YR$$F$Y$$$20240802$$MD$JP$
241685131$24168513$1$I$$20240730$20240802$20240802$EXP$$CO-AstraZeneca-2024A174535$ASTRAZENECA$$$$$M$Y$57$KG$20240802$$CN$CO$
241685141$24168514$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A169794$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241685161$24168516$1$I$$20240725$20240802$20240802$EXP$$ZA-AstraZeneca-2024A170979$ASTRAZENECA$$34$YR$$F$Y$$$20240802$$CN$ZA$
241685171$24168517$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A171473$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241685181$24168518$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170161$ASTRAZENECA$$$$$F$Y$53$KG$20240802$$CN$US$
241685191$24168519$1$I$$20240802$20240802$20240802$DIR$712551$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241685201$24168520$1$I$20240207$20240729$20240802$20240802$EXP$FR-AFSSAPS-RE2024000769$FR-RDY-SPO/FRA/24/0011157$DR REDDYS$$53$YR$A$F$Y$59$KG$20240802$$MD$FR$FR
241685211$24168521$1$I$20240701$20240724$20240802$20240802$PER$$US-SA-2024SA223947$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240802$$HP$US$US
241685221$24168522$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224607$SANOFI AVENTIS$$$$E$M$Y$88$KG$20240802$$MD$US$US
241685231$24168523$1$I$20240618$20240729$20240802$20240802$EXP$FR-RDY-SPO/FRA/24/0011140$FR-RDY-SPO/FRA/24/0011140$DR REDDYS$$52$YR$A$F$Y$73.5$KG$20240802$$PH$FR$FR
241685251$24168525$1$I$20240306$20240729$20240802$20240802$DIR$FDA-CDER-CTU-2024-53065$$FDA-CTU$$62$YR$$M$N$63.9$KG$20240729$N$$US$
241685261$24168526$1$I$$20240802$20240802$20240802$DIR$712555$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241685291$24168529$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53131$$FDA-CTU$$59$YR$$M$N$$$20240802$N$$US$
241685351$24168535$1$I$20240802$20240802$20240802$20240802$DIR$712547$$FDA-CTU$$48$YR$$F$N$47.9$KG$20240802$N$HP$US$
241685361$24168536$1$I$20240101$20240723$20240802$20240802$EXP$$GB-ABBVIE-5855085$ABBVIE$$$$A$M$Y$$$20240802$$CN$GB$GB
241685371$24168537$1$I$$20240725$20240802$20240802$PER$$US-ALXN-202407USA001943US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241685381$24168538$1$I$20240625$20240726$20240802$20240802$EXP$ES-AEMPS-1550307$ES-TEVA-VS-3226881$TEVA$$88$YR$$M$Y$$$20240802$$MD$ES$ES
241685401$24168540$1$I$20240101$20240729$20240802$20240802$EXP$$JP-DSJP-DSJ-2024-137769$DAIICHI$$8$DEC$$M$Y$47.1$KG$20240802$$MD$JP$JP
241685411$24168541$1$I$$20240726$20240802$20240802$EXP$$US-ROCHE-10000040547$ROCHE$$$$E$F$Y$$$20240802$$CN$US$US
241685421$24168542$1$I$20190304$20240722$20240802$20240802$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117035$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$51$KG$20240802$$MD$KR$KR
241685431$24168543$1$I$20240701$20240801$20240802$20240802$EXP$$US-BAYER-2024A105930$BAYER$$70$YR$E$M$Y$$$20240802$$CN$US$US
241685441$24168544$1$I$20240101$20240729$20240802$20240802$EXP$$LK-Genus_Lifesciences-USA-POI0580202400142$GENUS LIFESCIENCES$Abeyagunawardena I. Uncommon triggers of insulin autoimmune syndrome a case report. Journal of Medical Case Reports. 2024 JUN 27;18(1):292.$67$YR$E$M$Y$$$20240801$$MD$LK$LK
241685451$24168545$1$I$20240701$20240726$20240802$20240802$EXP$$US-ROCHE-10000040479$ROCHE$$77$YR$E$M$Y$$$20240802$$CN$US$US
241685461$24168546$1$I$$20240802$20240802$20240802$DIR$712556$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241685471$24168547$1$I$20231210$20240726$20240802$20240802$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20231200058$UPSHER SMITH LABORATORIES$$0$YR$$$Y$$$20240802$$$US$US
241685481$24168548$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122687$BRISTOL MYERS SQUIBB$$27$YR$A$M$Y$$$20240802$$HP$US$US
241685491$24168549$1$I$20240608$20240726$20240802$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121267$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$64$KG$20240802$$PH$JP$JP
241685501$24168550$1$I$$20240801$20240802$20240802$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122491$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240802$$HP$CA$CA
241685511$24168551$1$I$$20240725$20240802$20240802$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-122568$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240802$$MD$JP$JP
241685521$24168552$1$I$$20240722$20240802$20240802$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092649$GLENMARK$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al.. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy.. Experimental and Clinical Transplantation.. 2024;22(5):392-5$$$$$Y$$$20240802$$MD$US$US
241685533$24168553$3$F$$20240920$20240802$20240926$EXP$$CN-GSK-CN2024APC094470$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CN$CN
241685541$24168554$1$I$$20240801$20240802$20240802$PER$$US-JNJFOC-20240800858$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241685551$24168555$1$I$20210308$20240730$20240802$20240802$EXP$FR-SEATTLE GENETICS-2021SGN02572$FR-RDY-SPO/FRA/24/0011239$DR REDDYS$$$$$F$Y$$$20240802$$HP$FR$FR
241685561$24168556$1$I$$20240723$20240802$20240802$EXP$$US-RDY-LIT/USA/24/0011110$DR REDDYS$Churchill AB, Nguyen AD, Xia J, Nguyen VD, Agrawal N, Durant CE, et al. To Bite or Not to Bite: A Case of Non-bite Pasteurella Multicoda Resulting in Severe Septic Shock. American Journal of Respiratory and Critical Care Medicine. 2024 May;209: A1679. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1679.$68$YR$E$M$Y$$$20240802$$HP$US$US
241685572$24168557$2$F$$20240722$20240802$20240809$PER$$US-TEVA-VS-3226070$TEVA$$56$YR$$M$Y$$$20240809$$HP$US$US
241685581$24168558$1$I$20240717$20240729$20240802$20240802$EXP$$CN-AstraZeneca-2024A174272$ASTRAZENECA$$76$YR$$F$Y$46$KG$20240802$$MD$CN$
241685591$24168559$1$I$20240719$20240725$20240802$20240802$EXP$GB-MHRA-MED-202407251753217850-DHMKB$GB-TEVA-VS-3226465$TEVA$$81$YR$$M$Y$84$KG$20240802$$CN$GB$GB
241685602$24168560$2$F$$20240916$20240802$20240917$PER$$US-AstraZeneca-2024A174499$ASTRAZENECA$$$$$F$Y$49.9$KG$20240918$$CN$US$
241685611$24168561$1$I$$20211102$20240802$20240802$EXP$$US-AstraZeneca-2021A794361$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241685621$24168562$1$I$20240702$20240726$20240802$20240802$EXP$$CN-AstraZeneca-2024A173921$ASTRAZENECA$$14220$DY$$F$Y$77$KG$20240802$$MD$CN$
241685631$24168563$1$I$20240701$20240729$20240802$20240802$EXP$$US-AstraZeneca-2024A172797$ASTRAZENECA$$1068$MON$$F$Y$$$20240802$$CN$US$
241685641$24168564$1$I$20231114$20240726$20240802$20240802$EXP$$FR-AstraZeneca-2024A175796$ASTRAZENECA$$1$MON$$M$Y$4.2$KG$20240802$$MD$FR$
241685651$24168565$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170072$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241685661$24168566$1$I$$20240729$20240802$20240802$EXP$$US-AstraZeneca-2024A172365$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241685671$24168567$1$I$$20240722$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407014864$ELI LILLY AND CO$$$$$$Y$$$20240802$$CN$US$US
241685681$24168568$1$I$20170101$20240722$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407014495$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240802$$CN$US$US
241685692$24168569$2$F$$20240819$20240802$20240823$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407015385$ELI LILLY AND CO$$56$YR$A$F$Y$70$KG$20240823$$HP$GB$GB
241685701$24168570$1$I$20231012$20240723$20240802$20240802$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202310009573$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$BR$BR
241685711$24168571$1$I$20200101$20240722$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407014098$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240802$$CN$US$US
241685721$24168572$1$I$20240716$20240723$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015382$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241685731$24168573$1$I$$20240722$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015205$ELI LILLY AND CO$$86$YR$E$M$Y$$$20240802$$CN$US$US
241685742$24168574$2$F$$20240731$20240802$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000262$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240812$$CN$US$US
241685752$24168575$2$F$$20240802$20240802$20240815$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407014681$ELI LILLY AND CO$$39$YR$A$M$Y$200$KG$20240815$$CN$DE$DE
241685761$24168576$1$I$20220101$20240722$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407014481$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240802$$CN$US$US
241685771$24168577$1$I$20240722$20240722$20240802$20240802$EXP$GB-MHRA-MED-202407222112199500-TPSZK$GB-ELI_LILLY_AND_COMPANY-GB202407014676$ELI LILLY AND CO$$31$YR$A$F$Y$87$KG$20240802$$CN$GB$GB
241685782$24168578$2$F$20220101$20240731$20240802$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015516$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240812$$CN$US$US
241685791$24168579$1$I$$20240723$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015378$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241685801$24168580$1$I$$20240723$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016000$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240802$$CN$US$US
241685811$24168581$1$I$20220101$20240723$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015609$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240802$$CN$US$US
241685821$24168582$1$I$20240101$20240723$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015281$ELI LILLY AND CO$$$$$M$Y$$$20240802$$CN$US$US
241685831$24168583$1$I$20240722$20240723$20240802$20240802$EXP$GB-MHRA-MED-202407230757444280-TMZHD$GB-ELI_LILLY_AND_COMPANY-GB202407014723$ELI LILLY AND CO$$35$YR$A$F$Y$127$KG$20240802$$CN$GB$GB
241685841$24168584$1$I$$20240721$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013871$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241685851$24168585$1$I$$20240723$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015429$ELI LILLY AND CO$$$$$M$Y$$$20240802$$CN$US$US
241685862$24168586$2$F$$20240729$20240802$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202407020311$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240812$$CN$US$US
241685871$24168587$1$I$$20240722$20240802$20240802$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407014464$ELI LILLY AND CO$$$$$F$Y$$$20240802$$MD$DE$DE
241685881$24168588$1$I$$20240730$20240802$20240802$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407019841$ELI LILLY AND CO$$$$$$Y$$$20240802$$CN$JP$JP
241685892$24168589$2$F$$20240729$20240802$20240810$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407017195$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240810$$CN$FR$FR
241685901$24168590$1$I$$20240723$20240802$20240802$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202407017764$ELI LILLY AND CO$$93$YR$E$M$Y$$$20240802$$CN$TW$TW
241685911$24168591$1$I$$20240722$20240802$20240802$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202407014903$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240802$$HP$CA$CA
241685921$24168592$1$I$20230101$20240722$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407014242$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240802$$CN$US$US
241685931$24168593$1$I$$20240722$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015200$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240802$$CN$US$US
241685941$24168594$1$I$$20240723$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015513$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240802$$CN$US$US
241685951$24168595$1$I$20240622$20240722$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407014886$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241685961$24168596$1$I$20240401$20240721$20240802$20240802$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407010077$ELI LILLY AND CO$$$$$M$Y$149$KG$20240802$$CN$DE$DE
241685974$24168597$4$F$20240724$20240822$20240802$20240906$PER$$US-AstraZeneca-2024A169336$ASTRAZENECA$$21344$DY$$F$Y$$$20240906$$HP$US$
241685981$24168598$1$I$$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173763$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241685991$24168599$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A171256$ASTRAZENECA$$$$$$Y$$$20240802$$MD$US$
241686002$24168600$2$F$$20240903$20240802$20240911$EXP$$JP-AstraZeneca-2024A173328$ASTRAZENECA$$78$YR$$F$Y$$$20240911$$MD$JP$
241686011$24168601$1$I$$20240726$20240802$20240802$EXP$$IT-AstraZeneca-2024A172432$ASTRAZENECA$$$$$F$Y$$$20240802$$MD$IT$
241686021$24168602$1$I$20240710$20240722$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015441$ELI LILLY AND CO$$40$YR$A$F$Y$127$KG$20240802$$CN$US$US
241686031$24168603$1$I$$20240605$20240802$20240802$EXP$$CN-AstraZeneca-2024A166926$ASTRAZENECA$$$$A$F$Y$$$20240802$$MD$CN$
241686041$24168604$1$I$20130101$20240729$20240802$20240802$PER$$US-JNJFOC-20240781546$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240802$$LW$US$US
241686054$24168605$4$F$20240702$20240820$20240802$20240823$EXP$$CO-BAYER-2024A108237$BAYER$$72$YR$E$M$Y$$$20240823$$CN$CO$CO
241686061$24168606$1$I$$20240725$20240802$20240802$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR095669$VIIV$$$$$$Y$$$20240802$$HP$US$US
241686071$24168607$1$I$20240426$20240730$20240802$20240802$EXP$$US-MYLANLABS-2024M1055842$MYLAN$$43$YR$$F$Y$127.9$KG$20240802$$MD$US$US
241686091$24168609$1$I$20240725$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152904$AMGEN$$53$YR$A$F$Y$$$20240802$$HP$US$US
241686101$24168610$1$I$$20240801$20240802$20240802$EXP$$CZ-TAKEDA-2024TUS077292$TAKEDA$$44$YR$$M$Y$$$20240802$$HP$CZ$CZ
241686111$24168611$1$I$$20240801$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122408$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$97.98$KG$20240802$$HP$US$US
241686131$24168613$1$I$20240101$20240730$20240802$20240802$EXP$$US-PFIZER INC-202400226804$PFIZER$$71$YR$$F$Y$$$20240802$$MD$US$US
241686141$24168614$1$I$20240628$20240801$20240802$20240802$EXP$FR-AFSSAPS-ST2024001242$FR-PFIZER INC-202400227990$PFIZER$$73$YR$$F$Y$80$KG$20240802$$PH$FR$FR
241686151$24168615$1$I$20240627$20240730$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121808$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240802$$CN$US$US
241686161$24168616$1$I$20240701$20240725$20240802$20240802$EXP$DK-DKMA-30735513$DK-FERRINGPH-2024FE04170$FERRING$$$$$$Y$$$20240802$$MD$DK$DK
241686171$24168617$1$I$20240601$20240722$20240802$20240802$EXP$$US-FERRINGPH-2024FE04131$FERRING$$$$$$Y$$$20240802$$CN$US$US
241686181$24168618$1$I$$20240729$20240802$20240802$EXP$$CN-FERRINGPH-2024FE04249$FERRING$$$$$$Y$$$20240802$$CN$CN$CN
241686191$24168619$1$I$$20240730$20240802$20240802$EXP$$CN-FERRINGPH-2024FE04281$FERRING$$$$$$Y$$$20240802$$CN$CN$CN
241686201$24168620$1$I$$20240729$20240802$20240802$EXP$$CN-FERRINGPH-2024FE04250$FERRING$$$$$$Y$$$20240802$$CN$CN$CN
241686211$24168621$1$I$$20240801$20240802$20240802$PER$$US-HALEON-2190238$Haleon PLC$$$$$F$Y$$$20240802$$CN$US$US
241686221$24168622$1$I$20240701$20240724$20240802$20240802$EXP$$US-FERRINGPH-2024FE04215$FERRING$$$$$$Y$$$20240802$$CN$US$US
241686231$24168623$1$I$20240724$20240726$20240802$20240802$EXP$$US-FERRINGPH-2024FE04233$FERRING$$$$$$Y$$$20240802$$CN$US$US
241686242$24168624$2$F$$20240719$20240802$20240808$EXP$$TW-009507513-2407TWN012665$MERCK$$58$YR$$F$Y$47$KG$20240808$$MD$TW$TW
241686251$24168625$1$I$20240601$20240712$20240802$20240802$EXP$$US-PERRIGO-24US007258$PERRIGO$$21$YR$$F$Y$90.703$KG$20240802$$CN$US$US
241686261$24168626$1$I$20230505$20240729$20240802$20240802$EXP$$AU-JNJFOC-20240776220$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20240802$$MD$AU$AU
241686271$24168627$1$I$$20240722$20240802$20240802$EXP$$BR-BAYER-2024A106438$BAYER$$$$$$Y$$$20240802$$MD$BR$BR
241686291$24168629$1$I$$20240730$20240802$20240802$PER$$US-DSJP-DSU-2024-138444$DAIICHI$$$$$F$Y$$$20240802$$CN$US$US
241686302$24168630$2$F$$20240730$20240802$20240806$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138374$DAIICHI$$37$YR$$F$Y$$$20240806$$CN$US$US
241686311$24168631$1$I$20240702$20240702$20240802$20240802$PER$$US-ABBVIE-5864367$ABBVIE$$36$YR$$$Y$$$20240802$$HP$US$US
241686321$24168632$1$I$$20240730$20240802$20240802$EXP$$GB-MYLANLABS-2024M1070350$MYLAN$$$$$F$Y$$$20240802$$PH$GB$GB
241686331$24168633$1$I$$20240730$20240802$20240802$EXP$$DE-MYLANLABS-2024M1071635$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$14$YR$$M$Y$$$20240802$$HP$DE$DE
241686341$24168634$1$I$$20240726$20240802$20240802$EXP$GB-MHRA-MED-202407262147142410-THDNB$GB-TEVA-VS-3226795$TEVA$$39$YR$$M$Y$59$KG$20240802$$CN$GB$GB
241686361$24168636$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53173$$FDA-CTU$$70$YR$$F$N$$$20240802$N$$US$
241686371$24168637$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53140$$FDA-CTU$$41$YR$$M$N$$$20240802$N$$US$
241686381$24168638$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53130$$FDA-CTU$$32$YR$$F$N$103.42$KG$20240802$N$$US$
241686391$24168639$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53083$$FDA-CTU$$62$YR$$F$N$$$20240802$N$$US$
241686401$24168640$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53144$$FDA-CTU$$58$YR$$F$N$46.27$KG$20240802$N$$US$
241686421$24168642$1$I$$20240802$20240802$20240802$DIR$712557$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241686431$24168643$1$I$$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53062$$FDA-CTU$$$$$M$N$$$20240801$N$HP$US$
241686441$24168644$1$I$$20240802$20240802$20240802$DIR$712560$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241686451$24168645$1$I$$20240731$20240802$20240802$DIR$FDA-CDER-CTU-2024-53059$$FDA-CTU$$$$$M$N$$$20240731$N$HP$US$
241686471$24168647$1$I$$20240802$20240802$20240802$DIR$712522$$FDA-CTU$$$$$UNK$N$$$20240802$$CN$US$
241686481$24168648$1$I$20240618$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53199$$FDA-CTU$$51$YR$$F$N$$$20240802$N$$US$
241686491$24168649$1$I$20240801$20240802$20240802$20240802$DIR$712545$$FDA-CTU$$53$YR$$F$N$80.1$KG$20240802$N$CN$US$
241686511$24168651$1$I$20240723$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53198$$FDA-CTU$$68$YR$$M$N$$$20240802$Y$HP$US$
241686521$24168652$1$I$20240202$20240802$20240802$20240802$DIR$712548$$FDA-CTU$$55$YR$$F$N$81$KG$20240802$N$CN$US$
241686531$24168653$1$I$20240716$20240718$20240802$20240802$DIR$FDA-CDER-CTU-2024-53200$$FDA-CTU$$72$YR$$F$N$60.15$KG$20240718$N$HP$US$
241686541$24168654$1$I$20240625$20240627$20240802$20240802$DIR$FDA-CDER-CTU-2024-52977$$FDA-CTU$$39$YR$$M$N$78.3$KG$20240627$N$$US$
241686551$24168655$1$I$$20240619$20240802$20240802$DIR$FDA-CDER-CTU-2024-53133$$FDA-CTU$$$$$$N$$$20240619$N$$US$
241686572$24168657$2$F$20240701$20240805$20240802$20240807$EXP$NO-NOMAADVRE-RELISSO-2024-Vdkgbm$NO-BRISTOL-MYERS SQUIBB COMPANY-2024-122754$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240808$$MD$NO$NO
241686581$24168658$1$I$20201113$20240722$20240802$20240802$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-116890$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$69$KG$20240802$$MD$KR$KR
241686591$24168659$1$I$$20240730$20240802$20240802$DIR$FDA-CDER-CTU-2024-53197$$FDA-CTU$$$$$M$N$$$20240730$N$HP$US$
241686611$24168661$1$I$$20240729$20240802$20240802$PER$$US-JNJFOC-20240781645$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$LW$US$US
241686621$24168662$1$I$20240601$20240801$20240802$20240802$EXP$$ZA-ABBVIE-5863948$ABBVIE$$74$YR$$M$Y$$$20240802$$CN$ZA$ZA
241686631$24168663$1$I$$20240731$20240802$20240802$EXP$$US-BAUSCH-BL-2024-011605$BAUSCH AND LOMB$$41$YR$$M$Y$$$20240802$$CN$US$US
241686641$24168664$1$I$$20240718$20240802$20240802$EXP$$US-HLS-202400457$HLS THERAPEUTICS$$$$A$F$Y$$$20240802$$HP$US$US
241686651$24168665$1$I$20240714$20240723$20240802$20240802$EXP$$ES-SA-2024SA220997$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240802$$PH$ES$ES
241686661$24168666$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224195$SANOFI AVENTIS$$$$C$F$Y$22.6$KG$20240802$$MD$US$US
241686671$24168667$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA224186$SANOFI AVENTIS$$30$YR$A$M$Y$68.03$KG$20240802$$MD$US$US
241686681$24168668$1$I$20240601$20240724$20240802$20240802$PER$$US-SA-2024SA223577$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240802$$MD$US$US
241686691$24168669$1$I$$20240724$20240802$20240802$EXP$$ZA-SA-2024SA220589$SANOFI AVENTIS$$$$A$F$Y$$$20240802$$HP$ZA$ZA
241686701$24168670$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223195$SANOFI AVENTIS$$$$A$M$Y$67$KG$20240802$$MD$US$US
241686711$24168671$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA221888$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240802$$MD$US$US
241686722$24168672$2$F$20240101$20240815$20240802$20240828$PER$$US-SA-2024SA221815$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240828$$CN$US$US
241686731$24168673$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223738$SANOFI AVENTIS$$$$A$F$Y$76.2$KG$20240802$$MD$US$US
241686741$24168674$1$I$20240719$20240725$20240802$20240802$EXP$$CN-SA-2024SA223560$SANOFI AVENTIS$$61$YR$A$M$Y$72.8$KG$20240802$$HP$CN$CN
241686751$24168675$1$I$20240701$20240724$20240802$20240802$PER$$US-SA-2024SA224132$SANOFI AVENTIS$$20$YR$A$F$Y$106$KG$20240802$$MD$US$US
241686764$24168676$4$F$20190101$20240909$20240802$20240911$EXP$$FR-MYLANLABS-2022M1148491$MYLAN$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I et al.. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the surveillance system for toxic deaths in ?le-de-France (DCTOX-IdF). Toxicologie Analytique et Clinique. 2023;35(1):54-59$$$$M$Y$$$20240911$$HP$FR$FR
241686781$24168678$1$I$$20240801$20240802$20240802$PER$$US-BAUSCH-BL-2024-011774$BAUSCH AND LOMB$$$$$F$Y$$$20240802$$HP$US$US
241686791$24168679$1$I$$20240731$20240802$20240802$PER$$US-BAUSCH-BL-2024-011749$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240802$$CN$US$US
241686801$24168680$1$I$$20240726$20240802$20240802$EXP$$US-VANTIVE-2024VAN018692$Vantive US Healthcare$$$$$F$Y$56$KG$20240802$$HP$US$US
241686811$24168681$1$I$$20240731$20240802$20240802$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138489$DAIICHI$$$$$F$Y$$$20240802$$CN$US$US
241686822$24168682$2$F$$20240819$20240802$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US070010$SANDOZ$$$$$M$Y$$$20240821$$CN$US$US
241686831$24168683$1$I$$20240426$20240802$20240802$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06231$HIKMA$Akharume O, Ojeniyi S, Naqvi HA. Akharume O, Ojeniyi S, Naqvi HA. Systemic Amyloid A Protein Amyloidosis With Gastrointestinal Involvement.. ACG Case Reports Journal. 2024;11(4):11:e01311$40$YR$$M$Y$$$20240802$$MD$US$US
241686841$24168684$1$I$$20240731$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004695$STEMLINE THERAPEUTICS$$85$YR$E$F$Y$$$20240802$$CN$US$US
241686851$24168685$1$I$$20240726$20240802$20240802$EXP$$JP-AstraZeneca-2023A111063$ASTRAZENECA$$55$YR$$M$Y$$$20240802$$MD$JP$
241686861$24168686$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A173621$ASTRAZENECA$$$$$M$Y$$$20240802$$MD$US$
241686871$24168687$1$I$$20240730$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004663$STEMLINE THERAPEUTICS$$61$YR$A$F$Y$$$20240802$$CN$US$US
241686881$24168688$1$I$$20230724$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004698$STEMLINE THERAPEUTICS$$57$YR$A$F$Y$$$20240802$$CN$US$US
241686892$24168689$2$F$20210101$20240823$20240802$20240828$EXP$$JP-AstraZeneca-2024A104505$ASTRAZENECA$Kishida R. et al.. 18 A case of suspected irAE-related primary adrenal insufficiency more than 1 year after completion of immune checkpoint inhibitor therapy.. The 119th Annual Meeting of the Kansai Branch of the Japan Lung Cancer Society 2024;45-.$79$YR$$M$Y$168$KG$20240828$$MD$JP$
241686901$24168690$1$I$$20240717$20240802$20240802$PER$$US-INSUD PHARMA-2407US05763$INSUD PHARMA$$$$$$Y$$$20240802$$CN$US$US
241686911$24168691$1$I$20240701$20240717$20240802$20240802$PER$$US-INSUD PHARMA-2407US05758$INSUD PHARMA$$$$$F$Y$$$20240802$$CN$US$US
241686921$24168692$1$I$$20240729$20240802$20240802$EXP$$IL-AstraZeneca-2024A173590$ASTRAZENECA$$$$$F$Y$$$20240802$$MD$IL$
241686931$24168693$1$I$$20240726$20240802$20240802$EXP$$JP-AstraZeneca-2024A172564$ASTRAZENECA$$$$$$Y$$$20240802$$MD$JP$
241686941$24168694$1$I$20240624$20240725$20240802$20240802$EXP$FR-AFSSAPS-AN2024000914$FR-TEVA-VS-3226197$TEVA$$57$YR$$M$Y$71$KG$20240802$$HP$FR$FR
241686951$24168695$1$I$20231201$20240726$20240802$20240802$EXP$$FR-VIIV HEALTHCARE LIMITED-FR2024064890$VIIV$$$$$$Y$$$20240802$$MD$FR$FR
241686961$24168696$1$I$20160301$20240729$20240802$20240802$EXP$GR-GREOF-202400803$NL-KOWA-24EU001997$KOWA PHARM$$$$$$Y$$$20240802$$HP$NL$GR
241686971$24168697$1$I$20240529$20240729$20240802$20240802$EXP$$GB-SANDOZ INC.-SDZ2024GB050872$SANDOZ$$41$YR$$F$Y$$$20240802$$CN$GB$GB
241686981$24168698$1$I$$20240731$20240802$20240802$EXP$$CA-SANDOZ INC.-SDZ2024CA069708$SANDOZ$$$$$F$Y$$$20240802$$HP$CA$CA
241686991$24168699$1$I$20230301$20240724$20240802$20240802$EXP$$BR-SANDOZ INC.-NVSC2023BR127019$SANDOZ$$70$YR$$F$Y$$$20240802$$CN$BR$BR
241687001$24168700$1$I$$20240723$20240802$20240802$EXP$$CN-JNJFOC-20240768784$JOHNSON AND JOHNSON$$$$A$$Y$$$20240802$$HP$CN$CN
241687011$24168701$1$I$$20240731$20240802$20240802$EXP$GB-MHRA-MIDB-47c1db44-6630-44b5-9662-96cd28208d61$GB-MYLANLABS-2024M1071555$MYLAN$$66$YR$$F$Y$$$20240802$$PH$GB$GB
241687021$24168702$1$I$$20240801$20240802$20240802$30DAY$$US-SANDOZ INC.-SDZ2024US070004$SANDOZ$$$$$F$Y$$$20240802$$CN$US$US
241687031$24168703$1$I$$20240729$20240802$20240802$EXP$$US-ABBVIE-5860050$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241687041$24168704$1$I$$20240801$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US070050$SANDOZ$$$$$F$Y$$$20240802$$CN$US$US
241687051$24168705$1$I$20240716$20240722$20240802$20240802$EXP$$CO-FERRINGPH-2024FE04204$FERRING$$$$$$Y$$$20240802$$CN$CO$CO
241687061$24168706$1$I$20240515$20240724$20240802$20240802$EXP$$US-VANTIVE-2024VAN018687$Vantive US Healthcare$$38$YR$$F$Y$$$20240802$$HP$US$US
241687071$24168707$1$I$$20240723$20240802$20240802$EXP$$US-ZENPEP LLC-2024AIMT01052$AIMMUNE$$$$$$Y$$$20240802$$HP$US$US
241687081$24168708$1$I$20240610$20240726$20240802$20240802$EXP$FR-AFSSAPS-LY2024000974$FR-TEVA-VS-3227199$TEVA$$68$YR$$M$Y$78$KG$20240802$$CN$FR$FR
241687091$24168709$1$I$20230206$20240730$20240802$20240802$EXP$$EG-SANDOZ INC.-SDZ2024EG056750$SANDOZ$$41$YR$$M$Y$80$KG$20240802$$CN$EG$EG
241687101$24168710$1$I$20240429$20240726$20240802$20240802$EXP$PL-URPL-DML-MLP.4401.1.158.2024$PL-TEVA-VS-3227157$TEVA$$55$YR$$F$Y$86$KG$20240802$$PH$PL$PL
241687111$24168711$1$I$$20240722$20240802$20240802$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407014690$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240802$$CN$BR$BR
241687122$24168712$2$F$$20240805$20240802$20240819$EXP$$ID-ELI_LILLY_AND_COMPANY-ID202407013592$ELI LILLY AND CO$$68$YR$E$F$Y$33$KG$20240819$$MD$ID$ID
241687131$24168713$1$I$20240101$20240722$20240802$20240802$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407014645$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240802$$MD$CN$CN
241687141$24168714$1$I$20240601$20240722$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407014507$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240802$$HP$US$US
241687152$24168715$2$F$20240629$20240828$20240802$20240904$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407001856$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240904$$CN$JP$JP
241687161$24168716$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000598$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240802$$CN$US$US
241687171$24168717$1$I$20240501$20240722$20240802$20240802$EXP$$NZ-ELI_LILLY_AND_COMPANY-NZ202407016786$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240802$$MD$NZ$NZ
241687181$24168718$1$I$$20240722$20240802$20240802$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407014680$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$BR$BR
241687191$24168719$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000196$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240802$$CN$US$US
241687201$24168720$1$I$20240730$20240801$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004703$STEMLINE THERAPEUTICS$$72$YR$E$F$Y$$$20240802$$CN$US$US
241687211$24168721$1$I$$20240729$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004637$STEMLINE THERAPEUTICS$$$$$F$Y$$$20240802$$CN$US$US
241687221$24168722$1$I$$20240801$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004702$STEMLINE THERAPEUTICS$$83$YR$E$F$Y$$$20240802$$CN$US$US
241687231$24168723$1$I$20240727$20240730$20240802$20240802$EXP$$US-BAUSCH-BL-2024-011673$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240802$$CN$US$US
241687261$24168726$1$I$20240715$20240726$20240802$20240802$EXP$$GB-TEVA-VS-3226936$TEVA$$49$YR$$F$Y$87$KG$20240802$$CN$GB$GB
241687271$24168727$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA226093$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240802$$MD$US$US
241687281$24168728$1$I$$20240731$20240802$20240802$PER$$US-SA-2024SA228346$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240802$$CN$US$US
241687291$24168729$1$I$20240706$20240801$20240802$20240802$EXP$$US-Stemline Therapeutics, Inc.-2024ST004701$STEMLINE THERAPEUTICS$$69$YR$E$F$Y$$$20240802$$CN$US$US
241687301$24168730$1$I$20240425$20240730$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US019346$SANDOZ$$80$YR$$M$Y$$$20240802$$PH$US$US
241687316$24168731$6$F$20240720$20240816$20240802$20240822$30DAY$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02701$AMNEAL$$31$YR$$M$Y$108.84$KG$20240822$$CN$US$US
241687321$24168732$1$I$20240708$20240725$20240802$20240802$PER$$US-ABBVIE-5856490$ABBVIE$$$$$F$Y$$$20240802$$HP$US$US
241687332$24168733$2$F$$20240819$20240802$20240822$EXP$$AT-AMGEN-AUTSP2024152047$AMGEN$$58$YR$A$F$Y$63$KG$20240822$$MD$AT$AT
241687341$24168734$1$I$20240521$20240802$20240802$20240802$EXP$$FR-SANDOZ INC.-SDZ2024FR070066$SANDOZ$$68$YR$$F$Y$$$20240802$$MD$FR$FR
241687351$24168735$1$I$$20240731$20240802$20240802$EXP$$CA-SANDOZ INC.-NVSC2020CA029456$SANDOZ$$$$$M$Y$$$20240802$$CN$CA$CA
241687362$24168736$2$F$20240723$20240729$20240802$20240809$EXP$$CN-AMGEN-CHNSP2024151633$AMGEN$$61$YR$A$M$Y$$$20240809$$HP$CN$CN
241687371$24168737$1$I$$20240801$20240802$20240802$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043275$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240802$$MD$DE$DE
241687381$24168738$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152213$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241687391$24168739$1$I$20210302$20240729$20240802$20240802$EXP$GR-GREOF-202400830$NL-KOWA-24EU001999$KOWA PHARM$$$$$$Y$$$20240802$$HP$NL$GR
241687401$24168740$1$I$20240701$20240724$20240802$20240802$EXP$$US-JNJFOC-20240775766$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241687411$24168741$1$I$$20240723$20240802$20240802$EXP$$GB-BAXTER-2024BAX022196$BAXTER$$$$$M$Y$$$20240802$$HP$GB$GB
241687421$24168742$1$I$$20240723$20240802$20240802$EXP$$GB-BAXTER-2024BAX022170$BAXTER$$$$$M$Y$$$20240802$$CN$GB$GB
241687433$24168743$3$F$20240722$20240826$20240802$20240909$EXP$$US-BAXTER-2024BAX022410$BAXTER$$$$$M$Y$$$20240909$$HP$US$US
241687441$24168744$1$I$20240718$20240723$20240802$20240802$EXP$CN-NMPACDR-3301851884367202400044$CN-BAXTER-2024BAX022298$BAXTER$$42$YR$$M$Y$56$KG$20240802$$MD$CN$CN
241687451$24168745$1$I$20240601$20240729$20240802$20240802$EXP$$US-ABBVIE-5861195$ABBVIE$$42$YR$$F$Y$$$20240802$$CN$US$US
241687461$24168746$1$I$$20240731$20240802$20240802$PER$$US-DSJP-DSU-2024-138375$DAIICHI$$$$$F$Y$$$20240802$$HP$US$US
241687471$24168747$1$I$$20240730$20240802$20240802$PER$$US-APELLIS-2024-APL-0000593$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240802$$CN$US$US
241687483$24168748$3$F$$20240828$20240802$20240906$EXP$$ES-TEVA-VS-3228134$TEVA$Adrian CG, Ivan QCE, Richard B, Idoia MM, Cristina AP, Manuel SIJ et al. Mogamulizumab en el tratamiento de micosis fungoide avanzada y sindrome de sezary: A proposito de cuatro casos. LXIII Congreso Nacional de la SEHH - XXXVII Congreso Nacional de la SETH Pamplon. 2021;; Adrian CG, Ivan QCE, Richard B, Idoia MM, Cristina AP, Manuel SIJ et al. Mogamulizumab en el tratamiento de micosis fungoide avanzada y sindrome de sezary: A proposito de cuatro casos. LXIII Congreso Nacional de la SEHH - X...$73$YR$$M$Y$$$20240906$$HP$ES$ES
241687492$24168749$2$F$20240605$20240812$20240802$20240930$PER$$US-LUNDBECK-DKLU4000501$LUNDBECK$$$$$$Y$$$20240930$$HP$US$US
241687502$24168750$2$F$20240705$20240725$20240802$20240807$EXP$$SG-ABBVIE-5864591$ABBVIE$$84$YR$$M$Y$$$20240807$$CN$SG$SG
241687512$24168751$2$F$20240727$20240729$20240802$20240807$PER$$US-AMGEN-USASP2024150213$AMGEN$$64$YR$A$F$Y$$$20240807$$CN$US$US
241687521$24168752$1$I$20240701$20240730$20240802$20240802$EXP$$US-ABBVIE-5861231$ABBVIE$$58$YR$$F$Y$$$20240802$$CN$US$US
241687531$24168753$1$I$20240714$20240802$20240802$20240802$EXP$FR-AFSSAPS-BS2024000474$FR-SANDOZ INC.-SDZ2024FR070099$SANDOZ$$21$YR$$M$Y$$$20240802$$MD$FR$FR
241687541$24168754$1$I$20240715$20240802$20240802$20240802$EXP$FR-AFSSAPS-ST2024001245$FR-SANDOZ INC.-SDZ2024FR070119$SANDOZ$$56$YR$$F$Y$53.6$KG$20240802$$HP$FR$FR
241687551$24168755$1$I$$20240730$20240802$20240802$PER$$US-JNJFOC-20240780846$JOHNSON AND JOHNSON$$$$$$Y$$$20240802$$CN$US$US
241687561$24168756$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170264$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241687571$24168757$1$I$$20240801$20240802$20240802$EXP$$SG-AstraZeneca-2024A176035$ASTRAZENECA$Jin Hui Chin, S; Zaw Oo, T. VALPROIC ACID-INDUCED HYPERAMMONAEMIA MIMICKING HYPOXIC-ISCHEMIC ENCEPHALOPATHY ON NEUROIMAGING. AN INTERESTING CASE OF PROLONGED ENCEPHALOPATHY SECONDARY TO MULTIDRUG OVERDOSE. 22nd European Congress of Internal Medicine (ECIM) - European Federation of Internal Medicine (EFIM) 2024;$18$YR$$F$Y$$$20240802$$HP$SG$
241687581$24168758$1$I$$20240726$20240802$20240802$EXP$$GB-AstraZeneca-2024A170780$ASTRAZENECA$$$$$F$Y$$$20240802$$MD$GB$
241687591$24168759$1$I$$20240730$20240802$20240802$EXP$$ZA-AstraZeneca-2024A174774$ASTRAZENECA$$$$$M$Y$$$20240802$$MD$ZA$
241687601$24168760$1$I$$20240730$20240802$20240802$EXP$$JP-AstraZeneca-2024A174376$ASTRAZENECA$Sakurai N, et al.. EP-0990 A case of diffuse liver metastases from breast cancer.. The 32nd Annual Meeting of the Japanese Breast Cancer Society 2024;425.$60$YR$$F$Y$$$20240802$$MD$JP$
241687612$24168761$2$F$20230523$20240725$20240802$20240809$EXP$$TH-AstraZeneca-2024A166139$ASTRAZENECA$$28900$DY$$M$Y$69$KG$20240809$$HP$TH$
241687621$24168762$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A171470$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241687631$24168763$1$I$$20240726$20240802$20240802$EXP$$VN-AstraZeneca-2024A175324$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$VN$
241687651$24168765$1$I$$20240726$20240802$20240802$EXP$$ZA-AstraZeneca-2024A172665$ASTRAZENECA$$80$YR$$F$Y$$$20240802$$CN$ZA$
241687661$24168766$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A172019$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241687671$24168767$1$I$$20240729$20240802$20240802$EXP$$US-AstraZeneca-2024A144045$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241687681$24168768$1$I$20231117$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A174061$ASTRAZENECA$$68$YR$$M$Y$84$KG$20240802$$HP$US$
241687691$24168769$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170319$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241687701$24168770$1$I$20231201$20240725$20240802$20240802$EXP$$IE-AstraZeneca-2024A038261$ASTRAZENECA$$821$MON$$M$Y$$$20240802$$HP$IE$
241687711$24168771$1$I$20240309$20240725$20240802$20240802$EXP$$JP-AstraZeneca-2024A159294$ASTRAZENECA$$36$YR$$F$Y$76$KG$20240802$$MD$JP$
241687722$24168772$2$F$20240201$20240815$20240802$20240828$PER$$US-SA-2024SA226396$SANOFI AVENTIS$$52$YR$A$F$Y$83.91$KG$20240828$$MD$US$US
241687731$24168773$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA224153$SANOFI AVENTIS$$$$C$M$Y$22.22$KG$20240802$$MD$US$US
241687741$24168774$1$I$$20240730$20240802$20240802$EXP$$MX-DSJP-DSJ-2024-138596$DAIICHI$$$$$F$Y$$$20240802$$MD$MX$MX
241687752$24168775$2$F$$20240730$20240802$20240805$EXP$$US-Stemline Therapeutics, Inc.-2024ST004645$STEMLINE THERAPEUTICS$$67$YR$E$F$Y$$$20240802$$CN$US$US
241687762$24168776$2$F$$20240912$20240802$20240918$EXP$$JP-DSJP-DSJ-2024-138253$DAIICHI$Kishino E, Oota Y, Daitoku K, Matsumoto K, Nakamura Y, Saitou W, et al.. EP-1131 Two cases of drug-induced lung injury due to ENHERTU experienced at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Association. 2024;460$81$YR$$F$Y$$$20240918$$MD$JP$JP
241687771$24168777$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA224468$SANOFI AVENTIS$$54$YR$A$F$Y$90$KG$20240802$$MD$US$US
241687781$24168778$1$I$20240331$20240731$20240802$20240802$EXP$$US-ABBVIE-5863779$ABBVIE$$80$YR$$F$Y$$$20240802$$CN$US$US
241687801$24168780$1$I$$20240722$20240802$20240802$EXP$$CA-DSJP-DSJ-2024-138202$DAIICHI$$53$YR$$F$Y$82$KG$20240802$$CN$CA$CA
241687811$24168781$1$I$$20240730$20240802$20240802$PER$$US-APELLIS-2024-APL-0000594$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240802$$CN$US$US
241687821$24168782$1$I$20240501$20240731$20240802$20240802$EXP$$US-ABBVIE-5853830$ABBVIE$$74$YR$$M$Y$95.254$KG$20240802$$CN$US$US
241687831$24168783$1$I$20240101$20240719$20240802$20240802$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0429$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240802$$CN$US$US
241687841$24168784$1$I$20240722$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53090$$FDA-CTU$$27$YR$$F$N$$$20240802$N$$US$
241687861$24168786$1$I$$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53073$$FDA-CTU$$$$$F$N$$$20240801$N$HP$US$
241687871$24168787$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53055$$FDA-CTU$$80$YR$$M$N$$$20240802$N$$US$
241687891$24168789$1$I$$20240620$20240802$20240802$DIR$FDA-CDER-CTU-2024-53135$$FDA-CTU$$$$$$N$$$20240620$N$HP$US$
241687901$24168790$1$I$$20240627$20240802$20240802$DIR$FDA-CDER-CTU-2024-53107$$FDA-CTU$$$$$$N$$$20240627$N$$US$
241687911$24168791$1$I$$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53060$$FDA-CTU$$$$$F$N$$$20240801$N$HP$US$
241687921$24168792$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53068$$FDA-CTU$$62$YR$$F$N$$$20240802$N$$US$
241687931$24168793$1$I$$20240621$20240802$20240802$DIR$FDA-CDER-CTU-2024-53139$$FDA-CTU$$27$YR$$M$N$$$20240621$N$HP$US$
241687941$24168794$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53176$$FDA-CTU$$64$YR$$F$N$$$20240802$N$$US$
241687951$24168795$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53152$$FDA-CTU$$72$YR$$F$N$68.04$KG$20240802$N$$US$
241687961$24168796$1$I$$20240626$20240802$20240802$DIR$FDA-CDER-CTU-2024-53126$$FDA-CTU$$$$$$N$$$20240626$N$$US$
241687971$24168797$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53066$$FDA-CTU$$70$YR$$F$N$$$20240802$N$$US$
241687981$24168798$1$I$20240730$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53058$$FDA-CTU$$66$YR$$F$N$$$20240801$N$HP$US$
241687991$24168799$1$I$20240201$20240730$20240802$20240802$PER$$US-JNJFOC-20240782084$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240802$$CN$US$US
241688014$24168801$4$F$20240101$20240917$20240802$20240924$EXP$$CO-JNJFOC-20240383508$JOHNSON AND JOHNSON$$32$YR$A$M$Y$80$KG$20240924$$HP$CO$CO
241688023$24168802$3$F$20240101$20240911$20240802$20240919$EXP$$AR-JNJFOC-20240777650$JOHNSON AND JOHNSON$$78$YR$E$M$Y$85$KG$20240920$$CN$AR$AR
241688031$24168803$1$I$$20240722$20240802$20240802$EXP$$CA-DSJP-DSJ-2024-138014$DAIICHI$$61$YR$$F$Y$60$KG$20240802$$HP$CA$CA
241688041$24168804$1$I$$20240722$20240802$20240802$EXP$$CA-DSJP-DSJ-2024-138013$DAIICHI$$$$$F$Y$$$20240802$$MD$CA$CA
241688051$24168805$1$I$20240701$20240723$20240802$20240802$EXP$$US-VIIV HEALTHCARE LIMITED-US2024092321$VIIV$$51$YR$$M$Y$$$20240802$$HP$US$US
241688061$24168806$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53080$$FDA-CTU$$79$YR$$M$N$$$20240802$N$$US$
241688071$24168807$1$I$$20240628$20240802$20240802$DIR$FDA-CDER-CTU-2024-53111$$FDA-CTU$$$$$$N$$$20240628$N$HP$US$
241688081$24168808$1$I$$20240730$20240802$20240802$EXP$$US-ABBVIE-5861615$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241688111$24168811$1$I$20240704$20240722$20240802$20240802$EXP$ES-AEMPS-1548350$ES-GLENMARK PHARMACEUTICALS-2024GMK092706$GLENMARK$$$$$$Y$$$20240802$$MD$ES$ES
241688121$24168812$1$I$$20240619$20240802$20240802$DIR$FDA-CDER-CTU-2024-53134$$FDA-CTU$$$$$$N$$$20240619$N$$US$
241688131$24168813$1$I$$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152377$AMGEN$$$$$$Y$$$20240802$$HP$US$US
241688141$24168814$1$I$$20240731$20240802$20240802$EXP$NL-LRB-00993781$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-122730$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$70$KG$20240802$$MD$NL$NL
241688153$24168815$3$F$20240701$20240821$20240802$20240828$EXP$$US-ABBVIE-5861810$ABBVIE$$74$YR$$M$Y$$$20240828$$CN$US$US
241688162$24168816$2$F$20240719$20240808$20240802$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015924$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240820$$CN$US$US
241688171$24168817$1$I$20240622$20240722$20240802$20240802$EXP$FR-AFSSAPS-GR2024000921$FR-ELI_LILLY_AND_COMPANY-FR202407014662$ELI LILLY AND CO$$70$YR$E$M$Y$79$KG$20240802$$CN$FR$FR
241688181$24168818$1$I$20220101$20240723$20240802$20240802$EXP$FR-AFSSAPS-BX2024001473$FR-ELI_LILLY_AND_COMPANY-FR202407014717$ELI LILLY AND CO$$$$T$M$Y$$$20240802$$CN$FR$FR
241688191$24168819$1$I$20240201$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000333$ELI LILLY AND CO$$$$A$F$Y$$$20240802$$CN$US$US
241688201$24168820$1$I$$20240723$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015005$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240802$$HP$US$US
241688211$24168821$1$I$$20240723$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015808$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$US$US
241688221$24168822$1$I$$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000674$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240802$$CN$US$US
241688231$24168823$1$I$20240728$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53103$$FDA-CTU$$77$YR$$F$N$$$20240802$N$$US$
241688241$24168824$1$I$$20240723$20240802$20240802$EXP$$RO-ELI_LILLY_AND_COMPANY-RO202407016398$ELI LILLY AND CO$$$$$F$Y$$$20240802$$MD$RO$RO
241688251$24168825$1$I$$20240731$20240802$20240802$EXP$$AT-ABBVIE-5861291$ABBVIE$$47$YR$$F$Y$$$20240802$$MD$AT$AT
241688261$24168826$1$I$20240726$20240730$20240802$20240802$EXP$$US-JNJFOC-20240782946$JOHNSON AND JOHNSON$$$$$M$Y$$$20240802$$CN$US$US
241688271$24168827$1$I$$20240625$20240802$20240802$DIR$FDA-CDER-CTU-2024-53124$$FDA-CTU$$$$$$N$$$20240625$N$$US$
241688281$24168828$1$I$20231124$20240726$20240802$20240802$EXP$$CA-GSK-CA2023133243$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$CN$CA$CA
241688291$24168829$1$I$$20240726$20240802$20240802$PER$$US-ABBVIE-5857930$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241688301$24168830$1$I$$20240730$20240802$20240802$EXP$$US-ABBVIE-5861826$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241688311$24168831$1$I$$20240715$20240802$20240802$PER$$US-TEVA-VS-3222039$TEVA$$$$E$F$Y$$$20240802$$CN$US$US
241688321$24168832$1$I$$20240628$20240802$20240802$DIR$FDA-CDER-CTU-2024-53110$$FDA-CTU$$$$$$N$$$20240628$N$$US$
241688331$24168833$1$I$20240717$20240725$20240802$20240802$EXP$$CN-SA-2024SA224266$SANOFI AVENTIS$$56$YR$A$M$Y$56$KG$20240802$$HP$CN$CN
241688341$24168834$1$I$20130418$20240731$20240802$20240802$EXP$FR-009507513-1306FRA001208$FR-SANDOZ INC.-SDZ2024FR069716$SANDOZ$$65$YR$$F$Y$58$KG$20240802$$MD$FR$FR
241688351$24168835$1$I$$20240728$20240802$20240802$EXP$$VN-AstraZeneca-2024A173685$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$VN$
241688361$24168836$1$I$$20230517$20240802$20240802$EXP$$CA-AstraZeneca-2023A117086$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$CA$
241688371$24168837$1$I$$20240626$20240802$20240802$DIR$FDA-CDER-CTU-2024-53106$$FDA-CTU$$$$$$N$$$20240626$N$HP$US$
241688381$24168838$1$I$$20240725$20240802$20240802$EXP$$DE-AstraZeneca-2024A172697$ASTRAZENECA$$71$YR$$F$Y$$$20240802$$HP$DE$
241688391$24168839$1$I$20240606$20240723$20240802$20240802$EXP$$FR-AstraZeneca-2024A175398$ASTRAZENECA$$$$$F$Y$2.7$KG$20240802$$MD$FR$
241688401$24168840$1$I$$20240726$20240802$20240802$EXP$$SA-AstraZeneca-2024A170779$ASTRAZENECA$Tamur S. Metastatic adrenal gland neuroblastoma in an infant with trisomy 18: A case report. American Journal of Medical Genetics, Part A 2024;194(7):Article Number e6357.$19$MON$$F$Y$$$20240802$$HP$SA$
241688411$24168841$1$I$$20240627$20240802$20240802$DIR$FDA-CDER-CTU-2024-53109$$FDA-CTU$$$$$$N$$$20240627$N$$US$
241688421$24168842$1$I$$20240620$20240802$20240802$DIR$FDA-CDER-CTU-2024-53137$$FDA-CTU$$$$$$N$$$20240620$N$$US$
241688431$24168843$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170742$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241688441$24168844$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A171690$ASTRAZENECA$$$$$F$Y$$$20240802$$MD$US$
241688451$24168845$1$I$$20240729$20240802$20240802$EXP$$US-AstraZeneca-2024A173189$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241688461$24168846$1$I$20240707$20240726$20240802$20240802$EXP$$CN-AstraZeneca-2024A173245$ASTRAZENECA$$3426$WK$$F$Y$$$20240802$$MD$CN$
241688471$24168847$1$I$$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173461$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241688481$24168848$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53178$$FDA-CTU$$63$YR$$F$N$69.4$KG$20240802$N$$US$
241688491$24168849$1$I$20240627$20240726$20240802$20240802$EXP$$HR-AstraZeneca-2024A175641$ASTRAZENECA$$$$E$F$Y$$$20240802$$MD$HR$
241688501$24168850$1$I$20240508$20240726$20240802$20240802$EXP$$CN-AstraZeneca-2024A173175$ASTRAZENECA$$24965$DY$$M$Y$61$KG$20240802$$MD$CN$
241688511$24168851$1$I$$20240625$20240802$20240802$DIR$FDA-CDER-CTU-2024-53123$$FDA-CTU$$$$$$N$$$20240625$N$HP$US$
241688521$24168852$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53091$$FDA-CTU$$57$YR$$F$N$56.7$KG$20240802$N$$US$
241688531$24168853$1$I$20240603$20240729$20240802$20240802$EXP$$CN-AstraZeneca-2024A138370$ASTRAZENECA$$782$MON$$F$Y$55$KG$20240802$$PH$CN$
241688541$24168854$1$I$20240608$20240730$20240802$20240802$EXP$$JP-AstraZeneca-2024A150703$ASTRAZENECA$$80$YR$$M$Y$$$20240802$$PH$JP$US
241688551$24168855$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170835$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241688561$24168856$1$I$20240722$20240723$20240802$20240802$30DAY$$US-GSK-US2024092225$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240802$$CN$US$US
241688571$24168857$1$I$$20240727$20240802$20240802$PER$$US-ABBVIE-5860914$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241688591$24168859$1$I$$20240624$20240802$20240802$DIR$FDA-CDER-CTU-2024-53125$$FDA-CTU$$$$$$N$$$20240624$N$$US$
241688601$24168860$1$I$20240727$20240730$20240802$20240802$DIR$FDA-CDER-CTU-2024-53142$$FDA-CTU$$50$YR$$F$N$$$20240730$N$HP$US$
241688611$24168861$1$I$$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53061$$FDA-CTU$$$$$M$N$$$20240801$N$HP$US$
241688621$24168862$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53119$$FDA-CTU$$70$YR$$F$N$86.18$KG$20240802$N$$US$
241688632$24168863$2$F$$20240718$20240802$20240828$PER$$US-JNJFOC-20240755976$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240828$$CN$US$US
241688641$24168864$1$I$$20240726$20240802$20240802$EXP$$AU-RDY-SPO/AUS/24/0011179$DR REDDYS$$33$YR$A$M$Y$$$20240802$$CN$AU$AU
241688651$24168865$1$I$$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53054$$FDA-CTU$$$$$F$N$$$20240801$N$HP$US$
241688661$24168866$1$I$20240101$20240726$20240802$20240802$PER$$US-SA-2024SA226473$SANOFI AVENTIS$$34$YR$A$M$Y$72.5$KG$20240802$$MD$US$US
241688671$24168867$1$I$$20240724$20240802$20240802$PER$$US-ABBVIE-5854490$ABBVIE$$$$$F$Y$$$20240802$$HP$US$US
241688681$24168868$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA221894$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240802$$MD$US$US
241688691$24168869$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA221036$SANOFI AVENTIS$$14$YR$T$F$Y$51$KG$20240802$$CN$US$US
241688701$24168870$1$I$$20240726$20240802$20240802$EXP$$GB-TAKEDA-2023TUS116330$TAKEDA$$$$$F$Y$$$20240802$$CN$GB$GB
241688711$24168871$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA222083$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240802$$MD$US$US
241688722$24168872$2$F$20231201$20240730$20240802$20240814$EXP$$US-COOPERSURGICAL, INC.-2024CPS002236$COOPERSURGICAL$$21$YR$$F$Y$58.957$KG$20240814$$MD$US$US
241688733$24168873$3$F$$20240809$20240802$20240823$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-116820$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240823$$HP$DE$DE
241688741$24168874$1$I$$20240731$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121948$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$73.4$KG$20240802$$PH$US$US
241688751$24168875$1$I$$20240731$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122746$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240802$$CN$US$US
241688761$24168876$1$I$$20240801$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122563$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240802$$CN$US$US
241688771$24168877$1$I$$20240724$20240802$20240802$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-120022$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$$Y$$$20240802$$HP$CA$CA
241688781$24168878$1$I$20230601$20240729$20240802$20240802$EXP$$JP-PFIZER INC-PV202400098924$PFIZER$Suehiro, S.. A case of metastatic breast cancer complicated with bone marrow failure while receiving CDK4/6 inhibitors. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:332$5$DEC$$F$Y$$$20240802$$HP$JP$JP
241688791$24168879$1$I$20240701$20240731$20240802$20240802$EXP$HR-HALMED-300086211$HR-TAKEDA-2024TUS076986$TAKEDA$$28$YR$$F$Y$$$20240802$$HP$HR$HR
241688801$24168880$1$I$$20240723$20240802$20240802$EXP$$US-GSK-US2024092361$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241688811$24168881$1$I$$20240723$20240802$20240802$30DAY$$US-GSK-US2024092432$GLAXOSMITHKLINE$$$$$F$Y$$$20240802$$CN$US$US
241688821$24168882$1$I$$20240731$20240802$20240802$EXP$$US-LUNDBECK-DKLU4002508$LUNDBECK$$$$$$Y$$$20240802$$HP$US$US
241688831$24168883$1$I$20240729$20240730$20240802$20240802$PER$$US-ABBVIE-5864358$ABBVIE$$49$YR$$F$Y$$$20240802$$MD$US$US
241688841$24168884$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153171$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241688861$24168886$1$I$$20240724$20240802$20240802$PER$$US-BIOMARINAP-US-2024-159569$BIOMARIN$$$$$$Y$$$20240802$$CN$US$US
241688873$24168887$3$F$20240312$20240828$20240802$20240830$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-105588$REGENERON$$79$YR$$F$Y$$$20240830$$MD$JP$JP
241688881$24168888$1$I$$20240723$20240802$20240802$PER$$US-BIOMARINAP-US-2024-159568$BIOMARIN$$$$$$Y$$$20240802$$CN$US$US
241688891$24168889$1$I$20240725$20240729$20240802$20240802$EXP$$CA-ABBVIE-5862560$ABBVIE$$83$YR$$F$Y$$$20240802$$CN$CA$CA
241688903$24168890$3$F$$20240909$20240802$20240917$EXP$$NL-ABBVIE-5818847$ABBVIE$$$$E$M$Y$$$20240917$$CN$NL$NL
241688911$24168891$1$I$$20240730$20240802$20240802$EXP$$US-ABBVIE-5863318$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241688922$24168892$2$F$$20240828$20240802$20240904$30DAY$$US-GSK-US2024AMR092632$GLAXOSMITHKLINE$$$$$M$Y$$$20240904$$HP$US$US
241688931$24168893$1$I$$20240731$20240802$20240802$EXP$$US-ABBVIE-5864133$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241688941$24168894$1$I$$20240723$20240802$20240802$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR093270$VIIV$$$$$$Y$$$20240802$$MD$US$US
241688952$24168895$2$F$20231227$20240806$20240802$20240817$EXP$$US-UCBSA-2024037003$UCB$$86$YR$$F$Y$$$20240817$$HP$US$US
241688961$24168896$1$I$20240729$20240731$20240802$20240802$EXP$$US-BAYER-2024A111587$BAYER$$16$YR$T$M$Y$$$20240802$$CN$US$US
241688971$24168897$1$I$$20240726$20240802$20240802$EXP$$VN-AstraZeneca-2024A174301$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$VN$
241688991$24168899$1$I$20230501$20240726$20240802$20240802$EXP$$FR-AstraZeneca-2024A173167$ASTRAZENECA$$$$$F$Y$$$20240802$$MD$FR$
241689001$24168900$1$I$$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173529$ASTRAZENECA$$$$$M$Y$85.3$KG$20240802$$CN$US$
241689011$24168901$1$I$$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A174861$ASTRAZENECA$$$$$F$Y$$$20240802$$HP$US$
241689021$24168902$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122552$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240802$$MD$US$US
241689032$24168903$2$F$20211125$20240725$20240802$20240813$EXP$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-121975$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-121975$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$55$KG$20240813$$MD$FR$FR
241689041$24168904$1$I$20240420$20240731$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122822$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240802$$CN$US$US
241689051$24168905$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170180$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241689061$24168906$1$I$$20240730$20240802$20240802$EXP$$ES-AstraZeneca-2024A174662$ASTRAZENECA$$$$$$Y$$$20240802$$MD$ES$
241689081$24168908$1$I$$20240625$20240802$20240802$DIR$FDA-CDER-CTU-2024-53120$$FDA-CTU$$$$$$N$$$20240625$N$HP$US$
241689091$24168909$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53154$$FDA-CTU$$73$YR$$M$N$$$20240802$N$$US$
241689111$24168911$1$I$$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53076$$FDA-CTU$$$$$F$N$$$20240801$N$HP$US$
241689121$24168912$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019847$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240802$$CN$US$US
241689131$24168913$1$I$$20240722$20240802$20240802$EXP$NL-LRB-00986074$NL-GLENMARK PHARMACEUTICALS-2024GMK092713$GLENMARK$$$$$$Y$$$20240802$$CN$NL$NL
241689141$24168914$1$I$$20240725$20240802$20240802$PER$$US-AMGEN-USASP2024152628$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. Publication in journal JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240802$$MD$US$US
241689151$24168915$1$I$$20240730$20240802$20240802$PER$$US-DSJP-DSU-2024-138403$DAIICHI$$$$$F$Y$$$20240802$$CN$US$US
241689161$24168916$1$I$$20240723$20240802$20240802$EXP$$US-GSK-US2024AMR094124$GLAXOSMITHKLINE$$$$$$Y$$$20240802$$MD$US$US
241689171$24168917$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53145$$FDA-CTU$$53$YR$$F$N$$$20240802$N$$US$
241689181$24168918$1$I$20240725$20240725$20240802$20240802$PER$$US-GE HEALTHCARE-2024CSU008483$GE HEALTHCARE$$66$YR$$F$Y$$$20240802$$HP$US$US
241689191$24168919$1$I$20240701$20240731$20240802$20240802$PER$$US-ABBVIE-5863453$ABBVIE$$$$$$Y$$$20240802$$MD$US$US
241689201$24168920$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53082$$FDA-CTU$$40$YR$$M$N$$$20240802$N$$US$
241689211$24168921$1$I$20240101$20240726$20240802$20240802$PER$$US-ABBVIE-5858327$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241689221$24168922$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53092$$FDA-CTU$$63$YR$$M$N$83.91$KG$20240802$N$$US$
241689231$24168923$1$I$20240101$20240719$20240802$20240802$PER$$US-INSUD PHARMA-2407US05767$INSUD PHARMA$$$$$$Y$$$20240802$$CN$US$US
241689241$24168924$1$I$20240301$20240718$20240802$20240802$PER$$US-INSUD PHARMA-2407US05765$INSUD PHARMA$$$$$$Y$$$20240802$$CN$US$US
241689251$24168925$1$I$20240101$20240719$20240802$20240802$PER$$US-INSUD PHARMA-2407US05806$INSUD PHARMA$$$$$$Y$$$20240802$$CN$US$US
241689262$24168926$2$F$20240601$20240816$20240802$20240826$PER$$US-INSUD PHARMA-2407US05766$INSUD PHARMA$$$$$$Y$$$20240826$$CN$US$US
241689271$24168927$1$I$20200809$20240726$20240802$20240802$EXP$$CA-TAKEDA-2021TUS014485$TAKEDA$$56$YR$$F$Y$100$KG$20240802$$CN$CA$CA
241689281$24168928$1$I$20240701$20240720$20240802$20240802$PER$$US-INSUD PHARMA-2407US05807$INSUD PHARMA$$$$$$Y$$$20240802$$CN$US$US
241689291$24168929$1$I$20240701$20240720$20240802$20240802$PER$$US-INSUD PHARMA-2407US05808$INSUD PHARMA$$$$$$Y$$$20240802$$CN$US$US
241689301$24168930$1$I$20240727$20240727$20240802$20240802$PER$$US-ALXN-202407USA001965US$ALEXION PHARMACEUTICALS$$30$YR$$F$Y$$$20240802$$CN$US$US
241689311$24168931$1$I$$20240726$20240802$20240802$EXP$$US-ALXN-202407USA001914US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$HP$US$US
241689323$24168932$3$F$$20240912$20240802$20240923$EXP$$AU-TAKEDA-2024TUS077480$TAKEDA$$$$$M$Y$$$20240923$$CN$AU$AU
241689331$24168933$1$I$20231206$20240726$20240802$20240802$EXP$IT-MINISAL02-995672$IT-TEVA-VS-3226901$TEVA$$94$YR$$M$Y$$$20240802$$MD$IT$IT
241689341$24168934$1$I$20240511$20240729$20240802$20240802$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043251$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240802$$CN$US$US
241689351$24168935$1$I$$20240731$20240802$20240802$EXP$$US-DSJP-DSU-2024-138376$DAIICHI$$$$$F$Y$$$20240802$$CN$US$US
241689362$24168936$2$F$$20240819$20240802$20240830$EXP$$US-DSJP-DSU-2024-138366$DAIICHI$$$$$M$Y$$$20240830$$CN$US$US
241689381$24168938$1$I$20240701$20240728$20240802$20240802$PER$$US-SA-2024SA224784$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240802$$MD$US$US
241689392$24168939$2$F$20240701$20240819$20240802$20240829$PER$$US-SA-2024SA224791$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240829$$CN$US$US
241689401$24168940$1$I$20240728$20240729$20240802$20240802$PER$$US-BIOGEN-2024BI01275899$BIOGEN$$21$YR$$$Y$$$20240802$$CN$US$US
241689421$24168942$1$I$20240719$20240724$20240802$20240802$PER$$US-MYLANLABS-2024M1069598$MYLAN$$73$YR$$F$Y$58.97$KG$20240802$$CN$US$US
241689431$24168943$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53153$$FDA-CTU$$90$YR$$M$N$$$20240802$N$$US$
241689441$24168944$1$I$20240728$20240730$20240802$20240802$PER$$US-PFIZER INC-202400227024$PFIZER$$51$YR$$F$Y$$$20240802$$CN$US$US
241689451$24168945$1$I$20240731$20240731$20240802$20240802$PER$$US-PFIZER INC-PV202400100261$PFIZER$$70$YR$$$Y$$$20240802$$CN$US$US
241689461$24168946$1$I$20240701$20240731$20240802$20240802$PER$$US-PFIZER INC-202400227859$PFIZER$$$$$F$Y$$$20240802$$CN$US$US
241689471$24168947$1$I$$20240731$20240802$20240802$DIR$FDA-CDER-CTU-2024-53072$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
241689482$24168948$2$F$$20240904$20240802$20240904$PER$$US-PFIZER INC-202400226044$PFIZER$$$$$$Y$$$20240904$$PH$US$US
241689491$24168949$1$I$20240515$20240726$20240802$20240802$EXP$ES-AEMPS-1550563$ES-TEVA-VS-3226785$TEVA$$4$YR$$F$Y$$$20240802$$MD$ES$ES
241689501$24168950$1$I$20240101$20240729$20240802$20240802$PER$$US-PFIZER INC-PV202400099448$PFIZER$$78$YR$$M$Y$$$20240802$$CN$US$US
241689512$24168951$2$F$$20240804$20240802$20240806$PER$$US-PFIZER INC-PV202400099724$PFIZER$$45$YR$$F$Y$102.9$KG$20240806$$CN$US$US
241689521$24168952$1$I$20240722$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53093$$FDA-CTU$$27$YR$$F$N$$$20240802$N$$US$
241689532$24168953$2$F$20230101$20240816$20240802$20240821$PER$$US-PFIZER INC-PV202400089326$PFIZER$$74$YR$$M$Y$68.027$KG$20240821$$CN$US$US
241689541$24168954$1$I$$20240730$20240802$20240802$PER$$US-PFIZER INC-202400226837$PFIZER$$77$YR$$F$Y$$$20240802$$CN$US$US
241689561$24168956$1$I$20240701$20240731$20240802$20240802$PER$$US-PFIZER INC-202400227713$PFIZER$$76$YR$$F$Y$$$20240802$$MD$US$US
241689571$24168957$1$I$$20240801$20240802$20240802$PER$$US-PFIZER INC-202400228283$PFIZER$$69$YR$$F$Y$$$20240802$$CN$US$US
241689582$24168958$2$F$20240725$20240822$20240802$20240826$PER$$US-PFIZER INC-202400227778$PFIZER$$81$YR$$M$Y$$$20240826$$CN$US$US
241689592$24168959$2$F$$20240924$20240802$20240925$PER$$US-PFIZER INC-PV202400099914$PFIZER$$83$YR$$F$Y$$$20240925$$CN$US$US
241689603$24168960$3$F$20240401$20240929$20240802$20240930$PER$$US-PFIZER INC-202400226956$PFIZER$$36$YR$$F$Y$$$20240930$$CN$US$US
241689611$24168961$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-202400228455$PFIZER$$62$YR$$F$Y$$$20240802$$HP$US$US
241689621$24168962$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-PV202400100232$PFIZER$$56$YR$$F$Y$$$20240802$$HP$US$US
241689632$24168963$2$F$20240712$20240802$20240802$20240806$PER$$US-PFIZER INC-PV202400100507$PFIZER$$69$YR$$F$Y$85.6$KG$20240806$$HP$US$US
241689641$24168964$1$I$20240101$20240730$20240802$20240802$PER$$US-PFIZER INC-202400226915$PFIZER$$67$YR$$M$Y$105.69$KG$20240802$$CN$US$US
241689651$24168965$1$I$$20240730$20240802$20240802$PER$$US-PFIZER INC-PV202400100233$PFIZER$$43$YR$$F$Y$88.841$KG$20240802$$MD$US$US
241689661$24168966$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53099$$FDA-CTU$$21$YR$$M$N$$$20240802$N$$US$
241689681$24168968$1$I$$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53164$$FDA-CTU$$$$$M$N$$$20240801$N$HP$US$
241689691$24168969$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53156$$FDA-CTU$$41$YR$$F$N$$$20240802$N$$US$
241689711$24168971$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53063$$FDA-CTU$$66$YR$$M$N$$$20240802$N$$US$
241689721$24168972$1$I$20240718$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53086$$FDA-CTU$$59$YR$$F$N$$$20240801$N$HP$US$
241689741$24168974$1$I$20240718$20240802$20240802$20240802$DIR$712567$$FDA-CTU$$62$YR$$F$N$$$20240802$Y$PH$US$
241689751$24168975$1$I$20240601$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53146$$FDA-CTU$$57$YR$$F$N$$$20240802$N$PH$US$
241689771$24168977$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53079$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
241689781$24168978$1$I$20240802$20240802$20240802$20240802$DIR$712580$$FDA-CTU$$74$YR$$F$N$101.25$KG$20240802$N$HP$US$
241689801$24168980$1$I$$20240802$20240802$20240802$DIR$712571$$FDA-CTU$$$$$UNK$N$$$20240802$$CN$US$
241689811$24168981$1$I$$20240802$20240802$20240802$DIR$712565$$FDA-CTU$$$$$UNK$N$$$20240802$$CN$US$
241689831$24168983$1$I$$20240802$20240802$20240802$DIR$712566$$FDA-CTU$$$$$UNK$N$$$20240802$$CN$US$
241689841$24168984$1$I$$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024153019$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241689851$24168985$1$I$$20240730$20240802$20240802$PER$$US-PFIZER INC-202400227880$PFIZER$$49$YR$$F$Y$$$20240802$$HP$US$US
241689861$24168986$1$I$20240701$20240801$20240802$20240802$PER$$US-PFIZER INC-202400228487$PFIZER$$66$YR$$F$Y$$$20240802$$CN$US$US
241689871$24168987$1$I$$20240802$20240802$20240802$DIR$712569$$FDA-CTU$$$$$UNK$N$$$20240802$$CN$US$
241689882$24168988$2$F$$20240901$20240802$20240904$PER$$US-PFIZER INC-202400226349$PFIZER$$$$$$Y$$$20240904$$PH$US$US
241689901$24168990$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-PV202400041065$PFIZER$$75$YR$$F$Y$$$20240802$$MD$US$US
241689911$24168991$1$I$$20240730$20240802$20240802$PER$$US-PFIZER INC-202400226850$PFIZER$$$$$M$Y$$$20240802$$MD$US$US
241689921$24168992$1$I$20240730$20240730$20240802$20240802$PER$$US-PFIZER INC-202400227302$PFIZER$$65$YR$$F$Y$$$20240802$$CN$US$US
241689931$24168993$1$I$$20240802$20240802$20240802$DIR$712570$$FDA-CTU$$$$$UNK$N$$$20240802$$CN$US$
241689941$24168994$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-PV202400100373$PFIZER$$58$YR$$F$Y$$$20240802$$HP$US$US
241689951$24168995$1$I$$20240730$20240802$20240802$PER$$US-PFIZER INC-PV202400099647$PFIZER$$40$YR$$F$Y$$$20240802$$HP$US$US
241689962$24168996$2$F$$20240807$20240802$20240807$PER$$US-PFIZER INC-PV202400100278$PFIZER$$56$YR$$F$Y$$$20240807$$HP$US$US
241689971$24168997$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-202400228093$PFIZER$$$$$F$Y$$$20240802$$CN$US$US
241689981$24168998$1$I$$20240801$20240802$20240802$PER$$US-PFIZER INC-PV202400100629$PFIZER$$79$YR$$M$Y$$$20240802$$HP$US$US
241689991$24168999$1$I$20240101$20240731$20240802$20240802$PER$$US-PFIZER INC-202400227622$PFIZER$$60$YR$$F$Y$$$20240802$$HP$US$US
241690011$24169001$1$I$$20240729$20240802$20240802$PER$$US-PFIZER INC-PV202400098760$PFIZER$$55$YR$$F$Y$$$20240802$$HP$US$US
241690021$24169002$1$I$$20240801$20240802$20240802$PER$$US-PFIZER INC-202400228644$PFIZER$$70$YR$$F$Y$$$20240802$$CN$US$US
241690031$24169003$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-202400023242$PFIZER$$46$YR$$M$Y$$$20240802$$CN$US$US
241690042$24169004$2$F$20240817$20240820$20240802$20240822$PER$$US-PFIZER INC-202400227818$PFIZER$$54$YR$$F$Y$$$20240822$$HP$US$US
241690051$24169005$1$I$$20240729$20240802$20240802$PER$$US-PFIZER INC-202400226963$PFIZER$$55$YR$$F$Y$$$20240802$$CN$US$US
241690062$24169006$2$F$$20240808$20240802$20240809$PER$$US-PFIZER INC-PV202400100788$PFIZER$$60$YR$$F$Y$$$20240809$$HP$US$US
241690075$24169007$5$F$$20240909$20240802$20240910$PER$$US-PFIZER INC-PV202400099043$PFIZER$$53$YR$$F$Y$$$20240910$$HP$US$US
241690081$24169008$1$I$20240701$20240729$20240802$20240802$PER$$US-PFIZER INC-202400225944$PFIZER$$83$YR$$F$Y$$$20240802$$PH$US$US
241690091$24169009$1$I$$20240730$20240802$20240802$PER$$US-PFIZER INC-202400226750$PFIZER$$57$YR$$F$Y$102.06$KG$20240802$$CN$US$US
241690101$24169010$1$I$20240729$20240801$20240802$20240802$PER$$US-PFIZER INC-202400228643$PFIZER$$$$A$M$Y$$$20240802$$CN$US$US
241690111$24169011$1$I$20240731$20240731$20240802$20240802$PER$$US-PFIZER INC-202400227904$PFIZER$$57$YR$$F$Y$$$20240802$$CN$US$US
241690121$24169012$1$I$20240726$20240731$20240802$20240802$PER$$US-PFIZER INC-202400227543$PFIZER$$82$YR$$M$Y$$$20240802$$CN$US$US
241690131$24169013$1$I$$20240730$20240802$20240802$PER$$US-PFIZER INC-202400227231$PFIZER$$$$$M$Y$$$20240802$$CN$US$US
241690141$24169014$1$I$$20240801$20240802$20240802$PER$$US-PFIZER INC-202400228569$PFIZER$$$$$$Y$$$20240802$$CN$US$US
241690161$24169016$1$I$20240701$20240730$20240802$20240802$PER$$US-PFIZER INC-202400227125$PFIZER$$$$$F$Y$$$20240802$$CN$US$US
241690174$24169017$4$F$$20240927$20240802$20240930$PER$$US-PFIZER INC-PV202400100406$PFIZER$$57$YR$$F$Y$$$20240930$$HP$US$US
241690181$24169018$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-202400227809$PFIZER$$16$YR$$F$Y$$$20240802$$MD$US$US
241690191$24169019$1$I$20240711$20240730$20240802$20240802$PER$$US-PFIZER INC-PV202400099591$PFIZER$$74$YR$$F$Y$$$20240802$$HP$US$US
241690201$24169020$1$I$20240731$20240731$20240802$20240802$PER$$JP-PFIZER INC-202400227195$PFIZER$$$$$$Y$$$20240802$$PH$JP$JP
241690211$24169021$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-202400228019$PFIZER$$65$YR$$F$Y$$$20240802$$CN$US$US
241690221$24169022$1$I$$20240801$20240802$20240802$PER$$US-PFIZER INC-PV202400100641$PFIZER$$55$YR$$F$Y$$$20240802$$HP$US$US
241690231$24169023$1$I$20240701$20240731$20240802$20240802$PER$$US-PFIZER INC-PV202400100402$PFIZER$$74$YR$$$Y$$$20240802$$CN$US$US
241690241$24169024$1$I$$20240801$20240802$20240802$PER$$US-PFIZER INC-202400228428$PFIZER$$61$YR$$F$Y$$$20240802$$HP$US$US
241690252$24169025$2$F$20240101$20240813$20240802$20240816$PER$$US-PFIZER INC-PV202400099809$PFIZER$$38$YR$$F$Y$63$KG$20240816$$MD$US$US
241690261$24169026$1$I$20230101$20240731$20240802$20240802$PER$$US-PFIZER INC-202400228338$PFIZER$$62$YR$$F$Y$$$20240802$$HP$US$US
241690271$24169027$1$I$$20240730$20240802$20240802$PER$$US-PFIZER INC-202400226754$PFIZER$$$$$M$Y$$$20240802$$CN$US$US
241690281$24169028$1$I$20240731$20240801$20240802$20240802$PER$$US-PFIZER INC-202400228533$PFIZER$$61$YR$$M$Y$$$20240802$$CN$US$US
241690291$24169029$1$I$20240731$20240731$20240802$20240802$PER$$US-PFIZER INC-202400228066$PFIZER$$65$YR$$M$Y$$$20240802$$CN$US$US
241690302$24169030$2$F$20240719$20240823$20240802$20240827$PER$$US-PFIZER INC-202400227768$PFIZER$$64$YR$$M$Y$99.773$KG$20240827$$CN$US$US
241690323$24169032$3$F$$20240816$20240802$20240819$PER$$US-PFIZER INC-202400227507$PFIZER$$75$YR$$F$Y$69.85$KG$20240819$$CN$US$US
241690331$24169033$1$I$20240426$20240730$20240802$20240802$PER$$US-PFIZER INC-202400227870$PFIZER$$52$YR$$F$Y$$$20240802$$HP$US$US
241690341$24169034$1$I$20240723$20240730$20240802$20240802$PER$$US-PFIZER INC-202400227022$PFIZER$$68$YR$$F$Y$$$20240802$$CN$US$US
241690351$24169035$1$I$20240727$20240729$20240802$20240802$PER$$US-PFIZER INC-202400226316$PFIZER$$59$YR$$F$Y$$$20240802$$CN$US$US
241690361$24169036$1$I$20240731$20240731$20240802$20240802$PER$$US-PFIZER INC-202400227557$PFIZER$$$$$$Y$$$20240802$$HP$US$US
241690371$24169037$1$I$20240731$20240801$20240802$20240802$PER$$US-PFIZER INC-202400228522$PFIZER$$50$YR$$M$Y$$$20240802$$CN$US$US
241690382$24169038$2$F$$20240731$20240802$20240807$EXP$$US-PFIZER INC-202400227775$PFIZER$$61$YR$$F$Y$$$20240807$$MD$US$US
241690392$24169039$2$F$20240801$20240910$20240802$20240911$PER$$US-PFIZER INC-202400228489$PFIZER$$56$YR$$F$Y$86.168$KG$20240911$$HP$US$US
241690402$24169040$2$F$20240101$20240805$20240802$20240806$PER$$US-PFIZER INC-202400228528$PFIZER$$73$YR$$F$Y$$$20240806$$HP$US$US
241690412$24169041$2$F$20240730$20240902$20240802$20240904$PER$$US-PFIZER INC-202400227852$PFIZER$$68$YR$$M$Y$$$20240904$$HP$US$US
241690422$24169042$2$F$20240731$20240801$20240802$20240806$PER$$US-PFIZER INC-202400228104$PFIZER$$69$YR$$F$Y$97.98$KG$20240806$$HP$US$US
241690431$24169043$1$I$$20240729$20240802$20240802$PER$$US-PFIZER INC-PV202300118552$PFIZER$$77$YR$$F$Y$$$20240802$$CN$US$US
241690441$24169044$1$I$$20240730$20240802$20240802$PER$$US-PFIZER INC-PV202400099673$PFIZER$$69$YR$$F$Y$$$20240802$$HP$US$US
241690451$24169045$1$I$20240801$20240801$20240802$20240802$PER$$US-PFIZER INC-202400228526$PFIZER$$73$YR$$M$Y$$$20240802$$CN$US$US
241690461$24169046$1$I$20240801$20240801$20240802$20240802$PER$$US-PFIZER INC-202400228530$PFIZER$$67$YR$$F$Y$$$20240802$$CN$US$US
241690471$24169047$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-202400228456$PFIZER$$71$YR$$F$Y$$$20240802$$HP$US$US
241690482$24169048$2$F$$20240911$20240802$20240913$PER$$US-PFIZER INC-PV202400100517$PFIZER$$55$YR$$M$Y$$$20240913$$HP$US$US
241690491$24169049$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-202400227816$PFIZER$$69$YR$$F$Y$$$20240802$$CN$US$US
241690501$24169050$1$I$20240701$20240730$20240802$20240802$PER$$US-PFIZER INC-PV202400099638$PFIZER$$55$YR$$M$Y$$$20240802$$HP$US$US
241690512$24169051$2$F$$20240809$20240802$20240812$PER$$US-PFIZER INC-202400227974$PFIZER$$$$$F$Y$$$20240812$$CN$US$US
241690521$24169052$1$I$20240728$20240731$20240802$20240802$PER$$US-PFIZER INC-202400227842$PFIZER$$42$YR$$F$Y$$$20240802$$CN$US$US
241690532$24169053$2$F$$20240821$20240802$20240827$PER$$US-PFIZER INC-202400217090$PFIZER$$16$YR$$F$Y$$$20240827$$HP$US$US
241690542$24169054$2$F$$20240827$20240802$20240830$PER$$US-PFIZER INC-PV202400100582$PFIZER$$69$YR$$F$Y$$$20240830$$CN$US$US
241690551$24169055$1$I$$20240730$20240802$20240802$PER$$US-PFIZER INC-PV202400099684$PFIZER$$84$YR$$$Y$$$20240802$$CN$US$US
241690561$24169056$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-PV202400100339$PFIZER$$86$YR$$F$Y$$$20240802$$CN$US$US
241690571$24169057$1$I$$20240730$20240802$20240802$PER$$US-PFIZER INC-202400226921$PFIZER$$66$YR$$F$Y$$$20240802$$PH$US$US
241690582$24169058$2$F$20240727$20240903$20240802$20240905$PER$$US-PFIZER INC-202400227680$PFIZER$$36$YR$$M$Y$70.295$KG$20240905$$CN$US$US
241690591$24169059$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-202400227796$PFIZER$$64$YR$$F$Y$$$20240802$$PH$US$US
241690601$24169060$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-PV202400100398$PFIZER$$71$YR$$F$Y$$$20240802$$CN$US$US
241690612$24169061$2$F$$20240801$20240802$20240807$PER$$US-PFIZER INC-PV202400100775$PFIZER$$$$$M$Y$$$20240807$$CN$US$US
241690621$24169062$1$I$20240801$20240801$20240802$20240802$PER$$US-PFIZER INC-202400228532$PFIZER$$62$YR$$F$Y$$$20240802$$CN$US$US
241690631$24169063$1$I$20240729$20240730$20240802$20240802$PER$$US-PFIZER INC-202400227655$PFIZER$$73$YR$$F$Y$53.52$KG$20240802$$CN$US$US
241690642$24169064$2$F$20240801$20240805$20240802$20240806$PER$$US-PFIZER INC-202400228523$PFIZER$$42$YR$$F$Y$$$20240806$$CN$US$US
241690652$24169065$2$F$20240726$20240731$20240802$20240806$PER$$US-PFIZER INC-202400227629$PFIZER$$$$$F$Y$$$20240806$$PH$US$US
241690661$24169066$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-PV202400100287$PFIZER$$42$YR$$F$Y$$$20240802$$HP$US$US
241690671$24169067$1$I$20240729$20240731$20240802$20240802$PER$$US-PFIZER INC-202400227679$PFIZER$$84$YR$$M$Y$$$20240802$$CN$US$US
241690681$24169068$1$I$20240730$20240730$20240802$20240802$PER$$US-PFIZER INC-202400227243$PFIZER$$55$YR$$F$Y$$$20240802$$CN$US$US
241690691$24169069$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-202400228148$PFIZER$$76$YR$$F$Y$$$20240802$$CN$US$US
241690701$24169070$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-PV202400100578$PFIZER$$$$$$Y$$$20240802$$MD$US$US
241690711$24169071$1$I$$20240801$20240802$20240802$PER$$US-PFIZER INC-202400228568$PFIZER$$$$$$Y$$$20240802$$HP$US$US
241690731$24169073$1$I$20240101$20240724$20240802$20240802$PER$$US-SA-2024SA223086$SANOFI AVENTIS$$20$YR$A$M$Y$68$KG$20240802$$MD$US$US
241690741$24169074$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA223682$SANOFI AVENTIS$$$$A$F$Y$89$KG$20240802$$MD$US$US
241690752$24169075$2$F$20240806$20240807$20240802$20240815$PER$$US-SA-2024SA222180$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240815$$MD$US$US
241690763$24169076$3$F$$20240829$20240802$20240905$EXP$$US-TAKEDA-2024TUS076920$TAKEDA$$$$$F$Y$118$KG$20240905$$HP$US$US
241690771$24169077$1$I$$20240731$20240802$20240802$PER$$US-TAKEDA-2024TUS077178$TAKEDA$$$$$F$Y$$$20240802$$MD$US$US
241690784$24169078$4$F$$20240826$20240802$20240828$EXP$$CA-TAKEDA-2024TUS077470$TAKEDA$$$$$F$Y$$$20240828$$CN$CA$CA
241690792$24169079$2$F$20240718$20240719$20240802$20240912$EXP$$DE-UCBSA-2024037292$UCB$$44$YR$$F$Y$$$20240913$$CN$DE$DE
241690802$24169080$2$F$20240430$20240826$20240802$20240826$PER$$US-ALXN-202407USA001855US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$HP$US$US
241690811$24169081$1$I$$20240730$20240802$20240802$PER$$US-ABBVIE-5862380$ABBVIE$$$$$F$Y$$$20240802$$HP$US$US
241690821$24169082$1$I$$20240731$20240802$20240802$EXP$$US-ABBVIE-5863105$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241690832$24169083$2$F$$20240731$20240802$20240808$PER$$US-PFIZER INC-PV202400100196$PFIZER$$30$YR$$M$Y$$$20240808$$CN$US$US
241690841$24169084$1$I$$20240730$20240802$20240802$PER$$US-PFIZER INC-PV202400099612$PFIZER$$$$$F$Y$$$20240802$$CN$US$US
241690854$24169085$4$F$20240701$20240919$20240802$20240926$30DAY$$US-PFIZER INC-202400226001$PFIZER$$13$YR$$M$Y$29.48$KG$20240926$$CN$US$US
241690863$24169086$3$F$$20240907$20240802$20240909$30DAY$$US-PFIZER INC-202400225451$PFIZER$$8$YR$$$Y$$$20240909$$HP$US$US
241690871$24169087$1$I$20240727$20240730$20240802$20240802$EXP$$DE-PFIZER INC-202400226391$PFIZER$$40$YR$$F$Y$$$20240802$$CN$DE$DK
241690885$24169088$5$F$$20240918$20240802$20240918$30DAY$$US-PFIZER INC-202400226386$PFIZER$$3$YR$$M$Y$$$20240918$$CN$US$US
241690891$24169089$1$I$$20240723$20240802$20240802$PER$$US-JNJFOC-20240767578$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$CN$US$US
241690901$24169090$1$I$$20240730$20240802$20240802$EXP$$US-AMGEN-USASP2024152199$AMGEN$$$$$M$Y$$$20240802$$MD$US$US
241690911$24169091$1$I$$20240729$20240802$20240802$PER$$US-MYLANLABS-2024M1071391$MYLAN$$$$$$Y$$$20240802$$CN$US$US
241690922$24169092$2$F$$20240805$20240802$20240813$PER$$US-SA-2024SA224860$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240814$$MD$US$US
241690932$24169093$2$F$20240729$20240826$20240802$20240903$PER$$US-BIOGEN-2024BI01276083$BIOGEN$$3$YR$$F$Y$$$20240903$$CN$US$US
241690943$24169094$3$F$20240729$20240821$20240802$20240830$PER$$US-SA-2024SA225062$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240830$$CN$US$US
241690951$24169095$1$I$$20240801$20240802$20240802$PER$$NVSC2024US158220$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241690971$24169097$1$I$20240731$20240801$20240802$20240802$PER$$NVSC2024US158163$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241690982$24169098$2$F$20240801$20240801$20240802$20240807$EXP$$NVSC2024GB068759$NOVARTIS$$$$A$F$Y$$$20240807$$CN$GB$GB
241690991$24169099$1$I$20240704$20240726$20240802$20240802$EXP$ES-AEMPS-1547002$ES-TEVA-VS-3226903$TEVA$$85$YR$$M$Y$85$KG$20240802$$HP$ES$ES
241691001$24169100$1$I$20240326$20240726$20240802$20240802$EXP$FR-AFSSAPS-LL2024000697$FR-TEVA-VS-3226686$TEVA$$2$YR$$F$Y$15$KG$20240802$$PH$FR$FR
241691021$24169102$1$I$20240601$20240725$20240802$20240802$EXP$$NVSC2024BR113542$NOVARTIS$$58$YR$$F$Y$$$20240802$$CN$BR$BR
241691032$24169103$2$F$$20240924$20240802$20240927$EXP$$US-TAKEDA-2022TUS003021$TAKEDA$$$$$F$Y$75$KG$20240927$$CN$US$US
241691041$24169104$1$I$$20240801$20240802$20240802$EXP$$NVSC2024US158066$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241691061$24169106$1$I$$20231219$20240802$20240802$PER$$NVSC2023US275197$NOVARTIS$$$$$M$Y$$$20240802$$CN$US$US
241691071$24169107$1$I$20230101$20240108$20240802$20240802$PER$$NVSC2024US013801$NOVARTIS$$$$$M$Y$$$20240802$$CN$US$US
241691091$24169109$1$I$20240616$20240731$20240802$20240802$EXP$$NVSC2024CN157883$NOVARTIS$$78$YR$$F$Y$55$KG$20240802$$HP$CN$CN
241691101$24169110$1$I$20240521$20240801$20240802$20240802$EXP$FR-AFSSAPS-AM2024000624$NVSC2024FR157041$NOVARTIS$$20$YR$$M$Y$$$20240802$$MD$FR$FR
241691111$24169111$1$I$20240701$20240801$20240802$20240802$PER$$NVSC2024US158068$NOVARTIS$$$$$$Y$$$20240802$$MD$US$US
241691121$24169112$1$I$$20240801$20240802$20240802$PER$$NVSC2024US157913$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241691134$24169113$4$F$20230101$20240807$20240802$20240903$PER$$NVSC2023US187708$NOVARTIS$$$$$F$Y$$$20240903$$CN$US$US
241691141$24169114$1$I$20240712$20240726$20240802$20240802$EXP$$NVSC2024RU154870$NOVARTIS$$51$YR$$F$Y$80$KG$20240802$$HP$RU$RU
241691151$24169115$1$I$20240601$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000681$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240802$$MD$US$US
241691161$24169116$1$I$$20240730$20240802$20240802$PER$$NVSC2024US157327$NOVARTIS$$$$$$Y$$$20240802$$CN$US$US
241691171$24169117$1$I$20231001$20240723$20240802$20240802$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407014740$ELI LILLY AND CO$$38$YR$A$F$Y$86$KG$20240802$$CN$DE$DE
241691181$24169118$1$I$20231001$20240723$20240802$20240802$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407014702$ELI LILLY AND CO$$1$DY$N$M$Y$2.13$KG$20240802$$CN$DE$DE
241691191$24169119$1$I$20240715$20240723$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016053$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240802$$CN$US$US
241691201$24169120$1$I$$20240730$20240802$20240802$PER$$NVSC2024US157287$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
241691211$24169121$1$I$$20240709$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109594$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240802$$PH$US$US
241691221$24169122$1$I$20231212$20240726$20240802$20240802$EXP$$NVSC2023GB266887$NOVARTIS$$29$YR$$F$Y$$$20240802$$CN$GB$GB
241691231$24169123$1$I$$20240801$20240802$20240802$EXP$$NVSC2024US157767$NOVARTIS$$66$YR$$M$Y$$$20240802$$MD$US$US
241691241$24169124$1$I$$20240730$20240802$20240802$PER$$NVSC2024US157313$NOVARTIS$$$$$F$Y$$$20240802$$CN$US$US
241691261$24169126$1$I$$20240730$20240802$20240802$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138436$DAIICHI$$$$$F$Y$$$20240802$$CN$US$US
241691271$24169127$1$I$20240201$20240726$20240802$20240802$PER$$US-SA-2024SA226573$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240802$$MD$US$US
241691281$24169128$1$I$$20240724$20240802$20240802$PER$$US-SA-2024SA221559$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240802$$MD$US$US
241691291$24169129$1$I$20240702$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024152114$AMGEN$$61$YR$A$F$Y$$$20240802$$CN$US$US
241691318$24169131$8$F$20240720$20240920$20240802$20240930$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02736$AMNEAL$$46$YR$$F$Y$112.93$KG$20240930$$CN$US$US
241691321$24169132$1$I$20240701$20240801$20240802$20240802$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-122239$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240802$$CN$PR$PR
241691332$24169133$2$F$$20240814$20240802$20240824$EXP$$GB-TEVA-VS-3226900$TEVA$$33$YR$$F$Y$115$KG$20240824$$MD$GB$GB
241691341$24169134$1$I$$20240729$20240802$20240802$EXP$$CA-MYLANLABS-2024M1071402$MYLAN$$64$YR$$F$Y$69$KG$20240802$$HP$CA$CA
241691361$24169136$1$I$$20240730$20240802$20240802$EXP$$EG-AstraZeneca-2023A239854$ASTRAZENECA$$26710$DY$$F$Y$$$20240802$$CN$EG$
241691371$24169137$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170133$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241691381$24169138$1$I$20240729$20240729$20240802$20240802$EXP$$IN-ABBVIE-5864212$ABBVIE$$60$YR$$M$Y$$$20240802$$MD$IN$IN
241691391$24169139$1$I$$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173464$ASTRAZENECA$$$$$M$Y$$$20240802$$MD$US$
241691409$24169140$9$F$$20240902$20240802$20240913$EXP$$PT-ORGANON-O2408PRT000206$ORGANON$Correia I, Eca R, Barbosa MJ. et al.. Dress syndrome: A rare secondary response.. Congress of the Portuguese society of internal medicine. 30th national congress. 2024;846$30$YR$$M$Y$$$20240913$$MD$PT$PT
241691411$24169141$1$I$$20240726$20240802$20240802$EXP$$CA-AstraZeneca-2020SF30819$ASTRAZENECA$$38$YR$$M$Y$$$20240802$$MD$CA$
241691421$24169142$1$I$$20240726$20240802$20240802$PER$$US-AstraZeneca-2024A171462$ASTRAZENECA$$$$$F$Y$$$20240802$$HP$US$
241691431$24169143$1$I$$20240725$20240802$20240802$EXP$US-MLMSERVICE-20240722-PI139705-00232-1$US-RDY-SPO/USA/24/0011078$DR REDDYS$Attieh RM, Brumble L, Elwasila SM, Wadei HM. Disseminated Monkeypox Infection in a Kidney Transplant Recipient A Case Report. Transplantation Proceedings. 2023;55(3):667-71. DOI: /10.1016/j.transproceed.2023.02.031.$44$YR$A$M$Y$$$20240802$$MD$US$US
241691441$24169144$1$I$$20240724$20240802$20240802$PER$$US-ABBVIE-5855098$ABBVIE$$17$YR$$F$Y$$$20240802$$HP$US$US
241691451$24169145$1$I$20240705$20240719$20240802$20240802$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0782$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240802$$MD$US$US
241691461$24169146$1$I$$20240724$20240802$20240802$PER$$US-BAYER-2024A109102$BAYER$$51$YR$A$F$Y$$$20240802$$CN$US$US
241691471$24169147$1$I$$20240709$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109544$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$76.2$KG$20240802$$CN$US$US
241691481$24169148$1$I$20240802$20240802$20240802$20240802$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043546$BOEHRINGER INGELHEIM$$65$YR$E$$Y$$$20240802$$CN$US$US
241691491$24169149$1$I$20240510$20240802$20240802$20240802$EXP$$IT-SANDOZ INC.-SDZ2024IT070087$SANDOZ$$77$YR$$$Y$$$20240802$$MD$IT$IT
241691501$24169150$1$I$$20240729$20240802$20240802$PER$$US-ABBVIE-5860694$ABBVIE$$$$$F$Y$$$20240802$$HP$US$US
241691521$24169152$1$I$$20240725$20240802$20240802$EXP$$US-MYLANLABS-2024M1071093$MYLAN$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. J-Allergy-Clin-Immunol-Pract 2024; 12 (6): 1663-1665.$57$YR$$M$Y$$$20240802$$MD$US$US
241691531$24169153$1$I$20060901$20240724$20240802$20240802$EXP$$ES-MYLANLABS-2024M1071744$MYLAN$$46$YR$$M$Y$$$20240802$$CN$ES$ES
241691541$24169154$1$I$$20240723$20240802$20240802$EXP$$ES-MYLANLABS-2024M1069057$MYLAN$$56$YR$$M$Y$$$20240802$$HP$ES$ES
241691551$24169155$1$I$$20240724$20240802$20240802$EXP$NL-LRB-00986074$NL-MYLANLABS-2024M1069609$MYLAN$$73$YR$$F$Y$62$KG$20240802$$CN$NL$NL
241691561$24169156$1$I$20240801$20240801$20240802$20240802$EXP$$US-ABBVIE-5864974$ABBVIE$$$$A$F$Y$$$20240802$$HP$US$US
241691571$24169157$1$I$20240710$20240730$20240802$20240802$EXP$$US-AstraZeneca-2024A173456$ASTRAZENECA$$27979$DY$$F$Y$$$20240802$$PH$US$
241691581$24169158$1$I$$20240726$20240802$20240802$EXP$$GB-JNJFOC-20240772064$JOHNSON AND JOHNSON$$$$$F$Y$$$20240802$$CN$GB$GB
241691591$24169159$1$I$$20240723$20240802$20240802$PER$$US-SA-2024SA222222$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240802$$MD$US$US
241691601$24169160$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA224959$SANOFI AVENTIS$$$$C$M$Y$$$20240802$$MD$US$US
241691611$24169161$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA225023$SANOFI AVENTIS$$$$E$F$Y$$$20240802$$CN$US$US
241691621$24169162$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA226584$SANOFI AVENTIS$$$$A$F$Y$59.4$KG$20240802$$MD$US$US
241691631$24169163$1$I$20240101$20240729$20240802$20240802$PER$$US-SA-2024SA225155$SANOFI AVENTIS$$96$YR$E$M$Y$$$20240802$$MD$US$US
241691641$24169164$1$I$20230807$20240726$20240802$20240802$EXP$FR-AFSSAPS-AN2024000912$FR-TEVA-VS-3227202$TEVA$$83$YR$$F$Y$$$20240802$$PH$FR$FR
241691651$24169165$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122658$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240802$$CN$US$US
241691661$24169166$1$I$$20240802$20240802$20240802$EXP$$AU-ORGANON-O2408AUS000141$ORGANON$$$$$M$Y$$$20240802$$CN$AU$AU
241691671$24169167$1$I$$20240626$20240802$20240802$DIR$FDA-CDER-CTU-2024-53105$$FDA-CTU$$$$$$N$$$20240626$N$PH$US$
241691681$24169168$1$I$$20240731$20240802$20240802$EXP$$US-GENMAB-2024-02807$GENMAB$$$$A$M$Y$$$20240802$$MD$US$US
241691691$24169169$1$I$$20240627$20240802$20240802$DIR$FDA-CDER-CTU-2024-53108$$FDA-CTU$$$$$$N$$$20240627$N$HP$US$
241691701$24169170$1$I$$20240628$20240802$20240802$DIR$FDA-CDER-CTU-2024-53112$$FDA-CTU$$$$$$N$$$20240628$N$HP$US$
241691721$24169172$1$I$$20240622$20240802$20240802$DIR$FDA-CDER-CTU-2024-53121$$FDA-CTU$$$$$$N$$$20240622$N$$US$
241691731$24169173$1$I$$20240621$20240802$20240802$DIR$FDA-CDER-CTU-2024-53138$$FDA-CTU$$$$$$N$$$20240621$N$PH$US$
241691741$24169174$1$I$$20240619$20240802$20240802$DIR$FDA-CDER-CTU-2024-53128$$FDA-CTU$$$$$$N$$$20240619$N$HP$US$
241691751$24169175$1$I$$20240620$20240802$20240802$DIR$FDA-CDER-CTU-2024-53136$$FDA-CTU$$$$$$N$$$20240620$N$HP$US$
241691762$24169176$2$F$$20240805$20240802$20240808$EXP$$CA-PFIZER INC-202400224569$PFIZER$$48$YR$$M$Y$$$20240808$$CN$CA$CA
241691771$24169177$1$I$20240601$20240731$20240802$20240802$EXP$$US-PFIZER INC-PV202400100568$PFIZER$$70$YR$$M$Y$$$20240802$$HP$US$US
241691781$24169178$1$I$$20240731$20240802$20240802$EXP$$PK-PFIZER INC-202400227600$PFIZER$$$$$$Y$$$20240802$$PH$PK$PK
241691791$24169179$1$I$$20240729$20240802$20240802$EXP$$US-PFIZER INC-202400226291$PFIZER$$41$YR$$F$Y$$$20240802$$HP$US$US
241691802$24169180$2$F$20180822$20240802$20240802$20240808$EXP$$FR-PFIZER INC-2018526205$PFIZER$$52$YR$$F$Y$95$KG$20240808$$MD$FR$FR
241691811$24169181$1$I$20240101$20240731$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202408000710$ELI LILLY AND CO$$$$A$F$Y$$$20240802$$CN$US$US
241691821$24169182$1$I$20240515$20240724$20240802$20240802$EXP$FR-AFSSAPS-AVBX2024000387$FR-MYLANLABS-2024M1069896$MYLAN$$16$YR$$M$Y$$$20240802$$HP$FR$FR
241691851$24169185$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA223883$SANOFI AVENTIS$$$$A$M$Y$87.54$KG$20240802$$MD$US$US
241691861$24169186$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA222855$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240802$$MD$US$US
241691871$24169187$1$I$$20240723$20240802$20240802$EXP$$JP-TEVA-VS-3225983$TEVA$$52$YR$$M$Y$$$20240802$$MD$JP$JP
241691881$24169188$1$I$$20240730$20240802$20240802$EXP$NL-LRB-00993217$NL-MYLANLABS-2024M1070828$MYLAN$$91$YR$$M$Y$$$20240802$$MD$NL$NL
241691891$24169189$1$I$20170101$20240726$20240802$20240802$EXP$$US-SA-2024SA228573$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240802$$MD$US$US
241691902$24169190$2$F$20240725$20240905$20240802$20240905$30DAY$$AR-PFIZER INC-202400225763$PFIZER$$15$YR$$M$Y$$$20240905$$CN$AR$AR
241691912$24169191$2$F$$20240908$20240802$20240909$30DAY$$GB-PFIZER INC-PV202400096079$PFIZER$$70$YR$$F$Y$$$20240909$$CN$GB$GB
241691921$24169192$1$I$$20240723$20240802$20240802$30DAY$$GB-PFIZER INC-202400223791$PFIZER$$$$$$Y$$$20240802$$CN$GB$GB
241691941$24169194$1$I$$20240726$20240802$20240802$EXP$$JP-009507513-2408JPN000154$MERCK$$73$YR$$M$Y$$$20240802$$CN$JP$JP
241691951$24169195$1$I$20240708$20240729$20240802$20240802$EXP$GB-MHRA-MED-202407291049014540-PFWRM$GB-TEVA-VS-3227264$TEVA$$77$YR$$M$Y$64$KG$20240802$$CN$GB$GB
241691961$24169196$1$I$$20240731$20240802$20240802$EXP$$CA-PFIZER INC-2018435653$MYLAN$$74$YR$$F$Y$$$20240802$$MD$CA$CA
241691971$24169197$1$I$$20240731$20240802$20240802$PER$$US-TAKEDA-2024TUS077218$TAKEDA$$$$$F$Y$74$KG$20240802$$CN$US$US
241691981$24169198$1$I$20240501$20240731$20240802$20240802$EXP$$GB-TEVA-VS-3228651$TEVA$$56$YR$$M$Y$72$KG$20240802$$MD$GB$GB
241691991$24169199$1$I$$20240621$20240802$20240802$DIR$FDA-CDER-CTU-2024-53132$$FDA-CTU$$$$$$N$$$20240621$N$CN$US$
241692003$24169200$3$F$20240701$20240822$20240802$20240823$EXP$$US-PFIZER INC-202400226931$PFIZER$$$$$M$Y$$$20240823$$HP$US$US
241692011$24169201$1$I$$20240726$20240802$20240802$30DAY$$FR-SANDOZ INC.-SDZ2024FR068905$SANDOZ$$13$YR$$M$Y$$$20240802$$CN$FR$FR
241692022$24169202$2$F$$20240806$20240802$20240808$EXP$$JP-DSJP-DSJ-2024-138237$DAIICHI$$55$YR$$F$Y$$$20240808$$MD$JP$JP
241692031$24169203$1$I$$20240729$20240802$20240802$EXP$$US-SA-2024SA225575$SANOFI AVENTIS$$$$A$M$Y$$$20240802$$MD$US$US
241692041$24169204$1$I$20230902$20240723$20240802$20240802$EXP$$RU-SA-2024SA221235$SANOFI AVENTIS$$69$YR$E$F$Y$72$KG$20240802$$MD$RU$RU
241692051$24169205$1$I$20240525$20240731$20240802$20240802$EXP$FR-AFSSAPS-DJ2024000866$FR-009507513-2407FRA016091$MERCK$$78$YR$$F$Y$61$KG$20240802$$MD$FR$FR
241692061$24169206$1$I$$20110811$20240802$20240802$EXP$$FR-009507513-1108FRA00054$MERCK$$$$$$Y$$$20240802$$MD$FR$FR
241692071$24169207$1$I$$20240723$20240802$20240802$EXP$$US-BEH-2024176291$CSL BEHRING$$61$YR$A$F$Y$40.816$KG$20240802$$CN$US$US
241692081$24169208$1$I$20240723$20240729$20240802$20240802$30DAY$$CR-PFIZER INC-202400223231$PFIZER$$13$YR$$F$Y$$$20240802$$CN$CR$CR
241692102$24169210$2$F$20240729$20240907$20240802$20240909$30DAY$$DO-PFIZER INC-PV202400099968$PFIZER$$13$YR$$M$Y$$$20240909$$CN$DO$DO
241692124$24169212$4$F$20240728$20240924$20240802$20240927$30DAY$$GR-PFIZER INC-PV202400099103$PFIZER$$5$YR$$F$Y$16$KG$20240927$$CN$GR$GR
241692131$24169213$1$I$20240714$20240729$20240802$20240802$30DAY$$CL-PFIZER INC-202400227468$PFIZER$$8$YR$$$Y$$$20240802$$CN$CL$CL
241692153$24169215$3$F$$20240922$20240802$20240923$30DAY$$CO-PFIZER INC-PV202400099250$PFIZER$$14$YR$$M$Y$$$20240923$$CN$CO$CO
241692161$24169216$1$I$20230101$20240725$20240802$20240802$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-126943$DAIICHI$$76$YR$$M$Y$$$20240802$$MD$JP$JP
241692171$24169217$1$I$$20240625$20240802$20240802$PER$$US-FMCRTG-FMC-2406-000764$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240802$$HP$US$US
241692181$24169218$1$I$20240704$20240711$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000837$FRESENIUS MEDICAL CARE$$48$YR$A$M$Y$84$KG$20240802$$HP$US$US
241692191$24169219$1$I$20240625$20240628$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000772$FRESENIUS MEDICAL CARE$$81$YR$E$F$Y$73$KG$20240802$$HP$US$US
241692201$24169220$1$I$20240712$20240712$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000847$FRESENIUS MEDICAL CARE$$56$YR$A$M$Y$135$KG$20240802$$HP$US$US
241692211$24169221$1$I$$20240628$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000788$FRESENIUS MEDICAL CARE$$58$YR$A$M$Y$108.5$KG$20240802$$HP$US$US
241692221$24169222$1$I$$20240627$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000777$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240802$$CN$US$US
241692231$24169223$1$I$20240718$20240722$20240802$20240802$EXP$$US-FMCRTG-FMC-2407-000890$FRESENIUS MEDICAL CARE$$63$YR$A$M$Y$117$KG$20240802$$HP$US$US
241692241$24169224$1$I$$20240701$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000812$FRESENIUS MEDICAL CARE$$70$YR$E$M$Y$$$20240802$$HP$US$US
241692251$24169225$1$I$$20240624$20240802$20240802$PER$$US-FMCRTG-FMC-2406-000760$FRESENIUS MEDICAL CARE$$69$YR$E$F$Y$86$KG$20240802$$HP$US$US
241692261$24169226$1$I$20240404$20240709$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000851$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240802$$HP$US$US
241692271$24169227$1$I$20240708$20240708$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000823$FRESENIUS MEDICAL CARE$$86$YR$E$M$Y$92$KG$20240802$$HP$US$US
241692281$24169228$1$I$20240619$20240627$20240802$20240802$PER$$US-FMCRTG-FMC-2406-000768$FRESENIUS MEDICAL CARE$$31$YR$A$F$Y$106$KG$20240802$$HP$US$US
241692291$24169229$1$I$20240630$20240701$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000794$FRESENIUS MEDICAL CARE$$58$YR$A$F$Y$99.5$KG$20240802$$HP$US$US
241692301$24169230$1$I$$20240628$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000809$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240802$$CN$US$US
241692311$24169231$1$I$$20240610$20240802$20240802$PER$$US-FMCRTG-FMC-2406-000710$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240802$$HP$US$US
241692321$24169232$1$I$$20240710$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000829$FRESENIUS MEDICAL CARE$$67$YR$E$M$Y$64$KG$20240802$$HP$US$US
241692331$24169233$1$I$$20240701$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000791$FRESENIUS MEDICAL CARE$$76$YR$E$F$Y$$$20240802$$CN$US$US
241692341$24169234$1$I$$20240712$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000859$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240802$$CN$US$US
241692351$24169235$1$I$20240626$20240628$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000775$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240802$$CN$US$US
241692361$24169236$1$I$20240625$20240626$20240802$20240802$PER$$US-FMCRTG-FMC-2406-000763$FRESENIUS MEDICAL CARE$$76$YR$E$F$Y$$$20240802$$HP$US$US
241692371$24169237$1$I$20231201$20240801$20240802$20240802$EXP$$US-INCYTE CORPORATION-2024IN008069$INCYTE$$$$$$Y$$$20240802$$CN$US$US
241692381$24169238$1$I$20240710$20240722$20240802$20240802$EXP$$US-FMCRTG-FMC-2407-000891$FRESENIUS MEDICAL CARE$$67$YR$E$F$Y$$$20240802$$HP$US$US
241692391$24169239$1$I$$20240628$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000789$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240802$$CN$US$US
241692401$24169240$1$I$$20240707$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000858$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240802$$CN$US$US
241692411$24169241$1$I$$20240628$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000778$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240802$$HP$US$US
241692421$24169242$1$I$$20240723$20240802$20240802$EXP$$US-FMCRTG-FMC-2407-000894$FRESENIUS MEDICAL CARE$$75$YR$E$M$Y$89$KG$20240802$$HP$US$US
241692431$24169243$1$I$20240629$20240710$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000836$FRESENIUS MEDICAL CARE$$59$YR$A$M$Y$$$20240802$$HP$US$US
241692441$24169244$1$I$$20240701$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000811$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240802$$CN$US$US
241692451$24169245$1$I$$20240708$20240802$20240802$PER$$US-FMCRTG-FMC-2407-000857$FRESENIUS MEDICAL CARE$$69$YR$E$M$Y$76$KG$20240802$$HP$US$US
241692461$24169246$1$I$$20240731$20240802$20240802$EXP$$NVSC2024CN157737$NOVARTIS$$49$YR$$M$Y$$$20240802$$CN$CN$CN
241692471$24169247$1$I$20240414$20240726$20240802$20240802$EXP$GB-MHRA-31124029$GB-TEVA-VS-3226544$TEVA$$73$YR$$M$Y$99$KG$20240802$$PH$GB$GB
241692482$24169248$2$F$$20240816$20240802$20240819$PER$$NVSC2024US157974$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
241692491$24169249$1$I$20230101$20240725$20240802$20240802$PER$$US-SA-2024SA222727$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240802$$MD$US$US
241692501$24169250$1$I$$20240730$20240802$20240802$PER$$US-SA-2024SA227559$SANOFI AVENTIS$$$$E$M$Y$$$20240802$$MD$US$US
241692511$24169251$1$I$$20240730$20240802$20240802$PER$$US-SA-2024SA227557$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240802$$MD$US$US
241692521$24169252$1$I$20240601$20240726$20240802$20240802$PER$$US-SA-2024SA226674$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240802$$MD$US$US
241692531$24169253$1$I$$20240724$20240802$20240802$PER$$US-MYLANLABS-2024M1069962$MYLAN$$$$$$Y$$$20240802$$MD$US$US
241692541$24169254$1$I$20240714$20240721$20240802$20240802$EXP$GB-MHRA-MED-202407211052093100-BQCRM$GB-ELI_LILLY_AND_COMPANY-GB202407013648$ELI LILLY AND CO$$34$YR$A$M$Y$94$KG$20240802$$CN$GB$GB
241692551$24169255$1$I$20240707$20240722$20240802$20240802$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407013768$ELI LILLY AND CO$$35$YR$A$F$Y$75$KG$20240802$$CN$GB$GB
241692561$24169256$1$I$20240701$20240725$20240802$20240802$PER$$US-SA-2024SA222708$SANOFI AVENTIS$$13$YR$T$M$Y$48.98$KG$20240802$$MD$US$US
241692571$24169257$1$I$$20240721$20240802$20240802$EXP$GB-MHRA-MED-202407211651213650-MLGTY$GB-ELI_LILLY_AND_COMPANY-GB202407013649$ELI LILLY AND CO$$22$YR$A$F$Y$90$KG$20240802$$CN$GB$GB
241692581$24169258$1$I$20240709$20240721$20240802$20240802$EXP$GB-MHRA-MED-202407211950589200-WCZKH$GB-ELI_LILLY_AND_COMPANY-GB202407013784$ELI LILLY AND CO$$39$YR$A$F$Y$76$KG$20240802$$CN$GB$GB
241692591$24169259$1$I$$20240723$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015729$ELI LILLY AND CO$Fontana R.J.,Choi E.-Y.K.,Kaganove J.,Dodson A..First Report of Tirzepatide Hepatotoxicity with Jaundice.Clinical gastroenterology and hepatology: the official clinical practice journal 2024;:.DOI:10.1016/j.cgh.2024.06.025$64$YR$A$M$Y$$$20240802$$MD$US$US
241692601$24169260$1$I$$20240723$20240802$20240802$EXP$GB-MHRA-8915095$GB-ELI_LILLY_AND_COMPANY-GB202407014726$ELI LILLY AND CO$$$$$$Y$$$20240802$$CN$GB$GB
241692611$24169261$1$I$$20240731$20240802$20240802$EXP$$US-PFIZER INC-PV202400100371$PFIZER$$51$YR$$F$Y$$$20240802$$HP$US$US
241692621$24169262$1$I$20220801$20240724$20240802$20240802$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016204$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240802$$CN$US$US
241692641$24169264$1$I$$20240730$20240802$20240802$EXP$$US-PFIZER INC-202400227601$PFIZER$$$$A$M$Y$$$20240802$$CN$US$US
241692651$24169265$1$I$20240719$20240730$20240802$20240802$EXP$$CN-PFIZER INC-PV202400099517$PFIZER$$84$YR$$F$Y$50$KG$20240802$$HP$CN$CN
241692671$24169267$1$I$$20240731$20240802$20240802$EXP$$US-PFIZER INC-202400228516$PFIZER$$62$YR$$M$Y$$$20240802$$HP$US$US
241692681$24169268$1$I$$20240801$20240802$20240802$PER$$NVSC2024US158286$NOVARTIS$$$$$$Y$$$20240802$$MD$US$US
241692691$24169269$1$I$$20231009$20240802$20240802$PER$$NVSC2023US192452$NOVARTIS$$$$$M$Y$$$20240802$$CN$US$US
241692701$24169270$1$I$$20240116$20240802$20240802$PER$$NVSC2024US016994$NOVARTIS$$$$$M$Y$$$20240802$$CN$US$US
241692721$24169272$1$I$$20230522$20240802$20240802$EXP$$US-AstraZeneca-2023A121600$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241692731$24169273$1$I$$20240801$20240802$20240802$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043519$BOEHRINGER INGELHEIM$$$$$F$Y$62$KG$20240802$$HP$CO$CO
241692741$24169274$1$I$$20240729$20240802$20240802$PER$$US-MYLANLABS-2024M1070979$MYLAN$$82$YR$$F$Y$$$20240802$$MD$US$US
241692751$24169275$1$I$20240101$20240726$20240802$20240802$EXP$$US-TEVA-VS-3203274$TEVA$$21$YR$$F$Y$$$20240802$$MD$US$US
241692762$24169276$2$F$20240503$20240813$20240802$20240819$EXP$$CA-OTSUKA-2024_013624$OTSUKA$$$$$F$Y$$$20240819$$MD$CA$CA
241692772$24169277$2$F$$20240801$20240802$20240809$EXP$$US-BIOGEN-2024BI01275497$BIOGEN$$$$$F$Y$$$20240809$$MD$US$US
241692781$24169278$1$I$20240305$20240723$20240802$20240802$PER$$US-JNJFOC-20240804968$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240802$$CN$US$US
241692791$24169279$1$I$20240701$20240725$20240802$20240802$EXP$$GB-AMGEN-GBRSP2024149548$AMGEN$$$$$$Y$$$20240802$$MD$GB$GB
241692801$24169280$1$I$20240101$20240710$20240802$20240802$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000147$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240802$$CN$US$US
241692813$24169281$3$F$20240701$20240905$20240802$20240920$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0781$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240919$$HP$US$US
241692821$24169282$1$I$20240523$20240726$20240802$20240802$EXP$$NL-SANDOZ INC.-SDZ2024NL068500$SANDOZ$$52$YR$$F$Y$$$20240802$$CN$NL$NL
241692831$24169283$1$I$$20240724$20240802$20240802$PER$$US-Eisai-EC-2024-170890$EISAI$$$$$$Y$$$20240802$$MD$US$US
241692842$24169284$2$F$20240607$20240801$20240802$20240807$EXP$FR-AFSSAPS-PP2024000834$FR-OTSUKA-2024_021033$OTSUKA$$14$YR$$M$Y$107$KG$20240807$$MD$FR$FR
241692862$24169286$2$F$$20240926$20240802$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122858$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240927$$CN$US$US
241692871$24169287$1$I$20240719$20240731$20240802$20240802$EXP$$US-BAYER-2024A111427$BAYER$$59$YR$A$F$Y$$$20240802$$CN$US$US
241692881$24169288$1$I$20240601$20240730$20240802$20240802$EXP$$US-INCYTE CORPORATION-2024IN007981$INCYTE$$$$$$Y$$$20240802$$CN$US$US
241692891$24169289$1$I$$20240730$20240802$20240802$30DAY$$US-SANDOZ INC.-SDZ2024US069476$SANDOZ$$$$$M$Y$$$20240802$$CN$US$US
241692901$24169290$1$I$$20240731$20240802$20240802$EXP$$CA-SANDOZ INC.-SDZ2023CA076648$SANDOZ$$$$$F$Y$$$20240802$$HP$CA$CA
241692922$24169292$2$F$$20240820$20240802$20240822$EXP$$US-BAYER-2024A106901$BAYER$$62$YR$A$F$Y$$$20240822$$CN$US$US
241692931$24169293$1$I$20240729$20240729$20240802$20240802$EXP$$IN-ABBVIE-5862866$ABBVIE$$18$YR$$F$Y$$$20240802$$MD$IN$IN
241692941$24169294$1$I$$20240801$20240802$20240802$EXP$$US-SANDOZ INC.-SDZ2024US070121$SANDOZ$$$$$M$Y$$$20240802$$MD$US$US
241692951$24169295$1$I$$20240730$20240802$20240802$30DAY$$US-PFIZER INC-202400226874$PFIZER$$$$$$Y$$$20240802$$PH$US$US
241692961$24169296$1$I$$20240725$20240802$20240802$EXP$FR-AFSSAPS-AVLY2024000091$FR-TEVA-VS-3226381$TEVA$$14$YR$$M$Y$$$20240802$$MD$FR$FR
241692973$24169297$3$F$$20240904$20240802$20240918$30DAY$$CA-PFIZER INC-202400222882$PFIZER$$53$YR$$F$Y$$$20240918$$PH$CA$CA
241692982$24169298$2$F$$20240806$20240802$20240806$30DAY$$US-PFIZER INC-PV202400098971$PFIZER$$$$$M$Y$$$20240806$$CN$US$US
241692991$24169299$1$I$$20240731$20240802$20240802$30DAY$$GB-PFIZER INC-PV202400099804$PFIZER$$5$YR$$F$Y$$$20240802$$CN$GB$GB
241693001$24169300$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122142$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240802$$CN$US$US
241693011$24169301$1$I$20240501$20240731$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122210$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240802$$CN$US$US
241693021$24169302$1$I$$20240801$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122657$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240802$$CN$US$US
241693031$24169303$1$I$$20240731$20240802$20240802$EXP$$US-KYOWAKIRIN-2024KK018407$KYOWA$$$$$$Y$$$20240802$$CN$US$US
241693042$24169304$2$F$20240731$20240904$20240802$20240905$EXP$$JP-Eisai-EC-2024-171380$EISAI$$75$YR$E$F$Y$50$KG$20240905$$MD$JP$JP
241693051$24169305$1$I$20240701$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122826$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240802$$PH$US$US
241693061$24169306$1$I$20240701$20240729$20240802$20240802$EXP$$DE-BAYER-2024A111940$BAYER$$$$$$Y$$$20240802$$CN$DE$DE
241693081$24169308$1$I$$20230619$20240802$20240802$EXP$$US-AstraZeneca-2023A143461$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241693091$24169309$1$I$$20210909$20240802$20240802$EXP$$US-AstraZeneca-2021A721261$ASTRAZENECA$$$$$$Y$$$20240802$$CN$US$
241693101$24169310$1$I$$20240724$20240802$20240802$PER$$US-JNJFOC-20240767776$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240802$$CN$US$US
241693111$24169311$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170158$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241693122$24169312$2$F$$20240801$20240802$20240805$PER$$NVSC2024US157777$NOVARTIS$$$$$M$Y$$$20240805$$CN$US$US
241693131$24169313$1$I$$20240801$20240802$20240802$PER$$NVSC2024US158283$NOVARTIS$$$$$F$Y$$$20240802$$HP$US$US
241693142$24169314$2$F$$20240904$20240802$20240904$PER$$US-JNJFOC-20240777753$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$HP$US$US
241693151$24169315$1$I$$20240801$20240802$20240802$PER$$NVSC2024US157953$NOVARTIS$$$$$$Y$$$20240802$$MD$US$US
241693161$24169316$1$I$$20240725$20240802$20240802$PER$$US-BAYER-2024A108608$BAYER$$$$$F$Y$$$20240802$$CN$US$US
241693171$24169317$1$I$$20240724$20240802$20240802$EXP$$PL-TEVA-VS-3225859$TEVA$Citation: Korzeniowska K. Anaphylactic shock in a 7-year-old patient treated with cefaclor - case report and literature review. FARMACJA WSPOLCZESNA. 2024;(2):135-139 Awareness date: 24 Jul 2024; Citation: Korzeniowska K. Anaphylactic shock in a 7-year-old patient treated with cefaclor - case report and literature review. FARMACJA WSPOLCZESNA. 2024;(2):135-139 Awareness date: 24 Jul 2024$7$YR$$F$Y$18$KG$20240802$$HP$PL$PL
241693181$24169318$1$I$$20240801$20240802$20240802$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138586$DAIICHI$$$$$F$Y$$$20240802$$HP$US$US
241693192$24169319$2$F$20230411$20240806$20240802$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407018092AA$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240809$$CN$JP$JP
241693201$24169320$1$I$$20240723$20240802$20240802$EXP$GB-MHRA-MED-202407231017233100-JYLHQ$GB-ELI_LILLY_AND_COMPANY-GB202407014829$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$GB$GB
241693211$24169321$1$I$$20240725$20240802$20240802$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407019026$ELI LILLY AND CO$$$$$$Y$$$20240802$$CN$CN$CN
241693222$24169322$2$F$20200816$20240814$20240802$20240821$EXP$DE-CADRBFARM-2022291021$DE-ELI_LILLY_AND_COMPANY-DE202204007160$ELI LILLY AND CO$$28$YR$A$M$Y$83$KG$20240821$$CN$DE$DE
241693231$24169323$1$I$$20240726$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120129$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$50.4$KG$20240802$$PH$US$US
241693241$24169324$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122368$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240802$$CN$US$US
241693251$24169325$1$I$20240601$20240730$20240802$20240802$EXP$FR-AFSSAPS-RS2024000758$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-122801$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$60.4$KG$20240802$$PH$FR$FR
241693261$24169326$1$I$20240627$20240725$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118636$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$64.5$KG$20240802$$PH$US$US
241693281$24169328$1$I$$20240731$20240802$20240802$EXP$$US-KYOWAKIRIN-2024KK018465$KYOWA$$$$$$Y$$$20240802$$CN$US$US
241693291$24169329$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122510$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240802$$HP$US$US
241693301$24169330$1$I$$20240731$20240802$20240802$EXP$$DE-PURDUE-USA-2024-0310938$PURDUE$$90$YR$$F$Y$$$20240802$$PH$DE$DE
241693311$24169331$1$I$20240223$20240731$20240802$20240802$EXP$FR-AFSSAPS-AVMA2024000329$FR-PURDUE-USA-2024-0311100$PURDUE$$63$YR$$M$Y$$$20240802$$PH$FR$FR
241693321$24169332$1$I$20240611$20240731$20240802$20240802$EXP$$ES-PURDUE-USA-2024-0311104$PURDUE$$81$YR$$F$Y$$$20240802$$PH$ES$ES
241693331$24169333$1$I$$20240730$20240802$20240802$EXP$$DE-PURDUE-USA-2024-0311106$PURDUE$Jansen N, Wulff L, Conty M, Schabitz W-R, Klingebiel R.. CHANTER syndrome in the context of pain medication: a case report. BMC Neurology. 2024;24:1$62$YR$$M$Y$$$20240802$$HP$DE$DE
241693342$24169334$2$F$20200101$20240727$20240802$20240809$EXP$$NZ-PURDUE-USA-2024-0310742$PURDUE$$$$$$Y$$$20240809$$CN$NZ$NZ
241693351$24169335$1$I$$20240731$20240802$20240802$PER$$NVSC2024US158242$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241693361$24169336$1$I$$20240801$20240802$20240802$PER$$US-PURDUE PHARMA-USA-2024-0311091$PURDUE$$$$$M$Y$$$20240802$$CN$US$US
241693371$24169337$1$I$20240723$20240730$20240802$20240802$EXP$$US-INCYTE CORPORATION-2024IN007987$INCYTE$$$$$$Y$$$20240802$$CN$US$US
241693382$24169338$2$F$20240608$20240815$20240802$20240821$PER$$US-BAYER-2024A109459$BAYER$$38$YR$A$F$Y$$$20240821$$HP$US$US
241693392$24169339$2$F$$20240801$20240802$20240805$PER$$US-PURDUE PHARMA-USA-2024-0311092$PURDUE$$$$$M$Y$82.55$KG$20240805$$CN$US$US
241693401$24169340$1$I$$20240725$20240802$20240802$PER$$US-ABBVIE-5855896$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241693411$24169341$1$I$$20240124$20240802$20240802$PER$$NVSC2024US021559$NOVARTIS$$64$YR$$F$Y$$$20240802$$CN$US$US
241693421$24169342$1$I$$20240725$20240802$20240802$EXP$$CA-PURDUE-USA-2024-0311077$PURDUE$$50$YR$$F$Y$$$20240802$$HP$CA$CA
241693441$24169344$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121675$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$87.54$KG$20240802$$CN$US$US
241693461$24169346$1$I$20240801$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122936$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240802$$HP$US$US
241693471$24169347$1$I$20240220$20240731$20240802$20240802$PER$$US-BAYER-2024A111686$BAYER$$37$YR$A$F$Y$$$20240802$$HP$US$US
241693482$24169348$2$F$20240801$20240917$20240802$20240919$PER$$US-BAYER-2024A111831$BAYER$$25$YR$A$F$Y$$$20240919$$HP$US$US
241693491$24169349$1$I$20240628$20240801$20240802$20240802$PER$$CN-Eisai-EC-2024-171370$EISAI$$33$YR$A$F$Y$83.9$KG$20240802$$HP$CN$CN
241693501$24169350$1$I$$20240730$20240802$20240802$EXP$$AU-ANIPHARMA-2024-AU-000318$ANI$$$$$UNK$Y$$$20240802$$CN$AU$AU
241693512$24169351$2$F$$20240729$20240802$20240808$EXP$$JP-Eisai-EC-2022-126745$EISAI$Shimizu Riku et al.. A case of shunt embolisation for hepatic encephalopathy associated with hepatocellular carcinoma complicated by portal vein tumour embolism, which enabled multidisciplinary treatment of hepatocellular carcinoma. Japanese Journal of Portal Hypertension. 2022; 28(3): 104-104.$6$DEC$A$M$Y$63$KG$20240808$$MD$JP$JP
241693523$24169352$3$F$20240523$20240822$20240802$20240903$EXP$$US-BAYER-2024A084710$BAYER$$80$YR$E$M$Y$$$20240903$$CN$US$US
241693531$24169353$1$I$20240519$20240726$20240802$20240802$EXP$$GB-TEVA-VS-3226812$TEVA$$47$YR$$M$Y$89$KG$20240802$$PH$GB$GB
241693541$24169354$1$I$$20240726$20240802$20240802$EXP$GB-MHRA-31084100$GB-TEVA-VS-3226744$TEVA$$88$YR$$$Y$$$20240802$$HP$GB$GB
241693551$24169355$1$I$$20240718$20240802$20240802$EXP$$US-HLS-202400465$HLS THERAPEUTICS$$$$E$M$Y$$$20240802$$MD$US$US
241693561$24169356$1$I$$20240731$20240802$20240802$PER$$US-PFIZER INC-PV202400100344$PFIZER$$51$YR$$M$Y$$$20240802$$HP$US$US
241693572$24169357$2$F$$20240812$20240802$20240814$EXP$$US-INCYTE CORPORATION-2024IN007991$INCYTE$$$$$$Y$$$20240814$$CN$US$US
241693586$24169358$6$F$20240501$20240917$20240802$20240919$EXP$$NVSC2024CA115340$NOVARTIS$$40$YR$$F$Y$$$20240919$$CN$CA$CA
241693591$24169359$1$I$20240626$20240725$20240802$20240802$EXP$$DE-TEVA-VS-3226249$TEVA$$73$YR$$F$Y$93$KG$20240802$$MD$DE$DE
241693601$24169360$1$I$20240701$20240730$20240802$20240802$EXP$$US-INCYTE CORPORATION-2024IN007994$INCYTE$$$$$$Y$$$20240802$$CN$US$US
241693611$24169361$1$I$20240101$20240730$20240802$20240802$PER$$US-SA-2024SA227675$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240802$$MD$US$US
241693621$24169362$1$I$$20240725$20240802$20240802$PER$$US-IDORSIA-008307-2024-US$IDORSIA PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241693631$24169363$1$I$$20240725$20240802$20240802$EXP$$US-BAYER-2024A107723$BAYER$$72$YR$E$M$Y$$$20240802$$CN$US$US
241693641$24169364$1$I$20240101$20240729$20240802$20240802$EXP$$MY-ORGANON-O2407MYS002759$ORGANON$$35$YR$$F$Y$$$20240802$$MD$MY$MY
241693651$24169365$1$I$$20240731$20240802$20240802$EXP$$CA-SANDOZ INC.-SDZ2023CA076649$SANDOZ$$$$$F$Y$$$20240802$$HP$CA$CA
241693662$24169366$2$F$20240727$20240806$20240802$20240812$PER$$US-TRAVERE-2024TVT00747$TRAVERE THERAPEUTICS$$52$YR$A$F$Y$$$20240812$$CN$US$US
241693672$24169367$2$F$$20240820$20240802$20240828$EXP$$FR-BAUSCH-BL-2024-011797$BAUSCH AND LOMB$$19$YR$$F$Y$$$20240828$$PH$FR$FR
241693681$24169368$1$I$20240725$20240725$20240802$20240802$PER$$US-RDY-SPO/USA/24/0011062$DR REDDYS$$15$YR$T$F$Y$$$20240802$$MD$US$US
241693691$24169369$1$I$20240701$20240726$20240802$20240802$PER$$US-Eisai-EC-2024-171402$EISAI$$76$YR$E$F$Y$$$20240802$$CN$US$US
241693701$24169370$1$I$20240726$20240731$20240802$20240802$EXP$$US-KYOWAKIRIN-2024KK018457$KYOWA$$$$$$Y$$$20240802$$HP$US$US
241693711$24169371$1$I$20240601$20240731$20240802$20240802$PER$$CN-Eisai-EC-2024-171266$EISAI$$26$YR$A$F$Y$55$KG$20240802$$HP$CN$CN
241693721$24169372$1$I$20240101$20240722$20240802$20240802$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07470$NEUROCRINE BIOSCIENCES$$66$YR$$F$Y$$$20240802$$CN$US$US
241693731$24169373$1$I$20240122$20240725$20240802$20240802$EXP$FR-AFSSAPS-ST2024001179$FR-TEVA-VS-3225940$TEVA$$79$YR$$M$Y$75$KG$20240802$$HP$FR$FR
241693742$24169374$2$F$20230926$20240801$20240802$20240807$EXP$$US-KYOWAKIRIN-2024KK018455$KYOWA$$$$$$Y$$$20240807$$HP$US$US
241693751$24169375$1$I$$20240731$20240802$20240802$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407015842$ELI LILLY AND CO$$$$E$M$Y$$$20240802$$CN$JP$JP
241693761$24169376$1$I$$20240731$20240802$20240802$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408000527$ELI LILLY AND CO$$$$$$Y$$$20240802$$MD$CN$CN
241693771$24169377$1$I$$20240729$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019371$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240802$$CN$US$US
241693781$24169378$1$I$20240725$20240728$20240802$20240802$EXP$$EG-ELI_LILLY_AND_COMPANY-EG202407019085$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240802$$CN$EG$EG
241693801$24169380$1$I$$20240801$20240802$20240802$EXP$$NVSC2024GB157475$NOVARTIS$$67$YR$$F$Y$$$20240802$$HP$GB$GB
241693811$24169381$1$I$$20240801$20240802$20240802$EXP$$US-KYOWAKIRIN-2024KK018553$KYOWA$$$$$$Y$$$20240802$$HP$US$US
241693821$24169382$1$I$$20240722$20240802$20240802$EXP$$JP-PFIZER INC-PV202400100032$PFIZER$Nishimura, N.. A case of false-positive for BAR in SIGNIFY ER test after administration of fosphenytoin. The Japanese Journal of Clinical Toxicology. 2024;37(2):256$1$YR$$F$Y$6.4$KG$20240802$$HP$JP$JP
241693831$24169383$1$I$$20240729$20240802$20240802$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407017828$ELI LILLY AND CO$$$$$F$Y$$$20240802$$CN$AU$AU
241693842$24169384$2$F$20100404$20240813$20240802$20240823$EXP$GB-MHRA-MED-202407221232258900-WJLGD$GB-TEVA-VS-3226384$TEVA$$26$YR$$F$Y$$$20240823$$CN$GB$GB
241693851$24169385$1$I$$20240731$20240802$20240802$PER$$US-BAUSCH-BL-2024-011740$BAUSCH AND LOMB$$54$YR$$F$Y$$$20240802$$CN$US$US
241693861$24169386$1$I$20240428$20240730$20240802$20240802$EXP$$FR-ANIPHARMA-2024-FR-000124$ANI$$82$YR$$M$Y$$$20240802$$MD$FR$FR
241693872$24169387$2$F$20240401$20240906$20240802$20240919$PER$$US-SA-2024SA225467$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240919$$MD$US$US
241693881$24169388$1$I$20231030$20240801$20240802$20240802$EXP$$NVSC2024IN157993$NOVARTIS$$65$YR$$M$Y$$$20240802$$CN$IN$IN
241693891$24169389$1$I$20240710$20240729$20240802$20240802$EXP$$US-BEH-2024176557$CSL BEHRING$$18$YR$A$F$Y$$$20240802$$HP$US$US
241693901$24169390$1$I$$20240726$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119852$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$96.62$KG$20240802$$CN$US$US
241693911$24169391$1$I$20240730$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122155$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240802$$HP$US$US
241693921$24169392$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122577$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240802$$CN$US$US
241693931$24169393$1$I$$20240731$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121451$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240802$$CN$US$US
241693941$24169394$1$I$20240401$20240729$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121206$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240802$$CN$US$US
241693951$24169395$1$I$20211115$20211119$20240802$20240802$EXP$$US-AstraZeneca-2021A821060$ASTRAZENECA$$28405$DY$$$Y$$$20240802$$CN$US$
241693961$24169396$1$I$20211013$20211013$20240802$20240802$EXP$$CO-AstraZeneca-2021A777724$ASTRAZENECA$$21053$DY$$F$Y$$$20240802$$CN$CO$
241693971$24169397$1$I$20210328$20210429$20240802$20240802$EXP$$CO-AstraZeneca-2021A384480$ASTRAZENECA$$26178$DY$$M$Y$$$20240802$$CN$CO$
241693981$24169398$1$I$$20240729$20240802$20240802$PER$$US-ALXN-202407USA001970US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241693991$24169399$1$I$$20240729$20240802$20240802$EXP$$US-ALKERMES INC.-ALK-2024-001876$ALKERMES$$$$$F$Y$$$20240802$$HP$US$US
241694001$24169400$1$I$$20240724$20240802$20240802$PER$$US-ALKERMES INC.-ALK-2024-001960$ALKERMES$$$$$F$Y$$$20240802$$CN$US$US
241694011$24169401$1$I$$20240726$20240802$20240802$EXP$$CA-Covis Pharma GmbH-2021COV19185$COVIS PHARMA$$54$YR$A$F$Y$$$20240802$$CN$CA$CA
241694021$24169402$1$I$20240724$20240731$20240802$20240802$EXP$$CN-ROCHE-10000046648$ROCHE$$81$YR$E$F$Y$$$20240802$$HP$CN$CN
241694031$24169403$1$I$$20240729$20240802$20240802$EXP$$NVSC2024JP157703$NOVARTIS$Sawada K, Kawaji T, Yamana K, Matsuhashi K, Hara Y, Kuriyama N et al.. Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory distress syndrome: a case report. JOURNAL OF CARDIOTHORACIC SURGERY. 2024;19(358):1-7$40$YR$$F$Y$43$KG$20240802$$HP$JP$JP
241694041$24169404$1$I$20230101$20240729$20240802$20240802$EXP$$CN-Genus_Lifesciences-USA-POI0580202400143$GENUS LIFESCIENCES$Fang Y. Mediastinal hematoma after trans-radial cerebral angiography a case report. BMC Neurology. 2024 JUL 03;24(1):231.$81$YR$E$M$Y$$$20240802$$MD$CN$CN
241694051$24169405$1$I$$20191230$20240802$20240802$EXP$$CA-Covis Pharma GmbH-2021COV21773$COVIS PHARMA$$64$YR$A$F$Y$$$20240802$$$COUNTRY NOT SPECIFIED$CA
241694061$24169406$1$I$20240723$20240725$20240802$20240802$PER$$US-ABBVIE-5856816$ABBVIE$$76$YR$$F$Y$$$20240802$$CN$US$US
241694071$24169407$1$I$$20240801$20240802$20240802$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043495$BOEHRINGER INGELHEIM$$89$YR$E$F$Y$$$20240802$$CN$BR$BR
241694081$24169408$1$I$$20240730$20240802$20240802$PER$$US-Taiho Oncology Inc-2024-007446$TAIHO ONCOLOGY INC$$$$A$M$Y$70.35$KG$20240802$$MD$US$US
241694091$24169409$1$I$$20240724$20240802$20240802$PER$$US-009507513-2407USA014898$MERCK$$65$YR$$M$Y$$$20240802$$CN$US$US
241694112$24169411$2$F$$20240808$20240802$20240819$EXP$$AU-Ipsen Biopharmaceuticals, Inc.-2024-14609$IPSEN$$$$$M$Y$$$20240819$$MD$AU$AU
241694121$24169412$1$I$$20240801$20240802$20240802$EXP$$NVSC2024US157986$NOVARTIS$$13$YR$$M$Y$$$20240802$$HP$US$US
241694141$24169414$1$I$$20240725$20240802$20240802$EXP$$CZ-TEVA-VS-3227234$TEVA$$42$YR$$M$Y$$$20240802$$HP$CZ$CZ
241694151$24169415$1$I$$20240725$20240802$20240802$PER$$US-SA-2024SA224744$SANOFI AVENTIS$$$$A$M$Y$90.2$KG$20240802$$MD$US$US
241694161$24169416$1$I$20240721$20240725$20240802$20240802$EXP$$CN-AstraZeneca-2024A172143$ASTRAZENECA$$35$YR$$M$Y$65$KG$20240802$$MD$CN$
241694171$24169417$1$I$$20240726$20240802$20240802$EXP$$VN-AstraZeneca-2024A174303$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$VN$
241694181$24169418$1$I$20230327$20240724$20240802$20240802$EXP$FR-AFSSAPS-PO2024000789$FR-TEVA-VS-3225704$TEVA$$39$YR$$F$Y$110$KG$20240802$$MD$FR$FR
241694191$24169419$1$I$$20240801$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122795$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240802$$CN$US$US
241694201$24169420$1$I$$20240726$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119179$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240802$$HP$US$US
241694211$24169421$1$I$20180120$20190819$20240802$20240802$EXP$$US-Covis Pharma GmbH-2022COV19401$COVIS PHARMA$$$$$F$Y$$$20240802$$$COUNTRY NOT SPECIFIED$US
241694221$24169422$1$I$20190101$20190917$20240802$20240802$EXP$$US-Covis Pharma GmbH-2022COV19449$COVIS PHARMA$$69$YR$E$M$Y$79.4$KG$20240802$$$COUNTRY NOT SPECIFIED$US
241694231$24169423$1$I$$20200806$20240802$20240802$EXP$$US-Covis Pharma GmbH-2024COV00871$COVIS PHARMA$$43$YR$A$F$Y$$$20240802$$$COUNTRY NOT SPECIFIED$US
241694241$24169424$1$I$$20191031$20240802$20240802$EXP$$CA-Covis Pharma GmbH-2024COV00885$COVIS PHARMA$$61$YR$A$F$Y$$$20240802$$$COUNTRY NOT SPECIFIED$CA
241694251$24169425$1$I$20210301$20210419$20240802$20240802$EXP$$US-Covis Pharma GmbH-2024COV00927$COVIS PHARMA$$72$YR$E$F$Y$52.2$KG$20240802$$CN$US$US
241694261$24169426$1$I$$20210419$20240802$20240802$EXP$$CA-Covis Pharma GmbH-2024COV00926$COVIS PHARMA$$67$YR$E$F$Y$$$20240802$$$COUNTRY NOT SPECIFIED$CA
241694271$24169427$1$I$$20210518$20240802$20240802$EXP$$CA-Covis Pharma GmbH-2024COV00913$COVIS PHARMA$$$$$M$Y$$$20240802$$CN$CA$CA
241694281$24169428$1$I$20240617$20240716$20240802$20240802$PER$$US-009507513-2407USA010364$MERCK$$72$YR$$F$Y$$$20240802$$CN$US$US
241694292$24169429$2$F$20240727$20240819$20240802$20240822$PER$$US-ALXN-202407USA001964US$ALEXION PHARMACEUTICALS$$57$YR$$F$Y$$$20240822$$CN$US$US
241694301$24169430$1$I$$20190826$20240802$20240802$EXP$$US-Covis Pharma GmbH-2024COV00872$COVIS PHARMA$$$$$F$Y$$$20240802$$$COUNTRY NOT SPECIFIED$US
241694321$24169432$1$I$$20240723$20240802$20240802$EXP$$US-BIOMARINAP-US-2024-159353$BIOMARIN$$$$$$Y$$$20240802$$CN$US$US
241694331$24169433$1$I$$20240703$20240802$20240802$EXP$$CA-ANIPHARMA-2022-CA-001229$ANI$$46$YR$$F$Y$$$20240802$$CN$CA$CA
241694341$24169434$1$I$$20240731$20240802$20240802$EXP$$NVSC2024US157515$NOVARTIS$$$$$$Y$$$20240802$$CN$US$US
241694351$24169435$1$I$$20240801$20240802$20240802$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043393$BOEHRINGER INGELHEIM$$$$$$Y$$$20240802$$HP$US$US
241694361$24169436$1$I$20240701$20240723$20240802$20240802$EXP$$US-BAUSCHBL-2024BNL030584$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240802$$CN$US$US
241694371$24169437$1$I$20240101$20240725$20240802$20240802$PER$$US-ABBVIE-5857330$ABBVIE$$56$YR$$M$Y$$$20240802$$CN$US$US
241694381$24169438$1$I$20220101$20240724$20240802$20240802$EXP$$NVSC2024BR155916$NOVARTIS$$$$$F$Y$$$20240802$$CN$BR$BR
241694391$24169439$1$I$20240411$20240729$20240802$20240802$EXP$FR-AFSSAPS-GR2024000950$FR-REGENERON PHARMACEUTICALS, INC.-2024-104062$REGENERON$$78$YR$$M$Y$$$20240802$$PH$FR$FR
241694402$24169440$2$F$$20240804$20240802$20240805$PER$$US-BIOMARINAP-US-2024-159561$BIOMARIN$$$$$$Y$$$20240805$$CN$US$US
241694414$24169441$4$F$$20240802$20240802$20240911$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043557$BOEHRINGER INGELHEIM$$55$YR$A$F$Y$$$20240911$$CN$US$US
241694421$24169442$1$I$$20240729$20240802$20240802$EXP$$NVSC2024US155516$NOVARTIS$$$$$M$Y$$$20240802$$CN$US$US
241694431$24169443$1$I$20240215$20240728$20240802$20240802$EXP$FR-AFSSAPS-TO2024001420$FR-GE HEALTHCARE-2024CSU008508$GE HEALTHCARE$$46$YR$$F$Y$$$20240802$$MD$FR$FR
241694441$24169444$1$I$20240729$20240730$20240802$20240802$EXP$$NVSC2024CN157990$NOVARTIS$$70$YR$$F$Y$50$KG$20240802$$HP$CN$CN
241694451$24169445$1$I$$20240723$20240802$20240802$EXP$$CA-AstraZeneca-2024A169272$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$CA$
241694461$24169446$1$I$20240711$20240730$20240802$20240802$EXP$$CN-AstraZeneca-2024A175959$ASTRAZENECA$$70$YR$$F$Y$56$KG$20240802$$MD$CN$
241694472$24169447$2$F$20240701$20240828$20240802$20240905$EXP$$US-AstraZeneca-2024A171506$ASTRAZENECA$$729$MON$$M$Y$$$20240905$$CN$US$
241694481$24169448$1$I$$20230919$20240802$20240802$EXP$$US-AstraZeneca-2023A214173$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241694491$24169449$1$I$$20240725$20240802$20240802$EXP$$IN-AstraZeneca-2024A169707$ASTRAZENECA$$53$YR$$F$Y$73$KG$20240802$$CN$IN$
241694501$24169450$1$I$$20240731$20240802$20240802$PER$$US-ABBVIE-5864073$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241694511$24169451$1$I$20240718$20240725$20240802$20240802$EXP$$US-BIOGEN-2024BI01275853$BIOGEN$$26$YR$$F$Y$$$20240802$$CN$US$US
241694521$24169452$1$I$$20240726$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119923$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240802$$PH$US$US
241694541$24169454$1$I$20240530$20240802$20240802$20240802$EXP$FR-AFSSAPS-RN2024000839$NVSC2024FR157911$NOVARTIS$$60$YR$$F$Y$$$20240802$$MD$FR$FR
241694551$24169455$1$I$$20240723$20240802$20240802$EXP$$IE-ABBVIE-5862588$ABBVIE$$$$E$M$Y$$$20240802$$CN$IE$IE
241694572$24169457$2$F$20240722$20240821$20240802$20240829$EXP$$JP-Eisai-EC-2024-171278$EISAI$$81$YR$E$M$Y$51$KG$20240829$$PH$JP$JP
241694581$24169458$1$I$$20240731$20240802$20240802$PER$$US-ABBVIE-5863109$ABBVIE$$$$$$Y$$$20240802$$HP$US$US
241694591$24169459$1$I$20240724$20240723$20240802$20240802$PER$$US-JNJFOC-20240804970$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240802$$HP$US$US
241694601$24169460$1$I$20240101$20240711$20240802$20240802$PER$$US-009507513-2407USA008414$MERCK$$$$$M$Y$$$20240802$$CN$US$US
241694611$24169461$1$I$20220801$20230131$20240802$20240802$EXP$$US-AstraZeneca-2023A027851$ASTRAZENECA$$796$MON$$F$Y$$$20240802$$CN$US$
241694621$24169462$1$I$$20240703$20240802$20240802$EXP$$CA-ANIPHARMA-2022-CA-001222$ANI$$$$$F$Y$$$20240802$$HP$CA$CA
241694632$24169463$2$F$$20240821$20240802$20240823$PER$$US-ALXN-202407USA002012US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240823$$CN$US$US
241694641$24169464$1$I$$20240731$20240802$20240802$EXP$$JP-Eisai-EC-2024-171295$EISAI$$$$E$F$Y$$$20240802$$PH$JP$JP
241694651$24169465$1$I$$20240801$20240802$20240802$PER$$US-ROCHE-3569557$ROCHE$$$$A$F$Y$$$20240802$$CN$US$US
241694662$24169466$2$F$20240201$20240731$20240802$20240808$PER$SE-SEMPA-2024-001497$SE-Eisai-EC-2024-171202$EISAI$$81$YR$E$F$Y$$$20240808$$PH$SE$SE
241694672$24169467$2$F$20240701$20240730$20240802$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011363$JAZZ$$46$YR$$F$Y$$$20240808$$CN$US$US
241694682$24169468$2$F$20240730$20240809$20240802$20240819$PER$$US-BIOMARINAP-US-2024-159550$BIOMARIN$$$$$$Y$$$20240819$$CN$US$US
241694691$24169469$1$I$$20240729$20240802$20240802$PER$$US-BIOMARINAP-US-2024-159521$BIOMARIN$$$$$$Y$$$20240802$$CN$US$US
241694701$24169470$1$I$20240708$20240731$20240802$20240802$PER$$US-BIOMARINAP-US-2024-159416$BIOMARIN$$$$$$Y$$$20240802$$CN$US$US
241694721$24169472$1$I$$20240731$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122654$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240802$$CN$US$US
241694731$24169473$1$I$20240715$20240731$20240802$20240802$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121691$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$49.9$KG$20240802$$CN$US$US
241694741$24169474$1$I$20240701$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122398$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240802$$HP$US$US
241694751$24169475$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122864$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$68$KG$20240802$$CN$US$US
241694765$24169476$5$F$20220914$20240909$20240802$20240918$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-118784$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240918$$HP$DE$DE
241694771$24169477$1$I$20240716$20240725$20240802$20240802$EXP$$US-BIOGEN-2024BI01275846$BIOGEN$$28$YR$$F$Y$$$20240802$$CN$US$US
241694781$24169478$1$I$$20240729$20240802$20240802$PER$$US-ALXN-202407USA001976US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240802$$HP$US$US
241694791$24169479$1$I$$20240801$20240802$20240802$EXP$$FR-SANDOZ INC.-SDZ2024FR069857$SANDOZ$$7$YR$$F$Y$$$20240802$$HP$FR$FR
241694801$24169480$1$I$$20240730$20240802$20240802$PER$$US-SA-2024SA227666$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240802$$MD$US$US
241694811$24169481$1$I$20240701$20240801$20240802$20240802$PER$$NVSC2024US158125$NOVARTIS$$16$YR$$M$Y$$$20240802$$HP$US$US
241694821$24169482$1$I$$20240731$20240802$20240802$PER$$US-AstraZeneca-2024A174909$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241694831$24169483$1$I$$20240729$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019446$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240802$$HP$US$US
241694841$24169484$1$I$$20240729$20240802$20240802$EXP$$JP-009507513-2407JPN005235J$MERCK$Furuki S, Yamamoto C, Minakata D, Ashizawa M, Hatano K, Sato K, et al.. [22 Disseminated Adenovirus Infection and Invasive Fusarium Infection Complicated with Severe GVHD After Allogeneic Transplantation]. The 697th Meeting of The Japanese Society of Internal Medicine, Kanto Regional$64$YR$$F$Y$$$20240802$$MD$JP$JP
241694852$24169485$2$F$20240729$20240827$20240802$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202407019368$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240910$$CN$US$US
241694861$24169486$1$I$20240729$20240729$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019372$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240802$$CN$US$US
241694871$24169487$1$I$20180802$20240722$20240802$20240802$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117361$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$72$KG$20240802$$MD$KR$KR
241694882$24169488$2$F$20240720$20240809$20240802$20240814$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042119$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$38.5$KG$20240814$$PH$JP$JP
241694892$24169489$2$F$$20240821$20240802$20240823$PER$$US-ALXN-202407USA002095US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
241694901$24169490$1$I$20240414$20240730$20240802$20240802$EXP$$CA-ROCHE-10000045816$ROCHE$$59$YR$A$M$Y$$$20240802$$CN$CA$CA
241694911$24169491$1$I$20231203$20240703$20240802$20240802$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-06993$IPSEN$$30$YR$A$F$Y$52$KG$20240802$$CN$CA$CA
241694921$24169492$1$I$$20240731$20240802$20240802$PER$$NVSC2024US158246$NOVARTIS$$$$$$Y$$$20240802$$HP$US$US
241694931$24169493$1$I$$20230309$20240802$20240802$EXP$$US-AstraZeneca-2023A059062$ASTRAZENECA$$$$$M$Y$$$20240802$$CN$US$
241694941$24169494$1$I$20210916$20210917$20240802$20240802$EXP$$US-AstraZeneca-2021A733301$ASTRAZENECA$$64$YR$$F$Y$$$20240802$$CN$US$
241694952$24169495$2$F$$20240821$20240802$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121484$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$58.06$KG$20240830$$PH$US$US
241694961$24169496$1$I$$20240730$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019441$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240802$$CN$US$US
241694971$24169497$1$I$$20240730$20240802$20240802$EXP$$ZA-ROCHE-10000042920$ROCHE$$$$A$F$Y$$$20240802$$CN$ZA$ZA
241694981$24169498$1$I$20240724$20240729$20240802$20240802$PER$$US-ALXN-202407USA002010US$ALEXION PHARMACEUTICALS$$59$YR$$F$Y$$$20240802$$CN$US$US
241694991$24169499$1$I$$20240729$20240802$20240802$PER$$US-ALXN-202407USA002089US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240802$$CN$US$US
241695001$24169500$1$I$20240729$20240729$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019410$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240802$$CN$US$US
241695011$24169501$1$I$$20240801$20240802$20240802$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122192$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$60.33$KG$20240802$$CN$US$US
241695021$24169502$1$I$20180821$20240726$20240802$20240802$EXP$$CA-AstraZeneca-2020SF30073$ASTRAZENECA$$22$YR$$F$Y$51.2$KG$20240802$$MD$CA$
241695031$24169503$1$I$$20211001$20240802$20240802$EXP$$US-AstraZeneca-2021A757821$ASTRAZENECA$$$$$F$Y$$$20240802$$CN$US$
241695041$24169504$1$I$$20240723$20240802$20240802$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07345$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240802$$PH$US$US
241695052$24169505$2$F$$20240827$20240802$20240828$EXP$$US-BIOMARINAP-US-2024-159505$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
241695063$24169506$3$F$$20240826$20240802$20240826$PER$$US-ALXN-202407USA002051US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
241695071$24169507$1$I$$20240730$20240802$20240802$30DAY$$US-SANDOZ INC.-SDZ2024US069647$SANDOZ$$$$$F$Y$$$20240802$$CN$US$US
241695081$24169508$1$I$$20240229$20240802$20240802$PER$$NVSC2024US048393$NOVARTIS$$49$YR$$M$Y$150$KG$20240803$$CN$US$US
241695092$24169509$2$F$$20240729$20240802$20240806$PER$$NVSC2024US156123$NOVARTIS$$$$$$Y$$$20240806$$HP$US$US
241695101$24169510$1$I$$20240712$20240802$20240802$EXP$$CA-ANIPHARMA-2022-CA-001232$ANI$$35$YR$$M$Y$$$20240802$$CN$CA$CA
241695111$24169511$1$I$20240101$20240724$20240802$20240802$EXP$$CA-Eisai-EC-2024-171407$EISAI$$71$YR$E$F$Y$$$20240802$$CN$CA$CA
241695123$24169512$3$F$$20240802$20240802$20240806$PER$$US-ROCHE-10000047348$ROCHE$$$$E$$Y$$$20240806$$HP$US$US
241695131$24169513$1$I$20200414$20240726$20240802$20240802$EXP$PL-URPL-1-1334-2020$PL-TEVA-VS-3227263$TEVA$$17$YR$$M$Y$67.3$KG$20240802$$MD$PL$PL
241695141$24169514$1$I$20240802$20240802$20240802$20240802$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043585$BOEHRINGER INGELHEIM$$70$YR$E$$Y$$$20240802$$CN$US$US
241695151$24169515$1$I$20200605$20240731$20240802$20240802$EXP$PL-URPL-1-1623-2020$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-122739$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$65$KG$20240802$$MD$PL$PL
241695163$24169516$3$F$$20240905$20240802$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122499$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$65.77$KG$20240906$$CN$US$US
241695171$24169517$1$I$20240119$20240726$20240802$20240802$EXP$FR-AFSSAPS-TO2024001320$FR-TEVA-VS-3226975$TEVA$$55$YR$$M$Y$69$KG$20240802$$MD$FR$FR
241695181$24169518$1$I$20240611$20240726$20240802$20240802$EXP$FR-AFSSAPS-MA2024001066$FR-TEVA-VS-3226810$TEVA$$36$YR$$F$Y$$$20240802$$CN$FR$FR
241695201$24169520$1$I$$20240729$20240729$20240729$DIR$711933$$FDA-CTU$$$$$F$N$96.75$KG$20240729$N$CN$US$
241695211$24169521$1$I$$20240729$20240802$20240802$PER$$US-ELI_LILLY_AND_COMPANY-US202407019166$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240802$$CN$US$US
241695221$24169522$1$I$20230301$20240730$20240802$20240802$EXP$$DE-ROCHE-3321646$ROCHE$$38$YR$A$F$Y$$$20240802$$CN$DE$DE
241695231$24169523$1$I$$20240730$20240802$20240802$PER$$US-ROCHE-10000045388$ROCHE$$$$A$F$Y$$$20240802$$CN$US$US
241695241$24169524$1$I$$20240801$20240802$20240802$PER$$US-ROCHE-10000047170$ROCHE$$$$E$M$Y$$$20240802$$CN$US$US
241695252$24169525$2$F$20240226$20240828$20240802$20240906$EXP$$US-RADIUS HEALTH INC.-2024US005755$RADIUS PHARM$$75$YR$$F$Y$$$20240906$$CN$US$US
241695261$24169526$1$I$$20240726$20240802$20240802$EXP$$US-AstraZeneca-2024A174806$ASTRAZENECA$$$$$F$Y$$$20240803$$CN$US$
241695272$24169527$2$F$20240729$20240904$20240802$20240904$PER$$US-ALXN-202407USA002076US$ALEXION PHARMACEUTICALS$$41$YR$$F$Y$$$20240904$$CN$US$US
241695281$24169528$1$I$$20240725$20240802$20240802$EXP$$US-AstraZeneca-2024A170632$ASTRAZENECA$$$$$F$Y$$$20240803$$CN$US$
241695291$24169529$1$I$$20240731$20240802$20240802$EXP$$US-ASTELLAS-2024EU007631$ASTELLAS$$$$$M$Y$$$20240802$$CN$US$US
241695302$24169530$2$F$$20240821$20240802$20240823$PER$$US-ALXN-202407USA002069US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
241695312$24169531$2$F$$20240916$20240802$20240918$EXP$$US-AstraZeneca-2024A170393$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
241695321$24169532$1$I$$20240726$20240802$20240802$PER$$US-SA-2024SA225862$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240803$$CN$US$US
241695331$24169533$1$I$$20240729$20240802$20240802$PER$$US-ALXN-202407USA002073US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240803$$CN$US$US
241695341$24169534$1$I$20240101$20240726$20240802$20240802$PER$$US-SA-2024SA224465$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240803$$CN$US$US
241695351$24169535$1$I$$20240724$20240802$20240802$30DAY$$US-GSK-US2024092886$GLAXOSMITHKLINE$$$$$M$Y$$$20240802$$CN$US$US
241695361$24169536$1$I$20240701$20240731$20240802$20240802$EXP$$US-ROCHE-10000047503$ROCHE$$$$$$Y$$$20240803$$PH$US$US
241695381$24169538$1$I$$20240726$20240802$20240802$EXP$GB-MHRA-MED-202407261046426710-STWQJ$GB-TEVA-VS-3226743$TEVA$$$$$F$Y$$$20240802$$HP$GB$GB
241695391$24169539$1$I$20240511$20240802$20240802$20240802$EXP$SE-SEMPA-2024-005592$SE-ROCHE-10000047544$ROCHE$$50$YR$A$F$Y$85$KG$20240803$$MD$SE$SE
241695401$24169540$1$I$$20240726$20240802$20240802$EXP$$AR-AMGEN-ARGSP2024153483$AMGEN$$71$YR$E$F$Y$$$20240802$$CN$AR$AR
241695411$24169541$1$I$$20240730$20240802$20240802$EXP$$US-ROCHE-10000044765$ROCHE$$77$YR$E$F$Y$$$20240803$$CN$US$US
241695421$24169542$1$I$20221002$20221002$20240802$20240802$PER$$US-SERB S.A.S.-2159924$LABORATOIRES SERB$$36$YR$$M$Y$$$20240802$$MD$US$US
241695431$24169543$1$I$$20240722$20240802$20240802$EXP$$CA-B.Braun Medical Inc.-2159938$B BRAUN$$$$$F$Y$$$20240802$$$CA$CA
241695442$24169544$2$F$20240101$20240903$20240802$20240919$EXP$$IT-AMGEN-ITASP2024152403$AMGEN$$52$YR$A$F$Y$41$KG$20240919$$MD$IT$IT
241695451$24169545$1$I$20240701$20240731$20240802$20240802$EXP$$US-ABBVIE-5863770$ABBVIE$$77$YR$$F$Y$$$20240802$$CN$US$US
241695461$24169546$1$I$$20240731$20240802$20240802$EXP$$US-ABBVIE-5863776$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241695472$24169547$2$F$20230701$20240823$20240802$20240829$EXP$$US-ABBVIE-5572878$ABBVIE$$68$YR$$F$Y$48$KG$20240829$$CN$US$US
241695481$24169548$1$I$20240101$20240726$20240802$20240802$EXP$$US-ABBVIE-5858212$ABBVIE$$$$$F$Y$$$20240802$$HP$US$US
241695491$24169549$1$I$$20240729$20240802$20240802$EXP$$US-ABBVIE-5860097$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241695501$24169550$1$I$$20240730$20240802$20240802$EXP$$US-ABBVIE-5860974$ABBVIE$$$$$M$Y$$$20240802$$CN$US$US
241695512$24169551$2$F$20240723$20240730$20240802$20240810$EXP$$US-ABBVIE-5861795$ABBVIE$$50$YR$$F$Y$$$20240810$$CN$US$US
241696441$24169644$1$I$20240718$20240730$20240802$20240802$EXP$$US-ABBVIE-5861489$ABBVIE$$72$YR$$F$Y$$$20240802$$CN$US$US
241696451$24169645$1$I$20240101$20240730$20240802$20240802$EXP$$US-ABBVIE-5733165$ABBVIE$$62$YR$$M$Y$$$20240802$$CN$US$US
241696461$24169646$1$I$$20240731$20240802$20240802$PER$$NVSC2024US157958$NOVARTIS$$$$$$Y$$$20240803$$HP$US$US
241696471$24169647$1$I$20240701$20240724$20240802$20240802$PER$$US-ABBVIE-5856220$ABBVIE$$40$YR$$F$Y$$$20240802$$MD$US$US
241696481$24169648$1$I$$20240725$20240802$20240802$PER$$US-ABBVIE-5856145$ABBVIE$$$$$$Y$$$20240802$$CN$US$US
241696491$24169649$1$I$20240701$20240730$20240802$20240802$EXP$$CO-ABBVIE-5862769$ABBVIE$$68$YR$$F$Y$48$KG$20240802$$CN$CO$CO
241696502$24169650$2$F$20240717$20240815$20240802$20240816$EXP$$AM-ROCHE-10000035037$ROCHE$$46$YR$A$M$Y$79$KG$20240816$$CN$AM$AM
241696511$24169651$1$I$20240709$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152634$AMGEN$$65$YR$E$F$Y$$$20240802$$CN$US$US
241696521$24169652$1$I$20240716$20240719$20240802$20240802$EXP$$GB-HQ SPECIALTY-GB-2024INT000077$INTERCHEM$$52$YR$$F$Y$75$KG$20240803$$MD$GB$GB
241696531$24169653$1$I$20240629$20240725$20240802$20240802$EXP$FR-AFSSAPS-SE2024000580$FR-TEVA-VS-3225955$TEVA$$76$YR$$F$Y$77.6$KG$20240802$$MD$FR$FR
241696562$24169656$2$F$20240601$20240905$20240802$20240906$PER$$US-AMGEN-USASP2024152672$AMGEN$$86$YR$E$F$Y$$$20240906$$CN$US$US
241696572$24169657$2$F$20240420$20240916$20240802$20240925$EXP$$EG-ROCHE-3556960$ROCHE$$26$YR$A$F$Y$$$20240925$$CN$EG$EG
241696581$24169658$1$I$$20240725$20240802$20240802$PER$$US-ABBVIE-5857622$ABBVIE$$$$$F$Y$$$20240802$$CN$US$US
241696591$24169659$1$I$20240731$20240731$20240802$20240802$PER$$US-AMGEN-USASP2024152548$AMGEN$$59$YR$A$M$Y$$$20240802$$CN$US$US
241696601$24169660$1$I$20230101$20240729$20240802$20240802$EXP$$NVSC2024BR137620$NOVARTIS$$$$$F$Y$65$KG$20240803$$CN$BR$BR
241696611$24169661$1$I$20240722$20240731$20240802$20240802$PER$$US-ABBVIE-5862843$ABBVIE$$26$YR$$F$Y$$$20240802$$MD$US$US
241696621$24169662$1$I$$20240730$20240802$20240802$EXP$$LB-ROCHE-10000045293$ROCHE$$$$$$Y$$$20240803$$MD$LB$LB
241696632$24169663$2$F$20240728$20240813$20240802$20240815$PER$$US-AMGEN-USASP2024151082$AMGEN$$68$YR$E$M$Y$$$20240815$$MD$US$US
241696641$24169664$1$I$20240701$20240726$20240802$20240802$EXP$$JP-ROCHE-10000046302$ROCHE$$75$YR$E$M$Y$$$20240803$$MD$JP$JP
241696651$24169665$1$I$20240101$20240802$20240802$20240802$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043524$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240803$$CN$US$US
241696671$24169667$1$I$20240715$20240726$20240802$20240802$EXP$$GB-TEVA-VS-3226893$TEVA$$54$YR$$M$Y$92$KG$20240802$$MD$GB$GB
241696681$24169668$1$I$$20240802$20240802$20240802$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043496$BOEHRINGER INGELHEIM$$$$$$Y$$$20240803$$HP$US$US
241696691$24169669$1$I$20240730$20240730$20240802$20240802$PER$$US-ABBVIE-5862547$ABBVIE$$50$YR$$F$Y$$$20240802$$HP$US$US
241696702$24169670$2$F$$20240802$20240802$20240814$EXP$$JP-AMGEN-JPNSP2024153450$AMGEN$$$$$$Y$$$20240814$$PH$JP$JP
241696713$24169671$3$F$20240101$20240801$20240802$20240809$PER$$US-ABBVIE-5860892$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241696721$24169672$1$I$20240714$20240801$20240802$20240802$EXP$$CN-ROCHE-10000047376$ROCHE$$64$YR$A$F$Y$62$KG$20240803$$HP$CN$CN
241696731$24169673$1$I$$20240725$20240802$20240802$EXP$$IN-NOVITIUMPHARMA-2024INNVP01446$NOVITIUM PHARMA$Sonam Spalgais.Exfoliated dermatitis and hepatitis to first line Anti-Tubercular Therapy with treatment of Drug-Sensitive Tuberculosis with second line Anti-Tubercular Therapy: a roller coaster ride.Chest Disease Reports .03-JUN-2024;12(1):1-19$31$YR$A$M$Y$$$20240803$$HP$IN$IN
241696741$24169674$1$I$$20240726$20240802$20240802$EXP$$JP-ROCHE-10000047182$ROCHE$$9$DEC$E$$Y$$$20240803$$MD$JP$JP
241696751$24169675$1$I$20240515$20240729$20240802$20240802$EXP$$JP-ROCHE-10000047773$ROCHE$$8$DEC$E$$Y$$$20240803$$MD$JP$JP
241696761$24169676$1$I$20240724$20240801$20240802$20240802$EXP$$CN-ROCHE-10000047085$ROCHE$$51$YR$A$F$Y$55$KG$20240803$$HP$CN$CN
241696771$24169677$1$I$$20240726$20240802$20240802$EXP$$JP-AMGEN-JPNSP2024153500$AMGEN$$$$E$F$Y$$$20240802$$MD$JP$JP
241696781$24169678$1$I$$20240802$20240802$20240802$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043584$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240803$$CN$US$US
241696791$24169679$1$I$$20240730$20240802$20240802$EXP$$GB-ABBVIE-5865221$ABBVIE$$$$A$M$Y$$$20240802$$CN$GB$GB
241696801$24169680$1$I$20240712$20240731$20240802$20240802$EXP$$PK-ROCHE-10000045290$ROCHE$$64$YR$A$F$Y$$$20240803$$CN$PK$PK
241696811$24169681$1$I$$20240729$20240802$20240802$PER$$US-SA-2024SA226140$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240803$$MD$US$US
241696821$24169682$1$I$20240722$20240726$20240802$20240802$PER$$US-ABBVIE-5860454$ABBVIE$$37$YR$$F$Y$$$20240802$$MD$US$US
241696831$24169683$1$I$20240725$20240730$20240802$20240802$PER$$US-AMGEN-USASP2024151698$AMGEN$$56$YR$A$F$Y$$$20240802$$CN$US$US
241696841$24169684$1$I$20240722$20240726$20240802$20240802$PER$$US-AMGEN-USASP2024149407$AMGEN$$53$YR$A$F$Y$$$20240802$$HP$US$US
241696851$24169685$1$I$20240728$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024152116$AMGEN$$81$YR$E$M$Y$$$20240802$$CN$US$US
241696861$24169686$1$I$20240722$20240726$20240803$20240803$EXP$$CN-ROCHE-10000038279$ROCHE$$59$YR$A$F$Y$77$KG$20240803$$HP$CN$CN
241696871$24169687$1$I$$20240729$20240802$20240802$PER$$US-BEH-2024176625$CSL BEHRING$$6$DEC$A$F$Y$$$20240802$$HP$US$US
241696901$24169690$1$I$20240101$20240730$20240803$20240803$EXP$$DE-ABBVIE-5864423$ABBVIE$$$$$M$Y$$$20240803$$CN$DE$DE
241696911$24169691$1$I$$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024153331$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241696921$24169692$1$I$20240101$20240726$20240803$20240803$EXP$$US-ABBVIE-5859845$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241696932$24169693$2$F$20240607$20240906$20240803$20240914$EXP$$JP-AMGEN-JPNNI2024152291$AMGEN$$62$YR$A$F$Y$78$KG$20240914$$HP$JP$JP
241696941$24169694$1$I$20240501$20240731$20240803$20240803$EXP$$AR-ABBVIE-5864454$ABBVIE$$39$YR$$F$Y$$$20240803$$CN$AR$AR
241696951$24169695$1$I$$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024153060$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241696961$24169696$1$I$$20240728$20240803$20240803$PER$$US-AMGEN-USASP2024151568$AMGEN$$$$$$Y$$$20240802$$CN$US$US
241696972$24169697$2$F$$20240731$20240803$20240809$PER$$US-SA-2024SA226017$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240809$$CN$US$US
241696981$24169698$1$I$20240101$20240726$20240803$20240803$PER$$US-SA-2024SA224302$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240803$$MD$US$US
241696991$24169699$1$I$$20240801$20240803$20240803$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122327$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240803$$HP$US$US
241697003$24169700$3$F$20240301$20240813$20240803$20240819$EXP$$US-ABBVIE-5858831$ABBVIE$$62$YR$$M$Y$109$KG$20240819$$CN$US$US
241697011$24169701$1$I$20240725$20240726$20240803$20240803$EXP$GB-MHRA-MED-202407262210234940-NWSRC$GB-TEVA-VS-3226957$TEVA$$$$$$Y$$$20240803$$CN$GB$GB
241697021$24169702$1$I$20240101$20240729$20240803$20240803$EXP$$NVSC2024BR157701$NOVARTIS$$$$$M$Y$$$20240803$$CN$BR$BR
241697041$24169704$1$I$20240729$20240729$20240803$20240803$PER$$US-AMGEN-USASP2024152051$AMGEN$$75$YR$E$F$Y$$$20240802$$CN$US$US
241697052$24169705$2$F$20240101$20240806$20240803$20240812$EXP$$CA-ABBVIE-5860910$ABBVIE$$65$YR$$F$Y$$$20240812$$CN$CA$CA
241697061$24169706$1$I$$20240801$20240803$20240803$PER$$US-AMGEN-USASP2024154103$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241697071$24169707$1$I$$20240726$20240803$20240803$EXP$$IT-AMGEN-ITASP2024149178$AMGEN$Sabatino A. D.; Lenti M. V.; Ribaldone D. et al.. A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium. ESMO Open. 2024;9 (7):103632$$$$$Y$$$20240802$$HP$IT$IT
241697081$24169708$1$I$20240101$20240730$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-023002$UNITED THERAPEUTICS$$$$$F$Y$48.299$KG$20240803$$$US$US
241697091$24169709$1$I$$20240726$20240803$20240803$PER$$US-AMGEN-USASP2024153186$AMGEN$$$$$M$Y$$$20240802$$HP$US$US
241697101$24169710$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA227681$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240803$$MD$US$US
241697111$24169711$1$I$20240729$20240730$20240803$20240803$PER$$US-SA-2024SA227859$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240803$$MD$US$US
241697121$24169712$1$I$20230901$20240725$20240803$20240803$EXP$$CA-ABBVIE-5864208$ABBVIE$$43$YR$$F$Y$$$20240803$$CN$CA$CA
241697141$24169714$1$I$$20240722$20240803$20240803$EXP$$ZA-AUROBINDO-AUR-APL-2024-037404$AUROBINDO$Frigati LJ, Rabie H. Third-Line Antiretroviral Therapy: What Do We Do When the Appropriate Formulations Are Not Available? NF. Children. 2022;9(4):1-6$36$MON$$M$Y$17$KG$20240803$$HP$ZA$ZA
241697151$24169715$1$I$$20240722$20240803$20240803$PER$$US-TEVA-VS-3226414$TEVA$$58$YR$$F$Y$$$20240803$$CN$US$US
241697161$24169716$1$I$$20240730$20240803$20240803$EXP$$US-ABBVIE-5861475$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241697171$24169717$1$I$$20240731$20240803$20240803$EXP$$CA-ABBVIE-5864413$ABBVIE$$$$E$F$Y$$$20240803$$CN$CA$CA
241697185$24169718$5$F$20230309$20240830$20240803$20240902$EXP$$AT-ABBVIE-4716202$ABBVIE$$71$YR$$M$Y$67$KG$20240902$$MD$AT$AT
241697191$24169719$1$I$20240731$20240731$20240803$20240803$EXP$$PT-ABBVIE-5865436$ABBVIE$$72$YR$$F$Y$$$20240803$$HP$PT$PT
241697201$24169720$1$I$20240101$20240729$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-023564$UNITED THERAPEUTICS$$$$$F$Y$113.38$KG$20240803$$$US$US
241697211$24169721$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA226143$SANOFI AVENTIS$$$$A$F$Y$$$20240803$$CN$US$US
241697221$24169722$1$I$20240729$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024151735$AMGEN$$71$YR$E$F$Y$$$20240802$$CN$US$US
241697231$24169723$1$I$$20240725$20240803$20240803$PER$$US-ABBVIE-5856802$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241697241$24169724$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA228737$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240803$$MD$US$US
241697252$24169725$2$F$$20240820$20240803$20240828$PER$$US-ABBVIE-5864024$ABBVIE$$75$YR$$M$Y$$$20240828$$MD$US$US
241697261$24169726$1$I$$20240723$20240803$20240803$EXP$GB-MHRA-31183392$GB-Accord-438305$ACCORD$$$$$F$Y$$$20240802$$PH$GB$GB
241697271$24169727$1$I$20240722$20240722$20240803$20240803$EXP$$US-Accord-438401$ACCORD$$35$YR$A$M$Y$$$20240802$$MD$US$US
241697281$24169728$1$I$20240716$20240723$20240803$20240803$EXP$GB-MHRA-MED-202407230844123650-CNVJP$GB-Accord-438076$ACCORD$$32$YR$A$M$Y$92$KG$20240802$$CN$GB$GB
241697291$24169729$1$I$20240730$20240731$20240803$20240803$EXP$$CO-ABBVIE-5864417$ABBVIE$$40$YR$$F$Y$$$20240803$$CN$CO$CO
241697301$24169730$1$I$20211221$20221004$20240803$20240803$EXP$PL-URPL-DML-MLP.4401.1.2453.2021$PL-Accord-426887$ACCORD$$51$YR$A$M$Y$81$KG$20240802$$MD$PL$PL
241697311$24169731$1$I$$20240730$20240803$20240803$EXP$$JP-ABBVIE-5807133$ABBVIE$$9$DEC$$M$Y$$$20240803$$PH$JP$JP
241697321$24169732$1$I$20231121$20240723$20240803$20240803$EXP$FR-AFSSAPS-AM2024000561$FR-Accord-438199$ACCORD$$78$YR$E$M$Y$100$KG$20240802$$MD$FR$FR
241697331$24169733$1$I$$20240729$20240803$20240803$EXP$$US-ABBVIE-5860202$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241697341$24169734$1$I$$20240722$20240803$20240803$PER$$US-ABBVIE-5852095$ABBVIE$$$$$M$Y$$$20240803$$HP$US$US
241697351$24169735$1$I$$20240729$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-023662$UNITED THERAPEUTICS$$$$$F$Y$73.469$KG$20240803$$$US$US
241697362$24169736$2$F$20240101$20240808$20240803$20240815$EXP$$CA-ABBVIE-5857066$ABBVIE$$60$YR$$F$Y$$$20240815$$CN$CA$CA
241697371$24169737$1$I$20240701$20240729$20240803$20240803$EXP$$US-ABBVIE-5860833$ABBVIE$$58$YR$$M$Y$$$20240803$$CN$US$US
241697381$24169738$1$I$$20240730$20240803$20240803$EXP$$US-ABBVIE-5860998$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241697391$24169739$1$I$$20240722$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-037443$AUROBINDO$Osei KM, Wuni G, Mehta N, Gupta SK. Comparative Analysis of Right Ventricular (RV) Apical Pacing versus Physiologic Left Bundle Branch Area Pacing (LBBAP) in Hypertrophic Cardiomyopathy With Left Ventricular Outflow Tract Obstruction (LVOTO): A Case Study. Circulation. 2023$69$YR$$F$Y$$$20240803$$HP$US$US
241697402$24169740$2$F$$20240729$20240803$20240808$EXP$$US-Accord-438364$ACCORD$Attieh RM, Brumble L, Elwasila SM, Wadei HM. Disseminated Monkeypox Infection in a Kidney Transplant Recipient A Case Report. Transplantation Proceedings. 2023;55(3):667-71. DOI: /10.1016/j.transproceed.2023.02.031.$44$YR$A$M$Y$$$20240808$$MD$US$US
241697411$24169741$1$I$20240731$20240801$20240803$20240803$EXP$$US-ABBVIE-5865340$ABBVIE$$81$YR$$F$Y$$$20240803$$CN$US$US
241697421$24169742$1$I$20200101$20240730$20240803$20240803$EXP$$CO-ABBVIE-5865416$ABBVIE$$$$$F$Y$65$KG$20240803$$HP$CO$CO
241697431$24169743$1$I$$20240727$20240803$20240803$EXP$$CN-ABBVIE-5864475$ABBVIE$$$$$$Y$$$20240803$$MD$CN$CN
241697441$24169744$1$I$$20240722$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-037813$AUROBINDO$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Nguyen QD, et al.. Intravenous cyclophosphamide therapy for patients with severe ocular infammatory diseases who failed other immunomodulatory therapies. Journal of Ophthalmic Inflammation and Infection. 2024;14 (12):1-6$65$YR$$F$Y$$$20240803$$HP$US$US
241697452$24169745$2$F$20240101$20240911$20240803$20240919$EXP$$CA-ABBVIE-5862611$ABBVIE$$$$E$F$Y$$$20240919$$CN$CA$CA
241697462$24169746$2$F$20240101$20240903$20240803$20240909$EXP$$CA-ABBVIE-5862439$ABBVIE$$32$YR$$M$Y$$$20240909$$HP$CA$CA
241697471$24169747$1$I$$20240722$20240803$20240803$EXP$$ZA-AUROBINDO-AUR-APL-2024-037653$AUROBINDO$Nkoane MA, Adefolalu AO. Rapid-onset diarrhoea in HIV patient: The importance of suspecting cholera in non-endemic areas. Southern African Journal of Infectious Diseases. 2024;39No. 1:a619$48$YR$$M$Y$$$20240803$$HP$ZA$ZA
241697482$24169748$2$F$20240101$20240731$20240803$20240807$EXP$$CA-ABBVIE-5860957$ABBVIE$$94$YR$$F$Y$$$20240807$$CN$CA$CA
241697491$24169749$1$I$$20240731$20240803$20240803$EXP$$US-ABBVIE-5864489$ABBVIE$$$$E$M$Y$$$20240803$$MD$US$US
241697501$24169750$1$I$$20240722$20240803$20240803$EXP$$BR-AUROBINDO-AUR-APL-2024-037774$AUROBINDO$Silva GEB, Campos MAG, Ataides RJC, Ferreira MC, Alves AS. Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report. Immun-Inflamm-Dis. 2024;12:1-5$25$YR$$F$Y$$$20240803$$HP$BR$BR
241697511$24169751$1$I$$20240722$20240803$20240803$PER$$US-TEVA-VS-3225463$TEVA$$65$YR$$M$Y$$$20240803$$CN$US$US
241697521$24169752$1$I$$20240726$20240803$20240803$EXP$$US-SA-2024SA221886$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240803$$MD$US$US
241697532$24169753$2$F$$20240906$20240803$20240911$PER$$US-AstraZeneca-2024A166966$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
241697541$24169754$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA226818$SANOFI AVENTIS$$$$A$F$Y$72.5$KG$20240803$$MD$US$US
241697551$24169755$1$I$20240701$20240730$20240803$20240803$PER$$US-SA-2024SA227256$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240803$$MD$US$US
241697562$24169756$2$F$$20240909$20240803$20240918$30DAY$$US-GSK-US2024093759$GLAXOSMITHKLINE$$$$$M$Y$$$20240918$$CN$US$US
241697571$24169757$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA226856$SANOFI AVENTIS$$$$A$F$Y$$$20240803$$CN$US$US
241697581$24169758$1$I$$20240724$20240803$20240803$EXP$$CA-TEVA-VS-3225853$TEVA$$$$$$Y$$$20240803$$HP$CA$CA
241697591$24169759$1$I$$20240718$20240803$20240803$PER$$US-AstraZeneca-2024A168456$ASTRAZENECA$$$$$F$Y$$$20240803$$CN$US$
241697602$24169760$2$F$20240601$20240813$20240803$20240821$PER$$US-ABBVIE-5856302$ABBVIE$$$$$$Y$$$20240821$$CN$US$US
241697611$24169761$1$I$$20240730$20240803$20240803$EXP$$US-ABBVIE-5864516$ABBVIE$$$$$F$Y$$$20240803$$HP$US$US
241697621$24169762$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA226864$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240803$$MD$US$US
241697631$24169763$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA227264$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240803$$MD$US$US
241697641$24169764$1$I$20240101$20240725$20240803$20240803$PER$$US-SA-2024SA225962$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240803$$MD$US$US
241697651$24169765$1$I$20240726$20240726$20240803$20240803$PER$$US-SA-2024SA222149$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240803$$MD$US$US
241697662$24169766$2$F$20240730$20240809$20240803$20240814$30DAY$$US-AMGEN-USASP2024151706$AMGEN$$$$$$Y$$$20240814$$PH$US$US
241697672$24169767$2$F$20240725$20240905$20240803$20240912$PER$$US-AstraZeneca-2024A170583$ASTRAZENECA$$$$$M$Y$$$20240913$$MD$US$
241697681$24169768$1$I$$20240730$20240803$20240803$PER$$US-ABBVIE-5862616$ABBVIE$$$$$$Y$$$20240803$$CN$US$US
241697691$24169769$1$I$$20240730$20240803$20240803$EXP$$US-ABBVIE-5864505$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241697701$24169770$1$I$$20240723$20240803$20240803$EXP$$GB-AUROBINDO-AUR-APL-2024-037137$AUROBINDO$$$$$M$Y$$$20240803$$CN$GB$GB
241697711$24169771$1$I$20240730$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024152128$AMGEN$$79$YR$E$F$Y$$$20240802$$CN$US$US
241697721$24169772$1$I$20240727$20240727$20240803$20240803$EXP$GB-MHRA-MED-202407270917104810-QPYZV$GB-TEVA-VS-3227141$TEVA$$60$YR$$M$Y$78$KG$20240803$$MD$GB$GB
241697732$24169773$2$F$20240130$20240731$20240803$20240806$EXP$$US-ABBVIE-5864785$ABBVIE$$71$YR$$M$Y$$$20240806$$CN$US$US
241697741$24169774$1$I$$20240726$20240803$20240803$EXP$$TR-NOVITIUMPHARMA-2024TRNVP01458$NOVITIUM PHARMA$Fahri Cakan.Intraoperative Takotsubo Cardiomyopathy: A Case Report.Journal of Perianesthesia Nursing.21-MAR-2024;NA:1-7$18$YR$T$F$Y$50$KG$20240803$$HP$TR$TR
241697752$24169775$2$F$$20240912$20240803$20240922$PER$$US-GSK-US2024093751$GLAXOSMITHKLINE$$$$$M$Y$$$20240922$$CN$US$US
241697771$24169777$1$I$$20240730$20240803$20240803$EXP$$DE-ABBVIE-5863530$ABBVIE$$52$YR$$F$Y$$$20240803$$CN$DE$DE
241697781$24169778$1$I$$20240730$20240803$20240803$EXP$$US-ABBVIE-5862405$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241697792$24169779$2$F$$20240815$20240803$20240912$PER$$US-ABBVIE-5865099$ABBVIE$$$$$F$Y$$$20240912$$HP$US$US
241697801$24169780$1$I$$20240728$20240803$20240803$EXP$$US-GSK-US2024094355$GLAXOSMITHKLINE$$$$$$Y$$$20240803$$CN$US$US
241697811$24169781$1$I$20240702$20240723$20240803$20240803$EXP$$FR-AUROBINDO-AUR-APL-2024-036861$AUROBINDO$$51$YR$$F$Y$95.5$KG$20240803$$MD$FR$FR
241697821$24169782$1$I$20221001$20240726$20240803$20240803$EXP$$GB-JNJFOC-20240777452$JOHNSON AND JOHNSON$$$$$F$Y$$$20240803$$HP$GB$GB
241697831$24169783$1$I$$20240722$20240803$20240803$EXP$$UG-AUROBINDO-AUR-APL-2024-037630$AUROBINDO$Nambuya M, Mayanja-Kizza H.. A case report: recurrent anemia related to long term acyclovir use in a pregnant HIV infected Ugandan. Afr-Health-Sci. 2024;24(1):91-93$19$YR$$F$Y$$$20240803$$HP$UG$UG
241697841$24169784$1$I$$20240729$20240803$20240803$EXP$$CA-AMGEN-CANSP2024151150$AMGEN$$$$$F$Y$$$20240802$$MD$CA$CA
241697851$24169785$1$I$20240729$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024152233$AMGEN$$57$YR$A$F$Y$$$20240802$$CN$US$US
241697861$24169786$1$I$$20240722$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-037599$AUROBINDO$Rodriguez H, Tan J, Reddy S. A Missed Mass: An Exceedingly Rare Round Cell Sarcoma Leading to Respiratory Failure in a 19-year-old. Am-J-Respir-Crit-Care-Med. 2024;209:A6532$19$YR$$F$Y$$$20240803$$HP$US$US
241697871$24169787$1$I$$20240719$20240803$20240803$PER$$US-AstraZeneca-2024A165422$ASTRAZENECA$$$$$$Y$$$20240803$$CN$US$
241697881$24169788$1$I$$20240726$20240803$20240803$PER$$US-AstraZeneca-2024A172010$ASTRAZENECA$$$$$F$Y$$$20240803$$CN$US$
241697891$24169789$1$I$20240701$20240726$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-023333$UNITED THERAPEUTICS$$65$YR$$F$Y$79.819$KG$20240803$$$US$US
241697901$24169790$1$I$$20240730$20240803$20240803$PER$$US-JNJFOC-20240801724$JOHNSON AND JOHNSON$$$$$$Y$$$20240803$$MD$US$US
241697911$24169791$1$I$20240726$20240726$20240803$20240803$EXP$$IE-CELLTRION INC.-2024IE018425$CELLTRION$$$$$$Y$$$20240803$$CN$IE$IE
241697921$24169792$1$I$$20240729$20240803$20240803$EXP$$US-ROCHE-10000042420$ROCHE$$95$YR$E$F$Y$$$20240803$$CN$US$US
241697931$24169793$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-037850$AUROBINDO$$75$YR$$F$Y$64$KG$20240803$$HP$CA$CA
241697941$24169794$1$I$$20240729$20240803$20240803$EXP$$US-ROCHE-10000041769$ROCHE$$80$YR$E$F$Y$$$20240803$$CN$US$US
241697951$24169795$1$I$$20240723$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-037910$AUROBINDO$Marsela E, Hirsch E, Slipczuk L, Travin MI, Moadel RM, Vukelic S. High-Output Heart Failure in Multiple Myeloma: Novel Application of Tc99m MAA to Identify Intramedullary Shunting.. JACC. 2024;VOL. 29:1-4$51$YR$$M$Y$$$20240803$$MD$US$US
241697961$24169796$1$I$$20240723$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-037958$AUROBINDO$Migally K, Monge M, Wolfe B, Hammond N, Joong A. Paracorporeal Ventricular Assist Device as Bridge to Transplant after Suspected SARS-CoV-2 Myocarditis in Child with Stage IISingle Ventricle Palliation. ASAIO-J. 2024;70 (Suppl.)149:abstr. P70.$10$MON$$M$Y$9.2$KG$20240803$$HP$US$US
241697971$24169797$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038245$AUROBINDO$$40$YR$$F$Y$$$20240803$$CN$CA$CA
241697981$24169798$1$I$$20240729$20240803$20240803$PER$$US-AMGEN-USASP2024150422$AMGEN$$$$$F$Y$$$20240802$$CN$US$US
241697991$24169799$1$I$20240730$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024152723$AMGEN$$74$YR$E$F$Y$$$20240802$$CN$US$US
241698001$24169800$1$I$$20240730$20240803$20240803$EXP$$US-ROCHE-10000014449$ROCHE$$79$YR$E$M$Y$$$20240803$$CN$US$US
241698011$24169801$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA226865$SANOFI AVENTIS$$$$A$F$Y$$$20240803$$MD$US$US
241698021$24169802$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226786$TEVA$$65$YR$$F$Y$$$20240803$$HP$CA$CA
241698041$24169804$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226600$TEVA$$29$YR$$F$Y$57$KG$20240803$$HP$CA$CA
241698051$24169805$1$I$$20240724$20240803$20240803$EXP$$BE-AUROBINDO-AUR-APL-2024-037555$AUROBINDO$$44$YR$$F$Y$$$20240803$$PH$BE$BE
241698061$24169806$1$I$$20240730$20240803$20240803$EXP$$US-ROCHE-10000042863$ROCHE$$67$YR$E$F$Y$$$20240803$$CN$US$US
241698072$24169807$2$F$$20240726$20240803$20240806$EXP$$IN-GSK-IN2024APC094910$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$IN$IN
241698081$24169808$1$I$20240731$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024152694$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241698091$24169809$1$I$20231025$20240724$20240803$20240803$EXP$$FR-AUROBINDO-AUR-APL-2024-037689$AUROBINDO$$72$YR$$M$Y$$$20240803$$MD$FR$FR
241698112$24169811$2$F$$20240910$20240803$20240919$EXP$$US-AUROBINDO-AUR-APL-2024-037839$AUROBINDO$Bollam RR, Reddy VK. Persistent Pseudomonas Aeruginosa Pneumonia Due to Antimicrobial Resistance Development Requiring Lobectomy. Am-J-Respir-Crit-Care-Med. 2024;209:A2400$56$YR$$F$Y$$$20240919$$HP$US$US
241698121$24169812$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226746$TEVA$$62$YR$$M$Y$$$20240803$$HP$CA$CA
241698131$24169813$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3227324$TEVA$$$$N$M$Y$$$20240803$$HP$CA$CA
241698141$24169814$1$I$20240128$20240723$20240803$20240803$EXP$$GB-AUROBINDO-AUR-APL-2024-037059$AUROBINDO$$85$YR$$M$Y$80$KG$20240803$$CN$GB$GB
241698151$24169815$1$I$$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024153213$AMGEN$$$$$$Y$$$20240802$$PH$US$US
241698161$24169816$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226836$TEVA$$15$YR$$F$Y$54$KG$20240803$$HP$CA$CA
241698171$24169817$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038503$AUROBINDO$$55$YR$$M$Y$$$20240803$$HP$CA$CA
241698181$24169818$1$I$$20240731$20240803$20240803$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043418$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240803$$MD$US$US
241698201$24169820$1$I$$20240716$20240803$20240803$PER$$US-AstraZeneca-2024A170424$ASTRAZENECA$$$$$F$Y$$$20240803$$HP$US$
241698211$24169821$1$I$20240731$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024153138$AMGEN$$72$YR$E$F$Y$$$20240802$$CN$US$US
241698221$24169822$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038566$AUROBINDO$$38$YR$$M$Y$$$20240803$$HP$CA$CA
241698231$24169823$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA222979$SANOFI AVENTIS$$$$A$F$Y$$$20240803$$CN$US$US
241698241$24169824$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA226867$SANOFI AVENTIS$$$$A$F$Y$$$20240803$$CN$US$US
241698251$24169825$1$I$20240731$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024152766$AMGEN$$45$YR$A$M$Y$$$20240802$$CN$US$US
241698261$24169826$1$I$20240101$20240715$20240803$20240803$PER$$US-JNJFOC-20240751696$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240803$$CN$US$US
241698271$24169827$1$I$$20240723$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-037944$AUROBINDO$Allonce J, Patel V.. New-onset Refractory Status Epilepticus Induced by Synthetic Marijuana: A Case Report.. Am-J-Respir-Crit-Care-Med. 2024;209:A2117$26$YR$$M$Y$$$20240803$$HP$US$US
241698281$24169828$1$I$20240603$20240726$20240803$20240803$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012451$UNITED THERAPEUTICS$$48$YR$$M$Y$83.9$KG$20240803$$$US$US
241698291$24169829$1$I$20240701$20240731$20240803$20240803$EXP$$DE-ABBVIE-5864214$ABBVIE$$44$YR$$M$Y$76$KG$20240803$$MD$DE$DE
241698302$24169830$2$F$20240724$20240819$20240803$20240826$30DAY$$US-AMGEN-USASP2024149590$AMGEN$$86$YR$E$M$Y$$$20240826$$HP$US$US
241698311$24169831$1$I$20240701$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024152166$AMGEN$$$$$F$Y$$$20240802$$PH$US$US
241698321$24169832$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA223506$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240803$$MD$US$US
241698331$24169833$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA223186$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240803$$MD$US$US
241698341$24169834$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-037897$AUROBINDO$$73$YR$$F$Y$$$20240803$$MD$CA$CA
241698351$24169835$1$I$$20240731$20240803$20240803$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121873$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240803$$HP$US$US
241698361$24169836$1$I$20240720$20240722$20240803$20240803$PER$$US-TEVA-VS-3224665$TEVA$$76$YR$$F$Y$$$20240803$$CN$US$US
241698371$24169837$1$I$20240112$20240724$20240803$20240803$EXP$PT-INFARMED-J202402-203$PT-BAXTER-2024BAX013182$BAXTER$$31$YR$$F$Y$$$20240803$$MD$PT$PT
241698381$24169838$1$I$$20240727$20240803$20240803$EXP$GB-MHRA-MED-202407271536061010-QPHLF$GB-TEVA-VS-3227161$TEVA$$42$YR$$M$Y$82$KG$20240803$$CN$GB$GB
241698391$24169839$1$I$20240710$20240723$20240803$20240803$EXP$CN-NMPACDR-3101131055541202400172$CN-BAXTER-2024BAX022296$BAXTER$$67$YR$$F$Y$62.5$KG$20240803$$MD$CN$CN
241698401$24169840$1$I$$20240724$20240803$20240803$EXP$$DE-BAXTER-2024BAX022188$BAXTER$$24$YR$$F$Y$48$KG$20240803$$PH$DE$DE
241698411$24169841$1$I$20240704$20240724$20240803$20240803$EXP$CN-NMPACDR-6607011030753202400513$CN-BAXTER-2024BAX022349$BAXTER$$81$YR$$F$Y$55$KG$20240803$$MD$CN$CN
241698421$24169842$1$I$$20240725$20240803$20240803$EXP$FR-AFSSAPS-PB2024000818$FR-BAXTER-2024BAX022279$BAXTER$$71$YR$$F$Y$54$KG$20240803$$MD$FR$FR
241698431$24169843$1$I$$20240725$20240803$20240803$EXP$FR-AFSSAPS-NT2024000898$FR-BAXTER-2024BAX022280$BAXTER$$47$YR$$F$Y$$$20240803$$MD$FR$FR
241698441$24169844$1$I$20240716$20240724$20240803$20240803$EXP$CN-NMPACDR-3307811059962202400162$CN-BAXTER-2024BAX022344$BAXTER$$40$YR$$M$Y$60$KG$20240803$$MD$CN$CN
241698451$24169845$1$I$$20240730$20240803$20240803$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121876$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240803$$MD$JP$JP
241698471$24169847$1$I$20240725$20240801$20240803$20240803$PER$$US-JNJFOC-20240803424$JOHNSON AND JOHNSON$$$$$F$Y$$$20240803$$HP$US$US
241698481$24169848$1$I$20240619$20240725$20240803$20240803$EXP$FR-AFSSAPS-GR2024000952$FR-BAXTER-2024BAX022278$BAXTER$$70$YR$$M$Y$$$20240803$$PH$FR$FR
241698491$24169849$1$I$20240101$20240729$20240803$20240803$EXP$$US-ABBVIE-5860176$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241698502$24169850$2$F$20240215$20240826$20240803$20240903$EXP$$CN-BAXTER-2024BAX013648$BAXTER$$55$YR$$M$Y$60$KG$20240903$$MD$CN$CN
241698511$24169851$1$I$$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024152205$AMGEN$$$$$$Y$$$20240802$$HP$US$US
241698521$24169852$1$I$$20240723$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-037911$AUROBINDO$Gupta A, Wojnowski K, Gurung P.. Mucormycosis - A Rare Etiology of Empyema Nessisitans. AmJ-Respir-Crit-Care-Med. 2024;209:A2386$55$YR$$M$Y$$$20240803$$HP$US$US
241698531$24169853$1$I$20220101$20240730$20240803$20240803$EXP$$US-ABBVIE-5860898$ABBVIE$$$$$M$Y$83.914$KG$20240803$$CN$US$US
241698541$24169854$1$I$$20240730$20240803$20240803$EXP$$US-ABBVIE-5861096$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241698552$24169855$2$F$20240523$20240819$20240803$20240829$EXP$$US-BAXTER-2024BAX022247$BAXTER$$67$YR$$M$Y$79.016$KG$20240829$$MD$US$US
241698561$24169856$1$I$20240425$20240723$20240803$20240803$EXP$$FR-AUROBINDO-AUR-APL-2024-036867$AUROBINDO$$87$YR$$M$Y$98$KG$20240803$$MD$FR$FR
241698571$24169857$1$I$20240101$20240730$20240803$20240803$EXP$$US-ABBVIE-5861936$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241698581$24169858$1$I$$20240730$20240803$20240803$EXP$$US-ABBVIE-5863195$ABBVIE$$$$$M$Y$$$20240803$$HP$US$US
241698591$24169859$1$I$$20240731$20240803$20240803$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122736$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240803$$CN$US$US
241698601$24169860$1$I$20240101$20240731$20240803$20240803$EXP$$US-ABBVIE-5863171$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241698611$24169861$1$I$$20240723$20240803$20240803$EXP$$GB-AUROBINDO-AUR-APL-2024-037134$AUROBINDO$$83$YR$$F$Y$$$20240803$$PH$GB$GB
241698621$24169862$1$I$20240201$20240723$20240803$20240803$EXP$$DE-AUROBINDO-AUR-APL-2024-037375$AUROBINDO$$1$DY$$M$Y$3.905$KG$20240803$$MD$DE$DE
241698631$24169863$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226661$TEVA$$16$YR$$F$Y$$$20240803$$PH$CA$CA
241698641$24169864$1$I$20240705$20240726$20240803$20240803$EXP$$US-JNJFOC-20240721456$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240803$$CN$US$US
241698652$24169865$2$F$20240725$20240801$20240803$20240808$PER$$US-ROCHE-10000046186$ROCHE$$$$$F$Y$93.44$KG$20240808$$CN$US$US
241698661$24169866$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226648$TEVA$$50$YR$$M$Y$$$20240803$$HP$CA$CA
241698671$24169867$1$I$20240101$20240731$20240803$20240803$PER$$US-SA-2024SA227765$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240803$$MD$US$US
241698692$24169869$2$F$20240101$20240823$20240803$20240831$EXP$$CA-ABBVIE-5862576$ABBVIE$$18$YR$$F$Y$$$20240831$$CN$CA$CA
241698701$24169870$1$I$20240101$20240730$20240803$20240803$EXP$$CA-ABBVIE-5862580$ABBVIE$$54$YR$$M$Y$$$20240803$$CN$CA$CA
241698711$24169871$1$I$$20240801$20240803$20240803$PER$$US-ROCHE-10000047225$ROCHE$$$$A$F$Y$$$20240803$$CN$US$US
241698732$24169873$2$F$$20240729$20240803$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-037622$AUROBINDO$Salvado CA, Tojal A, Alves H, Fidalgo M.. CO-0176 - (4530) - A rare case of Sporopachydermia cereana infection. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional de Medicina Interna. Livro de resumos ( Book of abstracts). 2024;276-276$48$YR$$F$Y$$$20240809$$HP$PT$PT
241698741$24169874$1$I$$20240724$20240803$20240803$EXP$$DE-AUROBINDO-AUR-APL-2024-036096$AUROBINDO$$90$YR$$F$Y$$$20240803$$PH$DE$DE
241698753$24169875$3$F$$20240829$20240803$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-037336$AUROBINDO$Kordy F, Nashid N, Khan S, Read S, Macdougall G, Louch D, et al.. Video directly observed therapy to improve adherence of human immunodeficiency virus infected adolescents to combination antiretroviral therapy: a proof-of-concept study.. AIDS Care Psychological and Socio-medical Aspects of AIDS/HIV.. 2023;35:3:417-424$16$YR$$F$Y$$$20240909$$HP$CA$CA
241698762$24169876$2$F$20220312$20240905$20240803$20240914$EXP$$JP-AMGEN-HZN-2022-003069$AMGEN$$38$YR$A$M$Y$80.2$KG$20240914$$HP$JP$JP
241698771$24169877$1$I$20240731$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024152843$AMGEN$$19$YR$A$F$Y$$$20240803$$CN$US$US
241698781$24169878$1$I$20240101$20240729$20240803$20240803$PER$$US-SA-2024SA227354$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240803$$MD$US$US
241698791$24169879$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA226757$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240803$$MD$US$US
241698801$24169880$1$I$20240501$20240726$20240803$20240803$PER$$US-SA-2024SA225052$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240803$$MD$US$US
241698811$24169881$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA228113$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240803$$MD$US$US
241698821$24169882$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA226756$SANOFI AVENTIS$$$$A$M$Y$$$20240803$$CN$US$US
241698831$24169883$1$I$$20240721$20240803$20240803$EXP$$US-GTI-000256$Granulation Technology, INC$$76$YR$E$M$Y$$$20240724$$MD$US$US
241698841$24169884$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038517$AUROBINDO$$53$YR$$M$Y$$$20240803$$HP$CA$CA
241698853$24169885$3$F$20240101$20240919$20240803$20240928$EXP$$CA-CELLTRION INC.-2023CA024900$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
241698861$24169886$1$I$$20240722$20240803$20240803$PER$$US-TEVA-VS-3225937$TEVA$$66$YR$$M$Y$$$20240803$$CN$US$US
241698871$24169887$1$I$$20240725$20240803$20240803$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120849$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240803$$CN$US$US
241698881$24169888$1$I$20200101$20240730$20240803$20240803$EXP$$US-ABBVIE-5861576$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241698891$24169889$1$I$20240701$20240727$20240803$20240803$EXP$GB-MHRA-MED-202407271347329580-PZMJK$GB-TEVA-VS-3227152$TEVA$$63$YR$$F$Y$$$20240803$$CN$GB$GB
241698901$24169890$1$I$20170601$20240723$20240803$20240803$EXP$$US-ABBVIE-5855846$ABBVIE$$61$YR$$M$Y$77$KG$20240803$$CN$US$US
241698911$24169891$1$I$$20240726$20240803$20240803$PER$$US-ROCHE-10000039965$ROCHE$$$$$$Y$$$20240803$$PH$US$US
241698924$24169892$4$F$20140101$20240905$20240803$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-037420$AUROBINDO$Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs). pharmacological intolerance vs Ig E-mediated allergy. 2024;49:5-6$39$YR$$$Y$$$20240918$$HP$FR$FR
241698932$24169893$2$F$$20240730$20240803$20240806$PER$$US-ROCHE-10000038385$ROCHE$$$$A$F$Y$$$20240806$$CN$US$US
241698951$24169895$1$I$$20240722$20240803$20240803$PER$$US-TEVA-VS-3223321$TEVA$$75$YR$$F$Y$58.97$KG$20240803$$CN$US$US
241698961$24169896$1$I$20240701$20240726$20240803$20240803$EXP$$US-JNJFOC-20240768694$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240803$$CN$US$US
241698982$24169898$2$F$20240724$20240802$20240803$20240812$EXP$$US-GSK-US2024AMR094447$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240812$$CN$US$US
241698991$24169899$1$I$20240707$20240726$20240803$20240803$EXP$$BR-CELLTRION INC.-2024BR017800$CELLTRION$$$$$$Y$$$20240803$$CN$BR$BR
241699003$24169900$3$F$$20240913$20240803$20240926$EXP$$ES-AUROBINDO-AUR-APL-2024-037004$AUROBINDO$Romero Carratala M, P?rez de Amezaga Tom?s L, Sala Carazo M, Rialp Cervera G. Meropenem for the management of valproic acid intoxication: a case report and a review of the literature. Medicina intensiva. 2024;2058:1-3$59$YR$$F$Y$$$20240926$$PH$ES$ES
241699011$24169901$1$I$20240701$20240729$20240803$20240803$PER$$US-ROCHE-10000044188$ROCHE$$69$YR$E$F$Y$77.11$KG$20240803$$CN$US$US
241699021$24169902$1$I$20240101$20240729$20240803$20240803$PER$$US-SA-2024SA226734$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240803$$MD$US$US
241699031$24169903$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA226880$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240803$$MD$US$US
241699041$24169904$1$I$20240101$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024151457$AMGEN$$71$YR$E$F$Y$$$20240803$$HP$US$US
241699061$24169906$1$I$$20240731$20240803$20240803$PER$$US-ROCHE-10000046149$ROCHE$$$$$$Y$$$20240803$$CN$US$US
241699081$24169908$1$I$20240108$20240723$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-038269$AUROBINDO$$56$YR$$F$Y$$$20240803$$CN$US$US
241699091$24169909$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA223859$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240803$$CN$US$US
241699101$24169910$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA226886$SANOFI AVENTIS$$$$C$M$Y$$$20240803$$MD$US$US
241699121$24169912$1$I$20240701$20240801$20240803$20240803$PER$$US-ROCHE-10000047167$ROCHE$$14$YR$T$M$Y$$$20240803$$CN$US$US
241699132$24169913$2$F$$20240802$20240803$20240806$PER$$US-ROCHE-10000047082$ROCHE$$79$YR$E$M$Y$$$20240806$$CN$US$US
241699141$24169914$1$I$$20240801$20240803$20240803$PER$$US-AMGEN-USASP2024153865$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241699151$24169915$1$I$20240723$20240801$20240803$20240803$PER$$US-ROCHE-10000047215$ROCHE$$8$YR$C$M$Y$$$20240803$$CN$US$US
241699162$24169916$2$F$20240328$20240918$20240803$20240926$EXP$$IT-TEVA-VS-3224454$TEVA$$17$YR$$F$Y$$$20240926$$MD$IT$IT
241699171$24169917$1$I$$20240723$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-036978$AUROBINDO$Martin RD, Scanlon M, McCabe K.. Lidocaine-Associated CNS Toxicity at Therapeutic Dosage: A Case Report and Literature Review.. Cureus.. 2024;16(6):e62231$47$YR$$M$Y$133.9$KG$20240803$$MD$US$US
241699181$24169918$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226844$TEVA$$4$YR$$M$Y$16$KG$20240803$$PH$CA$CA
241699192$24169919$2$F$20230101$20240730$20240803$20240807$EXP$$KR-ABBVIE-5859896$ABBVIE$$23$YR$$M$Y$69$KG$20240807$$MD$KR$KR
241699202$24169920$2$F$20240718$20240802$20240803$20240806$PER$$US-AMGEN-USASP2024154180$AMGEN$$57$YR$A$F$Y$$$20240806$$CN$US$US
241699211$24169921$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-037906$AUROBINDO$$$$$F$Y$$$20240803$$HP$CA$CA
241699221$24169922$1$I$20240101$20240731$20240803$20240803$EXP$$CA-ABBVIE-5802162$ABBVIE$$69$YR$$F$Y$$$20240803$$CN$CA$CA
241699231$24169923$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226692$TEVA$$15$YR$$F$Y$$$20240803$$HP$CA$CA
241699241$24169924$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA227565$SANOFI AVENTIS$$$$T$F$Y$58.967$KG$20240803$$MD$US$US
241699251$24169925$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2023-031352$AUROBINDO$$$$$$Y$$$20240803$$CN$CA$CA
241699261$24169926$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA227715$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240803$$CN$US$US
241699271$24169927$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA223866$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240803$$CN$US$US
241699281$24169928$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226668$TEVA$$10$YR$$M$Y$$$20240803$$HP$CA$CA
241699291$24169929$1$I$$20240720$20240803$20240803$EXP$$IT-UCBSA-2024037977$UCB$$$$E$F$Y$$$20240803$$CN$IT$IT
241699301$24169930$1$I$$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024152281$AMGEN$$$$$$Y$$$20240803$$PH$US$US
241699311$24169931$1$I$20240501$20240730$20240803$20240803$PER$$US-SA-2024SA227875$SANOFI AVENTIS$$30$YR$A$F$Y$70.3$KG$20240803$$MD$US$US
241699321$24169932$1$I$20240617$20240722$20240803$20240803$PER$$US-TEVA-VS-3224355$TEVA$$75$YR$$F$Y$$$20240803$$CN$US$US
241699331$24169933$1$I$$20240730$20240803$20240803$PER$$US-ROCHE-10000044881$ROCHE$$$$$$Y$178$KG$20240803$$HP$US$US
241699341$24169934$1$I$$20240726$20240803$20240803$PER$$US-ROCHE-10000038716$ROCHE$$6$YR$C$M$Y$$$20240803$$MD$US$US
241699351$24169935$1$I$$20240725$20240803$20240803$EXP$$GB-TEVA-VS-3226144$TEVA$$40$YR$$M$Y$105$KG$20240803$$MD$GB$GB
241699362$24169936$2$F$20240725$20240904$20240803$20240909$PER$$US-ROCHE-10000040116$ROCHE$$28$YR$A$F$Y$61.23$KG$20240909$$CN$US$US
241699373$24169937$3$F$$20240910$20240803$20240912$PER$$US-ROCHE-10000043490$ROCHE$$6$YR$C$M$Y$$$20240912$$HP$US$US
241699381$24169938$1$I$$20240801$20240803$20240803$PER$$US-ROCHE-10000046032$ROCHE$$12$YR$T$M$Y$$$20240803$$CN$US$US
241699391$24169939$1$I$$20240801$20240803$20240803$PER$$US-JNJFOC-20240806272$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240803$$HP$US$US
241699401$24169940$1$I$$20240731$20240803$20240803$EXP$$CA-ROCHE-10000047048$ROCHE$$$$A$F$Y$$$20240803$$HP$CA$CA
241699411$24169941$1$I$20240731$20240801$20240803$20240803$PER$$US-AMGEN-USASP2024153889$AMGEN$$$$$$Y$$$20240803$$HP$US$US
241699421$24169942$1$I$$20240731$20240803$20240803$PER$$US-BEH-2024176679$CSL BEHRING$$60$YR$A$F$Y$$$20240803$$CN$US$US
241699431$24169943$1$I$$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024152372$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241699441$24169944$1$I$$20240726$20240803$20240803$PER$$US-JNJFOC-20240776981$JOHNSON AND JOHNSON$$$$$F$Y$$$20240803$$HP$US$US
241699451$24169945$1$I$$20240801$20240803$20240803$PER$$US-ROCHE-10000047405$ROCHE$$$$$F$Y$$$20240803$$CN$US$US
241699461$24169946$1$I$$20240731$20240803$20240803$PER$$US-ROCHE-10000046558$ROCHE$$$$A$F$Y$$$20240803$$HP$US$US
241699474$24169947$4$F$$20240901$20240803$20240910$EXP$$US-ROCHE-10000047525$ROCHE$$$$A$M$Y$$$20240910$$CN$US$US
241699481$24169948$1$I$$20240730$20240803$20240803$EXP$$US-ABBVIE-5862573$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241699491$24169949$1$I$$20240725$20240803$20240803$EXP$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-003437$PHARMAESSENTIA$$$$$F$Y$$$20240803$$CN$US$US
241699511$24169951$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038484$AUROBINDO$$$$$F$Y$$$20240803$$HP$CA$CA
241699521$24169952$1$I$$20240722$20240803$20240803$PER$$US-TEVA-VS-3226214$TEVA$$$$$$Y$$$20240803$$CN$US$US
241699531$24169953$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038464$AUROBINDO$$87$YR$$F$Y$$$20240803$$CN$CA$CA
241699541$24169954$1$I$$20240726$20240803$20240803$PER$$US-AstraZeneca-2024A171570$ASTRAZENECA$$$$$M$Y$$$20240803$$CN$US$
241699551$24169955$1$I$$20240725$20240803$20240803$EXP$$US-GSK-US2024AMR096087$GLAXOSMITHKLINE$$$$$$Y$$$20240803$$HP$US$US
241699561$24169956$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038513$AUROBINDO$$38$YR$$M$Y$80.73$KG$20240803$$CN$CA$CA
241699571$24169957$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038535$AUROBINDO$$25$YR$$F$Y$55$KG$20240803$$HP$CA$CA
241699581$24169958$1$I$$20240729$20240803$20240803$PER$$US-AMGEN-USASP2024150900$AMGEN$$$$$F$Y$$$20240803$$CN$US$US
241699591$24169959$1$I$20240715$20240724$20240803$20240803$EXP$CN-NMPACDR-3205051723546202400424$CN-BAXTER-2024BAX022364$BAXTER$$75$YR$$F$Y$68$KG$20240803$$MD$CN$CN
241699601$24169960$1$I$20240713$20240724$20240803$20240803$EXP$CN-NMPACDR-4403051928901202400430$CN-BAXTER-2024BAX022346$BAXTER$$83$YR$$M$Y$50$KG$20240803$$MD$CN$CN
241699611$24169961$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038538$AUROBINDO$$48$YR$$M$Y$$$20240803$$HP$CA$CA
241699621$24169962$1$I$20240101$20240730$20240803$20240803$EXP$$US-ABBVIE-5861202$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241699631$24169963$1$I$$20240730$20240803$20240803$EXP$$US-ABBVIE-5864081$ABBVIE$$$$$F$Y$$$20240803$$HP$US$US
241699642$24169964$2$F$$20240828$20240803$20240830$PER$$US-ROCHE-10000038419$ROCHE$$$$$$Y$$$20240830$$HP$US$US
241699651$24169965$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-037840$AUROBINDO$$73$YR$$F$Y$$$20240803$$HP$CA$CA
241699661$24169966$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA225479$SANOFI AVENTIS$$$$C$F$Y$$$20240803$$MD$US$US
241699672$24169967$2$F$20240708$20240916$20240803$20240924$PER$$US-SA-2024SA228045$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240924$$MD$US$US
241699682$24169968$2$F$$20240801$20240803$20240807$EXP$$US-ABBVIE-5862551$ABBVIE$$$$$M$Y$$$20240807$$HP$US$US
241699691$24169969$1$I$20231218$20240724$20240803$20240803$EXP$$FR-AUROBINDO-AUR-APL-2024-037726$AUROBINDO$$32$YR$$F$Y$100$KG$20240803$$MD$FR$FR
241699701$24169970$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038571$AUROBINDO$$69$YR$$F$Y$85$KG$20240803$$HP$CA$CA
241699713$24169971$3$F$20240528$20240911$20240803$20240926$EXP$$PT-BAXTER-2024BAX019723$BAXTER$$68$YR$$M$Y$100.8$KG$20240926$$MD$PT$PT
241699721$24169972$1$I$20240728$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024152748$AMGEN$$74$YR$E$F$Y$$$20240803$$CN$US$US
241699732$24169973$2$F$20240725$20240805$20240803$20240810$EXP$$MX-ROCHE-10000042296$ROCHE$$77$YR$E$M$Y$95$KG$20240810$$MD$MX$MX
241699742$24169974$2$F$$20240725$20240803$20240806$EXP$DE-EMBRYOTOX-202307987$DE-ABBVIE-5861990$ABBVIE$$$$$F$Y$$$20240806$$MD$DE$DE
241699751$24169975$1$I$20240628$20240726$20240803$20240803$EXP$$US-AMGEN-USASP2024150557$AMGEN$$82$YR$E$F$Y$$$20240803$$HP$US$US
241699771$24169977$1$I$$20240730$20240803$20240803$PER$$US-ABBVIE-5861305$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241699782$24169978$2$F$20240726$20240802$20240803$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-023110$UNITED THERAPEUTICS$$36$YR$$F$Y$$$20240809$$$US$US
241699794$24169979$4$F$20240701$20240822$20240803$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021671$UNITED THERAPEUTICS$$58$YR$$F$Y$70.295$KG$20240830$$$US$US
241699801$24169980$1$I$$20240719$20240803$20240803$PER$$US-TEVA-VS-3224219$TEVA$$$$$$Y$$$20240803$$MD$US$US
241699811$24169981$1$I$$20240731$20240803$20240803$PER$$US-SA-2024SA227795$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240803$$MD$US$US
241699821$24169982$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA226896$SANOFI AVENTIS$$$$A$F$Y$$$20240803$$MD$US$US
241699831$24169983$1$I$$20240731$20240803$20240803$PER$$US-SA-2024SA228980$SANOFI AVENTIS$$$$A$F$Y$$$20240803$$MD$US$US
241699841$24169984$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA224361$SANOFI AVENTIS$$$$A$M$Y$$$20240803$$MD$US$US
241699851$24169985$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA228976$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240803$$MD$US$US
241699861$24169986$1$I$20240724$20240725$20240803$20240803$EXP$GB-MHRA-MED-202407251110014900-GYJZH$GB-BAXTER-2024BAX022369$BAXTER$$80$YR$$F$Y$$$20240803$$PH$GB$GB
241699871$24169987$1$I$$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024151173$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241699881$24169988$1$I$20240101$20240719$20240803$20240803$PER$$US-TEVA-VS-3224657$TEVA$$28$YR$$M$Y$$$20240803$$HP$US$US
241699891$24169989$1$I$20240101$20240726$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-021678$UNITED THERAPEUTICS$$$$$F$Y$77.098$KG$20240803$$$US$US
241699901$24169990$1$I$20240712$20240725$20240803$20240803$PER$$US-ABBVIE-5860394$ABBVIE$$40$YR$$M$Y$$$20240803$$HP$US$US
241699911$24169991$1$I$20240712$20240726$20240803$20240803$EXP$FR-AFSSAPS-CN2024000710$FR-AMGEN-FRASP2024149329$AMGEN$$70$YR$E$F$Y$52$KG$20240803$$MD$FR$FR
241699921$24169992$1$I$$20240724$20240803$20240803$EXP$$ES-AUROBINDO-AUR-APL-2024-037534$AUROBINDO$$$$$$Y$$$20240803$$MD$ES$ES
241699931$24169993$1$I$20240523$20240724$20240803$20240803$EXP$$FR-AUROBINDO-AUR-APL-2024-037717$AUROBINDO$$26$YR$$M$Y$$$20240803$$PH$FR$FR
241699941$24169994$1$I$$20240722$20240803$20240803$EXP$$IN-MACLEODS PHARMA-MAC2024048529$MACLEODS$Jain D, Dash S.Pancytopenia due to extensive hemophagocytosis following anti-tubercular treatment.American journal of hematology.2004;75(2):118-9$$$$$Y$$$20240803$$HP$IN$IN
241699952$24169995$2$F$$20240725$20240803$20240821$PER$$US-BEH-2024176702$CSL BEHRING$$$$$$Y$$$20240821$$PH$US$US
241699963$24169996$3$F$20240101$20240729$20240803$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-022807$UNITED THERAPEUTICS$$$$$F$Y$66.213$KG$20240807$$$US$US
241699971$24169997$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3227344$TEVA$$85$YR$$M$Y$90$KG$20240803$$HP$CA$CA
241699981$24169998$1$I$$20240725$20240803$20240803$30DAY$$US-GSK-US2024093763$GLAXOSMITHKLINE$$$$$$Y$$$20240803$$HP$US$US
241699991$24169999$1$I$20240725$20240725$20240803$20240803$PER$$US-ABBVIE-5856886$ABBVIE$$45$YR$$F$Y$$$20240803$$MD$US$US
241700011$24170001$1$I$$20240726$20240803$20240803$EXP$$GB-TEVA-VS-3226481$TEVA$$30$YR$$M$Y$76$KG$20240803$$MD$GB$GB
241700031$24170003$1$I$20240727$20240729$20240803$20240803$EXP$$CA-ABBVIE-5862400$ABBVIE$$67$YR$$M$Y$$$20240803$$CN$CA$CA
241700053$24170005$3$F$$20240903$20240803$20240909$PER$$US-ABBVIE-5864492$ABBVIE$$$$$$Y$$$20240909$$MD$US$US
241700061$24170006$1$I$$20240730$20240803$20240803$EXP$$IL-ABBVIE-5862291$ABBVIE$$$$$M$Y$$$20240803$$CN$IL$IL
241700071$24170007$1$I$$20240726$20240803$20240803$PER$$US-ABBVIE-5858846$ABBVIE$$$$$$Y$$$20240803$$CN$US$US
241700081$24170008$1$I$$20240801$20240803$20240803$PER$$US-ELI_LILLY_AND_COMPANY-US202408000954$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240803$$CN$US$US
241700091$24170009$1$I$20240101$20240726$20240803$20240803$PER$$US-AstraZeneca-2024A171949$ASTRAZENECA$$61$YR$$$Y$$$20240803$$CN$US$
241700101$24170010$1$I$20240729$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024152131$AMGEN$$$$$$Y$$$20240803$$PH$US$US
241700114$24170011$4$F$20240101$20240829$20240803$20240925$PER$$US-SA-2024SA227720$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240925$$MD$US$US
241700121$24170012$1$I$20240715$20240725$20240803$20240803$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02738$AMNEAL$$77$YR$$M$Y$$$20240803$$CN$US$US
241700131$24170013$1$I$20240101$20240729$20240803$20240803$PER$$US-SA-2024SA227714$SANOFI AVENTIS$$37$YR$A$F$Y$89.35$KG$20240803$$MD$US$US
241700141$24170014$1$I$$20240801$20240803$20240803$PER$$US-JNJFOC-20240807531$JOHNSON AND JOHNSON$$$$$F$Y$$$20240803$$HP$US$US
241700151$24170015$1$I$$20240725$20240803$20240803$30DAY$$US-GSK-US2024093729$GLAXOSMITHKLINE$$$$$M$Y$$$20240803$$HP$US$US
241700161$24170016$1$I$$20240731$20240803$20240803$PER$$NVSC2024US157981$NOVARTIS$$$$$F$Y$$$20240803$$MD$US$US
241700171$24170017$1$I$20240101$20240731$20240803$20240803$PER$$US-SA-2024SA227825$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240803$$MD$US$US
241700181$24170018$1$I$$20240731$20240803$20240803$PER$$NVSC2024US157480$NOVARTIS$$$$$$Y$$$20240803$$CN$US$US
241700193$24170019$3$F$20240730$20240904$20240803$20240913$30DAY$$US-JNJFOC-20240785421$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240913$$PH$US$US
241700201$24170020$1$I$20240101$20240730$20240803$20240803$EXP$$US-ABBVIE-5861459$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241700213$24170021$3$F$20230101$20240917$20240803$20240923$EXP$$US-ABBVIE-5859279$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
241700221$24170022$1$I$$20240724$20240803$20240803$EXP$$JP-ROCHE-10000042229$ROCHE$$$$E$M$Y$$$20240803$$MD$JP$JP
241700231$24170023$1$I$20240713$20240725$20240803$20240803$EXP$$ES-AUROBINDO-AUR-APL-2024-037701$AUROBINDO$$89$YR$$M$Y$90$KG$20240803$$MD$ES$ES
241700243$24170024$3$F$20240715$20240823$20240803$20240827$EXP$$DE-JNJFOC-20240745427$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240827$$HP$DE$DE
241700251$24170025$1$I$$20240724$20240803$20240803$EXP$$CA-TEVA-VS-3226568$TEVA$$53$YR$$M$Y$$$20240803$$CN$CA$CA
241700261$24170026$1$I$$20240731$20240803$20240803$EXP$$US-ABBVIE-5863132$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241700271$24170027$1$I$$20240801$20240803$20240803$PER$$US-ABBVIE-5864458$ABBVIE$$$$$$Y$$$20240803$$CN$US$US
241700281$24170028$1$I$20240101$20240730$20240803$20240803$EXP$$US-ABBVIE-5861924$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241700293$24170029$3$F$20240101$20240827$20240803$20240902$EXP$$US-ABBVIE-5863188$ABBVIE$$$$$M$Y$53.523$KG$20240902$$CN$US$US
241700301$24170030$1$I$$20240730$20240803$20240803$EXP$$US-ABBVIE-5863058$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241700311$24170031$1$I$$20240726$20240803$20240803$EXP$GB-MHRA-MED-202407260940522970-MBTYF$GB-TEVA-VS-3226382$TEVA$$$$$F$Y$$$20240803$$HP$GB$GB
241700323$24170032$3$F$20240630$20240826$20240803$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020458$UNITED THERAPEUTICS$$60$YR$$F$Y$66.213$KG$20240830$$PH$US$US
241700331$24170033$1$I$20240101$20240724$20240803$20240803$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023018$UNITED THERAPEUTICS$$$$$F$Y$69.388$KG$20240803$$$US$US
241700342$24170034$2$F$20240101$20240903$20240803$20240904$EXP$$CA-ABBVIE-5824258$ABBVIE$$71$YR$$M$Y$$$20240904$$CN$CA$CA
241700351$24170035$1$I$20231010$20240726$20240803$20240803$EXP$$JP-ROCHE-3443148$ROCHE$$77$YR$E$M$Y$73$KG$20240803$$MD$JP$JP
241700361$24170036$1$I$$20240729$20240803$20240803$PER$$US-AMGEN-USASP2024150834$AMGEN$$$$$$Y$$$20240803$$PH$US$US
241700371$24170037$1$I$20240723$20240726$20240803$20240803$EXP$$GB-TEVA-VS-3226496$TEVA$$42$YR$$M$Y$82$KG$20240803$$HP$GB$GB
241700381$24170038$1$I$20240729$20240730$20240803$20240803$PER$$US-SA-2024SA227388$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240803$$CN$US$US
241700391$24170039$1$I$20240701$20240726$20240803$20240803$PER$$US-SA-2024SA225573$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240803$$MD$US$US
241700401$24170040$1$I$$20240731$20240803$20240803$EXP$$US-ABBVIE-5863016$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241700411$24170041$1$I$20240727$20240727$20240803$20240803$PER$$US-SA-2024SA224388$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240803$$MD$US$US
241700421$24170042$1$I$20210101$20240731$20240803$20240803$EXP$$BR-ABBVIE-5862444$ABBVIE$$$$$M$Y$89$KG$20240803$$CN$BR$BR
241700432$24170043$2$F$$20240813$20240803$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-038290$AUROBINDO$Mah J, Lieu A, Heck E, Quickfall D, Ugarte-Torres A.. Primary varicella in 2 adult immigrants to Canada. CMAJ. 2023;195(8):E300-3$52$YR$$M$Y$$$20240823$$HP$CA$CA
241700441$24170044$1$I$$20240730$20240803$20240803$PER$$US-ABBVIE-5862981$ABBVIE$$$$$$Y$$$20240803$$CN$US$US
241700451$24170045$1$I$$20230705$20240803$20240803$PER$$US-AUROBINDO-AUR-APL-2023-047124$AUROBINDO$$$$A$F$Y$$$20240803$$MD$US$US
241700461$24170046$1$I$$20230717$20240803$20240803$PER$$US-AUROBINDO-AUR-APL-2023-049580$AUROBINDO$$$$$F$Y$$$20240803$$MD$US$US
241700471$24170047$1$I$$20231107$20240803$20240803$PER$$US-AUROBINDO-AUR-APL-2023-056732$AUROBINDO$$$$A$F$Y$$$20240803$$MD$US$US
241700481$24170048$1$I$20240407$20240726$20240803$20240803$EXP$$US-TAKEDA-2024TUS034994$TAKEDA$$63$YR$$F$Y$56$KG$20240803$$CN$US$US
241700491$24170049$1$I$$20240112$20240803$20240803$PER$$US-AUROBINDO-AUR-APL-2024-002656$AUROBINDO$$$$A$F$Y$$$20240803$$MD$US$US
241700511$24170051$1$I$20240714$20240801$20240803$20240803$EXP$$FR-ABBVIE-5864734$ABBVIE$$60$YR$$M$Y$73$KG$20240803$$MD$FR$FR
241700521$24170052$1$I$$20240412$20240803$20240803$PER$$US-AUROBINDO-AUR-APL-2024-016893$AUROBINDO$$$$$M$Y$$$20240803$$HP$US$US
241700531$24170053$1$I$$20240412$20240803$20240803$PER$$US-AUROBINDO-AUR-APL-2024-017026$AUROBINDO$$$$$$Y$$$20240803$$HP$US$US
241700544$24170054$4$F$20240101$20240903$20240803$20240912$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023115$UNITED THERAPEUTICS$$$$$M$Y$74.83$KG$20240912$$$US$US
241700551$24170055$1$I$$20240610$20240803$20240803$PER$$US-AUROBINDO-AUR-APL-2024-029910$AUROBINDO$$$$A$F$Y$$$20240803$$MD$US$US
241700561$24170056$1$I$$20240731$20240803$20240803$EXP$$CA-ABBVIE-5863940$ABBVIE$$$$A$F$Y$$$20240803$$CN$CA$CA
241700571$24170057$1$I$$20240112$20240803$20240803$PER$$US-AUROBINDO-AUR-APL-2024-003117$AUROBINDO$$$$A$F$Y$$$20240803$$MD$US$US
241700581$24170058$1$I$$20240618$20240803$20240803$PER$$US-AUROBINDO-AUR-APL-2024-031250$AUROBINDO$$$$E$F$Y$$$20240803$$MD$US$US
241700591$24170059$1$I$20230101$20240730$20240803$20240803$EXP$FR-AFSSAPS-RS2024000700$FR-ROCHE-10000042200$ROCHE$$78$YR$E$M$Y$71$KG$20240803$$MD$FR$FR
241700601$24170060$1$I$20240718$20240729$20240803$20240803$PER$$US-BEH-2024176558$CSL BEHRING$$41$YR$A$F$Y$$$20240803$$HP$US$US
241700611$24170061$1$I$$20240731$20240803$20240803$EXP$$US-ABBVIE-5864005$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241700621$24170062$1$I$$20240726$20240803$20240803$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02748$AMNEAL$$$$$M$Y$$$20240803$$CN$US$US
241700631$24170063$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA116977$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240803$$MD$US$US
241700641$24170064$1$I$20190101$20240730$20240803$20240803$PER$$US-SA-2024SA226669$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240803$$CN$US$US
241700653$24170065$3$F$20240724$20240906$20240803$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023142$UNITED THERAPEUTICS$$51$YR$$M$Y$95.238$KG$20240914$$$US$US
241700661$24170066$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA227384$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240803$$MD$US$US
241700672$24170067$2$F$$20240731$20240803$20240809$PER$$US-SA-2024SA227826$SANOFI AVENTIS$$77$YR$E$F$Y$43.084$KG$20240809$$MD$US$US
241700681$24170068$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA224105$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240803$$MD$US$US
241700691$24170069$1$I$20240720$20240730$20240803$20240803$EXP$$US-ROCHE-10000043047$ROCHE$$55$YR$A$M$Y$$$20240803$$CN$US$US
241700701$24170070$1$I$20240401$20240729$20240803$20240803$EXP$$BR-ROCHE-10000042480$ROCHE$$73$YR$E$M$Y$$$20240803$$MD$BR$BR
241700712$24170071$2$F$$20240830$20240803$20240909$EXP$$JP-ROCHE-10000047107$ROCHE$$8$DEC$E$$Y$$$20240909$$MD$JP$JP
241700721$24170072$1$I$20240726$20240726$20240803$20240803$PER$$US-AstraZeneca-2024A171756$ASTRAZENECA$$$$A$F$Y$$$20240803$$HP$US$
241700732$24170073$2$F$20240101$20240824$20240803$20240828$EXP$$US-ABBVIE-5864362$ABBVIE$$80$YR$$F$Y$53$KG$20240828$$CN$US$US
241700741$24170074$1$I$20240101$20240731$20240803$20240803$EXP$$US-ABBVIE-5863771$ABBVIE$$$$$M$Y$$$20240803$$HP$US$US
241700751$24170075$1$I$20240401$20240726$20240803$20240803$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011464$UNITED THERAPEUTICS$$73$YR$$F$Y$74.376$KG$20240803$$$US$US
241700761$24170076$1$I$20240701$20240731$20240803$20240803$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023138$UNITED THERAPEUTICS$$19$YR$$F$Y$$$20240803$$$US$US
241700771$24170077$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038057$AUROBINDO$$93$YR$$F$Y$$$20240803$$HP$CA$CA
241700781$24170078$1$I$20240228$20240730$20240803$20240803$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00762$AMNEAL$$52$YR$$F$Y$$$20240803$$CN$US$US
241700791$24170079$1$I$20240729$20240801$20240803$20240803$PER$$US-JNJFOC-20240803752$JOHNSON AND JOHNSON$$$$$$Y$$$20240803$$CN$US$US
241700801$24170080$1$I$$20240801$20240803$20240803$EXP$$US-ABBVIE-5865376$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241700814$24170081$4$F$20240101$20240814$20240803$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-021852$UNITED THERAPEUTICS$$$$$F$Y$51.973$KG$20240820$$$US$US
241700821$24170082$1$I$20230501$20240730$20240803$20240803$EXP$$NVSC2024ZA156093$NOVARTIS$$73$YR$$M$Y$$$20240803$$HP$ZA$ZA
241700831$24170083$1$I$20240701$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024152714$AMGEN$$$$$$Y$$$20240803$$HP$US$US
241700841$24170084$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038477$AUROBINDO$$42$YR$$F$Y$$$20240803$$HP$CA$CA
241700852$24170085$2$F$20220101$20240812$20240803$20240821$EXP$$NO-ABBVIE-5865594$ABBVIE$$30$YR$$F$Y$$$20240821$$CN$NO$NO
241700861$24170086$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038559$AUROBINDO$$60$YR$$F$Y$$$20240803$$HP$CA$CA
241700871$24170087$1$I$20240727$20240801$20240803$20240803$PER$$US-AMGEN-USASP2024153860$AMGEN$$$$$$Y$$$20240803$$HP$US$US
241700883$24170088$3$F$20240731$20240813$20240803$20240814$PER$$US-AMGEN-USASP2024153948$AMGEN$$32$YR$A$F$Y$$$20240814$$CN$US$US
241700891$24170089$1$I$$20240801$20240803$20240803$PER$$US-ABBVIE-5865485$ABBVIE$$$$$F$Y$$$20240803$$HP$US$US
241700901$24170090$1$I$$20240801$20240803$20240803$EXP$$DE-ABBVIE-5865407$ABBVIE$$$$$$Y$$$20240803$$HP$DE$DE
241700911$24170091$1$I$$20240801$20240803$20240803$PER$$US-AMGEN-USASP2024153473$AMGEN$$$$$F$Y$$$20240803$$CN$US$US
241700922$24170092$2$F$$20240806$20240803$20240809$EXP$$US-AMGEN-USASL2023098614$AMGEN$$59$YR$A$F$Y$$$20240809$$CN$US$US
241700931$24170093$1$I$$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024151288$AMGEN$$$$$F$Y$$$20240803$$CN$US$US
241700941$24170094$1$I$$20240801$20240803$20240803$PER$$US-ABBVIE-5864866$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241700952$24170095$2$F$20240101$20240821$20240803$20240827$EXP$$CH-ABBVIE-5859170$ABBVIE$$38$YR$$F$Y$$$20240827$$PH$CH$CH
241700962$24170096$2$F$$20240918$20240803$20240920$EXP$$NVSC2024US155773$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
241700971$24170097$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA225080$SANOFI AVENTIS$$$$A$F$Y$$$20240803$$CN$US$US
241700981$24170098$1$I$20240502$20240723$20240803$20240803$EXP$$FR-AUROBINDO-AUR-APL-2024-036864$AUROBINDO$$87$YR$$M$Y$98$KG$20240803$$MD$FR$FR
241700991$24170099$1$I$$20240725$20240803$20240803$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024093574$VIIV$$$$$M$Y$$$20240803$$MD$US$US
241701001$24170100$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226609$TEVA$$65$YR$$F$Y$$$20240803$$MD$CA$CA
241701011$24170101$1$I$$20240729$20240803$20240803$PER$$US-AMGEN-USASP2024151685$AMGEN$$$$$$Y$$$20240803$$PH$US$US
241701021$24170102$1$I$20240730$20240801$20240803$20240803$PER$$US-AMGEN-USASP2024153879$AMGEN$$59$YR$A$F$Y$$$20240803$$CN$US$US
241701031$24170103$1$I$20240701$20240731$20240803$20240803$PER$$US-ABBVIE-5863487$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241701051$24170105$1$I$20240627$20240729$20240803$20240803$PER$$US-SA-2024SA227396$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240803$$MD$US$US
241701061$24170106$1$I$$20240723$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-037974$AUROBINDO$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients.. Arch-Dermatol-Res. 2024;316No. 5:194$$$$$Y$$$20240803$$HP$US$US
241701071$24170107$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038259$AUROBINDO$Love A, Jen R, Van Tongeren L, Ryan CF.. Rapid resolution of refractory hypoxemia and vascular spiders following liver transplantation. Can J Respir Crit Care Sleep Med. 2022;6(5):323-328$65$YR$$M$Y$$$20240803$$HP$CA$CA
241701081$24170108$1$I$20240708$20240725$20240803$20240803$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024093770$VIIV$$45$YR$$M$Y$$$20240803$$PH$US$US
241701091$24170109$1$I$$20240726$20240803$20240803$PER$$US-ABBVIE-5858368$ABBVIE$$$$$$Y$$$20240803$$CN$US$US
241701101$24170110$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038368$AUROBINDO$Farrell B, Galley E, Jeffs L, Howell P, McCarthy LM.. Kind of blurry: Deciphering clues to prevent, investigate and manage prescribing cascades.. PLOS-One. 2022;17 (8):1- 20$74$YR$$F$Y$$$20240803$$HP$CA$CA
241701112$24170111$2$F$20240101$20240802$20240803$20240820$EXP$$DE-AMGEN-DEUSP2024153377$AMGEN$$85$YR$E$F$Y$$$20240820$$MD$DE$DE
241701121$24170112$1$I$$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024152541$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241701131$24170113$1$I$$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024153042$AMGEN$$$$$F$Y$$$20240803$$MD$US$US
241701141$24170114$1$I$20240729$20240801$20240803$20240803$PER$$US-AMGEN-USASP2024154038$AMGEN$$$$$$Y$$$20240803$$PH$US$US
241701151$24170115$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038274$AUROBINDO$$71$YR$$M$Y$$$20240803$$HP$CA$CA
241701161$24170116$1$I$20240701$20240731$20240803$20240803$PER$$US-SA-2024SA228731$SANOFI AVENTIS$$$$A$F$Y$$$20240803$$HP$US$US
241701171$24170117$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA227398$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240803$$MD$US$US
241701181$24170118$1$I$$20240729$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-023653$UNITED THERAPEUTICS$$$$$M$Y$71.202$KG$20240803$$$US$US
241701193$24170119$3$F$20240101$20240830$20240803$20240903$PER$$US-AMGEN-USASP2024153955$AMGEN$$79$YR$E$F$Y$$$20240903$$HP$US$US
241701201$24170120$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-037941$AUROBINDO$Capua M, Amlicke M, Esposito E, Belfer J, Bellis M, Falkowitz D, Teng D. Time of  Observation in Xenobiotic Ingestions in Children Is 6 Hours Too Long?. Pediatric  Emergency Care. 2023;39 (1):e24-e29$$$$$Y$$$20240803$$HP$CA$CA
241701212$24170121$2$F$$20240725$20240803$20240822$PER$$US-BEH-2024176711$CSL BEHRING$$$$$$Y$$$20240822$$PH$US$US
241701221$24170122$1$I$$20240726$20240803$20240803$EXP$GB-MHRA-MIDB-538cdba0-a553-4ecf-a7dd-5b17618f3e21$GB-TEVA-VS-3226670$TEVA$$44$YR$$F$Y$$$20240803$$PH$GB$GB
241701231$24170123$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038248$AUROBINDO$LeBras, M... Nirmatrelvir-ritonavir for nonhospitalized patients with COVID-19 Casebased approach to assessment and treatment. Canadian Family Physician. 2023;69(8):546-549$71$YR$$M$Y$$$20240803$$HP$CA$CA
241701242$24170124$2$F$20240624$20240805$20240803$20240810$PER$$US-AMGEN-USASP2024153820$AMGEN$$51$YR$A$M$Y$97.052$KG$20240810$$CN$US$US
241701251$24170125$1$I$$20240726$20240803$20240803$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119252$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240803$$HP$US$US
241701261$24170126$1$I$20240501$20240731$20240803$20240803$EXP$$CA-ABBVIE-5864071$ABBVIE$$68$YR$$F$Y$$$20240803$$CN$CA$CA
241701271$24170127$1$I$$20240723$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-038745$AUROBINDO$Gupta A, Wojnowski K, Gurung P.. Mucormycosis - A Rare Etiology of Empyema Nessisitans. AmJ-Respir-Crit-Care-Med. 2024;209:A2386$55$YR$$M$Y$$$20240803$$HP$US$US
241701281$24170128$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA228753$SANOFI AVENTIS$$$$E$F$Y$$$20240803$$MD$US$US
241701292$24170129$2$F$$20240920$20240803$20240921$EXP$$JP-ABBVIE-5864605$ABBVIE$Iwasaki H, Hashi M, Mizutomi S, Kubo T, Nakamura T, Imi Y, et al. An infant with a ventricular septal defect who developed distributive shock and cardiac arrest during the induction of general anesthesia. The Japanese Society of Pediatric Cardiology and Cardiac Surgery The 60th Annual General Meeting and Scientific Conference of the Japanese Society of Pediatric Cardiology and Cardiac Surgery. 2024.; Iwasaki H. A case of an infant with ventricular septal defect who experienced distributive sh...$5$MON$$M$Y$$$20240921$$HP$JP$JP
241701301$24170130$1$I$$20240731$20240803$20240803$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121877$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$119.8$KG$20240803$$PH$US$US
241701311$24170131$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-037963$AUROBINDO$$67$YR$$F$Y$$$20240803$$HP$CA$CA
241701321$24170132$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA224476$SANOFI AVENTIS$$$$A$F$Y$69.3$KG$20240803$$MD$US$US
241701331$24170133$1$I$$20240731$20240803$20240803$PER$$US-SA-2024SA227855$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240803$$MD$US$US
241701341$24170134$1$I$20240703$20240801$20240803$20240803$PER$$US-AMGEN-USASP2024154153$AMGEN$$42$YR$A$F$Y$$$20240803$$CN$US$US
241701351$24170135$1$I$$20240730$20240803$20240803$EXP$$NVSC2024BR153382$NOVARTIS$$$$$F$Y$72$KG$20240803$$CN$BR$BR
241701361$24170136$1$I$20240101$20240731$20240803$20240803$PER$$US-SA-2024SA228593$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240803$$CN$US$US
241701371$24170137$1$I$20240628$20240724$20240803$20240803$PER$$US-RDY-SPO/USA/24/0011049$DR REDDYS$$43$YR$A$F$Y$$$20240803$$PH$US$US
241701381$24170138$1$I$$20240725$20240803$20240803$EXP$$DE-RDY-LIT/DEU/24/0011266$DR REDDYS$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S, et al. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. British Journal of Cancer. 2023;128(6): 1134-1147. doi:10.1038/s41416-022-02120-x.$$$$$Y$$$20240803$$HP$DE$DE
241701391$24170139$1$I$20220516$20240723$20240803$20240803$EXP$$CA-CELLTRION INC.-2022CA022735$CELLTRION$$$$$$Y$$$20240803$$MD$CA$CA
241701401$24170140$1$I$$20240724$20240803$20240803$EXP$$CA-TEVA-VS-3227918$TEVA$$40$YR$$F$Y$96$KG$20240803$$HP$CA$CA
241701411$24170141$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3227350$TEVA$$55$YR$$F$Y$79$KG$20240803$$HP$CA$CA
241701421$24170142$1$I$$20240729$20240803$20240803$EXP$$US-SA-2024SA225549$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240803$$MD$US$US
241701433$24170143$3$F$$20240902$20240803$20240905$30DAY$$IT-JNJFOC-20240754149$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$PH$IT$IT
241701441$24170144$1$I$$20240720$20240803$20240803$PER$$US-JNJFOC-20240759236$JOHNSON AND JOHNSON$$$$$$Y$$$20240803$$CN$US$US
241701451$24170145$1$I$$20240801$20240803$20240803$PER$$US-ABBVIE-5864433$ABBVIE$$$$$M$Y$$$20240803$$MD$US$US
241701461$24170146$1$I$20240720$20240731$20240803$20240803$EXP$$CN-ABBVIE-5863587$ABBVIE$$61$YR$$F$Y$55$KG$20240803$$MD$CN$CN
241701471$24170147$1$I$20240724$20240731$20240803$20240803$EXP$$US-ABBVIE-5864127$ABBVIE$$77$YR$$M$Y$$$20240803$$CN$US$US
241701491$24170149$1$I$$20240725$20240803$20240803$EXP$$AU-RDY-LIT/AUS/24/0011261$DR REDDYS$Yeoh K, Lass-Florl C, Lamoth F, Slavin MA, Williams E, Neofytos D. Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual. Transplant Infectious Disease. 2024;doi:10.1111/tid.14273.$53$YR$A$F$Y$$$20240803$$HP$AU$AU
241701501$24170150$1$I$$20240724$20240803$20240803$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR095585$VIIV$$$$$$Y$$$20240803$$HP$US$US
241701511$24170151$1$I$$20240729$20240803$20240803$EXP$$US-ROCHE-10000046815$ROCHE$Liu E, Real M Y. Analysis of Evusheld safety and efficacy in multiple sclerosis patients. Multiple sclerosis and related disorders. 2024-Aug;88:1-6. doi:10.1016/j.msard.2024.105733.$$$$$Y$$$20240803$$HP$US$US
241701521$24170152$1$I$$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024153285$AMGEN$$$$$$Y$$$20240803$$MD$US$US
241701541$24170154$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226589$TEVA$$70$YR$$M$Y$70$KG$20240803$$HP$CA$CA
241701554$24170155$4$F$$20240923$20240803$20240925$EXP$$NVSC2024GB155862$NOVARTIS$$27$YR$$F$Y$$$20240925$$CN$GB$GB
241701563$24170156$3$F$20240101$20240820$20240803$20240829$PER$$US-SA-2024SA224496$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240829$$MD$US$US
241701571$24170157$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA227024$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240803$$MD$US$US
241701581$24170158$1$I$20240621$20240730$20240803$20240803$EXP$$CA-ABBVIE-5864410$ABBVIE$$62$YR$$F$Y$$$20240803$$CN$CA$CA
241701592$24170159$2$F$20240729$20240820$20240803$20240824$PER$$US-ABBVIE-5860827$ABBVIE$$42$YR$$M$Y$$$20240824$$HP$US$US
241701602$24170160$2$F$20240301$20240801$20240803$20240808$EXP$$CA-CELLTRION INC.-2022CA022716$CELLTRION$$$$$$Y$$$20240808$$MD$CA$CA
241701611$24170161$1$I$$20240801$20240803$20240803$PER$$US-AMGEN-USASP2024154535$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241701631$24170163$1$I$20240726$20240730$20240803$20240803$EXP$$PR-ABBVIE-5862550$ABBVIE$$27$YR$$F$Y$$$20240803$$CN$PR$PR
241701641$24170164$1$I$20240101$20240731$20240803$20240803$EXP$$US-ABBVIE-5862726$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241701652$24170165$2$F$$20240805$20240803$20240813$PER$$US-SA-2024SA227863$SANOFI AVENTIS$$$$$$Y$$$20240814$$MD$US$US
241701661$24170166$1$I$20240701$20240729$20240803$20240803$PER$$US-SA-2024SA227428$SANOFI AVENTIS$$94$YR$E$M$Y$$$20240803$$CN$US$US
241701671$24170167$1$I$20240722$20240731$20240803$20240803$EXP$$CA-ABBVIE-5863977$ABBVIE$$39$YR$$F$Y$$$20240803$$CN$CA$CA
241701691$24170169$1$I$20240501$20240729$20240803$20240803$PER$$US-SA-2024SA227674$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240803$$MD$US$US
241701702$24170170$2$F$20240201$20240814$20240803$20240829$PER$$US-SA-2024SA226981$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240829$$MD$US$US
241701711$24170171$1$I$20240101$20240730$20240803$20240803$PER$$US-SA-2024SA227441$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240803$$MD$US$US
241701721$24170172$1$I$$20240731$20240803$20240803$PER$$US-SA-2024SA227869$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240803$$MD$US$US
241701731$24170173$1$I$$20240801$20240803$20240803$PER$$US-ABBVIE-5864451$ABBVIE$$$$$F$Y$$$20240803$$MD$US$US
241701741$24170174$1$I$$20240731$20240803$20240803$EXP$$US-ABBVIE-5863466$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241701751$24170175$1$I$20240726$20240725$20240803$20240803$PER$$US-ABBVIE-5856898$ABBVIE$$76$YR$$F$Y$$$20240803$$CN$US$US
241701762$24170176$2$F$20240730$20240802$20240803$20240806$EXP$$US-ABBVIE-5863782$ABBVIE$$81$YR$$F$Y$$$20240806$$CN$US$US
241701771$24170177$1$I$$20240721$20240803$20240803$EXP$$IN-Long Grove-000061$Long Grove Pharmaceuticals$Oli A, Bhatia A. Unusual clinical features and histopathological findings in a case of Pseudo-endophthalmitis in neovascular glaucoma. Rom J Ophthalmol. 2024 Apr-Jun;68(2):182-186.$54$YR$A$M$Y$$$20240803$$MD$IN$IN
241701781$24170178$1$I$$20240723$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-037815$AUROBINDO$Admane S, Clark M, Bruera E, Reddy A. Caught in the Name Game: Navigating the Data Linkage Conundrum. J-Pain-Symptom-Manage. 2024;68(1):e79-e81$55$YR$$F$Y$$$20240803$$HP$US$US
241701791$24170179$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226913$TEVA$$74$YR$$M$Y$$$20240803$$HP$CA$CA
241701801$24170180$1$I$$20240721$20240803$20240803$EXP$$JP-Inventia-000734$INVENTIA HEALTHCARE$Takahashi Y, Nakano H, Motoki M, Wakimoto Y, Ikechi D, Koyama Y, et. al.  Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review. Acute Med Surg. 2024 Jul 15;11(1): e981.$45$YR$A$F$Y$90$KG$20240803$$HP$JP$JP
241701812$24170181$2$F$20240614$20240806$20240803$20240813$PER$$US-SA-2024SA225087$SANOFI AVENTIS$$35$YR$A$M$Y$135.17$KG$20240814$$MD$US$US
241701821$24170182$1$I$20240715$20240729$20240803$20240803$PER$$US-SA-2024SA227429$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240803$$MD$US$US
241701831$24170183$1$I$20240729$20240731$20240803$20240803$EXP$$CA-ABBVIE-5864469$ABBVIE$$67$YR$$M$Y$$$20240803$$CN$CA$CA
241701841$24170184$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA227481$SANOFI AVENTIS$$$$E$M$Y$$$20240803$$MD$US$US
241701851$24170185$1$I$20240701$20240801$20240803$20240803$EXP$$US-ABBVIE-5864553$ABBVIE$$77$YR$$F$Y$$$20240803$$CN$US$US
241701862$24170186$2$F$20240201$20240904$20240803$20240906$EXP$$CA-ABBVIE-5864795$ABBVIE$$81$YR$$M$Y$$$20240906$$MD$CA$CA
241701871$24170187$1$I$20240101$20240731$20240803$20240803$EXP$$US-ABBVIE-5863252$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241701881$24170188$1$I$20240730$20240731$20240803$20240803$EXP$$IT-ABBVIE-5863974$ABBVIE$$70$YR$$F$Y$$$20240803$$CN$IT$IT
241701891$24170189$1$I$$20240721$20240803$20240803$EXP$$IT-MankindUS-000226$MANKIND PHARMA$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et.al. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicol Rep. 2024 Jun 21;13:101683$15$YR$T$F$Y$48$KG$20240803$$HP$IT$IT
241701901$24170190$1$I$$20240801$20240803$20240803$EXP$$US-ABBVIE-5865004$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241701911$24170191$1$I$20201219$20240801$20240803$20240803$EXP$$US-ABBVIE-5865655$ABBVIE$$20$YR$$M$Y$$$20240803$$CN$US$US
241701923$24170192$3$F$20240731$20240903$20240803$20240904$EXP$$JP-ABBVIE-5864501$ABBVIE$$73$YR$$M$Y$$$20240904$$PH$JP$JP
241701931$24170193$1$I$20240101$20240801$20240803$20240803$PER$$US-AMGEN-USASP2024154069$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241701941$24170194$1$I$$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024153246$AMGEN$$$$$$Y$$$20240803$$HP$US$US
241701951$24170195$1$I$$20240723$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-038310$AUROBINDO$$$$$M$Y$$$20240803$$CN$US$US
241701961$24170196$1$I$20240730$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024152416$AMGEN$$72$YR$E$M$Y$$$20240803$$CN$US$US
241701971$24170197$1$I$$20240722$20240803$20240803$EXP$$JP-ABBVIE-5863133$ABBVIE$$$$$M$Y$$$20240803$$HP$JP$JP
241701981$24170198$1$I$20240702$20240723$20240803$20240803$EXP$$FR-AUROBINDO-AUR-APL-2024-036855$AUROBINDO$$90$YR$$F$Y$54.5$KG$20240803$$PH$FR$FR
241701991$24170199$1$I$$20240725$20240803$20240803$PER$$US-ABBVIE-5857350$ABBVIE$$$$$M$Y$$$20240803$$HP$US$US
241702001$24170200$1$I$20240730$20240731$20240803$20240803$PER$$US-SA-2024SA228117$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240803$$CN$US$US
241702011$24170201$1$I$20240101$20240731$20240803$20240803$PER$$US-SA-2024SA228934$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240803$$CN$US$US
241702021$24170202$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226590$TEVA$$67$YR$$F$Y$66$KG$20240803$$HP$CA$CA
241702031$24170203$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA227050$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240803$$MD$US$US
241702041$24170204$1$I$20240101$20240730$20240803$20240803$PER$$US-SA-2024SA228070$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240803$$CN$US$US
241702051$24170205$1$I$$20240731$20240803$20240803$PER$$US-AstraZeneca-2024A175225$ASTRAZENECA$$$$$M$Y$$$20240803$$HP$US$
241702062$24170206$2$F$20240729$20240729$20240803$20240807$PER$$US-AMGEN-USASP2024150553$AMGEN$$69$YR$E$M$Y$$$20240806$$CN$US$US
241702071$24170207$1$I$$20240729$20240803$20240803$EXP$$US-ABBVIE-5860109$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241702081$24170208$1$I$$20240725$20240803$20240803$PER$$US-ABBVIE-5856544$ABBVIE$$$$$$Y$$$20240803$$CN$US$US
241702092$24170209$2$F$$20240805$20240803$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024093563$VIIV$$$$$M$Y$$$20240815$$MD$US$US
241702101$24170210$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA223928$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240803$$MD$US$US
241702112$24170211$2$F$20240101$20240730$20240803$20240808$PER$$US-SA-2024SA223757$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240808$$MD$US$US
241702121$24170212$1$I$20240513$20240726$20240803$20240803$EXP$$FR-AUROBINDO-AUR-APL-2024-037855$AUROBINDO$$73$YR$$F$Y$61$KG$20240803$$MD$FR$FR
241702131$24170213$1$I$20240701$20240726$20240803$20240803$PER$$US-SA-2024SA223419$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240803$$MD$US$US
241702142$24170214$2$F$20240729$20240729$20240803$20240807$PER$$US-SA-2024SA222635$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240807$$MD$US$US
241702151$24170215$1$I$20240724$20240729$20240803$20240803$PER$$US-SA-2024SA226088$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240803$$MD$US$US
241702162$24170216$2$F$20240701$20240731$20240803$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023815$UNITED THERAPEUTICS$$63$YR$$F$Y$53.515$KG$20240806$$$US$US
241702171$24170217$1$I$20230327$20230410$20240803$20240803$EXP$$CA-CELLTRION INC.-2022CA022717$CELLTRION$$$$$$Y$$$20240803$$MD$CA$CA
241702181$24170218$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA223551$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240803$$MD$US$US
241702191$24170219$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA223849$SANOFI AVENTIS$$$$A$M$Y$$$20240803$$MD$US$US
241702201$24170220$1$I$$20240802$20240803$20240803$PER$$US-AMGEN-USASP2024154236$AMGEN$$80$YR$E$F$Y$$$20240803$$CN$US$US
241702212$24170221$2$F$20240728$20240819$20240803$20240823$PER$$US-AMGEN-USASP2024151012$AMGEN$$64$YR$A$M$Y$$$20240822$$CN$US$US
241702221$24170222$1$I$20240701$20240729$20240803$20240803$PER$$US-SA-2024SA227490$SANOFI AVENTIS$$$$A$M$Y$$$20240803$$MD$US$US
241702232$24170223$2$F$20240728$20240729$20240803$20240807$PER$$US-SA-2024SA224534$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240807$$CN$US$US
241702241$24170224$1$I$$20240726$20240803$20240803$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-038087$JAZZ$$$$$F$Y$$$20240803$$MD$US$US
241702252$24170225$2$F$20240701$20240909$20240803$20240916$PER$$US-SA-2024SA223667$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240916$$MD$US$US
241702261$24170226$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA222870$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240803$$MD$US$US
241702271$24170227$1$I$20240601$20240725$20240803$20240803$PER$$US-SA-2024SA222935$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240803$$MD$US$US
241702281$24170228$1$I$20240701$20240725$20240803$20240803$PER$$US-SA-2024SA223697$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240803$$MD$US$US
241702291$24170229$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA223245$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240803$$MD$US$US
241702301$24170230$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA223753$SANOFI AVENTIS$$$$A$F$Y$79$KG$20240803$$MD$US$US
241702311$24170231$1$I$20240517$20240725$20240803$20240803$PER$$US-SA-2024SA223072$SANOFI AVENTIS$$18$YR$A$F$Y$94$KG$20240803$$MD$US$US
241702321$24170232$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA223034$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240803$$MD$US$US
241702331$24170233$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA223811$SANOFI AVENTIS$$$$A$F$Y$67$KG$20240803$$MD$US$US
241702341$24170234$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA223788$SANOFI AVENTIS$$$$A$M$Y$$$20240803$$MD$US$US
241702351$24170235$1$I$20240101$20240725$20240803$20240803$PER$$US-SA-2024SA223636$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240803$$MD$US$US
241702361$24170236$1$I$20240704$20240725$20240803$20240803$PER$$US-SA-2024SA223737$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240803$$MD$US$US
241702371$24170237$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA223723$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240803$$CN$US$US
241702381$24170238$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA227462$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240803$$MD$US$US
241702391$24170239$1$I$$20240724$20240803$20240803$EXP$$JP-MACLEODS PHARMA-MAC2024048555$MACLEODS$Matsumoto R, Kamada T, Aida T, Ohdaira H, Yamanouchi E, Suzuki Y.Balloon dilatation followed by triamcinolone acetonide injection for colostomy stenosis: A case report.International Journal of Surgery Case Reports.17 JUL 2024;121:110056$$$$$Y$$$20240803$$HP$JP$JP
241702401$24170240$1$I$20240715$20240724$20240803$20240803$EXP$GB-MHRA-MED-202407241446599570-YNRCZ$GB-MACLEODS PHARMA-MAC2024048577$MACLEODS$$$$$$Y$$$20240803$$MD$GB$GB
241702411$24170241$1$I$$20240724$20240803$20240803$EXP$$US-MACLEODS PHARMA-MAC2024048557$MACLEODS$Darnell H, Brenner A, Kern C, Flomenhoft D, Lee E.Sevelamer-Induced Ischemic Enteritis.Darnell H, Brenner A, Kern C, Flomenhoft D, Lee E.17-JUL-2024;11(7):e01451$$$$$Y$$$20240803$$MD$US$US
241702421$24170242$1$I$20240621$20240724$20240803$20240803$EXP$GB-MHRA-MED-202407241450446260-STWJP$GB-MACLEODS PHARMA-MAC2024048578$MACLEODS$$$$$$Y$$$20240803$$CN$GB$GB
241702431$24170243$1$I$$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024152238$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241702441$24170244$1$I$$20240724$20240803$20240803$EXP$GB-MHRA-MIDB-b0ac154e-0835-4945-b18d-d0ea9223a0c0$GB-MACLEODS PHARMA-MAC2024048583$MACLEODS$$$$$$Y$$$20240803$$PH$GB$GB
241702451$24170245$1$I$20240801$20240801$20240803$20240803$PER$$US-AMGEN-USASP2024153959$AMGEN$$$$$F$Y$$$20240803$$CN$US$US
241702461$24170246$1$I$20240101$20240730$20240803$20240803$EXP$$FR-ABBVIE-5736221$ABBVIE$$71$YR$$M$Y$90$KG$20240803$$PH$FR$FR
241702471$24170247$1$I$$20240802$20240803$20240803$PER$$US-JNJFOC-20240805942$JOHNSON AND JOHNSON$$$$$M$Y$$$20240803$$CN$US$US
241702481$24170248$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226839$TEVA$$70$YR$$$Y$67$KG$20240803$$HP$CA$CA
241702492$24170249$2$F$20240722$20240911$20240803$20240920$PER$$US-BEH-2024176492$CSL BEHRING$$10$YR$C$M$Y$$$20240920$$HP$US$US
241702511$24170251$1$I$20191213$20240725$20240803$20240803$EXP$$DE-TEVA-VS-3227900$TEVA$$$$$$Y$$$20240803$$MD$DE$DE
241702522$24170252$2$F$20240701$20240730$20240803$20240809$PER$$US-AMGEN-USASP2024152108$AMGEN$$61$YR$A$M$Y$$$20240809$$HP$US$US
241702531$24170253$1$I$20211201$20240729$20240803$20240803$PER$$US-SA-2024SA227439$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240803$$MD$US$US
241702541$24170254$1$I$20240101$20240730$20240803$20240803$PER$$US-SA-2024SA227095$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240803$$MD$US$US
241702551$24170255$1$I$$20240724$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-005414$AUROBINDO$Todd J, Saboori S, Zeidan J, Ahrens W, Jacobs C, Moshiree B et al.. Sevelamer Induced Gastrointestinal Disease in 12 Patients with End Stage Renal Disease: A Case Series. Clin Transl Gastroenterol. 2024;22$81$YR$$M$Y$$$20240803$$HP$US$US
241702571$24170257$1$I$$20240729$20240803$20240803$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-000089$JAZZ$$$$$M$Y$$$20240803$$CN$US$US
241702581$24170258$1$I$$20240723$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-037977$AUROBINDO$Green M, Williams L, Boh E, Kuraitis D. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients.. Arch-Dermatol-Res. 2024;316No. 5:194$$$$$Y$$$20240803$$HP$US$US
241702591$24170259$1$I$$20240723$20240803$20240803$EXP$$IT-862174955-ML2024-04229$MICRO LABS$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et al. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicology Reports. 2024 Jun 21;13: 1-4. doi:doi.org/10.1016/j.toxrep.2024.101683.$15$YR$T$F$Y$48$KG$20240803$$HP$IT$IT
241702601$24170260$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226716$TEVA$$$$$F$Y$1$KG$20240803$$HP$CA$CA
241702611$24170261$1$I$20240101$20240729$20240803$20240803$PER$$US-SA-2024SA228058$SANOFI AVENTIS$$57$YR$A$$Y$$$20240803$$MD$US$US
241702621$24170262$1$I$20230101$20240725$20240803$20240803$PER$$US-SA-2024SA221102$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240803$$CN$US$US
241702632$24170263$2$F$20231101$20240904$20240803$20240905$PER$$US-AMGEN-USASP2024151075$AMGEN$$48$YR$A$M$Y$$$20240905$$CN$US$US
241702642$24170264$2$F$$20240911$20240803$20240924$EXP$$US-AUROBINDO-AUR-APL-2024-037914$AUROBINDO$Darnell H, Brenner A, Kern C, Flomenhoft D, Lee E. Sevelamer-Induced Ischemic Enteritis. ACG CASE REPORTS JOURNAL. 2024;11:e01451$35$YR$$M$Y$$$20240924$$MD$US$US
241702651$24170265$1$I$$20240731$20240803$20240803$EXP$$CA-ABBVIE-5765686$ABBVIE$$$$A$F$Y$$$20240803$$CN$CA$CA
241702661$24170266$1$I$20240601$20240731$20240803$20240803$EXP$$JP-ABBVIE-22K-087-4479207-00$ABBVIE$$68$YR$$M$Y$$$20240803$$CN$JP$JP
241702671$24170267$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226715$TEVA$$72$YR$$F$Y$$$20240803$$HP$CA$CA
241702681$24170268$1$I$$20240730$20240803$20240803$EXP$$IN-KOANAAP-SML-IN-2024-00787$SHILPA MEDICARE$Paturu R, Lingaiah R, Singh S, Kumari N, Krishnani N. Case of Dynamic Molecular Profile in Metastatic Lung Adenocarcinoma and the Significance of Multiple-site Testing. Asian Pacific Journal of Cancer Biology. 2024;9(2): 247-250. doi:10.31557/APJCB.2024.9.2.247.$30$YR$A$M$Y$$$20240803$$MD$IN$IN
241702691$24170269$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-037832$AUROBINDO$$41$YR$$F$Y$112$KG$20240803$$HP$CA$CA
241702712$24170271$2$F$$20240725$20240803$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038465$AUROBINDO$$63$YR$$F$Y$58$KG$20240806$$HP$CA$CA
241702721$24170272$1$I$20240704$20240726$20240803$20240803$EXP$GB-MHRA-MED-202407261545577700-MVBWC$GB-TEVA-VS-3226761$TEVA$$76$YR$$F$Y$73$KG$20240803$$CN$GB$GB
241702731$24170273$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038546$AUROBINDO$$6$MON$$$Y$$$20240803$$CN$CA$CA
241702741$24170274$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038020$AUROBINDO$$$$$F$Y$$$20240803$$CN$CA$CA
241702751$24170275$1$I$20240507$20240726$20240803$20240803$EXP$ES-AEMPS-1550292$ES-TEVA-VS-3226863$TEVA$$60$YR$$M$Y$$$20240803$$HP$ES$ES
241702761$24170276$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038487$AUROBINDO$$46$YR$$F$Y$90$KG$20240803$$CN$CA$CA
241702773$24170277$3$F$20240701$20240829$20240803$20240902$PER$$US-AMGEN-USASP2024150982$AMGEN$$71$YR$E$F$Y$$$20240902$$CN$US$US
241702781$24170278$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-037817$AUROBINDO$$88$YR$$M$Y$$$20240803$$HP$CA$CA
241702791$24170279$1$I$20240722$20240723$20240803$20240803$EXP$$US-Accord-438416$ACCORD$$26$YR$A$M$Y$$$20240803$$HP$US$US
241702801$24170280$1$I$20240601$20240723$20240803$20240803$EXP$FR-AFSSAPS-LL2024001360$FR-Accord-438389$ACCORD$$61$YR$A$F$Y$$$20240803$$MD$FR$FR
241702811$24170281$1$I$$20240723$20240803$20240803$EXP$GB-MHRA-30767189$GB-Accord-438320$ACCORD$$$$$$Y$$$20240803$$CN$GB$GB
241702821$24170282$1$I$$20240724$20240803$20240803$EXP$$CA-TEVA-VS-3227331$TEVA$$40$YR$$F$Y$$$20240803$$HP$CA$CA
241702841$24170284$1$I$$20240723$20240803$20240803$EXP$$US-AUROBINDO-AUR-APL-2024-037886$AUROBINDO$Chhabra K, Gudipati S, Bloomingdale R.. Opioid Withdrawal Causing a Broken Heart!. Circulation. 2023$26$YR$$M$Y$$$20240803$$HP$US$US
241702851$24170285$1$I$20240101$20240725$20240803$20240803$EXP$$US-TEVA-VS-3228478$TEVA$$70$YR$$F$Y$$$20240803$$CN$US$US
241702861$24170286$1$I$$20240724$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038472$AUROBINDO$$25$YR$$F$Y$$$20240803$$HP$CA$CA
241702871$24170287$1$I$$20240725$20240803$20240803$EXP$$CA-AUROBINDO-AUR-APL-2024-038635$AUROBINDO$$38$YR$$F$Y$$$20240803$$MD$CA$CA
241702881$24170288$1$I$20240702$20240723$20240803$20240803$EXP$CN-HENLIUS-24CN016075$CN-Accord-439384$ACCORD$$59$YR$A$M$Y$60$KG$20240803$$MD$CN$CN
241702891$24170289$1$I$20240604$20240724$20240803$20240803$EXP$$US-Accord-438458$ACCORD$$48$YR$A$M$Y$$$20240803$$HP$US$US
241702901$24170290$1$I$20240612$20240723$20240803$20240803$EXP$FR-AFSSAPS-AN2024000933$FR-Accord-438136$ACCORD$$63$YR$A$M$Y$$$20240803$$MD$FR$FR
241702911$24170291$1$I$20240101$20240730$20240803$20240803$EXP$$NVSC2024BR157754$NOVARTIS$$$$$F$Y$$$20240803$$CN$BR$BR
241702923$24170292$3$F$20240723$20240913$20240803$20240923$EXP$$CA-CELLTRION INC.-2024CA018627$CELLTRION$$$$$$Y$$$20240923$$CN$CA$CA
241702931$24170293$1$I$20240610$20240724$20240803$20240803$EXP$IT-MINISAL02-995151$IT-TEVA-VS-3225360$TEVA$$78$YR$$M$Y$$$20240803$$MD$IT$IT
241702951$24170295$1$I$$20240722$20240803$20240803$EXP$$PH-Accord-437768$ACCORD$Legaspi LA, Ondinee-Igot M, Fernando G. Rare metastatic primary intra-abdominal follicular dendritic cell sarcoma poorly responsive to chemotherapy: A case report. Phillippine Journal of Internal Medicine. 2024;62(1):308-13.$33$YR$A$F$Y$$$20240803$$MD$PH$PH
241702961$24170296$1$I$$20240723$20240803$20240803$EXP$AU-TGA-807394$AU-Accord-437829$ACCORD$$$$$M$Y$$$20240803$$HP$AU$AU
241702971$24170297$1$I$20240710$20240723$20240803$20240803$EXP$$US-Accord-438992$ACCORD$$21$YR$A$F$Y$$$20240803$$HP$US$US
241702981$24170298$1$I$$20240723$20240803$20240803$EXP$AU-TGA-806485$AU-Accord-437843$ACCORD$$57$YR$A$M$Y$$$20240803$$HP$AU$AU
241702991$24170299$1$I$20240705$20240723$20240803$20240803$EXP$$US-Accord-438032$ACCORD$$29$YR$A$F$Y$$$20240803$$HP$US$US
241703001$24170300$1$I$$20240722$20240803$20240803$EXP$$US-Accord-437771$ACCORD$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy. Experimental and Clinical Transplantation. 2024;22(5):392-5.$68$YR$E$F$Y$$$20240803$$MD$US$US
241703011$24170301$1$I$$20240731$20240803$20240803$PER$$US-ABBVIE-5863872$ABBVIE$$85$YR$$F$Y$$$20240803$$CN$US$US
241703022$24170302$2$F$20240728$20240814$20240803$20240816$PER$$US-AMGEN-USASP2024151061$AMGEN$$55$YR$A$F$Y$$$20240815$$CN$US$US
241703031$24170303$1$I$$20240726$20240803$20240803$EXP$GB-MHRA-MED-202407261147501430-LWKNT$GB-TEVA-VS-3226477$TEVA$$71$YR$$F$Y$$$20240803$$HP$GB$GB
241703052$24170305$2$F$20240709$20240806$20240803$20240809$EXP$$US-ABBVIE-5863514$ABBVIE$$71$YR$$F$Y$$$20240809$$CN$US$US
241703061$24170306$1$I$$20240728$20240803$20240803$EXP$$DE-JNJFOC-20240780891$JOHNSON AND JOHNSON$$$$$M$Y$$$20240803$$HP$DE$DE
241703071$24170307$1$I$$20240721$20240803$20240803$EXP$$US-Indoco-000591$INDOCO$Kwon L. Portable Percussive Massage Device-Related Rectus Sheath Hematoma and Obstructive Uropathy: A Case Report. Biomed Hub. 2024 May 27;9(1):89-93.$6$DEC$A$M$Y$$$20240803$$HP$US$US
241703081$24170308$1$I$$20240721$20240803$20240803$EXP$$IT-CPL-004475$CADILA$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et.al. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicol Rep. 2024 Jun 21;13:101683$15$YR$T$F$Y$48$KG$20240803$$HP$IT$IT
241703091$24170309$1$I$$20240721$20240803$20240803$EXP$$MG-Axellia-005286$XELLIA PHARMACEUTICALS$Randrianarisoa RMF, Raulin O, Merlin A, Tonnelier M, Lecapitaine AL. A Case of Confusion in an Obese Patient Treated With Daptomycin: Neurotoxicity. Cureus. 2024 Jun 12;16(6):e62254$73$YR$E$M$Y$150$KG$20240803$$HP$MG$MN
241703101$24170310$1$I$$20240721$20240803$20240803$EXP$$US-MankindUS-000225$MANKIND PHARMA$Martin RD, Scanlon M, McCabe K. Lidocaine-Associated CNS Toxicity at Therapeutic Dosage: A Case Report and Literature Review. Cureus. 2024 Jun 12;16(6):e62231.$47$YR$A$M$Y$133.9$KG$20240803$$HP$US$US
241703111$24170311$1$I$$20240731$20240803$20240803$EXP$$US-AMGEN-USASP2024153353$AMGEN$Henao-martinez A.F.; Olivo Freites C.; Agudelo Higuita N.I. et al.. Clinical Characteristics and Outcomes of Disseminated Strongyloidiasis in the United States-A Multicenter Network Analysis. American Journal of Tropical Medicine and Hygiene. 2024;111 (1):89-92$$$$$Y$$$20240803$$HP$US$US
241703121$24170312$1$I$$20240721$20240803$20240803$EXP$$IT-Apnar-000185$APNAR PHARMA$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, et.al. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicol Rep. 2024 Jun 21;13:101683$15$YR$T$F$Y$48$KG$20240803$$HP$IT$IT
241703132$24170313$2$F$20240729$20240808$20240803$20240814$EXP$$GB-TEVA-VS-3227362$TEVA$$61$YR$$M$Y$112$KG$20240814$$HP$GB$GB
241703141$24170314$1$I$$20240722$20240803$20240803$EXP$$CN-TEYRO-2024-TY-000350$Teyro Labs$Zhang C, Sun YX, Yi DC, Jiang BY, Yan LX, Zhong WZ, et al..Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)..Cell Rep Med.2024;5:101615$$$$$Y$$$20240802$$HP$CN$CN
241703151$24170315$1$I$$20240721$20240803$20240803$EXP$$IN-CPL-004478$CADILA$Hithesh G Jr, Moorthy S, M L, Bhaskar E. Unveiling the Neurotoxicity of Metronidazole: A Clinical Conundrum. Cureus. 2024 Jun 12;16(6):e62219$61$YR$A$M$Y$$$20240803$$HP$IN$IN
241703162$24170316$2$F$20240716$20240725$20240803$20240827$EXP$$US-Accord-438905$ACCORD$$31$YR$A$M$Y$$$20240827$$MD$US$US
241703171$24170317$1$I$20240712$20240723$20240803$20240803$EXP$$US-Accord-438278$ACCORD$$73$YR$E$F$Y$$$20240803$$PH$US$US
241703181$24170318$1$I$$20240724$20240803$20240803$EXP$GB-MHRA-MED-202407241020397610-KDWHG$GB-Accord-438447$ACCORD$$55$YR$A$M$Y$91$KG$20240803$$PH$GB$GB
241703191$24170319$1$I$$20240723$20240803$20240803$EXP$NL-LRB-00993122$NL-Accord-438271$ACCORD$$54$YR$A$F$Y$$$20240803$$MD$NL$NL
241703202$24170320$2$F$20240523$20240902$20240803$20240913$EXP$$US-Accord-438750$ACCORD$$77$YR$E$F$Y$$$20240913$$MD$US$US
241703211$24170321$1$I$20240605$20240723$20240803$20240803$EXP$IT-MINISAL02-995889$IT-Accord-438391$ACCORD$$39$YR$A$F$Y$$$20240803$$MD$IT$IT
241703221$24170322$1$I$20240723$20240723$20240803$20240803$EXP$GB-MHRA-MED-202407230647463120-ZYNKC$GB-Accord-438091$ACCORD$$54$YR$A$M$Y$69$KG$20240803$$CN$GB$GB
241703231$24170323$1$I$$20240724$20240803$20240803$EXP$GB-MHRA-MED-202407240927293430-QGYBT$GB-Accord-438484$ACCORD$$$$$F$Y$$$20240803$$CN$GB$GB
241703241$24170324$1$I$$20240731$20240803$20240803$EXP$$US-ABBVIE-5863753$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241703251$24170325$1$I$20220415$20240726$20240803$20240803$EXP$FR-AFSSAPS-PP2024000812$FR-TEVA-VS-3227218$TEVA$$60$YR$$F$Y$75$KG$20240803$$MD$FR$FR
241703262$24170326$2$F$$20240826$20240803$20240828$EXP$$AU-JNJFOC-20240779099$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240828$$HP$AU$AU
241703271$24170327$1$I$$20240721$20240803$20240803$EXP$$JP-Indicus Pharma-001027$INDICUS$Takahashi Y, Nakano H, Motoki M, Wakimoto Y, Ikechi D, Koyama Y, et. al.  Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review. Acute Med Surg. 2024 Jul 15;11(1): e981.$45$YR$A$F$Y$90$KG$20240803$$HP$JP$JP
241703281$24170328$1$I$20240728$20240730$20240803$20240803$PER$$US-SA-2024SA227845$SANOFI AVENTIS$$7$YR$C$M$Y$48$KG$20240803$$MD$US$US
241703292$24170329$2$F$$20240718$20240803$20240926$PER$$US-TEVA-VS-3224650$TEVA$$63$YR$$M$Y$$$20240926$$HP$US$US
241703301$24170330$1$I$$20240726$20240803$20240803$EXP$GB-MHRA-MIDB-6862d2a9-cb86-4552-94c5-3abdfa4125a1$GB-TEVA-VS-3226737$TEVA$$74$YR$$$Y$$$20240803$$HP$GB$GB
241703311$24170331$1$I$20240723$20240726$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-023084$UNITED THERAPEUTICS$$55$YR$$F$Y$$$20240803$$$US$US
241703322$24170332$2$F$20240610$20240802$20240803$20240810$EXP$$BR-CELLTRION INC.-2024BR018392$CELLTRION$$$$$$Y$$$20240810$$CN$BR$BR
241703331$24170333$1$I$$20240730$20240803$20240803$EXP$$IN-VANTIVE-2024VAN018785$Vantive US Healthcare$$57$YR$$F$Y$$$20240803$$CN$IN$IN
241703343$24170334$3$F$$20240829$20240803$20240903$EXP$$IN-VANTIVE-2024VAN018766$Vantive US Healthcare$$67$YR$$M$Y$$$20240903$$CN$IN$IN
241703351$24170335$1$I$$20240802$20240803$20240803$EXP$$TR-ABBVIE-5865585$ABBVIE$$$$$F$Y$$$20240803$$CN$TR$TR
241703362$24170336$2$F$20231108$20240830$20240803$20240911$EXP$IT-MINISAL02-995646$IT-Accord-438080$ACCORD$$54$YR$A$F$Y$$$20240911$$MD$IT$IT
241703371$24170337$1$I$20240101$20240726$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-023297$UNITED THERAPEUTICS$$$$$F$Y$72.971$KG$20240803$$$US$US
241703382$24170338$2$F$20230926$20240830$20240803$20240911$EXP$$GB-Accord-438737$ACCORD$$81$YR$E$M$Y$$$20240911$$MD$GB$GB
241703391$24170339$1$I$20240702$20240723$20240803$20240803$EXP$FR-AFSSAPS-TS2024000834$FR-Accord-438123$ACCORD$$79$YR$E$F$Y$71$KG$20240803$$MD$FR$FR
241703401$24170340$1$I$20240618$20240724$20240803$20240803$EXP$CN-HENLIUS-24CN016110$CN-Accord-439386$ACCORD$$61$YR$A$F$Y$55$KG$20240803$$MD$CN$CN
241703411$24170341$1$I$$20240724$20240803$20240803$EXP$GB-MHRA-MIDB- 3c2cfb19-2f66-4d41-8848-95bff55a184d$GB-Accord-439014$ACCORD$$74$YR$E$F$Y$$$20240803$$PH$GB$GB
241703421$24170342$1$I$20231201$20240723$20240803$20240803$EXP$FR-AFSSAPS-AN2024000916$FR-Accord-438202$ACCORD$$74$YR$E$$Y$$$20240803$$MD$FR$FR
241703431$24170343$1$I$$20240731$20240803$20240803$EXP$$US-ABBVIE-5864921$ABBVIE$$$$$F$Y$$$20240803$$HP$US$US
241703451$24170345$1$I$20240701$20240725$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-023170$UNITED THERAPEUTICS$$60$YR$$M$Y$106.58$KG$20240803$$$US$US
241703462$24170346$2$F$$20240827$20240803$20240902$PER$$US-AMGEN-USASP2024153986$AMGEN$$40$YR$A$M$Y$$$20240901$$HP$US$US
241703471$24170347$1$I$20240501$20240730$20240803$20240803$PER$$US-SA-2024SA228659$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240803$$MD$US$US
241703481$24170348$1$I$20240101$20240729$20240803$20240803$PER$$US-SA-2024SA226086$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240803$$CN$US$US
241703491$24170349$1$I$20240702$20240725$20240803$20240803$EXP$FR-AFSSAPS-LL2024001290$FR-TEVA-VS-3226188$TEVA$$0$DY$$M$Y$$$20240803$$PH$FR$FR
241703501$24170350$1$I$$20240729$20240803$20240803$PER$$US-AMGEN-USASP2024152246$AMGEN$$$$A$F$Y$$$20240803$$CN$US$US
241703511$24170351$1$I$20240101$20240726$20240803$20240803$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023349$UNITED THERAPEUTICS$$$$$F$Y$77.098$KG$20240803$$$US$US
241703521$24170352$1$I$$20240724$20240803$20240803$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR095647$VIIV$$$$$$Y$$$20240803$$HP$US$US
241703531$24170353$1$I$$20240724$20240803$20240803$30DAY$$US-GSK-US2024092991$GLAXOSMITHKLINE$$$$$F$Y$$$20240803$$CN$US$US
241703542$24170354$2$F$$20240805$20240803$20240808$EXP$$ZA-AMGEN-ZAFSP2024153295$AMGEN$$$$$$Y$$$20240808$$CN$ZA$ZA
241703551$24170355$1$I$20240601$20240722$20240803$20240803$PER$$US-TEVA-VS-3225158$TEVA$$$$$F$Y$$$20240803$$CN$US$US
241703561$24170356$1$I$20240601$20240730$20240803$20240803$PER$$US-SA-2024SA228660$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240803$$MD$US$US
241703571$24170357$1$I$$20240727$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-023307$UNITED THERAPEUTICS$$$$$F$Y$100.23$KG$20240803$$$US$US
241703583$24170358$3$F$20240724$20240904$20240803$20240911$30DAY$$US-GSK-US2024093755$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240911$$MD$US$US
241703601$24170360$1$I$20240101$20240726$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-023317$UNITED THERAPEUTICS$$$$$M$Y$62.132$KG$20240803$$$US$US
241703611$24170361$1$I$20240605$20240723$20240803$20240803$EXP$FR-AFSSAPS-ST2024001180$FR-Accord-438586$ACCORD$$70$YR$E$M$Y$63$KG$20240803$$HP$FR$FR
241703621$24170362$1$I$$20240723$20240803$20240803$EXP$AU-TGA-807184$AU-Accord-437835$ACCORD$$59$YR$A$M$Y$$$20240803$$HP$AU$AU
241703631$24170363$1$I$20240111$20240723$20240803$20240803$EXP$FR-AFSSAPS-ST2024001188$FR-Accord-438358$ACCORD$$59$YR$A$M$Y$$$20240803$$HP$FR$FR
241703641$24170364$1$I$20240614$20240723$20240803$20240803$EXP$ES-AEMPS-1550749$ES-Accord-438505$ACCORD$$90$YR$E$M$Y$53$KG$20240803$$MD$ES$ES
241703651$24170365$1$I$20240705$20240730$20240803$20240803$PER$$US-ELI_LILLY_AND_COMPANY-US202408000192$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240803$$CN$US$US
241703661$24170366$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA227455$SANOFI AVENTIS$$$$A$M$Y$$$20240803$$MD$US$US
241703671$24170367$1$I$20240701$20240729$20240803$20240803$PER$$US-SA-2024SA227625$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240803$$MD$US$US
241703681$24170368$1$I$$20240723$20240803$20240803$PER$$US-SA-2024SA222526$SANOFI AVENTIS$$$$A$F$Y$76$KG$20240803$$MD$US$US
241703692$24170369$2$F$20240101$20240807$20240803$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-022179$UNITED THERAPEUTICS$$$$$F$Y$73.923$KG$20240814$$$US$US
241703701$24170370$1$I$20240101$20240727$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-022008$UNITED THERAPEUTICS$$$$$M$Y$63.492$KG$20240803$$$US$US
241703715$24170371$5$F$20240101$20240908$20240803$20240918$PER$$US-UNITED THERAPEUTICS-UNT-2024-023751$UNITED THERAPEUTICS$$$$$F$Y$54.875$KG$20240918$$$US$US
241703721$24170372$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226619$TEVA$$71$YR$$M$Y$$$20240803$$HP$CA$CA
241703731$24170373$1$I$20240101$20240730$20240803$20240803$PER$$US-SA-2024SA228744$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240803$$MD$US$US
241703741$24170374$1$I$$20240722$20240803$20240803$PER$$US-BEH-2024176302$CSL BEHRING$$$$$F$Y$$$20240803$$CN$US$US
241703751$24170375$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA226937$SANOFI AVENTIS$$$$A$F$Y$78.92$KG$20240803$$MD$US$US
241703761$24170376$1$I$$20240729$20240803$20240803$PER$$US-AMGEN-USASP2024151223$AMGEN$$$$$$Y$$$20240803$$HP$US$US
241703775$24170377$5$F$20240101$20240828$20240803$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-022747$UNITED THERAPEUTICS$$$$$F$Y$66.667$KG$20240905$$$US$US
241703781$24170378$1$I$20230406$20240725$20240803$20240803$EXP$FR-AFSSAPS-NY2024000819$FR-TEVA-VS-3226205$TEVA$$73$YR$$F$Y$100$KG$20240803$$PH$FR$FR
241703791$24170379$1$I$$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024152133$AMGEN$$$$$$Y$$$20240803$$HP$US$US
241703801$24170380$1$I$$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024152266$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241703811$24170381$1$I$$20240728$20240803$20240803$EXP$GB-MHRA-MED-202407280834110720-LGBZW$GB-TEVA-VS-3226925$TEVA$$48$YR$$F$Y$85$KG$20240803$$CN$GB$GB
241703822$24170382$2$F$$20240801$20240803$20240808$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138789$DAIICHI$$38$YR$$F$Y$$$20240808$$CN$US$US
241703832$24170383$2$F$$20240731$20240803$20240803$EXP$$CA-SANDOZ INC.-SDZ2023CA076644$SANDOZ$$$$$F$Y$$$20240803$$HP$CA$CA
241703841$24170384$1$I$$20240802$20240803$20240803$PER$$US-JNJFOC-20240806959$JOHNSON AND JOHNSON$$$$$$Y$$$20240803$$MD$US$US
241703851$24170385$1$I$20230901$20240731$20240803$20240803$EXP$$NVSC2023GB174842$NOVARTIS$$$$$F$Y$$$20240803$$CN$GB$GB
241703861$24170386$1$I$20240101$20240726$20240803$20240803$PER$$US-SA-2024SA224065$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240803$$MD$US$US
241703871$24170387$1$I$20240101$20240729$20240803$20240803$EXP$$US-ABBVIE-5859987$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241703881$24170388$1$I$20240724$20240802$20240803$20240803$PER$$US-JNJFOC-20240805997$JOHNSON AND JOHNSON$$$$$$Y$$$20240803$$CN$US$US
241703891$24170389$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226794$TEVA$$65$YR$$F$Y$34$KG$20240803$$HP$CA$CA
241703901$24170390$1$I$20240407$20240731$20240803$20240803$PER$$US-UNITED THERAPEUTICS-UNT-2024-010801$UNITED THERAPEUTICS$$49$YR$$F$Y$80.272$KG$20240803$$$US$US
241703911$24170391$1$I$20240501$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024151849$AMGEN$$54$YR$$F$Y$$$20240803$$CN$US$US
241703921$24170392$1$I$20240730$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024152881$AMGEN$$65$YR$E$M$Y$$$20240803$$CN$US$US
241703931$24170393$1$I$$20240724$20240803$20240803$EXP$$CA-TEVA-VS-3226628$TEVA$$73$YR$$M$Y$$$20240803$$CN$CA$CA
241703941$24170394$1$I$$20240731$20240803$20240803$PER$$US-AstraZeneca-2024A174953$ASTRAZENECA$$$$$$Y$$$20240803$$CN$US$
241703952$24170395$2$F$20240731$20240801$20240803$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-023818$UNITED THERAPEUTICS$$58$YR$$F$Y$36.735$KG$20240809$$$US$US
241703961$24170396$1$I$$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024151670$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241703972$24170397$2$F$20240605$20240805$20240803$20240813$EXP$$IN-ROCHE-10000046783$ROCHE$$59$YR$A$M$Y$$$20240813$$CN$IN$IN
241703981$24170398$1$I$$20240726$20240803$20240803$30DAY$$US-GSK-US2024094251$GLAXOSMITHKLINE$$$$$F$Y$$$20240803$$HP$US$US
241703991$24170399$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA228880$SANOFI AVENTIS$$$$A$F$Y$$$20240803$$MD$US$US
241704002$24170400$2$F$$20240729$20240803$20240806$EXP$$ES-ABBVIE-5865593$ABBVIE$$$$$F$Y$$$20240806$$MD$ES$ES
241704011$24170401$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA226283$SANOFI AVENTIS$$$$$$Y$$$20240803$$MD$US$US
241704021$24170402$1$I$20240101$20240729$20240803$20240803$PER$$US-SA-2024SA224426$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240803$$CN$US$US
241704031$24170403$1$I$$20240724$20240803$20240803$30DAY$$US-GSK-US2024093478$GLAXOSMITHKLINE$$$$$M$Y$$$20240803$$CN$US$US
241704041$24170404$1$I$20190101$20240726$20240803$20240803$EXP$RO-EMA-DD-20240717-7482661-101258$RO-TEVA-VS-3227116$TEVA$$64$YR$$F$Y$$$20240803$$MD$RO$RO
241704051$24170405$1$I$$20240726$20240803$20240803$EXP$$US-TEVA-VS-3226637$TEVA$$24$YR$$F$Y$$$20240803$$HP$US$US
241704062$24170406$2$F$$20240726$20240803$20240808$EXP$$US-TEVA-VS-3227429$TEVA$$62$YR$$M$Y$$$20240808$$CN$US$US
241704072$24170407$2$F$20231029$20240822$20240803$20240830$EXP$FR-AFSSAPS-TS2024000829$FR-TEVA-VS-3226848$TEVA$$$$$F$Y$2.7$KG$20240830$$MD$FR$FR
241704081$24170408$1$I$20240624$20240725$20240803$20240803$EXP$FR-AFSSAPS-TS2024000826$FR-TEVA-VS-3226366$TEVA$$68$YR$$M$Y$61$KG$20240803$$MD$FR$FR
241704091$24170409$1$I$20240729$20240729$20240803$20240803$PER$$US-BEH-2024176533$CSL BEHRING$$41$YR$A$F$Y$$$20240803$$HP$US$US
241704101$24170410$1$I$$20240724$20240803$20240803$PER$$US-BEH-2024176349$CSL BEHRING$$$$A$M$Y$$$20240803$$CN$US$US
241704111$24170411$1$I$$20240731$20240803$20240803$EXP$$US-ABBVIE-5863397$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241704121$24170412$1$I$20240101$20240725$20240803$20240803$EXP$$US-TEVA-VS-3227983$TEVA$$70$YR$$F$Y$$$20240803$$CN$US$US
241704132$24170413$2$F$20240717$20240822$20240803$20240828$EXP$$US-ABBVIE-5863636$ABBVIE$$66$YR$$M$Y$95$KG$20240828$$CN$US$US
241704142$24170414$2$F$20240101$20240924$20240803$20240928$EXP$$US-ABBVIE-5793315$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
241704151$24170415$1$I$$20240726$20240803$20240803$EXP$$US-TEVA-VS-3228105$TEVA$$67$YR$$F$Y$$$20240803$$CN$US$US
241704161$24170416$1$I$20240717$20240729$20240803$20240803$EXP$$GB-ABBVIE-5860917$ABBVIE$$74$YR$$F$Y$$$20240803$$CN$GB$GB
241704171$24170417$1$I$20230101$20240729$20240803$20240803$PER$$US-SA-2024SA225112$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240803$$CN$US$US
241704181$24170418$1$I$$20240725$20240803$20240803$EXP$$BG-TEVA-VS-3225664$TEVA$IVANOV KZ, Malignant ascites and place of peritoneal tunnel catheters in ?their treatment. Journal of the Bulgarian Oncological Scientific Society/Journal ?of Bulgarian Cancer Scientific Society, 2024/2, pg: 3-45; IVANOV KZ, Malignant ascites and place of peritoneal tunnel catheters in ?their treatment. Journal of the Bulgarian Oncological Scientific Society/Journal ?of Bulgarian Cancer Scientific Society, 2024/2, pg: 3-45$64$YR$$F$Y$$$20240803$$HP$BG$BG
241704191$24170419$1$I$$20240726$20240803$20240803$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02810$AMNEAL$Darnell H, Brenner A, Kern C, Flomenhoft D, Lee E.. Sevelamer-lnduced lschemic Enteritis. ACG Case Rep J. 2024;11(7):e01451$35$YR$$M$Y$$$20240803$$MD$US$US
241704201$24170420$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226717$TEVA$$$$$M$Y$$$20240803$$HP$CA$CA
241704211$24170421$1$I$20240717$20240725$20240803$20240803$PER$$US-SA-2024SA224032$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240803$$CN$US$US
241704221$24170422$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA227584$SANOFI AVENTIS$$$$A$M$Y$$$20240803$$CN$US$US
241704231$24170423$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA227034$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240803$$MD$US$US
241704241$24170424$1$I$20210101$20240729$20240803$20240803$PER$$US-SA-2024SA227572$SANOFI AVENTIS$$7$YR$C$M$Y$62.59$KG$20240803$$MD$US$US
241704251$24170425$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226890$TEVA$$80$YR$$M$Y$59$KG$20240803$$HP$CA$CA
241704262$24170426$2$F$20240729$20240812$20240803$20240814$PER$$US-AMGEN-USASP2024152565$AMGEN$$73$YR$E$M$Y$$$20240814$$CN$US$US
241704271$24170427$1$I$$20240731$20240803$20240803$PER$$US-ROCHE-10000046111$ROCHE$$86$YR$E$F$Y$$$20240803$$MD$US$US
241704281$24170428$1$I$20240602$20240724$20240803$20240803$EXP$$US-GSK-US2024AMR093036$GLAXOSMITHKLINE$$34$YR$$M$Y$$$20240803$$MD$US$US
241704291$24170429$1$I$$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024151946$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241704303$24170430$3$F$20240715$20240829$20240803$20240906$PER$$US-ROCHE-10000040783$ROCHE$$45$YR$A$F$Y$113.4$KG$20240906$$CN$US$US
241704311$24170431$1$I$$20240731$20240803$20240803$PER$$US-ROCHE-10000046353$ROCHE$$$$A$F$Y$$$20240803$$CN$US$US
241704322$24170432$2$F$$20240826$20240803$20240902$PER$$US-ROCHE-10000047332$ROCHE$$$$A$F$Y$$$20240902$$CN$US$US
241704331$24170433$1$I$$20240801$20240803$20240803$PER$$US-ROCHE-10000047138$ROCHE$$$$$$Y$$$20240803$$HP$US$US
241704343$24170434$3$F$20240704$20240904$20240803$20240906$PER$$US-ROCHE-10000038245$ROCHE$$60$YR$A$F$Y$82.55$KG$20240906$$CN$US$US
241704351$24170435$1$I$$20240723$20240803$20240803$EXP$AU-TGA-807951$AU-Accord-437808$ACCORD$$57$YR$A$M$Y$$$20240803$$HP$AU$AU
241704361$24170436$1$I$$20240723$20240803$20240803$EXP$$US-Accord-438441$ACCORD$Arens AM, Sheikh Said H, Driver BE, Cole JB. Physostigmine reversal of delirium from second generation antipsychotic exposure: a retrospective cohort study from a regional poison center. Clin Toxicol (Phila). 2024 Jul;62(7):463-467.$60$YR$A$M$Y$$$20240803$$HP$US$US
241704371$24170437$1$I$20240201$20240730$20240803$20240803$PER$$US-SA-2024SA228617$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240803$$MD$US$US
241704381$24170438$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226691$TEVA$$$$A$F$Y$$$20240803$$CN$CA$CA
241704391$24170439$1$I$$20240729$20240803$20240803$EXP$$US-TEVA-VS-3227914$TEVA$McQuinn D, Hyun M, Kim K, Kenkre VP, Fletcher CD, Rajguru SA, et al. Minimal Residual Disease (MRD) Testing By Next Generation Sequencing (NGS) after Two Cycles (CY) of Non-Intensive Chemoimmunotherapy Is Predictive of Remission Duration and Need for Maintenance Therapy (MT) in Previously Untreated Mantle Cell Lymphoma (MCL): A Wisconsin Oncology Network Study. Blood 2023; 142 (Suppl. 1) 4407-4408 (plus Poster).$$$A$$Y$$$20240803$$MD$US$US
241704401$24170440$1$I$$20240801$20240803$20240803$EXP$$US-VIIV HEALTHCARE LIMITED-US2024096294$VIIV$$$$$$Y$$$20240803$$MD$US$US
241704414$24170441$4$F$20240101$20240911$20240803$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016519$UNITED THERAPEUTICS$$$$$M$Y$57.143$KG$20240914$$$US$US
241704421$24170442$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA225124$SANOFI AVENTIS$$$$A$M$Y$$$20240803$$CN$US$US
241704431$24170443$1$I$20240601$20240726$20240803$20240803$PER$$US-SA-2024SA225131$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240803$$MD$US$US
241704441$24170444$1$I$20240101$20240731$20240803$20240803$PER$$US-SA-2024SA228320$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240803$$MD$US$US
241704451$24170445$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA223743$SANOFI AVENTIS$$$$A$F$Y$$$20240803$$MD$US$US
241704461$24170446$1$I$$20240724$20240803$20240803$EXP$$AZ-TEVA-VS-3226997$TEVA$$$$$$Y$$$20240803$$HP$AZ$AZ
241704471$24170447$1$I$$20240730$20240803$20240803$EXP$$CN-AMGEN-CHNSP2024151578$AMGEN$Zeng H.; Wang Y.; Xue Y. et al.. Treatment and outcomes of patients with B-ALL relapse after CD19 CAR-T therapy. Journal of Translational Medicine. 2024;22 (1):1-3$$$$$Y$$$20240803$$HP$CN$CN
241704483$24170448$3$F$20230421$20240814$20240803$20240821$EXP$$CO-TAKEDA-2023TUS042018$TAKEDA$$16$YR$$F$Y$60$KG$20240821$$CN$CO$CO
241704491$24170449$1$I$$20240729$20240803$20240803$EXP$$GB-AMGEN-GBRSP2024151784$AMGEN$$$$$M$Y$$$20240803$$CN$GB$GB
241704501$24170450$1$I$$20240725$20240803$20240803$PER$$US-AMGEN-USASP2024152799$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;El to E8$$$$$Y$$$20240803$$MD$US$US
241704511$24170451$1$I$$20240729$20240803$20240803$PER$$US-JNJFOC-20240783021$JOHNSON AND JOHNSON$$$$$$Y$$$20240803$$CN$US$US
241704521$24170452$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226704$TEVA$$59$YR$$F$Y$$$20240803$$CN$CA$CA
241704531$24170453$1$I$$20240725$20240803$20240803$PER$$US-AMGEN-USASP2024153402$AMGEN$Cowen E. W.; Tan I. J.; Ferrada M. A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes.. JAMA Dermatology. 2024;E1 to E8$$$$$Y$$$20240803$$MD$US$US
241704541$24170454$1$I$$20240731$20240803$20240803$EXP$$US-AMGEN-USASP2024152842$AMGEN$Grayson P. C.; Luo. Y.; Ferrada M. A. et.al. Ultra-rare genetic variation in relapsing polychondritis- a whole-exome sequencing study. Cancers. 2024;83 (2):253-260$$$$$Y$$$20240803$$MD$US$US
241704551$24170455$1$I$20240101$20240725$20240803$20240803$PER$$US-SA-2024SA223763$SANOFI AVENTIS$$$$T$F$Y$$$20240803$$CN$US$US
241704561$24170456$1$I$20240701$20240731$20240803$20240803$PER$$US-SA-2024SA228337$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240803$$MD$US$US
241704571$24170457$1$I$20240723$20240726$20240803$20240803$PER$$US-SA-2024SA224144$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240803$$CN$US$US
241704581$24170458$1$I$$20240724$20240803$20240803$EXP$$CA-TEVA-VS-3225846$TEVA$$44$YR$$F$Y$$$20240803$$HP$CA$CA
241704591$24170459$1$I$$20240728$20240803$20240803$EXP$$US-AMGEN-USASP2024152666$AMGEN$Kaur V.; Patel R.; Elghawy O. et al.. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer Reports. 2024;7 (7):1-6$84$YR$E$M$Y$$$20240803$$HP$US$US
241704601$24170460$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA227595$SANOFI AVENTIS$$$$A$M$Y$$$20240803$$MD$US$US
241704611$24170461$1$I$$20240726$20240803$20240803$PER$$US-SA-2024SA224145$SANOFI AVENTIS$$$$C$M$Y$$$20240803$$MD$US$US
241704622$24170462$2$F$$20240820$20240803$20240901$PER$$US-AstraZeneca-2024A174402$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
241704631$24170463$1$I$$20240725$20240803$20240803$EXP$$US-GSK-US2024093718$GLAXOSMITHKLINE$$$$$F$Y$$$20240803$$CN$US$US
241704641$24170464$1$I$$20240731$20240803$20240803$PER$$US-SA-2024SA227898$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240803$$MD$US$US
241704651$24170465$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226703$TEVA$$$$$F$Y$$$20240803$$MD$CA$CA
241704671$24170467$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA225532$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240803$$MD$US$US
241704681$24170468$1$I$$20240725$20240803$20240803$30DAY$$US-GSK-US2024AMR094344$GLAXOSMITHKLINE$$$$$F$Y$$$20240803$$CN$US$US
241704691$24170469$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA225529$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240803$$MD$US$US
241704701$24170470$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226676$TEVA$$71$YR$$M$Y$$$20240803$$HP$CA$CA
241704712$24170471$2$F$20240701$20240731$20240803$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020771$UNITED THERAPEUTICS$$73$YR$$F$Y$62.585$KG$20240809$$$US$US
241704721$24170472$1$I$20240731$20240801$20240803$20240803$PER$$US-AMGEN-USASP2024153485$AMGEN$$59$YR$A$M$Y$$$20240803$$HP$US$US
241704731$24170473$1$I$20240729$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024151917$AMGEN$$73$YR$E$F$Y$$$20240803$$CN$US$US
241704741$24170474$1$I$20240101$20240731$20240803$20240803$PER$$US-SA-2024SA228351$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240803$$CN$US$US
241704752$24170475$2$F$20240101$20240830$20240803$20240912$PER$$US-SA-2024SA227923$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240912$$MD$US$US
241704761$24170476$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA223924$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240803$$MD$US$US
241704782$24170478$2$F$$20240724$20240803$20240925$PER$$US-GSK-US2024AMR093086$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
241704791$24170479$1$I$$20240725$20240803$20240803$30DAY$$US-GSK-US2024093750$GLAXOSMITHKLINE$$$$$F$Y$$$20240803$$CN$US$US
241704801$24170480$1$I$$20240725$20240803$20240803$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024093580$VIIV$$7$DEC$$F$Y$$$20240803$$CN$US$US
241704811$24170481$1$I$$20240801$20240803$20240803$PER$$US-AstraZeneca-2024A175984$ASTRAZENECA$$$$$F$Y$$$20240803$$MD$US$
241704821$24170482$1$I$$20240729$20240803$20240803$PER$$US-AstraZeneca-2024A173086$ASTRAZENECA$$$$$F$Y$$$20240803$$CN$US$
241704832$24170483$2$F$$20240813$20240803$20240913$PER$$US-AstraZeneca-2024A173910$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
241704841$24170484$1$I$$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024152368$AMGEN$$$$$F$Y$$$20240803$$CN$US$US
241704851$24170485$1$I$$20240731$20240803$20240803$PER$$US-AMGEN-USASP2024152538$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241704861$24170486$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226660$TEVA$$50$YR$$F$Y$$$20240803$$MD$CA$CA
241704871$24170487$1$I$20240101$20240725$20240803$20240803$PER$$US-SA-2024SA223955$SANOFI AVENTIS$$54$YR$A$F$Y$117.9$KG$20240803$$MD$US$US
241704881$24170488$1$I$20210413$20240725$20240803$20240803$PER$$US-009507513-2408USA000317$MERCK$Sulaiman R, Aske JC, Espaillat LR, Lin X, Starks D, Dale A, et al.. Ex vivo platform en route to functional precision medicine: clinical relevance in gynecological cancers.. American Journal of Cancer Research. 2024;14(6):3083-103$66$YR$$F$Y$$$20240803$$HP$US$US
241704891$24170489$1$I$20200428$20240725$20240803$20240803$PER$$US-009507513-2407USA014528$MERCK$Sulaiman R, Aske JC, Espaillat LR, Lin X, Starks D, Dale A, et al.. Ex vivo platform en route to functional precision medicine: clinical relevance in gynecological cancers.. American Journal of Cancer Research. 2024;14(6):3083-103$62$YR$$F$Y$$$20240803$$HP$US$US
241704902$24170490$2$F$$20240910$20240803$20240917$30DAY$$US-GSK-US2024093476$GLAXOSMITHKLINE$$$$$F$Y$$$20240917$$CN$US$US
241704911$24170491$1$I$$20240725$20240803$20240803$30DAY$$US-GSK-US2024093540$GLAXOSMITHKLINE$$$$$F$Y$$$20240803$$CN$US$US
241704921$24170492$1$I$20240101$20240725$20240803$20240803$PER$$US-SA-2024SA224168$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240803$$MD$US$US
241704931$24170493$1$I$20240701$20240725$20240803$20240803$PER$$US-SA-2024SA224206$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240803$$MD$US$US
241704941$24170494$1$I$20240601$20240729$20240803$20240803$PER$$US-SA-2024SA225096$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240803$$CN$US$US
241704952$24170495$2$F$$20240805$20240803$20240807$PER$$US-AMGEN-USASP2024153098$AMGEN$$$$$M$Y$$$20240807$$MD$US$US
241704961$24170496$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA224369$SANOFI AVENTIS$$$$C$F$Y$41.5$KG$20240803$$MD$US$US
241704971$24170497$1$I$$20240730$20240803$20240803$EXP$$CN-AMGEN-CHNSP2024151543$AMGEN$Zeng H.; Wang Y.; Xue Y. et al.. Treatment and outcomes of patients with B-ALL relapse after CD19 CAR-T therapy. Journal of Translational Medicine. 2024;22 (1):1-3$$$$$Y$$$20240803$$HP$CN$CN
241704981$24170498$1$I$20240501$20240725$20240803$20240803$EXP$FR-AFSSAPS-RN2024000761$FR-TEVA-VS-3226369$TEVA$$57$YR$$M$Y$$$20240803$$MD$FR$FR
241704991$24170499$1$I$$20240730$20240803$20240803$EXP$$CN-AMGEN-CHNSP2024151567$AMGEN$Zeng H.; Wang Y.; Xue Y. et al.. Treatment and outcomes of patients with B-ALL relapse after CD19 CAR-T therapy. Journal of Translational Medicine. 2024;22 (1):1-3$$$$$Y$$$20240803$$HP$CN$CN
241705001$24170500$1$I$$20240730$20240803$20240803$EXP$$CN-AMGEN-CHNSP2024151895$AMGEN$Zeng H.; Wang Y.; Xue Y. et al.. Treatment and outcomes of patients with B-ALL relapse after CD19 CAR-T therapy. Journal of Translational Medicine. 2024;22 (1):1-3$$$$$Y$$$20240803$$HP$CN$CN
241705011$24170501$1$I$$20240722$20240803$20240803$EXP$$US-RDY-LIT/USA/24/0011099$DR REDDYS$Mariano A, Muralidharan S, Beri A, Jain T. TICAGRELOR^S ARRESTING PERFORMANCE AFTER ELECTIVE PCI. Journal of the American College of Cardiology. 2024 Apr 02;83(13): 3324. doi:10.1016/S0735-1097%2824%2905314-2.$66$YR$E$M$Y$$$20240803$$HP$US$US
241705021$24170502$1$I$$20240729$20240803$20240803$EXP$GB-MHRA-TPP49612862C9396304YC1721640855308$GB-RDY-SPO/GBR/24/0011215$DR REDDYS$$72$YR$E$M$Y$$$20240803$$HP$GB$GB
241705031$24170503$1$I$20220101$20240729$20240803$20240803$EXP$GB-MLMSERVICE-20240722-PI138085-00117-1$GB-RDY-SPO/GBR/24/0011227$DR REDDYS$Williams H, Thoppuram N, Law KY, Simms J. Post-operative Post-cognitive dysfunction: Progressive multifocal leukoencephalopathy (PML), an unexpected finding in an elderly patient. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24(Supplement):100041. DOI: 10.1016/j.clinme.2024.100048.$87$YR$E$F$Y$$$20240803$$MD$GB$GB
241705041$24170504$1$I$20240701$20240724$20240803$20240803$EXP$FR-AFSSAPS-ST2024001177$FR-TEVA-VS-3225752$TEVA$$37$YR$$F$Y$146$KG$20240803$$MD$FR$FR
241705051$24170505$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226745$TEVA$$59$YR$$F$Y$$$20240803$$CN$CA$CA
241705061$24170506$1$I$20231101$20240730$20240803$20240803$EXP$$US-JNJFOC-20240780650$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240803$$CN$US$US
241705071$24170507$1$I$$20240730$20240803$20240803$EXP$$CN-AMGEN-CHNSP2024151588$AMGEN$Zeng H.; Wang Y.; Xue Y. et al.. Treatment and outcomes of patients with B-ALL relapse after CD19 CAR-T therapy. Journal of Translational Medicine. 2024;22(1):1-3$$$$$Y$$$20240803$$HP$CN$CN
241705081$24170508$1$I$$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024152217$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241705091$24170509$1$I$20240701$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024151308$AMGEN$$18$MON$I$M$Y$9.5$KG$20240803$$PH$US$US
241705101$24170510$1$I$20240626$20240725$20240803$20240803$EXP$FR-AFSSAPS-LY2024001040$FR-TEVA-VS-3226334$TEVA$$71$YR$$F$Y$$$20240803$$PH$FR$FR
241705111$24170511$1$I$20240605$20240726$20240803$20240803$EXP$FR-AFSSAPS-GR2024000909$FR-TEVA-VS-3227002$TEVA$$75$YR$$M$Y$$$20240803$$PH$FR$FR
241705121$24170512$1$I$$20240731$20240803$20240803$PER$$US-JNJFOC-20240802124$JOHNSON AND JOHNSON$$$$$M$Y$$$20240803$$MD$US$US
241705131$24170513$1$I$$20240722$20240803$20240803$EXP$$US-TEVA-VS-3226012$TEVA$Applegarth J, Finn D, Tolkacz M, Iacco A. Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome. ASAIO-J 2024; 70 (Suppl. 3) 151 (plus Poster) abstr. P74.$18$YR$$F$Y$$$20240803$$HP$US$US
241705141$24170514$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA224618$SANOFI AVENTIS$$$$E$M$Y$83$KG$20240803$$MD$US$US
241705151$24170515$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA224380$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240803$$MD$US$US
241705161$24170516$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226748$TEVA$$3$YR$$M$Y$$$20240803$$HP$CA$CA
241705171$24170517$1$I$20210401$20240726$20240803$20240803$EXP$FR-EMA-DD-20240717-7482827-115727$FR-TEVA-VS-3227254$TEVA$$47$YR$$F$Y$$$20240803$$CN$FR$FR
241705181$24170518$1$I$$20240730$20240803$20240803$PER$$US-ABBVIE-5862528$ABBVIE$$$$$$Y$$$20240803$$HP$US$US
241705191$24170519$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA224608$SANOFI AVENTIS$$$$A$F$Y$61$KG$20240803$$MD$US$US
241705201$24170520$1$I$$20240731$20240803$20240803$PER$$US-SA-2024SA228260$SANOFI AVENTIS$$$$E$F$Y$$$20240803$$MD$US$US
241705211$24170521$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA224508$SANOFI AVENTIS$$$$A$F$Y$81.1$KG$20240803$$MD$US$US
241705221$24170522$1$I$$20240730$20240803$20240803$EXP$$US-JNJFOC-20240781253$JOHNSON AND JOHNSON$$$$$$Y$$$20240803$$CN$US$US
241705231$24170523$1$I$20240701$20240729$20240803$20240803$PER$$US-AMGEN-USASP2024150417$AMGEN$$65$YR$E$M$Y$$$20240803$$CN$US$US
241705241$24170524$1$I$20240701$20240731$20240803$20240803$PER$$US-AstraZeneca-2024A174966$ASTRAZENECA$$69$YR$$M$Y$96.2$KG$20240803$$MD$US$
241705251$24170525$1$I$20240730$20240730$20240803$20240803$PER$$US-AMGEN-USASP2024151789$AMGEN$$$$$$Y$$$20240803$$CN$US$US
241705261$24170526$1$I$$20240731$20240803$20240803$PER$$US-SA-2024SA228387$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240803$$MD$US$US
241705271$24170527$1$I$20240708$20240725$20240803$20240803$PER$$US-SA-2024SA224816$SANOFI AVENTIS$$48$YR$A$F$Y$70.3$KG$20240803$$MD$US$US
241705281$24170528$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA228277$SANOFI AVENTIS$$58$YR$A$F$Y$107$KG$20240803$$MD$US$US
241705291$24170529$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA225881$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240803$$MD$US$US
241705301$24170530$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA225923$SANOFI AVENTIS$$56$YR$A$M$Y$102$KG$20240803$$MD$US$US
241705311$24170531$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA225083$SANOFI AVENTIS$$$$A$M$Y$$$20240803$$MD$US$US
241705321$24170532$1$I$20240605$20240726$20240803$20240803$EXP$FR-AFSSAPS-AN2024000920$FR-TEVA-VS-3227064$TEVA$$53$YR$$F$Y$48.5$KG$20240803$$MD$FR$FR
241705332$24170533$2$F$$20240729$20240803$20240805$EXP$$US-AMGEN-USASP2024152025$AMGEN$$$$$$Y$$$20240805$$HP$US$US
241705341$24170534$1$I$$20240724$20240803$20240803$EXP$$US-GSK-US2024AMR094571$GLAXOSMITHKLINE$$$$$F$Y$$$20240803$$CN$US$US
241705351$24170535$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226638$TEVA$$$$E$F$Y$$$20240803$$HP$CA$CA
241705361$24170536$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226605$TEVA$$65$YR$$M$Y$$$20240803$$HP$CA$CA
241705371$24170537$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226621$TEVA$$78$YR$$F$Y$90$KG$20240803$$HP$CA$CA
241705381$24170538$1$I$$20240724$20240803$20240803$EXP$$CA-TEVA-VS-3226556$TEVA$$40$YR$$F$Y$96$KG$20240803$$HP$CA$CA
241705391$24170539$1$I$$20240726$20240803$20240803$PER$$US-AstraZeneca-2024A171735$ASTRAZENECA$$$$$M$Y$$$20240803$$CN$US$
241705402$24170540$2$F$$20240725$20240803$20240819$PER$$US-AstraZeneca-2024A172857$ASTRAZENECA$$$$$$Y$$$20240819$$HP$US$
241705411$24170541$1$I$$20240729$20240803$20240803$PER$$US-AstraZeneca-2024A173620$ASTRAZENECA$$$$$F$Y$$$20240803$$CN$US$
241705423$24170542$3$F$$20240906$20240803$20240913$EXP$$US-ABBVIE-5500854$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
241705431$24170543$1$I$$20240726$20240803$20240803$EXP$$US-AMGEN-USASP2024149866$AMGEN$$$$$F$Y$$$20240803$$CN$US$US
241705441$24170544$1$I$20221001$20240730$20240803$20240803$EXP$$US-ABBVIE-5851701$ABBVIE$$65$YR$$M$Y$90.718$KG$20240803$$CN$US$US
241705451$24170545$1$I$$20240724$20240803$20240803$EXP$$US-GSK-US2024093538$GLAXOSMITHKLINE$$$$$$Y$$$20240803$$PH$US$US
241705461$24170546$1$I$$20240730$20240803$20240803$EXP$$US-JNJFOC-20240781467$JOHNSON AND JOHNSON$$$$$$Y$$$20240803$$CN$US$US
241705471$24170547$1$I$20240101$20240730$20240803$20240803$EXP$$US-ABBVIE-5671971$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241705481$24170548$1$I$20150101$20240731$20240803$20240803$PER$$US-SA-2024SA228140$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240803$$CN$US$US
241705491$24170549$1$I$20240701$20240729$20240803$20240803$PER$$US-SA-2024SA225500$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240803$$CN$US$US
241705503$24170550$3$F$20240729$20240827$20240803$20240829$PER$$US-AMGEN-USASP2024152043$AMGEN$$66$YR$E$M$Y$$$20240828$$CN$US$US
241705511$24170551$1$I$20240501$20240724$20240803$20240803$30DAY$$US-GSK-US2024092919$GLAXOSMITHKLINE$$52$YR$$F$Y$72.562$KG$20240803$$CN$US$US
241705521$24170552$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3226624$TEVA$$45$YR$$M$Y$136$KG$20240803$$HP$CA$CA
241705532$24170553$2$F$20240731$20240731$20240803$20240809$PER$$US-SA-2024SA228076$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240809$$MD$US$US
241705541$24170554$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226742$TEVA$$75$YR$$M$Y$73$KG$20240803$$HP$CA$CA
241705551$24170555$1$I$$20240726$20240803$20240803$EXP$$CA-TEVA-VS-3226747$TEVA$$52$YR$$F$Y$69$KG$20240803$$HP$CA$CA
241705561$24170556$1$I$20240701$20240726$20240803$20240803$PER$$US-SA-2024SA225956$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240803$$MD$US$US
241705571$24170557$1$I$$20240731$20240803$20240803$EXP$$US-ABBVIE-5827512$ABBVIE$$$$$F$Y$$$20240803$$CN$US$US
241705581$24170558$1$I$20240115$20240726$20240803$20240803$EXP$FR-AFSSAPS-PC2024000580$FR-TEVA-VS-3227221$TEVA$$70$YR$$F$Y$60$KG$20240803$$PH$FR$FR
241705591$24170559$1$I$$20240731$20240803$20240803$PER$$US-ABBVIE-5864057$ABBVIE$$$$$$Y$$$20240803$$HP$US$US
241705601$24170560$1$I$20230901$20240730$20240803$20240803$EXP$$US-ABBVIE-5468444$ABBVIE$$57$YR$$M$Y$$$20240803$$CN$US$US
241705611$24170561$1$I$20240101$20240731$20240803$20240803$EXP$$US-ABBVIE-5864165$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241705621$24170562$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA227551$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240803$$CN$US$US
241705632$24170563$2$F$20240101$20240819$20240803$20240828$PER$$US-SA-2024SA223693$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240828$$MD$US$US
241705641$24170564$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA225100$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240803$$MD$US$US
241705651$24170565$1$I$20240710$20240731$20240803$20240803$EXP$$US-ABBVIE-5863938$ABBVIE$$38$YR$$F$Y$$$20240803$$CN$US$US
241705661$24170566$1$I$20231004$20240726$20240803$20240803$EXP$IT-MINISAL02-995602$IT-TEVA-VS-3226939$TEVA$$86$YR$$F$Y$$$20240803$$MD$IT$IT
241705671$24170567$1$I$20240101$20240731$20240803$20240803$EXP$$US-ABBVIE-5864083$ABBVIE$$$$$M$Y$$$20240803$$CN$US$US
241705681$24170568$1$I$20240717$20240801$20240803$20240803$EXP$$CA-ABBVIE-5864964$ABBVIE$$61$YR$$F$Y$$$20240803$$CN$CA$CA
241705692$24170569$2$F$$20240805$20240803$20240809$EXP$$US-ABBVIE-5862420$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241705701$24170570$1$I$20240719$20240730$20240803$20240803$EXP$$US-ABBVIE-5862144$ABBVIE$$46$YR$$F$Y$$$20240803$$CN$US$US
241705711$24170571$1$I$20240101$20240801$20240803$20240803$EXP$$AT-ABBVIE-5864175$ABBVIE$$35$YR$$F$Y$$$20240803$$CN$AT$AT
241705721$24170572$1$I$20240701$20240731$20240803$20240803$PER$$US-ABBVIE-5864264$ABBVIE$$81$YR$$M$Y$$$20240803$$MD$US$US
241705731$24170573$1$I$20240101$20240801$20240803$20240803$EXP$$UY-ABBVIE-5647671$ABBVIE$$$$$F$Y$$$20240803$$CN$UY$UY
241705741$24170574$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA223855$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240803$$MD$US$US
241705751$24170575$1$I$20240301$20240725$20240803$20240803$PER$$US-SA-2024SA223775$SANOFI AVENTIS$$24$YR$A$M$Y$110$KG$20240803$$MD$US$US
241705762$24170576$2$F$20240726$20240802$20240803$20240819$PER$$US-AMGEN-USASP2024151560$AMGEN$$66$YR$E$F$Y$$$20240819$$CN$US$US
241705771$24170577$1$I$20230901$20240725$20240803$20240803$EXP$CH-SM-2024-13937$CH-TEVA-VS-3227540$TEVA$$58$YR$$F$Y$$$20240803$$MD$CH$CH
241705791$24170579$1$I$$20240725$20240803$20240803$PER$$US-SA-2024SA223741$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240803$$MD$US$US
241705801$24170580$1$I$$20240729$20240803$20240803$EXP$$US-ALXN-202407USA001994US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240803$$CN$US$US
241705811$24170581$1$I$$20240726$20240803$20240803$EXP$$US-JNJFOC-20240773495$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240803$$MD$US$US
241705821$24170582$1$I$$20240729$20240803$20240803$PER$$US-SA-2024SA225379$SANOFI AVENTIS$$16$YR$T$M$Y$67.4$KG$20240803$$MD$US$US
241705831$24170583$1$I$20240615$20240725$20240803$20240803$EXP$CH-SM-2024-14134$CH-TEVA-VS-3226710$TEVA$$68$YR$$F$Y$$$20240803$$PH$CH$CH
241705841$24170584$1$I$$20240730$20240803$20240803$PER$$US-SA-2024SA227630$SANOFI AVENTIS$$$$A$M$Y$77.11$KG$20240803$$MD$US$US
241705851$24170585$1$I$20240101$20240729$20240803$20240803$PER$$US-SA-2024SA225372$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240803$$MD$US$US
241705861$24170586$1$I$$20240801$20240803$20240803$PER$$US-ELI_LILLY_AND_COMPANY-US202408001053$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240803$$CN$US$US
241705871$24170587$1$I$20240314$20240725$20240803$20240803$EXP$CH-SM-2024-13908$CH-TEVA-VS-3226739$TEVA$$88$YR$$M$Y$$$20240803$$PH$CH$CH
241705881$24170588$1$I$20240724$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53325$$FDA-CTU$$30$YR$$F$N$$$20240802$N$HP$US$
241705891$24170589$1$I$20240724$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53341$$FDA-CTU$$30$YR$$F$N$$$20240802$N$HP$US$
241705901$24170590$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53351$$FDA-CTU$$$$$M$N$$$20240802$N$HP$US$
241705911$24170591$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53356$$FDA-CTU$$$$$M$N$$$20240802$N$HP$US$
241705921$24170592$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53281$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
241705931$24170593$1$I$20240624$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53333$$FDA-CTU$$80$YR$$F$N$$$20240802$Y$PH$US$
241705941$24170594$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53291$$FDA-CTU$$59$YR$$F$N$$$20240802$N$HP$US$
241705951$24170595$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53345$$FDA-CTU$$66$YR$$F$N$$$20240802$N$$US$
241705961$24170596$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53247$$FDA-CTU$$45$YR$$F$N$$$20240802$N$$US$
241705981$24170598$1$I$20240712$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53264$$FDA-CTU$$29$YR$$F$N$$$20240802$N$$US$
241706001$24170600$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53255$$FDA-CTU$$63$YR$$F$N$40.82$KG$20240802$N$$US$
241706041$24170604$1$I$20240728$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53260$$FDA-CTU$$69$YR$$F$N$$$20240802$N$HP$US$
241706081$24170608$1$I$20240729$20240730$20240802$20240802$DIR$FDA-CDER-CTU-2024-53252$$FDA-CTU$$25$YR$$M$N$$$20240730$N$HP$US$
241706091$24170609$1$I$20240724$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-53218$$FDA-CTU$$71$YR$$F$N$69$KG$20240801$N$PH$US$
241706101$24170610$1$I$20240707$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-53226$$FDA-CTU$$21$YR$$F$N$124.74$KG$20240801$Y$CN$US$
241706171$24170617$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53243$$FDA-CTU$$36$YR$$F$N$$$20240802$N$$US$
241706181$24170618$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53242$$FDA-CTU$$42$YR$$F$N$211$LBS$20240802$N$HP$US$
241706191$24170619$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53329$$FDA-CTU$$30$YR$$F$N$150$LBS$20240802$N$$US$
241706221$24170622$1$I$20240725$20240802$20240802$20240802$DIR$712591$$FDA-CTU$$50$YR$$M$N$85.5$KG$20240802$N$CN$US$
241706231$24170623$1$I$20240801$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53246$$FDA-CTU$$67$YR$$M$N$$$20240802$N$HP$US$
241706241$24170624$1$I$20240731$20240802$20240802$20240802$DIR$712593$$FDA-CTU$$67$YR$$F$N$80.1$KG$20240802$N$CN$US$
241706251$24170625$1$I$$20240802$20240802$20240802$DIR$712601$$FDA-CTU$$70$YR$$F$N$$$20240802$N$CN$US$
241706261$24170626$1$I$20240731$20240802$20240802$20240802$DIR$712604$$FDA-CTU$$84$YR$$M$N$84.15$KG$20240802$N$CN$US$
241706271$24170627$1$I$20240621$20240802$20240805$20240805$DIR$FDA-CDER-CTU-2024-53364$$FDA-CTU$$14$YR$$M$N$60.8$KG$20240802$N$PH$US$
241706281$24170628$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53340$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
241706291$24170629$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53346$$FDA-CTU$$$$$M$N$$$20240802$N$HP$US$
241706301$24170630$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53343$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
241706311$24170631$1$I$20240802$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53301$$FDA-CTU$$82$YR$$M$N$$$20240802$Y$HP$US$
241706331$24170633$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53342$$FDA-CTU$$84$YR$$M$N$$$20240802$N$$US$
241706341$24170634$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53254$$FDA-CTU$$45$YR$$F$N$$$20240802$N$$US$
241706361$24170636$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53348$$FDA-CTU$$40$YR$$F$N$305$LBS$20240802$N$$US$
241706371$24170637$1$I$20240727$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53347$$FDA-CTU$$51$YR$$F$N$$$20240802$Y$PH$US$
241706381$24170638$1$I$20240724$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53297$$FDA-CTU$$68$YR$$M$N$$$20240802$N$HP$US$
241706391$24170639$1$I$20240718$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53262$$FDA-CTU$$80$YR$$F$N$$$20240802$Y$HP$US$
241706401$24170640$1$I$20240718$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53358$$FDA-CTU$$80$YR$$F$N$$$20240802$Y$PH$US$
241706411$24170641$1$I$20240718$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53359$$FDA-CTU$$80$YR$$F$N$$$20240802$Y$PH$US$
241706421$24170642$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53261$$FDA-CTU$$94$YR$$F$N$$$20240802$N$$US$
241706431$24170643$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53334$$FDA-CTU$$70$YR$$F$N$106$LBS$20240802$N$$US$
241706441$24170644$1$I$20240802$20240802$20240802$20240802$DIR$712650$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241706451$24170645$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53244$$FDA-CTU$$76$YR$$F$N$129$LBS$20240802$N$$US$
241706461$24170646$1$I$20240802$20240802$20240802$20240802$DIR$712666$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241706471$24170647$1$I$$20240802$20240802$20240802$DIR$712665$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241706481$24170648$1$I$20240802$20240802$20240802$20240802$DIR$712661$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241706491$24170649$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53277$$FDA-CTU$$73$YR$$F$N$$$20240802$N$$US$
241706501$24170650$1$I$20240802$20240802$20240802$20240802$DIR$712671$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241706511$24170651$1$I$20240802$20240802$20240802$20240802$DIR$712672$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241706521$24170652$1$I$$20240724$20240803$20240803$EXP$$CA-TEVA-VS-3227922$TEVA$$$$$F$Y$$$20240803$$HP$CA$CA
241706531$24170653$1$I$$20240725$20240803$20240803$EXP$$CA-TEVA-VS-3227920$TEVA$$72$YR$$M$Y$$$20240803$$HP$CA$CA
241706541$24170654$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53251$$FDA-CTU$$61$YR$$F$N$170$LBS$20240802$N$$US$
241706551$24170655$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53354$$FDA-CTU$$44$YR$$M$N$$$20240802$N$$US$
241706561$24170656$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53353$$FDA-CTU$$54$YR$$M$N$227$LBS$20240802$N$$US$
241706571$24170657$1$I$20231226$20240802$20240802$20240802$DIR$712605$$FDA-CTU$$15$YR$$F$N$$$20240802$N$CN$US$
241706601$24170660$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53266$$FDA-CTU$$44$YR$$M$N$$$20240802$N$$US$
241706621$24170662$1$I$$20240801$20240802$20240802$DIR$FDA-CDER-CTU-2024-53241$$FDA-CTU$$$$$F$N$$$20240801$N$HP$US$
241706641$24170664$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53267$$FDA-CTU$$58$YR$$F$N$$$20240802$N$$US$
241706651$24170665$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53263$$FDA-CTU$$81$YR$$F$N$$$20240802$N$$US$
241706661$24170666$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53282$$FDA-CTU$$80$YR$$F$N$$$20240802$N$$US$
241706671$24170667$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53337$$FDA-CTU$$85$YR$$F$N$180$LBS$20240802$N$HP$US$
241706681$24170668$1$I$20240528$20240802$20240802$20240802$DIR$712634$$FDA-CTU$$61$YR$$F$N$80.55$KG$20240802$Y$CN$US$
241706691$24170669$1$I$20240802$20240802$20240802$20240802$DIR$712676$$FDA-CTU$$$$$UNK$N$$$20240802$N$CN$US$
241706701$24170670$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53280$$FDA-CTU$$51$YR$$F$N$$$20240802$N$$US$
241706721$24170672$1$I$20240716$20240802$20240802$20240802$DIR$712680$$FDA-CTU$$69$YR$$F$N$54.9$KG$20240802$N$CN$US$
241706731$24170673$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53268$$FDA-CTU$$70$YR$$F$N$$$20240802$N$HP$US$
241706741$24170674$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53357$$FDA-CTU$$$$$M$N$$$20240802$N$HP$US$
241706751$24170675$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53352$$FDA-CTU$$$$$M$N$$$20240802$N$$US$
241706761$24170676$1$I$$20240802$20240802$20240802$DIR$712684$$FDA-CTU$$$$$M$N$$$20240802$Y$HP$US$
241706771$24170677$1$I$20240802$20240802$20240802$20240802$DIR$712678$$FDA-CTU$$43$YR$$M$N$$$20240802$N$$US$
241706781$24170678$1$I$$20240802$20240802$20240802$DIR$712637$$FDA-CTU$$$$$UNK$N$$$20240802$$CN$US$
241706791$24170679$1$I$20240213$20240802$20240802$20240802$DIR$712688$$FDA-CTU$$$$$UNK$N$$$20240802$N$PH$US$
241706801$24170680$1$I$20240731$20240802$20240802$20240802$DIR$712669$$FDA-CTU$$58$YR$$F$N$$$20240802$N$HP$US$
241706811$24170681$1$I$$20240802$20240803$20240803$DIR$FDA-CDER-CTU-2024-53270$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
241706821$24170682$1$I$20141001$20240802$20240802$20240802$DIR$712681$$FDA-CTU$$61$YR$$F$N$58.5$KG$20240802$N$CN$US$
241706831$24170683$1$I$20240222$20240802$20240802$20240802$DIR$712686$$FDA-CTU$$$$$UNK$N$$$20240802$N$PH$US$
241706851$24170685$1$I$20240802$20240802$20240802$20240802$DIR$712645$$FDA-CTU$$43$YR$$F$N$108$KG$20240802$N$HP$US$
241706861$24170686$1$I$20240204$20240802$20240802$20240802$DIR$712692$$FDA-CTU$$$$$UNK$N$$$20240802$N$PH$US$
241706881$24170688$1$I$20240802$20240802$20240802$20240802$DIR$712667$$FDA-CTU$$64$YR$$UNK$N$$$20240802$Y$$US$
241706891$24170689$1$I$20240715$20240802$20240802$20240802$DIR$712690$$FDA-CTU$$69$YR$$M$N$85.5$KG$20240802$N$CN$US$
241706901$24170690$1$I$20240802$20240802$20240802$20240802$DIR$712663$$FDA-CTU$$73$YR$$M$N$140.85$KG$20240802$N$PH$US$
241706931$24170693$1$I$$20240802$20240802$20240802$DIR$712689$$FDA-CTU$$$$$UNK$N$$$20240802$$CN$US$
241706941$24170694$1$I$20240531$20240802$20240802$20240802$DIR$712695$$FDA-CTU$$41$YR$$M$N$73.8$KG$20240802$Y$MD$US$
241706951$24170695$1$I$20230608$20240802$20240803$20240803$DIR$FDA-CDER-CTU-2024-53276$$FDA-CTU$$$$$F$N$67.7$KG$20240802$N$$US$
241706971$24170697$1$I$20240611$20240731$20240803$20240803$DIR$FDA-CDER-CTU-2024-53275$$FDA-CTU$$$$$F$N$81.2$KG$20240731$N$$US$
241706981$24170698$1$I$20230511$20240801$20240803$20240803$DIR$FDA-CDER-CTU-2024-53278$$FDA-CTU$$$$$F$N$68.2$KG$20240801$N$$US$
241707021$24170702$1$I$20240726$20240802$20240802$20240802$DIR$712705$$FDA-CTU$$50$YR$$M$N$129.15$KG$20240802$N$PH$US$
241707031$24170703$1$I$20240422$20240802$20240803$20240803$DIR$FDA-CDER-CTU-2024-53279$$FDA-CTU$$68$YR$$F$N$59.6$KG$20240802$N$$US$
241707041$24170704$1$I$20240801$20240802$20240803$20240803$DIR$FDA-CDER-CTU-2024-53272$$FDA-CTU$$$$$M$N$103.3$KG$20240802$N$$US$
241707081$24170708$1$I$20240801$20240802$20240803$20240803$DIR$FDA-CDER-CTU-2024-53273$$FDA-CTU$$$$$M$N$103.3$KG$20240802$N$$US$
241707101$24170710$1$I$$20240802$20240803$20240803$DIR$FDA-CDER-CTU-2024-53269$$FDA-CTU$$$$$M$N$$$20240802$N$HP$US$
241707111$24170711$1$I$$20240803$20240803$20240803$DIR$FDA-CDER-CTU-2024-53271$$FDA-CTU$$77$YR$$F$N$$$20240803$N$$US$
241707121$24170712$1$I$20240802$20240802$20240802$20240802$DIR$712710$$FDA-CTU$$43$YR$$M$N$117$KG$20240802$N$$US$
241707141$24170714$1$I$20240728$20240802$20240803$20240803$DIR$FDA-CDER-CTU-2024-53274$$FDA-CTU$$$$$M$N$135$KG$20240802$N$$US$
241707151$24170715$1$I$20240525$20240802$20240802$20240802$DIR$712702$$FDA-CTU$$24$YR$$F$N$128.7$KG$20240802$N$CN$US$
241707161$24170716$1$I$$20240722$20240805$20240805$EXP$$GB-AZURITY PHARMACEUTICALS, INC.-AZR202407-000190$AZURITY PHARMACEUTICALS$Kopernicka G, Chew J.. Acute urinary retention and constipation caused by multi-dermatomal herpes zoster in an immunosuppressed patient.. J Clin Med. 2024;24:9$71$YR$$F$Y$$$20240805$$HP$GB$GB
241707171$24170717$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000048493$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$72$YR$E$M$Y$$$20240805$$HP$JP$JP
241707181$24170718$1$I$20240723$20240723$20240805$20240805$PER$$US-BAYER-2024A107450$BAYER$$5$YR$C$M$Y$$$20240805$$CN$US$US
241707194$24170719$4$F$20240726$20240828$20240805$20240905$EXP$$BR-AKCEA THERAPEUTICS, INC.-2024IS006146$AKCEA THERAPEUTICS$$$$$$Y$$$20240904$$MD$BR$BR
241707201$24170720$1$I$$20240724$20240805$20240805$EXP$$IT-MEDLEY-000014$MEDLEY PHARMACEUTICALS$$30$YR$A$F$Y$$$20240726$$MD$IT$IT
241707222$24170722$2$F$20220425$20240802$20240805$20240806$EXP$$US-ROCHE-10000048205$ROCHE$$36$YR$A$F$Y$167.38$KG$20240806$$CN$US$US
241707231$24170723$1$I$20240624$20240729$20240805$20240805$EXP$GR-GREOF-202400805$GR-REGENERON PHARMACEUTICALS, INC.-2024-106083$REGENERON$$85$YR$$M$Y$$$20240805$$MD$GR$GR
241707242$24170724$2$F$20240801$20240808$20240805$20240809$EXP$$JP-BAYER-2024A112092$BAYER$$3$DEC$A$$Y$$$20240809$$PH$JP$JP
241707251$24170725$1$I$20240626$20240722$20240805$20240805$EXP$$DE-GLENMARK PHARMACEUTICALS-2024GMK092681$GLENMARK$$$$$$Y$$$20240805$$MD$DE$DE
241707261$24170726$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240805044$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$MD$US$US
241707272$24170727$2$F$20240801$20240807$20240805$20240809$EXP$$CA-ROCHE-10000048100$ROCHE$$41$YR$A$M$Y$$$20240809$$CN$CA$CA
241707283$24170728$3$F$20240827$20240827$20240805$20240905$EXP$$CA-AKCEA THERAPEUTICS, INC.-2024IS006120$AKCEA THERAPEUTICS$$$$$$Y$$$20240905$$CN$CA$CA
241707301$24170730$1$I$$20240728$20240805$20240805$EXP$$EG-JNJFOC-20240779550$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$HP$EG$EG
241707312$24170731$2$F$20240701$20240812$20240805$20240820$EXP$$DE-AKCEA THERAPEUTICS, INC.-2024IS006118$AKCEA THERAPEUTICS$$$$$$Y$$$20240820$$HP$DE$DE
241707333$24170733$3$F$20240728$20240823$20240805$20240826$PER$$US-ALXN-202407USA002111US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241707341$24170734$1$I$20230707$20240729$20240805$20240805$EXP$$JP-009507513-2407JPN005030J$MERCK$$68$YR$$M$Y$93$KG$20240805$$PH$JP$JP
241707351$24170735$1$I$20231103$20231206$20240805$20240805$EXP$$NVSC2023MX221166$NOVARTIS$$65$YR$$M$Y$69$KG$20240805$$CN$MX$MX
241707361$24170736$1$I$$20240729$20240805$20240805$EXP$$US-MYLANLABS-2024M1072678$MYLAN$Benes L, Nelson N, Sloane MF. Lemierre^s Syndrome Complicated by Tension Hemothorax in the Setting of the Concomitant Use of Intrapleural Fibrinolytics and Systemic Anticoagulation. Am-J-Respir-Crit-Care-Med 2023; 207.$20$YR$$M$Y$$$20240805$$HP$US$US
241707371$24170737$1$I$$20240802$20240804$20240804$DIR$FDA-CDER-CTU-2024-53360$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
241707381$24170738$1$I$$20240728$20240805$20240805$PER$$US-BAYER-2024A111852$BAYER$$$$$$Y$$$20240805$$CN$US$US
241707391$24170739$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122532$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$45.36$KG$20240805$$CN$US$US
241707401$24170740$1$I$$20240804$20240804$20240804$DIR$FDA-CDER-CTU-2024-53238$$FDA-CTU$$71$YR$$F$N$$$20240804$N$$US$
241707411$24170741$1$I$20211020$20240802$20240802$20240802$DIR$712713$$FDA-CTU$$65$YR$$M$N$76.5$KG$20240802$N$CN$US$
241707422$24170742$2$F$20240701$20240722$20240805$20240805$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000199$DENDREON$$$$$$Y$$$20240804$$HP$COUNTRY NOT SPECIFIED$US
241707431$24170743$1$I$$20240711$20240805$20240805$PER$$US-009507513-2407USA008595$MERCK$Permpalung N, Chiang TPY, Manothummetha K, Ostrander D, Datta K, Segev DL, et al. Invasive Fungal Infections in Inpatient Solid Organ Transplant Recipients With COVID-19: A Multicenter Retrospective Cohort. Transplantation. 2024;108:1613-1622$67$YR$$M$Y$$$20240805$$MD$US$US
241707451$24170745$1$I$$20240729$20240805$20240805$EXP$$ES-MYLANLABS-2024M1070746$MYLAN$Fern?ndez-Concha I, Pose K, de las Vecillas L, Lluch-Bernal M, Tom?s-P?rez M, Soto T, et al.. Successful desensitization to lenalidomide in leukocytoclastic vasculitis. Journal of Investigational Allergology + Clinical Immunology. 2024;34(5):1-2$82$YR$$F$Y$$$20240805$$HP$ES$ES
241707461$24170746$1$I$20240802$20240802$20240802$20240802$DIR$712708$$FDA-CTU$$46$YR$$F$N$$$20240802$N$CN$US$
241707472$24170747$2$F$20240719$20240725$20240805$20240805$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000204$DENDREON$$88$YR$$M$Y$$$20240804$$HP$US$US
241707491$24170749$1$I$$20240729$20240805$20240805$PER$$US-BAYER-2024A109945$BAYER$$$$$F$Y$$$20240805$$CN$US$US
241707504$24170750$4$F$20240305$20240919$20240805$20240926$EXP$$US-MYLANLABS-2024M1071859$MYLAN$$59$YR$$F$Y$90.72$KG$20240926$$CN$US$US
241707513$24170751$3$F$$20240822$20240805$20240829$30DAY$$US-MYLANLABS-2024M1071406$MYLAN$$$$$$Y$$$20240829$$PH$US$US
241707522$24170752$2$F$$20240905$20240805$20240913$30DAY$$US-MYLANLABS-2024M1070466$MYLAN$$$$$F$Y$$$20240913$$CN$US$US
241707531$24170753$1$I$20240520$20240802$20240802$20240802$DIR$712712$$FDA-CTU$$62$YR$$F$N$67.5$KG$20240802$Y$CN$US$
241707542$24170754$2$F$$20240813$20240805$20240819$EXP$$DE-MYLANLABS-2023M1041284$MYLAN$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$3$DY$$$Y$$$20240819$$MD$DE$DE
241707551$24170755$1$I$20240724$20240802$20240802$20240802$DIR$712716$$FDA-CTU$$48$YR$$M$N$98.1$KG$20240802$Y$CN$US$
241707561$24170756$1$I$20240401$20240716$20240805$20240805$PER$$CA-TOLMAR, INC.-24CA051086$TOLMAR$$62$YR$$M$Y$$$20240802$$CN$CA$CA
241707571$24170757$1$I$$20240716$20240805$20240805$PER$$CA-TOLMAR, INC.-24CA051087$TOLMAR$$$$$M$Y$$$20240802$$CN$CA$CA
241707582$24170758$2$F$$20240807$20240805$20240810$EXP$$CA-TAKEDA-2024TUS078001$TAKEDA$$$$$M$Y$$$20240810$$CN$CA$CA
241707591$24170759$1$I$20240718$20240729$20240805$20240805$EXP$$CN-SA-2024SA229569$SANOFI AVENTIS$$59$YR$A$M$Y$66.1$KG$20240805$$HP$CN$CN
241707621$24170762$1$I$$20240104$20240805$20240805$EXP$$NVSC2024US012074$NOVARTIS$$$$$M$Y$$$20240805$$CN$US$US
241707631$24170763$1$I$20231107$20240729$20240805$20240805$EXP$ES-AEMPS-1548582$ES-MYLANLABS-2024M1070873$MYLAN$$72$YR$$M$Y$$$20240805$$MD$ES$ES
241707641$24170764$1$I$20240731$20240731$20240805$20240805$EXP$$US-SA-2024SA228590$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240805$$MD$US$US
241707651$24170765$1$I$20240617$20240729$20240805$20240805$EXP$$BR-AKCEA THERAPEUTICS, INC.-2024IS006131$AKCEA THERAPEUTICS$$$$$$Y$$$20240802$$MD$BR$BR
241707661$24170766$1$I$20240717$20240730$20240805$20240805$EXP$$US-Stemline Therapeutics, Inc.-2024ST004658$STEMLINE THERAPEUTICS$$58$YR$A$F$Y$$$20240802$$CN$US$US
241707671$24170767$1$I$$20240725$20240805$20240805$EXP$$US-Stemline Therapeutics, Inc.-2024ST004553$STEMLINE THERAPEUTICS$$56$YR$A$F$Y$$$20240802$$CN$US$US
241707681$24170768$1$I$$20240731$20240805$20240805$EXP$$US-SA-2024SA228818$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$MD$US$US
241707691$24170769$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153476$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241707701$24170770$1$I$20240723$20240730$20240805$20240805$PER$$US-BAYER-2024A110263$BAYER$$37$YR$A$F$Y$$$20240805$$HP$US$US
241707711$24170771$1$I$$20240115$20240805$20240805$EXP$$NVSC2024US011885$NOVARTIS$$$$$M$Y$$$20240805$$CN$US$US
241707722$24170772$2$F$20240613$20240802$20240805$20240808$PER$$US-AMGEN-USASP2024154196$AMGEN$$70$YR$E$M$Y$$$20240807$$CN$US$US
241707731$24170773$1$I$20240723$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024153871$AMGEN$$$$$M$Y$$$20240805$$PH$US$US
241707741$24170774$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153464$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241707751$24170775$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123075$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$71.67$KG$20240805$$CN$US$US
241707761$24170776$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122428$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240805$$CN$US$US
241707771$24170777$1$I$20240723$20240729$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121116$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240805$$HP$US$US
241707781$24170778$1$I$20240731$20240725$20240805$20240805$EXP$$CA-TAKEDA-2024TUS076145$TAKEDA$$54$YR$$F$Y$$$20240805$$CN$CA$CA
241707791$24170779$1$I$20240719$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001328$ELI LILLY AND CO$$$$$M$Y$$$20240805$$CN$US$US
241707801$24170780$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001070$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240805$$CN$US$US
241707811$24170781$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001205$ELI LILLY AND CO$$$$$M$Y$$$20240805$$CN$US$US
241707821$24170782$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000049$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240805$$CN$US$US
241707831$24170783$1$I$$20240723$20240805$20240805$EXP$$US-CIPLA LTD.-2024US08268$CIPLA$Zulch E, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, et al.. Impact of post-transplant Cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143 (107530):1 to 8$$$$$Y$$$20240805$$HP$US$US
241707841$24170784$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001794$ELI LILLY AND CO$$$$A$F$Y$$$20240805$$CN$US$US
241707851$24170785$1$I$$20240802$20240805$20240805$EXP$$CA-ROCHE-10000048163$ROCHE$$$$A$F$Y$$$20240805$$CN$CA$CA
241707861$24170786$1$I$$20191202$20240805$20240805$EXP$$CA-Covis Pharma GmbH-2021COV22174$COVIS PHARMA$$67$YR$E$M$Y$86$KG$20240805$$$COUNTRY NOT SPECIFIED$CA
241707873$24170787$3$F$$20240911$20240805$20240923$EXP$$DE-ROVI-20240743$ROVIPHARM SAS$$$$A$M$Y$$$20240920$$MD$DE$DE
241707881$24170788$1$I$$20240723$20240805$20240805$EXP$$GB-CIPLA LTD.-2024GB08039$CIPLA$$$$$$Y$$$20240805$$CN$GB$GB
241707891$24170789$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153443$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241707901$24170790$1$I$$20240724$20240805$20240805$PER$$US-BAYER-2024A108203$BAYER$$9$YR$C$F$Y$$$20240805$$CN$US$US
241707911$24170791$1$I$$20240723$20240805$20240805$EXP$$US-CIPLA LTD.-2024US08413$CIPLA$Zulch E, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, et al.. Impact of post-transplant Cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143 (107530):1 to 8$$$$$Y$$$20240805$$HP$US$US
241707921$24170792$1$I$$20240119$20240805$20240805$EXP$$NVSC2024US017756$NOVARTIS$$$$$M$Y$$$20240805$$CN$US$US
241707931$24170793$1$I$20240705$20240802$20240805$20240805$EXP$$US-ABBVIE-5865893$ABBVIE$$32$YR$$F$Y$$$20240805$$CN$US$US
241707941$24170794$1$I$$20240723$20240805$20240805$EXP$$US-CIPLA LTD.-2024US08168$CIPLA$Zulch E, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, et al.. Impact of post-transplant Cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143 (107530):1 to 8$$$$$Y$$$20240805$$HP$US$US
241707951$24170795$1$I$$20240730$20240805$20240805$EXP$$US-PFIZER INC-202400227607$PFIZER$$$$$M$Y$$$20240805$$CN$US$US
241707961$24170796$1$I$20240708$20240726$20240805$20240805$EXP$$CN-PFIZER INC-PV202400098046$PFIZER$$81$YR$$F$Y$50$KG$20240805$$HP$CN$CN
241707971$24170797$1$I$20240717$20240731$20240805$20240805$EXP$$CN-PFIZER INC-PV202400100053$PFIZER$$7$YR$$M$Y$23.7$KG$20240805$$HP$CN$CN
241707981$24170798$1$I$20240727$20240730$20240805$20240805$EXP$GB-MHRA-MED-202407302037241980-FZTHB$GB-PFIZER INC-202400226864$PFIZER$$15$YR$$F$Y$$$20240805$$CN$GB$GB
241707991$24170799$1$I$20240729$20240731$20240805$20240805$EXP$$CN-PFIZER INC-PV202400100160$PFIZER$$55$YR$$F$Y$$$20240805$$HP$CN$CN
241708001$24170800$1$I$$20240730$20240805$20240805$EXP$$CA-PFIZER INC-202300060524$PFIZER$$$$$F$Y$$$20240805$$HP$CA$CA
241708011$24170801$1$I$$20240731$20240805$20240805$EXP$$CA-PFIZER INC-202400228254$PFIZER$$$$$$Y$$$20240805$$HP$CA$CA
241708021$24170802$1$I$20220101$20240731$20240805$20240805$EXP$$US-PFIZER INC-PV202400100309$PFIZER$$2$YR$$F$Y$$$20240805$$LW$US$US
241708032$24170803$2$F$20240723$20240731$20240805$20240809$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004896$SAREPTA THERAPEUTICS$$6$YR$$M$Y$$$20240809$$CN$US$US
241708041$24170804$1$I$20240715$20240730$20240805$20240805$EXP$IS-IMA-8760$IS-PFIZER INC-202400226396$PFIZER$$67$YR$$F$Y$$$20240805$$PH$IS$IS
241708051$24170805$1$I$$20240723$20240805$20240805$EXP$$US-CIPLA LTD.-2024US08414$CIPLA$Zulch E, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, et al.. Impact of post-transplant Cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143 (107530):1 to 8$$$$$Y$$$20240805$$HP$US$US
241708061$24170806$1$I$$20240123$20240805$20240805$EXP$$NVSC2024US021821$NOVARTIS$$$$$F$Y$$$20240805$$MD$US$US
241708071$24170807$1$I$20231201$20240725$20240805$20240805$PER$$US-RDY-SPO/USA/24/0011050$DR REDDYS$$20$YR$A$$Y$$$20240805$$MD$US$US
241708081$24170808$1$I$$20240711$20240805$20240805$PER$$US-009507513-2408USA000329$MERCK$Permpalung N, Chiang TPY, Manothummetha K, Ostrander D, Datta K, Segev DL, et al. Invasive Fungal Infections in Inpatient Solid Organ Transplant Recipients With COVID-19: A Multicenter Retrospective Cohort. Transplantation. 2024;108:1613-1622$55$YR$$M$Y$$$20240805$$MD$US$US
241708112$24170811$2$F$20231009$20240827$20240805$20240909$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001158$AKEBIA THERAPEUTICS$$85$YR$$M$Y$62.9$KG$20240909$$MD$JP$JP
241708121$24170812$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123115$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240805$$HP$US$US
241708131$24170813$1$I$20240724$20240731$20240805$20240805$30DAY$$US-GSK-US2024095758$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240805$$CN$US$US
241708141$24170814$1$I$20240731$20240802$20240802$20240802$DIR$712706$$FDA-CTU$$31$YR$$F$N$103.5$KG$20240802$N$CN$US$
241708152$24170815$2$F$$20240904$20240805$20240909$PER$$US-AMGEN-USASP2024154881$AMGEN$$64$YR$A$F$Y$$$20240909$$HP$US$US
241708161$24170816$1$I$20240730$20240730$20240805$20240805$PER$$US-BAYER-2024A110305$BAYER$$21$YR$A$F$Y$$$20240805$$MD$US$US
241708171$24170817$1$I$20201030$20240730$20240805$20240805$EXP$$US-AMGEN-USASP2024151900$AMGEN$Santin A. D.; Greenman M.; Bellone S. et al.. Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer. Gynecologic Oncology Reports. 2024;54:1-4$69$YR$E$F$Y$$$20240805$$HP$US$US
241708181$24170818$1$I$$20240729$20240805$20240805$PER$$US-BAYER-2024A111053$BAYER$$$$$F$Y$$$20240805$$CN$US$US
241708191$24170819$1$I$$20240729$20240805$20240805$PER$$US-ABBVIE-5865392$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241708201$24170820$1$I$20201221$20240131$20240805$20240805$EXP$$NVSC2024FR023765$NOVARTIS$$73$YR$$M$Y$74$KG$20240805$$MD$FR$FR
241708211$24170821$1$I$20240607$20240727$20240805$20240805$EXP$$IT-UCBSA-2024038398$UCB$$$$E$M$Y$$$20240805$$CN$IT$IT
241708221$24170822$1$I$$20240730$20240805$20240805$PER$$US-ABBVIE-5861937$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241708231$24170823$1$I$$20240802$20240805$20240805$EXP$$DE-SANDOZ INC.-SDZ2024DE070065$SANDOZ$$$$A$$Y$$$20240805$$HP$DE$DE
241708241$24170824$1$I$20240703$20240731$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2024US069782$SANDOZ$$76$YR$$F$Y$62.6$KG$20240805$$HP$US$US
241708251$24170825$1$I$$20240723$20240805$20240805$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK092725$GLENMARK$$$$$$Y$$$20240805$$PH$GB$GB
241708262$24170826$2$F$$20240729$20240805$20240807$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-15341$IPSEN$$$$$$Y$$$20240807$$MD$JP$JP
241708271$24170827$1$I$$20240730$20240805$20240805$PER$$US-BAYER-2024A110711$BAYER$$$$$F$Y$$$20240805$$HP$US$US
241708281$24170828$1$I$$20240730$20240805$20240805$EXP$$US-OTSUKA-2024_021195$OTSUKA$$$$$F$Y$$$20240805$$CN$US$US
241708291$24170829$1$I$$20240314$20240805$20240805$EXP$$NVSC2023US278915$NOVARTIS$$$$$M$Y$$$20240805$$CN$US$US
241708311$24170831$1$I$$20240726$20240805$20240805$EXP$$AU-RDY-SPO/AUS/24/0011172$DR REDDYS$$$$$F$Y$$$20240805$$CN$AU$AU
241708322$24170832$2$F$20240521$20240730$20240805$20240805$PER$$US-BIOGEN-2024BI01266195$BIOGEN$$38$YR$$F$Y$$$20240805$$CN$US$US
241708331$24170833$1$I$$20240730$20240805$20240805$PER$$US-LEO Pharma-372469$LEO PHARM$$45$YR$$$Y$$$20240805$$HP$US$US
241708341$24170834$1$I$$20240730$20240805$20240805$EXP$$US-EXELIXIS-CABO-24080017$EXELIXIS$$75$YR$$M$Y$$$20240805$$MD$US$US
241708351$24170835$1$I$$20240731$20240805$20240805$PER$$US-BEH-2024176667$CSL BEHRING$$$$$M$Y$$$20240805$$MD$US$US
241708361$24170836$1$I$20240601$20240802$20240805$20240805$EXP$FR-AFSSAPS-NT2024000953$FR-SANDOZ INC.-SDZ2024FR070156$SANDOZ$$$$A$M$Y$$$20240805$$MD$FR$FR
241708371$24170837$1$I$$20240729$20240805$20240805$EXP$$CA-Covis Pharma GmbH-2021COV21913$COVIS PHARMA$$56$YR$A$M$Y$$$20240805$$CN$CA$CA
241708381$24170838$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000047977$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$74$YR$E$M$Y$$$20240805$$HP$JP$JP
241708391$24170839$1$I$$20240729$20240805$20240805$EXP$$CA-Covis Pharma GmbH-2021COV21569$COVIS PHARMA$$56$YR$A$M$Y$$$20240805$$CN$CA$CA
241708401$24170840$1$I$$20240730$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121281$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$73.1$KG$20240805$$PH$US$US
241708411$24170841$1$I$$20240731$20240805$20240805$EXP$$AU-TORRENT-00000556$TORRENT$$62$YR$A$M$Y$$$20240805$$CN$AU$AU
241708421$24170842$1$I$$20231016$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2023CA043032$SANDOZ$$$$$$Y$$$20240805$$HP$CA$CA
241708431$24170843$1$I$20240725$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123426$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240805$$CN$US$US
241708441$24170844$1$I$$20240729$20240805$20240805$EXP$GB-MHRA-TPP49612862C9396304YC1721640855308$GB-TORRENT-00037440$TORRENT$$72$YR$E$M$Y$$$20240805$$HP$GB$GB
241708451$24170845$1$I$20231001$20240726$20240805$20240805$EXP$DE-EMBRYOTOX-202307295$DE-TORRENT-00027104$TORRENT$$1$DY$N$M$Y$2$KG$20240805$$MD$DE$DE
241708461$24170846$1$I$20240726$20240730$20240805$20240805$EXP$GB-MHRA-MED-202407300134326310-DVYRP$GB-TORRENT-00037443$TORRENT$$22$YR$A$F$Y$70$KG$20240805$$CN$GB$GB
241708471$24170847$1$I$20240728$20240728$20240805$20240805$EXP$GB-MHRA-MED-202407280259568670-CYMKB$GB-TORRENT-00037405$TORRENT$$58$YR$A$M$Y$78$KG$20240805$$CN$GB$GB
241708481$24170848$1$I$$20240727$20240805$20240805$EXP$GB-MHRA-MED-202407270735169410-MQLDJ$GB-TORRENT-00037421$TORRENT$$67$YR$E$F$Y$66$KG$20240805$$CN$GB$GB
241708492$24170849$2$F$20240730$20240906$20240805$20240909$EXP$$JP-PFIZER INC-PV202400099700$PFIZER$$7$DEC$$F$Y$57$KG$20240909$$PH$JP$JP
241708501$24170850$1$I$$20240802$20240805$20240805$EXP$$CA-PFIZER INC-202400229231$PFIZER$$37$YR$$F$Y$55$KG$20240805$$PH$CA$CA
241708511$24170851$1$I$$20240730$20240805$20240805$EXP$GB-MHRA-MED-202407301345582370-YRLZB$GB-TORRENT-00037456$TORRENT$$$$$F$Y$$$20240805$$MD$GB$GB
241708521$24170852$1$I$20240601$20240801$20240805$20240805$EXP$$BE-PFIZER INC-PV202400099184$PFIZER$$$$$M$Y$$$20240805$$MD$BE$BE
241708531$24170853$1$I$20240720$20240731$20240805$20240805$EXP$$CN-PFIZER INC-PV202400100045$PFIZER$$85$YR$$M$Y$65$KG$20240805$$HP$CN$CN
241708541$24170854$1$I$20240402$20240801$20240805$20240805$EXP$FR-AFSSAPS-BR2024000548$FR-PFIZER INC-202400227929$PFIZER$$58$YR$$M$Y$$$20240805$$MD$FR$FR
241708551$24170855$1$I$$20240801$20240805$20240805$EXP$CZ-CZSUKL-24002175$CZ-PFIZER INC-202400227928$PFIZER$$43$YR$$F$Y$47$KG$20240805$$MD$CZ$CZ
241708561$24170856$1$I$20240712$20240803$20240805$20240805$EXP$$IN-PFIZER INC-PV202400101571$PFIZER$$81$YR$$F$Y$$$20240805$$CN$IN$IN
241708571$24170857$1$I$$20240730$20240805$20240805$EXP$GB-MHRA-TPP22108890C20896881YC1721916123024$GB-TORRENT-00037461$TORRENT$$79$YR$E$F$Y$77$KG$20240805$$MD$GB$GB
241708581$24170858$1$I$20240624$20240801$20240805$20240805$EXP$FR-AFSSAPS-AM2024000616$FR-PFIZER INC-202400227999$PFIZER$$90$YR$$F$Y$52$KG$20240805$$PH$FR$FR
241708591$24170859$1$I$$20240802$20240805$20240805$EXP$$MA-PFIZER INC-PV202400101532$PFIZER$$$$$F$Y$$$20240805$$PH$MA$MA
241708601$24170860$1$I$20240731$20240802$20240805$20240805$EXP$GB-MHRA-MED-202408011431136960-HGFQY$GB-PFIZER INC-202400229081$PFIZER$$78$YR$$F$Y$$$20240805$$HP$GB$GB
241708613$24170861$3$F$20230816$20240807$20240805$20240814$EXP$$FR-PFIZER INC-PV202400100533$PFIZER$$35$YR$$M$Y$66.5$KG$20240814$$MD$FR$FR
241708631$24170863$1$I$$20240803$20240805$20240805$EXP$$IN-PFIZER INC-PV202400101394$PFIZER$$$$A$M$Y$$$20240805$$CN$IN$IN
241708643$24170864$3$F$20240101$20240912$20240805$20240916$EXP$$CA-PFIZER INC-202400228966$PFIZER$$76$YR$$M$Y$$$20240916$$HP$CA$CA
241708651$24170865$1$I$$20240730$20240805$20240805$PER$$US-BAYER-2024A110822$BAYER$$$$$F$Y$$$20240805$$HP$US$US
241708663$24170866$3$F$$20240923$20240805$20240924$EXP$$US-PFIZER INC-202400228334$PFIZER$$61$YR$$F$Y$$$20240924$$CN$US$US
241708671$24170867$1$I$20240325$20240801$20240805$20240805$EXP$$GB-PFIZER INC-202400228251$PFIZER$$47$YR$$$Y$$$20240805$$PH$GB$GB
241708702$24170870$2$F$20240528$20240731$20240805$20240806$30DAY$$AR-JNJFOC-20240773450$JOHNSON AND JOHNSON$$66$YR$E$F$Y$68$KG$20240806$$CN$AR$AR
241708711$24170871$1$I$20240616$20240801$20240805$20240805$EXP$$CN-PFIZER INC-PV202400100729$PFIZER$$69$YR$$M$Y$53$KG$20240805$$HP$CN$CN
241708722$24170872$2$F$$20240919$20240805$20240923$EXP$$US-PFIZER INC-PV202400083163$PFIZER$$65$YR$$F$Y$$$20240923$$CN$US$US
241708731$24170873$1$I$20231001$20240729$20240805$20240805$EXP$$US-BEH-2024176615$CSL BEHRING$$61$YR$A$F$Y$$$20240805$$CN$US$US
241708743$24170874$3$F$20240728$20240913$20240805$20240917$EXP$$US-TAKEDA-2024TUS057753$TAKEDA$$53$YR$$F$Y$$$20240917$$HP$US$US
241708751$24170875$1$I$$20240730$20240805$20240805$PER$$US-BAYER-2024A111543$BAYER$$24$YR$A$F$Y$$$20240805$$MD$US$US
241708761$24170876$1$I$20240730$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174342$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241708771$24170877$1$I$20100506$20240723$20240805$20240805$EXP$$AU-AstraZeneca-2024A176302$ASTRAZENECA$$48$YR$$M$Y$$$20240805$$MD$AU$
241708791$24170879$1$I$$20240731$20240805$20240805$EXP$$US-INCYTE CORPORATION-2024IN008017$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241708801$24170880$1$I$$20240801$20240805$20240805$PER$$US-GILEAD-2024-0682672$GILEAD$$$$A$M$Y$$$20240805$$HP$US$US
241708811$24170881$1$I$20240805$20240805$20240805$20240805$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043764$BOEHRINGER INGELHEIM$$$$$$Y$$$20240805$$CN$US$US
241708821$24170882$1$I$$20240730$20240805$20240805$EXP$GB-MHRA-WEBRADR-202407302045488330-TVNRC$GB-RDY-SPO/GBR/24/0011244$DR REDDYS$$49$YR$A$F$Y$$$20240805$$HP$GB$GB
241708831$24170883$1$I$$20231211$20240805$20240805$EXP$$IN-SANDOZ INC.-SDZ2023IN075256$SANDOZ$$$$$$Y$$$20240805$$HP$IN$IN
241708841$24170884$1$I$$20240729$20240805$20240805$EXP$$US-GSK-US2024AMR095534$GLAXOSMITHKLINE$$$$$F$Y$127$KG$20240805$$CN$US$US
241708851$24170885$1$I$20240414$20240723$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117715$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240805$$CN$US$US
241708861$24170886$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123081$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$51.71$KG$20240805$$CN$US$US
241708881$24170888$1$I$$20240725$20240805$20240805$PER$$US-INCYTE CORPORATION-2024IN007832$INCYTE$$$$$$Y$$$20240805$$PH$US$US
241708891$24170889$1$I$20240604$20240731$20240805$20240805$PER$$US-BAYER-2024A111628$BAYER$$27$YR$A$F$Y$$$20240805$$HP$US$US
241708901$24170890$1$I$$20240731$20240805$20240805$PER$$US-ROCHE-10000047847$ROCHE$$54$YR$A$F$Y$$$20240805$$HP$US$US
241708911$24170891$1$I$$20240729$20240805$20240805$PER$$US-TAKEDA-2024TUS076922$TAKEDA$$$$I$F$Y$$$20240805$$CN$US$US
241708921$24170892$1$I$$20240723$20240805$20240805$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-07414$LUPIN$Ancilla LC, Sundaram B, Pathak N, Raj A.. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. Journal of Nephropharmacology. 2024;13(2)e11681:1-5$55$YR$$M$Y$$$20240805$$HP$IN$IN
241708931$24170893$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000047429$ROCHE$$$$A$M$Y$$$20240805$$CN$US$US
241708942$24170894$2$F$$20240805$20240805$20240819$PER$$US-JNJFOC-20240808250$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240819$$MD$US$US
241708951$24170895$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000047128$ROCHE$$$$$$Y$$$20240805$$HP$US$US
241708961$24170896$1$I$$20240726$20240805$20240805$EXP$$US-GSK-US2024094246$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241708971$24170897$1$I$$20231108$20240805$20240805$EXP$$IL-SANDOZ INC.-SDZ2023IL050816$SANDOZ$Zornitzki L, Anuk L, Frydman S, Morag-Koren N, Zahler D, Freund O et al. Rate and predictors of blood culture positivity after antibiotic administration: a prospective single-center study. INFECTION. 2023;23:1-8$$$$$Y$$$20240805$$HP$IL$IL
241708992$24170899$2$F$$20240721$20240805$20240805$EXP$$TR-JUBILANT CADISTA PHARMACEUTICALS-2024JUB00060$JUBILANT$Ert?rk Cetin O., Algedik Pi., Aky?z G et al. Minor/Major Congenital Malformations and Neurodevelopmental Outcomes in Children Prenatally Exposed to Levetiracetam, Lamotrigine, and Carbamazepine Monotherapy. Clinical Neuropharmacology. 2024$$$I$$Y$$$20240805$$MD$TR$TR
241709031$24170903$1$I$20240616$20240802$20240802$20240802$DIR$712693$$FDA-CTU$$$$$UNK$N$$$20240802$N$PH$US$
241709041$24170904$1$I$$20240802$20240802$20240802$DIR$712691$$FDA-CTU$$$$$UNK$N$$$20240802$$CN$US$
241709051$24170905$1$I$20240630$20240802$20240802$20240802$DIR$712696$$FDA-CTU$$$$$UNK$N$$$20240802$N$PH$US$
241709061$24170906$1$I$$20240731$20240805$20240805$EXP$$VN-AstraZeneca-2024A176294$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$VN$
241709071$24170907$1$I$20240717$20240801$20240805$20240805$EXP$$US-AstraZeneca-2024A176235$ASTRAZENECA$$28469$DY$$M$Y$$$20240805$$CN$US$
241709081$24170908$1$I$$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174365$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241709091$24170909$1$I$$20240802$20240805$20240805$EXP$$IT-PFIZER INC-202400228977$PFIZER$Tursi, A.. Endoscopic appearance is not sufficient for a diagnosis of segmental colitis associated with diverticulosis.. Annals of Gastroenterology. 2024;37:377-380$41$YR$$F$Y$$$20240805$$MD$IT$IT
241709131$24170913$1$I$$20240731$20240805$20240805$EXP$$AR-BIOVITRUM-2024-AR-010563$BIOVITRUM$$$$$F$Y$$$20240805$$CN$AR$AR
241709141$24170914$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001449$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240805$$CN$US$US
241709151$24170915$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001577$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240805$$CN$US$US
241709161$24170916$1$I$$20240727$20240805$20240805$EXP$$US-BAYER-2024A111235$BAYER$$$$$$Y$$$20240805$$CN$US$US
241709172$24170917$2$F$20240208$20240731$20240805$20240808$EXP$FR-AFSSAPS-AN2024000952$FR-TAKEDA-2024TUS076333$TAKEDA$$77$YR$$M$Y$82$KG$20240808$$HP$FR$FR
241709182$24170918$2$F$$20240808$20240805$20240816$EXP$$US-ABBVIE-5858869$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
241709191$24170919$1$I$$20240801$20240805$20240805$EXP$$CA-MYLANLABS-2024M1072132$MYLAN$$$$$M$Y$$$20240805$$PH$CA$CA
241709202$24170920$2$F$$20240802$20240805$20240808$EXP$$IE-MYLANLABS-2024M1072425$MYLAN$$$$$F$Y$$$20240808$$CN$IE$IE
241709212$24170921$2$F$$20240807$20240805$20240812$EXP$$GB-MYLANLABS-2024M1072535$MYLAN$$$$$M$Y$$$20240812$$CN$GB$GB
241709231$24170923$1$I$$20240801$20240805$20240805$EXP$$GB-MYLANLABS-2024M1070141$MYLAN$$$$$M$Y$$$20240805$$CN$GB$GB
241709241$24170924$1$I$$20240802$20240805$20240805$EXP$$TW-DAIICHI SANKYO, INC.-DSJ-2024-138700$DAIICHI$$$$$F$Y$$$20240805$$CN$TW$TW
241709251$24170925$1$I$$20240801$20240805$20240805$EXP$FR-AFSSAPS-AVPO2024000146$FR-MYLANLABS-2024M1071869$MYLAN$$23$YR$$M$Y$$$20240805$$PH$FR$FR
241709261$24170926$1$I$$20240801$20240805$20240805$EXP$$US-MYLANLABS-2024M1072657$MYLAN$$$$$F$Y$$$20240805$$PH$US$US
241709271$24170927$1$I$$20240801$20240805$20240805$EXP$GB-MHRA-MIDB-d7ec6655-f16b-4641-8b26-e62ee252f37b$GB-DSJP-DSE-2024-138555$DAIICHI$$72$YR$$$Y$$$20240805$$PH$GB$GB
241709281$24170928$1$I$20140701$20240730$20240805$20240805$PER$$US-BIOGEN-2015BI046675$BIOGEN$$53$YR$$F$Y$$$20240805$$CN$US$US
241709292$24170929$2$F$$20240801$20240805$20240812$EXP$GB-MHRA-31377037$GB-MYLANLABS-2024M1071936$MYLAN$$38$YR$$M$Y$$$20240812$$PH$GB$GB
241709301$24170930$1$I$20240717$20240801$20240805$20240805$EXP$$CN-DSJP-DSJ-2024-138628$DAIICHI$$56$YR$$F$Y$$$20240805$$HP$CN$CN
241709312$24170931$2$F$20240702$20240812$20240805$20240815$EXP$$US-009507513-2408USA000188$MERCK$$67$YR$$F$Y$$$20240815$$CN$US$US
241709321$24170932$1$I$20220329$20240730$20240805$20240805$EXP$$CA-CELLTRION INC.-2021CA018688$CELLTRION$$$$$$Y$$$20240805$$MD$CA$CA
241709331$24170933$1$I$20240801$20240801$20240805$20240805$PER$$US-JNJFOC-20240806535$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$HP$US$US
241709342$24170934$2$F$$20240711$20240805$20240807$PER$$US-JNJFOC-20240767952$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
241709351$24170935$1$I$$20240730$20240805$20240805$PER$US-MLMSERVICE-20240723-PI141354-00034-1$US-RDY-SPO/USA/24/0011299$DR REDDYS$Navari Y, Chinnappan J, Dawood T, Marcus H. When rhythm correction turns risky: rare right-sided haemorrhagic pleural effusion post MAZE procedure. European Journal of Case Reports in Internal Medicine. 2024;11(7). DOI: 10.12890/2024_004647.$54$YR$A$F$Y$$$20240805$$MD$US$US
241709361$24170936$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53443$$FDA-CTU$$71$YR$$M$N$$$20240805$N$$US$
241709371$24170937$1$I$20240730$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-53401$$FDA-CTU$$$$$$N$$$20240801$N$CN$US$
241709381$24170938$1$I$20240701$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024153960$AMGEN$$$$$$Y$$$20240805$$MD$US$US
241709392$24170939$2$F$20240615$20240802$20240805$20240819$PER$$US-JNJFOC-20240777776$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$HP$US$US
241709401$24170940$1$I$20240730$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-53464$$FDA-CTU$$55$YR$$F$N$$$20240801$N$PH$US$
241709412$24170941$2$F$$20240807$20240805$20240812$PER$$US-BIOGEN-2024BI01276113$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
241709421$24170942$1$I$$20240730$20240805$20240805$PER$$US-BIOGEN-2024BI01276218$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
241709431$24170943$1$I$$20240730$20240805$20240805$PER$$US-BIOGEN-2024BI01276187$BIOGEN$$$$$M$Y$$$20240805$$CN$US$US
241709441$24170944$1$I$20240621$20240730$20240805$20240805$EXP$FR-AFSSAPS-LY2024001120$FR-MYLANLABS-2024M1071362$MYLAN$$41$YR$$F$Y$82$KG$20240805$$MD$FR$FR
241709452$24170945$2$F$$20240911$20240805$20240916$30DAY$$DE-MYLANLABS-2024M1071232$MYLAN$$$$$$Y$$$20240916$$CN$DE$DE
241709461$24170946$1$I$20240614$20240730$20240805$20240805$EXP$FR-AFSSAPS-MP2024001187$FR-MYLANLABS-2024M1071347$MYLAN$$1$MON$$M$Y$2.87$KG$20240805$$MD$FR$FR
241709472$24170947$2$F$20240707$20240809$20240805$20240816$EXP$$US-BAYER-2024A105461$BAYER$$73$YR$E$F$Y$134.24$KG$20240816$$HP$US$US
241709481$24170948$1$I$20230116$20230116$20240805$20240805$EXP$$AE-BIOVITRUM-2023AE01186$BIOVITRUM$$75$DY$$F$Y$$$20240805$$HP$AE$AE
241709493$24170949$3$F$$20240909$20240805$20240912$30DAY$$US-MYLANLABS-2024M1071376$MYLAN$$$$$$Y$$$20240912$$PH$US$US
241709501$24170950$1$I$$20240729$20240805$20240805$PER$$US-BAYER-2024A110139$BAYER$$25$YR$A$F$Y$$$20240805$$MD$US$US
241709511$24170951$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000047172$ROCHE$$$$E$F$Y$$$20240805$$CN$US$US
241709521$24170952$1$I$$20240801$20240805$20240805$EXP$$KR-AstraZeneca-2024A176490$ASTRAZENECA$$$$$$Y$$$20240805$$MD$KR$
241709532$24170953$2$F$20240614$20240911$20240805$20240918$EXP$$JP-Eisai-EC-2024-171294$EISAI$$75$YR$E$F$Y$$$20240918$$MD$JP$JP
241709541$24170954$1$I$$20240729$20240805$20240805$EXP$$NL-AstraZeneca-2024A176340$ASTRAZENECA$$40$YR$$M$Y$111$KG$20240805$$MD$NL$
241709551$24170955$1$I$$20231023$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2023CA047072$SANDOZ$Nizar J. Bahlis MD. Pomalidomide, Daratumumab, and Dexamethasone After Lenalidomide Treatment in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): Final Overall Survival (OS) Analysis of the Phase II MM-014 Study. Clinical Lymphoma, Myeloma + Leukemia. 2023;S494 to S495$$$$$Y$$$20240805$$MD$CA$CA
241709561$24170956$1$I$$20240723$20240805$20240805$EXP$$AU-AstraZeneca-2024A176822$ASTRAZENECA$$68$YR$$M$Y$$$20240805$$MD$AU$
241709571$24170957$1$I$20220519$20220602$20240805$20240805$EXP$$CO-BIOVITRUM-2022CO07692$BIOVITRUM$$212$DY$$M$Y$4$KG$20240805$$CN$CO$CO
241709581$24170958$1$I$20240720$20240802$20240805$20240805$EXP$$CN-ROCHE-10000048685$ROCHE$$59$YR$A$F$Y$64$KG$20240805$$HP$CN$CN
241709591$24170959$1$I$$20240731$20240805$20240805$EXP$$CA-TAKEDA-2024TUS077798$TAKEDA$$$$$M$Y$$$20240805$$CN$CA$CA
241709601$24170960$1$I$$20240722$20240805$20240805$EXP$$US-Marksans Pharma Limited-2160017$MARKSANS$Longobardi SA, Alkowati H, Kang G, Slade C, Oyesanmi O. Ibuprofen-Induced Pancytopenia and Erythema Multiforme in an Elderly Female Patient. Cureus. 2024 Jun 20;16(6):e62785. doi: 10.7759/cureus.62785. PMID: 39036150.$75$YR$$F$Y$$$20240805$$$US$US
241709621$24170962$1$I$20230101$20240729$20240805$20240805$PER$$US-BAYER-2024A110151$BAYER$$20$YR$A$F$Y$$$20240805$$MD$US$US
241709631$24170963$1$I$20240606$20240731$20240805$20240805$EXP$$FR-ROCHE-10000048306$ROCHE$$22$YR$A$F$Y$94$KG$20240805$$MD$FR$FR
241709641$24170964$1$I$20211223$20211228$20240805$20240805$EXP$$ES-BIOVITRUM-2021ES12986$BIOVITRUM$$107$DY$$M$Y$$$20240805$$CN$ES$ES
241709651$24170965$1$I$20080601$20240730$20240805$20240805$EXP$$US-AstraZeneca-2024A173146$ASTRAZENECA$$26$YR$$M$Y$83.9$KG$20240805$$CN$US$
241709661$24170966$1$I$$20240801$20240805$20240805$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-122945$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240805$$CN$ES$ES
241709671$24170967$1$I$20230701$20240802$20240805$20240805$EXP$$GB-TAKEDA-2024TUS078104$TAKEDA$$61$YR$$F$Y$84$KG$20240805$$HP$GB$GB
241709681$24170968$1$I$$20240724$20240805$20240805$PER$$US-IGSA-BIG0030082$GRIFOLS$$$$$F$Y$$$20240805$$CN$US$US
241709691$24170969$1$I$$20240726$20240805$20240805$EXP$$US-TEVA-VS-3228628$TEVA$$$$T$M$Y$$$20240805$$HP$US$US
241709701$24170970$1$I$$20240801$20240805$20240805$PER$$US-BAYER-2024A111903$BAYER$$$$$M$Y$$$20240805$$MD$US$US
241709711$24170971$1$I$$20240724$20240805$20240805$PER$$US-JNJFOC-20240771758$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241709721$24170972$1$I$$20240731$20240805$20240805$EXP$$US-JNJFOC-20240801402$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$US$US
241709731$24170973$1$I$20240723$20240726$20240805$20240805$PER$$US-JNJFOC-20240776168$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$US$US
241709741$24170974$1$I$$20240725$20240805$20240805$PER$$US-JNJFOC-20240775728$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$US$US
241709751$24170975$1$I$20240101$20240801$20240805$20240805$PER$$US-JNJFOC-20240803526$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240805$$PH$US$US
241709761$24170976$1$I$20240709$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-53467$$FDA-CTU$$79$YR$$M$N$54.3$KG$20240801$Y$HP$US$
241709771$24170977$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53455$$FDA-CTU$$70$YR$$F$N$$$20240805$N$$US$
241709781$24170978$1$I$20240708$20240724$20240805$20240805$DIR$FDA-CDER-CTU-2024-53240$$FDA-CTU$$$$$M$N$55.5$KG$20240724$N$$US$
241709791$24170979$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53542$$FDA-CTU$$71$YR$$F$N$$$20240805$N$$US$
241709801$24170980$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53437$$FDA-CTU$$39$YR$$F$N$79.38$KG$20240805$N$$US$
241709821$24170982$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53549$$FDA-CTU$$61$YR$$M$N$$$20240805$N$$US$
241709831$24170983$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53545$$FDA-CTU$$32$YR$$F$N$$$20240805$N$$US$
241709841$24170984$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53489$$FDA-CTU$$83$YR$$F$N$$$20240805$N$$US$
241709851$24170985$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53547$$FDA-CTU$$71$YR$$M$N$$$20240805$N$$US$
241709861$24170986$1$I$$20240802$20240805$20240805$DIR$FDA-CDER-CTU-2024-53365$$FDA-CTU$$$$$M$N$$$20240802$N$HP$US$
241709871$24170987$1$I$20240412$20240801$20240801$20240801$DIR$FDA-CDER-CTU-2024-53461$$FDA-CTU$$66$YR$$M$N$103.42$KG$20240801$N$CN$US$
241709881$24170988$1$I$20240615$20240726$20240805$20240805$EXP$CH-SM-2024-14209$CH-TEVA-VS-3226759$TEVA$$59$YR$$M$Y$$$20240803$$MD$CH$CH
241709892$24170989$2$F$20240101$20240916$20240805$20240918$PER$$US-SA-2024SA225362$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240918$$MD$US$US
241709901$24170990$1$I$20240722$20240730$20240805$20240805$PER$$US-SA-2024SA227634$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240803$$MD$US$US
241709911$24170991$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA225729$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240803$$MD$US$US
241709921$24170992$1$I$$20240724$20240805$20240805$EXP$$US-ADMA BIOLOGICS INC.-US-2024ADM000102$ADMA BIOLOGICS$Kherbek H., Itoh C.Y., Daley C., Eggers S.D., Hinson S., Sarker P. et al.. Clinical and serological insights into paraneoplastic brachial  amyotrophic diplegia. Journal of Neurology. 2024;271(7):4620-4627$53$YR$$M$Y$$$20240804$$HP$US$US
241709931$24170993$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002067US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240803$$CN$US$US
241709941$24170994$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227353$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240804$$MD$US$US
241709951$24170995$1$I$20240625$20240730$20240805$20240805$PER$$US-SA-2024SA227278$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240804$$HP$US$US
241709961$24170996$1$I$$20240724$20240805$20240805$EXP$$US-ADMA BIOLOGICS INC.-US-2024ADM000103$ADMA BIOLOGICS$Kherbek H., Itoh C.Y., Daley C., Eggers S.D., Hinson S., Sarker P. et al.. Clinical and serological insights into paraneoplastic brachial amyotrophic diplegia. Journal of Neurology. 2024;271(7):4620-4627$53$YR$$M$Y$$$20240804$$HP$US$US
241709971$24170997$1$I$$20240802$20240805$20240805$EXP$$IT-SANDOZ INC.-SDZ2024IT070077$SANDOZ$$68$YR$$F$Y$$$20240803$$MD$IT$IT
241709981$24170998$1$I$$20240723$20240805$20240805$PER$$US-SA-2024SA220884$SANOFI AVENTIS$$$$$M$Y$$$20240804$$MD$US$US
241709991$24170999$1$I$20190101$20240729$20240805$20240805$PER$$US-SA-2024SA227186$SANOFI AVENTIS$$$$$F$Y$$$20240804$$HP$US$US
241710001$24171000$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA224758$SANOFI AVENTIS$$$$E$F$Y$$$20240804$$MD$US$US
241710011$24171001$1$I$$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024152121$AMGEN$$$$$M$Y$$$20240803$$HP$US$US
241710021$24171002$1$I$20240701$20240725$20240805$20240805$PER$$US-SA-2024SA222159$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240804$$MD$US$US
241710031$24171003$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA222407$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240804$$CN$US$US
241710041$24171004$1$I$$20240801$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2024US070229$SANDOZ$$$$$M$Y$$$20240804$$HP$US$US
241710051$24171005$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA222896$SANOFI AVENTIS$$35$YR$A$F$Y$61$KG$20240804$$CN$US$US
241710061$24171006$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223124$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240804$$MD$US$US
241710071$24171007$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223292$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240804$$MD$US$US
241710081$24171008$1$I$20240717$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024153288$AMGEN$$60$YR$A$F$Y$$$20240803$$HP$US$US
241710091$24171009$1$I$20240730$20240730$20240805$20240805$PER$$US-SA-2024SA226400$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240804$$CN$US$US
241710101$24171010$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA223427$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240804$$MD$US$US
241710111$24171011$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223383$SANOFI AVENTIS$$60$YR$A$F$Y$55.7$KG$20240804$$MD$US$US
241710122$24171012$2$F$$20240826$20240805$20240910$PER$$US-SA-2024SA223362$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$MD$US$US
241710131$24171013$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223008$SANOFI AVENTIS$$29$YR$A$M$Y$81.6$KG$20240804$$MD$US$US
241710141$24171014$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA223051$SANOFI AVENTIS$$$$A$F$Y$65.77$KG$20240804$$MD$US$US
241710151$24171015$1$I$$20240725$20240805$20240805$30DAY$$US-GSK-US2024AMR094146$GLAXOSMITHKLINE$$$$$F$Y$$$20240804$$CN$US$US
241710161$24171016$1$I$$20240723$20240805$20240805$PER$$US-SA-2024SA223587$SANOFI AVENTIS$$$$E$M$Y$$$20240804$$MD$US$US
241710171$24171017$1$I$20240701$20240725$20240805$20240805$EXP$$US-GSK-US2024093558$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240804$$HP$US$US
241710182$24171018$2$F$20240101$20240812$20240805$20240826$PER$$US-SA-2024SA223545$SANOFI AVENTIS$$82$YR$E$M$Y$97.06$KG$20240826$$MD$US$US
241710191$24171019$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA223314$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240804$$MD$US$US
241710201$24171020$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223678$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240804$$CN$US$US
241710211$24171021$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223507$SANOFI AVENTIS$$$$E$M$Y$61.23$KG$20240804$$CN$US$US
241710221$24171022$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53414$$FDA-CTU$$52$YR$$M$N$$$20240805$N$$US$
241710231$24171023$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA227695$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240804$$MD$US$US
241710241$24171024$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225342$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240804$$MD$US$US
241710251$24171025$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227719$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240804$$MD$US$US
241710261$24171026$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001411$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240804$$CN$US$US
241710272$24171027$2$F$20240722$20240801$20240805$20240808$EXP$$US-SA-2024SA228289$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240808$$MD$US$US
241710281$24171028$1$I$$20240704$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06881$LUPIN$$$$$$Y$$$20240804$$CN$US$US
241710291$24171029$1$I$$20240704$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06854$LUPIN$$$$$$Y$$$20240804$$CN$US$US
241710301$24171030$1$I$20231220$20240726$20240805$20240805$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-011218$JAZZ$$35$YR$$M$Y$$$20240803$$CN$US$US
241710311$24171031$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06957$LUPIN$$$$$$Y$$$20240804$$CN$US$US
241710321$24171032$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223769$SANOFI AVENTIS$$$$$F$Y$$$20240804$$MD$US$US
241710331$24171033$1$I$$20240726$20240805$20240805$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-011553$JAZZ$$$$$F$Y$$$20240803$$MD$US$US
241710341$24171034$1$I$$20240725$20240805$20240805$EXP$$US-GSK-US2024093551$GLAXOSMITHKLINE$$$$$F$Y$$$20240804$$MD$US$US
241710351$24171035$1$I$20240715$20240725$20240805$20240805$EXP$$US-VIIV HEALTHCARE LIMITED-US2024093554$VIIV$$40$YR$$M$Y$$$20240804$$CN$US$US
241710361$24171036$1$I$20240726$20240730$20240805$20240805$PER$$US-SA-2024SA227654$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240804$$MD$US$US
241710371$24171037$1$I$20240524$20240725$20240805$20240805$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024094271$VIIV$$$$A$M$Y$$$20240804$$CN$US$US
241710391$24171039$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223877$SANOFI AVENTIS$$$$C$F$Y$$$20240804$$MD$US$US
241710401$24171040$1$I$20240723$20240726$20240805$20240805$EXP$$ES-TEVA-VS-3227562$TEVA$$75$YR$$F$Y$$$20240804$$CN$ES$ES
241710411$24171041$1$I$20240717$20240722$20240805$20240805$EXP$$US-009507513-2407USA012761$MERCK$$81$YR$$M$Y$$$20240804$$CN$US$US
241710422$24171042$2$F$$20240828$20240805$20240906$30DAY$$US-GSK-US2024095862$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
241710431$24171043$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA228376$SANOFI AVENTIS$$$$E$F$Y$71$KG$20240804$$MD$US$US
241710441$24171044$1$I$$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407018766$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240804$$CN$US$US
241710451$24171045$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227059$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240804$$MD$US$US
241710461$24171046$1$I$20240701$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407018723$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240804$$CN$US$US
241710472$24171047$2$F$20240801$20240819$20240805$20240828$PER$$US-SA-2024SA228427$SANOFI AVENTIS$$22$YR$A$F$Y$61.2$KG$20240828$$CN$US$US
241710482$24171048$2$F$20240701$20240819$20240805$20240821$EXP$$US-SA-2024SA224800$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240821$$CN$US$US
241710491$24171049$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA226042$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240804$$MD$US$US
241710501$24171050$1$I$$20240726$20240805$20240805$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008339$JAZZ$$$$$F$Y$$$20240804$$CN$US$US
241710511$24171051$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA226197$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240804$$MD$US$US
241710521$24171052$1$I$$20240722$20240805$20240805$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07399$LUPIN$Alam M, Abdelrahim B, Alam M, Horani MH. Iatrogenic thyroid storm treated with plasmapheresis. Journal of the Endocrine Society. 2022;6(1):A768-A769$25$YR$$M$Y$$$20240804$$HP$US$US
241710542$24171054$2$F$20240717$20240802$20240805$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407018812$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240807$$CN$US$US
241710551$24171055$1$I$20240726$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001392$ELI LILLY AND CO$$86$YR$E$F$Y$$$20240804$$CN$US$US
241710561$24171056$1$I$$20240731$20240805$20240805$30DAY$$US-GSK-US2024095883$GLAXOSMITHKLINE$$$$A$F$Y$$$20240804$$CN$US$US
241710571$24171057$1$I$$20240726$20240805$20240805$PER$$US-TEVA-VS-3228922$TEVA$$$$E$M$Y$$$20240804$$HP$US$US
241710581$24171058$1$I$20201202$20240729$20240805$20240805$EXP$$FR-AMGEN-FRANI2024151066$AMGEN$$67$YR$E$F$Y$50$KG$20240804$$MD$FR$FR
241710591$24171059$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06916$LUPIN$$$$$$Y$$$20240804$$CN$US$US
241710601$24171060$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06640$LUPIN$$$$$$Y$$$20240804$$CN$US$US
241710611$24171061$1$I$20240710$20240730$20240805$20240805$EXP$FR-AFSSAPS-MA2024001275$FR-RDY-SPO/FRA/24/0011240$DR REDDYS$$73$YR$E$M$Y$98$KG$20240804$$MD$FR$FR
241710621$24171062$1$I$$20240729$20240805$20240805$EXP$GB-MHRA-MIDB-b4ec86df-8fb5-4a61-a99a-095b4e7bd63a$GB-RDY-SPO/GBR/24/0011210$DR REDDYS$$80$YR$E$F$Y$$$20240804$$PH$GB$GB
241710631$24171063$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001366$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240804$$CN$US$US
241710641$24171064$1$I$20240601$20240730$20240805$20240805$PER$$US-SA-2024SA226357$SANOFI AVENTIS$$$$$$Y$$$20240804$$MD$US$US
241710651$24171065$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000047436$ROCHE$$65$YR$E$F$Y$$$20240804$$HP$US$US
241710661$24171066$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227116$SANOFI AVENTIS$$$$A$M$Y$97.5$KG$20240804$$MD$US$US
241710671$24171067$1$I$$20240726$20240805$20240805$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011404$JAZZ$$$$$F$Y$$$20240804$$CN$US$US
241710681$24171068$1$I$20210215$20240730$20240805$20240805$EXP$$FR-AMGEN-FRANI2024151501$AMGEN$$51$YR$A$F$Y$52$KG$20240804$$MD$FR$FR
241710691$24171069$1$I$20240601$20240730$20240805$20240805$PER$$US-SA-2024SA226319$SANOFI AVENTIS$$$$A$M$Y$$$20240804$$CN$US$US
241710701$24171070$1$I$$20240726$20240805$20240805$EXP$$GB-JNJFOC-20240778960$JOHNSON AND JOHNSON$$$$$M$Y$$$20240804$$HP$GB$GB
241710712$24171071$2$F$$20240729$20240805$20240805$PER$$US-AVEVA-000711$AVEVA$$$$$F$Y$$$20240804$$CN$US$US
241710721$24171072$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53407$$FDA-CTU$$44$YR$$M$N$$$20240805$N$$US$
241710731$24171073$1$I$$20240708$20240805$20240805$PER$$CA-AVEVACA-000028$AVEVA$$$$$M$Y$$$20240804$$CN$CA$CA
241710741$24171074$1$I$$20240716$20240805$20240805$PER$$US-AVEVA-000709$AVEVA$$$$$M$Y$$$20240804$$CN$US$US
241710751$24171075$1$I$$20240626$20240805$20240805$PER$$US-AVEVA-000696$AVEVA$$$$$$Y$$$20240804$$CN$US$US
241710761$24171076$1$I$$20240724$20240805$20240805$PER$$US-AVEVA-000718$AVEVA$$$$$$Y$$$20240804$$CN$US$US
241710772$24171077$2$F$$20240821$20240805$20240903$PER$$US-AVEVA-000712$AVEVA$$$$$F$Y$$$20240903$$CN$US$US
241710781$24171078$1$I$$20240729$20240805$20240805$PER$$US-AVEVA-000719$AVEVA$$$$$M$Y$$$20240804$$CN$US$US
241710791$24171079$1$I$20211201$20240723$20240805$20240805$PER$$US-AVEVA-000714$AVEVA$Allami N, O^Connor K, Bagley SM. A case of severe opioid and methamphetamine use disorder in a 14 year old. Addict Sci Clin Pract. 2024, 19(1):54. doi: 10.1186/s13722-024-00487-1. PMID: 39030629.$14$YR$T$$Y$$$20240804$$HP$US$US
241710802$24171080$2$F$$20240823$20240805$20240903$PER$$US-AVEVA-000717$AVEVA$$$$$F$Y$$$20240903$$CN$US$US
241710811$24171081$1$I$$20240715$20240805$20240805$PER$$US-AVEVA-000708$AVEVA$$$$$$Y$$$20240804$$PH$US$US
241710821$24171082$1$I$$20240718$20240805$20240805$PER$$US-AVEVA-000710$AVEVA$$$$$F$Y$$$20240804$$CN$US$US
241710831$24171083$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53422$$FDA-CTU$$71$YR$$F$N$$$20240805$N$$US$
241710841$24171084$1$I$20240223$20240730$20240805$20240805$EXP$$US-JNJFOC-20240780322$JOHNSON AND JOHNSON$$63$YR$A$F$Y$54.2$KG$20240804$$HP$US$US
241710853$24171085$3$F$$20240910$20240805$20240910$PER$$US-ALXN-202407USA002040US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
241710862$24171086$2$F$$20240802$20240805$20240809$PER$$US-ALXN-202407USA002045US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241710872$24171087$2$F$$20240823$20240805$20240823$PER$$US-ALXN-202407USA002039US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241710881$24171088$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002041US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240804$$CN$US$US
241710891$24171089$1$I$$20240726$20240805$20240805$EXP$$US-Bion-013568$BIONPHARMA$$$$$M$Y$$$20240804$$CN$US$US
241710901$24171090$1$I$$20240725$20240805$20240805$EXP$$US-Bion-013569$BIONPHARMA$$$$$M$Y$$$20240804$$CN$US$US
241710913$24171091$3$F$20240718$20240812$20240805$20240821$PER$$US-SA-2024SA228760$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240821$$MD$US$US
241710922$24171092$2$F$$20240821$20240805$20240823$PER$$US-ALXN-202407USA002052US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
241710932$24171093$2$F$20240701$20240804$20240805$20240808$EXP$$CA-JNJFOC-20240763284$JOHNSON AND JOHNSON$$62$YR$A$F$Y$76$KG$20240808$$HP$CA$CA
241710941$24171094$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06592$LUPIN$$$$$$Y$$$20240804$$CN$US$US
241710951$24171095$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002054US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240804$$CN$US$US
241710961$24171096$1$I$$20240728$20240805$20240805$EXP$GB-MHRA-MIDB-538cdba0-a553-4ecf-a7dd-5b17618f3e21$GB-DEXPHARM-2024-2467$DEXCEL$$44$YR$A$F$Y$$$20240804$$PH$GB$GB
241710971$24171097$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06766$LUPIN$$$$$$Y$$$20240804$$CN$US$US
241710981$24171098$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA224462$SANOFI AVENTIS$$$$$M$Y$$$20240804$$CN$US$US
241710991$24171099$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA228792$SANOFI AVENTIS$$$$T$M$Y$$$20240804$$MD$US$US
241711001$24171100$1$I$20230101$20240729$20240805$20240805$EXP$DE-AMK-278042$DE-DEXPHARM-2024-2475$DEXCEL$$64$YR$A$F$Y$150$KG$20240804$$PH$DE$DE
241711012$24171101$2$F$$20240830$20240805$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06872$LUPIN$$$$$$Y$$$20240920$$CN$US$US
241711022$24171102$2$F$$20240830$20240805$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06727$LUPIN$$$$$$Y$$$20240919$$CN$US$US
241711032$24171103$2$F$$20240916$20240805$20240918$PER$$US-AstraZeneca-2024A172515$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
241711041$24171104$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA225513$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240804$$MD$US$US
241711051$24171105$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223624$SANOFI AVENTIS$$$$E$F$Y$65$KG$20240804$$MD$US$US
241711061$24171106$1$I$$20240730$20240805$20240805$EXP$GB-MHRA-MED-202407251154413950-VRTCD$GB-DEXPHARM-2024-2605$DEXCEL$$$$$M$Y$$$20240804$$HP$GB$GB
241711072$24171107$2$F$20240101$20240801$20240805$20240810$PER$$US-SA-2024SA227520$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240810$$MD$US$US
241711081$24171108$1$I$20240724$20240801$20240805$20240805$EXP$SE-SEMPA-2024-005789$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-122650$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$85$KG$20240804$$MD$SE$SE
241711091$24171109$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA228603$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240804$$MD$US$US
241711101$24171110$1$I$20231201$20240730$20240805$20240805$PER$$US-SA-2024SA227645$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240804$$MD$US$US
241711111$24171111$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA228805$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240804$$MD$US$US
241711122$24171112$2$F$20240701$20240806$20240805$20240809$EXP$$US-SA-2024SA226178$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240809$$MD$US$US
241711138$24171113$8$F$20240719$20240808$20240805$20240917$EXP$$AU-BEH-2024176277$CSL BEHRING$$72$YR$E$M$Y$62$KG$20240917$$MD$AU$AU
241711141$24171114$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225043$SANOFI AVENTIS$$$$$$Y$$$20240804$$CN$US$US
241711151$24171115$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225775$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240804$$MD$US$US
241711161$24171116$1$I$$20240731$20240805$20240805$PER$$US-SA-2024SA228864$SANOFI AVENTIS$$$$$F$Y$$$20240804$$MD$US$US
241711171$24171117$1$I$20240709$20240730$20240805$20240805$EXP$$US-SA-2024SA227686$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240804$$MD$US$US
241711181$24171118$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225056$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240804$$CN$US$US
241711191$24171119$1$I$$20240731$20240805$20240805$PER$$US-SA-2024SA228633$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240804$$MD$US$US
241711201$24171120$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225832$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240804$$MD$US$US
241711211$24171121$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227413$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240804$$CN$US$US
241711222$24171122$2$F$20220101$20240730$20240805$20240808$PER$$US-SA-2024SA225521$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240808$$HP$US$US
241711231$24171123$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227290$SANOFI AVENTIS$$$$A$F$Y$$$20240804$$CN$US$US
241711241$24171124$1$I$$20240730$20240805$20240805$EXP$$NVSC2024US156680$NOVARTIS$$$$$F$Y$$$20240804$$CN$US$US
241711251$24171125$1$I$$20230905$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408362$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241711264$24171126$4$F$20240301$20240917$20240805$20240919$EXP$$NVSC2024GB094095$NOVARTIS$$$$$F$Y$$$20240919$$CN$GB$GB
241711271$24171127$1$I$20240701$20240730$20240805$20240805$EXP$$NVSC2024GB155678$NOVARTIS$$$$$F$Y$$$20240803$$CN$GB$GB
241711281$24171128$1$I$$20240726$20240805$20240805$EXP$$NVSC2024ZA154149$NOVARTIS$$60$YR$$M$Y$$$20240803$$HP$ZA$ZA
241711291$24171129$1$I$20240116$20240801$20240805$20240805$EXP$$NVSC2024GB018489$NOVARTIS$$62$YR$$F$Y$$$20240804$$CN$GB$GB
241711301$24171130$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53484$$FDA-CTU$$62$YR$$F$N$$$20240805$N$$US$
241711312$24171131$2$F$$20240816$20240805$20240821$EXP$$NVSC2024ZA155807$NOVARTIS$$29$YR$$F$Y$$$20240821$$HP$ZA$ZA
241711321$24171132$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158223$NOVARTIS$$$$$$Y$$$20240804$$HP$US$US
241711331$24171133$1$I$$20240731$20240805$20240805$EXP$$NVSC2024US157073$NOVARTIS$$$$$F$Y$$$20240803$$CN$US$US
241711342$24171134$2$F$$20240806$20240805$20240809$EXP$$NVSC2024ZA157060$NOVARTIS$$54$YR$$F$Y$$$20240809$$HP$ZA$ZA
241711351$24171135$1$I$$20240729$20240805$20240805$EXP$$NVSC2024EG157529$NOVARTIS$$$$$M$Y$$$20240804$$CN$EG$EG
241711361$24171136$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53544$$FDA-CTU$$32$YR$$F$N$$$20240805$N$$US$
241711371$24171137$1$I$$20240730$20240805$20240805$EXP$$NVSC2024ZA155728$NOVARTIS$$$$$M$Y$73$KG$20240803$$HP$ZA$ZA
241711381$24171138$1$I$20240501$20240730$20240805$20240805$EXP$$US-SA-2024SA226245$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240804$$MD$US$US
241711391$24171139$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53552$$FDA-CTU$$76$YR$$F$N$$$20240805$N$CN$US$
241711401$24171140$1$I$20240208$20240731$20240805$20240805$EXP$$NVSC2024GB034585$NOVARTIS$$53$YR$$M$Y$$$20240803$$CN$GB$GB
241711411$24171141$1$I$20240101$20240730$20240805$20240805$EXP$$US-SA-2024SA227779$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240804$$MD$US$US
241711421$24171142$1$I$$20240731$20240805$20240805$PER$$US-AstraZeneca-2024A174811$ASTRAZENECA$$$$$M$Y$$$20240804$$CN$US$
241711434$24171143$4$F$20240101$20240917$20240805$20240925$PER$$US-SA-2024SA223735$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240925$$MD$US$US
241711441$24171144$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA222933$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240804$$MD$US$US
241711451$24171145$1$I$20140101$20240729$20240805$20240805$PER$$US-SA-2024SA225071$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240804$$CN$US$US
241711461$24171146$1$I$$20240725$20240805$20240805$EXP$$US-GSK-US2024093473$GLAXOSMITHKLINE$$$$$F$Y$$$20240804$$CN$US$US
241711481$24171148$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001158$ELI LILLY AND CO$$$$$M$Y$$$20240804$$CN$US$US
241711491$24171149$1$I$$20240723$20240805$20240805$PER$$US-JNJFOC-20240806575$JOHNSON AND JOHNSON$$$$$$Y$$$20240804$$MD$US$US
241711501$24171150$1$I$$20220406$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-289529$RANBAXY$$$$A$M$Y$$$20240804$$HP$US$US
241711511$24171151$1$I$$20210625$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-302618$RANBAXY$$$$$M$Y$$$20240804$$CN$US$US
241711521$24171152$1$I$$20210106$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-276667$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241711531$24171153$1$I$20210201$20210416$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-293966$RANBAXY$$61$YR$A$M$Y$$$20240804$$CN$US$US
241711541$24171154$1$I$$20210209$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-280153$RANBAXY$$$$$M$Y$$$20240804$$CN$US$US
241711551$24171155$1$I$$20220107$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-324100$RANBAXY$Weissman JP, Samlowski W, Meoz R. Hedgehog Inhibitor Induction with Addition of Concurrent Superficial Radiotherapy in Patients with Locally Advanced Basal Cell Carcinoma: A Case Series. Oncologist. 2021;26(12):e2247-e2253$87$YR$$F$Y$$$20240804$$HP$US$US
241711561$24171156$1$I$$20210218$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-284217$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241711571$24171157$1$I$$20211005$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-286936$RANBAXY$$$$A$F$Y$$$20240804$$CN$US$US
241711581$24171158$1$I$$20221212$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-370633$RANBAXY$Patel AD, Ravichandran S, Kheterpal M. Hedgehog inhibitors with and without adjunctive therapy in treatment of locally advanced basal cell carcinoma. Int J Dermatol. 2022;61(1):118-124$75$YR$$F$Y$$$20240804$$HP$US$US
241711591$24171159$1$I$$20210706$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-303724$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241711601$24171160$1$I$20220201$20220928$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-358102$RANBAXY$$64$YR$A$F$Y$$$20240804$$CN$US$US
241711611$24171161$1$I$$20230123$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-375574$RANBAXY$$$$E$M$Y$$$20240804$$HP$US$US
241711621$24171162$1$I$$20230605$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-380825$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241711631$24171163$1$I$$20231116$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384217$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241711641$24171164$1$I$$20221202$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-361715$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241711651$24171165$1$I$20221108$20221108$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-325376$RANBAXY$$77$YR$E$M$Y$$$20240804$$CN$US$US
241711661$24171166$1$I$20230113$20230113$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-374344$RANBAXY$$74$YR$E$F$Y$$$20240804$$CN$US$US
241711671$24171167$1$I$$20230216$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-379763$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241711681$24171168$1$I$$20220121$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-325222$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241711691$24171169$1$I$$20221212$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-370652$RANBAXY$Patel AD, Ravichandran S, Kheterpal M. Hedgehog inhibitors with and without adjunctive therapy in treatment of locally advanced basal cell carcinoma. Int J Dermatol. 2022;61(1):118-124$54$YR$$M$Y$$$20240804$$HP$US$US
241711701$24171170$1$I$$20240624$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-373808$RANBAXY$$$$E$M$Y$$$20240804$$HP$US$US
241711711$24171171$1$I$$20230303$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-372748$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241711721$24171172$1$I$20221225$20230405$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-371804$RANBAXY$$73$YR$E$F$Y$$$20240804$$CN$US$US
241711731$24171173$1$I$$20220118$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-324557$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241711741$24171174$1$I$$20220624$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343073$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241711751$24171175$1$I$$20220505$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-336936$RANBAXY$Mechel E, Tran AQ, North VS, Kazim M. Corneal Invasion by Basal Cell Carcinoma. Ophthalmic Plast Reconstr Surg. 2022;38(2):e63$68$YR$$M$Y$$$20240804$$MD$US$US
241711761$24171176$1$I$20220729$20230208$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-347347$RANBAXY$$66$YR$E$M$Y$$$20240804$$CN$US$US
241711771$24171177$1$I$$20221121$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365922$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241711781$24171178$1$I$$20220107$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-324099$RANBAXY$Weissman JP, Samlowski W, Meoz R. Hedgehog Inhibitor Induction with Addition of Concurrent Superficial Radiotherapy in Patients with Locally Advanced Basal Cell Carcinoma: A Case Series. The Oncologist. 2021;26:e2248-e2253$72$YR$$F$Y$$$20240804$$HP$US$US
241711791$24171179$1$I$$20220107$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-312832$RANBAXY$Wang K, Patel M, Prabhu AV, Lewis GD. First reported case of concurrent sonidegib and radiotherapy for recurrent, advanced basal cell carcinoma. Rep Pract Oncol Radiother. 2021;26(1):149-152$85$YR$$M$Y$$$20240804$$MD$US$US
241711801$24171180$1$I$$20220303$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-329662$RANBAXY$$$$$M$Y$$$20240804$$HP$US$US
241711811$24171181$1$I$$20230327$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-383513$RANBAXY$$$$$M$Y$$$20240804$$CN$US$US
241711821$24171182$1$I$$20230224$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381065$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241711831$24171183$1$I$$20220422$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-334980$RANBAXY$$$$$M$Y$$$20240804$$CN$US$US
241711841$24171184$1$I$20220411$20220425$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-335305$RANBAXY$$61$YR$A$M$Y$$$20240804$$CN$US$US
241711851$24171185$1$I$$20230629$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389656$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241711861$24171186$1$I$20220729$20220805$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-348533$RANBAXY$$74$YR$E$F$Y$$$20240804$$CN$US$US
241711871$24171187$1$I$$20221212$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-370649$RANBAXY$Patel AD, Ravichandran S, Kheterpal M. Hedgehog inhibitors with and without adjunctive therapy in treatment of locally advanced basal cell carcinoma. Int J Dermatol. 2022;61(1):118-124$59$YR$$M$Y$$$20240804$$HP$US$US
241711881$24171188$1$I$$20221024$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-361571$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241711891$24171189$1$I$$20221019$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-360520$RANBAXY$$$$$M$Y$$$20240804$$CN$US$US
241711901$24171190$1$I$$20220720$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-321758$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241711911$24171191$1$I$$20220523$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-330483$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241711921$24171192$1$I$$20220302$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-325385$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241711931$24171193$1$I$$20220107$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-324101$RANBAXY$Weissman JP, Samlowski W, Meoz R. Hedgehog Inhibitor Induction with Addition of Concurrent Superficial Radiotherapy in Patients with Locally Advanced Basal Cell Carcinoma: A Case Series. Oncologist. 2021;26(12):e2247-e2253$88$YR$$M$Y$$$20240804$$HP$US$US
241711941$24171194$1$I$$20220222$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2018US-162439$RANBAXY$Ross AE, Hughes RM, Glavaris S, Ghabili K, He P, Anders NM et al. Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy. ONCOTARGET. 2017;8(61):104182-92$$$$M$Y$$$20240804$$HP$US$US
241711951$24171195$1$I$$20221212$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-370644$RANBAXY$Patel AD, Ravichandran S, Kheterpal M. Hedgehog inhibitors with and without adjunctive therapy in treatment of locally advanced basal cell carcinoma. Int J Dermatol. 2022;61(1):118-124$58$YR$$M$Y$$$20240804$$HP$US$US
241711961$24171196$1$I$20230613$20231010$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-392232$RANBAXY$$69$YR$E$M$Y$$$20240804$$CN$US$US
241711971$24171197$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223716$SANOFI AVENTIS$$$$A$F$Y$$$20240804$$MD$US$US
241711981$24171198$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA225889$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240804$$CN$US$US
241712001$24171200$1$I$$20230803$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404000$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712011$24171201$1$I$$20230802$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404001$RANBAXY$$$$$F$Y$$$20240804$$HP$US$US
241712021$24171202$1$I$$20230519$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390210$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241712031$24171203$1$I$$20230714$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400627$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241712041$24171204$1$I$20230728$20230804$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403996$RANBAXY$$80$YR$E$M$Y$$$20240804$$CN$US$US
241712051$24171205$1$I$$20230802$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403998$RANBAXY$$$$E$M$Y$$$20240804$$PH$US$US
241712061$24171206$1$I$20230701$20230703$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-398636$RANBAXY$$81$YR$E$M$Y$$$20240804$$CN$US$US
241712071$24171207$1$I$$20230705$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399584$RANBAXY$$$$E$M$Y$$$20240804$$HP$US$US
241712081$24171208$1$I$20230301$20230801$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403841$RANBAXY$$68$YR$E$M$Y$$$20240804$$CN$US$US
241712091$24171209$1$I$$20230615$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-395385$RANBAXY$$$$E$F$Y$$$20240804$$HP$US$US
241712101$24171210$1$I$20230604$20230907$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394583$RANBAXY$$77$YR$E$F$Y$$$20240804$$CN$US$US
241712111$24171211$1$I$$20230706$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399587$RANBAXY$$$$$F$Y$$$20240804$$HP$US$US
241712121$24171212$1$I$$20230805$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408266$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712131$24171213$1$I$$20191209$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-230864$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241712141$24171214$1$I$$20230709$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399628$RANBAXY$$$$$M$Y$$$20240804$$MD$US$US
241712151$24171215$1$I$20230609$20230609$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394584$RANBAXY$$66$YR$E$F$Y$$$20240804$$CN$US$US
241712161$24171216$1$I$$20240531$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-397407$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712171$24171217$1$I$20230801$20230802$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403840$RANBAXY$$80$YR$E$M$Y$$$20240804$$HP$US$US
241712181$24171218$1$I$$20230816$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405929$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712191$24171219$1$I$$20230825$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406437$RANBAXY$$57$YR$$F$Y$$$20240804$$HP$US$US
241712201$24171220$1$I$$20230726$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401934$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241712211$24171221$1$I$20230508$20230609$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-394585$RANBAXY$$52$YR$A$M$Y$$$20240804$$CN$US$US
241712221$24171222$1$I$$20231021$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409884$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712231$24171223$1$I$$20231103$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417028$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241712241$24171224$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439021$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241712251$24171225$1$I$$20231113$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-418775$RANBAXY$$$$E$M$Y$$$20240804$$MD$US$US
241712261$24171226$1$I$$20240124$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429930$RANBAXY$$$$$M$Y$$$20240804$$CN$US$US
241712271$24171227$1$I$20231203$20231208$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-423878$RANBAXY$$85$YR$E$M$Y$$$20240804$$CN$US$US
241712281$24171228$1$I$$20231115$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-416915$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241712291$24171229$1$I$$20231025$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-416423$RANBAXY$$$$E$F$Y$$$20240804$$MD$US$US
241712301$24171230$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439066$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241712311$24171231$1$I$$20230925$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410236$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712321$24171232$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53553$$FDA-CTU$$63$YR$$F$N$$$20240805$N$$US$
241712331$24171233$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440153$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241712341$24171234$1$I$$20240307$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436247$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241712351$24171235$1$I$$20240529$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434734$RANBAXY$$$$E$M$Y$$$20240804$$MD$US$US
241712361$24171236$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439009$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241712371$24171237$1$I$20231205$20231220$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425237$RANBAXY$$64$YR$A$M$Y$$$20240804$$CN$US$US
241712381$24171238$1$I$$20231130$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417964$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712391$24171239$1$I$20240726$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53559$$FDA-CTU$$76$YR$$F$N$$$20240805$Y$HP$US$
241712401$24171240$1$I$20240207$20240207$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-431057$RANBAXY$$66$YR$E$M$Y$$$20240804$$CN$US$US
241712411$24171241$1$I$$20231114$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419159$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712421$24171242$1$I$$20231005$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411902$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712431$24171243$1$I$$20231030$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-416854$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241712441$24171244$1$I$$20230314$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382072$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712451$24171245$1$I$$20231207$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-423873$RANBAXY$$$$E$M$Y$$$20240804$$MD$US$US
241712461$24171246$1$I$$20240207$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-431060$RANBAXY$$$$$F$Y$$$20240804$$HP$US$US
241712471$24171247$1$I$$20240201$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430765$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241712481$24171248$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439012$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241712491$24171249$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438980$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241712501$24171250$1$I$$20240221$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433532$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712511$24171251$1$I$$20240318$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438145$RANBAXY$$$$$M$Y$$$20240804$$CN$US$US
241712521$24171252$1$I$$20221006$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-358111$RANBAXY$$$$$M$Y$$$20240804$$CN$US$US
241712531$24171253$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439062$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241712541$24171254$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440169$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241712551$24171255$1$I$20230225$20230316$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381963$RANBAXY$$70$YR$E$F$Y$$$20240804$$CN$US$US
241712561$24171256$1$I$$20240227$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-434296$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241712571$24171257$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440173$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241712581$24171258$1$I$$20240529$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439473$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712591$24171259$1$I$$20230505$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-385032$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241712601$24171260$1$I$$20240213$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-432555$RANBAXY$$$$A$F$Y$$$20240804$$CN$US$US
241712611$24171261$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439075$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241712621$24171262$1$I$$20231113$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-418777$RANBAXY$$$$E$M$Y$$$20240804$$HP$US$US
241712631$24171263$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439033$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241712641$24171264$1$I$$20220107$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-324103$RANBAXY$WEISSMAN JP, SAMLOWSKI W, MEOZ R. Hedgehog Inhibitor Induction with Addition of Concurrent Superficial Radiotherapy in Patients with Locally Advanced Basal Cell Carcinoma: A Case Series. Oncologist. 2021;26 (12):e2247-e2253$60$YR$$F$Y$$$20240804$$HP$US$US
241712651$24171265$1$I$$20230117$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-374783$RANBAXY$$$$E$$Y$$$20240804$$CN$US$US
241712661$24171266$1$I$$20230126$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-234421$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712671$24171267$1$I$20230706$20230901$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-384485$RANBAXY$$62$YR$A$M$Y$$$20240804$$CN$US$US
241712681$24171268$1$I$$20240625$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430582$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712691$24171269$1$I$$20230114$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-374384$RANBAXY$$$$A$F$Y$$$20240804$$CN$US$US
241712701$24171270$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440151$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241712711$24171271$1$I$$20231004$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411611$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241712721$24171272$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440150$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241712731$24171273$1$I$$20220829$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-352971$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241712741$24171274$1$I$20230302$20230728$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382092$RANBAXY$$64$YR$A$F$Y$$$20240804$$MD$US$US
241712751$24171275$1$I$$20240310$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-437235$RANBAXY$$$$E$M$Y$$$20240804$$HP$US$US
241712761$24171276$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439001$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241712771$24171277$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439059$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241712781$24171278$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440172$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241712791$24171279$1$I$$20230919$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409204$RANBAXY$$$$E$M$Y$$$20240804$$MD$US$US
241712801$24171280$1$I$$20230501$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-382518$RANBAXY$$$$E$M$Y$$$20240804$$HP$US$US
241712811$24171281$1$I$$20220428$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-320462$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241712821$24171282$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440171$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241712831$24171283$1$I$$20230822$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406189$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241712841$24171284$1$I$20231223$20240301$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-426176$RANBAXY$$97$YR$E$F$Y$$$20240804$$CN$US$US
241712851$24171285$1$I$20221003$20221005$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-358911$RANBAXY$$77$YR$E$M$Y$$$20240804$$CN$US$US
241712861$24171286$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440164$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241712871$24171287$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438978$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241712881$24171288$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438983$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241712891$24171289$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440183$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241712901$24171290$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440149$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241712911$24171291$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439994$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241712921$24171292$1$I$$20240206$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-431056$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241712931$24171293$1$I$$20231012$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413091$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241712941$24171294$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440152$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241712951$24171295$1$I$$20221212$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-370648$RANBAXY$Patel AD, Ravichandran S, Kheterpal M. Hedgehog inhibitors with and without adjunctive therapy in treatment of locally advanced basal cell carcinoma. Int J Dermatol. 2022;61(1):118-124$62$YR$$F$Y$$$20240804$$HP$US$US
241712961$24171296$1$I$$20240123$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429589$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241712971$24171297$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227640$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240804$$MD$US$US
241712982$24171298$2$F$$20240807$20240805$20240814$PER$$US-SA-2024SA224596$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240814$$MD$US$US
241712991$24171299$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440036$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713001$24171300$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440080$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713011$24171301$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440127$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713021$24171302$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440130$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713031$24171303$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53568$$FDA-CTU$$64$YR$$M$N$$$20240805$N$$US$
241713041$24171304$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440145$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713051$24171305$1$I$$20240411$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442475$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713061$24171306$1$I$$20240409$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442167$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713071$24171307$1$I$$20240530$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450095$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241713081$24171308$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440122$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713091$24171309$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440024$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713101$24171310$1$I$$20240506$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445923$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713111$24171311$1$I$$20240506$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445919$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713131$24171313$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440048$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713141$24171314$1$I$$20240626$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442883$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713151$24171315$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440144$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241713161$24171316$1$I$$20240327$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439974$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713171$24171317$1$I$$20240603$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450501$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713181$24171318$1$I$$20240502$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445643$RANBAXY$$$$E$M$Y$$$20240804$$MD$US$US
241713191$24171319$1$I$$20240708$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457633$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713201$24171320$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440030$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713211$24171321$1$I$$20240627$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455591$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713221$24171322$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440124$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713231$24171323$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440118$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713241$24171324$1$I$$20240702$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456155$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241713251$24171325$1$I$$20240708$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442893$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241713261$24171326$1$I$$20240604$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441159$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241713271$24171327$1$I$$20240702$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456161$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713281$24171328$1$I$$20240710$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457630$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241713291$24171329$1$I$$20240410$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440188$RANBAXY$$$$A$M$Y$$$20240804$$HP$US$US
241713301$24171330$1$I$$20240513$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446636$RANBAXY$$$$A$F$Y$$$20240804$$CN$US$US
241713311$24171331$1$I$$20240627$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455579$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713321$24171332$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440000$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241713331$24171333$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440020$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713341$24171334$1$I$$20240520$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448328$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241713351$24171335$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440075$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713361$24171336$1$I$$20240426$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445086$RANBAXY$$$$$F$Y$$$20240804$$PH$US$US
241713371$24171337$1$I$$20240403$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441308$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241713381$24171338$1$I$$20240620$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453805$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241713391$24171339$1$I$$20240610$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451876$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713401$24171340$1$I$$20240719$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459710$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713411$24171341$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440086$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713421$24171342$1$I$$20240515$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447414$RANBAXY$$$$A$F$Y$$$20240804$$MD$US$US
241713431$24171343$1$I$$20240719$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458855$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241713441$24171344$1$I$$20240702$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456181$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241713451$24171345$1$I$$20240327$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439981$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241713461$24171346$1$I$$20240529$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450093$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713471$24171347$1$I$$20240625$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454671$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713481$24171348$1$I$$20240705$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456611$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241713491$24171349$1$I$$20240523$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446184$RANBAXY$$$$$M$Y$$$20240804$$MD$US$US
241713501$24171350$1$I$$20231222$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-389515$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241713511$24171351$1$I$20230828$20230911$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408536$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241713521$24171352$1$I$$20230927$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410613$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241713531$24171353$1$I$20230908$20231010$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407998$RANBAXY$$48$YR$A$M$Y$$$20240804$$CN$US$US
241713541$24171354$1$I$$20240304$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-435235$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241713551$24171355$1$I$$20231019$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-414225$RANBAXY$$$$$M$Y$$$20240804$$CN$US$US
241713561$24171356$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439063$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241713571$24171357$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440156$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713581$24171358$1$I$$20231211$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424188$RANBAXY$$$$E$$Y$$$20240804$$HP$US$US
241713591$24171359$1$I$$20231120$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420884$RANBAXY$$$$$F$Y$$$20240804$$HP$US$US
241713601$24171360$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439068$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713611$24171361$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439006$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713621$24171362$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53556$$FDA-CTU$$69$YR$$F$N$65.32$KG$20240805$N$$US$
241713631$24171363$1$I$$20240719$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-416792$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241713641$24171364$1$I$20231109$20231110$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-418655$RANBAXY$$86$YR$E$M$Y$$$20240804$$CN$US$US
241713651$24171365$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53567$$FDA-CTU$$51$YR$$$N$73.03$KG$20240805$N$$US$
241713661$24171366$1$I$$20240226$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433953$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713671$24171367$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439060$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713681$24171368$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438975$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713691$24171369$1$I$$20231207$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-423875$RANBAXY$$$$E$M$Y$$$20240804$$HP$US$US
241713701$24171370$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440184$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241713711$24171371$1$I$$20240220$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433530$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713721$24171372$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436250$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713731$24171373$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440170$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241713751$24171375$1$I$$20231128$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421853$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241713761$24171376$1$I$$20240123$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429928$RANBAXY$$$$$M$Y$$$20240804$$HP$US$US
241713771$24171377$1$I$$20240131$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429532$RANBAXY$$$$A$F$Y$$$20240804$$HP$US$US
241713781$24171378$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53565$$FDA-CTU$$83$YR$$F$N$60.78$KG$20240805$N$$US$
241713791$24171379$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53548$$FDA-CTU$$89$YR$$F$N$56.7$KG$20240805$N$$US$
241713801$24171380$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439058$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713811$24171381$1$I$$20231115$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419392$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241713821$24171382$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439074$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713831$24171383$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440187$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241713841$24171384$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440167$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713851$24171385$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440160$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713861$24171386$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439036$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713871$24171387$1$I$$20230921$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409132$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241713881$24171388$1$I$$20240502$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430927$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241713891$24171389$1$I$$20230914$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409231$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713901$24171390$1$I$$20240319$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439039$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713911$24171391$1$I$$20240206$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430924$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713921$24171392$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439997$RANBAXY$$$$$$Y$$$20240804$$MD$US$US
241713931$24171393$1$I$$20240502$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445921$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241713941$24171394$1$I$$20240605$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448120$RANBAXY$$$$E$M$Y$$$20240804$$MD$US$US
241713951$24171395$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440071$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241713961$24171396$1$I$$20240409$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442169$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713971$24171397$1$I$$20240618$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453260$RANBAXY$$$$E$M$Y$$$20240804$$CN$US$US
241713981$24171398$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440044$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241713991$24171399$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440035$RANBAXY$$$$$$Y$$$20240804$$HP$US$US
241714001$24171400$1$I$$20240509$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-446862$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241714011$24171401$1$I$$20240620$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453800$RANBAXY$$$$A$M$Y$$$20240804$$CN$US$US
241714021$24171402$1$I$$20240401$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441307$RANBAXY$$$$$M$Y$$$20240804$$CN$US$US
241714031$24171403$1$I$$20240701$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-456157$RANBAXY$$$$E$F$Y$$$20240804$$CN$US$US
241714041$24171404$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440146$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241714051$24171405$1$I$$20240326$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440038$RANBAXY$$$$$$Y$$$20240804$$CN$US$US
241714061$24171406$1$I$$20220922$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-357306$RANBAXY$$$$$F$Y$$$20240804$$CN$US$US
241714071$24171407$1$I$20240101$20240727$20240805$20240805$PER$$US-SA-2024SA226041$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240804$$CN$US$US
241714081$24171408$1$I$$20240727$20240805$20240805$PER$$US-SA-2024SA224723$SANOFI AVENTIS$$$$T$M$Y$$$20240804$$MD$US$US
241714091$24171409$1$I$20240719$20240722$20240805$20240805$PER$$US-AstraZeneca-2024A166629$ASTRAZENECA$$$$$M$Y$$$20240804$$CN$US$
241714101$24171410$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158136$NOVARTIS$$$$$F$Y$$$20240804$$MD$US$US
241714111$24171411$1$I$$20240730$20240805$20240805$EXP$$US-SA-2024SA226944$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240804$$MD$US$US
241714121$24171412$1$I$$20240722$20240805$20240805$EXP$$HU-Oxford Pharmaceuticals, LLC-2159979$OXFORD PHARMACEUTICALS$Source document$11$YR$$F$Y$$$20240804$$$HU$HU
241714141$24171414$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA222940$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240804$$MD$US$US
241714151$24171415$1$I$20240401$20240726$20240805$20240805$PER$$US-SA-2024SA225046$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240804$$MD$US$US
241714161$24171416$1$I$$20240726$20240805$20240805$EXP$$US-GSK-US2024094245$GLAXOSMITHKLINE$$$$$M$Y$$$20240804$$MD$US$US
241714171$24171417$1$I$$20240726$20240805$20240805$30DAY$$US-GSK-US2024094299$GLAXOSMITHKLINE$$$$$F$Y$$$20240804$$CN$US$US
241714181$24171418$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000997$ELI LILLY AND CO$$$$$F$Y$$$20240804$$CN$US$US
241714191$24171419$1$I$20240731$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000212$ELI LILLY AND CO$$$$$F$Y$$$20240804$$CN$US$US
241714201$24171420$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA226016$SANOFI AVENTIS$$$$$F$Y$$$20240804$$CN$US$US
241714211$24171421$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA227438$SANOFI AVENTIS$$$$E$M$Y$$$20240804$$MD$US$US
241714221$24171422$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA225634$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240804$$MD$US$US
241714231$24171423$1$I$$20240723$20240805$20240805$PER$$US-JNJFOC-20240764246$JOHNSON AND JOHNSON$$$$$F$Y$$$20240804$$CN$US$US
241714241$24171424$1$I$20240723$20240723$20240805$20240805$PER$$US-JNJFOC-20240767681$JOHNSON AND JOHNSON$$$$$F$Y$$$20240804$$CN$US$US
241714251$24171425$1$I$20240721$20240727$20240805$20240805$PER$$US-SA-2024SA224881$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240804$$MD$US$US
241714261$24171426$1$I$20240725$20240729$20240805$20240805$PER$$US-SA-2024SA227684$SANOFI AVENTIS$$57$YR$A$M$Y$106.59$KG$20240804$$MD$US$US
241714271$24171427$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA226697$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240804$$MD$US$US
241714281$24171428$1$I$20240731$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53478$$FDA-CTU$$87$YR$$F$N$$$20240802$N$HP$US$
241714291$24171429$1$I$$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53532$$FDA-CTU$$82$YR$$F$N$$$20240802$N$PH$US$
241714301$24171430$1$I$$20230501$20240805$20240805$EXP$$US-AstraZeneca-2023A102179$ASTRAZENECA$$$$$F$Y$$$20240804$$CN$US$
241714311$24171431$1$I$$20230223$20240805$20240805$EXP$$US-AstraZeneca-2023A047514$ASTRAZENECA$$$$$M$Y$$$20240804$$CN$US$
241714321$24171432$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53569$$FDA-CTU$$54$YR$$M$N$111.13$KG$20240805$N$$US$
241714331$24171433$1$I$$20240724$20240805$20240805$EXP$$US-JNJFOC-20240769389$JOHNSON AND JOHNSON$$$$$$Y$$$20240804$$MD$US$US
241714343$24171434$3$F$20240125$20240826$20240805$20240905$PER$$US-JNJFOC-20240769506$JOHNSON AND JOHNSON$$75$YR$E$M$Y$83.5$KG$20240905$$MD$US$US
241714351$24171435$1$I$$20240723$20240805$20240805$EXP$PT-EMA-2024717-AUTODUP-1721244935727$PT-Accord-438379$ACCORD$$65$YR$E$M$Y$87$KG$20240804$$MD$PT$PT
241714361$24171436$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226708$SANOFI AVENTIS$$$$A$F$Y$$$20240804$$MD$US$US
241714371$24171437$1$I$20240715$20240723$20240805$20240805$EXP$$ES-Accord-438345$ACCORD$$62$YR$A$M$Y$99.4$KG$20240804$$HP$ES$ES
241714381$24171438$1$I$20240729$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407018931$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240804$$CN$US$US
241714392$24171439$2$F$20240501$20240806$20240805$20240814$PER$$US-SA-2024SA225942$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240814$$MD$US$US
241714402$24171440$2$F$$20240916$20240805$20240916$PER$$NVSC2024US158057$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
241714412$24171441$2$F$20240711$20240918$20240805$20240925$PER$$US-SA-2024SA220583$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240925$$MD$US$US
241714421$24171442$1$I$20240727$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000418$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240804$$CN$US$US
241714431$24171443$1$I$$20240723$20240805$20240805$EXP$$CN-JNJFOC-20240772517$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240804$$HP$CN$CN
241714441$24171444$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240804204$JOHNSON AND JOHNSON$$$$$F$Y$$$20240804$$HP$US$US
241714451$24171445$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226689$SANOFI AVENTIS$$$$E$F$Y$$$20240804$$MD$US$US
241714461$24171446$1$I$$20240731$20240805$20240805$EXP$$AT-SA-2023SA254751$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240804$$MD$AT$AT
241714471$24171447$1$I$20211001$20220124$20240805$20240805$EXP$$US-AstraZeneca-2022A044333$ASTRAZENECA$$562$MON$$F$Y$$$20240804$$CN$US$
241714482$24171448$2$F$20240725$20240731$20240805$20240808$PER$$US-SA-2024SA226772$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240808$$MD$US$US
241714491$24171449$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000970$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240804$$CN$US$US
241714501$24171450$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001167$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240804$$CN$US$US
241714511$24171451$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06786$LUPIN$$$$$$Y$$$20240804$$CN$US$US
241714522$24171452$2$F$$20240806$20240805$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06745$LUPIN$$$$$$Y$$$20240830$$CN$US$US
241714531$24171453$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06867$LUPIN$$$$$$Y$$$20240804$$CN$US$US
241714541$24171454$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001271$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240804$$CN$US$US
241714551$24171455$1$I$$20240731$20240805$20240805$PER$$US-SA-2024SA229070$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240804$$MD$US$US
241714561$24171456$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06890$LUPIN$$$$$$Y$$$20240804$$PH$US$US
241714571$24171457$1$I$$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407018924$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240804$$CN$US$US
241714581$24171458$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000993$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240804$$CN$US$US
241714591$24171459$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA223113$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240804$$CN$US$US
241714601$24171460$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06930$LUPIN$$$$$$Y$$$20240804$$CN$US$US
241714611$24171461$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226670$SANOFI AVENTIS$$$$$$Y$$$20240804$$PH$US$US
241714631$24171463$1$I$$20240704$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04968$LUPIN$$$$$$Y$$$20240804$$CN$US$US
241714641$24171464$1$I$20240708$20240726$20240805$20240805$PER$$US-SA-2024SA222865$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240804$$MD$US$US
241714651$24171465$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2023SA402962$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240804$$MD$US$US
241714661$24171466$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA222620$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240804$$MD$US$US
241714671$24171467$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226686$SANOFI AVENTIS$$$$A$F$Y$$$20240804$$MD$US$US
241714681$24171468$1$I$20240709$20240725$20240805$20240805$EXP$$KR-BAXTER-2024BAX022532$BAXTER$$68$YR$$$Y$$$20240804$$CN$KR$KR
241714691$24171469$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000309$ELI LILLY AND CO$$$$$M$Y$$$20240804$$CN$US$US
241714701$24171470$1$I$20240419$20240725$20240805$20240805$EXP$CN-NMPACDR-3301051028618202400136$CN-BAXTER-2024BAX022383$BAXTER$$5$YR$$M$Y$20.8$KG$20240804$$MD$CN$CN
241714712$24171471$2$F$$20240808$20240805$20240809$EXP$$FR-BAXTER-2024BAX022330$BAXTER$$69$YR$$$Y$$$20240809$$HP$FR$FR
241714722$24171472$2$F$20240515$20240822$20240805$20240830$EXP$FR-AFSSAPS-TS2024000856$FR-BAXTER-2024BAX022272$BAXTER$$64$YR$$M$Y$82$KG$20240830$$MD$FR$FR
241714731$24171473$1$I$20240629$20240725$20240805$20240805$EXP$CN-NMPACDR-3701031012442202400230$CN-BAXTER-2024BAX022385$BAXTER$$57$YR$$F$Y$55$KG$20240804$$MD$CN$CN
241714741$24171474$1$I$$20240725$20240805$20240805$EXP$FR-AFSSAPS-TS2024000855$FR-BAXTER-2024BAX022257$BAXTER$$57$YR$$M$Y$68$KG$20240804$$MD$FR$FR
241714751$24171475$1$I$20240630$20240725$20240805$20240805$EXP$CN-NMPACDR-3301101038443202400487$CN-BAXTER-2024BAX022393$BAXTER$$47$YR$$M$Y$$$20240804$$MD$CN$CN
241714761$24171476$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA221761$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240804$$MD$US$US
241714771$24171477$1$I$$20240725$20240805$20240805$EXP$GB-MHRA-31118704$GB-BAXTER-2024BAX022284$BAXTER$$55$YR$$M$Y$$$20240804$$PH$GB$GB
241714781$24171478$1$I$20240209$20240725$20240805$20240805$EXP$FR-AFSSAPS-LM2024000159$FR-BAXTER-2024BAX022274$BAXTER$$80$YR$$M$Y$59$KG$20240804$$MD$FR$FR
241714791$24171479$1$I$20240720$20240730$20240805$20240805$PER$$US-SA-2024SA227470$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240804$$CN$US$US
241714801$24171480$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA223331$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240804$$CN$US$US
241714811$24171481$1$I$20240613$20240729$20240805$20240805$EXP$FR-AFSSAPS-TO2024001352$FR-SA-2024SA224848$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240804$$MD$FR$FR
241714821$24171482$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA222996$SANOFI AVENTIS$$$$E$M$Y$85.27$KG$20240804$$MD$US$US
241714841$24171484$1$I$$20240730$20240805$20240805$EXP$$US-JNJFOC-20240783757$JOHNSON AND JOHNSON$$$$$$Y$$$20240804$$CN$US$US
241714851$24171485$1$I$$20240724$20240805$20240805$30DAY$$US-GSK-US2024092984$GLAXOSMITHKLINE$$$$$F$Y$$$20240804$$CN$US$US
241714865$24171486$5$F$$20240823$20240805$20240827$PER$$US-ROCHE-10000047347$ROCHE$$$$E$F$Y$$$20240827$$HP$US$US
241714871$24171487$1$I$$20240731$20240805$20240805$PER$$US-SA-2024SA229079$SANOFI AVENTIS$$$$C$M$Y$$$20240804$$MD$US$US
241714881$24171488$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA222085$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240804$$MD$US$US
241714891$24171489$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA222419$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240804$$MD$US$US
241714901$24171490$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA143694$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240804$$MD$US$US
241714911$24171491$1$I$$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000990$ELI LILLY AND CO$$$$$$Y$$$20240804$$CN$US$US
241714921$24171492$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA223114$SANOFI AVENTIS$$$$E$F$Y$$$20240804$$MD$US$US
241714931$24171493$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA223092$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240804$$MD$US$US
241714941$24171494$1$I$$20240723$20240805$20240805$PER$$US-AstraZeneca-2024A172039$ASTRAZENECA$$$$$$Y$$$20240804$$CN$US$
241714951$24171495$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227558$SANOFI AVENTIS$$$$C$F$Y$$$20240804$$MD$US$US
241714971$24171497$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA223006$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240804$$MD$US$US
241714981$24171498$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53570$$FDA-CTU$$51$YR$$F$N$73.03$KG$20240805$N$$US$
241714992$24171499$2$F$20210804$20240823$20240805$20240903$EXP$$US-ROCHE-10000046232$ROCHE$$70$YR$E$M$Y$113.4$KG$20240903$$CN$US$US
241715001$24171500$1$I$$20240728$20240805$20240805$EXP$$KR-JNJFOC-20240779651$JOHNSON AND JOHNSON$$$$$$Y$$$20240804$$HP$KR$KR
241715011$24171501$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223885$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240804$$CN$US$US
241715021$24171502$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53575$$FDA-CTU$$65$YR$$M$N$$$20240805$N$$US$
241715041$24171504$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA224204$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240804$$MD$US$US
241715051$24171505$1$I$20240731$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122820$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240804$$PH$US$US
241715061$24171506$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA222104$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240804$$MD$US$US
241715071$24171507$1$I$$20240731$20240805$20240805$PER$$US-AstraZeneca-2024A174908$ASTRAZENECA$$$$$F$Y$$$20240804$$CN$US$
241715082$24171508$2$F$20240101$20240904$20240805$20240906$PER$$US-AstraZeneca-2024A173058$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
241715101$24171510$1$I$$20240731$20240805$20240805$EXP$$US-ROCHE-10000046462$ROCHE$$$$A$M$Y$$$20240804$$HP$US$US
241715111$24171511$1$I$$20240731$20240805$20240805$EXP$IT-MLMSERVICE-20240715-PI131817-00232-1$IT-ROCHE-10000043021$ROCHE$Acerbis A, Acerbis A O. Pre-engraftment neurological impairment in allogeneic stem cell transplant: A case report of atypical posterior reversible encephalopathy syndrome with pontine involvement. Frontiers in transplantation. 2023;1: doi:10.3389/frtra.2022.1089995.$59$YR$A$F$Y$$$20240804$$HP$IT$IT
241715121$24171512$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227052$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240804$$CN$US$US
241715133$24171513$3$F$20240101$20240806$20240805$20240819$PER$$US-SA-2024SA223778$SANOFI AVENTIS$$28$YR$A$M$Y$77$KG$20240819$$MD$US$US
241715141$24171514$1$I$20240701$20240729$20240805$20240805$EXP$$US-SA-2024SA224275$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240804$$MD$US$US
241715151$24171515$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA223561$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240804$$MD$US$US
241715161$24171516$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223603$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240804$$MD$US$US
241715171$24171517$1$I$20240701$20240726$20240805$20240805$PER$$US-SA-2024SA223337$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240804$$MD$US$US
241715181$24171518$1$I$$20240729$20240805$20240805$PER$$US-JNJFOC-20240777366$JOHNSON AND JOHNSON$$$$$F$Y$$$20240804$$CN$US$US
241715191$24171519$1$I$20240727$20240729$20240805$20240805$PER$$US-SA-2024SA221294$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240804$$MD$US$US
241715201$24171520$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000994$ELI LILLY AND CO$$$$$$Y$$$20240804$$CN$US$US
241715211$24171521$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001662$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240804$$CN$US$US
241715221$24171522$1$I$$20240724$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407016172$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240804$$CN$US$US
241715231$24171523$1$I$$20240729$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120619$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240804$$PH$US$US
241715241$24171524$1$I$$20240729$20240805$20240805$EXP$$TR-ROCHE-10000042069$ROCHE$Aygunes U, Karagun B, Sasmaz H, Antmen A, Tumgor G.. The Treatment of Steroid-Refractory Severe Gastrointestinal Acute Graft-Versus-Host Disease in Children after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience. Osmangazi Journal of Medicine. 2024-Apr-22;46 (3):394-403. doi:10.20515/otd.1420314.$3$YR$C$M$Y$$$20240804$$HP$TR$TR
241715251$24171525$1$I$$20240729$20240805$20240805$EXP$$TR-ROCHE-10000042065$ROCHE$Aygunes U, Karagun B, Sasmaz H, Antmen A, Tumgor G. The Treatment of Steroid-Refractory Severe Gastrointestinal Acute Graft-Versus-Host Disease in Children after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience. Osmangazi Journal of Medicine. 2024;46 (3):394-403. doi:10.20515/otd.1420314.$4$YR$C$F$Y$$$20240804$$HP$TR$TR
241715261$24171526$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226583$SANOFI AVENTIS$$$$C$M$Y$$$20240804$$MD$US$US
241715272$24171527$2$F$20240722$20240910$20240805$20240923$EXP$$US-BEH-2024176675$CSL BEHRING$$18$YR$A$M$Y$$$20240923$$CN$US$US
241715281$24171528$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001803$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240804$$CN$US$US
241715292$24171529$2$F$$20240725$20240805$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407018737$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240807$$CN$US$US
241715301$24171530$1$I$$20240729$20240805$20240805$EXP$$TR-ROCHE-10000042063$ROCHE$Aygunes U, Karagun B, Sasmaz H, Antmen A, Tumgor G. The Treatment of Steroid-Refractory Severe Gastrointestinal Acute Graft-Versus-Host Disease in Children after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience. Osmangazi Journal of Medicine. 2024-Apr-22;46 (3):394-403. doi:10.20515/otd.1420314.$12$YR$T$M$Y$$$20240804$$HP$TR$TR
241715311$24171531$1$I$$20240729$20240805$20240805$EXP$$TR-ROCHE-10000042059$ROCHE$Aygunes U, Karagun B, Sasmaz H, Antmen A, Tumgor G. The Treatment of Steroid-Refractory Severe Gastrointestinal Acute Graft-Versus-Host Disease in Children after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience. Osmangazi Journal of Medicine. 2024;46 (3):394-403. doi:10.20515/otd.1420314.$2$YR$C$F$Y$$$20240804$$HP$TR$TR
241715321$24171532$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226412$SANOFI AVENTIS$$$$$F$Y$$$20240804$$CN$US$US
241715331$24171533$1$I$$20240725$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000242$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240804$$CN$US$US
241715341$24171534$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA227633$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240804$$MD$US$US
241715361$24171536$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122183$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240804$$CN$US$US
241715371$24171537$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122635$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$93.44$KG$20240804$$CN$US$US
241715381$24171538$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA224782$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240804$$MD$US$US
241715391$24171539$1$I$$20240725$20240805$20240805$30DAY$$US-GSK-US2024093777$GLAXOSMITHKLINE$$$$$M$Y$$$20240804$$CN$US$US
241715401$24171540$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA224884$SANOFI AVENTIS$$$$A$F$Y$$$20240804$$MD$US$US
241715412$24171541$2$F$$20240801$20240805$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122933$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240819$$CN$US$US
241715422$24171542$2$F$20230101$20240806$20240805$20240814$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-101650$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240814$$MD$IT$IT
241715431$24171543$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223070$SANOFI AVENTIS$$$$A$M$Y$$$20240804$$MD$US$US
241715441$24171544$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225355$SANOFI AVENTIS$$$$A$F$Y$$$20240804$$MD$US$US
241715451$24171545$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225161$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240804$$MD$US$US
241715461$24171546$1$I$$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024151724$AMGEN$$$$A$M$Y$$$20240804$$HP$US$US
241715471$24171547$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152815$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1 to E8$$$$$Y$$$20240804$$MD$US$US
241715481$24171548$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153099$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240804$$MD$US$US
241715491$24171549$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153087$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et. al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240804$$MD$US$US
241715501$24171550$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153317$AMGEN$Cowen E. W.; Tan I. J.; Ferrada M. A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240804$$MD$US$US
241715511$24171551$1$I$20240507$20240730$20240805$20240805$EXP$$CN-JNJFOC-20240784269$JOHNSON AND JOHNSON$$33$YR$A$F$Y$87$KG$20240804$$HP$CN$CN
241715523$24171552$3$F$$20240821$20240805$20240916$PER$$US-SA-2024SA224772$SANOFI AVENTIS$$38$YR$A$M$Y$90.2$KG$20240916$$MD$US$US
241715532$24171553$2$F$20240707$20240905$20240805$20240920$EXP$$US-SA-2024SA225320$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240920$$MD$US$US
241715541$24171554$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002014US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240804$$CN$US$US
241715551$24171555$1$I$20240101$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024151656$AMGEN$$65$YR$E$F$Y$$$20240804$$CN$US$US
241715561$24171556$1$I$$20240729$20240805$20240805$PER$$US-AMGEN-USASP2024150606$AMGEN$$$$$F$Y$$$20240804$$PH$US$US
241715571$24171557$1$I$20240701$20240725$20240805$20240805$PER$$US-SA-2024SA225813$SANOFI AVENTIS$$20$YR$A$F$Y$86.18$KG$20240804$$MD$US$US
241715581$24171558$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153412$AMGEN$Cowen E. W.; Tan I. J.; Ferrada M. A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes.. JAMA Dermatology. 2024;E1 to E8$$$$$Y$$$20240804$$MD$US$US
241715591$24171559$1$I$$20240722$20240805$20240805$PER$$US-JNJFOC-20240767618$JOHNSON AND JOHNSON$$$$$F$Y$$$20240804$$CN$US$US
241715601$24171560$1$I$20240724$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024151518$AMGEN$$53$YR$A$M$Y$$$20240804$$CN$US$US
241715612$24171561$2$F$$20240828$20240805$20240920$PER$$US-SA-2024SA224756$SANOFI AVENTIS$$$$C$M$Y$34.649$KG$20240920$$MD$US$US
241715621$24171562$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153468$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1 to E8$$$$$Y$$$20240804$$MD$US$US
241715631$24171563$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002057US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240804$$CN$US$US
241715642$24171564$2$F$$20240731$20240805$20240807$EXP$$US-ALXN-202407USA002056US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240807$$CN$US$US
241715651$24171565$1$I$$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024153167$AMGEN$$$$A$M$Y$$$20240804$$CN$US$US
241715661$24171566$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA224494$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
241715671$24171567$1$I$20240714$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024152197$AMGEN$$59$YR$A$F$Y$$$20240804$$CN$US$US
241715691$24171569$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225507$SANOFI AVENTIS$$$$C$M$Y$46.9$KG$20240805$$MD$US$US
241715701$24171570$1$I$$20240730$20240805$20240805$EXP$$NVSC2024US156620$NOVARTIS$$$$$M$Y$$$20240805$$CN$US$US
241715711$24171571$1$I$$20240802$20240805$20240805$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043605$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240805$$CN$US$US
241715721$24171572$1$I$$20240730$20240805$20240805$EXP$$CN-AMGEN-CHNSP2024151892$AMGEN$Zeng H.; Wang Y.; Xue Y. et. al.. Treatment and outcomes of patients with B-ALL relapse after CD19 CAR-T therapy. Journal of Translational Medicine. 2024;22 (1):1-3$$$$$Y$$$20240804$$HP$CN$CN
241715731$24171573$1$I$20220301$20240730$20240805$20240805$EXP$$US-AMGEN-USASP2024151343$AMGEN$$60$YR$A$F$Y$$$20240804$$CN$US$US
241715742$24171574$2$F$20230501$20240805$20240805$20240812$EXP$$US-AMGEN-USASP2024151866$AMGEN$$78$YR$E$M$Y$$$20240812$$HP$US$US
241715751$24171575$1$I$$20240722$20240805$20240805$EXP$$CA-HLS-202401813$HLS THERAPEUTICS$$41$YR$A$F$Y$$$20240804$$MD$CA$CA
241715761$24171576$1$I$20240731$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001460$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240804$$CN$US$US
241715771$24171577$1$I$20240627$20240711$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407008099$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240804$$CN$US$US
241715781$24171578$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158393$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241715791$24171579$1$I$20240709$20240731$20240805$20240805$EXP$$RU-JNJFOC-20240805862$JOHNSON AND JOHNSON$$75$YR$E$M$Y$90$KG$20240805$$HP$RU$RU
241715801$24171580$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158395$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241715811$24171581$1$I$$20240730$20240805$20240805$EXP$$CA-JNJFOC-20240782634$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240805$$HP$CA$CA
241715821$24171582$1$I$$20240730$20240805$20240805$EXP$$US-JNJFOC-20240781656$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$PH$US$US
241715832$24171583$2$F$20220501$20240815$20240805$20240819$EXP$$JP-JNJFOC-20240804740$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240819$$PH$JP$JP
241715841$24171584$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158394$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241715851$24171585$1$I$$20240726$20240805$20240805$EXP$$JP-009507513-2407JPN016083$MERCK$$57$YR$$M$Y$$$20240804$$HP$JP$JP
241715871$24171587$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152922$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et. al. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1 to E8$$$$$Y$$$20240804$$MD$US$US
241715882$24171588$2$F$20240630$20240820$20240805$20240825$EXP$$NVSJ2024JP009337$NOVARTIS$$98$YR$$M$Y$$$20240826$$MD$JP$JP
241715891$24171589$1$I$$20240802$20240805$20240805$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043612$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240805$$CN$US$US
241715901$24171590$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA222786$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
241715913$24171591$3$F$20240727$20240919$20240805$20240924$EXP$$US-BEH-2024176539$CSL BEHRING$$36$YR$A$F$Y$$$20240924$$HP$US$US
241715921$24171592$1$I$20240101$20240726$20240805$20240805$EXP$$CA-ABBVIE-5860400$ABBVIE$$31$YR$$F$Y$$$20240804$$CN$CA$CA
241715931$24171593$1$I$20240315$20240729$20240805$20240805$EXP$$US-ABBVIE-5860384$ABBVIE$$18$YR$$F$Y$$$20240804$$CN$US$US
241715941$24171594$1$I$$20240725$20240805$20240805$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00290$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240802$$CN$US$US
241715951$24171595$1$I$$20240731$20240805$20240805$EXP$$US-ABBVIE-5863855$ABBVIE$$$$$F$Y$$$20240804$$CN$US$US
241715961$24171596$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240802108$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$MD$US$US
241715971$24171597$1$I$20240701$20240801$20240805$20240805$EXP$$GR-ABBVIE-5865584$ABBVIE$$85$YR$$M$Y$$$20240804$$CN$GR$GR
241715981$24171598$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226186$SANOFI AVENTIS$$$$E$F$Y$$$20240805$$MD$US$US
241715991$24171599$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002047US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241716001$24171600$1$I$20240506$20240729$20240805$20240805$PER$$US-SA-2024SA226562$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240805$$MD$US$US
241716011$24171601$1$I$20240701$20240726$20240805$20240805$PER$$US-SA-2024SA224405$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240805$$MD$US$US
241716021$24171602$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152954$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et. al. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1 to E8$$$$$Y$$$20240804$$MD$US$US
241716031$24171603$1$I$$20240801$20240805$20240805$PER$$NVSC2024US157987$NOVARTIS$$$$$F$Y$$$20240805$$CN$US$US
241716044$24171604$4$F$20240723$20240828$20240805$20240910$30DAY$$US-JNJFOC-20240765376$JOHNSON AND JOHNSON$$41$YR$A$$Y$$$20240910$$CN$US$US
241716052$24171605$2$F$$20240906$20240805$20240906$PER$$US-ALXN-202407USA002017US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
241716062$24171606$2$F$$20240807$20240805$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121944$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240812$$CN$US$US
241716071$24171607$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153055$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240804$$MD$US$US
241716081$24171608$1$I$20150401$20240726$20240805$20240805$PER$$US-JNJFOC-20240775890$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240805$$HP$US$US
241716093$24171609$3$F$20240508$20240904$20240805$20240908$EXP$$JP-SA-2024SA139777$SANOFI AVENTIS$$68$YR$E$M$Y$63.3$KG$20240909$$MD$JP$JP
241716101$24171610$1$I$20220101$20240802$20240805$20240805$EXP$$AU-ABBVIE-5865586$ABBVIE$$$$$M$Y$$$20240804$$CN$AU$AU
241716111$24171611$1$I$$20240729$20240805$20240805$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001552$BLUEPRINT MEDICINES$$$$$F$Y$$$20240805$$HP$US$US
241716121$24171612$1$I$$20240724$20240805$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121073$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$MD$JP$JP
241716131$24171613$1$I$$20240731$20240805$20240805$EXP$$US-JNJFOC-20240802162$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241716141$24171614$1$I$$20240731$20240805$20240805$EXP$$US-JNJFOC-20240802147$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$US$US
241716151$24171615$1$I$20240501$20240726$20240805$20240805$EXP$$CO-JNJFOC-20240778107$JOHNSON AND JOHNSON$$25$YR$A$M$Y$90$KG$20240805$$HP$CO$CO
241716171$24171617$1$I$20240724$20240730$20240805$20240805$EXP$$US-ABBVIE-5863115$ABBVIE$$83$YR$$M$Y$$$20240804$$CN$US$US
241716181$24171618$1$I$$20240725$20240805$20240805$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2159987$Chengdu Suncadia Medicine$Clinical analysis of 14 pregnancies in women with renal transplant.$$$$$Y$2.3$KG$20240804$$MD$CN$CN
241716191$24171619$1$I$20240718$20240730$20240805$20240805$EXP$$US-ABBVIE-5860803$ABBVIE$$46$YR$$F$Y$$$20240804$$CN$US$US
241716201$24171620$1$I$$20240730$20240805$20240805$EXP$$US-JNJFOC-20240783451$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240805$$HP$US$US
241716211$24171621$1$I$20240723$20240731$20240805$20240805$EXP$$JP-TAKEDA-2024TJP011512$TAKEDA$$10$YR$$M$Y$$$20240804$$MD$JP$JP
241716221$24171622$1$I$20240101$20240730$20240805$20240805$EXP$$US-ABBVIE-5723841$ABBVIE$$$$$F$Y$$$20240804$$CN$US$US
241716232$24171623$2$F$20230201$20240819$20240805$20240826$EXP$$JP-SA-2024SA220726$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240826$$MD$JP$JP
241716241$24171624$1$I$20240729$20240729$20240805$20240805$PER$$US-AMGEN-USASP2024150397$AMGEN$$58$YR$A$F$Y$$$20240804$$CN$US$US
241716251$24171625$1$I$$20240731$20240805$20240805$EXP$$US-JNJFOC-20240801836$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$HP$US$US
241716261$24171626$1$I$20240408$20240729$20240805$20240805$EXP$IT-MINISAL02-994926$IT-BIOGEN-2024BI01274302$BIOGEN$$49$YR$$F$Y$47$KG$20240804$$MD$IT$IT
241716271$24171627$1$I$20240101$20240731$20240805$20240805$EXP$$US-ABBVIE-5864411$ABBVIE$$$$$F$Y$$$20240804$$CN$US$US
241716281$24171628$1$I$20240720$20240729$20240805$20240805$EXP$$US-BIOGEN-2024BI01276084$BIOGEN$$57$YR$$F$Y$$$20240804$$MD$US$US
241716292$24171629$2$F$20240729$20240804$20240805$20240807$EXP$$SA-BIOGEN-2024BI01276093$BIOGEN$$3$YR$$M$Y$$$20240807$$CN$SA$SA
241716302$24171630$2$F$20240101$20240803$20240805$20240807$EXP$$US-ABBVIE-5863119$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241716311$24171631$1$I$$20240725$20240805$20240805$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2159988$Chengdu Suncadia Medicine$Clinical analysis of 14 pregnancies in women with renal transplant.$$$$$Y$2.42$KG$20240804$$MD$CN$CN
241716321$24171632$1$I$20240720$20240726$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011618$BEIGENE$$$$$$Y$$$20240804$$HP$CN$CN
241716331$24171633$1$I$$20240801$20240805$20240805$EXP$$FR-SANDOZ INC.-SDZ2024FR069813$SANDOZ$$64$YR$$M$Y$$$20240804$$HP$FR$FR
241716341$24171634$1$I$20240701$20240731$20240805$20240805$EXP$$US-JNJFOC-20240800918$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240805$$CN$US$US
241716361$24171636$1$I$20240218$20240726$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011631$BEIGENE$$$$$$Y$$$20240804$$HP$CN$CN
241716371$24171637$1$I$20240731$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53479$$FDA-CTU$$75$YR$$M$N$$$20240802$N$PH$US$
241716381$24171638$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158396$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241716391$24171639$1$I$20240730$20240731$20240805$20240805$EXP$$US-ABBVIE-5864799$ABBVIE$$70$YR$$M$Y$$$20240804$$CN$US$US
241716401$24171640$1$I$20240708$20240726$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011676$BEIGENE$$$$$$Y$$$20240804$$HP$CN$CN
241716411$24171641$1$I$20240701$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024151923$AMGEN$$72$YR$E$M$Y$$$20240804$$MD$US$US
241716421$24171642$1$I$$20240725$20240805$20240805$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2159989$Chengdu Suncadia Medicine$Clinical analysis of 14 pregnancies in women with renal transplant.$31$YR$$F$Y$$$20240804$$MD$CN$CN
241716431$24171643$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158398$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241716441$24171644$1$I$20240701$20240730$20240805$20240805$EXP$$US-BIOGEN-2024BI01276092$BIOGEN$$52$YR$$F$Y$$$20240804$$HP$US$US
241716451$24171645$1$I$20240301$20240729$20240805$20240805$EXP$$MA-BIOGEN-2024BI01276289$BIOGEN$$38$YR$$F$Y$80$KG$20240804$$MD$MA$MA
241716461$24171646$1$I$$20240729$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2024US069508$SANDOZ$Lauren Worth. Successful Treatment of Relapsing ChronicEosinophilic Pneumonia With Mepolizumab: ACase Report. Cureus. 2024;16(7)$73$YR$$M$Y$$$20240804$$MD$US$US
241716471$24171647$1$I$$20240731$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2023CA019934$SANDOZ$$$$$M$Y$$$20240804$$CN$CA$CA
241716483$24171648$3$F$20240627$20240815$20240805$20240822$30DAY$$US-JNJFOC-20240778015$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240822$$HP$US$US
241716491$24171649$1$I$$20240731$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2024CA070112$SANDOZ$$$$$$Y$$$20240804$$CN$CA$CA
241716501$24171650$1$I$$20240801$20240805$20240805$EXP$$JP-TAKEDA-2024TJP011592$TAKEDA$$65$YR$$F$Y$$$20240804$$MD$JP$JP
241716512$24171651$2$F$20240101$20240910$20240805$20240914$EXP$$US-ABBVIE-5864742$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
241716521$24171652$1$I$20220401$20240802$20240805$20240805$EXP$GB-MHRA-MED-202408011618310490-WTHVC$GB-SANDOZ INC.-SDZ2024GB070231$SANDOZ$$59$YR$$F$Y$$$20240804$$CN$GB$GB
241716531$24171653$1$I$$20240802$20240805$20240805$EXP$IT-VA000000599-2024000696$IT-SANDOZ INC.-SDZ2024IT070132$SANDOZ$$$$$F$Y$$$20240804$$MD$IT$IT
241716551$24171655$1$I$20240701$20240724$20240805$20240805$PER$$US-BAUSCHBL-2024BNL030608$BAUSCH AND LOMB$$$$$F$Y$$$20240805$$CN$US$US
241716562$24171656$2$F$20240724$20240731$20240805$20240805$EXP$$CA-BIOGEN-2024BI01276168$BIOGEN$$43$YR$$M$Y$$$20240805$$CN$CA$CA
241716571$24171657$1$I$20240101$20240724$20240805$20240805$PER$$US-BAUSCHBL-2024BNL030676$BAUSCH AND LOMB$$$$$F$Y$$$20240805$$CN$US$US
241716581$24171658$1$I$20240527$20240730$20240805$20240805$EXP$$US-BIOGEN-2024BI01276288$BIOGEN$$49$YR$$F$Y$$$20240804$$CN$US$US
241716591$24171659$1$I$20180101$20230712$20240805$20240805$EXP$$FR-SANDOZ INC.-PHHY2018FR065123$SANDOZ$Rozot P. Cas clinique :chirurgie combine cataracte-glaucome et implant a profoneteur de champ [Clinical case: combined cataract-glaucoma surgery and depth-of-field implant]. LA REVUE DE REFLEXIONS OPHTALMOLOGIQUES [OPHTHALMOLOGICAL REFLECTIONS]. 2018;23:33-5$$$$F$Y$$$20240804$$MD$FR$FR
241716601$24171660$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158457$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241716611$24171661$1$I$20240701$20240730$20240805$20240805$EXP$$US-ABBVIE-5861036$ABBVIE$$15$YR$$F$Y$$$20240804$$CN$US$US
241716631$24171663$1$I$20231101$20240730$20240805$20240805$EXP$$US-ABBVIE-5862871$ABBVIE$$75$YR$$M$Y$77.111$KG$20240804$$CN$US$US
241716641$24171664$1$I$20230419$20240729$20240805$20240805$EXP$FR-AFSSAPS-AM2024000595$FR-SANDOZ INC.-SDZ2024FR069176$SANDOZ$$43$YR$$M$Y$110$KG$20240804$$MD$FR$FR
241716652$24171665$2$F$20231201$20240903$20240805$20240909$EXP$$BR-SANDOZ INC.-SDZ2024BR062899$SANDOZ$$50$YR$$F$Y$$$20240909$$CN$BR$BR
241716661$24171666$1$I$20240101$20240802$20240805$20240805$EXP$$US-ABBVIE-5865629$ABBVIE$$$$$F$Y$$$20240804$$CN$US$US
241716671$24171667$1$I$20240721$20240726$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011677$BEIGENE$$$$$$Y$$$20240804$$HP$CN$CN
241716691$24171669$1$I$$20240731$20240805$20240805$EXP$$US-ABBVIE-5864718$ABBVIE$$$$$M$Y$$$20240804$$CN$US$US
241716701$24171670$1$I$20240701$20240730$20240805$20240805$EXP$$US-ABBVIE-5860988$ABBVIE$$76$YR$$F$Y$$$20240804$$CN$US$US
241716711$24171671$1$I$$20240731$20240805$20240805$EXP$$NVSC2024ES152183$NOVARTIS$$$$$M$Y$$$20240805$$HP$ES$ES
241716742$24171674$2$F$$20240806$20240805$20240807$EXP$$CA-BIOGEN-2024BI01276477$BIOGEN$$$$$F$Y$$$20240807$$MD$CA$CA
241716751$24171675$1$I$$20240730$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121898$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240805$$CN$US$US
241716761$24171676$1$I$$20240725$20240805$20240805$EXP$$ES-JNJFOC-20240774811$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240805$$HP$ES$ES
241716771$24171677$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5858472$ABBVIE$$$$$F$Y$$$20240804$$CN$US$US
241716783$24171678$3$F$20240702$20240912$20240805$20240919$EXP$$AT-BIOGEN-2024BI01276431$BIOGEN$$31$YR$$M$Y$$$20240919$$MD$AT$AT
241716791$24171679$1$I$$20240802$20240805$20240805$EXP$$US-JNJFOC-20240806597$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$US$US
241716811$24171681$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA226551$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240805$$MD$US$US
241716821$24171682$1$I$20240701$20240729$20240805$20240805$PER$$US-SA-2024SA227467$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240805$$MD$US$US
241716831$24171683$1$I$$20240725$20240805$20240805$PER$$US-BAUSCHBL-2024BNL030782$BAUSCH AND LOMB$$$$$F$Y$$$20240805$$CN$US$US
241716841$24171684$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA227280$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240805$$MD$US$US
241716851$24171685$1$I$20240729$20240730$20240805$20240805$PER$$US-SA-2024SA227045$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240805$$MD$US$US
241716861$24171686$1$I$20240601$20240725$20240805$20240805$PER$$US-SA-2024SA225863$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240805$$MD$US$US
241716871$24171687$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226545$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240805$$MD$US$US
241716881$24171688$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA226309$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240805$$CN$US$US
241716891$24171689$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226196$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240805$$MD$US$US
241716901$24171690$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226147$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240805$$MD$US$US
241716912$24171691$2$F$20240101$20240815$20240805$20240828$PER$$US-SA-2024SA225388$SANOFI AVENTIS$$29$YR$A$M$Y$81.65$KG$20240828$$MD$US$US
241716921$24171692$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA225306$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240805$$MD$US$US
241716931$24171693$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA226497$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240805$$MD$US$US
241716941$24171694$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225420$SANOFI AVENTIS$$$$A$F$Y$96.6$KG$20240805$$MD$US$US
241716951$24171695$1$I$20240710$20240726$20240805$20240805$PER$$US-SA-2024SA227261$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240805$$MD$US$US
241716961$24171696$1$I$20240725$20240729$20240805$20240805$PER$$US-SA-2024SA226209$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240805$$HP$US$US
241716971$24171697$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002030US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
241716981$24171698$1$I$$20240731$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121843$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$66.22$KG$20240805$$CN$US$US
241716991$24171699$1$I$$20240730$20240805$20240805$EXP$$BR-BIOGEN-2024BI01276472$BIOGEN$$$$$M$Y$$$20240804$$CN$BR$BR
241717001$24171700$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225447$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240805$$MD$US$US
241717011$24171701$1$I$$20240731$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2023CA076642$SANDOZ$$$$$F$Y$$$20240804$$HP$CA$CA
241717021$24171702$1$I$$20240726$20240805$20240805$PER$$US-JNJFOC-20240773833$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$US$US
241717031$24171703$1$I$$20240730$20240805$20240805$EXP$$CN-PFIZER INC-202400226432$PFIZER$$$$$$Y$$$20240804$$MD$CN$CN
241717042$24171704$2$F$$20240808$20240805$20240813$EXP$$CA-PFIZER INC-202400227546$PFIZER$$72$YR$$F$Y$$$20240813$$MD$CA$CA
241717051$24171705$1$I$$20240727$20240805$20240805$EXP$$LB-JNJFOC-20240776036$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$MD$LB$LB
241717061$24171706$1$I$20230101$20240729$20240805$20240805$EXP$ES-AEMPS-1553800$ES-PFIZER INC-202400225458$PFIZER$$76$YR$$F$Y$$$20240804$$MD$ES$ES
241717071$24171707$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53576$$FDA-CTU$$89$YR$$M$N$$$20240805$N$$US$
241717081$24171708$1$I$20240705$20240731$20240805$20240805$EXP$$CN-PFIZER INC-PV202400100063$PFIZER$$57$YR$$F$Y$55$KG$20240804$$HP$CN$CN
241717091$24171709$1$I$20230101$20240729$20240805$20240805$EXP$$US-PFIZER INC-202400226523$PFIZER$$55$YR$$F$Y$$$20240804$$MD$US$US
241717101$24171710$1$I$20240801$20240803$20240803$20240803$DIR$712485$$FDA-CTU$$$$$F$N$81$KG$20240803$N$CN$US$
241717111$24171711$1$I$$20240725$20240805$20240805$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2159991$Chengdu Suncadia Medicine$Literature title: Clinical analysis of 14 pregnancies in women with renal transplant.?Journal of publication: Journal of Reproductive Medicine, 2024, 33 (7): 878-884.?Authors: Bing Liang, Liyun Gong, Zhiwei Zhang, Hang Liu, Junli Lu.$$$$$Y$1.705$KG$20240804$$MD$CN$CN
241717121$24171712$1$I$20240625$20240727$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011685$BEIGENE$$$$$$Y$$$20240804$$HP$CN$CN
241717131$24171713$1$I$20240101$20240730$20240805$20240805$PER$$US-009507513-2407USA015709$MERCK$$$$$F$Y$$$20240804$$CN$US$US
241717141$24171714$1$I$20240801$20240803$20240803$20240803$DIR$712484$$FDA-CTU$$42$YR$$F$N$74.25$KG$20240803$Y$CN$US$
241717151$24171715$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53577$$FDA-CTU$$63$YR$$M$N$$$20240805$N$$US$
241717161$24171716$1$I$20240803$20240803$20240803$20240803$DIR$712775$$FDA-CTU$$68$YR$$F$N$92.7$KG$20240803$Y$CN$US$
241717171$24171717$1$I$20230301$20240730$20240805$20240805$EXP$FR-AFSSAPS-MA2024001111$FR-ABBVIE-5862266$ABBVIE$$73$YR$$M$Y$62$KG$20240804$$PH$FR$FR
241717181$24171718$1$I$20240731$20240731$20240805$20240805$EXP$$DE-ABBVIE-5863988$ABBVIE$$73$YR$$M$Y$$$20240804$$CN$DE$DE
241717201$24171720$1$I$20240619$20240727$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011689$BEIGENE$$$$$$Y$$$20240804$$HP$CN$CN
241717211$24171721$1$I$20240701$20240729$20240805$20240805$PER$$US-ABBVIE-5859190$ABBVIE$$65$YR$$F$Y$104$KG$20240804$$CN$US$US
241717231$24171723$1$I$20240512$20240730$20240805$20240805$30DAY$$US-GSK-US2024095347$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240804$$CN$US$US
241717242$24171724$2$F$20240731$20240801$20240805$20240814$EXP$$IT-ABBVIE-5864356$ABBVIE$$82$YR$$M$Y$$$20240814$$MD$IT$IT
241717251$24171725$1$I$20240612$20240730$20240805$20240805$EXP$ES-AEMPS-1553762$ES-JNJFOC-20240784884$JOHNSON AND JOHNSON$$58$YR$A$F$Y$61.8$KG$20240805$$MD$ES$ES
241717261$24171726$1$I$20240723$20240729$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011775$BEIGENE$$$$$$Y$$$20240804$$HP$CN$CN
241717271$24171727$1$I$20211101$20240730$20240805$20240805$EXP$$US-ABBVIE-5707753$ABBVIE$$60$YR$$F$Y$113$KG$20240804$$CN$US$US
241717281$24171728$1$I$20240708$20240729$20240805$20240805$EXP$$US-ABBVIE-5861487$ABBVIE$$68$YR$$F$Y$53$KG$20240804$$CN$US$US
241717291$24171729$1$I$20240601$20240731$20240805$20240805$EXP$$US-ABBVIE-5863277$ABBVIE$$73$YR$$F$Y$$$20240804$$CN$US$US
241717301$24171730$1$I$20240701$20240729$20240805$20240805$PER$$US-SA-2024SA225463$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240805$$MD$US$US
241717311$24171731$1$I$20240707$20240725$20240805$20240805$EXP$GB-MHRA-MED-202407251659369520-RWFLM$GB-ESPERIONTHERAPEUTICS-2024GBR01208$ESPERION THERAPEUTICS$$67$YR$$F$Y$60$KG$20240805$$CN$GB$GB
241717321$24171732$1$I$20240601$20240730$20240805$20240805$EXP$$US-ABBVIE-5862883$ABBVIE$$62$YR$$F$Y$$$20240804$$CN$US$US
241717331$24171733$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA224427$SANOFI AVENTIS$$56$YR$A$F$Y$63.5$KG$20240805$$MD$US$US
241717342$24171734$2$F$$20240906$20240805$20240916$EXP$$US-TAKEDA-2024TUS053781$TAKEDA$$$$$M$Y$$$20240916$$CN$US$US
241717352$24171735$2$F$20230101$20240903$20240805$20240912$PER$$US-SA-2024SA225676$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240912$$MD$US$US
241717361$24171736$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA225483$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240805$$MD$US$US
241717373$24171737$3$F$$20240911$20240805$20240919$EXP$$US-TAKEDA-2024TUS059100$TAKEDA$$$$$F$Y$$$20240919$$CN$US$US
241717383$24171738$3$F$$20240829$20240805$20240904$PER$$US-JNJFOC-20240778206$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$HP$US$US
241717391$24171739$1$I$20230101$20240730$20240805$20240805$EXP$$CA-AMGEN-CANNI2024153964$AMGEN$$$$$M$Y$$$20240804$$CN$CA$CA
241717411$24171741$1$I$20191225$20240730$20240805$20240805$EXP$$US-TAKEDA-US202000830$TAKEDA$$34$YR$$F$Y$$$20240804$$CN$US$US
241717421$24171742$1$I$$20240730$20240805$20240805$EXP$$US-ABBVIE-5863301$ABBVIE$$$$$F$Y$$$20240804$$HP$US$US
241717431$24171743$1$I$20240701$20240801$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122946$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240805$$CN$US$US
241717441$24171744$1$I$20240731$20240801$20240805$20240805$EXP$$US-ABBVIE-5864751$ABBVIE$$76$YR$$F$Y$$$20240804$$CN$US$US
241717452$24171745$2$F$20230901$20240806$20240805$20240810$EXP$$US-ABBVIE-5863884$ABBVIE$$76$YR$$F$Y$81.647$KG$20240810$$CN$US$US
241717461$24171746$1$I$20240622$20240729$20240805$20240805$EXP$FR-AFSSAPS-PV2024000686$FR-GSK-FR2024095131$GLAXOSMITHKLINE$$$$$$Y$$$20240804$$MD$FR$FR
241717471$24171747$1$I$20240101$20240801$20240805$20240805$EXP$$US-ABBVIE-5864724$ABBVIE$$$$$M$Y$$$20240804$$CN$US$US
241717482$24171748$2$F$$20240830$20240805$20240901$PER$$US-JNJFOC-20240778178$JOHNSON AND JOHNSON$$$$$$Y$$$20240901$$HP$US$US
241717491$24171749$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225490$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240805$$MD$US$US
241717502$24171750$2$F$$20240909$20240805$20240924$PER$$US-JNJFOC-20240777872$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$HP$US$US
241717511$24171751$1$I$20240101$20240801$20240805$20240805$EXP$$US-ABBVIE-5864688$ABBVIE$$$$$F$Y$$$20240804$$CN$US$US
241717521$24171752$1$I$$20240130$20240805$20240805$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202402-000075$UNICHEM$$75$YR$E$F$Y$56.69$KG$20240805$$CN$US$
241717531$24171753$1$I$$20240321$20240805$20240805$PER$$US-Benuvia Operations LLC.-BEN202403-000004$BENUVIA THERAPEUTICS$$$$$M$Y$$$20240805$$CN$US$
241717541$24171754$1$I$$20240614$20240805$20240805$PER$$US-Benuvia Operations LLC.-BEN202406-000007$BENUVIA THERAPEUTICS$$$$$$Y$$$20240805$$PH$US$
241717551$24171755$1$I$$20240731$20240805$20240805$EXP$$US-JNJFOC-20240802188$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240805$$HP$US$US
241717571$24171757$1$I$20240709$20240724$20240805$20240805$PER$$US-ABBVIE-5856352$ABBVIE$$37$YR$$F$Y$$$20240804$$HP$US$US
241717581$24171758$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA226498$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240805$$MD$US$US
241717591$24171759$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226810$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240805$$MD$US$US
241717602$24171760$2$F$$20240821$20240805$20240903$PER$$US-SA-2024SA226329$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240903$$MD$US$US
241717621$24171762$1$I$$20240729$20240805$20240805$EXP$$US-JNJFOC-20240780016$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$HP$US$US
241717631$24171763$1$I$20240715$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024151230$AMGEN$$61$YR$A$F$Y$$$20240804$$CN$US$US
241717641$24171764$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226467$SANOFI AVENTIS$$$$E$F$Y$$$20240805$$CN$US$US
241717651$24171765$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225742$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
241717661$24171766$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA225185$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240805$$MD$US$US
241717671$24171767$1$I$$20240803$20240803$20240803$DIR$712482$$FDA-CTU$$52$YR$$M$N$105.75$KG$20240803$N$$US$
241717682$24171768$2$F$20240801$20240805$20240805$20240806$PER$$US-AMGEN-USASP2024154715$AMGEN$$78$YR$E$M$Y$$$20240806$$CN$US$US
241717691$24171769$1$I$20140802$20240803$20240803$20240803$DIR$712483$$FDA-CTU$$45$YR$$F$N$$$20240803$Y$CN$US$
241717701$24171770$1$I$20240731$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024153909$AMGEN$$39$YR$A$F$Y$$$20240804$$PH$US$US
241717711$24171771$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225821$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240805$$MD$US$US
241717721$24171772$1$I$20240716$20240803$20240803$20240803$DIR$712753$$FDA-CTU$$78$YR$$F$N$79.2$KG$20240803$Y$HP$US$
241717731$24171773$1$I$$20240620$20240805$20240805$PER$$US-ROCHE-10000014390$ROCHE$$$$$$Y$$$20240805$$HP$US$US
241717741$24171774$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227534$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240805$$CN$US$US
241717751$24171775$1$I$20230701$20240728$20240805$20240805$PER$$US-SA-2024SA225947$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240805$$MD$US$US
241717771$24171777$1$I$20220101$20240728$20240805$20240805$PER$$US-SA-2024SA225950$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240805$$MD$US$US
241717781$24171778$1$I$$20240726$20240805$20240805$EXP$$BR-TAKEDA-2024TUS076816$TAKEDA$$$$$$Y$$$20240805$$HP$BR$BR
241717792$24171779$2$F$$20240913$20240805$20240924$EXP$$JP-BEH-2024176545$CSL BEHRING$$3$DEC$A$F$Y$$$20240924$$HP$JP$JP
241717801$24171780$1$I$$20240802$20240805$20240805$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043533$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240805$$CN$BR$BR
241717811$24171781$1$I$20240729$20240730$20240805$20240805$PER$$US-009507513-2407USA015951$MERCK$$$$$F$Y$$$20240805$$CN$US$US
241717821$24171782$1$I$$20240801$20240805$20240805$EXP$$AU-JAZZ PHARMACEUTICALS-2024-AU-011724$JAZZ$$$$$$Y$$$20240804$$HP$AU$AU
241717832$24171783$2$F$$20240812$20240805$20240815$EXP$$GB-GSK-GB2024EME095980$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$CN$GB$GB
241717841$24171784$1$I$$20240729$20240805$20240805$EXP$$US-ABBVIE-5859734$ABBVIE$$$$$$Y$$$20240805$$HP$US$US
241717851$24171785$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5857903$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241717861$24171786$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225888$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240805$$MD$US$US
241717871$24171787$1$I$$20230330$20240805$20240805$EXP$$US-AstraZeneca-2023A076230$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241717881$24171788$1$I$20221230$20230301$20240805$20240805$EXP$$CO-AstraZeneca-2023A054613$ASTRAZENECA$$26420$DY$$M$Y$71$KG$20240805$$CN$CO$
241717891$24171789$1$I$20240101$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024153748$AMGEN$$68$YR$E$F$Y$$$20240804$$HP$US$US
241717901$24171790$1$I$$20240731$20240805$20240805$EXP$$US-ABBVIE-5864400$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241717913$24171791$3$F$20240727$20240904$20240805$20240911$30DAY$$US-AMGEN-USASL2024151675$AMGEN$$78$YR$E$F$Y$$$20240910$$CN$US$US
241717921$24171792$1$I$20240101$20240728$20240805$20240805$PER$$US-SA-2024SA225954$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240805$$MD$US$US
241717931$24171793$1$I$20240701$20240726$20240805$20240805$PER$$US-SA-2024SA225874$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240805$$MD$US$US
241717941$24171794$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225824$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240805$$MD$US$US
241717951$24171795$1$I$$20240725$20240805$20240805$EXP$GB-MHRA-MED-202407251012454120-CJPMW$GB-RDY-SPO/GBR/24/0011080$DR REDDYS$$$$$M$Y$$$20240805$$CN$GB$GB
241717961$24171796$1$I$$20221118$20240805$20240805$EXP$$HN-AstraZeneca-2022A384975$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$HN$
241717973$24171797$3$F$$20240819$20240805$20240909$EXP$$JP-009507513-2407JPN004895J$MERCK$Harigane R, Kanazawa K, Tanaka R, Kumanaka T, Saito K, Kazama K, et al.. 2-1 A Case of Lung Adenocarcinoma in which Giant Omental Metastasis was Successfully Treated with Pembrolizumab Monotherapy. The 63rd Tohoku Branch Meeting of the Japan Lung Cancer Society, and the 50th To. 15$45$YR$$F$Y$$$20240909$$MD$JP$JP
241717991$24171799$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152769$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240804$$MD$US$US
241718001$24171800$1$I$20240101$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024153755$AMGEN$$$$$$Y$$$20240804$$HP$US$US
241718011$24171801$1$I$20230101$20240729$20240805$20240805$EXP$$US-ABBVIE-5832349$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241718021$24171802$1$I$$20240726$20240805$20240805$EXP$$AR-EMD Serono-2024040888$EMD SERONO INC$$$$T$F$Y$$$20240805$$CN$AR$AR
241718031$24171803$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158540$NOVARTIS$$$$$$Y$$$20240805$$CN$US$US
241718041$24171804$1$I$20240717$20240724$20240805$20240805$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024092848$VIIV$$43$YR$$M$Y$$$20240805$$HP$US$US
241718051$24171805$1$I$$20240726$20240805$20240805$EXP$$US-APOTEX-2024AP009026$APOTEX$Rafeq R, Salzman M.. Use of Concentrated Insulin in the Management of Calcium Channel Blocker Overdose:: A Case Report. Journal of Pharmacy Practice. 2023;36 (6):1519-1522$73$YR$$F$Y$69.9$KG$20240805$$PH$US$US
241718061$24171806$1$I$$20240723$20240805$20240805$EXP$$CA-APOTEX-2024AP008766$APOTEX$$3$YR$$M$Y$17$KG$20240805$$HP$CA$CA
241718071$24171807$1$I$$20240731$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122679$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240805$$CN$US$US
241718082$24171808$2$F$20220823$20240909$20240805$20240918$EXP$$US-AMGEN-USASP2024152750$AMGEN$$50$YR$A$F$Y$$$20240918$$LW$US$US
241718091$24171809$1$I$$20240725$20240805$20240805$EXP$$US-SA-2024SA221077$SANOFI AVENTIS$$$$$F$Y$$$20240805$$CN$US$US
241718101$24171810$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153441$AMGEN$Cowen E. W.; Tan I. J.; Ferrada M. A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes.. JAMA Dermatology. 2024;E1 to E8$$$$$Y$$$20240804$$MD$US$US
241718111$24171811$1$I$$20240725$20240805$20240805$EXP$$US-AMGEN-USASP2024148712$AMGEN$Ziyeh S.; Kim K.; Kim P. et al.. Extranodal diffuse large B-cell lymphoma presenting with extensive organ involvement. BMJ Case Reports. 2024;17:1-4$$$A$F$Y$$$20240804$$MD$US$US
241718122$24171812$2$F$20240729$20240821$20240805$20240823$PER$$US-ALXN-202407USA002042US$ALEXION PHARMACEUTICALS$$30$YR$$M$Y$$$20240823$$CN$US$US
241718131$24171813$1$I$20240730$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152898$AMGEN$$66$YR$E$F$Y$$$20240804$$CN$US$US
241718151$24171815$1$I$$20240724$20240805$20240805$PER$$US-CHATTEMPRD-2024OHG025346$CHATTEM$$$$$$Y$$$20240805$$CN$US$US
241718163$24171816$3$F$20240601$20240814$20240805$20240819$EXP$$US-SANDOZ INC.-SDZ2024US070319$SANDOZ$$58$YR$$M$Y$$$20240819$$HP$US$US
241718171$24171817$1$I$20240803$20240803$20240803$20240803$DIR$712792$$FDA-CTU$$42$YR$$F$N$99$KG$20240803$N$CN$US$
241718181$24171818$1$I$$20240726$20240805$20240805$PER$$US-CHATTEMPRD-2024OHG025566$CHATTEM$$$$$M$Y$$$20240805$$CN$US$US
241718192$24171819$2$F$$20240808$20240805$20240810$EXP$$JP-ABBVIE-5864884$ABBVIE$$10$YR$$F$Y$$$20240810$$MD$JP$JP
241718201$24171820$1$I$$20240730$20240805$20240805$EXP$$US-BIOGEN-2024BI01276244$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
241718211$24171821$1$I$$20240729$20240805$20240805$EXP$$US-BIOGEN-2024BI01275911$BIOGEN$$$$C$$Y$$$20240805$$MD$US$US
241718221$24171822$1$I$$20240801$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122944$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240805$$CN$US$US
241718231$24171823$1$I$$20240801$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122932$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240805$$CN$US$US
241718241$24171824$1$I$$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152300$AMGEN$$$$$M$Y$$$20240804$$CN$US$US
241718251$24171825$1$I$$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019032$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240805$$CN$US$US
241718261$24171826$1$I$20240601$20240725$20240805$20240805$EXP$$US-ENDO PHARMACEUTICALS INC-2024-001927$ENDO$$0$YR$$M$Y$9.36$KG$20240805$$HP$US$US
241718273$24171827$3$F$20240211$20240910$20240805$20240912$EXP$$US-ORGANON-O2408USA000200$ORGANON$$32$YR$$F$Y$68.03$KG$20240912$$HP$US$US
241718281$24171828$1$I$$20231006$20240805$20240805$EXP$$US-AstraZeneca-2023A228814$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241718291$24171829$1$I$$20240724$20240805$20240805$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR095671$VIIV$$$$$$Y$$$20240805$$HP$US$US
241718303$24171830$3$F$$20240802$20240805$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122642$BRISTOL MYERS SQUIBB$Blake VN, Samaan C, Alexandra F. A case of delayed and immediate hypersensitivity reactions induced by corticosteroids. American Contact Dermatitis Society. 2024;35(2):191-2. doi:10.1089/derm.2023.0146.$71$YR$E$M$Y$$$20240913$$HP$US$US
241718311$24171831$1$I$20210605$20211007$20240805$20240805$EXP$$CO-AstraZeneca-2021A769928$ASTRAZENECA$$23777$DY$$M$Y$70$KG$20240805$$CN$CO$
241718321$24171832$1$I$$20220727$20240805$20240805$EXP$$US-AstraZeneca-2022A248041$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241718331$24171833$1$I$$20230104$20240805$20240805$EXP$$US-AstraZeneca-2023A002967$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241718341$24171834$1$I$20240725$20240728$20240805$20240805$EXP$$GB-AstraZeneca-2024A170972$ASTRAZENECA$$49$YR$$F$Y$92$KG$20240805$$MD$GB$
241718351$24171835$1$I$$20240723$20240805$20240805$EXP$$HU-862174955-ML2024-04232$UNKNOWN$Korei A, Zsigrai S, Kurucz P, Lengyel B, Vagi O, Horvath V, et al. Hypoglycaemia-induced cardiac arrhythmia as the background of recurring syncope in an old patient with diabetes and cardiovascular autonomic neuropathy- A case report.. Diabetes, Stoffwechsel und Herz. 2024;33(3): 166-172.$84$YR$E$F$Y$$$20240805$$MD$HU$HU
241718361$24171836$1$I$$20240730$20240805$20240805$EXP$$CA-AMGEN-CANSP2024151608$AMGEN$$74$YR$E$F$Y$66.213$KG$20240804$$CN$CA$CA
241718371$24171837$1$I$20240706$20240708$20240805$20240805$PER$$TR-TOLMAR, INC.-24TR050854$TOLMAR$$62$YR$$M$Y$$$20240805$$MD$TR$TR
241718382$24171838$2$F$20240621$20240808$20240805$20240903$PER$$US-TOLMAR, INC.-24US050472$TOLMAR$$$$$M$Y$$$20240903$$PH$US$US
241718392$24171839$2$F$20240628$20240813$20240805$20240830$PER$$US-TOLMAR, INC.-24US050679$TOLMAR$$86$YR$$M$Y$$$20240829$$HP$US$US
241718401$24171840$1$I$20240624$20240708$20240805$20240805$PER$$US-TOLMAR, INC.-24US050812$TOLMAR$$71$YR$$M$Y$$$20240805$$HP$US$US
241718411$24171841$1$I$$20230424$20240805$20240805$EXP$$US-AstraZeneca-2023A095731$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241718421$24171842$1$I$$20230317$20240805$20240805$EXP$$US-AstraZeneca-2023A066061$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241718431$24171843$1$I$$20221031$20240805$20240805$EXP$$US-AstraZeneca-2022A361784$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241718441$24171844$1$I$$20230217$20240805$20240805$EXP$$US-AstraZeneca-2023A041948$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241718451$24171845$1$I$20210321$20210322$20240805$20240805$EXP$$TW-AstraZeneca-2021A183801$ASTRAZENECA$$69$YR$$F$Y$$$20240805$$CN$TW$
241718461$24171846$1$I$20220110$20220110$20240805$20240805$EXP$$US-AstraZeneca-2022A018139$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241718481$24171848$1$I$$20240726$20240805$20240805$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP009587$STRIDES$Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, et al.. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series.. J-Neurol. 2024;271:4028-4038$1$DEC$$F$Y$$$20240805$$HP$NL$NL
241718491$24171849$1$I$$20220913$20240805$20240805$EXP$$US-AstraZeneca-2022A318615$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241718501$24171850$1$I$$20230125$20240805$20240805$EXP$$US-AstraZeneca-2023A021928$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241718513$24171851$3$F$20240726$20240909$20240805$20240910$PER$$US-JNJFOC-20240777475$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
241718521$24171852$1$I$$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024154211$AMGEN$$$$$F$Y$$$20240804$$HP$US$US
241718531$24171853$1$I$$20240726$20240805$20240805$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP009589$STRIDES$Murt A, Bayram B, Yllmaz U, Seyahi N, Eskazan AE.. Chronic Myeloid Leukemia in Renal Transplantation Patients in the Era of Tyrosine Kinase Inhibitors: A Case Report and Review of the Literature.. Nephron. 2024;0(0)$63$YR$$F$Y$$$20240805$$HP$TR$TR
241718541$24171854$1$I$$20240729$20240805$20240805$PER$$US-APOTEX-2024AP009058$APOTEX$Osman AF, Eze B, Tahsin M, Ibrahim S, Varadarasa S, Naqvi A, et al.. A RARE CASE OF APIXABAN-INDUCED HYPERSENSITIVITY SKIN RASH IN THE CRITICAL CARE UNIT. Journal of the American College of Cardiology. 2024;83 (S13):3813$$$A$M$Y$$$20240805$$HP$US$US
241718552$24171855$2$F$$20240821$20240805$20240826$30DAY$$US-GSK-US2024094275$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$HP$US$US
241718561$24171856$1$I$$20240726$20240805$20240805$EXP$$LB-STRIDES ARCOLAB LIMITED-2024SP009611$STRIDES$Salem J, Fares F, El-Haddad R, Fares M, El-Helou G.. Legionella lymphadenitis in immunocompetent adult: Case report.. IDCases. 2024;37 (0)$53$YR$$F$Y$$$20240805$$HP$LB$LB
241718571$24171857$1$I$$20240801$20240805$20240805$EXP$$CN-VANTIVE-2024VAN018803$Vantive US Healthcare$$$$$M$Y$$$20240805$$CN$CN$CN
241718582$24171858$2$F$$20240829$20240805$20240902$EXP$$IN-VANTIVE-2024VAN018789$Vantive US Healthcare$$54$YR$$F$Y$$$20240902$$CN$IN$IN
241718591$24171859$1$I$20120101$20240723$20240805$20240805$EXP$$CH-NOVOPROD-1251491$NOVO NORDISK$$$$$M$Y$$$20240805$$CN$CH$CH
241718601$24171860$1$I$20240728$20240729$20240805$20240805$EXP$$SG-VANTIVE-2024VAN018740$Vantive US Healthcare$$90$YR$$F$Y$$$20240805$$CN$SG$SG
241718611$24171861$1$I$20240701$20240729$20240805$20240805$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001543$BLUEPRINT MEDICINES$$54$YR$A$F$Y$$$20240805$$CN$US$US
241718621$24171862$1$I$$20240723$20240805$20240805$EXP$$US-NOVOPROD-1260772$NOVO NORDISK$$38$YR$$$Y$$$20240805$$CN$US$US
241718631$24171863$1$I$20240701$20240723$20240805$20240805$EXP$$US-NOVOPROD-1261226$NOVO NORDISK$$$$A$F$Y$$$20240805$$CN$US$US
241718642$24171864$2$F$20240703$20240809$20240805$20240820$EXP$$US-NOVOPROD-1260618$NOVO NORDISK$$72$YR$$F$Y$$$20240820$$CN$US$US
241718651$24171865$1$I$$20240723$20240805$20240805$EXP$$GB-NOVOPROD-1260283$NOVO NORDISK$$$$$M$Y$$$20240805$$HP$GB$GB
241718661$24171866$1$I$$20240723$20240805$20240805$EXP$$BR-NOVOPROD-1260781$NOVO NORDISK$$$$$$Y$$$20240805$$CN$BR$BR
241718681$24171868$1$I$$20240723$20240805$20240805$EXP$$AT-NOVOPROD-1260350$NOVO NORDISK$$$$$M$Y$$$20240805$$MD$AT$AT
241718691$24171869$1$I$$20240723$20240805$20240805$EXP$$US-NOVOPROD-1260759$NOVO NORDISK$$44$YR$$$Y$$$20240805$$CN$US$US
241718702$24171870$2$F$20240401$20240805$20240805$20240814$EXP$$BR-NOVOPROD-1260963$NOVO NORDISK$$45$YR$$M$Y$110$KG$20240814$$CN$BR$BR
241718712$24171871$2$F$$20240903$20240805$20240913$EXP$$US-NOVOPROD-1261424$NOVO NORDISK$$77$YR$$F$Y$$$20240913$$MD$US$US
241718721$24171872$1$I$$20240723$20240805$20240805$EXP$$BR-NOVOPROD-1260869$NOVO NORDISK$$$$$F$Y$$$20240805$$CN$BR$BR
241718732$24171873$2$F$20240423$20240827$20240805$20240905$EXP$DK-DKMA-30735085$DK-NOVOPROD-1260376$NOVO NORDISK$$60$YR$$M$Y$140.6$KG$20240905$$MD$DK$DK
241718742$24171874$2$F$20240709$20240816$20240805$20240827$EXP$$US-NOVOPROD-1263480$NOVO NORDISK$$52$YR$$F$Y$$$20240827$$CN$US$US
241718751$24171875$1$I$$20240723$20240805$20240805$EXP$$US-NOVOPROD-1261066$NOVO NORDISK$$$$A$F$Y$$$20240805$$CN$US$US
241718762$24171876$2$F$20230101$20240909$20240805$20240919$EXP$DK-DKMA-30736230$DK-NOVOPROD-1260378$NOVO NORDISK$$60$YR$$M$Y$140$KG$20240919$$MD$DK$DK
241718771$24171877$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152888$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et. al. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240804$$MD$US$US
241718781$24171878$1$I$$20230717$20240805$20240805$EXP$$US-AstraZeneca-2023A166233$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241718791$24171879$1$I$$20230327$20240805$20240805$EXP$$US-AstraZeneca-2023A072589$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241718801$24171880$1$I$$20240726$20240805$20240805$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP009633$STRIDES$Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, et al.. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series.. J-Neurol. 2024;271:4028-4038$1$DEC$$M$Y$$$20240805$$HP$NL$NL
241718811$24171881$1$I$$20240723$20240805$20240805$EXP$$US-NOVOPROD-1261220$NOVO NORDISK$$$$A$F$Y$$$20240805$$CN$US$US
241718821$24171882$1$I$$20240723$20240805$20240805$EXP$$CO-NOVOPROD-1262025$NOVO NORDISK$$36$YR$$F$Y$$$20240805$$CN$CO$CO
241718831$24171883$1$I$$20230713$20240805$20240805$EXP$$US-AstraZeneca-2023A161474$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241718842$24171884$2$F$20070201$20240917$20240805$20240926$EXP$$US-NOVOPROD-1261666$NOVO NORDISK$$60$YR$$M$Y$$$20240926$$CN$US$US
241718851$24171885$1$I$$20240730$20240805$20240805$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP009604$STRIDES$Liang I, Berglund LJ, Brown DA, Suan D, Meybodi F, Lee AYS, et al.. Granulomatous mastitis and immunosuppression: Case series at an Australian quaternary referral center.. Int-J-Rheum-Diseases. 2024;27 (1)$$$$F$Y$$$20240805$$HP$AU$AU
241718861$24171886$1$I$$20240723$20240805$20240805$EXP$$US-NOVOPROD-1261811$NOVO NORDISK$$$$$F$Y$$$20240805$$CN$US$US
241718871$24171887$1$I$20240701$20240723$20240805$20240805$EXP$$US-NOVOPROD-1261477$NOVO NORDISK$$78$YR$$F$Y$$$20240805$$CN$US$US
241718881$24171888$1$I$$20240723$20240805$20240805$EXP$$US-NOVOPROD-1261766$NOVO NORDISK$$$$$M$Y$$$20240805$$CN$US$US
241718891$24171889$1$I$20230701$20240724$20240805$20240805$EXP$NO-NOMAADVRE-PASRAPP-2024-Vw6ewk$NO-NOVOPROD-1260503$NOVO NORDISK$$55$YR$$F$Y$95$KG$20240805$$CN$NO$NO
241718901$24171890$1$I$20130101$20240722$20240805$20240805$EXP$$FR-SERVIER-S17004773$Haleon PLC$$78$YR$$F$Y$$$20240802$$CN$FR$FR
241718911$24171891$1$I$20240715$20240724$20240805$20240805$EXP$GB-MHRA-MED-202407241343193020-KBDGQ$GB-NOVOPROD-1260296$NOVO NORDISK$$$$$F$Y$$$20240805$$PH$GB$GB
241718921$24171892$1$I$$20240729$20240805$20240805$PER$$US-AMGEN-USASP2024150382$AMGEN$$$$$F$Y$$$20240804$$CN$US$US
241718931$24171893$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153059$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240804$$MD$US$US
241718941$24171894$1$I$20240718$20240726$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011682$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241718951$24171895$1$I$$20240731$20240805$20240805$EXP$$US-ABBVIE-5863672$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241718961$24171896$1$I$20230622$20240726$20240805$20240805$EXP$$JP-009507513-2309JPN002659J$MERCK$Niimi K, Ikeda Y, Yoshida Y, Yoshiwara M, Tamauchi S, Shimizu Y, et al.. OS-111 Treatment of cervical cancer with pembrolizumab: A review of effective cases in use experience at our hospital. The journal of the Japan Society of Gynecologic Oncology  The 66th Annual Meetin. 2024;42(3):285$51$YR$$F$Y$$$20240805$$MD$JP$JP
241718971$24171897$1$I$20240713$20240801$20240805$20240805$EXP$$US-ABBVIE-5864740$ABBVIE$$70$YR$$F$Y$$$20240805$$CN$US$US
241718981$24171898$1$I$20240101$20240731$20240805$20240805$EXP$$US-ABBVIE-5864369$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241718991$24171899$1$I$$20240724$20240805$20240805$EXP$GB-MHRA-MIDB-3fa40c31-d9d2-4b32-994e-98a99e981237$GB-NOVOPROD-1260289$NOVO NORDISK$$82$YR$$$Y$$$20240805$$PH$GB$GB
241719001$24171900$1$I$20240711$20240727$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011690$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241719011$24171901$1$I$$20240724$20240805$20240805$EXP$$US-LAURUS LABS LIMITED-2024LAU000060$LAURUS LABS LIMITED$Jain S, Sekhon S, Leo Pradeep Chandran AS, Gummadi J, Patel P, Nakka R, et al.. Metformin-Associated Lactic Acidosis in an Older Adult: A Case Report and Review.. Cureus. 2024;16(6)$82$YR$$M$Y$$$20240805$$HP$US$US
241719021$24171902$1$I$20240101$20240731$20240805$20240805$EXP$$US-ABBVIE-5864427$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241719031$24171903$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153278$AMGEN$Cowen E. W.; Tan I. J.; Ferrada M. A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240804$$MD$US$US
241719041$24171904$1$I$$20240729$20240805$20240805$EXP$$US-GSK-US2024094694$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241719051$24171905$1$I$$20240730$20240805$20240805$EXP$$US-TAKEDA-2023TUS019417$TAKEDA$$$$$M$Y$127$KG$20240805$$CN$US$US
241719061$24171906$1$I$$20221129$20240805$20240805$EXP$$US-AstraZeneca-2022A393063$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241719071$24171907$1$I$$20230308$20240805$20240805$EXP$$US-AstraZeneca-2023A057634$ASTRAZENECA$$$$$F$Y$$$20240805$$HP$US$
241719081$24171908$1$I$20160928$20220316$20240805$20240805$EXP$$US-AstraZeneca-2022A116963$ASTRAZENECA$$20884$DY$$F$Y$72.6$KG$20240805$$CN$US$
241719091$24171909$1$I$$20211112$20240805$20240805$EXP$$US-AstraZeneca-2021A807150$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241719102$24171910$2$F$20230503$20240807$20240805$20240816$EXP$$TW-AstraZeneca-2023A155439$ASTRAZENECA$$70$YR$$M$Y$$$20240816$$CN$TW$
241719111$24171911$1$I$$20231214$20240805$20240805$EXP$$US-AstraZeneca-2023A246583$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241719121$24171912$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000963$ELI LILLY AND CO$$$$$F$Y$$$20240805$$HP$US$US
241719131$24171913$1$I$$20240731$20240805$20240805$EXP$$GB-HALEON-2190268$Haleon PLC$$$$$F$Y$$$20240805$$CN$GB$GB
241719141$24171914$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001432$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240805$$CN$US$US
241719151$24171915$1$I$$20240712$20240805$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003511$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241719162$24171916$2$F$20240730$20240807$20240805$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003510$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240829$$CN$US$US
241719171$24171917$1$I$$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024153535$AMGEN$$$$$$Y$$$20240804$$CN$US$US
241719181$24171918$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153346$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes.. JAMA Dermatology. 2024;E1 to E8$$$$$Y$$$20240804$$MD$US$US
241719192$24171919$2$F$$20240430$20240805$20240917$PER$$US-ENDO USA, INC.-2024-002077$ENDO$$$$$F$Y$$$20240917$$CN$US$US
241719201$24171920$1$I$20170101$20240730$20240805$20240805$EXP$$CA-ABBVIE-5862399$ABBVIE$$30$YR$$F$Y$$$20240805$$CN$CA$CA
241719212$24171921$2$F$$20240807$20240805$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003514$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
241719221$24171922$1$I$$20231218$20240805$20240805$PER$$US-ENDO USA, INC.-2023-006382$ENDO$$$$$M$Y$$$20240805$$CN$US$US
241719231$24171923$1$I$20240101$20240726$20240805$20240805$PER$$US-ABBVIE-5858886$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241719242$24171924$2$F$20240727$20240904$20240805$20240906$PER$$US-JNJFOC-20240777079$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240906$$CN$US$US
241719253$24171925$3$F$20240713$20240827$20240805$20240909$30DAY$$JP-JNJFOC-20240743840$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240909$$PH$JP$JP
241719261$24171926$1$I$20240725$20240726$20240805$20240805$30DAY$$US-GSK-US2024094269$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240805$$CN$US$US
241719272$24171927$2$F$20200101$20240822$20240805$20240904$EXP$$US-AUROBINDO-AUR-APL-2024-037842$AUROBINDO$Abdelmajid HA, Mustafa GMA, Fernandez A, Franco SD, Esquibies AE, Valencia GB, et al.. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring.. CaseRep-Perinat-Med. 2024;13(1):1-5$33$YR$$F$Y$$$20240904$$MD$US$US
241719281$24171928$1$I$20240101$20240729$20240805$20240805$EXP$$US-SA-2024SA225282$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240805$$MD$US$US
241719292$24171929$2$F$20240322$20240904$20240805$20240915$EXP$FR-AFSSAPS-AN2024000940$FR-SA-2024SA224588$SANOFI AVENTIS$$84$YR$E$M$Y$70$KG$20240915$$MD$FR$FR
241719301$24171930$1$I$$20240725$20240805$20240805$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2159994$Chengdu Suncadia Medicine$Literature title: Clinical analysis of 14 pregnancies in women with renal transplant.?Journal of publication: Journal of Reproductive Medicine, 2024, 33 (7): 878-884.?Authors: Bing Liang, Liyun Gong, Zhiwei Zhang, Hang Liu, Junli Lu.$32$YR$$F$Y$$$20240805$$MD$CN$CN
241719313$24171931$3$F$20240701$20240815$20240805$20240817$PER$$US-AMGEN-USASP2024154728$AMGEN$$70$YR$E$F$Y$$$20240817$$CN$US$US
241719321$24171932$1$I$$20240730$20240805$20240805$PER$$US-ABBVIE-5861135$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241719331$24171933$1$I$$20230125$20240805$20240805$EXP$$US-AstraZeneca-2023A023004$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241719341$24171934$1$I$$20230516$20240805$20240805$EXP$$US-AstraZeneca-2023A115431$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241719361$24171936$1$I$$20230405$20240805$20240805$EXP$$US-AstraZeneca-2023A081344$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241719371$24171937$1$I$$20220105$20240805$20240805$EXP$$US-AstraZeneca-2022A008874$ASTRAZENECA$$50$YR$$F$Y$$$20240805$$CN$US$
241719381$24171938$1$I$$20210818$20240805$20240805$EXP$$CA-AstraZeneca-2021A689991$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$CA$
241719391$24171939$1$I$$20240725$20240805$20240805$PER$$US-009507513-2407USA015990$MERCK$$$$$F$Y$$$20240805$$CN$US$US
241719401$24171940$1$I$$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024154151$AMGEN$$$$$$Y$$$20240804$$PH$US$US
241719411$24171941$1$I$20240602$20240731$20240805$20240805$EXP$$ES-AUROBINDO-AUR-APL-2024-038578$AUROBINDO$$52$YR$$M$Y$$$20240805$$MD$ES$ES
241719421$24171942$1$I$$20240726$20240805$20240805$EXP$$US-RDY-LIT/USA/24/0011196$DR REDDYS$Gupta NY, Diffalha SA, Russ KB. An Unusual Case of Colitis in a Bone Marrow Transplant Patient. Gastroenterology. 2024 Aug;167(3): e1-e4. doi:10.1053/j.gastro.2024.01.023.$65$YR$E$M$Y$$$20240805$$HP$US$US
241719432$24171943$2$F$20201201$20240730$20240805$20240808$EXP$PL-ROCHE-10000012563$PL-SANDOZ INC.-SDZ2024PL069285$SANDOZ$$49$YR$$M$Y$$$20240808$$HP$PL$PL
241719441$24171944$1$I$20240801$20240803$20240803$20240803$DIR$712806$$FDA-CTU$$39$YR$$F$N$58.5$KG$20240803$Y$CN$US$
241719453$24171945$3$F$$20240906$20240805$20240927$30DAY$$US-JNJFOC-20240777052$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
241719462$24171946$2$F$$20240829$20240805$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003550$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$HP$US$US
241719471$24171947$1$I$$20240725$20240805$20240805$EXP$$CA-Amarin Pharma, Inc-2024AMR000385$AMARIN$$78$YR$E$F$Y$$$20240802$$CN$CA$CA
241719481$24171948$1$I$20240726$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407020093$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240805$$CN$US$US
241719501$24171950$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001352$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240805$$CN$US$US
241719511$24171951$1$I$20240731$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152667$AMGEN$$89$YR$E$F$Y$$$20240804$$PH$US$US
241719521$24171952$1$I$$20240718$20240805$20240805$PER$$US-JNJFOC-20240760090$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$US$US
241719533$24171953$3$F$20240801$20240903$20240805$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003504$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240926$$CN$US$US
241719542$24171954$2$F$$20240912$20240805$20240913$EXP$$JP-TAKEDA-2024TJP011637$TAKEDA$$50$YR$$M$Y$$$20240913$$MD$JP$JP
241719551$24171955$1$I$$20240802$20240805$20240805$PER$$US-ABBVIE-5865636$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241719561$24171956$1$I$$20240712$20240805$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003505$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241719571$24171957$1$I$$20240724$20240805$20240805$EXP$$US-RDY-LIT/USA/24/0011199$DR REDDYS$Abedrabo S, Rodriguez TE, Klein LM, Bitran J. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142(1): doi:10.1182/blood-2023-174684.$$$$$Y$$$20240805$$MD$US$US
241719581$24171958$1$I$$20240122$20240805$20240805$PER$$US-AUROBINDO-AUR-APL-2024-004112$AUROBINDO$$28$YR$$F$Y$117.93$KG$20240805$$CN$US$US
241719602$24171960$2$F$20240731$20240731$20240805$20240808$PER$$US-AMGEN-USASP2024152793$AMGEN$$$$$$Y$$$20240808$$HP$US$US
241719611$24171961$1$I$$20230607$20240805$20240805$EXP$$US-AstraZeneca-2023A133526$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241719621$24171962$1$I$$20231108$20240805$20240805$EXP$$US-AstraZeneca-2023A254942$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241719631$24171963$1$I$$20231009$20240805$20240805$EXP$$US-AstraZeneca-2023A229805$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241719641$24171964$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1261642$NOVO NORDISK$$44$YR$$$Y$$$20240805$$CN$US$US
241719651$24171965$1$I$$20230117$20240805$20240805$EXP$$US-AstraZeneca-2023A024332$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241719661$24171966$1$I$20220801$20221212$20240805$20240805$EXP$$US-AstraZeneca-2022A404875$ASTRAZENECA$$73$YR$$F$Y$$$20240805$$CN$US$
241719671$24171967$1$I$$20240724$20240805$20240805$EXP$$IL-NOVOPROD-1261078$NOVO NORDISK$$53$YR$$F$Y$$$20240805$$MD$IL$IL
241719681$24171968$1$I$$20240724$20240805$20240805$EXP$$MX-NOVOPROD-1260973$NOVO NORDISK$$$$$M$Y$$$20240805$$MD$MX$MX
241719691$24171969$1$I$$20240724$20240805$20240805$EXP$$EG-NOVOPROD-1260810$NOVO NORDISK$$855$MON$$M$Y$95$KG$20240805$$CN$EG$EG
241719701$24171970$1$I$$20240724$20240805$20240805$EXP$$EG-NOVOPROD-1260786$NOVO NORDISK$$855$MON$$M$Y$95$KG$20240805$$CN$EG$EG
241719711$24171971$1$I$$20240724$20240805$20240805$EXP$$EG-NOVOPROD-1260871$NOVO NORDISK$$855$MON$$M$Y$95$KG$20240805$$CN$EG$EG
241719722$24171972$2$F$20240605$20240731$20240805$20240812$EXP$RO-NMA-2024-SP0482$RO-NOVOPROD-1260507$NOVO NORDISK$$67$YR$$F$Y$105$KG$20240812$$PH$RO$RO
241719731$24171973$1$I$$20240724$20240805$20240805$EXP$$CN-NOVOPROD-1260966$NOVO NORDISK$$$$$F$Y$$$20240805$$CN$CN$CN
241719741$24171974$1$I$$20240724$20240805$20240805$EXP$$CN-NOVOPROD-1260870$NOVO NORDISK$$60$YR$$F$Y$48$KG$20240805$$CN$CN$CN
241719751$24171975$1$I$20240715$20240724$20240805$20240805$EXP$CZ-CZSUKL-24002122$CZ-NOVOPROD-1260526$NOVO NORDISK$$69$YR$$M$Y$103$KG$20240805$$CN$CZ$CZ
241719761$24171976$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5857964$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241719771$24171977$1$I$$20240724$20240805$20240805$EXP$$BR-NOVOPROD-1260804$NOVO NORDISK$$813$MON$$F$Y$$$20240805$$CN$BR$BR
241719781$24171978$1$I$20240723$20240802$20240805$20240805$EXP$$JP-ROCHE-10000047696$ROCHE$$50$YR$A$M$Y$$$20240805$$CN$JP$JP
241719791$24171979$1$I$$20240727$20240805$20240805$PER$$US-AMGEN-USASP2024150564$AMGEN$$$$$$Y$$$20240804$$MD$US$US
241719801$24171980$1$I$$20240425$20240805$20240805$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06499$HIKMA$Shajihan A, Shlobin O, Nyquist A, Aryal S.. Shajihan A, Shlobin O, Nyquist A, Aryal S. A Case of Takotsubo Cardiomyopathy in a Bilateral Lung Transplant Recipient. Journal of Heart and Lung Transplantation. Journal of Heart and Lung Transplantation. 2024;43(4):Supplement:S490$53$YR$$F$Y$$$20240805$$MD$US$US
241719811$24171981$1$I$$20240712$20240805$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003502$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241719821$24171982$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153469$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240804$$MD$US$US
241719831$24171983$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262180$NOVO NORDISK$$40$YR$$$Y$$$20240805$$CN$US$US
241719841$24171984$1$I$$20240730$20240805$20240805$EXP$$CA-AMGEN-CANSP2024151711$AMGEN$$69$YR$E$F$Y$50$KG$20240804$$HP$CA$CA
241719851$24171985$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1261757$NOVO NORDISK$$73$YR$$F$Y$$$20240805$$PH$US$US
241719861$24171986$1$I$$20240724$20240805$20240805$EXP$$HU-PDX-000376$PHARMADAX$Kovacs M, Fogarasi A, Hegyi M, Siegler Z, Kelemen A, Mellar M, et al. Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort. Epileptic Disord. 2024 Jul 17. doi: 10.1002/epd2.20264.$16$YR$T$F$Y$$$20240805$$HP$HU$HU
241719872$24171987$2$F$20240701$20240822$20240805$20240912$PER$$US-APOTEX-2024AP008924$APOTEX$$$$$F$Y$$$20240912$$CN$US$US
241719881$24171988$1$I$$20240724$20240805$20240805$EXP$$HU-PDX-000374$PHARMADAX$Kovacs M, Fogarasi A, Hegyi M, Siegler Z, Kelemen A, Mellar M, et al. Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort. Epileptic Disord. 2024 Jul 17. doi: 10.1002/epd2.20264.$4$YR$C$F$Y$$$20240805$$HP$HU$HU
241719891$24171989$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262212$NOVO NORDISK$$69$YR$$$Y$$$20240805$$CN$US$US
241719902$24171990$2$F$$20240805$20240805$20240812$EXP$$JP-009507513-2407JPN004912J$MERCK$Yamashita R, Sumida Y, Sadaga Y, Kamoda Y, Iizuka H, Hirao M, et al.. 56 Two cases of Evans syndrome that developed as immune-related adverse event (irAE) due to immune checkpoint inhibitor. The 21st Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology. 45$76$YR$$M$Y$$$20240812$$MD$JP$JP
241719911$24171991$1$I$$20240724$20240805$20240805$EXP$$HU-PDX-000375$PHARMADAX$Kovacs M, Fogarasi A, Hegyi M, Siegler Z, Kelemen A, Mellar M, et al. Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort. Epileptic Disord. 2024 Jul 17. doi: 10.1002/epd2.20264.$5$YR$C$F$Y$$$20240805$$HP$HU$HU
241719921$24171992$1$I$$20240724$20240805$20240805$EXP$$HU-PDX-000378$PHARMADAX$Kovacs M, Fogarasi A, Hegyi M, Siegler Z, Kelemen A, Mellar M, et al. Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort. Epileptic Disord. 2024 Jul 17. doi: 10.1002/epd2.20264.$11$YR$C$F$Y$$$20240805$$HP$HU$HU
241719931$24171993$1$I$$20240726$20240805$20240805$EXP$$NZ-EMD Serono-2024041337$EMD SERONO INC$$22$YR$A$M$Y$$$20240805$$MD$NZ$NZ
241719951$24171995$1$I$$20240712$20240805$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003508$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241719962$24171996$2$F$20240725$20240806$20240805$20240813$30DAY$$US-AMGEN-USASP2024149491$AMGEN$$$$$$Y$$$20240813$$PH$US$US
241719971$24171997$1$I$20240501$20240730$20240805$20240805$EXP$$NVSC2024PA057802$NOVARTIS$$55$YR$$M$Y$$$20240805$$CN$PA$PA
241719981$24171998$1$I$$20240725$20240805$20240805$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2159996$Chengdu Suncadia Medicine$Clinical analysis of 14 pregnancies in women with renal transplant.$$$$$Y$2.295$KG$20240805$$MD$CN$CN
241719991$24171999$1$I$20240701$20240801$20240805$20240805$EXP$FR-AFSSAPS-TS2024000827$FR-ROCHE-10000046737$ROCHE$$62$YR$A$M$Y$97$KG$20240805$$MD$FR$FR
241720001$24172000$1$I$$20230518$20240805$20240805$EXP$$IN-AstraZeneca-2023A117868$ASTRAZENECA$$62$YR$$F$Y$$$20240805$$CN$IN$
241720011$24172001$1$I$$20240719$20240805$20240805$PER$$US-AstraZeneca-2024A165818$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241720031$24172003$1$I$20240626$20240712$20240805$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003521$ACADIA PHARMACEUTICALS$$95$YR$$F$Y$$$20240805$$CN$US$US
241720041$24172004$1$I$$20240725$20240805$20240805$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2159997$Chengdu Suncadia Medicine$Literature title: Clinical analysis of 14 pregnancies in women with renal transplant.?Journal of publication: Journal of Reproductive Medicine, 2024, 33 (7): 878-884.?Authors: Bing Liang, Liyun Gong, Zhiwei Zhang, Hang Liu, Junli Lu.$37$YR$$F$Y$$$20240805$$MD$CN$CN
241720051$24172005$1$I$$20230206$20240805$20240805$EXP$$US-AstraZeneca-2023A002490$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241720061$24172006$1$I$$20221125$20240805$20240805$EXP$$PH-AstraZeneca-2022A390076$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$PH$
241720071$24172007$1$I$$20240731$20240805$20240805$PER$$US-ROCHE-10000046146$ROCHE$$$$$F$Y$$$20240805$$PH$US$US
241720081$24172008$1$I$$20231016$20240805$20240805$EXP$$US-AstraZeneca-2023A235362$ASTRAZENECA$$$$$F$Y$122.9$KG$20240805$$CN$US$
241720091$24172009$1$I$20240612$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003523$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240805$$CN$US$US
241720101$24172010$1$I$20240706$20240724$20240805$20240805$EXP$$PK-ROCHE-10000040118$ROCHE$$69$YR$E$M$Y$$$20240805$$CN$PK$PK
241720111$24172011$1$I$20240703$20240726$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011672$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241720122$24172012$2$F$20230723$20240909$20240805$20240916$EXP$$BR-GSK-BR2023AMR104022$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$BR$BR
241720132$24172013$2$F$20240708$20240821$20240805$20240909$EXP$$BE-AMGEN-BELSP2024152971$AMGEN$$82$YR$E$F$Y$$$20240909$$PH$BE$BE
241720142$24172014$2$F$20240101$20240826$20240805$20240828$EXP$$US-UCBSA-2024038803$UCB$$$$$F$Y$45$KG$20240828$$CN$US$US
241720161$24172016$1$I$20240429$20240726$20240805$20240805$EXP$$GB-TEVA-VS-3226694$TEVA$$$$$F$Y$$$20240805$$HP$GB$GB
241720171$24172017$1$I$$20240729$20240805$20240805$PER$$US-JNJFOC-20240781754$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$HP$US$US
241720181$24172018$1$I$$20240730$20240805$20240805$EXP$$US-BEH-2024176579$CSL BEHRING$$$$$M$Y$$$20240805$$CN$US$US
241720191$24172019$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06941$LUPIN$$$$$$Y$$$20240805$$CN$US$US
241720201$24172020$1$I$20220501$20220516$20240805$20240805$EXP$$AR-AstraZeneca-2022A192447$ASTRAZENECA$$26726$DY$$M$Y$$$20240805$$CN$AR$
241720211$24172021$1$I$$20220112$20240805$20240805$EXP$$CA-AstraZeneca-2022A024096$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$CA$
241720221$24172022$1$I$$20230502$20240805$20240805$EXP$$US-AstraZeneca-2023A103753$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241720231$24172023$1$I$$20240730$20240805$20240805$EXP$$LB-ROCHE-10000044419$ROCHE$$$$$$Y$$$20240805$$MD$LB$LB
241720241$24172024$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001553$ELI LILLY AND CO$$$$$$Y$$$20240805$$CN$US$US
241720251$24172025$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001527$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240805$$CN$US$US
241720261$24172026$1$I$$20210809$20240805$20240805$EXP$$US-AstraZeneca-2021A675627$ASTRAZENECA$$65$YR$$F$Y$69.4$KG$20240805$$CN$US$
241720271$24172027$1$I$$20240725$20240805$20240805$EXP$$US-RDY-LIT/USA/24/0011262$DR REDDYS$Kolosky T, Erdemir G. A novel GRIN2B variant (p.F1340V) causes a severe neurodevelopmental disorder with refractory epileptic spasms. Epileptic Disorders. 2024;26(3): 395-397. doi:10.1002/epd2.20210.$2$MON$I$F$Y$$$20240805$$HP$US$US
241720281$24172028$1$I$20240731$20240731$20240805$20240805$PER$$US-AMGEN-USASL2024153114$AMGEN$$$$$F$Y$$$20240804$$CN$US$US
241720291$24172029$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001207$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240805$$CN$US$US
241720301$24172030$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001424$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240805$$CN$US$US
241720311$24172031$1$I$$20240726$20240805$20240805$EXP$$CA-APOTEX-2024AP008917$APOTEX$$55$YR$$F$Y$$$20240805$$HP$CA$CA
241720321$24172032$1$I$$20240730$20240805$20240805$PER$$US-LEO Pharma-372446$LEO PHARM$$70$YR$$F$Y$$$20240805$$CN$US$US
241720332$24172033$2$F$20240723$20240801$20240805$20240808$EXP$$US-KYOWAKIRIN-2024KK018514$KYOWA$$$$$$Y$$$20240808$$PH$US$US
241720341$24172034$1$I$20231003$20240730$20240805$20240805$EXP$ES-AEMPS-1554122$ES-ORGANON-O2407ESP002764$ORGANON$$86$YR$$F$Y$$$20240805$$MD$ES$ES
241720352$24172035$2$F$20240802$20240802$20240805$20240808$PER$$US-AMGEN-USASP2024154432$AMGEN$$59$YR$A$F$Y$$$20240808$$CN$US$US
241720361$24172036$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06949$LUPIN$$$$$$Y$$$20240805$$CN$US$US
241720371$24172037$1$I$$20240726$20240805$20240805$EXP$$CA-APOTEX-2024AP008912$APOTEX$$65$YR$$F$Y$56$KG$20240805$$HP$CA$CA
241720382$24172038$2$F$$20231218$20240805$20240917$PER$$US-ENDO USA, INC.-2024-001918$ENDO$$$$$F$Y$$$20240917$$HP$US$US
241720392$24172039$2$F$$20231218$20240805$20240916$PER$$US-ENDO USA, INC.-2024-001603$ENDO$$$$$F$Y$$$20240916$$CN$US$US
241720403$24172040$3$F$$20240514$20240805$20240916$PER$$US-ENDO USA, INC.-2024-001232$ENDO$$$$$M$Y$$$20240916$$HP$US$US
241720411$24172041$1$I$20240101$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152283$AMGEN$$$$$F$Y$$$20240804$$CN$US$US
241720422$24172042$2$F$$20231219$20240805$20240918$PER$$US-ENDO USA, INC.-2024-000162$ENDO$$$$$M$Y$$$20240918$$CN$US$US
241720442$24172044$2$F$$20231219$20240805$20240916$PER$$US-ENDO USA, INC.-2024-000095$ENDO$$$$$M$Y$$$20240916$$CN$US$US
241720453$24172045$3$F$20240701$20240909$20240805$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120821$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$94.35$KG$20240916$$CN$US$US
241720462$24172046$2$F$$20240814$20240805$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120911$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$94.8$KG$20240816$$HP$US$US
241720481$24172048$1$I$20240629$20240722$20240805$20240805$EXP$FR-AFSSAPS-LM2024000407$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110271$ZYDUS PHARM$$$$$$Y$$$20240805$$MD$FR$FR
241720491$24172049$1$I$20240514$20240722$20240805$20240805$EXP$FR-AFSSAPS-LY2024001076$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110257$ZYDUS PHARM$$$$$$Y$$$20240805$$PH$FR$FR
241720502$24172050$2$F$20240727$20240731$20240805$20240807$EXP$$AU-JNJFOC-20240780732$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240808$$CN$AU$AU
241720511$24172051$1$I$20170101$20240730$20240805$20240805$EXP$FR-AFSSAPS-SE2024000599$FR-ORGANON-O2408FRA000101$ORGANON$$63$YR$$M$Y$50$KG$20240805$$MD$FR$FR
241720521$24172052$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000047817$ROCHE$$60$YR$A$F$Y$$$20240805$$HP$US$US
241720531$24172053$1$I$$20240730$20240805$20240805$PER$$US-ALXN-202407USA002058US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241720543$24172054$3$F$20240101$20240916$20240805$20240917$PER$$US-AMGEN-USASP2024152975$AMGEN$$73$YR$E$F$Y$$$20240917$$CN$US$US
241720551$24172055$1$I$$20240722$20240805$20240805$EXP$$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001950$IPCA$Tayyaba Mehmood, Karim Elaidy and Olabambo Ogunbambi. A rare case of TEN-like acute cutaneous lupus. Clinical Medicine. 2024;24 (100041):33-34$$$$$Y$$$20240805$$HP$GB$GB
241720571$24172057$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001210$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240805$$CN$US$US
241720581$24172058$1$I$$20240724$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407017068$ELI LILLY AND CO$$52$YR$A$$Y$$$20240805$$CN$US$US
241720591$24172059$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53579$$FDA-CTU$$60$YR$$M$N$95.71$KG$20240805$N$$US$
241720601$24172060$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000941$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240805$$CN$US$US
241720611$24172061$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262320$NOVO NORDISK$$$$$M$Y$$$20240805$$HP$US$US
241720621$24172062$1$I$$20240724$20240805$20240805$EXP$$TR-NOVOPROD-1263011$NOVO NORDISK$$$$E$$Y$$$20240805$$PH$TR$TR
241720631$24172063$1$I$20240521$20240725$20240805$20240805$EXP$$HU-NOVOPROD-1244188$NOVO NORDISK$$792$MON$$F$Y$88$KG$20240805$$CN$HU$HU
241720641$24172064$1$I$$20240724$20240805$20240805$EXP$$NZ-NOVOPROD-1262214$NOVO NORDISK$$$$$F$Y$$$20240805$$CN$NZ$NZ
241720651$24172065$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262224$NOVO NORDISK$$78$YR$$F$Y$$$20240805$$HP$US$US
241720661$24172066$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262727$NOVO NORDISK$$$$A$F$Y$$$20240805$$CN$US$US
241720672$24172067$2$F$$20240910$20240805$20240920$EXP$$US-NOVOPROD-1262342$NOVO NORDISK$$74$YR$$M$Y$153.02$KG$20240920$$CN$US$US
241720681$24172068$1$I$20240404$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262341$NOVO NORDISK$$73$YR$$M$Y$$$20240805$$CN$US$US
241720701$24172070$1$I$20240702$20240725$20240805$20240805$EXP$FR-AFSSAPS-NT2024000920$FR-NOVOPROD-1260706$NOVO NORDISK$$27$YR$$M$Y$$$20240805$$CN$FR$FR
241720721$24172072$1$I$20240401$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262257$NOVO NORDISK$$77$YR$$F$Y$$$20240805$$CN$US$US
241720731$24172073$1$I$$20240724$20240805$20240805$EXP$$FR-NOVOPROD-1262746$NOVO NORDISK$$$$$F$Y$$$20240805$$CN$FR$FR
241720742$24172074$2$F$20240701$20240808$20240805$20240820$EXP$$US-NOVOPROD-1262291$NOVO NORDISK$$$$$F$Y$$$20240820$$CN$US$US
241720751$24172075$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53584$$FDA-CTU$$77$YR$$F$N$70.31$KG$20240805$N$$US$
241720761$24172076$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158518$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241720772$24172077$2$F$20240626$20240823$20240805$20240830$EXP$$ES-JNJFOC-20240804222$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240830$$CN$ES$ES
241720782$24172078$2$F$20240701$20240731$20240805$20240812$EXP$$PL-NOVOPROD-1261407$NOVO NORDISK$$38$YR$$F$Y$77$KG$20240812$$CN$PL$PL
241720801$24172080$1$I$20240711$20240725$20240805$20240805$EXP$GB-MHRA-MED-202407251055248370-MVWKZ$GB-NOVOPROD-1260799$NOVO NORDISK$$56$YR$$F$Y$104$KG$20240805$$HP$GB$GB
241720811$24172081$1$I$$20220207$20240805$20240805$EXP$$US-AstraZeneca-2022A062145$ASTRAZENECA$$$$$$Y$$$20240805$$MD$US$
241720821$24172082$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003525$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241720831$24172083$1$I$$20240723$20240805$20240805$EXP$$US-SPECGX-T202401603$SPECGX$Kane N, Rikard R, McCrory K, Marx A. Crushed posaconazole delayed-release tablets via enteral feeding tubes: A cautionary tale. Annals of Pharmacotherapy. 2024;1-3$26$YR$$F$Y$$$20240805$$PH$US$US
241720841$24172084$1$I$$20240723$20240805$20240805$EXP$$US-SPECGX-T202401631$SPECGX$Kane N, Rikard R, McCrory K, Marx A. Crushed posaconazole delayed-release tablets via enteral feeding tubes: A cautionary tale. Annals of Pharmacotherapy. 2024;1-3$74$YR$$M$Y$$$20240805$$PH$US$US
241720851$24172085$1$I$$20240730$20240805$20240805$EXP$$GB-CHATTEMPRD-2024OHG025841$CHATTEM$$49$YR$A$F$Y$$$20240805$$HP$GB$GB
241720861$24172086$1$I$$20240712$20240805$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003526$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
241720871$24172087$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008953$APOTEX$$74$YR$$M$Y$$$20240805$$CN$CA$CA
241720881$24172088$1$I$$20240730$20240805$20240805$PER$$US-ROCHE-10000043158$ROCHE$$$$A$F$Y$$$20240805$$HP$US$US
241720891$24172089$1$I$$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024154087$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
241720901$24172090$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152731$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241720911$24172091$1$I$20240601$20240730$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120850$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240805$$HP$US$US
241720921$24172092$1$I$20240701$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024153667$AMGEN$$$$A$F$Y$$$20240805$$MD$US$US
241720931$24172093$1$I$$20221107$20240805$20240805$EXP$$US-AstraZeneca-2022A368749$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241720941$24172094$1$I$$20230711$20240805$20240805$EXP$$US-AstraZeneca-2023A162939$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241720951$24172095$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122550$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240805$$CN$US$US
241720961$24172096$1$I$20240719$20240801$20240805$20240805$EXP$FR-AFSSAPS-PA2024001425$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-122838$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$56.9$KG$20240805$$MD$FR$FR
241720971$24172097$1$I$20240714$20240729$20240805$20240805$EXP$$PK-ROCHE-10000040972$ROCHE$$69$YR$E$M$Y$$$20240805$$CN$PK$PK
241720981$24172098$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000047536$ROCHE$$$$A$F$Y$$$20240805$$CN$US$US
241720992$24172099$2$F$$20240808$20240805$20240816$EXP$$US-GSK-US2024AMR096879$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
241721001$24172100$1$I$$20240702$20240805$20240805$30DAY$$US-UCBSA-2024034250$UCB$$$$$F$Y$$$20240805$$CN$US$US
241721011$24172101$1$I$$20240729$20240805$20240805$PER$$US-ROCHE-10000036904$ROCHE$$$$$F$Y$$$20240805$$CN$US$US
241721021$24172102$1$I$20240606$20240724$20240805$20240805$PER$$US-ROCHE-10000038692$ROCHE$$$$$$Y$$$20240805$$MD$US$US
241721031$24172103$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003527$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$HP$US$US
241721041$24172104$1$I$20240717$20240725$20240805$20240805$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000130-2024$QILU PHARMACEUTICAL$$25$YR$A$F$Y$75$KG$20240801$$HP$CN$CN
241721051$24172105$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP009004$APOTEX$$58$YR$$F$Y$$$20240805$$CN$CA$CA
241721061$24172106$1$I$$20240726$20240805$20240805$PER$$NVSC2024US158416$NOVARTIS$$6$WK$$$Y$$$20240805$$CN$US$US
241721072$24172107$2$F$$20240724$20240805$20240807$EXP$$NVSC2024TH152594$NOVARTIS$$72$YR$$M$Y$$$20240807$$MD$TH$TH
241721083$24172108$3$F$$20240220$20240805$20240918$PER$$US-ENDO USA, INC.-2024-001131$ENDO$$$$$M$Y$$$20240918$$CN$US$US
241721111$24172111$1$I$$20240804$20240805$20240805$DIR$FDA-CDER-CTU-2024-53609$$FDA-CTU$$$$$F$N$$$20240804$N$HP$US$
241721121$24172112$1$I$$20240726$20240805$20240805$EXP$$US-JNJFOC-20240779505$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$HP$US$US
241721132$24172113$2$F$$20240213$20240805$20240916$PER$$US-ENDO USA, INC.-2024-001052$ENDO$$$$$F$Y$$$20240916$$CN$US$US
241721143$24172114$3$F$$20240312$20240805$20240916$PER$$US-ENDO USA, INC.-2024-001395$ENDO$$$$$M$Y$$$20240916$$CN$US$US
241721152$24172115$2$F$$20240326$20240805$20240916$PER$$US-ENDO USA, INC.-2024-001567$ENDO$$$$$$Y$$$20240916$$CN$US$US
241721163$24172116$3$F$$20240905$20240805$20240912$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034554$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$$$20240912$$CN$CA$CA
241721172$24172117$2$F$$20240814$20240805$20240824$EXP$$US-GSK-US2024AMR094521$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
241721191$24172119$1$I$$20240722$20240805$20240805$EXP$$US-CHEPLA-2024009802$CHEPLAPHARM$$$$A$F$Y$$$20240805$$PH$COUNTRY NOT SPECIFIED$US
241721201$24172120$1$I$$20240802$20240805$20240805$DIR$FDA-CDER-CTU-2024-53586$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
241721211$24172121$1$I$20231009$20240803$20240803$20240803$DIR$712774$$FDA-CTU$$43$YR$$F$N$79.2$KG$20240803$N$CN$US$
241721221$24172122$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000957$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240805$$HP$US$US
241721231$24172123$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001254$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240805$$CN$US$US
241721241$24172124$1$I$20240724$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001059$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240805$$CN$US$US
241721251$24172125$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001531$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240805$$CN$US$US
241721264$24172126$4$F$$20240823$20240805$20240831$EXP$$IL-TAKEDA-2024TUS076744$TAKEDA$$$$$F$Y$$$20240831$$CN$IL$IL
241721271$24172127$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53589$$FDA-CTU$$71$YR$$M$N$$$20240805$N$$US$
241721281$24172128$1$I$20111201$20240726$20240805$20240805$EXP$$US-JNJFOC-20240805740$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240805$$LW$US$US
241721291$24172129$1$I$$20240722$20240805$20240805$EXP$$JP-IPCA LABORATORIES LIMITED-IPC-2024-JP-001948$IPCA$Yuji Takahashi , Hidehiko Nakano, Maiko Motoki, et.al.. Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and  literature review. Acute Med Surg. 2024;11(e981):1-5$$$$$Y$$$20240805$$HP$JP$JP
241721301$24172130$1$I$20240622$20240726$20240805$20240805$EXP$FR-AFSSAPS-GR2024000921$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07203$HIKMA$$$$$$Y$$$20240802$$PH$FR$FR
241721311$24172131$1$I$$20240724$20240805$20240805$EXP$$GB-AUROBINDO-AUR-APL-2024-037452$AUROBINDO$$83$YR$$F$Y$$$20240805$$PH$GB$GB
241721322$24172132$2$F$$20240814$20240805$20240820$PER$$US-ROCHE-10000046541$ROCHE$Boursier A, Boursier A, Sejourne A, Fardellone P, Goeb V. Psoria-sis paradoxal chez une femme traitee par tocilizumab pour une  polyarthrite rhumatoide. Rev Rhum. 2018;85:510-51. doi:10.1016/j.rhum.2017.01.009.$70$YR$E$F$Y$$$20240820$$HP$US$US
241721331$24172133$1$I$20240731$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152685$AMGEN$$$$$$Y$$$20240805$$PH$US$US
241721343$24172134$3$F$20240101$20240816$20240805$20240907$30DAY$$US-JNJFOC-20240734319$JOHNSON AND JOHNSON$$$$$$Y$$$20240907$$CN$US$US
241721351$24172135$1$I$$20240724$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118406$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240805$$CN$US$US
241721361$24172136$1$I$20240730$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024153061$AMGEN$$72$YR$E$F$Y$$$20240805$$CN$US$US
241721371$24172137$1$I$$20231003$20240805$20240805$PER$$US-APOTEX-2023AP014982$APOTEX$Lyes M, Yang KH, Castellanos J, Furnish T. Microdosing psilocybin for chronic pain: a case series. Pain. 2023;164(4):698-702$37$YR$$M$Y$$$20240805$$HP$US$US
241721381$24172138$1$I$20240630$20240725$20240805$20240805$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002098$Alvotech$$32$YR$$F$Y$$$20240805$$CN$CA$CA
241721391$24172139$1$I$$20240801$20240805$20240805$EXP$$US-BAUSCH-BL-2024-011771$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240805$$MD$US$US
241721401$24172140$1$I$20170503$20240730$20240805$20240805$EXP$$CA-SANDOZ INC.-PHHY2017CA067363$SANDOZ$$69$YR$$M$Y$$$20240805$$CN$CA$CA
241721411$24172141$1$I$$20240731$20240805$20240805$30DAY$$IT-SANDOZ INC.-SDZ2024IT070202$SANDOZ$$$$C$F$Y$$$20240805$$CN$IT$IT
241721421$24172142$1$I$$20240801$20240805$20240805$EXP$$DE-BAUSCH-BL-2024-011788$BAUSCH AND LOMB$$$$$F$Y$$$20240805$$CN$DE$DE
241721431$24172143$1$I$20211001$20240801$20240805$20240805$EXP$$RO-BAUSCH-BL-2024-011776$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240805$$MD$RO$RO
241721441$24172144$1$I$20240701$20240726$20240805$20240805$PER$$US-ABBVIE-5857968$ABBVIE$$40$YR$$$Y$$$20240805$$CN$US$US
241721462$24172146$2$F$$20240731$20240805$20240805$PER$$US-ROCHE-10000046991$ROCHE$$$$A$F$Y$$$20240805$$HP$US$US
241721471$24172147$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003535$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
241721481$24172148$1$I$20240215$20240725$20240805$20240805$EXP$FR-AFSSAPS-TO2024001360$FR-AMGEN-FRASP2024154366$AMGEN$$68$YR$E$M$Y$74$KG$20240805$$MD$FR$FR
241721492$24172149$2$F$$20240829$20240805$20240906$EXP$$CA-CELLTRION INC.-2024CA003914$CELLTRION$$$$$$Y$$$20240906$$CN$CA$CA
241721501$24172150$1$I$$20240721$20240805$20240805$PER$$US-JNJFOC-20240763932$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$US$US
241721512$24172151$2$F$20240719$20240729$20240805$20240808$PER$$CN-BEH-2024176600$CSL BEHRING$$46$YR$A$M$Y$90$KG$20240808$$CN$CN$CN
241721521$24172152$1$I$$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407018961$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240805$$CN$US$US
241721531$24172153$1$I$20240101$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001495$ELI LILLY AND CO$$56$YR$A$$Y$$$20240805$$CN$US$US
241721541$24172154$1$I$$20201007$20240805$20240805$EXP$$US-AstraZeneca-2020SF31783$ASTRAZENECA$$74$YR$$M$Y$$$20240805$$CN$US$
241721551$24172155$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152822$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240805$$MD$US$US
241721561$24172156$1$I$20240701$20240730$20240805$20240805$EXP$$US-AMGEN-USASP2024152058$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
241721571$24172157$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003528$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241721586$24172158$6$F$20240731$20240911$20240805$20240919$30DAY$$US-JNJFOC-20240800141$JOHNSON AND JOHNSON$$74$YR$E$F$Y$52.4$KG$20240919$$CN$US$US
241721591$24172159$1$I$$20240803$20240805$20240805$EXP$$CA-ROCHE-3291516$ROCHE$$70$YR$E$M$Y$$$20240805$$HP$CA$CA
241721601$24172160$1$I$20240621$20240731$20240805$20240805$EXP$$US-UCBSA-2024032850$UCB$$51$YR$$F$Y$$$20240805$$CN$US$US
241721611$24172161$1$I$20240729$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024153808$AMGEN$$57$YR$A$F$Y$$$20240805$$HP$US$US
241721621$24172162$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53592$$FDA-CTU$$59$YR$$F$N$52.16$KG$20240805$N$$US$
241721631$24172163$1$I$20240721$20240803$20240803$20240803$DIR$712772$$FDA-CTU$$36$YR$$M$N$121.5$KG$20240803$N$CN$US$
241721641$24172164$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53580$$FDA-CTU$$76$YR$$F$N$97.98$KG$20240805$N$$US$
241721651$24172165$1$I$20240112$20240803$20240803$20240803$DIR$712794$$FDA-CTU$$78$YR$$F$N$58.5$KG$20240803$N$CN$US$
241721661$24172166$1$I$$20240802$20240805$20240805$PER$$US-JNJFOC-20240806775$JOHNSON AND JOHNSON$$90$YR$E$M$Y$$$20240805$$HP$US$US
241721671$24172167$1$I$20240630$20240803$20240803$20240803$DIR$712811$$FDA-CTU$$$$$F$N$$$20240803$N$CN$US$
241721681$24172168$1$I$$20240731$20240805$20240805$EXP$$CA-ABBVIE-5863986$ABBVIE$$$$E$F$Y$$$20240805$$CN$CA$CA
241721691$24172169$1$I$$20240729$20240805$20240805$EXP$$MX-CHEPLA-2024009836$CHEPLAPHARM$$50$YR$$F$Y$56$KG$20240805$$CN$COUNTRY NOT SPECIFIED$MX
241721701$24172170$1$I$$20240724$20240805$20240805$EXP$$US-INSMED, INC.-2024-03034-US$INSMED$$$$$M$Y$$$20240805$$CN$US$US
241721711$24172171$1$I$20240724$20240730$20240805$20240805$EXP$$CA-TAKEDA-2024TUS077204$TAKEDA$$9$YR$$F$Y$$$20240805$$CN$CA$CA
241721721$24172172$1$I$$20240722$20240805$20240805$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092679$GLENMARK$$$$$$Y$$$20240805$$CN$US$US
241721731$24172173$1$I$20240727$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174690$ASTRAZENECA$$$$$M$Y$$$20240805$$MD$US$
241721751$24172175$1$I$20240310$20240731$20240805$20240805$EXP$FR-AFSSAPS-AN2024000995$FR-RDY-SPO/FRA/24/0011295$DR REDDYS$$69$YR$E$M$Y$50$KG$20240805$$MD$FR$FR
241721761$24172176$1$I$$20240729$20240805$20240805$EXP$$GB-SANDOZ INC.-NVSC2021GB139374$SANDOZ$$$$A$F$Y$$$20240805$$CN$GB$GB
241721771$24172177$1$I$20230101$20231127$20240805$20240805$EXP$$US-KHC-000060$Kilitch Healthcare$$$$$M$Y$$$20240805$$CN$US$US
241721781$24172178$1$I$$20240731$20240805$20240805$PER$$US-BIOGEN-2021BI00997912$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
241721791$24172179$1$I$$20240725$20240805$20240805$EXP$$AR-ROCHE-10000037274$ROCHE$$14$YR$T$M$Y$$$20240805$$MD$AR$AR
241721801$24172180$1$I$$20240730$20240805$20240805$PER$$US-BIOGEN-2024BI01276331$BIOGEN$$$$$$Y$$$20240805$$CN$US$US
241721811$24172181$1$I$20240501$20240730$20240805$20240805$PER$$US-BIOGEN-2024BI01276139$BIOGEN$$67$YR$$F$Y$$$20240805$$CN$US$US
241721822$24172182$2$F$$20240904$20240805$20240906$PER$$US-BIOGEN-2024BI01276067$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
241721831$24172183$1$I$$20240729$20240805$20240805$EXP$$NVSJ2024JP009184$NOVARTIS$$$$$$Y$$$20240805$$PH$JP$JP
241721841$24172184$1$I$20240717$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122741$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240805$$PH$US$US
241721851$24172185$1$I$20240101$20240729$20240805$20240805$PER$$US-BIOGEN-2024BI01254121$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
241721861$24172186$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001484$ELI LILLY AND CO$$$$$$Y$$$20240805$$HP$US$US
241721871$24172187$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001198$ELI LILLY AND CO$$$$$$Y$$$20240805$$CN$US$US
241721884$24172188$4$F$20240801$20240905$20240805$20240916$30DAY$$US-JNJFOC-20240802504$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240916$$CN$US$US
241721892$24172189$2$F$20240726$20240809$20240805$20240813$EXP$$US-AMGEN-USASP2024152950$AMGEN$$79$YR$E$F$Y$$$20240813$$CN$US$US
241721901$24172190$1$I$$20240730$20240805$20240805$EXP$$AT-JNJFOC-20240800808$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$MD$AT$AT
241721911$24172191$1$I$20240701$20240719$20240805$20240805$PER$$US-JNJFOC-20240756852$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240805$$CN$US$US
241721921$24172192$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153097$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240805$$MD$US$US
241721932$24172193$2$F$20240503$20240809$20240805$20240816$EXP$$US-INTERCEPT-PM2024001527$INTERCEPT PHARMACEUTICALS$$75$YR$$F$Y$$$20240816$$HP$US$US
241721941$24172194$1$I$20230825$20240729$20240805$20240805$EXP$$BE-TAKEDA-2023TUS085003$TAKEDA$$73$YR$$F$Y$56$KG$20240805$$MD$BE$BE
241721951$24172195$1$I$$20240730$20240805$20240805$EXP$$GB-TAKEDA-2024TUS077336$TAKEDA$Mohidin B, Needleman A, Fernando R, Lowe DM, Wechalekar A, Sheaff M, et al. Renal transplant outcomes in plasma cell dyscrasias and al amyloidosis after treatment with daratumumab. Journal Of Clinical Medicine. 2024;13(4109):1-10$59$YR$$M$Y$$$20240805$$HP$GB$GB
241721962$24172196$2$F$20240701$20240802$20240805$20240812$EXP$$US-INTERCEPT-PM2024001524$INTERCEPT PHARMACEUTICALS$$73$YR$$F$Y$69.841$KG$20240812$$CN$US$US
241721971$24172197$1$I$$20240722$20240805$20240805$EXP$$GB-CIPLA LTD.-2024GB07994$CIPLA$$$$$$Y$$$20240805$$CN$GB$GB
241721981$24172198$1$I$$20240729$20240805$20240805$EXP$$US-EMD Serono-2024041314$EMD SERONO INC$$42$YR$A$M$Y$$$20240805$$CN$US$US
241721991$24172199$1$I$$20220527$20240805$20240805$EXP$$US-AstraZeneca-2022A203653$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241722001$24172200$1$I$$20230802$20240805$20240805$EXP$$ZA-AstraZeneca-2023A177875$ASTRAZENECA$$61$YR$$M$Y$$$20240805$$CN$ZA$
241722011$24172201$1$I$$20230317$20240805$20240805$EXP$$US-AstraZeneca-2023A065386$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241722023$24172202$3$F$20220901$20240904$20240805$20240909$EXP$$CA-JNJFOC-20220949799$JOHNSON AND JOHNSON$$44$YR$A$F$Y$109$KG$20240909$$HP$CA$CA
241722031$24172203$1$I$20240610$20240712$20240805$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003541$ACADIA PHARMACEUTICALS$$96$YR$$F$Y$$$20240805$$CN$US$US
241722041$24172204$1$I$20171001$20240731$20240805$20240805$EXP$ES-AEMPS-1550112$ES-EMD Serono-2024041512$EMD SERONO INC$$74$YR$E$F$Y$65$KG$20240805$$CN$ES$ES
241722051$24172205$1$I$$20240730$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121904$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240805$$CN$US$US
241722061$24172206$1$I$20240101$20240801$20240805$20240805$EXP$$US-ABBVIE-5865206$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241722072$24172207$2$F$$20240815$20240805$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003579$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
241722081$24172208$1$I$20230101$20231220$20240805$20240805$EXP$$US-KHC-000064$Kilitch Healthcare$$$$$M$Y$$$20240805$$CN$US$US
241722092$24172209$2$F$$20231212$20240805$20240918$PER$$US-ENDO USA, INC.-2023-006189$ENDO$$$$$F$Y$$$20240918$$CN$US$US
241722101$24172210$1$I$$20240730$20240805$20240805$EXP$$US-JNJFOC-20240784311$JOHNSON AND JOHNSON$$$$$M$Y$156$KG$20240805$$HP$US$US
241722111$24172211$1$I$20240725$20240731$20240805$20240805$EXP$$CN-ORGANON-O2408CHN000173$ORGANON$$60$YR$$M$Y$70$KG$20240805$$HP$CN$CN
241722121$24172212$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153101$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et. al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240805$$MD$US$US
241722131$24172213$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152763$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241722151$24172215$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152754$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241722161$24172216$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153029$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241722171$24172217$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152855$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241722181$24172218$1$I$20240627$20240725$20240805$20240805$EXP$$JP-TAKEDA-2024TUS077512$TAKEDA$$26$YR$$M$Y$54$KG$20240805$$PH$JP$JP
241722191$24172219$1$I$20240701$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001385$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240805$$CN$US$US
241722201$24172220$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001420$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240805$$CN$US$US
241722211$24172221$1$I$$20240729$20240805$20240805$PER$$US-JNJFOC-20240780375$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$LW$US$US
241722221$24172222$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001364$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240805$$CN$US$US
241722231$24172223$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001241$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240805$$CN$US$US
241722242$24172224$2$F$20240727$20240904$20240805$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122885$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240909$$CN$US$US
241722251$24172225$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122442$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240805$$CN$US$US
241722261$24172226$1$I$20240601$20240726$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119808$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240805$$CN$US$US
241722271$24172227$1$I$20230221$20230316$20240805$20240805$EXP$$NL-TERSERA THERAPEUTICS LLC-2023TRS001293$TERSERA THERAPEUTICS$$$$$$Y$$$20240805$$CN$NL$NL
241722281$24172228$1$I$$20240724$20240805$20240805$EXP$$SG-ROCHE-10000035798$ROCHE$$74$YR$E$M$Y$$$20240805$$CN$SG$SG
241722291$24172229$1$I$20240701$20240731$20240805$20240805$EXP$$US-UCBSA-2024038944$UCB$$39$YR$$F$Y$130.16$KG$20240805$$HP$US$US
241722301$24172230$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153064$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241722312$24172231$2$F$$20240808$20240805$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003569$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
241722321$24172232$1$I$$20240125$20240805$20240805$PER$$US-APOTEX-2024AP001790$APOTEX$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series.. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY. 2023;33 (Number 10):433-438$15$YR$$M$Y$$$20240805$$PH$US$US
241722331$24172233$1$I$$20240125$20240805$20240805$PER$$US-APOTEX-2024AP001799$APOTEX$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series.. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY. 2023;33 (Number 10):433-438$16$YR$$F$Y$$$20240805$$PH$US$US
241722343$24172234$3$F$20231116$20240919$20240805$20240928$EXP$$CA-CELLTRION INC.-2023CA022667$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
241722351$24172235$1$I$20230101$20231122$20240805$20240805$EXP$$US-KHC-000068$Kilitch Healthcare$$33$YR$A$F$Y$$$20240805$$CN$US$US
241722361$24172236$1$I$$20231009$20240805$20240805$EXP$$US-AstraZeneca-2023A230512$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241722371$24172237$1$I$$20191106$20240805$20240805$EXP$$US-AstraZeneca-2019SF59144$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241722381$24172238$1$I$$20211018$20240805$20240805$EXP$$CA-AstraZeneca-2021A780141$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$CA$
241722393$24172239$3$F$20240718$20240813$20240805$20240820$PER$$US-AMGEN-USASP2024151768$AMGEN$$72$YR$E$F$Y$101$KG$20240820$$PH$US$US
241722411$24172241$1$I$$20230817$20240805$20240805$EXP$$US-AstraZeneca-2023A188937$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241722421$24172242$1$I$20220912$20240726$20240805$20240805$EXP$FR-AFSSAPS-CN2024000715$FR-AMGEN-FRASP2024149370$AMGEN$$69$YR$E$M$Y$$$20240805$$MD$FR$FR
241722431$24172243$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153367$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241722441$24172244$1$I$$20211230$20240805$20240805$EXP$$US-AstraZeneca-2021A909839$ASTRAZENECA$$$$$M$Y$$$20240805$$MD$US$
241722451$24172245$1$I$$20221101$20240805$20240805$EXP$$US-AstraZeneca-2022A363525$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241722461$24172246$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153373$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241722471$24172247$1$I$$20240725$20240805$20240805$EXP$$US-NOVOPROD-1262546$NOVO NORDISK$$$$$F$Y$$$20240805$$CN$US$US
241722482$24172248$2$F$20230601$20240801$20240805$20240813$EXP$$CA-NOVOPROD-1261696$NOVO NORDISK$$49$YR$$F$Y$$$20240813$$CN$CA$CA
241722491$24172249$1$I$$20230613$20240805$20240805$EXP$$US-AstraZeneca-2023A138054$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241722502$24172250$2$F$20220101$20240725$20240805$20240807$EXP$$US-NOVOPROD-1262680$NOVO NORDISK$$62$YR$$M$Y$47.619$KG$20240807$$CN$US$US
241722521$24172252$1$I$$20240725$20240805$20240805$EXP$$CA-NOVOPROD-1261938$NOVO NORDISK$$43$YR$$F$Y$$$20240805$$HP$CA$CA
241722531$24172253$1$I$$20240725$20240805$20240805$EXP$$US-NOVOPROD-1262278$NOVO NORDISK$$$$A$F$Y$$$20240805$$CN$US$US
241722552$24172255$2$F$$20240910$20240805$20240920$EXP$$GB-NOVOPROD-1262250$NOVO NORDISK$$$$$$Y$$$20240920$$CN$GB$GB
241722561$24172256$1$I$20240613$20240803$20240803$20240803$DIR$712835$$FDA-CTU$$54$YR$$M$N$$$20240803$N$CN$US$
241722581$24172258$1$I$$20240730$20240805$20240805$PER$$US-ABBVIE-5861626$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241722592$24172259$2$F$$20240801$20240805$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06946$LUPIN$$$$$$Y$$$20240827$$CN$US$US
241722603$24172260$3$F$$20240904$20240805$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003493$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241722611$24172261$1$I$20240715$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123041$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240805$$CN$US$US
241722621$24172262$1$I$20240722$20240730$20240805$20240805$EXP$$CN-TAKEDA-2024TUS076805$TAKEDA$$80$YR$$M$Y$60$KG$20240805$$HP$CN$CN
241722641$24172264$1$I$$20240726$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119694$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240805$$CN$US$US
241722651$24172265$1$I$20240727$20240803$20240803$20240803$DIR$712802$$FDA-CTU$$62$YR$$F$N$$$20240803$Y$CN$US$
241722661$24172266$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53585$$FDA-CTU$$69$YR$$F$N$104.33$KG$20240805$N$$US$
241722671$24172267$1$I$20240728$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152382$AMGEN$$62$YR$A$M$Y$$$20240805$$CN$US$US
241722681$24172268$1$I$$20240731$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121871$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240805$$HP$US$US
241722691$24172269$1$I$$20240802$20240805$20240805$PER$$US-ROCHE-10000048431$ROCHE$$73$YR$E$M$Y$$$20240805$$MD$US$US
241722701$24172270$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003499$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241722721$24172272$1$I$$20240712$20240805$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003497$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
241722731$24172273$1$I$20240319$20240803$20240803$20240803$DIR$712812$$FDA-CTU$$54$YR$$M$N$67.5$KG$20240803$N$CN$US$
241722751$24172275$1$I$20240215$20240803$20240803$20240803$DIR$712810$$FDA-CTU$$35$YR$$M$N$63$KG$20240803$N$CN$US$
241722762$24172276$2$F$20240705$20240909$20240805$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003494$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240919$$CN$US$US
241722772$24172277$2$F$$20240904$20240805$20240910$EXP$$JP-GSK-JP2024JPN095444$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$PH$JP$JP
241722781$24172278$1$I$20240712$20240729$20240805$20240805$EXP$$JP-AMGEN-JPNSP2024153537$AMGEN$$8$DEC$E$F$Y$$$20240805$$MD$JP$JP
241722791$24172279$1$I$$20240725$20240805$20240805$EXP$$PK-ROCHE-10000040039$ROCHE$$$$A$F$Y$$$20240805$$CN$PK$PK
241722801$24172280$1$I$$20240730$20240805$20240805$PER$$US-BEIGENE-BGN-2024-011982$BEIGENE$$$$$$Y$$$20240805$$MD$US$US
241722821$24172282$1$I$20240216$20240729$20240805$20240805$EXP$$DE-SANDOZ INC.-SDZ2024DE069894$SANDOZ$$59$YR$$F$Y$$$20240805$$MD$DE$DE
241722831$24172283$1$I$$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152943$AMGEN$$$$$F$Y$$$20240805$$HP$US$US
241722841$24172284$1$I$$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174584$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241722851$24172285$1$I$$20211228$20240805$20240805$EXP$$US-AstraZeneca-2021A908411$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241722861$24172286$1$I$$20240729$20240805$20240805$EXP$$JP-009507513-2406JPN003310J$MERCK$$9$DEC$$M$Y$$$20240805$$MD$JP$JP
241722871$24172287$1$I$$20211124$20240805$20240805$EXP$$US-AstraZeneca-2021A843426$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241722881$24172288$1$I$$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174619$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241722891$24172289$1$I$$20230426$20240805$20240805$EXP$$US-AstraZeneca-2023A098404$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241722901$24172290$1$I$$20230814$20240805$20240805$EXP$$US-AstraZeneca-2023A150286$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241722911$24172291$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001190$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240805$$CN$US$US
241722921$24172292$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000277$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240805$$CN$US$US
241722931$24172293$1$I$20240707$20240731$20240805$20240805$EXP$$FR-AstraZeneca-2024A173918$ASTRAZENECA$$68$YR$$F$Y$56$KG$20240805$$MD$FR$
241722941$24172294$1$I$$20220413$20240805$20240805$EXP$$US-AstraZeneca-2022A152184$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241722951$24172295$1$I$$20230419$20240805$20240805$EXP$$US-AstraZeneca-2023A091825$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241722961$24172296$1$I$$20240624$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001276$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240805$$CN$US$US
241722971$24172297$1$I$20210723$20210723$20240805$20240805$EXP$$US-AstraZeneca-2021A643849$ASTRAZENECA$$27158$DY$$F$Y$$$20240805$$CN$US$
241722982$24172298$2$F$20240501$20240807$20240805$20240809$EXP$FR-AFSSAPS-PV2024000649$FR-ROCHE-10000047734$ROCHE$$76$YR$E$M$Y$65$KG$20240809$$PH$FR$FR
241722991$24172299$1$I$$20240802$20240805$20240805$PER$$US-ROCHE-10000048470$ROCHE$$8$YR$C$M$Y$$$20240805$$CN$US$US
241723001$24172300$1$I$20240701$20240725$20240805$20240805$EXP$$CO-TERSERA THERAPEUTICS LLC-2024TRS003906$TERSERA THERAPEUTICS$$$$$$Y$$$20240805$$CN$CO$CO
241723011$24172301$1$I$20221101$20240729$20240805$20240805$EXP$CH-SM-2024-14254$CH-CHEPLA-2024009858$CHEPLAPHARM$$64$YR$$F$Y$$$20240805$$MD$COUNTRY NOT SPECIFIED$CH
241723021$24172302$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008988$APOTEX$$17$DY$$F$Y$$$20240805$$PH$CA$CA
241723031$24172303$1$I$20240408$20240724$20240805$20240805$EXP$IT-MINISAL02-984597$IT-SAMSUNG BIOEPIS-SB-2024-20581$SAMSUNG BIOEPIS$$54$YR$A$M$Y$$$20240805$$MD$IT$IT
241723041$24172304$1$I$$20240801$20240805$20240805$EXP$$GB-GSK-GB2024096341$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$MD$GB$GB
241723051$24172305$1$I$20240712$20240730$20240805$20240805$EXP$FR-AFSSAPS-LY2024001115$FR-ORGANON-O2407FRA002811$ORGANON$$69$YR$$M$Y$73$KG$20240805$$PH$FR$FR
241723062$24172306$2$F$20240728$20240805$20240805$20240811$EXP$$BR-JNJFOC-20240802168$JOHNSON AND JOHNSON$$57$YR$A$F$Y$79$KG$20240811$$CN$BR$BR
241723071$24172307$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240784900$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$US$US
241723081$24172308$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240802140$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$HP$US$US
241723091$24172309$1$I$$20240726$20240805$20240805$PER$US-MLMSERVICE-20240725-PI133208-00306-1$US-RDY-SPO/USA/24/0011159$DR REDDYS$Zouridis S, Oo YH, Syn WK. Role of Sirolimus and Rituximab in the Treatment of Autoimmune Hepatitis. ACG Case Reports Journal . 2024;11(7):e01414 DOI:10.14309/crj.0000000000001414.$23$YR$A$F$Y$$$20240805$$MD$US$US
241723101$24172310$1$I$20240620$20240802$20240805$20240805$EXP$FR-AFSSAPS-LY2024001038$FR-ROCHE-10000048138$ROCHE$$85$YR$E$F$Y$29$KG$20240805$$PH$FR$FR
241723113$24172311$3$F$$20240823$20240805$20240823$EXP$$US-ALXN-202407USA001977US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241723121$24172312$1$I$$20240729$20240805$20240805$EXP$GB-MHRA-31296597$GB-TEVA-VS-3227676$TEVA$$55$YR$$F$Y$$$20240805$$PH$GB$GB
241723132$24172313$2$F$20240715$20240808$20240805$20240819$PER$$US-JNJFOC-20240748916$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240819$$HP$US$US
241723142$24172314$2$F$$20240904$20240805$20240915$30DAY$$IT-JNJFOC-20240804143$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$IT$IT
241723151$24172315$1$I$20240723$20240726$20240805$20240805$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000132-2024$QILU PHARMACEUTICAL$$80$YR$E$M$Y$65$KG$20240805$$HP$CN$CN
241723171$24172317$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122103$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240805$$CN$US$US
241723181$24172318$1$I$$20240724$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119078$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240805$$CN$US$US
241723191$24172319$1$I$20240710$20240726$20240805$20240805$EXP$$CN-SA-2024SA228658$SANOFI AVENTIS$$73$YR$E$M$Y$47.7$KG$20240805$$HP$CN$CN
241723202$24172320$2$F$$20240801$20240805$20240805$EXP$$US-ROCHE-10000047668$ROCHE$$$$A$M$Y$79.83$KG$20240805$$CN$US$US
241723211$24172321$1$I$20240503$20240804$20240804$20240804$DIR$712844$$FDA-CTU$$62$YR$$M$N$89.1$KG$20240804$N$MD$US$
241723221$24172322$1$I$20100106$20240726$20240805$20240805$EXP$$JP-009507513-1001USA00914$MERCK$$58$YR$$M$Y$$$20240805$$MD$JP$JP
241723231$24172323$1$I$20240506$20240804$20240804$20240804$DIR$712845$$FDA-CTU$$62$YR$$M$N$89.1$KG$20240804$N$MD$US$
241723242$24172324$2$F$$20240819$20240805$20240903$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-07884$SAMSUNG BIOEPIS$$36$YR$A$M$Y$$$20240903$$HP$CA$CA
241723251$24172325$1$I$$20240729$20240805$20240805$EXP$$BR-SA-2024SA228429$SANOFI AVENTIS$$$$C$M$Y$$$20240805$$MD$BR$BR
241723261$24172326$1$I$$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152871$AMGEN$$$$$$Y$$$20240805$$CN$US$US
241723271$24172327$1$I$$20240729$20240805$20240805$EXP$$US-AMGEN-USASP2024151509$AMGEN$$$$$F$Y$$$20240805$$PH$US$US
241723281$24172328$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-037890$AUROBINDO$$46$YR$$F$Y$$$20240805$$MD$CA$CA
241723291$24172329$1$I$20240101$20240729$20240805$20240805$EXP$$US-SA-2024SA226216$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240805$$MD$US$US
241723301$24172330$1$I$$20240726$20240805$20240805$EXP$$AU-JNJFOC-20240777059$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$MD$AU$AU
241723311$24172331$1$I$$20240729$20240805$20240805$EXP$$US-SA-2024SA224357$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240805$$CN$US$US
241723321$24172332$1$I$20240101$20240729$20240805$20240805$EXP$$US-SA-2024SA226239$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240805$$CN$US$US
241723331$24172333$1$I$20240724$20240729$20240805$20240805$EXP$$CN-SA-2024SA227131$SANOFI AVENTIS$$70$YR$E$M$Y$63$KG$20240805$$HP$CN$CN
241723341$24172334$1$I$$20240729$20240805$20240805$EXP$$FR-ROCHE-10000045985$ROCHE$Farina A, Villagran-Garcia M, Benaiteau M, Lamblin F, Fourier A, Honnorat J, et al. Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors. Neurology(R) neuroimmunology + neuroinflammation.11 (5): doi:10.1212/NXI.0000000000200287.$52$YR$A$M$Y$$$20240805$$MD$FR$FR
241723351$24172335$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002128US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
241723361$24172336$1$I$$20240801$20240805$20240805$EXP$$US-GILEAD-2024-0682798$GILEAD$$45$YR$A$F$Y$$$20240805$$CN$US$US
241723371$24172337$1$I$$20240722$20240805$20240805$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092988$GLENMARK$Sood N., Vadnerkar A., Kodali M., Hamacher KL.. Cutaneous pneumocystis jirovecii infection in an allogeneic stem cell transplant recipient. European Journal of Case Reports in Internal Medicine. 2024;11$$$$$Y$$$20240805$$MD$US$US
241723381$24172338$1$I$20240310$20240802$20240805$20240805$EXP$FR-AFSSAPS-AN2024000995$FR-JNJFOC-20240807473$JOHNSON AND JOHNSON$$69$YR$E$M$Y$50$KG$20240805$$MD$FR$FR
241723391$24172339$1$I$$20240729$20240805$20240805$EXP$GR-SEATTLE GENETICS-2023SGN10213$GR-CHEPLA-2024009820$CHEPLAPHARM$$$$$F$Y$$$20240805$$MD$COUNTRY NOT SPECIFIED$GR
241723401$24172340$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001518$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240805$$CN$US$US
241723412$24172341$2$F$$20240726$20240805$20240805$EXP$$US-APOTEX-2024AP009028$APOTEX$Martino J, Elfessi Z, Szaflarska K, Suh M, Antonishina K.. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use. Journal of Pharmacy Practice. 2024;0(0):1-4$25$YR$$M$Y$$$20240805$$MD$US$US
241723421$24172342$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001806$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240805$$CN$US$US
241723431$24172343$1$I$20240730$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001389$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240805$$CN$US$US
241723441$24172344$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001405$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240805$$CN$US$US
241723451$24172345$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001300$ELI LILLY AND CO$$54$YR$A$$Y$$$20240805$$CN$US$US
241723461$24172346$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001301$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240805$$HP$US$US
241723471$24172347$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001892$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240805$$CN$US$US
241723481$24172348$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001309$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240805$$CN$US$US
241723491$24172349$1$I$20240702$20240722$20240805$20240805$EXP$FR-AFSSAPS-CN2024000696$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110230$ZYDUS PHARM$$$$$$Y$$$20240805$$MD$FR$FR
241723501$24172350$1$I$20200301$20240722$20240805$20240805$EXP$FR-AFSSAPS-PC2024000587$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110291$ZYDUS PHARM$$$$$$Y$$$20240805$$PH$FR$FR
241723511$24172351$1$I$20240627$20240722$20240805$20240805$EXP$ES-AEMPS-1547363$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-110300$ZYDUS PHARM$$$$$$Y$$$20240805$$MD$ES$ES
241723521$24172352$1$I$$20240730$20240805$20240805$EXP$$KR-AMGEN-KORSP2024151877$AMGEN$Kim J.; Kim K.; Kim S. et al.. Effects of daily versus weekly teriparatide for medication-related osteonecrosis of the jaw: A case-control study. Oral Diseases. 2024;30 (5):3286-3295$$$$$Y$$$20240805$$HP$KR$KR
241723531$24172353$1$I$20230515$20240724$20240805$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-037190$AUROBINDO$$63$YR$$M$Y$113$KG$20240805$$MD$FR$FR
241723541$24172354$1$I$$20240730$20240805$20240805$EXP$$US-ABBVIE-5862253$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241723551$24172355$1$I$20240101$20240801$20240805$20240805$EXP$$US-ABBVIE-5864879$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241723561$24172356$1$I$$20240801$20240805$20240805$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-105718$REGENERON$$$$$F$Y$$$20240805$$CN$US$US
241723571$24172357$1$I$20231212$20240723$20240805$20240805$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001437$Alvotech$$25$YR$$F$Y$$$20240805$$MD$CA$CA
241723581$24172358$1$I$20240101$20240724$20240805$20240805$EXP$$US-INSMED, INC.-2024-00146-US$INSMED$$$$$F$Y$$$20240805$$CN$US$US
241723591$24172359$1$I$$20210709$20240805$20240805$EXP$$US-AstraZeneca-2021A613855$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241723601$24172360$1$I$$20240612$20240805$20240805$PER$$US-009507513-2408USA000555$MERCK$$$$$M$Y$$$20240805$$CN$US$US
241723612$24172361$2$F$$20240920$20240805$20240930$PER$$US-GSK-US2024AMR096089$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$US$US
241723621$24172362$1$I$$20220823$20240805$20240805$EXP$$DE-AstraZeneca-2022A296359$ASTRAZENECA$$$$$$Y$$$20240805$$HP$DE$
241723631$24172363$1$I$$20220318$20240805$20240805$EXP$$US-AstraZeneca-2022A122640$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241723641$24172364$1$I$$20211122$20240805$20240805$EXP$$US-AstraZeneca-2021A829371$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241723653$24172365$3$F$$20240809$20240805$20240823$EXP$$JP-AMGEN-JPNSP2024153470$AMGEN$$8$DEC$E$M$Y$$$20240823$$MD$JP$JP
241723661$24172366$1$I$20221201$20230209$20240805$20240805$EXP$$BR-AstraZeneca-2023A036938$ASTRAZENECA$$822$MON$$M$Y$95$KG$20240805$$CN$BR$
241723671$24172367$1$I$$20230127$20240805$20240805$EXP$$US-AstraZeneca-2023A024293$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241723681$24172368$1$I$20240717$20240725$20240805$20240805$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000131-2024$QILU PHARMACEUTICAL$$68$YR$E$M$Y$75$KG$20240801$$HP$CN$CN
241723693$24172369$3$F$20240714$20240820$20240805$20240822$EXP$$US-HALEON-2190039$Haleon PLC$$49$YR$$F$Y$53.1$KG$20240822$$HP$US$US
241723701$24172370$1$I$$20240731$20240805$20240805$EXP$$GB-SA-2024SA227775$SANOFI AVENTIS$$$$$F$Y$$$20240805$$HP$GB$GB
241723711$24172371$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038325$AUROBINDO$Farrell B, Galley E, Jeffs L, Howell P, McCarthy LM.. Kind of blurry: Deciphering clues to prevent, investigate and manage prescribing cascades.. PLOS-One. 2022;17 (8):1- 20$84$YR$$M$Y$$$20240805$$HP$CA$CA
241723721$24172372$1$I$$20240731$20240805$20240805$EXP$$TW-GILEAD-2024-0682191$GILEAD$$69$YR$E$M$Y$$$20240805$$HP$TW$TW
241723731$24172373$1$I$$20240731$20240805$20240805$EXP$$US-ABBVIE-5864177$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241723742$24172374$2$F$20221201$20240808$20240805$20240821$EXP$MT-SEATTLE GENETICS-2023SGN05182$MT-ROCHE-10000047226$ROCHE$$3$DEC$A$F$Y$$$20240821$$MD$MT$MT
241723751$24172375$1$I$20240325$20240724$20240805$20240805$EXP$$GB-AUROBINDO-AUR-APL-2024-037409$AUROBINDO$$73$YR$$F$Y$70$KG$20240805$$MD$GB$GB
241723761$24172376$1$I$$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024154221$AMGEN$$$$$$Y$$$20240805$$PH$US$US
241723771$24172377$1$I$20240101$20240731$20240805$20240805$EXP$$US-ABBVIE-5849622$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241723791$24172379$1$I$20240301$20240730$20240805$20240805$PER$$US-ALXN-202407USA002108US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
241723801$24172380$1$I$$20240722$20240805$20240805$EXP$$IT-ROCHE-10000032676$ROCHE$Lenti M, Ribaldone D, De Andreis F, Vernero M, Barberio B, De Ruvo M, et al. A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium. ESMO Open. 2024-Jul;9 (7):1-10. doi:10.1016/j.esmoop.2024.103632.$$$$$Y$$$20240805$$HP$IT$IT
241723812$24172381$2$F$20240729$20240904$20240805$20240904$PER$$US-ALXN-202407USA002244US$ALEXION PHARMACEUTICALS$$38$YR$$F$Y$$$20240904$$CN$US$US
241723821$24172382$1$I$$20240731$20240805$20240805$EXP$$ZA-HALEON-2190101$Haleon PLC$$$$$$Y$$$20240805$$CN$ZA$ZA
241723831$24172383$1$I$20220515$20220531$20240805$20240805$EXP$$US-AstraZeneca-2022A205155$ASTRAZENECA$$26331$DY$$M$Y$$$20240805$$CN$US$
241723841$24172384$1$I$$20240730$20240805$20240805$EXP$$JP-GSK-JP2024095156$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$JP$JP
241723851$24172385$1$I$$20210621$20240805$20240805$EXP$$US-AstraZeneca-2021A553717$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241723861$24172386$1$I$$20210913$20240805$20240805$EXP$$US-AstraZeneca-2021A733402$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241723871$24172387$1$I$20240703$20240801$20240805$20240805$EXP$$US-UCBSA-2024038792$UCB$$41$YR$$F$Y$$$20240805$$CN$US$US
241723883$24172388$3$F$$20240916$20240805$20240918$PER$$US-AstraZeneca-2024A170730$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
241723891$24172389$1$I$$20221214$20240805$20240805$EXP$$IN-AstraZeneca-2022A409524$ASTRAZENECA$$71$YR$$F$Y$$$20240805$$CN$IN$
241723901$24172390$1$I$$20240731$20240805$20240805$EXP$$ZA-AstraZeneca-2024A175147$ASTRAZENECA$$78$YR$$F$Y$$$20240805$$CN$ZA$
241723911$24172391$1$I$20240730$20240804$20240804$20240804$DIR$712838$$FDA-CTU$$70$YR$$M$N$126$KG$20240804$N$CN$US$
241723922$24172392$2$F$20240710$20240814$20240805$20240819$PER$$US-JNJFOC-20240764478$JOHNSON AND JOHNSON$$77$YR$E$F$Y$56.7$KG$20240819$$CN$US$US
241723931$24172393$1$I$20240730$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122873$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$92.53$KG$20240805$$HP$US$US
241723942$24172394$2$F$$20240805$20240805$20240807$PER$$US-ABBVIE-5863707$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241723951$24172395$1$I$20240101$20240801$20240805$20240805$EXP$$US-ABBVIE-5864981$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241723961$24172396$1$I$$20240801$20240805$20240805$EXP$$IN-ADIENNEP-2024AD000604$ADIENNE PHARMA + BIOTECH$Chattopadhyay D, Abraham A, George B. Successful Hematopoietic Stem Cell Transplantation in a Child with Thalassemia major and Moderate Haemophilia A. Indian J Hematol Blood Transfus. 2024;40(3):543-4. DOI: 10.1007/s12288-024-01751-9$$$C$M$Y$$$20240802$$MD$IN$
241723971$24172397$1$I$$20240731$20240805$20240805$PER$$US-TAKEDA-2024TUS077367$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
241723981$24172398$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038005$AUROBINDO$$65$YR$$F$Y$$$20240805$$HP$CA$CA
241723991$24172399$1$I$20240701$20240729$20240805$20240805$EXP$$US-UCBSA-2024038258$UCB$$$$A$F$Y$$$20240805$$CN$US$US
241724001$24172400$1$I$20230214$20240724$20240805$20240805$EXP$$CA-ROCHE-10000037264$ROCHE$$19$YR$A$M$Y$$$20240805$$MD$CA$CA
241724012$24172401$2$F$$20240725$20240805$20240806$PER$$NVSC2024US153717$NOVARTIS$$$$$$Y$$$20240806$$CN$US$US
241724021$24172402$1$I$$20240730$20240805$20240805$30DAY$$US-GSK-US2024095390$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241724031$24172403$1$I$$20240724$20240805$20240805$EXP$$GB-AUROBINDO-AUR-APL-2024-037421$AUROBINDO$$89$YR$$M$Y$$$20240805$$PH$GB$GB
241724041$24172404$1$I$20240315$20240726$20240805$20240805$PER$$US-JNJFOC-20240775801$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241724051$24172405$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038496$AUROBINDO$$75$YR$$F$Y$$$20240805$$HP$CA$CA
241724063$24172406$3$F$20240520$20240812$20240805$20240819$30DAY$$US-AMGEN-USASP2024143481$AMGEN$$72$YR$E$M$Y$106$KG$20240819$$PH$US$US
241724071$24172407$1$I$$20240730$20240805$20240805$EXP$GB-MHRA-MED-202407251205574320-RQCGB$GB-RDY-SPO/GBR/24/0011278$DR REDDYS$$$$$$Y$$$20240805$$CN$GB$GB
241724081$24172408$1$I$$20240726$20240805$20240805$EXP$$AU-JUBILANT CADISTA PHARMACEUTICALS-2024AU001091$JUBILANT$$78$YR$$F$Y$$$20240805$$HP$AU$AU
241724091$24172409$1$I$$20240726$20240805$20240805$30DAY$$US-GSK-US2024094277$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241724101$24172410$1$I$$20240726$20240805$20240805$EXP$$US-GSK-US2024AMR096096$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$HP$US$US
241724111$24172411$1$I$20190101$20240722$20240805$20240805$EXP$$CA-JUBILANT PHARMA LTD-2024CA001109$JUBILANT$Colijn MA, Vrijsen S, Au PY, Abou El Asrar R, Houdou M, Van den Haute C, Sarna J, Montgomery G, Vangheluwe P.. Kufor-Rakeb syndrome-associated psychosis: a novel loss-of-function ATP13A2 variant and response to antipsychotic therapy. Neurogenetics. 2024$22$YR$$M$Y$$$20240805$$HP$CA$CA
241724121$24172412$1$I$$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024154288$AMGEN$$$$$$Y$$$20240805$$PH$US$US
241724131$24172413$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001179$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240805$$CN$US$US
241724141$24172414$1$I$$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001802$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240805$$CN$US$US
241724152$24172415$2$F$20240719$20240729$20240805$20240805$PER$$US-ABBVIE-5859398$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241724161$24172416$1$I$20240802$20240802$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408002023$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240805$$CN$US$US
241724171$24172417$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001231$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240805$$CN$US$US
241724181$24172418$1$I$$20240724$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407017317$ELI LILLY AND CO$$32$YR$A$$Y$$$20240805$$CN$US$US
241724191$24172419$1$I$$20240801$20240805$20240805$EXP$$FR-TAKEDA-2024TUS071405$TAKEDA$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al. Intravenous immunoglobulins for recurrent chronic histiocytic intervillositis: a series of case studies. American Journal Of Reproductive Immunology. 2024;92(1):e13898$36$YR$$F$Y$$$20240805$$HP$FR$FR
241724201$24172420$1$I$20240730$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000971$ELI LILLY AND CO$$$$$M$Y$$$20240805$$CN$US$US
241724211$24172421$1$I$20240708$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122341$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$68.95$KG$20240805$$HP$US$US
241724221$24172422$1$I$20240425$20240730$20240805$20240805$PER$$US-JNJFOC-20240783105$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20240805$$HP$US$US
241724231$24172423$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038697$AUROBINDO$$80$YR$$M$Y$$$20240805$$PH$CA$CA
241724251$24172425$1$I$$20240730$20240805$20240805$PER$$US-ALXN-202407USA002106US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241724261$24172426$1$I$$20240801$20240805$20240805$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122351$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$54$KG$20240805$$HP$CA$CA
241724271$24172427$1$I$$20240724$20240805$20240805$EXP$$CA-ALVOGEN-2024095207$ALVOGEN$Adamo A, Marshall K, Woodall KL. Fentanyl-Related Deaths in Ontario, Canada: Toxicological Findings and Circumstances of  Death in 4395 Cases (2020-2022). Journal of Analytical Toxicology. 2024; doi:https://doi.org/10.1093/jat/bkae061$38$YR$$M$Y$$$20240805$$HP$CA$CA
241724282$24172428$2$F$20240701$20240903$20240805$20240905$EXP$$JP-GSK-JP2024JPN095447$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
241724291$24172429$1$I$20240708$20240727$20240805$20240805$EXP$$CA-TOLMAR, INC.-24CA051019$TOLMAR$$84$YR$$M$Y$$$20240805$$CN$CA$CA
241724301$24172430$1$I$$20240802$20240805$20240805$PER$$US-ROCHE-10000048558$ROCHE$$38$YR$A$F$Y$$$20240805$$HP$US$US
241724311$24172431$1$I$$20240724$20240805$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-038222$AUROBINDO$Lauren Worth, Ali Khreisat.. Successful Treatment of Relapsing Chronic Eosinophilic Pneumonia With Mepolizumab: A Case Report.. Cureus. 2024$73$YR$$M$Y$$$20240805$$HP$US$US
241724321$24172432$1$I$$20240730$20240805$20240805$EXP$$JP-JNJFOC-20240809305$JOHNSON AND JOHNSON$$34$YR$A$$Y$$$20240805$$MD$JP$JP
241724331$24172433$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038643$AUROBINDO$$33$YR$$M$Y$$$20240805$$HP$CA$CA
241724341$24172434$1$I$$20240724$20240805$20240805$PER$$US-AstraZeneca-2024A169369$ASTRAZENECA$$$$$F$Y$$$20240805$$MD$US$
241724351$24172435$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038065$AUROBINDO$$80$YR$$F$Y$$$20240805$$MD$CA$CA
241724361$24172436$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038330$AUROBINDO$Farrell B, Galley E, Jeffs L, Howell P, McCarthy LM.. Kind of blurry: Deciphering clues  to prevent, investigate and manage prescribing cascades.. PLOS-One. 2022;17 (8):1- 20.$86$YR$$F$Y$$$20240805$$HP$CA$CA
241724371$24172437$1$I$$20240731$20240805$20240805$EXP$$US-JNJFOC-20240802167$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$US$US
241724381$24172438$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5858810$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241724392$24172439$2$F$20220101$20240904$20240805$20240913$EXP$$US-INSMED, INC.-2022-00693-US$INSMED$$$$$F$Y$47$KG$20240913$$CN$US$US
241724402$24172440$2$F$20240708$20240813$20240805$20240816$EXP$PT-INFARMED-T202407-470$PT-AMGEN-PRTSP2024153717$AMGEN$$79$YR$E$F$Y$$$20240816$$HP$PT$PT
241724412$24172441$2$F$20211123$20240806$20240805$20240813$EXP$$FR-SERVIER-S24009454$SERVIER$$$$$$Y$$$20240813$$MD$FR$FR
241724422$24172442$2$F$$20240807$20240805$20240808$EXP$$US-ABBVIE-5863740$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241724431$24172443$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5857517$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241724441$24172444$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2023-049156$AUROBINDO$Massicotte-Azarniouch D, Canney M, Sood MM, Hundemer GL.. Managing Hyperkalemia in the Modern Era: A Case-Based Approach.. Kidney International Reports.. 2023;8(7):1290-300$63$YR$$M$Y$$$20240805$$MD$CA$CA
241724451$24172445$1$I$$20240729$20240805$20240805$PER$$US-009507513-2407USA015189$MERCK$$$$$M$Y$69.841$KG$20240805$$CN$US$US
241724471$24172447$1$I$20240728$20240729$20240805$20240805$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001548$BLUEPRINT MEDICINES$$48$YR$A$F$Y$$$20240805$$CN$US$US
241724481$24172448$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038077$AUROBINDO$$69$YR$$F$Y$111$KG$20240805$$MD$CA$CA
241724492$24172449$2$F$$20240806$20240805$20240814$EXP$$US-GSK-US2024AMR094551$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
241724501$24172450$1$I$$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024153592$AMGEN$$$$A$F$Y$$$20240805$$CN$US$US
241724511$24172451$1$I$$20240723$20240805$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-120155$BRISTOL MYERS SQUIBB$Nojima H, Shimizu H, Hirota M, Obi S, Sato T, Fujino T, et al. A case of surgically removed simultaneous double cancer of hepatocellular carcinoma and mixed liver cancer. The 46th Meeting of Japanese Society for Research of Loco-Regional Cancer Therapy (Programs and Abstracts). 2024;(DP-50): 129-129.$78$YR$E$F$Y$$$20240805$$MD$JP$JP
241724521$24172452$1$I$$20240729$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120835$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240805$$CN$US$US
241724531$24172453$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-037877$AUROBINDO$$$$$F$Y$72.5$KG$20240805$$MD$CA$CA
241724541$24172454$1$I$$20240729$20240805$20240805$EXP$$US-CHEPLA-2024009795$CHEPLAPHARM$$78$YR$$F$Y$$$20240805$$CN$COUNTRY NOT SPECIFIED$US
241724551$24172455$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008949$APOTEX$$63$YR$$F$Y$$$20240805$$CN$CA$CA
241724561$24172456$1$I$$20240725$20240805$20240805$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003905$TERSERA THERAPEUTICS$$$$$$Y$$$20240805$$CN$AU$AU
241724571$24172457$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038567$AUROBINDO$$72$YR$$M$Y$$$20240805$$MD$CA$CA
241724581$24172458$1$I$20240101$20240726$20240805$20240805$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15162$IPSEN$$$$$F$Y$$$20240805$$HP$US$US
241724594$24172459$4$F$$20240828$20240805$20240903$EXP$$US-TAKEDA-2024TUS073611$TAKEDA$$$$$M$Y$$$20240903$$CN$US$US
241724601$24172460$1$I$$20240801$20240805$20240805$EXP$$US-TAKEDA-2024TUS077421$TAKEDA$$$$$M$Y$$$20240805$$HP$US$US
241724611$24172461$1$I$20240312$20240802$20240805$20240805$EXP$FR-AFSSAPS-TO2024001409$FR-JNJFOC-20240807562$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240805$$PH$FR$FR
241724621$24172462$1$I$$20240731$20240805$20240805$EXP$$US-ROCHE-10000045791$ROCHE$$31$YR$A$$Y$$$20240805$$HP$US$US
241724631$24172463$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038471$AUROBINDO$$55$YR$$F$Y$$$20240805$$HP$CA$CA
241724641$24172464$1$I$$20240731$20240805$20240805$EXP$$US-TAKEDA-2024TUS077732$TAKEDA$$$$$M$Y$$$20240805$$CN$US$US
241724651$24172465$1$I$20240731$20240801$20240805$20240805$EXP$$CN-ORGANON-O2408CHN000104$ORGANON$$25$YR$$M$Y$$$20240805$$HP$CN$CN
241724661$24172466$1$I$20240501$20240802$20240805$20240805$EXP$$PL-BEIGENE-BGN-2024-012096$BEIGENE$$$$$$Y$$$20240805$$MD$PL$PL
241724671$24172467$1$I$20240507$20240730$20240805$20240805$PER$$US-HALEON-2190260$Haleon PLC$$76$YR$$F$Y$$$20240805$$MD$US$US
241724681$24172468$1$I$$20240729$20240805$20240805$EXP$$JP-AMGEN-JPNSP2024151516$AMGEN$$$$E$F$Y$$$20240805$$MD$JP$JP
241724691$24172469$1$I$20240614$20240724$20240805$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-037612$AUROBINDO$$69$YR$$M$Y$60$KG$20240805$$MD$FR$FR
241724702$24172470$2$F$$20240813$20240805$20240819$PER$$US-AMGEN-USASP2024150443$AMGEN$$$$$F$Y$$$20240819$$CN$US$US
241724711$24172471$1$I$20240731$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024153257$AMGEN$$50$YR$A$F$Y$$$20240805$$CN$US$US
241724721$24172472$1$I$$20240730$20240805$20240805$PER$US-MLMSERVICE-20240726-PI139967-00174-3$US-RDY-SPO/USA/24/0011307$DR REDDYS$Surineni K, Le VY, Jones D. A Case of Oral-Buccal-Lingual Dyskinesia and Neuropsychiatric Symptoms After Prolonged Levetiracetam Exposure. Cureus. 2024;16(6):e62692. DOI:10.7759/cureus.62692.$86$YR$E$F$Y$$$20240805$$MD$US$US
241724733$24172473$3$F$$20240521$20240805$20240917$PER$$US-ENDO USA, INC.-2024-002369$ENDO$$$$$$Y$$$20240917$$CN$US$US
241724742$24172474$2$F$$20240528$20240805$20240917$PER$$US-ENDO USA, INC.-2024-002452$ENDO$$$$$F$Y$$$20240917$$CN$US$US
241724753$24172475$3$F$$20240521$20240805$20240916$PER$$US-ENDO USA, INC.-2024-002380$ENDO$$$$$M$Y$$$20240916$$CN$US$US
241724761$24172476$1$I$20180614$20240731$20240805$20240805$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011733$JAZZ$$74$YR$$F$Y$$$20240805$$HP$US$US
241724771$24172477$1$I$$20230929$20240805$20240805$EXP$$US-AstraZeneca-2023A187716$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241724781$24172478$1$I$20240621$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174667$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241724791$24172479$1$I$$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174343$ASTRAZENECA$$$$$M$Y$$$20240805$$MD$US$
241724801$24172480$1$I$20240714$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174432$ASTRAZENECA$$24177$DY$$M$Y$$$20240805$$CN$US$
241724811$24172481$1$I$$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019690$ELI LILLY AND CO$$$$$M$Y$$$20240805$$CN$US$US
241724821$24172482$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001007$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240805$$CN$US$US
241724832$24172483$2$F$$20231218$20240805$20240916$PER$$US-ENDO USA, INC.-2023-006335$ENDO$$$$$M$Y$$$20240916$$CN$US$US
241724841$24172484$1$I$$20240130$20240805$20240805$PER$$US-ENDO USA, INC.-2023-004735$ENDO$$$$$M$Y$$$20240805$$CN$US$US
241724851$24172485$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038628$AUROBINDO$$32$YR$$F$Y$102$KG$20240805$$HP$CA$CA
241724863$24172486$3$F$20240716$20240725$20240805$20240821$EXP$$CN-BEH-2024176507$CSL BEHRING$$82$YR$E$M$Y$55$KG$20240821$$CN$CN$CN
241724881$24172488$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038453$AUROBINDO$$59$YR$$F$Y$65$KG$20240805$$HP$CA$CA
241724891$24172489$1$I$$20231219$20240805$20240805$PER$$US-ENDO USA, INC.-2024-000062$ENDO$$$$$$Y$$$20240805$$CN$US$US
241724902$24172490$2$F$$20231219$20240805$20240916$PER$$US-ENDO USA, INC.-2024-000153$ENDO$$$$$M$Y$$$20240916$$CN$US$US
241724911$24172491$1$I$20240728$20240730$20240805$20240805$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011609$JAZZ$$4$YR$$M$Y$15$KG$20240805$$CN$US$US
241724921$24172492$1$I$20240609$20240802$20240805$20240805$EXP$$CA-ABBVIE-5865896$ABBVIE$$91$YR$$M$Y$$$20240805$$CN$CA$CA
241724931$24172493$1$I$$20240726$20240805$20240805$EXP$$US-GSK-US2024094121$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241724941$24172494$1$I$20240311$20240729$20240805$20240805$EXP$$CN-TAKEDA-2024TUS077263$TAKEDA$$48$YR$$F$Y$60$KG$20240805$$HP$CN$CN
241724951$24172495$1$I$$20240731$20240805$20240805$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-105619$REGENERON$$$$$F$Y$$$20240805$$CN$US$US
241724961$24172496$1$I$$20240724$20240805$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-037979$AUROBINDO$Elwood KF, Warner EJ, Chang JS, Kopplin LJ. Aspergillus Endophthalmitis Secondary to Infectious Scleritis: Utility of Diagnostic PCR. Retinal cases + brief reports. 2024$76$YR$$M$Y$$$20240805$$MD$US$US
241724971$24172497$1$I$$20240722$20240805$20240805$PER$$US-RDY-LIT/USA/24/0011023$DR REDDYS$Grissett B, Sosa-Pagan M, Iqbal QZ. Topiramate causing elevation of urinary cortisol assay. Journal of the Endocrine Society. 2022;6(1): A66-A67. doi:10.1210/jendso/bvac150.137.$69$YR$E$F$Y$105$KG$20240801$$MD$US$US
241724981$24172498$1$I$$20240729$20240805$20240805$EXP$$JP-GSK-JP2020JPN263114$GLAXOSMITHKLINE$Nemoto C, Shimoda Y, Kobayashi E, Sato Y, Ohyama M, Mizukawa Y.. A case of Hashimoto?s disease developed in the recovery phase of drug-induced hypersensitivity syndrome with recurrent eruption and persistent reactivation of virus. Japanese Journal of Clinical Dermatology. 2024;78:550-556$$$$$Y$$$20240805$$MD$JP$JP
241724991$24172499$1$I$$20240729$20240805$20240805$EXP$$JP-GSK-JP2020JPN263115$GLAXOSMITHKLINE$Nemoto C, Shimoda Y, Kobayashi E, Sato Y, Ohyama M, Mizukawa Y.. A case of Hashimoto?s disease developed in the recovery phase of drug-induced hypersensitivity syndrome with recurrent eruption and persistent reactivation of virus. Japanese Journal of Clinical Dermatology. 2024;78:550-556$$$$$Y$$$20240805$$MD$JP$JP
241725001$24172500$1$I$$20240729$20240805$20240805$EXP$$JP-GSK-JP2020JPN263113$GLAXOSMITHKLINE$Nemoto C, Shimoda Y, Kobayashi E, Sato Y, Ohyama M, Mizukawa Y.. A case of Hashimoto?s disease developed in the recovery phase of drug-induced hypersensitivity syndrome with recurrent eruption and persistent reactivation of virus. Japanese Journal of Clinical Dermatology. 2024;78:550-556$$$$$Y$$$20240805$$MD$JP$JP
241725011$24172501$1$I$$20240729$20240805$20240805$EXP$$JP-GSK-JP2020JPN263116$GLAXOSMITHKLINE$Nemoto C, Shimoda Y, Kobayashi E, Sato Y, Ohyama M, Mizukawa Y.. A case of Hashimoto?s disease developed in the recovery phase of drug-induced hypersensitivity syndrome with recurrent eruption and persistent reactivation of virus. Japanese Journal of Clinical Dermatology. 2024;78:550-556$$$$$Y$$$20240805$$MD$JP$JP
241725022$24172502$2$F$$20240731$20240805$20240809$PER$$US-ABBVIE-5863983$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241725031$24172503$1$I$$20240801$20240805$20240805$PER$$US-ABBVIE-5864738$ABBVIE$$$$$$Y$$$20240805$$MD$US$US
241725041$24172504$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122871$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240805$$HP$US$US
241725051$24172505$1$I$20240501$20240729$20240805$20240805$EXP$$CO-ABBVIE-5862775$ABBVIE$$67$YR$$M$Y$56$KG$20240805$$CN$CO$CO
241725061$24172506$1$I$$20240729$20240805$20240805$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001546$BLUEPRINT MEDICINES$$$$$M$Y$$$20240805$$CN$US$US
241725071$24172507$1$I$20230101$20230125$20240805$20240805$EXP$$KW-BIOVITRUM-2023KW01787$BIOVITRUM$$5$MON$$M$Y$$$20240805$$CN$KW$KW
241725081$24172508$1$I$$20230428$20240805$20240805$EXP$$NL-BIOVITRUM-2023-NL-010349$BIOVITRUM$$$$I$F$Y$4.8$KG$20240805$$HP$NL$NL
241725091$24172509$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008972$APOTEX$$67$YR$$M$Y$$$20240805$$CN$CA$CA
241725101$24172510$1$I$$20240725$20240805$20240805$EXP$$GB-AUROBINDO-AUR-APL-2024-037583$AUROBINDO$$$$$M$Y$$$20240805$$CN$GB$GB
241725112$24172511$2$F$$20240731$20240805$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-038048$AUROBINDO$Ara?jo M, Santos S, Viana J, Marques S. Metformin-associated lactic acidosis (MALA) - 4-year series at a university hospital. Congresses of the Portuguese Society of Internal Medicine. 2024;212$$$E$F$Y$$$20240808$$MD$PT$PT
241725121$24172512$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-037968$AUROBINDO$Boily P. Adrenoleukodystrophy and Secondary Hyperaldosteronism; A Clinical Demonstration of the Zona Glomerulosa Persistence. Journal of the Endocrine Society. 2021;5:A112-A113$31$YR$$M$Y$$$20240805$$HP$CA$CA
241725131$24172513$1$I$20240101$20240729$20240805$20240805$EXP$$US-SA-2024SA173611$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240805$$CN$US$US
241725152$24172515$2$F$$20240809$20240805$20240819$PER$$US-AMGEN-USASP2024152390$AMGEN$$$$$F$Y$$$20240818$$CN$US$US
241725161$24172516$1$I$$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024154159$AMGEN$$$$$$Y$$$20240805$$PH$US$US
241725171$24172517$1$I$$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174799$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241725181$24172518$1$I$20220625$20220715$20240805$20240805$EXP$$US-AstraZeneca-2022A260686$ASTRAZENECA$$22483$DY$$F$Y$$$20240805$$CN$US$
241725191$24172519$1$I$$20240731$20240805$20240805$PER$$US-AstraZeneca-2024A174670$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241725201$24172520$1$I$$20220228$20240805$20240805$EXP$$US-AstraZeneca-2022A093082$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241725211$24172521$1$I$$20230831$20240805$20240805$EXP$$RO-AstraZeneca-2023A200057$ASTRAZENECA$$86$YR$$F$Y$$$20240805$$CN$RO$
241725225$24172522$5$F$20210701$20240820$20240805$20240830$EXP$$PT-AUROBINDO-AUR-APL-2024-037874$AUROBINDO$Oliveira C, Queiroz L, Almeida M, Fernandes R, Caeiro C. Hepatoxicidade grave com ribociclib, a proposito de um caso desafiante [Challenging case of severe hepatotoxicity with ribociclib].( Severe hepatotoxicity with ribociclib, regarding a challenging case). REVISTA PORTUGUESA DE ONCOLOGIA(BRAZILIAN JOURNAL OF ONCOLOGY.). 2024;7 (N1-2):46-8$45$YR$$F$Y$$$20240830$$MD$PT$PT
241725231$24172523$1$I$$20240801$20240805$20240805$EXP$$US-ABBVIE-5865254$ABBVIE$$$$$F$Y$$$20240805$$HP$US$US
241725241$24172524$1$I$20240617$20240725$20240805$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-037664$AUROBINDO$$14$YR$$F$Y$56$KG$20240805$$CN$FR$FR
241725251$24172525$1$I$$20240801$20240805$20240805$PER$$US-ABBVIE-5865375$ABBVIE$$$$$F$Y$$$20240805$$HP$US$US
241725261$24172526$1$I$$20240725$20240805$20240805$EXP$$GB-AUROBINDO-AUR-APL-2024-037680$AUROBINDO$$$$$M$Y$$$20240805$$CN$GB$GB
241725271$24172527$1$I$$20240724$20240805$20240805$EXP$$PT-AUROBINDO-AUR-APL-2024-037640$AUROBINDO$$71$YR$$F$Y$$$20240805$$MD$PT$PT
241725282$24172528$2$F$20240709$20240807$20240805$20240809$EXP$$US-ARGENX-2024-ARGX-US006213$ARGENX BVBA$$$$$$Y$$$20240809$$HP$US$US
241725291$24172529$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001521$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240805$$CN$US$US
241725301$24172530$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000967$ELI LILLY AND CO$$$$$F$Y$$$20240805$$HP$US$US
241725311$24172531$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001786$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240805$$CN$US$US
241725321$24172532$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003574$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241725331$24172533$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000048234$ROCHE$$23$YR$A$M$Y$$$20240805$$CN$US$US
241725341$24172534$1$I$20240706$20240801$20240805$20240805$EXP$$TW-TAKEDA-2024TUS077499$TAKEDA$$39$YR$$F$Y$$$20240805$$CN$TW$TW
241725351$24172535$1$I$20240701$20240729$20240805$20240805$EXP$$US-ROCHE-10000042289$ROCHE$$21$YR$A$F$Y$$$20240805$$CN$US$US
241725361$24172536$1$I$$20240730$20240805$20240805$EXP$$TR-TAKEDA-2024TUS076935$TAKEDA$$$$$M$Y$$$20240805$$PH$TR$TR
241725371$24172537$1$I$20240704$20240729$20240805$20240805$EXP$$FI-AMGEN-FINSP2024150392$AMGEN$$73$YR$E$F$Y$$$20240805$$MD$FI$FI
241725382$24172538$2$F$$20240829$20240805$20240904$EXP$$MX-TAKEDA-2024TUS077620$TAKEDA$$$$$M$Y$$$20240904$$CN$MX$MX
241725391$24172539$1$I$20240627$20240724$20240805$20240805$EXP$$JP-ROCHE-10000041956$ROCHE$$58$YR$A$F$Y$62.9$KG$20240805$$PH$JP$JP
241725401$24172540$1$I$$20240605$20240805$20240805$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12834$ALKEM$Berger TM, Cook MJ, O^Marcaigh AS, et al.. Acute pancreatitis in a 12-year-old girl after an erythromycin overdose. Pediatrics. 1992;90:624 -626$12$YR$$F$Y$$$20240805$$HP$US$US
241725421$24172542$1$I$$20240730$20240805$20240805$PER$$US-TAKEDA-2024TUS076802$TAKEDA$$81$YR$$F$Y$$$20240805$$CN$US$US
241725431$24172543$1$I$20240101$20240729$20240805$20240805$EXP$$CA-UCBSA-2024038361$UCB$$$$$F$Y$$$20240805$$CN$CA$CA
241725441$24172544$1$I$$20240531$20240805$20240805$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12410$ALKEM$Orman ES, Conjeevaram HS, Vuppalanchi R, Freston JW, Rochon J, Kleiner DE, Hayashi PH. Clinical and histopathologic features of fluoroquinolone-induced liver injury. Clinical Gastroenterology and Hepatology. 2011;9:517-523$45$YR$$M$Y$$$20240805$$HP$US$US
241725451$24172545$1$I$$20240528$20240805$20240805$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12016$ALKEM$Haseeb-Ul-Rasool M, Elhawary A, Saha U, Sethi A, Swaminathan G, Abosheaishaa H. Resolution of severe gastroparesis induced by parasympathetic surge following facial trauma: a case report. Journal of Medical Case Reports.. 2024;18:248$46$YR$$M$Y$$$20240805$$HP$US$US
241725461$24172546$1$I$20240229$20240731$20240805$20240805$EXP$$IT-AMGEN-ITANI2024152272$AMGEN$$53$YR$A$M$Y$77$KG$20240805$$HP$IT$IT
241725471$24172547$1$I$$20240701$20240805$20240805$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14243$ALKEM$Selvan H, Samantaray PP, Rana M.. Bilateral Aggressive Mooren Ulcer in the Setting of Bilateral Pterygia and Pregnancy: A Unique Case. Cornea. 2024;00(00):1-5$39$YR$$F$Y$$$20240805$$MD$GB$GB
241725482$24172548$2$F$$20240917$20240805$20240921$EXP$$AU-ROCHE-10000042756$ROCHE$$59$YR$A$M$Y$$$20240921$$CN$AU$AU
241725491$24172549$1$I$20220720$20220721$20240805$20240805$EXP$$US-AstraZeneca-2022A264480$ASTRAZENECA$$79$YR$$F$Y$$$20240805$$CN$US$
241725511$24172551$1$I$$20240802$20240805$20240805$EXP$$US-TAKEDA-2024TUS077892$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
241725522$24172552$2$F$20240722$20240821$20240805$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120273$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240823$$CN$US$US
241725532$24172553$2$F$$20240729$20240805$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-120316$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240809$$PH$JP$JP
241725541$24172554$1$I$20240101$20240726$20240805$20240805$30DAY$$US-GSK-US2024094203$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240805$$CN$US$US
241725551$24172555$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152806$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240805$$MD$US$US
241725561$24172556$1$I$20231201$20240801$20240805$20240805$PER$$US-ROCHE-10000047731$ROCHE$$$$$$Y$$$20240805$$PH$US$US
241725571$24172557$1$I$20240725$20240726$20240805$20240805$EXP$$US-BEH-2024176565$CSL BEHRING$$44$YR$A$F$Y$63$KG$20240805$$PH$US$US
241725582$24172558$2$F$$20240903$20240805$20240910$EXP$$JP-ROCHE-10000044773$ROCHE$$$$C$M$Y$$$20240910$$PH$JP$JP
241725591$24172559$1$I$$20240730$20240805$20240805$EXP$$IE-GILEAD-2024-0682514$GILEAD$$$$$$Y$$$20240805$$CN$IE$IE
241725601$24172560$1$I$20240101$20240730$20240805$20240805$EXP$$US-ABBVIE-5862241$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241725611$24172561$1$I$20240701$20240725$20240805$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-037677$AUROBINDO$$46$YR$$M$Y$$$20240805$$MD$FR$FR
241725642$24172564$2$F$$20240821$20240805$20240823$PER$$US-ALXN-202407USA002099US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241725651$24172565$1$I$$20240725$20240805$20240805$EXP$$GB-AUROBINDO-AUR-APL-2024-037597$AUROBINDO$$65$YR$$M$Y$83$KG$20240805$$CN$GB$GB
241725661$24172566$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06940$LUPIN$$$$$$Y$$$20240805$$CN$US$US
241725672$24172567$2$F$$20240820$20240805$20240829$EXP$$ZA-TEVA-VS-3229114$TEVA$Liebenberg J, John TJ, Khalfey H, D^Andrea I, Kyriakakis C. Subacute dual stent thromboses in a COVID-19-positive patient. Cardiovasc-J-S-Afr 2022; 33 (6): 329-332.; Liebenberg J, John TJ, Khalfey H, D^Andrea I, Kyriakakis C. Subacute dual stent thromboses in a COVID-19-positive patient. Cardiovasc-J-S-Afr 2022; 33 (6): 329-332.$71$YR$$M$Y$$$20240829$$HP$ZA$ZA
241725681$24172568$1$I$20240729$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024151793$AMGEN$$$$$$Y$$$20240805$$PH$US$US
241725691$24172569$1$I$$20240728$20240805$20240805$EXP$$FR-AMGEN-FRASP2024153280$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Hepatology. 2024;1-13$$$$$Y$$$20240805$$MD$FR$FR
241725701$24172570$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153026$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240805$$MD$US$US
241725711$24172571$1$I$20240523$20240726$20240805$20240805$EXP$$NL-PERRIGO-24NL007061$PERRIGO$$52$YR$$F$Y$$$20240805$$CN$NL$NL
241725722$24172572$2$F$$20240903$20240805$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123009$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240906$$CN$US$US
241725731$24172573$1$I$20230120$20240726$20240805$20240805$EXP$$AU-TAKEDA-2023TUS063204$TAKEDA$$65$YR$$M$Y$$$20240805$$CN$AU$AU
241725741$24172574$1$I$$20240722$20240805$20240805$EXP$$US-UCBSA-2024037230$UCB$$$$$F$Y$106.58$KG$20240805$$HP$US$US
241725751$24172575$1$I$20240723$20240725$20240805$20240805$EXP$$GB-AUROBINDO-AUR-APL-2024-037576$AUROBINDO$$$$$$Y$93$KG$20240805$$CN$GB$GB
241725761$24172576$1$I$$20240725$20240805$20240805$EXP$$IN-ROCHE-10000039900$ROCHE$$$$A$M$Y$$$20240805$$MD$IN$IN
241725771$24172577$1$I$20240730$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000349$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240805$$CN$US$US
241725781$24172578$1$I$20220101$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001462$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240805$$CN$US$US
241725791$24172579$1$I$20240228$20240725$20240805$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-037690$AUROBINDO$$80$YR$$F$Y$$$20240805$$HP$FR$FR
241725801$24172580$1$I$$20240731$20240805$20240805$EXP$$CA-TAKEDA-2024TUS012517$TAKEDA$$$$$F$Y$$$20240805$$CN$CA$CA
241725811$24172581$1$I$$20240729$20240805$20240805$EXP$$US-AMGEN-USASP2024150239$AMGEN$$74$YR$E$M$Y$77.4$KG$20240805$$PH$US$US
241725823$24172582$3$F$$20240916$20240805$20240923$EXP$$CA-TAKEDA-2024TUS076546$TAKEDA$$$$$F$Y$$$20240923$$CN$CA$CA
241725831$24172583$1$I$$20240726$20240805$20240805$EXP$$BR-TAKEDA-2024TUS077756$TAKEDA$$$$$M$Y$$$20240805$$CN$BR$BR
241725841$24172584$1$I$$20220111$20240805$20240805$EXP$$US-AstraZeneca-2022A018580$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241725851$24172585$1$I$$20240726$20240805$20240805$EXP$$CA-APOTEX-2024AP008906$APOTEX$$70$YR$$F$Y$65$KG$20240805$$MD$CA$CA
241725862$24172586$2$F$$20240805$20240805$20240819$PER$$US-AstraZeneca-2024A174054$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
241725871$24172587$1$I$$20211111$20240805$20240805$EXP$$US-AstraZeneca-2021A805637$ASTRAZENECA$$$$$F$Y$48.5$KG$20240805$$CN$US$
241725881$24172588$1$I$$20230825$20240805$20240805$EXP$$US-AstraZeneca-2023A195236$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241725891$24172589$1$I$20211201$20220125$20240805$20240805$EXP$$US-AstraZeneca-2021A910834$ASTRAZENECA$$750$MON$$F$Y$$$20240805$$CN$US$
241725901$24172590$1$I$20240703$20240729$20240805$20240805$EXP$$CA-TAKEDA-2024TUS076724$TAKEDA$$58$YR$$M$Y$$$20240805$$MD$CA$CA
241725912$24172591$2$F$20190712$20240809$20240805$20240815$EXP$$CO-UCBSA-2024038995$UCB$$73$YR$$F$Y$$$20240815$$CN$CO$CO
241725921$24172592$1$I$20240101$20240801$20240805$20240805$EXP$$US-ORGANON-O2408USA000189$ORGANON$$$$$F$Y$$$20240805$$CN$US$US
241725931$24172593$1$I$20230101$20240729$20240805$20240805$EXP$$GB-LEO Pharma-372470$LEO PHARM$$42$YR$$F$Y$$$20240805$$CN$GB$GB
241725941$24172594$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5858339$ABBVIE$$$$$$Y$$$20240805$$HP$US$US
241725951$24172595$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000048479$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$56$YR$A$F$Y$$$20240805$$HP$JP$JP
241725961$24172596$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153333$AMGEN$Cowen E. W.; Tan I. J.; Ferrada M. A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241725971$24172597$1$I$20240101$20240731$20240805$20240805$EXP$$US-UCBSA-2024023707$UCB$$$$$F$Y$$$20240805$$CN$US$US
241725981$24172598$1$I$20240611$20240731$20240805$20240805$EXP$$US-ABBVIE-5862811$ABBVIE$$71$YR$$F$Y$$$20240805$$MD$US$US
241725991$24172599$1$I$20240601$20240802$20240805$20240805$EXP$IT-MINISAL02-996071$IT-ROCHE-10000048015$ROCHE$$42$YR$A$F$Y$$$20240805$$MD$IT$IT
241726001$24172600$1$I$20240701$20240730$20240805$20240805$EXP$$CA-JNJFOC-20240725450$JOHNSON AND JOHNSON$$44$YR$A$F$Y$55$KG$20240805$$HP$CA$CA
241726012$24172601$2$F$20240611$20240801$20240805$20240810$EXP$IT-MINISAL02-993393$IT-ABBVIE-5824691$ABBVIE$$44$YR$$M$Y$$$20240810$$MD$IT$IT
241726021$24172602$1$I$20180524$20240729$20240805$20240805$EXP$$CA-TAKEDA-2018TUS020160$TAKEDA$$59$YR$$F$Y$$$20240805$$CN$CA$CA
241726032$24172603$2$F$$20240724$20240805$20240805$PER$$US-ROCHE-10000036954$ROCHE$$$$$F$Y$$$20240805$$CN$US$US
241726041$24172604$1$I$20240715$20240731$20240805$20240805$EXP$$AR-TAKEDA-2024TUS077301$TAKEDA$$69$YR$$M$Y$$$20240805$$CN$AR$AR
241726051$24172605$1$I$$20240730$20240805$20240805$PER$$US-TAKEDA-2024TUS076865$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
241726071$24172607$1$I$$20230403$20240805$20240805$EXP$$US-AstraZeneca-2023A078467$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241726081$24172608$1$I$$20201211$20240805$20240805$EXP$$MX-AstraZeneca-2020SF66520$ASTRAZENECA$$73$YR$$M$Y$$$20240805$$CN$MX$
241726092$24172609$2$F$$20240802$20240805$20240808$EXP$$JP-AstraZeneca-2024A175064$ASTRAZENECA$Hattori M, et al. EP-1454 A case of metastases to uterus from breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society 2024;541.$63$YR$$F$Y$$$20240808$$MD$JP$
241726101$24172610$1$I$$20240802$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2024US070352$SANDOZ$$54$YR$$F$Y$$$20240805$$HP$US$US
241726111$24172611$1$I$20210901$20240725$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121502$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240805$$MD$US$US
241726121$24172612$1$I$$20201125$20240805$20240805$EXP$$US-AstraZeneca-2020SF59044$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241726131$24172613$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001394$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240805$$CN$US$US
241726141$24172614$1$I$20240701$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001208$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240805$$CN$US$US
241726151$24172615$1$I$$20240802$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408002017$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240805$$CN$US$US
241726162$24172616$2$F$$20240805$20240805$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001168$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240816$$CN$US$US
241726171$24172617$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001453$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240805$$CN$US$US
241726181$24172618$1$I$$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000039$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240805$$CN$US$US
241726191$24172619$1$I$$20240731$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122020$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240805$$CN$US$US
241726201$24172620$1$I$20240101$20240526$20240805$20240805$EXP$$GB-TEVA-VS-3220220$TEVA$$$$A$F$Y$$$20240805$$CN$GB$GB
241726212$24172621$2$F$$20240820$20240805$20240827$PER$$JP-RIGEL-20240700112$RIGEL PHARMACEUTICALS$$$$$$Y$$$20240827$$PH$JP$JP
241726221$24172622$1$I$20160101$20240801$20240805$20240805$EXP$$CO-SANDOZ INC.-SDZ2024CO070266$SANDOZ$$$$$F$Y$$$20240805$$CN$CO$CO
241726232$24172623$2$F$$20240902$20240805$20240913$30DAY$$GB-JNJFOC-20240800978$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$GB$GB
241726241$24172624$1$I$20240411$20240731$20240805$20240805$EXP$$US-TAKEDA-2024TUS000333$TAKEDA$$69$YR$$M$Y$$$20240805$$CN$US$US
241726251$24172625$1$I$20221001$20240803$20240805$20240805$EXP$$GB-SANDOZ INC.-SDZ2024GB070295$SANDOZ$$$$$F$Y$$$20240805$$HP$GB$GB
241726261$24172626$1$I$$20240802$20240805$20240805$PER$$US-HALEON-2190368$Haleon PLC$$66$YR$$F$Y$$$20240805$$CN$US$US
241726271$24172627$1$I$$20240731$20240805$20240805$PER$$US-ABBVIE-5863985$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241726281$24172628$1$I$$20240731$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2024US070057$SANDOZ$$$$$M$Y$$$20240805$$MD$US$US
241726291$24172629$1$I$$20240729$20240805$20240805$EXP$$US-GSK-US2024094860$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241726301$24172630$1$I$20240522$20240729$20240805$20240805$30DAY$$US-GSK-US2024094811$GLAXOSMITHKLINE$$$$$F$Y$47.63$KG$20240805$$CN$US$US
241726312$24172631$2$F$20240101$20240807$20240805$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043716$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240813$$HP$US$US
241726321$24172632$1$I$$20240731$20240805$20240805$EXP$$US-TAKEDA-2024TUS077380$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
241726331$24172633$1$I$$20240801$20240805$20240805$EXP$$CA-TAKEDA-2024TUS077952$TAKEDA$$$$$M$Y$$$20240805$$CN$CA$CA
241726341$24172634$1$I$$20240731$20240805$20240805$EXP$$US-ABBVIE-5863826$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241726353$24172635$3$F$$20240926$20240805$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122971$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240927$$CN$US$US
241726361$24172636$1$I$20240731$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152348$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
241726371$24172637$1$I$$20240730$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121654$BRISTOL MYERS SQUIBB$$$$A$F$Y$$$20240805$$HP$US$US
241726391$24172639$1$I$$20240730$20240805$20240805$PER$$US-HALEON-2189943$Haleon PLC$$$$$$Y$$$20240805$$CN$US$US
241726401$24172640$1$I$20240801$20240804$20240804$20240804$DIR$712854$$FDA-CTU$$78$YR$$F$N$72.9$KG$20240804$N$CN$US$
241726411$24172641$1$I$20240325$20240804$20240804$20240804$DIR$712840$$FDA-CTU$$38$YR$$F$N$71$KG$20240804$N$CN$SI$
241726422$24172642$2$F$$20240814$20240805$20240902$PER$$AU-TOLMAR, INC.-24AU051064$TOLMAR$$$$$M$Y$$$20240902$$CN$AU$AU
241726441$24172644$1$I$20240731$20240804$20240804$20240804$DIR$712843$$FDA-CTU$$59$YR$$F$N$96.3$KG$20240804$N$CN$US$
241726451$24172645$1$I$20210801$20240725$20240805$20240805$EXP$$CN-ROCHE-10000037520$ROCHE$Tuo Z, Yang H, Zhang B, Zhang X, Xia Y, Jin L. One case of anti-glomerular basement membrane nephritis with positive antineutrophil cytoplasmic antibody and lung infection treated with rituximab and literature review. Chinese Journal of Antituberculosis. 2024-Jun;46 (SUPP1):17-20.$66$YR$E$F$Y$$$20240805$$HP$CN$CN
241726461$24172646$1$I$$20240723$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117713$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$90.72$KG$20240805$$CN$US$US
241726471$24172647$1$I$$20240731$20240805$20240805$PER$$US-BEH-2024176714$CSL BEHRING$$43$YR$A$M$Y$$$20240805$$CN$US$US
241726481$24172648$1$I$20240728$20240730$20240805$20240805$30DAY$$US-GSK-US2024095307$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240805$$CN$US$US
241726491$24172649$1$I$20240522$20240522$20240805$20240805$PER$$US-AJANTA-2024AJA00100$AJANTA PHARMA$$$$$F$Y$$$20240805$$CN$US$US
241726511$24172651$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5858341$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241726521$24172652$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008948$APOTEX$$62$YR$$M$Y$$$20240805$$CN$CA$CA
241726531$24172653$1$I$20230427$20230428$20240805$20240805$EXP$$CO-BIOVITRUM-2023-CO-010500$BIOVITRUM$$292$DY$$F$Y$$$20240805$$CN$CO$CO
241726541$24172654$1$I$20240718$20240722$20240805$20240805$EXP$DE-CADRBFARM-2024329432$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-16493$ALKEM$$63$YR$$F$Y$$$20240805$$MD$DE$DE
241726551$24172655$1$I$$20240802$20240805$20240805$PER$$US-ROCHE-10000048882$ROCHE$$61$YR$A$F$Y$$$20240805$$MD$US$US
241726561$24172656$1$I$20220624$20240731$20240805$20240805$EXP$$CN-Orion Corporation ORION PHARMA-ENT 2024-0035$ORION$$77$YR$E$M$Y$65$KG$20240805$$HP$CN$
241726571$24172657$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000260$ELI LILLY AND CO$$$$A$F$Y$$$20240805$$CN$US$US
241726581$24172658$1$I$20240717$20240731$20240805$20240805$EXP$$CN-SA-2024SA229434$SANOFI AVENTIS$$41$YR$A$F$Y$61$KG$20240805$$HP$CN$CN
241726601$24172660$1$I$20240701$20240730$20240805$20240805$PER$$US-TAKEDA-2024TUS077188$TAKEDA$$41$YR$$F$Y$$$20240805$$CN$US$US
241726612$24172661$2$F$20240703$20240828$20240805$20240901$PER$$US-JNJFOC-20240782396$JOHNSON AND JOHNSON$$$$$F$Y$$$20240901$$HP$US$US
241726621$24172662$1$I$20240101$20240802$20240805$20240805$EXP$$NVSJ2024JP003425$NOVARTIS$$16$YR$$F$Y$$$20240805$$MD$JP$JP
241726631$24172663$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000048482$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$35$YR$A$F$Y$$$20240805$$HP$JP$JP
241726641$24172664$1$I$20240101$20240729$20240805$20240805$EXP$$NVSJ2024JP001754$NOVARTIS$$$$A$F$Y$$$20240805$$MD$JP$JP
241726651$24172665$1$I$20231201$20240729$20240805$20240805$EXP$$NVSC2024FR158291$NOVARTIS$$74$YR$$$Y$$$20240805$$CN$FR$FR
241726661$24172666$1$I$$20240801$20240805$20240805$EXP$$US-AstraZeneca-2024A175659$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241726672$24172667$2$F$$20240828$20240805$20240910$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07513$LUPIN$$$$$$Y$$$20240910$$PH$US$US
241726681$24172668$1$I$$20240801$20240805$20240805$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-105749$REGENERON$$$$$F$Y$$$20240805$$CN$US$US
241726691$24172669$1$I$20240529$20240730$20240805$20240805$EXP$FR-AFSSAPS-BS2024000431$FR-TEVA-VS-3227858$TEVA$$85$YR$$F$Y$$$20240805$$PH$FR$FR
241726701$24172670$1$I$$20240725$20240805$20240805$PER$$US-ABBVIE-5856808$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241726711$24172671$1$I$$20240730$20240805$20240805$PER$$US-ABBVIE-5862206$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241726721$24172672$1$I$$20230602$20240805$20240805$EXP$$US-AstraZeneca-2023A129418$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241726731$24172673$1$I$$20230221$20240805$20240805$EXP$$US-AstraZeneca-2023A005096$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241726741$24172674$1$I$$20220701$20240805$20240805$EXP$$US-AstraZeneca-2022A243843$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241726761$24172676$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000048490$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$78$YR$E$M$Y$$$20240805$$HP$JP$JP
241726771$24172677$1$I$$20240725$20240805$20240805$EXP$$CH-ROCHE-10000048514$ROCHE$$70$YR$E$$Y$$$20240805$$HP$CH$CH
241726781$24172678$1$I$20240730$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152333$AMGEN$$75$YR$E$F$Y$$$20240805$$CN$US$US
241726791$24172679$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5858560$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241726802$24172680$2$F$$20240807$20240805$20240814$EXP$$US-ZENPEP LLC-2024AIMT01146$AIMMUNE$$$$$$Y$$$20240814$$CN$US$US
241726811$24172681$1$I$$20240731$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2024US070246$SANDOZ$$$$$F$Y$$$20240805$$MD$US$US
241726831$24172683$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038480$AUROBINDO$$53$YR$$F$Y$$$20240805$$HP$CA$CA
241726841$24172684$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001373$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240805$$CN$US$US
241726852$24172685$2$F$$20240806$20240805$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002151$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240807$$CN$US$US
241726861$24172686$1$I$20240730$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000128$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240805$$CN$US$US
241726872$24172687$2$F$20230101$20240801$20240805$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003553$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
241726882$24172688$2$F$$20240813$20240805$20240816$EXP$GR-SEATTLE GENETICS-2023SGN12065$GR-ROCHE-10000047964$ROCHE$$$$$F$Y$$$20240816$$MD$GR$GR
241726892$24172689$2$F$20240709$20240806$20240805$20240808$EXP$$CA-UCBSA-2024038880$UCB$$59$YR$$F$Y$$$20240808$$CN$CA$CA
241726901$24172690$1$I$20240731$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001229$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240805$$CN$US$US
241726911$24172691$1$I$20240801$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024153620$AMGEN$$$$$M$Y$$$20240805$$CN$US$US
241726923$24172692$3$F$20240720$20240829$20240805$20240830$PER$$US-JNJFOC-20240764099$JOHNSON AND JOHNSON$$4$YR$C$F$Y$$$20240830$$CN$US$US
241726931$24172693$1$I$$20240720$20240805$20240805$PER$$US-JNJFOC-20240766987$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241726941$24172694$1$I$20070618$20240724$20240805$20240805$EXP$DE-002147023-GXKR2007DE06957$DE-ROCHE-10000035717$ROCHE$$58$YR$A$F$Y$60$KG$20240805$$MD$DE$DE
241726952$24172695$2$F$$20240801$20240805$20240821$PER$$US-TEVA-VS-3229211$TEVA$$$$$$Y$$$20240821$$CN$US$US
241726961$24172696$1$I$$20240731$20240805$20240805$PER$$US-ALXN-202407USA002207US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$HP$US$US
241726971$24172697$1$I$$20240802$20240805$20240805$PER$$US-HALEON-2190338$Haleon PLC$$$$$F$Y$$$20240805$$CN$US$US
241726981$24172698$1$I$$20240729$20240805$20240805$EXP$$CH-ROCHE-10000045080$ROCHE$$$$$M$Y$$$20240805$$MD$CH$CH
241726991$24172699$1$I$20240101$20240726$20240805$20240805$EXP$$US-TEVA-VS-3176881$TEVA$$37$YR$$M$Y$$$20240805$$CN$US$US
241727001$24172700$1$I$$20210316$20240805$20240805$EXP$$US-AstraZeneca-2021A164068$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241727011$24172701$1$I$20210406$20210520$20240805$20240805$EXP$$US-AstraZeneca-2021A459007$ASTRAZENECA$$17934$DY$$F$Y$$$20240805$$CN$US$
241727021$24172702$1$I$$20210416$20240805$20240805$EXP$$US-AstraZeneca-2021A325128$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241727032$24172703$2$F$$20240730$20240805$20240808$EXP$$TR-ROCHE-10000037296$ROCHE$Erdogan C, Kilinc M, Sahin B, Sungurtekin H. Secondary Infection and Co-infection in COVID-19 Patients Receiving Tocilizumab. Turkish Journal of Intensive Care. 2024-Jun;22 (2):110-5. doi:10.4274/tybd.galenos.2023.59354.$$$$$Y$$$20240808$$HP$TR$TR
241727041$24172704$1$I$$20240731$20240805$20240805$EXP$$US-GILEAD-2024-0677555$GILEAD$$58$YR$A$F$Y$$$20240805$$HP$US$US
241727051$24172705$1$I$$20240723$20240805$20240805$EXP$$US-ENDO USA, INC.-2024-003062$ENDO$$$$$F$Y$$$20240805$$CN$US$US
241727061$24172706$1$I$$20230301$20240805$20240805$EXP$$ZA-AstraZeneca-2023A052697$ASTRAZENECA$$46$YR$$F$Y$$$20240805$$CN$ZA$
241727071$24172707$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122920$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240805$$HP$US$US
241727082$24172708$2$F$20240727$20240729$20240805$20240812$EXP$$US-UCBSA-2024037508$UCB$$2$YR$$F$Y$15.42$KG$20240812$$HP$US$US
241727091$24172709$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122105$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$97.52$KG$20240805$$CN$US$US
241727101$24172710$1$I$20240704$20240805$20240805$20240805$EXP$SI-BoehringerIngelheim-2024-BI-043702$SI-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043702$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$$$20240805$$PH$SI$SI
241727111$24172711$1$I$20240701$20240724$20240805$20240805$EXP$$US-Emmaus Medical, Inc.-EMM202407-000370$EMMAUS LIFE SCIENCES$$46$YR$A$M$Y$$$20240805$$CN$US$
241727121$24172712$1$I$20240101$20240725$20240805$20240805$EXP$$US-Emmaus Medical, Inc.-EMM202407-000375$EMMAUS LIFE SCIENCES$$45$YR$A$F$Y$$$20240805$$CN$US$
241727132$24172713$2$F$20170101$20240816$20240805$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-038235$AUROBINDO$Cheng JJ, Shen J, Suresh Y, Akopyan N, Kapoor N. Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy: Case report. International Journal of Surgery Case Reports. 2024;122:1-4$72$YR$$M$Y$$$20240829$$HP$US$US
241727141$24172714$1$I$20240101$20240724$20240805$20240805$EXP$$DZ-MAIA Pharmaceuticals, Inc.-MAI202407-000025$MAIA PHARMACEUTICALS$$52$YR$A$F$Y$$$20240805$$HP$DZ$
241727151$24172715$1$I$20240715$20240722$20240805$20240805$EXP$DE-AMK-278462$DE-LUPIN PHARMACEUTICALS INC.-2024-07201$LUPIN$$$$$$Y$$$20240805$$PH$DE$DE
241727161$24172716$1$I$20200721$20240802$20240805$20240805$EXP$PL-URPL-1-1923-2020$PL-GSK-PL2024096845$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$MD$PL$PL
241727171$24172717$1$I$20240801$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024153818$AMGEN$$44$YR$A$F$Y$$$20240805$$CN$US$US
241727191$24172719$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240785513$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240805$$HP$US$US
241727201$24172720$1$I$20240701$20240801$20240805$20240805$PER$$US-ABBVIE-5865467$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241727211$24172721$1$I$$20240731$20240805$20240805$EXP$$GB-AMGEN-GBRSP2024152434$AMGEN$$66$YR$E$M$Y$$$20240805$$HP$GB$GB
241727222$24172722$2$F$$20240822$20240805$20240906$EXP$$US-UCBSA-2024038353$UCB$Solomon D, Gaines D, Peterson L. Levetiracetam pharmacokinetics in venovenous extracorporeal membrane oxygenation: A case report. Perfusion. 2024;0(0):1-4$40$YR$$F$Y$60$KG$20240906$$HP$US$US
241727233$24172723$3$F$20240501$20240826$20240805$20240830$EXP$$JP-GSK-JP2024JPN094674$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$PH$JP$JP
241727241$24172724$1$I$$20240802$20240805$20240805$PER$$US-HALEON-2190362$Haleon PLC$$$$$$Y$$$20240805$$CN$US$US
241727251$24172725$1$I$20240731$20240801$20240805$20240805$EXP$$US-JNJFOC-20240802278$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240805$$CN$US$US
241727261$24172726$1$I$$20240731$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122111$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240805$$CN$US$US
241727271$24172727$1$I$20240702$20240729$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120900$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$51.26$KG$20240805$$HP$US$US
241727281$24172728$1$I$$20210524$20240805$20240805$EXP$$RU-AstraZeneca-2021A470502$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$RU$
241727292$24172729$2$F$$20240808$20240805$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408001021$ELI LILLY AND CO$$39$YR$A$$Y$$$20240812$$CN$US$US
241727301$24172730$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001224$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240805$$CN$US$US
241727311$24172731$1$I$20240727$20240729$20240805$20240805$EXP$$NVSC2024IN158359$NOVARTIS$$67$YR$$F$Y$$$20240805$$CN$IN$IN
241727321$24172732$1$I$20230101$20240729$20240805$20240805$EXP$$NVSC2024DE156424$NOVARTIS$$$$E$M$Y$$$20240805$$CN$DE$DE
241727332$24172733$2$F$20240801$20240820$20240805$20240821$PER$$NVSC2024US159012$NOVARTIS$$69$YR$$F$Y$$$20240822$$HP$US$US
241727341$24172734$1$I$$20240802$20240805$20240805$PER$$NVSC2024US159005$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241727354$24172735$4$F$$20240910$20240805$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003718$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
241727361$24172736$1$I$$20240730$20240805$20240805$PER$$US-ABBVIE-5860882$ABBVIE$$$$$$Y$$$20240805$$MD$US$US
241727372$24172737$2$F$20240101$20240918$20240805$20240926$EXP$$US-UCBSA-2024038952$UCB$$$$$M$Y$111.11$KG$20240926$$HP$US$US
241727382$24172738$2$F$$20240913$20240805$20240925$EXP$$JP-UCBSA-2024037571$UCB$$$$$$Y$$$20240925$$MD$JP$JP
241727391$24172739$1$I$$20240731$20240805$20240805$EXP$$TW-MYLANLABS-2024M1071364$MYLAN$Tsai YC, Lin CH. Electroconvulsive Therapy Combined with the Treatments of Clozapine and Aripiprazole in a Patient with Treatment-resistant Mania: A Case Report. Taiwanese Journal of Psychiatry. 2024;38:99-101$47$YR$$F$Y$47$KG$20240805$$MD$TW$TW
241727402$24172740$2$F$$20240801$20240805$20240812$EXP$$GB-MYLANLABS-2024M1072103$MYLAN$$75$YR$$F$Y$67$KG$20240812$$MD$GB$GB
241727411$24172741$1$I$$20240801$20240805$20240805$EXP$$GB-MYLANLABS-2024M1072426$MYLAN$$$$$F$Y$$$20240805$$HP$GB$GB
241727421$24172742$1$I$$20240731$20240805$20240805$EXP$$GB-MYLANLABS-2024M1072169$MYLAN$$$$$M$Y$$$20240805$$PH$GB$GB
241727441$24172744$1$I$$20240802$20240805$20240805$EXP$$NVSC2024BG157912$NOVARTIS$$$$$F$Y$$$20240805$$MD$BG$BG
241727451$24172745$1$I$$20240722$20240805$20240805$EXP$$US-PADAGIS-2024PAD01234$PADAGIS$$$$$$Y$$$20240805$$CN$US$US
241727462$24172746$2$F$20240728$20240805$20240805$20240808$PER$$US-AMGEN-USASP2024150625$AMGEN$$61$YR$A$F$Y$$$20240808$$CN$US$US
241727481$24172748$1$I$20211025$20240731$20240805$20240805$EXP$$DE-ABBVIE-22K-062-4332640-00$ABBVIE$$26$YR$$M$Y$58$KG$20240805$$MD$DE$DE
241727492$24172749$2$F$$20240830$20240805$20240909$EXP$$NVSC2024FR157253$NOVARTIS$Dourthe ME, Yakouben K, David A, Thouvenin S, Chaillou D, Caillat-Zucman S et al.. Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY. 2024;205(1):373-7$4$YR$$M$Y$$$20240909$$HP$FR$FR
241727503$24172750$3$F$20221101$20240902$20240805$20240904$EXP$$AR-SANDOZ INC.-SDZ2024AR070262$SANDOZ$$4$YR$$F$Y$16$KG$20240904$$CN$AR$AR
241727511$24172751$1$I$$20240722$20240805$20240805$EXP$$DE-Unichem Pharmaceuticals (USA) Inc-UCM202407-000948$UNICHEM$$70$YR$E$F$Y$84$KG$20240805$$HP$DE$
241727531$24172753$1$I$$20240726$20240805$20240805$EXP$CZ-CZSUKL-24002123$CZ-SA-2024SA220716$SANOFI AVENTIS$$39$YR$A$F$Y$71$KG$20240805$$CN$CZ$CZ
241727542$24172754$2$F$20240715$20240809$20240805$20240814$EXP$$CA-ABBVIE-5863503$ABBVIE$$28$YR$$F$Y$41.7$KG$20240814$$MD$CA$CA
241727552$24172755$2$F$20240101$20240801$20240805$20240815$PER$$US-ABBVIE-5864985$ABBVIE$$49$YR$$F$Y$$$20240815$$HP$US$US
241727562$24172756$2$F$$20240905$20240805$20240916$30DAY$$TW-JNJFOC-20240800209$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$TW$TW
241727571$24172757$1$I$20150101$20240731$20240805$20240805$EXP$$AU-TAKEDA-2024TUS077869$TAKEDA$$76$YR$$M$Y$$$20240805$$MD$AU$AU
241727583$24172758$3$F$20240707$20240822$20240805$20240827$EXP$$NVSJ2024JP009223$NOVARTIS$$6$YR$$M$Y$$$20240827$$MD$JP$JP
241727591$24172759$1$I$20230122$20230131$20240805$20240805$EXP$$CO-AstraZeneca-2023A027793$ASTRAZENECA$$18933$DY$$F$Y$$$20240805$$CN$CO$
241727601$24172760$1$I$20180101$20220726$20240805$20240805$EXP$$CR-AstraZeneca-2022A269237$ASTRAZENECA$$77$YR$$F$Y$$$20240805$$CN$CR$
241727611$24172761$1$I$$20221031$20240805$20240805$EXP$$TW-AstraZeneca-2022A362548$ASTRAZENECA$$63$YR$$F$Y$$$20240805$$CN$TW$
241727621$24172762$1$I$$20240802$20240805$20240805$EXP$$US-TAKEDA-2024TUS077953$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
241727631$24172763$1$I$$20240801$20240805$20240805$EXP$$US-ABBVIE-5865612$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241727641$24172764$1$I$$20240729$20240805$20240805$EXP$BE-FAMHP-DHH-N2024-122398$BE-SA-2024SA223326$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240805$$PH$BE$BE
241727662$24172766$2$F$$20240724$20240805$20240808$EXP$$US-APOTEX-2024AP009045$APOTEX$Abedrabo S, Rodriguez TE, Klein LM, Bitran J.. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142 (Suppl. 1):7078$$$A$$Y$$$20240808$$MD$US$US
241727671$24172767$1$I$$20240731$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2023CA076652$SANDOZ$$$$$F$Y$$$20240805$$HP$CA$CA
241727681$24172768$1$I$$20240729$20240805$20240805$EXP$$US-AMGEN-USASP2024152215$AMGEN$Montag L.; Piver R.; Vidalin A. et. al.. Pembrolizumab-induced myasthenia gravis: Two patients experiences. Gynecologic Oncology Reports. 2024;54:1-4$80$YR$E$F$Y$$$20240805$$HP$US$US
241727691$24172769$1$I$20240724$20240730$20240805$20240805$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-106238$REGENERON$$83$YR$$M$Y$$$20240805$$MD$JP$JP
241727701$24172770$1$I$$20240722$20240805$20240805$EXP$$DE-UCBSA-2024037691$UCB$$9$YR$$$Y$$$20240805$$MD$DE$DE
241727712$24172771$2$F$$20240823$20240805$20240905$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07509$LUPIN$$$$$$Y$$$20240905$$PH$US$US
241727721$24172772$1$I$20240618$20240724$20240805$20240805$EXP$NO-NOMAADVRE-PASRAPP-2024-V9zgnq$NO-BAYER-2024A107496$BAYER$$41$YR$A$F$Y$65$KG$20240805$$CN$NO$NO
241727731$24172773$1$I$20240501$20240729$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121994$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$80.74$KG$20240805$$MD$US$US
241727741$24172774$1$I$$20240731$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122762$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240805$$CN$US$US
241727751$24172775$1$I$20240729$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024151796$AMGEN$$$$$$Y$$$20240805$$CN$US$US
241727761$24172776$1$I$$20240728$20240805$20240805$EXP$$CA-AMGEN-CANSP2024152771$AMGEN$Kumar D.; Solera J. T.; Arbol B. G. et al.. Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023. American Journal of Transplantation. 2024;24(7):1303-1316$$$$$Y$$$20240805$$HP$CA$CA
241727771$24172777$1$I$20240731$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001127$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240805$$CN$US$US
241727781$24172778$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001448$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240805$$PH$US$US
241727791$24172779$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-037818$AUROBINDO$$72$YR$$M$Y$$$20240805$$HP$CA$CA
241727801$24172780$1$I$20240101$20240731$20240805$20240805$EXP$$US-SA-2024SA228675$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240805$$CN$US$US
241727812$24172781$2$F$20240101$20240906$20240805$20240910$EXP$$US-SA-2024SA228838$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240910$$MD$US$US
241727822$24172782$2$F$$20240804$20240805$20240816$EXP$$GB-MACLEODS PHARMA-MAC2024048595$MACLEODS$Momoh R, Hassan A.A Case Report of an Acute Severe Tachyarrhythmia Presentation With Underlying Cardiomyopathy in a Patient With Anabolic Androgenic Steroid and Thyroxine Misuse.Cureus.2024;16(6):e62806$$$$$Y$$$20240816$$HP$GB$GB
241727831$24172783$1$I$$20240722$20240805$20240805$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-07079$HIKMA$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al.. Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy.. Experimental and Clinical Transplantation. 2024;22(5):392-395$68$YR$$F$Y$$$20240805$$MD$US$US
241727841$24172784$1$I$20240101$20240731$20240805$20240805$EXP$$US-Rigel Pharmaceuticals, Inc.-20240800006$RIGEL PHARMACEUTICALS$$$$$F$Y$104.33$KG$20240805$$HP$US$US
241727851$24172785$1$I$$20240725$20240805$20240805$EXP$$ZA-MACLEODS PHARMA-MAC2024048586$MACLEODS$$$$$$Y$$$20240805$$CN$ZA$ZA
241727864$24172786$4$F$$20240924$20240805$20240930$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2024JPN095451$VIIV$$$$$$Y$$$20240930$$MD$JP$JP
241727871$24172787$1$I$20240526$20240724$20240805$20240805$EXP$GB-MHRA-MIDB-0a67027d-cd82-466b-8331-8f69dc4c7ddf$GB-MACLEODS PHARMA-MAC2024048582$MACLEODS$$$$$$Y$$$20240805$$PH$GB$GB
241727881$24172788$1$I$$20240728$20240805$20240805$EXP$$US-AMGEN-USASP2024154375$AMGEN$Proute M.; Haynes T.; Fishberg R. et al.. Rethinking Prevention- Need for earlier intervention in Familial Hypercholesteremia despite Statin and PCSK9 Inhibitor Therapy. Journal of Clinical Lipidology. 2024;18 (4):e543-e543$47$YR$A$M$Y$$$20240805$$MD$US$US
241727891$24172789$1$I$$20240731$20240805$20240805$EXP$$AU-MYLANLABS-2024M1071271$MYLAN$$$$$F$Y$$$20240805$$CN$AU$AU
241727911$24172791$1$I$$20240730$20240805$20240805$EXP$$GB-AMGEN-GBRNI2024153078$AMGEN$$60$YR$A$F$Y$$$20240805$$PH$GB$GB
241727921$24172792$1$I$20240719$20240722$20240805$20240805$PER$$US-JNJFOC-20240763590$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240805$$CN$US$US
241727932$24172793$2$F$$20240920$20240805$20240927$EXP$$JP-009507513-2407JPN004744J$MERCK$$87$YR$$M$Y$$$20240927$$PH$JP$JP
241727941$24172794$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038500$AUROBINDO$$41$YR$$M$Y$$$20240805$$HP$CA$CA
241727953$24172795$3$F$20240328$20240802$20240805$20240813$EXP$FR-AFSSAPS-AN2024000959$FR-SA-2024SA226395$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240813$$MD$FR$FR
241727971$24172797$1$I$$20240724$20240805$20240805$EXP$$CA-MYLANLABS-2024M1071343$MYLAN$$63$YR$$F$Y$$$20240805$$HP$CA$CA
241727981$24172798$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2019-009975$AUROBINDO$$57$YR$$F$Y$$$20240805$$HP$CA$CA
241727991$24172799$1$I$20240722$20240724$20240805$20240805$EXP$$US-Accord-438790$ACCORD$$34$YR$A$M$Y$$$20240805$$HP$US$US
241728001$24172800$1$I$20240719$20240724$20240805$20240805$EXP$$US-Accord-438431$ACCORD$$21$YR$A$M$Y$$$20240805$$HP$US$US
241728011$24172801$1$I$20240501$20240724$20240805$20240805$EXP$GB-MHRA-31122984$GB-Accord-438550$ACCORD$$69$YR$E$F$Y$61$KG$20240805$$MD$GB$GB
241728021$24172802$1$I$$20240725$20240805$20240805$EXP$NL-LRB-00990669$NL-Accord-438532$ACCORD$$62$YR$A$F$Y$76$KG$20240805$$CN$NL$NL
241728032$24172803$2$F$$20240829$20240805$20240909$30DAY$$IE-JNJFOC-20240783593$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$CN$IE$IE
241728041$24172804$1$I$20240627$20240729$20240805$20240805$PER$$US-JNJFOC-20240777417$JOHNSON AND JOHNSON$$53$YR$A$F$Y$53.572$KG$20240805$$CN$US$US
241728051$24172805$1$I$$20210909$20240805$20240805$EXP$$AU-AstraZeneca-2021A720902$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$AU$
241728061$24172806$1$I$$20230602$20240805$20240805$EXP$$US-AstraZeneca-2023A129063$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241728071$24172807$1$I$$20230623$20240805$20240805$EXP$$US-AstraZeneca-2023A147082$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241728081$24172808$1$I$$20240729$20240805$20240805$EXP$NL-LRB-00990669$NL-MYLANLABS-2024M1071387$MYLAN$$62$YR$$F$Y$76$KG$20240805$$CN$NL$NL
241728091$24172809$1$I$20180419$20240729$20240805$20240805$EXP$PL-URPL-S1228/2018$PL-CHEPLA-2024009775$CHEPLAPHARM$$58$YR$A$M$Y$82$KG$20240805$$PH$COUNTRY NOT SPECIFIED$PL
241728101$24172810$1$I$20240730$20240730$20240805$20240805$30DAY$$US-AMGEN-USASP2024151696$AMGEN$$$$$$Y$$$20240805$$PH$US$US
241728111$24172811$1$I$$20240724$20240805$20240805$PER$$US-P+L Developments of Newyork Corporation-2160001$PL DEVELOPMENTS$$$$$$Y$$$20240805$$$US$US
241728121$24172812$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038339$AUROBINDO$$72$YR$$M$Y$$$20240805$$HP$CA$CA
241728131$24172813$1$I$20240702$20240725$20240805$20240805$EXP$$VN-ROCHE-10000046127$ROCHE$$48$YR$A$F$Y$$$20240805$$MD$VN$VN
241728141$24172814$1$I$$20240725$20240805$20240805$EXP$$ES-P+L Developments of Newyork Corporation-2160006$PL DEVELOPMENTS$Initial$5$YR$$M$Y$$$20240805$$$ES$ES
241728151$24172815$1$I$$20240725$20240805$20240805$EXP$$LK-P+L Developments of Newyork Corporation-2160009$PL DEVELOPMENTS$Initial$67$YR$$M$Y$$$20240805$$$LK$LK
241728171$24172817$1$I$20240628$20240724$20240805$20240805$EXP$CN-HENLIUS-24CN016107$CN-Accord-439207$ACCORD$$78$YR$E$M$Y$45$KG$20240805$$MD$CN$CN
241728181$24172818$1$I$20240719$20240725$20240805$20240805$EXP$GB-MHRA-MED-202407251753217850-DHMKB$GB-Accord-438845$ACCORD$$81$YR$E$M$Y$84$KG$20240805$$CN$GB$GB
241728191$24172819$1$I$$20240731$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2023CA076646$SANDOZ$$$$$F$Y$$$20240805$$HP$CA$CA
241728201$24172820$1$I$$20240725$20240805$20240805$EXP$GB-MHRA-MED-202407251356400930-ZGKRJ$GB-Accord-438941$ACCORD$$65$YR$E$M$Y$83$KG$20240805$$CN$GB$GB
241728211$24172821$1$I$20240704$20240725$20240805$20240805$EXP$FR-AFSSAPS-LL2024001386$FR-Accord-438523$ACCORD$$46$YR$A$F$Y$63$KG$20240805$$MD$FR$FR
241728221$24172822$1$I$$20240725$20240805$20240805$EXP$GB-MHRA-31118704$GB-Accord-438833$ACCORD$$55$YR$A$M$Y$$$20240805$$PH$GB$GB
241728231$24172823$1$I$20240510$20240724$20240805$20240805$EXP$$FR-Accord-439247$ACCORD$$$$$F$Y$$$20240805$$PH$FR$FR
241728241$24172824$1$I$20240716$20240724$20240805$20240805$EXP$$US-Accord-439155$ACCORD$$32$YR$$M$Y$$$20240805$$HP$US$US
241728251$24172825$1$I$$20240731$20240805$20240805$EXP$FR-EMA-2024724-AUTODUP-1721849700538$FR-Accord-439758$ACCORD$$$$$F$Y$$$20240805$$HP$FR$FR
241728262$24172826$2$F$20120403$20240828$20240805$20240909$EXP$GB-MHRA-MED-202407241045585120-DRSWJ$GB-Accord-438415$ACCORD$$$$$M$Y$$$20240909$$MD$GB$GB
241728271$24172827$1$I$20240723$20240730$20240805$20240805$PER$$US-JNJFOC-20240782339$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$HP$US$US
241728281$24172828$1$I$$20240724$20240805$20240805$PER$$US-JNJFOC-20240771489$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241728295$24172829$5$F$20240801$20240904$20240805$20240916$30DAY$$US-JNJFOC-20240802865$JOHNSON AND JOHNSON$$28$YR$A$$Y$$$20240916$$PH$US$US
241728301$24172830$1$I$$20240801$20240805$20240805$PER$$US-JNJFOC-20240803583$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240805$$HP$US$US
241728311$24172831$1$I$$20240722$20240805$20240805$EXP$$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-07122$HIKMA$Nunes A, Silva D, Riberio P.. Nunes A, Silva D, Riberio P. Leucemia miel?ide aguda: evolu??o no paradigma e impacto terap?utico. Hematologia e Oncologia. 2024;12(46):18-21$28$YR$$F$Y$$$20240805$$MD$PT$PT
241728322$24172832$2$F$$20240919$20240805$20240927$EXP$$CA-UCBSA-2024039011$UCB$$$$$F$Y$$$20240927$$CN$CA$CA
241728331$24172833$1$I$$20231016$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2023CA046560$SANDOZ$$$$$$Y$$$20240805$$MD$CA$CA
241728341$24172834$1$I$$20240726$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407017917$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240805$$CN$US$US
241728351$24172835$1$I$20230327$20240722$20240805$20240805$EXP$FR-AFSSAPS-PO2024000789$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110211$ZYDUS PHARM$$$$$$Y$$$20240805$$MD$FR$FR
241728361$24172836$1$I$$20240723$20240805$20240805$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0290$GRAVITI PHARMACEUTICALS$Wegner Wippel C, Deshpande H, Patwa H, Peixoto AJ.Neurogenic orthostatic hypotension after treatment with sorafenib.BMJ-Case-Rep.2022;15:12$74$YR$E$M$Y$$$20240805$$HP$US$US
241728371$24172837$1$I$20240716$20240727$20240805$20240805$EXP$$US-BEH-2024176598$CSL BEHRING$$33$YR$A$M$Y$$$20240805$$CN$US$US
241728381$24172838$1$I$$20240723$20240805$20240805$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0292$GRAVITI PHARMACEUTICALS$$4$YR$C$F$Y$$$20240805$$MD$US$US
241728391$24172839$1$I$$20240801$20240805$20240805$PER$$US-ABBVIE-5865014$ABBVIE$$49$YR$$F$Y$$$20240805$$CN$US$US
241728401$24172840$1$I$$20240722$20240805$20240805$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07364$LUPIN$Carranza Morales A, Blanco Jimenez JA, Madhavan A. A painful case of asthma. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5999$43$YR$$F$Y$$$20240805$$HP$US$US
241728411$24172841$1$I$$20221006$20240805$20240805$EXP$$US-AstraZeneca-2022A342057$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241728421$24172842$1$I$$20240724$20240805$20240805$PER$$US-ROCHE-3549095$ROCHE$$$$$F$Y$$$20240805$$MD$US$US
241728431$24172843$1$I$$20230418$20240805$20240805$EXP$$US-AstraZeneca-2023A053012$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241728441$24172844$1$I$$20240722$20240805$20240805$PER$$US-JNJFOC-20240763709$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241728451$24172845$1$I$$20240726$20240805$20240805$PER$$US-AstraZeneca-2024A174158$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241728462$24172846$2$F$$20240803$20240805$20240806$EXP$$US-ROCHE-10000048286$ROCHE$$4$YR$C$M$Y$16.2$KG$20240806$$CN$US$US
241728472$24172847$2$F$20240719$20240819$20240805$20240827$30DAY$$US-AMGEN-USASP2024150953$AMGEN$$55$YR$A$F$Y$68.934$KG$20240827$$HP$US$US
241728482$24172848$2$F$20240601$20240814$20240805$20240822$EXP$$US-BIOGEN-2024BI01276266$BIOGEN$$76$YR$$F$Y$$$20240822$$CN$US$US
241728493$24172849$3$F$20240717$20240819$20240805$20240826$30DAY$$US-AMGEN-USASP2024150698$AMGEN$$62$YR$A$F$Y$67.8$KG$20240826$$HP$US$US
241728501$24172850$1$I$20240131$20240724$20240805$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-037661$AUROBINDO$$64$YR$$M$Y$$$20240805$$MD$FR$FR
241728511$24172851$1$I$$20240725$20240805$20240805$EXP$CA-MHPD-001088330$CA-Accord-438633$ACCORD$$$$$F$Y$$$20240805$$CN$CA$CA
241728521$24172852$1$I$$20240725$20240805$20240805$EXP$CA-MHPD-E2B_001092559$CA-Accord-438567$ACCORD$$57$YR$A$F$Y$67$KG$20240805$$HP$CA$CA
241728531$24172853$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038553$AUROBINDO$$66$YR$$M$Y$$$20240805$$HP$CA$CA
241728541$24172854$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000048484$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$67$YR$E$M$Y$$$20240805$$HP$JP$JP
241728553$24172855$3$F$20240715$20240822$20240805$20240903$EXP$$US-Accord-438443$ACCORD$$62$YR$A$M$Y$79.52$KG$20240903$$HP$US$US
241728561$24172856$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038574$AUROBINDO$$73$YR$$F$Y$$$20240805$$CN$CA$CA
241728571$24172857$1$I$$20240725$20240805$20240805$EXP$$AU-STERISCIENCE B.V.-2024-ST-001129$Steriscience PTE$Yeoh K, Lass-Florl C, Lamoth F, Slavin MA, Williams E, Neofytos D. Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual.. Transpl-Infect-Dis. 2024$53$YR$$F$Y$$$20240805$$HP$AU$AU
241728581$24172858$1$I$$20240731$20240805$20240805$EXP$$US-AMGEN-USASP2024152318$AMGEN$$$$$M$Y$$$20240805$$CN$US$US
241728591$24172859$1$I$20210929$20240731$20240805$20240805$EXP$$FR-AMGEN-FRASP2024152307$AMGEN$$77$YR$E$M$Y$54$KG$20240805$$MD$FR$FR
241728601$24172860$1$I$$20240724$20240805$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-037659$AUROBINDO$Vandroux D, Aujoulat T, Gauzere A, Puech B, Guihard B, Martinet O.. Predicting factors for the need of extracorporeal membrane oxygenation for suicide attempts by cardiac medication: single-center cohort study. World-J-Emerg-Med. 2022;13(4):144-150$$$A$$Y$$$20240805$$MD$FR$FR
241728611$24172861$1$I$$20240723$20240805$20240805$EXP$GB-MHRA-MED-202407221836467660-FLBWV$GB-LUPIN PHARMACEUTICALS INC.-2024-07206$LUPIN$$$$$$Y$$$20240805$$CN$GB$GB
241728621$24172862$1$I$20240611$20240729$20240805$20240805$EXP$$NVSC2024CN158024$NOVARTIS$$68$YR$$F$Y$$$20240805$$HP$CN$CN
241728632$24172863$2$F$$20240830$20240805$20240906$EXP$$CO-GSK-CO2024AMR095589$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$CO$CO
241728641$24172864$1$I$$20240726$20240805$20240805$30DAY$$US-GSK-US2024094287$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$PH$US$US
241728651$24172865$1$I$20240714$20240730$20240805$20240805$EXP$$US-AstraZeneca-2024A173336$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241728661$24172866$1$I$20240601$20240802$20240805$20240805$EXP$$US-ARGENX-2024-ARGX-US006223$ARGENX BVBA$$$$$$Y$$$20240805$$HP$US$US
241728671$24172867$1$I$$20240725$20240805$20240805$EXP$$US-P+L Developments of Newyork Corporation-2160010$PL DEVELOPMENTS$Initial$38$YR$$M$Y$$$20240805$$MD$US$US
241728681$24172868$1$I$20240623$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019902$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240805$$CN$US$US
241728692$24172869$2$F$$20240801$20240805$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408001214$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$US$US
241728701$24172870$1$I$20240630$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019695$ELI LILLY AND CO$$$$$M$Y$$$20240805$$CN$US$US
241728712$24172871$2$F$$20240917$20240805$20240925$30DAY$$TR-JNJFOC-20240779647$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$TR$TR
241728722$24172872$2$F$20240729$20240923$20240805$20240930$EXP$$DE-BAXTER-2024BAX022474$BAXTER$$55$YR$$F$Y$$$20240930$$HP$DE$DE
241728731$24172873$1$I$20240605$20240724$20240805$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-037639$AUROBINDO$$22$YR$$F$Y$$$20240805$$HP$FR$FR
241728741$24172874$1$I$$20240726$20240805$20240805$EXP$$US-APOTEX-2024AP009027$APOTEX$Fenner EG, Simpson CE. An adult patient with pulmonary arterial hypertension, a NOTCH3 mutation, and leflunomide exposure. Pulmonary Circulation. 2024;14:e12411:1-4$39$YR$$F$Y$$$20240805$$HP$US$US
241728752$24172875$2$F$$20240807$20240805$20240816$30DAY$$US-GSK-US2024095884$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
241728761$24172876$1$I$$20240724$20240805$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-038218$AUROBINDO$Mcgourty M, Adams EW, Lyons J, Ayyaswami V, Holdorf JD. MDA-5 Associated Dermatomyositis: A Case of Delayed Care and Dire Consequences. Am-J-Respir-Crit-Care-Med. 2024;209no:A1994$43$YR$$M$Y$$$20240805$$HP$US$US
241728771$24172877$1$I$$20240724$20240805$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-038000$AUROBINDO$Becker DA. The Positive Assistance of Assisted Reproductive Technology.. Epilepsy-Curr-(EnglishEdition). 2024;24(3):180-181$$$$F$Y$$$20240805$$MD$US$US
241728781$24172878$1$I$$20240724$20240805$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-037820$AUROBINDO$Shakir M, Mohamed N, Vietor N, Mai V, Hoang T.. Acute Cardiovascular Complications FromTestosterone Therapy.. J-Endocr-Soc. 2019;3 (Suppl. 1):1-2$$$A$M$Y$$$20240805$$HP$US$US
241728791$24172879$1$I$20240101$20240731$20240805$20240805$EXP$$US-AMGEN-USASP2024152375$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
241728802$24172880$2$F$$20240724$20240805$20240808$EXP$$US-APOTEX-2024AP009048$APOTEX$Abedrabo S, Rodriguez TE, Klein LM, Bitran J.. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142 (Suppl. 1):7078$$$A$$Y$$$20240808$$MD$US$US
241728811$24172881$1$I$$20240725$20240805$20240805$EXP$$MY-STERISCIENCE B.V.-2024-ST-001132$Steriscience PTE$Azahar ZA, Ab Rahim MF, Ahmad N, Ramli R.. Achalasia in pregnancy.. BMJ-Case-Rep. 2024;17 (5):1-4$$$N$$Y$$$20240805$$HP$MY$MY
241728821$24172882$1$I$20211101$20240729$20240805$20240805$EXP$$CA-TAKEDA-2021TUS073707$TAKEDA$$32$YR$$F$Y$$$20240805$$CN$CA$CA
241728831$24172883$1$I$$20240723$20240805$20240805$PER$$US-JNJFOC-20240801821$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241728841$24172884$1$I$$20240728$20240805$20240805$EXP$$PK-Navinta LLC-000509$NAVINTA LLC$PK-Navinta LLC-000509-01$49$YR$A$F$Y$$$20240805$$HP$PK$
241728861$24172886$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-037915$AUROBINDO$$78$YR$$M$Y$$$20240805$$PH$CA$CA
241728871$24172887$1$I$20240801$20240801$20240805$20240805$EXP$$TW-TAKEDA-2024TUS077506$TAKEDA$$34$YR$$M$Y$$$20240805$$CN$TW$TW
241728881$24172888$1$I$20240117$20240729$20240805$20240805$EXP$$DE-CHEPLA-2024009767$CHEPLAPHARM$$67$YR$$F$Y$61$KG$20240805$$MD$COUNTRY NOT SPECIFIED$DE
241728894$24172889$4$F$20240722$20240913$20240805$20240917$PER$$US-BAYER-2024A110654$BAYER$$42$YR$A$F$Y$68.027$KG$20240917$$HP$US$US
241728901$24172890$1$I$20240725$20240802$20240805$20240805$EXP$$CN-ROCHE-10000048602$ROCHE$$40$YR$A$F$Y$75.5$KG$20240805$$HP$CN$CN
241728912$24172891$2$F$$20240724$20240805$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038021$AUROBINDO$$76$YR$$F$Y$$$20240807$$MD$CA$CA
241728921$24172892$1$I$20240424$20240805$20240805$20240805$EXP$ES-AEMPS-1556149$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043703$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$86$KG$20240805$$MD$ES$ES
241728931$24172893$1$I$20240703$20240729$20240805$20240805$EXP$$BR-JNJFOC-20240784873$JOHNSON AND JOHNSON$$41$YR$A$F$Y$61$KG$20240805$$HP$BR$BR
241728952$24172895$2$F$$20240724$20240805$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038029$AUROBINDO$$77$YR$$F$Y$$$20240807$$HP$CA$CA
241728962$24172896$2$F$20240729$20240806$20240805$20240819$PER$$US-AMGEN-USASP2024152313$AMGEN$$85$YR$E$F$Y$$$20240818$$CN$US$US
241728971$24172897$1$I$$20240726$20240805$20240805$EXP$$US-MYLANLABS-2024M1071518$MYLAN$Silverberg N, Meister HM, Lebwohl M. Case series of topical 1.5% ruxolitinib cream for pediatric vitiligo. Br-J-Dermatol 2024; 190 (Suppl. 2) ii71-ii72 abstr. 571.$11$YR$$$Y$$$20240805$$MD$US$US
241728981$24172898$1$I$$20240726$20240805$20240805$EXP$$US-MYLANLABS-2024M1071583$MYLAN$Gupta NY, Al Diffalha S, Russ KB. An Unusual Case of Colitis in a Bone Marrow Transplant Patient. Gastroenterology 2024; 167 (3): e1-e4.$65$YR$$M$Y$$$20240805$$MD$US$US
241729001$24172900$1$I$20230101$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024151269$AMGEN$$63$YR$A$F$Y$$$20240805$$HP$US$US
241729011$24172901$1$I$20240731$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152611$AMGEN$$67$YR$E$M$Y$$$20240805$$CN$US$US
241729021$24172902$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158481$NOVARTIS$$$$$$Y$$$20240805$$CN$US$US
241729031$24172903$1$I$$20240726$20240805$20240805$EXP$$US-GILEAD-2024-0682172$GILEAD$$46$YR$A$$Y$$$20240805$$CN$US$US
241729042$24172904$2$F$20240101$20240801$20240805$20240807$EXP$$US-ABBVIE-5865066$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241729051$24172905$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038597$AUROBINDO$$2$YR$$F$Y$13$KG$20240805$$HP$CA$CA
241729061$24172906$1$I$20240501$20240801$20240805$20240805$EXP$$US-ABBVIE-5860053$ABBVIE$$80$YR$$F$Y$$$20240805$$CN$US$US
241729071$24172907$1$I$$20240802$20240805$20240805$EXP$$US-ROCHE-10000048172$ROCHE$$$$$F$Y$$$20240805$$MD$US$US
241729081$24172908$1$I$20240701$20240730$20240805$20240805$EXP$$US-SA-2024SA227243$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240805$$MD$US$US
241729091$24172909$1$I$$20240801$20240805$20240805$30DAY$$US-GSK-US2024096228$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$MD$US$US
241729101$24172910$1$I$$20240730$20240805$20240805$30DAY$$US-GSK-US2024095391$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241729111$24172911$1$I$20240729$20240731$20240805$20240805$PER$$US-JNJFOC-20240801118$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240805$$CN$US$US
241729121$24172912$1$I$$20240726$20240805$20240805$EXP$$CA-APOTEX-2024AP008908$APOTEX$$$$$M$Y$$$20240805$$MD$CA$CA
241729131$24172913$1$I$$20240723$20240805$20240805$EXP$$BR-STERISCIENCE B.V.-2024-ST-001123$Steriscience PTE$Nobre L, Rosas C, Kalichsztein B, Nobre G, Kalichsztein M, Marinho A, et al.. Recurrent Pulmonary Hemorrhage in a Young Adult.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$48$YR$$F$Y$$$20240805$$HP$BR$BR
241729141$24172914$1$I$$20240724$20240805$20240805$EXP$$GB-AUROBINDO-AUR-APL-2024-037400$AUROBINDO$$95$YR$$F$Y$$$20240805$$PH$GB$GB
241729152$24172915$2$F$$20240730$20240805$20240807$EXP$$DE-AstraZeneca-2024A174202$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$DE$
241729161$24172916$1$I$$20240802$20240805$20240805$PER$$NVSC2024US159023$NOVARTIS$$$$$M$Y$$$20240805$$HP$US$US
241729171$24172917$1$I$$20240802$20240805$20240805$EXP$GB-MHRA-MED-202408021230525020-PZJYG$NVSC2024GB158418$NOVARTIS$$75$YR$$F$Y$$$20240805$$MD$GB$GB
241729191$24172919$1$I$20240710$20240729$20240805$20240805$EXP$ES-AEMPS-1549942$ES-CHEPLA-2024009801$CHEPLAPHARM$$57$YR$$F$Y$$$20240805$$MD$COUNTRY NOT SPECIFIED$ES
241729201$24172920$1$I$20240101$20240731$20240805$20240805$EXP$$US-ORGANON-O2408USA000082$ORGANON$$$$$F$Y$$$20240805$$MD$US$US
241729211$24172921$1$I$20240722$20240729$20240805$20240805$EXP$$US-ARGENX-2024-ARGX-US006024$ARGENX BVBA$$$$$$Y$$$20240805$$CN$US$US
241729222$24172922$2$F$$20240829$20240805$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122187$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240830$$CN$US$US
241729231$24172923$1$I$$20240727$20240805$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-122538$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240805$$PH$JP$JP
241729241$24172924$1$I$20240101$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024151814$AMGEN$$$$$$Y$$$20240805$$HP$US$US
241729251$24172925$1$I$20240804$20240804$20240804$20240804$DIR$712848$$FDA-CTU$$89$YR$$M$N$77.85$KG$20240804$N$CN$US$
241729261$24172926$1$I$$20240725$20240805$20240805$PER$$US-ROCHE-10000040102$ROCHE$$$$$$Y$$$20240805$$CN$US$US
241729271$24172927$1$I$$20240729$20240805$20240805$EXP$$US-AstraZeneca-2024A173532$ASTRAZENECA$$$$$M$Y$$$20240805$$HP$US$
241729281$24172928$1$I$20240730$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174574$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241729292$24172929$2$F$$20240809$20240805$20240815$EXP$$JP-GILEAD-2024-0682568$GILEAD$$76$YR$E$M$Y$$$20240815$$PH$JP$JP
241729303$24172930$3$F$20240318$20240913$20240805$20240919$EXP$$US-MYLANLABS-2024M1032347$MYLAN$$58$YR$$F$Y$68.94$KG$20240919$$CN$US$US
241729311$24172931$1$I$$20240802$20240805$20240805$PER$$US-TAKEDA-2024TUS078059$TAKEDA$$$$C$M$Y$$$20240805$$CN$US$US
241729321$24172932$1$I$20240708$20240724$20240805$20240805$EXP$$DE-AUROBINDO-AUR-APL-2024-037528$AUROBINDO$$39$YR$$M$Y$80$KG$20240805$$PH$DE$DE
241729342$24172934$2$F$$20240729$20240805$20240807$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-15344$IPSEN$$$$$$Y$$$20240807$$MD$JP$JP
241729352$24172935$2$F$$20240812$20240805$20240814$EXP$$DE-MYLANLABS-2024M1071620$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$12$YR$$M$Y$$$20240814$$HP$DE$DE
241729361$24172936$1$I$$20240730$20240805$20240805$EXP$$DE-MYLANLABS-2024M1071628$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$13$YR$$F$Y$$$20240805$$HP$DE$DE
241729372$24172937$2$F$$20240806$20240805$20240812$EXP$$GR-MYLANLABS-2024M1071985$MYLAN$$81$YR$$F$Y$$$20240812$$CN$GR$GR
241729381$24172938$1$I$$20240726$20240805$20240805$EXP$$US-Karo Pharma-2159799$Karo Pharma$$$$$F$Y$$$20240805$$$US$US
241729391$24172939$1$I$$20240730$20240805$20240805$EXP$$DE-MYLANLABS-2024M1071720$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2).$5$YR$$F$Y$$$20240805$$HP$DE$DE
241729401$24172940$1$I$$20240730$20240805$20240805$EXP$$DE-MYLANLABS-2024M1071652$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$4$YR$$M$Y$$$20240805$$HP$DE$DE
241729412$24172941$2$F$$20240730$20240805$20240808$EXP$$FR-MYLANLABS-2024M1071855$MYLAN$$$$$F$Y$$$20240808$$MD$FR$FR
241729421$24172942$1$I$20240520$20240708$20240805$20240805$EXP$$US-NEBO-663617$PHARMACOSMOS$$38$YR$$F$Y$$$20240805$$HP$US$US
241729431$24172943$1$I$20240714$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152338$AMGEN$$78$YR$E$M$Y$$$20240805$$HP$US$US
241729441$24172944$1$I$$20240724$20240805$20240805$EXP$$CA-ROCHE-10000043120$ROCHE$$66$YR$E$F$Y$$$20240805$$HP$CA$CA
241729451$24172945$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008994$APOTEX$$54$YR$$F$Y$$$20240805$$CN$CA$CA
241729462$24172946$2$F$20230801$20240815$20240805$20240830$EXP$$AU-Ascend Therapeutics US, LLC-2160012$ASCEND$$52$YR$$F$Y$$$20240830$$MD$AU$AU
241729471$24172947$1$I$$20240729$20240805$20240805$EXP$$US-CHEPLA-2024009754$CHEPLAPHARM$$41$YR$$F$Y$$$20240805$$MD$COUNTRY NOT SPECIFIED$US
241729482$24172948$2$F$$20240920$20240805$20240924$EXP$$GB-ROCHE-10000042414$ROCHE$$$$E$F$Y$$$20240924$$CN$GB$GB
241729491$24172949$1$I$20180101$20240801$20240805$20240805$PER$$US-ABBVIE-5865478$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241729501$24172950$1$I$20240716$20240802$20240805$20240805$EXP$FR-AFSSAPS-AVCF2024000524$FR-BAUSCH-BL-2024-011841$BAUSCH AND LOMB$$21$YR$$F$Y$$$20240805$$HP$FR$FR
241729511$24172951$1$I$$20240724$20240805$20240805$EXP$CA-MHPD-001088788$CA-Accord-438534$ACCORD$$66$YR$E$M$Y$122$KG$20240805$$HP$CA$CA
241729521$24172952$1$I$20240724$20240724$20240805$20240805$EXP$$US-Accord-438805$ACCORD$$34$YR$A$F$Y$$$20240805$$HP$US$US
241729532$24172953$2$F$$20240822$20240805$20240903$EXP$CA-MHPD-E2B_06943691$CA-Accord-421253$ACCORD$$73$YR$E$F$Y$$$20240903$$HP$CA$CA
241729551$24172955$1$I$20240724$20240725$20240805$20240805$EXP$GB-MHRA-MED-202407251110014900-GYJZH$GB-Accord-438844$ACCORD$$80$YR$E$F$Y$$$20240805$$PH$GB$GB
241729561$24172956$1$I$20240618$20240725$20240805$20240805$EXP$ES-AEMPS-1551605$ES-Accord-438652$ACCORD$$53$YR$A$F$Y$$$20240805$$PH$ES$ES
241729571$24172957$1$I$20240630$20240725$20240805$20240805$EXP$CN-HENLIUS-24CN016135$CN-Accord-439205$ACCORD$$31$YR$A$F$Y$47$KG$20240805$$MD$CN$CN
241729581$24172958$1$I$$20240724$20240805$20240805$EXP$AU-TGA-807837$AU-Accord-437950$ACCORD$$$$$F$Y$$$20240805$$HP$AU$AU
241729591$24172959$1$I$$20240725$20240805$20240805$EXP$$IE-Accord-438793$ACCORD$Kelliher J, Rahmani G, Carey JJ, Bergin D. Severe atypical iliac wing fracture associated with long-term bisphosphonate use. Skeletal radiology. 2024.$63$YR$A$F$Y$$$20240805$$HP$IE$IE
241729601$24172960$1$I$$20240725$20240805$20240805$EXP$$QA-P+L Developments of Newyork Corporation-2160013$PL DEVELOPMENTS$Initial$41$YR$$M$Y$$$20240805$$$QA$QA
241729611$24172961$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123105$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240805$$HP$US$US
241729621$24172962$1$I$20240722$20240724$20240805$20240805$EXP$$US-Accord-439149$ACCORD$$52$YR$A$F$Y$$$20240805$$PH$US$US
241729631$24172963$1$I$$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152668$AMGEN$$$$$F$Y$$$20240805$$PH$US$US
241729641$24172964$1$I$$20240716$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07335$LUPIN$$$$$$Y$$$20240805$$CN$US$US
241729651$24172965$1$I$20240729$20240731$20240805$20240805$PER$$US-JNJFOC-20240800718$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240805$$CN$US$US
241729661$24172966$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240800767$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241729671$24172967$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240804480$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$US$US
241729681$24172968$1$I$$20240724$20240805$20240805$PER$$US-JNJFOC-20240772093$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241729694$24172969$4$F$$20240904$20240805$20240910$30DAY$$US-JNJFOC-20240778284$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$HP$US$US
241729701$24172970$1$I$$20240726$20240805$20240805$EXP$$CA-APOTEX-2024AP008918$APOTEX$$47$YR$$F$Y$$$20240805$$PH$CA$CA
241729711$24172971$1$I$$20240503$20240805$20240805$EXP$$GB-SANDOZ INC.-SDZ2023GB058473$SANDOZ$$$$$$Y$$$20240805$$HP$GB$GB
241729721$24172972$1$I$$20240802$20240805$20240805$EXP$GB-ABBVIE-5862632$GB-ROCHE-10000048113$ROCHE$$$$A$F$Y$$$20240805$$MD$GB$GB
241729741$24172974$1$I$$20240730$20240805$20240805$30DAY$$US-GSK-US2024095412$GLAXOSMITHKLINE$$$$$M$Y$$$20240805$$CN$US$US
241729752$24172975$2$F$$20240920$20240805$20240925$EXP$$JP-GILEAD-2024-0682377$GILEAD$Ichikawa T, Takeuchi Y, Nagasaka A. 57 A case of AIDS in which blood HIV viral load was not suppressed. The 301st Hokkaido Regional Meeting of the Japanese Society of Internal Medicine. 2024;unk:unk$48$YR$A$M$Y$$$20240925$$MD$JP$JP
241729761$24172976$1$I$$20240729$20240805$20240805$30DAY$$US-GSK-US2024AMR095496$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$HP$US$US
241729772$24172977$2$F$$20240806$20240805$20240808$EXP$$CN-BAYER-2024A112067$BAYER$Jin F, Wang MM, Bu XB, Huang C. Epidemiological Analysis of Severe Allergic Reactions Caused by Moxifloxacin Based on Literatures and Examples. Anti-Infection Pharmacy. 2024;21(05):461$46$YR$A$F$Y$$$20240808$$PH$CN$CN
241729781$24172978$1$I$$20240802$20240805$20240805$EXP$$PL-GILEAD-2024-0682772$GILEAD$$48$YR$A$F$Y$$$20240805$$MD$PL$PL
241729801$24172980$1$I$$20240723$20240805$20240805$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092680$GLENMARK$Martin RD, Scanlon M, McCabe K.. Lidocaine-Associated CNS Toxicity at Therapeutic Dosage: A Case Report and Literature Review.. Cureus.. 2024;16(6):e62231$$$$$Y$$$20240805$$MD$US$US
241729811$24172981$1$I$$20240729$20240805$20240805$EXP$$AR-ROCHE-RCA5212509$ROCHE$Rojas-Roque C, Silvestrini C, Argento F, Sugg D, Augustovski F, Coelli J, et al. Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics. 2024-Jun-03;8:585-98. doi:10.1007/s41669-024-00495-6.$$$$$Y$$$20240805$$HP$AR$AR
241729822$24172982$2$F$$20240723$20240805$20240807$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004434$BLUEPRINT MEDICINES$$$$$$Y$$$20240801$$CN$US$US
241729831$24172983$1$I$20240804$20240804$20240804$20240804$DIR$712851$$FDA-CTU$$27$YR$$F$N$126$KG$20240804$N$CN$US$
241729842$24172984$2$F$$20240918$20240805$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123127$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240919$$CN$US$US
241729852$24172985$2$F$$20240917$20240805$20240926$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004432$Unknown Manufacturer$$$$$$Y$$$20240926$$CN$US$US
241729864$24172986$4$F$20240626$20240816$20240805$20240829$30DAY$$US-JNJFOC-20240778224$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$HP$US$US
241729891$24172989$1$I$$20240725$20240805$20240805$EXP$$US-ROCHE-10000038754$ROCHE$$77$YR$E$F$Y$$$20240805$$CN$US$US
241729901$24172990$1$I$$20240716$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07329$LUPIN$$$$$$Y$$$20240805$$CN$US$US
241729911$24172991$1$I$$20240726$20240805$20240805$30DAY$$US-GSK-US2024094290$GLAXOSMITHKLINE$$$$$M$Y$$$20240805$$CN$US$US
241729921$24172992$1$I$$20240730$20240805$20240805$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012555$VERTEX$$$$C$F$Y$$$20240805$$CN$GB$GB
241729951$24172995$1$I$20240701$20240731$20240805$20240805$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012610$VERTEX$$$$A$M$Y$$$20240805$$CN$GB$GB
241729961$24172996$1$I$20200101$20240730$20240805$20240805$PER$$US-VERTEX PHARMACEUTICALS-2021-000291$VERTEX$$$$$F$Y$$$20240805$$MD$US$US
241729971$24172997$1$I$20240201$20240724$20240805$20240805$EXP$SE-SEMPA-2024-001497$SE-JUBILANT PHARMA LTD-2024SE001079$JUBILANT$$81$YR$$F$Y$$$20240805$$PH$SE$SE
241729991$24172999$1$I$$20240730$20240805$20240805$PER$$US-ALXN-202407USA002096US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$HP$US$US
241730001$24173000$1$I$$20240722$20240805$20240805$PER$$US-RDY-SPO/USA/24/0011053$DR REDDYS$$$$$F$Y$$$20240805$$CN$US$US
241730011$24173001$1$I$$20240728$20240805$20240805$PER$$US-RDY-SPO/USA/24/0011137$DR REDDYS$$$$$$Y$$$20240805$$CN$US$US
241730021$24173002$1$I$20240601$20240730$20240805$20240805$30DAY$$US-GSK-US2024095305$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240805$$CN$US$US
241730031$24173003$1$I$20240101$20240801$20240805$20240805$EXP$$ES-ABBVIE-5865635$ABBVIE$$86$YR$$F$Y$51$KG$20240805$$CN$ES$ES
241730041$24173004$1$I$$20240802$20240805$20240805$PER$$US-ROCHE-10000048478$ROCHE$$$$E$F$Y$$$20240805$$CN$US$US
241730051$24173005$1$I$20240726$20240729$20240805$20240805$EXP$$US-MYLANLABS-2024M1071908$MYLAN$$36$YR$$F$Y$$$20240805$$MD$US$US
241730061$24173006$1$I$20230201$20240729$20240805$20240805$EXP$$FR-MYLANLABS-2024M1070795$MYLAN$$58$YR$$F$Y$$$20240805$$MD$FR$FR
241730072$24173007$2$F$20240101$20240816$20240805$20240826$PER$$US-INSUD PHARMA-2407US05760$INSUD PHARMA$$$$$$Y$$$20240826$$CN$US$US
241730081$24173008$1$I$20240627$20240725$20240805$20240805$EXP$$US-BEH-2024176403$CSL BEHRING$$60$YR$A$F$Y$$$20240805$$CN$US$US
241730091$24173009$1$I$$20240720$20240805$20240805$PER$$US-JNJFOC-20240764346$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$US$US
241730102$24173010$2$F$$20240830$20240805$20240906$30DAY$$JP-JNJFOC-20240779323$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$PH$JP$JP
241730113$24173011$3$F$$20240813$20240805$20240821$30DAY$$CA-JNJFOC-20240779599$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$HP$CA$CA
241730121$24173012$1$I$$20240804$20240805$20240805$PER$$US-HALEON-2190414$Haleon PLC$$$$$$Y$$$20240805$$CN$US$US
241730131$24173013$1$I$$20240723$20240805$20240805$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK092724$GLENMARK$$$$$$Y$$$20240805$$HP$GB$GB
241730141$24173014$1$I$20240625$20240724$20240805$20240805$EXP$CN-HENLIUS-24CN016109$CN-Accord-439382$ACCORD$$60$YR$A$F$Y$49$KG$20240805$$MD$CN$CN
241730151$24173015$1$I$$20240725$20240805$20240805$EXP$CA-MHPD-E2B_07184629$CA-Accord-438601$ACCORD$$85$YR$E$F$Y$$$20240805$$HP$CA$CA
241730161$24173016$1$I$$20240725$20240805$20240805$EXP$GB-MHRA-MED-202407251011475310-VZQYH$GB-Accord-438976$ACCORD$$$$$M$Y$$$20240805$$CN$GB$GB
241730171$24173017$1$I$$20240725$20240805$20240805$EXP$NL-LRB-00993123$NL-Accord-438533$ACCORD$$74$YR$E$F$Y$79$KG$20240805$$CN$NL$NL
241730181$24173018$1$I$20240719$20240724$20240805$20240805$EXP$$US-Accord-438791$ACCORD$$32$YR$A$M$Y$$$20240805$$HP$US$US
241730191$24173019$1$I$20240723$20240724$20240805$20240805$EXP$$US-Accord-438411$ACCORD$$28$YR$A$M$Y$$$20240805$$HP$US$US
241730201$24173020$1$I$20240726$20240804$20240804$20240804$DIR$712871$$FDA-CTU$$32$YR$$F$N$58.5$KG$20240804$Y$CN$US$
241730211$24173021$1$I$20240511$20240725$20240805$20240805$EXP$SE-SEMPA-2024-005592$SE-Accord-438879$ACCORD$$50$YR$A$F$Y$85$KG$20240805$$MD$SE$SE
241730221$24173022$1$I$$20240724$20240805$20240805$EXP$CA-MHPD-001092287$CA-Accord-438292$ACCORD$$2$YR$C$M$Y$14$KG$20240805$$HP$CA$CA
241730231$24173023$1$I$20240802$20240804$20240804$20240804$DIR$712876$$FDA-CTU$$29$YR$$F$N$91.35$KG$20240804$N$CN$US$
241730241$24173024$1$I$$20240716$20240805$20240805$PER$$CA-TOLMAR, INC.-24CA051081$TOLMAR$$$$$M$Y$$$20240802$$CN$CA$CA
241730251$24173025$1$I$$20240714$20240805$20240805$PER$$CA-TOLMAR, INC.-24CA051027$TOLMAR$$$$$M$Y$$$20240802$$CN$CA$CA
241730261$24173026$1$I$$20240716$20240805$20240805$PER$$CA-TOLMAR, INC.-24CA051083$TOLMAR$$$$$M$Y$$$20240802$$CN$CA$CA
241730271$24173027$1$I$20240607$20240804$20240804$20240804$DIR$712878$$FDA-CTU$$77$YR$$F$N$72$KG$20240804$N$CN$US$
241730291$24173029$1$I$$20240801$20240805$20240805$PER$$US-BIOVITRUM-2024-US-010348$BIOVITRUM$$65$YR$$F$Y$$$20240805$$CN$US$US
241730301$24173030$1$I$$20240723$20240805$20240805$EXP$$JP-TAKEDA-2024TUS077878$TAKEDA$Yasuhito Kaneko. Drug-induced hypersensitivity syndrome which was considered to be caused by Lansoprazole.. The Japanese Journal Of Dermatology.. 2017;127(2):213$52$YR$$M$Y$$$20240805$$MD$JP$JP
241730311$24173031$1$I$$20240716$20240805$20240805$PER$$CA-TOLMAR, INC.-24CA051084$TOLMAR$$$$$M$Y$$$20240802$$CN$CA$CA
241730331$24173033$1$I$$20240729$20240805$20240805$PER$$US-PFIZER INC-PV202400100898$PFIZER$$73$YR$$$Y$$$20240805$$CN$US$US
241730341$24173034$1$I$$20240728$20240805$20240805$PER$$US-PFIZER INC-PV202400099315$PFIZER$$$$$$Y$$$20240805$$CN$US$US
241730351$24173035$1$I$20240725$20240726$20240805$20240805$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00750$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
241730361$24173036$1$I$20240727$20240728$20240805$20240805$PER$$US-PFIZER INC-202400225202$PFIZER$$71$YR$$F$Y$$$20240805$$CN$US$US
241730373$24173037$3$F$$20240911$20240805$20240911$30DAY$$US-PFIZER INC-202400227642$PFIZER$$11$YR$$M$Y$32.653$KG$20240911$$MD$US$US
241730382$24173038$2$F$20240701$20240802$20240805$20240807$PER$$US-PFIZER INC-202400226852$PFIZER$$49$YR$$M$Y$$$20240807$$CN$US$US
241730392$24173039$2$F$20240724$20240804$20240805$20240807$PER$$US-PFIZER INC-202400225113$PFIZER$$50$YR$$F$Y$$$20240807$$CN$US$US
241730403$24173040$3$F$20240416$20240803$20240805$20240809$30DAY$$JP-PFIZER INC-PV202400050928$PFIZER$$$$$$Y$$$20240809$$HP$JP$JP
241730411$24173041$1$I$$20240729$20240805$20240805$PER$$US-PFIZER INC-202400226893$PFIZER$$34$YR$$F$Y$$$20240805$$CN$US$US
241730421$24173042$1$I$$20240731$20240805$20240805$PER$$US-PFIZER INC-PV202400100283$PFIZER$$72$YR$$F$Y$$$20240805$$CN$US$US
241730431$24173043$1$I$$20240729$20240805$20240805$PER$$US-PFIZER INC-202400226976$PFIZER$$70$YR$$F$Y$$$20240805$$HP$US$US
241730441$24173044$1$I$$20240802$20240805$20240805$EXP$$GB-MYLANLABS-2024M1072728$MYLAN$$$$$M$Y$$$20240805$$PH$GB$GB
241730451$24173045$1$I$$20240725$20240805$20240805$PER$$US-INCYTE CORPORATION-2024IN007820$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241730462$24173046$2$F$20240701$20240821$20240805$20240822$PER$$US-ALXN-202407USA001962US$ALEXION PHARMACEUTICALS$$65$YR$$F$Y$$$20240822$$CN$US$US
241730471$24173047$1$I$20240725$20240730$20240805$20240805$EXP$$US-ABBVIE-5864476$ABBVIE$$81$YR$$M$Y$$$20240805$$CN$US$US
241730481$24173048$1$I$20240424$20240729$20240805$20240805$EXP$PT-INFARMED-J202407-464$PT-FreseniusKabi-FK202411882$FRESENIUS KABI$$68$YR$E$F$Y$$$20240805$$PH$PT$PT
241730491$24173049$1$I$$20240725$20240805$20240805$EXP$$US-FreseniusKabi-FK202411931$FRESENIUS KABI$Spitz A, Shi H, Panjawatanan P, Skarda C, Shahsavari S, Welch T. Late-onset amiodarone-induced thyrotoxicosis (AIT) causing recurrent heart failure with reduced ejection fraction. Journal of the American College of Cardiology. 2024 Apr 02;83(13): doi:https://dx.doi.org/10.1016/S0735-1097%2824%2905172-6.$58$YR$A$M$Y$$$20240805$$HP$US$US
241730501$24173050$1$I$20240728$20240730$20240805$20240805$EXP$$CN-FreseniusKabi-FK202411964$FRESENIUS KABI$$48$YR$A$F$Y$90$KG$20240805$$HP$CN$CN
241730511$24173051$1$I$20230818$20240729$20240805$20240805$EXP$$FR-FreseniusKabi-FK202411867$FRESENIUS KABI$$$$E$F$Y$$$20240805$$HP$FR$FR
241730521$24173052$1$I$$20240721$20240805$20240805$EXP$$JP-Saptalis Pharmaceuticals LLC-2160016$SAPTALIS PHARMACEUTICALS$The case is a PubMed -literature (Forign) of 45-year-old diabetic woman on metformin therapy presented with severe lactic acidosis. A 71-g metformin packet was found at the patient^s home, suggesting an overdose. Severe lactic acidosis and hypotension persisted. Methylene blue was administered 32 h from the onset, which improved her metabolic and circulatory status. This case represents severe metformin intoxication that was treated with methylene blue (MB).$45$YR$$F$Y$$$20240805$$$US$JP
241730532$24173053$2$F$$20240805$20240805$20240812$EXP$$BR-NALPROPION PHARMACEUTICALS INC.-BR-2024CUR003662$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$BR$BR
241730541$24173054$1$I$$20240722$20240805$20240805$EXP$$JP-INSMED, INC.-2024-02992-JP$INSMED$$69$YR$$F$Y$$$20240805$$CN$JP$JP
241730552$24173055$2$F$20240701$20240808$20240805$20240821$EXP$$JP-INSMED, INC.-2024-03026-JP$INSMED$$72$YR$$F$Y$$$20240821$$MD$JP$JP
241730561$24173056$1$I$$20240722$20240805$20240805$PER$$US-COSETTE-CP2024US000189$COSETTE PHARMACEUTICALS$$66$YR$E$M$Y$165$KG$20240805$$CN$US$US
241730571$24173057$1$I$20240726$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123381$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240805$$CN$US$US
241730581$24173058$1$I$20240730$20240803$20240805$20240805$PER$$US-BAYER-2024A112383$BAYER$$65$YR$E$F$Y$$$20240805$$CN$US$US
241730593$24173059$3$F$$20240827$20240805$20240906$PER$$US-BAYER-2024A109951$BAYER$$25$YR$A$F$Y$56.7$KG$20240906$$CN$US$US
241730602$24173060$2$F$20240801$20240826$20240805$20240905$PER$$US-GRUNENTHAL-2024-123769$AVERITAS$$81$YR$$M$Y$$$20240905$$HP$US$US
241730611$24173061$1$I$20210101$20240802$20240805$20240805$EXP$GB-MHRA-31390098$GB-JNJFOC-20240809494$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$GB$GB
241730622$24173062$2$F$20240731$20240731$20240805$20240807$PER$$US-JNJFOC-20240784635$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240807$$CN$US$US
241730631$24173063$1$I$20240701$20240726$20240805$20240805$PER$$US-ABBVIE-5856931$ABBVIE$$59$YR$$F$Y$58.513$KG$20240805$$CN$US$US
241730651$24173065$1$I$$20240730$20240805$20240805$EXP$$GB-TAKEDA-2024TUS077379$TAKEDA$$$$$M$Y$$$20240805$$CN$GB$GB
241730661$24173066$1$I$$20240727$20240805$20240805$EXP$$US-TAKEDA-2024TUS076487$TAKEDA$$$$$M$Y$$$20240805$$CN$US$US
241730671$24173067$1$I$20240701$20240730$20240805$20240805$PER$$US-BIOGEN-2024BI01276120$BIOGEN$$49$YR$$F$Y$$$20240805$$CN$US$US
241730681$24173068$1$I$$20240730$20240805$20240805$PER$$US-BIOGEN-2024BI01276245$BIOGEN$$$$$$Y$$$20240805$$CN$US$US
241730691$24173069$1$I$$20240729$20240805$20240805$EXP$$US-BAYER-2024A111194$BAYER$$$$$$Y$$$20240805$$CN$US$US
241730701$24173070$1$I$$20240729$20240805$20240805$PER$$US-BAYER-2024A109626$BAYER$$18$YR$A$F$Y$$$20240805$$HP$US$US
241730711$24173071$1$I$20240101$20240729$20240805$20240805$EXP$$US-SA-2024SA226635$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240805$$MD$US$US
241730721$24173072$1$I$$20240802$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123139$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$90.26$KG$20240805$$CN$US$US
241730731$24173073$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122224$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$104$KG$20240805$$PH$US$US
241730751$24173075$1$I$$20240723$20240805$20240805$EXP$$IN-LUPIN LIMITED-2024-07415$LUPIN$Ancilla LC, Sundaram B, Pathak N, Raj A. Twin neurological enigmas radiological and medical insight into a dual encounter with Metformin induced encephalopathy. Journal of Nephropharmacology. 2024;13(2):1-5$58$YR$$M$Y$$$20240805$$HP$IN$IN
241730761$24173076$1$I$$20240802$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001134$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240805$$CN$US$US
241730772$24173077$2$F$20240727$20240806$20240805$20240809$EXP$$GB-MYLANLABS-2024M1050990$MYLAN$$73$YR$$M$Y$$$20240809$$MD$GB$GB
241730781$24173078$1$I$$20240729$20240805$20240805$PER$$US-BAYER-2024A109921$BAYER$$23$YR$A$F$Y$58$KG$20240805$$CN$US$US
241730791$24173079$1$I$20230215$20240802$20240805$20240805$EXP$FR-AFSSAPS-MA2024001061$FR-ROCHE-10000047478$ROCHE$$83$YR$E$M$Y$91$KG$20240805$$PH$FR$FR
241730802$24173080$2$F$$20240805$20240805$20240807$PER$$US-ROCHE-10000047508$ROCHE$$$$$F$Y$$$20240807$$CN$US$US
241730811$24173081$1$I$20240407$20240731$20240805$20240805$EXP$$CO-SA-2024SA116962$SANOFI AVENTIS$$69$YR$E$F$Y$58$KG$20240805$$CN$CO$CO
241730821$24173082$1$I$$20240731$20240805$20240805$EXP$$US-SA-2024SA227281$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$HP$US$US
241730831$24173083$1$I$20240101$20240731$20240805$20240805$EXP$$US-SA-2024SA229535$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240805$$MD$US$US
241730841$24173084$1$I$$20240731$20240805$20240805$EXP$$US-SA-2024SA229551$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240805$$MD$US$US
241730862$24173086$2$F$$20240913$20240805$20240916$30DAY$$US-PFIZER INC-202400228187$PFIZER$$$$$$Y$$$20240916$$CN$US$US
241730872$24173087$2$F$$20240928$20240805$20240930$30DAY$$CO-PFIZER INC-202400222794$PFIZER$$7$YR$$F$Y$$$20240930$$CN$CO$CO
241730881$24173088$1$I$$20240730$20240805$20240805$EXP$$CN-PFIZER INC-PV202400099299$PFIZER$Tao, Y.. Tropheryma whipplei pneumonia revealed by Metagenomic next-generation sequencing: Report of two cases. Diagnostic Microbiology and Infectious Disease. 2024;110 (1):10.1016/j.diagmicrobio.2024.11$60$YR$$F$Y$$$20240805$$HP$CN$CN
241730891$24173089$1$I$20240701$20240730$20240805$20240805$30DAY$$CL-PFIZER INC-202400227627$PFIZER$$12$YR$$M$Y$$$20240805$$CN$CL$CL
241730911$24173091$1$I$20230801$20240729$20240805$20240805$EXP$$JP-PFIZER INC-202400226958$PFIZER$Moriuchi, K.. O4-3: Clinical experience with benzylpenicillin benzathine intramuscular preparation for syphilis complicating pregnancy. The 40th Annual Meeting of the Japan Society for Infectious Diseases in Obstetri. 2024;40:102$$$N$F$Y$3.666$KG$20240805$$MD$JP$JP
241730931$24173093$1$I$$20240731$20240805$20240805$EXP$$US-KYOWAKIRIN-2024KK018516$KYOWA$$$$$$Y$$$20240805$$HP$US$US
241730942$24173094$2$F$20240101$20240925$20240805$20240925$EXP$$US-PFIZER INC-202400227265$PFIZER$$14$YR$$M$Y$$$20240925$$CN$US$US
241730953$24173095$3$F$20240701$20240808$20240805$20240808$30DAY$$US-PFIZER INC-202400226016$PFIZER$$14$YR$$M$Y$51.71$KG$20240808$$CN$US$US
241730962$24173096$2$F$$20240904$20240805$20240904$30DAY$$US-PFIZER INC-202400222858$PFIZER$$10$YR$$F$Y$$$20240904$$HP$US$US
241730972$24173097$2$F$$20240805$20240805$20240809$30DAY$$US-PFIZER INC-PV202400044364$PFIZER$$$$$$Y$$$20240809$$HP$US$US
241730981$24173098$1$I$$20240731$20240805$20240805$30DAY$$FR-PFIZER INC-PV202400028722$PFIZER$$8$YR$$F$Y$$$20240805$$HP$FR$FR
241730991$24173099$1$I$20230720$20240801$20240805$20240805$30DAY$$US-PFIZER INC-202400095579$PFIZER$$$$$M$Y$$$20240805$$HP$US$US
241731003$24173100$3$F$20231224$20240814$20240805$20240819$30DAY$$US-PFIZER INC-PV202400044259$PFIZER$$$$$$Y$$$20240819$$HP$US$US
241731012$24173101$2$F$$20240925$20240805$20240925$30DAY$$CO-PFIZER INC-PV202400099853$PFIZER$$14$YR$$M$Y$$$20240925$$CN$CO$CO
241731024$24173102$4$F$20231209$20240903$20240805$20240906$30DAY$$US-PFIZER INC-PV202400044254$PFIZER$$$$$$Y$$$20240906$$HP$US$US
241731032$24173103$2$F$$20240904$20240805$20240904$30DAY$$US-PFIZER INC-202400226957$PFIZER$$12$YR$$M$Y$$$20240904$$CN$US$US
241731043$24173104$3$F$$20240904$20240805$20240904$30DAY$$US-PFIZER INC-202400227118$PFIZER$$14$YR$$M$Y$$$20240904$$CN$US$US
241731054$24173105$4$F$$20240926$20240805$20240930$30DAY$$CA-PFIZER INC-202400229286$PFIZER$$$$$$Y$$$20240930$$HP$CA$CA
241731062$24173106$2$F$$20240924$20240805$20240927$30DAY$$US-PFIZER INC-202400222953$PFIZER$$13$YR$$F$Y$45.36$KG$20240927$$CN$US$US
241731072$24173107$2$F$$20240805$20240805$20240819$30DAY$$US-PFIZER INC-PV202400044278$PFIZER$$$$$$Y$$$20240819$$CN$US$US
241731081$24173108$1$I$20240701$20240730$20240805$20240805$EXP$$CA-PFIZER INC-202400227813$PFIZER$$79$YR$$F$Y$$$20240805$$HP$CA$CA
241731092$24173109$2$F$$20240905$20240805$20240905$30DAY$$US-PFIZER INC-202400226241$PFIZER$$5$YR$$F$Y$$$20240905$$CN$US$US
241731123$24173112$3$F$20221031$20240905$20240805$20240912$30DAY$$US-PFIZER INC-202400226077$PFIZER$$8$YR$$F$Y$30.839$KG$20240912$$CN$US$US
241731142$24173114$2$F$$20240904$20240805$20240904$30DAY$$US-PFIZER INC-202400227027$PFIZER$$15$YR$$M$Y$33.57$KG$20240904$$CN$US$US
241731152$24173115$2$F$20240731$20240807$20240805$20240819$30DAY$$AR-PFIZER INC-202400228349$PFIZER$$12$YR$$M$Y$$$20240819$$CN$AR$AR
241731161$24173116$1$I$20240722$20240723$20240805$20240805$30DAY$$AR-PFIZER INC-202400222896$PFIZER$$7$YR$$M$Y$$$20240805$$HP$AR$AR
241731171$24173117$1$I$20230809$20240801$20240805$20240805$30DAY$$US-PFIZER INC-PV202400044147$PFIZER$$$$$$Y$$$20240805$$CN$US$US
241731183$24173118$3$F$$20240917$20240805$20240920$30DAY$$US-PFIZER INC-202400226163$PFIZER$$12$YR$$M$Y$33.57$KG$20240920$$CN$US$US
241731202$24173120$2$F$20231209$20240802$20240805$20240808$30DAY$$US-PFIZER INC-PV202400044232$PFIZER$$$$$$Y$$$20240808$$HP$US$US
241731211$24173121$1$I$20240701$20240730$20240805$20240805$PER$$US-BAYER-2024A110415$BAYER$$28$YR$A$F$Y$$$20240805$$MD$US$US
241731221$24173122$1$I$20240724$20240802$20240805$20240805$EXP$$CN-ROCHE-10000048381$ROCHE$$61$YR$A$F$Y$60$KG$20240805$$HP$CN$CN
241731232$24173123$2$F$$20240806$20240805$20240806$30DAY$$US-PFIZER INC-202400226166$PFIZER$$$$$M$Y$$$20240806$$CN$US$US
241731242$24173124$2$F$$20240928$20240805$20240930$EXP$$AR-PFIZER INC-202400227448$PFIZER$$21$YR$$M$Y$$$20240930$$CN$AR$AR
241731256$24173125$6$F$$20240819$20240805$20240822$30DAY$$AR-PFIZER INC-202400228301$PFIZER$$6$YR$$M$Y$$$20240822$$HP$AR$AR
241731271$24173127$1$I$20231221$20240801$20240805$20240805$30DAY$$US-PFIZER INC-PV202400044263$PFIZER$$$$$$Y$$$20240805$$HP$US$US
241731284$24173128$4$F$20240701$20240927$20240805$20240927$30DAY$$CO-PFIZER INC-202400226585$PFIZER$$11$YR$$M$Y$$$20240927$$CN$CO$CO
241731292$24173129$2$F$$20240824$20240805$20240826$30DAY$$US-PFIZER INC-202400220750$PFIZER$$15$YR$$M$Y$$$20240826$$CN$US$US
241731311$24173131$1$I$20240129$20240730$20240805$20240805$EXP$FR-AFSSAPS-AVMA2024000328$FR-MYLANLABS-2024M1070779$MYLAN$$63$YR$$M$Y$$$20240805$$PH$FR$FR
241731321$24173132$1$I$$20240730$20240805$20240805$EXP$NL-LRB-00993360$NL-MYLANLABS-2024M1071149$MYLAN$$23$YR$$M$Y$70$KG$20240805$$MD$NL$NL
241731331$24173133$1$I$$20240729$20240805$20240805$EXP$$AU-AMNEAL PHARMACEUTICALS-2024-AMRX-02806$AMNEAL$Turow A, Yong TY, Fok JS, Li JY.. Azathioprine hypersensitivity presenting as cardiogenic shock and Sweet^s syndrome in a patient with microscopic polyangiitis. Intern Med. 2012;51(14):1889-92$69$YR$$F$Y$$$20240805$$HP$AU$AU
241731341$24173134$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53629$$FDA-CTU$$38$YR$$F$N$77.11$KG$20240805$N$$US$
241731353$24173135$3$F$20230228$20231117$20240805$20240806$EXP$$NVSC2023US247428$NOVARTIS$$75$YR$$M$Y$72$KG$20240806$$HP$US$US
241731362$24173136$2$F$$20240829$20240805$20240901$PER$$US-JNJFOC-20240778320$JOHNSON AND JOHNSON$$$$$M$Y$$$20240901$$HP$US$US
241731371$24173137$1$I$20180101$20240729$20240805$20240805$EXP$$PT-FreseniusKabi-FK202408863$FRESENIUS KABI$$73$YR$E$M$Y$$$20240805$$MD$PT$PT
241731381$24173138$1$I$20240702$20240802$20240805$20240805$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043713$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240805$$CN$US$US
241731391$24173139$1$I$$20240730$20240805$20240805$EXP$$US-TAKEDA-2024TUS077153$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
241731401$24173140$1$I$20230201$20240729$20240805$20240805$EXP$$PT-009507513-2408PRT000440$MERCK$$81$YR$$$Y$$$20240805$$MD$PT$PT
241731414$24173141$4$F$$20240828$20240805$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123343$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$45.36$KG$20240830$$CN$US$US
241731421$24173142$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123350$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240805$$CN$US$US
241731431$24173143$1$I$$20240724$20240805$20240805$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK092821$GLENMARK$$$$$$Y$$$20240805$$MD$GB$GB
241731441$24173144$1$I$$20240726$20240805$20240805$EXP$$US-BEH-2024176482$CSL BEHRING$$$$E$F$Y$$$20240805$$CN$US$US
241731451$24173145$1$I$20240101$20240801$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123312$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240805$$CN$US$US
241731461$24173146$1$I$$20240729$20240805$20240805$EXP$$US-GSK-US2024094848$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$MD$US$US
241731472$24173147$2$F$20240617$20240919$20240805$20240926$EXP$$US-KYOWAKIRIN-2024KK018552$KYOWA$$$$$$Y$$$20240926$$HP$US$US
241731481$24173148$1$I$20231201$20240729$20240805$20240805$EXP$$GB-ABBVIE-5862248$ABBVIE$$75$YR$$F$Y$$$20240805$$CN$GB$GB
241731491$24173149$1$I$$20230907$20240805$20240805$EXP$$AE-SANDOZ INC.-SDZ2023AE039426$SANDOZ$$$$$$Y$$$20240805$$HP$AE$AE
241731501$24173150$1$I$$20230905$20240805$20240805$EXP$$AU-SANDOZ INC.-SDZ2023AU049482$SANDOZ$$$$$$Y$$$20240805$$HP$AU$AU
241731512$24173151$2$F$20240101$20240801$20240805$20240807$EXP$$US-ABBVIE-5863675$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241731521$24173152$1$I$$20240729$20240805$20240805$PER$$US-JNJFOC-20240782831$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241731531$24173153$1$I$20240730$20240802$20240805$20240805$EXP$$US-KYOWAKIRIN-2024KK018627$KYOWA$$$$$$Y$$$20240805$$HP$US$US
241731541$24173154$1$I$$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152343$AMGEN$$$$$M$Y$$$20240805$$CN$US$US
241731551$24173155$1$I$$20240726$20240805$20240805$EXP$$US-APOTEX-2024AP009015$APOTEX$Gupta NY, Al Diffalha S, Russ KB.. An Unusual Case of Colitis in a Bone Marrow Transplant Patient. Gastroenterology. 2024;167 (3):e1-e4$65$YR$$M$Y$$$20240805$$HP$US$US
241731561$24173156$1$I$20090820$20240802$20240805$20240805$EXP$$FR-SANDOZ INC.-SDZ2024FR070089$SANDOZ$$56$YR$$M$Y$$$20240805$$HP$FR$FR
241731571$24173157$1$I$20240727$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174396$ASTRAZENECA$$$$$M$Y$$$20240805$$MD$US$
241731592$24173159$2$F$$20240806$20240805$20240809$EXP$$DE-PFIZER INC-202400228906$PFIZER$Schott-Seidenschwanz, I.. Todesfalle Metamizol?. BREMER AERZTEJOURNAL. 2011;64:20$70$YR$$F$Y$$$20240809$$MD$DE$DE
241731602$24173160$2$F$20240722$20240812$20240805$20240822$PER$$US-INCYTE CORPORATION-2024IN007842$INCYTE$$$$$$Y$$$20240822$$CN$US$US
241731611$24173161$1$I$$20240802$20240805$20240805$EXP$IT-EMA-DD-20240729-7482655-083756$IT-SANDOZ INC.-SDZ2024IT070103$SANDOZ$$15$YR$$F$Y$48$KG$20240805$$HP$IT$IT
241731622$24173162$2$F$20220509$20240806$20240805$20240808$EXP$$KR-PFIZER INC-PV202400100244$PFIZER$$51$YR$$F$Y$55$KG$20240808$$MD$KR$KR
241731631$24173163$1$I$$20240731$20240805$20240805$EXP$$CN-PFIZER INC-PV202400099942$PFIZER$Song, Y.. Recurrent spontaneous pneumothorax secondary to lung cystic lesions in a case of convalescent COVID-19: a case report and literature review. BMC Pulmonary Medicine. 2024;24(1):10.1186/s12890-024-03169-5$81$YR$$M$Y$$$20240805$$HP$CN$CN
241731643$24173164$3$F$20240719$20240812$20240805$20240819$EXP$$BR-PFIZER INC-PV202400100521$PFIZER$$71$YR$$F$Y$53.1$KG$20240819$$HP$BR$BR
241731671$24173167$1$I$$20240730$20240805$20240805$EXP$$FR-PFIZER INC-202400226743$PFIZER$Abisror, N.. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.. American Journal of Reproductive Immunology. 2024;92:1-6$37$YR$$F$Y$$$20240805$$HP$FR$FR
241731681$24173168$1$I$$20240802$20240805$20240805$PER$$US-HALEON-2190376$Haleon PLC$$66$YR$$F$Y$$$20240805$$CN$US$US
241731691$24173169$1$I$$20240729$20240805$20240805$EXP$$US-009507513-2407USA015638$MERCK$$$$$M$Y$$$20240805$$CN$US$US
241731701$24173170$1$I$$20240801$20240805$20240805$EXP$$JP-ABBVIE-5864810$ABBVIE$$$$$$Y$$$20240805$$PH$JP$JP
241731713$24173171$3$F$$20240902$20240805$20240910$EXP$$JP-009507513-2407JPN005510J$MERCK$Wasamoto S, Yui T, Kouzu Y, Takechi H, Yanagisawa S, Oura N. 15. A case of lung adenocarcinoma in which Sjogren^s syndrome was caused during treatment with Pemetrexed and Pembrolizumab.. The 125th Chubu Branch Meeting of The Japan Lung Cancer Society. 11$63$YR$$M$Y$$$20240910$$MD$JP$JP
241731721$24173172$1$I$20240704$20240804$20240804$20240804$DIR$712861$$FDA-CTU$$68$YR$$M$N$87.75$KG$20240804$Y$CN$US$
241731731$24173173$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53657$$FDA-CTU$$65$YR$$F$N$67.13$KG$20240805$N$$US$
241731741$24173174$1$I$$20240802$20240805$20240805$30DAY$$US-SANDOZ INC.-SDZ2024US070056$SANDOZ$$$$$$Y$$$20240805$$MD$US$US
241731751$24173175$1$I$20240804$20240804$20240804$20240804$DIR$712893$$FDA-CTU$$34$YR$$F$N$$$20240804$N$CN$US$
241731761$24173176$1$I$$20240730$20240805$20240805$PER$$US-TAKEDA-2024TUS076803$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
241731771$24173177$1$I$20240305$20240730$20240805$20240805$EXP$GR-GREOF-202400829$GR-MYLANLABS-2024M1071636$MYLAN$$40$YR$$M$Y$85$KG$20240805$$MD$GR$GR
241731781$24173178$1$I$$20240730$20240805$20240805$EXP$$US-MYLANLABS-2024M1071428$MYLAN$$$$$$Y$$$20240805$$LW$US$US
241731791$24173179$1$I$20240804$20240804$20240804$20240804$DIR$712875$$FDA-CTU$$14$YR$$F$N$49.5$KG$20240804$N$CN$US$
241731811$24173181$1$I$$20240730$20240805$20240805$EXP$$IR-MYLANLABS-2024M1072200$MYLAN$Alipour S, Gholami B, Orouji M, Heydari S. Imiquimod as a new treatment in refractory idiopathic granulomatous mastitis: report of two cases. DARU 2024; 32 (1): 443-447.$40$YR$$F$Y$$$20240805$$HP$IR$IR
241731822$24173182$2$F$$20240815$20240805$20240822$EXP$$ES-MYLANLABS-2024M1071306$MYLAN$Anto, C. Use of isavuconazole in children with invasive fungal infection: experience in a paediatric and tertiary care centre. 69? Congreso de la Asociacion Espanola de Pediatria (AEP) : Libro de comunicacio. 2023;493$16$YR$$F$Y$52$KG$20240822$$MD$ES$ES
241731831$24173183$1$I$20240703$20240730$20240805$20240805$EXP$FR-AFSSAPS-PV2024000680$FR-MYLANLABS-2024M1071171$MYLAN$$14$YR$$M$Y$32$KG$20240805$$MD$FR$FR
241731851$24173185$1$I$$20240730$20240805$20240805$EXP$DE-BFARM-24005167$DE-MYLANLABS-2024M1071229$MYLAN$$61$YR$$M$Y$$$20240805$$CN$DE$DE
241731861$24173186$1$I$20240616$20240730$20240805$20240805$EXP$FR-AFSSAPS-PB2024000796$FR-MYLANLABS-2024M1071165$MYLAN$$22$YR$$F$Y$59$KG$20240805$$MD$FR$FR
241731871$24173187$1$I$$20240730$20240805$20240805$EXP$$DE-MYLANLABS-2024M1071613$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$5$YR$$M$Y$$$20240805$$HP$DE$DE
241731882$24173188$2$F$$20240827$20240805$20240830$EXP$$AT-MYLANLABS-2024M1071524$MYLAN$Spanberger T.,. Therapeutic success in the relapse of multiple myeloma. Spectrum Onkologie. 2024;99$66$YR$$F$Y$$$20240830$$MD$AT$AT
241731891$24173189$1$I$20240710$20240804$20240804$20240804$DIR$712870$$FDA-CTU$$45$YR$$F$N$57.15$KG$20240804$N$CN$US$
241731901$24173190$1$I$20220423$20240804$20240804$20240804$DIR$712872$$FDA-CTU$$28$YR$$M$N$74.25$KG$20240804$N$CN$US$
241731911$24173191$1$I$$20240801$20240805$20240805$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043420$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240805$$CN$US$US
241731922$24173192$2$F$$20240809$20240805$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120323$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240814$$HP$US$US
241731935$24173193$5$F$20220101$20240902$20240805$20240904$EXP$$DE-ABBVIE-4706905$ABBVIE$$51$YR$$M$Y$$$20240904$$MD$DE$DE
241731943$24173194$3$F$20240207$20240919$20240805$20240928$EXP$$CA-CELLTRION INC.-2024CA003746$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
241731961$24173196$1$I$20240701$20240801$20240805$20240805$EXP$$TW-JNJFOC-20240760358$JOHNSON AND JOHNSON$$34$YR$A$F$Y$87$KG$20240805$$CN$TW$TW
241731971$24173197$1$I$$20240726$20240805$20240805$EXP$$GB-Ascend Therapeutics US, LLC-2160019$ASCEND$$48$YR$$M$Y$108$KG$20240805$$$GB$GB
241731981$24173198$1$I$$20240730$20240805$20240805$PER$$US-BIOGEN-2024BI01276264$BIOGEN$$$$$M$Y$$$20240805$$CN$US$US
241731991$24173199$1$I$$20240730$20240805$20240805$EXP$$AU-JNJFOC-20240801236$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$PH$AU$AU
241732001$24173200$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008964$APOTEX$$85$YR$$M$Y$$$20240805$$CN$CA$CA
241732011$24173201$1$I$20240709$20240712$20240805$20240805$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000618$PAREXEL$$$$$$Y$$$20240805$$PH$US$US
241732021$24173202$1$I$$20240731$20240805$20240805$EXP$$JP-EXELIXIS-CABO-24080157$EXELIXIS$$89$YR$$M$Y$$$20240805$$MD$JP$JP
241732031$24173203$1$I$20240801$20240802$20240805$20240805$EXP$$AU-MYLANLABS-2024M1072025$MYLAN$$37$YR$$F$Y$$$20240805$$PH$AU$AU
241732041$24173204$1$I$20230101$20240702$20240805$20240805$EXP$$SG-EXELIXIS-CABO-24077148$EXELIXIS$$$$$$Y$$$20240805$$MD$SG$SG
241732051$24173205$1$I$$20240731$20240805$20240805$EXP$$CA-EXELIXIS-CABO-24080164$EXELIXIS$$$$A$M$Y$$$20240805$$PH$CA$CA
241732061$24173206$1$I$20240729$20240801$20240805$20240805$EXP$$CN-JNJFOC-20240805222$JOHNSON AND JOHNSON$$77$YR$E$F$Y$85$KG$20240805$$HP$CN$CN
241732071$24173207$1$I$$20240730$20240805$20240805$PER$$US-ABBVIE-5861238$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241732081$24173208$1$I$20240101$20240805$20240805$20240805$EXP$FR-AFSSAPS-TS2024000872$FR-SANDOZ INC.-SDZ2024FR070429$SANDOZ$$71$YR$$M$Y$98$KG$20240805$$MD$FR$FR
241732092$24173209$2$F$$20240805$20240805$20240808$PER$$US-ORGANON-O2408USA000105$ORGANON$Nanah A, Daw H, Abdelghaffar B.. Venous Thromboembolic Disease Provoked by Hormone-Eluting Vaginal Rings.. American Journal of Therapeutics. 2023;31(4):1-5$26$YR$$F$Y$$$20240808$$HP$US$US
241732101$24173210$1$I$20240802$20240804$20240805$20240805$EXP$$CN-BAYER-2024A112647$BAYER$$58$YR$A$M$Y$60$KG$20240805$$HP$CN$CN
241732111$24173211$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53633$$FDA-CTU$$64$YR$$F$N$$$20240805$N$$US$
241732121$24173212$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53631$$FDA-CTU$$69$YR$$F$N$$$20240805$N$$US$
241732131$24173213$1$I$$20240729$20240805$20240805$EXP$DE-Dr. Reddy^s Laboratories, Inc.-GER/GER/09/0003195$DE-RDY-GER/GER/09/0003195$DR REDDYS$Lange-Asschenfeldt C, Blaeser I, Supprian T. Bipolar switching after carbamazepine withdrawal. Pharmacopsychiatry 2007 Mar; 40(2): 86-87. - Germany$74$YR$E$M$Y$$$20240805$$MD$DE$DE
241732151$24173215$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53658$$FDA-CTU$$54$YR$$M$N$$$20240805$N$$US$
241732161$24173216$1$I$$20240802$20240805$20240805$DIR$FDA-CDER-CTU-2024-53660$$FDA-CTU$$$$$M$N$$$20240802$N$HP$US$
241732171$24173217$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53656$$FDA-CTU$$23$YR$$F$N$$$20240805$N$HP$US$
241732181$24173218$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53617$$FDA-CTU$$67$YR$$F$N$$$20240805$N$HP$US$
241732191$24173219$1$I$20230601$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53620$$FDA-CTU$$57$YR$$F$N$$$20240805$N$$US$
241732201$24173220$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53659$$FDA-CTU$$54$YR$$M$N$$$20240805$N$$US$
241732211$24173221$1$I$$20240723$20240805$20240805$PER$$US-AstraZeneca-2024A171069$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241732221$24173222$1$I$$20240801$20240805$20240805$EXP$$US-ASTELLAS-2024EU007676$ASTELLAS$$$$$M$Y$$$20240805$$CN$US$US
241732231$24173223$1$I$20240301$20240726$20240805$20240805$EXP$$CN-TAKEDA-2024TUS077740$TAKEDA$$66$YR$$F$Y$$$20240805$$CN$CN$CN
241732241$24173224$1$I$$20240801$20240805$20240805$EXP$$US-ALXN-202408USA000016US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240805$$MD$US$US
241732251$24173225$1$I$20240719$20240731$20240805$20240805$EXP$$ZA-AstraZeneca-2024A174582$ASTRAZENECA$$30681$DY$$M$Y$$$20240805$$CN$ZA$
241732261$24173226$1$I$$20220315$20240805$20240805$EXP$$US-AstraZeneca-2022A115373$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241732271$24173227$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA225890$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240805$$MD$US$US
241732281$24173228$1$I$$20240730$20240805$20240805$PER$$US-ABBVIE-5861709$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241732292$24173229$2$F$20240425$20240820$20240805$20240826$EXP$$CA-SANDOZ INC.-SDZ2024CA048494$SANDOZ$$55$YR$$F$Y$$$20240826$$CN$CA$CA
241732301$24173230$1$I$$20220310$20240805$20240805$EXP$$US-AstraZeneca-2022A110665$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241732311$24173231$1$I$$20240730$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2024CA070222$SANDOZ$$61$YR$$M$Y$$$20240805$$CN$CA$CA
241732321$24173232$1$I$$20240731$20240805$20240805$PER$$US-HALEON-2190046$Haleon PLC$$$$$$Y$$$20240805$$CN$US$US
241732331$24173233$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA224576$SANOFI AVENTIS$$$$$F$Y$$$20240805$$MD$US$US
241732342$24173234$2$F$20230701$20240826$20240805$20240828$PER$$FR-JAZZ PHARMACEUTICALS-2023-FR-018514$JAZZ$$$$$$Y$$$20240827$$MD$FR$FR
241732351$24173235$1$I$20231117$20240801$20240805$20240805$EXP$$FR-JNJFOC-20240807187$JOHNSON AND JOHNSON$$71$YR$E$M$Y$57$KG$20240805$$MD$FR$FR
241732361$24173236$1$I$$20240729$20240805$20240805$EXP$$DE-JNJFOC-20240783710$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$MD$DE$DE
241732371$24173237$1$I$20240101$20240728$20240805$20240805$PER$$US-SA-2024SA225958$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240805$$MD$US$US
241732381$24173238$1$I$$20231016$20240805$20240805$EXP$$US-AstraZeneca-2023A236534$ASTRAZENECA$$$$$M$Y$127$KG$20240805$$MD$US$
241732391$24173239$1$I$$20240724$20240805$20240805$EXP$$IR-Hisun Pharmaceuticals-2159992$HISUN PHARMACEUTICALS$Source document$63$YR$$F$Y$$$20240805$$$IR$IR
241732401$24173240$1$I$20240101$20240801$20240805$20240805$EXP$$US-JNJFOC-20240804639$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240805$$CN$US$US
241732411$24173241$1$I$$20230807$20240805$20240805$EXP$$US-AstraZeneca-2023A180578$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241732421$24173242$1$I$$20230613$20240805$20240805$EXP$$CA-AstraZeneca-2023A141050$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$CA$
241732431$24173243$1$I$20210122$20210204$20240805$20240805$EXP$$US-AstraZeneca-2021A006456$ASTRAZENECA$$17582$DY$$F$Y$$$20240805$$CN$US$
241732441$24173244$1$I$20230101$20240726$20240805$20240805$EXP$$CA-ROCHE-10000040823$ROCHE$$14$YR$T$M$Y$$$20240805$$HP$CA$CA
241732452$24173245$2$F$20240715$20240805$20240805$20240808$EXP$$US-BIOGEN-2024BI01276246$BIOGEN$$76$YR$$F$Y$$$20240808$$CN$US$US
241732461$24173246$1$I$20240101$20240729$20240805$20240805$EXP$$GT-BIOGEN-2024BI01276468$BIOGEN$$$$$M$Y$40.8$KG$20240805$$CN$GT$GT
241732471$24173247$1$I$20240725$20240731$20240805$20240805$EXP$$US-ABBVIE-5863801$ABBVIE$$74$YR$$F$Y$$$20240805$$CN$US$US
241732482$24173248$2$F$$20240809$20240805$20240816$PER$$US-CHATTEMPRD-2024OHG025654$CHATTEM$$82$YR$E$F$Y$$$20240816$$CN$US$US
241732501$24173250$1$I$$20240729$20240805$20240805$EXP$$US-BIOGEN-2024BI01275910$BIOGEN$$$$T$$Y$$$20240805$$MD$US$US
241732511$24173251$1$I$$20240730$20240805$20240805$EXP$$AU-AMGEN-AUSSP2024151893$AMGEN$$$$$F$Y$$$20240804$$CN$AU$AU
241732521$24173252$1$I$$20240725$20240805$20240805$EXP$$US-GSK-US2024AMR096093$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$HP$US$US
241732532$24173253$2$F$20240816$20240823$20240805$20240830$EXP$$US-GSK-US2024AMR095920$GLAXOSMITHKLINE$$43$YR$$F$Y$104$KG$20240830$$CN$US$US
241732541$24173254$1$I$$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024153646$AMGEN$Shields C. L.; Desimone J. D.; Dockery P. W. et al.. Bilateral circumscribed choroidal hemangiomas in 2 patients: a rare finding. Canadian Journal of Ophthalmology. 2024;59 (4):e404-e407$51$YR$A$F$Y$$$20240804$$HP$US$US
241732551$24173255$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53635$$FDA-CTU$$44$YR$$F$N$$$20240805$N$$US$
241732561$24173256$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53611$$FDA-CTU$$55$YR$$M$N$$$20240805$N$$US$
241732571$24173257$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122525$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240805$$CN$US$US
241732581$24173258$1$I$$20240731$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122003$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240805$$HP$US$US
241732591$24173259$1$I$20210101$20211208$20240805$20240805$EXP$$US-AstraZeneca-2021A864218$ASTRAZENECA$$51$YR$$M$Y$70.3$KG$20240805$$CN$US$
241732601$24173260$1$I$20240718$20240801$20240805$20240805$EXP$FR-AFSSAPS-PB2024000840$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-122911$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$105$KG$20240805$$MD$FR$FR
241732611$24173261$1$I$20240621$20240731$20240805$20240805$EXP$FR-AFSSAPS-PC2024000632$FR-GSK-FR2024095527$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$HP$FR$FR
241732621$24173262$1$I$$20240726$20240805$20240805$30DAY$$US-GSK-US2024094280$GLAXOSMITHKLINE$$$$$M$Y$$$20240805$$CN$US$US
241732631$24173263$1$I$$20230724$20240805$20240805$EXP$$US-AstraZeneca-2023A169586$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241732641$24173264$1$I$$20240723$20240805$20240805$EXP$$IN-862174955-ML2024-04215$MICRO LABS$Batra CM, Jain S, Kumar KP, Goyal M, Kachroo V, Takkar S, Yadav R. Spontaneous Hypoglycaemia due to Insulin Autoimmune Syndrome in Six Cases, Response to Steroid Therapy and Rituximab. Indian Journal of Endocrinology and Metabolism. 2024 Jun 26; 28(3): 295-301. doi:10.4103/ijem.ijem_378_23.$79$YR$E$F$Y$$$20240805$$MD$IN$IN
241732651$24173265$1$I$$20240604$20240805$20240805$PER$$NL-TOLMAR, INC.-24NL051302$TOLMAR$$$$$M$Y$$$20240805$$CN$NL$NL
241732661$24173266$1$I$$20240724$20240805$20240805$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP009548$STRIDES$Kopernicka G, Chew J.. Acute urinary retention and constipation caused by multi-dermatomal herpes zoster in an immunosuppressed patient.. Clin-Med-London. 2024;24 (Suppl.)$71$YR$$F$Y$$$20240805$$HP$GB$GB
241732671$24173267$1$I$$20230301$20240805$20240805$EXP$$US-AstraZeneca-2023A051934$ASTRAZENECA$$$$$F$Y$70.8$KG$20240805$$CN$US$
241732681$24173268$1$I$20240628$20240708$20240805$20240805$PER$$GT-TOLMAR, INC.-24GT050894$TOLMAR$$80$YR$$M$Y$$$20240805$$MD$GT$GT
241732691$24173269$1$I$20240703$20240708$20240805$20240805$PER$$US-TOLMAR, INC.-24US050831$TOLMAR$$$$$M$Y$$$20240805$$HP$US$US
241732701$24173270$1$I$20240705$20240708$20240805$20240805$PER$$US-TOLMAR, INC.-24US050868$TOLMAR$$73$YR$$M$Y$$$20240805$$HP$US$US
241732711$24173271$1$I$20240708$20240708$20240805$20240805$PER$$US-TOLMAR, INC.-24US050858$TOLMAR$$76$YR$$M$Y$$$20240805$$HP$US$US
241732721$24173272$1$I$$20230714$20240805$20240805$EXP$$US-AstraZeneca-2023A162970$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241732731$24173273$1$I$20201103$20201103$20240805$20240805$EXP$$US-AstraZeneca-2020SF47014$ASTRAZENECA$$17378$DY$$F$Y$$$20240805$$CN$US$
241732741$24173274$1$I$$20220228$20240805$20240805$EXP$$US-AstraZeneca-2022A092274$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241732752$24173275$2$F$20240719$20240725$20240805$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118005$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$PH$JP$JP
241732761$24173276$1$I$20240723$20240728$20240805$20240805$EXP$GB-MHRA-MED-202407271406016560-FKCYN$GB-CHEPLA-2024009952$CHEPLAPHARM$$60$YR$$M$Y$64$KG$20240802$$CN$COUNTRY NOT SPECIFIED$GB
241732771$24173277$1$I$20230427$20230504$20240805$20240805$EXP$$US-AstraZeneca-2023A105333$ASTRAZENECA$$23077$DY$$F$Y$81$KG$20240805$$CN$US$
241732781$24173278$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53603$$FDA-CTU$$59$YR$$M$N$$$20240805$N$$US$
241732791$24173279$1$I$$20230213$20240805$20240805$EXP$$US-AstraZeneca-2023A037126$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241732801$24173280$1$I$$20221003$20240805$20240805$EXP$$US-AstraZeneca-2022A337031$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241732811$24173281$1$I$$20220830$20240805$20240805$EXP$$US-AstraZeneca-2022A304506$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241732821$24173282$1$I$$20220131$20240805$20240805$EXP$$US-AstraZeneca-2022A052490$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241732832$24173283$2$F$20240710$20240827$20240805$20240830$EXP$MT-ADM-07072024$MT-JNJFOC-20240804621$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240830$$PH$MT$MT
241732841$24173284$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153124$AMGEN$Cowen E. W.; Tan I. J.; Ferrada M. A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E I to E8$$$$$Y$$$20240804$$MD$US$US
241732852$24173285$2$F$$20240726$20240805$20240807$PER$$NVSC2024US154713$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
241732861$24173286$1$I$20240301$20240730$20240805$20240805$EXP$$US-TAKEDA-2023TUS094592$TAKEDA$$29$YR$$M$Y$$$20240805$$MD$US$US
241732871$24173287$1$I$20221001$20240729$20240805$20240805$EXP$$GR-CHEPLA-2024009790$CHEPLAPHARM$$47$YR$$F$Y$$$20240802$$MD$COUNTRY NOT SPECIFIED$GR
241732881$24173288$1$I$20240101$20240726$20240805$20240805$PER$$US-ABBVIE-5857917$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241732891$24173289$1$I$$20240801$20240805$20240805$EXP$$CN-TAKEDA-2024TUS077698$TAKEDA$$$$$M$Y$$$20240805$$CN$CN$CN
241732901$24173290$1$I$20240706$20240726$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011679$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241732911$24173291$1$I$20240611$20240730$20240805$20240805$EXP$$EC-VANTIVE-2024VAN018010$Vantive US Healthcare$$84$YR$$F$Y$49.9$KG$20240805$$HP$EC$EC
241732924$24173292$4$F$$20240909$20240805$20240918$EXP$$US-TAKEDA-2024TUS034769$TAKEDA$$$$$F$Y$78$KG$20240918$$CN$US$US
241732931$24173293$1$I$20240424$20240729$20240805$20240805$EXP$$CA-HALEON-2189814$Haleon PLC$$23$YR$$M$Y$62$KG$20240804$$HP$CA$CA
241732942$24173294$2$F$$20240731$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2023CA076654$SANDOZ$$$$$F$Y$$$20240805$$HP$CA$CA
241732951$24173295$1$I$$20240726$20240805$20240805$30DAY$$US-GSK-US2024094294$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241732961$24173296$1$I$$20240726$20240805$20240805$EXP$$GT-EMD Serono-2024040961$EMD SERONO INC$$$$C$F$Y$$$20240805$$CN$GT$GT
241732975$24173297$5$F$20240716$20240822$20240805$20240904$30DAY$$US-JNJFOC-20240744331$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240904$$CN$US$US
241732981$24173298$1$I$20201215$20240723$20240805$20240805$EXP$$EG-NOVOPROD-1260277$NOVO NORDISK$$$$$F$Y$$$20240805$$CN$EG$EG
241732991$24173299$1$I$$20240723$20240805$20240805$EXP$$JP-NOVOPROD-1261039$NOVO NORDISK$$81$YR$$M$Y$$$20240805$$PH$JP$JP
241733001$24173300$1$I$$20240723$20240805$20240805$EXP$$US-NOVOPROD-1260775$NOVO NORDISK$$38$YR$$$Y$$$20240805$$CN$US$US
241733011$24173301$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53581$$FDA-CTU$$77$YR$$M$N$$$20240805$N$$US$
241733021$24173302$1$I$20240601$20240723$20240805$20240805$EXP$$US-NOVOPROD-1260620$NOVO NORDISK$$57$YR$$M$Y$$$20240805$$CN$US$US
241733031$24173303$1$I$$20240723$20240805$20240805$EXP$$JP-NOVOPROD-1261073$NOVO NORDISK$$$$$M$Y$$$20240805$$CN$JP$JP
241733041$24173304$1$I$$20240723$20240805$20240805$EXP$$US-NOVOPROD-1260982$NOVO NORDISK$$$$A$F$Y$$$20240805$$CN$US$US
241733051$24173305$1$I$$20240723$20240805$20240805$EXP$$US-NOVOPROD-1260499$NOVO NORDISK$$$$E$M$Y$$$20240805$$CN$US$US
241733061$24173306$1$I$20240615$20240723$20240805$20240805$EXP$GB-MHRA-MED-202407231305589080-NHVMT$GB-NOVOPROD-1260355$NOVO NORDISK$$52$YR$$F$Y$$$20240805$$PH$GB$GB
241733071$24173307$1$I$20240702$20240723$20240805$20240805$EXP$$US-NOVOPROD-1261665$NOVO NORDISK$$$$$M$Y$$$20240805$$HP$US$US
241733081$24173308$1$I$20240705$20240724$20240805$20240805$EXP$DE-AMK-278111$DE-NOVOPROD-1260497$NOVO NORDISK$$63$YR$$F$Y$$$20240805$$PH$DE$DE
241733092$24173309$2$F$20240308$20240909$20240805$20240912$30DAY$$US-AMGEN-USASP2024150715$AMGEN$$53$YR$A$M$Y$113.38$KG$20240912$$PH$US$US
241733102$24173310$2$F$20240729$20240821$20240805$20240823$PER$$US-ALXN-202407USA002072US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
241733112$24173311$2$F$$20240913$20240805$20240920$EXP$$US-AMGEN-USASP2024153175$AMGEN$$$$$M$Y$$$20240920$$LW$US$US
241733121$24173312$1$I$$20240726$20240805$20240805$EXP$$DE-CELLTRION INC.-2024DE017799$CELLTRION$$$$$$Y$$$20240805$$PH$DE$DE
241733131$24173313$1$I$$20240731$20240805$20240805$EXP$GB-MHRA-31296597$GB-STRIDES ARCOLAB LIMITED-2024SP009636$STRIDES$$55$YR$$F$Y$$$20240805$$PH$GB$GB
241733141$24173314$1$I$$20240709$20240805$20240805$PER$$US-BEIGENE-BGN-2024-010833$BEIGENE$$$$$$Y$$$20240805$$CN$US$US
241733153$24173315$3$F$$20240918$20240805$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003509$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241733161$24173316$1$I$$20240801$20240805$20240805$EXP$$US-AstraZeneca-2024A175705$ASTRAZENECA$$$$$M$Y$$$20240805$$MD$US$
241733171$24173317$1$I$20240701$20240801$20240805$20240805$EXP$$DE-ABBVIE-5865427$ABBVIE$$79$YR$$M$Y$$$20240805$$CN$DE$DE
241733182$24173318$2$F$20240101$20240801$20240805$20240809$EXP$$US-ABBVIE-5864768$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241733191$24173319$1$I$20240529$20240802$20240805$20240805$EXP$BE-FAMHP-DHH-N2024-122424$NVSC2024BE158098$NOVARTIS$$67$YR$$F$Y$85$KG$20240805$$PH$BE$BE
241733201$24173320$1$I$$20221208$20240805$20240805$EXP$$US-AstraZeneca-2022A403401$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241733211$24173321$1$I$$20210602$20240805$20240805$EXP$$US-AstraZeneca-2021A497102$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241733221$24173322$1$I$$20230726$20240805$20240805$EXP$$US-AstraZeneca-2023A171920$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241733231$24173323$1$I$$20220504$20240805$20240805$EXP$$US-AstraZeneca-2022A175342$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241733241$24173324$1$I$$20220927$20240805$20240805$EXP$$TW-AstraZeneca-2022A333255$ASTRAZENECA$$74$YR$$F$Y$$$20240805$$CN$TW$
241733251$24173325$1$I$$20230508$20240805$20240805$EXP$$US-AstraZeneca-2023A108432$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241733261$24173326$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153358$AMGEN$Cowen E. W.; Tan I. J.; Ferrada M. A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes.. JAMA Dermatology. 2024;E1 to E8$$$$$Y$$$20240804$$MD$US$US
241733271$24173327$1$I$$20210915$20240805$20240805$EXP$$AU-AstraZeneca-2021A728864$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$AU$
241733281$24173328$1$I$$20230609$20240805$20240805$EXP$$US-AstraZeneca-2023A135665$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241733292$24173329$2$F$$20240412$20240805$20240916$PER$$US-ENDO USA, INC.-2024-001857$ENDO$$$$$F$Y$$$20240916$$CN$US$US
241733301$24173330$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53650$$FDA-CTU$$71$YR$$M$N$$$20240805$N$$US$
241733311$24173331$1$I$$20240729$20240805$20240805$EXP$$ES-ABBVIE-5865601$ABBVIE$$$$$F$Y$$$20240805$$MD$ES$ES
241733321$24173332$1$I$$20240731$20240805$20240805$EXP$$ZA-HALEON-2190098$Haleon PLC$$$$$$Y$$$20240804$$CN$ZA$ZA
241733331$24173333$1$I$20230201$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152491$AMGEN$$21$YR$A$F$Y$$$20240804$$CN$US$US
241733341$24173334$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003512$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241733351$24173335$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53653$$FDA-CTU$$76$YR$$M$N$$$20240805$N$$US$
241733361$24173336$1$I$20240723$20240726$20240805$20240805$30DAY$$US-GSK-US2024094311$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240805$$CN$US$US
241733371$24173337$1$I$$20240729$20240805$20240805$PER$$US-ABBVIE-5862583$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241733381$24173338$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153424$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes.. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240804$$MD$US$US
241733391$24173339$1$I$20240401$20240726$20240805$20240805$EXP$$GR-TAKEDA-2024TUS076879$TAKEDA$$33$YR$$F$Y$$$20240805$$CN$GR$GR
241733401$24173340$1$I$20231201$20240730$20240805$20240805$EXP$$AR-JNJFOC-20240802030$JOHNSON AND JOHNSON$$73$YR$E$F$Y$52$KG$20240805$$CN$AR$AR
241733411$24173341$1$I$20230322$20240726$20240805$20240805$EXP$$CO-JNJFOC-20240777827$JOHNSON AND JOHNSON$$36$YR$A$M$Y$75$KG$20240805$$HP$CO$CO
241733421$24173342$1$I$20240719$20240801$20240805$20240805$EXP$DE-CADRBFARM-2024329568$DE-JNJFOC-20240806145$JOHNSON AND JOHNSON$$47$YR$A$M$Y$100$KG$20240805$$CN$DE$DE
241733432$24173343$2$F$$20240801$20240805$20240808$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122344$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$98$KG$20240808$$HP$CA$CA
241733442$24173344$2$F$$20240812$20240805$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003515$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
241733452$24173345$2$F$$20240814$20240805$20240823$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000675$DECIPHERA PHARMACEUTICALS$$57$YR$A$M$Y$$$20240823$$CN$US$US
241733461$24173346$1$I$$20240723$20240805$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-037932$AUROBINDO$Anderson M, Brozzi N, Rosenthal R, Hernandez-Montfort J, Reddy R, Gopalan R.. Panel Discussion: Non-cardiac Surgery Interventions on Patients Receiving Impella Support. Interven-Cardiol-(London). 2024;19 (Suppl.):31-34$66$YR$$F$Y$$$20240805$$HP$US$US
241733471$24173347$1$I$20240717$20240717$20240805$20240805$PER$$US-APOTEX-2024AP008578$APOTEX$$$$$$Y$$$20240805$$PH$US$US
241733481$24173348$1$I$$20210709$20240805$20240805$EXP$$US-AstraZeneca-2021A616472$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241733491$24173349$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003516$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241733501$24173350$1$I$$20230110$20240805$20240805$EXP$$US-AstraZeneca-2022A391620$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241733511$24173351$1$I$$20231218$20240805$20240805$EXP$$CA-AstraZeneca-2023A145492$ASTRAZENECA$$$$$F$Y$$$20240805$$HP$CA$
241733521$24173352$1$I$20240626$20240712$20240805$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003517$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240805$$CN$US$US
241733531$24173353$1$I$$20210921$20240805$20240805$EXP$$US-AstraZeneca-2021A735613$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241733542$24173354$2$F$20240728$20240805$20240805$20240807$PER$$US-AMGEN-USASP2024152270$AMGEN$$76$YR$E$F$Y$$$20240807$$CN$US$US
241733551$24173355$1$I$$20240723$20240805$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-037921$AUROBINDO$Sanjeevi A, Clark BL, Aguirre A, Verghese BG. Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature.. Clin-Immunol-Commun. 2024$65$YR$$F$Y$$$20240805$$HP$US$US
241733561$24173356$1$I$$20230929$20240805$20240805$EXP$$US-AstraZeneca-2023A185811$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241733572$24173357$2$F$$20240725$20240805$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038023$AUROBINDO$$62$YR$$M$Y$$$20240807$$HP$CA$CA
241733581$24173358$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001152$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240805$$CN$US$US
241733591$24173359$1$I$$20240730$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2024US070046$SANDOZ$$$$$$Y$$$20240805$$CN$US$US
241733602$24173360$2$F$$20240816$20240805$20240902$PER$$US-APOTEX-2024AP008588$APOTEX$$$$$M$Y$$$20240902$$CN$US$US
241733611$24173361$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001043$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240805$$CN$US$US
241733621$24173362$1$I$$20240726$20240805$20240805$EXP$$GB-EMD Serono-2024041011$EMD SERONO INC$$$$A$F$Y$$$20240805$$CN$GB$GB
241733632$24173363$2$F$$20240809$20240805$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003501$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
241733641$24173364$1$I$20240730$20240730$20240805$20240805$EXP$$US-JNJFOC-20240781067$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$MD$US$US
241733653$24173365$3$F$$20240911$20240805$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003503$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241733661$24173366$1$I$20240719$20240802$20240805$20240805$EXP$$CN-ROCHE-10000047507$ROCHE$$72$YR$E$F$Y$50$KG$20240805$$HP$CN$CN
241733671$24173367$1$I$$20240801$20240805$20240805$EXP$$US-ABBVIE-5864769$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241733681$24173368$1$I$20220601$20230505$20240805$20240805$EXP$$US-AstraZeneca-2023A106248$ASTRAZENECA$$977$MON$$M$Y$$$20240805$$CN$US$
241733691$24173369$1$I$$20230802$20240805$20240805$EXP$$US-AstraZeneca-2023A177324$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241733701$24173370$1$I$20230826$20231128$20240805$20240805$EXP$$US-AstraZeneca-2023A270424$ASTRAZENECA$$21075$DY$$F$Y$$$20240805$$CN$US$
241733711$24173371$1$I$20240711$20240724$20240805$20240805$EXP$GB-MHRA-MED-202407242243288670-HFJDT$GB-NOVOPROD-1260802$NOVO NORDISK$$56$YR$$F$Y$$$20240805$$CN$GB$GB
241733721$24173372$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038197$AUROBINDO$$61$YR$$M$Y$113$KG$20240805$$HP$CA$CA
241733731$24173373$1$I$20210615$20210713$20240805$20240805$EXP$$AR-AstraZeneca-2021A623451$ASTRAZENECA$$26373$DY$$M$Y$$$20240805$$CN$AR$
241733742$24173374$2$F$$20240730$20240805$20240809$EXP$$EG-NOVOPROD-1261717$NOVO NORDISK$$855$MON$$M$Y$95$KG$20240809$$CN$EG$EG
241733751$24173375$1$I$20240717$20240724$20240805$20240805$EXP$$AR-NOVOPROD-1261041$NOVO NORDISK$$$$$M$Y$$$20240805$$CN$AR$AR
241733761$24173376$1$I$20240306$20240724$20240805$20240805$EXP$$US-NOVOPROD-1261498$NOVO NORDISK$$$$$F$Y$$$20240805$$CN$US$US
241733781$24173378$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1261673$NOVO NORDISK$$$$$M$Y$$$20240805$$CN$US$US
241733791$24173379$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1261502$NOVO NORDISK$$$$$M$Y$$$20240805$$CN$US$US
241733801$24173380$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003506$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241733812$24173381$2$F$$20240815$20240805$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003507$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
241733821$24173382$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1261844$NOVO NORDISK$$$$$F$Y$$$20240805$$CN$US$US
241733831$24173383$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262144$NOVO NORDISK$$$$$$Y$$$20240805$$CN$US$US
241733841$24173384$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262196$NOVO NORDISK$$43$YR$$M$Y$$$20240805$$CN$US$US
241733851$24173385$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262117$NOVO NORDISK$$$$$M$Y$$$20240805$$HP$US$US
241733861$24173386$1$I$$20240725$20240805$20240805$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2159995$Chengdu Suncadia Medicine$Clinical analysis of 14 pregnancies in women with renal transplant.$32$YR$$F$Y$$$20240805$$MD$CN$CN
241733871$24173387$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262175$NOVO NORDISK$$49$YR$$F$Y$$$20240805$$CN$US$US
241733881$24173388$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1261790$NOVO NORDISK$$$$$M$Y$$$20240805$$CN$US$US
241733891$24173389$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1261987$NOVO NORDISK$$$$$F$Y$$$20240805$$MD$US$US
241733901$24173390$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038651$AUROBINDO$$66$YR$$M$Y$$$20240805$$HP$CA$CA
241733911$24173391$1$I$$20240724$20240805$20240805$EXP$$HU-PDX-000381$PHARMADAX$Kovacs M, Fogarasi A, Hegyi M, Siegler Z, Kelemen A, Mellar M, et al. Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort. Epileptic Disord. 2024 Jul 17. doi: 10.1002/epd2.20264.$4$YR$C$F$Y$$$20240805$$HP$HU$HU
241733921$24173392$1$I$$20240724$20240805$20240805$EXP$$HU-PDX-000379$PHARMADAX$Kovacs M, Fogarasi A, Hegyi M, Siegler Z, Kelemen A, Mellar M, et al. Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort. Epileptic Disord. 2024 Jul 17. doi: 10.1002/epd2.20264.$4$YR$C$F$Y$$$20240805$$HP$HU$HU
241733931$24173393$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153359$AMGEN$Cowen E. W.; Tan I. J.; Ferrada M. A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240804$$MD$US$US
241733942$24173394$2$F$20240101$20240911$20240805$20240923$EXP$$US-NOVOPROD-1261836$NOVO NORDISK$$72$YR$$M$Y$$$20240923$$CN$US$US
241733951$24173395$1$I$20240731$20240731$20240805$20240805$EXP$$JP-TAKEDA-2024TJP011516$TAKEDA$$5$DEC$$M$Y$$$20240805$$MD$JP$JP
241733961$24173396$1$I$$20240731$20240805$20240805$EXP$$DE-AMGEN-DEUSP2024153123$AMGEN$$$$$M$Y$$$20240804$$MD$DE$DE
241733971$24173397$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152956$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E I to E8$$$$$Y$$$20240804$$MD$US$US
241733981$24173398$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001288$ELI LILLY AND CO$$$$$F$Y$$$20240805$$CN$US$US
241733992$24173399$2$F$$20240802$20240805$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408001897$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240807$$CN$US$US
241734001$24173400$1$I$$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019863$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240805$$CN$US$US
241734011$24173401$1$I$20240705$20240729$20240805$20240805$EXP$FR-AFSSAPS-AN2024000973$FR-BEH-2024176479$CSL BEHRING$$79$YR$E$M$Y$$$20240805$$MD$FR$FR
241734021$24173402$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152697$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240804$$MD$US$US
241734031$24173403$1$I$$20240726$20240805$20240805$EXP$$GR-BIOCON BIOLOGICS LIMITED-BBL2024005580$BIOCON$$$$$$Y$$$20240805$$MD$GR$GR
241734041$24173404$1$I$$20240726$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011632$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241734051$24173405$1$I$$20221222$20240805$20240805$EXP$$US-AstraZeneca-2022A415329$ASTRAZENECA$$$$A$$Y$$$20240805$$CN$US$
241734071$24173407$1$I$$20230824$20240805$20240805$EXP$$US-AstraZeneca-2023A194398$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241734081$24173408$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003555$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
241734091$24173409$1$I$$20240726$20240805$20240805$PER$$US-APOTEX-2024AP009029$APOTEX$Lam L, Bansal V, Chai T, Driver LC. Recurrent Pain From Chemotherapy- Induced Peripheral Neuropathy After COVID-19 Infection - A Case Report. Pain Medicine Case Reports. 2023;7(8):357-359$59$YR$$M$Y$$$20240805$$MD$US$US
241734101$24173410$1$I$20240630$20240730$20240805$20240805$EXP$$DE-JNJFOC-20240781032$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240805$$MD$DE$DE
241734112$24173411$2$F$20240115$20240903$20240805$20240912$EXP$$JP-ROCHE-3494320$ROCHE$$77$YR$E$M$Y$66$KG$20240912$$MD$JP$JP
241734121$24173412$1$I$20240711$20240726$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011675$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241734131$24173413$1$I$20240701$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003564$ACADIA PHARMACEUTICALS$$60$YR$$F$Y$$$20240805$$CN$US$US
241734141$24173414$1$I$20240613$20240726$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011683$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241734151$24173415$1$I$$20220503$20240805$20240805$EXP$$US-AstraZeneca-2022A174639$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241734161$24173416$1$I$$20230814$20240805$20240805$EXP$$US-AstraZeneca-2023A185723$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241734171$24173417$1$I$$20221018$20240805$20240805$EXP$$US-AstraZeneca-2022A351866$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241734181$24173418$1$I$$20210622$20240805$20240805$EXP$$US-AstraZeneca-2021A557157$ASTRAZENECA$$$$E$F$Y$$$20240805$$CN$US$
241734191$24173419$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001098$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240805$$CN$US$US
241734201$24173420$1$I$20240701$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000448$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240805$$CN$US$US
241734211$24173421$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001050$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240805$$CN$US$US
241734221$24173422$1$I$20240731$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001014$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240805$$CN$US$US
241734231$24173423$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001516$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240805$$CN$US$US
241734241$24173424$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001262$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240805$$CN$US$US
241734251$24173425$1$I$$20240726$20240805$20240805$EXP$$US-GSK-US2024AMR096098$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$HP$US$US
241734271$24173427$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000047224$ROCHE$Tsuboi T, Miyajima N, Kimura K, Matsushita H, Kawase Y.. EP-1220 A case of the development of pseudocirrhosis during chemotherapy for advanced breast cancer with multiple metastases to liver. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;482$6$DEC$A$F$Y$$$20240805$$MD$JP$JP
241734291$24173429$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152728$AMGEN$Cowen E. W.; Tan I. J.; Ferrada M. A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240804$$MD$US$US
241734301$24173430$1$I$$20240802$20240805$20240805$PER$$US-HALEON-2190329$Haleon PLC$$$$$M$Y$$$20240805$$CN$US$US
241734311$24173431$1$I$$20240729$20240805$20240805$EXP$$BE-SANDOZ INC.-SDZ2024BE044021$SANDOZ$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-induced anaphylaxis uncommon in mastocytosis: findings from two large cohorts. THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE. 2024;12(7):1850-62$48$YR$$$Y$$$20240805$$HP$BE$BE
241734322$24173432$2$F$20240825$20240826$20240805$20240829$PER$$US-AMGEN-USASP2024152892$AMGEN$$71$YR$E$F$Y$46.712$KG$20240829$$CN$US$US
241734331$24173433$1$I$$20240730$20240805$20240805$EXP$$CA-DEXPHARM-2024-2606$DEXCEL$Lundby C, Farrell B, Wilson A. Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects. British Journal of Clinical Pharmacology. 2024 May 2;90(7):1741?4. doi:10.1111/bcp.16078$76$YR$E$F$Y$$$20240805$$HP$CA$CA
241734341$24173434$1$I$20240724$20240802$20240805$20240805$EXP$$CN-ROCHE-10000047541$ROCHE$$56$YR$A$F$Y$$$20240805$$HP$CN$CN
241734351$24173435$1$I$$20240319$20240805$20240805$PER$$US-ENDO USA, INC.-2024-001461$ENDO$$$$$M$Y$$$20240805$$MD$US$US
241734361$24173436$1$I$20240514$20240729$20240805$20240805$EXP$$FI-CHEPLA-2024009804$CHEPLAPHARM$$16$YR$$F$Y$$$20240805$$MD$COUNTRY NOT SPECIFIED$FI
241734392$24173439$2$F$$20240828$20240805$20240905$30DAY$$US-GSK-US2024095864$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
241734401$24173440$1$I$20231101$20240115$20240805$20240805$EXP$$CA-AMGEN-CANSP2024152861$AMGEN$$82$YR$E$M$Y$58.2$KG$20240805$$MD$CA$CA
241734412$24173441$2$F$$20240724$20240805$20240808$EXP$$US-APOTEX-2024AP009050$APOTEX$Abedrabo S, Rodriguez TE, Klein LM, Bitran J.. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142 (Suppl. 1):7078$$$A$$Y$$$20240808$$MD$US$US
241734431$24173443$1$I$$20240730$20240805$20240805$EXP$$US-SA-2024SA213436$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240805$$MD$US$US
241734442$24173444$2$F$20240701$20240823$20240805$20240827$PER$$US-AMGEN-USASP2024152688$AMGEN$$81$YR$E$F$Y$$$20240827$$HP$US$US
241734451$24173445$1$I$20230801$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262229$NOVO NORDISK$$69$YR$$M$Y$$$20240805$$CN$US$US
241734461$24173446$1$I$20240627$20240725$20240805$20240805$EXP$$CA-NOVOPROD-1256204$NOVO NORDISK$$57$YR$$F$Y$104$KG$20240805$$CN$CA$CA
241734471$24173447$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001356$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240805$$CN$US$US
241734481$24173448$1$I$$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262228$NOVO NORDISK$$44$YR$$F$Y$$$20240805$$CN$US$US
241734491$24173449$1$I$20240603$20240724$20240805$20240805$EXP$$US-NOVOPROD-1262227$NOVO NORDISK$$69$YR$$M$Y$$$20240805$$CN$US$US
241734501$24173450$1$I$$20240729$20240805$20240805$EXP$$NVSC2024US155437$NOVARTIS$$$$$F$Y$$$20240805$$CN$US$US
241734511$24173451$1$I$$20240725$20240805$20240805$EXP$$IT-NOVOPROD-1261383$NOVO NORDISK$$73$YR$$M$Y$$$20240805$$CN$IT$IT
241734521$24173452$1$I$$20240725$20240805$20240805$EXP$$IL-NOVOPROD-1261072$NOVO NORDISK$$60$YR$$F$Y$$$20240805$$MD$IL$IL
241734531$24173453$1$I$20240715$20240725$20240805$20240805$EXP$$SI-NOVOPROD-1257783$NOVO NORDISK$$$$$F$Y$$$20240805$$CN$SI$SI
241734541$24173454$1$I$$20240725$20240805$20240805$EXP$$AU-NOVOPROD-1261729$NOVO NORDISK$$$$$M$Y$$$20240805$$CN$AU$AU
241734551$24173455$1$I$$20240725$20240805$20240805$EXP$$IL-NOVOPROD-1261124$NOVO NORDISK$$$$$F$Y$$$20240805$$MD$IL$IL
241734561$24173456$1$I$$20240725$20240805$20240805$EXP$$BR-NOVOPROD-1256951$NOVO NORDISK$$$$E$F$Y$$$20240805$$CN$BR$BR
241734572$24173457$2$F$20230401$20240820$20240805$20240827$EXP$GR-SEATTLE GENETICS-2023SGN04870$GR-CHEPLA-2024009846$CHEPLAPHARM$$49$YR$$F$Y$$$20240827$$MD$COUNTRY NOT SPECIFIED$GR
241734581$24173458$1$I$$20240719$20240805$20240805$PER$$US-AstraZeneca-2024A165423$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241734591$24173459$1$I$$20220713$20240805$20240805$EXP$$US-AstraZeneca-2022A255692$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241734601$24173460$1$I$20230821$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53593$$FDA-CTU$$82$YR$$M$N$70.31$KG$20240805$Y$CN$US$
241734612$24173461$2$F$$20240814$20240805$20240819$PER$$US-AMGEN-USASP2024152393$AMGEN$$64$YR$A$F$Y$$$20240819$$CN$US$US
241734622$24173462$2$F$20210806$20240829$20240805$20240907$EXP$$US-AMGEN-USASP2024153119$AMGEN$$55$YR$A$F$Y$$$20240907$$LW$US$US
241734631$24173463$1$I$$20240723$20240805$20240805$EXP$$US-SPECGX-T202401626$SPECGX$Kane N, Rikard R, McCrory K, Marx A. Crushed posaconazole delayed-release tablets via enteral feeding tubes: A cautionary tale. Annals of Pharmacotherapy. 2024;1-3$21$YR$$M$Y$$$20240805$$PH$US$US
241734641$24173464$1$I$$20240723$20240805$20240805$EXP$$US-SPECGX-T202401624$SPECGX$Kane N, Rikard R, McCrory K, Marx A. Crushed posaconazole delayed-release tablets via enteral feeding tubes: A cautionary tale. Annals of Pharmacotherapy. 2024;1-3$12$YR$$M$Y$$$20240805$$PH$US$US
241734652$24173465$2$F$$20240805$20240805$20240806$PER$$US-JNJFOC-20240801645$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$CN$US$US
241734661$24173466$1$I$$20240731$20240805$20240805$EXP$GB-MHRA-MED-202407301334377580-FHGQY$GB-DEXPHARM-2024-2629$DEXCEL$$$$$F$Y$$$20240805$$HP$GB$GB
241734671$24173467$1$I$$20240723$20240805$20240805$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-118681$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240805$$MD$GB$GB
241734681$24173468$1$I$$20230228$20240805$20240805$EXP$$US-AstraZeneca-2023A050221$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241734691$24173469$1$I$$20230727$20240805$20240805$EXP$$US-AstraZeneca-2023A171947$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241734701$24173470$1$I$$20240219$20240805$20240805$EXP$$CA-CHATTEMPRD-2024OHG001764$CHATTEM$$43$YR$A$F$Y$96$KG$20240805$$HP$CA$CA
241734711$24173471$1$I$$20240730$20240805$20240805$PER$$US-ROCHE-10000043406$ROCHE$$$$E$M$Y$$$20240805$$HP$US$US
241734721$24173472$1$I$$20240801$20240805$20240805$EXP$$US-TAKEDA-2024TUS077478$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
241734731$24173473$1$I$$20240723$20240805$20240805$EXP$$US-SPECGX-T202401607$SPECGX$Ratnasingam D, Woehrlen T, Koerber S, Drenth E, Marupudi N, Concepcion M et al. Utilizing combination intrathecal baclofen and analgesic medication to manage spasticity and pain in patients with pediatric-onset disability: Case series. Journal of Pediatric Rehabilitation Medicine. 2024;17:57-66$22$YR$$F$Y$$$20240805$$HP$US$US
241734742$24173474$2$F$$20240807$20240805$20240812$EXP$$US-ROCHE-10000038135$ROCHE$$$$E$F$Y$70.3$KG$20240812$$CN$US$US
241734751$24173475$1$I$20240701$20240724$20240805$20240805$EXP$$US-ABBVIE-5854303$ABBVIE$$57$YR$$F$Y$87.089$KG$20240805$$CN$US$US
241734761$24173476$1$I$$20240725$20240805$20240805$EXP$$US-JNJFOC-20240807293$JOHNSON AND JOHNSON$$66$YR$E$F$Y$55.5$KG$20240805$$MD$US$US
241734771$24173477$1$I$$20240730$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121203$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$54.43$KG$20240805$$CN$US$US
241734791$24173479$1$I$20240701$20240729$20240805$20240805$EXP$$US-ABBVIE-5860903$ABBVIE$$57$YR$$F$Y$$$20240805$$CN$US$US
241734801$24173480$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158256$NOVARTIS$$$$$$Y$$$20240805$$MD$US$US
241734811$24173481$1$I$20240715$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152698$AMGEN$$53$YR$A$F$Y$$$20240805$$CN$US$US
241734821$24173482$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152879$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241734832$24173483$2$F$20240101$20240813$20240805$20240814$EXP$$AU-AMGEN-AUSSP2024152519$AMGEN$$$$$F$Y$$$20240814$$HP$AU$AU
241734842$24173484$2$F$$20231219$20240805$20240918$PER$$US-ENDO USA, INC.-2024-000194$ENDO$$$$$F$Y$$$20240918$$HP$US$US
241734852$24173485$2$F$$20240326$20240805$20240916$PER$$US-ENDO USA, INC.-2024-001560$ENDO$$$$$M$Y$$$20240916$$CN$US$US
241734863$24173486$3$F$$20240305$20240805$20240918$PER$$US-ENDO USA, INC.-2024-001300$ENDO$$$$$F$Y$$$20240918$$CN$US$US
241734872$24173487$2$F$20240630$20240911$20240805$20240918$EXP$$JP-JNJFOC-20240804192$JOHNSON AND JOHNSON$$$$A$$Y$$$20240918$$MD$JP$JP
241734881$24173488$1$I$$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024153179$AMGEN$$$$$$Y$$$20240805$$CN$US$US
241734891$24173489$1$I$$20240801$20240805$20240805$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122884$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$86$KG$20240805$$HP$CA$CA
241734901$24173490$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001431$ELI LILLY AND CO$$$$A$F$Y$$$20240805$$CN$US$US
241734911$24173491$1$I$20240731$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001243$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240805$$CN$US$US
241734921$24173492$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001259$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240805$$CN$US$US
241734931$24173493$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153068$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240805$$MD$US$US
241734941$24173494$1$I$20240731$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001294$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240805$$HP$US$US
241734951$24173495$1$I$20230101$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019864$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240805$$CN$US$US
241734962$24173496$2$F$20240729$20240815$20240805$20240906$PER$$US-JNJFOC-20240781244$JOHNSON AND JOHNSON$$35$YR$A$$Y$$$20240906$$HP$US$US
241734971$24173497$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003529$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241734981$24173498$1$I$20240709$20240727$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011688$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241734991$24173499$1$I$$20240725$20240805$20240805$EXP$$CA-APOTEX-2024AP008844$APOTEX$$78$YR$$F$Y$93$KG$20240805$$HP$CA$CA
241735001$24173500$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003532$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
241735011$24173501$1$I$$20240730$20240805$20240805$PER$$US-ALXN-202407USA002078US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241735021$24173502$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003533$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
241735031$24173503$1$I$$20231111$20240805$20240805$PER$$US-APOTEX-2023AP016559$APOTEX$Sams C, Cheng S.. Atypical Withdrawal Symptoms after Abrupt Tramadol Discontinuation: A Case Report. Journal of Pain + Palliative Care Pharmacotherapy. 2023;1-3$68$YR$$F$Y$$$20240805$$PH$US$US
241735042$24173504$2$F$20240525$20240809$20240805$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-030272$AUROBINDO$$68$YR$$M$Y$90.71$KG$20240821$$CN$US$US
241735051$24173505$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153102$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et. al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240805$$MD$US$US
241735062$24173506$2$F$$20240909$20240805$20240912$EXP$$GR-BAUSCH-BL-2024-011742$BAUSCH AND LOMB$Siderakis E, Nikakis C, Vasilopoulou A, Georgiou F, Trichonas A, Mandilas D, Lioni A, Apostolopoulos A. Osteomyelitis of the 2nd metatarsal head in a patient with newly diagnosed diabetes mellitus after injury by a sharp object. 50th annual panhellenic medical congress, book of abstracts.. 2024 APR;209.$58$YR$$M$Y$$$20240912$$HP$GR$GR
241735071$24173507$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038693$AUROBINDO$$68$YR$$F$Y$66$KG$20240805$$HP$CA$CA
241735081$24173508$1$I$20240209$20240729$20240805$20240805$EXP$$MX-TAKEDA-2024TUS014856$TAKEDA$$3$YR$$M$Y$$$20240805$$CN$MX$MX
241735091$24173509$1$I$$20240729$20240805$20240805$30DAY$$US-GSK-US2024094889$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241735102$24173510$2$F$$20240521$20240805$20240917$PER$$US-ENDO USA, INC.-2024-002382$ENDO$$$$$M$Y$$$20240917$$CN$US$US
241735112$24173511$2$F$20220719$20240802$20240805$20240809$EXP$$CA-TAKEDA-2020TUS017887$TAKEDA$$70$YR$$F$Y$$$20240809$$CN$CA$CA
241735121$24173512$1$I$$20220915$20240805$20240805$EXP$$US-AstraZeneca-2022A319786$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241735132$24173513$2$F$$20240521$20240805$20240916$PER$$US-ENDO USA, INC.-2024-002373$ENDO$$$$$F$Y$$$20240916$$CN$US$US
241735142$24173514$2$F$$20240430$20240805$20240916$PER$$US-ENDO USA, INC.-2024-002079$ENDO$$$$$F$Y$$$20240916$$CN$US$US
241735151$24173515$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001478$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240805$$CN$US$US
241735161$24173516$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001796$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240805$$CN$US$US
241735171$24173517$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001327$ELI LILLY AND CO$$$$$$Y$$$20240805$$CN$US$US
241735181$24173518$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153327$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes.. JAMA Dermatology. 2024;E1 - E8$$$$$Y$$$20240805$$MD$US$US
241735191$24173519$1$I$$20240726$20240805$20240805$EXP$$US-GSK-US2024AMR095495$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241735201$24173520$1$I$20240728$20240802$20240805$20240805$EXP$GB-MHRA-MED-202407311154341160-FNMJW$GB-ROCHE-10000048112$ROCHE$$71$YR$E$F$Y$$$20240805$$PH$GB$GB
241735211$24173521$1$I$$20240722$20240805$20240805$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092648$GLENMARK$Joly L, Virgilio R, Yother C.. Posttransplant Lymphoproliferative Disorder in a Patient With Alpha-1 Antitrypsin Deficiency: A Case Report.. Cureus. 2024;16 (6):e62107$$$$$Y$$$20240805$$MD$US$US
241735221$24173522$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158143$NOVARTIS$$77$YR$$F$Y$$$20240805$$MD$US$US
241735231$24173523$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152960$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240805$$MD$US$US
241735241$24173524$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153074$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240805$$MD$US$US
241735251$24173525$1$I$$20240802$20240805$20240805$PER$$NVSC2024US158760$NOVARTIS$$$$$$Y$$$20240805$$CN$US$US
241735261$24173526$1$I$$20240730$20240805$20240805$PER$$US-BIOGEN-2024BI01276217$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
241735271$24173527$1$I$$20240730$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121432$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$PH$US$US
241735281$24173528$1$I$$20231115$20240805$20240805$EXP$$US-KHC-000058$Kilitch Healthcare$$$$$M$Y$$$20240805$$CN$US$US
241735291$24173529$1$I$$20231113$20240805$20240805$EXP$$US-KHC-000057$Kilitch Healthcare$$$$$$Y$$$20240805$$CN$US$US
241735301$24173530$1$I$20230101$20231127$20240805$20240805$EXP$$US-KHC-000066$Kilitch Healthcare$$52$YR$A$F$Y$$$20240805$$CN$US$US
241735321$24173532$1$I$$20240729$20240805$20240805$EXP$$JP-SA-2024SA222457$SANOFI AVENTIS$Kamata A, Hino K, Kawai K, Kamiyama K, Takasaka Y, Tazawa K, et al.. EP-1127: A case of multiple liver metastases from breast cancer that changed to pseudo-cirrhosis after complete response to chemotherapy.. The 32nd Annual Meeting of the Japanese Breast Cancer Society (11, 12, 13-Jul-20. UNK;UNK:459$60$YR$A$F$Y$$$20240805$$MD$JP$JP
241735331$24173533$1$I$20240501$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001270$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240805$$CN$US$US
241735341$24173534$1$I$$20240709$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407006557$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240805$$CN$US$US
241735352$24173535$2$F$$20240726$20240805$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038541$AUROBINDO$$$$$F$Y$$$20240806$$HP$CA$CA
241735361$24173536$1$I$$20240724$20240805$20240805$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07115$HIKMA$Chebrolu S, Mayl J, Bhave P.. Chebrolu S, Mayl J, Bhave P. Flecainide Toxicity in a Patient with a Functioning Pacemaker.. The Journal of innovations in cardiac rhythm management.. 2024;15(7):5951-4$$$$$Y$$$20240805$$MD$US$US
241735371$24173537$1$I$20240601$20240722$20240805$20240805$EXP$FR-AFSSAPS-LM2024000391$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-06965$HIKMA$$68$YR$$F$Y$54$KG$20240805$$MD$FR$FR
241735383$24173538$3$F$$20240807$20240805$20240819$EXP$$GB-INTERCEPT-PM2024001542$INTERCEPT PHARMACEUTICALS$$$$E$F$Y$$$20240819$$CN$GB$GB
241735392$24173539$2$F$$20240815$20240805$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003576$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
241735411$24173541$1$I$20240708$20240729$20240805$20240805$EXP$GB-MHRA-MED-202407291049014540-PFWRM$GB-SA-2024SA228464$SANOFI AVENTIS$$77$YR$E$M$Y$64$KG$20240805$$CN$GB$GB
241735421$24173542$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038508$AUROBINDO$$34$YR$$F$Y$86$KG$20240805$$CN$CA$CA
241735433$24173543$3$F$$20231219$20240805$20240918$PER$$US-ENDO USA, INC.-2024-000026$ENDO$$$$$F$Y$$$20240918$$CN$US$US
241735442$24173544$2$F$$20240829$20240805$20240908$EXP$$TW-AMGEN-TWNSP2024153324$AMGEN$$71$YR$E$F$Y$$$20240908$$HP$TW$TW
241735451$24173545$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152741$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241735461$24173546$1$I$$20240728$20240805$20240805$EXP$$US-AMGEN-USASP2024152744$AMGEN$Le T.; Kumar V.; Gondal K. et al.. Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: A case report. BMC Infectious Diseases. 2020;20 (1):1-3$74$YR$E$M$Y$$$20240805$$HP$US$US
241735472$24173547$2$F$20240718$20240801$20240805$20240808$30DAY$$US-AMGEN-USASL2024144161$AMGEN$$66$YR$E$F$Y$$$20240808$$PH$US$US
241735481$24173548$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152776$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241735491$24173549$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152760$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241735501$24173550$1$I$$20240705$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06710$LUPIN$$$$$$Y$$$20240805$$MD$US$US
241735511$24173551$1$I$20240716$20240729$20240805$20240805$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000128-2024$QILU PHARMACEUTICAL$$89$YR$E$M$Y$$$20240801$$HP$CN$CN
241735521$24173552$1$I$20240608$20240724$20240805$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-037615$AUROBINDO$$37$YR$$M$Y$70$KG$20240805$$MD$FR$FR
241735531$24173553$1$I$20240714$20240802$20240805$20240805$EXP$$CN-ROCHE-10000047513$ROCHE$$48$YR$A$M$Y$$$20240805$$HP$CN$CN
241735541$24173554$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001114$ELI LILLY AND CO$$$$$M$Y$$$20240805$$CN$US$US
241735551$24173555$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152917$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241735561$24173556$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001173$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240805$$CN$US$US
241735571$24173557$1$I$20240501$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019919$ELI LILLY AND CO$$$$$$Y$$$20240805$$CN$US$US
241735581$24173558$1$I$$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000440$ELI LILLY AND CO$$$$$$Y$$$20240805$$CN$US$US
241735591$24173559$1$I$20240730$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000129$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240805$$CN$US$US
241735601$24173560$1$I$20240731$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001290$ELI LILLY AND CO$$$$A$F$Y$$$20240805$$CN$US$US
241735611$24173561$1$I$$20240731$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121720$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$128.82$KG$20240805$$PH$US$US
241735621$24173562$1$I$20240601$20240726$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119468$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240805$$HP$US$US
241735631$24173563$1$I$$20240801$20240805$20240805$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122421$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$76$KG$20240805$$PH$CA$CA
241735641$24173564$1$I$$20240801$20240805$20240805$EXP$$US-TAKEDA-2024TUS018197$TAKEDA$$$$$F$Y$$$20240805$$HP$US$US
241735651$24173565$1$I$20240619$20240710$20240805$20240805$DIR$FDA-CDER-CTU-2024-53600$$FDA-CTU$$60$YR$$M$N$146.96$KG$20240710$N$CN$US$
241735661$24173566$1$I$20240416$20240722$20240805$20240805$EXP$ES-AEMPS-1550302$ES-GLENMARK PHARMACEUTICALS-2024GMK092709$GLENMARK$$$$$$Y$$$20240805$$MD$ES$ES
241735671$24173567$1$I$20230803$20240725$20240805$20240805$EXP$$BE-ROCHE-10000046371$ROCHE$$65$YR$E$F$Y$63$KG$20240805$$MD$BE$BE
241735681$24173568$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153054$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241735692$24173569$2$F$$20240812$20240805$20240815$PER$$US-AMGEN-USASP2024153044$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240815$$MD$US$US
241735701$24173570$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153354$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241735711$24173571$1$I$$20240802$20240805$20240805$EXP$$NVSC2024US158451$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241735721$24173572$1$I$$20240712$20240805$20240805$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003585$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
241735731$24173573$1$I$$20210911$20240805$20240805$EXP$$US-AstraZeneca-2021A724044$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241735744$24173574$4$F$20240101$20240916$20240805$20240919$PER$$US-AMGEN-USASP2024154777$AMGEN$$58$YR$A$M$Y$$$20240919$$CN$US$US
241735751$24173575$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153390$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes.. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241735762$24173576$2$F$20240422$20240731$20240805$20240809$EXP$$US-NOVOPROD-1262594$NOVO NORDISK$$76$YR$$F$Y$$$20240809$$CN$US$US
241735771$24173577$1$I$$20240725$20240805$20240805$EXP$$US-NOVOPROD-1262721$NOVO NORDISK$$22$YR$$M$Y$$$20240805$$MD$US$US
241735791$24173579$1$I$$20240725$20240805$20240805$EXP$$US-NOVOPROD-1262267$NOVO NORDISK$$$$$F$Y$$$20240805$$CN$US$US
241735801$24173580$1$I$$20240725$20240805$20240805$EXP$$US-NOVOPROD-1262668$NOVO NORDISK$$$$$M$Y$$$20240805$$CN$US$US
241735812$24173581$2$F$20240625$20240909$20240805$20240920$EXP$$US-NOVOPROD-1262263$NOVO NORDISK$$67$YR$$F$Y$$$20240920$$CN$US$US
241735821$24173582$1$I$$20240725$20240805$20240805$EXP$$US-NOVOPROD-1262565$NOVO NORDISK$$$$$M$Y$$$20240805$$CN$US$US
241735831$24173583$1$I$20211001$20240725$20240805$20240805$EXP$$US-NOVOPROD-1262334$NOVO NORDISK$$70$YR$$M$Y$$$20240805$$CN$US$US
241735843$24173584$3$F$$20240910$20240805$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003477$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241735851$24173585$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003483$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241735862$24173586$2$F$$20240909$20240805$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003490$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241735872$24173587$2$F$20240701$20240808$20240805$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003486$ACADIA PHARMACEUTICALS$$5$YR$$F$Y$$$20240829$$CN$US$US
241735882$24173588$2$F$20240730$20240826$20240805$20240903$30DAY$$US-AMGEN-USASP2024153034$AMGEN$$62$YR$A$F$Y$49.9$KG$20240903$$PH$US$US
241735891$24173589$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153391$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241735901$24173590$1$I$$20240726$20240805$20240805$EXP$$CA-APOTEX-2024AP008931$APOTEX$$60$YR$$F$Y$$$20240805$$HP$CA$CA
241735911$24173591$1$I$$20240731$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121655$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$58.97$KG$20240805$$CN$US$US
241735921$24173592$1$I$20240624$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003498$ACADIA PHARMACEUTICALS$$26$YR$$F$Y$$$20240805$$CN$US$US
241735931$24173593$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003482$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240805$$HP$US$US
241735942$24173594$2$F$20240628$20240812$20240805$20240820$30DAY$$US-AMGEN-USASP2024151905$AMGEN$$$$$$Y$$$20240820$$PH$US$US
241735951$24173595$1$I$$20240722$20240805$20240805$EXP$$NL-IPCA LABORATORIES LIMITED-IPC-2024-NL-001954$IPCA$Alyssa Faria. Marantic endocarditis and stroke: Case presentation. Clinical Medicine. 2024;24(100041):26$$$$$Y$$$20240805$$HP$NL$NL
241735961$24173596$1$I$$20240729$20240805$20240805$EXP$$DE-ROCHE-10000045960$ROCHE$$50$YR$A$F$Y$$$20240805$$MD$DE$DE
241735971$24173597$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153465$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241735982$24173598$2$F$$20240117$20240805$20240806$PER$$NVSC2024US015261$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
241735991$24173599$1$I$$20240802$20240805$20240805$PER$$NVSC2024US158819$NOVARTIS$$$$$$Y$$$20240805$$MD$US$US
241736001$24173600$1$I$$20240731$20240805$20240805$EXP$$US-CHATTEMPRD-2024OHG025937$CHATTEM$$$$$M$Y$$$20240805$$LW$US$US
241736011$24173601$1$I$20210101$20240801$20240805$20240805$EXP$$IT-ORGANON-O2408ITA000102$ORGANON$Romano A, Gasparro R, Campana MD, Pinchera B, Di Crescenzo RM, Del Guercio D, et al.. COVID-19 as a critical risk factor for osteonecrosis of the jaw: diagnostic challenge and surgical treatment.. Current Problems in Surgery.. 2024;61(9):101555$74$YR$$M$Y$$$20240805$$MD$IT$IT
241736021$24173602$1$I$$20240731$20240805$20240805$EXP$$US-ABBVIE-5852029$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241736031$24173603$1$I$$20240731$20240805$20240805$EXP$$US-ABBVIE-5863903$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241736041$24173604$1$I$20240729$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152399$AMGEN$$76$YR$E$M$Y$$$20240805$$CN$US$US
241736051$24173605$1$I$$20240717$20240805$20240805$PER$$US-SERVIER-S24009171$SERVIER$$$$$$Y$$$20240805$$HP$US$US
241736061$24173606$1$I$$20230303$20240805$20240805$EXP$$US-AstraZeneca-2023A015967$ASTRAZENECA$$$$$M$Y$95.5$KG$20240805$$CN$US$
241736071$24173607$1$I$20240719$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174769$ASTRAZENECA$$25740$DY$$M$Y$$$20240805$$MD$US$
241736082$24173608$2$F$$20240821$20240805$20240830$30DAY$$US-GSK-US2024094730$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$CN$US$US
241736091$24173609$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001242$ELI LILLY AND CO$$$$A$F$Y$$$20240805$$CN$US$US
241736103$24173610$3$F$20240101$20240924$20240805$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122469$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240926$$HP$US$US
241736112$24173611$2$F$$20240808$20240805$20240812$EXP$$US-ABBVIE-5864101$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241736121$24173612$1$I$20240101$20240731$20240805$20240805$EXP$$US-ABBVIE-5863800$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241736131$24173613$1$I$20240501$20240731$20240805$20240805$EXP$HR-HALMED-300085626$HR-TAKEDA-2024TUS077214$TAKEDA$$$$A$F$Y$$$20240805$$HP$HR$HR
241736142$24173614$2$F$$20231218$20240805$20240918$PER$$US-ENDO USA, INC.-2023-006386$ENDO$$$$$M$Y$$$20240918$$CN$US$US
241736151$24173615$1$I$$20231219$20240805$20240805$PER$$US-ENDO USA, INC.-2024-000098$ENDO$$$$$M$Y$$$20240805$$CN$US$US
241736161$24173616$1$I$$20240729$20240805$20240805$EXP$$JP-EXELIXIS-CABO-24080138$EXELIXIS$$75$YR$$M$Y$$$20240805$$MD$JP$JP
241736171$24173617$1$I$$20240729$20240805$20240805$EXP$$US-EMD Serono-2024041308$EMD SERONO INC$$$$$F$Y$$$20240805$$CN$US$US
241736182$24173618$2$F$$20240731$20240805$20240808$EXP$$US-ABBVIE-5864523$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241736191$24173619$1$I$20240101$20240731$20240805$20240805$EXP$$US-ABBVIE-5864061$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241736201$24173620$1$I$$20240724$20240805$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-037885$AUROBINDO$Walgamage M, Nunez Cuello L, Walgamage T. Can MRSA Really Do That? A Rare Case of Acute Cholecystitis With MRSA Bacteremia. Am-J-Respir-Crit-Care-Med. 2024;209:A1668$70$YR$$F$Y$$$20240805$$HP$US$US
241736211$24173621$1$I$20240101$20240731$20240805$20240805$EXP$$US-ABBVIE-5863773$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241736221$24173622$1$I$$20240726$20240805$20240805$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024004886$BIOCON$$$$$$Y$$$20240805$$CN$CA$CA
241736231$24173623$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038608$AUROBINDO$$6$YR$$F$Y$$$20240805$$PH$CA$CA
241736241$24173624$1$I$$20240614$20240805$20240805$DIR$FDA-CDER-CTU-2024-53638$$FDA-CTU$$59$YR$$$N$$$20240614$N$$US$
241736251$24173625$1$I$$20240614$20240805$20240805$DIR$FDA-CDER-CTU-2024-53639$$FDA-CTU$$$$$$N$$$20240614$N$$US$
241736261$24173626$1$I$20230106$20230109$20240805$20240805$EXP$$ES-BIOVITRUM-2023ES00664$BIOVITRUM$$1$YR$$M$Y$$$20240805$$CN$ES$ES
241736271$24173627$1$I$$20240801$20240805$20240805$EXP$$US-TAKEDA-2024TUS077853$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
241736281$24173628$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-037825$AUROBINDO$$52$YR$$F$Y$$$20240805$$MD$CA$CA
241736291$24173629$1$I$20240725$20240801$20240805$20240805$EXP$IT-MINISAL02-997073$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-122927$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240805$$MD$IT$IT
241736301$24173630$1$I$$20240730$20240805$20240805$EXP$$DE-TAKEDA-2024TUS058428$TAKEDA$$$$$F$Y$$$20240805$$CN$DE$DE
241736311$24173631$1$I$$20240728$20240805$20240805$EXP$$US-IHL-000597$INVENTIA HEALTHCARE$$$$I$F$Y$$$20240731$$MD$US$US
241736321$24173632$1$I$20240101$20240329$20240805$20240805$PER$$US-AMGEN-USASP2024151827$AMGEN$$75$YR$E$F$Y$$$20240805$$CN$US$US
241736331$24173633$1$I$$20220502$20240805$20240805$EXP$$US-AstraZeneca-2022A120775$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241736341$24173634$1$I$20240101$20240729$20240805$20240805$EXP$$US-SA-2024SA226517$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240805$$MD$US$US
241736351$24173635$1$I$20231001$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003567$ACADIA PHARMACEUTICALS$$65$YR$$M$Y$$$20240805$$CN$US$US
241736362$24173636$2$F$20240726$20240822$20240805$20240831$EXP$$US-AstraZeneca-2024A174431$ASTRAZENECA$$32088$DY$$F$Y$55.3$KG$20240831$$CN$US$
241736371$24173637$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003573$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241736381$24173638$1$I$20240725$20240727$20240805$20240805$EXP$$US-BEH-2024176555$CSL BEHRING$$58$YR$A$M$Y$119$KG$20240805$$HP$US$US
241736391$24173639$1$I$$20240803$20240805$20240805$PER$$US-ROCHE-10000048644$ROCHE$$35$YR$A$F$Y$$$20240805$$HP$US$US
241736401$24173640$1$I$$20240712$20240805$20240805$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003570$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241736411$24173641$1$I$$20240724$20240805$20240805$EXP$$NL-AUROBINDO-AUR-APL-2024-037581$AUROBINDO$$65$YR$$M$Y$88$KG$20240805$$CN$NL$NL
241736421$24173642$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001052$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240805$$CN$US$US
241736432$24173643$2$F$$20240911$20240805$20240921$30DAY$$US-GSK-US2024094281$GLAXOSMITHKLINE$$$$$M$Y$$$20240921$$CN$US$US
241736441$24173644$1$I$20240731$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152909$AMGEN$$76$YR$E$F$Y$$$20240805$$PH$US$US
241736451$24173645$1$I$$20240722$20240805$20240805$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459709$RANBAXY$$$$E$M$Y$$$20240805$$CN$US$US
241736461$24173646$1$I$$20240729$20240805$20240805$EXP$GB-MHRA-MED-202407251154413950-VRTCD$GB-TEVA-VS-3226935$TEVA$$$$$M$Y$$$20240805$$MD$GB$GB
241736472$24173647$2$F$$20240919$20240805$20240924$EXP$$US-TAKEDA-2024TUS077279$TAKEDA$$$$$M$Y$$$20240924$$MD$US$US
241736493$24173649$3$F$$20240903$20240805$20240907$EXP$$US-TAKEDA-2024TUS076658$TAKEDA$$$$$F$Y$$$20240907$$CN$US$US
241736502$24173650$2$F$20240701$20240729$20240805$20240819$EXP$$US-009507513-2407USA015126$MERCK$$78$YR$$F$Y$$$20240819$$CN$US$US
241736511$24173651$1$I$20240801$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024154034$AMGEN$$62$YR$A$F$Y$$$20240805$$CN$US$US
241736521$24173652$1$I$20210401$20221209$20240805$20240805$EXP$$US-AstraZeneca-2022A353806$ASTRAZENECA$$871$MON$$F$Y$79.4$KG$20240805$$CN$US$
241736531$24173653$1$I$$20221122$20240805$20240805$EXP$$US-AstraZeneca-2022A388745$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241736541$24173654$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038367$AUROBINDO$Farrell B, Galley E, Jeffs L, Howell P, McCarthy LM. Kind of blurry: Deciphering clues to prevent, investigate and manage prescribing cascades. PLOS-One. 2022;17 (8):1- 20$74$YR$$F$Y$$$20240805$$HP$CA$CA
241736551$24173655$1$I$$20220314$20240805$20240805$EXP$$ZA-AstraZeneca-2023A063968$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$ZA$
241736561$24173656$1$I$$20230908$20240805$20240805$EXP$$US-AstraZeneca-2023A206312$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241736572$24173657$2$F$20240702$20240726$20240805$20240806$EXP$$FR-AstraZeneca-2024A176405$ASTRAZENECA$$42$YR$$M$Y$110$KG$20240806$$MD$FR$
241736581$24173658$1$I$$20240801$20240805$20240805$PER$$US-ABBVIE-5865549$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241736591$24173659$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024152982$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E I to E8$$$$$Y$$$20240805$$MD$US$US
241736601$24173660$1$I$$20240724$20240805$20240805$EXP$$US-ROCHE-10000036204$ROCHE$$80$YR$E$M$Y$$$20240805$$CN$US$US
241736611$24173661$1$I$20240101$20240724$20240805$20240805$EXP$$JP-ROCHE-10000043615$ROCHE$$69$YR$E$F$Y$$$20240805$$PH$JP$JP
241736621$24173662$1$I$20240725$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024153050$AMGEN$$$$$$Y$$$20240805$$PH$US$US
241736631$24173663$1$I$$20231204$20240805$20240805$EXP$$GB-SANDOZ INC.-SDZ2023GB065338$SANDOZ$Ghorashian S, Lucchini G, Richardson R, Nguyen K, Teris C, Oporto-Espuelas M, et.al. Dual Antigen Targeting with Co-Transduced CD19/22 CAR T Cells May Prevent Antigen-Negative Relapse after CAR TCell Therapy for Relapsed/Refractory ALL. Blood. 2022;140 (Suppl 1):10352-10354$$$$$Y$$$20240805$$HP$GB$GB
241736642$24173664$2$F$20240726$20240812$20240805$20240819$PER$$US-AMGEN-USASP2024151693$AMGEN$$73$YR$E$F$Y$90.3$KG$20240819$$HP$US$US
241736651$24173665$1$I$20240401$20240731$20240805$20240805$EXP$$US-UCBSA-2024025939$UCB$$32$YR$$F$Y$$$20240805$$HP$US$US
241736661$24173666$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153048$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240805$$MD$US$US
241736672$24173667$2$F$$20240806$20240805$20240812$EXP$$GB-PERRIGO-24GB007092$PERRIGO$$$$$F$Y$$$20240812$$MD$GB$GB
241736681$24173668$1$I$20200703$20210609$20240805$20240805$EXP$$CA-CELLTRION INC.-2020CA035364$CELLTRION$$$$$$Y$$$20240805$$MD$CA$CA
241736691$24173669$1$I$20240522$20240725$20240805$20240805$EXP$$NL-PERRIGO-24NL005405$PERRIGO$$52$YR$$F$Y$$$20240805$$CN$NL$NL
241736702$24173670$2$F$20240709$20240819$20240805$20240824$EXP$$US-TAKEDA-2024TUS071226$TAKEDA$$57$YR$$M$Y$$$20240824$$HP$US$US
241736711$24173671$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000048481$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$81$YR$E$M$Y$$$20240805$$HP$JP$JP
241736721$24173672$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122547$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240805$$CN$US$US
241736733$24173673$3$F$$20240911$20240805$20240917$EXP$$US-TAKEDA-2024TUS074969$TAKEDA$$$$$M$Y$$$20240917$$CN$US$US
241736741$24173674$1$I$$20240726$20240805$20240805$EXP$$CA-TAKEDA-2024TUS076232$TAKEDA$$$$$M$Y$$$20240805$$CN$CA$CA
241736761$24173676$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000047983$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$70$YR$E$M$Y$$$20240805$$HP$JP$JP
241736771$24173677$1$I$$20240729$20240805$20240805$EXP$$US-009507513-2407USA015197$MERCK$$$$$M$Y$$$20240805$$MD$US$US
241736791$24173679$1$I$$20240605$20240805$20240805$DIR$FDA-CDER-CTU-2024-53642$$FDA-CTU$$$$$$N$$$20240605$N$$US$
241736801$24173680$1$I$$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024153011$AMGEN$$$$$F$Y$$$20240805$$HP$US$US
241736811$24173681$1$I$$20220111$20240805$20240805$EXP$$US-AstraZeneca-2022A018624$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241736821$24173682$1$I$$20211125$20240805$20240805$EXP$$GB-AstraZeneca-2021A836217$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$GB$
241736831$24173683$1$I$$20221017$20240805$20240805$EXP$$US-AstraZeneca-2022A349363$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241736841$24173684$1$I$$20240725$20240805$20240805$EXP$$TR-PIRAMAL CRITICAL CARE LIMITED-2024-PPL-000555$PIRAMAL$Erdoaan. A., Inan. D., Yildiz. U., Akgun. T.. A rare manifestation of brugada ecg pattern precipitated by general anesthesia for pituitary surgery. Turkish Cardiology Association Archive  (Turk Kardiyoloji Dernegi Arsivi). 2024;52(5):362- 364$$$$$Y$$$20240805$$MD$TR$TR
241736851$24173685$1$I$$20240802$20240805$20240805$PER$$US-ROCHE-10000048573$ROCHE$$18$YR$A$F$Y$$$20240805$$MD$US$US
241736871$24173687$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153326$AMGEN$Cowen E. W.; Tan I. J.; Ferrada M. A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E I to E8$$$$$Y$$$20240805$$MD$US$US
241736881$24173688$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000048373$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$79$YR$E$F$Y$$$20240805$$HP$JP$JP
241736891$24173689$1$I$$20240730$20240805$20240805$PER$US-MLMSERVICE-20240723-PI140053-00135-2$US-RDY-SPO/USA/24/0011314$DR REDDYS$Longobardi SA, Alkowati H, Kang G, Slade C, Oyesanmi O. Ibuprofen-Induced Pancytopenia and Erythema Multiforme in an Elderly Female Patient. Cureus. 2024;16(6):e62785. DOI: 10.7759/cureus.62785.$$$$F$Y$$$20240805$$MD$US$US
241736901$24173690$1$I$$20240725$20240805$20240805$EXP$$GB-ROCHE-10000006592$ROCHE$$$$A$M$Y$$$20240805$$CN$GB$GB
241736911$24173691$1$I$$20240729$20240805$20240805$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-121030$BRISTOL MYERS SQUIBB$Yildiz G, Torun Bayram M, Unlu ?M, Soylu A, Kavukcu S, Olgun N. Nivolumab-associated IgA nephropathy in a child with malignant melanoma. Journal of Pediatric Hematology/Oncology. 2024 Jul 25;1-3. doi:10.1097/MPH.0000000000002931.$7$YR$C$M$Y$$$20240805$$MD$TR$TR
241736951$24173695$1$I$$20240726$20240805$20240805$30DAY$$US-GSK-US2024094276$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241736961$24173696$1$I$$20240801$20240805$20240805$PER$$US-ABBVIE-5865195$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241736972$24173697$2$F$20240727$20240816$20240805$20240820$EXP$$CA-JNJFOC-20240771366$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240820$$HP$CA$CA
241736981$24173698$1$I$20180101$20240730$20240805$20240805$EXP$$US-AMGEN-USASL2023066570$AMGEN$$34$YR$A$F$Y$$$20240805$$CN$US$US
241736991$24173699$1$I$$20240801$20240805$20240805$EXP$$US-AstraZeneca-2024A175569$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241737001$24173700$1$I$20230609$20230609$20240805$20240805$EXP$$US-AstraZeneca-2023A135271$ASTRAZENECA$$15055$DY$$F$Y$$$20240805$$CN$US$
241737011$24173701$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001788$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240805$$HP$US$US
241737021$24173702$1$I$20240729$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019833$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240805$$CN$US$US
241737031$24173703$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001218$ELI LILLY AND CO$$$$$M$Y$$$20240805$$CN$US$US
241737041$24173704$1$I$20240801$20240802$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001956$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240805$$CN$US$US
241737051$24173705$1$I$20240321$20240729$20240805$20240805$EXP$$ES-AMGEN-ESPSP2024150393$AMGEN$$48$YR$A$M$Y$66.5$KG$20240805$$MD$ES$ES
241737061$24173706$1$I$$20240801$20240805$20240805$PER$$US-JNJFOC-20240806864$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$HP$US$US
241737071$24173707$1$I$20231005$20240730$20240805$20240805$EXP$$CL-SANDOZ INC.-SDZ2023CL043321$SANDOZ$$38$YR$$F$Y$$$20240805$$CN$CL$CL
241737082$24173708$2$F$20240226$20240808$20240805$20240813$EXP$$US-GSK-US2024094818$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
241737091$24173709$1$I$$20240725$20240805$20240805$EXP$$CZ-UCBSA-2024038724$UCB$Klocperk A, Bloomfield AM, Schneiderova H, Hlavackova E, Turno-Vec M, Tichy L, et al. Neonatal Screening of Severe Combined Immunodeficiency (SCID) in the Czech Repub. Allergies. 2024;85-90$$$$F$Y$$$20240805$$MD$CZ$CZ
241737111$24173711$1$I$20240701$20240719$20240805$20240805$PER$$US-JNJFOC-20240759175$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$US$US
241737121$24173712$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158121$NOVARTIS$$$$$$Y$$$20240805$$MD$US$US
241737131$24173713$1$I$$20240731$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121724$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240805$$CN$US$US
241737142$24173714$2$F$20240601$20240902$20240805$20240903$EXP$$CN-SA-2024SA182931$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240903$$CN$CN$CN
241737151$24173715$1$I$20240802$20240802$20240805$20240805$PER$$US-HALEON-2190340$Haleon PLC$$75$YR$$F$Y$$$20240805$$CN$US$US
241737161$24173716$1$I$20240101$20240708$20240805$20240805$PER$$US-TOLMAR, INC.-24US050903$TOLMAR$$$$$F$Y$$$20240805$$PH$US$US
241737172$24173717$2$F$20240708$20240820$20240805$20240909$PER$$US-TOLMAR, INC.-24US050926$TOLMAR$$$$$M$Y$$$20240909$$PH$US$US
241737182$24173718$2$F$20050501$20240731$20240805$20240806$EXP$$NVSC2024AU158297$NOVARTIS$$$$$$Y$$$20240807$$MD$AU$AU
241737193$24173719$3$F$$20240911$20240805$20240914$PER$$US-AMGEN-USASP2024152872$AMGEN$$$$$F$Y$$$20240914$$HP$US$US
241737213$24173721$3$F$$20240919$20240805$20240926$EXP$$PT-AUROBINDO-AUR-APL-2024-037285$AUROBINDO$Nogueira JV, Rodrigues L, Neves CF, Mesquita P, Vieira RM  Ribeiro Alves D et al.. CO-0173 - (2446) - DOEN?A RARA,TRATAMENTO EFICAZ: PNEUMONIA POR HHV6B EM DOENTE IMUNOSSUPRIMIDO (CO-0173 - (2446) - RARE DISEASE, EFFECTIVE TREATMENT: HHV6B PNEUMONIA IN AN IMMUNOSUPPRESSED PATIENT). Doen?as infeciosas e parasit?rias (Infectious and parasitic disease). 2024;273$83$YR$$M$Y$$$20240926$$MD$PT$PT
241737232$24173723$2$F$20240701$20240904$20240805$20240909$EXP$$US-JNJFOC-20240808224$JOHNSON AND JOHNSON$$57$YR$A$F$Y$124.5$KG$20240910$$HP$US$US
241737241$24173724$1$I$20240101$20240425$20240805$20240805$PER$$US-AJANTA-2024AJA00085$AJANTA PHARMA$$73$YR$E$F$Y$190$KG$20240805$$CN$US$US
241737251$24173725$1$I$$20240726$20240805$20240805$EXP$$US-VIOKACE LLC-2024AIMT01160$AIMMUNE$$$$$$Y$$$20240805$$CN$US$US
241737261$24173726$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001649$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240805$$CN$US$US
241737271$24173727$1$I$20240601$20240731$20240805$20240805$EXP$$CO-SA-2024SA227809$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240805$$CN$CO$CO
241737281$24173728$1$I$20240605$20240731$20240805$20240805$EXP$FR-AFSSAPS-PO2024000821$FR-SA-2024SA225399$SANOFI AVENTIS$$77$YR$E$F$Y$64$KG$20240805$$MD$FR$FR
241737292$24173729$2$F$$20240724$20240805$20240808$EXP$$US-APOTEX-2024AP009046$APOTEX$Abedrabo S, Rodriguez TE, Klein LM, Bitran J.. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142 (Suppl. 1):7078$$$A$$Y$$$20240808$$MD$US$US
241737301$24173730$1$I$20210712$20240722$20240805$20240805$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07050$HIKMA$$74$YR$$F$Y$62.6$KG$20240805$$MD$US$US
241737312$24173731$2$F$20240718$20240828$20240805$20240830$EXP$$NVSJ2024JP009338$NOVARTIS$$$$E$F$Y$$$20240830$$MD$JP$JP
241737321$24173732$1$I$$20230504$20240805$20240805$EXP$$US-AstraZeneca-2023A105612$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241737333$24173733$3$F$20240606$20240820$20240805$20240823$EXP$FR-AFSSAPS-TS2024000829$FR-ROCHE-10000045990$ROCHE$$$$$F$Y$2.7$KG$20240823$$MD$FR$FR
241737341$24173734$1$I$$20240725$20240805$20240805$PER$$US-AstraZeneca-2024A170047$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241737351$24173735$1$I$$20240801$20240805$20240805$EXP$$JP-GSK-JP2024096668$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$MD$JP$JP
241737361$24173736$1$I$20240130$20240730$20240805$20240805$EXP$$ES-ABBVIE-5865077$ABBVIE$$23$YR$$F$Y$60$KG$20240805$$HP$ES$ES
241737371$24173737$1$I$$20240731$20240805$20240805$EXP$$US-ABBVIE-5865234$ABBVIE$Hamdan A, Sharma S, Baynes K, Hajj Ali RA, Lowder CY, Srivastava SK. Management of uveitis patients on anti-tnf agents who develop demyelinating disease - a case series. J Ophthal Inflamm Infect. 2024;14(1):35.$$$$F$Y$$$20240805$$HP$US$US
241737381$24173738$1$I$$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A175512$ASTRAZENECA$$$$$M$Y$$$20240805$$HP$US$
241737391$24173739$1$I$$20220310$20240805$20240805$EXP$$CA-AstraZeneca-2022A112556$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$CA$
241737401$24173740$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000048500$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$78$YR$E$M$Y$$$20240805$$HP$JP$JP
241737411$24173741$1$I$$20240731$20240805$20240805$EXP$GB-MHRA-MED-202407301345582370-YRLZB$GB-DEXPHARM-2024-2630$DEXCEL$$$$$F$Y$$$20240805$$HP$GB$GB
241737421$24173742$1$I$$20240724$20240805$20240805$EXP$JP-MLMSERVICE-20240717-PI134950-00111-1$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP001090$JUBILANT$Katagiri H, Sato N, Inoue Y, Muto K, Tanaka H, Hirose Y.. Life-Threatening Hyperkalemia following Low-Dose Trimethoprim-Sulfamethoxazole: A Case Report.. Case Reports in  Acute Medicine. 2023;6(1):1-8$80$YR$$F$Y$48$KG$20240805$$PH$JP$JP
241737431$24173743$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000048489$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$82$YR$E$F$Y$$$20240805$$HP$JP$JP
241737443$24173744$3$F$20240724$20240821$20240805$20240829$EXP$$GT-BIOGEN-2024BI01276453$BIOGEN$$70$YR$$F$Y$63.5$KG$20240828$$CN$GT$GT
241737451$24173745$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008958$APOTEX$$64$YR$$M$Y$$$20240805$$CN$CA$CA
241737461$24173746$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038741$AUROBINDO$$64$YR$$M$Y$121$KG$20240805$$HP$CA$CA
241737471$24173747$1$I$20240701$20240719$20240805$20240805$PER$$US-JNJFOC-20240756053$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240805$$CN$US$US
241737481$24173748$1$I$$20240801$20240805$20240805$EXP$$US-ABBVIE-5865730$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241737491$24173749$1$I$20221211$20240731$20240805$20240805$EXP$$GB-JNJFOC-20230514406$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$72$KG$20240805$$MD$GB$GB
241737501$24173750$1$I$20240723$20240723$20240805$20240805$EXP$$US-SERVIER-S24009408$SERVIER$$$$$$Y$$$20240805$$MD$US$US
241737512$24173751$2$F$$20240815$20240805$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122766$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240822$$PH$US$US
241737521$24173752$1$I$20240727$20240801$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122899$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240805$$HP$US$US
241737531$24173753$1$I$20240727$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122200$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240805$$CN$US$US
241737541$24173754$1$I$$20240730$20240805$20240805$EXP$$TR-TAKEDA-2024TUS077344$TAKEDA$Efe A, Cura M, Ozturk Y, Kasak M, Secer S, Yuksel D. A rare phenomenon, recurrent acute dystonia after withdrawal of methylphenidate -immediate release form: a pediatric case with ADHD.. Clinical Psychopharmacology And Neuroscience : The Official Scientific Journal. 2024;22(3):544-9$6$YR$$M$Y$$$20240805$$HP$TR$TR
241737551$24173755$1$I$20240513$20240730$20240805$20240805$EXP$$NVSC2024US156149$NOVARTIS$$56$YR$$F$Y$$$20240805$$CN$US$US
241737561$24173756$1$I$20240801$20240801$20240805$20240805$PER$$ZA-REGENERON PHARMACEUTICALS, INC.-2024-106258$REGENERON$$$$$M$Y$$$20240805$$MD$ZA$ZA
241737571$24173757$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038654$AUROBINDO$$81$YR$$F$Y$$$20240805$$CN$CA$CA
241737591$24173759$1$I$$20240801$20240805$20240805$EXP$$IL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043596$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240805$$MD$IL$IL
241737601$24173760$1$I$$20240731$20240805$20240805$PER$$US-ABBVIE-5862717$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241737611$24173761$1$I$$20221025$20240805$20240805$EXP$$US-AstraZeneca-2022A357790$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241737621$24173762$1$I$$20220613$20240805$20240805$EXP$$US-AstraZeneca-2022A220782$ASTRAZENECA$$$$$$Y$52.2$KG$20240805$$CN$US$
241737632$24173763$2$F$20240101$20240801$20240805$20240814$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00589$MIRUM PHARMACEUTICALS$$$$$M$Y$25.8$KG$20240814$$CN$US$US
241737641$24173764$1$I$20240730$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024153235$AMGEN$$50$YR$A$F$Y$$$20240805$$CN$US$US
241737651$24173765$1$I$$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024151282$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
241737662$24173766$2$F$20240606$20240820$20240805$20240826$30DAY$$US-AMGEN-USASP2024150505$AMGEN$$58$YR$A$F$Y$74.372$KG$20240826$$PH$US$US
241737673$24173767$3$F$20240403$20240820$20240805$20240827$30DAY$$US-AMGEN-USASP2024150439$AMGEN$$65$YR$E$F$Y$54.15$KG$20240827$$PH$US$US
241737683$24173768$3$F$$20240814$20240805$20240815$EXP$$EG-ROCHE-10000040439$ROCHE$$28$YR$A$M$Y$58$KG$20240815$$CN$EG$EG
241737691$24173769$1$I$20240605$20240726$20240805$20240805$EXP$$US-ACORDA-ACO_177688_2024$ACORDA$$62$YR$$F$Y$88.889$KG$20240805$$CN$US$US
241737701$24173770$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122331$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$83.01$KG$20240805$$CN$US$US
241737711$24173771$1$I$$20240729$20240805$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123022$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240805$$PH$JP$JP
241737721$24173772$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5858013$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241737731$24173773$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008975$APOTEX$$67$YR$$M$Y$$$20240805$$CN$CA$CA
241737741$24173774$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06939$LUPIN$$$$$$Y$$$20240805$$CN$US$US
241737751$24173775$1$I$$20240801$20240805$20240805$EXP$$US-VIIV HEALTHCARE LIMITED-US2024096297$VIIV$$$$$$Y$$$20240805$$MD$US$US
241737761$24173776$1$I$$20240722$20240805$20240805$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-06982$HIKMA$Morao B, Ramos LR, Oliveira MH, Gloria L.. Morao B, Ramos LR, Oliveira MH, Gloria L. Malignancy and mass-forming phenotypes of IgG4-related disease: A challenging diagnosis.. British medical publisher. 2024;17(7):e257372:1-5$8$DEC$$F$Y$60$KG$20240805$$MD$PT$PT
241737771$24173777$1$I$$20240720$20240805$20240805$PER$$US-JNJFOC-20240757006$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$US$US
241737781$24173778$1$I$20231118$20240802$20240805$20240805$EXP$$IN-TAKEDA-2024TUS077790$TAKEDA$$59$YR$$M$Y$$$20240805$$CN$IN$IN
241737791$24173779$1$I$$20240703$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06947$LUPIN$$$$$$Y$$$20240805$$CN$US$US
241737801$24173780$1$I$20240701$20240722$20240805$20240805$PER$$US-JNJFOC-20240764769$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240805$$CN$US$US
241737811$24173781$1$I$$20240731$20240805$20240805$EXP$$US-LEO Pharma-372467$LEO PHARM$$62$YR$$M$Y$104$KG$20240805$$CN$US$US
241737821$24173782$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008961$APOTEX$$83$YR$$$Y$$$20240805$$CN$CA$CA
241737841$24173784$1$I$$20220727$20240805$20240805$EXP$$GB-AstraZeneca-2022A267870$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$GB$
241737851$24173785$1$I$$20240704$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06971$LUPIN$$$$$$Y$$$20240805$$CN$US$US
241737861$24173786$1$I$$20240729$20240805$20240805$EXP$$NVSC2024CL115797$NOVARTIS$$67$YR$$F$Y$$$20240805$$CN$CL$CL
241737871$24173787$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001013$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240805$$CN$US$US
241737882$24173788$2$F$$20240910$20240805$20240920$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-04042$HIKMA$$$$$F$Y$$$20240920$$CN$US$US
241737891$24173789$1$I$$20240802$20240805$20240805$EXP$$US-ROCHE-10000048168$ROCHE$$53$YR$A$F$Y$$$20240805$$MD$US$US
241737902$24173790$2$F$$20240806$20240805$20240812$EXP$$GB-MYLANLABS-2024M1072466$MYLAN$$$$$M$Y$$$20240812$$CN$GB$GB
241737911$24173791$1$I$$20240430$20240805$20240805$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06598$HIKMA$Martino J, Elfessi Z, Szaflarska K, Suh M, Antonishina K.. Martino J, Elfessi Z, Szaflarska K, Suh M, Antonishina K. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use. Journal of pharmacy practice. 2024;1-4:1$25$YR$$M$Y$$$20240805$$PH$US$US
241737921$24173792$1$I$20240721$20240723$20240805$20240805$EXP$$US-PADAGIS-2024PAD01231$PADAGIS$$$$$$Y$$$20240805$$CN$US$US
241737932$24173793$2$F$$20240802$20240805$20240806$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043638$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240806$$MD$JP$JP
241737942$24173794$2$F$$20240813$20240805$20240814$PER$$US-JNJFOC-20240805268$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$HP$US$US
241737951$24173795$1$I$20240722$20240729$20240805$20240805$EXP$$NVSC2024CN157895$NOVARTIS$$69$YR$$M$Y$60$KG$20240805$$HP$CN$CN
241737961$24173796$1$I$20240701$20240801$20240805$20240805$EXP$$US-UCBSA-2024038963$UCB$$67$YR$$M$Y$$$20240805$$HP$US$US
241737971$24173797$1$I$20240720$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152658$AMGEN$$68$YR$E$F$Y$$$20240805$$CN$US$US
241737981$24173798$1$I$20240628$20240730$20240805$20240805$EXP$FR-AFSSAPS-RN2024000842$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-122604$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240805$$MD$FR$FR
241737991$24173799$1$I$$20240729$20240805$20240805$EXP$$US-GSK-US2024094741$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241738001$24173800$1$I$20240719$20240726$20240805$20240805$30DAY$$US-GSK-US2024094274$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240805$$CN$US$US
241738011$24173801$1$I$20240723$20240723$20240805$20240805$PER$$US-BAYER-2024A107028$BAYER$$27$YR$A$F$Y$$$20240805$$HP$US$US
241738021$24173802$1$I$$20240725$20240805$20240805$EXP$$US-JNJFOC-20240772305$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$US$US
241738031$24173803$1$I$$20240801$20240805$20240805$EXP$$US-TAKEDA-2024TUS076484$TAKEDA$$$$$M$Y$$$20240805$$MD$US$US
241738041$24173804$1$I$20240101$20240801$20240805$20240805$EXP$$US-ABBVIE-5865545$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241738051$24173805$1$I$20210226$20210312$20240805$20240805$EXP$$US-AstraZeneca-2021A106950$ASTRAZENECA$$27306$DY$$F$Y$$$20240805$$CN$US$
241738061$24173806$1$I$20240719$20240729$20240805$20240805$EXP$DE-CADRBFARM-2024329519$DE-BIOCON-BCN-2024-000147$BIOCON$$71$YR$E$F$Y$70$KG$20240805$$MD$DE$DE
241738081$24173808$1$I$20240101$20240729$20240805$20240805$EXP$$US-SA-2024SA226169$SANOFI AVENTIS$$64$YR$A$F$Y$56.6$KG$20240805$$MD$US$US
241738091$24173809$1$I$20240701$20240722$20240805$20240805$PER$$US-JNJFOC-20240764359$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241738103$24173810$3$F$20240501$20240828$20240805$20240901$EXP$$JP-JNJFOC-20240808964$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240902$$MD$JP$JP
241738113$24173811$3$F$$20240920$20240805$20240925$EXP$$CA-AUROBINDO-AUR-APL-2024-037916$AUROBINDO$$78$YR$$M$Y$$$20240925$$MD$CA$CA
241738122$24173812$2$F$$20240724$20240805$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-037925$AUROBINDO$$80$YR$$F$Y$37$KG$20240807$$PH$CA$CA
241738132$24173813$2$F$20231029$20240820$20240805$20240830$EXP$FR-AFSSAPS-TS2024000829$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110226$ZYDUS PHARM$$$$$$Y$$$20240830$$MD$FR$FR
241738142$24173814$2$F$$20240830$20240805$20240906$EXP$$CA-TAKEDA-2022TUS071274$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
241738151$24173815$1$I$20230406$20240722$20240805$20240805$EXP$FR-AFSSAPS-NY2024000819$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110227$ZYDUS PHARM$$$$$$Y$$$20240805$$PH$FR$FR
241738161$24173816$1$I$$20240722$20240805$20240805$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110224$ZYDUS PHARM$Applegarth J, Finn D, Tolkacz M, Iacco A.. Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome.. ASAIO-J. 2024;70 (Suppl. 3):151 abstr. P74$$$$$Y$$$20240805$$HP$US$US
241738171$24173817$1$I$$20240801$20240805$20240805$EXP$$CA-ABBVIE-5865740$ABBVIE$$$$E$F$Y$$$20240805$$CN$CA$CA
241738182$24173818$2$F$20200201$20240830$20240805$20240905$EXP$$CA-Orion Corporation ORION PHARMA-21_00015138$ORION$$77$YR$E$M$Y$$$20240905$$MD$CA$
241738191$24173819$1$I$20240415$20240722$20240805$20240805$EXP$FR-AFSSAPS-AN2024000807$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110207$ZYDUS PHARM$$$$$$Y$$$20240805$$PH$FR$FR
241738201$24173820$1$I$20220101$20240725$20240805$20240805$EXP$GB-MHRA-MED-202407251100577430-VBNLD$GB-MACLEODS PHARMA-MAC2024048604$MACLEODS$$$$$$Y$$$20240805$$CN$GB$GB
241738211$24173821$1$I$$20240730$20240805$20240805$PER$$US-ABBVIE-5861789$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241738221$24173822$1$I$20221214$20240731$20240805$20240805$EXP$$GB-MYLANLABS-2024M1069261$MYLAN$$35$YR$$M$Y$69.9$KG$20240805$$MD$GB$GB
241738241$24173824$1$I$$20240722$20240805$20240805$EXP$$US-MYLANLABS-2024M1068548$MYLAN$$$$$F$Y$129.2$KG$20240805$$CN$US$US
241738251$24173825$1$I$20240731$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152531$AMGEN$$50$YR$A$M$Y$$$20240805$$CN$US$US
241738261$24173826$1$I$20231101$20231120$20240805$20240805$EXP$$AU-SANDOZ INC.-SDZ2023AU060556$SANDOZ$$$$$$Y$$$20240805$$CN$AU$AU
241738271$24173827$1$I$$20240724$20240805$20240805$30DAY$$DE-UCBSA-2024038894$UCB$$$$$F$Y$$$20240805$$CN$DE$DE
241738282$24173828$2$F$$20240725$20240805$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038626$AUROBINDO$$65$YR$$M$Y$92$KG$20240807$$PH$CA$CA
241738291$24173829$1$I$20240718$20240725$20240805$20240805$EXP$DE-BFARM-24005100$DE-Accord-438768$ACCORD$$63$YR$A$F$Y$$$20240805$$MD$DE$DE
241738301$24173830$1$I$$20240724$20240805$20240805$EXP$AU-TGA-812076$AU-Accord-437906$ACCORD$$44$YR$A$F$Y$$$20240805$$HP$AU$AU
241738311$24173831$1$I$$20240724$20240805$20240805$EXP$CA-MHPD-001086687$CA-Accord-438297$ACCORD$$3$YR$C$M$Y$$$20240805$$HP$CA$CA
241738321$24173832$1$I$20240701$20240725$20240805$20240805$EXP$FR-AFSSAPS-PB2024000804$FR-Accord-438646$ACCORD$$105$YR$E$F$Y$65.4$KG$20240805$$MD$FR$FR
241738331$24173833$1$I$$20240725$20240805$20240805$EXP$$US-Accord-438783$ACCORD$Kumar AB, Asamoah EM, Wetter DA, Davis MDP, Alavi A. Clinical Characteristics and Inciting Agents for Pseudoporphyria: The Mayo Clinic Experience, 1996-2020. Adv Skin Wound Care. 2024 Aug 1;37(8):406-411.$$$$$Y$$$20240805$$MD$US$US
241738342$24173834$2$F$$20240805$20240805$20240806$PER$$US-JNJFOC-20240809285$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241738361$24173836$1$I$$20211126$20240805$20240805$EXP$$US-AstraZeneca-2021A848189$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241738371$24173837$1$I$20240606$20240725$20240805$20240805$EXP$$SG-JNJFOC-20240785014$JOHNSON AND JOHNSON$$29$YR$A$$Y$$$20240805$$HP$SG$SG
241738381$24173838$1$I$$20230116$20240805$20240805$EXP$$US-AstraZeneca-2022A395601$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241738391$24173839$1$I$20240501$20240726$20240805$20240805$EXP$$DE-AstraZeneca-2024A176149$ASTRAZENECA$$74$YR$$M$Y$$$20240805$$MD$DE$
241738401$24173840$1$I$20240420$20240729$20240805$20240805$EXP$ES-AEMPS-1552206$ES-CHEPLA-2024009773$CHEPLAPHARM$$75$YR$$M$Y$$$20240805$$MD$COUNTRY NOT SPECIFIED$ES
241738411$24173841$1$I$$20240724$20240805$20240805$EXP$$US-BAYER-2024A110613$BAYER$Medina C.S.; Jijelava S.; Dancour E.; Wright P.. Middle Meningeal Artery Embolization in the Treatment of Acute Subdural Hematoma: A Case Series Featuring Access Through a Carotid Stent. Korean Journal of Neurotrauma. 2024;20:2:113-124$72$YR$E$F$Y$$$20240805$$HP$US$US
241738421$24173842$1$I$$20240724$20240805$20240805$EXP$$US-AUROBINDO-AUR-APL-2024-037949$AUROBINDO$Livia H, Kirsten W. A, Dong C, Joanna F, Daniel L, Zachary N. L, Barbara A. Neurosurgical bleeding in platelet storage pool disorder: a case report.. Platelets. 2024;35(1):1?6$18$YR$$M$Y$$$20240805$$HP$US$US
241738433$24173843$3$F$20230602$20240912$20240805$20240917$EXP$$JP-009507513-2407JPN005044J$MERCK$$60$YR$$M$Y$$$20240917$$MD$JP$JP
241738441$24173844$1$I$$20240726$20240805$20240805$EXP$MX-MLMSERVICE-20240719-PI137411-00120-1$MX-STRIDES ARCOLAB LIMITED-2024SP009535$STRIDES$Lopez-Vidal WL, Enriquez-Montes MF, Meza-Martinez DA, Gallardo-Cantua LM, Hernandez-Guedea MA. Anaphylaxis as an Unusual Cause of Shock in the Trauma Setting: A Case Report.. Cureus. 2024;16(7):e64696$51$YR$$M$Y$$$20240805$$MD$MX$MX
241738451$24173845$1$I$$20240801$20240805$20240805$EXP$$NL-AMGEN-NLDNI2024154167$AMGEN$$$$E$M$Y$$$20240805$$MD$NL$NL
241738461$24173846$1$I$$20240425$20240805$20240805$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-06232$HIKMA$Abiodun A, Crake T, Ghosh AK, Westwood M, Herrey AS, Manisty CH. Abiodun A, Crake T, Ghosh AK, Westwood M, Herrey AS, Manisty CH. CMR: A Mirror to the Multiple Faces of Cardiotoxicity. Journal of Cardiovascular Magnetic Resonance. 2024;26(Supplement 1:100854$81$YR$$F$Y$$$20240805$$MD$GB$GB
241738471$24173847$1$I$$20240730$20240805$20240805$30DAY$$US-GSK-US2024AMR095593$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241738481$24173848$1$I$$20240729$20240805$20240805$EXP$$JP-TEVA-VS-3215135$TEVA$$93$YR$$$Y$$$20240805$$MD$JP$JP
241738492$24173849$2$F$20240717$20240826$20240805$20240903$30DAY$$US-AMGEN-USASP2024145684$AMGEN$$43$YR$A$F$Y$$$20240903$$HP$US$US
241738512$24173851$2$F$20240712$20240805$20240805$20240812$PER$$US-AMGEN-USASP2024141722$AMGEN$$70$YR$E$F$Y$71$KG$20240812$$HP$US$US
241738521$24173852$1$I$$20240723$20240805$20240805$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0286$GRAVITI PHARMACEUTICALS$Abu-Heija U, Sadiq S, Abo Nofal A, Vedantam V.Furosemide induced acute necrotizing pancreatitis.Am-J-Med-Sci.2023;36 (5):S358$52$YR$A$F$Y$$$20240805$$HP$US$US
241738531$24173853$1$I$$20240730$20240805$20240805$PER$$US-MSNLABS-2024MSNSPO01706$MSN LABORATORIES$$$$$$Y$$$20240805$$PH$US$US
241738541$24173854$1$I$20231216$20240724$20240805$20240805$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160000$JIANGSU HENGRUI MEDICINE$$50$YR$$F$Y$59.9$KG$20240805$$MD$CN$CN
241738551$24173855$1$I$20240720$20240726$20240805$20240805$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160004$JIANGSU HENGRUI MEDICINE$$46$YR$$F$Y$52$KG$20240805$$MD$CN$CN
241738561$24173856$1$I$$20240802$20240805$20240805$PER$$US-AMGEN-USASP2024154640$AMGEN$$$$A$M$Y$$$20240805$$HP$US$US
241738571$24173857$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-037873$AUROBINDO$$76$YR$$F$Y$$$20240805$$MD$CA$CA
241738581$24173858$1$I$$20240724$20240805$20240805$PER$$US-P+L Developments of Newyork Corporation-2160002$PL DEVELOPMENTS$$$$$F$Y$$$20240805$$$US$US
241738591$24173859$1$I$$20240725$20240805$20240805$EXP$$ES-P+L Developments of Newyork Corporation-2160007$PL DEVELOPMENTS$Initial$3$YR$$F$Y$$$20240805$$$ES$ES
241738601$24173860$1$I$$20240725$20240805$20240805$EXP$CA-MHPD-E2B_07127508$CA-Accord-438569$ACCORD$$59$YR$A$M$Y$$$20240805$$CN$CA$CA
241738611$24173861$1$I$$20240724$20240805$20240805$EXP$GB-AMGEN-GBRSP2024146096$GB-Accord-440029$ACCORD$$$$$F$Y$$$20240805$$MD$GB$GB
241738621$24173862$1$I$20240724$20240724$20240805$20240805$EXP$$US-Accord-439505$ACCORD$$52$YR$A$M$Y$$$20240805$$PH$US$US
241738631$24173863$1$I$$20240725$20240805$20240805$EXP$GB-MHRA-MED-202407251006450820-HZBQV$GB-Accord-438848$ACCORD$$$$$M$Y$$$20240805$$CN$GB$GB
241738641$24173864$1$I$$20240725$20240805$20240805$EXP$$AT-Accord-438975$ACCORD$Haschka D, Petzer V, Schmidt S, Jukic E, Duftner C, Wolf D, et al. Azacitidine treatment of a patient with VEXAS syndrome and a new, causative UBA1 mutation. FAKTEN DER RHEUMATOLOGIE. 2024;(02):45-46.$$$$M$Y$$$20240805$$MD$AT$AT
241738651$24173865$1$I$20240722$20240724$20240805$20240805$EXP$$US-Accord-438802$ACCORD$$61$YR$A$F$Y$$$20240805$$PH$US$US
241738661$24173866$1$I$$20240725$20240805$20240805$EXP$$US-Accord-438796$ACCORD$Kumar AB, Asamoah EM, Wetter DA, Davis MDP, Alavi A. Clinical Characteristics and Inciting Agents for Pseudoporphyria: The Mayo Clinic Experience, 1996-2020. Adv Skin Wound Care. 2024 Aug 1;37(8):406-411.$$$$$Y$$$20240805$$MD$US$US
241738671$24173867$1$I$20240528$20240725$20240805$20240805$EXP$GB-MHRA-WEBRADR-202407251819467040-MQZVJ$GB-Accord-438837$ACCORD$$61$YR$A$F$Y$97$KG$20240805$$CN$GB$GB
241738681$24173868$1$I$$20240802$20240805$20240805$PER$$US-ABBVIE-5865546$ABBVIE$$$$$$Y$$$20240805$$HP$US$US
241738691$24173869$1$I$$20240802$20240805$20240805$30DAY$$US-SANDOZ INC.-SDZ2024US070367$SANDOZ$$$$$$Y$$$20240805$$CN$US$US
241738701$24173870$1$I$$20240725$20240805$20240805$EXP$$ES-P+L Developments of Newyork Corporation-2160003$PL DEVELOPMENTS$Initial$3$YR$$F$Y$$$20240805$$$ES$ES
241738711$24173871$1$I$$20240724$20240805$20240805$EXP$AU-TGA-806143$AU-Accord-437964$ACCORD$$60$YR$A$M$Y$$$20240805$$HP$AU$AU
241738721$24173872$1$I$$20240730$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2024US070155$SANDOZ$$$$$F$Y$$$20240805$$MD$US$US
241738731$24173873$1$I$$20230901$20240805$20240805$EXP$$AU-SANDOZ INC.-SDZ2023AU049613$SANDOZ$$$$$$Y$$$20240805$$HP$AU$AU
241738741$24173874$1$I$$20240724$20240805$20240805$EXP$$JP-Accord-438146$ACCORD$Katagiri H, Sato N, Inoue Y, Muto K, Tanaka H, Hirose Y. Life-Threatening Hyperkalemia following Low-Dose Trimethoprim-Sulfamethoxazole: A Case Report. Case Reports in Acute Medicine. 2023;6(1):1-8. DOI: 10.1159/000530450.$80$YR$E$F$Y$48$KG$20240805$$PH$JP$JP
241738751$24173875$1$I$$20240723$20240805$20240805$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0287$GRAVITI PHARMACEUTICALS$Kharawala A, Barzallo D, Seo J, Alhuarrat MAD, Sokol S, Faillace RT.LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION POST EXTENSIVE ANTERIOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI): MANAGEMENT STRATEGIES..J-Am-Coll-Cardiol.2023;81 (8):2714$82$YR$E$F$Y$$$20240805$$HP$US$US
241738761$24173876$1$I$$20240726$20240805$20240805$EXP$$US-BAYER-2024A112125$BAYER$Meyer N.S.; Ullrich L.. Giant splenic artery pseudoaneurysm with arteriovenous fistula: diagnostic challenges and interdisciplinary treatment considerations. BMJ Case Reports (2024) 17:7 Article Number: e259035. 2024;17:7:e259035$$$A$M$Y$$$20240805$$HP$US$US
241738771$24173877$1$I$$20240704$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06874$LUPIN$$$$$$Y$$$20240805$$CN$US$US
241738781$24173878$1$I$$20240725$20240805$20240805$EXP$$FR-MYLANLABS-2024M1071066$MYLAN$Armange L, Lacroix A, Petitgas P, Arvieux C, Piau-Couapel C, Poubeau P, et al. The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review. Eur-J-Clin-Microbiol-Infect-Dis 2023; 42 (4): 413-422.$61$YR$$F$Y$$$20240805$$HP$FR$FR
241738791$24173879$1$I$$20240729$20240805$20240805$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07359$HIKMA$Howell J, Maughan B, Fluchel M, Poppe M.. Howell J, Maughan B, Fluchel M, Poppe M. Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor:A case report.. Urol. Case Rep. 2024;56:102799:/$62$YR$$F$Y$$$20240805$$MD$US$US
241738801$24173880$1$I$$20240729$20240805$20240805$EXP$$GB-TEVA-VS-3227219$TEVA$$72$YR$$M$Y$$$20240805$$HP$GB$GB
241738811$24173881$1$I$20240702$20240723$20240805$20240805$EXP$FR-AFSSAPS-NT2024000877$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07030$HIKMA$$$$$$Y$$$20240805$$MD$FR$FR
241738822$24173882$2$F$$20240919$20240805$20240925$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06761$VIFOR$$$$E$F$Y$$$20240925$$HP$ZA$ZA
241738831$24173883$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008960$APOTEX$$64$YR$$F$Y$$$20240805$$CN$CA$CA
241738841$24173884$1$I$$20240723$20240805$20240805$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0294$GRAVITI PHARMACEUTICALS$Mathialagan K, Nketiah Sarpong K, Muralidharan K, Gopalratnam K.Loop Diuretic-Induced Pancreatitis.Am-J-Gastroenterol.2022;117 (Suppl. 2)(10):S1240-S1241$36$YR$A$F$Y$$$20240805$$MD$US$US
241738851$24173885$1$I$$20240730$20240805$20240805$EXP$$US-CHEPLA-2024009733$CHEPLAPHARM$$$$E$F$Y$$$20240805$$CN$COUNTRY NOT SPECIFIED$US
241738861$24173886$1$I$$20240723$20240805$20240805$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0298$GRAVITI PHARMACEUTICALS$Jakuboski S, Doyle T, Tawa M, Fisher DC, LeBoeuf N, Larocca C.Inpatient Considerations in the Diagnosis and Management of the Cutaneous T-Cell Lymphoma Patient.Curr-Derm-Rep.2022;11(4):233-243$$$$M$Y$$$20240805$$HP$US$US
241738871$24173887$1$I$20240726$20240729$20240805$20240805$EXP$$US-GSK-US2024094827$GLAXOSMITHKLINE$$7$DEC$$$Y$$$20240805$$HP$US$US
241738881$24173888$1$I$$20240726$20240805$20240805$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024094300$VIIV$$$$$$Y$$$20240805$$PH$US$US
241738891$24173889$1$I$20240715$20240801$20240805$20240805$EXP$$CN-ROCHE-10000047044$ROCHE$$58$YR$A$M$Y$60$KG$20240805$$HP$CN$CN
241738901$24173890$1$I$$20240726$20240805$20240805$EXP$$US-BAYER-2024A109068$BAYER$$20$YR$A$F$Y$$$20240805$$HP$US$US
241738911$24173891$1$I$$20240801$20240805$20240805$PER$$US-ABBVIE-5865534$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241738921$24173892$1$I$$20230907$20240805$20240805$EXP$$AE-SANDOZ INC.-SDZ2023AE039429$SANDOZ$$$$$$Y$$$20240805$$HP$AE$AE
241738931$24173893$1$I$20240701$20240725$20240805$20240805$EXP$FR-AFSSAPS-LL2024001385$FR-Accord-438640$ACCORD$$49$YR$A$F$Y$52.5$KG$20240805$$MD$FR$FR
241738941$24173894$1$I$20240607$20240725$20240805$20240805$EXP$ES-AEMPS-1551742$ES-Accord-438658$ACCORD$$66$YR$E$M$Y$$$20240805$$PH$ES$ES
241738951$24173895$1$I$20240624$20240731$20240805$20240805$EXP$DK-DKMA-30736601$DK-AMGEN-DNKSP2024152317$AMGEN$$62$YR$A$F$Y$70$KG$20240805$$MD$DK$DK
241738963$24173896$3$F$$20240809$20240805$20240813$EXP$$US-AMGEN-USASP2024154611$AMGEN$$$$$M$Y$$$20240813$$HP$US$US
241738972$24173897$2$F$20240101$20240822$20240805$20240903$EXP$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-01448$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$$$20240903$$MD$US$US
241738981$24173898$1$I$$20240722$20240805$20240805$PER$$US-TEVA-VS-3225395$TEVA$$74$YR$$M$Y$$$20240805$$HP$US$US
241738991$24173899$1$I$$20240730$20240805$20240805$PER$$US-ROCHE-10000048240$ROCHE$$$$$$Y$$$20240805$$MD$US$US
241739001$24173900$1$I$$20240730$20240805$20240805$EXP$GB-MHRA-MED-202407301512567220-TMCRW$GB-RDY-SPO/GBR/24/0011272$DR REDDYS$$$$$M$Y$$$20240805$$PH$GB$GB
241739022$24173902$2$F$20240216$20240814$20240805$20240821$EXP$$AU-BEH-2024176475$CSL BEHRING$$11$YR$C$$Y$37.2$KG$20240821$$MD$AU$AU
241739031$24173903$1$I$$20240802$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408002165$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240805$$CN$US$US
241739041$24173904$1$I$$20240722$20240805$20240805$EXP$$IT-ROCHE-10000034805$ROCHE$Tovoli F, Franceschini E, Vivaldi C, Federico P, Palloni A, Dalbeni A, et al. Management of portal hypertension in patients receiving atezolizumab-bevacizumab for hepatocellular carcinoma (Abstract number: F-47). Digestive and Liver Disease. 2024-Feb;56:S87. doi:10.1016/j.dld.2024.01.152.$$$$$Y$$$20240805$$HP$IT$IT
241739051$24173905$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000048486$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$60$YR$A$F$Y$$$20240805$$HP$JP$JP
241739061$24173906$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001322$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240805$$CN$US$US
241739071$24173907$1$I$$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019550$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240805$$CN$US$US
241739082$24173908$2$F$$20240802$20240805$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408001987$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240815$$HP$US$US
241739091$24173909$1$I$$20240802$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408002089$ELI LILLY AND CO$$61$YR$A$$Y$$$20240805$$CN$US$US
241739101$24173910$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001403$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240805$$CN$US$US
241739111$24173911$1$I$$20240802$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408002233$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240805$$CN$US$US
241739121$24173912$1$I$$20240802$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408002194$ELI LILLY AND CO$$8$YR$C$M$Y$$$20240805$$CN$US$US
241739131$24173913$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001909$ELI LILLY AND CO$$$$$$Y$$$20240805$$CN$US$US
241739141$24173914$1$I$20240725$20240726$20240805$20240805$EXP$GB-MHRA-MED-202407261358517160-LDNJT$GB-BAXTER-2024BAX022415$BAXTER$$74$YR$$M$Y$$$20240805$$HP$GB$GB
241739152$24173915$2$F$20240720$20240730$20240805$20240807$EXP$$MX-Rare Disease Therapeutics, Inc.-2160011$RARE DISEASE THERAPEUTICS$$26$YR$$F$Y$$$20240807$$MD$MX$MX
241739161$24173916$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000048763$ROCHE$Ishimaru K, Nomura M. S17-3 A case of recurrence of rare metastases after CR to chemotherapy in an anal canal cancer patient. The 79th General Meeting of the Japanese Society of Gastroenterological Surgery. 2024;2438$7$DEC$E$M$Y$$$20240805$$MD$JP$JP
241739181$24173918$1$I$$20240706$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06924$LUPIN$$$$$$Y$$$20240805$$CN$US$US
241739191$24173919$1$I$20240701$20240731$20240805$20240805$EXP$$US-ABBVIE-5863737$ABBVIE$$50$YR$$F$Y$$$20240805$$CN$US$US
241739201$24173920$1$I$$20240730$20240805$20240805$EXP$$US-009507513-2408USA000103$MERCK$$$$$F$Y$$$20240805$$CN$US$US
241739211$24173921$1$I$20220101$20240729$20240805$20240805$EXP$$GB-BAUSCHBL-2024BNL030820$BAUSCH AND LOMB$Williams H, Thoppuram N, Law K, Simms J. Post-operative post-cognitive dysfunction: Progressive multifocal leukoencephalopathy (PML), an unexpected finding in an elderly patient. Clinical Medicine. 2024;24(SUPPLEMENT):5. doi:10.1016/j.clinme.2024.100048$87$YR$$F$Y$$$20240805$$HP$GB$GB
241739222$24173922$2$F$$20240731$20240805$20240807$PER$$US-MYLANLABS-2024M1070404$MYLAN$$$$$F$Y$64.86$KG$20240807$$HP$US$US
241739231$24173923$1$I$$20240716$20240805$20240805$PER$$US-TEVA-VS-3225448$TEVA$$74$YR$$F$Y$$$20240805$$PH$US$US
241739244$24173924$4$F$$20240906$20240805$20240910$PER$$US-AMGEN-USASP2024152547$AMGEN$$$$$M$Y$$$20240910$$CN$US$US
241739251$24173925$1$I$$20240727$20240805$20240805$EXP$GB-MHRA-MED-202407272224566460-HYGZR$GB-862174955-ML2024-04217$MICRO LABS$$29$YR$A$F$Y$$$20240805$$CN$GB$GB
241739261$24173926$1$I$$20240726$20240805$20240805$EXP$$US-GSK-US2024094206$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241739271$24173927$1$I$$20240726$20240805$20240805$30DAY$$US-GSK-US2024094282$GLAXOSMITHKLINE$$$$$M$Y$$$20240805$$CN$US$US
241739281$24173928$1$I$$20240801$20240805$20240805$EXP$$AT-JNJFOC-20240809321$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$MD$AT$AT
241739301$24173930$1$I$$20240726$20240805$20240805$30DAY$$US-GSK-US2024083014$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241739311$24173931$1$I$$20240725$20240805$20240805$EXP$$US-BEH-2024176347$CSL BEHRING$$$$A$M$Y$$$20240805$$HP$US$US
241739321$24173932$1$I$$20240722$20240805$20240805$PER$$US-ROCHE-10000042131$ROCHE$$$$$$Y$$$20240805$$PH$US$US
241739331$24173933$1$I$20240601$20240723$20240805$20240805$PER$$US-JNJFOC-20240768039$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240805$$CN$US$US
241739341$24173934$1$I$$20240729$20240805$20240805$EXP$$US-SA-2024SA227840$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
241739351$24173935$1$I$20240728$20240729$20240805$20240805$PER$$US-RDY-SPO/USA/24/0011226$DR REDDYS$$16$YR$T$$Y$$$20240805$$CN$US$US
241739361$24173936$1$I$20240724$20240729$20240805$20240805$EXP$$US-BAYER-2024A110486$BAYER$$36$YR$A$F$Y$$$20240805$$HP$US$US
241739371$24173937$1$I$20190301$20240726$20240805$20240805$EXP$$BE-MYLANLABS-2024M1066214$MYLAN$$45$YR$$M$Y$$$20240805$$CN$BE$BE
241739381$24173938$1$I$$20240731$20240805$20240805$EXP$$GB-TAKEDA-2022TUS092849$TAKEDA$$$$$F$Y$$$20240805$$CN$GB$GB
241739391$24173939$1$I$20240717$20240726$20240805$20240805$EXP$$CN-009507513-2407CHN015707$MERCK$$60$YR$$F$Y$68$KG$20240805$$HP$CN$CN
241739401$24173940$1$I$$20240802$20240805$20240805$EXP$$US-ROCHE-10000048466$ROCHE$$69$YR$E$M$Y$$$20240805$$CN$US$US
241739411$24173941$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038558$AUROBINDO$$48$YR$$F$Y$$$20240805$$HP$CA$CA
241739421$24173942$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001240$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240805$$CN$US$US
241739431$24173943$1$I$20240731$20240801$20240805$20240805$EXP$$US-ABBVIE-5865811$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241739441$24173944$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5858478$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241739451$24173945$1$I$$20240729$20240805$20240805$EXP$$US-AMGEN-USASP2024150935$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
241739462$24173946$2$F$$20240724$20240805$20240808$EXP$$US-APOTEX-2024AP009049$APOTEX$Abedrabo S, Rodriguez TE, Klein LM, Bitran J.. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142 (Suppl. 1):7078$$$A$$Y$$$20240808$$MD$US$US
241739471$24173947$1$I$$20240724$20240805$20240805$EXP$$FR-AUROBINDO-AUR-APL-2024-037983$AUROBINDO$Canu D, Mary-Prey S, Legrand A, Leaute-labreze C. Use of spironolactone for the treatment of acne in adolescent girls. Ann-Dermatol-Venereol. 2024;151(2):103281$$$$F$Y$$$20240805$$HP$FR$FR
241739481$24173948$1$I$$20240724$20240805$20240805$EXP$$CA-AUROBINDO-AUR-APL-2024-038595$AUROBINDO$$58$YR$$F$Y$61$KG$20240805$$CN$CA$CA
241739493$24173949$3$F$20240723$20240830$20240805$20240904$EXP$$AU-AstraZeneca-2024A176725$ASTRAZENECA$$75$YR$$F$Y$85.8$KG$20240904$$MD$AU$
241739501$24173950$1$I$$20240722$20240805$20240805$EXP$$US-ROCHE-10000032733$ROCHE$$$$E$F$Y$$$20240805$$MD$US$US
241739511$24173951$1$I$$20240730$20240805$20240805$EXP$$CN-AMGEN-CHNSP2024151890$AMGEN$Zeng H.; Wang Y.; Xue Y. et. al.. Treatment and outcomes of patients with B-ALL relapse after CD19 CAR-T therapy. Journal of Translational Medicine. 2024;22 (1):1-3$$$$$Y$$$20240805$$HP$CN$CN
241739522$24173952$2$F$20240101$20240801$20240805$20240814$EXP$$US-UCBSA-2024038972$UCB$$$$$F$Y$$$20240814$$HP$US$US
241739531$24173953$1$I$20200615$20240730$20240805$20240805$EXP$$GB-UCBSA-2024039000$UCB$$73$YR$$M$Y$$$20240805$$CN$GB$GB
241739552$24173955$2$F$$20240802$20240805$20240809$EXP$$CA-MYLANLABS-2024M1071433$MYLAN$$$$$M$Y$$$20240809$$CN$CA$CA
241739561$24173956$1$I$$20240730$20240805$20240805$EXP$$GB-AMGEN-GBRSP2024152684$AMGEN$$$$$M$Y$$$20240805$$HP$GB$GB
241739571$24173957$1$I$$20231121$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2023CA057290$SANDOZ$$$$$$Y$$$20240805$$HP$CA$CA
241739581$24173958$1$I$$20240730$20240805$20240805$EXP$$IR-MYLANLABS-2024M1072682$MYLAN$Alipour S, Gholami B, Orouji M, Heydari S. Imiquimod as a new treatment in refractory idiopathic granulomatous mastitis: report of two cases. DARU 2024; 32 (1): 443-447.$35$YR$$F$Y$$$20240805$$HP$IR$IR
241739591$24173959$1$I$20240401$20240731$20240805$20240805$EXP$$US-AMGEN-USASP2024152460$AMGEN$$65$YR$E$F$Y$$$20240805$$CN$US$US
241739601$24173960$1$I$20210726$20240731$20240805$20240805$EXP$PL-URPL-DML-MLP.4401.1.4957.2021$PL-BAYER-2024A110741$BAYER$$59$YR$A$F$Y$80$KG$20240805$$HP$PL$PL
241739611$24173961$1$I$20240731$20240801$20240805$20240805$EXP$$US-BAYER-2024A112475$BAYER$$74$YR$E$F$Y$$$20240805$$HP$US$US
241739632$24173963$2$F$20240725$20240802$20240805$20240814$EXP$$US-Accord-438865$ACCORD$$33$YR$A$F$Y$$$20240814$$MD$US$US
241739641$24173964$1$I$20210920$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123085$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240805$$HP$US$US
241739651$24173965$1$I$20240723$20240724$20240805$20240805$EXP$$US-Accord-439139$ACCORD$$75$YR$E$M$Y$$$20240805$$HP$US$US
241739661$24173966$1$I$20240712$20240724$20240805$20240805$EXP$CN-HENLIUS-24CN016078$CN-Accord-439379$ACCORD$$45$YR$A$F$Y$49$KG$20240805$$MD$CN$CN
241739671$24173967$1$I$20240627$20240725$20240805$20240805$EXP$DE-BFARM-24005093$DE-Accord-438528$ACCORD$$74$YR$E$F$Y$89$KG$20240805$$CN$DE$DE
241739681$24173968$1$I$$20240724$20240805$20240805$EXP$AU-TGA-805508$AU-Accord-437840$ACCORD$$60$YR$A$M$Y$$$20240805$$HP$AU$AU
241739691$24173969$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001176$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240805$$CN$US$US
241739702$24173970$2$F$20240501$20240801$20240805$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408000444$ELI LILLY AND CO$$38$YR$$M$Y$$$20240808$$CN$US$US
241739711$24173971$1$I$$20240729$20240805$20240805$EXP$$CO-AMGEN-COLSP2024151116$AMGEN$$61$YR$A$F$Y$$$20240805$$MD$CO$CO
241739721$24173972$1$I$$20240724$20240805$20240805$EXP$CA-MHPD-E2B_07134287$CA-Accord-438312$ACCORD$$62$YR$A$F$Y$$$20240805$$MD$CA$CA
241739732$24173973$2$F$$20240820$20240805$20240821$EXP$$US-UCBSA-2024034975$UCB$$$$$F$Y$$$20240821$$CN$US$US
241739741$24173974$1$I$$20240802$20240805$20240805$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043726$BOEHRINGER INGELHEIM$$$$$$Y$$$20240805$$CN$US$US
241739751$24173975$1$I$$20240730$20240805$20240805$EXP$GB-MYLANLABS-2024M1018650$GB-CHEPLA-2024009995$CHEPLAPHARM$$$$$M$Y$$$20240805$$MD$COUNTRY NOT SPECIFIED$GB
241739761$24173976$1$I$20240722$20240801$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122299$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$95.4$KG$20240805$$PH$US$US
241739772$24173977$2$F$20240601$20240819$20240805$20240828$PER$$US-Kiniksa Pharmaceuticals Ltd.-2024KPU001241$KINIKSA PHARMACEUTICALS$$47$YR$A$F$Y$$$20240827$$CN$US$US
241739781$24173978$1$I$$20240725$20240805$20240805$EXP$$PT-ROCHE-10000038939$ROCHE$$$$$F$Y$$$20240805$$MD$PT$PT
241739791$24173979$1$I$$20240731$20240805$20240805$EXP$$US-OTSUKA-2024_021302$OTSUKA$$79$YR$$F$Y$$$20240805$$HP$US$US
241739801$24173980$1$I$20240101$20240731$20240805$20240805$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012611$VERTEX$$$$A$M$Y$$$20240805$$CN$GB$GB
241739824$24173982$4$F$20240101$20240903$20240805$20240906$EXP$$US-VERTEX PHARMACEUTICALS-2024-012569$VERTEX$$12$YR$$F$Y$$$20240906$$HP$US$US
241739831$24173983$1$I$20240717$20240729$20240805$20240805$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012478$VERTEX$$49$YR$$F$Y$$$20240805$$CN$GB$GB
241739841$24173984$1$I$$20240725$20240805$20240805$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004435$UNKNOWN$$$$$$Y$$$20240801$$PH$US$US
241739861$24173986$1$I$20240728$20240731$20240805$20240805$EXP$$US-VERTEX PHARMACEUTICALS-2024-012603$VERTEX$$38$YR$$M$Y$$$20240805$$CN$US$US
241739871$24173987$1$I$$20240716$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07330$LUPIN$$$$$$Y$$$20240805$$CN$US$US
241739881$24173988$1$I$$20240729$20240805$20240805$EXP$$ZA-ABBVIE-5865637$ABBVIE$$47$YR$$M$Y$$$20240805$$CN$ZA$ZA
241739892$24173989$2$F$$20240802$20240805$20240806$EXP$$US-ROCHE-10000048199$ROCHE$$42$YR$A$M$Y$$$20240806$$CN$US$US
241739901$24173990$1$I$$20240804$20240805$20240805$PER$$US-ROCHE-10000048426$ROCHE$$$$$$Y$$$20240805$$CN$US$US
241739921$24173992$1$I$20230101$20240805$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2024US070415$SANDOZ$$$$$F$Y$$$20240805$$CN$US$US
241739931$24173993$1$I$$20240725$20240805$20240805$EXP$$DE-RDY-LIT/DEU/24/0011302$DR REDDYS$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhel S, et al. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. British Journal of Cancer. 2023;128(6): 1134-1147. doi:10.1038/s41416-022-02120-x.$$$$$Y$$$20240805$$HP$DE$DE
241739941$24173994$1$I$$20240728$20240805$20240805$EXP$$US-AMGEN-USASP2024153338$AMGEN$Barrison L.; Park S.; Decherney A. et al.. Spontaneous conception in a 40-year-old woman after allogeneic stem cell transplant with active graft-versus-host disease: A case report. Case Reports in ^Women^s Health. 2024;43:1-3$36$YR$A$F$Y$$$20240805$$HP$US$US
241739951$24173995$1$I$$20240725$20240805$20240805$EXP$$AR-ROCHE-10000039885$ROCHE$$45$YR$A$M$Y$$$20240805$$MD$AR$AR
241739962$24173996$2$F$$20240725$20240805$20240809$EXP$$US-MYLANLABS-2024M1069987$MYLAN$$$$$F$Y$$$20240809$$CN$US$US
241739972$24173997$2$F$20230926$20240902$20240805$20240904$EXP$$GB-MYLANLABS-2024M1070700$MYLAN$$81$YR$$M$Y$53$KG$20240904$$CN$GB$GB
241739981$24173998$1$I$$20240729$20240805$20240805$EXP$NL-LRB-00993123$NL-MYLANLABS-2024M1070936$MYLAN$$74$YR$$F$Y$79$KG$20240805$$CN$NL$NL
241739992$24173999$2$F$20240716$20240807$20240805$20240813$EXP$IT-MINISAL02-996230$IT-MYLANLABS-2024M1070882$MYLAN$$77$YR$$M$Y$$$20240813$$MD$IT$IT
241740002$24174000$2$F$20240101$20240814$20240805$20240815$EXP$$DE-BAYER-2024A110554$BAYER$$42$YR$A$F$Y$$$20240815$$CN$DE$DE
241740011$24174001$1$I$20231201$20240725$20240805$20240805$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000109$PPD DEVELOPMENT LP$$$$$$Y$$$20240802$$CN$CN$CN
241740021$24174002$1$I$20240611$20240724$20240805$20240805$EXP$CN-HENLIUS-24CN016111$CN-Accord-439377$ACCORD$$37$YR$A$F$Y$$$20240805$$MD$CN$CN
241740031$24174003$1$I$20240723$20240724$20240805$20240805$EXP$$US-Accord-438803$ACCORD$$43$YR$A$F$Y$$$20240805$$PH$US$US
241740041$24174004$1$I$$20240725$20240805$20240805$EXP$$PK-Accord-438951$ACCORD$Akhtar MZ, Tayab GUN, Nawaz MI, Seher I. Excessive Dynamic Airway Collapse After Entecavir Use in a Patient With Pegylated Interferon-Induced Undifferentiated Connective Tissue Disease and Entecavir Use to Prevent Hepatitis B Virus Reactivation Upon Giving Rituximab. Cureus. 2024 Jun 21;16(6):e62835.$49$YR$A$F$Y$$$20240805$$HP$PK$PK
241740052$24174005$2$F$20240722$20240819$20240805$20240831$EXP$$US-Accord-438880$ACCORD$$37$YR$A$F$Y$$$20240831$$PH$US$US
241740061$24174006$1$I$$20240724$20240805$20240805$EXP$CA-MHPD-001088931$CA-Accord-438283$ACCORD$$12$YR$T$M$Y$45$KG$20240805$$PH$CA$CA
241740071$24174007$1$I$$20240725$20240805$20240805$EXP$CA-MHPD-E2B_07147520$CA-Accord-438575$ACCORD$$73$YR$E$F$Y$45$KG$20240805$$MD$CA$CA
241740081$24174008$1$I$$20240724$20240805$20240805$EXP$CA-MHPD-E2B_07169499$CA-Accord-438536$ACCORD$$$$E$$Y$$$20240805$$HP$CA$CA
241740091$24174009$1$I$$20240725$20240805$20240805$EXP$$AR-AKCEA THERAPEUTICS, INC.-2024IS006122$AKCEA THERAPEUTICS$$$$$$Y$$$20240802$$MD$AR$AR
241740111$24174011$1$I$$20240729$20240805$20240805$EXP$$JP-OTSUKA-2024_021102$OTSUKA$$$$$$Y$$$20240805$$HP$JP$JP
241740122$24174012$2$F$20240731$20240806$20240805$20240812$EXP$$US-AMGEN-USASP2024153092$AMGEN$$74$YR$E$F$Y$$$20240812$$CN$US$US
241740131$24174013$1$I$$20240731$20240805$20240805$EXP$$JP-OTSUKA-2024_018973$OTSUKA$$6$DEC$$F$Y$$$20240805$$PH$JP$JP
241740142$24174014$2$F$$20240901$20240805$20240904$EXP$$TW-009507513-2408TWN000060$MERCK$$38$YR$$M$Y$$$20240904$$MD$TW$TW
241740151$24174015$1$I$$20240729$20240805$20240805$EXP$$SE-MYLANLABS-2024M1071553$MYLAN$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J-Allergy-Clin-Immunol-Pract 2024; 12 (7): 1850-1862.$57$YR$$$Y$$$20240805$$MD$SE$SE
241740161$24174016$1$I$$20240723$20240805$20240805$EXP$$US-APOTEX-2024AP008815$APOTEX$Rai H K, Patel P, Reddy K. A Case Report on Metformin-Associated Lactic Acidosis. Cureus. 2020;12 (8):e9533$77$YR$$M$Y$$$20240805$$HP$US$US
241740171$24174017$1$I$$20240726$20240805$20240805$PER$$US-BAYER-2024A110964$BAYER$$$$$$Y$$$20240805$$CN$US$US
241740181$24174018$1$I$$20240729$20240805$20240805$EXP$$US-MYLANLABS-2024M1071874$MYLAN$Schott C, Massad KM, Held N. Disseminated Nocardiosis in a Sarcoidosis Patient Off Pneumocystis Pneumonia Prophylaxis. Am-J-Respir-Crit-Care-Med 2024; 209.$81$YR$$M$Y$$$20240805$$HP$US$US
241740191$24174019$1$I$$20240726$20240805$20240805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123245$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240805$$MD$JP$JP
241740201$24174020$1$I$20231127$20231208$20240805$20240805$EXP$$NVSC2023BR263657$NOVARTIS$$59$YR$$M$Y$$$20240805$$CN$BR$BR
241740211$24174021$1$I$20240620$20240801$20240805$20240805$EXP$IT-MINISAL02-996710$IT-REGENERON PHARMACEUTICALS, INC.-2024-106924$REGENERON$$75$YR$$M$Y$$$20240805$$MD$IT$IT
241740221$24174022$1$I$20240417$20240725$20240805$20240805$EXP$$CO-UCBSA-2024039034$UCB$$31$YR$$F$Y$$$20240805$$CN$CO$CO
241740231$24174023$1$I$20240101$20240726$20240805$20240805$PER$$US-ABBVIE-5858300$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241740242$24174024$2$F$20230101$20240813$20240805$20240819$EXP$$CZ-SA-2024SA226313$SANOFI AVENTIS$$$$A$F$Y$$$20240819$$MD$CZ$CZ
241740251$24174025$1$I$$20240729$20240805$20240805$EXP$$US-JNJFOC-20240809408$JOHNSON AND JOHNSON$Samuelson Bannow BT. Management of abnormal uterine bleeding on anticoagulation: the patient-clinician perspective. Journal of Thrombosis and Haemostasis (). 2024;22:7:1819-1825$27$YR$A$F$Y$$$20240805$$HP$US$US
241740261$24174026$1$I$20240723$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024153376$AMGEN$$65$YR$E$F$Y$$$20240805$$PH$US$US
241740271$24174027$1$I$$20240731$20240805$20240805$PER$$US-BEH-2024176724$CSL BEHRING$$$$A$M$Y$$$20240805$$HP$US$US
241740281$24174028$1$I$20230801$20240727$20240805$20240805$EXP$$IT-UCBSA-2023045048$UCB$$$$A$F$Y$$$20240805$$CN$IT$IT
241740291$24174029$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153475$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241740303$24174030$3$F$20240731$20240913$20240805$20240917$PER$$US-AMGEN-USASP2024153507$AMGEN$$31$YR$A$F$Y$$$20240916$$CN$US$US
241740312$24174031$2$F$20240401$20240813$20240805$20240822$PER$$US-BAYER-2024A110261$BAYER$$25$YR$A$F$Y$67.59$KG$20240822$$HP$US$US
241740321$24174032$1$I$$20240801$20240805$20240805$EXP$$US-TAKEDA-2024TUS078093$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
241740331$24174033$1$I$$20240802$20240805$20240805$EXP$$US-TAKEDA-2024TUS078108$TAKEDA$$$$$M$Y$$$20240805$$HP$US$US
241740341$24174034$1$I$$20240725$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118802$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$90.26$KG$20240805$$CN$US$US
241740352$24174035$2$F$$20240814$20240805$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122839$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240819$$CN$US$US
241740361$24174036$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153448$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241740371$24174037$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153453$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241740381$24174038$1$I$20230301$20240729$20240805$20240805$EXP$$US-ABBVIE-5862737$ABBVIE$$61$YR$$F$Y$$$20240805$$CN$US$US
241740401$24174040$1$I$20240728$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000265$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240805$$PH$US$US
241740411$24174041$1$I$$20240723$20240805$20240805$EXP$$GB-CIPLA LTD.-2024GB08036$CIPLA$$$$$$Y$$$20240805$$CN$GB$GB
241740431$24174043$1$I$20230101$20240711$20240805$20240805$EXP$$US-ROCHE-10000024421$ROCHE$$65$YR$E$F$Y$96.16$KG$20240805$$CN$US$US
241740441$24174044$1$I$$20240730$20240805$20240805$PER$$US-BAYER-2024A110264$BAYER$$31$YR$A$F$Y$$$20240805$$HP$US$US
241740451$24174045$1$I$$20240723$20240805$20240805$EXP$$JP-UCBSA-2024006918$UCB$$5$DEC$$M$Y$$$20240805$$MD$JP$JP
241740462$24174046$2$F$$20240807$20240805$20240812$EXP$$US-GILEAD-2024-0680974$GILEAD$$$$N$F$Y$$$20240812$$HP$US$US
241740472$24174047$2$F$20240730$20240802$20240805$20240808$EXP$$JP-PFIZER INC-PV202400099778$PFIZER$$74$YR$$M$Y$$$20240808$$PH$JP$JP
241740491$24174049$1$I$$20240731$20240805$20240805$EXP$$CA-PFIZER INC-202400228284$PFIZER$$$$$$Y$$$20240805$$HP$CA$CA
241740503$24174050$3$F$20240101$20240922$20240805$20240923$EXP$$CA-PFIZER INC-202400221475$PFIZER$$63$YR$$M$Y$$$20240923$$HP$CA$CA
241740511$24174051$1$I$20240710$20240730$20240805$20240805$EXP$$US-PFIZER INC-PV202400081466$PFIZER$$71$YR$$M$Y$70.4$KG$20240805$$HP$US$US
241740522$24174052$2$F$20230101$20240926$20240805$20240926$EXP$$CA-PFIZER INC-202300311892$PFIZER$$73$YR$$F$Y$84.354$KG$20240926$$CN$CA$CA
241740531$24174053$1$I$$20240731$20240805$20240805$EXP$$US-PFIZER INC-202400227484$PFIZER$$55$YR$$F$Y$$$20240805$$CN$US$US
241740551$24174055$1$I$$20240730$20240805$20240805$EXP$$KR-PFIZER INC-202400226646$PFIZER$$8$DEC$$F$Y$$$20240805$$PH$KR$KR
241740561$24174056$1$I$$20240731$20240805$20240805$EXP$$CA-PFIZER INC-202400227618$PFIZER$$51$YR$$F$Y$$$20240805$$MD$CA$CA
241740571$24174057$1$I$$20240711$20240805$20240805$PER$$US-009507513-2408USA000330$MERCK$Permpalung N, Chiang TPY, Manothummetha K, Ostrander D, Datta K, Segev DL, et al. Invasive Fungal Infections in Inpatient Solid Organ Transplant Recipients With COVID-19: A Multicenter Retrospective Cohort. Transplantation. 2024;108:1613-1622$69$YR$$F$Y$$$20240805$$MD$US$US
241740581$24174058$1$I$$20240726$20240805$20240805$EXP$$GR-BIOCON BIOLOGICS LIMITED-BBL2024005581$BIOCON$$$$$$Y$$$20240805$$MD$GR$GR
241740592$24174059$2$F$$20240924$20240805$20240930$EXP$$CA-TAKEDA-2024TUS077239$TAKEDA$$$$$F$Y$$$20240930$$CN$CA$CA
241740601$24174060$1$I$$20240731$20240805$20240805$EXP$NL-LRB-00993791$NL-009507513-2408NLD000279$MERCK$$67$YR$$M$Y$64$KG$20240805$$MD$NL$NL
241740611$24174061$1$I$$20240725$20240805$20240805$PER$$US-AMGEN-USASP2024153436$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240805$$MD$US$US
241740622$24174062$2$F$$20240820$20240805$20240830$EXP$$ES-TEVA-VS-3228784$TEVA$De La Rosa Valero VD, Del Carmen Hernandez Murciano M, Del Carmen Martinez Canovas E, Perez-Crespo CB, Alcazar II-P, Palao GP, et al. A FATAL STRONGYLOIDES STERCORALIS HYPERINFECTION SYNDROME IN A HIVINFECTED PATIENT. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl. 1) 410 abstr. 310.; De La Rosa Valero VD, Del Carmen Hernandez Murciano M, Del Carmen Martinez Canovas E, Perez-Crespo CB, Alcazar II-P, Palao GP, et al. A FATAL STRONGYLOIDES STERCORALIS HYPERINFECTION SYNDROME IN A HIVINFECTED PATIENT....$46$YR$$M$Y$$$20240830$$HP$ES$ES
241740631$24174063$1$I$$20240729$20240805$20240805$PER$$US-BAYER-2024A110928$BAYER$$$$$$Y$$$20240805$$CN$US$US
241740641$24174064$1$I$20240718$20240730$20240805$20240805$PER$$US-BAYER-2024A110368$BAYER$$29$YR$A$F$Y$$$20240805$$MD$US$US
241740651$24174065$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123074$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$73.48$KG$20240805$$CN$US$US
241740662$24174066$2$F$20231201$20240729$20240805$20240806$EXP$$JP-AstraZeneca-2023A294417$ASTRAZENECA$$$$T$F$Y$$$20240806$$MD$JP$
241740671$24174067$1$I$20240723$20240730$20240805$20240805$EXP$$AU-GE HEALTHCARE-2024CSU008636$GE HEALTHCARE$$64$YR$$F$Y$70$KG$20240805$$HP$AU$AU
241740681$24174068$1$I$20231010$20240129$20240805$20240805$EXP$$NVSC2024US024832$NOVARTIS$$57$YR$$M$Y$$$20240805$$CN$US$US
241740691$24174069$1$I$$20240730$20240805$20240805$PER$$US-BAYER-2024A110706$BAYER$$$$$F$Y$$$20240805$$HP$US$US
241740701$24174070$1$I$20220101$20240726$20240805$20240805$PER$$US-JNJFOC-20240773513$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240805$$CN$US$US
241740722$24174072$2$F$$20240910$20240805$20240912$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-138600$DAIICHI$$3$DEC$$$Y$$$20240912$$MD$JP$JP
241740731$24174073$1$I$$20240731$20240805$20240805$PER$$US-TAKEDA-2024TUS076976$TAKEDA$$$$$F$Y$$$20240805$$CN$US$US
241740741$24174074$1$I$20240730$20240730$20240805$20240805$PER$$US-BAYER-2024A110801$BAYER$$16$YR$T$F$Y$$$20240805$$MD$US$US
241740751$24174075$1$I$$20240802$20240805$20240805$EXP$$GB-MYLANLABS-2024M1072761$MYLAN$$$$$M$Y$$$20240805$$PH$GB$GB
241740761$24174076$1$I$20240602$20240802$20240805$20240805$EXP$$NZ-MYLANLABS-2024M1072165$MYLAN$$66$YR$$F$Y$41$KG$20240805$$HP$NZ$NZ
241740771$24174077$1$I$$20240730$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122821$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240805$$HP$US$US
241740781$24174078$1$I$$20240725$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122254$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240805$$MD$US$US
241740792$24174079$2$F$$20240905$20240805$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123327$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$100.24$KG$20240913$$CN$US$US
241740801$24174080$1$I$$20240726$20240805$20240805$EXP$GB-MHRA-MED-202407261611297380-YCDKF$GB-TORRENT-00037439$TORRENT$$$$$F$Y$$$20240805$$MD$GB$GB
241740811$24174081$1$I$$20240731$20240805$20240805$EXP$$US-PFIZER INC-202400228106$PFIZER$$46$YR$$M$Y$$$20240805$$MD$US$US
241740821$24174082$1$I$20190401$20240802$20240805$20240805$EXP$ES-AEMPS-1555674$ES-PFIZER INC-202400228790$PFIZER$$53$YR$$M$Y$$$20240805$$MD$ES$ES
241740831$24174083$1$I$$20240802$20240805$20240805$EXP$$US-PFIZER INC-PV202400101492$PFIZER$$49$YR$$F$Y$$$20240805$$HP$US$US
241740843$24174084$3$F$$20240904$20240805$20240906$EXP$$US-PFIZER INC-202400228953$PFIZER$$64$YR$$F$Y$$$20240906$$HP$US$US
241740851$24174085$1$I$20240729$20240731$20240805$20240805$EXP$$CA-PFIZER INC-202400173596$PFIZER$$54$YR$$F$Y$$$20240805$$HP$CA$CA
241740862$24174086$2$F$20240706$20240823$20240805$20240829$EXP$$JP-PFIZER INC-PV202400100752$PFIZER$$43$YR$$M$Y$71$KG$20240829$$MD$JP$JP
241740871$24174087$1$I$$20240801$20240805$20240805$EXP$$US-PFIZER INC-202400228490$PFIZER$$70$YR$$$Y$$$20240805$$CN$US$US
241740881$24174088$1$I$$20240802$20240805$20240805$EXP$$US-PFIZER INC-PV202400101177$PFIZER$$66$YR$$F$Y$$$20240805$$CN$US$US
241740892$24174089$2$F$20240617$20240925$20240805$20240925$EXP$$CA-PFIZER INC-202400228624$PFIZER$$66$YR$$F$Y$$$20240925$$HP$CA$CA
241740901$24174090$1$I$$20240801$20240805$20240805$EXP$$US-PFIZER INC-PV202400100786$PFIZER$$77$YR$$M$Y$$$20240805$$HP$US$US
241740912$24174091$2$F$$20240813$20240805$20240815$EXP$$AU-PFIZER INC-PV202400101323$PFIZER$$79$YR$$M$Y$$$20240815$$PH$AU$AU
241740921$24174092$1$I$20240101$20240801$20240805$20240805$EXP$$CO-PFIZER INC-PV202400090500$PFIZER$$77$YR$$M$Y$$$20240805$$CN$CO$CO
241740932$24174093$2$F$$20240926$20240805$20240926$EXP$$ZA-PFIZER INC-PV202400100489$PFIZER$$19$YR$$F$Y$$$20240926$$CN$ZA$ZA
241740942$24174094$2$F$20051117$20240806$20240805$20240807$EXP$$FR-PFIZER INC-202400227264$PFIZER$$69$YR$$F$Y$$$20240807$$MD$FR$FR
241740951$24174095$1$I$$20240731$20240805$20240805$EXP$$CA-PFIZER INC-202400227555$PFIZER$$95$YR$$M$Y$$$20240805$$CN$CA$CA
241740961$24174096$1$I$20240722$20240801$20240805$20240805$EXP$$DE-PFIZER INC-PV202400101046$PFIZER$$84$YR$$M$Y$$$20240805$$CN$DE$DE
241740973$24174097$3$F$$20240913$20240805$20240917$EXP$$US-PFIZER INC-202400228976$PFIZER$$82$YR$$F$Y$$$20240917$$CN$US$US
241740991$24174099$1$I$$20240803$20240805$20240805$EXP$$IN-PFIZER INC-PV202400101497$PFIZER$$41$YR$$F$Y$$$20240805$$CN$IN$IN
241741001$24174100$1$I$$20240731$20240805$20240805$EXP$$US-PFIZER INC-PV202400100302$PFIZER$$48$YR$$F$Y$$$20240805$$CN$US$US
241741012$24174101$2$F$20240101$20240830$20240805$20240902$PER$$US-JNJFOC-20240804440$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240902$$CN$US$US
241741021$24174102$1$I$$20240730$20240805$20240805$EXP$$US-OTSUKA-2024_021292$OTSUKA$$$$$M$Y$$$20240805$$HP$US$US
241741031$24174103$1$I$$20240801$20240805$20240805$PER$$US-BAYER-2024A111735$BAYER$$$$$M$Y$$$20240805$$CN$US$US
241741042$24174104$2$F$20240627$20240826$20240805$20240902$EXP$$CA-JNJFOC-20240767181$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240902$$CN$CA$CA
241741052$24174105$2$F$20240101$20240807$20240805$20240809$EXP$$CA-UCBSA-2024023204$UCB$$$$$F$Y$$$20240809$$CN$CA$CA
241741062$24174106$2$F$$20240823$20240805$20240829$PER$$US-ROCHE-10000043285$ROCHE$$14$YR$T$F$Y$$$20240829$$PH$US$US
241741071$24174107$1$I$20240801$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122219$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$54.43$KG$20240805$$HP$US$US
241741081$24174108$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123117$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$109.82$KG$20240805$$PH$US$US
241741091$24174109$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123063$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$98.43$KG$20240805$$CN$US$US
241741101$24174110$1$I$20240801$20240801$20240805$20240805$PER$$US-ABBVIE-5865468$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241741111$24174111$1$I$$20240622$20240805$20240805$PER$$US-ROCHE-10000046872$ROCHE$$$$$$Y$$$20240805$$CN$US$US
241741121$24174112$1$I$20240101$20240801$20240805$20240805$EXP$$US-GILEAD-2024-0682709$GILEAD$$60$YR$A$F$Y$$$20240805$$HP$US$US
241741131$24174113$1$I$20240715$20240802$20240805$20240805$EXP$GB-MHRA-MED-202407240808085920-WDRBP$GB-MYLANLABS-2024M1069053$MYLAN$$60$YR$$M$Y$68$KG$20240805$$CN$GB$GB
241741141$24174114$1$I$$20240731$20240805$20240805$EXP$$US-AMGEN-USASP2024152963$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
241741151$24174115$1$I$$20240723$20240805$20240805$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07412$LUPIN$Shultz J, Antar-Shultz M, Taha M, Zervogiannis P, Lazcano G, Lamarche J. Sevelamer-associated colitis: a trigger to change treatment approach. American Journal of Kidney Diseases. 2024;8 (4):S74$63$YR$$M$Y$$$20240805$$HP$US$US
241741161$24174116$1$I$20240730$20240801$20240805$20240805$PER$$US-BAYER-2024A112287$BAYER$$30$YR$A$F$Y$$$20240805$$MD$US$US
241741171$24174117$1$I$20240701$20240730$20240805$20240805$PER$$US-ROCHE-10000045915$ROCHE$$77$YR$E$F$Y$$$20240805$$CN$US$US
241741181$24174118$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000047656$ROCHE$$$$$$Y$$$20240805$$MD$US$US
241741191$24174119$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000047568$ROCHE$$$$A$F$Y$$$20240805$$MD$US$US
241741201$24174120$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000047187$ROCHE$$$$$$Y$$$20240805$$CN$US$US
241741211$24174121$1$I$$20240802$20240805$20240805$PER$$US-ROCHE-10000048511$ROCHE$$39$YR$A$F$Y$$$20240805$$MD$US$US
241741222$24174122$2$F$$20240816$20240805$20240817$PER$$US-JNJFOC-20240777898$JOHNSON AND JOHNSON$$$$$F$Y$$$20240817$$HP$US$US
241741232$24174123$2$F$$20240831$20240805$20240913$EXP$$CA-Ascend Therapeutics US, LLC-2160015$ASCEND$$$$$F$Y$$$20240913$$$CA$CA
241741241$24174124$1$I$$20240802$20240805$20240805$PER$$US-ROCHE-10000048518$ROCHE$$$$$F$Y$$$20240805$$MD$US$US
241741251$24174125$1$I$$20240729$20240805$20240805$EXP$$JP-PFIZER INC-202400229456$PFIZER$Tsujino, M.. A review of the usage of CDK4/6 inhibitors in patients with HR-positive, HER2-negative advanced or breast cancer recurrent at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:117$$$$$Y$$$20240805$$HP$JP$JP
241741261$24174126$1$I$20240614$20240726$20240805$20240805$EXP$$FR-AstraZeneca-2024A176563$ASTRAZENECA$$21$YR$$M$Y$$$20240805$$MD$FR$
241741271$24174127$1$I$20240715$20240725$20240805$20240805$PER$$US-INCYTE CORPORATION-2024IN007844$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241741282$24174128$2$F$$20240813$20240805$20240815$EXP$$US-KYOWAKIRIN-2024KK018558$KYOWA$$$$$$Y$$$20240815$$CN$US$US
241741291$24174129$1$I$$20240731$20240805$20240805$PER$$US-BAYER-2024A111098$BAYER$$$$$F$Y$$$20240805$$CN$US$US
241741301$24174130$1$I$20230501$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001221$ELI LILLY AND CO$$$$$$Y$$$20240805$$CN$US$US
241741311$24174131$1$I$20240617$20240726$20240805$20240805$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06732$VIFOR$$42$YR$$M$Y$$$20240805$$CN$ZA$ZA
241741321$24174132$1$I$20240701$20240726$20240805$20240805$EXP$RU-RZN-2484847$RU-Vifor (International) Inc.-VIT-2024-06845$VIFOR$$50$YR$$F$Y$100$KG$20240805$$HP$RU$RU
241741331$24174133$1$I$$20240726$20240805$20240805$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02754$AMNEAL$$$$$F$Y$$$20240805$$CN$US$US
241741341$24174134$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002198US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241741353$24174135$3$F$$20240918$20240805$20240927$EXP$$US-ALXN-202407USA002114US$ALEXION PHARMACEUTICALS$$50$YR$A$$Y$$$20240927$$MD$US$US
241741361$24174136$1$I$$20240801$20240805$20240805$PER$$US-JNJFOC-20240800979$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$US$US
241741371$24174137$1$I$20240715$20240722$20240805$20240805$PER$$US-IGSA-BIG0030071$GRIFOLS$$22$YR$$M$Y$126.98$KG$20240805$$CN$US$US
241741382$24174138$2$F$$20240820$20240805$20240829$EXP$$IT-TEVA-VS-3228686$TEVA$Lecis M, Stefanelli F, Montanari F, Biase ARD, Lucaccioni L, Iughetti L. Mesalamine-induced myopericarditis in children: a case report and a short revision of the literature. Acta-Biomed 2024; 95 (3):.; Lecis M, Stefanelli F, Montanari F, Biase ARD, Lucaccioni L, Iughetti L. Mesalamine-induced myopericarditis in children: a case report and a short revision of the literature. Acta-Biomed 2024; 95 (3):.; Lecis M, Stefanelli F, Montanari F, Biase ARD, Lucaccioni L, Iughetti L. Mesalamine-induced...$14$YR$$M$Y$$$20240829$$HP$IT$IT
241741392$24174139$2$F$$20240805$20240805$20240806$PER$$US-BIOVITRUM-2024-US-010578$BIOVITRUM$$74$YR$$F$Y$$$20240806$$CN$US$US
241741401$24174140$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008966$APOTEX$$85$YR$$F$Y$$$20240805$$CN$CA$CA
241741411$24174141$1$I$20240614$20240730$20240805$20240805$EXP$FR-AFSSAPS-TO2024001123$FR-MYLANLABS-2024M1071320$MYLAN$$58$YR$$M$Y$100$KG$20240805$$PH$FR$FR
241741421$24174142$1$I$20240409$20240730$20240805$20240805$EXP$FR-AFSSAPS-TO2024001362$FR-MYLANLABS-2024M1071140$MYLAN$$78$YR$$F$Y$60.2$KG$20240805$$MD$FR$FR
241741432$24174143$2$F$20240731$20240815$20240805$20240820$PER$$US-BEH-2024176758$CSL BEHRING$$31$YR$A$F$Y$$$20240820$$HP$US$US
241741441$24174144$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123259$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$66.68$KG$20240805$$MD$US$US
241741451$24174145$1$I$$20240731$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121895$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240805$$CN$US$US
241741461$24174146$1$I$$20240730$20240805$20240805$EXP$FR-AFSSAPS-PO2024000805$FR-MYLANLABS-2024M1071153$MYLAN$$26$YR$$F$Y$$$20240805$$MD$FR$FR
241741471$24174147$1$I$20240223$20240730$20240805$20240805$EXP$FR-AFSSAPS-AVMA2024000329$FR-MYLANLABS-2024M1071099$MYLAN$$63$YR$$M$Y$$$20240805$$PH$FR$FR
241741481$24174148$1$I$$20240730$20240805$20240805$EXP$$PT-MYLANLABS-2024M1071324$MYLAN$$60$YR$$M$Y$$$20240805$$MD$PT$PT
241741501$24174150$1$I$20240715$20240725$20240805$20240805$EXP$$CN-SA-2024SA225033$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240805$$HP$CN$CN
241741512$24174151$2$F$20240721$20240912$20240805$20240920$EXP$$JP-009507513-2407JPN005476J$MERCK$$77$YR$$M$Y$60$KG$20240920$$MD$JP$JP
241741522$24174152$2$F$20230816$20240920$20240805$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120951$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$83.91$KG$20240924$$CN$US$US
241741531$24174153$1$I$$20240724$20240805$20240805$EXP$GB-MHRA-MED-202407240927293430-QGYBT$GB-GLENMARK PHARMACEUTICALS-2024GMK092829$GLENMARK$$$$$$Y$$$20240805$$CN$GB$GB
241741551$24174155$1$I$20230928$20240801$20240805$20240805$EXP$$GB-MYLANLABS-2023M1103533$MYLAN$$38$YR$$F$Y$$$20240805$$MD$GB$GB
241741561$24174156$1$I$$20240731$20240805$20240805$EXP$$US-MYLANLABS-2024M1072814$MYLAN$$49$YR$$M$Y$$$20240805$$CN$US$US
241741572$24174157$2$F$$20240808$20240805$20240813$EXP$$GB-MYLANLABS-2024M1062606$MYLAN$$$$$M$Y$$$20240813$$MD$GB$GB
241741582$24174158$2$F$20240702$20240808$20240805$20240812$EXP$GB-MHRA-MED-202407311122437630-SVTGB$GB-MYLANLABS-2024M1071676$MYLAN$$70$YR$$M$Y$$$20240812$$PH$GB$GB
241741591$24174159$1$I$20230818$20240801$20240805$20240805$EXP$$FR-MYLANLABS-2024M1071828$MYLAN$$$$E$F$Y$$$20240805$$HP$FR$FR
241741601$24174160$1$I$$20240731$20240805$20240805$EXP$$CA-ROCHE-10000046100$ROCHE$$$$A$F$Y$$$20240805$$CN$CA$CA
241741612$24174161$2$F$20240701$20240814$20240805$20240820$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700052$UPSHER SMITH LABORATORIES$$38$YR$$F$Y$$$20240821$$MD$US$US
241741621$24174162$1$I$20200725$20240802$20240805$20240805$EXP$PL-URPL-1-1716-2020$PL-OTSUKA-2024_021450$OTSUKA$$39$YR$$F$Y$95$KG$20240805$$MD$PL$PL
241741631$24174163$1$I$$20240802$20240805$20240805$EXP$$US-TAKEDA-2024TUS077977$TAKEDA$$$$$M$Y$$$20240805$$CN$US$US
241741641$24174164$1$I$20240101$20240731$20240805$20240805$EXP$$US-SA-2024SA181089$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240805$$CN$US$US
241741651$24174165$1$I$$20240722$20240805$20240805$PER$$US-JNJFOC-20240766844$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241741661$24174166$1$I$20240726$20240726$20240805$20240805$EXP$$US-JNJFOC-20240780271$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240805$$HP$US$US
241741671$24174167$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240800680$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$US$US
241741681$24174168$1$I$20240802$20240802$20240805$20240805$PER$$US-AMGEN-USASP2024154759$AMGEN$$36$YR$A$F$Y$$$20240805$$CN$US$US
241741691$24174169$1$I$$20240729$20240805$20240805$EXP$$CA-APOTEX-2024AP008971$APOTEX$$66$YR$$M$Y$$$20240805$$CN$CA$CA
241741701$24174170$1$I$20240126$20240730$20240805$20240805$EXP$$KE-PFIZER INC-2023SGN11417$PFIZER$$32$YR$$F$Y$$$20240805$$PH$KE$KE
241741711$24174171$1$I$20240704$20240729$20240805$20240805$EXP$IT-MINISAL02-996584$IT-PFIZER INC-202400225405$PFIZER$$51$YR$$F$Y$62$KG$20240805$$PH$IT$IT
241741721$24174172$1$I$$20240730$20240805$20240805$EXP$$IR-PFIZER INC-PV202400100404$PFIZER$Abuotorabi-Zarchi, M.. Late Onset MS and Challenging in Diagnosis and Treatment. Multiple Sclerosis and Related Disorders. 2023;80:9$77$YR$$F$Y$$$20240805$$HP$IR$IR
241741731$24174173$1$I$$20240730$20240805$20240805$EXP$$US-PFIZER INC-PV202300158263$PFIZER$$60$YR$$F$Y$$$20240805$$CN$US$US
241741741$24174174$1$I$20240112$20240726$20240805$20240805$EXP$$FR-PFIZER INC-202400229191$PFIZER$$79$YR$$M$Y$69$KG$20240805$$MD$FR$FR
241741762$24174176$2$F$20210527$20240806$20240805$20240809$EXP$$PL-PFIZER INC-2022SGN08638$PFIZER$$77$YR$$M$Y$84$KG$20240809$$MD$PL$PL
241741771$24174177$1$I$$20230925$20240805$20240805$EXP$$AU-SANDOZ INC.-SDZ2023AU033297$SANDOZ$$$$$$Y$$$20240805$$CN$AU$AU
241741781$24174178$1$I$$20240722$20240805$20240805$EXP$$US-VIVUS LLC-2024V1000925$VIVUS$$$$E$F$Y$$$20240802$$CN$US$US
241741791$24174179$1$I$$20230929$20240805$20240805$EXP$$JP-SANDOZ INC.-SDZ2023JP039803$SANDOZ$$$$$$Y$$$20240805$$PH$JP$JP
241741801$24174180$1$I$$20240801$20240805$20240805$PER$$US-ABBVIE-5865552$ABBVIE$$$$$$Y$$$20240805$$CN$US$US
241741811$24174181$1$I$20240718$20240723$20240805$20240805$EXP$DE-CADRBFARM-2024329432$DE-GLENMARK PHARMACEUTICALS-2024GMK092861$GLENMARK$$$$$$Y$$$20240805$$MD$DE$DE
241741822$24174182$2$F$20230101$20240806$20240805$20240808$EXP$DE-EMA-DD-20240730-7482715-081833$DE-SANDOZ INC.-SDZ2024DE070380$SANDOZ$$35$YR$$M$Y$$$20240808$$MD$DE$DE
241741831$24174183$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123473$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240805$$CN$US$US
241741841$24174184$1$I$$20240729$20240805$20240805$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005599$BIOCON$$$$$$Y$$$20240805$$HP$CA$CA
241741851$24174185$1$I$20240622$20240802$20240805$20240805$EXP$$CN-ABBVIE-5864960$ABBVIE$$49$YR$$F$Y$$$20240805$$MD$CN$CN
241741862$24174186$2$F$20240910$20240910$20240805$20240918$EXP$$CA-BEH-2024176695$CSL BEHRING$$2$YR$C$M$Y$7.5$KG$20240918$$HP$CA$CA
241741871$24174187$1$I$$20240731$20240805$20240805$EXP$$IN-PFIZER INC-PV202400100260$PFIZER$Haridas, V.. Two case reports of tofacitinib topical treatment: A game-changer in the management of vasculitis ulcer?. International Journal of Rheumatic Diseases. 2024;27(8):e15283$45$YR$$F$Y$$$20240805$$HP$IN$IN
241741881$24174188$1$I$20230101$20240730$20240805$20240805$EXP$$IT-PFIZER INC-202400227286$PFIZER$Cannella, L.. Synovial sarcoma of the kidney: Diagnostic pitfalls in a case with myxoid monophasic differentiation and no epithelial biomarkers expression.. International Journal of Molecular Sciences. 2024;25(13):7382$37$YR$$M$Y$$$20240805$$MD$IT$IT
241741893$24174189$3$F$$20240812$20240805$20240821$PER$$US-SA-2024SA221545$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240821$$CN$US$US
241741901$24174190$1$I$$20240729$20240805$20240805$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024EME094528$VIIV$$$$$$Y$$$20240805$$CN$GB$GB
241741911$24174191$1$I$$20240729$20240805$20240805$EXP$$GB-GSK-GB2024EME094528$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$GB$GB
241741921$24174192$1$I$20240701$20240725$20240805$20240805$PER$$US-SA-2024SA223905$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240805$$MD$US$US
241741931$24174193$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA221925$SANOFI AVENTIS$$$$$F$Y$$$20240805$$CN$US$US
241741942$24174194$2$F$20240101$20240819$20240805$20240828$PER$$US-SA-2024SA224207$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240828$$MD$US$US
241741951$24174195$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA221695$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240805$$MD$US$US
241741961$24174196$1$I$20240725$20240725$20240805$20240805$PER$$US-SA-2024SA224768$SANOFI AVENTIS$$17$YR$T$M$Y$65.7$KG$20240805$$MD$US$US
241741971$24174197$1$I$20240701$20240725$20240805$20240805$PER$$US-SA-2024SA223787$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240805$$MD$US$US
241741982$24174198$2$F$20240101$20240802$20240805$20240813$PER$$US-SA-2024SA224190$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240814$$MD$US$US
241741991$24174199$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA224855$SANOFI AVENTIS$$41$YR$A$F$Y$63.492$KG$20240805$$MD$US$US
241742001$24174200$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223610$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240805$$MD$US$US
241742011$24174201$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA224191$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240805$$MD$US$US
241742021$24174202$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA225982$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240805$$MD$US$US
241742032$24174203$2$F$20240101$20240909$20240805$20240917$PER$$US-SA-2024SA223588$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240918$$MD$US$US
241742041$24174204$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA224613$SANOFI AVENTIS$$$$C$F$Y$$$20240805$$MD$US$US
241742051$24174205$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223368$SANOFI AVENTIS$$$$E$F$Y$67.5$KG$20240805$$MD$US$US
241742061$24174206$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA222113$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$HP$US$US
241742071$24174207$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA220688$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240805$$CN$US$US
241742081$24174208$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA224385$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240805$$MD$US$US
241742091$24174209$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223702$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240805$$MD$US$US
241742101$24174210$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA224368$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240805$$MD$US$US
241742111$24174211$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA227268$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240805$$MD$US$US
241742121$24174212$1$I$20240701$20240725$20240805$20240805$PER$$US-SA-2024SA223720$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240805$$MD$US$US
241742131$24174213$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA110168$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
241742141$24174214$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA178383$SANOFI AVENTIS$$$$E$F$Y$54.43$KG$20240805$$MD$US$US
241742151$24174215$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA215452$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240805$$MD$US$US
241742161$24174216$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223739$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240805$$MD$US$US
241742181$24174218$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA224470$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240805$$MD$US$US
241742191$24174219$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA225953$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240805$$MD$US$US
241742201$24174220$1$I$20240101$20240725$20240805$20240805$PER$$US-SA-2024SA223749$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240805$$MD$US$US
241742211$24174221$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA221697$SANOFI AVENTIS$$$$$$Y$$$20240805$$PH$US$US
241742221$24174222$1$I$20210101$20240725$20240805$20240805$PER$$US-SA-2024SA224515$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240805$$MD$US$US
241742233$24174223$3$F$20240101$20240909$20240805$20240916$EXP$$US-SA-2024SA225951$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240916$$MD$US$US
241742241$24174224$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA203711$SANOFI AVENTIS$$$$T$F$Y$$$20240805$$CN$US$US
241742251$24174225$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA225734$SANOFI AVENTIS$$16$YR$T$F$Y$83$KG$20240805$$MD$US$US
241742261$24174226$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA089069$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240805$$CN$US$US
241742271$24174227$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA222973$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$MD$US$US
241742281$24174228$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA226267$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$HP$US$US
241742292$24174229$2$F$20240101$20240821$20240805$20240829$PER$$US-SA-2024SA223026$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240829$$MD$US$US
241742301$24174230$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA179120$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240805$$MD$US$US
241742311$24174231$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225515$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240805$$MD$US$US
241742321$24174232$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA224054$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240805$$MD$US$US
241742331$24174233$1$I$20240701$20240726$20240805$20240805$PER$$US-SA-2024SA226705$SANOFI AVENTIS$$17$YR$T$M$Y$92.533$KG$20240805$$MD$US$US
241742341$24174234$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA226166$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240805$$MD$US$US
241742351$24174235$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA226748$SANOFI AVENTIS$$$$A$M$Y$106$KG$20240805$$MD$US$US
241742361$24174236$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA225804$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240805$$MD$US$US
241742371$24174237$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA224623$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240805$$MD$US$US
241742381$24174238$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225959$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240805$$MD$US$US
241742392$24174239$2$F$20240101$20240907$20240805$20240920$PER$$US-SA-2024SA224182$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240920$$HP$US$US
241742401$24174240$1$I$$20240726$20240805$20240805$PER$$US-SA-2023SA382899$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240805$$MD$US$US
241742411$24174241$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA221096$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240805$$MD$US$US
241742421$24174242$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA226168$SANOFI AVENTIS$$13$YR$T$F$Y$47.6$KG$20240805$$MD$US$US
241742432$24174243$2$F$20240101$20240822$20240805$20240906$PER$$US-SA-2024SA225098$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240906$$MD$US$US
241742441$24174244$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA225801$SANOFI AVENTIS$$56$YR$A$M$Y$84.8$KG$20240805$$MD$US$US
241742451$24174245$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA224443$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240805$$MD$US$US
241742471$24174247$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA224334$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240805$$MD$US$US
241742481$24174248$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA223580$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240805$$MD$US$US
241742491$24174249$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA227457$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240805$$MD$US$US
241742501$24174250$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA224778$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240805$$MD$US$US
241742511$24174251$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225623$SANOFI AVENTIS$$$$E$M$Y$65.77$KG$20240805$$MD$US$US
241742521$24174252$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225955$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240805$$MD$US$US
241742531$24174253$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA227415$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240805$$MD$US$US
241742542$24174254$2$F$20240101$20240820$20240805$20240902$PER$$US-SA-2024SA226508$SANOFI AVENTIS$$64$YR$A$F$Y$77.1$KG$20240902$$MD$US$US
241742551$24174255$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225200$SANOFI AVENTIS$$$$T$F$Y$58.9$KG$20240805$$MD$US$US
241742561$24174256$1$I$20240601$20240726$20240805$20240805$PER$$US-SA-2024SA224762$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240805$$MD$US$US
241742571$24174257$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA224455$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
241742581$24174258$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA223541$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240805$$MD$US$US
241742592$24174259$2$F$20240729$20240806$20240805$20240809$EXP$$US-KYOWAKIRIN-2024KK018539$KYOWA$$$$$$Y$$$20240809$$HP$US$US
241742602$24174260$2$F$$20240815$20240805$20240820$PER$$US-AMGEN-USASP2024150931$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
241742611$24174261$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225795$SANOFI AVENTIS$$$$E$F$Y$69.8$KG$20240805$$MD$US$US
241742621$24174262$1$I$20240501$20240726$20240805$20240805$PER$$US-SA-2024SA224433$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240805$$MD$US$US
241742631$24174263$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA227443$SANOFI AVENTIS$$$$E$F$Y$104$KG$20240805$$CN$US$US
241742641$24174264$1$I$20240201$20240726$20240805$20240805$PER$$US-SA-2024SA225782$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240805$$MD$US$US
241742652$24174265$2$F$$20240830$20240805$20240922$PER$$US-SA-2024SA058963$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240922$$MD$US$US
241742661$24174266$1$I$20240704$20240727$20240805$20240805$PER$$US-SA-2024SA226039$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240805$$MD$US$US
241742671$24174267$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225712$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240805$$MD$US$US
241742681$24174268$1$I$20240701$20240726$20240805$20240805$PER$$US-SA-2024SA225973$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240805$$MD$US$US
241742691$24174269$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225837$SANOFI AVENTIS$$$$T$F$Y$$$20240805$$MD$US$US
241742703$24174270$3$F$20240101$20240919$20240805$20240926$PER$$US-SA-2024SA226037$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240926$$MD$US$US
241742712$24174271$2$F$20240101$20240809$20240805$20240826$PER$$US-SA-2024SA227051$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240826$$MD$US$US
241742721$24174272$1$I$20240701$20240726$20240805$20240805$PER$$US-SA-2024SA225191$SANOFI AVENTIS$$40$YR$A$F$Y$63.492$KG$20240805$$MD$US$US
241742731$24174273$1$I$20240725$20240726$20240805$20240805$PER$$US-SA-2024SA224319$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240805$$MD$US$US
241742741$24174274$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225815$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
241742752$24174275$2$F$$20240805$20240805$20240813$PER$$US-SA-2024SA226668$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
241742761$24174276$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225740$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240805$$MD$US$US
241742771$24174277$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA224381$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240805$$MD$US$US
241742781$24174278$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA226034$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240805$$MD$US$US
241742791$24174279$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA226957$SANOFI AVENTIS$$$$E$F$Y$$$20240805$$CN$US$US
241742801$24174280$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA225850$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240805$$MD$US$US
241742812$24174281$2$F$20240701$20240806$20240805$20240815$PER$$US-SA-2024SA225066$SANOFI AVENTIS$$70$YR$E$F$Y$65.8$KG$20240815$$MD$US$US
241742821$24174282$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA223283$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240805$$MD$US$US
241742831$24174283$1$I$20240725$20240726$20240805$20240805$PER$$US-SA-2024SA225146$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240805$$MD$US$US
241742842$24174284$2$F$$20240809$20240805$20240813$EXP$$US-BIOVITRUM-2024-US-010555$BIOVITRUM$$82$YR$$F$Y$$$20240813$$HP$US$US
241742851$24174285$1$I$20240101$20240727$20240805$20240805$PER$$US-SA-2024SA225400$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240805$$MD$US$US
241742861$24174286$1$I$20240101$20240727$20240805$20240805$PER$$US-SA-2024SA224894$SANOFI AVENTIS$$$$C$F$Y$$$20240805$$MD$US$US
241742872$24174287$2$F$$20240801$20240805$20240809$PER$$US-SA-2024SA228372$SANOFI AVENTIS$$66$YR$E$F$Y$77.1$KG$20240809$$MD$US$US
241742881$24174288$1$I$20240601$20240727$20240805$20240805$PER$$US-SA-2024SA225639$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240805$$MD$US$US
241742891$24174289$1$I$20240601$20240727$20240805$20240805$PER$$US-SA-2024SA224673$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240805$$MD$US$US
241742901$24174290$1$I$20240101$20240727$20240805$20240805$PER$$US-SA-2024SA225299$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240805$$MD$US$US
241742911$24174291$1$I$20240101$20240728$20240805$20240805$PER$$US-SA-2024SA224660$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240805$$MD$US$US
241742921$24174292$1$I$20240726$20240731$20240805$20240805$PER$$US-SA-2024SA228495$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240805$$MD$US$US
241742931$24174293$1$I$20240601$20240727$20240805$20240805$PER$$US-SA-2024SA224406$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240805$$MD$US$US
241742941$24174294$1$I$20240601$20240727$20240805$20240805$PER$$US-SA-2024SA224888$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240805$$MD$US$US
241742951$24174295$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA228754$SANOFI AVENTIS$$$$C$F$Y$$$20240805$$MD$US$US
241742962$24174296$2$F$$20240731$20240805$20240809$PER$$US-SA-2024SA224107$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241742971$24174297$1$I$20240601$20240728$20240805$20240805$PER$$US-SA-2024SA226029$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240805$$MD$US$US
241742981$24174298$1$I$$20240728$20240805$20240805$PER$$US-SA-2024SA225498$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240805$$MD$US$US
241742991$24174299$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA224643$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
241743001$24174300$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225952$SANOFI AVENTIS$$$$T$F$Y$95.2$KG$20240805$$MD$US$US
241743011$24174301$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226326$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$CN$US$US
241743021$24174302$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227671$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240805$$MD$US$US
241743032$24174303$2$F$20240101$20240815$20240805$20240829$PER$$US-SA-2024SA227802$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240829$$MD$US$US
241743041$24174304$1$I$20240501$20240729$20240805$20240805$PER$$US-SA-2024SA226995$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240805$$HP$US$US
241743051$24174305$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA227124$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240805$$CN$US$US
241743061$24174306$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA227706$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240805$$MD$US$US
241743071$24174307$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA226212$SANOFI AVENTIS$$$$T$F$Y$$$20240805$$HP$US$US
241743081$24174308$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226828$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240805$$MD$US$US
241743091$24174309$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA227556$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240805$$HP$US$US
241743102$24174310$2$F$20230601$20240729$20240805$20240807$PER$$US-SA-2024SA227228$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240807$$MD$US$US
241743111$24174311$1$I$$20240729$20240805$20240805$PER$$US-SA-2021SA249474$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240805$$MD$US$US
241743121$24174312$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227464$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240805$$MD$US$US
241743132$24174313$2$F$$20240805$20240805$20240813$PER$$US-SA-2024SA226087$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
241743141$24174314$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227725$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240805$$MD$US$US
241743151$24174315$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA228734$SANOFI AVENTIS$$$$A$M$Y$72.57$KG$20240805$$MD$US$US
241743161$24174316$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227423$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240805$$MD$US$US
241743171$24174317$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225949$SANOFI AVENTIS$$$$A$M$Y$87.49$KG$20240805$$MD$US$US
241743181$24174318$1$I$20240701$20240729$20240805$20240805$PER$$US-SA-2024SA226858$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240805$$MD$US$US
241743191$24174319$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225099$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$HP$US$US
241743201$24174320$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA226364$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240805$$MD$US$US
241743211$24174321$1$I$20240601$20240729$20240805$20240805$PER$$US-SA-2024SA228786$SANOFI AVENTIS$$$$E$F$Y$49$KG$20240805$$MD$US$US
241743221$24174322$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA226406$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240805$$MD$US$US
241743232$24174323$2$F$20190321$20240902$20240805$20240910$PER$$US-FreseniusKabi-FK202411945$FRESENIUS KABI$$35$YR$A$F$Y$120.3$KG$20240910$$HP$US$US
241743241$24174324$1$I$20240715$20240730$20240805$20240805$EXP$CN-91110000556821568D-2024DRL001420$CN-RDY-SPO/CHN/24/0011323$DR REDDYS$$21$YR$A$F$Y$45$KG$20240805$$HP$CN$CN
241743251$24174325$1$I$20240725$20240729$20240805$20240805$PER$$US-SA-2024SA226879$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240805$$MD$US$US
241743261$24174326$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA225737$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240805$$MD$US$US
241743271$24174327$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226790$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240805$$MD$US$US
241743281$24174328$1$I$$20240731$20240805$20240805$PER$$US-SA-2024SA227814$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240805$$MD$US$US
241743291$24174329$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225058$SANOFI AVENTIS$$$$$M$Y$$$20240805$$CN$US$US
241743301$24174330$1$I$20230101$20240729$20240805$20240805$PER$$US-SA-2024SA227387$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240805$$MD$US$US
241743312$24174331$2$F$20240101$20240731$20240805$20240809$PER$$US-SA-2024SA227950$SANOFI AVENTIS$$59$YR$A$F$Y$74.8$KG$20240809$$MD$US$US
241743331$24174333$1$I$$20240731$20240805$20240805$PER$$US-SA-2024SA228420$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240805$$MD$US$US
241743342$24174334$2$F$$20240822$20240805$20240905$PER$$US-SA-2024SA227232$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240905$$MD$US$US
241743351$24174335$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226144$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240805$$MD$US$US
241743361$24174336$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227533$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$MD$US$US
241743372$24174337$2$F$20240724$20240809$20240805$20240816$PER$$US-SA-2024SA223530$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240816$$MD$US$US
241743381$24174338$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227708$SANOFI AVENTIS$$$$T$F$Y$$$20240805$$MD$US$US
241743391$24174339$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA227694$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240805$$MD$US$US
241743401$24174340$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225392$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240805$$MD$US$US
241743411$24174341$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA202941$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240805$$MD$US$US
241743421$24174342$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227430$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$MD$US$US
241743432$24174343$2$F$20240730$20240730$20240805$20240808$PER$$US-SA-2024SA226609$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240808$$MD$US$US
241743441$24174344$1$I$$20240731$20240805$20240805$PER$$US-SA-2024SA227942$SANOFI AVENTIS$$4$YR$C$F$Y$18$KG$20240805$$MD$US$US
241743451$24174345$1$I$20240730$20240730$20240805$20240805$PER$$US-SA-2024SA227652$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240805$$MD$US$US
241743461$24174346$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227010$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240805$$MD$US$US
241743471$24174347$1$I$20240601$20240730$20240805$20240805$PER$$US-SA-2024SA228007$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240805$$MD$US$US
241743481$24174348$1$I$20240724$20240729$20240805$20240805$PER$$US-SA-2024SA227712$SANOFI AVENTIS$$57$YR$A$F$Y$58.967$KG$20240805$$HP$US$US
241743491$24174349$1$I$20240731$20240731$20240805$20240805$PER$$US-SA-2024SA228379$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240805$$MD$US$US
241743501$24174350$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA067830$SANOFI AVENTIS$$$$E$F$Y$104.78$KG$20240805$$MD$US$US
241743511$24174351$1$I$$20240731$20240805$20240805$PER$$US-SA-2024SA228139$SANOFI AVENTIS$$$$$M$Y$$$20240805$$CN$US$US
241743521$24174352$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA190316$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$MD$US$US
241743531$24174353$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA166411$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240805$$MD$US$US
241743541$24174354$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227693$SANOFI AVENTIS$$1$YR$I$M$Y$11.3$KG$20240805$$MD$US$US
241743551$24174355$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227562$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240805$$MD$US$US
241743562$24174356$2$F$$20240731$20240805$20240809$PER$$US-SA-2024SA224889$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240809$$HP$US$US
241743571$24174357$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA227591$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240805$$MD$US$US
241743581$24174358$1$I$20240727$20240729$20240805$20240805$PER$$US-SA-2024SA225349$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240805$$CN$US$US
241743591$24174359$1$I$20240701$20240729$20240805$20240805$PER$$US-SA-2024SA228056$SANOFI AVENTIS$$52$YR$A$F$Y$74$KG$20240805$$MD$US$US
241743601$24174360$1$I$20240729$20240729$20240805$20240805$PER$$US-SA-2024SA225807$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240805$$CN$US$US
241743611$24174361$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227130$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240805$$MD$US$US
241743622$24174362$2$F$$20240731$20240805$20240827$PER$$US-SA-2024SA229216$SANOFI AVENTIS$$$$$$Y$$$20240827$$CN$US$US
241743631$24174363$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225466$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$CN$US$US
241743642$24174364$2$F$20240101$20240823$20240805$20240916$PER$$US-SA-2024SA226092$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240916$$MD$US$US
241743651$24174365$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA229217$SANOFI AVENTIS$$61$YR$A$F$Y$127$KG$20240805$$MD$US$US
241743661$24174366$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227257$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240805$$MD$US$US
241743671$24174367$1$I$20240601$20240729$20240805$20240805$PER$$US-SA-2024SA227531$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$MD$US$US
241743681$24174368$1$I$20240701$20240729$20240805$20240805$PER$$US-SA-2024SA226089$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240805$$MD$US$US
241743691$24174369$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225503$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240805$$MD$US$US
241743701$24174370$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA229278$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240805$$MD$US$US
241743711$24174371$1$I$$20240731$20240805$20240805$PER$$US-SA-2024SA228067$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240805$$CN$US$US
241743721$24174372$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227409$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240805$$MD$US$US
241743731$24174373$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227527$SANOFI AVENTIS$$$$T$F$Y$90.7$KG$20240805$$MD$US$US
241743741$24174374$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225119$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240805$$MD$US$US
241743751$24174375$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227696$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240805$$CN$US$US
241743761$24174376$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226557$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240805$$MD$US$US
241743774$24174377$4$F$$20240828$20240805$20240830$PER$$US-SA-2024SA226015$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240830$$CN$US$US
241743781$24174378$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA228323$SANOFI AVENTIS$$20$YR$A$M$Y$59$KG$20240805$$MD$US$US
241743791$24174379$1$I$20240601$20240729$20240805$20240805$PER$$US-SA-2024SA225556$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240805$$MD$US$US
241743801$24174380$1$I$20240601$20240729$20240805$20240805$PER$$US-SA-2024SA227637$SANOFI AVENTIS$$21$YR$A$M$Y$61.68$KG$20240805$$MD$US$US
241743811$24174381$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA226656$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240805$$CN$US$US
241743822$24174382$2$F$20240729$20240729$20240805$20240807$PER$$US-SA-2024SA223375$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240807$$CN$US$US
241743831$24174383$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227692$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240805$$MD$US$US
241743841$24174384$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227379$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$CN$US$US
241743851$24174385$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA228047$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240805$$MD$US$US
241743861$24174386$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227493$SANOFI AVENTIS$$$$A$F$Y$127$KG$20240805$$MD$US$US
241743871$24174387$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA227657$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240805$$MD$US$US
241743881$24174388$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA227087$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240805$$MD$US$US
241743894$24174389$4$F$20240724$20240913$20240805$20240920$PER$$US-SA-2024SA224731$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240920$$PH$US$US
241743901$24174390$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA226580$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240805$$MD$US$US
241743911$24174391$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227364$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
241743921$24174392$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA226436$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240805$$HP$US$US
241743931$24174393$1$I$20240624$20240729$20240805$20240805$PER$$US-SA-2024SA227721$SANOFI AVENTIS$$74$YR$E$F$Y$68$KG$20240805$$MD$US$US
241743941$24174394$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225538$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240805$$MD$US$US
241743951$24174395$1$I$20240701$20240729$20240805$20240805$PER$$US-SA-2024SA227435$SANOFI AVENTIS$$15$YR$T$F$Y$49.8$KG$20240805$$MD$US$US
241743961$24174396$1$I$20240701$20240729$20240805$20240805$PER$$US-SA-2024SA225523$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240805$$MD$US$US
241743971$24174397$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240801864$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$HP$US$US
241743981$24174398$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA226628$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240805$$CN$US$US
241743991$24174399$1$I$20240101$20240731$20240805$20240805$PER$$US-SA-2024SA228987$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$HP$US$US
241744001$24174400$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA228768$SANOFI AVENTIS$$49$YR$A$M$Y$77.111$KG$20240805$$MD$US$US
241744011$24174401$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA227647$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240805$$MD$US$US
241744021$24174402$1$I$20240701$20240729$20240805$20240805$PER$$US-SA-2024SA225511$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240805$$MD$US$US
241744031$24174403$1$I$20240501$20240729$20240805$20240805$PER$$US-SA-2024SA227579$SANOFI AVENTIS$$24$YR$A$F$Y$81$KG$20240805$$MD$US$US
241744041$24174404$1$I$20240728$20240729$20240805$20240805$PER$$US-SA-2024SA227723$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240805$$MD$US$US
241744051$24174405$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA224423$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
241744061$24174406$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA228789$SANOFI AVENTIS$$$$A$F$Y$66.2$KG$20240805$$MD$US$US
241744071$24174407$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA228935$SANOFI AVENTIS$$$$A$M$Y$90.7$KG$20240805$$MD$US$US
241744081$24174408$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226591$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240805$$MD$US$US
241744091$24174409$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA227709$SANOFI AVENTIS$$3$YR$C$M$Y$13.6$KG$20240805$$MD$US$US
241744101$24174410$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA228622$SANOFI AVENTIS$$$$A$F$Y$51.7$KG$20240805$$MD$US$US
241744121$24174412$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA227126$SANOFI AVENTIS$$14$YR$T$M$Y$61$KG$20240805$$MD$US$US
241744131$24174413$1$I$$20240731$20240805$20240805$PER$$US-SA-2024SA229896$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240805$$MD$US$US
241744142$24174414$2$F$20240101$20240821$20240805$20240911$PER$$US-SA-2024SA227009$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240911$$MD$US$US
241744151$24174415$1$I$20240701$20240729$20240805$20240805$PER$$US-SA-2024SA228615$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240805$$MD$US$US
241744162$24174416$2$F$20240101$20240915$20240805$20240923$PER$$US-SA-2024SA226191$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240923$$MD$US$US
241744171$24174417$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227109$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240805$$MD$US$US
241744181$24174418$1$I$20240701$20240729$20240805$20240805$PER$$US-SA-2024SA227799$SANOFI AVENTIS$$28$YR$A$M$Y$86$KG$20240805$$MD$US$US
241744191$24174419$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226392$SANOFI AVENTIS$$$$A$M$Y$136$KG$20240805$$MD$US$US
241744201$24174420$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227262$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240805$$MD$US$US
241744211$24174421$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA229265$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240805$$CN$US$US
241744221$24174422$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227618$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240805$$CN$US$US
241744231$24174423$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227702$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240805$$MD$US$US
241744241$24174424$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226091$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240805$$MD$US$US
241744251$24174425$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA227722$SANOFI AVENTIS$$66$YR$E$F$Y$134.7$KG$20240805$$MD$US$US
241744261$24174426$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227724$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240805$$CN$US$US
241744271$24174427$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA227296$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240805$$MD$US$US
241744282$24174428$2$F$$20240926$20240805$20240930$EXP$$RO-AMGEN-ROUSP2024152739$AMGEN$Rotaru V.; Chitoran E.; Ionescu S. et al.. Bevacizumab-Based Therapies in Malignant Tumors-Real-World Data on Effectiveness, Safety, and Cost. Cancers. 2024;16 (14):1-20$$$$$Y$$$20240930$$HP$RO$RO
241744291$24174429$1$I$$20240802$20240805$20240805$PER$$US-BAYER-2024A112249$BAYER$$$$$$Y$$$20240805$$CN$US$US
241744301$24174430$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA224347$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240805$$MD$US$US
241744311$24174431$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA229264$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240805$$CN$US$US
241744321$24174432$1$I$$20240731$20240805$20240805$PER$$US-SA-2024SA228160$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240805$$HP$US$US
241744331$24174433$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA224409$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240805$$CN$US$US
241744341$24174434$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227537$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240805$$MD$US$US
241744351$24174435$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA226356$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240805$$MD$US$US
241744361$24174436$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225829$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$CN$US$US
241744371$24174437$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA227648$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240805$$MD$US$US
241744384$24174438$4$F$20240101$20240814$20240805$20240819$PER$$US-SA-2024SA226512$SANOFI AVENTIS$$41$YR$A$F$Y$65.77$KG$20240819$$MD$US$US
241744391$24174439$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA226749$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240805$$MD$US$US
241744401$24174440$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA224399$SANOFI AVENTIS$$$$E$F$Y$$$20240805$$MD$US$US
241744411$24174441$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA226167$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240805$$MD$US$US
241744421$24174442$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA226291$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240805$$MD$US$US
241744431$24174443$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA226743$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240805$$MD$US$US
241744441$24174444$1$I$20240701$20240729$20240805$20240805$PER$$US-SA-2024SA226380$SANOFI AVENTIS$$58$YR$A$F$Y$54.6$KG$20240805$$MD$US$US
241744451$24174445$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA226171$SANOFI AVENTIS$$$$E$M$Y$$$20240805$$MD$US$US
241744461$24174446$1$I$20240724$20240729$20240805$20240805$PER$$US-SA-2024SA227358$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240805$$MD$US$US
241744481$24174448$1$I$20240101$20240731$20240805$20240805$PER$$US-SA-2024SA228490$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240805$$MD$US$US
241744491$24174449$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA228945$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240805$$MD$US$US
241744503$24174450$3$F$20240730$20240806$20240805$20240812$30DAY$$US-PFIZER INC-202400226964$PFIZER$$65$YR$$F$Y$$$20240812$$HP$US$US
241744511$24174451$1$I$20240612$20240724$20240805$20240805$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000699$PAREXEL$$$$$$Y$$$20240805$$HP$CN$CN
241744522$24174452$2$F$$20240812$20240805$20240820$EXP$$CN-SA-2024SA227301$SANOFI AVENTIS$Cheng W, Ren H, Hu W.. Multisystem Langerhans Cell Histiocytosis following Treatment of Initially Presumed Atopic Dermatitis with Dupilumab: A Case Report of an Extremely Confusing Scenario. Case Rep Dermatol. 2024;16:181-5$62$YR$A$F$Y$$$20240820$$HP$CN$CN
241744531$24174453$1$I$20240725$20240731$20240805$20240805$EXP$$US-SA-2024SA228583$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240805$$MD$US$US
241744541$24174454$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002029US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
241744551$24174455$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA224687$SANOFI AVENTIS$$$$A$M$Y$108$KG$20240805$$MD$US$US
241744561$24174456$1$I$20240627$20240724$20240805$20240805$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000693$PAREXEL$$$$$$Y$$$20240805$$HP$CN$CN
241744571$24174457$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA223967$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240805$$MD$US$US
241744581$24174458$1$I$$20240729$20240805$20240805$PER$$US-SA-2022SA476661$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240805$$MD$US$US
241744591$24174459$1$I$$20231001$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2023CA037194$SANDOZ$Nora M. Gibson, MD1 ; Joseph H. Oved, M.D. M.A.2 ; Kimberly Venella1 ; Caitlin W. Elgarten, MD, MSCE3 ; Lisa Wray, MD3  and Timothy S. Olson, MD, PhD. Matched Sibling Donor Bone Marrow Transplant withBusulfan + Fludarabine Conditioning Results in ExcellentOutcomes for Severe Congenital Neutropenia. 2021;S173-S174$$$$$Y$$$20240805$$MD$US$US
241744601$24174460$1$I$$20240727$20240805$20240805$PER$$US-SA-2024SA224251$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240805$$CN$US$US
241744611$24174461$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA222743$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240805$$MD$US$US
241744621$24174462$1$I$$20240802$20240805$20240805$EXP$$US-ABBVIE-5865657$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241744631$24174463$1$I$$20240801$20240805$20240805$EXP$$US-GILEAD-2024-0682662$GILEAD$$$$$M$Y$$$20240805$$MD$US$US
241744642$24174464$2$F$$20240806$20240805$20240814$EXP$$US-Calliditas-2024CAL01433$CALLIDITAS THERAPEUTICS$$46$YR$A$M$Y$$$20240813$$CN$US$US
241744651$24174465$1$I$20240426$20240722$20240805$20240805$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000704$PAREXEL$$$$$$Y$$$20240805$$HP$CN$CN
241744661$24174466$1$I$20240629$20240723$20240805$20240805$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000691$PAREXEL$$$$$$Y$$$20240805$$HP$CN$CN
241744671$24174467$1$I$20240714$20240802$20240805$20240805$EXP$$US-UCBSA-2024039038$UCB$$75$YR$$M$Y$$$20240805$$CN$US$US
241744681$24174468$1$I$20240101$20240801$20240805$20240805$EXP$$CA-UCBSA-2024022839$UCB$$$$$F$Y$$$20240805$$CN$CA$CA
241744691$24174469$1$I$$20240729$20240805$20240805$EXP$$US-GSK-US2024094879$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$US$US
241744701$24174470$1$I$$20240801$20240805$20240805$EXP$$US-GILEAD-2024-0682669$GILEAD$$$$$M$Y$$$20240805$$MD$US$US
241744711$24174471$1$I$20240726$20240729$20240805$20240805$EXP$$US-MYLANLABS-2024M1071928$MYLAN$$29$YR$$F$Y$64.86$KG$20240805$$MD$US$US
241744721$24174472$1$I$$20240802$20240805$20240805$EXP$$AU-MYLANLABS-2024M1072554$MYLAN$$$$$M$Y$$$20240805$$HP$AU$AU
241744731$24174473$1$I$20240724$20240730$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123501$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240805$$CN$US$US
241744751$24174475$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA226783$SANOFI AVENTIS$$$$A$F$Y$$$20240805$$MD$US$US
241744761$24174476$1$I$$20240724$20240805$20240805$EXP$$US-FARMAPROD-202407-2724$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240805$$CN$US$US
241744771$24174477$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225495$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$CN$US$US
241744781$24174478$1$I$20240604$20240724$20240805$20240805$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408001068$ELI LILLY AND CO$$43$YR$A$M$Y$45$KG$20240805$$CN$DE$CN
241744791$24174479$1$I$20240602$20240724$20240805$20240805$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407019042$ELI LILLY AND CO$$69$YR$E$M$Y$40$KG$20240805$$CN$DE$CN
241744811$24174481$1$I$20240620$20240724$20240805$20240805$EXP$PT-INFARMED-V202407-644$PT-ELI_LILLY_AND_COMPANY-PT202407016421$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240805$$CN$PT$PT
241744821$24174482$1$I$20240527$20240724$20240805$20240805$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408001034$ELI LILLY AND CO$$43$YR$A$M$Y$45$KG$20240805$$CN$DE$CN
241744831$24174483$1$I$20240801$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001017$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240805$$CN$US$US
241744841$24174484$1$I$$20240724$20240805$20240805$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407017273$ELI LILLY AND CO$$$$$$Y$$$20240805$$CN$CN$CN
241744851$24174485$1$I$20240520$20240724$20240805$20240805$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407017163$ELI LILLY AND CO$$79$YR$E$F$Y$60$KG$20240805$$CN$CN$CN
241744861$24174486$1$I$20240609$20240724$20240805$20240805$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407019954$ELI LILLY AND CO$$62$YR$A$M$Y$61$KG$20240805$$CN$DE$CN
241744871$24174487$1$I$20240730$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000215$ELI LILLY AND CO$$41$YR$A$$Y$$$20240805$$CN$US$US
241744881$24174488$1$I$20240715$20240725$20240805$20240805$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408000475$ELI LILLY AND CO$$58$YR$A$M$Y$68$KG$20240805$$CN$DE$CN
241744891$24174489$1$I$$20240724$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016237$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240805$$HP$US$US
241744901$24174490$1$I$$20240731$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000360$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240805$$CN$US$US
241744922$24174492$2$F$$20240806$20240805$20240816$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408000977$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240816$$CN$JP$JP
241744931$24174493$1$I$$20240730$20240805$20240805$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408001827$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240805$$CN$JP$JP
241744941$24174494$1$I$20200721$20240731$20240805$20240805$EXP$PL-URPL-1-1923-2020$PL-ELI_LILLY_AND_COMPANY-PL202408000732$ELI LILLY AND CO$$48$YR$A$F$Y$80$KG$20240805$$CN$PL$PL
241744951$24174495$1$I$$20240805$20240805$20240805$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043758$BOEHRINGER INGELHEIM$$$$$$Y$$$20240805$$CN$US$US
241744962$24174496$2$F$$20240812$20240805$20240815$PER$$US-ALXN-202407USA002215US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240815$$CN$US$US
241744971$24174497$1$I$20240630$20240729$20240805$20240805$EXP$$AU-TAKEDA-2024TUS077820$TAKEDA$$88$YR$$F$Y$$$20240805$$HP$AU$AU
241744981$24174498$1$I$$20240725$20240805$20240805$PER$$US-BEH-2024176379$CSL BEHRING$$$$A$M$Y$$$20240805$$MD$US$US
241744991$24174499$1$I$$20240715$20240805$20240805$PER$$AU-TOLMAR, INC.-24AU051022$TOLMAR$$$$$M$Y$$$20240805$$CN$AU$AU
241745011$24174501$1$I$$20240715$20240805$20240805$PER$$BR-TOLMAR, INC.-24BR051090$TOLMAR$$$$$F$Y$$$20240805$$CN$BR$BR
241745021$24174502$1$I$$20240715$20240805$20240805$PER$$AU-TOLMAR, INC.-24AU051062$TOLMAR$$$$$M$Y$$$20240805$$CN$AU$AU
241745031$24174503$1$I$20240715$20240715$20240805$20240805$PER$$AU-TOLMAR, INC.-24AU051061$TOLMAR$$83$YR$$M$Y$$$20240805$$HP$AU$AU
241745041$24174504$1$I$20240601$20240715$20240805$20240805$PER$$BR-TOLMAR, INC.-24BR051091$TOLMAR$$11$YR$$F$Y$$$20240805$$CN$BR$BR
241745051$24174505$1$I$20231101$20240715$20240805$20240805$PER$$CO-TOLMAR, INC.-23CO045501$TOLMAR$$82$YR$$M$Y$$$20240805$$CN$CO$CO
241745061$24174506$1$I$20240501$20240715$20240805$20240805$PER$$CA-TOLMAR, INC.-24CA050340$TOLMAR$$77$YR$$M$Y$$$20240805$$CN$CA$CA
241745071$24174507$1$I$20240401$20240715$20240805$20240805$PER$$CA-TOLMAR, INC.-24CA050568$TOLMAR$$74$YR$$M$Y$$$20240805$$CN$CA$CA
241745081$24174508$1$I$20240101$20240715$20240805$20240805$PER$$CA-TOLMAR, INC.-24CA050571$TOLMAR$$$$$M$Y$$$20240805$$CN$CA$CA
241745091$24174509$1$I$20240621$20240715$20240805$20240805$PER$$CA-TOLMAR, INC.-24CA050726$TOLMAR$$78$YR$$M$Y$$$20240805$$CN$CA$CA
241745101$24174510$1$I$$20240715$20240805$20240805$PER$$CA-TOLMAR, INC.-24CA050757$TOLMAR$$$$$M$Y$$$20240805$$CN$CA$CA
241745111$24174511$1$I$$20240802$20240805$20240805$PER$$US-HALEON-2190369$Haleon PLC$$$$$M$Y$$$20240805$$CN$US$US
241745124$24174512$4$F$20240715$20240731$20240805$20240906$EXP$$US-BEH-2024176708$CSL BEHRING$$30$YR$A$F$Y$61.229$KG$20240906$$HP$US$US
241745131$24174513$1$I$20240716$20240729$20240805$20240805$EXP$$CN-AMGEN-CHNSP2024151652$AMGEN$$89$YR$E$M$Y$$$20240805$$HP$CN$CN
241745141$24174514$1$I$20210101$20240731$20240805$20240805$EXP$$US-ABBVIE-5863085$ABBVIE$$92$YR$$F$Y$$$20240805$$CN$US$US
241745153$24174515$3$F$20240701$20240822$20240805$20240829$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006348$AURINIA PHARMACEUTICALS$$33$YR$$F$Y$$$20240829$$CN$US$US
241745162$24174516$2$F$$20240809$20240805$20240810$PER$$US-AstraZeneca-2024A156302$ASTRAZENECA$$$$$$Y$$$20240810$$MD$US$
241745171$24174517$1$I$20240726$20240730$20240805$20240805$EXP$$US-ABBVIE-5862540$ABBVIE$$56$YR$$F$Y$$$20240805$$CN$US$US
241745181$24174518$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240801533$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$HP$US$US
241745191$24174519$1$I$20240601$20240730$20240805$20240805$EXP$$US-TG THERAPEUTICS INC.-TGT003857$TG THERAPEUTICS$$$$$$Y$$$20240805$$HP$US$US
241745202$24174520$2$F$$20240830$20240805$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-038766$AUROBINDO$$27$YR$$F$Y$122.4$KG$20240912$$CN$US$US
241745211$24174521$1$I$20240727$20240730$20240805$20240805$EXP$$AU-BEH-2024176641$CSL BEHRING$$90$YR$E$F$Y$62$KG$20240805$$HP$AU$AU
241745221$24174522$1$I$$20240729$20240805$20240805$EXP$$US-VIVUS LLC-2024V1000960$VIVUS$$$$A$F$Y$$$20240805$$CN$US$US
241745231$24174523$1$I$20240616$20240730$20240805$20240805$EXP$FR-AFSSAPS-CF2024000393$FR-MYLANLABS-2024M1071240$MYLAN$$71$YR$$F$Y$55$KG$20240805$$MD$FR$FR
241745241$24174524$1$I$20240131$20240730$20240805$20240805$EXP$$FR-MYLANLABS-2024M1070780$MYLAN$$64$YR$$M$Y$$$20240805$$MD$FR$FR
241745251$24174525$1$I$$20240730$20240805$20240805$EXP$FR-AFSSAPS-AVPO2024000144$FR-MYLANLABS-2024M1071036$MYLAN$$42$YR$$M$Y$$$20240805$$PH$FR$FR
241745261$24174526$1$I$20200520$20240730$20240805$20240805$EXP$PL-URPL-1-1663-2020$PL-MYLANLABS-2024M1070794$MYLAN$$36$YR$$F$Y$49$KG$20240805$$MD$PL$PL
241745282$24174528$2$F$20240101$20240812$20240805$20240814$EXP$$US-UCBSA-2024039014$UCB$$$$$M$Y$$$20240814$$CN$US$US
241745293$24174529$3$F$$20240917$20240805$20240918$30DAY$$US-UCBSA-2024039007$UCB$$$$$F$Y$$$20240918$$CN$US$US
241745302$24174530$2$F$$20240814$20240805$20240820$EXP$$ES-MYLANLABS-2024M1070793$MYLAN$Anto, C. Use of isavuconazole in children with invasive fungal infection: experience in a paediatric and tertiary care centre. 69? Congreso de la Asociacion Espanola de Pediatria (AEP) : Libro de comunicacio. 2023;493$7$YR$$M$Y$24$KG$20240820$$MD$ES$ES
241745311$24174531$1$I$20240101$20240726$20240805$20240805$EXP$$US-ABBVIE-5857970$ABBVIE$$$$$F$Y$$$20240805$$HP$US$US
241745321$24174532$1$I$20230510$20240801$20240805$20240805$PER$$US-ORGANON-O2408USA000138$ORGANON$$29$YR$$F$Y$$$20240805$$CN$US$US
241745331$24174533$1$I$20240720$20240730$20240805$20240805$EXP$$US-ABBVIE-5860997$ABBVIE$$58$YR$$F$Y$$$20240805$$CN$US$US
241745342$24174534$2$F$20240121$20240813$20240805$20240819$EXP$$US-MYLANLABS-2024M1072257$MYLAN$$71$YR$$F$Y$90.71$KG$20240819$$CN$US$US
241745352$24174535$2$F$20240215$20240830$20240805$20240906$EXP$$JP-BIOMARINAP-JP-2024-159529$BIOMARIN$$$$$$Y$$$20240906$$MD$JP$JP
241745382$24174538$2$F$$20240731$20240805$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-122292$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240808$$MD$JP$JP
241745391$24174539$1$I$20240718$20240731$20240805$20240805$EXP$FR-AFSSAPS-MP2024001215$FR-009507513-2408FRA000064$MERCK$$53$YR$$F$Y$40$KG$20240805$$PH$FR$FR
241745402$24174540$2$F$20240101$20240805$20240805$20240812$EXP$$PH-009507513-2407PHL004171$MERCK$$45$YR$$M$Y$$$20240812$$CN$PH$PH
241745411$24174541$1$I$$20240726$20240805$20240805$EXP$$US-MYLANLABS-2024M1071574$MYLAN$Chumsky J, Kahn PJ, Carroll WL, Pierce KA, Hillier K. Lupus anti-coagulant hypoprothrombinemia syndrome across different ages: a case report and review of the literature. Clin-Rheumatol 2023; 42 (8): 2231-2236.$$$$F$Y$$$20240805$$HP$US$US
241745423$24174542$3$F$$20240826$20240805$20240826$PER$$US-ALXN-202407USA002117US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241745431$24174543$1$I$20240711$20240801$20240805$20240805$EXP$$US-GSK-US2023074379$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$HP$US$US
241745441$24174544$1$I$$20240731$20240805$20240805$EXP$$CA-TAKEDA-2024TUS076261$TAKEDA$$$$$F$Y$$$20240805$$CN$CA$CA
241745453$24174545$3$F$20240714$20240916$20240805$20240930$PER$$US-BELCHER PHARMACEUTICALS, LLC-2024US002409$PAREXEL$$$$$$Y$$$20240927$$HP$US$US
241745461$24174546$1$I$$20240726$20240805$20240805$EXP$$US-MYLANLABS-2024M1071762$MYLAN$Virupakshaiah A, Moseley CE, Elicegui S, Gerwitz LM, Spencer CM, George E, et al. Life-Threatening MOG Antibody-Associated Hemorrhagic ADEM With Elevated CSF IL-6. Neurol-Neuroimmunol-Neuroinflamm 2024; 11 (4):.$35$YR$$M$Y$$$20240805$$MD$US$US
241745473$24174547$3$F$20240708$20240916$20240805$20240925$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US002404$PAREXEL$$$$$$Y$$$20240924$$HP$US$US
241745482$24174548$2$F$20240719$20240816$20240805$20240822$PER$$US-BELCHER PHARMACEUTICALS, LLC-2024US002402$PAREXEL$$$$$$Y$$$20240822$$HP$US$US
241745503$24174550$3$F$20240703$20240905$20240805$20240916$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US002399$PAREXEL$$$$$$Y$$$20240913$$HP$US$US
241745512$24174551$2$F$20240708$20240821$20240805$20240829$PER$$US-BELCHER PHARMACEUTICALS, LLC-2024US002406$PAREXEL$$$$$$Y$$$20240829$$HP$US$US
241745521$24174552$1$I$$20240613$20240805$20240805$PER$$US-LUNDBECK-DKLU4000522$LUNDBECK$$$$$$Y$$$20240805$$HP$US$US
241745531$24174553$1$I$$20240731$20240805$20240805$PER$$US-ABBVIE-5862530$ABBVIE$$22$YR$$F$Y$$$20240805$$HP$US$US
241745541$24174554$1$I$20240713$20240801$20240805$20240805$EXP$$US-OTSUKA-2024_021403$OTSUKA$$58$YR$$M$Y$$$20240805$$CN$US$US
241745551$24174555$1$I$$20240613$20240805$20240805$PER$$US-LUNDBECK-DKLU4000498$LUNDBECK$$$$$$Y$$$20240805$$HP$US$US
241745561$24174556$1$I$20240723$20240729$20240805$20240805$EXP$$CO-ABBVIE-5865569$ABBVIE$$60$YR$$M$Y$76$KG$20240805$$HP$CO$CO
241745571$24174557$1$I$$20240730$20240805$20240805$PER$$US-BAYER-2024A110260$BAYER$$53$YR$A$F$Y$$$20240805$$MD$US$US
241745581$24174558$1$I$20240101$20240729$20240805$20240805$PER$$US-009507513-2407USA015305$MERCK$$$$$M$Y$$$20240805$$CN$US$US
241745591$24174559$1$I$$20240729$20240805$20240805$PER$$US-RDY-SPO/USA/24/0011288$DR REDDYS$$31$YR$A$M$Y$$$20240805$$MD$US$US
241745601$24174560$1$I$20240624$20240801$20240805$20240805$EXP$$US-OTSUKA-2024_021412$OTSUKA$$59$YR$$F$Y$$$20240805$$CN$US$US
241745611$24174561$1$I$$20240730$20240805$20240805$PER$$US-BAYER-2024A110556$BAYER$$$$$F$Y$$$20240805$$HP$US$US
241745621$24174562$1$I$$20240730$20240805$20240805$EXP$$PK-TAKEDA-2024TUS077356$TAKEDA$$$$$$Y$$$20240805$$CN$PK$PK
241745631$24174563$1$I$20240701$20240724$20240805$20240805$PER$$US-JNJFOC-20240772216$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241745641$24174564$1$I$$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174658$ASTRAZENECA$$$$$$Y$$$20240805$$MD$US$
241745652$24174565$2$F$$20240802$20240805$20240902$EXP$$TW-AstraZeneca-2024A176592$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$TW$
241745661$24174566$1$I$20240621$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174359$ASTRAZENECA$$28926$DY$$F$Y$$$20240805$$CN$US$
241745671$24174567$1$I$$20240801$20240805$20240805$EXP$$AU-MYLANLABS-2024M1072015$MYLAN$$$$$F$Y$$$20240805$$HP$AU$AU
241745681$24174568$1$I$$20240726$20240805$20240805$EXP$$GB-Ascend Therapeutics US, LLC-2160020$ASCEND$$48$YR$$M$Y$$$20240805$$$GB$GB
241745691$24174569$1$I$$20240731$20240805$20240805$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-121777$BRISTOL MYERS SQUIBB$$78$YR$E$$Y$83$KG$20240805$$MD$FR$FR
241745702$24174570$2$F$$20240806$20240805$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202407018889$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240816$$CN$US$US
241745712$24174571$2$F$$20240826$20240805$20240902$EXP$$US-GSK-US2024094888$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
241745721$24174572$1$I$$20240730$20240805$20240805$EXP$$US-BEH-2024176631$CSL BEHRING$$$$$F$Y$$$20240805$$CN$US$US
241745731$24174573$1$I$$20231117$20240805$20240805$EXP$$AU-SANDOZ INC.-SDZ2023AU055733$SANDOZ$$$$$$Y$$$20240805$$HP$AU$AU
241745741$24174574$1$I$20240722$20240729$20240805$20240805$EXP$$AR-GSK-AR2024AMR095195$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$AR$AR
241745752$24174575$2$F$$20240821$20240805$20240823$PER$$US-ALXN-202407USA002001US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241745761$24174576$1$I$20240713$20240726$20240805$20240805$EXP$CN-NMPACDR-1305341527121202400088$CN-BAXTER-2024BAX022432$BAXTER$$49$YR$$F$Y$55$KG$20240805$$MD$CN$CN
241745781$24174578$1$I$$20240730$20240805$20240805$EXP$$NL-002147023-PHHY2014NL010151$MYLAN$Zuilekom S.V, Gijsman H.J. A patient on clozapine in the general hospital: The need for discussion between specialists from different disciplines and for close monitoring of the patients plasma level. Tijdschrift voor psychiatrie. 2013;55(12):955-959$49$YR$$M$Y$$$20240805$$HP$NL$NL
241745791$24174579$1$I$20240208$20240801$20240805$20240805$EXP$FR-AFSSAPS-AN2024000952$FR-JNJFOC-20240809706$JOHNSON AND JOHNSON$$77$YR$E$M$Y$82$KG$20240805$$PH$FR$FR
241745801$24174580$1$I$20240716$20240730$20240805$20240805$EXP$IT-MINISAL02-996339$IT-MYLANLABS-2024M1071244$MYLAN$$70$YR$$F$Y$$$20240805$$MD$IT$IT
241745811$24174581$1$I$$20240730$20240805$20240805$PER$$US-HALEON-2190407$Haleon PLC$$40$YR$$F$Y$$$20240805$$HP$US$US
241745821$24174582$1$I$20240709$20240726$20240805$20240805$EXP$CN-NMPACDR-4403041004551202400556$CN-BAXTER-2024BAX022430$BAXTER$$11$YR$$M$Y$36$KG$20240805$$MD$CN$CN
241745834$24174583$4$F$20240725$20240917$20240805$20240923$EXP$$US-INCYTE CORPORATION-2024IN007848$INCYTE$$$$$$Y$$$20240923$$CN$US$US
241745842$24174584$2$F$$20240820$20240805$20240828$EXP$$US-TEVA-VS-3228604$TEVA$Riestra I, Carmona Porquera EM. Fibrocystic Sarcoidosis: Should Patients Be on Prophylaxis for Opportunistic Infections?. Am-J-Respir-Crit-Care-Med 2023; 207; Riestra I, Carmona Porquera EM. Fibrocystic Sarcoidosis: Should Patients Be on Prophylaxis for Opportunistic Infections?. Am-J-Respir-Crit-Care-Med 2023; 207.$53$YR$$M$Y$$$20240828$$HP$US$US
241745852$24174585$2$F$$20240906$20240805$20240916$30DAY$$CA-JNJFOC-20240800350$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$PH$CA$CA
241745861$24174586$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123330$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240805$$MD$US$US
241745871$24174587$1$I$$20240716$20240805$20240805$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07328$LUPIN$$$$$$Y$$$20240805$$CN$US$US
241745881$24174588$1$I$$20240725$20240805$20240805$PER$$US-INCYTE CORPORATION-2024IN007825$INCYTE$$$$$$Y$$$20240805$$PH$US$US
241745891$24174589$1$I$20240720$20240730$20240805$20240805$EXP$$US-VANTIVE-2024VAN018738$Vantive US Healthcare$$69$YR$$F$Y$$$20240805$$CN$US$US
241745911$24174591$1$I$20240731$20240731$20240805$20240805$EXP$$US-VANTIVE-2024VAN018814$Vantive US Healthcare$$$$$M$Y$$$20240805$$CN$US$US
241745921$24174592$1$I$20231222$20240801$20240805$20240805$EXP$$US-GSK-US2024096274$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$HP$US$US
241745932$24174593$2$F$20240729$20240815$20240805$20240823$EXP$$GB-VANTIVE-2024VAN018706$Vantive US Healthcare$$67$YR$$F$Y$55.8$KG$20240823$$CN$GB$GB
241745941$24174594$1$I$$20230925$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2023US033921$SANDOZ$Holmberg, Leona A, Maloney, David G, Connelly-Smith, Laura. Bortezomib and Vorinostat Therapy as Maintenance Therapy Post AutologousTransplant for Non-Hodgkin^s Lymphoma Using R-BEAM or BEAM TransplantConditioning Regimen. Acta Haematologica. 2023;1421-9662$$$$$Y$$$20240805$$HP$US$US
241745951$24174595$1$I$20240618$20240731$20240805$20240805$EXP$FR-AFSSAPS-AN2024000972$FR-GSK-FR2024095523$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$PH$FR$FR
241745961$24174596$1$I$$20240726$20240805$20240805$PER$$US-INCYTE CORPORATION-2024IN007884$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241745971$24174597$1$I$20240618$20240726$20240805$20240805$EXP$$EC-VANTIVE-2024VAN018413$Vantive US Healthcare$$82$YR$$M$Y$67$KG$20240805$$HP$EC$EC
241745981$24174598$1$I$20240703$20240728$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011691$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241745991$24174599$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227698$SANOFI AVENTIS$$$$A$M$Y$$$20240805$$MD$US$US
241746001$24174600$1$I$20240701$20240731$20240805$20240805$EXP$$US-BEH-2024176740$CSL BEHRING$$65$YR$E$F$Y$$$20240805$$PH$US$US
241746011$24174601$1$I$$20240730$20240805$20240805$EXP$$US-INCYTE CORPORATION-2024IN007864$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241746023$24174602$3$F$$20240903$20240805$20240906$EXP$$JP-PFIZER INC-PV202400100826$PFIZER$Kita, Y.. Fanconi syndrome with karyomegalic interstitial nephritis after ifosfamide treatment for osteosarcoma: a case report. CEN Case Reports. 2024;1-6$18$YR$$M$Y$$$20240906$$HP$JP$JP
241746031$24174603$1$I$$20240731$20240805$20240805$EXP$$PT-PFIZER INC-202400227194$PFIZER$Carrilho, M. CO-0062 - (4147) - MYOCARDITIS DUE TO CMV. 30th National Congress of Internal Medicine. 2024;1625$72$YR$$F$Y$$$20240805$$MD$PT$PT
241746041$24174604$1$I$$20240730$20240805$20240805$EXP$$JP-PFIZER INC-PV202300164465$PFIZER$Watanabe, K.. A case of MPO-ANCA-associated vasculitis with late onset neutropenia after rituximab administration. The Japanese Journal of Nephrology. 2023;65(6-W):760$91$YR$$F$Y$$$20240805$$HP$JP$JP
241746051$24174605$1$I$20230101$20240729$20240805$20240805$EXP$$JP-PFIZER INC-PV202400098955$PFIZER$Matsuoka, Y.. A case of multiple duodenal ulcer haemorrhage/perforation due to CMV reactivation during acute hepatic failure treatment, where the patient^s life was saved with repeated arterial embolization. Journal of the Tohoku Branch of the Japanese Society of Gastroenterology. 2024;2:45$41$YR$$F$Y$$$20240805$$HP$JP$JP
241746061$24174606$1$I$20000101$20240731$20240805$20240805$EXP$$JP-PFIZER INC-PV202400100765$PFIZER$Sawabe, T.. Cyclosporin-induced cortical blindness in a patient with dermatomyositis. Mod Rheumatol. 2004;14:271-273$49$YR$$F$Y$$$20240805$$HP$JP$JP
241746071$24174607$1$I$$20240729$20240805$20240805$EXP$$JP-PFIZER INC-PV202400098964$PFIZER$Enomoto, K.. A case of drug-induced liver disorder during postoperative exemestane administration. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:468$72$YR$$F$Y$$$20240805$$HP$JP$JP
241746081$24174608$1$I$$20240729$20240805$20240805$EXP$$JP-PFIZER INC-PV202400098931$PFIZER$Sakaguchi, M.. A case of methotrexate-associated lymphoproliferative disorder observed in a sentinel lymph node. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:422$8$DEC$$F$Y$$$20240805$$HP$JP$JP
241746091$24174609$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002044US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
241746101$24174610$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002000US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240805$$CN$US$US
241746111$24174611$1$I$$20240801$20240805$20240805$EXP$$CA-JNJFOC-20240805010$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240805$$CN$CA$CA
241746121$24174612$1$I$20240701$20240729$20240805$20240805$PER$$US-JNJFOC-20240802616$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240805$$CN$US$US
241746131$24174613$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002195US$ALEXION PHARMACEUTICALS$$$$$F$Y$42.177$KG$20240805$$CN$US$US
241746141$24174614$1$I$20240716$20240731$20240805$20240805$PER$IT-MINISAL02-996555$IT-BRACCO-2024IT04686$BRACCO$$74$YR$$M$Y$$$20240805$$MD$IT$IT
241746154$24174615$4$F$20240731$20240911$20240805$20240918$30DAY$$US-JNJFOC-20240785521$JOHNSON AND JOHNSON$$63$YR$A$F$Y$174.4$KG$20240919$$HP$US$US
241746161$24174616$1$I$$20240730$20240805$20240805$EXP$$JP-009507513-2407JPN005322J$MERCK$$76$YR$$F$Y$$$20240805$$PH$JP$JP
241746171$24174617$1$I$$20240730$20240805$20240805$EXP$$US-INCYTE CORPORATION-2024IN007980$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241746181$24174618$1$I$$20240729$20240805$20240805$PER$$US-RDY-SPO/USA/24/0011289$DR REDDYS$$12$YR$T$F$Y$$$20240805$$MD$US$US
241746191$24174619$1$I$$20240729$20240805$20240805$PER$$US-RDY-SPO/USA/24/0011291$DR REDDYS$$19$YR$A$F$Y$$$20240805$$MD$US$US
241746201$24174620$1$I$$20240726$20240805$20240805$EXP$$GR-BIOCON BIOLOGICS LIMITED-BBL2024005579$BIOCON$$$$$$Y$$$20240805$$MD$GR$GR
241746221$24174622$1$I$20240720$20240801$20240805$20240805$EXP$$US-GSK-US2024096280$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$US$US
241746231$24174623$1$I$$20240730$20240805$20240805$PER$$US-MYLANLABS-2024M1072331$MYLAN$$$$$F$Y$$$20240805$$CN$US$US
241746242$24174624$2$F$$20240903$20240805$20240906$EXP$$CA-TAKEDA-2019TUS050457$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
241746251$24174625$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123084$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240805$$HP$US$US
241746261$24174626$1$I$$20240731$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122843$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$89.81$KG$20240805$$CN$US$US
241746271$24174627$1$I$20240731$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024153743$AMGEN$$67$YR$E$M$Y$$$20240805$$CN$US$US
241746281$24174628$1$I$$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024152435$AMGEN$$$$$$Y$$$20240805$$CN$US$US
241746291$24174629$1$I$20200101$20240730$20240805$20240805$EXP$$US-ORGANON-O2407USA002942$ORGANON$$$$$F$Y$$$20240805$$MD$US$US
241746301$24174630$1$I$20240201$20240729$20240805$20240805$PER$$US-SA-2024SA227482$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240805$$MD$US$US
241746311$24174631$1$I$20240726$20240802$20240805$20240805$PER$$US-AMGEN-USASP2024154668$AMGEN$$43$YR$A$M$Y$$$20240805$$HP$US$US
241746321$24174632$1$I$20240701$20240801$20240805$20240805$PER$$US-JNJFOC-20240805462$JOHNSON AND JOHNSON$$71$YR$E$$Y$$$20240805$$HP$US$US
241746331$24174633$1$I$$20240712$20240805$20240805$PER$$US-009507513-2407USA009654$MERCK$$80$YR$$M$Y$$$20240805$$HP$US$US
241746341$24174634$1$I$$20240709$20240805$20240805$PER$$US-INCYTE CORPORATION-2024IN007230$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241746351$24174635$1$I$$20240731$20240805$20240805$PER$$US-PFIZER INC-202400227958$PFIZER$$16$YR$$M$Y$$$20240805$$CN$US$US
241746361$24174636$1$I$$20240731$20240805$20240805$PER$$US-PFIZER INC-202400228265$PFIZER$$65$YR$$M$Y$79.83$KG$20240805$$HP$US$US
241746373$24174637$3$F$20240728$20240917$20240805$20240919$PER$$US-PFIZER INC-202400227663$PFIZER$$74$YR$$F$Y$83.91$KG$20240919$$CN$US$US
241746382$24174638$2$F$$20240805$20240805$20240807$PER$$US-PFIZER INC-PV202400100294$PFIZER$$$$$$Y$$$20240807$$CN$US$US
241746391$24174639$1$I$$20240730$20240805$20240805$PER$$US-PFIZER INC-PV202400100519$PFIZER$$69$YR$$F$Y$$$20240805$$HP$US$US
241746411$24174641$1$I$20240725$20240801$20240805$20240805$PER$$US-PFIZER INC-PV202400101300$PFIZER$$55$YR$$F$Y$$$20240805$$HP$US$US
241746421$24174642$1$I$$20240731$20240805$20240805$PER$$US-PFIZER INC-202400227516$PFIZER$$75$YR$$M$Y$$$20240805$$MD$US$US
241746431$24174643$1$I$$20240730$20240805$20240805$PER$$US-PFIZER INC-202400227496$PFIZER$$$$$M$Y$$$20240805$$HP$US$US
241746451$24174645$1$I$$20240730$20240805$20240805$PER$$US-PFIZER INC-202400227721$PFIZER$$78$YR$$F$Y$$$20240805$$HP$US$US
241746462$24174646$2$F$20240101$20240805$20240805$20240807$PER$$US-PFIZER INC-PV202400101368$PFIZER$$31$YR$$F$Y$$$20240807$$PH$US$US
241746472$24174647$2$F$$20240808$20240805$20240813$PER$$US-PFIZER INC-202400226819$PFIZER$$92$YR$$F$Y$$$20240813$$CN$US$US
241746482$24174648$2$F$$20240801$20240805$20240809$PER$$US-PFIZER INC-PV202400101183$PFIZER$$70$YR$$F$Y$$$20240809$$CN$US$US
241746491$24174649$1$I$$20240731$20240805$20240805$PER$$JP-PFIZER INC-202400226891$PFIZER$$$$$$Y$$$20240805$$PH$JP$JP
241746501$24174650$1$I$$20240731$20240805$20240805$PER$$US-PFIZER INC-PV202400100000$PFIZER$$52$YR$$F$Y$$$20240805$$CN$US$US
241746513$24174651$3$F$$20240910$20240805$20240911$PER$$US-PFIZER INC-202400227226$PFIZER$$76$YR$$M$Y$$$20240911$$MD$US$US
241746522$24174652$2$F$20240729$20240808$20240805$20240812$PER$$PR-PFIZER INC-202400227580$PFIZER$$44$YR$$M$Y$122.47$KG$20240812$$CN$PR$PR
241746531$24174653$1$I$20240729$20240730$20240805$20240805$PER$$US-PFIZER INC-202400227001$PFIZER$$64$YR$$F$Y$$$20240805$$HP$US$US
241746542$24174654$2$F$$20240821$20240805$20240823$PER$$US-PFIZER INC-202400227699$PFIZER$$23$YR$$M$Y$$$20240823$$CN$US$US
241746551$24174655$1$I$20240101$20240802$20240805$20240805$PER$$US-PFIZER INC-PV202400101339$PFIZER$$64$YR$$$Y$$$20240805$$CN$US$US
241746562$24174656$2$F$$20240808$20240805$20240812$PER$$US-PFIZER INC-PV202400100338$PFIZER$$12$YR$$F$Y$$$20240812$$CN$US$US
241746572$24174657$2$F$$20240830$20240805$20240904$PER$$US-PFIZER INC-202400049513$PFIZER$$37$YR$$M$Y$$$20240904$$CN$US$US
241746582$24174658$2$F$20240729$20240808$20240805$20240809$PER$$US-PFIZER INC-202400227300$PFIZER$$52$YR$$M$Y$102.06$KG$20240809$$CN$US$US
241746591$24174659$1$I$$20240730$20240805$20240805$PER$$US-PFIZER INC-PV202400099640$PFIZER$$75$YR$$F$Y$$$20240805$$HP$US$US
241746601$24174660$1$I$20240729$20240730$20240805$20240805$PER$$US-PFIZER INC-202400227003$PFIZER$$63$YR$$F$Y$$$20240805$$CN$US$US
241746611$24174661$1$I$$20240731$20240805$20240805$PER$$US-PFIZER INC-PV202400075106$PFIZER$$80$YR$$F$Y$$$20240805$$HP$US$US
241746621$24174662$1$I$20240729$20240731$20240805$20240805$PER$$US-PFIZER INC-PV202400100317$PFIZER$$75$YR$$F$Y$$$20240805$$CN$US$US
241746632$24174663$2$F$$20240802$20240805$20240808$PER$$US-PFIZER INC-PV202400100229$PFIZER$$54$YR$$F$Y$77.2$KG$20240808$$MD$US$US
241746641$24174664$1$I$20240701$20240802$20240805$20240805$PER$$US-PFIZER INC-PV202400101487$PFIZER$$26$YR$$F$Y$$$20240805$$HP$US$US
241746651$24174665$1$I$$20240731$20240805$20240805$PER$$US-PFIZER INC-202400227636$PFIZER$$53$YR$$F$Y$$$20240805$$CN$US$US
241746661$24174666$1$I$20240729$20240731$20240805$20240805$PER$$US-PFIZER INC-202400227677$PFIZER$$30$YR$$M$Y$$$20240805$$CN$US$US
241746672$24174667$2$F$20200101$20240808$20240805$20240812$PER$$US-PFIZER INC-PV202400101332$PFIZER$$$$$$Y$$$20240812$$CN$US$US
241746682$24174668$2$F$20240701$20240809$20240805$20240809$PER$$US-PFIZER INC-202400227716$PFIZER$$77$YR$$F$Y$$$20240809$$CN$US$US
241746691$24174669$1$I$20240701$20240730$20240805$20240805$PER$$US-PFIZER INC-202400227755$PFIZER$$61$YR$$M$Y$$$20240805$$HP$US$US
241746701$24174670$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-PV202400101474$PFIZER$$60$YR$$F$Y$$$20240805$$HP$US$US
241746722$24174672$2$F$$20240823$20240805$20240828$PER$$US-PFIZER INC-PV202400100254$PFIZER$$76$YR$$M$Y$$$20240828$$CN$US$US
241746731$24174673$1$I$$20240731$20240805$20240805$PER$$US-PFIZER INC-202400228971$PFIZER$$$$$F$Y$$$20240805$$PH$US$US
241746741$24174674$1$I$20240730$20240731$20240805$20240805$PER$$US-PFIZER INC-202400227495$PFIZER$$65$YR$$F$Y$$$20240805$$CN$US$US
241746751$24174675$1$I$$20240731$20240805$20240805$PER$$US-PFIZER INC-PV202400100368$PFIZER$$59$YR$$F$Y$$$20240805$$HP$US$US
241746761$24174676$1$I$20240731$20240731$20240805$20240805$PER$$US-PFIZER INC-202400227696$PFIZER$$61$YR$$F$Y$93.44$KG$20240805$$MD$US$US
241746771$24174677$1$I$20240729$20240730$20240805$20240805$PER$$US-PFIZER INC-202400226729$PFIZER$$81$YR$$F$Y$$$20240805$$CN$US$US
241746781$24174678$1$I$$20240731$20240805$20240805$PER$$US-PFIZER INC-202400228119$PFIZER$$51$YR$$F$Y$$$20240805$$MD$US$US
241746791$24174679$1$I$$20240731$20240805$20240805$PER$$US-PFIZER INC-202400227756$PFIZER$$$$$$Y$$$20240805$$CN$US$US
241746801$24174680$1$I$20240101$20240802$20240805$20240805$PER$$US-PFIZER INC-PV202400101472$PFIZER$$60$YR$$F$Y$$$20240805$$HP$US$US
241746811$24174681$1$I$$20240730$20240805$20240805$PER$$US-PFIZER INC-202400227801$PFIZER$$63$YR$$M$Y$$$20240805$$HP$US$US
241746821$24174682$1$I$$20240731$20240805$20240805$PER$$KR-PFIZER INC-PV202400099403$PFIZER$$$$$$Y$$$20240805$$CN$KR$KR
241746831$24174683$1$I$20240727$20240730$20240805$20240805$PER$$US-PFIZER INC-202400226996$PFIZER$$64$YR$$F$Y$$$20240805$$HP$US$US
241746841$24174684$1$I$$20240731$20240805$20240805$PER$$US-PFIZER INC-202400228550$PFIZER$$47$YR$$F$Y$$$20240805$$HP$US$US
241746851$24174685$1$I$$20240730$20240805$20240805$PER$$US-PFIZER INC-202400227535$PFIZER$$$$$$Y$$$20240805$$PH$US$US
241746862$24174686$2$F$20240101$20240918$20240805$20240923$EXP$$US-PFIZER INC-PV202400012417$PFIZER$$73$YR$$F$Y$$$20240923$$HP$US$US
241746871$24174687$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001251$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240805$$CN$US$US
241746881$24174688$1$I$20240726$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019913$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240805$$CN$US$US
241746891$24174689$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407020332$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240805$$CN$US$US
241746901$24174690$1$I$20240701$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001485$ELI LILLY AND CO$$$$$F$Y$$$20240805$$CN$US$US
241746911$24174691$1$I$$20240727$20240805$20240805$PER$$US-INCYTE CORPORATION-2024IN007883$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241746921$24174692$1$I$$20240726$20240805$20240805$PER$$US-MYLANLABS-2024M1070774$MYLAN$$$$$M$Y$$$20240805$$HP$US$US
241746932$24174693$2$F$20240415$20240829$20240805$20240910$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI06724$NEUROCRINE BIOSCIENCES$$62$YR$$F$Y$$$20240911$$MD$JP$JP
241746941$24174694$1$I$20240728$20240729$20240805$20240805$EXP$$DE-BAXTER-2024BAX022461$BAXTER$$69$YR$$M$Y$$$20240805$$HP$DE$DE
241746951$24174695$1$I$$20240729$20240805$20240805$EXP$$JP-ROCHE-10000048485$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$49$YR$A$M$Y$$$20240805$$HP$JP$JP
241746961$24174696$1$I$$20240801$20240805$20240805$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122960$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$49$KG$20240805$$HP$CA$CA
241746971$24174697$1$I$20240715$20240729$20240805$20240805$EXP$$US-BEH-2024176620$CSL BEHRING$$77$YR$E$F$Y$56.689$KG$20240805$$CN$US$US
241746981$24174698$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123177$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240805$$HP$US$US
241746991$24174699$1$I$$20240725$20240805$20240805$PER$$US-JNJFOC-20240776499$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241747001$24174700$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA227718$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240805$$MD$US$US
241747011$24174701$1$I$20180727$20240727$20240805$20240805$EXP$$GB-TEVA-VS-3227096$TEVA$$31$YR$$M$Y$79$KG$20240805$$CN$GB$GB
241747032$24174703$2$F$$20240805$20240805$20240807$EXP$$US-PFIZER INC-PV202400099851$PFIZER$Young, W.. Transient blindness after lumbar epidural steroid injection: a case report and literature review. Spine. 2002;27(21):E476-477$39$YR$$M$Y$$$20240807$$MD$US$US
241747041$24174704$1$I$$20240730$20240805$20240805$EXP$$US-PFIZER INC-PV202400099857$PFIZER$McGrew, R.. Sudden blindness secondary to injections of common drugs in the head and neck: I. Clinical experiences. Otolaryngology. 1978;86(1):147-151$29$YR$$F$Y$$$20240805$$MD$US$US
241747051$24174705$1$I$$20240802$20240805$20240805$PER$$US-ABBVIE-5866134$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241747062$24174706$2$F$$20240801$20240805$20240807$EXP$$US-PFIZER INC-202400227732$PFIZER$Bally, K.. A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone. Cureus. 2024;16(6):10.7759/cureus.62695$95$YR$$F$Y$$$20240807$$MD$US$US
241747072$24174707$2$F$20210501$20240813$20240805$20240821$EXP$$FR-AstraZeneca-2024A176342$ASTRAZENECA$$43$YR$$M$Y$95.5$KG$20240821$$MD$FR$
241747081$24174708$1$I$20240731$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152660$AMGEN$$65$YR$E$F$Y$$$20240805$$CN$US$US
241747092$24174709$2$F$$20240904$20240805$20240904$PER$$US-ALXN-202407USA001973US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240904$$CN$US$US
241747101$24174710$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA002263US$ALEXION PHARMACEUTICALS$$$$$M$Y$63.3$KG$20240805$$HP$US$US
241747112$24174711$2$F$$20240906$20240805$20240906$PER$$US-ALXN-202407USA002038US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
241747121$24174712$1$I$20240101$20240729$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120891$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$MD$US$US
241747131$24174713$1$I$$20240801$20240805$20240805$PER$$US-ABBVIE-5866171$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241747141$24174714$1$I$20240101$20240725$20240805$20240805$EXP$$US-ARDELYX-2024ARDX005707$ARDELYX$$$$$F$Y$$$20240805$$CN$US$US
241747151$24174715$1$I$20240101$20240801$20240805$20240805$PER$$US-JNJFOC-20240803787$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240805$$HP$US$US
241747161$24174716$1$I$20240408$20240726$20240805$20240805$EXP$$US-BIOMARINAP-US-2024-159484$BIOMARIN$$$$$$Y$$$20240805$$CN$US$US
241747171$24174717$1$I$20100527$20240729$20240805$20240805$PER$$US-JNJFOC-20240782070$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20240805$$HP$US$US
241747181$24174718$1$I$20240701$20240729$20240805$20240805$PER$$US-BIOGEN-2024BI01276124$BIOGEN$$45$YR$$F$Y$$$20240805$$CN$US$US
241747192$24174719$2$F$$20240916$20240805$20240918$EXP$$US-AstraZeneca-2024A175083$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
241747201$24174720$1$I$20240604$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A175140$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241747221$24174722$1$I$20240301$20240729$20240805$20240805$PER$$US-AMGEN-USASP2024150420$AMGEN$$56$YR$A$F$Y$47.619$KG$20240805$$CN$US$US
241747231$24174723$1$I$$20240724$20240805$20240805$EXP$$GB-AMGEN-GBRSP2024152442$AMGEN$$51$YR$A$F$Y$$$20240805$$CN$GB$GB
241747241$24174724$1$I$20240524$20240723$20240805$20240805$EXP$$AU-AstraZeneca-2024A176861$ASTRAZENECA$$68$YR$$M$Y$$$20240805$$MD$AU$
241747251$24174725$1$I$$20240729$20240805$20240805$PER$$US-HALEON-2189661$Haleon PLC$$$$$$Y$$$20240805$$CN$US$US
241747261$24174726$1$I$$20240802$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123344$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240805$$CN$US$US
241747271$24174727$1$I$20240125$20240729$20240805$20240805$EXP$$US-BEH-2024168517$CSL BEHRING$$63$YR$A$M$Y$76.644$KG$20240805$$CN$US$US
241747284$24174728$4$F$$20240822$20240805$20240827$EXP$$US-ABBVIE-5866258$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
241747291$24174729$1$I$$20240725$20240805$20240805$EXP$$CA-SA-2024SA219041$SANOFI AVENTIS$$$$$M$Y$$$20240805$$HP$CA$CA
241747301$24174730$1$I$$20211126$20240805$20240805$EXP$$NL-BIOVITRUM-2021NL11677$BIOVITRUM$$$$I$M$Y$3.5$KG$20240805$$CN$NL$NL
241747321$24174732$1$I$$20240729$20240805$20240805$EXP$$CA-Covis Pharma GmbH-2021COV21932$COVIS PHARMA$$56$YR$A$M$Y$91$KG$20240805$$MD$CA$CA
241747331$24174733$1$I$20240228$20240731$20240805$20240805$EXP$FR-AFSSAPS-TO2024001226$FR-SA-2024SA209646$SANOFI AVENTIS$$80$YR$E$M$Y$69$KG$20240805$$CN$FR$FR
241747341$24174734$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA225856$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240805$$MD$US$US
241747351$24174735$1$I$20230420$20230606$20240805$20240805$EXP$$ZA-BIOVITRUM-2023-ZA-010138$BIOVITRUM$$153$DY$$F$Y$4$KG$20240805$$CN$ZA$ZA
241747361$24174736$1$I$$20240222$20240805$20240805$EXP$$ZA-BIOVITRUM-2022ZA06989$BIOVITRUM$$$$C$F$Y$2.8$KG$20240805$$CN$ZA$ZA
241747371$24174737$1$I$$20230418$20240805$20240805$EXP$$NL-BIOVITRUM-2023-NL-009858$BIOVITRUM$$$$I$F$Y$6.8$KG$20240805$$HP$NL$NL
241747381$24174738$1$I$$20240729$20240805$20240805$EXP$$CA-AMGEN-CANSP2024151244$AMGEN$$$$$$Y$$$20240805$$CN$CA$CA
241747392$24174739$2$F$$20240731$20240805$20240810$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-122975$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240810$$MD$JP$JP
241747401$24174740$1$I$20240629$20240801$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122467$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240805$$PH$US$US
241747411$24174741$1$I$20240802$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123544$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240805$$CN$US$US
241747421$24174742$1$I$20240713$20240729$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121340$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240805$$HP$US$US
241747431$24174743$1$I$20230101$20240729$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120706$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$106.59$KG$20240805$$CN$US$US
241747442$24174744$2$F$20240726$20240905$20240805$20240910$30DAY$$US-MYLANLABS-2024M1070975$MYLAN$$63$YR$$M$Y$$$20240910$$CN$US$US
241747451$24174745$1$I$$20211006$20240805$20240805$EXP$$NL-BIOVITRUM-2021NL9118$BIOVITRUM$$$$I$F$Y$6.8$KG$20240805$$CN$NL$NL
241747472$24174747$2$F$$20240820$20240805$20240829$EXP$$JP-TEVA-VS-3227379$TEVA$Nishio T, Toukairin Y, Hoshi T, Arai T, Nogami M. A case of lacosamide and mirtazapine self-poisoning. Leg-Med-Tokyo 2024; 69 1-7.; Nishio T, Toukairin Y, Hoshi T, Arai T, Nogami M. A case of lacosamide and mirtazapine self-poisoning. Leg-Med-Tokyo 2024; 69 1-7.$$$A$F$Y$$$20240829$$HP$JP$JP
241747481$24174748$1$I$20220625$20220630$20240805$20240805$EXP$$CO-BIOVITRUM-2022CO08578$BIOVITRUM$$174$DY$$F$Y$$$20240805$$CN$CO$CO
241747491$24174749$1$I$20220208$20240729$20240805$20240805$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-13798$IPSEN$$75$YR$E$M$Y$$$20240805$$MD$JP$JP
241747502$24174750$2$F$20240726$20240801$20240805$20240812$EXP$$MX-BIOVITRUM-2024-MX-010566$BIOVITRUM$$988$DY$$M$Y$11$KG$20240812$$CN$MX$MX
241747521$24174752$1$I$20240703$20240727$20240805$20240805$EXP$$CN-SA-2024SA228652$SANOFI AVENTIS$$59$YR$A$M$Y$50$KG$20240805$$HP$CN$CN
241747531$24174753$1$I$20230221$20230313$20240805$20240805$EXP$$CO-BIOVITRUM-2023-CO-007324$BIOVITRUM$$109$DY$$F$Y$5$KG$20240805$$CN$CO$CO
241747542$24174754$2$F$20240704$20240731$20240805$20240808$EXP$PT-INFARMED-T202407-374$PT-SA-2024SA229773$SANOFI AVENTIS$$84$YR$E$F$Y$60$KG$20240808$$MD$PT$PT
241747551$24174755$1$I$20240728$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019345$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240805$$CN$US$US
241747561$24174756$1$I$$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024152135$AMGEN$$$$$F$Y$$$20240805$$MD$US$US
241747571$24174757$1$I$$20240730$20240805$20240805$PER$$US-AMGEN-USASP2024152921$AMGEN$$$$$$Y$$$20240805$$CN$US$US
241747581$24174758$1$I$20220615$20220727$20240805$20240805$EXP$$CO-BIOVITRUM-2022CO09239$BIOVITRUM$$231$DY$$M$Y$9$KG$20240805$$CN$CO$CO
241747591$24174759$1$I$$20240722$20240805$20240805$EXP$$JP-BEXIMCO-2024BEX00038$BEXIMCO PHARMACEUTICALS$Takahashi Y, Nakano H, Motoki M. et.al.. Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review. Acute Medicine + Surgery. 2024;11:1-5$45$YR$$F$Y$90$KG$20240801$$HP$JP$JP
241747601$24174760$1$I$20240701$20240805$20240805$20240805$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043785$BOEHRINGER INGELHEIM$$$$$$Y$$$20240805$$CN$US$US
241747611$24174761$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA226032$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240805$$MD$US$US
241747621$24174762$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA227697$SANOFI AVENTIS$$$$E$F$Y$$$20240805$$MD$US$US
241747631$24174763$1$I$20240802$20240802$20240805$20240805$EXP$$GB-MYLANLABS-2024M1072450$MYLAN$$51$YR$$F$Y$89$KG$20240805$$MD$GB$GB
241747641$24174764$1$I$$20240801$20240805$20240805$EXP$$GB-AstraZeneca-2024A175262$ASTRAZENECA$$55$YR$$F$Y$68$KG$20240805$$MD$GB$
241747651$24174765$1$I$$20240731$20240805$20240805$EXP$$US-AstraZeneca-2024A174379$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241747661$24174766$1$I$$20240723$20240805$20240805$EXP$$AU-AstraZeneca-2024A176660$ASTRAZENECA$$$$$$Y$$$20240805$$MD$AU$
241747671$24174767$1$I$20240617$20240715$20240805$20240805$PER$$US-009507513-2407USA009673$MERCK$$$$$F$Y$$$20240805$$CN$US$US
241747691$24174769$1$I$$20240727$20240805$20240805$EXP$$GB-AstraZeneca-2024A176989$ASTRAZENECA$$89$YR$$$Y$$$20240805$$HP$GB$
241747701$24174770$1$I$20240724$20240726$20240805$20240805$EXP$$CN-ALCON LABORATORIES-ALC2024CN003573$ALCON$$41$YR$$M$Y$70$KG$20240805$$HP$CN$CN
241747711$24174771$1$I$$20240731$20240805$20240805$EXP$$US-Taiho Oncology Inc-2024-007442$TAIHO ONCOLOGY INC$$65$YR$E$M$Y$$$20240805$$CN$US$US
241747721$24174772$1$I$$20240730$20240805$20240805$EXP$CZ-CZSUKL-24002123$CZ-MYLANLABS-2024M1071411$MYLAN$$39$YR$$F$Y$71$KG$20240805$$CN$CZ$CZ
241747731$24174773$1$I$$20240730$20240805$20240805$EXP$$RO-MYLANLABS-2024M1071420$MYLAN$Ciurescu IA, Lencioni R, Stemmer SM, Farbstein M, Harpaz Z, Bareket-Samish A, et al.. A long-term complete response to namodenoson in liver cancer with Child-Pugh B cirrhosis: A case report.. Exper-Ther-Med. 2024;27 (6)$$$A$F$Y$$$20240805$$HP$RO$IL
241747741$24174774$1$I$$20240725$20240805$20240805$EXP$$CN-ROCHE-RCA5205354$ROCHE$Lin Y, Kuang Q, Li H, Jiang Q, Yang X. Case report: A highly active refractory myasthenia gravis with treatment of telitacicept combined with efgartigimod. DOI:10.3389/fimmu.2024.1400459. Frontiers in Immunology.15:1-6. doi:10.3389/fimmu.2024.1400459.$37$YR$A$F$Y$55$KG$20240805$$HP$CN$CN
241747751$24174775$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123384$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240805$$CN$US$US
241747761$24174776$1$I$20240724$20240802$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123185$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240805$$PH$US$US
241747771$24174777$1$I$$20240729$20240805$20240805$EXP$$IN-BAUSCH-BL-2024-011609$BAUSCH AND LOMB$Sharma P, Venkatapura R. Acute suppression of the hypothalamo-pituitary-adrenal axis from a large singular dose of dexamethasone: A case report on a hypothesis for resistant intraoperative hypotension. Surgical Neurology International. 2024 JUL 05;15(230):1-3. doi:10.25259/SNI_273_2024$9$YR$$F$Y$20$KG$20240805$$HP$IN$IN
241747781$24174778$1$I$$20240729$20240805$20240805$EXP$$IT-BAUSCH-BL-2024-011674$BAUSCH AND LOMB$Pigni S, Cristofolini G, Jaafar S, Maida G, Grossrubatscher E, Dalino P, Carioni E, Mazziotti G, Lania A, Zampetti B, Chiodini I. Late-onset Schmidt^s Syndrome Presenting with Severe Hyponatremia: A Case Report. Endocrine, metabolic and immune disorders drug targets. 2024 JUL 15;. doi:10.2174/0118715303323053240611075428$73$YR$$F$Y$$$20240805$$HP$IT$IT
241747791$24174779$1$I$$20240802$20240805$20240805$EXP$$DE-GILEAD-2024-0682770$GILEAD$$71$YR$E$M$Y$$$20240805$$HP$DE$DE
241747801$24174780$1$I$$20240802$20240805$20240805$EXP$$DE-GILEAD-2024-0682762$GILEAD$$58$YR$A$M$Y$$$20240805$$HP$DE$DE
241747811$24174781$1$I$20240730$20240731$20240805$20240805$PER$$US-ABBVIE-5864556$ABBVIE$$25$YR$$F$Y$$$20240805$$HP$US$US
241747821$24174782$1$I$20191213$20240803$20240805$20240805$EXP$$DE-BAUSCH-BL-2024-011867$BAUSCH AND LOMB$$$$$$Y$$$20240805$$MD$DE$DE
241747831$24174783$1$I$20240718$20240726$20240805$20240805$EXP$$US-VIIV HEALTHCARE LIMITED-US2024094192$VIIV$$68$YR$$F$Y$$$20240805$$CN$US$US
241747841$24174784$1$I$$20240726$20240805$20240805$EXP$$BE-DSJP-DSJ-2024-138650$DAIICHI$$$$A$F$Y$$$20240805$$MD$BE$BE
241747851$24174785$1$I$$20240729$20240805$20240805$EXP$$CN-JNJFOC-20240780955$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$HP$CN$CN
241747861$24174786$1$I$20240620$20240730$20240805$20240805$EXP$FR-AFSSAPS-PB2024000797$FR-MYLANLABS-2024M1071162$MYLAN$$65$YR$$F$Y$55$KG$20240805$$MD$FR$FR
241747871$24174787$1$I$$20240730$20240805$20240805$EXP$FR-AFSSAPS-RE2024000752$FR-MYLANLABS-2024M1070870$MYLAN$$74$YR$$F$Y$$$20240805$$HP$FR$FR
241747881$24174788$1$I$20240504$20240730$20240805$20240805$EXP$FR-AFSSAPS-PP2024000810$FR-MYLANLABS-2024M1071141$MYLAN$$80$YR$$M$Y$$$20240805$$MD$FR$FR
241747891$24174789$1$I$$20240730$20240805$20240805$EXP$$US-ABBVIE-5864534$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241747901$24174790$1$I$20240801$20240801$20240805$20240805$PER$$US-JNJFOC-20240803487$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$US$US
241747911$24174791$1$I$20231227$20240730$20240805$20240805$EXP$FR-AFSSAPS-NY2024000829$FR-MYLANLABS-2024M1071127$MYLAN$$58$YR$$F$Y$77$KG$20240805$$HP$FR$FR
241747921$24174792$1$I$20220701$20240726$20240805$20240805$PER$$US-JNJFOC-20240807362$JOHNSON AND JOHNSON$$$$E$M$Y$131.5$KG$20240805$$MD$US$US
241747942$24174794$2$F$$20240820$20240805$20240829$EXP$$US-TEVA-VS-3228605$TEVA$Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwari A. OVERWHELMING CYTOCHROME P450 ISOENZYME ACTIVITY GENERATING DRUGINDUCED LIVER INJURY RESULTING IN FULMINANT LIVER FAILURE. Hepatology 2023; 78 (Suppl.) S643-S644; Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwari A. OVERWHELMING CYTOCHROME P450 ISOENZYME ACTIVITY GENERATING DRUGINDUCED LIVER INJURY RESULTING IN FULMINANT LIVER FAILURE. Hepatology 2023; 78 (Suppl.) S643-S644.$41$YR$$F$Y$$$20240829$$HP$US$US
241747951$24174795$1$I$$20240725$20240805$20240805$PER$$US-JNJFOC-20240803045$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$MD$US$US
241747961$24174796$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240801496$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$US$US
241747974$24174797$4$F$20240731$20240905$20240805$20240915$30DAY$$US-JNJFOC-20240803426$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240916$$PH$US$US
241747981$24174798$1$I$20240801$20240801$20240805$20240805$PER$$US-JNJFOC-20240802683$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240805$$CN$US$US
241747992$24174799$2$F$20240711$20240724$20240805$20240807$EXP$$US-UCBSA-2024037704$UCB$$26$YR$$M$Y$70.8$KG$20240807$$MD$US$US
241748001$24174800$1$I$20240101$20240729$20240805$20240805$EXP$$FR-VIIV HEALTHCARE LIMITED-FR2024EME054378$VIIV$$$$$$Y$$$20240805$$MD$FR$FR
241748011$24174801$1$I$20240709$20240717$20240805$20240805$EXP$CN-NMPA-3201271886349202400142$CN-Ipsen Biopharmaceuticals, Inc.-2024-15234$IPSEN$$78$YR$E$M$Y$44$KG$20240805$$HP$CN$CN
241748021$24174802$1$I$$20240731$20240805$20240805$EXP$$GB-TAKEDA-2023TUS122020$TAKEDA$$$$$F$Y$97$KG$20240805$$CN$GB$GB
241748031$24174803$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122793$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240805$$CN$US$US
241748041$24174804$1$I$$20240801$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123390$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240805$$CN$US$US
241748051$24174805$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123432$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240805$$CN$US$US
241748061$24174806$1$I$$20240726$20240805$20240805$EXP$$JP-009507513-2407JPN014444$MERCK$$73$YR$$M$Y$$$20240805$$CN$JP$JP
241748071$24174807$1$I$20240301$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123428$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240805$$CN$US$US
241748081$24174808$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122811$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$HP$US$US
241748091$24174809$1$I$20211201$20240729$20240805$20240805$EXP$$KR-TAKEDA-2024TUS076754$TAKEDA$$66$YR$$F$Y$$$20240805$$CN$KR$KR
241748101$24174810$1$I$20240601$20240729$20240805$20240805$PER$$US-SA-2024SA229323$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240805$$MD$US$US
241748111$24174811$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225159$SANOFI AVENTIS$$$$$M$Y$$$20240805$$HP$US$US
241748121$24174812$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225169$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240805$$MD$US$US
241748132$24174813$2$F$20240726$20240807$20240805$20240813$PER$$US-ABBVIE-5861445$ABBVIE$$79$YR$$$Y$$$20240813$$CN$US$US
241748141$24174814$1$I$$20230417$20240805$20240805$EXP$$US-AstraZeneca-2023A090982$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241748151$24174815$1$I$20240724$20240802$20240805$20240805$EXP$$PL-AstraZeneca-2024A176356$ASTRAZENECA$$58$YR$$M$Y$$$20240805$$MD$PL$
241748161$24174816$1$I$$20240730$20240805$20240805$EXP$FR-AFSSAPS-AVMA2024000323$FR-MYLANLABS-2024M1071378$MYLAN$$50$YR$$F$Y$$$20240805$$PH$FR$FR
241748172$24174817$2$F$20240702$20240730$20240805$20240813$EXP$$BR-MYLANLABS-2024M1071958$MYLAN$$$$$$Y$$$20240813$$CN$BR$BR
241748181$24174818$1$I$20240201$20240730$20240805$20240805$EXP$FR-AFSSAPS-GR2024000939$FR-MYLANLABS-2024M1071329$MYLAN$$80$YR$$M$Y$$$20240805$$PH$FR$FR
241748191$24174819$1$I$$20240730$20240805$20240805$EXP$$IT-MYLANLABS-2024M1071091$MYLAN$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al.. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting.. Clinical Therapeutics. 2024;e1-5$77$YR$$F$Y$$$20240805$$MD$IT$IT
241748201$24174820$1$I$$20240730$20240805$20240805$EXP$$IT-MYLANLABS-2024M1071181$MYLAN$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al.. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$88$YR$$M$Y$$$20240805$$MD$IT$IT
241748211$24174821$1$I$$20240729$20240805$20240805$EXP$$CA-BAYER-2024A085477$BAYER$$30$YR$A$F$Y$$$20240805$$HP$CA$CA
241748223$24174822$3$F$20210701$20240814$20240805$20240820$EXP$$PT-MYLANLABS-2024M1071284$MYLAN$Oliveira, Camila.; Queir?z, Lu?sa.; Almeida, Marta.; Fernandes, Ricardo.; Caiero, Cla?dia.. - Coelho, B.; Vicente, E. Challenging case of severe hepatotoxicity with ribociclib. REVISTA PORTUGUESA DE ONCOLOGIA. 2024;7 (N1-2):46-8$45$YR$$F$Y$$$20240820$$HP$PT$PT
241748232$24174823$2$F$20190101$20240807$20240805$20240812$EXP$$US-KYOWAKIRIN-2024KK018556$KYOWA$$$$$$Y$$$20240812$$CN$US$US
241748241$24174824$1$I$20240730$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407020333$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240805$$CN$US$US
241748251$24174825$1$I$$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407020312$ELI LILLY AND CO$$$$$$Y$$$20240805$$CN$US$US
241748261$24174826$1$I$20240625$20240731$20240805$20240805$EXP$ES-AEMPS-1554198$ES-TAKEDA-2024TUS076977$TAKEDA$$58$YR$$M$Y$$$20240805$$HP$ES$ES
241748272$24174827$2$F$$20240919$20240805$20240926$EXP$$JP-AMGEN-JPNSP2024151307$AMGEN$$$$E$F$Y$$$20240926$$HP$JP$JP
241748281$24174828$1$I$$20240805$20240805$20240805$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043783$BOEHRINGER INGELHEIM$$$$$$Y$$$20240805$$CN$US$US
241748291$24174829$1$I$$20240729$20240805$20240805$EXP$$CO-TAKEDA-2024TUS077139$TAKEDA$$$$A$F$Y$$$20240805$$CN$CO$CO
241748301$24174830$1$I$$20240801$20240805$20240805$PER$$US-ABBVIE-5864467$ABBVIE$$$$$$Y$$$20240805$$MD$US$US
241748311$24174831$1$I$20240101$20240528$20240805$20240805$PER$$US-KARYOPHARM-2024KPT001137$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240805$$CN$US$US
241748332$24174833$2$F$20240101$20240808$20240805$20240903$PER$$US-KARYOPHARM-2024KPT001382$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
241748341$24174834$1$I$$20240731$20240805$20240805$EXP$$CA-GENMAB-2024-02823$GENMAB$$$$E$F$Y$$$20240805$$MD$CA$CA
241748351$24174835$1$I$$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152785$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
241748362$24174836$2$F$$20240902$20240805$20240910$EXP$$CA-APOTEX-2024AP008901$APOTEX$$59$YR$$F$Y$$$20240910$$HP$CA$CA
241748371$24174837$1$I$20240620$20240731$20240805$20240805$PER$$DK-Covis Pharma GmbH-2024COV00949$COVIS PHARMA$$70$YR$E$M$Y$77$KG$20240805$$MD$DK$DK
241748381$24174838$1$I$$20240729$20240805$20240805$EXP$$CA-Covis Pharma GmbH-2021COV21942$COVIS PHARMA$$39$YR$A$M$Y$$$20240805$$CN$CA$CA
241748392$24174839$2$F$$20240729$20240805$20240820$EXP$$CA-Covis Pharma GmbH-2021COV21938$COVIS PHARMA$$48$YR$A$M$Y$69$KG$20240820$$MD$CA$CA
241748401$24174840$1$I$20240101$20240731$20240805$20240805$PER$$US-AMGEN-USASP2024152899$AMGEN$$77$YR$E$F$Y$$$20240805$$MD$US$US
241748411$24174841$1$I$$20240212$20240805$20240805$EXP$CA-DRL-USA-SPO/CAN/24/0002809$CA-RDY-SPO/CAN/24/0002809$DR REDDYS$$64$YR$A$F$Y$$$20240805$$HP$CA$CA
241748421$24174842$1$I$20210702$20240218$20240805$20240805$EXP$GB-MHRA-MED-202402151236563720-VYJMN$GB-RDY-SPO/GBR/24/0003304$DR REDDYS$$61$YR$A$F$Y$$$20240805$$MD$GB$GB
241748432$24174843$2$F$$20240802$20240805$20240809$EXP$$BR-GSK-BR2024AMR005275$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$BR$BR
241748441$24174844$1$I$20240701$20240725$20240805$20240805$PER$$US-MYLANLABS-2024M1070189$MYLAN$$$$$F$Y$$$20240805$$CN$US$US
241748451$24174845$1$I$20240424$20240425$20240805$20240805$PER$$US-KARYOPHARM-2024KPT000952$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240805$$CN$US$US
241748461$24174846$1$I$$20240731$20240805$20240805$EXP$$US-AMGEN-USASP2024153013$AMGEN$$$$A$$Y$$$20240805$$CN$US$US
241748481$24174848$1$I$$20240802$20240805$20240805$PER$$US-ABBVIE-5866765$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241748491$24174849$1$I$20240524$20240801$20240805$20240805$EXP$$SE-ANIPHARMA-2024-SE-000022$ANI$$90$YR$$F$Y$$$20240805$$MD$SE$SE
241748501$24174850$1$I$$20240805$20240805$20240805$PER$$US-JNJFOC-20240809948$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$HP$US$US
241748512$24174851$2$F$20240721$20240905$20240805$20240908$EXP$$JP-ALXN-202408JPN000012JP$ALEXION PHARMACEUTICALS$$79$YR$$M$Y$$$20240908$$MD$JP$JP
241748521$24174852$1$I$$20240801$20240805$20240805$EXP$$US-KYOWAKIRIN-2024KK018603$KYOWA$$$$$$Y$$$20240805$$HP$US$US
241748531$24174853$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123170$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240805$$CN$US$US
241748541$24174854$1$I$$20240715$20240805$20240805$EXP$SE-SEMPA-2024-004576$SE-TAKEDA-2024TUS077986$TAKEDA$$75$YR$$F$Y$$$20240805$$HP$SE$SE
241748551$24174855$1$I$20240101$20240731$20240805$20240805$EXP$$DE-AMGEN-DEUSP2024152911$AMGEN$$60$YR$A$F$Y$$$20240805$$MD$DE$DE
241748562$24174856$2$F$20240722$20240807$20240805$20240821$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002102$CORCEPT$$$$$$Y$$$20240821$$MD$US$US
241748571$24174857$1$I$20230101$20240729$20240805$20240805$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2023CUR004434$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$CA$CA
241748581$24174858$1$I$$20240801$20240805$20240805$EXP$$GB-JNJFOC-20240809693$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$GB$GB
241748591$24174859$1$I$20240608$20240802$20240805$20240805$EXP$$US-TAKEDA-2024TUS059265$TAKEDA$$78$YR$$F$Y$$$20240805$$MD$US$US
241748601$24174860$1$I$$20240730$20240805$20240805$EXP$$US-AstraZeneca-2024A174178$ASTRAZENECA$$$$$F$Y$63.5$KG$20240805$$CN$US$
241748612$24174861$2$F$$20240828$20240805$20240905$EXP$$ZA-AstraZeneca-2024A174851$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$ZA$
241748623$24174862$3$F$$20240912$20240805$20240918$EXP$$US-GILEAD-2024-0681091$GILEAD$$$$E$F$Y$$$20240918$$CN$US$US
241748631$24174863$1$I$$20230511$20240805$20240805$EXP$$US-AstraZeneca-2023A110963$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241748642$24174864$2$F$20240724$20240815$20240805$20240815$EXP$$US-BAYER-2024A112900$BAYER$$88$YR$E$M$Y$$$20240815$$CN$US$US
241748651$24174865$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122967$BRISTOL MYERS SQUIBB$$83$YR$E$$Y$$$20240805$$HP$US$US
241748671$24174867$1$I$$20240731$20240805$20240805$EXP$$US-BAUSCH-BL-2024-011726$BAUSCH AND LOMB$$$$$$Y$$$20240805$$PH$US$US
241748681$24174868$1$I$$20240729$20240805$20240805$EXP$$FR-AMGEN-FRANI2024150750$AMGEN$$72$YR$E$F$Y$$$20240805$$HP$FR$FR
241748692$24174869$2$F$20240724$20240801$20240805$20240813$EXP$$NVSC2024CN158190$NOVARTIS$$74$YR$$F$Y$$$20240813$$HP$CN$CN
241748712$24174871$2$F$$20240814$20240805$20240828$PER$$US-SA-2024SA229280$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240828$$MD$US$US
241748722$24174872$2$F$$20240911$20240805$20240911$30DAY$$CL-PFIZER INC-202400223891$PFIZER$$$$$$Y$$$20240911$$CN$CL$CL
241748731$24174873$1$I$20240701$20240729$20240805$20240805$PER$$US-SA-2024SA225173$SANOFI AVENTIS$$23$YR$A$F$Y$86.18$KG$20240805$$MD$US$US
241748741$24174874$1$I$20240601$20240730$20240805$20240805$PER$$US-SA-2024SA227279$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240805$$MD$US$US
241748751$24174875$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA227041$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240805$$MD$US$US
241748761$24174876$1$I$20240101$20240727$20240805$20240805$PER$$US-SA-2024SA227517$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240805$$MD$US$US
241748771$24174877$1$I$20240728$20240729$20240805$20240805$PER$$US-SA-2024SA227405$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240805$$CN$US$US
241748782$24174878$2$F$20240101$20240829$20240805$20240911$PER$$US-SA-2024SA227798$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240911$$MD$US$US
241748791$24174879$1$I$$20240801$20240805$20240805$PER$$US-JNJFOC-20240804986$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240805$$CN$US$US
241748801$24174880$1$I$20240718$20240731$20240805$20240805$EXP$$CN-DSJP-DSJ-2024-138417$DAIICHI$$65$YR$$F$Y$41$KG$20240805$$HP$CN$CN
241748812$24174881$2$F$20240312$20240917$20240805$20240920$EXP$FR-AFSSAPS-PP2024000836$FR-009507513-2407FRA015352$MERCK$$48$YR$$F$Y$93$KG$20240920$$MD$FR$FR
241748822$24174882$2$F$$20240822$20240805$20240823$PER$$US-ALXN-202407USA002173US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241748843$24174884$3$F$$20240730$20240805$20240819$PER$$NVSC2024US157337$NOVARTIS$$82$YR$$M$Y$$$20240819$$PH$US$US
241748851$24174885$1$I$$20240730$20240805$20240805$PER$$US-ALXN-202407USA002189US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241748861$24174886$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123436$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240805$$CN$US$US
241748873$24174887$3$F$20240328$20240814$20240805$20240823$EXP$FR-AFSSAPS-AN2024000959$FR-TEVA-VS-3228869$TEVA$$66$YR$$M$Y$$$20240823$$MD$FR$FR
241748881$24174888$1$I$$20240725$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123506$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$150.14$KG$20240805$$HP$US$US
241748891$24174889$1$I$$20240801$20240805$20240805$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-122940$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240805$$HP$TW$TW
241748902$24174890$2$F$20240724$20240917$20240805$20240924$EXP$$DE-BAXTER-2024BAX022481$BAXTER$$61$YR$$M$Y$$$20240924$$HP$DE$DE
241748911$24174891$1$I$$20191231$20240805$20240805$EXP$$CA-Covis Pharma GmbH-2021COV21924$COVIS PHARMA$$59$YR$A$F$Y$$$20240805$$$COUNTRY NOT SPECIFIED$CA
241748921$24174892$1$I$$20191230$20240805$20240805$EXP$$CA-Covis Pharma GmbH-2021COV21778$COVIS PHARMA$$70$YR$E$M$Y$$$20240805$$$COUNTRY NOT SPECIFIED$CA
241748942$24174894$2$F$20240701$20240806$20240805$20240809$EXP$$US-KYOWAKIRIN-2024KK018642$KYOWA$$$$$$Y$$$20240809$$HP$US$US
241748952$24174895$2$F$20240101$20240808$20240805$20240813$EXP$$DE-JNJFOC-20240801452$JOHNSON AND JOHNSON$$56$YR$A$F$Y$68$KG$20240813$$MD$DE$DE
241748962$24174896$2$F$$20240902$20240805$20240904$PER$$US-JNJFOC-20240806029$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240904$$CN$US$US
241748981$24174898$1$I$20240101$20240731$20240805$20240805$EXP$$CA-PFIZER INC-202400229487$PFIZER$$78$YR$$M$Y$111$KG$20240805$$CN$CA$CA
241748991$24174899$1$I$$20240731$20240805$20240805$EXP$$CA-PFIZER INC-202400227604$PFIZER$$13$YR$$M$Y$$$20240805$$HP$CA$CA
241749001$24174900$1$I$$20240731$20240805$20240805$EXP$GB-MHRA-31372529$GB-PFIZER INC-202400227591$PFIZER$$72$YR$$F$Y$$$20240805$$PH$GB$GB
241749011$24174901$1$I$$20240731$20240805$20240805$EXP$$BE-PFIZER INC-PV202400099983$PFIZER$Stabel, C.. Sulfasalazine-Induced Epstein-Barr Virus-Positive Mucocutaneous Ulcer. Case Reports in Hematology. 2024;2024:10.1155/2024/6883657$68$YR$$M$Y$$$20240805$$HP$BE$BE
241749021$24174902$1$I$$20240731$20240805$20240805$EXP$$JP-PFIZER INC-202400227763$PFIZER$$$$E$M$Y$$$20240805$$MD$JP$JP
241749031$24174903$1$I$20231222$20240730$20240805$20240805$EXP$FR-AFSSAPS-NY2024000853$FR-PFIZER INC-202400229059$PFIZER$$65$YR$$M$Y$70$KG$20240805$$MD$FR$FR
241749041$24174904$1$I$20240101$20240731$20240805$20240805$EXP$$CA-PFIZER INC-202300179913$PFIZER$$77$YR$$M$Y$111$KG$20240805$$HP$CA$CA
241749051$24174905$1$I$$20240725$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123525$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$150.14$KG$20240805$$HP$US$US
241749061$24174906$1$I$$20240801$20240805$20240805$PER$$US-AMGEN-USASP2024153387$AMGEN$Farouji A.; Kloub M. N.; Haddad A. W. et al.. A RARE CASE OF MEMBRANOUS NEPHROPATHY COMPLICATED BY CHYLOTHORAX. European Journal of Case Reports in Internal Medicine. 2024;11$66$YR$E$F$Y$$$20240805$$HP$US$US
241749071$24174907$1$I$$20240801$20240805$20240805$EXP$$CN-TAKEDA-2022TUS048028$TAKEDA$$$$$M$Y$$$20240805$$CN$CN$CN
241749082$24174908$2$F$$20240827$20240805$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122416$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240829$$CN$US$US
241749101$24174910$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5858397$ABBVIE$$$$$$Y$$$20240805$$HP$US$US
241749111$24174911$1$I$$20240729$20240805$20240805$PER$$US-ABBVIE-5859791$ABBVIE$$$$$F$Y$$$20240805$$HP$US$US
241749121$24174912$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-PV202400101027$PFIZER$$58$YR$$F$Y$$$20240805$$HP$US$US
241749131$24174913$1$I$$20240724$20240805$20240805$30DAY$$CO-PFIZER INC-PV202400097216$PFIZER$$$$$$Y$$$20240805$$CN$CO$CO
241749141$24174914$1$I$$20240728$20240805$20240805$EXP$$US-AMGEN-USASP2024152882$AMGEN$Elwood K. F.; Warner E. J.; Chang J. S. et al.. Aspergillus Endophthalmitis Secondary to Infectious Scleritis: Utility of Diagnostic PCR. Retinal cases + brief reports. 2024;1-15$76$YR$E$M$Y$$$20240805$$MD$US$US
241749151$24174915$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-PV202400100928$PFIZER$$44$YR$$F$Y$$$20240805$$PH$US$US
241749161$24174916$1$I$20240801$20240801$20240805$20240805$PER$$US-PFIZER INC-PV202400101176$PFIZER$$57$YR$$F$Y$$$20240805$$HP$US$US
241749172$24174917$2$F$$20240814$20240805$20240816$PER$$US-PFIZER INC-202400200076$PFIZER$$57$YR$$F$Y$$$20240816$$MD$US$US
241749181$24174918$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-202400228724$PFIZER$$34$YR$$M$Y$$$20240805$$MD$US$US
241749191$24174919$1$I$20240718$20240801$20240805$20240805$PER$$US-PFIZER INC-202400229031$PFIZER$$41$YR$$F$Y$$$20240805$$HP$US$US
241749201$24174920$1$I$20240728$20240801$20240805$20240805$PER$$US-PFIZER INC-202400228628$PFIZER$$53$YR$$M$Y$$$20240805$$CN$US$US
241749211$24174921$1$I$20240729$20240801$20240805$20240805$PER$$US-PFIZER INC-202400228854$PFIZER$$$$$$Y$$$20240805$$CN$US$US
241749231$24174923$1$I$20240101$20240731$20240805$20240805$PER$$US-PFIZER INC-PV202400100989$PFIZER$$28$YR$$F$Y$$$20240805$$HP$US$US
241749242$24174924$2$F$$20240802$20240805$20240808$PER$$US-PFIZER INC-202400228609$PFIZER$$67$YR$$F$Y$$$20240808$$CN$US$US
241749253$24174925$3$F$20240730$20240816$20240805$20240821$PER$$US-PFIZER INC-202400228385$PFIZER$$79$YR$$F$Y$67.59$KG$20240821$$CN$US$US
241749261$24174926$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-PV202400100816$PFIZER$$53$YR$$$Y$$$20240805$$CN$US$US
241749272$24174927$2$F$$20240804$20240805$20240807$PER$$US-PFIZER INC-202400228960$PFIZER$$$$$$Y$$$20240807$$MD$US$US
241749281$24174928$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-202400228837$PFIZER$$66$YR$$F$Y$$$20240805$$CN$US$US
241749291$24174929$1$I$20240731$20240801$20240805$20240805$PER$$US-PFIZER INC-202400228774$PFIZER$$40$YR$$F$Y$$$20240805$$HP$US$US
241749311$24174931$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-PV202300208838$PFIZER$$86$YR$$F$Y$$$20240805$$MD$US$US
241749321$24174932$1$I$20240501$20240801$20240805$20240805$PER$$US-PFIZER INC-202400229165$PFIZER$$$$$F$Y$$$20240805$$HP$US$US
241749332$24174933$2$F$20240701$20240918$20240805$20240923$PER$$US-PFIZER INC-PV202400100822$PFIZER$$54$YR$$F$Y$$$20240923$$HP$US$US
241749341$24174934$1$I$20240717$20240801$20240805$20240805$PER$$US-PFIZER INC-202400228848$PFIZER$$37$YR$$F$Y$$$20240805$$CN$US$US
241749352$24174935$2$F$$20240823$20240805$20240829$PER$$US-PFIZER INC-202400228973$PFIZER$$38$YR$$F$Y$$$20240829$$HP$US$US
241749361$24174936$1$I$20240101$20240801$20240805$20240805$PER$$US-PFIZER INC-202400229197$PFIZER$$67$YR$$F$Y$$$20240805$$HP$US$US
241749371$24174937$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-PV202400100873$PFIZER$$87$YR$$F$Y$$$20240805$$CN$US$US
241749381$24174938$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-PV202400101110$PFIZER$$85$YR$$M$Y$$$20240805$$HP$US$US
241749391$24174939$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-202400228675$PFIZER$$73$YR$$F$Y$$$20240805$$CN$US$US
241749401$24174940$1$I$20240101$20240801$20240805$20240805$PER$$US-PFIZER INC-202400229062$PFIZER$$60$YR$$F$Y$$$20240805$$HP$US$US
241749411$24174941$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-PV202400100897$PFIZER$$42$YR$$F$Y$$$20240805$$HP$US$US
241749422$24174942$2$F$$20240911$20240805$20240911$30DAY$$CL-PFIZER INC-202400223957$PFIZER$$$$$M$Y$$$20240911$$CN$CL$CL
241749431$24174943$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-PV202400093622$PFIZER$$53$YR$$F$Y$$$20240805$$CN$US$US
241749441$24174944$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-202400228713$PFIZER$$$$A$F$Y$$$20240805$$MD$US$US
241749451$24174945$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-202400228982$PFIZER$$55$YR$$F$Y$$$20240805$$HP$US$US
241749462$24174946$2$F$20240701$20240821$20240805$20240823$EXP$$BR-BEIGENE-BGN-2024-012147$BEIGENE$$$$$$Y$$$20240823$$MD$BR$BR
241749481$24174948$1$I$$20240801$20240805$20240805$EXP$$GB-JNJFOC-20240805670$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240805$$HP$GB$GB
241749491$24174949$1$I$$20240731$20240805$20240805$EXP$$ZA-AstraZeneca-2024A175468$ASTRAZENECA$$24471$DY$$F$Y$$$20240805$$CN$ZA$
241749501$24174950$1$I$$20240801$20240805$20240805$EXP$$RU-AstraZeneca-2024A176330$ASTRAZENECA$$58$YR$$F$Y$$$20240805$$MD$RU$
241749512$24174951$2$F$20240510$20240728$20240805$20240808$EXP$$PT-AstraZeneca-2024A121188$ASTRAZENECA$$65$YR$$F$Y$62$KG$20240808$$MD$PT$
241749521$24174952$1$I$$20240730$20240805$20240805$PER$$US-ALXN-202407USA002141US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241749531$24174953$1$I$20240101$20240801$20240805$20240805$EXP$$US-KYOWAKIRIN-2024KK018654$KYOWA$$$$$$Y$$$20240805$$HP$US$US
241749541$24174954$1$I$20211101$20240723$20240805$20240805$EXP$$AU-AstraZeneca-2024A176271$ASTRAZENECA$$$$$M$Y$$$20240805$$MD$AU$
241749551$24174955$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA223191$SANOFI AVENTIS$$$$A$M$Y$79.3$KG$20240805$$MD$US$US
241749562$24174956$2$F$20240101$20240731$20240805$20240809$EXP$$JP-009507513-2401JPN002420J$MERCK$$8$DEC$$M$Y$$$20240809$$MD$JP$JP
241749571$24174957$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA229332$SANOFI AVENTIS$$$$A$F$Y$63.5$KG$20240805$$HP$US$US
241749591$24174959$1$I$$20240723$20240805$20240805$PER$$US-SA-2024SA224543$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240805$$CN$US$US
241749611$24174961$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA226633$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240805$$CN$US$US
241749621$24174962$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA225669$SANOFI AVENTIS$$$$E$F$Y$$$20240805$$MD$US$US
241749631$24174963$1$I$20210601$20240729$20240805$20240805$PER$$US-SA-2024SA227699$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240805$$MD$US$US
241749642$24174964$2$F$20240730$20240802$20240805$20240811$PER$$US-SA-2024SA225253$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240811$$HP$US$US
241749651$24174965$1$I$20240701$20240731$20240805$20240805$PER$$US-SA-2024SA228432$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240805$$MD$US$US
241749662$24174966$2$F$20240730$20240829$20240805$20240906$30DAY$$US-AMGEN-USASP2024151192$AMGEN$$$$$M$Y$$$20240906$$CN$US$US
241749671$24174967$1$I$20240708$20240802$20240805$20240805$EXP$$CN-PFIZER INC-PV202400101230$PFIZER$$68$YR$$F$Y$40$KG$20240805$$HP$CN$CN
241749681$24174968$1$I$$20240802$20240805$20240805$EXP$$JP-PFIZER INC-202400228634$PFIZER$$$$$$Y$$$20240805$$PH$JP$JP
241749711$24174971$1$I$20240719$20240731$20240805$20240805$EXP$$CN-PFIZER INC-PV202400100048$PFIZER$$68$YR$$F$Y$$$20240805$$HP$CN$CN
241749722$24174972$2$F$20240520$20240929$20240805$20240930$EXP$$PK-PFIZER INC-PV202400036324$PFIZER$$37$YR$$M$Y$64$KG$20240930$$CN$PK$PK
241749731$24174973$1$I$20090817$20240801$20240805$20240805$EXP$$FR-PFIZER INC-202400227950$PFIZER$$56$YR$$M$Y$$$20240805$$MD$FR$FR
241749742$24174974$2$F$$20240822$20240805$20240826$EXP$$GB-MYLANLABS-2024M1070137$MYLAN$$$$$M$Y$$$20240826$$PH$GB$GB
241749751$24174975$1$I$$20240722$20240805$20240805$EXP$$TR-NOVOPROD-1263394$NOVO NORDISK$$$$$F$Y$$$20240805$$CN$TR$TR
241749771$24174977$1$I$20180315$20240731$20240805$20240805$EXP$$NVSC2021DE054966$NOVARTIS$$67$YR$$F$Y$70$KG$20240805$$MD$DE$DE
241749782$24174978$2$F$$20240819$20240805$20240827$30DAY$$US-GSK-US2024094283$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
241749791$24174979$1$I$$20240730$20240805$20240805$EXP$$JP-DSJP-DSJ-2024-138244$DAIICHI$Nakagawa J, Ishido K, Kimura N, Nagase H, Wakasa Y, Yokoyama S, et al.. O-06 A patient with AKI who had a combination of clarithromycin and rifampicin in which the active metabolite M-4 of edoxaban showed abnormally high value/The 7th Hokkaido and Tohoku Association for the Japanese Society of Clinical Pharmacology and Therapeutics. See Journal Title following Article Title. 2024;27$68$YR$$M$Y$$$20240805$$PH$JP$JP
241749802$24174980$2$F$$20240820$20240805$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202407019738$ELI LILLY AND CO$$21$YR$A$M$Y$$$20240821$$CN$US$US
241749811$24174981$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001003$ELI LILLY AND CO$$$$$F$Y$$$20240805$$CN$US$US
241749821$24174982$1$I$$20240802$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408002326$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240805$$CN$US$US
241749831$24174983$1$I$20240501$20240729$20240805$20240805$PER$$US-SA-2024SA228749$SANOFI AVENTIS$$63$YR$A$F$Y$76.2$KG$20240805$$MD$US$US
241749843$24174984$3$F$20240722$20240801$20240805$20240808$EXP$$DE-PFIZER INC-202400228237$PFIZER$$70$YR$$M$Y$76$KG$20240808$$HP$DE$DE
241749851$24174985$1$I$$20240801$20240805$20240805$EXP$$TR-PFIZER INC-PV202400100923$PFIZER$Isbilen, G.. Intrathecal Tigecycline in the Treatment of Hospital-Acquired Meningitis: A Review of Four Cases. Surgical infections. 2024;10.1089/sur.2024.063$55$YR$$M$Y$$$20240805$$HP$TR$TR
241749861$24174986$1$I$20230920$20240726$20240805$20240805$EXP$$US-TEVA-VS-3228318$TEVA$$$$I$F$Y$$$20240805$$HP$US$US
241749871$24174987$1$I$20230210$20240729$20240805$20240805$PER$$CA-Covis Pharma GmbH-2024COV00937$COVIS PHARMA$$65$YR$E$F$Y$$$20240805$$CN$CA$CA
241749881$24174988$1$I$$20240723$20240805$20240805$PER$$US-Covis Pharma GmbH-2024COV00942$COVIS PHARMA$$79$YR$E$M$Y$$$20240805$$CN$US$US
241749891$24174989$1$I$$20231117$20240805$20240805$EXP$$AU-SANDOZ INC.-SDZ2023AU056002$SANDOZ$$$$$$Y$$$20240805$$CN$AU$AU
241749901$24174990$1$I$$20240731$20240805$20240805$PER$$US-TAKEDA-2024TUS077891$TAKEDA$$$$$F$Y$$$20240805$$PH$US$US
241749911$24174991$1$I$$20231116$20240805$20240805$EXP$$AU-SANDOZ INC.-SDZ2023AU055171$SANDOZ$$$$$$Y$$$20240805$$HP$AU$AU
241749921$24174992$1$I$20240710$20240730$20240805$20240805$EXP$$JP-DSJP-DSJ-2024-138009$DAIICHI$$75$YR$$M$Y$71$KG$20240805$$HP$JP$JP
241749931$24174993$1$I$20240712$20240726$20240805$20240805$30DAY$$US-GSK-US2024094288$GLAXOSMITHKLINE$$80$YR$$M$Y$$$20240805$$CN$US$US
241749942$24174994$2$F$$20240726$20240805$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR094130$VIIV$$$$A$M$Y$$$20240809$$CN$US$US
241749951$24174995$1$I$20240706$20240731$20240805$20240805$EXP$$CN-ROCHE-10000047161$ROCHE$$81$YR$E$F$Y$$$20240805$$HP$CN$CN
241749961$24174996$1$I$$20240522$20240805$20240805$PER$$US-ABBVIE-5866215$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241749971$24174997$1$I$$20240724$20240805$20240805$PER$$US-ABBVIE-5856457$ABBVIE$$28$YR$$M$Y$$$20240805$$MD$US$US
241749982$24174998$2$F$20210101$20240813$20240805$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2021-US-016392$JAZZ$$$$$M$Y$$$20240819$$MD$US$US
241749994$24174999$4$F$$20240916$20240805$20240918$PER$$NVSC2024US159168$NOVARTIS$$$$$M$Y$$$20240918$$HP$US$US
241750001$24175000$1$I$$20240801$20240805$20240805$PER$$NVSC2024US159170$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241750011$24175001$1$I$20240401$20240731$20240805$20240805$EXP$$NVSC2024BR158422$NOVARTIS$$82$YR$$M$Y$$$20240805$$CN$BR$BR
241750031$24175003$1$I$$20240731$20240805$20240805$PER$$US-ROCHE-10000046188$ROCHE$$$$$$Y$$$20240805$$HP$US$US
241750041$24175004$1$I$$20240627$20240805$20240805$PER$$US-ROCHE-10000011680$ROCHE$$$$$$Y$$$20240805$$PH$US$US
241750051$24175005$1$I$20240617$20240730$20240805$20240805$EXP$FR-AFSSAPS-BX2024001453$FR-MYLANLABS-2024M1071120$MYLAN$$42$YR$$M$Y$58.5$KG$20240805$$MD$FR$FR
241750062$24175006$2$F$$20240725$20240805$20240809$EXP$$CA-AstraZeneca-2024A170152$ASTRAZENECA$$$$$M$Y$$$20240809$$HP$CA$
241750071$24175007$1$I$$20240730$20240805$20240805$EXP$$PT-MYLANLABS-2024M1071187$MYLAN$$71$YR$$M$Y$$$20240805$$MD$PT$PT
241750081$24175008$1$I$20220701$20240730$20240805$20240805$EXP$FR-AFSSAPS-RS2024000730$FR-MYLANLABS-2024M1071368$MYLAN$$70$YR$$M$Y$63$KG$20240805$$PH$FR$FR
241750091$24175009$1$I$20240618$20240730$20240805$20240805$EXP$FR-AFSSAPS-MA2024001093$FR-MYLANLABS-2024M1071622$MYLAN$$33$YR$$F$Y$$$20240805$$CN$FR$FR
241750101$24175010$1$I$20140101$20240730$20240805$20240805$EXP$$FR-MYLANLABS-2024M1071197$MYLAN$Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs).. Pharmacological intolerance vs Ig E-mediated allergy.. 2024;49:5-6$39$YR$$$Y$$$20240805$$HP$FR$FR
241750111$24175011$1$I$$20240726$20240805$20240805$EXP$$LB-MYLANLABS-2024M1072689$MYLAN$Salem J, Fares F, El-Haddad R, Fares M, El-Helou G. Legionella lymphadenitis in immunocompetent adult: Case report. IDCases 2024; 37 (0):.$53$YR$$F$Y$$$20240805$$HP$LB$LB
241750121$24175012$1$I$20240201$20240730$20240805$20240805$EXP$SE-SEMPA-2024-001497$SE-MYLANLABS-2024M1071455$MYLAN$$81$YR$$F$Y$$$20240805$$PH$SE$SE
241750131$24175013$1$I$$20240730$20240805$20240805$EXP$$IT-MYLANLABS-2024M1071179$MYLAN$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al.. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case?Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5$80$YR$$F$Y$$$20240805$$MD$IT$IT
241750141$24175014$1$I$20240420$20240730$20240805$20240805$EXP$ES-AEMPS-1552206$ES-MYLANLABS-2024M1071444$MYLAN$$75$YR$$M$Y$$$20240805$$MD$ES$ES
241750151$24175015$1$I$$20240731$20240805$20240805$EXP$$US-MYLANLABS-2024M1072830$MYLAN$$$$$M$Y$$$20240805$$CN$US$US
241750161$24175016$1$I$$20240802$20240805$20240805$EXP$$KR-PFIZER INC-202400229121$PFIZER$$9$DEC$$$Y$$$20240805$$MD$KR$KR
241750171$24175017$1$I$$20240801$20240805$20240805$EXP$GB-MHRA-31377350$GB-PFIZER INC-202400228199$PFIZER$$$$$$Y$$$20240805$$CN$GB$GB
241750181$24175018$1$I$$20240801$20240805$20240805$EXP$$US-PFIZER INC-202400228704$PFIZER$$73$YR$$F$Y$55.329$KG$20240805$$CN$US$US
241750191$24175019$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000047518$ROCHE$$$$$$Y$$$20240805$$PH$US$US
241750201$24175020$1$I$$20240724$20240805$20240805$PER$$US-JNJFOC-20240772494$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$US$US
241750211$24175021$1$I$20240709$20240731$20240805$20240805$PER$$CN-Eisai-EC-2024-171416$EISAI$$76$YR$E$M$Y$$$20240805$$HP$CN$CN
241750221$24175022$1$I$20240725$20240730$20240805$20240805$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-138164$DAIICHI$$$$$F$Y$$$20240805$$CN$US$US
241750231$24175023$1$I$$20231102$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2023CA003243$SANDOZ$$$$$$Y$$$20240805$$HP$CA$CA
241750241$24175024$1$I$20231201$20240801$20240805$20240805$PER$$US-Eisai-EC-2024-171467$EISAI$$74$YR$E$M$Y$101$KG$20240805$$CN$US$US
241750252$24175025$2$F$$20240820$20240805$20240826$PER$$US-ROCHE-10000038987$ROCHE$$$$C$M$Y$72.57$KG$20240826$$CN$US$US
241750261$24175026$1$I$$20240731$20240805$20240805$PER$$US-ROCHE-10000046166$ROCHE$$$$A$F$Y$$$20240805$$CN$US$US
241750271$24175027$1$I$$20231013$20240805$20240805$EXP$$CA-SANDOZ INC.-SDZ2023CA043313$SANDOZ$$$$$$Y$$$20240805$$HP$CA$CA
241750281$24175028$1$I$$20240802$20240805$20240805$PER$$US-BAUSCH-BL-2024-011811$BAUSCH AND LOMB$$32$YR$$F$Y$$$20240805$$MD$US$US
241750291$24175029$1$I$20240701$20240726$20240805$20240805$PER$$US-SA-2024SA224868$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240805$$MD$US$US
241750301$24175030$1$I$$20240725$20240805$20240805$PER$$US-SA-2024SA224276$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240805$$MD$US$US
241750311$24175031$1$I$20220723$20240726$20240805$20240805$PER$$US-SA-2024SA226438$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240805$$MD$US$US
241750321$24175032$1$I$$20240722$20240805$20240805$EXP$$AT-ORGANON-O2408AUT000222$ORGANON$$$$$F$Y$$$20240805$$MD$AT$AT
241750331$24175033$1$I$20240101$20240731$20240805$20240805$PER$$US-SA-2024SA227828$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240805$$MD$US$US
241750341$24175034$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227573$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240805$$MD$US$US
241750352$24175035$2$F$20240729$20240730$20240805$20240808$PER$$US-SA-2024SA227108$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240808$$MD$US$US
241750362$24175036$2$F$20240701$20240827$20240805$20240911$PER$$US-SA-2024SA227716$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240911$$MD$US$US
241750372$24175037$2$F$$20240802$20240805$20240813$PER$$US-SA-2024SA228010$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240814$$MD$US$US
241750381$24175038$1$I$20220101$20240730$20240805$20240805$PER$$US-SA-2024SA227056$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240805$$CN$US$US
241750391$24175039$1$I$$20240802$20240805$20240805$PER$$NVSC2024US159147$NOVARTIS$$62$YR$$M$Y$$$20240805$$MD$US$US
241750401$24175040$1$I$20140101$20240730$20240805$20240805$EXP$$NVSC2024HN158442$NOVARTIS$$$$$M$Y$$$20240805$$CN$HN$HN
241750412$24175041$2$F$20240101$20240826$20240805$20240910$PER$$US-SA-2024SA229086$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240910$$MD$US$US
241750422$24175042$2$F$20240731$20240821$20240805$20240828$PER$$NVSC2024US159143$NOVARTIS$$75$YR$$F$Y$73.5$KG$20240828$$HP$US$US
241750431$24175043$1$I$20240329$20240729$20240805$20240805$EXP$$NVSC2024FR158316$NOVARTIS$$61$YR$$M$Y$67.7$KG$20240805$$CN$FR$FR
241750451$24175045$1$I$20240110$20240730$20240805$20240805$PER$$US-INCYTE CORPORATION-2024IN007988$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241750471$24175047$1$I$20240101$20240731$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121842$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240805$$HP$US$US
241750481$24175048$1$I$$20240801$20240805$20240805$EXP$$US-GILEAD-2024-0682838$GILEAD$$$$C$F$Y$$$20240805$$CN$US$US
241750491$24175049$1$I$$20240801$20240805$20240805$EXP$$NVSC2024US158067$NOVARTIS$$$$$M$Y$$$20240805$$CN$US$US
241750501$24175050$1$I$$20230929$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2023US036629$SANDOZ$Agarwal R, Czechowicz A, Felber M, Klinger E, Saini G, Kunte N et al. TCRa?+  T-Cell/CD19+  B-Cell Depleted Haploidentical Stem Cell Transplantation for Fanconi Anemia: The Stanford Children^s Experience. Transplantation and Cellular Therapy. 2023;29(2):S282-83$$$$$Y$$$20240805$$HP$US$US
241750511$24175051$1$I$20240601$20240731$20240805$20240805$EXP$$NVSC2024GT158530$NOVARTIS$$65$YR$$F$Y$$$20240805$$CN$GT$GT
241750521$24175052$1$I$$20240726$20240805$20240805$EXP$$NVSC2024US154715$NOVARTIS$$48$YR$$F$Y$$$20240805$$CN$US$US
241750532$24175053$2$F$$20240911$20240805$20240917$EXP$$NVSC2024DE157544$NOVARTIS$$$$A$M$Y$$$20240917$$CN$DE$DE
241750541$24175054$1$I$20240620$20240730$20240805$20240805$EXP$$NVSC2024CN157866$NOVARTIS$$79$YR$$F$Y$79$KG$20240805$$HP$CN$CN
241750551$24175055$1$I$$20240726$20240805$20240805$30DAY$$US-GSK-US2024094297$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$HP$US$US
241750561$24175056$1$I$$20240731$20240805$20240805$PER$$US-BIOVITRUM-2024-US-010521$BIOVITRUM$$41$YR$$F$Y$$$20240805$$CN$US$US
241750571$24175057$1$I$$20240730$20240805$20240805$PER$$PR-JNJFOC-20240801184$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$MD$PR$PR
241750582$24175058$2$F$$20240820$20240805$20240820$PER$$US-JNJFOC-20240785510$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240820$$PH$US$US
241750591$24175059$1$I$20240701$20240731$20240805$20240805$PER$$US-BIOVITRUM-2024-US-010543$BIOVITRUM$$72$YR$E$M$Y$$$20240805$$CN$US$US
241750601$24175060$1$I$$20240805$20240805$20240805$EXP$BE-EMA-DD-20240730-7482653-064835$BE-SANDOZ INC.-SDZ2024BE070390$SANDOZ$$73$YR$$M$Y$$$20240805$$HP$BE$BE
241750611$24175061$1$I$$20240729$20240805$20240805$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-15100$IPSEN$$$$$M$Y$$$20240805$$HP$US$US
241750621$24175062$1$I$$20240802$20240805$20240805$EXP$$NVSC2024GB158779$NOVARTIS$$$$$F$Y$$$20240805$$CN$GB$GB
241750632$24175063$2$F$20240904$20240904$20240805$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US070223$SANDOZ$$60$YR$$M$Y$$$20240909$$CN$US$US
241750642$24175064$2$F$20240630$20240807$20240805$20240809$EXP$PT-INFARMED-T202407-736$PT-GILEAD-2024-0682903$GILEAD$$60$YR$A$M$Y$76$KG$20240809$$PH$PT$PT
241750651$24175065$1$I$20210301$20240729$20240805$20240805$EXP$$US-MYLANLABS-2024M1070462$MYLAN$$78$YR$$M$Y$74.38$KG$20240805$$CN$US$US
241750661$24175066$1$I$$20230713$20240805$20240805$EXP$$US-AstraZeneca-2023A161316$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241750671$24175067$1$I$$20230925$20240805$20240805$EXP$$US-AstraZeneca-2023A219197$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241750681$24175068$1$I$$20221007$20240805$20240805$EXP$$US-AstraZeneca-2022A342527$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241750691$24175069$1$I$20240419$20240723$20240805$20240805$EXP$$AU-AstraZeneca-2024A176323$ASTRAZENECA$$85$YR$$F$Y$$$20240805$$MD$AU$
241750701$24175070$1$I$$20230710$20240805$20240805$EXP$$US-AstraZeneca-2023A158402$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241750711$24175071$1$I$$20240805$20240805$20240805$EXP$$FR-SANDOZ INC.-SDZ2024FR070434$SANDOZ$$18$YR$$F$Y$$$20240805$$HP$FR$FR
241750721$24175072$1$I$$20230314$20240805$20240805$EXP$$US-AstraZeneca-2023A063602$ASTRAZENECA$$$$$$Y$$$20240805$$CN$US$
241750731$24175073$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA226349$SANOFI AVENTIS$$$$E$F$Y$54.4$KG$20240805$$CN$US$US
241750741$24175074$1$I$$20240723$20240805$20240805$PER$$US-SA-2024SA221024$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240805$$MD$US$US
241750752$24175075$2$F$20240622$20240904$20240805$20240906$PER$$NVSC2024US155920$NOVARTIS$$$$$M$Y$$$20240906$$HP$US$US
241750761$24175076$1$I$$20240730$20240805$20240805$EXP$$US-OTSUKA-2024_021206$OTSUKA$$$$$F$Y$99.79$KG$20240805$$CN$US$US
241750771$24175077$1$I$20240701$20240730$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019768$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240805$$PH$US$US
241750794$24175079$4$F$$20240813$20240805$20240819$EXP$$JP-ABBVIE-5866791$ABBVIE$Konishi-Izuchi N, Onogi Y, Shukuin R, Watanabe N, Noro K. Case report: A case of cutaneous cryptococcosis in a botulinum toxin type A injection site for hemifacial spasm. Japanese Journal of Clinical Dermatology. 2024;78:613-619.; Konishi-Izuchi N, Onogi Y, Shukuin R, Watanabe N, Noro K. Case report: A case of cutaneous cryptococcosis in a botulinum toxin type A injection site for hemifacial spasm. Japanese Journal of Clinical Dermatology. 2024;78:613-619.$62$YR$$M$Y$$$20240819$$MD$JP$JP
241750801$24175080$1$I$$20240730$20240805$20240805$PER$$US-APELLIS-2024-APL-0000595$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
241750811$24175081$1$I$$20240802$20240805$20240805$EXP$$DE-SANDOZ INC.-SDZ2024DE070135$SANDOZ$$70$YR$$F$Y$$$20240805$$MD$DE$DE
241750821$24175082$1$I$20230701$20240802$20240805$20240805$EXP$$GB-SANDOZ INC.-SDZ2024GB070293$SANDOZ$$61$YR$$F$Y$84$KG$20240805$$PH$GB$GB
241750832$24175083$2$F$20230828$20240807$20240805$20240808$EXP$IT-MINISAL02-997097$IT-GILEAD-2024-0682892$GILEAD$$63$YR$A$M$Y$$$20240808$$MD$IT$IT
241750841$24175084$1$I$20240717$20240724$20240805$20240805$PER$$US-JNJFOC-20240809139$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240805$$HP$US$US
241750852$24175085$2$F$20150101$20240729$20240805$20240808$EXP$$NVSC2024NO158279$NOVARTIS$$67$YR$$F$Y$$$20240808$$CN$NO$NO
241750861$24175086$1$I$$20240726$20240805$20240805$EXP$$IT-FreseniusKabi-FK202411975$FRESENIUS KABI$Tuccori M, Maiese A, Scatena A, Bonaso M, Marcacci I, Convertino I. Fat overload syndrome following intravenous lipid emulsion  administration as antidote in suspected anesthetic intoxication: insights from a clinical and forensic case experience. La Clinica terapeutica. 2024 Jul;175(4): 211-215. doi:10.7417/CT.2024.5065.$30$YR$A$F$Y$$$20240805$$HP$IT$IT
241750881$24175088$1$I$20240701$20240801$20240805$20240805$EXP$SE-SEMPA-2024-005853$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-122661$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240805$$MD$SE$SE
241750894$24175089$4$F$20230101$20240916$20240805$20240919$EXP$$US-SANDOZ INC.-SDZ2024US070452$SANDOZ$$58$YR$$F$Y$61.22$KG$20240919$$CN$US$US
241750901$24175090$1$I$$20240730$20240805$20240805$EXP$CH-SM-2024-13907$CH-SANDOZ INC.-SDZ2024CH069334$SANDOZ$$68$YR$$M$Y$$$20240805$$PH$CH$CH
241750914$24175091$4$F$$20240913$20240805$20240922$EXP$$US-SANDOZ INC.-SDZ2024US070218$SANDOZ$$$$$F$Y$$$20240922$$CN$US$US
241750921$24175092$1$I$$20240729$20240805$20240805$PER$$SK-BAUSCH-BL-2024-010077$BAUSCH AND LOMB$Dragasek J, Vancova Z. Duloxetin v liecbe pacientov s depresiou  so sprievodnou bolestou a kognitivnymi priznakmi. Psychiatria pre prax. 2024;25(1):25-30.$$$A$F$Y$$$20240805$$MD$SK$SK
241750931$24175093$1$I$$20240731$20240805$20240805$EXP$$CA-MYLANLABS-2024M1071401$MYLAN$$88$YR$$F$Y$$$20240805$$CN$CA$CA
241750941$24175094$1$I$20240607$20240731$20240805$20240805$EXP$$US-MYLANLABS-2024M1056720$MYLAN$$32$YR$$M$Y$110.2$KG$20240805$$MD$US$US
241750951$24175095$1$I$20240310$20240802$20240805$20240805$EXP$FR-AFSSAPS-AN2024000995$FR-BAUSCH-BL-2024-011837$BAUSCH AND LOMB$$69$YR$$M$Y$50$KG$20240805$$MD$FR$FR
241750961$24175096$1$I$20220101$20240729$20240805$20240805$EXP$$GB-BAUSCH-BL-2024-011634$BAUSCH AND LOMB$Williams H, Thoppuram N, Law K, Simms J. Post-operative cognitive dysfunction: Progressive multifocal leukoencephalopathy (PML), an unexpected finding in an elderly patient. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24:5. doi:10.1016/j.clinme.2024.100048$87$YR$$F$Y$$$20240805$$HP$GB$GB
241750972$24175097$2$F$$20240911$20240805$20240913$EXP$$NVSC2024CN158462$NOVARTIS$$$$$M$Y$82$KG$20240913$$CN$CN$CN
241750981$24175098$1$I$$20240731$20240805$20240805$EXP$$NVSC2024FR157700$NOVARTIS$$$$$M$Y$$$20240805$$MD$FR$FR
241750992$24175099$2$F$$20240822$20240805$20240829$EXP$$PT-TEVA-VS-3228783$TEVA$Castro Silva B, Machado A, Marques ACB, Carvalho R, Domingos G, Flores MA, et al. DRESS INDUCED BY ALLOPURINOL TREATED WITH CYCLOSPORIN, A CLINICAL CASE. Eur-J-Case-Rep-Intern-Med 2023; 10 (Suppl. 1) 559 abstr. 1216.; Castro Silva B, Machado A, Marques ACB, Carvalho R, Domingos G, Flores MA, et al. DRESS INDUCED BY ALLOPURINOL TREATED WITH CYCLOSPORIN, A CLINICAL CASE. Eur-J-Case-Rep-Intern-Med 2023; 10 (Suppl. 1) 559 abstr. 1216.$67$YR$$M$Y$$$20240829$$HP$PT$PT
241751001$24175100$1$I$$20240729$20240805$20240805$EXP$$US-009507513-2408USA000612$MERCK$$$$$F$Y$$$20240805$$MD$US$US
241751011$24175101$1$I$$20240801$20240805$20240805$EXP$$NZ-BRISTOL-MYERS SQUIBB COMPANY-2024-122265$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240805$$HP$NZ$NZ
241751021$24175102$1$I$$20240724$20240805$20240805$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07522$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240805$$CN$US$US
241751031$24175103$1$I$$20240802$20240805$20240805$EXP$$NVSC2024CA152669$NOVARTIS$$60$YR$$M$Y$$$20240805$$CN$CA$CA
241751041$24175104$1$I$$20240723$20240805$20240805$PER$$US-SA-2024SA220893$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240805$$MD$US$US
241751051$24175105$1$I$$20240730$20240805$20240805$EXP$$US-AMGEN-USASP2024151810$AMGEN$$$$A$F$Y$$$20240805$$MD$US$US
241751061$24175106$1$I$$20240729$20240805$20240805$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2024AMR095276$VIIV$$$$$$Y$$$20240805$$MD$CA$CA
241751072$24175107$2$F$$20240806$20240805$20240810$EXP$$IN-SA-2024SA226174$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240810$$MD$IN$IN
241751081$24175108$1$I$20240730$20240801$20240805$20240805$PER$$US-TAKEDA-2024TUS077909$TAKEDA$$61$YR$$F$Y$63$KG$20240805$$HP$US$US
241751091$24175109$1$I$$20240725$20240805$20240805$PER$$US-MYLANLABS-2024M1069553$MYLAN$$81$YR$$F$Y$$$20240805$$CN$US$US
241751101$24175110$1$I$$20240730$20240805$20240805$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006374$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240805$$HP$US$US
241751115$24175111$5$F$20240701$20240830$20240805$20240904$PER$$US-PFIZER INC-PV202400101029$PFIZER$$73$YR$$F$Y$$$20240904$$HP$US$US
241751121$24175112$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229263$PFIZER$$77$YR$$F$Y$$$20240805$$CN$US$US
241751134$24175113$4$F$20240101$20240913$20240805$20240923$PER$$US-PFIZER INC-PV202400101108$PFIZER$$43$YR$$F$Y$$$20240923$$HP$US$US
241751141$24175114$1$I$20240101$20240801$20240805$20240805$PER$$US-PFIZER INC-202400186029$PFIZER$$76$YR$$F$Y$74.84$KG$20240805$$CN$US$US
241751151$24175115$1$I$20240701$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229658$PFIZER$$$$E$F$Y$$$20240805$$CN$US$US
241751161$24175116$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-202400229239$PFIZER$$24$YR$$F$Y$$$20240805$$HP$US$US
241751171$24175117$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-PV202400100838$PFIZER$$49$YR$$F$Y$$$20240805$$HP$US$US
241751181$24175118$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229268$PFIZER$$$$$F$Y$$$20240805$$CN$US$US
241751191$24175119$1$I$20240101$20240801$20240805$20240805$PER$$US-PFIZER INC-202400228763$PFIZER$$60$YR$$M$Y$$$20240805$$CN$US$US
241751201$24175120$1$I$20240731$20240802$20240805$20240805$PER$$US-PFIZER INC-202400228941$PFIZER$$69$YR$$F$Y$$$20240805$$CN$US$US
241751211$24175121$1$I$20240801$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229626$PFIZER$$50$YR$$F$Y$$$20240805$$HP$US$US
241751221$24175122$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229630$PFIZER$$$$$F$Y$$$20240805$$CN$US$US
241751232$24175123$2$F$20230101$20240924$20240805$20240926$PER$$US-PFIZER INC-202400229071$PFIZER$$67$YR$$F$Y$78.02$KG$20240926$$CN$US$US
241751241$24175124$1$I$20240731$20240801$20240805$20240805$PER$$US-PFIZER INC-202400228493$PFIZER$$34$YR$$F$Y$$$20240805$$CN$US$US
241751251$24175125$1$I$20240801$20240801$20240805$20240805$PER$$US-PFIZER INC-202400229472$PFIZER$$20$YR$$$Y$$$20240805$$HP$US$US
241751264$24175126$4$F$20240730$20240923$20240805$20240927$PER$$US-PFIZER INC-202400228641$PFIZER$$77$YR$$F$Y$74$KG$20240927$$CN$US$US
241751271$24175127$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-202400229060$PFIZER$$71$YR$$F$Y$$$20240805$$CN$US$US
241751282$24175128$2$F$$20240801$20240805$20240809$PER$$US-PFIZER INC-202400228403$PFIZER$$67$YR$$F$Y$108.86$KG$20240809$$CN$US$US
241751291$24175129$1$I$20240802$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229463$PFIZER$$83$YR$$F$Y$$$20240805$$CN$US$US
241751302$24175130$2$F$20230201$20240910$20240805$20240912$PER$$US-PFIZER INC-PV202300067670$PFIZER$$43$YR$$M$Y$$$20240912$$HP$US$US
241751311$24175131$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229266$PFIZER$$70$YR$$F$Y$$$20240805$$CN$US$US
241751341$24175134$1$I$20240725$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229608$PFIZER$$56$YR$$F$Y$$$20240805$$CN$US$US
241751351$24175135$1$I$20230801$20240801$20240805$20240805$PER$$US-PFIZER INC-PV202400100783$PFIZER$$37$YR$$F$Y$$$20240805$$HP$US$US
241751364$24175136$4$F$20160101$20240918$20240805$20240923$PER$$US-PFIZER INC-2017403188$PFIZER$$37$YR$$F$Y$51.701$KG$20240923$$MD$US$US
241751371$24175137$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229806$PFIZER$$77$YR$$F$Y$$$20240805$$CN$US$US
241751381$24175138$1$I$20240801$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229137$PFIZER$$62$YR$$M$Y$$$20240805$$CN$US$US
241751391$24175139$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229520$PFIZER$$55$YR$$F$Y$$$20240805$$CN$US$US
241751401$24175140$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229591$PFIZER$$$$$$Y$$$20240805$$CN$US$US
241751411$24175141$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229171$PFIZER$$32$YR$$F$Y$$$20240805$$MD$US$US
241751421$24175142$1$I$20240730$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229204$PFIZER$$67$YR$$M$Y$$$20240805$$CN$US$US
241751431$24175143$1$I$$20240801$20240805$20240805$PER$$US-PFIZER INC-202400228307$PFIZER$$67$YR$$F$Y$$$20240805$$CN$US$US
241751442$24175144$2$F$$20240801$20240805$20240806$PER$$US-PFIZER INC-PV202400101437$PFIZER$$28$YR$$F$Y$$$20240806$$HP$US$US
241751451$24175145$1$I$$20240801$20240805$20240805$PER$$PR-PFIZER INC-202400228483$PFIZER$$64$YR$$M$Y$$$20240805$$PH$PR$PR
241751461$24175146$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-PV202400101331$PFIZER$$52$YR$$$Y$$$20240805$$CN$US$US
241751471$24175147$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229634$PFIZER$$$$$F$Y$$$20240805$$CN$US$US
241751481$24175148$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229277$PFIZER$$$$$F$Y$$$20240805$$CN$US$US
241751491$24175149$1$I$20240731$20240803$20240805$20240805$PER$$US-PFIZER INC-202400229703$PFIZER$$49$YR$$F$Y$$$20240805$$CN$US$US
241751501$24175150$1$I$$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229097$PFIZER$$49$YR$$F$Y$$$20240805$$CN$US$US
241751512$24175151$2$F$20240701$20240805$20240805$20240806$PER$$US-PFIZER INC-202400229602$PFIZER$$67$YR$$F$Y$$$20240806$$HP$US$US
241751522$24175152$2$F$$20240805$20240805$20240807$PER$$US-PFIZER INC-202400228969$PFIZER$$$$$F$Y$$$20240807$$HP$US$US
241751531$24175153$1$I$20240701$20240801$20240805$20240805$PER$$US-PFIZER INC-202400229233$PFIZER$$75$YR$$F$Y$$$20240805$$HP$US$US
241751541$24175154$1$I$$20240724$20240805$20240805$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118041$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240805$$HP$CA$CA
241751554$24175155$4$F$20240601$20240829$20240805$20240904$EXP$$NVSC2023CR199835$NOVARTIS$$53$YR$$F$Y$62.5$KG$20240904$$CN$CR$CR
241751561$24175156$1$I$20240701$20240726$20240805$20240805$PER$$US-ABBVIE-5858080$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241751571$24175157$1$I$20240101$20240628$20240805$20240805$PER$$US-AMERICAN REGENT INC-2024002512$AMERICAN REGENT$$14$YR$$M$Y$$$20240805$$HP$US$US
241751581$24175158$1$I$$20240724$20240805$20240805$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122716$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240805$$HP$CA$CA
241751591$24175159$1$I$20240716$20240724$20240805$20240805$EXP$$US-FMCRTG-FMC-2407-000909$FRESENIUS MEDICAL CARE$$76$YR$E$F$Y$$$20240805$$HP$US$US
241751601$24175160$1$I$$20240705$20240805$20240805$PER$$US-FMCRTG-FMC-2407-000821$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240805$$CN$US$US
241751611$24175161$1$I$$20240703$20240805$20240805$PER$$US-FMCRTG-FMC-2407-000824$FRESENIUS MEDICAL CARE$$52$YR$A$M$Y$$$20240805$$HP$US$US
241751621$24175162$1$I$$20240705$20240805$20240805$PER$$US-FMCRTG-FMC-2407-000806$FRESENIUS MEDICAL CARE$$58$YR$A$M$Y$$$20240805$$HP$US$US
241751631$24175163$1$I$$20240705$20240805$20240805$PER$$US-FMCRTG-FMC-2407-000831$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240805$$CN$US$US
241751641$24175164$1$I$$20240704$20240805$20240805$PER$$US-FMCRTG-FMC-2407-000804$FRESENIUS MEDICAL CARE$$58$YR$A$M$Y$68$KG$20240805$$HP$US$US
241751651$24175165$1$I$20240709$20240726$20240805$20240805$EXP$$US-FMCRTG-FMC-2407-000918$FRESENIUS MEDICAL CARE$$65$YR$E$M$Y$68$KG$20240805$$HP$US$US
241751661$24175166$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122816$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240805$$CN$US$US
241751671$24175167$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123254$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240805$$HP$US$US
241751681$24175168$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122950$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240805$$CN$US$US
241751701$24175170$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123268$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$85.28$KG$20240805$$CN$US$US
241751711$24175171$1$I$$20240803$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123421$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$58.51$KG$20240805$$CN$US$US
241751721$24175172$1$I$$20240723$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122607$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240805$$HP$US$US
241751731$24175173$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123378$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240805$$CN$US$US
241751741$24175174$1$I$$20240723$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122615$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240805$$HP$US$US
241751752$24175175$2$F$$20240831$20240805$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123238$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$66.68$KG$20240904$$CN$US$US
241751761$24175176$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123191$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$46.27$KG$20240805$$CN$US$US
241751771$24175177$1$I$20240601$20240620$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240993$IRONSHORE PHARMA$$8$YR$C$M$Y$$$20240805$$MD$COUNTRY NOT SPECIFIED$US
241751781$24175178$1$I$$20240417$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240847$IRONSHORE PHARMA$$$$$M$Y$$$20240805$$CN$US$US
241751791$24175179$1$I$$20240315$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240779$IRONSHORE PHARMA$$$$$M$Y$$$20240805$$$US$US
241751801$24175180$1$I$20240601$20240620$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240994$IRONSHORE PHARMA$$11$YR$C$M$Y$$$20240805$$MD$COUNTRY NOT SPECIFIED$US
241751811$24175181$1$I$$20240125$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240031$IRONSHORE PHARMA$$$$$$Y$$$20240805$$CN$US$US
241751821$24175182$1$I$20231101$20231214$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20230365$IRONSHORE PHARMA$$8$YR$C$M$Y$$$20240805$$$US$US
241751831$24175183$1$I$20240101$20240712$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241031$IRONSHORE PHARMA$$$$$M$Y$$$20240805$$CN$US$US
241751841$24175184$1$I$20170524$20240730$20240805$20240805$EXP$GR-GREOF-202400831$GR-MYLANLABS-2024M1071645$MYLAN$$76$YR$$F$Y$77$KG$20240805$$MD$GR$GR
241751851$24175185$1$I$$20240730$20240805$20240805$EXP$NL-LRB-00990264$NL-MYLANLABS-2024M1071820$MYLAN$$71$YR$$F$Y$82$KG$20240805$$CN$NL$NL
241751861$24175186$1$I$20240625$20240730$20240805$20240805$EXP$FR-AFSSAPS-AVLY2024000108$FR-MYLANLABS-2024M1071951$MYLAN$$18$YR$$F$Y$55$KG$20240805$$MD$FR$FR
241751871$24175187$1$I$20240423$20240802$20240805$20240805$EXP$GB-MHRA-MED-202408012055539780-NRLTM$GB-SANDOZ INC.-SDZ2024GB070216$SANDOZ$$72$YR$$F$Y$53$KG$20240805$$CN$GB$GB
241751881$24175188$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000068$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240805$$CN$US$US
241751891$24175189$1$I$20240731$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000943$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240805$$CN$US$US
241751901$24175190$1$I$$20240729$20240805$20240805$EXP$$NVSC2024SA157539$NOVARTIS$$38$YR$$M$Y$$$20240805$$MD$SA$SA
241751911$24175191$1$I$20240730$20240801$20240805$20240805$EXP$$NVSC2024CN159113$NOVARTIS$$31$YR$$M$Y$56$KG$20240805$$HP$CN$CN
241751931$24175193$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240802308$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$HP$US$US
241751941$24175194$1$I$$20240731$20240805$20240805$PER$$US-JNJFOC-20240801639$JOHNSON AND JOHNSON$$$$$M$Y$$$20240805$$CN$US$US
241751951$24175195$1$I$$20240723$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122600$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$M$Y$$$20240805$$HP$US$US
241751961$24175196$1$I$$20240801$20240805$20240805$30DAY$$US-SANDOZ INC.-NVSC2022US001138$SANDOZ$$$$$F$Y$$$20240805$$CN$US$US
241751971$24175197$1$I$20240723$20240729$20240805$20240805$EXP$$CN-SA-2024SA228044$SANOFI AVENTIS$$69$YR$E$M$Y$39$KG$20240805$$HP$CN$CN
241751991$24175199$1$I$20240729$20240730$20240805$20240805$EXP$$CO-BIOMARINAP-CO-2024-159602$BIOMARIN$$$$$$Y$$$20240805$$CN$CO$CO
241752001$24175200$1$I$20240727$20240727$20240805$20240805$EXP$$US-FreseniusKabi-FK202411950$FRESENIUS KABI$$$$$$Y$$$20240805$$HP$US$US
241752011$24175201$1$I$20211130$20220105$20240805$20240805$EXP$$TW-AstraZeneca-2022A011297$ASTRAZENECA$$77$YR$$M$Y$$$20240805$$CN$TW$
241752022$24175202$2$F$20230510$20240911$20240805$20240916$EXP$$JP-AstraZeneca-2024A110198$ASTRAZENECA$Morita Y, et al.. MO-235 Study of gemcitabine, cisplatin and durvalumab combination therapy for biliary carcinoma in clinical practice.. Journal of Japanese Society of Gastroenterology 2024;121(S): A426-. .$70$YR$$M$Y$67$KG$20240916$$MD$JP$
241752032$24175203$2$F$20190901$20240822$20240805$20240829$EXP$$RU-AstraZeneca-2024A177122$ASTRAZENECA$Lubennikova EV, Ganshina IP, Manukyan MSh, Tyurin IE, Artamonova EV.. Expanding the treatment options for HER2-low metastatic breast cancer: Experience with trastuzumab deruxtecan in aggressive luminal HER2-low breast cancer.. Meditsinskiy Sovet 2024;18(10):66?73.$45$YR$$F$Y$$$20240829$$HP$RU$
241752041$24175204$1$I$$20230531$20240805$20240805$EXP$$US-AstraZeneca-2023A127048$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241752051$24175205$1$I$$20240723$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122573$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240805$$HP$US$US
241752061$24175206$1$I$$20240801$20240805$20240805$PER$$US-ABBVIE-5865533$ABBVIE$$$$$$Y$$$20240805$$HP$US$US
241752071$24175207$1$I$$20240723$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122572$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240805$$HP$US$US
241752091$24175209$1$I$20240101$20240729$20240805$20240805$PER$$US-ALXN-202407USA002203US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241752101$24175210$1$I$20240101$20240801$20240805$20240805$EXP$$CA-BIOMARINAP-CA-2024-157840$BIOMARIN$$$$$$Y$$$20240805$$CN$CA$CA
241752111$24175211$1$I$$20240801$20240805$20240805$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138790$DAIICHI$$$$$F$Y$$$20240805$$CN$US$US
241752121$24175212$1$I$$20240729$20240805$20240805$PER$$US-SA-2024SA228029$SANOFI AVENTIS$$$$E$F$Y$53.52$KG$20240805$$MD$US$US
241752131$24175213$1$I$$20240726$20240805$20240805$EXP$$JP-009507513-2408JPN000205$MERCK$$73$YR$$M$Y$$$20240805$$CN$JP$JP
241752141$24175214$1$I$20240801$20240802$20240805$20240805$PER$$US-PFIZER INC-202400229619$PFIZER$$56$YR$$F$Y$$$20240805$$CN$US$US
241752151$24175215$1$I$20240801$20240804$20240805$20240805$PER$$US-PFIZER INC-202400230164$PFIZER$$72$YR$$M$Y$$$20240805$$CN$US$US
241752161$24175216$1$I$$20240803$20240805$20240805$PER$$US-PFIZER INC-202400229582$PFIZER$$$$$M$Y$$$20240805$$CN$US$US
241752171$24175217$1$I$$20240803$20240805$20240805$PER$$US-PFIZER INC-202400229596$PFIZER$$$$$$Y$$$20240805$$CN$US$US
241752182$24175218$2$F$$20240809$20240805$20240814$PER$$US-PFIZER INC-PV202400101121$PFIZER$$62$YR$$F$Y$$$20240814$$HP$US$US
241752191$24175219$1$I$20240804$20240804$20240805$20240805$PER$$US-PFIZER INC-202400229764$PFIZER$$68$YR$$M$Y$$$20240805$$CN$US$US
241752201$24175220$1$I$20240803$20240803$20240805$20240805$PER$$US-PFIZER INC-202400229740$PFIZER$$41$YR$$F$Y$$$20240805$$HP$US$US
241752221$24175222$1$I$20240422$20240729$20240805$20240805$EXP$$JP-GENMAB-2024-02755$GENMAB$$$$$$Y$$$20240805$$MD$JP$JP
241752231$24175223$1$I$$20240801$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2024US070400$SANDOZ$$$$$F$Y$$$20240805$$MD$US$US
241752241$24175224$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123585$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240805$$CN$US$US
241752251$24175225$1$I$$20240723$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122583$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$M$Y$$$20240805$$HP$US$US
241752261$24175226$1$I$$20240723$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122593$BRISTOL MYERS SQUIBB$Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, et al. The impact of high-dose glucocorticoids on the outcome of immune-checkpoint inhibitor-related thyroid disorders. Cancer Immunology Research. 2019 Jul 01;7(7):1214-20. doi:10.1158/2326-6066.CIR-18-0613.$$$$F$Y$$$20240805$$HP$US$US
241752281$24175228$1$I$$20230327$20240805$20240805$EXP$$US-AstraZeneca-2023A073238$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241752291$24175229$1$I$$20230516$20240805$20240805$EXP$$US-AstraZeneca-2023A114765$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241752301$24175230$1$I$20240601$20240729$20240805$20240805$EXP$$US-ABBVIE-5861509$ABBVIE$$63$YR$$F$Y$$$20240805$$CN$US$US
241752311$24175231$1$I$$20230807$20240805$20240805$EXP$$US-AstraZeneca-2023A180809$ASTRAZENECA$$$$$M$Y$71.7$KG$20240805$$CN$US$
241752321$24175232$1$I$$20240730$20240805$20240805$PER$$US-JNJFOC-20240781209$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$HP$US$US
241752331$24175233$1$I$20240501$20240730$20240805$20240805$EXP$$NVSC2024CN150681$NOVARTIS$$58$YR$$M$Y$51$KG$20240805$$CN$CN$CN
241752341$24175234$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123280$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$73.48$KG$20240805$$CN$US$US
241752351$24175235$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123128$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240805$$CN$US$US
241752362$24175236$2$F$20240701$20240909$20240805$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123354$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$81.65$KG$20240913$$CN$US$US
241752371$24175237$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123143$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240805$$HP$US$US
241752381$24175238$1$I$$20240731$20240805$20240805$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-123496$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$87$KG$20240805$$HP$CA$CA
241752391$24175239$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122626$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240805$$CN$US$US
241752403$24175240$3$F$$20240827$20240805$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123400$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240829$$CN$US$US
241752411$24175241$1$I$$20240803$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123325$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$61.23$KG$20240805$$CN$US$US
241752421$24175242$1$I$$20240729$20240805$20240805$PER$$US-JNJFOC-20240781678$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$MD$US$US
241752432$24175243$2$F$20240101$20240911$20240805$20240913$PER$$US-Millicent Holdings Ltd.-MILL20241057$MILLICENT HOLDINGS$$63$YR$A$F$Y$$$20240913$$CN$US$US
241752442$24175244$2$F$$20240804$20240805$20240807$PER$$US-JNJFOC-20240802408$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241752461$24175246$1$I$20240621$20240729$20240805$20240805$EXP$$NVSC2024FR158319$NOVARTIS$$74$YR$$M$Y$$$20240805$$CN$FR$FR
241752471$24175247$1$I$$20240801$20240805$20240805$PER$$NVSC2024US158620$NOVARTIS$$49$YR$$M$Y$115.2$KG$20240805$$CN$US$US
241752482$24175248$2$F$20240720$20240821$20240805$20240823$EXP$$US-INSUD PHARMA-2407US06085$INSUD PHARMA$$$$$$Y$$$20240823$$MD$US$US
241752492$24175249$2$F$$20240808$20240805$20240827$PER$$US-PFIZER INC-202400228444$PFIZER$$69$YR$$M$Y$$$20240827$$HP$US$US
241752501$24175250$1$I$$20240725$20240805$20240805$PER$$US-PFIZER INC-PV202400099582$PFIZER$$$$$M$Y$$$20240805$$MD$US$US
241752513$24175251$3$F$20240730$20240926$20240805$20240926$30DAY$$CO-PFIZER INC-PV202400100497$PFIZER$$11$YR$$M$Y$$$20240926$$CN$CO$CO
241752521$24175252$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5858566$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241752531$24175253$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123291$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240805$$CN$US$US
241752541$24175254$1$I$$20240409$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000177$PAREXEL$$$$$$Y$$$20240805$$PH$US$US
241752551$24175255$1$I$$20240620$20240805$20240805$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407015470$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240805$$CN$DE$FR
241752561$24175256$1$I$$20240802$20240805$20240805$EXP$$GB-MYLANLABS-2024M1072574$MYLAN$$77$YR$$F$Y$$$20240805$$HP$GB$GB
241752571$24175257$1$I$20240612$20240703$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000402$PAREXEL$$$$$$Y$$$20240805$$CN$US$US
241752581$24175258$1$I$20240415$20240416$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000196$PAREXEL$$63$YR$$F$Y$149.66$KG$20240805$$CN$US$US
241752591$24175259$1$I$20240505$20240505$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000252$PAREXEL$$$$$F$Y$$$20240805$$CN$US$US
241752601$24175260$1$I$20240525$20240703$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000395$PAREXEL$$$$$$Y$$$20240805$$CN$US$US
241752611$24175261$1$I$20240622$20240623$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000378$PAREXEL$$$$$$Y$$$20240805$$CN$US$US
241752621$24175262$1$I$20240604$20240604$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000331$PAREXEL$$$$$$Y$$$20240805$$CN$US$US
241752634$24175263$4$F$20230101$20240809$20240805$20240820$PER$$US-ALKERMES INC.-ALK-2024-001977$ALKERMES$$$$$F$Y$61.224$KG$20240820$$CN$US$US
241752641$24175264$1$I$20240526$20240530$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000326$PAREXEL$$$$$$Y$$$20240805$$CN$US$US
241752652$24175265$2$F$20240101$20240731$20240805$20240828$PER$$US-IMP-2024000529$Harrow Health$$72$YR$E$M$Y$$$20240828$$CN$US$US
241752661$24175266$1$I$20230122$20240722$20240805$20240805$EXP$$US-ASTELLAS-2023US003884$ASTELLAS$$81$YR$$M$Y$$$20240805$$CN$US$US
241752671$24175267$1$I$20240101$20240801$20240805$20240805$EXP$$US-ABBVIE-5864522$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241752681$24175268$1$I$20240101$20240717$20240805$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000261$UNKNOWN$$$$$$Y$$$20240805$$CN$US$US
241752691$24175269$1$I$20240101$20240715$20240805$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000260$THERATECHNOLOGIES$$$$$$Y$$$20240805$$CN$US$US
241752701$24175270$1$I$20240716$20240718$20240805$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000263$THERATECHNOLOGIES$$$$$$Y$$$20240805$$CN$US$US
241752711$24175271$1$I$20240701$20240718$20240805$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000264$THERATECHNOLOGIES$$$$$$Y$$$20240805$$CN$US$US
241752731$24175273$1$I$20240601$20240718$20240805$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000266$THERATECHNOLOGIES$$$$$$Y$$$20240805$$CN$US$US
241752741$24175274$1$I$20240612$20240717$20240805$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000271$THERATECHNOLOGIES$$$$$$Y$$$20240805$$CN$US$US
241752761$24175276$1$I$20240718$20240725$20240805$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000280$THERATECHNOLOGIES$$$$$$Y$$$20240805$$CN$US$US
241752771$24175277$1$I$20240101$20240718$20240805$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000220$THERATECHNOLOGIES$$$$$$Y$$$20240805$$CN$US$US
241752781$24175278$1$I$$20240717$20240805$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000103$UNKNOWN$$$$$$Y$$$20240805$$CN$US$US
241752791$24175279$1$I$20240626$20240716$20240805$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000238$UNKNOWN$$$$$$Y$$$20240805$$CN$US$US
241752801$24175280$1$I$20240701$20240726$20240805$20240805$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000259$UNKNOWN$$$$$$Y$$$20240805$$CN$US$US
241752811$24175281$1$I$$20230523$20240805$20240805$EXP$$US-AstraZeneca-2023A120288$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241752821$24175282$1$I$$20240729$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120528$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240805$$CN$US$US
241752832$24175283$2$F$20240718$20240823$20240805$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121592$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$59.87$KG$20240902$$CN$US$US
241752843$24175284$3$F$$20240826$20240805$20240910$EXP$$US-ASTELLAS-2024US021109$ASTELLAS$$44$YR$A$F$Y$$$20240910$$HP$US$US
241752851$24175285$1$I$20220501$20240801$20240805$20240805$EXP$FR-AFSSAPS-AVPO2024000145$FR-MYLANLABS-2024M1071770$MYLAN$$42$YR$$F$Y$$$20240805$$PH$FR$FR
241752861$24175286$1$I$20240702$20240801$20240805$20240805$EXP$FR-AFSSAPS-PA2024001389$FR-MYLANLABS-2024M1071756$MYLAN$$21$YR$$M$Y$71.4$KG$20240805$$MD$FR$FR
241752871$24175287$1$I$$20240725$20240805$20240805$EXP$$DE-MYLANLABS-2024M1070801$MYLAN$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S, et al. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. Br-J-Cancer 2023; 128 (6): 1134-1147.$$$$$Y$$$20240805$$HP$DE$DE
241752881$24175288$1$I$$20240516$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000293$PAREXEL$$$$$$Y$$$20240805$$HP$US$US
241752891$24175289$1$I$20240427$20240429$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000234$PAREXEL$$84$YR$$F$Y$49.433$KG$20240805$$CN$US$US
241752901$24175290$1$I$20240509$20240510$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000279$PAREXEL$$$$$$Y$$$20240805$$CN$US$US
241752911$24175291$1$I$20240510$20240510$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000251$PAREXEL$$$$$$Y$$$20240805$$CN$US$US
241752921$24175292$1$I$20240425$20240425$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000224$PAREXEL$$90$YR$$F$Y$$$20240805$$CN$US$US
241752931$24175293$1$I$20240426$20240426$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000229$PAREXEL$$61$YR$$M$Y$72.562$KG$20240805$$CN$US$US
241752941$24175294$1$I$$20240731$20240805$20240805$EXP$$CA-MYLANLABS-2024M1071423$MYLAN$$74$YR$$F$Y$65$KG$20240805$$MD$CA$CA
241752951$24175295$1$I$$20240604$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000330$PAREXEL$$$$$$Y$$$20240805$$HP$US$US
241752961$24175296$1$I$20240516$20240516$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000292$PAREXEL$$79$YR$$M$Y$80.272$KG$20240805$$CN$US$US
241752971$24175297$1$I$20240101$20240723$20240805$20240805$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-000657$SK LIFE SCIENCE$$$$$$Y$$$20240805$$HP$CA$CA
241752981$24175298$1$I$20230601$20240801$20240805$20240805$EXP$AT-BASGAGES-2024-005650$NVSC2024AT157232$NOVARTIS$$66$YR$$F$Y$78$KG$20240805$$PH$AT$AT
241752991$24175299$1$I$20240706$20240722$20240805$20240805$EXP$$US-ACORDA-ACO_177673_2024$ACORDA$$56$YR$$F$Y$$$20240805$$CN$US$US
241753002$24175300$2$F$$20240821$20240805$20240822$PER$$NVSC2024US159210$NOVARTIS$$$$$M$Y$$$20240822$$HP$US$US
241753013$24175301$3$F$20240101$20240724$20240805$20240819$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-000911$SK LIFE SCIENCE$$$$$$Y$$$20240819$$HP$CA$CA
241753021$24175302$1$I$20231002$20240723$20240805$20240805$EXP$SE-SEMPA-2024-005560$SE-SK LIFE SCIENCE, INC-SKPVG-2024-001783$SK LIFE SCIENCE$$$$$$Y$$$20240805$$MD$SE$SE
241753031$24175303$1$I$20240610$20240723$20240805$20240805$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001673$SK LIFE SCIENCE$$$$$$Y$$$20240805$$CN$US$US
241753042$24175304$2$F$20240616$20240822$20240805$20240904$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001703$SK LIFE SCIENCE$$$$$$Y$$$20240904$$CN$US$US
241753051$24175305$1$I$$20240801$20240805$20240805$EXP$$NVSC2024IN158287$NOVARTIS$Srinivas SM, Gowda VK, Gowdra A, Veerappa BG, Kumar P. Lack of association of Stevens-Johnson syndrome/toxic epidermal necrolysis due to aromatic anticonvulsants and HLA-B alleles in South Indian children. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024;63(5):e97-e99$12$YR$$M$Y$$$20240805$$HP$IN$IN
241753061$24175306$1$I$20240705$20240730$20240805$20240805$EXP$FR-AFSSAPS-PV2024000668$FR-MYLANLABS-2024M1071174$MYLAN$$89$YR$$M$Y$70$KG$20240805$$PH$FR$FR
241753071$24175307$1$I$20220701$20240730$20240805$20240805$EXP$$ES-MYLANLABS-2024M1071332$MYLAN$Jimenez Alvaro S, Galeano ?lvarez C, Elias Trevino S, Ferreria Bermejo M, Fernandez Lucas M.. Safe immunosuppression. New tool for personalized immunosuppressant treatment in renal transplantation. A case report.. Archives of Organ Transplantation. 2024;9(1):5-8$$$E$M$Y$$$20240805$$HP$ES$ES
241753081$24175308$1$I$20240629$20240730$20240805$20240805$EXP$FR-AFSSAPS-NC2024000888$FR-MYLANLABS-2024M1071078$MYLAN$$51$YR$$M$Y$$$20240805$$MD$FR$FR
241753091$24175309$1$I$$20240730$20240805$20240805$EXP$$ES-MYLANLABS-2024M1070888$MYLAN$Anto, C.. Use of isavuconazole in children with invasive fungal infection: experience in a paediatric and tertiary care centre. 493$14$YR$$M$Y$48$KG$20240805$$MD$ES$ES
241753101$24175310$1$I$20240618$20240730$20240805$20240805$EXP$FR-AFSSAPS-GR2024000935$FR-MYLANLABS-2024M1071241$MYLAN$$21$YR$$F$Y$55$KG$20240805$$PH$FR$FR
241753112$24175311$2$F$$20240814$20240805$20240820$EXP$$ES-MYLANLABS-2024M1070785$MYLAN$Anto, C.. Use of isavuconazole in children with invasive fungal infection: experience in a paediatric and tertiary care centre.. 69? Congreso de la Asociacion Espanola de Pediatria (AEP) : Libro de comunicacio. 2023;493$15$YR$$M$Y$60$KG$20240820$$MD$ES$ES
241753121$24175312$1$I$20240605$20240730$20240805$20240805$EXP$FR-AFSSAPS-AVCN2024000571$FR-MYLANLABS-2024M1071207$MYLAN$$22$YR$$F$Y$$$20240805$$HP$FR$FR
241753132$24175313$2$F$20240723$20240920$20240805$20240925$EXP$$ES-JAZZ PHARMACEUTICALS-2024-ES-011768$JAZZ$$$$$$Y$$$20240924$$MD$ES$ES
241753141$24175314$1$I$20240711$20240712$20240805$20240805$PER$$US-009507513-2407USA008993$MERCK$$41$YR$$F$Y$$$20240805$$CN$US$US
241753151$24175315$1$I$$20231018$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240614$IRONSHORE PHARMA$$8$YR$C$M$Y$$$20240805$$MD$US$US
241753161$24175316$1$I$20231025$20231027$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240617$IRONSHORE PHARMA$$8$YR$C$M$Y$$$20240805$$CN$US$US
241753171$24175317$1$I$$20231010$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240611$IRONSHORE PHARMA$$7$YR$C$M$Y$$$20240805$$MD$US$US
241753181$24175318$1$I$$20231209$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240630$IRONSHORE PHARMA$$$$$M$Y$$$20240805$$CN$US$US
241753191$24175319$1$I$$20231109$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240621$IRONSHORE PHARMA$$$$C$M$Y$$$20240805$$MD$US$US
241753201$24175320$1$I$$20231020$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240615$IRONSHORE PHARMA$$$$$$Y$$$20240805$$MD$US$US
241753211$24175321$1$I$$20231005$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240627$IRONSHORE PHARMA$$13$YR$T$M$Y$$$20240805$$HP$US$US
241753221$24175322$1$I$$20231010$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240629$IRONSHORE PHARMA$$$$$M$Y$$$20240805$$MD$US$US
241753231$24175323$1$I$$20240726$20240805$20240805$EXP$$PT-ACRAF SpA-2024-035299$SK LIFE SCIENCE$$$$$$Y$$$20240805$$MD$PT$PT
241753242$24175324$2$F$$20240802$20240805$20240822$EXP$$US-GILEAD-2024-0682756$GILEAD$$$$E$F$Y$$$20240822$$CN$US$US
241753251$24175325$1$I$20240501$20240523$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000309$PAREXEL$$$$$$Y$$$20240805$$CN$US$US
241753261$24175326$1$I$20240603$20240624$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000377$PAREXEL$$$$$$Y$$$20240805$$CN$US$US
241753271$24175327$1$I$20240507$20240508$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000270$PAREXEL$$90$YR$$F$Y$$$20240805$$CN$US$US
241753281$24175328$1$I$$20240419$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000203$PAREXEL$$$$$M$Y$83.9$KG$20240805$$CN$US$US
241753291$24175329$1$I$20240516$20240522$20240805$20240805$PER$$US-SCPHARMACEUTICALS-2024-SCPH-US000307$PAREXEL$$77$YR$$M$Y$90.1$KG$20240805$$HP$US$US
241753301$24175330$1$I$$20240802$20240805$20240805$PER$$NVSC2024US159215$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241753312$24175331$2$F$$20240730$20240805$20240821$EXP$$NVSC2023DE252900$NOVARTIS$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert R, Fischer L et al.. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients.. CHILDREN. 2023;10 (367):1-11$11$YR$$M$Y$$$20240821$$HP$DE$DE
241753322$24175332$2$F$$20240802$20240805$20240806$EXP$$NVSC2024US027755$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
241753331$24175333$1$I$$20240802$20240805$20240805$PER$$NVSC2024US159209$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241753342$24175334$2$F$20240701$20240829$20240805$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043768$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240829$$CN$US$US
241753352$24175335$2$F$$20240828$20240805$20240830$EXP$$BE-SANDOZ INC.-SDZ2024BE070428$SANDOZ$$73$YR$$M$Y$$$20240830$$MD$BE$BE
241753361$24175336$1$I$20240705$20240731$20240805$20240805$EXP$HR-HALMED-300086208$HR-TAKEDA-2024TUS076980$TAKEDA$$41$YR$$M$Y$$$20240805$$HP$HR$HR
241753371$24175337$1$I$$20240730$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000254$ELI LILLY AND CO$$$$$F$Y$$$20240805$$CN$US$US
241753381$24175338$1$I$$20240723$20240805$20240805$EXP$$TR-ELI_LILLY_AND_COMPANY-TR202407004533$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240805$$PH$TR$TR
241753391$24175339$1$I$$20240722$20240805$20240805$EXP$GB-MHRA-MED-202407222335568780-FWZQC$GB-ELI_LILLY_AND_COMPANY-GB202407014846$ELI LILLY AND CO$$40$YR$A$F$Y$111$KG$20240805$$CN$GB$GB
241753401$24175340$1$I$$20240724$20240805$20240805$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202407017371$ELI LILLY AND CO$$$$$$Y$$$20240805$$CN$ES$ES
241753411$24175341$1$I$$20240725$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017630$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240805$$CN$US$US
241753421$24175342$1$I$$20240724$20240805$20240805$EXP$GB-MHRA-MED-202407240825318350-PRSLV$GB-ELI_LILLY_AND_COMPANY-GB202407015582$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240805$$CN$GB$GB
241753431$24175343$1$I$$20240724$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016795$ELI LILLY AND CO$$30$YR$A$M$Y$$$20240805$$HP$US$US
241753441$24175344$1$I$20240703$20240730$20240805$20240805$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407019835$ELI LILLY AND CO$$80$YR$E$F$Y$40$KG$20240805$$CN$CN$CN
241753451$24175345$1$I$20240718$20240724$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016335$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240805$$CN$US$US
241753461$24175346$1$I$20240717$20240724$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016926$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240805$$CN$US$US
241753471$24175347$1$I$$20240722$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015567$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240805$$CN$US$US
241753482$24175348$2$F$20240101$20240809$20240805$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016213$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240816$$CN$US$US
241753491$24175349$1$I$20240601$20240724$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016401$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240805$$CN$US$US
241753501$24175350$1$I$20240724$20240724$20240805$20240805$EXP$GB-MHRA-MED-202407240912234260-VMFQJ$GB-ELI_LILLY_AND_COMPANY-GB202407015583$ELI LILLY AND CO$$59$YR$A$F$Y$133$KG$20240805$$CN$GB$GB
241753511$24175351$1$I$$20240725$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017915$ELI LILLY AND CO$$39$YR$A$$Y$$$20240805$$LW$US$US
241753521$24175352$1$I$20221020$20240620$20240805$20240805$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407014810$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240805$$CN$DE$FR
241753531$24175353$1$I$$20240725$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407018122$ELI LILLY AND CO$$$$$$Y$$$20240805$$CN$US$US
241753541$24175354$1$I$20240726$20240726$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017818$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240805$$CN$US$US
241753552$24175355$2$F$20230101$20240724$20240805$20240807$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016189$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240807$$CN$US$US
241753561$24175356$1$I$$20240724$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407018066$ELI LILLY AND CO$$$$$M$Y$$$20240805$$CN$US$US
241753571$24175357$1$I$$20240730$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019561$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240805$$CN$US$US
241753581$24175358$1$I$$20240724$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016168$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240805$$CN$US$US
241753591$24175359$1$I$$20240712$20240805$20240805$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407016661$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240805$$CN$BR$BR
241753611$24175361$1$I$$20240724$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016377$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240805$$CN$US$US
241753621$24175362$1$I$$20240724$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016833$ELI LILLY AND CO$$70$YR$E$$Y$$$20240805$$LW$US$US
241753631$24175363$1$I$$20240725$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016955$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240805$$CN$US$US
241753641$24175364$1$I$$20240731$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000656$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240805$$CN$US$US
241753651$24175365$1$I$20240718$20240724$20240805$20240805$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016310$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240805$$CN$US$US
241753661$24175366$1$I$20240401$20240724$20240805$20240805$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407017032$ELI LILLY AND CO$$$$$F$Y$$$20240805$$CN$DE$DE
241753673$24175367$3$F$20240728$20240806$20240805$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019914$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240816$$CN$US$US
241753681$24175368$1$I$20240712$20240722$20240805$20240805$EXP$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01122$TARO$$$$$$Y$$$20240806$$CN$US$US
241753691$24175369$1$I$$20230530$20240805$20240805$EXP$$US-AstraZeneca-2023A126142$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241753701$24175370$1$I$$20230901$20240805$20240805$EXP$$US-AstraZeneca-2023A200625$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$US$
241753711$24175371$1$I$$20230130$20240805$20240805$EXP$$US-AstraZeneca-2023A025697$ASTRAZENECA$$$$$F$Y$$$20240805$$MD$US$
241753721$24175372$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123407$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240805$$CN$US$US
241753732$24175373$2$F$20240627$20240815$20240805$20240821$EXP$$JP-GENMAB-2024-02749$GENMAB$$75$YR$$M$Y$$$20240821$$MD$JP$JP
241753741$24175374$1$I$20240731$20240731$20240805$20240805$PER$$US-SA-2024SA229082$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240805$$HP$US$US
241753761$24175376$1$I$$20240804$20240805$20240805$EXP$$AU-GILEAD-2024-0682819$GILEAD$$33$YR$A$$Y$$$20240805$$HP$AU$AU
241753771$24175377$1$I$20240423$20240802$20240805$20240805$EXP$GB-MHRA-MED-202408012055539780-NRLTM$GB-MYLANLABS-2024M1072588$MYLAN$$72$YR$$F$Y$53$KG$20240805$$CN$GB$GB
241753782$24175378$2$F$$20240820$20240805$20240821$PER$$NVSC2024US159017$NOVARTIS$$$$$M$Y$$$20240822$$HP$US$US
241753791$24175379$1$I$$20240801$20240805$20240805$EXP$$NVSC2024PT158043$NOVARTIS$Pereira I, Ferreira IM, Barbosa FR, Pereira D, Gabriel DF. POSA-126 - (4330) - Intoxicacao por carbamazepina: causae/ou consequencia. Congressos da Sociedade Portuguesa de Medicina Interna: 30. CONGRESSO NACIONAL DE MEDICINA INTERNA - LIVRO DE RESUMOS. 2024;1199$66$YR$$M$Y$$$20240805$$HP$PT$PT
241753801$24175380$1$I$20231227$20240729$20240805$20240805$EXP$FR-AFSSAPS-NY2024000829$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07290$HIKMA$$58$YR$$F$Y$77$KG$20240805$$HP$FR$FR
241753811$24175381$1$I$20240706$20240801$20240805$20240805$EXP$FR-AFSSAPS-PO2024000787$FR-MYLANLABS-2024M1071784$MYLAN$$58$YR$$F$Y$43.8$KG$20240805$$MD$FR$FR
241753823$24175382$3$F$20240131$20240816$20240805$20240819$EXP$$NZ-MYLANLABS-2024M1010927$MYLAN$$77$YR$$F$Y$$$20240819$$PH$NZ$NZ
241753832$24175383$2$F$20240101$20240822$20240805$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121611$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240829$$CN$US$US
241753841$24175384$1$I$$20240802$20240805$20240805$EXP$$NVSC2024PT153391$NOVARTIS$Leite JB, Costa TS, Laczkovits BB, Sousa M, Morais JR. Pulmonary toxicity to everolimus - exploring a fever without a focus.. CONGRESSES OF THE PORTUGUESE SOCIETY OF INTERNAL MEDICINE. 2024;1165$72$YR$$M$Y$$$20240805$$HP$PT$PT
241753851$24175385$1$I$$20240730$20240805$20240805$EXP$$NVSC2024IT158237$NOVARTIS$Conversano E, Debiec H, Colucci M, Emma F, Ronco P, Vivarelli M. A child with semaphorin 3b?associated membranous nephropathy  efectively treated with obinutuzumab after rituximab resistance. PEDIATRIC NEPHROLOGY. 2024;39:305-8$9$YR$$M$Y$$$20240805$$HP$IT$IT
241753861$24175386$1$I$20240201$20240731$20240805$20240805$EXP$$US-LUNDBECK-DKLU4002524$LUNDBECK$$$$$$Y$$$20240805$$HP$US$US
241753871$24175387$1$I$20200521$20240801$20240805$20240805$EXP$$PL-MYLANLABS-2020M1057299$MYLAN$$36$YR$$F$Y$60$KG$20240805$$MD$PL$PL
241753881$24175388$1$I$$20240802$20240805$20240805$PER$$NVSC2024US159216$NOVARTIS$$$$$F$Y$$$20240805$$HP$US$US
241753893$24175389$3$F$$20240824$20240805$20240829$PER$$US-ALXN-202407USA002171US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
241753901$24175390$1$I$20240802$20240804$20240805$20240805$EXP$GB-MHRA-MED-202408040955137530-ZCWSM$GB-BAYER-2024A112388$BAYER$$6$YR$C$M$Y$20$KG$20240805$$CN$GB$GB
241753911$24175391$1$I$20240609$20240730$20240805$20240805$EXP$DE-CADRBFARM-2024329453$DE-MYLANLABS-2024M1071327$MYLAN$$34$YR$$M$Y$117$KG$20240805$$CN$DE$DE
241753921$24175392$1$I$$20240728$20240805$20240805$PER$$NVSC2024US154935$NOVARTIS$$$$$$Y$$$20240805$$CN$US$US
241753931$24175393$1$I$20240731$20240802$20240805$20240805$EXP$$NVSC2022IN093286$NOVARTIS$$64$YR$$M$Y$$$20240805$$MD$IN$IN
241753941$24175394$1$I$$20240802$20240805$20240805$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043694$BOEHRINGER INGELHEIM$$$$$$Y$$$20240805$$CN$US$US
241753951$24175395$1$I$$20240804$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123468$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240805$$CN$US$US
241753961$24175396$1$I$$20240730$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121322$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240805$$PH$US$US
241753972$24175397$2$F$$20240801$20240805$20240807$EXP$$NVSC2024GB149685$NOVARTIS$$42$YR$$F$Y$$$20240807$$HP$GB$GB
241753991$24175399$1$I$20240723$20240723$20240805$20240805$PER$$US-ALKERMES INC.-ALK-2024-001956$ALKERMES$$35$YR$$F$Y$$$20240805$$PH$US$US
241754001$24175400$1$I$$20240725$20240805$20240805$EXP$GB-MHRA-MED-202407230649218540-CKHWV$GB-ELI_LILLY_AND_COMPANY-GB202407016552$ELI LILLY AND CO$$54$YR$A$F$Y$79$KG$20240805$$CN$GB$GB
241754011$24175401$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001948$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240805$$CN$US$US
241754021$24175402$1$I$$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407018809$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240805$$CN$US$US
241754031$24175403$1$I$20230710$20240724$20240805$20240805$EXP$SE-SEMPA-2024-005677$SE-ELI_LILLY_AND_COMPANY-SE202407016520$ELI LILLY AND CO$$56$YR$A$F$Y$84$KG$20240805$$CN$SE$SE
241754041$24175404$1$I$$20240802$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001983$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240805$$CN$US$US
241754051$24175405$1$I$20240722$20240724$20240805$20240805$EXP$GB-MHRA-MED-202407240604250210-DLZGH$GB-ELI_LILLY_AND_COMPANY-GB202407015580$ELI LILLY AND CO$$48$YR$A$F$Y$86$KG$20240805$$CN$GB$GB
241754061$24175406$1$I$20240722$20240724$20240805$20240805$EXP$GB-MHRA-MED-202407241624170040-NTKFS$GB-ELI_LILLY_AND_COMPANY-GB202407016507$ELI LILLY AND CO$$$$$$Y$66$KG$20240805$$CN$GB$GB
241754073$24175407$3$F$20240101$20240924$20240805$20240926$EXP$$US-PFIZER INC-202400229450$PFIZER$$55$YR$$M$Y$$$20240926$$CN$US$US
241754092$24175409$2$F$$20240822$20240805$20240829$EXP$$IL-TEVA-VS-3229158$TEVA$Atamna B, Raanani P, Gurion R, Wolach O. Warburg-Effect Driven Lactic Acidosis Is Associated with Early Death in Patients with Lymphoma. Blood 2023; 142 (Suppl.) 6307.; Atamna B, Raanani P, Gurion R, Wolach O. Warburg-Effect Driven Lactic Acidosis Is Associated with Early Death in Patients with Lymphoma. Blood 2023; 142 (Suppl.) 6307.$$$$$Y$$$20240829$$HP$IL$IL
241754102$24175410$2$F$20240726$20240911$20240805$20240911$30DAY$$AR-PFIZER INC-202400226680$PFIZER$$7$YR$$F$Y$$$20240911$$CN$AR$AR
241754111$24175411$1$I$$20240729$20240805$20240805$EXP$$JP-009507513-2407JPN005252J$MERCK$$$$$F$Y$$$20240805$$MD$JP$JP
241754121$24175412$1$I$$20240717$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114475$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240805$$CN$US$US
241754132$24175413$2$F$20240417$20240801$20240805$20240806$PER$$NVSC2024US159243$NOVARTIS$$71$YR$$F$Y$$$20240806$$HP$US$US
241754141$24175414$1$I$20240729$20240730$20240805$20240805$PER$$US-APELLIS-2024-APL-0000598$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240805$$CN$US$US
241754164$24175416$4$F$20220901$20240906$20240805$20240910$EXP$$NVSC2024CN048109$NOVARTIS$$65$YR$$M$Y$68$KG$20240910$$CN$CN$CN
241754171$24175417$1$I$20240101$20240725$20240805$20240805$EXP$$US-RADIUS HEALTH INC.-2024US005785$RADIUS PHARM$$$$$F$Y$61.224$KG$20240805$$CN$US$US
241754181$24175418$1$I$20240718$20240802$20240805$20240805$PER$$NVSC2024US159202$NOVARTIS$$67$YR$$M$Y$$$20240805$$HP$US$US
241754192$24175419$2$F$20240501$20240917$20240805$20240918$EXP$FR-AFSSAPS-AN2024000917$NVSC2024FR158302$NOVARTIS$$63$YR$$$Y$$$20240918$$CN$FR$FR
241754202$24175420$2$F$$20240802$20240805$20240806$EXP$$NVSC2024US158992$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
241754211$24175421$1$I$$20240731$20240805$20240805$PER$$NVSC2024US157139$NOVARTIS$$$$$F$Y$$$20240805$$HP$US$US
241754222$24175422$2$F$$20240917$20240805$20240918$PER$$NVSC2024US159173$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
241754241$24175424$1$I$$20240802$20240805$20240805$PER$$NVSC2024US159203$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241754251$24175425$1$I$$20240802$20240805$20240805$EXP$$US-GILEAD-2024-0682849$GILEAD$$76$YR$E$F$Y$$$20240805$$CN$US$US
241754261$24175426$1$I$$20240719$20240805$20240805$PER$$US-LUNDBECK-DKLU4002303$LUNDBECK$$$$$$Y$$$20240805$$PH$US$US
241754271$24175427$1$I$20240517$20240730$20240805$20240805$EXP$$US-OTSUKA-2024_014753$OTSUKA$$77$YR$$F$Y$70.76$KG$20240805$$CN$US$US
241754281$24175428$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122516$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240805$$HP$US$US
241754291$24175429$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122652$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240805$$HP$US$US
241754301$24175430$1$I$$20240730$20240805$20240805$EXP$$LV-009507513-2408LVA000284$MERCK$$$$$F$Y$$$20240805$$MD$LV$LV
241754312$24175431$2$F$20240726$20240813$20240805$20240815$PER$$US-009507513-2407USA015975$MERCK$$72$YR$$F$Y$$$20240815$$HP$US$US
241754321$24175432$1$I$$20240729$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120704$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240805$$CN$US$US
241754331$24175433$1$I$$20240802$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408002375$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240805$$CN$US$US
241754341$24175434$1$I$$20240620$20240805$20240805$PER$$US-LUNDBECK-DKLU4001092$LUNDBECK$$$$$$Y$$$20240805$$CN$US$US
241754351$24175435$1$I$$20240731$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123624$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240805$$CN$US$US
241754362$24175436$2$F$$20240829$20240805$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123625$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240902$$CN$US$US
241754371$24175437$1$I$$20240613$20240805$20240805$PER$$US-LUNDBECK-DKLU4000511$LUNDBECK$$$$$$Y$$$20240805$$HP$US$US
241754381$24175438$1$I$20240619$20240710$20240805$20240805$PER$$US-SETONPHARMA-2024SETSPO00003$SETON$$57$YR$A$$Y$$$20240729$$CN$US$US
241754391$24175439$1$I$20240721$20240801$20240805$20240805$EXP$$NVSC2024CN158972$NOVARTIS$$61$YR$$F$Y$64$KG$20240805$$HP$CN$CN
241754401$24175440$1$I$20240621$20240710$20240805$20240805$PER$$US-SETONPHARMA-2024SETSPO00004$SETON$$70$YR$E$$Y$$$20240729$$CN$US$US
241754411$24175441$1$I$20240725$20240725$20240805$20240805$PER$$US-ALKERMES INC.-ALK-2024-001978$ALKERMES$$29$YR$$F$Y$$$20240805$$HP$US$US
241754422$24175442$2$F$20230801$20240904$20240805$20240915$PER$$US-009507513-2408USA000680$MERCK$$64$YR$$M$Y$$$20240915$$CN$US$US
241754432$24175443$2$F$$20240805$20240805$20240807$EXP$$NVSC2024TR156445$NOVARTIS$$21$YR$$M$Y$$$20240807$$CN$TR$TR
241754441$24175444$1$I$$20240802$20240805$20240805$PER$$NVSC2024US159212$NOVARTIS$$$$$F$Y$$$20240805$$CN$US$US
241754451$24175445$1$I$$20240725$20240805$20240805$PER$$US-ALKERMES INC.-ALK-2024-001989$ALKERMES$$$$A$M$Y$$$20240805$$HP$US$US
241754471$24175447$1$I$20240714$20240726$20240805$20240805$PER$$CN-Eisai-EC-2024-171072$EISAI$$53$YR$A$F$Y$44$KG$20240805$$HP$CN$CN
241754481$24175448$1$I$$20240725$20240805$20240805$PER$$US-ALKERMES INC.-ALK-2024-001990$ALKERMES$$$$A$F$Y$$$20240805$$HP$US$US
241754491$24175449$1$I$$20240801$20240805$20240805$EXP$$FR-AstraZeneca-2024A141797$ASTRAZENECA$$84$YR$$M$Y$82$KG$20240805$$MD$FR$
241754501$24175450$1$I$$20240509$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000889$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240805$$CN$US$US
241754511$24175451$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408001727$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240805$$MD$US$US
241754521$24175452$1$I$$20230814$20240805$20240805$EXP$$CA-AstraZeneca-2023A186556$ASTRAZENECA$$$$$M$Y$$$20240805$$HP$CA$
241754532$24175453$2$F$$20240820$20240805$20240829$EXP$$JP-TEVA-VS-3227412$TEVA$Nakamoto K, Horimasu Y, Yamaguchi K, Sakamoto S, Masuda T, Miyamoto S, et al. Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases. Intern-Med 2024; 63 (12): 1783-1787.; Nakamoto K, Horimasu Y, Yamaguchi K, Sakamoto S, Masuda T, Miyamoto S, et al. Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases. Intern-Med 20...$63$YR$$M$Y$$$20240829$$HP$JP$JP
241754542$24175454$2$F$$20240919$20240805$20240919$PER$$NVSC2024US159145$NOVARTIS$$$$$$Y$$$20240919$$MD$US$US
241754551$24175455$1$I$20240507$20240730$20240805$20240805$PER$$NVSC2024US159144$NOVARTIS$$76$YR$$F$Y$$$20240805$$CN$US$US
241754562$24175456$2$F$$20240918$20240805$20240918$PER$$NVSC2024US159208$NOVARTIS$$$$$F$Y$$$20240918$$MD$US$US
241754571$24175457$1$I$$20240730$20240805$20240805$EXP$$NVSC2024US157281$NOVARTIS$$$$$$Y$$$20240805$$CN$US$US
241754581$24175458$1$I$$20240723$20240805$20240805$PER$$US-Calliditas-2024CAL01380$CALLIDITAS THERAPEUTICS$$34$YR$A$F$Y$70.7$KG$20240805$$CN$US$US
241754601$24175460$1$I$$20240805$20240805$20240805$PER$$NVSC2024US159280$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241754611$24175461$1$I$$20240728$20240805$20240805$EXP$$NVSC2024TW093843$NOVARTIS$$$$$$Y$$$20240805$$MD$TW$TW
241754621$24175462$1$I$20230201$20240729$20240805$20240805$EXP$$NVSC2024FR157964$NOVARTIS$$$$$$Y$$$20240805$$MD$FR$FR
241754631$24175463$1$I$20240301$20240729$20240805$20240805$EXP$$NVSC2024US123803$NOVARTIS$$16$YR$$F$Y$$$20240805$$HP$US$US
241754641$24175464$1$I$$20240731$20240805$20240805$PER$$NVSC2024US159279$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241754651$24175465$1$I$20240731$20240801$20240805$20240805$PER$$NVSC2024US159010$NOVARTIS$$$$$M$Y$$$20240805$$HP$US$US
241754681$24175468$1$I$$20240607$20240805$20240805$PER$$US-Amphastar Pharmaceuticals, Inc.-2160024$AMPHASTAR$$$$$F$Y$$$20240805$$$US$US
241754691$24175469$1$I$20230101$20230818$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000122$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754701$24175470$1$I$20230701$20230719$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000123$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754711$24175471$1$I$$20230721$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000125$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754721$24175472$1$I$20230101$20240212$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000126$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754731$24175473$1$I$$20230802$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000131$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754741$24175474$1$I$$20230803$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000133$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754751$24175475$1$I$$20230724$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000128$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754761$24175476$1$I$$20240729$20240805$20240805$EXP$$JP-TEVA-VS-3227413$TEVA$Nakamoto K, Horimasu Y, Yamaguchi K, Sakamoto S, Masuda T, Miyamoto S, et al. Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases. Intern-Med 2024; 63 (12): 1783-1787.; Nakamoto K, Horimasu Y, Yamaguchi K, Sakamoto S, Masuda T, Miyamoto S, et al. Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases. Intern-Med 20...$88$YR$$M$Y$$$20240805$$HP$JP$JP
241754771$24175477$1$I$$20230803$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000132$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754781$24175478$1$I$20230701$20230807$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000134$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754791$24175479$1$I$$20230707$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000118$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754801$24175480$1$I$$20230622$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000107$EVOKE PHARMA$$$$$$Y$$$20240716$$HP$US$US
241754811$24175481$1$I$20230601$20230626$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000110$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754821$24175482$1$I$$20230626$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000111$EVOKE PHARMA$$$$$$Y$$$20240716$$HP$US$US
241754831$24175483$1$I$$20230628$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000112$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754841$24175484$1$I$$20230628$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000113$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754851$24175485$1$I$20230101$20230707$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000116$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754861$24175486$1$I$$20230707$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000117$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241754871$24175487$1$I$$20230809$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000136$EVOKE PHARMA$$$$$$Y$$$20240724$$CN$US$US
241754881$24175488$1$I$20230101$20230815$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000137$EVOKE PHARMA$$$$$$Y$$$20240724$$CN$US$US
241754891$24175489$1$I$$20230822$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000144$EVOKE PHARMA$$$$$$Y$$$20240724$$CN$US$US
241754901$24175490$1$I$$20230823$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000145$EVOKE PHARMA$$$$$$Y$$$20240724$$HP$US$US
241754911$24175491$1$I$$20230824$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000149$EVOKE PHARMA$$$$$$Y$$$20240724$$MD$US$US
241754921$24175492$1$I$$20230829$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000150$EVOKE PHARMA$$$$$$Y$$$20240724$$HP$US$US
241754931$24175493$1$I$$20230828$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000152$EVOKE PHARMA$$$$$$Y$$$20240724$$CN$US$US
241754941$24175494$1$I$$20231215$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000153$EVOKE PHARMA$$$$$$Y$$$20240724$$CN$US$US
241754951$24175495$1$I$$20230901$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000155$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241754961$24175496$1$I$$20230906$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000157$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241754971$24175497$1$I$$20230906$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000158$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241754981$24175498$1$I$$20230913$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000159$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241754991$24175499$1$I$20230701$20230714$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000120$EVOKE PHARMA$$$$$$Y$$$20240716$$CN$US$US
241755001$24175500$1$I$20230801$20230823$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000147$EVOKE PHARMA$$$$$$Y$$$20240724$$CN$US$US
241755011$24175501$1$I$20230901$20230902$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000156$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755021$24175502$1$I$$20230921$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000162$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755031$24175503$1$I$$20230926$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000165$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755041$24175504$1$I$20230912$20230919$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000161$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755051$24175505$1$I$20230901$20230920$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000163$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755061$24175506$1$I$$20231024$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000187$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755071$24175507$1$I$$20231031$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000190$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755081$24175508$1$I$$20231120$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000193$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755091$24175509$1$I$20230101$20231026$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000181$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755101$24175510$1$I$20230101$20231024$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000182$EVOKE PHARMA$$$$$M$Y$$$20240723$$MD$US$US
241755111$24175511$1$I$$20231019$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000183$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755121$24175512$1$I$$20231023$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000185$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755131$24175513$1$I$20230101$20231027$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000188$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755141$24175514$1$I$$20231120$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000192$EVOKE PHARMA$$$$$$Y$$$20240723$$PH$US$US
241755151$24175515$1$I$$20231010$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000167$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755161$24175516$1$I$$20230929$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000168$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755171$24175517$1$I$20230901$20231010$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000171$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755181$24175518$1$I$$20231010$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000172$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755191$24175519$1$I$$20231013$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000173$EVOKE PHARMA$$$$$$Y$$$20240723$$HP$US$US
241755201$24175520$1$I$20231001$20231017$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000174$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755211$24175521$1$I$$20231017$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000178$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755221$24175522$1$I$$20231018$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000179$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755231$24175523$1$I$$20231026$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000180$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755241$24175524$1$I$20231101$20240111$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000006$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755251$24175525$1$I$$20240207$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000011$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755261$24175526$1$I$$20240215$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000015$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755271$24175527$1$I$20240101$20240312$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000016$EVOKE PHARMA$$$$$$Y$$$20240723$$MD$US$US
241755281$24175528$1$I$20240101$20240221$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000017$EVOKE PHARMA$$$$$F$Y$$$20240723$$CN$US$US
241755291$24175529$1$I$20240201$20240226$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000020$EVOKE PHARMA$$27$YR$$F$Y$$$20240723$$CN$US$US
241755301$24175530$1$I$20240201$20240313$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000022$EVOKE PHARMA$$18$YR$$F$Y$$$20240723$$HP$US$US
241755311$24175531$1$I$$20231215$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000196$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755321$24175532$1$I$$20231121$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000194$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755331$24175533$1$I$20231001$20231215$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000199$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755341$24175534$1$I$$20231218$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000201$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755351$24175535$1$I$$20231221$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000203$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755361$24175536$1$I$$20240102$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000205$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755371$24175537$1$I$20230101$20240102$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000001$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755381$24175538$1$I$$20240102$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000002$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755391$24175539$1$I$$20240424$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000032$EVOKE PHARMA$$62$YR$$F$Y$$$20240723$$HP$US$US
241755401$24175540$1$I$$20240501$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000033$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755411$24175541$1$I$$20240319$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000023$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755421$24175542$1$I$20240101$20240401$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000025$EVOKE PHARMA$$18$YR$$F$Y$$$20240723$$HP$US$US
241755431$24175543$1$I$20240322$20240402$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000026$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755441$24175544$1$I$20240301$20240506$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000034$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755451$24175545$1$I$$20240222$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000014$EVOKE PHARMA$$$$$$Y$$$20240723$$MD$US$US
241755461$24175546$1$I$20240501$20240606$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000035$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755471$24175547$1$I$$20230620$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000106$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755481$24175548$1$I$20230601$20230626$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000109$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755491$24175549$1$I$$20230706$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000115$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755501$24175550$1$I$$20230714$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000121$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755511$24175551$1$I$$20230623$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000108$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755521$24175552$1$I$$20230705$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000114$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755531$24175553$1$I$$20230713$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000119$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755541$24175554$1$I$$20230719$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000124$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755551$24175555$1$I$$20230724$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000127$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755561$24175556$1$I$$20230726$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000129$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755571$24175557$1$I$$20230727$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000130$EVOKE PHARMA$$$$$$Y$$$20240723$$HP$US$US
241755581$24175558$1$I$$20230816$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000138$EVOKE PHARMA$$$$$$Y$$$20240723$$MD$US$US
241755591$24175559$1$I$$20230901$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000140$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755601$24175560$1$I$20230801$20230818$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000141$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755611$24175561$1$I$$20230829$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000151$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755621$24175562$1$I$$20230926$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000164$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755631$24175563$1$I$$20231016$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000175$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755641$24175564$1$I$20240301$20240423$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000031$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755651$24175565$1$I$$20230818$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000142$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755661$24175566$1$I$20231125$20231228$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000207$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755671$24175567$1$I$20240430$20240607$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000037$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755681$24175568$1$I$$20231016$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000176$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755691$24175569$1$I$$20231014$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000177$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755701$24175570$1$I$$20231020$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000184$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755711$24175571$1$I$$20231027$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000186$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755721$24175572$1$I$$20231031$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000189$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755731$24175573$1$I$$20231214$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000197$EVOKE PHARMA$$$$$$Y$$$20240723$$MD$US$US
241755741$24175574$1$I$$20231214$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000198$EVOKE PHARMA$$$$$$Y$$$20240723$$MD$US$US
241755751$24175575$1$I$20231001$20231215$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000200$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755761$24175576$1$I$20240213$20240327$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000013$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755771$24175577$1$I$$20240112$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000007$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755781$24175578$1$I$$20240108$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000004$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755791$24175579$1$I$$20240209$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000012$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755801$24175580$1$I$20231218$20231229$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000202$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755811$24175581$1$I$$20231220$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000204$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755821$24175582$1$I$$20231222$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000206$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755831$24175583$1$I$$20240105$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000003$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755841$24175584$1$I$20240223$20240223$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000019$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755851$24175585$1$I$20240128$20240304$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000021$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755861$24175586$1$I$20240415$20240415$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000030$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755871$24175587$1$I$20240410$20240410$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000028$EVOKE PHARMA$$$$$$Y$$$20240723$$HP$US$US
241755881$24175588$1$I$20240501$20240524$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000036$EVOKE PHARMA$$40$YR$$F$Y$$$20240723$$MD$US$US
241755891$24175589$1$I$20240101$20240221$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000018$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755901$24175590$1$I$20240101$20240606$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000038$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755911$24175591$1$I$20230101$20240222$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2024EVO000010$EVOKE PHARMA$$$$$$Y$$$20240723$$MD$US$US
241755921$24175592$1$I$$20231201$20240805$20240805$PER$$US-EVOKE PHARMA, INC.-2023EVO000195$EVOKE PHARMA$$$$$$Y$$$20240723$$CN$US$US
241755931$24175593$1$I$$20240731$20240805$20240805$EXP$$US-OTSUKA-2024_017039$OTSUKA$$$$$F$Y$$$20240805$$MD$US$US
241755941$24175594$1$I$$20240805$20240805$20240805$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043845$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240805$$CN$US$US
241755951$24175595$1$I$20170825$20240724$20240805$20240805$EXP$$GB-BAUSCHBL-2024BNL031046$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240805$$CN$GB$GB
241755961$24175596$1$I$$20240725$20240805$20240805$PER$$US-JNJFOC-20240775289$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241755971$24175597$1$I$20240603$20240729$20240805$20240805$EXP$DE-PEI-CADR2024329527$DE-009507513-2407DEU015382$MERCK$$68$YR$$F$Y$41$KG$20240805$$MD$DE$DE
241755982$24175598$2$F$$20240820$20240805$20240829$EXP$$US-TEVA-VS-3227908$TEVA$Mcgourty M, Adams EW, Lyons J, Ayyaswami V, Holdorf JD. MDA-5 Associated Dermatomyositis: A Case of Delayed Care and Dire Consequences. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.; Mcgourty M, Adams EW, Lyons J, Ayyaswami V, Holdorf JD. MDA-5 Associated Dermatomyositis: A Case of Delayed Care and Dire Consequences. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.$43$YR$$M$Y$$$20240829$$HP$US$US
241755992$24175599$2$F$20240705$20240815$20240805$20240820$EXP$$US-OTSUKA-2024_021306$OTSUKA$$$$$F$Y$$$20240820$$MD$US$US
241756001$24175600$1$I$20240730$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407020362$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240805$$CN$US$US
241756011$24175601$1$I$$20240723$20240805$20240805$EXP$$NVSC2024CA155611$NOVARTIS$$50$YR$$F$Y$$$20240805$$HP$CA$CA
241756031$24175603$1$I$20240531$20240729$20240805$20240805$EXP$$EC-Ipsen Biopharmaceuticals, Inc.-2024-15440$IPSEN$$86$YR$E$M$Y$$$20240805$$MD$EC$EC
241756042$24175604$2$F$$20240813$20240805$20240909$PER$$US-LUNDBECK-DKLU4001012$LUNDBECK$$$$$$Y$$$20240909$$CN$US$US
241756052$24175605$2$F$$20240912$20240805$20240918$PER$$US-AMGEN-USASP2024152141$AMGEN$$23$YR$A$F$Y$$$20240917$$CN$US$US
241756061$24175606$1$I$20240419$20240731$20240805$20240805$EXP$$AU-WAYLIS-2024-AU-000314$Waylis$$79$YR$$M$Y$$$20240801$$CN$AU$AU
241756072$24175607$2$F$20240719$20240817$20240805$20240821$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043842$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$41$KG$20240821$$HP$CO$CO
241756081$24175608$1$I$$20240727$20240805$20240805$EXP$$AE-BAUSCHBL-2024BNL030822$BAUSCH AND LOMB$$59$YR$$M$Y$$$20240805$$MD$AE$AE
241756091$24175609$1$I$$20230125$20240805$20240805$EXP$$US-AstraZeneca-2023A022359$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241756102$24175610$2$F$$20240819$20240805$20240904$PER$$US-AstraZeneca-2024A166908$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
241756111$24175611$1$I$$20220117$20240805$20240805$EXP$$CA-AstraZeneca-2022A031497$ASTRAZENECA$$$$$F$Y$$$20240805$$CN$CA$
241756131$24175613$1$I$$20230524$20240805$20240805$EXP$$US-AstraZeneca-2023A121813$ASTRAZENECA$$$$$M$Y$$$20240805$$CN$US$
241756141$24175614$1$I$$20240716$20240805$20240805$PER$$US-009507513-2407USA010348$MERCK$$$$$F$Y$$$20240805$$PH$US$US
241756151$24175615$1$I$$20240803$20240805$20240805$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043792$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240805$$MD$BR$BR
241756172$24175617$2$F$20240201$20240809$20240805$20240814$EXP$$US-INCYTE CORPORATION-2024IN007921$INCYTE$$$$$$Y$$$20240814$$HP$US$US
241756181$24175618$1$I$$20231208$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240714$IRONSHORE PHARMA$$9$YR$C$$Y$$$20240805$$MD$US$US
241756191$24175619$1$I$$20231113$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240717$IRONSHORE PHARMA$$$$$M$Y$$$20240805$$HP$US$US
241756201$24175620$1$I$$20231101$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240713$IRONSHORE PHARMA$$$$$M$Y$$$20240805$$CN$US$US
241756211$24175621$1$I$20231101$20231110$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240716$IRONSHORE PHARMA$$11$YR$C$M$Y$$$20240805$$HP$US$US
241756221$24175622$1$I$$20231108$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240715$IRONSHORE PHARMA$$$$$$Y$$$20240805$$MD$US$US
241756231$24175623$1$I$$20231109$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240718$IRONSHORE PHARMA$$$$C$M$Y$$$20240805$$MD$US$US
241756241$24175624$1$I$$20231109$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240719$IRONSHORE PHARMA$$$$C$M$Y$$$20240805$$MD$US$US
241756251$24175625$1$I$20240611$20240724$20240805$20240805$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407020290$ELI LILLY AND CO$$54$YR$A$M$Y$55$KG$20240805$$CN$DE$CN
241756262$24175626$2$F$20240605$20240801$20240805$20240814$EXP$IT-MINISAL02-996341$IT-ELI_LILLY_AND_COMPANY-IT202407016435$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240814$$CN$IT$IT
241756271$24175627$1$I$$20231109$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240720$IRONSHORE PHARMA$$$$C$M$Y$$$20240805$$MD$US$US
241756281$24175628$1$I$$20240726$20240805$20240805$PER$$US-JNJFOC-20240775944$JOHNSON AND JOHNSON$$$$$$Y$$$20240805$$CN$US$US
241756292$24175629$2$F$$20240725$20240805$20240816$PER$$US-JNJFOC-20240772190$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$US$US
241756301$24175630$1$I$20240718$20240724$20240805$20240805$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407020296$ELI LILLY AND CO$$64$YR$A$F$Y$50$KG$20240805$$CN$DE$CN
241756311$24175631$1$I$20240301$20240614$20240805$20240805$PER$$US-LUNDBECK-DKLU4000567$LUNDBECK$$$$$$Y$$$20240805$$CN$US$US
241756321$24175632$1$I$$20240801$20240805$20240805$EXP$$US-INCYTE CORPORATION-2024IN008101$INCYTE$$$$$$Y$$$20240805$$CN$US$US
241756331$24175633$1$I$20240731$20240731$20240805$20240805$EXP$$AU-GE HEALTHCARE-2024CSU008719$GE HEALTHCARE$$22$YR$$M$Y$110$KG$20240805$$HP$AU$AU
241756341$24175634$1$I$20240723$20240729$20240805$20240805$EXP$$AU-GE HEALTHCARE-2024CSU008559$GE HEALTHCARE$$49$YR$$M$Y$98$KG$20240805$$HP$AU$AU
241756351$24175635$1$I$20231109$20240728$20240805$20240805$EXP$DE-DCGMA-24203655$DE-GE HEALTHCARE-2024CSU008509$GE HEALTHCARE$$83$YR$$F$Y$47$KG$20240805$$HP$DE$DE
241756361$24175636$1$I$$20240715$20240805$20240805$PER$$US-009507513-2407USA010500$MERCK$$$$$F$Y$$$20240805$$CN$US$US
241756371$24175637$1$I$20240525$20240729$20240805$20240805$EXP$$CH-GE HEALTHCARE-2024CSU008561$GE HEALTHCARE$$67$YR$$F$Y$$$20240805$$HP$CH$CH
241756381$24175638$1$I$20240714$20240729$20240805$20240805$EXP$$CN-AstraZeneca-2024A174280$ASTRAZENECA$$16380$DY$$F$Y$40$KG$20240805$$MD$CN$
241756391$24175639$1$I$20240701$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122114$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240805$$CN$US$US
241756401$24175640$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122073$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240805$$HP$US$US
241756411$24175641$1$I$$20240613$20240805$20240805$PER$$US-LUNDBECK-DKLU4000516$LUNDBECK$$$$$$Y$$$20240805$$CN$US$US
241756431$24175643$1$I$20230301$20240723$20240805$20240805$EXP$$AU-OTSUKA AUSTRALIA PHARMACEUTICALS PTY LTD-2024_020674$OTSUKA$$38$YR$$F$Y$$$20240805$$CN$AU$AU
241756441$24175644$1$I$20240726$20240731$20240805$20240805$EXP$$US-INCYTE CORPORATION-2024IN008031$INCYTE$$$$$$Y$$$20240805$$MD$US$US
241756451$24175645$1$I$$20240725$20240805$20240805$PER$$US-JNJFOC-20240809378$JOHNSON AND JOHNSON$$7$DEC$E$F$Y$$$20240805$$CN$US$US
241756461$24175646$1$I$$20240802$20240805$20240805$PER$$US-GILEAD-2024-0682812$GILEAD$$$$$M$Y$$$20240805$$MD$US$US
241756471$24175647$1$I$$20240801$20240805$20240805$EXP$$AR-BIOGEN-2024BI01276928$BIOGEN$$$$$F$Y$$$20240805$$MD$AR$AR
241756481$24175648$1$I$$20231109$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240723$IRONSHORE PHARMA$$$$C$M$Y$$$20240805$$MD$US$US
241756491$24175649$1$I$$20231109$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240722$IRONSHORE PHARMA$$$$C$M$Y$$$20240805$$MD$US$US
241756501$24175650$1$I$$20231109$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240721$IRONSHORE PHARMA$$$$C$M$Y$$$20240805$$MD$US$US
241756511$24175651$1$I$$20231121$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240727$IRONSHORE PHARMA$$22$YR$A$M$Y$$$20240805$$HP$US$US
241756521$24175652$1$I$$20231110$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240731$IRONSHORE PHARMA$$12$YR$T$$Y$$$20240805$$HP$US$US
241756531$24175653$1$I$20231026$20231120$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240725$IRONSHORE PHARMA$$11$YR$C$F$Y$$$20240805$$MD$US$US
241756541$24175654$1$I$$20231122$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240728$IRONSHORE PHARMA$$9$YR$C$M$Y$$$20240805$$MD$US$US
241756551$24175655$1$I$$20231205$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240732$IRONSHORE PHARMA$$8$YR$C$M$Y$$$20240805$$MD$US$US
241756561$24175656$1$I$$20240802$20240805$20240805$PER$$US-JNJFOC-20240806746$JOHNSON AND JOHNSON$$$$$F$Y$$$20240805$$CN$US$US
241756571$24175657$1$I$20231101$20231204$20240805$20240805$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240730$IRONSHORE PHARMA$$12$YR$T$M$Y$$$20240805$$CN$US$US
241756581$24175658$1$I$$20240801$20240805$20240805$EXP$$US-INCYTE CORPORATION-2024IN008086$INCYTE$$$$$$Y$$$20240805$$HP$US$US
241756591$24175659$1$I$20240718$20240724$20240805$20240805$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07463$NEUROCRINE BIOSCIENCES$$54$YR$$F$Y$$$20240805$$CN$US$US
241756612$24175661$2$F$$20240827$20240805$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123563$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$79.38$KG$20240828$$CN$US$US
241756622$24175662$2$F$$20240917$20240805$20240918$PER$$NVSC2024US159281$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
241756631$24175663$1$I$$20240730$20240805$20240805$EXP$$CA-ANIPHARMA-2024-CA-003472$ANI$$69$YR$$M$Y$$$20240805$$HP$CA$CA
241756642$24175664$2$F$20240703$20240810$20240805$20240815$EXP$$FR-ANIPHARMA-2024-FR-000126$ANI$$89$YR$$M$Y$103$KG$20240815$$MD$FR$FR
241756651$24175665$1$I$$20240802$20240805$20240805$PER$$NVSC2024US159205$NOVARTIS$$$$$$Y$$$20240805$$HP$US$US
241756661$24175666$1$I$$20240730$20240805$20240805$EXP$$US-SANDOZ INC.-SDZ2024US070058$SANDOZ$$$$$$Y$$$20240805$$CN$US$US
241756671$24175667$1$I$$20240724$20240805$20240805$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407008893$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240805$$CN$KR$KR
241756681$24175668$1$I$$20240805$20240805$20240805$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043853$BOEHRINGER INGELHEIM$$$$$$Y$$$20240805$$CN$US$US
241756691$24175669$1$I$$20240729$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407019451$ELI LILLY AND CO$$$$$$Y$$$20240805$$HP$US$US
241756701$24175670$1$I$$20240805$20240805$20240805$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043870$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240805$$CN$US$US
241756711$24175671$1$I$20240424$20240729$20240805$20240805$EXP$IT-MINISAL02-996559$IT-009507513-2407ITA015840$MERCK$$67$YR$$M$Y$175$KG$20240805$$MD$IT$IT
241756722$24175672$2$F$$20240919$20240805$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121474$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$113.85$KG$20240924$$HP$US$US
241756731$24175673$1$I$20200717$20240801$20240805$20240805$EXP$$US-PURDUE PHARMA-USA-2024-0311110$PURDUE$$34$YR$$M$Y$$$20240805$$CN$US$US
241756741$24175674$1$I$$20240722$20240805$20240805$EXP$$NVSC2024CN158815$NOVARTIS$Zhihui M. Exposure to sacubitril/valsartan in late pregnancy causes premature birth and acute renal failure in newborns. JOURNAL OF ADVERSE DRUG REACTIONS. 2024;25$$$N$M$Y$2.23$KG$20240806$$HP$CN$CN
241756751$24175675$1$I$20240424$20240729$20240805$20240805$EXP$$NVSC2024DE124231$NOVARTIS$$43$YR$$F$Y$58$KG$20240806$$MD$DE$DE
241756773$24175677$3$F$20201201$20240730$20240805$20240814$EXP$PL-ROCHE-10000012563$NVSC2024PL154602$NOVARTIS$$49$YR$$M$Y$$$20240814$$HP$PL$PL
241756781$24175678$1$I$20240701$20240730$20240805$20240805$PER$$US-JNJFOC-20240782191$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240805$$CN$US$US
241756791$24175679$1$I$20230905$20240730$20240805$20240805$EXP$LT-JNJFOC-20231112562$LT-GILEAD-2024-0682750$GILEAD$$$$E$F$Y$$$20240805$$MD$LT$LT
241756801$24175680$1$I$$20240804$20240805$20240805$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043670$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240805$$HP$DE$DE
241756811$24175681$1$I$$20240730$20240805$20240805$PER$$US-ALXN-202407USA002146US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241756821$24175682$1$I$20240725$20240726$20240805$20240805$PER$$US-SA-2024SA226238$SANOFI AVENTIS$$54$YR$A$F$Y$83.9$KG$20240806$$MD$US$US
241756831$24175683$1$I$$20240801$20240805$20240805$EXP$$IN-ROCHE-10000048873$ROCHE$$71$YR$E$M$Y$$$20240805$$CN$IN$IN
241756841$24175684$1$I$20240401$20240730$20240805$20240805$PER$$US-ALXN-202407USA002147US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240805$$CN$US$US
241756851$24175685$1$I$20240723$20240723$20240805$20240805$PER$$US-TEVA-VS-3226953$TEVA$$67$YR$$M$Y$$$20240805$$CN$US$US
241756861$24175686$1$I$20210101$20240731$20240805$20240805$EXP$$PT-009507513-2408PRT001141$MERCK$$60$YR$$M$Y$$$20240805$$MD$PT$PT
241756872$24175687$2$F$20240701$20240801$20240805$20240809$EXP$$MY-ANIPHARMA-2024-MY-000014$ANI$$$$$F$Y$$$20240809$$MD$MY$MY
241756881$24175688$1$I$$20240730$20240805$20240805$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042895$BOEHRINGER INGELHEIM$Atsushi Masuyama, Hideto Ishii; Exploratory Research of the Efficacy, Usefulness and Safety of the Dietary-management Application for Adult Patients with Type 2 Diabetes Receiving Insulin Treatment; Journal of New Remedies + Clinics;2024;73;7;667-685$$$$$Y$$$20240805$$CN$JP$JP
241756891$24175689$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA227410$SANOFI AVENTIS$$17$YR$T$M$Y$69.85$KG$20240806$$MD$US$US
241756902$24175690$2$F$20240101$20240814$20240805$20240820$PER$$US-AMGEN-USASP2024153856$AMGEN$$54$YR$A$F$Y$74.83$KG$20240820$$CN$US$US
241756911$24175691$1$I$$20240802$20240805$20240805$PER$$NVSC2024US159013$NOVARTIS$$$$$$Y$$$20240806$$HP$US$US
241756922$24175692$2$F$20240718$20240910$20240805$20240910$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043847$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$79$KG$20240910$$MD$CA$CA
241756932$24175693$2$F$20220101$20240813$20240805$20240820$PER$$US-ALXN-202407USA002113US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
241756941$24175694$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA227407$SANOFI AVENTIS$$$$E$M$Y$81.6$KG$20240806$$MD$US$US
241756951$24175695$1$I$$20240729$20240805$20240805$EXP$$US-MTPC-MTDA2024-0015863$UNKNOWN$$61$YR$$F$Y$$$20240805$$CN$US$US
241756961$24175696$1$I$20240721$20240729$20240805$20240805$PER$$US-MTPC-MTDA2024-0015879$UNKNOWN$$55$YR$$F$Y$$$20240805$$CN$US$US
241756971$24175697$1$I$$20240716$20240805$20240805$PER$$US-009507513-2407USA011308$MERCK$$$$$F$Y$$$20240805$$HP$US$US
241756981$24175698$1$I$20230801$20240730$20240805$20240805$EXP$$US-009507513-2407USA015863$MERCK$Newman M.T, Bikhchandani M. A Fatal Case of Immune Checkpoint Inhibitor-Mediated Myasthenia Gravis, Myositis, and Cardiomyopathy Overlap Syndrome in Urothelial Carcinoma. Cancer reports. 2024;7:e2140$87$YR$$M$Y$$$20240805$$HP$US$US
241756991$24175699$1$I$$20240801$20240805$20240805$PER$$US-BIOMARINAP-US-2024-159574$BIOMARIN$$$$$$Y$$$20240805$$CN$US$US
241757001$24175700$1$I$$20240730$20240805$20240805$PER$$US-BIOMARINAP-US-2024-159558$BIOMARIN$$$$$$Y$$$20240805$$CN$US$US
241757011$24175701$1$I$$20240731$20240805$20240805$PER$$US-BIOMARINAP-US-2024-159540$BIOMARIN$$$$$$Y$$$20240805$$CN$US$US
241757022$24175702$2$F$$20240822$20240805$20240903$PER$$US-BIOMARINAP-US-2024-159587$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
241757031$24175703$1$I$$20240722$20240805$20240805$EXP$$CA-HLS-202401557$HLS THERAPEUTICS$$$$$F$Y$$$20240805$$HP$CA$CA
241757061$24175706$1$I$$20240801$20240805$20240805$PER$$US-BIOMARINAP-US-2024-159590$BIOMARIN$$$$$$Y$$$20240805$$CN$US$US
241757072$24175707$2$F$20230926$20240801$20240805$20240829$EXP$$JP-AstraZeneca-2024A159205$ASTRAZENECA$$86$YR$$F$Y$$$20240829$$MD$JP$
241757081$24175708$1$I$$20240801$20240805$20240805$PER$$US-BIOMARINAP-US-2024-159598$BIOMARIN$$$$$$Y$$$20240805$$CN$US$US
241757101$24175710$1$I$20240730$20240731$20240805$20240805$PER$$US-BIOMARINAP-US-2024-159564$BIOMARIN$$$$$$Y$$$20240805$$CN$US$US
241757111$24175711$1$I$$20240731$20240805$20240805$EXP$$NVSC2024US157557$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
241757121$24175712$1$I$$20240709$20240805$20240805$PER$$US-AstraZeneca-2024A158658$ASTRAZENECA$$15$YR$$F$Y$$$20240806$$MD$US$
241757131$24175713$1$I$20240721$20240724$20240805$20240805$PER$$US-JNJFOC-20240768156$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240806$$CN$US$US
241757141$24175714$1$I$20240101$20240805$20240805$20240805$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043879$BOEHRINGER INGELHEIM$$$$$$Y$$$20240806$$HP$US$US
241757151$24175715$1$I$20210101$20240723$20240805$20240805$EXP$$JP-SMPA-2024SMP011338$SUNOVION$$$$$$Y$$$20240805$$CN$JP$JP
241757161$24175716$1$I$$20240624$20240805$20240805$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202407017449$ELI LILLY AND CO$$$$E$$Y$$$20240805$$CN$CA$CA
241757171$24175717$1$I$$20240802$20240805$20240805$PER$$NVSC2024US158604$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
241757182$24175718$2$F$20240611$20240805$20240805$20240806$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-033283$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240806$$CN$US$US
241757191$24175719$1$I$20240101$20240731$20240805$20240805$EXP$$US-JNJFOC-20240802153$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240806$$HP$US$US
241757211$24175721$1$I$$20240801$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408002038$ELI LILLY AND CO$$$$$F$Y$$$20240805$$MD$US$US
241757221$24175722$1$I$$20240805$20240805$20240805$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043890$BOEHRINGER INGELHEIM$$$$$$Y$$$20240806$$CN$US$US
241757232$24175723$2$F$20240710$20240801$20240805$20240807$PER$$US-AMGEN-USASP2024152699$AMGEN$$69$YR$E$M$Y$$$20240806$$HP$US$US
241757241$24175724$1$I$20240725$20240802$20240805$20240805$PER$$US-BIOMARINAP-US-2024-159618$BIOMARIN$$$$$$Y$$$20240805$$CN$US$US
241757251$24175725$1$I$$20240801$20240805$20240805$PER$$US-BIOMARINAP-US-2024-159585$BIOMARIN$$$$$$Y$$$20240805$$CN$US$US
241757262$24175726$2$F$$20240829$20240805$20240902$EXP$$DE-SANDOZ INC.-SDZ2024DE070457$SANDOZ$$46$YR$$F$Y$$$20240902$$HP$DE$DE
241757271$24175727$1$I$$20240727$20240805$20240805$PER$$US-AMGEN-USASP2024150962$AMGEN$$$$$F$Y$$$20240805$$HP$US$US
241757281$24175728$1$I$$20240802$20240805$20240805$PER$$NVSC2024US159284$NOVARTIS$$$$$$Y$$$20240806$$HP$US$US
241757291$24175729$1$I$$20240805$20240805$20240805$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043894$BOEHRINGER INGELHEIM$$$$$$Y$$$20240806$$CN$US$US
241757302$24175730$2$F$$20240905$20240805$20240913$EXP$$NVSJ2024JP009323$NOVARTIS$$67$YR$$M$Y$62$KG$20240913$$MD$JP$JP
241757311$24175731$1$I$$20240730$20240805$20240805$EXP$$JP-009507513-2407JPN005454J$MERCK$$$$$F$Y$$$20240805$$MD$JP$JP
241757321$24175732$1$I$20231001$20240730$20240805$20240805$EXP$$CO-JNJFOC-20240370357$JOHNSON AND JOHNSON$$52$YR$A$M$Y$70$KG$20240806$$HP$CO$CO
241757331$24175733$1$I$$20240730$20240805$20240805$EXP$$AR-AMGEN-ARGSP2024154568$AMGEN$$57$YR$A$F$Y$$$20240805$$CN$AR$AR
241757341$24175734$1$I$20240607$20240805$20240805$20240805$EXP$FR-AFSSAPS-LY2024000956$FR-JNJFOC-20240809799$JOHNSON AND JOHNSON$$66$YR$E$F$Y$47.6$KG$20240806$$PH$FR$FR
241757352$24175735$2$F$20240229$20240909$20240805$20240912$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043813$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$88$KG$20240912$$MD$DE$DE
241757361$24175736$1$I$20240612$20240730$20240805$20240805$EXP$$JP-009507513-2407JPN005462J$MERCK$$9$DEC$$M$Y$$$20240805$$MD$JP$JP
241757371$24175737$1$I$20240804$20240805$20240805$20240805$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043851$BOEHRINGER INGELHEIM$$85$YR$E$$Y$$$20240806$$CN$US$US
241757382$24175738$2$F$$20240910$20240805$20240920$EXP$$CA-APOTEX-2024AP008909$APOTEX$$74$YR$$F$Y$$$20240920$$CN$CA$CA
241757391$24175739$1$I$$20240801$20240805$20240805$PER$$US-JNJFOC-20240803525$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$US$US
241757401$24175740$1$I$$20240726$20240805$20240805$PER$$US-JNJFOC-20240774969$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$US$US
241757411$24175741$1$I$$20240731$20240805$20240805$EXP$$US-JNJFOC-20240785417$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241757422$24175742$2$F$20231121$20240808$20240805$20240814$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043147$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$64.6$KG$20240814$$MD$US$US
241757431$24175743$1$I$$20240729$20240805$20240805$PER$$US-ALXN-202407USA001969US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$HP$US$US
241757441$24175744$1$I$$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123439$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240806$$MD$US$US
241757451$24175745$1$I$20240717$20240729$20240805$20240805$EXP$$CN-AstraZeneca-2024A174259$ASTRAZENECA$$22498$DY$$M$Y$70$KG$20240806$$MD$CN$
241757462$24175746$2$F$$20240909$20240805$20240911$EXP$$JP-TAKEDA-2024TJP011638$TAKEDA$$13$YR$$M$Y$$$20240911$$MD$JP$JP
241757471$24175747$1$I$$20240730$20240805$20240805$EXP$$US-BIOGEN-2024BI01276283$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
241757482$24175748$2$F$$20240827$20240805$20240829$PER$$US-AMGEN-USASP2024153903$AMGEN$$$$$F$Y$$$20240829$$CN$US$US
241757491$24175749$1$I$$20240729$20240805$20240805$EXP$$IL-AMGEN-ISRSP2024152692$AMGEN$$52$YR$A$F$Y$$$20240805$$MD$IL$IL
241757503$24175750$3$F$20231201$20240805$20240805$20240809$PER$$US-ORGANON-O2407USA002366$ORGANON$$30$YR$$F$Y$107.94$KG$20240809$$MD$US$US
241757511$24175751$1$I$$20240805$20240805$20240805$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043901$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240806$$CN$US$US
241757521$24175752$1$I$20240201$20240730$20240805$20240805$EXP$$BR-BIOGEN-2024BI01276553$BIOGEN$$55$YR$$F$Y$60$KG$20240805$$HP$BR$BR
241757541$24175754$1$I$20240718$20240719$20240805$20240805$PER$$US-JNJFOC-20240756175$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$CN$US$US
241757551$24175755$1$I$$20240802$20240805$20240805$PER$$US-JNJFOC-20240807308$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$US$US
241757561$24175756$1$I$20240701$20240801$20240805$20240805$EXP$$US-ABBVIE-5865821$ABBVIE$$67$YR$$M$Y$$$20240805$$HP$US$US
241757571$24175757$1$I$$20240729$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120568$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240806$$HP$US$US
241757581$24175758$1$I$$20240801$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122922$BRISTOL MYERS SQUIBB$$28$YR$A$M$Y$81.65$KG$20240806$$CN$US$US
241757601$24175760$1$I$$20240728$20240805$20240805$PER$$US-AMGEN-USASP2024154390$AMGEN$Proute M.; Haynes T.; Fishberg R. et al.. Rethinking Prevention: Need for earlier intervention in Familial Hypercholesteremia despite Statin and PCSK9 Inhibitor Therapy. Journal of Clinical Lipidology. 2024;18 (4):e543$49$YR$A$M$Y$$$20240805$$MD$US$US
241757611$24175761$1$I$$20240725$20240805$20240805$PER$$US-ROCHE-10000040251$ROCHE$$68$YR$E$M$Y$$$20240806$$CN$US$US
241757621$24175762$1$I$$20240729$20240805$20240805$EXP$$JP-MTPC-MTPC2024-0016164$UNKNOWN$Kazume D. Varicella without skin eruption -Bilateral medial medullary infarction due to herpes zoster virus vasculopathy in a young female patient. Clinical Neurology. 2024$36$YR$$F$Y$$$20240805$$MD$JP$JP
241757631$24175763$1$I$$20240726$20240805$20240805$EXP$$CZ-ABBVIE-5859155$ABBVIE$$$$$F$Y$$$20240805$$CN$CZ$CZ
241757642$24175764$2$F$20240701$20240822$20240805$20240823$PER$$US-ALXN-202407USA002142US$ALEXION PHARMACEUTICALS$$37$YR$$F$Y$$$20240823$$CN$US$US
241757652$24175765$2$F$20240726$20240805$20240805$20240808$PER$$US-ROCHE-10000040908$ROCHE$$$$$$Y$$$20240808$$PH$US$US
241757661$24175766$1$I$$20240731$20240805$20240805$EXP$$US-ABBVIE-5863263$ABBVIE$$56$YR$$F$Y$$$20240805$$CN$US$US
241757671$24175767$1$I$20240101$20240801$20240805$20240805$EXP$$US-ABBVIE-5865232$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241757681$24175768$1$I$$20240730$20240805$20240805$PER$$US-ROCHE-10000044270$ROCHE$$$$$M$Y$$$20240806$$MD$US$US
241757691$24175769$1$I$20240731$20240801$20240805$20240805$EXP$$US-ABBVIE-5865214$ABBVIE$$79$YR$$M$Y$$$20240805$$CN$US$US
241757702$24175770$2$F$20240301$20240826$20240805$20240829$PER$$US-ROCHE-10000041679$ROCHE$$49$YR$A$F$Y$90.72$KG$20240829$$MD$US$US
241757712$24175771$2$F$$20240823$20240805$20240828$EXP$$US-ABBVIE-5864541$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
241757722$24175772$2$F$$20240801$20240805$20240809$PER$$US-BAUSCHBL-2024BNL030915$BAUSCH AND LOMB$$$$$F$Y$$$20240809$$CN$US$US
241757731$24175773$1$I$$20240731$20240805$20240805$EXP$$CA-TAKEDA-2024TUS077485$TAKEDA$$$$$F$Y$$$20240805$$CN$CA$CA
241757741$24175774$1$I$$20240731$20240805$20240805$PER$$US-ROCHE-10000046357$ROCHE$$$$E$F$Y$$$20240806$$CN$US$US
241757752$24175775$2$F$$20240808$20240805$20240814$EXP$$CA-TAKEDA-2024TUS076961$TAKEDA$$$$$M$Y$$$20240814$$CN$CA$CA
241757761$24175776$1$I$$20240731$20240805$20240805$PER$$US-ROCHE-10000046324$ROCHE$$$$$$Y$$$20240806$$CN$US$US
241757771$24175777$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227013$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
241757781$24175778$1$I$20240101$20240729$20240805$20240805$PER$$US-SA-2024SA227219$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240806$$CN$US$US
241757791$24175779$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA227091$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240806$$MD$US$US
241757801$24175780$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA227118$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240806$$CN$US$US
241757811$24175781$1$I$20240615$20240730$20240805$20240805$PER$$US-SA-2024SA226806$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240806$$HP$US$US
241757821$24175782$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000047261$ROCHE$$$$$$Y$$$20240806$$CN$US$US
241757831$24175783$1$I$$20240801$20240805$20240805$PER$$US-ROCHE-10000047438$ROCHE$$$$$$Y$$$20240806$$CN$US$US
241757841$24175784$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA226910$SANOFI AVENTIS$$$$C$M$Y$$$20240806$$MD$US$US
241757851$24175785$1$I$20240715$20240729$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011790$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241757861$24175786$1$I$20240715$20240729$20240805$20240805$PER$$US-SA-2024SA227222$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240806$$MD$US$US
241757871$24175787$1$I$20240601$20240730$20240805$20240805$PER$$US-SA-2024SA227192$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240806$$MD$US$US
241757881$24175788$1$I$20240101$20240726$20240805$20240805$PER$$US-SA-2024SA224397$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240806$$MD$US$US
241757891$24175789$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA227528$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240806$$MD$US$US
241757901$24175790$1$I$20231218$20240731$20240805$20240805$EXP$$CA-TAKEDA-2024TUS077495$TAKEDA$$54$YR$$M$Y$$$20240805$$CN$CA$CA
241757911$24175791$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227176$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240806$$MD$US$US
241757921$24175792$1$I$20240701$20240730$20240805$20240805$PER$$US-SA-2024SA227575$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240806$$MD$US$US
241757933$24175793$3$F$$20240906$20240805$20240911$PER$$US-ROCHE-10000047594$ROCHE$$$$A$F$Y$$$20240911$$CN$US$US
241757942$24175794$2$F$$20240813$20240805$20240814$PER$$US-AstraZeneca-2024A159597$ASTRAZENECA$$$$$F$Y$$$20240814$$MD$US$
241757951$24175795$1$I$20240716$20240729$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011795$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241757961$24175796$1$I$$20240729$20240805$20240805$EXP$$CA-ABBVIE-5866490$ABBVIE$$$$A$F$Y$$$20240805$$CN$CA$CA
241757971$24175797$1$I$$20240801$20240805$20240805$PER$$US-TAKEDA-2024TUS077414$TAKEDA$$$$$F$Y$53$KG$20240805$$MD$US$US
241757981$24175798$1$I$$20240731$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122991$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240806$$HP$US$US
241757991$24175799$1$I$20240101$20240802$20240805$20240805$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122974$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240806$$HP$US$US
241758001$24175800$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA229088$SANOFI AVENTIS$$$$A$F$Y$65$KG$20240806$$MD$US$US
241758011$24175801$1$I$$20240726$20240805$20240805$PER$$US-SA-2024SA224250$SANOFI AVENTIS$$$$A$M$Y$$$20240806$$MD$US$US
241758021$24175802$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA229279$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240806$$MD$US$US
241758031$24175803$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA227566$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240806$$MD$US$US
241758041$24175804$1$I$$20240731$20240805$20240805$EXP$$US-ABBVIE-5640275$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241758051$24175805$1$I$$20240729$20240805$20240805$EXP$$JP-JNJFOC-20221056826$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240806$$MD$JP$JP
241758061$24175806$1$I$$20240731$20240805$20240805$EXP$$CA-ABBVIE-5865480$ABBVIE$$$$E$F$Y$$$20240805$$CN$CA$CA
241758071$24175807$1$I$20240701$20240731$20240805$20240805$EXP$$CA-ABBVIE-5864372$ABBVIE$$15$YR$$M$Y$$$20240805$$HP$CA$CA
241758081$24175808$1$I$20240717$20240729$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011777$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241758091$24175809$1$I$$20240723$20240805$20240805$EXP$$US-UCBSA-2024037331$UCB$$$$$M$Y$$$20240806$$HP$US$US
241758102$24175810$2$F$$20240822$20240805$20240902$PER$$US-BAUSCHBL-2024BNL030682$BAUSCH AND LOMB$$$$$F$Y$$$20240902$$CN$US$US
241758111$24175811$1$I$20240722$20240729$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011778$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241758122$24175812$2$F$20240701$20240823$20240805$20240902$PER$$US-BAUSCHBL-2024BNL030755$BAUSCH AND LOMB$$$$$F$Y$$$20240903$$CN$US$US
241758131$24175813$1$I$20230101$20240726$20240805$20240805$PER$$US-BAUSCHBL-2024BNL030769$BAUSCH AND LOMB$$83$YR$$M$Y$$$20240806$$CN$US$US
241758141$24175814$1$I$$20240731$20240805$20240805$EXP$$CA-009507513-2408CAN000669$MERCK$$$$$$Y$$$20240805$$CN$CA$CA
241758153$24175815$3$F$$20240813$20240805$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122277$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$82.55$KG$20240821$$CN$US$US
241758161$24175816$1$I$$20240802$20240805$20240805$EXP$$IT-ABBVIE-5867167$ABBVIE$$76$YR$$M$Y$$$20240805$$CN$IT$IT
241758175$24175817$5$F$20240101$20240823$20240805$20240830$EXP$$ES-ABBVIE-5852513$ABBVIE$$$$$F$Y$40$KG$20240830$$CN$ES$ES
241758182$24175818$2$F$$20240821$20240805$20240825$EXP$$US-BAUSCHBL-2024BNL030878$BAUSCH AND LOMB$$88$YR$$F$Y$$$20240825$$CN$US$US
241758191$24175819$1$I$$20240730$20240805$20240805$PER$$US-BIOGEN-2024BI01276257$BIOGEN$$$$$$Y$$$20240805$$HP$US$US
241758201$24175820$1$I$20240718$20240731$20240805$20240805$EXP$$US-BIOGEN-2024BI01276424$BIOGEN$$47$YR$$$Y$$$20240805$$HP$US$US
241758211$24175821$1$I$20240620$20240729$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011787$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241758223$24175822$3$F$$20240812$20240805$20240904$PER$$US-AstraZeneca-2024A158882$ASTRAZENECA$$$$$$Y$$$20240904$$HP$US$
241758231$24175823$1$I$$20240801$20240805$20240805$30DAY$$US-SANDOZ INC.-SDZ2024US070525$SANDOZ$$$$$$Y$$$20240805$$HP$US$US
241758241$24175824$1$I$$20240803$20240805$20240805$30DAY$$US-SANDOZ INC.-SDZ2024US070404$SANDOZ$$$$$$Y$$$20240805$$CN$US$US
241758254$24175825$4$F$20240101$20240910$20240805$20240913$EXP$$ES-ABBVIE-5864178$ABBVIE$$$$$M$Y$$$20240913$$CN$ES$ES
241758261$24175826$1$I$$20240802$20240805$20240805$EXP$$US-ABBVIE-5865676$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241758271$24175827$1$I$$20240731$20240805$20240805$EXP$$CA-ABBVIE-5865758$ABBVIE$$$$E$M$Y$$$20240805$$CN$CA$CA
241758281$24175828$1$I$20240301$20240801$20240805$20240805$EXP$$US-ABBVIE-5865648$ABBVIE$$65$YR$$M$Y$$$20240805$$MD$US$US
241758291$24175829$1$I$20240101$20240802$20240805$20240805$EXP$$US-ABBVIE-5865909$ABBVIE$$82$YR$$M$Y$$$20240805$$CN$US$US
241758301$24175830$1$I$$20240724$20240805$20240805$EXP$$HU-STL-000227$Stallion Laboratories$Kovacs M, Fogarasi A, Hegyi M, Siegler Z, Kelemen A, Mellar M, et al. Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort. Epileptic Disord. 2024 Jul 17. doi: 10.1002/epd2.20264.$5$YR$$F$Y$$$20240805$$HP$HU$HU
241758311$24175831$1$I$$20240724$20240805$20240805$EXP$$HU-STL-000228$Stallion Laboratories$Kovacs M, Fogarasi A, Hegyi M, Siegler Z, Kelemen A, Mellar M, et al. Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort. Epileptic Disord. 2024 Jul 17. doi: 10.1002/epd2.20264.$16$YR$$F$Y$$$20240805$$HP$HU$HU
241758321$24175832$1$I$$20240724$20240805$20240805$EXP$$HU-STL-000230$Stallion Laboratories$Kovacs M, Fogarasi A, Hegyi M, Siegler Z, Kelemen A, Mellar M, et al. Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort. Epileptic Disord. 2024 Jul 17. doi: 10.1002/epd2.20264.$4$YR$$F$Y$$$20240805$$HP$HU$HU
241758331$24175833$1$I$$20240724$20240805$20240805$EXP$$HU-STL-000231$Stallion Laboratories$Kovacs M, Fogarasi A, Hegyi M, Siegler Z, Kelemen A, Mellar M, et al. Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort. Epileptic Disord. 2024 Jul 17. doi: 10.1002/epd2.20264.$4$YR$$F$Y$$$20240805$$HP$HU$HU
241758341$24175834$1$I$$20240724$20240805$20240805$EXP$$HU-STL-000226$Stallion Laboratories$Kovacs M, Fogarasi A, Hegyi M, Siegler Z, Kelemen A, Mellar M, et al. Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort. Epileptic Disord. 2024 Jul 17. doi: 10.1002/epd2.20264.$4$YR$$F$Y$$$20240805$$HP$HU$HU
241758351$24175835$1$I$$20240724$20240805$20240805$EXP$$HU-STL-000229$Stallion Laboratories$Kovacs M, Fogarasi A, Hegyi M, Siegler Z, Kelemen A, Mellar M, et al. Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort. Epileptic Disord. 2024 Jul 17. doi: 10.1002/epd2.20264.$11$YR$$F$Y$$$20240805$$HP$HU$HU
241758361$24175836$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA229284$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240806$$MD$US$US
241758371$24175837$1$I$20101112$20240802$20240805$20240805$EXP$$NZ-ASTELLAS-2024EU007708$ASTELLAS$$45$YR$$M$Y$52$KG$20240806$$HP$GB$NZ
241758381$24175838$1$I$$20240724$20240805$20240805$EXP$$US-PDX-000382$PHARMADAX$Surineni K, Le V, Jones D. A Case of Oral-Buccal-Lingual Dyskinesia and Neuropsychiatric Symptoms After Prolonged Levetiracetam Exposure. Cureus. 2024 Jun 19;16(6):e62692. doi: 10.7759/cureus.62692.$86$YR$E$F$Y$$$20240805$$HP$US$
241758391$24175839$1$I$20240101$20240802$20240805$20240805$EXP$$CA-ABBVIE-5866249$ABBVIE$$77$YR$$F$Y$$$20240805$$CN$CA$CA
241758401$24175840$1$I$$20240730$20240805$20240805$EXP$$US-ABBVIE-5862296$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241758411$24175841$1$I$$20240727$20240805$20240805$EXP$$US-JNJFOC-20240776727$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$MD$US$US
241758421$24175842$1$I$20240723$20240730$20240805$20240805$EXP$$US-ABBVIE-5862234$ABBVIE$$56$YR$$F$Y$$$20240805$$CN$US$US
241758431$24175843$1$I$20240701$20240802$20240805$20240805$EXP$$US-ABBVIE-5865776$ABBVIE$$69$YR$$M$Y$$$20240805$$CN$US$US
241758441$24175844$1$I$$20240730$20240805$20240805$EXP$$US-JNJFOC-20240781997$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$HP$US$US
241758451$24175845$1$I$20240307$20240729$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011785$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241758461$24175846$1$I$$20240730$20240805$20240805$EXP$$US-BIOGEN-2024BI01276285$BIOGEN$$$$$F$Y$$$20240805$$MD$US$US
241758472$24175847$2$F$20240701$20240913$20240805$20240920$EXP$$US-BIOGEN-2024BI01276462$BIOGEN$$55$YR$$M$Y$$$20240920$$CN$US$US
241758481$24175848$1$I$$20240802$20240805$20240805$EXP$$US-ABBVIE-5865950$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241758491$24175849$1$I$20240725$20240730$20240805$20240805$EXP$$CN-JNJFOC-20240783818$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240806$$HP$CN$CN
241758501$24175850$1$I$20240801$20240802$20240805$20240805$EXP$$CA-ABBVIE-5866205$ABBVIE$$$$A$F$Y$$$20240805$$CN$CA$CA
241758513$24175851$3$F$$20240912$20240805$20240919$EXP$$US-BIOGEN-2024BI01276665$BIOGEN$$$$$F$Y$$$20240919$$HP$US$US
241758521$24175852$1$I$20240503$20240731$20240805$20240805$EXP$$NL-BIOGEN-2024BI01276689$BIOGEN$$60$YR$$F$Y$$$20240805$$CN$NL$NL
241758531$24175853$1$I$$20240801$20240805$20240805$EXP$$US-BIOGEN-2024BI01276721$BIOGEN$$42$YR$$F$Y$$$20240805$$HP$US$US
241758541$24175854$1$I$$20240726$20240805$20240805$EXP$$US-JNJFOC-20240774967$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$US$US
241758551$24175855$1$I$$20240801$20240805$20240805$EXP$$KR-BEIGENE-BGN-2024-011996$BEIGENE$$$$$$Y$$$20240805$$MD$KR$KR
241758561$24175856$1$I$20240401$20240731$20240805$20240805$EXP$$NL-BIOGEN-2024BI01276720$BIOGEN$$70$YR$$F$Y$$$20240805$$CN$NL$NL
241758571$24175857$1$I$$20240731$20240805$20240805$EXP$$US-BIOGEN-2024BI01276478$BIOGEN$$$$$F$Y$$$20240805$$CN$US$US
241758581$24175858$1$I$20240101$20240802$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408002424$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240805$$CN$US$US
241758591$24175859$1$I$20240716$20240801$20240805$20240805$EXP$$US-ABBVIE-5865656$ABBVIE$$61$YR$$F$Y$$$20240805$$CN$US$US
241758601$24175860$1$I$20240101$20240805$20240805$20240805$EXP$SI-JAZMP-NCPHV-2024SI0832_0832$SI-JNJFOC-20240810234$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240806$$MD$SI$SI
241758611$24175861$1$I$$20240729$20240805$20240805$EXP$$ZA-ABBVIE-5864009$ABBVIE$$62$YR$$M$Y$$$20240805$$CN$ZA$ZA
241758621$24175862$1$I$20230420$20240731$20240805$20240805$EXP$$US-ABBVIE-5864015$ABBVIE$$56$YR$$F$Y$$$20240805$$CN$US$US
241758631$24175863$1$I$20240729$20240730$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011898$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241758641$24175864$1$I$$20240805$20240805$20240805$EXP$$CA-ORGANON-O2408CAN000299$ORGANON$$$$$F$Y$$$20240805$$MD$CA$CA
241758656$24175865$6$F$20240701$20240924$20240805$20240930$EXP$$JP-JNJFOC-20240807427$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$MD$JP$JP
241758661$24175866$1$I$20240701$20240801$20240805$20240805$EXP$$US-ABBVIE-5865311$ABBVIE$$61$YR$$F$Y$$$20240805$$CN$US$US
241758671$24175867$1$I$$20240729$20240805$20240805$30DAY$$US-GSK-US2024094780$GLAXOSMITHKLINE$$$$$F$Y$$$20240805$$CN$US$US
241758681$24175868$1$I$20240313$20240729$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011767$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241758691$24175869$1$I$20240101$20240730$20240805$20240805$EXP$$CA-ABBVIE-5862721$ABBVIE$$72$YR$$M$Y$$$20240805$$CN$CA$CA
241758703$24175870$3$F$20240101$20240807$20240805$20240814$EXP$$US-ABBVIE-5865690$ABBVIE$$$$$F$Y$61$KG$20240814$$CN$US$US
241758711$24175871$1$I$$20240730$20240805$20240805$EXP$$CA-JNJFOC-20240784594$JOHNSON AND JOHNSON$$$$T$F$Y$$$20240806$$HP$CA$CA
241758721$24175872$1$I$20240601$20240801$20240805$20240805$EXP$$US-ABBVIE-5865055$ABBVIE$$66$YR$$M$Y$$$20240805$$CN$US$US
241758731$24175873$1$I$$20240802$20240805$20240805$EXP$$UY-ABBVIE-5865703$ABBVIE$$$$$F$Y$$$20240805$$CN$UY$UY
241758741$24175874$1$I$20240101$20240802$20240805$20240805$EXP$$US-ABBVIE-5865680$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241758751$24175875$1$I$$20240801$20240805$20240805$EXP$$US-ABBVIE-5865249$ABBVIE$$$$$F$Y$$$20240805$$HP$US$US
241758761$24175876$1$I$20240708$20240714$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202407013078$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240805$$CN$US$US
241758771$24175877$1$I$20240101$20240731$20240805$20240805$EXP$$US-ABBVIE-5864051$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241758781$24175878$1$I$20240718$20240729$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011776$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241758791$24175879$1$I$20240801$20240801$20240805$20240805$EXP$$US-ABBVIE-5865814$ABBVIE$$61$YR$$F$Y$$$20240805$$CN$US$US
241758801$24175880$1$I$$20240731$20240805$20240805$EXP$$US-ABBVIE-5865212$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241758811$24175881$1$I$$20240731$20240805$20240805$EXP$$NVSC2024US157975$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
241758821$24175882$1$I$20240716$20240801$20240805$20240805$EXP$$US-TAKEDA-2024TUS056167$TAKEDA$$75$YR$$M$Y$113.37$KG$20240805$$CN$US$US
241758831$24175883$1$I$$20240801$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122970$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240806$$MD$US$US
241758841$24175884$1$I$20240522$20240801$20240805$20240805$EXP$SE-SEMPA-2024-005671$SE-TAKEDA-2024TUS077419$TAKEDA$$26$YR$$M$Y$88$KG$20240805$$HP$SE$SE
241758851$24175885$1$I$20240710$20240729$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011780$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241758861$24175886$1$I$$20240730$20240805$20240805$EXP$$US-TAKEDA-2024TUS076776$TAKEDA$$$$$M$Y$$$20240805$$CN$US$US
241758871$24175887$1$I$20240717$20240729$20240805$20240805$EXP$$CN-BEIGENE-BGN-2024-011782$BEIGENE$$$$$$Y$$$20240805$$HP$CN$CN
241758882$24175888$2$F$20240201$20240910$20240805$20240916$EXP$$US-TAKEDA-2023TUS111641$TAKEDA$$74$YR$$M$Y$52.608$KG$20240916$$CN$US$US
241758891$24175889$1$I$$20240802$20240805$20240805$EXP$$US-TAKEDA-2024TUS078213$TAKEDA$$$$$F$Y$$$20240805$$MD$US$US
241758901$24175890$1$I$$20240729$20240805$20240805$PER$$US-ABBVIE-5860061$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241758911$24175891$1$I$$20240802$20240805$20240805$EXP$$US-TAKEDA-2024TUS078157$TAKEDA$$$$$M$Y$$$20240805$$CN$US$US
241758921$24175892$1$I$$20240731$20240805$20240805$PER$$US-ELI_LILLY_AND_COMPANY-US202408000565$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240805$$CN$US$US
241758931$24175893$1$I$$20240726$20240805$20240805$PER$$US-ABBVIE-5859642$ABBVIE$$$$$M$Y$$$20240805$$CN$US$US
241758942$24175894$2$F$$20240913$20240805$20240925$EXP$$US-BSC-2024000079$BOSTON SCIENTIFIC$$$$$F$Y$$$20240925$$CN$US$US
241758951$24175895$1$I$$20240801$20240805$20240805$EXP$$CA-TAKEDA-2019TUS052970$TAKEDA$$$$$M$Y$$$20240805$$MD$CA$CA
241758963$24175896$3$F$$20240924$20240805$20240926$EXP$$US-TAKEDA-2024TUS078067$TAKEDA$$$$$M$Y$$$20240926$$CN$US$US
241758972$24175897$2$F$20240719$20240813$20240805$20240823$30DAY$$JP-JNJFOC-20240762324$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$JP$JP
241758981$24175898$1$I$$20240730$20240805$20240805$PER$$US-JNJFOC-20240781388$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$US$US
241758991$24175899$1$I$20240101$20240731$20240805$20240805$EXP$$CA-JNJFOC-20240251115$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240806$$HP$CA$CA
241759011$24175901$1$I$20240701$20240729$20240805$20240805$EXP$$AR-GSK-AR2024AMR041960$GLAXOSMITHKLINE$$$$$$Y$$$20240805$$CN$AR$AR
241759021$24175902$1$I$20240101$20240730$20240805$20240805$PER$$US-SA-2024SA229885$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240806$$MD$US$US
241759031$24175903$1$I$$20240731$20240805$20240805$PER$$US-SA-2024SA228940$SANOFI AVENTIS$$$$$F$Y$$$20240806$$MD$US$US
241759041$24175904$1$I$$20240730$20240805$20240805$PER$$US-SA-2024SA228018$SANOFI AVENTIS$$$$A$M$Y$$$20240806$$MD$US$US
241759051$24175905$1$I$$20240729$20240805$20240805$EXP$$JP-JNJFOC-20240809876$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$PH$JP$JP
241759071$24175907$1$I$20240520$20240802$20240805$20240805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123582$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240806$$CN$US$US
241759081$24175908$1$I$20230101$20240730$20240805$20240805$EXP$FR-AFSSAPS-NT2024000937$FR-SA-2024SA226381$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240806$$MD$FR$FR
241759093$24175909$3$F$20231215$20240815$20240805$20240820$EXP$$CA-TAKEDA-2023TUS111039$TAKEDA$$52$YR$$F$Y$$$20240820$$CN$CA$CA
241759101$24175910$1$I$$20240801$20240805$20240805$EXP$$US-ABBVIE-5865875$ABBVIE$$30$YR$$M$Y$$$20240805$$MD$US$US
241759111$24175911$1$I$20240101$20240802$20240805$20240805$EXP$$US-ABBVIE-5865632$ABBVIE$$$$$F$Y$$$20240805$$CN$US$US
241759121$24175912$1$I$$20240722$20240806$20240806$EXP$$PT-AZURITY PHARMACEUTICALS, INC.-AZR202407-000202$AZURITY PHARMACEUTICALS$$82$YR$$F$Y$$$20240805$$MD$PT$PT
241759132$24175913$2$F$$20240826$20240806$20240906$EXP$$JP-AMGEN-JPNSP2024154858$AMGEN$$$$$$Y$$$20240906$$PH$JP$JP
241759141$24175914$1$I$$20240731$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121494$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240806$$HP$US$US
241759151$24175915$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123584$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$85.73$KG$20240806$$CN$US$US
241759161$24175916$1$I$$20240730$20240806$20240806$EXP$$GB-AMGEN-GBRSP2024154523$AMGEN$$66$YR$E$F$Y$$$20240805$$HP$GB$GB
241759181$24175918$1$I$$20240731$20240806$20240806$PER$$US-AMGEN-USASP2024152902$AMGEN$$$$$$Y$$$20240805$$CN$US$US
241759191$24175919$1$I$20240101$20240729$20240806$20240806$EXP$GB-MHRA-MED-202407231127052880-JKYWN$GB-TAKEDA-2024TUS076189$TAKEDA$$$$$F$Y$66$KG$20240806$$HP$GB$GB
241759201$24175920$1$I$20240731$20240731$20240806$20240806$EXP$$US-JNJFOC-20240805355$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240806$$MD$US$US
241759221$24175922$1$I$20240701$20240801$20240806$20240806$EXP$$BR-ABBVIE-5864456$ABBVIE$$52$YR$$M$Y$99$KG$20240806$$CN$BR$BR
241759231$24175923$1$I$20240501$20240801$20240806$20240806$EXP$$US-ABBVIE-5803578$ABBVIE$$72$YR$$F$Y$$$20240806$$CN$US$US
241759241$24175924$1$I$20240101$20240802$20240806$20240806$EXP$$US-ABBVIE-5865734$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241759251$24175925$1$I$20240701$20240730$20240806$20240806$PER$$US-AMGEN-USASP2024151931$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
241759261$24175926$1$I$$20231121$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA057231$SANDOZ$$$$$$Y$$$20240806$$HP$CA$CA
241759271$24175927$1$I$20240325$20240730$20240806$20240806$PER$$US-ABBVIE-5861440$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241759282$24175928$2$F$20120101$20240829$20240806$20240903$PER$$US-JNJFOC-20240805289$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240903$$LW$US$US
241759291$24175929$1$I$$20200803$20240806$20240806$EXP$$US-AstraZeneca-2020SE98689$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241759301$24175930$1$I$$20210603$20240806$20240806$EXP$$US-AstraZeneca-2021A500951$ASTRAZENECA$$$$$F$Y$65.3$KG$20240806$$CN$US$
241759312$24175931$2$F$$20240813$20240806$20240814$PER$$US-AstraZeneca-2024A157462$ASTRAZENECA$$47$YR$$M$Y$$$20240814$$HP$US$
241759321$24175932$1$I$$20230327$20240806$20240806$EXP$$US-AstraZeneca-2023A073073$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241759331$24175933$1$I$$20240729$20240806$20240806$EXP$$AR-NOVITIUMPHARMA-2024ARNVP01466$NOVITIUM PHARMA$Sara Smiles.Abdominal tuberculosis in pediatrics: A case report.Archivos Argentinos de Pediatria.01-APR-2024;122:1-5$15$YR$T$M$Y$$$20240806$$HP$AR$AR
241759341$24175934$1$I$20240101$20240802$20240806$20240806$EXP$$US-ABBVIE-5865788$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241759351$24175935$1$I$$20240730$20240806$20240806$EXP$$NVSC2024AU157903$NOVARTIS$$$$$$Y$$$20240806$$MD$AU$AU
241759372$24175937$2$F$20240101$20240904$20240806$20240911$EXP$$BG-ABBVIE-5865619$ABBVIE$$62$YR$$F$Y$$$20240911$$CN$BG$BG
241759381$24175938$1$I$$20240801$20240806$20240806$EXP$$US-ABBVIE-5703846$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241759391$24175939$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5795604$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241759401$24175940$1$I$$20240731$20240806$20240806$EXP$$CA-ABBVIE-5864292$ABBVIE$$$$E$F$Y$$$20240806$$HP$CA$CA
241759411$24175941$1$I$20240801$20240802$20240806$20240806$EXP$$US-ABBVIE-5865831$ABBVIE$$70$YR$$M$Y$$$20240806$$CN$US$US
241759421$24175942$1$I$20240725$20240804$20240806$20240806$EXP$$CN-ABBVIE-5866469$ABBVIE$$42$YR$$F$Y$60$KG$20240806$$MD$CN$CN
241759431$24175943$1$I$20240101$20240731$20240806$20240806$EXP$$US-ABBVIE-5864550$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241759442$24175944$2$F$$20240810$20240806$20240813$PER$$US-PURDUE PHARMA-USA-2024-0311136$PURDUE$$58$YR$$F$Y$$$20240813$$CN$US$US
241759451$24175945$1$I$$20231121$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA057279$SANDOZ$$$$$$Y$$$20240806$$HP$CA$CA
241759462$24175946$2$F$20240804$20240804$20240806$20240813$EXP$$CH-ABBVIE-5867149$ABBVIE$$86$YR$$M$Y$$$20240813$$HP$CH$CH
241759482$24175948$2$F$20231126$20240809$20240806$20240812$EXP$$US-UCBSA-2023026967$UCB$$63$YR$$F$Y$$$20240812$$CN$US$US
241759492$24175949$2$F$20240712$20240917$20240806$20240926$EXP$$DE-ABBVIE-5867200$ABBVIE$$67$YR$$M$Y$$$20240926$$HP$DE$DE
241759501$24175950$1$I$$20240802$20240806$20240806$EXP$GB-MHRA-MED-202408022141372590-MNJKL$GB-ABBVIE-5865659$ABBVIE$$35$YR$$F$Y$73$KG$20240806$$CN$GB$GB
241759511$24175951$1$I$$20240731$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122834$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$70.31$KG$20240806$$PH$US$US
241759521$24175952$1$I$20240701$20240802$20240806$20240806$EXP$$US-ABBVIE-5865879$ABBVIE$$39$YR$$M$Y$$$20240806$$CN$US$US
241759531$24175953$1$I$20240101$20240802$20240806$20240806$EXP$$CA-ABBVIE-5836740$ABBVIE$$75$YR$$M$Y$$$20240806$$MD$CA$CA
241759541$24175954$1$I$20240726$20240804$20240806$20240806$EXP$$CN-ABBVIE-5866451$ABBVIE$$59$YR$$F$Y$60$KG$20240806$$MD$CN$CN
241759552$24175955$2$F$20240201$20240807$20240806$20240812$PER$$US-AMGEN-USASP2024155310$AMGEN$$76$YR$E$F$Y$$$20240812$$CN$US$US
241759562$24175956$2$F$20240727$20240906$20240806$20240911$PER$$US-AMGEN-USASP2024152632$AMGEN$$80$YR$E$F$Y$$$20240911$$CN$US$US
241759572$24175957$2$F$20240601$20240802$20240806$20240812$30DAY$$US-AMGEN-USASP2024152682$AMGEN$$59$YR$A$F$Y$56.9$KG$20240811$$HP$US$US
241759583$24175958$3$F$20240725$20240902$20240806$20240906$30DAY$$US-AMGEN-USASL2024150793$AMGEN$$65$YR$E$M$Y$$$20240905$$PH$US$US
241759591$24175959$1$I$20240101$20240731$20240806$20240806$EXP$$US-ABBVIE-5863898$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241759601$24175960$1$I$20240717$20240726$20240806$20240806$PER$$US-SA-2024SA226682$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240806$$MD$US$US
241759631$24175963$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA225350$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240806$$MD$US$US
241759641$24175964$1$I$20240701$20240730$20240806$20240806$PER$$US-SA-2024SA226435$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240806$$MD$US$US
241759652$24175965$2$F$20240701$20240731$20240806$20240809$PER$$US-SA-2024SA229282$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240809$$MD$US$US
241759661$24175966$1$I$20240101$20240725$20240806$20240806$PER$$US-SA-2024SA224387$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240806$$MD$US$US
241759671$24175967$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA226900$SANOFI AVENTIS$$$$A$M$Y$90.7$KG$20240806$$MD$US$US
241759681$24175968$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA228304$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240806$$CN$US$US
241759691$24175969$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA229293$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240806$$MD$US$US
241759701$24175970$1$I$20240101$20240726$20240806$20240806$PER$$US-SA-2024SA223731$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240806$$MD$US$US
241759711$24175971$1$I$20240101$20240731$20240806$20240806$PER$$US-SA-2024SA228730$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240806$$CN$US$US
241759721$24175972$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA225838$SANOFI AVENTIS$$$$A$M$Y$$$20240806$$MD$US$US
241759731$24175973$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA226777$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240806$$MD$US$US
241759741$24175974$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA227394$SANOFI AVENTIS$$42$YR$A$F$Y$142$KG$20240806$$MD$US$US
241759753$24175975$3$F$20240701$20240802$20240806$20240812$PER$$US-SA-2024SA226137$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240812$$MD$US$US
241759761$24175976$1$I$20240601$20240801$20240806$20240806$EXP$$US-ABBVIE-5842155$ABBVIE$$63$YR$$F$Y$$$20240806$$CN$US$US
241759774$24175977$4$F$$20240816$20240806$20240828$30DAY$$CA-JNJFOC-20240763859$JOHNSON AND JOHNSON$$$$$M$Y$$$20240828$$PH$CA$CA
241759781$24175978$1$I$$20240802$20240806$20240806$EXP$$CA-ABBVIE-5865923$ABBVIE$$$$A$M$Y$$$20240806$$CN$CA$CA
241759791$24175979$1$I$20240707$20240802$20240806$20240806$EXP$$US-ABBVIE-5865804$ABBVIE$$72$YR$$M$Y$$$20240806$$CN$US$US
241759801$24175980$1$I$$20240801$20240806$20240806$EXP$$US-ABBVIE-5865001$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241759811$24175981$1$I$20230314$20230320$20240806$20240806$EXP$$US-AstraZeneca-2023A066772$ASTRAZENECA$$19567$DY$$M$Y$88$KG$20240806$$CN$US$
241759821$24175982$1$I$20240101$20240731$20240806$20240806$PER$$US-ABBVIE-5862929$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241759831$24175983$1$I$$20230831$20240806$20240806$EXP$$US-AstraZeneca-2023A200954$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241759841$24175984$1$I$20210915$20211006$20240806$20240806$EXP$$CO-AstraZeneca-2021A767760$ASTRAZENECA$$25461$DY$$M$Y$64$KG$20240806$$CN$CO$
241759851$24175985$1$I$$20211027$20240806$20240806$EXP$$US-AstraZeneca-2021A789633$ASTRAZENECA$$$$$M$Y$59$KG$20240806$$CN$US$
241759861$24175986$1$I$$20220106$20240806$20240806$EXP$$US-AstraZeneca-2022A011589$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241759871$24175987$1$I$$20220210$20240806$20240806$EXP$$US-AstraZeneca-2022A068731$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241759881$24175988$1$I$$20230914$20240806$20240806$EXP$$US-AstraZeneca-2023A210988$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241759891$24175989$1$I$$20240725$20240806$20240806$EXP$$CA-CHATTEMPRD-2024OHG017807$CHATTEM$$40$YR$A$F$Y$$$20240806$$HP$CA$CA
241759901$24175990$1$I$20240501$20240726$20240806$20240806$EXP$$FR-ABBVIE-5865029$ABBVIE$$59$YR$$F$Y$55$KG$20240806$$PH$FR$FR
241759912$24175991$2$F$20240501$20240828$20240806$20240909$EXP$$JP-AMGEN-JPNSP2024155001$AMGEN$$8$DEC$E$M$Y$$$20240908$$MD$JP$JP
241759921$24175992$1$I$$20240729$20240806$20240806$EXP$$TR-NOVITIUMPHARMA-2024TRNVP01468$NOVITIUM PHARMA$Gul Rahsar Yilmaz.Treatment of Pneumocystis jirovecii Pneumonia with Caspofungin and Clindamycin: An HIV Patient and Literature Review.Flora 2024.22-MAR-2024;29(1):139-144$54$YR$A$M$Y$$$20240806$$HP$TR$TR
241759931$24175993$1$I$$20240801$20240806$20240806$EXP$$IE-ROCHE-10000047940$ROCHE$$$$$$Y$$$20240806$$MD$IE$IE
241759941$24175994$1$I$$20240723$20240806$20240806$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0281$GRAVITI PHARMACEUTICALS$Fuchs R, Litell J, Topeff J, Spanier M, Cole J.Severe hypermagnesemia from ingestion of (not so) trace mineral drops leading to respiratory failure and requiring hemodialysis.Clin-Toxicol-(Phila).2022;60 (2):135-136$58$YR$A$M$Y$$$20240806$$HP$US$US
241759951$24175995$1$I$20240716$20240722$20240806$20240806$EXP$GB-MHRA-31250470$GB-USV-002806$USV PRIVATE$$$$$M$Y$$$20240805$$HP$GB$GB
241759971$24175997$1$I$$20240724$20240806$20240806$EXP$$US-SMPA-2024MYSCI0701068$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241759981$24175998$1$I$$20240724$20240806$20240806$EXP$$US-SMPA-2024MYSCI0701044$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241759991$24175999$1$I$$20240724$20240806$20240806$EXP$$US-SMPA-2024MYSCI0701031$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241760001$24176000$1$I$$20240724$20240806$20240806$EXP$$US-SMPA-202407-URV-001113$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241760012$24176001$2$F$$20240812$20240806$20240826$EXP$$US-SMPA-2024MYSCI0701069$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
241760021$24176002$1$I$20240101$20240723$20240806$20240806$EXP$$US-SMPA-2024MYSCI0700933$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241760031$24176003$1$I$20240701$20240731$20240806$20240806$EXP$$US-ABBVIE-5863735$ABBVIE$$61$YR$$$Y$$$20240806$$CN$US$US
241760041$24176004$1$I$$20240724$20240806$20240806$EXP$$US-SMPA-202407-URV-001112$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241760051$24176005$1$I$20240702$20240722$20240806$20240806$EXP$PT-INFARMED-R202407-241$HU-SMPA-2024MYSCI0701072$SUNOVION$$$$$$Y$$$20240806$$PH$PT$PT
241760061$24176006$1$I$$20240723$20240806$20240806$EXP$$US-SMPA-202407-URV-001105$SUNOVION$$$$$$Y$$$20240806$$HP$US$US
241760071$24176007$1$I$20240721$20240724$20240806$20240806$EXP$GB-MHRA-MED-202407241451375180-YMNHK$HU-SMPA-2024SPA000200$SUNOVION$$$$$$Y$$$20240806$$PH$GB$GB
241760081$24176008$1$I$20240301$20240723$20240806$20240806$EXP$GB-MHRA-MED-202407230307455170-QRDCH$HU-SMPA-2024SPA000346$SUNOVION$$$$$$Y$$$20240806$$CN$GB$GB
241760091$24176009$1$I$$20240724$20240806$20240806$EXP$$US-SMPA-2024SPA000182$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241760101$24176010$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5866040$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241760121$24176012$1$I$$20231121$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA057308$SANDOZ$$$$$$Y$$$20240806$$HP$CA$CA
241760131$24176013$1$I$$20240805$20240806$20240806$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043918$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240806$$CN$US$US
241760143$24176014$3$F$20240711$20240814$20240806$20240817$PER$$US-AMGEN-USASP2024154051$AMGEN$$70$YR$E$F$Y$$$20240817$$CN$US$US
241760153$24176015$3$F$20240429$20240820$20240806$20240828$30DAY$$US-AMGEN-USASP2024150508$AMGEN$$42$YR$A$M$Y$82.993$KG$20240828$$PH$US$US
241760171$24176017$1$I$20240101$20240802$20240806$20240806$EXP$$CA-ABBVIE-5866200$ABBVIE$$25$YR$$M$Y$$$20240806$$CN$CA$CA
241760184$24176018$4$F$20240723$20240827$20240806$20240902$PER$$US-ABBVIE-5864535$ABBVIE$$41$YR$$F$Y$79.832$KG$20240902$$MD$US$US
241760201$24176020$1$I$20240101$20240802$20240806$20240806$EXP$$US-ABBVIE-5865860$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241760211$24176021$1$I$$20240723$20240806$20240806$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0296$GRAVITI PHARMACEUTICALS$Incognito C, Parker J, Arustamyan M, Matta M, Posadas K, Lee R.Large Left Ventricular Pseudoaneurysm Presenting as an Embolic Stroke After a ^Silent^ Myocardial Infarction.Tex-Heart-Inst-J.2023;50:1 to 6$72$YR$E$F$Y$$$20240806$$MD$US$US
241760221$24176022$1$I$$20240802$20240806$20240806$EXP$$ES-SANDOZ INC.-SDZ2024ES070318$SANDOZ$$77$YR$$F$Y$$$20240806$$MD$ES$ES
241760232$24176023$2$F$20240701$20240830$20240806$20240904$EXP$$CA-SANDOZ INC.-SDZ2024CA070309$SANDOZ$$65$YR$$M$Y$115.7$KG$20240904$$MD$CA$CA
241760241$24176024$1$I$$20240805$20240806$20240806$EXP$$AU-SANDOZ INC.-SDZ2024AU070477$SANDOZ$$$$$$Y$$$20240806$$HP$AU$AU
241760251$24176025$1$I$$20240731$20240806$20240806$EXP$$IN-Bion-013593$BIONPHARMA$$27$YR$A$F$Y$$$20240805$$HP$IN$IN
241760261$24176026$1$I$$20240723$20240806$20240806$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0300$GRAVITI PHARMACEUTICALS$Hunley TE, Hidalgo G, Ng KH, Shirai Y, Miura K, Beng HM, et al.Pioglitazone enhances proteinuria reduction in complicated pediatric nephrotic syndrome.Pediatr-Nephrol.2023;38(4):1127-1138$6$YR$C$M$Y$$$20240806$$HP$US$US
241760271$24176027$1$I$20240201$20240729$20240806$20240806$EXP$FR-AFSSAPS-TO2024001155$FR-STERISCIENCE B.V.-2024-ST-001128$Steriscience PTE$$59$YR$$M$Y$$$20240806$$PH$FR$FR
241760281$24176028$1$I$20240731$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153973$AMGEN$$$$$M$Y$$$20240805$$CN$US$US
241760291$24176029$1$I$20240719$20240730$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US069996$SANDOZ$$67$YR$$M$Y$63.039$KG$20240806$$HP$US$US
241760301$24176030$1$I$20240601$20240726$20240806$20240806$PER$$US-SA-2024SA226031$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240806$$MD$US$US
241760311$24176031$1$I$$20240730$20240806$20240806$EXP$$GR-Bion-013573$BIONPHARMA$$76$YR$E$F$Y$$$20240805$$HP$GR$GR
241760321$24176032$1$I$20240726$20240729$20240806$20240806$PER$$US-SA-2024SA227274$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240806$$MD$US$US
241760331$24176033$1$I$$20240724$20240806$20240806$PER$$US-SA-2024SA223653$SANOFI AVENTIS$$$$A$M$Y$$$20240806$$MD$US$US
241760341$24176034$1$I$$20240731$20240806$20240806$EXP$$IN-Bion-013598$BIONPHARMA$$$$N$F$Y$1.6$KG$20240805$$HP$IN$IN
241760352$24176035$2$F$$20240904$20240806$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122285$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240905$$CN$US$US
241760361$24176036$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA230232$SANOFI AVENTIS$$$$E$F$Y$68$KG$20240806$$MD$US$US
241760371$24176037$1$I$$20240731$20240806$20240806$EXP$$PT-Bion-013594$BIONPHARMA$$64$YR$A$F$Y$$$20240805$$HP$PT$PT
241760381$24176038$1$I$$20240730$20240806$20240806$EXP$$TR-Bion-013571$BIONPHARMA$$27$YR$A$M$Y$$$20240805$$HP$TR$TR
241760391$24176039$1$I$$20240730$20240806$20240806$EXP$GB-MHRA-MED-202407291144214310-MHVBY$GB-ESPERIONTHERAPEUTICS-2024GBR01230$ESPERION THERAPEUTICS$$76$YR$$F$Y$$$20240806$$MD$GB$GB
241760401$24176040$1$I$$20240729$20240806$20240806$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001544$BLUEPRINT MEDICINES$$$$$M$Y$$$20240806$$CN$US$US
241760411$24176041$1$I$$20231130$20240806$20240806$EXP$$US-AstraZeneca-2023A272554$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241760421$24176042$1$I$$20220706$20240806$20240806$EXP$$US-AstraZeneca-2022A248076$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241760431$24176043$1$I$$20230505$20240806$20240806$EXP$$US-AstraZeneca-2023A106516$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241760441$24176044$1$I$$20240730$20240806$20240806$EXP$$GB-NOVITIUMPHARMA-2024GBNVP01473$NOVITIUM PHARMA$Tayyaba Mehmood.A rare case of TEN-like acute cutaneous lupus.Clinical Medicine.24-APR-2024;24:33-34$32$YR$A$F$Y$$$20240806$$HP$GB$GB
241760451$24176045$1$I$$20220124$20240806$20240806$EXP$$US-AstraZeneca-2022A045091$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241760461$24176046$1$I$$20230523$20240806$20240806$EXP$$US-AstraZeneca-2023A121013$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241760471$24176047$1$I$20240701$20240719$20240806$20240806$PER$$US-CHATTEMPRD-2024OHG024955$CHATTEM$$$$$F$Y$$$20240806$$CN$US$US
241760481$24176048$1$I$20240401$20240729$20240806$20240806$EXP$$ZA-AstraZeneca-2024A173646$ASTRAZENECA$$60$YR$$M$Y$$$20240806$$CN$ZA$
241760491$24176049$1$I$20070101$20220106$20240806$20240806$EXP$$US-AstraZeneca-2022A011526$ASTRAZENECA$$51$YR$$F$Y$95.3$KG$20240806$$CN$US$
241760501$24176050$1$I$$20220114$20240806$20240806$EXP$$US-AstraZeneca-2022A025478$ASTRAZENECA$$$$$$Y$$$20240806$$HP$US$
241760511$24176051$1$I$$20220114$20240806$20240806$EXP$$CA-AstraZeneca-2021A574855$ASTRAZENECA$$73$YR$$F$Y$$$20240806$$MD$CA$
241760521$24176052$1$I$20240601$20240730$20240806$20240806$PER$$US-SA-2024SA079017$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240806$$MD$US$US
241760531$24176053$1$I$20240701$20240730$20240806$20240806$PER$$US-SA-2024SA225946$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240806$$MD$US$US
241760541$24176054$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA225115$SANOFI AVENTIS$$$$C$M$Y$23.5$KG$20240806$$MD$US$US
241760552$24176055$2$F$$20240731$20240806$20240809$PER$$US-SA-2024SA226007$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240809$$HP$US$US
241760561$24176056$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA225724$SANOFI AVENTIS$$$$E$F$Y$$$20240806$$MD$US$US
241760571$24176057$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA225491$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240806$$MD$US$US
241760582$24176058$2$F$20240601$20240827$20240806$20240917$PER$$US-SA-2024SA224876$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240918$$MD$US$US
241760591$24176059$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA226150$SANOFI AVENTIS$$$$T$F$Y$$$20240806$$MD$US$US
241760601$24176060$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA227570$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
241760611$24176061$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA224410$SANOFI AVENTIS$$$$A$M$Y$28$KG$20240806$$MD$US$US
241760621$24176062$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA224354$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240806$$MD$US$US
241760631$24176063$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA225505$SANOFI AVENTIS$$$$$M$Y$$$20240806$$CN$US$US
241760651$24176065$1$I$20230701$20240725$20240806$20240806$EXP$CH-SM-2024-13633$CH-UCBSA-2024037736$UCB$$$$$M$Y$$$20240806$$PH$CH$CH
241760661$24176066$1$I$$20240730$20240806$20240806$EXP$$US-Bion-013574$BIONPHARMA$$49$YR$A$M$Y$$$20240805$$HP$US$US
241760672$24176067$2$F$20240701$20240812$20240806$20240815$PER$$US-AMGEN-USASP2024152867$AMGEN$$66$YR$E$M$Y$63.8$KG$20240815$$PH$US$US
241760682$24176068$2$F$20240101$20240802$20240806$20240808$EXP$$ES-ABBVIE-5865564$ABBVIE$$$$$M$Y$$$20240808$$CN$ES$ES
241760691$24176069$1$I$20240401$20240729$20240806$20240806$PER$$US-SA-2024SA227418$SANOFI AVENTIS$$1$YR$I$M$Y$9.5$KG$20240806$$MD$US$US
241760701$24176070$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA227678$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240806$$MD$US$US
241760711$24176071$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA227631$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240806$$MD$US$US
241760721$24176072$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA226993$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240806$$MD$US$US
241760731$24176073$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA227078$SANOFI AVENTIS$$54$YR$A$M$Y$81$KG$20240806$$MD$US$US
241760741$24176074$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865809$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241760751$24176075$1$I$$20240731$20240806$20240806$EXP$$US-Bion-013578$BIONPHARMA$$76$YR$E$M$Y$$$20240805$$CN$US$US
241760761$24176076$1$I$$20240729$20240806$20240806$EXP$$US-Bion-013579$BIONPHARMA$$$$$F$Y$$$20240805$$CN$US$US
241760771$24176077$1$I$$20240730$20240806$20240806$EXP$$US-Bion-013577$BIONPHARMA$$78$YR$E$M$Y$$$20240805$$CN$US$US
241760781$24176078$1$I$20240101$20240801$20240806$20240806$EXP$$US-ABBVIE-5864533$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241760791$24176079$1$I$$20240802$20240806$20240806$PER$$NVSC2024US159455$NOVARTIS$$$$$$Y$$$20240806$$HP$US$US
241760801$24176080$1$I$$20240802$20240806$20240806$EXP$$CA-ABBVIE-5866193$ABBVIE$$$$A$F$Y$$$20240806$$CN$CA$CA
241760812$24176081$2$F$$20240731$20240806$20240808$PER$$US-CHATTEMPRD-2024OHG025907$CHATTEM$$$$$F$Y$$$20240808$$CN$US$US
241760821$24176082$1$I$20240726$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123419$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240806$$CN$US$US
241760831$24176083$1$I$$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121475$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$113$KG$20240806$$PH$US$US
241760841$24176084$1$I$20230101$20240724$20240806$20240806$EXP$$CA-ABBVIE-5864430$ABBVIE$$$$A$F$Y$$$20240806$$HP$CA$CA
241760851$24176085$1$I$20240101$20240803$20240806$20240806$PER$$US-AMGEN-USASP2024155131$AMGEN$$37$YR$A$F$Y$45$KG$20240805$$HP$US$US
241760863$24176086$3$F$20240101$20240805$20240806$20240809$PER$$US-AMGEN-USASP2024154367$AMGEN$$64$YR$A$F$Y$$$20240809$$CN$US$US
241760871$24176087$1$I$$20240723$20240806$20240806$EXP$$JP-AMGEN-JPNSP2024154345$AMGEN$$$$$$Y$$$20240805$$MD$JP$JP
241760881$24176088$1$I$$20240802$20240806$20240806$EXP$$CN-TAKEDA-2024TUS078150$TAKEDA$$$$$F$Y$$$20240806$$CN$CN$CN
241760891$24176089$1$I$20190219$20240730$20240806$20240806$EXP$$US-ABBVIE-5843634$ABBVIE$$62$YR$$F$Y$102$KG$20240806$$CN$US$US
241760902$24176090$2$F$$20240813$20240806$20240816$EXP$$NVSC2024CA156152$NOVARTIS$$56$YR$$F$Y$$$20240816$$CN$CA$CA
241760911$24176091$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121545$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240806$$CN$US$US
241760921$24176092$1$I$20240310$20240801$20240806$20240806$EXP$$US-ABBVIE-5865168$ABBVIE$$64$YR$$F$Y$$$20240806$$CN$US$US
241760931$24176093$1$I$20240101$20240731$20240806$20240806$EXP$$US-ABBVIE-5863690$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241760942$24176094$2$F$20240601$20240805$20240806$20240808$EXP$$US-ABBVIE-5866441$ABBVIE$$79$YR$$M$Y$$$20240808$$CN$US$US
241760951$24176095$1$I$$20240730$20240806$20240806$EXP$$IN-NOVITIUMPHARMA-2024INNVP01475$NOVITIUM PHARMA$U P Holla.SSA mediated endocardial fibroelastosis treated with dexamethasone and IVIG.Indian Journal of Rheumatology.2023;18:S358-S359$27$YR$A$F$Y$$$20240806$$HP$IN$IN
241760961$24176096$1$I$20240613$20240724$20240806$20240806$EXP$$CN-HALEON-2188809$Haleon PLC$$55$YR$$M$Y$82.2$KG$20240805$$HP$CN$CN
241760971$24176097$1$I$$20240725$20240806$20240806$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2160033$Chengdu Suncadia Medicine$Intestinal lymphoproliferative disease after liver transplant in children: Clinical pathological analysis of 3 cases.$$$$M$Y$$$20240806$$MD$CN$CN
241760981$24176098$1$I$$20240731$20240806$20240806$EXP$$JP-SANDOZ INC.-SDZ2024JP024751$SANDOZ$Nakamura N, Mizumoto C, Kanda J, Yamashita K, Takaori A. Nelarabine-Induced Leukoencephalopathy Suggested at Post-transplant Autopsy in T Lymphoblastic Leukaemia/Lymphoma. The 119th Kinki Regional Meeting on Hematology (Program and Abstracts). 2023;07$50$YR$$M$Y$$$20240806$$MD$JP$JP
241760991$24176099$1$I$20240701$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001075$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240806$$CN$US$US
241761001$24176100$1$I$$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001185$ELI LILLY AND CO$$$$$M$Y$$$20240806$$CN$US$US
241761012$24176101$2$F$20240802$20240823$20240806$20240829$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011787$JAZZ$$17$YR$$F$Y$$$20240829$$HP$US$US
241761021$24176102$1$I$20240530$20240731$20240806$20240806$EXP$$US-ABBVIE-5863937$ABBVIE$$80$YR$$M$Y$$$20240806$$CN$US$US
241761031$24176103$1$I$20240729$20240802$20240806$20240806$EXP$$US-TAKEDA-2024TUS014149$TAKEDA$$68$YR$$M$Y$$$20240806$$HP$US$US
241761041$24176104$1$I$20240501$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123171$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240806$$CN$US$US
241761051$24176105$1$I$$20240730$20240806$20240806$EXP$$JP-ROCHE-10000047824$ROCHE$$7$DEC$E$F$Y$$$20240806$$MD$JP$JP
241761071$24176107$1$I$$20240731$20240806$20240806$PER$$US-ROCHE-10000047571$ROCHE$$$$$$Y$$$20240806$$CN$US$US
241761081$24176108$1$I$$20240729$20240806$20240806$EXP$$JP-AMGEN-JPNSP2024154434$AMGEN$$$$$$Y$$$20240805$$MD$JP$JP
241761091$24176109$1$I$$20231106$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA051372$SANDOZ$$$$$$Y$$$20240806$$MD$CA$CA
241761101$24176110$1$I$$20220625$20240806$20240806$EXP$$US-AstraZeneca-2022A237244$ASTRAZENECA$$$$$$Y$$$20240806$$MD$US$
241761111$24176111$1$I$$20211223$20240806$20240806$EXP$$US-AstraZeneca-2021A899861$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241761121$24176112$1$I$20240726$20240801$20240806$20240806$PER$$US-ROCHE-10000047738$ROCHE$$18$YR$A$M$Y$$$20240806$$CN$US$US
241761131$24176113$1$I$20240730$20240801$20240806$20240806$PER$$US-ROCHE-10000047337$ROCHE$$37$YR$A$M$Y$$$20240806$$CN$US$US
241761141$24176114$1$I$$20240801$20240806$20240806$PER$$US-ROCHE-10000047199$ROCHE$$$$C$M$Y$$$20240806$$CN$US$US
241761151$24176115$1$I$20240719$20240801$20240806$20240806$PER$$US-ROCHE-10000047310$ROCHE$$11$YR$C$M$Y$$$20240806$$CN$US$US
241761161$24176116$1$I$20210601$20220119$20240806$20240806$EXP$$CA-AstraZeneca-2022A035975$ASTRAZENECA$$939$MON$$M$Y$$$20240806$$CN$CA$
241761171$24176117$1$I$$20230328$20240806$20240806$EXP$$US-AstraZeneca-2023A037139$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241761181$24176118$1$I$$20230704$20240806$20240806$EXP$$US-AstraZeneca-2023A106600$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241761191$24176119$1$I$20230801$20240731$20240806$20240806$EXP$$US-ABBVIE-5856447$ABBVIE$$28$YR$$F$Y$54.431$KG$20240806$$CN$US$US
241761212$24176121$2$F$$20240801$20240806$20240809$PER$$US-AMGEN-USASP2024153727$AMGEN$$$$$F$Y$$$20240809$$HP$US$US
241761221$24176122$1$I$$20240731$20240806$20240806$PER$$US-AMGEN-USASP2024152376$AMGEN$$$$$F$Y$$$20240805$$CN$US$US
241761232$24176123$2$F$20240618$20240809$20240806$20240815$EXP$$JP-AMGEN-JPNSP2024120961$AMGEN$$$$E$M$Y$$$20240815$$MD$JP$JP
241761261$24176126$1$I$$20240725$20240806$20240806$PER$$US-AMGEN-USASP2024153004$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et. al. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1- E8$$$$$Y$$$20240805$$MD$US$US
241761271$24176127$1$I$20240101$20240730$20240806$20240806$EXP$$CN-UCBSA-2024038730$UCB$$35$YR$$F$Y$$$20240806$$MD$CN$CN
241761281$24176128$1$I$$20240723$20240806$20240806$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0295$GRAVITI PHARMACEUTICALS$Geeting D, Alibrahim O, Patel M, Kumar R, Mallory P. COVID-19 and Severe Rhabdomyolysis Causing Acute Kidney Injury and Life-Threatening Hyperkalemia in a Pediatric Patient: a Case Report.SN-Compr-Clin-Med.2023;5:121:1 to 5$15$YR$T$M$Y$$$20240806$$HP$US$US
241761291$24176129$1$I$$20240214$20240806$20240806$EXP$$JP-SANDOZ INC.-SDZ2024JP017730$SANDOZ$$$$$$Y$$$20240806$$MD$JP$JP
241761301$24176130$1$I$$20240729$20240806$20240806$EXP$GR-SEATTLE GENETICS-2023SGN11900$GR-CHEPLA-2024009913$CHEPLAPHARM$$$$$F$Y$$$20240805$$MD$COUNTRY NOT SPECIFIED$GR
241761311$24176131$1$I$$20240730$20240806$20240806$EXP$$IN-NOVITIUMPHARMA-2024INNVP01497$NOVITIUM PHARMA$U P Holla.SSA mediated endocardial fibroelastosis treated with dexamethasone and IVIG.Indian Journal of Rheumatology.2023;18:S358-S359$$$$F$Y$1.6$KG$20240806$$HP$IN$IN
241761321$24176132$1$I$20240322$20240729$20240806$20240806$EXP$$CN-BEIGENE-BGN-2024-011763$BEIGENE$$$$$$Y$$$20240806$$HP$CN$CN
241761332$24176133$2$F$20240101$20240812$20240806$20240824$EXP$$US-UCBSA-2024012885$UCB$$$$$F$Y$63.5$KG$20240824$$CN$US$US
241761341$24176134$1$I$$20230303$20240806$20240806$EXP$$US-AstraZeneca-2023A053565$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241761351$24176135$1$I$$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A175858$ASTRAZENECA$$$$$M$Y$$$20240806$$HP$US$
241761361$24176136$1$I$$20230519$20240806$20240806$EXP$$US-AstraZeneca-2023A117898$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241761371$24176137$1$I$$20230308$20240806$20240806$EXP$$TW-AstraZeneca-2023A059351$ASTRAZENECA$$64$YR$$M$Y$$$20240806$$CN$TW$
241761381$24176138$1$I$20230101$20240730$20240806$20240806$PER$$US-ABBVIE-5861699$ABBVIE$$26$YR$$F$Y$$$20240806$$HP$US$US
241761391$24176139$1$I$$20240729$20240806$20240806$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP009699$STRIDES$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al.. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF).. Toxic-Analyt-Clinique. 2023;35 (1):54-59$68$YR$$F$Y$$$20240806$$HP$FR$FR
241761401$24176140$1$I$$20220131$20240806$20240806$EXP$$GB-AstraZeneca-2022A051457$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$GB$
241761411$24176141$1$I$$20230915$20240806$20240806$EXP$$US-AstraZeneca-2023A212150$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241761421$24176142$1$I$20180101$20210424$20240806$20240806$EXP$$US-AstraZeneca-2021A354314$ASTRAZENECA$$57$YR$$F$Y$104.3$KG$20240806$$CN$US$
241761431$24176143$1$I$$20221123$20240806$20240806$EXP$$US-AstraZeneca-2022A388308$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241761441$24176144$1$I$$20210322$20240806$20240806$EXP$$TW-AstraZeneca-2021A192803$ASTRAZENECA$$59$YR$$F$Y$$$20240806$$CN$TW$
241761451$24176145$1$I$$20240801$20240806$20240806$EXP$GB-MHRA-MED-202407300742060690-TMPNY$GB-STRIDES ARCOLAB LIMITED-2024SP009665$STRIDES$$$$$M$Y$$$20240806$$HP$GB$GB
241761461$24176146$1$I$$20240725$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119195$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240806$$CN$US$US
241761471$24176147$1$I$$20240731$20240806$20240806$PER$$US-BIOGEN-2024BI01276494$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241761481$24176148$1$I$$20240729$20240806$20240806$EXP$PT-MLMSERVICE-20240513-PI059858-00222-1$PT-STRIDES ARCOLAB LIMITED-2024SP009684$STRIDES$Reis C, Dias F, Grijo C, Ribeiro A, Almeida J.. PSEUDOMEMBRANOUS COLITIS FOLLOWING HELICOBACTER PILORY ERADICATION WITH THE BISMUTH-BASED QUADRUPLE THERAPY.. Eur-J-Case-Rep-Intern-Med. 2023;10 (Suppl. 1):237 abstr. 493.$84$YR$$F$Y$$$20240806$$HP$PT$PT
241761491$24176149$1$I$20240610$20240801$20240806$20240806$EXP$GB-MHRA-TPP125955C4465987YC1721938491226$GB-STRIDES ARCOLAB LIMITED-2024SP009666$STRIDES$$60$YR$$M$Y$97$KG$20240806$$MD$GB$GB
241761501$24176150$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153800$AMGEN$$$$$$Y$$$20240805$$CN$US$US
241761511$24176151$1$I$20240601$20240729$20240806$20240806$EXP$$DE-PIRAMAL CRITICAL CARE LIMITED-2024-PPL-000573$PIRAMAL$$$$$$Y$$$20240806$$MD$DE$DE
241761521$24176152$1$I$$20240726$20240806$20240806$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009709$STRIDES$Zhang T, Ye L, Gao H, Dong J, Wang C.. Clinical and pathological features of drug- induced liver injury with different types of bile duct injury:An analysis of four cases. [Chinese]. J-Clin-Hepatol. 2023;39 (7):1665-1672$47$YR$$M$Y$$$20240806$$HP$CN$CN
241761532$24176153$2$F$20240717$20240821$20240806$20240826$EXP$GB-MHRA-MED-202407251204342300-HMTGD$GB-STRIDES ARCOLAB LIMITED-2024SP009691$STRIDES$$25$YR$$M$Y$85$KG$20240826$$CN$GB$GB
241761541$24176154$1$I$$20231007$20240806$20240806$EXP$$CN-SANDOZ INC.-SDZ2023CN042323$SANDOZ$$$$$$Y$$$20240806$$HP$CN$CN
241761551$24176155$1$I$$20240712$20240806$20240806$EXP$$VN-ROCHE-10000047671$ROCHE$Thao N, Sang P, Hoa N, Quy N. Evaluating results of neoadjuvant chemotherapy for HER-2 positive stage II-III breast cancer at Viet Tiep friendship hospital. Vietnam medical journal. 2024-Jun;539:450-8.$$$$F$Y$$$20240806$$MD$VN$VN
241761561$24176156$1$I$$20240805$20240806$20240806$EXP$$CA-ORGANON-O2408CAN000273$ORGANON$$5$YR$$M$Y$$$20240806$$CN$CA$CA
241761571$24176157$1$I$20240201$20240723$20240806$20240806$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2024-07231$LUPIN$$$$$$Y$$$20240806$$MD$DE$DE
241761581$24176158$1$I$$20240801$20240806$20240806$PER$$US-BIOGEN-2024BI01276706$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241761591$24176159$1$I$20240625$20240801$20240806$20240806$EXP$$JP-VANTIVE-2024VAN018381$Vantive US Healthcare$$8$DEC$$M$Y$$$20240806$$MD$JP$JP
241761601$24176160$1$I$$20240802$20240806$20240806$PER$$US-JNJFOC-20240807156$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$US$US
241761612$24176161$2$F$20240301$20240821$20240806$20240904$EXP$$CA-UCBSA-2024020709$UCB$$28$YR$$F$Y$$$20240904$$CN$CA$CA
241761621$24176162$1$I$20240708$20240802$20240806$20240806$EXP$GB-MHRA-MED-202408021222108700-YKTDC$GB-GSK-GB2024096894$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$HP$GB$GB
241761631$24176163$1$I$20240719$20240729$20240806$20240806$EXP$$US-BEH-2024176534$CSL BEHRING$$32$YR$A$F$Y$$$20240806$$CN$US$US
241761642$24176164$2$F$$20240725$20240806$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038658$AUROBINDO$$57$YR$$F$Y$$$20240807$$HP$CA$CA
241761651$24176165$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA226335$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240806$$MD$US$US
241761661$24176166$1$I$$20240801$20240806$20240806$30DAY$$US-GSK-US2024096354$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$CN$US$US
241761671$24176167$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA226827$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240806$$MD$US$US
241761681$24176168$1$I$20240701$20240729$20240806$20240806$PER$$US-SA-2024SA227690$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240806$$MD$US$US
241761691$24176169$1$I$$20240723$20240806$20240806$EXP$$US-CIPLA LTD.-2024US08049$CIPLA$$$$$$Y$$$20240806$$HP$US$US
241761701$24176170$1$I$20240101$20240726$20240806$20240806$PER$$US-SA-2024SA226385$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240806$$MD$US$US
241761713$24176171$3$F$$20231219$20240806$20240918$PER$$US-ENDO USA, INC.-2024-000049$ENDO$$$$$F$Y$$$20240918$$CN$US$US
241761721$24176172$1$I$$20240718$20240806$20240806$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118248$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240806$$HP$CA$CA
241761731$24176173$1$I$$20231121$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA056833$SANDOZ$$$$$$Y$$$20240806$$HP$CA$CA
241761741$24176174$1$I$$20240805$20240806$20240806$EXP$$LT-SANDOZ INC.-SDZ2024LT070473$SANDOZ$$53$YR$$F$Y$$$20240806$$HP$LT$LT
241761751$24176175$1$I$$20211021$20240806$20240806$EXP$$US-AstraZeneca-2021A784265$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241761761$24176176$1$I$$20231013$20240806$20240806$EXP$$HN-AstraZeneca-2023A235445$ASTRAZENECA$$82$YR$$M$Y$$$20240806$$PH$HN$
241761771$24176177$1$I$20211119$20211216$20240806$20240806$EXP$$AU-AstraZeneca-2021A886461$ASTRAZENECA$$1849$WK$$F$Y$$$20240806$$CN$AU$
241761781$24176178$1$I$$20221003$20240806$20240806$EXP$$US-AstraZeneca-2022A336866$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241761791$24176179$1$I$$20230505$20240806$20240806$EXP$$US-AstraZeneca-2023A107685$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241761801$24176180$1$I$$20220426$20240806$20240806$EXP$$US-AstraZeneca-2022A164971$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241761811$24176181$1$I$$20220711$20240806$20240806$EXP$$US-AstraZeneca-2022A253430$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241761821$24176182$1$I$$20220314$20240806$20240806$EXP$$US-AstraZeneca-2022A113744$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241761831$24176183$1$I$20210808$20211022$20240806$20240806$EXP$$US-AstraZeneca-2021A729379$ASTRAZENECA$$26930$DY$$$Y$$$20240806$$CN$US$
241761841$24176184$1$I$$20210715$20240806$20240806$EXP$$US-AstraZeneca-2021A570440$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241761851$24176185$1$I$$20230824$20240806$20240806$EXP$$US-AstraZeneca-2023A194321$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241761861$24176186$1$I$20200308$20220322$20240806$20240806$EXP$$IL-AstraZeneca-2020SF17895$ASTRAZENECA$$19587$DY$$M$Y$$$20240806$$HP$IL$
241761871$24176187$1$I$$20240730$20240806$20240806$30DAY$$US-GSK-US2024095402$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$CN$US$US
241761881$24176188$1$I$$20240729$20240806$20240806$PER$$US-AMGEN-USASP2024154136$AMGEN$$$$$$Y$$$20240805$$CN$US$US
241761891$24176189$1$I$$20240731$20240806$20240806$PER$$US-AMGEN-USASP2024153853$AMGEN$$$$$$Y$$$20240805$$CN$US$US
241761902$24176190$2$F$$20240719$20240806$20240806$PER$$US-ALXN-202407USA000932US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$CN$US$US
241761911$24176191$1$I$20240730$20240730$20240806$20240806$EXP$$US-JNJFOC-20240780956$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$US$US
241761921$24176192$1$I$$20231225$20240806$20240806$EXP$$CN-SANDOZ INC.-SDZ2023CN074868$SANDOZ$$$$$$Y$$$20240806$$CN$CN$CN
241761931$24176193$1$I$$20240304$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089370$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241761942$24176194$2$F$$20240715$20240806$20240806$PER$$US-ALXN-202407USA000820US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$HP$US$US
241761951$24176195$1$I$$20240801$20240806$20240806$PER$$US-ABBVIE-5864657$ABBVIE$$$$$F$Y$$$20240806$$HP$US$US
241761961$24176196$1$I$$20240711$20240806$20240806$PER$$US-ALXN-A202204844$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240719$$CN$US$US
241761971$24176197$1$I$20240702$20240729$20240806$20240806$EXP$$CN-BEIGENE-BGN-2024-011789$BEIGENE$$$$$$Y$$$20240806$$HP$CN$CN
241761981$24176198$1$I$$20240803$20240806$20240806$PER$$NVSC2024US159155$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
241761991$24176199$1$I$$20240723$20240806$20240806$EXP$$US-CIPLA LTD.-2024US08266$CIPLA$Zulch E, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, et al.. Impact of post-transplant Cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143 (107530):1 to 8$$$$$Y$$$20240806$$HP$US$US
241762011$24176201$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229324$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240806$$MD$US$US
241762021$24176202$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA224193$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240806$$MD$US$US
241762031$24176203$1$I$20200101$20240725$20240806$20240806$PER$$US-SA-2024SA224771$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240806$$MD$US$US
241762041$24176204$1$I$$20240723$20240806$20240806$PER$$US-SA-2023SA333068$SANOFI AVENTIS$$$$T$M$Y$$$20240806$$MD$US$US
241762051$24176205$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA227800$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240806$$MD$US$US
241762062$24176206$2$F$$20240808$20240806$20240816$PER$$US-SA-2024SA229326$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240817$$MD$US$US
241762071$24176207$1$I$20240701$20240730$20240806$20240806$PER$$US-SA-2024SA228033$SANOFI AVENTIS$$23$YR$A$M$Y$72.57$KG$20240806$$MD$US$US
241762081$24176208$1$I$$20240730$20240806$20240806$PER$$US-PCCINC-2024-PPL-000599$PIRAMAL$$$$$$Y$$$20240806$$CN$US$US
241762091$24176209$1$I$$20240723$20240806$20240806$EXP$$US-CIPLA LTD.-2024US08333$CIPLA$Mumtaz S, Wilson C, Vibhute P, Eggenberger ER, Berianu F, Abril A.. Central retinal artery occlusion associated with Takayasu arteritis. Diagnostics. 2024;14 (1329):1 to 7$$$$$Y$$$20240806$$HP$US$US
241762101$24176210$1$I$$20240724$20240806$20240806$EXP$$US-PADAGIS-2024PAD01251$PADAGIS$$$$$$Y$$$20240806$$CN$US$US
241762111$24176211$1$I$$20240722$20240806$20240806$EXP$$US-PADAGIS-2024PAD01236$PADAGIS$$$$$$Y$$$20240806$$MD$US$US
241762121$24176212$1$I$$20240723$20240806$20240806$EXP$$US-PADAGIS-2024PAD01238$PADAGIS$$$$$$Y$$$20240806$$CN$US$US
241762141$24176214$1$I$$20240724$20240806$20240806$EXP$$US-PADAGIS-2024PAD01253$PADAGIS$$$$$$Y$$$20240806$$PH$US$US
241762151$24176215$1$I$$20240725$20240806$20240806$EXP$$US-PADAGIS-2024PAD01254$PADAGIS$$$$$$Y$$$20240806$$CN$US$US
241762161$24176216$1$I$20240724$20240725$20240806$20240806$EXP$$US-PADAGIS-2024PAD01256$PADAGIS$$$$$$Y$$$20240806$$CN$US$US
241762171$24176217$1$I$$20240717$20240806$20240806$EXP$$US-PADAGIS-2024PAD01258$PADAGIS$$$$$$Y$$$20240806$$CN$US$US
241762181$24176218$1$I$$20240724$20240806$20240806$EXP$$US-PADAGIS-2024PAD01260$PADAGIS$Maggi R G, Calchi A C, Moore C O, Kingston E, Breitschwerdt E B. Human Babesia odocoilei and Bartonella spp. co-infections in the Americas. Parasites + Vectors. 2024;17(1):302$$$$$Y$$$20240806$$HP$US$US
241762191$24176219$1$I$$20240729$20240806$20240806$EXP$$US-PADAGIS-2024PAD01196$PADAGIS$Thor, Danielle C DC, Patel, Krut K, Singh, Monisha M. Navigation of a New-Onset Pulmonary Embolism in a Patient Receiving Female-to-Male Gender-Affirming Care: A Case Report.. Cureus. 2024;16(6):e63101$$$$$Y$$$20240806$$HP$US$US
241762202$24176220$2$F$$20240805$20240806$20240813$EXP$$US-PADAGIS-2024PAD01248$PADAGIS$$$$$$Y$$$20240812$$CN$US$US
241762211$24176221$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA227568$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240806$$CN$US$US
241762221$24176222$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA230148$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240806$$MD$US$US
241762231$24176223$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA228326$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240806$$MD$US$US
241762241$24176224$1$I$$20240728$20240806$20240806$PER$$US-SA-2022SA448249$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240806$$MD$US$US
241762253$24176225$3$F$$20240905$20240806$20240916$PER$$US-SA-2024SA226812$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240916$$MD$US$US
241762262$24176226$2$F$20240101$20240916$20240806$20240925$PER$$US-SA-2024SA228766$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240925$$MD$US$US
241762272$24176227$2$F$20240601$20240725$20240806$20240909$PER$$US-SA-2024SA225933$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240909$$MD$US$US
241762281$24176228$1$I$20210101$20240730$20240806$20240806$PER$$US-SA-2024SA229296$SANOFI AVENTIS$$65$YR$E$F$Y$104.32$KG$20240806$$MD$US$US
241762291$24176229$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA227704$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240806$$MD$US$US
241762301$24176230$1$I$20230101$20240731$20240806$20240806$PER$$US-SA-2024SA227974$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240806$$MD$US$US
241762314$24176231$4$F$20240711$20240903$20240806$20240914$PER$$US-ABBVIE-5867260$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
241762323$24176232$3$F$$20240319$20240806$20240917$PER$$US-ENDO USA, INC.-2024-001477$ENDO$$$$$F$Y$$$20240917$$CN$US$US
241762332$24176233$2$F$$20240312$20240806$20240916$PER$$US-ENDO USA, INC.-2024-001392$ENDO$$$$$M$Y$$$20240916$$CN$US$US
241762342$24176234$2$F$$20240514$20240806$20240916$PER$$US-ENDO USA, INC.-2024-002228$ENDO$$$$$M$Y$$$20240916$$CN$US$US
241762352$24176235$2$F$$20240220$20240806$20240916$PER$$US-ENDO USA, INC.-2024-001130$ENDO$$$$$M$Y$$$20240916$$CN$US$US
241762362$24176236$2$F$$20231219$20240806$20240916$PER$$US-ENDO USA, INC.-2024-000168$ENDO$$$$$F$Y$$$20240916$$CN$US$US
241762373$24176237$3$F$$20231219$20240806$20240918$PER$$US-ENDO USA, INC.-2024-000203$ENDO$$$$$$Y$$$20240918$$CN$US$US
241762382$24176238$2$F$$20240423$20240806$20240916$PER$$US-ENDO USA, INC.-2024-001980$ENDO$$$$$F$Y$$$20240916$$CN$US$US
241762391$24176239$1$I$$20240730$20240806$20240806$PER$$US-PCCINC-2024-PPL-000600$PIRAMAL$$$$$$Y$$$20240806$$HP$US$US
241762401$24176240$1$I$$20240723$20240806$20240806$EXP$$US-CIPLA LTD.-2024US08267$CIPLA$Zulch E, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, et al.. Impact of post-transplant Cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143 (107530):1 to 8$$$$$Y$$$20240806$$HP$US$US
241762411$24176241$1$I$$20240723$20240806$20240806$EXP$$US-CIPLA LTD.-2024US08269$CIPLA$Zulch E, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, et al.. Impact of post-transplant Cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143 (107530):1 to 8$$$$$Y$$$20240806$$HP$US$US
241762421$24176242$1$I$$20240724$20240806$20240806$EXP$$US-AUROBINDO-AUR-APL-2024-038201$AUROBINDO$Marvin JE, McSweeney T, Cohen E, Davis MW, Belfield K, Do V, et al.. Nocardiosis in Kidney Transplant Recipients and Possible Association With Decreased Utilization of Trimethoprim/Sulfamethoxazole During COVID-19. Transplantation. 2024;108(7):e150-e151$39$YR$$$Y$$$20240806$$MD$US$US
241762431$24176243$1$I$$20240725$20240806$20240806$EXP$$CO-NOVOPROD-1263440$NOVO NORDISK$$75$YR$$M$Y$79$KG$20240806$$CN$CO$CO
241762441$24176244$1$I$$20240726$20240806$20240806$EXP$$ES-NOVOPROD-1261158$NOVO NORDISK$$$$$F$Y$$$20240806$$MD$ES$ES
241762452$24176245$2$F$$20240731$20240806$20240814$EXP$$BR-NOVOPROD-1261050$NOVO NORDISK$$886$MON$$F$Y$$$20240814$$CN$BR$BR
241762461$24176246$1$I$$20240711$20240806$20240806$PER$$US-ALXN-202407USA000888US$ALEXION PHARMACEUTICALS$$$$$F$Y$65.76$KG$20240719$$CN$US$US
241762471$24176247$1$I$$20240725$20240806$20240806$EXP$$US-NOVOPROD-1262719$NOVO NORDISK$$60$YR$$M$Y$$$20240806$$MD$US$US
241762481$24176248$1$I$$20240723$20240806$20240806$EXP$$US-NOVOPROD-1264559$NOVO NORDISK$$$$$F$Y$$$20240806$$CN$US$US
241762492$24176249$2$F$$20240814$20240806$20240823$EXP$$PL-NOVOPROD-1261045$NOVO NORDISK$$64$YR$$F$Y$$$20240823$$MD$PL$PL
241762501$24176250$1$I$20240701$20240724$20240806$20240806$EXP$$US-NOVOPROD-1262207$NOVO NORDISK$$$$$F$Y$$$20240806$$CN$US$US
241762521$24176252$1$I$20240731$20240802$20240806$20240806$EXP$$CN-HALEON-2190381$Haleon PLC$$19$YR$$F$Y$48$KG$20240806$$HP$CN$CN
241762531$24176253$1$I$$20240726$20240806$20240806$EXP$GB-MHRA-MIDB-25642b1d-4baf-4deb-8653-ad9fd9ed5b16$GB-NOVOPROD-1261332$NOVO NORDISK$$81$YR$$F$Y$$$20240806$$PH$GB$GB
241762541$24176254$1$I$20240712$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024155178$AMGEN$$$$$$Y$$$20240805$$HP$US$US
241762561$24176256$1$I$$20240730$20240806$20240806$PER$$US-PCCINC-2024-PPL-000601$PIRAMAL$$$$$$Y$$$20240806$$HP$US$US
241762571$24176257$1$I$20220920$20221129$20240806$20240806$EXP$$US-AstraZeneca-2022A335270$ASTRAZENECA$$26109$DY$$M$Y$$$20240806$$CN$US$
241762581$24176258$1$I$20240611$20240724$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037602$AUROBINDO$$23$YR$$M$Y$$$20240806$$PH$FR$FR
241762591$24176259$1$I$$20220426$20240806$20240806$EXP$$CA-AstraZeneca-2022A122932$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$CA$
241762601$24176260$1$I$$20230324$20240806$20240806$EXP$$US-AstraZeneca-2023A071300$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241762611$24176261$1$I$20220516$20220523$20240806$20240806$EXP$$AE-AstraZeneca-2022A200396$ASTRAZENECA$$12724$DY$$F$Y$$$20240806$$CN$AE$
241762621$24176262$1$I$$20221025$20240806$20240806$EXP$$US-AstraZeneca-2022A317351$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241762631$24176263$1$I$$20211220$20240806$20240806$EXP$$US-AstraZeneca-2021A889689$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241762641$24176264$1$I$20221001$20221101$20240806$20240806$EXP$$US-AstraZeneca-2022A363198$ASTRAZENECA$$89$YR$$F$Y$$$20240806$$CN$US$
241762651$24176265$1$I$$20220110$20240806$20240806$EXP$$AU-AstraZeneca-2022A015670$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$AU$
241762661$24176266$1$I$$20240801$20240806$20240806$EXP$$ZA-AstraZeneca-2024A175542$ASTRAZENECA$$$$$F$Y$$$20240806$$MD$ZA$
241762671$24176267$1$I$$20240725$20240806$20240806$EXP$$TR-P+L Developments of Newyork Corporation-2160034$PL DEVELOPMENTS$Initial$8$YR$$$Y$$$20240806$$$TR$TR
241762681$24176268$1$I$$20230719$20240806$20240806$EXP$$US-AstraZeneca-2023A166165$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241762691$24176269$1$I$$20211126$20240806$20240806$EXP$$US-AstraZeneca-2021A848388$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241762701$24176270$1$I$20240601$20240727$20240806$20240806$PER$$US-BEH-2024176578$CSL BEHRING$$41$YR$A$F$Y$$$20240806$$CN$US$US
241762711$24176271$1$I$20220427$20240119$20240806$20240806$EXP$$IT-SANDOZ INC.-SDZ2024IT006468$SANDOZ$$$$$$Y$$$20240806$$MD$IT$IT
241762721$24176272$1$I$20240724$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153722$AMGEN$$73$YR$E$F$Y$$$20240805$$CN$US$US
241762741$24176274$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154319$AMGEN$$$$$M$Y$$$20240805$$CN$US$US
241762751$24176275$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024154111$AMGEN$$$$$$Y$$$20240805$$HP$US$US
241762761$24176276$1$I$$20240730$20240806$20240806$PER$$US-PCCINC-2024-PPL-000602$PIRAMAL$$$$$$Y$$$20240806$$HP$US$US
241762771$24176277$1$I$$20240730$20240806$20240806$PER$$NVSC2024US156213$NOVARTIS$$$$$F$Y$$$20240806$$HP$US$US
241762782$24176278$2$F$$20240808$20240806$20240813$EXP$$PT-TAKEDA-2024TUS077971$TAKEDA$$46$YR$$F$Y$$$20240813$$MD$PT$PT
241762791$24176279$1$I$$20240730$20240806$20240806$EXP$$CN-JNJFOC-20240804840$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$CN$CN
241762801$24176280$1$I$$20240730$20240806$20240806$PER$$US-PCCINC-2024-PPL-000603$PIRAMAL$$$$$$Y$$$20240806$$HP$US$US
241762811$24176281$1$I$$20231121$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA057283$SANDOZ$$$$$$Y$$$20240806$$HP$CA$CA
241762821$24176282$1$I$20240618$20240802$20240806$20240806$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039134$BOEHRINGER INGELHEIM$$89$YR$E$F$Y$$$20240806$$MD$JP$JP
241762831$24176283$1$I$$20231106$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA051533$SANDOZ$$$$$$Y$$$20240806$$MD$CA$CA
241762841$24176284$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122343$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$77.11$KG$20240806$$CN$US$US
241762852$24176285$2$F$$20240805$20240806$20240806$PER$$US-AMGEN-USASP2024154634$AMGEN$$$$$F$Y$$$20240806$$PH$US$US
241762871$24176287$1$I$$20240723$20240806$20240806$EXP$$US-BELUSA-2024BELLIT0089$BIOLOGICAL E.$Weigle DP, Nielsen A, Braunecker S.Uncommon and Unfavorable: Heparin-Induced Hyperkalemia.Journal of Cardio thoracic and Vascular Anesthesia.2024;1-4$$$$$Y$$$20240806$$MD$US$US
241762881$24176288$1$I$20240701$20240731$20240806$20240806$PER$$US-AMGEN-USASP2024152621$AMGEN$$58$YR$A$F$Y$$$20240805$$CN$US$US
241762891$24176289$1$I$$20240307$20240806$20240806$EXP$$DE-SANDOZ INC.-SDZ2018DE000014$SANDOZ$$$$$$Y$$$20240806$$PH$DE$DE
241762901$24176290$1$I$20240705$20240726$20240806$20240806$EXP$$CN-ROCHE-10000040606$ROCHE$$62$YR$A$F$Y$59$KG$20240806$$HP$CN$CN
241762911$24176291$1$I$20220101$20230131$20240806$20240806$EXP$$US-AstraZeneca-2023A026645$ASTRAZENECA$$81$YR$$F$Y$$$20240806$$CN$US$
241762921$24176292$1$I$$20231129$20240806$20240806$EXP$$US-AstraZeneca-2023A271950$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241762931$24176293$1$I$$20231013$20240806$20240806$EXP$$ZA-AstraZeneca-2023A234147$ASTRAZENECA$$46$YR$$M$Y$$$20240806$$CN$ZA$
241762941$24176294$1$I$$20230327$20240806$20240806$EXP$$US-AstraZeneca-2023A072467$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241762951$24176295$1$I$20240306$20240724$20240806$20240806$EXP$$US-HALEON-2190219$Haleon PLC$$82$YR$$F$Y$73.02$KG$20240805$$CN$US$US
241762961$24176296$1$I$$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A176881$ASTRAZENECA$$$$$$Y$$$20240806$$HP$US$
241762971$24176297$1$I$$20210715$20240806$20240806$EXP$$TW-AstraZeneca-2021A626955$ASTRAZENECA$$64$YR$$M$Y$$$20240806$$CN$TW$
241762981$24176298$1$I$$20211227$20240806$20240806$EXP$$US-AstraZeneca-2021A907133$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241762991$24176299$1$I$$20220602$20240806$20240806$EXP$$TW-AstraZeneca-2022A211251$ASTRAZENECA$$65$YR$$F$Y$$$20240806$$CN$TW$
241763001$24176300$1$I$20211001$20211020$20240806$20240806$EXP$$US-AstraZeneca-2021A781860$ASTRAZENECA$$761$MON$$M$Y$$$20240806$$CN$US$
241763011$24176301$1$I$$20230419$20240806$20240806$EXP$$US-AstraZeneca-2023A092489$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241763021$24176302$1$I$$20230201$20240806$20240806$EXP$$US-AstraZeneca-2023A029655$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241763031$24176303$1$I$20210809$20210816$20240806$20240806$EXP$$AE-AstraZeneca-2021A686269$ASTRAZENECA$$25846$DY$$M$Y$$$20240806$$CN$AE$
241763041$24176304$1$I$$20230816$20240806$20240806$EXP$$TW-AstraZeneca-2023A187315$ASTRAZENECA$$$$$F$Y$$$20240806$$HP$TW$
241763051$24176305$1$I$$20240723$20240806$20240806$PER$$US-AstraZeneca-2024A168150$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241763061$24176306$1$I$$20210826$20240806$20240806$EXP$$US-AstraZeneca-2021A702273$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241763071$24176307$1$I$$20240801$20240806$20240806$PER$$US-TAKEDA-2024TUS077762$TAKEDA$$77$YR$$F$Y$$$20240806$$CN$US$US
241763081$24176308$1$I$$20240116$20240806$20240806$EXP$$TR-SANDOZ INC.-SDZ2024TR006887$SANDOZ$$$$$$Y$$$20240806$$CN$TR$TR
241763091$24176309$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122286$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$58.06$KG$20240806$$CN$US$US
241763102$24176310$2$F$$20240823$20240806$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123488$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240902$$CN$US$US
241763111$24176311$1$I$$20210324$20240806$20240806$EXP$$US-AstraZeneca-2021A224224$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241763121$24176312$1$I$20191213$20240805$20240806$20240806$EXP$$DE-SANDOZ INC.-SDZ2024DE070536$SANDOZ$$$$$$Y$$$20240806$$MD$DE$DE
241763133$24176313$3$F$20240801$20240816$20240806$20240819$PER$$US-AMGEN-USASP2024155160$AMGEN$$50$YR$A$F$Y$$$20240819$$CN$US$US
241763141$24176314$1$I$20240701$20240805$20240806$20240806$EXP$SE-SEMPA-2024-005846$SE-SANDOZ INC.-SDZ2024SE070414$SANDOZ$$67$YR$$F$Y$$$20240806$$MD$SE$SE
241763151$24176315$1$I$$20240805$20240806$20240806$EXP$BG-GLPHARMA-24.0962$BG-UCBSA-2024039125$UCB$$$$$F$Y$$$20240806$$MD$BG$BG
241763171$24176317$1$I$20240722$20240726$20240806$20240806$EXP$$JP-ROCHE-10000046043$ROCHE$$$$E$F$Y$$$20240806$$MD$JP$JP
241763181$24176318$1$I$$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001461$ELI LILLY AND CO$$$$$M$Y$$$20240806$$CN$US$US
241763191$24176319$1$I$$20240724$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2020-049421$AUROBINDO$Descamps V.. Drug reaction with eosinophilia and systemic symptoms and thyroiditis: Human herpesvirus-6, the possible common link.. British Journal of Dermatology. 2013;169(4):952$62$YR$$M$Y$$$20240806$$MD$FR$FR
241763201$24176320$1$I$$20240728$20240806$20240806$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000264$EMCURE$Kumar AB, Asamoah EM, Wetter DA, Davis MDP, Alavi A.. Clinical Characteristics and Inciting Agents for Pseudoporphyria: The Mayo Clinic Experience, 1996-2020. Adv Skin Wound Care. 2024;37(8):406-411$$$$$Y$$$20240806$$MD$US$US
241763211$24176321$1$I$$20240728$20240806$20240806$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000265$EMCURE$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024$$$N$M$Y$$$20240806$$MD$US$US
241763221$24176322$1$I$$20240728$20240806$20240806$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000269$EMCURE$Kumar AB, Asamoah EM, Wetter DA, Davis MDP, Alavi A.. Clinical Characteristics and Inciting Agents for Pseudoporphyria: The Mayo Clinic Experience, 1996-2020. Adv Skin Wound Care. 2024;37(8):406-411$$$$$Y$$$20240806$$MD$US$US
241763231$24176323$1$I$$20240728$20240806$20240806$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000273$EMCURE$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024$$$N$M$Y$$$20240806$$MD$US$US
241763241$24176324$1$I$$20240728$20240806$20240806$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000268$EMCURE$Kumar AB, Asamoah EM, Wetter DA, Davis MDP, Alavi A.. Clinical Characteristics and Inciting Agents for Pseudoporphyria: The Mayo Clinic Experience, 1996-2020. Adv Skin Wound Care. 2024;37(8):406-411$$$$$Y$$$20240806$$MD$US$US
241763251$24176325$1$I$$20240802$20240806$20240806$PER$$NVSC2024US159015$NOVARTIS$$$$$$Y$$$20240806$$CN$US$US
241763261$24176326$1$I$$20240728$20240806$20240806$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000271$EMCURE$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024$$$N$M$Y$$$20240806$$MD$US$US
241763281$24176328$1$I$$20240728$20240806$20240806$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000272$EMCURE$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024$$$N$F$Y$$$20240806$$MD$US$US
241763291$24176329$1$I$$20240725$20240806$20240806$PER$$US-AMGEN-USASP2024153006$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et.al. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1 to E8$$$$$Y$$$20240805$$MD$US$US
241763302$24176330$2$F$20240801$20240801$20240806$20240808$PER$$US-AMGEN-USASP2024154322$AMGEN$$77$YR$E$M$Y$$$20240808$$CN$US$US
241763311$24176331$1$I$$20240725$20240806$20240806$PER$$US-AMGEN-USASP2024153456$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1 - E8$$$$$Y$$$20240805$$MD$US$US
241763321$24176332$1$I$20220201$20240103$20240806$20240806$EXP$$RO-SANDOZ INC.-SDZ2023RO070918$SANDOZ$$$$$$Y$$$20240806$$CN$RO$RO
241763331$24176333$1$I$20240601$20240726$20240806$20240806$EXP$$US-NOVOPROD-1262663$NOVO NORDISK$$$$$F$Y$$$20240806$$CN$US$US
241763342$24176334$2$F$20240701$20240805$20240806$20240814$EXP$$DE-NOVOPROD-1261649$NOVO NORDISK$$58$YR$$F$Y$106$KG$20240814$$HP$DE$DE
241763351$24176335$1$I$20240101$20240726$20240806$20240806$EXP$$US-NOVOPROD-1262931$NOVO NORDISK$$73$YR$$M$Y$$$20240806$$CN$US$US
241763361$24176336$1$I$20240720$20240726$20240806$20240806$EXP$GB-MHRA-MED-202407261530387940-YJPWS$GB-NOVOPROD-1261345$NOVO NORDISK$$66$YR$$F$Y$$$20240806$$CN$GB$GB
241763371$24176337$1$I$$20240726$20240806$20240806$EXP$$US-NOVOPROD-1262750$NOVO NORDISK$$$$$F$Y$$$20240806$$CN$US$US
241763381$24176338$1$I$20100101$20240727$20240806$20240806$EXP$$EG-NOVOPROD-1262361$NOVO NORDISK$$732$MON$$F$Y$76$KG$20240806$$CN$EG$EG
241763391$24176339$1$I$20240501$20240726$20240806$20240806$EXP$GB-MHRA-MED-202407261911003090-KVQZD$GB-NOVOPROD-1261343$NOVO NORDISK$$49$YR$$F$Y$$$20240806$$CN$GB$GB
241763403$24176340$3$F$20240716$20240910$20240806$20240915$EXP$$JP-ROCHE-10000048733$ROCHE$$67$YR$E$M$Y$$$20240915$$MD$JP$JP
241763411$24176341$1$I$$20240729$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120198$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240806$$HP$US$US
241763421$24176342$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122199$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$49.44$KG$20240806$$HP$US$US
241763431$24176343$1$I$20100101$20240727$20240806$20240806$EXP$$EG-NOVOPROD-1261877$NOVO NORDISK$$732$MON$$F$Y$76$KG$20240806$$CN$EG$EG
241763441$24176344$1$I$$20240727$20240806$20240806$EXP$$CN-NOVOPROD-1261751$NOVO NORDISK$$$$$F$Y$$$20240806$$CN$CN$CN
241763451$24176345$1$I$$20240726$20240806$20240806$EXP$$FR-NOVOPROD-1262269$NOVO NORDISK$$$$$F$Y$107$KG$20240806$$MD$FR$FR
241763461$24176346$1$I$$20240727$20240806$20240806$EXP$$EG-NOVOPROD-1261713$NOVO NORDISK$$35$YR$$M$Y$$$20240806$$CN$EG$EG
241763471$24176347$1$I$20231001$20240726$20240806$20240806$EXP$RU-RZN-2482561$RU-NOVOPROD-1262241$NOVO NORDISK$$2$YR$$F$Y$18$KG$20240806$$HP$RU$RU
241763481$24176348$1$I$$20240726$20240806$20240806$EXP$$EG-NOVOPROD-1261739$NOVO NORDISK$$3$YR$$F$Y$$$20240806$$MD$EG$EG
241763491$24176349$1$I$$20240727$20240806$20240806$EXP$$EG-NOVOPROD-1261793$NOVO NORDISK$$732$MON$$F$Y$76$KG$20240806$$CN$EG$EG
241763501$24176350$1$I$$20240803$20240806$20240806$EXP$$CA-ROCHE-3296962$ROCHE$$89$YR$E$F$Y$$$20240806$$HP$CA$CA
241763512$24176351$2$F$20240501$20240907$20240806$20240920$EXP$$MX-NOVOPROD-1261839$NOVO NORDISK$$71$YR$$M$Y$110$KG$20240920$$CN$MX$MX
241763521$24176352$1$I$$20240802$20240806$20240806$EXP$TR-MLMSERVICE-20240716-PI133858-00306-1$TR-ROCHE-10000043188$ROCHE$Kaynar K, Ertekin T, ?reyener GE, Mungan S, Abuhadwan H. Hodgkin lymphoma in a patient with kidney transplantation. Nefrologia. 2024;44(4):601-3. DOI:10.1016/j.nefro.2023.03.006.$35$YR$A$M$Y$$$20240806$$MD$TR$TR
241763531$24176353$1$I$$20240730$20240806$20240806$PER$$US-ALXN-202407USA002120US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$MD$US$US
241763541$24176354$1$I$$20231016$20240806$20240806$EXP$$US-AstraZeneca-2023A235812$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241763551$24176355$1$I$$20231009$20240806$20240806$EXP$$US-AstraZeneca-2023A230385$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241763561$24176356$1$I$20231101$20231101$20240806$20240806$EXP$$US-AstraZeneca-2023A249481$ASTRAZENECA$$23830$DY$$F$Y$$$20240806$$CN$US$
241763571$24176357$1$I$$20221108$20240806$20240806$EXP$$US-AstraZeneca-2022A370564$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241763581$24176358$1$I$20230201$20230202$20240806$20240806$EXP$$US-AstraZeneca-2023A030172$ASTRAZENECA$$23728$DY$$F$Y$$$20240806$$CN$US$
241763591$24176359$1$I$20210428$20210527$20240806$20240806$EXP$$GB-AstraZeneca-2021A454615$ASTRAZENECA$$11391$DY$$F$Y$$$20240806$$CN$GB$
241763601$24176360$1$I$$20210701$20240806$20240806$EXP$$US-AstraZeneca-2021A585720$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241763611$24176361$1$I$20240729$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153979$AMGEN$$79$YR$E$F$Y$$$20240805$$CN$US$US
241763621$24176362$1$I$20231006$20240805$20240806$20240806$EXP$FR-AFSSAPS-NY2024000892$FR-JNJFOC-20240810230$JOHNSON AND JOHNSON$$74$YR$E$M$Y$75.9$KG$20240806$$MD$FR$FR
241763632$24176363$2$F$20240731$20240808$20240806$20240813$EXP$$US-BEIGENE-BGN-2024-012155$BEIGENE$$$$$$Y$$$20240813$$CN$US$US
241763642$24176364$2$F$20220101$20240927$20240806$20240927$EXP$$SK-SANDOZ INC.-SDZ2024SK000478$SANDOZ$$$$$$Y$$$20240927$$MD$SK$SK
241763652$24176365$2$F$20210101$20240820$20240806$20240827$EXP$$US-AMGEN-USASP2024154019$AMGEN$$56$YR$A$F$Y$$$20240827$$HP$US$US
241763661$24176366$1$I$$20231121$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA057358$SANDOZ$$$$$$Y$$$20240806$$HP$CA$CA
241763671$24176367$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024154534$AMGEN$$$$$$Y$$$20240805$$PH$US$US
241763681$24176368$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038705$AUROBINDO$$65$YR$$F$Y$$$20240806$$HP$CA$CA
241763691$24176369$1$I$$20240801$20240806$20240806$PER$$US-ROCHE-10000047217$ROCHE$$$$$F$Y$$$20240806$$HP$US$US
241763701$24176370$1$I$$20240801$20240806$20240806$30DAY$$US-GSK-US2024096852$GLAXOSMITHKLINE$$$$$M$Y$$$20240806$$CN$US$US
241763716$24176371$6$F$20240716$20240916$20240806$20240926$EXP$$ZA-CELLTRION INC.-2024ZA017806$CELLTRION$$$$$$Y$$$20240926$$CN$ZA$ZA
241763721$24176372$1$I$$20231121$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA063331$SANDOZ$$$$$$Y$$$20240806$$HP$CA$CA
241763731$24176373$1$I$20240720$20240801$20240806$20240806$EXP$$CN-ROCHE-10000047071$ROCHE$$70$YR$E$M$Y$61$KG$20240806$$HP$CN$CN
241763741$24176374$1$I$$20240729$20240806$20240806$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001549$BLUEPRINT MEDICINES$$$$$F$Y$$$20240806$$CN$US$US
241763751$24176375$1$I$$20240730$20240806$20240806$PER$$US-ABBVIE-5863121$ABBVIE$$63$YR$$F$Y$$$20240806$$CN$US$US
241763761$24176376$1$I$$20240725$20240806$20240806$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2160036$Chengdu Suncadia Medicine$Intestinal lymphoproliferative disease after liver transplant in children: Clinical pathological analysis of 3 cases$16$MON$$M$Y$$$20240806$$MD$CN$CN
241763771$24176377$1$I$$20240725$20240806$20240806$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2160035$Chengdu Suncadia Medicine$Literature title: Intestinal lymphoproliferative disease after liver transplant in children: Clinical pathological analysis of 3 cases. ?Literature publication journal: Chinese Journal of Clinical and Experimental Pathology 2024; 40 (7): 762-765.?Literature authors: Lian Yang, Wenwen Li, Man Xu, Jin Zhu.$95$YR$$M$Y$$$20240806$$MD$CN$CN
241763781$24176378$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002019$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240806$$CN$US$US
241763792$24176379$2$F$$20240528$20240806$20240916$PER$$US-ENDO USA, INC.-2024-002471$ENDO$$$$$F$Y$$$20240916$$CN$US$US
241763801$24176380$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038735$AUROBINDO$$48$YR$$M$Y$$$20240806$$HP$CA$CA
241763811$24176381$1$I$$20230806$20240806$20240806$PER$$US-ENDO PHARMACEUTICALS INC-2023-004665$ENDO$$$$$$Y$$$20240806$$CN$US$US
241763822$24176382$2$F$$20240521$20240806$20240917$PER$$US-ENDO USA, INC.-2024-002376$ENDO$$$$A$M$Y$$$20240917$$CN$US$US
241763833$24176383$3$F$20240604$20240903$20240806$20240913$30DAY$$US-GSK-US2024096282$GLAXOSMITHKLINE$$50$YR$$M$Y$$$20240913$$CN$US$US
241763842$24176384$2$F$$20240521$20240806$20240917$PER$$US-ENDO USA, INC.-2024-002366$ENDO$$$$$M$Y$$$20240917$$CN$US$US
241763851$24176385$1$I$$20240726$20240806$20240806$EXP$$US-NOVOPROD-1263172$NOVO NORDISK$$$$A$F$Y$$$20240806$$CN$US$US
241763861$24176386$1$I$$20240726$20240806$20240806$EXP$$US-NOVOPROD-1263200$NOVO NORDISK$$$$$F$Y$$$20240806$$CN$US$US
241763871$24176387$1$I$20240601$20240726$20240806$20240806$EXP$$US-NOVOPROD-1263141$NOVO NORDISK$$$$A$M$Y$$$20240806$$MD$US$US
241763881$24176388$1$I$20240701$20240726$20240806$20240806$EXP$$US-NOVOPROD-1263307$NOVO NORDISK$$$$$F$Y$$$20240806$$CN$US$US
241763891$24176389$1$I$20230426$20240103$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US000711$SANDOZ$$$$$$Y$$$20240806$$HP$US$US
241763911$24176391$1$I$$20230519$20240806$20240806$EXP$$US-AstraZeneca-2023A117308$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241763921$24176392$1$I$$20211004$20240806$20240806$EXP$$US-AstraZeneca-2021A766937$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241763931$24176393$1$I$20210607$20210611$20240806$20240806$EXP$$US-AstraZeneca-2021A523539$ASTRAZENECA$$25796$DY$$$Y$$$20240806$$CN$US$
241763941$24176394$1$I$$20210511$20240806$20240806$EXP$$US-AstraZeneca-2021A435151$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241763951$24176395$1$I$$20240726$20240806$20240806$EXP$$AU-JAZZ PHARMACEUTICALS-2024-AU-011296$JAZZ$$$$$M$Y$$$20240805$$MD$AU$AU
241763961$24176396$1$I$$20230125$20240806$20240806$EXP$$US-AstraZeneca-2023A022401$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241763971$24176397$1$I$20210927$20211001$20240806$20240806$EXP$$US-AstraZeneca-2021A759298$ASTRAZENECA$$67$YR$$F$Y$57.6$KG$20240806$$CN$US$
241763981$24176398$1$I$$20230316$20240806$20240806$EXP$$US-AstraZeneca-2023A063989$ASTRAZENECA$$$$$$Y$$$20240806$$MD$US$
241763991$24176399$1$I$20240705$20240730$20240806$20240806$EXP$FR-AFSSAPS-PB2024000801$FR-CHEPLA-2024009853$CHEPLAPHARM$$60$YR$$F$Y$72$KG$20240806$$MD$COUNTRY NOT SPECIFIED$FR
241764011$24176401$1$I$20240731$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153439$AMGEN$$67$YR$E$F$Y$$$20240805$$CN$US$US
241764021$24176402$1$I$$20210709$20240806$20240806$EXP$$US-AstraZeneca-2021A612155$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241764031$24176403$1$I$$20210429$20240806$20240806$EXP$$US-AstraZeneca-2021A390410$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241764041$24176404$1$I$20221115$20221115$20240806$20240806$EXP$$ZA-AstraZeneca-2022A380672$ASTRAZENECA$$24995$DY$$M$Y$$$20240806$$CN$ZA$
241764051$24176405$1$I$$20211229$20240806$20240806$EXP$$US-AstraZeneca-2021A909509$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241764061$24176406$1$I$$20230130$20240806$20240806$EXP$$US-AstraZeneca-2023A025941$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241764071$24176407$1$I$$20220118$20240806$20240806$EXP$$US-AstraZeneca-2022A031269$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241764081$24176408$1$I$$20240726$20240806$20240806$EXP$$DE-NOVOPROD-1263483$NOVO NORDISK$$10$YR$$F$Y$$$20240806$$HP$DE$DE
241764091$24176409$1$I$20240718$20240726$20240806$20240806$EXP$$US-NOVOPROD-1263321$NOVO NORDISK$$90$YR$$M$Y$$$20240806$$CN$US$US
241764101$24176410$1$I$20230101$20240726$20240806$20240806$EXP$$US-NOVOPROD-1263345$NOVO NORDISK$$54$YR$$M$Y$$$20240806$$CN$US$US
241764113$24176411$3$F$20240601$20240905$20240806$20240917$EXP$$IL-NOVOPROD-1263506$NOVO NORDISK$$61$YR$$M$Y$100$KG$20240917$$MD$IL$IL
241764121$24176412$1$I$20240712$20240726$20240806$20240806$EXP$$US-NOVOPROD-1263877$NOVO NORDISK$$67$YR$$F$Y$$$20240806$$CN$US$US
241764131$24176413$1$I$20240727$20240729$20240806$20240806$EXP$$US-NOVOPROD-1262975$NOVO NORDISK$$75$YR$$M$Y$$$20240806$$CN$US$US
241764141$24176414$1$I$20230601$20240726$20240806$20240806$EXP$$US-NOVOPROD-1263320$NOVO NORDISK$$$$$F$Y$$$20240806$$CN$US$US
241764151$24176415$1$I$20220207$20220207$20240806$20240806$EXP$$US-AstraZeneca-2022A062927$ASTRAZENECA$$25668$DY$$$Y$$$20240806$$CN$US$
241764161$24176416$1$I$$20231004$20240806$20240806$EXP$$US-AstraZeneca-2023A226612$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241764171$24176417$1$I$20240610$20240722$20240806$20240806$EXP$ES-AEMPS-1550297$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-110314$ZYDUS PHARM$$$$$$Y$$$20240806$$MD$ES$ES
241764181$24176418$1$I$20240416$20240722$20240806$20240806$EXP$ES-AEMPS-1550302$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-110316$ZYDUS PHARM$$$$$$Y$$$20240806$$MD$ES$ES
241764191$24176419$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA224636$SANOFI AVENTIS$$$$A$M$Y$$$20240806$$MD$US$US
241764201$24176420$1$I$$20231004$20240806$20240806$EXP$$DE-SANDOZ INC.-SDZ2023DE041847$SANDOZ$Kutsch N, Holmes E, Robrecht S, Sch?ler G, Vehling-Kaiser U, Decker T et al.,. Efficacy and safety of obinutuzumab combinedwith fludarabine and cyclophosphamide (FCG) orbendamustine (BG) in relapsed or refractory CLLpatients followed by maintenance therapy withobinutuzumab for responding patients. Leukemia + Lymphoma. 2023;64:478-482$$$$$Y$$$20240806$$HP$DE$DE
241764211$24176421$1$I$20070901$20240722$20240806$20240806$EXP$FR-EMA-DD-20240717-7482677-080126$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110293$ZYDUS PHARM$Yameogo TM, Tchaou B, Azon-Kouanou A et al.. Lyell^ disease, visceral damage and evolution.. About two cases Annales Francaises d^Anesthesie et de Reanimation. 2010;29 (7-8):597-598$$$$$Y$$$20240806$$MD$FR$FR
241764231$24176423$1$I$$20240724$20240806$20240806$EXP$$US-RDY-LIT/USA/24/0011115$DR REDDYS$Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwari A, Russe JR. OVERWHELMING CYTOCHROME P450 ISOENZYME ACTIVITY GENERATING DRUG-INDUCED LIVER INJURY RESULTING IN FULMINANT LIVER FAILURE. Hepatology. 2023 Oct;78: S643-S644. doi:10.1097/HEP.0000000000000580.$41$YR$A$F$Y$$$20240806$$HP$US$US
241764241$24176424$1$I$$20240101$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US000061$SANDOZ$Guillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, Karen W L Yee, Amer M Zeidan, Aref Al-Kali, H Joachim Deeg, Prapti A Patel, Mitchell Sablof et al. Oral decitabine-cedazuridine versus intravenous decitabinefor myelodysplastic syndromes and chronic myelomonocyticleukaemia (ASCERTAIN): a registrational, randomised,crossover, pharmacokinetics, phase 3 study. Lancet Haematol. 2024;11:r187893$$$$$Y$$$20240806$$MD$US$US
241764251$24176425$1$I$20240701$20240801$20240806$20240806$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-105616$REGENERON$$$$$F$Y$$$20240806$$CN$US$US
241764261$24176426$1$I$$20240729$20240806$20240806$PER$$US-EMD Serono-2024041307$EMD SERONO INC$$$$$F$Y$$$20240806$$CN$US$US
241764271$24176427$1$I$20240101$20240801$20240806$20240806$PER$$US-ABBVIE-5865149$ABBVIE$$$$A$F$Y$$$20240806$$HP$US$US
241764281$24176428$1$I$$20240801$20240806$20240806$PER$$NVSC2024US158897$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
241764292$24176429$2$F$$20240807$20240806$20240808$PER$$US-JNJFOC-20240801792$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240808$$MD$US$US
241764301$24176430$1$I$$20240724$20240806$20240806$EXP$$PT-AUROBINDO-AUR-APL-2024-037398$AUROBINDO$Juliana V. Nogueira1; Leonor Rodrigues1; Christian Fernandes Neves1;Paula Mesquita1; Raquel M. Vieira1; Daniela Ribeiro Alves1; et al.. CO-0173 - (2446) - DOEN?A RARA,TRATAMENTO EFICAZ: PNEUMONIA POR HHV6B EM DOENTE IMUNOSSUPRIMIDO. Doen?as infeciosas e parasit?rias Caso cl?nico$83$YR$$M$Y$$$20240806$$MD$PT$PT
241764311$24176431$1$I$$20240724$20240806$20240806$EXP$$US-AUROBINDO-AUR-APL-2024-037144$AUROBINDO$Chebrolu S, Mayl J, Bhave P.. Flecainide Toxicity in a Patient with a Functioning Pacemaker.. The Journal of innovations in cardiac rhythm management.. 2024;15(7):5951-5954$75$YR$$M$Y$$$20240806$$MD$US$US
241764321$24176432$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038189$AUROBINDO$$$$$F$Y$$$20240806$$HP$CA$CA
241764331$24176433$1$I$$20240801$20240806$20240806$EXP$$US-EXELIXIS-CABO-24080186$EXELIXIS$$$$$F$Y$$$20240805$$MD$US$US
241764341$24176434$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038119$AUROBINDO$$13$YR$$F$Y$$$20240806$$HP$CA$CA
241764351$24176435$1$I$20141210$20240728$20240806$20240806$EXP$GB-MHRA-MED-202407281102397300-SCHFT$GB-TEVA-VS-3226778$TEVA$$60$YR$$M$Y$77$KG$20240806$$CN$GB$GB
241764361$24176436$1$I$$20240109$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2024CA002334$SANDOZ$$$$$$Y$$$20240806$$CN$CA$CA
241764371$24176437$1$I$$20240101$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US000854$SANDOZ$Guillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, Karen W L Yee, Amer M Zeidan, Aref Al-Kali, H Joachim Deeg, Prapti A Patel, Mitchell Sablof et al. Oral decitabine-cedazuridine versus intravenous decitabinefor myelodysplastic syndromes and chronic myelomonocyticleukaemia (ASCERTAIN): a registrational, randomised,crossover, pharmacokinetics, phase 3 study. The Lancet. Haematology. 11:r187893$$$$$Y$$$20240806$$MD$US$US
241764381$24176438$1$I$20240707$20240729$20240806$20240806$EXP$$IN-ROCHE-10000042560$ROCHE$$57$YR$A$M$Y$$$20240806$$CN$IN$IN
241764391$24176439$1$I$$20240731$20240806$20240806$PER$$US-JNJFOC-20240784401$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$CN$US$US
241764402$24176440$2$F$20240701$20240730$20240806$20240807$EXP$$CA-JNJFOC-20240783636$JOHNSON AND JOHNSON$$21$YR$A$M$Y$108$KG$20240807$$HP$CA$CA
241764411$24176441$1$I$$20240731$20240806$20240806$PER$$US-009507513-2407USA016105$MERCK$$$$$F$Y$$$20240806$$HP$US$US
241764422$24176442$2$F$20240313$20240802$20240806$20240807$EXP$$US-JNJFOC-20240349539$JOHNSON AND JOHNSON$$75$YR$E$M$Y$68.6$KG$20240807$$HP$US$US
241764431$24176443$1$I$20230901$20240801$20240806$20240806$EXP$FR-AFSSAPS-LY2023001576$FR-EMD Serono-2024041818$EMD SERONO INC$$$$A$F$Y$$$20240806$$MD$FR$FR
241764442$24176444$2$F$20240201$20240826$20240806$20240909$EXP$$DE-AMGEN-DEUSP2024153461$AMGEN$$73$YR$E$M$Y$78$KG$20240908$$HP$DE$DE
241764451$24176445$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190486$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241764461$24176446$1$I$$20240724$20240806$20240806$EXP$$US-AUROBINDO-AUR-APL-2024-037819$AUROBINDO$Shakir M, Mohamed N, Vietor N, Mai V, Hoang T.. Acute Cardiovascular Complications FromTestosterone Therapy. J-Endocr-Soc. 2019;3 (Suppl. 1):1-2$$$$M$Y$$$20240806$$HP$US$US
241764471$24176447$1$I$$20240730$20240806$20240806$EXP$$JP-ROCHE-10000047285$ROCHE$$6$DEC$A$F$Y$$$20240806$$MD$JP$JP
241764481$24176448$1$I$20240724$20240724$20240806$20240806$PER$$US-RDY-SPO/USA/24/0011077$DR REDDYS$$23$YR$A$F$Y$$$20240806$$MD$US$US
241764491$24176449$1$I$$20240802$20240806$20240806$30DAY$$US-GSK-US2024096899$GLAXOSMITHKLINE$$$$$M$Y$$$20240806$$MD$US$US
241764501$24176450$1$I$$20240801$20240806$20240806$30DAY$$US-GSK-US2024096348$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$CN$US$US
241764511$24176451$1$I$$20240101$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US000856$SANDOZ$Guillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, Karen W L Yee, Amer M Zeidan, Aref Al-Kali, H Joachim Deeg, Prapti A Patel, Mitchell Sablof et al. Oral decitabine-cedazuridine versus intravenous decitabinefor myelodysplastic syndromes and chronic myelomonocyticleukaemia (ASCERTAIN): a registrational, randomised,crossover, pharmacokinetics, phase 3 study. Lancet Haematol. 2024;11:r187893$$$$$Y$$$20240806$$MD$US$US
241764522$24176452$2$F$20210101$20240805$20240806$20240807$EXP$RO-EMA-DD-20240730-7483181-075742$RO-SANDOZ INC.-SDZ2024RO070423$SANDOZ$$52$YR$$F$Y$$$20240807$$HP$RO$RO
241764531$24176453$1$I$$20240725$20240806$20240806$EXP$$CA-TEVA-VS-3227340$TEVA$$61$YR$$F$Y$$$20240806$$HP$CA$CA
241764541$24176454$1$I$20240101$20240726$20240806$20240806$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-120417$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240806$$PH$PR$PR
241764551$24176455$1$I$20240323$20240729$20240806$20240806$EXP$$BR-CELLTRION INC.-2024BR008349$CELLTRION$$$$$$Y$$$20240806$$CN$BR$BR
241764561$24176456$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865951$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241764582$24176458$2$F$20230201$20240905$20240806$20240909$PER$$US-BIOGEN-2023BI01189432$BIOGEN$$73$YR$$M$Y$$$20240909$$CN$US$US
241764591$24176459$1$I$$20240731$20240806$20240806$PER$$US-BIOGEN-2022BI01175149$BIOGEN$$$$$M$Y$$$20240806$$CN$US$US
241764602$24176460$2$F$$20240807$20240806$20240813$PER$$US-BIOGEN-2024BI01275352$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
241764611$24176461$1$I$$20240802$20240806$20240806$PER$$US-BIOGEN-2024BI01276872$BIOGEN$$$$$F$Y$$$20240806$$HP$US$US
241764621$24176462$1$I$20240731$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153970$AMGEN$$58$YR$A$M$Y$$$20240805$$CN$US$US
241764632$24176463$2$F$20240601$20240814$20240806$20240828$PER$$US-SA-2024SA224366$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240828$$MD$US$US
241764641$24176464$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA223149$SANOFI AVENTIS$$$$E$F$Y$$$20240806$$MD$US$US
241764651$24176465$1$I$20240701$20240726$20240806$20240806$PER$$US-SA-2024SA227370$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240806$$MD$US$US
241764661$24176466$1$I$$20240729$20240806$20240806$EXP$$ES-TOLMAR, INC.-24ES051373$TOLMAR$$$$$$Y$$$20240806$$MD$ES$ES
241764671$24176467$1$I$20240601$20240729$20240806$20240806$EXP$$NL-TOLMAR, INC.-24NL051338$TOLMAR$$76$YR$$M$Y$$$20240806$$CN$NL$NL
241764681$24176468$1$I$$20240729$20240806$20240806$EXP$$NL-TOLMAR, INC.-24NL051340$TOLMAR$$$$$M$Y$$$20240806$$CN$NL$NL
241764691$24176469$1$I$$20230301$20240806$20240806$EXP$$US-AstraZeneca-2023A051428$ASTRAZENECA$$$$$F$Y$$$20240806$$MD$US$
241764701$24176470$1$I$$20220711$20240806$20240806$EXP$$US-AstraZeneca-2022A253550$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241764711$24176471$1$I$$20220111$20240806$20240806$EXP$$CA-AstraZeneca-2022A019486$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$CA$
241764721$24176472$1$I$$20221206$20240806$20240806$EXP$$US-AstraZeneca-2022A402341$ASTRAZENECA$$$$$F$Y$$$20240806$$HP$US$
241764731$24176473$1$I$$20220523$20240806$20240806$EXP$$GB-AstraZeneca-2022A194578$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$GB$
241764741$24176474$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA228762$SANOFI AVENTIS$$$$A$F$Y$85.7$KG$20240806$$MD$US$US
241764751$24176475$1$I$20240701$20240729$20240806$20240806$PER$$US-SA-2024SA228510$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240806$$MD$US$US
241764762$24176476$2$F$20240101$20240801$20240806$20240808$PER$$US-SA-2024SA227973$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240808$$MD$US$US
241764771$24176477$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA226004$SANOFI AVENTIS$$$$$M$Y$$$20240806$$HP$US$US
241764781$24176478$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229297$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
241764791$24176479$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA227667$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240806$$MD$US$US
241764801$24176480$1$I$20240101$20240731$20240806$20240806$PER$$US-SA-2024SA229120$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240806$$MD$US$US
241764811$24176481$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA224692$SANOFI AVENTIS$$$$$$Y$$$20240806$$MD$US$US
241764821$24176482$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229105$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240806$$CN$US$US
241764831$24176483$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229213$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240806$$CN$US$US
241764841$24176484$1$I$20240727$20240729$20240806$20240806$PER$$US-SA-2024SA225072$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240806$$HP$US$US
241764851$24176485$1$I$20240701$20240726$20240806$20240806$PER$$US-SA-2024SA224565$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240806$$MD$US$US
241764861$24176486$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229299$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240806$$MD$US$US
241764871$24176487$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA227679$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240806$$MD$US$US
241764881$24176488$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA228602$SANOFI AVENTIS$$$$T$M$Y$68.22$KG$20240806$$MD$US$US
241764891$24176489$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA224837$SANOFI AVENTIS$$$$I$M$Y$$$20240806$$MD$US$US
241764901$24176490$1$I$$20211213$20240806$20240806$EXP$$US-AstraZeneca-2021A872704$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241764911$24176491$1$I$$20211117$20240806$20240806$EXP$$AU-AstraZeneca-2021A789105$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$AU$
241764921$24176492$1$I$20230105$20230106$20240806$20240806$EXP$$US-AstraZeneca-2023A005260$ASTRAZENECA$$49$YR$$M$Y$73$KG$20240806$$CN$US$
241764931$24176493$1$I$$20231017$20240806$20240806$EXP$$US-AstraZeneca-2023A237163$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241764942$24176494$2$F$$20240913$20240806$20240918$EXP$$JP-JNJFOC-20240811566$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$PH$JP$JP
241764951$24176495$1$I$20240731$20240801$20240806$20240806$PER$$US-JNJFOC-20240802287$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240806$$PH$US$US
241764961$24176496$1$I$$20220107$20240806$20240806$EXP$$US-AstraZeneca-2022A013003$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241764971$24176497$1$I$$20230327$20240806$20240806$EXP$$CA-AstraZeneca-2023A073344$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$CA$
241764981$24176498$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002200$ELI LILLY AND CO$$$$$M$Y$$$20240806$$CN$US$US
241764991$24176499$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002088$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240806$$CN$US$US
241765001$24176500$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001919$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240806$$CN$US$US
241765011$24176501$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001952$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240806$$CN$US$US
241765021$24176502$1$I$20240724$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002207$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240806$$CN$US$US
241765031$24176503$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038710$AUROBINDO$$34$YR$$F$Y$$$20240806$$CN$CA$CA
241765041$24176504$1$I$$20231013$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085850$GLENMARK$$$$$$Y$$$20240806$$PH$US$US
241765051$24176505$1$I$20230801$20230828$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084718$GLENMARK$$$$$$Y$$$20240805$$CN$US$US
241765061$24176506$1$I$$20240513$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090847$GLENMARK$$$$$$Y$$$20240805$$CN$US$US
241765071$24176507$1$I$$20240507$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090822$GLENMARK$$$$$$Y$$$20240805$$CN$US$US
241765081$24176508$1$I$20230905$20231122$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085504$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765091$24176509$1$I$$20230807$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084165$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765101$24176510$1$I$$20230731$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084091$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765111$24176511$1$I$$20230912$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085001$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765121$24176512$1$I$$20231004$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083459$GLENMARK$$$$$$Y$$$20240806$$PH$US$US
241765131$24176513$1$I$$20231011$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085755$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765141$24176514$1$I$20230101$20231031$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084627$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765151$24176515$1$I$$20230705$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083282$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765161$24176516$1$I$$20240629$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091570$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765171$24176517$1$I$$20240624$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091946$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765181$24176518$1$I$$20240430$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090611$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765191$24176519$1$I$$20240415$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090268$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765201$24176520$1$I$$20231114$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086582$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765211$24176521$1$I$$20231108$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086442$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765221$24176522$1$I$$20240311$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089384$GLENMARK$$$$$$Y$$$20240806$$PH$US$US
241765231$24176523$1$I$$20240416$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090337$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765241$24176524$1$I$$20240208$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088885$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765251$24176525$1$I$20240301$20240411$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089814$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765261$24176526$1$I$$20240125$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087969$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765271$24176527$1$I$$20240326$20240806$20240806$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089773$GLENMARK$$$$$$Y$$$20240806$$CN$US$US
241765282$24176528$2$F$$20240806$20240806$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07516$LUPIN$$$$$$Y$$$20240828$$HP$US$US
241765291$24176529$1$I$20230719$20240220$20240806$20240806$EXP$$IT-SANDOZ INC.-SDZ2024IT017689$SANDOZ$$$$$$Y$$$20240806$$HP$IT$IT
241765301$24176530$1$I$$20240724$20240806$20240806$EXP$$PT-AUROBINDO-AUR-APL-2024-037617$AUROBINDO$Esteves S, Carapinha F, Cavaco L, Rodrigues AF, Pedro AO.. Um caso cl?nico de infe??o por parvov?rus b19 num adulto imunocomprometido. SPMI Case Reports. 2024;2(1- Edi?Esp):32-35$53$YR$$F$Y$$$20240806$$HP$PT$PT
241765311$24176531$1$I$$20240801$20240806$20240806$PER$$US-BEH-2024176805$CSL BEHRING$$$$A$F$Y$$$20240806$$CN$US$US
241765321$24176532$1$I$$20240805$20240806$20240806$EXP$$PL-SANDOZ INC.-SDZ2024PL070519$SANDOZ$$61$YR$$F$Y$$$20240806$$MD$PL$PL
241765331$24176533$1$I$20240401$20240801$20240806$20240806$EXP$$BR-JNJFOC-20240806629$JOHNSON AND JOHNSON$$50$YR$A$F$Y$70$KG$20240806$$CN$BR$BR
241765341$24176534$1$I$20240501$20240724$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037353$AUROBINDO$$69$YR$$F$Y$61$KG$20240806$$MD$GB$GB
241765352$24176535$2$F$$20240813$20240806$20240820$EXP$$ES-JNJFOC-20240800967$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$MD$ES$ES
241765362$24176536$2$F$20240701$20240805$20240806$20240806$PER$$US-JNJFOC-20240807417$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240806$$CN$US$US
241765371$24176537$1$I$20230417$20240112$20240806$20240806$EXP$$IT-SANDOZ INC.-SDZ2024IT003960$SANDOZ$$$$$$Y$$$20240806$$MD$IT$IT
241765382$24176538$2$F$20240716$20240729$20240806$20240807$EXP$$NVSJ2024JP008565$NOVARTIS$$$$E$F$Y$51$KG$20240808$$MD$JP$JP
241765391$24176539$1$I$20240730$20240730$20240806$20240806$EXP$$TW-AMGEN-TWNSP2024154539$AMGEN$$$$E$M$Y$$$20240805$$HP$TW$TW
241765402$24176540$2$F$20240701$20240801$20240806$20240808$EXP$$US-SA-2024SA227245$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240808$$MD$US$US
241765411$24176541$1$I$20240223$20240724$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037710$AUROBINDO$$63$YR$$M$Y$$$20240806$$PH$FR$FR
241765421$24176542$1$I$$20240802$20240806$20240806$PER$$US-ROCHE-10000048601$ROCHE$$$$E$M$Y$$$20240806$$CN$US$US
241765441$24176544$1$I$$20240729$20240806$20240806$PER$US-MLMSERVICE-20240723-PI139056-00128-3$US-RDY-SPO/USA/24/0011221$DR REDDYS$Howell J, Maughan B, Fluchel M, Poppe M. Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor:A case report. Urology Case Reports. 2024;56:102799. DOI: 10.1016/j.eucr.2024.102799.$62$YR$A$F$Y$$$20240806$$MD$US$US
241765451$24176545$1$I$$20240801$20240806$20240806$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-122954$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240806$$MD$PL$PL
241765461$24176546$1$I$$20240730$20240806$20240806$PER$$US-ROCHE-10000047818$ROCHE$$$$$$Y$$$20240806$$PH$US$US
241765471$24176547$1$I$$20240802$20240806$20240806$PER$$US-ROCHE-10000048372$ROCHE$$65$YR$E$M$Y$$$20240806$$CN$US$US
241765483$24176548$3$F$20240622$20240918$20240806$20240925$EXP$$JP-GENMAB-2024-02392AA$GENMAB$$84$YR$$F$Y$$$20240925$$MD$JP$JP
241765492$24176549$2$F$$20240813$20240806$20240826$EXP$$CA-AUROBINDO-AUR-APL-2023-031130$AUROBINDO$Farrell B, Galley E, Jeffs L, Howell P, McCarthy LM.. Kind of blurry: Deciphering clues to prevent, investigate and manage prescribing cascades.. PLOS-One. 2022;17 (8) e0272418:1- 20$82$YR$$F$Y$$$20240826$$HP$CA$CA
241765502$24176550$2$F$$20240911$20240806$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-039094$AUROBINDO$Habraszka D, Gaweda S, Spa?ek A, Helbig G.. Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia with accompanying hereditary hemorrhagic telangiectasia.. Acta Haematologica Polonica.. 2024;55 (2):123-5$42$YR$$F$Y$$$20240918$$HP$PL$PL
241765511$24176551$1$I$$20240729$20240806$20240806$PER$$US-EMD Serono-2024041129$EMD SERONO INC$$37$YR$A$M$Y$$$20240806$$CN$US$US
241765521$24176552$1$I$20240721$20240724$20240806$20240806$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160037$JIANGSU HENGRUI MEDICINE$$21$YR$$M$Y$48$KG$20240806$$MD$CN$CN
241765531$24176553$1$I$$20240111$20240806$20240806$EXP$$FR-SANDOZ INC.-SDZ2024FR003523$SANDOZ$$$$$$Y$$$20240806$$HP$FR$FR
241765542$24176554$2$F$20240801$20240813$20240806$20240816$PER$$US-AMGEN-USASP2024153462$AMGEN$$61$YR$A$M$Y$$$20240816$$CN$US$US
241765552$24176555$2$F$20240801$20240806$20240806$20240807$PER$$US-AMGEN-USASL2024155090$AMGEN$$$$A$M$Y$$$20240807$$CN$US$US
241765561$24176556$1$I$20231201$20240729$20240806$20240806$EXP$$BR-TAKEDA-2024TUS010823$TAKEDA$$57$YR$$F$Y$$$20240806$$CN$BR$BR
241765571$24176557$1$I$20210512$20240726$20240806$20240806$EXP$ES-PFIZER INC-2021SGN02751$ES-ROCHE-10000038555$ROCHE$$$$A$F$Y$$$20240806$$MD$ES$ES
241765581$24176558$1$I$$20231201$20240806$20240806$EXP$$RU-SANDOZ INC.-SDZ2023RU066488$SANDOZ$$$$$$Y$$$20240806$$HP$RU$RU
241765591$24176559$1$I$$20240727$20240806$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023500$UNITED THERAPEUTICS$$$$$F$Y$47.982$KG$20240806$$$US$US
241765601$24176560$1$I$$20240729$20240806$20240806$30DAY$$US-GSK-US2024094856$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$CN$US$US
241765611$24176561$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-037887$AUROBINDO$$77$YR$$F$Y$$$20240806$$HP$CA$CA
241765621$24176562$1$I$20240703$20240729$20240806$20240806$EXP$$CN-BEIGENE-BGN-2024-011784$BEIGENE$$$$$$Y$$$20240806$$HP$CN$CN
241765631$24176563$1$I$20240725$20240731$20240806$20240806$EXP$$CN-ALXN-202407CHN002184CN$ALEXION PHARMACEUTICALS$$53$YR$$M$Y$60$KG$20240806$$HP$CN$CN
241765641$24176564$1$I$$20240731$20240806$20240806$EXP$$US-TAKEDA-2024TUS077651$TAKEDA$$$$$F$Y$$$20240806$$CN$US$US
241765651$24176565$1$I$20240720$20240729$20240806$20240806$EXP$$GB-HETERO-AMR2024GB02511$HETERO$$47$YR$$F$Y$75$KG$20240806$$MD$GB$GB
241765661$24176566$1$I$$20240801$20240806$20240806$PER$$US-JNJFOC-20240802632$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241765671$24176567$1$I$$20240801$20240806$20240806$EXP$$BR-JNJFOC-20240806358$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$BR$BR
241765681$24176568$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA224650$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240806$$MD$US$US
241765691$24176569$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA224792$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
241765701$24176570$1$I$20240501$20240801$20240806$20240806$30DAY$$US-GSK-US2024096997$GLAXOSMITHKLINE$$30$YR$$F$Y$$$20240806$$HP$US$US
241765711$24176571$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA224664$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240806$$MD$US$US
241765721$24176572$1$I$$20240801$20240806$20240806$PER$$US-ROCHE-10000047091$ROCHE$$$$$$Y$$$20240806$$HP$US$US
241765731$24176573$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865799$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241765743$24176574$3$F$$20240731$20240806$20240808$PER$$US-AMGEN-USASP2024152191$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241765751$24176575$1$I$20240723$20240801$20240806$20240806$EXP$$CA-ABBVIE-5865945$ABBVIE$$82$YR$$M$Y$$$20240806$$HP$CA$CA
241765761$24176576$1$I$$20240801$20240806$20240806$EXP$$NVSJ2024JP009381$NOVARTIS$$72$YR$$M$Y$$$20240806$$MD$JP$JP
241765771$24176577$1$I$$20240802$20240806$20240806$PER$$US-HALEON-2190339$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241765782$24176578$2$F$$20240919$20240806$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123037$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$PH$JP$JP
241765791$24176579$1$I$$20240731$20240806$20240806$EXP$$US-ABBVIE-5863006$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241765801$24176580$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153472$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241765821$24176582$1$I$$20240725$20240806$20240806$EXP$$NL-AUROBINDO-AUR-APL-2024-037930$AUROBINDO$$72$YR$$F$Y$60$KG$20240806$$CN$NL$NL
241765831$24176583$1$I$20240718$20240722$20240806$20240806$EXP$$US-AstraZeneca-2024A166932$ASTRAZENECA$$28443$DY$$M$Y$$$20240806$$CN$US$
241765841$24176584$1$I$$20220218$20240806$20240806$EXP$$US-AstraZeneca-2022A083806$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241765851$24176585$1$I$$20240729$20240806$20240806$EXP$$ZA-AstraZeneca-2024A172256$ASTRAZENECA$$60$YR$$M$Y$$$20240806$$CN$ZA$
241765861$24176586$1$I$$20231130$20240806$20240806$EXP$$US-AstraZeneca-2023A272801$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241765872$24176587$2$F$$20240906$20240806$20240921$PER$$US-RISINGPHARMA-US-2024RISSPO00267$RISING PHARMACEUTICALS$$$$$$Y$$$20240921$$PH$US$US
241765881$24176588$1$I$20210101$20220324$20240806$20240806$EXP$$CA-AstraZeneca-2022A127894$ASTRAZENECA$$70$YR$$F$Y$$$20240806$$CN$CA$
241765891$24176589$1$I$$20230815$20240806$20240806$EXP$$US-AstraZeneca-2023A186853$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241765901$24176590$1$I$$20240725$20240806$20240806$EXP$$NL-AUROBINDO-AUR-APL-2024-037924$AUROBINDO$$69$YR$$F$Y$70$KG$20240806$$MD$NL$NL
241765921$24176592$1$I$$20240801$20240806$20240806$PER$$US-JNJFOC-20240802532$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$CN$US$US
241765931$24176593$1$I$20240101$20240801$20240806$20240806$EXP$FR-AFSSAPS-DJ2024000886$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-122925$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$92$KG$20240806$$MD$FR$FR
241765941$24176594$1$I$20240627$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-038096$AUROBINDO$$62$YR$$M$Y$90$KG$20240806$$PH$FR$FR
241765951$24176595$1$I$20240101$20240730$20240806$20240806$EXP$$US-ABBVIE-5863569$ABBVIE$$$$$$Y$$$20240806$$CN$US$US
241765961$24176596$1$I$20240703$20240801$20240806$20240806$EXP$$CN-ROCHE-10000049322$ROCHE$$73$YR$E$M$Y$79$KG$20240806$$HP$CN$CN
241765971$24176597$1$I$20240724$20240725$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037697$AUROBINDO$$80$YR$$F$Y$$$20240806$$PH$GB$GB
241765981$24176598$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038674$AUROBINDO$$$$$F$Y$$$20240806$$HP$CA$CA
241765991$24176599$1$I$$20240723$20240806$20240806$EXP$$US-RISINGPHARMA-US-2024RISLIT00270$RISING PHARMACEUTICALS$Nadia Allami.A case of severe opioid and methamphetamine use disorder in a 14 year old.Addiction Science + Clinical  Practice.2024;19(1):1-4$14$YR$T$F$Y$$$20240806$$HP$US$US
241766002$24176600$2$F$$20240910$20240806$20240919$PER$$US-SA-2024SA228457$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240919$$MD$US$US
241766011$24176601$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA227978$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240806$$MD$US$US
241766021$24176602$1$I$$20240725$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037558$AUROBINDO$$78$YR$$F$Y$$$20240806$$PH$GB$GB
241766031$24176603$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA228006$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240806$$MD$US$US
241766042$24176604$2$F$20240401$20240730$20240806$20240808$PER$$US-SA-2024SA224339$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240808$$MD$US$US
241766051$24176605$1$I$20240701$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP009012$APOTEX$$83$YR$E$M$Y$$$20240806$$PH$CA$CA
241766061$24176606$1$I$$20240716$20240806$20240806$PER$$US-AstraZeneca-2024A162631$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241766071$24176607$1$I$$20240725$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037563$AUROBINDO$$$$$M$Y$$$20240806$$CN$GB$GB
241766082$24176608$2$F$$20240806$20240806$20240807$PER$$US-AMGEN-USASP2024155315$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241766091$24176609$1$I$20240101$20240424$20240806$20240806$PER$$US-AJANTA-2024AJA00083$AJANTA PHARMA$$52$YR$A$F$Y$199$KG$20240805$$CN$US$US
241766101$24176610$1$I$$20240729$20240806$20240806$EXP$$US-SA-2024SA226526$SANOFI AVENTIS$$$$A$M$Y$54.43$KG$20240806$$MD$US$US
241766111$24176611$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123088$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$74.84$KG$20240806$$HP$US$US
241766122$24176612$2$F$20240229$20240812$20240806$20240816$EXP$$PR-SA-2024SA077155$SANOFI AVENTIS$$52$YR$A$F$Y$101.59$KG$20240816$$HP$PR$PR
241766131$24176613$1$I$$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121915$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$58.51$KG$20240806$$HP$US$US
241766141$24176614$1$I$20200521$20240725$20240806$20240806$EXP$$PL-AUROBINDO-AUR-APL-2024-037865$AUROBINDO$$36$YR$$F$Y$60$KG$20240806$$MD$PL$PL
241766161$24176616$1$I$$20240725$20240806$20240806$EXP$$US-AUROBINDO-AUR-APL-2024-037333$AUROBINDO$Krishnamoorthy S, Kaur R, Ameer N, Uzoma AA, Enemuo NR, Gopal S, et al.. Type I Kounis Syndrome: Allergic Myocardial Infarction Triggered by Ciprofloxacin.. Cureus. 2024;16(6):e62460.$35$YR$$F$Y$$$20240806$$MD$US$US
241766171$24176617$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038792$AUROBINDO$$$$$F$Y$$$20240806$$CN$CA$CA
241766183$24176618$3$F$20240723$20240920$20240806$20240925$PER$$US-AMGEN-USASP2024147919$AMGEN$$77$YR$E$M$Y$5$KG$20240925$$PH$US$US
241766192$24176619$2$F$20240101$20240802$20240806$20240812$PER$$US-SA-2024SA229575$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240812$$CN$US$US
241766201$24176620$1$I$20240728$20240730$20240806$20240806$PER$$US-SA-2024SA227539$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240806$$MD$US$US
241766211$24176621$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA227253$SANOFI AVENTIS$$$$E$F$Y$$$20240806$$MD$US$US
241766221$24176622$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA224522$SANOFI AVENTIS$$$$A$F$Y$90.703$KG$20240806$$MD$US$US
241766231$24176623$1$I$20240401$20240730$20240806$20240806$EXP$$US-SA-2024SA217464$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240806$$MD$US$US
241766241$24176624$1$I$$20240729$20240806$20240806$EXP$$JP-ALXN-202407JPN001840JP$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$MD$JP$JP
241766251$24176625$1$I$20200521$20240725$20240806$20240806$EXP$$PL-AUROBINDO-AUR-APL-2024-038017$AUROBINDO$$39$YR$$M$Y$76$KG$20240806$$MD$PL$PL
241766261$24176626$1$I$20240601$20240730$20240806$20240806$PER$$US-SA-2024SA229300$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240806$$MD$US$US
241766272$24176627$2$F$20240410$20240911$20240806$20240913$PER$$US-ROCHE-10000047844$ROCHE$$90$YR$E$F$Y$$$20240913$$CN$US$US
241766281$24176628$1$I$$20240730$20240806$20240806$EXP$$US-GSK-US2024AMR095640$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$US$US
241766291$24176629$1$I$20240728$20240729$20240806$20240806$30DAY$$US-GSK-US2024094846$GLAXOSMITHKLINE$$92$YR$$F$Y$$$20240806$$CN$US$US
241766301$24176630$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038694$AUROBINDO$$$$$F$Y$$$20240806$$HP$CA$CA
241766311$24176631$1$I$$20240725$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037580$AUROBINDO$$$$$M$Y$$$20240806$$CN$GB$GB
241766321$24176632$1$I$$20240802$20240806$20240806$PER$$NVSC2024US159391$NOVARTIS$$$$$F$Y$$$20240806$$MD$US$US
241766331$24176633$1$I$$20240802$20240806$20240806$PER$$US-ROCHE-10000048423$ROCHE$$72$YR$E$M$Y$$$20240806$$CN$US$US
241766341$24176634$1$I$$20240729$20240806$20240806$PER$$US-TEVA-VS-3229359$TEVA$$$$$F$Y$$$20240806$$CN$US$US
241766351$24176635$1$I$$20240725$20240806$20240806$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2160039$Chengdu Suncadia Medicine$Literature title: Clinical analysis of 14 pregnancies in women with renal transplant.?Journal of publication: Journal of Reproductive Medicine, 2024, 33 (7): 878-884.?Authors: Bing Liang, Liyun Gong, Zhiwei Zhang, Hang Liu, Junli Lu.$$$$$Y$1.93$KG$20240806$$MD$CN$CN
241766361$24176636$1$I$$20240801$20240806$20240806$30DAY$$IT-SANDOZ INC.-SDZ2024IT070550$SANDOZ$$$$$M$Y$$$20240806$$CN$IT$IT
241766371$24176637$1$I$$20231220$20240806$20240806$EXP$$FR-SANDOZ INC.-SDZ2023FR070629$SANDOZ$$$$$$Y$$$20240806$$MD$FR$FR
241766381$24176638$1$I$20240802$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001986$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240806$$CN$US$US
241766391$24176639$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001976$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240806$$CN$US$US
241766401$24176640$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002037$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240806$$CN$US$US
241766411$24176641$1$I$20240624$20240731$20240806$20240806$EXP$$CA-JNJFOC-20240801843$JOHNSON AND JOHNSON$$32$YR$A$F$Y$77$KG$20240806$$HP$CA$CA
241766424$24176642$4$F$$20240902$20240806$20240923$30DAY$$AU-JNJFOC-20240779726$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$PH$AU$AU
241766431$24176643$1$I$$20240731$20240806$20240806$EXP$$CA-AMGEN-CANSP2024152312$AMGEN$$$$$F$Y$$$20240806$$CN$CA$CA
241766441$24176644$1$I$$20240730$20240806$20240806$EXP$$GB-AMGEN-GBRSL2024152608$AMGEN$$$$$F$Y$$$20240806$$CN$GB$GB
241766451$24176645$1$I$20240731$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153305$AMGEN$$53$YR$A$F$Y$$$20240806$$CN$US$US
241766461$24176646$1$I$20240601$20240725$20240806$20240806$PER$$US-SA-2024SA224424$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240806$$MD$US$US
241766471$24176647$1$I$$20240726$20240806$20240806$EXP$DE-SAMSUNG BIOEPIS-SB-2024-20353$DE-ROCHE-10000038772$ROCHE$$$$A$F$Y$65$KG$20240806$$MD$DE$DE
241766481$24176648$1$I$$20240723$20240806$20240806$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0270$GRAVITI PHARMACEUTICALS$$35$YR$A$M$Y$$$20240806$$HP$US$US
241766491$24176649$1$I$20200101$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037693$AUROBINDO$$62$YR$$M$Y$$$20240806$$MD$FR$FR
241766501$24176650$1$I$$20240729$20240806$20240806$EXP$$ZA-AstraZeneca-2024A172599$ASTRAZENECA$$32507$DY$$F$Y$$$20240806$$CN$ZA$
241766512$24176651$2$F$20230101$20240903$20240806$20240910$EXP$$CA-CELLTRION INC.-2024CA000759$CELLTRION$$$$$$Y$$$20240910$$CN$CA$CA
241766522$24176652$2$F$20240720$20240802$20240806$20240812$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00812$CATALYST PHARMA$$76$YR$$M$Y$79.819$KG$20240812$$CN$US$US
241766531$24176653$1$I$$20231117$20240806$20240806$EXP$$US-AstraZeneca-2023A262921$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241766541$24176654$1$I$20240712$20240725$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037628$AUROBINDO$$57$YR$$M$Y$79$KG$20240806$$CN$GB$GB
241766551$24176655$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA225061$SANOFI AVENTIS$$68$YR$E$F$Y$57.15$KG$20240806$$MD$US$US
241766561$24176656$1$I$$20240730$20240806$20240806$EXP$$CN-DEXPHARM-2024-2662$DEXCEL$Wei, J.; Ning, J.  Successful treatment of penicillin-resistant pneumococcal meningitis following ventriculo-peritoneal shunt for congenital hydrocephalus: A case report on the efficacy of linezolid. Asian Journal of Surgery 2024, V47, P3389A$1$YR$I$F$Y$$$20240806$$HP$CN$CN
241766571$24176657$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA224641$SANOFI AVENTIS$$11$YR$C$M$Y$58.9$KG$20240806$$MD$US$US
241766581$24176658$1$I$20240101$20240730$20240806$20240806$EXP$$US-SA-2024SA227259$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240806$$MD$US$US
241766591$24176659$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229383$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240806$$CN$US$US
241766601$24176660$1$I$20240101$20240725$20240806$20240806$PER$$US-SA-2024SA225957$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240806$$MD$US$US
241766611$24176661$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA223046$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240806$$MD$US$US
241766621$24176662$1$I$20240501$20240730$20240806$20240806$EXP$$US-SA-2024SA227240$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240806$$MD$US$US
241766631$24176663$1$I$20240101$20240725$20240806$20240806$PER$$US-SA-2024SA223483$SANOFI AVENTIS$$57$YR$A$F$Y$89$KG$20240806$$MD$US$US
241766641$24176664$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA225053$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240806$$MD$US$US
241766652$24176665$2$F$$20240822$20240806$20240913$PER$$US-SA-2024SA224633$SANOFI AVENTIS$$10$YR$C$F$Y$34$KG$20240913$$MD$US$US
241766661$24176666$1$I$20240201$20240729$20240806$20240806$PER$$US-SA-2024SA229334$SANOFI AVENTIS$$62$YR$A$F$Y$81.64$KG$20240806$$MD$US$US
241766671$24176667$1$I$$20210722$20240806$20240806$EXP$$US-AstraZeneca-2021A637875$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241766681$24176668$1$I$20180101$20240725$20240806$20240806$EXP$$SE-AUROBINDO-AUR-APL-2024-037736$AUROBINDO$$54$YR$$F$Y$$$20240806$$CN$SE$SE
241766701$24176670$1$I$$20240730$20240806$20240806$PER$$US-BEH-2024176678$CSL BEHRING$$$$A$F$Y$$$20240806$$CN$US$US
241766721$24176672$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038659$AUROBINDO$$32$YR$$F$Y$$$20240806$$HP$CA$CA
241766731$24176673$1$I$20240706$20240725$20240806$20240806$EXP$$ES-AUROBINDO-AUR-APL-2024-037783$AUROBINDO$$90$YR$$M$Y$$$20240806$$MD$ES$ES
241766741$24176674$1$I$20240604$20240804$20240806$20240806$EXP$GB-MHRA-WEBRADR-202408041109247600-DCMKP$GB-ORGANON-O2408GBR000281$ORGANON$$85$YR$$F$Y$76$KG$20240806$$CN$GB$GB
241766751$24176675$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865778$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241766761$24176676$1$I$$20240725$20240806$20240806$EXP$$PT-AUROBINDO-AUR-APL-2024-038050$AUROBINDO$Valente CT, Tenreiro P, Figueiredo RS, et al.. A case of toxidermia to imatinib. Congresses of the Portuguese Society of Internal Medicine. 2024;1470$76$YR$$F$Y$$$20240806$$MD$PT$PT
241766771$24176677$1$I$20240712$20240725$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037686$AUROBINDO$$44$YR$$M$Y$106$KG$20240806$$CN$GB$GB
241766782$24176678$2$F$$20240905$20240806$20240911$EXP$$CA-JNJFOC-20240807942$JOHNSON AND JOHNSON$$54$YR$A$F$Y$67$KG$20240911$$HP$CA$CA
241766792$24176679$2$F$20240501$20240819$20240806$20240828$PER$$US-SA-2024SA229330$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240828$$MD$US$US
241766801$24176680$1$I$20240101$20240726$20240806$20240806$PER$$US-SA-2024SA224698$SANOFI AVENTIS$$$$E$F$Y$90.71$KG$20240806$$MD$US$US
241766811$24176681$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229211$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240806$$MD$US$US
241766821$24176682$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA224531$SANOFI AVENTIS$$$$I$F$Y$8.164$KG$20240806$$MD$US$US
241766831$24176683$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA224526$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240806$$MD$US$US
241766841$24176684$1$I$20240101$20240726$20240806$20240806$PER$$US-SA-2024SA224873$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240806$$MD$US$US
241766851$24176685$1$I$$20240723$20240806$20240806$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0279$GRAVITI PHARMACEUTICALS$Eads AV, Cole JL.Efficacy and Safety of Vancomycin Therapy After the Transition to AUC/MIC Monitoring in a Primary Facility.J-Pharm-Pract.2022;35(5):680-685$$$$M$Y$$$20240806$$HP$US$US
241766861$24176686$1$I$20231101$20240730$20240806$20240806$PER$$US-SA-2024SA229387$SANOFI AVENTIS$$55$YR$A$F$Y$63$KG$20240806$$MD$US$US
241766871$24176687$1$I$20240702$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037672$AUROBINDO$$21$YR$$M$Y$71.4$KG$20240806$$MD$FR$FR
241766882$24176688$2$F$$20240725$20240806$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038612$AUROBINDO$$$$$F$Y$$$20240807$$CN$CA$CA
241766891$24176689$1$I$$20240726$20240806$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-122232$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240806$$MD$JP$JP
241766922$24176692$2$F$20240723$20240808$20240806$20240813$EXP$$US-ABBVIE-5865940$ABBVIE$$71$YR$$F$Y$$$20240813$$CN$US$US
241766932$24176693$2$F$20230101$20240806$20240806$20240807$EXP$DE-EMA-DD-20240730-7482715-081833$DE-SANDOZ INC.-SDZ2024DE070388$SANDOZ$$35$YR$$M$Y$$$20240807$$MD$DE$DE
241766941$24176694$1$I$$20240716$20240806$20240806$PER$$BR-TOLMAR, INC.-24BR051112$TOLMAR$$$$$M$Y$$$20240806$$CN$BR$BR
241766951$24176695$1$I$20240401$20240716$20240806$20240806$PER$$AU-TOLMAR, INC.-24AU051101$TOLMAR$$67$YR$$M$Y$$$20240806$$CN$AU$AU
241766962$24176696$2$F$$20240716$20240806$20240813$PER$$BR-TOLMAR, INC.-24BR051114$TOLMAR$$$$$F$Y$$$20240813$$CN$BR$BR
241766971$24176697$1$I$20240627$20240718$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA050792$TOLMAR$$76$YR$$M$Y$$$20240806$$CN$CA$CA
241766981$24176698$1$I$20240201$20240718$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA050806$TOLMAR$$76$YR$$M$Y$$$20240806$$CN$CA$CA
241766991$24176699$1$I$$20240719$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA050845$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241767001$24176700$1$I$20240703$20240718$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA050815$TOLMAR$$84$YR$$M$Y$$$20240806$$CN$CA$CA
241767011$24176701$1$I$20240101$20240727$20240806$20240806$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-23399$SAMSUNG BIOEPIS$$42$YR$A$F$Y$$$20240806$$PH$CA$CA
241767021$24176702$1$I$20240629$20240718$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA050846$TOLMAR$$97$YR$$M$Y$$$20240806$$CN$CA$CA
241767031$24176703$1$I$20240420$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-038101$AUROBINDO$$43$YR$$F$Y$$$20240806$$MD$FR$FR
241767042$24176704$2$F$$20240725$20240806$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037651$AUROBINDO$$22$YR$$M$Y$$$20240807$$MD$GB$GB
241767051$24176705$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865644$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241767061$24176706$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038495$AUROBINDO$$4$DEC$$F$Y$102$KG$20240806$$HP$CA$CA
241767071$24176707$1$I$$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037722$AUROBINDO$$23$YR$$M$Y$$$20240806$$PH$FR$FR
241767081$24176708$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865948$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241767091$24176709$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024154170$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241767102$24176710$2$F$$20240911$20240806$20240912$PER$$US-AMGEN-USASP2024153432$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
241767111$24176711$1$I$$20240731$20240806$20240806$PER$$US-JNJFOC-20240805543$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$HP$US$US
241767121$24176712$1$I$20240201$20240801$20240806$20240806$EXP$$US-ABBVIE-5865305$ABBVIE$$64$YR$$F$Y$$$20240806$$CN$US$US
241767131$24176713$1$I$$20240724$20240806$20240806$EXP$$US-SUNPHARMA-2024R1-460240AA$RANBAXY$$$$A$M$Y$$$20240806$$MD$US$US
241767151$24176715$1$I$20240101$20240730$20240806$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000674$DECIPHERA PHARMACEUTICALS$$74$YR$E$M$Y$$$20240806$$CN$US$US
241767162$24176716$2$F$20240101$20240801$20240806$20240808$EXP$$CA-CELLTRION INC.-2024CA018641$CELLTRION$$$$$$Y$$$20240808$$HP$CA$CA
241767171$24176717$1$I$$20240730$20240806$20240806$EXP$$CA-GSK-CA2023079731$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$HP$CA$CA
241767181$24176718$1$I$20240101$20240801$20240806$20240806$EXP$$US-ABBVIE-5865262$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241767191$24176719$1$I$20240201$20240801$20240806$20240806$EXP$$TN-ABBVIE-5865617$ABBVIE$$31$YR$$M$Y$$$20240806$$CN$TN$TN
241767201$24176720$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865704$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241767213$24176721$3$F$20240101$20240826$20240806$20240828$EXP$$CA-ABBVIE-5865911$ABBVIE$$57$YR$$M$Y$$$20240828$$HP$CA$CA
241767221$24176722$1$I$$20240725$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037565$AUROBINDO$$55$YR$$M$Y$$$20240806$$PH$GB$GB
241767232$24176723$2$F$20240701$20240814$20240806$20240819$PER$$US-AMGEN-USASP2024153252$AMGEN$$78$YR$E$F$Y$$$20240819$$CN$US$US
241767241$24176724$1$I$$20240723$20240806$20240806$EXP$$CN-AptaPharma Inc.-2160040$APTAPHARMA$Full text$22$YR$$M$Y$90$KG$20240806$$$CN$CN
241767251$24176725$1$I$$20240802$20240806$20240806$EXP$$US-JNJFOC-20240806221$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$MD$US$US
241767261$24176726$1$I$20240501$20240718$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA050951$TOLMAR$$80$YR$$M$Y$$$20240806$$CN$CA$CA
241767271$24176727$1$I$20240601$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA050722$TOLMAR$$62$YR$$M$Y$$$20240806$$CN$CA$CA
241767281$24176728$1$I$$20240717$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051024$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241767291$24176729$1$I$20240716$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051073$TOLMAR$$74$YR$$M$Y$$$20240806$$CN$CA$CA
241767301$24176730$1$I$20240716$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051049$TOLMAR$$55$YR$$M$Y$$$20240806$$CN$CA$CA
241767311$24176731$1$I$20240716$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051047$TOLMAR$$67$YR$$M$Y$$$20240806$$CN$CA$CA
241767321$24176732$1$I$$20240717$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051075$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241767331$24176733$1$I$$20240717$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051074$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241767341$24176734$1$I$20240712$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051077$TOLMAR$$83$YR$$M$Y$$$20240806$$CN$CA$CA
241767352$24176735$2$F$20240902$20240906$20240806$20240924$PER$$CA-TOLMAR, INC.-24CA051079$TOLMAR$$86$YR$$M$Y$$$20240924$$CN$CA$CA
241767361$24176736$1$I$$20240717$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051085$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241767371$24176737$1$I$$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051080$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241767381$24176738$1$I$$20240717$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051117$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241767391$24176739$1$I$$20240717$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051119$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241767401$24176740$1$I$$20240717$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051120$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241767411$24176741$1$I$20240705$20240717$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051130$TOLMAR$$81$YR$$M$Y$$$20240806$$CN$CA$CA
241767421$24176742$1$I$$20240718$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051157$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241767431$24176743$1$I$20240717$20240717$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051156$TOLMAR$$69$YR$$M$Y$$$20240806$$CN$CA$CA
241767441$24176744$1$I$20240605$20240719$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051158$TOLMAR$$75$YR$$M$Y$$$20240806$$CN$CA$CA
241767451$24176745$1$I$$20240721$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051222$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241767461$24176746$1$I$$20240719$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051159$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241767472$24176747$2$F$$20240806$20240806$20240830$PER$$CA-TOLMAR, INC.-24CA051229$TOLMAR$$$$$M$Y$$$20240830$$CN$CA$CA
241767481$24176748$1$I$$20240730$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407020050$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240806$$CN$US$US
241767491$24176749$1$I$$20240801$20240806$20240806$PER$$US-JNJFOC-20240806023$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$US$US
241767501$24176750$1$I$$20240730$20240806$20240806$EXP$$CA-APOTEX-2024AP009032$APOTEX$$64$YR$$M$Y$92$KG$20240806$$PH$CA$CA
241767511$24176751$1$I$20220425$20220427$20240806$20240806$EXP$$US-AstraZeneca-2022A166403$ASTRAZENECA$$23068$DY$$F$Y$$$20240806$$CN$US$
241767521$24176752$1$I$$20240728$20240806$20240806$EXP$$NVSC2024US155005$NOVARTIS$$$$$$Y$$$20240806$$CN$US$US
241767531$24176753$1$I$$20240725$20240806$20240806$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-17370$SAMSUNG BIOEPIS$$65$YR$E$F$Y$$$20240806$$CN$GB$GB
241767541$24176754$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038014$AUROBINDO$$52$YR$$F$Y$$$20240806$$HP$CA$CA
241767551$24176755$1$I$$20200606$20240806$20240806$EXP$$US-AstraZeneca-2020SE74111$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241767561$24176756$1$I$$20240726$20240806$20240806$EXP$$CZ-ROCHE-10000047932$ROCHE$Matlova K, Sakarova B, Loffelmannova M and Pikner R. Two Cases of Rare Bisphosphonates Treatment Side Effects : Atypical Femoral Fracture and Inflammatory Eye Reaction [Abstract number: P263]. DOI: 10.1002/jbm4.10738. 50th European Calcified Tissue Society Congress (ECTS). 2023;:-.$82$YR$E$F$Y$$$20240806$$HP$CZ$CZ
241767571$24176757$1$I$$20210921$20240806$20240806$EXP$$US-AstraZeneca-2021A736188$ASTRAZENECA$$59$YR$$F$Y$73.5$KG$20240806$$CN$US$
241767581$24176758$1$I$$20240725$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037554$AUROBINDO$$$$$F$Y$$$20240806$$MD$GB$GB
241767591$24176759$1$I$$20240729$20240806$20240806$PER$$US-ROCHE-10000046903$ROCHE$$67$YR$E$F$Y$$$20240806$$CN$US$US
241767601$24176760$1$I$$20240730$20240806$20240806$EXP$$CZ-AMGEN-CZESP2024154528$AMGEN$$$$$F$Y$$$20240806$$MD$CZ$CZ
241767611$24176761$1$I$$20240801$20240806$20240806$EXP$$US-COSETTE-CP2024US000203$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
241767621$24176762$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008963$APOTEX$$64$YR$$F$Y$$$20240806$$CN$CA$CA
241767631$24176763$1$I$20240718$20240731$20240806$20240806$EXP$$CA-JNJFOC-20240763818$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240806$$CN$CA$CA
241767641$24176764$1$I$$20240730$20240806$20240806$PER$$US-JNJFOC-20240781772$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$HP$US$US
241767662$24176766$2$F$20240724$20240806$20240806$20240809$30DAY$$US-AMGEN-USASP2024150483$AMGEN$$59$YR$A$F$Y$89.7$KG$20240809$$HP$US$US
241767681$24176768$1$I$$20240723$20240806$20240806$EXP$$US-AptaPharma Inc.-2160042$APTAPHARMA$Full text$38$YR$$M$Y$$$20240806$$MD$US$US
241767691$24176769$1$I$20070124$20240805$20240806$20240806$EXP$$FR-SANDOZ INC.-SDZ2024FR070625$SANDOZ$$36$YR$$F$Y$$$20240806$$HP$FR$FR
241767702$24176770$2$F$$20240729$20240806$20240816$EXP$$US-BEH-2024176528$CSL BEHRING$$$$A$F$Y$$$20240816$$HP$US$US
241767721$24176772$1$I$$20231023$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2023US047566$SANDOZ$Nizar J. Bahlis MD 1 , Christy Samaras DO 2 Kevin Song MD, FRCPC10, Christ, Donna Reece MD, FRCPC 3 , Michael Sebag MD, PhD 4 , Jeffrey Matous MD 5 , Jes?s G. Berdeja MD 6 , Jesse Shustik MD 7 , Gary. 20231023_ Lenalidomide, Pomalidomide, Dexamethasone_Ref112657$$$$$Y$$$20240806$$MD$US$US
241767731$24176773$1$I$$20240729$20240806$20240806$EXP$$JP-TEVA-VS-3229495$TEVA$$$$E$M$Y$$$20240806$$MD$JP$JP
241767741$24176774$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2022-002225$AUROBINDO$$72$YR$$F$Y$$$20240806$$HP$CA$CA
241767752$24176775$2$F$20230327$20240826$20240806$20240904$EXP$$FR-DECIPHERA PHARMACEUTICALS LLC-2024FR000458$DECIPHERA PHARMACEUTICALS$$69$YR$E$F$Y$55$KG$20240904$$MD$FR$FR
241767763$24176776$3$F$20240601$20240819$20240806$20240820$EXP$$JP-BEH-2024176651$CSL BEHRING$$50$YR$A$M$Y$$$20240820$$HP$JP$JP
241767781$24176778$1$I$20181101$20240726$20240806$20240806$PER$$US-SA-2024SA225374$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240806$$MD$US$US
241767791$24176779$1$I$20240101$20240801$20240806$20240806$PER$$US-SA-2024SA228890$SANOFI AVENTIS$$$$$F$Y$$$20240806$$MD$US$US
241767801$24176780$1$I$20240706$20240726$20240806$20240806$PER$$US-SA-2024SA225111$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240806$$MD$US$US
241767811$24176781$1$I$20240101$20240726$20240806$20240806$PER$$US-SA-2024SA224415$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240806$$MD$US$US
241767821$24176782$1$I$20211201$20220207$20240806$20240806$EXP$$CR-AstraZeneca-2022A064620$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$CR$
241767832$24176783$2$F$$20220701$20240806$20240807$EXP$$US-AstraZeneca-2022A243999$ASTRAZENECA$$$$E$F$Y$$$20240807$$CN$US$
241767841$24176784$1$I$$20211209$20240806$20240806$EXP$$US-AstraZeneca-2021A867209$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241767851$24176785$1$I$20240607$20240725$20240806$20240806$EXP$$ES-AUROBINDO-AUR-APL-2024-037785$AUROBINDO$$57$YR$$F$Y$$$20240806$$MD$ES$ES
241767861$24176786$1$I$$20240730$20240806$20240806$EXP$$US-SA-2024SA227682$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
241767872$24176787$2$F$20240304$20240906$20240806$20240918$EXP$$US-UCBSA-2024037461$UCB$$67$YR$$M$Y$$$20240918$$MD$US$US
241767892$24176789$2$F$$20240826$20240806$20240830$EXP$$JP-AMGEN-JPNSP2024152961$AMGEN$$$$E$M$Y$$$20240830$$MD$JP$JP
241767901$24176790$1$I$20240723$20240725$20240806$20240806$EXP$$US-Accord-439581$ACCORD$$47$YR$A$F$Y$$$20240806$$HP$US$US
241767911$24176791$1$I$$20240725$20240806$20240806$EXP$GB-MHRA-MED-202407251012454120-CJPMW$GB-Accord-438850$ACCORD$$$$$M$Y$$$20240806$$CN$GB$GB
241767921$24176792$1$I$20240724$20240725$20240806$20240806$EXP$$US-Accord-438869$ACCORD$$36$YR$A$F$Y$$$20240806$$HP$US$US
241767931$24176793$1$I$$20240726$20240806$20240806$EXP$CA-MHPD-E2B_07134566$CA-Accord-438764$ACCORD$$48$YR$A$F$Y$$$20240806$$HP$CA$CA
241767941$24176794$1$I$20240101$20240803$20240806$20240806$PER$$US-AMGEN-USASP2024154928$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241767953$24176795$3$F$$20240812$20240806$20240813$PER$$US-AMGEN-USASP2024153368$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
241767961$24176796$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865946$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241767971$24176797$1$I$20240604$20240702$20240806$20240806$PER$$US-AMGEN-USASP2024155099$AMGEN$$80$YR$E$M$Y$$$20240806$$CN$US$US
241767981$24176798$1$I$20240101$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153366$AMGEN$$$$$M$Y$$$20240806$$CN$US$US
241767992$24176799$2$F$20240101$20240802$20240806$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408002027$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240814$$CN$US$US
241768001$24176800$1$I$$20231205$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2023US066690$SANDOZ$Holly Wobma, Malika Kapadia, Haesook T. Kim, Francesca Alvarez-Calderon, Susanne H. C. Baumeister et al. Real-world experience with low-dose IL-2 for children and youngadults with refractory chronic graft-versus-host disease. Blood advances. 2023;VOLUME 7, NUMBE:4647-4657$$$$$Y$$$20240806$$HP$US$US
241768011$24176801$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002082$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240806$$CN$US$US
241768021$24176802$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002214$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240806$$CN$US$US
241768031$24176803$1$I$20240701$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002161$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240806$$CN$US$US
241768041$24176804$1$I$20240101$20240731$20240806$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023811$UNITED THERAPEUTICS$$$$$M$Y$23.583$KG$20240806$$$US$US
241768051$24176805$1$I$20240731$20240731$20240806$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023833$UNITED THERAPEUTICS$$42$YR$$F$Y$71.655$KG$20240806$$$US$US
241768062$24176806$2$F$20240630$20240807$20240806$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-020011$UNITED THERAPEUTICS$$52$YR$$F$Y$56.236$KG$20240813$$$US$US
241768071$24176807$1$I$20240701$20240731$20240806$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023788$UNITED THERAPEUTICS$$49$YR$$F$Y$58.503$KG$20240806$$$US$US
241768081$24176808$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002028$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240806$$CN$US$US
241768093$24176809$3$F$20240101$20240920$20240806$20240930$EXP$$CA-CELLTRION INC.-2024CA018625$CELLTRION$$$$$$Y$$$20240930$$CN$CA$CA
241768101$24176810$1$I$20240730$20240731$20240806$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023849$UNITED THERAPEUTICS$$25$YR$$F$Y$58.957$KG$20240806$$$US$US
241768111$24176811$1$I$$20240731$20240806$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023192$UNITED THERAPEUTICS$$$$$F$Y$79.819$KG$20240806$$$US$US
241768121$24176812$1$I$20240101$20240730$20240806$20240806$EXP$$US-SA-2024SA226222$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240806$$MD$US$US
241768131$24176813$1$I$20240801$20240801$20240806$20240806$EXP$$ES-ABBVIE-5865618$ABBVIE$$76$YR$$M$Y$$$20240806$$CN$ES$ES
241768141$24176814$1$I$20240101$20240801$20240806$20240806$EXP$$US-ABBVIE-5864604$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241768151$24176815$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA229322$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240806$$MD$US$US
241768161$24176816$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA227246$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240806$$MD$US$US
241768171$24176817$1$I$20240601$20240729$20240806$20240806$PER$$US-SA-2024SA229331$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240806$$MD$US$US
241768181$24176818$1$I$$20240724$20240806$20240806$EXP$$US-STL-000232$Stallion Laboratories$Surineni K, Le V, Jones D. A Case of Oral-Buccal-Lingual Dyskinesia and Neuropsychiatric Symptoms After Prolonged Levetiracetam Exposure. Cureus. 2024 Jun 19;16(6):e62692. doi: 10.7759/cureus.62692.$86$YR$$F$Y$$$20240806$$HP$US$US
241768191$24176819$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA227660$SANOFI AVENTIS$$$$A$F$Y$124.72$KG$20240806$$MD$US$US
241768201$24176820$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865714$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241768211$24176821$1$I$$20240724$20240806$20240806$PER$$US-JNJFOC-20240775929$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241768222$24176822$2$F$20240101$20240820$20240806$20240823$EXP$$CA-JNJFOC-20240587956$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240823$$HP$CA$CA
241768237$24176823$7$F$20240701$20240906$20240806$20240912$EXP$$CL-JNJFOC-20240773694$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240913$$CN$CL$CL
241768241$24176824$1$I$$20240724$20240806$20240806$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR094936$VIIV$$$$$$Y$$$20240806$$HP$US$US
241768251$24176825$1$I$20240101$20240801$20240806$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023943$UNITED THERAPEUTICS$$$$$M$Y$89.342$KG$20240806$$$US$US
241768261$24176826$1$I$$20231219$20240806$20240806$EXP$$SE-SANDOZ INC.-SDZ2023SE070040$SANDOZ$$$$$$Y$$$20240806$$HP$SE$SE
241768271$24176827$1$I$$20240725$20240806$20240806$EXP$$IN-ROCHE-10000038114$ROCHE$Garg A, Trivedi M, Raj A, Shah K, Patel K, Vachhani A, et al. Haploidentical Stem Cell Transplantation: Half Match but More Hope!-Single Centre Experience from Western India. Indian Society of Hematology and Blood Transfusion. 2024-Jul;40 (3):385-91. doi:10.1007/s12288-023-01722-6.$$$$$Y$$$20240806$$MD$IN$IN
241768281$24176828$1$I$$20240730$20240806$20240806$EXP$$JP-SA-2024SA222316$SANOFI AVENTIS$$$$$$Y$$$20240806$$MD$JP$JP
241768291$24176829$1$I$20230401$20240729$20240806$20240806$EXP$$US-LEO Pharma-372460$LEO PHARM$$$$N$$Y$$$20240806$$HP$US$US
241768301$24176830$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-037961$AUROBINDO$Capua M, Amlicke M, Esposito E, Belfer J, Bellis M, Falkowitz D, Teng D.. Time of Observation in Xenobiotic Ingestions in Children Is 6 Hours Too Long?.. Pediatric Emergency Care.. 2023;39 (1):e24-e29$$$$$Y$$$20240806$$HP$CA$CA
241768311$24176831$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA226737$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240806$$MD$US$US
241768321$24176832$1$I$$20240729$20240806$20240806$EXP$$US-CELLTRION INC.-2024US018454$CELLTRION$Patel R, Elghawy O, Gibbs A, Gupta S, Kaur V. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer Reports. 2024;7(7):e2110$$$$$Y$$$20240806$$HP$US$US
241768331$24176833$1$I$20221101$20240730$20240806$20240806$EXP$$CA-GSK-CA2023082279$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$CA$CA
241768341$24176834$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-037935$AUROBINDO$$48$YR$$F$Y$$$20240806$$CN$CA$CA
241768351$24176835$1$I$$20240729$20240806$20240806$EXP$$PL-EXELIXIS-CABO-24080171$EXELIXIS$MIROCHA AS, MIROCHA M.. Cabozantinib in front line treatment of metastatic clear cell renal cell carcinoma.$72$YR$$M$Y$$$20240806$$MD$PL$PL
241768371$24176837$1$I$20220101$20220110$20240806$20240806$EXP$$TW-AstraZeneca-2022A018133$ASTRAZENECA$$77$YR$$F$Y$$$20240806$$CN$TW$
241768381$24176838$1$I$$20230413$20240806$20240806$EXP$$US-AstraZeneca-2023A087257$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241768391$24176839$1$I$$20240730$20240806$20240806$EXP$$IL-REGENERON PHARMACEUTICALS, INC.-2024-107028$REGENERON$$$$$F$Y$$$20240806$$CN$IL$IL
241768401$24176840$1$I$$20240725$20240806$20240806$EXP$$US-SAMSUNG BIOEPIS-SB-2024-23195$SAMSUNG BIOEPIS$Hodson E, Kranyak A, Salem I, Buckey Jr J. Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases. Journal of Tissue Viability. 2024 JUN 05;33/2024:449-451. doi:10.1016/j.jtv.2024.06.001$54$YR$A$F$Y$$$20240806$$HP$US$US
241768412$24176841$2$F$20240101$20240816$20240806$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-019506$UNITED THERAPEUTICS$$$$$M$Y$115.19$KG$20240821$$$US$US
241768442$24176844$2$F$20220101$20240806$20240806$20240810$EXP$$KR-ROCHE-10000038175$ROCHE$Jo E, Song S. Primary peritoneal carcinoma presented with abdominal pain in patient with kidney transplantation. Korean Journal of Internal Medicine. 2024-Jul;39 (4):693-694. doi:10.3904/kjim.2023.254.$61$YR$A$F$Y$$$20240810$$HP$KR$KR
241768451$24176845$1$I$20240730$20240731$20240806$20240806$PER$$US-ABBVIE-5863567$ABBVIE$$69$YR$$F$Y$$$20240806$$CN$US$US
241768461$24176846$1$I$$20240731$20240806$20240806$PER$$US-ABBVIE-5863698$ABBVIE$$46$YR$$F$Y$$$20240806$$MD$US$US
241768471$24176847$1$I$20240719$20240805$20240806$20240806$EXP$FR-AFSSAPS-NT2024000997$FR-SANDOZ INC.-SDZ2024FR070561$SANDOZ$$71$YR$$M$Y$$$20240806$$MD$FR$FR
241768481$24176848$1$I$$20231130$20240806$20240806$EXP$$FR-SANDOZ INC.-SDZ2023FR062708$SANDOZ$$$$$$Y$$$20240806$$HP$FR$FR
241768494$24176849$4$F$20240101$20240813$20240806$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023598$UNITED THERAPEUTICS$$$$$F$Y$83.9$KG$20240823$$$US$US
241768501$24176850$1$I$$20240311$20240806$20240806$EXP$$CN-SANDOZ INC.-SDZ2024CN032068$SANDOZ$Nan L, Xiwen Y, Huaibin Y, Ningbo W. Clinical observation on the treatment of heart failure with reduced ejection fraction of yang deficiency and blood stasis type by bushen huoxue decoction and wuling powder. CLINICAL JOURNAL OF TRADITIONAL CHINESE MEDICINE. 2024;36(2):doi:10.16448/j.cjtcm.2024.0223$$$$$Y$$$20240806$$HP$CN$CN
241768514$24176851$4$F$$20240909$20240806$20240917$30DAY$$BR-JNJFOC-20240778054$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$PH$BR$BR
241768521$24176852$1$I$20240701$20240729$20240806$20240806$EXP$$US-JNJFOC-20240812427$JOHNSON AND JOHNSON$$55$YR$A$M$Y$86.168$KG$20240806$$CN$US$US
241768531$24176853$1$I$$20240731$20240806$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023757$UNITED THERAPEUTICS$$$$$F$Y$$$20240806$$MD$US$US
241768541$24176854$1$I$20231115$20240729$20240806$20240806$EXP$SE-SEMPA-2024-005615$SE-TEVA-VS-3227780$TEVA$$82$YR$$F$Y$$$20240806$$MD$SE$SE
241768552$24176855$2$F$20240727$20240816$20240806$20240823$EXP$$NVSC2024CA156870$NOVARTIS$$24$YR$$F$Y$$$20240823$$CN$CA$CA
241768561$24176856$1$I$$20240712$20240806$20240806$PER$$US-JNJFOC-20240737564$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241768571$24176857$1$I$20240109$20240722$20240806$20240806$EXP$FR-AFSSAPS-NY2024000843$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110333$ZYDUS PHARM$$$$$$Y$$$20240806$$PH$FR$FR
241768581$24176858$1$I$$20240731$20240806$20240806$EXP$$NVSC2024US157197$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
241768591$24176859$1$I$$20240729$20240806$20240806$EXP$$JP-ROCHE-10000048495$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$63$YR$A$F$Y$$$20240806$$HP$JP$JP
241768601$24176860$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002045$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240806$$HP$US$US
241768611$24176861$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001931$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240806$$CN$US$US
241768621$24176862$1$I$$20240725$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407019977$ELI LILLY AND CO$$62$YR$A$$Y$$$20240806$$LW$US$US
241768631$24176863$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002064$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240806$$HP$US$US
241768641$24176864$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001903$ELI LILLY AND CO$$$$$$Y$$$20240806$$CN$US$US
241768651$24176865$1$I$20240801$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001993$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240806$$CN$US$US
241768661$24176866$1$I$$20240805$20240806$20240806$EXP$$US-UCBSA-2024039206$UCB$$$$$M$Y$$$20240806$$CN$US$US
241768672$24176867$2$F$$20240806$20240806$20240807$EXP$$RU-SANDOZ INC.-SDZ2023RU041155$SANDOZ$Fedyukova YG, Zyuzgin IS, Volchenkov SA, Novik SN. Use of post-transplant cyclophosphamide in allogeneic hematopoietic stem cell transplantation after total body irradiation in children with acute lymphoblastic leukemia. Experience of one Center. PEDIATRIC HEMATOLOGY/ONCOLOGY AND IMMUNOPATHOLOGY. 2023;22(2):126$$$$$Y$$$20240807$$HP$RU$RU
241768681$24176868$1$I$20240726$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153696$AMGEN$$75$YR$E$M$Y$$$20240806$$CN$US$US
241768702$24176870$2$F$$20240912$20240806$20240919$PER$$US-TAKEDA-2024TUS077494$TAKEDA$$$$$M$Y$108$KG$20240919$$MD$US$US
241768711$24176871$1$I$$20240722$20240806$20240806$PER$$US-JNJFOC-20240757187$JOHNSON AND JOHNSON$$74$YR$E$F$Y$48.124$KG$20240806$$CN$US$US
241768721$24176872$1$I$20210508$20220411$20240806$20240806$EXP$$US-AstraZeneca-2022A149811$ASTRAZENECA$$24700$DY$$F$Y$$$20240806$$CN$US$
241768731$24176873$1$I$$20240222$20240806$20240806$EXP$$IN-SANDOZ INC.-SDZ2024IN019475$SANDOZ$Vidushi Mahajan, Anam Siddiqui, Anita Tahlan, Sanjay D.Cruz ? Shivani Jaiswal. Spectrum of Anemia in Indian children with Nephrotic Syndrome:a prospective observational study. European Journal of Pediatrics. 2023;182:4723-4729$$$$$Y$$$20240806$$HP$IN$IN
241768741$24176874$1$I$$20221017$20240806$20240806$EXP$$US-AstraZeneca-2022A349342$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241768751$24176875$1$I$$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A175381$ASTRAZENECA$$$$$F$Y$$$20240806$$HP$US$
241768761$24176876$1$I$$20240730$20240806$20240806$PER$$US-ROCHE-3577689$ROCHE$Adames A, O^Brien DR, Kelly AR, Saltz LB, Garcia-Aguilar J, Zinovoy M, et al. Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series. Doi: 10.1007/s00384-024-04647-2.. International Journal of Colorectal Disease 2024;39:75-.$67$YR$E$M$Y$$$20240806$$HP$US$US
241768771$24176877$1$I$20220101$20240729$20240806$20240806$EXP$$SG-ROCHE-10000042378$ROCHE$$69$YR$E$M$Y$$$20240806$$CN$SG$SG
241768781$24176878$1$I$$20240729$20240806$20240806$EXP$NL-LRB-00993078$NL-TEVA-VS-3227776$TEVA$$65$YR$$M$Y$92$KG$20240806$$CN$NL$NL
241768793$24176879$3$F$$20240903$20240806$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121271$BRISTOL MYERS SQUIBB$Akhdar G, Akpan I. Navigating the nexus: lenalidomide-associated thrombotic thrombocytopenic purpura. Cureus. 2024 Jun 23;16(6):1-4.doi:10.7759/cureus.62975.$56$YR$A$M$Y$$$20240906$$HP$US$US
241768801$24176880$1$I$20240701$20240729$20240806$20240806$EXP$$CA-CELLTRION INC.-2024CA018681$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
241768811$24176881$1$I$$20240801$20240806$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023924$UNITED THERAPEUTICS$$$$$F$Y$74.376$KG$20240806$$$US$US
241768821$24176882$1$I$$20240801$20240806$20240806$EXP$$JP-GILEAD-2024-0682586$GILEAD$$51$YR$A$M$Y$$$20240806$$PH$JP$JP
241768833$24176883$3$F$20240628$20240814$20240806$20240819$PER$$US-AMGEN-USASP2024151930$AMGEN$$75$YR$E$F$Y$$$20240819$$MD$US$US
241768841$24176884$1$I$$20240719$20240806$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000638$DECIPHERA PHARMACEUTICALS$$75$YR$E$M$Y$$$20240806$$CN$US$US
241768851$24176885$1$I$20230121$20240729$20240806$20240806$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-000456$Alvotech$$41$YR$$F$Y$$$20240806$$CN$CA$CA
241768862$24176886$2$F$20240724$20240726$20240806$20240806$EXP$$US-ROCHE-10000039980$ROCHE$$80$YR$E$F$Y$56.24$KG$20240806$$PH$US$US
241768871$24176887$1$I$$20240722$20240806$20240806$PER$$US-GRANULES-US-2024GRASPO00304$GRANULES INDIA$$$$$F$Y$$$20240806$$CN$US$US
241768882$24176888$2$F$20240722$20240816$20240806$20240826$30DAY$$GB-JNJFOC-20240771876$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240826$$CN$GB$GB
241768893$24176889$3$F$20240201$20240916$20240806$20240924$EXP$$NL-EMD Serono-2024041234$EMD SERONO INC$$34$YR$A$F$Y$$$20240924$$CN$NL$NL
241768902$24176890$2$F$$20240730$20240806$20240812$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-17011$ALKEM$Cowley E, Omar MA.. Suspected Drug-Induced Rhabdomyolysis From the Combination of Atorvastatin, Amiodarone, and Ciprofloxacin. Annals of Pharmacotherapy. 2021;55(3):415-416$55$YR$$M$Y$$$20240812$$HP$CA$CA
241768912$24176891$2$F$$20240730$20240806$20240812$EXP$$SA-ALKEM LABORATORIES LIMITED-SA-ALKEM-2024-16976$ALKEM$Irfan F, Karim SI. Co-prescription of ciprofloxacin and statins; a dangerous combination: Case Report. J Pak Med Assoc. 2020;70(7):1272-1274$65$YR$$F$Y$$$20240812$$HP$SA$SA
241768921$24176892$1$I$$20240722$20240806$20240806$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16761$ALKEM$Niyas AM, Haseefa F, Cox JC, Movahed MR.. Suspected colchicine-induced late myocardial rupture occurring after the late presentation of acute inferior ST-elevation myocardial infarction. Am J Cardiovasc Dis. 2024;14(2):116-120$61$YR$$M$Y$$$20240806$$HP$US$US
241768931$24176893$1$I$$20240801$20240806$20240806$EXP$$US-LEO Pharma-372487$LEO PHARM$$72$YR$$F$Y$$$20240806$$HP$US$US
241768951$24176895$1$I$20240801$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153699$AMGEN$$70$YR$E$M$Y$$$20240806$$CN$US$US
241768961$24176896$1$I$$20240801$20240806$20240806$EXP$$US-ALXN-202408ASI000026TW$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$MD$US$TW
241768971$24176897$1$I$$20240730$20240806$20240806$PER$$US-ALXN-202407USA002170US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
241768981$24176898$1$I$20221101$20231019$20240806$20240806$EXP$$SG-SANDOZ INC.-SDZ2023SG047277$SANDOZ$$$$$$Y$$$20240806$$HP$SG$SG
241768991$24176899$1$I$20240724$20240729$20240806$20240806$EXP$$CN-BEIGENE-BGN-2024-011772$BEIGENE$$$$$$Y$$$20240806$$HP$CN$CN
241769001$24176900$1$I$20240101$20240729$20240806$20240806$EXP$$US-SA-2024SA223011$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240806$$MD$US$US
241769022$24176902$2$F$20240620$20240902$20240806$20240909$EXP$FR-AFSSAPS-LL2024001456$FR-AMGEN-FRASP2024152303$AMGEN$$73$YR$E$M$Y$$$20240909$$MD$FR$FR
241769031$24176903$1$I$20240731$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153511$AMGEN$$64$YR$A$F$Y$$$20240806$$CN$US$US
241769061$24176906$1$I$$20240729$20240806$20240806$EXP$$US-AMAROX PHARMA-ASP2024US02526$ASPIRO PHARMA$Patel S, Tsai C, Slampak-Cindric A. When in Doubt, Examine the Medication List: A Rare Case of Daptomycin-Induced Lung Injury. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2025$75$YR$$F$Y$$$20240806$$HP$US$US
241769071$24176907$1$I$$20240729$20240806$20240806$EXP$$ZA-AstraZeneca-2024A172597$ASTRAZENECA$$70$YR$$F$Y$$$20240806$$CN$ZA$
241769081$24176908$1$I$$20220222$20240806$20240806$EXP$$US-AstraZeneca-2022A084529$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241769091$24176909$1$I$$20230307$20240806$20240806$EXP$$US-AstraZeneca-2023A058025$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241769101$24176910$1$I$$20240726$20240806$20240806$PER$$US-AstraZeneca-2024A173475$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241769111$24176911$1$I$$20240725$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407017945$ELI LILLY AND CO$$42$YR$A$$Y$$$20240806$$LW$US$US
241769121$24176912$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001873$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240806$$CN$US$US
241769131$24176913$1$I$20240801$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001889$ELI LILLY AND CO$$$$$F$Y$$$20240806$$CN$US$US
241769141$24176914$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001989$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240806$$CN$US$US
241769151$24176915$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002227$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240806$$CN$US$US
241769162$24176916$2$F$$20240730$20240806$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202407020062$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240812$$CN$US$US
241769171$24176917$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002177$ELI LILLY AND CO$$61$YR$A$$Y$$$20240806$$CN$US$US
241769181$24176918$1$I$20240720$20240722$20240806$20240806$PER$$US-GRANULES-US-2024GRASPO00314$GRANULES INDIA$$82$YR$E$F$Y$$$20240806$$CN$US$US
241769202$24176920$2$F$20230301$20240802$20240806$20240813$EXP$$AT-ROCHE-10000045851$ROCHE$$63$YR$A$M$Y$$$20240813$$MD$AT$AT
241769211$24176921$1$I$$20240801$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123472$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240806$$CN$US$US
241769222$24176922$2$F$$20240829$20240806$20240901$PER$$US-JNJFOC-20240802646$JOHNSON AND JOHNSON$$$$$M$Y$$$20240901$$PH$US$US
241769231$24176923$1$I$20240719$20240725$20240806$20240806$EXP$$PK-ROCHE-10000039952$ROCHE$$72$YR$E$F$Y$$$20240806$$CN$PK$PK
241769242$24176924$2$F$$20240821$20240806$20240828$EXP$$GB-CELLTRION INC.-2024GB018487$CELLTRION$$$$$$Y$$$20240828$$CN$GB$GB
241769251$24176925$1$I$$20240730$20240806$20240806$EXP$$GB-AMGEN-GBRSP2024154592$AMGEN$$80$YR$E$F$Y$$$20240806$$CN$GB$GB
241769261$24176926$1$I$20240804$20240803$20240806$20240806$PER$$US-AMGEN-USASP2024155715$AMGEN$$75$YR$E$M$Y$$$20240806$$HP$US$US
241769271$24176927$1$I$20230101$20230303$20240806$20240806$EXP$$BR-BIOVITRUM-2023-BR-006634$BIOVITRUM$$$$$F$Y$$$20240806$$CN$BR$BR
241769282$24176928$2$F$20240730$20240801$20240806$20240808$EXP$$GB-CELLTRION INC.-2024GB018525$CELLTRION$$$$$$Y$$$20240808$$CN$GB$GB
241769301$24176930$1$I$20230215$20230221$20240806$20240806$EXP$$CO-BIOVITRUM-2023-CO-005881$BIOVITRUM$$120$DY$$F$Y$2.8$KG$20240806$$CN$CO$CO
241769311$24176931$1$I$$20240730$20240806$20240806$EXP$$CA-JNJFOC-20240801674$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240806$$HP$CA$CA
241769322$24176932$2$F$20240801$20240815$20240806$20240817$PER$$US-AMGEN-USASP2024155173$AMGEN$$70$YR$E$F$Y$$$20240817$$CN$US$US
241769341$24176934$1$I$20240718$20240724$20240806$20240806$PER$$US-FARMAPROD-202407-2726$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240806$$CN$US$US
241769352$24176935$2$F$20240501$20240814$20240806$20240820$PER$$US-JNJFOC-20240728232$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240820$$CN$US$US
241769361$24176936$1$I$20210101$20240726$20240806$20240806$EXP$$CA-ROCHE-10000040829$ROCHE$$15$YR$T$M$Y$$$20240806$$HP$CA$CA
241769371$24176937$1$I$$20240730$20240806$20240806$EXP$CH-MLMSERVICE-20240716-PI131447-00101-1$CH-CHEPLA-2024009983$CHEPLAPHARM$Genoud V, Dutoit V, Thang NT, Janowczyk A, McKee T, Chalandon Y, et al. Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin. Haematologica. 2024;109:2364-67. DOI: 10.3324/haematol.2023.284318.$22$YR$$M$Y$$$20240806$$MD$COUNTRY NOT SPECIFIED$CH
241769381$24176938$1$I$20240728$20240727$20240806$20240806$EXP$$IN-ROCHE-10000041510$ROCHE$$62$YR$A$F$Y$$$20240806$$CN$IN$IN
241769391$24176939$1$I$$20240730$20240806$20240806$EXP$$DE-SA-2024SA228298$SANOFI AVENTIS$$$$$F$Y$$$20240806$$CN$DE$DE
241769411$24176941$1$I$20240708$20240729$20240806$20240806$EXP$$US-SA-2024SA227835$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240806$$MD$US$US
241769421$24176942$1$I$20230101$20240726$20240806$20240806$EXP$$CA-ROCHE-10000040837$ROCHE$$15$YR$T$M$Y$$$20240806$$HP$CA$CA
241769441$24176944$1$I$20231204$20240730$20240806$20240806$EXP$$JP-ROCHE-10000048455$ROCHE$$9$DEC$E$M$Y$$$20240806$$MD$JP$JP
241769451$24176945$1$I$20231201$20240725$20240806$20240806$EXP$$CR-JNJFOC-20240136738$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240806$$HP$CR$CR
241769471$24176947$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123591$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240806$$CN$US$US
241769481$24176948$1$I$$20240731$20240806$20240806$PER$$US-JNJFOC-20240802169$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240806$$CN$US$US
241769502$24176950$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0682978$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241769511$24176951$1$I$20240723$20240723$20240806$20240806$PER$$US-ABBVIE-5867652$ABBVIE$$67$YR$$M$Y$$$20240806$$CN$US$US
241769521$24176952$1$I$20240607$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A175681$ASTRAZENECA$$30617$DY$$F$Y$$$20240806$$CN$US$
241769531$24176953$1$I$$20240729$20240806$20240806$PER$$US-ABBVIE-5860125$ABBVIE$$$$$F$Y$$$20240806$$HP$US$US
241769542$24176954$2$F$20240731$20240805$20240806$20240814$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000672$DECIPHERA PHARMACEUTICALS$$70$YR$E$M$Y$$$20240814$$CN$US$US
241769552$24176955$2$F$$20240725$20240806$20240822$PER$$US-BEH-2024176712$CSL BEHRING$$$$$$Y$$$20240822$$PH$US$US
241769561$24176956$1$I$$20240731$20240806$20240806$EXP$$JP-GILEAD-2024-0682538$GILEAD$$5$DEC$A$M$Y$$$20240806$$PH$JP$JP
241769571$24176957$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008947$APOTEX$$71$YR$$F$Y$$$20240806$$CN$CA$CA
241769581$24176958$1$I$$20240731$20240806$20240806$EXP$$CA-JNJFOC-20240610267$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240806$$HP$CA$CA
241769591$24176959$1$I$20231129$20240726$20240806$20240806$PER$$US-JNJFOC-20240776086$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240806$$CN$US$US
241769611$24176961$1$I$$20240731$20240806$20240806$PER$$US-AMGEN-USASP2024152305$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241769621$24176962$1$I$20240726$20240731$20240806$20240806$PER$$US-AMGEN-USASP2024152691$AMGEN$$$$$$Y$$$20240806$$HP$US$US
241769631$24176963$1$I$$20240801$20240806$20240806$EXP$$US-LEO Pharma-372485$LEO PHARM$$80$YR$$M$Y$$$20240806$$HP$US$US
241769641$24176964$1$I$20240714$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001797$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240806$$CN$US$US
241769651$24176965$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407007610$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240806$$CN$US$US
241769661$24176966$1$I$20240801$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002052$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240806$$CN$US$US
241769671$24176967$1$I$20240802$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408003030$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240806$$CN$US$US
241769681$24176968$1$I$$20240729$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001468$ELI LILLY AND CO$$$$$M$Y$$$20240806$$CN$US$US
241769691$24176969$1$I$20240126$20240724$20240806$20240806$EXP$DE-PEI-CADR2024326051$DE-ROCHE-10000035824$ROCHE$$72$YR$E$F$Y$88$KG$20240806$$CN$DE$DE
241769701$24176970$1$I$20240701$20240731$20240806$20240806$PER$$US-ALVOTECHPMS-2024-ALVOTECHPMS-002092$Alvotech$$$$$M$Y$$$20240806$$CN$US$
241769721$24176972$1$I$20240101$20240731$20240806$20240806$EXP$$US-AMGEN-USASP2024153118$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241769732$24176973$2$F$$20240827$20240806$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-113270$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240904$$PH$JP$JP
241769741$24176974$1$I$$20240802$20240806$20240806$PER$$US-JNJFOC-20240809025$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$US$US
241769751$24176975$1$I$20240719$20240730$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01307$AMNEAL$$69$YR$$M$Y$$$20240806$$CN$US$US
241769764$24176976$4$F$20240609$20240821$20240806$20240827$EXP$$KR-CELLTRION INC.-2024KR018596$CELLTRION$$$$$$Y$$$20240827$$HP$KR$KR
241769771$24176977$1$I$20230215$20240731$20240806$20240806$EXP$$CN-Orion Corporation ORION PHARMA-ENT 2024-0037$ORION$$71$YR$E$M$Y$50$KG$20240806$$HP$CN$
241769781$24176978$1$I$$20240729$20240806$20240806$EXP$$ES-ROCHE-10000041826$ROCHE$Escudero L, Cobelas Cartagena S, Esperilla M. Efficacy and safety of second-line immunotherapy in patients with advanced non-small cell lung cancer (abstract number: e20571). Journal of clinical oncology. 2024;42 (supp 16):$$$$$Y$$$20240806$$HP$ES$ES
241769791$24176979$1$I$20240723$20240730$20240806$20240806$EXP$$CN-GSK-CN2024GSK096679$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$HP$CN$CN
241769801$24176980$1$I$$20240725$20240806$20240806$PER$$US-FARMAPROD-202407-2745$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240806$$CN$US$US
241769811$24176981$1$I$$20240731$20240806$20240806$EXP$$US-AMGEN-USASP2024152619$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241769822$24176982$2$F$20240804$20240806$20240806$20240808$PER$$US-AMGEN-USASP2024155697$AMGEN$$83$YR$E$F$Y$$$20240808$$CN$US$US
241769831$24176983$1$I$$20240729$20240806$20240806$EXP$$US-CELLTRION INC.-2024US018499$CELLTRION$$$$$$Y$$$20240806$$CN$US$US
241769841$24176984$1$I$$20240726$20240806$20240806$PER$$US-RDY-SPO/USA/24/0011134$DR REDDYS$$27$YR$A$F$Y$$$20240806$$MD$US$US
241769851$24176985$1$I$$20240731$20240806$20240806$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-005046$JAZZ$$$$$M$Y$$$20240806$$CN$US$US
241769861$24176986$1$I$$20240730$20240806$20240806$EXP$$CA-EMD Serono-2024041360$EMD SERONO INC$$$$A$M$Y$$$20240806$$CN$CA$CA
241769871$24176987$1$I$20240704$20240802$20240806$20240806$EXP$$US-ABBVIE-5865708$ABBVIE$$52$YR$$F$Y$$$20240806$$CN$US$US
241769882$24176988$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0682979$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241769891$24176989$1$I$$20240723$20240806$20240806$PER$$US-TEVA-VS-3226320$TEVA$$77$YR$$M$Y$$$20240806$$CN$US$US
241769901$24176990$1$I$$20240730$20240806$20240806$EXP$$CA-APOTEX-2024AP009070$APOTEX$$$$E$M$Y$$$20240806$$CN$CA$CA
241769911$24176991$1$I$$20240729$20240806$20240806$PER$$US-ABBVIE-5859422$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241769921$24176992$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008970$APOTEX$$81$YR$$M$Y$$$20240806$$CN$CA$CA
241769931$24176993$1$I$$20240726$20240806$20240806$EXP$GB-MHRA-MED-202407261046426710-STWQJ$GB-AMAROX PHARMA-AMR2024GB02497$HETERO$$$$$F$Y$$$20240806$$HP$GB$GB
241769944$24176994$4$F$20240726$20240903$20240806$20240909$PER$$US-AMGEN-USASP2024151787$AMGEN$$66$YR$E$F$Y$64.399$KG$20240909$$MD$US$US
241769951$24176995$1$I$20221030$20221125$20240806$20240806$EXP$$FR-RECORDATI-2022006207$RECORDATI$$$$$$Y$$$20240806$$MD$FR$FR
241769961$24176996$1$I$20240201$20240731$20240806$20240806$EXP$$US-BIOGEN-2024BI01276768$BIOGEN$$70$YR$$F$Y$$$20240806$$CN$US$US
241769974$24176997$4$F$20240101$20240821$20240806$20240827$EXP$$US-ABBVIE-5863743$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
241769981$24176998$1$I$$20240725$20240806$20240806$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR094515$VIIV$$$$$$Y$$$20240806$$MD$US$US
241769991$24176999$1$I$$20240731$20240806$20240806$EXP$$NVSC2024BR158423$NOVARTIS$$$$$M$Y$$$20240806$$CN$BR$BR
241770001$24177000$1$I$$20240729$20240806$20240806$EXP$$US-ROCHE-10000044922$ROCHE$$33$YR$A$F$Y$$$20240806$$CN$US$US
241770011$24177001$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A173822$ASTRAZENECA$$829$MON$$F$Y$$$20240806$$CN$US$
241770021$24177002$1$I$$20240731$20240806$20240806$PER$$US-AstraZeneca-2024A175115$ASTRAZENECA$$60$YR$$F$Y$$$20240806$$HP$US$
241770031$24177003$1$I$$20240729$20240806$20240806$EXP$$CA-AstraZeneca-2024A173934$ASTRAZENECA$$78$YR$$F$Y$61$KG$20240806$$MD$CA$
241770041$24177004$1$I$$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A175656$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241770051$24177005$1$I$20210801$20240801$20240806$20240806$EXP$$JP-AstraZeneca-2024A174603$ASTRAZENECA$$$$E$$Y$$$20240806$$MD$JP$
241770071$24177007$1$I$20240506$20240722$20240806$20240806$EXP$$CN-OCTA-ALB12124$OCTAPHARMA$$92$YR$E$M$Y$70$KG$20240805$$HP$CN$CN
241770082$24177008$2$F$20240301$20240923$20240806$20240927$EXP$$US-ABBVIE-5863831$ABBVIE$$67$YR$$F$Y$$$20240927$$CN$US$US
241770091$24177009$1$I$20240701$20240731$20240806$20240806$EXP$$CA-ABBVIE-5863529$ABBVIE$$73$YR$$$Y$$$20240806$$HP$CA$CA
241770101$24177010$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123399$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240806$$CN$US$US
241770111$24177011$1$I$$20240801$20240806$20240806$EXP$$US-JNJFOC-20240803609$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240806$$HP$US$US
241770122$24177012$2$F$$20240806$20240806$20240807$PER$$US-JNJFOC-20240763147$JOHNSON AND JOHNSON$$$$A$F$Y$90$KG$20240807$$CN$US$US
241770131$24177013$1$I$$20240801$20240806$20240806$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122278$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240806$$HP$CA$CA
241770151$24177015$1$I$20240731$20240802$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123056$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$81.65$KG$20240806$$PH$US$US
241770161$24177016$1$I$20240101$20240719$20240806$20240806$EXP$$NL-AMGEN-NLDNI2024154839$AMGEN$$$$E$F$Y$$$20240806$$CN$NL$NL
241770191$24177019$1$I$$20240724$20240806$20240806$EXP$$GB-LAURUS LABS LIMITED-2024LAU000061$LAURUS LABS LIMITED$Fadden EJ, Longley C, Mahambrey T. Metformin-associated lactic acidosis.. BMJ Case Rep.. 2021;14(7)$58$YR$$F$Y$$$20240806$$HP$GB$GB
241770211$24177021$1$I$$20240607$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000250$Tarsus Pharmaceuticals$$$$$$Y$$$20240806$$MD$US$US
241770221$24177022$1$I$20240501$20240718$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000319$Tarsus Pharmaceuticals$$$$$M$Y$$$20240806$$MD$US$US
241770231$24177023$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123039$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$79.38$KG$20240806$$CN$US$US
241770241$24177024$1$I$20240801$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123420$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240806$$PH$US$US
241770251$24177025$1$I$20240521$20240730$20240806$20240806$EXP$$NVSC2024MX111648$NOVARTIS$$63$YR$$F$Y$74$KG$20240806$$CN$MX$MX
241770261$24177026$1$I$20240701$20240709$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000306$Tarsus Pharmaceuticals$$77$YR$$F$Y$$$20240806$$CN$US$US
241770271$24177027$1$I$$20240709$20240806$20240806$PER$$US-JNJFOC-20240727077$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240806$$CN$US$US
241770281$24177028$1$I$20240101$20240801$20240806$20240806$EXP$$JP-JNJFOC-20240812288$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$PH$JP$JP
241770292$24177029$2$F$20240601$20240814$20240806$20240819$EXP$$CA-JNJFOC-20240803011$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240819$$CN$CA$CA
241770301$24177030$1$I$$20230814$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02343$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241770311$24177031$1$I$$20230814$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02342$AMNEAL$$$$$$Y$$$20240806$$MD$US$US
241770321$24177032$1$I$$20230918$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02419$AMNEAL$$$$$$Y$$$20240806$$CN$US$US
241770331$24177033$1$I$20230626$20230814$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02344$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241770341$24177034$1$I$$20230814$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02366$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241770351$24177035$1$I$20230621$20230720$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02259$AMNEAL$$63$YR$$F$Y$$$20240806$$MD$US$US
241770361$24177036$1$I$$20230921$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02371$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241770371$24177037$1$I$20230706$20230814$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02420$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241770381$24177038$1$I$$20230626$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02381$AMNEAL$$$$$F$Y$$$20240806$$HP$US$US
241770392$24177039$2$F$20240726$20240920$20240806$20240930$EXP$$US-TEVA-VS-3228791$TEVA$$29$YR$$F$Y$$$20240930$$HP$US$US
241770401$24177040$1$I$20230629$20230814$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02367$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241770411$24177041$1$I$20240802$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002049$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240806$$CN$US$US
241770422$24177042$2$F$20240802$20240805$20240806$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002782$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240807$$CN$US$US
241770431$24177043$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002755$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240806$$CN$US$US
241770441$24177044$1$I$$20240728$20240806$20240806$EXP$$FR-AMGEN-FRASP2024153247$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut. 2024;1-13$$$$$Y$$$20240806$$MD$FR$FR
241770451$24177045$1$I$$20240801$20240806$20240806$EXP$$US-ABBVIE-5865885$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241770461$24177046$1$I$$20240724$20240806$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000652$DECIPHERA PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
241770471$24177047$1$I$$20240722$20240806$20240806$PER$$US-TEVA-VS-3223274$TEVA$$$$$F$Y$$$20240806$$CN$US$US
241770481$24177048$1$I$$20230713$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02508$AMNEAL$$$$$M$Y$$$20240806$$MD$US$US
241770491$24177049$1$I$20230803$20230804$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02794$AMNEAL$$40$YR$$M$Y$75$KG$20240806$$HP$US$US
241770501$24177050$1$I$$20230706$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02422$AMNEAL$$$$$$Y$$$20240806$$MD$US$US
241770511$24177051$1$I$20230705$20230814$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02512$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241770521$24177052$1$I$$20230707$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02431$AMNEAL$$$$$M$Y$$$20240806$$MD$US$US
241770531$24177053$1$I$20230112$20230808$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02841$AMNEAL$$22$YR$$F$Y$73$KG$20240806$$MD$US$US
241770541$24177054$1$I$20230613$20230710$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02460$AMNEAL$$17$YR$$M$Y$$$20240806$$MD$US$US
241770551$24177055$1$I$$20231012$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02775$AMNEAL$$$$$$Y$$$20240806$$CN$US$US
241770561$24177056$1$I$20230101$20230720$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02591$AMNEAL$$15$YR$$M$Y$$$20240806$$HP$US$US
241770571$24177057$1$I$$20230814$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02429$AMNEAL$$$$$F$Y$$$20240806$$HP$US$US
241770581$24177058$1$I$$20230814$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02486$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241770591$24177059$1$I$20230701$20231012$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02667$AMNEAL$$$$$$Y$$$20240806$$PH$US$US
241770601$24177060$1$I$20230809$20231017$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02914$AMNEAL$$$$$$Y$$$20240806$$CN$US$US
241770611$24177061$1$I$$20230720$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02575$AMNEAL$$$$$F$Y$$$20240806$$HP$US$US
241770621$24177062$1$I$$20230710$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02464$AMNEAL$$$$$M$Y$$$20240806$$MD$US$US
241770631$24177063$1$I$20230719$20230720$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02574$AMNEAL$$22$YR$$M$Y$$$20240806$$HP$US$US
241770641$24177064$1$I$20230710$20230731$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02689$AMNEAL$$18$YR$$M$Y$43.991$KG$20240806$$MD$US$US
241770651$24177065$1$I$$20231016$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02715$AMNEAL$$$$$$Y$$$20240806$$MD$US$US
241770661$24177066$1$I$$20230710$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02518$AMNEAL$$$$$F$Y$$$20240806$$MD$US$US
241770671$24177067$1$I$$20230810$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02852$AMNEAL$$$$$M$Y$90.7$KG$20240806$$MD$US$US
241770681$24177068$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008974$APOTEX$$49$YR$$F$Y$$$20240806$$CN$CA$CA
241770691$24177069$1$I$$20240801$20240806$20240806$PER$$US-JNJFOC-20240804592$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$CN$US$US
241770701$24177070$1$I$20230101$20230927$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03281$AMNEAL$$$$$F$Y$$$20240806$$MD$US$US
241770711$24177071$1$I$$20230825$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03190$AMNEAL$$$$$M$Y$79$KG$20240806$$MD$US$US
241770721$24177072$1$I$20230823$20230825$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03055$AMNEAL$$28$YR$$M$Y$75$KG$20240806$$MD$US$US
241770731$24177073$1$I$20230927$20230928$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03405$AMNEAL$$35$YR$$M$Y$145.13$KG$20240806$$MD$US$US
241770741$24177074$1$I$20230901$20230925$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03366$AMNEAL$$18$YR$$F$Y$$$20240806$$MD$US$US
241770751$24177075$1$I$20230818$20230828$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03064$AMNEAL$$29$YR$$M$Y$$$20240806$$MD$US$US
241770761$24177076$1$I$20231106$20231226$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03950$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241770771$24177077$1$I$20230913$20230915$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03314$AMNEAL$$48$YR$$M$Y$$$20240806$$MD$US$US
241770781$24177078$1$I$20231001$20231023$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03782$AMNEAL$$46$YR$$M$Y$$$20240806$$MD$US$US
241770791$24177079$1$I$20230824$20231004$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03048$AMNEAL$$49$YR$$M$Y$125.62$KG$20240806$$HP$US$US
241770801$24177080$1$I$$20231122$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03503$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241770811$24177081$1$I$$20230928$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03445$AMNEAL$$$$$F$Y$$$20240806$$MD$US$US
241770821$24177082$1$I$$20230921$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03360$AMNEAL$$$$$M$Y$79.365$KG$20240806$$MD$US$US
241770831$24177083$1$I$$20231016$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03695$AMNEAL$$$$$F$Y$$$20240806$$MD$US$US
241770841$24177084$1$I$20230920$20231027$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03798$AMNEAL$$45$YR$$M$Y$94.331$KG$20240806$$MD$US$US
241770851$24177085$1$I$20231027$20231129$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03913$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241770861$24177086$1$I$20230814$20240124$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02915$AMNEAL$$59$YR$$M$Y$$$20240806$$MD$US$US
241770871$24177087$1$I$$20230822$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-03020$AMNEAL$$$$$F$Y$$$20240806$$MD$US$US
241770881$24177088$1$I$20230807$20230815$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02931$AMNEAL$$44$YR$$M$Y$$$20240806$$MD$US$US
241770891$24177089$1$I$20230612$20230817$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-02952$AMNEAL$$35$YR$$M$Y$$$20240806$$MD$US$US
241770901$24177090$1$I$$20240731$20240806$20240806$EXP$$FR-DECIPHERA PHARMACEUTICALS LLC-2024FR000671$DECIPHERA PHARMACEUTICALS$$$$E$F$Y$48$KG$20240806$$PH$FR$FR
241770912$24177091$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0682980$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241770921$24177092$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A172856$ASTRAZENECA$$$$$F$Y$$$20240806$$MD$US$
241770931$24177093$1$I$20240725$20240801$20240806$20240806$EXP$$CO-AstraZeneca-2024A176344$ASTRAZENECA$$24199$DY$$F$Y$$$20240806$$CN$CO$
241770941$24177094$1$I$$20230306$20240806$20240806$EXP$$US-AstraZeneca-2023A055503$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241770951$24177095$1$I$$20240729$20240806$20240806$EXP$$ZA-AstraZeneca-2024A172317$ASTRAZENECA$$73$YR$$F$Y$$$20240806$$CN$ZA$
241770971$24177097$1$I$$20240731$20240806$20240806$EXP$$ZA-AstraZeneca-2024A174357$ASTRAZENECA$$56$YR$$M$Y$$$20240806$$CN$ZA$
241770981$24177098$1$I$20240610$20240726$20240806$20240806$EXP$$US-FARMAPROD-202406-2228$DOMPE FARMACEUTICI$$85$YR$E$F$Y$$$20240806$$MD$US$US
241770993$24177099$3$F$20240709$20240823$20240806$20240902$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024092915$VIIV$$47$YR$$M$Y$$$20240902$$CN$US$US
241771001$24177100$1$I$$20240730$20240806$20240806$EXP$$US-GSK-US2024095392$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$US$US
241771012$24177101$2$F$$20240910$20240806$20240917$EXP$$US-GSK-US2024095314$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$US$US
241771022$24177102$2$F$20230422$20240911$20240806$20240918$EXP$$JP-ROCHE-3358828$ROCHE$$71$YR$E$F$Y$56$KG$20240918$$MD$JP$JP
241771031$24177103$1$I$$20240723$20240806$20240806$EXP$$IN-ROCHE-10000042373$ROCHE$S D, Sathiamma P. Clinical profile and pregnancy outcomes of COVID positive pregnant women in phase I and II infection - a comparative study. Asian Journal of Pharmaceutical and Clinical Research. 2024-Jul;17 (7):37-40. doi:10.22159/ajpcr.2024v17i7.51090.$$$$$Y$$$20240806$$HP$IN$IN
241771044$24177104$4$F$20240730$20240823$20240806$20240827$EXP$$US-ROCHE-10000048380$ROCHE$$8$YR$C$M$Y$38.1$KG$20240827$$PH$US$US
241771051$24177105$1$I$20231123$20240119$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00203$AMNEAL$$$$$$Y$$$20240806$$MD$US$US
241771061$24177106$1$I$20240605$20240729$20240806$20240806$EXP$IT-MINISAL02-995889$IT-TEVA-VS-3227640$TEVA$$39$YR$$F$Y$$$20240806$$MD$IT$IT
241771071$24177107$1$I$$20240116$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00158$AMNEAL$$$$$F$Y$$$20240806$$CN$US$US
241771081$24177108$1$I$20231101$20231201$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-04502$AMNEAL$$27$YR$$M$Y$$$20240806$$CN$US$US
241771091$24177109$1$I$$20231213$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-04401$AMNEAL$$$$$$Y$$$20240806$$CN$US$US
241771101$24177110$1$I$$20231215$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-04392$AMNEAL$$$$$$Y$$$20240806$$MD$US$US
241771111$24177111$1$I$$20240105$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00023$AMNEAL$$$$$M$Y$$$20240806$$MD$US$US
241771121$24177112$1$I$$20231215$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-04391$AMNEAL$$$$$M$Y$$$20240806$$HP$US$US
241771131$24177113$1$I$20230104$20240320$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00022$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241771141$24177114$1$I$$20231218$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-04408$AMNEAL$$$$$F$Y$$$20240806$$MD$US$US
241771151$24177115$1$I$20231213$20240123$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04413$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241771161$24177116$1$I$$20231225$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-04601$AMNEAL$$$$$M$Y$$$20240806$$MD$US$US
241771171$24177117$1$I$$20240108$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00062$AMNEAL$$$$$M$Y$$$20240806$$MD$US$US
241771181$24177118$1$I$$20240320$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00151$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241771191$24177119$1$I$20231107$20231115$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-04010$AMNEAL$$72$YR$$M$Y$$$20240806$$MD$US$US
241771201$24177120$1$I$20231207$20240112$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-04368$AMNEAL$$29$YR$$M$Y$$$20240806$$MD$US$US
241771211$24177121$1$I$20231207$20231211$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-04319$AMNEAL$$21$YR$$F$Y$51.701$KG$20240806$$HP$US$US
241771221$24177122$1$I$20231207$20240104$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-04380$AMNEAL$$63$YR$$M$Y$$$20240806$$MD$US$US
241771231$24177123$1$I$20231212$20231214$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-04330$AMNEAL$$55$YR$$M$Y$$$20240806$$MD$US$US
241771251$24177125$1$I$20240220$20240221$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00643$AMNEAL$$25$YR$$M$Y$$$20240806$$MD$US$US
241771261$24177126$1$I$$20231226$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03964$AMNEAL$$$$$M$Y$$$20240806$$CN$US$US
241771271$24177127$1$I$20231212$20231214$20240806$20240806$EXP$$US-AMNEAL-2023-AMRX-04364$AMNEAL$$58$YR$$F$Y$65.76$KG$20240806$$MD$US$US
241771281$24177128$1$I$20240227$20240313$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00708$AMNEAL$$49$YR$$M$Y$$$20240806$$MD$US$US
241771291$24177129$1$I$20240209$20240306$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00787$AMNEAL$$17$YR$$F$Y$$$20240806$$CN$US$US
241771301$24177130$1$I$20240213$20240219$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00619$AMNEAL$$18$YR$$M$Y$$$20240806$$MD$US$US
241771311$24177131$1$I$$20240215$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00458$AMNEAL$$$$$F$Y$$$20240806$$MD$US$US
241771321$24177132$1$I$20240131$20240202$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00370$AMNEAL$$56$YR$$F$Y$$$20240806$$MD$US$US
241771331$24177133$1$I$$20240219$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00605$AMNEAL$$$$$M$Y$17$KG$20240806$$MD$US$US
241771341$24177134$1$I$20240111$20240312$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00886$AMNEAL$$33$YR$$F$Y$61$KG$20240806$$HP$US$US
241771351$24177135$1$I$20240313$20240321$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00893$AMNEAL$$26$YR$$M$Y$$$20240806$$MD$US$US
241771361$24177136$1$I$20240203$20240304$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00425$AMNEAL$$18$YR$$F$Y$54.422$KG$20240806$$MD$US$US
241771371$24177137$1$I$$20240313$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00606$AMNEAL$$$$$M$Y$61.224$KG$20240806$$MD$US$US
241771381$24177138$1$I$$20240213$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00558$AMNEAL$$$$$F$Y$$$20240806$$MD$US$US
241771391$24177139$1$I$$20240320$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00733$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241771401$24177140$1$I$20240117$20240207$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00446$AMNEAL$$35$YR$$M$Y$145.2$KG$20240806$$MD$US$US
241771411$24177141$1$I$$20240409$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00947$AMNEAL$$$$$M$Y$$$20240806$$CN$US$US
241771421$24177142$1$I$20240126$20240130$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00329$AMNEAL$$56$YR$$M$Y$$$20240806$$MD$US$US
241771431$24177143$1$I$20231214$20240228$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00697$AMNEAL$$18$YR$$M$Y$$$20240806$$MD$US$US
241771441$24177144$1$I$20240206$20240222$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00528$AMNEAL$$40$YR$$M$Y$$$20240806$$MD$US$US
241771451$24177145$1$I$20240101$20240126$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00299$AMNEAL$$41$YR$$F$Y$61.224$KG$20240806$$MD$US$US
241771461$24177146$1$I$20240108$20240226$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00727$AMNEAL$$24$YR$$M$Y$$$20240806$$MD$US$US
241771471$24177147$1$I$$20240723$20240806$20240806$EXP$$SA-Unichem Pharmaceuticals (USA) Inc-UCM202407-000955$UNICHEM$$$$A$M$Y$$$20240806$$$COUNTRY NOT SPECIFIED$
241771491$24177149$1$I$$20240724$20240806$20240806$EXP$$BE-Unichem Pharmaceuticals (USA) Inc-UCM202407-000961$UNICHEM$$57$YR$A$M$Y$$$20240806$$HP$BE$
241771501$24177150$1$I$$20230804$20240806$20240806$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202308-001046$UNICHEM$$68$YR$E$F$Y$77.56$KG$20240806$$CN$US$
241771511$24177151$1$I$$20240212$20240806$20240806$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202402-000143$UNICHEM$$$$$$Y$$$20240806$$CN$US$
241771521$24177152$1$I$$20240426$20240806$20240806$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202405-000468$UNICHEM$$47$YR$A$F$Y$$$20240806$$PH$US$
241771531$24177153$1$I$$20240403$20240806$20240806$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202403-000303$UNICHEM$$50$YR$A$F$Y$$$20240806$$CN$US$
241771541$24177154$1$I$$20240411$20240806$20240806$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202404-000404$UNICHEM$$34$YR$A$F$Y$81.6$KG$20240806$$CN$US$
241771551$24177155$1$I$$20231108$20240806$20240806$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202311-001415$UNICHEM$$41$YR$A$F$Y$$$20240806$$CN$US$
241771571$24177157$1$I$$20230912$20240806$20240806$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202309-001199$UNICHEM$$$$$F$Y$$$20240806$$CN$US$
241771581$24177158$1$I$20240101$20240801$20240806$20240806$EXP$$CA-ABBVIE-5865741$ABBVIE$$54$YR$$F$Y$$$20240806$$CN$CA$CA
241771591$24177159$1$I$$20240729$20240806$20240806$EXP$$US-GSK-US2024AMR095628$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$CN$US$US
241771601$24177160$1$I$$20240729$20240806$20240806$EXP$$AT-EMD Serono-2024042012$EMD SERONO INC$$40$YR$A$F$Y$$$20240806$$CN$AT$AT
241771611$24177161$1$I$$20240731$20240806$20240806$PER$$US-ALXN-202407USA002182US$ALEXION PHARMACEUTICALS$$$$$F$Y$62.595$KG$20240806$$CN$US$US
241771621$24177162$1$I$20240401$20240731$20240806$20240806$EXP$$FR-BIOGEN-2024BI01276707$BIOGEN$$54$YR$$M$Y$86$KG$20240806$$MD$FR$FR
241771631$24177163$1$I$20240331$20240731$20240806$20240806$EXP$FR-AFSSAPS-PC2024000596$FR-BIOGEN-2024BI01276700$BIOGEN$$42$YR$$M$Y$84$KG$20240806$$MD$FR$FR
241771642$24177164$2$F$$20240827$20240806$20240831$PER$$US-AMGEN-USASP2024154006$AMGEN$$$$$M$Y$$$20240831$$HP$US$US
241771651$24177165$1$I$20240307$20240328$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01053$AMNEAL$$45$YR$$M$Y$73.923$KG$20240806$$MD$US$US
241771661$24177166$1$I$20231128$20240328$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01028$AMNEAL$$42$YR$$M$Y$131.52$KG$20240806$$MD$US$US
241771671$24177167$1$I$$20240531$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01752$AMNEAL$$$$$M$Y$$$20240806$$MD$US$US
241771681$24177168$1$I$20240101$20240528$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01265$AMNEAL$$$$$F$Y$68.027$KG$20240806$$MD$US$US
241771691$24177169$1$I$20240325$20240417$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01052$AMNEAL$$$$$$Y$$$20240806$$CN$US$US
241771701$24177170$1$I$20240522$20240523$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01906$AMNEAL$$31$YR$$F$Y$$$20240806$$MD$US$US
241771711$24177171$1$I$20240319$20240410$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01248$AMNEAL$$52$YR$$M$Y$$$20240806$$MD$US$US
241771721$24177172$1$I$20240507$20240508$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01659$AMNEAL$$59$YR$$F$Y$84.354$KG$20240806$$MD$US$US
241771731$24177173$1$I$20240320$20240710$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01231$AMNEAL$$44$YR$$M$Y$79.365$KG$20240806$$MD$US$US
241771741$24177174$1$I$20240604$20240612$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-02094$AMNEAL$$41$YR$$M$Y$62$KG$20240806$$MD$US$US
241771751$24177175$1$I$20240317$20240328$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01015$AMNEAL$$57$YR$$F$Y$53.968$KG$20240806$$MD$US$US
241771761$24177176$1$I$$20240522$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01871$AMNEAL$$$$$M$Y$48$KG$20240806$$MD$US$US
241771771$24177177$1$I$20240529$20240621$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-02066$AMNEAL$$22$YR$$F$Y$$$20240806$$MD$US$US
241771781$24177178$1$I$$20240705$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01533$AMNEAL$$$$$$Y$$$20240806$$CN$US$US
241771791$24177179$1$I$20240529$20240624$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-02041$AMNEAL$$63$YR$$F$Y$$$20240806$$MD$US$US
241771801$24177180$1$I$20240330$20240419$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01347$AMNEAL$$61$YR$$M$Y$$$20240806$$MD$US$US
241771811$24177181$1$I$20230825$20240529$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01976$AMNEAL$$46$YR$$F$Y$$$20240806$$MD$US$US
241771821$24177182$1$I$$20240417$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-00962$AMNEAL$$$$$M$Y$$$20240806$$CN$US$US
241771831$24177183$1$I$20240429$20240501$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01545$AMNEAL$$61$YR$$M$Y$$$20240806$$MD$US$US
241771841$24177184$1$I$$20240723$20240806$20240806$EXP$$US-BELUSA-2024BELLIT0088$BIOLOGICAL E.$Osei KM, Wuni G, Mehta N, Gupta SK.Comparative Analysis of Right Ventricular (RV) Apical Pacing versus Physiologic Left Bundle Branch Area Pacing (LBBAP) in Hypertrophic Cardiomyopathy With Left Ventricular Outflow Tract Obstruction (LVOTO): A Case Study.Circulation.06-NOV-2023;148 (1)$$$$$Y$$$20240806$$HP$US$US
241771851$24177185$1$I$20200311$20240418$20240806$20240806$EXP$$US-AMNEAL-2024-AMRX-01415$AMNEAL$$52$YR$$F$Y$$$20240806$$CN$US$US
241771861$24177186$1$I$$20240729$20240806$20240806$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005626$BIOCON$$$$$$Y$$$20240806$$CN$CA$CA
241771871$24177187$1$I$$20240805$20240806$20240806$PER$$NVSC2024US159774$NOVARTIS$$$$$$Y$$$20240806$$HP$US$US
241771881$24177188$1$I$20240724$20240729$20240806$20240806$EXP$$BR-TAKEDA-2024TUS077211$TAKEDA$$35$YR$$F$Y$$$20240806$$CN$BR$BR
241771891$24177189$1$I$$20240725$20240806$20240806$PER$$US-ROCHE-10000038363$ROCHE$$$$$$Y$$$20240806$$HP$US$US
241771911$24177191$1$I$$20240509$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02325$AMNEAL$$$$$M$Y$$$20240806$$HP$US$US
241771921$24177192$1$I$$20240729$20240806$20240806$EXP$$IN-ROCHE-10000042298$ROCHE$$35$YR$A$F$Y$$$20240806$$MD$IN$IN
241771931$24177193$1$I$$20240728$20240806$20240806$EXP$$FR-AMGEN-FRASP2024153264$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut. 2024;1-13$$$$$Y$$$20240806$$MD$FR$FR
241771941$24177194$1$I$20240710$20240723$20240806$20240806$PER$$US-ROCHE-10000035280$ROCHE$$64$YR$A$F$Y$44.9$KG$20240806$$CN$US$US
241771951$24177195$1$I$20240701$20240731$20240806$20240806$EXP$$US-ROCHE-10000046670$ROCHE$$$$$$Y$$$20240806$$PH$US$US
241771961$24177196$1$I$$20240730$20240806$20240806$EXP$$US-BIOGEN-2024BI01276278$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241771972$24177197$2$F$20240101$20240805$20240806$20240810$EXP$$US-ABBVIE-5864711$ABBVIE$$$$$F$Y$43$KG$20240810$$CN$US$US
241771981$24177198$1$I$$20240801$20240806$20240806$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122449$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$67$KG$20240806$$HP$CA$CA
241771992$24177199$2$F$$20240802$20240806$20240808$EXP$$NVSC2024US098082$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241772001$24177200$1$I$$20240711$20240806$20240806$PER$$US-009507513-2407USA006899$MERCK$$73$YR$$M$Y$$$20240806$$CN$US$US
241772012$24177201$2$F$$20240802$20240806$20240814$EXP$$CA-AUROBINDO-AUR-APL-2022-004729$AUROBINDO$$57$YR$$F$Y$95$KG$20240814$$PH$CA$CA
241772021$24177202$1$I$20230925$20240802$20240806$20240806$EXP$$BE-GILEAD-2024-0682741$GILEAD$$$$A$F$Y$108$KG$20240806$$MD$BE$BE
241772033$24177203$3$F$$20240828$20240806$20240909$EXP$$IT-AUROBINDO-AUR-APL-2024-034065$AUROBINDO$Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports.. Journal of pediatric hematology/oncology. 2024;0(0):1-4$13$YR$$M$Y$$$20240909$$MD$IT$IT
241772042$24177204$2$F$$20240729$20240806$20240808$EXP$$GB-TAKEDA-2024TUS077222$TAKEDA$$$$$M$Y$$$20240808$$MD$GB$GB
241772051$24177205$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038181$AUROBINDO$$66$YR$$F$Y$79$KG$20240806$$HP$CA$CA
241772061$24177206$1$I$$20211019$20240806$20240806$EXP$$US-AstraZeneca-2021A780352$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241772071$24177207$1$I$$20240729$20240806$20240806$EXP$$BR-AstraZeneca-2024A175805$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$BR$
241772081$24177208$1$I$20240708$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A175753$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241772091$24177209$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A172712$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241772101$24177210$1$I$20240321$20240729$20240806$20240806$PER$$US-AstraZeneca-2024A173124$ASTRAZENECA$$25456$DY$$M$Y$122.5$KG$20240806$$HP$US$
241772111$24177211$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002063$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240806$$CN$US$US
241772121$24177212$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001999$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240806$$CN$US$US
241772131$24177213$1$I$20240705$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001990$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240806$$CN$US$US
241772142$24177214$2$F$$20240801$20240806$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002098$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240809$$CN$US$US
241772151$24177215$1$I$20240731$20240802$20240806$20240806$PER$$US-BIOVITRUM-2024-US-010583$BIOVITRUM$$56$YR$$F$Y$$$20240806$$CN$US$US
241772162$24177216$2$F$20230323$20240924$20240806$20240930$PER$$US-BIOVITRUM-2024-US-010579$BIOVITRUM$$46$YR$$M$Y$$$20240930$$CN$US$US
241772171$24177217$1$I$$20240731$20240806$20240806$EXP$$CA-Bion-013585$BIONPHARMA$$7$YR$C$F$Y$$$20240806$$HP$CA$CA
241772181$24177218$1$I$20240101$20240805$20240806$20240806$EXP$$US-UCBSA-2024027665$UCB$$$$$M$Y$$$20240806$$CN$US$US
241772191$24177219$1$I$$20240731$20240806$20240806$EXP$$CN-Bion-013592$BIONPHARMA$$71$YR$E$F$Y$$$20240806$$HP$CN$CN
241772201$24177220$1$I$$20240729$20240806$20240806$EXP$$UA-ROCHE-10000042441$ROCHE$$57$YR$A$M$Y$$$20240806$$MD$UA$UA
241772211$24177221$1$I$20230601$20230908$20240806$20240806$PER$$US-APOTEX-2023AP010507$APOTEX$$$$$F$Y$$$20240806$$CN$US$US
241772221$24177222$1$I$$20231010$20240806$20240806$PER$$US-APOTEX-2023AP014219$APOTEX$$$$$$Y$$$20240806$$PH$US$US
241772231$24177223$1$I$$20231010$20240806$20240806$PER$$US-APOTEX-2023AP014146$APOTEX$$$$$$Y$$$20240806$$PH$US$US
241772251$24177225$1$I$20230101$20231213$20240806$20240806$PER$$US-APOTEX-2023AP016891$APOTEX$$$$$F$Y$$$20240806$$CN$US$US
241772261$24177226$1$I$$20231010$20240806$20240806$PER$$US-APOTEX-2023AP014222$APOTEX$$$$$$Y$$$20240806$$PH$US$US
241772271$24177227$1$I$20230701$20230811$20240806$20240806$PER$$US-APOTEX-2023AP010680$APOTEX$$$$$M$Y$$$20240806$$CN$US$US
241772281$24177228$1$I$$20231010$20240806$20240806$PER$$US-APOTEX-2023AP014220$APOTEX$$$$$$Y$$$20240806$$PH$US$US
241772291$24177229$1$I$$20231010$20240806$20240806$PER$$US-APOTEX-2023AP014221$APOTEX$$$$$$Y$$$20240806$$PH$US$US
241772301$24177230$1$I$$20240731$20240806$20240806$EXP$$US-Bion-013586$BIONPHARMA$$10$YR$C$F$Y$$$20240806$$HP$US$US
241772311$24177231$1$I$$20240803$20240806$20240806$EXP$$US-TAKEDA-2024TUS078188$TAKEDA$$$$$F$Y$$$20240806$$CN$US$US
241772321$24177232$1$I$$20240726$20240806$20240806$EXP$$US-Bion-013597$BIONPHARMA$$$$$F$Y$$$20240806$$CN$US$US
241772331$24177233$1$I$$20240730$20240806$20240806$PER$$US-ABBVIE-5863274$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241772341$24177234$1$I$20240726$20240726$20240806$20240806$EXP$$US-Bion-013609$BIONPHARMA$$84$YR$E$M$Y$$$20240806$$CN$US$US
241772351$24177235$1$I$$20240728$20240806$20240806$EXP$$FR-AMGEN-FRASP2024153287$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut. 2024;1-13$$$$$Y$$$20240806$$MD$FR$FR
241772361$24177236$1$I$20240730$20240730$20240806$20240806$EXP$$US-Bion-013619$BIONPHARMA$$69$YR$E$F$Y$64.4$KG$20240806$$CN$US$US
241772371$24177237$1$I$$20240731$20240806$20240806$EXP$$US-ABBVIE-5865129$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241772381$24177238$1$I$$20240801$20240806$20240806$PER$$US-JNJFOC-20240803882$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240806$$HP$US$US
241772401$24177240$1$I$$20240731$20240806$20240806$PER$$US-LEO Pharma-372493$LEO PHARM$$$$$M$Y$$$20240806$$CN$US$US
241772411$24177241$1$I$$20240731$20240806$20240806$EXP$$NVSC2024US158105$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
241772421$24177242$1$I$$20240729$20240806$20240806$PER$$US-ABBVIE-5860175$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241772432$24177243$2$F$$20240806$20240806$20240816$EXP$$GB-TEVA-VS-3227680$TEVA$$$$E$F$Y$$$20240816$$CN$GB$GB
241772442$24177244$2$F$$20240822$20240806$20240830$EXP$$CA-APOTEX-2024AP009003$APOTEX$$63$YR$$F$Y$$$20240830$$HP$CA$CA
241772451$24177245$1$I$$20240801$20240806$20240806$EXP$$US-ABBVIE-5864537$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241772461$24177246$1$I$$20240801$20240806$20240806$EXP$$BR-BIOGEN-2024BI01276791$BIOGEN$$$$$M$Y$$$20240806$$HP$BR$BR
241772471$24177247$1$I$20240101$20240801$20240806$20240806$EXP$FR-AFSSAPS-TS2024000836$FR-ROCHE-10000046851$ROCHE$$39$YR$A$F$Y$$$20240806$$MD$FR$FR
241772481$24177248$1$I$20240701$20240731$20240806$20240806$EXP$GB-MHRA-MED-202407311114544420-JCHBF$GB-RDY-SPO/GBR/24/0011337$DR REDDYS$$$$$M$Y$$$20240806$$MD$GB$GB
241772491$24177249$1$I$$20240729$20240806$20240806$EXP$$US-RDY-SPO/USA/24/0011225$DR REDDYS$$27$YR$A$F$Y$$$20240806$$CN$US$US
241772501$24177250$1$I$20240706$20240729$20240806$20240806$PER$$US-RDY-SPO/USA/24/0011304$DR REDDYS$$$$$F$Y$$$20240806$$HP$US$US
241772511$24177251$1$I$20191128$20240731$20240806$20240806$EXP$$IT-SANDOZ INC.-NVSC2019IT058338$SANDOZ$$64$YR$$F$Y$66$KG$20240806$$MD$IT$IT
241772521$24177252$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038729$AUROBINDO$$62$YR$$M$Y$$$20240806$$HP$CA$CA
241772531$24177253$1$I$$20240117$20240806$20240806$EXP$$ES-SANDOZ INC.-SDZ2024ES005528$SANDOZ$$$$$$Y$$$20240806$$MD$ES$ES
241772542$24177254$2$F$$20240821$20240806$20240829$EXP$$BE-BEH-2024176596$CSL BEHRING$$$$E$M$Y$$$20240829$$MD$BE$BE
241772551$24177255$1$I$20240101$20240722$20240806$20240806$EXP$$US-INSMED, INC.-2024-02302-US$INSMED$$$$$M$Y$$$20240806$$CN$US$US
241772562$24177256$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0682981$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241772574$24177257$4$F$20240726$20240917$20240806$20240923$PER$$US-AMGEN-USASP2024150943$AMGEN$$73$YR$E$F$Y$42.18$KG$20240923$$HP$US$US
241772581$24177258$1$I$20240731$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154632$AMGEN$$61$YR$A$M$Y$$$20240806$$CN$US$US
241772591$24177259$1$I$20240615$20240722$20240806$20240806$EXP$FR-AFSSAPS-NC2024000837$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110254$ZYDUS PHARM$$$$$$Y$$$20240806$$MD$FR$FR
241772601$24177260$1$I$$20240723$20240806$20240806$EXP$$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-109885$ZYDUS PHARM$Lizondo Lopez T, Font I Barcelo A, Garcia Gutierrez C, Blasco M, Grafia I, Bastida C, et al.. Clopidogrel-induced thrombotic microangiopathy: a case report.. European journal of hospital pharmacy : science and practice. 2024;0:1-4$$$$$Y$$$20240806$$PH$ES$ES
241772611$24177261$1$I$$20240730$20240806$20240806$EXP$$US-ROCHE-10000046167$ROCHE$$71$YR$E$F$Y$$$20240806$$CN$US$US
241772621$24177262$1$I$20231121$20240722$20240806$20240806$EXP$FR-AFSSAPS-AM2024000561$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110268$ZYDUS PHARM$$$$$$Y$$$20240806$$MD$FR$FR
241772631$24177263$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190492$Haleon PLC$$75$YR$$F$Y$$$20240806$$CN$US$US
241772642$24177264$2$F$$20240820$20240806$20240827$EXP$$JP-GSK-JP2024095159$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$JP$JP
241772651$24177265$1$I$20221101$20240729$20240806$20240806$EXP$$CA-CELLTRION INC.-2024CA018483$CELLTRION$Oryniak D, Brown M, Cholakis L, Elgazzar R.. Case Report: Development of medication-related osteonecrosis of the jaw in a patient on long-term infliximab therapy.. Frontiers in Oral Health. 2024$$$$$Y$$$20240806$$MD$CA$CA
241772661$24177266$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038648$AUROBINDO$$$$$M$Y$$$20240806$$HP$CA$CA
241772671$24177267$1$I$$20240730$20240806$20240806$30DAY$$US-GSK-US2024095421$GLAXOSMITHKLINE$$$$$M$Y$$$20240806$$CN$US$US
241772683$24177268$3$F$20240406$20240824$20240806$20240828$EXP$$CA-TAKEDA-2024TUS076511$TAKEDA$$41$YR$$M$Y$$$20240828$$CN$CA$CA
241772691$24177269$1$I$$20240724$20240806$20240806$EXP$GB-MHRA-MIDB-b0ac154e-0835-4945-b18d-d0ea9223a0c0$GB-JUBILANT PHARMA LTD-2024GB001085$JUBILANT$$83$YR$$F$Y$$$20240806$$PH$GB$GB
241772701$24177270$1$I$$20240731$20240806$20240806$EXP$$GB-TAKEDA-2024TUS077136$TAKEDA$$69$YR$$F$Y$$$20240806$$CN$GB$GB
241772711$24177271$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122947$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$70.31$KG$20240806$$CN$US$US
241772721$24177272$1$I$$20240730$20240806$20240806$PER$$US-ALXN-202407USA002087US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$CN$US$US
241772731$24177273$1$I$$20240729$20240806$20240806$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005625$BIOCON$$$$$$Y$$$20240806$$PH$CA$CA
241772741$24177274$1$I$$20240729$20240806$20240806$EXP$$US-AMGEN-USASP2024153898$AMGEN$Pavlovic M.; Gianos E.; Szema A. et al.. Pericardial and Pleural Effusions after Evolocumab in a Patient with Severe Familial Hypercholesterolemia. Journal of Clinical Lipidology. 2024;18 (4):e506-e507$70$YR$E$M$Y$$$20240806$$HP$US$US
241772751$24177275$1$I$$20240805$20240806$20240806$EXP$$US-TAKEDA-2023TUS091405$TAKEDA$$$$$M$Y$$$20240806$$CN$US$US
241772761$24177276$1$I$$20240118$20240806$20240806$EXP$$IE-SANDOZ INC.-SDZ2024IE005945$SANDOZ$$$$$$Y$$$20240806$$MD$IE$IE
241772771$24177277$1$I$$20230504$20240806$20240806$EXP$$US-AstraZeneca-2023A073481$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241772781$24177278$1$I$$20240729$20240806$20240806$EXP$$JP-AstraZeneca-2024A175068$ASTRAZENECA$$$$$$Y$$$20240806$$MD$JP$
241772792$24177279$2$F$$20230721$20240806$20240806$PER$$US-CHIESI-2023CHF03819$CHIESI$$$$$$Y$$$20240806$$MD$US$US
241772801$24177280$1$I$$20230926$20240806$20240806$PER$$US-CHIESI-2023CHF05089$CHIESI$$$$$$Y$$$20240806$$HP$US$US
241772821$24177282$1$I$20230929$20230930$20240806$20240806$PER$$US-CHIESI-2023CHF05127$CHIESI$$$$$F$Y$$$20240806$$PH$US$US
241772831$24177283$1$I$$20230807$20240806$20240806$PER$$US-CHIESI-2023CHF04130$CHIESI$$43$YR$$$Y$$$20240806$$PH$US$US
241772841$24177284$1$I$20230909$20231009$20240806$20240806$PER$$US-CHIESI-2023CHF04757$CHIESI$$$$$M$Y$$$20240806$$MD$US$US
241772851$24177285$1$I$$20231206$20240806$20240806$PER$$US-CHIESI-2023CHF06616$CHIESI$$$$$M$Y$$$20240806$$MD$US$US
241772861$24177286$1$I$20231201$20231201$20240806$20240806$PER$$US-CHIESI-2023CHF06564$CHIESI$$47$YR$$F$Y$$$20240806$$MD$US$US
241772871$24177287$1$I$20231221$20231221$20240806$20240806$PER$$US-CHIESI-2023CHF06983$CHIESI$$57$YR$$M$Y$$$20240806$$HP$US$US
241772881$24177288$1$I$$20230727$20240806$20240806$PER$$US-CHIESI-2023CHF03921$CHIESI$$$$$$Y$$$20240806$$HP$US$US
241772891$24177289$1$I$$20230725$20240806$20240806$PER$$US-CHIESI-2023CHF03867$CHIESI$$$$$$Y$$$20240806$$PH$US$US
241772903$24177290$3$F$20240728$20240905$20240806$20240910$PER$$US-JNJFOC-20240803830$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240910$$CN$US$US
241772911$24177291$1$I$$20240731$20240806$20240806$EXP$$AU-JAZZ PHARMACEUTICALS-2024-AU-011636$JAZZ$$$$$M$Y$$$20240806$$HP$AU$AU
241772921$24177292$1$I$$20240729$20240806$20240806$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005624$BIOCON$$$$$$Y$$$20240806$$MD$CA$CA
241772931$24177293$1$I$$20240802$20240806$20240806$PER$$US-ROCHE-10000048213$ROCHE$$$$$$Y$$$20240806$$CN$US$US
241772941$24177294$1$I$20211105$20240731$20240806$20240806$EXP$$CA-TAKEDA-2020TUS031999$TAKEDA$$75$YR$$M$Y$$$20240806$$CN$CA$CA
241772951$24177295$1$I$20240726$20240801$20240806$20240806$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043552$BOEHRINGER INGELHEIM$$82$YR$E$M$Y$50$KG$20240806$$HP$CN$CN
241772962$24177296$2$F$$20240820$20240806$20240820$PER$$US-JNJFOC-20240806797$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
241772971$24177297$1$I$20190717$20240731$20240806$20240806$EXP$$US-ROCHE-10000046182$ROCHE$$38$YR$A$F$Y$86.63$KG$20240806$$CN$US$US
241772982$24177298$2$F$$20240815$20240806$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-038740$AUROBINDO$unknown. unknown. unknown. unkn;unknown:unknown$$$$M$Y$$$20240828$$CN$CA$CA
241772991$24177299$1$I$$20240728$20240806$20240806$EXP$$CN-JNJFOC-20240782131$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$CN$CN
241773001$24177300$1$I$$20240801$20240806$20240806$PER$$US-JNJFOC-20240806194$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$HP$US$US
241773011$24177301$1$I$$20240802$20240806$20240806$PER$$US-JNJFOC-20240808450$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$US$US
241773021$24177302$1$I$20240802$20240802$20240806$20240806$PER$$US-JNJFOC-20240806632$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$US$US
241773032$24177303$2$F$$20240919$20240806$20240919$PER$$NVSC2024US158529$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
241773041$24177304$1$I$$20240802$20240806$20240806$PER$$NVSC2024US159027$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
241773051$24177305$1$I$$20240805$20240806$20240806$PER$$US-ROCHE-10000049540$ROCHE$$$$$$Y$$$20240806$$CN$US$US
241773061$24177306$1$I$20140101$20240729$20240806$20240806$PER$$US-JNJFOC-20240779376$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240806$$HP$US$US
241773071$24177307$1$I$20240401$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002060$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240806$$CN$US$US
241773082$24177308$2$F$$20240802$20240806$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408001505$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240808$$CN$US$US
241773092$24177309$2$F$$20240802$20240806$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002372$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240808$$CN$US$US
241773101$24177310$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001932$ELI LILLY AND CO$$68$YR$E$$Y$$$20240806$$HP$US$US
241773111$24177311$1$I$$20240726$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407017927$ELI LILLY AND CO$$63$YR$A$$Y$$$20240806$$LW$US$US
241773121$24177312$1$I$20240720$20240725$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407016866$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240806$$CN$US$US
241773131$24177313$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154469$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241773142$24177314$2$F$20240801$20240819$20240806$20240821$PER$$US-AMGEN-USASP2024154610$AMGEN$$66$YR$E$M$Y$$$20240821$$CN$US$US
241773151$24177315$1$I$$20240731$20240806$20240806$PER$$US-BIOGEN-2024BI01276425$BIOGEN$$$$$$Y$$$20240806$$CN$US$US
241773161$24177316$1$I$$20240731$20240806$20240806$PER$$US-BIOGEN-2024BI01276433$BIOGEN$$$$$M$Y$$$20240806$$CN$US$US
241773171$24177317$1$I$$20240802$20240806$20240806$EXP$$GB-AMGEN-GBRSP2024154249$AMGEN$$$$$M$Y$$$20240806$$HP$GB$GB
241773181$24177318$1$I$$20240728$20240806$20240806$EXP$$FR-AMGEN-FRASP2024153112$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages. Gut. 2024;1-13$$$$$Y$$$20240806$$HP$FR$FR
241773191$24177319$1$I$$20240730$20240806$20240806$EXP$$GB-TAKEDA-2021TUS077842$TAKEDA$$$$$F$Y$$$20240806$$HP$GB$GB
241773201$24177320$1$I$$20240730$20240806$20240806$EXP$$US-TAKEDA-2024TUS077277$TAKEDA$$$$$M$Y$$$20240806$$MD$US$US
241773212$24177321$2$F$20240620$20240829$20240806$20240905$EXP$FR-AFSSAPS-LL2024001456$FR-BIOCON BIOLOGICS LIMITED-BBL2024005617$BIOCON$$$$$$Y$$$20240905$$MD$FR$FR
241773221$24177322$1$I$20240718$20240725$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037545$AUROBINDO$$61$YR$$F$Y$97$KG$20240806$$CN$GB$GB
241773233$24177323$3$F$20240701$20240904$20240806$20240910$EXP$$CA-ABBVIE-5865904$ABBVIE$$67$YR$$F$Y$$$20240910$$CN$CA$CA
241773241$24177324$1$I$20230101$20240729$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121222$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240806$$CN$US$US
241773251$24177325$1$I$20240716$20240731$20240806$20240806$EXP$HR-HALMED-300086216$HR-TAKEDA-2024TUS076990$TAKEDA$$41$YR$$M$Y$$$20240806$$HP$HR$HR
241773261$24177326$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123630$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$70.76$KG$20240806$$HP$US$US
241773274$24177327$4$F$20240901$20240906$20240806$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123321$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240918$$CN$US$US
241773282$24177328$2$F$$20240919$20240806$20240919$PER$$NVSC2024US158483$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
241773291$24177329$1$I$$20240117$20240806$20240806$PER$$US-CHIESI-2024CHF00242$CHIESI$$$$$M$Y$$$20240806$$PH$US$US
241773301$24177330$1$I$$20240117$20240806$20240806$PER$$US-CHIESI-2024CHF00243$CHIESI$$$$$$Y$$$20240806$$PH$US$US
241773311$24177331$1$I$$20240105$20240806$20240806$PER$$US-CHIESI-2024CHF00066$CHIESI$$$$$M$Y$$$20240806$$PH$US$US
241773321$24177332$1$I$$20240801$20240806$20240806$PER$$US-LEO Pharma-372489$LEO PHARM$$14$YR$$F$Y$$$20240806$$HP$US$US
241773331$24177333$1$I$20230706$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037411$AUROBINDO$$51$YR$$M$Y$77.7$KG$20240806$$MD$FR$FR
241773341$24177334$1$I$20231228$20240802$20240806$20240806$EXP$$US-ABBVIE-5865942$ABBVIE$$60$YR$$M$Y$$$20240806$$CN$US$US
241773352$24177335$2$F$20240701$20240821$20240806$20240828$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001557$BLUEPRINT MEDICINES$$48$YR$A$M$Y$$$20240828$$PH$US$US
241773361$24177336$1$I$20240427$20240723$20240806$20240806$EXP$GB-MHRA-MED-202407231656238410-SWVHN$GB-UCBSA-2024037201$UCB$$70$YR$$M$Y$$$20240806$$HP$GB$GB
241773381$24177338$1$I$$20240724$20240806$20240806$EXP$$CA-TEVA-VS-3226557$TEVA$$40$YR$$F$Y$$$20240806$$HP$CA$CA
241773391$24177339$1$I$$20240801$20240806$20240806$EXP$$US-ABBVIE-5864669$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241773402$24177340$2$F$20240622$20240827$20240806$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-037707$AUROBINDO$$5$YR$$F$Y$19$KG$20240906$$MD$FR$FR
241773411$24177341$1$I$$20240801$20240806$20240806$EXP$$US-JNJFOC-20240803440$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$HP$US$US
241773432$24177343$2$F$20240614$20240905$20240806$20240911$PER$$US-ROCHE-10000041450$ROCHE$$42$YR$A$F$Y$68.04$KG$20240911$$CN$US$US
241773441$24177344$1$I$$20240805$20240806$20240806$EXP$$US-TAKEDA-2024TUS078424$TAKEDA$$$$$F$Y$$$20240806$$CN$US$US
241773451$24177345$1$I$20240619$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037804$AUROBINDO$$70$YR$$M$Y$$$20240806$$PH$FR$FR
241773462$24177346$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0682982$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241773471$24177347$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154371$AMGEN$$$$$F$Y$$$20240806$$MD$US$US
241773481$24177348$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASL2024154643$AMGEN$$$$$$Y$$$20240806$$MD$US$US
241773491$24177349$1$I$$20240801$20240806$20240806$PER$$US-LEO Pharma-372492$LEO PHARM$$60$YR$$F$Y$$$20240806$$PH$US$US
241773501$24177350$1$I$$20240802$20240806$20240806$PER$$US-TAKEDA-2024TUS078241$TAKEDA$$$$$M$Y$100$KG$20240806$$MD$US$US
241773511$24177351$1$I$$20240802$20240806$20240806$PER$$US-TAKEDA-2024TUS078224$TAKEDA$$39$YR$$F$Y$$$20240806$$CN$US$US
241773521$24177352$1$I$20240731$20240731$20240806$20240806$EXP$GB-MHRA-TPP36479158C6663697YC1722424768133$GB-RDY-SPO/GBR/24/0011334$DR REDDYS$$81$YR$E$M$Y$91$KG$20240806$$PH$GB$GB
241773531$24177353$1$I$20240710$20240802$20240806$20240806$EXP$FR-AFSSAPS-BX2024001479$FR-GILEAD-2024-0682866$GILEAD$$60$YR$A$F$Y$$$20240806$$PH$FR$FR
241773541$24177354$1$I$$20240802$20240806$20240806$EXP$$JP-ABBVIE-5865210$ABBVIE$$$$$F$Y$$$20240806$$CN$JP$JP
241773561$24177356$1$I$$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123618$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240806$$CN$US$US
241773571$24177357$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123167$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240806$$HP$US$US
241773581$24177358$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123209$BRISTOL MYERS SQUIBB$$27$YR$A$M$Y$$$20240806$$HP$US$US
241773591$24177359$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123169$BRISTOL MYERS SQUIBB$$1$YR$I$M$Y$$$20240806$$HP$US$US
241773602$24177360$2$F$$20240902$20240806$20240910$EXP$$JP-TEVA-VS-3227374$TEVA$Shinohara RC, Oshima T, Otsubo T, Ariga K, Ono T, Muneoka K, et al. Successful utilization of clozapine for a patient with treatment-resistant schizophrenia after recurrent violent behavior. Neuropsychopharmacol-Rep 2024;; Shinohara RC, Oshima T, Otsubo T, Ariga K, Ono T, Muneoka K, et al. Successful utilization of clozapine for a patient with treatment-resistant schizophrenia after recurrent violent behavior. Neuropsychopharmacol-Rep 2024;.$19$YR$$M$Y$$$20240910$$HP$JP$JP
241773621$24177362$1$I$$20240801$20240806$20240806$EXP$$NVSC2024US149857$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
241773631$24177363$1$I$$20240805$20240806$20240806$PER$$NVSC2024US159700$NOVARTIS$$$$$F$Y$$$20240806$$HP$US$US
241773641$24177364$1$I$$20240731$20240806$20240806$EXP$$DE-TAKEDA-2024TUS077627$TAKEDA$$39$YR$$F$Y$$$20240806$$CN$DE$DE
241773651$24177365$1$I$$20240801$20240806$20240806$PER$$US-TAKEDA-2024TUS077758$TAKEDA$$$$$$Y$$$20240806$$CN$US$US
241773662$24177366$2$F$20240701$20240812$20240806$20240822$PER$$US-ABBVIE-5858722$ABBVIE$$71$YR$$F$Y$86.183$KG$20240822$$CN$US$US
241773671$24177367$1$I$$20230424$20240806$20240806$EXP$$US-AstraZeneca-2023A095795$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241773681$24177368$1$I$20231201$20240729$20240806$20240806$EXP$$GB-AstraZeneca-2024A172154$ASTRAZENECA$$64$YR$$M$Y$119$KG$20240806$$MD$GB$
241773691$24177369$1$I$20221201$20230927$20240806$20240806$EXP$$US-AstraZeneca-2023A186729$ASTRAZENECA$$878$MON$$F$Y$$$20240806$$CN$US$
241773701$24177370$1$I$$20240725$20240806$20240806$EXP$$US-MALLINCKRODT-MNK202400033$MALLINCKRODT$$61$YR$A$F$Y$$$20240806$$CN$US$US
241773711$24177371$1$I$$20240712$20240806$20240806$EXP$$NZ-ROCHE-10000032674$ROCHE$$$$A$F$Y$71.2$KG$20240806$$MD$NZ$NZ
241773722$24177372$2$F$$20240823$20240806$20240903$EXP$$US-MALLINCKRODT-MNK202402284$MALLINCKRODT$$$$$M$Y$$$20240903$$CN$US$US
241773731$24177373$1$I$20240601$20240723$20240806$20240806$EXP$$US-MALLINCKRODT-MNK202403795$MALLINCKRODT$$57$YR$$F$Y$$$20240806$$HP$US$US
241773741$24177374$1$I$$20240724$20240806$20240806$EXP$$US-MALLINCKRODT-MNK202404780$MALLINCKRODT$$$$$M$Y$$$20240806$$CN$US$US
241773761$24177376$1$I$20240101$20240723$20240806$20240806$EXP$$US-MALLINCKRODT-MNK202404754$MALLINCKRODT$$72$YR$E$F$Y$$$20240806$$CN$US$US
241773771$24177377$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038468$AUROBINDO$$70$YR$$F$Y$$$20240806$$HP$CA$CA
241773782$24177378$2$F$20240101$20240805$20240806$20240806$PER$$US-AMGEN-USASP2024154323$AMGEN$$65$YR$E$F$Y$$$20240806$$CN$US$US
241773791$24177379$1$I$$20240728$20240806$20240806$EXP$$FR-AMGEN-FRASP2024153196$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages. Gut. 2024;1-13$$$$$Y$$$20240806$$HP$FR$FR
241773801$24177380$1$I$$20240731$20240806$20240806$EXP$$US-BIOGEN-2024BI01276482$BIOGEN$$$$$M$Y$$$20240806$$HP$US$US
241773812$24177381$2$F$20240601$20240816$20240806$20240826$30DAY$$US-GSK-US2024095325$GLAXOSMITHKLINE$$52$YR$$F$Y$64.41$KG$20240826$$CN$US$US
241773821$24177382$1$I$20240101$20240729$20240806$20240806$PER$$US-ABBVIE-5859223$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241773831$24177383$1$I$20240704$20240723$20240806$20240806$EXP$$JP-ROCHE-10000048571$ROCHE$$7$DEC$E$F$Y$$$20240806$$MD$JP$JP
241773841$24177384$1$I$20240725$20240726$20240806$20240806$EXP$$PK-ROCHE-10000039874$ROCHE$$43$YR$A$M$Y$$$20240806$$CN$PK$PK
241773851$24177385$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008946$APOTEX$$33$YR$$F$Y$$$20240806$$CN$CA$CA
241773861$24177386$1$I$20240722$20240722$20240806$20240806$PER$$US-GLANDPHARMA-US-2024GLNSPO00548$GLAND PHARMA$$30$YR$A$F$Y$$$20240806$$HP$US$US
241773871$24177387$1$I$$20240723$20240806$20240806$PER$$US-TEVA-VS-3226220$TEVA$$$$$F$Y$$$20240806$$HP$US$US
241773881$24177388$1$I$$20240801$20240806$20240806$EXP$$CA-HALEON-2190279$Haleon PLC$$43$YR$$F$Y$68$KG$20240806$$HP$CA$CA
241773891$24177389$1$I$20230701$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037711$AUROBINDO$$57$YR$$M$Y$68$KG$20240806$$MD$FR$FR
241773901$24177390$1$I$20240701$20240730$20240806$20240806$EXP$DE-CADRBFARM-2024329606$DE-AMAROX PHARMA-AMR2024DE02520$HETERO$$83$YR$$M$Y$60$KG$20240806$$MD$DE$DE
241773912$24177391$2$F$$20240806$20240806$20240817$EXP$$PT-AUROBINDO-AUR-APL-2024-037240$AUROBINDO$Governs J, Marquis B, Avelar P, Ribeiro M, Sim?es L, Borges S, et al.. PO-0116 - (4016) - INTOXICA??O MEDICAMENTOSAPOR QUETIAPINE - AL?M DA ANAMNESE (DRUG POISONING BY QUETIAPINE -  BEYOND HISTORY). Urg?ncia, cuidados interm?dios e doente cr?tico | Caso cl?nico (Emergency, inter. 2024;486$61$YR$$F$Y$$$20240817$$MD$PT$PT
241773921$24177392$1$I$$20240724$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-038223$AUROBINDO$Sharayah S, Agner SC, Shinawi M, Rudnick D, Mar S.. Neurological Improvement in a Patient with Cerebroretinal Microangiopathy with Calcifications and Cysts-1 Treated with Bevacizumab.. Ann-Child-Neurol. 2023;31(1):52-55$$$T$M$Y$$$20240806$$MD$FR$US
241773931$24177393$1$I$$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037973$AUROBINDO$$$$C$M$Y$$$20240806$$HP$FR$FR
241773941$24177394$1$I$$20240730$20240806$20240806$EXP$$GB-HALEON-2190247$Haleon PLC$Abdolrasouli A, Borman AM, Johnson EM, Hay RJ, Arias M. Terbinafine-resistant Trichophyton indotineae causing extensive dermatophytosis in a returning traveller, London, UK. Clin Exp Dermatol. 2024;49(6):635-637.; Abdolrasouli A, Borman AM, Johnson EM, Hay RJ, Arias M. Terbinafine-resistant Trichophyton indotineae causing?extensive dermatophytosis in a returning traveller, London, UK. Clin Exp Dermatol. 2024;49(6):635-7$26$YR$$M$Y$$$20240806$$HP$GB$GB
241773953$24177395$3$F$20220601$20240829$20240806$20240905$EXP$$US-009507513-2407USA015871$MERCK$$$$$$Y$$$20240905$$CN$US$US
241773961$24177396$1$I$$20231225$20240806$20240806$EXP$$IN-SANDOZ INC.-SDZ2023IN075511$SANDOZ$Lekshmipriya K, Pradeesh A, Vasudevan B, Dash M, Sood A, Gera V. An observational study of severe cutaneous adverse reactions at a tertiary care teaching hospital. MEDICAL JOURNAL ARMED FORCES INDIA. 2023;79(1):S209-S216$$$$$Y$$$20240806$$HP$IN$IN
241773971$24177397$1$I$$20240731$20240806$20240806$PER$$US-ALXN-202407USA002261US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$HP$US$US
241773981$24177398$1$I$20200713$20210716$20240806$20240806$EXP$$CA-CELLTRION INC.-2020CA035365$CELLTRION$$$$$$Y$$$20240806$$CN$CA$CA
241773991$24177399$1$I$$20240731$20240806$20240806$EXP$$AR-JNJFOC-20240802507$JOHNSON AND JOHNSON$$72$YR$E$F$Y$69$KG$20240806$$CN$AR$AR
241774004$24177400$4$F$20240730$20240916$20240806$20240924$EXP$$US-BIOGEN-2024BI01276691$BIOGEN$$77$YR$$M$Y$$$20240924$$MD$US$US
241774011$24177401$1$I$20150826$20240730$20240806$20240806$EXP$$BR-BIOGEN-2015BI00160741$BIOGEN$$36$YR$$F$Y$78$KG$20240806$$HP$BR$BR
241774023$24177402$3$F$20240101$20240831$20240806$20240905$EXP$$US-ABBVIE-5865229$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
241774031$24177403$1$I$20240724$20240725$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037655$AUROBINDO$$10$YR$$M$Y$50$KG$20240806$$HP$GB$GB
241774041$24177404$1$I$$20240729$20240806$20240806$EXP$PL-URPL-1-3861-2020$PL-TEVA-VS-3227492$TEVA$$23$YR$$M$Y$100$KG$20240806$$MD$PL$PL
241774051$24177405$1$I$20210930$20240725$20240806$20240806$EXP$$US-ROCHE-10000040751$ROCHE$$$$A$F$Y$$$20240806$$HP$US$US
241774061$24177406$1$I$$20240730$20240806$20240806$EXP$$JP-GSK-JP2024095163$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$MD$JP$JP
241774071$24177407$1$I$20240801$20240801$20240806$20240806$EXP$$US-ABBVIE-5865255$ABBVIE$$43$YR$$F$Y$$$20240806$$CN$US$US
241774081$24177408$1$I$20240628$20240731$20240806$20240806$EXP$$CO-TAKEDA-2024TUS073312$TAKEDA$$21$YR$$F$Y$65$KG$20240806$$CN$CO$CO
241774091$24177409$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153603$AMGEN$$$$$$Y$$$20240806$$MD$US$US
241774102$24177410$2$F$$20240814$20240806$20240821$PER$$US-AMGEN-USASP2024153621$AMGEN$$$$$M$Y$$$20240821$$CN$US$US
241774111$24177411$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123192$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240806$$HP$US$US
241774121$24177412$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123545$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240806$$HP$US$US
241774131$24177413$1$I$$20240717$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115518$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240806$$MD$US$US
241774141$24177414$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123867$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240806$$CN$US$US
241774152$24177415$2$F$20240726$20240812$20240806$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121891$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240823$$CN$US$US
241774161$24177416$1$I$20240710$20240801$20240806$20240806$EXP$$CN-ABBVIE-5864886$ABBVIE$$50$YR$$F$Y$$$20240806$$MD$CN$CN
241774171$24177417$1$I$$20240728$20240806$20240806$EXP$$FR-AMGEN-FRASP2024153273$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages. Gut. 2024;1-13$$$$$Y$$$20240806$$HP$FR$FR
241774182$24177418$2$F$$20240724$20240806$20240808$EXP$$DE-ADVANZ PHARMA-202406005190$ADVANZ PHARMA$$$$$$Y$$$20240808$$CN$DE$DE
241774191$24177419$1$I$20240701$20240801$20240806$20240806$EXP$$US-ABBVIE-5865317$ABBVIE$$45$YR$$F$Y$$$20240806$$CN$US$US
241774201$24177420$1$I$20161217$20240731$20240806$20240806$EXP$FR-AFSSAPS-ST2024001216$FR-JNJFOC-20240812392$JOHNSON AND JOHNSON$$1$DY$N$M$Y$1.975$KG$20240806$$MD$FR$FR
241774212$24177421$2$F$20230101$20240809$20240806$20240813$PER$$US-JNJFOC-20240805679$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240813$$CN$US$US
241774221$24177422$1$I$$20240801$20240806$20240806$PER$$US-JNJFOC-20240806170$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$HP$US$US
241774241$24177424$1$I$$20240726$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407017937$ELI LILLY AND CO$$65$YR$E$$Y$$$20240806$$LW$US$US
241774251$24177425$1$I$20240722$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408003007$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240806$$CN$US$US
241774261$24177426$1$I$$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002937$ELI LILLY AND CO$$$$$F$Y$$$20240806$$CN$US$US
241774271$24177427$1$I$20240720$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001789$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240806$$CN$US$US
241774281$24177428$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001543$ELI LILLY AND CO$$$$$$Y$$$20240806$$PH$US$US
241774292$24177429$2$F$$20240806$20240806$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002867$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240809$$CN$US$US
241774301$24177430$1$I$20240727$20240729$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407018788$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240806$$CN$US$US
241774311$24177431$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001978$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240806$$CN$US$US
241774321$24177432$1$I$20231201$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000047$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240806$$CN$US$US
241774332$24177433$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0682983$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241774341$24177434$1$I$$20240728$20240806$20240806$EXP$$FR-AMGEN-FRASP2024153325$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut. 2024;1-13$$$$$Y$$$20240806$$MD$FR$FR
241774351$24177435$1$I$$20240729$20240806$20240806$PER$$US-ABBVIE-5859703$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241774361$24177436$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038663$AUROBINDO$$3$DEC$$$Y$$$20240806$$HP$CA$CA
241774371$24177437$1$I$$20240207$20240806$20240806$PER$$US-STRIDES ARCOLAB LIMITED-2024SP001473$STRIDES$$$$$F$Y$58.957$KG$20240806$$CN$US$US
241774381$24177438$1$I$$20240725$20240806$20240806$EXP$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-01443$ULTRAGENYX PHARMACEUTICAL$$$$$M$Y$$$20240806$$CN$US$US
241774391$24177439$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008999$APOTEX$$61$YR$$F$Y$$$20240806$$CN$CA$CA
241774411$24177441$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038653$AUROBINDO$$$$$M$Y$$$20240806$$HP$CA$CA
241774421$24177442$1$I$$20240801$20240806$20240806$EXP$$US-ABBVIE-5864391$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241774431$24177443$1$I$20240730$20240731$20240806$20240806$EXP$$KR-EMD Serono-2024041822$EMD SERONO INC$$12$YR$T$M$Y$$$20240806$$CN$KR$KR
241774441$24177444$1$I$20240715$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037718$AUROBINDO$$21$YR$$F$Y$96$KG$20240806$$HP$FR$FR
241774451$24177445$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A173938$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241774461$24177446$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A173038$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241774471$24177447$1$I$20190101$20240729$20240806$20240806$EXP$$ZA-AstraZeneca-2024A172440$ASTRAZENECA$$25932$DY$$F$Y$$$20240806$$CN$ZA$
241774481$24177448$1$I$$20240725$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037660$AUROBINDO$$87$YR$$$Y$$$20240806$$PH$GB$GB
241774491$24177449$1$I$$20231006$20240806$20240806$EXP$$US-AstraZeneca-2023A228806$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241774501$24177450$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A176840$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241774511$24177451$1$I$20240707$20240801$20240806$20240806$EXP$$ZA-AstraZeneca-2024A175668$ASTRAZENECA$$21184$DY$$M$Y$$$20240806$$CN$ZA$
241774521$24177452$1$I$$20231016$20240806$20240806$EXP$$IT-AstraZeneca-2023A219415$ASTRAZENECA$$$$$$Y$$$20240806$$MD$IT$
241774531$24177453$1$I$20240727$20240730$20240806$20240806$EXP$GB-MHRA-MED-202407302037241980-FZTHB$GB-TEVA-VS-3228544$TEVA$$15$YR$$F$Y$$$20240806$$CN$GB$GB
241774541$24177454$1$I$20210101$20240722$20240806$20240806$PER$$US-JNJFOC-20240763795$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$CN$US$US
241774551$24177455$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038640$AUROBINDO$$$$$F$Y$$$20240806$$HP$CA$CA
241774561$24177456$1$I$20240709$20240801$20240806$20240806$EXP$$IN-ROCHE-10000048851$ROCHE$$69$YR$E$M$Y$$$20240806$$CN$IN$IN
241774571$24177457$1$I$$20240730$20240806$20240806$PER$$US-ALXN-202407USA002129US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$CN$US$US
241774581$24177458$1$I$20230801$20240801$20240806$20240806$EXP$$PR-ABBVIE-5865623$ABBVIE$$47$YR$$F$Y$79$KG$20240806$$CN$PR$PR
241774591$24177459$1$I$$20240803$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123323$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$55.34$KG$20240806$$CN$US$US
241774611$24177461$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2023-030153$AUROBINDO$Youykheang M, Al Hallaq Z, Menelas K, Biskin RS, Dagenais-Beaule V. Combination of LongActing Injectable Antipsychotics in the Treatment of Psychiatric Disorders-A Systematic Review of the Literature and Case Series. J-Clin-Psychopharmacol. 2023;43(1):20-27$55$YR$$F$Y$$$20240806$$PH$CA$CA
241774621$24177462$1$I$20240310$20240731$20240806$20240806$EXP$FR-AFSSAPS-AN2024000995$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-122890$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$50$KG$20240806$$MD$FR$FR
241774631$24177463$1$I$$20240801$20240806$20240806$PER$$US-LEO Pharma-372495$LEO PHARM$$91$YR$$F$Y$$$20240806$$HP$US$US
241774641$24177464$1$I$20240101$20240729$20240806$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000670$DECIPHERA PHARMACEUTICALS$$63$YR$A$M$Y$88$KG$20240806$$CN$US$US
241774651$24177465$1$I$20240501$20240801$20240806$20240806$PER$$US-BEH-2024176771$CSL BEHRING$$53$YR$A$F$Y$$$20240806$$CN$US$US
241774661$24177466$1$I$20230918$20240725$20240806$20240806$EXP$DE-SEATTLE GENETICS-2024SGN02213$DE-ROCHE-10000047118$ROCHE$$61$YR$A$F$Y$89$KG$20240806$$MD$DE$DE
241774671$24177467$1$I$$20240728$20240806$20240806$EXP$$FR-AMGEN-FRASP2024153306$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages. Gut. 2024;1-13$$$$$Y$$$20240806$$HP$FR$FR
241774681$24177468$1$I$20240101$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154776$AMGEN$$60$YR$A$F$Y$$$20240806$$CN$US$US
241774691$24177469$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153463$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241774701$24177470$1$I$20240803$20240805$20240806$20240806$PER$$US-AMGEN-USASP2024155345$AMGEN$$$$$M$Y$$$20240806$$CN$US$US
241774711$24177471$1$I$$20231108$20240806$20240806$EXP$$IL-SANDOZ INC.-SDZ2023IL051072$SANDOZ$Zornitzki L, Anuk L, Frydman S, Morag-Koren N, Zahler D, Freund O et al. Rate and predictors of blood culture positivity after antibiotic administration: a prospective single-center study. INFECTION. 2023$$$$$Y$$$20240806$$HP$IL$IL
241774721$24177472$1$I$$20240729$20240806$20240806$EXP$$JP-TEVA-VS-3227377$TEVA$Tanaka H, Sakakibara M, Hiratsuka M, Sugiura Y, Hiruta N. [Improved QOL in a Case of Breast Cancer with Meningeal Carcinomatosis Treated with Radiation Therapy and Intrathecal Chemotherapy]. [Japanese]. Gan-To-Kagaku-Ryoho 2022; 49 (13): 1938-1940.$6$DEC$$F$Y$$$20240806$$HP$JP$JP
241774731$24177473$1$I$20190101$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037730$AUROBINDO$$51$YR$$M$Y$98$KG$20240806$$PH$FR$FR
241774742$24177474$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0682965$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241774751$24177475$1$I$20240701$20240716$20240806$20240806$PER$$US-JNJFOC-20240748287$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$CN$US$US
241774763$24177476$3$F$$20240814$20240806$20240826$EXP$$US-ROCHE-10000031680$ROCHE$$79$YR$E$F$Y$$$20240826$$CN$US$US
241774771$24177477$1$I$$20240805$20240806$20240806$PER$$US-JNJFOC-20240810123$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$HP$US$US
241774791$24177479$1$I$20240101$20240726$20240806$20240806$EXP$$GB-JNJFOC-20240778918$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$GB$GB
241774801$24177480$1$I$$20240724$20240806$20240806$PER$$US-JNJFOC-20240775945$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241774811$24177481$1$I$$20240724$20240806$20240806$EXP$$US-ALVOGEN-2024095188$ALVOGEN$Wilson R, Ko C, Kashyap R. COVID-19 in the Setting of HIV and Severe Hemophilia A: A Case Report. HCA Healthcare Journal of Medicine. 2024;5:2:145-150. doi:https://doi.org/10.36518/2689-0216.1615$48$YR$$M$Y$$$20240806$$MD$US$US
241774823$24177482$3$F$20240701$20240807$20240806$20240820$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00805$CATALYST PHARMA$$41$YR$$F$Y$$$20240820$$CN$US$US
241774832$24177483$2$F$$20240815$20240806$20240820$PER$$US-LEO Pharma-372494$LEO PHARM$$75$YR$$M$Y$$$20240820$$CN$US$US
241774841$24177484$1$I$20240424$20240731$20240806$20240806$EXP$$FR-BIOGEN-2024BI01276698$BIOGEN$$27$YR$$M$Y$75$KG$20240806$$MD$FR$FR
241774851$24177485$1$I$$20240730$20240806$20240806$PER$$US-ABBVIE-5861358$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241774861$24177486$1$I$$20240729$20240806$20240806$EXP$$IT-ROCHE-10000042299$ROCHE$$14$YR$T$F$Y$$$20240806$$PH$IT$IT
241774871$24177487$1$I$$20240723$20240806$20240806$EXP$$US-UCBSA-2024037314$UCB$$$$$F$Y$$$20240806$$HP$US$US
241774882$24177488$2$F$20240724$20240820$20240806$20240913$30DAY$$NL-UCBSA-2024038786$UCB$$61$YR$$M$Y$$$20240913$$PH$NL$NL
241774891$24177489$1$I$20240101$20240730$20240806$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000676$DECIPHERA PHARMACEUTICALS$$50$YR$A$M$Y$$$20240806$$HP$US$US
241774903$24177490$3$F$$20240816$20240806$20240828$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024093535$VIIV$$$$$M$Y$$$20240828$$HP$US$US
241774911$24177491$1$I$$20240726$20240806$20240806$EXP$$US-ALVOGEN-2024095221$ALVOGEN$Rezvani A, Shah S. Treatment of primary cardiac diffuse large B-cell lymphoma involving  the coronary sinus with R-EPOCH: a case report and literature review. Annals of Hematology. 2024;103:2557?2560. doi:https://doi.org/10.1007/s00277-024-05793-x$75$YR$$M$Y$$$20240806$$HP$US$US
241774921$24177492$1$I$$20240730$20240806$20240806$EXP$$CA-GSK-CA2024095266$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$PH$CA$CA
241774932$24177493$2$F$20230601$20240816$20240806$20240823$EXP$$CA-GSK-CA2023076080$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$CA$CA
241774942$24177494$2$F$$20240821$20240806$20240827$EXP$$JP-AMGEN-JPNSP2024152070$AMGEN$$$$E$F$Y$$$20240827$$MD$JP$JP
241774951$24177495$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190510$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241774961$24177496$1$I$20240101$20240729$20240806$20240806$EXP$$JP-GENMAB-2024-02743$GENMAB$$87$YR$$M$Y$$$20240806$$MD$JP$JP
241774971$24177497$1$I$$20240729$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120566$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$96.16$KG$20240806$$PH$US$US
241774981$24177498$1$I$20240601$20240725$20240806$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000667$DECIPHERA PHARMACEUTICALS$$56$YR$A$M$Y$$$20240806$$CN$US$US
241774991$24177499$1$I$$20240729$20240806$20240806$EXP$$JP-ROCHE-10000047985$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$71$YR$E$M$Y$$$20240806$$HP$JP$JP
241775001$24177500$1$I$$20240726$20240806$20240806$PER$$US-FARMAPROD-202407-2762$DOMPE FARMACEUTICI$$$$A$M$Y$66.22$KG$20240806$$CN$US$US
241775012$24177501$2$F$20240724$20240808$20240806$20240809$PER$$US-JNJFOC-20240784797$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240809$$MD$US$US
241775031$24177503$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153765$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241775042$24177504$2$F$20240101$20240805$20240806$20240819$EXP$$CA-AMGEN-CANNI2024155435$AMGEN$$70$YR$E$M$Y$$$20240818$$CN$CA$CA
241775051$24177505$1$I$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0682984$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241775061$24177506$1$I$$20240729$20240806$20240806$EXP$IT-ROCHE-RCA4859636$IT-ROCHE-RCA4859636$ROCHE$Fabozzi F, Palumbo G, Di Pastena M, Zangari P, Bernardi S. Prolonged neutropenia in patients with lymphoma treated with antiretroviral therapy: Raltegravir too? A single-case report. DOI: 10.1002/pbc.30086. Pediatric Blood and Cancer. 2023-Apr-01;70 (4):1-2. doi:10.1002/pbc.30086.$6$YR$C$F$Y$$$20240806$$HP$IT$IT
241775071$24177507$1$I$$20240728$20240806$20240806$EXP$$FR-AMGEN-FRASP2024153309$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages. Gut. 2024;1-13$$$$$Y$$$20240806$$HP$FR$FR
241775091$24177509$1$I$$20240729$20240806$20240806$EXP$$JP-ROCHE-10000047987$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$76$YR$E$M$Y$$$20240806$$HP$JP$JP
241775101$24177510$1$I$$20240729$20240806$20240806$EXP$$VN-ROCHE-10000047722$ROCHE$Hang V, Hao H, Tien D. Effectiveness of carboplatin/paclitaxel regimen with or without bevacizumab in the treatment of advanced stage ovarian epithelial cancer. Vietnam Medical Journal. 2024-Mar;536:$$$$$Y$$$20240806$$HP$VN$VN
241775111$24177511$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121823$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240806$$HP$US$US
241775121$24177512$1$I$$20240731$20240806$20240806$PER$$US-LEO Pharma-372505$LEO PHARM$$14$YR$$M$Y$$$20240806$$PH$US$US
241775131$24177513$1$I$20240620$20240725$20240806$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000658$DECIPHERA PHARMACEUTICALS$$72$YR$E$M$Y$$$20240806$$HP$US$US
241775141$24177514$1$I$$20210812$20240806$20240806$EXP$$GB-AstraZeneca-2021A679654$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$GB$
241775151$24177515$1$I$20240709$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A172202$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241775161$24177516$1$I$$20231023$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA048503$SANDOZ$Bahlis NJ, Samaras C, Reece D, Sebag M, Matous J, Berdeja J, et.al. Pomalidomide, Daratumumab, and Dexamethasone After Lenalidomide Treatment in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): Final Overall Survival (OS) Analysis of the Phase II MM-014 Study. Clinical Lymphoma, Myeloma + Leukemia. 2023;23(1):S494$$$$$Y$$$20240806$$MD$CA$CA
241775171$24177517$1$I$$20240729$20240806$20240806$EXP$$IT-ROCHE-RCA5211109$ROCHE$Cuniolo L, Gipponi M, Murelli F, Depaoli F, Cornacchia C, Franchelli S, et al. Multidisciplinary and Tailored Treatment of Locally Advanced Breast Cancer in Progression during Neoadjuvant Chemotherapy: Case Report. Current Oncology. 2024-May;31 (5):2856-6. doi:10.3390/curroncol31050217.$55$YR$A$F$Y$$$20240806$$HP$IT$IT
241775181$24177518$1$I$$20220114$20240806$20240806$EXP$$US-AstraZeneca-2022A030666$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241775191$24177519$1$I$$20220104$20240806$20240806$EXP$$CA-AstraZeneca-2022A009585$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$CA$
241775201$24177520$1$I$$20220204$20240806$20240806$EXP$$US-AstraZeneca-2021A908361$ASTRAZENECA$$79$YR$$M$Y$$$20240806$$CN$US$
241775211$24177521$1$I$$20220414$20240806$20240806$EXP$$US-AstraZeneca-2022A152057$ASTRAZENECA$$81$YR$$F$Y$$$20240806$$CN$US$
241775221$24177522$1$I$20220509$20220509$20240806$20240806$EXP$$US-AstraZeneca-2022A179933$ASTRAZENECA$$21747$DY$$F$Y$$$20240806$$CN$US$
241775231$24177523$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002421$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240806$$CN$US$US
241775241$24177524$1$I$20200101$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002304$ELI LILLY AND CO$$$$$$Y$$$20240806$$CN$US$US
241775252$24177525$2$F$$20240904$20240806$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408002053$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240909$$CN$US$US
241775261$24177526$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002505$ELI LILLY AND CO$$$$$$Y$$$20240806$$CN$US$US
241775271$24177527$1$I$$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001791$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240806$$CN$US$US
241775281$24177528$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002065$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240806$$CN$US$US
241775291$24177529$1$I$$20240723$20240806$20240806$EXP$GB-MHRA-30755771$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001935$IPCA$$$$$$Y$$$20240806$$PH$GB$GB
241775301$24177530$1$I$$20240729$20240806$20240806$EXP$$JP-ROCHE-10000048492$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$86$YR$E$F$Y$$$20240806$$HP$JP$JP
241775311$24177531$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-013037$AUROBINDO$Agarwal SM, Hahn MK, Prasad F, Chintoh AF, Korann V, De R, et al. Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series. Therapeutic Advances in Psychopharmacology. 2023;13:1?10$59$YR$$M$Y$$$20240806$$HP$CA$CA
241775321$24177532$1$I$$20231016$20240806$20240806$EXP$$IN-SANDOZ INC.-SDZ2023IN047964$SANDOZ$$$$$$Y$$$20240806$$HP$IN$IN
241775331$24177533$1$I$20240801$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153575$AMGEN$$58$YR$A$F$Y$$$20240806$$CN$US$US
241775341$24177534$1$I$20240801$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153983$AMGEN$$68$YR$E$M$Y$$$20240806$$CN$US$US
241775351$24177535$1$I$20210101$20240728$20240806$20240806$EXP$$FR-AMGEN-FRASP2024153357$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut. 2024;1-13$$$$M$Y$$$20240806$$MD$FR$FR
241775361$24177536$1$I$$20240728$20240806$20240806$EXP$$FR-AMGEN-FRASP2024153329$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages. Gut. 2024;1-13$$$$$Y$$$20240806$$HP$FR$FR
241775371$24177537$1$I$$20240731$20240806$20240806$PER$$US-ABBVIE-5863010$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241775381$24177538$1$I$$20240729$20240806$20240806$EXP$$DE-ROCHE-10000042035$ROCHE$$40$YR$A$M$Y$$$20240806$$MD$DE$DE
241775391$24177539$1$I$$20240729$20240806$20240806$EXP$$JP-ROCHE-10000048494$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$84$YR$E$F$Y$$$20240806$$HP$JP$JP
241775401$24177540$1$I$$20240731$20240806$20240806$EXP$$BR-JNJFOC-20240805729$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$BR$BR
241775412$24177541$2$F$20230701$20240801$20240806$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011599$JAZZ$$52$YR$$F$Y$$$20240808$$CN$US$US
241775421$24177542$1$I$$20231110$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2023US053867$SANDOZ$$$$$$Y$$$20240806$$CN$US$US
241775431$24177543$1$I$$20231107$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2023US052960$SANDOZ$M. Ogledzinski, W. Lin, S. Gondek, K. Milejczyk, B. Juengel, L. Basto, L. Perea, L.-J. Wang, M. Tibudan, R.N. Barth, J.J. Fung, P. Witkowski;. Islet allotransplantation into pre-vascularised Sernova Cell PouchT: results from the first patient cohort. Diabetologia. 2023;66 (Suppl 1):S1:S98$$$$$Y$$$20240806$$MD$US$US
241775441$24177544$1$I$$20231120$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2023US058056$SANDOZ$Vipin Varghese, Akanksh Ramanand, Lauren Cohen, Dustin R. Chalmers, Juan Carlos Q. Velez. Parenchymal and Nontraditional Etiologies of AKI in Patients withEnd-Stage Liver Disease. Epidemiology, Risk Factors, Prevention - II. 2023;34$$$$$Y$$$20240806$$HP$US$US
241775451$24177545$1$I$$20240801$20240806$20240806$EXP$$NVSC2024RO157968$NOVARTIS$$$$$M$Y$$$20240806$$MD$RO$RO
241775461$24177546$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024154015$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241775471$24177547$1$I$$20240731$20240806$20240806$EXP$$TW-AMGEN-TWNSP2024155023$AMGEN$$$$A$F$Y$$$20240806$$HP$TW$TW
241775491$24177549$1$I$$20240731$20240806$20240806$EXP$$US-TAKEDA-2024TUS077707$TAKEDA$$$$$F$Y$$$20240806$$CN$US$US
241775501$24177550$1$I$$20240730$20240806$20240806$EXP$$GB-TAKEDA-2024TUS077483$TAKEDA$$$$$F$Y$$$20240806$$MD$GB$GB
241775522$24177552$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0682985$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241775542$24177554$2$F$$20240808$20240806$20240816$30DAY$$MX-SANDOZ INC.-SDZ2024MX070682$SANDOZ$$$$$M$Y$$$20240816$$CN$MX$MX
241775551$24177555$1$I$$20231201$20240806$20240806$EXP$$RU-SANDOZ INC.-SDZ2023RU066544$SANDOZ$Shasheleva DA, Shelikhova LN, Balashov DN, Molostova OO, Kozlovskaya SN, Ilyushina MA et al. . Transplantation from matched unrelated donors in pediatric severe aplastic anemia: TCR alpha/beta and CD19 depletion of the graft is associated with high survival and low GvHD rates. CTT JOURNAL. 2023;12(3):77-8$$$$$Y$$$20240806$$HP$RU$RU
241775561$24177556$1$I$20210308$20240806$20240806$20240806$EXP$SK-SUKLSK-20214582$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043956$BOEHRINGER INGELHEIM$$84$YR$E$M$Y$80$KG$20240806$$MD$SK$SK
241775571$24177557$1$I$$20240802$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070695$SANDOZ$$$$E$F$Y$$$20240806$$MD$US$US
241775581$24177558$1$I$20240731$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153380$AMGEN$$65$YR$E$F$Y$$$20240806$$CN$US$US
241775591$24177559$1$I$20240702$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153534$AMGEN$$70$YR$E$F$Y$$$20240806$$CN$US$US
241775601$24177560$1$I$$20240730$20240806$20240806$EXP$NL-LRB-00993315$NL-AMAROX PHARMA-AMR2024NL02521$HETERO$$33$YR$$F$Y$70$KG$20240806$$CN$NL$NL
241775612$24177561$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0682975$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241775622$24177562$2$F$$20240830$20240806$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123536$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240904$$CN$US$US
241775631$24177563$1$I$$20240801$20240806$20240806$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122763$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$72$KG$20240806$$HP$CA$CA
241775651$24177565$1$I$20230622$20240730$20240806$20240806$EXP$$US-TAKEDA-2023TUS063476$TAKEDA$$72$YR$$F$Y$$$20240806$$MD$US$US
241775662$24177566$2$F$20240722$20240731$20240806$20240808$EXP$$ES-SA-2024SA231178$SANOFI AVENTIS$$45$YR$A$F$Y$67.5$KG$20240808$$MD$ES$ES
241775691$24177569$1$I$20240101$20240802$20240806$20240806$EXP$$US-ABBVIE-5865914$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241775701$24177570$1$I$$20231213$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2023US071750$SANDOZ$$$$$$Y$$$20240806$$HP$US$US
241775712$24177571$2$F$$20240905$20240806$20240906$EXP$$US-SANDOZ INC.-SDZ2024US069574$SANDOZ$$86$YR$$F$Y$$$20240906$$MD$US$US
241775721$24177572$1$I$20240804$20240805$20240806$20240806$30DAY$$US-SANDOZ INC.-SDZ2024US070690$SANDOZ$$37$YR$$F$Y$$$20240806$$CN$US$US
241775731$24177573$1$I$$20240729$20240806$20240806$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP009700$STRIDES$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al.. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF).. Toxic-Analyt-Clinique. 2023;35 (1):54-59$53$YR$$F$Y$$$20240806$$HP$FR$FR
241775741$24177574$1$I$$20240805$20240806$20240806$EXP$FR-EMA-DD-20240731-7482827-114521$FR-SANDOZ INC.-SDZ2024FR070588$SANDOZ$$53$YR$$M$Y$$$20240806$$HP$FR$FR
241775751$24177575$1$I$$20240725$20240806$20240806$EXP$$US-IMMUNOCORE, LTD.-2024-IMC-002896$IMMUNOCORE$$$$$M$Y$$$20240806$$PH$US$US
241775761$24177576$1$I$20240101$20240726$20240806$20240806$EXP$$US-SA-2024SA192218$SANOFI AVENTIS$$$$$M$Y$$$20240806$$MD$US$US
241775771$24177577$1$I$$20240801$20240806$20240806$PER$$US-TAKEDA-2024TUS078078$TAKEDA$$$$$F$Y$39$KG$20240806$$CN$US$US
241775781$24177578$1$I$$20240731$20240806$20240806$EXP$$BD-SANDOZ INC.-SDZ2024BD070369$SANDOZ$$$$$F$Y$$$20240806$$CN$BD$BD
241775791$24177579$1$I$$20240605$20240805$20240805$DIR$FDA-CDER-CTU-2024-53643$$FDA-CTU$$$$$$N$$$20240605$N$$US$
241775801$24177580$1$I$$20240605$20240805$20240805$DIR$FDA-CDER-CTU-2024-53645$$FDA-CTU$$$$$$N$$$20240605$N$HP$US$
241775821$24177582$1$I$$20240730$20240806$20240806$EXP$$US-GSK-US2024095350$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$HP$US$US
241775831$24177583$1$I$$20240729$20240806$20240806$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP009701$STRIDES$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al.. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF).. Toxic-Analyt-Clinique. 2023;35 (1):54-59$$$$M$Y$$$20240806$$HP$FR$FR
241775841$24177584$1$I$$20240723$20240806$20240806$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07400$LUPIN$Ocasio V, Kapoor S, Atteih S, Sadreameli SC, Mogayzel PJ. A case of Trimethoprim-sulfamethoxazole associated fulminant respiratory failure in a 15- year-old male. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2329$15$YR$$M$Y$$$20240806$$HP$US$US
241775852$24177585$2$F$20240606$20240812$20240806$20240816$EXP$IT-MINISAL02-997201$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-122543$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240816$$MD$IT$IT
241775861$24177586$1$I$20240404$20240805$20240806$20240806$EXP$FR-AFSSAPS-AN2024001003$FR-SANDOZ INC.-SDZ2024FR070557$SANDOZ$$60$YR$$M$Y$$$20240806$$PH$FR$FR
241775871$24177587$1$I$$20240729$20240806$20240806$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009680$STRIDES$Kaur S, Isaac S, Westerman J.. Life threatening hematologic emergency from low dose methrotrexate.. South-Med-J. 2023;116:641-642$63$YR$$F$Y$$$20240806$$MD$US$US
241775881$24177588$1$I$$20240801$20240806$20240806$PER$$US-TAKEDA-2024TUS077715$TAKEDA$$$$$$Y$$$20240806$$CN$US$US
241775893$24177589$3$F$20220101$20240819$20240806$20240902$EXP$$FR-SA-2024SA229750$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240902$$MD$FR$FR
241775902$24177590$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0682986$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241775911$24177591$1$I$20240706$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037705$AUROBINDO$$58$YR$$F$Y$43.8$KG$20240806$$MD$FR$FR
241775921$24177592$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153749$AMGEN$$$$$M$Y$$$20240806$$CN$US$US
241775931$24177593$1$I$20240802$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154744$AMGEN$$46$YR$A$F$Y$$$20240806$$CN$US$US
241775941$24177594$1$I$$20240730$20240806$20240806$EXP$$JP-AMGEN-JPNSP2024154617$AMGEN$Miyajima N, Kimura K, Tsuboi T, Matsushita H, Kawase Y. EP-1193 A case of bone metastasis of breast cancer that became bone marrow carcinomatosis and worsened acutely during drug therapy, although Stable Disease.. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;476$75$YR$E$M$Y$$$20240806$$MD$JP$JP
241775951$24177595$1$I$20240801$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154590$AMGEN$$77$YR$E$M$Y$$$20240806$$CN$US$US
241775961$24177596$1$I$20240401$20240731$20240806$20240806$EXP$$CL-JNJFOC-20240807108$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240806$$CN$CL$CL
241775971$24177597$1$I$$20240801$20240806$20240806$EXP$$FR-JAZZ PHARMACEUTICALS-2024-FR-011764$JAZZ$$$$$$Y$$$20240806$$MD$FR$FR
241775981$24177598$1$I$20240101$20240729$20240806$20240806$EXP$$US-JNJFOC-20240777204$JOHNSON AND JOHNSON$$32$YR$A$$Y$$$20240806$$CN$US$US
241775992$24177599$2$F$$20240906$20240806$20240910$30DAY$$FR-JNJFOC-20240807346$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$HP$FR$FR
241776003$24177600$3$F$$20240814$20240806$20240823$30DAY$$DE-JNJFOC-20240782294$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$PH$DE$DE
241776011$24177601$1$I$$20240801$20240806$20240806$EXP$$JP-JNJFOC-20240812294$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240806$$PH$JP$JP
241776021$24177602$1$I$$20231017$20240806$20240806$EXP$$GB-SANDOZ INC.-SDZ2023DE044011$SANDOZ$$$$$$Y$$$20240806$$PH$GB$DE
241776031$24177603$1$I$$20240729$20240806$20240806$EXP$$NVSC2024US155591$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
241776041$24177604$1$I$$20240606$20240805$20240805$DIR$FDA-CDER-CTU-2024-53646$$FDA-CTU$$$$$$N$$$20240606$N$HP$US$
241776052$24177605$2$F$$20240807$20240806$20240814$EXP$$JP-GSK-JP2024JPN095562$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$PH$JP$JP
241776062$24177606$2$F$$20240821$20240806$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121928$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240823$$HP$US$US
241776071$24177607$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122774$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240806$$CN$US$US
241776081$24177608$1$I$20240501$20240724$20240806$20240806$EXP$GB-MHRA-31122984$GB-GLENMARK PHARMACEUTICALS-2024GMK092822$GLENMARK$$$$$$Y$$$20240806$$MD$GB$GB
241776092$24177609$2$F$$20240818$20240806$20240819$EXP$$US-SANDOZ INC.-SDZ2024US070726$SANDOZ$$73$YR$$F$Y$$$20240819$$CN$US$US
241776101$24177610$1$I$$20231023$20240806$20240806$EXP$$PT-SANDOZ INC.-SDZ2023PT046970$SANDOZ$Lourenco MH.. Cytomegalovirus and rheumatic diseases cases-based review. RP rheumatology$$$$$Y$$$20240806$$MD$PT$PT
241776111$24177611$1$I$$20240606$20240805$20240805$DIR$FDA-CDER-CTU-2024-53670$$FDA-CTU$$$$$$N$0.71$KG$20240606$N$HP$US$
241776122$24177612$2$F$$20240820$20240806$20240829$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07454$LUPIN$$$$$$Y$$$20240829$$CN$US$US
241776131$24177613$1$I$$20240729$20240806$20240806$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP009681$STRIDES$Naim G, Malissin I, Megarbane B.. Cerebral microbleeds in the poisoned patient: An observational magnetic resonance imaging study.. Basic-Clin-Pharmacol-Toxicol. 2023;133:770-777$40$YR$$M$Y$$$20240806$$HP$FR$FR
241776141$24177614$1$I$$20240731$20240806$20240806$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001562$BLUEPRINT MEDICINES$$$$$F$Y$$$20240806$$CN$US$US
241776151$24177615$1$I$20240514$20240805$20240806$20240806$EXP$GB-MHRA-MED-202408050953359720-PQTGV$GB-SANDOZ INC.-SDZ2024GB070481$SANDOZ$$67$YR$$M$Y$$$20240806$$PH$GB$GB
241776171$24177617$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000955$ELI LILLY AND CO$$$$$$Y$$$20240806$$CN$US$US
241776181$24177618$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001293$ELI LILLY AND CO$$65$YR$E$$Y$$$20240806$$LW$US$US
241776201$24177620$1$I$$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000515$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240806$$CN$US$US
241776211$24177621$1$I$20240726$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001967$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240806$$CN$US$US
241776232$24177623$2$F$20240801$20240805$20240806$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002081$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240813$$CN$US$US
241776241$24177624$1$I$20240729$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001708$ELI LILLY AND CO$$$$A$M$Y$$$20240806$$CN$US$US
241776251$24177625$1$I$$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000953$ELI LILLY AND CO$$$$$$Y$$$20240806$$CN$US$US
241776261$24177626$1$I$$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000235$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240806$$CN$US$US
241776271$24177627$1$I$$20240729$20240806$20240806$EXP$GB-MHRA-MED-202407290946084720-KBZVW$GB-TEVA-VS-3226949$TEVA$$34$YR$$F$Y$$$20240806$$CN$GB$GB
241776281$24177628$1$I$$20240729$20240806$20240806$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP009683$STRIDES$Naim G, Malissin I, Megarbane B.. Cerebral microbleeds in the poisoned patient: An observational magnetic resonance imaging study.. Basic-Clin-Pharmacol-Toxicol. 2023;133:770-777$72$YR$$F$Y$$$20240806$$HP$FR$FR
241776291$24177629$1$I$20240716$20240730$20240806$20240806$EXP$$US-GSK-US2024095371$GLAXOSMITHKLINE$$20$YR$$F$Y$$$20240806$$CN$US$US
241776301$24177630$1$I$20220624$20240802$20240806$20240806$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-106186$REGENERON$$$$$F$Y$$$20240806$$CN$US$US
241776311$24177631$1$I$$20240729$20240806$20240806$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP009685$STRIDES$Carreira MS, Cunha A, Couto M, Ramalho P.. MYXEDEMA COMA, A LATE POSTOPERATIVE COMPLICATION - THE ODDS OF RARITY.. Eur-J-Case-Rep-Intern-Med. 2019;6 (Suppl. 1):265 abstr. 1141.$85$YR$$M$Y$$$20240806$$HP$PT$PT
241776322$24177632$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0682976$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241776331$24177633$1$I$20240801$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123485$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240806$$PH$US$US
241776345$24177634$5$F$20220729$20240927$20240806$20240930$EXP$FR-AFSSAPS-PV2024000678$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043976$BOEHRINGER INGELHEIM$$36$YR$A$F$Y$$$20241001$$MD$FR$FR
241776352$24177635$2$F$20240731$20240807$20240806$20240812$PER$$IQ-REGENERON PHARMACEUTICALS, INC.-2024-107293$REGENERON$$69$YR$$M$Y$$$20240812$$CN$IQ$IQ
241776361$24177636$1$I$$20240729$20240806$20240806$EXP$$IE-STRIDES ARCOLAB LIMITED-2024SP009688$STRIDES$Crotty TJ, Sexton GP, Kavanagh F, Kinsella J, Lennon P, Timon CV, et al.. Fatal cerebritis and ventriculitis secondary to tracheoesophageal prosthesis.. J-Surg-Case-Rep. 2024;2024(4)$70$YR$$M$Y$$$20240806$$HP$IE$IE
241776372$24177637$2$F$20230101$20240807$20240806$20240902$EXP$$US-TEVA-VS-3226782$TEVA$$61$YR$$F$Y$$$20240902$$LW$US$US
241776391$24177639$1$I$20240601$20240805$20240806$20240806$EXP$IT-MINISAL02-997202$NVSC2024IT159152$NOVARTIS$$62$YR$$F$Y$$$20240806$$PH$IT$IT
241776411$24177641$1$I$$20240730$20240806$20240806$EXP$$CA-AMGEN-CANSP2024152573$AMGEN$$43$YR$A$F$Y$$$20240806$$PH$CA$CA
241776421$24177642$1$I$20240620$20240730$20240806$20240806$EXP$$US-JNJFOC-20240802198$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$US$US
241776431$24177643$1$I$$20240726$20240806$20240806$PER$$US-JNJFOC-20240776078$JOHNSON AND JOHNSON$$41$YR$A$$Y$$$20240806$$CN$US$US
241776441$24177644$1$I$$20230818$20240806$20240806$PER$$US-CIPLA LTD.-2023US05763$CIPLA$$$$$$Y$$$20240806$$CN$US$US
241776451$24177645$1$I$$20231025$20240806$20240806$PER$$US-CIPLA LTD.-2023US06186$CIPLA$$$$$$Y$$$20240806$$CN$US$US
241776471$24177647$1$I$$20240722$20240806$20240806$EXP$$IN-EPICPHARMA-IN-2024EPCLIT00920$EPIC PHARM$Anupma Kaul.The Unusual Adverse Effects of Antituberculosis Therapy in Kidney Patients..International Journal of Mycobacteriology.15-JUN-2024;13:183-190$16$YR$T$M$Y$$$20240806$$HP$IN$IN
241776481$24177648$1$I$$20201012$20240806$20240806$EXP$$US-AstraZeneca-2020SF33827$ASTRAZENECA$$57$YR$$M$Y$$$20240806$$CN$US$
241776492$24177649$2$F$20240101$20240809$20240806$20240819$EXP$$US-ABBVIE-5858056$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
241776501$24177650$1$I$20240722$20240725$20240806$20240806$EXP$$US-IMMUNOCORE, LTD.-2024-IMC-002900$IMMUNOCORE$$84$YR$$M$Y$$$20240806$$CN$US$US
241776511$24177651$1$I$$20220111$20240806$20240806$EXP$$US-AstraZeneca-2022A018523$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241776521$24177652$1$I$20240524$20240729$20240806$20240806$EXP$$ES-AstraZeneca-2024A171714$ASTRAZENECA$$81$YR$$M$Y$100$KG$20240806$$MD$ES$
241776531$24177653$1$I$$20220213$20240806$20240806$EXP$$US-AstraZeneca-2022A072630$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241776541$24177654$1$I$$20240730$20240806$20240806$EXP$$SE-STRIDES ARCOLAB LIMITED-2024SP009686$STRIDES$Elimam A, Khalil K.. Hereditary TTP in pregnant saudi lady with family history of TTP.. Clin-Med-London. 2024;24 (Suppl.):23-24$26$YR$$F$Y$$$20240806$$HP$SE$SE
241776551$24177655$1$I$$20211028$20240806$20240806$EXP$$CA-AstraZeneca-2021A792456$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$CA$
241776561$24177656$1$I$$20230405$20240806$20240806$EXP$$US-AstraZeneca-2023A081271$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241776571$24177657$1$I$$20231115$20240806$20240806$EXP$$DE-AstraZeneca-2023A262493$ASTRAZENECA$$$$$$Y$$$20240806$$MD$DE$
241776581$24177658$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024155780$AMGEN$$$$$$Y$$$20240806$$MD$US$US
241776601$24177660$1$I$$20240723$20240806$20240806$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-110398$ZYDUS PHARM$Panigrahi PK, Mishra S, Samal P, Sahoo D, Yadav T.. All trans retinoic acid-induced bilateral disc edema in a case of acute promyelocytic leukemia.. Oman-J-Ophthalmol. 2024;17(2):278-280$$$$$Y$$$20240806$$HP$IN$IN
241776611$24177661$1$I$$20240711$20240806$20240806$PER$23075288$US-LUPIN PHARMACEUTICALS INC.-2024-05026$LUPIN$$$$$$Y$$$20240806$$CN$US$US
241776621$24177662$1$I$$20240729$20240806$20240806$EXP$GB-MHRA-MED-202407251141093720-GLVBC$GB-TEVA-VS-3227196$TEVA$$$$$F$Y$$$20240806$$HP$GB$GB
241776631$24177663$1$I$$20230504$20240806$20240806$EXP$$US-AstraZeneca-2023A079648$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241776641$24177664$1$I$$20240723$20240806$20240806$EXP$$US-CIPLA LTD.-2024US08265$CIPLA$Zulch E, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, et al.. Impact of post-transplant Cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia Research. 2024;143 (107530):1 to 8$$$$$Y$$$20240806$$HP$US$US
241776652$24177665$2$F$$20240909$20240806$20240918$30DAY$$TR-JNJFOC-20240807221$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$TR$TR
241776661$24177666$1$I$$20211027$20240806$20240806$EXP$$CA-AstraZeneca-2021A649763$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$CA$
241776671$24177667$1$I$$20240730$20240806$20240806$EXP$$US-JNJFOC-20240784054$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241776681$24177668$1$I$$20240726$20240806$20240806$EXP$$CN-JNJFOC-20240775559$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240806$$HP$CN$CN
241776691$24177669$1$I$$20211207$20240806$20240806$EXP$$AU-AstraZeneca-2021A857371$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$AU$
241776701$24177670$1$I$$20230327$20240806$20240806$EXP$$US-AstraZeneca-2023A072988$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241776711$24177671$1$I$$20240729$20240806$20240806$EXP$$CA-AstraZeneca-2024A173556$ASTRAZENECA$$87$YR$$F$Y$$$20240806$$MD$CA$
241776721$24177672$1$I$20210810$20210813$20240806$20240806$EXP$$US-AstraZeneca-2021A686742$ASTRAZENECA$$16388$DY$$F$Y$$$20240806$$CN$US$
241776731$24177673$1$I$$20220621$20240806$20240806$EXP$$US-AstraZeneca-2022A230176$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241776741$24177674$1$I$20181108$20240729$20240806$20240806$EXP$$CA-AstraZeneca-2019SF91309$ASTRAZENECA$$48$YR$$F$Y$$$20240806$$MD$CA$
241776751$24177675$1$I$$20240801$20240806$20240806$EXP$$US-ABBVIE-5865608$ABBVIE$$$$$$Y$$$20240806$$HP$US$US
241776761$24177676$1$I$20240729$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153477$AMGEN$$69$YR$E$M$Y$$$20240806$$PH$US$US
241776771$24177677$1$I$20240711$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153992$AMGEN$$$$$$Y$$$20240806$$MD$US$US
241776781$24177678$1$I$20240301$20240730$20240806$20240806$EXP$$US-GSK-US2024095363$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$US$US
241776791$24177679$1$I$$20240729$20240806$20240806$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-105211$REGENERON$$$$$$Y$$$20240806$$HP$CA$CA
241776801$24177680$1$I$20240709$20240709$20240806$20240806$PER$$US-SERVIER-S24008716$SERVIER$$$$$$Y$$$20240806$$HP$US$US
241776811$24177681$1$I$$20240806$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070721$SANDOZ$$$$$F$Y$$$20240806$$LW$US$US
241776821$24177682$1$I$$20240117$20240806$20240806$EXP$GB-MHRA-MED-202401161330403530-JWNSC$GB-SANDOZ INC.-SDZ2024GB005796$SANDOZ$$$$$$Y$$$20240806$$PH$GB$GB
241776831$24177683$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123590$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240806$$PH$US$US
241776841$24177684$1$I$$20240801$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122855$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$78.02$KG$20240806$$CN$US$US
241776851$24177685$1$I$$20240117$20240806$20240806$EXP$GB-MHRA-MED-202401161342176080-VHMCL$GB-SANDOZ INC.-SDZ2024GB005554$SANDOZ$$$$$$Y$$$20240806$$PH$GB$GB
241776861$24177686$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123066$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240806$$HP$US$US
241776872$24177687$2$F$20230101$20240806$20240806$20240807$EXP$DE-EMA-DD-20240730-7482715-081833$DE-SANDOZ INC.-SDZ2024DE070419$SANDOZ$$35$YR$$M$Y$$$20240807$$MD$DE$DE
241776882$24177688$2$F$$20240803$20240806$20240807$EXP$GB-MHRA-MED-202408031432555040-RDJNT$GB-ABBVIE-5865987$ABBVIE$$40$YR$$M$Y$84$KG$20240807$$PH$GB$GB
241776892$24177689$2$F$$20240717$20240806$20240807$EXP$$AU-Orion Corporation ORION PHARMA-24_00030963$ORION$$38$YR$A$M$Y$65$KG$20240807$$MD$AU$
241776903$24177690$3$F$$20240809$20240806$20240813$30DAY$$FR-SANDOZ INC.-SDZ2024FR070564$SANDOZ$$5$YR$$F$Y$$$20240813$$CN$FR$FR
241776922$24177692$2$F$$20240819$20240806$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US070563$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
241776932$24177693$2$F$20240726$20240801$20240806$20240814$EXP$$NVSC2024CN158197$NOVARTIS$$81$YR$$F$Y$64$KG$20240814$$HP$CN$CN
241776941$24177694$1$I$$20240729$20240806$20240806$EXP$$JP-TEVA-VS-3227414$TEVA$Taniguchi SH, Komine K, Takenaga N, Yoshida Y, Sasaki K, Kawamura Y, et al. FOLFIRI Chemotherapy for Patients With Metastatic Urachal Carcinoma. Anticancer-Res 2023; 43 (12): 5699-5704.; Taniguchi SH, Komine K, Takenaga N, Yoshida Y, Sasaki K, Kawamura Y, et al. FOLFIRI Chemotherapy for Patients With Metastatic Urachal Carcinoma. Anticancer-Res 2023; 43 (12): 5699-5704.$$$A$$Y$$$20240806$$HP$JP$JP
241776953$24177695$3$F$20220101$20240808$20240806$20240816$PER$$US-AMGEN-USASP2024153062$AMGEN$$69$YR$E$M$Y$106.1$KG$20240816$$LW$US$US
241776961$24177696$1$I$$20240801$20240806$20240806$PER$$US-ABBVIE-5864370$ABBVIE$$$$$$Y$$$20240806$$CN$US$US
241776971$24177697$1$I$$20240724$20240806$20240806$PER$$US-JNJFOC-20240770947$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$CN$US$US
241776982$24177698$2$F$$20240819$20240806$20240827$EXP$$KR-CELLTRION INC.-2024KR018600$CELLTRION$$$$$$Y$$$20240827$$HP$KR$KR
241776992$24177699$2$F$$20240902$20240806$20240911$EXP$$JP-TEVA-VS-3227411$TEVA$Taniguchi SH, Komine K, Takenaga N, Yoshida Y, Sasaki K, Kawamura Y, et al. FOLFIRI Chemotherapy for Patients With Metastatic Urachal Carcinoma. Anticancer-Res 2023; 43 (12): 5699-5704.; Taniguchi SH, Komine K, Takenaga N, Yoshida Y, Sasaki K, Kawamura Y, et al. FOLFIRI Chemotherapy for Patients With Metastatic Urachal Carcinoma. Anticancer-Res 2023; 43 (12): 5699-5704.; Taniguchi SH, Komine K, Takenaga N, Yoshida Y, Sasaki K, Kawamura Y, et al. FOLFIRI Chemotherapy for Patients With Metastat...$$$A$$Y$$$20240911$$HP$JP$JP
241777001$24177700$1$I$$20240125$20240806$20240806$EXP$$CN-SANDOZ INC.-SDZ2024CN007895$SANDOZ$Chen Yong ,Ren Jianwei ,Zhu Guangfa,Liu Yulei ,Wu Shaoqin. Clinical features and management of non-transplant patients with invasive pulmonary aspergillosis: analysis of 32 cases. Chinese Journal of Lung Disease. 2023;16:809-813$$$$$Y$$$20240806$$HP$CN$CN
241777011$24177701$1$I$$20240722$20240806$20240806$EXP$$IN-EPICPHARMA-IN-2024EPCLIT00921$EPIC PHARM$Anupma Kaul.The Unusual Adverse Effects of Antituberculosis Therapy in  Kidney Patients.International Journal of Mycobacteriology.2024;13:183-190$55$YR$A$F$Y$$$20240806$$HP$IN$IN
241777021$24177702$1$I$20240620$20240730$20240806$20240806$PER$$US-RDY-SPO/USA/24/0011284$DR REDDYS$$20$YR$A$$Y$$$20240806$$HP$US$US
241777031$24177703$1$I$20240719$20240730$20240806$20240806$PER$$US-RDY-SPO/USA/24/0011287$DR REDDYS$$30$YR$A$$Y$$$20240806$$MD$US$US
241777041$24177704$1$I$$20240613$20240806$20240806$PER$$US-LUNDBECK-DKLU4000441$LUNDBECK$$$$$$Y$$$20240806$$HP$US$US
241777061$24177706$1$I$$20240730$20240806$20240806$PER$$US-RDY-SPO/USA/24/0011277$DR REDDYS$$17$YR$T$F$Y$$$20240806$$MD$US$US
241777081$24177708$1$I$20240731$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122647$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240806$$CN$US$US
241777101$24177710$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122749$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240806$$HP$US$US
241777111$24177711$1$I$20201004$20240722$20240806$20240806$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-117211$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$59$KG$20240806$$MD$KR$KR
241777121$24177712$1$I$20240310$20240805$20240806$20240806$EXP$$SA-SANDOZ INC.-SDZ2024SA035609$SANDOZ$$21$YR$$F$Y$$$20240806$$CN$SA$SA
241777141$24177714$1$I$$20231021$20240806$20240806$EXP$$EG-SANDOZ INC.-SDZ2023EG045867$SANDOZ$$$$$$Y$$$20240806$$MD$EG$EG
241777151$24177715$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153650$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241777161$24177716$1$I$$20240202$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00411$AMNEAL$$$$$F$Y$$$20240806$$CN$US$US
241777171$24177717$1$I$$20230627$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02358$AMNEAL$$$$$$Y$$$20240806$$CN$US$US
241777191$24177719$1$I$20240731$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153764$AMGEN$$82$YR$E$M$Y$$$20240806$$CN$US$US
241777212$24177721$2$F$20240801$20240903$20240806$20240904$PER$$US-AMGEN-USASP2024154624$AMGEN$$81$YR$E$F$Y$$$20240903$$HP$US$US
241777232$24177723$2$F$$20240730$20240806$20240807$EXP$$US-JNJFOC-20240804944$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$HP$US$US
241777241$24177724$1$I$$20240805$20240806$20240806$PER$$US-JNJFOC-20240811222$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$HP$US$US
241777251$24177725$1$I$$20240724$20240806$20240806$PER$$US-JNJFOC-20240772178$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241777261$24177726$1$I$$20240726$20240806$20240806$EXP$$IN-ROCHE-10000040766$ROCHE$$63$YR$A$F$Y$$$20240806$$MD$IN$IN
241777271$24177727$1$I$20240601$20240725$20240806$20240806$30DAY$$CO-JNJFOC-20240781402$JOHNSON AND JOHNSON$$48$YR$A$M$Y$80$KG$20240806$$HP$CO$CO
241777284$24177728$4$F$$20240816$20240806$20240821$PER$$US-HALEON-2190500$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
241777291$24177729$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123445$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240806$$CN$US$US
241777301$24177730$1$I$$20240613$20240806$20240806$PER$$US-LUNDBECK-DKLU4000505$LUNDBECK$$$$$$Y$$$20240806$$CN$US$US
241777311$24177731$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123201$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$81.19$KG$20240806$$CN$US$US
241777321$24177732$1$I$20240718$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024154001$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241777331$24177733$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153840$AMGEN$$$$$F$Y$$$20240806$$PH$US$US
241777342$24177734$2$F$20240805$20240806$20240806$20240807$PER$$US-AMGEN-USASP2024155646$AMGEN$$70$YR$E$F$Y$$$20240807$$CN$US$US
241777351$24177735$1$I$$20240730$20240806$20240806$EXP$$CA-AMGEN-CANSP2024151635$AMGEN$$69$YR$E$F$Y$$$20240806$$HP$CA$CA
241777361$24177736$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190511$Haleon PLC$$$$$M$Y$$$20240806$$CN$US$US
241777371$24177737$1$I$$20240801$20240806$20240806$EXP$$BR-SANDOZ INC.-SDZ2024BR070712$SANDOZ$$$$$F$Y$$$20240806$$CN$BR$BR
241777391$24177739$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A172992$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241777401$24177740$1$I$$20230405$20240806$20240806$EXP$$US-AstraZeneca-2023A081724$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241777411$24177741$1$I$$20211104$20240806$20240806$EXP$$CA-AstraZeneca-2021A789176$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$CA$
241777421$24177742$1$I$20210703$20210712$20240806$20240806$EXP$$RU-AstraZeneca-2021A617924$ASTRAZENECA$$29299$DY$$F$Y$68$KG$20240806$$CN$RU$
241777431$24177743$1$I$$20240724$20240806$20240806$PER$$US-JNJFOC-20240780312$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241777441$24177744$1$I$20230801$20240801$20240806$20240806$EXP$$CA-UCBSA-2023041003$UCB$$57$YR$$F$Y$$$20240806$$CN$CA$CA
241777451$24177745$1$I$$20240723$20240806$20240806$EXP$$CN-JNJFOC-20240772102$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$CN$CN
241777461$24177746$1$I$$20240722$20240806$20240806$EXP$$IN-EPICPHARMA-IN-2024EPCLIT00922$EPIC PHARM$Anupma Kaul.The Unusual Adverse Effects of Antituberculosis Therapy in Kidney Patients..International Journal of Mycobacteriology.15-JUN-2024;13:183-190$66$YR$E$M$Y$$$20240806$$HP$IN$IN
241777472$24177747$2$F$20230504$20240903$20240806$20240913$EXP$$CA-CELLTRION INC.-2022CA022722$CELLTRION$$$$$$Y$$$20240913$$CN$CA$CA
241777481$24177748$1$I$$20240615$20240806$20240806$PER$$US-LUNDBECK-DKLU4000619$LUNDBECK$$$$$$Y$$$20240806$$HP$US$US
241777491$24177749$1$I$20211105$20240729$20240806$20240806$EXP$ES-AEMPS-1549197$ES-TEVA-VS-3227323$TEVA$$62$YR$$F$Y$48$KG$20240806$$MD$ES$ES
241777502$24177750$2$F$20230801$20240813$20240806$20240820$EXP$$CA-PUMA BIOTECHNOLOGY, LTD.-2023-PUM-CA001496$PUMA$$$$$$Y$$$20240820$$MD$CA$CA
241777513$24177751$3$F$$20240828$20240806$20240902$EXP$$JP-GSK-JP2024JPN095568$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$HP$JP$JP
241777521$24177752$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123644$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240806$$CN$US$US
241777531$24177753$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123322$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240806$$CN$US$US
241777541$24177754$1$I$$20240116$20240806$20240806$EXP$$CH-SANDOZ INC.-SDZ2024CH006525$SANDOZ$Radan AP, Camponovo C, Amylidi-Mohr S, Zdanowicz J, Baumann M, Mihaela-Madalina F, et.al. Does amniotic fluid viral load correlate withadverse outcome in pregnancies complicatedby congenital Cytomegalovirus infection?. Gynecol Obstet Invest. 2023;88:8$$$$$Y$$$20240806$$HP$CH$CH
241777603$24177760$3$F$20240208$20240808$20240806$20240816$EXP$FR-AFSSAPS-AN2024000952$FR-TEVA-VS-3229762$TEVA$$77$YR$$M$Y$82$KG$20240816$$PH$FR$FR
241777611$24177761$1$I$20240730$20240731$20240806$20240806$PER$$US-AMGEN-USASP2024154897$AMGEN$$33$YR$A$F$Y$$$20240806$$CN$US$US
241777631$24177763$1$I$20240101$20240717$20240806$20240806$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000633$DECIPHERA PHARMACEUTICALS$$76$YR$E$M$Y$$$20240806$$CN$US$US
241777641$24177764$1$I$$20240724$20240806$20240806$EXP$$US-MYLANLABS-2024M1070296$MYLAN$Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwari A. Overwhelming cytochrome p450 isoenzyme activity generating druginduced liver injury resulting in fulminant liver failure. Hepatology 2023; 78 (Suppl.) S643-S644.$41$YR$$F$Y$$$20240806$$HP$US$US
241777651$24177765$1$I$$20240430$20240806$20240806$PER$$US-ROCHE-10000049464$ROCHE$$$$$$Y$$$20240806$$CN$US$US
241777662$24177766$2$F$20240101$20240812$20240806$20240820$EXP$$CA-CELLTRION INC.-2024CA018128$CELLTRION$$$$$$Y$$$20240820$$HP$CA$CA
241777671$24177767$1$I$$20240726$20240806$20240806$EXP$$US-NOVAST LABORATORIES INC.-2024NOV000286$NOVAST$Kuraitis D, Bogner P, Gopalakrishnan D, Pei S.. Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis. JAAD Case Reports. 2024;50:33-36$68$YR$$M$Y$$$20240806$$MD$US$US
241777681$24177768$1$I$$20240726$20240806$20240806$EXP$$US-NOVAST LABORATORIES INC.-2024NOV000284$NOVAST$Jain S, Sekhon S, Leo Pradeep Chandran AS, Gummadi J, Patel P, Nakka R, et,al.. Metformin-Associated Lactic Acidosis in an Older Adult: A Case Report and Review. Cureus. 2024;16(6)$82$YR$$M$Y$$$20240806$$HP$US$US
241777692$24177769$2$F$20240801$20240913$20240806$20240915$PER$$US-JNJFOC-20240804364$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240915$$CN$US$US
241777701$24177770$1$I$$20240802$20240806$20240806$EXP$$JP-JNJFOC-20240812339$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240806$$PH$JP$JP
241777711$24177771$1$I$20230324$20240805$20240806$20240806$EXP$FR-AFSSAPS-RE2023000364$FR-UCBSA-2023021030$UCB$$29$YR$$F$Y$56$KG$20240806$$MD$FR$FR
241777721$24177772$1$I$$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120919$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240806$$CN$US$US
241777731$24177773$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122895$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240806$$MD$US$US
241777741$24177774$1$I$$20240801$20240806$20240806$EXP$$US-ABBVIE-5865236$ABBVIE$$$$$M$Y$$$20240806$$HP$US$US
241777751$24177775$1$I$$20231020$20240806$20240806$EXP$$AU-TERSERA THERAPEUTICS LLC-2023TRS004613$TERSERA THERAPEUTICS$$$$$$Y$$$20240806$$CN$AU$AU
241777761$24177776$1$I$$20220113$20240806$20240806$EXP$$NL-TERSERA THERAPEUTICS LLC-2022TRS000180$TERSERA THERAPEUTICS$$$$$$Y$$$20240806$$CN$NL$NL
241777771$24177777$1$I$$20221102$20240806$20240806$EXP$$NL-TERSERA THERAPEUTICS LLC-2022TRS004879$TERSERA THERAPEUTICS$$$$$$Y$$$20240806$$CN$NL$NL
241777781$24177778$1$I$20231016$20240802$20240806$20240806$EXP$$US-ABBVIE-5865795$ABBVIE$$68$YR$$F$Y$$$20240806$$CN$US$US
241777791$24177779$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865961$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241777801$24177780$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865957$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241777811$24177781$1$I$$20240722$20240806$20240806$EXP$$CA-PURACAP-CA-2024EPCLIT00916$PURACAP$Julie Herrington.Asymptomatic intraspinal epidermoid cyst in a 7-year-old male with juvenile  idiopathic arthritis identified by an advanced physiotherapist practitioner:  a case report. Journal of Manual and Manipulative Therapy.02-APR-2024;32:343-351$7$YR$C$M$Y$$$20240806$$HP$CA$CA
241777821$24177782$1$I$20240101$20240731$20240806$20240806$EXP$$CA-Orion Corporation ORION PHARMA-23_00023473$ORION$$77$YR$E$M$Y$111$KG$20240806$$HP$CA$
241777831$24177783$1$I$$20240729$20240806$20240806$PER$$US-ABBVIE-5859981$ABBVIE$$$$$$Y$$$20240806$$CN$US$US
241777842$24177784$2$F$$20240904$20240806$20240916$30DAY$$TH-JNJFOC-20240803971$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$PH$TH$TH
241777851$24177785$1$I$20240724$20240725$20240806$20240806$EXP$$US-JNJFOC-20240771091$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$MD$US$US
241777861$24177786$1$I$20240731$20240801$20240806$20240806$PER$$US-JNJFOC-20240803704$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240806$$CN$US$US
241777871$24177787$1$I$$20240615$20240806$20240806$PER$$US-LUNDBECK-DKLU4000617$LUNDBECK$$$$$$Y$$$20240806$$HP$US$US
241777881$24177788$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038002$AUROBINDO$$65$YR$$F$Y$$$20240806$$HP$CA$CA
241777891$24177789$1$I$$20240613$20240806$20240806$PER$$US-LUNDBECK-DKLU4000517$LUNDBECK$$$$$$Y$$$20240806$$CN$US$US
241777901$24177790$1$I$$20240730$20240806$20240806$EXP$GB-MHRA-MED-202407260753521180-LKRTB$GB-862174955-ML2024-04286$MICRO LABS$$60$YR$A$F$Y$$$20240806$$MD$GB$GB
241777911$24177791$1$I$$20240729$20240806$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023550$UNITED THERAPEUTICS$$$$$F$Y$38.549$KG$20240806$$$US$US
241777921$24177792$1$I$$20240729$20240806$20240806$EXP$$GB-862174955-ML2024-04268$UNKNOWN$$72$YR$E$M$Y$91$KG$20240806$$PH$GB$GB
241777931$24177793$1$I$$20240730$20240806$20240806$EXP$$GB-862174955-ML2024-04290$MICRO LABS$$79$YR$E$F$Y$77$KG$20240806$$MD$GB$GB
241777941$24177794$1$I$$20240726$20240806$20240806$PER$$US-ROCHE-10000040151$ROCHE$$6$YR$C$M$Y$$$20240806$$MD$US$US
241777954$24177795$4$F$20240730$20240912$20240806$20240916$PER$$US-ROCHE-10000044863$ROCHE$$67$YR$E$F$Y$$$20240916$$CN$US$US
241777971$24177797$1$I$$20240802$20240806$20240806$EXP$$IN-SANDOZ INC.-SDZ2024IN070633$SANDOZ$$$$$M$Y$$$20240806$$CN$IN$IN
241777981$24177798$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121801$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240806$$HP$US$US
241777991$24177799$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122988$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240806$$CN$US$US
241778002$24177800$2$F$$20240906$20240806$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123086$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240911$$HP$US$US
241778011$24177801$1$I$20240601$20240729$20240806$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023610$UNITED THERAPEUTICS$$60$YR$$F$Y$67.12$KG$20240806$$$US$US
241778022$24177802$2$F$$20240813$20240806$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-037831$AUROBINDO$$74$YR$$M$Y$$$20240823$$HP$CA$CA
241778031$24177803$1$I$$20240731$20240806$20240806$30DAY$$US-GSK-US2024095860$GLAXOSMITHKLINE$$$$$M$Y$$$20240806$$CN$US$US
241778041$24177804$1$I$$20240722$20240806$20240806$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459711$RANBAXY$$$$E$M$Y$$$20240806$$CN$US$US
241778051$24177805$1$I$$20240726$20240806$20240806$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460506$RANBAXY$$$$E$F$Y$$$20240806$$CN$US$US
241778061$24177806$1$I$$20240730$20240806$20240806$PER$$US-UNITED THERAPEUTICS-UNT-2024-023744$UNITED THERAPEUTICS$$$$$F$Y$87.982$KG$20240806$$$US$US
241778071$24177807$1$I$$20240802$20240806$20240806$EXP$$GB-ABBVIE-5867438$ABBVIE$$$$A$M$Y$$$20240806$$CN$GB$GB
241778081$24177808$1$I$$20240805$20240806$20240806$PER$$US-ROCHE-10000049541$ROCHE$$$$$$Y$$$20240806$$MD$US$US
241778095$24177809$5$F$20240718$20240926$20240806$20240927$PER$$US-ROCHE-10000048235$ROCHE$$25$YR$A$F$Y$$$20240927$$CN$US$US
241778101$24177810$1$I$$20240805$20240806$20240806$PER$$US-ROCHE-10000049503$ROCHE$$$$E$M$Y$$$20240806$$MD$US$US
241778111$24177811$1$I$$20240722$20240806$20240806$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459712$RANBAXY$$$$E$M$Y$$$20240806$$CN$US$US
241778121$24177812$1$I$$20240729$20240806$20240806$EXP$$CN-ROCHE-RCA5210764$ROCHE$Tan H, Han X, Li C, Liu W, Li K, Sheng X, et al. Myelopreservation with Trilaciclib in recurrent advanced ovarian cancer: a case report. Frontiers in Oncology. 2024;14:1-8. doi:10.3389/fonc.2024.1343239.$68$YR$E$F$Y$39$KG$20240806$$HP$CN$CN
241778141$24177814$1$I$20240701$20240730$20240806$20240806$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010712$JAZZ$$24$YR$$F$Y$$$20240806$$CN$US$US
241778171$24177817$1$I$$20230504$20240806$20240806$EXP$$US-AstraZeneca-2023A105446$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241778182$24177818$2$F$20240722$20240729$20240806$20240816$EXP$$JP-AstraZeneca-2024A173827$ASTRAZENECA$$70$YR$$M$Y$$$20240816$$MD$JP$
241778191$24177819$1$I$$20211126$20240806$20240806$EXP$$US-AstraZeneca-2021A843830$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241778201$24177820$1$I$$20230318$20240806$20240806$EXP$$US-AstraZeneca-2023A065868$ASTRAZENECA$$$$$M$Y$68$KG$20240806$$CN$US$
241778211$24177821$1$I$20210701$20210807$20240806$20240806$EXP$$US-AstraZeneca-2021A678252$ASTRAZENECA$$1031$MON$$F$Y$$$20240806$$CN$US$
241778221$24177822$1$I$$20240722$20240806$20240806$EXP$NL-LRB-00990425$NL-HIKMA PHARMACEUTICALS-NL-H14001-24-06964$HIKMA$$$$$$Y$$$20240805$$MD$NL$NL
241778231$24177823$1$I$$20240801$20240806$20240806$PER$$US-ABBVIE-5865251$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241778241$24177824$1$I$20240802$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002399$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240806$$CN$US$US
241778251$24177825$1$I$$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408003022$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240806$$CN$US$US
241778261$24177826$1$I$20240715$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002094$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240806$$CN$US$US
241778271$24177827$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002339$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240806$$CN$US$US
241778281$24177828$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002179$ELI LILLY AND CO$$87$YR$E$M$Y$$$20240806$$CN$US$US
241778291$24177829$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002003$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240806$$CN$US$US
241778301$24177830$1$I$20240701$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002034$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240806$$CN$US$US
241778311$24177831$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002067$ELI LILLY AND CO$$$$A$F$Y$$$20240806$$CN$US$US
241778321$24177832$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002096$ELI LILLY AND CO$$$$$$Y$$$20240806$$CN$US$US
241778351$24177835$1$I$$20240803$20240806$20240806$PER$$NVSC2024US158942$NOVARTIS$$$$$$Y$$$20240806$$CN$US$US
241778361$24177836$1$I$$20240723$20240806$20240806$PER$$US-TEVA-VS-3226209$TEVA$$$$$$Y$$$20240806$$CN$US$US
241778371$24177837$1$I$$20240801$20240806$20240806$PER$$US-ABBVIE-5865553$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241778381$24177838$1$I$$20240722$20240806$20240806$EXP$$IN-EPICPHARMA-IN-2024EPCLIT00912$EPIC PHARM$Anupma Kaul.The Unusual Adverse Effects of Antituberculosis Therapy in Kidney Patients..International Journal of Mycobacteriology.15-JUN-2024;13:183-190$40$YR$A$F$Y$$$20240806$$HP$IN$IN
241778391$24177839$1$I$20240730$20240731$20240806$20240806$EXP$$KR-MALLINCKRODT-MNK202404917$MALLINCKRODT$$1$DY$N$$Y$0.67$KG$20240806$$HP$KR$KR
241778401$24177840$1$I$20240718$20240802$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123515$BRISTOL MYERS SQUIBB$$100$YR$E$F$Y$$$20240806$$CN$US$US
241778411$24177841$1$I$20240619$20240802$20240806$20240806$EXP$$US-UCBSA-2024039023$UCB$$30$YR$$M$Y$$$20240806$$CN$US$US
241778423$24177842$3$F$20240719$20240814$20240806$20240819$PER$$US-AMGEN-USASP2024153478$AMGEN$$62$YR$A$M$Y$$$20240819$$CN$US$US
241778443$24177844$3$F$20240726$20240913$20240806$20240924$30DAY$$US-AMGEN-USASP2024150951$AMGEN$$59$YR$A$M$Y$68$KG$20240924$$PH$US$US
241778453$24177845$3$F$20240701$20240815$20240806$20240819$EXP$$US-AMGEN-USASP2024154690$AMGEN$$85$YR$E$F$Y$$$20240819$$MD$US$US
241778472$24177847$2$F$20240802$20240821$20240806$20240826$PER$$US-AMGEN-USASP2024154626$AMGEN$$61$YR$A$F$Y$$$20240826$$CN$US$US
241778481$24177848$1$I$20240728$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153845$AMGEN$$66$YR$E$F$Y$$$20240806$$CN$US$US
241778501$24177850$1$I$$20240726$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037940$AUROBINDO$$39$YR$$M$Y$59$KG$20240806$$CN$GB$GB
241778511$24177851$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-037835$AUROBINDO$$75$YR$$F$Y$63.5$KG$20240806$$MD$CA$CA
241778521$24177852$1$I$20240717$20240731$20240806$20240806$PER$$US-JNJFOC-20240800781$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$MD$US$US
241778531$24177853$1$I$20240416$20240730$20240806$20240806$EXP$$US-JNJFOC-20240809195$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240806$$HP$US$US
241778541$24177854$1$I$$20240731$20240806$20240806$EXP$$US-TAKEDA-2023TUS060858$TAKEDA$$$$$M$Y$$$20240806$$CN$US$US
241778551$24177855$1$I$$20240801$20240806$20240806$PER$$US-JNJFOC-20240803280$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$PH$US$US
241778561$24177856$1$I$$20231204$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04225$AMNEAL$$$$$M$Y$$$20240806$$CN$US$US
241778571$24177857$1$I$20230901$20230906$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03361$AMNEAL$$72$YR$$M$Y$113.38$KG$20240806$$CN$US$US
241778581$24177858$1$I$$20230621$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02244$AMNEAL$$$$$$Y$$$20240806$$CN$US$US
241778591$24177859$1$I$$20230630$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02355$AMNEAL$$$$$F$Y$56.689$KG$20240806$$CN$US$US
241778601$24177860$1$I$$20231206$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04329$AMNEAL$$$$$F$Y$$$20240806$$CN$US$US
241778611$24177861$1$I$20231201$20240108$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00067$AMNEAL$$$$$M$Y$$$20240806$$CN$US$US
241778621$24177862$1$I$$20240226$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00665$AMNEAL$$$$$F$Y$91.61$KG$20240806$$CN$US$US
241778631$24177863$1$I$$20240607$20240805$20240805$DIR$FDA-CDER-CTU-2024-53674$$FDA-CTU$$$$$$N$$$20240607$N$HP$US$
241778641$24177864$1$I$$20231229$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04625$AMNEAL$$$$$$Y$$$20240806$$CN$US$US
241778651$24177865$1$I$20240126$20240129$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00289$AMNEAL$$76$YR$$F$Y$102.04$KG$20240806$$CN$US$US
241778661$24177866$1$I$20240326$20240326$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00998$AMNEAL$$48$YR$$F$Y$66.667$KG$20240806$$CN$US$US
241778671$24177867$1$I$20230729$20240509$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02814$AMNEAL$$63$YR$$F$Y$81.633$KG$20240806$$CN$US$US
241778691$24177869$1$I$$20230721$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02582$AMNEAL$$$$$M$Y$107.03$KG$20240806$$CN$US$US
241778701$24177870$1$I$$20240320$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01002$AMNEAL$$$$$F$Y$$$20240806$$CN$US$US
241778711$24177871$1$I$$20240103$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04637$AMNEAL$$$$$M$Y$$$20240806$$CN$US$US
241778721$24177872$1$I$$20240111$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00111$AMNEAL$$$$$F$Y$$$20240806$$CN$US$US
241778731$24177873$1$I$$20230626$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02323$AMNEAL$$$$$F$Y$69.841$KG$20240806$$CN$US$US
241778741$24177874$1$I$20240111$20240112$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00136$AMNEAL$$61$YR$$F$Y$54.422$KG$20240806$$CN$US$US
241778751$24177875$1$I$20240121$20240122$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00226$AMNEAL$$69$YR$$F$Y$$$20240806$$CN$US$US
241778761$24177876$1$I$20230801$20230814$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02906$AMNEAL$$63$YR$$M$Y$95.238$KG$20240806$$CN$US$US
241778771$24177877$1$I$$20240123$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00177$AMNEAL$$$$$M$Y$$$20240806$$CN$US$US
241778781$24177878$1$I$$20240724$20240806$20240806$PER$$US-SA-2024SA229764$SANOFI AVENTIS$$$$$$Y$$$20240806$$CN$US$US
241778791$24177879$1$I$$20240614$20240805$20240805$DIR$FDA-CDER-CTU-2024-53647$$FDA-CTU$$$$$$N$$$20240614$N$$US$
241778801$24177880$1$I$$20240702$20240806$20240806$PER$$US-BAYER-2024A112594$BAYER$$$$$$Y$$$20240806$$CN$US$US
241778811$24177881$1$I$$20240613$20240806$20240806$PER$$US-LUNDBECK-DKLU4000404$LUNDBECK$$$$$$Y$$$20240806$$HP$US$US
241778891$24177889$1$I$$20240403$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01222$AMNEAL$$$$$F$Y$$$20240806$$CN$US$US
241778901$24177890$1$I$$20240424$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01317$AMNEAL$$$$$$Y$$$20240806$$HP$US$US
241778911$24177891$1$I$$20240515$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01777$AMNEAL$$$$$$Y$$$20240806$$CN$US$US
241778921$24177892$1$I$$20240524$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01960$AMNEAL$$$$$F$Y$$$20240806$$CN$US$US
241778931$24177893$1$I$$20240729$20240806$20240806$30DAY$$US-GSK-US2024094878$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$CN$US$US
241778941$24177894$1$I$20240701$20240729$20240806$20240806$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011853$JAZZ$$63$YR$$$Y$$$20240806$$MD$JP$JP
241778951$24177895$1$I$$20240726$20240806$20240806$EXP$$US-ROCHE-10000040055$ROCHE$$$$E$$Y$$$20240806$$CN$US$US
241778963$24177896$3$F$$20240919$20240806$20240923$EXP$$US-TAKEDA-2024TUS078129$TAKEDA$$$$$F$Y$$$20240923$$CN$US$US
241778972$24177897$2$F$20240731$20240911$20240806$20240919$EXP$$US-JNJFOC-20240808257$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240919$$MD$US$US
241778981$24177898$1$I$$20240723$20240806$20240806$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00372$RIBON THERAPEUTICS$Qiongwen  X et al.. Effect on mortality of Dapagliflozin combined with Sacubitril Valsartan in the treatment of patients with chronic heart failure and type 2 diabetes mellitus. Clinical Research, DOCTOR 2024;9(11):59-62.$$$$$Y$$$20240806$$MD$CN$CN
241778991$24177899$1$I$$20240727$20240806$20240806$EXP$$LB-TAKEDA-2024TUS077966$TAKEDA$$$$$F$Y$$$20240806$$MD$LB$LB
241779001$24177900$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123235$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240806$$HP$US$US
241779011$24177901$1$I$$20240801$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122443$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$59.42$KG$20240806$$CN$US$US
241779023$24177902$3$F$20240405$20240816$20240806$20240819$EXP$FR-AFSSAPS-ST2024001270$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-123581$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$76$KG$20240819$$HP$FR$FR
241779032$24177903$2$F$$20240806$20240806$20240808$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-123187$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240808$$HP$GB$GB
241779041$24177904$1$I$$20240801$20240806$20240806$PER$$US-DSJP-DSU-2024-138868$DAIICHI$$$$$F$Y$$$20240806$$CN$US$US
241779051$24177905$1$I$$20240801$20240806$20240806$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138786$DAIICHI$$$$$F$Y$$$20240806$$CN$US$US
241779071$24177907$1$I$$20240801$20240806$20240806$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138785$DAIICHI$$$$$F$Y$$$20240806$$CN$US$US
241779082$24177908$2$F$$20240801$20240806$20240812$EXP$$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-17173$ALKEM$Chiu TY, Weng CC, Ha SC, Tsai HW, Koh CC, Chen Y.. Management of COVID-19 Infection in a Small Bowel Transplant Recipient: A Case Report. Transplantation Proceedings. 2023;55:1873-1876$33$YR$$F$Y$$$20240812$$HP$TW$TW
241779092$24177909$2$F$$20240801$20240806$20240812$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-17169$ALKEM$Cordero CG, De Vicente MS.. Elevated Tacrolimus Blood Concentration Due to the Interaction with Nirmatrelvir/Ritonavir During COVID-19 Treatment: A Case Report. Transplantation Proceedings. 2023;55:1826-1828$83$YR$$F$Y$$$20240812$$HP$ES$ES
241779102$24177910$2$F$$20240801$20240806$20240812$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-16847$ALKEM$Olaizola I, Ellger T, Young P, Bosebeck F, Evers S, Kellinghaus C. Pregabalin-associated acute psychosis and epileptiform EEG-changes. Seizure. 2006;15:208-10$44$YR$$F$Y$$$20240812$$HP$DE$DE
241779111$24177911$1$I$20240201$20240805$20240806$20240806$EXP$IT-MINISAL02-997654$NVSC2024IT159003$NOVARTIS$$67$YR$$M$Y$$$20240806$$MD$IT$IT
241779121$24177912$1$I$$20240802$20240806$20240806$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-138781$DAIICHI$$$$$F$Y$$$20240806$$CN$US$US
241779132$24177913$2$F$$20240805$20240806$20240820$EXP$US-MLMSERVICE-20240715-PI133231-00232-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16708$ALKEM$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al.. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy. Experimental and Clinical Transplantation. 2024;22(5):392-5$68$YR$$F$Y$$$20240820$$MD$US$US
241779141$24177914$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038545$AUROBINDO$$62$YR$$M$Y$80$KG$20240806$$HP$CA$CA
241779152$24177915$2$F$$20240805$20240806$20240820$EXP$US-MLMSERVICE-20240718-PI133351-00306-2$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16709$ALKEM$Joly L, Virgilio R, Yother C.. Posttransplant Lymphoproliferative Disorder in a Patient With Alpha-1 Antitrypsin Deficiency: A Case Report. Cureus. 2024;16(6):e62107$13$YR$$M$Y$$$20240820$$MD$US$US
241779162$24177916$2$F$$20240805$20240806$20240820$EXP$IT-MLMSERVICE-20240715-PI131817-00232-1$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16707$ALKEM$Acerbis A, Orofino G, Campodonico E, Del Poggio A, Xue E, di Matteo F, Spelta G, Bruno A, Falini A, Ciceri F, Peccatori J, Greco R.. Pre-engraftment neurological impairment in allogeneic stem cell transplant: A case report of atypical posterior reversible encephalopathy syndrome with pontine involvement. Frontiers in transplantation. 2023;1:1089995$59$YR$$F$Y$$$20240820$$MD$IT$IT
241779181$24177918$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024155132$AMGEN$$$$$$Y$$$20240806$$HP$US$US
241779191$24177919$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154619$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241779202$24177920$2$F$20200101$20240808$20240806$20240813$PER$$US-AMGEN-USASP2024155507$AMGEN$$$$$$Y$$$20240813$$CN$US$US
241779212$24177921$2$F$20240731$20240801$20240806$20240809$PER$$US-AMGEN-USASP2024153679$AMGEN$$49$YR$A$M$Y$$$20240809$$CN$US$US
241779221$24177922$1$I$$20240723$20240806$20240806$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110447$ZYDUS PHARM$Haynes TM, Kukuc L, Proute M, Fishberg R.. A PCSK9 and APOB Double Heterozygote Presenting Phenotypically Similar to Homozygous Familial Hypercholesterolemia.. Circulation. 2023$$$$$Y$$$20240806$$HP$US$US
241779231$24177923$1$I$$20220131$20240806$20240806$EXP$$US-AstraZeneca-2022A038790$ASTRAZENECA$$4875$WK$$F$Y$$$20240806$$CN$US$
241779241$24177924$1$I$$20230601$20240806$20240806$EXP$$US-AstraZeneca-2023A129382$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241779251$24177925$1$I$$20240723$20240806$20240806$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110397$ZYDUS PHARM$Uluc K, Ambady P, Mcintyre MK, Tabb JP, Kersch CN, Nerison CS, et al.. Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors.. Neurooncol-Adv. 2022;4 No. 1:1-11$$$$$Y$$$20240806$$HP$US$US
241779261$24177926$1$I$$20220525$20240806$20240806$EXP$$US-AstraZeneca-2022A200592$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241779271$24177927$1$I$$20210201$20240806$20240806$EXP$$US-AstraZeneca-2021A026892$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241779281$24177928$1$I$$20230810$20240806$20240806$EXP$$US-AstraZeneca-2023A183938$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241779291$24177929$1$I$$20230823$20240806$20240806$EXP$$US-AstraZeneca-2023A193401$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241779301$24177930$1$I$$20240722$20240806$20240806$EXP$$US-PURACAP-US-2024EPCLIT00923$PURACAP$Hasan S. Raza.Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding.ACG Case Reports Journal.07-JUN-2024;11:1-3$38$YR$A$M$Y$$$20240806$$MD$US$US
241779311$24177931$1$I$$20240724$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-039169$AUROBINDO$$$YR$$$Y$$$20240806$$PH$CA$CA
241779321$24177932$1$I$$20240725$20240806$20240806$EXP$$GB-RDY-LIT/GBR/24/0011260$DR REDDYS$Tatarinova OS, Furness CL, Borman AM, Barber J, Muthialu N, Ferreras-Antolin L. Neosartorya udagawae pulmonary infection requiring a surgical treatment in a paediatric haematopoietic progenitor cell recipient. Medical Mycology Case Reports. 2024;44: 1-4. doi:10.1016/j.mmcr.2024.100645.$3$YR$C$M$Y$$$20240806$$HP$GB$GB
241779331$24177933$1$I$20240419$20240729$20240806$20240806$EXP$IT-MINISAL02-996399$IT-EMD Serono-2024040994$EMD SERONO INC$$73$YR$E$F$Y$$$20240806$$MD$IT$IT
241779341$24177934$1$I$$20240731$20240806$20240806$PER$$US-JNJFOC-20240802926$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$CN$US$US
241779351$24177935$1$I$$20240806$20240806$20240806$PER$$US-HALEON-2190563$Haleon PLC$$$$$M$Y$$$20240806$$MD$US$US
241779362$24177936$2$F$20240409$20240812$20240806$20240813$PER$$US-AMGEN-USASP2024155932$AMGEN$$62$YR$A$F$Y$$$20240813$$CN$US$US
241779371$24177937$1$I$$20240729$20240806$20240806$EXP$$US-AMGEN-USASP2024150703$AMGEN$Montag L.; Piver R.; Vidalin A. et. al.. Pembrolizumab-induced myasthenia gravis: Two patients experiences. Gynecologic Oncology Reports. 2024;54:1-4$85$YR$E$F$Y$$$20240806$$HP$US$US
241779381$24177938$1$I$$20240726$20240806$20240806$EXP$$IT-MYLANLABS-2024M1071570$MYLAN$Di Paolo M, Maiese A, Scatena A, Bonaso M, Marcacci I, Convertino I, et al. Fat overload syndrome following intravenous lipid emulsion administration as antidote in suspected anesthetic intoxication: insights from a clinical and forensic case experience. Clin-Ter 2024; 175 (4): 211-215.$30$YR$$F$Y$$$20240806$$MD$IT$IT
241779392$24177939$2$F$$20240821$20240806$20240827$EXP$$JP-VIATRISJAPAN-2024M1069296AA$MYLAN$Kimura H, Shinohara T, Yasuda M, Koyama S, Suzuki K, Itatani K. A Case of Treatment and Repair of Ventricular Septal Defect in Severe Noonan Syndrome with Severe Pulmonary Hypertension and Hypertrophic Cardiomyopathy. The 60th AM of Japanese Society of Pediatric Cardiology and Cardiac Surgery. 2024$1$YR$$$Y$$$20240827$$MD$JP$JP
241779401$24177940$1$I$$20240805$20240806$20240806$EXP$$GB-MYLANLABS-2024M1073031$MYLAN$$$$$M$Y$$$20240806$$HP$GB$GB
241779411$24177941$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008991$APOTEX$$18$YR$$F$Y$49$KG$20240806$$HP$CA$CA
241779421$24177942$1$I$$20240726$20240806$20240806$EXP$$NL-MYLANLABS-2024M1071532$MYLAN$Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, et al. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series. J-Neurol 2024; 271 4028-4038.$34$MON$$F$Y$$$20240806$$HP$NL$NL
241779431$24177943$1$I$20240729$20240801$20240806$20240806$EXP$$AU-MYLANLABS-2024M1072019$MYLAN$$60$YR$$M$Y$$$20240806$$HP$AU$AU
241779441$24177944$1$I$20240720$20240801$20240806$20240806$EXP$$CN-MYLANLABS-2024M1072310$MYLAN$$75$YR$$M$Y$64$KG$20240806$$HP$CN$CN
241779451$24177945$1$I$$20240731$20240806$20240806$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-107278$REGENERON$$$$$F$Y$$$20240806$$CN$CA$CA
241779461$24177946$1$I$20200101$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001311$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240806$$CN$US$US
241779471$24177947$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002224$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240806$$CN$US$US
241779481$24177948$1$I$$20240722$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407016269$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240806$$CN$US$US
241779491$24177949$1$I$$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000930$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240806$$CN$US$US
241779501$24177950$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002110$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240806$$CN$US$US
241779511$24177951$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002130$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240806$$CN$US$US
241779521$24177952$1$I$$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002578$ELI LILLY AND CO$$76$YR$E$$Y$$$20240806$$CN$US$US
241779531$24177953$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190577$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241779542$24177954$2$F$20240713$20240911$20240806$20240913$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011826$JAZZ$$4$YR$$F$Y$$$20240913$$HP$US$US
241779552$24177955$2$F$$20240819$20240806$20240823$30DAY$$BR-JNJFOC-20240803980$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$PH$BR$BR
241779561$24177956$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP009018$APOTEX$$59$YR$$F$Y$$$20240806$$CN$CA$CA
241779571$24177957$1$I$$20240805$20240806$20240806$EXP$$CA-ORGANON-O2408CAN000298$ORGANON$$65$YR$$F$Y$$$20240806$$MD$CA$CA
241779581$24177958$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123534$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240806$$CN$US$US
241779591$24177959$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123427$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240806$$CN$US$US
241779611$24177961$1$I$20230101$20240730$20240806$20240806$EXP$$CA-CELLTRION INC.-2023CA013262$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
241779621$24177962$1$I$$20240728$20240806$20240806$EXP$$CN-DEXPHARM-2024-2477$DEXCEL$Li X-L; Luan C-Y; Fan Y-J; Lin X-Y; Jiang, D.; Su M-X; Wang, G.; Yang, X.  A Rare Case of Acute Infectious Purpura Fulminans Caused by Klebsiella Pneumoniae and Human Herpesvirus Type 5. Journal of Inflammation Research 2022, V15, P4251-4260$22$YR$A$M$Y$90$KG$20240806$$HP$CN$CN
241779642$24177964$2$F$$20240925$20240806$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123560$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240927$$CN$US$US
241779651$24177965$1$I$$20240801$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122639$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$73.94$KG$20240806$$CN$US$US
241779661$24177966$1$I$20240702$20240802$20240806$20240806$EXP$GB-MHRA-MED-202408011123548920-DHFBL$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-123206$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$71$KG$20240806$$MD$GB$GB
241779671$24177967$1$I$20240722$20240722$20240806$20240806$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01206$INTRA-CELLULAR THERAPIES$$19$YR$$M$Y$$$20240806$$MD$US$US
241779681$24177968$1$I$20240701$20240729$20240806$20240806$30DAY$$US-GSK-US2024094767$GLAXOSMITHKLINE$$41$YR$$F$Y$$$20240806$$CN$US$US
241779691$24177969$1$I$$20240726$20240806$20240806$EXP$$US-BAYER-2024A111051$BAYER$$$$$F$Y$$$20240806$$CN$US$US
241779701$24177970$1$I$$20240722$20240806$20240806$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01200$INTRA-CELLULAR THERAPIES$$$$$M$Y$97.522$KG$20240806$$CN$US$US
241779721$24177972$1$I$$20240802$20240806$20240806$PER$$US-TAKEDA-2024TUS078581$TAKEDA$$$$$M$Y$$$20240806$$CN$US$US
241779753$24177975$3$F$20240803$20240816$20240806$20240819$PER$$US-AMGEN-USASP2024155412$AMGEN$$67$YR$E$F$Y$$$20240819$$CN$US$US
241779762$24177976$2$F$20240730$20240805$20240806$20240807$PER$$US-AMGEN-USASP2024152572$AMGEN$$79$YR$E$F$Y$$$20240807$$CN$US$US
241779771$24177977$1$I$$20240805$20240806$20240806$PER$$US-AMGEN-USASP2024155399$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241779781$24177978$1$I$$20240723$20240806$20240806$PER$$US-TEVA-VS-3226169$TEVA$$49$YR$$F$Y$54.43$KG$20240806$$CN$US$US
241779791$24177979$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA223243$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240806$$MD$US$US
241779801$24177980$1$I$20240711$20240725$20240806$20240806$PER$$US-SA-2024SA224456$SANOFI AVENTIS$$58$YR$A$F$Y$81.646$KG$20240806$$MD$US$US
241779811$24177981$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA224208$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240806$$MD$US$US
241779822$24177982$2$F$20240101$20240919$20240806$20240927$PER$$US-SA-2024SA225581$SANOFI AVENTIS$$16$YR$T$F$Y$47.17$KG$20240927$$MD$US$US
241779831$24177983$1$I$20240720$20240725$20240806$20240806$PER$$US-SA-2024SA225948$SANOFI AVENTIS$$33$YR$A$F$Y$90$KG$20240806$$MD$US$US
241779841$24177984$1$I$20240201$20240801$20240806$20240806$EXP$$FR-LEO Pharma-370440$LEO PHARM$$33$YR$$M$Y$$$20240806$$MD$FR$FR
241779861$24177986$1$I$20240101$20240725$20240806$20240806$PER$$US-SA-2024SA171344$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240806$$MD$US$US
241779871$24177987$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA223269$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
241779881$24177988$1$I$20240518$20240805$20240806$20240806$EXP$FR-AFSSAPS-PB2024000829$FR-SA-2024SA231286$SANOFI AVENTIS$$82$YR$E$F$Y$58$KG$20240806$$PH$FR$FR
241779891$24177989$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA226868$SANOFI AVENTIS$$$$C$F$Y$$$20240806$$CN$US$US
241779901$24177990$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA225769$SANOFI AVENTIS$$60$YR$A$M$Y$122$KG$20240806$$MD$US$US
241779911$24177991$1$I$20240101$20240726$20240806$20240806$PER$$US-SA-2024SA225827$SANOFI AVENTIS$$26$YR$A$M$Y$106$KG$20240806$$MD$US$US
241779921$24177992$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA226044$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
241779931$24177993$1$I$20240601$20240726$20240806$20240806$PER$$US-SA-2024SA225883$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240806$$MD$US$US
241779941$24177994$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA225105$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240806$$MD$US$US
241779952$24177995$2$F$20240101$20240813$20240806$20240827$PER$$US-SA-2024SA227069$SANOFI AVENTIS$$18$YR$A$F$Y$63$KG$20240827$$MD$US$US
241779962$24177996$2$F$20240701$20240812$20240806$20240813$PER$$US-JNJFOC-20240772447$JOHNSON AND JOHNSON$$28$YR$A$F$Y$90$KG$20240813$$CN$US$US
241779971$24177997$1$I$20240101$20240726$20240806$20240806$PER$$US-SA-2024SA225822$SANOFI AVENTIS$$16$YR$T$F$Y$79$KG$20240806$$MD$US$US
241779981$24177998$1$I$20240726$20240726$20240806$20240806$PER$$US-SA-2024SA224430$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240806$$MD$US$US
241779993$24177999$3$F$$20240903$20240806$20240916$PER$$US-SA-2024SA134387$SANOFI AVENTIS$$$$A$M$Y$115$KG$20240916$$MD$US$US
241780001$24178000$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA225689$SANOFI AVENTIS$$31$YR$A$F$Y$56$KG$20240806$$MD$US$US
241780011$24178001$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA148313$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240806$$MD$US$US
241780021$24178002$1$I$20240701$20240726$20240806$20240806$PER$$US-SA-2024SA228580$SANOFI AVENTIS$$11$YR$C$F$Y$44.9$KG$20240806$$MD$US$US
241780031$24178003$1$I$$20240729$20240806$20240806$EXP$$GB-CELLTRION INC.-2024GB018456$CELLTRION$$$$$$Y$$$20240806$$CN$GB$GB
241780041$24178004$1$I$20240131$20240801$20240806$20240806$EXP$$NVSC2024CN158804$NOVARTIS$$57$YR$$M$Y$$$20240806$$HP$CN$CN
241780052$24178005$2$F$$20240902$20240806$20240910$EXP$$JP-TEVA-VS-3227380$TEVA$Akao S, Akao K, Rokutanda R, Suzuki T. Renal perivasculitis induced by sulfasalazine. J-Nephrol 2023; 37 1161-1164.; Akao S, Akao K, Rokutanda R, Suzuki T. Renal perivasculitis induced by sulfasalazine. J-Nephrol 2023; 37 1161-1164.; Akao S, Akao K, Rokutanda R, Suzuki T. Renal perivasculitis induced by sulfasalazine. J-Nephrol 2023; 37 1161-1164.$54$YR$$F$Y$$$20240910$$HP$JP$JP
241780071$24178007$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123530$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240806$$HP$US$US
241780081$24178008$1$I$20240731$20240802$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123495$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240806$$CN$US$US
241780091$24178009$1$I$$20240802$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123559$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240806$$CN$US$US
241780111$24178011$1$I$20240601$20240730$20240806$20240806$PER$$US-SA-2024SA228965$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
241780121$24178012$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA227076$SANOFI AVENTIS$$$$A$F$Y$56$KG$20240806$$MD$US$US
241780131$24178013$1$I$20240101$20240731$20240806$20240806$PER$$US-SA-2024SA228649$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240806$$MD$US$US
241780141$24178014$1$I$20240522$20240726$20240806$20240806$PER$$US-SA-2024SA226875$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240806$$MD$US$US
241780152$24178015$2$F$20240628$20240729$20240806$20240806$PER$$US-SA-2024SA224414$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240806$$MD$US$US
241780181$24178018$1$I$20240701$20240726$20240806$20240806$PER$$US-SA-2024SA224138$SANOFI AVENTIS$$64$YR$A$F$Y$134.24$KG$20240806$$MD$US$US
241780192$24178019$2$F$20240725$20240822$20240806$20240829$PER$$US-SA-2024SA221870$SANOFI AVENTIS$$$$$F$Y$$$20240829$$CN$US$US
241780201$24178020$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229309$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240806$$MD$US$US
241780211$24178021$1$I$20240101$20240726$20240806$20240806$PER$$US-SA-2024SA224797$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240806$$MD$US$US
241780221$24178022$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA148479$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240806$$MD$US$US
241780231$24178023$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA227471$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240806$$MD$US$US
241780241$24178024$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229691$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240806$$MD$US$US
241780251$24178025$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA225524$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240806$$MD$US$US
241780261$24178026$1$I$20240101$20240731$20240806$20240806$PER$$US-SA-2024SA169794$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240806$$MD$US$US
241780271$24178027$1$I$20240101$20240727$20240806$20240806$PER$$US-SA-2024SA226853$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240806$$MD$US$US
241780283$24178028$3$F$20240701$20240827$20240806$20240830$PER$$US-SA-2024SA229050$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240830$$MD$US$US
241780291$24178029$1$I$20240701$20240730$20240806$20240806$PER$$US-SA-2024SA228930$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240806$$MD$US$US
241780302$24178030$2$F$20240722$20240910$20240806$20240924$EXP$$US-UCBSA-2024039255$UCB$$77$YR$$F$Y$78.912$KG$20240924$$CN$US$US
241780321$24178032$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229501$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240806$$MD$US$US
241780331$24178033$1$I$$20240805$20240806$20240806$EXP$PT-AUROBINDO-AUR-APL-2024-037298$PT-UCBSA-2024039143$UCB$$74$YR$$M$Y$$$20240806$$HP$PT$PT
241780341$24178034$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229628$SANOFI AVENTIS$$$$A$M$Y$72.57$KG$20240806$$MD$US$US
241780351$24178035$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA227250$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
241780363$24178036$3$F$20240730$20240821$20240806$20240919$PER$$US-SA-2024SA227285$SANOFI AVENTIS$$33$YR$A$F$Y$61.6$KG$20240919$$MD$US$US
241780371$24178037$1$I$20231101$20240730$20240806$20240806$PER$$US-SA-2024SA230369$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240806$$MD$US$US
241780381$24178038$1$I$20240723$20240730$20240806$20240806$PER$$US-SA-2024SA228383$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240806$$MD$US$US
241780401$24178040$1$I$20240730$20240731$20240806$20240806$PER$$US-SA-2024SA229074$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240806$$MD$US$US
241780411$24178041$1$I$20240601$20240731$20240806$20240806$PER$$US-SA-2024SA227917$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240806$$MD$US$US
241780421$24178042$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA230257$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240806$$MD$US$US
241780431$24178043$1$I$20240401$20240730$20240806$20240806$PER$$US-SA-2024SA229302$SANOFI AVENTIS$$16$YR$T$M$Y$72.57$KG$20240806$$MD$US$US
241780441$24178044$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA228643$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240806$$MD$US$US
241780451$24178045$1$I$20240701$20240730$20240806$20240806$PER$$US-SA-2024SA228985$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240806$$MD$US$US
241780461$24178046$1$I$20240601$20240730$20240806$20240806$PER$$US-SA-2024SA228758$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240806$$MD$US$US
241780471$24178047$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229333$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240806$$MD$US$US
241780481$24178048$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA230430$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240806$$MD$US$US
241780492$24178049$2$F$$20240802$20240806$20240812$PER$$US-SA-2024SA229481$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240812$$CN$US$US
241780501$24178050$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2023SA272365$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240806$$MD$US$US
241780511$24178051$1$I$20240701$20240729$20240806$20240806$PER$$US-SA-2024SA227269$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240806$$CN$US$US
241780521$24178052$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA230222$SANOFI AVENTIS$$$$E$M$Y$$$20240806$$MD$US$US
241780531$24178053$1$I$20240727$20240730$20240806$20240806$PER$$US-SA-2024SA230240$SANOFI AVENTIS$$35$YR$A$F$Y$89.99$KG$20240806$$MD$US$US
241780541$24178054$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229210$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240806$$MD$US$US
241780551$24178055$1$I$$20240729$20240806$20240806$PER$$US-SA-2023SA206580$SANOFI AVENTIS$$$$C$F$Y$$$20240806$$MD$US$US
241780561$24178056$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA230673$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240806$$MD$US$US
241780571$24178057$1$I$20230601$20240731$20240806$20240806$PER$$US-SA-2024SA230971$SANOFI AVENTIS$$71$YR$E$M$Y$81.6$KG$20240806$$MD$US$US
241780581$24178058$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA230175$SANOFI AVENTIS$$$$E$F$Y$$$20240806$$MD$US$US
241780591$24178059$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA226862$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240806$$MD$US$US
241780602$24178060$2$F$$20240909$20240806$20240918$PER$$US-SA-2024SA229308$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240918$$MD$US$US
241780611$24178061$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229307$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240806$$MD$US$US
241780621$24178062$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229914$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240806$$MD$US$US
241780631$24178063$1$I$20240701$20240730$20240806$20240806$PER$$US-SA-2024SA228967$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240806$$MD$US$US
241780641$24178064$1$I$20240725$20240730$20240806$20240806$PER$$US-SA-2024SA228785$SANOFI AVENTIS$$$$$M$Y$$$20240806$$MD$US$US
241780651$24178065$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229329$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240806$$MD$US$US
241780661$24178066$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229306$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240806$$MD$US$US
241780671$24178067$1$I$20240508$20240730$20240806$20240806$PER$$US-SA-2024SA229072$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240806$$MD$US$US
241780681$24178068$1$I$20240729$20240730$20240806$20240806$PER$$US-SA-2024SA230062$SANOFI AVENTIS$$11$YR$C$F$Y$35.83$KG$20240806$$MD$US$US
241780692$24178069$2$F$20240715$20240731$20240806$20240813$PER$$US-AMGEN-USASP2024152817$AMGEN$$70$YR$E$F$Y$$$20240812$$PH$US$US
241780701$24178070$1$I$20240418$20240428$20240806$20240806$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01579$AMNEAL$$64$YR$$F$Y$56.689$KG$20240806$$CN$US$US
241780712$24178071$2$F$20240802$20240805$20240806$20240810$PER$$US-AMGEN-USASP2024154337$AMGEN$$62$YR$A$F$Y$$$20240810$$CN$US$US
241780721$24178072$1$I$20240501$20240730$20240806$20240806$PER$$US-SA-2024SA230134$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240806$$MD$US$US
241780731$24178073$1$I$20220701$20240725$20240806$20240806$EXP$$DE-AUROBINDO-AUR-APL-2024-037901$AUROBINDO$$81$YR$$F$Y$$$20240806$$CN$DE$DE
241780741$24178074$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038750$AUROBINDO$$51$YR$$M$Y$$$20240806$$HP$CA$CA
241780751$24178075$1$I$20240601$20240730$20240806$20240806$PER$$US-SA-2024SA229953$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240806$$MD$US$US
241780761$24178076$1$I$$20240729$20240806$20240806$PER$$US-AMGEN-USASP2024153084$AMGEN$Ortega-loayza A.G.; Choe S.; Shettig A. et al.. Pyoderma Gangrenosum of the Genitalia, Anus, and Perineum: Two Case Reports and a Review of Published Cases. Sexually Transmitted Diseases. 2024;51:548-550$45$YR$A$F$Y$$$20240806$$MD$US$US
241780771$24178077$1$I$$20240801$20240806$20240806$PER$$US-SA-2024SA229590$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240806$$CN$US$US
241780781$24178078$1$I$$20231013$20240806$20240806$EXP$$US-AstraZeneca-2023A234861$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241780791$24178079$1$I$$20231019$20240806$20240806$EXP$$US-AstraZeneca-2023A238594$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241780801$24178080$1$I$20210704$20210721$20240806$20240806$EXP$$US-AstraZeneca-2021A634956$ASTRAZENECA$$19199$DY$$M$Y$$$20240806$$CN$US$
241780811$24178081$1$I$$20231117$20240806$20240806$EXP$$US-AstraZeneca-2023A263205$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241780831$24178083$1$I$20240725$20240802$20240806$20240806$PER$$US-ROCHE-10000048563$ROCHE$$47$YR$A$F$Y$$$20240806$$CN$US$US
241780841$24178084$1$I$$20230524$20240806$20240806$EXP$$US-AstraZeneca-2023A120761$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241780851$24178085$1$I$20220715$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037712$AUROBINDO$$56$YR$$F$Y$64$KG$20240806$$CN$FR$FR
241780861$24178086$1$I$20240606$20240730$20240806$20240806$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160050$JIANGSU HENGRUI MEDICINE$$54$YR$$M$Y$$$20240806$$MD$CN$CN
241780872$24178087$2$F$20240101$20240920$20240806$20240927$EXP$$BR-BAYER-2024A008038$BAYER$$41$YR$A$F$Y$$$20240927$$CN$BR$BR
241780881$24178088$1$I$$20240725$20240806$20240806$EXP$$TR-P+L Developments of Newyork Corporation-2160060$PL DEVELOPMENTS$Initial$13$YR$$$Y$$$20240806$$$TR$TR
241780891$24178089$1$I$20240418$20240730$20240806$20240806$EXP$$US-JNJFOC-20240278052$JOHNSON AND JOHNSON$$75$YR$E$F$Y$63.6$KG$20240806$$HP$US$US
241780901$24178090$1$I$20100215$20240730$20240806$20240806$EXP$$US-BIOGEN-2010BI006670$BIOGEN$$49$YR$$F$Y$$$20240806$$CN$US$US
241780911$24178091$1$I$20240726$20240730$20240806$20240806$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160052$JIANGSU HENGRUI MEDICINE$$65$YR$$M$Y$53$KG$20240806$$MD$CN$CN
241780921$24178092$1$I$20240708$20240802$20240806$20240806$EXP$$NVSC2024US159261$NOVARTIS$$39$YR$$F$Y$$$20240806$$HP$US$US
241780931$24178093$1$I$$20240723$20240806$20240806$EXP$$US-WES Pharma Inc-2160046$WES PHARMA$Abstract$26$YR$$M$Y$$$20240806$$$US$US
241780951$24178095$1$I$$20240723$20240806$20240806$EXP$$US-Guardian Drug Company-2160047$GUARDIAN PHARMACEUTICALS$Full text$38$YR$$M$Y$$$20240806$$MD$US$US
241780961$24178096$1$I$$20240725$20240806$20240806$EXP$$TR-P+L Developments of Newyork Corporation-2160056$PL DEVELOPMENTS$Initial$5$YR$$$Y$$$20240806$$$TR$TR
241780971$24178097$1$I$$20240725$20240806$20240806$EXP$$TR-P+L Developments of Newyork Corporation-2160053$PL DEVELOPMENTS$Initial$14$YR$$$Y$$$20240806$$$TR$TR
241780981$24178098$1$I$20240706$20240803$20240806$20240806$EXP$GB-MHRA-MED-202408032339429080-BFPVN$NVSC2024GB159264$NOVARTIS$$13$YR$$F$Y$40$KG$20240806$$CN$GB$GB
241781001$24178100$1$I$20240724$20240730$20240806$20240806$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160049$JIANGSU HENGRUI MEDICINE$$80$YR$$M$Y$59$KG$20240806$$MD$CN$CN
241781011$24178101$1$I$$20240725$20240806$20240806$EXP$$TR-P+L Developments of Newyork Corporation-2160048$PL DEVELOPMENTS$Initial$9$YR$$$Y$$$20240806$$$TR$TR
241781021$24178102$1$I$$20240725$20240806$20240806$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2160045$Chengdu Suncadia Medicine$Literature title: Clinical analysis of 14 pregnancies in women with renal transplant.?Journal of publication: Journal of Reproductive Medicine, 2024, 33 (7): 878-884.?Authors: Bing Liang, Liyun Gong, Zhiwei Zhang, Hang Liu, Junli Lu.$37$YR$$F$Y$$$20240806$$MD$CN$CN
241781031$24178103$1$I$$20240726$20240806$20240806$PER$$US-P+L Developments of Newyork Corporation-2160058$PL DEVELOPMENTS$$$$$$Y$$$20240806$$$US$US
241781041$24178104$1$I$$20240725$20240806$20240806$EXP$$TR-P+L Developments of Newyork Corporation-2160059$PL DEVELOPMENTS$Initial$9$YR$$$Y$$$20240806$$$TR$TR
241781051$24178105$1$I$$20240725$20240806$20240806$EXP$$TR-P+L Developments of Newyork Corporation-2160055$PL DEVELOPMENTS$Initial$13$YR$$$Y$$$20240806$$$TR$TR
241781061$24178106$1$I$$20240725$20240806$20240806$EXP$$TR-P+L Developments of Newyork Corporation-2160054$PL DEVELOPMENTS$Initial$14$YR$$$Y$$$20240806$$$TR$TR
241781071$24178107$1$I$$20240730$20240806$20240806$PER$$US-LEO Pharma-372465$LEO PHARM$$21$YR$$F$Y$$$20240806$$PH$US$US
241781081$24178108$1$I$$20240725$20240806$20240806$EXP$$TR-P+L Developments of Newyork Corporation-2160051$PL DEVELOPMENTS$Initial$16$YR$$$Y$$$20240806$$$TR$TR
241781092$24178109$2$F$$20240909$20240806$20240921$EXP$$ES-AUROBINDO-AUR-APL-2024-037497$AUROBINDO$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transpl Infect Dis. 2024;26(3):e14276$4$MON$$F$Y$$$20240921$$MD$ES$ES
241781101$24178110$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008996$APOTEX$$54$YR$$F$Y$$$20240806$$CN$CA$CA
241781111$24178111$1$I$$20240725$20240806$20240806$EXP$$TR-P+L Developments of Newyork Corporation-2160061$PL DEVELOPMENTS$Initial$17$YR$$$Y$$$20240806$$$TR$TR
241781132$24178113$2$F$20240611$20240826$20240806$20240830$PER$$US-ROCHE-10000048274$ROCHE$$81$YR$E$$Y$$$20240830$$MD$US$US
241781141$24178114$1$I$$20240723$20240806$20240806$EXP$$US-WES Pharma Inc-2160044$WES PHARMA$Abstract$64$YR$$F$Y$$$20240806$$$US$US
241781151$24178115$1$I$$20240801$20240806$20240806$PER$$US-ROCHE-10000047318$ROCHE$$$$$$Y$$$20240806$$MD$US$US
241781163$24178116$3$F$20240701$20240903$20240806$20240905$PER$$US-AMGEN-USASP2024154750$AMGEN$$59$YR$A$F$Y$$$20240905$$HP$US$US
241781171$24178117$1$I$20240722$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153680$AMGEN$$70$YR$E$F$Y$$$20240806$$CN$US$US
241781181$24178118$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038634$AUROBINDO$Persad AR, Coote NR, Waterhouse K, McLeod S, Norton JA, Gould L, et al.. Medial forebrain bundle stimulation after failed subcallosal cingulate deep brain stimulation for treatment-resistant depression: Efficacy of a dual deep brain stimulation system for depression.. Brain-Stimulat.. 2024;17 (1):68-70.$$$$M$Y$$$20240806$$HP$CA$CA
241781191$24178119$1$I$20231128$20240802$20240802$20240802$DIR$FDA-CDER-CTU-2024-53687$$FDA-CTU$$74$YR$$M$N$80.74$KG$20240802$N$$US$
241781202$24178120$2$F$$20240823$20240806$20240827$EXP$$RU-TAKEDA-2024TUS078510$TAKEDA$$84$YR$$F$Y$71$KG$20240827$$HP$RU$RU
241781212$24178121$2$F$$20240807$20240806$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-037326$AUROBINDO$Attieh RM, Brumble L, Elwasila SM, Wadei HM. Disseminated Monkeypox Infection in a Kidney Transplant Recipient A Case Report. Transplantation Proceedings. 2023;55(3):667-71$44$YR$$M$Y$$$20240820$$MD$US$US
241781231$24178123$1$I$20240708$20240711$20240806$20240806$PER$$US-Eisai-EC-2024-170081$EISAI$$73$YR$E$F$Y$$$20240806$$CN$US$US
241781241$24178124$1$I$20240626$20240710$20240806$20240806$PER$$US-Eisai-EC-2024-169971$EISAI$$81$YR$E$M$Y$$$20240806$$HP$US$US
241781251$24178125$1$I$20240801$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154727$AMGEN$$74$YR$E$F$Y$$$20240806$$CN$US$US
241781261$24178126$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154830$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241781271$24178127$1$I$$20240725$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038731$AUROBINDO$$$$$F$Y$$$20240806$$CN$CA$CA
241781281$24178128$1$I$$20240730$20240806$20240806$EXP$$CA-AMGEN-CANSP2024151669$AMGEN$$77$YR$E$F$Y$53$KG$20240806$$PH$CA$CA
241781292$24178129$2$F$$20240812$20240806$20240813$PER$$US-AMGEN-USASP2024154825$AMGEN$$$$$$Y$$$20240813$$CN$US$US
241781314$24178131$4$F$20240701$20240812$20240806$20240826$EXP$$US-JNJFOC-20240809186$JOHNSON AND JOHNSON$$62$YR$A$M$Y$84$KG$20240826$$MD$US$US
241781321$24178132$1$I$$20240730$20240806$20240806$EXP$$US-ASTELLAS-2024EU007622$ASTELLAS$Manuel SL, Sapone J, Lin F. Tacrolimus-Induced Recurrent Acute Coronary Syndrome Due to an Unknown Mechanism. Cureus. 2024;16(6):1-4$74$YR$$F$Y$$$20240806$$HP$US$US
241781331$24178133$1$I$$20240715$20240806$20240806$PER$$US-B.Braun Medical Inc.-2160062$B BRAUN$$36$YR$$F$Y$$$20240806$$$US$US
241781341$24178134$1$I$20240726$20240730$20240806$20240806$30DAY$$US-GSK-US2024095357$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240806$$CN$US$US
241781351$24178135$1$I$$20240802$20240806$20240806$PER$$NVSC2024US159020$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
241781361$24178136$1$I$$20240730$20240806$20240806$PER$$US-ROCHE-10000044220$ROCHE$$$$E$F$Y$$$20240806$$MD$US$US
241781372$24178137$2$F$$20240824$20240806$20240827$30DAY$$US-ROCHE-10000046719$ROCHE$$$$$$Y$$$20240827$$CN$US$US
241781383$24178138$3$F$20240702$20240820$20240806$20240829$EXP$$JP-ASTELLAS-2024JP004613$ASTELLAS$$8$DEC$E$M$Y$$$20240824$$MD$JP$JP
241781402$24178140$2$F$$20240806$20240806$20240813$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001061$ALEMBIC$$$$$$Y$$$20240812$$CN$US$US
241781412$24178141$2$F$$20240816$20240806$20240830$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001062$ALEMBIC$$$$$$Y$$$20240830$$CN$US$US
241781422$24178142$2$F$20240101$20240828$20240806$20240906$EXP$$ES-AUROBINDO-AUR-APL-2024-010921$AUROBINDO$$43$YR$$F$Y$$$20240906$$CN$ES$ES
241781433$24178143$3$F$20240802$20240813$20240806$20240819$PER$$US-AMGEN-USASP2024154722$AMGEN$$61$YR$A$F$Y$48.98$KG$20240819$$CN$US$US
241781443$24178144$3$F$20240726$20240812$20240806$20240816$30DAY$$US-AMGEN-USASP2024151805$AMGEN$$$$$$Y$$$20240816$$PH$US$US
241781452$24178145$2$F$20240628$20240820$20240806$20240826$30DAY$$US-AMGEN-USASP2024150565$AMGEN$$58$YR$A$F$Y$74.376$KG$20240826$$PH$US$US
241781461$24178146$1$I$20240730$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154789$AMGEN$$67$YR$E$M$Y$$$20240806$$CN$US$US
241781473$24178147$3$F$20240730$20240812$20240806$20240815$PER$$US-AMGEN-USASP2024152890$AMGEN$$51$YR$A$M$Y$73$KG$20240815$$PH$US$US
241781482$24178148$2$F$20240804$20240805$20240806$20240808$PER$$US-AMGEN-USASP2024155484$AMGEN$$65$YR$E$F$Y$$$20240807$$CN$US$US
241781491$24178149$1$I$$20240721$20240806$20240806$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001065$ALEMBIC$$$$$$Y$$$20240806$$CN$US$US
241781511$24178151$1$I$$20240729$20240806$20240806$EXP$$NL-AMGEN-NLDSP2024151084$AMGEN$Wijnsma K.L; Schijvens A.M; Bouwmeester R.N. et al.. Mutations in Genes Encoding Subunits of the RNA Exosome as a Potential Novel Cause of Thrombotic Microangiopathy. International Journal of Molecular Sciences. 2024;25 (14):1-8$$$I$F$Y$$$20240806$$HP$NL$NL
241781521$24178152$1$I$20240727$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001790$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240806$$CN$US$US
241781531$24178153$1$I$$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002837$ELI LILLY AND CO$$$$$F$Y$$$20240806$$CN$US$US
241781541$24178154$1$I$$20240723$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000810$ELI LILLY AND CO$$$$$$Y$$$20240806$$HP$US$US
241781551$24178155$1$I$$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000928$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240806$$CN$US$US
241781561$24178156$1$I$20240707$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001864$ELI LILLY AND CO$$$$A$F$Y$$$20240806$$CN$US$US
241781571$24178157$1$I$$20240729$20240806$20240806$EXP$$US-MYLANLABS-2024M1072677$MYLAN$Sinclair De FriasJ, Olivero L, Fleissner Z, Burns J, Chadha R, Moreno Franco P. Intraoperative vascular air embolism and intracardiac thrombosis complicating liver transplantation: a case report. J-Med-Case-Rep 2024; 18 1-4.$60$YR$$F$Y$$$20240806$$HP$US$US
241781581$24178158$1$I$$20240729$20240806$20240806$EXP$$US-MYLANLABS-2024M1072126$MYLAN$Puthumana RM, Mintz J, Perez M, Gaddipati S, Gorman D. Too Much of a Good Thing: A Case of Beta Blocker and Warfarin Toxicity. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A5692.$38$YR$$M$Y$$$20240806$$HP$US$US
241781591$24178159$1$I$$20240729$20240806$20240806$EXP$$US-MYLANLABS-2024M1071853$MYLAN$Kaur S, Isaac S, Westerman J. Life threatening hematologic emergency from low dose methrotrexate. South-Med-J 2023; 116 641-642.$63$YR$$F$Y$$$20240806$$MD$US$US
241781601$24178160$1$I$$20240729$20240806$20240806$EXP$$US-MYLANLABS-2024M1072764$MYLAN$Das S, Ailawadhi S, Sher T, Roy V, Fernandez A, Parrondo RD. Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety. Curr-Oncol 2023; 30 9627-9633.$62$YR$$F$Y$$$20240806$$HP$US$US
241781611$24178161$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA225945$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240806$$CN$US$US
241781621$24178162$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA230117$SANOFI AVENTIS$$$$A$F$Y$97.5$KG$20240806$$HP$US$US
241781631$24178163$1$I$$20240801$20240806$20240806$PER$$US-SA-2024SA229464$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240806$$CN$US$US
241781641$24178164$1$I$20240101$20240726$20240806$20240806$PER$$US-SA-2024SA225726$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240806$$MD$US$US
241781651$24178165$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA225716$SANOFI AVENTIS$$$$E$M$Y$77.11$KG$20240806$$MD$US$US
241781661$24178166$1$I$$20240801$20240806$20240806$PER$$US-SA-2024SA229483$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240806$$CN$US$US
241781671$24178167$1$I$$20240802$20240806$20240806$EXP$$US-TAKEDA-2024TUS073323$TAKEDA$$$$$F$Y$$$20240806$$CN$US$US
241781691$24178169$1$I$20240524$20240802$20240806$20240806$EXP$FR-AFSSAPS-AM2024000623$FR-TAKEDA-2024TUS077863$TAKEDA$$74$YR$$M$Y$64$KG$20240806$$HP$FR$FR
241781701$24178170$1$I$20240101$20240802$20240806$20240806$EXP$$US-ABBVIE-5865915$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241781711$24178171$1$I$20240701$20240730$20240806$20240806$PER$$US-SA-2024SA228997$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240806$$MD$US$US
241781721$24178172$1$I$20230101$20240726$20240806$20240806$PER$$US-SA-2024SA227230$SANOFI AVENTIS$$16$YR$T$F$Y$55.7$KG$20240806$$CN$US$US
241781731$24178173$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA227083$SANOFI AVENTIS$$$$E$M$Y$78.9$KG$20240806$$MD$US$US
241781741$24178174$1$I$20240701$20240729$20240806$20240806$PER$$US-SA-2024SA226019$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240806$$CN$US$US
241781751$24178175$1$I$20240701$20240728$20240806$20240806$PER$$US-SA-2024SA226030$SANOFI AVENTIS$$58$YR$A$F$Y$79.3$KG$20240806$$CN$US$US
241781761$24178176$1$I$20240701$20240726$20240806$20240806$PER$$US-SA-2024SA225548$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240806$$MD$US$US
241781771$24178177$1$I$$20240730$20240806$20240806$EXP$CA-MLMSERVICE-20240719-PI137468-00206-4$CA-CHEPLA-2024010016$CHEPLAPHARM$Reyes NG, Bendahan N, Swinkin E, Lang AE, Bassett AS. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2024:1-6. DOI: 10.1007/s10072-024-07705-3.$47$YR$$F$Y$$$20240806$$MD$COUNTRY NOT SPECIFIED$CA
241781782$24178178$2$F$$20240808$20240806$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-037760$AUROBINDO$$$$$F$Y$$$20240819$$CN$FR$FR
241781791$24178179$1$I$$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121924$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240806$$CN$US$US
241781801$24178180$1$I$20240724$20240802$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123492$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240806$$CN$US$US
241781812$24178181$2$F$$20240819$20240806$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123380$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240827$$MD$US$US
241781822$24178182$2$F$20240722$20240829$20240806$20240909$PER$$US-ROCHE-10000040821$ROCHE$$$$$$Y$$$20240909$$MD$US$US
241781831$24178183$1$I$$20240726$20240806$20240806$EXP$$US-AUROBINDO-AUR-APL-2024-038514$AUROBINDO$$64$YR$$M$Y$$$20240806$$PH$US$US
241781841$24178184$1$I$$20240730$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122775$BRISTOL MYERS SQUIBB$Levin S, Houser JN, Siblini H, Marshall M, Wolf J. Persistent listeria monocytogenes cerebritis mimicking cerebral metastases due to melanoma. Cureus. 2024 Jun 18;16(6):1-7. doi:10.7759/cureus.62634.$8$DEC$E$F$Y$$$20240806$$MD$US$US
241781851$24178185$1$I$$20240731$20240806$20240806$EXP$$US-GSK-US2024AMR097370$GLAXOSMITHKLINE$$$$$F$Y$59.592$KG$20240806$$CN$US$US
241781862$24178186$2$F$$20240719$20240806$20240904$PER$$US-AstraZeneca-2024A165694$ASTRAZENECA$$$$$$Y$$$20240904$$CN$US$
241781871$24178187$1$I$20240101$20240726$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-038252$AUROBINDO$$35$YR$$M$Y$$$20240806$$HP$FR$FR
241781882$24178188$2$F$20240801$20240813$20240806$20240816$EXP$$CL-PFIZER INC-PV202400100511$PFIZER$$7$YR$$F$Y$24$KG$20240816$$CN$CL$CL
241781914$24178191$4$F$20240731$20240822$20240806$20240822$30DAY$$CO-PFIZER INC-PV202400100493$PFIZER$$8$YR$$M$Y$$$20240822$$CN$CO$CO
241781923$24178192$3$F$20240702$20240907$20240806$20240909$30DAY$$US-PFIZER INC-PV202400081092$PFIZER$$14$YR$$M$Y$53$KG$20240909$$MD$US$US
241781931$24178193$1$I$$20240801$20240806$20240806$30DAY$$US-PFIZER INC-PV202400044207$PFIZER$$$$$F$Y$$$20240806$$HP$US$US
241781941$24178194$1$I$$20240731$20240806$20240806$30DAY$$TR-PFIZER INC-PV202400084613$PFIZER$$$$$$Y$$$20240806$$PH$TR$TR
241781951$24178195$1$I$$20240729$20240806$20240806$30DAY$$JP-PFIZER INC-202400190136$PFIZER$$$$$$Y$$$20240806$$PH$JP$JP
241781961$24178196$1$I$$20240802$20240806$20240806$EXP$$CA-PFIZER INC-202400230294$PFIZER$$64$YR$$F$Y$$$20240806$$MD$CA$CA
241781971$24178197$1$I$20240703$20240802$20240806$20240806$EXP$GB-MHRA-MED-202408021652047320-ZHLTQ$GB-PFIZER INC-202400229323$PFIZER$$$$$F$Y$45$KG$20240806$$MD$GB$GB
241781984$24178198$4$F$$20240909$20240806$20240911$30DAY$$US-PFIZER INC-202400228127$PFIZER$$14$YR$$M$Y$$$20240911$$CN$US$US
241781991$24178199$1$I$20240703$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037723$AUROBINDO$$21$YR$$F$Y$57$KG$20240806$$PH$FR$FR
241782001$24178200$1$I$$20240729$20240806$20240806$EXP$$US-ROCHE-10000042070$ROCHE$$68$YR$E$F$Y$$$20240806$$CN$US$US
241782011$24178201$1$I$$20240729$20240806$20240806$PER$$US-BEH-2024176536$CSL BEHRING$$$$A$M$Y$$$20240806$$HP$US$US
241782021$24178202$1$I$20240101$20240801$20240806$20240806$EXP$$US-ABBVIE-5864613$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241782031$24178203$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024154060$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241782041$24178204$1$I$20210201$20240730$20240806$20240806$EXP$$ES-ASTELLAS-2024EU007546$ASTELLAS$$60$YR$$M$Y$$$20240806$$HP$ES$ES
241782051$24178205$1$I$20211201$20240729$20240806$20240806$EXP$US-MLMSERVICE-20240723-PI138209-00145-1$US-RDY-SPO/USA/24/0011232$DR REDDYS$Allami N, O^Connor K, Bagley SM. A case of severe opioid and methamphetamine use disorder in a 14 year old. Addiction Science and Clinical Practice. 2024;19:54. DOI:10.1186/s13722-024-00487-1.$14$YR$T$F$Y$$$20240806$$HP$US$US
241782062$24178206$2$F$$20240814$20240806$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-037858$AUROBINDO$$33$YR$$F$Y$115$KG$20240827$$MD$GB$GB
241782071$24178207$1$I$20240609$20240729$20240806$20240806$EXP$DE-CADRBFARM-2024329453$DE-CHEPLA-2024009908$CHEPLAPHARM$$34$YR$$M$Y$117$KG$20240806$$CN$COUNTRY NOT SPECIFIED$DE
241782081$24178208$1$I$20240101$20240801$20240806$20240806$EXP$$CA-ABBVIE-5866190$ABBVIE$$87$YR$$M$Y$$$20240806$$HP$CA$CA
241782092$24178209$2$F$$20240905$20240806$20240916$30DAY$$TR-JNJFOC-20240804199$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$TR$TR
241782102$24178210$2$F$$20240903$20240806$20240906$EXP$$CA-JNJFOC-20240155374$JOHNSON AND JOHNSON$$71$YR$E$F$Y$69$KG$20240906$$HP$CA$CA
241782111$24178211$1$I$20240801$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153944$AMGEN$$81$YR$E$F$Y$$$20240806$$CN$US$US
241782131$24178213$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024155170$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241782142$24178214$2$F$$20240906$20240806$20240913$EXP$$JP-AMGEN-JPNSP2024153237$AMGEN$$$$E$F$Y$$$20240912$$MD$JP$JP
241782161$24178216$1$I$20240304$20240726$20240806$20240806$EXP$$ES-AUROBINDO-AUR-APL-2024-038196$AUROBINDO$$76$YR$$F$Y$$$20240806$$MD$ES$ES
241782171$24178217$1$I$20240728$20240805$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123753$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240806$$HP$US$US
241782213$24178221$3$F$$20240808$20240806$20240814$EXP$$US-ABBVIE-5865823$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
241782221$24178222$1$I$$20240725$20240806$20240806$EXP$CA-MHPD-001092510$CA-Accord-438594$ACCORD$$80$YR$E$M$Y$72$KG$20240806$$HP$CA$CA
241782231$24178223$1$I$20240704$20240725$20240806$20240806$EXP$CN-HENLIUS-24CN016134$CN-Accord-439375$ACCORD$$62$YR$A$F$Y$59$KG$20240806$$MD$CN$CN
241782252$24178225$2$F$$20240822$20240806$20240904$EXP$CA-MHPD-E2B_07184725$CA-Accord-438572$ACCORD$$64$YR$A$M$Y$$$20240903$$HP$CA$CA
241782261$24178226$1$I$$20240726$20240806$20240806$EXP$CA-MHPD-001086787$CA-Accord-438867$ACCORD$$70$YR$E$M$Y$$$20240806$$MD$CA$CA
241782271$24178227$1$I$$20240729$20240806$20240806$EXP$$US-BAYER-2024A111100$BAYER$$$$$$Y$$$20240806$$CN$US$US
241782281$24178228$1$I$$20240726$20240806$20240806$EXP$GB-MHRA-MED-202407262147142410-THDNB$GB-Accord-439091$ACCORD$$39$YR$A$M$Y$59$KG$20240806$$CN$GB$GB
241782291$24178229$1$I$$20230928$20240806$20240806$EXP$$AT-SANDOZ INC.-SDZ2023AT036585$SANDOZ$$$$$$Y$$$20240806$$MD$AT$AT
241782301$24178230$1$I$20240726$20240726$20240806$20240806$PER$$US-ABBVIE-5859296$ABBVIE$$48$YR$$M$Y$$$20240806$$CN$US$US
241782311$24178231$1$I$$20231219$20240806$20240806$EXP$$PT-SANDOZ INC.-SDZ2023PT070318$SANDOZ$$$$$$Y$$$20240806$$CN$PT$PT
241782321$24178232$1$I$$20240213$20240806$20240806$EXP$$KR-SANDOZ INC.-SDZ2024KR015800$SANDOZ$Jang D K, Lee J K.. Drug-induced A cute Pancreatitis: A Hospital-based Analysis.. Gut and Liver. 11:166$$$$$Y$$$20240806$$HP$KR$KR
241782331$24178233$1$I$20240728$20240730$20240806$20240806$EXP$$CN-ROCHE-10000042646$ROCHE$$50$YR$A$F$Y$$$20240806$$MD$CN$CN
241782341$24178234$1$I$$20240226$20240806$20240806$EXP$$CN-SANDOZ INC.-SDZ2024CN021439$SANDOZ$Yang Yang , Jingsong He , Yi Zhao , Wenjun Wu , Gaofeng Zheng , Xiaoyan Han , Donghua He , Tao Cheng , Zhen Cai. Preliminary Outcomes of Orelabrutinib Plus R-CHOP in Treatment-Naive Patients with Double-Expression Diffuse Large B-Cell Lymphoma. Blood. 2023$$$$$Y$$$20240806$$MD$CN$CN
241782351$24178235$1$I$$20240725$20240806$20240806$EXP$$AU-Accord-438376$ACCORD$Roberts MB, Lee J, Murphy MC, Kim AY, Coglianese EE, Hilburn C. Case 37-2022: A 55-Year-Old Man with Fatigue, Weight Loss, and Pulmonary Nodules. New England Journal of Medicine. 2022;387(23):2172-83$55$YR$A$M$Y$$$20240806$$MD$AU$AU
241782363$24178236$3$F$$20240912$20240806$20240920$30DAY$$US-GSK-US2024096373$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$PH$US$US
241782371$24178237$1$I$$20240730$20240806$20240806$EXP$$US-GSK-US2024AMR095571$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$US$US
241782381$24178238$1$I$$20240726$20240806$20240806$EXP$$US-MYLANLABS-2024M1071588$MYLAN$Pushparaji B, Sankar PR, Achuthanandan S, Basnet A, Cordeiro N, Epstein DJ, et al. ECMO rescue in fulminant myocarditis: taming the VT STORM. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3851.$38$YR$$F$Y$$$20240806$$HP$US$US
241782391$24178239$1$I$$20240726$20240806$20240806$EXP$$NL-MYLANLABS-2024M1071658$MYLAN$Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, et al. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series. J-Neurol 2024; 271 4028-4038.$14$YR$$F$Y$$$20240806$$HP$NL$NL
241782401$24178240$1$I$20240723$20240725$20240806$20240806$EXP$$US-Accord-438910$ACCORD$$80$YR$E$$Y$$$20240806$$HP$US$US
241782411$24178241$1$I$20240706$20240726$20240806$20240806$EXP$GB-MHRA-TPP21320611C3283055YC1722018200841$GB-Accord-439117$ACCORD$$75$YR$E$M$Y$84$KG$20240806$$MD$GB$GB
241782421$24178242$1$I$$20240725$20240806$20240806$EXP$$US-Accord-438878$ACCORD$$60$YR$A$F$Y$$$20240806$$MD$US$US
241782431$24178243$1$I$$20240728$20240806$20240806$EXP$$LT-Accord-439081$ACCORD$Ulianskaite G, Timinskaite F, Raudonis T. Severe pityriasis rubra pilaris complicated with Kaposi^s varicelliform eruption and cutaneous MRSA infection case report. Heliyon. 2024 Jun 27;10(13):e33750. doi: 10.1016/j.heliyon.2024.e33750.$62$YR$A$F$Y$$$20240806$$HP$LT$LT
241782441$24178244$1$I$20240508$20240726$20240806$20240806$EXP$PT-INFARMED-B202407-259$PT-Accord-438715$ACCORD$$58$YR$A$M$Y$$$20240806$$MD$PT$PT
241782472$24178247$2$F$20240316$20240828$20240806$20240911$EXP$$IN-ROCHE-10000046034$ROCHE$$78$YR$E$F$Y$$$20240911$$HP$IN$IN
241782482$24178248$2$F$20240802$20240802$20240806$20240807$EXP$$US-ROCHE-10000048224$ROCHE$$59$YR$A$F$Y$$$20240807$$CN$US$US
241782493$24178249$3$F$20240101$20240920$20240806$20240920$30DAY$$US-PFIZER INC-202400227733$PFIZER$$4$YR$$M$Y$$$20240920$$CN$US$US
241782502$24178250$2$F$20240729$20240827$20240806$20240830$30DAY$$KR-PFIZER INC-PV202400100331$PFIZER$$5$YR$$M$Y$$$20240830$$HP$KR$KR
241782511$24178251$1$I$20230621$20240801$20240806$20240806$30DAY$$US-PFIZER INC-PV202400044257$PFIZER$$$$$$Y$$$20240806$$HP$US$US
241782522$24178252$2$F$$20240905$20240806$20240905$30DAY$$US-PFIZER INC-202400228146$PFIZER$$10$YR$$M$Y$$$20240905$$CN$US$US
241782531$24178253$1$I$$20240802$20240806$20240806$30DAY$$US-PFIZER INC-PV202400044482$PFIZER$$$$$$Y$$$20240806$$HP$US$US
241782543$24178254$3$F$$20240912$20240806$20240912$30DAY$$US-PFIZER INC-202400225042$PFIZER$$9$YR$$F$Y$$$20240912$$CN$US$US
241782552$24178255$2$F$$20240905$20240806$20240905$30DAY$$US-PFIZER INC-PV202400097397$PFIZER$$15$YR$$M$Y$$$20240905$$HP$US$US
241782562$24178256$2$F$20230731$20240827$20240806$20240830$EXP$$CA-PFIZER INC-202300250410$PFIZER$$68$YR$$M$Y$$$20240830$$HP$CA$CA
241782572$24178257$2$F$20240701$20240906$20240806$20240909$30DAY$$US-PFIZER INC-202400227902$PFIZER$$10$YR$$M$Y$$$20240909$$CN$US$US
241782582$24178258$2$F$20230101$20240927$20240806$20240927$EXP$$CA-PFIZER INC-202300373169$PFIZER$$83$YR$$F$Y$$$20240927$$HP$CA$CA
241782592$24178259$2$F$$20240905$20240806$20240905$30DAY$$US-PFIZER INC-202400224209$PFIZER$$15$YR$$M$Y$$$20240905$$CN$US$US
241782613$24178261$3$F$$20240828$20240806$20240903$30DAY$$US-PFIZER INC-202400228154$PFIZER$$11$YR$$F$Y$38.55$KG$20240903$$HP$US$US
241782621$24178262$1$I$$20240802$20240806$20240806$30DAY$$US-PFIZER INC-PV202400044720$PFIZER$$$$$$Y$$$20240806$$HP$US$US
241782633$24178263$3$F$$20240907$20240806$20240909$30DAY$$US-PFIZER INC-202400226476$PFIZER$$14$YR$$M$Y$$$20240909$$CN$US$US
241782642$24178264$2$F$$20240905$20240806$20240905$30DAY$$US-PFIZER INC-202400227233$PFIZER$$7$YR$$M$Y$$$20240905$$CN$US$US
241782651$24178265$1$I$$20240730$20240806$20240806$EXP$$CN-CHEPLA-2024009947$CHEPLAPHARM$Qian YF, Chen HP, Ren GF. Acute therapy-related myelodysplastic syndromes following capecitabine and oxaliplatin therapy in gastric malignant tumor: A case report. Medicine (Baltimore). 2024;103(30):e39049. doi: 10.1097/MD.0000000000039049.$60$YR$$M$Y$$$20240806$$HP$COUNTRY NOT SPECIFIED$CN
241782661$24178266$1$I$$20240726$20240806$20240806$30DAY$$CO-PFIZER INC-PV202400098586$PFIZER$$11$YR$$M$Y$$$20240806$$CN$CO$CO
241782671$24178267$1$I$$20240801$20240806$20240806$EXP$$GB-PFIZER INC-PV202400100415$PFIZER$$61$YR$$F$Y$$$20240806$$CN$GB$GB
241782681$24178268$1$I$$20240802$20240806$20240806$30DAY$$US-PFIZER INC-PV202400044717$PFIZER$$$$$$Y$$$20240806$$HP$US$US
241782692$24178269$2$F$$20240920$20240806$20240924$30DAY$$JP-PFIZER INC-PV202400099416$PFIZER$$10$YR$$M$Y$$$20240924$$MD$JP$JP
241782705$24178270$5$F$20240729$20240920$20240806$20240925$30DAY$$GR-PFIZER INC-PV202400100437$PFIZER$$4$YR$$F$Y$17$KG$20240925$$HP$GR$GR
241782721$24178272$1$I$20240626$20240726$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037851$AUROBINDO$$66$YR$$F$Y$$$20240806$$MD$FR$FR
241782731$24178273$1$I$20240601$20240729$20240806$20240806$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010273$JAZZ$$59$YR$$$Y$$$20240806$$MD$JP$JP
241782741$24178274$1$I$$20240729$20240806$20240806$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005621$BIOCON$$$$$$Y$$$20240806$$HP$CA$CA
241782751$24178275$1$I$20211001$20240730$20240806$20240806$EXP$$US-BIOGEN-2024BI01276466$BIOGEN$$62$YR$$F$Y$$$20240806$$CN$US$US
241782761$24178276$1$I$$20240802$20240806$20240806$EXP$$FI-ROCHE-10000046912$ROCHE$$$$E$M$Y$$$20240806$$PH$FI$FI
241782772$24178277$2$F$$20240902$20240806$20240911$EXP$$JP-TEVA-VS-3227381$TEVA$Nakai T, Seki H, Makino A, Kadota Y, Kaburagi T, Okumura T, et al. Development of neuro-Behcet^s disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy: A case report. Breast-Disease 2024; 43 (1): 223-229.; Nakai T, Seki H, Makino A, Kadota Y, Kaburagi T, Okumura T, et al. Development of neuro-Behcet^s disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy: A case report. Breast-Disease 2024; 43 (1): 223-229.; Nak...$40$YR$$F$Y$$$20240911$$HP$JP$JP
241782781$24178278$1$I$$20240725$20240806$20240806$EXP$$TR-P+L Developments of Newyork Corporation-2160063$PL DEVELOPMENTS$Initial$13$YR$$$Y$$$20240806$$$TR$TR
241782791$24178279$1$I$$20240731$20240806$20240806$PER$$US-009507513-2408USA000508$MERCK$$$$$F$Y$$$20240806$$CN$US$US
241782801$24178280$1$I$20240601$20240729$20240806$20240806$EXP$$IN-ROCHE-10000042585$ROCHE$$76$YR$E$M$Y$$$20240806$$CN$IN$IN
241782821$24178282$1$I$20220101$20230117$20240806$20240806$EXP$$US-RECORDATI-2022006852$RECORDATI$$$$$$Y$$$20240806$$CN$US$US
241782831$24178283$1$I$$20240729$20240806$20240806$EXP$$IE-MYLANLABS-2024M1071994$MYLAN$Crotty TJ, Sexton GP, Kavanagh F, Kinsella J, Lennon P, Timon CV, et al. Fatal cerebritis and ventriculitis secondary to tracheoesophageal prosthesis. J-Surg-Case-Rep 2024; 2024 (4):.$70$YR$$M$Y$$$20240806$$HP$IE$IE
241782841$24178284$1$I$$20240729$20240806$20240806$EXP$$JP-MYLANLABS-2024M1071971$MYLAN$Kakeshita K, Imamura T, Onoda H, Kinugawa K. Impact of Goreisan upon aquaporin-2-incorporated aquaresis system in patients with congestive heart failure. CEN-Case-Rep 2023; 12 (1): 73-77.. 2023;12 (1):73-77$81$YR$$M$Y$$$20240806$$HP$JP$JP
241782852$24178285$2$F$$20240805$20240806$20240814$EXP$$FR-MYLANLABS-2024M1071787$MYLAN$Naim G, Malissin I, Megarbane B. Cerebral microbleeds in the poisoned patient: An observational magnetic resonance imaging study. Basic-Clin-Pharmacol-Toxicol 2023; 133 770-777.$72$YR$$F$Y$$$20240814$$HP$FR$FR
241782861$24178286$1$I$$20240729$20240806$20240806$EXP$$FR-MYLANLABS-2024M1071830$MYLAN$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2023; 35 (1): 54-59.$45$YR$$M$Y$$$20240806$$HP$FR$FR
241782871$24178287$1$I$$20240729$20240806$20240806$EXP$$MY-MYLANLABS-2024M1072097$MYLAN$Abdullah N, Rosly N, Pauzi SHM, Mustapha AW, Arifuddin Y. Case report: Axillary lymph node metastases from primary ovarian cancer: a report of two cases and literature review. Front-Oncol 2024; 14.$54$YR$$F$Y$$$20240806$$HP$MY$MY
241782881$24178288$1$I$$20240730$20240806$20240806$PER$$US-ALXN-202407USA002256US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$HP$US$US
241782891$24178289$1$I$20240802$20240802$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123347$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240806$$CN$US$US
241782912$24178291$2$F$$20240924$20240806$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123617$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240926$$HP$US$US
241782922$24178292$2$F$$20240826$20240806$20240826$EXP$$US-ALXN-202407USA002218US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241782932$24178293$2$F$$20240807$20240806$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121231$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240809$$CN$US$US
241782943$24178294$3$F$$20240919$20240806$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123603$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$58.06$KG$20240920$$CN$US$US
241782951$24178295$1$I$20240701$20240731$20240806$20240806$PER$$US-SA-2024SA230490$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240806$$MD$US$US
241782961$24178296$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA225830$SANOFI AVENTIS$$$$C$M$Y$$$20240806$$MD$US$US
241782971$24178297$1$I$20240701$20240730$20240806$20240806$PER$$US-SA-2024SA226613$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240806$$CN$US$US
241782981$24178298$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA097313$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240806$$MD$US$US
241782991$24178299$1$I$20240701$20240726$20240806$20240806$PER$$US-SA-2024SA225736$SANOFI AVENTIS$$49$YR$A$M$Y$77$KG$20240806$$MD$US$US
241783001$24178300$1$I$20240723$20240731$20240806$20240806$PER$$US-SA-2024SA230141$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240806$$HP$US$US
241783011$24178301$1$I$$20240802$20240806$20240806$PER$$NVSC2024US158808$NOVARTIS$$$$$$Y$$$20240806$$HP$US$US
241783021$24178302$1$I$$20240612$20240805$20240805$DIR$FDA-CDER-CTU-2024-53669$$FDA-CTU$$$$$$N$$$20240612$N$$US$
241783031$24178303$1$I$$20240726$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-039054$AUROBINDO$$76$YR$$F$Y$$$20240806$$PH$CA$CA
241783041$24178304$1$I$$20240729$20240806$20240806$EXP$$AR-CHEPLA-2024010046$CHEPLAPHARM$Espindola M, Rojas NG, Vaisentein G, Da Prat G, Cesarini M, Etcheverry JL, et.al. Suicide attempt in a dopamine agonist withdrawal syndrome in Parkinson^s disease. Parkinsonism and Related Disorders. 2024;121:106017. doi: 10.1016/j.parkreldis.2024.106017.$43$YR$$M$Y$$$20240806$$HP$COUNTRY NOT SPECIFIED$AR
241783051$24178305$1$I$$20240729$20240806$20240806$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005611$BIOCON$$$$$$Y$$$20240806$$MD$CA$CA
241783061$24178306$1$I$$20240226$20240806$20240806$EXP$$TH-SANDOZ INC.-SDZ2024TH021090$SANDOZ$Bunworasate, U., Wudhikarn, K., Rattanathammethee, T., Norasetthada, L., Niparuck, P., Chancharunee, S., Chansung, K., Khuhapinant, A., Wong, P., Praditsuktavorn, P., Numbenjapon, T., Julamanee, J., +. Brentuximab vedotin in combination with methotrexate, L-Asparaginase, and Dexamethasone (B-mad) as frontline treatment for patients with extranodal NK/T-cell lymphoma. Blood. 2023;142:4434$$$$$Y$$$20240806$$MD$TH$TH
241783071$24178307$1$I$20240319$20240726$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037864$AUROBINDO$$79$YR$$$Y$$$20240806$$PH$GB$GB
241783084$24178308$4$F$20240728$20240914$20240806$20240916$30DAY$$US-PFIZER INC-202400227330$PFIZER$$12$YR$$F$Y$$$20240916$$CN$US$US
241783091$24178309$1$I$$20240731$20240806$20240806$30DAY$$PA-PFIZER INC-202400228330$PFIZER$$$$$$Y$$$20240806$$CN$PA$PA
241783102$24178310$2$F$$20240906$20240806$20240909$30DAY$$US-PFIZER INC-202400223121$PFIZER$$14$YR$$M$Y$$$20240909$$CN$US$US
241783112$24178311$2$F$20240329$20240809$20240806$20240814$30DAY$$US-PFIZER INC-PV202400044125$PFIZER$$$$$$Y$$$20240814$$HP$US$US
241783121$24178312$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008950$APOTEX$$64$YR$$M$Y$$$20240806$$CN$CA$CA
241783132$24178313$2$F$20240722$20240828$20240806$20240830$PER$$US-ROCHE-10000047153$ROCHE$$45$YR$A$F$Y$$$20240830$$CN$US$US
241783141$24178314$1$I$$20240117$20240806$20240806$EXP$$AT-SANDOZ INC.-SDZ2024AT005874$SANDOZ$Ertl B.. Parenterals containing magnesium.. Medical Tribune.. 2024$$$$$Y$$$20240806$$HP$AT$AT
241783151$24178315$1$I$$20240728$20240806$20240806$EXP$$US-IHL-000596$INVENTIA HEALTHCARE$$$$N$M$Y$$$20240730$$MD$US$US
241783161$24178316$1$I$$20240802$20240806$20240806$PER$$NVSC2024US159238$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
241783171$24178317$1$I$20240706$20240726$20240806$20240806$EXP$$GB-AUROBINDO-AUR-APL-2024-037929$AUROBINDO$$75$YR$$M$Y$84$KG$20240806$$MD$GB$GB
241783181$24178318$1$I$$20240726$20240806$20240806$EXP$$US-RDY-LIT/USA/24/0011195$DR REDDYS$Rafeq R, Salzman M. Use of Concentrated Insulin in the Management of Calcium Channel Blocker Overdose: A Case Report. Journal of pharmacy practice. 2023;36(6): 1519-1522. doi:10.1177/08971900221116189.$73$YR$E$F$Y$69.9$KG$20240806$$PH$US$US
241783191$24178319$1$I$$20240723$20240806$20240806$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110400$ZYDUS PHARM$Golob S, Ting P, Pires K, Soetanto V, Pagano B, Wan K-L, et al.. Bupropion Overdose Requiring Veno-Arterial Extracorporeal Membrane Oxygenation.. Circulation. 2023;148 (Suppl.)$$$$$Y$$$20240806$$HP$US$US
241783211$24178321$1$I$$20240730$20240806$20240806$EXP$$US-BAYER-2024A091813$BAYER$$57$YR$A$F$Y$64.853$KG$20240806$$CN$US$US
241783221$24178322$1$I$$20240725$20240806$20240806$EXP$$US-B.Braun Medical Inc.-2160064$B BRAUN$Literature Article$50$YR$$M$Y$$$20240806$$$US$US
241783231$24178323$1$I$$20240723$20240806$20240806$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07116$HIKMA$Belmore L, Ahn T, Nguyen E, Lenz T.. Belmore L, Ahn T, Nguyen E, Lenz T. Acute non-ST segment elevation myocardial infarction following intravenous injection of sublingual Suboxone.. Prehospital emergency care. 2024;1-11:1-4$41$YR$$M$Y$$$20240806$$MD$US$US
241783243$24178324$3$F$20240101$20240808$20240806$20240905$PER$$US-BEH-2024176556$CSL BEHRING$$$$A$F$Y$$$20240905$$CN$US$US
241783251$24178325$1$I$$20240729$20240806$20240806$EXP$$IN-MYLANLABS-2024M1072204$MYLAN$Saha AK, Padhi P, Hota D, Rathore V. Neonatal Acute Kidney Injury due to Maternal Olmesartan Intake. Indian-J-Pediatr 2024; 91 (8): 869.$$$$F$Y$$$20240806$$HP$IN$IN
241783261$24178326$1$I$$20240726$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038832$AUROBINDO$$$$$M$Y$97$KG$20240806$$HP$CA$CA
241783271$24178327$1$I$20230101$20240729$20240806$20240806$EXP$$US-ROCHE-10000041872$ROCHE$$57$YR$A$F$Y$$$20240806$$CN$US$US
241783283$24178328$3$F$$20240906$20240806$20240914$PER$$US-ROCHE-10000049092$ROCHE$$$$$$Y$$$20240914$$MD$US$US
241783291$24178329$1$I$$20240729$20240806$20240806$EXP$$JP-ROCHE-10000028476$ROCHE$Takada T, Katoh R, Yamada K, Ojima H. Two cases of metastatic colorectal cancer with prolonged liver injury following capecitabine combination chemotherapy. BMJ Case Rep. 2024;(17):1-4. doi:10.1136/bcr-2024- 260012.$5$DEC$A$M$Y$$$20240806$$MD$JP$JP
241783301$24178330$1$I$$20240729$20240806$20240806$EXP$$NL-MYLANLABS-2024M1071789$MYLAN$Storm KK, De Herdt D, Coudere K, Verweij JJ, Torn L, Hundscheid T, et al. Severe neonatal enterovirus infection in twins with different outcomes: A case report. Front-Pediatr 2023; 11.$7$DY$$F$Y$2.05$KG$20240806$$HP$NL$NL
241783311$24178331$1$I$$20210917$20240806$20240806$EXP$$US-AstraZeneca-2021A733612$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241783321$24178332$1$I$$20220317$20240806$20240806$EXP$$US-AstraZeneca-2022A120530$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241783332$24178333$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683071$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241783341$24178334$1$I$$20240729$20240806$20240806$EXP$$GR-BIOCON BIOLOGICS LIMITED-BBL2024005604$BIOCON$$$$$$Y$$$20240806$$MD$GR$GR
241783351$24178335$1$I$$20221207$20240806$20240806$EXP$$TW-AstraZeneca-2022A372475$ASTRAZENECA$$73$YR$$F$Y$$$20240806$$CN$TW$
241783361$24178336$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001998$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240806$$CN$US$US
241783371$24178337$1$I$$20240725$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407017252$ELI LILLY AND CO$$$$$$Y$$$20240806$$CN$US$US
241783381$24178338$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001981$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240806$$CN$US$US
241783391$24178339$1$I$$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000255$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240806$$CN$US$US
241783401$24178340$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001949$ELI LILLY AND CO$$16$YR$T$F$Y$$$20240806$$HP$US$US
241783421$24178342$1$I$$20240619$20240805$20240805$DIR$FDA-CDER-CTU-2024-53654$$FDA-CTU$$$$$$N$$$20240619$N$HP$US$
241783431$24178343$1$I$20240709$20240729$20240806$20240806$EXP$$IN-ROCHE-10000049312$ROCHE$$42$YR$A$$Y$$$20240806$$MD$IN$IN
241783441$24178344$1$I$$20240801$20240806$20240806$EXP$$US-TAKEDA-2024TUS078114$TAKEDA$$$$$M$Y$$$20240806$$MD$US$US
241783452$24178345$2$F$20240601$20240814$20240806$20240822$EXP$$EG-BIOGEN-2024BI01276469$BIOGEN$$0$YR$$M$Y$$$20240822$$CN$EG$EG
241783461$24178346$1$I$20240804$20240805$20240806$20240806$EXP$$GB-MYLANLABS-2024M1073088$MYLAN$$$$$F$Y$$$20240806$$PH$GB$GB
241783486$24178348$6$F$$20240925$20240806$20240930$EXP$$PT-HALEON-2190255$Haleon PLC$Tenreiro A., Alfaiate F., Figueira J., Cala?a S., Carvalho S. PO-0116 - (4016) - Quetiapine drug?poisoning - beyond the anamnesis. PO-0119 - (4141) - Lyell syndrome: about a case. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. 2024 May: 489.; Literature Reference:  Tenreiro A., Alfaiate F., Figueira J., Cala?a S., Carvalho S. PO-0116 - (4016) - Quetiapine drug poisoning - beyond the anamnesis. PO-0119 - (4141) - Lyel...$81$YR$$M$Y$$$20240928$$HP$PT$PT
241783491$24178349$1$I$20240706$20240803$20240806$20240806$EXP$GB-MHRA-MED-202408032339429080-BFPVN$GB-MYLANLABS-2024M1072720$MYLAN$$13$YR$$F$Y$40$KG$20240806$$CN$GB$GB
241783501$24178350$1$I$$20240802$20240806$20240806$EXP$$US-BEH-2024176797$CSL BEHRING$$$$A$M$Y$$$20240806$$MD$US$US
241783511$24178351$1$I$20240731$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024154003$AMGEN$$80$YR$E$M$Y$$$20240806$$CN$US$US
241783531$24178353$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153429$AMGEN$$83$YR$E$F$Y$$$20240806$$CN$US$US
241783542$24178354$2$F$20240731$20240823$20240806$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122969$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240903$$CN$US$US
241783551$24178355$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123653$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240806$$CN$US$US
241783562$24178356$2$F$$20240812$20240806$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123317$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$77.11$KG$20240813$$CN$US$US
241783571$24178357$1$I$$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121022$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240806$$CN$US$US
241783583$24178358$3$F$$20240826$20240806$20240829$EXP$$CA-ROCHE-10000045914$ROCHE$$$$A$F$Y$$$20240829$$CN$CA$CA
241783601$24178360$1$I$$20240726$20240806$20240806$EXP$$CA-AUROBINDO-AUR-APL-2024-038826$AUROBINDO$$$$$F$Y$$$20240806$$HP$CA$CA
241783621$24178362$1$I$20240727$20240729$20240806$20240806$PER$$US-SA-2024SA225768$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240806$$MD$US$US
241783631$24178363$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229266$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240806$$CN$US$US
241783641$24178364$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229059$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240806$$MD$US$US
241783651$24178365$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA227980$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240806$$MD$US$US
241783661$24178366$1$I$20240721$20240726$20240806$20240806$PER$$US-SA-2024SA228654$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240806$$MD$US$US
241783671$24178367$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA225759$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240806$$MD$US$US
241783681$24178368$1$I$$20240801$20240806$20240806$EXP$$US-TAKEDA-2024TUS077793$TAKEDA$$$$$F$Y$$$20240806$$CN$US$US
241783701$24178370$1$I$$20240802$20240806$20240806$EXP$$US-TAKEDA-2023TUS111287$TAKEDA$$$$$M$Y$$$20240806$$HP$US$US
241783711$24178371$1$I$20210219$20240726$20240806$20240806$EXP$DE-ROCHE-2823735$DE-ROCHE-10000040190$ROCHE$$$$$F$Y$$$20240806$$HP$DE$DE
241783721$24178372$1$I$20230724$20240724$20240806$20240806$PER$$US-JNJFOC-20240771039$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240806$$CN$US$US
241783731$24178373$1$I$20240730$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122880$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240806$$CN$US$US
241783741$24178374$1$I$20240614$20240801$20240806$20240806$EXP$FR-AFSSAPS-DJ2024000877$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-123377$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$98$KG$20240806$$MD$FR$FR
241783763$24178376$3$F$20230101$20240828$20240806$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123622$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$96.16$KG$20240829$$CN$US$US
241783771$24178377$1$I$20240422$20240726$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-038297$AUROBINDO$$53$YR$$M$Y$$$20240806$$MD$FR$FR
241783791$24178379$1$I$20210219$20240802$20240806$20240806$EXP$PT-EMA-DD-20240729-7482705-080137$PT-GILEAD-2024-0682779$GILEAD$$75$YR$E$M$Y$$$20240806$$PH$PT$PT
241783802$24178380$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0682987$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241783812$24178381$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0683076$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241783822$24178382$2$F$$20240830$20240806$20240902$30DAY$$DE-UCBSA-2024039102$UCB$$$$$F$Y$$$20240902$$CN$DE$DE
241783831$24178383$1$I$$20240731$20240806$20240806$PER$$US-BIOGEN-2024BI01276391$BIOGEN$$$$$M$Y$$$20240806$$CN$US$US
241783841$24178384$1$I$$20240801$20240806$20240806$PER$$US-BIOGEN-2024BI01275933$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241783851$24178385$1$I$$20240803$20240806$20240806$EXP$$US-KYOWAKIRIN-2024KK018705$KYOWA$$$$$$Y$$$20240806$$HP$US$US
241783861$24178386$1$I$$20240801$20240806$20240806$EXP$$US-BIOGEN-2024BI01275620$BIOGEN$$$$$M$Y$$$20240806$$HP$US$US
241783871$24178387$1$I$20240717$20240805$20240806$20240806$EXP$IS-IMA-8768$IS-GILEAD-2024-0682888$GILEAD$$71$YR$E$F$Y$$$20240806$$PH$IS$IS
241783881$24178388$1$I$20240318$20240731$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US069773$SANDOZ$$71$YR$$F$Y$56.3$KG$20240806$$HP$US$US
241783891$24178389$1$I$20240703$20240725$20240806$20240806$EXP$CZ-CZSUKL-24002064$CZ-Accord-438409$ACCORD$$63$YR$A$M$Y$75$KG$20240806$$MD$CZ$CZ
241783901$24178390$1$I$20240725$20240725$20240806$20240806$EXP$$US-Accord-438872$ACCORD$$52$YR$A$$Y$$$20240806$$HP$US$US
241783911$24178391$1$I$20240724$20240725$20240806$20240806$EXP$$US-Accord-439623$ACCORD$$45$YR$A$M$Y$$$20240806$$HP$US$US
241783921$24178392$1$I$$20240725$20240806$20240806$EXP$GB-MHRA-MED-202407251004357380-PQSYK$GB-Accord-438977$ACCORD$$$$$M$Y$$$20240806$$CN$GB$GB
241783931$24178393$1$I$$20240726$20240806$20240806$EXP$GB-MHRA-MIDB-538cdba0-a553-4ecf-a7dd-5b17618f3e21$GB-Accord-439093$ACCORD$$44$YR$A$F$Y$$$20240806$$PH$GB$GB
241783962$24178396$2$F$20240723$20240731$20240806$20240812$EXP$$US-Accord-438909$ACCORD$$34$YR$A$M$Y$$$20240812$$HP$US$US
241783971$24178397$1$I$20240511$20240725$20240806$20240806$EXP$FR-AFSSAPS-AM2024000586$FR-Accord-438637$ACCORD$$67$YR$E$F$Y$74$KG$20240806$$PH$FR$FR
241783981$24178398$1$I$20240724$20240725$20240806$20240806$EXP$$US-Accord-439630$ACCORD$$37$YR$A$M$Y$$$20240806$$PH$US$US
241783991$24178399$1$I$20240723$20240725$20240806$20240806$EXP$$US-Accord-438874$ACCORD$$68$YR$E$M$Y$$$20240806$$HP$US$US
241784001$24178400$1$I$$20240726$20240806$20240806$EXP$$HU-Accord-438625$ACCORD$Korei A, Zsigrai S, Kurucz P, Lengyel B, Vagi O, Horvath V, et al. Hypoglycaemia-induced cardiac arrhythmia as the background of recurring syncope in an old patient with diabetes and cardiovascular autonomic neuropathy - A case report. Diabetes, Stoffwechsel und Herz. 2024;33(3):166-72.$84$YR$E$F$Y$$$20240806$$MD$HU$HU
241784011$24178401$1$I$$20240726$20240806$20240806$EXP$CA-MHPD-E2B_07170154$CA-Accord-438881$ACCORD$$6$MON$I$F$Y$$$20240806$$HP$CA$CA
241784021$24178402$1$I$$20240726$20240806$20240806$EXP$CA-MHPD-001089100$CA-Accord-438671$ACCORD$$14$YR$T$M$Y$41$KG$20240806$$PH$CA$CA
241784031$24178403$1$I$20240614$20240726$20240806$20240806$EXP$FR-AFSSAPS-TO2024001123$FR-Accord-438696$ACCORD$$58$YR$A$M$Y$100$KG$20240806$$PH$FR$FR
241784041$24178404$1$I$$20240130$20240806$20240806$EXP$$GB-SANDOZ INC.-SDZ2024GB010549$SANDOZ$$$$$$Y$$$20240806$$HP$GB$GB
241784052$24178405$2$F$$20240812$20240806$20240813$EXP$$CA-ROCHE-10000023316$ROCHE$$$$A$F$Y$$$20240813$$CN$CA$CA
241784061$24178406$1$I$$20240725$20240806$20240806$PER$$US-JNJFOC-20240775756$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241784073$24178407$3$F$$20240902$20240806$20240909$EXP$$JP-ROCHE-10000048679$ROCHE$$9$DEC$E$M$Y$$$20240909$$MD$JP$JP
241784081$24178408$1$I$20240801$20240803$20240806$20240806$PER$$US-JNJFOC-20240808457$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240806$$CN$US$US
241784091$24178409$1$I$$20240729$20240806$20240806$EXP$$US-CHEPLA-2024010026$CHEPLAPHARM$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024; 1-6. DOI:10.3233/NPM-230165.$$$N$M$Y$$$20240806$$HP$COUNTRY NOT SPECIFIED$US
241784111$24178411$1$I$$20240611$20240805$20240805$DIR$FDA-CDER-CTU-2024-53668$$FDA-CTU$$$$$$N$$$20240611$N$$US$
241784121$24178412$1$I$20240802$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154618$AMGEN$$74$YR$E$M$Y$$$20240806$$CN$US$US
241784131$24178413$1$I$20240731$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153662$AMGEN$$77$YR$E$M$Y$$$20240806$$CN$US$US
241784142$24178414$2$F$20240801$20240809$20240806$20240812$PER$$US-AMGEN-USASP2024154066$AMGEN$$87$YR$E$F$Y$$$20240812$$CN$US$US
241784151$24178415$1$I$$20240801$20240806$20240806$EXP$$US-AMGEN-USASP2024153817$AMGEN$$50$YR$A$F$Y$$$20240806$$CN$US$US
241784161$24178416$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121593$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240806$$CN$US$US
241784171$24178417$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123776$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240806$$HP$US$US
241784181$24178418$1$I$$20240803$20240806$20240806$PER$$US-TAKEDA-2024TUS078245$TAKEDA$$$$$$Y$$$20240806$$CN$US$US
241784191$24178419$1$I$$20240730$20240806$20240806$EXP$$DE-MYLANLABS-2024M1071923$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$11$YR$$M$Y$$$20240806$$HP$DE$DE
241784202$24178420$2$F$$20240822$20240806$20240827$EXP$$GB-MYLANLABS-2024M1072070$MYLAN$$$$$M$Y$$$20240827$$MD$GB$GB
241784211$24178421$1$I$$20240730$20240806$20240806$EXP$$GB-MYLANLABS-2024M1072745$MYLAN$Cavanna AE, Paini G, Purpura G, Riva A, Nacinovich R, Seri S. Gilles de la Tourette syndrome as a rare co-morbidity of Klinefelter syndrome. Neurol-Sci 2024; 45 4033?4035.$$$$M$Y$$$20240806$$HP$GB$GB
241784221$24178422$1$I$$20240730$20240806$20240806$EXP$$TW-MYLANLABS-2024M1072243$MYLAN$Tsai J-H, Lee K-T. The Real-world Experiences of Abemaciclib for Estrogen Receptor-positive Human Epidermal Growth Factor Receptor-negative-2 Metastatic Breast Cancer - Sharing from a Single Institute in Southern Taiwan. J-Cancer-Res-Pract 2024; 11 (2): 73-76.$83$YR$$F$Y$$$20240806$$MD$TW$TW
241784231$24178423$1$I$$20240730$20240806$20240806$EXP$$DE-MYLANLABS-2024M1071919$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$7$YR$$M$Y$$$20240806$$HP$DE$DE
241784241$24178424$1$I$20240728$20240729$20240806$20240806$EXP$$US-MYLANLABS-2024M1070967$MYLAN$$$$$F$Y$$$20240806$$CN$US$US
241784251$24178425$1$I$$20240730$20240806$20240806$EXP$$DE-MYLANLABS-2024M1071621$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$16$YR$$F$Y$$$20240806$$HP$DE$DE
241784261$24178426$1$I$20240601$20240730$20240806$20240806$PER$$US-SA-2024SA230307$SANOFI AVENTIS$$16$YR$T$M$Y$90.718$KG$20240806$$MD$US$US
241784271$24178427$1$I$20240701$20240726$20240806$20240806$PER$$US-SA-2024SA172048$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240806$$MD$US$US
241784281$24178428$1$I$20240601$20240730$20240806$20240806$PER$$US-SA-2024SA206851$SANOFI AVENTIS$$44$YR$A$F$Y$72.5$KG$20240806$$MD$US$US
241784291$24178429$1$I$$20240805$20240806$20240806$PER$$US-ROCHE-10000049683$ROCHE$$52$YR$A$F$Y$$$20240806$$HP$US$US
241784301$24178430$1$I$20240726$20240801$20240806$20240806$PER$$US-SA-2024SA230269$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240806$$HP$US$US
241784311$24178431$1$I$$20240617$20240805$20240805$DIR$FDA-CDER-CTU-2024-53648$$FDA-CTU$$$$$$N$$$20240617$N$HP$US$
241784321$24178432$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA230403$SANOFI AVENTIS$$$$A$F$Y$77.11$KG$20240806$$MD$US$US
241784341$24178434$1$I$20240804$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53885$$FDA-CTU$$88$YR$$F$N$$$20240805$Y$PH$US$
241784351$24178435$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190581$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241784361$24178436$1$I$20240729$20240731$20240806$20240806$PER$$US-BIOGEN-2024BI01276386$BIOGEN$$46$YR$$F$Y$$$20240806$$CN$US$US
241784372$24178437$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0682977$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241784382$24178438$2$F$20240802$20240807$20240806$20240809$PER$$US-AMGEN-USASP2024154774$AMGEN$$74$YR$E$F$Y$$$20240809$$CN$US$US
241784391$24178439$1$I$$20240728$20240806$20240806$EXP$$FR-AMGEN-FRASP2024153310$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut. 2024;1-13$$$$$Y$$$20240806$$MD$FR$FR
241784401$24178440$1$I$$20240729$20240806$20240806$PER$$US-ABBVIE-5860019$ABBVIE$$$$$$Y$$$20240806$$HP$US$US
241784411$24178441$1$I$$20240702$20240806$20240806$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06809$LUPIN$$$$$$Y$$$20240806$$CN$US$US
241784431$24178443$1$I$$20240731$20240806$20240806$PER$$US-RDY-SPO/USA/24/0011406$DR REDDYS$$22$YR$A$F$Y$$$20240806$$CN$US$US
241784441$24178444$1$I$$20240711$20240806$20240806$PER$$US-Eisai-EC-2024-170070$EISAI$$$$$F$Y$$$20240806$$HP$US$US
241784452$24178445$2$F$20240708$20240808$20240806$20240814$EXP$$US-TAKEDA-2024TUS078486$TAKEDA$$66$YR$$M$Y$$$20240814$$PH$US$US
241784461$24178446$1$I$$20240729$20240806$20240806$EXP$GB-MYLANLABS-2024M1018650$GB-RDY-SPO/GBR/24/0011206$DR REDDYS$$$$$M$Y$$$20240806$$MD$GB$GB
241784471$24178447$1$I$$20240801$20240806$20240806$EXP$$US-JNJFOC-20240805165$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241784484$24178448$4$F$$20240904$20240806$20240911$PER$$US-ROCHE-10000042363$ROCHE$$$$T$M$Y$$$20240911$$CN$US$US
241784491$24178449$1$I$20240615$20240804$20240806$20240806$EXP$GB-MHRA-MED-202408042148217470-WLNZK$GB-SANDOZ INC.-SDZ2024GB070572$SANDOZ$$39$YR$$F$Y$$$20240806$$CN$GB$GB
241784502$24178450$2$F$$20240909$20240806$20240912$EXP$$PH-TAKEDA-2024TUS077714$TAKEDA$$$$$M$Y$$$20240912$$MD$PH$PH
241784511$24178451$1$I$20240701$20240731$20240806$20240806$PER$$US-BIOGEN-2024BI01276439$BIOGEN$$48$YR$$F$Y$$$20240806$$CN$US$US
241784521$24178452$1$I$20231002$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037709$AUROBINDO$$78$YR$$M$Y$80$KG$20240806$$MD$FR$FR
241784531$24178453$1$I$$20240729$20240806$20240806$EXP$$US-CHEPLA-2024010037$CHEPLAPHARM$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024; 1-6. DOI:10.3233/NPM-230165.$$$N$M$Y$$$20240806$$HP$COUNTRY NOT SPECIFIED$US
241784541$24178454$1$I$20240802$20240802$20240806$20240806$EXP$GB-MHRA-MED-202408020906084330-PFLRZ$GB-MYLANLABS-2024M1072552$MYLAN$$62$YR$$M$Y$65$KG$20240806$$CN$GB$GB
241784551$24178455$1$I$20180101$20240802$20240806$20240806$EXP$GB-MHRA-MED-202408021518269360-JPZHR$GB-MYLANLABS-2024M1072443$MYLAN$$12$YR$$F$Y$$$20240806$$CN$GB$GB
241784571$24178457$1$I$20240710$20240802$20240806$20240806$EXP$GB-MHRA-MED-202408020016238690-BYRJM$GB-MYLANLABS-2024M1072726$MYLAN$$48$YR$$M$Y$127$KG$20240806$$CN$GB$GB
241784581$24178458$1$I$$20231102$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA050019$SANDOZ$$$$$$Y$$$20240806$$CN$CA$CA
241784591$24178459$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP009024$APOTEX$$59$YR$$F$Y$$$20240806$$CN$CA$CA
241784601$24178460$1$I$20240727$20240729$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407019208$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240806$$CN$US$US
241784611$24178461$1$I$20240301$20240716$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407010194$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240806$$CN$US$US
241784621$24178462$1$I$20240801$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002046$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240806$$CN$US$US
241784631$24178463$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002080$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240806$$CN$US$US
241784641$24178464$1$I$$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002777$ELI LILLY AND CO$$$$$M$Y$$$20240806$$CN$US$US
241784651$24178465$1$I$20240805$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408003155$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240806$$CN$US$US
241784661$24178466$1$I$20240605$20240801$20240806$20240806$EXP$ES-AEMPS-1554641$ES-SA-2024SA230359$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240806$$PH$ES$ES
241784671$24178467$1$I$$20240131$20240806$20240806$EXP$$DE-SANDOZ INC.-SDZ2024DE011645$SANDOZ$$$$$$Y$$$20240806$$CN$DE$DE
241784681$24178468$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA225133$SANOFI AVENTIS$$$$A$M$Y$$$20240806$$MD$US$US
241784691$24178469$1$I$20240101$20240731$20240806$20240806$PER$$US-SA-2024SA230451$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240806$$MD$US$US
241784701$24178470$1$I$$20240730$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070162$SANDOZ$$$$$F$Y$$$20240806$$MD$US$US
241784711$24178471$1$I$$20240802$20240806$20240806$PER$$US-SA-2024SA231777$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240806$$MD$US$US
241784722$24178472$2$F$$20240815$20240806$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-038630$AUROBINDO$unknown. unknown. unknown. unkn;unknown:unknown$67$YR$$F$Y$$$20240828$$HP$CA$CA
241784732$24178473$2$F$$20240819$20240806$20240823$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122646$BRISTOL MYERS SQUIBB$Literature citation unavailable$$$$M$Y$$$20240823$$HP$CA$CA
241784741$24178474$1$I$$20240731$20240806$20240806$PER$$US-ALXN-202407USA002220US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$HP$US$US
241784751$24178475$1$I$$20240723$20240806$20240806$EXP$$US-Long Grove-000062$Long Grove Pharmaceuticals$$$$$$Y$$$20240806$$PH$US$US
241784761$24178476$1$I$20220701$20240729$20240806$20240806$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP009507$STRIDES$$81$YR$$F$Y$$$20240806$$CN$DE$DE
241784771$24178477$1$I$20240802$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154708$AMGEN$$62$YR$A$F$Y$$$20240806$$CN$US$US
241784781$24178478$1$I$$20240727$20240806$20240806$PER$$US-JNJFOC-20240776605$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241784791$24178479$1$I$$20240722$20240806$20240806$PER$$US-JNJFOC-20240763601$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241784801$24178480$1$I$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683078$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241784812$24178481$2$F$20240322$20240831$20240806$20240911$EXP$FR-AFSSAPS-AN2024000940$FR-AUROBINDO-AUR-APL-2024-037734$AUROBINDO$$84$YR$$M$Y$70$KG$20240911$$MD$FR$FR
241784821$24178482$1$I$$20240801$20240806$20240806$EXP$$US-BIOGEN-2024BI01276726$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241784831$24178483$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53879$$FDA-CTU$$80$YR$$F$N$60.2$KG$20240805$N$PH$US$
241784851$24178485$1$I$$20240805$20240806$20240806$PER$$NVSC2024US159658$NOVARTIS$$$$$$Y$$$20240806$$HP$US$US
241784861$24178486$1$I$20240619$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53881$$FDA-CTU$$15$YR$$F$N$54.43$KG$20240805$N$HP$US$
241784872$24178487$2$F$$20240908$20240806$20240910$30DAY$$CL-PFIZER INC-202400225727$PFIZER$$$$$M$Y$$$20240910$$CN$CL$CL
241784881$24178488$1$I$20240730$20240730$20240806$20240806$EXP$$PK-ROCHE-10000042243$ROCHE$$51$YR$A$M$Y$$$20240806$$CN$PK$PK
241784891$24178489$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008956$APOTEX$$79$YR$$F$Y$$$20240806$$CN$CA$CA
241784901$24178490$1$I$$20240722$20240806$20240806$EXP$$BR-EPICPHARMA-BR-2024EPCLIT00915$EPIC PHARM$Arnildo Linck Junior.Malignant hyperthermia without fever in a burned child after bandaging: A case report.Journal of Pediatric Surgery Case Reports.2023;92:1-4$16$MON$I$F$Y$$$20240806$$HP$BR$BR
241784911$24178491$1$I$20240701$20240725$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-037395$AUROBINDO$$14$YR$$M$Y$107$KG$20240806$$MD$FR$FR
241784921$24178492$1$I$20200101$20240802$20240806$20240806$PER$$US-ABBVIE-5867363$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241784931$24178493$1$I$20230101$20240726$20240806$20240806$EXP$$CA-ROCHE-10000041265$ROCHE$$15$YR$T$M$Y$$$20240806$$HP$CA$CA
241784941$24178494$1$I$$20220224$20240806$20240806$EXP$$US-AstraZeneca-2022A090057$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241784951$24178495$1$I$$20240801$20240806$20240806$PER$$US-AstraZeneca-2024A175377$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241784962$24178496$2$F$$20240909$20240806$20240916$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS003928$TERSERA THERAPEUTICS$$$$$$Y$$$20240916$$CN$AU$AU
241784971$24178497$1$I$$20230501$20240806$20240806$EXP$$NL-AstraZeneca-2023A101301$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$NL$
241784981$24178498$1$I$$20240729$20240806$20240806$EXP$$US-CHEPLA-2024010039$CHEPLAPHARM$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024; 1-6. DOI:10.3233/NPM-230165.$$$N$F$Y$$$20240806$$HP$COUNTRY NOT SPECIFIED$US
241784993$24178499$3$F$20240804$20240913$20240806$20240916$PER$$US-AMGEN-USASP2024155710$AMGEN$$61$YR$A$$Y$$$20240916$$CN$US$US
241785011$24178501$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153741$AMGEN$$$$$M$Y$$$20240806$$MD$US$US
241785021$24178502$1$I$20240731$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024154017$AMGEN$$79$YR$E$M$Y$$$20240806$$CN$US$US
241785031$24178503$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024155071$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241785051$24178505$1$I$20240101$20240722$20240806$20240806$PER$$US-ALMUS-US-2024-1785$ALMUS$$$$$F$Y$$$20240806$$CN$US$US
241785061$24178506$1$I$$20240801$20240806$20240806$PER$$US-JNJFOC-20240748796$JOHNSON AND JOHNSON$$$$$F$Y$65.9$KG$20240806$$CN$US$US
241785071$24178507$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA230760$SANOFI AVENTIS$$$$E$M$Y$96.1$KG$20240806$$MD$US$US
241785081$24178508$1$I$$20240725$20240806$20240806$PER$$US-SA-2024SA223704$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$HP$US$US
241785091$24178509$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229992$SANOFI AVENTIS$$$$A$F$Y$56$KG$20240806$$MD$US$US
241785101$24178510$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA225937$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240806$$CN$US$US
241785111$24178511$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123567$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240806$$CN$US$US
241785121$24178512$1$I$20240701$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123794$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240806$$CN$US$US
241785131$24178513$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA228750$SANOFI AVENTIS$$$$$F$Y$$$20240806$$CN$US$US
241785141$24178514$1$I$20240701$20240729$20240806$20240806$PER$$US-SA-2024SA225749$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240806$$MD$US$US
241785151$24178515$1$I$20240101$20240731$20240806$20240806$PER$$US-SA-2024SA229271$SANOFI AVENTIS$$$$A$M$Y$$$20240806$$HP$US$US
241785162$24178516$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683070$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241785171$24178517$1$I$$20230501$20240806$20240806$EXP$$US-AstraZeneca-2023A101722$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241785181$24178518$1$I$$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A175697$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241785191$24178519$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA228356$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240806$$MD$US$US
241785201$24178520$1$I$$20220322$20240806$20240806$EXP$$US-AstraZeneca-2022A123704$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241785211$24178521$1$I$$20240802$20240806$20240806$PER$$US-ABBVIE-5867231$ABBVIE$$$$$$Y$$$20240806$$CN$US$US
241785221$24178522$1$I$20230419$20230419$20240806$20240806$EXP$$US-AstraZeneca-2023A092209$ASTRAZENECA$$63$YR$$F$Y$$$20240806$$CN$US$
241785231$24178523$1$I$20240804$20240805$20240806$20240806$30DAY$$US-SANDOZ INC.-SDZ2024US070688$SANDOZ$$36$YR$$M$Y$$$20240806$$CN$US$US
241785241$24178524$1$I$20220701$20240805$20240806$20240806$EXP$$DE-SANDOZ INC.-SDZ2024DE070613$SANDOZ$$56$YR$$F$Y$$$20240806$$MD$DE$DE
241785252$24178525$2$F$20240101$20240805$20240806$20240813$PER$$US-SA-2024SA230390$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240814$$MD$US$US
241785262$24178526$2$F$20240701$20240802$20240806$20240813$PER$$US-SA-2023SA302976$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240814$$MD$US$US
241785271$24178527$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA230066$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
241785283$24178528$3$F$$20240815$20240806$20240821$PER$$US-SA-2024SA231358$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
241785291$24178529$1$I$20240718$20240731$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123726$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240806$$CN$US$US
241785301$24178530$1$I$$20240731$20240806$20240806$PER$$US-AMGEN-USASP2024153079$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241785322$24178532$2$F$20240731$20240814$20240806$20240817$PER$$US-AMGEN-USASP2024153663$AMGEN$$51$YR$A$M$Y$$$20240817$$CN$US$US
241785331$24178533$1$I$20240201$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53874$$FDA-CTU$$22$YR$$F$N$61.23$KG$20240805$Y$HP$US$
241785341$24178534$1$I$20240105$20240725$20240806$20240806$EXP$$CO-UCBSA-2024002710$UCB$$34$YR$$F$Y$58$KG$20240806$$CN$CO$CO
241785351$24178535$1$I$20220101$20240723$20240806$20240806$EXP$$US-SPECGX-T202401621$SPECGX$Friederich LW, Cox ME, Hyson BE, Bishop-Freeman SC. Suspected North Carolina counterfeit pill-involved deaths, 2020-2022. Journal of Analytical Toxicology. 2024;48(4):242-51$40$YR$$M$Y$$$20240806$$HP$US$US
241785361$24178536$1$I$$20240729$20240806$20240806$EXP$$US-AMGEN-USASP2024153077$AMGEN$Ortega-loayza A.G.; Choe S.; Shettig A. et al.. Pyoderma Gangrenosum of the Genitalia, Anus, and Perineum: Two Case Reports and a Review of Published Cases. Sexually Transmitted Diseases. 2024;51:548-550$58$YR$A$M$Y$$$20240806$$MD$US$US
241785371$24178537$1$I$$20240611$20240805$20240805$DIR$FDA-CDER-CTU-2024-53666$$FDA-CTU$$$$$$N$$$20240611$N$$US$
241785381$24178538$1$I$$20231102$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA050089$SANDOZ$$$$$$Y$$$20240806$$CN$CA$CA
241785391$24178539$1$I$$20240722$20240806$20240806$EXP$$IN-EPICPHARMA-IN-2024EPCLIT00910$EPIC PHARM$Anupma Kaul.The Unusual Adverse Effects of Antituberculosis Therapy in Kidney Patients.International Journal of Mycobacteriology.15-JUN-2024;13:183-190$56$YR$A$M$Y$$$20240806$$HP$IN$IN
241785402$24178540$2$F$20230301$20240823$20240806$20240829$EXP$$BR-ABBVIE-5862684$ABBVIE$$$$$F$Y$$$20240829$$MD$BR$BR
241785421$24178542$1$I$$20240610$20240805$20240805$DIR$FDA-CDER-CTU-2024-53664$$FDA-CTU$$$$$$N$$$20240610$N$$US$
241785442$24178544$2$F$20240601$20240819$20240806$20240827$EXP$$JP-009507513-2407JPN005251J$MERCK$$71$YR$$F$Y$$$20240827$$MD$JP$JP
241785452$24178545$2$F$20240101$20240903$20240806$20240912$EXP$$US-UCBSA-2024034898$UCB$$$$$F$Y$$$20240912$$HP$US$US
241785461$24178546$1$I$20231201$20240801$20240806$20240806$PER$$US-Eisai-EC-2024-171473$EISAI$$74$YR$E$M$Y$101$KG$20240806$$CN$US$US
241785471$24178547$1$I$$20240213$20240806$20240806$EXP$$KR-SANDOZ INC.-SDZ2024KR015803$SANDOZ$Jang D K, Lee J K.. Drug-induced Acute Pancreatitis: A Hospital-based Analysis.. Gut and Liver. 11:166$$$$$Y$$$20240806$$HP$KR$KR
241785483$24178548$3$F$20240701$20240919$20240806$20240926$EXP$$US-BEH-2024176378$CSL BEHRING$$27$YR$A$F$Y$$$20240926$$CN$US$US
241785493$24178549$3$F$20240724$20240911$20240806$20240917$PER$$US-AMGEN-USASP2024149845$AMGEN$$81$YR$E$M$Y$74$KG$20240917$$PH$US$US
241785501$24178550$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154581$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241785511$24178551$1$I$$20240728$20240806$20240806$PER$$US-JNJFOC-20240776687$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241785521$24178552$1$I$$20240802$20240806$20240806$PER$$US-JNJFOC-20240809174$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$CN$US$US
241785531$24178553$1$I$20240801$20240802$20240806$20240806$PER$$US-JNJFOC-20240807289$JOHNSON AND JOHNSON$$66$YR$$F$Y$$$20240806$$HP$US$US
241785542$24178554$2$F$20240802$20240913$20240806$20240917$PER$$US-JNJFOC-20240806616$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240917$$HP$US$US
241785551$24178555$1$I$20240101$20240724$20240806$20240806$PER$$US-JNJFOC-20240768100$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241785561$24178556$1$I$$20240803$20240806$20240806$EXP$$US-ABBVIE-5866422$ABBVIE$$$$$$Y$$$20240806$$CN$US$US
241785581$24178558$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008973$APOTEX$$67$YR$$F$Y$$$20240806$$CN$CA$CA
241785591$24178559$1$I$$20240722$20240806$20240806$EXP$$IN-EPICPHARMA-IN-2024EPCLIT00913$EPIC PHARM$Devang Rana.Global trigger tool: proficient adverse drug reaction autodetection method in critical care patient units.Indian journal of critical care medicine.MAR-2020;24 (3):172-178$$$$$Y$$$20240806$$HP$IN$IN
241785601$24178560$1$I$20240501$20240731$20240806$20240806$EXP$$US-TAKEDA-2024TUS076581$TAKEDA$$19$YR$$M$Y$$$20240806$$PH$US$US
241785611$24178561$1$I$20230801$20240801$20240806$20240806$PER$$US-BIOGEN-2024BI01276508$BIOGEN$$22$YR$$M$Y$$$20240806$$CN$US$US
241785621$24178562$1$I$$20240731$20240806$20240806$PER$$US-BIOGEN-2024BI01276637$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241785631$24178563$1$I$20240723$20240731$20240806$20240806$EXP$$US-BAYER-2024A111541$BAYER$$68$YR$E$F$Y$$$20240806$$CN$US$US
241785641$24178564$1$I$20240701$20240731$20240806$20240806$EXP$$US-ABBVIE-5863765$ABBVIE$$67$YR$$F$Y$$$20240806$$CN$US$US
241785652$24178565$2$F$$20240809$20240806$20240809$PER$$US-PFIZER INC-PV202400100401$PFIZER$$80$YR$$F$Y$$$20240809$$MD$US$US
241785661$24178566$1$I$20240701$20240731$20240806$20240806$PER$$US-PFIZER INC-202400227515$PFIZER$$69$YR$$F$Y$$$20240806$$CN$US$US
241785671$24178567$1$I$20240501$20240731$20240806$20240806$PER$$US-PFIZER INC-202400228503$PFIZER$$52$YR$$F$Y$$$20240806$$HP$US$US
241785681$24178568$1$I$$20240730$20240806$20240806$PER$$US-PFIZER INC-202400227178$PFIZER$$83$YR$$F$Y$$$20240806$$CN$US$US
241785691$24178569$1$I$$20240711$20240806$20240806$PER$$US-PFIZER INC-PV202400101902$PFIZER$$59$YR$$F$Y$$$20240806$$CN$US$US
241785701$24178570$1$I$$20240731$20240806$20240806$PER$$US-PFIZER INC-PV202400100326$PFIZER$$66$YR$$F$Y$$$20240806$$HP$US$US
241785711$24178571$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-202400229757$PFIZER$$12$YR$$F$Y$$$20240806$$CN$US$US
241785721$24178572$1$I$$20240731$20240806$20240806$PER$$US-PFIZER INC-202400228448$PFIZER$$77$YR$$F$Y$$$20240806$$HP$US$US
241785731$24178573$1$I$$20240731$20240806$20240806$PER$$US-PFIZER INC-202400228337$PFIZER$$$$$F$Y$$$20240806$$PH$US$US
241785742$24178574$2$F$$20240906$20240806$20240906$PER$$US-PFIZER INC-202400228701$PFIZER$$59$YR$$M$Y$$$20240906$$CN$US$US
241785751$24178575$1$I$$20240727$20240806$20240806$EXP$$JP-ROCHE-10000045992$ROCHE$$78$YR$E$F$Y$$$20240806$$MD$JP$JP
241785761$24178576$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-PV202400100957$PFIZER$$55$YR$$F$Y$$$20240806$$HP$US$US
241785771$24178577$1$I$$20240731$20240806$20240806$PER$$US-PFIZER INC-202400229181$PFIZER$$$$A$$Y$$$20240806$$HP$US$US
241785781$24178578$1$I$$20240610$20240805$20240805$DIR$FDA-CDER-CTU-2024-53665$$FDA-CTU$$$$$$N$$$20240610$N$$US$
241785791$24178579$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-202300360790$PFIZER$$42$YR$$F$Y$$$20240806$$CN$US$US
241785801$24178580$1$I$$20240729$20240806$20240806$PER$$US-PFIZER INC-202400226886$PFIZER$$58$YR$$F$Y$$$20240806$$HP$US$US
241785813$24178581$3$F$20240101$20240830$20240806$20240905$EXP$$US-ABBVIE-5865787$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
241785821$24178582$1$I$$20240731$20240806$20240806$EXP$$CA-ABBVIE-5866343$ABBVIE$$$$$M$Y$$$20240806$$PH$CA$CA
241785832$24178583$2$F$20240101$20240905$20240806$20240910$EXP$$US-ABBVIE-5865525$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
241785841$24178584$1$I$$20240731$20240806$20240806$PER$$US-LEO Pharma-372486$LEO PHARM$$64$YR$$M$Y$$$20240806$$CN$US$US
241785851$24178585$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190573$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241785861$24178586$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002112$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240806$$CN$US$US
241785872$24178587$2$F$20240810$20240830$20240806$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408003158$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240902$$CN$US$US
241785881$24178588$1$I$20190901$20231212$20240806$20240806$EXP$$AT-SANDOZ INC.-SDZ2023AT067468$SANDOZ$$$$$$Y$$$20240806$$MD$AT$AT
241785891$24178589$1$I$$20240801$20240806$20240806$EXP$$US-ABBVIE-5864680$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241785901$24178590$1$I$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0683077$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241785911$24178591$1$I$20240731$20240731$20240806$20240806$EXP$$CA-ABBVIE-5867357$ABBVIE$$83$YR$$M$Y$$$20240806$$HP$CA$CA
241785931$24178593$1$I$20240101$20240729$20240806$20240806$EXP$$CA-CELLTRION INC.-2024CA006682$CELLTRION$$$$$$Y$$$20240806$$HP$CA$CA
241785941$24178594$1$I$20240101$20240311$20240806$20240806$EXP$$NVSC2023BR178103$NOVARTIS$$60$YR$$F$Y$$$20240806$$CN$BR$BR
241785951$24178595$1$I$$20240801$20240806$20240806$EXP$$CA-ABBVIE-5867338$ABBVIE$$$$$M$Y$$$20240806$$HP$CA$CA
241785964$24178596$4$F$20240101$20240829$20240806$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021577$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240906$$$US$US
241785972$24178597$2$F$$20240823$20240806$20240827$EXP$$JP-BAUSCH-BL-2024-011884$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240827$$PH$JP$JP
241785981$24178598$1$I$$20240724$20240806$20240806$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07552$LUPIN$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D. Rhabdomyolysis risk: the dangers of tribulus terrestris, an over-the-counter supplement. American Journal of Case Reports. 2024;25:e943492-1-e943492-3$71$YR$$M$Y$$$20240806$$HP$US$US
241785991$24178599$1$I$$20240729$20240806$20240806$EXP$$EU-BAUSCHBL-2024BNL030766$BAUSCH AND LOMB$$63$YR$$M$Y$$$20240806$$MD$EU$EU
241786001$24178600$1$I$$20240730$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121569$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$72.57$KG$20240806$$CN$US$US
241786011$24178601$1$I$$20240729$20240806$20240806$EXP$$GB-BAUSCHBL-2024BNL030819$BAUSCH AND LOMB$Ameli R. Interesting case of Strongyloides hyperinfection syndrome in an immunocompromised patient. Clinical Medicine, Journal of the Royal College of Physicians of London.. 2024;24:1-2. doi:10.1016/j.clinme.2024.100043$42$YR$$F$Y$$$20240806$$MD$GB$GB
241786021$24178602$1$I$20240222$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123388$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$97.52$KG$20240806$$CN$US$US
241786031$24178603$1$I$$20240730$20240806$20240806$PER$$US-EMD Serono-2024041382$EMD SERONO INC$$77$YR$E$M$Y$$$20240806$$CN$US$US
241786041$24178604$1$I$20240601$20240801$20240806$20240806$EXP$FR-AFSSAPS-LM2024000425$FR-BAYER-2024A111348$BAYER$$30$YR$A$M$Y$73$KG$20240806$$MD$FR$FR
241786051$24178605$1$I$$20240802$20240806$20240806$PER$$US-JNJFOC-20240807395$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$PH$US$US
241786062$24178606$2$F$$20240806$20240806$20240808$EXP$$GB-MYLANLABS-2024M1072462$MYLAN$$$$$F$Y$$$20240808$$HP$GB$GB
241786071$24178607$1$I$$20230405$20240806$20240806$EXP$$ZA-AstraZeneca-2023A081842$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$ZA$
241786081$24178608$1$I$$20220222$20240806$20240806$EXP$$US-AstraZeneca-2022A085722$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241786091$24178609$1$I$$20231106$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA051235$SANDOZ$$$$$$Y$$$20240806$$MD$CA$CA
241786101$24178610$1$I$$20240801$20240806$20240806$EXP$$NVSC2024US158474$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
241786111$24178611$1$I$20230829$20240805$20240806$20240806$EXP$BE-FAMPH-DHH-N2024-122457$NVSC2024BE159179$NOVARTIS$$62$YR$$F$Y$$$20240806$$PH$BE$BE
241786121$24178612$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229298$SANOFI AVENTIS$$$$A$M$Y$102.05$KG$20240806$$MD$US$US
241786131$24178613$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229313$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240806$$MD$US$US
241786141$24178614$1$I$$20240801$20240806$20240806$PER$$NVSC2024US158476$NOVARTIS$$$$$$Y$$$20240806$$CN$US$US
241786151$24178615$1$I$$20240801$20240806$20240806$EXP$$ZA-AstraZeneca-2024A175762$ASTRAZENECA$$67$YR$$M$Y$$$20240806$$CN$ZA$
241786161$24178616$1$I$$20211206$20240806$20240806$EXP$$US-AstraZeneca-2021A859852$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241786172$24178617$2$F$20230101$20240905$20240806$20240905$PER$$US-PFIZER INC-202400228924$PFIZER$$30$YR$$F$Y$$$20240905$$CN$US$US
241786182$24178618$2$F$$20240906$20240806$20240906$PER$$US-PFIZER INC-202400228821$PFIZER$$65$YR$$M$Y$$$20240906$$CN$US$US
241786192$24178619$2$F$$20240905$20240806$20240905$PER$$US-PFIZER INC-202400228948$PFIZER$$43$YR$$F$Y$$$20240905$$CN$US$US
241786201$24178620$1$I$$20240726$20240806$20240806$PER$$US-GILEAD-2024-0682809$GILEAD$$38$YR$A$$Y$$$20240806$$CN$US$US
241786212$24178621$2$F$$20240826$20240806$20240827$EXP$$CZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043948$BOEHRINGER INGELHEIM$Sitina m. Euglykemick? ketoacid?za asociovan? se SGLT2 inhibitory a DPP4 inhibitory ? rozbor kazuistik. ANESTEZIOLOGIE A INTENZIVN? MEDIC?NA.$59$YR$A$F$Y$$$20240827$$MD$CZ$CZ
241786221$24178622$1$I$20240714$20240730$20240806$20240806$EXP$CZ-CZSUKL-24002133$CZ-SA-2024SA224994$SANOFI AVENTIS$$31$YR$A$$Y$$$20240806$$MD$CZ$CZ
241786232$24178623$2$F$20240730$20240902$20240806$20240904$PER$$US-JNJFOC-20240806871$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240904$$PH$US$US
241786241$24178624$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229881$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240806$$MD$US$US
241786252$24178625$2$F$20240101$20240918$20240806$20240926$PER$$US-SA-2024SA230388$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240926$$MD$US$US
241786261$24178626$1$I$$20240722$20240806$20240806$EXP$$US-EPICPHARMA-US-2024EPCLIT00903$EPIC PHARM$I Pien.Osteonecrosis of Trapezium Occurring in Patient with History of Recurrent Carpometacarpal Corticosteroid Injection.The Journal of Hand Surgery (Asian-Pacific Volume).FEB-2023;28:129-133$59$YR$A$F$Y$$$20240806$$HP$US$US
241786271$24178627$1$I$$20231106$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA051255$SANDOZ$$$$$$Y$$$20240806$$MD$CA$CA
241786281$24178628$1$I$$20240724$20240806$20240806$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118341$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240806$$HP$CA$CA
241786291$24178629$1$I$$20240723$20240806$20240806$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00374$MELINTA THERAPEUTICS$Qiongwen  X et al.. Effect on mortality of Dapagliflozin combined with Sacubitril Valsartan in the treatment of patients with chronic heart failure and type 2 diabetes mellitus. Clinical Research, DOCTOR 2024;9(11):59-62.$$$$$Y$$$20240806$$MD$CN$CN
241786301$24178630$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024155506$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241786311$24178631$1$I$20200117$20240730$20240806$20240806$EXP$$PL-AMGEN-POLSP2024152202$AMGEN$$58$YR$A$M$Y$$$20240806$$MD$PL$PL
241786321$24178632$1$I$$20240801$20240806$20240806$EXP$$US-TAKEDA-2024TUS030920$TAKEDA$$$$$F$Y$58$KG$20240806$$CN$US$US
241786331$24178633$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024155171$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241786341$24178634$1$I$20240730$20240730$20240806$20240806$PER$$US-AMGEN-USASP2024151650$AMGEN$$82$YR$E$F$Y$$$20240806$$CN$US$US
241786371$24178637$1$I$$20240805$20240805$20240805$DIR$712925$$FDA-CTU$$$$$M$N$$$20240805$N$PH$US$
241786381$24178638$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008979$APOTEX$$69$YR$$F$Y$$$20240806$$CN$CA$CA
241786391$24178639$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP008951$APOTEX$$73$YR$$M$Y$$$20240806$$CN$CA$CA
241786401$24178640$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190587$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241786411$24178641$1$I$$20240722$20240806$20240806$EXP$$US-EPICPHARMA-US-2024EPCLIT00905$EPIC PHARM$B Van Noord .A Case of Delayed and Immediate Hypersensitivity Reactions Induced by Corticosteroids.Dermatitis.JAN-2024;35:191-192$71$YR$E$M$Y$$$20240806$$HP$US$US
241786423$24178642$3$F$20240101$20240826$20240806$20240903$EXP$$CA-CELLTRION INC.-2024CA018639$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
241786431$24178643$1$I$20240715$20240725$20240806$20240806$EXP$GB-MHRA-MED-202407241446599570-YNRCZ$GB-LUPIN PHARMACEUTICALS INC.-2024-07309$LUPIN$$95$YR$$F$Y$$$20240806$$MD$GB$GB
241786441$24178644$1$I$20240601$20240731$20240806$20240806$PER$$US-AMGEN-USASP2024153881$AMGEN$$71$YR$E$F$Y$$$20240806$$PH$US$US
241786451$24178645$1$I$20240801$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153674$AMGEN$$65$YR$E$M$Y$$$20240806$$CN$US$US
241786461$24178646$1$I$$20240802$20240806$20240806$EXP$$US-BAYER-2024A112334$BAYER$$$$$F$Y$$$20240806$$CN$US$US
241786472$24178647$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683082$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241786481$24178648$1$I$20190101$20240730$20240806$20240806$EXP$$US-ROCHE-10000043526$ROCHE$$46$YR$A$F$Y$82.1$KG$20240806$$CN$US$US
241786491$24178649$1$I$20240101$20240709$20240806$20240806$PER$$US-JNJFOC-20240727203$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240806$$HP$US$US
241786501$24178650$1$I$$20240729$20240806$20240806$PER$$US-ROCHE-10000044592$ROCHE$DeSimone J, Dockery P, Vempuluru V, Konstantinou E, Singla K, Lally S, et al. Bilateral circumscribed choroidal hemangiomas in 2 patients: a rare finding. Canadian Journal of Ophthalmology. 2024-Aug;59 (4):e404-7. doi:10.1016/j.jcjo.2023.11.001.$51$YR$A$F$Y$$$20240806$$HP$US$US
241786531$24178653$1$I$$20240723$20240806$20240806$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00375$MELINTA THERAPEUTICS$Qiongwen  X et al.. Effect on mortality of Dapagliflozin combined with Sacubitril Valsartan in the treatment of patients with chronic heart failure and type 2 diabetes mellitus. Clinical Research, DOCTOR 2024;9(11):59-62.$$$$$Y$$$20240806$$MD$CN$CN
241786543$24178654$3$F$$20240821$20240806$20240825$EXP$$CA-GSK-CA2024AMR096837$GLAXOSMITHKLINE$$$$$$Y$$$20240825$$MD$CA$CA
241786551$24178655$1$I$20240711$20240725$20240806$20240806$EXP$CN-NMPA-3205821037749202400172$CN-Ipsen Biopharmaceuticals, Inc.-2024-15552$IPSEN$$67$YR$E$M$Y$$$20240806$$HP$CN$CN
241786561$24178656$1$I$$20240731$20240806$20240806$EXP$$US-MYLANLABS-2024M1072747$MYLAN$Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. Blood 2023; 142 (Suppl. 1) 5898.$$$A$$Y$$$20240806$$MD$US$US
241786571$24178657$1$I$$20240731$20240806$20240806$EXP$$NL-MYLANLABS-2024M1072266$MYLAN$Fijen LM, Petersen RS, Cohn DM. Facial swelling due to angioedema: often mast cell mediated, but not always. [Dutch]. Ned-Tijdschr-Geneeskd 2023; 167 (42):.$18$YR$$F$Y$$$20240806$$HP$NL$NL
241786581$24178658$1$I$20221201$20230106$20240806$20240806$EXP$$US-RECORDATI-2023000083$RECORDATI$$$$$$Y$$$20240806$$CN$US$US
241786591$24178659$1$I$20240625$20240731$20240806$20240806$EXP$$CN-MYLANLABS-2024M1071801$MYLAN$$14$YR$$F$Y$48$KG$20240806$$HP$CN$CN
241786601$24178660$1$I$20240724$20240731$20240806$20240806$EXP$$CN-MYLANLABS-2024M1071827$MYLAN$$55$YR$$M$Y$75$KG$20240806$$HP$CN$CN
241786611$24178661$1$I$20240501$20240802$20240806$20240806$EXP$$US-BAYER-2024A112523$BAYER$$$$$$Y$$$20240806$$CN$US$US
241786621$24178662$1$I$$20231106$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA051362$SANDOZ$$$$$$Y$$$20240806$$MD$CA$CA
241786631$24178663$1$I$$20240731$20240806$20240806$EXP$$US-MYLANLABS-2024M1072831$MYLAN$Wang J, Elghawy O, Kurpiel B, Kaur V. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors. Clin-J-Gastroenterol 2023; 16 807-814.$70$YR$$M$Y$$$20240806$$HP$US$US
241786641$24178664$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123666$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240806$$CN$US$US
241786652$24178665$2$F$$20240802$20240806$20240807$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-139301$DAIICHI$$48$YR$$F$Y$$$20240807$$CN$US$US
241786661$24178666$1$I$$20240731$20240806$20240806$PER$$US-HALEON-2190413$Haleon PLC$$$$$M$Y$3.575$KG$20240806$$MD$US$US
241786671$24178667$1$I$$20240115$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2024CA005468$SANDOZ$$$$$$Y$$$20240806$$CN$CA$CA
241786681$24178668$1$I$20240705$20240724$20240806$20240806$EXP$$CN-009507513-2407CHN014774$MERCK$$71$YR$$F$Y$60.5$KG$20240806$$HP$CN$CN
241786691$24178669$1$I$20240710$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153980$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241786701$24178670$1$I$20240802$20240805$20240806$20240806$PER$$US-AMGEN-USASP2024155372$AMGEN$$42$YR$A$F$Y$$$20240806$$CN$US$US
241786711$24178671$1$I$$20240729$20240806$20240806$PER$$US-JNJFOC-20240780191$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$LW$US$US
241786721$24178672$1$I$$20240802$20240806$20240806$PER$$US-JNJFOC-20240806489$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$US$US
241786731$24178673$1$I$$20240805$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070783$SANDOZ$$$$$F$Y$$$20240806$$CN$US$US
241786741$24178674$1$I$$20231203$20240806$20240806$EXP$$CH-SANDOZ INC.-SDZ2023CH063955$SANDOZ$$$$$$Y$$$20240806$$CN$CH$CH
241786753$24178675$3$F$20240712$20240913$20240806$20240925$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US002397$PAREXEL$$$$$$Y$$$20240925$$HP$US$US
241786761$24178676$1$I$20240801$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001170$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240806$$CN$US$US
241786771$24178677$1$I$20240601$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407018074$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240806$$CN$US$US
241786781$24178678$1$I$20240805$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408003144$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240806$$CN$US$US
241786791$24178679$1$I$$20240725$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407017466$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240806$$CN$US$US
241786801$24178680$1$I$20240622$20240730$20240806$20240806$EXP$PT-INFARMED-T202407-442$PT-MYLANLABS-2024M1071203$MYLAN$$47$YR$$F$Y$$$20240806$$PH$PT$PT
241786811$24178681$1$I$$20240730$20240806$20240806$EXP$$PT-MYLANLABS-2024M1071199$MYLAN$$71$YR$$F$Y$$$20240806$$MD$PT$PT
241786823$24178682$3$F$$20240917$20240806$20240923$EXP$$RO-MYLANLABS-2024M1071278$MYLAN$Cristian Nicolae POPAa, b, Vladimir Dan BRATUa, e, Elisa Cristina POPAa, e, Daniela Elena DINUa, b, Cristina IOSIFc, et al.. Neoadjuvant Chemotherapy: Friend or Foe. Maedica - a Journal of Clinical Medicine. 2024;19(2):417-422$71$YR$$F$Y$$$20240923$$HP$RO$RO
241786831$24178683$1$I$$20240730$20240806$20240806$EXP$BE-FAMHP-DHH-N2024-122398$BE-MYLANLABS-2024M1071796$MYLAN$$44$YR$$F$Y$$$20240806$$PH$BE$BE
241786842$24178684$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0683085$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241786852$24178685$2$F$$20240802$20240806$20240816$EXP$$NL-VER-202400049$VERITY PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$NL$NL
241786861$24178686$1$I$$20240722$20240806$20240806$EXP$$TR-EPICPHARMA-TR-2024EPCLIT00917$EPIC PHARM$Enes Elvin Gul.Brugada phenocopy associated with multiple psychotic drugs .Journal of Electrocardiology.NOV-2023;81:156-158$17$YR$T$F$Y$$$20240806$$MD$TR$TR
241786871$24178687$1$I$$20240729$20240806$20240806$EXP$$CA-APOTEX-2024AP009002$APOTEX$$58$YR$$M$Y$$$20240806$$CN$CA$CA
241786881$24178688$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122796$BRISTOL MYERS SQUIBB$$6$YR$C$F$Y$$$20240806$$MD$US$US
241786891$24178689$1$I$20240101$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122206$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240806$$HP$US$US
241786901$24178690$1$I$$20240723$20240806$20240806$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00373$MELINTA THERAPEUTICS$Qiongwen  X et al.. Effect on mortality of Dapagliflozin combined with Sacubitril Valsartan in the treatment of patients with chronic heart failure and type 2 diabetes mellitus. Clinical Research, DOCTOR 2024;9(11):59-62.$$$$$Y$$$20240806$$MD$CN$CN
241786911$24178691$1$I$20240703$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122266$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240806$$HP$US$US
241786921$24178692$1$I$20240101$20240731$20240806$20240806$PER$$US-ABBVIE-5864594$ABBVIE$$$$$$Y$$$20240806$$MD$US$US
241786931$24178693$1$I$20240722$20240803$20240806$20240806$EXP$$CN-BAYER-2024A112674$BAYER$$35$YR$A$F$Y$$$20240806$$HP$CN$CN
241786941$24178694$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229337$SANOFI AVENTIS$$$$E$F$Y$63$KG$20240806$$MD$US$US
241786951$24178695$1$I$20240713$20240717$20240806$20240806$PER$$US-SA-2024SA206250$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240806$$CN$US$US
241786961$24178696$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229724$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240806$$MD$US$US
241786971$24178697$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA229338$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240806$$MD$US$US
241786981$24178698$1$I$20240718$20240805$20240806$20240806$EXP$$FR-GILEAD-2024-0682925$GILEAD$$27$YR$A$M$Y$$$20240806$$MD$FR$FR
241786991$24178699$1$I$$20240801$20240806$20240806$EXP$$BR-JNJFOC-20240806264$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240806$$CN$BR$BR
241787011$24178701$1$I$$20240722$20240806$20240806$EXP$$ES-EPICPHARMA-ES-2024EPCLIT00918$EPIC PHARM$Maria Luisa Ales-Palmer.Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM.International Journal of Molecular Sciences .01-SEP-2023;24:1-17$3$YR$C$F$Y$$$20240806$$HP$ES$ES
241787021$24178702$1$I$20240601$20240731$20240806$20240806$PER$$US-SA-2024SA231058$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240806$$MD$US$US
241787032$24178703$2$F$$20240805$20240806$20240808$EXP$$JP-PFIZER INC-PV202400101434$PFIZER$$$$$$Y$$$20240808$$PH$JP$JP
241787041$24178704$1$I$$20240802$20240806$20240806$EXP$$US-PFIZER INC-202400230096$PFIZER$$48$YR$$M$Y$113.4$KG$20240806$$CN$US$US
241787052$24178705$2$F$$20240925$20240806$20240925$EXP$$US-PFIZER INC-202400229420$PFIZER$$54$YR$$F$Y$$$20240925$$HP$US$US
241787061$24178706$1$I$$20240731$20240806$20240806$EXP$$FR-PFIZER INC-202400227262$PFIZER$$57$YR$$F$Y$$$20240806$$HP$FR$FR
241787081$24178708$1$I$$20240801$20240806$20240806$EXP$GB-MHRA-MED-202408011231456190-JCPVZ$GB-PFIZER INC-202400228234$PFIZER$$59$YR$$F$Y$$$20240806$$HP$GB$GB
241787091$24178709$1$I$20190101$20240802$20240806$20240806$EXP$$BR-PFIZER INC-202400230393$PFIZER$$89$YR$$F$Y$$$20240806$$CN$BR$BR
241787101$24178710$1$I$$20240729$20240806$20240806$EXP$$JP-PFIZER INC-202400230778$PFIZER$Tsujino, M.. A review of the usage of CDK4/6 inhibitors in patients with HR-positive, HER2-negative advanced or breast cancer recurrent at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:117$$$$$Y$$$20240806$$HP$JP$JP
241787111$24178711$1$I$20240117$20240801$20240806$20240806$EXP$FR-AFSSAPS-NC2024000919$FR-PFIZER INC-202400227994$PFIZER$$48$YR$$F$Y$97$KG$20240806$$MD$FR$FR
241787121$24178712$1$I$$20240730$20240806$20240806$EXP$$US-PFIZER INC-202400227606$PFIZER$$$$$M$Y$$$20240806$$CN$US$US
241787131$24178713$1$I$$20240801$20240806$20240806$EXP$$NZ-PFIZER INC-PV202400100603$PFIZER$$26$YR$$M$Y$$$20240806$$MD$NZ$NZ
241787142$24178714$2$F$20230901$20240828$20240806$20240902$EXP$$PE-PFIZER INC-PV202300189282$PFIZER$$63$YR$$F$Y$58$KG$20240902$$CN$PE$PE
241787151$24178715$1$I$20240707$20240802$20240806$20240806$EXP$$AR-PFIZER INC-202400229253$PFIZER$$53$YR$$F$Y$$$20240806$$CN$AR$AR
241787161$24178716$1$I$$20240801$20240806$20240806$EXP$$CA-PFIZER INC-202400229209$PFIZER$$$$$F$Y$$$20240806$$HP$CA$CA
241787172$24178717$2$F$20240101$20240927$20240806$20240927$EXP$$CA-PFIZER INC-202400023571$PFIZER$$35$YR$$F$Y$$$20240927$$HP$CA$CA
241787181$24178718$1$I$20240423$20240801$20240806$20240806$EXP$$US-PFIZER INC-202400229190$PFIZER$$77$YR$$M$Y$$$20240806$$HP$US$US
241787191$24178719$1$I$20240624$20240801$20240806$20240806$EXP$FR-AFSSAPS-ST2024001243$FR-PFIZER INC-202400227995$PFIZER$$62$YR$$F$Y$54$KG$20240806$$PH$FR$FR
241787202$24178720$2$F$$20240801$20240806$20240807$EXP$$US-PFIZER INC-PV202400101104$PFIZER$$92$YR$$M$Y$$$20240807$$HP$US$US
241787211$24178721$1$I$20240101$20240801$20240806$20240806$EXP$$CA-PFIZER INC-202400054159$PFIZER$$56$YR$$M$Y$$$20240806$$MD$CA$CA
241787222$24178722$2$F$20240701$20240913$20240806$20240913$EXP$$JP-PFIZER INC-202400226890$PFIZER$$74$YR$$F$Y$$$20240913$$MD$JP$JP
241787231$24178723$1$I$20240521$20240801$20240806$20240806$EXP$FR-AFSSAPS-NC2024000916$FR-PFIZER INC-202400227998$PFIZER$$68$YR$$F$Y$$$20240806$$MD$FR$FR
241787243$24178724$3$F$20240101$20240909$20240806$20240911$EXP$$JP-PFIZER INC-PV202400092598$PFIZER$$69$YR$$F$Y$38$KG$20240911$$PH$JP$JP
241787252$24178725$2$F$20240701$20240927$20240806$20240927$EXP$$CA-PFIZER INC-202400227556$PFIZER$$76$YR$$M$Y$$$20240927$$HP$CA$CA
241787261$24178726$1$I$20230427$20240801$20240806$20240806$EXP$FR-AFSSAPS-AN2024000896$FR-PFIZER INC-202400209482$PFIZER$$88$YR$$F$Y$78$KG$20240806$$PH$FR$FR
241787271$24178727$1$I$$20240731$20240806$20240806$EXP$$US-TAKEDA-2024TUS077817$TAKEDA$$$$$$Y$$$20240806$$CN$US$US
241787292$24178729$2$F$$20240805$20240806$20240816$EXP$$US-AUROBINDO-AUR-APL-2024-037314$AUROBINDO$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D.. Rhabdomyolysis Risk: The Dangers of Tribulus terrestris, an Over-the-Counter Supplement.. Am J Case Rep.. 2024;25:e943492$71$YR$$M$Y$$$20240816$$MD$US$US
241787301$24178730$1$I$$20240726$20240806$20240806$EXP$$SG-ROCHE-10000041086$ROCHE$$85$YR$E$M$Y$$$20240806$$CN$SG$SG
241787312$24178731$2$F$20240731$20240807$20240806$20240810$EXP$$IE-ROCHE-10000045520$ROCHE$$$$$F$Y$$$20240810$$CN$IE$IE
241787322$24178732$2$F$$20240916$20240806$20240924$EXP$$FR-Merck Healthcare KGaA-2023478580$MERCK KGAA$$52$YR$A$F$Y$73$KG$20240923$$CN$FR$FR
241787331$24178733$1$I$20240601$20240806$20240806$20240806$EXP$GB-MHRA-MED-202408061010159990-PVTRN$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043999$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240806$$MD$GB$GB
241787341$24178734$1$I$$20240731$20240806$20240806$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-122287$BRISTOL MYERS SQUIBB$Kaul R, Soosapilla K, Nguyen C, Fathieh S, Premawardhana U, Kadappu K. Takotsubo^s cardiomyopathy post-commencement of oral azacitidine for NPM1+ AML. Heart Lung and Circulation. 2024 Aug 01;33(Suppl 4):S288-9. doi:10.1016/j.hlc.2024.06.353.$64$YR$A$F$Y$$$20240806$$HP$AU$AU
241787351$24178735$1$I$$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123730$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$55.34$KG$20240806$$CN$US$US
241787361$24178736$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123556$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240806$$HP$US$US
241787371$24178737$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123649$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$70.7$KG$20240806$$PH$US$US
241787381$24178738$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123130$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240806$$HP$US$US
241787391$24178739$1$I$$20240801$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122804$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240806$$MD$US$US
241787401$24178740$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123646$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$71.67$KG$20240806$$CN$US$US
241787411$24178741$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865677$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241787421$24178742$1$I$20240101$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123796$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240806$$HP$US$US
241787431$24178743$1$I$20240701$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123918$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240806$$CN$US$US
241787441$24178744$1$I$$20240803$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123348$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240806$$MD$US$US
241787451$24178745$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123505$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240806$$CN$US$US
241787461$24178746$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123458$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240806$$MD$US$US
241787471$24178747$1$I$20240701$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53855$$FDA-CTU$$84$YR$$M$N$$$20240805$N$PH$US$
241787481$24178748$1$I$20240725$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53703$$FDA-CTU$$39$YR$$F$N$$$20240805$Y$PH$US$
241787491$24178749$1$I$20240718$20240731$20240805$20240805$DIR$FDA-CDER-CTU-2024-53801$$FDA-CTU$$71$YR$$F$N$$$20240731$N$HP$US$
241787501$24178750$1$I$20240623$20240805$20240806$20240806$EXP$FR-AFSSAPS-SE2024000546$FR-SANDOZ INC.-SDZ2024FR070567$SANDOZ$$70$YR$$F$Y$$$20240806$$MD$FR$FR
241787511$24178751$1$I$20240621$20240802$20240806$20240806$EXP$$CN-BAYER-2024A112815$BAYER$$67$YR$E$M$Y$56$KG$20240806$$HP$CN$CN
241787521$24178752$1$I$20200711$20240726$20240806$20240806$EXP$PL-URPL-1-2126-2020$PL-Merck Healthcare KGaA-2024040617$MERCK KGAA$$48$YR$A$F$Y$70$KG$20240802$$MD$PL$PL
241787532$24178753$2$F$$20240913$20240806$20240923$PER$$US-TAKEDA-2024TUS078238$TAKEDA$$$$$F$Y$$$20240923$$CN$US$US
241787541$24178754$1$I$$20240722$20240806$20240806$EXP$$DK-EPICPHARMA-DK-2024EPCLIT00906$EPIC PHARM$Ronald Antulov.Opioid-Induced Leukoencephalopathies: A Report of Two Cases.Case Reports in Neurology.01-FEB-2022;14:25-30$24$YR$A$M$Y$$$20240806$$HP$DK$DK
241787551$24178755$1$I$20240703$20240731$20240806$20240806$EXP$FR-AFSSAPS-AM2024000588$FR-Merck Healthcare KGaA-2024041514$MERCK KGAA$$34$YR$A$F$Y$$$20240802$$MD$FR$FR
241787561$24178756$1$I$$20240805$20240806$20240806$EXP$GB-MHRA-MED-202408051639462300-VJRGM$GB-ROCHE-10000049496$ROCHE$$69$YR$E$M$Y$$$20240806$$MD$GB$GB
241787571$24178757$1$I$20221004$20231129$20240806$20240806$EXP$$CA-CELLTRION INC.-2022CA022740$CELLTRION$$$$$$Y$$$20240806$$MD$CA$CA
241787581$24178758$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA227786$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240806$$MD$US$US
241787591$24178759$1$I$$20240607$20240805$20240805$DIR$FDA-CDER-CTU-2024-53675$$FDA-CTU$$$$$$N$$$20240607$N$HP$US$
241787601$24178760$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123657$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240806$$CN$US$US
241787611$24178761$1$I$20240101$20240806$20240806$20240806$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043996$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240806$$MD$SK$SK
241787621$24178762$1$I$20240616$20240806$20240806$20240806$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035506$BOEHRINGER INGELHEIM$$89$YR$E$M$Y$$$20240806$$CN$JP$JP
241787632$24178763$2$F$20240802$20240806$20240806$20240808$PER$$US-AMGEN-USASP2024155433$AMGEN$$41$YR$A$F$Y$$$20240807$$CN$US$US
241787661$24178766$1$I$$20240728$20240806$20240806$PER$$US-AMGEN-USASP2024155047$AMGEN$Barrison L.; Park S.; Decherney A. et al.. Spontaneous conception in a 40-year-old woman after allogeneic stem cell transplant with active graft-versus-host disease: A case report. Case Reports in Women^s Health. 2024;43:1-3$$$N$M$Y$1.73$KG$20240806$$HP$US$US
241787672$24178767$2$F$20240611$20240904$20240806$20240910$30DAY$$US-JNJFOC-20240811520$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240910$$CN$US$US
241787681$24178768$1$I$$20230825$20240806$20240806$EXP$$CA-AstraZeneca-2023A061678$ASTRAZENECA$$$$$M$Y$$$20240806$$HP$CA$
241787691$24178769$1$I$$20240729$20240806$20240806$PER$$US-AstraZeneca-2024A175918$ASTRAZENECA$$76$YR$$M$Y$$$20240806$$CN$US$
241787701$24178770$1$I$$20220316$20240806$20240806$EXP$$US-AstraZeneca-2022A117606$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241787711$24178771$1$I$$20230324$20240806$20240806$EXP$$US-AstraZeneca-2023A073316$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241787721$24178772$1$I$20210624$20211005$20240806$20240806$EXP$$CA-AstraZeneca-2021A600439$ASTRAZENECA$$24613$DY$$M$Y$$$20240806$$CN$CA$
241787731$24178773$1$I$$20240730$20240806$20240806$EXP$$GR-BIOCON BIOLOGICS LIMITED-BBL2024005648$BIOCON$$$$$$Y$$$20240806$$MD$GR$GR
241787741$24178774$1$I$20240701$20240731$20240806$20240806$PER$$US-Eisai-EC-2024-171497$EISAI$$56$YR$A$F$Y$$$20240806$$CN$US$US
241787761$24178776$1$I$$20240801$20240806$20240806$EXP$$BR-BIOVITRUM-2024-BR-010607$BIOVITRUM$$$$$F$Y$$$20240806$$CN$BR$BR
241787771$24178777$1$I$20240701$20240801$20240806$20240806$EXP$$US-ABBVIE-5864679$ABBVIE$$31$YR$$M$Y$$$20240806$$CN$US$US
241787781$24178778$1$I$$20240731$20240806$20240806$PER$$US-TAKEDA-2024TUS077319$TAKEDA$$$$$$Y$$$20240806$$CN$US$US
241787791$24178779$1$I$20231201$20240805$20240806$20240806$EXP$$US-TAKEDA-US202023794$TAKEDA$$70$YR$$F$Y$$$20240806$$HP$US$US
241787801$24178780$1$I$$20240726$20240806$20240806$PER$$US-GILEAD-2024-0682810$GILEAD$$15$YR$T$$Y$$$20240806$$CN$US$US
241787812$24178781$2$F$20240723$20240806$20240806$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-122256$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$63$KG$20240816$$MD$JP$JP
241787821$24178782$1$I$$20240802$20240806$20240806$EXP$$BR-BIOVITRUM-2024-BR-010618$BIOVITRUM$$$$$M$Y$$$20240806$$CN$BR$BR
241787831$24178783$1$I$$20240730$20240806$20240806$EXP$$US-ABBVIE-5861114$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241787841$24178784$1$I$$20240731$20240806$20240806$PER$$US-JNJFOC-20240784831$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$US$US
241787851$24178785$1$I$$20240722$20240806$20240806$EXP$$US-EPICPHARMA-US-2024EPCLIT00914$EPIC PHARM$Cardona Quinones RA.A neuropsychiatric case of delayed post-hypoxic leukoencephalopathy from opioid intoxication resulting in Anton-Babinski syndrome and quadriplegia.Neurocase.JAN-2023;29:160-166$26$YR$A$M$Y$$$20240806$$HP$US$US
241787861$24178786$1$I$20240723$20240729$20240806$20240806$EXP$$CO-JNJFOC-20240780882$JOHNSON AND JOHNSON$$60$YR$$M$Y$64$KG$20240806$$HP$CO$CO
241787881$24178788$1$I$$20240729$20240806$20240806$EXP$$US-MYLANLABS-2024M1071903$MYLAN$$$$$$Y$$$20240806$$CN$US$US
241787892$24178789$2$F$$20240811$20240806$20240815$EXP$$US-BAYER-2024A110957$BAYER$$36$YR$A$F$Y$$$20240815$$MD$US$US
241787904$24178790$4$F$$20240814$20240806$20240817$EXP$$NVSC2024CA159053$NOVARTIS$$72$YR$$F$Y$$$20240817$$CN$CA$CA
241787921$24178792$1$I$20240716$20240805$20240806$20240806$EXP$$TH-PFIZER INC-PV202400101905$PFIZER$$74$YR$$F$Y$$$20240806$$CN$TH$TH
241787941$24178794$1$I$$20240801$20240806$20240806$EXP$$US-PFIZER INC-202400229579$PFIZER$$38$YR$$F$Y$$$20240806$$HP$US$US
241787951$24178795$1$I$20231004$20240801$20240806$20240806$EXP$$CA-PFIZER INC-202300283348$PFIZER$$59$YR$$M$Y$$$20240806$$MD$CA$CA
241787961$24178796$1$I$$20240731$20240806$20240806$EXP$$US-PFIZER INC-PV202400100324$PFIZER$$72$YR$$F$Y$$$20240806$$CN$US$US
241787972$24178797$2$F$20240101$20240807$20240806$20240812$EXP$$CA-PFIZER INC-202400229205$PFIZER$$80$YR$$M$Y$$$20240812$$CN$CA$CA
241787981$24178798$1$I$20191105$20240802$20240806$20240806$EXP$PL-URPL-2-417-2020$PL-PFIZER INC-202400228747$PFIZER$$13$YR$$$Y$39.4$KG$20240806$$CN$PL$PL
241787991$24178799$1$I$$20240805$20240806$20240806$EXP$$CA-PFIZER INC-202400230355$PFIZER$$21$YR$$F$Y$$$20240806$$HP$CA$CA
241788002$24178800$2$F$20240715$20240909$20240806$20240916$EXP$$JP-009507513-2407JPN003224J$MERCK$$74$YR$$F$Y$$$20240916$$MD$JP$JP
241788011$24178801$1$I$$20240802$20240806$20240806$EXP$$CA-PFIZER INC-202400230395$PFIZER$$65$YR$$M$Y$91$KG$20240806$$MD$CA$CA
241788021$24178802$1$I$20231219$20240802$20240806$20240806$EXP$$PT-PFIZER INC-202400229156$PFIZER$$48$YR$$F$Y$57$KG$20240806$$MD$PT$PT
241788034$24178803$4$F$20240723$20240927$20240806$20240927$EXP$$CA-PFIZER INC-202400213516$PFIZER$$35$YR$$F$Y$$$20240927$$MD$CA$CA
241788041$24178804$1$I$20240305$20240805$20240806$20240806$EXP$$TH-PFIZER INC-PV202400101938$PFIZER$$$$$F$Y$$$20240806$$CN$TH$TH
241788058$24178805$8$F$$20240914$20240806$20240918$EXP$$IN-PFIZER INC-PV202400097760$PFIZER$$74$YR$$M$Y$$$20240918$$CN$IN$IN
241788061$24178806$1$I$20240616$20240802$20240806$20240806$EXP$FR-AFSSAPS-AN2024000997$FR-PFIZER INC-202400228796$PFIZER$$64$YR$$M$Y$53.4$KG$20240806$$MD$FR$FR
241788071$24178807$1$I$20240731$20240802$20240806$20240806$EXP$$CN-PFIZER INC-PV202400101271$PFIZER$$45$YR$$F$Y$70$KG$20240806$$HP$CN$CN
241788081$24178808$1$I$20200615$20240730$20240806$20240806$EXP$$CN-PFIZER INC-202400230659$PFIZER$$56$YR$$M$Y$58$KG$20240806$$HP$CN$CN
241788091$24178809$1$I$$20240801$20240806$20240806$EXP$$TR-PFIZER INC-202400228964$PFIZER$Isbilen, G.. Intrathecal Tigecycline in the Treatment of Hospital-Acquired Meningitis: A Review of Four Cases. Surgical infections. 2024;10.1089/sur.2024.063$70$YR$$F$Y$$$20240806$$HP$TR$TR
241788101$24178810$1$I$20240729$20240802$20240806$20240806$EXP$$GB-PFIZER INC-202400228987$PFIZER$$$$$$Y$$$20240806$$CN$GB$GB
241788112$24178811$2$F$20230101$20240802$20240806$20240815$EXP$$BR-PFIZER INC-PV202400099333$PFIZER$$58$YR$$F$Y$$$20240815$$CN$BR$BR
241788121$24178812$1$I$20240716$20240803$20240806$20240806$EXP$$CN-PFIZER INC-PV202400101194$PFIZER$$52$YR$$F$Y$52$KG$20240806$$HP$CN$CN
241788131$24178813$1$I$$20240805$20240806$20240806$EXP$$US-PFIZER INC-202400192447$PFIZER$$60$YR$$F$Y$$$20240806$$HP$US$US
241788143$24178814$3$F$20240702$20240927$20240806$20240927$EXP$$CA-PFIZER INC-202400188798$PFIZER$$72$YR$$M$Y$154$KG$20240927$$MD$CA$CA
241788151$24178815$1$I$20240714$20240801$20240806$20240806$EXP$$CN-PFIZER INC-PV202400100726$PFIZER$$51$YR$$M$Y$$$20240806$$HP$CN$CN
241788161$24178816$1$I$20240701$20240801$20240806$20240806$EXP$GB-MHRA-31354159$GB-PFIZER INC-202400228310$PFIZER$$75$YR$$M$Y$$$20240806$$CN$GB$GB
241788172$24178817$2$F$20170101$20240828$20240806$20240904$EXP$$CA-PFIZER INC-202400229242$PFIZER$$48$YR$$F$Y$90.7$KG$20240904$$HP$CA$CA
241788182$24178818$2$F$20240715$20240913$20240806$20240916$EXP$$US-PFIZER INC-PV202400101697$PFIZER$$76$YR$$F$Y$$$20240916$$HP$US$US
241788191$24178819$1$I$20240510$20240801$20240806$20240806$EXP$$IT-PFIZER INC-202400228050$PFIZER$$77$YR$$$Y$$$20240806$$MD$IT$IT
241788201$24178820$1$I$20240731$20240805$20240806$20240806$EXP$$CN-PFIZER INC-PV202400101848$PFIZER$$32$YR$$F$Y$42$KG$20240806$$HP$CN$CN
241788211$24178821$1$I$$20240801$20240806$20240806$EXP$$TR-PFIZER INC-202400228965$PFIZER$Isbilen, G.. Intrathecal Tigecycline in the Treatment of Hospital-Acquired Meningitis: A Review of Four Cases. Surgical infections. 2024;10.1089/sur.2024.063$55$YR$$M$Y$$$20240806$$HP$TR$TR
241788231$24178823$1$I$20240718$20240801$20240806$20240806$EXP$$CN-PFIZER INC-PV202400100699$PFIZER$$35$YR$$F$Y$45.5$KG$20240806$$HP$CN$CN
241788241$24178824$1$I$$20240801$20240806$20240806$EXP$$TR-PFIZER INC-202400228963$PFIZER$Isbilen, G.. Intrathecal Tigecycline in the Treatment of Hospital-Acquired Meningitis: A Review of Four Cases. Surgical infections. 2024;10.1089/sur.2024.063$77$YR$$M$Y$$$20240806$$HP$TR$TR
241788251$24178825$1$I$20240118$20240731$20240806$20240806$EXP$$US-PFIZER INC-202400228450$PFIZER$$68$YR$$F$Y$$$20240806$$HP$US$US
241788262$24178826$2$F$$20240806$20240806$20240808$EXP$$US-PFIZER INC-PV202400102012$PFIZER$$64$YR$$F$Y$$$20240808$$HP$US$US
241788271$24178827$1$I$$20240730$20240806$20240806$EXP$$DE-PFIZER INC-202400226447$PFIZER$$63$YR$$M$Y$$$20240806$$MD$DE$DE
241788281$24178828$1$I$$20240805$20240806$20240806$EXP$$CA-PFIZER INC-202400230334$PFIZER$$71$YR$$F$Y$$$20240806$$HP$CA$CA
241788291$24178829$1$I$$20240805$20240806$20240806$EXP$GB-MHRA-MED-202408051639462300-VJRGM$GB-PFIZER INC-202400230416$PFIZER$$69$YR$$M$Y$$$20240806$$MD$GB$GB
241788301$24178830$1$I$20240730$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002078$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240806$$CN$US$US
241788311$24178831$1$I$20240801$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002128$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240806$$CN$US$US
241788321$24178832$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002117$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240806$$CN$US$US
241788331$24178833$1$I$20231201$20240801$20240806$20240806$EXP$$US-ABBVIE-5864676$ABBVIE$$44$YR$$F$Y$$$20240806$$CN$US$US
241788343$24178834$3$F$20240727$20240903$20240806$20240903$PER$$US-ALXN-202407USA002131US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
241788351$24178835$1$I$20240101$20240731$20240806$20240806$EXP$$US-ABBVIE-5864580$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241788361$24178836$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024155079$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241788382$24178838$2$F$$20240808$20240806$20240812$EXP$GB-MHRA-MED-202407301334377580-FHGQY$GB-TORRENT-00037466$TORRENT$$$$$F$Y$$$20240812$$MD$GB$GB
241788391$24178839$1$I$20240803$20240806$20240806$20240806$PER$$US-AMGEN-USASP2024155317$AMGEN$$30$YR$A$F$Y$$$20240806$$CN$US$US
241788401$24178840$1$I$$20240728$20240806$20240806$EXP$$US-TORRENT-00013693$TORRENT$$$$$F$Y$$$20240806$$PH$US$US
241788411$24178841$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190593$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241788421$24178842$1$I$$20240802$20240806$20240806$EXP$$IE-MYLANLABS-2024M1015927$MYLAN$$$$$M$Y$$$20240806$$CN$IE$IE
241788431$24178843$1$I$$20240730$20240806$20240806$PER$$US-MYLANLABS-2024M1072349$MYLAN$$$$$F$Y$$$20240806$$CN$US$US
241788441$24178844$1$I$$20240802$20240806$20240806$PER$$NVSC2024US159702$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
241788452$24178845$2$F$$20240729$20240806$20240811$PER$$US-SA-2024SA230419$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240811$$CN$US$US
241788461$24178846$1$I$$20240722$20240806$20240806$EXP$$CN-PURACAP-CN-2024EPCLIT00919$PURACAP$Xiao-Lan Li.A Rare Case of Acute Infectious Purpura  Fulminans Caused by Klebsiella Pneumoniae and Human Herpesvirus Type 5.Journal of Inflammation Research.26-JUL-2022;15:4251-4260$22$YR$A$M$Y$90$KG$20240806$$HP$CN$CN
241788481$24178848$1$I$$20240731$20240806$20240806$PER$$US-BAYER-2024A111530$BAYER$$$$$F$Y$$$20240806$$CN$US$US
241788491$24178849$1$I$20240802$20240805$20240805$20240805$DIR$712928$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241788501$24178850$1$I$20240701$20240725$20240806$20240806$EXP$FR-AFSSAPS-MA2024001219$FR-Atnahs Limited-ATNAHS20240702159$Atnahs Healthcare$$46$YR$A$M$Y$$$20240805$$MD$FR$FR
241788521$24178852$1$I$20230101$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154605$AMGEN$$71$YR$E$F$Y$$$20240806$$HP$US$US
241788541$24178854$1$I$$20240805$20240805$20240805$DIR$712939$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241788551$24178855$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190503$Haleon PLC$$$$$M$Y$$$20240806$$CN$US$US
241788564$24178856$4$F$20240726$20240919$20240806$20240926$EXP$$JP-GENMAB-2024-02830$GENMAB$$72$YR$$F$Y$55$KG$20240926$$MD$JP$JP
241788571$24178857$1$I$$20240805$20240806$20240806$EXP$$US-JNJFOC-20240810763$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$CN$US$US
241788581$24178858$1$I$20240122$20240805$20240806$20240806$EXP$IT-MINISAL02-997064$IT-JNJFOC-20240811501$JOHNSON AND JOHNSON$$30$YR$A$M$Y$72$KG$20240806$$PH$IT$IT
241788591$24178859$1$I$$20240726$20240806$20240806$EXP$$US-BRAEBURN-US-BRA-24-000708$BRAEBURN PHARMACEUTICALS$$$$$F$Y$50.34$KG$20240806$$CN$US$US
241788601$24178860$1$I$$20240731$20240806$20240806$PER$$US-ABBVIE-5863076$ABBVIE$$$$$$Y$$$20240806$$CN$US$US
241788611$24178861$1$I$20240720$20240729$20240806$20240806$PER$$US-RDY-SPO/USA/24/0011128$DR REDDYS$$$$$M$Y$$$20240806$$CN$US$US
241788621$24178862$1$I$$20240723$20240806$20240806$EXP$GB-MHRA-31008345$GB-Atnahs Limited-ATNAHS20240702149$Atnahs Healthcare$$62$YR$A$F$Y$62$KG$20240731$$CN$GB$GB
241788631$24178863$1$I$$20240722$20240806$20240806$EXP$$CH-EPICPHARMA-CH-2024EPCLIT00908$EPIC PHARM$Bujana Batusha Sopi.Unhappy hearts with the antidepressant venlafaxine.Swiss medical weekly.2024;154 (278):63S-64S$82$YR$E$M$Y$$$20240806$$HP$CH$CH
241788641$24178864$1$I$$20240731$20240806$20240806$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043228$BOEHRINGER INGELHEIM$$42$YR$A$M$Y$$$20240806$$CN$US$US
241788651$24178865$1$I$20240712$20240802$20240806$20240806$EXP$$US-BAYER-2024A112851$BAYER$$32$YR$A$M$Y$$$20240806$$CN$US$US
241788661$24178866$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123755$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$61.69$KG$20240806$$CN$US$US
241788671$24178867$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123655$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240806$$CN$US$US
241788681$24178868$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123737$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240806$$HP$US$US
241788691$24178869$1$I$$20240729$20240806$20240806$EXP$$US-MYLANLABS-2024M1072829$MYLAN$Bayless SL, Walker NV, Scott MM, Leo RJ. Clozapine-Related Cecal Volvulus. Prim-Care-Companion-CNS-Disord 2024; 26 (4):.$58$YR$$F$Y$$$20240806$$MD$US$US
241788701$24178870$1$I$20240709$20240803$20240806$20240806$EXP$$CN-GILEAD-2024-0682872$GILEAD$$48$YR$A$M$Y$66$KG$20240806$$CN$CN$CN
241788711$24178871$1$I$20240606$20240731$20240806$20240806$EXP$$CN-JNJFOC-20240801943$JOHNSON AND JOHNSON$$69$YR$E$F$Y$57$KG$20240806$$HP$CN$CN
241788721$24178872$1$I$$20240726$20240806$20240806$EXP$$US-JNJFOC-20240805890$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$HP$US$US
241788731$24178873$1$I$$20240730$20240806$20240806$PER$$US-ALXN-202407USA002125US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
241788742$24178874$2$F$$20240821$20240806$20240823$EXP$$JP-TAKEDA-2024TUS078553$TAKEDA$Miura M, Miyata K, Kaneko T, Akahoshi S, Morikawa Y, Matsushima T, et al. Methylprednisolone pulse and prednisolone for intensification of primary treatment in kawasaki disease patients at high risk of treatment resistance: a multicenter prospective cohort study. European Journal Of Pediatrics. 2024;1-10$$$I$$Y$$$20240823$$HP$JP$JP
241788751$24178875$1$I$$20240802$20240806$20240806$PER$$US-BAUSCH-BL-2024-011875$BAUSCH AND LOMB$$44$YR$$F$Y$$$20240806$$CN$US$US
241788761$24178876$1$I$20240104$20240722$20240806$20240806$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460832$RANBAXY$$48$YR$$F$Y$$$20240806$$MD$ES$ES
241788771$24178877$1$I$20240116$20240722$20240806$20240806$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460823$RANBAXY$$86$YR$$F$Y$$$20240806$$HP$IT$IT
241788781$24178878$1$I$20240422$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460342$RANBAXY$$44$YR$$F$Y$89$KG$20240806$$MD$FR$FR
241788791$24178879$1$I$$20240722$20240806$20240806$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460696$RANBAXY$Ito C, Odajima K, Niimura Y, Fujii M, Sone M, Asakawa S, et al.. IgA vasculitis with transient glomerular hematuria, diarrhea, and pericarditis following COVID-19 mRNA vaccination in a young patient with possible pre-existing ulcerative colitis.. CEN Case Rep. 2023;12 (1):84-90$18$YR$$M$Y$$$20240806$$HP$JP$JP
241788801$24178880$1$I$$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460846$RANBAXY$$18$YR$$M$Y$$$20240806$$HP$FR$FR
241788811$24178881$1$I$20221206$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460828$RANBAXY$$82$YR$$F$Y$69$KG$20240806$$MD$FR$FR
241788821$24178882$1$I$$20240722$20240806$20240806$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460672$RANBAXY$Fetzer K, Forchhammer S, Silber T, Volc S. A rare case of acute generalized exanthematous pustulosis induced by gadobutrol. Contact Dermatitis. 2024;91 (2):158-161$50$YR$$M$Y$$$20240806$$HP$DE$DE
241788831$24178883$1$I$$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460874$RANBAXY$$40$YR$$M$Y$$$20240806$$PH$FR$FR
241788841$24178884$1$I$20240411$20240722$20240806$20240806$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460745$RANBAXY$$19$YR$$F$Y$$$20240806$$MD$IT$IT
241788851$24178885$1$I$$20240722$20240806$20240806$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460555$RANBAXY$De Almeida T, Bertoluci M, Barkan S, Marobin R, Czepielewski M. Failure Of Pasireotide To Control Hypoglycemia In A Men-1 Patient With Metastatic Insulinoma. J Endocr Soc. 2019;Apr-May; 3 (S1):SUN-319; 1-2$39$YR$$F$Y$$$20240806$$HP$BR$BR
241788861$24178886$1$I$$20240722$20240806$20240806$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460912$RANBAXY$Matsuki S, Taniuchi N, Okada N, Sato J, Nishijima N, Kamio K, et al. A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non Small Cell Lung Cancer. Journal of Nippon Medical School. 2024;91 (3):339-346$67$YR$$M$Y$$$20240806$$HP$JP$JP
241788871$24178887$1$I$$20240722$20240806$20240806$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461135$RANBAXY$Nagpal S, Pokhriyal S, Bhandari P, Elabbassi AM, Yadav R. A Case of Rituximab-induced Interstitial Lung Disease. Am J Respir Crit Care Med. 2023;May;207:A6672 (D103)$78$YR$$F$Y$$$20240806$$HP$US$US
241788882$24178888$2$F$20231231$20240814$20240806$20240829$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460859$RANBAXY$$85$YR$$M$Y$$$20240829$$HP$BE$BE
241788893$24178889$3$F$$20240809$20240806$20240813$PER$$US-BAYER-2024A112014$BAYER$$31$YR$A$F$Y$$$20240813$$MD$US$US
241788901$24178890$1$I$20240216$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460813$RANBAXY$$72$YR$$M$Y$148$KG$20240806$$PH$FR$FR
241788911$24178891$1$I$$20240802$20240806$20240806$EXP$$US-BAYER-2024A112987$BAYER$$84$YR$E$F$Y$$$20240806$$CN$US$US
241788921$24178892$1$I$$20240722$20240806$20240806$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460857$RANBAXY$$21$YR$$M$Y$$$20240806$$MD$IT$IT
241788931$24178893$1$I$$20240722$20240806$20240806$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460831$RANBAXY$Ahn S, Lee Y, Han M, Lee JA, Kim JH, Jeong SJ. Within-host Viral Evolution and Neutralizing Antibody Response in Immunocompromised Patients with Persistent SARS-CoV-2 Infection Receiving B Cell Depleting Treatment. Open Forum Infect Dis. 2023;10(1):278-279$38$YR$$F$Y$$$20240806$$HP$KR$KR
241788941$24178894$1$I$$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460963$RANBAXY$$39$YR$$M$Y$$$20240806$$HP$FR$FR
241788951$24178895$1$I$20240717$20240722$20240806$20240806$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460792$RANBAXY$$94$YR$$F$Y$53$KG$20240806$$MD$GB$GB
241788961$24178896$1$I$$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460730$RANBAXY$Mourabiti H, Esayh G, Hoummani H, Amrani Hanchi S, Chaouche I, Achour S, et al. Paraparesis secondary to metformin: A rare condition to be aware of, with characteristic MRI images. Toxic Analyt Clinique. 2024;0 (0):6 pages$63$YR$$F$Y$$$20240806$$HP$FR$MA
241788971$24178897$1$I$20240229$20240722$20240806$20240806$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460929$RANBAXY$$63$YR$$M$Y$$$20240806$$MD$SE$SE
241788981$24178898$1$I$$20240722$20240806$20240806$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461171$RANBAXY$Okamori S, Kamimoto S, Uchida T, Ozawa T, Miyazaki M, Baba R, et al.. A Case of a Ferrous Sulphate Tablet Aspiration Leading to Bronchial Stenosis. Am J Respir Crit Care Med. 2023;207:not available$81$YR$$M$Y$$$20240806$$HP$JP$JP
241788991$24178899$1$I$$20240722$20240806$20240806$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460568$RANBAXY$Costa T, Macieira F, Pena E, Moura MJ, Fernandes A, Cunha JC. A Case Report of Empyema Caused by Carbapenemase Producing Bacteria-A Therapeutic Challenge. Eur J Case Rep Intern Med. 2023;10(Suppl.):491-492$68$YR$$M$Y$$$20240806$$HP$PT$PT
241789001$24178900$1$I$20240509$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460284$RANBAXY$$76$YR$$F$Y$59$KG$20240806$$PH$FR$FR
241789011$24178901$1$I$20240506$20240722$20240806$20240806$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461091$RANBAXY$$58$YR$$F$Y$67$KG$20240806$$PH$DE$DE
241789021$24178902$1$I$20240501$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461189$RANBAXY$$60$YR$$F$Y$$$20240806$$PH$FR$FR
241789031$24178903$1$I$20240216$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460957$RANBAXY$$15$YR$$F$Y$53.4$KG$20240806$$HP$FR$FR
241789041$24178904$1$I$$20240722$20240806$20240806$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460917$RANBAXY$Riestra I, Carmona Porquera EM. Fibrocystic Sarcoidosis: Should Patients Be on Prophylaxis for Opportunistic Infections?. Am J Respir Crit Care Med. 2023;May 22;207:A3251;B38$53$YR$$M$Y$$$20240806$$HP$US$US
241789051$24178905$1$I$$20240722$20240806$20240806$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460548$RANBAXY$Mohammed A, Tang B, Sadikot S, Barmaimon G. Acute Eosinophilic Pneumonia Induced by Immune Checkpoint Inhibitor and Anti-TIGIT Therapy. Am J Case Rep. 2024;25(0):e943740/38970243$46$YR$$F$Y$$$20240806$$HP$US$US
241789061$24178906$1$I$$20240722$20240806$20240806$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460576$RANBAXY$Nagashiromani D, Vignesh M. Case series of methotrexate induced pancytopenia. Case series of methotrexate induced pancytopenia. Indian J Rheumatol. 2023;18 (Suppl.):S170-S171$$$$$Y$$$20240806$$HP$IN$IN
241789071$24178907$1$I$$20240722$20240806$20240806$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460659$RANBAXY$Shih J, Hamera L. Multiorgan Failure in the Aftermath of Pre-eclampsia With Intracerebral Hemorrhage and HELLP Syndrome. Am J Respir Crit Care Med. 2023;207:A4354$18$YR$$F$Y$$$20240806$$HP$US$US
241789081$24178908$1$I$20240506$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460744$RANBAXY$$77$YR$$M$Y$66$KG$20240806$$MD$FR$FR
241789091$24178909$1$I$20240406$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460803$RANBAXY$$55$YR$$F$Y$68$KG$20240806$$MD$FR$FR
241789101$24178910$1$I$$20240722$20240806$20240806$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460677$RANBAXY$Gillespie M, Wert MJ. Airway Obstruction Due to Invasive Tracheobronchial Aspergillosis. Am J Respir Crit Care Med. 2023;207:A6099$50$YR$$M$Y$$$20240806$$HP$US$US
241789111$24178911$1$I$$20240722$20240806$20240806$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460711$RANBAXY$Wang J, Lan H, Mao X, Chen Y. Pituitary-adrenal axis dysfunction induced by tislelizumab immunotherapy for non-small cell lung cancer: a case series and literature review. BMC Pulm Med. 2024;24(1):327(1-8)$56$YR$$M$Y$$$20240806$$HP$CN$CN
241789122$24178912$2$F$20190501$20240801$20240806$20240816$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460684$RANBAXY$Tanaka H, Sakakibara M,Hiratsuka M, Sugiura Y, Hiruta N. Improved QOL in a Case of Breast Cancer with Meningeal Carcinomatosis Treated with Radiation Therapy and Intrathecal Chemotherapy. Jpn J Cancer Chemother. 2022;Dec;49(13):1938-1940$6$DEC$$F$Y$$$20240816$$HP$JP$JP
241789131$24178913$1$I$$20240722$20240806$20240806$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460700$RANBAXY$Schambach S, Esteitie R, Nader A. Diffuse Disseminated Demyelination: A Detrimental Outcome. Am J Respir Crit Care Med. 2023;207:A1742$27$YR$$M$Y$$$20240806$$HP$US$US
241789141$24178914$1$I$20240326$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460357$RANBAXY$$57$YR$$F$Y$58$KG$20240806$$MD$FR$FR
241789151$24178915$1$I$20240415$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460966$RANBAXY$$67$YR$$F$Y$46.5$KG$20240806$$MD$FR$FR
241789161$24178916$1$I$$20240722$20240806$20240806$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460690$RANBAXY$Miyazaki M, Nakano M,Takahashi H, Isaka Y, Hiura Y. Euglycemic Ketoacidosis in a Patient without Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure. Am J Case Rep. 2024;25 (0):e943945-1-e943945-5$83$YR$$F$Y$$$20240806$$HP$JP$JP
241789171$24178917$1$I$$20240722$20240806$20240806$EXP$$BG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460538$RANBAXY$Gorcheva DI, Lozanov LB. Potential Risks of GLP-1RA and SGLT-2i Treatment (Case reports). Endocrinol. 2023;XXVIII(1):57-61$46$YR$$M$Y$$$20240806$$HP$BG$BG
241789181$24178918$1$I$$20240722$20240806$20240806$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460709$RANBAXY$Xu L, Wang L, Song Y, Tong L. Metagenomic next-generation sequencing assistance in identifying Mycobacterium iranicum pulmonary infection: A case report. Diagn Microbiol Infect Dis. 2024;Jul 14;110(1):116445;Online ahead of print.$65$YR$$F$Y$$$20240806$$HP$CN$CN
241789191$24178919$1$I$20181117$20240722$20240806$20240806$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-194463$RANBAXY$$69$YR$$F$Y$75$KG$20240806$$MD$DE$DE
241789201$24178920$1$I$20240416$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461125$RANBAXY$$49$YR$$M$Y$$$20240806$$CN$FR$FR
241789211$24178921$1$I$$20240722$20240806$20240806$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460373$RANBAXY$Usman S, Ashraf A, Badar F, ftikhar A. Evidence Based Management of Right Heart Failure in Intensive Care Unit:  A Case Report. Am J Respir Crit Care Med. 2023;207$93$YR$$F$Y$$$20240806$$HP$US$US
241789221$24178922$1$I$20240118$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461127$RANBAXY$$43$YR$$F$Y$79$KG$20240806$$PH$FR$FR
241789234$24178923$4$F$$20240902$20240806$20240913$EXP$$PT-Atnahs Limited-ATNAHS20240702200$Atnahs Healthcare$Patricia A, Diogo R, Ricardo V, Joana P, Lelita S. SiNDROME MALIGNA DOS NEUROLEPTICOS (NEUROLEPTIC MALIGNANT SYNDROME: REPORT OF A CLINICAL CASE). Other | Clinical case. 1071$70$YR$E$F$Y$$$20240912$$HP$PT$PT
241789241$24178924$1$I$$20240722$20240806$20240806$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460714$RANBAXY$Khan S, Yetiskul E, Khattar G, Ghada A, Afif S, Khan MWZ, et al. FAILURE OF THE PD-1 BLOCKING AGENT PEMBROLIZUMAB TO BENEFIT A PATIENT WITH RENAL SQUAMOUS CELL CANCER. Eur J Case Rep Intern Med. 2024;11 (7):1-4$80$YR$$F$Y$$$20240806$$HP$US$US
241789251$24178925$1$I$$20240722$20240806$20240806$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460585$RANBAXY$Kawanaka H, Ogano M, Hibako K, Tanabe J. Takotsubo Cardiomyopathy Presenting with QT Prolongation and Torsade de Pointes in a Patient with Coronavirus Disease 2019. J Nippon Med Sch. 2024;91 (1):124-128$58$YR$$F$Y$$$20240806$$HP$JP$JP
241789261$24178926$1$I$20240703$20240722$20240806$20240806$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460716$RANBAXY$$36$YR$$F$Y$73$KG$20240806$$CN$GB$GB
241789272$24178927$2$F$$20240730$20240806$20240814$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460734$RANBAXY$Malavade P, Kavitha. Hyper magnesaemia, maternal quadriparesis, and encephalopathy a case report. Indian J Nephrol. 2021;31 (Suppl. 1):S57-S58$28$YR$$F$Y$$$20240814$$HP$IN$IN
241789281$24178928$1$I$20240416$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460540$RANBAXY$$81$YR$$F$Y$80$KG$20240806$$MD$FR$FR
241789291$24178929$1$I$$20240722$20240806$20240806$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460703$RANBAXY$Zhang W, Liu X, Wang X, Ma H, Zhang P. Case report: Propylthiouracil-induced serious side effect: Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis or IgA vasculitis?. Medicine. 2024;103 (27):e38790; 1-6$28$YR$$F$Y$55.4$KG$20240806$$HP$CN$CN
241789301$24178930$1$I$$20240722$20240806$20240806$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460515$RANBAXY$Squicimari-de Cardenas FA, Bosques-Lorenzo J, Alejandro L-V, Rodriguez C, Carlos C-S, Castellano JMC. Euglycemic Diabetic Ketoacidosis When Combining Empagliflozin With Cocaine. J Endocr Soc. 2023;7 (Suppl.1):A570 / SAT439 / bvad114.1069$66$YR$$M$Y$$$20240806$$MD$US$US
241789312$24178931$2$F$20200106$20240827$20240806$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459972$RANBAXY$$54$YR$A$F$Y$$$20240911$$CN$US$US
241789321$24178932$1$I$20240502$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460248$RANBAXY$$14$MON$$F$Y$$$20240806$$HP$FR$FR
241789331$24178933$1$I$$20240731$20240806$20240806$EXP$$AU-JAZZ PHARMACEUTICALS-2024-AU-011626$JAZZ$$$$$M$Y$$$20240806$$CN$AU$AU
241789341$24178934$1$I$$20240722$20240806$20240806$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460647$RANBAXY$Parra DV, Sanchez PC, Del Carmen Rebollo Najera M, Guerrero JAC,  De Pablos AN, Otero JA, et al. GROUND-GLASS OPACITIES AND DYSPNOEA IN A PATIENT WITH SARCOIDOSIS IN THE COVID-19 PANDEMIC. Eur J Case Rep Intern Med. 2023;10 (Suppl.):329-330(706-submission no.822)$48$YR$$M$Y$$$20240806$$HP$ES$ES
241789351$24178935$1$I$20220501$20240722$20240806$20240806$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460623$RANBAXY$Ahn S, Lee Y, Han M, Lee JA, Kim JH, Jeong SJ, et al. Within-host Viral Evolution and Neutralizing Antibody Response in Immunocompromised Patients with Persistent SARS-CoV-2 Infection Receiving B Cell Depleting Treatment. Open Forum Infect Dis. 2023;Oct 12;10(S2):S278-S279;456$53$YR$$M$Y$$$20240806$$MD$KR$KR
241789361$24178936$1$I$$20240731$20240806$20240806$EXP$$JP-PFIZER INC-PV202400100008$PFIZER$Masayuki, M.. A case in which a paradoxical reaction occurred during treatment with a tumor necrosis factor-alpha inhibitor and treatment with eppikajutsuto proved effective in a patient with psoriasis vulgaris.. The 2024 Fukushima Prefectural General Meeting of the Japan Society for Oriental. 2024$83$YR$$M$Y$$$20240806$$MD$JP$JP
241789372$24178937$2$F$20240301$20240925$20240806$20240926$EXP$$US-PFIZER INC-202400228267$PFIZER$$58$YR$$F$Y$57.6$KG$20240926$$PH$US$US
241789381$24178938$1$I$$20240801$20240806$20240806$30DAY$$US-PFIZER INC-PV202400044216$PFIZER$$$$$$Y$$$20240806$$HP$US$US
241789393$24178939$3$F$$20240913$20240806$20240917$30DAY$$BR-PFIZER INC-202400227406$PFIZER$$$$$M$Y$$$20240917$$CN$BR$BR
241789402$24178940$2$F$$20240912$20240806$20240917$30DAY$$CL-PFIZER INC-PV202400101080$PFIZER$$13$YR$$M$Y$$$20240917$$CN$CL$CL
241789411$24178941$1$I$$20221214$20240806$20240806$EXP$$US-AstraZeneca-2022A410562$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241789421$24178942$1$I$$20240729$20240806$20240806$EXP$$IL-BAUSCH-BL-2024-011529$BAUSCH AND LOMB$Rabinovich E, Hershko-Klement A, Bentov Y. A differential expression of an identical mutation in CYP17A1 gene in two infertility patients: A case report. Journal of Medical Case Reports. 2024 JUL 23;18(336):1-6. doi:10.1186/s13256-024-04654-5$24$YR$$F$Y$$$20240806$$HP$IL$IL
241789431$24178943$1$I$$20240722$20240806$20240806$EXP$$CN-EPICPHARMA-CN-2024EPCLIT00904$EPIC PHARM$Haili Xin.Pregabalin-induced rhabdomyolysis: a case series and literature analysis. Journal of International Medical Research.2024;52:1-7$10$DEC$E$F$Y$$$20240806$$HP$CN$CN
241789441$24178944$1$I$$20240731$20240806$20240806$EXP$$US-ABBVIE-5864355$ABBVIE$$$$$$Y$$$20240806$$CN$US$US
241789451$24178945$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190595$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241789471$24178947$1$I$$20240801$20240806$20240806$EXP$$US-ABBVIE-5865173$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241789481$24178948$1$I$$20240709$20240806$20240806$PER$$US-JNJFOC-20240724186$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240806$$CN$US$US
241789492$24178949$2$F$20240731$20240909$20240806$20240913$EXP$$CA-ABBVIE-5864371$ABBVIE$$41$YR$$F$Y$$$20240913$$CN$CA$CA
241789501$24178950$1$I$$20240801$20240806$20240806$PER$$NVSC2024US158802$NOVARTIS$$$$$M$Y$$$20240806$$MD$US$US
241789511$24178951$1$I$20240723$20240805$20240806$20240806$EXP$$US-UCBSA-2024039291$UCB$$45$YR$$M$Y$$$20240806$$CN$US$US
241789521$24178952$1$I$$20240805$20240806$20240806$EXP$$US-UCBSA-2024035582$UCB$$$$$M$Y$$$20240806$$CN$US$US
241789531$24178953$1$I$$20240801$20240806$20240806$PER$$NVSC2024US158133$NOVARTIS$$$$$M$Y$$$20240806$$CN$US$US
241789541$24178954$1$I$20240623$20240725$20240806$20240806$EXP$$CN-ASTELLAS-2024US022095$ASTELLAS$$51$YR$$F$Y$60$KG$20240806$$CN$CN$CN
241789551$24178955$1$I$20240312$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460743$RANBAXY$$70$YR$$F$Y$104$KG$20240806$$MD$FR$FR
241789561$24178956$1$I$$20240722$20240806$20240806$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460635$RANBAXY$Carvalho DV, Carvalho Ferraz L, Meireles D, Araujo AR, Ferreira AR. IATROGENIC PERIMYOCARDITIS:A RARE SIDEEFFECT OF MESALAZINE. Eur J Case Rep Intern Med. 2019;6 (Suppl.):129$21$YR$$F$Y$$$20240806$$HP$PT$PT
241789571$24178957$1$I$$20240722$20240806$20240806$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461151$RANBAXY$$$$$F$Y$$$20240806$$PH$GB$GB
241789582$24178958$2$F$$20240730$20240806$20240814$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460735$RANBAXY$Malavade P, Kavitha. Hyper magnesaemia, maternal quadriparesis, and encephalopathy a case report. Indian J Nephrol. 2021;31 (Suppl.):S57-S58$$$N$$Y$1.4$KG$20240814$$HP$IN$IN
241789591$24178959$1$I$$20240722$20240806$20240806$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460706$RANBAXY$Wang J, Lan H, Mao X, Chen Y. Pituitary-adrenal axis dysfunction induced by tislelizumab immunotherapy for non-small cell lung cancer: a case series and literature review. BMC Pulm Med. 2024;24(1):327/1-8$51$YR$$M$Y$$$20240806$$HP$CN$CN
241789602$24178960$2$F$20240507$20240821$20240806$20240905$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460774$RANBAXY$$58$YR$$F$Y$$$20240905$$MD$IT$IT
241789611$24178961$1$I$20240328$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460286$RANBAXY$$20$YR$$M$Y$68$KG$20240806$$MD$FR$FR
241789621$24178962$1$I$$20240722$20240806$20240806$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460543$RANBAXY$Grissett B, Sosa-Pagan M, Iqbal QZ. Topiramate causing elevation of urinary cortisol assay. J Endocr Soc. 2022;6(Suppl.):A66-A67/ODP058/bvac150.137$69$YR$$F$Y$105$KG$20240806$$MD$US$US
241789631$24178963$1$I$20240325$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460569$RANBAXY$$69$YR$$M$Y$$$20240806$$MD$FR$FR
241789641$24178964$1$I$$20240722$20240806$20240806$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460721$RANBAXY$Pan W, Xiang S, Zhang J,Gao Y, Liu S. Chemotherapy-induced pneumatosis intestinalis followed by hepatic portal venous gas. A case report. J Int Med Res. 2024;52 (3):1-5$6$DEC$$M$Y$$$20240806$$HP$CN$CN
241789651$24178965$1$I$20240513$20240722$20240806$20240806$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460280$RANBAXY$$63$YR$$M$Y$$$20240806$$HP$IT$IT
241789661$24178966$1$I$20220312$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460885$RANBAXY$$75$YR$$M$Y$$$20240806$$MD$FR$FR
241789671$24178967$1$I$$20240722$20240806$20240806$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460580$RANBAXY$Nagashiromani D, Vignesh M. Case series of methotrexate induced pancytopenia. Indian J Rheumatol. 2023;18 (Suppl2):S170-S171;POS071$$$$$Y$$$20240806$$HP$IN$IN
241789681$24178968$1$I$20240525$20240722$20240806$20240806$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460723$RANBAXY$$$$$F$Y$$$20240806$$HP$GB$GB
241789702$24178970$2$F$$20240806$20240806$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460523$RANBAXY$Madhavan P, Nallu R, Samat A. Malady or Remedy? Hypertensive Crisis in a Young Woman with Use of St John^s Wort for Depression. J Enodcr Soc. 2019;3 (Suppl.1):MON-429$39$YR$$F$Y$$$20240821$$MD$US$US
241789711$24178971$1$I$$20240722$20240806$20240806$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460662$RANBAXY$Binczyk W, Drozdz O, Siudek B, Gluszczyk AM Plizga JI, Grajnert FJ. The Significance of Precise Diabetes Diagnosis: A Case of Euglycemic Diabetic Ketoacidosis Induced by The Introduction of Empagliflozin With Simultaneous Reduction of Insulin Dosage. Eur J Case Rep Intern Med. 2024;11(6):no pagination$50$YR$$M$Y$$$20240806$$HP$PL$PL
241789722$24178972$2$F$20220101$20240731$20240806$20240814$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415951$RANBAXY$Gurbanova AA, Pereverzeva KG, Yakushin SS, Budanova IV. Ventricular tachycardia and myocardial infarction during antiarrhythmic therapy: a case report. Ration Pharmacother Cardiol. 2023;19(3):264-269$80$YR$$$Y$$$20240814$$HP$RU$RU
241789731$24178973$1$I$$20240722$20240806$20240806$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460707$RANBAXY$Wang J, Lan H, Mao X, Chen Y. Pituitary-adrenal axis dysfunction induced by tislelizumab immunotherapy for non-small cell lung cancer: a case series and literature review. BMC Pulm Med. 2024;24(1):327/1-8$74$YR$$M$Y$$$20240806$$HP$CN$CN
241789741$24178974$1$I$$20240722$20240806$20240806$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-416846$RANBAXY$Capron T, Botto G, Roujon J-J, Miltgen J, Berard H. Drug-induced interstitial lung disease: Indictment for apixaban. Respir Med Res. 2023;84:101024$67$YR$$F$Y$$$20240806$$HP$FR$FR
241789751$24178975$1$I$$20240722$20240806$20240806$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460925$RANBAXY$Zhang Y, Chakraborti MD C. REFINING PAIN MANAGEMENT IN CRYPTOCOCCAL IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME. South Med J. 2022;115:560$28$YR$$M$Y$$$20240806$$HP$US$US
241789761$24178976$1$I$$20240805$20240806$20240806$PER$$US-AMGEN-USASP2024155917$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241789771$24178977$1$I$20240801$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153971$AMGEN$$78$YR$E$F$Y$$$20240806$$CN$US$US
241789781$24178978$1$I$$20240728$20240806$20240806$EXP$$DE-JNJFOC-20240809612$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$HP$DE$DE
241789791$24178979$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154659$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241789801$24178980$1$I$$20240729$20240806$20240806$EXP$$IT-TEVA-VS-3229228$TEVA$Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al. Pickering Syndrome: An Overlooked Renovascular Cause of Recurrent Heart Failure. J-Am-Heart-Assoc 2023; 12 (19):.; Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al. Pickering Syndrome: An Overlooked Renovascular Cause of Recurrent Heart Failure. J-Am-Heart-Assoc 2023; 12 (19):.$75$YR$$M$Y$$$20240806$$MD$IT$IT
241789812$24178981$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683080$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241789821$24178982$1$I$$20240722$20240806$20240806$EXP$$IT-EPICPHARMA-IT-2024EPCLIT00907$EPIC PHARM$M. Marano.Pharmacokinetic effects of endoscopic gastric decontamination for  multidrug gastric pharmacobezoars.Toxicology Reports .21-JUN-2024;13:1-4$15$YR$T$F$Y$48$KG$20240806$$HP$IT$IT
241789831$24178983$1$I$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0683018$GILEAD$$19$YR$A$M$Y$$$20240806$$CN$US$US
241789841$24178984$1$I$20240805$20240805$20240805$20240805$DIR$712933$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241789851$24178985$1$I$20240805$20240805$20240805$20240805$DIR$712941$$FDA-CTU$$57$YR$$F$N$$$20240805$N$HP$US$
241789861$24178986$1$I$$20240805$20240805$20240805$DIR$712935$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241789891$24178989$1$I$20240620$20240723$20240806$20240806$EXP$FR-AFSSAPS-ST2024001142$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07020$HIKMA$$$$$$Y$$$20240806$$MD$FR$FR
241789901$24178990$1$I$$20240730$20240806$20240806$EXP$$PT-MYLANLABS-2024M1072096$MYLAN$Esteves S, Carapinha F, Cavaco L, Rodrigues AF, Pedro AO.. A clinical case of parvovirus b19 infection in an immunocompromised adult.. SPMI Case Reports. 2024;2(1):32-35$53$YR$$F$Y$$$20240806$$HP$PT$PT
241789911$24178991$1$I$$20240730$20240806$20240806$EXP$$US-MYLANLABS-2024M1072824$MYLAN$Lee K, Hussain K, Balasubramanian S, Salazar JP, Karagodin I, Levisay JP, et al. A ^vein^ attempt at angioplasty. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 4092.$59$YR$$M$Y$$$20240806$$HP$US$US
241789922$24178992$2$F$$20240919$20240806$20240919$PER$$NVSC2024US158250$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
241789931$24178993$1$I$$20240801$20240806$20240806$PER$$US-BAYER-2024A111943$BAYER$$19$YR$A$F$Y$$$20240806$$CN$US$US
241789941$24178994$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229652$SANOFI AVENTIS$$$$A$M$Y$124$KG$20240806$$MD$US$US
241789951$24178995$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA229368$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240806$$MD$US$US
241789961$24178996$1$I$$20240802$20240806$20240806$EXP$$US-SA-2024SA230687$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240806$$MD$US$US
241789971$24178997$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA225315$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$HP$US$US
241789981$24178998$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123002$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240806$$HP$US$US
241789991$24178999$1$I$20240804$20240805$20240806$20240806$PER$$US-AMGEN-USASP2024155631$AMGEN$$54$YR$A$F$Y$$$20240806$$CN$US$US
241790002$24179000$2$F$20240801$20240820$20240806$20240823$PER$$US-AMGEN-USASP2024153644$AMGEN$$$$$F$Y$$$20240823$$HP$US$US
241790021$24179002$1$I$20240801$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153686$AMGEN$$61$YR$A$M$Y$$$20240806$$CN$US$US
241790032$24179003$2$F$20230908$20240827$20240806$20240906$EXP$$JP-UCBSA-2024037818$UCB$Inui T, et al. Two cases where lacosamide was used as analgesic support for cancer pain;The proceedings of Joint Meeting of The 29th Congress of the Japanese Society for Palliative Medicine and The 37th Annual meeting of the Japan Psycho-Oncology Society. The 37th Annual meeting of the Japan Psycho-Oncology Society. 2024;P41-7$52$YR$$F$Y$$$20240906$$MD$JP$JP
241790041$24179004$1$I$$20240722$20240806$20240806$EXP$$CH-EPICPHARMA-CH-2024EPCLIT00909$EPIC PHARM$Bujana Batusha Sopi.Unhappy Hearts with the Antidepressant Venlafaxine.Swiss Medical Weekly.2024;154:63S-64S$77$YR$E$F$Y$$$20240806$$HP$CH$CH
241790051$24179005$1$I$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683086$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241790061$24179006$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001941$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240806$$CN$US$US
241790071$24179007$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002118$ELI LILLY AND CO$$$$$F$Y$$$20240806$$CN$US$US
241790081$24179008$1$I$20240716$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051097$TOLMAR$$65$YR$$M$Y$$$20240806$$CN$CA$CA
241790091$24179009$1$I$$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051100$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241790101$24179010$1$I$20230611$20240805$20240805$20240805$DIR$712936$$FDA-CTU$$78$YR$$M$N$67.5$KG$20240805$Y$CN$US$
241790111$24179011$1$I$20240716$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051094$TOLMAR$$81$YR$$M$Y$$$20240806$$CN$CA$CA
241790121$24179012$1$I$$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051138$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241790131$24179013$1$I$20240716$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051141$TOLMAR$$59$YR$$M$Y$$$20240806$$CN$CA$CA
241790141$24179014$1$I$20240801$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53676$$FDA-CTU$$44$YR$$F$N$$$20240805$Y$HP$US$
241790161$24179016$1$I$20240729$20240805$20240805$20240805$DIR$712913$$FDA-CTU$$37$YR$$F$N$74.25$KG$20240805$N$CN$US$
241790171$24179017$1$I$$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051132$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241790181$24179018$1$I$20231201$20240801$20240806$20240806$EXP$$RO-MYLANLABS-2024M1072086$MYLAN$$73$YR$$F$Y$$$20240806$$MD$RO$RO
241790191$24179019$1$I$$20240801$20240806$20240806$EXP$GB-MHRA-31354159$GB-MYLANLABS-2024M1072219$MYLAN$$75$YR$$M$Y$$$20240806$$CN$GB$GB
241790201$24179020$1$I$$20240801$20240806$20240806$EXP$$GB-MYLANLABS-2024M1072510$MYLAN$$$$$F$Y$$$20240806$$CN$GB$GB
241790211$24179021$1$I$$20240801$20240806$20240806$EXP$$GB-MYLANLABS-2024M1072427$MYLAN$$$$$M$Y$$$20240806$$CN$GB$GB
241790221$24179022$1$I$20240325$20240801$20240806$20240806$EXP$$GB-MYLANLABS-2024M1072163$MYLAN$$47$YR$$$Y$$$20240806$$PH$GB$GB
241790241$24179024$1$I$$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051146$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241790251$24179025$1$I$$20240716$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051144$TOLMAR$$$$$M$Y$$$20240806$$CN$CA$CA
241790261$24179026$1$I$20240718$20240718$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051161$TOLMAR$$68$YR$$M$Y$$$20240806$$CN$CA$CA
241790271$24179027$1$I$20240718$20240718$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051162$TOLMAR$$73$YR$$M$Y$$$20240806$$CN$CA$CA
241790281$24179028$1$I$20240717$20240717$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051165$TOLMAR$$65$YR$$M$Y$$$20240806$$CN$CA$CA
241790291$24179029$1$I$20240710$20240718$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051166$TOLMAR$$$$$$Y$$$20240806$$HP$CA$CA
241790301$24179030$1$I$20240717$20240717$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051174$TOLMAR$$74$YR$$M$Y$$$20240806$$CN$CA$CA
241790311$24179031$1$I$20240719$20240719$20240806$20240806$PER$$CA-TOLMAR, INC.-24CA051181$TOLMAR$$55$YR$$M$Y$$$20240806$$CN$CA$CA
241790322$24179032$2$F$20240712$20240830$20240806$20240923$PER$$FR-TOLMAR, INC.-24FR051066$TOLMAR$$$$$M$Y$$$20240923$$HP$FR$FR
241790361$24179036$1$I$20230101$20240726$20240806$20240806$EXP$$SG-ROCHE-10000040848$ROCHE$$$$$F$Y$$$20240806$$CN$SG$SG
241790371$24179037$1$I$$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121133$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240806$$PH$US$US
241790381$24179038$1$I$$20240802$20240806$20240806$EXP$$AU-MYLANLABS-2024M1072724$MYLAN$$$$$F$Y$$$20240806$$PH$AU$AU
241790391$24179039$1$I$20240723$20240731$20240806$20240806$EXP$$US-TAKEDA-2024TUS077673$TAKEDA$$19$YR$$F$Y$$$20240806$$CN$US$US
241790401$24179040$1$I$$20230719$20240806$20240806$EXP$$US-FERRINGPH-2023FE03676$FERRING$$$$$$Y$$$20240806$$CN$US$US
241790411$24179041$1$I$$20231228$20240806$20240806$EXP$$US-FERRINGPH-2023FE03650$FERRING$$$$$F$Y$$$20240806$$CN$US$US
241790421$24179042$1$I$20240710$20240802$20240806$20240806$EXP$GB-MHRA-MED-202408021930281890-FPRZV$GB-MYLANLABS-2024M1072464$MYLAN$$44$YR$$$Y$$$20240806$$PH$GB$GB
241790431$24179043$1$I$$20230728$20240806$20240806$EXP$$US-FERRINGPH-2023FE03754$FERRING$$$$$F$Y$$$20240806$$HP$US$US
241790441$24179044$1$I$$20231017$20240806$20240806$EXP$$US-FERRINGPH-2023FE05146$FERRING$$$$$F$Y$$$20240806$$CN$US$US
241790451$24179045$1$I$$20231017$20240806$20240806$EXP$$US-FERRINGPH-2023FE05148$FERRING$$$$$F$Y$$$20240806$$CN$US$US
241790461$24179046$1$I$$20230911$20240806$20240806$EXP$$US-FERRINGPH-2023FE04557$FERRING$$$$$F$Y$$$20240806$$CN$US$US
241790471$24179047$1$I$$20240802$20240806$20240806$EXP$$NVSC2024US159246$NOVARTIS$$$$$$Y$$$20240806$$CN$US$US
241790481$24179048$1$I$$20240207$20240806$20240806$EXP$$US-FERRINGPH-2024FE00603$FERRING$$$$$F$Y$$$20240806$$CN$US$US
241790491$24179049$1$I$$20240207$20240806$20240806$EXP$$US-FERRINGPH-2023FE05145$FERRING$$$$$F$Y$$$20240806$$CN$US$US
241790501$24179050$1$I$20240101$20240603$20240806$20240806$EXP$$US-FERRINGPH-2024FE02948$FERRING$$$$$F$Y$$$20240806$$CN$US$US
241790511$24179051$1$I$$20240405$20240806$20240806$EXP$$GB-FERRINGPH-2024FE01720$FERRING$$$$$$Y$$$20240806$$CN$GB$US
241790531$24179053$1$I$$20231017$20240806$20240806$EXP$$US-FERRINGPH-2023FE05147$FERRING$$$$$F$Y$$$20240806$$CN$US$US
241790541$24179054$1$I$$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A176526$ASTRAZENECA$$$$$$Y$$$20240806$$MD$US$
241790551$24179055$1$I$20240713$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A175685$ASTRAZENECA$$25719$DY$$$Y$$$20240806$$MD$US$
241790561$24179056$1$I$$20230418$20240806$20240806$EXP$$US-AstraZeneca-2023A055078$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241790571$24179057$1$I$$20240724$20240806$20240806$PER$$US-BAYER-2024A107702$BAYER$$$$$$Y$$$20240806$$CN$US$US
241790581$24179058$1$I$$20240722$20240806$20240806$EXP$$US-EPICPHARMA-US-2024EPCLIT00911$EPIC PHARM$C Siler.Polypharmacy in Older Adults: A Case Study.South Dakota Medicine.MAR-2023;76:124-127$64$YR$A$F$Y$$$20240806$$HP$US$US
241790591$24179059$1$I$20240731$20240805$20240806$20240806$EXP$$CN-ROCHE-10000049305$ROCHE$$59$YR$A$M$Y$51.5$KG$20240806$$HP$CN$CN
241790611$24179061$1$I$20240728$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154527$AMGEN$$71$YR$E$$Y$$$20240806$$CN$US$US
241790621$24179062$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153847$AMGEN$$$$$M$Y$$$20240806$$CN$US$US
241790641$24179064$1$I$$20240802$20240806$20240806$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-15544$IPSEN$$$$$F$Y$$$20240806$$CN$GB$GB
241790651$24179065$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5867083$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241790661$24179066$1$I$$20240805$20240806$20240806$EXP$$PT-NORDICGR-057046$NORDIC PHARMA$Ferreira IP, Sousa C, Silva IF, Borges J, Sousa A, Queijo C, Lopes N, Salvador F. Glomerulonefrite pauciimune em doente imunocomprometido - a prop?sito de um caso cl?nico. Congresso de Medicina Interna. 2024; 30(Sup 1 ):353.$70$YR$$M$Y$$$20240806$$MD$PT$PT
241790671$24179067$1$I$20240514$20240729$20240806$20240806$EXP$$DE-NORDICGR-057042$NORDIC PHARMA$$53$YR$$F$Y$$$20240805$$MD$DE$DE
241790681$24179068$1$I$20230201$20240726$20240806$20240806$EXP$GB-MHRA-MED-202407261508040100-VTCJL$GB-NOVOPROD-1261355$NOVO NORDISK$$42$YR$$F$Y$83$KG$20240806$$PH$GB$GB
241790691$24179069$1$I$20230831$20240729$20240806$20240806$EXP$FR-AFSSAPS-TO2024000667$FR-NORDICGR-056444$NORDIC PHARMA$$78$YR$$M$Y$$$20240806$$MD$FR$FR
241790701$24179070$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53843$$FDA-CTU$$61$YR$$F$N$$$20240805$N$$US$
241790711$24179071$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53796$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
241790731$24179073$1$I$20240804$20240805$20240805$20240805$DIR$712947$$FDA-CTU$$88$YR$$F$N$37.8$KG$20240805$N$$US$
241790741$24179074$1$I$$20240802$20240805$20240805$DIR$FDA-CDER-CTU-2024-53827$$FDA-CTU$$56$YR$$F$N$$$20240802$N$HP$US$
241790751$24179075$1$I$$20240725$20240806$20240806$EXP$AU-TGA-812049$AU-Accord-438336$ACCORD$$$$$$Y$$$20240806$$HP$AU$AU
241790771$24179077$1$I$20240708$20240726$20240806$20240806$EXP$CN-HENLIUS-24CN016141$CN-Accord-439378$ACCORD$$50$YR$A$F$Y$46.5$KG$20240806$$MD$CN$CN
241790791$24179079$1$I$$20240726$20240806$20240806$EXP$GB-MHRA-MED-202407262113594890-VKHFP$GB-Accord-439108$ACCORD$$63$YR$A$M$Y$78$KG$20240806$$CN$GB$GB
241790801$24179080$1$I$$20240726$20240806$20240806$EXP$CA-MHPD-E2B_07127658$CA-Accord-438868$ACCORD$$80$YR$E$F$Y$$$20240806$$HP$CA$CA
241790811$24179081$1$I$$20240725$20240806$20240806$EXP$$US-Accord-438876$ACCORD$$21$YR$A$M$Y$$$20240806$$HP$US$US
241790821$24179082$1$I$20240729$20240729$20240806$20240806$PER$$US-BAYER-2024A110974$BAYER$$$$$$Y$$$20240806$$CN$US$US
241790831$24179083$1$I$20240622$20240725$20240806$20240806$EXP$FR-AFSSAPS-GR2024000921$FR-Accord-438525$ACCORD$$70$YR$E$M$Y$79$KG$20240806$$PH$FR$FR
241790841$24179084$1$I$20240414$20240726$20240806$20240806$EXP$GB-MHRA-31124029$GB-Accord-439115$ACCORD$$73$YR$E$M$Y$99$KG$20240806$$PH$GB$GB
241790851$24179085$1$I$20240711$20240805$20240805$20240805$DIR$712955$$FDA-CTU$$41$YR$$F$N$$$20240805$N$HP$US$
241790871$24179087$1$I$20240717$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53865$$FDA-CTU$$64$YR$$F$N$$$20240805$N$HP$US$
241790881$24179088$1$I$$20240805$20240805$20240805$DIR$712959$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241790891$24179089$1$I$$20240726$20240806$20240806$EXP$GB-MHRA-MED-202407261611297380-YCDKF$GB-Accord-439150$ACCORD$$$$$F$Y$$$20240806$$MD$GB$GB
241790901$24179090$1$I$20240714$20240805$20240805$20240805$DIR$712952$$FDA-CTU$$53$YR$$M$N$100$KG$20240805$N$HP$US$
241790921$24179092$1$I$$20240805$20240805$20240805$DIR$712961$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241790931$24179093$1$I$$20240725$20240806$20240806$EXP$$CZ-Accord-439185$ACCORD$Weinbergerova B, Mayer J, Kabut T, Sperr WR, Stevkova J, Jonasova A, et al. Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis. Br J Haematol. 2024 Jul 23. doi: 10.1111/bjh.19670.$65$YR$E$$Y$$$20240806$$HP$CZ$CZ
241790941$24179094$1$I$$20240725$20240806$20240806$EXP$CA-MHPD-001087625$CA-Accord-438574$ACCORD$$66$YR$E$F$Y$$$20240806$$HP$CA$CA
241790962$24179096$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683104$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241790971$24179097$1$I$$20240801$20240806$20240806$PER$$NVSC2024US158225$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
241790981$24179098$1$I$$20240730$20240806$20240806$PER$$US-ALXN-202407USA002061US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
241790992$24179099$2$F$20240701$20240809$20240806$20240816$PER$$US-AMGEN-USASP2024152381$AMGEN$$$$$F$Y$$$20240815$$CN$US$US
241791001$24179100$1$I$20240614$20240729$20240806$20240806$EXP$ES-AEMPS-1550749$ES-TEVA-VS-3227600$TEVA$$90$YR$$M$Y$53$KG$20240806$$MD$ES$ES
241791011$24179101$1$I$20230712$20240729$20240806$20240806$EXP$ES-AEMPS-1550896$ES-TEVA-VS-3227533$TEVA$$60$YR$$F$Y$$$20240806$$MD$ES$ES
241791021$24179102$1$I$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683090$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241791032$24179103$2$F$20210901$20240730$20240806$20240808$EXP$$DE-ABBVIE-5863956$ABBVIE$$68$YR$$M$Y$$$20240808$$MD$DE$DE
241791041$24179104$1$I$20240701$20240802$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123301$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240806$$CN$US$US
241791051$24179105$1$I$20231001$20240801$20240806$20240806$EXP$$PR-ABBVIE-5865633$ABBVIE$$47$YR$$F$Y$79$KG$20240806$$CN$PR$PR
241791062$24179106$2$F$$20240814$20240806$20240820$EXP$$US-BAYER-2024A112917$BAYER$$86$YR$E$F$Y$$$20240820$$CN$US$US
241791071$24179107$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865654$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241791081$24179108$1$I$20240730$20240731$20240806$20240806$PER$$US-JNJFOC-20240801865$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240806$$PH$US$US
241791091$24179109$1$I$20240719$20240722$20240806$20240806$PER$$US-009507513-2407USA012775$MERCK$$59$YR$$M$Y$$$20240806$$PH$US$US
241791102$24179110$2$F$20110101$20240828$20240806$20240902$EXP$$US-KYOWAKIRIN-2024KK018660$KYOWA$$$$$$Y$$$20240902$$CN$US$US
241791111$24179111$1$I$20240704$20240731$20240806$20240806$EXP$$CN-OTSUKA-2024_021368$OTSUKA$$68$YR$$M$Y$70$KG$20240806$$HP$CN$CN
241791121$24179112$1$I$$20240730$20240806$20240806$PER$$US-BAYER-2024A110257$BAYER$$35$YR$A$F$Y$$$20240806$$MD$US$US
241791141$24179114$1$I$$20240802$20240806$20240806$PER$$US-ROCHE-10000048344$ROCHE$$$$$$Y$$$20240806$$MD$US$US
241791151$24179115$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154328$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241791161$24179116$1$I$20231211$20240731$20240806$20240806$EXP$$AU-AMGEN-AUSSP2024154799$AMGEN$$53$YR$A$$Y$$$20240806$$MD$AU$AU
241791171$24179117$1$I$20240101$20240731$20240806$20240806$PER$$US-LEO Pharma-372528$LEO PHARM$$42$YR$$F$Y$$$20240806$$PH$US$US
241791182$24179118$2$F$20240101$20240808$20240806$20240813$EXP$$US-ABBVIE-5865679$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
241791191$24179119$1$I$$20240730$20240806$20240806$PER$$US-ABBVIE-5861180$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241791201$24179120$1$I$20240703$20240731$20240806$20240806$EXP$CN-91110000556821568D-2024DRL001430$CN-RDY-SPO/CHN/24/0011370$DR REDDYS$$70$YR$E$M$Y$67$KG$20240806$$HP$CN$CN
241791211$24179121$1$I$$20240805$20240806$20240806$30DAY$$US-SANDOZ INC.-SDZ2024US070760$SANDOZ$$$$$$Y$$$20240806$$HP$US$US
241791221$24179122$1$I$20240624$20240801$20240806$20240806$EXP$$US-OTSUKA-2024_018812$OTSUKA$$$$$M$Y$$$20240806$$MD$US$US
241791231$24179123$1$I$$20240801$20240806$20240806$PER$$US-ABBVIE-5866140$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241791241$24179124$1$I$$20240729$20240806$20240806$PER$$US-APOTEX-2024AP009052$APOTEX$Barsoum G, Talal A. MATERNAL MONITORING FOR MULTI-DRUG REGRACTORY FETAL SUPRAVENTRICULAR TACHYCARDIA: A MANAGEMENT CHALLENGE. Journal of Investigative Medicine. 2023;71:7:35-36$38$YR$$F$Y$$$20240806$$HP$US$US
241791251$24179125$1$I$20240101$20240802$20240806$20240806$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004314$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240806$$CN$US$US
241791261$24179126$1$I$20240712$20240802$20240806$20240806$EXP$$US-ABBVIE-5665299$ABBVIE$$70$YR$$F$Y$$$20240806$$CN$US$US
241791271$24179127$1$I$$20240730$20240806$20240806$PER$$US-BAYER-2024A110979$BAYER$$$$$F$Y$$$20240806$$CN$US$US
241791282$24179128$2$F$20230101$20240808$20240806$20240817$PER$$US-SA-2024SA225187$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240817$$MD$US$US
241791291$24179129$1$I$20240701$20240730$20240806$20240806$PER$$US-SA-2024SA227356$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240806$$MD$US$US
241791301$24179130$1$I$20240714$20240805$20240806$20240806$EXP$FR-AFSSAPS-RN2024000851$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-123528$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240806$$MD$FR$FR
241791311$24179131$1$I$20240704$20240805$20240806$20240806$EXP$$CN-BAYER-2024A113108$BAYER$$57$YR$A$F$Y$60$KG$20240806$$HP$CN$CN
241791321$24179132$1$I$$20240805$20240806$20240806$PER$$US-AMGEN-USASP2024155849$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241791331$24179133$1$I$$20230329$20240806$20240806$EXP$$CA-AstraZeneca-2023A076746$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$CA$
241791341$24179134$1$I$20240101$20240725$20240806$20240806$EXP$$US-INSMED, INC.-2024-03052-US$INSMED$$$$$M$Y$$$20240806$$HP$US$US
241791351$24179135$1$I$20170101$20240805$20240806$20240806$EXP$BG-ROCHE-10000031553$BG-SANDOZ INC.-SDZ2024BG070411$SANDOZ$$64$YR$$F$Y$$$20240806$$MD$BG$BG
241791371$24179137$1$I$$20240709$20240806$20240806$PER$$US-JNJFOC-20240724226$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20240806$$CN$US$US
241791381$24179138$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001881$ELI LILLY AND CO$$44$YR$A$$Y$$$20240806$$CN$US$US
241791392$24179139$2$F$20240401$20240809$20240806$20240816$EXP$$NVSC2024US157162$NOVARTIS$$57$YR$$F$Y$$$20240816$$CN$US$US
241791401$24179140$1$I$$20240802$20240806$20240806$PER$$NVSC2024US159236$NOVARTIS$$$$$$Y$$$20240806$$MD$US$US
241791411$24179141$1$I$20231121$20240802$20240806$20240806$EXP$$US-AstraZeneca-2024A177778$ASTRAZENECA$$79$YR$$M$Y$87$KG$20240806$$HP$US$
241791431$24179143$1$I$$20240805$20240805$20240805$DIR$712972$$FDA-CTU$$$$$F$N$$$20240805$N$$US$
241791441$24179144$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53813$$FDA-CTU$$52$YR$$M$N$102.06$KG$20240805$N$$US$
241791471$24179147$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53826$$FDA-CTU$$92$YR$$M$N$$$20240805$N$$US$
241791481$24179148$1$I$20240802$20240805$20240806$20240806$EXP$$CN-BAYER-2024A113118$BAYER$$57$YR$A$F$Y$57$KG$20240806$$HP$CN$CN
241791492$24179149$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0683097$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241791501$24179150$1$I$20240719$20240724$20240806$20240806$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07482$LUPIN$$$$$$Y$$$20240806$$CN$US$US
241791511$24179151$1$I$$20240729$20240806$20240806$EXP$$SG-ROCHE-10000042396$ROCHE$$75$YR$E$F$Y$$$20240806$$CN$SG$SG
241791522$24179152$2$F$$20240806$20240806$20240807$PER$$US-BIOVITRUM-2024-US-010626$BIOVITRUM$$72$YR$$M$Y$$$20240807$$CN$US$US
241791532$24179153$2$F$20240723$20240801$20240806$20240814$EXP$$NVSC2024CN159106$NOVARTIS$$41$YR$$M$Y$82$KG$20240814$$HP$CN$CN
241791541$24179154$1$I$$20240805$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070754$SANDOZ$$$$$F$Y$$$20240806$$CN$US$US
241791551$24179155$1$I$$20240730$20240806$20240806$EXP$$GB-GSK-GB2024EME096097$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$GB$GB
241791561$24179156$1$I$$20240802$20240806$20240806$PER$$US-BIOVITRUM-2024-US-010636$BIOVITRUM$$85$YR$$M$Y$$$20240806$$CN$US$US
241791582$24179158$2$F$$20240802$20240806$20240812$EXP$$JP-PFIZER INC-PV202400100904$PFIZER$Omori, K.. Vertebral osteomyelitis caused by Mycobacteroides abscessus subsp. abscessus resulting in spinal cord injury due to vertebral body fractures. Journal of Infection and Chemotherapy. 2022;28(2):290-294$74$YR$$M$Y$$$20240812$$HP$JP$JP
241791591$24179159$1$I$$20240729$20240806$20240806$EXP$$TW-PFIZER INC-HQWYE477315SEP05$PFIZER$Chao A.. Hysteroscopic management of cesarean scar pregnancy after unsuccessful methotrexate treatment. Journal of Minimally Invasive Gynecology. 2005;12(4):374-376$33$YR$$F$Y$$$20240806$$MD$TW$TW
241791601$24179160$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53821$$FDA-CTU$$54$YR$$F$N$118.84$KG$20240805$N$$US$
241791611$24179161$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53691$$FDA-CTU$$38$YR$$F$N$$$20240805$N$$US$
241791622$24179162$2$F$$20240806$20240806$20240809$EXP$$PT-PFIZER INC-202400228818$PFIZER$Lagarteira, J.. PO-0091 - (4099) - Um caso de cardiotoxicidade por quimioterapia. 30th Congressos da Sociedade Portuguesa de Medicina Interna. 2024;463$66$YR$$M$Y$$$20240809$$MD$PT$PT
241791632$24179163$2$F$$20240807$20240806$20240812$EXP$$ES-PFIZER INC-PV202400100975$PFIZER$Carrasco-Sanchez, M.. From clarinet notes to critical care: dual antifungal therapy in an immunocompetent patient with a diagnosis of invasive pulmonary aspergilosis. Case report. Revista de Patologia Respiratoria. 2024;27(2):91-94$65$YR$$M$Y$$$20240812$$HP$ES$ES
241791641$24179164$1$I$$20240726$20240806$20240806$EXP$$US-THEA-2024001490$Thea Pharma$$$$$F$Y$$$20240806$$CN$US$US
241791651$24179165$1$I$$20240729$20240806$20240806$EXP$$US-Calliditas-2024CAL01440$CALLIDITAS THERAPEUTICS$$59$YR$A$M$Y$$$20240806$$CN$US$US
241791661$24179166$1$I$20240719$20240729$20240806$20240806$EXP$$BR-GSK-BR2024AMR095376$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$BR$BR
241791672$24179167$2$F$20240110$20240810$20240806$20240814$PER$$US-009507513-2408USA000933$MERCK$$68$YR$$M$Y$$$20240814$$MD$US$US
241791681$24179168$1$I$$20240726$20240806$20240806$PER$$US-BEH-2024176769$CSL BEHRING$$$$A$F$Y$$$20240806$$HP$US$US
241791691$24179169$1$I$20240802$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154661$AMGEN$$43$YR$A$F$Y$$$20240806$$CN$US$US
241791702$24179170$2$F$20240804$20240806$20240806$20240808$PER$$US-AMGEN-USASP2024155386$AMGEN$$46$YR$A$F$Y$$$20240808$$CN$US$US
241791711$24179171$1$I$$20240724$20240806$20240806$EXP$$CA-GSK-CA2024AMR093050$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$CA$CA
241791721$24179172$1$I$20240601$20240802$20240806$20240806$PER$$US-ABBVIE-5867216$ABBVIE$$34$YR$$F$Y$$$20240806$$CN$US$US
241791731$24179173$1$I$20240614$20240730$20240806$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-099983$BRISTOL MYERS SQUIBB$$9$DEC$E$F$Y$$$20240806$$PH$JP$JP
241791741$24179174$1$I$$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121304$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240806$$HP$US$US
241791751$24179175$1$I$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683100$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241791761$24179176$1$I$20240101$20240717$20240806$20240806$PER$$US-009507513-2407USA011373$MERCK$$$$$F$Y$$$20240806$$CN$US$US
241791771$24179177$1$I$20240529$20240805$20240806$20240806$EXP$FR-AFSSAPS-NC2024000923$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-123553$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$82$KG$20240806$$MD$FR$FR
241791781$24179178$1$I$20240702$20240723$20240806$20240806$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000153$MARINUS PHARMACEUTICALS$$34$YR$$F$Y$70$KG$20240806$$MD$US$US
241791791$24179179$1$I$$20240803$20240805$20240805$DIR$FDA-CDER-CTU-2024-53836$$FDA-CTU$$63$YR$$M$N$$$20240803$N$$US$
241791801$24179180$1$I$20240621$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53854$$FDA-CTU$$64$YR$$M$N$$$20240805$N$HP$US$
241791811$24179181$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53846$$FDA-CTU$$51$YR$$F$N$$$20240805$N$$US$
241791821$24179182$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53849$$FDA-CTU$$52$YR$$F$N$$$20240805$N$$US$
241791831$24179183$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53811$$FDA-CTU$$76$YR$$M$N$$$20240805$N$$US$
241791841$24179184$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53847$$FDA-CTU$$75$YR$$M$N$$$20240805$N$$US$
241791851$24179185$1$I$$20240802$20240805$20240805$DIR$FDA-CDER-CTU-2024-53820$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
241791861$24179186$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53825$$FDA-CTU$$84$YR$$M$N$$$20240805$N$$US$
241791871$24179187$1$I$$20240802$20240806$20240806$EXP$$NVSC2024RU158755$NOVARTIS$$$$$F$Y$$$20240806$$HP$RU$RU
241791881$24179188$1$I$$20240802$20240806$20240806$PER$$NVSC2024US159177$NOVARTIS$$$$$$Y$$$20240806$$HP$US$US
241791893$24179189$3$F$$20240816$20240806$20240822$EXP$$SG-ROCHE-10000024535$ROCHE$$56$YR$A$F$Y$60$KG$20240822$$CN$SG$SG
241791902$24179190$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683098$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241791911$24179191$1$I$$20240729$20240806$20240806$PER$$US-JNJFOC-20240783617$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241791921$24179192$1$I$$20240801$20240806$20240806$PER$$US-BIOGEN-2024BI01275178$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241791931$24179193$1$I$20240731$20240731$20240806$20240806$PER$$US-BAYER-2024A110839$BAYER$$17$YR$T$F$Y$$$20240806$$MD$US$US
241791941$24179194$1$I$20240801$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154833$AMGEN$$71$YR$E$M$Y$$$20240806$$CN$US$US
241791952$24179195$2$F$20240101$20240830$20240806$20240905$EXP$$US-ORGANON-O2407USA002964$ORGANON$$$$$F$Y$$$20240905$$MD$US$US
241791961$24179196$1$I$20240516$20240803$20240806$20240806$EXP$$NVSC2024CN159114$NOVARTIS$$68$YR$$F$Y$$$20240806$$HP$CN$CN
241791971$24179197$1$I$$20240731$20240806$20240806$EXP$$NVSC2024AR158590$NOVARTIS$$$$$M$Y$$$20240806$$CN$AR$AR
241791981$24179198$1$I$$20240801$20240806$20240806$EXP$$US-TAKEDA-2024TUS078184$TAKEDA$$$$$F$Y$$$20240806$$MD$US$US
241792001$24179200$1$I$20240101$20240730$20240806$20240806$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700057$UPSHER SMITH LABORATORIES$$$$$$Y$$$20240806$$$US$US
241792023$24179202$3$F$$20240807$20240806$20240814$PER$$US-SA-2024SA231739$SANOFI AVENTIS$$$$E$M$Y$95.25$KG$20240814$$MD$US$US
241792031$24179203$1$I$$20240801$20240806$20240806$EXP$$TR-PFIZER INC-202400229036$PFIZER$Isbilen, G.. Intrathecal Tigecycline in the Treatment of Hospital-Acquired Meningitis: A Review of Four Cases. Surgical infections. 2024;10.1089/sur.2024.063$77$YR$$M$Y$$$20240806$$HP$TR$TR
241792041$24179204$1$I$$20240730$20240806$20240806$EXP$$US-PFIZER INC-202400227449$PFIZER$McGrew, R.. Sudden blindness secondary to injections of common drugs in the head and neck: I. Clinical experiences. Otolaryngology. 1978;86(1):147-151$47$YR$$F$Y$$$20240806$$MD$US$US
241792052$24179205$2$F$$20240912$20240806$20240919$EXP$$US-ROCHE-10000049977$ROCHE$$79$YR$E$F$Y$$$20240919$$CN$US$US
241792061$24179206$1$I$$20240730$20240806$20240806$EXP$$US-VANTIVE-2024VAN018771$Vantive US Healthcare$$$$$M$Y$$$20240806$$HP$US$US
241792071$24179207$1$I$$20240726$20240806$20240806$EXP$$JP-EXELIXIS-CABO-24080221$EXELIXIS$$81$YR$$M$Y$$$20240806$$MD$JP$JP
241792092$24179209$2$F$$20240911$20240806$20240918$EXP$$IN-VANTIVE-2024VAN018777$Vantive US Healthcare$$58$YR$$F$Y$$$20240918$$CN$IN$IN
241792101$24179210$1$I$20240101$20240730$20240806$20240806$EXP$$CN-009507513-2408CHN000826$MERCK$$66$YR$$F$Y$52$KG$20240806$$HP$CN$CN
241792111$24179211$1$I$20240731$20240731$20240806$20240806$PER$$US-BAYER-2024A111095$BAYER$$32$YR$A$F$Y$$$20240806$$CN$US$US
241792121$24179212$1$I$20240126$20240731$20240806$20240806$EXP$$FR-EXELIXIS-XL18424075148$EXELIXIS$$$$$$Y$$$20240806$$MD$FR$FR
241792131$24179213$1$I$$20240731$20240806$20240806$PER$$US-ALXN-202407USA002277US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
241792141$24179214$1$I$20240628$20240730$20240806$20240806$EXP$$CL-VANTIVE-2024VAN018539$Vantive US Healthcare$$56$YR$$F$Y$64$KG$20240806$$HP$CL$CL
241792154$24179215$4$F$$20240826$20240806$20240829$EXP$$CA-TAKEDA-2019TUS059378$TAKEDA$$$$$F$Y$$$20240829$$CN$CA$CA
241792161$24179216$1$I$$20240730$20240806$20240806$EXP$$US-SA-2024SA230678$SANOFI AVENTIS$$$$A$F$Y$98.8$KG$20240806$$MD$US$US
241792173$24179217$3$F$$20240813$20240806$20240820$EXP$$PT-OTSUKA-2024_021326$OTSUKA$Quadrado F, Vieira AT, Jacinto M, Ribeirinho R.. Meningoencephalitis at VHS-7. Infectious and parasitic diseases. 2024;30:657$20$YR$$F$Y$$$20240820$$MD$PT$PT
241792181$24179218$1$I$20240701$20240801$20240806$20240806$EXP$$US-SA-2024SA231128$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240806$$MD$US$US
241792191$24179219$1$I$20240730$20240731$20240806$20240806$PER$$US-BAYER-2024A111188$BAYER$$36$YR$A$F$Y$$$20240806$$MD$US$US
241792201$24179220$1$I$20240701$20240729$20240806$20240806$PER$$US-SA-2024SA228876$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240806$$MD$US$US
241792211$24179221$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA227445$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240806$$MD$US$US
241792221$24179222$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229286$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240806$$MD$US$US
241792241$24179224$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA229016$SANOFI AVENTIS$$35$YR$A$F$Y$92.063$KG$20240806$$MD$US$US
241792252$24179225$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0683101$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241792261$24179226$1$I$20231101$20240729$20240806$20240806$EXP$FI-FIMEA-202402219$FI-TAKEDA-2024TUS078044$TAKEDA$$30$YR$$F$Y$$$20240806$$HP$FI$FI
241792271$24179227$1$I$$20240802$20240806$20240806$PER$$US-HALEON-2190495$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241792282$24179228$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683099$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241792291$24179229$1$I$$20240729$20240806$20240806$EXP$$JP-TAKEDA-2024TUS078248$TAKEDA$$$$$M$Y$$$20240806$$MD$JP$JP
241792302$24179230$2$F$$20240917$20240806$20240923$EXP$$CA-TAKEDA-2024TUS078460$TAKEDA$$$$$F$Y$$$20240923$$MD$CA$CA
241792311$24179231$1$I$20240101$20240801$20240806$20240806$EXP$$US-SA-2024SA231757$SANOFI AVENTIS$$93$YR$E$F$Y$$$20240806$$CN$US$US
241792321$24179232$1$I$20240101$20240801$20240806$20240806$EXP$$GB-ORGANON-O2408GBR000230$ORGANON$$28$YR$$F$Y$$$20240806$$MD$GB$GB
241792331$24179233$1$I$$20240730$20240806$20240806$EXP$$CA-BAXTER-2024BAX022477$BAXTER$$71$YR$$M$Y$$$20240806$$PH$CA$CA
241792341$24179234$1$I$20240704$20240727$20240806$20240806$EXP$CN-NMPACDR-3411011513148202400471$CN-BAXTER-2024BAX022429$BAXTER$$53$YR$$F$Y$54.5$KG$20240806$$MD$CN$CN
241792351$24179235$1$I$20240717$20240727$20240806$20240806$EXP$CN-NMPACDR-3716211015650202400436$CN-BAXTER-2024BAX022428$BAXTER$$80$YR$$F$Y$80$KG$20240806$$MD$CN$CN
241792361$24179236$1$I$20240723$20240729$20240806$20240806$EXP$CN-NMPACDR-3708281020400202400562$CN-BAXTER-2024BAX022504$BAXTER$$48$YR$$F$Y$69$KG$20240806$$MD$CN$CN
241792371$24179237$1$I$$20240723$20240806$20240806$EXP$$US-BAXTER-2024BAX022626$BAXTER$$71$YR$$F$Y$$$20240806$$HP$US$US
241792382$24179238$2$F$20240714$20240806$20240806$20240816$EXP$$US-BAXTER-2024BAX022469$BAXTER$$68$YR$$M$Y$$$20240816$$PH$US$US
241792391$24179239$1$I$20240719$20240729$20240806$20240806$EXP$CN-NMPACDR-4307011003555202400597$CN-BAXTER-2024BAX022502$BAXTER$$53$YR$$F$Y$58$KG$20240806$$MD$CN$CN
241792402$24179240$2$F$20240721$20240806$20240806$20240816$EXP$$US-BAXTER-2024BAX022484$BAXTER$$78$YR$$M$Y$$$20240816$$PH$US$US
241792411$24179241$1$I$20240726$20240726$20240806$20240806$PER$$US-ABBVIE-5859476$ABBVIE$$24$YR$$F$Y$$$20240806$$CN$US$US
241792421$24179242$1$I$20240606$20240731$20240806$20240806$EXP$FR-AFSSAPS-AVMA2024000327$FR-MYLANLABS-2024M1071790$MYLAN$$44$YR$$M$Y$$$20240806$$CN$FR$FR
241792431$24179243$1$I$20240701$20240729$20240806$20240806$PER$$US-SA-2024SA229343$SANOFI AVENTIS$$80$YR$E$F$Y$83.4$KG$20240806$$MD$US$US
241792451$24179245$1$I$$20240731$20240806$20240806$PER$$US-BAYER-2024A111279$BAYER$$$$$F$Y$$$20240806$$CN$US$US
241792461$24179246$1$I$$20240729$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123793$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240806$$CN$US$US
241792471$24179247$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122952$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$45.81$KG$20240806$$HP$US$US
241792481$24179248$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123551$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240806$$PH$US$US
241792492$24179249$2$F$20240101$20240902$20240806$20240928$PER$$US-009507513-2407USA003679$MERCK$$$$$F$Y$37.642$KG$20240928$$CN$US$US
241792502$24179250$2$F$20240718$20240802$20240806$20240812$EXP$$AR-JNJFOC-20240777397$JOHNSON AND JOHNSON$$69$YR$E$M$Y$74$KG$20240812$$MD$AR$AR
241792521$24179252$1$I$$20240728$20240806$20240806$PER$$US-AMGEN-USASP2024153328$AMGEN$Zouridis S.; Oo Y.H.; Syn W.K.. Role of Sirolimus and Rituximab in the Treatment of Autoimmune Hepatitis. ACG CASE REPORTS JOURNAL. 2024;11 (7):1-4$23$YR$A$F$Y$$$20240806$$MD$US$US
241792531$24179253$1$I$20240730$20240802$20240806$20240806$EXP$$CO-JNJFOC-20240811334$JOHNSON AND JOHNSON$$51$YR$A$M$Y$90$KG$20240806$$HP$CO$CO
241792541$24179254$1$I$20210115$20240730$20240806$20240806$EXP$$CN-PFIZER INC-202400229145$PFIZER$$65$YR$$F$Y$56.5$KG$20240806$$HP$CN$CN
241792551$24179255$1$I$$20240729$20240806$20240806$EXP$$BR-PFIZER INC-202400230407$PFIZER$$57$YR$$F$Y$90$KG$20240806$$CN$BR$BR
241792561$24179256$1$I$20240712$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53823$$FDA-CTU$$41$YR$$F$N$70.76$KG$20240805$Y$$US$
241792571$24179257$1$I$$20240801$20240806$20240806$PER$$US-TAKEDA-2024TUS078229$TAKEDA$$$$A$M$Y$$$20240806$$CN$US$US
241792581$24179258$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154272$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241792591$24179259$1$I$$20240729$20240806$20240806$EXP$$ES-TEVA-VS-3227791$TEVA$$$$$F$Y$$$20240806$$CN$ES$ES
241792601$24179260$1$I$$20240722$20240806$20240806$PER$$US-INSUD PHARMA-2407US05884$INSUD PHARMA$$$$$$Y$$$20240806$$CN$US$US
241792611$24179261$1$I$20240315$20240705$20240806$20240806$EXP$GB-MHRA-MED-202405041130250620-QHZPN$GB-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2407GB05287$INSUD PHARMA$$51$YR$$F$Y$54$KG$20240806$$CN$GB$GB
241792621$24179262$1$I$20240301$20240801$20240806$20240806$EXP$$GB-LABORATORIOS LICONSA S.A.-2408GB06156$INSUD PHARMA$$71$YR$$M$Y$$$20240806$$CN$GB$GB
241792632$24179263$2$F$20240629$20240819$20240806$20240830$EXP$$US-ARDELYX-2024ARDX005847$ARDELYX$$50$YR$$M$Y$$$20240830$$HP$US$US
241792641$24179264$1$I$$20230120$20240806$20240806$EXP$$IN-AstraZeneca-2023A017915$ASTRAZENECA$$61$YR$$F$Y$$$20240806$$CN$IN$
241792652$24179265$2$F$$20240903$20240806$20240911$EXP$$JP-ARDELYX-2024ARDX005927$ARDELYX$$5$DEC$$M$Y$$$20240911$$MD$JP$JP
241792661$24179266$1$I$$20240707$20240806$20240806$30DAY$$US-VEROBIOTECH-2024USVEROSPO00160$VERO BIOTECH$$$$$$Y$$$20240806$$HP$US$US
241792671$24179267$1$I$$20240731$20240806$20240806$PER$$US-BAYER-2024A111337$BAYER$$42$YR$A$F$Y$$$20240806$$MD$US$US
241792681$24179268$1$I$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683088$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241792692$24179269$2$F$20240716$20240816$20240806$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123961$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240820$$CN$US$US
241792713$24179271$3$F$20240703$20240829$20240806$20240904$EXP$$NVSC2024CO158547$NOVARTIS$$39$YR$$F$Y$77$KG$20240904$$CN$CO$CO
241792721$24179272$1$I$$20240802$20240806$20240806$EXP$$NVSC2024US158901$NOVARTIS$$$$$M$Y$$$20240806$$HP$US$US
241792741$24179274$1$I$$20240722$20240806$20240806$PER$$US-INSUD PHARMA-2407US05882$INSUD PHARMA$$$$$$Y$$$20240806$$CN$US$US
241792752$24179275$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683103$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241792761$24179276$1$I$20240723$20240802$20240806$20240806$EXP$$US-AstraZeneca-2024A177085$ASTRAZENECA$$27885$DY$$M$Y$64$KG$20240806$$HP$US$
241792771$24179277$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A173024$ASTRAZENECA$$$$$M$Y$102$KG$20240806$$CN$US$
241792781$24179278$1$I$20220120$20220214$20240806$20240806$EXP$$CO-AstraZeneca-2022A044623$ASTRAZENECA$$18722$DY$$F$Y$85$KG$20240806$$CN$CO$
241792791$24179279$1$I$$20240805$20240806$20240806$PER$$US-BAYER-2024A113106$BAYER$$$$$$Y$$$20240806$$CN$US$US
241792801$24179280$1$I$$20240801$20240806$20240806$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012671$VERTEX$$$$A$M$Y$$$20240806$$CN$GB$GB
241792811$24179281$1$I$$20240801$20240806$20240806$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012721$VERTEX$$$$$M$Y$$$20240806$$CN$GB$GB
241792821$24179282$1$I$$20240729$20240806$20240806$PER$$US-VERTEX PHARMACEUTICALS-2024-012514$VERTEX$$3$YR$$M$Y$$$20240806$$CN$US$US
241792832$24179283$2$F$$20240814$20240806$20240819$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012605$VERTEX$$$$E$F$Y$$$20240819$$CN$GB$GB
241792841$24179284$1$I$$20240731$20240806$20240806$PER$$US-VERTEX PHARMACEUTICALS-2024-012642$VERTEX$$$$$$Y$$$20240806$$CN$US$US
241792851$24179285$1$I$20240101$20240731$20240806$20240806$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012729$VERTEX$$$$C$F$Y$$$20240806$$CN$GB$GB
241792863$24179286$3$F$20240101$20240904$20240806$20240910$EXP$$US-VERTEX PHARMACEUTICALS-2024-012665$VERTEX$$$$$F$Y$65$KG$20240910$$MD$US$US
241792871$24179287$1$I$20240101$20240801$20240806$20240806$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012731$VERTEX$$$$C$F$Y$$$20240806$$CN$GB$GB
241792883$24179288$3$F$20240802$20240903$20240806$20240909$PER$$US-VERTEX PHARMACEUTICALS-2024-012580$VERTEX$$16$MON$$M$Y$$$20240909$$HP$US$US
241792891$24179289$1$I$20240101$20240722$20240806$20240806$PER$$US-INSUD PHARMA-2407US05881$INSUD PHARMA$$$$$$Y$$$20240806$$CN$US$US
241792901$24179290$1$I$$20240801$20240806$20240806$EXP$$US-VERTEX PHARMACEUTICALS-2024-012718$VERTEX$$$$$F$Y$$$20240806$$CN$US$US
241792911$24179291$1$I$20240714$20240805$20240806$20240806$EXP$FR-AFSSAPS-PC2024000613$FR-ROCHE-10000048927$ROCHE$$31$YR$A$F$Y$$$20240806$$MD$FR$FR
241792921$24179292$1$I$20240601$20240730$20240806$20240806$EXP$FR-AFSSAPS-GR2024000940$FR-VERTEX PHARMACEUTICALS-2024-012522$VERTEX$$28$YR$$M$Y$52$KG$20240806$$PH$FR$FR
241792931$24179293$1$I$20240404$20240730$20240806$20240806$EXP$DK-DKMA-30730743$DK-VERTEX PHARMACEUTICALS-2024-012520$VERTEX$$11$YR$$M$Y$30$KG$20240806$$MD$DK$DK
241792941$24179294$1$I$$20240803$20240806$20240806$PER$$US-BAYER-2024A112314$BAYER$$$$$$Y$$$20240806$$CN$US$US
241792951$24179295$1$I$$20240729$20240806$20240806$EXP$$JP-JNJFOC-20240809504$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240806$$MD$JP$JP
241792961$24179296$1$I$20240101$20240730$20240806$20240806$EXP$$US-JNJFOC-20240805083$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240806$$HP$US$US
241792981$24179298$1$I$20240422$20240802$20240806$20240806$EXP$FR-AFSSAPS-AVMA2024000337$FR-MYLANLABS-2024M1072335$MYLAN$$53$YR$$M$Y$$$20240806$$MD$FR$FR
241792992$24179299$2$F$$20240905$20240806$20240910$PER$$US-TAKEDA-2024TUS076751$TAKEDA$$$$$F$Y$90$KG$20240910$$HP$US$US
241793001$24179300$1$I$20240802$20240802$20240806$20240806$PER$$NVSC2024US159558$NOVARTIS$$55$YR$$M$Y$$$20240806$$CN$US$US
241793022$24179302$2$F$20230301$20240827$20240806$20240829$EXP$$US-ORGANON-O2408USA000220$ORGANON$$22$YR$$F$Y$108.3$KG$20240829$$MD$US$US
241793031$24179303$1$I$20231101$20240730$20240806$20240806$EXP$$US-JAZZ-2023-US-000472$JAZZ$$42$YR$$F$Y$$$20240806$$CN$US$US
241793041$24179304$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53845$$FDA-CTU$$54$YR$$M$N$$$20240805$N$$US$
241793051$24179305$1$I$$20240803$20240806$20240806$PER$$US-BAYER-2024A112361$BAYER$$$$$$Y$$$20240806$$CN$US$US
241793061$24179306$1$I$$20240731$20240806$20240806$PER$$US-BAYER-2024A111917$BAYER$$$$$F$Y$$$20240806$$CN$US$US
241793071$24179307$1$I$20240723$20240801$20240806$20240806$EXP$$US-SA-2024SA231008$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240806$$MD$US$US
241793081$24179308$1$I$20240701$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53832$$FDA-CTU$$70$YR$$F$N$$$20240805$N$HP$US$
241793091$24179309$1$I$$20240731$20240806$20240806$EXP$$US-SA-2024SA230978$SANOFI AVENTIS$$$$A$F$Y$72.57$KG$20240806$$MD$US$US
241793111$24179311$1$I$$20240802$20240806$20240806$PER$$US-TAKEDA-2024TUS078057$TAKEDA$$$$$$Y$$$20240806$$CN$US$US
241793121$24179312$1$I$20240702$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53841$$FDA-CTU$$69$YR$$M$N$$$20240805$Y$HP$US$
241793131$24179313$1$I$20240101$20240801$20240806$20240806$EXP$$US-SA-2024SA231481$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240806$$MD$US$US
241793141$24179314$1$I$20240803$20240806$20240806$20240806$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044045$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240806$$CN$US$US
241793151$24179315$1$I$20240604$20240801$20240806$20240806$PER$$US-BAYER-2024A111953$BAYER$$31$YR$A$F$Y$$$20240806$$HP$US$US
241793161$24179316$1$I$$20240802$20240806$20240806$PER$$US-BAYER-2024A112248$BAYER$$$$$$Y$$$20240806$$CN$US$US
241793171$24179317$1$I$20231220$20240802$20240806$20240806$EXP$GB-MHRA-MED-202408011848076220-KWQZD$GB-ABBVIE-5867224$ABBVIE$$26$YR$$F$Y$$$20240806$$CN$GB$GB
241793181$24179318$1$I$20240607$20240730$20240806$20240806$EXP$$CN-BAYER-2024A110414$BAYER$$70$YR$E$F$Y$50$KG$20240806$$HP$CN$CN
241793191$24179319$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53835$$FDA-CTU$$65$YR$$F$N$$$20240805$N$$US$
241793201$24179320$1$I$20240701$20240730$20240806$20240806$PER$$US-SA-2024SA228994$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240806$$MD$US$US
241793212$24179321$2$F$$20240802$20240806$20240808$EXP$$US-PFIZER INC-202400228696$PFIZER$Navari, Y.. When rhythm correction turns risky: rare right-sided haemorrhagic pleural effusion post MAZE procedure. European Journal of Case Reports in Internal Medicine. 2024;11(7):10.12890/2024_004647$54$YR$$F$Y$$$20240808$$MD$US$US
241793221$24179322$1$I$$20240801$20240806$20240806$EXP$$JP-PFIZER INC-202400228549$PFIZER$$$$A$$Y$$$20240806$$MD$JP$JP
241793231$24179323$1$I$$20240805$20240806$20240806$EXP$GB-MHRA-MED-202408051209423520-GZLKV$GB-ROCHE-10000049195$ROCHE$$$$$F$Y$$$20240806$$HP$GB$GB
241793241$24179324$1$I$20240803$20240805$20240806$20240806$PER$$US-JNJFOC-20240811233$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240806$$CN$US$US
241793252$24179325$2$F$$20240806$20240806$20240807$PER$$US-JNJFOC-20240812570$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241793261$24179326$1$I$$20240802$20240805$20240805$DIR$FDA-CDER-CTU-2024-53859$$FDA-CTU$$$$$M$N$$$20240802$N$HP$US$
241793271$24179327$1$I$$20240730$20240806$20240806$PER$$US-ALXN-202407USA002119US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240806$$CN$US$US
241793282$24179328$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0683107$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241793291$24179329$1$I$$20240729$20240806$20240806$EXP$$US-Calliditas-2024CAL01439$CALLIDITAS THERAPEUTICS$$81$YR$E$F$Y$$$20240806$$CN$US$US
241793302$24179330$2$F$$20240905$20240806$20240912$EXP$$BR-SANDOZ INC.-SDZ2024BR070718$SANDOZ$$$$$F$Y$78$KG$20240912$$CN$BR$BR
241793311$24179331$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53848$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
241793321$24179332$1$I$20200101$20240731$20240806$20240806$PER$$US-BAYER-2024A112009$BAYER$$22$YR$A$F$Y$$$20240806$$CN$US$US
241793344$24179334$4$F$20240401$20240917$20240806$20240926$EXP$$AU-TAKEDA-2024TUS066928$TAKEDA$$39$YR$$F$Y$$$20240926$$HP$AU$AU
241793351$24179335$1$I$20230802$20240731$20240806$20240806$EXP$ES-AEMPS-1554205$ES-MYLANLABS-2024M1072147$MYLAN$$16$YR$$M$Y$$$20240806$$PH$ES$ES
241793362$24179336$2$F$20240710$20240812$20240806$20240816$PER$$US-BAYER-2024A112333$BAYER$$35$YR$A$F$Y$$$20240816$$HP$US$US
241793372$24179337$2$F$$20240821$20240806$20240826$PER$$US-BAYER-2024A113041$BAYER$$88$YR$E$F$Y$$$20240826$$CN$US$US
241793381$24179338$1$I$20170101$20240730$20240806$20240806$EXP$$US-ROCHE-10000043018$ROCHE$$57$YR$A$M$Y$86.18$KG$20240806$$CN$US$US
241793391$24179339$1$I$20240729$20240730$20240806$20240806$PER$$US-Eisai-EC-2024-171427$EISAI$$46$YR$A$F$Y$$$20240806$$MD$US$US
241793411$24179341$1$I$$20240801$20240806$20240806$PER$$US-BAYER-2024A112400$BAYER$$40$YR$A$F$Y$$$20240806$$MD$US$US
241793421$24179342$1$I$20240719$20240725$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017886$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240806$$CN$US$US
241793431$24179343$1$I$$20240725$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017136$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240806$$CN$US$US
241793441$24179344$1$I$$20240725$20240806$20240806$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407017632$ELI LILLY AND CO$$$$E$F$Y$$$20240806$$CN$JP$JP
241793451$24179345$1$I$20240713$20240726$20240806$20240806$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407020023$ELI LILLY AND CO$$66$YR$E$M$Y$43$KG$20240806$$CN$DE$CN
241793461$24179346$1$I$20240701$20240725$20240806$20240806$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407017432$ELI LILLY AND CO$$26$YR$A$F$Y$70$KG$20240806$$CN$GB$GB
241793471$24179347$1$I$20231001$20240725$20240806$20240806$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202311001208$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240806$$CN$JP$JP
241793481$24179348$1$I$20240716$20240725$20240806$20240806$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407016936$ELI LILLY AND CO$$37$YR$A$F$Y$60$KG$20240806$$CN$CN$CN
241793491$24179349$1$I$20240722$20240724$20240806$20240806$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408002425$ELI LILLY AND CO$$63$YR$A$F$Y$63$KG$20240806$$CN$DE$CN
241793501$24179350$1$I$$20240802$20240806$20240806$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202408001443$ELI LILLY AND CO$$$$$F$Y$$$20240806$$CN$KR$KR
241793511$24179351$1$I$20240401$20240731$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000386$ELI LILLY AND CO$$$$$F$Y$$$20240806$$CN$US$US
241793521$24179352$1$I$20240627$20240731$20240806$20240806$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408000578$ELI LILLY AND CO$$71$YR$E$F$Y$60$KG$20240806$$CN$CN$CN
241793531$24179353$1$I$20180411$20240723$20240806$20240806$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202308011043$ELI LILLY AND CO$$58$YR$A$F$Y$69$KG$20240806$$CN$JP$JP
241793541$24179354$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001809$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240806$$CN$US$US
241793551$24179355$1$I$20240421$20240802$20240806$20240806$EXP$FR-AFSSAPS-LL2024001461$FR-009507513-2408FRA000961$MERCK$$64$YR$$M$Y$$$20240806$$MD$FR$FR
241793561$24179356$1$I$20240701$20240729$20240806$20240806$EXP$$US-ANIPHARMA-2024-US-040918$ANI$$77$YR$$F$Y$$$20240806$$HP$US$US
241793572$24179357$2$F$$20240802$20240806$20240808$PER$$US-BIOGEN-2024BI01276631$BIOGEN$$$$$M$Y$$$20240808$$CN$US$US
241793581$24179358$1$I$$20231024$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2023US047228$SANDOZ$RodriguezV, MitchellB, StanekJ,. Improving anticoagulation care for pediatric oncology patients.. Research and Practice in Thrombosis and Haemostasis.. 2023;7$$$$$Y$$$20240806$$HP$US$US
241793591$24179359$1$I$20240730$20240731$20240806$20240806$PER$$US-BAYER-2024A111368$BAYER$$76$YR$E$F$Y$$$20240806$$CN$US$US
241793601$24179360$1$I$$20240730$20240806$20240806$EXP$$US-PFIZER INC-PV202400031655$PFIZER$Le, V.. A Case of Partially Reversible Oral-buccal-lingual Dyskinesia after Prolonged Levetiracetam Exposure. American Journal of Geriatric Psychiatry. 2024;32(4 Suppl):S106$86$YR$$F$Y$$$20240806$$MD$US$US
241793611$24179361$1$I$20240101$20240722$20240806$20240806$PER$$US-ALKERMES INC.-ALK-2024-001938$ALKERMES$$51$YR$$F$Y$$$20240806$$HP$US$US
241793621$24179362$1$I$$20240725$20240806$20240806$PER$$US-JNJFOC-20240805713$JOHNSON AND JOHNSON$$$$$F$Y$65$KG$20240806$$MD$US$US
241793631$24179363$1$I$20240101$20240730$20240806$20240806$EXP$$BR-ORGANON-O2407BRA002336$ORGANON$$31$YR$$F$Y$$$20240806$$MD$BR$BR
241793642$24179364$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0683091$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241793651$24179365$1$I$$20240730$20240806$20240806$EXP$$US-SA-2024SA229363$SANOFI AVENTIS$$$$E$M$Y$$$20240806$$MD$US$US
241793661$24179366$1$I$$20240731$20240806$20240806$EXP$$DE-TAKEDA-2024TUS077619$TAKEDA$$$$$F$Y$$$20240806$$CN$DE$DE
241793671$24179367$1$I$$20240730$20240806$20240806$EXP$$IN-MYLANLABS-2024M1072207$MYLAN$Goud CR. Coronary thrombosis in infants with Kawasaki disease. Indian-J-Rheumatol 2023; 18 (Suppl.) S373 abstr. CAS145.$3$MON$$M$Y$$$20240806$$HP$IN$IN
241793682$24179368$2$F$$20240812$20240806$20240812$EXP$$US-PFIZER INC-PV202400101119$PFIZER$$$$$$Y$$$20240812$$CN$US$US
241793691$24179369$1$I$$20231102$20240806$20240806$EXP$$SG-SANDOZ INC.-SDZ2023SG052274$SANDOZ$$$$$$Y$$$20240806$$HP$SG$SG
241793701$24179370$1$I$$20240805$20240806$20240806$30DAY$$US-SANDOZ INC.-SDZ2024US070714$SANDOZ$$$$$M$Y$$$20240806$$CN$US$US
241793711$24179371$1$I$$20231127$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2023US061921$SANDOZ$UnizonyS, MatzaMA, JarvieA, et al.. Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, openlabel, proof-of-concept study. The Lancet Rheumatology. 2023;5:e736$$$$$Y$$$20240806$$HP$US$US
241793721$24179372$1$I$20240101$20240722$20240806$20240806$PER$$US-ALKERMES INC.-ALK-2024-001955$ALKERMES$$$$$M$Y$$$20240806$$CN$US$US
241793731$24179373$1$I$$20240730$20240806$20240806$EXP$$US-JNJFOC-20240780781$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$PH$US$US
241793741$24179374$1$I$20240605$20240729$20240806$20240806$EXP$FR-AFSSAPS-PA2024001381$FR-TAKEDA-2024TUS076200$TAKEDA$$47$YR$$M$Y$90$KG$20240806$$HP$FR$FR
241793751$24179375$1$I$20240101$20240802$20240806$20240806$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043932$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240806$$CN$US$US
241793761$24179376$1$I$20240723$20240723$20240806$20240806$PER$$US-ALKERMES INC.-ALK-2024-001953$ALKERMES$$$$$F$Y$$$20240806$$HP$US$US
241793773$24179377$3$F$20240726$20240826$20240806$20240830$PER$$US-Eisai-EC-2024-171420$EISAI$$68$YR$E$F$Y$61.7$KG$20240830$$MD$US$US
241793781$24179378$1$I$20240724$20240725$20240806$20240806$EXP$GB-MHRA-TPP51263210C8263963YC1721839010950$GB-RDY-SPO/GBR/24/0011071$DR REDDYS$$10$YR$C$M$Y$50$KG$20240806$$HP$GB$GB
241793791$24179379$1$I$$20240728$20240806$20240806$PER$$US-RDY-SPO/USA/24/0011133$DR REDDYS$$19$YR$A$F$Y$$$20240806$$MD$US$US
241793801$24179380$1$I$$20240804$20240806$20240806$EXP$$IL-ABBVIE-5866263$ABBVIE$$40$YR$$M$Y$$$20240806$$MD$IL$IL
241793811$24179381$1$I$20210301$20240801$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123148$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$99.79$KG$20240806$$CN$US$US
241793821$24179382$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124170$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240806$$CN$US$US
241793831$24179383$1$I$$20240802$20240805$20240805$DIR$FDA-CDER-CTU-2024-53679$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
241793841$24179384$1$I$$20240802$20240805$20240805$DIR$FDA-CDER-CTU-2024-53842$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
241793851$24179385$1$I$$20240803$20240805$20240805$DIR$FDA-CDER-CTU-2024-53787$$FDA-CTU$$$$$M$N$$$20240803$N$HP$US$
241793861$24179386$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53829$$FDA-CTU$$52$YR$$F$N$99.79$KG$20240805$N$$US$
241793871$24179387$1$I$$20240723$20240806$20240806$PER$$US-ALKERMES INC.-ALK-2024-001946$ALKERMES$$$$$F$Y$$$20240806$$MD$US$US
241793881$24179388$1$I$20240722$20240723$20240806$20240806$PER$$US-ALKERMES INC.-ALK-2024-001945$ALKERMES$$47$YR$$M$Y$108.84$KG$20240806$$CN$US$US
241793891$24179389$1$I$20240429$20240726$20240806$20240806$PER$$US-TOLMAR, INC.-24US050955$TOLMAR$$86$YR$$M$Y$$$20240805$$HP$US$US
241793907$24179390$7$F$20240101$20240919$20240806$20240928$EXP$$CA-CELLTRION INC.-2024CA018707$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
241793911$24179391$1$I$20231010$20240729$20240806$20240806$EXP$$US-BAYER-2024A109316$BAYER$$34$YR$A$F$Y$$$20240806$$CN$US$US
241793921$24179392$1$I$$20240729$20240806$20240806$PER$$US-ABBVIE-5861688$ABBVIE$$$$$$Y$$$20240806$$HP$US$US
241793931$24179393$1$I$$20231127$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2023US063225$SANDOZ$Sebastian Unizony, Mark A Matza, Adam Jarvie, David O^Dea, Ana D Fernandes, John H Stone. Treatment for giant cell arteritis with 8 weeks of prednisonein combination with tocilizumab: a single-arm, open-label,proof-of-concept study. www.thelancet.com/rheumatology. 2023;5:E736$$$$$Y$$$20240806$$HP$US$US
241793941$24179394$1$I$$20240729$20240806$20240806$EXP$NL-LRB-00993122$NL-TEVA-VS-3227759$TEVA$$54$YR$$F$Y$$$20240806$$MD$NL$NL
241793951$24179395$1$I$$20240801$20240806$20240806$EXP$$TW-BAYER-2024A112791$BAYER$$$$$$Y$$$20240806$$MD$TW$TW
241793961$24179396$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA226399$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240806$$CN$US$US
241793971$24179397$1$I$$20240805$20240805$20240805$DIR$712945$$FDA-CTU$$$$$UNK$N$$$20240805$$CN$US$
241793981$24179398$1$I$$20240805$20240806$20240806$EXP$FR-AFSSAPS-TO2024001411$FR-SA-2024SA230366$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240806$$PH$FR$FR
241793991$24179399$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123938$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$85.73$KG$20240806$$CN$US$US
241794002$24179400$2$F$$20240805$20240806$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123940$BRISTOL MYERS SQUIBB$$12$YR$T$F$Y$$$20240809$$HP$US$US
241794011$24179401$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123922$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240806$$HP$US$US
241794031$24179403$1$I$20240715$20240724$20240806$20240806$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00794$CATALYST PHARMA$$6$YR$$M$Y$22.898$KG$20240806$$CN$US$US
241794041$24179404$1$I$20240630$20240805$20240806$20240806$EXP$$US-BAYER-2024A113119$BAYER$$67$YR$E$M$Y$$$20240806$$CN$US$US
241794051$24179405$1$I$$20240729$20240806$20240806$PER$$US-BAYER-2024A112844$BAYER$$$$$$Y$$$20240806$$CN$US$US
241794063$24179406$3$F$$20240903$20240806$20240909$EXP$$JP-PFIZER INC-202400228955$PFIZER$Kita, Y.. Fanconi syndrome with karyomegalic interstitial nephritis after ifosfamide treatment for osteosarcoma: A case report. CEN case reports. 2024;1-6$18$YR$$M$Y$$$20240909$$HP$JP$JP
241794074$24179407$4$F$20240701$20240823$20240806$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023576$UNITED THERAPEUTICS$$65$YR$$M$Y$62.585$KG$20240830$$PH$US$US
241794081$24179408$1$I$20240722$20240723$20240806$20240806$PER$$US-ALKERMES INC.-ALK-2024-001948$ALKERMES$$$$$M$Y$$$20240806$$HP$US$US
241794092$24179409$2$F$$20240806$20240806$20240806$PER$$US-JNJFOC-20240808627$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$CN$US$US
241794102$24179410$2$F$$20240822$20240806$20240827$EXP$$NL-JNJFOC-20240811733$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240827$$CN$NL$NL
241794111$24179411$1$I$$20240729$20240806$20240806$EXP$$JP-PFIZER INC-PV202400098958$PFIZER$Shiota, M.. A case of increased blood level of clozapine after administration of nirmatrelvir/ritonavir developing convulsion and consciousness disturbed, leading to hospitalisation. Japanese Journal of Pharmaceutical Health Care and Sciences. 2024;50(7):345-350$6$DEC$$M$Y$85.7$KG$20240806$$HP$JP$JP
241794121$24179412$1$I$20230926$20240803$20240806$20240806$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-271280$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240806$$CN$US$US
241794131$24179413$1$I$20240701$20240802$20240806$20240806$EXP$$US-SA-2024SA231009$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240806$$MD$US$US
241794141$24179414$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA226700$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240806$$CN$US$US
241794151$24179415$1$I$$20240805$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123949$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$77.56$KG$20240806$$HP$US$US
241794162$24179416$2$F$$20240822$20240806$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123453$BRISTOL MYERS SQUIBB$Hattori Y, Ide R, Okada A, Kawahori T, Itamoto S, Mukai S, et al. Perforation of small intestinal metastasis of lung squamous cell carcinoma: a case report. Proceedings of the 79th General Meeting of the Japanese Society of Gastroenterological Surgery (the 79th General Meeting of the Japanese Society of Gastroenterological Surgery). 2024 Jan 01;ME06-6.$64$YR$A$M$Y$$$20240829$$MD$JP$JP
241794171$24179417$1$I$$20240725$20240806$20240806$PER$$US-RDY-LIT/USA/24/0011255$DR REDDYS$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. Journal of Allergy and Clinical Immunology: In Practice. 2024;12(6): 1663-1665. doi:10.1016/j.jaip.2024.02.023.$36$YR$A$F$Y$$$20240806$$MD$US$US
241794181$24179418$1$I$$20220620$20240806$20240806$EXP$$US-AstraZeneca-2021A853589$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241794191$24179419$1$I$$20230404$20240806$20240806$EXP$$US-AstraZeneca-2023A080232$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241794201$24179420$1$I$$20240729$20240806$20240806$EXP$$RU-AstraZeneca-2024A173489$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$RU$
241794212$24179421$2$F$$20240801$20240806$20240809$EXP$$CA-AstraZeneca-2024A176644$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$CA$
241794221$24179422$1$I$$20240729$20240806$20240806$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005608$BIOCON$$$$$$Y$$$20240806$$MD$CA$CA
241794245$24179424$5$F$20240724$20240809$20240806$20240814$30DAY$$US-ALKERMES INC.-ALK-2024-001961$ALKERMES$$69$YR$$M$Y$$$20240814$$HP$US$US
241794252$24179425$2$F$20240626$20240805$20240806$20240820$EXP$$US-COOPERSURGICAL, INC.-2024CPS002259$COOPERSURGICAL$$34$YR$$F$Y$66.667$KG$20240820$$CN$US$US
241794262$24179426$2$F$20240621$20240805$20240806$20240820$EXP$$US-COOPERSURGICAL, INC.-2024CPS002260$COOPERSURGICAL$$23$YR$$F$Y$86.168$KG$20240820$$CN$US$US
241794272$24179427$2$F$20240705$20240805$20240806$20240820$EXP$$US-COOPERSURGICAL, INC.-2024CPS002257$COOPERSURGICAL$$47$YR$$F$Y$66.667$KG$20240820$$HP$US$US
241794281$24179428$1$I$20240802$20240802$20240806$20240806$EXP$$GB-JNJFOC-20240812719$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240806$$HP$GB$GB
241794291$24179429$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123871$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240806$$CN$US$US
241794301$24179430$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123812$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240806$$CN$US$US
241794312$24179431$2$F$$20240826$20240806$20240826$PER$$US-ALXN-202407USA002100US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
241794321$24179432$1$I$20231201$20240725$20240806$20240806$PER$$US-ALKERMES INC.-ALK-2024-001974$ALKERMES$$65$YR$$F$Y$$$20240806$$MD$US$US
241794332$24179433$2$F$20240101$20240828$20240806$20240905$PER$$US-MYLANLABS-2024M1071219$MYLAN$$$$$F$Y$$$20240905$$CN$US$US
241794351$24179435$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-202400228412$PFIZER$$$$$F$Y$$$20240806$$CN$US$US
241794361$24179436$1$I$20240801$20240801$20240806$20240806$PER$$US-PFIZER INC-202400229458$PFIZER$$34$YR$$F$Y$$$20240806$$MD$US$US
241794371$24179437$1$I$20240803$20240803$20240806$20240806$PER$$US-PFIZER INC-202400229731$PFIZER$$61$YR$$M$Y$$$20240806$$CN$US$US
241794382$24179438$2$F$$20240926$20240806$20240930$PER$$US-PFIZER INC-PV202400101999$PFIZER$$58$YR$$F$Y$$$20240930$$HP$US$US
241794391$24179439$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-202400231011$PFIZER$$$$$$Y$$$20240806$$MD$US$US
241794401$24179440$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-202400230531$PFIZER$$66$YR$$F$Y$$$20240806$$HP$US$US
241794421$24179442$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-PV202400100781$PFIZER$$42$YR$$M$Y$$$20240806$$CN$US$US
241794432$24179443$2$F$$20240906$20240806$20240910$PER$$US-PFIZER INC-PV202400100644$PFIZER$$66$YR$$F$Y$$$20240910$$HP$US$US
241794441$24179444$1$I$$20240805$20240806$20240806$PER$$US-PFIZER INC-202400230831$PFIZER$$$$$F$Y$$$20240806$$MD$US$US
241794451$24179445$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-PV202400101790$PFIZER$$78$YR$$F$Y$$$20240806$$MD$US$US
241794461$24179446$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-202400229310$PFIZER$$$$A$$Y$$$20240806$$HP$US$US
241794472$24179447$2$F$20240726$20240828$20240806$20240904$PER$$US-PFIZER INC-202400230660$PFIZER$$83$YR$$M$Y$72.562$KG$20240904$$CN$US$US
241794481$24179448$1$I$20240726$20240802$20240806$20240806$PER$$US-PFIZER INC-202400229953$PFIZER$$83$YR$$F$Y$$$20240806$$CN$US$US
241794492$24179449$2$F$$20240823$20240806$20240904$PER$$US-PFIZER INC-202400228849$PFIZER$$73$YR$$M$Y$81.65$KG$20240904$$CN$US$US
241794501$24179450$1$I$20240804$20240804$20240806$20240806$PER$$US-PFIZER INC-202400230152$PFIZER$$35$YR$$F$Y$$$20240806$$HP$US$US
241794513$24179451$3$F$$20240916$20240806$20240919$PER$$US-PFIZER INC-PV202400101916$PFIZER$$70$YR$$F$Y$$$20240919$$HP$US$US
241794521$24179452$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-202400231013$PFIZER$$$$$$Y$$$20240806$$MD$US$US
241794531$24179453$1$I$20240101$20240801$20240806$20240806$PER$$US-PFIZER INC-PV202400100735$PFIZER$$83$YR$$M$Y$$$20240806$$HP$US$US
241794541$24179454$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-202400229167$PFIZER$$82$YR$$F$Y$$$20240806$$CN$US$US
241794551$24179455$1$I$$20240805$20240806$20240806$PER$$US-PFIZER INC-PV202400102002$PFIZER$$58$YR$$F$Y$$$20240806$$HP$US$US
241794561$24179456$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-2024SGN05381$PFIZER$$58$YR$$F$Y$$$20240806$$CN$US$US
241794572$24179457$2$F$20240802$20240812$20240806$20240814$PER$$US-PFIZER INC-202400229328$PFIZER$$65$YR$$F$Y$$$20240814$$CN$US$US
241794581$24179458$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-PV202400100754$PFIZER$$23$YR$$F$Y$$$20240806$$CN$US$US
241794591$24179459$1$I$20230101$20240802$20240806$20240806$PER$$US-PFIZER INC-202400229668$PFIZER$$27$YR$$F$Y$$$20240806$$CN$US$US
241794601$24179460$1$I$$20240805$20240805$20240805$DIR$712968$$FDA-CTU$$$$$F$N$$$20240805$Y$PH$US$
241794611$24179461$1$I$$20240805$20240806$20240806$PER$$US-PFIZER INC-202400230511$PFIZER$$80$YR$$F$Y$$$20240806$$CN$US$US
241794621$24179462$1$I$20240731$20240802$20240806$20240806$PER$$US-PFIZER INC-202400229797$PFIZER$$$$$F$Y$$$20240806$$MD$US$US
241794633$24179463$3$F$20240729$20240830$20240806$20240905$PER$$US-PFIZER INC-202400228535$PFIZER$$28$YR$$F$Y$43.991$KG$20240905$$MD$US$US
241794641$24179464$1$I$20240801$20240805$20240805$20240805$DIR$712965$$FDA-CTU$$43$YR$$F$N$$$20240805$N$CN$US$
241794652$24179465$2$F$20240730$20240822$20240806$20240828$PER$$US-PFIZER INC-202400228531$PFIZER$$72$YR$$M$Y$114$KG$20240828$$PH$US$US
241794662$24179466$2$F$20240620$20240823$20240806$20240827$PER$$US-PFIZER INC-202400229922$PFIZER$$71$YR$$F$Y$92.99$KG$20240827$$CN$US$US
241794671$24179467$1$I$$20240802$20240806$20240806$EXP$$FR-PFIZER INC-202400228814$PFIZER$$12$YR$$F$Y$$$20240806$$HP$FR$FR
241794681$24179468$1$I$20240701$20240801$20240806$20240806$EXP$$CA-PFIZER INC-PV202400101635$PFIZER$$77$YR$$F$Y$$$20240806$$CN$CA$CA
241794691$24179469$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-2023SGN10130$PFIZER$$70$YR$$F$Y$$$20240806$$CN$US$US
241794711$24179471$1$I$$20240805$20240805$20240805$DIR$712973$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241794722$24179472$2$F$20240719$20240821$20240806$20240823$PER$$US-PFIZER INC-202400228515$PFIZER$$46$YR$$M$Y$110$KG$20240823$$PH$US$US
241794731$24179473$1$I$20231201$20240802$20240806$20240806$PER$$US-PFIZER INC-PV202400101363$PFIZER$$55$YR$$F$Y$$$20240806$$HP$US$US
241794741$24179474$1$I$20240101$20240802$20240806$20240806$PER$$US-PFIZER INC-202400230414$PFIZER$$74$YR$$F$Y$$$20240806$$HP$US$US
241794751$24179475$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-PV202400100937$PFIZER$$49$YR$$F$Y$$$20240806$$CN$US$US
241794761$24179476$1$I$20240701$20240731$20240806$20240806$PER$$US-PFIZER INC-202400227714$PFIZER$$67$YR$$M$Y$108.86$KG$20240806$$CN$US$US
241794772$24179477$2$F$20240728$20240925$20240806$20240927$PER$$US-PFIZER INC-202400228485$PFIZER$$63$YR$$F$Y$74.83$KG$20240927$$CN$US$US
241794782$24179478$2$F$20240802$20240806$20240806$20240809$PER$$US-PFIZER INC-202400230085$PFIZER$$81$YR$$M$Y$76.19$KG$20240809$$CN$US$US
241794791$24179479$1$I$20240427$20240805$20240805$20240805$DIR$712964$$FDA-CTU$$63$YR$$M$N$91.8$KG$20240805$N$HP$US$
241794801$24179480$1$I$20240802$20240803$20240806$20240806$PER$$US-PFIZER INC-202400230141$PFIZER$$58$YR$$M$Y$$$20240806$$CN$US$US
241794811$24179481$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-PV202400101317$PFIZER$$51$YR$$F$Y$$$20240806$$MD$US$US
241794821$24179482$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-PV202400101372$PFIZER$$$$$F$Y$$$20240806$$CN$US$US
241794831$24179483$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-202400230401$PFIZER$$53$YR$$F$Y$$$20240806$$HP$US$US
241794841$24179484$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-202400229530$PFIZER$$$$$$Y$$$20240806$$CN$US$US
241794851$24179485$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-PV202400100634$PFIZER$$35$YR$$M$Y$$$20240806$$HP$US$US
241794861$24179486$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-PV202400100738$PFIZER$$55$YR$$F$Y$$$20240806$$HP$US$US
241794872$24179487$2$F$$20240906$20240806$20240909$PER$$US-PFIZER INC-202400230644$PFIZER$$$$$$Y$$$20240909$$CN$US$US
241794891$24179489$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-202400230050$PFIZER$$63$YR$$M$Y$$$20240806$$CN$US$US
241794904$24179490$4$F$20240608$20240904$20240806$20240909$PER$$US-PFIZER INC-PV202400100631$PFIZER$$29$YR$$M$Y$88.7$KG$20240909$$PH$US$US
241794912$24179491$2$F$20240608$20240812$20240806$20240814$PER$$US-PFIZER INC-202400228612$PFIZER$$45$YR$$M$Y$86.5$KG$20240814$$PH$US$US
241794925$24179492$5$F$20240801$20240912$20240806$20240916$EXP$$US-PFIZER INC-PV202400101443$PFIZER$$62$YR$$M$Y$$$20240916$$HP$US$US
241794931$24179493$1$I$20240803$20240804$20240806$20240806$PER$$US-PFIZER INC-202400230123$PFIZER$$67$YR$$F$Y$$$20240806$$CN$US$US
241794941$24179494$1$I$$20240805$20240806$20240806$PER$$US-PFIZER INC-202400230879$PFIZER$$52$YR$$F$Y$$$20240806$$CN$US$US
241794952$24179495$2$F$20240311$20240812$20240806$20240814$EXP$$ZA-PFIZER INC-PV202400100350$PFIZER$$61$YR$$M$Y$85$KG$20240814$$HP$ZA$ZA
241794961$24179496$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-PV202400101494$PFIZER$$94$YR$$F$Y$$$20240806$$HP$US$US
241794971$24179497$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-202400231012$PFIZER$$$$$$Y$$$20240806$$MD$US$US
241794981$24179498$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-PV202400101673$PFIZER$$$$C$F$Y$$$20240806$$CN$US$US
241794991$24179499$1$I$20240101$20240802$20240806$20240806$PER$$US-PFIZER INC-PV202400022743$PFIZER$$43$YR$$M$Y$$$20240806$$HP$US$US
241795002$24179500$2$F$$20240813$20240806$20240815$PER$$US-PFIZER INC-202400229600$PFIZER$$$$$F$Y$$$20240815$$CN$US$US
241795012$24179501$2$F$$20240813$20240806$20240819$PER$$US-PFIZER INC-202400208996$PFIZER$$75$YR$$F$Y$$$20240819$$CN$US$US
241795021$24179502$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-202400229914$PFIZER$$29$YR$$M$Y$$$20240806$$MD$US$US
241795031$24179503$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-PV202400101322$PFIZER$$$$$M$Y$$$20240806$$CN$US$US
241795042$24179504$2$F$$20240916$20240806$20240918$EXP$$US-PFIZER INC-PV202400101700$PFIZER$$63$YR$$F$Y$$$20240918$$HP$US$US
241795052$24179505$2$F$$20240801$20240806$20240809$PER$$US-PFIZER INC-PV202400100731$PFIZER$$65$YR$$F$Y$$$20240809$$CN$US$US
241795063$24179506$3$F$$20240808$20240806$20240808$PER$$US-PFIZER INC-202400228681$PFIZER$$$$$M$Y$$$20240808$$CN$US$US
241795071$24179507$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-202400229692$PFIZER$$11$YR$$M$Y$$$20240806$$HP$US$US
241795082$24179508$2$F$$20240827$20240806$20240904$PER$$US-PFIZER INC-PV202400101615$PFIZER$$49$YR$$M$Y$$$20240904$$HP$US$US
241795095$24179509$5$F$$20240922$20240806$20240923$PER$$US-PFIZER INC-PV202400101674$PFIZER$$39$YR$$F$Y$$$20240923$$HP$US$US
241795101$24179510$1$I$20240101$20240804$20240806$20240806$PER$$US-PFIZER INC-PV202400101389$PFIZER$$65$YR$$$Y$$$20240806$$CN$US$US
241795111$24179511$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-202400229275$PFIZER$$70$YR$$F$Y$$$20240806$$CN$US$US
241795121$24179512$1$I$20240716$20240802$20240806$20240806$PER$$US-PFIZER INC-202400230063$PFIZER$$63$YR$$F$Y$$$20240806$$HP$US$US
241795131$24179513$1$I$$20240802$20240806$20240806$PER$$US-PFIZER INC-202400229762$PFIZER$$75$YR$$F$Y$$$20240806$$MD$US$US
241795142$24179514$2$F$$20240808$20240806$20240814$PER$$US-PFIZER INC-PV202400101908$PFIZER$$30$YR$$M$Y$$$20240814$$HP$US$US
241795151$24179515$1$I$20240801$20240802$20240806$20240806$PER$$US-PFIZER INC-202400229946$PFIZER$$30$YR$$F$Y$$$20240806$$CN$US$US
241795161$24179516$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-202400227790$PFIZER$$68$YR$$F$Y$$$20240806$$CN$US$US
241795171$24179517$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-202400228922$PFIZER$$$$$$Y$$$20240806$$MD$US$US
241795181$24179518$1$I$20240802$20240802$20240806$20240806$PER$$US-PFIZER INC-202400229982$PFIZER$$68$YR$$F$Y$$$20240806$$CN$US$US
241795191$24179519$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-PV202400101694$PFIZER$$88$YR$$F$Y$$$20240806$$CN$US$US
241795201$24179520$1$I$$20240801$20240806$20240806$PER$$US-PFIZER INC-202400228423$PFIZER$$$$$$Y$$$20240806$$CN$US$US
241795211$24179521$1$I$20240401$20240716$20240806$20240806$EXP$$US-TAKEDA-US201704177$TAKEDA$$48$YR$$M$Y$$$20240806$$CN$US$US
241795221$24179522$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154380$AMGEN$$$$$F$Y$$$20240806$$PH$US$US
241795231$24179523$1$I$20240805$20240805$20240806$20240806$PER$$US-HALEON-2190513$Haleon PLC$$$$$M$Y$$$20240806$$CN$US$US
241795242$24179524$2$F$20240429$20240812$20240806$20240826$PER$$US-Calliditas-2024CAL01384$CALLIDITAS THERAPEUTICS$$55$YR$A$M$Y$$$20240826$$CN$US$US
241795251$24179525$1$I$20240726$20240726$20240806$20240806$PER$$US-ALKERMES INC.-ALK-2024-001995$ALKERMES$$$$$M$Y$$$20240806$$MD$US$US
241795261$24179526$1$I$20240801$20240802$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123947$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240806$$CN$US$US
241795271$24179527$1$I$20240101$20240729$20240806$20240806$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700124$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
241795281$24179528$1$I$20240708$20240729$20240806$20240806$EXP$$US-RIGEL-20240700118$RIGEL PHARMACEUTICALS$$80$YR$$F$Y$72.575$KG$20240806$$CN$US$US
241795291$24179529$1$I$20240710$20240725$20240806$20240806$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00795$CATALYST PHARMA$$68$YR$$F$Y$81.179$KG$20240806$$CN$US$US
241795301$24179530$1$I$$20240801$20240806$20240806$EXP$$CA-AMGEN-CANSP2024154612$AMGEN$$65$YR$E$M$Y$$$20240806$$HP$CA$CA
241795321$24179532$1$I$20240803$20240803$20240805$20240805$DIR$FDA-CDER-CTU-2024-53833$$FDA-CTU$$50$YR$$F$N$$$20240803$N$HP$US$
241795331$24179533$1$I$$20240805$20240805$20240805$DIR$712976$$FDA-CTU$$80$YR$$M$N$76.95$KG$20240805$N$PH$US$
241795341$24179534$1$I$$20240805$20240805$20240805$DIR$712988$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241795351$24179535$1$I$$20240805$20240805$20240805$DIR$712978$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241795371$24179537$1$I$20240723$20240801$20240806$20240806$PER$$US-BAYER-2024A111747$BAYER$$47$YR$A$F$Y$$$20240806$$MD$US$US
241795382$24179538$2$F$20220401$20240811$20240806$20240820$EXP$$US-BAYER-2024A112172$BAYER$$42$YR$A$F$Y$$$20240820$$CN$US$US
241795391$24179539$1$I$20240730$20240730$20240806$20240806$PER$$US-009507513-2407USA015842$MERCK$$$$$F$Y$$$20240806$$CN$US$US
241795401$24179540$1$I$$20240802$20240806$20240806$EXP$$IT-009507513-2408ITA001018$MERCK$$42$YR$$M$Y$$$20240806$$MD$IT$IT
241795411$24179541$1$I$20240708$20240725$20240806$20240806$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2024-001581$SK LIFE SCIENCE$$$$$$Y$$$20240806$$CN$US$US
241795421$24179542$1$I$$20240731$20240806$20240806$EXP$GB-MHRA-30722561$GB-BAYER-2024A111217$BAYER$$$$$F$Y$$$20240806$$CN$GB$GB
241795431$24179543$1$I$20240407$20240730$20240806$20240806$EXP$$FR-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00792$BIOCRYST PHARMACEUTICALS$$47$YR$$F$Y$$$20240806$$MD$FR$FR
241795441$24179544$1$I$20240801$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153494$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241795452$24179545$2$F$$20240905$20240806$20240913$EXP$$US-TEVA-VS-3228272$TEVA$Zubair N, Isaac S, Westerman J. Drug-induced Euglycemic Diabetic Ketoacidosis in a Patient with Systemic Sarcoidosis. South-Med-J 2022; 116 93.; Zubair N, Isaac S, Westerman J. Drug-induced Euglycemic Diabetic Ketoacidosis in a Patient with Systemic Sarcoidosis. South-Med-J 2022; 116 93.$78$YR$$F$Y$$$20240913$$MD$US$US
241795463$24179546$3$F$20240701$20240910$20240806$20240919$EXP$$CA-JNJFOC-20240801018$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240919$$HP$CA$CA
241795471$24179547$1$I$20240727$20240730$20240806$20240806$EXP$$CO-JNJFOC-20240619567$JOHNSON AND JOHNSON$$25$YR$A$M$Y$65$KG$20240806$$HP$CO$CO
241795481$24179548$1$I$$20240730$20240806$20240806$EXP$$US-SA-2022SA388614$SANOFI AVENTIS$$$$E$M$Y$$$20240806$$MD$US$US
241795491$24179549$1$I$$20240801$20240806$20240806$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-117032$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240806$$CN$DE$DE
241795501$24179550$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123948$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240806$$CN$US$US
241795511$24179551$1$I$20240403$20240729$20240806$20240806$EXP$FR-AFSSAPS-NY2024000438$FR-TEVA-VS-3195209$TEVA$$60$YR$$F$Y$75.8$KG$20240806$$PH$FR$FR
241795521$24179552$1$I$$20240802$20240806$20240806$EXP$$GB-MYLANLABS-2024M1072794$MYLAN$$$$$M$Y$$$20240806$$PH$GB$GB
241795533$24179553$3$F$20190519$20240823$20240806$20240827$EXP$$ES-MYLANLABS-2024M1072213$MYLAN$$79$YR$$F$Y$$$20240827$$HP$ES$ES
241795541$24179554$1$I$20240418$20240801$20240806$20240806$EXP$$AU-AMERICAN REGENT INC-2024002973$AMERICAN REGENT$$73$YR$$M$Y$$$20240806$$HP$AU$AU
241795551$24179555$1$I$20240701$20240731$20240806$20240806$PER$$US-SA-2024SA230203$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240806$$MD$US$US
241795561$24179556$1$I$20240101$20240801$20240806$20240806$PER$$US-SA-2024SA230048$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240806$$MD$US$US
241795571$24179557$1$I$$20240731$20240806$20240806$EXP$$US-ROCHE-10000046125$ROCHE$$$$T$M$Y$$$20240806$$CN$US$US
241795583$24179558$3$F$20231214$20240822$20240806$20240831$EXP$FR-AFSSAPS-NY2024000838$FR-TEVA-VS-3227737$TEVA$$47$YR$$M$Y$60.3$KG$20240831$$MD$FR$FR
241795592$24179559$2$F$$20240902$20240806$20240905$PER$$US-ROCHE-10000048319$ROCHE$$$$E$M$Y$$$20240905$$CN$US$US
241795601$24179560$1$I$$20240729$20240806$20240806$EXP$$ZA-AstraZeneca-2024A172331$ASTRAZENECA$$73$YR$$F$Y$$$20240806$$CN$ZA$
241795611$24179561$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A172912$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241795621$24179562$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A172378$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241795631$24179563$1$I$20240708$20240801$20240806$20240806$EXP$$IN-ROCHE-10000047937$ROCHE$$84$YR$E$M$Y$$$20240806$$CN$IN$IN
241795643$24179564$3$F$20220212$20240924$20240806$20240930$EXP$$CA-TAKEDA-2022TUS012428$TAKEDA$$69$YR$$M$Y$$$20240930$$CN$CA$CA
241795651$24179565$1$I$20240403$20240722$20240806$20240806$EXP$$US-BRAINTREE LABORATORIES, INC.-2024BTE00463$BRAINTREE$$65$YR$$F$Y$$$20240806$$CN$US$US
241795661$24179566$1$I$20240803$20240805$20240806$20240806$EXP$GB-MHRA-MED-202408050827305840-GFZRB$GB-ABBVIE-5867366$ABBVIE$$45$YR$$F$Y$$$20240806$$CN$GB$GB
241795671$24179567$1$I$$20240804$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123336$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$76.2$KG$20240806$$CN$US$US
241795681$24179568$1$I$20240725$20240802$20240806$20240806$EXP$$GB-AMERICAN REGENT INC-2024002990$AMERICAN REGENT$$84$YR$$F$Y$51$KG$20240806$$HP$GB$GB
241795691$24179569$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154847$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241795701$24179570$1$I$20240720$20240729$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407018674$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240806$$CN$US$US
241795711$24179571$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002482$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240806$$CN$US$US
241795721$24179572$1$I$20240515$20240802$20240806$20240806$EXP$$NVSC2024CN159866$NOVARTIS$$71$YR$$F$Y$67$KG$20240806$$HP$CN$CN
241795732$24179573$2$F$20240528$20240809$20240806$20240819$EXP$$BO-ROCHE-10000047375$ROCHE$$36$YR$A$M$Y$$$20240819$$MD$BO$BO
241795741$24179574$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010364$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795751$24179575$1$I$$20240620$20240806$20240806$PER$$US-GALDERMA-US2024010234$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795761$24179576$1$I$$20240730$20240806$20240806$EXP$$LT-SANDOZ INC.-SDZ2024LT070150$SANDOZ$Ulianskaite G., Timinskaite F., Raudonis T.. Severe pityriasis rubra pilaris complicated with Kaposi^svaricelliform eruption and cutaneous MRSA infection case report. Heliyon. 2024;10:1-6$62$YR$$F$Y$$$20240806$$HP$LT$LT
241795771$24179577$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010421$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795781$24179578$1$I$$20240619$20240806$20240806$PER$$US-GALDERMA-US2024010450$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795791$24179579$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010436$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795801$24179580$1$I$$20240626$20240806$20240806$PER$$US-GALDERMA-US2024010628$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795811$24179581$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010444$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795821$24179582$1$I$20240614$20240614$20240806$20240806$PER$$US-GALDERMA-US2024010128$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795831$24179583$1$I$$20240620$20240806$20240806$PER$$US-GALDERMA-US2024010456$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795841$24179584$1$I$20240703$20240802$20240806$20240806$EXP$$US-ABBVIE-5865784$ABBVIE$$80$YR$$F$Y$$$20240806$$CN$US$US
241795852$24179585$2$F$20240501$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010626$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795861$24179586$1$I$20240401$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010339$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795871$24179587$1$I$20240301$20240614$20240806$20240806$PER$$US-GALDERMA-US2024010194$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795881$24179588$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010370$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795891$24179589$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010418$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795901$24179590$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010343$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795911$24179591$1$I$$20240615$20240806$20240806$PER$$US-GALDERMA-US2024010204$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795921$24179592$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010434$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795931$24179593$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010446$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795941$24179594$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010241$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795951$24179595$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010363$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795961$24179596$1$I$20240501$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010365$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795971$24179597$1$I$20200101$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010511$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795981$24179598$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010367$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241795991$24179599$1$I$20240401$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010368$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796001$24179600$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010433$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796011$24179601$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010445$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796021$24179602$1$I$20240501$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010451$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796031$24179603$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53837$$FDA-CTU$$62$YR$$F$N$$$20240805$N$$US$
241796041$24179604$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010239$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796051$24179605$1$I$$20240731$20240806$20240806$PER$$US-BIOGEN-2024BI01276443$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241796061$24179606$1$I$$20240619$20240806$20240806$PER$$US-GALDERMA-US2024010608$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796071$24179607$1$I$$20240619$20240806$20240806$PER$$US-GALDERMA-US2024010403$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796081$24179608$1$I$20240101$20240619$20240806$20240806$PER$$US-GALDERMA-US2024010606$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796092$24179609$2$F$20240721$20240804$20240806$20240808$EXP$$CN-ABBVIE-5866920$ABBVIE$$79$YR$$F$Y$62$KG$20240808$$MD$CN$CN
241796101$24179610$1$I$$20240619$20240806$20240806$PER$$US-GALDERMA-US2024010452$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796111$24179611$1$I$$20240620$20240806$20240806$PER$$US-GALDERMA-US2024010527$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796121$24179612$1$I$$20240621$20240806$20240806$PER$$US-GALDERMA-US2024010542$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796131$24179613$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53831$$FDA-CTU$$85$YR$$M$N$$$20240805$N$$US$
241796141$24179614$1$I$20240101$20240620$20240806$20240806$PER$$US-GALDERMA-US2024010533$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796151$24179615$1$I$$20240620$20240806$20240806$PER$$US-GALDERMA-US2024010530$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796161$24179616$1$I$$20240621$20240806$20240806$PER$$US-GALDERMA-US2024010534$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796171$24179617$1$I$$20240621$20240806$20240806$PER$$US-GALDERMA-US2024010536$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796181$24179618$1$I$$20240621$20240806$20240806$PER$$US-GALDERMA-US2024010927$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796191$24179619$1$I$20240301$20240621$20240806$20240806$PER$$US-GALDERMA-US2024010929$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796201$24179620$1$I$$20240624$20240806$20240806$PER$$US-GALDERMA-US2024010740$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796211$24179621$1$I$$20240622$20240806$20240806$PER$$US-GALDERMA-US2024010630$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796221$24179622$1$I$$20240624$20240806$20240806$PER$$US-GALDERMA-US2024010743$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796231$24179623$1$I$20220101$20240624$20240806$20240806$PER$$US-GALDERMA-US2024010741$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796241$24179624$1$I$$20240624$20240806$20240806$PER$$US-GALDERMA-US2024010744$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796251$24179625$1$I$$20240624$20240806$20240806$PER$$US-GALDERMA-US2024010748$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796261$24179626$1$I$$20240624$20240806$20240806$PER$$US-GALDERMA-US2024010751$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796271$24179627$1$I$$20240624$20240806$20240806$PER$$US-GALDERMA-US2024010749$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796281$24179628$1$I$$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010745$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796291$24179629$1$I$$20240626$20240806$20240806$PER$$US-GALDERMA-US2024010834$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796301$24179630$1$I$$20240805$20240805$20240805$DIR$712980$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241796311$24179631$1$I$$20240626$20240806$20240806$PER$$US-GALDERMA-US2024010835$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796321$24179632$1$I$$20240626$20240806$20240806$PER$$US-GALDERMA-US2024010836$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796331$24179633$1$I$20230101$20240627$20240806$20240806$PER$$US-GALDERMA-US2024010850$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796341$24179634$1$I$$20240701$20240806$20240806$PER$$US-GALDERMA-US2024010851$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796351$24179635$1$I$$20240628$20240806$20240806$PER$$US-GALDERMA-US2024010852$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796361$24179636$1$I$$20240614$20240806$20240806$PER$$US-GALDERMA-US2024010193$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796371$24179637$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010416$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796381$24179638$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010347$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796391$24179639$1$I$$20240626$20240806$20240806$PER$$US-GALDERMA-US2024010845$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796401$24179640$1$I$$20240620$20240806$20240806$PER$$US-GALDERMA-US2024010499$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796411$24179641$1$I$$20240621$20240806$20240806$PER$$US-GALDERMA-US2024010624$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796421$24179642$1$I$20231201$20240620$20240806$20240806$PER$$US-GALDERMA-US2024010454$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796431$24179643$1$I$$20240624$20240806$20240806$PER$$US-GALDERMA-US2024010838$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796441$24179644$1$I$$20240621$20240806$20240806$PER$$US-GALDERMA-US2024010544$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796451$24179645$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53852$$FDA-CTU$$88$YR$$F$N$$$20240805$N$$US$
241796471$24179647$1$I$$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010822$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796481$24179648$1$I$$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010823$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796491$24179649$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010415$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796501$24179650$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010417$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796511$24179651$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010437$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796521$24179652$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010440$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796531$24179653$1$I$20240726$20240805$20240805$20240805$DIR$712971$$FDA-CTU$$68$YR$$F$N$84.15$KG$20240805$N$CN$US$
241796541$24179654$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010508$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796551$24179655$1$I$20240203$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010348$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796561$24179656$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010441$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796571$24179657$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010449$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796581$24179658$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010455$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796591$24179659$1$I$20240501$20240619$20240806$20240806$PER$$US-GALDERMA-US2024010406$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796601$24179660$1$I$$20240619$20240806$20240806$PER$$US-GALDERMA-US2024010607$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796611$24179661$1$I$$20240621$20240806$20240806$PER$$US-GALDERMA-US2024010535$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796621$24179662$1$I$$20240617$20240806$20240806$PER$$US-GALDERMA-US2024010461$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796631$24179663$1$I$20240101$20240620$20240806$20240806$PER$$US-GALDERMA-US2024010532$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796641$24179664$1$I$$20240627$20240806$20240806$PER$$US-GALDERMA-US2024010903$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796651$24179665$1$I$$20240619$20240806$20240806$PER$$US-GALDERMA-US2024010593$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796661$24179666$1$I$20240401$20240619$20240806$20240806$PER$$US-GALDERMA-US2024010231$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796671$24179667$1$I$$20240618$20240806$20240806$PER$$US-GALDERMA-US2024010102$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796681$24179668$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53818$$FDA-CTU$$39$YR$$F$N$219$LBS$20240805$N$$US$
241796691$24179669$1$I$$20240615$20240806$20240806$PER$$US-GALDERMA-US2024010119$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796701$24179670$1$I$20240301$20240618$20240806$20240806$PER$$US-GALDERMA-US2024009944$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796711$24179671$1$I$$20240621$20240806$20240806$PER$$US-GALDERMA-US2024010538$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796721$24179672$1$I$$20240621$20240806$20240806$PER$$US-GALDERMA-US2024010485$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796731$24179673$1$I$$20240620$20240806$20240806$PER$$US-GALDERMA-US2024010310$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796741$24179674$1$I$$20240623$20240806$20240806$PER$$US-GALDERMA-US2024010587$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796751$24179675$1$I$$20240628$20240806$20240806$PER$$US-GALDERMA-US2024011069$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796761$24179676$1$I$$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010821$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796771$24179677$1$I$$20240708$20240806$20240806$PER$$US-GALDERMA-US2024011196$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796781$24179678$1$I$$20240626$20240806$20240806$PER$$US-GALDERMA-US2024010564$GALDERMA$$$$$$Y$$$20240806$$HP$US$US
241796791$24179679$1$I$$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010559$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796801$24179680$1$I$$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010561$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796811$24179681$1$I$$20240802$20240805$20240805$DIR$FDA-CDER-CTU-2024-53719$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
241796821$24179682$1$I$$20240629$20240806$20240806$PER$$US-GALDERMA-US2024010766$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796831$24179683$1$I$$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010562$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796841$24179684$1$I$$20240701$20240806$20240806$PER$$US-GALDERMA-US2024010801$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796851$24179685$1$I$$20240627$20240806$20240806$PER$$US-GALDERMA-US2024010670$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796861$24179686$1$I$20240630$20240701$20240806$20240806$PER$$US-GALDERMA-US2024010767$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796871$24179687$1$I$$20240708$20240806$20240806$PER$$US-GALDERMA-US2024011379$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796881$24179688$1$I$$20240705$20240806$20240806$PER$$US-GALDERMA-US2024011331$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796891$24179689$1$I$$20240712$20240806$20240806$PER$$US-GALDERMA-US2024011340$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796901$24179690$1$I$20240101$20240620$20240806$20240806$PER$$US-GALDERMA-US2024010235$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796911$24179691$1$I$20240601$20240705$20240806$20240806$PER$$US-GALDERMA-US2024011088$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796921$24179692$1$I$20240401$20240624$20240806$20240806$PER$$US-GALDERMA-US2024010746$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796931$24179693$1$I$20240805$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53830$$FDA-CTU$$64$YR$$F$N$$$20240805$N$$US$
241796941$24179694$1$I$20240401$20240624$20240806$20240806$PER$$US-GALDERMA-US2024010752$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796951$24179695$1$I$20240501$20240624$20240806$20240806$PER$$US-GALDERMA-US2024010856$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796961$24179696$1$I$$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010817$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796971$24179697$1$I$20230101$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010819$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796981$24179698$1$I$$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010844$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241796991$24179699$1$I$$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010820$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797001$24179700$1$I$$20240625$20240806$20240806$PER$$US-GALDERMA-US2024011031$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797011$24179701$1$I$20240802$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53822$$FDA-CTU$$60$YR$$M$N$$$20240805$N$$US$
241797021$24179702$1$I$20240621$20240626$20240806$20240806$PER$$US-GALDERMA-US2024010832$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797031$24179703$1$I$$20240626$20240806$20240806$PER$$US-GALDERMA-US2024011018$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797041$24179704$1$I$20240601$20240626$20240806$20240806$PER$$US-GALDERMA-US2024010833$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797051$24179705$1$I$20240101$20240627$20240806$20240806$PER$$US-GALDERMA-US2024010901$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797061$24179706$1$I$$20240628$20240806$20240806$PER$$US-GALDERMA-US2024010999$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797071$24179707$1$I$$20240628$20240806$20240806$PER$$US-GALDERMA-US2024010978$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797081$24179708$1$I$$20240628$20240806$20240806$PER$$US-GALDERMA-US2024011070$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797091$24179709$1$I$$20240628$20240806$20240806$PER$$US-GALDERMA-US2024011071$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797101$24179710$1$I$$20240628$20240806$20240806$PER$$US-GALDERMA-US2024011072$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797111$24179711$1$I$20240101$20240628$20240806$20240806$PER$$US-GALDERMA-US2024011073$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797131$24179713$1$I$$20240628$20240806$20240806$PER$$US-GALDERMA-US2024011076$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797141$24179714$1$I$$20240701$20240806$20240806$PER$$US-GALDERMA-US2024011095$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797151$24179715$1$I$$20240701$20240806$20240806$PER$$US-GALDERMA-US2024011102$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797161$24179716$1$I$20230101$20240701$20240806$20240806$PER$$US-GALDERMA-US2024011116$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797171$24179717$1$I$$20240701$20240806$20240806$PER$$US-GALDERMA-US2024011104$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797181$24179718$1$I$20240101$20240701$20240806$20240806$PER$$US-GALDERMA-US2024011118$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797191$24179719$1$I$$20240701$20240806$20240806$PER$$US-GALDERMA-US2024011194$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797201$24179720$1$I$$20240702$20240806$20240806$PER$$US-GALDERMA-US2024011119$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797211$24179721$1$I$$20240702$20240806$20240806$PER$$US-GALDERMA-US2024011122$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797221$24179722$1$I$$20240702$20240806$20240806$PER$$US-GALDERMA-US2024011123$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797231$24179723$1$I$20240805$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53853$$FDA-CTU$$61$YR$$M$N$54$KG$20240805$N$PH$US$
241797241$24179724$1$I$$20240703$20240806$20240806$PER$$US-GALDERMA-US2024011192$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797251$24179725$1$I$$20240703$20240806$20240806$PER$$US-GALDERMA-US2024011199$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797261$24179726$1$I$$20240703$20240806$20240806$PER$$US-GALDERMA-US2024011200$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797271$24179727$1$I$$20240705$20240806$20240806$PER$$US-GALDERMA-US2024011332$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797281$24179728$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53844$$FDA-CTU$$86$YR$$M$N$$$20240805$N$$US$
241797291$24179729$1$I$$20240708$20240806$20240806$PER$$US-GALDERMA-US2024011378$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797301$24179730$1$I$$20240705$20240806$20240806$PER$$US-GALDERMA-US2024011333$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797311$24179731$1$I$$20240708$20240806$20240806$PER$$US-GALDERMA-US2024011339$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797321$24179732$1$I$$20240708$20240806$20240806$PER$$US-GALDERMA-US2024011377$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797331$24179733$1$I$$20240709$20240806$20240806$PER$$US-GALDERMA-US2024011386$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797341$24179734$1$I$$20240708$20240806$20240806$PER$$US-GALDERMA-US2024011380$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797351$24179735$1$I$$20240708$20240806$20240806$PER$$US-GALDERMA-US2024011384$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797361$24179736$1$I$20240501$20240709$20240806$20240806$PER$$US-GALDERMA-US2024011389$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797371$24179737$1$I$$20240710$20240806$20240806$PER$$US-GALDERMA-US2024011441$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797381$24179738$1$I$$20240709$20240806$20240806$PER$$US-GALDERMA-US2024011330$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797391$24179739$1$I$$20240709$20240806$20240806$PER$$US-GALDERMA-US2024011388$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797401$24179740$1$I$$20240710$20240806$20240806$PER$$US-GALDERMA-US2024011443$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797411$24179741$1$I$$20240710$20240806$20240806$PER$$US-GALDERMA-US2024011530$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797421$24179742$1$I$$20240710$20240806$20240806$PER$$US-GALDERMA-US2024011526$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797431$24179743$1$I$20240501$20240625$20240806$20240806$PER$$US-GALDERMA-US2024010825$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797441$24179744$1$I$$20240628$20240806$20240806$PER$$US-GALDERMA-US2024010979$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797451$24179745$1$I$20220101$20240701$20240806$20240806$PER$$US-GALDERMA-US2024011093$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797461$24179746$1$I$20240101$20240702$20240806$20240806$PER$$US-GALDERMA-US2024011125$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797471$24179747$1$I$$20240702$20240806$20240806$PER$$US-GALDERMA-US2024011117$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797482$24179748$2$F$$20240807$20240806$20240826$PER$$US-GALDERMA-US2024011376$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
241797491$24179749$1$I$$20240628$20240806$20240806$PER$$US-GALDERMA-US2024011098$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797501$24179750$1$I$$20240701$20240806$20240806$PER$$US-GALDERMA-US2024011103$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797511$24179751$1$I$$20240708$20240806$20240806$PER$$US-GALDERMA-US2024011685$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797521$24179752$1$I$$20240703$20240806$20240806$PER$$US-GALDERMA-US2024011191$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797531$24179753$1$I$$20240708$20240806$20240806$PER$$US-GALDERMA-US2024011684$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797541$24179754$1$I$20240401$20240708$20240806$20240806$PER$$US-GALDERMA-US2024011678$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797551$24179755$1$I$20240601$20240709$20240806$20240806$PER$$US-GALDERMA-US2024011382$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797561$24179756$1$I$20240601$20240710$20240806$20240806$PER$$US-GALDERMA-US2024011442$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797571$24179757$1$I$20240601$20240709$20240806$20240806$PER$$US-GALDERMA-US2024011383$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797581$24179758$1$I$20230101$20240710$20240806$20240806$PER$$US-GALDERMA-US2024011524$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797591$24179759$1$I$$20240711$20240806$20240806$PER$$US-GALDERMA-US2024002399$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797601$24179760$1$I$$20240711$20240806$20240806$PER$$US-GALDERMA-US2024011381$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797611$24179761$1$I$$20240711$20240806$20240806$PER$$US-GALDERMA-US2024011476$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797621$24179762$1$I$$20240712$20240806$20240806$PER$$US-GALDERMA-US2024011542$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797631$24179763$1$I$$20240712$20240806$20240806$PER$$US-GALDERMA-US2024011543$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797641$24179764$1$I$$20240715$20240806$20240806$PER$$US-GALDERMA-US2024011677$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797651$24179765$1$I$$20240717$20240806$20240806$PER$$US-GALDERMA-US2024011588$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797661$24179766$1$I$$20240627$20240806$20240806$PER$$US-GALDERMA-US2024010721$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797671$24179767$1$I$$20240718$20240806$20240806$PER$$US-GALDERMA-US2024011672$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797681$24179768$1$I$20240101$20240710$20240806$20240806$PER$$US-GALDERMA-US2024011280$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797691$24179769$1$I$$20240707$20240806$20240806$PER$$US-GALDERMA-US2024011276$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797701$24179770$1$I$$20240711$20240806$20240806$PER$$US-GALDERMA-US2024011354$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797711$24179771$1$I$$20240724$20240806$20240806$PER$$US-GALDERMA-US2024011982$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797721$24179772$1$I$$20240717$20240806$20240806$PER$$US-GALDERMA-US2024011899$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797731$24179773$1$I$$20240717$20240806$20240806$PER$$US-GALDERMA-US2024011900$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797741$24179774$1$I$20240501$20240715$20240806$20240806$PER$$US-GALDERMA-US2024011417$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797751$24179775$1$I$20240707$20240712$20240806$20240806$PER$$US-GALDERMA-US2024011356$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797761$24179776$1$I$$20240724$20240806$20240806$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000274$THERATECHNOLOGIES$$$$$$Y$$$20240806$$CN$US$US
241797771$24179777$1$I$$20240610$20240806$20240806$PER$$US-GALDERMA-US2024009691$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797781$24179778$1$I$$20240611$20240806$20240806$PER$$US-GALDERMA-US2024009901$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797791$24179779$1$I$$20240329$20240806$20240806$PER$$US-GALDERMA-US2024006011$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797802$24179780$2$F$$20240605$20240806$20240806$PER$$US-GALDERMA-US2024009479$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797811$24179781$1$I$20240101$20240605$20240806$20240806$PER$$US-GALDERMA-US2024009739$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797821$24179782$1$I$20240710$20240722$20240806$20240806$EXP$$US-OTTER-US-2024AST000271$Otter$$56$YR$$M$Y$$$20240806$$MD$US$US
241797831$24179783$1$I$$20240611$20240806$20240806$PER$$US-GALDERMA-US2024009865$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797841$24179784$1$I$20240101$20240611$20240806$20240806$PER$$US-GALDERMA-US2024009960$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797851$24179785$1$I$$20240607$20240806$20240806$PER$$US-GALDERMA-US2024009844$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797861$24179786$1$I$$20240613$20240806$20240806$PER$$US-GALDERMA-US2024010026$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797871$24179787$1$I$$20240613$20240806$20240806$PER$$US-GALDERMA-US2024010029$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797881$24179788$1$I$$20240602$20240806$20240806$PER$$US-GALDERMA-US2024009676$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797891$24179789$1$I$$20240602$20240806$20240806$PER$$US-GALDERMA-US2024009678$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797901$24179790$1$I$$20240611$20240806$20240806$PER$$US-GALDERMA-US2024010116$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797911$24179791$1$I$20240101$20240612$20240806$20240806$PER$$US-GALDERMA-US2024009989$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797921$24179792$1$I$$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009612$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797931$24179793$1$I$20240101$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009613$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797941$24179794$1$I$$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009646$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797951$24179795$1$I$$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009639$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797961$24179796$1$I$$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009641$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797971$24179797$1$I$20240529$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009718$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797981$24179798$1$I$$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009645$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241797991$24179799$1$I$$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009716$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798001$24179800$1$I$$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009728$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798011$24179801$1$I$$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009720$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798021$24179802$1$I$$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009730$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798031$24179803$1$I$$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009736$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798041$24179804$1$I$20240301$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009729$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798051$24179805$1$I$$20240603$20240806$20240806$PER$$US-GALDERMA-US2024009732$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798061$24179806$1$I$$20240604$20240806$20240806$PER$$US-GALDERMA-US2024009622$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798071$24179807$1$I$$20240604$20240806$20240806$PER$$US-GALDERMA-US2024009624$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798081$24179808$1$I$$20240604$20240806$20240806$PER$$US-GALDERMA-US2024009623$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798091$24179809$1$I$$20240604$20240806$20240806$PER$$US-GALDERMA-US2024009625$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798101$24179810$1$I$$20240604$20240806$20240806$PER$$US-GALDERMA-US2024009626$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798111$24179811$1$I$$20240604$20240806$20240806$PER$$US-GALDERMA-US2024009627$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798121$24179812$1$I$20210101$20240604$20240806$20240806$PER$$US-GALDERMA-US2024009628$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798131$24179813$1$I$20240201$20240605$20240806$20240806$PER$$US-GALDERMA-US2024009693$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798141$24179814$1$I$$20240605$20240806$20240806$PER$$US-GALDERMA-US2024009695$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798151$24179815$1$I$$20240605$20240806$20240806$PER$$US-GALDERMA-US2024009735$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798161$24179816$1$I$$20240731$20240806$20240806$PER$$US-AMGEN-USASP2024152835$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241798171$24179817$1$I$$20240605$20240806$20240806$PER$$US-GALDERMA-US2024009696$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798181$24179818$1$I$$20240605$20240806$20240806$PER$$US-GALDERMA-US2024009731$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798191$24179819$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53838$$FDA-CTU$$74$YR$$M$N$$$20240805$N$$US$
241798201$24179820$1$I$20240803$20240805$20240805$20240805$DIR$712983$$FDA-CTU$$49$YR$$F$N$76.5$KG$20240805$N$CN$US$
241798211$24179821$1$I$$20240606$20240806$20240806$PER$$US-GALDERMA-US2024010877$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798221$24179822$1$I$$20240605$20240806$20240806$PER$$US-GALDERMA-US2024009733$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798231$24179823$1$I$$20240605$20240806$20240806$PER$$US-GALDERMA-US2024010528$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798241$24179824$1$I$$20240805$20240805$20240805$DIR$712984$$FDA-CTU$$$$$F$N$$$20240805$Y$HP$US$
241798251$24179825$1$I$$20240805$20240805$20240805$DIR$712987$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241798261$24179826$1$I$$20240614$20240806$20240806$PER$$US-GALDERMA-US2024010301$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798271$24179827$1$I$20210101$20240606$20240806$20240806$PER$$US-GALDERMA-US2024009602$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798281$24179828$1$I$$20240803$20240805$20240805$DIR$FDA-CDER-CTU-2024-53851$$FDA-CTU$$$$$M$N$$$20240803$N$HP$US$
241798291$24179829$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53860$$FDA-CTU$$81$YR$$M$N$$$20240805$N$$US$
241798311$24179831$1$I$$20240606$20240806$20240806$PER$$US-GALDERMA-US2024009744$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798321$24179832$1$I$$20240606$20240806$20240806$PER$$US-GALDERMA-US2024009740$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798331$24179833$1$I$20240501$20240606$20240806$20240806$PER$$US-GALDERMA-US2024009753$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798341$24179834$1$I$$20240606$20240806$20240806$PER$$US-GALDERMA-US2024009783$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798351$24179835$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53815$$FDA-CTU$$71$YR$$M$N$$$20240805$N$$US$
241798361$24179836$1$I$20240805$20240805$20240805$20240805$DIR$712996$$FDA-CTU$$70$YR$$M$N$$$20240805$N$$US$
241798371$24179837$1$I$20240601$20240805$20240805$20240805$DIR$712986$$FDA-CTU$$81$YR$$F$N$$$20240805$N$HP$US$
241798381$24179838$1$I$$20240606$20240806$20240806$PER$$US-GALDERMA-US2024009871$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798391$24179839$1$I$$20240606$20240806$20240806$PER$$US-GALDERMA-US2024009874$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798401$24179840$1$I$$20240805$20240805$20240805$DIR$712940$$FDA-CTU$$$$$UNK$N$$$20240805$$CN$US$
241798411$24179841$1$I$$20240607$20240806$20240806$PER$$US-GALDERMA-US2024009790$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798421$24179842$1$I$20210101$20240607$20240806$20240806$PER$$US-GALDERMA-US2024009789$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798431$24179843$1$I$20240101$20240607$20240806$20240806$PER$$US-GALDERMA-US2024009791$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798441$24179844$1$I$$20240607$20240806$20240806$PER$$US-GALDERMA-US2024009792$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798451$24179845$1$I$20240101$20240607$20240806$20240806$PER$$US-GALDERMA-US2024009793$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798461$24179846$1$I$$20240607$20240806$20240806$PER$$US-GALDERMA-US2024009794$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798471$24179847$1$I$$20240607$20240806$20240806$PER$$US-GALDERMA-US2024009869$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798481$24179848$1$I$20240101$20240607$20240806$20240806$PER$$US-GALDERMA-US2024009863$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798491$24179849$1$I$$20240607$20240806$20240806$PER$$US-GALDERMA-US2024009870$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798501$24179850$1$I$$20240610$20240806$20240806$PER$$US-GALDERMA-US2024009738$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798511$24179851$1$I$$20240610$20240806$20240806$PER$$US-GALDERMA-US2024009762$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798521$24179852$1$I$$20240610$20240806$20240806$PER$$US-GALDERMA-US2024009764$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798531$24179853$1$I$$20240610$20240806$20240806$PER$$US-GALDERMA-US2024009940$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798541$24179854$1$I$$20240610$20240806$20240806$PER$$US-GALDERMA-US2024010269$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798551$24179855$1$I$20240501$20240610$20240806$20240806$PER$$US-GALDERMA-US2024009958$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798561$24179856$1$I$$20240610$20240806$20240806$PER$$US-GALDERMA-US2024009941$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798571$24179857$1$I$$20240610$20240806$20240806$PER$$US-GALDERMA-US2024009957$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798581$24179858$1$I$$20240611$20240806$20240806$PER$$US-GALDERMA-US2024009798$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798591$24179859$1$I$$20240611$20240806$20240806$PER$$US-GALDERMA-US2024009904$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798601$24179860$1$I$$20240610$20240806$20240806$PER$$US-GALDERMA-US2024010270$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798611$24179861$1$I$20240601$20240612$20240806$20240806$PER$$US-GALDERMA-US2024009943$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798621$24179862$1$I$$20240612$20240806$20240806$PER$$US-GALDERMA-US2024009948$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798631$24179863$1$I$$20240612$20240806$20240806$PER$$US-GALDERMA-US2024009951$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798641$24179864$1$I$$20240612$20240806$20240806$PER$$US-GALDERMA-US2024009949$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798651$24179865$1$I$$20240612$20240806$20240806$PER$$US-GALDERMA-US2024009954$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798661$24179866$1$I$$20240612$20240806$20240806$PER$$US-GALDERMA-US2024009955$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798681$24179868$1$I$$20240612$20240806$20240806$PER$$US-GALDERMA-US2024009961$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798691$24179869$1$I$20240401$20240612$20240806$20240806$PER$$US-GALDERMA-US2024009962$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798701$24179870$1$I$$20240612$20240806$20240806$PER$$US-GALDERMA-US2024009966$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798711$24179871$1$I$$20240801$20240806$20240806$EXP$$US-ROCHE-10000047196$ROCHE$$$$T$M$Y$$$20240806$$CN$US$US
241798721$24179872$1$I$$20240612$20240806$20240806$PER$$US-GALDERMA-US2024010274$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798731$24179873$1$I$20240501$20240613$20240806$20240806$PER$$US-GALDERMA-US2024010027$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798741$24179874$1$I$$20240613$20240806$20240806$PER$$US-GALDERMA-US2024010075$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798751$24179875$1$I$20240410$20240613$20240806$20240806$PER$$US-GALDERMA-US2024010076$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798762$24179876$2$F$20240101$20240708$20240806$20240806$PER$$US-GALDERMA-US2024010195$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798771$24179877$1$I$$20240614$20240806$20240806$PER$$US-GALDERMA-US2024010271$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798781$24179878$1$I$20240601$20240614$20240806$20240806$PER$$US-GALDERMA-US2024010243$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798791$24179879$1$I$$20240614$20240806$20240806$PER$$US-GALDERMA-US2024010272$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798801$24179880$1$I$$20240613$20240806$20240806$PER$$US-GALDERMA-US2024010467$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798811$24179881$1$I$$20240614$20240806$20240806$PER$$US-GALDERMA-US2024010273$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798821$24179882$1$I$$20240614$20240806$20240806$PER$$US-GALDERMA-US2024010385$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798832$24179883$2$F$$20240805$20240806$20240821$EXP$$CA-ORGANON-O2408CAN000312$ORGANON$$45$YR$$F$Y$$$20240821$$CN$CA$CA
241798841$24179884$1$I$$20240614$20240806$20240806$PER$$US-GALDERMA-US2024010459$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798851$24179885$1$I$$20240614$20240806$20240806$PER$$US-GALDERMA-US2024010541$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798862$24179886$2$F$$20240826$20240806$20240826$PER$$US-ALXN-202407USA002037US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
241798871$24179887$1$I$20240303$20240305$20240805$20240805$DIR$FDA-CDER-CTU-2024-53850$$FDA-CTU$$51$YR$$F$N$$$20240305$N$CN$US$
241798881$24179888$1$I$$20240611$20240806$20240806$PER$$US-GALDERMA-US2024009902$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798891$24179889$1$I$20240101$20240610$20240806$20240806$PER$$US-GALDERMA-US2024010206$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798901$24179890$1$I$$20240612$20240806$20240806$PER$$US-GALDERMA-US2024010275$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798911$24179891$1$I$$20240611$20240806$20240806$PER$$US-GALDERMA-US2024010086$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798921$24179892$1$I$20240731$20240802$20240805$20240805$DIR$FDA-CDER-CTU-2024-53824$$FDA-CTU$$50$YR$$F$N$$$20240802$N$HP$US$
241798931$24179893$1$I$20240724$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53857$$FDA-CTU$$73$YR$$M$N$$$20240805$N$HP$US$
241798941$24179894$1$I$$20240805$20240805$20240805$DIR$FDA-CDER-CTU-2024-53839$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
241798951$24179895$1$I$20240730$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122062$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240806$$CN$US$US
241798961$24179896$1$I$$20240612$20240806$20240806$PER$$US-GALDERMA-US2024009963$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798971$24179897$1$I$$20240729$20240806$20240806$PER$$US-ALXN-202407USA002209US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240806$$CN$US$US
241798981$24179898$1$I$20240501$20240613$20240806$20240806$PER$$US-GALDERMA-US2024010028$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241798991$24179899$1$I$$20240610$20240806$20240806$PER$$US-GALDERMA-US2024009766$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241799001$24179900$1$I$$20240611$20240806$20240806$PER$$US-GALDERMA-US2024011101$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241799011$24179901$1$I$20240101$20240610$20240806$20240806$PER$$US-GALDERMA-US2024009637$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241799021$24179902$1$I$$20240612$20240806$20240806$PER$$US-GALDERMA-US2024011100$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241799031$24179903$1$I$$20240611$20240806$20240806$PER$$US-GALDERMA-US2024009775$GALDERMA$$$$$$Y$$$20240806$$CN$US$US
241799041$24179904$1$I$20240622$20240724$20240806$20240806$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000275$THERATECHNOLOGIES$$$$$$Y$$$20240806$$CN$US$US
241799051$24179905$1$I$$20240723$20240806$20240806$PER$$US-TEVA-VS-3226832$TEVA$$$$$M$Y$$$20240806$$MD$US$US
241799061$24179906$1$I$20240725$20240805$20240806$20240806$EXP$$CN-BAYER-2024A113141$BAYER$$60$YR$A$M$Y$$$20240806$$HP$CN$CN
241799071$24179907$1$I$$20240729$20240806$20240806$EXP$$JP-PFIZER INC-202400230849$PFIZER$Tsujino, M.. A review of the usage of CDK4/6 inhibitors in patients with HR-positive, HER2-negative advanced or breast cancer recurrent at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:117$$$$$Y$$$20240806$$HP$JP$JP
241799081$24179908$1$I$$20240729$20240806$20240806$EXP$$JP-PFIZER INC-202400230848$PFIZER$Tsujino, M.. A review of the usage of CDK4/6 inhibitors in patients with HR-positive, HER2-negative advanced or breast cancer recurrent at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:117$$$$$Y$$$20240806$$HP$JP$JP
241799091$24179909$1$I$$20240729$20240806$20240806$EXP$$JP-PFIZER INC-202400230847$PFIZER$Tsujino, M.. A review of the usage of CDK4/6 inhibitors in patients with HR-positive, HER2-negative advanced or breast cancer recurrent at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:117$$$$$Y$$$20240806$$HP$JP$JP
241799101$24179910$1$I$20240609$20240805$20240805$20240805$DIR$712991$$FDA-CTU$$73$YR$$M$N$108.5$KG$20240805$N$HP$US$
241799111$24179911$1$I$20240802$20240805$20240805$20240805$DIR$712995$$FDA-CTU$$65$YR$$UNK$N$$$20240805$N$HP$US$
241799121$24179912$1$I$20240606$20240805$20240805$20240805$DIR$712997$$FDA-CTU$$71$YR$$M$N$65.2$KG$20240805$N$HP$US$
241799132$24179913$2$F$$20240905$20240806$20240913$30DAY$$AU-JNJFOC-20240772428$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$PH$AU$AU
241799141$24179914$1$I$20240717$20240805$20240805$20240805$DIR$712956$$FDA-CTU$$30$YR$$M$N$$$20240805$Y$PH$US$
241799151$24179915$1$I$$20240805$20240805$20240805$DIR$712998$$FDA-CTU$$$$$UNK$N$$$20240805$$CN$US$
241799173$24179917$3$F$20240826$20240910$20240806$20240916$EXP$$US-OTSUKA-2024_021497$OTSUKA$$51$YR$$M$Y$$$20240916$$MD$US$US
241799181$24179918$1$I$$20240802$20240806$20240806$PER$$US-BAYER-2024A112427$BAYER$$54$YR$A$F$Y$$$20240806$$CN$US$US
241799191$24179919$1$I$$20240802$20240806$20240806$PER$$US-ABBVIE-5866285$ABBVIE$$$$$F$Y$$$20240806$$MD$US$US
241799201$24179920$1$I$$20240730$20240806$20240806$EXP$$US-AMERICAN REGENT INC-2024002956$AMERICAN REGENT$Gwiazdowski M, Niraula S, Bewley B. A Unique Case Presentation of Takotsubo Cardiomyopathy After Cardiac Arrest and Resuscitation Without CPR. American Journal of Respiratory and Critical Care Medicine. 2023;207:A1787 [abstract]$81$YR$$F$Y$$$20240806$$HP$US$US
241799211$24179921$1$I$$20240729$20240806$20240806$EXP$$US-ABBVIE-5824265$ABBVIE$$49$YR$$M$Y$73$KG$20240806$$HP$US$US
241799231$24179923$1$I$$20240805$20240806$20240806$EXP$$US-ROCHE-10000049648$ROCHE$$$$T$M$Y$$$20240806$$CN$US$US
241799241$24179924$1$I$$20240801$20240806$20240806$EXP$$PH-OTSUKA-2024_021503$OTSUKA$$$$$M$Y$$$20240806$$CN$PH$PH
241799251$24179925$1$I$$20240729$20240806$20240806$EXP$$JP-PFIZER INC-202400230850$PFIZER$Tsujino, M.. A review of the usage of CDK4/6 inhibitors in patients with HR-positive, HER2-negative advanced or breast cancer recurrent at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:117$$$$$Y$$$20240806$$HP$JP$JP
241799261$24179926$1$I$$20240729$20240806$20240806$EXP$$JP-PFIZER INC-202400230852$PFIZER$Tsujino, M.. A review of the usage of CDK4/6 inhibitors in patients with HR-positive, HER2-negative advanced or breast cancer recurrent at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:117$$$$$Y$$$20240806$$HP$JP$JP
241799271$24179927$1$I$$20240729$20240806$20240806$EXP$$JP-PFIZER INC-202400230851$PFIZER$Tsujino, M.. A review of the usage of CDK4/6 inhibitors in patients with HR-positive, HER2-negative advanced or breast cancer recurrent at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:117$$$$$Y$$$20240806$$HP$JP$JP
241799281$24179928$1$I$20240126$20240805$20240806$20240806$EXP$$US-BAUSCH-BL-2024-001457$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240806$$CN$US$US
241799291$24179929$1$I$20240727$20240803$20240806$20240806$EXP$IT-MINISAL02-997200$IT-BAUSCH-BL-2024-011862$BAUSCH AND LOMB$$25$YR$$M$Y$64$KG$20240806$$CN$IT$IT
241799301$24179930$1$I$$20240729$20240806$20240806$PER$$US-BAYER-2024A112843$BAYER$$$$$$Y$$$20240806$$CN$US$US
241799312$24179931$2$F$20240101$20240808$20240806$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-019263$UNITED THERAPEUTICS$$$$$M$Y$104.31$KG$20240816$$$US$US
241799321$24179932$1$I$$20240801$20240806$20240806$EXP$$US-JNJFOC-20240808468$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$US$US
241799332$24179933$2$F$$20240731$20240806$20240809$EXP$$PL-BAUSCH-BL-2024-011728$BAUSCH AND LOMB$$55$YR$$F$Y$$$20240809$$PH$PL$PL
241799341$24179934$1$I$20240101$20240804$20240806$20240806$EXP$$CN-JNJFOC-20240813071$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$CN$CN
241799355$24179935$5$F$20240101$20240912$20240806$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-024031$UNITED THERAPEUTICS$$$$$F$Y$58.957$KG$20240921$$MD$US$US
241799362$24179936$2$F$$20240804$20240806$20240808$EXP$$US-PURDUE PHARMA-USA-2024-0311140$PURDUE$$$$$F$Y$$$20240808$$CN$US$US
241799371$24179937$1$I$$20240802$20240806$20240806$PER$$US-ROCHE-10000049744$ROCHE$$$$$$Y$$$20240806$$CN$US$US
241799381$24179938$1$I$$20240805$20240806$20240806$PER$$US-ROCHE-10000049736$ROCHE$$$$A$M$Y$$$20240806$$CN$US$US
241799392$24179939$2$F$20240101$20240821$20240806$20240828$EXP$$US-009507513-2406USA007448$MERCK$$$$$F$Y$$$20240828$$HP$US$US
241799411$24179941$1$I$20240401$20240801$20240806$20240806$EXP$$CA-OTSUKA-2024_021562$OTSUKA$$39$YR$$F$Y$$$20240806$$CN$CA$CA
241799422$24179942$2$F$$20240730$20240806$20240807$PER$$US-BAYER-2024A111547$BAYER$$49$YR$A$F$Y$$$20240807$$MD$US$US
241799432$24179943$2$F$$20240826$20240806$20240826$PER$$US-ALXN-202407USA002148US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
241799442$24179944$2$F$20130915$20240730$20240806$20240812$EXP$$BR-ORGANON-O2408BRA000168$ORGANON$$$$$F$Y$$$20240812$$HP$BR$BR
241799451$24179945$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123548$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$66.68$KG$20240806$$CN$US$US
241799461$24179946$1$I$20240701$20240731$20240806$20240806$PER$$US-SA-2024SA229835$SANOFI AVENTIS$$8$YR$C$M$Y$32.6$KG$20240806$$MD$US$US
241799471$24179947$1$I$20240805$20240805$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123975$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240806$$CN$US$US
241799481$24179948$1$I$20240727$20240730$20240806$20240806$EXP$$US-Vifor (International) Inc.-VIT-2024-06858$VIFOR$$33$YR$$F$Y$60$KG$20240806$$HP$US$US
241799491$24179949$1$I$$20240731$20240806$20240806$EXP$$US-SA-2024SA230126$SANOFI AVENTIS$$96$YR$E$F$Y$50.348$KG$20240806$$MD$US$US
241799502$24179950$2$F$$20240820$20240806$20240827$EXP$$KW-JNJFOC-20240737302$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240827$$MD$KW$KW
241799511$24179951$1$I$$20240731$20240806$20240806$PER$$US-BIOMARINAP-US-2024-159554$BIOMARIN$$$$$$Y$$$20240806$$CN$US$US
241799521$24179952$1$I$20240101$20240806$20240806$20240806$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044041$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240806$$CN$US$US
241799531$24179953$1$I$$20240723$20240806$20240806$EXP$$US-HQ SPECIALTY-US-2024INT000078$INTERCHEM$Klopp AH, Enserro D, Powell M, Randall M, Schink JC, Mannel RS, et al. Radiation therapy with or without cisplatin for local recurrences of endometrial cancer: results from an NRG oncology/GOG prospective randomized multicenter clinical trial. Journal of Clinical Oncology. 2024;42(20):2425-35$$$$F$Y$$$20240806$$MD$US$US
241799541$24179954$1$I$20240617$20240731$20240806$20240806$EXP$$CN-SANDOZ INC.-SDZ2024CN070703$SANDOZ$$88$YR$$F$Y$60$KG$20240806$$HP$CN$CN
241799552$24179955$2$F$$20240827$20240806$20240903$30DAY$$GB-JNJFOC-20240800326$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$GB$GB
241799562$24179956$2$F$20240219$20240812$20240806$20240819$EXP$$NVSC2024AR154967$NOVARTIS$$73$YR$$F$Y$72$KG$20240819$$CN$AR$AR
241799571$24179957$1$I$20230111$20231019$20240806$20240806$EXP$$SG-SANDOZ INC.-SDZ2023SG047128$SANDOZ$$$$$$Y$$$20240806$$HP$SG$SG
241799581$24179958$1$I$$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408003114$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240806$$CN$US$US
241799591$24179959$1$I$$20240729$20240806$20240806$EXP$PL-URPL-1-3862-2020$PL-TEVA-VS-3226701$TEVA$$40$YR$$M$Y$90$KG$20240806$$MD$PL$PL
241799601$24179960$1$I$$20240802$20240806$20240806$EXP$$US-BEH-2024176794$CSL BEHRING$$$$E$M$Y$$$20240806$$HP$US$US
241799611$24179961$1$I$20240701$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000502$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240806$$CN$US$US
241799621$24179962$1$I$$20240731$20240806$20240806$EXP$$CA-009507513-2408CAN000919$MERCK$$49$YR$$F$Y$$$20240806$$HP$CA$CA
241799631$24179963$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001769$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240806$$HP$US$US
241799641$24179964$1$I$$20240730$20240806$20240806$EXP$$JP-009507513-2407JPN005448J$MERCK$$7$DEC$$$Y$$$20240806$$MD$JP$JP
241799651$24179965$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002138$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240806$$CN$US$US
241799661$24179966$1$I$20240721$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001388$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240806$$CN$US$US
241799671$24179967$1$I$20240111$20240729$20240806$20240806$EXP$FR-AFSSAPS-ST2024001188$FR-TEVA-VS-3227693$TEVA$$59$YR$$M$Y$$$20240806$$HP$FR$FR
241799681$24179968$1$I$$20240802$20240806$20240806$EXP$$FR-MYLANLABS-2024M1072171$MYLAN$Samalin, E.. Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients.. Digestive and Liver Disease.. 2024;56(8):1375-1381$$$A$$Y$$$20240806$$HP$FR$FR
241799692$24179969$2$F$20230604$20240814$20240806$20240820$EXP$$GB-BAYER-2024A109298$BAYER$$28$YR$A$F$Y$$$20240820$$CN$GB$GB
241799701$24179970$1$I$$20240802$20240806$20240806$PER$$US-JNJFOC-20240808469$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$HP$US$US
241799711$24179971$1$I$20140513$20240805$20240806$20240806$EXP$FR-AFSSAPS-MA20141208$FR-SANDOZ INC.-PHHY2014FR176228$SANDOZ$$12$YR$$F$Y$$$20240806$$HP$FR$FR
241799721$24179972$1$I$$20240802$20240806$20240806$PER$$US-ABBVIE-5868369$ABBVIE$$$$$$Y$$$20240806$$CN$US$US
241799732$24179973$2$F$$20240806$20240806$20240830$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001182$AKEBIA THERAPEUTICS$Imai, Enyu; Imai, Atsuhiro. The Comparison between Vadadustat and Daprodustat Regarding Dose, Cost, and Safety of Treatment for Renal Anemia in Non-dialysis Patients with Chronic Kidney Diseases. Internal medicine (Tokyo, Japan). 2024;63:13:1855-1861$$$$$Y$$$20240830$$HP$JP$JP
241799741$24179974$1$I$20240714$20240802$20240806$20240806$PER$$NVSC2024US159452$NOVARTIS$$44$YR$$M$Y$$$20240806$$CN$US$US
241799751$24179975$1$I$20240426$20240805$20240805$20240805$DIR$713000$$FDA-CTU$$45$YR$$M$N$$$20240805$N$MD$US$
241799761$24179976$1$I$20240619$20240805$20240805$20240805$DIR$713002$$FDA-CTU$$34$YR$$F$N$$$20240805$N$MD$US$
241799781$24179978$1$I$20240724$20240729$20240806$20240806$PER$$US-ABBVIE-5861107$ABBVIE$$26$YR$$F$Y$$$20240806$$CN$US$US
241799801$24179980$1$I$$20240805$20240805$20240805$DIR$712999$$FDA-CTU$$$$$UNK$N$$$20240805$$CN$US$
241799811$24179981$1$I$20240628$20240805$20240805$20240805$DIR$712994$$FDA-CTU$$69$YR$$F$N$80.9$KG$20240805$N$HP$US$
241799821$24179982$1$I$20240701$20240805$20240806$20240806$EXP$$US-UCBSA-2024039303$UCB$$30$YR$$F$Y$$$20240806$$CN$US$US
241799831$24179983$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A172626$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241799841$24179984$1$I$20210101$20240731$20240806$20240806$EXP$$US-ABBVIE-5863883$ABBVIE$$61$YR$$M$Y$$$20240806$$CN$US$US
241799851$24179985$1$I$20240701$20240801$20240806$20240806$EXP$$US-ABBVIE-5865006$ABBVIE$$20$YR$$F$Y$$$20240806$$CN$US$US
241799861$24179986$1$I$$20240802$20240806$20240806$EXP$$US-UCBSA-2024039001$UCB$$$$$F$Y$$$20240806$$CN$US$US
241799871$24179987$1$I$$20240729$20240806$20240806$EXP$$ZA-AstraZeneca-2024A172439$ASTRAZENECA$$78$YR$$F$Y$$$20240806$$CN$ZA$
241799881$24179988$1$I$20240801$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024154064$AMGEN$$64$YR$A$F$Y$$$20240806$$CN$US$US
241799891$24179989$1$I$20240729$20240805$20240805$20240805$DIR$712949$$FDA-CTU$$66$YR$$F$N$$$20240805$N$PH$US$
241799901$24179990$1$I$20171121$20240729$20240806$20240806$EXP$$CA-AstraZeneca-2020SE06017$ASTRAZENECA$$75$YR$$M$Y$65.5$KG$20240806$$MD$CA$
241799911$24179991$1$I$20240618$20240730$20240806$20240806$EXP$$CO-GSK-CO2023AMR151033$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$CO$CO
241799921$24179992$1$I$$20240802$20240806$20240806$EXP$$US-OTSUKA-2024_021531$OTSUKA$$$$$F$Y$$$20240806$$CN$US$US
241799933$24179993$3$F$20240701$20240827$20240806$20240904$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00807$CATALYST PHARMA$$83$YR$$M$Y$86.168$KG$20240904$$CN$US$US
241799941$24179994$1$I$$20240729$20240806$20240806$EXP$$FR-AUROBINDO-AUR-APL-2024-039302$AUROBINDO$Margot. C, Sylvine. P, Hester.C, Angele. S, Cl?ment. D, Vanessa.B. Donepezil as a safe alternative treatment after maculo-papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data. PSYCHOGERIATRICS. 2024$79$YR$$M$Y$$$20240806$$HP$FR$FR
241799952$24179995$2$F$20240727$20240805$20240806$20240815$EXP$$US-FreseniusKabi-FK202411951$FRESENIUS KABI$$$$$$Y$$$20240815$$HP$US$US
241799961$24179996$1$I$20240718$20240729$20240806$20240806$EXP$CN-NMPACDR-3301021026599202400166$CN-BAXTER-2024BAX022521$BAXTER$$12$YR$$M$Y$38$KG$20240806$$MD$CN$CN
241799971$24179997$1$I$20140101$20240722$20240806$20240806$EXP$$KR-IMP-2024000545$Harrow Health$$$$E$M$Y$$$20240806$$CN$KR$KR
241799991$24179999$1$I$20240701$20240805$20240805$20240805$DIR$713006$$FDA-CTU$$92$YR$$F$N$84.6$KG$20240805$N$PH$US$
241800001$24180000$1$I$$20240805$20240805$20240805$DIR$713007$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241800011$24180001$1$I$20240301$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-53873$$FDA-CTU$$$$$F$N$75.3$KG$20240805$N$$US$
241800021$24180002$1$I$20240620$20240805$20240805$20240805$DIR$713008$$FDA-CTU$$60$YR$$F$N$64.2$KG$20240805$N$MD$US$
241800041$24180004$1$I$$20240805$20240805$20240805$DIR$713014$$FDA-CTU$$$$$F$N$83.25$KG$20240805$Y$MD$US$
241800051$24180005$1$I$20240701$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-53959$$FDA-CTU$$84$YR$$M$N$$$20240805$N$PH$US$
241800061$24180006$1$I$20240630$20240805$20240805$20240805$DIR$712958$$FDA-CTU$$32$YR$$F$N$74.25$KG$20240805$N$CN$US$
241800071$24180007$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54013$$FDA-CTU$$64$YR$$F$N$83.91$KG$20240806$N$$US$
241800082$24180008$2$F$$20240805$20240806$20240807$PER$$US-JNJFOC-20240809301$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241800091$24180009$1$I$20240601$20240802$20240806$20240806$PER$$US-JNJFOC-20240807341$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$PH$US$US
241800111$24180011$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123588$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240806$$CN$US$US
241800121$24180012$1$I$$20240731$20240806$20240806$PER$$US-009507513-2408USA000129$MERCK$$$$$F$Y$$$20240806$$MD$US$US
241800131$24180013$1$I$$20240725$20240806$20240806$PER$$US-009507513-2408USA001579$MERCK$Vittayawacharin P, Lee B, Griffin S, Doh J, Nam H, Blodget E, et al. Extended Letermovir Prophylaxis in Patients Receiving Haploidentical Transplantation. Transplantation and Cellular Therapy. 2024;30 (2 Suppl):S434$$$A$$Y$$$20240806$$MD$US$US
241800141$24180014$1$I$20240705$20240801$20240806$20240806$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-15547$IPSEN$$66$YR$E$M$Y$$$20240806$$CN$US$US
241800152$24180015$2$F$20220620$20240911$20240806$20240918$EXP$$CA-TAKEDA-2024TUS078064$TAKEDA$$70$YR$$F$Y$$$20240918$$CN$CA$CA
241800162$24180016$2$F$$20240806$20240806$20240821$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001181$AKEBIA THERAPEUTICS$Imai, Enyu; Imai, Atsuhiro. The Comparison between Vadadustat and Daprodustat Regarding Dose, Cost, and Safety of Treatment for Renal Anemia in Non-dialysis Patients with Chronic Kidney Diseases. Internal medicine (Tokyo, Japan). 2024;13:1855-1861$$$$$Y$$$20240821$$HP$JP$JP
241800171$24180017$1$I$20240805$20240805$20240806$20240806$EXP$$IT-UCBSA-2024039330$UCB$$$$$$Y$$$20240806$$MD$IT$IT
241800181$24180018$1$I$20240710$20240730$20240806$20240806$EXP$$CO-GSK-CO2024AMR096450$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$CO$CO
241800191$24180019$1$I$20211029$20211111$20240806$20240806$EXP$$IE-BIOVITRUM-2021IE10949$BIOVITRUM$$119$DY$$M$Y$$$20240806$$HP$IE$IE
241800201$24180020$1$I$$20240731$20240806$20240806$EXP$$IT-BIOVITRUM-2024-IT-010504$BIOVITRUM$Naviglio S, Cicalese MP, Rivers E, Ferrua F, Bonfim C, Cenciarelli S, et al. Interleukin-1 blockade in patients with Wiskott-Aldrich Syndrome: a retrospective multinational case series. Blood. 1-13. doi:10.1182/blood.2024024524.$3$MON$$M$Y$$$20240806$$MD$IT$IT
241800211$24180021$1$I$$20240729$20240806$20240806$PER$$US-ABBVIE-5860163$ABBVIE$$$$$$Y$$$20240806$$HP$US$US
241800221$24180022$1$I$20240724$20240731$20240806$20240806$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004286$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240806$$HP$CA$CA
241800231$24180023$1$I$$20240731$20240806$20240806$EXP$$NVSC2024AU158424$NOVARTIS$$25$YR$$F$Y$$$20240806$$MD$AU$AU
241800242$24180024$2$F$$20240802$20240806$20240809$PER$$US-Calliditas-2024CAL01353$CALLIDITAS THERAPEUTICS$$62$YR$A$M$Y$85.7$KG$20240809$$CN$US$US
241800251$24180025$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123609$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$111.13$KG$20240806$$CN$US$US
241800261$24180026$1$I$$20211227$20240806$20240806$EXP$$NL-BIOVITRUM-2022NL00043$BIOVITRUM$$$$I$M$Y$7.5$KG$20240806$$HP$NL$NL
241800272$24180027$2$F$$20240806$20240806$20240821$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001184$AKEBIA THERAPEUTICS$Imai, Enyu; Imai, Atsuhiro. The Comparison between Vadadustat and Daprodustat Regarding Dose, Cost, and Safety of Treatment for Renal Anemia in Non-dialysis Patients with Chronic Kidney Diseases. Internal medicine. 2024;13:1855-1861$$$$$Y$$$20240821$$HP$JP$JP
241800281$24180028$1$I$20240801$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154680$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241800291$24180029$1$I$$20240729$20240806$20240806$EXP$$NVSC2024BR158141$NOVARTIS$Oliveira VF, Silva GDD, Silva LT, Goncalves VL, Rivas PE, Marques AC et al.. Histoplasmosis in a fingolimod-treated patient: case report and scoping review. JOURNAL OF THE SAO PAULO INSTITUTE OF TROPICAL MEDICINE. 2024;66:e39:1-4$30$YR$$F$Y$$$20240806$$HP$BR$BR
241800301$24180030$1$I$$20220114$20240806$20240806$EXP$$NL-BIOVITRUM-2022NL01065$BIOVITRUM$$$$I$F$Y$5.4$KG$20240806$$HP$NL$NL
241800311$24180031$1$I$20240802$20240805$20240806$20240806$EXP$$CN-PFIZER INC-PV202400101867$PFIZER$$73$YR$$M$Y$$$20240806$$HP$CN$CN
241800331$24180033$1$I$20240209$20240730$20240806$20240806$EXP$FR-AFSSAPS-LM2024000159$FR-PFIZER INC-2024SGN04124$PFIZER$$80$YR$$M$Y$59$KG$20240806$$MD$FR$FR
241800341$24180034$1$I$$20240801$20240806$20240806$EXP$$CA-MYLANLABS-2024M1072364$MYLAN$$$$$M$Y$$$20240806$$CN$CA$CA
241800351$24180035$1$I$20240628$20240805$20240806$20240806$EXP$FR-AFSSAPS-ST2024001242$FR-FreseniusKabi-FK202412161$FRESENIUS KABI$$73$YR$E$F$Y$80$KG$20240806$$PH$FR$FR
241800361$24180036$1$I$$20240731$20240806$20240806$EXP$$US-FreseniusKabi-FK202412107$FRESENIUS KABI$Stewart MA, Rives TA, Blanton K, Baldwin L. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecologic Oncology Reports. 2024 Aug;54: 1-3. doi:https://doi.org/10.1016/j.gore.2024.101452.$33$YR$A$F$Y$$$20240806$$HP$US$US
241800372$24180037$2$F$$20240808$20240806$20240812$EXP$$US-JNJFOC-20240808234$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240812$$HP$US$US
241800384$24180038$4$F$$20240902$20240806$20240913$30DAY$$DE-JNJFOC-20240771334$JOHNSON AND JOHNSON$$61$YR$A$M$Y$83$KG$20240913$$HP$DE$DE
241800391$24180039$1$I$$20240723$20240806$20240806$EXP$$KZ-ROCHE-10000045965$ROCHE$Kylyshbekova G, Kalmenova G, Bekmuratova J, Uskhanova B. A rare case of congenital enteropathy caused by mutations in the NEUROG3 gene. Clinical Medicine And Pharmacology. 2024-May-30;3 (254):207-12. doi:10.53511/pharmkaz.2024.39.14.024.$$$N$M$Y$4.02$KG$20240806$$HP$KZ$KZ
241800401$24180040$1$I$20240729$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A173330$ASTRAZENECA$$22098$DY$$F$Y$$$20240806$$CN$US$
241800412$24180041$2$F$20240420$20240802$20240806$20240816$EXP$FR-AFSSAPS-AM2024000601$FR-MYLANLABS-2024M1072182$MYLAN$$70$YR$$M$Y$80$KG$20240816$$MD$FR$FR
241800421$24180042$1$I$$20240731$20240806$20240806$EXP$$US-AstraZeneca-2024A174548$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241800431$24180043$1$I$$20240801$20240806$20240806$EXP$$FR-AstraZeneca-2024A176701$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$FR$
241800442$24180044$2$F$20221201$20240802$20240806$20240808$EXP$$DE-AstraZeneca-2024A173773$ASTRAZENECA$$$$E$F$Y$71$KG$20240808$$MD$DE$
241800451$24180045$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001084$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240806$$CN$US$US
241800461$24180046$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002145$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240806$$CN$US$US
241800471$24180047$1$I$20240804$20240805$20240805$20240805$DIR$712982$$FDA-CTU$$37$YR$$F$N$103$KG$20240805$N$CN$AE$
241800481$24180048$1$I$20240802$20240805$20240805$20240805$DIR$713017$$FDA-CTU$$67$YR$$F$N$75.6$KG$20240805$N$$US$
241800491$24180049$1$I$20240801$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001351$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240806$$CN$US$US
241800501$24180050$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002147$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240806$$CN$US$US
241800521$24180052$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-53951$$FDA-CTU$$54$YR$$F$N$$$20240806$N$$US$
241800531$24180053$1$I$20240728$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-54009$$FDA-CTU$$49$YR$$F$N$$$20240805$N$HP$US$
241800551$24180055$1$I$20240802$20240805$20240805$20240805$DIR$713011$$FDA-CTU$$42$YR$$F$N$90$KG$20240805$N$CN$US$
241800561$24180056$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54038$$FDA-CTU$$53$YR$$F$N$$$20240806$N$$US$
241800571$24180057$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54007$$FDA-CTU$$67$YR$$F$N$$$20240806$N$$US$
241800581$24180058$1$I$20240708$20240725$20240806$20240806$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000710$PAREXEL$$$$$$Y$$$20240806$$HP$CN$CN
241800591$24180059$1$I$20230828$20240729$20240806$20240806$EXP$$JP-OTSUKA-2024_021038$OTSUKA$$$$E$F$Y$48$KG$20240806$$MD$JP$JP
241800604$24180060$4$F$20240802$20240911$20240806$20240919$30DAY$$US-JNJFOC-20240807213$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240919$$HP$US$US
241800612$24180061$2$F$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683120$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241800621$24180062$1$I$20240731$20240731$20240806$20240806$EXP$$US-OTSUKA-2024_021285$OTSUKA$$$$$F$Y$$$20240806$$CN$US$US
241800631$24180063$1$I$$20240802$20240806$20240806$EXP$$US-OTSUKA-2024_021507$OTSUKA$$$$$F$Y$$$20240806$$HP$US$US
241800641$24180064$1$I$20240730$20240801$20240806$20240806$PER$$US-SA-2024SA229625$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240806$$CN$US$US
241800651$24180065$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA229693$SANOFI AVENTIS$$48$YR$A$F$Y$76.2$KG$20240806$$MD$US$US
241800661$24180066$1$I$20240701$20240729$20240806$20240806$PER$$US-SA-2024SA225292$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240806$$MD$US$US
241800672$24180067$2$F$$20240903$20240806$20240912$PER$$US-SA-2024SA227156$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240912$$MD$US$US
241800681$24180068$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA227184$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240806$$MD$US$US
241800691$24180069$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA227970$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$CN$US$US
241800701$24180070$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA225304$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$HP$US$US
241800711$24180071$1$I$20240701$20240730$20240806$20240806$PER$$US-SA-2024SA229702$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240806$$MD$US$US
241800721$24180072$1$I$20240803$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-53866$$FDA-CTU$$$$$M$N$94.9$KG$20240805$N$$US$
241800732$24180073$2$F$$20240806$20240806$20240821$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001183$AKEBIA THERAPEUTICS$Imai, Enyu; Imai, Atsuhiro. The Comparison between Vadadustat and Daprodustat Regarding Dose, Cost, and Safety of Treatment for Renal Anemia in Non-dialysis Patients with Chronic Kidney Diseases. Internal medicine. 2024;13:1855-1861$$$$$Y$$$20240821$$HP$JP$JP
241800741$24180074$1$I$20240301$20240730$20240806$20240806$EXP$$US-SA-2024SA229528$SANOFI AVENTIS$$54$YR$A$M$Y$111$KG$20240806$$MD$US$US
241800751$24180075$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54042$$FDA-CTU$$71$YR$$M$N$$$20240806$N$$US$
241800761$24180076$1$I$20240731$20240731$20240806$20240806$PER$$US-ALXN-202407USA002268US$ALEXION PHARMACEUTICALS$$35$YR$$F$Y$$$20240806$$CN$US$US
241800771$24180077$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154964$AMGEN$$$$A$M$Y$$$20240806$$CN$US$US
241800781$24180078$1$I$20240401$20240426$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000164$Tarsus Pharmaceuticals$$67$YR$$F$Y$$$20240806$$CN$US$US
241800791$24180079$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54033$$FDA-CTU$$70$YR$$M$N$$$20240806$N$$US$
241800801$24180080$1$I$20240315$20240708$20240806$20240806$DIR$FDA-CDER-CTU-2024-53869$$FDA-CTU$$36$YR$$M$N$83.3$KG$20240708$N$$US$
241800811$24180081$1$I$20240705$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-53867$$FDA-CTU$$$$$M$N$103.6$KG$20240805$N$$US$
241800821$24180082$1$I$20240101$20240522$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000159$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$CN$US$US
241800831$24180083$1$I$20240401$20240426$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000162$Tarsus Pharmaceuticals$$$$E$M$Y$$$20240806$$MD$US$US
241800841$24180084$1$I$$20240424$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000158$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$CN$US$US
241800851$24180085$1$I$$20240426$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000163$Tarsus Pharmaceuticals$$$$$M$Y$$$20240806$$CN$US$US
241800861$24180086$1$I$$20240425$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000165$Tarsus Pharmaceuticals$$$$$M$Y$$$20240806$$CN$US$US
241800871$24180087$1$I$$20240424$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000160$Tarsus Pharmaceuticals$$$$$M$Y$$$20240806$$MD$US$US
241800881$24180088$1$I$$20240503$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000161$Tarsus Pharmaceuticals$$36$YR$$F$Y$$$20240806$$PH$US$US
241800891$24180089$1$I$$20240427$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000166$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$CN$US$US
241800901$24180090$1$I$$20240424$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000156$Tarsus Pharmaceuticals$$57$YR$$F$Y$$$20240806$$PH$US$US
241800911$24180091$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA229899$SANOFI AVENTIS$$$$I$F$Y$$$20240806$$MD$US$US
241800921$24180092$1$I$20240501$20240730$20240806$20240806$PER$$US-SA-2024SA230633$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240806$$MD$US$US
241800931$24180093$1$I$20240601$20240730$20240806$20240806$PER$$US-SA-2024SA227146$SANOFI AVENTIS$$$$$$Y$$$20240806$$MD$US$US
241800941$24180094$1$I$20240101$20240801$20240806$20240806$EXP$$US-SA-2024SA231378$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240806$$MD$US$US
241800951$24180095$1$I$20240527$20240724$20240806$20240806$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000709$PAREXEL$$$$$$Y$$$20240806$$HP$CN$CN
241800961$24180096$1$I$20240726$20240801$20240806$20240806$EXP$$CN-SA-2024SA231112$SANOFI AVENTIS$$63$YR$A$M$Y$47$KG$20240806$$HP$CN$CN
241800971$24180097$1$I$20240717$20240726$20240806$20240806$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000701$PAREXEL$$$$$$Y$$$20240806$$HP$CN$CN
241800981$24180098$1$I$20240313$20240726$20240806$20240806$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000711$PAREXEL$$$$$$Y$$$20240806$$HP$CN$CN
241800992$24180099$2$F$20240101$20240819$20240806$20240827$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00273$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
241801011$24180101$1$I$$20240729$20240806$20240806$EXP$$US-ROCHE-10000046967$ROCHE$$53$YR$A$M$Y$$$20240806$$MD$US$US
241801021$24180102$1$I$20240802$20240805$20240806$20240806$PER$$US-ABBVIE-5868144$ABBVIE$$$$$F$Y$$$20240806$$MD$US$US
241801031$24180103$1$I$$20240729$20240806$20240806$EXP$$US-JNJFOC-20240780559$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$CN$US$US
241801041$24180104$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-53986$$FDA-CTU$$66$YR$$F$N$$$20240806$N$$US$
241801051$24180105$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54035$$FDA-CTU$$80$YR$$F$N$125$LBS$20240806$N$$US$
241801061$24180106$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54044$$FDA-CTU$$60$YR$$F$N$229$LBS$20240806$N$$US$
241801071$24180107$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-53950$$FDA-CTU$$$$$F$N$108.18$KG$20240806$N$MD$US$
241801091$24180109$1$I$$20240805$20240806$20240806$EXP$$US-ORGANON-O2408USA000371$ORGANON$$$$$F$Y$$$20240806$$CN$US$US
241801101$24180110$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124259$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240806$$CN$US$US
241801111$24180111$1$I$$20240726$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120622$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240806$$CN$US$US
241801121$24180112$1$I$$20240801$20240806$20240806$EXP$$CA-MYLANLABS-2024M1072304$MYLAN$$$$$$Y$$$20240806$$CN$CA$CA
241801131$24180113$1$I$$20240507$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000188$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$CN$US$US
241801141$24180114$1$I$$20240501$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000179$Tarsus Pharmaceuticals$$$$$$Y$$$20240806$$MD$US$US
241801151$24180115$1$I$$20240507$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000185$Tarsus Pharmaceuticals$$4$DEC$$F$Y$$$20240806$$MD$US$US
241801161$24180116$1$I$20211119$20240729$20240806$20240806$EXP$$CN-ASTELLAS-2024US021817$ASTELLAS$$26$YR$$F$Y$$$20240806$$HP$CN$CN
241801171$24180117$1$I$20240229$20240530$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000182$Tarsus Pharmaceuticals$$54$YR$$F$Y$$$20240806$$MD$US$US
241801181$24180118$1$I$$20240507$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000186$Tarsus Pharmaceuticals$$$$A$F$Y$$$20240806$$MD$US$US
241801191$24180119$1$I$$20240503$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000181$Tarsus Pharmaceuticals$$$$$$Y$$$20240806$$PH$US$US
241801201$24180120$1$I$$20240429$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000170$Tarsus Pharmaceuticals$$$$$$Y$$$20240806$$MD$US$US
241801211$24180121$1$I$$20240429$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000168$Tarsus Pharmaceuticals$$$$$$Y$$$20240806$$MD$US$US
241801221$24180122$1$I$$20240429$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000173$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$CN$US$US
241801231$24180123$1$I$$20240430$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000176$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$MD$US$US
241801241$24180124$1$I$$20240429$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000175$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$MD$US$US
241801251$24180125$1$I$$20240427$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000184$Tarsus Pharmaceuticals$$$$$$Y$$$20240806$$MD$US$US
241801261$24180126$1$I$$20240430$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000174$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$PH$US$US
241801271$24180127$1$I$20240101$20240429$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000167$Tarsus Pharmaceuticals$$72$YR$$F$Y$$$20240806$$PH$US$US
241801281$24180128$1$I$20240401$20240429$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000172$Tarsus Pharmaceuticals$$86$YR$$F$Y$$$20240806$$CN$US$US
241801291$24180129$1$I$$20240502$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000183$Tarsus Pharmaceuticals$$$$$M$Y$$$20240806$$CN$US$US
241801301$24180130$1$I$$20240507$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000187$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$MD$US$US
241801311$24180131$1$I$$20240429$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000169$Tarsus Pharmaceuticals$$$$$$Y$$$20240806$$MD$US$US
241801321$24180132$1$I$$20240501$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000180$Tarsus Pharmaceuticals$$$$$$Y$$$20240806$$MD$US$US
241801331$24180133$1$I$$20240729$20240806$20240806$EXP$$US-TAKEDA-2024TUS076406$TAKEDA$$$$$F$Y$$$20240806$$MD$US$US
241801342$24180134$2$F$$20240822$20240806$20240822$PER$$US-ALXN-202407USA002257US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
241801351$24180135$1$I$$20240507$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000189$Tarsus Pharmaceuticals$$$$$M$Y$$$20240806$$CN$US$US
241801361$24180136$1$I$20240424$20240429$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000171$Tarsus Pharmaceuticals$$82$YR$$F$Y$$$20240806$$PH$US$US
241801371$24180137$1$I$20231127$20231207$20240806$20240806$EXP$$SG-SANDOZ INC.-SDZ2023SG068298$SANDOZ$$$$$$Y$$$20240806$$HP$SG$SG
241801381$24180138$1$I$$20240724$20240806$20240806$PER$$US-Calliditas-2024CAL01405$CALLIDITAS THERAPEUTICS$$$$$$Y$$$20240806$$MD$US$US
241801391$24180139$1$I$$20240729$20240806$20240806$PER$$US-ABBVIE-5860368$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241801401$24180140$1$I$$20240315$20240806$20240806$EXP$$GB-SANDOZ INC.-SDZ2024GB030461$SANDOZ$$$$$$Y$$$20240806$$PH$GB$GB
241801411$24180141$1$I$20240101$20240730$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121482$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240806$$HP$US$US
241801421$24180142$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123256$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240806$$CN$US$US
241801431$24180143$1$I$$20230918$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA033936$SANDOZ$$$$$$Y$$$20240806$$HP$CA$CA
241801441$24180144$1$I$$20240805$20240806$20240806$PER$$US-ABBVIE-5868464$ABBVIE$$$$$$Y$$$20240806$$HP$US$US
241801451$24180145$1$I$$20240805$20240806$20240806$PER$$US-GILEAD-2024-0683096$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241801461$24180146$1$I$$20240730$20240806$20240806$EXP$$NVSC2024IN158882$NOVARTIS$$$$$M$Y$$$20240806$$CN$IN$IN
241801471$24180147$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190534$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241801482$24180148$2$F$$20240821$20240806$20240827$PER$$US-PFIZER INC-202400228344$PFIZER$$72$YR$$F$Y$93.44$KG$20240827$$PH$US$US
241801491$24180149$1$I$20240731$20240802$20240806$20240806$PER$$US-PFIZER INC-202400229129$PFIZER$$59$YR$$M$Y$$$20240806$$CN$US$US
241801512$24180151$2$F$$20240808$20240806$20240816$EXP$$JP-ARGENX-2024-ARGX-JP006040$ARGENX BVBA$$$$$$Y$$$20240816$$PH$JP$JP
241801521$24180152$1$I$20240707$20240802$20240806$20240806$EXP$FR-AFSSAPS-BX2024001538$FR-GSK-FR2024096829$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$MD$FR$FR
241801531$24180153$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190605$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241801541$24180154$1$I$$20240805$20240806$20240806$EXP$$CN-TAKEDA-2024TUS078629$TAKEDA$$$$$F$Y$$$20240806$$CN$CN$CN
241801551$24180155$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024155169$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241801563$24180156$3$F$20240801$20240909$20240806$20240916$30DAY$$US-JNJFOC-20240807206$JOHNSON AND JOHNSON$$27$YR$A$M$Y$75$KG$20240916$$PH$US$US
241801571$24180157$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA230072$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240806$$MD$US$US
241801584$24180158$4$F$$20240902$20240806$20240913$30DAY$$BR-JNJFOC-20240765286$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$BR$BR
241801591$24180159$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA227003$SANOFI AVENTIS$$46$YR$A$M$Y$108.84$KG$20240806$$MD$US$US
241801601$24180160$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA226182$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240806$$MD$US$US
241801611$24180161$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121802$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240806$$CN$US$US
241801621$24180162$1$I$$20231121$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA057286$SANDOZ$$$$$$Y$$$20240806$$HP$CA$CA
241801631$24180163$1$I$20240101$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121118$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240806$$CN$US$US
241801642$24180164$2$F$$20240812$20240806$20240819$EXP$$NVSC2020CO048631$NOVARTIS$$$$$F$Y$68$KG$20240819$$CN$CO$CO
241801671$24180167$1$I$$20240802$20240806$20240806$EXP$$GB-MYLANLABS-2024M1072582$MYLAN$$$$$M$Y$$$20240806$$MD$GB$GB
241801681$24180168$1$I$20240731$20240731$20240806$20240806$PER$$JP-Eisai-EC-2024-171367$EISAI$$76$YR$E$F$Y$65$KG$20240806$$MD$JP$JP
241801691$24180169$1$I$20240201$20240729$20240806$20240806$EXP$$MX-AstraZeneca-2024A173605$ASTRAZENECA$$45$MON$$M$Y$23$KG$20240806$$CN$MX$
241801701$24180170$1$I$20240721$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A175479$ASTRAZENECA$$24583$DY$$F$Y$$$20240806$$HP$US$
241801711$24180171$1$I$$20240802$20240806$20240806$EXP$$PT-AstraZeneca-2024A177551$ASTRAZENECA$$$$$M$Y$$$20240806$$MD$PT$
241801721$24180172$1$I$20240729$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A173177$ASTRAZENECA$$62$YR$$F$Y$$$20240806$$CN$US$
241801731$24180173$1$I$20240405$20240731$20240806$20240806$EXP$$GB-AstraZeneca-2024A174305$ASTRAZENECA$$90$YR$$F$Y$66$KG$20240806$$MD$GB$
241801742$24180174$2$F$20240804$20240806$20240806$20240808$PER$$US-AMGEN-USASP2024155964$AMGEN$$52$YR$A$M$Y$$$20240808$$CN$US$US
241801751$24180175$1$I$$20240725$20240806$20240806$EXP$$US-AstraZeneca-2024A172676$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241801761$24180176$1$I$$20240729$20240806$20240806$EXP$$JP-AstraZeneca-2024A175741$ASTRAZENECA$$93$YR$$F$Y$$$20240806$$PH$JP$
241801771$24180177$1$I$20240723$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A176698$ASTRAZENECA$$26877$DY$$M$Y$$$20240806$$CN$US$
241801791$24180179$1$I$$20240729$20240806$20240806$EXP$$CN-AstraZeneca-2024A174246$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$CN$
241801801$24180180$1$I$$20240731$20240806$20240806$EXP$$US-AMGEN-USASP2024153032$AMGEN$Fatima R.; Altorok N.. Secukinumab-Induced Bullous Pemphigoid in a Patient With Psoriatic Arthritis. American Journal of Therapeutics. 2023;31 (4):e434-e435$62$YR$A$M$Y$$$20240806$$MD$US$US
241801812$24180181$2$F$$20240807$20240806$20240809$PER$$US-AMGEN-USASP2024154561$AMGEN$$$$$M$Y$$$20240809$$HP$US$US
241801821$24180182$1$I$$20240731$20240806$20240806$EXP$$NVSC2024ES157563$NOVARTIS$$84$YR$$F$Y$$$20240806$$CN$ES$ES
241801831$24180183$1$I$20160101$20240801$20240806$20240806$EXP$$NVSC2024CO159255$NOVARTIS$$$$$F$Y$$$20240806$$CN$CO$CO
241801842$24180184$2$F$$20240805$20240806$20240807$PER$$NVSC2024US159207$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
241801851$24180185$1$I$20240730$20240731$20240806$20240806$PER$$US-ALXN-202407USA002270US$ALEXION PHARMACEUTICALS$$38$YR$$F$Y$$$20240806$$CN$US$US
241801861$24180186$1$I$$20240517$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000207$Tarsus Pharmaceuticals$$63$YR$$F$Y$$$20240806$$CN$US$US
241801871$24180187$1$I$$20240621$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000204$Tarsus Pharmaceuticals$$25$YR$$M$Y$$$20240806$$CN$US$US
241801881$24180188$1$I$20240509$20240510$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000194$Tarsus Pharmaceuticals$$64$YR$$F$Y$$$20240806$$PH$US$US
241801891$24180189$1$I$$20240520$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000206$Tarsus Pharmaceuticals$$15$YR$$F$Y$$$20240806$$PH$US$US
241801901$24180190$1$I$$20240515$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000198$Tarsus Pharmaceuticals$$60$YR$$F$Y$$$20240806$$MD$US$US
241801911$24180191$1$I$20240516$20240528$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000200$Tarsus Pharmaceuticals$$77$YR$$F$Y$$$20240806$$PH$US$US
241801931$24180193$1$I$$20240606$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000196$Tarsus Pharmaceuticals$$73$YR$$F$Y$$$20240806$$PH$US$US
241801941$24180194$1$I$20240504$20240604$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000195$Tarsus Pharmaceuticals$$65$YR$$F$Y$$$20240806$$CN$US$US
241801951$24180195$1$I$20240503$20240507$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000190$Tarsus Pharmaceuticals$$76$YR$$F$Y$$$20240806$$CN$US$US
241801961$24180196$1$I$20240516$20240517$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000202$Tarsus Pharmaceuticals$$74$YR$$M$Y$$$20240806$$MD$US$US
241801971$24180197$1$I$20240501$20240520$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000208$Tarsus Pharmaceuticals$$60$YR$$F$Y$$$20240806$$PH$US$US
241801981$24180198$1$I$20240621$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-53995$$FDA-CTU$$64$YR$$M$N$$$20240805$N$HP$US$
241801991$24180199$1$I$20240501$20240517$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000201$Tarsus Pharmaceuticals$$86$YR$$F$Y$$$20240806$$PH$US$US
241802001$24180200$1$I$20231229$20240528$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000199$Tarsus Pharmaceuticals$$77$YR$$F$Y$$$20240806$$PH$US$US
241802011$24180201$1$I$$20240520$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000191$Tarsus Pharmaceuticals$$81$YR$$M$Y$$$20240806$$PH$US$US
241802021$24180202$1$I$20240508$20240508$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000193$Tarsus Pharmaceuticals$$77$YR$$F$Y$$$20240806$$CN$US$US
241802031$24180203$1$I$$20240508$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000192$Tarsus Pharmaceuticals$$42$YR$$M$Y$$$20240806$$PH$US$US
241802051$24180205$1$I$20240501$20240514$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000197$Tarsus Pharmaceuticals$$74$YR$$F$Y$$$20240806$$PH$US$US
241802061$24180206$1$I$20240802$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154875$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241802071$24180207$1$I$$20240520$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000211$Tarsus Pharmaceuticals$$16$YR$$F$Y$$$20240806$$PH$US$US
241802081$24180208$1$I$$20240731$20240806$20240806$EXP$$CA-TAKEDA-2022TUS079223$TAKEDA$$$$$M$Y$$$20240806$$MD$CA$CA
241802091$24180209$1$I$$20240621$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000210$Tarsus Pharmaceuticals$$$$$M$Y$$$20240806$$PH$US$US
241802101$24180210$1$I$$20240520$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000209$Tarsus Pharmaceuticals$$59$YR$$M$Y$$$20240806$$CN$US$US
241802111$24180211$1$I$$20240521$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000212$Tarsus Pharmaceuticals$$$$$F$Y$$$20240806$$CN$US$US
241802121$24180212$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A176397$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241802133$24180213$3$F$$20240823$20240806$20240902$EXP$$US-ROCHE-10000048201$ROCHE$$31$YR$A$$Y$$$20240902$$CN$US$US
241802141$24180214$1$I$20240101$20240802$20240806$20240806$EXP$$JP-AstraZeneca-2024A176181$ASTRAZENECA$$$$E$$Y$$$20240806$$MD$JP$
241802151$24180215$1$I$20240606$20240805$20240806$20240806$EXP$IT-MINISAL02-997782$NVSC2024IT159158$NOVARTIS$$58$YR$$M$Y$$$20240806$$MD$IT$IT
241802162$24180216$2$F$20240101$20240815$20240806$20240827$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00055$XERIS PHARMACEUTICALS$$73$YR$$F$Y$$$20240823$$CN$US$US
241802171$24180217$1$I$20240802$20240804$20240806$20240806$PER$$US-JNJFOC-20240808813$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240806$$CN$US$US
241802181$24180218$1$I$20230101$20240801$20240806$20240806$PER$$US-JNJFOC-20240804500$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240806$$CN$US$US
241802191$24180219$1$I$$20240711$20240806$20240806$PER$$US-JNJFOC-20240732134$JOHNSON AND JOHNSON$$$$$F$Y$$$20240806$$CN$US$US
241802201$24180220$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA227178$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240806$$MD$US$US
241802221$24180222$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024155200$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241802231$24180223$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229047$SANOFI AVENTIS$$63$YR$A$M$Y$122.47$KG$20240806$$MD$US$US
241802241$24180224$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54047$$FDA-CTU$$82$YR$$F$N$188$LBS$20240806$N$$US$
241802251$24180225$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-53943$$FDA-CTU$$66$YR$$M$N$$$20240806$N$$US$
241802261$24180226$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54003$$FDA-CTU$$53$YR$$F$N$$$20240806$N$$US$
241802271$24180227$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54008$$FDA-CTU$$77$YR$$F$N$86.18$KG$20240806$N$$US$
241802281$24180228$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54036$$FDA-CTU$$78$YR$$F$N$$$20240806$N$$US$
241802291$24180229$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54045$$FDA-CTU$$48$YR$$F$N$$$20240806$N$$US$
241802301$24180230$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54048$$FDA-CTU$$61$YR$$M$N$86.18$KG$20240806$N$$US$
241802313$24180231$3$F$20240101$20240821$20240806$20240924$PER$$US-Eisai-EC-2024-170390$EISAI$$83$YR$E$F$Y$82.1$KG$20240924$$CN$US$US
241802321$24180232$1$I$20240101$20240628$20240806$20240806$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000205$Tarsus Pharmaceuticals$$$$$M$Y$$$20240806$$CN$US$US
241802331$24180233$1$I$$20240724$20240806$20240806$EXP$$RU-GLENMARK PHARMACEUTICALS-2024GMK092553$GLENMARK$Soldatova OV, Goryanskaya IY, Namazova LE,  Muhtarov OY.. Myocarditis associated with COVID-19: Review of a fatal case report.. Archives of internal medicine. 2024;14 (3):221-227$$$$$Y$$$20240806$$HP$RU$RU
241802341$24180234$1$I$20240101$20240726$20240806$20240806$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00119$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240802$$CN$US$US
241802351$24180235$1$I$20240607$20240801$20240806$20240806$EXP$FR-AFSSAPS-LY2024000956$FR-RDY-SPO/FRA/24/0011343$DR REDDYS$$66$YR$A$F$Y$47.6$KG$20240806$$PH$FR$FR
241802362$24180236$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0683129$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241802371$24180237$1$I$20240101$20240731$20240806$20240806$EXP$$US-SA-2024SA230604$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240806$$MD$US$US
241802381$24180238$1$I$$20240730$20240806$20240806$EXP$BE-FAMHP-DHH-N2024-122427$BE-SA-2024SA225758$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240806$$PH$BE$BE
241802391$24180239$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54050$$FDA-CTU$$62$YR$$F$N$$$20240806$N$$US$
241802401$24180240$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54024$$FDA-CTU$$71$YR$$F$N$$$20240806$N$$US$
241802411$24180241$1$I$20240805$20240805$20240806$20240806$PER$$US-JNJFOC-20240813262$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$HP$US$US
241802422$24180242$2$F$$20240727$20240806$20240814$EXP$$JP-009507513-2407JPN005039J$MERCK$Koyama S, Miura T, Nunomura Y, Sakamoto H, Shiratori T, Ishioka Y, et al.. 2-4. A Case of NUT Lung Cancer in a Young Female which Rapidly Reached Outcome. The 63rd Tohoku Branch Meeting of the Japan Lung Cancer Society and the 50th Toh. 16$31$YR$$F$Y$$$20240814$$MD$JP$JP
241802433$24180243$3$F$20240726$20240910$20240806$20240913$PER$$US-ROCHE-10000041406$ROCHE$$80$YR$E$M$Y$85.27$KG$20240913$$CN$US$US
241802441$24180244$1$I$$20240729$20240806$20240806$PER$$US-JNJFOC-20240779760$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241802453$24180245$3$F$$20240816$20240806$20240821$PER$$US-ROCHE-10000047984$ROCHE$$$$T$F$Y$$$20240821$$CN$US$US
241802461$24180246$1$I$20240725$20240726$20240806$20240806$PER$$US-ROCHE-10000042214$ROCHE$$$$$F$Y$$$20240806$$HP$US$US
241802473$24180247$3$F$$20240801$20240806$20240814$EXP$$NVSC2024US158595$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
241802492$24180249$2$F$$20240805$20240806$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002647$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240807$$CN$US$US
241802501$24180250$1$I$$20240730$20240806$20240806$PER$$US-ROCHE-10000044847$ROCHE$$$$A$F$Y$$$20240806$$CN$US$US
241802515$24180251$5$F$20240124$20240828$20240806$20240830$PER$$US-ROCHE-10000048202$ROCHE$$$$$F$Y$$$20240830$$CN$US$US
241802524$24180252$4$F$20240729$20240904$20240806$20240910$PER$$US-ROCHE-10000048556$ROCHE$$77$YR$E$M$Y$$$20240911$$CN$US$US
241802531$24180253$1$I$$20240730$20240806$20240806$30DAY$$US-GSK-US2024095382$GLAXOSMITHKLINE$$$$E$F$Y$$$20240806$$CN$US$US
241802542$24180254$2$F$$20240919$20240806$20240926$PER$$US-MYLANLABS-2024M1071943$MYLAN$$$$$$Y$$$20240926$$CN$US$US
241802551$24180255$1$I$20240707$20240802$20240806$20240806$EXP$FR-AFSSAPS-PP2024000835$FR-MYLANLABS-2024M1072276$MYLAN$$76$YR$$F$Y$41$KG$20240806$$MD$FR$FR
241802563$24180256$3$F$$20240920$20240806$20240926$EXP$$US-TAKEDA-2024TUS074639$TAKEDA$$$$$F$Y$$$20240926$$CN$US$US
241802574$24180257$4$F$20240701$20240904$20240806$20240912$EXP$$US-009507513-2408USA001146$MERCK$$1$DY$$$Y$5.215$KG$20240912$$HP$US$US
241802581$24180258$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190586$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241802591$24180259$1$I$$20240725$20240806$20240806$PER$$US-AMGEN-USASP2024153459$AMGEN$Cowen E.W.; Tan I.J.; Ferrada M.A. et al.. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatology. 2024;E1-E8$$$$$Y$$$20240806$$MD$US$US
241802601$24180260$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024154080$AMGEN$Boyce R. M.; Iyamu O. I.; Ciccone E. J. et al.. Neurological manifestations of ehrlichiosis among a cohort of patients: prevalence and clinical symptoms. BMC Infectious Diseases. 2024;24(1):1-9$42$YR$A$M$Y$$$20240806$$HP$US$US
241802612$24180261$2$F$20240802$20240905$20240806$20240925$PER$$US-JNJFOC-20240807503$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240925$$MD$US$US
241802621$24180262$1$I$20240101$20240805$20240806$20240806$PER$$US-JNJFOC-20240809251$JOHNSON AND JOHNSON$$90$YR$E$M$Y$$$20240806$$CN$US$US
241802631$24180263$1$I$20240725$20240801$20240806$20240806$EXP$$CN-SA-2024SA231764$SANOFI AVENTIS$$47$YR$A$F$Y$45$KG$20240806$$HP$CN$CN
241802642$24180264$2$F$20240731$20240902$20240806$20240904$PER$$US-ROCHE-10000048191$ROCHE$$$$$$Y$$$20240904$$CN$US$US
241802651$24180265$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA225308$SANOFI AVENTIS$$$$E$M$Y$$$20240806$$CN$US$US
241802661$24180266$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA225386$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$CN$US$US
241802671$24180267$1$I$20240801$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124015$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240806$$CN$US$US
241802681$24180268$1$I$20240501$20240729$20240806$20240806$PER$$US-SA-2024SA225836$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240806$$MD$US$US
241802691$24180269$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123451$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$82.1$KG$20240806$$PH$US$US
241802703$24180270$3$F$20240730$20240809$20240806$20240820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121001$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240820$$PH$JP$JP
241802711$24180271$1$I$$20240802$20240806$20240806$EXP$$GB-MYLANLABS-2024M1072524$MYLAN$$$$$F$Y$$$20240806$$HP$GB$GB
241802731$24180273$1$I$$20240802$20240806$20240806$PER$$US-ROCHE-10000048606$ROCHE$$$$A$F$Y$$$20240806$$CN$US$US
241802744$24180274$4$F$$20240925$20240806$20240930$PER$$US-ROCHE-10000049388$ROCHE$$$$E$F$Y$180$KG$20240930$$CN$US$US
241802751$24180275$1$I$20240101$20240802$20240806$20240806$EXP$$JP-AstraZeneca-2024A176211$ASTRAZENECA$$$$E$F$Y$$$20240806$$MD$JP$
241802761$24180276$1$I$$20240805$20240806$20240806$PER$$US-ROCHE-10000049860$ROCHE$$$$E$F$Y$$$20240806$$HP$US$US
241802771$24180277$1$I$$20240729$20240806$20240806$EXP$$CR-AstraZeneca-2024A173623$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$CR$
241802781$24180278$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A176798$ASTRAZENECA$$$$$M$Y$96.2$KG$20240806$$CN$US$
241802791$24180279$1$I$$20230330$20240806$20240806$EXP$$US-AstraZeneca-2023A076054$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241802802$24180280$2$F$20240101$20240725$20240806$20240806$EXP$$CL-BIOMARINAP-CL-2024-159623$BIOMARIN$$$$$$Y$$$20240806$$CN$US$CL
241802812$24180281$2$F$$20240730$20240806$20240807$EXP$$US-AstraZeneca-2024A176944$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241802822$24180282$2$F$20240401$20240917$20240806$20240918$EXP$$RO-AstraZeneca-2024A176242$ASTRAZENECA$$20480$DY$$F$Y$72$KG$20240918$$MD$RO$
241802831$24180283$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A172761$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241802841$24180284$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A172802$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241802851$24180285$1$I$$20240729$20240806$20240806$EXP$$PT-AstraZeneca-2024A171653$ASTRAZENECA$Aparicio D, Mendes LML, Marques R, Nascimento E. Dapaglifozin and Guillain-Barre - trick or treat.. Congresses of the Portuguese Society of Internal Medicine 2024;851.$75$YR$$F$Y$$$20240806$$MD$PT$
241802861$24180286$1$I$20240523$20240801$20240806$20240806$PER$$US-AstraZeneca-2024A175649$ASTRAZENECA$$12$YR$$M$Y$$$20240806$$HP$US$
241802871$24180287$1$I$$20240729$20240806$20240806$EXP$$US-GSK-US2024094816$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$US$US
241802881$24180288$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A172969$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241802891$24180289$1$I$$20240730$20240806$20240806$EXP$$CA-AMGEN-CANSP2024151655$AMGEN$$78$YR$E$F$Y$61$KG$20240806$$HP$CA$CA
241802901$24180290$1$I$$20240729$20240806$20240806$EXP$$US-AMGEN-USASP2024150645$AMGEN$Gong Y. Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma. International Journal of Molecular Sciences. 2024;25(14):1-15$$$$$Y$$$20240806$$HP$US$US
241802911$24180291$1$I$$20240805$20240806$20240806$EXP$GB-MHRA-MED-202408051005127000-JCLST$GB-MYLANLABS-2024M1073057$MYLAN$$34$YR$$M$Y$$$20240806$$CN$GB$GB
241802921$24180292$1$I$$20240430$20240806$20240806$PER$$US-IMMUNOCORE, LTD-2024-IMC-002581$IMMUNOCORE$$$$$$Y$$$20240806$$PH$US$US
241802931$24180293$1$I$$20240805$20240806$20240806$EXP$$DE-BAUSCH-BL-2024-011914$BAUSCH AND LOMB$$$$$M$Y$$$20240806$$CN$DE$DE
241802941$24180294$1$I$$20240710$20240806$20240806$PER$$US-IMMUNOCORE, LTD-2024-IMC-002842$IMMUNO$$$$$$Y$$$20240806$$HP$US$US
241802951$24180295$1$I$$20240724$20240806$20240806$PER$$US-IMMUNOCORE, LTD-2024-IMC-002894$IMMUNOCORE$$$$$$Y$$$20240806$$MD$US$US
241802961$24180296$1$I$$20240602$20240806$20240806$PER$$US-IMMUNOCORE, LTD-2024-IMC-002706$IMMUNOCORE$$$$A$$Y$$$20240806$$MD$US$US
241802971$24180297$1$I$20240501$20240520$20240806$20240806$PER$$US-IMMUNOCORE, LTD-2024-IMC-002655$IMMUNOCORE$$$$$F$Y$$$20240806$$CN$US$US
241802981$24180298$1$I$$20240613$20240806$20240806$PER$$US-IMMUNOCORE, LTD-2024-IMC-002739$IMMUNOCORE$$$$$M$Y$$$20240806$$HP$US$US
241802991$24180299$1$I$20240627$20240708$20240806$20240806$PER$$US-IMMUNOCORE, LTD-2024-IMC-002822$IMMUNOCORE$$66$YR$$M$Y$$$20240806$$PH$US$US
241803001$24180300$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124300$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240806$$CN$US$US
241803011$24180301$1$I$20240701$20240805$20240806$20240806$PER$$US-JNJFOC-20240811424$JOHNSON AND JOHNSON$$68$YR$E$$Y$$$20240806$$PH$US$US
241803023$24180302$3$F$$20240812$20240806$20240814$EXP$$FR-JNJFOC-20240737662$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$FR$FR
241803031$24180303$1$I$$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-53996$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
241803051$24180305$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54040$$FDA-CTU$$53$YR$$F$N$$$20240806$N$$US$
241803061$24180306$1$I$20240701$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-53994$$FDA-CTU$$70$YR$$M$N$$$20240805$Y$PH$US$
241803071$24180307$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54034$$FDA-CTU$$43$YR$$M$N$$$20240806$N$$US$
241803082$24180308$2$F$20240729$20240822$20240806$20240826$PER$$US-ROCHE-10000044290$ROCHE$$77$YR$E$F$Y$$$20240826$$CN$US$US
241803092$24180309$2$F$20240701$20240805$20240806$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-024090$UNITED THERAPEUTICS$$56$YR$$F$Y$$$20240810$$$US$US
241803103$24180310$3$F$20240515$20240820$20240806$20240828$30DAY$$US-AMGEN-USASP2024152908$AMGEN$$65$YR$E$M$Y$$$20240828$$HP$US$US
241803111$24180311$1$I$20240701$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123405$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240806$$HP$US$US
241803121$24180312$1$I$20240220$20240722$20240806$20240806$EXP$$CH-GSK-CH2024EME092555$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$MD$CH$CH
241803131$24180313$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-109195$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240806$$HP$US$US
241803141$24180314$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123999$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240806$$MD$US$US
241803151$24180315$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124087$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$53.97$KG$20240806$$CN$US$US
241803161$24180316$1$I$20240705$20240805$20240806$20240806$EXP$FR-AFSSAPS-TS2024000877$NVSC2024FR159178$NOVARTIS$$62$YR$$M$Y$70$KG$20240806$$MD$FR$FR
241803172$24180317$2$F$20240101$20240826$20240806$20240910$EXP$$JP-ASTELLAS-2024US021713$ASTELLAS$$9$DEC$E$F$Y$$$20240910$$MD$JP$JP
241803181$24180318$1$I$$20240806$20240806$20240806$PER$$US-HALEON-2190591$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241803191$24180319$1$I$20240301$20240725$20240806$20240806$EXP$$US-ASTELLAS-2024US016479$ASTELLAS$$53$YR$$F$Y$$$20240806$$CN$US$US
241803201$24180320$1$I$20230201$20240730$20240806$20240806$EXP$$CA-BAUSCH-BL-2023-014031$BAUSCH AND LOMB$$42$YR$$F$Y$$$20240806$$CN$CA$CA
241803211$24180321$1$I$20240730$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154674$AMGEN$$58$YR$A$M$Y$$$20240806$$CN$US$US
241803221$24180322$1$I$$20240802$20240806$20240806$PER$$US-ROCHE-10000048289$ROCHE$$$$A$F$Y$$$20240806$$CN$US$US
241803231$24180323$1$I$$20240803$20240806$20240806$PER$$US-ROCHE-10000048859$ROCHE$$$$E$F$Y$$$20240806$$CN$US$US
241803241$24180324$1$I$$20240803$20240806$20240806$PER$$US-ROCHE-10000048804$ROCHE$$68$YR$E$F$Y$$$20240806$$CN$US$US
241803252$24180325$2$F$$20240909$20240806$20240911$PER$$US-ROCHE-10000048515$ROCHE$$79$YR$E$F$Y$$$20240911$$MD$US$US
241803272$24180327$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0683130$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241803281$24180328$1$I$$20240801$20240806$20240806$EXP$$JP-009507513-2408JPN001263$MERCK$Goto E, Hattori A, Fukui M, Matsugana T, Takamochi K, Suzuki K.. Salvage extended surgery after immune?checkpoint inhibitor treatment for advanced non?small cell lung cancer. Surgery Today. 2024;54 (8):917-926$64$YR$$F$Y$$$20240806$$HP$JP$JP
241803292$24180329$2$F$$20240911$20240806$20240920$30DAY$$US-GSK-US2024094853$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
241803301$24180330$1$I$$20240729$20240806$20240806$PER$$US-ABBVIE-5860899$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241803312$24180331$2$F$$20240806$20240806$20240902$PER$$US-ROCHE-10000049917$ROCHE$$53$YR$A$M$Y$$$20240902$$CN$US$US
241803322$24180332$2$F$20240101$20240801$20240806$20240807$EXP$$CA-BAUSCH-BL-2024-011874$BAUSCH AND LOMB$$63$YR$$M$Y$$$20240807$$CN$CA$CA
241803331$24180333$1$I$20240719$20240731$20240806$20240806$EXP$$CN-SA-2024SA231579$SANOFI AVENTIS$$56$YR$A$F$Y$57$KG$20240806$$HP$CN$CN
241803341$24180334$1$I$20240701$20240730$20240806$20240806$PER$$US-SA-2024SA228077$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240806$$MD$US$US
241803351$24180335$1$I$20240101$20240806$20240806$20240806$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044035$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240806$$MD$SK$SK
241803361$24180336$1$I$$20240801$20240806$20240806$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122422$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$45$KG$20240806$$MD$CA$CA
241803371$24180337$1$I$20240729$20240802$20240806$20240806$PER$$US-BIOMARINAP-US-2024-159622$BIOMARIN$$$$$$Y$$$20240806$$CN$US$US
241803381$24180338$1$I$$20240729$20240806$20240806$EXP$$GR-AstraZeneca-2024A176413$ASTRAZENECA$$$$$F$Y$$$20240806$$HP$GR$
241803391$24180339$1$I$$20240801$20240806$20240806$EXP$$PT-AstraZeneca-2024A176046$ASTRAZENECA$Jose S.F; Jorge L; Arsenio S; Lelita S. INTERACTION BETWEEN STATIN AND SGLT-2 INHIBITOR: A CASE REPORT. 22nd European Congress of Internal Medicine (ECIM) - European Federation of Internal Medicine (EFIM)$78$YR$$F$Y$$$20240806$$HP$PT$
241803401$24180340$1$I$$20240729$20240806$20240806$EXP$$RU-AstraZeneca-2024A176349$ASTRAZENECA$$$$$M$Y$$$20240806$$MD$RU$
241803411$24180341$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54025$$FDA-CTU$$46$YR$$F$N$$$20240806$N$$US$
241803421$24180342$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A175798$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241803431$24180343$1$I$$20240725$20240806$20240806$PER$$US-AstraZeneca-2024A170602$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241803441$24180344$1$I$$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A175494$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241803451$24180345$1$I$20240725$20240805$20240805$20240805$DIR$713004$$FDA-CTU$$42$YR$$F$N$74.25$KG$20240805$N$CN$US$
241803461$24180346$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54004$$FDA-CTU$$48$YR$$M$N$105.69$KG$20240806$N$$US$
241803473$24180347$3$F$20240718$20240813$20240806$20240816$EXP$$PL-PFIZER INC-202400228009$PFIZER$$68$YR$$F$Y$69.2$KG$20240816$$MD$PL$PL
241803482$24180348$2$F$20240422$20240826$20240806$20240829$EXP$$FR-PFIZER INC-202400228808$PFIZER$$76$YR$$M$Y$60$KG$20240829$$MD$FR$FR
241803491$24180349$1$I$20240507$20240805$20240806$20240806$EXP$$BE-PFIZER INC-PV202400101712$PFIZER$$74$YR$$M$Y$100$KG$20240806$$MD$BE$BE
241803501$24180350$1$I$20240731$20240801$20240806$20240806$EXP$GB-MHRA-TPP33499941C22675043YC1722417279116$GB-PFIZER INC-202400228248$PFIZER$$52$YR$$F$Y$95$KG$20240806$$MD$GB$GB
241803511$24180351$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002047$ELI LILLY AND CO$$60$YR$A$$Y$$$20240806$$CN$US$US
241803521$24180352$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002042$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240806$$CN$US$US
241803531$24180353$1$I$$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408003037$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240806$$CN$US$US
241803541$24180354$1$I$20240730$20240801$20240806$20240806$EXP$$NVSC2024CN159093$NOVARTIS$$17$YR$$F$Y$47$KG$20240806$$HP$CN$CN
241803562$24180356$2$F$$20240729$20240806$20240808$EXP$$FR-TEVA-VS-3229230$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$85$YR$$F$Y$$$20240808$$HP$FR$FR
241803571$24180357$1$I$20240701$20240801$20240806$20240806$EXP$$US-SA-2024SA231012$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240806$$MD$US$US
241803581$24180358$1$I$20240101$20240801$20240806$20240806$EXP$$US-SA-2024SA231786$SANOFI AVENTIS$$56$YR$A$F$Y$134$KG$20240806$$MD$US$US
241803591$24180359$1$I$20240805$20240805$20240805$20240805$DIR$713020$$FDA-CTU$$38$YR$$F$N$$$20240805$N$PH$US$
241803601$24180360$1$I$20230701$20240729$20240806$20240806$PER$$US-SA-2024SA225279$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240806$$CN$US$US
241803612$24180361$2$F$$20240812$20240806$20240827$PER$$US-SA-2024SA225809$SANOFI AVENTIS$$$$E$M$Y$100.68$KG$20240827$$MD$US$US
241803631$24180363$1$I$20240802$20240805$20240805$20240805$DIR$713035$$FDA-CTU$$40$YR$$M$N$74.79$KG$20240805$N$$US$
241803652$24180365$2$F$20240804$20240812$20240806$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124237$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240813$$CN$US$US
241803661$24180366$1$I$20240701$20240725$20240806$20240806$PER$$US-SA-2024SA225969$SANOFI AVENTIS$$25$YR$A$M$Y$122.46$KG$20240806$$MD$US$US
241803671$24180367$1$I$20240501$20240801$20240806$20240806$EXP$$US-SA-2024SA231803$SANOFI AVENTIS$$86$YR$E$F$Y$55.79$KG$20240806$$MD$US$US
241803681$24180368$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA225348$SANOFI AVENTIS$$$$E$F$Y$$$20240806$$MD$US$US
241803691$24180369$1$I$$20240805$20240805$20240805$DIR$713027$$FDA-CTU$$$$$UNK$N$$$20240805$N$CN$US$
241803701$24180370$1$I$20240701$20240728$20240806$20240806$PER$$US-SA-2024SA226451$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240806$$MD$US$US
241803711$24180371$1$I$20240601$20240729$20240806$20240806$EXP$FR-AFSSAPS-LL2024001360$FR-TEVA-VS-3227652$TEVA$$61$YR$$F$Y$$$20240806$$MD$FR$FR
241803721$24180372$1$I$20240708$20240805$20240806$20240806$EXP$BE-FAMHP-DHH-N2024-122446$BE-JNJFOC-20240809907$JOHNSON AND JOHNSON$$40$YR$A$M$Y$80$KG$20240806$$CN$BE$BE
241803731$24180373$1$I$$20240801$20240806$20240806$EXP$$AU-INDIVIOR US-INDV-146237-2024$RECKITT BENCKISER$$$$$$Y$$$20240806$$HP$AU$AU
241803741$24180374$1$I$20240716$20240731$20240806$20240806$PER$$US-JNJFOC-20240804110$JOHNSON AND JOHNSON$$67$YR$E$$Y$$$20240806$$MD$US$US
241803751$24180375$1$I$$20240729$20240806$20240806$EXP$$JP-JNJFOC-20240804606$JOHNSON AND JOHNSON$Norio MIZUGUCHI, et al.; Department of Ophthalmology, Faculty of Medicine, University of Tsukuba. Two cases of fungal scleritis after sub-Tenon triamcinolone acetonide injection. Folia Japonica de Ophthalmologica Clinica/.2024;17(7)540-544$85$YR$E$F$Y$$$20240806$$MD$JP$JP
241803761$24180376$1$I$$20240723$20240806$20240806$PER$$US-JNJFOC-20240764103$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241803772$24180377$2$F$20240725$20240814$20240806$20240820$PER$$US-AMGEN-USASP2024152389$AMGEN$$$$$M$Y$101.5$KG$20240820$$PH$US$US
241803781$24180378$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA230821$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240806$$MD$US$US
241803791$24180379$1$I$20240628$20240802$20240806$20240806$EXP$$NVSC2024RU158702$NOVARTIS$$10$YR$$M$Y$$$20240806$$HP$RU$RU
241803801$24180380$1$I$20240601$20240730$20240806$20240806$EXP$$NVSC2024US118615$NOVARTIS$$80$YR$$M$Y$$$20240806$$CN$US$US
241803811$24180381$1$I$$20240802$20240806$20240806$EXP$$NVSC2024US158824$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
241803821$24180382$1$I$$20240729$20240806$20240806$EXP$PL-URPL-1-4242-2020$PL-TEVA-VS-3227650$TEVA$$24$YR$$F$Y$76$KG$20240806$$MD$PL$PL
241803841$24180384$1$I$$20240802$20240806$20240806$PER$$US-ROCHE-10000048607$ROCHE$$$$E$F$Y$$$20240806$$CN$US$US
241803851$24180385$1$I$$20240801$20240806$20240806$PER$$US-FreseniusKabi-FK202412041$FRESENIUS KABI$$$$$$Y$$$20240806$$PH$US$US
241803861$24180386$1$I$$20240724$20240806$20240806$EXP$$CA-ASTELLAS-2024US021962$ASTELLAS$$68$YR$$F$Y$$$20240806$$CN$CA$CA
241803872$24180387$2$F$20240725$20240806$20240806$20240813$EXP$$NVSC2024ZA155668$NOVARTIS$$62$YR$$F$Y$$$20240813$$HP$ZA$ZA
241803883$24180388$3$F$20240701$20240903$20240806$20240910$EXP$$NVSC2024DE154857$NOVARTIS$$$$$M$Y$$$20240910$$CN$DE$DE
241803891$24180389$1$I$20240701$20240731$20240806$20240806$EXP$$US-TAKEDA-2024TUS077811$TAKEDA$$63$YR$$M$Y$$$20240806$$CN$US$US
241803901$24180390$1$I$20240721$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154749$AMGEN$$57$YR$A$M$Y$$$20240806$$CN$US$US
241803913$24180391$3$F$20240725$20240813$20240806$20240817$PER$$US-AMGEN-USASP2024153689$AMGEN$$94$YR$E$F$Y$$$20240817$$CN$US$US
241803923$24180392$3$F$20240730$20240823$20240806$20240826$PER$$US-AMGEN-USASP2024154433$AMGEN$$76$YR$E$F$Y$$$20240826$$CN$US$US
241803931$24180393$1$I$$20240805$20240806$20240806$PER$$US-HALEON-2190562$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241803941$24180394$1$I$$20240802$20240806$20240806$PER$$US-ABBVIE-5866811$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241803951$24180395$1$I$20240101$20240730$20240806$20240806$EXP$$CO-GSK-CO2024AMR008217$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$CO$CO
241803961$24180396$1$I$$20240802$20240806$20240806$EXP$$US-GSK-US2024096934$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$US$US
241803971$24180397$1$I$20240710$20240805$20240806$20240806$EXP$$US-TAKEDA-2024TUS066617$TAKEDA$$65$YR$$F$Y$$$20240806$$CN$US$US
241803981$24180398$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-53985$$FDA-CTU$$74$YR$$M$N$$$20240806$N$$US$
241803991$24180399$1$I$20240803$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-54053$$FDA-CTU$$60$YR$$F$N$$$20240805$N$HP$US$
241804003$24180400$3$F$20240801$20240830$20240806$20240923$PER$$US-SA-2024SA229998$SANOFI AVENTIS$$73$YR$E$F$Y$105$KG$20240923$$MD$US$US
241804011$24180401$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54049$$FDA-CTU$$54$YR$$F$N$$$20240806$N$$US$
241804021$24180402$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54039$$FDA-CTU$$53$YR$$F$N$$$20240806$N$$US$
241804031$24180403$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54041$$FDA-CTU$$70$YR$$F$N$$$20240806$N$$US$
241804041$24180404$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54046$$FDA-CTU$$87$YR$$F$N$$$20240806$N$$US$
241804051$24180405$1$I$20240723$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-54006$$FDA-CTU$$30$YR$$M$N$$$20240805$N$HP$US$
241804061$24180406$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54026$$FDA-CTU$$50$YR$$F$N$$$20240806$N$$US$
241804071$24180407$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54005$$FDA-CTU$$74$YR$$F$N$$$20240806$N$$US$
241804111$24180411$1$I$20240805$20240805$20240805$20240805$DIR$713042$$FDA-CTU$$81$YR$$M$N$$$20240805$N$$US$
241804121$24180412$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54001$$FDA-CTU$$71$YR$$F$N$78.02$KG$20240806$N$$US$
241804131$24180413$1$I$$20230406$20240806$20240806$EXP$$US-NOVOPROD-1245687$NOVO NORDISK$$$$$M$Y$$$20240806$$CN$US$US
241804141$24180414$1$I$$20230824$20240806$20240806$EXP$$US-NOVOPROD-1245698$NOVO NORDISK$$$$$M$Y$$$20240806$$CN$US$US
241804151$24180415$1$I$$20240805$20240805$20240805$DIR$713030$$FDA-CTU$$75$YR$$F$N$59.85$KG$20240805$N$CN$US$
241804161$24180416$1$I$20240714$20240805$20240805$20240805$DIR$713028$$FDA-CTU$$23$YR$$F$N$67.5$KG$20240805$N$PH$US$
241804171$24180417$1$I$20240731$20240805$20240805$20240805$DIR$713039$$FDA-CTU$$18$YR$$F$N$135$KG$20240805$N$CN$US$
241804182$24180418$2$F$20240730$20240924$20240806$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120879$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240925$$CN$US$US
241804192$24180419$2$F$20240105$20240816$20240806$20240823$PER$$US-BAYER-2024A110950$BAYER$$24$YR$A$F$Y$$$20240823$$MD$US$US
241804201$24180420$1$I$20240803$20240804$20240806$20240806$PER$$US-JNJFOC-20240808752$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240806$$CN$US$US
241804211$24180421$1$I$20240805$20240805$20240805$20240805$DIR$713032$$FDA-CTU$$50$YR$$F$N$72.9$KG$20240805$N$CN$US$
241804221$24180422$1$I$$20240731$20240806$20240806$PER$$US-BAYER-2024A111695$BAYER$$25$YR$A$F$Y$$$20240806$$MD$US$US
241804231$24180423$1$I$20240701$20240722$20240806$20240806$PER$$US-INSUD PHARMA-2407US05873$INSUD PHARMA$$$$$$Y$$$20240806$$CN$US$US
241804241$24180424$1$I$$20240722$20240806$20240806$PER$$US-INSUD PHARMA-2407US05880$INSUD PHARMA$$$$$$Y$$$20240806$$CN$US$US
241804251$24180425$1$I$20240101$20240722$20240806$20240806$PER$$US-INSUD PHARMA-2407US05877$INSUD PHARMA$$$$$$Y$$$20240806$$CN$US$US
241804262$24180426$2$F$$20240905$20240806$20240910$PER$$US-AstraZeneca-2024A172595$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
241804271$24180427$1$I$$20240802$20240806$20240806$EXP$$CN-AstraZeneca-2024A177400$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$CN$
241804282$24180428$2$F$20240401$20240906$20240806$20240911$EXP$$US-AstraZeneca-2024A172964$ASTRAZENECA$$508$MON$$F$Y$$$20240911$$HP$US$
241804291$24180429$1$I$$20240729$20240806$20240806$EXP$$CA-AstraZeneca-2020SE06147$ASTRAZENECA$$52$YR$$F$Y$$$20240806$$MD$CA$
241804312$24180431$2$F$$20240730$20240806$20240807$EXP$$US-AstraZeneca-2024A176677$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241804321$24180432$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A172803$ASTRAZENECA$$$$$F$Y$61.2$KG$20240806$$CN$US$
241804332$24180433$2$F$$20240917$20240806$20240923$EXP$$IN-009507513-2408IND001226$MERCK$$$$$F$Y$$$20240923$$CN$IN$IN
241804341$24180434$1$I$20200711$20240731$20240806$20240806$EXP$$PL-AstraZeneca-2024A178150$ASTRAZENECA$$48$YR$$F$Y$70$KG$20240806$$MD$PL$
241804362$24180436$2$F$20240727$20240805$20240806$20240911$PER$$US-Eisai-EC-2024-171150$EISAI$$79$YR$E$F$Y$$$20240911$$CN$US$US
241804371$24180437$1$I$20240409$20240731$20240806$20240806$EXP$$FR-BIOGEN-2024BI01276697$BIOGEN$$39$YR$$F$Y$60$KG$20240806$$MD$FR$FR
241804381$24180438$1$I$20240710$20240731$20240806$20240806$PER$$US-RDY-SPO/USA/24/0011402$DR REDDYS$$26$YR$A$F$Y$$$20240806$$CN$US$US
241804391$24180439$1$I$20230901$20240802$20240806$20240806$EXP$FR-AFSSAPS-LY2023001576$FR-MYLANLABS-2024M1072231$MYLAN$$$$A$F$Y$$$20240806$$MD$FR$FR
241804403$24180440$3$F$$20240829$20240806$20240904$EXP$$US-TAKEDA-2024TUS056407$TAKEDA$$$$$M$Y$$$20240904$$CN$US$US
241804411$24180441$1$I$$20240802$20240806$20240806$PER$$US-BAYER-2024A112330$BAYER$$23$YR$A$F$Y$$$20240806$$MD$US$US
241804421$24180442$1$I$20240510$20240730$20240806$20240806$EXP$FR-AFSSAPS-PP2024000654$FR-SA-2024SA225750$SANOFI AVENTIS$$45$YR$A$M$Y$75$KG$20240806$$CN$FR$FR
241804431$24180443$1$I$20240726$20240731$20240806$20240806$PER$$US-SA-2024SA230277$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240806$$MD$US$US
241804452$24180445$2$F$$20240805$20240806$20240806$EXP$$US-GILEAD-2024-0683151$GILEAD$$$$$$Y$$$20240806$$LW$US$US
241804462$24180446$2$F$$20240821$20240806$20240905$EXP$$US-Accord-439694$ACCORD$$78$YR$$M$Y$$$20240905$$CN$US$US
241804471$24180447$1$I$$20240803$20240806$20240806$EXP$GB-MHRA-MED-202408031106086060-QNTZV$GB-MYLANLABS-2024M1072772$MYLAN$$26$YR$$F$Y$$$20240806$$CN$GB$GB
241804481$24180448$1$I$20240601$20240724$20240806$20240806$EXP$GB-MHRA-MED-202407241008296830-JQVTL$GB-ELI_LILLY_AND_COMPANY-GB202407015587$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240806$$CN$GB$GB
241804492$24180449$2$F$$20240820$20240806$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017197$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$US$US
241804501$24180450$1$I$20240501$20240725$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017203$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240806$$CN$US$US
241804512$24180451$2$F$$20240801$20240806$20240812$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407018359$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$BR$BR
241804521$24180452$1$I$$20240726$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202407018668$ELI LILLY AND CO$$69$YR$E$$Y$$$20240806$$LW$US$US
241804532$24180453$2$F$$20240801$20240806$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000269$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240813$$PH$US$US
241804541$24180454$1$I$$20240725$20240806$20240806$EXP$GB-MHRA-MED-202407251008469460-DPNSZ$GB-ELI_LILLY_AND_COMPANY-GB202407016596$ELI LILLY AND CO$$$$$M$Y$$$20240806$$CN$GB$GB
241804551$24180455$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001464$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240806$$CN$US$US
241804562$24180456$2$F$$20240812$20240806$20240820$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407016693$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$BR$BR
241804571$24180457$1$I$$20240726$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202407018705$ELI LILLY AND CO$$59$YR$A$$Y$$$20240806$$LW$US$US
241804581$24180458$1$I$20240713$20240730$20240806$20240806$EXP$GB-MHRA-MED-202407251605503070-KFPNR$GB-ELI_LILLY_AND_COMPANY-GB202407020116$ELI LILLY AND CO$$43$YR$A$M$Y$133$KG$20240806$$CN$GB$GB
241804591$24180459$1$I$$20240725$20240806$20240806$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202404017037$ELI LILLY AND CO$$$$$F$Y$$$20240806$$CN$MX$MX
241804601$24180460$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002103$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240806$$CN$US$US
241804611$24180461$1$I$$20240730$20240806$20240806$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408000657$ELI LILLY AND CO$$$$$M$Y$$$20240806$$CN$CN$CN
241804621$24180462$1$I$20240605$20240725$20240806$20240806$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407017314$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240806$$CN$CN$CN
241804631$24180463$1$I$$20240725$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202306001523$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240806$$HP$US$US
241804641$24180464$1$I$20240716$20240725$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016901$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240806$$CN$US$US
241804651$24180465$1$I$20240607$20240805$20240806$20240806$EXP$FR-AFSSAPS-LY2024000956$FR-TAKEDA-2024TUS078437$TAKEDA$$66$YR$$F$Y$47.6$KG$20240806$$HP$FR$FR
241804661$24180466$1$I$$20240730$20240806$20240806$EXP$$CA-AMGEN-CANSP2024151701$AMGEN$$59$YR$A$F$Y$99.77$KG$20240806$$CN$CA$CA
241804672$24180467$2$F$20240610$20240802$20240806$20240823$EXP$$AT-DSJP-DSE-2024-138782$DAIICHI$$81$YR$$M$Y$63$KG$20240823$$MD$AT$AT
241804681$24180468$1$I$$20240805$20240806$20240806$EXP$$NVSC2024ET159857$NOVARTIS$$$$$M$Y$$$20240806$$MD$ET$ET
241804693$24180469$3$F$20240101$20240827$20240806$20240903$EXP$$US-AMGEN-USASP2024151767$AMGEN$$59$YR$A$F$Y$$$20240902$$HP$US$US
241804701$24180470$1$I$$20240729$20240806$20240806$EXP$$US-GSK-US2024094881$GLAXOSMITHKLINE$$$$$F$Y$$$20240806$$CN$US$US
241804711$24180471$1$I$20240409$20240802$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123924$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240806$$CN$US$US
241804721$24180472$1$I$$20240802$20240806$20240806$EXP$$SE-MYLANLABS-2024M1072199$MYLAN$Kahn L, Kriikku P, J?nsson A.. Loperamide positive deaths in Sweden 2012-2022 and Finland 2017-2022: Fatal loperamide intoxication exclusively for Sweden.. Forensic Science International.. 2024;361$22$YR$$M$Y$$$20240806$$MD$SE$SE
241804741$24180474$1$I$$20240724$20240806$20240806$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240700054$UPSHER SMITH LABORATORIES$$$$$M$Y$$$20240806$$MD$US$US
241804751$24180475$1$I$20230228$20231102$20240806$20240806$EXP$$SG-SANDOZ INC.-SDZ2023SG051743$SANDOZ$$$$$$Y$$$20240806$$HP$SG$SG
241804761$24180476$1$I$$20240108$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US002229$SANDOZ$$$$$$Y$$$20240806$$CN$US$US
241804771$24180477$1$I$$20230719$20240806$20240806$EXP$$JP-SANDOZ INC.-SDZ2023JP007295$SANDOZ$Oki T, Takeki T, Ishida N, Nakamura I, Fukunaga Y.. Review of cases of jaw osteonecrosis associated with antiresorptive agents in our department. Japanese Breast Cancer Society. 2023;148-1$$$$$Y$$$20240806$$HP$JP$JP
241804791$24180479$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54002$$FDA-CTU$$92$YR$$M$N$$$20240806$N$$US$
241804801$24180480$1$I$20240803$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-54054$$FDA-CTU$$60$YR$$F$N$$$20240805$N$HP$US$
241804811$24180481$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54021$$FDA-CTU$$81$YR$$F$N$$$20240806$N$$US$
241804821$24180482$1$I$20240723$20240805$20240805$20240805$DIR$713043$$FDA-CTU$$37$YR$$M$N$60.9$KG$20240805$N$MD$US$
241804831$24180483$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54028$$FDA-CTU$$64$YR$$F$N$84.82$KG$20240806$N$$US$
241804841$24180484$1$I$$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-53868$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
241804851$24180485$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54031$$FDA-CTU$$46$YR$$F$N$$$20240806$N$$US$
241804861$24180486$1$I$20240522$20240729$20240806$20240806$EXP$$NL-MYLANLABS-2024M1071309$MYLAN$$52$YR$$F$Y$$$20240806$$HP$NL$NL
241804871$24180487$1$I$$20240729$20240806$20240806$EXP$$NVSC2024US108855$NOVARTIS$$$$$F$Y$$$20240806$$CN$US$US
241804881$24180488$1$I$$20240724$20240806$20240806$PER$$US-RDY-LIT/USA/24/0011194$DR REDDYS$Chaudhary HS, Zeidman E, Punjani N, Tashman Y. Sleep-related painful erections treated with sodium oxybate. Journal of Clinical Sleep Medicine. 20(7): 1209-1211.$39$YR$A$M$Y$$$20240806$$MD$US$US
241804891$24180489$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA227979$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240806$$CN$US$US
241804902$24180490$2$F$$20240809$20240806$20240819$EXP$$US-SA-2024SA228402$SANOFI AVENTIS$$$$A$$Y$$$20240819$$MD$US$US
241804911$24180491$1$I$$20240724$20240806$20240806$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07072$HIKMA$$$$$$Y$$$20240806$$CN$US$US
241804931$24180493$1$I$$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122924$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$54.43$KG$20240806$$CN$US$US
241804941$24180494$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124127$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240806$$CN$US$US
241804951$24180495$1$I$$20240315$20240806$20240806$EXP$$GB-SANDOZ INC.-SDZ2024GB030995$SANDOZ$$$$$$Y$$$20240806$$HP$GB$GB
241804962$24180496$2$F$20240101$20240903$20240806$20240909$PER$$US-ABBVIE-5864754$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
241804971$24180497$1$I$20240301$20240411$20240806$20240806$EXP$$NVSC2024US064868$NOVARTIS$$83$YR$$F$Y$$$20240806$$CN$US$US
241804981$24180498$1$I$20231020$20240413$20240806$20240806$EXP$$NVSC2023CA229713$NOVARTIS$$52$YR$$F$Y$$$20240806$$CN$CA$CA
241804991$24180499$1$I$$20240802$20240806$20240806$PER$$US-JNJFOC-20240809646$JOHNSON AND JOHNSON$$68$YR$E$F$Y$57.6$KG$20240806$$CN$US$US
241805002$24180500$2$F$20200808$20240815$20240806$20240819$EXP$PL-URPL-1-1720-2020$PL-MYLANLABS-2024M1072202$MYLAN$$21$YR$$M$Y$75$KG$20240819$$MD$PL$PL
241805011$24180501$1$I$20240715$20240729$20240806$20240806$EXP$$CO-AstraZeneca-2024A174059$ASTRAZENECA$$4840$WK$$F$Y$45$KG$20240806$$CN$CO$
241805021$24180502$1$I$$20240527$20240806$20240806$EXP$$BR-AstraZeneca-2024A127962$ASTRAZENECA$$25202$DY$$F$Y$$$20240806$$CN$BR$
241805031$24180503$1$I$20240723$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A177823$ASTRAZENECA$$$$$F$Y$$$20240806$$HP$US$
241805041$24180504$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA227842$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240806$$CN$US$US
241805053$24180505$3$F$20230630$20240828$20240806$20240917$PER$$US-SA-2024SA225792$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240918$$MD$US$US
241805061$24180506$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA230108$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240806$$MD$US$US
241805071$24180507$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA230019$SANOFI AVENTIS$$$$A$M$Y$83$KG$20240806$$MD$US$US
241805081$24180508$1$I$$20240729$20240806$20240806$PER$$US-SA-2023SA264198$SANOFI AVENTIS$$$$T$M$Y$$$20240806$$MD$US$US
241805091$24180509$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA227237$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240806$$MD$US$US
241805101$24180510$1$I$20240101$20240730$20240806$20240806$EXP$$JP-009507513-2401JPN008213J$MERCK$$$$$F$Y$$$20240806$$MD$JP$JP
241805111$24180511$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA225583$SANOFI AVENTIS$$$$E$M$Y$$$20240806$$CN$US$US
241805125$24180512$5$F$$20240823$20240806$20240830$EXP$$CA-GSK-CA2024AMR096834$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$CA$CA
241805131$24180513$1$I$20230804$20240801$20240806$20240806$EXP$$CA-JNJFOC-20230969684$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240806$$HP$CA$CA
241805141$24180514$1$I$20111031$20141211$20240806$20240806$EXP$$DE-JNJFOC-20230421694$JOHNSON AND JOHNSON$$13$YR$T$F$Y$$$20240806$$HP$DE$DE
241805151$24180515$1$I$20240303$20240305$20240806$20240806$DIR$FDA-CDER-CTU-2024-54000$$FDA-CTU$$51$YR$$F$N$$$20240305$N$$US$
241805161$24180516$1$I$$20240729$20240806$20240806$EXP$$CO-ASTELLAS-2024US021819$ASTELLAS$$65$YR$$M$Y$$$20240806$$CN$CO$CO
241805211$24180521$1$I$20240601$20240805$20240805$20240805$DIR$713019$$FDA-CTU$$36$YR$$F$N$65.25$KG$20240805$N$CN$US$
241805241$24180524$1$I$$20240522$20240806$20240806$DIR$FDA-CDER-CTU-2024-53981$$FDA-CTU$$$$$$N$$$20240522$N$$US$
241805251$24180525$1$I$$20240805$20240806$20240806$EXP$$JP-ABBVIE-5867892$ABBVIE$$$$E$M$Y$$$20240806$$HP$JP$JP
241805261$24180526$1$I$$20240729$20240806$20240806$PER$$US-RDY-SPO/USA/24/0011297$DR REDDYS$$18$YR$A$F$Y$$$20240806$$MD$US$US
241805271$24180527$1$I$$20240802$20240806$20240806$PER$$NVSC2024US159029$NOVARTIS$$$$$$Y$$$20240806$$HP$US$US
241805281$24180528$1$I$$20240805$20240806$20240806$EXP$$US-ABBVIE-5868605$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241805291$24180529$1$I$20240724$20240801$20240806$20240806$EXP$FR-AFSSAPS-AVLL2024000188$FR-MYLANLABS-2024M1072616$MYLAN$$48$YR$$M$Y$$$20240806$$MD$FR$FR
241805311$24180531$1$I$20240805$20240805$20240805$20240805$DIR$713072$$FDA-CTU$$$$$F$N$$$20240805$N$CN$US$
241805321$24180532$1$I$20240717$20240722$20240806$20240806$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0833$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240806$$MD$US$US
241805331$24180533$1$I$$20240523$20240806$20240806$DIR$FDA-CDER-CTU-2024-53956$$FDA-CTU$$$$$$N$$$20240523$N$PH$US$
241805341$24180534$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124162$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240806$$CN$US$US
241805351$24180535$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122144$BRISTOL MYERS SQUIBB$$28$YR$A$F$Y$$$20240806$$CN$US$US
241805361$24180536$1$I$$20240528$20240806$20240806$DIR$FDA-CDER-CTU-2024-53968$$FDA-CTU$$$$$$N$$$20240528$N$PH$US$
241805371$24180537$1$I$20240424$20240805$20240805$20240805$DIR$713050$$FDA-CTU$$76$YR$$F$N$135$KG$20240805$N$HP$US$
241805381$24180538$1$I$$20240801$20240806$20240806$EXP$$IE-JNJFOC-20240809522$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240806$$CN$IE$IE
241805391$24180539$1$I$$20240730$20240806$20240806$PER$$US-AstraZeneca-2024A173888$ASTRAZENECA$$$$$F$Y$$$20240806$$HP$US$
241805401$24180540$1$I$$20240722$20240806$20240806$EXP$$PL-GILEAD-2024-0681085$GILEAD$$35$YR$A$F$Y$$$20240806$$MD$PL$PL
241805411$24180541$1$I$$20240528$20240806$20240806$DIR$FDA-CDER-CTU-2024-53952$$FDA-CTU$$$$$$N$$$20240528$N$$US$
241805421$24180542$1$I$20240702$20240805$20240805$20240805$DIR$713051$$FDA-CTU$$68$YR$$F$N$92.25$KG$20240805$Y$CN$US$
241805441$24180544$1$I$$20240729$20240806$20240806$EXP$$CA-AstraZeneca-2020SF26975$ASTRAZENECA$$66$YR$$F$Y$$$20240806$$MD$CA$
241805451$24180545$1$I$20200701$20240729$20240806$20240806$EXP$$JP-AstraZeneca-2024A175074$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$JP$
241805461$24180546$1$I$20240614$20240805$20240805$20240805$DIR$713055$$FDA-CTU$$52$YR$$F$N$121.7$KG$20240805$N$MD$US$
241805472$24180547$2$F$20240716$20240801$20240806$20240821$EXP$$ZA-REGENERON PHARMACEUTICALS, INC.-2024-107322$REGENERON$$$$$$Y$$$20240821$$HP$ZA$ZA
241805481$24180548$1$I$$20240729$20240806$20240806$EXP$$US-AMGEN-USASP2024154135$AMGEN$Mumtaz S.; Wilson C.; Vibhute P. et al.. Central Retinal Artery Occlusion Associated with Takayasu Arteritis. Diagnostics. 2024;14 (13):1-7$35$YR$A$F$Y$$$20240806$$HP$US$US
241805491$24180549$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121673$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240806$$HP$US$US
241805501$24180550$1$I$$20240730$20240806$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-122387$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240806$$MD$JP$JP
241805511$24180551$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865888$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241805521$24180552$1$I$20240101$20240801$20240806$20240806$EXP$$US-ABBVIE-5865033$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241805531$24180553$1$I$20240729$20240731$20240806$20240806$EXP$$NVSC2024CN158036$NOVARTIS$$85$YR$$M$Y$75$KG$20240806$$HP$CN$CN
241805541$24180554$1$I$$20240805$20240806$20240806$PER$$US-ROCHE-10000049807$ROCHE$$$$A$F$Y$$$20240806$$CN$US$US
241805551$24180555$1$I$20240101$20240801$20240806$20240806$EXP$$US-ABBVIE-5856870$ABBVIE$$$$$M$Y$82.1$KG$20240806$$CN$US$US
241805561$24180556$1$I$20240731$20240805$20240805$20240805$DIR$713056$$FDA-CTU$$70$YR$$M$N$95$KG$20240805$Y$MD$US$
241805571$24180557$1$I$20240805$20240805$20240805$20240805$DIR$713060$$FDA-CTU$$25$YR$$M$N$$$20240805$N$$US$
241805581$24180558$1$I$20240718$20240805$20240805$20240805$DIR$713049$$FDA-CTU$$27$YR$$F$N$$$20240805$Y$PH$US$
241805601$24180560$1$I$$20240729$20240806$20240806$EXP$$DK-TEVA-VS-3229221$TEVA$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic-Sci-Int 2009; 184 (1-3): 74-79.$55$YR$$M$Y$$$20240806$$HP$DK$DK
241805611$24180561$1$I$$20240801$20240806$20240806$EXP$$FR-MYLANLABS-2024M1072486$MYLAN$$8$DEC$$M$Y$$$20240806$$PH$FR$FR
241805621$24180562$1$I$$20240801$20240806$20240806$EXP$$DE-SHIONOGI, INC-2024001908$SHIONOGI$$$$$$Y$$$20240806$$MD$DE$DE
241805631$24180563$1$I$20240516$20240729$20240806$20240806$EXP$PL-URPL-DML-MLP.4401.1.159.2024$PL-TEVA-VS-3227645$TEVA$$38$YR$$F$Y$84$KG$20240806$$MD$PL$PL
241805641$24180564$1$I$$20240801$20240806$20240806$EXP$$CA-ABBVIE-5865668$ABBVIE$$$$$F$Y$$$20240806$$CN$CA$CA
241805651$24180565$1$I$$20240731$20240806$20240806$EXP$$CA-009507513-2408CAN000760$MERCK$$73$YR$$M$Y$87$KG$20240806$$PH$CA$CA
241805661$24180566$1$I$20240726$20240726$20240806$20240806$PER$$US-Millicent Holdings Ltd.-MILL20241058$MILLICENT HOLDINGS$$$$$F$Y$$$20240806$$CN$US$US
241805671$24180567$1$I$20210101$20240802$20240806$20240806$PER$$US-BAYER-2024A112411$BAYER$$31$YR$A$F$Y$$$20240806$$HP$US$US
241805682$24180568$2$F$$20240910$20240806$20240911$PER$$US-JNJFOC-20240809199$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$HP$US$US
241805691$24180569$1$I$20231114$20240803$20240806$20240806$EXP$GB-MHRA-MED-202408031347395290-HKZNV$GB-ORGANON-O2408GBR000271$ORGANON$$9$YR$$F$Y$42$KG$20240806$$CN$GB$GB
241805711$24180571$1$I$$20240730$20240806$20240806$EXP$$JP-ANIPHARMA-2024-JP-000220$ANI$Jiyuge M.A case of postoperative breast cancer in which agranulocytosis due to tamoxifen developed after the improvement of interstitial pneumonia due to anastrozole..The 32nd Annual Meeting of the Japanese Breast Cancer Societ.2024;493.$70$YR$$F$Y$$$20240806$$HP$JP$JP
241805721$24180572$1$I$$20240802$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123992$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240806$$CN$US$US
241805732$24180573$2$F$$20240729$20240806$20240806$EXP$$US-AMGEN-USASP2024152026$AMGEN$$$$$$Y$$$20240806$$HP$US$US
241805741$24180574$1$I$$20240728$20240806$20240806$PER$$US-AMGEN-USASP2024154815$AMGEN$Silverman S. L.; Reginster J.; Czerwinski E. et al.. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis International. 2024;1-12$$$$$Y$$$20240806$$HP$US$US
241805761$24180576$1$I$$20240729$20240806$20240806$EXP$$DK-TEVA-VS-3229222$TEVA$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic-Sci-Int 2009; 184 (1-3): 74-79.$54$YR$$M$Y$$$20240806$$HP$DK$DK
241805771$24180577$1$I$$20240730$20240806$20240806$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024095257$VIIV$$$$$$Y$$$20240806$$HP$GB$GB
241805781$24180578$1$I$$20240805$20240806$20240806$PER$$US-BAYER-2024A113035$BAYER$$19$YR$A$F$Y$$$20240806$$MD$US$US
241805791$24180579$1$I$20240701$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124316$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240806$$PH$US$US
241805801$24180580$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153396$AMGEN$Krivda K.R.; Okoro U.J.; Logemann N.F.. The use of systemic corticosteroids in debilitating sycosis barbae, sycosis barbae fulminans. Dermatology Online Journal. 2024;30 (3):1-5$62$YR$A$M$Y$$$20240806$$MD$US$US
241805812$24180581$2$F$$20240803$20240806$20240816$EXP$$BR-AstraZeneca-2024A177881$ASTRAZENECA$$37$YR$$F$Y$$$20240816$$CN$BR$
241805841$24180584$1$I$20240721$20240801$20240806$20240806$EXP$$US-AstraZeneca-2024A175396$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241805851$24180585$1$I$$20240729$20240806$20240806$EXP$$US-AstraZeneca-2024A172355$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241805863$24180586$3$F$$20240831$20240806$20240905$EXP$$BG-AstraZeneca-2024A171481$ASTRAZENECA$$79$YR$$F$Y$100$KG$20240905$$MD$BG$
241805871$24180587$1$I$$20240801$20240806$20240806$EXP$$CA-AstraZeneca-2024A130488$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$CA$
241805881$24180588$1$I$$20240729$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001483$ELI LILLY AND CO$$$$$F$Y$$$20240806$$CN$US$US
241805891$24180589$1$I$$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002324$ELI LILLY AND CO$$$$$$Y$$$20240806$$CN$US$US
241805901$24180590$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002271$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240806$$HP$US$US
241805911$24180591$1$I$20240723$20240724$20240806$20240806$EXP$$GB-CIPLA (EU) LIMITED-2024GB08095$CIPLA$$$$$$Y$$$20240806$$CN$GB$GB
241805941$24180594$1$I$20240601$20240805$20240805$20240805$DIR$713095$$FDA-CTU$$51$YR$$F$N$80.1$KG$20240805$N$CN$US$
241805971$24180597$1$I$20240729$20240805$20240805$20240805$DIR$713058$$FDA-CTU$$33$YR$$F$N$67.5$KG$20240805$N$CN$US$
241805991$24180599$1$I$20240523$20240805$20240805$20240805$DIR$713022$$FDA-CTU$$46$YR$$M$N$94.5$KG$20240805$N$CN$US$
241806001$24180600$1$I$20240228$20240805$20240805$20240805$DIR$713034$$FDA-CTU$$30$YR$$F$N$98.55$KG$20240805$N$CN$US$
241806021$24180602$1$I$20240710$20240805$20240805$20240805$DIR$713041$$FDA-CTU$$79$YR$$F$N$97.65$KG$20240805$Y$CN$US$
241806031$24180603$1$I$20240724$20240725$20240806$20240806$EXP$$US-CIPLA LTD.-2024US08195$CIPLA$$$$$$Y$$$20240806$$CN$US$US
241806041$24180604$1$I$$20240724$20240806$20240806$EXP$$GB-CIPLA LTD.-2024GB08051$CIPLA$$$$$$Y$$$20240806$$CN$GB$GB
241806051$24180605$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA226690$SANOFI AVENTIS$$$$$$Y$$$20240806$$MD$US$US
241806061$24180606$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123098$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240806$$HP$US$US
241806071$24180607$1$I$20240731$20240802$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123566$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240806$$CN$US$US
241806081$24180608$1$I$$20240724$20240806$20240806$EXP$$US-CIPLA LTD.-2024US08109$CIPLA$Haynes TM, Kukuc L, Proute M, Fishberg R. A PCSK9 and APOB double heterozygote presenting phenotypically similar to homozygous familial hypercholesterolemia. Circulation. 2023;148 (Suppl.)$$$$$Y$$$20240806$$HP$US$US
241806091$24180609$1$I$$20240805$20240806$20240806$PER$$US-JNJFOC-20240811476$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$HP$US$US
241806101$24180610$1$I$$20240724$20240806$20240806$EXP$$US-CIPLA LTD.-2024US08140$CIPLA$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D. Rhabdomyolysis risk: The dangers of Tribulus Terrestris, an over-the-counter supplement. Am J Case Rep. 2024;25: e943492:1941 to 5923$$$$$Y$$$20240806$$MD$US$US
241806113$24180611$3$F$20240801$20240906$20240806$20240909$PER$$US-JNJFOC-20240806053$JOHNSON AND JOHNSON$$54$YR$A$$Y$$$20240909$$CN$US$US
241806121$24180612$1$I$20240701$20240729$20240806$20240806$EXP$FR-AFSSAPS-DJ2024000851$FR-TEVA-VS-3227561$TEVA$$78$YR$$F$Y$$$20240806$$MD$FR$FR
241806132$24180613$2$F$20240616$20240807$20240806$20240812$30DAY$$US-PFIZER INC-PV202400099106$PFIZER$$$$$$Y$$$20240812$$CN$US$US
241806152$24180615$2$F$$20240807$20240806$20240807$30DAY$$US-PFIZER INC-202400223135$PFIZER$$$$$$Y$$$20240807$$HP$US$US
241806162$24180616$2$F$$20240813$20240806$20240813$30DAY$$US-PFIZER INC-PV202400098328$PFIZER$$$$$$Y$$$20240813$$CN$US$US
241806173$24180617$3$F$20240730$20240905$20240806$20240910$30DAY$$AR-PFIZER INC-202400228243$PFIZER$$78$YR$$F$Y$$$20240910$$CN$AR$AR
241806181$24180618$1$I$20240702$20240729$20240806$20240806$EXP$FR-AFSSAPS-GR2024000918$FR-TEVA-VS-3227556$TEVA$$70$YR$$F$Y$73$KG$20240806$$PH$FR$FR
241806191$24180619$1$I$$20240801$20240806$20240806$30DAY$$CO-PFIZER INC-PV202400101051$PFIZER$$$$$$Y$$$20240806$$CN$CO$CO
241806201$24180620$1$I$$20240801$20240806$20240806$EXP$$JP-PFIZER INC-PV202400100628$PFIZER$Nemoto, H.. Effectiveness of isavuconazole in invasive cerebral aspergillosis during hematopoietic stem cell transplantation in a pediatric patient with myelodysplastic syndrome: A case report. Journal of infection and chemotherapy. 2024;10.1016/j.jiac.2024.07.018$4$YR$$M$Y$$$20240806$$HP$JP$JP
241806222$24180622$2$F$$20240906$20240806$20240909$30DAY$$US-PFIZER INC-202400225131$PFIZER$$13$YR$$F$Y$$$20240909$$CN$US$US
241806231$24180623$1$I$$20240731$20240806$20240806$30DAY$$PA-PFIZER INC-PV202400100550$PFIZER$$$$$M$Y$$$20240806$$CN$PA$PA
241806241$24180624$1$I$$20240725$20240806$20240806$EXP$AU-TGA-814262$AU-Accord-438337$ACCORD$$78$YR$E$F$Y$$$20240806$$HP$AU$AU
241806251$24180625$1$I$$20240726$20240806$20240806$EXP$GB-MHRA-MIDB-2febd9d7-3b66-453e-bebb-fba455297ab9$GB-Accord-439128$ACCORD$$85$YR$E$F$Y$$$20240806$$PH$GB$GB
241806261$24180626$1$I$$20240726$20240806$20240806$EXP$GB-MHRA-MED-202407260010004620-VJKDB$GB-Accord-439140$ACCORD$$$$$F$Y$$$20240806$$CN$GB$GB
241806271$24180627$1$I$$20240725$20240806$20240806$EXP$AU-TGA-814261$AU-Accord-438342$ACCORD$$65$YR$E$M$Y$$$20240806$$HP$AU$AU
241806281$24180628$1$I$$20240725$20240806$20240806$EXP$CA-MHPD-E2B_07136980$CA-Accord-438617$ACCORD$$$$$$Y$$$20240806$$HP$CA$CA
241806291$24180629$1$I$$20240725$20240806$20240806$EXP$CA-MHPD-E2B_07180317$CA-Accord-438589$ACCORD$$77$YR$E$M$Y$$$20240806$$HP$CA$CA
241806301$24180630$1$I$20240601$20240725$20240806$20240806$EXP$SE-SEMPA-2024-005474$SE-Accord-438543$ACCORD$$81$YR$E$F$Y$$$20240806$$MD$SE$SE
241806311$24180631$1$I$20201130$20240725$20240806$20240806$EXP$AT-EMA-DD-20240719-7482645-092045$AT-Accord-438576$ACCORD$$63$YR$A$F$Y$55$KG$20240806$$MD$AT$AT
241806322$24180632$2$F$20240723$20240805$20240806$20240817$EXP$$US-Accord-438912$ACCORD$$54$YR$A$F$Y$$$20240817$$HP$US$US
241806331$24180633$1$I$$20240726$20240806$20240806$EXP$CA-MHPD-001086662$CA-Accord-438913$ACCORD$$5$YR$C$F$Y$$$20240806$$HP$CA$CA
241806342$24180634$2$F$$20240829$20240806$20240910$EXP$$CZ-Accord-439182$ACCORD$Weinbergerova B, Mayer J, Kabut T, Sperr WR, Stevkova J, Jonasova A, et al. Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis. Br J Haematol. 2024 Jul 23.$75$YR$E$$Y$$$20240910$$HP$CZ$CZ
241806351$24180635$1$I$$20240726$20240806$20240806$EXP$$TR-Accord-438808$ACCORD$Celen Arabaci I, Nurozler Tabakci B, Onal I, Yildirim Y. Erlotinib-induced blepharitis: Management of two challenging cases. J Fr Ophtalmol. 2024 Jul 16:104247.$40$YR$A$F$Y$$$20240806$$HP$TR$TR
241806361$24180636$1$I$20240724$20240725$20240806$20240806$EXP$GB-MHRA-TPP51263210C8263963YC1721839010950$GB-Accord-438826$ACCORD$$10$YR$C$M$Y$50$KG$20240806$$HP$GB$GB
241806371$24180637$1$I$$20240725$20240806$20240806$EXP$CA-MHPD-E2B_07121159$CA-Accord-438634$ACCORD$$$$A$M$Y$$$20240806$$HP$CA$CA
241806381$24180638$1$I$20240724$20240726$20240806$20240806$EXP$CN-HENLIUS-24CN016160$CN-Accord-439574$ACCORD$$61$YR$A$F$Y$48.5$KG$20240806$$MD$CN$CN
241806391$24180639$1$I$$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121386$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240806$$CN$US$US
241806411$24180641$1$I$20230101$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123891$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$88.45$KG$20240806$$CN$US$US
241806421$24180642$1$I$$20240805$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124069$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240806$$CN$US$US
241806431$24180643$1$I$$20240708$20240806$20240806$PER$$US-LEX-000380$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240806$$MD$US$US
241806441$24180644$1$I$$20240806$20240806$20240806$EXP$$NZ-MYLANLABS-2024M1073177$MYLAN$$$$$M$Y$$$20240806$$HP$NZ$NZ
241806452$24180645$2$F$20240804$20240806$20240806$20240812$PER$$US-AMGEN-USASP2024156248$AMGEN$$76$YR$E$M$Y$$$20240812$$CN$US$US
241806461$24180646$1$I$$20240801$20240806$20240806$EXP$$US-APELLIS-2024-APL-0000623$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240806$$PH$US$US
241806471$24180647$1$I$$20240805$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070770$SANDOZ$$$$$F$Y$$$20240806$$HP$US$US
241806481$24180648$1$I$$20240729$20240806$20240806$EXP$$DK-TEVA-VS-3229223$TEVA$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic-Sci-Int 2009; 184 (1-3): 74-79.$54$YR$$F$Y$$$20240806$$HP$DK$DK
241806491$24180649$1$I$$20240804$20240806$20240806$PER$$US-PFIZER INC-PV202400102096$PFIZER$$24$YR$$F$Y$$$20240806$$HP$US$US
241806501$24180650$1$I$$20240619$20240805$20240805$DIR$FDA-CDER-CTU-2024-53655$$FDA-CTU$$$$$$N$$$20240619$N$$US$
241806512$24180651$2$F$$20240813$20240806$20240814$PER$$US-PFIZER INC-202400231208$PFIZER$$16$YR$$F$Y$$$20240814$$HP$US$US
241806521$24180652$1$I$20240601$20240806$20240806$20240806$EXP$DK-DKMA-30737136$DK-SANDOZ INC.-SDZ2024DK070736$SANDOZ$$59$YR$$F$Y$$$20240806$$HP$DK$DK
241806551$24180655$1$I$20240310$20240805$20240806$20240806$EXP$FR-AFSSAPS-AN2024000995$FR-SANDOZ INC.-SDZ2024FR070447$SANDOZ$$69$YR$$M$Y$50$KG$20240806$$MD$FR$FR
241806562$24180656$2$F$$20240813$20240806$20240819$EXP$$NO-MYLANLABS-2024M1071184$MYLAN$Dalaker VM, Furuhaugen H, Brekke M, Bjornaas MA, Krpo M, Oiestad EL, Vallersnes OM.. Drugs in blood and urine samples from victims of suspected exposure to drink spiking: A prospective observational study from Oslo, Norway.. PLoS One. 2024;19(7):e0306191$29$YR$$F$Y$$$20240819$$HP$NO$NO
241806571$24180657$1$I$20240608$20240730$20240806$20240806$EXP$FR-AFSSAPS-NY2024000839$FR-MYLANLABS-2024M1071345$MYLAN$$37$YR$$M$Y$70$KG$20240806$$MD$FR$FR
241806581$24180658$1$I$20240620$20240801$20240806$20240806$EXP$$ZA-AMERICAN REGENT INC-2024002974$AMERICAN REGENT$$30$YR$$F$Y$$$20240806$$CN$ZA$ZA
241806592$24180659$2$F$20240801$20240806$20240806$20240811$EXP$$US-ABBVIE-5865941$ABBVIE$$70$YR$$M$Y$$$20240811$$CN$US$US
241806602$24180660$2$F$20240801$20240830$20240806$20240903$PER$$US-AMGEN-USASP2024154752$AMGEN$$80$YR$E$M$Y$$$20240902$$CN$US$US
241806611$24180661$1$I$20231023$20240729$20240806$20240806$EXP$FR-AFSSAPS-NY2024000834$FR-TEVA-VS-3227489$TEVA$$64$YR$$F$Y$75$KG$20240806$$PH$FR$FR
241806621$24180662$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA229001$SANOFI AVENTIS$$63$YR$A$M$Y$92.98$KG$20240806$$MD$US$US
241806631$24180663$1$I$$20240729$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120575$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240806$$CN$US$US
241806641$24180664$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA224351$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240806$$CN$US$US
241806651$24180665$1$I$$20240728$20240806$20240806$PER$$US-ABBVIE-5858738$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241806661$24180666$1$I$20230101$20240730$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000088$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240806$$CN$US$US
241806672$24180667$2$F$20240630$20240801$20240806$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408001918$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240813$$CN$US$US
241806681$24180668$1$I$$20240731$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000719$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240806$$CN$US$US
241806692$24180669$2$F$$20240904$20240806$20240913$EXP$$US-ASTELLAS-2024EU007775$ASTELLAS$$$$E$M$Y$$$20240913$$CN$US$US
241806701$24180670$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA227561$SANOFI AVENTIS$$$$A$F$Y$67$KG$20240806$$MD$US$US
241806712$24180671$2$F$20240725$20240920$20240806$20240925$EXP$$US-KYOWAKIRIN-2024KK018730$KYOWA$$$$$$Y$$$20240925$$HP$US$US
241806721$24180672$1$I$$20240731$20240806$20240806$EXP$$US-ASTELLAS-2024EU007653$ASTELLAS$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. Journal of Oncology Pharmacy Practice. 2024;no information:1-4$56$YR$$F$Y$$$20240806$$HP$US$US
241806732$24180673$2$F$$20240904$20240806$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124149$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$85.28$KG$20240919$$CN$US$US
241806743$24180674$3$F$20240730$20240820$20240806$20240826$EXP$$CA-ABBVIE-5864311$ABBVIE$$$$A$F$Y$$$20240826$$CN$CA$CA
241806751$24180675$1$I$20230718$20240801$20240806$20240806$EXP$$CA-SANDOZ INC.-SDZ2023CA006709$SANDOZ$$83$YR$$F$Y$$$20240806$$CN$CA$CA
241806761$24180676$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121740$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240806$$HP$US$US
241806772$24180677$2$F$$20240829$20240806$20240830$EXP$$ES-SANDOZ INC.-NVSC2021ES225588$SANDOZ$$10$YR$$$Y$$$20240830$$MD$ES$ES
241806782$24180678$2$F$$20240808$20240806$20240814$EXP$$DE-SANDOZ INC.-SDZ2024DE070554$SANDOZ$$54$YR$$$Y$$$20240814$$HP$DE$DE
241806791$24180679$1$I$$20240802$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070341$SANDOZ$$$$$F$Y$$$20240806$$HP$US$US
241806801$24180680$1$I$20240730$20240801$20240806$20240806$EXP$$FR-ABBVIE-5867150$ABBVIE$$69$YR$$F$Y$$$20240806$$CN$FR$FR
241806811$24180681$1$I$20240705$20240805$20240806$20240806$EXP$$GB-MYLANLABS-2024M1065067$MYLAN$$24$YR$$M$Y$$$20240806$$PH$GB$GB
241806821$24180682$1$I$$20240801$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070750$SANDOZ$$$$$F$Y$$$20240806$$MD$US$US
241806841$24180684$1$I$$20240731$20240806$20240806$EXP$$US-INCYTE CORPORATION-2024IN008016$INCYTE$$$$$$Y$$$20240806$$CN$US$US
241806851$24180685$1$I$20210208$20240802$20240806$20240806$EXP$$DE-SANDOZ INC.-NVSC2021DE079399$SANDOZ$$$$E$F$Y$49.5$KG$20240806$$MD$DE$DE
241806861$24180686$1$I$20220214$20240729$20240806$20240806$PER$$US-INCYTE CORPORATION-2024IN007927$INCYTE$$$$$$Y$$$20240806$$CN$US$US
241806871$24180687$1$I$$20240730$20240806$20240806$EXP$$JP-ANIPHARMA-2024-JP-000218$ANI$Sato E, et al.EP-0344 Two cases of rhomboid flap reconstruction for postoperative local recurrence of breast cancer..32nd Annual Meeting of the Japanese Breast Cancer Society.2024;263.$67$YR$$F$Y$$$20240806$$HP$JP$JP
241806881$24180688$1$I$$20240708$20240806$20240806$PER$$US-LEX-000384$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
241806891$24180689$1$I$$20240729$20240806$20240806$PER$$US-INCYTE CORPORATION-2024IN007928$INCYTE$$$$$$Y$$$20240806$$CN$US$US
241806901$24180690$1$I$$20240805$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070775$SANDOZ$$$$$F$Y$$$20240806$$CN$US$US
241806911$24180691$1$I$$20240731$20240806$20240806$EXP$$JP-SANDOZ INC.-SDZ2024JP070772$SANDOZ$$$$A$M$Y$$$20240806$$CN$JP$JP
241806921$24180692$1$I$$20220202$20240806$20240806$EXP$$US-AstraZeneca-2022A056745$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241806931$24180693$1$I$$20240731$20240806$20240806$EXP$$US-ASTELLAS-2024EU007660$ASTELLAS$Dykes K, Tzachanis D, Koura D. A difficult case of calcineurin inhibitor neurotoxicity post-haploidentical HCT with a successful novel solution: Cytotoxic T-lymphocyte-associated protein 4-immunoglobulin blockade for GVHD prophylaxis. Cell transplantation. 2024;33:1-7$24$YR$$M$Y$$$20240806$$HP$US$US
241806941$24180694$1$I$$20240725$20240806$20240806$EXP$$US-AstraZeneca-2024A170078$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241806951$24180695$1$I$$20230721$20240806$20240806$EXP$$US-AstraZeneca-2023A168003$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241806961$24180696$1$I$20210419$20220328$20240806$20240806$EXP$$CA-AstraZeneca-2021A774077$ASTRAZENECA$$57$YR$$F$Y$$$20240806$$MD$CA$
241806971$24180697$1$I$$20240805$20240806$20240806$30DAY$$US-SANDOZ INC.-SDZ2024US070815$SANDOZ$$$$$F$Y$$$20240806$$CN$US$US
241806982$24180698$2$F$$20240820$20240806$20240822$EXP$$VN-SANDOZ INC.-SDZ2024VN070723$SANDOZ$Phuong LT, Dieu Thuy NT, Ngoc NT, Huy NN, Tu TM, Huong NT. et al. Treatment outcomes of pediatric lupus nephritis class iii and iv in national children?s hospital. JOURNAL OF MEDICAL RESEARCH. 2022;154 (6):69-75$$$C$$Y$$$20240822$$HP$VN$VN
241806992$24180699$2$F$$20240814$20240806$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA026676$SANDOZ$$$$$M$Y$$$20240819$$CN$CA$CA
241807002$24180700$2$F$20240401$20240828$20240806$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-022099$JAZZ$$53$YR$$F$Y$$$20240830$$MD$US$US
241807012$24180701$2$F$20230824$20240924$20240806$20240925$EXP$$DE-SANDOZ INC.-SDZ2024DE013472$SANDOZ$$68$YR$$M$Y$80$KG$20240925$$MD$DE$DE
241807021$24180702$1$I$$20240802$20240806$20240806$EXP$$US-GILEAD-2024-0683011$GILEAD$$74$YR$E$F$Y$$$20240806$$HP$US$US
241807041$24180704$1$I$20240415$20240731$20240806$20240806$EXP$$GB-APELLIS-2024-APL-0000045$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240806$$HP$GB$GB
241807051$24180705$1$I$20240626$20240802$20240806$20240806$EXP$$US-TAKEDA-2024TUS078197$TAKEDA$$32$YR$$M$Y$$$20240806$$CN$US$US
241807061$24180706$1$I$$20240726$20240806$20240806$PER$$US-JNJFOC-20240776161$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241807071$24180707$1$I$$20240804$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070791$SANDOZ$$$$$$Y$$$20240806$$CN$US$US
241807081$24180708$1$I$$20240805$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070811$SANDOZ$$$$$F$Y$$$20240806$$CN$US$US
241807091$24180709$1$I$20240701$20240730$20240806$20240806$PER$$US-INCYTE CORPORATION-2024IN007972$INCYTE$$$$$$Y$$$20240806$$CN$US$US
241807101$24180710$1$I$20240501$20240731$20240806$20240806$EXP$$CO-ASTELLAS-2024US000688$ASTELLAS$$85$YR$$M$Y$62$KG$20240806$$CN$CO$CO
241807111$24180711$1$I$$20240806$20240806$20240806$EXP$FR-AFSSAPS-LY2024000767$FR-SANDOZ INC.-SDZ2024FR070794$SANDOZ$$59$YR$$F$Y$$$20240806$$PH$FR$FR
241807121$24180712$1$I$$20240803$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070704$SANDOZ$$53$YR$$M$Y$$$20240806$$CN$US$US
241807131$24180713$1$I$$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123324$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240806$$CN$US$US
241807141$24180714$1$I$20240101$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123680$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240806$$HP$US$US
241807151$24180715$1$I$$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120959$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240806$$HP$US$US
241807161$24180716$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123914$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240806$$CN$US$US
241807172$24180717$2$F$$20240805$20240806$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123178$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240821$$CN$US$US
241807182$24180718$2$F$$20240917$20240806$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123944$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240919$$CN$US$US
241807191$24180719$1$I$$20240708$20240806$20240806$PER$$US-LEX-000387$LEXICON PHARMACEUTICALS$$54$YR$$F$Y$$$20240806$$CN$US$US
241807201$24180720$1$I$20240322$20240805$20240806$20240806$EXP$FR-AFSSAPS-NY2024000894$FR-SANDOZ INC.-SDZ2024FR070790$SANDOZ$$78$YR$$M$Y$$$20240806$$MD$FR$FR
241807212$24180721$2$F$$20240809$20240806$20240819$PER$$US-ABBVIE-5859685$ABBVIE$$$$$F$Y$$$20240819$$MD$US$US
241807221$24180722$1$I$$20230412$20240806$20240806$EXP$$ZA-AstraZeneca-2023A085531$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$ZA$
241807231$24180723$1$I$$20230308$20240806$20240806$EXP$$US-AstraZeneca-2023A057344$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241807243$24180724$3$F$$20240812$20240806$20240829$PER$$US-AstraZeneca-2024A158631$ASTRAZENECA$$$$$$Y$$$20240829$$MD$US$
241807251$24180725$1$I$20230101$20240802$20240806$20240806$EXP$$US-ABBVIE-5866015$ABBVIE$$76$YR$$M$Y$$$20240806$$CN$US$US
241807261$24180726$1$I$20080101$20240802$20240806$20240806$EXP$$BR-AMERICAN REGENT INC-2024002992$AMERICAN REGENT$$$$$F$Y$60$KG$20240806$$CN$BR$BR
241807271$24180727$1$I$20200717$20240802$20240806$20240806$EXP$PL-URPL-1-3866-2020$PL-MYLANLABS-2024M1072311$MYLAN$$59$YR$$F$Y$50$KG$20240806$$MD$PL$PL
241807291$24180729$1$I$$20240729$20240806$20240806$EXP$$DK-TEVA-VS-3229232$TEVA$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic-Sci-Int 2009; 184 (1-3): 74-79.$25$YR$$F$Y$$$20240806$$HP$DK$DK
241807301$24180730$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA227661$SANOFI AVENTIS$$$$$M$Y$$$20240806$$CN$US$US
241807312$24180731$2$F$$20240805$20240806$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123441$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240812$$HP$US$US
241807321$24180732$1$I$$20240730$20240806$20240806$EXP$$US-009507513-2408USA000266$MERCK$Baschnagel A.M, Flakus M.J, Wallat E.M, Wuschner A.E, Chappell R.J, Bayliss A,et al.. APhase 2Randomized Clinical Trial Evaluating 4-Dimensional Computed Tomography Ventilation-Based Functional Lung Avoidance  Radiation Therapy for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology. 2024;119 (5):1394-1402$$$$M$Y$$$20240806$$MD$US$US
241807331$24180733$1$I$$20240801$20240806$20240806$EXP$$CN-FERRINGPH-2024FE04336$FERRING$$$$$$Y$$$20240806$$CN$CN$CN
241807341$24180734$1$I$20240701$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001940$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240806$$CN$US$US
241807351$24180735$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001877$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240806$$CN$US$US
241807361$24180736$1$I$20240729$20240730$20240806$20240806$EXP$$MY-FERRINGPH-2024FE04286$FERRING$$$$$$Y$$$20240806$$MD$MY$MY
241807371$24180737$1$I$20240611$20240725$20240806$20240806$EXP$ES-AEMPS-1551435$ES-FERRINGPH-2024FE04205$FERRING$$$$$$Y$$$20240806$$PH$ES$ES
241807382$24180738$2$F$20240424$20240813$20240806$20240819$EXP$$CO-FERRINGPH-2024FE04247$FERRING$$$$$$Y$$$20240819$$CN$CO$CO
241807391$24180739$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024155095$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241807401$24180740$1$I$$20240728$20240806$20240806$PER$$US-HALEON-2189614$Haleon PLC$$$$$$Y$$$20240806$$CN$US$US
241807411$24180741$1$I$20240529$20240804$20240806$20240806$EXP$FR-AFSSAPS-NC2024000923$FR-BAUSCH-BL-2024-011901$BAUSCH AND LOMB$$74$YR$$F$Y$82$KG$20240806$$MD$FR$FR
241807421$24180742$1$I$20240801$20240805$20240806$20240806$EXP$$US-SANDOZ INC.-SDZ2024US070694$SANDOZ$$55$YR$$F$Y$$$20240806$$CN$US$US
241807431$24180743$1$I$$20240805$20240806$20240806$PER$$US-BAUSCH-BL-2024-011910$BAUSCH AND LOMB$$$$$F$Y$$$20240806$$CN$US$US
241807441$24180744$1$I$$20240802$20240806$20240806$30DAY$$US-SANDOZ INC.-SDZ2024US070539$SANDOZ$$$$$F$Y$$$20240806$$CN$US$US
241807451$24180745$1$I$$20240805$20240806$20240806$EXP$$FR-BAUSCH-BL-2024-011923$BAUSCH AND LOMB$$90$YR$$F$Y$$$20240806$$MD$FR$FR
241807461$24180746$1$I$20240403$20240805$20240806$20240806$EXP$FR-AFSSAPS-TS2024000885$FR-BAUSCH-BL-2024-011924$BAUSCH AND LOMB$$81$YR$$F$Y$50$KG$20240806$$MD$FR$FR
241807472$24180747$2$F$$20240818$20240806$20240823$EXP$$IT-BAUSCH-BL-2019-022746$BAUSCH AND LOMB$$24$YR$$M$Y$$$20240823$$MD$IT$IT
241807481$24180748$1$I$20240708$20240708$20240806$20240806$PER$$US-LEX-000385$LEXICON PHARMACEUTICALS$$49$YR$$M$Y$$$20240806$$CN$US$US
241807491$24180749$1$I$$20240806$20240806$20240806$EXP$$CN-BAYER-2024A084869$BAYER$$72$YR$E$M$Y$$$20240806$$CN$CN$CN
241807502$24180750$2$F$20240426$20240731$20240806$20240819$EXP$$US-APELLIS-2024-APL-0000114$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240819$$HP$US$US
241807511$24180751$1$I$$20240728$20240806$20240806$PER$$US-JNJFOC-20240776245$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$CN$US$US
241807521$24180752$1$I$$20240802$20240806$20240806$PER$$US-JNJFOC-20240805892$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$HP$US$US
241807541$24180754$1$I$$20240806$20240806$20240806$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044076$BOEHRINGER INGELHEIM$$$$$$Y$$$20240806$$CN$US$US
241807551$24180755$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA227563$SANOFI AVENTIS$$$$A$M$Y$58.9$KG$20240806$$MD$US$US
241807561$24180756$1$I$20190101$20240730$20240806$20240806$PER$$US-SA-2024SA227658$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240806$$CN$US$US
241807571$24180757$1$I$20240501$20240802$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123925$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240806$$MD$US$US
241807582$24180758$2$F$$20240801$20240806$20240809$EXP$$BR-MYLANLABS-2024M1072381$MYLAN$$$$$F$Y$$$20240809$$CN$BR$BR
241807592$24180759$2$F$20231101$20240814$20240806$20240819$EXP$$GB-MYLANLABS-2024M1072112$MYLAN$$$$I$$Y$$$20240819$$PH$GB$GB
241807601$24180760$1$I$$20240802$20240806$20240806$EXP$$SE-MYLANLABS-2024M1072236$MYLAN$Kahn L, Kriikku P, J?nsson A.. Loperamide positive deaths in Sweden 2012-2022 and Finland 2017-2022: Fatal loperamide intoxication exclusively for Sweden. Forensic Science International. 2024;361$32$YR$$M$Y$$$20240806$$MD$SE$SE
241807612$24180761$2$F$$20240801$20240806$20240812$EXP$$CA-MYLANLABS-2024M1072194$MYLAN$$15$YR$$F$Y$$$20240812$$HP$CA$CA
241807621$24180762$1$I$20240222$20240731$20240806$20240806$EXP$$HN-MYLANLABS-2024M1072318$MYLAN$$68$YR$$F$Y$$$20240806$$CN$HN$HN
241807632$24180763$2$F$$20240731$20240806$20240806$EXP$$US-AMGEN-USASP2024152482$AMGEN$$$$$M$Y$$$20240806$$PH$US$US
241807641$24180764$1$I$$20240802$20240806$20240806$30DAY$$US-SANDOZ INC.-SDZ2024US070725$SANDOZ$$$$$F$Y$$$20240806$$MD$US$US
241807651$24180765$1$I$$20240730$20240806$20240806$EXP$$US-SMPA-2024SPA000436$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241807661$24180766$1$I$20240803$20240806$20240806$20240806$EXP$$NVSC2024KE159938$NOVARTIS$$36$YR$$M$Y$$$20240806$$MD$KE$KE
241807671$24180767$1$I$20230101$20240805$20240806$20240806$PER$$US-ABBVIE-5867619$ABBVIE$$$$$M$Y$$$20240806$$HP$US$US
241807681$24180768$1$I$20240708$20240730$20240806$20240806$EXP$DE-AMK-278251$DE-MYLANLABS-2024M1071170$MYLAN$$39$YR$$M$Y$80$KG$20240806$$PH$DE$DE
241807691$24180769$1$I$20240521$20240730$20240806$20240806$EXP$FR-AFSSAPS-MA2024000997$FR-MYLANLABS-2024M1071223$MYLAN$$17$YR$$F$Y$49$KG$20240806$$MD$FR$FR
241807701$24180770$1$I$$20240801$20240806$20240806$EXP$$ID-009507513-2408IDN001147$MERCK$$$$$F$Y$$$20240806$$MD$ID$ID
241807711$24180771$1$I$$20230524$20240806$20240806$EXP$$CA-DSJP-DSJ-2023-114420$DAIICHI$$$$$F$Y$$$20240806$$MD$CA$CA
241807731$24180773$1$I$$20240729$20240806$20240806$EXP$$FR-MYLANLABS-2024M1072770$MYLAN$Chanut M, Bonny V, Joly AC, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Arch-Cardiovasc-Dis 2024; 117 (4): 297-300.$65$YR$$F$Y$$$20240806$$HP$FR$FR
241807741$24180774$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123619$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$58.51$KG$20240806$$CN$US$US
241807751$24180775$1$I$20240720$20240731$20240806$20240806$EXP$$NVSC2024CN158210$NOVARTIS$$71$YR$$M$Y$66.3$KG$20240806$$HP$CN$CN
241807761$24180776$1$I$$20240805$20240806$20240806$PER$$NVSC2024US159709$NOVARTIS$$$$$$Y$$$20240806$$CN$US$US
241807771$24180777$1$I$$20230419$20240806$20240806$EXP$$CA-DSJP-DSJ-2023-111526$DAIICHI$$$$$F$Y$57.5$KG$20240806$$MD$CA$CA
241807781$24180778$1$I$$20240729$20240806$20240806$EXP$$DK-TEVA-VS-3228837$TEVA$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic-Sci-Int 2009; 184 (1-3): 74-79.$41$YR$$M$Y$$$20240806$$HP$DK$DK
241807791$24180779$1$I$$20240523$20240806$20240806$PER$$NVSC2024US116217$NOVARTIS$$20$MON$$F$Y$$$20240806$$MD$US$US
241807801$24180780$1$I$$20240801$20240806$20240806$EXP$$US-INCYTE CORPORATION-2024IN008074$INCYTE$$$$$$Y$$$20240806$$CN$US$US
241807811$24180781$1$I$20230101$20240726$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407018533$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240806$$CN$US$US
241807821$24180782$1$I$$20240805$20240806$20240806$PER$$US-DSJP-DSU-2024-139315$DAIICHI$$$$$F$Y$$$20240806$$CN$US$US
241807832$24180783$2$F$$20240802$20240806$20240808$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-139312$DAIICHI$$42$YR$$F$Y$$$20240808$$CN$US$US
241807841$24180784$1$I$20240101$20240805$20240806$20240806$PER$$US-DSJP-DSU-2024-139317$DAIICHI$$$$$F$Y$$$20240806$$PH$US$US
241807861$24180786$1$I$$20230825$20240806$20240806$EXP$$US-AstraZeneca-2023A195673$ASTRAZENECA$$$$$$Y$$$20240806$$CN$US$
241807871$24180787$1$I$$20200406$20240806$20240806$EXP$$US-AstraZeneca-2020SE48287$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241807881$24180788$1$I$$20230822$20240806$20240806$EXP$$US-AstraZeneca-2023A192034$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241807891$24180789$1$I$$20230831$20240806$20240806$EXP$$US-AstraZeneca-2023A200006$ASTRAZENECA$$$$$$Y$$$20240806$$HP$US$
241807901$24180790$1$I$$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124350$BRISTOL MYERS SQUIBB$$6$DEC$A$F$Y$$$20240806$$MD$US$US
241807911$24180791$1$I$$20240730$20240806$20240806$EXP$$DE-DUCHESNAY-2024DE000299$DUCHESNAY$$$$$$Y$$$20240806$$MD$DE$DE
241807921$24180792$1$I$$20240801$20240806$20240806$EXP$$US-INCYTE CORPORATION-2024IN008077$INCYTE$$$$$$Y$$$20240806$$CN$US$US
241807931$24180793$1$I$$20240805$20240806$20240806$PER$$US-PFIZER INC-PV202400102223$PFIZER$$88$YR$$F$Y$$$20240806$$CN$US$US
241807941$24180794$1$I$20240801$20240802$20240806$20240806$PER$$US-PFIZER INC-202400229554$PFIZER$$52$YR$$F$Y$58.97$KG$20240806$$CN$US$US
241807951$24180795$1$I$$20240801$20240806$20240806$EXP$$US-INCYTE CORPORATION-2024IN008084$INCYTE$$$$$$Y$$$20240806$$MD$US$US
241807961$24180796$1$I$$20240801$20240806$20240806$EXP$$US-INCYTE CORPORATION-2024IN007724$INCYTE$$$$$$Y$$$20240806$$CN$US$US
241807971$24180797$1$I$20240111$20240725$20240806$20240806$EXP$FR-AFSSAPS-ST2024001188$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07185$HIKMA$$59$YR$$M$Y$$$20240806$$HP$FR$FR
241807981$24180798$1$I$20240731$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153670$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241807991$24180799$1$I$20240605$20240725$20240806$20240806$EXP$FR-AFSSAPS-ST2024001180$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07187$HIKMA$$70$YR$$M$Y$63$KG$20240806$$HP$FR$FR
241808001$24180800$1$I$20240701$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122761$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240806$$PH$US$US
241808011$24180801$1$I$20240612$20240729$20240806$20240806$EXP$FR-AFSSAPS-NC2024000864$FR-TEVA-VS-3227463$TEVA$$46$YR$$M$Y$98$KG$20240806$$MD$FR$FR
241808021$24180802$1$I$20240701$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123146$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240806$$HP$US$US
241808032$24180803$2$F$20240101$20240808$20240806$20240903$PER$$US-009507513-2407USA011156$MERCK$$$$$F$Y$80.7$KG$20240903$$CN$US$US
241808041$24180804$1$I$20240625$20240722$20240806$20240806$EXP$$RU-GLENMARK PHARMACEUTICALS-2024GMK092687$GLENMARK$$$$$$Y$$$20240806$$MD$RU$RU
241808052$24180805$2$F$20240708$20240807$20240806$20240809$EXP$IT-MINISAL02-997281$IT-GILEAD-2024-0682901$GILEAD$$53$YR$A$M$Y$68$KG$20240809$$MD$IT$IT
241808062$24180806$2$F$20240101$20240813$20240806$20240828$PER$$US-KARYOPHARM-2024KPT001337$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
241808071$24180807$1$I$20240701$20240715$20240806$20240806$PER$$US-KARYOPHARM-2024KPT001319$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240806$$CN$US$US
241808081$24180808$1$I$20240601$20240729$20240806$20240806$PER$$US-KARYOPHARM-2024KPT001372$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240806$$CN$US$US
241808091$24180809$1$I$20240720$20240731$20240806$20240806$EXP$IT-MINISAL02-996425$IT-MYLANLABS-2024M1071698$MYLAN$$81$YR$$M$Y$$$20240806$$MD$IT$IT
241808101$24180810$1$I$20240513$20240731$20240806$20240806$EXP$FR-AFSSAPS-AVPO2024000111$FR-MYLANLABS-2024M1071615$MYLAN$$30$YR$$F$Y$$$20240806$$PH$FR$FR
241808111$24180811$1$I$20240101$20240723$20240806$20240806$PER$$US-TEVA-VS-3226042$TEVA$$82$YR$$M$Y$$$20240806$$HP$US$US
241808121$24180812$1$I$20191201$20240802$20240806$20240806$EXP$$US-INCYTE CORPORATION-2024IN008149$INCYTE$$$$$$Y$$$20240806$$CN$US$US
241808131$24180813$1$I$20240713$20240725$20240806$20240806$EXP$$US-FMCRTG-FMC-2407-000913$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240806$$HP$US$US
241808151$24180815$1$I$$20240802$20240806$20240806$EXP$$BR-DSJP-DSE-2024-138580$DAIICHI$$$$$F$Y$$$20240806$$MD$BR$BR
241808161$24180816$1$I$$20240805$20240806$20240806$EXP$$AU-GILEAD-2024-0682992$GILEAD$$$$E$M$Y$$$20240806$$MD$AU$AU
241808181$24180818$1$I$$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124238$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$78.3$KG$20240806$$HP$US$US
241808191$24180819$1$I$$20230414$20240806$20240806$EXP$$ZA-AstraZeneca-2023A088798$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$ZA$
241808201$24180820$1$I$$20211006$20240806$20240806$EXP$$US-AstraZeneca-2021A766737$ASTRAZENECA$$$$$M$Y$$$20240806$$CN$US$
241808211$24180821$1$I$20240519$20240731$20240806$20240806$EXP$$CN-PURDUE-USA-2024-0311151$PURDUE$$60$YR$$M$Y$45$KG$20240806$$HP$CN$CN
241808221$24180822$1$I$20240501$20240802$20240806$20240806$EXP$$US-PURDUE-USA-2024-0311112$PURDUE$$35$YR$$F$Y$73.03$KG$20240806$$CN$US$US
241808231$24180823$1$I$$20240801$20240806$20240806$EXP$$ES-PURDUE-USA-2024-0311176$PURDUE$Ana Maria Panadero Alcala, Cesar Margarit Ferri, Vicente Lopez Gil, Yolanda Sastre Peris, Luis Gomez Salinas. Benedikt Eiden Hospital general universitario doctor Balmis de Alicante. Paraparesia en paciente portador de bomba de infusi?n intratecal./ Benedikt Eiden General university hospital doctor Balmis in Alicante. Paraparesia in a patient with an intrathecal infusion pump. Revista Sociedad Epanola del dolor/ Spanish Pain Society Journal. 2024;31 Supp:1$62$YR$$M$Y$$$20240806$$HP$ES$ES
241808251$24180825$1$I$$20240718$20240806$20240806$PER$$US-JNJFOC-20240756531$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240806$$CN$US$US
241808261$24180826$1$I$$20240727$20240806$20240806$PER$$US-BAYER-2024A110923$BAYER$$$$$$Y$$$20240806$$CN$US$US
241808271$24180827$1$I$$20240730$20240806$20240806$EXP$$JP-DSJP-DSJ-2024-138445$DAIICHI$Ono Y, Kimiduka K, Sugiyama J, Fukatsu Y, Miyake H, Ogura M. EP-1295 A case of postoperative bone metastasis of right breast cancer with cervical subcutaneous emphysema and mediastinitis from bone resorption drug-related osteonecrosis of the jaw (ARONJ). The 32nd Annual Meeting of the Japan Breast Cancer Societ. 2024;501$66$YR$$F$Y$$$20240806$$MD$JP$JP
241808282$24180828$2$F$$20240828$20240806$20240903$EXP$$NVSC2024IE159235$NOVARTIS$Kelliher J, Rahmani G, Carey JJ, Bergin D. Severe atypical iliac wing fracture associated with long-term bisphosphonate use. SKELETAL RADIOLOGY. 2024$63$YR$$F$Y$$$20240903$$HP$IE$IE
241808291$24180829$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA225961$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240806$$MD$US$US
241808301$24180830$1$I$$20240802$20240806$20240806$EXP$$NVSC2024ES159779$NOVARTIS$Vargas-Osorio K, Calatayud-Cubes A, Diaz-Lopez EJ, Barbaran-Corral C, Lazare-Iglesias H, Anido-Herranz U et al.. Expression of somatostatin receptors in radioiodine refractory follicular cell derived thyroid carcinomas detected with [68Ga] Ga-DOTA-TOC. VIRCHOWS ARCHIV. 2023;483 (Suppl. 1):S251$41$YR$$M$Y$$$20240806$$HP$ES$ES
241808311$24180831$1$I$20240101$20240708$20240806$20240806$PER$$US-LEX-000386$LEXICON PHARMACEUTICALS$$83$YR$$F$Y$$$20240806$$CN$US$US
241808322$24180832$2$F$$20240808$20240806$20240816$PER$$US-ROCHE-10000048973$ROCHE$$$$A$F$Y$$$20240816$$MD$US$US
241808332$24180833$2$F$$20240729$20240806$20240808$EXP$$FR-TEVA-VS-3229231$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$82$YR$$M$Y$$$20240808$$HP$FR$FR
241808341$24180834$1$I$$20240725$20240806$20240806$EXP$$NVSC2024IN154775$NOVARTIS$$$$$M$Y$$$20240806$$CN$IN$IN
241808351$24180835$1$I$$20240801$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122108$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240806$$CN$US$US
241808361$24180836$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA226221$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$MD$US$US
241808371$24180837$1$I$$20240730$20240806$20240806$EXP$$US-MYLANLABS-2024M1072225$MYLAN$$$$C$$Y$$$20240806$$CN$US$US
241808382$24180838$2$F$$20240729$20240806$20240808$EXP$$NVSC2024TR159901$NOVARTIS$Demirport E, Aycan MB, Metan G, Kahraman V, Karatoprak GS. HANGi ARAC VORiKONAZOL DOZUNU OPTiMiZE ETMEK iciN EN iYi REHBERDiR TERAP?TiK iZLEME Mi YOKSA SiTOKROM P450 POLiMORFiZMi Mi [Which tool is the best guide optimize the voriconazole dosage: Therapeutic drug monitoring or cytochrome p450 polymorphism]. SA?LIK BILIMLERI DERGISI (JOURNAL OF HEALTH SCIENCES). 2024;33(2):182-9$52$YR$$$Y$$$20240808$$HP$TR$TR
241808413$24180841$3$F$20240701$20240731$20240806$20240814$EXP$$CN-009507513-2408CHN001023$MERCK$$49$YR$$F$Y$$$20240814$$HP$CN$CN
241808422$24180842$2$F$$20240902$20240806$20240910$EXP$$US-TEVA-VS-3228275$TEVA$Joshi A, Ghnaima H, Nader G, Alattal S. A Trifecta of Challenges: A Case Report of Triple Valve Endocarditis. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination; Joshi A, Ghnaima H, Nader G, Alattal S. A Trifecta of Challenges: A Case Report of Triple Valve Endocarditis. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.$37$YR$$M$Y$$$20240910$$HP$US$US
241808433$24180843$3$F$20240101$20240903$20240806$20240909$EXP$$US-VERTEX PHARMACEUTICALS-2024-012585$VERTEX$$29$YR$$F$Y$92$KG$20240909$$HP$US$US
241808442$24180844$2$F$20240630$20240830$20240806$20240905$EXP$FR-AFSSAPS-LL2024001449$FR-009507513-2408FRA000962$MERCK$$61$YR$$F$Y$59$KG$20240905$$MD$FR$FR
241808451$24180845$1$I$$20240725$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016808$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240806$$CN$US$US
241808463$24180846$3$F$$20240808$20240806$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002136$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240813$$CN$US$US
241808471$24180847$1$I$$20240725$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017895$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240806$$CN$US$US
241808481$24180848$1$I$$20240731$20240806$20240806$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202408002290$ELI LILLY AND CO$$$$$F$Y$$$20240806$$CN$CO$CO
241808491$24180849$1$I$20240702$20240725$20240806$20240806$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408000865$ELI LILLY AND CO$$50$YR$A$M$Y$55$KG$20240806$$CN$DE$CN
241808501$24180850$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA230526$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240806$$MD$US$US
241808511$24180851$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA226230$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240806$$CN$US$US
241808521$24180852$1$I$20240408$20240802$20240806$20240806$EXP$FR-AFSSAPS-AVMA2024000338$FR-MYLANLABS-2024M1072209$MYLAN$$53$YR$$M$Y$$$20240806$$MD$FR$FR
241808531$24180853$1$I$20240615$20240729$20240806$20240806$EXP$FR-AFSSAPS-TO2024001186$FR-TEVA-VS-3227357$TEVA$$52$YR$$F$Y$$$20240806$$PH$FR$FR
241808542$24180854$2$F$$20240902$20240806$20240910$EXP$$US-TEVA-VS-3228274$TEVA$Garg A, Joong A, Gambetta K, Monge M, Thrush P. To VAD or Not VAD? How to Get to Heart Transplant in a Child with Duchenne Muscular Dystrophy. J-Heart-Lung-Transplant 2024; 43 (Suppl.) (4): S633 abstr. 1376.; Garg A, Joong A, Gambetta K, Monge M, Thrush P. To VAD or Not VAD? How to Get to Heart Transplant in a Child with Duchenne Muscular Dystrophy. J-Heart-Lung-Transplant 2024; 43 (Suppl.) (4): S633 abstr. 1376.$9$YR$$M$Y$$$20240910$$HP$US$US
241808551$24180855$1$I$$20240725$20240806$20240806$PER$$US-JNJFOC-20240812820$JOHNSON AND JOHNSON$$$$$$Y$$$20240806$$MD$US$US
241808571$24180857$1$I$$20240802$20240806$20240806$PER$$US-JNJFOC-20240808352$JOHNSON AND JOHNSON$$$$T$$Y$$$20240806$$MD$US$US
241808581$24180858$1$I$$20240724$20240806$20240806$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-120637$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240806$$HP$CA$CA
241808592$24180859$2$F$$20240815$20240806$20240823$PER$$US-ALKERMES INC.-ALK-2024-002013$ALKERMES$$$$$M$Y$$$20240823$$HP$US$US
241808613$24180861$3$F$20240709$20240823$20240806$20240902$PER$$US-JNJFOC-20240812842$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240902$$CN$US$US
241808631$24180863$1$I$20240501$20240611$20240806$20240806$PER$$US-JNJFOC-20240813052$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240806$$PH$US$US
241808641$24180864$1$I$20240501$20240611$20240806$20240806$PER$$US-JNJFOC-20240813162$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240806$$PH$US$US
241808651$24180865$1$I$20240501$20240611$20240806$20240806$PER$$US-JNJFOC-20240813148$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240806$$PH$US$US
241808671$24180867$1$I$$20240731$20240806$20240806$EXP$$US-APELLIS-2024-APL-0000609$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240805$$HP$US$US
241808681$24180868$1$I$20200630$20240731$20240806$20240806$EXP$PL-URPL-1-1620-2020$PL-NALPROPION PHARMACEUTICALS INC.-PL-2024CUR003620$CURRAX PHARMACEUTICALS$$47$YR$$M$Y$105$KG$20240806$$MD$PL$PL
241808691$24180869$1$I$20240723$20240802$20240806$20240806$EXP$$US-ABBVIE-5867168$ABBVIE$$43$YR$$F$Y$$$20240806$$CN$US$US
241808701$24180870$1$I$20240718$20240801$20240806$20240806$PER$$CN-Eisai-EC-2024-171372$EISAI$$33$YR$A$F$Y$83.9$KG$20240806$$HP$CN$CN
241808711$24180871$1$I$20240729$20240730$20240806$20240806$EXP$$GB-BAUSCH-BL-2024-011933$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240806$$CN$GB$GB
241808732$24180873$2$F$20240101$20240725$20240806$20240828$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15027$IPSEN$$33$YR$A$F$Y$61.2$KG$20240828$$CN$US$US
241808741$24180874$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA226299$SANOFI AVENTIS$$$$C$M$Y$$$20240806$$MD$US$US
241808751$24180875$1$I$$20240709$20240806$20240806$PER$$US-JNJFOC-20240727259$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240806$$CN$US$US
241808762$24180876$2$F$20240101$20240813$20240806$20240826$PER$$US-SA-2024SA226260$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240826$$MD$US$US
241808771$24180877$1$I$$20240805$20240806$20240806$PER$$US-PURDUE-USA-2024-0311147$PURDUE$$$$$M$Y$$$20240806$$PH$US$US
241808781$24180878$1$I$$20240803$20240806$20240806$PER$$US-PURDUE PHARMA-USA-2024-0311141$PURDUE$$$$$F$Y$$$20240806$$CN$US$US
241808791$24180879$1$I$$20240803$20240806$20240806$PER$$US-PURDUE PHARMA-USA-2024-0311163$PURDUE$$37$YR$$M$Y$$$20240806$$CN$US$US
241808802$24180880$2$F$20230402$20240803$20240806$20240808$EXP$$US-PURDUE PHARMA-USA-2024-0311138$PURDUE$$$$$M$Y$$$20240808$$CN$US$US
241808811$24180881$1$I$$20240803$20240806$20240806$PER$$US-PURDUE PHARMA-USA-2024-0311142$PURDUE$$51$YR$$M$Y$$$20240806$$CN$US$US
241808821$24180882$1$I$$20240803$20240806$20240806$PER$$US-PURDUE PHARMA-USA-2024-0311139$PURDUE$$$$$M$Y$$$20240806$$CN$US$US
241808831$24180883$1$I$$20240805$20240806$20240806$PER$$US-PURDUE PHARMA-USA-2024-0311145$PURDUE$$$$$$Y$$$20240806$$CN$US$US
241808841$24180884$1$I$$20240804$20240806$20240806$PER$$US-PURDUE PHARMA-USA-2024-0311144$PURDUE$$$$$M$Y$$$20240806$$CN$US$US
241808852$24180885$2$F$20240726$20240805$20240806$20240807$PER$$US-PURDUE PHARMA-USA-2024-0311146$PURDUE$$47$YR$$M$Y$68.04$KG$20240807$$CN$US$US
241808861$24180886$1$I$20200211$20240801$20240806$20240806$PER$$US-PURDUE PHARMA-USA-2024-0309972$PURDUE$$40$YR$$F$Y$$$20240806$$HP$US$US
241808871$24180887$1$I$$20240801$20240806$20240806$PER$$US-PURDUE PHARMA-USA-2024-0311143$PURDUE$$$$$M$Y$$$20240806$$HP$US$US
241808882$24180888$2$F$20240219$20240719$20240806$20240806$EXP$FR-AFSSAPS-ST2024001166$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-117528$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$78$KG$20240726$$HP$FR$FR
241808892$24180889$2$F$$20240724$20240806$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118663$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240927$$CN$US$US
241808902$24180890$2$F$20240704$20240719$20240806$20240806$EXP$FR-AFSSAPS-CN2024000709$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-117066$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$63.5$KG$20240726$$MD$FR$FR
241808911$24180891$1$I$20240723$20240725$20240806$20240806$EXP$GB-MHRA-MED-202407251128486820-MYPRL$GB-ELI_LILLY_AND_COMPANY-GB202407016570$ELI LILLY AND CO$$32$YR$A$F$Y$88$KG$20240806$$CN$GB$GB
241808921$24180892$1$I$20230101$20240725$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017527$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240806$$CN$US$US
241808931$24180893$1$I$$20240725$20240806$20240806$EXP$GB-MHRA-MED-202407251443357650-YKTFJ$GB-ELI_LILLY_AND_COMPANY-GB202407016609$ELI LILLY AND CO$$$$$F$Y$$$20240806$$CN$GB$GB
241808941$24180894$1$I$$20240725$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017934$ELI LILLY AND CO$$$$$$Y$$$20240806$$CN$US$US
241808951$24180895$1$I$$20240726$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001085$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240806$$CN$US$US
241808961$24180896$1$I$20200101$20240725$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017094$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240806$$CN$US$US
241808971$24180897$1$I$$20240801$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408001705$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240806$$HP$US$US
241808981$24180898$1$I$20240719$20240725$20240806$20240806$EXP$GB-MHRA-MED-202407251834548080-NBQSH$GB-ELI_LILLY_AND_COMPANY-GB202407017287$ELI LILLY AND CO$$55$YR$A$F$Y$90$KG$20240806$$CN$GB$GB
241809001$24180900$1$I$$20240725$20240806$20240806$EXP$$US-ELI_LILLY_AND_COMPANY-US202407018176$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240806$$CN$US$US
241809013$24180901$3$F$20240531$20240910$20240806$20240910$PER$$US-ALXN-202407USA002036US$ALEXION PHARMACEUTICALS$$39$YR$$F$Y$$$20240910$$CN$US$US
241809021$24180902$1$I$$20240725$20240806$20240806$EXP$GB-MHRA-MED-202407251711326560-TBDNG$GB-ELI_LILLY_AND_COMPANY-GB202407017362$ELI LILLY AND CO$$$$$F$Y$116$KG$20240806$$CN$GB$GB
241809031$24180903$1$I$$20240708$20240806$20240806$PER$$US-009507513-2407USA003912$MERCK$$$$$F$Y$$$20240806$$HP$US$US
241809041$24180904$1$I$$20211020$20240806$20240806$EXP$$US-AstraZeneca-2021A781831$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241809051$24180905$1$I$20240601$20240729$20240806$20240806$PER$$US-SA-2024SA226427$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240806$$MD$US$US
241809061$24180906$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA226153$SANOFI AVENTIS$$$$A$F$Y$$$20240806$$CN$US$US
241809071$24180907$1$I$$20240729$20240806$20240806$PER$$US-SA-2024SA226518$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240806$$MD$US$US
241809091$24180909$1$I$$20211126$20240806$20240806$EXP$$CA-AstraZeneca-2021A794621$ASTRAZENECA$$$$$F$Y$$$20240806$$HP$CA$
241809102$24180910$2$F$20200723$20240901$20240806$20240905$EXP$$TW-009507513-2408TWN001003$MERCK$$49$YR$$M$Y$$$20240905$$MD$TW$TW
241809111$24180911$1$I$$20220228$20240806$20240806$EXP$$US-AstraZeneca-2022A092199$ASTRAZENECA$$$$$F$Y$$$20240806$$CN$US$
241809121$24180912$1$I$$20240805$20240806$20240806$30DAY$$US-SANDOZ INC.-SDZ2024US070692$SANDOZ$$$$$M$Y$$$20240806$$CN$US$US
241809142$24180914$2$F$$20240822$20240806$20240822$PER$$US-ALXN-202407USA001998US$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240822$$CN$US$US
241809151$24180915$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA228614$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240806$$MD$US$US
241809161$24180916$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA227665$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240806$$MD$US$US
241809172$24180917$2$F$$20240902$20240806$20240910$EXP$$US-TEVA-VS-3228276$TEVA$Fatima M, Gandhi ZJ, Simonetti G, Saladi L, Naik S. Fatal Case of Cryptococcal Arthritis. Am-J-Respir-Crit-Care-Med 2023; 207.; Fatima M, Gandhi ZJ, Simonetti G, Saladi L, Naik S. Fatal Case of Cryptococcal Arthritis. Am-J-Respir-Crit-Care-Med 2023; 207.$57$YR$$F$Y$$$20240910$$HP$US$US
241809191$24180919$1$I$20240601$20240801$20240806$20240806$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043422$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240806$$CN$US$US
241809201$24180920$1$I$20240501$20240611$20240806$20240806$PER$$US-JNJFOC-20240813206$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240806$$PH$US$US
241809211$24180921$1$I$20230601$20240801$20240806$20240806$EXP$$PL-BAUSCH-BL-2024-011799$BAUSCH AND LOMB$$58$YR$$F$Y$$$20240806$$HP$PL$PL
241809222$24180922$2$F$$20240902$20240806$20240910$EXP$$US-TEVA-VS-3228596$TEVA$: Duarte A, Teague TT. Acute Epiglottitis Due to Combined COVID-19 Infection and Haemophilus Influenzae Bacteremia. Am-J-Respir-Crit-Care-Med 2024; 209.; Duarte A, Teague TT. Acute Epiglottitis Due to Combined COVID-19 Infection and Haemophilus Influenzae Bacteremia. Am-J-Respir-Crit-Care-Med 2024; 209.$67$YR$$M$Y$$$20240910$$HP$US$US
241809232$24180923$2$F$$20240802$20240806$20240816$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-23717$SAMSUNG BIOEPIS$Oryniak D, Brown M, Elgazzar R. Development of medication-related osteonecrosis of the jaw in a patient on long-term infliximab therapy. Frontiersin oral health. 2024 JUL 09;. doi:10.3389/froh.2024.1427060$78$YR$E$M$Y$$$20240814$$HP$CA$CA
241809243$24180924$3$F$$20240913$20240806$20240921$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-23462$SAMSUNG BIOEPIS$$35$YR$A$F$Y$$$20240921$$HP$CA$CA
241809251$24180925$1$I$$20240729$20240806$20240806$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-23451$SAMSUNG BIOEPIS$$64$YR$A$F$Y$$$20240806$$CN$GB$GB
241809262$24180926$2$F$$20240826$20240806$20240826$PER$$US-ALXN-202407USA002130US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
241809273$24180927$3$F$$20240823$20240806$20240823$PER$$US-ALXN-202407USA001980US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
241809281$24180928$1$I$$20240729$20240806$20240806$EXP$$CA-AstraZeneca-2020SE05975$ASTRAZENECA$$75$YR$$M$Y$$$20240806$$MD$CA$
241809311$24180931$1$I$20240501$20240611$20240806$20240806$PER$$US-JNJFOC-20240813240$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240806$$PH$US$US
241809323$24180932$3$F$20240701$20240910$20240806$20240911$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044099$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240911$$CN$US$US
241809331$24180933$1$I$20240101$20240729$20240806$20240806$PER$$US-SA-2024SA228004$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240806$$MD$US$US
241809341$24180934$1$I$20240601$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123435$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$79$KG$20240806$$HP$US$US
241809351$24180935$1$I$20240101$20240725$20240806$20240806$PER$$US-SA-2024SA225892$SANOFI AVENTIS$$30$YR$A$M$Y$117.48$KG$20240806$$MD$US$US
241809362$24180936$2$F$$20240901$20240806$20240904$EXP$$TW-009507513-2408TWN001680$MERCK$$33$YR$$M$Y$$$20240904$$MD$TW$TW
241809371$24180937$1$I$$20240731$20240806$20240806$EXP$$US-ABBVIE-5863283$ABBVIE$$$$$F$Y$$$20240806$$HP$US$US
241809381$24180938$1$I$$20240729$20240806$20240806$EXP$$CN-JNJFOC-20240802175$JOHNSON AND JOHNSON$$$$C$$Y$$$20240806$$HP$CN$CN
241809392$24180939$2$F$20220225$20240830$20240806$20240906$EXP$$US-009507513-2407USA008234$MERCK$$84$YR$$F$Y$39.456$KG$20240906$$HP$US$US
241809401$24180940$1$I$$20240730$20240806$20240806$PER$$US-ALXN-202407USA002088US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
241809421$24180942$1$I$$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002583$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240806$$CN$US$US
241809431$24180943$1$I$20240612$20240731$20240806$20240806$EXP$$CN-009507513-2408CHN001054$MERCK$$58$YR$$M$Y$62$KG$20240806$$HP$CN$CN
241809441$24180944$1$I$$20240731$20240806$20240806$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-23650$SAMSUNG BIOEPIS$$52$YR$A$F$Y$$$20240806$$MD$CA$CA
241809452$24180945$2$F$20240728$20240912$20240806$20240920$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-23573$SAMSUNG BIOEPIS$$36$YR$A$F$Y$$$20240920$$CN$GB$GB
241809461$24180946$1$I$$20240731$20240806$20240806$PER$$US-BEH-2024176644$CSL BEHRING$$$$A$F$Y$$$20240806$$CN$US$US
241809471$24180947$1$I$$20240617$20240806$20240806$PER$$US-LUNDBECK-DKLU4000729$LUNDBECK$$$$$$Y$$$20240806$$CN$US$US
241809481$24180948$1$I$$20240801$20240806$20240806$EXP$$US-AMGEN-USASP2024154054$AMGEN$$$$$F$Y$$$20240806$$PH$US$US
241809491$24180949$1$I$20240729$20240801$20240806$20240806$EXP$$CN-ROCHE-10000049547$ROCHE$$72$YR$E$M$Y$60$KG$20240806$$HP$CN$CN
241809511$24180951$1$I$$20240618$20240806$20240806$PER$$US-LUNDBECK-DKLU4000918$LUNDBECK$$$$$$Y$$$20240806$$CN$US$US
241809521$24180952$1$I$$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408003072$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240806$$CN$US$US
241809531$24180953$1$I$20240101$20240806$20240806$20240806$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044132$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240806$$CN$US$US
241809541$24180954$1$I$$20240730$20240806$20240806$PER$$US-APELLIS-2024-APL-0000607$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240806$$MD$US$US
241809551$24180955$1$I$$20240617$20240806$20240806$PER$$US-LUNDBECK-DKLU4000679$LUNDBECK$$$$$$Y$$$20240806$$HP$US$US
241809561$24180956$1$I$$20240731$20240806$20240806$EXP$$IT-SA-2024SA226461$SANOFI AVENTIS$Fiumara A, Sapuppo A, Gasperini S, Crescitelli V, Sacchini M, Procopio E, et al.. Avalglucosidase alfa in infantile-onset Pompe disease: A snapshot of real-world experience in Italy.. Molecular Genetics and Metabolism Reports. 2024;40:1-8$11$MON$I$M$Y$$$20240807$$HP$IT$IT
241809571$24180957$1$I$$20240617$20240806$20240806$PER$$US-LUNDBECK-DKLU4000893$LUNDBECK$$$$$$Y$$$20240806$$HP$US$US
241809581$24180958$1$I$$20240617$20240806$20240806$PER$$US-LUNDBECK-DKLU4000847$LUNDBECK$$$$$$Y$$$20240806$$CN$US$US
241809591$24180959$1$I$$20240722$20240806$20240806$EXP$$CA-HLS-202401858$HLS THERAPEUTICS$$$$E$M$Y$$$20240806$$HP$CA$CA
241809601$24180960$1$I$20240617$20240617$20240806$20240806$PER$$US-LUNDBECK-DKLU4000681$LUNDBECK$$$$$$Y$$$20240806$$CN$US$US
241809611$24180961$1$I$$20240801$20240806$20240806$PER$$NVSC2024US157972$NOVARTIS$$$$$M$Y$$$20240807$$MD$US$US
241809621$24180962$1$I$$20240618$20240806$20240806$PER$$US-LUNDBECK-DKLU4000920$LUNDBECK$$$$$$Y$$$20240806$$CN$US$US
241809632$24180963$2$F$20240101$20240919$20240806$20240919$PER$$NVSC2024US159241$NOVARTIS$$$$$M$Y$$$20240919$$MD$US$US
241809642$24180964$2$F$$20240808$20240806$20240925$PER$$US-LUNDBECK-DKLU4000618$LUNDBECK$$$$$$Y$$$20240925$$HP$US$US
241809651$24180965$1$I$$20240617$20240806$20240806$PER$$US-LUNDBECK-DKLU4000680$LUNDBECK$$$$$$Y$$$20240806$$HP$US$US
241809671$24180967$1$I$$20240806$20240806$20240806$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044136$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240806$$MD$US$US
241809682$24180968$2$F$20240802$20240805$20240806$20240808$PER$$NVSC2024US158996$NOVARTIS$$59$YR$$F$Y$$$20240808$$CN$US$US
241809691$24180969$1$I$20240721$20240730$20240806$20240806$EXP$$CN-ROCHE-10000048405$ROCHE$$75$YR$E$M$Y$85$KG$20240806$$HP$CN$CN
241809701$24180970$1$I$20240101$20240617$20240806$20240806$PER$$US-LUNDBECK-DKLU4000731$LUNDBECK$$$$$$Y$$$20240806$$CN$US$US
241809712$24180971$2$F$$20240826$20240806$20240826$PER$$US-ALXN-202407USA002112US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241809721$24180972$1$I$$20240806$20240806$20240806$EXP$$GB-ANIPHARMA-2024-UK-000142$ANI$Rossi NP, Sathyanarayanan G, Mahmood M, Shakespeare D.Toxic leukoencephalopathy versus delayed post-hypoxic leukoencephalopathy after oral morphine sulphate overdose..BMJ Case Reports.2023;16(9):.$4$DEC$$M$Y$$$20240806$$MD$GB$GB
241809731$24180973$1$I$20240723$20240801$20240806$20240806$EXP$$DE-JNJFOC-20240813277$JOHNSON AND JOHNSON$$$$$M$Y$$$20240806$$MD$DE$DE
241809741$24180974$1$I$$20240723$20240806$20240806$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07407$NEUROCRINE BIOSCIENCES$$6$DEC$$F$Y$$$20240806$$HP$US$US
241809751$24180975$1$I$20230101$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153870$AMGEN$$71$YR$E$F$Y$$$20240806$$PH$US$US
241809772$24180977$2$F$$20240814$20240806$20240819$EXP$$ES-TAKEDA-2024TUS078705$TAKEDA$$$$$F$Y$$$20240819$$CN$GB$ES
241809791$24180979$1$I$$20240803$20240806$20240806$EXP$$US-TAKEDA-2024TUS078567$TAKEDA$$$$$F$Y$$$20240806$$MD$US$US
241809801$24180980$1$I$20240709$20240806$20240806$20240806$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044127$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240806$$CN$US$US
241809811$24180981$1$I$20240701$20240722$20240806$20240806$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07417$NEUROCRINE BIOSCIENCES$$68$YR$$M$Y$$$20240806$$HP$US$US
241809821$24180982$1$I$20240601$20240722$20240806$20240806$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07445$NEUROCRINE BIOSCIENCES$$35$YR$$F$Y$$$20240806$$HP$US$US
241809831$24180983$1$I$20220422$20240731$20240806$20240806$EXP$FR-AFSSAPS-ST2024001213$FR-JNJFOC-20240812731$JOHNSON AND JOHNSON$$1$DY$N$M$Y$3.19$KG$20240806$$MD$FR$FR
241809841$24180984$1$I$$20240723$20240806$20240806$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07484$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240806$$HP$US$US
241809861$24180986$1$I$20220401$20240802$20240806$20240806$EXP$$NVSC2024RU158651$NOVARTIS$$60$YR$$F$Y$$$20240807$$MD$RU$RU
241809871$24180987$1$I$$20240724$20240806$20240806$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07506$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240806$$HP$US$US
241809881$24180988$1$I$$20240805$20240806$20240806$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044015$BOEHRINGER INGELHEIM$$55$YR$A$$Y$$$20240806$$CN$US$US
241809891$24180989$1$I$20191026$20240731$20240806$20240806$EXP$FR-AFSSAPS-ST2024001220$FR-JNJFOC-20240812723$JOHNSON AND JOHNSON$$1$DY$N$F$Y$2.23$KG$20240806$$MD$FR$FR
241809961$24180996$1$I$$20240801$20240806$20240806$PER$$US-ALXN-202408USA000056US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
241809972$24180997$2$F$$20240822$20240806$20240823$PER$$US-ALXN-202407USA002185US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
241809982$24180998$2$F$$20240805$20240806$20240807$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044107$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240807$$CN$US$US
241809993$24180999$3$F$$20240826$20240806$20240917$EXP$$JP-MTPC-MTPC2024-0016309$MITSUBISHI TANABE PHARMA$Matsuo H, Hamada S, Tamura R, Yabata H, Yamakawa I, Urushitani M, et al.. A-01 An autopsy case of amyotrophic lateral sclerosis with relatively preserved activities of daily living until late in life. The 128th Meeting of Japanese Society of Neurology Kinki Branch. 2024;28$80$YR$$M$Y$$$20240917$$MD$JP$JP
241810001$24181000$1$I$20240605$20240722$20240806$20240806$EXP$$US-HLS-202400500$HLS THERAPEUTICS$$59$YR$A$$Y$$$20240806$$MD$US$US
241810011$24181001$1$I$20240705$20240726$20240806$20240806$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07532$NEUROCRINE BIOSCIENCES$$46$YR$$M$Y$$$20240806$$CN$US$US
241810021$24181002$1$I$$20240731$20240806$20240806$EXP$$US-MTPC-MTDA2024-0016261$MITSUBISHI TANABE PHARMA$$$$E$F$Y$$$20240806$$CN$US$US
241810041$24181004$1$I$20240724$20240724$20240806$20240806$PER$$US-SA-2024SA230501$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240807$$MD$US$US
241810051$24181005$1$I$20240620$20240805$20240806$20240806$EXP$IT-MINISAL02-997078$NVSC2024IT159107$NOVARTIS$$82$YR$$F$Y$$$20240807$$MD$IT$IT
241810061$24181006$1$I$$20240730$20240806$20240806$EXP$$NVSC2024TW158388$NOVARTIS$Tsai JH, Lee KT. The Real-world Experiences of Abemaciclib for Estrogen Receptor-positive Human Epidermal Growth Factor Receptor-negative-2 Metastatic Breast Cancer - Sharing from a Single Institute in Southern Taiwan.. JOURNAL OF CANCER RESEARCH AND PRACTICE. 2024;11(2):73-6$62$YR$$F$Y$$$20240807$$HP$TW$TW
241810071$24181007$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229081$SANOFI AVENTIS$$$$A$M$Y$97.052$KG$20240807$$MD$US$US
241810081$24181008$1$I$$20240726$20240806$20240806$PER$$US-SA-2024SA222889$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240807$$MD$US$US
241810091$24181009$1$I$$20240730$20240806$20240806$PER$$US-ALXN-202407USA002116US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240806$$CN$US$US
241810101$24181010$1$I$20240101$20240730$20240806$20240806$PER$$US-SA-2024SA229294$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240807$$MD$US$US
241810111$24181011$1$I$20240731$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002592$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240806$$CN$US$US
241810121$24181012$1$I$$20240722$20240806$20240806$EXP$$US-HLS-202400499$HLS THERAPEUTICS$$$$T$$Y$$$20240806$$HP$US$US
241810131$24181013$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153874$AMGEN$$62$YR$A$F$Y$49.887$KG$20240806$$HP$US$US
241810142$24181014$2$F$$20240827$20240806$20240905$EXP$$US-BIOGEN-2024BI01276714$BIOGEN$$$$$F$Y$$$20240905$$MD$US$US
241810151$24181015$1$I$20240729$20240802$20240806$20240806$EXP$$CA-BIOGEN-2024BI01276942$BIOGEN$$78$YR$$M$Y$$$20240806$$CN$CA$CA
241810161$24181016$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229311$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240807$$MD$US$US
241810171$24181017$1$I$$20240722$20240806$20240806$EXP$$US-HLS-202400489$HLS THERAPEUTICS$$$$A$F$Y$$$20240806$$HP$US$US
241810181$24181018$1$I$20240730$20240730$20240806$20240806$PER$$US-SA-2024SA229312$SANOFI AVENTIS$$80$YR$E$M$Y$83$KG$20240807$$CN$US$US
241810191$24181019$1$I$$20240731$20240806$20240806$PER$$US-SA-2024SA229314$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240807$$MD$US$US
241810211$24181021$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024154029$AMGEN$$$$$M$Y$$$20240806$$CN$US$US
241810221$24181022$1$I$20220101$20240722$20240806$20240806$EXP$$US-HLS-202400487$HLS THERAPEUTICS$$30$YR$A$M$Y$$$20240806$$MD$US$US
241810231$24181023$1$I$$20240730$20240806$20240806$PER$$US-SA-2024SA229321$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240807$$MD$US$US
241810241$24181024$1$I$$20240801$20240806$20240806$PER$$US-BIOGEN-2024BI01276687$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241810251$24181025$1$I$$20240722$20240806$20240806$EXP$$CA-HLS-202401814$HLS THERAPEUTICS$$$$$F$Y$$$20240806$$MD$CA$CA
241810261$24181026$1$I$$20240726$20240806$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-151378$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240807$$MD$JP$JP
241810272$24181027$2$F$$20240826$20240806$20240902$EXP$$US-GSK-US2024095419$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
241810281$24181028$1$I$20240730$20240730$20240806$20240806$EXP$$US-GSK-US2024095295$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$CN$US$US
241810291$24181029$1$I$20240625$20240801$20240806$20240806$EXP$$CA-JNJFOC-20240805799$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240807$$HP$CA$CA
241810301$24181030$1$I$20240715$20240730$20240806$20240806$EXP$$US-GSK-US2024095414$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240806$$CN$US$US
241810311$24181031$1$I$20240705$20240731$20240806$20240806$30DAY$$US-GSK-US2024095880$GLAXOSMITHKLINE$$18$YR$$F$Y$$$20240806$$CN$US$US
241810321$24181032$1$I$20240716$20240801$20240806$20240806$30DAY$$US-GSK-US2024096283$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240806$$CN$US$US
241810333$24181033$3$F$20240801$20240826$20240806$20240903$EXP$$US-BIOGEN-2024BI01277024$BIOGEN$$46$YR$$F$Y$$$20240903$$CN$US$US
241810351$24181035$1$I$$20240801$20240806$20240806$EXP$$US-BIOGEN-2024BI01276911$BIOGEN$$$$$F$Y$$$20240806$$CN$US$US
241810361$24181036$1$I$$20240729$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407019443$ELI LILLY AND CO$$$$$M$Y$$$20240806$$CN$US$US
241810371$24181037$1$I$20240701$20240717$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407013393$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240806$$CN$US$US
241810381$24181038$1$I$20240701$20240729$20240806$20240806$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001551$BLUEPRINT MEDICINES$$58$YR$A$F$Y$$$20240807$$HP$US$US
241810391$24181039$1$I$$20240801$20240806$20240806$EXP$$US-BIOGEN-2024BI01276705$BIOGEN$$$$$F$Y$$$20240806$$HP$US$US
241810401$24181040$1$I$20240731$20240731$20240806$20240806$EXP$$PR-JNJFOC-20240803334$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$MD$PR$PR
241810411$24181041$1$I$$20240805$20240806$20240806$PER$$US-ORGANON-O2408USA000370$ORGANON$$30$YR$$F$Y$$$20240806$$MD$US$US
241810421$24181042$1$I$$20240731$20240806$20240806$EXP$$GB-BIOGEN-2024BI01276499$BIOGEN$$$$$F$Y$$$20240806$$CN$GB$TR
241810431$24181043$1$I$20230801$20240729$20240806$20240806$EXP$$PL-AMGEN-POLSP2024151869$AMGEN$$35$YR$A$F$Y$$$20240806$$MD$PL$PL
241810441$24181044$1$I$20231001$20240730$20240806$20240806$EXP$$PL-AMGEN-POLSP2024152214$AMGEN$$66$YR$E$M$Y$$$20240806$$MD$PL$PL
241810452$24181045$2$F$$20240828$20240806$20240903$EXP$$US-ABBVIE-5863915$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
241810463$24181046$3$F$$20240821$20240806$20240826$EXP$$GB-ABBVIE-5864398$ABBVIE$$$$E$F$Y$$$20240826$$CN$GB$GB
241810471$24181047$1$I$$20240731$20240806$20240806$EXP$$US-ABBVIE-5864180$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241810481$24181048$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865634$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241810491$24181049$1$I$20230101$20240730$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408000407$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240806$$CN$US$US
241810501$24181050$1$I$20240801$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154707$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241810512$24181051$2$F$20231201$20240821$20240806$20240829$EXP$$CO-JNJFOC-20240479702$JOHNSON AND JOHNSON$$50$YR$A$M$Y$90$KG$20240829$$HP$CO$CO
241810521$24181052$1$I$20240301$20240731$20240806$20240806$EXP$$US-BIOGEN-2024BI01276484$BIOGEN$$75$YR$$F$Y$$$20240806$$CN$US$US
241810531$24181053$1$I$20240804$20240805$20240806$20240806$EXP$$CO-ABBVIE-5867732$ABBVIE$$58$YR$$F$Y$$$20240806$$CN$CO$CO
241810541$24181054$1$I$20240731$20240731$20240806$20240806$EXP$$US-JNJFOC-20240804347$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240807$$HP$US$US
241810551$24181055$1$I$20240101$20240802$20240806$20240806$EXP$$US-ABBVIE-5608409$ABBVIE$$67$YR$$F$Y$$$20240806$$CN$US$US
241810561$24181056$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865903$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241810571$24181057$1$I$20240806$20240806$20240806$20240806$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044135$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240807$$CN$US$US
241810582$24181058$2$F$$20240828$20240806$20240830$PER$$US-AMGEN-USASP2024154623$AMGEN$$$$$F$Y$$$20240830$$PH$US$US
241810601$24181060$1$I$20240101$20240805$20240806$20240806$EXP$$AU-ABBVIE-5867486$ABBVIE$$$$$F$Y$$$20240806$$CN$AU$AU
241810611$24181061$1$I$$20240731$20240806$20240806$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001558$BLUEPRINT MEDICINES$$$$$F$Y$$$20240807$$CN$US$US
241810621$24181062$1$I$$20240729$20240806$20240806$EXP$$CA-JNJFOC-20240801655$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240807$$MD$CA$CA
241810631$24181063$1$I$20240803$20240805$20240806$20240806$EXP$$US-ABBVIE-5868306$ABBVIE$$71$YR$$F$Y$$$20240806$$HP$US$US
241810641$24181064$1$I$20240615$20240731$20240806$20240806$EXP$$BR-BIOGEN-2024BI01276498$BIOGEN$$41$YR$$F$Y$104$KG$20240806$$CN$BR$BR
241810651$24181065$1$I$$20240731$20240806$20240806$EXP$$JP-BIOGEN-2024BI01276865$BIOGEN$$9$YR$$M$Y$$$20240806$$MD$JP$JP
241810661$24181066$1$I$20240626$20240805$20240806$20240806$EXP$$NVSJ2024JP007866$NOVARTIS$$$$E$F$Y$$$20240807$$MD$JP$JP
241810672$24181067$2$F$20240801$20240802$20240806$20240816$EXP$$CA-HLS-202401939$HLS THERAPEUTICS$$67$YR$E$F$Y$$$20240816$$CN$CA$CA
241810682$24181068$2$F$20240523$20240819$20240806$20240826$EXP$$CZ-ABBVIE-5864182$ABBVIE$$68$YR$$M$Y$90$KG$20240826$$CN$CZ$CZ
241810693$24181069$3$F$$20240920$20240806$20240925$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001555$BLUEPRINT MEDICINES$$$$$M$Y$$$20240925$$CN$US$US
241810701$24181070$1$I$20240101$20240806$20240806$20240806$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044032$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240807$$MD$SK$SK
241810711$24181071$1$I$20240420$20240802$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122978$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240807$$HP$US$US
241810721$24181072$1$I$20240101$20240806$20240806$20240806$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044000$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240807$$MD$SK$SK
241810731$24181073$1$I$20240101$20240806$20240806$20240806$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044004$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240807$$MD$SK$SK
241810741$24181074$1$I$20240101$20240806$20240806$20240806$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044029$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240807$$MD$SK$SK
241810752$24181075$2$F$20240725$20240806$20240806$20240809$PER$$US-ORGANON-O2408USA000366$ORGANON$$$$$F$Y$$$20240809$$CN$US$US
241810761$24181076$1$I$20240101$20240806$20240806$20240806$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044002$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240807$$MD$SK$SK
241810771$24181077$1$I$20240801$20240805$20240806$20240806$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043805$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240807$$CN$US$US
241810781$24181078$1$I$20240701$20240731$20240806$20240806$EXP$$US-ABBVIE-5863620$ABBVIE$$47$YR$$M$Y$$$20240806$$CN$US$US
241810791$24181079$1$I$$20240724$20240806$20240806$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118083$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$96$KG$20240807$$HP$CA$CA
241810801$24181080$1$I$$20240805$20240806$20240806$EXP$$US-ABBVIE-5867787$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241810811$24181081$1$I$$20240802$20240806$20240806$PER$$US-ABBVIE-5867198$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241810821$24181082$1$I$20240707$20240805$20240806$20240806$EXP$$US-ABBVIE-5868625$ABBVIE$$62$YR$$M$Y$$$20240806$$CN$US$US
241810832$24181083$2$F$$20240920$20240806$20240927$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001556$BLUEPRINT MEDICINES$$$$$F$Y$$$20240927$$CN$US$US
241810841$24181084$1$I$20240524$20240730$20240806$20240806$EXP$$US-ABBVIE-5863787$ABBVIE$$69$YR$$M$Y$$$20240806$$CN$US$US
241810851$24181085$1$I$20240601$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002338$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240806$$CN$US$US
241810863$24181086$3$F$$20240806$20240806$20240812$30DAY$$CA-JNJFOC-20240772225$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$HP$CA$CA
241810871$24181087$1$I$$20240806$20240806$20240806$PER$$US-JNJFOC-20240813838$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
241810881$24181088$1$I$$20240801$20240806$20240806$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001568$BLUEPRINT MEDICINES$$$$$F$Y$$$20240807$$CN$US$US
241810891$24181089$1$I$$20240805$20240806$20240806$PER$$US-ROCHE-10000049661$ROCHE$$52$YR$A$F$Y$$$20240807$$CN$US$US
241810901$24181090$1$I$$20240801$20240806$20240806$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001565$BLUEPRINT MEDICINES$$$$$F$Y$$$20240807$$CN$US$US
241810911$24181091$1$I$$20240729$20240806$20240806$PER$$US-ABBVIE-5859305$ABBVIE$$$$$$Y$$$20240806$$CN$US$US
241810921$24181092$1$I$$20240805$20240806$20240806$EXP$$US-TAKEDA-2024TUS054345$TAKEDA$$$$$F$Y$36.893$KG$20240806$$HP$US$US
241810931$24181093$1$I$20240717$20240730$20240806$20240806$EXP$$CN-BEIGENE-BGN-2024-011869$BEIGENE$$$$$$Y$$$20240806$$HP$CN$CN
241810941$24181094$1$I$$20240731$20240806$20240806$EXP$$US-009507513-2408USA000391$MERCK$$$$$F$Y$$$20240806$$CN$US$US
241810951$24181095$1$I$20240627$20240730$20240806$20240806$EXP$$CN-BEIGENE-BGN-2024-011864$BEIGENE$$$$$$Y$$$20240806$$HP$CN$CN
241810962$24181096$2$F$$20240812$20240806$20240817$EXP$FR-ROCHE-3536478$FR-SANDOZ INC.-SDZ2024FR061953$SANDOZ$$2$YR$$F$Y$$$20240817$$HP$FR$FR
241810973$24181097$3$F$$20240814$20240806$20240828$30DAY$$PT-JNJFOC-20240771415$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240828$$HP$PT$PT
241810982$24181098$2$F$20240801$20240801$20240806$20240809$PER$$NVSC2024US158401$NOVARTIS$$72$YR$$F$Y$$$20240809$$CN$US$US
241810991$24181099$1$I$20240201$20240802$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408002059$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240806$$CN$US$US
241811001$24181100$1$I$$20240729$20240806$20240806$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001550$BLUEPRINT MEDICINES$$$$$M$Y$$$20240807$$CN$US$US
241811012$24181101$2$F$20240622$20240816$20240806$20240822$EXP$$US-ABBVIE-5865722$ABBVIE$$86$YR$$F$Y$$$20240822$$CN$US$US
241811021$24181102$1$I$$20240723$20240806$20240806$EXP$$US-HLS-202400510$HLS THERAPEUTICS$$$$A$M$Y$$$20240806$$HP$US$US
241811031$24181103$1$I$20240724$20240730$20240806$20240806$EXP$$CN-BEIGENE-BGN-2024-011868$BEIGENE$$$$$$Y$$$20240806$$HP$CN$CN
241811052$24181105$2$F$20240101$20240828$20240806$20240903$EXP$$US-009507513-2408USA000313$MERCK$$72$YR$$M$Y$$$20240903$$CN$US$US
241811061$24181106$1$I$20240724$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154579$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241811071$24181107$1$I$$20240801$20240806$20240806$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2024JPN093025$VIIV$$$$$$Y$$$20240806$$PH$JP$JP
241811081$24181108$1$I$20240731$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154694$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241811091$24181109$1$I$20220830$20240804$20240806$20240806$EXP$$CN-BEIGENE-BGN-2024-012178$BEIGENE$Yu H, Wang X, Pan Y, Li H. Myasthenia gravis due to anti-PD-1 treatment for an advanced colon cancer patient: a case report and literature review. Journal of Neurology. 2024$$$$$Y$$$20240806$$MD$CN$CN
241811101$24181110$1$I$20240730$20240730$20240806$20240806$EXP$$CA-JNJFOC-20240754893$JOHNSON AND JOHNSON$$47$YR$A$F$Y$151$KG$20240807$$HP$CA$CA
241811111$24181111$1$I$20240726$20240730$20240806$20240806$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000213$DENDREON$$$$$$Y$$$20240806$$HP$COUNTRY NOT SPECIFIED$US
241811123$24181112$3$F$$20240814$20240806$20240821$PER$$US-AMGEN-USASP2024154656$AMGEN$$$$$M$Y$$$20240821$$CN$US$US
241811131$24181113$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865962$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241811141$24181114$1$I$20240701$20240731$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121580$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240807$$PH$US$US
241811151$24181115$1$I$$20240731$20240806$20240806$EXP$$IN-TAKEDA-2024TUS078209$TAKEDA$$$$$M$Y$$$20240806$$MD$IN$IN
241811161$24181116$1$I$$20240729$20240806$20240806$EXP$$GB-TEVA-VS-3227188$TEVA$$68$YR$$M$Y$92$KG$20240806$$MD$GB$GB
241811171$24181117$1$I$20240101$20240805$20240806$20240806$EXP$$US-ABBVIE-5867657$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241811182$24181118$2$F$20240301$20240815$20240806$20240821$EXP$$US-JNJFOC-20240782547$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20240821$$CN$US$US
241811191$24181119$1$I$$20240731$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121902$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240807$$HP$US$US
241811201$24181120$1$I$20231101$20240730$20240806$20240806$EXP$$US-ABBVIE-5854060$ABBVIE$$65$YR$$F$Y$127$KG$20240806$$CN$US$US
241811231$24181123$1$I$20240101$20240805$20240806$20240806$EXP$$US-ABBVIE-5855383$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241811241$24181124$1$I$20240101$20240730$20240806$20240806$EXP$$US-ABBVIE-5862532$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241811251$24181125$1$I$20240101$20240802$20240806$20240806$EXP$$CO-ABBVIE-5867720$ABBVIE$$$$$F$Y$75$KG$20240806$$CN$CO$CO
241811262$24181126$2$F$20220608$20240808$20240806$20240811$EXP$$US-SANDOZ INC.-SDZ2024US070338$SANDOZ$$9$YR$$M$Y$47.5$KG$20240811$$MD$US$US
241811271$24181127$1$I$$20240805$20240806$20240806$30DAY$$US-SANDOZ INC.-SDZ2024US043442$SANDOZ$$$$$M$Y$$$20240806$$CN$US$US
241811281$24181128$1$I$20231001$20240803$20240806$20240806$30DAY$$EG-SANDOZ INC.-SDZ2024EG070751$SANDOZ$$10$YR$$F$Y$$$20240806$$CN$EG$EG
241811292$24181129$2$F$20240804$20240821$20240806$20240823$PER$$US-AMGEN-USASP2024155868$AMGEN$$47$YR$A$F$Y$$$20240823$$CN$US$US
241811301$24181130$1$I$20240701$20240730$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122184$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240807$$HP$US$US
241811312$24181131$2$F$$20240910$20240806$20240918$EXP$$CN-JNJFOC-20240784163$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$CN$CN
241811321$24181132$1$I$$20240805$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202408003218$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240806$$CN$US$US
241811332$24181133$2$F$20240711$20240807$20240806$20240808$PER$$US-AMGEN-USASP2024153998$AMGEN$$73$YR$E$M$Y$$$20240808$$HP$US$US
241811341$24181134$1$I$20240101$20240730$20240806$20240806$EXP$$US-ABBVIE-5861689$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241811351$24181135$1$I$20240506$20240730$20240806$20240806$EXP$$US-ABBVIE-5825241$ABBVIE$$59$YR$$F$Y$$$20240806$$CN$US$US
241811361$24181136$1$I$20240626$20240731$20240806$20240806$EXP$$US-ABBVIE-5860080$ABBVIE$$67$YR$$$Y$77$KG$20240806$$CN$US$US
241811371$24181137$1$I$20240716$20240805$20240806$20240806$EXP$$US-ABBVIE-5868294$ABBVIE$$86$YR$$M$Y$$$20240806$$CN$US$US
241811381$24181138$1$I$20240101$20240802$20240806$20240806$EXP$$US-ABBVIE-5865927$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241811391$24181139$1$I$20240729$20240801$20240806$20240806$EXP$$US-ABBVIE-5864551$ABBVIE$$23$YR$$F$Y$$$20240806$$CN$US$US
241811401$24181140$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865889$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241811421$24181142$1$I$20240626$20240730$20240806$20240806$EXP$$CN-BEIGENE-BGN-2024-011896$BEIGENE$$$$$$Y$$$20240806$$HP$CN$CN
241811431$24181143$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865906$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241811451$24181145$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5868001$ABBVIE$$$$$M$Y$$$20240806$$MD$US$US
241811461$24181146$1$I$$20240731$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122247$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240807$$CN$US$US
241811471$24181147$1$I$20240101$20240801$20240806$20240806$EXP$$CA-ABBVIE-5866230$ABBVIE$$77$YR$$F$Y$$$20240806$$CN$CA$CA
241811483$24181148$3$F$20240401$20240828$20240806$20240903$EXP$$IL-ABBVIE-5868103$ABBVIE$$46$YR$$M$Y$$$20240903$$CN$IL$IL
241811493$24181149$3$F$20240715$20240814$20240806$20240816$EXP$$TW-ABBVIE-5866547$ABBVIE$$84$YR$$F$Y$$$20240816$$CN$TW$TW
241811501$24181150$1$I$$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024156150$AMGEN$$$$$F$Y$$$20240806$$PH$US$US
241811511$24181151$1$I$20240101$20240730$20240806$20240806$EXP$$US-ABBVIE-5862571$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241811522$24181152$2$F$$20240827$20240806$20240829$PER$$US-AMGEN-USASP2024153617$AMGEN$$$$$F$Y$$$20240829$$HP$US$US
241811531$24181153$1$I$20240723$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154689$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241811541$24181154$1$I$$20240805$20240806$20240806$EXP$$US-ABBVIE-5867646$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241811551$24181155$1$I$20240101$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153619$AMGEN$$78$YR$E$F$Y$$$20240806$$CN$US$US
241811561$24181156$1$I$20240730$20240805$20240806$20240806$EXP$$US-ABBVIE-5868217$ABBVIE$$49$YR$$M$Y$$$20240806$$CN$US$US
241811571$24181157$1$I$20240101$20240729$20240806$20240806$EXP$$US-ABBVIE-5860658$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241811581$24181158$1$I$$20240802$20240806$20240806$EXP$$US-ABBVIE-5865768$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241811593$24181159$3$F$$20240829$20240806$20240902$EXP$$GR-ABBVIE-5867121$ABBVIE$$$$$M$Y$62$KG$20240902$$CN$GR$GR
241811612$24181161$2$F$$20240805$20240806$20240809$EXP$$US-ABBVIE-5865213$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241811621$24181162$1$I$20240101$20240805$20240806$20240806$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124097$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240807$$HP$US$US
241811632$24181163$2$F$20240718$20240829$20240806$20240903$EXP$$US-JNJFOC-20240808262$JOHNSON AND JOHNSON$$42$YR$A$M$Y$81.72$KG$20240904$$HP$US$US
241811641$24181164$1$I$20240701$20240730$20240806$20240806$EXP$$US-JNJFOC-20240782501$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240807$$CN$US$US
241811651$24181165$1$I$20240407$20240804$20240806$20240806$EXP$$US-ABBVIE-5867552$ABBVIE$$84$YR$$M$Y$$$20240806$$CN$US$US
241811661$24181166$1$I$$20240805$20240806$20240806$EXP$$US-ABBVIE-5867770$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241811671$24181167$1$I$$20240805$20240806$20240806$EXP$$US-ABBVIE-5867764$ABBVIE$$$$$M$Y$$$20240806$$CN$US$US
241811683$24181168$3$F$20240725$20240809$20240806$20240826$30DAY$$GB-JNJFOC-20240772334$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240826$$CN$GB$GB
241811691$24181169$1$I$$20240801$20240806$20240806$EXP$$US-ABBVIE-5868455$ABBVIE$$$$$F$Y$$$20240806$$CN$US$US
241811701$24181170$1$I$20240720$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153751$AMGEN$$70$YR$E$F$Y$$$20240806$$CN$US$US
241811711$24181171$1$I$20231101$20240801$20240806$20240806$PER$$US-AMGEN-USASP2024153805$AMGEN$$$$$M$Y$$$20240806$$CN$US$US
241811721$24181172$1$I$$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024155673$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241811731$24181173$1$I$$20240805$20240806$20240806$EXP$$US-ABBVIE-5867735$ABBVIE$$$$$$Y$$$20240806$$MD$US$US
241811741$24181174$1$I$$20240731$20240806$20240806$PER$$US-ALXN-202407USA002164US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241811751$24181175$1$I$20240101$20240802$20240806$20240806$EXP$$US-JNJFOC-20240808148$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240807$$HP$US$US
241811761$24181176$1$I$$20240731$20240806$20240806$PER$$US-TAKEDA-2024TUS078082$TAKEDA$$$$$$Y$$$20240806$$CN$US$US
241811771$24181177$1$I$20240802$20240802$20240806$20240806$PER$$US-AMGEN-USASP2024154335$AMGEN$$72$YR$E$F$Y$$$20240806$$CN$US$US
241811781$24181178$1$I$$20240710$20240806$20240806$PER$$US-SMPA-2024MYSCI0700401$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811792$24181179$2$F$20240716$20240823$20240806$20240919$PER$$US-SMPA-2024MYSCI0700534$SUNOVION$$$$$$Y$$$20240919$$$US$US
241811801$24181180$1$I$$20240710$20240806$20240806$PER$$US-SMPA-2024MYSCI0700355$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811811$24181181$1$I$$20240708$20240806$20240806$PER$$US-SMPA-2024MYSCI0700282$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811821$24181182$1$I$20240708$20240710$20240806$20240806$PER$$US-SMPA-2024MYSCI0700369$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811831$24181183$1$I$$20240719$20240806$20240806$PER$$US-SMPA-2024MYSCI0700785$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811841$24181184$1$I$$20240710$20240806$20240806$PER$$US-SMPA-2024MYSCI0700409$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811851$24181185$1$I$$20240709$20240806$20240806$PER$$US-SMPA-2024MYSCI0700346$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811861$24181186$1$I$20240701$20240709$20240806$20240806$PER$$US-SMPA-2024MYSCI0700361$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811871$24181187$1$I$$20240719$20240806$20240806$PER$$US-SMPA-202407-URV-001093$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811881$24181188$1$I$$20240716$20240806$20240806$PER$$US-SMPA-202407-URV-001077$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811891$24181189$1$I$$20240712$20240806$20240806$PER$$US-SMPA-2024MYSCI0700502$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811901$24181190$1$I$$20240710$20240806$20240806$PER$$US-SMPA-2024MYSCI0700388$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811922$24181192$2$F$$20240711$20240806$20240809$PER$$US-SMPA-2024MYSCI0700470$SUNOVION$$$$$$Y$$$20240809$$HP$US$US
241811931$24181193$1$I$$20240708$20240806$20240806$PER$$US-SMPA-2024MYSCI0700287$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811941$24181194$1$I$$20240709$20240806$20240806$PER$$US-SMPA-2024MYSCI0700313$SUNOVION$$$$$$Y$$$20240806$$HP$US$US
241811952$24181195$2$F$$20240806$20240806$20240903$PER$$US-SMPA-2024MYSCI0700849$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
241811964$24181196$4$F$$20240903$20240806$20240910$EXP$$US-SMPA-2024MYSCI0700389$SUNOVION$$$$$$Y$$$20240910$$HP$US$US
241811971$24181197$1$I$$20240709$20240806$20240806$PER$$US-SMPA-2024MYSCI0700340$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241811982$24181198$2$F$$20240710$20240806$20240809$PER$$US-SMPA-2024MYSCI0600527$SUNOVION$$$$$$Y$$$20240809$$HP$US$US
241811992$24181199$2$F$$20240813$20240806$20240823$PER$$US-SMPA-2024MYSCI0700420$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
241812001$24181200$1$I$20240709$20240710$20240806$20240806$PER$$US-SMPA-2024MYSCI0700395$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241812012$24181201$2$F$$20240812$20240806$20240826$PER$$US-SMPA-2024MYSCI0700659$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
241812021$24181202$1$I$$20240716$20240806$20240806$PER$$US-SMPA-2024MYSCI0700643$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241812031$24181203$1$I$$20240719$20240806$20240806$PER$$US-SMPA-2024MYSCI0700833$SUNOVION$$$$$$Y$$$20240806$$MD$US$US
241812051$24181205$1$I$$20240710$20240806$20240806$PER$$US-SMPA-2024MYSCI0600871$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241812061$24181206$1$I$$20240710$20240806$20240806$PER$$US-SMPA-2024MYSCI0700396$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241812071$24181207$1$I$$20240712$20240806$20240806$PER$$US-SMPA-2024MYSCI0700486$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241812083$24181208$3$F$20240601$20240904$20240806$20240927$PER$$US-SMPA-2024MYSCI0600580$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
241812091$24181209$1$I$20221211$20240801$20240806$20240806$EXP$$CO-TAKEDA-2022TUS098678$TAKEDA$$40$YR$$M$Y$82$KG$20240806$$CN$CO$CO
241812103$24181210$3$F$20230101$20240820$20240806$20240823$EXP$$PL-TAKEDA-2024TUS078644$TAKEDA$$$$$F$Y$68$KG$20240823$$HP$PL$PL
241812111$24181211$1$I$$20240731$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122025$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240807$$CN$US$US
241812121$24181212$1$I$$20240731$20240806$20240806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121906$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240807$$CN$US$US
241812131$24181213$1$I$$20240710$20240806$20240806$PER$$US-SMPA-2024MYSCI0700421$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241812141$24181214$1$I$20200101$20240801$20240806$20240806$EXP$$BR-JNJFOC-20240806628$JOHNSON AND JOHNSON$$56$YR$A$F$Y$68$KG$20240807$$CN$BR$BR
241812151$24181215$1$I$20240728$20240801$20240806$20240806$EXP$$US-TAKEDA-2022TUS089379$TAKEDA$$3$YR$$F$Y$$$20240806$$MD$US$US
241812161$24181216$1$I$20240625$20240806$20240806$20240806$EXP$FR-AFSSAPS-AM2024000619$FR-ORGANON-O2408FRA000450$ORGANON$$87$YR$$F$Y$68.6$KG$20240806$$PH$FR$FR
241812171$24181217$1$I$$20240805$20240806$20240806$EXP$$JP-ASTELLAS-2024JP005672$ASTELLAS$$$$$F$Y$$$20240807$$MD$JP$JP
241812181$24181218$1$I$$20240726$20240806$20240806$EXP$$US-SMPA-2024SPA000174$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241812194$24181219$4$F$$20240917$20240806$20240920$EXP$$US-TAKEDA-2024TUS075702$TAKEDA$$$$$M$Y$$$20240920$$CN$US$US
241812205$24181220$5$F$$20240911$20240806$20240925$EXP$$US-SMPA-2024SPA000189$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
241812211$24181221$1$I$20240724$20240724$20240806$20240806$EXP$$PT-SMPA-2024SPA000448$SUNOVION$$$$$$Y$$$20240806$$MD$DE$DE
241812221$24181222$1$I$$20240725$20240806$20240806$EXP$$US-SMPA-2024SPA000166$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241812231$24181223$1$I$$20240725$20240806$20240806$EXP$$US-SMPA-2024SPA000217$SUNOVION$$$$$$Y$$$20240806$$CN$US$US
241812242$24181224$2$F$$20240820$20240806$20240822$EXP$$VN-SANDOZ INC.-SDZ2024VN070932$SANDOZ$Phuong LT, Dieu Thuy NT, Ngoc NT, Huy NN, Tu TM, Huong NT et al. . Treatment outcomes of pediatric lupus nephritis class iii and iv in national children?s hospital. JOURNAL OF MEDICAL RESEARCH. 2022;10 (6):69-75$$$C$$Y$$$20240822$$HP$VN$VN
241812251$24181225$1$I$20240101$20240805$20240806$20240806$EXP$$IL-TAKEDA-2024TUS078440$TAKEDA$$$$A$F$Y$$$20240806$$MD$IL$IL
241812261$24181226$1$I$20240201$20240802$20240806$20240806$EXP$$US-JNJFOC-20240808225$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240807$$HP$US$US
241812272$24181227$2$F$$20240819$20240806$20240822$EXP$$US-JNJFOC-20240810476$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240822$$HP$US$US
241812281$24181228$1$I$$20240717$20240806$20240806$PER$$US-ELI_LILLY_AND_COMPANY-US202407013074$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240806$$CN$US$US
241812292$24181229$2$F$20240701$20240814$20240806$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202407010522$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240816$$CN$US$US
241812301$24181230$1$I$$20240730$20240806$20240806$EXP$$US-PFIZER INC-PV202400099629$PFIZER$$72$YR$$M$Y$$$20240806$$CN$US$US
241812312$24181231$2$F$20240701$20240911$20240806$20240915$EXP$$CA-PFIZER INC-202400229542$PFIZER$$69$YR$$M$Y$$$20240915$$PH$CA$CA
241812321$24181232$1$I$$20240802$20240806$20240806$EXP$$CA-PFIZER INC-202400230409$PFIZER$$61$YR$$M$Y$$$20240806$$CN$CA$CA
241812331$24181233$1$I$$20240802$20240806$20240806$EXP$$US-PFIZER INC-202300037801$PFIZER$$76$YR$$M$Y$97.052$KG$20240806$$CN$US$US
241812341$24181234$1$I$$20240719$20240806$20240806$PER$$US-AMGEN-USASL2024145276$AMGEN$$$$$F$Y$$$20240806$$HP$US$US
241812352$24181235$2$F$20240709$20240731$20240806$20240812$EXP$$CN-009507513-2408CHN001055$MERCK$$76$YR$$M$Y$$$20240812$$HP$CN$CN
241812361$24181236$1$I$$20240806$20240806$20240806$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044175$BOEHRINGER INGELHEIM$$$$$$Y$$$20240807$$HP$SG$SG
241812372$24181237$2$F$20240701$20240819$20240806$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023716$UNITED THERAPEUTICS$$74$YR$$M$Y$146.94$KG$20240828$$$US$US
241812381$24181238$1$I$20240701$20240806$20240806$20240806$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044164$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240807$$HP$SG$SG
241812391$24181239$1$I$20240601$20240802$20240806$20240806$EXP$$US-JNJFOC-20240808278$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240807$$HP$US$US
241812401$24181240$1$I$20240507$20240731$20240806$20240806$EXP$$NZ-GSK-NZ2024095840$GLAXOSMITHKLINE$$$$$$Y$$$20240806$$HP$NZ$NZ
241812411$24181241$1$I$$20240727$20240806$20240806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123510$BRISTOL MYERS SQUIBB$Horaguchi R, et al. Myelodysplastic syndrome complicated by mycobacterium abscessus species bacteremia during chemotherapy with azacitidine. The 42nd Hokuriku Regional Meeting of the Japanese Society of Hematology.$77$YR$E$M$Y$$$20240807$$HP$JP$JP
241812421$24181242$1$I$20240201$20240730$20240806$20240806$EXP$$NVSC2024AR125480$NOVARTIS$$77$YR$$F$Y$$$20240807$$CN$AR$AR
241812432$24181243$2$F$20240731$20240811$20240807$20240815$EXP$$DE-ABBVIE-5867718$ABBVIE$$66$YR$$F$Y$$$20240815$$HP$DE$DE
241812441$24181244$1$I$$20221115$20240807$20240807$EXP$$US-AstraZeneca-2022A335918$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241812453$24181245$3$F$20240726$20240905$20240807$20240913$EXP$$NL-ABBVIE-5863989$ABBVIE$$$$E$M$Y$$$20240913$$HP$NL$NL
241812461$24181246$1$I$$20220621$20240807$20240807$EXP$$US-AstraZeneca-2021A853050$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241812471$24181247$1$I$20240320$20240803$20240807$20240807$EXP$$JP-ABBVIE-5749508$ABBVIE$$74$YR$$F$Y$53$KG$20240807$$MD$JP$JP
241812481$24181248$1$I$$20240729$20240807$20240807$EXP$$US-JNJFOC-20240778208$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
241812491$24181249$1$I$$20220314$20240807$20240807$EXP$$US-AstraZeneca-2022A113286$ASTRAZENECA$$$$$F$Y$60.5$KG$20240807$$HP$US$
241812501$24181250$1$I$$20240731$20240807$20240807$PER$$NVSC2024US158512$NOVARTIS$$$$$$Y$$$20240807$$CN$US$US
241812511$24181251$1$I$20240726$20240802$20240807$20240807$EXP$$KR-GSK-KR2024096397$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$KR$KR
241812521$24181252$1$I$$20240731$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121861$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240807$$CN$US$US
241812531$24181253$1$I$$20240726$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119278$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240807$$HP$US$US
241812541$24181254$1$I$20240729$20240802$20240807$20240807$EXP$$DE-ABBVIE-5867693$ABBVIE$$68$YR$$M$Y$$$20240807$$CN$DE$DE
241812553$24181255$3$F$20240101$20240820$20240807$20240827$EXP$$ES-ABBVIE-5865641$ABBVIE$$$$$M$Y$$$20240827$$CN$ES$ES
241812561$24181256$1$I$20240711$20240730$20240807$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023730$UNITED THERAPEUTICS$$61$YR$$M$Y$81.633$KG$20240807$$$US$US
241812571$24181257$1$I$$20240805$20240807$20240807$EXP$$US-UCBSA-2024012162$UCB$Le V, Surineni K, Elias G.. A Case of Partially Reversible Oral-buccal-lingual Dyskinesia after Prolonged Levetiracetam Exposure. American Journal of Geriatric Psychiatry. 2024;32(4):S106$86$YR$$F$Y$$$20240807$$MD$US$US
241812582$24181258$2$F$20220101$20240904$20240807$20240909$EXP$$DE-AMGEN-DEUSP2024153518$AMGEN$$58$YR$A$F$Y$66$KG$20240909$$CN$DE$DE
241812592$24181259$2$F$20230101$20240813$20240807$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US070921$SANDOZ$$$$$M$Y$$$20240820$$CN$US$US
241812601$24181260$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5867741$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241812611$24181261$1$I$20240701$20240731$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123615$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$77.11$KG$20240807$$PH$US$US
241812621$24181262$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5867645$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241812631$24181263$1$I$20240617$20240715$20240807$20240807$PER$$US-009507513-2407USA009837$MERCK$$57$YR$$F$Y$$$20240807$$CN$US$US
241812641$24181264$1$I$20240722$20240729$20240807$20240807$EXP$$ES-TEVA-VS-3228526$TEVA$$61$YR$$F$Y$$$20240807$$CN$ES$ES
241812651$24181265$1$I$$20240806$20240807$20240807$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044171$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240807$$HP$SG$SG
241812661$24181266$1$I$20240701$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123879$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$113.85$KG$20240807$$CN$US$US
241812671$24181267$1$I$$20240724$20240807$20240807$EXP$$US-RDY-LIT/USA/24/0011203$DR REDDYS$George MN, Seervai RN, Chon SY. Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series. JAAD Case Reports. 2024 Jan 16;47: 72-79. doi:10.1016/j.jdcr.2023.11.027.$62$YR$A$F$Y$$$20240807$$HP$US$US
241812681$24181268$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123896$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240807$$HP$US$US
241812691$24181269$1$I$$20230504$20240807$20240807$EXP$$US-AstraZeneca-2023A105328$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241812701$24181270$1$I$20230807$20230818$20240807$20240807$EXP$$US-AstraZeneca-2023A189663$ASTRAZENECA$$24160$DY$$F$Y$$$20240807$$CN$US$
241812712$24181271$2$F$20240101$20240807$20240807$20240809$EXP$$US-ABBVIE-5865920$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241812721$24181272$1$I$$20240724$20240807$20240807$EXP$$US-RDY-LIT/USA/24/0011217$DR REDDYS$George MN, Seervai RN, Chon SY. Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series. JAAD Case Reports. 47: 72-79. doi:10.1016/j.jdcr.2023.11.027.$73$YR$E$F$Y$$$20240807$$HP$US$US
241812731$24181273$1$I$$20240729$20240807$20240807$EXP$$EG-NOVOPROD-1262425$NOVO NORDISK$$771$MON$$F$Y$90$KG$20240807$$CN$EG$EG
241812741$24181274$1$I$$20240729$20240807$20240807$EXP$$CA-NOVOPROD-1262377$NOVO NORDISK$$$$A$F$Y$$$20240807$$CN$CA$CA
241812751$24181275$1$I$20240702$20240730$20240807$20240807$EXP$$GR-CHATTEMPRD-2024OHG025948$CHATTEM$$43$YR$A$F$Y$$$20240807$$HP$GR$GR
241812761$24181276$1$I$20231211$20240806$20240807$20240807$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044174$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240807$$HP$SG$SG
241812771$24181277$1$I$20230324$20240802$20240807$20240807$EXP$$GB-CHATTEMPRD-2024OHG026167$CHATTEM$$50$YR$A$F$Y$80$KG$20240807$$MD$GB$GB
241812781$24181278$1$I$$20240805$20240807$20240807$PER$$US-JNJFOC-20240810492$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$HP$US$US
241812791$24181279$1$I$$20231208$20240807$20240807$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424240$RANBAXY$$63$YR$$M$Y$$$20240807$$CN$US$US
241812801$24181280$1$I$$20231114$20240807$20240807$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420187$RANBAXY$$55$YR$$M$Y$$$20240807$$CN$US$US
241812811$24181281$1$I$$20240226$20240807$20240807$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-435888$RANBAXY$$$$$$Y$$$20240807$$CN$US$US
241812821$24181282$1$I$$20240612$20240807$20240807$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452666$RANBAXY$$$$E$F$Y$$$20240807$$CN$US$US
241812831$24181283$1$I$$20240611$20240807$20240807$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449264$RANBAXY$$$$$$Y$$$20240807$$CN$US$US
241812841$24181284$1$I$20240101$20240729$20240807$20240807$EXP$$US-NOVOPROD-1261600$NOVO NORDISK$$$$$F$Y$$$20240807$$CN$US$US
241812851$24181285$1$I$$20240802$20240807$20240807$EXP$$GR-ABBVIE-5867701$ABBVIE$$88$YR$$F$Y$$$20240807$$CN$GR$GR
241812861$24181286$1$I$20240517$20240801$20240807$20240807$EXP$FR-AFSSAPS-NT2024000971$FR-GSK-FR2024096599$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$FR$FR
241812871$24181287$1$I$20240729$20240805$20240807$20240807$EXP$$ZA-ABBVIE-5867717$ABBVIE$$79$YR$$F$Y$$$20240807$$MD$ZA$ZA
241812891$24181289$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124046$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$83.01$KG$20240807$$HP$US$US
241812904$24181290$4$F$20240801$20240916$20240807$20240918$PER$$US-AMGEN-USASP2024156316$AMGEN$$19$YR$A$F$Y$$$20240918$$CN$US$US
241812911$24181291$1$I$$20240801$20240807$20240807$EXP$$SE-ABBVIE-5865423$ABBVIE$$$$A$F$Y$$$20240807$$CN$SE$SE
241812921$24181292$1$I$$20240802$20240807$20240807$PER$$NVSC2024US159400$NOVARTIS$$$$$M$Y$$$20240807$$HP$US$US
241812931$24181293$1$I$$20240730$20240807$20240807$EXP$$US-GSK-US2024AMR097278$GLAXOSMITHKLINE$$$$$F$Y$80.499$KG$20240807$$CN$US$US
241812943$24181294$3$F$20240903$20240903$20240807$20240909$EXP$$CA-TAKEDA-2024TUS035953$TAKEDA$$68$YR$$M$Y$$$20240909$$CN$CA$CA
241812951$24181295$1$I$$20220111$20240807$20240807$EXP$$US-AstraZeneca-2022A022202$ASTRAZENECA$$$$$F$Y$$$20240807$$HP$US$
241812961$24181296$1$I$20200824$20200909$20240807$20240807$EXP$$US-AstraZeneca-2020SF08707$ASTRAZENECA$$24397$DY$$F$Y$$$20240807$$CN$US$
241812971$24181297$1$I$20240101$20240804$20240807$20240807$EXP$$US-ABBVIE-5866453$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241812981$24181298$1$I$$20240804$20240807$20240807$EXP$$ES-GSK-ES2024GSK097332$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$ES$ES
241812991$24181299$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA229139$SANOFI AVENTIS$$$$C$$Y$$$20240807$$HP$US$US
241813001$24181300$1$I$20240727$20240802$20240807$20240807$EXP$$HU-ROCHE-10000049210$ROCHE$$52$YR$A$F$Y$$$20240807$$MD$HU$HU
241813013$24181301$3$F$20240805$20240808$20240807$20240812$PER$$US-AMGEN-USASP2024155420$AMGEN$$52$YR$A$$Y$$$20240812$$CN$US$US
241813021$24181302$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000049562$ROCHE$$$$E$$Y$$$20240807$$HP$US$US
241813031$24181303$1$I$$20240801$20240807$20240807$EXP$$CA-JNJFOC-20240807791$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240807$$HP$CA$CA
241813041$24181304$1$I$$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154697$AMGEN$$$$$M$Y$$$20240806$$HP$US$US
241813052$24181305$2$F$20191201$20240815$20240807$20240822$EXP$$US-GSK-US2024GSK096847$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$MD$US$US
241813061$24181306$1$I$$20240729$20240807$20240807$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009790$STRIDES$Hsieh C-Y, Yu S-C, Lee J-A, Tsai T-F.. Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosed in a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Association?.. Indian-J-Dermatol. 2024;69 (3):264-267$66$YR$$M$Y$$$20240807$$HP$CN$CN
241813072$24181307$2$F$20240801$20240909$20240807$20240911$PER$$US-AMGEN-USASP2024154555$AMGEN$$62$YR$A$F$Y$$$20240910$$CN$US$US
241813082$24181308$2$F$20240712$20240904$20240807$20240909$PER$$US-AMGEN-USASP2024152347$AMGEN$$78$YR$E$M$Y$$$20240908$$MD$US$US
241813091$24181309$1$I$$20240725$20240807$20240807$EXP$$IT-ROCHE-10000010819$ROCHE$Tursi A, Nenna R. Endoscopic appearance is not sufficient for a diagnosis of segmental colitis associated with diverticulosis. Annals of Gastroenterology. 2024-Jun-01;37 (3):377-80. doi:10.20524/aog.2024.0875.$41$YR$A$F$Y$$$20240807$$MD$IT$IT
241813101$24181310$1$I$20240702$20240802$20240807$20240807$EXP$$HU-ROCHE-10000049149$ROCHE$$54$YR$A$F$Y$$$20240807$$MD$HU$HU
241813111$24181311$1$I$$20240729$20240807$20240807$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP009793$STRIDES$Kim JH, Chung SW, Lee YJ.. Corticosteroid-free adalimumab-cyclophosphamide combination therapy for acute phase neuro-Behcet^s disease: a case report.. J-Rheum-Dis. 2024;31 (3):178-181$4$DEC$$M$Y$$$20240807$$MD$KR$KR
241813121$24181312$1$I$$20240802$20240807$20240807$EXP$$US-SA-2024SA231745$SANOFI AVENTIS$$$$E$F$Y$$$20240807$$MD$US$US
241813131$24181313$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA229317$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240807$$MD$US$US
241813141$24181314$1$I$$20240401$20240807$20240807$PER$$AP-2024-US-5831$AILEX PHARMACEUTICALS$$11$YR$$F$Y$$$20240807$$CN$US$US
241813151$24181315$1$I$20240601$20240730$20240807$20240807$PER$$US-SA-2024SA229295$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240807$$MD$US$US
241813163$24181316$3$F$20240101$20240830$20240807$20240904$EXP$$PR-ABBVIE-5868305$ABBVIE$$$$$F$Y$$$20240904$$CN$PR$PR
241813171$24181317$1$I$$20240729$20240807$20240807$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009797$STRIDES$Masuda H, Yamamoto Y, Kimura S, Matsuda K, Kobayashi K, Ae R.. Spontaneous Abdominal Wall Hematoma: Early Recurrence without an Anticoagulant in an Elderly Woman Receiving Chronic Corticosteroid Treatment.. Intern-Med. 2024;63 (14):2097-2100$73$YR$$F$Y$$$20240807$$MD$JP$JP
241813181$24181318$1$I$$20240802$20240807$20240807$EXP$$CA-TAKEDA-2024TUS059316$TAKEDA$$$$$M$Y$$$20240807$$MD$CA$CA
241813191$24181319$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA229930$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240807$$MD$US$US
241813202$24181320$2$F$20240101$20240823$20240807$20240827$EXP$$CA-ABBVIE-5865929$ABBVIE$$62$YR$$$Y$$$20240827$$MD$CA$CA
241813211$24181321$1$I$$20240713$20240807$20240807$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003542$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
241813221$24181322$1$I$$20240725$20240807$20240807$PER$$US-ROCHE-10000039812$ROCHE$$$$$F$Y$$$20240807$$HP$US$US
241813231$24181323$1$I$$20210414$20240807$20240807$EXP$$US-AstraZeneca-2021A225223$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241813241$24181324$1$I$$20230714$20240807$20240807$EXP$$US-AstraZeneca-2023A162897$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241813251$24181325$1$I$20240627$20240805$20240807$20240807$EXP$IT-MINISAL02-997115$IT-VIIV HEALTHCARE LIMITED-IT2024097444$VIIV$$$$$$Y$$$20240807$$MD$IT$IT
241813261$24181326$1$I$$20240729$20240807$20240807$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202407019795$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240807$$CN$CA$CA
241813271$24181327$1$I$$20240725$20240807$20240807$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407018221$ELI LILLY AND CO$Bertolotti A., Reviron R.,Joly E..Vitiligo treated with oral baricitinib and heliotherapy: A case series..Annales de Dermatologie et de Venereologie. 2024;151 (3):1-3.DOI:https://doi.org/10.1016/j.annder.2024.103300$53$YR$A$F$Y$$$20240807$$HP$FR$FR
241813291$24181329$1$I$$20240724$20240807$20240807$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407017425$ELI LILLY AND CO$Jung Ho Im, Jeong Il Yu, Tae Hyun Kim, Tae Gyu Kim, Jun Won Kim, Jinsil Seong.Combined High-Dose Radiotherapy with Sequential Gemcitabine-Cisplatin Based Chemotherapy Increase the Resectability and Survival in Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma: A Multi-institutional Cohort Study.Cancer Res Treat 2024;6(3):838-846.DOI:10.4143/crt.2023.886$$$A$$Y$$$20240807$$HP$KR$KR
241813301$24181330$1$I$$20240725$20240807$20240807$EXP$$US-ELI_LILLY_AND_COMPANY-US202407016810$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240807$$CN$US$US
241813311$24181331$1$I$20231101$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408001963$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240807$$CN$US$US
241813321$24181332$1$I$$20240729$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407018846$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241813331$24181333$1$I$20240724$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154732$AMGEN$$65$YR$E$F$Y$$$20240806$$CN$US$US
241813342$24181334$2$F$$20240802$20240807$20240813$30DAY$$CA-JNJFOC-20240806251$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$PH$CA$CA
241813351$24181335$1$I$20210713$20240801$20240807$20240807$EXP$$CA-TAKEDA-2024TUS077895$TAKEDA$$55$YR$$M$Y$$$20240807$$CN$CA$CA
241813361$24181336$1$I$$20240730$20240807$20240807$PER$$US-ALXN-202407USA002122US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241813373$24181337$3$F$$20240907$20240807$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003698$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
241813381$24181338$1$I$20240730$20240731$20240807$20240807$PER$$US-JNJFOC-20240785283$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$US$US
241813401$24181340$1$I$20240617$20240805$20240807$20240807$EXP$IT-MINISAL02-997128$IT-VIIV HEALTHCARE LIMITED-IT2024097456$VIIV$$$$$$Y$$$20240807$$MD$IT$IT
241813411$24181341$1$I$$20240729$20240807$20240807$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004141$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241813421$24181342$1$I$20231026$20240731$20240807$20240807$EXP$$CA-TAKEDA-2024TUS077451$TAKEDA$$90$YR$$M$Y$$$20240807$$CN$CA$CA
241813431$24181343$1$I$$20240728$20240807$20240807$PER$$US-ABBVIE-5858937$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241813441$24181344$1$I$20240713$20240731$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011964$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241813451$24181345$1$I$$20240801$20240807$20240807$PER$$US-CHATTEMPRD-2024OHG026011$CHATTEM$$$$$$Y$$$20240807$$CN$US$US
241813462$24181346$2$F$20240101$20240730$20240807$20240809$EXP$$US-TEVA-VS-3229101$TEVA$$36$YR$$F$Y$$$20240809$$HP$US$US
241813471$24181347$1$I$$20240801$20240807$20240807$PER$$US-CHATTEMPRD-2024OHG026062$CHATTEM$$$$$F$Y$$$20240807$$CN$US$US
241813481$24181348$1$I$$20240802$20240807$20240807$EXP$$DE-JAZZ PHARMACEUTICALS-2024-DE-011976$JAZZ$$$$$$Y$$$20240806$$HP$DE$DE
241813491$24181349$1$I$$20240731$20240807$20240807$PER$$US-ROCHE-10000047879$ROCHE$$13$YR$T$M$Y$$$20240807$$CN$US$US
241813501$24181350$1$I$$20240730$20240807$20240807$PER$$US-ROCHE-10000042963$ROCHE$$$$$$Y$$$20240807$$HP$US$US
241813511$24181351$1$I$20240201$20240730$20240807$20240807$EXP$$JP-JNJFOC-20240612979$JOHNSON AND JOHNSON$$9$DEC$E$M$Y$$$20240807$$MD$JP$JP
241813521$24181352$1$I$$20240802$20240807$20240807$PER$$US-ROCHE-10000048880$ROCHE$$$$$$Y$$$20240807$$MD$US$US
241813531$24181353$1$I$20240701$20240731$20240807$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123777$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240807$$MD$JP$JP
241813541$24181354$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000049663$ROCHE$$$$A$M$Y$$$20240807$$CN$US$US
241813552$24181355$2$F$$20240919$20240807$20240924$PER$$US-ROCHE-10000049997$ROCHE$$$$A$M$Y$$$20240924$$CN$US$US
241813563$24181356$3$F$20240730$20240909$20240807$20240913$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011944$JAZZ$$$$$M$Y$$$20240913$$MD$JP$JP
241813571$24181357$1$I$$20240729$20240807$20240807$EXP$$ZA-ABBVIE-5869493$ABBVIE$$42$YR$$F$Y$$$20240807$$CN$ZA$ZA
241813581$24181358$1$I$$20210326$20240807$20240807$EXP$$GB-AstraZeneca-2021A241272$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$GB$
241813591$24181359$1$I$20220107$20220215$20240807$20240807$EXP$$US-AstraZeneca-2022A025373$ASTRAZENECA$$27360$DY$$F$Y$$$20240807$$CN$US$
241813601$24181360$1$I$$20240801$20240807$20240807$EXP$$US-GSK-US2024096207$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
241813611$24181361$1$I$$20230405$20240807$20240807$EXP$$US-AstraZeneca-2023A081060$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241813621$24181362$1$I$$20200926$20240807$20240807$EXP$$US-AstraZeneca-2020SF25854$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241813631$24181363$1$I$$20230724$20240807$20240807$EXP$$US-AstraZeneca-2023A169671$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241813641$24181364$1$I$$20220218$20240807$20240807$EXP$$CA-AstraZeneca-2022A059866$ASTRAZENECA$$$$$M$Y$$$20240807$$MD$CA$
241813651$24181365$1$I$20230225$20230327$20240807$20240807$EXP$$IN-AstraZeneca-2023A073518$ASTRAZENECA$$19319$DY$$F$Y$$$20240807$$CN$IN$
241813661$24181366$1$I$20221221$20240730$20240807$20240807$PER$$US-AstraZeneca-2024A177183$ASTRAZENECA$$27171$DY$$F$Y$86.2$KG$20240807$$CN$US$
241813672$24181367$2$F$20240801$20240815$20240807$20240820$PER$$US-AMGEN-USASP2024154162$AMGEN$$88$YR$E$$Y$$$20240820$$HP$US$US
241813681$24181368$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000048829$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$60$YR$A$F$Y$$$20240807$$HP$JP$JP
241813691$24181369$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000048830$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$49$YR$A$M$Y$$$20240807$$HP$JP$JP
241813701$24181370$1$I$$20240412$20240807$20240807$PER$$AP-2024-US-5859$AILEX PHARMACEUTICALS$$9$YR$$F$Y$$$20240807$$CN$US$US
241813721$24181372$1$I$$20240802$20240807$20240807$EXP$$US-ABBVIE-5865862$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241813731$24181373$1$I$$20240728$20240807$20240807$PER$$US-ABBVIE-5858938$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241813741$24181374$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000048831$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$54$YR$A$F$Y$$$20240807$$HP$JP$JP
241813751$24181375$1$I$$20240715$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407011095$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240807$$CN$US$US
241813761$24181376$1$I$$20240729$20240807$20240807$EXP$$US-JNJFOC-20240782221$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
241813772$24181377$2$F$20231001$20240917$20240807$20240925$EXP$$JP-ROCHE-10000048432$ROCHE$$64$YR$A$F$Y$82$KG$20240925$$MD$JP$JP
241813781$24181378$1$I$20240201$20240731$20240807$20240807$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-122042$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240807$$CN$CN$CN
241813791$24181379$1$I$20240101$20240729$20240807$20240807$PER$$US-SA-2024SA226797$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240807$$MD$US$US
241813801$24181380$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA226817$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240807$$MD$US$US
241813811$24181381$1$I$20220601$20240729$20240807$20240807$PER$$US-SA-2024SA227063$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240807$$MD$US$US
241813821$24181382$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA227101$SANOFI AVENTIS$$$$A$M$Y$$$20240807$$MD$US$US
241813831$24181383$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA227114$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240807$$MD$US$US
241813842$24181384$2$F$$20240826$20240807$20240826$PER$$US-ALXN-202407USA002238US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241813852$24181385$2$F$$20240910$20240807$20240930$EXP$$CA-HALEON-CACH2023046593$Haleon PLC$$44$YR$$F$Y$97$KG$20240930$$MD$CA$CA
241813861$24181386$1$I$20240101$20240729$20240807$20240807$PER$$US-SA-2024SA227102$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240807$$MD$US$US
241813872$24181387$2$F$20240101$20240828$20240807$20240911$PER$$US-SA-2024SA227182$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240911$$MD$US$US
241813881$24181388$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA229353$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240807$$MD$US$US
241813891$24181389$1$I$$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024154164$AMGEN$$$$$$Y$$$20240806$$HP$US$US
241813901$24181390$1$I$$20240731$20240807$20240807$EXP$$DE-AMGEN-DEUSP2024152656$AMGEN$$$$$F$Y$$$20240806$$CN$DE$DE
241813911$24181391$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA226717$SANOFI AVENTIS$$$$E$F$Y$$$20240807$$MD$US$US
241813921$24181392$1$I$20240802$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154734$AMGEN$$73$YR$E$F$Y$$$20240806$$CN$US$US
241813931$24181393$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000049937$ROCHE$$59$YR$A$F$Y$$$20240807$$HP$US$US
241813941$24181394$1$I$$20240114$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US005718$SANDOZ$Shankar A., Shrestha R., Sharma A., Rosu D., Hays J.V., Agoston I.. A Triple Threat: Takayasu Arteritis, Bicuspid Aortic Valve, and Triplets. JACC: Case reports. 2023;28$$$$$Y$$$20240807$$MD$US$US
241813951$24181395$1$I$$20230419$20240807$20240807$EXP$$US-AstraZeneca-2023A092161$ASTRAZENECA$$$$$$Y$$$20240807$$CN$US$
241813961$24181396$1$I$20230105$20230314$20240807$20240807$EXP$$US-AstraZeneca-2023A025356$ASTRAZENECA$$19901$DY$$F$Y$$$20240807$$CN$US$
241813971$24181397$1$I$20240801$20240801$20240807$20240807$EXP$$NL-BIOGEN-2024BI01276946$BIOGEN$$65$YR$$M$Y$$$20240807$$CN$NL$NL
241813981$24181398$1$I$$20240802$20240807$20240807$EXP$$US-BIOGEN-2024BI01276969$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
241813991$24181399$1$I$$20231113$20240807$20240807$EXP$$GB-AstraZeneca-2023A215676$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$GB$
241814001$24181400$1$I$$20211206$20240807$20240807$EXP$$US-AstraZeneca-2021A859861$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241814011$24181401$1$I$$20220721$20240807$20240807$EXP$$US-AstraZeneca-2022A264494$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241814021$24181402$1$I$$20240730$20240807$20240807$EXP$$JP-ROCHE-10000048725$ROCHE$$7$DEC$E$M$Y$$$20240807$$MD$JP$JP
241814031$24181403$1$I$$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024155177$AMGEN$$$$$$Y$$$20240806$$PH$US$US
241814041$24181404$1$I$$20240802$20240807$20240807$PER$$US-JNJFOC-20240807425$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$PH$US$US
241814052$24181405$2$F$20240726$20240911$20240807$20240914$PER$$US-AMGEN-USASP2024156146$AMGEN$$$$$M$Y$$$20240914$$CN$US$US
241814062$24181406$2$F$20240719$20240903$20240807$20240905$EXP$$FI-ORGANON-O2408FIN000470$ORGANON$$77$YR$$F$Y$$$20240905$$CN$FI$FI
241814071$24181407$1$I$$20240801$20240807$20240807$PER$$US-ABBVIE-5867295$ABBVIE$$$$$F$Y$$$20240807$$HP$US$US
241814081$24181408$1$I$$20240215$20240807$20240807$EXP$$JP-SANDOZ INC.-SDZ2024JP005789$SANDOZ$$$$$$Y$$$20240807$$PH$JP$JP
241814091$24181409$1$I$20240711$20240730$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011895$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241814101$24181410$1$I$$20240731$20240807$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123810$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240807$$PH$JP$JP
241814111$24181411$1$I$20240701$20240730$20240807$20240807$PER$$US-SA-2024SA229388$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240807$$MD$US$US
241814121$24181412$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA230003$SANOFI AVENTIS$$$$T$M$Y$81.633$KG$20240807$$MD$US$US
241814131$24181413$1$I$$20231025$20240807$20240807$EXP$$VN-SANDOZ INC.-NVSC2023VN099519$SANDOZ$$$$$$Y$$$20240807$$MD$VN$VN
241814141$24181414$1$I$20240801$20240801$20240807$20240807$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR097275$VIIV$$$$$$Y$$$20240807$$CN$US$US
241814151$24181415$1$I$$20240802$20240807$20240807$EXP$$JP-EXELIXIS-CABO-24080244$EXELIXIS$$$$$$Y$$$20240806$$MD$JP$JP
241814161$24181416$1$I$20240730$20240730$20240807$20240807$PER$$US-JNJFOC-20240780570$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$US$US
241814171$24181417$1$I$$20240802$20240807$20240807$EXP$$BR-JNJFOC-20240815366$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$BR$BR
241814181$24181418$1$I$$20240805$20240807$20240807$PER$$US-JNJFOC-20240811343$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$PH$US$US
241814192$24181419$2$F$20231222$20240913$20240807$20240920$EXP$$JP-JNJFOC-20240814929$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240920$$MD$JP$JP
241814202$24181420$2$F$20240802$20240813$20240807$20240814$PER$$US-AMGEN-USASP2024155179$AMGEN$$$$$$Y$$$20240814$$CN$US$US
241814211$24181421$1$I$20240726$20240731$20240807$20240807$EXP$$CN-ROCHE-10000046390$ROCHE$$72$YR$E$M$Y$$$20240807$$HP$CN$CN
241814221$24181422$1$I$$20240730$20240807$20240807$EXP$$US-Laboratoire X.O-NOD202408-000106$Laboratoire X.O$$35$YR$A$M$Y$$$20240807$$HP$US$
241814231$24181423$1$I$$20240731$20240807$20240807$EXP$$US-GSK-US2024AMR096103$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
241814241$24181424$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA227627$SANOFI AVENTIS$$$$A$M$Y$$$20240807$$MD$US$US
241814251$24181425$1$I$20240101$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155573$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241814261$24181426$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA227628$SANOFI AVENTIS$$$$A$F$Y$71.655$KG$20240807$$MD$US$US
241814271$24181427$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA229516$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240807$$CN$US$US
241814281$24181428$1$I$20240601$20240730$20240807$20240807$PER$$US-SA-2024SA229700$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240807$$MD$US$US
241814291$24181429$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA229390$SANOFI AVENTIS$$$$A$M$Y$$$20240807$$MD$US$US
241814301$24181430$1$I$$20240801$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408001694$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240807$$HP$US$US
241814311$24181431$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA229327$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240807$$MD$US$US
241814324$24181432$4$F$$20240821$20240807$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202407019570$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240823$$HP$US$US
241814333$24181433$3$F$20240101$20240815$20240807$20240820$PER$$US-AMGEN-USASP2024155628$AMGEN$$70$YR$E$M$Y$$$20240820$$CN$US$US
241814341$24181434$1$I$$20240728$20240807$20240807$EXP$$FR-AMGEN-FRASP2024153319$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Hepatology. 2024;1-13$$$$$Y$$$20240806$$MD$FR$FR
241814352$24181435$2$F$$20240827$20240807$20240829$PER$$US-AMGEN-USASP2024154567$AMGEN$$$$$$Y$$$20240828$$CN$US$US
241814361$24181436$1$I$20240517$20240805$20240807$20240807$EXP$$UY-ABBVIE-5809699$ABBVIE$$70$YR$$F$Y$$$20240807$$CN$UY$UY
241814371$24181437$1$I$$20231220$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2023CN071804$SANDOZ$Yan Xi-yue. Isosorbide mononitrate combined with nicorandil in the treatment of unstable angina Clinical effect with mild to moderate stenosis. renowned doctor. 14:159-161$$$$$Y$$$20240807$$HP$CN$CN
241814381$24181438$1$I$20210101$20240802$20240807$20240807$EXP$FR-AFSSAPS-RN2024000843$FR-TAKEDA-2024TUS077716$TAKEDA$$87$YR$$F$Y$$$20240807$$HP$FR$FR
241814392$24181439$2$F$$20240808$20240807$20240814$EXP$$JP-AMGEN-JPNSP2024155049$AMGEN$$55$YR$A$F$Y$$$20240814$$PH$JP$JP
241814403$24181440$3$F$20211025$20240829$20240807$20240905$EXP$$US-AMGEN-USASP2024153251$AMGEN$$63$YR$A$F$Y$$$20240905$$LW$US$US
241814412$24181441$2$F$$20240913$20240807$20240920$EXP$$BR-SANDOZ INC.-SDZ2024BR070908$SANDOZ$$81$YR$$F$Y$$$20240920$$CN$BR$BR
241814421$24181442$1$I$$20240724$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-039216$AUROBINDO$$36$YR$$F$Y$$$20240807$$HP$CA$CA
241814431$24181443$1$I$$20240805$20240807$20240807$EXP$PL-URPL-1-3861-2020$PL-HALEON-2190552$Haleon PLC$$23$YR$$M$Y$100$KG$20240807$$MD$PL$PL
241814441$24181444$1$I$$20240729$20240807$20240807$EXP$$US-VIIV HEALTHCARE LIMITED-US2024094729$VIIV$$$$$M$Y$$$20240807$$HP$US$US
241814451$24181445$1$I$20240601$20240725$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024093747$VIIV$$39$YR$$M$Y$$$20240807$$HP$US$US
241814461$24181446$1$I$20221120$20240805$20240807$20240807$EXP$$AT-ROCHE-10000050265$ROCHE$$20$YR$A$F$Y$$$20240807$$MD$AT$AT
241814471$24181447$1$I$$20240731$20240807$20240807$PER$$US-ALXN-202407USA002174US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
241814481$24181448$1$I$$20240723$20240807$20240807$EXP$$CA-IMP-2024000540$Harrow Health$$61$YR$A$M$Y$$$20240807$$CN$CA$CA
241814491$24181449$1$I$$20240731$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124228$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$44$KG$20240807$$CN$US$US
241814501$24181450$1$I$$20240801$20240807$20240807$PER$$US-ABBVIE-5864877$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241814511$24181451$1$I$$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124100$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240807$$CN$US$US
241814521$24181452$1$I$$20240716$20240807$20240807$PER$$US-BEIGENE-BGN-2024-011105$BEIGENE$$$$$$Y$$$20240807$$MD$US$US
241814531$24181453$1$I$20230705$20240801$20240807$20240807$EXP$PL-URPL-DML-MLP.4401.2.121.2024$PL-JNJFOC-20240804699$JOHNSON AND JOHNSON$$41$YR$A$M$Y$95$KG$20240807$$CN$PL$PL
241814541$24181454$1$I$$20240716$20240807$20240807$PER$$US-BEIGENE-BGN-2024-011202$BEIGENE$$$$$$Y$$$20240807$$PH$US$US
241814551$24181455$1$I$20240711$20240730$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011875$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241814562$24181456$2$F$20240710$20240809$20240807$20240815$EXP$$JP-JNJFOC-20240800498$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240816$$MD$JP$JP
241814571$24181457$1$I$20240701$20240729$20240807$20240807$EXP$$US-AMGEN-USASP2024151054$AMGEN$$77$YR$E$F$Y$$$20240806$$CN$US$US
241814581$24181458$1$I$$20240731$20240807$20240807$EXP$$PL-ROCHE-10000048965$ROCHE$$$$A$F$Y$$$20240807$$MD$PL$PL
241814591$24181459$1$I$20240601$20240730$20240807$20240807$PER$$US-ABBVIE-5860773$ABBVIE$$59$YR$$F$Y$$$20240807$$CN$US$US
241814601$24181460$1$I$$20240801$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122980$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240807$$CN$US$US
241814611$24181461$1$I$$20231110$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2023CN051635$SANDOZ$WANG Qi. Amlodipine besylate combined with calcium Atorvastatin in the treatment of elderly hypertensive patients with dyslipidemia. China Academic Journal Electronic Publishing House. 2023;67-69$$$$$Y$$$20240807$$MD$CN$CN
241814623$24181462$3$F$$20240902$20240807$20240906$30DAY$$AU-JNJFOC-20240776958$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$HP$AU$AU
241814632$24181463$2$F$$20240904$20240807$20240904$PER$$US-ALXN-202407USA002241US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
241814641$24181464$1$I$$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124082$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240807$$HP$US$US
241814651$24181465$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124049$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240807$$HP$US$US
241814661$24181466$1$I$$20240802$20240807$20240807$EXP$$DE-009507513-2408DEU000916$MERCK$$$$$F$Y$$$20240807$$MD$DE$DE
241814671$24181467$1$I$$20240805$20240807$20240807$EXP$$US-TAKEDA-2024TUS078663$TAKEDA$$$$$F$Y$$$20240807$$CN$US$US
241814681$24181468$1$I$$20231204$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2023CN064894$SANDOZ$Shuai Z,  Xiaobing J. Efficacy and rate of cardiovascular events in older patients with coronary artery disease were analyzed with atorvastatin calcium plus trametasine. Women^s Health. 2023;283-284$$$$$Y$$$20240807$$HP$CN$CN
241814691$24181469$1$I$20240721$20240723$20240807$20240807$EXP$$US-MDD US Operations-MDD202407-002668$MDD OPERATIONS$$77$YR$$M$Y$$$20240807$$CN$US$
241814701$24181470$1$I$$20211103$20240807$20240807$EXP$$US-AstraZeneca-2021A796877$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241814711$24181471$1$I$$20210203$20240807$20240807$EXP$$US-AstraZeneca-2021A033710$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241814721$24181472$1$I$$20230713$20240807$20240807$EXP$$US-AstraZeneca-2023A161603$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241814731$24181473$1$I$$20210323$20240807$20240807$EXP$$US-AstraZeneca-2021A208832$ASTRAZENECA$$84$YR$$F$Y$$$20240807$$CN$US$
241814741$24181474$1$I$$20221122$20240807$20240807$EXP$$CA-AstraZeneca-2022A388728$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$CA$
241814751$24181475$1$I$$20230628$20240807$20240807$EXP$$US-AstraZeneca-2023A149424$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241814762$24181476$2$F$20240101$20240819$20240807$20240830$PER$$US-SA-2024SA227656$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240830$$MD$US$US
241814771$24181477$1$I$20240612$20240805$20240807$20240807$EXP$$AU-TAKEDA-2024TUS059397$TAKEDA$$39$YR$$F$Y$$$20240807$$CN$AU$AU
241814782$24181478$2$F$20240723$20240805$20240807$20240813$PER$$US-SA-2024SA227701$SANOFI AVENTIS$$82$YR$E$M$Y$89.81$KG$20240814$$MD$US$US
241814791$24181479$1$I$20240101$20240729$20240807$20240807$EXP$$US-ABBVIE-5775625$ABBVIE$$$$$M$Y$97$KG$20240807$$CN$US$US
241814801$24181480$1$I$$20240801$20240807$20240807$EXP$$DE-Bion-013608$BIONPHARMA$$$$N$$Y$$$20240807$$HP$DE$DE
241814811$24181481$1$I$$20240731$20240807$20240807$EXP$$GB-Bion-013596$BIONPHARMA$$7$DEC$E$F$Y$$$20240807$$HP$GB$GB
241814821$24181482$1$I$$20240801$20240807$20240807$EXP$$JP-Bion-013604$BIONPHARMA$$72$YR$E$M$Y$71.4$KG$20240807$$HP$JP$JP
241814831$24181483$1$I$$20240801$20240807$20240807$PER$$NVSC2024US159213$NOVARTIS$$65$YR$$M$Y$$$20240807$$CN$US$US
241814841$24181484$1$I$$20240801$20240807$20240807$PER$$NVSC2024US160200$NOVARTIS$$$$$F$Y$$$20240807$$MD$US$US
241814852$24181485$2$F$20240701$20240805$20240807$20240809$PER$$US-AMGEN-USASP2024155320$AMGEN$$72$YR$E$M$Y$$$20240809$$CN$US$US
241814861$24181486$1$I$$20240801$20240807$20240807$EXP$$US-Bion-013599$BIONPHARMA$$73$YR$E$F$Y$$$20240807$$HP$US$US
241814871$24181487$1$I$$20240730$20240807$20240807$EXP$$US-Bion-013610$BIONPHARMA$$$$$F$Y$$$20240807$$CN$US$US
241814881$24181488$1$I$20240701$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024154737$AMGEN$$76$YR$E$F$Y$$$20240806$$CN$US$US
241814891$24181489$1$I$$20240801$20240807$20240807$EXP$$US-ABBVIE-5755161$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241814901$24181490$1$I$$20240730$20240807$20240807$EXP$$GB-CELLTRION INC.-2024GB018561$CELLTRION$$$$$$Y$$$20240807$$CN$GB$GB
241814911$24181491$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124083$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240807$$CN$US$US
241814921$24181492$1$I$$20231204$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2023CN064899$SANDOZ$HU Xuejing, LIU Qingmin, ZHANG Tiezheng, WANG Long, LIU Caixia, LI Ping, YAN Ruyu. Effect Analysis of Enhanced Extracorreal Counterpulsation for Coronary Heart Disease Angina Pectoris of Qi Deficiency and Blood Stasis Type. Smart Healthcare. 2023;90-101$$$$$Y$$$20240807$$MD$CN$CN
241814931$24181493$1$I$$20240724$20240807$20240807$EXP$$AU-MEDLEY-000016$MEDLEY PHARMACEUTICALS$$$$A$M$Y$$$20240726$$MD$AU$AU
241814942$24181494$2$F$$20240809$20240807$20240815$EXP$$NVSJ2024JP009447$NOVARTIS$$$$$$Y$$$20240816$$MD$JP$JP
241814951$24181495$1$I$20240501$20240801$20240807$20240807$EXP$$US-ABBVIE-5864540$ABBVIE$$39$YR$$F$Y$$$20240807$$CN$US$US
241814961$24181496$1$I$$20240711$20240807$20240807$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044176$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240807$$CN$US$US
241814971$24181497$1$I$$20240724$20240807$20240807$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122714$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$HP$CA$CA
241814981$24181498$1$I$$20240731$20240807$20240807$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000270$EMCURE$$$$$$Y$$$20240807$$CN$US$US
241814991$24181499$1$I$$20240730$20240807$20240807$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000267$EMCURE$Wagle L, Regmi DR, Regmi R, Poudel S, Pant HN.. Metformin Toxicity Leading to Severe Refractory Hyperkalemia and Metabolic Acidosis: A Case Report. Cureus. 2024;16(6):e63130$74$YR$$M$Y$$$20240807$$HP$US$US
241815001$24181500$1$I$$20240801$20240807$20240807$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000280$EMCURE$$$$$$Y$$$20240807$$CN$US$US
241815011$24181501$1$I$$20240730$20240807$20240807$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000277$EMCURE$Munjal V, Macielak RJ, Kaul VF, Dodson EE, Ren Y.. Leflunomide-Associated Wound Complication After Cochlear Implantation: A Case Report.. Ann Otol Rhinol Laryngol.. 2024;34894241266792$81$YR$$M$Y$$$20240807$$MD$US$US
241815021$24181502$1$I$20240414$20240805$20240807$20240807$EXP$FR-AFSSAPS-LL2024001422$FR-ROCHE-10000048677$ROCHE$$57$YR$A$F$Y$$$20240807$$PH$FR$FR
241815031$24181503$1$I$$20240805$20240807$20240807$EXP$$IT-ABBVIE-5868414$ABBVIE$$82$YR$$F$Y$$$20240807$$CN$IT$IT
241815041$24181504$1$I$$20240729$20240807$20240807$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004095$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241815051$24181505$1$I$20240730$20240806$20240807$20240807$EXP$$TH-ROCHE-10000050297$ROCHE$$$$$F$Y$$$20240807$$CN$TH$TH
241815061$24181506$1$I$20240701$20240806$20240807$20240807$EXP$FR-AFSSAPS-NT2024000981$FR-JNJFOC-20240815337$JOHNSON AND JOHNSON$$68$YR$E$M$Y$85$KG$20240807$$PH$FR$FR
241815072$24181507$2$F$20240804$20240810$20240807$20240812$PER$$US-AMGEN-USASP2024155616$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241815081$24181508$1$I$$20230814$20240807$20240807$EXP$$US-AstraZeneca-2023A186004$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241815091$24181509$1$I$$20240117$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2024CN003569$SANDOZ$Xiaoyu Z, Jialin W, Weihua Z, Rongli Z, Donglin Y, Aiming P et.al.,. Isavuconazole and voriconazole as oral sequential treatments for hematological malignancies Comparison of efficacy and safety in patients with invasive aspergillosis. Journal of Clinical Hematology. 2024;37:14-18$$$$$Y$$$20240807$$HP$CN$CN
241815101$24181510$1$I$$20230621$20240807$20240807$EXP$$US-AstraZeneca-2023A143949$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241815111$24181511$1$I$$20230922$20240807$20240807$EXP$$US-AstraZeneca-2023A217261$ASTRAZENECA$$$$$F$Y$$$20240807$$HP$US$
241815121$24181512$1$I$20240701$20240805$20240807$20240807$EXP$FR-AFSSAPS-PB2024000825$FR-ROCHE-10000048701$ROCHE$$$$A$F$Y$47$KG$20240807$$PH$FR$FR
241815132$24181513$2$F$$20240904$20240807$20240912$30DAY$$AR-JNJFOC-20240811543$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$AR$AR
241815143$24181514$3$F$$20240926$20240807$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123919$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240930$$CN$US$US
241815151$24181515$1$I$20240726$20240805$20240807$20240807$EXP$GB-MHRA-MED-202408051140567160-HBMFC$GB-UCBSA-2024039141$UCB$$33$YR$$M$Y$$$20240807$$PH$GB$GB
241815161$24181516$1$I$20240629$20240729$20240807$20240807$EXP$FR-AFSSAPS-LM2024000407$FR-TEVA-VS-3227752$TEVA$$57$YR$$M$Y$90$KG$20240807$$MD$FR$FR
241815171$24181517$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408001929$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240807$$CN$US$US
241815182$24181518$2$F$20240721$20240805$20240807$20240830$PER$$US-ROCHE-10000049771$ROCHE$$14$YR$T$M$Y$$$20240830$$CN$US$US
241815192$24181519$2$F$$20240909$20240807$20240913$EXP$$JP-GSK-JP2024097642$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$JP$JP
241815202$24181520$2$F$$20240804$20240807$20240808$EXP$$IL-ROCHE-10000048956$ROCHE$$$$A$F$Y$$$20240808$$CN$IL$IL
241815212$24181521$2$F$$20240805$20240807$20240807$EXP$$US-ROCHE-10000049738$ROCHE$$56$YR$A$F$Y$$$20240807$$CN$US$US
241815221$24181522$1$I$$20240208$20240807$20240807$30DAY$$US-SANDOZ INC.-SDZ2024US013851$SANDOZ$$$$$$Y$$$20240807$$CN$US$US
241815231$24181523$1$I$20240801$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024155174$AMGEN$$73$YR$E$F$Y$$$20240806$$CN$US$US
241815242$24181524$2$F$$20240902$20240807$20240912$EXP$$AU-AMGEN-AUSSP2024154472$AMGEN$$$$$F$Y$$$20240912$$HP$AU$AU
241815252$24181525$2$F$20231224$20240816$20240807$20240821$30DAY$$US-AMGEN-USASP2024152858$AMGEN$$85$YR$E$M$Y$$$20240821$$HP$US$US
241815261$24181526$1$I$$20240731$20240807$20240807$PER$$US-BIOGEN-2024BI01276398$BIOGEN$$$$$M$Y$$$20240807$$CN$US$US
241815271$24181527$1$I$$20240801$20240807$20240807$PER$$US-BIOGEN-2024BI01276509$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
241815281$24181528$1$I$20240628$20240729$20240807$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021034$UNITED THERAPEUTICS$$79$YR$$M$Y$68.027$KG$20240807$$$US$US
241815293$24181529$3$F$$20240919$20240807$20240924$PER$$US-BIOGEN-2024BI01252157$BIOGEN$$$$$F$Y$$$20240924$$CN$US$US
241815301$24181530$1$I$$20240805$20240807$20240807$EXP$$CN-TAKEDA-2024TUS078650$TAKEDA$$$$$M$Y$$$20240807$$CN$CN$CN
241815312$24181531$2$F$$20240828$20240807$20240905$EXP$$US-APOTEX-2024AP009056$APOTEX$Bayless SL, Walker NV, Scott MM, Leo RJ.. Clozapine-Related Cecal Volvulus. The Primary Care Companion for CNS Disorders. 2024;26(4):24cr03729$58$YR$$F$Y$$$20240905$$MD$US$US
241815322$24181532$2$F$$20240821$20240807$20240823$EXP$$JP-TAKEDA-2024TUS078554$TAKEDA$Miura M, Miyata K, Kaneko T, Akahoshi S, Morikawa Y, Matsushima T, et al. Methylprednisolone pulse and prednisolone for intensification of primary treatment in kawasaki disease patients at high risk of treatment resistance: a multicenter prospective cohort study. European Journal Of Pediatrics. 2024;1-10$$$I$$Y$$$20240823$$HP$JP$JP
241815331$24181533$1$I$$20240802$20240807$20240807$EXP$$CL-JNJFOC-20240810978$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$MD$CL$CL
241815342$24181534$2$F$$20240910$20240807$20240916$30DAY$$JP-JNJFOC-20240811448$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$PH$JP$JP
241815351$24181535$1$I$$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154417$AMGEN$$$$A$M$Y$$$20240806$$CN$US$US
241815361$24181536$1$I$$20211110$20240807$20240807$EXP$$US-AstraZeneca-2021A802928$ASTRAZENECA$$$$$M$Y$60.8$KG$20240807$$CN$US$
241815373$24181537$3$F$20240501$20240919$20240807$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR090838$VIIV$$50$YR$$M$Y$$$20240927$$PH$US$US
241815381$24181538$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091309$VIIV$$31$YR$$M$Y$$$20240807$$PH$US$US
241815391$24181539$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090842$VIIV$$51$YR$$M$Y$$$20240807$$PH$US$US
241815401$24181540$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090653$VIIV$$54$YR$$F$Y$$$20240807$$PH$US$US
241815411$24181541$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090646$VIIV$$24$YR$$M$Y$$$20240807$$PH$US$US
241815423$24181542$3$F$20240501$20240919$20240807$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR090828$VIIV$$45$YR$$M$Y$$$20240927$$PH$US$US
241815433$24181543$3$F$20240501$20240919$20240807$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR090351$VIIV$$47$YR$$M$Y$$$20240929$$PH$US$US
241815441$24181544$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090840$VIIV$$25$YR$$M$Y$$$20240807$$PH$US$US
241815451$24181545$1$I$20240501$20240601$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024096302$VIIV$$29$YR$$M$Y$$$20240807$$HP$US$US
241815461$24181546$1$I$$20230926$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2023CN036991$SANDOZ$$$$$$Y$$$20240807$$CN$CN$CN
241815471$24181547$1$I$$20230522$20240807$20240807$EXP$$US-AstraZeneca-2023A121574$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241815481$24181548$1$I$$20220315$20240807$20240807$EXP$$US-AstraZeneca-2022A117086$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241815491$24181549$1$I$$20220124$20240807$20240807$EXP$$US-AstraZeneca-2022A041853$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241815501$24181550$1$I$$20230328$20240807$20240807$EXP$$US-AstraZeneca-2023A038442$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241815511$24181551$1$I$$20220116$20240807$20240807$EXP$$US-AstraZeneca-2022A032959$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241815521$24181552$1$I$$20230330$20240807$20240807$EXP$$US-AstraZeneca-2023A053713$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241815531$24181553$1$I$20220121$20220124$20240807$20240807$EXP$$US-AstraZeneca-2022A044164$ASTRAZENECA$$19724$DY$$F$Y$$$20240807$$CN$US$
241815541$24181554$1$I$$20210304$20240807$20240807$EXP$$US-AstraZeneca-2021A112104$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241815551$24181555$1$I$20200102$20200316$20240807$20240807$EXP$$TW-AstraZeneca-2020SE38784$ASTRAZENECA$$52$YR$$F$Y$$$20240807$$CN$TW$
241815561$24181556$1$I$20200101$20230117$20240807$20240807$EXP$$US-AstraZeneca-2023A015663$ASTRAZENECA$$31025$DY$$$Y$$$20240807$$CN$US$
241815572$24181557$2$F$$20240925$20240807$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US014370$SANDOZ$$$$$$Y$$$20240925$$CN$US$US
241815583$24181558$3$F$20240818$20240919$20240807$20240921$EXP$$US-TAKEDA-2024TUS042170$TAKEDA$$48$YR$$F$Y$$$20240921$$CN$US$US
241815591$24181559$1$I$$20240722$20240807$20240807$EXP$$CH-AMGEN-CHESP2024156172$AMGEN$$$$$$Y$$$20240806$$MD$CH$CH
241815601$24181560$1$I$20230516$20240801$20240807$20240807$EXP$$NVSJ2024JP002105$NOVARTIS$$33$YR$$F$Y$60.1$KG$20240807$$MD$JP$JP
241815611$24181561$1$I$20240801$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154587$AMGEN$$81$YR$E$F$Y$$$20240806$$CN$US$US
241815624$24181562$4$F$20240803$20240909$20240807$20240911$PER$$US-AMGEN-USASP2024155620$AMGEN$$77$YR$E$M$Y$$$20240911$$CN$US$US
241815631$24181563$1$I$$20240723$20240807$20240807$PER$$US-TEVA-VS-3226201$TEVA$$81$YR$$F$Y$$$20240807$$PH$US$US
241815641$24181564$1$I$$20240801$20240807$20240807$EXP$$US-ABBVIE-5865532$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241815651$24181565$1$I$$20240723$20240807$20240807$EXP$$US-TAKEDA-2024TUS074712$TAKEDA$$$$$F$Y$93.4$KG$20240807$$HP$US$US
241815661$24181566$1$I$20240726$20240801$20240807$20240807$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-023981$UNITED THERAPEUTICS$$63$YR$$$Y$$$20240807$$$CA$CA
241815671$24181567$1$I$20231031$20240729$20240807$20240807$EXP$$CO-UCBSA-2024039426$UCB$$89$YR$$M$Y$$$20240807$$CN$CO$CO
241815681$24181568$1$I$$20240228$20240807$20240807$EXP$GB-MHRA-MED-202401101600268480-DGJVP$GB-SANDOZ INC.-SDZ2024GB021490$SANDOZ$$$$$$Y$$$20240807$$PH$GB$GB
241815691$24181569$1$I$20240501$20240729$20240807$20240807$EXP$FR-AFSSAPS-LY2024001097$FR-TEVA-VS-3227671$TEVA$$63$YR$$F$Y$$$20240807$$PH$FR$FR
241815701$24181570$1$I$20240412$20240801$20240807$20240807$EXP$IT-MINISAL02-997235$IT-GENMAB-2024-02845$GENMAB$$78$YR$$M$Y$$$20240807$$MD$IT$IT
241815711$24181571$1$I$$20240730$20240807$20240807$EXP$$US-NOVITIUMPHARMA-2024USNVP01500$NOVITIUM PHARMA$$$$$F$Y$24$KG$20240807$$CN$US$US
241815721$24181572$1$I$20240802$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154395$AMGEN$$$$$F$Y$$$20240806$$CN$US$US
241815731$24181573$1$I$20240725$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154265$AMGEN$$66$YR$E$M$Y$$$20240806$$CN$US$US
241815741$24181574$1$I$20240804$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155679$AMGEN$$74$YR$E$F$Y$$$20240806$$CN$US$US
241815751$24181575$1$I$$20240709$20240807$20240807$EXP$$AU-GSK-AU2024APC085776$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$AU$AU
241815761$24181576$1$I$$20240228$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US022226$SANDOZ$$$$$$Y$$$20240807$$HP$US$US
241815771$24181577$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003171$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241815781$24181578$1$I$20240723$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003451$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240807$$CN$US$US
241815791$24181579$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002875$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240807$$CN$US$US
241815801$24181580$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002584$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240807$$CN$US$US
241815811$24181581$1$I$$20240725$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002874$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240807$$CN$US$US
241815821$24181582$1$I$$20240730$20240807$20240807$PER$$US-ROCHE-10000046137$ROCHE$$$$$$Y$$$20240807$$MD$US$US
241815831$24181583$1$I$$20240802$20240807$20240807$PER$$US-ROCHE-10000048255$ROCHE$$$$$$Y$$$20240807$$CN$US$US
241815841$24181584$1$I$$20240803$20240807$20240807$PER$$US-ROCHE-10000049516$ROCHE$$$$$$Y$$$20240807$$CN$US$US
241815851$24181585$1$I$$20240801$20240807$20240807$PER$$US-ROCHE-10000047902$ROCHE$$39$YR$A$F$Y$$$20240807$$CN$US$US
241815861$24181586$1$I$20230101$20230404$20240807$20240807$EXP$$US-AstraZeneca-2023A079596$ASTRAZENECA$$720$MON$$F$Y$$$20240807$$CN$US$
241815871$24181587$1$I$$20240730$20240807$20240807$EXP$$JP-AstraZeneca-2024A175491$ASTRAZENECA$Tanaka H, et al.. EP-0668: A case of gastric metastasis of invasive lobular carcinoma that required 2 years for a diagnosis.. The 32nd Annual Meeting of the Japanese Breast Cancer Society 2024;344-.$76$YR$$F$Y$$$20240807$$MD$JP$
241815881$24181588$1$I$$20240802$20240807$20240807$PER$$US-GILEAD-2024-0682786$GILEAD$$$$E$M$Y$$$20240806$$CN$US$US
241815891$24181589$1$I$$20221118$20240807$20240807$EXP$$US-AstraZeneca-2022A392051$ASTRAZENECA$$$$$F$Y$$$20240807$$HP$US$
241815901$24181590$1$I$$20221111$20240807$20240807$EXP$$ZA-AstraZeneca-2022A375215$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$ZA$
241815911$24181591$1$I$20240725$20240801$20240807$20240807$EXP$$US-AstraZeneca-2024A175800$ASTRAZENECA$$23830$DY$$F$Y$89.4$KG$20240807$$CN$US$
241815921$24181592$1$I$$20220411$20240807$20240807$EXP$$US-AstraZeneca-2022A147189$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241815931$24181593$1$I$$20210713$20240807$20240807$EXP$$US-AstraZeneca-2021A623963$ASTRAZENECA$$$$$F$Y$47.6$KG$20240807$$CN$US$
241815941$24181594$1$I$20211224$20220118$20240807$20240807$EXP$$CA-AstraZeneca-2022A032018$ASTRAZENECA$$23844$DY$$F$Y$$$20240807$$CN$CA$
241815951$24181595$1$I$$20240730$20240807$20240807$EXP$$GB-AstraZeneca-2024A175021$ASTRAZENECA$$$$$F$Y$$$20240807$$MD$GB$
241815961$24181596$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000049549$ROCHE$$$$$$Y$$$20240807$$CN$US$US
241815971$24181597$1$I$$20240220$20240807$20240807$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002095$STRIDES$$$$$F$Y$66.213$KG$20240807$$CN$US$US
241815981$24181598$1$I$$20231106$20240807$20240807$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017054$STRIDES$Sambommatsu Y, Bruno DA, Imai D, Lee SD, Khan AA, Sharma A, et al. Domino Liver Transplantation for Unresectable Colon Cancer Liver Metastasis From a Donor With Heterozygous Familial Hyperlipidemia: A Case Report. Transplant-Proc. 2023;55(8):1930-1933$30$YR$$F$Y$$$20240807$$MD$US$US
241815991$24181599$1$I$$20240728$20240807$20240807$EXP$$IN-IHL-000594$INVENTIA HEALTHCARE$$62$YR$A$F$Y$$$20240730$$MD$IN$IN
241816001$24181600$1$I$$20240725$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024093579$VIIV$$6$DEC$$M$Y$$$20240807$$CN$US$US
241816011$24181601$1$I$20240701$20240801$20240807$20240807$EXP$$BR-GSK-BR2024AMR066663$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$BR$BR
241816021$24181602$1$I$20240101$20240801$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-021610$UNITED THERAPEUTICS$$$$$F$Y$71.202$KG$20240807$$$US$US
241816031$24181603$1$I$$20240728$20240807$20240807$EXP$$US-AMAROX PHARMA-HET2024US02579$HETERO$Denton J, Ozgur H, Sazegar P, Galgiani J, Riaz T.. Musculoskeletal and CNS coccidiomycosis in an individual with multiple  sclerosis on fingolimod - A case report. IDCases. 2024;37:1-5$56$YR$$F$Y$$$20240807$$HP$US$US
241816042$24181604$2$F$$20240806$20240807$20240809$PER$$US-ROCHE-10000049558$ROCHE$$26$YR$A$F$Y$$$20240809$$CN$US$US
241816051$24181605$1$I$$20240724$20240807$20240807$EXP$$US-RDY-LIT/USA/24/0011200$DR REDDYS$Abedrabo S, Rodriguez TE, Klein LM, Bitran J. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142(1): doi:10.1182/blood-2023-174684.$$$$$Y$$$20240807$$MD$US$US
241816061$24181606$1$I$$20240806$20240807$20240807$EXP$$US-JNJFOC-20240813494$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
241816071$24181607$1$I$$20240730$20240807$20240807$EXP$$PT-NOVITIUMPHARMA-2024PTNVP01477$NOVITIUM PHARMA$Lorena  Lozano  Rea.FEVER IN COVID-19 TIMES.European Journal of Case Reports in Internal Medicine.29-JUN-2022;9(1):378$68$YR$A$F$Y$$$20240807$$HP$PT$PT
241816081$24181608$1$I$20240701$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155863$AMGEN$$51$YR$A$M$Y$$$20240806$$CN$US$US
241816091$24181609$1$I$$20240319$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US031192$SANDOZ$$$$$$Y$$$20240807$$CN$US$US
241816101$24181610$1$I$$20240802$20240807$20240807$30DAY$$US-GSK-US2024097049$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241816111$24181611$1$I$$20240726$20240807$20240807$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2024GSK094599$VIIV$Adachi E, Sedohara A, Arizono K, Takahashi K, Otani A, Kanno Y et al. Hepatitis B Virus Reactivation after Switch to Cabotegravir/Rilpivirine in Patient with Low Hepatitis B Surface Antibody. Emerging infectious diseases. 2024;30 (8):1668-1671$$$$$Y$$$20240807$$MD$JP$JP
241816121$24181612$1$I$$20240805$20240807$20240807$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044236$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240807$$CN$US$US
241816131$24181613$1$I$$20240723$20240807$20240807$EXP$$US-RISINGPHARMA-US-2024RISLIT00274$RISING PHARMACEUTICALS$Benjamin T Cocanougher.The severity of MUSK pathogenic variants is predicted by the protein domain they disrupt.HCG Advances.18-JUL-2024;5(3):100288$$$N$M$Y$3.17$KG$20240807$$HP$US$US
241816141$24181614$1$I$20240805$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155327$AMGEN$$76$YR$E$F$Y$$$20240806$$CN$US$US
241816151$24181615$1$I$$20240728$20240807$20240807$EXP$$FR-AMGEN-FRASP2024153242$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut. 2024;1-13$$$$$Y$$$20240806$$MD$FR$FR
241816161$24181616$1$I$20240714$20240805$20240807$20240807$EXP$GB-MHRA-MED-202408051654157590-JKGFT$GB-SANDOZ INC.-SDZ2024GB070870$SANDOZ$$31$YR$$F$Y$70$KG$20240807$$MD$GB$GB
241816171$24181617$1$I$20240401$20240731$20240807$20240807$EXP$$CO-JNJFOC-20240550306$JOHNSON AND JOHNSON$$30$YR$A$M$Y$80$KG$20240807$$HP$CO$CO
241816181$24181618$1$I$$20240729$20240807$20240807$EXP$$JP-GSK-JP2020JPN263117$GLAXOSMITHKLINE$Nemoto C, Shimoda Y, Kobayashi E, Sato Y, Ohyama M, Mizukawa Y.. A case of Hashimoto?s disease developed in the recovery phase of drug-induced hypersensitivity syndrome with recurrent eruption and persistent reactivation of virus. Japanese Journal of Clinical Dermatology. 2024;78:550-556$$$$$Y$$$20240807$$MD$JP$JP
241816192$24181619$2$F$20230420$20240822$20240807$20240827$EXP$$JP-GSK-JP2024JPN091967$GLAXOSMITHKLINE$Saito T, Namera A, Tsuji T, Maki Y, Yamamoto R, Morita S, et al. P-034 - LC-MSMS analysis of valaciclovir and aciclovir in serum. The Japanese Journal of Clinical Toxicology. 2024;37:247$$$$$Y$$$20240827$$MD$JP$JP
241816201$24181620$1$I$$20240731$20240807$20240807$EXP$$PT-GSK-PT2024GSK096182$GLAXOSMITHKLINE$Miranda T, Maio Herculano M, Sousa Torres J, Das Neves Coelho F, Rebelo M. From Bronchodilation to Lactic Acidosis: A Case Report on Salbutamol^s Adverse Effect. Cureus. 2024;16(6)$$$$$Y$$$20240807$$MD$PT$PT
241816211$24181621$1$I$$20240805$20240807$20240807$EXP$FR-EMA-20170209-gdhingrap-155720719$FR-SANDOZ INC.-SDZ2024FR070443$SANDOZ$$58$YR$$F$Y$$$20240807$$MD$FR$FR
241816221$24181622$1$I$$20240725$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-039318$AUROBINDO$Almutawa F, Kim SH, Cabrera A, Delport J. Yokenella regensburgei infection in an immunocompetent individual after trauma following a fall from a personal conveyance. JAMMI. 2023;8 (1):94-98$38$YR$$M$Y$$$20240807$$HP$CA$CA
241816231$24181623$1$I$$20240730$20240807$20240807$PER$$US-ALXN-202407USA002258US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
241816242$24181624$2$F$$20240910$20240807$20240918$30DAY$$DE-JNJFOC-20240807317$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$DE$DE
241816261$24181626$1$I$$20240731$20240807$20240807$PER$$US-ABBVIE-5862911$ABBVIE$$54$YR$$F$Y$$$20240807$$CN$US$US
241816272$24181627$2$F$20240722$20240807$20240807$20240816$PER$$US-AMGEN-USASP2024154488$AMGEN$$65$YR$E$M$Y$$$20240815$$CN$US$US
241816281$24181628$1$I$20240804$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156076$AMGEN$$45$YR$A$F$Y$$$20240806$$CN$US$US
241816291$24181629$1$I$$20240731$20240807$20240807$PER$$US-AMGEN-USASP2024153275$AMGEN$$$$$$Y$$$20240806$$CN$US$US
241816301$24181630$1$I$$20240729$20240807$20240807$EXP$$JP-AMGEN-JPNSP2024155778$AMGEN$EP-0606 Initial use experience with Pegfilgrastim BodyPod. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 329$$$$F$Y$$$20240806$$MD$JP$JP
241816311$24181631$1$I$$20211208$20240807$20240807$EXP$$US-AstraZeneca-2021A867557$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241816321$24181632$1$I$$20240722$20240807$20240807$PER$$US-AstraZeneca-2024A167605$ASTRAZENECA$$$$$F$Y$$$20240807$$PH$US$
241816331$24181633$1$I$20230402$20230405$20240807$20240807$EXP$$US-AstraZeneca-2023A081747$ASTRAZENECA$$30836$DY$$$Y$$$20240807$$CN$US$
241816341$24181634$1$I$$20220531$20240807$20240807$EXP$$US-AstraZeneca-2022A205935$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241816351$24181635$1$I$$20220118$20240807$20240807$EXP$$US-AstraZeneca-2022A032220$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241816361$24181636$1$I$$20220202$20240807$20240807$EXP$$US-AstraZeneca-2022A058855$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241816371$24181637$1$I$20240101$20240802$20240807$20240807$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-106310$REGENERON$$$$$F$Y$$$20240807$$CN$US$US
241816381$24181638$1$I$20240615$20240729$20240807$20240807$EXP$FR-AFSSAPS-MP2024001128$FR-TEVA-VS-3227663$TEVA$$41$YR$$M$Y$$$20240807$$MD$FR$FR
241816391$24181639$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003125$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240807$$CN$US$US
241816401$24181640$1$I$20240719$20240801$20240807$20240807$EXP$$CN-ROCHE-10000047356$ROCHE$$58$YR$A$F$Y$63.6$KG$20240807$$HP$CN$CN
241816412$24181641$2$F$$20240819$20240807$20240820$EXP$$FR-SANDOZ INC.-SDZ2024FR070527$SANDOZ$$16$YR$$M$Y$$$20240820$$HP$FR$FR
241816421$24181642$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002876$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241816441$24181644$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003102$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241816451$24181645$1$I$20240804$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003068$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240807$$CN$US$US
241816461$24181646$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002788$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240807$$CN$US$US
241816471$24181647$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002104$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240807$$HP$US$US
241816481$24181648$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003334$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241816491$24181649$1$I$$20240729$20240807$20240807$EXP$$JP-AMGEN-JPNSP2024154452$AMGEN$$6$DEC$A$F$Y$$$20240806$$MD$JP$JP
241816501$24181650$1$I$$20240731$20240807$20240807$EXP$GB-MHRA-MED-202407311605065140-ZKQWJ$GB-ESPERIONTHERAPEUTICS-2024GBR01235$ESPERION THERAPEUTICS$$$$$$Y$$$20240807$$PH$GB$GB
241816511$24181651$1$I$20240716$20240731$20240807$20240807$EXP$GB-MHRA-TPP20640899C6519831YC1722347811120$GB-ESPERIONTHERAPEUTICS-2024GBR01234$ESPERION THERAPEUTICS$$$$$$Y$$$20240807$$MD$GB$GB
241816521$24181652$1$I$$20240731$20240807$20240807$EXP$GB-MHRA-TPP11363864C10569487YC1722244409017$GB-ESPERIONTHERAPEUTICS-2024GBR01236$ESPERION THERAPEUTICS$$76$YR$$F$Y$125$KG$20240807$$PH$GB$GB
241816531$24181653$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090844$VIIV$$59$YR$$M$Y$$$20240807$$PH$US$US
241816551$24181655$1$I$20240701$20240729$20240807$20240807$PER$$US-SA-2024SA229961$SANOFI AVENTIS$$64$YR$A$F$Y$83.9$KG$20240807$$MD$US$US
241816561$24181656$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA229745$SANOFI AVENTIS$$$$A$F$Y$111.5$KG$20240807$$PH$US$US
241816571$24181657$1$I$$20240728$20240807$20240807$EXP$$US-HETERO-HET2024US02615$HETERO$Denton J, Ozgur H, Sazegar P, Galgiani J, Riaz T.. Musculoskeletal and CNS coccidiomycosis in an individual with multiple  sclerosis on fingolimod ? A case report. IDCases. 2024;37:1-5$56$YR$$F$Y$$$20240807$$HP$US$US
241816582$24181658$2$F$20240716$20240801$20240807$20240810$PER$$US-SA-2024SA229753$SANOFI AVENTIS$$79$YR$E$F$Y$49.89$KG$20240810$$MD$US$US
241816601$24181660$1$I$$20240730$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051466$TOLMAR$$13$YR$$F$Y$$$20240807$$MD$CA$CA
241816611$24181661$1$I$$20240730$20240807$20240807$EXP$$CA-TOLMAR, INC.-24CA051467$TOLMAR$$80$YR$$M$Y$$$20240807$$CN$CA$CA
241816621$24181662$1$I$$20240730$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051468$TOLMAR$$13$YR$$F$Y$$$20240807$$CN$CA$CA
241816631$24181663$1$I$$20240730$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051469$TOLMAR$$16$YR$$M$Y$$$20240807$$MD$CA$CA
241816641$24181664$1$I$$20240730$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051470$TOLMAR$$12$YR$$F$Y$$$20240807$$MD$CA$CA
241816651$24181665$1$I$$20240730$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051471$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
241816661$24181666$1$I$$20240730$20240807$20240807$EXP$$CA-TOLMAR, INC.-24CA051472$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
241816671$24181667$1$I$$20240730$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051473$TOLMAR$$15$YR$$F$Y$$$20240807$$MD$CA$CA
241816681$24181668$1$I$$20240730$20240807$20240807$EXP$$CA-TOLMAR, INC.-24CA051474$TOLMAR$$$$E$M$Y$$$20240807$$CN$CA$CA
241816691$24181669$1$I$$20240730$20240807$20240807$EXP$$CA-TOLMAR, INC.-24CA051476$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
241816701$24181670$1$I$$20240730$20240807$20240807$EXP$$CA-TOLMAR, INC.-24CA051477$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
241816711$24181671$1$I$$20240730$20240807$20240807$EXP$$CA-TOLMAR, INC.-24CA051478$TOLMAR$$$$$M$Y$$$20240807$$MD$CA$CA
241816721$24181672$1$I$$20240730$20240807$20240807$EXP$$CA-TOLMAR, INC.-24CA051479$TOLMAR$$89$YR$$M$Y$$$20240807$$CN$CA$CA
241816731$24181673$1$I$$20240731$20240807$20240807$EXP$$CA-TOLMAR, INC.-24CA051520$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
241816741$24181674$1$I$$20240730$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051480$TOLMAR$$80$YR$$M$Y$$$20240807$$CN$CA$CA
241816751$24181675$1$I$$20240730$20240807$20240807$EXP$$CA-TOLMAR, INC.-24CA051484$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
241816762$24181676$2$F$$20240913$20240807$20240923$EXP$$US-TOLMAR, INC.-24US051376$TOLMAR$$$$$$Y$$$20240923$$MD$US$US
241816771$24181677$1$I$$20240731$20240807$20240807$EXP$$US-TOLMAR, INC.-24US051493$TOLMAR$$$$$M$Y$82.99$KG$20240807$$HP$US$US
241816781$24181678$1$I$$20240731$20240807$20240807$EXP$$CA-TOLMAR, INC.-24CA051528$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
241816792$24181679$2$F$$20240912$20240807$20240912$PER$$US-ALXN-202407USA002124US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
241816801$24181680$1$I$20240322$20240803$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-039339$AUROBINDO$$78$YR$$M$Y$$$20240807$$MD$FR$FR
241816812$24181681$2$F$20240719$20240731$20240807$20240812$PER$$US-BIOGEN-2024BI01276418$BIOGEN$$55$YR$$F$Y$$$20240812$$HP$US$US
241816821$24181682$1$I$$20240729$20240807$20240807$EXP$$US-GSK-US2024094768$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
241816831$24181683$1$I$$20240726$20240807$20240807$EXP$$US-AUROBINDO-AUR-APL-2024-038475$AUROBINDO$$$$$$Y$$$20240807$$CN$US$US
241816841$24181684$1$I$$20240118$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US006686$SANDOZ$$$$$$Y$$$20240807$$MD$US$US
241816851$24181685$1$I$20240726$20240802$20240807$20240807$EXP$$CN-HALEON-2190402$Haleon PLC$$38$YR$$M$Y$80$KG$20240807$$HP$CN$CN
241816861$24181686$1$I$20240101$20240801$20240807$20240807$30DAY$$US-GSK-US2024096333$GLAXOSMITHKLINE$$61$YR$$M$Y$$$20240807$$CN$US$US
241816881$24181688$1$I$$20240731$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024095804$VIIV$$4$DEC$$$Y$$$20240807$$PH$US$US
241816891$24181689$1$I$$20240724$20240807$20240807$EXP$$US-RDY-LIT/USA/24/0011201$DR REDDYS$Abedrabo S, Rodriguez TE, Klein LM, Bitran J. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142(1): doi:10.1182/blood-2023-174684.$$$$$Y$$$20240807$$MD$US$US
241816901$24181690$1$I$$20240723$20240807$20240807$EXP$$CN-JNJFOC-20240768194$JOHNSON AND JOHNSON$$$$A$$Y$$$20240807$$HP$CN$CN
241816911$24181691$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123628$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240807$$HP$US$US
241816921$24181692$1$I$$20240802$20240807$20240807$EXP$$US-JNJFOC-20240809419$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240807$$CN$US$US
241816931$24181693$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124178$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240807$$CN$US$US
241816951$24181695$1$I$$20240730$20240807$20240807$EXP$$JP-AMGEN-JPNSP2024155782$AMGEN$Ono Y, Kimiduka K, Sugiyama J, Fukatsu Y, Miyake H, Ogura M. EP-1295 A case of postoperative bone metastasis of right breast cancer with cervical subcutaneous emphysema and mediastinitis from bone resorption drug-related osteonecrosis of the jaw (ARONJ). The 32nd Annual Meeting of the Japan Breast Cancer Societ. 2024;501$66$YR$E$F$Y$$$20240806$$MD$JP$JP
241816961$24181696$1$I$$20240728$20240807$20240807$30DAY$$US-GSK-US2024AMR095626$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
241816971$24181697$1$I$20240802$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154720$AMGEN$$71$YR$E$M$Y$$$20240806$$CN$US$US
241816982$24181698$2$F$$20240802$20240807$20240809$PER$$US-ROCHE-10000047458$ROCHE$$78$YR$E$M$Y$$$20240809$$CN$US$US
241816991$24181699$1$I$$20231107$20240807$20240807$EXP$$ZA-SANDOZ INC.-SDZ2023ZA051927$SANDOZ$$$$$$Y$$$20240807$$CN$ZA$ZA
241817001$24181700$1$I$20240722$20240801$20240807$20240807$EXP$$CN-ROCHE-10000047290$ROCHE$$72$YR$E$F$Y$81$KG$20240807$$HP$CN$CN
241817011$24181701$1$I$$20240802$20240807$20240807$EXP$$DE-JNJFOC-20240815466$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$MD$DE$DE
241817021$24181702$1$I$$20240723$20240807$20240807$PER$$US-TEVA-VS-3225157$TEVA$$43$YR$$F$Y$$$20240807$$CN$US$US
241817031$24181703$1$I$$20240731$20240807$20240807$PER$$US-ABBVIE-5862991$ABBVIE$$$$$$Y$$$20240807$$CN$US$US
241817041$24181704$1$I$$20240728$20240807$20240807$EXP$$FR-AMGEN-FRASP2024153219$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Hepatology. 2024;1-13$$$$$Y$$$20240807$$MD$FR$FR
241817052$24181705$2$F$20240621$20240816$20240807$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024093775$VIIV$$50$YR$$M$Y$$$20240830$$CN$US$US
241817061$24181706$1$I$20240701$20240725$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037584$AUROBINDO$$26$YR$$F$Y$70$KG$20240807$$MD$GB$GB
241817071$24181707$1$I$$20240705$20240807$20240807$EXP$$ZA-ROCHE-10000030728$ROCHE$$$$A$F$Y$$$20240807$$CN$ZA$ZA
241817081$24181708$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156165$AMGEN$$$$$F$Y$$$20240807$$HP$US$US
241817091$24181709$1$I$$20240804$20240807$20240807$PER$$US-ROCHE-3579590$ROCHE$$71$YR$E$F$Y$$$20240807$$CN$US$US
241817101$24181710$1$I$$20240729$20240807$20240807$PER$$US-ROCHE-10000042312$ROCHE$$$$$$Y$$$20240807$$PH$US$US
241817113$24181711$3$F$20221115$20240813$20240807$20240814$EXP$$US-UCBSA-2024039390$UCB$$67$YR$$F$Y$$$20240814$$HP$US$US
241817121$24181712$1$I$$20240807$20240807$20240807$EXP$$GB-JNJFOC-20240653675$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$GB$GB
241817132$24181713$2$F$20240101$20240730$20240807$20240810$PER$$US-ABBVIE-5861100$ABBVIE$$$$A$M$Y$$$20240810$$MD$US$US
241817141$24181714$1$I$$20240729$20240807$20240807$EXP$$IN-AMAROX PHARMA-HET2024IN02564$HETERO$Nath S, Padhy SK, Kumari S.. Ivabradine-induced delirium in a patient taking clozapine for treatment-resistant schizophrenia: a case report. East Asian Archives of Psychiatry. 2024;34(1):18-19$42$YR$$M$Y$$$20240807$$HP$IN$IN
241817151$24181715$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002919$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240807$$CN$US$US
241817161$24181716$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003034$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240807$$CN$US$US
241817171$24181717$1$I$20240805$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003108$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240807$$CN$US$US
241817181$24181718$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002951$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240807$$CN$US$US
241817191$24181719$1$I$$20240729$20240807$20240807$30DAY$$US-GSK-US2024094866$GLAXOSMITHKLINE$$$$$M$Y$$$20240807$$CN$US$US
241817201$24181720$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000049954$ROCHE$$14$YR$T$M$Y$$$20240807$$CN$US$US
241817212$24181721$2$F$20240727$20240807$20240807$20240816$PER$$US-AMGEN-USASP2024154641$AMGEN$$74$YR$E$M$Y$$$20240816$$CN$US$US
241817221$24181722$1$I$$20231215$20240807$20240807$EXP$$SG-SANDOZ INC.-SDZ2023SG072120$SANDOZ$$$$$$Y$$$20240807$$HP$SG$SG
241817231$24181723$1$I$20240527$20240805$20240807$20240807$EXP$$US-JNJFOC-20240810172$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240807$$CN$US$US
241817242$24181724$2$F$20120901$20240730$20240807$20240809$EXP$$JP-CHATTEMPRD-2023SA018197$CHATTEM$$65$YR$E$M$Y$$$20240809$$MD$JP$JP
241817251$24181725$1$I$$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024154091$AMGEN$$$$$$Y$$$20240807$$CN$US$US
241817261$24181726$1$I$$20240728$20240807$20240807$EXP$$FR-AMGEN-FRASP2024153255$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Hepatology. 2024;1-13$$$$$Y$$$20240807$$MD$FR$FR
241817271$24181727$1$I$20240101$20240731$20240807$20240807$PER$$US-AMGEN-USASP2024153936$AMGEN$$60$YR$A$F$Y$$$20240807$$CN$US$US
241817281$24181728$1$I$$20240729$20240807$20240807$EXP$$US-TAKEDA-2024TUS076696$TAKEDA$$$$$F$Y$$$20240807$$CN$US$US
241817292$24181729$2$F$20240101$20240826$20240807$20240829$PER$$US-AMGEN-USASP2024156023$AMGEN$$62$YR$A$M$Y$$$20240829$$HP$US$US
241817301$24181730$1$I$20230101$20240802$20240807$20240807$EXP$FR-AFSSAPS-NY2024000871$FR-SA-2024SA231269$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240807$$MD$FR$FR
241817311$24181731$1$I$$20221117$20240807$20240807$EXP$$US-AstraZeneca-2022A382898$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241817321$24181732$1$I$$20240719$20240807$20240807$PER$$US-AstraZeneca-2024A165515$ASTRAZENECA$$$$$$Y$$$20240807$$CN$US$
241817331$24181733$1$I$$20191017$20240807$20240807$EXP$$US-AstraZeneca-2019SF49592$ASTRAZENECA$$83$YR$$M$Y$$$20240807$$CN$US$
241817341$24181734$1$I$$20220503$20240807$20240807$EXP$$US-AstraZeneca-2022A175316$ASTRAZENECA$$$$$F$Y$70.8$KG$20240807$$CN$US$
241817351$24181735$1$I$$20220622$20240807$20240807$EXP$$CA-AstraZeneca-2022A230137$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$CA$
241817361$24181736$1$I$$20191022$20240807$20240807$EXP$$US-AstraZeneca-2019SF51454$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241817371$24181737$1$I$$20220123$20240807$20240807$EXP$$US-AstraZeneca-2022A042005$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241817381$24181738$1$I$$20220224$20240807$20240807$EXP$$US-AstraZeneca-2022A091114$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241817391$24181739$1$I$$20240729$20240807$20240807$EXP$$CA-APOTEX-2024AP008969$APOTEX$$67$YR$$M$Y$$$20240807$$MD$CA$CA
241817401$24181740$1$I$20240603$20240801$20240807$20240807$PER$$US-009507513-2408USA000525$MERCK$$63$YR$$F$Y$$$20240807$$CN$US$US
241817411$24181741$1$I$$20240729$20240807$20240807$30DAY$$US-GSK-US2024094884$GLAXOSMITHKLINE$$$$$M$Y$$$20240807$$CN$US$US
241817421$24181742$1$I$20240702$20240801$20240807$20240807$EXP$$US-VIIV HEALTHCARE LIMITED-US2024096911$VIIV$$40$YR$$F$Y$$$20240807$$HP$US$US
241817441$24181744$1$I$$20240725$20240807$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121735$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$PH$JP$JP
241817451$24181745$1$I$$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124182$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$66.22$KG$20240807$$CN$US$US
241817461$24181746$1$I$20170101$20231222$20240807$20240807$EXP$$NO-SANDOZ INC.-SDZ2023NO074719$SANDOZ$$$$$$Y$$$20240807$$CN$NO$NO
241817471$24181747$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124342$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240807$$CN$US$US
241817481$24181748$1$I$20240731$20240801$20240807$20240807$PER$$US-CHATTEMPRD-2024OHG026021$CHATTEM$$86$YR$E$F$Y$$$20240807$$CN$US$US
241817491$24181749$1$I$$20240801$20240807$20240807$EXP$$US-JNJFOC-20240803726$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
241817501$24181750$1$I$$20210730$20240807$20240807$EXP$$IT-AstraZeneca-2021A666555$ASTRAZENECA$$$$$$Y$$$20240807$$MD$IT$
241817511$24181751$1$I$$20221012$20240807$20240807$EXP$$US-AstraZeneca-2022A346791$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241817521$24181752$1$I$20230326$20230412$20240807$20240807$EXP$$US-AstraZeneca-2023A083840$ASTRAZENECA$$19728$DY$$F$Y$$$20240807$$CN$US$
241817531$24181753$1$I$$20211111$20240807$20240807$EXP$$AU-AstraZeneca-2021A805568$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$AU$
241817541$24181754$1$I$$20220524$20240807$20240807$EXP$$GT-AstraZeneca-2022A199288$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$GT$
241817551$24181755$1$I$20211001$20221114$20240807$20240807$EXP$$US-AstraZeneca-2022A334804$ASTRAZENECA$$492$MON$$F$Y$$$20240807$$CN$US$
241817561$24181756$1$I$$20220124$20240807$20240807$EXP$$US-AstraZeneca-2022A044875$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241817572$24181757$2$F$$20240920$20240807$20240930$EXP$$ZA-TAKEDA-2024TUS077735$TAKEDA$$$$$F$Y$$$20240930$$CN$ZA$ZA
241817581$24181758$1$I$20240701$20240805$20240807$20240807$EXP$$US-UCBSA-2024039298$UCB$$61$YR$$F$Y$$$20240807$$CN$US$US
241817591$24181759$1$I$20240801$20240801$20240807$20240807$EXP$$CL-JNJFOC-20240811365$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240807$$CN$CL$CL
241817601$24181760$1$I$20220501$20240725$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-037956$AUROBINDO$$42$YR$$F$Y$$$20240807$$PH$FR$FR
241817613$24181761$3$F$20240805$20240912$20240807$20240919$30DAY$$US-JNJFOC-20240813548$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240919$$PH$US$US
241817621$24181762$1$I$20200101$20240730$20240807$20240807$PER$$US-ROCHE-10000046958$ROCHE$$$$$F$Y$$$20240807$$CN$US$US
241817631$24181763$1$I$$20240805$20240807$20240807$PER$$US-HALEON-2190612$Haleon PLC$$$$$$Y$$$20240807$$CN$US$US
241817642$24181764$2$F$$20240815$20240807$20240820$PER$$US-AMGEN-USASP2024155781$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
241817652$24181765$2$F$20240704$20240909$20240807$20240917$EXP$$JP-009507513-2407JPN003539J$MERCK$$67$YR$$F$Y$$$20240917$$MD$JP$JP
241817661$24181766$1$I$20240702$20240725$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-037719$AUROBINDO$$23$YR$$F$Y$$$20240807$$CN$FR$FR
241817671$24181767$1$I$$20240726$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119134$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240807$$CN$US$US
241817681$24181768$1$I$$20240725$20240807$20240807$EXP$GB-MHRA-31118704$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001945$IPCA$$$$$$Y$$$20240807$$PH$GB$GB
241817691$24181769$1$I$$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124349$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240807$$CN$US$US
241817701$24181770$1$I$20240524$20240805$20240807$20240807$EXP$$US-UCBSA-2024039161$UCB$$60$YR$$F$Y$$$20240807$$CN$US$US
241817711$24181771$1$I$$20231226$20240807$20240807$EXP$$NL-SANDOZ INC.-SDZ2023NL072982$SANDOZ$$$$$$Y$$$20240807$$CN$NL$NL
241817721$24181772$1$I$20240515$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-038287$AUROBINDO$$56$YR$$M$Y$$$20240807$$PH$FR$FR
241817731$24181773$1$I$20240409$20240725$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-037738$AUROBINDO$$14$YR$$F$Y$53$KG$20240807$$MD$FR$FR
241817745$24181774$5$F$20230404$20240916$20240807$20240923$EXP$$IL-JNJFOC-20240785318$JOHNSON AND JOHNSON$$62$YR$A$F$Y$62$KG$20240923$$MD$IL$IL
241817751$24181775$1$I$20240714$20240801$20240807$20240807$EXP$FR-AFSSAPS-BS2024000474$FR-JNJFOC-20240804323$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240807$$MD$FR$FR
241817761$24181776$1$I$$20240804$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002992$ELI LILLY AND CO$$62$YR$A$$Y$$$20240807$$CN$US$US
241817771$24181777$1$I$$20240801$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002087$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241817781$24181778$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002004$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240807$$CN$US$US
241817791$24181779$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002957$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240807$$CN$US$US
241817801$24181780$1$I$$20240805$20240807$20240807$EXP$$US-ROCHE-10000049395$ROCHE$$$$E$F$Y$$$20240807$$CN$US$US
241817811$24181781$1$I$$20240105$20240807$20240807$EXP$$VN-SANDOZ INC.-SDZ2023VN075362$SANDOZ$Vu LH, Dung PX, Tung NQ. Study on treatment of diffuse large b-cell lymphoma, CD20(+) with or without MYC, BCL2 and BCL6 gene rearrangements by R-CHOP regimen at HCM city oncology hospital.. VIETNAM MEDICAL JOURNAL. 2023;533:422-32$$$$$Y$$$20240807$$MD$VN$VN
241817821$24181782$1$I$$20240724$20240807$20240807$PER$$US-AstraZeneca-2024A169392$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241817831$24181783$1$I$$20240730$20240807$20240807$PER$$US-AstraZeneca-2024A173610$ASTRAZENECA$$$$$F$Y$$$20240807$$HP$US$
241817842$24181784$2$F$20220911$20240909$20240807$20240920$EXP$$JP-JNJFOC-20221056435$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240920$$MD$JP$JP
241817851$24181785$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038867$AUROBINDO$$9$YR$$M$Y$$$20240807$$CN$CA$CA
241817861$24181786$1$I$$20240725$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038698$AUROBINDO$Amarasekera R, Wood E.. Worsening stimulant use disorder outcomes coinciding with off-label antipsychotic prescribing: A commonly unrecognised side effect?. BMJ Case Rep. 2023;16:e255129$2$DEC$$M$Y$$$20240807$$HP$CA$CA
241817871$24181787$1$I$$20210524$20240807$20240807$EXP$$US-AstraZeneca-2021A474817$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241817891$24181789$1$I$20240308$20240725$20240807$20240807$EXP$$JP-AMGEN-JPNSP2024088754$AMGEN$$$$$$Y$$$20240807$$MD$JP$JP
241817901$24181790$1$I$$20240728$20240807$20240807$EXP$$FR-AMGEN-FRASP2024153283$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Hepatology. 2024;1-13$$$$$Y$$$20240807$$MD$FR$FR
241817911$24181791$1$I$20240722$20240724$20240807$20240807$PER$$US-RDY-CLI/USA/24/0011036$DR REDDYS$$13$YR$C$F$Y$$$20240807$$CN$US$US
241817923$24181792$3$F$20230911$20240910$20240807$20240917$EXP$$BR-GSK-BR2023AMR126738$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$BR$BR
241817931$24181793$1$I$20240505$20240730$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011876$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241817941$24181794$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123763$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$60.78$KG$20240807$$CN$US$US
241817951$24181795$1$I$20240802$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124194$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240807$$CN$US$US
241817961$24181796$1$I$$20240110$20240807$20240807$EXP$$VN-SANDOZ INC.-SDZ2024VN003944$SANDOZ$$$$$$Y$$$20240807$$MD$VN$VN
241817971$24181797$1$I$20240601$20240724$20240807$20240807$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00376$MELINTA THERAPEUTICS$$$$$$Y$$$20240807$$CN$BR$BR
241817981$24181798$1$I$20240401$20240731$20240807$20240807$EXP$$GB-SANDOZ INC.-SDZ2023GB061803$SANDOZ$$85$YR$$F$Y$$$20240807$$CN$GB$GB
241817991$24181799$1$I$$20240731$20240807$20240807$PER$$US-ABBVIE-5864055$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241818001$24181800$1$I$20240607$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-038277$AUROBINDO$$76$YR$$F$Y$$$20240807$$MD$FR$FR
241818021$24181802$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155791$AMGEN$$46$YR$A$F$Y$$$20240807$$HP$US$US
241818031$24181803$1$I$20240201$20240725$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-037681$AUROBINDO$$59$YR$$M$Y$$$20240807$$PH$FR$FR
241818041$24181804$1$I$20240513$20240725$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-037933$AUROBINDO$$30$YR$$F$Y$$$20240807$$PH$FR$FR
241818051$24181805$1$I$$20240515$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-024712$AUROBINDO$$39$YR$$M$Y$$$20240807$$HP$CA$CA
241818061$24181806$1$I$20240630$20240802$20240807$20240807$EXP$$NVSC2024CO159419$NOVARTIS$$30$YR$$F$Y$93$KG$20240807$$CN$CO$CO
241818071$24181807$1$I$$20240729$20240807$20240807$PER$$US-ABBVIE-5860389$ABBVIE$$$$$$Y$$$20240807$$CN$US$US
241818081$24181808$1$I$20240706$20240730$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011900$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241818091$24181809$1$I$20240725$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154583$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241818102$24181810$2$F$$20240916$20240807$20240917$PER$$US-AMGEN-USASP2024155414$AMGEN$$$$$M$Y$$$20240917$$CN$US$US
241818111$24181811$1$I$$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154786$AMGEN$$$$$F$Y$$$20240807$$HP$US$US
241818121$24181812$1$I$$20240725$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-039321$AUROBINDO$$53$YR$$F$Y$$$20240807$$HP$CA$CA
241818132$24181813$2$F$20240101$20240920$20240807$20240930$EXP$$CA-CELLTRION INC.-2023CA022557$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
241818141$24181814$1$I$$20240731$20240807$20240807$EXP$GB-MHRA-30722561$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-07454$HIKMA$$$$$F$Y$$$20240807$$CN$GB$GB
241818151$24181815$1$I$20240208$20240725$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-037716$AUROBINDO$$77$YR$$M$Y$82$KG$20240807$$PH$FR$FR
241818162$24181816$2$F$$20240809$20240807$20240813$EXP$$PL-ABBVIE-5869541$ABBVIE$$54$YR$$M$Y$$$20240813$$CN$PL$PL
241818171$24181817$1$I$20140101$20240801$20240807$20240807$EXP$$AU-SANDOZ INC.-SDZ2024AU069852$SANDOZ$$$$$M$Y$$$20240807$$CN$AU$AU
241818181$24181818$1$I$20240803$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124328$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240807$$CN$US$US
241818192$24181819$2$F$$20240920$20240807$20240924$PER$$NVSC2024US159460$NOVARTIS$$$$$F$Y$98$KG$20240924$$HP$US$US
241818201$24181820$1$I$20240729$20240730$20240807$20240807$PER$$US-ABBVIE-5861011$ABBVIE$$53$YR$$F$Y$77.11$KG$20240807$$CN$US$US
241818211$24181821$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038986$AUROBINDO$$$$$M$Y$$$20240807$$HP$CA$CA
241818222$24181822$2$F$20240702$20240903$20240807$20240909$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-124023$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$107.5$KG$20240909$$CN$PR$PR
241818231$24181823$1$I$20240101$20240802$20240807$20240807$EXP$$CA-UCBSA-2024039430$UCB$$$$$F$Y$$$20240807$$CN$CA$CA
241818241$24181824$1$I$20240614$20240729$20240807$20240807$EXP$FR-AFSSAPS-AVCN2024000554$FR-TEVA-VS-3227762$TEVA$$21$YR$$M$Y$$$20240807$$MD$FR$FR
241818252$24181825$2$F$$20240812$20240807$20240822$EXP$$US-TEVA-VS-3228035$TEVA$Anwar A, Chahine Z, Piecoro D, Kesler M, Qasrawi A. Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia. Hum-Pathol-Rep 2023; 33 300713.; Anwar A, Chahine Z, Piecoro D, Kesler M, Qasrawi A. Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia. Hum-Pathol-Rep 2023; 33 300713.; Anwar A, Chahine Z, Piecoro D, Kesler M, Qasrawi A. Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocyto...$51$YR$$F$Y$$$20240822$$HP$US$US
241818261$24181826$1$I$$20240723$20240807$20240807$EXP$$TR-Nexus Pharma-000297$NEXUS PHARMACEUTICALS$Erturk Cetin O, Algedik P, Akyuz G, Surmeli R, Zanapalioglu U, Alev Saltak G, Guven S. Minor/Major Congenital Malformations and Neurodevelopmental Outcomes in Children Prenatally Exposed to Levetiracetam, Lamotrigine, and Carbamazepine Monotherapy. Clin Neuropharmacol. 2024 Jun 24.$$$N$$Y$$$20240807$$MD$TR$TR
241818271$24181827$1$I$$20240726$20240807$20240807$PER$$US-AstraZeneca-2024A144004$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241818281$24181828$1$I$$20210519$20240807$20240807$EXP$$CA-AstraZeneca-2021A447084$ASTRAZENECA$$65$YR$$$Y$81$KG$20240807$$MD$CA$
241818291$24181829$1$I$$20240112$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US004430$SANDOZ$$$$$$Y$$$20240807$$HP$US$US
241818301$24181830$1$I$$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-038331$AUROBINDO$Samalin, E.. Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients. Digestive and Liver Disease. 2024;56(8):1375-1381$$$A$$Y$$$20240807$$HP$FR$FR
241818312$24181831$2$F$$20240801$20240807$20240811$PER$$US-AMGEN-USASP2024153993$AMGEN$$$$$F$Y$$$20240811$$CN$US$US
241818321$24181832$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002206$ELI LILLY AND CO$$$$A$F$Y$$$20240807$$CN$US$US
241818331$24181833$1$I$20240803$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003453$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240807$$CN$US$US
241818342$24181834$2$F$$20240807$20240807$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002086$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241818351$24181835$1$I$20240803$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002953$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240807$$CN$US$US
241818361$24181836$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002845$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240807$$CN$US$US
241818371$24181837$1$I$20240805$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003130$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241818391$24181839$1$I$$20240729$20240807$20240807$30DAY$$US-GSK-US2024AMR095561$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
241818401$24181840$1$I$$20230821$20240807$20240807$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00411$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240730$$CN$US$US
241818411$24181841$1$I$20230101$20230922$20240807$20240807$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00478$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240730$$CN$US$US
241818421$24181842$1$I$20230706$20240806$20240807$20240807$EXP$FR-AFSSAPS-TO2024001479$FR-SANDOZ INC.-SDZ2024FR070855$SANDOZ$$80$YR$$M$Y$$$20240807$$PH$FR$FR
241818432$24181843$2$F$$20240808$20240807$20240814$PER$$US-JNJFOC-20240813801$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$US$US
241818442$24181844$2$F$$20240830$20240807$20240913$30DAY$$CA-JNJFOC-20240803932$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$HP$CA$CA
241818451$24181845$1$I$20240722$20240801$20240807$20240807$PER$$US-JNJFOC-20240804346$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240807$$CN$US$US
241818461$24181846$1$I$$20240806$20240807$20240807$PER$$US-JNJFOC-20240814108$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$PH$US$US
241818472$24181847$2$F$20240101$20240806$20240807$20240809$EXP$$CA-JNJFOC-20240767230$JOHNSON AND JOHNSON$$$$T$M$Y$99$KG$20240809$$HP$CA$CA
241818484$24181848$4$F$20240701$20240903$20240807$20240913$30DAY$$IL-JNJFOC-20240756465$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240913$$CN$IL$IL
241818491$24181849$1$I$$20240729$20240807$20240807$EXP$$US-SPECGX-T202401661$SPECGX$Cooperman NA, Lu SE, Hanley AW, Puvananayagam T, Dooley-Budsock P, Kline A et al. Telehealth mindfulness-oriented recovery enhancement vs usual care in individuals with opioid use disorder and pain: A randomized clinical trial. JAMA Psychiatry. 2024;81(4):338-46$$$$$Y$$$20240807$$HP$US$US
241818501$24181850$1$I$$20240723$20240807$20240807$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07410$LUPIN$Mikhail E, Alexander D, Jankowski M, Pandya D, Kunadi A. Survival and vision restoration following severe Metformin-associated metabolic acidosis with transient blindness: A case report and review of the literature. American Journal of Respiratory and Critical Care Medicine. 2024;209:A3410$72$YR$$F$Y$$$20240807$$HP$US$US
241818511$24181851$1$I$$20240726$20240807$20240807$EXP$$JP-EXELIXIS-CABO-24080251$EXELIXIS$$81$YR$$M$Y$$$20240807$$MD$JP$JP
241818541$24181854$1$I$$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037904$AUROBINDO$$85$YR$$F$Y$$$20240807$$PH$GB$GB
241818551$24181855$1$I$$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154421$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241818561$24181856$1$I$20240803$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156037$AMGEN$$74$YR$E$F$Y$$$20240807$$CN$US$US
241818571$24181857$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2019-057125$AUROBINDO$$77$YR$$M$Y$$$20240807$$HP$CA$CA
241818581$24181858$1$I$$20240802$20240807$20240807$30DAY$$US-GSK-US2024097037$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241818591$24181859$1$I$$20240731$20240807$20240807$EXP$$US-RDY-CLI/USA/24/0011346$DR REDDYS$$33$YR$A$M$Y$83.91$KG$20240807$$CN$US$US
241818601$24181860$1$I$20240703$20240726$20240807$20240807$EXP$FR-AFSSAPS-LY2024001144$FR-AUROBINDO-AUR-APL-2024-038083$AUROBINDO$$20$YR$$F$Y$50$KG$20240807$$PH$FR$FR
241818611$24181861$1$I$20240702$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-037848$AUROBINDO$$37$YR$$F$Y$52$KG$20240807$$MD$FR$FR
241818621$24181862$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000048496$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$84$YR$E$F$Y$$$20240807$$HP$JP$JP
241818631$24181863$1$I$$20240115$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US005541$SANDOZ$Li Y,Drappatz J,Mantica M.. FLUDARABINE NEUROTOXICITY IN PATIENTS UNDERGOING CAR T-CELLTHERAPY - A REPORT OF 2 CASES. Neuro-Oncolog. 2024;25(Supplement 5)$$$$$Y$$$20240807$$MD$US$US
241818641$24181864$1$I$20240804$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155832$AMGEN$$62$YR$A$F$Y$$$20240807$$CN$US$US
241818651$24181865$1$I$20240731$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154692$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241818671$24181867$1$I$20240101$20240806$20240807$20240807$EXP$$US-UCBSA-2024039418$UCB$$$$$F$Y$$$20240807$$CN$US$US
241818682$24181868$2$F$20240701$20240820$20240807$20240827$EXP$$JP-ALXN-202407JPN002046JP$ALEXION PHARMACEUTICALS$$60$YR$$F$Y$$$20240827$$MD$JP$JP
241818693$24181869$3$F$$20240826$20240807$20240826$PER$$US-ALXN-202407USA002240US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
241818701$24181870$1$I$$20240806$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US070998$SANDOZ$$$$$F$Y$$$20240807$$HP$US$US
241818711$24181871$1$I$20240501$20240726$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR095170$VIIV$$34$YR$$M$Y$72.562$KG$20240807$$CN$US$US
241818721$24181872$1$I$$20240122$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US007890$SANDOZ$Raj Vuppalanchi, Yi-Ju Li, Don C. Rockey, Robert J. Fontana, Herbert L. Bonkovsky, Christopher Koh, Victor J. Navarro, Md, Joseph Odin,. CLINICAL AND HLA CORRELATES IN CEPHALOSPORININDUCED LIVER INJURY. 2024;1729-A$$$$$Y$$$20240807$$HP$US$US
241818741$24181874$1$I$20240716$20240802$20240807$20240807$EXP$$ZA-AstraZeneca-2024A176301$ASTRAZENECA$$79$YR$$M$Y$$$20240807$$CN$ZA$
241818752$24181875$2$F$20190708$20240827$20240807$20240829$EXP$$CO-UCBSA-2024039427$UCB$$55$YR$$F$Y$$$20240829$$CN$CO$CO
241818761$24181876$1$I$$20240731$20240807$20240807$EXP$$US-ABBVIE-5864191$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241818771$24181877$1$I$$20240605$20240807$20240807$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-12683$ALKEM$Poldermans D, van Blankenstein M.. Pancreatitis induced by disodium azodisalicylate. Am J Gastroenterol. 1998;83:578-580$24$YR$$F$Y$$$20240807$$HP$NL$NL
241818781$24181878$1$I$$20240603$20240807$20240807$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-11738$ALKEM$Lee HY, Baek DH.. Perimyocarditis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid. Korean J Gastroenterol. 2024;83(5):197-199$29$YR$$F$Y$$$20240807$$HP$KR$KR
241818791$24181879$1$I$$20240605$20240807$20240807$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-12687$ALKEM$Sachedina B, Saibil F, Choen LB, et al.. Acute pancreatitis due to 5-aminosalicylate. Ann Intern Med. 1989;110:490-492$32$YR$$F$Y$$$20240807$$HP$CA$CA
241818801$24181880$1$I$$20240429$20240807$20240807$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-09148$ALKEM$Hayashi D, Nishida T, Osugi N, Kusunoki Y, Okabe S, Fujii Y, Nakamatsu D, Matsumoto K, Yamamoto M, Fukui K. Drug-induced Interstitial Nephritis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid. Internal Medicine. 2024;63(8):1081-1085$76$YR$$M$Y$$$20240807$$HP$JP$JP
241818811$24181881$1$I$$20240416$20240807$20240807$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-08406$ALKEM$Hayashi T, Terashima T, Nishitani M, Orita N, Miyazawa M, Seki A, Nakagawa H, Nio K, Iida N, Yamada S, Takatori H, Shimakami T, Yamashita T.. Gastroduodenitis Associated with Active Ulcerative Colitis Treated with Infliximab: Different Clinical Course in the Colon and Gastroduodenal Lesions. Internal Medicine. 2024;63:929-935$29$YR$$M$Y$$$20240807$$HP$JP$JP
241818821$24181882$1$I$$20240517$20240807$20240807$EXP$$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-10929$ALKEM$Chi MS, Hsieh PH, Huang SH, Hsu HC, Chi KH. Chronic radiation proctitis refractory to steroid enema was successfully treated by metformin and sodium butyrate: a case report. Medical Case Reports. 2024;18:239$70$YR$$M$Y$$$20240807$$HP$TW$TW
241818831$24181883$1$I$20240801$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024153490$AMGEN$$82$YR$E$$Y$$$20240807$$CN$US$US
241818841$24181884$1$I$$20240613$20240807$20240807$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-13475$ALKEM$Tursi A. Concomitant hidradenitis suppurativa and pyostomatitis vegetans in silent ulcerative colitis successfully treated with golimumab. Dig Liver Dis. 2016;48:511-1512$42$YR$$F$Y$$$20240807$$HP$IT$IT
241818851$24181885$1$I$$20240715$20240807$20240807$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-15693$ALKEM$Dicorato MM, Caretto P, Colucci C, Ciaccia M, Rella M, Muscogiuri E, Colonna P.. Cardiac magnetic resonance in a rare case of recurrent mesalazine-induced myocarditis. Future Cardiology. 2024;unk:1-7$25$YR$$M$Y$$$20240807$$HP$IT$IT
241818861$24181886$1$I$$20240507$20240807$20240807$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-10100$ALKEM$Zhang P, Chen J, Zhao W, Liu J.. Lower-dose intravenous immunoglobulin therapy for geriatric inflammatory bowel disease accompanied by COVID-19 multisystem inflammatory syndrome: A case report. Medicine. 2024;103:17$80$YR$$M$Y$$$20240807$$MD$CN$CN
241818871$24181887$1$I$$20240729$20240807$20240807$EXP$$FR-ROCHE-RCA5212623$ROCHE$Bourguiba R, Terr? A, Savey L, Oziol E, Hanslik T, Kahn J, et al. Symptomatic SARS-CoV2 infection associated with high mortality in AA amyloidosis. Amyloid. 2024;31 (2):156-8. doi:10.1080/13506129.2023.2294434.$86$YR$E$F$Y$$$20240807$$HP$FR$FR
241818881$24181888$1$I$$20240801$20240807$20240807$30DAY$$US-GSK-US2024096359$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241818891$24181889$1$I$20240101$20240802$20240807$20240807$EXP$$US-ABBVIE-5865840$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241818901$24181890$1$I$20240701$20240802$20240807$20240807$EXP$$US-ABBVIE-5865926$ABBVIE$$29$YR$$M$Y$$$20240807$$CN$US$US
241818911$24181891$1$I$20240101$20240805$20240807$20240807$EXP$$US-ABBVIE-5867728$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241818933$24181893$3$F$20240721$20240816$20240807$20240824$EXP$$US-CELLTRION INC.-2024US018143$CELLTRION$$$$$$Y$$$20240824$$HP$US$US
241818951$24181895$1$I$20240615$20240731$20240807$20240807$EXP$$CN-ROCHE-10000049429$ROCHE$$80$YR$E$F$Y$37$KG$20240807$$HP$CN$CN
241818971$24181897$1$I$$20240804$20240807$20240807$PER$$US-JNJFOC-20240809404$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$US$US
241818982$24181898$2$F$$20240807$20240807$20240816$EXP$$KR-JNJFOC-20240810224$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$HP$KR$KR
241818991$24181899$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5868777$ABBVIE$$$$$F$Y$$$20240807$$HP$US$US
241819001$24181900$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002267$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240807$$CN$US$US
241819011$24181901$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038960$AUROBINDO$$82$YR$$M$Y$74$KG$20240807$$HP$CA$CA
241819021$24181902$1$I$$20240731$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408000488$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240807$$CN$US$US
241819031$24181903$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003046$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240807$$CN$US$US
241819041$24181904$1$I$20240801$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002467$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240807$$CN$US$US
241819051$24181905$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202406015495$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240807$$CN$US$US
241819061$24181906$1$I$20240730$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002939$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240807$$CN$US$US
241819091$24181909$1$I$20240325$20240731$20240807$20240807$EXP$ES-AEMPS-1550309$ES-ROCHE-10000044229$ROCHE$$51$YR$A$F$Y$$$20240807$$HP$ES$ES
241819101$24181910$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5867600$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241819111$24181911$1$I$20240605$20240729$20240807$20240807$EXP$FR-AFSSAPS-ST2024001180$FR-TEVA-VS-3227547$TEVA$$70$YR$$M$Y$63$KG$20240807$$HP$FR$FR
241819121$24181912$1$I$$20240724$20240807$20240807$EXP$$PE-ALVOTECHPMS-2024-ALVOTECHPMS-002088$Alvotech$Coronado-Rivera EF, Alcantara-Figueroa CE. Upadacitinib in a patient with Crohn^s disease with loss of response to ustekinumab: A case report. Rev Gastroenterol Mex (Engl Ed). 2024 Jul 20:S2255-534X(24)00064-1. doi: 10.1016/j.rgmxen.2024.04.008.$30$YR$$F$Y$$$20240807$$HP$PE$
241819131$24181913$1$I$20221201$20240724$20240807$20240807$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-000386$Alvotech$$67$YR$$F$Y$$$20240807$$PH$CA$CA
241819142$24181914$2$F$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0683108$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241819151$24181915$1$I$20200706$20240726$20240807$20240807$EXP$$PL-AUROBINDO-AUR-APL-2024-038516$AUROBINDO$$50$YR$$M$Y$130$KG$20240807$$MD$PL$PL
241819161$24181916$1$I$20240712$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154559$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241819171$24181917$1$I$$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154717$AMGEN$$$$$$Y$$$20240807$$CN$US$US
241819182$24181918$2$F$20240801$20240926$20240807$20240927$PER$$US-AMGEN-USASP2024154853$AMGEN$$80$YR$E$M$Y$$$20240927$$CN$US$US
241819191$24181919$1$I$$20240728$20240807$20240807$EXP$$FR-AMGEN-FRASP2024153339$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Hepatology. 2024;1-13$$$$$Y$$$20240807$$MD$FR$FR
241819202$24181920$2$F$20240701$20240808$20240807$20240810$PER$$US-AMGEN-USASP2024155577$AMGEN$$79$YR$E$F$Y$$$20240810$$CN$US$US
241819211$24181921$1$I$$20240729$20240807$20240807$PER$$US-ABBVIE-5859910$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241819221$24181922$1$I$20240101$20240805$20240807$20240807$EXP$$US-ABBVIE-5868059$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241819232$24181923$2$F$20240501$20240914$20240807$20240923$EXP$$CA-JNJFOC-20240662465$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240923$$HP$CA$CA
241819241$24181924$1$I$20240802$20240802$20240807$20240807$PER$$US-JNJFOC-20240806991$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$HP$US$US
241819251$24181925$1$I$20240614$20240729$20240807$20240807$PER$$US-AMGEN-USASP2024150355$AMGEN$$62$YR$A$M$Y$$$20240807$$CN$US$US
241819261$24181926$1$I$20240101$20240801$20240807$20240807$EXP$$GB-ABBVIE-5865592$ABBVIE$$47$YR$$F$Y$$$20240807$$CN$GB$GB
241819271$24181927$1$I$$20240730$20240807$20240807$PER$$US-CHATTEMPRD-2024OHG025839$CHATTEM$$$$A$M$Y$$$20240807$$HP$US$US
241819281$24181928$1$I$$20240730$20240807$20240807$EXP$$JP-ROCHE-3579669$ROCHE$Yazaki T, Kimoto M, Minagawa A, Maruno T, Yamanaka M, Sonehara K, Hama M, Nakamura T, Kanda S, Hanaoka M and Hachiya T Simultaneous acquisition of T790M mutation and SCLC transformation during targeted therapy in EGFR-mutated lung adenocarcinoma: a rare case report. DOI:10.12659/AJCR.943466. American Journal of Case Reports 2024;25:-.$66$YR$E$M$Y$$$20240807$$HP$JP$JP
241819291$24181929$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000050152$ROCHE$$$$$F$Y$$$20240807$$MD$US$US
241819301$24181930$1$I$20240803$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155891$AMGEN$$70$YR$E$F$Y$$$20240807$$CN$US$US
241819311$24181931$1$I$20240723$20240723$20240807$20240807$PER$$US-RDY-SPO/USA/24/0011016$DR REDDYS$$$$$F$Y$$$20240807$$CN$US$US
241819321$24181932$1$I$$20240801$20240807$20240807$EXP$GB-MHRA-31377037$GB-RDY-SPO/GBR/24/0011414$DR REDDYS$$38$YR$A$M$Y$$$20240807$$PH$GB$GB
241819332$24181933$2$F$20240719$20240812$20240807$20240815$EXP$$US-SA-2024SA231762$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240815$$MD$US$US
241819341$24181934$1$I$20240101$20240806$20240807$20240807$EXP$$US-UCBSA-2024009997$UCB$$$$$F$Y$$$20240807$$CN$US$US
241819351$24181935$1$I$$20240802$20240807$20240807$EXP$$US-ABBVIE-5865686$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241819361$24181936$1$I$20230101$20240802$20240807$20240807$EXP$$US-ABBVIE-5860392$ABBVIE$$$$$F$Y$48$KG$20240807$$CN$US$US
241819371$24181937$1$I$$20240122$20240807$20240807$PER$$US-CHIESI-2024CHF00443$CHIESI$$$$$M$Y$$$20240807$$PH$US$US
241819381$24181938$1$I$$20240119$20240807$20240807$PER$$US-CHIESI-2024CHF00359$CHIESI$$$$$F$Y$$$20240807$$MD$US$US
241819391$24181939$1$I$20240701$20240718$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115356$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240807$$PH$US$US
241819402$24181940$2$F$20240701$20240807$20240807$20240814$EXP$$US-ABBVIE-5865718$ABBVIE$$77$YR$$M$Y$53$KG$20240814$$CN$US$US
241819412$24181941$2$F$20240701$20240829$20240807$20240905$EXP$$CO-ABBVIE-5869573$ABBVIE$$65$YR$$M$Y$49$KG$20240905$$HP$CO$CO
241819421$24181942$1$I$$20240805$20240807$20240807$PER$$US-JNJFOC-20240812597$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
241819431$24181943$1$I$$20240223$20240807$20240807$PER$$US-CHIESI-2024CHF01041$CHIESI$$$$$$Y$$$20240807$$HP$US$US
241819441$24181944$1$I$$20240201$20240807$20240807$PER$$US-CHIESI-2024CHF00627$CHIESI$$$$$$Y$$$20240807$$HP$US$US
241819451$24181945$1$I$$20240326$20240807$20240807$PER$$US-CHIESI-2024CHF01737$CHIESI$$74$YR$$M$Y$$$20240807$$PH$US$US
241819461$24181946$1$I$$20240201$20240807$20240807$PER$$US-CHIESI-2024CHF00624$CHIESI$$$$$$Y$$$20240807$$HP$US$US
241819471$24181947$1$I$$20240201$20240807$20240807$PER$$US-CHIESI-2024CHF00626$CHIESI$$$$$$Y$$$20240807$$HP$US$US
241819481$24181948$1$I$20240409$20240730$20240807$20240807$EXP$$CZ-CELLTRION INC.-2024CZ008655$CELLTRION$$$$$$Y$$$20240807$$MD$CZ$CZ
241819492$24181949$2$F$$20240808$20240807$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07536$LUPIN$$$$$$Y$$$20240822$$CN$US$US
241819501$24181950$1$I$$20240729$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-023566$UNITED THERAPEUTICS$$$$$M$Y$$$20240807$$$US$US
241819511$24181951$1$I$$20240710$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06986$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241819521$24181952$1$I$20240101$20240730$20240807$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-015100$UNITED THERAPEUTICS$$$$$F$Y$$$20240807$$$US$US
241819531$24181953$1$I$$20240728$20240807$20240807$EXP$$FR-AMGEN-FRASP2024153343$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Hepatology. 2024;1-13$$$$$Y$$$20240807$$MD$FR$FR
241819541$24181954$1$I$20240101$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154651$AMGEN$$79$YR$E$F$Y$$$20240807$$CN$US$US
241819551$24181955$1$I$20240805$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156109$AMGEN$$52$YR$A$F$Y$$$20240807$$CN$US$US
241819562$24181956$2$F$$20240808$20240807$20240813$EXP$$JP-CELLTRION INC.-2024JP018738$CELLTRION$Mamori T, Tsukioki T, Mimata A, Nakamoto S, Iwatani Y, Takahashi Y, et. al.. EP-1210 Evaluation of 2 cases in which long-term inpatient hospitalization was required for serious drug-induced cardiac failure. The 32nd Annual Meeting of the Japanese Breast Cancer Society (11-, 12-, and 13-. 2024;480$$$$$Y$$$20240813$$MD$JP$JP
241819571$24181957$1$I$20240519$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037854$AUROBINDO$$47$YR$$M$Y$89$KG$20240807$$PH$GB$GB
241819581$24181958$1$I$20240612$20240730$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011863$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241819591$24181959$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5868395$ABBVIE$$$$$M$Y$$$20240807$$HP$US$US
241819601$24181960$1$I$$20240723$20240807$20240807$EXP$$US-OSMOTICA PHARMACEUTICALS-2024ALO00364$OSMOTICA PHARMA$C. H. Chen, J. M. Alexander, D. Hofstede, T Rizvi. Malignant cerebellar edema in three-year-old girl following accidental opioid ingestion and fentanyl administration. Neuroradiol J. 2019;(32) 5:386?391$3$YR$$F$Y$13.5$KG$20240807$$HP$US$US
241819612$24181961$2$F$20230401$20240826$20240807$20240830$PER$$US-ROCHE-10000047532$ROCHE$$47$YR$A$F$Y$66.22$KG$20240830$$HP$US$US
241819621$24181962$1$I$$20240729$20240807$20240807$EXP$$CN-JNJFOC-20240779889$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$MD$CN$CN
241819631$24181963$1$I$$20240728$20240807$20240807$EXP$$FR-AMGEN-FRASP2024153351$AMGEN$Nault J.; Campani C.; Imbeaud S. et al.. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut. 2024;1-13$$$$$Y$$$20240807$$MD$FR$FR
241819641$24181964$1$I$20230101$20240724$20240807$20240807$EXP$$CN-UCBSA-2024021304$UCB$$29$YR$$F$Y$68$KG$20240807$$CN$CN$CN
241819651$24181965$1$I$$20240801$20240807$20240807$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122889$BRISTOL MYERS SQUIBB$$15$YR$T$M$Y$90$KG$20240807$$PH$CA$CA
241819662$24181966$2$F$20240729$20240805$20240807$20240826$PER$$US-009507513-2408USA000363$MERCK$$59$YR$$F$Y$$$20240826$$CN$US$US
241819673$24181967$3$F$$20240807$20240807$20240818$EXP$$CA-AUROBINDO-AUR-APL-2024-038831$AUROBINDO$$77$YR$$M$Y$$$20240818$$MD$CA$CA
241819682$24181968$2$F$20240628$20240802$20240807$20240809$EXP$$CA-JNJFOC-20240716933$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240809$$HP$CA$CA
241819691$24181969$1$I$$20240802$20240807$20240807$EXP$$US-SA-2024SA230996$SANOFI AVENTIS$$$$I$$Y$$$20240807$$HP$US$US
241819701$24181970$1$I$20240802$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002159$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240807$$CN$US$US
241819711$24181971$1$I$20240726$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002387$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240807$$CN$US$US
241819721$24181972$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003312$ELI LILLY AND CO$$49$YR$A$$Y$$$20240807$$CN$US$US
241819731$24181973$1$I$20240731$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002286$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241819741$24181974$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003186$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240807$$CN$US$US
241819751$24181975$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002309$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240807$$CN$US$US
241819761$24181976$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002838$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240807$$CN$US$US
241819771$24181977$1$I$20240802$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154949$AMGEN$$$$$M$Y$$$20240807$$CN$US$US
241819781$24181978$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155561$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241819791$24181979$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002356$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240807$$CN$US$US
241819801$24181980$1$I$20240804$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002795$ELI LILLY AND CO$$52$YR$A$$Y$$$20240807$$CN$US$US
241819811$24181981$1$I$20240802$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002115$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240807$$CN$US$US
241819821$24181982$1$I$20240228$20240731$20240807$20240807$EXP$$JP-AMGEN-JPNSP2024104185$AMGEN$$8$DEC$E$M$Y$$$20240807$$MD$JP$JP
241819831$24181983$1$I$20240730$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154804$AMGEN$$74$YR$E$F$Y$$$20240807$$CN$US$US
241819841$24181984$1$I$$20240802$20240807$20240807$PER$$US-BEH-2024176781$CSL BEHRING$$$$E$F$Y$$$20240807$$CN$US$US
241819851$24181985$1$I$20240701$20240723$20240807$20240807$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01295$AVADEL CNS PHARMA$$48$YR$$F$Y$$$20240807$$HP$US$US
241819861$24181986$1$I$20240724$20240725$20240807$20240807$EXP$GB-MHRA-MED-202407251110014900-GYJZH$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001947$IPCA$$$$$$Y$$$20240807$$PH$GB$GB
241819871$24181987$1$I$20220101$20240726$20240807$20240807$EXP$$CZ-AUROBINDO-AUR-APL-2024-038139$AUROBINDO$Matlova K, Sakarova B, Loffelmannova M, Pikner R.. Two Cases of Rare Bisphosphonates Treatment Side Effects : Atypical Femoral Fracture and Inflammatory Eye Reaction.. JBMR Plus.. 2023;7(Supplement 3):e10738.$72$YR$$F$Y$$$20240807$$MD$CZ$CZ
241819881$24181988$1$I$20240701$20240805$20240807$20240807$EXP$$US-ABBVIE-5850714$ABBVIE$$62$YR$$F$Y$79$KG$20240807$$CN$US$US
241819891$24181989$1$I$$20240731$20240807$20240807$PER$$US-ALXN-202407USA002165US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241819901$24181990$1$I$$20240730$20240807$20240807$EXP$GB-MHRA-31193571$GB-RDY-SPO/GBR/24/0011491$DR REDDYS$$$$$M$Y$$$20240807$$CN$GB$GB
241819921$24181992$1$I$20220101$20240802$20240807$20240807$EXP$$US-ABBVIE-5865791$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241819934$24181993$4$F$20240101$20240902$20240807$20240916$EXP$$DE-AMICUS THERAPEUTICS, INC.-AMI_3275$AMICUS THERAPEUTICS$$$$$M$Y$118.2$KG$20240916$$HP$DE$DE
241819941$24181994$1$I$$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024153423$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241819951$24181995$1$I$20240802$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155279$AMGEN$$$$$$Y$$$20240807$$CN$US$US
241819961$24181996$1$I$20240731$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024153742$AMGEN$$78$YR$E$F$Y$$$20240807$$CN$US$US
241819971$24181997$1$I$$20240731$20240807$20240807$EXP$GB-MHRA-MED-202407311157498130-FKZLG$GB-RDY-SPO/GBR/24/0011335$DR REDDYS$$$$$$Y$$$20240807$$PH$GB$GB
241819981$24181998$1$I$$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124036$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240807$$HP$US$US
241819992$24181999$2$F$20240101$20240808$20240807$20240812$EXP$$CA-UCBSA-2024039022$UCB$$$$$M$Y$$$20240812$$CN$CA$CA
241820002$24182000$2$F$20240501$20240905$20240807$20240910$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090839$VIIV$$38$YR$$F$Y$$$20240910$$PH$US$US
241820011$24182001$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091508$VIIV$$54$YR$$F$Y$$$20240807$$PH$US$US
241820021$24182002$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091312$VIIV$$38$YR$$F$Y$$$20240807$$PH$US$US
241820033$24182003$3$F$20240501$20240919$20240807$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR090845$VIIV$$41$YR$$M$Y$$$20240926$$PH$US$US
241820042$24182004$2$F$20240501$20240823$20240807$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090846$VIIV$$58$YR$$M$Y$104$KG$20240831$$PH$US$US
241820051$24182005$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091310$VIIV$$54$YR$$F$Y$$$20240807$$PH$US$US
241820061$24182006$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090843$VIIV$$67$YR$$M$Y$$$20240807$$PH$US$US
241820071$24182007$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090841$VIIV$$30$YR$$M$Y$$$20240807$$PH$US$US
241820081$24182008$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091510$VIIV$$39$YR$$F$Y$$$20240807$$PH$US$US
241820091$24182009$1$I$20240501$20240611$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090848$VIIV$$33$YR$$M$Y$$$20240807$$PH$US$US
241820101$24182010$1$I$$20240802$20240807$20240807$EXP$$ZA-JNJFOC-20240805935$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$HP$ZA$ZA
241820112$24182011$2$F$$20240909$20240807$20240916$30DAY$$AU-JNJFOC-20240807154$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$AU$AU
241820121$24182012$1$I$20240101$20240731$20240807$20240807$EXP$$CA-JNJFOC-20240804678$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240807$$HP$CA$CA
241820132$24182013$2$F$20240701$20240828$20240807$20240911$EXP$$US-Solstice Neurosciences, LLC-SOL202407-002779$SOLSTICE NEUROSCIENCES$$64$YR$$F$Y$$$20240911$$HP$US$
241820141$24182014$1$I$20240101$20240802$20240807$20240807$EXP$$US-ABBVIE-5865917$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241820151$24182015$1$I$20240710$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154989$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241820161$24182016$1$I$20240623$20240731$20240807$20240807$EXP$$US-CHEPLA-2024010091$CHEPLAPHARM$$94$YR$E$F$Y$$$20240807$$CN$COUNTRY NOT SPECIFIED$US
241820172$24182017$2$F$$20240805$20240807$20240813$EXP$$US-ROCHE-10000047658$ROCHE$$$$$$Y$$$20240813$$CN$US$US
241820181$24182018$1$I$$20240726$20240807$20240807$EXP$$DE-AUROBINDO-AUR-APL-2024-038527$AUROBINDO$Trabert J, Pullen R. Polymedikation und Deprescribing bei ?lteren Menschen Polypharmazie und potenziell inad?quate Medikamente. Hessisches ?rzteblatt. 2024;85(7-8):412-15$89$YR$$F$Y$$$20240807$$MD$DE$DE
241820191$24182019$1$I$20221130$20240729$20240807$20240807$EXP$$CO-UCBSA-2024039432$UCB$$54$YR$$F$Y$$$20240807$$CN$CO$CO
241820211$24182021$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5868584$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241820221$24182022$1$I$20240401$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-038120$AUROBINDO$$36$YR$$M$Y$$$20240807$$CN$FR$FR
241820232$24182023$2$F$20240725$20240830$20240807$20240910$EXP$$GR-BEH-2024176489$CSL BEHRING$$5$YR$C$M$Y$$$20240910$$MD$GR$GR
241820242$24182024$2$F$$20240904$20240807$20240913$30DAY$$AU-JNJFOC-20240807611$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$HP$AU$AU
241820251$24182025$1$I$$20240731$20240807$20240807$PER$$US-RDY-SPO/USA/24/0011409$DR REDDYS$$16$YR$T$F$Y$$$20240807$$MD$US$US
241820261$24182026$1$I$$20240731$20240807$20240807$PER$$US-RDY-SPO/USA/24/0011408$DR REDDYS$$18$YR$A$F$Y$$$20240807$$HP$US$US
241820271$24182027$1$I$$20221216$20240807$20240807$EXP$$CA-CELLTRION INC.-2022CA022745$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
241820281$24182028$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160386$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241820291$24182029$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124261$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240807$$CN$US$US
241820302$24182030$2$F$$20240916$20240807$20240917$PER$$NVSC2024US160421$NOVARTIS$$$$$$Y$$$20240917$$HP$US$US
241820311$24182031$1$I$$20220301$20240807$20240807$EXP$$PL-SANDOZ INC.-NVSC2022PL050329$SANDOZ$$$$$$Y$$$20240807$$MD$PL$PL
241820323$24182032$3$F$20210304$20240826$20240807$20240902$EXP$$NVSC2021IN071057$NOVARTIS$$64$YR$$F$Y$$$20240902$$CN$IN$IN
241820331$24182033$1$I$20221209$20240805$20240807$20240807$EXP$FR-AFSSAPS-AM2024000624$FR-UCBSA-2024039149$UCB$$20$YR$$M$Y$$$20240807$$MD$FR$FR
241820342$24182034$2$F$$20240729$20240807$20240813$EXP$$JP-ROCHE-10000048840$ROCHE$Suzuki Y, Aritake H, Kitagawa Y, Kawabata K. A case of gastric lymphoma with positive COVID19 antigen suspected of reactivation after gastrectomy (Abstract number:P103-7). The 79th General Meeting of the Japanese Society of Gastroenterological Surgery. 2024;1481.$87$YR$E$F$Y$$$20240813$$MD$JP$JP
241820354$24182035$4$F$$20240827$20240807$20240829$EXP$$CA-ROCHE-10000050181$ROCHE$$$$A$F$Y$$$20240829$$CN$CA$CA
241820362$24182036$2$F$20240717$20240726$20240807$20240813$EXP$NO-NOMAADVRE-RELISSO-2024-Vxepq7$NO-BEH-2024176546$CSL BEHRING$$55$YR$A$M$Y$$$20240813$$HP$NO$NO
241820371$24182037$1$I$$20240803$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003141$ELI LILLY AND CO$$$$A$F$Y$$$20240807$$CN$US$US
241820381$24182038$1$I$20240804$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003008$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240807$$CN$US$US
241820391$24182039$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002835$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240807$$HP$US$US
241820401$24182040$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002849$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240807$$CN$US$US
241820411$24182041$1$I$$20240801$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002818$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241820421$24182042$1$I$20240804$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002959$ELI LILLY AND CO$$60$YR$A$$Y$$$20240807$$CN$US$US
241820431$24182043$1$I$$20240730$20240807$20240807$EXP$$JP-CELLTRION INC.-2024JP018743$CELLTRION$Mamori T, Tsukioki T, Mimata A, Nakamoto S, Iwatani Y, Takahashi Y, et al.. EP-1210 Evaluation of 2 cases in which long-term inpatient hospitalization was required for serious drug-induced cardiac failure. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;11, 12, and 13:480$$$$$Y$$$20240807$$MD$JP$JP
241820441$24182044$1$I$$20240801$20240807$20240807$EXP$$CZ-CHEPLA-2023014793$CHEPLAPHARM$Masopust J, et. al. Differences between brexpiprazole and aripiprazole in clinical practice. Case series. Psychiatr. praxi. 2023;24(3):182-190 | DOI: 10.36290/psy.2023.034.$22$YR$$M$Y$$$20240807$$HP$COUNTRY NOT SPECIFIED$CZ
241820452$24182045$2$F$$20240806$20240807$20240809$EXP$$IE-ROCHE-10000050279$ROCHE$$$$$F$Y$$$20240809$$CN$IE$IE
241820461$24182046$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5868631$ABBVIE$$$$$F$Y$$$20240807$$HP$US$US
241820471$24182047$1$I$20240803$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156084$AMGEN$$64$YR$A$$Y$$$20240807$$CN$US$US
241820491$24182049$1$I$20240501$20240726$20240807$20240807$EXP$$SG-ROCHE-3491180$ROCHE$$75$YR$E$F$Y$$$20240807$$CN$SG$SG
241820501$24182050$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160395$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241820511$24182051$1$I$20240708$20240731$20240807$20240807$EXP$$US-GSK-US2024095748$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
241820521$24182052$1$I$20240531$20240730$20240807$20240807$EXP$$US-CHIESI-2024CHF04759$CHIESI$$2$YR$$M$Y$10.8$KG$20240807$$CN$US$US
241820531$24182053$1$I$20240805$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123931$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240807$$CN$US$US
241820541$24182054$1$I$20240701$20240726$20240807$20240807$PER$$US-Encube-000848$ENCUBE ETHICALS$$$$$M$Y$$$20240807$$CN$US$
241820551$24182055$1$I$$20240728$20240807$20240807$PER$$US-HALEON-2189757$Haleon PLC$$$$$$Y$$$20240807$$CN$US$US
241820561$24182056$1$I$$20240709$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07146$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241820571$24182057$1$I$20240701$20240801$20240807$20240807$PER$$US-CHATTEMPRD-2024OHG026056$CHATTEM$$7$YR$C$M$Y$$$20240807$$CN$US$US
241820581$24182058$1$I$$20240801$20240807$20240807$EXP$$GB-JNJFOC-20240809720$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240807$$CN$GB$GB
241820591$24182059$1$I$$20240802$20240807$20240807$PER$$US-JNJFOC-20240809752$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
241820601$24182060$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160367$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241820611$24182061$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000048497$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$66$YR$E$M$Y$$$20240807$$HP$JP$JP
241820631$24182063$1$I$20240301$20240805$20240807$20240807$EXP$FR-AFSSAPS-TS2024000869$FR-UCBSA-2024039122$UCB$$41$YR$$F$Y$88$KG$20240807$$MD$FR$FR
241820642$24182064$2$F$$20240830$20240807$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123679$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240903$$CN$US$US
241820651$24182065$1$I$20240101$20240730$20240807$20240807$EXP$$IL-AMGEN-ISRSL2024152418$AMGEN$$63$YR$A$F$Y$$$20240807$$CN$IL$IL
241820662$24182066$2$F$$20240822$20240807$20240828$EXP$$GB-CELLTRION INC.-2024GB018544$CELLTRION$$$$$$Y$$$20240828$$CN$GB$GB
241820671$24182067$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160397$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241820681$24182068$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160449$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241820691$24182069$1$I$20240722$20240723$20240807$20240807$PER$$US-COSETTE-CP2024US000190$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241820701$24182070$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160472$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241820711$24182071$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160429$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241820732$24182073$2$F$20240701$20240819$20240807$20240821$PER$$US-AMGEN-USASP2024155642$AMGEN$$83$YR$E$M$Y$$$20240821$$CN$US$US
241820741$24182074$1$I$$20240802$20240807$20240807$EXP$$US-JNJFOC-20240806759$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241820751$24182075$1$I$$20240723$20240807$20240807$EXP$$NL-MEDEXUS PHARMA, INC.-2024MED00330$MEDEXUS PHARMA$Musters AH, van Lookeren FL, van der Gang LF, et al. Real-world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry. J Eur Acad Dermatol Venereol. 2024;38(3):530-542$$$$M$Y$$$20240807$$HP$NL$NL
241820761$24182076$1$I$20220101$20240723$20240807$20240807$EXP$$CN-MEDEXUS PHARMA, INC.-2024MED00329$MEDEXUS PHARMA$Liu H, Li Q, Long K.et.al.. Rheumatoid arthritis with pulmonary accelerated rheumatoid nodules treated by baricitinib: a case-based review.. Clin Rheumatol.. 2024;43(2):775-784$47$YR$$F$Y$$$20240807$$HP$CN$CN
241820771$24182077$1$I$20240101$20240729$20240807$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019978$UNITED THERAPEUTICS$$$$$F$Y$$$20240807$$$US$US
241820781$24182078$1$I$$20240730$20240807$20240807$EXP$$US-SA-2024SA226251$SANOFI AVENTIS$$$$$M$Y$$$20240807$$CN$US$US
241820791$24182079$1$I$20240701$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024153848$AMGEN$$77$YR$$F$Y$$$20240807$$CN$US$US
241820802$24182080$2$F$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0683109$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241820812$24182081$2$F$20230904$20240826$20240807$20240903$EXP$$DE-SA-2024SA229927$SANOFI AVENTIS$$39$YR$A$F$Y$70$KG$20240903$$HP$DE$DE
241820821$24182082$1$I$20240731$20240801$20240807$20240807$EXP$$NVSC2024CN158913$NOVARTIS$$69$YR$$F$Y$37$KG$20240807$$HP$CN$CN
241820833$24182083$3$F$20240731$20240812$20240807$20240819$PER$$US-ROCHE-10000049177$ROCHE$$74$YR$E$M$Y$84.36$KG$20240819$$CN$US$US
241820841$24182084$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123973$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240807$$CN$US$US
241820851$24182085$1$I$$20240731$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122702$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240807$$HP$US$US
241820861$24182086$1$I$$20240730$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005690$BIOCON$$$$$$Y$$$20240807$$MD$CA$CA
241820871$24182087$1$I$$20240726$20240807$20240807$EXP$$US-PTA-005742$BANNER$$84$YR$E$M$Y$$$20240807$$CN$US$US
241820881$24182088$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002986$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240807$$CN$US$US
241820891$24182089$1$I$$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037846$AUROBINDO$$$$$$Y$$$20240807$$CN$GB$GB
241820901$24182090$1$I$20240101$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002870$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240807$$CN$US$US
241820911$24182091$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002934$ELI LILLY AND CO$$26$YR$A$$Y$$$20240807$$CN$US$US
241820921$24182092$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002945$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240807$$CN$US$US
241820931$24182093$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002888$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240807$$PH$US$US
241820941$24182094$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002882$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240807$$CN$US$US
241820951$24182095$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002816$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240807$$CN$US$US
241820961$24182096$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002172$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240807$$CN$US$US
241820971$24182097$1$I$$20240723$20240807$20240807$EXP$$US-EPICPHARMA-US-2024EPCSPO00924$EPIC PHARM$$77$YR$E$M$Y$$$20240807$$CN$US$US
241820983$24182098$3$F$20240802$20240910$20240807$20240924$PER$$US-JNJFOC-20240807431$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240924$$CN$US$US
241821003$24182100$3$F$20240806$20240924$20240807$20240926$PER$$US-AMGEN-USASP2024154645$AMGEN$$55$YR$A$M$Y$$$20240926$$HP$US$US
241821011$24182101$1$I$20220101$20240731$20240807$20240807$EXP$$NO-ABBVIE-5867561$ABBVIE$$$$E$M$Y$$$20240807$$MD$NO$NO
241821021$24182102$1$I$$20240801$20240807$20240807$EXP$$US-AMGEN-USASP2024153985$AMGEN$Markantonis J. E.; Yi S.; Ghimire R. et al.. Pulmonary Actinomycosis in a 65-Year-Old Female with Poor Oral Dentition. BMC Infectious Diseases. 2024;14 (13):1-9$65$YR$E$F$Y$$$20240807$$HP$US$US
241821032$24182103$2$F$$20240813$20240807$20240822$EXP$$JP-BAXTER-2024BAX022486$BAXTER$$$$A$$Y$$$20240822$$HP$JP$JP
241821041$24182104$1$I$20240731$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024154959$AMGEN$$71$YR$E$F$Y$$$20240807$$PH$US$US
241821052$24182105$2$F$20240101$20240826$20240807$20240902$PER$$US-009507513-2408USA000847$MERCK$$$$$M$Y$87.5$KG$20240902$$CN$US$US
241821061$24182106$1$I$$20240723$20240807$20240807$EXP$$IT-LEADINGPHARMA-IT-2024LEALIT00330$LEADING PHARMA$M Marano.Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars.Toxicology Reports.21-JUN-2024;13:101683$15$YR$T$F$Y$$$20240807$$HP$IT$IT
241821071$24182107$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160510$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241821081$24182108$1$I$$20240730$20240807$20240807$EXP$$US-AstraZeneca-2024A176668$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241821091$24182109$1$I$$20240805$20240807$20240807$EXP$$JP-JNJFOC-20240815974$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240807$$MD$JP$JP
241821101$24182110$1$I$20221018$20240725$20240807$20240807$EXP$AU-TGA-0000801562$AU-COLLEGIUM PHARMACEUTICAL, INC.-20240700562$COLLEGIUM PHARMACEUTICAL$$76$YR$$M$Y$$$20240807$$CN$AU$AU
241821111$24182111$1$I$20220808$20240726$20240807$20240807$EXP$AU-TGA-0000801571$AU-COLLEGIUM PHARMACEUTICAL, INC.-20240700566$COLLEGIUM PHARMACEUTICAL$$18$YR$$F$Y$$$20240807$$CN$AU$AU
241821121$24182112$1$I$20220902$20240729$20240807$20240807$EXP$AU-TGA-0000801585$AU-COLLEGIUM PHARMACEUTICAL, INC.-20240700568$COLLEGIUM PHARMACEUTICAL$$22$YR$$M$Y$$$20240807$$CN$AU$AU
241821131$24182113$1$I$20221012$20240725$20240807$20240807$EXP$AU-TGA-0000800948$AU-COLLEGIUM PHARMACEUTICAL, INC.-20240700561$COLLEGIUM PHARMACEUTICAL$$41$YR$$F$Y$$$20240807$$CN$AU$AU
241821141$24182114$1$I$20240708$20240805$20240807$20240807$EXP$$AT-ABBVIE-5869544$ABBVIE$$72$YR$$M$Y$$$20240807$$CN$AT$AT
241821151$24182115$1$I$$20240802$20240807$20240807$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001572$BLUEPRINT MEDICINES$$$$$M$Y$$$20240807$$CN$US$US
241821161$24182116$1$I$20240521$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154646$AMGEN$$76$YR$E$F$Y$$$20240807$$CN$US$US
241821174$24182117$4$F$$20240911$20240807$20240918$EXP$$BR-TAKEDA-2024TUS069272$TAKEDA$$$$$M$Y$$$20240918$$CN$BR$BR
241821181$24182118$1$I$$20240801$20240807$20240807$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122711$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240807$$HP$CA$CA
241821191$24182119$1$I$$20240728$20240807$20240807$PER$$US-AMGEN-USASP2024154254$AMGEN$Silverman S.L.; Reginster J.; Czerwinski E. et al.. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis International. 2024;1-12$$$$F$Y$$$20240807$$HP$US$US
241821201$24182120$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124164$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240807$$CN$US$US
241821211$24182121$1$I$$20240723$20240807$20240807$EXP$$JP-LEADINGPHARMA-JP-2024LEALIT00337$LEADING PHARMA$Morio Ono.Successful treatment of vasospastic angina refractory to various therapies using stenting: A case report.Journal of Cardiology Cases.2024;1-4$47$YR$A$F$Y$$$20240807$$MD$JP$JP
241821221$24182122$1$I$20240701$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124183$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240807$$HP$US$US
241821231$24182123$1$I$20240704$20240723$20240807$20240807$EXP$$CN-JNJFOC-20240771743$JOHNSON AND JOHNSON$$4$YR$C$M$Y$14$KG$20240807$$HP$CN$CN
241821241$24182124$1$I$20240602$20240731$20240807$20240807$EXP$ES-AEMPS-1555664$ES-HETERO-AMR2024ES02538$HETERO$$52$YR$$M$Y$$$20240807$$MD$ES$ES
241821252$24182125$2$F$$20240805$20240807$20240809$EXP$$US-ROCHE-10000049608$ROCHE$$56$YR$A$M$Y$$$20240809$$CN$US$US
241821261$24182126$1$I$$20240801$20240807$20240807$EXP$$US-BEIGENE-BGN-2024-012208$BEIGENE$$$$$$Y$$$20240807$$CN$US$US
241821271$24182127$1$I$$20240729$20240807$20240807$EXP$$US-ROCHE-10000044043$ROCHE$Patel R, Elghawy O, Gibbs A, Gupta S, Kaur V. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer reports (Hoboken, N.J.). 2024-Jul;7 (7):1-6. doi:10.1002/cnr2.2110.$84$YR$E$M$Y$$$20240807$$MD$US$US
241821281$24182128$1$I$$20240722$20240807$20240807$PER$$US-AstraZeneca-2024A166961$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241821291$24182129$1$I$$20240722$20240807$20240807$PER$$US-AstraZeneca-2024A166632$ASTRAZENECA$$$$$F$Y$$$20240807$$PH$US$
241821301$24182130$1$I$20240727$20240805$20240807$20240807$EXP$$ZA-ABBVIE-5869543$ABBVIE$$84$YR$$M$Y$$$20240807$$CN$ZA$ZA
241821311$24182131$1$I$$20240723$20240807$20240807$EXP$$CN-LEADINGPHARMA-CN-2024LEALIT00341$LEADING PHARMA$$40$YR$A$M$Y$$$20240807$$HP$CN$CN
241821321$24182132$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160524$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241821332$24182133$2$F$20240613$20240813$20240807$20240820$EXP$$NVSC2024MX159333$NOVARTIS$$45$YR$$M$Y$63$KG$20240820$$CN$MX$MX
241821341$24182134$1$I$$20240802$20240807$20240807$EXP$$US-BIOGEN-2024BI01276877$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
241821351$24182135$1$I$$20240802$20240807$20240807$PER$$US-JNJFOC-20240808431$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
241821361$24182136$1$I$20240601$20240801$20240807$20240807$EXP$$CA-JNJFOC-20240808079$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240807$$HP$CA$CA
241821371$24182137$1$I$20230601$20240730$20240807$20240807$EXP$$CA-CELLTRION INC.-2021CA019467$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
241821391$24182139$1$I$$20240801$20240807$20240807$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122332$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240807$$HP$CA$CA
241821401$24182140$1$I$$20240729$20240807$20240807$EXP$ES-TEVA-VS-3217550$ES-ROCHE-10000040950$ROCHE$$72$YR$E$F$Y$$$20240807$$CN$ES$ES
241821411$24182141$1$I$20240701$20240806$20240807$20240807$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044199$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$$$20240807$$HP$SG$SG
241821421$24182142$1$I$20240801$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024153666$AMGEN$$78$YR$E$M$Y$$$20240807$$CN$US$US
241821431$24182143$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156099$AMGEN$$$$$M$Y$$$20240807$$HP$US$US
241821441$24182144$1$I$$20240802$20240807$20240807$EXP$$US-AMGEN-USASP2024154731$AMGEN$$59$YR$A$F$Y$$$20240807$$CN$US$US
241821451$24182145$1$I$20240728$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154995$AMGEN$$67$YR$E$M$Y$$$20240807$$CN$US$US
241821461$24182146$1$I$20240622$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156157$AMGEN$$78$YR$E$F$Y$$$20240807$$CN$US$US
241821481$24182148$1$I$20200717$20240726$20240807$20240807$EXP$$PL-AUROBINDO-AUR-APL-2024-038184$AUROBINDO$$59$YR$$F$Y$50$KG$20240807$$MD$PL$PL
241821491$24182149$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002984$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241821501$24182150$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003038$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240807$$CN$US$US
241821511$24182151$1$I$$20240801$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408001417$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240807$$CN$US$US
241821521$24182152$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002051$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240807$$CN$US$US
241821531$24182153$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002834$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240807$$CN$US$US
241821541$24182154$1$I$20240701$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002900$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240807$$CN$US$US
241821551$24182155$1$I$20240804$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002887$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240807$$CN$US$US
241821561$24182156$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002977$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241821571$24182157$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002320$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241821581$24182158$1$I$20240607$20240802$20240807$20240807$EXP$SE-SEMPA-2024-005094$SE-TAKEDA-2024TUS078071$TAKEDA$$32$YR$$F$Y$$$20240807$$HP$SE$SE
241821593$24182159$3$F$$20240820$20240807$20240822$PER$$US-ROCHE-10000050031$ROCHE$$$$A$F$Y$55.34$KG$20240822$$CN$US$US
241821601$24182160$1$I$20240801$20240805$20240807$20240807$PER$$US-ROCHE-10000050180$ROCHE$$29$YR$A$F$Y$$$20240807$$CN$US$US
241821611$24182161$1$I$20231106$20240805$20240807$20240807$EXP$FR-AFSSAPS-AN2024001001$FR-TAKEDA-2024TUS077996$TAKEDA$$49$YR$$M$Y$$$20240807$$HP$FR$FR
241821621$24182162$1$I$$20240730$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005686$BIOCON$$$$$$Y$$$20240807$$CN$CA$CA
241821633$24182163$3$F$20240726$20240820$20240807$20240822$30DAY$$NL-UCBSA-2024038758$UCB$$70$YR$$F$Y$$$20240822$$PH$NL$NL
241821642$24182164$2$F$$20240909$20240807$20240913$EXP$$JP-009507513-2407JPN005495J$MERCK$$$$$M$Y$$$20240913$$MD$JP$JP
241821651$24182165$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461281$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$75$YR$$F$Y$$$20240807$$HP$FR$FR
241821661$24182166$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461285$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$60$YR$$M$Y$$$20240807$$HP$FR$FR
241821671$24182167$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461200$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$85$YR$$F$Y$$$20240807$$HP$FR$FR
241821681$24182168$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461268$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$$$$F$Y$$$20240807$$HP$FR$FR
241821691$24182169$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461225$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$76$YR$$M$Y$$$20240807$$HP$FR$FR
241821701$24182170$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461260$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$73$YR$$M$Y$$$20240807$$HP$FR$FR
241821711$24182171$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461283$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$57$YR$$M$Y$$$20240807$$HP$FR$FR
241821721$24182172$1$I$$20240723$20240807$20240807$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461021$RANBAXY$Nishikawa M, Inoue A, Moritani K, Kagajo M, Kitazawa R, Kunieda T. An extremely rare case of primary alveolar rhabdomyosarcoma in the central nervous system. Surg Neurol Int. 2024;15 (0):221$20$YR$$M$Y$$$20240807$$HP$JP$JP
241821731$24182173$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461233$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$53$YR$$M$Y$$$20240807$$HP$FR$FR
241821741$24182174$1$I$$20240723$20240807$20240807$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461303$RANBAXY$Merz V, Maines F, Marcucci S, Sartori C, Frisinghelli M, Trentin C, et al. Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma. J Cancer Res Clin Oncol. 2024;150(7):1-7$69$YR$$M$Y$$$20240807$$HP$IT$IT
241821751$24182175$1$I$20200101$20240723$20240807$20240807$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460999$RANBAXY$Busutti M, Baraldi O, Porcu CV, Samele G, Campus A, Grandinetti V, et al. Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn^s Disease. Kidney Int Rep. 2023;8 (8):1676-1679$64$YR$$F$Y$$$20240807$$HP$IT$IT
241821761$24182176$1$I$$20240723$20240807$20240807$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460948$RANBAXY$Holla UP, Patil A. SSA mediated endocardial fibroelastosis treated with dexamethasone and IVIG. Indian J Rheumatol. 2023;18 (Suppl.):S358-S359; CAS124$29$YR$$F$Y$$$20240807$$HP$IN$IN
241821771$24182177$1$I$$20240723$20240807$20240807$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460865$RANBAXY$Majid M, Arockiam AD, Yaker ZS, Kumar A, Agrawal A, Bhalla JS, et al.. A CASE OF LONGSTANDING CHRONIC RECURRENT PERICARDITIS MANAGED WITH ADVANCED DIAGNOSTIC AND THERAPEUTIC METHODS. J Am Coll Cardiol. 2024;83 (13;SA):3496$65$YR$$F$Y$$$20240807$$HP$US$US
241821781$24182178$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461279$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$71$YR$$F$Y$$$20240807$$HP$FR$FR
241821791$24182179$1$I$20240716$20240723$20240807$20240807$EXP$$CA-SUNPHARMA-2024R1-458143AA$RANBAXY$$39$YR$A$M$Y$$$20240807$$CN$CA$CA
241821801$24182180$1$I$$20240723$20240807$20240807$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461163$RANBAXY$$41$YR$$M$Y$$$20240807$$PH$GB$GB
241821811$24182181$1$I$20240520$20240723$20240807$20240807$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461155$RANBAXY$$91$YR$$$Y$$$20240807$$PH$GB$GB
241821821$24182182$1$I$$20240723$20240807$20240807$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461194$RANBAXY$Nieto Pinar Y, Sala Carazo M, Barcelo Martin B. Use of continuous venovenous hemodiafiltration in a case of severe pentobarbital poisoning. Med Clin Barc. 2023;161 (4):178-179$50$YR$$M$Y$$$20240807$$HP$ES$ES
241821833$24182183$3$F$20240708$20240808$20240807$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021810$UNITED THERAPEUTICS$$76$YR$$F$Y$65.306$KG$20240817$$$US$US
241821841$24182184$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461186$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$75$YR$$M$Y$$$20240807$$HP$FR$FR
241821851$24182185$1$I$20240601$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460918$RANBAXY$$$$$M$Y$$$20240807$$CN$FR$FR
241821861$24182186$1$I$20150101$20240723$20240807$20240807$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461062$RANBAXY$Kumar S, Mishra Y, Koshy V, Khurana H. The Janus face of the immune system: Acute myeloid leukaemia with systemic lupus erythematosus. Indian J Rheumatol. 2023;18 (Suppl2):S327 (CAS077)$45$YR$$F$Y$$$20240807$$HP$IN$IN
241821871$24182187$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461290$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$71$YR$$M$Y$$$20240807$$HP$FR$FR
241821881$24182188$1$I$$20240723$20240807$20240807$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460801$RANBAXY$Siddiqui R, Salman Z, Sarwar M. Pulmonary Nodules in Immunosuppressed Patient. Am J Respir Crit Care Med. 2024;209(0)::A2385/A65$62$YR$$M$Y$$$20240807$$HP$US$US
241821891$24182189$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461296$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$64$YR$$M$Y$$$20240807$$HP$FR$FR
241821902$24182190$2$F$$20240802$20240807$20240816$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460896$RANBAXY$Ghazavi M, Allameh Z. Levofloxacin-Induced Oromandibular Dystonia in a 9-Year-Old Patient. Iranian J Child Nerol. 2024;18 (3):151-157$9$YR$$M$Y$$$20240816$$MD$IR$IR
241821911$24182191$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461219$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$71$YR$$M$Y$$$20240807$$HP$FR$FR
241821921$24182192$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461262$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$42$YR$$M$Y$$$20240807$$HP$FR$FR
241821931$24182193$1$I$20210101$20240723$20240807$20240807$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461002$RANBAXY$Busutti M, Baraldi O, Porcu CV, Samele G, Campus A, Grandinetti V, et al. Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn^s Disease. Kidney Int Rep. 2023;8 (8):1676-1679$56$YR$$M$Y$$$20240807$$HP$IT$IT
241821941$24182194$1$I$$20240723$20240807$20240807$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460913$RANBAXY$Churchill AB, Nguyen AD, Xia J, Nguyen VD, Agrawal N, Durant CE, et al.. To bite or not to bite: A case of non-bite pasteurella multicoda resulting in severe septic shock. Am-J-Respir-Crit-Care-Med. 2024;209:no pagination$68$YR$$M$Y$$$20240807$$HP$US$US
241821951$24182195$1$I$20220101$20240723$20240807$20240807$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460888$RANBAXY$Arasiewicz H, Lesiak A, Dec M, Lesniak-Jakubiec L.. Successful treatment of a child?s generalized pustular psoriasis with adalimumab in combination with low-dose acitretin. Adv Dermatol Allergol. 2023;Jun XL (3):464-466$36$MON$$M$Y$$$20240807$$MD$PL$PL
241821961$24182196$1$I$$20240723$20240807$20240807$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460812$RANBAXY$Jimenez D, Rabe MS, Agarwal AN, Dalton SR, Anstead GM. An Exuberant Case of Ulceronodular-Rupioid (Malignant) Syphilis in an HIV Patient: A Proposal for New Diagnostic Criteria. Infect Dis Rep. 2024;16 (3):499-518$28$YR$$M$Y$$$20240807$$HP$US$US
241821971$24182197$1$I$$20240723$20240807$20240807$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460942$RANBAXY$Holla UP, Patil A. SSA mediated endocardial fibroelastosis treated with dexamethasone and IVIG. Indian J Rheumatol. 2024;18 (Suppl.):S358-S359/ CAS124$27$YR$$F$Y$$$20240807$$HP$IN$IN
241821981$24182198$1$I$$20240723$20240807$20240807$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460807$RANBAXY$Tavares M, Pereira I, Nicolau M, Mendes AC, Ferreira C. BURKHOLDERIA CEPACIA COMPLEX: A RARE PERITONITIS CASE REPORT. Clin Chem Lab Med. 2024;62 (6):PO39/eA175-eA176$87$YR$$F$Y$$$20240807$$HP$PT$PT
241821991$24182199$1$I$$20240723$20240807$20240807$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461097$RANBAXY$$65$YR$$F$Y$$$20240807$$PH$GB$GB
241822001$24182200$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461302$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$81$YR$$M$Y$$$20240807$$HP$FR$FR
241822011$24182201$1$I$$20240723$20240807$20240807$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460886$RANBAXY$Cheng JJ, Shen J, Suresh Y, Akopyan NA, Kapoor NS.. Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy. Int J Surg Case Rep. 2024;July 18:Online ahead of print$72$YR$$M$Y$$$20240807$$HP$US$US
241822021$24182202$1$I$$20240723$20240807$20240807$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460404$RANBAXY$Koto S, Kanda Y, Ohnou N, Morita Y. Chronic myeloid leukaemia with soft tissue mass formed by mature granulocytes. BMJ Case Rep. 2024;17(6):no pagination$60$YR$$F$Y$$$20240807$$HP$JP$JP
241822031$24182203$1$I$$20240723$20240807$20240807$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460904$RANBAXY$Nobre L, Rosas C, Kalichsztein B, Nobre G, Kalichsztein M, Marinho A, et al. Recurrent Pulmonary Hemorrhage in a Young Adult. Am J Respir Crit Care Med. 2024;209:A7055$48$YR$$F$Y$$$20240807$$HP$BR$BR
241822041$24182204$1$I$$20240723$20240807$20240807$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461413$RANBAXY$Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al. Pickering syndrome: an overlooked renovascular cause of recurrent heart failure. J Am Heart Assoc. 2023;12:1-11$79$YR$$M$Y$$$20240807$$MD$IT$IT
241822051$24182205$1$I$$20240723$20240807$20240807$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460820$RANBAXY$Kulkarni R, Abdelrahman A, Ghesani M, Ghesani N, Wolin E, Oh W, et al. Management Of Concomitant Prostate Cancer and Pancreatic Neuroendocrine Tumour: Role of Nuclear Medicine in therapeutic decision making. j Nucl Med. 2023;64 (Suppl.):1-8/P1440$71$YR$$M$Y$$$20240807$$HP$US$US
241822062$24182206$2$F$$20240816$20240807$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461154$RANBAXY$Kamel ME, Marzullo C, Maguet H, Checkouri A, Pointurier V, Oudeville P. Metabolic acidosis in a context of chronic paracetamol intoxication. Toxic Analyt Clinique. 2024;36(2):42$18$YR$$F$Y$$$20240830$$HP$FR$FR
241822071$24182207$1$I$$20240723$20240807$20240807$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461433$RANBAXY$Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al. Pickering syndrome: an overlooked renovascular cause of recurrent heart failure. J Am Heart Assoc. 2023;12:1-11$78$YR$$M$Y$$$20240807$$MD$IT$IT
241822092$24182209$2$F$$20240802$20240807$20240816$EXP$$ID-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460844$RANBAXY$Rohmah SN, Puspitasari M, Wardhani Y, Ananda NR, Khotijah AA. Diagnostic and therapeutic challenges of tuberculosis in kidney transplant recipients; a case series study. J Nephropharmacol. 2024;13 (2):e11679$60$YR$$M$Y$$$20240816$$HP$ID$ID
241822101$24182210$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461271$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$79$YR$$M$Y$$$20240807$$HP$FR$FR
241822111$24182211$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461288$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$75$YR$$M$Y$$$20240807$$HP$FR$FR
241822121$24182212$1$I$$20240723$20240807$20240807$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461064$RANBAXY$Medeiros T, Sequeira S, Mendes M, Hierro F, Duarte S. Primary central nervous system lymphoma complicated by cerebral venous sinus thrombosis: a case report. EJCRIM. 2023;10:1-5$64$YR$$F$Y$$$20240807$$HP$PT$PT
241822131$24182213$1$I$$20240723$20240807$20240807$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461066$RANBAXY$Xing F, Xia Y, Lu Q, Lo SKF, Lau SKP, Woo PCY. Rapid diagnosis of fatal nocardia kroppenstedtii bacteremic pneumonia and empyema thoracis by next-generation sequencing: a case report. Front Med. 2023;10:1226126$71$YR$$F$Y$$$20240807$$HP$CN$CN
241822141$24182214$1$I$$20240723$20240807$20240807$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459983$RANBAXY$Imataki O, Fujita H, Uemura M. Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus. Int J Hematol. 2024;120 (1):1-2$58$YR$$M$Y$$$20240807$$HP$JP$JP
241822151$24182215$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461161$RANBAXY$Kamel ME, Marzullo C, Maguet H, Checkouri A, Pointurier V, Oudeville P. Metabolic acidosis in a context of chronic paracetamol intoxication. Toxic Analyt Clinique. 2024;36(2):42$$$N$$Y$$$20240807$$HP$FR$FR
241822161$24182216$1$I$20240611$20240805$20240807$20240807$EXP$$US-GILEAD-2024-0678141$GILEAD$$33$YR$A$F$Y$$$20240807$$CN$US$US
241822171$24182217$1$I$$20240723$20240807$20240807$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460771$RANBAXY$Perlato M, Mecheri V, Vivarelli E, Accinno M, Vultaggio A, Matucci A. ^Patient remodeling^ as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend. J Asthma. 2024;61 (1):72-75$28$YR$$F$Y$$$20240807$$MD$IT$IT
241822181$24182218$1$I$$20240729$20240807$20240807$30DAY$$US-GSK-US2024094871$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241822191$24182219$1$I$$20240802$20240807$20240807$EXP$$US-GSK-US2024AMR097705$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240807$$CN$US$US
241822201$24182220$1$I$$20240723$20240807$20240807$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449602$RANBAXY$Nishio T, Toukairin Y, Hoshi T, Arai T, Nogami M. A case of lacosamide and mirtazapine self-poisoning. Leg Med (Tokyo). 2024;Jul; 69 (0):102457$$$A$F$Y$41$KG$20240807$$HP$JP$JP
241822212$24182221$2$F$$20240910$20240807$20240925$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448125$RANBAXY$$$$E$F$Y$$$20240925$$CN$US$US
241822222$24182222$2$F$$20240731$20240807$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-437393$RANBAXY$$$$A$F$Y$60.771$KG$20240814$$CN$US$US
241822232$24182223$2$F$20240805$20240806$20240807$20240807$EXP$$US-ROCHE-10000050733$ROCHE$$49$YR$A$F$Y$93.44$KG$20240807$$CN$US$US
241822241$24182224$1$I$20240725$20240802$20240807$20240807$EXP$$US-AstraZeneca-2024A176353$ASTRAZENECA$$$$$$Y$$$20240807$$CN$US$
241822251$24182225$1$I$20240218$20240802$20240807$20240807$EXP$$US-AstraZeneca-2024A176339$ASTRAZENECA$$29246$DY$$$Y$$$20240807$$HP$US$
241822261$24182226$1$I$$20240730$20240807$20240807$EXP$$US-AstraZeneca-2024A174387$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241822271$24182227$1$I$20240727$20240729$20240807$20240807$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110418$ZYDUS PHARM$$$$$$Y$$$20240807$$PH$US$US
241822281$24182228$1$I$$20240730$20240807$20240807$EXP$$RS-AstraZeneca-2024A174631$ASTRAZENECA$$$$$M$Y$$$20240807$$MD$RS$
241822291$24182229$1$I$$20240801$20240807$20240807$PER$$US-ABBVIE-5865160$ABBVIE$$$$$F$Y$$$20240807$$HP$US$US
241822302$24182230$2$F$20240322$20240902$20240807$20240912$EXP$FR-AFSSAPS-AN2024000940$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110606$ZYDUS PHARM$$$$$$Y$$$20240912$$MD$FR$FR
241822311$24182231$1$I$20240801$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024156679$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241822322$24182232$2$F$$20240903$20240807$20240910$EXP$$JP-JNJFOC-20240815249$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240911$$PH$JP$JP
241822331$24182233$1$I$20240805$20240805$20240807$20240807$PER$$US-JNJFOC-20240809787$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
241822346$24182234$6$F$20231001$20240828$20240807$20240926$PER$$US-ROCHE-10000047088$ROCHE$$79$YR$E$F$Y$58.51$KG$20240926$$CN$US$US
241822351$24182235$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160572$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241822362$24182236$2$F$$20240728$20240807$20240809$PER$$NVSC2024US154971$NOVARTIS$$$$$$Y$$$20240809$$CN$US$US
241822371$24182237$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160505$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
241822381$24182238$1$I$20240723$20240731$20240807$20240807$PER$$US-BEH-2024176761$CSL BEHRING$$$$$F$Y$$$20240807$$CN$US$US
241822391$24182239$1$I$20240619$20240726$20240807$20240807$EXP$$IT-AUROBINDO-AUR-APL-2024-038319$AUROBINDO$$84$YR$$F$Y$$$20240807$$PH$IT$IT
241822401$24182240$1$I$$20240723$20240807$20240807$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461115$RANBAXY$Oda K, Katanoda T, Arakaki H, Katsume T, Matsuyama K, Jono H. Thiamylal serum concentration for refractory convulsive status epilepticus while associated decreased concentrations of concomitant antiepileptics: a case report. J Pharm Health Care Sci. 2024;10(1):no pagination$72$YR$$M$Y$71.4$KG$20240807$$HP$JP$JP
241822412$24182241$2$F$$20240802$20240807$20240816$EXP$$ID-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460840$RANBAXY$Rohmah SN, Puspitasari M, Wardhani Y, Ananda NR, Khotijah AA. Diagnostic and therapeutic challenges of tuberculosis in kidney transplant recipients; a case series study. J Nephropharmacol. 2024;13 (2):e11679$42$YR$$M$Y$$$20240816$$HP$ID$ID
241822421$24182242$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461293$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$82$YR$$M$Y$$$20240807$$HP$FR$FR
241822431$24182243$1$I$$20240723$20240807$20240807$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460858$RANBAXY$Kalsoom S, Khan M, Zaman MA, Vitellas M. A Silent Inferior Wall ST Segment Elevation Myocardial Infarction. Arterioscler Thromb Vasc Biol. 2023;43 (1):1-5 abs 671$36$YR$$M$Y$$$20240807$$HP$US$US
241822441$24182244$1$I$$20240723$20240807$20240807$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460564$RANBAXY$Duarte A, Teague TT. Acute Epiglottitis Due to Combined COVID-19 Infection and Haemophilus Influenzae Bacteremia. Am J Respir Crit Care Med. 2024;209(0):A1649$67$YR$$M$Y$$$20240807$$HP$US$US
241822452$24182245$2$F$$20240802$20240807$20240816$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460910$RANBAXY$Dutta A, Manohar H. Understanding diagnostic dilemmas in childhood posttraumatic stress disorder with psychotic symptoms - A case report. Indian J Psychiatry. 2024;Jan 66 (S1):S220$13$YR$$F$Y$$$20240816$$HP$IN$IN
241822461$24182246$1$I$$20240723$20240807$20240807$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460945$RANBAXY$Holla UP, Patil A. SSA mediated endocardial fibroelastosis treated with dexamethasone and IVIG. Indian J Rheumatol. 2024;18 (Suppl.):S358-S359/ CAS124$$$N$F$Y$1.6$KG$20240807$$HP$IN$IN
241822471$24182247$1$I$$20240723$20240807$20240807$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460658$RANBAXY$Ocasio V, Kapoor S, Atteih S, Sadreameli SC, Mogayzel PJ. A Case of Trimethoprim-sulfamethoxazole Associated Fulminant Respiratory Failure in a 15-year-old Male. Am j Respir Crit Care Med. 2024;209:A2329$15$YR$$M$Y$$$20240807$$HP$US$US
241822481$24182248$1$I$$20240723$20240807$20240807$EXP$$PE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460035$RANBAXY$Vilchez RAP, Cusihuallpa HC, Gamarra HC, Ramirez KA, Valverde JES, Valenzuela OC, et al. Oral and Cervicofacial Infection Secondary to Agranulocytosis Caused by Antithyroid Medication: A Case Report. Rev Estomatol Hered. 2023;Abr-Jun;33(2):162-168$26$YR$$F$Y$$$20240807$$HP$PE$PE
241822491$24182249$1$I$$20240723$20240807$20240807$EXP$$MX-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460900$RANBAXY$Herrera RFL, De La Cruz Tun Pech J, Cisneros IG.. SSRI-related hyponatremia as a seizure detonating effect in a patient previously diagnosed with epilepsy. Eur J Case Rep Intern Med. 2023;10 (Suppl.):153(313)$59$YR$$F$Y$$$20240807$$HP$MX$MX
241822511$24182251$1$I$$20240723$20240807$20240807$EXP$$AM-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461159$RANBAXY$N. Sargsyan, L Hambardzumyan, S Petrosyan, G Tamamyan, I Karapetyan, A Harutyunyan, S Danelyan, K. Arustamyan, K. Ginosyan, H Khachatryan. Recurrent Thrombosis, Myocardial Infarction in a Patient with Antiphospholipid Syndrome; A Case Report. Res Pract Thromb Haemost. 2023;7 (Suppl.):1133-1134$42$YR$$M$Y$$$20240807$$HP$AM$AM
241822521$24182252$1$I$$20240723$20240807$20240807$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460987$RANBAXY$$$$$F$Y$$$20240807$$HP$GB$GB
241822531$24182253$1$I$$20240723$20240807$20240807$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461266$RANBAXY$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie. 2024;79 (3):365-370$$$$F$Y$$$20240807$$HP$FR$FR
241822541$24182254$1$I$$20240723$20240807$20240807$EXP$$NZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461067$RANBAXY$Fong PCC, Kwiatkowski M, Mosca A, Valderrama BP, Huang Y-H, Zedan AH, et al. Coformulation of pembrolizumab and vibostolimab in patients (pts) with docetaxelpretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE- 365 cohort G. J Clin Oncol. 2024;42 (Suppl.) (4):149$$$$M$Y$$$20240807$$HP$NZ$NZ
241822552$24182255$2$F$20240801$20240905$20240807$20240910$30DAY$$US-AMGEN-USASL2024154409$AMGEN$$55$YR$A$M$Y$$$20240910$$HP$US$US
241822564$24182256$4$F$20240731$20240819$20240807$20240822$PER$$US-AMGEN-USASP2024155558$AMGEN$$77$YR$E$F$Y$$$20240822$$CN$US$US
241822571$24182257$1$I$20230401$20240802$20240807$20240807$EXP$$JP-GSK-JP2024097865$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$JP$JP
241822584$24182258$4$F$$20240903$20240807$20240910$EXP$$US-GSK-US2024096177$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
241822592$24182259$2$F$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0683117$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241822601$24182260$1$I$20240705$20240802$20240807$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011884$JAZZ$$47$YR$$F$Y$$$20240807$$CN$US$US
241822611$24182261$1$I$$20240406$20240807$20240807$PER$$US-CHIESI-2024CHF01979$CHIESI$$80$YR$$F$Y$$$20240807$$MD$US$US
241822621$24182262$1$I$20240401$20240411$20240807$20240807$PER$$US-CHIESI-2024CHF02088$CHIESI$$$$$$Y$$$20240807$$CN$US$US
241822631$24182263$1$I$$20240503$20240807$20240807$PER$$US-CHIESI-2024CHF02625$CHIESI$$$$$$Y$$$20240807$$PH$US$US
241822641$24182264$1$I$$20240605$20240807$20240807$PER$$US-CHIESI-2024CHF03392$CHIESI$$$$$F$Y$$$20240807$$MD$US$US
241822651$24182265$1$I$$20240409$20240807$20240807$PER$$US-CHIESI-2024CHF02075$CHIESI$$73$YR$$M$Y$$$20240807$$HP$US$US
241822661$24182266$1$I$$20240406$20240807$20240807$PER$$US-CHIESI-2024CHF01976$CHIESI$$$$$F$Y$$$20240807$$MD$US$US
241822671$24182267$1$I$$20240805$20240807$20240807$EXP$$CN-TAKEDA-2024TUS078578$TAKEDA$$$$$M$Y$$$20240807$$CN$CN$CN
241822682$24182268$2$F$$20240808$20240807$20240808$PER$$US-JNJFOC-20240812084$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240808$$MD$US$US
241822692$24182269$2$F$$20240813$20240807$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-038617$AUROBINDO$$8$YR$$M$Y$22$KG$20240822$$PH$CA$CA
241822702$24182270$2$F$$20240919$20240807$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124422$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240925$$CN$US$US
241822711$24182271$1$I$20240711$20240726$20240807$20240807$PER$$US-TLX-2024000173$TELIX PHARMACEUTICALS$$$$$M$Y$$$20240807$$HP$US$US
241822721$24182272$1$I$20240708$20240729$20240807$20240807$EXP$IT-MINISAL02-995786$IT-TEVA-VS-3227646$TEVA$$67$YR$$M$Y$72$KG$20240807$$MD$IT$IT
241822731$24182273$1$I$20240627$20240725$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-037720$AUROBINDO$$83$YR$$M$Y$67.5$KG$20240807$$PH$FR$FR
241822741$24182274$1$I$20240710$20240711$20240807$20240807$PER$$US-TLX-2024000172$TELIX PHARMACEUTICALS$$$$$M$Y$$$20240807$$HP$US$US
241822751$24182275$1$I$20240718$20240718$20240807$20240807$PER$$US-TLX-2024000175$TELIX PHARMACEUTICALS$$74$YR$E$M$Y$93.44$KG$20240807$$CN$US$US
241822761$24182276$1$I$$20240725$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037614$AUROBINDO$$69$YR$$$Y$$$20240807$$PH$GB$GB
241822772$24182277$2$F$$20240801$20240807$20240812$PER$$US-AMGEN-USASP2024153471$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241822781$24182278$1$I$20240401$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-038123$AUROBINDO$$76$YR$$M$Y$86.1$KG$20240807$$MD$FR$FR
241822791$24182279$1$I$$20240729$20240807$20240807$PER$$US-JNJFOC-20240780849$JOHNSON AND JOHNSON$$11$MON$I$F$Y$$$20240807$$CN$US$US
241822801$24182280$1$I$20240801$20240802$20240807$20240807$EXP$$US-GILEAD-2024-0682933$GILEAD$$23$YR$A$M$Y$$$20240807$$CN$US$US
241822811$24182281$1$I$$20240730$20240807$20240807$EXP$PL-URPL-1-3703-2020$PL-TEVA-VS-3228279$TEVA$$76$YR$$F$Y$95$KG$20240807$$MD$PL$PL
241822821$24182282$1$I$$20240725$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037635$AUROBINDO$$40$YR$$M$Y$105$KG$20240807$$MD$GB$GB
241822841$24182284$1$I$20240701$20240724$20240807$20240807$EXP$$US-INFO-20240226$INFORLIFE$$$$$F$Y$$$20240726$$CN$US$
241822852$24182285$2$F$20240804$20240911$20240807$20240913$PER$$US-AMGEN-USASP2024155638$AMGEN$$69$YR$E$M$Y$$$20240913$$CN$US$US
241822862$24182286$2$F$$20240820$20240807$20240821$PER$$NVSC2024US160581$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
241822871$24182287$1$I$20220101$20240802$20240807$20240807$EXP$$JP-AstraZeneca-2022A215499$ASTRAZENECA$$$$$$Y$$$20240807$$MD$JP$
241822881$24182288$1$I$20240804$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003059$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240807$$CN$US$US
241822891$24182289$1$I$20240719$20240725$20240807$20240807$EXP$$DE-AUROBINDO-AUR-APL-2024-037762$AUROBINDO$$71$YR$$F$Y$70$KG$20240807$$MD$DE$DE
241822901$24182290$1$I$$20240513$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003999$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241822911$24182291$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003087$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240807$$CN$US$US
241822921$24182292$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003456$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240807$$CN$US$US
241822931$24182293$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002455$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240807$$CN$US$US
241822941$24182294$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002872$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240807$$CN$US$US
241822951$24182295$1$I$$20240806$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003796$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240807$$CN$US$US
241822961$24182296$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003311$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240807$$CN$US$US
241822981$24182298$1$I$20240730$20240730$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407019665$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240807$$CN$US$US
241822991$24182299$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002776$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241823001$24182300$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003190$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241823011$24182301$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155743$AMGEN$$$$$$Y$$$20240807$$CN$US$US
241823021$24182302$1$I$20240601$20240724$20240807$20240807$EXP$$US-UCBSA-2024037712$UCB$$62$YR$$F$Y$$$20240807$$HP$US$US
241823031$24182303$1$I$20240806$20240806$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408004055$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240807$$CN$US$US
241823041$24182304$1$I$20191024$20240802$20240807$20240807$EXP$$US-ABBVIE-5865796$ABBVIE$$30$YR$$M$Y$$$20240807$$CN$US$US
241823051$24182305$1$I$20240101$20240801$20240807$20240807$EXP$$PR-ABBVIE-5864457$ABBVIE$$$$$M$Y$165$KG$20240807$$CN$PR$PR
241823061$24182306$1$I$20240101$20240801$20240807$20240807$EXP$$US-ABBVIE-5865087$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241823071$24182307$1$I$$20240725$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037568$AUROBINDO$$$$$$Y$$$20240807$$CN$GB$GB
241823081$24182308$1$I$20210101$20240802$20240807$20240807$PER$$US-ABBVIE-5866693$ABBVIE$$$$$M$Y$75.749$KG$20240807$$CN$US$US
241823092$24182309$2$F$$20240806$20240807$20240807$PER$$US-JNJFOC-20240812844$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241823101$24182310$1$I$20230419$20240725$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-038113$AUROBINDO$$$$A$M$Y$$$20240807$$MD$FR$FR
241823111$24182311$1$I$$20240802$20240807$20240807$EXP$$NVSC2024IN160065$NOVARTIS$$$$$M$Y$$$20240807$$CN$IN$IN
241823121$24182312$1$I$$20240723$20240807$20240807$PER$$US-TEVA-VS-3226223$TEVA$$$$$$Y$$$20240807$$HP$US$US
241823131$24182313$1$I$$20240729$20240807$20240807$EXP$GB-MHRA-MIDB-28ea4413-1972-4bd3-bc83-87998b74591e$GB-ROCHE-10000041042$ROCHE$$73$YR$E$$Y$$$20240807$$PH$GB$GB
241823141$24182314$1$I$$20240727$20240807$20240807$EXP$$CN-ROCHE-10000040002$ROCHE$Gao Z, Fan Z, Liu Z, Ye X, Zeng Y, Xuan L. Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease. Frontiers in Immunology. 2024-Jul-03;15:1-10. doi:10.3389/fimmu.2024.1408211.$$$$$Y$$$20240807$$HP$CN$CN
241823151$24182315$1$I$20240805$20240806$20240807$20240807$PER$$US-AMGEN-USASP2024156391$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241823161$24182316$1$I$$20240805$20240807$20240807$EXP$$CA-ORGANON-O2408CAN000309$ORGANON$$65$YR$$F$Y$34$KG$20240807$$HP$CA$CA
241823172$24182317$2$F$20240731$20240830$20240807$20240904$30DAY$$US-AMGEN-USASL2024152732$AMGEN$$71$YR$E$M$Y$100$KG$20240904$$PH$US$US
241823181$24182318$1$I$20231025$20240725$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-037713$AUROBINDO$$64$YR$$M$Y$85$KG$20240807$$MD$FR$FR
241823201$24182320$1$I$20240729$20240731$20240807$20240807$EXP$$DE-JNJFOC-20240801708$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$DE$DE
241823211$24182321$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2019-057436$AUROBINDO$$$$$F$Y$$$20240807$$MD$CA$CA
241823221$24182322$1$I$$20240805$20240807$20240807$EXP$$CN-TAKEDA-2024TUS078640$TAKEDA$$$$$M$Y$$$20240807$$CN$CN$CN
241823232$24182323$2$F$$20240918$20240807$20240926$EXP$$CA-APOTEX-2024AP008959$APOTEX$$80$YR$$F$Y$$$20240926$$CN$CA$CA
241823241$24182324$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124466$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240807$$HP$US$US
241823251$24182325$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160585$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241823261$24182326$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160584$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241823271$24182327$1$I$20240601$20240724$20240807$20240807$EXP$$US-UCBSA-2024037559$UCB$$62$YR$$F$Y$$$20240807$$HP$US$US
241823282$24182328$2$F$$20240730$20240807$20240812$EXP$$JP-UCBSA-2024038707$UCB$$66$YR$$M$Y$$$20240812$$PH$JP$JP
241823292$24182329$2$F$$20240807$20240807$20240819$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-07542$LUPIN$$$$$$Y$$$20240819$$CN$IN$IN
241823301$24182330$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-039057$AUROBINDO$$84$YR$$F$Y$64$KG$20240807$$HP$CA$CA
241823311$24182331$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2023-081739$AUROBINDO$$54$YR$$M$Y$$$20240807$$MD$CA$CA
241823321$24182332$1$I$$20240803$20240807$20240807$PER$$US-ABBVIE-5868667$ABBVIE$$$$$$Y$$$20240807$$HP$US$US
241823331$24182333$1$I$20240201$20240801$20240807$20240807$EXP$$PL-ROCHE-10000049109$ROCHE$$$$$F$Y$$$20240807$$MD$PL$PL
241823352$24182335$2$F$20240801$20240807$20240807$20240820$EXP$$US-ALCON LABORATORIES-ALC2024US003652$ALCON$$$$$F$Y$$$20240820$$CN$US$US
241823361$24182336$1$I$20240101$20240806$20240807$20240807$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044205$BOEHRINGER INGELHEIM$$50$YR$A$M$Y$$$20240807$$HP$SG$SG
241823371$24182337$1$I$20240715$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154684$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241823381$24182338$1$I$$20240729$20240807$20240807$EXP$$CA-APOTEX-2024AP008957$APOTEX$$80$YR$$M$Y$$$20240807$$CN$CA$CA
241823391$24182339$1$I$$20240725$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-039322$AUROBINDO$$43$YR$$F$Y$$$20240807$$HP$CA$CA
241823401$24182340$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160586$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241823411$24182341$1$I$$20240729$20240807$20240807$PER$$US-ABBVIE-5859644$ABBVIE$$$$$$Y$$$20240807$$CN$US$US
241823421$24182342$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038893$AUROBINDO$$$$$M$Y$$$20240807$$HP$CA$CA
241823431$24182343$1$I$$20240730$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005675$BIOCON$$$$$$Y$$$20240807$$HP$CA$CA
241823452$24182345$2$F$20240715$20240820$20240807$20240827$PER$$US-JNJFOC-20240776001$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240827$$CN$US$US
241823461$24182346$1$I$$20240802$20240807$20240807$PER$$US-JNJFOC-20240809560$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241823471$24182347$1$I$$20240801$20240807$20240807$EXP$$CA-JNJFOC-20240713143$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240807$$HP$CA$CA
241823481$24182348$1$I$$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124287$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240807$$HP$US$US
241823491$24182349$1$I$$20240724$20240807$20240807$EXP$$US-UCBSA-2024037710$UCB$$$$$$Y$$$20240807$$CN$US$US
241823502$24182350$2$F$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0683119$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241823512$24182351$2$F$$20240820$20240807$20240902$EXP$$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110734$ZYDUS PHARM$Vigue p, cidolit s, hamed hadj hamdi s, ben salah m, amalou r, botramamy a, et al. L^hypoparathyroidie n^a pas d^age de survenue ou l^histoire d^une centenaire robuste (Hypoparathyroidism has no age of onset or the history of a robust centenarian). Rev Geriatr. 2024;49 (6):349-54$$$$$Y$$$20240902$$HP$FR$FR
241823521$24182352$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156051$AMGEN$$$$$$Y$$$20240807$$HP$US$US
241823532$24182353$2$F$20240701$20240828$20240807$20240903$30DAY$$US-AMGEN-USASP2024148844$AMGEN$$74$YR$E$F$Y$79.11$KG$20240903$$HP$US$US
241823541$24182354$1$I$20211214$20211228$20240807$20240807$EXP$$NL-TERSERA THERAPEUTICS LLC-2021TRS006216$TERSERA THERAPEUTICS$$$$$$Y$$$20240807$$CN$NL$NL
241823551$24182355$1$I$$20240805$20240807$20240807$EXP$$IT-ABBVIE-5868418$ABBVIE$$76$YR$$M$Y$$$20240807$$CN$IT$IT
241823561$24182356$1$I$20240715$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037866$AUROBINDO$$54$YR$$M$Y$92$KG$20240807$$MD$GB$GB
241823571$24182357$1$I$20240705$20240724$20240807$20240807$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS003883$TERSERA THERAPEUTICS$$$$$$Y$$$20240807$$CN$NL$NL
241823581$24182358$1$I$$20240802$20240807$20240807$PER$$NVSC2024US160457$NOVARTIS$$$$$M$Y$$$20240807$$HP$US$US
241823591$24182359$1$I$$20240801$20240807$20240807$PER$$US-LEO Pharma-372535$LEO PHARM$$$$$F$Y$$$20240807$$CN$US$US
241823601$24182360$1$I$20240731$20240802$20240807$20240807$EXP$$NVSC2024US158985$NOVARTIS$$61$YR$$M$Y$$$20240807$$CN$US$US
241823611$24182361$1$I$20240804$20240805$20240807$20240807$EXP$$AU-ABBVIE-5869551$ABBVIE$$66$YR$$F$Y$$$20240807$$CN$AU$AU
241823621$24182362$1$I$20231115$20240730$20240807$20240807$EXP$$FR-AstraZeneca-2024A177532$ASTRAZENECA$$29$DY$$F$Y$$$20240807$$HP$FR$
241823631$24182363$1$I$20240411$20240802$20240807$20240807$EXP$$ZA-AstraZeneca-2024A176303$ASTRAZENECA$$25567$DY$$M$Y$$$20240807$$CN$ZA$
241823641$24182364$1$I$$20240730$20240807$20240807$EXP$$US-AstraZeneca-2024A173949$ASTRAZENECA$$$$$$Y$$$20240807$$CN$US$
241823651$24182365$1$I$20240607$20240730$20240807$20240807$EXP$$ES-AstraZeneca-2024A172936$ASTRAZENECA$$57$YR$$F$Y$$$20240807$$MD$ES$
241823661$24182366$1$I$$20240731$20240807$20240807$EXP$$GB-TAKEDA-2024TUS077760$TAKEDA$$$$$M$Y$$$20240807$$CN$GB$GB
241823671$24182367$1$I$$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024155180$AMGEN$$$$$$Y$$$20240807$$HP$US$US
241823681$24182368$1$I$20240101$20240805$20240807$20240807$EXP$$RO-ABBVIE-5867692$ABBVIE$$$$E$F$Y$$$20240807$$MD$RO$RO
241823691$24182369$1$I$$20240730$20240807$20240807$EXP$$US-GSK-US2024095406$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241823701$24182370$1$I$20240701$20240803$20240807$20240807$EXP$$US-ABBVIE-5867284$ABBVIE$$86$YR$$F$Y$$$20240807$$CN$US$US
241823711$24182371$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-039007$AUROBINDO$$75$YR$$F$Y$81$KG$20240807$$PH$CA$CA
241823731$24182373$1$I$$20240802$20240807$20240807$PER$$US-JNJFOC-20240809261$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$US$US
241823741$24182374$1$I$20240101$20240801$20240807$20240807$EXP$$CA-BIOGEN-2024BI01243483$BIOGEN$$$$$M$Y$$$20240807$$CN$CA$CA
241823751$24182375$1$I$20240720$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037857$AUROBINDO$$66$YR$$F$Y$$$20240807$$HP$GB$GB
241823761$24182376$1$I$20240701$20240726$20240807$20240807$EXP$$PT-AUROBINDO-AUR-APL-2024-038232$AUROBINDO$$84$YR$$F$Y$60$KG$20240807$$MD$PT$PT
241823772$24182377$2$F$20210203$20240807$20240807$20240813$EXP$$CA-TAKEDA-2024TUS078723$TAKEDA$$42$YR$$M$Y$$$20240813$$CN$CA$CA
241823781$24182378$1$I$$20240730$20240807$20240807$EXP$$US-ROCHE-10000043907$ROCHE$$$$$$Y$$$20240807$$CN$US$US
241823802$24182380$2$F$20240101$20240819$20240807$20240820$EXP$$US-UCBSA-2024036090$UCB$$$$$F$Y$$$20240820$$CN$US$US
241823812$24182381$2$F$$20240819$20240807$20240822$EXP$$US-GILEAD-2024-0682996$GILEAD$$$$E$F$Y$$$20240822$$HP$US$US
241823821$24182382$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038888$AUROBINDO$$84$YR$$F$Y$68$KG$20240807$$HP$CA$CA
241823831$24182383$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003224$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240807$$CN$US$US
241823841$24182384$1$I$20210101$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002775$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240807$$CN$US$US
241823851$24182385$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003779$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240807$$CN$US$US
241823861$24182386$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003164$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241823871$24182387$1$I$20240803$20240803$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002809$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240807$$CN$US$US
241823881$24182388$1$I$20191126$20240731$20240807$20240807$EXP$$CA-TAKEDA-2024TUS074451$TAKEDA$$34$YR$$M$Y$$$20240807$$CN$CA$CA
241823891$24182389$1$I$20240601$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-037767$AUROBINDO$$30$YR$$M$Y$73$KG$20240807$$MD$FR$FR
241823902$24182390$2$F$20240724$20240828$20240807$20240906$30DAY$$US-AMGEN-USASL2024150534$AMGEN$$67$YR$E$F$Y$$$20240906$$HP$US$US
241823911$24182391$1$I$20240801$20240805$20240807$20240807$EXP$$CN-TAKEDA-2024TUS078682$TAKEDA$$68$YR$$M$Y$$$20240807$$CN$CN$CN
241823921$24182392$1$I$$20240728$20240807$20240807$EXP$$IL-TEVA-VS-3228528$TEVA$$71$YR$$F$Y$$$20240807$$CN$IL$IL
241823931$24182393$1$I$20230510$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-038051$AUROBINDO$$68$YR$$F$Y$100$KG$20240807$$MD$FR$FR
241823941$24182394$1$I$20240301$20240730$20240807$20240807$EXP$$US-JNJFOC-20240784351$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240807$$HP$US$US
241823951$24182395$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160368$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
241823961$24182396$1$I$20240714$20240802$20240807$20240807$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-123275$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240807$$HP$PR$PR
241823971$24182397$1$I$$20240730$20240807$20240807$EXP$$US-JNJFOC-20240780699$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240807$$CN$US$US
241823982$24182398$2$F$$20240812$20240807$20240822$EXP$$US-TEVA-VS-3228843$TEVA$Pepin A, Lee V, O^Brien S, Mulugeta P, Taunk NK. Management of Dry Eye Toxicity After Treatment With 177Lu-PSMA-617 Radioligand Therapy. Prac-Radiat-Oncol 2024; 14 (4): 301-304.; Pepin A, Lee V, O^Brien S, Mulugeta P, Taunk NK. Management of Dry Eye Toxicity After Treatment With 177Lu-PSMA-617 Radioligand Therapy. Prac-Radiat-Oncol 2024; 14 (4): 301-304.; Pepin A, Lee V, O^Brien S, Mulugeta P, Taunk NK. Management of Dry Eye Toxicity After Treatment With 177Lu-PSMA-617 Radioligand Therapy. Pr...$82$YR$$M$Y$$$20240822$$MD$US$US
241823991$24182399$1$I$$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124285$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240807$$CN$US$US
241824002$24182400$2$F$$20240812$20240807$20240820$EXP$$US-TEVA-VS-3227915$TEVA$Whitford R. A Case Report of Unusual Differential Hypoxia. ASAIO-J 2024; 70 (Suppl. 3) 103 abstr. SHOCK9.; Whitford R. A Case Report of Unusual Differential Hypoxia. ASAIO-J 2024; 70 (Suppl. 3) 103 abstr. SHOCK9.$18$YR$$M$Y$$$20240820$$HP$US$US
241824011$24182401$1$I$$20240806$20240807$20240807$PER$$US-AMGEN-USASP2024156674$AMGEN$$72$YR$E$F$Y$$$20240807$$HP$US$US
241824022$24182402$2$F$$20240805$20240807$20240809$PER$$US-GILEAD-2024-0682967$GILEAD$$$$A$F$Y$$$20240808$$CN$US$US
241824032$24182403$2$F$20240728$20240827$20240807$20240830$EXP$$US-SA-2024SA231311$SANOFI AVENTIS$$57$YR$A$M$Y$74.39$KG$20240830$$MD$US$US
241824041$24182404$1$I$$20240729$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005636$BIOCON$$$$$$Y$$$20240807$$MD$CA$CA
241824053$24182405$3$F$20240724$20240820$20240807$20240827$EXP$$US-Vifor (International) Inc.-VIT-2024-06920$VIFOR$$55$YR$$M$Y$101$KG$20240827$$HP$US$US
241824061$24182406$1$I$20240802$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024155252$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241824071$24182407$1$I$20240702$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155822$AMGEN$$29$YR$A$F$Y$$$20240807$$PH$US$US
241824082$24182408$2$F$20240701$20240809$20240807$20240816$PER$$US-AMGEN-USASP2024151786$AMGEN$$58$YR$A$M$Y$101.2$KG$20240816$$PH$US$US
241824092$24182409$2$F$$20240731$20240807$20240812$PER$$NVSC2024US157358$NOVARTIS$$49$YR$$M$Y$$$20240812$$CN$US$US
241824101$24182410$1$I$$20240802$20240807$20240807$EXP$$EU-BAUSCHBL-2024BNL031067$BAUSCH AND LOMB$$47$YR$$F$Y$$$20240807$$MD$EU$EU
241824111$24182411$1$I$$20240801$20240807$20240807$EXP$$PK-ROCHE-10000046534$ROCHE$$35$YR$A$M$Y$$$20240807$$CN$PK$PK
241824121$24182412$1$I$$20240807$20240807$20240807$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044244$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240807$$CN$JP$JP
241824131$24182413$1$I$20240101$20240728$20240807$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010309$UNITED THERAPEUTICS$$$$$F$Y$56.236$KG$20240807$$$US$US
241824141$24182414$1$I$$20240728$20240807$20240807$PER$$US-JNJFOC-20240779252$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241824151$24182415$1$I$$20240729$20240807$20240807$PER$$US-ALXN-A202111685$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240807$$CN$US$US
241824162$24182416$2$F$20230101$20240806$20240807$20240811$EXP$$US-ROCHE-10000050455$ROCHE$$27$YR$A$F$Y$$$20240811$$CN$US$US
241824171$24182417$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124213$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240807$$CN$US$US
241824181$24182418$1$I$$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123950$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240807$$HP$US$US
241824191$24182419$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123951$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$95.25$KG$20240807$$CN$US$US
241824202$24182420$2$F$20240801$20240823$20240807$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122460$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240902$$HP$US$US
241824211$24182421$1$I$20240724$20240729$20240807$20240807$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00790$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240807$$CN$US$US
241824231$24182423$1$I$$20240723$20240807$20240807$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461437$RANBAXY$Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al. Pickering syndrome: an overlooked renovascular cause of recurrent heart failure. J Am Heart Assoc. 2023;12:1-11$76$YR$$F$Y$$$20240807$$MD$IT$IT
241824241$24182424$1$I$$20240723$20240807$20240807$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461429$RANBAXY$Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al. Pickering syndrome: an overlooked renovascular cause of recurrent heart failure. J Am Heart Assoc. 2023;12:1-11$75$YR$$M$Y$$$20240807$$MD$IT$IT
241824251$24182425$1$I$20240420$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-038052$AUROBINDO$$70$YR$$M$Y$80$KG$20240807$$MD$FR$FR
241824261$24182426$1$I$$20240731$20240807$20240807$EXP$$NVSC2024KR158971$NOVARTIS$$$$$F$Y$$$20240807$$MD$KR$KR
241824281$24182428$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160577$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241824291$24182429$1$I$20240220$20240731$20240807$20240807$EXP$$AU-TAKEDA-2024TUS066869$TAKEDA$$30$YR$$M$Y$76$KG$20240807$$CN$AU$AU
241824301$24182430$1$I$20240721$20240801$20240807$20240807$PER$$US-BEH-2024176744$CSL BEHRING$$36$YR$A$F$Y$$$20240807$$CN$US$US
241824321$24182432$1$I$$20240730$20240807$20240807$EXP$$US-AstraZeneca-2024A173843$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241824331$24182433$1$I$$20230105$20240807$20240807$EXP$$US-AstraZeneca-2023A004237$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241824341$24182434$1$I$20240428$20240729$20240807$20240807$EXP$FR-AFSSAPS-GR2024000893$FR-ROCHE-10000047757$ROCHE$$64$YR$A$F$Y$47.5$KG$20240807$$PH$FR$FR
241824351$24182435$1$I$$20240730$20240807$20240807$EXP$$ZA-AstraZeneca-2024A173531$ASTRAZENECA$$64$YR$$M$Y$$$20240807$$CN$ZA$
241824361$24182436$1$I$20240801$20240802$20240807$20240807$EXP$$US-AstraZeneca-2024A176191$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241824371$24182437$1$I$$20240730$20240807$20240807$EXP$$US-AstraZeneca-2024A173480$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241824381$24182438$1$I$$20240802$20240807$20240807$EXP$$US-AstraZeneca-2024A176142$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241824391$24182439$1$I$$20230327$20240807$20240807$EXP$$US-AstraZeneca-2023A072402$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241824401$24182440$1$I$$20231216$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2023CN072113$SANDOZ$$$$$$Y$$$20240807$$CN$CN$CN
241824411$24182441$1$I$20230925$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037871$AUROBINDO$$69$YR$$F$Y$$$20240807$$PH$GB$GB
241824421$24182442$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-039123$AUROBINDO$$32$YR$$F$Y$$$20240807$$HP$CA$CA
241824431$24182443$1$I$20230901$20240805$20240807$20240807$EXP$$CA-UCBSA-2024013990$UCB$$60$YR$$F$Y$$$20240807$$CN$CA$CA
241824441$24182444$1$I$$20240730$20240807$20240807$EXP$$JP-AMGEN-JPNSP2024154291$AMGEN$$$$$$Y$$$20240807$$MD$JP$JP
241824451$24182445$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038851$AUROBINDO$$65$YR$$M$Y$108$KG$20240807$$HP$CA$CA
241824461$24182446$1$I$20210215$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2021-017013$AUROBINDO$$51$YR$$F$Y$52$KG$20240807$$MD$FR$FR
241824471$24182447$1$I$20240414$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037870$AUROBINDO$$73$YR$$M$Y$99$KG$20240807$$PH$GB$GB
241824482$24182448$2$F$20240606$20240821$20240807$20240827$EXP$$CA-JNJFOC-20240626521$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240827$$CN$CA$CA
241824492$24182449$2$F$20240620$20240808$20240807$20240812$30DAY$$US-AMGEN-USASP2024154844$AMGEN$$41$YR$A$F$Y$$$20240812$$HP$US$US
241824501$24182450$1$I$$20240729$20240807$20240807$PER$$US-TAKEDA-2024TUS076882$TAKEDA$$$$A$$Y$$$20240807$$MD$US$US
241824511$24182451$1$I$$20240723$20240807$20240807$EXP$$US-GLANDPHARMA-US-2024GLNSPO00547$GLAND PHARMA$$$$$$Y$$$20240807$$HP$US$US
241824521$24182452$1$I$$20240729$20240807$20240807$EXP$$ES-AMGEN-ESPSP2024150873$AMGEN$Mateos M.. Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of Clinical Oncology. 2024;1-14$$$$$Y$$$20240807$$MD$ES$ES
241824531$24182453$1$I$$20240730$20240807$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-007177$JAZZ$$$$$F$Y$$$20240807$$HP$US$US
241824541$24182454$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160556$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241824551$24182455$1$I$$20240730$20240807$20240807$EXP$$ID-NOVITIUMPHARMA-2024IDNVP01482$NOVITIUM PHARMA$Siti Nur Rohmah.Diagnostic and therapeutic challenges of tuberculosis in kidney transplant recipients; a case series study.Journal of Nephropharmacology.24-JUN-2024;13(2):1-8$42$YR$A$M$Y$$$20240807$$HP$ID$ID
241824563$24182456$3$F$20240701$20240923$20240807$20240926$EXP$$US-AMGEN-USASP2024155061$AMGEN$$70$YR$E$M$Y$$$20240926$$HP$US$US
241824572$24182457$2$F$20240727$20240806$20240807$20240808$PER$$US-AMGEN-USASP2024152509$AMGEN$$53$YR$A$F$Y$$$20240808$$CN$US$US
241824581$24182458$1$I$$20240730$20240807$20240807$EXP$$JP-AMGEN-JPNSP2024155249$AMGEN$$$$$$Y$$$20240807$$CN$JP$JP
241824591$24182459$1$I$$20230924$20240807$20240807$EXP$$SI-SANDOZ INC.-SDZ2023SI034042$SANDOZ$$$$$$Y$$$20240807$$MD$SI$SI
241824601$24182460$1$I$20240201$20240729$20240807$20240807$EXP$FR-AFSSAPS-LM2024000399$FR-TEVA-VS-3227775$TEVA$$77$YR$$M$Y$58$KG$20240807$$MD$FR$FR
241824611$24182461$1$I$20230101$20240730$20240807$20240807$EXP$$JP-AMGEN-JPNSP2024154549$AMGEN$Suehiro S.. EP-0619 A case of metastatic breast cancer complicated by bone marrow failure while receiving a CDK4/6 inhibitor. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;332$40$YR$A$F$Y$$$20240807$$MD$JP$JP
241824621$24182462$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123970$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240807$$CN$US$US
241824632$24182463$2$F$20240729$20240816$20240807$20240822$PER$$US-AMGEN-USASP2024151686$AMGEN$$50$YR$A$F$Y$59.229$KG$20240822$$HP$US$US
241824641$24182464$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123954$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240807$$CN$US$US
241824651$24182465$1$I$$20240801$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124482$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240807$$CN$US$US
241824661$24182466$1$I$$20240719$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-115986$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240807$$CN$US$US
241824671$24182467$1$I$$20240728$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-038103$AUROBINDO$$$$$F$Y$$$20240807$$CN$GB$GB
241824681$24182468$1$I$20240612$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124050$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240807$$HP$US$US
241824691$24182469$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124357$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240807$$HP$US$US
241824701$24182470$1$I$$20240226$20240807$20240807$EXP$$IL-SANDOZ INC.-SDZ2024IL021245$SANDOZ$Danylesko, I., Shimoni, A., Avigdor, A., Kedmi, M., Shem-Tov, N., Yerushalmi, R. et al. Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with relapsed or refractory acute myeloid leukemia (AML)- an open-label, phase II, study.. Blood. 2023;142:4292-4293$$$$$Y$$$20240807$$MD$IL$IL
241824712$24182471$2$F$20240122$20240814$20240807$20240815$EXP$IT-MINISAL02-997064$IT-TAKEDA-2024TUS078732$TAKEDA$$30$YR$$M$Y$72$KG$20240815$$HP$IT$IT
241824721$24182472$1$I$$20240730$20240807$20240807$PER$$US-ALXN-202407USA002118US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
241824731$24182473$1$I$$20240805$20240807$20240807$PER$$US-ABBVIE-5868054$ABBVIE$$$$$F$Y$$$20240807$$MD$US$US
241824741$24182474$1$I$$20231110$20240807$20240807$EXP$$IL-SANDOZ INC.-SDZ2023IL053532$SANDOZ$Jacoby E., Adam E., Hutt D., Somech R., Malkiel S., Toren A.,et.al.,. Improved Outcome Following Busulfan-Based Conditioningin Children with Functional Neutrophil Disorders UndergoingHematopoietic Stem Cell Transplant from HLA-Matched Donors. Journal of Clinical Immunology. 2023;43:1603-1610$$$$$Y$$$20240807$$HP$IL$IL
241824752$24182475$2$F$$20240805$20240807$20240807$EXP$$US-GILEAD-2024-0683092$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241824761$24182476$1$I$$20240803$20240807$20240807$PER$$US-JNJFOC-20240809913$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$US$US
241824771$24182477$1$I$$20240730$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005683$BIOCON$$$$$$Y$$$20240807$$MD$CA$CA
241824781$24182478$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002825$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240807$$CN$US$US
241824791$24182479$1$I$$20240726$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407019079$ELI LILLY AND CO$$31$YR$A$$Y$$$20240807$$LW$US$US
241824801$24182480$1$I$20230101$20240730$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407019895$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240807$$CN$US$US
241824811$24182481$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003198$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240807$$CN$US$US
241824821$24182482$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002878$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240807$$CN$US$US
241824831$24182483$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003353$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240807$$CN$US$US
241824841$24182484$1$I$$20240726$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407017951$ELI LILLY AND CO$$51$YR$A$$Y$$$20240807$$LW$US$US
241824851$24182485$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002893$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240807$$CN$US$US
241824861$24182486$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003655$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240807$$CN$US$US
241824871$24182487$1$I$20240501$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003003$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240807$$CN$US$US
241824881$24182488$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003081$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240807$$CN$US$US
241824891$24182489$1$I$$20240731$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408000167$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240807$$CN$US$US
241824901$24182490$1$I$20240701$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002859$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240807$$CN$US$US
241824911$24182491$1$I$$20240801$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002894$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241824921$24182492$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002866$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241824931$24182493$1$I$20240101$20240730$20240807$20240807$PER$$US-ABBVIE-5861065$ABBVIE$$$$$$Y$$$20240807$$CN$US$US
241824942$24182494$2$F$$20240805$20240807$20240809$EXP$$NVSC2024DE159521$NOVARTIS$$$$A$F$Y$$$20240809$$MD$DE$DE
241824952$24182495$2$F$20240730$20240814$20240807$20240821$PER$$US-BIOGEN-2024BI01276626$BIOGEN$$37$YR$$F$Y$$$20240821$$CN$US$US
241824961$24182496$1$I$$20240723$20240807$20240807$EXP$$IN-GLANDPHARMA-IN-2024GLNLIT00579$GLAND PHARMA$Anupma Kaul.The Unusual Adverse Effects of Antituberculosis Therapy in  Kidney Patients.International Journal of Mycobacteriology.JUN-2024;13:183-190$16$YR$T$M$Y$$$20240807$$HP$IN$IN
241824972$24182497$2$F$20240501$20240806$20240807$20240815$PER$$US-AMGEN-USASP2024156344$AMGEN$$$$$F$Y$$$20240815$$CN$US$US
241825002$24182500$2$F$20220601$20240919$20240807$20240930$EXP$$JP-JNJFOC-20230323731$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240930$$CN$JP$JP
241825012$24182501$2$F$20240730$20240808$20240807$20240808$EXP$$GB-JNJFOC-20240814157$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240809$$CN$GB$GB
241825022$24182502$2$F$20240729$20240807$20240807$20240814$PER$$US-AMGEN-USASP2024154099$AMGEN$$44$YR$A$M$Y$$$20240814$$HP$US$US
241825032$24182503$2$F$20230226$20240829$20240807$20240909$EXP$$FR-ORGANON-O2407FRA002785$ORGANON$$22$YR$$F$Y$93$KG$20240909$$MD$FR$FR
241825041$24182504$1$I$20210101$20240726$20240807$20240807$EXP$$SG-ROCHE-10000041094$ROCHE$$78$YR$E$F$Y$$$20240807$$CN$SG$SG
241825051$24182505$1$I$$20240805$20240807$20240807$EXP$$IN-ROCHE-3550256$ROCHE$$59$YR$A$M$Y$$$20240807$$MD$IN$IN
241825061$24182506$1$I$$20240730$20240807$20240807$EXP$$US-AstraZeneca-2024A173487$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241825071$24182507$1$I$20221106$20230117$20240807$20240807$EXP$$US-AstraZeneca-2022A399844$ASTRAZENECA$$67$YR$$F$Y$$$20240807$$CN$US$
241825081$24182508$1$I$$20220318$20240807$20240807$EXP$$US-AstraZeneca-2022A122299$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241825091$24182509$1$I$$20240729$20240807$20240807$PER$$US-AstraZeneca-2024A175825$ASTRAZENECA$$$$$$Y$$$20240807$$HP$US$
241825101$24182510$1$I$20220623$20220629$20240807$20240807$EXP$$US-AstraZeneca-2022A239944$ASTRAZENECA$$22945$DY$$F$Y$$$20240807$$CN$US$
241825111$24182511$1$I$20210801$20211004$20240807$20240807$EXP$$US-AstraZeneca-2021A761797$ASTRAZENECA$$59$YR$$M$Y$$$20240807$$CN$US$
241825121$24182512$1$I$$20240730$20240807$20240807$EXP$$ZA-AstraZeneca-2024A173512$ASTRAZENECA$$$$A$M$Y$$$20240807$$MD$ZA$
241825132$24182513$2$F$$20240812$20240807$20240822$EXP$$DK-TEVA-VS-3229615$TEVA$Foslund IT, Von Magius SAV, Ainsworth AP, Detlefsen S, Fristrup CW, Knudsen AO, et al. Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). Pleura-Peritoneum 2024; 9 (2): 69-77.; Foslund IT, Von Magius SAV, Ainsworth AP, Detlefsen S, Fristrup CW, Knudsen AO, et al. Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). Pleura-P...$$$$F$Y$$$20240822$$MD$DK$DK
241825141$24182514$1$I$$20230927$20240807$20240807$EXP$$SI-SANDOZ INC.-SDZ2023SI036132$SANDOZ$Deticek A, et al.. ANTIDEPRESSANTSINDUCED SEROTONIN SYNDROME-TWO CLINICAL CASE. Farmacevtski Vestnik. 2023$$$$$Y$$$20240807$$HP$SI$SI
241825151$24182515$1$I$$20240723$20240807$20240807$EXP$$US-PHARMAAND GMBH-2024PHR00443$pharmaAND$$$$$F$Y$76.92$KG$20240807$$CN$US$US
241825161$24182516$1$I$$20240703$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06635$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241825171$24182517$1$I$$20240729$20240807$20240807$EXP$$DK-TEVA-VS-3229616$TEVA$Foslund IT, Von Magius SAV, Ainsworth AP, Detlefsen S, Fristrup CW, Knudsen AO, et al. Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). Pleura-Peritoneum 2024; 9 (2): 69-77.$$$$F$Y$$$20240807$$MD$DK$DK
241825181$24182518$1$I$20230801$20240723$20240807$20240807$EXP$$DE-PHARMAAND GMBH-2024PHR00445$pharmaAND$$$$$F$Y$2.506$KG$20240807$$MD$DE$DE
241825191$24182519$1$I$20240701$20240729$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-023355$UNITED THERAPEUTICS$$56$YR$$F$Y$$$20240807$$$US$US
241825201$24182520$1$I$$20240731$20240807$20240807$EXP$$CA-CELLTRION INC.-2023CA025572$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
241825211$24182521$1$I$20240802$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154614$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241825221$24182522$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156085$AMGEN$$$$$$Y$$$20240807$$CN$US$US
241825231$24182523$1$I$20220825$20240326$20240807$20240807$EXP$$CA-CELLTRION INC.-2022CA022747$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
241825241$24182524$1$I$20230101$20240725$20240807$20240807$EXP$CH-SM-2024-13633$CH-UCBSA-2024038409$UCB$$29$YR$$F$Y$$$20240807$$PH$CH$CH
241825252$24182525$2$F$$20240730$20240807$20240809$EXP$$US-APOTEX-2024AP009079$APOTEX$Embry E, Xiong J, Zahid U, Abdelghani L.. Massive Hemoptysis Preceded by Dabigatran in a Patient With Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 2024;209$66$YR$$M$Y$$$20240809$$HP$US$US
241825261$24182526$1$I$$20240703$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06955$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241825271$24182527$1$I$20221101$20240730$20240807$20240807$EXP$$JP-TAKEDA-2024TUS078175$TAKEDA$$60$YR$$F$Y$$$20240807$$MD$JP$JP
241825281$24182528$1$I$$20240723$20240807$20240807$EXP$$US-GLANDPHARMA-US-2024GLNLIT00573$GLAND PHARMA$C. Rodriguez.BRASH: A Deadly Acronym.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A1596$84$YR$E$F$Y$$$20240807$$HP$US$US
241825291$24182529$1$I$20240722$20240730$20240807$20240807$EXP$$CA-CELLTRION INC.-2024CA017409$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
241825301$24182530$1$I$20240730$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123718$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$73.94$KG$20240807$$HP$US$US
241825331$24182533$1$I$20240501$20240802$20240807$20240807$EXP$$US-JNJFOC-20240808156$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240807$$HP$US$US
241825341$24182534$1$I$20180101$20240730$20240807$20240807$EXP$$CO-UCBSA-2024015897$UCB$$66$YR$$F$Y$45$KG$20240807$$CN$CO$CO
241825352$24182535$2$F$$20240806$20240807$20240812$PER$$US-AMGEN-USASP2024156527$AMGEN$$$$$$Y$$$20240812$$CN$US$US
241825362$24182536$2$F$20240101$20240808$20240807$20240816$PER$$US-AMGEN-USASP2024155560$AMGEN$$71$YR$E$F$Y$$$20240815$$CN$US$US
241825371$24182537$1$I$$20240806$20240807$20240807$PER$$US-HALEON-2190688$Haleon PLC$$$$$$Y$$$20240807$$CN$US$US
241825381$24182538$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000048780$ROCHE$Kimura M, Kasahara Y, Horita K, Kato K, Takahashi T, Shimada T.. EP-1333 A case of metastasis to subclavian lymph nodes infiltrating the subclavian vein and bleeding to death. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;511$68$YR$E$F$Y$$$20240807$$MD$JP$JP
241825391$24182539$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000047301$ROCHE$Matono R, Kometani T, Yasui D. EP-0626 Two cases of advanced breast cancer which presented with tumour lysis syndrome after chemotherapy. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;334$8$DEC$E$F$Y$$$20240807$$MD$JP$JP
241825401$24182540$1$I$20240723$20240802$20240807$20240807$EXP$DE-CADRBFARM-2024329591$DE-TORRENT-00027113$TORRENT$$2$DY$N$M$Y$3$KG$20240807$$MD$DE$DE
241825411$24182541$1$I$$20240730$20240807$20240807$EXP$GB-MHRA-31193571$GB-TORRENT-00037484$TORRENT$$$$$M$Y$$$20240807$$CN$GB$GB
241825421$24182542$1$I$$20240730$20240807$20240807$EXP$$US-TORRENT-00013698$TORRENT$$95$YR$E$F$Y$$$20240807$$MD$US$US
241825431$24182543$1$I$$20240730$20240807$20240807$EXP$$US-TORRENT-00013455$TORRENT$$86$YR$E$F$Y$$$20240807$$MD$US$US
241825441$24182544$1$I$$20240805$20240807$20240807$PER$$US-ABBVIE-5868172$ABBVIE$$$$$$Y$$$20240807$$HP$US$US
241825451$24182545$1$I$$20240805$20240807$20240807$EXP$$TW-GILEAD-2024-0682886$GILEAD$$48$YR$A$F$Y$$$20240807$$HP$TW$TW
241825461$24182546$1$I$$20240805$20240807$20240807$PER$$US-TAKEDA-2024TUS078773$TAKEDA$$$$$F$Y$$$20240807$$CN$US$US
241825473$24182547$3$F$20240709$20240812$20240807$20240820$EXP$$NVSC2024PT160119$NOVARTIS$$81$YR$$M$Y$$$20240820$$MD$PT$PT
241825481$24182548$1$I$$20230703$20240807$20240807$EXP$$SI-SANDOZ INC.-SDZ2023SI002726$SANDOZ$Matej Dobravc Verbic. Adverse drug reactions in the ambulatory internal patients at the emergency_NeW_lInE_cHaR_department: Focus on causality assessment and drug-drug interactions. Acta Pharmaceutica, Acta Pharm.. 2023;73:195-210$$$$$Y$$$20240807$$PH$SI$SI
241825491$24182549$1$I$20240610$20240802$20240807$20240807$EXP$$US-009507513-2408USA000573$MERCK$$$$$M$Y$$$20240807$$HP$US$US
241825501$24182550$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160631$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241825511$24182551$1$I$$20240703$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06639$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241825522$24182552$2$F$20240730$20240912$20240807$20240912$PER$$US-JNJFOC-20240807070$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240912$$CN$US$US
241825532$24182553$2$F$20240726$20240802$20240807$20240809$PER$$US-JNJFOC-20240806210$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240809$$CN$US$US
241825541$24182554$1$I$20200414$20240802$20240807$20240807$EXP$PL-URPL-1-1334-2020$PL-HALEON-2190267$Haleon PLC$$17$YR$$M$Y$67.3$KG$20240807$$MD$PL$PL
241825552$24182555$2$F$$20240831$20240807$20240905$EXP$$IN-ROCHE-10000041060$ROCHE$$49$YR$A$M$Y$$$20240905$$CN$IN$IN
241825563$24182556$3$F$$20240829$20240807$20240831$EXP$$IL-ROCHE-10000049226$ROCHE$$$$E$F$Y$$$20240831$$CN$IL$IL
241825572$24182557$2$F$$20240828$20240807$20240904$EXP$$US-ROCHE-10000046367$ROCHE$$64$YR$A$M$Y$$$20240904$$CN$US$US
241825581$24182558$1$I$20221007$20221127$20240807$20240807$EXP$$NL-TERSERA THERAPEUTICS LLC-2022TRS005433$TERSERA THERAPEUTICS$$$$$$Y$$$20240807$$CN$NL$NL
241825591$24182559$1$I$20220912$20220920$20240807$20240807$EXP$$NL-TERSERA THERAPEUTICS LLC-2022TRS004098$TERSERA THERAPEUTICS$$$$$$Y$$$20240807$$CN$NL$NL
241825601$24182560$1$I$20230213$20230227$20240807$20240807$EXP$$NL-TERSERA THERAPEUTICS LLC-2023TRS000984$TERSERA THERAPEUTICS$$$$$$Y$$$20240807$$CN$NL$NL
241825611$24182561$1$I$$20240730$20240807$20240807$EXP$$US-NOVITIUMPHARMA-2024USNVP01483$NOVITIUM PHARMA$Brian M. Nguyen.Iris atrophy following intracameral dexamethasone injection: a report of two pediatric cases.Journal of AAPOS.25-MAR-2024;28:103901$10$YR$C$F$Y$$$20240807$$HP$US$US
241825621$24182562$1$I$$20240723$20240807$20240807$EXP$$DE-GLANDPHARMA-DE-2024GLNLIT00575$GLAND PHARMA$Felix Patricius Hans .A potentially lifesaving error: unintentional high-dose adrenaline administration in anaphylaxis-induced cardiac arrest; a case report.International Journal of Emergency Medicine.28-JUN-2024;17 (No. 1):1-5$66$YR$E$F$Y$$$20240807$$HP$DE$DE
241825631$24182563$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160632$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241825641$24182564$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160623$NOVARTIS$$$$$$Y$$$20240807$$CN$US$US
241825652$24182565$2$F$$20240729$20240807$20240807$EXP$GB-MLMSERVICE-20240722-PI138634-00270-1$GB-STRIDES ARCOLAB LIMITED-2024SP009713$STRIDES$Ameli R.. Interesting case of Strongyloides hyperinfection syndrome in an immunocompromised patient. Clinical Medicine.. Journal of the Royal College of Physicians of London. 2024;24(Supplement):100043$42$YR$$F$Y$$$20240807$$MD$GB$GB
241825661$24182566$1$I$$20240806$20240807$20240807$PER$$US-HALEON-2190740$Haleon PLC$$$$$$Y$$$20240807$$CN$US$US
241825671$24182567$1$I$20220101$20240729$20240807$20240807$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009735$STRIDES$Olowoyo O, Sanghi P.. ^DOC, MY HEAD POUNDS^ -A RARE CAUSE OF HEADACHE IN A KIDNEY TRANSPLANT PATIENT -A CASE REPORT.. Am-J-Kidney-Dis. 2024;83(Suppl. 2)(4):S148 abstr. 480$46$YR$$F$Y$$$20240807$$HP$US$US
241825681$24182568$1$I$$20240729$20240807$20240807$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP009766$STRIDES$Goncalves LA, Song ATW, Gimenes VMF, Magri MMC, Abdala E.. ESPOROTRICOSE CUTANEA DISSEMINADA EM RECEPTOR DE TRANSPLANTE DE FIGADO: UMA INFECCAO RARA E DESAFIADORA.. Brazil-J-Infect-Dis. 2023;27 (Suppl. 1):227$57$YR$$F$Y$$$20240807$$HP$BR$BR
241825692$24182569$2$F$$20240806$20240807$20240819$EXP$$JP-ROCHE-10000048745$ROCHE$Nakauchi C, Nishida Y. A case where pseudocirrhosis was observed during anticancer therapy against metastases to liver of breast cancer, including study on 19 cases reported in our country. [Abstract number: EP-0631]. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;335.$77$YR$E$F$Y$$$20240819$$MD$JP$JP
241825701$24182570$1$I$20230221$20230221$20240807$20240807$EXP$$KW-BIOVITRUM-2023-KW-005921$BIOVITRUM$$606$DY$$M$Y$$$20240807$$CN$KW$KW
241825711$24182571$1$I$20220525$20220526$20240807$20240807$EXP$$ZA-BIOVITRUM-2022ZA07323$BIOVITRUM$$97$DY$$F$Y$2.5$KG$20240807$$CN$ZA$ZA
241825721$24182572$1$I$$20240729$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005638$BIOCON$$$$$$Y$$$20240807$$HP$CA$CA
241825731$24182573$1$I$20240322$20240801$20240807$20240807$EXP$FR-AFSSAPS-RN2024000835$FR-EMD Serono-2024041805$EMD SERONO INC$$76$YR$E$M$Y$76$KG$20240807$$MD$FR$FR
241825741$24182574$1$I$20230325$20230405$20240807$20240807$EXP$$CO-BIOVITRUM-2023-CO-009202$BIOVITRUM$$229$DY$$M$Y$8.7$KG$20240807$$CN$CO$CO
241825751$24182575$1$I$$20240729$20240807$20240807$EXP$$FR-KOANAAP-SML-FR-2024-00779$SHILPA MEDICARE$$57$YR$A$F$Y$$$20240807$$HP$FR$FR
241825761$24182576$1$I$$20240718$20240807$20240807$PER$$US-EMD Serono-2024039551$EMD SERONO INC$$$$E$F$Y$$$20240807$$MD$US$US
241825771$24182577$1$I$$20240731$20240807$20240807$EXP$$US-EMD Serono-2024041847$EMD SERONO INC$$53$YR$A$F$Y$$$20240807$$MD$US$US
241825782$24182578$2$F$20240713$20240731$20240807$20240809$EXP$DE-BFARM-24005219$DE-EMD Serono-2024040837$EMD SERONO INC$$35$YR$A$F$Y$$$20240809$$MD$DE$DE
241825792$24182579$2$F$20240729$20240813$20240807$20240821$30DAY$$US-AMGEN-USASP2024153726$AMGEN$$66$YR$E$F$Y$64.2$KG$20240821$$PH$US$US
241825801$24182580$1$I$$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024153835$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241825811$24182581$1$I$$20240723$20240807$20240807$EXP$$US-GLANDPHARMA-US-2024GLNLIT00576$GLAND PHARMA$K Patel.Two cases of hepatoblastoma in Bohring-Opitz syndrome: An emerging association.Pediatric Blood and Cancer.JUL-2024;71: No. 7$15$MON$I$F$Y$$$20240807$$HP$US$US
241825821$24182582$1$I$20231121$20240729$20240807$20240807$EXP$FR-AFSSAPS-AM2024000561$FR-TEVA-VS-3227757$TEVA$$78$YR$$M$Y$100$KG$20240807$$MD$FR$FR
241825831$24182583$1$I$20240801$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154267$AMGEN$$72$YR$E$F$Y$$$20240807$$CN$US$US
241825841$24182584$1$I$$20240803$20240807$20240807$PER$$US-AMGEN-USASP2024155408$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241825851$24182585$1$I$$20240730$20240807$20240807$EXP$$IN-KOANAAP-SML-IN-2024-00785$SHILPA MEDICARE$Dr Sachin M, Dr Sumith P, Dr Athira K. Imatinib Induced Iron Overload. Eur-J-Cardiovasc-Med. 2023;930-932.$60$YR$A$M$Y$$$20240807$$MD$IN$IN
241825871$24182587$1$I$20240701$20240802$20240807$20240807$EXP$$BR-JNJFOC-20240810734$JOHNSON AND JOHNSON$$43$YR$A$M$Y$99$KG$20240807$$CN$BR$BR
241825881$24182588$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160578$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241825892$24182589$2$F$$20240805$20240807$20240807$EXP$$US-GILEAD-2024-0683093$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241825901$24182590$1$I$$20210922$20240807$20240807$EXP$$US-AstraZeneca-2021A738710$ASTRAZENECA$$$$$M$Y$$$20240807$$MD$US$
241825912$24182591$2$F$$20240730$20240807$20240829$EXP$$US-AstraZeneca-2024A173765$ASTRAZENECA$$$$$F$Y$$$20240829$$HP$US$
241825921$24182592$1$I$20240516$20240719$20240807$20240807$EXP$$US-AstraZeneca-2024A119420$ASTRAZENECA$$23344$DY$$M$Y$$$20240807$$CN$US$
241825931$24182593$1$I$$20220224$20240807$20240807$EXP$$US-AstraZeneca-2022A088260$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241825941$24182594$1$I$$20240726$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407019106$ELI LILLY AND CO$$60$YR$A$$Y$$$20240807$$LW$US$US
241825951$24182595$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003113$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240807$$CN$US$US
241825961$24182596$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003163$ELI LILLY AND CO$$$$$F$Y$$$20240807$$MD$US$US
241825971$24182597$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408001992$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240807$$CN$US$US
241825981$24182598$1$I$20240802$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002964$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240807$$CN$US$US
241825991$24182599$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002988$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240807$$CN$US$US
241826001$24182600$1$I$20240701$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002912$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240807$$CN$US$US
241826012$24182601$2$F$$20240809$20240807$20240821$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019094$ELI LILLY AND CO$$60$YR$A$$Y$$$20240821$$LW$US$US
241826021$24182602$1$I$20240728$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002099$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240807$$CN$US$US
241826031$24182603$1$I$$20240729$20240807$20240807$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009745$STRIDES$Doi M, Hamada M, Ishizawa K, Fushimi N, Kase Y, Ikezono T, et al.. Diagnostic utility of cytology in a patient with Epstein-Barr virus-positive mucocutaneous ulcer in palatine tonsils: A case report.. Diagn-Cytopathol. 2024;52 (7):E154-E158$82$YR$$M$Y$$$20240807$$HP$JP$JP
241826052$24182605$2$F$20240805$20240808$20240807$20240812$PER$$US-AMGEN-USASP2024156501$AMGEN$$77$YR$E$F$Y$$$20240811$$CN$US$US
241826061$24182606$1$I$20240613$20240805$20240807$20240807$EXP$FR-AFSSAPS-MA2024001288$FR-UCBSA-2024039150$UCB$$45$YR$$M$Y$$$20240807$$MD$FR$FR
241826071$24182607$1$I$$20240724$20240807$20240807$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-05063$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241826081$24182608$1$I$$20240729$20240807$20240807$EXP$$CA-APOTEX-2024AP008977$APOTEX$$68$YR$$F$Y$$$20240807$$CN$CA$CA
241826092$24182609$2$F$$20240816$20240807$20240823$30DAY$$CA-JNJFOC-20240813420$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$CA$CA
241826103$24182610$3$F$20240729$20240906$20240807$20240918$30DAY$$US-JNJFOC-20240781663$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240919$$CN$US$US
241826112$24182611$2$F$$20240822$20240807$20240911$PER$$US-APOTEX-2024AP008987$APOTEX$$$$$M$Y$$$20240911$$CN$US$US
241826122$24182612$2$F$$20240805$20240807$20240807$EXP$$US-GILEAD-2024-0683122$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241826131$24182613$1$I$$20240729$20240807$20240807$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009810$STRIDES$Nakai K, Sato K, Nohara N, Takagi M, Kihara M, Ueda S, et al.. Successful Pregnancy and Delivery in a Chronic Renal Failure Patient with Membranoproliferative Glomerulonephritis and Preeclampsia-related Nephrotic Syndrome.. Intern-Med. 2024;63 (14):2035-2042$$$$M$Y$$$20240807$$MD$JP$JP
241826141$24182614$1$I$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0682932$GILEAD$$3$YR$C$F$Y$$$20240807$$MD$US$US
241826161$24182616$1$I$20240729$20240725$20240807$20240807$EXP$$JP-ROCHE-10000049909$ROCHE$$32$YR$A$F$Y$$$20240807$$MD$JP$JP
241826171$24182617$1$I$$20240729$20240807$20240807$30DAY$$US-GSK-US2024094870$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241826181$24182618$1$I$$20240723$20240807$20240807$EXP$$RU-GLANDPHARMA-RU-2024GLNLIT00577$GLAND PHARMA$VY Skoropad.Toxicity analysis during neoadjuvant induction chemotherapy and subsequent chemoradiotherapy in patients with locally advanced gastric cancer.Onkologiya. Zhurnal imeni P.A. Gercena.JAN-2024;13 (No.2):15-20$$$$$Y$$$20240807$$HP$RU$RU
241826191$24182619$1$I$$20240731$20240807$20240807$EXP$$US-TAKEDA-2024TUS077634$TAKEDA$$$$$M$Y$$$20240807$$CN$US$US
241826201$24182620$1$I$$20240801$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122865$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240807$$CN$US$US
241826211$24182621$1$I$$20240728$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005616$BIOCON$$$$$$Y$$$20240807$$CN$CA$CA
241826221$24182622$1$I$20240801$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154447$AMGEN$$68$YR$E$M$Y$$$20240807$$CN$US$US
241826231$24182623$1$I$20240701$20240725$20240807$20240807$PER$$US-JNJFOC-20240772310$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$HP$US$US
241826241$24182624$1$I$20240507$20240731$20240807$20240807$EXP$$GB-TAKEDA-2024TUS046358$TAKEDA$$77$YR$$F$Y$$$20240807$$CN$GB$GB
241826251$24182625$1$I$$20240729$20240807$20240807$EXP$IT-PFIZER INC-PV202400089808$IT-ROCHE-10000041658$ROCHE$Tondulli, L.. Po a rare case of pulmonary vasculitis due to new antiangiogenic drugs. Annals of Oncology. 2009;20 (Suppl 5):10.1093/annonc/mdp218. doi:10.1093/annonc/mdp218$67$YR$E$F$Y$$$20240807$$HP$IT$IT
241826261$24182626$1$I$20240124$20240802$20240807$20240807$EXP$$JP-EXELIXIS-CABO-24074092$EXELIXIS$$8$DEC$$M$Y$$$20240807$$MD$JP$JP
241826271$24182627$1$I$$20240802$20240807$20240807$EXP$$JP-EXELIXIS-CABO-24078036$EXELIXIS$$$$$M$Y$$$20240807$$MD$JP$JP
241826281$24182628$1$I$$20240726$20240807$20240807$PER$$US-ROCHE-10000041088$ROCHE$$$$$$Y$$$20240807$$PH$US$US
241826301$24182630$1$I$$20240730$20240807$20240807$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009723$STRIDES$Sun H, Zhu Y, Li J, Zhao L, Yang G, Yan Z, et al.. Picalm::MLLT10 can Identify a New Subgroup of Acute Leukemias of Ambiguous Lineage with Unique Extramedullary Disease and Treatment Response.. Blood. 2023;142 (Suppl. 1):6078$34$YR$$F$Y$$$20240807$$HP$CN$CN
241826314$24182631$4$F$20240322$20240910$20240807$20240916$EXP$$FR-TAKEDA-2024TUS078152$TAKEDA$$84$YR$$M$Y$70$KG$20240916$$HP$FR$FR
241826321$24182632$1$I$20230101$20240730$20240807$20240807$EXP$$PL-AMGEN-POLSP2024151565$AMGEN$$76$YR$E$M$Y$91$KG$20240807$$MD$PL$PL
241826331$24182633$1$I$$20240730$20240807$20240807$EXP$$US-KOANAAP-SML-US-2024-00786$SHILPA MEDICARE$SW Q, N M, M P, E I. SIGNIFICANT ESOPHAGEAL AND INTESTIINALULCERATIONS IN THE SETTING OF RECENT CHEMOTHERAPY FOR PANCREATICADENOCARCINOMA.. Gastroenterology. 2023;164: S-1209-S-1210.$72$YR$E$M$Y$$$20240807$$MD$US$US
241826342$24182634$2$F$20240101$20240823$20240807$20240830$EXP$$US-BIOGEN-2024BI01276655$BIOGEN$$$$$F$Y$87$KG$20240830$$CN$US$US
241826351$24182635$1$I$$20240730$20240807$20240807$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009736$STRIDES$Moore M, King SI, Aschner Y.. Endobronchial Mucormycosis Presenting as Stridor in a Diabetic Adult.. Am-J-Respir-Crit-Care-Med. 2024;209:abstr. A7420$49$YR$$M$Y$$$20240807$$HP$US$US
241826361$24182636$1$I$$20240802$20240807$20240807$EXP$$ZA-TAKEDA-2024TUS078415$TAKEDA$$$$$M$Y$$$20240807$$CN$ZA$ZA
241826371$24182637$1$I$$20240728$20240807$20240807$EXP$$US-AMAROX PHARMA-HET2024US02610$HETERO$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024;1-6$1$DY$$M$Y$$$20240807$$MD$US$US
241826381$24182638$1$I$$20240723$20240807$20240807$EXP$$IT-GLANDPHARMA-IT-2024GLNLIT00581$GLAND PHARMA$M Marano.Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars.Toxicology Reports.2024;13:101683$15$YR$T$F$Y$48$KG$20240807$$HP$IT$IT
241826391$24182639$1$I$$20240802$20240807$20240807$EXP$$AU-SA-2024SA230609$SANOFI AVENTIS$$$$$$Y$$$20240807$$HP$AU$AU
241826401$24182640$1$I$$20240730$20240807$20240807$EXP$NL-LRB-00990669$NL-TEVA-VS-3228568$TEVA$$62$YR$$F$Y$76$KG$20240807$$CN$NL$NL
241826412$24182641$2$F$$20240911$20240807$20240924$PER$$US-GSK-US2024094875$GLAXOSMITHKLINE$$$$$M$Y$$$20240924$$CN$US$US
241826421$24182642$1$I$$20240801$20240807$20240807$EXP$PL-URPL-1-1720-2020$PL-SA-2024SA229870$SANOFI AVENTIS$$21$YR$A$M$Y$75$KG$20240807$$MD$PL$PL
241826431$24182643$1$I$$20240730$20240807$20240807$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009770$STRIDES$Jia D, Zhang F, Li H, Shen Y, Jin Z, Shi FD, et al.. Responsiveness to Tocilizumab in Anti-Acetylcholine Receptor-Positive Generalized Myasthenia Gravis.. Aging-Dis. 2024;15 (2):824-830$61$YR$$F$Y$$$20240807$$HP$CN$CN
241826441$24182644$1$I$20240703$20240802$20240807$20240807$PER$$US-ABBVIE-5868474$ABBVIE$$30$YR$$F$Y$$$20240807$$MD$US$US
241826452$24182645$2$F$20240621$20240802$20240807$20240813$EXP$FR-AFSSAPS-ST2024001140$FR-ROCHE-10000042129$ROCHE$$62$YR$A$F$Y$104$KG$20240813$$MD$FR$FR
241826462$24182646$2$F$$20240809$20240807$20240814$EXP$$NVSC2024GB159489$NOVARTIS$$$$$F$Y$$$20240814$$CN$GB$GB
241826471$24182647$1$I$$20240729$20240807$20240807$PER$$US-APOTEX-2024AP009051$APOTEX$Lawson C, Mohsen A, Myers I.. A CASE OF DIABETES INSIPIDUS MASKED BY SEVERE HYPONATREMIA. American Journal of Kidney Diseases. 2024;83:4 (Suppl. 2):S31$41$YR$$M$Y$$$20240807$$HP$US$US
241826481$24182648$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000047978$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$51$YR$A$M$Y$$$20240807$$HP$JP$JP
241826491$24182649$1$I$$20240729$20240807$20240807$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP009794$STRIDES$Saha AK, Padhi P, Hota D, Rathore V.. Neonatal Acute Kidney Injury due to Maternal Olmesartan Intake.. Indian-J-Pediatr. 2024;91 (8):869$$$$F$Y$$$20240807$$HP$IN$IN
241826501$24182650$1$I$$20240723$20240807$20240807$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00578$GLAND PHARMA$Xiaolu Shi.Distribution of drug-resistant genes in alveolar lavage fluid from patients with psittacosis and traceability analysis of causative organisms.Frontiers in Microbiology.22-JUN-2023;14:1-12$73$YR$E$M$Y$$$20240807$$HP$CN$CN
241826511$24182651$1$I$$20240724$20240807$20240807$PER$$US-JNJFOC-20240772352$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241826521$24182652$1$I$$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024154638$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241826531$24182653$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000049884$ROCHE$$56$YR$A$F$Y$$$20240807$$MD$US$US
241826541$24182654$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003004$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240807$$CN$US$US
241826551$24182655$1$I$$20240731$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408000380$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240807$$CN$US$US
241826571$24182657$1$I$$20240726$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407019099$ELI LILLY AND CO$$59$YR$A$$Y$$$20240807$$CN$US$US
241826581$24182658$1$I$$20240729$20240807$20240807$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009809$STRIDES$Nakai K, Sato K, Nohara N, Takagi M, Kihara M, Ueda S, et al.. Successful Pregnancy and Delivery in a Chronic Renal Failure Patient with Membranoproliferative Glomerulonephritis and Preeclampsia-related Nephrotic Syndrome.. Intern-Med. 2024;63 (14):2035-2042$37$YR$$F$Y$$$20240807$$MD$JP$JP
241826591$24182659$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003285$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240807$$CN$US$US
241826601$24182660$1$I$$20240806$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003815$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241826611$24182661$1$I$$20240725$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407016993$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240807$$CN$US$US
241826621$24182662$1$I$20240802$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002851$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240807$$CN$US$US
241826631$24182663$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002432$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240807$$HP$US$US
241826641$24182664$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000048835$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$47$YR$A$M$Y$$$20240807$$HP$JP$JP
241826651$24182665$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003373$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240807$$CN$US$US
241826661$24182666$1$I$$20240109$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US002556$SANDOZ$$$$$$Y$$$20240807$$CN$US$US
241826671$24182667$1$I$$20240730$20240807$20240807$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009792$STRIDES$Hayashino K, Yoshida C, Ayata Y, Yukawa R, Komura A, Nakamura M, et al.. Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified. J-Clin-Exp-Hematopathol. 2024;64 (1):52-58$52$YR$$M$Y$$$20240807$$HP$JP$JP
241826681$24182668$1$I$20180101$20240805$20240807$20240807$EXP$$FR-SANDOZ INC.-SDZ2024FR070623$SANDOZ$$51$YR$$F$Y$$$20240807$$LW$FR$FR
241826691$24182669$1$I$20200108$20240802$20240807$20240807$EXP$$CA-TAKEDA-2024TUS078829$TAKEDA$$58$YR$$M$Y$$$20240807$$CN$CA$CA
241826702$24182670$2$F$$20240806$20240807$20240812$EXP$$VN-SANDOZ INC.-SDZ2024VN070984$SANDOZ$Pham HBT, Nguyen LTH. VIEM THAN KINH THI THEO SAU VIEM NAO TUY LAN TOA CAP TINHO TRE EM LIEN QUAN KHANG THE ANTI-MOG: BAO CAO TRUONG HOP LAM SANG [A report of cases in children with anti-mog associated acute disseminated encephalomyelitis followed by optic neuritis (adem-on)]. VIETNAM MEDICAL JOURNAL. 2024;540 (1):3-10$9$YR$$M$Y$$$20240812$$HP$VN$VN
241826711$24182671$1$I$$20240726$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119327$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$109.86$KG$20240807$$PH$US$US
241826721$24182672$1$I$$20240731$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124263$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240807$$CN$US$US
241826731$24182673$1$I$20240805$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124219$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240807$$CN$US$US
241826742$24182674$2$F$20240731$20240807$20240807$20240813$EXP$$JP-ASTELLAS-2024JP005644$ASTELLAS$$82$YR$$M$Y$$$20240813$$MD$JP$JP
241826751$24182675$1$I$20231215$20240730$20240807$20240807$EXP$ES-AEMPS-1551405$ES-CHEPLA-2024009851$CHEPLAPHARM$$74$YR$$M$Y$$$20240807$$MD$COUNTRY NOT SPECIFIED$ES
241826762$24182676$2$F$20240801$20240829$20240807$20240831$PER$$US-AMGEN-USASP2024154405$AMGEN$$71$YR$E$$Y$$$20240831$$HP$US$US
241826781$24182678$1$I$$20240723$20240807$20240807$EXP$$ES-GLANDPHARMA-ES-2024GLNLIT00580$GLAND PHARMA$Maria Luisa Ales-Palmer.Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM.International Journal of Molecular Sciences .01-SEP-2023;24 (No. 17):1-17$1$YR$I$F$Y$$$20240807$$HP$ES$ES
241826792$24182679$2$F$$20240903$20240807$20240913$EXP$$US-ASTELLAS-2024EU007768$ASTELLAS$$$$E$M$Y$$$20240913$$CN$US$US
241826801$24182680$1$I$$20240804$20240807$20240807$EXP$$EG-ASTELLAS-2024US022190$ASTELLAS$$$$E$M$Y$$$20240807$$PH$EG$EG
241826822$24182682$2$F$$20240813$20240807$20240828$EXP$$JP-ASTELLAS-2024JP002668$ASTELLAS$$84$YR$E$M$Y$$$20240822$$HP$JP$JP
241826832$24182683$2$F$$20240805$20240807$20240808$EXP$$US-ASTELLAS-2024US022226$ASTELLAS$$$$$M$Y$$$20240808$$CN$US$US
241826841$24182684$1$I$$20240731$20240807$20240807$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009796$STRIDES$Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al.. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes.. Blood. 2023;142 (Suppl. 1):5898$$$A$$Y$$$20240807$$MD$US$US
241826861$24182686$1$I$$20240806$20240807$20240807$30DAY$$US-SANDOZ INC.-SDZ2024US071035$SANDOZ$$$$$F$Y$$$20240807$$HP$US$US
241826871$24182687$1$I$$20240801$20240807$20240807$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP009760$STRIDES$Srinivas SM, Gowda VK, Gowdra A, Gangasamudra Veerappa B, Kumar P.. Lack of association of Stevens-Johnson syndrome/toxic epidermal necrolysis due to aromatic anticonvulsants and HLA-B alleles in South Indian children. Int-J-Dermatol. 2024;63 (5):e97-e99$4$YR$$M$Y$$$20240807$$HP$IN$IN
241826881$24182688$1$I$$20240725$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038795$AUROBINDO$$16$YR$$M$Y$$$20240807$$PH$CA$CA
241826892$24182689$2$F$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0683094$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241826911$24182691$1$I$20240801$20240805$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US070715$SANDOZ$$46$YR$$F$Y$$$20240807$$CN$US$US
241826922$24182692$2$F$20240719$20240801$20240807$20240905$EXP$$DE-AstraZeneca-2024A178507$ASTRAZENECA$$71$YR$$F$Y$70$KG$20240905$$MD$DE$
241826931$24182693$1$I$$20240806$20240807$20240807$30DAY$$US-SANDOZ INC.-SDZ2024US071009$SANDOZ$$$$$M$Y$$$20240807$$CN$US$US
241826961$24182696$1$I$$20240801$20240807$20240807$EXP$$AE-ASTELLAS-2024EU007701$ASTELLAS$$5$YR$$F$Y$$$20240807$$MD$AE$AE
241826971$24182697$1$I$20240701$20240805$20240807$20240807$EXP$$RU-SANDOZ INC.-SDZ2024RU070553$SANDOZ$$$$$F$Y$55$KG$20240807$$MD$RU$RU
241826981$24182698$1$I$20240704$20240725$20240807$20240807$EXP$$DE-AUROBINDO-AUR-APL-2024-038028$AUROBINDO$$70$YR$$M$Y$70$KG$20240807$$MD$DE$DE
241826992$24182699$2$F$20240401$20240809$20240807$20240813$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095771$VIIV$$$$$$Y$$$20240813$$CN$US$US
241827001$24182700$1$I$$20240726$20240807$20240807$EXP$$SG-ROCHE-3579183$ROCHE$$45$YR$A$F$Y$$$20240807$$CN$SG$SG
241827021$24182702$1$I$20240101$20240722$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117658$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240807$$CN$US$US
241827041$24182704$1$I$20091211$20240802$20240807$20240807$EXP$$NZ-ASTELLAS-2024US022000$ASTELLAS$$58$YR$$M$Y$120$KG$20240807$$HP$GB$NZ
241827051$24182705$1$I$$20240802$20240807$20240807$EXP$$JP-ASTELLAS-2024JP005329$ASTELLAS$$79$YR$$M$Y$$$20240807$$PH$JP$JP
241827061$24182706$1$I$20240730$20240802$20240807$20240807$EXP$$JP-ASTELLAS-2024JP005637$ASTELLAS$$6$DEC$$M$Y$$$20240807$$PH$JP$JP
241827072$24182707$2$F$$20240802$20240807$20240812$EXP$$DE-ASTELLAS-2024EU007704$ASTELLAS$$$$A$M$Y$$$20240812$$CN$DE$DE
241827081$24182708$1$I$20240802$20240802$20240807$20240807$EXP$$US-ASTELLAS-2024US022101$ASTELLAS$$69$YR$$M$Y$$$20240807$$CN$US$US
241827091$24182709$1$I$$20240802$20240807$20240807$EXP$$KR-ASTELLAS-2024US021737$ASTELLAS$$$$E$$Y$$$20240807$$CN$KR$KR
241827101$24182710$1$I$$20240802$20240807$20240807$EXP$$JP-ASTELLAS-2024JP005648$ASTELLAS$$51$YR$$F$Y$$$20240807$$MD$JP$JP
241827111$24182711$1$I$20240701$20240805$20240807$20240807$PER$$US-JNJFOC-20240810212$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240807$$CN$US$US
241827121$24182712$1$I$$20240724$20240807$20240807$PER$$US-JNJFOC-20240772228$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240807$$CN$US$US
241827134$24182713$4$F$20240729$20240821$20240807$20240829$EXP$$US-ASTELLAS-2024US022154$ASTELLAS$$61$YR$A$M$Y$149$KG$20240823$$MD$US$US
241827141$24182714$1$I$$20240806$20240807$20240807$EXP$FR-Merck Healthcare KGaA-2024040762$FR-SANDOZ INC.-SDZ2024FR070922$SANDOZ$$90$YR$$F$Y$$$20240807$$MD$FR$FR
241827151$24182715$1$I$$20240730$20240807$20240807$EXP$$CA-Amarin Pharma, Inc-2024AMR000390$AMARIN$$65$YR$E$F$Y$$$20240807$$CN$CA$CA
241827162$24182716$2$F$$20240809$20240807$20240819$EXP$$GB-EMD Serono-2024041461$EMD SERONO INC$$51$YR$A$F$Y$$$20240819$$HP$GB$GB
241827171$24182717$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160530$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241827181$24182718$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160517$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241827201$24182720$1$I$$20240806$20240807$20240807$EXP$$NVSC2024GB160140$NOVARTIS$$$$$F$Y$$$20240807$$CN$GB$GB
241827211$24182721$1$I$$20240723$20240807$20240807$EXP$$US-GLANDPHARMA-US-2024GLNLIT00574$GLAND PHARMA$K Patel.Two cases of hepatoblastoma in Bohring-Opitz syndrome: An emerging association.Pediatric Blood and Cancer.JUL-2024;71: No. 7$2$YR$I$M$Y$$$20240807$$HP$US$US
241827221$24182722$1$I$$20230412$20240807$20240807$EXP$$US-AstraZeneca-2023A087348$ASTRAZENECA$$$$$M$Y$65.8$KG$20240807$$CN$US$
241827232$24182723$2$F$20240729$20240809$20240807$20240814$EXP$$US-ABBVIE-5868375$ABBVIE$$65$YR$$F$Y$56$KG$20240814$$CN$US$US
241827241$24182724$1$I$20230701$20240730$20240807$20240807$EXP$$SK-AstraZeneca-2024A174404$ASTRAZENECA$$24837$DY$$M$Y$$$20240807$$MD$SK$
241827251$24182725$1$I$$20240805$20240807$20240807$EXP$$GB-SANDOZ INC.-SDZ2024GB057357$SANDOZ$$$$$F$Y$$$20240807$$CN$GB$GB
241827261$24182726$1$I$$20220824$20240807$20240807$EXP$$US-AstraZeneca-2022A299879$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241827271$24182727$1$I$$20240801$20240807$20240807$EXP$$US-AstraZeneca-2024A176882$ASTRAZENECA$$$$$F$Y$56.7$KG$20240807$$CN$US$
241827281$24182728$1$I$$20220811$20240807$20240807$EXP$$US-AstraZeneca-2022A287170$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241827291$24182729$1$I$20231121$20240730$20240807$20240807$EXP$$FR-AstraZeneca-2024A177553$ASTRAZENECA$$4$MON$$F$Y$4.3$KG$20240807$$HP$FR$
241827301$24182730$1$I$$20240730$20240807$20240807$EXP$$CR-AstraZeneca-2024A174515$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$CR$
241827321$24182732$1$I$20230101$20240801$20240807$20240807$EXP$$NVSC2023BR029768$NOVARTIS$$65$YR$$F$Y$$$20240807$$CN$BR$BR
241827331$24182733$1$I$$20240805$20240807$20240807$PER$$US-TAKEDA-2024TUS078852$TAKEDA$$39$YR$$F$Y$$$20240807$$PH$US$US
241827341$24182734$1$I$20240731$20240731$20240807$20240807$EXP$$JP-ASTELLAS-2024JP005565$ASTELLAS$$7$DEC$$M$Y$$$20240807$$PH$JP$JP
241827351$24182735$1$I$$20240731$20240807$20240807$EXP$$JP-ASTELLAS-2024JP005578$ASTELLAS$Watanabe S, Yano M, Aoki R, Yagi Y, Kashiwagi K, Maezawa M, et al. A case of secondary membranoproliferative glomerulonephritis caused by hepatic vein stenosis after liver transplantation. Japanese journal of pediatric nephrology. 2024;37:1-7$8$YR$$M$Y$20.9$KG$20240807$$MD$JP$JP
241827361$24182736$1$I$$20240729$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005600$BIOCON$$$$$$Y$$$20240807$$HP$CA$CA
241827371$24182737$1$I$$20231101$20240807$20240807$EXP$$TR-SANDOZ INC.-SDZ2023TR050529$SANDOZ$$$$$$Y$$$20240807$$CN$TR$TR
241827381$24182738$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156095$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241827391$24182739$1$I$20240802$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154666$AMGEN$$74$YR$E$F$Y$$$20240807$$CN$US$US
241827401$24182740$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156170$AMGEN$$$$$$Y$$$20240807$$CN$US$US
241827411$24182741$1$I$$20240725$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-039315$AUROBINDO$$76$YR$$M$Y$$$20240807$$HP$CA$CA
241827421$24182742$1$I$$20240803$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US070743$SANDOZ$$$$$F$Y$$$20240807$$CN$US$US
241827432$24182743$2$F$20240802$20240909$20240807$20240910$PER$$US-AMGEN-USASP2024154412$AMGEN$$44$YR$A$F$Y$$$20240910$$CN$US$US
241827441$24182744$1$I$$20240801$20240807$20240807$EXP$$JP-ASTELLAS-2024JP005604$ASTELLAS$$85$YR$$M$Y$$$20240807$$PH$JP$JP
241827453$24182745$3$F$$20240806$20240807$20240809$EXP$$GB-SANDOZ INC.-SDZ2024GB070276$SANDOZ$$$$$F$Y$$$20240809$$CN$GB$GB
241827472$24182747$2$F$20240718$20240910$20240807$20240918$EXP$$JP-ASTELLAS-2024JP005586$ASTELLAS$$89$YR$E$M$Y$$$20240918$$MD$JP$JP
241827481$24182748$1$I$$20240724$20240807$20240807$PER$$US-JNJFOC-20240770991$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
241827491$24182749$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2019-019773$AUROBINDO$$55$YR$$M$Y$82$KG$20240807$$HP$CA$CA
241827502$24182750$2$F$$20240819$20240807$20240822$EXP$$IT-SANDOZ INC.-NVSC2020IT109480$SANDOZ$$24$YR$$F$Y$$$20240822$$MD$IT$IT
241827511$24182751$1$I$$20240806$20240807$20240807$PER$$US-HALEON-2190749$Haleon PLC$$$$$$Y$$$20240807$$CN$US$US
241827521$24182752$1$I$20231201$20240727$20240807$20240807$EXP$$US-AMICUS THERAPEUTICS, INC.-AMI_3281$AMICUS THERAPEUTICS$$$$$M$Y$$$20240807$$CN$US$US
241827531$24182753$1$I$$20240723$20240807$20240807$EXP$$KR-GLANDPHARMA-KR-2024GLNLIT00583$GLAND PHARMA$$79$YR$E$M$Y$$$20240807$$HP$KR$KR
241827541$24182754$1$I$$20240728$20240807$20240807$EXP$$US-AMAROX PHARMA-HET2024US02612$HETERO$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024;1-6$$$I$F$Y$$$20240807$$MD$US$US
241827551$24182755$1$I$$20240730$20240807$20240807$EXP$$AU-CELLTRION INC.-2024AU018507$CELLTRION$$$$$$Y$$$20240807$$HP$AU$AU
241827582$24182758$2$F$20240801$20240807$20240807$20240808$PER$$US-AMGEN-USASP2024156493$AMGEN$$82$YR$E$F$Y$$$20240808$$CN$US$US
241827591$24182759$1$I$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0683095$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241827601$24182760$1$I$20230627$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037946$AUROBINDO$$61$YR$$F$Y$61$KG$20240807$$PH$GB$GB
241827611$24182761$1$I$20240603$20240725$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-037691$AUROBINDO$$81$YR$$F$Y$67.2$KG$20240807$$PH$FR$FR
241827623$24182762$3$F$20100806$20240815$20240807$20240829$EXP$$NZ-ASTELLAS-2024US021944$ASTELLAS$$72$YR$E$M$Y$69$KG$20240821$$CN$NZ$NZ
241827633$24182763$3$F$20240801$20240903$20240807$20240909$EXP$$FR-ASTELLAS-2024US022038$ASTELLAS$$50$YR$A$M$Y$$$20240909$$PH$FR$FR
241827642$24182764$2$F$20240401$20240918$20240807$20240924$EXP$$JP-ASTELLAS-2024JP005432$ASTELLAS$$61$YR$A$M$Y$$$20240924$$PH$JP$JP
241827651$24182765$1$I$20240704$20240801$20240807$20240807$EXP$$US-ASTELLAS-2024US022156$ASTELLAS$$24$YR$$F$Y$$$20240807$$CN$US$US
241827662$24182766$2$F$20230620$20240828$20240807$20240906$EXP$$JP-ASTELLAS-2023JP007865$ASTELLAS$$8$DEC$E$M$Y$$$20240906$$MD$JP$JP
241827671$24182767$1$I$20240701$20240724$20240807$20240807$EXP$$US-UCBSA-2024037679$UCB$$69$YR$$F$Y$$$20240807$$HP$US$US
241827681$24182768$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156053$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241827691$24182769$1$I$$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024153843$AMGEN$$$$$F$Y$$$20240807$$MD$US$US
241827701$24182770$1$I$20240328$20240801$20240807$20240807$EXP$$CA-GSK-CA2021AMR135514$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$CA$CA
241827711$24182771$1$I$$20240731$20240807$20240807$EXP$$US-GSK-US2024095772$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$HP$US$US
241827721$24182772$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123857$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240807$$HP$US$US
241827731$24182773$1$I$$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124325$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240807$$CN$US$US
241827742$24182774$2$F$$20240808$20240807$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117799$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240809$$CN$US$US
241827751$24182775$1$I$20240701$20240729$20240807$20240807$EXP$$US-JNJFOC-20240778619$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$US$US
241827761$24182776$1$I$$20240729$20240807$20240807$30DAY$$GB-JNJFOC-20240813265$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$GB$GB
241827772$24182777$2$F$20240101$20240809$20240807$20240822$EXP$$US-INSMED, INC.-2024-00891-US$INSMED$$$$$M$Y$$$20240822$$CN$US$US
241827791$24182779$1$I$$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-036511$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L.. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:1-6$33$YR$$F$Y$$$20240807$$HP$FR$FR
241827802$24182780$2$F$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0683128$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241827811$24182781$1$I$$20240729$20240807$20240807$PER$$US-ABBVIE-5860976$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241827821$24182782$1$I$20201123$20240730$20240807$20240807$EXP$PL-URPL-1-4248-2020$PL-TEVA-VS-3228329$TEVA$$19$YR$$F$Y$70$KG$20240807$$MD$PL$PL
241827831$24182783$1$I$$20240726$20240807$20240807$EXP$$PL-AUROBINDO-AUR-APL-2024-038334$AUROBINDO$Jarocki M, Florek K, Wietrzyk W, Modrzejewska K, Kuliczkowski W, Blaziak M. Eisenmenger syndrome complicated by the presence of an aneurysm of the pulmonary trunk and compression of the left main coronary artery. Postepy w Kardiologii Interwencyjnej$45$YR$$F$Y$$$20240807$$HP$PL$PL
241827841$24182784$1$I$20240728$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003187$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240807$$CN$US$US
241827861$24182786$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003241$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240807$$CN$US$US
241827871$24182787$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002240$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240807$$CN$US$US
241827881$24182788$1$I$20240802$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002967$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240807$$CN$US$US
241827891$24182789$1$I$20240804$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003025$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240807$$CN$US$US
241827901$24182790$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002842$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240807$$CN$US$US
241827911$24182791$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002958$ELI LILLY AND CO$$$$$$Y$$$20240807$$MD$US$US
241827921$24182792$1$I$20240501$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002982$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240807$$CN$US$US
241827931$24182793$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003039$ELI LILLY AND CO$$$$$$Y$$$20240807$$MD$US$US
241827941$24182794$1$I$$20240726$20240807$20240807$EXP$$US-ASTELLAS-2024US021511$ASTELLAS$$10$DEC$$F$Y$$$20240807$$MD$US$US
241827961$24182796$1$I$$20240731$20240807$20240807$30DAY$$US-GSK-US2024095823$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241827971$24182797$1$I$20240722$20240730$20240807$20240807$30DAY$$US-GSK-US2024095294$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240807$$CN$US$US
241827981$24182798$1$I$$20240802$20240807$20240807$30DAY$$US-GSK-US2024097020$GLAXOSMITHKLINE$$$$$M$Y$$$20240807$$CN$US$US
241827991$24182799$1$I$$20240730$20240807$20240807$EXP$$US-ASTELLAS-2024US021797$ASTELLAS$$64$YR$$F$Y$$$20240807$$HP$US$US
241828001$24182800$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-039003$AUROBINDO$$$$$F$Y$$$20240807$$CN$CA$CA
241828011$24182801$1$I$$20240730$20240807$20240807$EXP$$HN-ASTELLAS-2024US021900$ASTELLAS$$$$$M$Y$$$20240807$$CN$CL$HN
241828021$24182802$1$I$$20240730$20240807$20240807$EXP$$US-ASTELLAS-2024US021795$ASTELLAS$$84$YR$$M$Y$$$20240807$$CN$US$US
241828031$24182803$1$I$$20240730$20240807$20240807$EXP$$DE-ASTELLAS-2024US021956$ASTELLAS$$77$YR$$M$Y$53$KG$20240807$$CN$DE$DE
241828041$24182804$1$I$$20240806$20240807$20240807$PER$$US-GILEAD-2024-0683216$GILEAD$$5$DEC$A$F$Y$$$20240807$$MD$US$US
241828051$24182805$1$I$20240722$20240729$20240807$20240807$PER$$US-ABBVIE-5861759$ABBVIE$$45$YR$$F$Y$$$20240807$$CN$US$US
241828061$24182806$1$I$20240126$20240731$20240807$20240807$EXP$$US-ASTELLAS-2024US021889$ASTELLAS$$$$$M$Y$$$20240807$$HP$US$US
241828072$24182807$2$F$$20240726$20240807$20240808$EXP$GB-MHRA-MED-202407261611297380-YCDKF$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-110389$ZYDUS PHARM$$$$$$Y$$$20240808$$MD$GB$GB
241828083$24182808$3$F$$20240827$20240807$20240906$EXP$$CN-ASTELLAS-2024US021995$ASTELLAS$Tang M, Liu L. Syndrome of inappropriate anti-diuretic hormone secretion secondary to disseminated strongyloidiasis in a kidney transplant recipient A case report. Heliyon. 2024;10(13): 1-4. doi:10.1016/j.heliyon.2024.e33978.$43$YR$A$M$Y$$$20240906$$HP$CN$CN
241828092$24182809$2$F$20230324$20240830$20240807$20240911$EXP$$JP-ASTELLAS-2024JP005605$ASTELLAS$$5$YR$C$M$Y$$$20240911$$HP$JP$JP
241828101$24182810$1$I$$20240731$20240807$20240807$EXP$$TH-ASTELLAS-2024US021907$ASTELLAS$$$$A$$Y$50$KG$20240807$$CN$TH$TH
241828112$24182811$2$F$$20240824$20240807$20240904$EXP$$US-ASTELLAS-2024EU007652$ASTELLAS$$93$YR$E$M$Y$$$20240904$$CN$US$US
241828121$24182812$1$I$$20240801$20240807$20240807$EXP$$CA-JNJFOC-20231009782$JOHNSON AND JOHNSON$$$$$M$Y$90$KG$20240807$$HP$CA$CA
241828131$24182813$1$I$$20240731$20240807$20240807$EXP$$CN-JNJFOC-20240783582$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$MD$CN$CN
241828141$24182814$1$I$20240601$20240802$20240807$20240807$EXP$$CA-JNJFOC-20240808411$JOHNSON AND JOHNSON$$10$YR$C$F$Y$$$20240807$$HP$CA$CA
241828151$24182815$1$I$$20240731$20240807$20240807$PER$$US-JNJFOC-20240784981$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240807$$HP$US$US
241828171$24182817$1$I$$20240801$20240807$20240807$PER$$US-TAKEDA-2024TUS077982$TAKEDA$$$$$M$Y$118$KG$20240807$$MD$US$US
241828192$24182819$2$F$$20240809$20240807$20240812$PER$$US-AMGEN-USASP2024155922$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
241828201$24182820$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156075$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241828212$24182821$2$F$$20240805$20240807$20240811$PER$$US-AMGEN-USASP2024155288$AMGEN$$$$$F$Y$$$20240811$$CN$US$US
241828221$24182822$1$I$$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154797$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241828231$24182823$1$I$20240731$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154809$AMGEN$$92$YR$E$F$Y$$$20240807$$CN$US$US
241828242$24182824$2$F$20221028$20240912$20240807$20240920$EXP$$JP-AMGEN-JPNSP2023144769$AMGEN$$71$YR$E$F$Y$$$20240920$$MD$JP$JP
241828251$24182825$1$I$20200101$20240730$20240807$20240807$EXP$PT-INFARMED-R202407-420$PT-TEVA-VS-3228288$TEVA$$65$YR$$M$Y$70$KG$20240807$$MD$PT$PT
241828261$24182826$1$I$$20240725$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038725$AUROBINDO$Youykheang M, Hallaq ZA, Menelas K, Biskin RS, Dagenais-Beaule V.. Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders-A Systematic Review of the Literature and Case Series.. J Clin Psychopharmacol. 2023;43(1):20-27$37$YR$$F$Y$$$20240807$$PH$CA$CA
241828271$24182827$1$I$$20240730$20240807$20240807$EXP$$JP-AstraZeneca-2024A174954$ASTRAZENECA$Ito Y, et al.. EP-0290 Current status and issues of BRCA test for patients eligible for the administraiton of olaparib in the postoperative treatment. The 32nd Annual Meeting of the Japanese Breast Cancer Society 2024;250.$$$A$$Y$$$20240807$$MD$JP$
241828281$24182828$1$I$$20240729$20240807$20240807$EXP$$CA-Orion Corporation ORION PHARMA-24_00031127$ORION$Aboguddah A, Stein H. Herpes simplex hepatitis in a patient with psoriatic arthritis taking prednisone and methotrexate. Report and review of the literature. J Rheumatol. 1991 SEP;18(9):1406-12.$43$YR$A$F$Y$$$20240807$$MD$CA$
241828291$24182829$1$I$20230321$20240730$20240807$20240807$EXP$$KR-AstraZeneca-2024A173299$ASTRAZENECA$$830$MON$$F$Y$$$20240807$$MD$KR$
241828311$24182831$1$I$$20240730$20240807$20240807$EXP$$US-AstraZeneca-2024A174087$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241828321$24182832$1$I$20240709$20240730$20240807$20240807$EXP$$DE-AstraZeneca-2024A172752$ASTRAZENECA$$85$YR$$M$Y$68$KG$20240807$$MD$DE$
241828331$24182833$1$I$$20240802$20240807$20240807$PER$$US-ALXN-202408USA000158US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241828342$24182834$2$F$$20240829$20240807$20240903$EXP$$CA-AstraZeneca-2024A176492$ASTRAZENECA$$70$YR$$F$Y$66$KG$20240903$$MD$CA$
241828351$24182835$1$I$20231201$20240726$20240807$20240807$EXP$$CA-AstraZeneca-2024A171176$ASTRAZENECA$$830$MON$$F$Y$$$20240807$$CN$CA$
241828362$24182836$2$F$$20240812$20240807$20240820$EXP$$US-TEVA-VS-3228065$TEVA$: Behbahani-Nejad N, Palepu R, Kotha A, Nayef HA. Fentanyl-Induced Wooden Chest Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209.; Behbahani-Nejad N, Palepu R, Kotha A, Nayef HA. Fentanyl-Induced Wooden Chest Syndrome. Am-J-Respir-Crit-Care-Med 2024; 209.$30$YR$$F$Y$$$20240820$$HP$US$US
241828371$24182837$1$I$20180727$20240727$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-038073$AUROBINDO$$31$YR$$M$Y$79$KG$20240807$$CN$GB$GB
241828383$24182838$3$F$$20240920$20240807$20240920$PER$$NVSC2024US158253$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
241828391$24182839$1$I$$20240730$20240807$20240807$30DAY$$US-GSK-US2024095425$GLAXOSMITHKLINE$$$$$M$Y$$$20240807$$CN$US$US
241828401$24182840$1$I$20231101$20240731$20240807$20240807$EXP$$CA-CELLTRION INC.-2023CA021715$CELLTRION$$$$$$Y$$$20240807$$HP$CA$CA
241828411$24182841$1$I$$20240806$20240807$20240807$30DAY$$US-SANDOZ INC.-SDZ2024US070991$SANDOZ$$$$$$Y$$$20240807$$CN$US$US
241828421$24182842$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155293$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241828431$24182843$1$I$$20240723$20240807$20240807$EXP$$US-GLANDPHARMA-US-2024GLNLIT00587$GLAND PHARMA$Erin A. Dean.Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report.Case Reports in Oncology.09-JAN-2024;17 (No. 1):75-81$64$YR$A$F$Y$$$20240807$$HP$US$US
241828441$24182844$1$I$20240408$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-038164$AUROBINDO$$53$YR$$M$Y$$$20240807$$MD$FR$FR
241828451$24182845$1$I$20240730$20240802$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122959$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240807$$CN$US$US
241828461$24182846$1$I$$20231019$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2023US045294$SANDOZ$$$$$$Y$$$20240807$$CN$US$US
241828481$24182848$1$I$$20240724$20240807$20240807$EXP$GB-MHRA-TPP19250208C9433810YC1721401337492$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-16820$ALKEM$$69$YR$$M$Y$64$KG$20240807$$MD$GB$GB
241828502$24182850$2$F$$20240802$20240807$20240813$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17044$ALKEM$Ning X, Rahman W, Malek R.. Medical management of primary hyperparathyroidism in pregnancy: a case report and brief literature review. J Endocrinol Metab. 2020;10(2):49-53$$$$F$Y$$$20240813$$HP$US$US
241828512$24182851$2$F$$20240802$20240807$20240813$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17045$ALKEM$Ning X, Rahman W, Malek R.. Medical management of primary hyperparathyroidism in pregnancy: a case report and brief literature review. J Endocrinol Metab. 2020;10(2):49-53$$$N$$Y$$$20240813$$HP$US$US
241828522$24182852$2$F$$20240805$20240807$20240820$EXP$TR-MLMSERVICE-20240716-PI133858-00306-1$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-17152$ALKEM$Kaynar K, Ertekin T, Ureyener GE, Mungan S, Abuhadwan H.. Hodgkin lymphoma in a patient with kidney transplantation. Nefrologia. 2024;44(4):582-613$35$YR$$M$Y$$$20240820$$MD$TR$TR
241828531$24182853$1$I$$20240724$20240807$20240807$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-16788$ALKEM$$73$YR$$F$Y$$$20240807$$HP$AU$AU
241828541$24182854$1$I$$20240724$20240807$20240807$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17139$ALKEM$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D.. Rhabdomyolysis Risk: The Dangers of Tribulus Terrestris, an Over-the-Counter Supplement. Am J Case Rep. 2024;25:e943492$71$YR$$M$Y$$$20240807$$HP$US$US
241828551$24182855$1$I$$20240724$20240807$20240807$EXP$AU-MLMSERVICE-20221215-3958774-1$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-17151$ALKEM$Timmons P, Williamson A, Gibbs V, Torgersen A.. Weak legs. Acute medicine. 2022;21(3):153-6$48$YR$$F$Y$$$20240807$$MD$AU$AU
241828561$24182856$1$I$$20240724$20240807$20240807$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-16787$ALKEM$$$$$M$Y$$$20240807$$HP$AU$AU
241828571$24182857$1$I$$20240724$20240807$20240807$EXP$IN-MLMSERVICE-20240709-PI127049-00306-1$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-16059$ALKEM$Sivagnanam H, Kumar PK, Palaniselvam S, Viswanathan R.. Two-Year Follow-up of Necrotic Herpetic Retinopathy in a Renal Transplant Recipient.. Indian Journal of Transplantation. 2024;18(2):184-188$32$YR$$M$Y$$$20240807$$MD$IN$IN
241828581$24182858$1$I$$20240724$20240807$20240807$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-16786$ALKEM$$$$$M$Y$$$20240807$$HP$AU$AU
241828591$24182859$1$I$20230101$20240724$20240807$20240807$EXP$CN-MLMSERVICE-20240709-PI127400-00202-1$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-16120$ALKEM$Liu W, Yang L, Qin H, Zhang P.. Successful Treatment of Intractable Tuberculous Peritonitis in a Woman with Chronic Kidney Allograft Dysfunction Using Contezolid Containing Regimen. Infection and Drug Resistance. 2024;17:2713-2718$54$YR$$F$Y$40$KG$20240807$$HP$CN$CN
241828601$24182860$1$I$$20240730$20240807$20240807$EXP$$CA-CELLTRION INC.-2024CA002645$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
241828611$24182861$1$I$$20240724$20240807$20240807$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-16822$ALKEM$$50$YR$$F$Y$$$20240807$$HP$AU$AU
241828632$24182863$2$F$$20240729$20240807$20240810$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01161$AIMMUNE$$$$$$Y$$$20240810$$MD$US$US
241828641$24182864$1$I$20240723$20240801$20240807$20240807$30DAY$$US-GSK-US2024096311$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240807$$HP$US$US
241828651$24182865$1$I$$20240802$20240807$20240807$30DAY$$US-GSK-US2024097024$GLAXOSMITHKLINE$$36$YR$$F$Y$$$20240807$$HP$US$US
241828661$24182866$1$I$$20240731$20240807$20240807$EXP$$US-GSK-US2024AMR097317$GLAXOSMITHKLINE$$$$$M$Y$$$20240807$$HP$US$US
241828671$24182867$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-037560$AUROBINDO$Bassett AS, Reyes NG, Bendahan N, Swinkin E, Lang AE. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome.. Neurological sciences : official journal of the Italian Neurological Society and. 2024$49$YR$$F$Y$$$20240807$$MD$CA$CA
241828682$24182868$2$F$$20240822$20240807$20240903$EXP$$US-AUROBINDO-AUR-APL-2024-038506$AUROBINDO$$67$YR$$F$Y$$$20240903$$PH$US$US
241828691$24182869$1$I$$20240803$20240807$20240807$PER$$NVSC2024US159260$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
241828701$24182870$1$I$20240620$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-037694$AUROBINDO$$73$YR$$M$Y$$$20240807$$PH$FR$FR
241828721$24182872$1$I$$20240731$20240807$20240807$EXP$$JP-CHEPLA-2024010156$CHEPLAPHARM$$$$$$Y$$$20240807$$PH$COUNTRY NOT SPECIFIED$JP
241828731$24182873$1$I$$20240729$20240807$20240807$PER$$US-ABBVIE-5860341$ABBVIE$$$$$$Y$$$20240807$$HP$US$US
241828742$24182874$2$F$20240501$20240904$20240807$20240910$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090850$VIIV$$66$YR$$F$Y$$$20240910$$PH$US$US
241828751$24182875$1$I$20240619$20240726$20240807$20240807$EXP$$IT-AUROBINDO-AUR-APL-2024-038317$AUROBINDO$$51$YR$$M$Y$$$20240807$$PH$IT$IT
241828761$24182876$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-037620$AUROBINDO$Reyes NG, Bendahan N, Swinkin E, Lang AE, Bassett AS.. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome.. Neurological sciences :official journal of the Italian Neurological Society. 2024$53$YR$$F$Y$$$20240807$$MD$CA$CA
241828771$24182877$1$I$$20240805$20240807$20240807$PER$$US-JNJFOC-20240811198$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
241828781$24182878$1$I$$20240802$20240807$20240807$EXP$$NL-AMGEN-NLDSP2024154649$AMGEN$Boer J.M.; Ilan U.; Boeree A. et al.. Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTBER study experience. HemaSphere. 2024;8 (7):1-13$$$$$Y$$$20240807$$HP$NL$NL
241828791$24182879$1$I$20240802$20240805$20240807$20240807$PER$$US-ROCHE-10000049754$ROCHE$$$$$$Y$$$20240807$$PH$US$US
241828811$24182881$1$I$$20240710$20240807$20240807$PER$$US-009507513-2407USA006102$MERCK$Denton J, Ozgur H, Sazegar P, Galgiani J, Riaz T. Musculoskeletal and CNS coccidiomycosis in an individual with multiple sclerosis on fingolimod - A case report. IDCases. 2024;37$56$YR$$F$Y$$$20240807$$HP$US$US
241828821$24182882$1$I$20240711$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154663$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241828831$24182883$1$I$$20240226$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2024CN021014$SANDOZ$Jia Jin, Yalan Wang, Xi Wang, Yonghong Tang, Shan Zeng, Juan Du, Junning Cao. Zanubrutinib Combined with R-CHOP in Previously Untreated Non-Germinal Center B-Cell (GCB) Diffuse Large B-Cell Lymphoma (DLBCL) Patients with BCL2 and MYC Protein Co-Expression: A Multicenter, Phase II Study. Blood. 2023;142:4468-4469$$$$$Y$$$20240807$$HP$CN$CN
241828841$24182884$1$I$$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154985$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241828852$24182885$2$F$$20240802$20240807$20240812$PER$$US-AMGEN-USASP2024154730$AMGEN$$$$$$Y$$$20240812$$HP$US$US
241828862$24182886$2$F$20230101$20240822$20240807$20240905$EXP$$CA-UCBSA-2023053919$UCB$$$$$F$Y$$$20240905$$CN$CA$CA
241828873$24182887$3$F$$20240827$20240807$20240909$PER$$US-ALXN-202408USA000116US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
241828891$24182889$1$I$$20240801$20240807$20240807$PER$$US-ABBVIE-5866014$ABBVIE$$$$$$Y$$$20240807$$HP$US$US
241828901$24182890$1$I$$20240730$20240807$20240807$30DAY$$US-GSK-US2024095378$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241828911$24182891$1$I$$20240802$20240807$20240807$30DAY$$US-GSK-US2024097034$GLAXOSMITHKLINE$$$$$M$Y$$$20240807$$CN$US$US
241828922$24182892$2$F$$20240909$20240807$20240916$EXP$$US-EMD Serono-2024041071$EMD SERONO INC$$$$A$F$Y$60$KG$20240916$$HP$US$US
241828931$24182893$1$I$20240101$20240726$20240807$20240807$EXP$$DE-AUROBINDO-AUR-APL-2024-038399$AUROBINDO$$69$YR$$F$Y$$$20240807$$MD$DE$DE
241828941$24182894$1$I$20240708$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-038268$AUROBINDO$$93$YR$$F$Y$68$KG$20240807$$PH$FR$FR
241828951$24182895$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050399$ROCHE$$$$$F$Y$$$20240807$$CN$US$US
241828962$24182896$2$F$$20240903$20240807$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124336$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240905$$CN$US$US
241828972$24182897$2$F$$20240911$20240807$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124484$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$72.12$KG$20240912$$CN$US$US
241828981$24182898$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123987$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240807$$HP$US$US
241828991$24182899$1$I$20240805$20240807$20240807$20240807$PER$$US-AMGEN-USASP2024155907$AMGEN$$64$YR$A$F$Y$$$20240807$$CN$US$US
241829001$24182900$1$I$20240806$20240806$20240807$20240807$PER$$US-AMGEN-USASP2024156473$AMGEN$$$$$M$Y$$$20240807$$CN$US$US
241829011$24182901$1$I$$20240228$20240807$20240807$EXP$GB-MHRA-MED-202401101538269760-CZQMF$GB-SANDOZ INC.-SDZ2024GB021548$SANDOZ$$$$$$Y$$$20240807$$PH$GB$GB
241829032$24182903$2$F$$20240724$20240807$20240808$EXP$$HU-UCBSA-2024038516$UCB$$$$$$Y$$$20240808$$MD$HU$HU
241829041$24182904$1$I$$20240802$20240807$20240807$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-106038$REGENERON$$$$$F$Y$$$20240807$$CN$US$US
241829061$24182906$1$I$$20240730$20240807$20240807$EXP$$AU-CELLTRION INC.-2024AU018522$CELLTRION$$$$$$Y$$$20240807$$HP$AU$AU
241829071$24182907$1$I$$20240730$20240807$20240807$EXP$$US-AstraZeneca-2024A173731$ASTRAZENECA$$$$$F$Y$73$KG$20240807$$CN$US$
241829081$24182908$1$I$$20240730$20240807$20240807$EXP$$VN-AstraZeneca-2024A176253$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$VN$
241829092$24182909$2$F$$20240819$20240807$20240821$EXP$$DE-AstraZeneca-2024A175867$ASTRAZENECA$$$$A$M$Y$$$20240821$$MD$DE$
241829101$24182910$1$I$20240401$20240726$20240807$20240807$EXP$$FR-AUROBINDO-AUR-APL-2024-038114$AUROBINDO$$66$YR$$M$Y$$$20240807$$MD$FR$FR
241829131$24182913$1$I$$20220720$20240807$20240807$EXP$$CA-AstraZeneca-2022A216151$ASTRAZENECA$$$$$M$Y$$$20240807$$MD$CA$
241829141$24182914$1$I$20240717$20240802$20240807$20240807$EXP$$US-AstraZeneca-2024A176844$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241829151$24182915$1$I$$20211101$20240807$20240807$EXP$$US-AstraZeneca-2021A792596$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241829161$24182916$1$I$$20240726$20240807$20240807$EXP$$US-MACLEODS PHARMA-MAC2024048589$MACLEODS$$73$YR$E$F$Y$52.16$KG$20240807$$CN$US$US
241829171$24182917$1$I$$20240726$20240807$20240807$EXP$$US-MACLEODS PHARMA-MAC2024048590$MACLEODS$$$$$$Y$$$20240807$$CN$US$US
241829181$24182918$1$I$$20240726$20240807$20240807$EXP$GB-MHRA-MED-202407261520428400-HWMCJ$GB-MACLEODS PHARMA-MAC2024048623$MACLEODS$$$$$$Y$$$20240807$$HP$GB$GB
241829191$24182919$1$I$20240704$20240726$20240807$20240807$EXP$GB-MHRA-MED-202407261545577700-MVBWC$GB-MACLEODS PHARMA-MAC2024048626$MACLEODS$$$$$$Y$$$20240807$$CN$GB$GB
241829201$24182920$1$I$$20240726$20240807$20240807$EXP$$CA-MACLEODS PHARMA-MAC2024048605$MACLEODS$Reyes NG, Bendahan N, Swinkin E, Lang AE, Bassett AS..Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome.Neurological Sciences..2024$4$DEC$A$F$Y$$$20240807$$MD$CA$CA
241829211$24182921$1$I$$20240726$20240807$20240807$EXP$GB-MHRA-MED-202407261307507540-CDNYM$GB-MACLEODS PHARMA-MAC2024048616$MACLEODS$$$$$$Y$$$20240807$$PH$GB$GB
241829221$24182922$1$I$20240101$20240802$20240807$20240807$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-106252$REGENERON$$$$$F$Y$$$20240807$$CN$US$US
241829231$24182923$1$I$20240429$20240726$20240807$20240807$EXP$$GB-MACLEODS PHARMA-MAC2024048636$MACLEODS$$$$$$Y$$$20240807$$HP$GB$GB
241829241$24182924$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003337$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240807$$CN$US$US
241829261$24182926$1$I$20240804$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002969$ELI LILLY AND CO$$40$YR$A$$Y$$$20240807$$CN$US$US
241829271$24182927$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003026$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241829281$24182928$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003071$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241829291$24182929$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003299$ELI LILLY AND CO$$65$YR$E$$Y$$$20240807$$MD$US$US
241829301$24182930$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003055$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240807$$CN$US$US
241829311$24182931$1$I$20240805$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003366$ELI LILLY AND CO$$76$YR$E$$Y$$$20240807$$CN$US$US
241829321$24182932$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050847$ROCHE$$$$A$M$Y$$$20240807$$CN$US$US
241829332$24182933$2$F$20240623$20240730$20240807$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407001329$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240809$$CN$US$US
241829341$24182934$1$I$$20240801$20240807$20240807$EXP$$NVSC2024GB158611$NOVARTIS$$$$$F$Y$$$20240807$$CN$GB$GB
241829361$24182936$1$I$$20240805$20240807$20240807$PER$$US-ABBVIE-5869497$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241829371$24182937$1$I$20240630$20240806$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US070992$SANDOZ$$76$YR$$F$Y$$$20240807$$HP$US$US
241829391$24182939$1$I$$20240731$20240807$20240807$EXP$$AU-EMD Serono-2024041574$EMD SERONO INC$$$$A$F$Y$$$20240807$$CN$AU$AU
241829401$24182940$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160644$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241829411$24182941$1$I$$20240709$20240807$20240807$PER$$US-JNJFOC-20240812657$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240807$$CN$US$US
241829421$24182942$1$I$20240727$20240728$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-038095$AUROBINDO$$$$$F$Y$$$20240807$$CN$GB$GB
241829431$24182943$1$I$$20240729$20240807$20240807$EXP$$US-APOTEX-2024AP009038$APOTEX$Abdelsalam M, Sleem M, Islam A. High dose dexamethasone for edema associated with brain tumor leading to acute sigmoid diverticular perforation. The American Journal of the Medical Sciences. 2024;367 (S1):S41$65$YR$$F$Y$$$20240807$$HP$US$US
241829441$24182944$1$I$20120101$20240805$20240807$20240807$PER$$US-JNJFOC-20240813796$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240807$$HP$US$US
241829451$24182945$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160540$NOVARTIS$$$$$F$Y$$$20240807$$HP$US$US
241829461$24182946$1$I$$20231025$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2023US047707$SANDOZ$$$$$$Y$$$20240807$$HP$US$US
241829471$24182947$1$I$$20240730$20240807$20240807$30DAY$$US-GSK-US2024AMR095621$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241829492$24182949$2$F$$20240806$20240807$20240816$EXP$$US-GSK-US2024AMR096889$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
241829501$24182950$1$I$$20240802$20240807$20240807$30DAY$$US-GSK-US2024097036$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240807$$CN$US$US
241829511$24182951$1$I$$20240730$20240807$20240807$30DAY$$US-GSK-US2024095409$GLAXOSMITHKLINE$$$$$M$Y$$$20240807$$CN$US$US
241829521$24182952$1$I$$20240729$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123197$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$51.26$KG$20240807$$HP$US$US
241829534$24182953$4$F$$20240919$20240807$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124578$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240927$$CN$US$US
241829542$24182954$2$F$$20240827$20240807$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124004$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240830$$CN$US$US
241829551$24182955$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124235$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$129.27$KG$20240807$$CN$US$US
241829561$24182956$1$I$20240501$20240718$20240807$20240807$PER$$US-TEVA-VS-3226252$TEVA$$34$YR$$F$Y$81.65$KG$20240807$$CN$US$US
241829581$24182958$1$I$$20240726$20240807$20240807$PER$$US-JNJFOC-20240775970$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$US$US
241829631$24182963$1$I$$20240522$20240806$20240806$DIR$FDA-CDER-CTU-2024-53977$$FDA-CTU$$$$$$N$$$20240522$N$$US$
241829664$24182966$4$F$20240720$20240812$20240807$20240818$PER$$US-AMGEN-USASP2024155290$AMGEN$$82$YR$E$F$Y$$$20240818$$CN$US$US
241829671$24182967$1$I$20240716$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154569$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241829681$24182968$1$I$$20240228$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2024CN020810$SANDOZ$Zhao A, Wang L, Wang J, Wang X, Liu Z ,Kuang P et al.. Herombopag, a Second Generation Thrombopoietin-Receptor Agonist, Stimulates Platelet Engraftment after Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 2023;142(1):6957 -58$$$$$Y$$$20240807$$HP$CN$CN
241829692$24182969$2$F$$20240812$20240807$20240822$EXP$$GB-TEVA-VS-3229892$TEVA$Javed A, Fatima A. An unexpected case of cryoglobulinaemia vasculitis that presented as respiratory failure. Clin-Med-London 2024; 24 (Suppl.).; Javed A, Fatima A. An unexpected case of cryoglobulinaemia vasculitis that presented as respiratory failure. Clin-Med-London 2024; 24 (Suppl.).$66$YR$$F$Y$$$20240822$$HP$GB$GB
241829701$24182970$1$I$20230401$20240723$20240807$20240807$EXP$$RS-GLANDPHARMA-RS-2024GLNLIT00585$GLAND PHARMA$Andrej Pesic.UNIQUE PRESENTATION OF T-CELL/HISTIOCYTE-RICH LARGE B CELL LYMPHOMA COMPLICATED WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: CASE REPORT AND REVIEW OF THE LITERATURE.Journal of Medical Biochemistry.JAN-2024;43 (No. 4):631-637$32$YR$A$M$Y$$$20240807$$HP$RS$RS
241829711$24182971$1$I$$20240801$20240807$20240807$EXP$$BR-TAKEDA-2024TUS078526$TAKEDA$$$$$F$Y$$$20240807$$CN$BR$BR
241829721$24182972$1$I$20240717$20240731$20240807$20240807$EXP$$US-GSK-US2024095809$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
241829741$24182974$1$I$$20240730$20240807$20240807$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02828$AMNEAL$$$$$M$Y$16.599$KG$20240807$$CN$US$US
241829751$24182975$1$I$20240622$20240729$20240807$20240807$EXP$FR-AFSSAPS-LM2024000410$FR-TEVA-VS-3227765$TEVA$$92$YR$$F$Y$84$KG$20240807$$MD$FR$FR
241829781$24182978$1$I$20240806$20240806$20240807$20240807$PER$$US-AMGEN-USASP2024156364$AMGEN$$76$YR$E$$Y$$$20240807$$CN$US$US
241829792$24182979$2$F$20211216$20240805$20240807$20240812$EXP$$CA-CELLTRION INC.-2021CA004664$CELLTRION$$$$$$Y$$$20240812$$HP$CA$CA
241829801$24182980$1$I$20240101$20240805$20240807$20240807$EXP$$US-KYOWAKIRIN-2024KK018709$KYOWA$$$$$$Y$$$20240807$$HP$US$US
241829811$24182981$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160678$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241829821$24182982$1$I$$20240729$20240807$20240807$EXP$$CA-APOTEX-2024AP008976$APOTEX$$50$YR$$M$Y$$$20240807$$CN$CA$CA
241829831$24182983$1$I$$20240730$20240807$20240807$EXP$$US-SA-2024SA227801$SANOFI AVENTIS$$58$YR$A$F$Y$86.1$KG$20240807$$MD$US$US
241829841$24182984$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038880$AUROBINDO$$72$YR$$$Y$$$20240807$$HP$CA$CA
241829862$24182986$2$F$$20240909$20240807$20240913$30DAY$$US-MYLANLABS-2024M1072183$MYLAN$$$$$$Y$$$20240913$$CN$US$US
241829872$24182987$2$F$$20240909$20240807$20240912$30DAY$$US-MYLANLABS-2024M1072221$MYLAN$$$$$$Y$$$20240912$$CN$US$US
241829891$24182989$1$I$$20240730$20240807$20240807$EXP$$ZA-AstraZeneca-2024A173661$ASTRAZENECA$$65$YR$$M$Y$$$20240807$$CN$ZA$
241829911$24182991$1$I$$20240802$20240807$20240807$EXP$$US-AstraZeneca-2024A176143$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241829921$24182992$1$I$$20240801$20240807$20240807$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-123547$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240807$$HP$CA$CA
241829942$24182994$2$F$$20240805$20240807$20240809$EXP$$DE-AstraZeneca-2024A174880$ASTRAZENECA$$$$E$M$Y$$$20240809$$MD$DE$
241829951$24182995$1$I$$20240730$20240807$20240807$EXP$$VN-AstraZeneca-2024A176218$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$VN$
241829961$24182996$1$I$$20240729$20240807$20240807$EXP$$US-TEVA-VS-3227998$TEVA$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$31$YR$$F$Y$$$20240807$$HP$US$US
241829971$24182997$1$I$20240801$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024154030$AMGEN$$$$A$F$Y$$$20240807$$HP$US$US
241829981$24182998$1$I$20240601$20240802$20240807$20240807$EXP$$GB-AMGEN-GBRSL2024155241$AMGEN$$43$YR$A$M$Y$$$20240807$$CN$GB$GB
241829991$24182999$1$I$20240423$20240729$20240807$20240807$EXP$ES-AEMPS-1549496$ES-ROCHE-10000040913$ROCHE$$47$YR$A$F$Y$56$KG$20240807$$PH$ES$ES
241830001$24183000$1$I$$20240731$20240807$20240807$EXP$$US-GSK-US2024095899$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
241830012$24183001$2$F$20240513$20240828$20240807$20240904$EXP$$US-GSK-US2024095830$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$US$US
241830021$24183002$1$I$$20240806$20240807$20240807$PER$$US-BAYER-2024A113371$BAYER$$$$$$Y$$$20240807$$CN$US$US
241830031$24183003$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038898$AUROBINDO$$74$YR$$F$Y$$$20240807$$HP$CA$CA
241830041$24183004$1$I$20231201$20240805$20240807$20240807$EXP$$CA-UCBSA-2023059765$UCB$$23$YR$$F$Y$$$20240807$$CN$CA$CA
241830052$24183005$2$F$$20240905$20240807$20240909$EXP$$JP-MYLANLABS-2024M1069342$MYLAN$Makata H, Matsuo N, Nonaka H, and Kadoya R. A case of possible involvement of psychological factors in accidental injection of adrenalin self-injection. Japanese Journal of Pediatric Clinical Allergy. 2024;22(2):193$8$YR$$M$Y$$$20240909$$MD$JP$JP
241830062$24183006$2$F$20240625$20240805$20240807$20240809$EXP$$US-KYOWAKIRIN-2024KK018747$KYOWA$$$$$$Y$$$20240809$$HP$US$US
241830072$24183007$2$F$$20240812$20240807$20240820$EXP$$US-TEVA-VS-3228007$TEVA$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$38$YR$$M$Y$$$20240820$$HP$US$US
241830081$24183008$1$I$$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037863$AUROBINDO$$74$YR$$F$Y$$$20240807$$MD$GB$GB
241830091$24183009$1$I$$20240806$20240807$20240807$PER$$US-BAYER-2024A113394$BAYER$$$$$$Y$$$20240807$$CN$US$US
241830101$24183010$1$I$$20240727$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-038080$AUROBINDO$$67$YR$$F$Y$66$KG$20240807$$CN$GB$GB
241830111$24183011$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156208$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241830121$24183012$1$I$20240802$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154601$AMGEN$$$$$F$Y$$$20240807$$PH$US$US
241830131$24183013$1$I$$20240806$20240807$20240807$PER$$US-BAYER-2024A113500$BAYER$$$$$M$Y$$$20240807$$CN$US$US
241830141$24183014$1$I$20240803$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155572$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241830151$24183015$1$I$20240422$20240522$20240806$20240806$DIR$FDA-CDER-CTU-2024-53980$$FDA-CTU$$$$$$N$$$20240522$N$$US$
241830171$24183017$1$I$$20240531$20240806$20240806$DIR$FDA-CDER-CTU-2024-53972$$FDA-CTU$$$$$$N$$$20240531$N$PH$US$
241830191$24183019$1$I$20240722$20240725$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407017277$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240807$$CN$US$US
241830201$24183020$1$I$$20240605$20240806$20240806$DIR$FDA-CDER-CTU-2024-53955$$FDA-CTU$$$$$$N$$$20240605$N$PH$US$
241830211$24183021$1$I$20120101$20240805$20240807$20240807$PER$$US-JNJFOC-20240813679$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20240807$$HP$US$US
241830221$24183022$1$I$$20240802$20240807$20240807$EXP$$US-JNJFOC-20240809262$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$US$US
241830231$24183023$1$I$20240729$20240731$20240807$20240807$EXP$$US-ROCHE-10000046082$ROCHE$$62$YR$A$F$Y$$$20240807$$CN$US$US
241830241$24183024$1$I$$20240726$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407018112$ELI LILLY AND CO$$39$YR$A$$Y$$$20240807$$LW$US$US
241830251$24183025$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003136$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240807$$CN$US$US
241830261$24183026$1$I$$20240530$20240806$20240806$DIR$FDA-CDER-CTU-2024-53970$$FDA-CTU$$$$$$N$$$20240530$N$PH$US$
241830271$24183027$1$I$20240722$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003091$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240807$$CN$US$US
241830281$24183028$1$I$$20240726$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407019065$ELI LILLY AND CO$$54$YR$A$$Y$$$20240807$$LW$US$US
241830291$24183029$1$I$20240701$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003363$ELI LILLY AND CO$$52$YR$A$$Y$$$20240807$$CN$US$US
241830301$24183030$1$I$$20240729$20240807$20240807$EXP$$JP-MYLANLABS-2024M1071968$MYLAN$Yoshimoto K, Kobayashi T, Matsuoka H, Nishimura N, Kawashima H, Yoneima R, et al. Neuro-Behcet^s disease with atypical subcortical nodular lesions: A case report and treatment approach. Mod-Rheumatol-Case-Rep 2024; 8 (2): 348-351.. 2024;8 (2):348-351$25$YR$$M$Y$$$20240807$$HP$JP$JP
241830311$24183031$1$I$$20240729$20240807$20240807$EXP$$FR-MYLANLABS-2024M1072727$MYLAN$Chanut M, Bonny V, Joly AC, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Arch-Cardiovasc-Dis 2024; 117 (4): 297-300.$54$YR$$F$Y$$$20240807$$HP$FR$FR
241830321$24183032$1$I$$20240729$20240807$20240807$EXP$$US-MYLANLABS-2024M1071778$MYLAN$Lawson C, Mohsen A, Myers I. A case of diabetes insipidus masked by severe hyponatremia. Am-J-Kidney-Dis 2024; 83 (Suppl. 2) (4): S31.$41$YR$$M$Y$$$20240807$$HP$US$US
241830331$24183033$1$I$$20240729$20240807$20240807$EXP$$FR-MYLANLABS-2022M1141525$MYLAN$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Lorinee La Grandmaison G, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2022;34 (Suppl.)(3):S109.$53$YR$$F$Y$$$20240807$$HP$FR$FR
241830341$24183034$1$I$$20240722$20240807$20240807$PER$$US-NXDC-2024GLE00060$NX DEVELOPMENT CORPORATION$$$$$$Y$$$20240807$$HP$US$US
241830351$24183035$1$I$$20240729$20240807$20240807$EXP$$AU-MYLANLABS-2024M1072723$MYLAN$Shibu R, Mohsen W. Leukocytoclastic Vasculitis-Associated Myocarditis as an Extraintestinal Manifestation of Crohn^s Disease. ACG-Case-Rep-J 2024; 11 (6):.$45$YR$$F$Y$$$20240807$$MD$AU$AU
241830361$24183036$1$I$$20240729$20240807$20240807$EXP$$AU-MYLANLABS-2024M1071991$MYLAN$Donnan M, Siemienowicz M, Tay HS, McLean C, Philpot S, Mason C, et al. Trimethoprim-sulfamethoxazole acute respiratory distress syndrome requiring lung transplantation. Respirol-Case-Rep 2024; 12 (7):.$18$YR$$F$Y$$$20240807$$HP$AU$AU
241830371$24183037$1$I$20240801$20240806$20240807$20240807$PER$$US-AMGEN-USASP2024156361$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241830383$24183038$3$F$20240101$20240919$20240807$20240920$PER$$US-AMGEN-USASP2024156479$AMGEN$$55$YR$A$M$Y$174.33$KG$20240920$$MD$US$US
241830391$24183039$1$I$$20240806$20240807$20240807$PER$$US-HALEON-2190745$Haleon PLC$$$$$$Y$$$20240807$$CN$US$US
241830411$24183041$1$I$$20240806$20240807$20240807$PER$$US-BAYER-2024A113511$BAYER$$$$$F$Y$$$20240807$$CN$US$US
241830422$24183042$2$F$$20240805$20240807$20240811$PER$$US-AMGEN-USASP2024156144$AMGEN$$$$$M$Y$$$20240811$$CN$US$US
241830432$24183043$2$F$20240806$20240807$20240807$20240809$PER$$US-AMGEN-USASP2024156480$AMGEN$$70$YR$E$F$Y$$$20240809$$CN$US$US
241830441$24183044$1$I$20240801$20240806$20240807$20240807$PER$$US-AMGEN-USASP2024156256$AMGEN$$55$YR$A$F$Y$$$20240807$$HP$US$US
241830451$24183045$1$I$$20240730$20240807$20240807$EXP$$CN-AMGEN-CHNNI2024155272$AMGEN$KONG S, WANG H.. Effect of Ivabradine on the vulnerable phase of heart failure in patients with hypotensive HfrEF.. Chinese journal of integrative medicine on cardio-cerebrovascular disease$$$$$Y$$$20240807$$MD$CN$CN
241830461$24183046$1$I$$20240805$20240807$20240807$EXP$$NVSC2024PK159350$NOVARTIS$$$$$F$Y$62$KG$20240807$$CN$PK$PK
241830471$24183047$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050524$ROCHE$$$$$$Y$$$20240807$$CN$US$US
241830481$24183048$1$I$$20240731$20240807$20240807$EXP$FR-AFSSAPS-GR2024000910$FR-ROCHE-10000044391$ROCHE$$88$YR$E$F$Y$$$20240807$$PH$FR$FR
241830493$24183049$3$F$20240530$20240819$20240807$20240906$PER$$US-JNJFOC-20240812412$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240906$$CN$US$US
241830506$24183050$6$F$20240713$20240916$20240807$20240926$30DAY$$US-JNJFOC-20240811007$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240926$$CN$US$US
241830513$24183051$3$F$20240803$20240912$20240807$20240920$PER$$US-JNJFOC-20240811038$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240920$$CN$US$US
241830525$24183052$5$F$20240803$20240912$20240807$20240930$30DAY$$US-JNJFOC-20240810805$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240930$$CN$US$US
241830532$24183053$2$F$20240803$20240827$20240807$20240904$PER$$US-JNJFOC-20240810629$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240904$$HP$US$US
241830541$24183054$1$I$20240402$20240806$20240807$20240807$EXP$FR-AFSSAPS-NC2024000947$FR-JNJFOC-20240815698$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240807$$PH$FR$FR
241830571$24183057$1$I$$20240522$20240806$20240806$DIR$FDA-CDER-CTU-2024-53982$$FDA-CTU$$$$$$N$$$20240522$N$PH$US$
241830581$24183058$1$I$$20240603$20240806$20240806$DIR$FDA-CDER-CTU-2024-53944$$FDA-CTU$$$$$$N$$$20240603$N$PH$US$
241830591$24183059$1$I$$20240523$20240806$20240806$DIR$FDA-CDER-CTU-2024-53957$$FDA-CTU$$$$$$N$$$20240523$N$PH$US$
241830601$24183060$1$I$$20240522$20240806$20240806$DIR$FDA-CDER-CTU-2024-53976$$FDA-CTU$$$$$$N$$$20240522$N$PH$US$
241830611$24183061$1$I$$20240630$20240806$20240806$DIR$FDA-CDER-CTU-2024-53945$$FDA-CTU$$$$$$N$$$20240630$N$PH$US$
241830621$24183062$1$I$$20240530$20240806$20240806$DIR$FDA-CDER-CTU-2024-53971$$FDA-CTU$$$$$$N$$$20240530$N$PH$US$
241830631$24183063$1$I$$20240604$20240806$20240806$DIR$FDA-CDER-CTU-2024-53954$$FDA-CTU$$$$$$N$$$20240604$N$PH$US$
241830651$24183065$1$I$$20240603$20240806$20240806$DIR$FDA-CDER-CTU-2024-53946$$FDA-CTU$$$$$$N$$$20240603$N$PH$US$
241830661$24183066$1$I$$20240522$20240806$20240806$DIR$FDA-CDER-CTU-2024-53975$$FDA-CTU$$$$$$N$$$20240522$N$PH$US$
241830671$24183067$1$I$$20240524$20240806$20240806$DIR$FDA-CDER-CTU-2024-53958$$FDA-CTU$$73$YR$$$N$$$20240524$N$PH$US$
241830681$24183068$1$I$$20240529$20240806$20240806$DIR$FDA-CDER-CTU-2024-53969$$FDA-CTU$$$$$$N$$$20240529$N$PH$US$
241830691$24183069$1$I$$20240604$20240806$20240806$DIR$FDA-CDER-CTU-2024-53947$$FDA-CTU$$$$$$N$$$20240604$N$PH$US$
241830721$24183072$1$I$20240727$20240805$20240807$20240807$EXP$$US-BAUSCH-BL-2024-011922$BAUSCH AND LOMB$$82$YR$$M$Y$$$20240807$$CN$US$US
241830731$24183073$1$I$$20240723$20240807$20240807$EXP$$US-GLANDPHARMA-US-2024GLNLIT00589$GLAND PHARMA$Fangyu Chen.Aortoesophageal Fistula Following a Cervical Epidural Steroid Injection: Case Report.Pain Medicine Case Reports.31-DEC-2023;Volume 7, Number 8:345-347$7$DEC$$M$Y$$$20240807$$MD$US$US
241830741$24183074$1$I$20240805$20240805$20240807$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011910$JAZZ$$71$YR$$F$Y$$$20240807$$CN$US$US
241830761$24183076$1$I$$20240724$20240807$20240807$EXP$GB-MHRA-MIDB-1d6f194f-9eff-4b8d-ac06-422583a7fbe3$GB-GLENMARK PHARMACEUTICALS-2024GMK092833$GLENMARK$$$$$$Y$$$20240807$$PH$GB$GB
241830771$24183077$1$I$$20240730$20240807$20240807$EXP$$AU-CELLTRION INC.-2024AU018529$CELLTRION$$$$$$Y$$$20240807$$HP$AU$AU
241830782$24183078$2$F$20240801$20240828$20240807$20240830$EXP$$NVSJ2024JP009416$NOVARTIS$$$$$$Y$$$20240830$$PH$JP$JP
241830792$24183079$2$F$$20240905$20240807$20240909$EXP$$NVSJ2024JP009432$NOVARTIS$$$$E$M$Y$$$20240909$$MD$JP$JP
241830803$24183080$3$F$20240101$20240926$20240807$20240930$EXP$$NVSJ2024JP009383$NOVARTIS$$70$YR$$M$Y$$$20240930$$MD$JP$JP
241830821$24183082$1$I$$20240730$20240807$20240807$EXP$$US-BAUSCH-BL-2024-011692$BAUSCH AND LOMB$Jain S, Sekhon S, Leo Pradeep Chandran A, Gummadi J, Patel P, Nakka R, Gunendran T, Nanjundappa A, Jose T, Garapati H, Shekar S, Kanitkar A. Metformin-associated lactic acidosis in an older adult: A case report and review. Cureus. 2024 JUN 19;16(6):1-6. doi:10.7759/cureus.62729$82$YR$$M$Y$$$20240807$$HP$US$US
241830831$24183083$1$I$$20240806$20240807$20240807$PER$$US-BAYER-2024A113796$BAYER$$69$YR$E$F$Y$$$20240807$$CN$US$US
241830841$24183084$1$I$$20240603$20240806$20240806$DIR$FDA-CDER-CTU-2024-53967$$FDA-CTU$$$$$$N$$$20240603$N$PH$US$
241830853$24183085$3$F$20240101$20240903$20240807$20240910$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00818$CATALYST PHARMA$$$$$M$Y$77.687$KG$20240910$$CN$US$US
241830861$24183086$1$I$20240715$20240803$20240807$20240807$EXP$ES-AEMPS-1556166$ES-BAUSCH-BL-2024-011865$BAUSCH AND LOMB$$78$YR$$M$Y$74$KG$20240807$$HP$ES$ES
241830881$24183088$1$I$20240710$20240731$20240807$20240807$EXP$$CN-009507513-2408CHN001202$MERCK$$64$YR$$M$Y$57.5$KG$20240807$$HP$CN$CN
241830891$24183089$1$I$20230816$20240804$20240807$20240807$EXP$FR-AFSSAPS-NC2024000932$FR-BAUSCH-BL-2024-011900$BAUSCH AND LOMB$$33$YR$$F$Y$90$KG$20240807$$HP$FR$FR
241830901$24183090$1$I$$20240804$20240807$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011937$JAZZ$$$$$F$Y$$$20240807$$CN$US$US
241830911$24183091$1$I$$20240805$20240807$20240807$PER$$US-BAYER-2024A113314$BAYER$$$$$$Y$$$20240807$$CN$US$US
241830922$24183092$2$F$20240726$20240802$20240807$20240809$EXP$$NVSC2024AT158621$NOVARTIS$$76$YR$$F$Y$103$KG$20240809$$MD$AT$AT
241830931$24183093$1$I$20240701$20240802$20240807$20240807$EXP$$US-AstraZeneca-2024A176890$ASTRAZENECA$$950$MON$$M$Y$$$20240807$$HP$US$
241830951$24183095$1$I$20240804$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155285$AMGEN$$68$YR$E$M$Y$$$20240807$$CN$US$US
241830961$24183096$1$I$20240805$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155686$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241830972$24183097$2$F$20240801$20240806$20240807$20240811$EXP$$TW-AMGEN-TWNSP2024155485$AMGEN$$54$YR$A$M$Y$$$20240811$$HP$TW$TW
241830982$24183098$2$F$20240801$20240809$20240807$20240813$PER$$US-AMGEN-USASP2024155619$AMGEN$$30$YR$A$F$Y$$$20240813$$CN$US$US
241830991$24183099$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155902$AMGEN$$$$$$Y$$$20240807$$CN$US$US
241831001$24183100$1$I$$20240711$20240807$20240807$PER$$US-JNJFOC-20240732778$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$US$US
241831011$24183101$1$I$$20240724$20240807$20240807$EXP$$CA-ALVOGEN-2024095208$ALVOGEN$Adamo A, Marshall K, Woodall K L. Fentanyl-Related Deaths in Ontario, Canada: Toxicological Findings and Circumstances of  Death in 4395 Cases (2020-2022). Journal of Analytical Toxicology. 2024; doi:https://doi.org/10.1093/jat/bkae061$62$YR$$F$Y$$$20240807$$HP$CA$CA
241831021$24183102$1$I$$20240726$20240807$20240807$EXP$$IN-ALVOGEN-2024095213$ALVOGEN$Vaidyanathan S, Raghunathan S, Udupa S T, Munoli R N, Manjushree M S, Praharaj S K. Disulfiram-Associated Generalized Tonic?Clonic Seizures. American Journal of Therapeutics. 2024;31(4):e422-e426.$41$YR$$M$Y$$$20240807$$MD$IN$IN
241831034$24183103$4$F$20230401$20240823$20240807$20240904$EXP$$US-ALVOGEN-2024094893$ALVOGEN$$$$$M$Y$$$20240904$$CN$US$US
241831041$24183104$1$I$$20240726$20240807$20240807$EXP$$IT-AUROBINDO-AUR-APL-2024-036032$AUROBINDO$Parisi S, Sciacca M, Critelli P, Ferrantelli G, Chillari F, Venuti V et al.. Lattice radiotherapy in inflammatory breast cancer: report of a first case treated with curative aim.. Radiation Oncology Journal.. 2024;42 (2):160-165$49$YR$$F$Y$$$20240807$$HP$IT$IT
241831051$24183105$1$I$$20240806$20240807$20240807$EXP$FR-AFSSAPS-PV2024000722$FR-SANDOZ INC.-SDZ2024FR070819$SANDOZ$$$$N$M$Y$0.32$KG$20240807$$MD$FR$FR
241831061$24183106$1$I$$20240729$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123824$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$72.57$KG$20240807$$CN$US$US
241831071$24183107$1$I$$20240805$20240807$20240807$EXP$$US-ROCHE-10000049452$ROCHE$$$$A$F$Y$$$20240807$$CN$US$US
241831092$24183109$2$F$20170101$20240830$20240807$20240906$EXP$$CA-Orion Corporation ORION PHARMA-24_00031186$ORION$$48$YR$A$F$Y$90.7$KG$20240906$$HP$CA$
241831101$24183110$1$I$$20240125$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2024CN007926$SANDOZ$Li Zhuo, Zong Yuan, Ma Juan, Zhang Peng, Cao Lu. Comparative study of antifungal treatment regimens for severe patients with invasive pulmonary aspergillosis. Practical Pharmacy And Clinical Remedy. 2024;27:35-39$$$$$Y$$$20240807$$PH$CN$CN
241831111$24183111$1$I$20240801$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154566$AMGEN$$56$YR$A$F$Y$$$20240807$$CN$US$US
241831121$24183112$1$I$20240622$20240724$20240807$20240807$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160069$JIANGSU HANSOH PHARMACEUTICAL$$67$YR$$M$Y$50$KG$20240807$$MD$CN$CN
241831132$24183113$2$F$20240703$20240806$20240807$20240815$PER$$US-AMGEN-USASP2024150380$AMGEN$$63$YR$A$M$Y$68.8$KG$20240815$$PH$US$US
241831143$24183114$3$F$20240728$20240813$20240807$20240829$30DAY$$CA-JNJFOC-20240780713$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240829$$HP$CA$CA
241831151$24183115$1$I$$20240805$20240807$20240807$PER$$US-ABBVIE-5867871$ABBVIE$$$$$$Y$$$20240807$$CN$US$US
241831161$24183116$1$I$$20240723$20240807$20240807$EXP$$IT-Changzhou Pharmaceutical Factory-2160072$CHANGZHOU PHARMACEUTICAL FACTORY$Full text$15$YR$$F$Y$48$KG$20240807$$$IT$IT
241831171$24183117$1$I$$20240729$20240807$20240807$EXP$$CA-BAYER-2024A109802$BAYER$$48$YR$A$M$Y$$$20240807$$HP$CA$CA
241831181$24183118$1$I$20240731$20240731$20240807$20240807$EXP$GB-MHRA-MED-202407311413458760-CJTWP$GB-JNJFOC-20240805963$JOHNSON AND JOHNSON$$35$YR$A$F$Y$85$KG$20240807$$CN$GB$GB
241831191$24183119$1$I$20240731$20240731$20240807$20240807$EXP$$US-VANTIVE-2024VAN018797$Vantive US Healthcare$$$$$$Y$$$20240807$$HP$US$US
241831201$24183120$1$I$$20240805$20240807$20240807$EXP$$CN-VANTIVE-2024VAN018865$Vantive US Healthcare$$$$$M$Y$$$20240807$$CN$CN$CN
241831211$24183121$1$I$$20240805$20240807$20240807$EXP$$CN-VANTIVE-2024VAN018861$Vantive US Healthcare$$$$$F$Y$$$20240807$$CN$CN$CN
241831221$24183122$1$I$20220101$20240730$20240807$20240807$EXP$$SG-ROCHE-10000044356$ROCHE$$60$YR$A$M$Y$$$20240807$$CN$SG$SG
241831231$24183123$1$I$$20240723$20240807$20240807$EXP$$TR-AptaPharma Inc.-2160070$APTAPHARMA$Full text$17$YR$$F$Y$$$20240807$$MD$TR$TR
241831251$24183125$1$I$20240601$20240806$20240806$20240806$DIR$713109$$FDA-CTU$$64$YR$$M$N$99.1$KG$20240806$N$$US$
241831261$24183126$1$I$20240805$20240806$20240806$20240806$DIR$713119$$FDA-CTU$$$$$UNK$N$$$20240806$N$CN$US$
241831271$24183127$1$I$20240619$20240806$20240806$20240806$DIR$713111$$FDA-CTU$$67$YR$$M$N$90$KG$20240806$N$CN$US$
241831302$24183130$2$F$20240701$20240829$20240807$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024054$UNITED THERAPEUTICS$$70$YR$$M$Y$$$20240906$$$US$US
241831311$24183131$1$I$$20240805$20240807$20240807$EXP$$US-GILEAD-2024-0683193$GILEAD$$24$YR$A$F$Y$$$20240807$$CN$US$US
241831321$24183132$1$I$$20240725$20240807$20240807$EXP$$TR-P+L Developments of Newyork Corporation-2160067$PL DEVELOPMENTS$Initial$16$YR$$$Y$$$20240807$$$TR$TR
241831331$24183133$1$I$20240620$20240801$20240807$20240807$EXP$$US-RIGEL-20240800019$RIGEL PHARMACEUTICALS$$88$YR$$F$Y$105.23$KG$20240807$$CN$US$US
241831341$24183134$1$I$$20240805$20240807$20240807$EXP$$US-GSK-US2024097553$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$MD$US$US
241831352$24183135$2$F$$20240828$20240807$20240906$30DAY$$US-GSK-US2024096255$GLAXOSMITHKLINE$$$$$M$Y$$$20240906$$CN$US$US
241831361$24183136$1$I$$20240730$20240807$20240807$EXP$$US-BAYER-2024A110566$BAYER$$51$YR$A$F$Y$$$20240807$$CN$US$US
241831373$24183137$3$F$20240725$20240829$20240807$20240829$EXP$$TW-BAYER-2024A110338$BAYER$$$$$M$Y$$$20240829$$MD$TW$TW
241831381$24183138$1$I$20240628$20240805$20240807$20240807$EXP$GB-MHRA-MED-202408051635370580-RMKZV$GB-MYLANLABS-2024M1073084$MYLAN$$68$YR$$F$Y$62$KG$20240807$$MD$GB$GB
241831391$24183139$1$I$20240715$20240804$20240807$20240807$EXP$GB-MHRA-MED-202408042020419620-WSLTM$GB-MYLANLABS-2024M1072763$MYLAN$$50$YR$$F$Y$67$KG$20240807$$CN$GB$GB
241831401$24183140$1$I$$20240804$20240807$20240807$EXP$GB-MHRA-MED-202408041232260030-PTGCB$GB-MYLANLABS-2024M1072758$MYLAN$$102$YR$$F$Y$$$20240807$$CN$GB$GB
241831411$24183141$1$I$$20240806$20240807$20240807$EXP$$GB-MYLANLABS-2024M1073564$MYLAN$$$$$M$Y$$$20240807$$PH$GB$GB
241831431$24183143$1$I$$20240722$20240807$20240807$EXP$$US-Nostrum Laboratories, Inc.-2160080$NOSTRUM$$78$YR$$F$Y$$$20240807$$$US$US
241831441$24183144$1$I$$20240726$20240807$20240807$EXP$$US-AUROBINDO-AUR-APL-2024-037600$AUROBINDO$Jones DT, Srinivasmurthy R, Pandit M, Tovar R, Ho L, Wairimu K.. Raoultella ornithinolytica Urinary Tract Infection in a Patient With Triple-Negative Breast Cancer.. Cureus. 2024;16(7):e64742$81$YR$$F$Y$$$20240807$$MD$US$US
241831451$24183145$1$I$$20240731$20240807$20240807$EXP$$IN-MYLANLABS-2024M1073034$MYLAN$Sharma, S., Bhat, S., Zahoor, A.. Neuroleptic malignant syndrome with acute renal failure associated with rhabdomyolysis: A case report. The Egyptian Journal of Internal Medicine. 2024;36:57$67$YR$$F$Y$$$20240807$$HP$IN$IN
241831462$24183146$2$F$$20240905$20240807$20240917$EXP$$JP-ROCHE-10000047754$ROCHE$Uda Y, Nakano T A. B-20 A case in which headache and chest pain developed after the administration of bevacizumab for peritoneal carcinoma and reversible cerebral vasoconstriction syndrome (RCVS) was diagnosed. The 128th Kinki Regional Meeting of the Japanese Society of Neurology.. 2024;38.$61$YR$A$F$Y$$$20240917$$MD$JP$JP
241831471$24183147$1$I$20240721$20240723$20240807$20240807$EXP$$US-Time-Cap Labs, Inc.-2160081$TIME CAPS$$30$YR$$F$Y$$$20240807$$$US$US
241831481$24183148$1$I$$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037948$AUROBINDO$$$$$F$Y$$$20240807$$HP$GB$GB
241831491$24183149$1$I$$20240404$20240807$20240807$PER$$US-Armstrong Pharmaceuticals, Inc.-2160088$ARMSTRONG$$$$$M$Y$$$20240807$$$US$US
241831501$24183150$1$I$$20240724$20240807$20240807$EXP$$IN-OrBion Pharmaceuticals Private Limited-2160094$ORBION PHARMACEUTICALS$Shetty SS, AnnajiGowda HH, Dahale AB. Valproate-induced hyperammonemia, neuroleptic sensitivity, and cerebellar atrophy-A clinical conundrum in the management of bipolar disorder. Bipolar Disord. 2024 Mar; 26(2):200-203. doi: 10.1111/bdi.13403.$36$YR$$M$Y$$$20240807$$MD$IN$IN
241831511$24183151$1$I$$20240725$20240807$20240807$EXP$$TR-P+L Developments of Newyork Corporation-2160092$PL DEVELOPMENTS$Initial$13$YR$$$Y$$$20240807$$$TR$TR
241831531$24183153$1$I$20240101$20240731$20240807$20240807$EXP$$CA-JNJFOC-20240805002$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240807$$CN$CA$CA
241831541$24183154$1$I$$20240711$20240807$20240807$PER$$US-JNJFOC-20240739880$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241831551$24183155$1$I$20240731$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002944$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240807$$CN$US$US
241831561$24183156$1$I$20240726$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002153$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240807$$CN$US$US
241831571$24183157$1$I$$20240723$20240807$20240807$EXP$$CN-Guardian Drug Company-2160071$GUARDIAN PHARMACEUTICALS$Full text$22$YR$$M$Y$90$KG$20240807$$$CN$CN
241831581$24183158$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002991$ELI LILLY AND CO$$44$YR$A$$Y$$$20240807$$CN$US$US
241831591$24183159$1$I$$20240726$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407019015$ELI LILLY AND CO$$68$YR$E$$Y$$$20240807$$LW$US$US
241831601$24183160$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002954$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240807$$CN$US$US
241831611$24183161$1$I$$20240724$20240807$20240807$EXP$$US-OrBion Pharmaceuticals Private Limited-2160093$ORBION PHARMACEUTICALS$Applegarth J, Finn D, Tolkacz M, Iacco A. Calcium Channel Blocker Overdose and ECMO: A Unique ?Presentation of Harlequin Syndrome. ASAIO J 2024; 70 (Suppl. 3)151 abstr. P74.$18$YR$$F$Y$$$20240807$$MD$US$US
241831621$24183162$1$I$$20240725$20240807$20240807$EXP$$US-B.Braun Medical Inc.-2160066$B BRAUN$Literature Article$19$YR$$F$Y$$$20240807$$$US$US
241831642$24183164$2$F$$20240823$20240807$20240912$EXP$$US-HETERO-HET2024US02527$HETERO$$$$$F$Y$167.6$KG$20240830$$CN$US$US
241831661$24183166$1$I$$20240725$20240807$20240807$EXP$$TR-P+L Developments of Newyork Corporation-2160095$PL DEVELOPMENTS$Initial$8$YR$$$Y$$$20240807$$$TR$TR
241831681$24183168$1$I$$20240722$20240807$20240807$EXP$$US-Nostrum Laboratories, Inc.-2160078$NOSTRUM$$56$YR$$F$Y$$$20240807$$$US$US
241831692$24183169$2$F$$20240812$20240807$20240820$EXP$$US-BAYER-2024A110875$BAYER$$29$YR$A$F$Y$$$20240820$$HP$US$US
241831701$24183170$1$I$$20240730$20240807$20240807$PER$$US-ROCHE-10000046802$ROCHE$$$$$$Y$$$20240807$$CN$US$US
241831711$24183171$1$I$20240402$20240402$20240807$20240807$PER$$US-Armstrong Pharmaceuticals, Inc.-2160089$ARMSTRONG$$$$$M$Y$$$20240807$$$US$US
241831721$24183172$1$I$20240727$20240731$20240807$20240807$EXP$$CA-GSK-CA2021AMR206683$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$CA$CA
241831731$24183173$1$I$20240802$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123119$BRISTOL MYERS SQUIBB$$1$YR$I$F$Y$$$20240807$$PH$US$US
241831741$24183174$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123831$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240807$$HP$US$US
241831751$24183175$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124218$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$PH$US$US
241831762$24183176$2$F$$20240913$20240807$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123306$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240919$$CN$US$US
241831771$24183177$1$I$20240720$20240729$20240807$20240807$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-121485$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240807$$PH$GB$GB
241831781$24183178$1$I$$20240801$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122656$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240807$$CN$US$US
241831791$24183179$1$I$20240701$20240805$20240807$20240807$EXP$FR-AFSSAPS-NT2024000981$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-124308$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$85$KG$20240807$$PH$FR$FR
241831801$24183180$1$I$20240511$20240730$20240807$20240807$EXP$SE-SEMPA-2024-005592$SE-TEVA-VS-3228203$TEVA$$50$YR$$F$Y$85$KG$20240807$$MD$SE$SE
241831811$24183181$1$I$$20240703$20240807$20240807$PER$$US-Nostrum Laboratories, Inc.-2160073$NOSTRUM$$72$YR$$F$Y$$$20240807$$$US$US
241831831$24183183$1$I$$20240724$20240807$20240807$EXP$$IN-OrBion Pharmaceuticals Private Limited-2160096$ORBION PHARMACEUTICALS$Shetty SS, AnnajiGowda HH, Dahale AB. Valproate-induced hyperammonemia, neuroleptic sensitivity, and cerebellar atrophy-A clinical conundrum in the management of bipolar disorder. Bipolar Disord. 2024 Mar; 26(2):200-203. doi: 10.1111/bdi.13403.$63$YR$$M$Y$$$20240807$$MD$IN$IN
241831841$24183184$1$I$$20240725$20240807$20240807$EXP$$TR-P+L Developments of Newyork Corporation-2160101$PL DEVELOPMENTS$Initial$12$YR$$$Y$$$20240807$$$TR$TR
241831851$24183185$1$I$20240622$20240717$20240807$20240807$PER$$US-OrBion Pharmaceuticals Private Limited-2160098$ORBION PHARMACEUTICALS$$56$YR$$F$Y$$$20240807$$$US$US
241831861$24183186$1$I$20240701$20240716$20240807$20240807$PER$$US-OrBion Pharmaceuticals Private Limited-2160099$ORBION PHARMACEUTICALS$$49$YR$$F$Y$$$20240807$$$US$US
241831871$24183187$1$I$$20240724$20240807$20240807$EXP$$AR-OrBion Pharmaceuticals Private Limited-2160097$ORBION PHARMACEUTICALS$Espindola M, Rojas NG, Vaisentein G, Da Prat G, Cesarini M, Etcheverry JL, Gatto EM. Suicide attempt in a dopamine agonist withdrawal syndrome in Parkinson^s disease. Parkinsonism Relat Disord. 2024 Apr; 121:106017. doi: 10.1016/j.parkreldis.2024.106017.$43$YR$$M$Y$$$20240807$$MD$AR$AR
241831881$24183188$1$I$20240501$20240724$20240807$20240807$PER$$US-OrBion Pharmaceuticals Private Limited-2160100$ORBION PHARMACEUTICALS$$52$YR$$F$Y$$$20240807$$$US$US
241831891$24183189$1$I$20220407$20240725$20240807$20240807$EXP$$CA-ROCHE-10000046668$ROCHE$$53$YR$A$F$Y$$$20240807$$CN$CA$CA
241831901$24183190$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000047751$ROCHE$Tachikawa H, Shikishima K, Kuwahara S, Maeda H, Yamamoto M, Tomioka N et al.. EP-1186 Three cases of patients with breast cancer whose lives could be saved by early diagnosis of pulmonary tumour thrombotic microangiopathy (PTTM). The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;474$53$YR$A$F$Y$$$20240807$$MD$JP$JP
241831911$24183191$1$I$20240724$20240731$20240807$20240807$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160109$JIANGSU HENGRUI MEDICINE$$52$YR$$M$Y$70$KG$20240807$$MD$CN$CN
241831921$24183192$1$I$$20240806$20240806$20240806$DIR$713128$$FDA-CTU$$$$$UNK$N$$$20240806$N$CN$US$
241831931$24183193$1$I$$20240806$20240806$20240806$DIR$713108$$FDA-CTU$$$$$UNK$N$$$20240806$$CN$US$
241831941$24183194$1$I$20240723$20240729$20240807$20240807$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160103$JIANGSU HENGRUI MEDICINE$$61$YR$$F$Y$50$KG$20240807$$MD$CN$CN
241831951$24183195$1$I$$20240806$20240806$20240806$DIR$713127$$FDA-CTU$$$$$UNK$N$$$20240806$N$CN$US$
241831961$24183196$1$I$$20230301$20240807$20240807$EXP$$US-Appco Pharma LLC-2160112$APPCO PHARMA$Initial$36$YR$$M$Y$$$20240807$$$US$US
241831971$24183197$1$I$$20230301$20240807$20240807$EXP$$FR-Appco Pharma LLC-2160111$APPCO PHARMA$Initial$15$MON$$F$Y$$$20240807$$$FR$FR
241831981$24183198$1$I$$20230301$20240807$20240807$EXP$$GB-Appco Pharma LLC-2160108$APPCO PHARMA$Initial$26$YR$$F$Y$$$20240807$$$GB$GB
241831991$24183199$1$I$$20240731$20240807$20240807$EXP$$US-Appco Pharma LLC-2160105$APPCO PHARMA$Initial$43$YR$$M$Y$$$20240807$$$US$US
241832001$24183200$1$I$$20240725$20240807$20240807$EXP$$GR-P+L Developments of Newyork Corporation-2160102$PL DEVELOPMENTS$Initial$76$YR$$F$Y$$$20240807$$$GR$GR
241832011$24183201$1$I$20240722$20240723$20240807$20240807$PER$$US-P+L Developments of Newyork Corporation-2160107$PL DEVELOPMENTS$$$$$F$Y$$$20240807$$$US$US
241832021$24183202$1$I$$20240806$20240806$20240806$DIR$713125$$FDA-CTU$$$$$UNK$N$$$20240806$N$CN$US$
241832031$24183203$1$I$20240804$20240806$20240806$20240806$DIR$713115$$FDA-CTU$$69$YR$$F$N$$$20240806$N$$US$
241832041$24183204$1$I$$20240731$20240807$20240807$EXP$$US-Appco Pharma LLC-2160106$APPCO PHARMA$Initial$18$YR$$F$Y$$$20240807$$$US$US
241832051$24183205$1$I$20240805$20240806$20240806$20240806$DIR$713113$$FDA-CTU$$7$YR$$F$N$$$20240806$N$HP$US$
241832061$24183206$1$I$20240722$20240730$20240807$20240807$EXP$$US-BAYER-2024A111465$BAYER$$43$YR$A$F$Y$$$20240807$$HP$US$US
241832081$24183208$1$I$$20230822$20240807$20240807$PER$$US-AUROBINDO-AUR-APL-2023-054587$AUROBINDO$$75$YR$$F$Y$$$20240807$$CN$US$US
241832091$24183209$1$I$$20240726$20240807$20240807$EXP$$US-AUROBINDO-AUR-APL-2024-038552$AUROBINDO$Celli SI, Nash R, Money KM, Garza M, Borko TL, Borko TL et al.. Successful Autologous Hematopoietic Stem Cell Transplant in Glycine Receptor Antibody-Positive Stiff Person Syndrome: A Case Report. Neurology Neuroimmunology + Neuroinflammation. 2024;11(2):1-10$55$YR$$M$Y$$$20240807$$MD$US$US
241832101$24183210$1$I$20240323$20240613$20240807$20240807$PER$$US-AUROBINDO-AUR-APL-2024-015162$AUROBINDO$$$$$F$Y$$$20240807$$CN$US$US
241832111$24183211$1$I$20240703$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54108$$FDA-CTU$$76$YR$$F$N$$$20240806$Y$PH$US$
241832131$24183213$1$I$$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-54103$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
241832141$24183214$1$I$20240805$20240806$20240806$20240806$DIR$713130$$FDA-CTU$$$$$UNK$N$$$20240806$N$CN$US$
241832151$24183215$1$I$$20240806$20240807$20240807$EXP$GB-MHRA-MED-202408051005127000-JCLST$GB-ORGANON-O2408GBR000357$ORGANON$$34$YR$$M$Y$$$20240807$$CN$GB$GB
241832161$24183216$1$I$$20240804$20240807$20240807$PER$$US-AMGEN-USASP2024155264$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241832171$24183217$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155765$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241832181$24183218$1$I$$20240730$20240807$20240807$EXP$$US-ROCHE-10000046323$ROCHE$$$$$$Y$$$20240807$$CN$US$US
241832191$24183219$1$I$$20240805$20240807$20240807$EXP$$NVSC2024US160376$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241832201$24183220$1$I$$20240509$20240807$20240807$PER$$US-AUROBINDO-AUR-APL-2024-023074$AUROBINDO$$86$YR$$M$Y$79.365$KG$20240807$$CN$US$US
241832211$24183221$1$I$20240806$20240806$20240806$20240806$DIR$713098$$FDA-CTU$$35$YR$$F$N$$$20240806$N$CN$US$
241832221$24183222$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038978$AUROBINDO$$97$YR$$M$Y$$$20240807$$HP$CA$CA
241832231$24183223$1$I$20240101$20240731$20240807$20240807$EXP$$DE-BIOGEN-2024BI01276488$BIOGEN$$60$YR$$F$Y$$$20240807$$PH$DE$DE
241832252$24183225$2$F$$20240806$20240807$20240813$EXP$$IN-ROCHE-3506222$ROCHE$$61$YR$A$M$Y$$$20240813$$CN$IN$IN
241832261$24183226$1$I$$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124373$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240807$$CN$US$US
241832271$24183227$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124260$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$71.67$KG$20240807$$CN$US$US
241832281$24183228$1$I$$20240806$20240807$20240807$EXP$GB-MHRA-31414945$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044253$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240807$$CN$GB$GB
241832291$24183229$1$I$$20240731$20240807$20240807$EXP$$BE-MYLANLABS-2024M1072756$MYLAN$Aleksandrova N, De Rop J, Camu F, Hubloue I, Devue K. A diagnostic dilemma: distinguishing a sulfasalazine induced DRESS hypersensitivity syndrome from a CD30 + lymphoma in a young patient. Int-J-Emerg-Med 2024; 17 (1):.$26$YR$$M$Y$$$20240807$$HP$BE$BE
241832301$24183230$1$I$20220101$20240729$20240807$20240807$EXP$$SG-ROCHE-10000042366$ROCHE$$68$YR$E$M$Y$$$20240807$$CN$SG$SG
241832311$24183231$1$I$$20240731$20240807$20240807$EXP$$US-MYLANLABS-2024M1072820$MYLAN$Omiwade O, Prevallet A. Gastrointestinal Bleeding and Hemorrhagic Shock in a Patient Diagnosed with Disseminated Histoplasmosis. ACG-Case-Rep-J 2024; 11 (7): e01402.$63$YR$$M$Y$$$20240807$$MD$US$US
241832321$24183232$1$I$$20240731$20240807$20240807$EXP$$US-MYLANLABS-2024M1072767$MYLAN$Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. Blood 2023; 142 (Suppl. 1) 5898.$$$A$$Y$$$20240807$$MD$US$US
241832331$24183233$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038933$AUROBINDO$$61$YR$$M$Y$$$20240807$$HP$CA$CA
241832341$24183234$1$I$$20240731$20240807$20240807$EXP$$CA-HALEON-2182972$Haleon PLC$$40$YR$$F$Y$96$KG$20240807$$HP$CA$CA
241832351$24183235$1$I$20240717$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54120$$FDA-CTU$$79$YR$$F$N$$$20240806$Y$PH$US$
241832361$24183236$1$I$20240805$20240806$20240806$20240806$DIR$713103$$FDA-CTU$$25$YR$$M$N$$$20240806$N$$US$
241832371$24183237$1$I$20240525$20240806$20240806$20240806$DIR$713107$$FDA-CTU$$47$YR$$M$N$92$KG$20240806$N$HP$US$
241832381$24183238$1$I$20240805$20240806$20240806$20240806$DIR$713102$$FDA-CTU$$82$YR$$F$N$$$20240806$N$$US$
241832401$24183240$1$I$20240709$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54122$$FDA-CTU$$82$YR$$M$N$$$20240806$Y$HP$US$
241832411$24183241$1$I$20240708$20240806$20240806$20240806$DIR$713138$$FDA-CTU$$64$YR$$M$N$82.8$KG$20240806$N$CN$US$
241832421$24183242$1$I$20240709$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54121$$FDA-CTU$$82$YR$$M$N$$$20240806$Y$HP$US$
241832441$24183244$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000047980$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$53$YR$A$F$Y$$$20240807$$HP$JP$JP
241832452$24183245$2$F$20240604$20240726$20240807$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038394$AUROBINDO$$73$YR$$M$Y$$$20240808$$MD$FR$FR
241832462$24183246$2$F$20240709$20240726$20240807$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038267$AUROBINDO$$88$YR$$F$Y$$$20240808$$MD$FR$FR
241832472$24183247$2$F$$20240726$20240807$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-038871$AUROBINDO$$53$YR$$M$Y$$$20240808$$HP$CA$CA
241832481$24183248$1$I$20240722$20240725$20240807$20240807$EXP$$US-Accord-439046$ACCORD$$44$YR$A$F$Y$$$20240807$$MD$US$US
241832491$24183249$1$I$20240723$20240726$20240807$20240807$EXP$$US-Accord-439094$ACCORD$$28$YR$A$M$Y$$$20240807$$HP$US$US
241832501$24183250$1$I$20200711$20240727$20240807$20240807$EXP$PL-URPL-1-2126-2020$PL-Accord-438776$ACCORD$$48$YR$A$F$Y$70$KG$20240807$$MD$PL$PL
241832511$24183251$1$I$$20240726$20240807$20240807$EXP$AU-TGA-811232$AU-Accord-438407$ACCORD$$48$YR$$M$Y$$$20240807$$HP$AU$AU
241832531$24183253$1$I$$20240728$20240807$20240807$EXP$AU-TGA-809647$AU-Accord-438689$ACCORD$$68$YR$E$M$Y$$$20240807$$HP$AU$AU
241832541$24183254$1$I$$20240727$20240807$20240807$EXP$GB-MHRA-MED-202407270735169410-MQLDJ$GB-Accord-439221$ACCORD$$67$YR$E$F$Y$66$KG$20240807$$CN$GB$GB
241832551$24183255$1$I$20240709$20240726$20240807$20240807$EXP$$NL-AUROBINDO-AUR-APL-2024-038518$AUROBINDO$$63$YR$$M$Y$$$20240807$$MD$NL$NL
241832562$24183256$2$F$20220101$20240819$20240807$20240828$EXP$$JP-ROCHE-10000048836$ROCHE$Matsumoto M, Katagiri Y, Horisawa N, Ito K. EP-1149 A case of metastases of breast cancer to liver complicated by pseudocirrhosis which responded to progesterone preparation. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;465$53$YR$A$$Y$$$20240828$$MD$JP$JP
241832571$24183257$1$I$20240101$20240801$20240807$20240807$EXP$$US-JNJFOC-20240809086$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240807$$HP$US$US
241832581$24183258$1$I$20240701$20240729$20240807$20240807$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00811$CATALYST PHARMA$$17$YR$$F$Y$$$20240807$$CN$US$US
241832602$24183260$2$F$20220101$20240731$20240807$20240808$EXP$$NVSC2024BR158665$NOVARTIS$$78$YR$$F$Y$$$20240808$$MD$BR$BR
241832611$24183261$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54069$$FDA-CTU$$60$YR$$F$N$$$20240806$N$$US$
241832621$24183262$1$I$20240701$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024153426$AMGEN$$64$YR$$F$Y$$$20240807$$CN$US$US
241832641$24183264$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54104$$FDA-CTU$$54$YR$$F$N$$$20240806$N$$US$
241832661$24183266$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54106$$FDA-CTU$$55$YR$$M$N$74.9$KG$20240806$N$PH$US$
241832671$24183267$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124842$BRISTOL MYERS SQUIBB$$96$YR$E$M$Y$$$20240807$$CN$US$US
241832681$24183268$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000048932$ROCHE$Arima H, Shimizu Y, Yamanaka T, Watanabe Y, Yanai M, Osawa H, et al. A case of rectal MiNEN with mixed NET G1 and adenocarcinoma (Abstract number: ME18-8). The 79th General Meeting of the Japanese Society of Gastroenterological Surgery. 2024;2622.$65$YR$E$M$Y$$$20240807$$MD$JP$JP
241832691$24183269$1$I$20240201$20240727$20240807$20240807$EXP$FR-AFSSAPS-PO2024000805$FR-Accord-438736$ACCORD$$26$YR$A$F$Y$$$20240807$$MD$FR$FR
241832701$24183270$1$I$20240727$20240727$20240807$20240807$EXP$GB-MHRA-MED-202407270917104810-QPYZV$GB-Accord-439167$ACCORD$$60$YR$A$M$Y$78$KG$20240807$$MD$GB$GB
241832711$24183271$1$I$$20240727$20240807$20240807$EXP$NL-LRB-00993360$NL-Accord-438722$ACCORD$$23$YR$A$M$Y$70$KG$20240807$$MD$NL$NL
241832721$24183272$1$I$20240702$20240726$20240807$20240807$EXP$$US-Accord-439629$ACCORD$$36$YR$A$F$Y$$$20240807$$HP$US$US
241832731$24183273$1$I$20240711$20240726$20240807$20240807$EXP$$US-Accord-438816$ACCORD$$65$YR$E$M$Y$$$20240807$$HP$US$US
241832743$24183274$3$F$$20240917$20240807$20240927$EXP$$GB-Accord-438936$ACCORD$Kopernicka G, Chew J. Acute urinary retention and constipation caused by multi-dermatomal herpes zoster in an immunosuppressed patient. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24.$71$YR$E$F$Y$$$20240927$$MD$GB$GB
241832751$24183275$1$I$$20240728$20240807$20240807$EXP$AU-TGA-811310$AU-Accord-438792$ACCORD$$32$YR$A$F$Y$$$20240807$$HP$AU$AU
241832761$24183276$1$I$$20240801$20240807$20240807$EXP$FR-AFSSAPS-AVPO2024000146$FR-CHEPLA-2024009984$CHEPLAPHARM$$23$YR$$M$Y$$$20240807$$PH$COUNTRY NOT SPECIFIED$FR
241832771$24183277$1$I$$20240727$20240807$20240807$EXP$DE-BFARM-24005167$DE-Accord-438738$ACCORD$$61$YR$A$M$Y$$$20240807$$CN$DE$DE
241832781$24183278$1$I$20240717$20240726$20240807$20240807$EXP$$US-Accord-439248$ACCORD$$22$YR$A$F$Y$$$20240807$$PH$US$US
241832791$24183279$1$I$$20240727$20240807$20240807$EXP$CA-MHPD-E2B_07127039$CA-Accord-439065$ACCORD$$71$YR$E$M$Y$$$20240807$$HP$CA$CA
241832801$24183280$1$I$20220801$20240728$20240807$20240807$EXP$$HU-Accord-439217$ACCORD$Mehes G, Mokanszki A, Ujfalusi A, Hevessy Z, Miltenyi Z, Gergely L, et al. Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: Tracing the Paths to Leukemic Transformation. Int J Mol Sci. 2024 Jul 22;25(14):8003. doi: 10.3390/ijms25148003.$51$YR$A$M$Y$$$20240807$$HP$HU$HU
241832811$24183281$1$I$$20240728$20240807$20240807$EXP$$US-Accord-438968$ACCORD$Latif R, Aloqaily M, Rabadi A, Arshad K, Kurian AI, Obeidat I, Al-Sanouri I. Apixaban-Induced Hemopericardium in a Post-TAVR Patient: A Case Report Highlighting Diagnostic and Management Challenges. Am J Case Rep. 2024 Jul 26;25:e944173.$66$YR$E$M$Y$$$20240807$$HP$US$US
241832821$24183282$1$I$$20240727$20240807$20240807$EXP$$US-Accord-439246$ACCORD$$46$YR$$F$Y$$$20240807$$PH$US$US
241832831$24183283$1$I$$20240728$20240807$20240807$EXP$$VN-Accord-439422$ACCORD$Huynh CG, Truong BT, Thai TT, Doan PT. Small-Cell Neuroendocrine Cervical Carcinoma Mimicking a Polyp in a 20-Year-Old Patient With a Five-Year Follow-Up: A Case Report. Cureus. 2024 Jun 22;16(6):e62893. doi: 10.7759/cureus.62893.$20$YR$A$F$Y$45$KG$20240807$$MD$VN$VN
241832843$24183284$3$F$$20240913$20240807$20240919$EXP$$US-ROCHE-10000048530$ROCHE$$46$YR$A$F$Y$$$20240919$$CN$US$US
241832851$24183285$1$I$$20240617$20240807$20240807$EXP$$CA-HALEON-2188909$Haleon PLC$$44$YR$$F$Y$97$KG$20240807$$HP$CA$CA
241832862$24183286$2$F$20230711$20240904$20240807$20240905$EXP$$ES-Accord-438993$ACCORD$$50$YR$A$M$Y$68.2$KG$20240905$$HP$ES$ES
241832871$24183287$1$I$20240724$20240802$20240807$20240807$EXP$$SG-JNJFOC-20240813423$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240807$$HP$SG$SG
241832881$24183288$1$I$$20240801$20240807$20240807$EXP$$US-JNJFOC-20240805170$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241832893$24183289$3$F$20240719$20240905$20240807$20240916$30DAY$$US-JNJFOC-20240777583$JOHNSON AND JOHNSON$$53$YR$A$$Y$$$20240916$$CN$US$US
241832901$24183290$1$I$20201101$20240801$20240807$20240807$EXP$$AU-AMGEN-AUSSP2020191575$AMGEN$$76$YR$E$F$Y$$$20240807$$CN$AU$AU
241832911$24183291$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156105$AMGEN$$$$$$Y$$$20240807$$HP$US$US
241832921$24183292$1$I$20240618$20240730$20240807$20240807$EXP$ES-AEMPS-1551605$ES-TEVA-VS-3227892$TEVA$$53$YR$$F$Y$$$20240807$$PH$ES$ES
241832931$24183293$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038911$AUROBINDO$$8$YR$$M$Y$30$KG$20240807$$CN$CA$CA
241832941$24183294$1$I$20240223$20240726$20240807$20240807$EXP$$DE-AUROBINDO-AUR-APL-2024-038300$AUROBINDO$$58$YR$$F$Y$$$20240807$$MD$DE$DE
241832953$24183295$3$F$20240712$20240819$20240807$20240822$EXP$$NVSC2024AT149237$NOVARTIS$$79$YR$$F$Y$60$KG$20240822$$MD$AT$AT
241832962$24183296$2$F$20240726$20240814$20240807$20240823$EXP$$CA-APOTEX-2024AP009085$APOTEX$$80$YR$E$M$Y$$$20240823$$CN$CA$CA
241832981$24183298$1$I$$20240801$20240807$20240807$30DAY$$US-GSK-US2024AMR097295$GLAXOSMITHKLINE$$$$$M$Y$$$20240807$$CN$US$US
241832991$24183299$1$I$$20240728$20240807$20240807$EXP$$US-Accord-414051$ACCORD$Le V, Surineni K, Elias G. A Case of Partially Reversible Oral-buccal-lingual Dyskinesia after Prolonged Levetiracetam Exposure. American Journal of Geriatric Psychiatry, 2024;32(4):S106. DOI:10.1016/j.jagp.2024.01.190.$86$YR$E$F$Y$$$20240807$$MD$US$US
241833002$24183300$2$F$$20240806$20240807$20240813$PER$$US-ABBVIE-5865144$ABBVIE$$$$$F$Y$101$KG$20240813$$CN$US$US
241833011$24183301$1$I$20240601$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124179$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240807$$CN$US$US
241833021$24183302$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124171$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$PH$US$US
241833032$24183303$2$F$$20240821$20240807$20240827$EXP$$US-AMGEN-USASP2024155048$AMGEN$$$$$M$Y$$$20240827$$HP$US$US
241833042$24183304$2$F$20240601$20240912$20240807$20240918$EXP$$US-BAYER-2024A112956$BAYER$$71$YR$E$F$Y$$$20240918$$CN$US$US
241833051$24183305$1$I$20220715$20240806$20240807$20240807$EXP$FR-AFSSAPS-AM2024000580$FR-ROCHE-10000049856$ROCHE$$56$YR$A$F$Y$64$KG$20240807$$CN$FR$FR
241833061$24183306$1$I$20240801$20240805$20240807$20240807$PER$$NVSC2024US160562$NOVARTIS$$$$$$Y$$$20240807$$MD$US$US
241833072$24183307$2$F$$20240814$20240807$20240904$PER$$US-AstraZeneca-2024A173872$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
241833081$24183308$1$I$$20240730$20240807$20240807$EXP$$JP-AstraZeneca-2024A098258$ASTRAZENECA$$80$YR$$F$Y$$$20240807$$MD$JP$
241833091$24183309$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160481$NOVARTIS$$$$$M$Y$$$20240807$$CN$US$US
241833112$24183311$2$F$20240726$20240819$20240807$20240827$EXP$$SA-AstraZeneca-2024A112151$ASTRAZENECA$$45$YR$$F$Y$$$20240827$$CN$SA$
241833131$24183313$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54101$$FDA-CTU$$50$YR$$M$N$$$20240806$N$$US$
241833141$24183314$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54105$$FDA-CTU$$81$YR$$F$N$$$20240806$N$$US$
241833151$24183315$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54056$$FDA-CTU$$77$YR$$F$N$140$LBS$20240806$N$$US$
241833161$24183316$1$I$$20240801$20240807$20240807$EXP$$US-MYLANLABS-2024M1072333$MYLAN$$$$$$Y$$$20240807$$LW$US$US
241833171$24183317$1$I$$20240801$20240807$20240807$EXP$$JP-MYE-2024M1071571AA$MYLAN$Suzuki S, Yamaguchi R, Yoshida K, Ito S, Toyoda Y, Oiwa T, et al. Two cases of PTP accidental ingestion. The 79th General Meeting of the Japanese Society of Gastroenterological Surgery. 2024;2649$85$YR$$F$Y$$$20240807$$MD$JP$JP
241833181$24183318$1$I$$20240731$20240807$20240807$EXP$$GB-MYLANLABS-2024M1053735$MYLAN$$$$$F$Y$$$20240807$$MD$GB$GB
241833191$24183319$1$I$20240501$20240729$20240807$20240807$PER$FR-AFSSAPS-PV2024000687$FR-PFM-2024-04396$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240807$$MD$FR$FR
241833211$24183321$1$I$20220501$20240802$20240807$20240807$EXP$$CN-BAYER-2024A112694$BAYER$$38$YR$A$F$Y$78$KG$20240807$$HP$CN$CN
241833221$24183322$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408001996$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240807$$CN$US$US
241833231$24183323$1$I$20240805$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002848$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241833241$24183324$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002219$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240807$$CN$US$US
241833251$24183325$1$I$20240804$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003443$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240807$$CN$US$US
241833261$24183326$1$I$$20240806$20240807$20240807$EXP$$US-GILEAD-2024-0683183$GILEAD$$$$$$Y$$$20240807$$HP$US$US
241833272$24183327$2$F$20240601$20240814$20240807$20240822$EXP$$AR-BIOGEN-2024BI01276663$BIOGEN$$59$YR$$M$Y$$$20240822$$CN$AR$AR
241833281$24183328$1$I$20240101$20240730$20240807$20240807$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00820$CATALYST PHARMA$$$$$F$Y$81.633$KG$20240807$$CN$US$US
241833291$24183329$1$I$$20240727$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037994$AUROBINDO$$30$YR$$M$Y$$$20240807$$CN$GB$GB
241833301$24183330$1$I$$20240724$20240807$20240807$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092847$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241833311$24183331$1$I$$20240801$20240807$20240807$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122396$BRISTOL MYERS SQUIBB$Literature citation unavailable$85$YR$E$F$Y$$$20240807$$HP$CA$CA
241833321$24183332$1$I$$20240801$20240807$20240807$EXP$$US-ARGENX-2024-ARGX-US006193$ARGENX BVBA$$$$$$Y$$$20240807$$CN$US$US
241833331$24183333$1$I$20240802$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124224$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240807$$CN$US$US
241833341$24183334$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123756$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240807$$HP$US$US
241833352$24183335$2$F$20240801$20240805$20240807$20240809$EXP$$CN-BAYER-2024A112467$BAYER$$29$YR$A$M$Y$$$20240809$$MD$CN$CN
241833361$24183336$1$I$20240601$20240731$20240807$20240807$30DAY$$US-GSK-US2024095790$GLAXOSMITHKLINE$$46$YR$$F$Y$95.25$KG$20240807$$CN$US$US
241833371$24183337$1$I$20240726$20240802$20240807$20240807$EXP$EU-SEMPA-2024-005800$EU-SEPTODONT-2024018873$SEPTODONT$$$$T$$Y$$$20240807$$HP$EU$EU
241833381$24183338$1$I$$20240724$20240807$20240807$PER$$US-TEVA-VS-3226046$TEVA$$$$$M$Y$$$20240807$$CN$US$US
241833391$24183339$1$I$20191112$20240730$20240807$20240807$EXP$$CO-UCBSA-2024039448$UCB$$54$YR$$M$Y$$$20240807$$CN$CO$CO
241833401$24183340$1$I$20240731$20240802$20240807$20240807$EXP$$CA-JNJFOC-20240809671$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240807$$HP$CA$CA
241833411$24183341$1$I$$20240730$20240807$20240807$EXP$GB-MHRA-MED-202407300742060690-TMPNY$GB-TEVA-VS-3227551$TEVA$$$$$M$Y$$$20240807$$HP$GB$GB
241833421$24183342$1$I$$20240725$20240807$20240807$EXP$$GB-B.Braun Medical Inc.-2160116$B BRAUN$$72$YR$$F$Y$$$20240807$$$GB$GB
241833433$24183343$3$F$20240722$20240827$20240807$20240906$EXP$$US-Accord-439121$ACCORD$$29$YR$A$M$Y$$$20240906$$PH$US$US
241833443$24183344$3$F$20240716$20240906$20240807$20240918$EXP$$CN-Accord-438917$ACCORD$$61$YR$A$M$Y$63$KG$20240918$$HP$CN$CN
241833451$24183345$1$I$$20240726$20240807$20240807$EXP$GB-MHRA-MED-202407261147501430-LWKNT$GB-Accord-439114$ACCORD$$71$YR$E$F$Y$$$20240807$$HP$GB$GB
241833461$24183346$1$I$$20240726$20240807$20240807$EXP$AU-TGA-809294$AU-Accord-438544$ACCORD$$51$YR$A$M$Y$$$20240807$$HP$AU$AU
241833471$24183347$1$I$$20240727$20240807$20240807$EXP$CA-MHPD-E2B_001087497$CA-Accord-439067$ACCORD$$72$YR$E$F$Y$$$20240807$$HP$CA$CA
241833481$24183348$1$I$$20240726$20240807$20240807$EXP$GB-MHRA-MED-202407260750560180-BTWRH$GB-Accord-439110$ACCORD$$67$YR$E$M$Y$102$KG$20240807$$MD$GB$GB
241833492$24183349$2$F$20240725$20240810$20240807$20240822$EXP$$US-Accord-439590$ACCORD$$73$YR$E$F$Y$$$20240822$$HP$US$US
241833501$24183350$1$I$20240509$20240727$20240807$20240807$EXP$PL-URPL-DML-MLP.4401.1.160.2024$PL-Accord-439055$ACCORD$$11$YR$C$M$Y$41$KG$20240807$$HP$PL$PL
241833511$24183351$1$I$20240504$20240727$20240807$20240807$EXP$FR-AFSSAPS-PP2024000810$FR-Accord-438721$ACCORD$$80$YR$E$M$Y$$$20240807$$MD$FR$FR
241833521$24183352$1$I$20240614$20240727$20240807$20240807$EXP$FR-AFSSAPS-MA2024001095$FR-Accord-439074$ACCORD$$56$YR$A$F$Y$$$20240807$$MD$FR$FR
241833531$24183353$1$I$$20240727$20240807$20240807$EXP$CA-MHPD-E2B_07121061$CA-Accord-438935$ACCORD$$61$YR$A$M$Y$113$KG$20240807$$HP$CA$CA
241833541$24183354$1$I$20240801$20240801$20240807$20240807$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02832$AMNEAL$$70$YR$$F$Y$40.816$KG$20240807$$CN$US$US
241833551$24183355$1$I$$20240725$20240807$20240807$EXP$$ZA-AMGEN-ZAFSP2024154598$AMGEN$$72$YR$E$M$Y$$$20240807$$CN$ZA$ZA
241833561$24183356$1$I$$20240731$20240807$20240807$EXP$$VN-SANDOZ INC.-SDZ2024VN070724$SANDOZ$Phuong LT, Dieu Thuy NT, Ngoc NT, Huy NN, Tu TM, Huong NT. Treatment outcomes of pediatric lupus nephritis class iii and iv in national children^s hospital. JOURAL OF MEDICAL RESEARCH. 2024;154(6):69-75$$$C$$Y$$$20240807$$HP$VN$VN
241833573$24183357$3$F$20240713$20240820$20240807$20240826$EXP$$AU-AMGEN-AUSSP2024152989$AMGEN$$$$$F$Y$$$20240826$$HP$AU$AU
241833581$24183358$1$I$20240804$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155728$AMGEN$$52$YR$A$F$Y$$$20240807$$CN$US$US
241833591$24183359$1$I$$20240729$20240807$20240807$EXP$$CA-ROCHE-10000046025$ROCHE$$43$YR$A$F$Y$$$20240807$$MD$CA$CA
241833601$24183360$1$I$$20240731$20240807$20240807$EXP$$GB-ROCHE-10000046201$ROCHE$$$$$F$Y$$$20240807$$HP$GB$GB
241833611$24183361$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54125$$FDA-CTU$$50$YR$$M$N$$$20240806$N$$US$
241833621$24183362$1$I$20240801$20240801$20240806$20240806$DIR$FDA-CDER-CTU-2024-54098$$FDA-CTU$$39$YR$$F$N$150$LBS$20240801$N$HP$US$
241833631$24183363$1$I$$20240729$20240807$20240807$EXP$$GB-TEVA-VS-3226945$TEVA$$72$YR$$M$Y$91$KG$20240807$$PH$GB$GB
241833641$24183364$1$I$20231010$20240805$20240807$20240807$EXP$FR-AFSSAPS-TO2024001472$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-124125$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$84$KG$20240807$$MD$FR$FR
241833661$24183366$1$I$20240730$20240731$20240807$20240807$EXP$$PT-GSK-PT2024EME096071$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$PH$PT$PT
241833671$24183367$1$I$$20240725$20240807$20240807$EXP$$DK-CTRS-202400157$ADDMEDICA$Dall-Jepsen C, M?ller AZ, Tram L, Gielstrup TCG, Danstrup-Dinesen P. . Spontant epiduralt h?matom hos en p?diatrisk patient med seglcellesygdom. . Ugeskrift for L?ger. 2024 Mar 11;186:V11230703.:. doi:10.6$15$YR$T$F$Y$$$20240807$$MD$DK$
241833681$24183368$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54082$$FDA-CTU$$70$YR$$F$N$$$20240806$N$$US$
241833691$24183369$1$I$20230310$20240806$20240806$20240806$DIR$713239$$FDA-CTU$$38$YR$$F$N$74.25$KG$20240806$N$CN$US$
241833701$24183370$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54084$$FDA-CTU$$62$YR$$M$N$$$20240806$N$$US$
241833711$24183371$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54095$$FDA-CTU$$62$YR$$F$N$$$20240806$N$$US$
241833721$24183372$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54079$$FDA-CTU$$66$YR$$F$N$$$20240806$N$$US$
241833741$24183374$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54067$$FDA-CTU$$30$YR$$F$N$$$20240806$N$$US$
241833751$24183375$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54070$$FDA-CTU$$54$YR$$F$N$$$20240806$N$$US$
241833761$24183376$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54077$$FDA-CTU$$55$YR$$F$N$206$LBS$20240806$N$$US$
241833782$24183378$2$F$$20240726$20240807$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-037836$AUROBINDO$$74$YR$$$Y$$$20240808$$HP$GB$GB
241833791$24183379$1$I$$20240805$20240807$20240807$EXP$$US-JNJFOC-20240810348$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
241833801$24183380$1$I$20240726$20240801$20240807$20240807$EXP$$JP-009507513-2408JPN000184J$MERCK$$9$DEC$$M$Y$$$20240807$$MD$JP$JP
241833812$24183381$2$F$$20240811$20240807$20240816$EXP$$US-ROCHE-10000050002$ROCHE$$$$$$Y$$$20240816$$CN$US$US
241833821$24183382$1$I$20240320$20240805$20240807$20240807$EXP$FR-AFSSAPS-PP2024000820$FR-ROCHE-10000048742$ROCHE$$56$YR$A$F$Y$45.5$KG$20240807$$MD$FR$FR
241833831$24183383$1$I$$20240730$20240807$20240807$EXP$$AU-MYLANLABS-2024M1071510$MYLAN$Liang I, Berglund LJ, Brown DA, Suan D, Meybodi F, Lee AYS, et al. Granulomatous mastitis and immunosuppression: Case series at an Australian quaternary referral center. Int-J-Rheum-Diseases 2024; 27 (1).$$$$F$Y$$$20240807$$HP$AU$AU
241833841$24183384$1$I$$20240730$20240807$20240807$EXP$$DE-MYLANLABS-2024M1071612$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$14$YR$$F$Y$$$20240807$$HP$DE$DE
241833851$24183385$1$I$$20240730$20240807$20240807$EXP$$IN-MYLANLABS-2024M1072208$MYLAN$Goud CR. Coronary thrombosis in infants with Kawasaki disease. Indian-J-Rheumatol 2023; 18 (Suppl.) S373 abstr. CAS145.$10$MON$$F$Y$$$20240807$$HP$IN$IN
241833861$24183386$1$I$$20240730$20240807$20240807$EXP$$TW-MYLANLABS-2024M1072246$MYLAN$Tsai J-H, Lee K-T. The Real-world Experiences of Abemaciclib for Estrogen Receptor-positive Human Epidermal Growth Factor Receptor-negative-2 Metastatic Breast Cancer - Sharing from a Single Institute in Southern Taiwan. J-Cancer-Res-Pract 2024; 11 (2): 73-76.$64$YR$$F$Y$$$20240807$$MD$TW$TW
241833871$24183387$1$I$$20240730$20240807$20240807$EXP$$TW-MYLANLABS-2024M1072244$MYLAN$Tsai J-H, Lee K-T. The Real-world Experiences of Abemaciclib for Estrogen Receptor-positive Human Epidermal Growth Factor Receptor-negative-2 Metastatic Breast Cancer - Sharing from a Single Institute in Southern Taiwan. J-Cancer-Res-Pract 2024; 11 (2): 73-76.$62$YR$$F$Y$$$20240807$$MD$TW$TW
241833881$24183388$1$I$$20240730$20240807$20240807$EXP$$TW-MYLANLABS-2024M1072804$MYLAN$Tsai J-H, Lee K-T. The Real-world Experiences of Abemaciclib for Estrogen Receptor-positive Human Epidermal Growth Factor Receptor-negative-2 Metastatic Breast Cancer - Sharing from a Single Institute in Southern Taiwan. J-Cancer-Res-Pract 2024; 11 (2): 73-76.$73$YR$$F$Y$$$20240807$$MD$TW$TW
241833891$24183389$1$I$20230120$20240730$20240807$20240807$EXP$$CO-UCBSA-2024039519$UCB$$70$YR$$F$Y$$$20240807$$CN$CO$CO
241833901$24183390$1$I$$20240801$20240807$20240807$EXP$$US-BIOGEN-2024BI01276630$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
241833911$24183391$1$I$20240726$20240802$20240807$20240807$EXP$EU-SEMPA-2024-005878$EU-SEPTODONT-2024018872$SEPTODONT$$$$T$$Y$$$20240807$$HP$EU$EU
241833921$24183392$1$I$$20240723$20240807$20240807$EXP$$US-GLANDPHARMA-US-2024GLNLIT00584$GLAND PHARMA$Drew Kuraitis.Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis.JAAD Case reports.AUG-2024;50:33-36$68$YR$A$M$Y$$$20240807$$MD$US$US
241833931$24183393$1$I$$20240806$20240807$20240807$EXP$$CN-TAKEDA-2024TUS078907$TAKEDA$$$$$F$Y$$$20240807$$CN$CN$CN
241833941$24183394$1$I$$20240801$20240807$20240807$EXP$$GB-TAKEDA-2024TUS078518$TAKEDA$$$$$F$Y$$$20240807$$CN$GB$GB
241833961$24183396$1$I$$20240802$20240807$20240807$EXP$$SG-JNJFOC-20240813251$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$HP$SG$SG
241833971$24183397$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038941$AUROBINDO$$6$YR$$M$Y$35$KG$20240807$$CN$CA$CA
241833981$24183398$1$I$20231008$20240128$20240807$20240807$EXP$$NVSC2023IL219393$NOVARTIS$$60$YR$$F$Y$$$20240807$$HP$IL$IL
241833991$24183399$1$I$20240301$20240805$20240807$20240807$EXP$FR-AFSSAPS-RS2024000768$FR-AMGEN-FRASP2024155393$AMGEN$$69$YR$E$F$Y$$$20240807$$MD$FR$FR
241834002$24183400$2$F$20240101$20240906$20240807$20240911$PER$$US-AMGEN-USASP2024156210$AMGEN$$61$YR$A$F$Y$$$20240910$$MD$US$US
241834011$24183401$1$I$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0683147$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241834021$24183402$1$I$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0683131$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241834032$24183403$2$F$$20240821$20240807$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123762$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240830$$CN$US$US
241834041$24183404$1$I$$20240729$20240807$20240807$EXP$$CN-ROCHE-10000046776$ROCHE$Wei F, An J, Hua Y, Ding X, Sun S. Safety and efficacy of osimertinib plus bevacizumab as first-line treatment in EGFR-mutant NSCLC with brain metastases: A dynamic ctDNA-guided study (Abstract no. e20606). Journal of clinical oncology. 2024;42 (Suppl 16):$$$$$Y$$$20240807$$HP$CN$CN
241834051$24183405$1$I$20240616$20240806$20240807$20240807$EXP$JP-NBI-2024-BI-037160$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037160$BOEHRINGER INGELHEIM$$89$YR$E$M$Y$55$KG$20240807$$PH$JP$JP
241834062$24183406$2$F$$20240809$20240807$20240813$EXP$$US-MYLANLABS-2024M1072842$MYLAN$$$$$F$Y$$$20240813$$PH$US$US
241834071$24183407$1$I$$20240802$20240807$20240807$EXP$$SE-MYLANLABS-2024M1072232$MYLAN$Kahn L, Kriikku P, J?nsson A. Loperamide positive deaths in Sweden 2012-2022 and Finland 2017-2022: Fatal loperamide intoxication exclusively for Sweden.. Forensic Science International.. 2024;361$34$YR$$M$Y$$$20240807$$MD$SE$SE
241834081$24183408$1$I$$20240802$20240807$20240807$EXP$$US-MYLANLABS-2024M1033369$MYLAN$$$$$F$Y$41.7$KG$20240807$$HP$US$US
241834091$24183409$1$I$20240715$20240802$20240807$20240807$EXP$$US-MYLANLABS-2024M1073280$MYLAN$$22$YR$$F$Y$$$20240807$$MD$US$US
241834101$24183410$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038934$AUROBINDO$$40$YR$$F$Y$$$20240807$$HP$CA$CA
241834112$24183411$2$F$20240103$20240912$20240807$20240916$EXP$$NZ-MYLANLABS-2024M1002709$MYLAN$$75$YR$$M$Y$$$20240916$$PH$NZ$NZ
241834121$24183412$1$I$$20240803$20240807$20240807$EXP$GB-MHRA-MED-202408031111078320-RZWSQ$GB-MYLANLABS-2024M1072789$MYLAN$$26$YR$$F$Y$$$20240807$$CN$GB$GB
241834131$24183413$1$I$$20240802$20240807$20240807$EXP$$US-MYLANLABS-2024M1072760$MYLAN$Gupta S, Gowda N, Shin D, Gogineni K, Bower D, Greer M. PP01.127 A rare case of pulmonary enteric adenocarcinoma in a 26-year-old female non-smoker. J-Thorac-Oncol 2024; 19 (Suppl.) (7): e55-e56 abstr. PP01.127.$26$YR$$F$Y$$$20240807$$MD$US$US
241834141$24183414$1$I$$20240801$20240807$20240807$EXP$$US-GSK-US2024096357$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241834151$24183415$1$I$20240729$20240729$20240807$20240807$EXP$$US-VIIV HEALTHCARE LIMITED-US2024094757$VIIV$$64$YR$$M$Y$$$20240807$$CN$US$US
241834161$24183416$1$I$20240626$20240717$20240807$20240807$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024090123$VIIV$$5$DEC$$F$Y$$$20240807$$MD$US$US
241834171$24183417$1$I$$20240731$20240807$20240807$PER$$NVSC2024US159254$NOVARTIS$$$$$F$Y$$$20240807$$HP$US$US
241834182$24183418$2$F$$20240917$20240807$20240927$EXP$$US-BIOCON BIOLOGICS LIMITED-BBL2024005632$BIOCON$$$$$$Y$$$20240927$$CN$US$US
241834191$24183419$1$I$20240805$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-54065$$FDA-CTU$$55$YR$$F$N$56$KG$20240805$N$$US$
241834201$24183420$1$I$20240801$20240806$20240806$20240806$DIR$713131$$FDA-CTU$$39$YR$$M$N$$$20240806$N$HP$US$
241834211$24183421$1$I$$20231213$20240807$20240807$EXP$$NVSC2023US267834$NOVARTIS$$83$YR$$F$Y$$$20240807$$MD$US$US
241834221$24183422$1$I$$20240730$20240807$20240807$PER$$NVSC2024US156805$NOVARTIS$$$$$$Y$$$20240807$$CN$US$US
241834231$24183423$1$I$$20240619$20240807$20240807$EXP$$NVSC2024CA130603$NOVARTIS$$8$YR$$M$Y$$$20240807$$HP$CA$CA
241834241$24183424$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-039090$AUROBINDO$$$$$M$Y$$$20240807$$HP$CA$CA
241834251$24183425$1$I$$20240731$20240807$20240807$EXP$$CA-PFIZER INC-202400228232$PFIZER$$33$YR$$F$Y$$$20240807$$HP$CA$CA
241834262$24183426$2$F$20231201$20240821$20240807$20240904$EXP$$DE-UCBSA-2024025844$UCB$$24$YR$$F$Y$$$20240904$$MD$DE$DE
241834281$24183428$1$I$20240803$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156114$AMGEN$$74$YR$E$$Y$$$20240807$$CN$US$US
241834291$24183429$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155739$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241834301$24183430$1$I$$20240728$20240807$20240807$PER$$US-AMGEN-USASP2024154275$AMGEN$Silverman S.L.; Reginster J.; Czerwinski E. et al.. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis International. 2024;1-12$$$$F$Y$$$20240807$$HP$US$US
241834311$24183431$1$I$$20240729$20240807$20240807$EXP$$IT-SANDOZ INC.-NVSC2022IT259060$SANDOZ$Marina M, Erika M, Luliana B, Federica C, Giovanni R, Luisa B. Challenges in the diagnostic approach of pulmonary embolism: COVID-19 or autoimmune manifestation? What is the better therapy?. 59TH NATIONAL CONGRESS OF THE ITALIAN SOCIETY OF RHEUMATOLOGY. 2022;1-2$$$N$$Y$$$20240807$$MD$IT$IT
241834321$24183432$1$I$$20240308$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2024CN026313$SANDOZ$Xiumei Z. Atorvastatin combined with ezetimibe Analysis of clinical efficacy in treating coronary heart disease and hyperlipidemia in the elderly. JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH. 2023;2(35):72-74$$$$$Y$$$20240807$$MD$CN$CN
241834331$24183433$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003694$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241834341$24183434$1$I$$20240806$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408004073$ELI LILLY AND CO$$$$$M$Y$$$20240807$$CN$US$US
241834351$24183435$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003124$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240807$$CN$US$US
241834361$24183436$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408000353$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240807$$CN$US$US
241834371$24183437$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003097$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240807$$HP$US$US
241834381$24183438$1$I$$20240726$20240807$20240807$EXP$$NL-AUROBINDO-AUR-APL-2024-038336$AUROBINDO$$69$YR$$M$Y$106$KG$20240807$$CN$NL$NL
241834401$24183440$1$I$$20240730$20240807$20240807$EXP$$AU-MYLANLABS-2024M1072725$MYLAN$Yang J, McCarthy J, Shah SS, Ng E, Shen J, Libianto R, et al. Challenges in Diagnosing and Managing the Spectrum of Primary Aldosteronism. J-Endocr-Soc 2024; 8 (7):.$77$YR$$M$Y$$$20240807$$MD$AU$AU
241834411$24183441$1$I$$20240723$20240807$20240807$EXP$$XK-LEADINGPHARMA-XK-2024LEALIT00348$LEADING PHARMA$Xhevdet Krasniqi.Acute myocardial infarction and polycythemia rubra vera: The double effect of treatment with hydroxyurea.Radiology Case Reports.25-MAY-2024;19:3386-3389$35$YR$A$F$Y$$$20240807$$MD$XK$XK
241834421$24183442$1$I$20240727$20240729$20240807$20240807$PER$$US-BAUSCHBL-2024BNL030839$BAUSCH AND LOMB$$$$$F$Y$$$20240807$$CN$US$US
241834431$24183443$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160419$NOVARTIS$$$$$$Y$$$20240807$$MD$US$US
241834451$24183445$1$I$$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124281$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240807$$CN$US$US
241834461$24183446$1$I$20240101$20240731$20240807$20240807$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00276$CATALYST PHARMA$$$$$F$Y$44.898$KG$20240807$$CN$US$US
241834471$24183447$1$I$20240707$20240727$20240807$20240807$EXP$$IN-ROCHE-10000041659$ROCHE$$63$YR$A$M$Y$$$20240807$$CN$IN$IN
241834481$24183448$1$I$20240705$20240801$20240807$20240807$EXP$$CA-TAKEDA-2023TUS079845$TAKEDA$$63$YR$$F$Y$$$20240807$$CN$CA$CA
241834501$24183450$1$I$20240726$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54080$$FDA-CTU$$82$YR$$F$N$85.9$KG$20240806$N$PH$US$
241834511$24183451$1$I$20240803$20240806$20240806$20240806$DIR$713168$$FDA-CTU$$72$YR$$F$N$97$KG$20240806$N$PH$US$
241834521$24183452$1$I$$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037882$AUROBINDO$$23$YR$$$Y$$$20240807$$CN$GB$GB
241834543$24183454$3$F$$20240828$20240807$20240830$30DAY$$AU-PFIZER INC-202400227783$PFIZER$$6$DEC$$F$Y$$$20240830$$CN$AU$AU
241834551$24183455$1$I$$20240801$20240807$20240807$30DAY$$US-PFIZER INC-PV202400044211$PFIZER$$$$$$Y$$$20240807$$HP$US$US
241834562$24183456$2$F$20240801$20240906$20240807$20240906$PER$$US-PFIZER INC-202400229675$PFIZER$$13$YR$$M$Y$$$20240906$$CN$US$US
241834572$24183457$2$F$20240601$20240927$20240807$20240927$EXP$$US-PFIZER INC-202400229136$PFIZER$$68$YR$$M$Y$$$20240927$$HP$US$US
241834583$24183458$3$F$20240101$20240913$20240807$20240916$30DAY$$US-PFIZER INC-202400229188$PFIZER$$38$YR$$F$Y$61.224$KG$20240916$$CN$US$US
241834592$24183459$2$F$$20240820$20240807$20240826$30DAY$$CO-PFIZER INC-PV202400101637$PFIZER$$$$$M$Y$$$20240826$$CN$CO$CO
241834612$24183461$2$F$$20240907$20240807$20240909$PER$$US-PFIZER INC-PV202400101730$PFIZER$$$$$$Y$$$20240909$$CN$US$US
241834621$24183462$1$I$$20240801$20240807$20240807$30DAY$$CA-PFIZER INC-202400229267$PFIZER$$80$YR$$F$Y$$$20240807$$CN$CA$CA
241834632$24183463$2$F$20240802$20240812$20240807$20240812$EXP$$US-PFIZER INC-202400229688$PFIZER$$$$$$Y$$$20240812$$HP$US$US
241834643$24183464$3$F$20240101$20240918$20240807$20240920$EXP$$US-PFIZER INC-202400230473$PFIZER$$21$YR$$F$Y$61.224$KG$20240920$$HP$US$US
241834661$24183466$1$I$$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-54060$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
241834671$24183467$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54117$$FDA-CTU$$46$YR$$F$N$$$20240806$N$$US$
241834692$24183469$2$F$20240725$20240808$20240807$20240815$EXP$$PK-ROCHE-10000045475$ROCHE$$57$YR$A$M$Y$$$20240815$$CN$PK$PK
241834701$24183470$1$I$20231208$20240730$20240807$20240807$EXP$$FR-AstraZeneca-2024A177528$ASTRAZENECA$$19$DY$$M$Y$$$20240807$$MD$FR$
241834711$24183471$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54096$$FDA-CTU$$47$YR$$F$N$98$LBS$20240806$N$$US$
241834721$24183472$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54087$$FDA-CTU$$44$YR$$F$N$249$LBS$20240806$N$$US$
241834741$24183474$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54062$$FDA-CTU$$69$YR$$F$N$221$LBS$20240806$N$$US$
241834752$24183475$2$F$20240725$20240913$20240807$20240917$EXP$$US-SANDOZ INC.-SDZ2024US070707$SANDOZ$$76$YR$$M$Y$86$KG$20240917$$MD$US$US
241834761$24183476$1$I$$20240730$20240807$20240807$EXP$$ZA-AstraZeneca-2024A173576$ASTRAZENECA$$52$YR$$M$Y$$$20240807$$CN$ZA$
241834771$24183477$1$I$$20240807$20240807$20240807$EXP$FR-MLMSERVICE-20240730-PI148643-00050-2$FR-ROCHE-10000050951$ROCHE$Fidan I, Fidan I, Delamotte E, Colombier M, Agossa K. Non-surgical Treatment of Severe Drug-Influenced Gingival Enlargement: A Report of Two Cases. Cureus. 2024;16 (6):e63214. doi:10.7759/cureus.63214.$58$YR$A$M$Y$$$20240807$$HP$FR$FR
241834781$24183478$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54074$$FDA-CTU$$38$YR$$M$N$$$20240806$N$$US$
241834792$24183479$2$F$$20240819$20240807$20240822$EXP$$NVSC2024CN159902$NOVARTIS$$$$$$Y$$$20240822$$MD$CN$CN
241834811$24183481$1$I$20240212$20240324$20240807$20240807$EXP$$NVSC2023IL141696$NOVARTIS$$32$YR$$F$Y$$$20240807$$HP$IL$IL
241834822$24183482$2$F$20240101$20240827$20240807$20240906$PER$$US-MYLANLABS-2024M1070960$MYLAN$$$$$F$Y$60.78$KG$20240906$$CN$US$US
241834831$24183483$1$I$$20240729$20240807$20240807$EXP$$US-VIVUS, Inc.-2024V1000959$VIVUS$$$$A$F$Y$$$20240806$$CN$US$US
241834841$24183484$1$I$20240805$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156091$AMGEN$$76$YR$E$F$Y$$$20240807$$CN$US$US
241834854$24183485$4$F$20240101$20240814$20240807$20240816$PER$$US-AMGEN-USASP2024155601$AMGEN$$74$YR$E$F$Y$$$20240816$$CN$US$US
241834861$24183486$1$I$20220101$20240807$20240807$20240807$EXP$$NZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044223$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240807$$HP$NZ$NZ
241834871$24183487$1$I$20231221$20240805$20240807$20240807$EXP$FR-AFSSAPS-ST2024001261$FR-JNJFOC-20240815142$JOHNSON AND JOHNSON$$63$YR$A$F$Y$105$KG$20240807$$HP$FR$FR
241834882$24183488$2$F$$20240805$20240807$20240811$PER$$US-AMGEN-USASP2024156138$AMGEN$$$$$M$Y$$$20240811$$HP$US$US
241834892$24183489$2$F$$20240805$20240807$20240807$EXP$$US-GILEAD-2024-0683149$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241834911$24183491$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124318$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$88.9$KG$20240807$$CN$US$US
241834921$24183492$1$I$20240618$20240805$20240807$20240807$EXP$$US-GILEAD-2024-0682941$GILEAD$$52$YR$A$F$Y$72.109$KG$20240807$$HP$US$US
241834931$24183493$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124264$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240807$$CN$US$US
241834941$24183494$1$I$20240805$20240805$20240807$20240807$EXP$$US-BAYER-2024A113120$BAYER$$75$YR$E$M$Y$$$20240807$$CN$US$US
241834951$24183495$1$I$20240802$20240802$20240807$20240807$EXP$$US-AMGEN-USASP2024154639$AMGEN$$58$YR$A$F$Y$$$20240807$$CN$US$US
241834963$24183496$3$F$20240804$20240911$20240807$20240912$PER$$US-AMGEN-USASP2024156025$AMGEN$$75$YR$E$F$Y$$$20240912$$CN$US$US
241834971$24183497$1$I$$20240802$20240807$20240807$EXP$$IT-AMGEN-ITASP2024155074$AMGEN$Gaio M.; Vastarella M.; Sullo M. et al.. Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis. Pharmaceuticals. 2024;17 (7):1-15$$$$$Y$$$20240807$$HP$IT$IT
241834981$24183498$1$I$20240101$20240615$20240807$20240807$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000083$UROGEN PHARMA$$$$$$Y$$$20240807$$CN$US$US
241834991$24183499$1$I$$20240612$20240807$20240807$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000081$UROGEN PHARMA$$$$$$Y$$$20240807$$$US$US
241835001$24183500$1$I$$20220531$20240807$20240807$EXP$$US-AstraZeneca-2022A206400$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241835011$24183501$1$I$20220124$20220124$20240807$20240807$EXP$$CA-AstraZeneca-2022A046463$ASTRAZENECA$$24851$DY$$M$Y$$$20240807$$CN$CA$
241835021$24183502$1$I$$20240724$20240807$20240807$EXP$$IN-Innogenix, LLC-2160117$INNOGENIX$Full text$16$YR$$M$Y$$$20240807$$$IN$IN
241835031$24183503$1$I$20240101$20240729$20240807$20240807$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022890$UNITED THERAPEUTICS$$$$$F$Y$49.887$KG$20240807$$$US$US
241835041$24183504$1$I$$20240801$20240807$20240807$EXP$$US-MYLANLABS-2024M1073478$MYLAN$Malik S, Brucato MF, Faiver L, Phan T, Yassin MH, Bishop JM, et al. Severe Fatal ARDS Due to Untreated Human Granulocytic Anaplasmosis in a 67-Year-Old Man: A Case Report. Am-J-Case-Rep 2024; 25 (0):.$67$YR$$M$Y$$$20240807$$HP$US$US
241835051$24183505$1$I$$20240804$20240807$20240807$EXP$GB-MHRA-MED-202408042322104450-DZMQV$GB-MYLANLABS-2024M1072862$MYLAN$$21$YR$$F$Y$55$KG$20240807$$CN$GB$GB
241835061$24183506$1$I$$20240801$20240807$20240807$EXP$$GB-MYLANLABS-2024M1065323$MYLAN$$$$$F$Y$$$20240807$$CN$GB$GB
241835071$24183507$1$I$20240604$20240804$20240807$20240807$EXP$$GB-MYLANLABS-2024M1072736$MYLAN$$85$YR$$F$Y$76$KG$20240807$$CN$GB$GB
241835081$24183508$1$I$$20240801$20240807$20240807$EXP$$IN-MYLANLABS-2024M1073476$MYLAN$Joseph JT, Jammigumpula A, Jaise J, Naik P, Purohith AN, Shenoy S, et al. Long-term repetitive transcranial magnetic stimulation for treatment-resistant depression: Report of two cases. Indian-J-Psychiatry 2024; 66 (7): 679-681.$56$YR$$M$Y$$$20240807$$HP$IN$IN
241835091$24183509$1$I$$20240729$20240807$20240807$EXP$$US-MYLANLABS-2024M1072750$MYLAN$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy. Exp-Clin-Transplant 2024; 22 (5): 392-395.$68$YR$$F$Y$$$20240807$$HP$US$US
241835102$24183510$2$F$$20240912$20240807$20240912$30DAY$$JO-PFIZER INC-202400223780$PFIZER$$$$$$Y$$$20240912$$CN$JO$JO
241835111$24183511$1$I$$20240806$20240807$20240807$PER$$US-HALEON-2190793$Haleon PLC$$$$$$Y$$$20240807$$CN$US$US
241835121$24183512$1$I$20240726$20240805$20240807$20240807$EXP$GB-MHRA-MED-202408051140567160-HBMFC$GB-PFIZER INC-202400230209$PFIZER$$33$YR$$M$Y$$$20240807$$PH$GB$GB
241835132$24183513$2$F$20240801$20240807$20240807$20240810$PER$$US-AMGEN-USASP2024154615$AMGEN$$59$YR$A$F$Y$$$20240810$$HP$US$US
241835142$24183514$2$F$$20240805$20240807$20240809$EXP$$US-ROCHE-10000049849$ROCHE$$$$E$F$Y$$$20240809$$CN$US$US
241835151$24183515$1$I$20240624$20240731$20240807$20240807$EXP$$CO-UCBSA-2024039573$UCB$$75$YR$$M$Y$$$20240807$$CN$CO$CO
241835161$24183516$1$I$$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037970$AUROBINDO$$84$YR$$F$Y$$$20240807$$MD$GB$GB
241835171$24183517$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038834$AUROBINDO$$$$$M$Y$$$20240807$$HP$CA$CA
241835181$24183518$1$I$$20240805$20240807$20240807$EXP$$NVSC2024US160355$NOVARTIS$$$$$M$Y$$$20240807$$CN$US$US
241835191$24183519$1$I$$20240802$20240807$20240807$EXP$$US-BIOGEN-2024BI01276945$BIOGEN$$$$$F$Y$$$20240807$$MD$US$US
241835201$24183520$1$I$20240101$20240730$20240807$20240807$PER$$US-ABBVIE-5861644$ABBVIE$$$$A$F$Y$$$20240807$$HP$US$US
241835211$24183521$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124161$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240807$$CN$US$US
241835221$24183522$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124048$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240807$$HP$US$US
241835231$24183523$1$I$20240701$20240802$20240807$20240807$EXP$$US-ABBVIE-5867264$ABBVIE$$65$YR$$F$Y$$$20240807$$CN$US$US
241835241$24183524$1$I$$20240806$20240807$20240807$EXP$GB-MHRA-MED-202408061233211950-KGVQH$GB-MYLANLABS-2024M1073338$MYLAN$$$$$M$Y$$$20240807$$CN$GB$GB
241835251$24183525$1$I$20240719$20240806$20240807$20240807$EXP$GB-MHRA-31414252$GB-MYLANLABS-2024M1073444$MYLAN$$73$YR$$F$Y$77$KG$20240807$$CN$GB$GB
241835261$24183526$1$I$20240504$20240729$20240807$20240807$EXP$$MX-Rare Disease Therapeutics, Inc.-2160119$RARE DISEASE THERAPEUTICS$$20$YR$$F$Y$62$KG$20240807$$PH$MX$MX
241835271$24183527$1$I$$20240731$20240807$20240807$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00825$CATALYST PHARMA$$$$$$Y$$$20240807$$CN$US$US
241835281$24183528$1$I$$20240801$20240807$20240807$EXP$$US-ALXN-202408USA000178US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$MD$US$US
241835291$24183529$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038906$AUROBINDO$$72$YR$$F$Y$$$20240807$$HP$CA$CA
241835301$24183530$1$I$$20240805$20240807$20240807$EXP$$JP-BAYER-2024A113263$BAYER$$$$$M$Y$$$20240807$$MD$JP$JP
241835311$24183531$1$I$20240715$20240729$20240807$20240807$PER$$US-009507513-2407USA015246$MERCK$$72$YR$$F$Y$$$20240807$$CN$US$US
241835321$24183532$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54068$$FDA-CTU$$72$YR$$F$N$$$20240806$N$$US$
241835331$24183533$1$I$20240228$20240730$20240807$20240807$EXP$$CH-TAKEDA-2024TUS077699$TAKEDA$$68$YR$$M$Y$$$20240807$$HP$CH$CH
241835341$24183534$1$I$$20240724$20240807$20240807$EXP$$PL-Innogenix, LLC-2160120$INNOGENIX$Full text$57$YR$$F$Y$$$20240807$$$PL$PL
241835351$24183535$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54116$$FDA-CTU$$60$YR$$F$N$300$LBS$20240806$N$HP$US$
241835361$24183536$1$I$$20240806$20240806$20240806$DIR$713157$$FDA-CTU$$$$$UNK$N$$$20240806$$CN$US$
241835371$24183537$1$I$$20240729$20240807$20240807$EXP$$CA-APOTEX-2024AP009000$APOTEX$$63$YR$$F$Y$$$20240807$$HP$CA$CA
241835381$24183538$1$I$$20240806$20240806$20240806$DIR$713192$$FDA-CTU$$$$$UNK$N$$$20240806$N$CN$US$
241835391$24183539$1$I$$20240507$20240807$20240807$EXP$US-MLMSERVICE-20240501-PI041964-00153-1-00$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06647$HIKMA$Haghparast, P., Nadybal, M., Yuan, C. Haghparast P, Nadybal M, Yuan C. Treatment-Resistant Priapism in a 61-Year-Old Male After Combined Use of Trazodone, Quetiapine, and Fluoxetine. Journal of clinical psychopharmacology. 2024;44(3):316-317$61$YR$$M$Y$105$KG$20240807$$PH$US$US
241835401$24183540$1$I$$20240805$20240807$20240807$EXP$$HK-MYLANLABS-2024M1073441$MYLAN$$$$$M$Y$$$20240807$$CN$HK$HK
241835411$24183541$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54078$$FDA-CTU$$59$YR$$F$N$$$20240806$N$$US$
241835421$24183542$1$I$20240723$20240724$20240807$20240807$EXP$$US-UCBSA-2024037676$UCB$$29$YR$$F$Y$$$20240807$$HP$US$US
241835431$24183543$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-038891$AUROBINDO$$74$YR$$M$Y$$$20240807$$HP$CA$CA
241835441$24183544$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54094$$FDA-CTU$$70$YR$$F$N$$$20240806$N$$US$
241835455$24183545$5$F$$20240909$20240807$20240912$EXP$$AT-ORGANON-O2408AUT000425$ORGANON$$66$YR$$F$Y$$$20240912$$MD$AT$AT
241835461$24183546$1$I$20240806$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54119$$FDA-CTU$$86$YR$$F$N$$$20240806$N$HP$US$
241835481$24183548$1$I$20240101$20240729$20240807$20240807$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011945$JAZZ$$76$YR$$F$Y$$$20240807$$MD$JP$JP
241835491$24183549$1$I$$20240731$20240807$20240807$EXP$$JP-GENMAB-2024-02769$GENMAB$$$$$$Y$$$20240807$$PH$JP$JP
241835502$24183550$2$F$20240501$20240905$20240807$20240918$EXP$$JP-INSMED, INC.-2024-01895-JP$INSMED$$79$YR$$F$Y$$$20240918$$CN$JP$JP
241835513$24183551$3$F$$20240912$20240807$20240923$EXP$$US-TAKEDA-2024TUS078505$TAKEDA$$$$$F$Y$127$KG$20240923$$MD$US$US
241835522$24183552$2$F$$20240802$20240807$20240820$EXP$$JP-ABBVIE-5867105$ABBVIE$Shimizu A, Tsuboi N, Haruhara K, Shirai I, Ogawa K, Miura A, et al. Active flare of IgA nephropathy during long-term therapy with anti-tumor necrosis factor-  antibody drugs for Crohn^s disease: three case reports and literature review. CEN Case Rep. 2023;13(4):249-257.$30$YR$$M$Y$$$20240820$$HP$JP$JP
241835531$24183553$1$I$20240509$20240730$20240807$20240807$EXP$$MX-Rare Disease Therapeutics, Inc.-2160121$RARE DISEASE THERAPEUTICS$$36$YR$$M$Y$120$KG$20240807$$PH$MX$MX
241835542$24183554$2$F$20240808$20240808$20240807$20240814$EXP$$CA-BIOGEN-2024BI01276927$BIOGEN$$40$YR$$F$Y$$$20240814$$CN$CA$CA
241835561$24183556$1$I$$20240730$20240807$20240807$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06817$VIFOR$$78$YR$$M$Y$$$20240807$$HP$ZA$ZA
241835571$24183557$1$I$$20240731$20240807$20240807$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06884$VIFOR$$$$A$F$Y$$$20240807$$CN$ZA$ZA
241835581$24183558$1$I$$20240731$20240807$20240807$PER$$US-MYLANLABS-2024M1072368$MYLAN$$$$$$Y$$$20240807$$CN$US$US
241835591$24183559$1$I$$20240806$20240807$20240807$PER$$US-TAKEDA-2024TUS078861$TAKEDA$$$$$$Y$$$20240807$$CN$US$US
241835601$24183560$1$I$$20240801$20240807$20240807$PER$$US-TAKEDA-2024TUS077749$TAKEDA$$$$$F$Y$$$20240807$$CN$US$US
241835612$24183561$2$F$20240101$20240919$20240807$20240927$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00827$CATALYST PHARMA$$$$$M$Y$106.12$KG$20240927$$CN$US$US
241835621$24183562$1$I$$20240801$20240807$20240807$30DAY$$US-GSK-US2024096383$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241835631$24183563$1$I$$20240731$20240807$20240807$EXP$$US-GSK-US2024095711$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
241835641$24183564$1$I$$20240806$20240807$20240807$EXP$$US-BAYER-2024A113457$BAYER$$$$$M$Y$$$20240807$$CN$US$US
241835651$24183565$1$I$$20240311$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2024CN027193$SANDOZ$Hu C, Yang T, Jun L, Zhang W, Guo B, Wang C, Liu J, Xiao C, Huang D, Yang Z, Liu T.. Zanubrutinib Combined with R-CHOP As the First-Line Treatment for Newly Diagnosed Diffuse Large B-CellLymphoma with Extranodal Involvement: A Prospective Phase II Trial in China. Blood. 2023;142:6285-6286$$$$$Y$$$20240807$$HP$CN$CN
241835662$24183566$2$F$20240802$20240827$20240807$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408003787$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240830$$CN$US$US
241835671$24183567$1$I$20240701$20240806$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408004027$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240807$$CN$US$US
241835681$24183568$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160806$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241835692$24183569$2$F$$20240812$20240807$20240820$EXP$$US-TEVA-VS-3228598$TEVA$Sahni T, Vessal A, Mayo-Olano S, Silverman B. Catastrophic Antiphospholipid Syndrome as a Unique Trigger for Rapidly Progressive Interstitial Lung Disease. Am-J-Respir-Crit-Care-Med 2024; 209 A1974.; Sahni T, Vessal A, Mayo-Olano S, Silverman B. Catastrophic Antiphospholipid Syndrome as a Unique Trigger for Rapidly Progressive Interstitial Lung Disease. Am-J-Respir-Crit-Care-Med 2024; 209 A1974.$46$YR$$F$Y$$$20240820$$HP$US$US
241835702$24183570$2$F$$20240809$20240807$20240809$EXP$$TW-BAYER-2024A113539$BAYER$$63$YR$A$M$Y$$$20240809$$HP$TW$TW
241835711$24183571$1$I$20240710$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154696$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241835721$24183572$1$I$20240710$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154765$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241835732$24183573$2$F$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0683150$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241835741$24183574$1$I$$20240731$20240807$20240807$EXP$$JP-AMGEN-JPNSP2024155452$AMGEN$$$$A$F$Y$$$20240807$$MD$JP$JP
241835751$24183575$1$I$20240804$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155890$AMGEN$$24$YR$A$F$Y$$$20240807$$CN$US$US
241835761$24183576$1$I$$20240731$20240807$20240807$EXP$$DE-AMGEN-DEUSP2024153144$AMGEN$$60$YR$A$M$Y$$$20240807$$HP$DE$DE
241835771$24183577$1$I$20220101$20240730$20240807$20240807$EXP$$FR-MYLANLABS-2024M1071087$MYLAN$Furst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R, et al.. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLAimmunized adults with sickle cell disease.. Bone Marrow Transplantation.. 2024;59 (7):918-27$30$YR$$F$Y$$$20240807$$HP$FR$FR
241835782$24183578$2$F$20240701$20240830$20240807$20240906$EXP$$US-AstraZeneca-2024A169676$ASTRAZENECA$$777$MON$$M$Y$$$20240906$$CN$US$
241835791$24183579$1$I$20240703$20240802$20240807$20240807$EXP$FR-AFSSAPS-LL2024001511$FR-TAKEDA-2024TUS077653$TAKEDA$$84$YR$$M$Y$$$20240807$$HP$FR$FR
241835801$24183580$1$I$$20240731$20240807$20240807$EXP$$US-OTSUKA-2024_021426$OTSUKA$$$$$$Y$$$20240807$$HP$US$US
241835811$24183581$1$I$20191213$20240724$20240807$20240807$EXP$$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-07097$HIKMA$$$$$$Y$$$20240807$$MD$DE$DE
241835822$24183582$2$F$$20240807$20240807$20240815$EXP$$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-07297$HIKMA$$$$$$Y$$$20240815$$MD$GB$GB
241835831$24183583$1$I$$20240730$20240807$20240807$EXP$$ZA-AstraZeneca-2024A173852$ASTRAZENECA$$74$YR$$M$Y$$$20240807$$CN$ZA$
241835841$24183584$1$I$20171001$20240726$20240807$20240807$EXP$$ES-AUROBINDO-AUR-APL-2024-038132$AUROBINDO$$74$YR$$F$Y$65$KG$20240807$$CN$ES$ES
241835851$24183585$1$I$$20240724$20240807$20240807$EXP$$IN-Eywa Pharma Inc.-2160122$EYWA PHARMA$Full text$16$YR$$M$Y$$$20240807$$$IN$IN
241835862$24183586$2$F$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0683142$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241835874$24183587$4$F$20240802$20240820$20240807$20240917$PER$$US-AMGEN-USASP2024155614$AMGEN$$87$YR$E$M$Y$$$20240916$$CN$US$US
241835881$24183588$1$I$20240724$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54113$$FDA-CTU$$80$YR$$M$N$$$20240806$N$$US$
241835891$24183589$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54129$$FDA-CTU$$37$YR$$F$N$$$20240806$N$$US$
241835901$24183590$1$I$20240805$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54071$$FDA-CTU$$67$YR$$F$N$$$20240806$N$HP$US$
241835911$24183591$1$I$20240701$20240802$20240807$20240807$EXP$$US-AMGEN-USASL2024142513$AMGEN$$60$YR$A$F$Y$$$20240807$$MD$US$US
241835932$24183593$2$F$$20240906$20240807$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124290$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240910$$CN$US$US
241835941$24183594$1$I$$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-54089$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
241835951$24183595$1$I$20240806$20240806$20240807$20240807$EXP$$US-BAYER-2024A113660$BAYER$$49$YR$A$F$Y$$$20240807$$CN$US$US
241835961$24183596$1$I$$20240729$20240807$20240807$PER$$US-MYLANLABS-2024M1070898$MYLAN$$$$$F$Y$$$20240807$$CN$US$US
241835981$24183598$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2019-057025$AUROBINDO$$55$YR$$M$Y$$$20240807$$HP$CA$CA
241835991$24183599$1$I$20240101$20240724$20240807$20240807$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000152$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240807$$CN$US$US
241836001$24183600$1$I$$20240228$20240807$20240807$EXP$$CN-SANDOZ INC.-SDZ2024CN021450$SANDOZ$Wu Wenzhen; Wang Yiting. Clinical value of atorvastatin in emergency treatment of myocardial infarction. Corporate hygiene in urban and rural areas of China. 2024;119-121$$$$$Y$$$20240807$$HP$CN$CN
241836031$24183603$1$I$20240727$20240806$20240806$20240806$DIR$713202$$FDA-CTU$$79$YR$$F$N$89.1$KG$20240806$N$HP$US$
241836041$24183604$1$I$20240806$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54072$$FDA-CTU$$65$YR$$F$N$$$20240806$Y$HP$US$
241836061$24183606$1$I$$20240805$20240807$20240807$EXP$$MX-TAKEDA-2024TUS078843$TAKEDA$$$$$$Y$$$20240807$$HP$MX$MX
241836071$24183607$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160825$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241836081$24183608$1$I$20230419$20240801$20240807$20240807$EXP$FR-AFSSAPS-AM2024000595$FR-MYLANLABS-2024M1072159$MYLAN$$43$YR$$M$Y$110$KG$20240807$$MD$FR$FR
241836091$24183609$1$I$20240408$20240801$20240807$20240807$EXP$FR-AFSSAPS-DJ2024000844$FR-MYLANLABS-2024M1072463$MYLAN$$51$YR$$M$Y$108$KG$20240807$$MD$FR$FR
241836101$24183610$1$I$20230701$20240801$20240807$20240807$EXP$FR-AFSSAPS-TS2024000855$FR-MYLANLABS-2024M1072444$MYLAN$$57$YR$$M$Y$68$KG$20240807$$MD$FR$FR
241836111$24183611$1$I$20240704$20240801$20240807$20240807$EXP$IT-MINISAL02-996619$IT-MYLANLABS-2024M1071895$MYLAN$$48$YR$$F$Y$53$KG$20240807$$MD$IT$IT
241836121$24183612$1$I$$20240805$20240807$20240807$EXP$$US-BEH-2024176883$CSL BEHRING$$$$E$F$Y$$$20240807$$HP$US$US
241836131$24183613$1$I$20240715$20240715$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051067$TOLMAR$$68$YR$$M$Y$$$20240807$$CN$CA$CA
241836141$24183614$1$I$20240715$20240715$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051037$TOLMAR$$66$YR$$M$Y$$$20240807$$CN$CA$CA
241836151$24183615$1$I$20240706$20240715$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051013$TOLMAR$$75$YR$$M$Y$$$20240807$$CN$CA$CA
241836161$24183616$1$I$$20240715$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051103$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
241836171$24183617$1$I$20240715$20240715$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051092$TOLMAR$$81$YR$$M$Y$$$20240807$$CN$CA$CA
241836181$24183618$1$I$20240715$20240715$20240807$20240807$PER$$FR-TOLMAR, INC.-24FR051031$TOLMAR$$73$YR$$M$Y$$$20240807$$PH$FR$FR
241836191$24183619$1$I$20240715$20240715$20240807$20240807$PER$$FR-TOLMAR, INC.-24FR051072$TOLMAR$$76$YR$$M$Y$$$20240807$$PH$FR$FR
241836201$24183620$1$I$20240101$20240715$20240807$20240807$PER$$CO-TOLMAR, INC.-24CO051108$TOLMAR$$$$$M$Y$$$20240807$$CN$CO$CO
241836211$24183621$1$I$$20240715$20240807$20240807$PER$$NL-TOLMAR, INC.-24NL050987$TOLMAR$$$$$M$Y$$$20240807$$CN$NL$NL
241836221$24183622$1$I$20240806$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54086$$FDA-CTU$$74$YR$$F$N$$$20240806$Y$HP$US$
241836231$24183623$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54099$$FDA-CTU$$81$YR$$M$N$$$20240806$N$$US$
241836243$24183624$3$F$20240101$20240905$20240807$20240909$EXP$$US-JNJFOC-20240725659$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240910$$CN$US$US
241836251$24183625$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54102$$FDA-CTU$$55$YR$$F$N$$$20240806$N$$US$
241836261$24183626$1$I$$20240726$20240807$20240807$EXP$$CA-AUROBINDO-AUR-APL-2024-039119$AUROBINDO$$78$YR$$F$Y$$$20240807$$HP$CA$CA
241836271$24183627$1$I$20240728$20240731$20240807$20240807$EXP$$CN-009507513-2408CHN001079$MERCK$$51$YR$$M$Y$67$KG$20240807$$HP$CN$CN
241836284$24183628$4$F$20240314$20240809$20240807$20240925$EXP$$GB-BEH-2024169163$CSL BEHRING$$64$YR$A$F$Y$$$20240925$$HP$GB$GB
241836301$24183630$1$I$20240726$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154768$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241836311$24183631$1$I$20240731$20240806$20240807$20240807$PER$$US-AMGEN-USASP2024156654$AMGEN$$79$YR$E$M$Y$$$20240807$$CN$US$US
241836321$24183632$1$I$20221001$20221114$20240807$20240807$EXP$$KW-BIOVITRUM-2022KW13517$BIOVITRUM$$2$MON$$F$Y$$$20240807$$CN$KW$KW
241836331$24183633$1$I$20221116$20221117$20240807$20240807$EXP$$BR-BIOVITRUM-2022BR13888$BIOVITRUM$$181$DY$$M$Y$$$20240807$$CN$BR$BR
241836341$24183634$1$I$20240318$20240724$20240807$20240807$EXP$IT-MINISAL02-995586$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-07034$HIKMA$$57$YR$$F$Y$54$KG$20240807$$MD$IT$IT
241836351$24183635$1$I$$20240728$20240807$20240807$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000154$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240807$$CN$US$US
241836361$24183636$1$I$20230228$20231017$20240807$20240807$EXP$$MX-BIOVITRUM-2023-MX-017147$BIOVITRUM$$152$DY$$F$Y$$$20240807$$CN$MX$MX
241836391$24183639$1$I$$20240802$20240807$20240807$EXP$$MY-PFIZER INC-PV202400101574$PFIZER$Goh, A.. Acute myopathy after status asthmaticus: Steroids, myorelaxants or carbon dioxide?. Respirology. 1999;4:97-99$11$YR$$M$Y$$$20240807$$HP$MY$MY
241836401$24183640$1$I$$20240802$20240807$20240807$EXP$$ES-PFIZER INC-PV202400101354$PFIZER$Silvente Bernal, S.. Late effects of Wilms^ tumor treatment. Cirugia Pediatrica. 2024;37(3):116-122$$$$M$Y$$$20240807$$MD$ES$ES
241836411$24183641$1$I$$20240802$20240807$20240807$EXP$$MY-PFIZER INC-202400230149$PFIZER$GOH, A.. Acute myopathy after status asthmaticus: Steroids, myorelaxants or carbon dioxide?. Respirology. 1999;4(1):97-99$11$YR$$M$Y$$$20240807$$HP$MY$MY
241836423$24183642$3$F$$20240919$20240807$20240919$30DAY$$US-PFIZER INC-202400226015$PFIZER$$11$YR$$F$Y$$$20240919$$MD$US$US
241836431$24183643$1$I$$20240726$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-037923$AUROBINDO$$44$YR$$F$Y$$$20240807$$PH$GB$GB
241836441$24183644$1$I$$20240802$20240807$20240807$EXP$$CA-PFIZER INC-202400230404$PFIZER$$66$YR$$M$Y$$$20240807$$HP$CA$CA
241836451$24183645$1$I$20240725$20240729$20240807$20240807$30DAY$$CL-PFIZER INC-202400227528$PFIZER$$8$YR$$$Y$$$20240807$$CN$CL$CL
241836461$24183646$1$I$20210101$20240806$20240807$20240807$EXP$SE-SEMPA-2024-005863$SE-ORGANON-O2408SWE000446$ORGANON$$77$YR$$F$Y$$$20240807$$CN$SE$SE
241836471$24183647$1$I$$20240723$20240807$20240807$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07411$LUPIN$Shultz J, Antar-Shultz M, Taha M, Zervogiannis P, Lazcano G, Lamarche J. Sevelamer-associated colitis: a trigger to change treatment approach. American Journal of Kidney Diseases. 2024;83 (4):S74$63$YR$$F$Y$$$20240807$$HP$US$US
241836491$24183649$1$I$20210311$20240730$20240807$20240807$EXP$$CO-UCBSA-2024039466$UCB$$62$YR$$F$Y$$$20240807$$CN$CO$CO
241836501$24183650$1$I$$20240729$20240807$20240807$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07410$HIKMA$Majid S, Hamzavi-Abedi Y.. Majid S, Hamzavi-Abedi Y. Correction to ^Dose Dependent: A Case report of NSAID-induced urticaria and angioedema in an otherwise asymptomatic individual M058^.. Ann Allergy Asthma Immunol.. 2023;131(5S1):S114$71$YR$$F$Y$$$20240807$$MD$US$US
241836511$24183651$1$I$$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024155193$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241836522$24183652$2$F$20240801$20240903$20240807$20240903$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044306$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240903$$CN$US$US
241836531$24183653$1$I$20240624$20240802$20240807$20240807$EXP$$CN-AMGEN-CHNSP2024154199$AMGEN$$56$YR$A$F$Y$66$KG$20240807$$HP$CN$CN
241836542$24183654$2$F$20240802$20240808$20240807$20240816$PER$$US-AMGEN-USASP2024154413$AMGEN$$75$YR$E$F$Y$$$20240816$$CN$US$US
241836551$24183655$1$I$$20240724$20240807$20240807$EXP$$US-IMMUNOGEN, INC.-US-IMGN-24-00592$IMMUNOGEN$$$$$F$Y$$$20240807$$CN$US$US
241836562$24183656$2$F$20240723$20240906$20240807$20240912$PER$$US-AstraZeneca-2024A169577$ASTRAZENECA$$19754$DY$$F$Y$$$20240912$$CN$US$
241836571$24183657$1$I$$20240726$20240807$20240807$PER$$US-AstraZeneca-2024A171902$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241836581$24183658$1$I$20240802$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124347$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240807$$HP$US$US
241836604$24183660$4$F$$20240909$20240807$20240917$30DAY$$US-PFIZER INC-202400227734$PFIZER$$12$YR$$M$Y$$$20240917$$CN$US$US
241836611$24183661$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002414$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240807$$CN$US$US
241836631$24183663$1$I$20240707$20240719$20240806$20240806$DIR$FDA-CDER-CTU-2024-54075$$FDA-CTU$$74$YR$$M$N$80$KG$20240719$N$PH$US$
241836641$24183664$1$I$20231106$20240802$20240807$20240807$EXP$$CA-UCBSA-2024022889$UCB$$38$YR$$F$Y$$$20240807$$CN$CA$CA
241836652$24183665$2$F$$20240906$20240807$20240909$30DAY$$US-PFIZER INC-202400227277$PFIZER$$8$YR$$M$Y$$$20240909$$CN$US$US
241836663$24183666$3$F$20240731$20240906$20240807$20240909$30DAY$$US-PFIZER INC-202400228137$PFIZER$$13$YR$$M$Y$$$20240909$$HP$US$US
241836684$24183668$4$F$20240731$20240919$20240807$20240923$30DAY$$US-PFIZER INC-202400229008$PFIZER$$15$YR$$M$Y$$$20240923$$CN$US$US
241836703$24183670$3$F$20240101$20240906$20240807$20240909$30DAY$$US-PFIZER INC-202400228497$PFIZER$$15$YR$$M$Y$$$20240909$$CN$US$US
241836731$24183673$1$I$$20240802$20240807$20240807$EXP$$CN-PFIZER INC-PV202400100806$PFIZER$Lin, Y.. Pharmaceutical care of acute liver injury in a patient with colon cancer induced by irinotecan. Chinese Journal of Pharmacovigilance. 2024;21(6):693-696$74$YR$$M$Y$62$KG$20240807$$PH$CN$CN
241836752$24183675$2$F$$20240816$20240807$20240821$EXP$$RU-TAKEDA-2024TUS078805$TAKEDA$$48$YR$$F$Y$90$KG$20240821$$CN$RU$RU
241836761$24183676$1$I$20240701$20240722$20240807$20240807$PER$$US-JNJFOC-20240763858$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240807$$CN$US$US
241836782$24183678$2$F$20240723$20240823$20240807$20240829$EXP$$US-ROCHE-10000050475$ROCHE$$67$YR$E$M$Y$$$20240829$$CN$US$US
241836791$24183679$1$I$20240527$20240730$20240807$20240807$EXP$IT-ALFASIGMA-2024-AER-03846$IT-ROCHE-10000043981$ROCHE$$72$YR$E$M$Y$70$KG$20240807$$HP$IT$IT
241836801$24183680$1$I$$20240801$20240807$20240807$PER$$US-BIOGEN-2024BI01277046$BIOGEN$$$$$F$Y$$$20240807$$HP$US$US
241836812$24183681$2$F$20240802$20240918$20240807$20240920$PER$$US-BIOGEN-2024BI01276853$BIOGEN$$54$YR$$F$Y$$$20240920$$CN$US$US
241836821$24183682$1$I$20240801$20240801$20240807$20240807$PER$$US-BIOGEN-2024BI01276633$BIOGEN$$63$YR$$F$Y$$$20240807$$CN$US$US
241836831$24183683$1$I$$20240801$20240807$20240807$PER$$US-BIOGEN-2024BI01276685$BIOGEN$$$$$F$Y$$$20240807$$MD$US$US
241836841$24183684$1$I$$20240730$20240807$20240807$EXP$$PT-Atnahs Limited-ATNAHS20240702199$Atnahs Healthcare$Joana FJ, Neves DSA, Pinheiro d, Vilas PA.. PO-0424 - (2190)- POLIMEDICACAO,UM PROBLEMA ATUAL  GRAVE (POLYMEDICATION, A  SERIOUS CURRENT PROBLEM).. Medicina geriatrica/ Caso clinico (Geriatric medicine | Clinical case). 785$85$YR$E$F$Y$$$20240807$$HP$PT$PT
241836851$24183685$1$I$$20240801$20240807$20240807$PER$$US-BIOGEN-2024BI01276847$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
241836861$24183686$1$I$$20240724$20240807$20240807$PER$$US-BAYER-2024A108635$BAYER$Austin J.E.; Begotka A.M.. A Diaper Fading Protocol to Treat Toilet Refusal: Four Case Studies. Cognitive and Behavioral Practice. 2024;31:3:(335-344)$30$MON$C$F$Y$$$20240807$$MD$US$US
241836871$24183687$1$I$$20240730$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005694$BIOCON$$$$$$Y$$$20240807$$MD$CA$CA
241836881$24183688$1$I$$20240805$20240807$20240807$EXP$$AU-GILEAD-2024-0683000$GILEAD$$$$$M$Y$$$20240807$$MD$AU$AU
241836891$24183689$1$I$$20240726$20240807$20240807$PER$$US-BAYER-2024A111396$BAYER$$$$$$Y$$$20240807$$CN$US$US
241836901$24183690$1$I$$20240801$20240807$20240807$EXP$GB-MHRA-MED-202408011231456190-JCPVZ$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-07458$HIKMA$$59$YR$$F$Y$$$20240807$$HP$GB$GB
241836911$24183691$1$I$$20240726$20240807$20240807$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07313$HIKMA$Venkatraman S, Mehta T, Deng F. Venkatraman S, Mehta T, Deng F. A Rare Neurotoxicity Syndrome Following Opioid Intoxication. Annals of Neurology. 2024;96(2):412-5$55$YR$$F$Y$$$20240807$$MD$US$US
241836922$24183692$2$F$20240507$20240903$20240807$20240906$PER$$US-GILEAD-2024-0682944$GILEAD$$71$YR$E$M$Y$103.2$KG$20240906$$HP$US$US
241836931$24183693$1$I$$20240801$20240807$20240807$EXP$$US-AMGEN-USASP2024153896$AMGEN$$$$A$M$Y$$$20240807$$HP$US$US
241836941$24183694$1$I$$20240728$20240807$20240807$EXP$$GB-AUROBINDO-AUR-APL-2024-038115$AUROBINDO$$$$$M$Y$$$20240807$$CN$GB$GB
241836951$24183695$1$I$$20240729$20240807$20240807$EXP$$US-AMGEN-USASP2024152706$AMGEN$Koethe, Y.. Safety and Effectiveness of Portal Vein Embolization after Hepatic Arterial Infusion Therapy. Journal of Vascular and Interventional Radiology. 2024;35(8):1209-1214$$$$$Y$$$20240807$$MD$US$US
241836962$24183696$2$F$20240101$20240906$20240807$20240909$30DAY$$US-PFIZER INC-202400227333$PFIZER$$16$YR$$M$Y$$$20240909$$CN$US$US
241836972$24183697$2$F$$20240906$20240807$20240909$30DAY$$US-PFIZER INC-202400227254$PFIZER$$14$YR$$M$Y$$$20240909$$CN$US$US
241836981$24183698$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160640$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241837001$24183700$1$I$$20240730$20240807$20240807$EXP$$NVSC2024GB159877$NOVARTIS$Abdolrasouli A, Borman AM, Johnson EM, Hay RJ, Arias M. Terbinafine-resistant Trichophyton indotineae causing extensive dermatophytosis in a returning traveller. CLIN EXP DERMATOL. 2024;49 (6):635-7$26$YR$$M$Y$$$20240807$$HP$GB$GB
241837011$24183701$1$I$20240614$20240806$20240806$20240806$DIR$713203$$FDA-CTU$$48$YR$$F$N$65.25$KG$20240806$N$CN$US$
241837021$24183702$1$I$20240701$20240727$20240807$20240807$EXP$GB-MHRA-MED-202407271347329580-PZMJK$GB-Atnahs Limited-ATNAHS20240802282$Atnahs Healthcare$$63$YR$A$F$Y$$$20240807$$CN$GB$GB
241837031$24183703$1$I$$20240729$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005631$BIOCON$$$$$$Y$$$20240807$$CN$CA$CA
241837041$24183704$1$I$20240730$20240731$20240807$20240807$PER$$US-ALXN-202407USA002222US$ALEXION PHARMACEUTICALS$$58$YR$$F$Y$$$20240807$$CN$US$US
241837051$24183705$1$I$$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-54073$$FDA-CTU$$75$YR$$M$N$$$20240805$N$HP$US$
241837062$24183706$2$F$20240402$20240905$20240807$20240911$PER$$US-GILEAD-2024-0682946$GILEAD$$59$YR$A$M$Y$$$20240911$$HP$US$US
241837073$24183707$3$F$20240101$20240909$20240807$20240910$PER$$US-AMGEN-USASP2024154426$AMGEN$$69$YR$E$M$Y$$$20240910$$CN$US$US
241837081$24183708$1$I$$20240727$20240807$20240807$PER$$US-BAYER-2024A110926$BAYER$$$$$$Y$$$20240807$$CN$US$US
241837091$24183709$1$I$20240729$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-54066$$FDA-CTU$$59$YR$$F$N$$$20240805$N$HP$US$
241837101$24183710$1$I$20240720$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-54093$$FDA-CTU$$77$YR$$F$N$$$20240805$N$HP$US$
241837111$24183711$1$I$20191106$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54118$$FDA-CTU$$57$YR$$M$N$$$20240806$Y$HP$US$
241837121$24183712$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54076$$FDA-CTU$$69$YR$$F$N$$$20240806$N$$US$
241837131$24183713$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54057$$FDA-CTU$$96$YR$$F$N$$$20240806$N$$US$
241837141$24183714$1$I$20240719$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54064$$FDA-CTU$$85$YR$$M$N$$$20240806$N$HP$US$
241837151$24183715$1$I$$20240806$20240807$20240807$EXP$$NVSC2024US160361$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241837161$24183716$1$I$20240723$20240723$20240807$20240807$PER$$US-TEVA-VS-3226150$TEVA$$$$$M$Y$$$20240807$$CN$US$US
241837171$24183717$1$I$$20240729$20240807$20240807$EXP$$CA-TEVA-VS-3227550$TEVA$$$$$$Y$$$20240807$$HP$CA$CA
241837181$24183718$1$I$$20240710$20240807$20240807$30DAY$$US-VEROBIOTECH-2024USVEROSPO00162$VERO BIOTECH$$$$$$Y$$$20240807$$HP$US$US
241837192$24183719$2$F$$20240813$20240807$20240816$30DAY$$GB-PFIZER INC-202400225764$PFIZER$$$$$M$Y$$$20240816$$HP$GB$GB
241837212$24183721$2$F$20230817$20240805$20240807$20240815$30DAY$$US-PFIZER INC-PV202400044136$PFIZER$$$$$$Y$$$20240815$$HP$US$US
241837224$24183722$4$F$$20240911$20240807$20240916$30DAY$$US-PFIZER INC-202400227861$PFIZER$$14$YR$$M$Y$54.422$KG$20240916$$CN$US$US
241837232$24183723$2$F$$20240802$20240807$20240808$30DAY$$US-PFIZER INC-PV202400044227$PFIZER$$$$$$Y$$$20240808$$HP$US$US
241837252$24183725$2$F$$20240812$20240807$20240820$EXP$$US-TEVA-VS-3228599$TEVA$Rahman O, Javed F, Iqbal M, Fulkerson Z, Chaudhry A, Pasha N, et al. Progressive Refractory Interstitial Lung Disease Due to Recurrent Aspiration in Bulimia Nervosa. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).; Rahman O, Javed F, Iqbal M, Fulkerson Z, Chaudhry A, Pasha N, et al. Progressive Refractory Interstitial Lung Disease Due to Recurrent Aspiration in Bulimia Nervosa. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$44$YR$$F$Y$$$20240820$$HP$US$US
241837261$24183726$1$I$$20240725$20240807$20240807$EXP$$US-BIOCODEX2-2024001096$BIOCODEX$$21$YR$$F$Y$72.8$KG$20240807$$CN$US$US
241837271$24183727$1$I$20240416$20240730$20240807$20240807$EXP$$US-BAYER-2024A110694$BAYER$$39$YR$A$F$Y$$$20240807$$CN$US$US
241837281$24183728$1$I$$20240801$20240807$20240807$PER$$US-BAYER-2024A111854$BAYER$$16$YR$T$M$Y$$$20240807$$CN$US$US
241837291$24183729$1$I$20240501$20240731$20240807$20240807$EXP$SE-SEMPA-2024-005705$SE-SA-2024SA229661$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240807$$MD$SE$SE
241837301$24183730$1$I$$20240710$20240807$20240807$30DAY$$US-VEROBIOTECH-2024USVEROSPO00163$VERO BIOTECH$$$$$$Y$$$20240807$$CN$US$US
241837311$24183731$1$I$$20240726$20240807$20240807$EXP$$US-YoungTech Pharmaceuticals, Inc.-2160123$YOUNGTECH PHARMACEUTICALS, INC$Full text$84$YR$$F$Y$$$20240807$$$US$US
241837322$24183732$2$F$20240709$20240924$20240807$20240927$EXP$$DE-SA-2024SA231336$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240927$$MD$DE$DE
241837332$24183733$2$F$$20240906$20240807$20240909$30DAY$$US-PFIZER INC-202400229440$PFIZER$$68$YR$$M$Y$$$20240909$$CN$US$US
241837341$24183734$1$I$$20240802$20240807$20240807$30DAY$$US-PFIZER INC-PV202400044256$PFIZER$$$$$$Y$$$20240807$$HP$US$US
241837351$24183735$1$I$$20240729$20240807$20240807$PER$$US-AstraZeneca-2024A173856$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241837362$24183736$2$F$20240801$20240918$20240807$20240923$30DAY$$US-PFIZER INC-202400228446$PFIZER$$10$YR$$M$Y$$$20240923$$CN$US$US
241837372$24183737$2$F$$20240903$20240807$20240906$30DAY$$US-PFIZER INC-PV202400044127$PFIZER$$$$$$Y$$$20240906$$CN$US$US
241837383$24183738$3$F$20240723$20240902$20240807$20240904$EXP$$JP-PFIZER INC-PV202400101476$PFIZER$$43$YR$$M$Y$74$KG$20240904$$MD$JP$JP
241837393$24183739$3$F$$20240912$20240807$20240912$30DAY$$US-PFIZER INC-202400226350$PFIZER$$9$YR$$M$Y$$$20240912$$HP$US$US
241837411$24183741$1$I$$20240805$20240807$20240807$30DAY$$US-PFIZER INC-PV202400044133$PFIZER$$$$$$Y$$$20240807$$HP$US$US
241837451$24183745$1$I$$20240729$20240807$20240807$PER$$US-ABBVIE-5859852$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241837461$24183746$1$I$20240704$20240731$20240807$20240807$EXP$$KR-KARYOPHARM-2024KPT001333$KARYOPHARM THERAPEUTICS$$65$YR$$M$Y$65.5$KG$20240807$$MD$KR$KR
241837471$24183747$1$I$20240701$20240805$20240807$20240807$PER$$US-Eisai-EC-2024-170675$EISAI$$56$YR$A$M$Y$$$20240807$$CN$US$US
241837481$24183748$1$I$$20240709$20240807$20240807$30DAY$$US-VEROBIOTECH-2024USVEROSPO00161$VERO BIOTECH$$$$$$Y$$$20240807$$HP$US$US
241837491$24183749$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160433$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
241837501$24183750$1$I$$20240321$20240807$20240807$EXP$$FR-SANDOZ INC.-PHHY2019FR183025$SANDOZ$$$$$$Y$$$20240807$$MD$FR$FR
241837511$24183751$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124621$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$CN$US$US
241837521$24183752$1$I$$20240805$20240807$20240807$PER$$US-JNJFOC-20240811965$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
241837531$24183753$1$I$$20240802$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123939$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240807$$CN$US$US
241837541$24183754$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54111$$FDA-CTU$$76$YR$$F$N$88$KG$20240806$N$$US$
241837551$24183755$1$I$20231129$20240730$20240807$20240807$EXP$$CO-UCBSA-2024039470$UCB$$52$YR$$M$Y$$$20240807$$CN$CO$CO
241837561$24183756$1$I$20240704$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54059$$FDA-CTU$$59$YR$$M$N$$$20240806$N$PH$US$
241837571$24183757$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54061$$FDA-CTU$$54$YR$$M$N$111.13$KG$20240806$N$$US$
241837581$24183758$1$I$20240701$20240730$20240807$20240807$30DAY$$US-GSK-US2024095260$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240807$$CN$US$US
241837591$24183759$1$I$20240101$20240801$20240807$20240807$EXP$$US-AMGEN-USASP2024153289$AMGEN$$80$YR$E$M$Y$$$20240807$$CN$US$US
241837601$24183760$1$I$$20240801$20240807$20240807$EXP$$TH-ROCHE-10000050863$ROCHE$$54$YR$A$M$Y$$$20240807$$CN$TH$TH
241837612$24183761$2$F$$20240812$20240807$20240822$EXP$$US-TEVA-VS-3228074$TEVA$Ambalavanan J, Hubbard C, Khan LZ. Acceleration of Preexisting Aortic Stenosis After Teriparatide Initiation. AACE-Clin-Case-Rep 2024; 10 (4): 152-155.; Ambalavanan J, Hubbard C, Khan LZ. Acceleration of Preexisting Aortic Stenosis After Teriparatide Initiation. AACE-Clin-Case-Rep 2024; 10 (4): 152-155.$84$YR$$F$Y$$$20240822$$MD$US$US
241837623$24183762$3$F$20240801$20240829$20240807$20240903$EXP$$JP-PFIZER INC-PV202400102053$PFIZER$$65$YR$$M$Y$107.6$KG$20240903$$MD$JP$JP
241837633$24183763$3$F$$20240911$20240807$20240911$30DAY$$US-PFIZER INC-PV202400044100$PFIZER$$$$$$Y$$$20240911$$HP$US$US
241837641$24183764$1$I$20240804$20240805$20240807$20240807$EXP$$KR-PFIZER INC-PV202400101460$PFIZER$$$$$F$Y$$$20240807$$CN$KR$KR
241837652$24183765$2$F$20240101$20240912$20240807$20240919$EXP$$CA-PFIZER INC-202400230235$PFIZER$$88$YR$$M$Y$$$20240919$$HP$CA$CA
241837662$24183766$2$F$20240610$20240912$20240807$20240917$EXP$$JP-PFIZER INC-PV202400100756$PFIZER$$30$YR$$M$Y$43.4$KG$20240917$$PH$JP$JP
241837673$24183767$3$F$$20240921$20240807$20240923$30DAY$$US-PFIZER INC-PV202400044450$PFIZER$$$$$$Y$$$20240923$$CN$US$US
241837681$24183768$1$I$20231105$20240805$20240807$20240807$30DAY$$US-PFIZER INC-PV202400044506$PFIZER$$$$$$Y$$$20240807$$CN$US$US
241837691$24183769$1$I$$20240801$20240807$20240807$EXP$$CA-PFIZER INC-2020398656$PFIZER$$7$DEC$$M$Y$$$20240807$$MD$CA$CA
241837701$24183770$1$I$20240723$20240802$20240807$20240807$EXP$FR-AFSSAPS-MP2024001238$FR-PFIZER INC-202400228756$PFIZER$$84$YR$$M$Y$88$KG$20240807$$HP$FR$FR
241837711$24183771$1$I$$20240802$20240807$20240807$EXP$$CA-PFIZER INC-202400230271$PFIZER$$25$YR$$F$Y$58$KG$20240807$$CN$CA$CA
241837723$24183772$3$F$$20240918$20240807$20240926$EXP$$CA-PFIZER INC-202400230352$PFIZER$$66$YR$$M$Y$$$20240926$$HP$CA$CA
241837731$24183773$1$I$$20240802$20240807$20240807$EXP$$US-INDIVIOR US-INDV-153109-2024$RECKITT BENCKISER$$$$$$Y$$$20240807$$CN$US$US
241837742$24183774$2$F$$20240806$20240807$20240812$30DAY$$US-PFIZER INC-PV202400044410$PFIZER$$$$$$Y$$$20240812$$HP$US$US
241837752$24183775$2$F$20240101$20240805$20240807$20240809$EXP$$AR-PFIZER INC-202400230444$PFIZER$$72$YR$$F$Y$$$20240809$$CN$AR$AR
241837761$24183776$1$I$20240701$20240802$20240807$20240807$EXP$$US-PFIZER INC-202400230405$PFIZER$$75$YR$$M$Y$$$20240807$$CN$US$US
241837773$24183777$3$F$$20240915$20240807$20240919$30DAY$$US-PFIZER INC-PV202400044695$PFIZER$$$$$$Y$$$20240919$$HP$US$US
241837783$24183778$3$F$$20240816$20240807$20240821$30DAY$$US-PFIZER INC-PV202400044091$PFIZER$$$$$$Y$$$20240821$$HP$US$US
241837792$24183779$2$F$20240705$20240909$20240807$20240911$EXP$$JP-PFIZER INC-PV202400100919$PFIZER$$41$YR$$M$Y$83.1$KG$20240911$$MD$JP$JP
241837801$24183780$1$I$$20240802$20240807$20240807$EXP$$CA-PFIZER INC-202400230358$PFIZER$$65$YR$$F$Y$$$20240807$$MD$CA$CA
241837811$24183781$1$I$$20240726$20240807$20240807$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07314$HIKMA$Measer J, Gray A, Braehler M.. Measer J, Gray A, Braehler M. Subdural Spread of Local Anesthetic Mimicking Cerebrovascular Accident: A Case Report of Horner^s Syndrome, Upper Limb Paresthesia, and Motor Weakness After Thoracic Epidural Analgesia. A and A Practice. 2024;18(7):1-5$53$YR$$F$Y$$$20240807$$MD$US$US
241837821$24183782$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002211$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240807$$CN$US$US
241837831$24183783$1$I$$20240726$20240807$20240807$PER$$US-HALEON-2190792$Haleon PLC$$$$$$Y$$$20240807$$CN$US$US
241837841$24183784$1$I$$20240725$20240807$20240807$EXP$$DE-JNJFOC-20240772551$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$DE$DE
241837851$24183785$1$I$20240805$20240805$20240806$20240806$DIR$FDA-CDER-CTU-2024-54097$$FDA-CTU$$61$YR$$M$N$54$KG$20240805$N$PH$US$
241837861$24183786$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54100$$FDA-CTU$$70$YR$$F$N$$$20240806$N$$US$
241837871$24183787$1$I$20240723$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54081$$FDA-CTU$$12$YR$$F$N$$$20240806$N$HP$US$
241837881$24183788$1$I$$20240801$20240807$20240807$EXP$$IN-ROCHE-10000048715$ROCHE$$33$YR$A$M$Y$$$20240807$$CN$IN$IN
241837891$24183789$1$I$$20240724$20240807$20240807$EXP$$US-UCBSA-2024037675$UCB$$$$$F$Y$$$20240807$$HP$US$US
241837903$24183790$3$F$20240101$20240910$20240807$20240911$PER$$US-KARYOPHARM-2024KPT001374$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240911$$CN$US$US
241837912$24183791$2$F$20240622$20240808$20240807$20240904$PER$$US-KARYOPHARM-2024KPT001331$KARYOPHARM THERAPEUTICS$$49$YR$$F$Y$$$20240904$$MD$US$US
241837933$24183793$3$F$20240804$20240911$20240807$20240911$30DAY$$US-PFIZER INC-202400230536$PFIZER$$16$YR$$M$Y$$$20240911$$CN$US$US
241837941$24183794$1$I$$20240806$20240807$20240807$EXP$$CA-PFIZER INC-PV202400102335$PFIZER$$71$YR$$M$Y$$$20240807$$HP$CA$CA
241837951$24183795$1$I$20240724$20240802$20240807$20240807$EXP$$CN-PFIZER INC-PV202400101288$PFIZER$$56$YR$$M$Y$45$KG$20240807$$HP$CN$CN
241837961$24183796$1$I$$20240806$20240807$20240807$EXP$$PH-PFIZER INC-PV202400102174$PFIZER$$$$$F$Y$$$20240807$$CN$PH$PH
241837973$24183797$3$F$20240701$20240827$20240807$20240829$EXP$$CN-PFIZER INC-202400228997$PFIZER$$65$YR$$F$Y$$$20240829$$MD$CN$CN
241837991$24183799$1$I$20220101$20240731$20240807$20240807$EXP$$JP-PFIZER INC-PV202300158243$PFIZER$Yoshida, H.. A case of elevated tacrolimus blood levels in a post-lung transplant patient taking tacrolimus extended-release capsules and receiving concomitant nirmatrelvir/ritonavir. The 61st Annual Congress of Japan Municipal Hospital Association in Hokkaido. 2023;61st$7$DEC$$F$Y$$$20240807$$HP$JP$JP
241838001$24183800$1$I$$20240806$20240807$20240807$EXP$$US-PFIZER INC-202400231231$PFIZER$$67$YR$$F$Y$$$20240807$$CN$US$US
241838011$24183801$1$I$$20240806$20240807$20240807$EXP$$US-KYOWAKIRIN-2024KK018756$KYOWA$$$$$$Y$$$20240807$$HP$US$US
241838022$24183802$2$F$$20240803$20240807$20240808$PER$$NVSC2024US160498$NOVARTIS$$$$$$Y$$$20240808$$MD$US$US
241838031$24183803$1$I$20240716$20240802$20240807$20240807$EXP$$NVSC2024CN159909$NOVARTIS$$74$YR$$M$Y$$$20240807$$HP$CN$CN
241838042$24183804$2$F$$20240823$20240807$20240823$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044278$BOEHRINGER INGELHEIM$$50$YR$A$M$Y$$$20240823$$MD$DE$DE
241838051$24183805$1$I$$20240724$20240807$20240807$EXP$$BR-GSK-BR2024AMR093584$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$BR$BR
241838061$24183806$1$I$$20240729$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005629$BIOCON$$$$$$Y$$$20240807$$MD$CA$CA
241838071$24183807$1$I$$20240801$20240807$20240807$EXP$$IN-ROCHE-10000048876$ROCHE$$73$YR$E$M$Y$$$20240807$$CN$IN$IN
241838082$24183808$2$F$20240731$20240904$20240807$20240904$PER$$US-ALXN-202407USA002197US$ALEXION PHARMACEUTICALS$$25$YR$$F$Y$$$20240904$$CN$US$US
241838092$24183809$2$F$$20240806$20240807$20240807$PER$$US-GILEAD-2024-0683207$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241838101$24183810$1$I$20190101$20240801$20240807$20240807$EXP$FR-AFSSAPS-AN2024000948$FR-MYLANLABS-2024M1072406$MYLAN$$51$YR$$M$Y$98$KG$20240807$$PH$FR$FR
241838111$24183811$1$I$$20240728$20240807$20240807$PER$$US-AMGEN-USASP2024154758$AMGEN$Silverman S.L.; Reginster J.; Czerwinski E. et al.. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis International. 2024;1-12$$$$F$Y$$$20240807$$HP$US$US
241838121$24183812$1$I$$20240728$20240807$20240807$PER$$US-AMGEN-USASP2024154644$AMGEN$Silverman S.L.; Reginster J.; Czerwinski E. et al.. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis International. 2024;1-12$$$$F$Y$$$20240807$$HP$US$US
241838131$24183813$1$I$$20240802$20240807$20240807$EXP$$US-HORIZON THERAPEUTICS-HZN-2023-001439$AMGEN$Patidar K. R.; Sanyal A. J.; Tu W.; Gotter T. G. et al.. Design of a multicenter randomized clinical trial for treatment of Alcohol Associated Hepatitis. Contemporary Clinical Trials Communications. 2023$$$$$Y$$$20240807$$MD$US$US
241838141$24183814$1$I$20240805$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155941$AMGEN$$57$YR$A$M$Y$$$20240807$$CN$US$US
241838151$24183815$1$I$20240301$20240801$20240807$20240807$PER$$US-BAYER-2024A111918$BAYER$$78$YR$E$M$Y$$$20240807$$CN$US$US
241838161$24183816$1$I$20240417$20240802$20240807$20240807$EXP$$JP-009507513-2406JPN003562J$MERCK$$75$YR$$F$Y$$$20240807$$MD$JP$JP
241838171$24183817$1$I$$20240806$20240807$20240807$EXP$$US-KYOWAKIRIN-2024KK018794$KYOWA$$$$$$Y$$$20240807$$HP$US$US
241838182$24183818$2$F$20240701$20240805$20240807$20240808$30DAY$$US-JNJFOC-20240741891$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240808$$HP$US$US
241838191$24183819$1$I$$20240729$20240807$20240807$30DAY$$US-UCBSA-2024039457$UCB$$$$$F$Y$$$20240807$$CN$US$US
241838202$24183820$2$F$20220304$20240827$20240807$20240829$EXP$$US-GILEAD-2024-0682766$GILEAD$$57$YR$A$M$Y$$$20240829$$MD$US$US
241838211$24183821$1$I$20240806$20240806$20240807$20240807$EXP$$US-TAKEDA-2023TUS067367$TAKEDA$$62$YR$$F$Y$$$20240807$$HP$US$US
241838221$24183822$1$I$20240725$20240726$20240807$20240807$EXP$$US-PERRIGO-24US007191$PERRIGO$$$$$F$Y$$$20240807$$CN$US$US
241838231$24183823$1$I$20240802$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155676$AMGEN$$57$YR$A$M$Y$$$20240807$$CN$US$US
241838243$24183824$3$F$$20240823$20240807$20240830$PER$$NVSC2024US160835$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
241838251$24183825$1$I$20240627$20240729$20240807$20240807$EXP$HR-HALMED-300086124$HR-TEVA-VS-3227151$TEVA$$$$A$F$Y$$$20240807$$MD$HR$HR
241838261$24183826$1$I$$20240802$20240807$20240807$PER$$US-BAYER-2024A112357$BAYER$$$$$M$Y$$$20240807$$CN$US$US
241838271$24183827$1$I$20240802$20240803$20240807$20240807$EXP$$GB-MYLANLABS-2024M1072753$MYLAN$$$$$M$Y$$$20240807$$CN$GB$GB
241838281$24183828$1$I$20240629$20240801$20240807$20240807$EXP$FR-AFSSAPS-LY2024001142$FR-MYLANLABS-2024M1072328$MYLAN$$76$YR$$F$Y$76$KG$20240807$$PH$FR$FR
241838291$24183829$1$I$$20240806$20240806$20240806$DIR$713164$$FDA-CTU$$$$$UNK$N$$$20240806$N$CN$US$
241838301$24183830$1$I$20240806$20240806$20240806$20240806$DIR$713163$$FDA-CTU$$$$$UNK$N$$$20240806$N$CN$US$
241838311$24183831$1$I$20240805$20240806$20240806$20240806$DIR$713159$$FDA-CTU$$$$$UNK$N$$$20240806$N$CN$US$
241838321$24183832$1$I$20240624$20240806$20240806$20240806$DIR$713235$$FDA-CTU$$18$YR$$F$N$54.9$KG$20240806$N$CN$US$
241838331$24183833$1$I$$20240806$20240806$20240806$DIR$713171$$FDA-CTU$$$$$UNK$N$$$20240806$N$CN$US$
241838351$24183835$1$I$$20240312$20240807$20240807$EXP$$DE-SANDOZ INC.-PHHY2018DE026802$SANDOZ$$$$$$Y$$$20240807$$MD$DE$DE
241838361$24183836$1$I$20240722$20240801$20240807$20240807$PER$$CN-Eisai-EC-2024-171378$EISAI$$79$YR$E$M$Y$$$20240807$$HP$CN$CN
241838371$24183837$1$I$20240611$20240802$20240807$20240807$EXP$$JP-Eisai-EC-2024-171452$EISAI$$66$YR$E$M$Y$59$KG$20240807$$PH$JP$JP
241838382$24183838$2$F$$20240729$20240807$20240808$EXP$$NVSC2024BR158151$NOVARTIS$Goncalves LA, Song ATW, Gimenes VMF, Magri MMC, Abdala E. ESPOROTRICOSE CUTANEA DISSEMINADA EM RECEPTOR DE TRANSPLANTE DE FIGADO: UMA INFECC? AO RARA E DESAFIADORA [Disseminated cutaneous sporotrichosis in a liver transplant recipient: a rare and challenging infection]. BRAZIL-J-INFECT-DIS. 2023;27(Suppl. 1):227$57$YR$$F$Y$$$20240808$$HP$BR$BR
241838392$24183839$2$F$$20240807$20240807$20240823$EXP$$CA-TAKEDA-2024TUS078963$TAKEDA$$$$$M$Y$$$20240823$$MD$CA$CA
241838401$24183840$1$I$20240630$20240711$20240807$20240807$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00735$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240807$$CN$US$US
241838411$24183841$1$I$$20240731$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121822$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240807$$HP$US$US
241838422$24183842$2$F$20240101$20240904$20240807$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122713$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$101.15$KG$20240906$$CN$US$US
241838431$24183843$1$I$20240101$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124425$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$78.6$KG$20240807$$PH$US$US
241838441$24183844$1$I$20240617$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124600$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240807$$HP$US$US
241838452$24183845$2$F$$20240812$20240807$20240820$EXP$$US-TEVA-VS-3227986$TEVA$Hochfeld U, Heyer M, Mohammed A, Baig M, Barmaimon G, Omidvari K. Non-ARDS Chloramine Induced Lung Injury Managed by Venovenous Extracorporeal Membrane Oxygenation (ECMO): A Novel Approach. Am-J-Respir-Crit-Care-Med 2023; 207 no pagination.; Hochfeld U, Heyer M, Mohammed A, Baig M, Barmaimon G, Omidvari K. Non-ARDS Chloramine Induced Lung Injury Managed by Venovenous Extracorporeal Membrane Oxygenation (ECMO): A Novel Approach. Am-J-Respir-Crit-Care-Med 2023; 207 no pagination.$65$YR$$M$Y$$$20240820$$HP$US$US
241838463$24183846$3$F$20220101$20240903$20240807$20240912$EXP$$NVSC2024EG158647$NOVARTIS$$$$$M$Y$71$KG$20240912$$CN$EG$EG
241838475$24183847$5$F$20240601$20240917$20240807$20240923$EXP$$NVSC2024AR144931$NOVARTIS$$73$YR$$F$Y$$$20240923$$CN$AR$AR
241838481$24183848$1$I$$20240730$20240807$20240807$EXP$$US-BAYER-2024A110472$BAYER$$63$YR$A$F$Y$$$20240807$$CN$US$US
241838492$24183849$2$F$20240724$20240909$20240807$20240917$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07331$HIKMA$$59$YR$$F$Y$$$20240917$$CN$US$US
241838501$24183850$1$I$$20240716$20240807$20240807$PER$$US-OTSUKA-2024_020052$OTSUKA$$$$$$Y$$$20240807$$HP$US$US
241838511$24183851$1$I$20240501$20240702$20240807$20240807$PER$$US-OTSUKA-2024_018826$OTSUKA$$$$$F$Y$$$20240807$$HP$US$US
241838522$24183852$2$F$$20240605$20240807$20240808$EXP$$US-OTSUKA-2024_016203$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241838533$24183853$3$F$$20240823$20240807$20240828$30DAY$$US-PFIZER INC-202400227228$PFIZER$$8$YR$$M$Y$21.45$KG$20240828$$HP$US$US
241838542$24183854$2$F$$20240805$20240807$20240807$EXP$$PT-PFIZER INC-202400230052$PFIZER$Carvalhinha, C.. PO-0487 - (4622) - A COMMON MANIFESTATION, A RARE ENTITY. 30th Congressos da Sociedade Portuguesa de Medicina Interna. 2024;847$61$YR$$F$Y$$$20240807$$MD$PT$PT
241838552$24183855$2$F$$20240919$20240807$20240923$EXP$$ZA-PFIZER INC-PV202400100965$PFIZER$Rensburg, D.. Acute corticosteroid-induced rhabdomyolysis in a golf player. SAJSM. 2012;24(4):129-130$27$YR$$M$Y$$$20240923$$MD$ZA$ZA
241838562$24183856$2$F$$20240813$20240807$20240813$PER$$US-PFIZER INC-202400230145$PFIZER$$$$$$Y$$$20240813$$CN$US$US
241838571$24183857$1$I$20240806$20240806$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408004147$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240807$$CN$US$US
241838581$24183858$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003107$ELI LILLY AND CO$$61$YR$A$$Y$$$20240807$$CN$US$US
241838591$24183859$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002787$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240807$$CN$US$US
241838601$24183860$1$I$20220501$20240802$20240807$20240807$EXP$$KR-PFIZER INC-PV202400101432$PFIZER$Ahn, S.. Within-host Viral Evolution and Neutralizing Antibody Response in Immunocompromised Patients with Persistent SARS-CoV-2 Infection Receiving B Cell Depleting Treatment. Open-Forum-Infect-Dis. 2023;10 (Suppl. 2):S278- S279$53$YR$$M$Y$$$20240807$$HP$KR$KR
241838611$24183861$1$I$20240802$20240801$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002187$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240807$$CN$US$US
241838621$24183862$1$I$$20240806$20240807$20240807$EXP$$US-GILEAD-2024-0683208$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241838631$24183863$1$I$20240803$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155552$AMGEN$$59$YR$A$M$Y$$$20240807$$CN$US$US
241838642$24183864$2$F$$20240805$20240807$20240813$PER$$US-AMGEN-USASP2024155808$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
241838651$24183865$1$I$20240717$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154879$AMGEN$$76$YR$E$F$Y$$$20240807$$CN$US$US
241838661$24183866$1$I$$20240613$20240807$20240807$PER$$US-OTSUKA-2024_017027$OTSUKA$$3$DEC$$M$Y$$$20240807$$HP$US$US
241838671$24183867$1$I$$20240725$20240807$20240807$PER$$US-OTSUKA-2024_020821$OTSUKA$$$$$M$Y$$$20240807$$HP$US$US
241838681$24183868$1$I$$20240710$20240807$20240807$PER$$US-OTSUKA-2024_019567$OTSUKA$$$$$F$Y$$$20240807$$HP$US$US
241838691$24183869$1$I$$20240723$20240807$20240807$PER$$US-OTSUKA-2024_014616$OTSUKA$$$$$$Y$$$20240807$$HP$US$US
241838701$24183870$1$I$$20240618$20240807$20240807$PER$$US-OTSUKA-2024_017498$OTSUKA$$$$$F$Y$$$20240807$$PH$US$US
241838711$24183871$1$I$20240430$20240701$20240807$20240807$PER$$US-OTSUKA-2024_012583$OTSUKA$$60$YR$$F$Y$96.61$KG$20240807$$HP$US$US
241838722$24183872$2$F$$20240604$20240807$20240808$PER$$US-OTSUKA-2024_016113$OTSUKA$$$$A$F$Y$$$20240808$$HP$US$US
241838732$24183873$2$F$$20240531$20240807$20240808$PER$$US-OTSUKA-2024_015696$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241838741$24183874$1$I$$20240712$20240807$20240807$PER$$US-OTSUKA-2024_019761$OTSUKA$$$$$M$Y$$$20240807$$HP$US$US
241838751$24183875$1$I$20240101$20240702$20240807$20240807$PER$$US-OTSUKA-2024_018837$OTSUKA$$$$$$Y$$$20240807$$HP$US$US
241838761$24183876$1$I$$20240716$20240807$20240807$PER$$US-OTSUKA-2024_020036$OTSUKA$$$$$$Y$$$20240807$$MD$US$US
241838771$24183877$1$I$$20240429$20240807$20240807$PER$$DK-OTSUKA-2024_012574$OTSUKA$$$$$$Y$$$20240807$$CN$DK$US
241838782$24183878$2$F$$20240618$20240807$20240808$EXP$$US-OTSUKA-2024_017557$OTSUKA$$$$$M$Y$$$20240808$$MD$US$US
241838791$24183879$1$I$20240510$20240712$20240807$20240807$PER$$US-OTSUKA-2024_013596$OTSUKA$$$$$F$Y$$$20240807$$PH$US$US
241838802$24183880$2$F$$20240507$20240807$20240808$EXP$$US-OTSUKA-2024_013362$OTSUKA$$55$YR$$M$Y$$$20240808$$HP$US$US
241838811$24183881$1$I$$20240722$20240807$20240807$PER$$US-OTSUKA-2024_020535$OTSUKA$$$$$$Y$$$20240807$$CN$US$US
241838821$24183882$1$I$$20240730$20240807$20240807$PER$$US-OTSUKA-2024_020543$OTSUKA$$$$$F$Y$$$20240807$$HP$US$US
241838832$24183883$2$F$$20240806$20240807$20240808$PER$$US-OTSUKA-2024_016309$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241838841$24183884$1$I$$20240805$20240807$20240807$EXP$$FR-GILEAD-2024-0682926$GILEAD$$41$YR$A$M$Y$88$KG$20240807$$CN$FR$FR
241838851$24183885$1$I$20240411$20240730$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124639$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240807$$CN$US$US
241838863$24183886$3$F$20240802$20240809$20240807$20240815$EXP$$US-AMGEN-USASP2024154886$AMGEN$$79$YR$E$F$Y$$$20240815$$CN$US$US
241838871$24183887$1$I$$20240806$20240806$20240806$DIR$713156$$FDA-CTU$$$$$UNK$N$$$20240806$$CN$US$
241838883$24183888$3$F$$20240906$20240807$20240911$PER$$US-AMGEN-USASP2024155474$AMGEN$$$$A$F$Y$$$20240910$$HP$US$US
241838891$24183889$1$I$20240802$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154396$AMGEN$$83$YR$E$F$Y$$$20240807$$CN$US$US
241838901$24183890$1$I$$20240728$20240807$20240807$PER$$US-AMGEN-USASP2024154767$AMGEN$Silverman S.L.; Reginster J.; Czerwinski E. et al.. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis International. 2024;1-12$$$$F$Y$$$20240807$$HP$US$US
241838911$24183891$1$I$20240101$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156154$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241838931$24183893$1$I$20240806$20240806$20240806$20240806$DIR$713136$$FDA-CTU$$77$YR$$F$N$64.8$KG$20240806$Y$HP$US$
241838941$24183894$1$I$20240801$20240806$20240806$20240806$DIR$713209$$FDA-CTU$$80$YR$$F$N$$$20240806$Y$HP$US$
241838951$24183895$1$I$$20240725$20240807$20240807$PER$$US-SA-2024SA223031$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$MD$US$US
241838961$24183896$1$I$20240601$20240726$20240807$20240807$PER$$US-SA-2024SA231403$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240807$$CN$US$US
241838971$24183897$1$I$$20240730$20240807$20240807$EXP$$FR-AstraZeneca-2024A177558$ASTRAZENECA$$3$MON$$F$Y$$$20240807$$MD$FR$
241838981$24183898$1$I$$20240730$20240807$20240807$EXP$$ZA-AstraZeneca-2024A173838$ASTRAZENECA$$72$YR$$F$Y$$$20240807$$CN$ZA$
241838993$24183899$3$F$20240807$20240828$20240807$20240911$PER$$US-AstraZeneca-2024A178831$ASTRAZENECA$$27900$DY$$M$Y$$$20240911$$CN$US$
241839001$24183900$1$I$$20240730$20240807$20240807$EXP$$GB-AstraZeneca-2024A173267$ASTRAZENECA$$65$YR$$M$Y$$$20240807$$MD$GB$
241839011$24183901$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA227265$SANOFI AVENTIS$$$$$F$Y$$$20240807$$CN$US$US
241839021$24183902$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA229355$SANOFI AVENTIS$$8$YR$C$F$Y$37$KG$20240807$$MD$US$US
241839031$24183903$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA229381$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240807$$CN$US$US
241839041$24183904$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA230016$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240807$$MD$US$US
241839051$24183905$1$I$20240701$20240729$20240807$20240807$PER$$US-SA-2024SA226696$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240807$$MD$US$US
241839061$24183906$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA228746$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240807$$MD$US$US
241839071$24183907$1$I$20240701$20240731$20240807$20240807$PER$$US-SA-2024SA229919$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240807$$MD$US$US
241839081$24183908$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA229379$SANOFI AVENTIS$$$$A$M$Y$95.25$KG$20240807$$MD$US$US
241839091$24183909$1$I$20240101$20240726$20240807$20240807$PER$$US-SA-2024SA225063$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240807$$MD$US$US
241839101$24183910$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA227466$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240807$$CN$US$US
241839111$24183911$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA229487$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240807$$MD$US$US
241839121$24183912$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA230411$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240807$$MD$US$US
241839132$24183913$2$F$20240814$20240814$20240807$20240821$EXP$$US-TAKEDA-US201722543$TAKEDA$$73$YR$$F$Y$$$20240821$$MD$US$US
241839142$24183914$2$F$$20240826$20240807$20240902$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001071$ALEMBIC$$$$$$Y$$$20240902$$CN$US$US
241839151$24183915$1$I$20240706$20240731$20240807$20240807$PER$$US-SA-2024SA231711$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240807$$MD$US$US
241839162$24183916$2$F$20240712$20240806$20240807$20240812$EXP$$US-KYOWAKIRIN-2024KK018716$KYOWA$$$$$$Y$$$20240812$$HP$US$US
241839171$24183917$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA230418$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$MD$US$US
241839181$24183918$1$I$20240701$20240730$20240807$20240807$PER$$US-SA-2024SA229367$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240807$$MD$US$US
241839191$24183919$1$I$20240601$20240730$20240807$20240807$PER$$US-SA-2024SA230578$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240807$$MD$US$US
241839201$24183920$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA229929$SANOFI AVENTIS$$$$E$F$Y$$$20240807$$MD$US$US
241839212$24183921$2$F$20240101$20240830$20240807$20240926$PER$$US-SA-2024SA229389$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240926$$MD$US$US
241839232$24183923$2$F$20240101$20240828$20240807$20240923$PER$$US-SA-2024SA229894$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240923$$MD$US$US
241839241$24183924$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA232047$SANOFI AVENTIS$$$$A$M$Y$118$KG$20240807$$MD$US$US
241839251$24183925$1$I$20240701$20240731$20240807$20240807$PER$$US-SA-2024SA232049$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240807$$MD$US$US
241839261$24183926$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA230116$SANOFI AVENTIS$$$$A$F$Y$83.01$KG$20240807$$MD$US$US
241839271$24183927$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA226414$SANOFI AVENTIS$$4$MON$I$F$Y$$$20240807$$CN$US$US
241839281$24183928$1$I$20230101$20240730$20240807$20240807$PER$$US-SA-2024SA230248$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240807$$MD$US$US
241839291$24183929$1$I$20240101$20240730$20240807$20240807$PER$$US-SA-2024SA230563$SANOFI AVENTIS$$55$YR$A$F$Y$85.2$KG$20240807$$MD$US$US
241839302$24183930$2$F$$20240816$20240807$20240827$PER$$US-SA-2024SA229364$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
241839312$24183931$2$F$20240101$20240902$20240807$20240911$PER$$US-SA-2024SA228606$SANOFI AVENTIS$$$$C$F$Y$$$20240911$$MD$US$US
241839321$24183932$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA229762$SANOFI AVENTIS$$$$T$F$Y$$$20240807$$CN$US$US
241839331$24183933$1$I$20240701$20240730$20240807$20240807$PER$$US-SA-2024SA230637$SANOFI AVENTIS$$57$YR$A$F$Y$61.23$KG$20240807$$MD$US$US
241839342$24183934$2$F$20240724$20240807$20240807$20240816$PER$$US-SA-2024SA230236$SANOFI AVENTIS$$66$YR$E$F$Y$88.31$KG$20240816$$MD$US$US
241839351$24183935$1$I$20240701$20240730$20240807$20240807$PER$$US-SA-2024SA230550$SANOFI AVENTIS$$34$YR$A$M$Y$105$KG$20240807$$MD$US$US
241839361$24183936$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA232042$SANOFI AVENTIS$$$$A$M$Y$$$20240807$$MD$US$US
241839371$24183937$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA227601$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240807$$CN$US$US
241839381$24183938$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA231490$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240807$$MD$US$US
241839391$24183939$1$I$$20240729$20240807$20240807$EXP$$JP-TRIS PHARMA, INC.-24JP011581$TRIS PHARM$Nagaoka M., Murata T., Nagamine T., Fujise N.. Methylphenidate-Associated Creatine Kinase Level Elevation. American journal of therapeutics. 2024;31 (4):e498-e502$$$$$Y$$$20240807$$MD$JP$JP
241839421$24183942$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA229994$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240807$$MD$US$US
241839431$24183943$1$I$$20240725$20240807$20240807$EXP$$US-CORIUM, LLC-2024COR000148$CORIUM$$$$$$Y$$$20240807$$CN$US$US
241839441$24183944$1$I$$20240730$20240807$20240807$EXP$$AE-RDY-SPO/ARE/24/0011316$DR REDDYS$$51$YR$A$M$Y$$$20240807$$MD$AE$AE
241839451$24183945$1$I$$20240729$20240807$20240807$EXP$$DE-RDY-LIT/DEU/24/0011328$DR REDDYS$Hoeltzenbein M, Slimi S, Fietz A, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023 Apr;107: 107-113. doi:10.1016/j.seizure.2023.02.015.$$$$F$Y$$$20240807$$HP$DE$DE
241839481$24183948$1$I$20240701$20240731$20240807$20240807$PER$$US-SA-2024SA231535$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240807$$MD$US$US
241839491$24183949$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA231555$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240807$$MD$US$US
241839501$24183950$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA230607$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240807$$MD$US$US
241839511$24183951$1$I$20240423$20240806$20240806$20240806$DIR$713166$$FDA-CTU$$79$YR$$F$N$58.5$KG$20240806$N$CN$US$
241839522$24183952$2$F$$20240828$20240807$20240923$PER$$US-SA-2024SA232016$SANOFI AVENTIS$$$$A$F$Y$79$KG$20240923$$MD$US$US
241839551$24183955$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA230455$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240807$$HP$US$US
241839562$24183956$2$F$$20240805$20240807$20240813$PER$$US-SA-2024SA228413$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240814$$MD$US$US
241839571$24183957$1$I$20240701$20240730$20240807$20240807$PER$$US-SA-2024SA232129$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240807$$CN$US$US
241839581$24183958$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA230395$SANOFI AVENTIS$$$$E$F$Y$$$20240807$$MD$US$US
241839591$24183959$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA229345$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$MD$US$US
241839601$24183960$1$I$20240625$20240730$20240807$20240807$PER$$US-SA-2024SA231299$SANOFI AVENTIS$$59$YR$A$F$Y$122$KG$20240807$$MD$US$US
241839611$24183961$1$I$20240701$20240731$20240807$20240807$PER$$US-SA-2024SA229281$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240807$$MD$US$US
241839621$24183962$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA118211$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240807$$MD$US$US
241839631$24183963$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA231050$SANOFI AVENTIS$$$$T$F$Y$$$20240807$$MD$US$US
241839641$24183964$1$I$20240101$20240730$20240807$20240807$PER$$US-SA-2024SA232643$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240807$$MD$US$US
241839651$24183965$1$I$20230101$20240729$20240807$20240807$PER$$US-SA-2024SA189197$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240807$$MD$US$US
241839661$24183966$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA231671$SANOFI AVENTIS$$$$A$M$Y$81$KG$20240807$$MD$US$US
241839672$24183967$2$F$20240701$20240823$20240807$20240918$PER$$US-SA-2024SA230439$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240918$$MD$US$US
241839681$24183968$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA230712$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240807$$MD$US$US
241839691$24183969$1$I$20240701$20240731$20240807$20240807$PER$$US-SA-2024SA229168$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240807$$MD$US$US
241839701$24183970$1$I$20240722$20240730$20240807$20240807$PER$$US-SA-2024SA230102$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240807$$MD$US$US
241839711$24183971$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA230262$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240807$$MD$US$US
241839722$24183972$2$F$$20240806$20240807$20240809$PER$$US-BIOGEN-2024BI01276628$BIOGEN$$$$$F$Y$$$20240809$$MD$US$US
241839731$24183973$1$I$20170501$20240802$20240807$20240807$PER$$US-BIOGEN-2017BI00435458$BIOGEN$$49$YR$$F$Y$$$20240807$$CN$US$US
241839741$24183974$1$I$20240730$20240806$20240807$20240807$EXP$$CA-SANDOZ INC.-NVSC2022CA200870$SANDOZ$$68$YR$$M$Y$$$20240807$$CN$CA$CA
241839751$24183975$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124317$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240807$$CN$US$US
241839761$24183976$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124625$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240807$$HP$US$US
241839771$24183977$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA230484$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240807$$MD$US$US
241839791$24183979$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA230496$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$MD$US$US
241839801$24183980$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA230651$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240807$$MD$US$US
241839811$24183981$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA230763$SANOFI AVENTIS$$$$E$M$Y$$$20240807$$MD$US$US
241839821$24183982$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA230378$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240807$$MD$US$US
241839831$24183983$1$I$20240601$20240731$20240807$20240807$PER$$US-SA-2024SA231848$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240807$$MD$US$US
241839841$24183984$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA230421$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240807$$MD$US$US
241839852$24183985$2$F$20240101$20240827$20240807$20240903$PER$$US-SA-2024SA225248$SANOFI AVENTIS$$77$YR$E$M$Y$69.39$KG$20240903$$MD$US$US
241839861$24183986$1$I$20240101$20240729$20240807$20240807$PER$$US-SA-2024SA048912$SANOFI AVENTIS$$$$T$M$Y$44.17$KG$20240807$$MD$US$US
241839871$24183987$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA231518$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240807$$CN$US$US
241839881$24183988$1$I$20240626$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54109$$FDA-CTU$$83$YR$$F$N$$$20240806$N$$US$
241839891$24183989$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA230564$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240807$$MD$US$US
241839902$24183990$2$F$20240719$20240819$20240807$20240828$PER$$US-SA-2024SA227710$SANOFI AVENTIS$$79$YR$E$M$Y$81.6$KG$20240828$$MD$US$US
241839911$24183991$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA227586$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240807$$MD$US$US
241839922$24183992$2$F$20240729$20240731$20240807$20240809$PER$$US-SA-2024SA230405$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240809$$MD$US$US
241839931$24183993$1$I$20240806$20240806$20240806$20240806$DIR$713177$$FDA-CTU$$36$YR$$F$N$80.1$KG$20240806$Y$HP$US$
241839941$24183994$1$I$20240415$20240806$20240806$20240806$DIR$713188$$FDA-CTU$$22$YR$$M$N$65.7$KG$20240806$$CN$US$
241839951$24183995$1$I$20240706$20240706$20240806$20240806$DIR$FDA-CDER-CTU-2024-54126$$FDA-CTU$$81$YR$$M$N$$$20240706$N$PH$US$
241839971$24183997$1$I$$20240806$20240806$20240806$DIR$713210$$FDA-CTU$$35$YR$$F$N$$$20240806$N$CN$US$
241839981$24183998$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA231850$SANOFI AVENTIS$$$$A$F$Y$106.5$KG$20240807$$MD$US$US
241839991$24183999$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA230194$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240807$$MD$US$US
241840001$24184000$1$I$20240701$20240730$20240807$20240807$PER$$US-SA-2024SA229301$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240807$$MD$US$US
241840011$24184001$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA230301$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240807$$CN$US$US
241840021$24184002$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA206127$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240807$$CN$US$US
241840031$24184003$1$I$20240722$20240729$20240807$20240807$PER$$US-SA-2024SA230179$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240807$$MD$US$US
241840041$24184004$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA229950$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240807$$CN$US$US
241840051$24184005$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA229310$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240807$$MD$US$US
241840061$24184006$1$I$$20240729$20240807$20240807$EXP$$US-TEVA-VS-3227708$TEVA$$$$$F$Y$$$20240807$$CN$US$US
241840071$24184007$1$I$20240601$20240731$20240807$20240807$PER$$US-SA-2024SA230495$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240807$$MD$US$US
241840081$24184008$1$I$20240727$20240730$20240807$20240807$PER$$US-SA-2024SA230551$SANOFI AVENTIS$$61$YR$A$F$Y$88.4$KG$20240807$$MD$US$US
241840091$24184009$1$I$20240101$20240730$20240807$20240807$PER$$US-SA-2024SA229269$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240807$$MD$US$US
241840101$24184010$1$I$20240101$20240729$20240807$20240807$EXP$$US-JNJFOC-20240777316$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240807$$HP$US$US
241840111$24184011$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA229813$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240807$$MD$US$US
241840121$24184012$1$I$$20240801$20240807$20240807$PER$$US-JNJFOC-20240809719$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$US$US
241840131$24184013$1$I$$20240801$20240807$20240807$PER$$US-SA-2024SA230504$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240807$$MD$US$US
241840141$24184014$1$I$20230825$20240731$20240807$20240807$PER$$US-SA-2024SA231532$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240807$$MD$US$US
241840151$24184015$1$I$$20240802$20240807$20240807$PER$$US-SA-2024SA231029$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240807$$CN$US$US
241840162$24184016$2$F$20240101$20240814$20240807$20240828$PER$$US-SA-2024SA230461$SANOFI AVENTIS$$50$YR$A$M$Y$85.5$KG$20240828$$MD$US$US
241840181$24184018$1$I$20240723$20240730$20240807$20240807$PER$$US-SA-2024SA227700$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240807$$MD$US$US
241840191$24184019$1$I$$20240801$20240807$20240807$PER$$US-SA-2024SA231345$SANOFI AVENTIS$$$$$F$Y$$$20240807$$CN$US$US
241840201$24184020$1$I$$20240801$20240807$20240807$PER$$US-SA-2024SA231912$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240807$$MD$US$US
241840211$24184021$1$I$20240730$20240801$20240807$20240807$PER$$US-SA-2024SA231556$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240807$$CN$US$US
241840221$24184022$1$I$$20240801$20240807$20240807$PER$$US-SA-2024SA229533$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240807$$CN$US$US
241840231$24184023$1$I$20240701$20240731$20240807$20240807$PER$$US-SA-2024SA230377$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240807$$MD$US$US
241840245$24184024$5$F$20240101$20240830$20240807$20240904$PER$$US-SA-2024SA231387$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240904$$CN$US$US
241840251$24184025$1$I$$20240802$20240807$20240807$PER$$US-SA-2024SA231479$SANOFI AVENTIS$$$$$F$Y$$$20240807$$CN$US$US
241840263$24184026$3$F$20240803$20240814$20240807$20240909$PER$$US-AMGEN-USASP2024155333$AMGEN$$67$YR$E$M$Y$$$20240909$$CN$US$US
241840272$24184027$2$F$20240731$20240814$20240807$20240820$30DAY$$US-AMGEN-USASP2024153706$AMGEN$$67$YR$E$F$Y$48.9$KG$20240820$$HP$US$US
241840281$24184028$1$I$20240726$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155604$AMGEN$$61$YR$A$M$Y$$$20240807$$CN$US$US
241840291$24184029$1$I$$20240728$20240807$20240807$PER$$US-AMGEN-USASP2024154796$AMGEN$Silverman S.L.; Reginster J.; Czerwinski E. et al.. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis International. 2024;1-12$$$$F$Y$$$20240807$$HP$US$US
241840301$24184030$1$I$20240510$20240805$20240807$20240807$EXP$FR-AFSSAPS-NT2024000965$FR-TAKEDA-2024TUS077964$TAKEDA$$53$YR$$M$Y$$$20240807$$HP$FR$FR
241840311$24184031$1$I$$20240806$20240807$20240807$EXP$$CN-TAKEDA-2024TUS078909$TAKEDA$$$$$M$Y$$$20240807$$CN$CN$CN
241840321$24184032$1$I$20231001$20240725$20240807$20240807$EXP$$CN-NOVOPROD-1261093$NOVO NORDISK$$$$$F$Y$$$20240807$$CN$CN$CN
241840332$24184033$2$F$20210101$20240901$20240807$20240904$EXP$$TW-009507513-2408TWN000931$MERCK$$67$YR$$F$Y$$$20240904$$MD$TW$TW
241840341$24184034$1$I$$20240806$20240807$20240807$PER$$US-HALEON-2190782$Haleon PLC$$$$$$Y$$$20240807$$CN$US$US
241840361$24184036$1$I$$20240806$20240806$20240806$DIR$713112$$FDA-CTU$$90$YR$$F$N$59.85$KG$20240806$Y$CN$US$
241840371$24184037$1$I$20240803$20240806$20240806$20240806$DIR$713242$$FDA-CTU$$43$YR$$M$N$83.25$KG$20240806$Y$CN$US$
241840381$24184038$1$I$20240101$20240730$20240807$20240807$PER$$US-SA-2024SA144459$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240807$$MD$US$US
241840391$24184039$1$I$20240724$20240729$20240807$20240807$PER$$US-SA-2024SA230780$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240807$$MD$US$US
241840401$24184040$1$I$$20240806$20240806$20240806$DIR$713186$$FDA-CTU$$$$$M$N$$$20240806$N$$US$
241840411$24184041$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA229969$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$MD$US$US
241840421$24184042$1$I$$20240730$20240807$20240807$PER$$US-ALXN-202407USA002127US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
241840441$24184044$1$I$20240417$20240702$20240807$20240807$EXP$$US-NOVOPROD-1263864$NOVO NORDISK$$67$YR$$M$Y$104$KG$20240807$$MD$US$US
241840452$24184045$2$F$20240802$20240806$20240807$20240821$PER$$US-AMGEN-USASP2024155349$AMGEN$$$$$$Y$$$20240821$$CN$US$US
241840461$24184046$1$I$20240101$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155919$AMGEN$$62$YR$A$F$Y$$$20240807$$CN$US$US
241840471$24184047$1$I$20220201$20240801$20240807$20240807$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004381$BLUEPRINT MEDICINES$$$$$$Y$$$20240807$$HP$CN$CN
241840483$24184048$3$F$20240701$20240925$20240807$20240928$EXP$$US-SA-2024SA232442$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240928$$MD$US$US
241840491$24184049$1$I$$20240729$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005637$BIOCON$$$$$$Y$$$20240807$$HP$CA$CA
241840501$24184050$1$I$$20240724$20240807$20240807$EXP$$CH-TEVA-VS-3227067$TEVA$$$$N$M$Y$$$20240807$$CN$CH$CH
241840512$24184051$2$F$$20240812$20240807$20240820$EXP$$US-TEVA-VS-3228087$TEVA$Beesley S, Lanspa MJ. Calcium Channel Overdose and Insulin Therapy Dosing. Am-J-Respir-Crit-Care-Med 2024; 209.; Beesley S, Lanspa MJ. Calcium Channel Overdose and Insulin Therapy Dosing. Am-J-Respir-Crit-Care-Med 2024; 209.$28$YR$$M$Y$$$20240820$$HP$US$US
241840523$24184052$3$F$$20240917$20240807$20240919$EXP$$US-TAKEDA-2024TUS078711$TAKEDA$$$$$F$Y$$$20240919$$CN$US$US
241840531$24184053$1$I$20240101$20240726$20240807$20240807$PER$$US-SA-2024SA227061$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240807$$MD$US$US
241840541$24184054$1$I$20230701$20240731$20240807$20240807$PER$$US-SA-2024SA231567$SANOFI AVENTIS$$45$YR$A$M$Y$84$KG$20240807$$MD$US$US
241840551$24184055$1$I$$20240723$20240807$20240807$PER$$US-RDY-SPO/USA/24/0011428$DR REDDYS$$$$$F$Y$$$20240807$$CN$US$US
241840571$24184057$1$I$$20240729$20240807$20240807$EXP$$DE-RDY-LIT/DEU/24/0011349$DR REDDYS$Hoeltzenbein M, Slimi S, Fietz A, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023 Apr;107: 107-113. doi:10.1016/j.seizure.2023.02.015.$$$N$$Y$$$20240807$$HP$DE$DE
241840591$24184059$1$I$$20240729$20240807$20240807$EXP$$CA-APOTEX-2024AP008980$APOTEX$$70$YR$$F$Y$$$20240807$$CN$CA$CA
241840601$24184060$1$I$$20240731$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123888$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240807$$CN$US$US
241840611$24184061$1$I$$20240731$20240807$20240807$EXP$$NVSC2024ZA157348$NOVARTIS$$52$YR$$F$Y$$$20240807$$HP$ZA$ZA
241840631$24184063$1$I$20240701$20240723$20240807$20240807$PER$$US-JNJFOC-20240764308$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
241840641$24184064$1$I$$20240730$20240807$20240807$EXP$$US-AstraZeneca-2024A173649$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241840651$24184065$1$I$$20240726$20240807$20240807$EXP$$MA-SA-2024SA224495$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240807$$CN$MA$MA
241840661$24184066$1$I$$20240722$20240807$20240807$PER$$AU-TOLMAR, INC.-24AU051217$TOLMAR$$$$$M$Y$$$20240806$$CN$AU$AU
241840671$24184067$1$I$$20240722$20240807$20240807$PER$$AU-TOLMAR, INC.-24AU051186$TOLMAR$$$$$M$Y$$$20240806$$CN$AU$AU
241840681$24184068$1$I$20240719$20240719$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051183$TOLMAR$$67$YR$$M$Y$$$20240806$$CN$CA$CA
241840691$24184069$1$I$20240718$20240718$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051191$TOLMAR$$58$YR$$M$Y$$$20240806$$CN$CA$CA
241840701$24184070$1$I$20240718$20240718$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051189$TOLMAR$$81$YR$$M$Y$$$20240806$$CN$CA$CA
241840711$24184071$1$I$20240301$20240719$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051205$TOLMAR$$84$YR$$M$Y$$$20240806$$CN$CA$CA
241840721$24184072$1$I$20240719$20240719$20240807$20240807$PER$$CA-TOLMAR, INC.-24CA051227$TOLMAR$$75$YR$$M$Y$$$20240806$$CN$CA$CA
241840731$24184073$1$I$20240101$20240717$20240807$20240807$PER$$CO-TOLMAR, INC.-24CO051152$TOLMAR$$$$$M$Y$$$20240806$$CN$CO$CO
241840741$24184074$1$I$20230101$20240719$20240807$20240807$PER$$CO-TOLMAR, INC.-24CO046033$TOLMAR$$73$YR$$M$Y$$$20240806$$CN$CO$CO
241840751$24184075$1$I$$20240728$20240807$20240807$EXP$AU-TGA-809292$AU-Accord-438684$ACCORD$$$$$$Y$$$20240807$$HP$AU$AU
241840761$24184076$1$I$$20240727$20240807$20240807$EXP$GB-MHRA-MED-202407272224566460-HYGZR$GB-Accord-439163$ACCORD$$29$YR$A$F$Y$$$20240807$$CN$GB$GB
241840771$24184077$1$I$20240701$20240727$20240807$20240807$EXP$FR-AFSSAPS-2024064508$FR-Accord-439119$ACCORD$$74$YR$E$F$Y$$$20240807$$PH$FR$FR
241840781$24184078$1$I$$20240728$20240807$20240807$EXP$AU-TGA-811196$AU-Accord-438798$ACCORD$$$$$F$Y$$$20240807$$HP$AU$
241840791$24184079$1$I$20231101$20240727$20240807$20240807$EXP$FR-AFSSAPS-LM2024000417$FR-Accord-438769$ACCORD$$50$YR$A$M$Y$64$KG$20240807$$MD$FR$FR
241840811$24184081$1$I$$20240728$20240807$20240807$EXP$$HU-Accord-439218$ACCORD$Mehes G, Mokanszki A, Ujfalusi A, Hevessy Z, Miltenyi Z, Gergely L, et.al. Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: Tracing the Paths to Leukemic Transformation. Int J Mol Sci. 2024 Jul 22;25(14):8003.$71$YR$E$M$Y$$$20240807$$HP$HU$HU
241840821$24184082$1$I$20240805$20240806$20240806$20240806$DIR$713144$$FDA-CTU$$66$YR$$M$N$$$20240806$Y$HP$US$
241840831$24184083$1$I$20240509$20240729$20240807$20240807$EXP$FR-AFSSAPS-NC2024000863$FR-TEVA-VS-3227694$TEVA$$59$YR$$F$Y$80$KG$20240807$$MD$FR$FR
241840851$24184085$1$I$20240724$20240725$20240807$20240807$EXP$$US-Accord-439585$ACCORD$$59$YR$A$F$Y$$$20240807$$HP$US$US
241840861$24184086$1$I$20240712$20240726$20240807$20240807$EXP$$US-Accord-439070$ACCORD$$34$YR$A$M$Y$$$20240807$$PH$US$US
241840871$24184087$1$I$20240714$20240806$20240806$20240806$DIR$713198$$FDA-CTU$$69$YR$$M$N$$$20240806$N$HP$US$
241840881$24184088$1$I$$20240806$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003990$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240807$$CN$US$US
241840891$24184089$1$I$20240803$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002948$ELI LILLY AND CO$$$$$M$Y$$$20240807$$CN$US$US
241840901$24184090$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003345$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240807$$CN$US$US
241840911$24184091$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002850$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241840921$24184092$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002461$ELI LILLY AND CO$$58$YR$A$$Y$$$20240807$$CN$US$US
241840931$24184093$1$I$20240803$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003324$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240807$$CN$US$US
241840941$24184094$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002462$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240807$$CN$US$US
241840952$24184095$2$F$$20240805$20240807$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408002264$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240812$$CN$US$US
241840961$24184096$1$I$20240701$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003000$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240807$$CN$US$US
241840971$24184097$1$I$20240717$20240806$20240806$20240806$DIR$713101$$FDA-CTU$$73$YR$$F$N$55.7$KG$20240806$N$HP$US$
241840981$24184098$1$I$$20240806$20240806$20240806$DIR$713193$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
241840991$24184099$1$I$20240723$20240806$20240806$20240806$DIR$713169$$FDA-CTU$$10$YR$$M$N$27$KG$20240806$N$CN$US$
241841021$24184102$1$I$20240715$20240806$20240806$20240806$DIR$713212$$FDA-CTU$$72$YR$$M$N$105.75$KG$20240806$N$CN$US$
241841031$24184103$1$I$$20240806$20240806$20240806$DIR$713161$$FDA-CTU$$$$$UNK$N$$$20240806$N$CN$US$
241841041$24184104$1$I$20240616$20240806$20240806$20240806$DIR$713181$$FDA-CTU$$61$YR$$F$N$99$KG$20240806$N$CN$US$
241841051$24184105$1$I$20240717$20240806$20240806$20240806$DIR$713191$$FDA-CTU$$66$YR$$F$N$70.9$KG$20240806$N$PH$US$
241841072$24184107$2$F$$20240806$20240807$20240812$EXP$$TW-PFIZER INC-202400230032$PFIZER$Sung, M.. Secondary hemophagocytic lymphohistiocytosis triggered by Staphylococcus aureus bacteremia:A case report and systemic review. IDCases. 2024;37:e02031$86$YR$$F$Y$$$20240812$$MD$TW$TW
241841081$24184108$1$I$$20240805$20240807$20240807$EXP$$JP-PFIZER INC-PV202400101918$PFIZER$Ikeda, T.. A case of non-HIV PCP caused by methotrexate in a patient with low blood cells. 132nd Annual Meeting of Kinki Chapter of the Japanese Society for Tuberculosis. 2024;132nd:73$78$YR$$F$Y$$$20240807$$HP$JP$JP
241841091$24184109$1$I$20240101$20240730$20240807$20240807$EXP$$JP-PFIZER INC-PV202400095285$PFIZER$$3$YR$$M$Y$$$20240807$$PH$JP$JP
241841101$24184110$1$I$20240101$20240731$20240807$20240807$EXP$FR-AFSSAPS-PB2024000816$FR-PFIZER INC-202400229350$PFIZER$$30$YR$$M$Y$$$20240807$$MD$FR$FR
241841112$24184111$2$F$$20240807$20240807$20240812$30DAY$$US-PFIZER INC-PV202400044338$PFIZER$$$$$$Y$$$20240812$$HP$US$US
241841121$24184112$1$I$20230601$20240731$20240807$20240807$EXP$$US-PFIZER INC-202400228546$PFIZER$$77$YR$$F$Y$$$20240807$$HP$US$US
241841143$24184114$3$F$20221208$20240820$20240807$20240822$EXP$$MY-PFIZER INC-PV202400100762$PFIZER$$73$YR$$M$Y$63.4$KG$20240822$$MD$MY$MY
241841151$24184115$1$I$$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154733$AMGEN$$$$$$Y$$$20240807$$CN$US$US
241841161$24184116$1$I$$20240728$20240807$20240807$PER$$US-AMGEN-USASP2024154311$AMGEN$Silverman S. L.; Reginster J.; Czerwinski E. et al.. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis International. 2024;1-12$$$$F$Y$$$20240807$$HP$US$US
241841171$24184117$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA227748$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240807$$MD$US$US
241841181$24184118$1$I$20240722$20240731$20240807$20240807$EXP$$CN-SA-2024SA231543$SANOFI AVENTIS$$71$YR$E$M$Y$60$KG$20240807$$HP$CN$CN
241841191$24184119$1$I$20220101$20240729$20240807$20240807$EXP$$RU-AMGEN-RUSSP2024151183$AMGEN$Babushkina G.; Gubaeva A.;  Zhumaniyazova A. et al.. A case of metastatic heart disease in kidney cancer. Vrach. 2024;35 (6):35-40$73$YR$E$M$Y$$$20240807$$MD$RU$RU
241841203$24184120$3$F$20240727$20240906$20240807$20240930$PER$$US-SA-2024SA226003$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240929$$MD$US$US
241841211$24184121$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA230413$SANOFI AVENTIS$$$$A$M$Y$$$20240807$$MD$US$US
241841221$24184122$1$I$20240628$20240730$20240807$20240807$EXP$$JP-EMD Serono-2024041393$EMD SERONO INC$$8$DEC$E$M$Y$$$20240807$$MD$JP$JP
241841231$24184123$1$I$20240722$20240729$20240807$20240807$EXP$$US-BAXTER-2024BAX022489$BAXTER$$$$$$Y$$$20240807$$CN$US$US
241841241$24184124$1$I$20240712$20240729$20240807$20240807$EXP$CN-NMPACDR-4401051005912202400303$CN-BAXTER-2024BAX022503$BAXTER$$75$YR$$M$Y$55$KG$20240807$$MD$CN$CN
241841251$24184125$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA226803$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240807$$MD$US$US
241841261$24184126$1$I$20240722$20240802$20240807$20240807$EXP$$CA-ROCHE-10000050251$ROCHE$$47$YR$A$M$Y$$$20240807$$CN$CA$CA
241841271$24184127$1$I$20231214$20240730$20240807$20240807$EXP$FR-AFSSAPS-LY2024000209$FR-BAXTER-2024BAX012727$BAXTER$$62$YR$$F$Y$57$KG$20240807$$HP$FR$FR
241841281$24184128$1$I$20240620$20240730$20240807$20240807$EXP$CN-NMPACDR-4602001068793202400101$CN-BAXTER-2024BAX022572$BAXTER$$52$YR$$F$Y$$$20240807$$MD$CN$CN
241841291$24184129$1$I$$20240731$20240807$20240807$PER$$US-ALXN-202407USA002247US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240807$$PH$US$US
241841302$24184130$2$F$$20240812$20240807$20240814$EXP$$US-GILEAD-2024-0683267$GILEAD$$61$YR$A$F$Y$$$20240814$$CN$US$US
241841311$24184131$1$I$$20240717$20240807$20240807$EXP$$CA-PFIZER INC-202400231297$PFIZER$$80$YR$$F$Y$$$20240807$$MD$CA$CA
241841321$24184132$1$I$$20240728$20240807$20240807$PER$$US-AMGEN-USASP2024154266$AMGEN$Silverman S. L.; Reginster J.; Czerwinski E. et al.. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis International. 2024;1-12$$$$F$Y$$$20240807$$HP$US$US
241841331$24184133$1$I$20240802$20240806$20240806$20240806$DIR$713182$$FDA-CTU$$$$$UNK$N$$$20240806$Y$CN$US$
241841352$24184135$2$F$20240301$20240916$20240807$20240923$PER$$US-SA-2024SA156798$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240923$$MD$US$US
241841361$24184136$1$I$$20240806$20240806$20240806$DIR$713185$$FDA-CTU$$$$$UNK$N$$$20240806$$CN$US$
241841371$24184137$1$I$$20240806$20240806$20240806$DIR$713104$$FDA-CTU$$57$YR$$M$N$$$20240806$N$PH$US$
241841381$24184138$1$I$20240806$20240806$20240806$20240806$DIR$713145$$FDA-CTU$$38$YR$$F$N$$$20240806$Y$HP$US$
241841401$24184140$1$I$$20240725$20240807$20240807$EXP$$JP-VIATRISJAPAN-2024M1069370AA$MYLAN$Nakamura R, Takanashi M, Kimura S, Honda T, Kitagawa A, Tamura Y, et al. Case report of beta-blocker-induced refractory anaphylactic shock after Fontan surgery in a 6-year-old boy. Kitasato Medicine. 2024;54(1):17-23$6$YR$$M$Y$14$KG$20240807$$MD$JP$JP
241841411$24184141$1$I$$20240801$20240807$20240807$EXP$$IN-ROCHE-10000047870$ROCHE$$71$YR$E$M$Y$$$20240807$$CN$IN$IN
241841421$24184142$1$I$$20240802$20240807$20240807$EXP$$US-GILEAD-2024-0683017$GILEAD$$$$A$M$Y$$$20240807$$CN$US$US
241841431$24184143$1$I$$20240728$20240807$20240807$PER$$US-AMGEN-USASP2024154271$AMGEN$Silverman S. L.; Reginster J.; Czerwinski E. et al.. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis International. 2024;1-12$$$$F$Y$$$20240807$$HP$US$US
241841441$24184144$1$I$20240722$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155602$AMGEN$$83$YR$E$F$Y$$$20240807$$CN$US$US
241841451$24184145$1$I$20230801$20240726$20240807$20240807$EXP$$US-INSMED-2023-03349-USAA$INSMED$$67$YR$$F$Y$$$20240807$$CN$US$US
241841471$24184147$1$I$$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54213$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
241841482$24184148$2$F$$20240725$20240807$20240808$EXP$$CA-MYLANLABS-2024M1070025$MYLAN$$11$YR$$M$Y$$$20240808$$HP$CA$CA
241841491$24184149$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160851$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241841511$24184151$1$I$$20240805$20240807$20240807$PER$$US-HALEON-2190798$Haleon PLC$$$$$F$Y$$$20240807$$CN$US$US
241841521$24184152$1$I$$20240729$20240807$20240807$EXP$$CA-TEVA-VS-3227729$TEVA$$62$YR$$M$Y$80$KG$20240807$$HP$CA$CA
241841531$24184153$1$I$$20240802$20240807$20240807$EXP$$US-SA-2024SA233153$SANOFI AVENTIS$$$$E$F$Y$$$20240807$$MD$US$US
241841541$24184154$1$I$$20240709$20240807$20240807$PER$$US-LEX-000388$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241841552$24184155$2$F$$20240807$20240807$20240808$PER$$US-TAKEDA-2024TUS078860$TAKEDA$$$$$F$Y$$$20240808$$HP$US$US
241841561$24184156$1$I$20230222$20221201$20240807$20240807$EXP$$CA-CELLTRION INC.-2022CA022480$CELLTRION$$$$$$Y$$$20240807$$MD$CA$CA
241841571$24184157$1$I$$20240806$20240807$20240807$PER$$US-GILEAD-2024-0683209$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241841581$24184158$1$I$$20240728$20240807$20240807$EXP$$US-AMGEN-USASP2024155764$AMGEN$Silverman S. L.; Reginster J.; Czerwinski E. et al.. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis International. 2024;1-12$$$$F$Y$$$20240807$$HP$US$US
241841591$24184159$1$I$20240720$20240725$20240807$20240807$EXP$$CN-BEH-2024176448$CSL BEHRING$$95$YR$E$M$Y$52$KG$20240807$$CN$CN$CN
241841601$24184160$1$I$20240525$20240729$20240807$20240807$EXP$$CO-UCBSA-2024039594$UCB$$56$YR$$F$Y$$$20240807$$CN$CO$CO
241841611$24184161$1$I$20240731$20240806$20240807$20240807$EXP$$NVSC2024GB160171$NOVARTIS$$$$$F$Y$$$20240807$$CN$GB$GB
241841621$24184162$1$I$20240701$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124513$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240807$$HP$US$US
241841631$24184163$1$I$$20240731$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121639$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$106.59$KG$20240807$$CN$US$US
241841641$24184164$1$I$20240601$20240731$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121577$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240807$$HP$US$US
241841651$24184165$1$I$$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123368$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240807$$CN$US$US
241841661$24184166$1$I$20240801$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155948$AMGEN$$77$YR$E$F$Y$$$20240807$$CN$US$US
241841672$24184167$2$F$20240805$20240910$20240807$20240911$PER$$US-AMGEN-USASP2024155659$AMGEN$$58$YR$A$F$Y$$$20240911$$CN$US$US
241841681$24184168$1$I$$20240731$20240807$20240807$EXP$$JP-AMGEN-JPNSP2024152039$AMGEN$$$$$$Y$$$20240807$$CN$JP$JP
241841691$24184169$1$I$$20240720$20240807$20240807$PER$$US-JNJFOC-20240756236$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241841701$24184170$1$I$20240101$20240801$20240807$20240807$EXP$$CL-JNJFOC-20240807165$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240807$$CN$CL$CL
241841711$24184171$1$I$20240805$20240805$20240807$20240807$EXP$$GB-MYLANLABS-2024M1073037$MYLAN$$$$$M$Y$$$20240807$$CN$GB$GB
241841721$24184172$1$I$20240802$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155926$AMGEN$$51$YR$A$F$Y$$$20240807$$CN$US$US
241841731$24184173$1$I$20240715$20240729$20240807$20240807$PER$$US-SA-2024SA226909$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240807$$MD$US$US
241841741$24184174$1$I$20240701$20240729$20240807$20240807$PER$$US-SA-2024SA226541$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240807$$MD$US$US
241841751$24184175$1$I$20240702$20240709$20240807$20240807$PER$$US-Eisai-EC-2024-169814$EISAI$$78$YR$E$M$Y$$$20240807$$CN$US$US
241841761$24184176$1$I$$20240726$20240807$20240807$EXP$$AU-RDY-SPO/AUS/24/0011164$DR REDDYS$$$$$$Y$$$20240807$$CN$AU$AU
241841771$24184177$1$I$$20240726$20240807$20240807$EXP$$AU-RDY-SPO/AUS/24/0011163$DR REDDYS$$$$$$Y$$$20240807$$CN$AU$AU
241841781$24184178$1$I$$20240726$20240807$20240807$EXP$$AU-RDY-SPO/AUS/24/0011170$DR REDDYS$$$$$$Y$$$20240807$$CN$AU$AU
241841791$24184179$1$I$$20240726$20240807$20240807$EXP$$AU-RDY-SPO/AUS/24/0011165$DR REDDYS$$$$$$Y$$$20240807$$CN$AU$AU
241841801$24184180$1$I$$20240726$20240807$20240807$EXP$$AU-RDY-SPO/AUS/24/0011161$DR REDDYS$$$$$$Y$$$20240807$$CN$AU$AU
241841812$24184181$2$F$$20240812$20240807$20240822$EXP$$US-TEVA-VS-3227987$TEVA$Mikhail E, Alexander D, Jankowski M, Pandya D, Kunadi A. Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature. Am-J-Respir-Crit-Care-Med 2024; 209.; Mikhail E, Alexander D, Jankowski M, Pandya D, Kunadi A. Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature. Am-J-Respir-Crit-Care-Med 2...$72$YR$$F$Y$$$20240822$$HP$US$US
241841825$24184182$5$F$20240805$20240906$20240807$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124204$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240912$$CN$US$US
241841831$24184183$1$I$20240615$20240729$20240807$20240807$EXP$HR-HALMED-300086092$HR-TEVA-VS-3227149$TEVA$$62$YR$$F$Y$$$20240807$$MD$HR$HR
241841841$24184184$1$I$$20240801$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122306$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240807$$HP$US$US
241841851$24184185$1$I$20231211$20240731$20240807$20240807$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006383$AURINIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240807$$MD$US$US
241841864$24184186$4$F$20240729$20240903$20240807$20240912$EXP$$US-ROCHE-10000044892$ROCHE$$40$YR$A$F$Y$$$20240912$$MD$US$US
241841871$24184187$1$I$$20240801$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122371$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240807$$HP$US$US
241841881$24184188$1$I$20240718$20240730$20240807$20240807$EXP$DE-CADRBFARM-2024329432$DE-TEVA-VS-3228307$TEVA$$63$YR$$F$Y$$$20240807$$MD$DE$DE
241841892$24184189$2$F$$20240826$20240807$20240902$EXP$$CA-TAKEDA-2024TUS078834$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
241841901$24184190$1$I$$20240731$20240807$20240807$EXP$$GB-GSK-GB2024EME096133$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$GB$GB
241841912$24184191$2$F$$20240802$20240807$20240809$EXP$$IN-PFIZER INC-PV202400101585$PFIZER$$53$YR$$M$Y$$$20240809$$CN$IN$IN
241841921$24184192$1$I$$20240801$20240807$20240807$EXP$$US-TAKEDA-2021TUS027373$TAKEDA$$$$$F$Y$70.29$KG$20240807$$HP$US$US
241841931$24184193$1$I$20240101$20240801$20240807$20240807$EXP$$US-PFIZER INC-PV202300088446$PFIZER$$67$YR$$M$Y$$$20240807$$HP$US$US
241841941$24184194$1$I$$20240802$20240807$20240807$EXP$$US-PFIZER INC-202400229289$PFIZER$$$$$F$Y$$$20240807$$MD$US$US
241841951$24184195$1$I$20240610$20240801$20240807$20240807$EXP$ES-AEMPS-1554443$ES-PFIZER INC-202400231720$PFIZER$$79$YR$$M$Y$64$KG$20240807$$MD$ES$ES
241841961$24184196$1$I$20240714$20240803$20240807$20240807$EXP$$CN-PFIZER INC-PV202400101204$PFIZER$$54$YR$$M$Y$90$KG$20240807$$HP$CN$CN
241841971$24184197$1$I$$20240802$20240807$20240807$EXP$$US-PFIZER INC-202400229282$PFIZER$$$$$F$Y$$$20240807$$CN$US$US
241841981$24184198$1$I$20230301$20240802$20240807$20240807$EXP$FR-AFSSAPS-NT2024000966$FR-PFIZER INC-202400228776$PFIZER$$46$YR$$M$Y$119$KG$20240807$$MD$FR$FR
241841992$24184199$2$F$$20240829$20240807$20240904$EXP$$US-PFIZER INC-202400229481$PFIZER$$56$YR$$F$Y$$$20240904$$MD$US$US
241842001$24184200$1$I$$20240802$20240807$20240807$EXP$$GB-PFIZER INC-202400229222$PFIZER$$$$A$F$Y$$$20240807$$MD$GB$GB
241842011$24184201$1$I$20240107$20240802$20240807$20240807$EXP$FR-AFSSAPS-TO2024001399$FR-PFIZER INC-202400228799$PFIZER$$66$YR$$M$Y$$$20240807$$PH$FR$FR
241842021$24184202$1$I$20240710$20240802$20240807$20240807$EXP$GB-MHRA-MED-202408021809155270-HMTVR$GB-PFIZER INC-202400229322$PFIZER$$71$YR$$F$Y$88$KG$20240807$$MD$GB$GB
241842031$24184203$1$I$$20240731$20240807$20240807$EXP$$US-PFIZER INC-202400228438$PFIZER$$61$YR$$F$Y$$$20240807$$HP$US$US
241842051$24184205$1$I$$20240802$20240807$20240807$PER$$US-LEO Pharma-372538$LEO PHARM$$55$YR$$F$Y$$$20240807$$HP$US$US
241842061$24184206$1$I$20100111$20240802$20240807$20240807$EXP$$FR-PFIZER INC-202400228794$PFIZER$$22$YR$$M$Y$$$20240807$$MD$FR$FR
241842081$24184208$1$I$20240701$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003021$ELI LILLY AND CO$$64$YR$A$$Y$$$20240807$$CN$US$US
241842091$24184209$1$I$$20240805$20240807$20240807$EXP$$US-GILEAD-2024-0683206$GILEAD$$87$YR$E$F$Y$$$20240807$$CN$US$US
241842101$24184210$1$I$20240723$20240730$20240807$20240807$EXP$$CN-GE HEALTHCARE-2024CSU008743$GE HEALTHCARE$$61$YR$$M$Y$$$20240807$$HP$CN$CN
241842111$24184211$1$I$20240724$20240801$20240807$20240807$EXP$GB-MHRA-MED-202408010844030970-FDRYV$GB-GE HEALTHCARE-2024CSU008775$GE HEALTHCARE$$54$YR$$M$Y$$$20240807$$HP$GB$GB
241842121$24184212$1$I$$20240801$20240807$20240807$PER$$US-ABBVIE-5864650$ABBVIE$$$$$$Y$$$20240807$$CN$US$US
241842131$24184213$1$I$$20240806$20240806$20240806$DIR$713190$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
241842141$24184214$1$I$20240720$20240806$20240806$20240806$DIR$713140$$FDA-CTU$$63$YR$$F$N$51.75$KG$20240806$N$CN$US$
241842151$24184215$1$I$20240715$20240803$20240807$20240807$EXP$$ES-AUROBINDO-AUR-APL-2024-039303$AUROBINDO$$62$YR$$M$Y$99.4$KG$20240807$$MD$ES$ES
241842161$24184216$1$I$20240608$20240806$20240806$20240806$DIR$713167$$FDA-CTU$$89$YR$$M$N$$$20240806$N$HP$US$
241842172$24184217$2$F$$20240808$20240807$20240809$PER$$US-JNJFOC-20240812218$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$HP$US$US
241842181$24184218$1$I$$20240806$20240806$20240806$DIR$713152$$FDA-CTU$$$$$UNK$N$$$20240806$$CN$US$
241842191$24184219$1$I$20240715$20240806$20240806$20240806$DIR$713135$$FDA-CTU$$79$YR$$M$N$$$20240806$Y$HP$US$
241842202$24184220$2$F$$20240814$20240807$20240820$EXP$$CA-TAKEDA-2024TUS077230$TAKEDA$$$$$M$Y$$$20240820$$CN$CA$CA
241842231$24184223$1$I$$20240805$20240807$20240807$PER$$US-GILEAD-2024-0682998$GILEAD$$$$A$F$Y$$$20240807$$CN$US$US
241842241$24184224$1$I$20240623$20240805$20240807$20240807$EXP$$IL-PFIZER INC-PV202400102064$PFIZER$$36$YR$$F$Y$$$20240807$$PH$IL$IL
241842251$24184225$1$I$$20240804$20240807$20240807$EXP$$US-PFIZER INC-PV202400101388$PFIZER$$50$YR$$F$Y$$$20240807$$CN$US$US
241842261$24184226$1$I$20240529$20240805$20240807$20240807$EXP$$IL-PFIZER INC-PV202400102210$PFIZER$$29$YR$$F$Y$$$20240807$$PH$IL$IL
241842271$24184227$1$I$$20240804$20240807$20240807$EXP$$JO-PFIZER INC-202400230179$PFIZER$$$$$M$Y$$$20240807$$MD$JO$JO
241842281$24184228$1$I$20240725$20240804$20240807$20240807$EXP$$CN-PFIZER INC-202400229470$PFIZER$$40$YR$$M$Y$$$20240807$$MD$CN$CN
241842291$24184229$1$I$$20240805$20240807$20240807$EXP$$US-PFIZER INC-PV202300126216$PFIZER$$78$YR$$F$Y$56.689$KG$20240807$$MD$US$US
241842302$24184230$2$F$20240729$20240807$20240807$20240809$EXP$$US-PFIZER INC-202400230926$PFIZER$$77$YR$$M$Y$$$20240809$$PH$US$US
241842311$24184231$1$I$$20240729$20240807$20240807$EXP$$CA-APOTEX-2024AP008993$APOTEX$$23$YR$$F$Y$$$20240807$$HP$CA$CA
241842331$24184233$1$I$20240806$20240806$20240806$20240806$DIR$713199$$FDA-CTU$$76$YR$$M$N$99$KG$20240806$N$HP$US$
241842341$24184234$1$I$$20240730$20240807$20240807$EXP$$FR-AstraZeneca-2024A172869$ASTRAZENECA$$76$YR$$F$Y$$$20240807$$MD$FR$
241842352$24184235$2$F$$20240917$20240807$20240923$PER$$US-SA-2024SA230476$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240923$$CN$US$US
241842361$24184236$1$I$$20240806$20240806$20240806$DIR$713148$$FDA-CTU$$$$$UNK$N$$$20240806$$CN$US$
241842371$24184237$1$I$20240806$20240806$20240806$20240806$DIR$713175$$FDA-CTU$$$$$F$N$$$20240806$N$CN$US$
241842381$24184238$1$I$$20240806$20240806$20240806$DIR$713151$$FDA-CTU$$$$$UNK$N$$$20240806$N$$US$
241842392$24184239$2$F$20240630$20240813$20240807$20240819$EXP$$US-SA-2024SA230982$SANOFI AVENTIS$$74$YR$E$F$Y$84.36$KG$20240819$$MD$US$US
241842401$24184240$1$I$20240501$20240801$20240807$20240807$PER$$US-ROCHE-10000047858$ROCHE$$58$YR$A$F$Y$40.37$KG$20240807$$CN$US$US
241842411$24184241$1$I$20240802$20240806$20240806$20240806$DIR$713195$$FDA-CTU$$19$YR$$F$N$66.22$KG$20240806$Y$HP$US$
241842421$24184242$1$I$20230901$20240806$20240806$20240806$DIR$713158$$FDA-CTU$$25$YR$$F$N$168.75$KG$20240806$Y$CN$US$
241842431$24184243$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155945$AMGEN$$$$$F$Y$$$20240807$$HP$US$US
241842441$24184244$1$I$$20240730$20240807$20240807$PER$$US-AMGEN-USASP2024152144$AMGEN$$$$$F$Y$$$20240807$$HP$US$US
241842451$24184245$1$I$20240605$20240801$20240807$20240807$PER$$US-Eisai-EC-2024-171644$EISAI$$77$YR$E$M$Y$$$20240807$$CN$US$US
241842461$24184246$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000050756$ROCHE$Krause P, Rogers R, Shah M, Kang H, Parsonnet J, Kodama R, et al. Tafenoquine for relapsing babesiosis: a case series. Clinical Infectious Diseases. 2024-Jul-15;79 (1):130-7. doi:10.1093/cid/ciae238.$52$YR$A$M$Y$$$20240807$$HP$US$US
241842471$24184247$1$I$$20240726$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN007975$INCYTE$$$$$$Y$$$20240807$$MD$US$US
241842481$24184248$1$I$$20210824$20240807$20240807$EXP$$US-AstraZeneca-2021A697655$ASTRAZENECA$$$$$F$Y$88.5$KG$20240807$$CN$US$
241842491$24184249$1$I$$20240730$20240807$20240807$EXP$$AU-AstraZeneca-2024A174430$ASTRAZENECA$$$$$F$Y$$$20240807$$MD$AU$
241842501$24184250$1$I$20240101$20240729$20240807$20240807$PER$$US-SA-2024SA229886$SANOFI AVENTIS$$58$YR$A$F$Y$68$KG$20240807$$MD$US$US
241842512$24184251$2$F$20240101$20240814$20240807$20240821$PER$$US-SA-2024SA230704$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240821$$MD$US$US
241842521$24184252$1$I$20240101$20240729$20240807$20240807$PER$$US-SA-2024SA230746$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$CN$US$US
241842541$24184254$1$I$20210801$20240729$20240807$20240807$PER$$US-SA-2024SA229376$SANOFI AVENTIS$$51$YR$A$F$Y$88.45$KG$20240807$$MD$US$US
241842551$24184255$1$I$20240717$20240729$20240807$20240807$PER$$US-SA-2024SA227151$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240807$$MD$US$US
241842561$24184256$1$I$20240701$20240730$20240807$20240807$PER$$US-SA-2024SA230397$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240807$$MD$US$US
241842572$24184257$2$F$20240730$20240805$20240807$20240813$EXP$$US-ROCHE-10000049822$ROCHE$$79$YR$E$M$Y$84.82$KG$20240813$$CN$US$US
241842581$24184258$1$I$20221005$20240729$20240807$20240807$EXP$$CO-UCBSA-2024039534$UCB$$69$YR$$F$Y$$$20240807$$CN$CO$CO
241842601$24184260$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050421$ROCHE$$53$YR$A$F$Y$113.39$KG$20240807$$CN$US$US
241842611$24184261$1$I$$20240805$20240807$20240807$EXP$$US-GILEAD-2024-0683121$GILEAD$$8$YR$C$M$Y$$$20240807$$CN$US$US
241842622$24184262$2$F$20240101$20240731$20240807$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-035620$AUROBINDO$$$$A$M$Y$$$20240917$$PH$FR$FR
241842631$24184263$1$I$$20240729$20240807$20240807$EXP$$CA-TEVA-VS-3227751$TEVA$$55$YR$$M$Y$$$20240807$$HP$CA$CA
241842641$24184264$1$I$$20240725$20240807$20240807$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK092930$GLENMARK$$$$$$Y$$$20240807$$MD$CA$CA
241842653$24184265$3$F$20240715$20240809$20240807$20240814$EXP$$BR-CELLTRION INC.-2024BR018558$CELLTRION$$$$$$Y$$$20240814$$CN$BR$BR
241842661$24184266$1$I$$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124067$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$64.86$KG$20240807$$CN$US$US
241842672$24184267$2$F$$20240805$20240807$20240807$EXP$$US-GILEAD-2024-0683127$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241842683$24184268$3$F$20240101$20240829$20240807$20240905$30DAY$$US-JNJFOC-20240750514$JOHNSON AND JOHNSON$$67$YR$E$$Y$$$20240906$$CN$US$US
241842691$24184269$1$I$$20240716$20240807$20240807$PER$$PL-TOLMAR, INC.-24PL050997$TOLMAR$$$$$$Y$$$20240807$$HP$PL$PL
241842701$24184270$1$I$$20240716$20240807$20240807$PER$$RO-TOLMAR, INC.-24RO051176$TOLMAR$$$$$$Y$$$20240807$$HP$RO$RO
241842711$24184271$1$I$20240713$20240716$20240807$20240807$PER$$TR-TOLMAR, INC.-24TR051105$TOLMAR$$86$YR$$M$Y$$$20240807$$PH$TR$TR
241842721$24184272$1$I$$20240716$20240807$20240807$PER$$TR-TOLMAR, INC.-24TR050963$TOLMAR$$60$YR$$M$Y$$$20240807$$MD$TR$TR
241842732$24184273$2$F$20240705$20240819$20240807$20240910$PER$$US-TOLMAR, INC.-24US050823$TOLMAR$$$$$$Y$$$20240910$$HP$US$US
241842741$24184274$1$I$$20240802$20240807$20240807$EXP$$US-INCYTE CORPORATION-2024IN008091$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241842751$24184275$1$I$20240703$20240716$20240807$20240807$PER$$US-TOLMAR, INC.-24US051045$TOLMAR$$62$YR$$M$Y$$$20240807$$PH$US$US
241842762$24184276$2$F$20240715$20240828$20240807$20240917$PER$$US-TOLMAR, INC.-24US051096$TOLMAR$$74$YR$$M$Y$$$20240917$$HP$US$US
241842771$24184277$1$I$20240601$20240716$20240807$20240807$PER$$US-TOLMAR, INC.-24US051139$TOLMAR$$$$$M$Y$$$20240807$$HP$US$US
241842781$24184278$1$I$20240612$20240806$20240806$20240806$DIR$713207$$FDA-CTU$$58$YR$$F$N$$$20240806$Y$PH$US$
241842791$24184279$1$I$20240803$20240806$20240806$20240806$DIR$713194$$FDA-CTU$$87$YR$$M$N$$$20240806$Y$HP$US$
241842802$24184280$2$F$20240101$20240913$20240807$20240916$EXP$$JP-PFIZER INC-PV202400102061$PFIZER$$8$DEC$$M$Y$$$20240916$$MD$JP$JP
241842812$24184281$2$F$20240101$20240822$20240807$20240827$EXP$$US-PFIZER INC-PV202400102219$PFIZER$$59$YR$$F$Y$$$20240827$$HP$US$US
241842821$24184282$1$I$$20240805$20240807$20240807$EXP$$US-PFIZER INC-202400230408$PFIZER$$61$YR$$F$Y$$$20240807$$CN$US$US
241842831$24184283$1$I$20240701$20240806$20240807$20240807$EXP$$TW-PFIZER INC-PV202400102517$PFIZER$$$$E$F$Y$$$20240807$$HP$TW$TW
241842841$24184284$1$I$$20240806$20240807$20240807$EXP$$CN-PFIZER INC-PV202400102182$PFIZER$$$$A$M$Y$$$20240807$$CN$CN$CN
241842861$24184286$1$I$20240727$20240805$20240807$20240807$EXP$$CN-PFIZER INC-PV202400101820$PFIZER$$64$YR$$M$Y$50$KG$20240807$$HP$CN$CN
241842871$24184287$1$I$$20240805$20240807$20240807$EXP$$US-PFIZER INC-PV202400102159$PFIZER$$62$YR$$$Y$$$20240807$$CN$US$US
241842881$24184288$1$I$$20240805$20240807$20240807$EXP$$CN-PFIZER INC-PV202400102576$PFIZER$$95$YR$$F$Y$$$20240807$$CN$CN$CN
241842891$24184289$1$I$$20240805$20240807$20240807$EXP$$CA-PFIZER INC-PV202400102329$PFIZER$$44$YR$$M$Y$$$20240807$$MD$CA$CA
241842901$24184290$1$I$20221101$20240729$20240807$20240807$EXP$$PT-TEVA-VS-3227784$TEVA$$65$YR$$M$Y$87$KG$20240807$$MD$PT$PT
241842911$24184291$1$I$20240409$20240801$20240807$20240807$EXP$FR-AFSSAPS-NT2024000908$FR-MYLANLABS-2024M1072261$MYLAN$$14$YR$$F$Y$53$KG$20240807$$MD$FR$FR
241842921$24184292$1$I$20220715$20240801$20240807$20240807$EXP$FR-AFSSAPS-AM2024000580$FR-MYLANLABS-2024M1072248$MYLAN$$56$YR$$F$Y$64$KG$20240807$$CN$FR$FR
241842931$24184293$1$I$$20240805$20240807$20240807$EXP$$IT-FreseniusKabi-FK202412114$FRESENIUS KABI$$$$$F$Y$$$20240807$$MD$IT$IT
241842941$24184294$1$I$20240724$20240806$20240807$20240807$PER$$IN-Eisai-EC-2024-171584$EISAI$$64$YR$A$F$Y$$$20240807$$CN$IN$IN
241842951$24184295$1$I$20240716$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54212$$FDA-CTU$$54$YR$$F$N$$$20240806$N$HP$US$
241842961$24184296$1$I$$20240731$20240807$20240807$PER$US-MLMSERVICE-20240725-PI141969-00034-2$US-RDY-SPO/USA/24/0011341$DR REDDYS$Worth L, Khreisat A, Iacobelli A. Successful Treatment of Relapsing Chronic Eosinophilic Pneumonia With Mepolizumab: A Case Report. Cureus. 2024;16(7):e65097. DOI: 10.7759/cureus.65097.$73$YR$E$M$Y$$$20240807$$MD$US$US
241842971$24184297$1$I$20240704$20240710$20240807$20240807$PER$$US-LEX-000390$LEXICON PHARMACEUTICALS$$69$YR$$M$Y$$$20240807$$CN$US$US
241842981$24184298$1$I$$20240726$20240807$20240807$EXP$$AU-RDY-SPO/AUS/24/0011169$DR REDDYS$$$$$$Y$$$20240807$$CN$AU$AU
241842991$24184299$1$I$$20240726$20240807$20240807$EXP$$AU-RDY-SPO/AUS/24/0011168$DR REDDYS$$$$$$Y$$$20240807$$CN$AU$AU
241843001$24184300$1$I$20240701$20240713$20240807$20240807$PER$$US-009507513-2407USA009743$MERCK$$$$$F$Y$$$20240807$$CN$US$US
241843012$24184301$2$F$20240725$20240919$20240807$20240926$EXP$$FR-OTSUKA-2024_021376$OTSUKA$$32$YR$$M$Y$$$20240926$$PH$FR$FR
241843021$24184302$1$I$20240802$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156125$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241843031$24184303$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124785$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240807$$CN$US$US
241843041$24184304$1$I$20240701$20240731$20240807$20240807$EXP$$US-ABBVIE-5863551$ABBVIE$$39$YR$$M$Y$$$20240807$$CN$US$US
241843051$24184305$1$I$20240301$20240731$20240807$20240807$PER$$US-SA-2024SA232183$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240807$$MD$US$US
241843071$24184307$1$I$20240701$20240725$20240807$20240807$PER$$US-SA-2024SA228612$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240807$$MD$US$US
241843081$24184308$1$I$$20240731$20240807$20240807$EXP$$US-SA-2024SA231342$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240807$$MD$US$US
241843092$24184309$2$F$20240803$20240909$20240807$20240910$PER$$US-AMGEN-USASP2024155683$AMGEN$$69$YR$E$M$Y$$$20240910$$CN$US$US
241843101$24184310$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003361$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240807$$CN$US$US
241843111$24184311$1$I$20240805$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003048$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240807$$CN$US$US
241843121$24184312$1$I$$20240805$20240807$20240807$EXP$$US-GILEAD-2024-0683222$GILEAD$$$$A$F$Y$$$20240807$$HP$US$US
241843131$24184313$1$I$20240702$20240729$20240807$20240807$EXP$FR-AFSSAPS-TS2024000834$FR-TEVA-VS-3227747$TEVA$$79$YR$$F$Y$71$KG$20240807$$MD$FR$FR
241843141$24184314$1$I$20240713$20240729$20240807$20240807$EXP$FR-AFSSAPS-PO2024000796$FR-TEVA-VS-3227704$TEVA$$74$YR$$M$Y$93$KG$20240807$$PH$FR$FR
241843152$24184315$2$F$20240701$20240910$20240807$20240912$EXP$FR-AFSSAPS-MP2024001211$FR-TAKEDA-2024TUS077660$TAKEDA$$66$YR$$M$Y$71$KG$20240912$$HP$FR$FR
241843171$24184317$1$I$20240101$20240805$20240807$20240807$EXP$$US-ABBVIE-5869515$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241843181$24184318$1$I$$20240730$20240807$20240807$EXP$$CN-JNJFOC-20240804770$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$MD$CN$CN
241843191$24184319$1$I$$20240730$20240807$20240807$EXP$$ZA-AstraZeneca-2024A173643$ASTRAZENECA$$25567$DY$$F$Y$$$20240807$$CN$ZA$
241843203$24184320$3$F$$20240812$20240807$20240820$EXP$$CA-AstraZeneca-2024A174715$ASTRAZENECA$$$$$F$Y$$$20240820$$HP$CA$
241843211$24184321$1$I$20240725$20240729$20240807$20240807$EXP$$CN-VANTIVE-2024VAN018731$Vantive US Healthcare$$38$YR$$F$Y$41$KG$20240807$$CN$CN$CN
241843221$24184322$1$I$$20240729$20240807$20240807$PER$$US-ABBVIE-5860060$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241843231$24184323$1$I$$20240730$20240807$20240807$EXP$$GB-VANTIVE-2024VAN018734$Vantive US Healthcare$$$$$M$Y$$$20240807$$CN$GB$GB
241843241$24184324$1$I$20240101$20240802$20240807$20240807$EXP$$CO-SA-2024SA233252$SANOFI AVENTIS$$78$YR$E$F$Y$65$KG$20240807$$HP$CO$CO
241843251$24184325$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA227119$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240807$$MD$US$US
241843261$24184326$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA230023$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240807$$MD$US$US
241843271$24184327$1$I$20240101$20240801$20240807$20240807$PER$$US-SA-2024SA231878$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240807$$MD$US$US
241843281$24184328$1$I$20090129$20240802$20240807$20240807$EXP$$SG-SA-2024SA233234$SANOFI AVENTIS$$59$YR$A$M$Y$61$KG$20240807$$HP$SG$SG
241843293$24184329$3$F$20210101$20240906$20240807$20240910$EXP$$US-ORGANON-O2406USA000811$ORGANON$$$$$F$Y$137.87$KG$20240910$$MD$US$US
241843301$24184330$1$I$20240510$20240805$20240807$20240807$EXP$$IT-FreseniusKabi-FK202412116$FRESENIUS KABI$$77$YR$E$$Y$$$20240807$$MD$IT$IT
241843311$24184331$1$I$20211117$20240805$20240807$20240807$EXP$$PL-FreseniusKabi-FK202412140$FRESENIUS KABI$$72$YR$E$M$Y$$$20240807$$MD$PL$PL
241843321$24184332$1$I$20200825$20240805$20240807$20240807$EXP$PL-URPL-1-2929-2020$PL-FreseniusKabi-FK202412134$FRESENIUS KABI$$53$YR$A$M$Y$70$KG$20240807$$MD$PL$PL
241843332$24184333$2$F$20240720$20240729$20240807$20240809$EXP$$CN-FreseniusKabi-FK202411914$FRESENIUS KABI$$68$YR$E$M$Y$50.5$KG$20240809$$HP$CN$CN
241843342$24184334$2$F$$20240814$20240807$20240902$EXP$$US-ASTELLAS-2024US021540$ASTELLAS$$$$$$Y$$$20240902$$HP$US$US
241843351$24184335$1$I$20240729$20240802$20240807$20240807$EXP$$CN-ABBVIE-5866519$ABBVIE$$36$YR$$M$Y$48$KG$20240807$$MD$CN$CN
241843361$24184336$1$I$$20240805$20240807$20240807$EXP$$FR-FreseniusKabi-FK202412158$FRESENIUS KABI$$57$YR$A$F$Y$$$20240807$$HP$FR$FR
241843371$24184337$1$I$20240722$20240723$20240807$20240807$DIR$FDA-CDER-CTU-2024-54131$$FDA-CTU$$48$YR$$F$N$86.3$KG$20240723$N$$US$
241843392$24184339$2$F$$20240816$20240807$20240823$PER$$US-BIOGEN-2024BI01276623$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
241843402$24184340$2$F$$20240725$20240807$20240814$PER$$US-Calliditas-2024CAL01415$CALLIDITAS THERAPEUTICS$$70$YR$E$M$Y$95.7$KG$20240812$$CN$US$US
241843411$24184341$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54240$$FDA-CTU$$0$YR$$F$N$$$20240807$N$$US$
241843421$24184342$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54215$$FDA-CTU$$73$YR$$M$N$$$20240807$N$$US$
241843431$24184343$1$I$20240712$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54123$$FDA-CTU$$62$YR$$M$N$137$KG$20240806$N$$US$
241843441$24184344$1$I$$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124038$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240807$$CN$US$US
241843451$24184345$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124742$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240807$$HP$US$US
241843463$24184346$3$F$$20240905$20240807$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124005$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240909$$HP$US$US
241843472$24184347$2$F$$20240805$20240807$20240820$EXP$$DE-SANDOZ INC.-SDZ2024DE070942$SANDOZ$Dyballa N, Alexander H?rtel J, Prangenberg J, Andresen-Streichert H et al.. A case of a lidocaine intoxication of a 12 week old boy due to acircumcision in a domestic setting ? clinical, toxicological and forensicaspects. Forensic Science, Medicine and Pathology. 2024$12$WK$$M$Y$$$20240820$$HP$DE$DE
241843481$24184348$1$I$$20240802$20240807$20240807$EXP$$GB-MYLANLABS-2014M1001028$MYLAN$$58$YR$$F$Y$$$20240807$$CN$GB$GB
241843491$24184349$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54218$$FDA-CTU$$75$YR$$F$N$39.46$KG$20240807$N$HP$US$
241843511$24184351$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156202$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241843521$24184352$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160488$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241843532$24184353$2$F$20240802$20240909$20240807$20240910$PER$$US-JNJFOC-20240807055$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240910$$PH$US$US
241843551$24184355$1$I$20240701$20240806$20240807$20240807$EXP$$CN-JNJFOC-20240815984$JOHNSON AND JOHNSON$$83$YR$E$F$Y$62$KG$20240807$$HP$CN$CN
241843561$24184356$1$I$$20240730$20240807$20240807$EXP$$ES-MYLANLABS-2024M1071388$MYLAN$$$$I$F$Y$$$20240807$$MD$ES$ES
241843571$24184357$1$I$20240801$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154795$AMGEN$$63$YR$A$F$Y$$$20240807$$CN$US$US
241843582$24184358$2$F$$20240822$20240807$20240823$PER$$NVSC2024US160856$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
241843591$24184359$1$I$20240806$20240806$20240807$20240807$EXP$$NVSC2024DE160667$NOVARTIS$$$$$$Y$$$20240807$$CN$DE$DE
241843601$24184360$1$I$$20240806$20240807$20240807$EXP$$NVSC2024PH160295$NOVARTIS$$38$YR$$F$Y$$$20240807$$MD$PH$PH
241843621$24184362$1$I$$20240802$20240807$20240807$EXP$$CL-JNJFOC-20240478210$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240807$$CN$CL$CL
241843641$24184364$1$I$20240212$20240215$20240807$20240807$EXP$$NVSC2024PE033950$NOVARTIS$$60$YR$$F$Y$$$20240807$$CN$PE$PE
241843651$24184365$1$I$20240729$20240806$20240807$20240807$EXP$$SG-FreseniusKabi-FK202412169$FRESENIUS KABI$$54$YR$A$F$Y$$$20240807$$HP$SG$SG
241843661$24184366$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54217$$FDA-CTU$$67$YR$$F$N$$$20240807$N$$US$
241843671$24184367$1$I$20240221$20240805$20240807$20240807$EXP$FR-AFSSAPS-NC2024000919$FR-FreseniusKabi-FK202412173$FRESENIUS KABI$$48$YR$A$F$Y$97$KG$20240807$$MD$FR$FR
241843681$24184368$1$I$20240624$20240805$20240807$20240807$EXP$FR-AFSSAPS-ST2024001243$FR-FreseniusKabi-FK202412160$FRESENIUS KABI$$62$YR$A$F$Y$54$KG$20240807$$PH$FR$FR
241843691$24184369$1$I$20240404$20240805$20240807$20240807$EXP$FR-AFSSAPS-AN2024001003$FR-FreseniusKabi-FK202412203$FRESENIUS KABI$$60$YR$A$M$Y$$$20240807$$PH$FR$FR
241843701$24184370$1$I$$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54201$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
241843721$24184372$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54243$$FDA-CTU$$46$YR$$F$N$75.3$KG$20240807$N$$US$
241843731$24184373$1$I$20240630$20240805$20240807$20240807$EXP$FR-AFSSAPS-DJ2024000874$FR-FreseniusKabi-FK202412199$FRESENIUS KABI$$68$YR$E$F$Y$$$20240807$$MD$FR$FR
241843741$24184374$1$I$$20240730$20240807$20240807$PER$$US-MYLANLABS-2024M1071416$MYLAN$$$$$F$Y$64.41$KG$20240807$$CN$US$US
241843752$24184375$2$F$$20240730$20240807$20240910$EXP$$AT-Ipsen Biopharmaceuticals, Inc.-2024-15284$IPSEN$Jeryczynski, Georg, Berger, Julia M., Letsch, Felix, et al. ^A case of fungal peritonitis in a patient with paramalignant ascites^, Medical Mycology Case Reports, 01-Jan-2024, Vol. 45.0, Iss. nan, Pp. nan. doi: 10.1016/j.mmcr.2024.100660$$$A$M$Y$$$20240910$$MD$AT$AT
241843761$24184376$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124946$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240807$$CN$US$US
241843771$24184377$1$I$20240802$20240805$20240807$20240807$PER$$NVSC2024US160469$NOVARTIS$$66$YR$$F$Y$$$20240807$$HP$US$US
241843781$24184378$1$I$20240727$20240805$20240807$20240807$EXP$$NVSC2024US160400$NOVARTIS$$65$YR$$F$Y$97.98$KG$20240807$$HP$US$US
241843811$24184381$1$I$20231001$20240802$20240807$20240807$EXP$$DE-ABBVIE-5867526$ABBVIE$$74$YR$$F$Y$$$20240807$$CN$DE$DE
241843821$24184382$1$I$$20240729$20240807$20240807$PER$$US-ABBVIE-5859714$ABBVIE$$$$$$Y$$$20240807$$HP$US$US
241843831$24184383$1$I$20240730$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54231$$FDA-CTU$$86$YR$$M$N$$$20240806$N$HP$US$
241843841$24184384$1$I$20240701$20240731$20240807$20240807$PER$$US-SA-2024SA229063$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240807$$MD$US$US
241843851$24184385$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA230666$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240807$$MD$US$US
241843872$24184387$2$F$$20240812$20240807$20240820$EXP$$US-TEVA-VS-3228242$TEVA$Patel EJ, Ahmad M, Schwartz BS, van Zante A, Kersten R, Loftus P. Invasive Fungal Sinusitis in an Immunocompetent Patient After Sinus Surgery for Chronic Rhinosinusitis with Nasal Polyps and a Mycetoma. Laryngoscope 2024;.; Patel EJ, Ahmad M, Schwartz BS, van Zante A, Kersten R, Loftus P. Invasive Fungal Sinusitis in an Immunocompetent Patient After Sinus Surgery for Chronic Rhinosinusitis with Nasal Polyps and a Mycetoma. Laryngoscope 2024;.$38$YR$$F$Y$$$20240820$$MD$US$US
241843882$24184388$2$F$20191201$20240809$20240807$20240812$EXP$$NVSC2024ES157567$NOVARTIS$$70$YR$$F$Y$$$20240812$$MD$ES$ES
241843891$24184389$1$I$$20240730$20240807$20240807$EXP$$IT-MYLANLABS-2024M1072265$MYLAN$Di Zio I, Cisternino R. A rare case of thrombocytopenia secondary to taking febuxostat. Italian-J-Med 2024; 18 (2):.$63$YR$$M$Y$$$20240807$$HP$IT$IT
241843902$24184390$2$F$20200201$20240904$20240807$20240912$EXP$$JP-ROCHE-10000047769$ROCHE$Kikuta K, Arishima H, Matsuda K, Isozaki M, Higashino Y, Yamauchi T. Two cases of long-term administration of bevacizumab for type 2 neurofibromatosis. [abstract number: SY1-3].. The 33rd Annual Meeting of Japanese Society of Acoustic Neuroma.. 2024;23:$25$YR$A$M$Y$$$20240912$$MD$JP$JP
241843913$24184391$3$F$20240701$20240828$20240807$20240902$EXP$$US-ABBVIE-5868536$ABBVIE$$92$YR$$F$Y$$$20240902$$CN$US$US
241843921$24184392$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA229973$SANOFI AVENTIS$$$$T$M$Y$49.89$KG$20240807$$MD$US$US
241843931$24184393$1$I$$20240802$20240807$20240807$EXP$$US-SA-2024SA232491$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240807$$MD$US$US
241843941$24184394$1$I$20240701$20240729$20240807$20240807$PER$$US-SA-2024SA229873$SANOFI AVENTIS$$8$YR$C$F$Y$24.58$KG$20240807$$MD$US$US
241843951$24184395$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA230730$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240807$$MD$US$US
241843961$24184396$1$I$$20240805$20240807$20240807$EXP$$US-JNJFOC-20240814010$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240807$$HP$US$US
241843973$24184397$3$F$20240301$20240910$20240807$20240916$EXP$$TN-ABBVIE-5867248$ABBVIE$$26$YR$$M$Y$$$20240916$$CN$TN$TN
241843981$24184398$1$I$$20240806$20240807$20240807$EXP$$NVSC2024GB076558$NOVARTIS$$$$$F$Y$$$20240807$$CN$GB$GB
241843991$24184399$1$I$20240805$20240805$20240807$20240807$EXP$$US-ABBVIE-5867554$ABBVIE$$84$YR$$M$Y$$$20240807$$CN$US$US
241844001$24184400$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA227944$SANOFI AVENTIS$$65$YR$E$F$Y$70.5$KG$20240807$$MD$US$US
241844011$24184401$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA229977$SANOFI AVENTIS$$53$YR$A$F$Y$73$KG$20240807$$MD$US$US
241844021$24184402$1$I$20240731$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024156544$AMGEN$$$$$$Y$$$20240807$$HP$US$US
241844031$24184403$1$I$20240625$20240805$20240807$20240807$EXP$FR-AFSSAPS-NT2024000968$FR-FreseniusKabi-FK202412162$FRESENIUS KABI$$83$YR$E$F$Y$$$20240807$$MD$FR$FR
241844041$24184404$1$I$$20240726$20240807$20240807$EXP$$AU-RDY-SPO/AUS/24/0011166$DR REDDYS$$$$$$Y$$$20240807$$CN$AU$AU
241844051$24184405$1$I$$20240725$20240807$20240807$PER$$US-RDY-LIT/USA/24/0011257$DR REDDYS$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. Journal of Allergy and Clinical Immunology: In Practice. 2024;12(6): 1663-1665. doi:10.1016/j.jaip.2024.02.023.$57$YR$A$M$Y$$$20240807$$MD$US$US
241844061$24184406$1$I$$20240725$20240807$20240807$PER$$US-RDY-LIT/USA/24/0011259$DR REDDYS$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. Journal of Allergy and Clinical Immunology: In Practice. 2024 Jun;12(6): 1663-1665. doi:10.1016/j.jaip.2024.02.023.$49$YR$A$F$Y$$$20240807$$MD$US$US
241844071$24184407$1$I$$20240725$20240807$20240807$PER$$US-RDY-LIT/USA/24/0011256$DR REDDYS$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. Journal of Allergy and Clinical Immunology: In Practice. 2024;12(6): 1663-1665. doi:10.1016/j.jaip.2024.02.023.$32$YR$A$F$Y$$$20240807$$MD$US$US
241844081$24184408$1$I$$20240725$20240807$20240807$PER$$US-RDY-LIT/USA/24/0011258$DR REDDYS$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. Journal of Allergy and Clinical Immunology: In Practice. 2024 Jun;12(6): 1663-1665. doi:10.1016/j.jaip.2024.02.023.$46$YR$A$F$Y$$$20240807$$MD$US$US
241844091$24184409$1$I$$20240726$20240807$20240807$EXP$$AU-RDY-SPO/AUS/24/0011171$DR REDDYS$$$$$$Y$$$20240807$$CN$AU$AU
241844101$24184410$1$I$20240719$20240731$20240807$20240807$EXP$$US-BAYER-2024A111870$BAYER$$52$YR$A$F$Y$$$20240807$$PH$US$US
241844112$24184411$2$F$$20240801$20240807$20240809$EXP$$JP-009507513-2408JPN000160J$MERCK$$8$DEC$$M$Y$$$20240809$$MD$JP$JP
241844123$24184412$3$F$20240101$20240814$20240807$20240913$EXP$$US-Axsome Therapeutics, Inc.-AXS202407-001108$AXSOME THERAPEUTICS$$16$YR$T$F$Y$$$20240913$$MD$US$
241844141$24184414$1$I$$20240806$20240807$20240807$EXP$$US-GILEAD-2024-0683215$GILEAD$$$$A$F$Y$$$20240807$$CN$US$US
241844151$24184415$1$I$20231009$20240711$20240807$20240807$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041110$BOEHRINGER INGELHEIM$$$$$$Y$$$20240807$$CN$US$US
241844161$24184416$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54214$$FDA-CTU$$74$YR$$M$N$$$20240807$N$$US$
241844172$24184417$2$F$$20240812$20240807$20240821$EXP$$PT-MYLANLABS-2024M1072675$MYLAN$Goulart I, Petrucci T, Virtuoso J, Rodrigues AB, Martins JR, Gomes MF, et al. Washing the sewer. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl. 1) 468-469 abstr. 1127.$41$YR$$M$Y$$$20240821$$HP$PT$PT
241844181$24184418$1$I$$20240801$20240807$20240807$EXP$$IN-MYLANLABS-2024M1073467$MYLAN$Joseph JT, Jammigumpula A, Jaise J, Naik P, Purohith AN, Shenoy S, et al. Long-term repetitive transcranial magnetic stimulation for treatment-resistant depression: Report of two cases. Indian-J-Psychiatry 2024; 66 (7): 679-681.$40$YR$$M$Y$$$20240807$$HP$IN$IN
241844191$24184419$1$I$$20240805$20240807$20240807$DIR$FDA-CDER-CTU-2024-54248$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
241844201$24184420$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54247$$FDA-CTU$$72$YR$$F$N$116.57$KG$20240807$N$$US$
241844221$24184422$1$I$20240703$20240801$20240807$20240807$EXP$FR-AFSSAPS-GR2024000951$FR-MYLANLABS-2024M1072403$MYLAN$$21$YR$$F$Y$57$KG$20240807$$PH$FR$FR
241844241$24184424$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5867756$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241844252$24184425$2$F$$20240813$20240807$20240815$PER$$US-PFIZER INC-PV202400101445$PFIZER$$40$YR$$F$Y$$$20240815$$HP$US$US
241844261$24184426$1$I$20240803$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230543$PFIZER$$40$YR$$F$Y$$$20240807$$CN$US$US
241844271$24184427$1$I$$20240805$20240807$20240807$PER$$US-PFIZER INC-PV202400102255$PFIZER$$$$$$Y$$$20240807$$CN$US$US
241844282$24184428$2$F$20240805$20240808$20240807$20240812$PER$$US-PFIZER INC-202400231400$PFIZER$$49$YR$$M$Y$$$20240812$$CN$US$US
241844291$24184429$1$I$20240726$20240804$20240807$20240807$PER$$US-PFIZER INC-202400230081$PFIZER$$36$YR$$F$Y$$$20240807$$CN$US$US
241844301$24184430$1$I$$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230443$PFIZER$$17$YR$$M$Y$$$20240807$$HP$US$US
241844311$24184431$1$I$$20240802$20240807$20240807$PER$$US-PFIZER INC-PV202400101411$PFIZER$$$$$F$Y$$$20240807$$CN$US$US
241844321$24184432$1$I$$20240802$20240807$20240807$PER$$US-PFIZER INC-PV202400101682$PFIZER$$54$YR$$F$Y$$$20240807$$HP$US$US
241844331$24184433$1$I$$20240804$20240807$20240807$PER$$US-PFIZER INC-PV202400101914$PFIZER$$18$YR$$F$Y$$$20240807$$HP$US$US
241844341$24184434$1$I$$20240803$20240807$20240807$PER$$US-PFIZER INC-202400229564$PFIZER$$15$YR$$M$Y$$$20240807$$MD$US$US
241844351$24184435$1$I$20240802$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230491$PFIZER$$78$YR$$M$Y$$$20240807$$CN$US$US
241844361$24184436$1$I$20240801$20240803$20240807$20240807$PER$$US-PFIZER INC-202400229705$PFIZER$$$$A$F$Y$$$20240807$$CN$US$US
241844371$24184437$1$I$20240801$20240802$20240807$20240807$PER$$US-PFIZER INC-202400230049$PFIZER$$69$YR$$F$Y$$$20240807$$CN$US$US
241844382$24184438$2$F$20240802$20240810$20240807$20240814$PER$$US-PFIZER INC-202400229580$PFIZER$$67$YR$$F$Y$$$20240814$$CN$US$US
241844391$24184439$1$I$$20240802$20240807$20240807$PER$$US-PFIZER INC-202400229228$PFIZER$$52$YR$$F$Y$65.32$KG$20240807$$CN$US$US
241844401$24184440$1$I$20240801$20240803$20240807$20240807$PER$$US-PFIZER INC-202400229734$PFIZER$$47$YR$$M$Y$$$20240807$$CN$US$US
241844411$24184441$1$I$$20240804$20240807$20240807$PER$$US-PFIZER INC-PV202400101500$PFIZER$$70$YR$$$Y$$$20240807$$CN$US$US
241844421$24184442$1$I$20240804$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230656$PFIZER$$33$YR$$F$Y$$$20240807$$CN$US$US
241844431$24184443$1$I$$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230423$PFIZER$$3$DEC$$M$Y$$$20240807$$HP$US$US
241844441$24184444$1$I$20240802$20240803$20240807$20240807$PER$$US-PFIZER INC-202400229730$PFIZER$$46$YR$$F$Y$$$20240807$$HP$US$US
241844451$24184445$1$I$20240731$20240804$20240807$20240807$PER$$US-PFIZER INC-202400229752$PFIZER$$73$YR$$M$Y$$$20240807$$CN$US$US
241844461$24184446$1$I$20240726$20240802$20240807$20240807$PER$$US-PFIZER INC-202400230054$PFIZER$$38$YR$$M$Y$$$20240807$$CN$US$US
241844472$24184447$2$F$20240801$20240811$20240807$20240813$PER$$US-PFIZER INC-202400229570$PFIZER$$$$$$Y$$$20240813$$CN$US$US
241844481$24184448$1$I$20240101$20240730$20240807$20240807$PER$$US-PFIZER INC-PV202400099988$PFIZER$$49$YR$$F$Y$$$20240807$$HP$US$US
241844501$24184450$1$I$$20240802$20240807$20240807$PER$$US-PFIZER INC-PV202400101364$PFIZER$$58$YR$$F$Y$$$20240807$$CN$US$US
241844511$24184451$1$I$$20240802$20240807$20240807$PER$$US-PFIZER INC-PV202400101751$PFIZER$$71$YR$$F$Y$$$20240807$$CN$US$US
241844532$24184453$2$F$20240701$20240918$20240807$20240923$EXP$$US-PFIZER INC-PV202400102311$PFIZER$$54$YR$$F$Y$65.306$KG$20240923$$HP$US$US
241844541$24184454$1$I$20240729$20240802$20240807$20240807$PER$$US-PFIZER INC-202400230060$PFIZER$$41$YR$$F$Y$$$20240807$$CN$US$US
241844551$24184455$1$I$$20240803$20240807$20240807$PER$$US-PFIZER INC-202400229723$PFIZER$$43$YR$$M$Y$$$20240807$$CN$US$US
241844571$24184457$1$I$$20240805$20240807$20240807$PER$$US-PFIZER INC-202400231243$PFIZER$$71$YR$$F$Y$$$20240807$$MD$US$US
241844581$24184458$1$I$$20240802$20240807$20240807$PER$$US-PFIZER INC-202400230482$PFIZER$$56$YR$$M$Y$$$20240807$$HP$US$US
241844591$24184459$1$I$20240731$20240803$20240807$20240807$PER$$US-PFIZER INC-202400229732$PFIZER$$81$YR$$M$Y$$$20240807$$CN$US$US
241844601$24184460$1$I$20240801$20240802$20240807$20240807$PER$$US-PFIZER INC-202400229569$PFIZER$$77$YR$$F$Y$92.99$KG$20240807$$CN$US$US
241844611$24184461$1$I$20240703$20240803$20240807$20240807$PER$$US-PFIZER INC-202400229699$PFIZER$$70$YR$$F$Y$$$20240807$$CN$US$US
241844621$24184462$1$I$20240713$20240802$20240807$20240807$PER$$US-PFIZER INC-202400229927$PFIZER$$75$YR$$F$Y$$$20240807$$CN$US$US
241844632$24184463$2$F$20240612$20240812$20240807$20240813$PER$$US-PFIZER INC-202400228611$PFIZER$$57$YR$$M$Y$68.1$KG$20240813$$PH$US$US
241844641$24184464$1$I$$20240804$20240807$20240807$PER$$US-PFIZER INC-PV202400102113$PFIZER$$24$YR$$F$Y$$$20240807$$HP$US$US
241844651$24184465$1$I$$20240804$20240807$20240807$PER$$US-PFIZER INC-202400229977$PFIZER$$$$$$Y$$$20240807$$CN$US$US
241844661$24184466$1$I$$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230596$PFIZER$$$$$M$Y$$$20240807$$HP$US$US
241844671$24184467$1$I$$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230520$PFIZER$$$$$M$Y$$$20240807$$HP$US$US
241844681$24184468$1$I$20240801$20240802$20240807$20240807$PER$$US-PFIZER INC-202400229988$PFIZER$$$$A$F$Y$$$20240807$$CN$US$US
241844691$24184469$1$I$$20240803$20240807$20240807$PER$$US-PFIZER INC-202400229727$PFIZER$$37$YR$$F$Y$$$20240807$$CN$US$US
241844702$24184470$2$F$20240802$20240807$20240807$20240807$PER$$US-PFIZER INC-202400230637$PFIZER$$37$YR$$F$Y$$$20240807$$CN$US$US
241844711$24184471$1$I$$20240802$20240807$20240807$PER$$US-PFIZER INC-PV202400101749$PFIZER$$64$YR$$F$Y$$$20240807$$HP$US$US
241844721$24184472$1$I$20240802$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230553$PFIZER$$69$YR$$F$Y$$$20240807$$CN$US$US
241844741$24184474$1$I$20240723$20240805$20240807$20240807$PER$$US-PFIZER INC-202400231311$PFIZER$$61$YR$$M$Y$$$20240807$$HP$US$US
241844751$24184475$1$I$20240802$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230533$PFIZER$$54$YR$$F$Y$$$20240807$$CN$US$US
241844761$24184476$1$I$20240805$20240805$20240807$20240807$PER$$US-PFIZER INC-202400222100$PFIZER$$62$YR$$F$Y$$$20240807$$CN$US$US
241844772$24184477$2$F$20240803$20240813$20240807$20240816$PER$$US-PFIZER INC-202400229781$PFIZER$$$$$$Y$$$20240816$$CN$US$US
241844781$24184478$1$I$20240801$20240802$20240807$20240807$PER$$US-PFIZER INC-202400229245$PFIZER$$$$$F$Y$$$20240807$$CN$US$US
241844791$24184479$1$I$$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230516$PFIZER$$72$YR$$M$Y$$$20240807$$CN$US$US
241844801$24184480$1$I$$20240804$20240807$20240807$PER$$US-PFIZER INC-202400229733$PFIZER$$51$YR$$F$Y$$$20240807$$CN$US$US
241844811$24184481$1$I$20240802$20240803$20240807$20240807$PER$$US-PFIZER INC-202400229729$PFIZER$$50$YR$$F$Y$$$20240807$$CN$US$US
241844821$24184482$1$I$20230101$20240805$20240807$20240807$PER$$US-PFIZER INC-PV202300138842$PFIZER$$69$YR$$F$Y$$$20240807$$CN$US$US
241844831$24184483$1$I$$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230508$PFIZER$$$$$F$Y$$$20240807$$HP$US$US
241844841$24184484$1$I$20240726$20240804$20240807$20240807$PER$$US-PFIZER INC-202400230117$PFIZER$$70$YR$$F$Y$$$20240807$$CN$US$US
241844851$24184485$1$I$$20240805$20240807$20240807$PER$$US-PFIZER INC-202400231405$PFIZER$$56$YR$$F$Y$$$20240807$$CN$US$US
241844861$24184486$1$I$20240802$20240802$20240807$20240807$PER$$US-PFIZER INC-202400230031$PFIZER$$72$YR$$F$Y$$$20240807$$CN$US$US
241844873$24184487$3$F$20240801$20240919$20240807$20240923$PER$$US-PFIZER INC-202400229232$PFIZER$$78$YR$$M$Y$88.45$KG$20240923$$CN$US$US
241844881$24184488$1$I$$20240805$20240807$20240807$PER$$US-PFIZER INC-PV202400102233$PFIZER$$67$YR$$M$Y$$$20240807$$HP$US$US
241844891$24184489$1$I$$20240801$20240807$20240807$PER$$US-PFIZER INC-202400228604$PFIZER$$47$YR$$F$Y$67.13$KG$20240807$$CN$US$US
241844901$24184490$1$I$20240803$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230583$PFIZER$$50$YR$$F$Y$$$20240807$$CN$US$US
241844912$24184491$2$F$$20240808$20240807$20240813$PER$$US-PFIZER INC-PV202400102078$PFIZER$$63$YR$$$Y$$$20240813$$CN$US$US
241844921$24184492$1$I$$20240802$20240807$20240807$PER$$US-PFIZER INC-PV202400101428$PFIZER$$$$A$$Y$$$20240807$$CN$US$US
241844931$24184493$1$I$20240802$20240804$20240807$20240807$PER$$US-PFIZER INC-202400230146$PFIZER$$49$YR$$F$Y$$$20240807$$CN$US$US
241844941$24184494$1$I$20240801$20240803$20240807$20240807$PER$$US-PFIZER INC-202400229736$PFIZER$$39$YR$$F$Y$$$20240807$$HP$US$US
241844952$24184495$2$F$20240730$20240821$20240807$20240826$PER$$US-PFIZER INC-202400229677$PFIZER$$59$YR$$F$Y$62.132$KG$20240826$$CN$US$US
241844961$24184496$1$I$20240803$20240804$20240807$20240807$PER$$US-PFIZER INC-202400230166$PFIZER$$34$YR$$F$Y$$$20240807$$PH$US$US
241844972$24184497$2$F$20240802$20240823$20240807$20240827$PER$$US-PFIZER INC-202400230147$PFIZER$$70$YR$$F$Y$$$20240827$$CN$US$US
241844991$24184499$1$I$$20240803$20240807$20240807$PER$$NVSC2024US160575$NOVARTIS$$$$$$Y$$$20240807$$CN$US$US
241845001$24184500$1$I$$20240805$20240807$20240807$EXP$$US-TAKEDA-2024TUS078918$TAKEDA$$$$$F$Y$$$20240807$$MD$US$US
241845041$24184504$1$I$$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54206$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
241845051$24184505$1$I$20240803$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54204$$FDA-CTU$$50$YR$$F$N$$$20240806$N$HP$US$
241845061$24184506$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54239$$FDA-CTU$$70$YR$$M$N$109.77$KG$20240807$N$$US$
241845071$24184507$1$I$20240726$20240801$20240807$20240807$DIR$FDA-CDER-CTU-2024-54130$$FDA-CTU$$45$YR$$F$N$77.6$KG$20240801$N$$US$
241845081$24184508$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54230$$FDA-CTU$$73$YR$$F$N$$$20240807$N$$US$
241845101$24184510$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54244$$FDA-CTU$$28$YR$$M$N$$$20240807$N$$US$
241845111$24184511$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54250$$FDA-CTU$$59$YR$$F$N$$$20240807$N$$US$
241845121$24184512$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54242$$FDA-CTU$$71$YR$$F$N$$$20240807$N$HP$US$
241845131$24184513$1$I$$20240725$20240807$20240807$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-IBA-000284$Unknown Manufacturer$$$$$$Y$$$20240807$$CN$US$US
241845141$24184514$1$I$$20240705$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06693$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241845151$24184515$1$I$20240722$20240805$20240807$20240807$EXP$HR-HALMED-300086275$HR-SANDOZ INC.-SDZ2024HR070833$SANDOZ$$67$YR$$F$Y$67$KG$20240807$$PH$HR$HR
241845192$24184519$2$F$20240725$20240812$20240807$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023503$UNITED THERAPEUTICS$$72$YR$$M$Y$56.689$KG$20240821$$$US$US
241845211$24184521$1$I$20240719$20240806$20240807$20240807$PER$$US-ROCHE-10000050049$ROCHE$$31$YR$A$M$Y$$$20240807$$CN$US$US
241845221$24184522$1$I$$20240806$20240807$20240807$EXP$$US-JNJFOC-20240815220$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$HP$US$US
241845231$24184523$1$I$$20240806$20240807$20240807$PER$$US-HALEON-2190690$Haleon PLC$$$$$F$Y$$$20240807$$CN$US$US
241845241$24184524$1$I$20240624$20240729$20240807$20240807$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001739$SK LIFE SCIENCE$$$$$$Y$$$20240807$$CN$US$US
241845251$24184525$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050941$ROCHE$$$$I$M$Y$9.07$KG$20240807$$CN$US$US
241845261$24184526$1$I$20240722$20240806$20240807$20240807$EXP$$CN-BAYER-2024A113610$BAYER$$64$YR$A$M$Y$65$KG$20240807$$HP$CN$CN
241845273$24184527$3$F$20240101$20240808$20240807$20240813$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004332$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240813$$MD$US$US
241845281$24184528$1$I$20240723$20240731$20240807$20240807$EXP$GB-MHRA-MED-202407311622365840-WBKCQ$GB-Ipsen Biopharmaceuticals, Inc.-2024-15320$IPSEN$$75$YR$E$M$Y$$$20240807$$MD$GB$GB
241845291$24184529$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160866$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241845301$24184530$1$I$$20240731$20240807$20240807$EXP$$US-009507513-2408USA000195$MERCK$$$$$F$Y$$$20240807$$CN$US$US
241845311$24184531$1$I$20240731$20240731$20240807$20240807$EXP$$JP-009507513-2407JPN005646J$MERCK$$79$YR$$F$Y$$$20240807$$PH$JP$JP
241845321$24184532$1$I$20240701$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155644$AMGEN$$77$YR$E$F$Y$$$20240807$$CN$US$US
241845331$24184533$1$I$20240805$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155869$AMGEN$$$$$M$Y$$$20240807$$CN$US$US
241845341$24184534$1$I$$20240802$20240807$20240807$EXP$$US-AMGEN-USASP2024154282$AMGEN$$$$$F$Y$$$20240807$$HP$US$US
241845351$24184535$1$I$$20240729$20240807$20240807$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001748$SK LIFE SCIENCE$$$$$$Y$$$20240807$$CN$US$US
241845361$24184536$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000048935$ROCHE$Hatayama R, Godai T, Suzuki S. S35-1 A case of Segmental Absence of Intestinal Musculature discovered during treatment of rectal cancer. The 79th General Meeting of the Japanese Society of Gastroenterological Surgery. 2024;2516$56$YR$A$M$Y$$$20240807$$MD$JP$JP
241845371$24184537$1$I$20240208$20240805$20240807$20240807$EXP$FR-AFSSAPS-TO2024001330$FR-Eisai-EC-2024-171466$EISAI$$87$YR$E$F$Y$56.4$KG$20240807$$PH$FR$FR
241845381$24184538$1$I$$20240801$20240807$20240807$PER$$JP-Eisai-EC-2024-171363$EISAI$$$$$F$Y$$$20240807$$MD$JP$JP
241845391$24184539$1$I$20230101$20240803$20240807$20240807$PER$$JP-Eisai-EC-2024-171513$EISAI$$74$YR$E$M$Y$$$20240807$$MD$JP$JP
241845411$24184541$1$I$$20240802$20240807$20240807$EXP$$US-TAKEDA-2024TUS070720$TAKEDA$$$$$F$Y$$$20240807$$CN$US$US
241845422$24184542$2$F$20240101$20240923$20240807$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120816$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240926$$CN$US$US
241845431$24184543$1$I$20240725$20240801$20240807$20240807$EXP$$CN-PURDUE-USA-2024-0311189$PURDUE$$69$YR$$F$Y$57$KG$20240807$$HP$CN$CN
241845442$24184544$2$F$$20240816$20240807$20240821$EXP$$PT-PURDUE-USA-2024-0311177$PURDUE$Nunes AP, Jardim M, Gomes S, Almada S, Fernandes AC, Pestana A et al. [CO-0177 - (4798) - Drifting withdrawal. Congresses of the Portuguese Society of Internal Medicine:. 30th National Congress of Internal Medicine - Book of abstracts [CNMI]. 2024;277$63$YR$$F$Y$$$20240821$$MD$PT$PT
241845452$24184545$2$F$$20240826$20240807$20240829$EXP$$JP-PURDUE-USA-2024-0311188$PURDUE$Shuji K, Masafumi T.. A case of an elderly patient with postherpetic neuralgia whose polypharmacy was manifested by worsening renal function. The 53rd Annual Meeting of the Japanese Society for the Study of Chronic Pain.. 2024;O12-2$81$YR$$F$Y$$$20240829$$MD$JP$JP
241845461$24184546$1$I$$20240728$20240807$20240807$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000155$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240807$$CN$US$US
241845471$24184547$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003764$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240807$$CN$US$US
241845492$24184549$2$F$$20240809$20240807$20240816$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004359$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240816$$CN$US$US
241845501$24184550$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003599$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240807$$CN$US$US
241845511$24184551$1$I$$20240801$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002768$ELI LILLY AND CO$$$$$M$Y$$$20240807$$CN$US$US
241845521$24184552$1$I$$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54207$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
241845531$24184553$1$I$20240726$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002119$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240807$$CN$US$US
241845541$24184554$1$I$20240805$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003441$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240807$$CN$US$US
241845552$24184555$2$F$$20240808$20240807$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408003450$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240812$$CN$US$US
241845561$24184556$1$I$$20240801$20240807$20240807$EXP$$CA-PURDUE-USA-2024-0311164$PURDUE$$40$YR$$F$Y$$$20240807$$HP$CA$CA
241845571$24184557$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54252$$FDA-CTU$$63$YR$$M$N$$$20240807$N$$US$
241845581$24184558$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54251$$FDA-CTU$$70$YR$$M$N$$$20240807$N$$US$
241845591$24184559$1$I$$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54216$$FDA-CTU$$$$$F$N$$$20240806$N$$US$
241845601$24184560$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123966$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$63.96$KG$20240807$$HP$US$US
241845611$24184561$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125016$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240807$$CN$US$US
241845621$24184562$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000048833$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$66$YR$E$F$Y$$$20240807$$HP$JP$JP
241845631$24184563$1$I$20240726$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54235$$FDA-CTU$$43$YR$$M$N$$$20240807$N$HP$US$
241845641$24184564$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54253$$FDA-CTU$$71$YR$$F$N$57.15$KG$20240807$N$$US$
241845651$24184565$1$I$$20240725$20240807$20240807$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK092932$GLENMARK$$$$$$Y$$$20240807$$HP$CA$CA
241845661$24184566$1$I$$20240802$20240807$20240807$PER$$US-ABBVIE-5867133$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241845672$24184567$2$F$20240722$20240807$20240807$20240812$PER$$US-AMGEN-USASP2024155373$AMGEN$$82$YR$E$F$Y$$$20240812$$CN$US$US
241845682$24184568$2$F$20240629$20240809$20240807$20240814$EXP$$US-AMGEN-USASP2024154002$AMGEN$$83$YR$E$M$Y$$$20240814$$CN$US$US
241845691$24184569$1$I$$20240806$20240807$20240807$EXP$$US-UCBSA-2024039608$UCB$$$$$M$Y$70.295$KG$20240807$$HP$US$US
241845702$24184570$2$F$$20240802$20240807$20240812$PER$$US-ABBVIE-5866070$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241845711$24184571$1$I$$20240729$20240807$20240807$EXP$$CN-JNJFOC-20240802195$JOHNSON AND JOHNSON$$$$C$$Y$$$20240807$$HP$CN$CN
241845722$24184572$2$F$20240802$20240813$20240807$20240814$PER$$US-JNJFOC-20240807135$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
241845731$24184573$1$I$$20240802$20240807$20240807$PER$$US-JNJFOC-20240805959$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$MD$US$US
241845741$24184574$1$I$20220101$20240729$20240807$20240807$EXP$$GB-JNJFOC-20240781152$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240807$$HP$GB$GB
241845751$24184575$1$I$$20240805$20240807$20240807$EXP$$US-JNJFOC-20240813437$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240807$$HP$US$US
241845761$24184576$1$I$$20240731$20240807$20240807$EXP$$US-JNJFOC-20240809211$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240807$$HP$US$US
241845771$24184577$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA218322$SANOFI AVENTIS$$34$YR$A$F$Y$61.1$KG$20240807$$MD$US$US
241845781$24184578$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160580$NOVARTIS$$$$$M$Y$$$20240807$$HP$US$US
241845791$24184579$1$I$$20240731$20240807$20240807$EXP$$NVSC2024IT159736$NOVARTIS$Cecchi N, Giannotta JA, Capecchi M, Barcellini W, Fattizzo B. Efficacy of thrombopoietin receptor agonists in evans syndrome: a single center series. HAEMATOLOGICA. 2021;106 (Suppl. 3):37$62$YR$$F$Y$$$20240807$$HP$IT$IT
241845803$24184580$3$F$20240801$20240814$20240807$20240820$EXP$$AU-BEH-2024176828$CSL BEHRING$$25$YR$A$F$Y$57.9$KG$20240820$$HP$AU$AU
241845811$24184581$1$I$20240719$20240802$20240807$20240807$EXP$FR-FreseniusKabi-FK202412031$FR-FreseniusKabi-FK202412031$FRESENIUS KABI$$71$YR$E$M$Y$86$KG$20240807$$HP$FR$FR
241845832$24184583$2$F$20240802$20240823$20240807$20240828$EXP$$US-BAYER-2024A113952$BAYER$$81$YR$E$F$Y$$$20240828$$HP$US$US
241845841$24184584$1$I$$20240806$20240807$20240807$EXP$$CA-ROCHE-10000050375$ROCHE$$$$A$M$Y$$$20240807$$CN$CA$CA
241845851$24184585$1$I$20240715$20240730$20240807$20240807$EXP$DK-DKMA-30736221$DK-TEVA-VS-3228315$TEVA$$79$YR$$F$Y$$$20240807$$MD$DK$DK
241845861$24184586$1$I$20240727$20240730$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121925$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240807$$CN$US$US
241845871$24184587$1$I$$20240731$20240807$20240807$EXP$$CA-BIOVITRUM-2024-CA-010520$BIOVITRUM$$$$$F$Y$$$20240807$$HP$CA$CA
241845882$24184588$2$F$$20240812$20240807$20240821$EXP$$US-TEVA-VS-3228059$TEVA$Schambach S, Esteitie R, Nader A. Diffuse Disseminated Demyelination: A Detrimental Outcome. Am-J-Respir-Crit-Care-Med 2023; 207.; Schambach S, Esteitie R, Nader A. Diffuse Disseminated Demyelination: A Detrimental Outcome. Am-J-Respir-Crit-Care-Med 2023; 207.$27$YR$$M$Y$$$20240821$$HP$US$US
241845892$24184589$2$F$$20240812$20240807$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124296$BRISTOL MYERS SQUIBB$$29$YR$A$M$Y$88.7$KG$20240816$$PH$US$US
241845902$24184590$2$F$$20240909$20240807$20240918$EXP$$NVSC2024IT159760$NOVARTIS$Cecchi N, Giannotta JA, Capecchi M, Barcellini W, Fattizzo B. Efficacy of thrombopoietin receptor agonists in evans syndrome: a single center series. HAEMATOLOGICA. 2021;106 (Suppl. 3):37$54$YR$$M$Y$$$20240918$$HP$IT$IT
241845911$24184591$1$I$20230101$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154622$AMGEN$$61$YR$A$M$Y$$$20240807$$CN$US$US
241845921$24184592$1$I$$20240806$20240807$20240807$PER$$US-JNJFOC-20240814741$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
241845931$24184593$1$I$20240712$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124084$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$48.56$KG$20240807$$PH$US$US
241845942$24184594$2$F$$20240827$20240807$20240904$EXP$$JP-TAKEDA-2024TUS078252$TAKEDA$$92$YR$$M$Y$$$20240904$$MD$JP$JP
241845952$24184595$2$F$$20240920$20240807$20240924$EXP$$AU-MYLANLABS-2024M1073493$MYLAN$$$$$M$Y$$$20240924$$PH$AU$AU
241845961$24184596$1$I$20160301$20240802$20240807$20240807$EXP$GR-GREOF-202400803$GR-MYLANLABS-2024M1072562$MYLAN$$77$YR$$F$Y$85$KG$20240807$$MD$GR$GR
241845971$24184597$1$I$20240807$20240807$20240807$20240807$EXP$$AU-GILEAD-2024-0683224$GILEAD$$$$$F$Y$$$20240807$$MD$AU$AU
241845981$24184598$1$I$$20240730$20240807$20240807$PER$$US-BAYER-2024A110497$BAYER$$$$$M$Y$$$20240807$$MD$US$US
241845992$24184599$2$F$20240729$20240808$20240807$20240813$EXP$$CA-BIOMARINAP-CA-2024-159627$BIOMARIN$$$$$$Y$$$20240813$$CN$CA$CA
241846001$24184600$1$I$20240201$20240802$20240807$20240807$EXP$$RU-BIOMARINAP-RU-2024-159586$BIOMARIN$$$$$$Y$$$20240807$$CN$RU$RU
241846012$24184601$2$F$$20240820$20240807$20240828$EXP$$US-BIOMARINAP-US-2024-159570$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
241846021$24184602$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160415$NOVARTIS$$$$$F$Y$$$20240807$$HP$US$US
241846031$24184603$1$I$20240725$20240729$20240807$20240807$30DAY$$US-GSK-US2024094826$GLAXOSMITHKLINE$$42$YR$$F$Y$$$20240807$$CN$US$US
241846041$24184604$1$I$20170101$20240729$20240807$20240807$EXP$FR-AFSSAPS-AVCN2024000543$FR-TEVA-VS-3227738$TEVA$$46$YR$$F$Y$$$20240807$$MD$FR$FR
241846052$24184605$2$F$20240701$20240830$20240807$20240906$EXP$$CA-GSK-CA2024095816$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$CA$CA
241846061$24184606$1$I$$20240801$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122915$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240807$$CN$US$US
241846071$24184607$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124172$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240807$$CN$US$US
241846081$24184608$1$I$$20240731$20240807$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123166$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$CN$JP$JP
241846091$24184609$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124209$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240807$$HP$US$US
241846102$24184610$2$F$20240101$20240909$20240807$20240916$EXP$$JP-009507513-2407JPN005306J$MERCK$$67$YR$$F$Y$$$20240916$$MD$JP$JP
241846111$24184611$1$I$20240101$20240724$20240807$20240807$PER$$US-TEVA-VS-3226430$TEVA$$$$$M$Y$$$20240807$$CN$US$US
241846131$24184613$1$I$20240702$20240805$20240807$20240807$EXP$FR-AFSSAPS-MP2024001150$FR-ROCHE-10000048784$ROCHE$$74$YR$E$F$Y$44.5$KG$20240807$$PH$FR$FR
241846141$24184614$1$I$$20240802$20240807$20240807$EXP$$CA-JNJFOC-20240813629$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$HP$CA$CA
241846151$24184615$1$I$20230501$20240803$20240807$20240807$EXP$$CA-SANDOZ INC.-NVSC2022CA178836$SANDOZ$$26$YR$$F$Y$$$20240807$$CN$CA$CA
241846161$24184616$1$I$20240701$20240729$20240807$20240807$PER$$US-ABBVIE-5861039$ABBVIE$$32$YR$$M$Y$$$20240807$$MD$US$US
241846172$24184617$2$F$20240729$20240808$20240807$20240816$EXP$$NZ-GUERBET / LLC-NZ-20240004$GUERBET$$28$YR$A$F$Y$55$KG$20240816$$HP$NZ$NZ
241846181$24184618$1$I$$20240807$20240807$20240807$EXP$GB-MHRA-MED-202408061728378870-SHCJK$GB-ORGANON-O2408GBR000500$ORGANON$$$$$M$Y$$$20240807$$CN$GB$GB
241846191$24184619$1$I$20240713$20240726$20240807$20240807$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000020$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240806$$MD$US$US
241846211$24184621$1$I$$20240807$20240807$20240807$DIR$713253$$FDA-CTU$$$$$UNK$N$$$20240807$N$CN$US$
241846221$24184622$1$I$$20240807$20240807$20240807$DIR$713254$$FDA-CTU$$$$$UNK$N$$$20240807$N$CN$US$
241846231$24184623$1$I$$20240807$20240807$20240807$DIR$713255$$FDA-CTU$$$$$UNK$N$$$20240807$N$CN$US$
241846251$24184625$1$I$$20240806$20240807$20240807$EXP$$NVSC2024US160636$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241846261$24184626$1$I$$20240805$20240807$20240807$EXP$$NVSC2024US160609$NOVARTIS$$$$$M$Y$$$20240807$$CN$US$US
241846271$24184627$1$I$$20240731$20240807$20240807$EXP$$US-009507513-2408USA000434$MERCK$$54$YR$$F$Y$$$20240807$$CN$US$US
241846281$24184628$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124337$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240807$$CN$US$US
241846292$24184629$2$F$20240802$20240805$20240807$20240812$PER$$US-AMGEN-USASP2024156130$AMGEN$$62$YR$A$F$Y$$$20240812$$CN$US$US
241846301$24184630$1$I$20240701$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024153665$AMGEN$$24$YR$A$F$Y$$$20240807$$CN$US$US
241846311$24184631$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000050118$ROCHE$$$$E$F$Y$$$20240807$$CN$US$US
241846321$24184632$1$I$$20240730$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407019942$ELI LILLY AND CO$$67$YR$E$$Y$$$20240807$$LW$US$US
241846331$24184633$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54260$$FDA-CTU$$79$YR$$F$N$185$LBS$20240807$N$$US$
241846341$24184634$1$I$$20240730$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408000439$ELI LILLY AND CO$$54$YR$A$$Y$$$20240807$$LW$US$US
241846351$24184635$1$I$$20240802$20240807$20240807$PER$$US-ROCHE-10000049892$ROCHE$$$$$$Y$$$20240807$$CN$US$US
241846361$24184636$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000050170$ROCHE$$48$YR$A$M$Y$$$20240807$$CN$US$US
241846372$24184637$2$F$20240724$20240806$20240807$20240813$PER$$US-SA-2024SA230719$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240814$$CN$US$US
241846381$24184638$1$I$20240711$20240801$20240807$20240807$EXP$$CN-OTSUKA-2024_021451$OTSUKA$$73$YR$$F$Y$50$KG$20240807$$HP$CN$CN
241846391$24184639$1$I$20240101$20240806$20240807$20240807$EXP$$NVSC2024TW160661$NOVARTIS$$$$$$Y$$$20240807$$MD$TW$TW
241846401$24184640$1$I$$20240806$20240807$20240807$PER$US-MLMSERVICE-20240729-PI146451-00232-1$US-ROCHE-10000049604$ROCHE$Acob T, Acob T, Jumaah O, Kakhktsyan T, Hakobyan K, Prabhakaran S. Unmasking focal segmental glomerulosclerosis in a patient with lupus nephritis. Cureus. 2024;16 (6):e63008. doi:10.7759/cureus.63008.$28$YR$A$M$Y$$$20240807$$MD$US$US
241846411$24184641$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000049910$ROCHE$$55$YR$A$F$Y$$$20240807$$CN$US$US
241846421$24184642$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000049765$ROCHE$$$$E$M$Y$$$20240807$$CN$US$US
241846431$24184643$1$I$$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54261$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
241846442$24184644$2$F$20240727$20240906$20240807$20240910$PER$$US-ROCHE-10000049363$ROCHE$$43$YR$A$F$Y$106.6$KG$20240910$$CN$US$US
241846451$24184645$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54263$$FDA-CTU$$78$YR$$F$N$160$LBS$20240807$N$$US$
241846461$24184646$1$I$$20240730$20240807$20240807$EXP$GB-MHRA-MED-202407260753521180-LKRTB$GB-TEVA-VS-3227712$TEVA$$60$YR$$F$Y$$$20240807$$MD$GB$GB
241846471$24184647$1$I$$20240807$20240807$20240807$DIR$713262$$FDA-CTU$$$$$M$N$$$20240807$N$HP$US$
241846481$24184648$1$I$20240706$20240730$20240807$20240807$EXP$CN-NMPACDR-6403241026256202400083$CN-BAXTER-2024BAX022573$BAXTER$$63$YR$$F$Y$44$KG$20240807$$MD$CN$CN
241846491$24184649$1$I$20240723$20240730$20240807$20240807$EXP$GB-MHRA-MED-202407251232512840-ZCHFY$GB-TEVA-VS-3227739$TEVA$$73$YR$$F$Y$$$20240807$$HP$GB$GB
241846501$24184650$1$I$$20240806$20240807$20240807$PER$$US-BIOVITRUM-2024-US-010680$BIOVITRUM$$45$YR$$M$Y$$$20240807$$CN$US$US
241846511$24184651$1$I$$20240730$20240807$20240807$EXP$GB-MHRA-MED-202407301623194640-SBVJD$GB-TEVA-VS-3228540$TEVA$$$$$F$Y$$$20240807$$CN$GB$GB
241846521$24184652$1$I$20240726$20240730$20240807$20240807$EXP$GB-MHRA-MED-202407300134326310-DVYRP$GB-TEVA-VS-3227523$TEVA$$22$YR$$F$Y$70$KG$20240807$$CN$GB$GB
241846531$24184653$1$I$$20240729$20240807$20240807$EXP$$JP-BAXTER-2024BAX022589$BAXTER$Kawahara K..A case of signet-ring cell carcinoma of ascending colon developing as secondary cancer after hematopoietic cell transplant.The 46th Annual Meeting of the Japanese Society for Research of Loco-Regional 2024;:.$64$YR$$F$Y$$$20240807$$MD$JP$JP
241846541$24184654$1$I$$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124426$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240807$$CN$US$US
241846551$24184655$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050547$ROCHE$$$$$$Y$$$20240807$$CN$US$US
241846561$24184656$1$I$20210101$20240805$20240807$20240807$PER$$US-ROCHE-10000050092$ROCHE$$$$$$Y$$$20240807$$MD$US$US
241846571$24184657$1$I$20240704$20240731$20240807$20240807$EXP$$CN-ROCHE-10000046224$ROCHE$$55$YR$A$F$Y$60$KG$20240807$$HP$CN$CN
241846581$24184658$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050387$ROCHE$$$$T$M$Y$$$20240807$$CN$US$US
241846591$24184659$1$I$20231213$20240730$20240807$20240807$EXP$$NZ-BAXTER-2024BAX022595$BAXTER$$65$YR$$F$Y$55.6$KG$20240807$$MD$NZ$NZ
241846601$24184660$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050405$ROCHE$$74$YR$E$F$Y$65.31$KG$20240807$$CN$US$US
241846611$24184661$1$I$20240702$20240726$20240807$20240807$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000722$PAREXEL$$$$$$Y$$$20240807$$HP$CN$CN
241846621$24184662$1$I$$20240802$20240807$20240807$EXP$$US-AstraZeneca-2024A177473$ASTRAZENECA$$$$$M$Y$$$20240807$$MD$US$
241846631$24184663$1$I$$20240730$20240807$20240807$EXP$$US-AstraZeneca-2024A173994$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241846641$24184664$1$I$$20220119$20240807$20240807$EXP$$CA-AstraZeneca-2022A031304$ASTRAZENECA$$$$$M$Y$$$20240807$$PH$CA$
241846652$24184665$2$F$20240610$20240805$20240807$20240807$EXP$FR-AFSSAPS-BX2024001585$NVSC2024FR159249$NOVARTIS$$6$MON$$M$Y$8.8$KG$20240807$$MD$FR$FR
241846661$24184666$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050593$ROCHE$$$$E$F$Y$$$20240807$$CN$US$US
241846671$24184667$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA118420$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240807$$MD$US$US
241846681$24184668$1$I$20240719$20240807$20240807$20240807$EXP$FR-AFSSAPS-PP2024000825$FR-JNJFOC-20240817174$JOHNSON AND JOHNSON$$16$YR$T$M$Y$48$KG$20240807$$MD$FR$FR
241846692$24184669$2$F$20240626$20240826$20240807$20240904$PER$$US-JNJFOC-20240769455$JOHNSON AND JOHNSON$$72$YR$E$M$Y$85.5$KG$20240904$$MD$US$US
241846704$24184670$4$F$20240701$20240913$20240807$20240919$30DAY$$US-JNJFOC-20240814678$JOHNSON AND JOHNSON$$85$YR$E$$Y$$$20240919$$HP$US$US
241846711$24184671$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050627$ROCHE$$$$$$Y$$$20240807$$CN$US$US
241846721$24184672$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050703$ROCHE$$$$A$F$Y$$$20240807$$CN$US$US
241846731$24184673$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050781$ROCHE$$$$A$F$Y$$$20240807$$CN$US$US
241846741$24184674$1$I$$20240807$20240807$20240807$DIR$713268$$FDA-CTU$$$$$UNK$N$$$20240807$N$CN$US$
241846761$24184676$1$I$$20240801$20240807$20240807$30DAY$$US-GSK-US2024096379$GLAXOSMITHKLINE$$$$$M$Y$$$20240807$$CN$US$US
241846773$24184677$3$F$$20240905$20240807$20240910$30DAY$$US-MYLANLABS-2024M1070492$MYLAN$$$$$F$Y$$$20240910$$CN$US$US
241846781$24184678$1$I$20240806$20240807$20240807$20240807$DIR$713261$$FDA-CTU$$50$YR$$F$N$52.83$KG$20240807$N$HP$US$
241846791$24184679$1$I$$20240806$20240807$20240807$PER$$US-ROCHE-10000050881$ROCHE$$$$A$F$Y$$$20240807$$CN$US$US
241846801$24184680$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54264$$FDA-CTU$$63$YR$$F$N$$$20240807$N$$US$
241846811$24184681$1$I$$20240729$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120201$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240807$$HP$US$US
241846821$24184682$1$I$$20240729$20240807$20240807$EXP$$JP-ROCHE-10000047982$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$67$YR$E$F$Y$$$20240807$$HP$JP$JP
241846842$24184684$2$F$$20240905$20240807$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124751$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$54.88$KG$20240909$$CN$US$US
241846851$24184685$1$I$20240301$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124518$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$51.71$KG$20240807$$PH$US$US
241846871$24184687$1$I$20240806$20240807$20240807$20240807$DIR$713249$$FDA-CTU$$48$YR$$M$N$$$20240807$N$$US$
241846882$24184688$2$F$20240802$20240910$20240807$20240911$PER$$US-JNJFOC-20240811821$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240911$$CN$US$US
241846891$24184689$1$I$20221114$20240805$20240807$20240807$EXP$$US-TAKEDA-2022TUS085386$TAKEDA$$14$YR$$M$Y$$$20240807$$HP$US$US
241846901$24184690$1$I$$20240729$20240807$20240807$30DAY$$US-GSK-US2024094738$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241846911$24184691$1$I$20240101$20240731$20240807$20240807$EXP$$US-GSK-US2024095780$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$US$US
241846921$24184692$1$I$20240725$20240801$20240807$20240807$EXP$$CN-ROCHE-10000047074$ROCHE$$56$YR$A$F$Y$59$KG$20240807$$HP$CN$CN
241846931$24184693$1$I$$20240730$20240807$20240807$PER$$US-BAYER-2024A111299$BAYER$$$$$F$Y$$$20240807$$CN$US$US
241846941$24184694$1$I$$20240806$20240807$20240807$PER$$US-BIOVITRUM-2024-US-010682$BIOVITRUM$$69$YR$$M$Y$$$20240807$$HP$US$US
241846951$24184695$1$I$$20240705$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06855$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241846961$24184696$1$I$$20240806$20240807$20240807$PER$$US-GILEAD-2024-0683226$GILEAD$$61$YR$A$F$Y$$$20240807$$CN$US$US
241846971$24184697$1$I$$20240807$20240807$20240807$DIR$713267$$FDA-CTU$$$$$UNK$N$$$20240807$$CN$US$
241846981$24184698$1$I$$20240725$20240807$20240807$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07624$LUPIN$Hui M, Gunzenhauser R, Dillon A, Tsui I. Unexpected vision loss following six intravitreal injections for Neovascular age-related macular degeneration. Case Reports in Ophthalmology. 2024;15:518-524$83$YR$$M$Y$$$20240807$$HP$US$US
241846991$24184699$1$I$$20240807$20240807$20240807$DIR$713276$$FDA-CTU$$$$$F$N$103.5$KG$20240807$N$CN$US$
241847001$24184700$1$I$$20240807$20240807$20240807$DIR$713250$$FDA-CTU$$$$$UNK$N$$$20240807$N$CN$US$
241847011$24184701$1$I$20240723$20240804$20240807$20240807$EXP$GB-MHRA-MED-202408041722466200-YRPCJ$GB-MYLANLABS-2024M1072746$MYLAN$$75$YR$$F$Y$78$KG$20240807$$CN$GB$GB
241847021$24184702$1$I$$20240731$20240807$20240807$EXP$$NVSC2024US157474$NOVARTIS$$$$$M$Y$$$20240807$$CN$US$US
241847031$24184703$1$I$$20240731$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122041$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240807$$CN$US$US
241847041$24184704$1$I$20240701$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124637$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240807$$HP$US$US
241847071$24184707$1$I$20240617$20240731$20240807$20240807$EXP$$NVSC2024US157503$NOVARTIS$$61$YR$$F$Y$$$20240807$$CN$US$US
241847081$24184708$1$I$$20240729$20240807$20240807$EXP$$IT-BAUSCH-BL-2024-011973$BAUSCH AND LOMB$Mancini M, Di Nardo G, Casciani E, Feudi M, Bargiacchi L, Petraroli A. The Multifaceted Complexity of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS): A Case Report Highlighting Atypical Gastrointestinal Manifestations. Diagnostics. 2024;14(1337):1-7.$3$DEC$$F$Y$$$20240807$$HP$IT$IT
241847091$24184709$1$I$$20240705$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06920$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241847101$24184710$1$I$20240223$20240730$20240807$20240807$EXP$$FR-BAUSCH-BL-2024-011887$BAUSCH AND LOMB$$63$YR$$M$Y$$$20240807$$PH$FR$FR
241847111$24184711$1$I$20240716$20240801$20240807$20240807$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000719$PAREXEL$$58$YR$$M$Y$$$20240807$$HP$CN$CN
241847121$24184712$1$I$$20240730$20240807$20240807$EXP$$BR-AstraZeneca-2024A176310$ASTRAZENECA$$$$$$Y$$$20240807$$MD$BR$
241847131$24184713$1$I$20240712$20240730$20240807$20240807$EXP$GB-MHRA-MED-202407251255323230-DYHJM$GB-TEVA-VS-3228282$TEVA$$70$YR$$F$Y$$$20240807$$HP$GB$GB
241847142$24184714$2$F$$20240801$20240807$20240913$EXP$$LK-AstraZeneca-2024A176388$ASTRAZENECA$$$$$$Y$$$20240913$$CN$LK$
241847151$24184715$1$I$20240723$20240730$20240807$20240807$PER$$US-009507513-2407USA015879$MERCK$$73$YR$$F$Y$$$20240807$$CN$US$US
241847161$24184716$1$I$20240401$20240724$20240807$20240807$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407011861$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240807$$CN$DE$DE
241847171$24184717$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002772$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241847181$24184718$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156111$AMGEN$$$$$$Y$$$20240807$$HP$US$US
241847191$24184719$1$I$20240807$20240807$20240807$20240807$DIR$713277$$FDA-CTU$$68$YR$$M$N$73.35$KG$20240807$N$HP$US$
241847201$24184720$1$I$20240705$20240807$20240807$20240807$DIR$713246$$FDA-CTU$$42$YR$$F$N$67.5$KG$20240807$N$CN$US$
241847211$24184721$1$I$20240805$20240807$20240807$20240807$DIR$713259$$FDA-CTU$$59$YR$$F$N$81.9$KG$20240807$N$CN$US$
241847221$24184722$1$I$20240801$20240807$20240807$20240807$DIR$713279$$FDA-CTU$$39$YR$$F$N$54.45$KG$20240807$N$CN$US$
241847231$24184723$1$I$$20240705$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06933$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241847241$24184724$1$I$$20240807$20240807$20240807$EXP$$NVSC2024CZ160440$NOVARTIS$$42$YR$$M$Y$$$20240807$$HP$CZ$CZ
241847251$24184725$1$I$$20240705$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06926$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241847261$24184726$1$I$$20240805$20240807$20240807$EXP$$NVSC2024US160500$NOVARTIS$$$$$F$Y$$$20240807$$HP$US$US
241847272$24184727$2$F$$20240812$20240807$20240820$EXP$$US-TEVA-VS-3228127$TEVA$Haynes TM, Kukuc L, Proute M, Fishberg R. A PCSK9 and APOB Double Heterozygote Presenting Phenotypically Similar to Homozygous Familial Hypercholesterolemia. Circulation 2023; 148 (Suppl.).; Haynes TM, Kukuc L, Proute M, Fishberg R. A PCSK9 and APOB Double Heterozygote Presenting Phenotypically Similar to Homozygous Familial Hypercholesterolemia. Circulation 2023; 148 (Suppl.).$73$YR$$F$Y$$$20240820$$HP$US$US
241847281$24184728$1$I$$20240802$20240807$20240807$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-124303$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$MD$DE$DE
241847291$24184729$1$I$$20240731$20240807$20240807$PER$$US-BEH-2024176690$CSL BEHRING$$$$E$F$Y$$$20240807$$MD$US$US
241847301$24184730$1$I$$20240801$20240807$20240807$EXP$$CA-MYLANLABS-2020172455$MYLAN$$43$YR$$F$Y$$$20240807$$HP$CA$CA
241847321$24184732$1$I$$20240705$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06923$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241847331$24184733$1$I$$20240805$20240807$20240807$EXP$$GB-SANDOZ INC.-SDZ2024GB070954$SANDOZ$$$$A$F$Y$$$20240807$$CN$GB$GB
241847341$24184734$1$I$$20240801$20240807$20240807$EXP$$US-JNJFOC-20240809011$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240807$$HP$US$US
241847351$24184735$1$I$$20240723$20240807$20240807$PER$$US-TPU-TPU-2024-00410$TEIKOKU$$$$$F$Y$$$20240807$$CN$US$US
241847361$24184736$1$I$$20240806$20240807$20240807$EXP$$SG-ALXN-202408ASI000183SG$ALEXION PHARMACEUTICALS$$$$C$M$Y$25$KG$20240807$$PH$SG$SG
241847371$24184737$1$I$$20240731$20240807$20240807$EXP$$CA-JNJFOC-20240808351$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240807$$CN$CA$CA
241847382$24184738$2$F$$20240812$20240807$20240822$EXP$$US-TEVA-VS-3228026$TEVA$Khalil H, Cota D. MULTIORGAN FAILURE FROM IVERMECTIN AND DEET TOXICITY CONCEALED BEHIND ALCOHOL WITHDRAWAL. Crit-Care-Med 2024; 52 (Suppl.) (1): S440.; Khalil H, Cota D. MULTIORGAN FAILURE FROM IVERMECTIN AND DEET TOXICITY CONCEALED BEHIND ALCOHOL WITHDRAWAL. Crit-Care-Med 2024; 52 (Suppl.) (1): S440.$63$YR$$M$Y$$$20240822$$HP$US$US
241847391$24184739$1$I$$20240723$20240807$20240807$PER$$US-TPU-TPU-2024-00407$TEIKOKU$$$$$$Y$$$20240807$$CN$US$US
241847401$24184740$1$I$20240701$20240806$20240807$20240807$PER$$US-BAYER-2024A113502$BAYER$$41$YR$A$F$Y$$$20240807$$MD$US$US
241847411$24184741$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160884$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241847421$24184742$1$I$20191101$20240729$20240807$20240807$EXP$$US-ROCHE-2504016$ROCHE$$59$YR$A$F$Y$79.38$KG$20240807$$CN$US$US
241847431$24184743$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160883$NOVARTIS$$$$$$Y$$$20240807$$MD$US$US
241847451$24184745$1$I$$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124760$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240807$$CN$US$US
241847461$24184746$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125020$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240807$$CN$US$US
241847471$24184747$1$I$20240601$20240806$20240807$20240807$PER$$US-ABBVIE-5869928$ABBVIE$$$$A$F$Y$$$20240807$$HP$US$US
241847481$24184748$1$I$$20240730$20240807$20240807$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-15664$IPSEN$Yoshida J, Sawai T, Ozawa K, Hirohashi M, Maruo K, Uehara T, et al. Current Status and Poor Prognostic Factors of Liposomal Irinotecan + 5FU/LV Therapy at Our Hospital. Journal of the Japan Pancreas Society. 2024;39 (3): A465$$$A$F$Y$$$20240807$$MD$JP$JP
241847491$24184749$1$I$20240604$20240730$20240807$20240807$EXP$FR-AFSSAPS-AM2024000562$FR-SA-2024SA229786$SANOFI AVENTIS$$69$YR$E$F$Y$67.2$KG$20240807$$MD$FR$FR
241847501$24184750$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160847$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241847511$24184751$1$I$20240304$20240807$20240807$20240807$DIR$713278$$FDA-CTU$$27$YR$$M$N$99$KG$20240807$N$CN$US$
241847521$24184752$1$I$20240528$20240807$20240807$20240807$DIR$713251$$FDA-CTU$$33$YR$$M$N$$$20240807$N$$US$
241847531$24184753$1$I$$20240807$20240807$20240807$DIR$713269$$FDA-CTU$$$$$UNK$N$$$20240807$$CN$US$
241847551$24184755$1$I$20240508$20240729$20240807$20240807$EXP$IT-MINISAL02-995408$IT-TEVA-VS-3227128$TEVA$$16$YR$$M$Y$75$KG$20240807$$PH$IT$IT
241847561$24184756$1$I$20240501$20240725$20240807$20240807$EXP$$FR-CIPLA LTD.-2024FR08155$CIPLA$$$$$$Y$$$20240807$$MD$FR$FR
241847571$24184757$1$I$20240101$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124762$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240807$$CN$US$US
241847581$24184758$1$I$$20240725$20240807$20240807$EXP$$US-CIPLA LTD.-2024US08172$CIPLA$Lester D, Weiland G, Kotay M, Fan Q.. Exercise in clinical reasoning: getting a foothold on lower extremity weakness.. J Gen Intern Med.. 2024;39 (9):1756 to 1761$$$$$Y$$$20240807$$MD$US$US
241847593$24184759$3$F$20240401$20240731$20240807$20240819$EXP$$NVSC2024TH156228$NOVARTIS$$54$YR$$F$Y$67$KG$20240819$$MD$TH$TH
241847602$24184760$2$F$20240721$20240812$20240807$20240814$PER$$US-AMGEN-USASP2024156246$AMGEN$$78$YR$E$F$Y$$$20240814$$CN$US$US
241847611$24184761$1$I$20240101$20240801$20240807$20240807$PER$$US-SA-2024SA231851$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240807$$MD$US$US
241847621$24184762$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA231307$SANOFI AVENTIS$$39$YR$A$F$Y$82.5$KG$20240807$$MD$US$US
241847631$24184763$1$I$20240101$20240802$20240807$20240807$PER$$US-SA-2024SA231681$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240807$$CN$US$US
241847641$24184764$1$I$$20240729$20240807$20240807$EXP$$BR-AMGEN-BRASP2024154068$AMGEN$De Souza A.; Savioli B.; Torquato H. et al.. Effector CD4+ T-cell subsets in Takayasu arteritis-differences between the peripheral blood and the aorta. Clinical and Experimental Immunology. 2024;217 (2):183-194$$$$$Y$$$20240807$$HP$BR$BR
241847651$24184765$1$I$20240601$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154867$AMGEN$$81$YR$E$F$Y$$$20240807$$CN$US$US
241847661$24184766$1$I$$20240801$20240807$20240807$PER$$US-SA-2024SA231872$SANOFI AVENTIS$$$$A$M$Y$$$20240807$$MD$US$US
241847671$24184767$1$I$$20240730$20240807$20240807$EXP$$CA-JNJFOC-20240783855$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240807$$CN$CA$CA
241847682$24184768$2$F$20240801$20240827$20240807$20240903$EXP$$US-JNJFOC-20240808043$JOHNSON AND JOHNSON$$34$YR$A$F$Y$106.69$KG$20240903$$HP$US$US
241847694$24184769$4$F$$20240909$20240807$20240919$EXP$$ES-JNJFOC-20240783862$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$PH$ES$ES
241847701$24184770$1$I$20240701$20240801$20240807$20240807$EXP$$IT-Taiho Oncology Inc-2024-007566$TAIHO ONCOLOGY INC$$65$YR$E$M$Y$$$20240807$$MD$IT$IT
241847711$24184771$1$I$$20240731$20240807$20240807$EXP$$US-GSK-US2024095787$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$HP$US$US
241847722$24184772$2$F$$20240812$20240807$20240822$EXP$$BR-TEVA-VS-3228685$TEVA$Aranda CS, Silvestre KMC, Marques KDS, Lee ML, Sole D. Methotrexate might become the sole treatment option for leukemia following the occurrence of Stevens-Johnson syndrome. Allergol-Immunopathol 2024; 52 (4): 81-83.; Aranda CS, Silvestre KMC, Marques KDS, Lee ML, Sole D. Methotrexate might become the sole treatment option for leukemia following the occurrence of Stevens-Johnson syndrome. Allergol-Immunopathol 2024; 52 (4): 81-83.$3$YR$$M$Y$$$20240822$$HP$BR$BR
241847731$24184773$1$I$$20240801$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124344$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$97.07$KG$20240807$$CN$US$US
241847741$24184774$1$I$$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124769$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240807$$CN$US$US
241847751$24184775$1$I$$20240801$20240807$20240807$EXP$$UA-TAKEDA-2024TUS078549$TAKEDA$$$$$F$Y$$$20240807$$CN$UA$UA
241847761$24184776$1$I$20240725$20240802$20240807$20240807$EXP$$US-GILEAD-2024-0682794$GILEAD$$54$YR$A$M$Y$$$20240807$$CN$US$US
241847771$24184777$1$I$20240101$20240805$20240807$20240807$EXP$$US-ABBVIE-5868765$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241847791$24184779$1$I$20240509$20240731$20240807$20240807$PER$$US-SA-2024SA231354$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240807$$MD$US$US
241847801$24184780$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002861$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240807$$CN$US$US
241847813$24184781$3$F$$20240925$20240807$20240927$30DAY$$GB-PFIZER INC-202400226693$PFIZER$$48$YR$$F$Y$$$20240927$$CN$GB$GB
241847862$24184786$2$F$$20240919$20240807$20240923$30DAY$$CO-PFIZER INC-PV202400101664$PFIZER$$9$YR$$F$Y$$$20240923$$CN$CO$CO
241847872$24184787$2$F$$20240910$20240807$20240917$30DAY$$VN-JNJFOC-20240811496$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$VN$VN
241847882$24184788$2$F$$20240912$20240807$20240923$30DAY$$TW-JNJFOC-20240813072$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$TW$TW
241847892$24184789$2$F$20210601$20240802$20240807$20240809$EXP$$BR-JNJFOC-20240810786$JOHNSON AND JOHNSON$$45$YR$A$F$Y$98$KG$20240809$$CN$BR$BR
241847901$24184790$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160459$NOVARTIS$$$$$F$Y$55$KG$20240807$$CN$US$US
241847922$24184792$2$F$20240725$20240820$20240807$20240823$EXP$$US-TAKEDA-2024TUS075766$TAKEDA$$80$YR$$M$Y$71.655$KG$20240823$$CN$US$US
241847931$24184793$1$I$20240712$20240730$20240807$20240807$EXP$$GR-BAYER-2024A110101$BAYER$$81$YR$E$M$Y$$$20240807$$MD$GR$GR
241847941$24184794$1$I$20240101$20240802$20240807$20240807$EXP$$US-ABBVIE-5865938$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241847951$24184795$1$I$20240721$20240805$20240807$20240807$EXP$$US-BAYER-2024A113249$BAYER$$43$YR$A$M$Y$$$20240807$$CN$US$US
241847962$24184796$2$F$$20240812$20240807$20240820$EXP$$US-TEVA-VS-3227910$TEVA$Gault KS. THE ROLE OF PHYSICAL THERAPY WITHIN A MULTIDISCIPLINARY PANCREATIC CANCER CLINIC TO OPTIMIZE CARE. Rehabil-Oncol 2024; 42 (2): 119.; Gault KS. THE ROLE OF PHYSICAL THERAPY WITHIN A MULTIDISCIPLINARY PANCREATIC CANCER CLINIC TO OPTIMIZE CARE. Rehabil-Oncol 2024; 42 (2): 119.$78$YR$$F$Y$$$20240820$$HP$US$US
241847971$24184797$1$I$20240731$20240802$20240807$20240807$EXP$$NVSC2024CN159890$NOVARTIS$$68$YR$$M$Y$65$KG$20240807$$HP$CN$CN
241847982$24184798$2$F$$20240812$20240807$20240823$EXP$$US-TEVA-VS-3228277$TEVA$Erickson KA, Norton JE, Law J, Soriano N, Strojny M, Gentry N, et al. Prevention of allergic reactions during oxaliplatin desensitization through inhibition of Bruton tyrosine kinase. J-Allergy-Clin-Immunol 2024; 154 (1): 222-228.e4.; Erickson KA, Norton JE, Law J, Soriano N, Strojny M, Gentry N, et al. Prevention of allergic reactions during oxaliplatin desensitization through inhibition of Bruton tyrosine kinase. J-Allergy-Clin-Immunol 2024; 154 (1): 222-228.e4.; Erickson KA, Norton JE, Law...$52$YR$$M$Y$$$20240823$$HP$US$US
241847991$24184799$1$I$$20240805$20240807$20240807$EXP$$US-TAKEDA-2024TUS078589$TAKEDA$$$$$F$Y$82$KG$20240807$$MD$US$US
241848001$24184800$1$I$$20240729$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005630$BIOCON$$$$$$Y$$$20240807$$CN$CA$CA
241848011$24184801$1$I$$20240730$20240807$20240807$EXP$$VN-AstraZeneca-2024A176219$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$VN$
241848021$24184802$1$I$$20240730$20240807$20240807$EXP$$JP-AstraZeneca-2024A174319$ASTRAZENECA$$$$$$Y$$$20240807$$PH$JP$
241848031$24184803$1$I$20240524$20240711$20240807$20240807$EXP$$ZA-AstraZeneca-2024A178854$ASTRAZENECA$$85$YR$$F$Y$$$20240807$$CN$ZA$
241848041$24184804$1$I$$20240730$20240807$20240807$EXP$$FR-AstraZeneca-2024A175793$ASTRAZENECA$$$$$F$Y$$$20240807$$MD$FR$
241848051$24184805$1$I$$20210416$20240807$20240807$EXP$$US-AstraZeneca-2021A328860$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241848061$24184806$1$I$20240728$20240801$20240807$20240807$EXP$CN-91110000556821568D-2024DRL001432$CN-RDY-SPO/CHN/24/0011430$DR REDDYS$$22$YR$A$M$Y$62$KG$20240807$$HP$CN$CN
241848071$24184807$1$I$$20240730$20240807$20240807$EXP$$US-AstraZeneca-2024A174193$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241848081$24184808$1$I$20240731$20240802$20240807$20240807$EXP$$US-AstraZeneca-2024A176467$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241848091$24184809$1$I$$20240723$20240807$20240807$PER$$US-JNJFOC-20240768233$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
241848102$24184810$2$F$$20240727$20240807$20240807$EXP$$US-ROCHE-10000040633$ROCHE$$$$$F$Y$$$20240807$$CN$US$US
241848111$24184811$1$I$20240607$20240805$20240807$20240807$EXP$FR-AFSSAPS-TS2024000882$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-123979$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$91$KG$20240807$$MD$FR$FR
241848121$24184812$1$I$20240613$20240805$20240807$20240807$EXP$$CN-TAKEDA-2024TUS078662$TAKEDA$$43$YR$$M$Y$53.4$KG$20240807$$HP$CN$CN
241848131$24184813$1$I$$20240801$20240807$20240807$EXP$$CN-AMGEN-CHNSP2024155068$AMGEN$Yun L.; Xin Y.. Study on the Efficacy and Safety of Early Application of Evolocumab After Percutaneous Coronary Intervention for Coronary Heart Disease. Chin J Health Care Med. 2024;26 (3):367-369$$$$$Y$$$20240807$$HP$CN$CN
241848141$24184814$1$I$20240101$20240803$20240807$20240807$EXP$$US-AMGEN-USASL2024154887$AMGEN$$66$YR$E$F$Y$$$20240807$$HP$US$US
241848151$24184815$1$I$$20230523$20240807$20240807$EXP$$US-AstraZeneca-2023A120438$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241848161$24184816$1$I$$20230602$20240807$20240807$EXP$$US-AstraZeneca-2023A129370$ASTRAZENECA$$$$$F$Y$$$20240807$$HP$US$
241848171$24184817$1$I$$20240730$20240807$20240807$EXP$$JP-AstraZeneca-2024A174315$ASTRAZENECA$$$$$$Y$$$20240807$$HP$JP$
241848182$24184818$2$F$$20240801$20240807$20240809$EXP$$CA-AstraZeneca-2024A176604$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$CA$
241848193$24184819$3$F$$20240812$20240807$20240821$EXP$$CA-AstraZeneca-2024A138427$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$CA$
241848201$24184820$1$I$$20230531$20240807$20240807$EXP$$US-AstraZeneca-2023A127071$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241848211$24184821$1$I$$20240805$20240807$20240807$PER$$US-JNJFOC-20240813453$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$HP$US$US
241848221$24184822$1$I$20240101$20240730$20240807$20240807$EXP$DE-CADRBFARM-2024329426$DE-TEVA-VS-3228281$TEVA$$25$YR$$F$Y$80$KG$20240807$$CN$DE$DE
241848231$24184823$1$I$20240724$20240725$20240807$20240807$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK092876$GLENMARK$$$$$$Y$$$20240807$$HP$GB$GB
241848241$24184824$1$I$$20240730$20240807$20240807$EXP$NL-LRB-00992851$NL-TEVA-VS-3228298$TEVA$$71$YR$$F$Y$54$KG$20240807$$CN$NL$NL
241848251$24184825$1$I$$20240729$20240807$20240807$PER$$US-MYLANLABS-2024M1071933$MYLAN$$$$$$Y$$$20240807$$CN$US$US
241848262$24184826$2$F$$20240801$20240807$20240810$PER$$US-SA-2024SA231081$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240810$$MD$US$US
241848271$24184827$1$I$20240701$20240730$20240807$20240807$PER$$US-SA-2024SA232155$SANOFI AVENTIS$$25$YR$A$F$Y$83$KG$20240807$$MD$US$US
241848281$24184828$1$I$$20240801$20240807$20240807$PER$$US-SA-2024SA231857$SANOFI AVENTIS$$41$YR$A$F$Y$146$KG$20240807$$MD$US$US
241848291$24184829$1$I$20240805$20240805$20240807$20240807$PER$$US-PFIZER INC-202400231181$PFIZER$$38$YR$$M$Y$$$20240807$$CN$US$US
241848301$24184830$1$I$20240804$20240806$20240807$20240807$PER$$US-PFIZER INC-202400231862$PFIZER$$74$YR$$F$Y$$$20240807$$CN$US$US
241848311$24184831$1$I$$20240806$20240807$20240807$PER$$US-PFIZER INC-202400231290$PFIZER$$41$YR$$F$Y$$$20240807$$MD$US$US
241848321$24184832$1$I$$20240806$20240807$20240807$PER$$US-PFIZER INC-PV202400102545$PFIZER$$58$YR$$$Y$$$20240807$$CN$US$US
241848332$24184833$2$F$$20240807$20240807$20240809$PER$$US-PFIZER INC-202400231354$PFIZER$$85$YR$$F$Y$$$20240809$$CN$US$US
241848342$24184834$2$F$20240806$20240823$20240807$20240829$PER$$US-PFIZER INC-202400231262$PFIZER$$72$YR$$F$Y$54.422$KG$20240829$$CN$US$US
241848352$24184835$2$F$20240803$20240809$20240807$20240813$PER$$KR-PFIZER INC-202400230362$PFIZER$$63$YR$$M$Y$$$20240813$$PH$KR$KR
241848361$24184836$1$I$$20240806$20240807$20240807$PER$$US-PFIZER INC-202400231227$PFIZER$$52$YR$$F$Y$$$20240807$$CN$US$US
241848371$24184837$1$I$20240725$20240806$20240807$20240807$PER$$US-PFIZER INC-202400231669$PFIZER$$70$YR$$F$Y$$$20240807$$CN$US$US
241848382$24184838$2$F$$20240807$20240807$20240809$PER$$US-PFIZER INC-202400231610$PFIZER$$$$$$Y$$$20240809$$HP$US$US
241848391$24184839$1$I$$20240806$20240807$20240807$PER$$US-PFIZER INC-202400231364$PFIZER$$$$$M$Y$$$20240807$$HP$US$US
241848402$24184840$2$F$$20240820$20240807$20240822$PER$$US-PFIZER INC-202400231384$PFIZER$$79$YR$$F$Y$$$20240822$$CN$US$US
241848411$24184841$1$I$20240803$20240805$20240807$20240807$PER$$US-PFIZER INC-202400230624$PFIZER$$36$YR$$F$Y$$$20240807$$HP$US$US
241848431$24184843$1$I$20240805$20240806$20240807$20240807$PER$$US-PFIZER INC-202400231683$PFIZER$$58$YR$$F$Y$$$20240807$$HP$US$US
241848441$24184844$1$I$20240806$20240806$20240807$20240807$PER$$US-PFIZER INC-202400231333$PFIZER$$34$YR$$M$Y$$$20240807$$CN$US$US
241848452$24184845$2$F$$20240821$20240807$20240826$PER$$US-PFIZER INC-202400231500$PFIZER$$53$YR$$F$Y$$$20240826$$HP$US$US
241848461$24184846$1$I$$20240806$20240807$20240807$PER$$US-PFIZER INC-202400231330$PFIZER$$35$YR$$M$Y$$$20240807$$HP$US$US
241848471$24184847$1$I$20240805$20240806$20240807$20240807$PER$$US-PFIZER INC-202400231710$PFIZER$$71$YR$$F$Y$$$20240807$$CN$US$US
241848481$24184848$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156204$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241848491$24184849$1$I$$20240805$20240807$20240807$PER$$US-BAYER-2024A113031$BAYER$$21$YR$A$F$Y$$$20240807$$MD$US$US
241848501$24184850$1$I$20240101$20240801$20240807$20240807$PER$$KR-Eisai-EC-2024-171419$EISAI$$$$$M$Y$$$20240807$$CN$KR$KR
241848511$24184851$1$I$20240717$20240807$20240807$20240807$EXP$GB-MHRA-MED-202408070925260880-ZCSDG$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044280$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$67$KG$20240807$$PH$GB$GB
241848521$24184852$1$I$$20240730$20240807$20240807$PER$$US-AMGEN-USASP2024154089$AMGEN$Defilippis E.M.; Donald E.M.; Driggin E. et.al.. Cardio-Renal-Metabolic Outcomes Associated With the Use of GLP- I Receptor Agonists After Heart Transplantation. Clinical Transplantation. 2024;38 (7):1-9$$$$$Y$$$20240807$$HP$US$US
241848531$24184853$1$I$$20240731$20240807$20240807$EXP$$US-AMGEN-USASP2024154743$AMGEN$Hanje A. J.; Jasti V. V.. Necrotizing Sarcoid Granulomatosis With Hepatic Involvement and Reversible Noncirrhotic Portal Hypertension. ACG Case Reports. 2024;11 (7):1-3$44$YR$A$F$Y$$$20240807$$MD$US$US
241848541$24184854$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54269$$FDA-CTU$$69$YR$$M$N$$$20240807$N$$US$
241848551$24184855$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54284$$FDA-CTU$$76$YR$$F$N$104.78$KG$20240807$N$HP$US$
241848561$24184856$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54277$$FDA-CTU$$80$YR$$M$N$$$20240807$N$$US$
241848571$24184857$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54273$$FDA-CTU$$85$YR$$F$N$81.65$KG$20240807$N$$US$
241848581$24184858$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54286$$FDA-CTU$$78$YR$$M$N$$$20240807$N$$US$
241848591$24184859$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54296$$FDA-CTU$$72$YR$$F$N$94.8$KG$20240807$N$$US$
241848601$24184860$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54292$$FDA-CTU$$66$YR$$F$N$52.16$KG$20240807$N$$US$
241848611$24184861$1$I$20240405$20240722$20240807$20240807$PER$$US-Taiho Oncology Inc-2024-007507$TAIHO ONCOLOGY INC$$66$YR$E$M$Y$$$20240807$$HP$US$US
241848621$24184862$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54278$$FDA-CTU$$61$YR$$M$N$$$20240807$N$$US$
241848631$24184863$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54266$$FDA-CTU$$38$YR$$M$N$$$20240807$N$$US$
241848641$24184864$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54287$$FDA-CTU$$76$YR$$F$N$$$20240807$N$$US$
241848651$24184865$1$I$$20240805$20240807$20240807$EXP$$US-JNJFOC-20240811962$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240807$$HP$US$US
241848661$24184866$1$I$$20240612$20240807$20240807$PER$$US-HQ SPECIALTY-US-2024INT000061$INTERCHEM$$$$$F$Y$$$20240807$$PH$US$US
241848672$24184867$2$F$$20240820$20240807$20240823$EXP$$ES-ABBVIE-5864312$ABBVIE$$$$$F$Y$$$20240823$$CN$ES$ES
241848681$24184868$1$I$$20240726$20240807$20240807$30DAY$$US-JNJFOC-20240808286$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241848691$24184869$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54291$$FDA-CTU$$76$YR$$M$N$$$20240807$N$$US$
241848701$24184870$1$I$$20240805$20240807$20240807$PER$$US-BAYER-2024A113032$BAYER$$31$YR$A$F$Y$$$20240807$$MD$US$US
241848711$24184871$1$I$$20240805$20240807$20240807$PER$$US-BAYER-2024A113046$BAYER$$39$YR$A$F$Y$$$20240807$$MD$US$US
241848721$24184872$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003623$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240807$$CN$US$US
241848732$24184873$2$F$$20240802$20240807$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002043$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240808$$CN$US$US
241848741$24184874$1$I$20230330$20240731$20240807$20240807$PER$$US-SA-2024SA230519$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240807$$MD$US$US
241848751$24184875$1$I$$20240802$20240807$20240807$EXP$PL-URPL-1-3869-2020$PL-JNJFOC-20240811980$JOHNSON AND JOHNSON$$26$YR$A$M$Y$80$KG$20240807$$MD$PL$PL
241848761$24184876$1$I$20240101$20240805$20240807$20240807$EXP$$US-JNJFOC-20240816303$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240807$$HP$US$US
241848771$24184877$1$I$$20240731$20240807$20240807$EXP$$IT-AMGEN-ITASP2024150630$AMGEN$Tovoli F.; Chen R.; Vivaldi C. et al.. Aetiology of hepatocellular carcinoma and response to immunotherapy: is the problem inherent in the classification of non-viral disease?. Digestive and Liver Disease. 2024;56:S92-S93$$$$$Y$$$20240807$$HP$IT$IT
241848781$24184878$1$I$$20240805$20240807$20240807$PER$$US-BAYER-2024A113052$BAYER$$30$YR$A$F$Y$$$20240807$$CN$US$US
241848791$24184879$1$I$$20240802$20240807$20240807$EXP$$CA-TAKEDA-2024TUS078999$TAKEDA$$$$$F$Y$$$20240807$$CN$CA$CA
241848801$24184880$1$I$$20240729$20240807$20240807$EXP$$CA-TEVA-VS-3227530$TEVA$$55$YR$$F$Y$$$20240807$$HP$CA$CA
241848811$24184881$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124787$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$75.75$KG$20240807$$CN$US$US
241848831$24184883$1$I$$20240802$20240807$20240807$EXP$$US-ABBVIE-5865816$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241848841$24184884$1$I$$20240730$20240807$20240807$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-15662$IPSEN$Yoshida J, Sawai T, Ozawa K, Hirohashi M, Maruo K, Uehara T, et al.. Current Status and Poor Prognostic Factors of Liposomal Irinotecan + 5FU/LV Therapy at Our Hospital. Journal of the Japan Pancreas Society. 2024;39 (3): A465$$$E$M$Y$$$20240807$$MD$JP$JP
241848851$24184885$1$I$$20240731$20240807$20240807$PER$$US-AstraZeneca-2024A175747$ASTRAZENECA$$$$$$Y$$$20240807$$MD$US$
241848861$24184886$1$I$$20220525$20240807$20240807$EXP$$US-AstraZeneca-2022A200613$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241848871$24184887$1$I$$20240524$20240807$20240807$EXP$$US-AstraZeneca-2024A122522$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241848882$24184888$2$F$$20240809$20240807$20240816$EXP$$JP-AstraZeneca-2024A175341$ASTRAZENECA$Ota N, et al.. EP-0599 A study of drug-induced interstitial pneumonia in a breast cancer patient in our hospital.. The 32nd Annual Meeting of the Japanese Breast Cancer Society 2024;327-.$$$A$F$Y$$$20240816$$MD$JP$
241848891$24184889$1$I$20170101$20240730$20240807$20240807$EXP$$CA-AstraZeneca-2020SF27422$ASTRAZENECA$$60$YR$$M$Y$$$20240807$$MD$CA$
241848901$24184890$1$I$$20240611$20240807$20240807$EXP$$US-NOVOPROD-1243574$NOVO NORDISK$$$$$F$Y$$$20240807$$MD$US$US
241848911$24184891$1$I$20240729$20240802$20240807$20240807$EXP$$CN-PFIZER INC-PV202400101253$PFIZER$$65$YR$$F$Y$60$KG$20240807$$HP$CN$CN
241848921$24184892$1$I$20070124$20240802$20240807$20240807$EXP$$FR-PFIZER INC-202400228795$PFIZER$$36$YR$$F$Y$$$20240807$$HP$FR$FR
241848931$24184893$1$I$20240601$20240806$20240807$20240807$PER$$US-ABBVIE-5870149$ABBVIE$$$$A$F$Y$$$20240807$$HP$US$US
241848941$24184894$1$I$$20240805$20240807$20240807$PER$$US-BAYER-2024A113057$BAYER$$39$YR$A$F$Y$$$20240807$$HP$US$US
241848951$24184895$1$I$$20240730$20240807$20240807$PER$$US-ABBVIE-5861537$ABBVIE$$$$$$Y$$$20240807$$HP$US$US
241848961$24184896$1$I$20240701$20240805$20240807$20240807$EXP$$US-ABBVIE-5869583$ABBVIE$$$$$$Y$$$20240807$$CN$US$US
241848971$24184897$1$I$$20240725$20240807$20240807$EXP$$FR-ROCHE-10000048084$ROCHE$Leclercq M, Seve P, Biard L, Vautier M, Maalouf G, Leroux G, et al. Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitis. The British journal of ophthalmology. 2024-Jul-16;1-7. doi:10.1136/bjo-2024-325163.$$$$$Y$$$20240807$$MD$FR$FR
241848981$24184898$1$I$$20240801$20240807$20240807$EXP$$JP-GUERBET / LLC-JP-20240108$GUERBET$Ohata K. A case of small bowel aneurysm hemorrhage with submucosal tumor-like findings. DEN Open.. 2024;4(e335): 1-5. doi:https://doi.org/10.1002/deo2.335.$51$YR$A$F$Y$$$20240807$$MD$JP$JP
241848991$24184899$1$I$20240729$20240806$20240807$20240807$PER$$US-BAYER-2024A113686$BAYER$$26$YR$A$F$Y$$$20240807$$MD$US$US
241849001$24184900$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54285$$FDA-CTU$$56$YR$$F$N$$$20240807$N$$US$
241849013$24184901$3$F$20240701$20240826$20240807$20240903$PER$$US-AMGEN-USASP2024153825$AMGEN$$80$YR$E$M$Y$67$KG$20240903$$PH$US$US
241849022$24184902$2$F$20240729$20240912$20240807$20240914$PER$$US-AMGEN-USASP2024156261$AMGEN$$63$YR$A$F$Y$$$20240914$$CN$US$US
241849031$24184903$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54297$$FDA-CTU$$55$YR$$F$N$88.9$KG$20240807$N$$US$
241849041$24184904$1$I$$20240728$20240807$20240807$EXP$$CA-TEVA-VS-3230373$TEVA$Alzaid, Khalid, Jones, Barry D. 1997. A Case Report of Risperidone-Induced Obsessive-Compulsive Symptoms. Journal of Clinical Psychopharmacology, Vol. 17, Issue. 1, p. 58$38$YR$$F$Y$$$20240807$$HP$CA$CA
241849051$24184905$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54283$$FDA-CTU$$70$YR$$F$N$93.89$KG$20240807$N$$US$
241849061$24184906$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54298$$FDA-CTU$$66$YR$$F$N$108.86$KG$20240807$N$$US$
241849071$24184907$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54268$$FDA-CTU$$60$YR$$F$N$$$20240807$N$$US$
241849081$24184908$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54299$$FDA-CTU$$57$YR$$F$N$127.01$KG$20240807$N$$US$
241849091$24184909$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54267$$FDA-CTU$$62$YR$$F$N$102.06$KG$20240807$N$$US$
241849101$24184910$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54281$$FDA-CTU$$31$YR$$F$N$95.71$KG$20240807$N$$US$
241849111$24184911$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54274$$FDA-CTU$$33$YR$$M$N$$$20240807$N$$US$
241849121$24184912$1$I$20240719$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54265$$FDA-CTU$$78$YR$$F$N$$$20240807$N$$US$
241849131$24184913$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54275$$FDA-CTU$$73$YR$$F$N$$$20240807$N$$US$
241849141$24184914$1$I$$20240801$20240807$20240807$30DAY$$US-GSK-US2024096367$GLAXOSMITHKLINE$$$$$F$Y$$$20240807$$CN$US$US
241849152$24184915$2$F$$20240814$20240807$20240821$EXP$$US-GSK-US2024097027$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
241849162$24184916$2$F$$20240813$20240807$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123575$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240815$$PH$US$US
241849172$24184917$2$F$$20240806$20240807$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124332$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$81.65$KG$20240808$$CN$US$US
241849181$24184918$1$I$$20240802$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124214$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240807$$HP$US$US
241849191$24184919$1$I$20240601$20240805$20240807$20240807$EXP$SE-SEMPA-2024-005913$SE-DSJP-DSE-2024-139084$DAIICHI$$74$YR$$M$Y$$$20240807$$MD$SE$SE
241849201$24184920$1$I$$20240704$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06818$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241849212$24184921$2$F$20240729$20240903$20240807$20240907$30DAY$$US-AMGEN-USASP2024153694$AMGEN$$66$YR$E$F$Y$34.467$KG$20240907$$HP$US$US
241849221$24184922$1$I$20240629$20240805$20240807$20240807$EXP$GB-MHRA-MED-202408050942328210-TYRHD$GB-MYLANLABS-2024M1072994$MYLAN$$53$YR$$F$Y$$$20240807$$MD$GB$GB
241849232$24184923$2$F$$20240812$20240807$20240822$EXP$$US-TEVA-VS-3228020$TEVA$Beshay L, Thakkar A. A Case Of Mature Onset Diabetes Of The Young. J-Endocr-Soc 2023; 7 (Suppl. 1) A513.; Beshay L, Thakkar A. A Case Of Mature Onset Diabetes Of The Young. J-Endocr-Soc 2023; 7 (Suppl. 1) A513.$21$YR$$F$Y$$$20240822$$MD$US$US
241849251$24184925$1$I$20230101$20240730$20240807$20240807$EXP$$US-PERRIGO-24US007300$PERRIGO$Longobardi SA, Alkowati H, Kang G, Slade C, Oyesanmi O. Ibuprofen-Induced Pancytopenia and Erythema Multiforme in an Elderly Female Patient. Cureus. 2024;16(6):e62785. DOI: 10.7759/cureus.62785.$75$YR$$F$Y$$$20240807$$MD$US$US
241849261$24184926$1$I$$20240201$20240807$20240807$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000002$LANNETT$$$$$F$Y$$$20240807$$CN$US$US
241849272$24184927$2$F$20240531$20240807$20240807$20240809$EXP$IT-MINISAL02-997306$IT-DSJP-DSE-2024-139050$DAIICHI$$79$YR$$F$Y$60$KG$20240809$$MD$IT$IT
241849281$24184928$1$I$$20240207$20240807$20240807$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000030$LANNETT$$$$$$Y$$$20240807$$CN$US$US
241849291$24184929$1$I$20240626$20240805$20240807$20240807$EXP$$KR-DSJP-DSJ-2024-139096$DAIICHI$$71$YR$$F$Y$$$20240807$$CN$KR$KR
241849301$24184930$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54301$$FDA-CTU$$63$YR$$F$N$89.81$KG$20240807$N$$US$
241849311$24184931$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA231267$SANOFI AVENTIS$$$$A$F$Y$67.1$KG$20240807$$MD$US$US
241849321$24184932$1$I$20240720$20240729$20240807$20240807$PER$$US-SA-2024SA229877$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240807$$MD$US$US
241849331$24184933$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA231539$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$MD$US$US
241849341$24184934$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54282$$FDA-CTU$$65$YR$$F$N$$$20240807$N$$US$
241849351$24184935$1$I$20240701$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54300$$FDA-CTU$$62$YR$$M$N$73.9$KG$20240807$N$HP$US$
241849364$24184936$4$F$20240101$20240819$20240807$20240823$EXP$$US-ABBVIE-5862912$ABBVIE$$$$$F$Y$73.481$KG$20240823$$CN$US$US
241849371$24184937$1$I$20240701$20240802$20240807$20240807$EXP$$US-ABBVIE-5865640$ABBVIE$$55$YR$$F$Y$$$20240807$$CN$US$US
241849381$24184938$1$I$$20240729$20240807$20240807$EXP$$US-GUERBET / LLC-US-20240120$GUERBET$A Case of Acute Respiratory Failure Following Lymphangiography. Am-J-Respir-Crit-Care-Med. 2024.$57$YR$A$F$Y$$$20240807$$MD$US$US
241849391$24184939$1$I$20240718$20240729$20240807$20240807$PER$$CN-Eisai-EC-2024-171106$EISAI$$88$YR$E$M$Y$70$KG$20240807$$HP$CN$CN
241849401$24184940$1$I$$20240730$20240807$20240807$PER$$JP-Eisai-EC-2024-171275$EISAI$$$$E$F$Y$$$20240807$$MD$JP$JP
241849414$24184941$4$F$20220101$20240905$20240807$20240911$EXP$$IT-TAKEDA-2022TUS002659$TAKEDA$$62$YR$$M$Y$$$20240911$$CN$IT$IT
241849421$24184942$1$I$20240718$20240729$20240807$20240807$PER$$JP-Eisai-EC-2024-171198$EISAI$$71$YR$E$F$Y$$$20240807$$MD$JP$JP
241849432$24184943$2$F$$20240826$20240807$20240830$EXP$$US-Taiho Oncology Inc-2024-007476$TAIHO ONCOLOGY INC$$$$E$M$Y$$$20240830$$CN$US$US
241849441$24184944$1$I$20230523$20240731$20240807$20240807$PER$$US-APELLIS-2024-APL-0000596$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240807$$CN$US$US
241849452$24184945$2$F$20240701$20240806$20240807$20240809$PER$$JP-Eisai-EC-2024-171277$EISAI$$$$E$M$Y$$$20240809$$MD$JP$JP
241849461$24184946$1$I$20230101$20240730$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-087671$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240807$$MD$US$US
241849471$24184947$1$I$20240701$20240728$20240807$20240807$EXP$$US-BIOGEN-2024BI01275881$BIOGEN$$30$YR$$F$Y$$$20240807$$CN$US$US
241849481$24184948$1$I$20240607$20240730$20240807$20240807$EXP$ES-AEMPS-1551742$ES-TEVA-VS-3227891$TEVA$$66$YR$$M$Y$$$20240807$$PH$ES$ES
241849491$24184949$1$I$$20240705$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06917$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241849501$24184950$1$I$$20221110$20240807$20240807$EXP$$US-AstraZeneca-2022A374776$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241849511$24184951$1$I$$20230523$20240807$20240807$EXP$$US-AstraZeneca-2023A121129$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241849521$24184952$1$I$$20240730$20240807$20240807$PER$$US-AstraZeneca-2024A174030$ASTRAZENECA$$70$YR$$M$Y$$$20240807$$HP$US$
241849531$24184953$1$I$$20240802$20240807$20240807$EXP$$NL-ABBVIE-5869545$ABBVIE$$73$YR$$F$Y$$$20240807$$CN$NL$NL
241849543$24184954$3$F$$20240906$20240807$20240916$30DAY$$FR-JNJFOC-20240776362$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$PH$FR$FR
241849551$24184955$1$I$20240727$20240801$20240807$20240807$PER$$US-AMGEN-USASP2024153861$AMGEN$$63$YR$A$M$Y$$$20240807$$HP$US$US
241849561$24184956$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54276$$FDA-CTU$$65$YR$$M$N$74.84$KG$20240807$N$$US$
241849572$24184957$2$F$20240614$20240830$20240807$20240903$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-129709$DAIICHI$$7$DEC$$F$Y$$$20240903$$PH$JP$JP
241849583$24184958$3$F$20240727$20240926$20240807$20240930$EXP$$CN-ABBVIE-5863331$ABBVIE$$71$YR$$M$Y$$$20240929$$MD$CN$CN
241849591$24184959$1$I$$20240730$20240807$20240807$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005713$BIOCON$$$$$$Y$$$20240807$$CN$CA$CA
241849602$24184960$2$F$$20240829$20240807$20240829$PER$$US-ALXN-202408USA000092US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
241849611$24184961$1$I$$20240708$20240807$20240807$30DAY$$US-VEROBIOTECH-2024USVEROSPO00164$VERO BIOTECH$$$$I$F$Y$$$20240807$$HP$US$US
241849621$24184962$1$I$20171212$20240802$20240807$20240807$EXP$$ES-MYLANLABS-2020M1060672$MYLAN$Jimenez Moreno MA, Hontoria Bautista G, Pereda Garcia R. Acute pancreatitis associated with levofloxacin [published online ahead of print. Rev Esp Enferm Dig. 2020;112 (6):510$28$YR$$F$Y$$$20240807$$HP$ES$ES
241849631$24184963$1$I$$20240802$20240807$20240807$EXP$$FR-MYLANLABS-2024M1072459$MYLAN$$65$YR$$F$Y$$$20240807$$MD$FR$FR
241849642$24184964$2$F$20230926$20240911$20240807$20240916$EXP$$GB-MYLANLABS-2024M1072849$MYLAN$$81$YR$$M$Y$$$20240916$$MD$GB$GB
241849651$24184965$1$I$20240607$20240802$20240807$20240807$EXP$ES-AEMPS-1553165$ES-MYLANLABS-2024M1072658$MYLAN$$57$YR$$F$Y$$$20240807$$MD$ES$ES
241849661$24184966$1$I$20240805$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124644$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$CN$US$US
241849671$24184967$1$I$20240628$20240806$20240807$20240807$PER$$US-BAYER-2024A113836$BAYER$$20$YR$A$F$Y$$$20240807$$HP$US$US
241849683$24184968$3$F$20240731$20240827$20240807$20240829$EXP$$US-ARGENX-2024-ARGX-US006164$ARGENX BVBA$$$$$$Y$$$20240829$$HP$US$US
241849691$24184969$1$I$$20240729$20240807$20240807$EXP$$CA-GUERBET / LLC-CA-20240003$GUERBET$Coil migration into the pulmonary artery after gastric variceal EUS-guided coil embolization. Gastrointestinal endoscopy 2024; 100(2): 330-331.$61$YR$A$M$Y$$$20240807$$MD$CA$CA
241849701$24184970$1$I$$20240712$20240807$20240807$PER$$US-FMCRTG-FMC-2407-000842$FRESENIUS MEDICAL CARE$$74$YR$E$F$Y$59.42$KG$20240807$$HP$US$US
241849711$24184971$1$I$$20240713$20240807$20240807$PER$$US-FMCRTG-FMC-2407-000863$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240807$$CN$US$US
241849721$24184972$1$I$$20240708$20240807$20240807$PER$$US-FMCRTG-FMC-2407-000817$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240807$$CN$US$US
241849732$24184973$2$F$$20240723$20240807$20240807$EXP$$US-FMCRTG-FMC-2407-000868$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240807$$HP$US$US
241849741$24184974$1$I$20240714$20240705$20240807$20240807$PER$$US-FMCRTG-FMC-2407-000818$FRESENIUS MEDICAL CARE$$46$YR$A$F$Y$51$KG$20240807$$HP$US$US
241849751$24184975$1$I$$20240711$20240807$20240807$PER$$US-FMCRTG-FMC-2407-000861$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240807$$HP$US$US
241849761$24184976$1$I$$20240728$20240807$20240807$PER$$US-Eisai-EC-2024-171263$EISAI$$$$$$Y$$$20240807$$HP$US$US
241849771$24184977$1$I$$20240730$20240807$20240807$PER$$US-ABBVIE-5861033$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241849781$24184978$1$I$$20240802$20240807$20240807$EXP$$US-JNJFOC-20240809650$JOHNSON AND JOHNSON$$$$$F$Y$$$20240807$$CN$US$US
241849801$24184980$1$I$20240528$20240730$20240807$20240807$EXP$FR-AFSSAPS-LY2024000820$FR-Eisai-EC-2024-171140$EISAI$$10$YR$C$M$Y$27$KG$20240807$$HP$FR$FR
241849811$24184981$1$I$20240804$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155660$AMGEN$$79$YR$E$M$Y$$$20240807$$CN$US$US
241849821$24184982$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124943$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240807$$CN$US$US
241849831$24184983$1$I$20240719$20240730$20240807$20240807$EXP$CZ-CZSUKL-24002180$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-122830$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$67$KG$20240807$$PH$CZ$CZ
241849841$24184984$1$I$20240714$20240728$20240807$20240807$EXP$$GB-JNJFOC-20240778874$JOHNSON AND JOHNSON$$33$YR$A$$Y$$$20240807$$CN$GB$GB
241849861$24184986$1$I$$20240806$20240807$20240807$EXP$$US-TAKEDA-2024TUS078989$TAKEDA$$$$$M$Y$$$20240807$$CN$US$US
241849871$24184987$1$I$$20240802$20240807$20240807$EXP$$JP-TAKEDA-2024TUS078885$TAKEDA$$8$DEC$$M$Y$$$20240807$$MD$JP$JP
241849881$24184988$1$I$$20240802$20240807$20240807$EXP$$US-ANIPHARMA-2024-US-041860$ANI$Carranza Morales A, Blanco Jimenez JA, Madhavan A.A painful case of asthma..American Journal of Respiratory and Critical Care Medicine.2024;209A5999.$43$YR$$F$Y$$$20240807$$HP$US$US
241849891$24184989$1$I$$20240801$20240807$20240807$EXP$$CA-JNJFOC-20240634421$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240807$$PH$CA$CA
241849901$24184990$1$I$20240703$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155368$AMGEN$$73$YR$E$M$Y$$$20240807$$CN$US$US
241849921$24184992$1$I$$20240804$20240807$20240807$PER$$NVSC2024US159406$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
241849931$24184993$1$I$$20240806$20240807$20240807$PER$$US-BAYER-2024A113884$BAYER$$34$YR$A$F$Y$$$20240807$$MD$US$US
241849941$24184994$1$I$$20240807$20240807$20240807$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044341$BOEHRINGER INGELHEIM$$$$$$Y$$$20240807$$CN$US$US
241849951$24184995$1$I$$20240731$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124207$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$64.41$KG$20240807$$HP$US$US
241849963$24184996$3$F$20240731$20240905$20240807$20240918$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003699$CURRAX PHARMACEUTICALS$$61$YR$$F$Y$$$20240918$$CN$CA$CA
241849971$24184997$1$I$$20240731$20240807$20240807$EXP$$KR-009507513-2408KOR000852$MERCK$$$$$M$Y$$$20240807$$CN$KR$KR
241849981$24184998$1$I$$20240806$20240807$20240807$PER$$US-BAYER-2024A113888$BAYER$$31$YR$A$F$Y$$$20240807$$MD$US$US
241849992$24184999$2$F$20240131$20240807$20240807$20240813$EXP$$CO-GSK-CO2024AMR015242$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CO$CO
241850001$24185000$1$I$20231201$20240731$20240807$20240807$EXP$$CA-GSK-CA2024096188$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$CA$CA
241850011$24185001$1$I$$20240802$20240807$20240807$EXP$$CA-PFIZER INC-202400230388$PFIZER$$$$$$Y$$$20240807$$HP$CA$CA
241850021$24185002$1$I$$20240802$20240807$20240807$EXP$$US-PFIZER INC-PV202400101321$PFIZER$$63$YR$$$Y$$$20240807$$CN$US$US
241850031$24185003$1$I$20240703$20240805$20240807$20240807$EXP$$US-PFIZER INC-202400230384$PFIZER$$71$YR$$F$Y$$$20240807$$CN$US$US
241850041$24185004$1$I$$20240724$20240807$20240807$PER$$US-TEVA-VS-3226706$TEVA$$$$$F$Y$$$20240807$$CN$US$US
241850051$24185005$1$I$$20240729$20240807$20240807$EXP$EU-AFSSAPS-LL2024001430$EU-AFSSAPS-LL2024001430$UNITED THERAPEUTICS$$62$YR$$$Y$$$20240807$$MD$EU$EU
241850062$24185006$2$F$$20240916$20240807$20240918$EXP$$US-AstraZeneca-2024A173984$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
241850071$24185007$1$I$20240701$20240726$20240807$20240807$PER$$US-AstraZeneca-2024A171879$ASTRAZENECA$$954$MON$$F$Y$65.3$KG$20240807$$HP$US$
241850091$24185009$1$I$$20240730$20240807$20240807$EXP$$US-BAUSCH-BL-2024-011690$BAUSCH AND LOMB$Longobardi S, Alkowati H, Kang G, Slade C, Oyesanmi O. Ibuprofen-Induced Pancytopenia and Erythema Multiforme in an Elderly Female Patient. Cureus. 2024 JUN 20;16(6):1-8. doi:10.7759/cureus.62785.$$$$F$Y$$$20240807$$HP$US$US
241850101$24185010$1$I$$20240805$20240807$20240807$PER$$US-BAUSCH-BL-2024-011919$BAUSCH AND LOMB$$81$YR$$F$Y$77.18$KG$20240807$$CN$US$US
241850111$24185011$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125070$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240807$$CN$US$US
241850121$24185012$1$I$$20240805$20240807$20240807$PER$$US-ABBVIE-5869732$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241850131$24185013$1$I$20240621$20240801$20240807$20240807$EXP$$CA-BAYER-2024A111803$BAYER$$46$YR$A$F$Y$$$20240807$$CN$CA$CA
241850141$24185014$1$I$20240708$20240802$20240807$20240807$EXP$$US-BAYER-2024A112452$BAYER$$39$YR$A$F$Y$$$20240807$$HP$US$US
241850151$24185015$1$I$$20240802$20240807$20240807$PER$$US-BAUSCH-BL-2024-011816$BAUSCH AND LOMB$$51$YR$$F$Y$$$20240807$$MD$US$US
241850161$24185016$1$I$20240802$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002152$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240807$$CN$US$US
241850171$24185017$1$I$20240726$20240730$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407018323$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240807$$CN$US$US
241850181$24185018$1$I$$20240806$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408004355$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241850191$24185019$1$I$$20240731$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202403003629$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240807$$CN$US$US
241850201$24185020$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002054$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240807$$CN$US$US
241850211$24185021$1$I$20240701$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003121$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240807$$CN$US$US
241850222$24185022$2$F$20240722$20240913$20240807$20240925$EXP$$JP-ROCHE-10000048914$ROCHE$$26$YR$A$F$Y$$$20240925$$MD$JP$JP
241850231$24185023$1$I$20240628$20240725$20240807$20240807$EXP$$JP-VANTIVE-2024VAN018088$Vantive US Healthcare$$8$DEC$$M$Y$$$20240807$$MD$JP$JP
241850241$24185024$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA232023$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240807$$HP$US$US
241850251$24185025$1$I$20240622$20240801$20240807$20240807$EXP$FR-AFSSAPS-PV2024000686$FR-MYLANLABS-2024M1072131$MYLAN$$5$YR$$F$Y$19$KG$20240807$$MD$FR$FR
241850261$24185026$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125072$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240807$$CN$US$US
241850271$24185027$1$I$$20240710$20240807$20240807$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06988$LUPIN$$$$$$Y$$$20240807$$CN$US$US
241850281$24185028$1$I$$20240801$20240807$20240807$EXP$$IL-ABBVIE-5869360$ABBVIE$$$$$F$Y$$$20240807$$CN$IL$IL
241850291$24185029$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54302$$FDA-CTU$$39$YR$$F$N$$$20240807$N$$US$
241850311$24185031$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54303$$FDA-CTU$$73$YR$$F$N$58.51$KG$20240807$N$$US$
241850321$24185032$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54304$$FDA-CTU$$67$YR$$F$N$$$20240807$N$$US$
241850331$24185033$1$I$20240730$20240807$20240807$20240807$DIR$713275$$FDA-CTU$$42$YR$$M$N$$$20240807$N$HP$US$
241850341$24185034$1$I$20240717$20240807$20240807$20240807$DIR$713247$$FDA-CTU$$33$YR$$F$N$$$20240807$N$HP$US$
241850351$24185035$1$I$$20240807$20240807$20240807$DIR$713286$$FDA-CTU$$$$$F$N$$$20240807$N$PH$US$
241850361$24185036$1$I$$20240801$20240807$20240807$EXP$$GR-MYLANLABS-2024M1033872$MYLAN$Papadokostaki E., Koutrakou P., Mastrogiorgakis D., Emmanouilidou E., Papazachariou A., Repa A., Philippatos T.. P29 Atorvastatin-induced autoimmune necrotizing myositis. 22nd Panhellenic Diabetes Conference. 2024;68$68$YR$$M$Y$$$20240807$$MD$GR$GR
241850371$24185037$1$I$20240101$20240730$20240807$20240807$PER$$US-SA-2024SA230802$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240807$$MD$US$US
241850381$24185038$1$I$20240101$20240730$20240807$20240807$PER$$US-SA-2024SA231171$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240807$$MD$US$US
241850391$24185039$1$I$$20240802$20240807$20240807$PER$$US-SA-2024SA232934$SANOFI AVENTIS$$29$YR$A$M$Y$87.99$KG$20240807$$MD$US$US
241850401$24185040$1$I$20240701$20240729$20240807$20240807$PER$$US-SA-2024SA229824$SANOFI AVENTIS$$16$YR$T$F$Y$61.224$KG$20240807$$MD$US$US
241850411$24185041$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA231351$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$MD$US$US
241850421$24185042$1$I$20240101$20240730$20240807$20240807$PER$$US-SA-2024SA231207$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240807$$MD$US$US
241850431$24185043$1$I$20240601$20240802$20240807$20240807$PER$$US-BAYER-2024A112947$BAYER$$40$YR$A$F$Y$$$20240807$$CN$US$US
241850441$24185044$1$I$$20240806$20240807$20240807$EXP$$JP-BAYER-2024A113128$BAYER$$$$$F$Y$$$20240807$$MD$JP$JP
241850451$24185045$1$I$20201103$20240729$20240807$20240807$EXP$PL-URPL-1-4244-2020$PL-TEVA-VS-3227495$TEVA$$29$YR$$F$Y$75$KG$20240807$$MD$PL$PL
241850463$24185046$3$F$20240814$20240821$20240807$20240828$PER$$NVSC2024US160907$NOVARTIS$$76$YR$$M$Y$78.82$KG$20240828$$HP$US$US
241850472$24185047$2$F$20240618$20240812$20240807$20240820$EXP$FR-AFSSAPS-AN2024000972$FR-TAKEDA-2024TUS077161$TAKEDA$$52$YR$$F$Y$73.5$KG$20240820$$HP$FR$FR
241850481$24185048$1$I$$20240726$20240807$20240807$PER$$US-TAKEDA-2024TUS075990$TAKEDA$$$$$M$Y$63.492$KG$20240807$$MD$US$US
241850491$24185049$1$I$20240326$20240801$20240807$20240807$EXP$FR-AFSSAPS-PP2024000709$FR-MYLANLABS-2024M1072123$MYLAN$$97$YR$$M$Y$65$KG$20240807$$PH$FR$FR
241850501$24185050$1$I$20240429$20240801$20240807$20240807$EXP$$US-ABBVIE-5820018$ABBVIE$$76$YR$$F$Y$76.6$KG$20240807$$CN$US$US
241850511$24185051$1$I$20230831$20240801$20240807$20240807$EXP$FR-AFSSAPS-TO2024000667$FR-MYLANLABS-2024M1036776$MYLAN$$78$YR$$M$Y$$$20240807$$MD$FR$FR
241850521$24185052$1$I$$20240802$20240807$20240807$EXP$$JP-DSJP-DSJ-2024-138613$DAIICHI$$9$DEC$$$Y$$$20240807$$PH$JP$JP
241850531$24185053$1$I$$20240801$20240807$20240807$EXP$$US-AstraZeneca-2024A175589$ASTRAZENECA$$$$$F$Y$$$20240807$$HP$US$
241850541$24185054$1$I$$20240730$20240807$20240807$EXP$$US-AstraZeneca-2024A173563$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241850551$24185055$1$I$$20240730$20240807$20240807$EXP$$JP-AstraZeneca-2024A174932$ASTRAZENECA$Tohyama S, et al. EP-1361 A case of immune checkpoint inhibitor-induced hepatic disorder. The 32nd Annual Meeting of the Japanese Breast Cancer Society; 2024;518-.$56$YR$$F$Y$$$20240807$$MD$JP$
241850561$24185056$1$I$$20240806$20240807$20240807$PER$$US-BAYER-2024A113819$BAYER$$$$$M$Y$$$20240807$$CN$US$US
241850571$24185057$1$I$$20240723$20240807$20240807$EXP$$JP-JNJFOC-20240816911$JOHNSON AND JOHNSON$Matsuoka K. Health Labour Sciences Research Grant. Research on rare and intractable diseases. Research on refractoryinflammatory intestinal disorder.. Co-investigation report (FY 2016).$$$$$Y$$$20240807$$HP$JP$JP
241850581$24185058$1$I$20240711$20240730$20240807$20240807$EXP$FR-AFSSAPS-NC2024000894$FR-BAXTER-2024BAX022668$BAXTER$$66$YR$$F$Y$90$KG$20240807$$MD$FR$FR
241850591$24185059$1$I$20230718$20240729$20240807$20240807$EXP$$US-BAXTER-2024BAX022488$BAXTER$$57$YR$$F$Y$85.9$KG$20240807$$HP$US$US
241850601$24185060$1$I$20130521$20240801$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124192$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$136.9$KG$20240807$$HP$US$US
241850611$24185061$1$I$$20240801$20240807$20240807$PER$$US-TAKEDA-2024TUS077834$TAKEDA$$$$$F$Y$$$20240807$$CN$US$US
241850621$24185062$1$I$$20240802$20240807$20240807$PER$$US-BAYER-2024A112340$BAYER$$40$YR$A$F$Y$$$20240807$$MD$US$US
241850631$24185063$1$I$20240724$20240807$20240807$20240807$DIR$713294$$FDA-CTU$$77$YR$$F$N$60.75$KG$20240807$N$HP$US$
241850643$24185064$3$F$20240703$20240802$20240807$20240813$EXP$FR-AFSSAPS-TS2024000863$FR-TAKEDA-2024TUS077920$TAKEDA$$89$YR$$M$Y$103$KG$20240813$$HP$FR$FR
241850651$24185065$1$I$$20240730$20240807$20240807$EXP$$US-PFIZER INC-202400230197$PFIZER$Bernini, J.. Acute Basophilic leukemia in a child. Anaphylactoid reaction and coagulopathy secondary to vincristine-mediated degranulation. Cancer. 1995;75(1):110-114$9$MON$$F$Y$$$20240807$$MD$US$US
241850661$24185066$1$I$20240709$20240723$20240807$20240807$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0859$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240807$$HP$US$US
241850671$24185067$1$I$$20240730$20240807$20240807$EXP$$US-PFIZER INC-202400230436$PFIZER$Bernini, J.. Acute Basophilic leukemia in a child. Anaphylactoid reaction and coagulopathy secondary to vincristine-mediated degranulation. Cancer. 1995;75(1):110-114$9$MON$$F$Y$$$20240807$$MD$US$US
241850681$24185068$1$I$20240702$20240801$20240807$20240807$EXP$FR-AFSSAPS-AVMA2024000333$FR-MYLANLABS-2024M1072283$MYLAN$$23$YR$$F$Y$$$20240807$$CN$FR$FR
241850691$24185069$1$I$20240101$20240731$20240807$20240807$PER$$US-BAYER-2024A110962$BAYER$$46$YR$A$F$Y$$$20240807$$MD$US$US
241850701$24185070$1$I$$20240807$20240807$20240807$DIR$713298$$FDA-CTU$$$$$UNK$N$$$20240807$N$CN$US$
241850731$24185073$1$I$20240720$20240807$20240807$20240807$DIR$713299$$FDA-CTU$$70$YR$$M$N$$$20240807$N$$US$
241850741$24185074$1$I$20240807$20240807$20240807$20240807$DIR$713295$$FDA-CTU$$60$YR$$F$N$$$20240807$N$$US$
241850751$24185075$1$I$20240718$20240807$20240807$20240807$DIR$713297$$FDA-CTU$$73$YR$$F$N$$$20240807$N$HP$US$
241850771$24185077$1$I$20180727$20240807$20240807$20240807$DIR$713280$$FDA-CTU$$24$YR$$F$N$50.4$KG$20240807$N$CN$CA$
241850782$24185078$2$F$$20240806$20240807$20240812$EXP$$NVSC2024TW158131$NOVARTIS$$$$A$M$Y$$$20240812$$MD$TW$TW
241850792$24185079$2$F$20240701$20240830$20240807$20240903$EXP$$US-BAYER-2024A111685$BAYER$$40$YR$A$F$Y$$$20240903$$CN$US$US
241850801$24185080$1$I$$20240731$20240807$20240807$EXP$$NVSC2024IT159746$NOVARTIS$Cecchi N, Giannotta JA, Capecchi M, Barcellini W, Fattizzo B. Efficacy of thrombopoietin receptor agonists in evans syndrome: a single center series. HAEMATOLOGICA. 2021;106 (Suppl. 3):37$67$YR$$F$Y$$$20240807$$HP$IT$IT
241850811$24185081$1$I$$20240805$20240807$20240807$PER$$US-ABBVIE-5869776$ABBVIE$$$$$$Y$$$20240807$$HP$US$US
241850821$24185082$1$I$$20240802$20240807$20240807$PER$$US-BAYER-2024A112337$BAYER$$28$YR$A$F$Y$$$20240807$$HP$US$US
241850831$24185083$1$I$20160301$20240730$20240807$20240807$EXP$$BR-TAKEDA-2024TUS078876$TAKEDA$$55$YR$$F$Y$$$20240807$$CN$BR$BR
241850842$24185084$2$F$20240730$20240806$20240807$20240809$EXP$$US-KYOWAKIRIN-2024KK018796$KYOWA$$$$$$Y$$$20240809$$HP$US$US
241850851$24185085$1$I$$20240806$20240807$20240807$PER$$US-JNJFOC-20240815179$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$MD$US$US
241850861$24185086$1$I$20240701$20240801$20240807$20240807$EXP$$US-GSK-US2024096310$GLAXOSMITHKLINE$$40$YR$$F$Y$$$20240807$$CN$US$US
241850871$24185087$1$I$$20240806$20240807$20240807$EXP$GB-MHRA-31415142$GB-MYLANLABS-2024M1073439$MYLAN$$$$$$Y$$$20240807$$CN$GB$GB
241850881$24185088$1$I$20240501$20240802$20240807$20240807$EXP$SE-SEMPA-2024-005733$SE-MYLANLABS-2024M1072404$MYLAN$$22$YR$$F$Y$$$20240807$$MD$SE$SE
241850892$24185089$2$F$20240801$20240815$20240807$20240823$EXP$GB-MHRA-MED-202408061821540410-NBCRV$GB-MYLANLABS-2024M1073492$MYLAN$$69$YR$$M$Y$85$KG$20240823$$MD$GB$GB
241850901$24185090$1$I$$20240731$20240807$20240807$PER$$US-BAYER-2024A111689$BAYER$$43$YR$A$F$Y$$$20240807$$CN$US$US
241850911$24185091$1$I$$20240802$20240807$20240807$PER$$NVSC2024US160629$NOVARTIS$$$$$F$Y$$$20240807$$CN$US$US
241850921$24185092$1$I$20240804$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003131$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240807$$CN$US$US
241850931$24185093$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002208$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241850941$24185094$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002253$ELI LILLY AND CO$$22$YR$A$M$Y$$$20240807$$CN$US$US
241850951$24185095$1$I$$20240729$20240807$20240807$30DAY$$CO-PFIZER INC-202400225739$PFIZER$$$$$M$Y$$$20240807$$CN$CO$CO
241850961$24185096$1$I$20240729$20240801$20240807$20240807$EXP$$US-ABBVIE-5865670$ABBVIE$$74$YR$$M$Y$60$KG$20240807$$CN$US$US
241850971$24185097$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000050757$ROCHE$Krause P, Rogers R, Shah M, Kang H, Parsonnet J, Kodama R, et al. Tafenoquine for relapsing babesiosis: a case series. Clinical Infectious Diseases. 2024-Jul-15;79 (1):130-7. doi:10.1093/cid/ciae238.$70$YR$E$F$Y$$$20240807$$HP$US$US
241850982$24185098$2$F$$20240805$20240807$20240830$PER$$US-ROCHE-10000049781$ROCHE$$$$A$F$Y$$$20240830$$CN$US$US
241850992$24185099$2$F$$20240806$20240807$20240815$PER$$US-ROCHE-10000050629$ROCHE$$$$$$Y$$$20240815$$CN$US$US
241851001$24185100$1$I$$20240805$20240807$20240807$PER$$US-ROCHE-10000048862$ROCHE$Krause P, Rogers R, Shah M, Kang H, Parsonnet J, Kodama R, et al. Tafenoquine for relapsing babesiosis: a case series. Clinical Infectious Diseases. 2024-Jul-15;79 (1):130-7. doi:10.1093/cid/ciae238.$80$YR$E$M$Y$$$20240807$$HP$US$US
241851012$24185101$2$F$$20240807$20240807$20240808$PER$$US-ROCHE-10000050943$ROCHE$$30$YR$A$F$Y$$$20240808$$PH$US$US
241851032$24185103$2$F$20210101$20240801$20240807$20240814$EXP$$PT-MYLANLABS-2024M1072491$MYLAN$$61$YR$$M$Y$88$KG$20240814$$CN$PT$PT
241851041$24185104$1$I$$20240801$20240807$20240807$EXP$NL-LRB-00993530$NL-MYLANLABS-2024M1072555$MYLAN$$58$YR$$F$Y$77$KG$20240807$$PH$NL$NL
241851052$24185105$2$F$20240806$20240916$20240807$20240925$PER$$US-JNJFOC-20240816280$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240926$$MD$US$US
241851061$24185106$1$I$$20240731$20240807$20240807$PER$$US-BAYER-2024A111811$BAYER$$23$YR$A$F$Y$$$20240807$$HP$US$US
241851071$24185107$1$I$20240201$20240731$20240807$20240807$EXP$$AR-GSK-AR2024AMR097823$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$CN$AR$AR
241851081$24185108$1$I$20240601$20240806$20240807$20240807$PER$$US-ABBVIE-5869960$ABBVIE$$$$A$F$Y$$$20240807$$HP$US$US
241851091$24185109$1$I$20240101$20240801$20240807$20240807$EXP$$JP-009507513-2408JPN000017J$MERCK$$$$E$F$Y$$$20240807$$CN$JP$JP
241851102$24185110$2$F$$20240830$20240807$20240903$EXP$$TR-AstraZeneca-2024A178350$ASTRAZENECA$Isiklar, A; Basaran, G. Hemophagocytic Histiocytosislike Syndrome After Initiation Of Ribociclib Therapy In Advanced Breast Cancer Patient. European Journal of Case Reports in Internal Medicine 2024;11(S1):729.$44$YR$$F$Y$$$20240903$$HP$TR$
241851111$24185111$1$I$$20240801$20240807$20240807$EXP$BE-FAMHP-DHH-N2024-122427$BE-MYLANLABS-2024M1072470$MYLAN$$50$YR$$M$Y$$$20240807$$PH$BE$BE
241851121$24185112$1$I$20210520$20240731$20240807$20240807$EXP$GB-MHRA-MED-202205291306127090-RANQU$GB-BAYER-2022A076533$BAYER$$54$YR$A$F$Y$53$KG$20240807$$CN$GB$GB
241851132$24185113$2$F$$20240809$20240807$20240814$PER$$US-BAYER-2024A110952$BAYER$$30$YR$A$F$Y$99.773$KG$20240814$$CN$US$US
241851141$24185114$1$I$$20240723$20240807$20240807$EXP$$CA-HLS-202401852$HLS THERAPEUTICS$$$$A$F$Y$$$20240807$$PH$CA$CA
241851151$24185115$1$I$$20240807$20240807$20240807$PER$$NVSC2024US160914$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241851161$24185116$1$I$$20240722$20240807$20240807$PER$$US-Taiho Oncology Inc-2024-007508$TAIHO ONCOLOGY INC$$$$$M$Y$$$20240807$$HP$US$US
241851171$24185117$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124730$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240807$$CN$US$US
241851182$24185118$2$F$$20240807$20240807$20240808$PER$$US-JNJFOC-20240814482$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241851191$24185119$1$I$$20240801$20240807$20240807$EXP$$US-JNJFOC-20240803221$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$HP$US$US
241851202$24185120$2$F$20240601$20240830$20240807$20240909$30DAY$$US-GSK-US2024096296$GLAXOSMITHKLINE$$39$YR$$F$Y$$$20240909$$MD$US$US
241851221$24185122$1$I$20240514$20240807$20240807$20240807$DIR$713287$$FDA-CTU$$$$$F$N$$$20240807$Y$$US$
241851231$24185123$1$I$$20240807$20240807$20240807$DIR$713301$$FDA-CTU$$$$$UNK$N$$$20240807$N$HP$US$
241851241$24185124$1$I$20240710$20240807$20240807$20240807$DIR$713292$$FDA-CTU$$42$YR$$F$N$$$20240807$N$HP$US$
241851271$24185127$1$I$20220201$20240731$20240807$20240807$PER$$US-BAYER-2024A111937$BAYER$$34$YR$A$F$Y$$$20240807$$CN$US$US
241851282$24185128$2$F$$20240807$20240807$20240808$30DAY$$US-SANDOZ INC.-SDZ2024US071131$SANDOZ$$$$$F$Y$$$20240808$$CN$US$US
241851291$24185129$1$I$$20240806$20240807$20240807$30DAY$$US-SANDOZ INC.-SDZ2024US071006$SANDOZ$$$$C$$Y$$$20240807$$HP$US$US
241851301$24185130$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA231514$SANOFI AVENTIS$$65$YR$E$F$Y$84$KG$20240807$$MD$US$US
241851311$24185131$1$I$20231001$20240802$20240807$20240807$PER$$US-SA-2024SA232416$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240807$$MD$US$US
241851321$24185132$1$I$20240718$20240730$20240807$20240807$PER$$US-SA-2024SA230420$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240807$$MD$US$US
241851331$24185133$1$I$$20240801$20240807$20240807$EXP$$US-ABBVIE-5865128$ABBVIE$$$$$F$Y$$$20240807$$HP$US$US
241851341$24185134$1$I$20240720$20240803$20240807$20240807$EXP$$CN-PFIZER INC-PV202400101189$PFIZER$$33$YR$$F$Y$52$KG$20240807$$HP$CN$CN
241851351$24185135$1$I$$20240802$20240807$20240807$EXP$$US-ABBVIE-5867629$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241851361$24185136$1$I$$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154977$AMGEN$$$$$M$Y$$$20240807$$CN$US$US
241851371$24185137$1$I$$20240807$20240807$20240807$PER$$US-BAYER-2024A114101$BAYER$$$$$$Y$$$20240807$$CN$US$US
241851381$24185138$1$I$20231124$20240802$20240807$20240807$PER$$US-BAYER-2024A112329$BAYER$$20$YR$A$F$Y$$$20240807$$HP$US$US
241851391$24185139$1$I$$20240803$20240807$20240807$EXP$$AU-ABBVIE-5867893$ABBVIE$$$$E$M$Y$$$20240807$$MD$AU$AU
241851402$24185140$2$F$$20240806$20240807$20240808$PER$$NVSC2024US160594$NOVARTIS$$$$$M$Y$$$20240808$$CN$US$US
241851411$24185141$1$I$20240101$20240724$20240807$20240807$PER$$US-009507513-2407USA014948$MERCK$$65$YR$$M$Y$$$20240807$$HP$US$US
241851421$24185142$1$I$$20240731$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124641$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240807$$CN$US$US
241851431$24185143$1$I$20240501$20240805$20240807$20240807$EXP$$US-ABBVIE-5868616$ABBVIE$$78$YR$$M$Y$$$20240807$$CN$US$US
241851442$24185144$2$F$20240625$20240816$20240807$20240822$EXP$$FR-AMERICAN REGENT INC-2024002993$AMERICAN REGENT$$57$YR$$M$Y$$$20240822$$PH$FR$FR
241851451$24185145$1$I$$20240730$20240807$20240807$EXP$$US-BAUSCH-BL-2024-011695$BAUSCH AND LOMB$Bally K, Trusty R, Naher K. A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone. Cureus. 2024;16(6):. doi:10.7759/cureus.62695$95$YR$$F$Y$$$20240807$$HP$US$US
241851461$24185146$1$I$$20240806$20240807$20240807$EXP$$US-BAUSCH-BL-2024-011950$BAUSCH AND LOMB$$$$$F$Y$$$20240807$$CN$US$US
241851481$24185148$1$I$20240701$20240802$20240807$20240807$EXP$$US-SA-2024SA233261$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240807$$CN$US$US
241851491$24185149$1$I$$20240802$20240807$20240807$EXP$$US-SA-2024SA233255$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240807$$MD$US$US
241851501$24185150$1$I$$20240801$20240807$20240807$PER$$US-BAYER-2024A112331$BAYER$$30$YR$A$F$Y$$$20240807$$MD$US$US
241851521$24185152$1$I$$20240802$20240807$20240807$EXP$$US-SA-2024SA233232$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240807$$MD$US$US
241851541$24185154$1$I$20240401$20240729$20240807$20240807$PER$$US-SA-2024SA229365$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240807$$MD$US$US
241851551$24185155$1$I$20240805$20240806$20240807$20240807$EXP$GB-MHRA-MED-202408061718410700-TMNSD$GB-009507513-2408GBR002109$MERCK$$74$YR$$F$Y$$$20240807$$HP$GB$GB
241851561$24185156$1$I$20240701$20240802$20240807$20240807$EXP$$US-SA-2024SA233259$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240807$$MD$US$US
241851571$24185157$1$I$$20240805$20240807$20240807$PER$$US-JNJFOC-20240813399$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240807$$CN$US$US
241851582$24185158$2$F$20240101$20240808$20240807$20240818$EXP$$BR-ORGANON-O2408BRA000504$ORGANON$$20$YR$$F$Y$64$KG$20240818$$MD$BR$BR
241851591$24185159$1$I$$20240725$20240807$20240807$EXP$$US-B.Braun Medical Inc.-2160143$B BRAUN$Literature Article$56$YR$$F$Y$$$20240807$$$US$US
241851621$24185162$1$I$20240101$20240806$20240807$20240807$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-139711$DAIICHI$$41$YR$$F$Y$$$20240807$$HP$US$US
241851631$24185163$1$I$$20240801$20240807$20240807$PER$$US-BAYER-2024A112332$BAYER$$36$YR$A$F$Y$$$20240807$$CN$US$US
241851642$24185164$2$F$20240601$20240801$20240807$20240809$EXP$$DE-AstraZeneca-2024A166937$ASTRAZENECA$$78$YR$$M$Y$$$20240809$$CN$DE$
241851651$24185165$1$I$20240601$20240806$20240807$20240807$PER$$US-ABBVIE-5869991$ABBVIE$$45$YR$$F$Y$68$KG$20240807$$HP$US$US
241851661$24185166$1$I$20240101$20240730$20240807$20240807$EXP$$JP-AstraZeneca-2024A104560$ASTRAZENECA$$82$YR$$M$Y$82$KG$20240807$$MD$JP$
241851671$24185167$1$I$$20240807$20240807$20240807$PER$$NVSC2024US160926$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241851691$24185169$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002220$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240807$$CN$US$US
241851701$24185170$1$I$20240716$20240730$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407011354$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240807$$MD$US$US
241851711$24185171$1$I$$20240725$20240807$20240807$EXP$$US-B.Braun Medical Inc.-2160142$B BRAUN$$$$$$Y$$$20240807$$$US$US
241851721$24185172$1$I$$20240516$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090269$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851731$24185173$1$I$$20240517$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090311$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851741$24185174$1$I$$20240517$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090310$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851751$24185175$1$I$20240414$20240610$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090406$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851761$24185176$1$I$20240401$20240615$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090360$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851771$24185177$1$I$$20240415$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090280$GLENMARK$$$$$$Y$$$20240807$$HP$US$US
241851781$24185178$1$I$$20240529$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090584$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851791$24185179$1$I$20240401$20240525$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090522$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851801$24185180$1$I$$20240529$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090590$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851811$24185181$1$I$$20240620$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090524$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851821$24185182$1$I$$20240525$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090529$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851831$24185183$1$I$$20240605$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090596$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851841$24185184$1$I$20240101$20240530$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090594$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851851$24185185$1$I$$20240427$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090592$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241851861$24185186$1$I$20240101$20240523$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090447$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851871$24185187$1$I$20240424$20240423$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090464$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851881$24185188$1$I$20240401$20240523$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090432$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851891$24185189$1$I$$20240523$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090433$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851901$24185190$1$I$$20240525$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090481$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851911$24185191$1$I$20240401$20240522$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090423$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851921$24185192$1$I$$20240523$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090466$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851931$24185193$1$I$$20240601$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090651$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241851941$24185194$1$I$$20240608$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090825$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241851951$24185195$1$I$20240105$20240606$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090823$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851961$24185196$1$I$$20240606$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090758$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851971$24185197$1$I$$20240605$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090707$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851981$24185198$1$I$$20240606$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090739$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241851991$24185199$1$I$$20240606$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090751$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852001$24185200$1$I$$20240501$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090650$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852011$24185201$1$I$$20240610$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090887$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852021$24185202$1$I$$20240424$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090478$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852031$24185203$1$I$$20240608$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090858$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852041$24185204$1$I$$20240513$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090882$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852051$24185205$1$I$$20240608$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090827$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852061$24185206$1$I$$20240610$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090883$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852071$24185207$1$I$$20240513$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090879$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852081$24185208$1$I$$20240613$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090878$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852091$24185209$1$I$20231113$20240608$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090826$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852101$24185210$1$I$$20240612$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090881$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852111$24185211$1$I$20240412$20240605$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090706$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852121$24185212$1$I$$20240614$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090954$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852131$24185213$1$I$20240501$20240529$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090648$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852141$24185214$1$I$$20240517$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090953$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852151$24185215$1$I$$20240703$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090944$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852161$24185216$1$I$20240101$20240621$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090923$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852171$24185217$1$I$20240201$20240612$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090880$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852181$24185218$1$I$$20240614$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091146$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852191$24185219$1$I$$20240522$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091148$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852201$24185220$1$I$$20240518$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091055$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852211$24185221$1$I$$20240620$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091133$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852221$24185222$1$I$$20240622$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091150$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852231$24185223$1$I$$20240517$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091137$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852241$24185224$1$I$$20240612$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090627$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852251$24185225$1$I$$20240709$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091152$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852261$24185226$1$I$$20240628$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091236$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852271$24185227$1$I$$20240528$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091238$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852281$24185228$1$I$$20240522$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091149$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852291$24185229$1$I$20240101$20240610$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090956$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852301$24185230$1$I$$20240626$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091171$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852311$24185231$1$I$$20240621$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091235$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852321$24185232$1$I$$20240524$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091181$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852331$24185233$1$I$$20240622$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091153$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852341$24185234$1$I$$20240529$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091271$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852351$24185235$1$I$$20240528$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091246$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852361$24185236$1$I$$20240704$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091353$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852371$24185237$1$I$$20240601$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091638$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852381$24185238$1$I$$20240628$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091637$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852391$24185239$1$I$$20240531$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091322$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852401$24185240$1$I$$20240725$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091360$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852411$24185241$1$I$$20240529$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091296$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852421$24185242$1$I$$20240704$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091567$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852431$24185243$1$I$$20240529$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091272$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852441$24185244$1$I$$20240529$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091297$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852451$24185245$1$I$$20240703$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091361$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852461$24185246$1$I$$20240604$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091634$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852471$24185247$1$I$$20240705$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091649$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852481$24185248$1$I$$20240705$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091632$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852491$24185249$1$I$$20240709$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091635$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852501$24185250$1$I$$20240712$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091645$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852511$24185251$1$I$20240101$20240608$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091648$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852521$24185252$1$I$$20240704$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091644$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852531$24185253$1$I$$20240705$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091631$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852541$24185254$1$I$$20240607$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091647$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852551$24185255$1$I$$20240704$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091584$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852561$24185256$1$I$$20240611$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091660$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852571$24185257$1$I$$20240613$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091704$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852581$24185258$1$I$$20240531$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091321$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852591$24185259$1$I$$20240516$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090297$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852601$24185260$1$I$$20240705$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090952$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852611$24185261$1$I$20240516$20240516$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090948$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852621$24185262$1$I$$20240705$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091633$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852631$24185263$1$I$$20240628$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091248$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852641$24185264$1$I$$20240711$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091681$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852651$24185265$1$I$$20240611$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091658$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852661$24185266$1$I$$20240711$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091805$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852671$24185267$1$I$20230404$20240713$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091705$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852681$24185268$1$I$$20240717$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091764$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852691$24185269$1$I$$20240611$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091646$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852701$24185270$1$I$$20240605$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091640$GLENMARK$$$$$$Y$$$20240807$$HP$US$US
241852711$24185271$1$I$$20240612$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091701$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852721$24185272$1$I$$20240711$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091661$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852731$24185273$1$I$20240610$20240712$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091682$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852741$24185274$1$I$20240507$20240713$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091702$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852751$24185275$1$I$$20240625$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091885$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852761$24185276$1$I$$20240701$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092331$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852771$24185277$1$I$$20240713$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091703$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852781$24185278$1$I$$20240724$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091950$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852791$24185279$1$I$$20240702$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092162$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852801$24185280$1$I$$20240628$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091787$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852811$24185281$1$I$$20240709$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092289$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852821$24185282$1$I$$20240725$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091963$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852831$24185283$1$I$$20240703$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092204$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852841$24185284$1$I$$20240718$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091767$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852851$24185285$1$I$$20240622$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091925$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852861$24185286$1$I$20240620$20240712$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091872$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852871$24185287$1$I$$20240715$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091765$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852881$24185288$1$I$$20240718$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091693$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852891$24185289$1$I$$20240717$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091874$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852901$24185290$1$I$$20240620$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091859$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852911$24185291$1$I$$20240718$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091876$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852921$24185292$1$I$$20240715$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091696$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852931$24185293$1$I$$20240703$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092269$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852941$24185294$1$I$20230901$20240731$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092143$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852951$24185295$1$I$$20240705$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092264$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852961$24185296$1$I$$20240702$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092099$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241852971$24185297$1$I$20240617$20240710$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091806$GLENMARK$$$$$$Y$$$20240807$$HP$US$US
241852981$24185298$1$I$$20240619$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091865$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241852991$24185299$1$I$20240628$20240705$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092281$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853001$24185300$1$I$$20240708$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092272$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241853011$24185301$1$I$$20240709$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092422$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853021$24185302$1$I$20240101$20240620$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091014$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241853031$24185303$1$I$$20240705$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092270$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853041$24185304$1$I$$20240415$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090266$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853051$24185305$1$I$20240101$20240606$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091144$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853061$24185306$1$I$$20240628$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092090$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853071$24185307$1$I$$20240723$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091901$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241853081$24185308$1$I$$20240725$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092017$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241853091$24185309$1$I$$20240724$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091943$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853101$24185310$1$I$$20240725$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092011$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241853111$24185311$1$I$$20240624$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091917$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853121$24185312$1$I$$20240621$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091962$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241853131$24185313$1$I$20230922$20240621$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090405$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853141$24185314$1$I$20230611$20240717$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091945$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853151$24185315$1$I$$20240725$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092098$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241853161$24185316$1$I$$20240726$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092013$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853171$24185317$1$I$20230611$20240726$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092015$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853181$24185318$1$I$20240607$20240620$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091875$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853191$24185319$1$I$$20240610$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090971$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853201$24185320$1$I$20240709$20240712$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092383$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853211$24185321$1$I$$20240709$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092450$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241853221$24185322$1$I$$20240712$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092451$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853231$24185323$1$I$20240709$20240712$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK093009$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853241$24185324$1$I$$20240710$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092442$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241853251$24185325$1$I$$20240712$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092455$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853261$24185326$1$I$$20240710$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092512$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853271$24185327$1$I$$20240710$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092513$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853281$24185328$1$I$20240709$20240709$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092449$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853291$24185329$1$I$$20240727$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092210$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853301$24185330$1$I$$20240710$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092437$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241853311$24185331$1$I$$20240712$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092550$GLENMARK$$$$$$Y$$$20240807$$CN$US$US
241853321$24185332$1$I$$20240712$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092444$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853331$24185333$1$I$20240101$20240730$20240807$20240807$EXP$$US-TG THERAPEUTICS INC.-TGT003856$TG THERAPEUTICS$$$$$$Y$$$20240807$$HP$US$US
241853341$24185334$1$I$$20240802$20240807$20240807$PER$$US-BAYER-2024A112907$BAYER$$$$$F$Y$$$20240807$$CN$US$US
241853351$24185335$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5867968$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241853361$24185336$1$I$$20240801$20240807$20240807$PER$$US-BAYER-2024A112405$BAYER$$16$YR$T$F$Y$$$20240807$$HP$US$US
241853371$24185337$1$I$$20240709$20240807$20240807$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092511$GLENMARK$$$$$$Y$$$20240807$$PH$US$US
241853381$24185338$1$I$20210317$20240802$20240807$20240807$EXP$$FR-AMGEN-FRANI2024154654$AMGEN$$50$YR$A$F$Y$126$KG$20240807$$MD$FR$FR
241853402$24185340$2$F$$20240916$20240807$20240917$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044232$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240917$$CN$US$US
241853411$24185341$1$I$$20240730$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121646$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240807$$HP$US$US
241853421$24185342$1$I$$20240805$20240807$20240807$EXP$GB-MHRA-TPP17742326C576475YC1722345779072$GB-ORGANON-O2408GBR000514$ORGANON$$56$YR$$M$Y$125$KG$20240807$$HP$GB$GB
241853431$24185343$1$I$$20240806$20240807$20240807$EXP$$CN-TAKEDA-2024TUS078972$TAKEDA$$$$$M$Y$$$20240807$$CN$CN$CN
241853441$24185344$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124905$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240807$$HP$US$US
241853451$24185345$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124982$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240807$$HP$US$US
241853461$24185346$1$I$20240722$20240801$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122877$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240807$$PH$US$US
241853471$24185347$1$I$20240726$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124195$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$93.44$KG$20240807$$HP$US$US
241853481$24185348$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5761194$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241853492$24185349$2$F$20200101$20240828$20240807$20240830$PER$$NVSC2024US160477$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
241853501$24185350$1$I$$20240803$20240807$20240807$EXP$$JP-009507513-2408JPN000343J$MERCK$$$$$F$Y$$$20240807$$MD$JP$JP
241853512$24185351$2$F$$20240904$20240807$20240904$PER$$US-ALXN-202408USA000050US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
241853521$24185352$1$I$$20240730$20240807$20240807$PER$$US-SA-2024SA230810$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$MD$US$US
241853531$24185353$1$I$20240101$20240729$20240807$20240807$PER$$US-SA-2024SA229884$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240807$$CN$US$US
241853541$24185354$1$I$20240101$20240730$20240807$20240807$PER$$US-SA-2024SA229303$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240807$$MD$US$US
241853551$24185355$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA230800$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$MD$US$US
241853561$24185356$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA229841$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240807$$MD$US$US
241853571$24185357$1$I$20240728$20240729$20240807$20240807$PER$$US-SA-2024SA227726$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240807$$MD$US$US
241853582$24185358$2$F$20240722$20240731$20240807$20240809$PER$$US-SA-2024SA226932$SANOFI AVENTIS$$59$YR$A$F$Y$151.9$KG$20240809$$MD$US$US
241853591$24185359$1$I$20240602$20240731$20240807$20240807$EXP$$JP-BAYER-2024A082288$BAYER$$5$DEC$A$F$Y$$$20240807$$HP$JP$JP
241853601$24185360$1$I$20240801$20240802$20240807$20240807$PER$$US-PFIZER INC-202400229778$PFIZER$$74$YR$$M$Y$$$20240807$$CN$US$US
241853611$24185361$1$I$$20240806$20240807$20240807$PER$$US-PFIZER INC-202400231938$PFIZER$$78$YR$$F$Y$$$20240807$$HP$US$US
241853621$24185362$1$I$$20240805$20240807$20240807$PER$$US-PFIZER INC-PV202400102321$PFIZER$$56$YR$$F$Y$$$20240807$$CN$US$US
241853631$24185363$1$I$20240501$20240805$20240807$20240807$PER$$US-PFIZER INC-PV202400102326$PFIZER$$69$YR$$F$Y$$$20240807$$HP$US$US
241853641$24185364$1$I$20220101$20240804$20240807$20240807$PER$$US-PFIZER INC-PV202400101486$PFIZER$$54$YR$$F$Y$$$20240807$$CN$US$US
241853651$24185365$1$I$$20240805$20240807$20240807$PER$$US-PFIZER INC-202400231562$PFIZER$$$$$$Y$$$20240807$$HP$US$US
241853661$24185366$1$I$20240729$20240803$20240807$20240807$PER$$US-PFIZER INC-202400229742$PFIZER$$69$YR$$M$Y$$$20240807$$CN$US$US
241853671$24185367$1$I$20240701$20240806$20240807$20240807$EXP$FR-AFSSAPS-NT2024000981$FR-TAKEDA-2024TUS078879$TAKEDA$$68$YR$$M$Y$85$KG$20240807$$HP$FR$FR
241853681$24185368$1$I$20240125$20240715$20240807$20240807$EXP$SE-SEMPA-2024-004586$SE-TAKEDA-2024TUS078045$TAKEDA$$46$YR$$M$Y$$$20240807$$HP$SE$SE
241853691$24185369$1$I$$20240805$20240807$20240807$EXP$$AU-ASTELLAS-2024US022298$ASTELLAS$$32$YR$$F$Y$$$20240807$$CN$AU$AU
241853701$24185370$1$I$20240807$20240807$20240807$20240807$DIR$713306$$FDA-CTU$$66$YR$$M$N$$$20240807$$CN$US$
241853711$24185371$1$I$$20240807$20240807$20240807$EXP$$US-Imprimis NJOF, LLC-2160145$IMPRIMIS PHARMACEUTICALS, INC. - COMPOUNDING$$$$$M$Y$$$20240807$$$US$US
241853721$24185372$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125007$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240807$$CN$US$US
241853732$24185373$2$F$20240701$20240830$20240807$20240909$EXP$$US-Rigel Pharmaceuticals, Inc.-20240800007$RIGEL PHARMACEUTICALS$$42$YR$$F$Y$$$20240909$$CN$US$US
241853741$24185374$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124532$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240807$$HP$US$US
241853751$24185375$1$I$20240310$20240802$20240807$20240807$EXP$FR-AFSSAPS-AN2024000995$FR-GSK-FR2024096868$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$MD$FR$FR
241853761$24185376$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA231809$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240807$$MD$US$US
241853771$24185377$1$I$20240117$20240802$20240807$20240807$PER$$US-SA-2024SA233599$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240807$$MD$US$US
241853781$24185378$1$I$$20240729$20240807$20240807$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700117$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241853793$24185379$3$F$$20240813$20240807$20240827$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044098$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240827$$CN$DE$DE
241853801$24185380$1$I$$20240802$20240807$20240807$EXP$NO-NOMAADVRE-RELISSO-2024-Vdkg8d$NO-GSK-NO2024096849$GLAXOSMITHKLINE$$$$$$Y$$$20240807$$PH$NO$NO
241853811$24185381$1$I$$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123293$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240807$$PH$US$US
241853821$24185382$1$I$$20240730$20240807$20240807$PER$$US-MYLANLABS-2024M1071935$MYLAN$$$$$M$Y$$$20240807$$CN$US$US
241853831$24185383$1$I$20231201$20240729$20240807$20240807$EXP$FR-AFSSAPS-AN2024000916$FR-TEVA-VS-3227509$TEVA$$74$YR$$$Y$$$20240807$$MD$FR$FR
241853841$24185384$1$I$$20240801$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002199$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240807$$CN$US$US
241853851$24185385$1$I$$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002123$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240807$$CN$US$US
241853861$24185386$1$I$20240802$20240802$20240807$20240807$PER$$NVSC2024US160924$NOVARTIS$$72$YR$$$Y$$$20240807$$CN$US$US
241853872$24185387$2$F$20240805$20240807$20240807$20240808$PER$$US-AMGEN-USASP2024155632$AMGEN$$64$YR$A$F$Y$$$20240808$$CN$US$US
241853881$24185388$1$I$20240807$20240807$20240807$20240807$DIR$713305$$FDA-CTU$$66$YR$$F$N$$$20240807$N$HP$US$
241853891$24185389$1$I$20240807$20240807$20240807$20240807$DIR$713307$$FDA-CTU$$75$YR$$F$N$75.15$KG$20240807$N$HP$US$
241853901$24185390$1$I$$20240807$20240807$20240807$DIR$713312$$FDA-CTU$$$$$UNK$N$$$20240807$N$CN$US$
241853921$24185392$1$I$$20240805$20240807$20240807$EXP$$GB-SANDOZ INC.-SDZ2024GB064363$SANDOZ$$$$$M$Y$$$20240807$$CN$GB$GB
241853931$24185393$1$I$20240627$20240802$20240807$20240807$EXP$$CN-MYLANLABS-2024M1072874$MYLAN$$59$YR$$M$Y$80$KG$20240807$$HP$CN$CN
241853942$24185394$2$F$$20240917$20240807$20240918$PER$$NVSC2024US160925$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
241853951$24185395$1$I$20240701$20240802$20240807$20240807$EXP$$US-Eisai-EC-2024-171425$EISAI$$76$YR$E$M$Y$$$20240807$$CN$US$US
241853961$24185396$1$I$20240801$20240802$20240807$20240807$PER$$US-Eisai-EC-2024-171494$EISAI$$64$YR$A$M$Y$$$20240807$$PH$US$US
241853991$24185399$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124890$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240807$$CN$US$US
241854001$24185400$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124841$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240807$$CN$US$US
241854012$24185401$2$F$$20240826$20240807$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124011$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240904$$CN$US$US
241854021$24185402$1$I$20240701$20240731$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124256$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240807$$PH$US$US
241854031$24185403$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124728$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$52.16$KG$20240807$$CN$US$US
241854041$24185404$1$I$$20240730$20240807$20240807$PER$$US-ABBVIE-5861040$ABBVIE$$$$A$$Y$$$20240807$$CN$US$US
241854052$24185405$2$F$$20240805$20240807$20240813$EXP$$US-SANDOZ INC.-SDZ2024US070888$SANDOZ$$$$$M$Y$$$20240813$$CN$US$US
241854061$24185406$1$I$$20240805$20240807$20240807$30DAY$$US-SANDOZ INC.-SDZ2024US057590$SANDOZ$$$$$F$Y$$$20240807$$CN$US$US
241854071$24185407$1$I$$20240806$20240807$20240807$EXP$$US-SANDOZ INC.-SDZ2024US071099$SANDOZ$$$$$$Y$$$20240807$$CN$US$US
241854081$24185408$1$I$$20240726$20240807$20240807$EXP$$AU-PERRIGO-24AU007354$PERRIGO$Dhaliwal N, Roberts DM. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clin-Toxicol-(Phila) 2024; 0 (0): 1-6$$$$$Y$$$20240807$$HP$AU$AU
241854091$24185409$1$I$$20240726$20240807$20240807$EXP$AU-TGA-0000811977$AU-PERRIGO-24AU007101$PERRIGO$$23$YR$$F$Y$$$20240807$$CN$AU$AU
241854101$24185410$1$I$20240520$20240726$20240807$20240807$EXP$AU-TGA-0000812395$AU-PERRIGO-24AU007099$PERRIGO$$42$YR$$F$Y$$$20240807$$HP$AU$AU
241854111$24185411$1$I$$20240726$20240807$20240807$EXP$$AU-PERRIGO-24AU007352$PERRIGO$Dhaliwal N, Roberts DM. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clin-Toxicol-(Phila) 2024; 0 (0): 1-6$$$$$Y$$$20240807$$HP$AU$AU
241854121$24185412$1$I$20240601$20240726$20240807$20240807$EXP$AU-TGA-0000811667$AU-PERRIGO-24AU007075$PERRIGO$$20$YR$$F$Y$$$20240807$$HP$AU$AU
241854131$24185413$1$I$$20240726$20240807$20240807$EXP$AU-MYLANLABS-2024M1055056$AU-PERRIGO-24AU007344$PERRIGO$Dhaliwal N, Roberts DM. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clin-Toxicol-(Phila) 2024; 0 (0): 1-6.$$$$$Y$$$20240807$$HP$AU$AU
241854151$24185415$1$I$$20220311$20240807$20240807$EXP$$US-AstraZeneca-2022A111871$ASTRAZENECA$$$$$F$Y$$$20240807$$CN$US$
241854161$24185416$1$I$$20240729$20240807$20240807$PER$$US-MYLANLABS-2024M1071238$MYLAN$$$$$M$Y$113.4$KG$20240807$$CN$US$US
241854171$24185417$1$I$20240804$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124432$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$99.79$KG$20240807$$CN$US$US
241854181$24185418$1$I$$20240802$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123943$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240807$$CN$US$US
241854191$24185419$1$I$20240806$20240806$20240807$20240807$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-124835$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$66.68$KG$20240807$$CN$PR$PR
241854201$24185420$1$I$20210101$20240729$20240807$20240807$EXP$$RU-AMGEN-RUSSP2024151024$AMGEN$Teremov D.D.; Rumyantsev V.A.. Management strategy of a periodontist in treating a patient with bisphosphonate- related jaw osteonecrosis: a clinical case. PARODONTOLOGIYA. 2024;29 (2):163-169$48$YR$A$F$Y$$$20240807$$HP$RU$RU
241854212$24185421$2$F$20240726$20240808$20240807$20240819$EXP$GB-MHRA-TPP27735692C23117855YC1722010764663$GB-PERRIGO-24GB007187$PERRIGO$$29$YR$$F$Y$78$KG$20240819$$MD$GB$GB
241854221$24185422$1$I$20240731$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155404$AMGEN$$82$YR$E$M$Y$$$20240807$$CN$US$US
241854231$24185423$1$I$20240701$20240802$20240807$20240807$EXP$$US-KARYOPHARM-2024KPT001391$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240807$$CN$US$US
241854241$24185424$1$I$$20240725$20240807$20240807$PER$$US-009507513-2407USA014515$MERCK$Sikora A, Johnson J, Velez A, Greene J. Invasive phaeohyphomycosis co-infection with Alternaria spp. and Curvularia spp. in a neutropenic host. Journal of Medical Mycology. 2024;34:101497$35$YR$$M$Y$$$20240807$$HP$US$US
241854251$24185425$1$I$20240507$20240729$20240807$20240807$EXP$FR-AFSSAPS-RN2024000776$FR-SA-2024SA217537$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240807$$MD$FR$FR
241854261$24185426$1$I$20210101$20240726$20240807$20240807$EXP$AU-ASPEN-AUS2024AU003585$AU-PERRIGO-24AU007074$PERRIGO$Hawkes C, Dale RC, Scher S, Cornish JL, Perez DL et.al. Bridging the Divide: An Integrated Neurobio-Psycho-Social Approach to Treating Antibody Negative Inflammatory Encephalitis in a School-Aged Child. Harvard Review of Psychiatry. 2024;32(3):101-116$10$YR$$F$Y$$$20240807$$HP$AU$AU
241854271$24185427$1$I$20240717$20240731$20240807$20240807$EXP$$CN-PURDUE-USA-2024-0311186$PURDUE$$73$YR$$M$Y$70$KG$20240807$$HP$CN$CN
241854281$24185428$1$I$20240722$20240802$20240807$20240807$EXP$$CN-PURDUE-USA-2024-0311195$PURDUE$$69$YR$$M$Y$49$KG$20240807$$HP$CN$CN
241854291$24185429$1$I$20240709$20240806$20240807$20240807$EXP$FR-AFSSAPS-AM2024000618$FR-PURDUE-USA-2024-0311184$PURDUE$$90$YR$$F$Y$52$KG$20240807$$PH$FR$FR
241854301$24185430$1$I$$20240802$20240807$20240807$EXP$$CA-PURDUE-USA-2024-0311193$PURDUE$Garneau B, Roy C, Motard J, Desharnais B, Bouchard C ,Mireault P.. Atypical postmortem redistribution in chronic methadone consumers. Journal of Analytical Toxicology. 2024;48:5:343-349$36$YR$$M$Y$$$20240807$$HP$CA$CA
241854321$24185432$1$I$$20240805$20240807$20240807$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044261$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240807$$CN$US$US
241854332$24185433$2$F$$20240920$20240807$20240924$EXP$$CA-SANDOZ INC.-SDZ2023CA004553$SANDOZ$$$$$F$Y$$$20240924$$CN$CA$CA
241854341$24185434$1$I$$20240731$20240807$20240807$EXP$GB-MHRA-TPP45639031C7229749YC1722333009276$GB-PERRIGO-24GB007211$PERRIGO$$32$YR$$F$Y$$$20240807$$MD$GB$GB
241854351$24185435$1$I$$20240731$20240807$20240807$EXP$GB-MHRA-31372440$GB-PERRIGO-24GB007209$PERRIGO$$86$YR$$M$Y$$$20240807$$PH$GB$GB
241854361$24185436$1$I$20240723$20240806$20240807$20240807$EXP$$JP-ABBVIE-5857654$ABBVIE$$80$YR$$F$Y$$$20240807$$MD$JP$JP
241854371$24185437$1$I$$20240725$20240807$20240807$PER$$US-MEDICUREINC-2024USSPO00031$MEDICURE$$$$A$M$Y$$$20240807$$HP$US$US
241854392$24185439$2$F$20240101$20240806$20240807$20240812$EXP$$US-PFIZER INC-PV202300009011$PFIZER$$69$YR$$F$Y$128.82$KG$20240812$$CN$US$US
241854402$24185440$2$F$20240731$20240811$20240807$20240819$PER$$US-PFIZER INC-202400229775$PFIZER$$54$YR$$F$Y$$$20240819$$HP$US$US
241854411$24185441$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA230416$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240807$$MD$US$US
241854421$24185442$1$I$20240701$20240730$20240807$20240807$PER$$US-SA-2024SA230663$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240807$$MD$US$US
241854431$24185443$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA229395$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240807$$CN$US$US
241854441$24185444$1$I$20240701$20240729$20240807$20240807$PER$$US-SA-2024SA229378$SANOFI AVENTIS$$27$YR$A$M$Y$68$KG$20240807$$MD$US$US
241854451$24185445$1$I$$20240801$20240807$20240807$PER$$US-SA-2024SA229709$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240807$$MD$US$US
241854461$24185446$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA229034$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240807$$CN$US$US
241854472$24185447$2$F$20240701$20240821$20240807$20240905$PER$$US-SA-2024SA229682$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240905$$MD$US$US
241854481$24185448$1$I$20240801$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002231$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240807$$CN$US$US
241854491$24185449$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003170$ELI LILLY AND CO$$52$YR$A$$Y$$$20240807$$CN$US$US
241854501$24185450$1$I$20240730$20240801$20240807$20240807$PER$$US-PFIZER INC-202400228421$PFIZER$$77$YR$$F$Y$74.84$KG$20240807$$CN$US$US
241854511$24185451$1$I$$20240806$20240807$20240807$PER$$US-HALEON-2190730$Haleon PLC$$$$$$Y$$$20240807$$CN$US$US
241854521$24185452$1$I$20240101$20240805$20240807$20240807$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043939$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240807$$MD$US$US
241854531$24185453$1$I$20240710$20240806$20240807$20240807$EXP$$US-BEH-2024176916$CSL BEHRING$$28$YR$A$M$Y$$$20240807$$HP$US$US
241854541$24185454$1$I$$20240805$20240807$20240807$EXP$$EG-SANDOZ INC.-SDZ2024EG069816$SANDOZ$$$$$F$Y$$$20240807$$CN$EG$EG
241854551$24185455$1$I$$20240731$20240807$20240807$PER$$US-ABBVIE-5863087$ABBVIE$$$$$$Y$$$20240807$$CN$US$US
241854561$24185456$1$I$$20240805$20240807$20240807$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-124826$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240807$$PH$JP$JP
241854571$24185457$1$I$20240624$20240801$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123045$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240807$$PH$US$US
241854581$24185458$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124886$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240807$$HP$US$US
241854591$24185459$1$I$$20240802$20240807$20240807$EXP$$SG-JNJFOC-20240813232$JOHNSON AND JOHNSON$$80$YR$E$$Y$$$20240807$$HP$SG$SG
241854603$24185460$3$F$$20240917$20240807$20240920$30DAY$$US-PFIZER INC-202400229499$PFIZER$$$$$$Y$$$20240920$$CN$US$US
241854632$24185463$2$F$$20240808$20240807$20240808$30DAY$$US-PFIZER INC-202400227079$PFIZER$$$$$$Y$$$20240808$$CN$US$US
241854641$24185464$1$I$$20240802$20240807$20240807$EXP$$CA-PFIZER INC-202400230397$PFIZER$$73$YR$$F$Y$$$20240807$$HP$CA$CA
241854653$24185465$3$F$20240701$20240911$20240807$20240911$30DAY$$US-PFIZER INC-202400227163$PFIZER$$11$YR$$F$Y$$$20240911$$CN$US$US
241854662$24185466$2$F$$20240907$20240807$20240909$30DAY$$US-PFIZER INC-202400229422$PFIZER$$17$YR$$F$Y$$$20240909$$CN$US$US
241854671$24185467$1$I$20240122$20240805$20240807$20240807$EXP$IT-MINISAL02-997064$IT-PFIZER INC-202400229876$PFIZER$$30$YR$$M$Y$72$KG$20240807$$PH$IT$IT
241854681$24185468$1$I$20240731$20240731$20240807$20240807$30DAY$$CO-PFIZER INC-202400229105$PFIZER$$$$$F$Y$$$20240807$$MD$CO$CO
241854691$24185469$1$I$20220601$20240803$20240807$20240807$EXP$$IN-PFIZER INC-PV202300017717$PFIZER$$65$YR$$F$Y$52$KG$20240807$$CN$IN$IN
241854701$24185470$1$I$$20240806$20240807$20240807$EXP$FR-AFSSAPS-PV2024000590$FR-SANDOZ INC.-SDZ2024FR070871$SANDOZ$$1$DY$$M$Y$0.79$KG$20240807$$HP$FR$FR
241854711$24185471$1$I$20200101$20240801$20240807$20240807$EXP$FR-AFSSAPS-AN2024000957$FR-MYLANLABS-2024M1072362$MYLAN$$62$YR$$M$Y$$$20240807$$MD$FR$FR
241854721$24185472$1$I$20240514$20240801$20240807$20240807$EXP$FR-AFSSAPS-AVLY2024000117$FR-MYLANLABS-2024M1072138$MYLAN$$23$YR$$F$Y$$$20240807$$MD$FR$FR
241854732$24185473$2$F$$20240917$20240807$20240920$EXP$$ES-MYLANLABS-2024M1072504$MYLAN$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transpl Infect Dis. 2024;26(3):e14276$$$C$F$Y$$$20240920$$MD$ES$ES
241854741$24185474$1$I$20240601$20240801$20240807$20240807$EXP$CZ-CZSUKL-24002134$CZ-MYLANLABS-2024M1072066$MYLAN$$71$YR$$F$Y$69$KG$20240807$$CN$CZ$CZ
241854751$24185475$1$I$20240709$20240802$20240807$20240807$EXP$$NL-MYLANLABS-2024M1072442$MYLAN$$63$YR$$M$Y$$$20240807$$MD$NL$NL
241854762$24185476$2$F$20240229$20240807$20240807$20240813$EXP$$ES-MYLANLABS-2024M1072309$MYLAN$$75$YR$$F$Y$$$20240813$$CN$ES$ES
241854772$24185477$2$F$20240322$20240905$20240807$20240911$EXP$FR-AFSSAPS-AN2024000940$FR-MYLANLABS-2024M1072408$MYLAN$$84$YR$$M$Y$70$KG$20240911$$MD$FR$FR
241854781$24185478$1$I$20240208$20240801$20240807$20240807$EXP$FR-AFSSAPS-AN2024000952$FR-MYLANLABS-2024M1072398$MYLAN$$77$YR$$M$Y$82$KG$20240807$$PH$FR$FR
241854791$24185479$1$I$$20240806$20240807$20240807$PER$$US-ABBVIE-5870785$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241854801$24185480$1$I$$20240730$20240807$20240807$EXP$$IN-AstraZeneca-2024A175243$ASTRAZENECA$$66$YR$$F$Y$55$KG$20240807$$CN$IN$
241854811$24185481$1$I$20240601$20240730$20240807$20240807$EXP$$CN-AstraZeneca-2024A175254$ASTRAZENECA$$52$YR$$F$Y$$$20240807$$MD$CN$
241854821$24185482$1$I$$20240725$20240807$20240807$EXP$$US-SMPA-2024SPA000168$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241854831$24185483$1$I$$20240725$20240807$20240807$EXP$$US-SMPA-2024SPA000167$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241854851$24185485$1$I$20240530$20240730$20240807$20240807$EXP$$CN-AstraZeneca-2024A175281$ASTRAZENECA$$28056$DY$$F$Y$65$KG$20240807$$MD$CN$
241854861$24185486$1$I$$20240725$20240807$20240807$EXP$$US-SMPA-2024SPA000179$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241854881$24185488$1$I$20240708$20240802$20240807$20240807$EXP$$SG-JNJFOC-20240812811$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240807$$HP$SG$SG
241854891$24185489$1$I$$20240725$20240807$20240807$EXP$$US-SMPA-2024SPA000176$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241854901$24185490$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124104$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240807$$CN$US$US
241854911$24185491$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124124$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240807$$CN$US$US
241854921$24185492$1$I$$20240802$20240807$20240807$EXP$$US-AMGEN-USASP2024154672$AMGEN$$$$$$Y$$$20240807$$MD$US$US
241854931$24185493$1$I$$20240728$20240807$20240807$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007296$AEGERION$$$$$M$Y$$$20240807$$CN$US$US
241854942$24185494$2$F$20190918$20240826$20240807$20240830$EXP$$PL-MYLANLABS-2024M1071910$MYLAN$$62$YR$$M$Y$98$KG$20240830$$MD$PL$PL
241854951$24185495$1$I$20240101$20240801$20240807$20240807$PER$$US-ABBVIE-5864351$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241854961$24185496$1$I$$20240709$20240807$20240807$PER$$US-009507513-2407USA004419$MERCK$$$$$F$Y$$$20240807$$CN$US$US
241854991$24185499$1$I$$20240804$20240807$20240807$EXP$$US-BAYER-2024A112861$BAYER$$$$$$Y$$$20240807$$CN$US$US
241855001$24185500$1$I$$20240807$20240807$20240807$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044358$BOEHRINGER INGELHEIM$$$$$$Y$$$20240807$$CN$US$US
241855011$24185501$1$I$20240101$20240729$20240807$20240807$EXP$$CA-APOTEX-2024AP008978$APOTEX$$$$T$M$Y$106$KG$20240807$$PH$CA$CA
241855021$24185502$1$I$20240501$20240723$20240807$20240807$PER$$US-JNJFOC-20240767124$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240807$$CN$US$US
241855031$24185503$1$I$20240501$20240611$20240807$20240807$PER$$US-JNJFOC-20240815825$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240807$$PH$US$US
241855041$24185504$1$I$20240101$20240729$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-023496$UNITED THERAPEUTICS$$$$$M$Y$83.9$KG$20240807$$$US$US
241855053$24185505$3$F$20240101$20240802$20240807$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023579$UNITED THERAPEUTICS$$$$$F$Y$$$20240810$$$US$US
241855061$24185506$1$I$20240701$20240726$20240807$20240807$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15057$IPSEN$$$$$F$Y$$$20240807$$HP$US$US
241855071$24185507$1$I$$20240729$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-023526$UNITED THERAPEUTICS$$$$$F$Y$50.794$KG$20240807$$$US$US
241855081$24185508$1$I$$20240731$20240807$20240807$PER$$US-BAYER-2024A111297$BAYER$$69$YR$E$F$Y$$$20240807$$CN$US$US
241855091$24185509$1$I$$20240803$20240807$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011924$JAZZ$$$$$M$Y$$$20240807$$CN$US$US
241855101$24185510$1$I$$20240729$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-023487$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240807$$$US$US
241855112$24185511$2$F$20240101$20240801$20240807$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-023502$UNITED THERAPEUTICS$$$$$F$Y$118.37$KG$20240809$$$US$US
241855121$24185512$1$I$$20240729$20240807$20240807$EXP$$DK-TEVA-VS-3229217$TEVA$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic-Sci-Int 2009; 184 (1-3): 74-79.$48$YR$$F$Y$$$20240807$$HP$DK$DK
241855131$24185513$1$I$20240101$20240729$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-023543$UNITED THERAPEUTICS$$$$$F$Y$69.388$KG$20240807$$$US$US
241855151$24185515$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160448$NOVARTIS$$$$$M$Y$$$20240807$$CN$US$US
241855161$24185516$1$I$$20240802$20240807$20240807$EXP$$GB-AMGEN-GBRSL2024155534$AMGEN$$58$YR$A$M$Y$$$20240807$$CN$GB$GB
241855171$24185517$1$I$20240701$20240730$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-023655$UNITED THERAPEUTICS$$83$YR$$M$Y$78.458$KG$20240807$$$US$US
241855181$24185518$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002661$ELI LILLY AND CO$$65$YR$E$$Y$$$20240807$$CN$US$US
241855191$24185519$1$I$20240730$20240803$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003050$ELI LILLY AND CO$$31$YR$A$M$Y$$$20240807$$CN$US$US
241855201$24185520$1$I$20240101$20240730$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-023709$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240807$$$US$US
241855211$24185521$1$I$20240804$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003182$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240807$$CN$US$US
241855221$24185522$1$I$$20240731$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002654$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240807$$CN$US$US
241855231$24185523$1$I$$20240627$20240807$20240807$EXP$$BE-AstraZeneca-2024A178547$ASTRAZENECA$$$$$M$Y$$$20240807$$MD$BE$
241855241$24185524$1$I$20240624$20240801$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-023808$UNITED THERAPEUTICS$$68$YR$$$Y$$$20240807$$$US$US
241855251$24185525$1$I$20240724$20240801$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-023872$UNITED THERAPEUTICS$$68$YR$$M$Y$$$20240807$$$US$US
241855271$24185527$1$I$20240329$20240731$20240807$20240807$PER$$US-Eisai-EC-2024-171327$EISAI$$67$YR$E$F$Y$$$20240807$$MD$US$US
241855291$24185529$1$I$$20240730$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-012605$UNITED THERAPEUTICS$$$$$M$Y$63.492$KG$20240807$$$US$US
241855301$24185530$1$I$$20240731$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-023877$UNITED THERAPEUTICS$$$$$F$Y$62.857$KG$20240807$$$US$US
241855311$24185531$1$I$$20240805$20240807$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012014$JAZZ$$$$$F$Y$$$20240807$$CN$US$US
241855322$24185532$2$F$20240731$20240913$20240807$20240920$EXP$$JP-009507513-2407JPN005661J$MERCK$$40$YR$$F$Y$$$20240920$$MD$JP$JP
241855331$24185533$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124956$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240807$$HP$US$US
241855341$24185534$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124184$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240807$$CN$US$US
241855351$24185535$1$I$20170101$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123107$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240807$$HP$US$US
241855363$24185536$3$F$20240101$20240910$20240807$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-023912$UNITED THERAPEUTICS$$$$$M$Y$79.365$KG$20240917$$$US$US
241855372$24185537$2$F$20240101$20240815$20240807$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-021648$UNITED THERAPEUTICS$$$$$M$Y$74.83$KG$20240823$$$US$US
241855381$24185538$1$I$20240726$20240806$20240807$20240807$PER$$PR-JNJFOC-20240816693$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20240807$$CN$PR$PR
241855391$24185539$1$I$$20240806$20240807$20240807$EXP$$GB-MYLANLABS-2024M1069345$MYLAN$$$$$M$Y$71.4$KG$20240807$$PH$GB$GB
241855401$24185540$1$I$$20240731$20240807$20240807$EXP$$US-ALKERMES INC.-ALK-2024-002037$ALKERMES$$$$$F$Y$$$20240807$$HP$US$US
241855411$24185541$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA229677$SANOFI AVENTIS$$$$A$F$Y$$$20240807$$MD$US$US
241855431$24185543$1$I$$20240729$20240807$20240807$PER$$US-SA-2024SA229360$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240807$$MD$US$US
241855442$24185544$2$F$20240701$20240805$20240807$20240814$PER$$US-SA-2024SA227064$SANOFI AVENTIS$$$$$F$Y$$$20240814$$CN$US$US
241855451$24185545$1$I$20240718$20240801$20240807$20240807$EXP$$US-ALKERMES INC.-ALK-2024-002033$ALKERMES$$42$YR$$M$Y$$$20240807$$HP$US$US
241855461$24185546$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA229384$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240807$$MD$US$US
241855471$24185547$1$I$20240701$20240731$20240807$20240807$PER$$US-SA-2024SA229285$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240807$$MD$US$US
241855482$24185548$2$F$$20240814$20240807$20240828$PER$$US-SA-2024SA229737$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240828$$MD$US$US
241855491$24185549$1$I$20240727$20240729$20240807$20240807$PER$$US-SA-2024SA229374$SANOFI AVENTIS$$66$YR$E$F$Y$135$KG$20240807$$MD$US$US
241855503$24185550$3$F$20240801$20240807$20240807$20240816$EXP$$US-BAYER-2024A110103$BAYER$$66$YR$E$M$Y$68.027$KG$20240816$$CN$US$US
241855511$24185551$1$I$20240101$20240729$20240807$20240807$PER$$US-SA-2024SA229344$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240807$$MD$US$US
241855521$24185552$1$I$$20240729$20240807$20240807$EXP$$DK-TEVA-VS-3229218$TEVA$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic-Sci-Int 2009; 184 (1-3): 74-79.$53$YR$$M$Y$$$20240807$$HP$DK$DK
241855531$24185553$1$I$20240705$20240729$20240807$20240807$EXP$PT-INFARMED-B202407-175$PT-TEVA-VS-3227763$TEVA$$41$YR$$M$Y$$$20240807$$MD$PT$PT
241855542$24185554$2$F$$20240830$20240807$20240905$EXP$$JP-009507513-2407JPN005524J$MERCK$$94$YR$$M$Y$$$20240905$$PH$JP$JP
241855552$24185555$2$F$$20240805$20240807$20240809$30DAY$$AR-PFIZER INC-202400225920$PFIZER$$12$YR$$M$Y$$$20240809$$HP$AR$AR
241855562$24185556$2$F$20240726$20240729$20240807$20240812$EXP$$BR-MYLANLABS-2024M1071947$MYLAN$$80$YR$$F$Y$70$KG$20240812$$CN$BR$BR
241855571$24185557$1$I$$20240729$20240807$20240807$EXP$$CA-MYLANLABS-2024M1071822$MYLAN$$$$$M$Y$$$20240807$$MD$CA$CA
241855581$24185558$1$I$$20240730$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN007974$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241855591$24185559$1$I$$20240806$20240807$20240807$EXP$$US-KYOWAKIRIN-2024KK018840$KYOWA$$$$$$Y$$$20240807$$HP$US$US
241855612$24185561$2$F$$20240806$20240807$20240809$EXP$$US-PURDUE PHARMA-USA-2024-0311194$PURDUE$$$$$M$Y$$$20240809$$CN$US$US
241855621$24185562$1$I$$20240805$20240807$20240807$EXP$$US-PURDUE PHARMA-USA-2024-0311182$PURDUE$$$$$F$Y$$$20240807$$CN$US$US
241855633$24185563$3$F$$20240821$20240807$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-024028$UNITED THERAPEUTICS$$$$$F$Y$48.98$KG$20240828$$$US$US
241855641$24185564$1$I$20240729$20240730$20240807$20240807$PER$$US-009507513-2407USA015867$MERCK$$68$YR$$F$Y$$$20240807$$CN$US$US
241855651$24185565$1$I$$20240729$20240807$20240807$EXP$$CA-TEVA-VS-3227674$TEVA$$$$$M$Y$$$20240807$$CN$CA$CA
241855661$24185566$1$I$$20240729$20240807$20240807$EXP$$CA-TEVA-VS-3227521$TEVA$$36$YR$$F$Y$$$20240807$$HP$CA$CA
241855671$24185567$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002965$ELI LILLY AND CO$$$$$M$Y$$$20240807$$HP$US$US
241855681$24185568$1$I$$20240801$20240807$20240807$EXP$$US-MYLANLABS-2024M1072818$MYLAN$Hung E, Face C, Yu DH. Is Osimertinib the New Medical ICU Miracle Drug? The Role of Osimertinib in Critical Illness for Patients With Metastatic EGFR Mutated Lung Cancer. Am-J-Respir-Crit-Care-Med 2024; 209.$33$YR$$F$Y$$$20240807$$HP$US$US
241855702$24185570$2$F$$20240828$20240807$20240909$EXP$$US-SMPA-2024SPA000276$SUNOVION$$$$$$Y$$$20240909$$MD$US$US
241855711$24185571$1$I$$20240726$20240807$20240807$EXP$$GB-SMPA-2024SPA000461$SUNOVION$$$$$$Y$$$20240807$$PH$GB$GB
241855721$24185572$1$I$$20240726$20240807$20240807$EXP$$US-SMPA-2024SPA000281$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241855744$24185574$4$F$20240101$20240910$20240807$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-024114$UNITED THERAPEUTICS$$$$$F$Y$54.875$KG$20240917$$$US$US
241855753$24185575$3$F$20240601$20240819$20240807$20240830$EXP$$HU-SMPA-2024SPA000349$SUNOVION$$$$$$Y$$$20240830$$MD$GB$GB
241855762$24185576$2$F$$20240821$20240807$20240904$EXP$$US-SMPA-2024SPA000278$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
241855773$24185577$3$F$$20240828$20240807$20240910$EXP$$US-SMPA-2024SPA000287$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
241855781$24185578$1$I$20240722$20240805$20240807$20240807$EXP$$US-ABBVIE-5868643$ABBVIE$$85$YR$$F$Y$$$20240807$$CN$US$US
241855792$24185579$2$F$$20240823$20240807$20240905$EXP$$US-SMPA-2024SPA000357$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
241855801$24185580$1$I$$20240730$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-002606$UNITED THERAPEUTICS$$$$$M$Y$99.773$KG$20240807$$$US$US
241855811$24185581$1$I$20240502$20240723$20240807$20240807$EXP$$CA-VER-202400360$VERITY PHARMACEUTICALS$$77$YR$E$M$Y$$$20240807$$CN$CA$CA
241855821$24185582$1$I$$20240801$20240807$20240807$EXP$$US-BAUSCHBL-2024BNL031045$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240807$$CN$US$US
241855831$24185583$1$I$20240501$20240611$20240807$20240807$PER$$US-JNJFOC-20240815756$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240807$$PH$US$US
241855841$24185584$1$I$$20240730$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN007973$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241855851$24185585$1$I$$20240723$20240807$20240807$PER$$US-JNJFOC-20240776114$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241855861$24185586$1$I$$20240729$20240807$20240807$PER$$US-BAUSCHBL-2024BNL030812$BAUSCH AND LOMB$$$$$F$Y$$$20240807$$MD$US$US
241855871$24185587$1$I$20240601$20240730$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN007989$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241855881$24185588$1$I$$20240731$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-021337$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240807$$$US$US
241855891$24185589$1$I$20240701$20240806$20240807$20240807$EXP$$US-KYOWAKIRIN-2024KK018832$KYOWA$$$$$$Y$$$20240807$$HP$US$US
241855901$24185590$1$I$$20240730$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN008001$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241855911$24185591$1$I$20240715$20240723$20240807$20240807$EXP$$CA-VER-202400361$VERITY PHARMACEUTICALS$$76$YR$E$M$Y$$$20240807$$CN$CA$CA
241855921$24185592$1$I$$20240730$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN008002$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241855931$24185593$1$I$$20240806$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124780$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240807$$HP$US$US
241855941$24185594$1$I$20240501$20240611$20240807$20240807$PER$$US-JNJFOC-20240815861$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240807$$PH$US$US
241855951$24185595$1$I$20240501$20240611$20240807$20240807$PER$$US-JNJFOC-20240815973$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240807$$PH$US$US
241855962$24185596$2$F$20240501$20240823$20240807$20240902$PER$$US-JNJFOC-20240816042$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240902$$PH$US$US
241855972$24185597$2$F$20240501$20240905$20240807$20240915$PER$$US-JNJFOC-20240816040$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240915$$PH$US$US
241855981$24185598$1$I$20240501$20240611$20240807$20240807$PER$$US-JNJFOC-20240815893$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240807$$PH$US$US
241855991$24185599$1$I$20240501$20240611$20240807$20240807$PER$$US-JNJFOC-20240815976$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240807$$PH$US$US
241856001$24185600$1$I$$20240807$20240807$20240807$PER$$NVSC2024US160929$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241856011$24185601$1$I$20211201$20240801$20240807$20240807$PER$$US-009507513-2408USA000741$MERCK$Majeed U, Li S, Seegobin K, Nassar A, Manochakian R, Zhao Y et al. First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non-Small Cell Lung Adenocarcinoma With a Novel Combination of Temozolomide and Lorlatinib: A Case Report. JTO Clinical and Research Report. 2023;4 (7):100536$58$YR$$M$Y$$$20240807$$MD$US$US
241856022$24185602$2$F$20240701$20240815$20240807$20240826$PER$$US-BAUSCHBL-2024BNL030836$BAUSCH AND LOMB$$61$YR$$F$Y$$$20240826$$CN$US$US
241856041$24185604$1$I$20240101$20240805$20240807$20240807$PER$$US-UNITED THERAPEUTICS-UNT-2024-024290$UNITED THERAPEUTICS$$$$$M$Y$86.168$KG$20240807$$$US$US
241856052$24185605$2$F$20240101$20240805$20240807$20240813$PER$$US-BAUSCHBL-2024BNL030875$BAUSCH AND LOMB$$68$YR$$F$Y$$$20240814$$CN$US$US
241856061$24185606$1$I$20240501$20240611$20240807$20240807$PER$$US-JNJFOC-20240816847$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240807$$PH$US$US
241856091$24185609$1$I$$20240803$20240807$20240807$EXP$$US-INCYTE CORPORATION-2024IN008135$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241856102$24185610$2$F$20240501$20240904$20240807$20240910$PER$$US-JNJFOC-20240816593$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240910$$PH$US$US
241856111$24185611$1$I$20240501$20240611$20240807$20240807$PER$$US-JNJFOC-20240816044$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240807$$PH$US$US
241856121$24185612$1$I$$20240729$20240807$20240807$EXP$$DK-TEVA-VS-3229219$TEVA$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic-Sci-Int 2009; 184 (1-3): 74-79.$25$YR$$M$Y$$$20240807$$HP$DK$DK
241856131$24185613$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160918$NOVARTIS$$$$$$Y$$$20240807$$HP$US$US
241856141$24185614$1$I$20240604$20240805$20240807$20240807$EXP$$JP-ABBVIE-5799458$ABBVIE$$60$YR$$M$Y$$$20240807$$MD$JP$JP
241856151$24185615$1$I$20240517$20240730$20240807$20240807$EXP$DK-DKMA-30735689$DK-TEVA-VS-3228292$TEVA$$70$YR$$M$Y$87$KG$20240807$$MD$DK$DK
241856161$24185616$1$I$20240101$20240731$20240807$20240807$PER$$US-BAUSCHBL-2024BNL031025$BAUSCH AND LOMB$$$$$M$Y$$$20240807$$CN$US$US
241856171$24185617$1$I$$20240801$20240807$20240807$EXP$$US-ABBVIE-5864494$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241856181$24185618$1$I$20240717$20240806$20240807$20240807$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012012$JAZZ$$6$YR$$F$Y$$$20240807$$CN$US$US
241856202$24185620$2$F$20240731$20240816$20240807$20240820$EXP$$US-INCYTE CORPORATION-2024IN008163$INCYTE$$$$$$Y$$$20240820$$CN$US$US
241856211$24185621$1$I$20240701$20240729$20240807$20240807$PER$$US-BAUSCHBL-2024BNL030987$BAUSCH AND LOMB$$81$YR$$F$Y$$$20240807$$CN$US$US
241856221$24185622$1$I$20150131$20240729$20240807$20240807$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407017483$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240807$$CN$AU$AU
241856231$24185623$1$I$$20240726$20240807$20240807$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407017864$ELI LILLY AND CO$$75$YR$E$$Y$$$20240807$$CN$JP$JP
241856242$24185624$2$F$20240528$20240902$20240807$20240916$EXP$$SK-ELI_LILLY_AND_COMPANY-SK202407018205$ELI LILLY AND CO$$51$YR$A$F$Y$75$KG$20240916$$CN$SK$SK
241856251$24185625$1$I$20240301$20240726$20240807$20240807$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202405005795$ELI LILLY AND CO$$57$YR$A$M$Y$100$KG$20240807$$CN$DE$DE
241856261$24185626$1$I$20240726$20240726$20240807$20240807$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407017649$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240807$$CN$JP$JP
241856271$24185627$1$I$20240701$20240801$20240807$20240807$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006342$AURINIA PHARMACEUTICALS$$61$YR$$F$Y$$$20240807$$CN$US$US
241856281$24185628$1$I$$20240806$20240807$20240807$PER$$US-PURDUE-USA-2024-0311180$PURDUE$$$$$F$Y$$$20240807$$PH$US$US
241856291$24185629$1$I$$20240806$20240807$20240807$PER$$US-PURDUE PHARMA-USA-2024-0311191$PURDUE$$$$$M$Y$$$20240807$$CN$US$US
241856301$24185630$1$I$$20240803$20240807$20240807$PER$$US-PURDUE PHARMA-USA-2024-0311178$PURDUE$$$$$M$Y$$$20240807$$CN$US$US
241856311$24185631$1$I$$20240806$20240807$20240807$PER$$US-PURDUE PHARMA-USA-2024-0311181$PURDUE$$46$YR$$F$Y$$$20240807$$CN$US$US
241856321$24185632$1$I$20230105$20240806$20240807$20240807$PER$$US-PURDUE PHARMA-USA-2024-0311179$PURDUE$$48$YR$$M$Y$$$20240807$$CN$US$US
241856331$24185633$1$I$$20240806$20240807$20240807$PER$$US-PURDUE PHARMA-USA-2024-0311185$PURDUE$$$$$$Y$$$20240807$$CN$US$US
241856341$24185634$1$I$$20240731$20240807$20240807$EXP$$NVSC2024TN159223$NOVARTIS$Mhiri M, Dhia RB, Dridi F, Gouta N, Frih-Ayed M. Immune reconstitution inflammatory syndrome after fingolimod cessation. MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023;80(105151):60$51$YR$$F$Y$$$20240807$$HP$TN$TN
241856351$24185635$1$I$20240730$20240730$20240807$20240807$PER$$US-009507513-2407USA015887$MERCK$$$$$$Y$$$20240807$$CN$US$US
241856361$24185636$1$I$$20221004$20240807$20240807$EXP$$FR-JNJFOC-20221009096$JOHNSON AND JOHNSON$$$$A$M$Y$74$KG$20240807$$MD$FR$FR
241856371$24185637$1$I$$20230329$20240807$20240807$EXP$$US-AstraZeneca-2023A075295$ASTRAZENECA$$$$$M$Y$$$20240807$$CN$US$
241856381$24185638$1$I$$20240730$20240807$20240807$PER$$DE-Eisai-EC-2024-171336$EISAI$$61$YR$A$M$Y$$$20240807$$MD$DE$DE
241856391$24185639$1$I$$20240801$20240807$20240807$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006398$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240807$$CN$US$US
241856401$24185640$1$I$$20240724$20240807$20240807$PER$$US-TEVA-VS-3227423$TEVA$$$$A$M$Y$$$20240807$$HP$US$US
241856411$24185641$1$I$20240722$20240722$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-037154$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240807$$CN$US$US
241856421$24185642$1$I$$20240731$20240807$20240807$EXP$$NVSC2024IT159765$NOVARTIS$Cecchi N, Giannotta JA, Capecchi M, Barcellini W, Fattizzo B. Efficacy of thrombopoietin receptor agonists in evans syndrome: a single center series. HAEMATOLOGICA. 2021;106 (Suppl. 3):37$37$YR$$F$Y$$$20240807$$HP$IT$IT
241856441$24185644$1$I$20240628$20240712$20240807$20240807$PER$$US-JNJFOC-20240733675$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240807$$HP$US$US
241856451$24185645$1$I$$20240731$20240807$20240807$PER$$US-ABBVIE-5863615$ABBVIE$$48$YR$$F$Y$$$20240807$$MD$US$US
241856461$24185646$1$I$20181108$20240729$20240807$20240807$EXP$$CA-Covis Pharma GmbH-2024COV00974$COVIS PHARMA$$48$YR$A$F$Y$$$20240807$$CN$CA$CA
241856471$24185647$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA231833$SANOFI AVENTIS$$$$T$F$Y$62$KG$20240807$$MD$US$US
241856482$24185648$2$F$20230829$20240806$20240807$20240817$EXP$$FR-VER-202400011$VERITY PHARMACEUTICALS$$75$YR$E$M$Y$110$KG$20240817$$HP$FR$FR
241856501$24185650$1$I$20240601$20240725$20240807$20240807$PER$$US-JNJFOC-20240815540$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$HP$US$US
241856512$24185651$2$F$20240101$20240913$20240807$20240916$PER$$US-AMGEN-USASP2024154907$AMGEN$$67$YR$E$M$Y$$$20240916$$CN$US$US
241856521$24185652$1$I$$20240730$20240807$20240807$EXP$$PK-BAUSCH-BL-2024-011698$BAUSCH AND LOMB$Akhtar M, Tayab G, Nawaz M, Seher I. Excessive Dynamic Airway Collapse After Entecavir Use in a Patient With Pegylated Interferon-Induced Undifferentiated Connective Tissue Disease and Entecavir Use to Prevent Hepatitis B Virus Reactivation Upon Giving Rituximab. Cureus. 2024 JUN 21;16(6):1-7. doi:10.7759/cureus.62835$49$YR$$F$Y$$$20240807$$HP$PK$PK
241856531$24185653$1$I$$20240801$20240807$20240807$PER$$US-BIOGEN-2024BI01276723$BIOGEN$$$$$M$Y$$$20240807$$CN$US$US
241856541$24185654$1$I$$20240725$20240807$20240807$PER$$US-JNJFOC-20240815776$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240807$$CN$US$US
241856551$24185655$1$I$20240101$20240731$20240807$20240807$EXP$$DE-ROCHE-10000046491$ROCHE$$49$WK$I$M$Y$$$20240807$$MD$DE$DE
241856561$24185656$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002833$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240807$$CN$US$US
241856581$24185658$1$I$$20240725$20240807$20240807$EXP$$US-ACORDA-ACO_177678_2024$ACORDA$$$$$F$Y$$$20240807$$CN$US$US
241856591$24185659$1$I$20240714$20240723$20240807$20240807$EXP$$US-PARI RESPIRATORY EQUIPMENT, INC.-2024PAR00055$PARI RESPIRATORY EQUIPMENT$$45$YR$$F$Y$68.889$KG$20240807$$HP$US$US
241856601$24185660$1$I$$20240805$20240807$20240807$PER$$NVSC2024US160484$NOVARTIS$$$$$F$Y$72.57$KG$20240807$$CN$US$US
241856611$24185661$1$I$$20240730$20240807$20240807$EXP$$US-RIGEL-20240700098$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240807$$CN$US$US
241856621$24185662$1$I$$20240726$20240807$20240807$EXP$$US-ACORDA-ACO_177676_2024$ACORDA$$$$$F$Y$$$20240807$$CN$US$US
241856631$24185663$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155974$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241856641$24185664$1$I$$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123093$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240807$$HP$US$US
241856651$24185665$1$I$20240501$20240611$20240807$20240807$PER$$US-JNJFOC-20240816807$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240807$$PH$US$US
241856671$24185667$1$I$20240401$20240731$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN008015$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241856681$24185668$1$I$20240501$20240611$20240807$20240807$PER$$US-JNJFOC-20240815808$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240807$$PH$US$US
241856691$24185669$1$I$20240106$20240731$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN008019$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241856701$24185670$1$I$$20240731$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN008021$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241856711$24185671$1$I$20240514$20240514$20240807$20240807$PER$$US-GE HEALTHCARE-2024CSU005184$GE HEALTHCARE$$66$YR$$M$Y$$$20240807$$HP$US$US
241856724$24185672$4$F$20240706$20240910$20240807$20240919$EXP$$CN-VER-202400011$VERITY PHARMACEUTICALS$$79$YR$E$M$Y$171$KG$20240919$$PH$CN$CN
241856731$24185673$1$I$20240605$20240731$20240807$20240807$PER$$BR-Eisai-EC-2024-171470$EISAI$$77$YR$E$F$Y$73$KG$20240807$$HP$BR$BR
241856741$24185674$1$I$$20240803$20240807$20240807$EXP$$CA-ROCHE-10000048215$ROCHE$$40$YR$A$F$Y$$$20240807$$HP$CA$CA
241856751$24185675$1$I$20231101$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154341$AMGEN$$40$YR$$F$Y$$$20240807$$HP$US$US
241856761$24185676$1$I$$20240731$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN008045$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241856771$24185677$1$I$$20240806$20240807$20240807$PER$$US-TAKEDA-2024TUS078975$TAKEDA$$$$$$Y$$$20240807$$PH$US$US
241856782$24185678$2$F$$20240812$20240807$20240822$EXP$$DK-TEVA-VS-3228833$TEVA$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic-Sci-Int 2009; 184 (1-3): 74-79.; Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic-Sci-Int 2009; 184 (1-3): 74-79.$40$YR$$M$Y$$$20240822$$HP$DK$DK
241856791$24185679$1$I$20240510$20240727$20240807$20240807$EXP$GB-MHRA-MED-202407271201586060-NQBHC$GB-ELI_LILLY_AND_COMPANY-GB202407018293$ELI LILLY AND CO$$$$$$Y$76$KG$20240807$$CN$GB$GB
241856803$24185680$3$F$20240712$20240806$20240807$20240814$EXP$$DE-PFIZER INC-202400231058$PFIZER$$$$E$M$Y$80$KG$20240814$$HP$DE$DE
241856811$24185681$1$I$$20240726$20240807$20240807$EXP$$US-ELI_LILLY_AND_COMPANY-US202407018912$ELI LILLY AND CO$$20$YR$A$M$Y$$$20240807$$CN$US$US
241856821$24185682$1$I$20230101$20240730$20240807$20240807$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019541$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240807$$CN$US$US
241856831$24185683$1$I$20240517$20240806$20240807$20240807$EXP$$JP-PFIZER INC-PV202400102387$PFIZER$$50$YR$$F$Y$$$20240807$$MD$JP$JP
241856841$24185684$1$I$20230101$20240729$20240807$20240807$EXP$$US-PFIZER INC-202400179454$PFIZER$$79$YR$$M$Y$$$20240807$$HP$US$US
241856851$24185685$1$I$$20240805$20240807$20240807$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408002735$ELI LILLY AND CO$$$$$$Y$$$20240807$$PH$JP$JP
241856861$24185686$1$I$$20240726$20240807$20240807$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407017416$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$DE$DE
241856871$24185687$1$I$$20240726$20240807$20240807$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019174$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240807$$LW$US$US
241856882$24185688$2$F$20240718$20240729$20240807$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407017603$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240809$$CN$US$US
241856892$24185689$2$F$$20240802$20240807$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019963$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240814$$CN$US$US
241856901$24185690$1$I$20240703$20240726$20240807$20240807$EXP$GB-MHRA-MED-202407262140597740-MNHSL$GB-ELI_LILLY_AND_COMPANY-GB202407018278$ELI LILLY AND CO$$40$YR$A$F$Y$83$KG$20240807$$CN$GB$GB
241856911$24185691$1$I$20240716$20240726$20240807$20240807$EXP$GB-MHRA-MED-202407261156400860-YGQZS$GB-ELI_LILLY_AND_COMPANY-GB202407018275$ELI LILLY AND CO$$49$YR$A$F$Y$79$KG$20240807$$CN$GB$GB
241856921$24185692$1$I$$20240726$20240807$20240807$EXP$$US-ELI_LILLY_AND_COMPANY-US202407020067$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240807$$CN$US$US
241856943$24185694$3$F$$20240807$20240807$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003609$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240819$$CN$US$US
241856951$24185695$1$I$$20240806$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408004467$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241856963$24185696$3$F$20240501$20240814$20240807$20240828$EXP$DE-BFARM-24005333$DE-ELI_LILLY_AND_COMPANY-DE202407020141$ELI LILLY AND CO$$43$YR$A$F$Y$76$KG$20240828$$CN$DE$DE
241856971$24185697$1$I$$20240726$20240807$20240807$EXP$$US-ELI_LILLY_AND_COMPANY-US202407010348$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240807$$CN$US$US
241856981$24185698$1$I$20240518$20240802$20240807$20240807$EXP$$US-JNJFOC-20240812643$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240807$$MD$US$US
241856991$24185699$1$I$20240701$20240726$20240807$20240807$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407018140$ELI LILLY AND CO$$82$YR$E$M$Y$90$KG$20240807$$CN$DE$DE
241857001$24185700$1$I$20240101$20240801$20240807$20240807$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408000487$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240807$$CN$DE$DE
241857011$24185701$1$I$$20240806$20240807$20240807$EXP$$US-GILEAD-2024-0683186$GILEAD$$$$$F$Y$$$20240807$$MD$US$US
241857021$24185702$1$I$20240101$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155328$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241857031$24185703$1$I$20220401$20240731$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN008062$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241857041$24185704$1$I$$20240805$20240807$20240807$30DAY$$US-SANDOZ INC.-SDZ2024US009863$SANDOZ$$$$$M$Y$$$20240807$$MD$US$US
241857051$24185705$1$I$20240401$20240726$20240807$20240807$EXP$FR-AFSSAPS-AN2024000959$FR-ELI_LILLY_AND_COMPANY-FR202407018368$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240807$$CN$FR$FR
241857061$24185706$1$I$20240601$20240806$20240807$20240807$EXP$$AU-WAYLIS-2024-AU-000319$Waylis$$$$$M$Y$$$20240807$$CN$AU$AU
241857071$24185707$1$I$$20240731$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN008052$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241857081$24185708$1$I$$20240731$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN008064$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241857091$24185709$1$I$$20240806$20240807$20240807$EXP$$US-GILEAD-2024-0683258$GILEAD$$63$YR$A$F$Y$$$20240807$$HP$US$US
241857101$24185710$1$I$$20240802$20240807$20240807$PER$$US-ABBVIE-5866236$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241857111$24185711$1$I$$20240731$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN008065$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241857121$24185712$1$I$20240717$20240724$20240807$20240807$EXP$$NL-VER-202400050$VERITY PHARMACEUTICALS$$70$YR$E$M$Y$$$20240807$$CN$NL$NL
241857131$24185713$1$I$$20240731$20240807$20240807$PER$$US-INCYTE CORPORATION-2024IN008048$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241857141$24185714$1$I$$20240804$20240807$20240807$EXP$$US-INCYTE CORPORATION-2024IN008168$INCYTE$$$$$$Y$$$20240807$$CN$US$US
241857151$24185715$1$I$$20240731$20240807$20240807$PER$$US-SA-2024SA231996$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240807$$MD$US$US
241857161$24185716$1$I$20240101$20240731$20240807$20240807$PER$$US-SA-2024SA231046$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240807$$MD$US$US
241857171$24185717$1$I$$20240806$20240807$20240807$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044362$BOEHRINGER INGELHEIM$$$$$$Y$$$20240807$$CN$CA$CA
241857181$24185718$1$I$$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123855$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$89.58$KG$20240807$$CN$US$US
241857192$24185719$2$F$20240610$20240805$20240807$20240816$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-23677$SAMSUNG BIOEPIS$$56$YR$A$F$Y$$$20240814$$CN$GB$GB
241857201$24185720$1$I$20231012$20240730$20240807$20240807$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-23654$SAMSUNG BIOEPIS$$46$YR$A$M$Y$$$20240807$$MD$DE$DE
241857211$24185721$1$I$$20240729$20240807$20240807$PER$$US-JNJFOC-20240783448$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241857221$24185722$1$I$$20240730$20240807$20240807$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-23641$SAMSUNG BIOEPIS$$80$YR$E$F$Y$$$20240807$$HP$GB$GB
241857231$24185723$1$I$$20240802$20240807$20240807$EXP$$US-APELLIS-2024-APL-0000631$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240807$$HP$US$US
241857242$24185724$2$F$$20240909$20240807$20240923$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-17339$SAMSUNG BIOEPIS$$77$YR$E$M$Y$$$20240923$$CN$AU$AU
241857251$24185725$1$I$20231101$20240603$20240807$20240807$EXP$$ES-SAMSUNG BIOEPIS-SB-2024-22555$SAMSUNG BIOEPIS$$83$YR$E$M$Y$$$20240807$$MD$ES$ES
241857271$24185727$1$I$$20240802$20240807$20240807$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07433$HIKMA$$$$$$Y$$$20240807$$HP$CA$CA
241857281$24185728$1$I$$20240729$20240807$20240807$EXP$$ES-SAMSUNG BIOEPIS-SB-2024-23469$SAMSUNG BIOEPIS$$80$YR$E$F$Y$$$20240807$$CN$ES$ES
241857291$24185729$1$I$20240802$20240805$20240807$20240807$PER$$US-009507513-2408USA001674$MERCK$$$$$M$Y$$$20240807$$CN$US$US
241857301$24185730$1$I$$20240731$20240807$20240807$EXP$$US-HLS-202400666$HLS THERAPEUTICS$$31$YR$A$M$Y$$$20240807$$HP$US$US
241857312$24185731$2$F$20240701$20240826$20240807$20240909$EXP$$US-SA-2024SA206712$SANOFI AVENTIS$$9$MON$I$M$Y$$$20240909$$MD$US$US
241857321$24185732$1$I$20240101$20240729$20240807$20240807$PER$$US-JNJFOC-20240782636$JOHNSON AND JOHNSON$$$$$M$Y$$$20240807$$CN$US$US
241857341$24185734$1$I$$20240807$20240807$20240807$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044396$BOEHRINGER INGELHEIM$$$$$$Y$$$20240807$$CN$US$US
241857351$24185735$1$I$$20240801$20240807$20240807$PER$$US-GILEAD-2024-0682705$GILEAD$$52$YR$A$M$Y$$$20240807$$MD$US$US
241857362$24185736$2$F$20240701$20240802$20240807$20240917$PER$$US-LUNDBECK-DKLU4001358$LUNDBECK$$$$$$Y$$$20240917$$CN$US$US
241857371$24185737$1$I$$20240723$20240807$20240807$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00365$AVION PHARMACEUTICALS$Olives T D, Boley S P, LeRoy J M, Stellpflug, S J. Ten Years of Robotripping: Evidence of Tolerance to Dextromethorphan Hydrobromide in a Long-Term User.. Journal of Medical Toxicology. 2019;(15):192?197$32$YR$$M$Y$$$20240807$$HP$US$US
241857381$24185738$1$I$20240807$20240807$20240807$20240807$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044386$BOEHRINGER INGELHEIM$$84$YR$E$F$Y$$$20240807$$CN$US$US
241857391$24185739$1$I$20240731$20240807$20240807$20240807$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044374$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240807$$CN$US$US
241857401$24185740$1$I$$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124623$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240807$$CN$US$US
241857411$24185741$1$I$20240729$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124957$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240807$$CN$US$US
241857421$24185742$1$I$$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124981$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240807$$MD$US$US
241857431$24185743$1$I$$20240725$20240807$20240807$EXP$$US-HLS-202400563$HLS THERAPEUTICS$$$$A$F$Y$$$20240807$$HP$US$US
241857441$24185744$1$I$20240501$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002674$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240807$$CN$US$US
241857451$24185745$1$I$$20240806$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408004466$ELI LILLY AND CO$$$$$F$Y$$$20240807$$CN$US$US
241857461$24185746$1$I$20240612$20240802$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408002146$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240807$$CN$US$US
241857471$24185747$1$I$20240730$20240731$20240807$20240807$PER$$US-APELLIS-2024-APL-0000608$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240807$$CN$US$US
241857482$24185748$2$F$$20240904$20240807$20240904$PER$$US-ALXN-202407USA002188US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
241857491$24185749$1$I$20240802$20240802$20240807$20240807$PER$$US-BIOMARINAP-US-2024-159656$BIOMARIN$$$$$$Y$$$20240807$$CN$US$US
241857501$24185750$1$I$20240101$20240724$20240807$20240807$PER$$US-BIOMARINAP-US-2024-159584$BIOMARIN$$$$$$Y$$$20240807$$HP$US$US
241857511$24185751$1$I$$20240802$20240807$20240807$PER$$US-BIOMARINAP-US-2024-159639$BIOMARIN$$$$$$Y$$$20240807$$CN$US$US
241857521$24185752$1$I$$20240802$20240807$20240807$PER$$US-BIOMARINAP-US-2024-159612$BIOMARIN$$$$$$Y$$$20240807$$CN$US$US
241857533$24185753$3$F$$20240806$20240807$20240809$PER$$NVSC2024US160432$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
241857541$24185754$1$I$$20240803$20240807$20240807$EXP$$CA-TAKEDA-2024TUS078903$TAKEDA$$$$$M$Y$$$20240807$$CN$CA$CA
241857553$24185755$3$F$20240724$20240809$20240807$20240816$EXP$$CA-HLS-202401862$HLS THERAPEUTICS$$60$YR$A$F$Y$$$20240816$$HP$CA$CA
241857562$24185756$2$F$$20240904$20240807$20240904$PER$$US-ALXN-202407USA002191US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
241857571$24185757$1$I$$20240802$20240807$20240807$PER$$US-BIOMARINAP-US-2024-159666$BIOMARIN$$$$$$Y$$$20240807$$CN$US$US
241857582$24185758$2$F$20240705$20240820$20240807$20240828$PER$$US-BIOMARINAP-US-2024-159631$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
241857592$24185759$2$F$$20240727$20240807$20240808$PER$$US-JNJFOC-20240780341$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241857601$24185760$1$I$$20240710$20240807$20240807$PER$$US-009507513-2407USA005087$MERCK$Pabon CM, Yeboa DN, O^Brien BJ, Majd NK, Wang C, Blum Murphy MA. Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literature. Journal of Gastrointestinal Oncology. 2024;15(3):1331-40$71$YR$$M$Y$$$20240807$$HP$US$US
241857621$24185762$1$I$$20240724$20240807$20240807$EXP$$US-HLS-202400531$HLS THERAPEUTICS$$$$A$$Y$$$20240807$$PH$US$US
241857631$24185763$1$I$$20240727$20240807$20240807$PER$$US-JNJFOC-20240776455$JOHNSON AND JOHNSON$$$$$$Y$$$20240807$$CN$US$US
241857641$24185764$1$I$$20240802$20240807$20240807$EXP$$US-TAKEDA-US201801210$TAKEDA$$$$$F$Y$$$20240807$$MD$US$US
241857651$24185765$1$I$20240423$20240802$20240807$20240807$EXP$$JP-009507513-2404JPN002581J$MERCK$$8$DEC$$F$Y$$$20240807$$MD$JP$JP
241857661$24185766$1$I$20240723$20240801$20240807$20240807$PER$$US-SA-2024SA231666$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240808$$MD$US$US
241857671$24185767$1$I$$20240724$20240807$20240807$EXP$$US-HLS-202400539$HLS THERAPEUTICS$$76$YR$E$F$Y$$$20240807$$HP$US$US
241857681$24185768$1$I$20230511$20240725$20240807$20240807$EXP$$CA-VER-202400365$VERITY PHARMACEUTICALS$$71$YR$E$M$Y$$$20240807$$CN$CA$CA
241857691$24185769$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003782$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240807$$CN$US$US
241857701$24185770$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003364$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240807$$CN$US$US
241857713$24185771$3$F$20240727$20240926$20240807$20240930$PER$$US-JNJFOC-20240776101$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240930$$CN$US$US
241857721$24185772$1$I$20240730$20240804$20240807$20240807$EXP$$US-BIOMARINAP-US-2024-159659$BIOMARIN$$$$$$Y$$$20240807$$CN$US$US
241857734$24185773$4$F$20240820$20240828$20240807$20240903$EXP$$CA-TAKEDA-2024TUS078798$TAKEDA$$48$YR$$M$Y$$$20240903$$CN$CA$CA
241857741$24185774$1$I$20240802$20240802$20240807$20240807$PER$$US-AMGEN-USASP2024154685$AMGEN$$54$YR$A$M$Y$$$20240807$$CN$US$US
241857752$24185775$2$F$$20240808$20240807$20240816$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01167$AIMMUNE$$$$$$Y$$$20240816$$HP$US$US
241857762$24185776$2$F$20240601$20240919$20240807$20240926$PER$$JP-Eisai-EC-2024-171355$EISAI$$$$E$F$Y$$$20240926$$MD$JP$JP
241857771$24185777$1$I$$20240729$20240807$20240807$EXP$$JP-Eisai-EC-2023-142137$EISAI$Komeda Yusuke. A case of Fournier^s gangrene during treatment with lenvatinib for advanced hepatocellular carcinoma. The 28th Japan Association of Systemic Therapy for HCC.$66$YR$E$M$Y$85$KG$20240807$$MD$JP$JP
241857791$24185779$1$I$$20240731$20240807$20240807$EXP$$US-ZENPEP LLC-2024AIMT01183$AIMMUNE$$$$$$Y$$$20240807$$CN$US$US
241857801$24185780$1$I$$20240807$20240807$20240807$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044369$BOEHRINGER INGELHEIM$$$$$$Y$$$20240807$$CN$US$US
241857811$24185781$1$I$20240715$20240731$20240807$20240807$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408004041$ELI LILLY AND CO$$73$YR$E$M$Y$65$KG$20240807$$CN$DE$CN
241857821$24185782$1$I$$20240730$20240807$20240807$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202408000470$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240807$$MD$SA$SA
241857831$24185783$1$I$$20240802$20240807$20240807$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002085$ELI LILLY AND CO$$$$$$Y$$$20240807$$CN$US$US
241857843$24185784$3$F$20240808$20240906$20240807$20240912$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408000160$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240912$$CN$JP$JP
241857852$24185785$2$F$20240701$20240806$20240807$20240814$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407019525$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240814$$CN$JP$JP
241857861$24185786$1$I$$20240730$20240807$20240807$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202407020316$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240807$$MD$CA$CA
241857873$24185787$3$F$20220704$20240909$20240807$20240912$EXP$$US-TAKEDA-2021TUS069548$TAKEDA$$52$YR$$F$Y$91$KG$20240912$$HP$US$US
241857881$24185788$1$I$$20240723$20240807$20240807$EXP$$US-HLS-202400513$HLS THERAPEUTICS$$51$YR$A$F$Y$$$20240807$$CN$US$US
241857891$24185789$1$I$20240601$20240801$20240807$20240807$EXP$FR-AFSSAPS-RS2024000767$FR-ELI_LILLY_AND_COMPANY-FR202408000638$ELI LILLY AND CO$$25$YR$A$$Y$$$20240807$$CN$FR$FR
241857901$24185790$1$I$20240702$20240801$20240807$20240807$EXP$FR-AFSSAPS-CF2024000392$FR-ELI_LILLY_AND_COMPANY-FR202408000634$ELI LILLY AND CO$$15$YR$T$F$Y$59$KG$20240807$$CN$FR$FR
241857911$24185791$1$I$20240221$20240801$20240807$20240807$EXP$$CA-APELLIS-APL-2024-004211$APELLIS PHARMACEUTICALS$$$$$$Y$58$KG$20240807$$MD$CA$CA
241857921$24185792$1$I$$20240805$20240807$20240807$PER$$US-BIOMARINAP-US-2024-159661$BIOMARIN$$$$$$Y$$$20240807$$CN$US$US
241857931$24185793$1$I$$20240807$20240807$20240807$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044404$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240807$$MD$US$US
241857941$24185794$1$I$20240604$20240805$20240807$20240807$PER$$US-BIOMARINAP-US-2024-159647$BIOMARIN$$$$$$Y$$$20240807$$CN$US$US
241857952$24185795$2$F$20240714$20240815$20240807$20240820$EXP$$TR-JNJFOC-20240816651$JOHNSON AND JOHNSON$$72$YR$E$$Y$$$20240820$$MD$TR$TR
241857961$24185796$1$I$$20240722$20240807$20240807$PER$$US-JNJFOC-20240763662$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240807$$CN$US$US
241857972$24185797$2$F$20240802$20240809$20240807$20240814$PER$$US-BIOMARINAP-US-2024-159637$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
241857981$24185798$1$I$$20240712$20240807$20240807$PER$$US-009507513-2407USA008430$MERCK$$$$$F$Y$$$20240807$$MD$US$US
241857991$24185799$1$I$20240719$20240729$20240807$20240807$PER$$US-JNJFOC-20240780524$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240807$$CN$US$US
241858002$24185800$2$F$$20240910$20240807$20240912$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044040$BOEHRINGER INGELHEIM$$$$E$M$Y$85$KG$20240912$$PH$FR$FR
241858013$24185801$3$F$$20240828$20240807$20240828$PER$$US-ALXN-202408USA000098US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
241858021$24185802$1$I$$20240731$20240807$20240807$PER$$US-MTPC-MTDA2024-0016247$MITSUBISHI TANABE PHARMA$$$$A$M$Y$$$20240807$$CN$US$US
241858041$24185804$1$I$20210101$20240805$20240807$20240807$EXP$$AT-SANDOZ INC.-SDZ2024AT070825$SANDOZ$$$$$M$Y$$$20240807$$MD$AT$AT
241858051$24185805$1$I$20240401$20240723$20240807$20240807$EXP$$CO-AZURITY PHARMACEUTICALS, INC.-AZR202407-000281$AZURITY PHARMACEUTICALS$$8$YR$$F$Y$$$20240807$$CN$CO$CO
241858061$24185806$1$I$20240101$20240731$20240807$20240807$EXP$$US-MALLINCKRODT-MNK202404407$MALLINCKRODT$$72$YR$E$F$Y$$$20240808$$HP$US$US
241858071$24185807$1$I$$20240807$20240807$20240807$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044407$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240808$$CN$US$US
241858081$24185808$1$I$$20240801$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122799$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$CN$US$US
241858091$24185809$1$I$20240605$20240729$20240807$20240807$EXP$$US-JNJFOC-20240778825$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240808$$HP$US$US
241858101$24185810$1$I$20240729$20240730$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124062$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240808$$HP$US$US
241858121$24185812$1$I$$20240801$20240807$20240807$EXP$$US-MALLINCKRODT-MNK202404946$MALLINCKRODT$$52$YR$A$M$Y$$$20240808$$CN$US$US
241858131$24185813$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123659$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240808$$HP$US$US
241858141$24185814$1$I$20240701$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124024$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240808$$HP$US$US
241858151$24185815$1$I$20240101$20240801$20240807$20240807$EXP$$US-MALLINCKRODT-MNK202404956$MALLINCKRODT$$23$YR$A$F$Y$121$KG$20240808$$HP$US$US
241858161$24185816$1$I$$20240806$20240807$20240807$EXP$$NVSJ2024JP009511$NOVARTIS$$$$$$Y$$$20240808$$MD$JP$JP
241858172$24185817$2$F$$20240727$20240807$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-120456$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240808$$MD$JP$JP
241858182$24185818$2$F$$20240918$20240807$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123770$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240923$$HP$US$US
241858191$24185819$1$I$$20240807$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125143$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240808$$CN$US$US
241858201$24185820$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408004267$ELI LILLY AND CO$$29$YR$A$$Y$$$20240807$$CN$US$US
241858211$24185821$1$I$$20240807$20240807$20240807$PER$$NVSC2024US160968$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241858221$24185822$1$I$20240725$20240805$20240807$20240807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123989$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$$$20240808$$CN$US$US
241858231$24185823$1$I$20240803$20240805$20240807$20240807$EXP$$AR-BIOGEN-2024BI01277111$BIOGEN$$3$YR$$F$Y$$$20240807$$CN$AR$AR
241858243$24185824$3$F$20240601$20240923$20240807$20240926$EXP$$RO-BIOGEN-2024BI01276955$BIOGEN$$56$YR$$M$Y$$$20240926$$MD$RO$RO
241858262$24185826$2$F$$20240731$20240807$20240814$PER$$US-JNJFOC-20240785376$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240814$$HP$US$US
241858271$24185827$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156090$AMGEN$$$$$$Y$$$20240807$$HP$US$US
241858281$24185828$1$I$$20240802$20240807$20240807$EXP$$US-BAUSCH-BL-2024-011883$BAUSCH AND LOMB$$49$YR$$M$Y$$$20240808$$MD$US$US
241858301$24185830$1$I$20240101$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155637$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241858311$24185831$1$I$$20240730$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121575$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240808$$CN$US$US
241858321$24185832$1$I$20240724$20240807$20240807$20240807$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044380$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240808$$HP$US$US
241858331$24185833$1$I$$20240805$20240807$20240807$EXP$$PT-BIOGEN-2024BI01277162$BIOGEN$Fonte J, Abreu V,  Silva A, Santos E. MULTIPLE SCLEROSIS: MIMIC OF NEUROMYELITIS OPTICA SPECTRUM DISEASE  ASSOCIATED WITH ANTI-MOG ANTIBODIES?. Sinapse. 2023.. 1:.$49$YR$$F$Y$$$20240807$$MD$PT$PT
241858341$24185834$1$I$$20240807$20240807$20240807$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044399$BOEHRINGER INGELHEIM$$82$YR$E$M$Y$$$20240808$$CN$US$US
241858351$24185835$1$I$$20240729$20240807$20240807$PER$$FR-Blueprint Medicines Corporation-SP-FR-2024-001545$BLUEPRINT MEDICINES$$$$$F$Y$$$20240808$$PH$FR$FR
241858361$24185836$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5868563$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241858371$24185837$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5868613$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241858381$24185838$1$I$$20240806$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408004537$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240807$$HP$US$US
241858391$24185839$1$I$$20240725$20240807$20240807$EXP$$JP-SMPA-2024SMP011459$SUNOVION$$$$$$Y$$$20240807$$CN$JP$JP
241858401$24185840$1$I$$20240229$20240807$20240807$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00099$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240726$$CN$US$US
241858412$24185841$2$F$20240701$20240822$20240807$20240830$EXP$$GR-JNJFOC-20240744842$JOHNSON AND JOHNSON$$29$YR$A$F$Y$55$KG$20240830$$CN$GR$GR
241858421$24185842$1$I$20240101$20240304$20240807$20240807$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00102$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240726$$CN$US$US
241858431$24185843$1$I$$20231021$20240807$20240807$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00555$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240726$$CN$US$US
241858441$24185844$1$I$20231001$20231115$20240807$20240807$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00583$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240726$$CN$US$US
241858451$24185845$1$I$$20240110$20240807$20240807$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00013$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240726$$CN$US$US
241858461$24185846$1$I$$20240222$20240807$20240807$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00091$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240726$$CN$US$US
241858471$24185847$1$I$$20240731$20240807$20240807$PER$$US-JNJFOC-20240815794$JOHNSON AND JOHNSON$$4$DEC$A$$Y$$$20240808$$PH$US$US
241858491$24185849$1$I$20240705$20240731$20240807$20240807$PER$$US-BIOGEN-2024BI01276713$BIOGEN$$43$YR$$M$Y$$$20240807$$PH$US$US
241858502$24185850$2$F$20240101$20240807$20240807$20240809$EXP$$US-ABBVIE-5867706$ABBVIE$$$$$F$Y$39$KG$20240809$$CN$US$US
241858511$24185851$1$I$$20240423$20240807$20240807$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00192$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240726$$CN$US$US
241858521$24185852$1$I$20231008$20231009$20240807$20240807$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00526$PRINSTON PHARMACEUTICAL$$74$YR$$F$Y$123.4$KG$20240726$$CN$US$US
241858531$24185853$1$I$$20240805$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123784$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240808$$HP$US$US
241858541$24185854$1$I$20230919$20230920$20240807$20240807$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00468$PRINSTON PHARMACEUTICAL$$83$YR$$F$Y$$$20240726$$CN$US$US
241858551$24185855$1$I$$20240806$20240807$20240807$EXP$$NVSC2024CA160858$NOVARTIS$$$$$$Y$$$20240808$$MD$CA$CA
241858561$24185856$1$I$$20240802$20240807$20240807$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001569$BLUEPRINT MEDICINES$$$$$M$Y$$$20240808$$CN$US$US
241858571$24185857$1$I$20240606$20240806$20240807$20240807$EXP$FR-AFSSAPS-LY2024001126$FR-JNJFOC-20240816027$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240808$$PH$FR$FR
241858581$24185858$1$I$20240702$20240805$20240807$20240807$EXP$$US-ABBVIE-5868590$ABBVIE$$77$YR$$M$Y$$$20240807$$CN$US$US
241858592$24185859$2$F$$20240913$20240807$20240917$EXP$$NVSC2024CA160134$NOVARTIS$$$$$M$Y$$$20240917$$MD$CA$CA
241858602$24185860$2$F$20230828$20240809$20240807$20240814$EXP$$US-ABBVIE-5864482$ABBVIE$$60$YR$$M$Y$99$KG$20240814$$CN$US$US
241858611$24185861$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156012$AMGEN$$$$$$Y$$$20240807$$CN$US$US
241858621$24185862$1$I$20240101$20240805$20240807$20240807$EXP$$CO-AMGEN-COLSP2024156874$AMGEN$$85$YR$E$M$Y$$$20240807$$CN$CO$CO
241858633$24185863$3$F$20240701$20240829$20240807$20240906$EXP$$US-ABBVIE-5868768$ABBVIE$$58$YR$$F$Y$113.85$KG$20240906$$CN$US$US
241858641$24185864$1$I$$20240725$20240807$20240807$PER$$US-SMPA-2024SPA000235$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858651$24185865$1$I$20240708$20240731$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011935$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241858671$24185867$1$I$$20240724$20240807$20240807$PER$$US-SMPA-2024MYSCI0701056$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858681$24185868$1$I$$20240713$20240807$20240807$PER$$US-SMPA-2024MYSCI0700524$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858691$24185869$1$I$$20240715$20240807$20240807$PER$$US-SMPA-2024MYSCI0700586$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858701$24185870$1$I$20240529$20240724$20240807$20240807$PER$$US-SMPA-2024MYSCI0601124$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858711$24185871$1$I$$20240715$20240807$20240807$PER$$US-SMPA-2024MYSCI0700565$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858721$24185872$1$I$$20240726$20240807$20240807$PER$$US-SMPA-2024SPA000412$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858732$24185873$2$F$$20240724$20240807$20240821$PER$$US-SMPA-2024SPA000177$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
241858751$24185875$1$I$$20240725$20240807$20240807$PER$$US-SMPA-2024SPA000218$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858761$24185876$1$I$$20240730$20240807$20240807$PER$$US-SMPA-2024SPA000440$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858771$24185877$1$I$$20240729$20240807$20240807$PER$$US-SMPA-2024SPA000441$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858781$24185878$1$I$$20240712$20240807$20240807$PER$$US-SMPA-2024MYSCI0600150$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858791$24185879$1$I$$20240712$20240807$20240807$PER$$US-SMPA-2024MYSCI0600523$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858801$24185880$1$I$20240705$20240723$20240807$20240807$PER$$US-SMPA-202407-URV-000996$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858811$24185881$1$I$$20240729$20240807$20240807$PER$$US-SMPA-2024SPA000494$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858821$24185882$1$I$$20240725$20240807$20240807$PER$$US-SMPA-2024SPA000232$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858831$24185883$1$I$$20240725$20240807$20240807$PER$$US-SMPA-2024SPA000231$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858841$24185884$1$I$20240101$20240723$20240807$20240807$PER$$US-SMPA-2024MYSCI0700993$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858851$24185885$1$I$20240708$20240710$20240807$20240807$PER$$US-SMPA-2024MYSCI0700390$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858862$24185886$2$F$$20240823$20240807$20240828$PER$$US-SMPA-2024SPA000444$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
241858871$24185887$1$I$$20240709$20240807$20240807$PER$$US-SMPA-2024MYSCI0700325$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858881$24185888$1$I$$20240715$20240807$20240807$PER$$US-SMPA-2024MYSCI0700580$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858891$24185889$1$I$$20240723$20240807$20240807$PER$$US-SMPA-202407-URV-001106$SUNOVION$$$$$$Y$$$20240807$$$US$US
241858901$24185890$1$I$$20240726$20240807$20240807$PER$$US-SMPA-2024SPA000294$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858911$24185891$1$I$$20240726$20240807$20240807$PER$$US-SMPA-2024SPA000501$SUNOVION$$$$$$Y$$$20240807$$MD$US$US
241858921$24185892$1$I$$20240723$20240807$20240807$PER$$US-SMPA-202407-URV-001107$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858931$24185893$1$I$$20240710$20240807$20240807$PER$$US-SMPA-2024MYSCI0601130$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858941$24185894$1$I$$20240712$20240807$20240807$PER$$US-SMPA-2024MYSCI0700490$SUNOVION$$$$$$Y$$$20240807$$HP$US$US
241858951$24185895$1$I$$20240724$20240807$20240807$PER$$US-SMPA-2024SPA000251$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858961$24185896$1$I$$20240723$20240807$20240807$PER$$US-SMPA-2024MYSCI0700994$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858972$24185897$2$F$$20240826$20240807$20240919$PER$$US-SMPA-2024SPA000264$SUNOVION$$$$$$Y$$$20240919$$MD$US$US
241858981$24185898$1$I$$20240725$20240807$20240807$PER$$US-SMPA-2024MYSCI0401170$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241858992$24185899$2$F$$20240724$20240807$20240808$PER$$US-SMPA-2024SPA000183$SUNOVION$$$$$$Y$$$20240808$$CN$US$US
241859001$24185900$1$I$$20240723$20240807$20240807$PER$$US-SMPA-2024MYSCI0700998$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241859011$24185901$1$I$$20240725$20240807$20240807$PER$$US-SMPA-2024SPA000212$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241859021$24185902$1$I$$20240711$20240807$20240807$PER$$US-SMPA-2024MYSCI0700431$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241859031$24185903$1$I$$20240725$20240807$20240807$PER$$US-SMPA-2024SPA000274$SUNOVION$$$$$$Y$$$20240807$$HP$US$US
241859041$24185904$1$I$$20240724$20240807$20240807$PER$$US-SMPA-202407-URV-001111$SUNOVION$$$$$$Y$$$20240807$$MD$US$US
241859051$24185905$1$I$20240702$20240806$20240807$20240807$EXP$FR-AFSSAPS-SE2024000627$FR-ORGANON-O2408FRA000444$ORGANON$$51$YR$$F$Y$84$KG$20240807$$MD$FR$FR
241859061$24185906$1$I$$20240802$20240807$20240807$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2024096798$VIIV$$$$$$Y$$$20240807$$PH$JP$JP
241859071$24185907$1$I$20240709$20240805$20240807$20240807$EXP$$US-ABBVIE-5869477$ABBVIE$$28$YR$$F$Y$$$20240807$$CN$US$US
241859081$24185908$1$I$20240101$20240731$20240807$20240807$EXP$$US-ABBVIE-5862877$ABBVIE$$63$YR$$F$Y$$$20240807$$CN$US$US
241859091$24185909$1$I$$20240730$20240807$20240807$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001560$BLUEPRINT MEDICINES$$$$$M$Y$$$20240808$$CN$US$US
241859101$24185910$1$I$20240719$20240731$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011971$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241859121$24185912$1$I$$20240731$20240807$20240807$PER$$US-BAUSCHBL-2024BNL030956$BAUSCH AND LOMB$$$$$F$Y$$$20240808$$CN$US$US
241859131$24185913$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5868580$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241859141$24185914$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156072$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241859151$24185915$1$I$20230101$20240801$20240807$20240807$EXP$$DE-ABBVIE-5867585$ABBVIE$$$$$M$Y$$$20240807$$CN$DE$DE
241859162$24185916$2$F$20240101$20240807$20240807$20240813$EXP$$CA-ABBVIE-5867275$ABBVIE$$$$$M$Y$$$20240813$$PH$CA$CA
241859171$24185917$1$I$20240620$20240805$20240807$20240807$EXP$$US-ABBVIE-5868480$ABBVIE$$56$YR$$M$Y$$$20240807$$CN$US$US
241859191$24185919$1$I$$20240731$20240807$20240807$EXP$$SG-JNJFOC-20240784152$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$HP$SG$SG
241859202$24185920$2$F$20240101$20240820$20240807$20240827$EXP$$JP-BIOGEN-2024BI01276597$BIOGEN$$65$YR$$F$Y$$$20240827$$PH$JP$JP
241859211$24185921$1$I$20240101$20240807$20240807$20240807$EXP$$NVSJ2024JP009516$NOVARTIS$$$$E$M$Y$$$20240808$$MD$JP$JP
241859222$24185922$2$F$20240729$20240823$20240807$20240902$PER$$US-BAUSCHBL-2024BNL030851$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240903$$CN$US$US
241859231$24185923$1$I$$20240801$20240807$20240807$EXP$$FR-JNJFOC-20240816312$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240808$$MD$FR$FR
241859242$24185924$2$F$$20240828$20240807$20240905$PER$$US-BAUSCHBL-2024BNL030896$BAUSCH AND LOMB$$$$$F$Y$$$20240906$$CN$US$US
241859253$24185925$3$F$20240721$20240903$20240807$20240913$30DAY$$CA-JNJFOC-20240772633$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240913$$PH$CA$CA
241859261$24185926$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5869494$ABBVIE$$$$$F$Y$$$20240807$$HP$US$US
241859273$24185927$3$F$20240701$20240917$20240807$20240924$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-025864$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240924$$HP$CA$CA
241859283$24185928$3$F$20230313$20240830$20240807$20240904$EXP$$US-ABBVIE-5868299$ABBVIE$$41$YR$$F$Y$$$20240904$$CN$US$US
241859291$24185929$1$I$20240725$20240731$20240807$20240807$EXP$$US-JNJFOC-20240801682$JOHNSON AND JOHNSON$$66$YR$E$M$Y$78.36$KG$20240808$$MD$US$US
241859301$24185930$1$I$$20240731$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011974$BEIGENE$He-wei Zhang, Hai-bo Yu. Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib,and GEMOX in one case. Frontiers in Oncology. 2024$$$$$Y$$$20240807$$MD$CN$CN
241859321$24185932$1$I$$20240805$20240807$20240807$EXP$$US-TAKEDA-2024TUS078865$TAKEDA$$$$$M$Y$$$20240807$$MD$US$US
241859331$24185933$1$I$$20240805$20240807$20240807$EXP$$ZA-AMGEN-ZAFSP2024156514$AMGEN$$$$$F$Y$$$20240807$$HP$ZA$ZA
241859341$24185934$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156058$AMGEN$$73$YR$E$M$Y$$$20240807$$CN$US$US
241859352$24185935$2$F$20230101$20240805$20240807$20240820$EXP$$US-ABBVIE-5868066$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
241859361$24185936$1$I$$20240806$20240807$20240807$EXP$$US-ABBVIE-5870106$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241859372$24185937$2$F$$20240827$20240807$20240905$PER$$US-BAUSCHBL-2024BNL030833$BAUSCH AND LOMB$$$$$F$Y$$$20240905$$CN$US$US
241859381$24185938$1$I$20240101$20240802$20240807$20240807$PER$$US-ABBVIE-5869403$ABBVIE$$60$YR$$F$Y$$$20240807$$HP$US$US
241859391$24185939$1$I$20230101$20240805$20240807$20240807$EXP$$DE-ABBVIE-5870006$ABBVIE$$$$$F$Y$$$20240807$$CN$DE$DE
241859401$24185940$1$I$20240711$20240731$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011952$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241859411$24185941$1$I$$20240802$20240807$20240807$EXP$$US-TAKEDA-2024TUS078412$TAKEDA$$$$$F$Y$$$20240807$$CN$US$US
241859423$24185942$3$F$20240701$20240902$20240807$20240913$30DAY$$CA-JNJFOC-20240783774$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240913$$HP$CA$CA
241859431$24185943$1$I$20240101$20240805$20240807$20240807$EXP$$US-ABBVIE-5868599$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241859441$24185944$1$I$$20240801$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122338$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240808$$HP$US$US
241859451$24185945$1$I$$20240801$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122158$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240808$$HP$US$US
241859462$24185946$2$F$20240618$20240830$20240807$20240902$EXP$$US-TAKEDA-2024TUS060815$TAKEDA$$47$YR$$M$Y$$$20240902$$CN$US$US
241859471$24185947$1$I$20240706$20240806$20240807$20240807$EXP$$CA-HLS-202401975$HLS THERAPEUTICS$$33$YR$A$M$Y$$$20240807$$CN$CA$CA
241859482$24185948$2$F$$20240828$20240807$20240905$EXP$$JP-JNJFOC-20240816225$JOHNSON AND JOHNSON$Uchiyama A, Ohita K, Toiyama Y. [S25-8 Laparoscopic resection of the rectum for ulcerative colitis with rectal stenosis] The 79th General Meeting of the Japanese Society of Gastroenterological Surgery. 2024.7.17,18,19;2477$71$YR$E$M$Y$$$20240906$$MD$JP$JP
241859491$24185949$1$I$20240713$20240731$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011953$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241859501$24185950$1$I$20240531$20240806$20240807$20240807$EXP$FR-AFSSAPS-LY2024000954$FR-ORGANON-O2408FRA000465$ORGANON$$48$YR$$M$Y$85$KG$20240807$$PH$FR$FR
241859511$24185951$1$I$$20240725$20240807$20240807$EXP$$US-UCBSA-2024038193$UCB$$$$$$Y$$$20240808$$MD$US$US
241859521$24185952$1$I$$20240807$20240807$20240807$EXP$$NVSJ2024JP009517$NOVARTIS$$$$E$M$Y$$$20240808$$MD$JP$JP
241859542$24185954$2$F$$20240801$20240807$20240808$EXP$$US-BEIGENE-BGN-2024-002148$BEIGENE$$$$$$Y$$$20240808$$CN$US$US
241859551$24185955$1$I$$20240731$20240807$20240807$EXP$$US-SMPA-2024SPA000428$SUNOVION$$$$$$Y$$$20240807$$CN$US$US
241859561$24185956$1$I$$20240805$20240807$20240807$PER$$US-TAKEDA-2024TUS078991$TAKEDA$$$$$F$Y$$$20240807$$CN$US$US
241859582$24185958$2$F$20240523$20240828$20240807$20240908$PER$$US-BAUSCHBL-2024BNL030856$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240909$$CN$US$US
241859591$24185959$1$I$$20240727$20240807$20240807$PER$$US-BAUSCHBL-2024BNL030816$BAUSCH AND LOMB$$$$$M$Y$$$20240808$$CN$US$US
241859601$24185960$1$I$20240704$20240731$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011937$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241859611$24185961$1$I$$20240802$20240807$20240807$EXP$$US-ABBVIE-5865913$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241859622$24185962$2$F$20240704$20240809$20240807$20240812$PER$$US-AMGEN-USASP2024156652$AMGEN$$45$YR$A$M$Y$$$20240812$$CN$US$US
241859632$24185963$2$F$$20240911$20240807$20240912$PER$$US-TAKEDA-2024TUS078771$TAKEDA$$$$$F$Y$$$20240912$$CN$US$US
241859641$24185964$1$I$20240710$20240731$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011938$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241859651$24185965$1$I$20240715$20240805$20240807$20240807$EXP$$CN-ABBVIE-5868378$ABBVIE$$77$YR$$M$Y$50$KG$20240807$$MD$CN$CN
241859661$24185966$1$I$20240401$20240805$20240807$20240807$EXP$$US-ABBVIE-5868773$ABBVIE$$32$YR$$M$Y$$$20240807$$CN$US$US
241859671$24185967$1$I$20240801$20240805$20240807$20240807$EXP$$US-ABBVIE-5867971$ABBVIE$$62$YR$$F$Y$$$20240807$$CN$US$US
241859682$24185968$2$F$20020101$20240823$20240807$20240830$EXP$$US-ABBVIE-5856579$ABBVIE$$$$$F$Y$54$KG$20240828$$CN$US$US
241859693$24185969$3$F$20240101$20240815$20240807$20240820$EXP$$US-ABBVIE-5869719$ABBVIE$$$$$F$Y$90$KG$20240820$$CN$US$US
241859702$24185970$2$F$$20240807$20240807$20240808$EXP$GB-MHRA-MIDB-e367bea6-16fc-4f66-9a1c-77673e972fcf$GB-JNJFOC-20240816716$JOHNSON AND JOHNSON$$40$YR$A$$Y$$$20240808$$PH$GB$GB
241859711$24185971$1$I$20240618$20240731$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011941$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241859721$24185972$1$I$$20240802$20240807$20240807$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123586$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240808$$CN$US$US
241859731$24185973$1$I$20240604$20240731$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011972$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241859741$24185974$1$I$20240703$20240729$20240807$20240807$PER$$US-JNJFOC-20240809598$JOHNSON AND JOHNSON$$73$YR$E$M$Y$91.4$KG$20240808$$CN$US$US
241859751$24185975$1$I$$20240731$20240807$20240807$EXP$$US-BIOGEN-2024BI01276678$BIOGEN$$$$$F$Y$$$20240807$$CN$US$US
241859761$24185976$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5868575$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241859771$24185977$1$I$$20240801$20240807$20240807$PER$$US-SA-2024SA230622$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240808$$MD$US$US
241859781$24185978$1$I$$20240804$20240807$20240807$EXP$$US-EMD Serono-2024042454$EMD SERONO INC$$$$A$M$Y$$$20240808$$CN$US$US
241859791$24185979$1$I$20240620$20240731$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011943$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241859801$24185980$1$I$$20240726$20240807$20240807$30DAY$$US-JNJFOC-20240775097$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241859812$24185981$2$F$$20240826$20240807$20240830$EXP$$JP-GSK-JP2024JPN095927$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$PH$JP$JP
241859822$24185982$2$F$$20240820$20240807$20240823$EXP$JP-MMM-GHKMNSDX$JP-GSK-JP2024097055$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$JP$JP
241859832$24185983$2$F$20240101$20240814$20240807$20240822$EXP$$BR-BIOGEN-2024BI01276829$BIOGEN$$$$$F$Y$68$KG$20240822$$CN$BR$BR
241859841$24185984$1$I$20240601$20240726$20240807$20240807$PER$$US-ROCHE-10000044168$ROCHE$$$$$$Y$$$20240808$$CN$US$US
241859851$24185985$1$I$$20240731$20240807$20240807$EXP$$BR-BIOGEN-2024BI01276708$BIOGEN$$$$$M$Y$70$KG$20240807$$CN$BR$BR
241859861$24185986$1$I$$20240805$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408003611$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240807$$CN$US$US
241859871$24185987$1$I$20230101$20240805$20240807$20240807$EXP$$US-ABBVIE-5868458$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241859881$24185988$1$I$$20240716$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202407010528$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240807$$CN$US$US
241859891$24185989$1$I$$20240806$20240807$20240807$PER$$US-ELI_LILLY_AND_COMPANY-US202408004543$ELI LILLY AND CO$$$$$M$Y$$$20240807$$CN$US$US
241859901$24185990$1$I$20240731$20240804$20240807$20240807$EXP$$US-ABBVIE-5868100$ABBVIE$$70$YR$$M$Y$$$20240807$$CN$US$US
241859911$24185991$1$I$$20240801$20240807$20240807$PER$$US-ALXN-202408USA000124US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241859922$24185992$2$F$$20240807$20240807$20240812$EXP$$CA-JNJFOC-20231002880$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240812$$HP$CA$CA
241859931$24185993$1$I$20240727$20240731$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-011966$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241859943$24185994$3$F$20240301$20240831$20240807$20240905$PER$$US-ABBVIE-5865905$ABBVIE$$75$YR$$M$Y$79$KG$20240905$$CN$US$US
241859952$24185995$2$F$20240627$20240814$20240807$20240820$EXP$$US-JNJFOC-20240808185$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240820$$HP$US$US
241859961$24185996$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024157023$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241859971$24185997$1$I$20240521$20240801$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-012034$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241859982$24185998$2$F$$20240920$20240807$20240920$PER$$NVSC2024US160473$NOVARTIS$$$$$M$Y$$$20240920$$HP$US$US
241859992$24185999$2$F$$20240812$20240807$20240813$EXP$$US-ABBVIE-5866782$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
241860001$24186000$1$I$20240620$20240802$20240807$20240807$EXP$GB-MHRA-MED-202408020707588650-FTPMR$GB-ESPERIONTHERAPEUTICS-2024GBR01240$ESPERION THERAPEUTICS$$$$$$Y$$$20240808$$MD$GB$GB
241860011$24186001$1$I$$20240806$20240807$20240807$PER$$NVSC2024US161075$NOVARTIS$$$$$M$Y$$$20240808$$MD$US$US
241860022$24186002$2$F$20240101$20240905$20240807$20240913$EXP$$US-ABBVIE-5867973$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
241860032$24186003$2$F$20240401$20240820$20240807$20240824$EXP$$US-ABBVIE-5868169$ABBVIE$$82$YR$$M$Y$95$KG$20240824$$CN$US$US
241860041$24186004$1$I$20240709$20240805$20240807$20240807$EXP$$CN-PFIZER INC-PV202400101812$PFIZER$$50$YR$$F$Y$50$KG$20240807$$HP$CN$CN
241860052$24186005$2$F$$20240927$20240807$20240927$EXP$$CA-PFIZER INC-202400228693$PFIZER$$44$YR$$F$Y$84.4$KG$20240927$$HP$CA$CA
241860061$24186006$1$I$20240719$20240805$20240807$20240807$EXP$ES-AEMPS-1556169$ES-PFIZER INC-202400230236$PFIZER$$50$YR$$F$Y$$$20240807$$PH$ES$ES
241860072$24186007$2$F$$20240816$20240807$20240820$EXP$$PT-PFIZER INC-202400230003$PFIZER$$85$YR$$F$Y$$$20240820$$MD$PT$PT
241860081$24186008$1$I$$20240802$20240807$20240807$EXP$$CA-PFIZER INC-202400230310$PFIZER$$$$$F$Y$$$20240807$$CN$CA$CA
241860091$24186009$1$I$20240724$20240805$20240807$20240807$EXP$PT-INFARMED-J202407-1112$PT-PFIZER INC-202400229898$PFIZER$$10$YR$$M$Y$27$KG$20240807$$PH$PT$PT
241860101$24186010$1$I$20180101$20240805$20240807$20240807$EXP$$PR-ABBVIE-5387558$ABBVIE$$$$$F$Y$45$KG$20240807$$CN$PR$PR
241860112$24186011$2$F$$20240812$20240807$20240814$EXP$$US-ABBVIE-5868623$ABBVIE$$$$$F$Y$108$KG$20240814$$CN$US$US
241860121$24186012$1$I$20231130$20240805$20240807$20240807$EXP$$IT-TAKEDA-2023TUS117652$TAKEDA$$$$E$M$Y$$$20240807$$CN$IT$IT
241860132$24186013$2$F$20240725$20240808$20240807$20240816$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000215$DENDREON$$$$$$Y$$$20240816$$HP$US$US
241860141$24186014$1$I$20240801$20240801$20240807$20240807$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000223$DENDREON$$$$$$Y$$$20240807$$HP$US$US
241860152$24186015$2$F$$20240823$20240807$20240902$30DAY$$US-GSK-US2024095411$GLAXOSMITHKLINE$$$$$M$Y$$$20240902$$MD$US$US
241860161$24186016$1$I$20240803$20240806$20240807$20240807$EXP$$US-ABBVIE-5870486$ABBVIE$$89$YR$$M$Y$$$20240807$$CN$US$US
241860171$24186017$1$I$20240729$20240801$20240807$20240807$EXP$$JP-009507513-2408JPN000140J$MERCK$$70$YR$$M$Y$$$20240807$$MD$JP$JP
241860191$24186019$1$I$20240701$20240722$20240807$20240807$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000324$Tarsus Pharmaceuticals$$85$YR$$F$Y$$$20240808$$PH$US$US
241860201$24186020$1$I$$20240806$20240807$20240807$PER$$NVSC2024US160520$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241860211$24186021$1$I$20220620$20240801$20240807$20240807$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-125014$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$$$20240808$$MD$DE$DE
241860221$24186022$1$I$$20240806$20240807$20240807$EXP$$US-ABBVIE-5869994$ABBVIE$$$$$M$Y$$$20240807$$HP$US$US
241860231$24186023$1$I$$20240802$20240807$20240807$EXP$$JP-SA-2024SA228063$SANOFI AVENTIS$$$$$F$Y$$$20240808$$CN$JP$JP
241860241$24186024$1$I$$20240805$20240807$20240807$EXP$$PL-ABBVIE-5867472$ABBVIE$$78$YR$$M$Y$$$20240807$$MD$PL$PL
241860251$24186025$1$I$$20240802$20240807$20240807$EXP$$US-ABBVIE-5870085$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241860261$24186026$1$I$$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024156038$AMGEN$$$$$$Y$$$20240807$$PH$US$US
241860272$24186027$2$F$$20240815$20240807$20240823$EXP$$CA-TAKEDA-2024TUS078927$TAKEDA$$$$$F$Y$$$20240823$$CN$CA$CA
241860281$24186028$1$I$$20240805$20240807$20240807$EXP$$CA-TAKEDA-2024TUS078926$TAKEDA$$$$$F$Y$$$20240807$$CN$CA$CA
241860291$24186029$1$I$$20240802$20240807$20240807$EXP$$TW-AMGEN-TWNSP2024156460$AMGEN$$$$A$M$Y$$$20240807$$HP$TW$TW
241860301$24186030$1$I$20231101$20240731$20240807$20240807$EXP$$US-ABBVIE-5863849$ABBVIE$$74$YR$$M$Y$77$KG$20240807$$CN$US$US
241860314$24186031$4$F$20230301$20240821$20240807$20240823$EXP$$IT-ORGANON-O2408ITA000533$ORGANON$Ferri R.; Taraschi G.; Vecchiet J.; Falasca K.; Ucciferri C.. ARE NEW LIPID LOWERING AGENTS A GOOD OPTION FOR ACHIEVE LIPID GOAL IN HIV SUBJECTS? 16th Italian Conference on AIDS and Antiviral Research (ICAR) - Italian Society of Infectious and Tropical Diseases (SIMIT).. Abstract of Congress$62$YR$$M$Y$$$20240823$$HP$IT$IT
241860321$24186032$1$I$$20240806$20240807$20240807$EXP$$CA-PFIZER INC-202400231327$PFIZER$$56$YR$$F$Y$$$20240807$$HP$CA$CA
241860341$24186034$1$I$20240804$20240805$20240807$20240807$EXP$$US-PFIZER INC-202400230368$PFIZER$$57$YR$$F$Y$131.54$KG$20240807$$CN$US$US
241860352$24186035$2$F$$20240826$20240807$20240902$EXP$$FR-TAKEDA-2024TUS078758$TAKEDA$$$$A$F$Y$$$20240902$$CN$FR$FR
241860361$24186036$1$I$20240508$20240802$20240807$20240807$EXP$FR-AFSSAPS-AN2024000998$FR-PFIZER INC-202400228813$PFIZER$$64$YR$$M$Y$77$KG$20240807$$MD$FR$FR
241860371$24186037$1$I$20240522$20240805$20240807$20240807$PER$$US-ABBVIE-5870480$ABBVIE$$68$YR$$F$Y$$$20240807$$MD$US$US
241860381$24186038$1$I$20240201$20240806$20240807$20240807$EXP$$US-ABBVIE-5870628$ABBVIE$$83$YR$$F$Y$$$20240807$$CN$US$US
241860402$24186040$2$F$20240701$20240731$20240807$20240815$EXP$$CA-ABBVIE-5864415$ABBVIE$$$$E$M$Y$$$20240815$$HP$CA$CA
241860411$24186041$1$I$20240708$20240802$20240807$20240807$EXP$$CN-BEIGENE-BGN-2024-012056$BEIGENE$$$$$$Y$$$20240807$$HP$CN$CN
241860421$24186042$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5867978$ABBVIE$$$$$M$Y$$$20240807$$CN$US$US
241860432$24186043$2$F$$20240806$20240807$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408001076$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241860451$24186045$1$I$20240803$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155878$AMGEN$$$$$$Y$$$20240807$$HP$US$US
241860461$24186046$1$I$20240118$20240626$20240807$20240807$EXP$$HU-SMPA-2024SPA000589$SUNOVION$$$$$$Y$$$20240807$$HP$GB$GB
241860471$24186047$1$I$20240601$20240805$20240807$20240807$EXP$$US-ABBVIE-5868360$ABBVIE$$43$YR$$F$Y$$$20240807$$CN$US$US
241860481$24186048$1$I$$20240807$20240807$20240807$PER$$NVSC2024US160949$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241860491$24186049$1$I$20240101$20240805$20240807$20240807$EXP$$US-ABBVIE-5868161$ABBVIE$$$$$$Y$$$20240807$$CN$US$US
241860501$24186050$1$I$$20240805$20240807$20240807$EXP$$US-ABBVIE-5869647$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241860511$24186051$1$I$$20240725$20240807$20240807$EXP$$DE-UCBSA-2024038414$UCB$$19$YR$$F$Y$$$20240808$$MD$DE$DE
241860521$24186052$1$I$$20240805$20240807$20240807$PER$$US-ABBVIE-5869503$ABBVIE$$$$$F$Y$$$20240807$$CN$US$US
241860531$24186053$1$I$20240727$20240806$20240807$20240807$EXP$$US-ABBVIE-5870237$ABBVIE$$52$YR$$M$Y$$$20240807$$CN$US$US
241860541$24186054$1$I$$20240731$20240807$20240807$PER$$US-TAKEDA-2024TUS077098$TAKEDA$$61$YR$$F$Y$66$KG$20240807$$CN$US$US
241860572$24186057$2$F$$20240726$20240807$20240809$PER$$NVSC2024US160948$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241860581$24186058$1$I$$20240724$20240807$20240807$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-118050$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240808$$HP$CA$CA
241860591$24186059$1$I$$20240731$20240807$20240807$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009824$STRIDES$Attieh RM, Brumble L, Elwasila SM, Wadei HM.. Disseminated Monkeypox Infection in a Kidney Transplant Recipient: A Case Report.. Transplant-Proc. 2023;55 (3):667-671$$$$$Y$$$20240808$$MD$US$US
241860602$24186060$2$F$20240717$20240806$20240807$20240811$EXP$$TW-ABBVIE-5864562$ABBVIE$$65$YR$$F$Y$62$KG$20240811$$CN$TW$TW
241860611$24186061$1$I$20240802$20240805$20240807$20240807$PER$$US-AMGEN-USASP2024155635$AMGEN$$63$YR$A$F$Y$$$20240807$$HP$US$US
241860621$24186062$1$I$$20240805$20240807$20240807$PER$$US-JNJFOC-20240811695$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241860631$24186063$1$I$$20240806$20240807$20240807$EXP$$US-JNJFOC-20240816646$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241860641$24186064$1$I$$20240806$20240808$20240808$EXP$GB-MHRA-MED-202408061233211950-KGVQH$GB-ORGANON-O2408GBR000488$ORGANON$$$$$M$Y$$$20240807$$CN$GB$GB
241860651$24186065$1$I$$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155376$AMGEN$$$$$$Y$$$20240807$$CN$US$US
241860661$24186066$1$I$$20240805$20240808$20240808$EXP$$GB-ABBVIE-5870007$ABBVIE$$$$E$F$Y$$$20240808$$MD$GB$GB
241860672$24186067$2$F$20240101$20240805$20240808$20240809$EXP$$ES-ABBVIE-5870058$ABBVIE$$$$$F$Y$70$KG$20240809$$CN$ES$ES
241860682$24186068$2$F$20210101$20240827$20240808$20240829$EXP$$US-ABBVIE-5287239$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
241860691$24186069$1$I$20240802$20240802$20240808$20240808$EXP$$FR-ABBVIE-5869603$ABBVIE$$73$YR$$F$Y$$$20240808$$HP$FR$FR
241860701$24186070$1$I$$20240724$20240808$20240808$PER$$US-TEVA-VS-3226429$TEVA$$71$YR$$F$Y$51.26$KG$20240808$$CN$US$US
241860711$24186071$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5869531$ABBVIE$$$$$M$Y$$$20240808$$HP$US$US
241860722$24186072$2$F$20240101$20240813$20240808$20240815$EXP$$US-ABBVIE-5761199$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
241860731$24186073$1$I$20240101$20240805$20240808$20240808$EXP$$US-ABBVIE-5867771$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241860741$24186074$1$I$$20240806$20240808$20240808$EXP$$NVSJ2024JP009514$NOVARTIS$$$$A$M$Y$$$20240808$$MD$JP$JP
241860762$24186076$2$F$20240802$20240812$20240808$20240815$PER$$US-AMGEN-USASP2024155752$AMGEN$$38$YR$A$F$Y$$$20240814$$HP$US$US
241860771$24186077$1$I$20240321$20240806$20240808$20240808$EXP$FR-AFSSAPS-NT2024000990$FR-GSK-FR2024097941$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$MD$FR$FR
241860781$24186078$1$I$20240701$20240730$20240808$20240808$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011269$JAZZ$$67$YR$$$Y$$$20240807$$MD$JP$JP
241860792$24186079$2$F$20240701$20240807$20240808$20240810$EXP$$IT-ABBVIE-5867525$ABBVIE$$79$YR$$F$Y$$$20240810$$CN$IT$IT
241860802$24186080$2$F$20240101$20240805$20240808$20240816$EXP$$US-ABBVIE-5867981$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
241860812$24186081$2$F$$20240812$20240808$20240813$PER$$US-HALEON-2190748$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
241860822$24186082$2$F$20120101$20240809$20240808$20240813$EXP$$US-ABBVIE-5868491$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
241860832$24186083$2$F$20240301$20240807$20240808$20240813$EXP$$US-ABBVIE-5865792$ABBVIE$$56$YR$$F$Y$58$KG$20240813$$HP$US$US
241860841$24186084$1$I$20240701$20240806$20240808$20240808$EXP$GB-MHRA-MED-202408011518553880-VWMGS$GB-GSK-GB2024097913$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$GB$GB
241860851$24186085$1$I$$20240730$20240808$20240808$EXP$$JP-JNJFOC-20240816223$JOHNSON AND JOHNSON$Kiso K, Shimoyama Y, Ariga Y, Yasuda Y, Ogasawara K, Matsushita R, et al. [O-11 Inflammatory bowel disease complicated by Pneumocystis pneumonia in two cases] Journal of the Tohoku Branch of the Japanese Society of Gastroenterology. The 217th Annual Meeting of the Tohoku Branch of the Japanese Society of Gastroenterology. 2024.7.5;2024.7.5;2:92$7$DEC$E$M$Y$$$20240808$$MD$JP$JP
241860861$24186086$1$I$$20240806$20240808$20240808$EXP$$US-AstraZeneca-2024A178515$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241860871$24186087$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA229141$SANOFI AVENTIS$$$$$M$Y$$$20240808$$CN$US$US
241860891$24186089$1$I$$20240725$20240808$20240808$EXP$$GB-CIPLA LTD.-2024GB08178$CIPLA$$$$$$Y$$$20240808$$CN$GB$GB
241860901$24186090$1$I$$20240806$20240808$20240808$PER$$NVSC2024US161078$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241860911$24186091$1$I$20240101$20240805$20240808$20240808$EXP$$US-ABBVIE-5869499$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241860921$24186092$1$I$20240101$20240805$20240808$20240808$EXP$$US-ABBVIE-5837632$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241860932$24186093$2$F$20240512$20240808$20240808$20240813$EXP$$US-ABBVIE-5825737$ABBVIE$$67$YR$$F$Y$$$20240813$$CN$US$US
241860941$24186094$1$I$20200519$20240805$20240808$20240808$EXP$$KR-JNJFOC-20240812760$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240808$$HP$KR$KR
241860953$24186095$3$F$20240801$20240823$20240808$20240827$PER$$US-AMGEN-USASP2024155950$AMGEN$$75$YR$E$F$Y$$$20240826$$CN$US$US
241860961$24186096$1$I$20240802$20240802$20240808$20240808$PER$$US-AMGEN-USASP2024154700$AMGEN$$83$YR$E$F$Y$$$20240807$$CN$US$US
241860971$24186097$1$I$20240726$20240801$20240808$20240808$PER$$US-SA-2024SA231861$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240808$$MD$US$US
241860981$24186098$1$I$20240101$20240731$20240808$20240808$EXP$$US-ABBVIE-5863079$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241860991$24186099$1$I$20240801$20240806$20240808$20240808$PER$$NVSC2024US161066$NOVARTIS$$$$$F$Y$$$20240808$$MD$US$US
241861001$24186100$1$I$$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124135$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$MD$US$US
241861011$24186101$1$I$20240101$20240801$20240808$20240808$EXP$$CA-CELLTRION INC.-2024CA010324$CELLTRION$$$$$$Y$$$20240808$$MD$CA$CA
241861021$24186102$1$I$$20240801$20240808$20240808$EXP$$DE-JNJFOC-20240803935$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$MD$DE$DE
241861031$24186103$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5867980$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241861041$24186104$1$I$$20240731$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR097960$VIIV$$$$$$Y$$$20240808$$HP$US$US
241861051$24186105$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA232243$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240808$$MD$US$US
241861062$24186106$2$F$20231201$20240807$20240808$20240813$EXP$$US-ABBVIE-5869743$ABBVIE$$53$YR$$F$Y$$$20240813$$CN$US$US
241861071$24186107$1$I$$20240801$20240808$20240808$EXP$$JP-JNJFOC-20240817073$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$PH$JP$JP
241861081$24186108$1$I$$20240807$20240808$20240808$30DAY$$US-SANDOZ INC.-SDZ2024US071193$SANDOZ$$68$YR$$F$Y$$$20240808$$CN$US$US
241861092$24186109$2$F$$20240807$20240808$20240809$EXP$$NVSC2024US160927$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241861102$24186110$2$F$$20240730$20240808$20240906$PER$$US-AstraZeneca-2024A174182$ASTRAZENECA$$$$$F$Y$$$20240906$$HP$US$
241861111$24186111$1$I$20240301$20240805$20240808$20240808$EXP$$US-ABBVIE-5868352$ABBVIE$$71$YR$$F$Y$$$20240808$$CN$US$US
241861121$24186112$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5867979$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241861131$24186113$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5869532$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241861141$24186114$1$I$20240101$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024156743$AMGEN$$$$$$Y$$$20240807$$CN$US$US
241861161$24186116$1$I$$20240115$20240808$20240808$EXP$$CA-HALEON-2190214$Haleon PLC$$44$YR$$F$Y$97$KG$20240807$$HP$CA$CA
241861172$24186117$2$F$20220901$20240809$20240808$20240813$EXP$$US-CIPLA LTD.-2024US08206$CIPLA$Shah N, Fontana RJ, Dib EG, Joseph N.. Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits?. American Association for the Study of Liver Diseases. 2024;23(1):e0125:1 to 5$$$$$Y$$$20240813$$HP$US$US
241861181$24186118$1$I$$20240725$20240808$20240808$EXP$$GB-CIPLA LTD.-2024GB08176$CIPLA$$$$$$Y$$$20240808$$CN$GB$GB
241861191$24186119$1$I$20240720$20240731$20240808$20240808$EXP$$CN-GSK-CN2024APC095978$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$HP$CN$CN
241861205$24186120$5$F$20240101$20240919$20240808$20240927$EXP$$JP-ROCHE-10000046631$ROCHE$$75$YR$E$M$Y$55$KG$20240927$$MD$JP$JP
241861211$24186121$1$I$$20240725$20240808$20240808$EXP$$GB-CIPLA LTD.-2024GB08177$CIPLA$$$$$$Y$$$20240808$$CN$GB$GB
241861221$24186122$1$I$$20240711$20240808$20240808$PER$$RO-TOLMAR, INC.-24RO051535$TOLMAR$$$$$$Y$$$20240808$$CN$RO$RO
241861232$24186123$2$F$20240801$20240808$20240808$20240809$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044456$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240809$$CN$US$US
241861242$24186124$2$F$20240805$20240813$20240808$20240819$PER$$US-AMGEN-USASP2024155394$AMGEN$$74$YR$E$F$Y$$$20240819$$CN$US$US
241861251$24186125$1$I$20240101$20240801$20240808$20240808$EXP$$US-SA-2024SA231005$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240808$$MD$US$US
241861261$24186126$1$I$19880101$20240730$20240808$20240808$EXP$$US-ABBVIE-5860913$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241861271$24186127$1$I$20240101$20240801$20240808$20240808$EXP$$US-ABBVIE-5865245$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241861291$24186129$1$I$$20240731$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124288$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$109.77$KG$20240808$$CN$US$US
241861302$24186130$2$F$20230501$20240809$20240808$20240814$EXP$$US-ABBVIE-5868056$ABBVIE$$66$YR$$F$Y$$$20240814$$CN$PR$PR
241861311$24186131$1$I$$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123352$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240808$$HP$US$US
241861321$24186132$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870306$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241861331$24186133$1$I$$20240730$20240808$20240808$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009724$STRIDES$Sun H, Zhu Y, Li J, Zhao L, Yang G, Yan Z, et al.. Picalm::MLLT10 can Identify a New Subgroup of Acute Leukemias of Ambiguous Lineage with Unique Extramedullary Disease and Treatment Response.. Blood. 2023;142 (Suppl. 1):6078.$28$YR$$F$Y$$$20240808$$HP$CN$CN
241861342$24186134$2$F$20240229$20240816$20240808$20240821$EXP$$NVSC2024PT159611$NOVARTIS$$51$YR$$M$Y$$$20240821$$MD$PT$PT
241861351$24186135$1$I$$20240802$20240808$20240808$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00387$VELOXIS PHARMACEUTICALS$Bae E K, Chandran M M, Everitt M D, Benz E, Bock M.. LCP-tacrolimus extended-release (Envarsus XR) use in adolescent and young adult solid organ transplant recipients.. Clinical Transplantation. 2024;38:e15417:1-7$20$YR$$M$Y$$$20240808$$HP$US$US
241861361$24186136$1$I$20220606$20220719$20240808$20240808$EXP$$US-AstraZeneca-2022A261007$ASTRAZENECA$$25691$DY$$F$Y$55.3$KG$20240808$$CN$US$
241861371$24186137$1$I$$20240731$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408001188$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240808$$CN$US$US
241861381$24186138$1$I$$20240731$20240808$20240808$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP009852$STRIDES$Cowan TL, Makhija M, Murrell DF.. Pemphigoid gestationis and preeclampsia in a donor-egg IVF pregnancy.. Int-J-Womens-Dermatol. 2022;8$$$$M$Y$$$20240808$$MD$AU$AU
241861391$24186139$1$I$$20240802$20240808$20240808$EXP$$MA-STRIDES ARCOLAB LIMITED-2024SP009860$STRIDES$Jamal A, Draoui N, Assarrar I, Rouf S, Latrech H.. Apoplexy of a giant clival ectopic prolactinoma: A very rare case report.. International Journal of Surgery Case Reports. 2024;120:109874$45$YR$$F$Y$$$20240808$$HP$MA$MA
241861402$24186140$2$F$20240724$20240904$20240808$20240904$PER$$US-ALXN-202408USA000049US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
241861411$24186141$1$I$$20240801$20240808$20240808$PER$$US-ALXN-202408USA000036US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
241861421$24186142$1$I$$20240802$20240808$20240808$EXP$$CA-STRIDES ARCOLAB LIMITED-2024SP009861$STRIDES$Guay-Gagnon M, Cheng R, Beauregard C, Lacroix A.. ACTH-dependent Cushing Syndrome with No Peripheral Response But a Marked Petrosal Sinus ACTH Response to Desmopressin.. JCEM Case Reports. 2024;2(6):luae092$32$YR$$M$Y$$$20240808$$HP$CA$CA
241861431$24186143$1$I$$20240806$20240808$20240808$PER$$US-ROCHE-10000050426$ROCHE$$75$YR$E$M$Y$$$20240808$$CN$US$US
241861441$24186144$1$I$$20240806$20240808$20240808$PER$$US-ROCHE-10000050734$ROCHE$$$$E$F$Y$$$20240808$$CN$US$US
241861452$24186145$2$F$20240101$20240828$20240808$20240904$EXP$$JP-GENMAB-2024-02770$GENMAB$$75$YR$$F$Y$$$20240904$$MD$JP$JP
241861461$24186146$1$I$20220207$20220228$20240808$20240808$EXP$$BE-BIOVITRUM-2022BE03376$BIOVITRUM$$275$DY$$M$Y$6$KG$20240808$$HP$BE$BE
241861471$24186147$1$I$$20240806$20240808$20240808$EXP$$US-TAKEDA-2024TUS078949$TAKEDA$$$$$M$Y$$$20240808$$HP$US$US
241861481$24186148$1$I$20240806$20240806$20240808$20240808$EXP$GB-MHRA-TPP17351013C10420834YC1722950063950$GB-ORGANON-O2408GBR000509$ORGANON$$85$YR$$F$Y$74$KG$20240808$$MD$GB$GB
241861491$24186149$1$I$20220414$20220422$20240808$20240808$EXP$$ZA-BIOVITRUM-2022ZA05796$BIOVITRUM$$155$DY$$F$Y$6.3$KG$20240808$$CN$ZA$ZA
241861501$24186150$1$I$20220310$20220506$20240808$20240808$EXP$$ZA-BIOVITRUM-2022ZA04171$BIOVITRUM$$82$DY$$M$Y$2.4$KG$20240808$$MD$ZA$ZA
241861521$24186152$1$I$$20240731$20240808$20240808$PER$$US-SA-2023SA295204$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240808$$MD$US$US
241861531$24186153$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231877$SANOFI AVENTIS$$$$T$F$Y$$$20240808$$MD$US$US
241861541$24186154$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231247$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240808$$CN$US$US
241861551$24186155$1$I$20240712$20240725$20240808$20240808$EXP$$CN-Techdow-J2024HPR000479$SHENZHEN TECHDOW PHARMACEUTICAL$$66$YR$E$M$Y$80$KG$20240808$$MD$CN$CN
241861561$24186156$1$I$20240101$20240801$20240808$20240808$EXP$$CA-ABBVIE-5865665$ABBVIE$$$$A$M$Y$103$KG$20240808$$CN$CA$CA
241861571$24186157$1$I$$20240728$20240808$20240808$EXP$$US-JNJFOC-20240780194$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$MD$US$US
241861582$24186158$2$F$$20240808$20240808$20240818$EXP$$JP-AMGEN-JPNSP2024156277$AMGEN$$$$$$Y$$$20240818$$PH$JP$JP
241861591$24186159$1$I$20240803$20240805$20240808$20240808$PER$$US-JNJFOC-20240811366$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241861601$24186160$1$I$$20240801$20240808$20240808$EXP$$US-EMD Serono-2024042088$EMD SERONO INC$$$$$F$Y$$$20240808$$CN$US$US
241861611$24186161$1$I$$20240801$20240808$20240808$EXP$$US-ABBVIE-5864796$ABBVIE$$$$$F$Y$92$KG$20240808$$CN$US$US
241861621$24186162$1$I$$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123299$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$64.86$KG$20240808$$CN$US$US
241861634$24186163$4$F$20240729$20240917$20240808$20240926$30DAY$$US-JNJFOC-20240814415$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240926$$HP$US$US
241861641$24186164$1$I$20240730$20240803$20240808$20240808$EXP$$CN-JNJFOC-20240809431$JOHNSON AND JOHNSON$$57$YR$A$M$Y$66.5$KG$20240808$$HP$CN$CN
241861651$24186165$1$I$$20240729$20240808$20240808$EXP$$IR-NOVITIUMPHARMA-2024IRNVP01463$NOVITIUM PHARMA$Amin Tajerian.Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Myocarditis: A Case Report and Literature Review on Fatal Complications of Reactivated Viral Infections.Iranian Journal of Allergy, Asthma and Immunology.05-JUN-2024;23(3):339-346$21$YR$A$F$Y$$$20240808$$HP$IR$IR
241861661$24186166$1$I$20231101$20240806$20240808$20240808$PER$$US-ABBVIE-5871277$ABBVIE$$$$A$F$Y$$$20240808$$MD$US$US
241861672$24186167$2$F$20230101$20240809$20240808$20240816$EXP$$US-ABBVIE-5867658$ABBVIE$$$$$M$Y$69.853$KG$20240816$$CN$US$US
241861682$24186168$2$F$20240729$20240904$20240808$20240905$PER$$US-JNJFOC-20240814098$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240905$$CN$US$US
241861691$24186169$1$I$$20240801$20240808$20240808$EXP$$US-ABBVIE-5865752$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241861701$24186170$1$I$20240804$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155748$AMGEN$$83$YR$E$M$Y$$$20240807$$CN$US$US
241861711$24186171$1$I$20240618$20240802$20240808$20240808$EXP$$ES-AMGEN-ESPSP2024137476$AMGEN$$78$YR$E$F$Y$78$KG$20240807$$MD$ES$ES
241861721$24186172$1$I$20240729$20240730$20240808$20240808$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02801$AMNEAL$$56$YR$$F$Y$$$20240808$$CN$US$US
241861731$24186173$1$I$20240720$20240801$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012040$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241861741$24186174$1$I$$20240731$20240808$20240808$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000279$EMCURE$Manuel SL, Sapone J, Lin F.. Tacrolimus-Induced Recurrent Acute Coronary Syndrome Due to an Unknown Mechanism. Cureus. 2024;16(6):e63266$74$YR$$F$Y$$$20240808$$HP$US$US
241861751$24186175$1$I$$20221007$20240808$20240808$EXP$$US-AstraZeneca-2022A342615$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241861761$24186176$1$I$$20240802$20240808$20240808$EXP$$US-ABBVIE-4288036$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241861771$24186177$1$I$$20240807$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044468$BOEHRINGER INGELHEIM$$$$$$Y$$$20240808$$CN$US$US
241861781$24186178$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231845$SANOFI AVENTIS$$$$C$F$Y$$$20240808$$MD$US$US
241861791$24186179$1$I$$20240806$20240808$20240808$EXP$$RO-ROCHE-10000051154$ROCHE$$$$$M$Y$$$20240808$$PH$RO$RO
241861801$24186180$1$I$$20240731$20240808$20240808$PER$$US-ABBVIE-5862801$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241861811$24186181$1$I$20240721$20240731$20240808$20240808$EXP$$CN-EMD Serono-2024041639$EMD SERONO INC$$29$YR$A$F$Y$82$KG$20240808$$HP$CN$CN
241861821$24186182$1$I$20240804$20240806$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012264$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241861831$24186183$1$I$20220301$20220622$20240808$20240808$EXP$$US-AstraZeneca-2022A232067$ASTRAZENECA$$62$YR$$F$Y$$$20240808$$HP$US$
241861841$24186184$1$I$$20230830$20240808$20240808$EXP$$GB-AstraZeneca-2023A197998$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$GB$
241861851$24186185$1$I$20240101$20240729$20240808$20240808$PER$$US-AstraZeneca-2024A172756$ASTRAZENECA$$69$YR$$M$Y$$$20240808$$CN$US$
241861861$24186186$1$I$$20230901$20240808$20240808$EXP$$US-AstraZeneca-2023A174290$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241861872$24186187$2$F$20240518$20240902$20240808$20240904$EXP$$CA-SANDOZ INC.-SDZ2024CA052121$SANDOZ$$28$YR$$M$Y$$$20240904$$HP$CA$CA
241861881$24186188$1$I$$20221006$20240808$20240808$EXP$$US-AstraZeneca-2022A342160$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241861891$24186189$1$I$$20230920$20240808$20240808$EXP$$US-AstraZeneca-2023A216841$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241861901$24186190$1$I$$20230623$20240808$20240808$EXP$$US-AstraZeneca-2023A146544$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241861912$24186191$2$F$$20240819$20240808$20240819$EXP$$JP-SA-2024SA230883$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240820$$MD$JP$JP
241861921$24186192$1$I$$20230509$20240808$20240808$EXP$$US-AstraZeneca-2023A108335$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241861932$24186193$2$F$20240101$20240731$20240808$20240809$PER$$US-SA-2024SA229357$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240809$$MD$US$US
241861942$24186194$2$F$20240101$20240809$20240808$20240813$PER$$US-AMGEN-USASP2024155882$AMGEN$$56$YR$A$F$Y$$$20240812$$HP$US$US
241861951$24186195$1$I$20240601$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155639$AMGEN$$54$YR$A$F$Y$$$20240807$$MD$US$US
241861961$24186196$1$I$20240722$20240801$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012042$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241861971$24186197$1$I$20240501$20240731$20240808$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116594$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240808$$PH$JP$JP
241861982$24186198$2$F$$20240806$20240808$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124912$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240812$$CN$US$US
241861991$24186199$1$I$20240720$20240731$20240808$20240808$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000135-2024$QILU PHARMACEUTICAL$$52$YR$A$F$Y$50$KG$20240808$$HP$CN$CN
241862002$24186200$2$F$20240802$20240802$20240808$20240811$PER$$US-AMGEN-USASP2024155006$AMGEN$$49$YR$A$F$Y$$$20240811$$CN$US$US
241862011$24186201$1$I$$20240802$20240808$20240808$EXP$$US-GSK-US2022025089$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
241862021$24186202$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA232109$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240808$$MD$US$US
241862031$24186203$1$I$20240628$20240729$20240808$20240808$PER$$US-SA-2024SA229375$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240808$$MD$US$US
241862041$24186204$1$I$20240101$20240801$20240808$20240808$PER$$US-SA-2024SA230499$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240808$$MD$US$US
241862054$24186205$4$F$20240807$20240904$20240808$20240905$PER$$US-AMGEN-USASP2024156478$AMGEN$$74$YR$E$M$Y$$$20240904$$CN$US$US
241862061$24186206$1$I$$20240724$20240808$20240808$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-125128$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240808$$HP$CA$CA
241862071$24186207$1$I$$20240729$20240808$20240808$EXP$$US-EMD Serono-2024041166$EMD SERONO INC$$40$YR$A$F$Y$$$20240808$$CN$US$US
241862082$24186208$2$F$20240101$20240819$20240808$20240820$EXP$$US-UCBSA-2024039620$UCB$$$$$F$Y$$$20240820$$CN$US$US
241862091$24186209$1$I$$20240729$20240808$20240808$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01465$NOVITIUM PHARMA$Fanfan Xing.Rapid diagnosis of fatal Nocardia kroppenstedtii bacteremic pneumonia and empyema thoracis by next-generation sequencing: a case report.Frontiers in Medicine.18-JUL-2023;10:1-6$71$YR$E$F$Y$$$20240808$$HP$CN$CN
241862103$24186210$3$F$$20240807$20240808$20240813$PER$$US-ROCHE-10000049945$ROCHE$$56$YR$A$F$Y$93.44$KG$20240813$$CN$US$US
241862112$24186211$2$F$$20240823$20240808$20240829$EXP$$JP-JNJFOC-20240818491$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$PH$JP$JP
241862121$24186212$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003785$ELI LILLY AND CO$$$$T$$Y$$$20240808$$CN$US$US
241862131$24186213$1$I$$20240805$20240808$20240808$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001577$BLUEPRINT MEDICINES$$$$$F$Y$$$20240808$$CN$US$US
241862151$24186215$1$I$20240717$20240806$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012265$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241862161$24186216$1$I$$20240730$20240808$20240808$PER$$US-CHATTEMPRD-2024OHG026235$CHATTEM$$$$$$Y$$$20240808$$CN$US$US
241862172$24186217$2$F$20240701$20240807$20240808$20240809$PER$$US-AMGEN-USASP2024156237$AMGEN$$71$YR$E$F$Y$$$20240809$$CN$US$US
241862181$24186218$1$I$20240418$20240731$20240808$20240808$EXP$$AU-AMGEN-AUSSP2024155105$AMGEN$$73$YR$E$M$Y$$$20240807$$HP$AU$AU
241862191$24186219$1$I$$20220819$20240808$20240808$EXP$$US-AstraZeneca-2022A292681$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241862201$24186220$1$I$20211201$20220117$20240808$20240808$EXP$$US-AstraZeneca-2022A033322$ASTRAZENECA$$926$MON$$F$Y$81$KG$20240808$$CN$US$
241862211$24186221$1$I$$20221019$20240808$20240808$EXP$$US-AstraZeneca-2022A351806$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241862221$24186222$1$I$20220619$20220705$20240808$20240808$EXP$$US-AstraZeneca-2022A246790$ASTRAZENECA$$57$YR$$M$Y$$$20240808$$CN$US$
241862231$24186223$1$I$$20240731$20240808$20240808$EXP$$IT-BIOGEN-2024BI01274538$BIOGEN$$$$$M$Y$$$20240808$$MD$IT$IT
241862241$24186224$1$I$$20220809$20240808$20240808$EXP$$US-AstraZeneca-2022A283100$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241862251$24186225$1$I$$20220623$20240808$20240808$EXP$$US-AstraZeneca-2022A237671$ASTRAZENECA$$$$$$Y$$$20240808$$MD$US$
241862261$24186226$1$I$$20240729$20240808$20240808$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01189$NOVITIUM PHARMA$Islam Amine Larabi.Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).Toxicologie Analytique et Clinique.10-AUG-2023;35(3):175-197$43$YR$A$M$Y$$$20240808$$HP$FR$FR
241862272$24186227$2$F$$20240814$20240808$20240821$PER$$US-AMGEN-USASP2024153604$AMGEN$$58$YR$A$M$Y$$$20240821$$MD$US$US
241862281$24186228$1$I$20240802$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156774$AMGEN$$$$$M$Y$$$20240807$$CN$US$US
241862291$24186229$1$I$$20240731$20240808$20240808$EXP$$AU-AMGEN-AUSSP2024152988$AMGEN$$55$YR$A$F$Y$$$20240807$$HP$AU$AU
241862301$24186230$1$I$20240525$20240731$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-011944$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241862311$24186231$1$I$$20240731$20240808$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123722$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$PH$JP$JP
241862321$24186232$1$I$20230510$20240731$20240808$20240808$EXP$$FR-EMD Serono-2024041415$EMD SERONO INC$$68$YR$E$F$Y$100$KG$20240808$$MD$FR$FR
241862331$24186233$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5868615$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241862341$24186234$1$I$20240711$20240731$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-011950$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241862351$24186235$1$I$20240727$20240727$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038072$AUROBINDO$$60$YR$$M$Y$78$KG$20240808$$MD$GB$GB
241862361$24186236$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683354$GILEAD$$$$$$Y$$$20240807$$LW$US$US
241862371$24186237$1$I$20240712$20240730$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-011894$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241862381$24186238$1$I$20240708$20240731$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-011970$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241862391$24186239$1$I$$20240801$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122948$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240808$$MD$US$US
241862401$24186240$1$I$20240804$20240804$20240808$20240808$PER$$US-CHATTEMPRD-2024OHG026188$CHATTEM$$$$E$F$Y$$$20240808$$CN$US$US
241862411$24186241$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125099$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240808$$CN$US$US
241862421$24186242$1$I$$20240802$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124282$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$85.73$KG$20240808$$CN$US$US
241862431$24186243$1$I$$20240805$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124369$BRISTOL MYERS SQUIBB$$98$YR$E$M$Y$$$20240808$$CN$US$US
241862441$24186244$1$I$$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124838$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240808$$HP$US$US
241862451$24186245$1$I$$20240802$20240808$20240808$PER$$US-CHATTEMPRD-2024OHG026197$CHATTEM$$$$$F$Y$$$20240808$$CN$US$US
241862462$24186246$2$F$$20240729$20240808$20240814$PER$$US-CHATTEMPRD-2024OHG025740$CHATTEM$$$$A$$Y$$$20240814$$CN$US$US
241862472$24186247$2$F$20240101$20240904$20240808$20240911$EXP$$US-GSK-US2024096941$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$US$US
241862491$24186249$1$I$20240718$20240729$20240808$20240808$30DAY$$US-GSK-US2024094720$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240808$$CN$US$US
241862501$24186250$1$I$20240701$20240730$20240808$20240808$PER$$US-SA-2024SA232113$SANOFI AVENTIS$$70$YR$E$M$Y$92.98$KG$20240808$$MD$US$US
241862511$24186251$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA232108$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240808$$MD$US$US
241862522$24186252$2$F$20240804$20240807$20240808$20240809$PER$$US-AMGEN-USASP2024156963$AMGEN$$57$YR$A$F$Y$$$20240808$$CN$US$US
241862534$24186253$4$F$20240731$20240820$20240808$20240823$PER$$US-AMGEN-USASP2024156516$AMGEN$$86$YR$E$F$Y$$$20240823$$CN$US$US
241862542$24186254$2$F$$20240911$20240808$20240911$PER$$US-ALXN-202408USA000065US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
241862551$24186255$1$I$20240201$20240805$20240808$20240808$EXP$$US-009507513-2408USA001306$MERCK$$50$YR$$F$Y$$$20240808$$CN$US$US
241862581$24186258$1$I$$20240729$20240808$20240808$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01485$NOVITIUM PHARMA$Islam Amine Larabi.Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).Toxicologie Analytique et Clinique.10-AUG-2023;35(3):175-197$47$YR$A$M$Y$$$20240808$$HP$FR$FR
241862592$24186259$2$F$$20240903$20240808$20240912$EXP$$US-TEVA-VS-3228267$TEVA$Simpson T, Aljareh A, Shah U, Yoon S, Petrovic Elbaz M, Khan Z, et al. Atypical Presentation of Rhinovirus Infection With Rapid Deterioration Requiring Mechanical Ventilation. Am-J-Respir-Crit-Care-Med 2023; 207.; Simpson T, Aljareh A, Shah U, Yoon S, Petrovic Elbaz M, Khan Z, et al. Atypical Presentation of Rhinovirus Infection With Rapid Deterioration Requiring Mechanical Ventilation. Am-J-Respir-Crit-Care-Med 2023; 207.$45$YR$$M$Y$$$20240912$$HP$US$US
241862602$24186260$2$F$20240101$20240719$20240808$20240831$PER$$US-TEVA-VS-3222860$TEVA$$85$YR$$F$Y$41.28$KG$20240831$$CN$US$US
241862611$24186261$1$I$20240709$20240801$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012044$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241862621$24186262$1$I$$20221212$20240808$20240808$EXP$$US-AstraZeneca-2022A405289$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241862631$24186263$1$I$$20230307$20240808$20240808$EXP$$US-AstraZeneca-2023A056535$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241862641$24186264$1$I$$20220422$20240808$20240808$EXP$$US-AstraZeneca-2022A162550$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241862651$24186265$1$I$20240601$20240729$20240808$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011009$JAZZ$$23$YR$$F$Y$$$20240807$$CN$US$US
241862661$24186266$1$I$20220406$20220527$20240808$20240808$EXP$$US-AstraZeneca-2022A147685$ASTRAZENECA$$31513$DY$$M$Y$$$20240808$$CN$US$
241862671$24186267$1$I$$20220401$20240808$20240808$EXP$$US-AstraZeneca-2022A138538$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241862681$24186268$1$I$20220702$20220712$20240808$20240808$EXP$$US-AstraZeneca-2022A253131$ASTRAZENECA$$33468$DY$$M$Y$$$20240808$$CN$US$
241862691$24186269$1$I$$20230620$20240808$20240808$EXP$$US-AstraZeneca-2023A142943$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241862701$24186270$1$I$$20220615$20240808$20240808$EXP$$US-AstraZeneca-2022A223469$ASTRAZENECA$$$$$M$Y$93.9$KG$20240808$$CN$US$
241862711$24186271$1$I$$20240806$20240808$20240808$EXP$$US-AstraZeneca-2024A179038$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241862721$24186272$1$I$$20220510$20240808$20240808$EXP$$US-AstraZeneca-2022A181640$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241862731$24186273$1$I$20240707$20240731$20240808$20240808$EXP$SE-SEMPA-2024-005516$SE-HALEON-2190753$Haleon PLC$$44$YR$$M$Y$$$20240808$$MD$SE$SE
241862741$24186274$1$I$$20220323$20240808$20240808$EXP$$US-AstraZeneca-2022A126081$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241862751$24186275$1$I$$20230703$20240808$20240808$EXP$$US-AstraZeneca-2023A153401$ASTRAZENECA$$$$$M$Y$$$20240808$$MD$US$
241862761$24186276$1$I$$20230109$20240808$20240808$EXP$$US-AstraZeneca-2023A006367$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241862771$24186277$1$I$$20221121$20240808$20240808$EXP$$US-AstraZeneca-2022A385025$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241862781$24186278$1$I$$20220621$20240808$20240808$EXP$$US-AstraZeneca-2022A229816$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241862791$24186279$1$I$$20230815$20240808$20240808$EXP$$MX-AstraZeneca-2023A188455$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$MX$
241862801$24186280$1$I$$20220624$20240808$20240808$EXP$$US-AstraZeneca-2022A235334$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241862811$24186281$1$I$$20230414$20240808$20240808$EXP$$US-AstraZeneca-2023A088472$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241862821$24186282$1$I$$20230620$20240808$20240808$EXP$$US-AstraZeneca-2023A144092$ASTRAZENECA$$$$$F$Y$50.8$KG$20240808$$CN$US$
241862831$24186283$1$I$$20220909$20240808$20240808$EXP$$US-AstraZeneca-2022A316059$ASTRAZENECA$$$$$$Y$72.6$KG$20240808$$CN$US$
241862841$24186284$1$I$$20230613$20240808$20240808$EXP$$US-AstraZeneca-2023A138959$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241862851$24186285$1$I$$20221227$20240808$20240808$EXP$$US-AstraZeneca-2022A418774$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241862861$24186286$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA232025$SANOFI AVENTIS$$10$YR$C$M$Y$42.2$KG$20240808$$MD$US$US
241862871$24186287$1$I$20240601$20240801$20240808$20240808$PER$$US-SA-2024SA231897$SANOFI AVENTIS$$74$YR$E$F$Y$55.3$KG$20240808$$CN$US$US
241862881$24186288$1$I$20240701$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002997$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240808$$CN$US$US
241862901$24186290$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003993$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240808$$CN$US$US
241862911$24186291$1$I$20240806$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003852$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240808$$CN$US$US
241862921$24186292$1$I$20240729$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002976$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240808$$CN$US$US
241862931$24186293$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003332$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240808$$CN$US$US
241862952$24186295$2$F$20240405$20240920$20240808$20240926$EXP$$MX-TAKEDA-2024TUS035443$TAKEDA$$12$YR$$M$Y$$$20240926$$CN$MX$MX
241862961$24186296$1$I$20240722$20240801$20240808$20240808$EXP$$JP-GENMAB-2024-02799$GENMAB$$77$YR$$M$Y$$$20240808$$MD$JP$JP
241862971$24186297$1$I$20240802$20240805$20240808$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012013$JAZZ$$13$YR$$F$Y$$$20240807$$HP$US$US
241862981$24186298$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231893$SANOFI AVENTIS$$$$E$M$Y$$$20240808$$MD$US$US
241862991$24186299$1$I$$20240728$20240808$20240808$EXP$$JP-Accord-439478$ACCORD$Tasaki Y, Yamazaki T, Miyazaki S, Takeda T, Nakatake M, Nakamura D, et al. Additional chemoradiotherapy for superficial esophageal squamous cell carcinoma after near-circumferential or full-circumferential noncurative endoscopic submucosal dissection: a retrospective study. BMC Gastroenterol. 2024 Jul 23;24(1):232.$$$$$Y$$$20240807$$HP$JP$JP
241863001$24186300$1$I$$20240728$20240808$20240808$EXP$$JP-Accord-439982$ACCORD$Tasaki Y, Yamazaki T, Miyazaki S, Takeda T, Nakatake M, Nakamura D, et al. Additional chemoradiotherapy for superficial esophageal squamous cell carcinoma after near-circumferential or full-circumferential noncurative endoscopic submucosal dissection: a retrospective study. BMC Gastroenterol. 2024 Jul 23;24(1):232.$$$$$Y$$$20240807$$HP$JP$JP
241863011$24186301$1$I$20240729$20240731$20240808$20240808$EXP$$CO-BIOVITRUM-2024-CO-010722$BIOVITRUM$$130$DY$$F$Y$$$20240808$$CN$CO$CO
241863021$24186302$1$I$$20240729$20240808$20240808$30DAY$$US-GSK-US2024094732$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240808$$CN$US$US
241863041$24186304$1$I$20240501$20240611$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091315$VIIV$$44$YR$$M$Y$$$20240808$$PH$US$US
241863051$24186305$1$I$20240501$20240611$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090849$VIIV$$37$YR$$M$Y$$$20240808$$PH$US$US
241863061$24186306$1$I$20240501$20240611$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091295$VIIV$$42$YR$$M$Y$$$20240808$$PH$US$US
241863071$24186307$1$I$20240501$20240611$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR090847$VIIV$$34$YR$$M$Y$$$20240808$$PH$US$US
241863081$24186308$1$I$20240501$20240611$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091509$VIIV$$53$YR$$M$Y$$$20240808$$PH$US$US
241863091$24186309$1$I$20240501$20240611$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091172$VIIV$$27$YR$$M$Y$$$20240808$$PH$US$US
241863101$24186310$1$I$20240501$20240611$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091511$VIIV$$24$YR$$M$Y$$$20240808$$PH$US$US
241863111$24186311$1$I$20240501$20240611$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091179$VIIV$$58$YR$$M$Y$$$20240808$$PH$US$US
241863121$24186312$1$I$20240701$20240802$20240808$20240808$PER$$US-AMGEN-USASP2024154747$AMGEN$$53$YR$A$M$Y$$$20240807$$CN$US$US
241863132$24186313$2$F$20240802$20240813$20240808$20240820$30DAY$$US-AMGEN-USASP2024154938$AMGEN$$42$YR$A$F$Y$105$KG$20240820$$PH$US$US
241863142$24186314$2$F$20240730$20240813$20240808$20240819$PER$$US-AMGEN-USASP2024154478$AMGEN$$68$YR$E$F$Y$112$KG$20240819$$HP$US$US
241863151$24186315$1$I$20240501$20240611$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091311$VIIV$$38$YR$$M$Y$$$20240808$$PH$US$US
241863161$24186316$1$I$20240501$20240611$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR091298$VIIV$$34$YR$$M$Y$$$20240808$$PH$US$US
241863171$24186317$1$I$20240102$20240806$20240808$20240808$EXP$ES-AEMPS-1555832$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043960$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$51.1$KG$20240808$$MD$ES$ES
241863183$24186318$3$F$20240731$20240904$20240808$20240913$EXP$$US-BEH-2024176799$CSL BEHRING$$61$YR$A$F$Y$$$20240913$$CN$US$US
241863191$24186319$1$I$20240806$20240806$20240808$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012021$JAZZ$$44$YR$$M$Y$$$20240807$$CN$US$US
241863201$24186320$1$I$20240718$20240731$20240808$20240808$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022757$UNITED THERAPEUTICS$$45$YR$$F$Y$50.794$KG$20240808$$$US$US
241863211$24186321$1$I$$20240806$20240808$20240808$PER$$US-JNJFOC-20240814579$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$HP$US$US
241863221$24186322$1$I$$20240729$20240808$20240808$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01486$NOVITIUM PHARMA$Islam Amine Larabi.Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).Toxicologie Analytique et Clinique.10-AUG-2023;35(3):175-197$44$YR$A$M$Y$$$20240808$$HP$FR$FR
241863231$24186323$1$I$$20240730$20240808$20240808$PER$$US-JNJFOC-20240802073$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240808$$CN$US$US
241863241$24186324$1$I$20240718$20240730$20240808$20240808$PER$$US-SA-2024SA230278$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240808$$MD$US$US
241863251$24186325$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA229356$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240808$$MD$US$US
241863261$24186326$1$I$$20240806$20240808$20240808$PER$$US-BEH-2024176880$CSL BEHRING$$$$$M$Y$$$20240808$$MD$US$US
241863271$24186327$1$I$$20240806$20240808$20240808$PER$$US-TAKEDA-2024TUS078905$TAKEDA$$$$$$Y$$$20240808$$CN$US$US
241863281$24186328$1$I$$20240731$20240808$20240808$EXP$$AU-AMGEN-AUSSP2024155073$AMGEN$$42$YR$A$F$Y$$$20240807$$HP$AU$AU
241863292$24186329$2$F$20240711$20240807$20240808$20240813$30DAY$$US-AMGEN-USASP2024155201$AMGEN$$52$YR$A$F$Y$83$KG$20240812$$PH$US$US
241863301$24186330$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124987$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240808$$HP$US$US
241863311$24186331$1$I$$20240805$20240808$20240808$PER$$US-TAKEDA-2024TUS078763$TAKEDA$$$$$M$Y$$$20240808$$CN$US$US
241863322$24186332$2$F$$20240805$20240808$20240808$EXP$$US-ROCHE-10000049304$ROCHE$$$$$$Y$$$20240808$$CN$US$US
241863331$24186333$1$I$$20220708$20240808$20240808$EXP$$TW-AstraZeneca-2022A252953$ASTRAZENECA$$53$YR$$M$Y$$$20240808$$CN$TW$
241863341$24186334$1$I$$20211202$20240808$20240808$EXP$$US-AstraZeneca-2021A854099$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241863351$24186335$1$I$$20230717$20240808$20240808$EXP$$US-AstraZeneca-2023A164115$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241863361$24186336$1$I$$20240802$20240808$20240808$PER$$US-BIOGEN-2023BI01207703$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241863372$24186337$2$F$20240101$20240806$20240808$20240812$PER$$US-BIOGEN-2024BI01277023$BIOGEN$$$$$M$Y$$$20240812$$CN$US$US
241863381$24186338$1$I$$20240801$20240808$20240808$PER$$US-BIOGEN-2024BI01277034$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241863401$24186340$1$I$20210101$20220111$20240808$20240808$EXP$$GT-AstraZeneca-2022A022199$ASTRAZENECA$$22$YR$$M$Y$$$20240808$$CN$GT$
241863411$24186341$1$I$$20240806$20240808$20240808$PER$$US-BIOGEN-2024BI01276817$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241863421$24186342$1$I$$20240802$20240808$20240808$PER$$US-BIOGEN-2023BI01197569$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241863431$24186343$1$I$$20221017$20240808$20240808$EXP$$US-AstraZeneca-2022A349660$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241863441$24186344$1$I$$20230526$20240808$20240808$EXP$$US-AstraZeneca-2023A123648$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241863452$24186345$2$F$20210801$20211001$20240808$20240915$EXP$$US-AstraZeneca-2021A757790$ASTRAZENECA$$560$MON$$M$Y$95.3$KG$20240916$$CN$US$
241863461$24186346$1$I$20220316$20230503$20240808$20240808$EXP$$CA-AstraZeneca-2023A067529$ASTRAZENECA$$20688$DY$$F$Y$$$20240808$$CN$CA$
241863471$24186347$1$I$$20220822$20240808$20240808$EXP$$US-AstraZeneca-2022A294836$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241863481$24186348$1$I$$20220728$20240808$20240808$EXP$$US-AstraZeneca-2022A270725$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241863491$24186349$1$I$20210920$20211021$20240808$20240808$EXP$$US-AstraZeneca-2021A785895$ASTRAZENECA$$24034$DY$$F$Y$$$20240808$$CN$US$
241863501$24186350$1$I$$20230131$20240808$20240808$EXP$$US-AstraZeneca-2023A027091$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241863511$24186351$1$I$$20230810$20240808$20240808$EXP$$US-AstraZeneca-2023A183842$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241863521$24186352$1$I$$20230811$20240808$20240808$EXP$$US-AstraZeneca-2023A186550$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241863531$24186353$1$I$$20231006$20240808$20240808$EXP$$US-AstraZeneca-2023A228560$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241863541$24186354$1$I$$20210902$20240808$20240808$EXP$$US-AstraZeneca-2021A712159$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241863551$24186355$1$I$$20230210$20240808$20240808$EXP$$US-AstraZeneca-2023A036654$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241863561$24186356$1$I$$20210611$20240808$20240808$EXP$$US-AstraZeneca-2021A524874$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241863571$24186357$1$I$$20230104$20240808$20240808$EXP$$CA-AstraZeneca-2023A003159$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$CA$
241863581$24186358$1$I$$20240730$20240808$20240808$PER$$US-AstraZeneca-2024A177293$ASTRAZENECA$$$$$$Y$$$20240808$$HP$US$
241863591$24186359$1$I$$20220107$20240808$20240808$EXP$$US-AstraZeneca-2022A012895$ASTRAZENECA$$57$YR$$F$Y$73.5$KG$20240808$$CN$US$
241863601$24186360$1$I$20210915$20211206$20240808$20240808$EXP$$US-AstraZeneca-2021A859887$ASTRAZENECA$$23736$DY$$F$Y$$$20240808$$CN$US$
241863611$24186361$1$I$$20211109$20240808$20240808$EXP$$US-AstraZeneca-2021A765896$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241863621$24186362$1$I$$20230419$20240808$20240808$EXP$$US-AstraZeneca-2023A091784$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241863631$24186363$1$I$20240101$20240731$20240808$20240808$EXP$$US-SA-2024SA230692$SANOFI AVENTIS$$$$A$F$Y$$$20240808$$MD$US$US
241863641$24186364$1$I$$20240801$20240808$20240808$EXP$$BR-SA-2024SA232444$SANOFI AVENTIS$$$$A$F$Y$$$20240808$$MD$BR$BR
241863652$24186365$2$F$$20240816$20240808$20240821$EXP$$NVSC2024ZA159883$NOVARTIS$$47$YR$$F$Y$$$20240821$$HP$ZA$ZA
241863661$24186366$1$I$20220101$20240805$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125119$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240808$$CN$US$US
241863672$24186367$2$F$20240801$20240808$20240808$20240810$PER$$US-AMGEN-USASP2024155388$AMGEN$$75$YR$E$F$Y$$$20240810$$CN$US$US
241863681$24186368$1$I$$20240729$20240808$20240808$EXP$$US-AMGEN-USASL2024152138$AMGEN$$$$$F$Y$$$20240807$$CN$US$US
241863693$24186369$3$F$20230101$20240814$20240808$20240830$EXP$$US-ABBVIE-5870324$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
241863701$24186370$1$I$$20240718$20240808$20240808$PER$$US-BEIGENE-BGN-2024-011360$BEIGENE$$$$$$Y$$$20240808$$CN$US$US
241863711$24186371$1$I$$20240729$20240808$20240808$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01487$NOVITIUM PHARMA$Islam Amine Larabi.Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).Toxicologie Analytique et Clinique.10-AUG-2023;35(3):175-197$38$YR$A$M$Y$$$20240808$$HP$FR$FR
241863721$24186372$1$I$20240717$20240805$20240808$20240808$EXP$$NVSJ2024JP009073$NOVARTIS$$$$A$M$Y$$$20240808$$MD$JP$JP
241863731$24186373$1$I$$20240804$20240808$20240808$EXP$$NVSC2024US159219$NOVARTIS$$21$YR$$F$Y$63.492$KG$20240808$$CN$US$US
241863742$24186374$2$F$20240508$20240829$20240808$20240902$PER$$US-ROCHE-10000050980$ROCHE$$32$YR$A$M$Y$102.06$KG$20240902$$CN$US$US
241863751$24186375$1$I$20240625$20240802$20240808$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011830$JAZZ$$70$YR$$M$Y$$$20240807$$HP$US$US
241863763$24186376$3$F$20240726$20240819$20240808$20240824$PER$$US-AMGEN-USASP2024155172$AMGEN$$75$YR$E$F$Y$$$20240824$$CN$US$US
241863771$24186377$1$I$20240805$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024156067$AMGEN$$64$YR$A$M$Y$$$20240807$$CN$US$US
241863781$24186378$1$I$$20240801$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123735$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240808$$HP$US$US
241863791$24186379$1$I$20240614$20240730$20240808$20240808$EXP$$US-PCCINC-2024-PPS-000003$PIRAMAL$$$$$$Y$$$20240808$$CN$US$US
241863801$24186380$1$I$$20240729$20240808$20240808$PER$$NVSC2024US157459$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241863811$24186381$1$I$$20240729$20240808$20240808$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01488$NOVITIUM PHARMA$Islam Amine Larabi.Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).Toxicologie Analytique et Clinique.10-AUG-2023;35(3):175-197$55$YR$A$M$Y$$$20240808$$HP$FR$FR
241863821$24186382$1$I$20170510$20240731$20240808$20240808$PER$$US-BIOGEN-2024BI01276373$BIOGEN$$37$YR$$F$Y$$$20240808$$HP$US$US
241863831$24186383$1$I$20240729$20240802$20240808$20240808$EXP$$CO-JNJFOC-20240816818$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240808$$CN$CO$CO
241863841$24186384$1$I$$20240729$20240808$20240808$EXP$$CA-APOTEX-2024AP009016$APOTEX$$62$YR$$F$Y$$$20240808$$MD$CA$CA
241863851$24186385$1$I$$20240801$20240808$20240808$EXP$$US-ROCHE-10000049948$ROCHE$$12$YR$T$M$Y$$$20240808$$CN$US$US
241863861$24186386$1$I$$20240729$20240808$20240808$EXP$$GB-INTERCEPT-PM2024000017$INTERCEPT PHARMACEUTICALS$$$$E$F$Y$$$20240808$$CN$GB$GB
241863871$24186387$1$I$$20240730$20240808$20240808$EXP$$US-GSK-US2024095269$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241863882$24186388$2$F$$20240812$20240808$20240826$EXP$$US-KVK-TECH, INC-20240800098$KVK-TECH$$$$$M$Y$104.31$KG$20240826$$CN$US$US
241863892$24186389$2$F$20240713$20240830$20240808$20240911$EXP$$CA-INTERCEPT-PM2024001554$INTERCEPT PHARMACEUTICALS$$64$YR$$F$Y$$$20240911$$MD$CA$CA
241863901$24186390$1$I$$20240731$20240808$20240808$EXP$$CA-CELLTRION INC.-2023CA003691$CELLTRION$$$$$$Y$$$20240808$$CN$CA$CA
241863911$24186391$1$I$20240705$20240731$20240808$20240808$EXP$$JP-AMGEN-JPNSP2024125162$AMGEN$$$$E$M$Y$$$20240807$$PH$JP$JP
241863921$24186392$1$I$20240101$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156948$AMGEN$$48$YR$A$M$Y$$$20240807$$HP$US$US
241863931$24186393$1$I$$20220908$20240808$20240808$EXP$$US-AstraZeneca-2022A313295$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241863941$24186394$1$I$$20230320$20240808$20240808$EXP$$US-AstraZeneca-2023A032740$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241863951$24186395$1$I$20220101$20220803$20240808$20240808$EXP$$CA-AstraZeneca-2022A231348$ASTRAZENECA$$66$YR$$M$Y$$$20240808$$CN$CA$
241863961$24186396$1$I$$20220927$20240808$20240808$EXP$$CA-AstraZeneca-2022A334029$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$CA$
241863971$24186397$1$I$20220909$20221102$20240808$20240808$EXP$$US-AstraZeneca-2022A364877$ASTRAZENECA$$27646$DY$$F$Y$$$20240808$$CN$US$
241863981$24186398$1$I$20211006$20211026$20240808$20240808$EXP$$CA-AstraZeneca-2021A766562$ASTRAZENECA$$22812$DY$$F$Y$$$20240808$$HP$CA$
241863991$24186399$1$I$$20230502$20240808$20240808$EXP$$IN-AstraZeneca-2023A105998$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$IN$
241864001$24186400$1$I$20201201$20210729$20240808$20240808$EXP$$US-AstraZeneca-2021A653196$ASTRAZENECA$$753$MON$$M$Y$$$20240808$$CN$US$
241864011$24186401$1$I$20220311$20220323$20240808$20240808$EXP$$TH-AstraZeneca-2022A125891$ASTRAZENECA$$21980$DY$$M$Y$$$20240808$$CN$TH$
241864021$24186402$1$I$$20231010$20240808$20240808$EXP$$US-AstraZeneca-2023A194144$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241864031$24186403$1$I$$20210527$20240808$20240808$EXP$$US-AstraZeneca-2021A484924$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241864041$24186404$1$I$$20220107$20240808$20240808$EXP$$AU-AstraZeneca-2022A014824$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$AU$
241864051$24186405$1$I$$20220211$20240808$20240808$EXP$$US-AstraZeneca-2022A031064$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241864061$24186406$1$I$$20220705$20240808$20240808$EXP$$US-AstraZeneca-2022A195760$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241864071$24186407$1$I$$20220525$20240808$20240808$EXP$$US-AstraZeneca-2022A200646$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241864081$24186408$1$I$$20230515$20240808$20240808$EXP$$US-AstraZeneca-2023A113478$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241864091$24186409$1$I$$20221005$20240808$20240808$EXP$$US-AstraZeneca-2022A339539$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241864101$24186410$1$I$$20230207$20240808$20240808$EXP$$US-AstraZeneca-2022A419018$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241864111$24186411$1$I$$20220712$20240808$20240808$EXP$$US-AstraZeneca-2022A202401$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241864121$24186412$1$I$$20220623$20240808$20240808$EXP$$US-AstraZeneca-2022A235552$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241864131$24186413$1$I$20230516$20230526$20240808$20240808$EXP$$US-AstraZeneca-2023A123626$ASTRAZENECA$$22299$DY$$M$Y$$$20240808$$CN$US$
241864141$24186414$1$I$$20240729$20240808$20240808$PER$$US-SA-2024SA229875$SANOFI AVENTIS$$$$A$F$Y$69.841$KG$20240808$$MD$US$US
241864152$24186415$2$F$$20240909$20240808$20240916$30DAY$$AU-JNJFOC-20240813639$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$PH$AU$AU
241864163$24186416$3$F$20240601$20240911$20240808$20240911$PER$$US-ALXN-202407USA002181US$ALEXION PHARMACEUTICALS$$50$YR$$F$Y$$$20240911$$CN$US$US
241864173$24186417$3$F$20240101$20240917$20240808$20240925$PER$$US-SA-2024SA230432$SANOFI AVENTIS$$26$YR$A$M$Y$70.3$KG$20240925$$MD$US$US
241864181$24186418$1$I$$20240801$20240808$20240808$30DAY$$US-GSK-US2024096378$GLAXOSMITHKLINE$$$$E$F$Y$$$20240808$$CN$US$US
241864192$24186419$2$F$20240701$20240920$20240808$20240925$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-021928$UNITED THERAPEUTICS$$65$YR$$M$Y$$$20240925$$$JP$JP
241864201$24186420$1$I$$20240802$20240808$20240808$PER$$US-SA-2024SA232838$SANOFI AVENTIS$$$$A$$Y$$$20240808$$HP$US$US
241864211$24186421$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA231657$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240808$$MD$US$US
241864221$24186422$1$I$20240715$20240801$20240808$20240808$PER$$US-SA-2024SA229539$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240808$$CN$US$US
241864231$24186423$1$I$$20240731$20240808$20240808$PER$$US-ABBVIE-5862638$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241864241$24186424$1$I$20240717$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155693$AMGEN$$74$YR$E$M$Y$$$20240807$$CN$US$US
241864251$24186425$1$I$20240701$20240802$20240808$20240808$EXP$$US-SA-2024SA233267$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240808$$MD$US$US
241864261$24186426$1$I$$20240805$20240808$20240808$PER$$NVSC2024US160621$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241864271$24186427$1$I$20231201$20240802$20240808$20240808$EXP$$US-SA-2024SA232428$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240808$$MD$US$US
241864281$24186428$1$I$$20240730$20240808$20240808$EXP$$NVSC2024IT145779$NOVARTIS$$$$A$M$Y$$$20240808$$MD$IT$IT
241864291$24186429$1$I$$20240729$20240808$20240808$EXP$$HR-ROCHE-10000047135$ROCHE$Skoric M, Basic Kes V, Grbic N, Lazibat I, Pavelin S. Ocrelizumab in people with primary progressive multiple sclerosis: A real-world multicentric study. Multiple Sclerosis and Related Disorders. 2024-Sep;89:1-6. doi:10.1016/j.msard.2024.105776.$$$$$Y$$$20240808$$HP$HR$HR
241864301$24186430$1$I$$20240802$20240808$20240808$EXP$$US-JNJFOC-20240809550$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241864311$24186431$1$I$$20240729$20240808$20240808$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01489$NOVITIUM PHARMA$Islam Amine Larabi.Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).Toxicologie Analytique et Clinique.10-AUG-2023;35(3):175-197$26$YR$A$M$Y$$$20240808$$HP$FR$FR
241864321$24186432$1$I$$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156821$AMGEN$$$$$$Y$$$20240807$$CN$US$US
241864331$24186433$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161201$NOVARTIS$$$$$F$Y$$$20240808$$MD$US$US
241864341$24186434$1$I$$20240806$20240808$20240808$PER$$US-TAKEDA-2024TUS079032$TAKEDA$$$$$$Y$$$20240808$$PH$US$US
241864351$24186435$1$I$$20240710$20240808$20240808$PER$$US-ABBVIE-5865673$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241864361$24186436$1$I$$20240731$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408000289$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240808$$CN$US$US
241864371$24186437$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004117$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240808$$CN$US$US
241864381$24186438$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003904$ELI LILLY AND CO$$$$$$Y$$$20240808$$MD$US$US
241864391$24186439$1$I$$20240804$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002916$ELI LILLY AND CO$$42$YR$A$$Y$$$20240808$$LW$US$US
241864401$24186440$1$I$$20240802$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002265$ELI LILLY AND CO$$45$YR$A$$Y$$$20240808$$LW$US$US
241864411$24186441$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004098$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241864421$24186442$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003925$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240808$$CN$US$US
241864431$24186443$1$I$20240712$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004056$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240808$$CN$US$US
241864441$24186444$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003882$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240808$$CN$US$US
241864451$24186445$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004203$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240808$$CN$US$US
241864461$24186446$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004047$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240808$$CN$US$US
241864471$24186447$1$I$$20240801$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004583$ELI LILLY AND CO$$59$YR$A$F$Y$68.481$KG$20240808$$CN$US$US
241864481$24186448$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5868476$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241864491$24186449$1$I$$20240729$20240808$20240808$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01490$NOVITIUM PHARMA$Islam Amine Larabi.Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).Toxicologie Analytique et Clinique.10-AUG-2023;35(3):175-197$35$YR$A$M$Y$$$20240808$$HP$FR$FR
241864502$24186450$2$F$$20240821$20240808$20240825$EXP$$NZ-JNJFOC-20240813804$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240825$$PH$NZ$NZ
241864511$24186451$1$I$$20240730$20240808$20240808$EXP$$CN-UCBSA-2024038898$UCB$Qingqing T, Qiumei Y, Hui H. Clinical analysis of sodium valproate combined with levetiracetam in the treatment of post-stroke epilepsy in the elderly. Geriatr Health Care. 2024;30(3):677-89$$$E$$Y$$$20240808$$HP$CN$CN
241864521$24186452$1$I$$20240806$20240808$20240808$PER$$US-JNJFOC-20240814388$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$HP$US$US
241864532$24186453$2$F$20231001$20240813$20240808$20240815$EXP$$PR-ABBVIE-5865630$ABBVIE$$47$YR$$F$Y$78.925$KG$20240815$$CN$PR$PR
241864541$24186454$1$I$$20240731$20240808$20240808$PER$$US-ALXN-202407USA002271US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241864551$24186455$1$I$20240802$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156715$AMGEN$$74$YR$E$F$Y$$$20240807$$CN$US$US
241864561$24186456$1$I$20240805$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155681$AMGEN$$70$YR$E$F$Y$$$20240807$$CN$US$US
241864571$24186457$1$I$20240804$20240806$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012274$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241864581$24186458$1$I$20220101$20220502$20240808$20240808$EXP$$US-AstraZeneca-2022A118374$ASTRAZENECA$$767$MON$$M$Y$$$20240808$$CN$US$
241864601$24186460$1$I$$20220204$20240808$20240808$EXP$$ZA-AstraZeneca-2022A015130$ASTRAZENECA$$90$YR$$F$Y$$$20240808$$CN$ZA$
241864611$24186461$1$I$$20211004$20240808$20240808$EXP$$US-AstraZeneca-2021A763953$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241864621$24186462$1$I$$20210806$20240808$20240808$EXP$$US-AstraZeneca-2021A673283$ASTRAZENECA$$59$YR$$M$Y$70.3$KG$20240808$$CN$US$
241864631$24186463$1$I$$20220119$20240808$20240808$EXP$$US-AstraZeneca-2022A033454$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241864641$24186464$1$I$$20230130$20240808$20240808$EXP$$US-AstraZeneca-2023A026836$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241864663$24186466$3$F$$20240909$20240808$20240919$30DAY$$US-JNJFOC-20240813775$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$HP$US$US
241864678$24186467$8$F$$20240905$20240808$20240918$30DAY$$AR-JNJFOC-20240784628$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$CN$AR$AR
241864681$24186468$1$I$$20220716$20240808$20240808$EXP$$US-AstraZeneca-2022A258789$ASTRAZENECA$$$$$M$Y$86$KG$20240808$$CN$US$
241864691$24186469$1$I$$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024157028$AMGEN$$42$YR$A$M$Y$$$20240807$$HP$US$US
241864701$24186470$1$I$$20240729$20240808$20240808$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01491$NOVITIUM PHARMA$Islam Amine Larabi.Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).Toxicologie Analytique et Clinique.10-AUG-2023;35(3):175-197$33$YR$A$M$Y$$$20240808$$HP$FR$FR
241864711$24186471$1$I$$20240729$20240808$20240808$EXP$GB-MHRA-MED-202407251141093720-GLVBC$GB-Accord-439487$ACCORD$$$$$F$Y$$$20240807$$HP$GB$GB
241864721$24186472$1$I$20240725$20240726$20240808$20240808$EXP$$US-Accord-439200$ACCORD$$52$YR$A$M$Y$$$20240807$$PH$US$US
241864735$24186473$5$F$20240101$20240916$20240808$20240924$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019191$UNITED THERAPEUTICS$$$$$F$Y$66.213$KG$20240924$$$US$US
241864741$24186474$1$I$$20240729$20240808$20240808$EXP$GB-MHRA-TPP19665692C21550945YC1721826781416$GB-Accord-439360$ACCORD$$72$YR$E$M$Y$91$KG$20240807$$PH$GB$GB
241864751$24186475$1$I$$20240731$20240808$20240808$PER$$US-RDY-SPO/USA/24/0011426$DR REDDYS$$20$YR$A$F$Y$$$20240808$$MD$US$US
241864761$24186476$1$I$20240715$20240727$20240808$20240808$EXP$DE-BFARM-24005135$DE-Accord-438770$ACCORD$$80$YR$E$F$Y$$$20240807$$PH$DE$DE
241864771$24186477$1$I$$20240729$20240808$20240808$EXP$GB-MHRA-TPP49612862C9396304YC1721640855308$GB-Accord-439358$ACCORD$$72$YR$E$M$Y$$$20240807$$HP$GB$GB
241864781$24186478$1$I$20221209$20240727$20240808$20240808$EXP$FR-AFSSAPS-PC2024000593$FR-Accord-439059$ACCORD$$45$YR$A$F$Y$$$20240807$$PH$FR$FR
241864791$24186479$1$I$$20240731$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121890$BRISTOL MYERS SQUIBB$$30$YR$A$M$Y$$$20240808$$MD$US$US
241864811$24186481$1$I$$20240729$20240808$20240808$EXP$$US-Accord-438947$ACCORD$Howell J, Maughan B, Fluchel M, Poppe M. Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor:A case report. Urology Case Reports. 2024;56:102799.$62$YR$A$F$Y$$$20240807$$MD$US$US
241864821$24186482$1$I$$20240804$20240808$20240808$PER$$NVSC2024US160439$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241864842$24186484$2$F$20240215$20240804$20240808$20240813$EXP$FR-AFSSAPS-PO2024000849$FR-LEO Pharma-372504$LEO PHARM$$40$YR$$F$Y$54$KG$20240813$$CN$FR$FR
241864851$24186485$1$I$$20240802$20240808$20240808$EXP$$JP-GENMAB-2024-02802$GENMAB$$$$$$Y$$$20240808$$PH$JP$JP
241864861$24186486$1$I$20231003$20240729$20240808$20240808$EXP$$ES-AUROBINDO-AUR-APL-2024-038446$AUROBINDO$$86$YR$$F$Y$$$20240808$$MD$ES$ES
241864871$24186487$1$I$$20240730$20240808$20240808$PER$$US-ABBVIE-5861166$ABBVIE$$$$$F$Y$$$20240808$$HP$US$US
241864881$24186488$1$I$$20240729$20240808$20240808$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01492$NOVITIUM PHARMA$Islam Amine Larabi.Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).Toxicologie Analytique et Clinique.10-AUG-2023;35(3):175-197$49$YR$A$M$Y$$$20240808$$HP$FR$FR
241864892$24186489$2$F$20240727$20240822$20240808$20240902$PER$$US-JNJFOC-20240782919$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240902$$CN$US$US
241864902$24186490$2$F$$20240905$20240808$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024094790$VIIV$$$$$M$Y$97.5$KG$20240911$$MD$US$US
241864913$24186491$3$F$20240716$20240820$20240808$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07061$LUPIN$$$$$$Y$$$20240905$$CN$US$US
241864922$24186492$2$F$$20240911$20240808$20240912$PER$$US-AMGEN-USASP2024155738$AMGEN$$$$$$Y$$$20240912$$PH$US$US
241864931$24186493$1$I$20240708$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155988$AMGEN$$75$YR$E$F$Y$$$20240807$$HP$US$US
241864941$24186494$1$I$$20240802$20240808$20240808$PER$$US-SA-2024SA232716$SANOFI AVENTIS$$$$$F$Y$$$20240808$$HP$US$US
241864951$24186495$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA232355$SANOFI AVENTIS$$$$E$M$Y$$$20240808$$MD$US$US
241864962$24186496$2$F$20240701$20240919$20240808$20240924$EXP$$JP-SA-2024SA227821$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240924$$MD$JP$JP
241864972$24186497$2$F$$20240729$20240808$20240817$PER$$US-TEVA-VS-3227744$TEVA$$$$$F$Y$$$20240817$$CN$US$US
241864981$24186498$1$I$$20240806$20240808$20240808$EXP$$TR-Bion-013630$BIONPHARMA$$23$YR$A$M$Y$$$20240808$$HP$TR$TR
241864991$24186499$1$I$$20240802$20240808$20240808$EXP$$US-Bion-013612$BIONPHARMA$$62$YR$A$M$Y$$$20240808$$HP$US$US
241865001$24186500$1$I$$20240802$20240808$20240808$EXP$$CA-JNJFOC-20240816548$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240808$$HP$CA$CA
241865021$24186502$1$I$$20240804$20240808$20240808$EXP$$CA-JNJFOC-20240809575$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$CA$CA
241865032$24186503$2$F$20240301$20240815$20240808$20240820$PER$$US-AMGEN-USASP2024157037$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
241865051$24186505$1$I$$20240801$20240808$20240808$EXP$$US-Bion-013620$BIONPHARMA$$$$$F$Y$$$20240808$$CN$US$US
241865061$24186506$1$I$$20240801$20240808$20240808$EXP$$US-Bion-013621$BIONPHARMA$$$$E$F$Y$$$20240808$$CN$US$US
241865071$24186507$1$I$$20240730$20240808$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123661$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$MD$JP$JP
241865081$24186508$1$I$$20240802$20240808$20240808$EXP$$US-Bion-013622$BIONPHARMA$$$$$F$Y$$$20240808$$CN$US$US
241865091$24186509$1$I$$20240724$20240808$20240808$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110491$ZYDUS PHARM$Kuczmarski TM, Lynch RC.. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma.. Br-J-Haematol. 2024;205(1):100-108.$$$$$Y$$$20240808$$HP$US$US
241865101$24186510$1$I$$20240802$20240808$20240808$EXP$$US-Bion-013623$BIONPHARMA$$$$$$Y$$$20240808$$CN$US$US
241865111$24186511$1$I$$20240805$20240808$20240808$EXP$$US-Bion-013624$BIONPHARMA$$$$$$Y$$$20240808$$CN$US$US
241865131$24186513$1$I$$20240729$20240808$20240808$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01493$NOVITIUM PHARMA$Islam Amine Larabi.Chemsex in France: A national study through interlaboratory collaboration under the auspices of the French Society of Analytical Toxicology (SFTA).Toxicologie Analytique et Clinique.10-AUG-2023;35(3):175-197$33$YR$A$M$Y$$$20240808$$HP$FR$FR
241865143$24186514$3$F$20240806$20240812$20240808$20240814$EXP$$NVSC2024US160447$NOVARTIS$$59$YR$$F$Y$$$20240814$$CN$US$US
241865161$24186516$1$I$$20201202$20240808$20240808$EXP$$AU-AstraZeneca-2020SF44835$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$AU$
241865171$24186517$1$I$$20240726$20240808$20240808$PER$$US-AstraZeneca-2024A171090$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241865181$24186518$1$I$20220409$20220415$20240808$20240808$EXP$$US-AstraZeneca-2022A153361$ASTRAZENECA$$30898$DY$$M$Y$$$20240808$$CN$US$
241865191$24186519$1$I$$20220225$20240808$20240808$EXP$$US-AstraZeneca-2022A090545$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241865201$24186520$1$I$$20220915$20240808$20240808$EXP$$US-AstraZeneca-2022A319958$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241865212$24186521$2$F$20230118$20240815$20240808$20240824$EXP$$CA-AstraZeneca-2023A068805$ASTRAZENECA$$3197$WK$$M$Y$$$20240823$$HP$CA$
241865222$24186522$2$F$$20240814$20240808$20240827$EXP$$FR-AUROBINDO-AUR-APL-2024-039552$AUROBINDO$Margot. C, Sylvine. P, Hester.C, Angele. S, Cl?ment. D, Vanessa.B. Donepezil as a safe alternative treatment after maculo-papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data. PSYCHOGERIATRICS. 2024;1-4$79$YR$$M$Y$$$20240827$$HP$FR$FR
241865231$24186523$1$I$$20240730$20240808$20240808$EXP$$US-LUOXIN-LUX-2024-US-LIT-00045$LUOXIN AUROVITAS PHARMA(CHENGDU)$Curtis TM, Sady KM, Randall JT, Kervin P, Mosher DM, Dailey MW. .18-Month-Old with Lethargy and Accelerated Idioventricular Rhythm in Prehospital Setting: A Case Report..Prehospital Emergency Care.2024;NA:1-4$18$MON$I$M$Y$$$20240808$$HP$US$US
241865245$24186524$5$F$20240731$20240905$20240808$20240912$PER$$US-JNJFOC-20240809851$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240912$$HP$US$US
241865252$24186525$2$F$$20240906$20240808$20240916$30DAY$$AU-JNJFOC-20240813263$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$PH$AU$AU
241865261$24186526$1$I$20240601$20240730$20240808$20240808$EXP$SE-SEMPA-2024-005474$SE-TEVA-VS-3228371$TEVA$$81$YR$$F$Y$$$20240808$$MD$SE$SE
241865271$24186527$1$I$$20240804$20240808$20240808$PER$$US-AMGEN-USASP2024155012$AMGEN$$$$E$F$Y$$$20240807$$CN$US$US
241865281$24186528$1$I$20240702$20240729$20240808$20240808$EXP$FR-AFSSAPS-PC2024000583$FR-TEVA-VS-3227711$TEVA$$42$YR$$M$Y$110$KG$20240808$$MD$FR$FR
241865291$24186529$1$I$$20240801$20240808$20240808$PER$$UM-Blueprint Medicines Corporation-SP-US-2024-001271$BLUEPRINT MEDICINES$$$$$M$Y$$$20240808$$CN$US$US
241865301$24186530$1$I$$20240730$20240808$20240808$EXP$$US-LUOXIN-LUX-2024-US-LIT-00043$LUOXIN AUROVITAS PHARMA(CHENGDU)$Simpson T, Aljareh A, Shah U, Yoon S, Petrovic Elbaz M, Khan Z, et al.Atypical Presentation of Rhinovirus Infection With Rapid Deterioration Requiring Mechanical Ventilation.Am-J-Respir-Crit-Care-Med.2023;207:A1369$45$YR$A$M$Y$$$20240808$$HP$US$US
241865311$24186531$1$I$$20240806$20240808$20240808$EXP$$US-JNJFOC-20240814561$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$HP$US$US
241865321$24186532$1$I$20240803$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156459$AMGEN$$78$YR$E$M$Y$$$20240807$$CN$US$US
241865331$24186533$1$I$$20240802$20240808$20240808$EXP$$US-TAKEDA-2024TUS079090$TAKEDA$$$$$F$Y$102$KG$20240808$$HP$US$US
241865341$24186534$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125053$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240808$$HP$US$US
241865351$24186535$1$I$$20231010$20240808$20240808$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413311$RANBAXY$$$$$$Y$$$20240808$$MD$US$US
241865361$24186536$1$I$$20240730$20240808$20240808$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460518$RANBAXY$$$$E$M$Y$$$20240808$$CN$US$US
241865371$24186537$1$I$$20240308$20240808$20240808$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436664$RANBAXY$$$$$F$Y$$$20240808$$MD$US$US
241865381$24186538$1$I$$20240523$20240808$20240808$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449383$RANBAXY$$$$E$M$Y$$$20240808$$CN$US$US
241865391$24186539$1$I$$20240524$20240808$20240808$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449443$RANBAXY$$$$E$M$Y$$$20240808$$CN$US$US
241865401$24186540$1$I$$20240205$20240808$20240808$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430922$RANBAXY$$$$E$F$Y$$$20240808$$CN$US$US
241865412$24186541$2$F$$20240823$20240808$20240902$EXP$$US-TEVA-VS-3227906$TEVA$Sharayah S, Agner SC, Shinawi M, Rudnick D, Mar S. Neurological Improvement in a Patient with Cerebroretinal Microangiopathy with Calcifications and Cysts-1 Treated with Bevacizumab. Ann-Child-Neurol 2023; 31 (1): 52-55; Sharayah S, Agner SC, Shinawi M, Rudnick D, Mar S. Neurological Improvement in a Patient with Cerebroretinal Microangiopathy with Calcifications and Cysts-1 Treated with Bevacizumab. Ann-Child-Neurol 2023; 31 (1): 52-55.$$$T$M$Y$$$20240902$$MD$US$US
241865451$24186545$1$I$$20240730$20240808$20240808$EXP$$US-LUOXIN-LUX-2024-US-LIT-00042$LUOXIN AUROVITAS PHARMA(CHENGDU)$Patel R, Awad A, Purdy J.Inhalation Without Ignition: A Case of Severe Asthma Exacerbation From Occupational Cannabis Exposure..Am-J-Respir-Crit-Care-Med.2023;207:A1852$60$YR$A$M$Y$$$20240808$$HP$US$US
241865461$24186546$1$I$$20240805$20240808$20240808$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001574$BLUEPRINT MEDICINES$$$$$M$Y$$$20240808$$CN$US$US
241865481$24186548$1$I$20191026$20240731$20240808$20240808$EXP$FR-AFSSAPS-ST2024001222$FR-JNJFOC-20240819131$JOHNSON AND JOHNSON$$1$DY$N$F$Y$3.23$KG$20240808$$MD$FR$FR
241865492$24186549$2$F$20230101$20240809$20240808$20240814$EXP$$US-SA-2023SA284825$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240814$$MD$US$US
241865502$24186550$2$F$20240802$20240808$20240808$20240812$PER$$US-AMGEN-USASP2024156922$AMGEN$$27$YR$A$F$Y$$$20240812$$CN$US$US
241865511$24186551$1$I$$20240729$20240808$20240808$EXP$$US-GSK-US2024094824$GLAXOSMITHKLINE$$$$$M$Y$$$20240808$$CN$US$US
241865521$24186552$1$I$$20240730$20240808$20240808$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01479$NOVITIUM PHARMA$Jun Wei.Successful treatment of penicillin-resistant pneumococcal meningitis following ventriculo-peritoneal shunt for congenital hydrocephalus: A case report on the efficacy of linezolid.Asian Journal of Surgery.27-JUN-2024;47(7):3389$1$YR$N$F$Y$$$20240808$$HP$CN$CN
241865531$24186553$1$I$$20240730$20240808$20240808$EXP$$US-LUOXIN-LUX-2024-US-LIT-00044$LUOXIN AUROVITAS PHARMA(CHENGDU)$Hochfeld U, Heyer M, Mohammed A, Baig M, Barmaimon G, Omidvari K. .Non-ARDS Chloramine Induced Lung Injury Managed by Venovenous Extracorporeal Membrane Oxygenation (ECMO): A Novel Approach..Am-J-Respir-Crit-Care-Med.2023;207:A3205$65$YR$A$M$Y$$$20240808$$HP$US$US
241865541$24186554$1$I$20240614$20240805$20240808$20240808$EXP$GB-MHRA-MED-202408051235400280-NKCHF$GB-TEVA-VS-3230195$TEVA$$56$YR$$F$Y$$$20240808$$PH$GB$GB
241865551$24186555$1$I$$20240801$20240808$20240808$PER$$US-ALXN-202408USA000102US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240808$$CN$US$US
241865561$24186556$1$I$20240701$20240730$20240808$20240808$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001303$BLUEPRINT MEDICINES$$49$YR$A$F$Y$$$20240808$$CN$US$US
241865572$24186557$2$F$20240726$20240805$20240808$20240814$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095293$VIIV$$60$YR$$M$Y$$$20240814$$CN$US$US
241865583$24186558$3$F$20230226$20240923$20240808$20240925$EXP$$BR-SANDOZ INC.-NVSC2023BR059360$SANDOZ$$77$YR$$F$Y$55$KG$20240925$$MD$BR$BR
241865591$24186559$1$I$20240716$20240805$20240808$20240808$EXP$$CN-JNJFOC-20240819155$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240808$$HP$CN$CN
241865602$24186560$2$F$$20240911$20240808$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-038624$AUROBINDO$Ayme-Dietrich E, Kaguelidou F, Bertschy G, Chouchana L. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.. Pharmacoepidemiol-Drug-Saf. 2024;33:e5814$7$YR$$F$Y$$$20240923$$HP$FR$FR
241865611$24186561$1$I$$20240806$20240808$20240808$PER$$US-LEO Pharma-372597$LEO PHARM$$45$YR$$M$Y$$$20240808$$CN$US$US
241865622$24186562$2$F$20240402$20240805$20240808$20240815$30DAY$$US-AMGEN-USASP2024150480$AMGEN$$44$YR$A$F$Y$55.057$KG$20240815$$PH$US$US
241865632$24186563$2$F$20240716$20240808$20240808$20240812$PER$$US-AMGEN-USASP2024155551$AMGEN$$71$YR$E$F$Y$$$20240812$$MD$US$US
241865641$24186564$1$I$$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004666$ELI LILLY AND CO$$58$YR$A$$Y$$$20240808$$MD$US$US
241865651$24186565$1$I$20240621$20240729$20240808$20240808$EXP$$ES-AUROBINDO-AUR-APL-2024-038442$AUROBINDO$$16$YR$$F$Y$$$20240808$$MD$ES$ES
241865661$24186566$1$I$20240802$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003058$ELI LILLY AND CO$$$$$M$Y$$$20240808$$CN$US$US
241865671$24186567$1$I$$20240729$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407019747$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240808$$LW$US$US
241865681$24186568$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003977$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240808$$CN$US$US
241865691$24186569$1$I$20240723$20240729$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407018736$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240808$$CN$US$US
241865701$24186570$1$I$20240708$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004243$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240808$$HP$US$US
241865712$24186571$2$F$20220101$20240812$20240808$20240815$PER$$US-ABBVIE-5862955$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
241865731$24186573$1$I$$20240805$20240808$20240808$PER$$US-LEO Pharma-372583$LEO PHARM$$$$$F$Y$$$20240808$$HP$US$US
241865741$24186574$1$I$$20240730$20240808$20240808$30DAY$$US-GSK-US2024095403$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241865751$24186575$1$I$$20240731$20240808$20240808$PER$$NVSC2024US158216$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241865761$24186576$1$I$$20240729$20240808$20240808$EXP$$US-MSNLABS-2024MSNLIT01698$MSN LABORATORIES$Murphy A, Cordisco A, Khan AH, Craft CA.AN UNCOMMON CUASE OF COMPLETE HEART BLOCK IN A PATIENT WITH A HISTORY OF SEIZURES.Journal of the American College of Cardiology.2024;83 (13):2881$$$$$Y$$$20240808$$HP$US$US
241865771$24186577$1$I$$20240801$20240808$20240808$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122842$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$60$KG$20240808$$HP$CA$CA
241865782$24186578$2$F$$20240814$20240808$20240823$EXP$$US-TAKEDA-2024TUS078153$TAKEDA$$$$$M$Y$$$20240823$$CN$US$US
241865791$24186579$1$I$$20240806$20240808$20240808$EXP$$JP-TAKEDA-2024TJP011749$TAKEDA$$8$DEC$$M$Y$$$20240808$$MD$JP$JP
241865801$24186580$1$I$$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038217$AUROBINDO$$35$YR$$F$Y$$$20240808$$CN$GB$GB
241865812$24186581$2$F$20240101$20240815$20240808$20240823$EXP$$CA-ALK-ABELLO A/S-2024AA002611$ALK-ABELLO$$$$$$Y$$$20240823$$MD$CA$CA
241865821$24186582$1$I$$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038363$AUROBINDO$$73$YR$$F$Y$$$20240808$$MD$FR$FR
241865831$24186583$1$I$20240401$20240731$20240808$20240808$EXP$FR-AFSSAPS-AN2024000959$FR-EMD Serono-2024041411$EMD SERONO INC$$66$YR$E$M$Y$$$20240808$$MD$FR$FR
241865842$24186584$2$F$$20240823$20240808$20240902$EXP$$US-TEVA-VS-3227976$TEVA$Khachatryan A, Isseh I, Vavilin I, Saeed IM, Harutyunyan H, Bansro V, et al. RECURRENT PERIMYOCARDITIS ASSOCIATED WITH LONG-TERM METHYLPHENIDATE USE. J-Am-Coll-Cardiol 2024; 83 (Suppl. 2) (13): 3543; Khachatryan A, Isseh I, Vavilin I, Saeed IM, Harutyunyan H, Bansro V, et al. RECURRENT PERIMYOCARDITIS ASSOCIATED WITH LONG-TERM METHYLPHENIDATE USE. J-Am-Coll-Cardiol 2024; 83 (Suppl. 2) (13): 3543.$19$YR$$M$Y$$$20240902$$HP$US$US
241865851$24186585$1$I$$20211018$20240808$20240808$EXP$$US-AstraZeneca-2021A780794$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241865861$24186586$1$I$20240407$20240422$20240808$20240808$EXP$$US-GRAVITIPHARMA-GRA-2404-US-SPO-0100$GRAVITI PHARMACEUTICALS$$47$YR$A$M$Y$245$KG$20240808$$CN$US$US
241865871$24186587$1$I$$20210720$20240808$20240808$EXP$$US-AstraZeneca-2021A632303$ASTRAZENECA$$47$YR$$F$Y$64.9$KG$20240808$$CN$US$
241865881$24186588$1$I$20240716$20240731$20240808$20240808$EXP$$NVSC2024PE149300$NOVARTIS$$62$YR$$F$Y$$$20240808$$CN$PE$PE
241865901$24186590$1$I$$20230216$20240808$20240808$EXP$$US-AstraZeneca-2023A040585$ASTRAZENECA$$$$$M$Y$95.3$KG$20240808$$CN$US$
241865911$24186591$1$I$$20230710$20240808$20240808$EXP$$US-AstraZeneca-2023A158401$ASTRAZENECA$$$$$F$Y$97.1$KG$20240808$$CN$US$
241865921$24186592$1$I$$20230327$20240808$20240808$EXP$$US-AstraZeneca-2023A073036$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241865931$24186593$1$I$$20230503$20240808$20240808$EXP$$US-AstraZeneca-2023A104574$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241865941$24186594$1$I$$20240731$20240808$20240808$PER$$US-AstraZeneca-2024A175218$ASTRAZENECA$$$$$F$Y$$$20240808$$HP$US$
241865952$24186595$2$F$$20240904$20240808$20240905$PER$$US-AstraZeneca-2024A174117$ASTRAZENECA$$$$$F$Y$$$20240905$$HP$US$
241865961$24186596$1$I$$20240807$20240808$20240808$EXP$$TH-ROCHE-10000051155$ROCHE$$$$$$Y$$$20240808$$CN$TH$TH
241865971$24186597$1$I$20240714$20240801$20240808$20240808$EXP$$CN-ROCHE-10000050476$ROCHE$$55$YR$A$M$Y$75$KG$20240808$$HP$CN$CN
241865981$24186598$1$I$$20240801$20240808$20240808$EXP$$JP-009507513-2408JPN000010J$MERCK$$8$DEC$$F$Y$$$20240808$$PH$JP$JP
241865991$24186599$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124882$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240808$$CN$US$US
241866001$24186600$1$I$$20240802$20240808$20240808$EXP$$NVSC2024CA159617$NOVARTIS$$$$$M$Y$$$20240808$$HP$CA$CA
241866011$24186601$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124804$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240808$$CN$US$US
241866023$24186602$3$F$20240101$20240904$20240808$20240913$EXP$$FI-TEVA-VS-3228919$TEVA$$36$YR$$F$Y$$$20240913$$HP$FI$FI
241866041$24186604$1$I$20240706$20240731$20240808$20240808$EXP$$NVSC2024CN158012$NOVARTIS$$41$YR$$F$Y$60$KG$20240808$$HP$CN$CN
241866052$24186605$2$F$$20240819$20240808$20240827$EXP$$BR-SANDOZ INC.-SDZ2024BR033622$SANDOZ$$$$$F$Y$$$20240827$$CN$BR$BR
241866062$24186606$2$F$20240802$20240812$20240808$20240815$30DAY$$US-AMGEN-USASP2024155721$AMGEN$$66$YR$E$M$Y$70.45$KG$20240815$$HP$US$US
241866073$24186607$3$F$20240604$20240816$20240808$20240822$30DAY$$US-AMGEN-USASP2024154836$AMGEN$$69$YR$E$F$Y$$$20240822$$HP$US$US
241866081$24186608$1$I$20240805$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155633$AMGEN$$74$YR$E$M$Y$$$20240808$$CN$US$US
241866092$24186609$2$F$$20240729$20240808$20240819$EXP$$JP-009507513-2407JPN005326J$MERCK$Ohsaki M, Ohashi K, Nakahara M, Shimada T, Matoba K, Nishimura R. 64 A case of fulminant type 1 diabetes mellitus and acute myocardial infarction after pembrolizumab administration.. The 697th Kanto Regional Meeting of the Japanese Society of Internal Medicine. 64$72$YR$$F$Y$$$20240819$$MD$JP$JP
241866101$24186610$1$I$$20211115$20240808$20240808$EXP$$US-AstraZeneca-2021A851312$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241866111$24186611$1$I$$20211228$20240808$20240808$EXP$$CA-AstraZeneca-2021A621852$ASTRAZENECA$$$$$M$Y$$$20240808$$HP$CA$
241866121$24186612$1$I$$20231005$20240808$20240808$EXP$$AU-AstraZeneca-2023A228140$ASTRAZENECA$$$$$M$Y$$$20240808$$HP$AU$
241866131$24186613$1$I$$20230614$20240808$20240808$EXP$$US-AstraZeneca-2023A160749$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241866142$24186614$2$F$$20240827$20240808$20240903$EXP$$JP-ROCHE-10000049411$ROCHE$$$$$F$Y$$$20240903$$MD$JP$JP
241866151$24186615$1$I$$20240802$20240808$20240808$PER$$US-AstraZeneca-2024A177126$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241866161$24186616$1$I$20210908$20211023$20240808$20240808$EXP$$US-AstraZeneca-2021A786910$ASTRAZENECA$$13167$DY$$F$Y$$$20240808$$CN$US$
241866171$24186617$1$I$$20240801$20240808$20240808$PER$$US-JNJFOC-20240805189$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241866181$24186618$1$I$20240501$20240730$20240808$20240808$EXP$$JP-BIOVITRUM-2024-JP-010689$BIOVITRUM$$$$I$F$Y$$$20240808$$MD$JP$JP
241866191$24186619$1$I$$20240807$20240808$20240808$EXP$$US-SANDOZ INC.-SDZ2024US071143$SANDOZ$$36$YR$$M$Y$$$20240808$$HP$US$US
241866201$24186620$1$I$$20240731$20240808$20240808$PER$$US-AMGEN-USASP2024153301$AMGEN$Sivamani R.K.; Min M.; Dulai A.S.. Recalcitrant multi-variant lichen planus successfully treated with oral baricitinib and topical ruxolitinib cream. Dermatology Online Journal. 2024;30 (3):1-4$61$YR$A$F$Y$$$20240808$$MD$US$US
241866214$24186621$4$F$20240709$20240906$20240808$20240910$30DAY$$US-AMGEN-USASP2024154230$AMGEN$$63$YR$A$F$Y$90.7$KG$20240910$$HP$US$US
241866221$24186622$1$I$$20240731$20240808$20240808$PER$$US-AMGEN-USASP2024154073$AMGEN$Gudavalli M.R.; Siciliano T.B.; Kruse R.. Spinal manipulation and mobilization forces delivered treating sciatica: a case report. Frontiers in Integrative Neuroscience. 2024;18:1-7$59$YR$A$F$Y$86.182$KG$20240808$$HP$US$US
241866231$24186623$1$I$$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024156935$AMGEN$$$$$M$Y$$$20240808$$CN$US$US
241866241$24186624$1$I$20240728$20240801$20240808$20240808$EXP$$CN-ROCHE-10000049691$ROCHE$$67$YR$E$F$Y$$$20240808$$HP$CN$CN
241866254$24186625$4$F$20220401$20240925$20240808$20240927$PER$$US-BIOVITRUM-2024-US-010702$BIOVITRUM$$82$YR$$F$Y$$$20240927$$CN$US$US
241866261$24186626$1$I$$20240806$20240808$20240808$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001581$BLUEPRINT MEDICINES$$$$$F$Y$$$20240808$$CN$US$US
241866271$24186627$1$I$$20240801$20240808$20240808$PER$$US-RDY-SPO/USA/24/0011425$DR REDDYS$$63$YR$A$M$Y$$$20240808$$CN$US$US
241866281$24186628$1$I$20240701$20240729$20240808$20240808$PER$$US-RDY-SPO/USA/24/0011282$DR REDDYS$$52$YR$A$F$Y$$$20240808$$CN$US$US
241866291$24186629$1$I$20240226$20240805$20240808$20240808$PER$$US-BIOVITRUM-2024-US-010704$BIOVITRUM$$73$YR$$M$Y$$$20240808$$CN$US$US
241866301$24186630$1$I$20231010$20240802$20240808$20240808$EXP$$CO-UCBSA-2024039680$UCB$$75$YR$$M$Y$$$20240808$$CN$CO$CO
241866311$24186631$1$I$$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038215$AUROBINDO$$72$YR$$M$Y$$$20240808$$HP$GB$GB
241866322$24186632$2$F$$20240903$20240808$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-124659$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240911$$PH$JP$JP
241866331$24186633$1$I$$20240729$20240808$20240808$EXP$$JP-MSNLABS-2024MSNLIT01713$MSN LABORATORIES$Nakamoto K, Horimasu Y, Yamaguchi K, Sakamoto S, Masuda T, Miyamoto S, Nakashima T, Iwamoto H, Ohshimo S, Sadamori T, Fujitaka K, Hamada H, Shime N, Hattori N.Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases.Internal Medicine.2024;63(12):1783-1787$$$$$Y$$$20240808$$MD$JP$JP
241866341$24186634$1$I$$20240801$20240808$20240808$EXP$$US-ALXN-202408USA000037US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$HP$US$US
241866361$24186636$1$I$$20240729$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024094843$VIIV$$$$$M$Y$$$20240808$$MD$US$US
241866371$24186637$1$I$$20240729$20240808$20240808$EXP$$JP-ROCHE-10000047986$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$80$YR$E$F$Y$$$20240808$$HP$JP$JP
241866381$24186638$1$I$$20240730$20240808$20240808$PER$$US-ABBVIE-5862651$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241866391$24186639$1$I$$20240801$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407008664$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240808$$CN$US$US
241866402$24186640$2$F$$20240806$20240808$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408004109$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240811$$CN$US$US
241866411$24186641$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002942$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240808$$CN$US$US
241866432$24186643$2$F$20240805$20240806$20240808$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004195$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240812$$CN$US$US
241866441$24186644$1$I$20240701$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004217$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240808$$CN$US$US
241866451$24186645$1$I$20240201$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004346$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240808$$CN$US$US
241866461$24186646$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003814$ELI LILLY AND CO$$47$YR$A$$Y$$$20240808$$CN$US$US
241866471$24186647$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683370$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241866481$24186648$1$I$20240805$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155727$AMGEN$$$$$$Y$$$20240808$$HP$US$US
241866491$24186649$1$I$$20240801$20240808$20240808$EXP$$GB-JNJFOC-20240808006$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$HP$GB$GB
241866501$24186650$1$I$$20240805$20240808$20240808$EXP$$US-JNJFOC-20240811409$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241866511$24186651$1$I$20240725$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038163$AUROBINDO$$18$YR$$M$Y$$$20240808$$MD$GB$GB
241866521$24186652$1$I$$20240730$20240808$20240808$EXP$$PT-NOVITIUMPHARMA-2024PTNVP01476$NOVITIUM PHARMA$Teresa Medeiros.PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA COMPLICATED BY CEREBRAL VENOUS SINUS THROMBOSIS: A CASE REPORT.European Journal of Case Reports in Internal Medicine.28-JUL-2023;10(8):1-5$64$YR$A$F$Y$$$20240808$$HP$PT$PT
241866531$24186653$1$I$$20240731$20240808$20240808$PER$$US-ABBVIE-5862920$ABBVIE$$30$YR$$F$Y$$$20240808$$HP$US$US
241866541$24186654$1$I$$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038931$AUROBINDO$Sahloul O, Louapre C, Beigneux Y, Lubetzki C, Maillart E, Roux T.. Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapies. Multiple Sclerosis and Related Disorders. 2024;85$$$N$$Y$$$20240808$$HP$FR$FR
241866551$24186655$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161333$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241866561$24186656$1$I$$20230411$20240808$20240808$EXP$$US-AstraZeneca-2023A085879$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241866574$24186657$4$F$$20240801$20240808$20240812$EXP$$US-ROCHE-10000048010$ROCHE$$$$$M$Y$$$20240812$$HP$US$US
241866582$24186658$2$F$$20240829$20240808$20240902$PER$$US-BIOVITRUM-2024-US-010729$BIOVITRUM$$57$YR$$F$Y$$$20240902$$CN$US$US
241866591$24186659$1$I$20240625$20240731$20240808$20240808$EXP$$CN-AstraZeneca-2024A176374$ASTRAZENECA$$24143$DY$$F$Y$55$KG$20240808$$MD$CN$
241866601$24186660$1$I$$20240729$20240808$20240808$EXP$$US-UCBSA-2024038091$UCB$$$$$F$Y$$$20240808$$CN$US$US
241866611$24186661$1$I$$20240801$20240808$20240808$EXP$$GB-TAKEDA-2024TUS006390$TAKEDA$$$$$F$Y$$$20240808$$CN$GB$GB
241866621$24186662$1$I$20190901$20191120$20240808$20240808$EXP$$RU-AstraZeneca-2019SF68089$ASTRAZENECA$$46$YR$$M$Y$75$KG$20240808$$CN$RU$
241866631$24186663$1$I$20240728$20240729$20240808$20240808$EXP$$CN-JNJFOC-20240780053$JOHNSON AND JOHNSON$$83$YR$E$F$Y$49$KG$20240808$$HP$CN$CN
241866641$24186664$1$I$20240727$20240731$20240808$20240808$PER$$US-JNJFOC-20240800047$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241866651$24186665$1$I$$20210806$20240808$20240808$EXP$$US-AstraZeneca-2021A703498$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241866661$24186666$1$I$20240711$20240729$20240808$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-038649$AUROBINDO$$41$YR$$M$Y$$$20240808$$MD$PT$PT
241866671$24186667$1$I$20240601$20240803$20240808$20240808$PER$$US-ABBVIE-5869514$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241866692$24186669$2$F$20221227$20240815$20240808$20240819$EXP$$CA-TAKEDA-2024TUS078060$TAKEDA$$71$YR$$M$Y$$$20240819$$CN$CA$CA
241866701$24186670$1$I$$20211026$20240808$20240808$EXP$$US-AstraZeneca-2021A788185$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241866711$24186671$1$I$$20240729$20240808$20240808$EXP$$JP-BIOCON BIOLOGICS LIMITED-BBL2024005704$BIOCON$Ando T,  Kubota M,  Yasukawa T,  Miyase T,  Ishiguro K,  Esaki Y et al.. Macular hole with retinal pigment epithelium tear after anti-VEGF therapy in an eye with neovascular age-related macular degeneration.. American Journal of Ophthalmology. 2024;36$$$$$Y$$$20240808$$HP$JP$JP
241866721$24186672$1$I$$20230320$20240808$20240808$EXP$$US-AstraZeneca-2023A067114$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241866731$24186673$1$I$20240728$20240729$20240808$20240808$PER$$US-AstraZeneca-2024A172352$ASTRAZENECA$$28340$DY$$M$Y$$$20240808$$CN$US$
241866741$24186674$1$I$20240701$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038605$AUROBINDO$$72$YR$$M$Y$$$20240808$$MD$FR$FR
241866751$24186675$1$I$$20230824$20240808$20240808$EXP$$US-AstraZeneca-2023A196807$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241866761$24186676$1$I$$20240802$20240808$20240808$PER$$US-AMGEN-USASP2024154738$AMGEN$$$$$$Y$$$20240808$$CN$US$US
241866774$24186677$4$F$20240601$20240913$20240808$20240913$PER$$US-AMGEN-USASP2024155593$AMGEN$$74$YR$E$F$Y$$$20240913$$CN$US$US
241866781$24186678$1$I$$20220701$20240808$20240808$EXP$$US-AstraZeneca-2022A243489$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241866791$24186679$1$I$$20240801$20240808$20240808$PER$$US-JNJFOC-20240803449$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241866801$24186680$1$I$$20240805$20240808$20240808$PER$$US-JNJFOC-20240815092$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$MD$US$US
241866814$24186681$4$F$20231201$20240911$20240808$20240912$PER$$US-ROCHE-10000048267$ROCHE$$$$$F$Y$86.18$KG$20240912$$CN$US$US
241866821$24186682$1$I$$20220404$20240808$20240808$EXP$$US-AstraZeneca-2022A142739$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241866831$24186683$1$I$$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038173$AUROBINDO$$34$YR$$F$Y$$$20240808$$CN$GB$GB
241866841$24186684$1$I$20240101$20240726$20240808$20240808$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240600036$UPSHER SMITH LABORATORIES$$$$$M$Y$$$20240808$$HP$US$US
241866851$24186685$1$I$20240507$20240806$20240808$20240808$EXP$$US-ROCHE-10000000891$ROCHE$$67$YR$E$M$Y$$$20240808$$MD$US$US
241866862$24186686$2$F$20240130$20240814$20240808$20240820$EXP$$CA-TAKEDA-2024TUS076632$TAKEDA$$72$YR$$F$Y$$$20240820$$CN$CA$CA
241866871$24186687$1$I$$20220214$20240808$20240808$EXP$$US-AstraZeneca-2022A011344$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241866881$24186688$1$I$$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038247$AUROBINDO$$63$YR$$$Y$66$KG$20240808$$CN$GB$GB
241866893$24186689$3$F$20240701$20240830$20240808$20240909$EXP$$CA-CELLTRION INC.-2024CA017680$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
241866901$24186690$1$I$20240805$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155933$AMGEN$$87$YR$E$F$Y$$$20240808$$CN$US$US
241866911$24186691$1$I$20230901$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038382$AUROBINDO$$$$A$F$Y$$$20240808$$MD$FR$FR
241866921$24186692$1$I$20240601$20240806$20240808$20240808$EXP$FR-AFSSAPS-NT2024000982$FR-TAKEDA-2024TUS078875$TAKEDA$$68$YR$$M$Y$85$KG$20240808$$HP$FR$FR
241866931$24186693$1$I$$20240802$20240808$20240808$EXP$$IN-ROCHE-10000049009$ROCHE$$$$A$M$Y$$$20240808$$MD$IN$IN
241866942$24186694$2$F$$20240905$20240808$20240913$EXP$$US-TEVA-VS-3228418$TEVA$Shih J, Hamera L. Multiorgan Failure in the Aftermath of Pre-eclampsia With Intracerebral Hemorrhage and HELLP Syndrome. Am-J-Respir-Crit-Care-Med 2023; 207.; Shih J, Hamera L. Multiorgan Failure in the Aftermath of Pre-eclampsia With Intracerebral Hemorrhage and HELLP Syndrome. Am-J-Respir-Crit-Care-Med 2023; 207.$18$YR$$F$Y$$$20240913$$HP$US$US
241866951$24186695$1$I$$20240719$20240808$20240808$PER$$US-RDY-SPO/USA/24/0010855$DR REDDYS$$23$YR$A$F$Y$$$20240808$$MD$US$US
241866961$24186696$1$I$$20240802$20240808$20240808$EXP$$NVSC2024CA097698$NOVARTIS$$60$YR$$F$Y$$$20240808$$CN$CA$CA
241866971$24186697$1$I$$20240725$20240808$20240808$PER$$US-RDY-LIT/USA/24/0011114$DR REDDYS$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. Journal of Allergy and Clinical Immunology: In Practice. 2024 Jun;12(6): 1663-1665. doi:10.1016/j.jaip.2024.02.023.$43$YR$A$F$Y$$$20240808$$MD$US$US
241866981$24186698$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161352$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241866991$24186699$1$I$$20240731$20240808$20240808$EXP$$CA-JNJFOC-20240810427$JOHNSON AND JOHNSON$$90$YR$E$M$Y$64$KG$20240808$$PH$CA$CA
241867005$24186700$5$F$20240805$20240912$20240808$20240925$30DAY$$US-JNJFOC-20240814337$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240925$$HP$US$US
241867021$24186702$1$I$20240502$20240805$20240808$20240808$EXP$FR-AFSSAPS-BS2024000477$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-124286$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$71$KG$20240808$$MD$FR$FR
241867031$24186703$1$I$20240710$20240805$20240808$20240808$EXP$IT-MINISAL02-997519$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-123587$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240808$$MD$IT$IT
241867041$24186704$1$I$$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124863$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240808$$CN$US$US
241867052$24186705$2$F$$20240805$20240808$20240814$EXP$$SY-TAKEDA-2024TUS079084$TAKEDA$$$$$$Y$$$20240814$$CN$SY$SY
241867061$24186706$1$I$$20240807$20240808$20240808$EXP$$CA-ROCHE-10000050668$ROCHE$$$$$M$Y$$$20240808$$HP$CA$CA
241867071$24186707$1$I$$20240729$20240808$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-038820$AUROBINDO$Bonito IG, Carvalho IP, Coimbra A, Pona AP, Fernandes M, Ferreira J. THROMBOTIC RISK IN CANCER PATIENTS - ABOUT A CLINICAL CASE Congressos da Sociedade Portuguesa de Medicina Interna: 30.?. Congresso Nacional de Medicina Interna - Livro de resumos. 2024;972$76$YR$$F$Y$$$20240808$$MD$PT$PT
241867081$24186708$1$I$20240701$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003932$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240808$$HP$US$US
241867091$24186709$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004187$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240808$$CN$US$US
241867101$24186710$1$I$$20240725$20240808$20240808$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK092933$GLENMARK$$$$$$Y$$$20240808$$CN$CA$CA
241867111$24186711$1$I$$20240730$20240808$20240808$EXP$$US-NOVITIUMPHARMA-2024USNVP00108$NOVITIUM PHARMA$$$$$F$Y$22$KG$20240808$$CN$US$US
241867121$24186712$1$I$20211111$20211130$20240808$20240808$EXP$$US-AstraZeneca-2021A850967$ASTRAZENECA$$4041$WK$$M$Y$$$20240808$$CN$US$
241867132$24186713$2$F$$20240807$20240808$20240808$PER$$NVSC2024US161350$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241867142$24186714$2$F$$20240829$20240808$20240908$EXP$$JP-AMGEN-JPNSP2024156786$AMGEN$$$$$$Y$$$20240908$$MD$JP$JP
241867151$24186715$1$I$$20200214$20240808$20240808$EXP$$US-AstraZeneca-2020SE25611$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241867162$24186716$2$F$20230327$20240805$20240808$20240813$EXP$$FR-SANDOZ INC.-SDZ2024FR070752$SANDOZ$$39$YR$$F$Y$110$KG$20240813$$MD$FR$FR
241867171$24186717$1$I$$20220131$20240808$20240808$EXP$$US-AstraZeneca-2021A896252$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241867181$24186718$1$I$20240802$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155762$AMGEN$$74$YR$E$F$Y$$$20240808$$CN$US$US
241867191$24186719$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124551$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$78.47$KG$20240808$$CN$US$US
241867201$24186720$1$I$$20211011$20240808$20240808$EXP$$US-AstraZeneca-2021A770004$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241867211$24186721$1$I$20240601$20240716$20240808$20240808$PER$$BR-TOLMAR, INC.-24BR051116$TOLMAR$$8$YR$$F$Y$$$20240808$$CN$BR$BR
241867222$24186722$2$F$$20240806$20240808$20240812$EXP$$US-ROCHE-2139174$ROCHE$$60$YR$A$F$Y$$$20240812$$MD$US$US
241867231$24186723$1$I$$20240731$20240808$20240808$EXP$$US-JNJFOC-20240784679$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241867241$24186724$1$I$$20200716$20240808$20240808$EXP$$US-AstraZeneca-2020SE91224$ASTRAZENECA$$$$A$M$Y$$$20240808$$CN$US$
241867251$24186725$1$I$$20220614$20240808$20240808$EXP$$US-AstraZeneca-2022A222287$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241867261$24186726$1$I$$20240731$20240808$20240808$EXP$$CA-TOLMAR, INC.-24CA051522$TOLMAR$$$$$M$Y$$$20240808$$PH$CA$CA
241867271$24186727$1$I$$20240731$20240808$20240808$PER$$CA-TOLMAR, INC.-24CA051525$TOLMAR$$$$$M$Y$$$20240808$$CN$CA$CA
241867281$24186728$1$I$$20240724$20240808$20240808$PER$$US-APOTEX-2024AP008811$APOTEX$$$$$F$Y$$$20240808$$CN$US$US
241867291$24186729$1$I$$20210922$20240808$20240808$EXP$$US-AstraZeneca-2021A737818$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241867301$24186730$1$I$$20240725$20240808$20240808$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK092934$GLENMARK$$$$$$Y$$$20240808$$CN$CA$CA
241867311$24186731$1$I$$20230912$20240808$20240808$EXP$$US-AstraZeneca-2023A155704$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241867321$24186732$1$I$$20240806$20240808$20240808$PER$$US-BIOVITRUM-2024-US-010696$BIOVITRUM$$72$YR$$F$Y$$$20240808$$MD$US$US
241867333$24186733$3$F$$20240905$20240808$20240916$30DAY$$FR-JNJFOC-20240779236$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240916$$PH$FR$FR
241867341$24186734$1$I$$20240729$20240808$20240808$EXP$$DE-AUROBINDO-AUR-APL-2018-021228$AUROBINDO$Diestelmann M, Zangl A, Herrle I, Koch E, Graw M, Paul LD.. Psychotic and aggressive behavior in relation to plasma concentrations.. Forensic Science International.. 2018;283:72-84$29$YR$$M$Y$$$20240808$$HP$DE$DE
241867351$24186735$1$I$$20240729$20240808$20240808$EXP$$GB-MSNLABS-2024MSNSPO01697$MSN LABORATORIES$$$$$$Y$$$20240808$$PH$GB$GB
241867361$24186736$1$I$$20240806$20240808$20240808$EXP$$CA-SANDOZ INC.-NVSC2022CA041082$SANDOZ$$$$$F$Y$$$20240808$$CN$CA$CA
241867373$24186737$3$F$$20240806$20240808$20240827$EXP$$US-GSK-US2024097471$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$HP$US$US
241867381$24186738$1$I$20240723$20240730$20240808$20240808$EXP$$DE-AUROBINDO-AUR-APL-2024-038721$AUROBINDO$$2$DY$$M$Y$3$KG$20240808$$MD$DE$DE
241867393$24186739$3$F$$20240806$20240808$20240814$PER$$NVSC2024US161087$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
241867402$24186740$2$F$$20240820$20240808$20240822$PER$$US-AMGEN-USASP2024156678$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
241867412$24186741$2$F$20240101$20240807$20240808$20240809$PER$$US-AMGEN-USASP2024157251$AMGEN$$73$YR$E$F$Y$$$20240809$$CN$US$US
241867422$24186742$2$F$20240604$20240813$20240808$20240813$EXP$$CO-UCBSA-2024039688$UCB$$19$YR$$M$Y$$$20240813$$CN$CO$CO
241867431$24186743$1$I$$20240731$20240808$20240808$EXP$$DE-AUROBINDO-AUR-APL-2024-039173$AUROBINDO$$$$$F$Y$$$20240808$$MD$DE$DE
241867441$24186744$1$I$$20240712$20240808$20240808$PER$$US-009507513-2407USA010916$MERCK$$$$$M$Y$$$20240808$$CN$US$US
241867451$24186745$1$I$$20240725$20240808$20240808$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK092935$GLENMARK$$$$$$Y$$$20240808$$CN$CA$CA
241867461$24186746$1$I$20240801$20240805$20240808$20240808$EXP$$US-JNJFOC-20240811832$JOHNSON AND JOHNSON$$56$YR$$M$Y$$$20240808$$CN$US$US
241867471$24186747$1$I$$20240807$20240808$20240808$PER$$US-JNJFOC-20240817661$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$HP$US$US
241867481$24186748$1$I$$20210614$20240808$20240808$EXP$$US-AstraZeneca-2021A526910$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241867491$24186749$1$I$$20210402$20240808$20240808$EXP$$US-AstraZeneca-2021A274732$ASTRAZENECA$$$$$$Y$47.2$KG$20240808$$CN$US$
241867501$24186750$1$I$$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156946$AMGEN$$$$$$Y$$$20240808$$PH$US$US
241867511$24186751$1$I$20220101$20240805$20240808$20240808$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-107531$REGENERON$$$$$F$Y$$$20240808$$CN$US$US
241867522$24186752$2$F$20051117$20240803$20240808$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-038857$AUROBINDO$$69$YR$$F$Y$$$20240816$$MD$FR$FR
241867535$24186753$5$F$20240101$20240917$20240808$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022968$UNITED THERAPEUTICS$$$$$F$Y$$$20240925$$$US$US
241867541$24186754$1$I$20240101$20240717$20240808$20240808$PER$$US-JNJFOC-20240748544$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240808$$CN$US$US
241867552$24186755$2$F$$20240826$20240808$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124821$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$117.03$KG$20240902$$HP$US$US
241867561$24186756$1$I$$20240801$20240808$20240808$PER$$US-UNITED THERAPEUTICS-UNT-2024-024016$UNITED THERAPEUTICS$$$$$M$Y$122.45$KG$20240808$$$US$US
241867572$24186757$2$F$20240729$20240806$20240808$20240813$EXP$$CN-ROCHE-10000047509$ROCHE$$55$YR$A$M$Y$$$20240813$$MD$CN$CN
241867581$24186758$1$I$$20240806$20240808$20240808$PER$$US-HALEON-2190774$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241867591$24186759$1$I$20240806$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004062$ELI LILLY AND CO$$$$A$F$Y$$$20240808$$CN$US$US
241867602$24186760$2$F$20240101$20240827$20240808$20240830$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-106278$REGENERON$$$$$M$Y$$$20240830$$CN$US$US
241867611$24186761$1$I$20240520$20240722$20240808$20240808$PER$$US-GLANDPHARMA-US-2024GLNSPO00600$GLAND PHARMA$$53$YR$A$M$Y$$$20240808$$PH$US$US
241867621$24186762$1$I$20240501$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003101$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240808$$CN$US$US
241867631$24186763$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003839$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$US$US
241867641$24186764$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003982$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240808$$CN$US$US
241867651$24186765$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004136$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240808$$CN$US$US
241867661$24186766$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004127$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240808$$CN$US$US
241867671$24186767$1$I$20240806$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004413$ELI LILLY AND CO$$44$YR$A$$Y$$$20240808$$CN$US$US
241867681$24186768$1$I$20240701$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003966$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240808$$CN$US$US
241867701$24186770$1$I$$20240805$20240808$20240808$PER$$NVSC2024US160595$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241867712$24186771$2$F$$20240828$20240808$20240905$EXP$$JP-AMGEN-JPNSP2024154970$AMGEN$$7$DEC$E$F$Y$$$20240904$$MD$JP$JP
241867721$24186772$1$I$20240802$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024156121$AMGEN$$85$YR$E$F$Y$$$20240808$$CN$US$US
241867731$24186773$1$I$$20240731$20240808$20240808$EXP$$US-ABBVIE-5863744$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241867741$24186774$1$I$$20240807$20240808$20240808$PER$$US-TAKEDA-2024TUS079104$TAKEDA$$$$$F$Y$$$20240808$$CN$US$US
241867761$24186776$1$I$$20240807$20240808$20240808$EXP$$US-JNJFOC-20240817071$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$HP$US$US
241867772$24186777$2$F$$20240909$20240808$20240918$30DAY$$GB-JNJFOC-20240813848$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$GB$GB
241867781$24186778$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161339$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241867791$24186779$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5869474$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241867801$24186780$1$I$$20240729$20240808$20240808$EXP$815061$AU-LUPIN PHARMACEUTICALS INC.-2024-07615$LUPIN$$$$$$Y$$$20240808$$CN$AU$AU
241867811$24186781$1$I$20240707$20240801$20240808$20240808$EXP$$IN-ROCHE-10000010714$ROCHE$$66$YR$E$M$Y$$$20240808$$CN$IN$IN
241867821$24186782$1$I$$20240801$20240808$20240808$PER$$US-AMGEN-USASP2024154197$AMGEN$$$$$F$Y$$$20240808$$CN$US$US
241867831$24186783$1$I$20240101$20240805$20240808$20240808$EXP$$US-ABBVIE-5869530$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241867842$24186784$2$F$$20240903$20240808$20240913$EXP$$US-TEVA-VS-3228266$TEVA$Rajevac H. A Rare Case of Primary Pulmonary Malignant Myoepithelioma of Soft Tissue. Am-J-Respir-Crit-Care-Med 2023; 207.; Rajevac H. A Rare Case of Primary Pulmonary Malignant Myoepithelioma of Soft Tissue. Am-J-Respir-Crit-Care-Med 2023; 207.$64$YR$$M$Y$$$20240913$$HP$US$US
241867851$24186785$1$I$$20240724$20240808$20240808$PER$$US-COSETTE-CP2024US000193$COSETTE PHARMACEUTICALS$$56$YR$A$F$Y$$$20240808$$CN$US$US
241867861$24186786$1$I$$20240712$20240808$20240808$PER$$US-009507513-2407USA009437$MERCK$$$$$F$Y$$$20240808$$MD$US$US
241867871$24186787$1$I$$20210721$20240808$20240808$EXP$$US-AstraZeneca-2021A634554$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241867881$24186788$1$I$$20220322$20240808$20240808$EXP$$US-AstraZeneca-2022A123179$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241867891$24186789$1$I$$20240806$20240808$20240808$PER$$NVSC2024US161091$NOVARTIS$$$$$F$Y$$$20240808$$HP$US$US
241867901$24186790$1$I$$20240803$20240808$20240808$PER$$US-ABBVIE-5868706$ABBVIE$$$$$F$Y$$$20240808$$MD$US$US
241867911$24186791$1$I$$20240729$20240808$20240808$EXP$$GR-AMGEN-GRCSP2024157166$AMGEN$$62$YR$A$F$Y$$$20240808$$CN$GR$GR
241867922$24186792$2$F$$20240807$20240808$20240814$PER$$US-AMGEN-USASP2024157297$AMGEN$$$$$F$Y$$$20240814$$HP$US$US
241867931$24186793$1$I$20231101$20240730$20240808$20240808$EXP$$US-ABBVIE-5863839$ABBVIE$$74$YR$$M$Y$77$KG$20240808$$CN$US$US
241867942$24186794$2$F$20240701$20240730$20240808$20240819$PER$$US-TEVA-VS-3228549$TEVA$$81$YR$$M$Y$$$20240819$$CN$US$US
241867952$24186795$2$F$$20240823$20240808$20240902$EXP$$US-TEVA-VS-3227909$TEVA$Bollam RR, Reddy VK. Persistent Pseudomonas Aeruginosa Pneumonia Due to Antimicrobial Resistance Development Requiring Lobectomy. Am-J-Respir-Crit-Care-Med 2024; 209 (0): (plus Poster).; Bollam RR, Reddy VK. Persistent Pseudomonas Aeruginosa Pneumonia Due to Antimicrobial Resistance Development Requiring Lobectomy. Am-J-Respir-Crit-Care-Med 2024; 209 (0): (plus Poster).$56$YR$$F$Y$$$20240902$$HP$US$US
241867962$24186796$2$F$$20240829$20240808$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124699$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240902$$HP$US$US
241867971$24186797$1$I$$20240805$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124528$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$73.03$KG$20240808$$CN$US$US
241867981$24186798$1$I$20240806$20240806$20240808$20240808$EXP$GB-MHRA-MED-202408060909533130-QRBTN$GB-ABBVIE-5870944$ABBVIE$$63$YR$$M$Y$$$20240808$$CN$GB$GB
241867991$24186799$1$I$20240201$20240806$20240808$20240808$EXP$FR-AFSSAPS-NC2024000946$FR-JNJFOC-20240815899$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240808$$PH$FR$FR
241868002$24186800$2$F$20240101$20240812$20240808$20240814$PER$$US-JNJFOC-20240813763$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240814$$CN$US$US
241868011$24186801$1$I$20240301$20240730$20240808$20240808$PER$$US-ABBVIE-5862836$ABBVIE$$53$YR$$F$Y$$$20240808$$CN$US$US
241868031$24186803$1$I$20240611$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038548$AUROBINDO$$46$YR$$F$Y$$$20240808$$CN$FR$FR
241868041$24186804$1$I$20220228$20240802$20240808$20240808$EXP$$CO-UCBSA-2024039664$UCB$$57$YR$$M$Y$$$20240808$$CN$CO$CO
241868051$24186805$1$I$20240701$20240730$20240808$20240808$EXP$$US-RECORDATI RARE DISEASE INC.-2024005965$RECORDATI$$$$$$Y$$$20240808$$CN$US$US
241868061$24186806$1$I$$20240806$20240808$20240808$EXP$$US-JNJFOC-20240816533$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241868071$24186807$1$I$$20240802$20240808$20240808$EXP$$IE-JNJFOC-20240808300$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$HP$IE$IE
241868082$24186808$2$F$20240701$20240807$20240808$20240811$PER$$US-AMGEN-USASP2024156331$AMGEN$$82$YR$E$F$Y$$$20240811$$CN$US$US
241868091$24186809$1$I$$20240724$20240808$20240808$EXP$$CA-GRANULES-CA-2024GRALIT00307$GRANULES INDIA$Julie Herrington.Asymptomatic intraspinal epidermoid cyst in a 7-year-old male with juvenile  idiopathic arthritis identified by an advanced physiotherapist practitioner:  a case report.Journal of Manual and Manipulative Therapy.02-APR-2024;32:343-351$7$YR$C$M$Y$$$20240808$$HP$CA$CA
241868101$24186810$1$I$$20240804$20240808$20240808$EXP$$EG-AMGEN-EGYSP2024156841$AMGEN$$40$YR$A$F$Y$$$20240808$$CN$EG$EG
241868122$24186812$2$F$20240101$20240911$20240808$20240920$EXP$$CA-CELLTRION INC.-2024CA018697$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
241868131$24186813$1$I$20240101$20240801$20240808$20240808$EXP$$US-ABBVIE-5864527$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241868141$24186814$1$I$20231101$20240730$20240808$20240808$PER$$US-SA-2024SA230572$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240808$$MD$US$US
241868151$24186815$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA232123$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240808$$MD$US$US
241868161$24186816$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA231979$SANOFI AVENTIS$$$$E$F$Y$89.811$KG$20240808$$MD$US$US
241868172$24186817$2$F$20240101$20240910$20240808$20240916$PER$$US-SA-2024SA230634$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240916$$MD$US$US
241868181$24186818$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA229046$SANOFI AVENTIS$$$$I$$Y$$$20240808$$MD$US$US
241868192$24186819$2$F$20240730$20240731$20240808$20240808$PER$$US-SA-2024SA229240$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240808$$MD$US$US
241868201$24186820$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA022086$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240808$$MD$US$US
241868211$24186821$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA169020$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240808$$MD$US$US
241868221$24186822$1$I$$20240801$20240808$20240808$EXP$$IN-ROCHE-10000047945$ROCHE$$58$YR$A$M$Y$$$20240808$$CN$IN$IN
241868231$24186823$1$I$20240701$20240801$20240808$20240808$EXP$$US-ABBVIE-5865829$ABBVIE$$63$YR$$M$Y$$$20240808$$CN$US$US
241868241$24186824$1$I$20240401$20240731$20240808$20240808$PER$$US-SA-2024SA231729$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240808$$MD$US$US
241868252$24186825$2$F$$20240830$20240808$20240924$PER$$US-SA-2024SA231916$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240924$$MD$US$US
241868261$24186826$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA231807$SANOFI AVENTIS$$23$YR$A$F$Y$68$KG$20240808$$MD$US$US
241868271$24186827$1$I$$20240802$20240808$20240808$PER$$US-SA-2024SA233099$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240808$$CN$US$US
241868281$24186828$1$I$20231101$20240731$20240808$20240808$PER$$US-SA-2024SA230434$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240808$$HP$US$US
241868291$24186829$1$I$$20240804$20240808$20240808$PER$$US-SA-2024SA233120$SANOFI AVENTIS$$$$$M$Y$$$20240808$$CN$US$US
241868301$24186830$1$I$20240729$20240730$20240808$20240808$PER$$US-SA-2024SA231585$SANOFI AVENTIS$$54$YR$A$M$Y$89.3$KG$20240808$$MD$US$US
241868311$24186831$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA229601$SANOFI AVENTIS$$$$C$M$Y$$$20240808$$MD$US$US
241868321$24186832$1$I$20240731$20240801$20240808$20240808$PER$$US-SA-2024SA231871$SANOFI AVENTIS$$42$YR$A$F$Y$55.7$KG$20240808$$MD$US$US
241868331$24186833$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA230541$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240808$$MD$US$US
241868342$24186834$2$F$20240101$20240815$20240808$20240828$PER$$US-SA-2024SA229014$SANOFI AVENTIS$$33$YR$A$F$Y$81.65$KG$20240828$$MD$US$US
241868351$24186835$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231052$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240808$$MD$US$US
241868361$24186836$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA150948$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240808$$MD$US$US
241868372$24186837$2$F$20240801$20240903$20240808$20240925$PER$$US-SA-2024SA231875$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240925$$HP$US$US
241868381$24186838$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA228977$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240808$$CN$US$US
241868391$24186839$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA230382$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240808$$MD$US$US
241868402$24186840$2$F$$20240806$20240808$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202408004383$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240918$$CN$US$US
241868411$24186841$1$I$$20240801$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408001937$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240808$$CN$US$US
241868421$24186842$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004531$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241868431$24186843$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003942$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241868441$24186844$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003954$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240808$$CN$US$US
241868451$24186845$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003909$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$US$US
241868461$24186846$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003878$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240808$$CN$US$US
241868471$24186847$1$I$$20240802$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002588$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240808$$CN$US$US
241868482$24186848$2$F$$20240806$20240808$20240815$PER$$US-SA-2024SA233321$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240815$$CN$US$US
241868491$24186849$1$I$$20240805$20240808$20240808$PER$$US-SA-2024SA233302$SANOFI AVENTIS$$$$$F$Y$$$20240808$$HP$US$US
241868501$24186850$1$I$$20240805$20240808$20240808$PER$$US-SA-2024SA233701$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240808$$CN$US$US
241868511$24186851$1$I$$20240725$20240808$20240808$EXP$$US-SA-2024SA232421$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240808$$MD$US$US
241868521$24186852$1$I$$20240805$20240808$20240808$PER$$US-SA-2024SA233743$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240808$$CN$US$US
241868531$24186853$1$I$$20240801$20240808$20240808$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-124695$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240808$$HP$CA$CA
241868541$24186854$1$I$20240101$20240806$20240808$20240808$EXP$$NVSC2024GB072756$NOVARTIS$$$$$F$Y$$$20240808$$CN$GB$GB
241868552$24186855$2$F$20240705$20240806$20240808$20240809$PER$$US-AMGEN-USASP2024156149$AMGEN$$70$YR$E$M$Y$$$20240808$$HP$US$US
241868561$24186856$1$I$20240101$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024156021$AMGEN$$34$YR$A$F$Y$$$20240808$$HP$US$US
241868581$24186858$1$I$$20240731$20240808$20240808$EXP$$US-ROCHE-10000046175$ROCHE$$72$YR$E$F$Y$$$20240808$$HP$US$US
241868591$24186859$1$I$$20240724$20240808$20240808$EXP$$IT-GRANULES-IT-2024GRALIT00310$GRANULES INDIA$M. Marano.Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars .Toxicology Reports.21-JUN-2024;13:1-4$15$YR$T$F$Y$48$KG$20240808$$HP$IT$IT
241868601$24186860$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A175160$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241868621$24186862$1$I$$20240805$20240808$20240808$EXP$PL-URPL-1-4242-2020$PL-HALEON-2190556$Haleon PLC$$24$YR$$F$Y$76$KG$20240808$$MD$PL$PL
241868631$24186863$1$I$$20240806$20240808$20240808$PER$$US-AMGEN-USASL2024156904$AMGEN$$$$$$Y$$$20240808$$CN$US$US
241868641$24186864$1$I$$20240807$20240808$20240808$PER$$US-ROCHE-10000051572$ROCHE$$37$YR$A$F$Y$$$20240808$$MD$US$US
241868661$24186866$1$I$20240701$20240806$20240808$20240808$EXP$$US-ABBVIE-5871246$ABBVIE$$77$YR$$M$Y$$$20240808$$CN$US$US
241868672$24186867$2$F$20230327$20240827$20240808$20240829$EXP$$FR-ORGANON-O2408FRA000440$ORGANON$$39$YR$$F$Y$110$KG$20240829$$MD$FR$FR
241868681$24186868$1$I$$20240807$20240808$20240808$30DAY$$US-SANDOZ INC.-SDZ2024US071285$SANDOZ$$$$$M$Y$$$20240808$$CN$US$US
241868691$24186869$1$I$$20240729$20240808$20240808$EXP$$JP-ROCHE-10000041575$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$74$YR$E$M$Y$$$20240808$$HP$JP$JP
241868701$24186870$1$I$$20240711$20240808$20240808$EXP$$ZA-ROCHE-10000050032$ROCHE$$$$A$F$Y$$$20240808$$CN$ZA$ZA
241868711$24186871$1$I$$20240724$20240808$20240808$EXP$$TR-GRANULES-TR-2024GRALIT00313$GRANULES INDIA$Enes Elvin Gul.Brugada phenocopy associated with multiple psychotic drugs .Journal of Electrocardiology.17-SEP-2023;81:156-158$17$YR$T$F$Y$$$20240808$$MD$TR$TR
241868722$24186872$2$F$$20240808$20240808$20240809$PER$$US-JNJFOC-20240779342$JOHNSON AND JOHNSON$$$$$F$Y$61$KG$20240809$$CN$US$US
241868731$24186873$1$I$20240101$20240806$20240808$20240808$EXP$$US-JNJFOC-20240816381$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240808$$HP$US$US
241868741$24186874$1$I$20240626$20240717$20240808$20240808$PER$$US-JNJFOC-20240817185$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240808$$MD$US$US
241868751$24186875$1$I$$20240802$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123415$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240808$$CN$US$US
241868761$24186876$1$I$20240726$20240802$20240808$20240808$PER$$US-BEH-2024176835$CSL BEHRING$$62$YR$A$F$Y$$$20240808$$CN$US$US
241868771$24186877$1$I$$20240729$20240808$20240808$PER$$US-ABBVIE-5859710$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241868781$24186878$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683371$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241868792$24186879$2$F$$20240809$20240808$20240822$EXP$$JP-AMGEN-JPNSP2024156195$AMGEN$EP-0757 Use experience with G-LASTA BodyPod in our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society (11, 12, and 13 JU. 2024;367$$$$$Y$$$20240821$$MD$JP$JP
241868801$24186880$1$I$$20240731$20240808$20240808$EXP$$TR-NOVITIUMPHARMA-2024TRNVP01503$NOVITIUM PHARMA$Gulfem Akin.The Significance of Eosinophil-to-Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series.Indian Journal of Dermatology.FEB-2024;81-85:69(1)$72$YR$E$M$Y$$$20240808$$HP$TR$TR
241868811$24186881$1$I$$20240805$20240808$20240808$EXP$$US-GSK-US2024097523$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$PH$US$US
241868821$24186882$1$I$20231201$20240802$20240808$20240808$EXP$$US-ABBVIE-5868493$ABBVIE$$51$YR$$M$Y$$$20240808$$CN$US$US
241868831$24186883$1$I$20240720$20240806$20240808$20240808$EXP$$PL-ABBVIE-5871442$ABBVIE$$$$$$Y$$$20240808$$MD$PL$PL
241868841$24186884$1$I$$20240712$20240808$20240808$EXP$$VN-ROCHE-10000047219$ROCHE$Nguyen H, Tran T, Vu T, Pham Q, Pham P, Nguyen H. EVALUATION OF TREATMENT RESULTS OF ATEZOLIZUMAB COMBINED WITH BEVACIZUMAB REGIMENIN HEPATOCELLULAR CARCINOMA. VIETNAM MEDICAL JOURNAL. 2024-May-06;538:271-7.$$$$$Y$$$20240808$$HP$VN$VN
241868862$24186886$2$F$20240805$20240911$20240808$20240912$PER$$US-AMGEN-USASP2024156245$AMGEN$$71$YR$E$F$Y$$$20240912$$CN$US$US
241868871$24186887$1$I$20240804$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024157108$AMGEN$$73$YR$E$F$Y$$$20240808$$CN$US$US
241868881$24186888$1$I$$20240412$20240808$20240808$EXP$$US-GRAVITIPHARMA-GRA-2404-US-SPO-0101$GRAVITI PHARMACEUTICALS$$$$$M$Y$86$KG$20240808$$CN$US$US
241868892$24186889$2$F$$20240910$20240808$20240920$30DAY$$US-GSK-US2024095386$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
241868901$24186890$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A175582$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241868911$24186891$1$I$$20240731$20240808$20240808$EXP$$CN-AstraZeneca-2024A175713$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$CN$
241868921$24186892$1$I$20240101$20240807$20240808$20240808$EXP$$US-UCBSA-2024039716$UCB$$$$$F$Y$$$20240808$$CN$US$US
241868931$24186893$1$I$$20220110$20240808$20240808$EXP$$CA-AstraZeneca-2022A019567$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$CA$
241868941$24186894$1$I$$20230207$20240808$20240808$EXP$$US-AstraZeneca-2022A418947$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241868951$24186895$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004164$ELI LILLY AND CO$$$$$$Y$$$20240808$$HP$US$US
241868961$24186896$1$I$$20240731$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408000234$ELI LILLY AND CO$$48$YR$A$$Y$$$20240808$$LW$US$US
241868971$24186897$1$I$$20240801$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408001310$ELI LILLY AND CO$$57$YR$A$$Y$$$20240808$$LW$US$US
241868981$24186898$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003869$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240808$$CN$US$US
241869002$24186900$2$F$$20240829$20240808$20240906$EXP$$NL-ABBVIE-5869524$ABBVIE$$$$E$F$Y$$$20240906$$PH$NL$NL
241869011$24186901$1$I$20240716$20240801$20240808$20240808$EXP$$IT-EMD Serono-2024040134$EMD SERONO INC$$77$YR$E$M$Y$$$20240808$$MD$IT$IT
241869022$24186902$2$F$20240101$20240807$20240808$20240814$EXP$$CA-UCBSA-2024039691$UCB$$$$$F$Y$$$20240814$$CN$CA$CA
241869042$24186904$2$F$20240721$20240913$20240808$20240920$EXP$$US-SERVIER-S24009536$SERVIER$$$$$$Y$$$20240920$$MD$US$US
241869061$24186906$1$I$$20240806$20240808$20240808$EXP$$GB-SANDOZ INC.-NVSC2019GB012360$SANDOZ$$$$$F$Y$$$20240808$$HP$GB$GB
241869071$24186907$1$I$20240804$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156686$AMGEN$$67$YR$E$M$Y$$$20240808$$CN$US$US
241869081$24186908$1$I$20240709$20240724$20240808$20240808$EXP$$CN-EAGLE PHARMACEUTICALS, INC.-CN-2024EAG000193$EAGLE$$72$YR$$F$Y$45$KG$20240808$$HP$CN$CN
241869091$24186909$1$I$20240719$20240805$20240808$20240808$EXP$$CA-JNJFOC-20240759937$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240808$$CN$CA$CA
241869101$24186910$1$I$$20240727$20240808$20240808$EXP$$IN-MSNLABS-2024MSNSPO01699$MSN LABORATORIES$$$$$$Y$$$20240808$$CN$IN$IN
241869111$24186911$1$I$$20240729$20240808$20240808$PER$$US-JNJFOC-20240815747$JOHNSON AND JOHNSON$$$$$M$Y$125$KG$20240808$$MD$US$US
241869121$24186912$1$I$$20240516$20240808$20240808$EXP$$US-GRAVITIPHARMA-GRA-2405-US-SPO-0157$GRAVITI PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241869131$24186913$1$I$$20240803$20240808$20240808$PER$$US-ABBVIE-5869700$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241869144$24186914$4$F$20240801$20240919$20240808$20240920$PER$$US-AMGEN-USASP2024156027$AMGEN$$73$YR$E$F$Y$$$20240920$$CN$US$US
241869152$24186915$2$F$20240101$20240821$20240808$20240904$PER$$US-SA-2024SA198109$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240904$$CN$US$US
241869161$24186916$1$I$20201229$20240731$20240808$20240808$PER$$US-SA-2024SA229847$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240808$$MD$US$US
241869172$24186917$2$F$$20240827$20240808$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001575$BLUEPRINT MEDICINES$$$$$F$Y$$$20240830$$CN$US$US
241869183$24186918$3$F$$20240830$20240808$20240903$PER$$US-SA-2024SA229270$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240903$$CN$US$US
241869191$24186919$1$I$20240701$20240801$20240808$20240808$PER$$US-SA-2024SA231929$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240808$$MD$US$US
241869201$24186920$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA230389$SANOFI AVENTIS$$$$C$M$Y$$$20240808$$MD$US$US
241869211$24186921$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA230213$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240808$$MD$US$US
241869221$24186922$1$I$$20240802$20240808$20240808$PER$$US-SA-2024SA231919$SANOFI AVENTIS$$$$A$M$Y$$$20240808$$MD$US$US
241869231$24186923$1$I$$20240805$20240808$20240808$EXP$$NVSJ2024JP009460$NOVARTIS$$$$E$M$Y$$$20240808$$MD$JP$JP
241869241$24186924$1$I$$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024156123$AMGEN$$$$$$Y$$$20240808$$HP$US$US
241869251$24186925$1$I$20240101$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156601$AMGEN$$42$YR$A$F$Y$$$20240808$$CN$US$US
241869263$24186926$3$F$$20240815$20240808$20240827$EXP$$US-INSMED, INC.-2024-03058-US$INSMED$$$$$F$Y$$$20240827$$HP$US$US
241869271$24186927$1$I$$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124649$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240808$$CN$US$US
241869282$24186928$2$F$20230701$20240813$20240808$20240816$EXP$$CR-ROCHE-10000051152$ROCHE$$67$YR$E$F$Y$$$20240816$$MD$CR$CR
241869292$24186929$2$F$20240501$20240806$20240808$20240813$EXP$$CA-JNJFOC-20240760154$JOHNSON AND JOHNSON$$60$YR$A$M$Y$65$KG$20240813$$HP$CA$CA
241869301$24186930$1$I$20201130$20240730$20240808$20240808$EXP$$AT-TEVA-VS-3228633$TEVA$$63$YR$$F$Y$55$KG$20240808$$MD$AT$AT
241869311$24186931$1$I$20240722$20240801$20240808$20240808$EXP$$US-JNJFOC-20240803617$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241869321$24186932$1$I$20220301$20240729$20240808$20240808$PER$$US-UNITED THERAPEUTICS-UNT-2022-005049$UNITED THERAPEUTICS$$55$YR$$M$Y$74.83$KG$20240808$$$US$US
241869331$24186933$1$I$20240601$20240806$20240808$20240808$EXP$$US-ABBVIE-5870627$ABBVIE$$47$YR$$F$Y$$$20240808$$CN$US$US
241869341$24186934$1$I$20231103$20240805$20240808$20240808$EXP$DE-SANDOZ-SDZ2024DE068283$DE-UCBSA-2024039139$UCB$$$$A$F$Y$$$20240808$$HP$DE$DE
241869353$24186935$3$F$20240801$20240813$20240808$20240819$EXP$$ES-ABBVIE-5865599$ABBVIE$$79$YR$$M$Y$$$20240819$$HP$ES$ES
241869361$24186936$1$I$$20240807$20240808$20240808$EXP$$US-SANDOZ INC.-SDZ2024US071297$SANDOZ$$$$$F$Y$$$20240808$$CN$US$US
241869371$24186937$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125294$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$99.79$KG$20240808$$CN$US$US
241869391$24186939$1$I$$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024156160$AMGEN$$$$$$Y$$$20240808$$MD$US$US
241869401$24186940$1$I$$20240729$20240808$20240808$PER$$US-AMGEN-USASL2024155471$AMGEN$$$$$$Y$$$20240808$$CN$US$US
241869411$24186941$1$I$20240201$20240801$20240808$20240808$EXP$FR-AFSSAPS-TO2024001155$FR-ACS-20240274$ACS DOBFAR$$59$YR$A$M$Y$$$20240801$$PH$FR$FR
241869421$24186942$1$I$20240703$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155740$AMGEN$$60$YR$A$M$Y$$$20240808$$CN$US$US
241869431$24186943$1$I$20240701$20240729$20240808$20240808$PER$$US-UNITED THERAPEUTICS-UNT-2024-023478$UNITED THERAPEUTICS$$52$YR$$M$Y$57.596$KG$20240808$$$US$US
241869442$24186944$2$F$20240805$20240821$20240808$20240826$PER$$US-AMGEN-USASP2024155912$AMGEN$$76$YR$E$F$Y$$$20240826$$CN$US$US
241869451$24186945$1$I$20240501$20240729$20240808$20240808$EXP$$ES-AUROBINDO-AUR-APL-2024-038435$AUROBINDO$$16$YR$$M$Y$$$20240808$$MD$ES$ES
241869461$24186946$1$I$$20240801$20240808$20240808$EXP$$US-SA-2024SA231756$SANOFI AVENTIS$$$$E$M$Y$$$20240808$$MD$US$US
241869481$24186948$1$I$20240701$20240801$20240808$20240808$EXP$$US-SA-2024SA231855$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240808$$MD$US$US
241869491$24186949$1$I$$20240729$20240808$20240808$EXP$$NL-AUROBINDO-AUR-APL-2024-038388$AUROBINDO$$58$YR$$F$Y$77$KG$20240808$$PH$NL$NL
241869501$24186950$1$I$20240322$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038556$AUROBINDO$$76$YR$$M$Y$76$KG$20240808$$MD$FR$FR
241869521$24186952$1$I$$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156475$AMGEN$$$$$$Y$$$20240808$$PH$US$US
241869531$24186953$1$I$20240707$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038016$AUROBINDO$$76$YR$$F$Y$41$KG$20240808$$MD$FR$FR
241869541$24186954$1$I$$20240805$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124226$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240808$$CN$US$US
241869552$24186955$2$F$20240701$20240903$20240808$20240912$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-023809$UNITED THERAPEUTICS$$64$YR$$M$Y$$$20240912$$$JP$JP
241869561$24186956$1$I$$20240724$20240808$20240808$EXP$$CN-GRANULES-CN-2024GRALIT00316$GRANULES INDIA$Xiao-Lan Li.A Rare Case of Acute Infectious Purpura Fulminans Caused by Klebsiella Pneumoniae and Human Herpesvirus Type 5.Journal of Inflammation Research.26-JUL-2022;15:4251-4260$22$YR$A$M$Y$$$20240808$$HP$CN$CN
241869571$24186957$1$I$20240101$20240719$20240808$20240808$PER$$CA-TOLMAR, INC.-24CA050878$TOLMAR$$$$$M$Y$$$20240808$$CN$CA$CA
241869581$24186958$1$I$$20240719$20240808$20240808$PER$$CA-TOLMAR, INC.-24CA050910$TOLMAR$$$$$M$Y$$$20240808$$CN$CA$CA
241869591$24186959$1$I$20240717$20240717$20240808$20240808$PER$$CA-TOLMAR, INC.-24CA050923$TOLMAR$$54$YR$$M$Y$$$20240808$$CN$CA$CA
241869601$24186960$1$I$20240720$20240720$20240808$20240808$PER$$CA-TOLMAR, INC.-24CA051211$TOLMAR$$69$YR$$M$Y$$$20240808$$CN$CA$CA
241869612$24186961$2$F$20240201$20240806$20240808$20240828$PER$$US-TOLMAR, INC.-24US051262$TOLMAR$$75$YR$$M$Y$$$20240827$$HP$US$US
241869621$24186962$1$I$20240701$20240719$20240808$20240808$PER$$UY-TOLMAR, INC.-24UY051195$TOLMAR$$73$YR$$M$Y$$$20240808$$MD$UY$UY
241869631$24186963$1$I$20240730$20240806$20240808$20240808$EXP$$CA-JNJFOC-20240817317$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240808$$HP$CA$CA
241869651$24186965$1$I$$20240730$20240808$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-037679$AUROBINDO$Mariana Baptista. A SESS?O III DA SABATINA DE  HEMATOLOGIA, DA TARDE DO  20 DE ABRIL, FOI DEDICADA O  MIELOMAM?LTIPLO (MM).  SOB MODERA??O DE RUI  BERGANTIM, FOI  APRESENTADO UM CASO  Imunoterapia aplicadaao  mieloma m?ltiplo(SESSION III OF THE HEMATOLOGY SABBATH, ON THE AFTERNOON OF APRIL 20, WAS DEDICATED TO MULTIPLE MYELOM (MM).  UNDER RUI BERGANTIM^S MODERATION, A CASE WAS PRESENTED Immunotherapy applied to multiple myeloma). 32 SABATINA DE HEMATOLOGIA. (32nd HEMATOLOGY SABATINE). 2024;46:13$46$YR$$F$Y$$$20240808$$MD$PT$PT
241869662$24186966$2$F$$20240802$20240808$20240814$EXP$$DE-JNJFOC-20240808186$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$MD$DE$DE
241869681$24186968$1$I$$20240804$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002799$ELI LILLY AND CO$$68$YR$E$$Y$$$20240808$$LW$US$US
241869691$24186969$1$I$20240731$20240731$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408001135$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241869701$24186970$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004237$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240808$$CN$US$US
241869711$24186971$1$I$$20240802$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002331$ELI LILLY AND CO$$71$YR$E$$Y$$$20240808$$LW$US$US
241869721$24186972$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004081$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240808$$CN$US$US
241869731$24186973$1$I$20240806$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004000$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240808$$CN$US$US
241869741$24186974$1$I$20240804$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003633$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240808$$CN$US$US
241869751$24186975$1$I$$20240729$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407017251$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240808$$CN$US$US
241869761$24186976$1$I$20240806$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003992$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240808$$HP$US$US
241869771$24186977$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003935$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240808$$CN$US$US
241869781$24186978$1$I$20240501$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003918$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240808$$CN$US$US
241869791$24186979$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229528$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$71$YR$$M$Y$$$20240808$$HP$FR$FR
241869801$24186980$1$I$$20240802$20240808$20240808$EXP$$BR-TAKEDA-2021TUS057090$TAKEDA$$$$$F$Y$$$20240808$$CN$BR$BR
241869811$24186981$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003244$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240808$$CN$US$US
241869821$24186982$1$I$$20240802$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002817$ELI LILLY AND CO$$58$YR$A$$Y$$$20240808$$LW$US$US
241869831$24186983$1$I$$20240516$20240808$20240808$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091048$GLENMARK$$$$$$Y$$$20240808$$CN$US$US
241869841$24186984$1$I$$20240404$20240808$20240808$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089963$GLENMARK$$$$$$Y$$$20240808$$CN$US$US
241869851$24186985$1$I$$20230629$20240808$20240808$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083288$GLENMARK$$$$$$Y$$$20240808$$CN$US$US
241869861$24186986$1$I$20230729$20230803$20240808$20240808$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK084119$GLENMARK$$$$$$Y$$$20240808$$CN$US$US
241869871$24186987$1$I$$20231017$20240808$20240808$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086038$GLENMARK$$$$$$Y$$$20240808$$CN$US$US
241869881$24186988$1$I$$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038161$AUROBINDO$$$$$F$Y$$$20240808$$HP$GB$GB
241869891$24186989$1$I$20240101$20240802$20240808$20240808$EXP$$CA-ABBVIE-5866256$ABBVIE$$33$YR$$M$Y$$$20240808$$CN$CA$CA
241869901$24186990$1$I$20240801$20240805$20240808$20240808$PER$$US-ABBVIE-5871157$ABBVIE$$42$YR$$F$Y$$$20240808$$MD$US$US
241869911$24186991$1$I$$20240730$20240808$20240808$PER$$US-ABBVIE-5861377$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241869922$24186992$2$F$20240629$20240904$20240808$20240911$EXP$$US-ABBVIE-5865825$ABBVIE$$60$YR$$F$Y$68.492$KG$20240911$$CN$US$US
241869941$24186994$1$I$$20240801$20240808$20240808$EXP$$JP-AMGEN-JPNSP2024111801$AMGEN$$8$DEC$E$F$Y$$$20240808$$MD$JP$JP
241869951$24186995$1$I$$20240516$20240808$20240808$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07061$HIKMA$Stoffer JN, Ebert JJ, Nicola MD, Isernhagen BA, Sood AB, Dundervill RF, et al.. Stoffer JN, Ebert JJ, Nicola MD, Isernhagen BA, Sood AB, Dundervill RF, et al. Chronic central serous chorioretinopathy in the pediatric population: A case series. Retinal cases and brief reports. 2024;18(3):360-4$$$$$Y$$$20240808$$MD$US$US
241869961$24186996$1$I$$20240731$20240808$20240808$PER$$NVSC2024US157365$NOVARTIS$$$$$M$Y$$$20240808$$CN$US$US
241869971$24186997$1$I$20240805$20240805$20240808$20240808$30DAY$$US-GSK-US2024097570$GLAXOSMITHKLINE$$89$YR$$F$Y$$$20240808$$CN$US$US
241869992$24186999$2$F$$20240906$20240808$20240913$30DAY$$TR-JNJFOC-20240813858$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$TR$TR
241870011$24187001$1$I$$20240724$20240808$20240808$EXP$$US-GRANULES-US-2024GRALIT00311$GRANULES INDIA$Hasan S. Raza.Parvimonas micra Bacteremia: A Rare Complication After Esophagogastroduodenoscopy for Upper Gastrointestinal Bleeding.ACG Case Reports Journal.07-JUN-2024;11:1-3$38$YR$A$M$Y$$$20240808$$MD$US$US
241870021$24187002$1$I$20240706$20240726$20240808$20240808$EXP$$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-110390$ZYDUS PHARM$$$$$$Y$$$20240808$$MD$GB$GB
241870031$24187003$1$I$20240101$20240731$20240808$20240808$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110803$ZYDUS PHARM$$$$$$Y$$$20240808$$CN$US$US
241870041$24187004$1$I$20240731$20240731$20240808$20240808$PER$$US-AstraZeneca-2024A175106$ASTRAZENECA$$$$$$Y$$$20240808$$MD$US$
241870051$24187005$1$I$$20200622$20240808$20240808$EXP$$CR-AstraZeneca-2020SE74164$ASTRAZENECA$$81$YR$$F$Y$$$20240808$$MD$CR$
241870061$24187006$1$I$$20240729$20240808$20240808$EXP$$AU-CADILA HEALTHCARE LIMITED-AU-ZYDUS-110391$ZYDUS PHARM$$$$$$Y$$$20240808$$HP$AU$AU
241870072$24187007$2$F$$20240823$20240808$20240902$EXP$$US-TEVA-VS-3227912$TEVA$Chittal A, Disilvio BE, Dumont T. Amiodarone Not the Only Anti-arrhythmic Wreaking Havoc on the Lung: A Case of Flecainide Induced Pneumonitis. Am-J-Respir-Crit-Care-Med 2024; 209.; Chittal A, Disilvio BE, Dumont T. Amiodarone Not the Only Anti-arrhythmic Wreaking Havoc on the Lung: A Case of Flecainide Induced Pneumonitis. Am-J-Respir-Crit-Care-Med 2024; 209.$69$YR$$F$Y$$$20240902$$HP$US$US
241870081$24187008$1$I$20220501$20220526$20240808$20240808$EXP$$US-AstraZeneca-2022A200529$ASTRAZENECA$$801$MON$$M$Y$$$20240808$$CN$US$
241870091$24187009$1$I$$20220119$20240808$20240808$EXP$$GB-AstraZeneca-2022A031919$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$GB$
241870101$24187010$1$I$20240101$20240802$20240808$20240808$EXP$$US-ABBVIE-5867348$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241870112$24187011$2$F$20240101$20240909$20240808$20240912$EXP$$IL-ABBVIE-5869538$ABBVIE$$$$$F$Y$$$20240912$$CN$IL$IL
241870121$24187012$1$I$20200317$20240731$20240808$20240808$EXP$$PL-AUROBINDO-AUR-APL-2024-039145$AUROBINDO$$50$YR$$F$Y$$$20240808$$MD$PL$PL
241870131$24187013$1$I$$20240730$20240808$20240808$EXP$$US-BIOCON BIOLOGICS LIMITED-BBL2024005663$BIOCON$$$$$$Y$$$20240808$$CN$US$US
241870142$24187014$2$F$$20240823$20240808$20240902$EXP$$US-TEVA-VS-3228067$TEVA$Robertson IJ, Robbins QC, Li PC. Case of metastatic clear cell odontogenic carcinoma with response to chemoimmunotherapy. BMJ-Case-Rep 2024; 17 (4): 1-4.; Robertson IJ, Robbins QC, Li PC. Case of metastatic clear cell odontogenic carcinoma with response to chemoimmunotherapy. BMJ-Case-Rep 2024; 17 (4): 1-4.$$$$F$Y$$$20240902$$HP$US$US
241870151$24187015$1$I$$20240801$20240808$20240808$EXP$$GB-TAKEDA-2022TUS037508$TAKEDA$$$$$F$Y$$$20240808$$MD$GB$GB
241870161$24187016$1$I$20240617$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038376$AUROBINDO$$79$YR$$M$Y$80.4$KG$20240808$$MD$FR$FR
241870171$24187017$1$I$$20240731$20240808$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-039237$AUROBINDO$Antunes Salvado C, Tojal A, Alves H, Fidalgo M.. Antunes Salvado C, Tojal A, Alves H, Fidalgo M.. CO-0176 - (4530) - A rare case of Sporopachydermia cereana infection.. Congressos da Sociedade Portuguesa de Medicina Interna.. 2024$48$YR$$F$Y$$$20240808$$MD$PT$PT
241870191$24187019$1$I$20240805$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156707$AMGEN$$54$YR$A$F$Y$$$20240808$$CN$US$US
241870201$24187020$1$I$20230701$20240802$20240808$20240808$EXP$$AT-TAKEDA-2024TUS003067$TAKEDA$$35$YR$$F$Y$$$20240808$$CN$AT$AT
241870211$24187021$1$I$$20240724$20240808$20240808$EXP$$JP-GRANULES-JP-2024GRALIT00309$GRANULES INDIA$Tanomogi N.Fatal cerebral venous sinus thrombosis with preceding thrombocytopenia in a patient with new-onset eosinophilic granulomatosis with polyangiitis.Modern Rheumatology Case Reports.JUL-2023;7:410-415$44$YR$A$F$Y$$$20240808$$HP$JP$JP
241870221$24187022$1$I$20240101$20240806$20240808$20240808$EXP$$US-ABBVIE-5870610$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241870231$24187023$1$I$$20240731$20240808$20240808$EXP$$VN-AstraZeneca-2024A177555$ASTRAZENECA$$$$$F$Y$$$20240808$$HP$VN$
241870241$24187024$1$I$$20221128$20240808$20240808$EXP$$US-AstraZeneca-2022A391790$ASTRAZENECA$$$$A$F$Y$81$KG$20240808$$CN$US$
241870251$24187025$1$I$$20231017$20240808$20240808$EXP$$US-AstraZeneca-2023A192570$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241870261$24187026$1$I$20211222$20220121$20240808$20240808$EXP$$US-AstraZeneca-2022A038660$ASTRAZENECA$$30938$DY$$M$Y$98$KG$20240808$$CN$US$
241870271$24187027$1$I$20240619$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038150$AUROBINDO$$78$DY$$F$Y$89$KG$20240808$$CN$GB$GB
241870281$24187028$1$I$$20230503$20240808$20240808$EXP$$US-AstraZeneca-2023A104404$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241870291$24187029$1$I$$20230712$20240808$20240808$EXP$$US-AstraZeneca-2023A160534$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241870301$24187030$1$I$$20210421$20240808$20240808$EXP$$GB-AstraZeneca-2021A351698$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$GB$
241870311$24187031$1$I$$20230620$20240808$20240808$EXP$$US-AstraZeneca-2023A143021$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241870321$24187032$1$I$20240802$20240802$20240808$20240808$EXP$$US-GSK-US2024096937$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240808$$CN$US$US
241870331$24187033$1$I$20221001$20230117$20240808$20240808$EXP$$US-AstraZeneca-2023A015488$ASTRAZENECA$$663$MON$$F$Y$37$KG$20240808$$HP$US$
241870341$24187034$1$I$$20220317$20240808$20240808$EXP$$US-AstraZeneca-2022A120435$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241870351$24187035$1$I$20240727$20240803$20240808$20240808$EXP$$US-TAKEDA-2023TUS076032$TAKEDA$$41$YR$$M$Y$$$20240808$$CN$US$US
241870361$24187036$1$I$$20240713$20240808$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05056$LUPIN$$$$$$Y$$$20240808$$CN$US$US
241870372$24187037$2$F$20240101$20240911$20240808$20240912$PER$$US-AMGEN-USASP2024155292$AMGEN$$56$YR$A$F$Y$$$20240911$$CN$US$US
241870381$24187038$1$I$$20240730$20240808$20240808$EXP$$BR-ROCHE-RCA5212756$ROCHE$Delamain M, Cardoso A, Pericole F, Da Silva Araujo S, Fogliatto L, Higashi M, et al. Long-Term Safety and Effectiveness of Rituximab Biosimilar RTXM83: A Retrospective Extension Study in Brazilian Patients with Diffuse Large B-Cell Lymphoma. Oncology and Therapy. 2024-Jun-03;1-14. doi:10.1007/s40487-024-00282-7.$$$$$Y$$$20240808$$HP$BR$BR
241870391$24187039$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229785$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$57$YR$$M$Y$$$20240808$$HP$FR$FR
241870401$24187040$1$I$$20240807$20240808$20240808$PER$$US-ROCHE-10000051623$ROCHE$$$$T$F$Y$80.74$KG$20240808$$PH$US$US
241870411$24187041$1$I$$20240731$20240808$20240808$EXP$$US-NOVITIUMPHARMA-2024USNVP01507$NOVITIUM PHARMA$Nida Zubair.Drug-induced Euglycemic Diabetic Ketoacidosis in a Patient with Systemic Sarcoidosis.Southern Medical Journal.19-DEC-2022;NA:1-3$78$YR$E$F$Y$$$20240808$$HP$US$US
241870421$24187042$1$I$$20240807$20240808$20240808$EXP$$AU-ROCHE-10000050801$ROCHE$$$$$$Y$$$20240808$$MD$AU$AU
241870431$24187043$1$I$20240101$20240805$20240808$20240808$EXP$$US-ABBVIE-5868618$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241870451$24187045$1$I$20240226$20240805$20240808$20240808$EXP$$US-ABBVIE-5659758$ABBVIE$$64$YR$$M$Y$$$20240808$$CN$US$US
241870472$24187047$2$F$$20240903$20240808$20240905$EXP$$NVSC2024GB160164$NOVARTIS$$$$A$F$Y$$$20240906$$CN$GB$GB
241870481$24187048$1$I$20240101$20240805$20240808$20240808$PER$$US-ABBVIE-5867743$ABBVIE$$$$$F$Y$72.574$KG$20240808$$CN$US$US
241870491$24187049$1$I$$20240805$20240808$20240808$EXP$$US-JNJFOC-20240811134$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241870501$24187050$1$I$$20240807$20240808$20240808$PER$$US-JNJFOC-20240818279$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240808$$HP$US$US
241870511$24187051$1$I$$20240804$20240808$20240808$EXP$$BE-JNJFOC-20240809014$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$BE$BE
241870521$24187052$1$I$$20240806$20240808$20240808$EXP$$PL-JNJFOC-20240816977$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240808$$HP$PL$PL
241870531$24187053$1$I$$20240801$20240808$20240808$PER$$US-JNJFOC-20240804359$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241870541$24187054$1$I$20240801$20240802$20240808$20240808$EXP$$US-GSK-US2024097032$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
241870551$24187055$1$I$20240624$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003998$ELI LILLY AND CO$$45$YR$A$$Y$$$20240808$$CN$US$US
241870561$24187056$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003907$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240808$$CN$US$US
241870571$24187057$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004134$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240808$$CN$US$US
241870581$24187058$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003964$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240808$$CN$US$US
241870591$24187059$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004317$ELI LILLY AND CO$$47$YR$A$$Y$$$20240808$$CN$US$US
241870601$24187060$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004022$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240808$$CN$US$US
241870611$24187061$1$I$$20240806$20240808$20240808$EXP$CZ-CZSUKL-24002138$CZ-ROCHE-10000050808$ROCHE$$39$YR$A$F$Y$56$KG$20240808$$MD$CZ$CZ
241870621$24187062$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161392$NOVARTIS$$$$$F$Y$$$20240808$$MD$US$US
241870632$24187063$2$F$20240804$20240823$20240808$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408003289$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240827$$CN$US$US
241870641$24187064$1$I$$20240730$20240808$20240808$EXP$$PH-ROCHE-RCA5212962$ROCHE$Perillo , Rene J, Kimura A, Wong S. Cure can be Achieved by Conversion to Microwave Ablation following Atezolizumab- Bevacizumab Therapy in Unresectable Hepatocellular Carcinoma. Journal of liver cancer. doi:10.17998/jlc.2024.05.23.$$$$$Y$$$20240808$$MD$PH$PH
241870651$24187065$1$I$$20240729$20240808$20240808$EXP$$CA-AMNEAL PHARMACEUTICALS-2024-AMRX-02818$AMNEAL$Su S, Wang YM, Zaborniak K, Hamza S, Jassal DS, et al. Severe distributive shock, neutrophilic dermatosis, and ST-elevation myocardial infarction in the setting of azathioprine hypersensitivity syndrome. Allergy Asthma Clin Immunol. 2024;20 (1)$59$YR$$M$Y$$$20240808$$HP$CA$CA
241870661$24187066$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229787$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$60$YR$$M$Y$$$20240808$$HP$FR$FR
241870682$24187068$2$F$$20240807$20240808$20240814$PER$$US-AMGEN-USASP2024157520$AMGEN$$$$E$F$Y$$$20240814$$CN$US$US
241870691$24187069$1$I$20240805$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156390$AMGEN$$34$YR$A$F$Y$$$20240808$$CN$US$US
241870701$24187070$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5868146$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241870711$24187071$1$I$20240731$20240801$20240808$20240808$EXP$$US-JNJFOC-20240785650$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240808$$MD$US$US
241870722$24187072$2$F$20240723$20240730$20240808$20240812$PER$$US-ABBVIE-5862574$ABBVIE$$52$YR$$F$Y$$$20240812$$CN$US$US
241870731$24187073$1$I$$20240724$20240808$20240808$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110493$ZYDUS PHARM$Kuczmarski TM, Lynch RC.. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma.. Br-J-Haematol. 2024;205(1):100-108.$$$$$Y$$$20240808$$HP$US$US
241870741$24187074$1$I$20240805$20240805$20240808$20240808$PER$$US-JNJFOC-20240811865$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240808$$MD$US$US
241870751$24187075$1$I$$20220314$20240808$20240808$EXP$$US-AstraZeneca-2022A115302$ASTRAZENECA$$$$$$Y$101.2$KG$20240808$$CN$US$
241870761$24187076$1$I$$20230324$20240808$20240808$EXP$$US-AstraZeneca-2023A071527$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241870771$24187077$1$I$20200915$20200915$20240808$20240808$EXP$$US-AstraZeneca-2020SF19114$ASTRAZENECA$$0$WK$$$Y$$$20240808$$CN$US$
241870781$24187078$1$I$$20210611$20240808$20240808$EXP$$US-AstraZeneca-2021A525362$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241870791$24187079$1$I$$20230125$20240808$20240808$EXP$$US-AstraZeneca-2023A022023$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241870801$24187080$1$I$20240731$20240805$20240808$20240808$EXP$$US-GSK-US2024097516$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240808$$HP$US$US
241870811$24187081$1$I$$20240805$20240808$20240808$EXP$$GB-ABBVIE-5870008$ABBVIE$$$$E$F$Y$$$20240808$$CN$GB$GB
241870821$24187082$1$I$$20200203$20240808$20240808$EXP$$US-AstraZeneca-2020SE19798$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241870832$24187083$2$F$$20240826$20240808$20240903$30DAY$$US-GSK-US2024094873$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$CN$US$US
241870841$24187084$1$I$$20240802$20240808$20240808$PER$$US-ABBVIE-5867206$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241870852$24187085$2$F$$20240807$20240808$20240812$EXP$$FR-ROCHE-2923469$ROCHE$$$$$F$Y$$$20240812$$HP$FR$FR
241870862$24187086$2$F$$20240805$20240808$20240808$EXP$$ES-AUROBINDO-AUR-APL-2022-024501$AUROBINDO$HR M, Pla Almendros E, Orozco Mossi N, Gallardo GM, Gorriz G E, Gonzales C A. Myasthenia gravis and solifenacin. a case report. fml. (a prop?sito de un caso. fml). 2022;27 (1):1-4.$80$YR$$M$Y$$$20240808$$MD$ES$ES
241870872$24187087$2$F$20200101$20240731$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-039114$AUROBINDO$$31$YR$$M$Y$$$20240808$$MD$FR$FR
241870881$24187088$1$I$20220101$20240801$20240808$20240808$PER$$US-RDY-SPO/USA/24/0011481$DR REDDYS$$17$YR$A$$Y$$$20240808$$CN$US$US
241870891$24187089$1$I$20240731$20240801$20240808$20240808$PER$$US-RDY-SPO/USA/24/0011459$DR REDDYS$$24$YR$A$F$Y$$$20240808$$CN$US$US
241870902$24187090$2$F$$20240813$20240808$20240820$PER$$US-RDY-SPO/USA/24/0011424$DR REDDYS$$$$$F$Y$$$20240820$$CN$US$US
241870911$24187091$1$I$20240801$20240801$20240808$20240808$PER$$US-RDY-SPO/USA/24/0011462$DR REDDYS$$15$YR$T$$Y$$$20240808$$MD$US$US
241870921$24187092$1$I$$20240802$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123000$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240808$$CN$US$US
241870931$24187093$1$I$20240801$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124997$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240808$$CN$US$US
241870941$24187094$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161125$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241870961$24187096$1$I$20240713$20240802$20240808$20240808$EXP$$CO-UCBSA-2024039683$UCB$$77$YR$$M$Y$$$20240808$$CN$CO$CO
241870972$24187097$2$F$20240802$20240807$20240808$20240809$PER$$US-AMGEN-USASP2024157525$AMGEN$$68$YR$E$F$Y$$$20240809$$CN$US$US
241870982$24187098$2$F$20180726$20240925$20240808$20240927$EXP$$US-GILEAD-2024-0683375$GILEAD$$47$YR$A$M$Y$$$20240927$$LW$US$US
241870991$24187099$1$I$20220101$20240805$20240808$20240808$EXP$$US-TAKEDA-2022TUS012841$TAKEDA$$71$YR$$M$Y$$$20240808$$CN$US$US
241871001$24187100$1$I$$20240801$20240808$20240808$PER$$US-ALXN-202408USA000082US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$HP$US$US
241871011$24187101$1$I$$20240801$20240808$20240808$EXP$$CA-APOTEX-2024AP009094$APOTEX$$$$A$F$Y$$$20240808$$CN$CA$CA
241871022$24187102$2$F$20240805$20240808$20240808$20240820$PER$$US-AMGEN-USASP2024156117$AMGEN$$88$YR$E$F$Y$$$20240820$$CN$US$US
241871031$24187103$1$I$$20240805$20240808$20240808$EXP$$US-GILEAD-2024-0683277$GILEAD$$71$YR$E$F$Y$$$20240808$$CN$US$US
241871041$24187104$1$I$20221209$20240729$20240808$20240808$EXP$$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07289$HIKMA$$45$YR$$F$Y$$$20240808$$PH$FR$FR
241871051$24187105$1$I$$20240731$20240808$20240808$EXP$$US-NOVITIUMPHARMA-2024USNVP01509$NOVITIUM PHARMA$I. Riestra.Fibrocystic Sarcoidosis: Should Patients Be on Prophylaxis for Opportunistic Infections?.American Journal of Respiratory and Critical Care Medicine.22-MAY-2024;NA:A3251$53$YR$A$M$Y$$$20240808$$HP$US$US
241871061$24187106$1$I$$20240804$20240808$20240808$PER$$US-LEO Pharma-372572$LEO PHARM$$62$YR$$M$Y$$$20240808$$PH$US$US
241871072$24187107$2$F$$20240823$20240808$20240902$EXP$$US-TEVA-VS-3228070$TEVA$Viswanath P, Zhao H, Wayland J, Dean J, Heynekamp TR. Decoding the Enigma of Eosinophils in Pleural Fluid. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Viswanath P, Zhao H, Wayland J, Dean J, Heynekamp TR. Decoding the Enigma of Eosinophils in Pleural Fluid. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$34$YR$$M$Y$$$20240902$$HP$US$US
241871083$24187108$3$F$$20240916$20240808$20240926$EXP$$US-AUROBINDO-AUR-APL-2024-039035$AUROBINDO$$30$YR$$F$Y$$$20240926$$MD$US$US
241871092$24187109$2$F$$20240807$20240808$20240812$PER$$NVSC2024US161005$NOVARTIS$$$$$$Y$$$20240812$$CN$US$US
241871101$24187110$1$I$$20240724$20240808$20240808$EXP$$JP-GRANULES-JP-2024GRALIT00308$GRANULES INDIA$S R Kim.Acetaminophen-induced liver injury with atypical histopathologic findings: a case report.Kanzo.JAN-2024;65:74-80$10$DEC$E$F$Y$$$20240808$$HP$JP$JP
241871111$24187111$1$I$$20240807$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044513$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240808$$CN$US$US
241871121$24187112$1$I$20240731$20240805$20240808$20240808$EXP$$JP-GILEAD-2024-0682960$GILEAD$$77$YR$E$M$Y$$$20240808$$MD$JP$JP
241871131$24187113$1$I$$20240801$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122825$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240808$$PH$US$US
241871142$24187114$2$F$$20240813$20240808$20240815$PER$$US-ABBVIE-5870182$ABBVIE$$$$$F$Y$$$20240815$$HP$US$US
241871151$24187115$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-037895$AUROBINDO$Howell J, Maughan B, Fluchel M, Poppe M. Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor:A case report. Urology Case Reports. 2024;56:102799$62$YR$$F$Y$$$20240808$$MD$US$US
241871162$24187116$2$F$$20240808$20240808$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07043$LUPIN$$$$$$Y$$$20240827$$MD$US$US
241871171$24187117$1$I$$20240802$20240808$20240808$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07451$HIKMA$$58$YR$$F$Y$112$KG$20240808$$HP$CA$CA
241871181$24187118$1$I$20240612$20240805$20240808$20240808$EXP$$AU-AstraZeneca-2024A177640$ASTRAZENECA$$22811$DY$$M$Y$$$20240808$$HP$AU$
241871191$24187119$1$I$$20240722$20240808$20240808$EXP$$JP-AMGEN-JPNSP2024150670$AMGEN$Kobayashi, T.. Experience of treating periprosthetic joint infection that occurred while using biological products. The 47th Annual Meeting of Japanese Society for Study of Bone and Joint. 2024;47th:78$77$YR$E$F$Y$$$20240808$$HP$JP$JP
241871201$24187120$1$I$20210101$20240805$20240808$20240808$EXP$$SE-AstraZeneca-2024A178509$ASTRAZENECA$$77$YR$$F$Y$$$20240808$$MD$SE$
241871211$24187121$1$I$20240501$20240611$20240808$20240808$PER$$US-JNJFOC-20240817701$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240808$$PH$US$US
241871221$24187122$1$I$$20240731$20240808$20240808$PER$$US-JNJFOC-20240784980$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241871231$24187123$1$I$$20240802$20240808$20240808$PER$$NVSC2024US159180$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241871242$24187124$2$F$$20240829$20240808$20240830$PER$$NVSC2024US161458$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
241871253$24187125$3$F$$20240904$20240808$20240910$EXP$$US-JNJFOC-20240809951$JOHNSON AND JOHNSON$$69$YR$E$M$Y$59$KG$20240910$$HP$US$US
241871261$24187126$1$I$$20240724$20240808$20240808$PER$$US-APOTEX-2024AP008826$APOTEX$$$$A$F$Y$$$20240808$$CN$US$US
241871272$24187127$2$F$20230101$20240730$20240808$20240808$EXP$US-MLMSERVICE-20240723-PI140053-00030-1$US-STRIDES ARCOLAB LIMITED-2024SP009816$STRIDES$Longobardi SA, Alkowati H, Kang G, Slade C, Oyesanmi O.. Ibuprofen-Induced Pancytopenia and Erythema Multiforme in an Elderly Female Patient.. Cureus. 2024;16(6):e62785$75$YR$$F$Y$$$20240808$$MD$US$US
241871281$24187128$1$I$$20240802$20240808$20240808$EXP$$US-GSK-US2024096915$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$HP$US$US
241871291$24187129$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004021$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240808$$CN$US$US
241871301$24187130$1$I$20240804$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003994$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240808$$CN$US$US
241871311$24187131$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004026$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240808$$CN$US$US
241871322$24187132$2$F$20240101$20240819$20240808$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-020071$UNITED THERAPEUTICS$$$$$M$Y$106.58$KG$20240824$$$US$US
241871331$24187133$1$I$$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004847$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240808$$CN$US$US
241871341$24187134$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003879$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240808$$CN$US$US
241871351$24187135$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004266$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240808$$CN$US$US
241871361$24187136$1$I$20240101$20240807$20240808$20240808$EXP$$US-UCBSA-2024039677$UCB$$$$$F$Y$$$20240808$$CN$US$US
241871371$24187137$1$I$20221130$20240729$20240808$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-038743$AUROBINDO$$62$YR$$F$Y$$$20240808$$MD$PT$PT
241871381$24187138$1$I$20240730$20240801$20240808$20240808$EXP$$US-GSK-US2024096200$GLAXOSMITHKLINE$$68$YR$$M$Y$$$20240808$$CN$US$US
241871401$24187140$1$I$$20240724$20240808$20240808$EXP$$US-GRANULES-US-2024GRALIT00312$GRANULES INDIA$C. Rodriguez.BRASH: A Deadly Acronym.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A1596$84$YR$E$F$Y$$$20240808$$HP$US$US
241871421$24187142$1$I$20240422$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038380$AUROBINDO$$30$YR$$M$Y$$$20240808$$MD$FR$FR
241871431$24187143$1$I$$20240802$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123930$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240808$$CN$US$US
241871441$24187144$1$I$$20240806$20240808$20240808$PER$$US-GILEAD-2024-0683309$GILEAD$$$$A$F$Y$$$20240808$$HP$US$US
241871461$24187146$1$I$20240119$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038549$AUROBINDO$$89$YR$$M$Y$94$KG$20240808$$MD$FR$FR
241871472$24187147$2$F$20240201$20240730$20240808$20240812$EXP$$CO-UCBSA-2024039678$UCB$$78$YR$$M$Y$82$KG$20240812$$CN$CL$CL
241871481$24187148$1$I$$20240805$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044265$BOEHRINGER INGELHEIM$$$$$$Y$$$20240808$$CN$US$US
241871492$24187149$2$F$$20240812$20240808$20240822$EXP$$DE-TEVA-VS-3229160$TEVA$Pottharst A, Schaumann F, Tritschler J, Bruder C, Brucker R, Hengstler H, et al. Specialized Palliative Care in a 54 y/o pat with RAS G12Cmutated NSCLC in need of high-flow oxygen at dischargement: An ethical and logistic dilemma. Oncol-Res-Treat 2023; 46 (Suppl.) 332.; Pottharst A, Schaumann F, Tritschler J, Bruder C, Brucker R, Hengstler H, et al. Specialized Palliative Care in a 54 y/o pat with RAS G12Cmutated NSCLC in need of high-flow oxygen at dischargement: An ethical and logistic dile...$54$YR$$$Y$$$20240822$$HP$DE$DE
241871501$24187150$1$I$$20240731$20240808$20240808$PER$$PR-ABBVIE-5863624$ABBVIE$$$$$$Y$$$20240808$$CN$PR$PR
241871511$24187151$1$I$$20240802$20240808$20240808$PER$$NVSC2024US160535$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241871521$24187152$1$I$$20240729$20240808$20240808$EXP$$US-VIIV HEALTHCARE LIMITED-US2024094766$VIIV$$$$$M$Y$$$20240808$$HP$US$US
241871531$24187153$1$I$20240610$20240729$20240808$20240808$EXP$$ES-AUROBINDO-AUR-APL-2024-038026$AUROBINDO$$79$YR$$M$Y$64$KG$20240808$$MD$ES$ES
241871541$24187154$1$I$$20240726$20240808$20240808$EXP$GB-MHRA-MED-202407251356400930-ZGKRJ$GB-MSNLABS-2024MSNSPO01690$MSN LABORATORIES$$$$$$Y$$$20240808$$CN$GB$GB
241871552$24187155$2$F$$20240902$20240808$20240907$EXP$$JP-JNJFOC-20240818910$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240908$$PH$JP$JP
241871571$24187157$1$I$20240720$20240802$20240808$20240808$EXP$$CA-JNJFOC-20240408395$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240808$$HP$CA$CA
241871591$24187159$1$I$$20240802$20240808$20240808$EXP$$ZA-TAKEDA-2024TUS078802$TAKEDA$$$$$F$Y$$$20240808$$CN$ZA$ZA
241871601$24187160$1$I$$20240724$20240808$20240808$EXP$$US-APOTEX-2024AP009047$APOTEX$Abedrabo S, Rodriguez TE, Klein LM, Bitran J.. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142 (Suppl. 1):7078$$$A$$Y$$$20240808$$MD$US$US
241871611$24187161$1$I$20231228$20240103$20240808$20240808$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04631$AMNEAL$$$$$F$Y$$$20240808$$CN$US$US
241871623$24187162$3$F$20110101$20240905$20240808$20240913$EXP$$US-ABBVIE-5792742$ABBVIE$$$$$M$Y$63.956$KG$20240913$$CN$US$US
241871632$24187163$2$F$20170101$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038419$AUROBINDO$$58$YR$$F$Y$$$20240809$$MD$FR$FR
241871641$24187164$1$I$$20230626$20240808$20240808$EXP$$NL-SA-2024SA231603$SANOFI AVENTIS$Van Der Lans RJL, Otten JJ, Adriaensen GFJPM, Hoven DR, Benoist LB, Fokkens WJ, et al.. Two- year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months. Allergy.. 2023;78:2684?97$$$$$Y$$$20240808$$HP$NL$NL
241871661$24187166$1$I$20240301$20240403$20240808$20240808$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01171$AMNEAL$$62$YR$$F$Y$66.667$KG$20240808$$CN$US$US
241871673$24187167$3$F$$20240829$20240808$20240903$EXP$$US-TAKEDA-2024TUS079040$TAKEDA$$$$$F$Y$$$20240903$$CN$US$US
241871682$24187168$2$F$20240802$20240807$20240808$20240813$EXP$$NVSC2024US160953$NOVARTIS$$$$$M$Y$$$20240813$$HP$US$US
241871692$24187169$2$F$$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038104$AUROBINDO$$72$YR$$M$Y$91$KG$20240809$$PH$GB$GB
241871701$24187170$1$I$20240723$20240805$20240808$20240808$EXP$$US-GILEAD-2024-0683194$GILEAD$$74$YR$E$F$Y$$$20240808$$CN$US$US
241871711$24187171$1$I$$20240729$20240808$20240808$30DAY$$FR-JNJFOC-20240816036$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$FR$FR
241871721$24187172$1$I$$20240802$20240808$20240808$30DAY$$US-GSK-US2024097033$GLAXOSMITHKLINE$$$$E$F$Y$$$20240808$$CN$US$US
241871732$24187173$2$F$20240724$20240904$20240808$20240913$30DAY$$US-GSK-US2024097587$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240913$$CN$US$US
241871741$24187174$1$I$$20240807$20240808$20240808$PER$$US-ROCHE-10000051644$ROCHE$$$$$$Y$$$20240808$$CN$US$US
241871751$24187175$1$I$$20240731$20240808$20240808$EXP$$CA-ROCHE-3409014$ROCHE$$67$YR$E$F$Y$$$20240808$$CN$CA$CA
241871761$24187176$1$I$20240221$20240730$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038719$AUROBINDO$$48$YR$$F$Y$97$KG$20240808$$MD$FR$FR
241871771$24187177$1$I$$20240801$20240808$20240808$PER$$US-BEH-2024176777$CSL BEHRING$$$$$F$Y$$$20240808$$PH$US$US
241871782$24187178$2$F$20230201$20240903$20240808$20240909$EXP$$US-ABBVIE-5868303$ABBVIE$$51$YR$$M$Y$$$20240909$$CN$US$US
241871791$24187179$1$I$20240412$20240730$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038907$AUROBINDO$$68$YR$$F$Y$$$20240808$$PH$FR$FR
241871802$24187180$2$F$$20240904$20240808$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124715$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240905$$CN$US$US
241871811$24187181$1$I$$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124865$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240808$$MD$US$US
241871821$24187182$1$I$$20240730$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124280$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$76.38$KG$20240808$$CN$US$US
241871831$24187183$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124720$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$87.54$KG$20240808$$CN$US$US
241871841$24187184$1$I$20230101$20240731$20240808$20240808$EXP$$US-SA-2024SA228353$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240808$$CN$US$US
241871853$24187185$3$F$20240729$20240809$20240808$20240823$PER$$US-HALEON-2190892$Haleon PLC$$45$YR$$M$Y$$$20240823$$CN$US$US
241871861$24187186$1$I$$20240805$20240808$20240808$EXP$$US-AstraZeneca-2024A177920$ASTRAZENECA$$$$$F$Y$$$20240808$$MD$US$
241871871$24187187$1$I$20240727$20240805$20240808$20240808$EXP$$US-ABBVIE-5871292$ABBVIE$$77$YR$$M$Y$$$20240808$$CN$US$US
241871882$24187188$2$F$20240523$20240904$20240808$20240912$EXP$$PL-AstraZeneca-2024A179715$ASTRAZENECA$$23376$DY$$M$Y$126$KG$20240912$$HP$PL$
241871891$24187189$1$I$$20221215$20240808$20240808$EXP$$US-AstraZeneca-2022A409890$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241871901$24187190$1$I$$20220513$20240808$20240808$EXP$$US-AstraZeneca-2022A134346$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241871911$24187191$1$I$$20211227$20240808$20240808$EXP$$NL-AstraZeneca-2021A902013$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$NL$
241871921$24187192$1$I$20230101$20231013$20240808$20240808$EXP$$US-AstraZeneca-2023A237957$ASTRAZENECA$$66$YR$$M$Y$$$20240808$$CN$US$
241871931$24187193$1$I$$20210802$20240808$20240808$EXP$$US-AstraZeneca-2021A660277$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241871941$24187194$1$I$$20211124$20240808$20240808$EXP$$US-AstraZeneca-2021A843900$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241871951$24187195$1$I$$20220423$20240808$20240808$EXP$$JP-AstraZeneca-2022A162291$ASTRAZENECA$$$$$$Y$$$20240808$$MD$JP$
241871961$24187196$1$I$20200101$20210521$20240808$20240808$EXP$$US-AstraZeneca-2021A471046$ASTRAZENECA$$64$YR$$F$Y$84.4$KG$20240808$$CN$US$
241871972$24187197$2$F$20240627$20240820$20240808$20240823$EXP$$IE-AMGEN-IRLSP2024155271$AMGEN$$70$YR$E$F$Y$$$20240823$$MD$IE$IE
241871981$24187198$1$I$$20240802$20240808$20240808$EXP$$DE-JNJFOC-20240807941$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240808$$MD$DE$DE
241871992$24187199$2$F$$20240808$20240808$20240819$EXP$PL-EMA-DD-20240730-7482709-071317$PL-SA-2024SA231492$SANOFI AVENTIS$Skowronski M, Halicki P, Halicka A.. Disseminated BCGitis after intravesical Bacillus Calmette-Guerin therapy in a patient with bladder cancer.. Pol-Arch-Med-Wewn .. 2024;134 (5):unk$58$YR$A$M$Y$$$20240819$$MD$PL$PL
241872004$24187200$4$F$20211014$20240919$20240808$20240923$EXP$$US-GILEAD-2024-0683400$GILEAD$$60$YR$A$F$Y$$$20240923$$LW$US$US
241872011$24187201$1$I$$20240806$20240808$20240808$EXP$$US-GILEAD-2024-0683297$GILEAD$$$$A$M$Y$$$20240808$$CN$US$US
241872021$24187202$1$I$$20240806$20240808$20240808$PER$$US-HALEON-2190783$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241872031$24187203$1$I$20240502$20240802$20240808$20240808$EXP$$FR-TEVA-VS-3228820$TEVA$$71$YR$$M$Y$74.5$KG$20240808$$MD$FR$FR
241872042$24187204$2$F$20230401$20240815$20240808$20240826$EXP$$TW-ROCHE-10000049943$ROCHE$$53$YR$A$M$Y$50$KG$20240826$$MD$TW$TW
241872051$24187205$1$I$$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155887$AMGEN$$$$$F$Y$$$20240808$$PH$US$US
241872061$24187206$1$I$$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024156126$AMGEN$$$$$$Y$$$20240808$$MD$US$US
241872072$24187207$2$F$$20240809$20240808$20240812$EXP$$JP-SA-2024SA233201$SANOFI AVENTIS$Marunaka Y, Ohashi T, Kubota T, Nishibeppu K, Konishi H, Shiozaki A et al.. Dropped head syndrome suspected due to oxaliplatin used in adjuvant chemotherapy for gastric cancer: a case report.. Surgical case reports.. 2024;10(1):174$72$YR$E$M$Y$60.7$KG$20240813$$MD$JP$JP
241872083$24187208$3$F$20240801$20240820$20240808$20240822$EXP$$US-SA-2024SA231718$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240822$$MD$US$US
241872091$24187209$1$I$$20240801$20240808$20240808$EXP$$AR-ROCHE-10000047951$ROCHE$$51$YR$A$$Y$$$20240808$$CN$AR$AR
241872101$24187210$1$I$20240728$20240729$20240808$20240808$EXP$$JP-ROCHE-10000047765$ROCHE$$7$DEC$E$F$Y$$$20240808$$MD$JP$JP
241872111$24187211$1$I$$20240729$20240808$20240808$EXP$$JP-ROCHE-10000048847$ROCHE$Nara S, Nakamura S, Goto T, Kawahara Y, Kamada H, Hosokawa Y. A case in which treatment with anti-HER2 therapy alone was remarkably effective for metastatic breast cancer with jaundice associated with high-grade hepatic function disorder (Abstract number:EP-0722). The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;358.$47$YR$A$F$Y$$$20240808$$MD$JP$JP
241872121$24187212$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004199$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240808$$CN$US$US
241872131$24187213$1$I$20240804$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003976$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240808$$CN$US$US
241872141$24187214$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004051$ELI LILLY AND CO$$$$T$F$Y$$$20240808$$CN$US$US
241872151$24187215$1$I$$20240729$20240808$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-039045$AUROBINDO$Real LL, Rodrigues AC, Araujo PS, Iashchuk M, Silva D, Quelhas M, et al.. FEVER IN COVID-19 TIMES. Eur-J-Case-Rep-Intern-Med. 2022;9 (Suppl.):378$68$YR$$F$Y$$$20240808$$HP$PT$PT
241872171$24187217$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004044$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240808$$CN$US$US
241872181$24187218$1$I$20240701$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003129$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240808$$CN$US$US
241872192$24187219$2$F$20240701$20240808$20240808$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408004148$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240814$$CN$US$US
241872201$24187220$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004298$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240808$$CN$US$US
241872211$24187221$1$I$20240803$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004191$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240808$$CN$US$US
241872221$24187222$1$I$$20240729$20240808$20240808$30DAY$$US-GSK-US2024094864$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241872231$24187223$1$I$20211021$20240802$20240808$20240808$EXP$GR-GREOF-202400826$GR-REGENERON PHARMACEUTICALS, INC.-2024-108133$REGENERON$$73$YR$$F$Y$$$20240808$$MD$GR$GR
241872243$24187224$3$F$$20240826$20240808$20240827$PER$$NVSC2024US161347$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
241872251$24187225$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161459$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241872261$24187226$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-038929$AUROBINDO$Thompson C, Barrett K, Scott D, Lofters J, Rastogi N.. OH, WHAT A STORM: A CASE OF BLINATUMOMAB-INDUCED CYTOKINE RELEASE SYNDROME. J-Invest-Med. 2023;71(7):140- 141$72$YR$$F$Y$$$20240808$$HP$US$US
241872271$24187227$1$I$20230201$20240801$20240808$20240808$EXP$$US-CHIESI-2024CHF04723$CHIESI$$15$YR$$M$Y$$$20240808$$MD$US$US
241872281$24187228$1$I$20240602$20240806$20240808$20240808$EXP$FR-AFSSAPS-PP2024000871$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-125136$BRISTOL MYERS SQUIBB$$72$YR$A$M$Y$$$20240808$$MD$FR$FR
241872291$24187229$1$I$20231101$20240806$20240808$20240808$EXP$SE-SEMPA-2024-005942$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-125122$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240808$$MD$SE$SE
241872302$24187230$2$F$$20240823$20240808$20240902$EXP$$US-TEVA-VS-3228072$TEVA$Pollack ED, Richardson C, Powell B, Patel K. Meningoencephalitis With Transverse Myelitis in a Patient With West Nile Virus - Clinical Insights and Awareness. Am-J-Respir-Crit-Care-Med 2024; 209 A5619 (plus Poster).; Pollack ED, Richardson C, Powell B, Patel K. Meningoencephalitis With Transverse Myelitis in a Patient With West Nile Virus - Clinical Insights and Awareness. Am-J-Respir-Crit-Care-Med 2024; 209 A5619 (plus Poster).$42$YR$$M$Y$$$20240902$$HP$US$US
241872311$24187231$1$I$20200428$20240731$20240808$20240808$EXP$$PL-AUROBINDO-AUR-APL-2024-039199$AUROBINDO$$52$YR$$F$Y$$$20240808$$MD$PL$PL
241872321$24187232$1$I$$20240729$20240808$20240808$EXP$$GB-AMAROX PHARMA-AMR2024GB02515$HETERO$$72$YR$$M$Y$$$20240808$$HP$GB$GB
241872331$24187233$1$I$20240731$20240801$20240808$20240808$EXP$$CN-EMD Serono-2024041968$EMD SERONO INC$$48$YR$A$M$Y$65$KG$20240808$$HP$CN$CN
241872341$24187234$1$I$20240703$20240729$20240808$20240808$EXP$$IT-AUROBINDO-AUR-APL-2024-037058$AUROBINDO$$70$YR$$F$Y$$$20240808$$MD$IT$IT
241872351$24187235$1$I$$20240804$20240808$20240808$EXP$$NVSC2024US160951$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241872361$24187236$1$I$$20240730$20240808$20240808$PER$$NVSC2024US157464$NOVARTIS$$34$YR$$$Y$$$20240808$$CN$US$US
241872371$24187237$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161076$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241872381$24187238$1$I$$20240726$20240808$20240808$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110459$ZYDUS PHARM$Behbahani-Nejad N, Palepu R, Kotha A, Nayef HA.. Fentanyl-induced wooden chest syndrome.. Am-J-Respir-Crit-Care-Med. 2024;209:A5674$$$$$Y$$$20240808$$HP$US$US
241872391$24187239$1$I$20240514$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038599$AUROBINDO$$23$YR$$F$Y$$$20240808$$MD$FR$FR
241872401$24187240$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125098$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$HP$US$US
241872411$24187241$1$I$20231204$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124309$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240808$$HP$US$US
241872421$24187242$1$I$$20240801$20240808$20240808$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122235$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$80$KG$20240808$$HP$CA$CA
241872431$24187243$1$I$$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124723$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240808$$CN$US$US
241872441$24187244$1$I$$20240802$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123376$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240808$$CN$US$US
241872451$24187245$1$I$20240101$20240731$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121880$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$55.2$KG$20240808$$HP$US$US
241872461$24187246$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125036$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240808$$HP$US$US
241872471$24187247$1$I$20240701$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125011$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$58.06$KG$20240808$$CN$US$US
241872481$24187248$1$I$20230901$20240731$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124571$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$77.11$KG$20240808$$CN$US$US
241872491$24187249$1$I$20220721$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038530$AUROBINDO$$5$YR$$F$Y$30$KG$20240808$$CN$GB$GB
241872502$24187250$2$F$$20240823$20240808$20240902$EXP$$US-TEVA-VS-3228071$TEVA$Lee E, Lin A, Su Y, Cho C, Seo SK. The Clinical Significance of the Drug-Drug Interaction between Letermovir and Voriconazole in Stem Cell Transplantation. Transplant-Cell-Ther 2024; 30 (Suppl.) (2): S438.; Lee E, Lin A, Su Y, Cho C, Seo SK. The Clinical Significance of the Drug-Drug Interaction between Letermovir and Voriconazole in Stem Cell Transplantation. Transplant-Cell-Ther 2024; 30 (Suppl.) (2): S438.$$$A$$Y$$$20240902$$PH$US$US
241872513$24187251$3$F$20240101$20240822$20240808$20240824$PER$$US-AMGEN-USASP2024155785$AMGEN$$53$YR$A$M$Y$$$20240824$$HP$US$US
241872521$24187252$1$I$20220101$20240725$20240808$20240808$EXP$$CN-Merck Healthcare KGaA-9303806$MERCK KGAA$$$$$M$Y$$$20240802$$CN$CN$CN
241872531$24187253$1$I$20180620$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038378$AUROBINDO$$93$YR$$F$Y$44$KG$20240808$$PH$FR$FR
241872541$24187254$1$I$$20230106$20240808$20240808$EXP$$US-AstraZeneca-2023A005334$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241872551$24187255$1$I$$20210318$20240808$20240808$EXP$$US-AstraZeneca-2021A184211$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241872561$24187256$1$I$$20230201$20240808$20240808$EXP$$US-AstraZeneca-2023A029565$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241872571$24187257$1$I$20231113$20231129$20240808$20240808$EXP$$US-AstraZeneca-2023A272398$ASTRAZENECA$$22802$DY$$M$Y$$$20240808$$CN$US$
241872582$24187258$2$F$$20240916$20240808$20240918$EXP$$US-AstraZeneca-2024A175048$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
241872591$24187259$1$I$20240711$20240729$20240808$20240808$EXP$$GR-ROCHE-10000041311$ROCHE$$58$YR$A$F$Y$$$20240808$$CN$GR$GR
241872601$24187260$1$I$$20191127$20240808$20240808$EXP$$US-AstraZeneca-2019SF57440$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241872611$24187261$1$I$$20221222$20240808$20240808$EXP$$US-AstraZeneca-2022A416039$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241872621$24187262$1$I$$20230221$20240808$20240808$EXP$$US-AstraZeneca-2023A044810$ASTRAZENECA$$$$$M$Y$$$20240808$$MD$US$
241872632$24187263$2$F$$20240821$20240808$20240827$EXP$$AU-TAKEDA-2024TUS076760$TAKEDA$$30$YR$$M$Y$$$20240827$$HP$AU$AU
241872641$24187264$1$I$20231227$20240805$20240808$20240808$EXP$FR-AFSSAPS-NY2024000890$FR-UCBSA-2024039151$UCB$$95$YR$$M$Y$70.4$KG$20240808$$MD$FR$FR
241872651$24187265$1$I$$20230810$20240808$20240808$EXP$$US-AstraZeneca-2023A184141$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241872661$24187266$1$I$$20230103$20240808$20240808$EXP$$US-AstraZeneca-2023A001766$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241872672$24187267$2$F$20160113$20240919$20240808$20240923$PER$$US-GILEAD-2024-0683359$GILEAD$$36$YR$A$F$Y$$$20240923$$LW$US$US
241872681$24187268$1$I$20221001$20240725$20240808$20240808$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00366$ACELLA$$78$YR$$M$Y$$$20240808$$CN$US$US
241872691$24187269$1$I$$20240725$20240808$20240808$EXP$$KR-Axellia-005288$XELLIA PHARMACEUTICALS$Kim Y, Bae S, Huh KY, Joo JS, Lee J, Song SH, et.al. Coadministration of Voriconazole and Rifabutin Can Increase the Risk of Adverse Drug Reactions in Patients with Multiple Infections. Ther Drug Monit. 2024 Jul 16.$69$YR$E$M$Y$$$20240808$$MD$KR$KP
241872711$24187271$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123904$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$56.25$KG$20240808$$CN$US$US
241872722$24187272$2$F$$20240808$20240808$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124113$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$63.05$KG$20240812$$CN$US$US
241872731$24187273$1$I$$20240730$20240808$20240808$EXP$$PK-ROCHE-10000043037$ROCHE$$53$YR$A$M$Y$$$20240808$$CN$PK$PK
241872741$24187274$1$I$$20240725$20240808$20240808$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2019-05933$ALKEM$Pinninti NR and Mahajan DS. Gabapentin-associated aggression. J Neuropsychiatry Clin Neurosci. 2001;13:424$51$YR$$M$Y$$$20240808$$HP$GB$US
241872751$24187275$1$I$$20240725$20240808$20240808$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2018-07175$ALKEM$Reeves, A.L.; So, E.L.; Sharbrough, F.W.; Krahn, L.E.. Movement disorders associated with the use of Gabapentin. Epilepsia.. 1996;37:988-90$24$YR$$M$Y$$$20240808$$HP$GB$GB
241872761$24187276$1$I$$20240725$20240808$20240808$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17787$ALKEM$Ghaly RF, Plesca A, Rana S, Candido KD, Knezevic NN.. Gabapentin-related suicide: Myth or fact?. Surgical Neurology International. 2018;9:210$54$YR$$M$Y$$$20240808$$HP$US$US
241872773$24187277$3$F$$20240812$20240808$20240824$EXP$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17969$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17969$ALKEM$Mohamad Alhoda MA, Perez A, Williams B, Joyce E. Severe Gabapentin Toxicity After Acute Kidney Injury in Hospitalized Patient with Acute Pain (P6.020). Neurology. 2018;90:P6.020$47$YR$$F$Y$$$20240825$$HP$US$US
241872781$24187278$1$I$$20240725$20240808$20240808$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17395$ALKEM$Pierce DA, Holt SR, Reeves-Daniel A.. A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. Clin Ther. 2008;30:1681-1684$46$YR$$F$Y$$$20240808$$HP$US$US
241872791$24187279$1$I$$20240725$20240808$20240808$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17398$ALKEM$Onuigbo MAC, Nye D. Drug-induced encephalopathy secondary to non renal dosing of common medications in Two dialysis patients. Adv Perit Dial. 2009;25:89-91$$$$$Y$$$20240808$$HP$US$US
241872801$24187280$1$I$$20240725$20240808$20240808$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17786$ALKEM$Ghaly RF, Plesca A, Rana S, Candido KD, Knezevic NN.. Gabapentin-related suicide: Myth or fact?. Surgical Neurology International. 2018;9:210$52$YR$$M$Y$$$20240808$$HP$US$US
241872811$24187281$1$I$$20240725$20240808$20240808$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17419$ALKEM$Sechi G, Murgia B, Sau G, Peddone L, Tirotto A, Barrocu M, Rosati G.. Asterixis and toxic encephalopathy induced by gabapentin. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:195-199$$$$F$Y$$$20240808$$HP$IT$IT
241872821$24187282$1$I$$20240725$20240808$20240808$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17476$ALKEM$Bookwalter T, Gitlin M.. Gabapentin-Induced Neurologic Toxicities. Pharmacotherapy. 2005;25:1817-1819$75$YR$$M$Y$$$20240808$$HP$US$US
241872831$24187283$1$I$$20240725$20240808$20240808$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17417$ALKEM$Sechi G, Murgia B, Sau G, Peddone L, Tirotto A, Barrocu M, Rosati G.. Asterixis and toxic encephalopathy induced by gabapentin. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:195-199$$$$F$Y$$$20240808$$HP$IT$IT
241872841$24187284$1$I$$20240729$20240808$20240808$EXP$$CA-ROCHE-10000046068$ROCHE$$25$YR$A$M$Y$$$20240808$$MD$CA$CA
241872851$24187285$1$I$$20240731$20240808$20240808$EXP$$US-AMGEN-USASP2024154237$AMGEN$$62$YR$A$M$Y$$$20240808$$CN$US$US
241872861$24187286$1$I$$20240730$20240808$20240808$EXP$$US-GSK-US2024095356$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241872872$24187287$2$F$$20240829$20240808$20240903$PER$$US-ALXN-202408USA000095US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$HP$US$US
241872881$24187288$1$I$20240628$20240730$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038718$AUROBINDO$$73$YR$$F$Y$80$KG$20240808$$PH$FR$FR
241872891$24187289$1$I$$20240730$20240808$20240808$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110750$ZYDUS PHARM$$$$$$Y$$$20240808$$MD$US$US
241872901$24187290$1$I$$20240805$20240808$20240808$PER$$US-HALEON-2190951$Haleon PLC$$$$C$$Y$$$20240808$$HP$US$US
241872911$24187291$1$I$20240715$20240730$20240808$20240808$EXP$IT-MINISAL02-996033$IT-TEVA-VS-3227932$TEVA$$43$YR$$F$Y$53$KG$20240808$$PH$IT$IT
241872921$24187292$1$I$$20240802$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002321$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240808$$CN$US$US
241872931$24187293$1$I$20240806$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003959$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240808$$CN$US$US
241872942$24187294$2$F$20240803$20240905$20240808$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408004285$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240909$$CN$US$US
241872951$24187295$1$I$20240729$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004358$ELI LILLY AND CO$$65$YR$E$$Y$$$20240808$$CN$US$US
241872961$24187296$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004188$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240808$$CN$US$US
241872971$24187297$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004119$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240808$$CN$US$US
241872981$24187298$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004078$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240808$$CN$US$US
241872991$24187299$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003947$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$US$US
241873001$24187300$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003804$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240808$$CN$US$US
241873011$24187301$1$I$20240806$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004192$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240808$$CN$US$US
241873021$24187302$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004239$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240808$$CN$US$US
241873031$24187303$1$I$$20240730$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038505$AUROBINDO$$19$YR$$F$Y$63$KG$20240808$$CN$GB$GB
241873041$24187304$1$I$$20240709$20240808$20240808$PER$22537362$US-LUPIN PHARMACEUTICALS INC.-2024-04980$LUPIN$$$$$$Y$$$20240808$$CN$US$US
241873051$24187305$1$I$$20240715$20240808$20240808$PER$$US-AMGEN-USASP2024157265$AMGEN$$$$$$Y$$$20240808$$CN$US$US
241873061$24187306$1$I$$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156651$AMGEN$$$$$F$Y$$$20240808$$CN$US$US
241873071$24187307$1$I$$20240725$20240808$20240808$PER$$US-JNJFOC-20240776120$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241873081$24187308$1$I$20220912$20240803$20240808$20240808$EXP$$CA-JNJFOC-20220721908$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240808$$CN$CA$CA
241873091$24187309$1$I$$20240805$20240808$20240808$30DAY$$US-GSK-US2024097488$GLAXOSMITHKLINE$$$$$M$Y$$$20240808$$CN$US$US
241873111$24187311$1$I$20240101$20240731$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-039098$AUROBINDO$$71$YR$$M$Y$98$KG$20240808$$MD$FR$FR
241873121$24187312$1$I$$20240801$20240808$20240808$EXP$$IN-ROCHE-10000047939$ROCHE$$64$YR$A$F$Y$$$20240808$$CN$IN$IN
241873131$24187313$1$I$$20240730$20240808$20240808$PER$$US-ABBVIE-5862677$ABBVIE$$$$$$Y$$$20240808$$MD$US$US
241873141$24187314$1$I$20240101$20240805$20240808$20240808$EXP$$US-ABBVIE-5869482$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241873151$24187315$1$I$$20240802$20240808$20240808$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00404$VELOXIS PHARMACEUTICALS$Bae E K, Chandran M M, Everitt M D, Benz E, Bock M.. LCP-tacrolimus extended-release (Envarsus XR) use in adolescent and young adult solid organ transplant recipients.. Clinical Transplantation. 2024;38:e15417:1-7$16$YR$$M$Y$$$20240808$$HP$US$US
241873161$24187316$1$I$20240730$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123392$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240808$$PH$US$US
241873171$24187317$1$I$20240801$20240801$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123983$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240808$$HP$US$US
241873181$24187318$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124854$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240808$$CN$US$US
241873192$24187319$2$F$20240722$20240730$20240808$20240814$EXP$$CN-BEH-2024176670$CSL BEHRING$$39$YR$A$F$Y$55$KG$20240814$$CN$CN$CN
241873201$24187320$1$I$$20240730$20240808$20240808$EXP$$IN-ROCHE-3579605$ROCHE$Padhi T, Bhunia S, Shah M, Sahu S, Das T, Bhusal U, Singh A, Samantaray B, Patro K, Devi S, Routray D, Mohamed A, Pradhan L and Jalali S. Outcome of eyes treated for retinopathy of prematurity in posterior zone I. DOI: 10.1097/IAE.0000000000004067. Retina 2024 Jun 01;44 (6):1073-82.$$$$$Y$$$20240808$$MD$IN$IN
241873211$24187321$1$I$$20240725$20240808$20240808$PER$$US-APOTEX-2024AP008896$APOTEX$Ward C, DePalo D, Patel N, Carr M, Longbottom B, Cunningham K, et al.. Assessing the Efficacy of Imiquimod Use in Patients With Persistent Locally Advanced Melanoma In Situ. Journal of Drugs in Dermatology. 2023;22(5):457-464$77$YR$$F$Y$$$20240808$$HP$US$US
241873231$24187323$1$I$20220315$20220315$20240808$20240808$EXP$$US-AstraZeneca-2022A115532$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241873241$24187324$1$I$$20240725$20240808$20240808$EXP$$US-UCBSA-2024037940$UCB$$$$$F$Y$$$20240808$$HP$US$US
241873252$24187325$2$F$20240701$20240807$20240808$20240809$EXP$DE-CADRBFARM-2024329606$DE-TORRENT-00027115$TORRENT$$83$YR$E$M$Y$60$KG$20240809$$MD$DE$DE
241873261$24187326$1$I$20211101$20220811$20240808$20240808$EXP$$US-AstraZeneca-2022A285442$ASTRAZENECA$$884$MON$$F$Y$$$20240808$$CN$US$
241873271$24187327$1$I$$20240729$20240808$20240808$EXP$$CA-APOTEX-2024AP008952$APOTEX$$64$YR$$M$Y$$$20240808$$CN$CA$CA
241873281$24187328$1$I$$20211207$20240808$20240808$EXP$$US-AstraZeneca-2021A859733$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241873291$24187329$1$I$20240704$20240801$20240808$20240808$EXP$$IN-TORRENT-00003627$TORRENT$$29$YR$A$M$Y$75$KG$20240808$$MD$IN$IN
241873301$24187330$1$I$$20230106$20240808$20240808$EXP$$US-AstraZeneca-2023A005246$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241873311$24187331$1$I$20240702$20240802$20240808$20240808$EXP$GB-MHRA-MED-202408011123548920-DHFBL$GB-TORRENT-00037494$TORRENT$$71$YR$E$M$Y$71$KG$20240808$$MD$GB$GB
241873321$24187332$1$I$20231220$20240802$20240808$20240808$EXP$GB-MHRA-MED-202408011848076220-KWQZD$GB-TORRENT-00037496$TORRENT$$26$YR$A$F$Y$$$20240808$$CN$GB$GB
241873331$24187333$1$I$$20220401$20240808$20240808$EXP$$US-AstraZeneca-2022A137928$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241873352$24187335$2$F$$20240916$20240808$20240925$EXP$$US-TORRENT-00013701$TORRENT$$$$I$M$Y$$$20240925$$HP$US$US
241873361$24187336$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A175061$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241873371$24187337$1$I$$20211207$20240808$20240808$EXP$$US-AstraZeneca-2021A859899$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241873381$24187338$1$I$$20210813$20240808$20240808$EXP$$US-AstraZeneca-2021A684703$ASTRAZENECA$$$$$F$Y$52.2$KG$20240808$$CN$US$
241873392$24187339$2$F$$20240916$20240808$20240926$EXP$$US-TORRENT-00013704$TORRENT$$$$I$M$Y$$$20240926$$HP$US$US
241873402$24187340$2$F$$20240916$20240808$20240926$EXP$$US-TORRENT-00013702$TORRENT$$$$I$M$Y$$$20240926$$HP$US$US
241873411$24187341$1$I$20240801$20240805$20240808$20240808$EXP$$US-ABBVIE-5868648$ABBVIE$$68$YR$$F$Y$$$20240808$$CN$US$US
241873421$24187342$1$I$$20240618$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-031251$AUROBINDO$$67$YR$$F$Y$$$20240808$$CN$US$US
241873431$24187343$1$I$$20240730$20240808$20240808$EXP$$US-ROCHE-10000049785$ROCHE$$39$YR$A$F$Y$$$20240808$$MD$US$US
241873441$24187344$1$I$$20240802$20240808$20240808$EXP$$BR-GSK-BR2024AMR097564$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$HP$BR$BR
241873451$24187345$1$I$20240806$20240806$20240808$20240808$EXP$$AU-ABBVIE-5870343$ABBVIE$$68$YR$$F$Y$$$20240808$$CN$AU$AU
241873461$24187346$1$I$$20240729$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR097961$VIIV$$$$$$Y$$$20240808$$HP$US$US
241873472$24187347$2$F$20210325$20240920$20240808$20240923$PER$$US-GILEAD-2024-0683412$GILEAD$$35$YR$A$M$Y$$$20240923$$LW$US$US
241873482$24187348$2$F$$20240802$20240808$20240829$EXP$$CA-TERSERA THERAPEUTICS LLC-2024TRS003940$TERSERA THERAPEUTICS$$$$$$Y$$$20240829$$MD$CA$CA
241873491$24187349$1$I$$20240801$20240808$20240808$EXP$$US-ABBVIE-5864702$ABBVIE$$$$$$Y$$$20240808$$MD$US$US
241873501$24187350$1$I$20240701$20240805$20240808$20240808$EXP$$ES-ABBVIE-5870054$ABBVIE$$78$YR$$M$Y$$$20240808$$HP$ES$ES
241873511$24187351$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161366$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241873521$24187352$1$I$20230601$20240730$20240808$20240808$EXP$DK-DKMA-30736397$DK-ROCHE-10000050438$ROCHE$$75$DY$I$F$Y$$$20240808$$MD$DK$DK
241873531$24187353$1$I$$20240730$20240808$20240808$EXP$$US-HETERO-HET2024US02535$HETERO$Bally K, Trusty RK, Naher K.. A Case Report of Myxedema Coma in the Setting of Normal Thyroid  Stimulating Hormone. Cureus. 2024;16(6):e62695$95$YR$$F$Y$$$20240808$$HP$US$US
241873541$24187354$1$I$$20240802$20240808$20240808$EXP$$JP-009507513-2408JPN000584J$MERCK$$46$YR$$F$Y$$$20240808$$MD$JP$JP
241873551$24187355$1$I$20240807$20240807$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044524$BOEHRINGER INGELHEIM$$$$$$Y$$$20240808$$CN$US$US
241873561$24187356$1$I$$20240731$20240808$20240808$EXP$$US-AMGEN-USASP2024152813$AMGEN$Suvannasankha, A.. Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma. Cancer. 2024;130 (15):2629-2641$$$$$Y$$$20240808$$MD$US$US
241873571$24187357$1$I$$20240805$20240808$20240808$PER$$US-JNJFOC-20240816059$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241873581$24187358$1$I$$20240731$20240808$20240808$EXP$$US-CHATTEMPRD-2024OHG025971$CHATTEM$$$$$M$Y$$$20240808$$LW$US$US
241873593$24187359$3$F$$20240920$20240808$20240923$PER$$NVSC2024US160830$NOVARTIS$$$$$F$Y$$$20240923$$MD$US$US
241873602$24187360$2$F$$20240903$20240808$20240913$EXP$$US-TEVA-VS-3228169$TEVA$Larson J, O^Callaghan T, Kolbe K, Claar D. A 66-Year-Old Man with Persistent Altered Mental Status and New Rash. Ann-Am-Thorac-Soc 2023; 20 (3): 466-469.; Larson J, O^Callaghan T, Kolbe K, Claar D. A 66-Year-Old Man with Persistent Altered Mental Status and New Rash. Ann-Am-Thorac-Soc 2023; 20 (3): 466-469.$66$YR$$M$Y$$$20240913$$MD$US$US
241873612$24187361$2$F$$20240807$20240808$20240808$EXP$$US-GILEAD-2024-0683406$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241873621$24187362$1$I$20240805$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125129$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240808$$CN$US$US
241873631$24187363$1$I$20240805$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125013$BRISTOL MYERS SQUIBB$$23$YR$A$F$Y$$$20240808$$PH$US$US
241873641$24187364$1$I$$20240802$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124310$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240808$$CN$US$US
241873652$24187365$2$F$20240725$20240801$20240808$20240811$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122156$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240812$$CN$US$US
241873661$24187366$1$I$$20240729$20240808$20240808$EXP$$IE-STERISCIENCE B.V.-2024-ST-001145$Steriscience PTE$Crotty TJ, Sexton GP, Kavanagh F, Kinsella J, Lennon P, Timon CV, et al.. Fatal cerebritis and ventriculitis secondary to tracheoesophageal prosthesis.. J-Surg-Case-Rep 2024. 2024;4$70$YR$$M$Y$$$20240808$$HP$IE$IE
241873671$24187367$1$I$20240805$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125089$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$HP$US$US
241873681$24187368$1$I$$20240730$20240808$20240808$EXP$PL-URPL-2-435-2020$PL-ROCHE-10000049582$ROCHE$$76$YR$E$F$Y$$$20240808$$CN$PL$PL
241873691$24187369$1$I$$20240731$20240808$20240808$EXP$$US-CHATTEMPRD-2024OHG025921$CHATTEM$$$$$M$Y$$$20240808$$LW$US$US
241873701$24187370$1$I$$20240730$20240808$20240808$EXP$$VE-STERISCIENCE B.V.-2024-ST-001146$Steriscience PTE$Sarmiento-Pina M, Reyna-Villasmil E.. Pneumorrhachis as a complication of epidural anesthesia during the puerperium.. Rev-Peruan-Ginec-Obstet. 2024;70 (2):1-4$21$YR$$F$Y$$$20240808$$MD$VE$VE
241873712$24187371$2$F$$20240809$20240808$20240822$EXP$$US-INSMED, INC.-2024-03077-US$INSMED$$$$$F$Y$$$20240822$$CN$US$US
241873721$24187372$1$I$$20240802$20240808$20240808$EXP$$US-BIOGEN-2024BI01276875$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241873731$24187373$1$I$$20240807$20240808$20240808$PER$$US-HALEON-2190945$Haleon PLC$$$$$F$Y$$$20240808$$CN$US$US
241873751$24187375$1$I$$20240730$20240808$20240808$EXP$$CN-STERISCIENCE B.V.-2024-ST-001152$Steriscience PTE$Zhou L, Cui X, Mo G, Wei J, Mo M, Zhong Y.. Immediate fever during anaesthesia recovery after surgical procedure with scoliosis: A case report and literature review.. Int-J-Surg-Case-Rep. 2024;121 (0)$15$YR$$F$Y$$$20240808$$HP$CN$CN
241873761$24187376$1$I$$20240729$20240808$20240808$EXP$$CA-APOTEX-2024AP008998$APOTEX$$55$YR$$F$Y$$$20240808$$CN$CA$CA
241873771$24187377$1$I$$20240805$20240808$20240808$PER$$US-JNJFOC-20240812830$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241873783$24187378$3$F$20230101$20240827$20240808$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-015127$UNITED THERAPEUTICS$$$$$F$Y$$$20240905$$$US$US
241873791$24187379$1$I$$20240731$20240808$20240808$EXP$$AU-STERISCIENCE B.V.-2024-ST-001158$Steriscience PTE$Cowan TL, Makhija M, Murrell DF.. Pemphigoid gestationis and preeclampsia in a donor-egg IVF pregnancy.. Int-J-Womens-Dermatol. 2022;8$$$N$M$Y$1.58$KG$20240808$$MD$AU$AU
241873802$24187380$2$F$20240703$20240826$20240808$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-038586$AUROBINDO$$89$YR$$M$Y$103$KG$20240904$$MD$FR$FR
241873811$24187381$1$I$20220407$20220418$20240808$20240808$EXP$$CO-AstraZeneca-2022A156284$ASTRAZENECA$$24117$DY$$M$Y$72$KG$20240808$$CN$CO$
241873821$24187382$1$I$20221001$20221017$20240808$20240808$EXP$$US-AstraZeneca-2022A351027$ASTRAZENECA$$64$YR$$F$Y$$$20240808$$CN$US$
241873831$24187383$1$I$20211228$20211228$20240808$20240808$EXP$$KW-AstraZeneca-2021A908442$ASTRAZENECA$$14518$DY$$M$Y$$$20240808$$CN$KW$
241873841$24187384$1$I$$20240806$20240808$20240808$EXP$$US-AstraZeneca-2024A179018$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241873851$24187385$1$I$$20210621$20240808$20240808$EXP$$US-AstraZeneca-2021A550728$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241873861$24187386$1$I$$20221013$20240808$20240808$EXP$$US-AstraZeneca-2022A346801$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241873871$24187387$1$I$$20220624$20240808$20240808$EXP$$US-AstraZeneca-2022A206654$ASTRAZENECA$$$$$M$Y$76.2$KG$20240808$$CN$US$
241873881$24187388$1$I$$20240731$20240808$20240808$EXP$$ZA-AstraZeneca-2024A174583$ASTRAZENECA$$81$YR$$F$Y$$$20240808$$CN$ZA$
241873891$24187389$1$I$20240322$20240731$20240808$20240808$EXP$$FR-AstraZeneca-2024A173980$ASTRAZENECA$$76$YR$$M$Y$76$KG$20240808$$MD$FR$
241873901$24187390$1$I$$20240731$20240808$20240808$EXP$$VN-AstraZeneca-2024A177771$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$VN$
241873911$24187391$1$I$20230101$20240725$20240808$20240808$EXP$$US-COOPERSURGICAL, INC.-2024CPS002321$COOPERSURGICAL$$$$$F$Y$$$20240808$$CN$US$US
241873931$24187393$1$I$20240804$20240804$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002918$ELI LILLY AND CO$$$$$F$Y$$$20240808$$HP$US$US
241873942$24187394$2$F$20240701$20240906$20240808$20240913$EXP$$US-BIOGEN-2024BI01277110$BIOGEN$$58$YR$$F$Y$$$20240913$$CN$US$US
241873951$24187395$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004367$ELI LILLY AND CO$$$$$M$Y$$$20240808$$CN$US$US
241873961$24187396$1$I$20240804$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004097$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240808$$CN$US$US
241873971$24187397$1$I$20240401$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003972$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240808$$CN$US$US
241873981$24187398$1$I$20240805$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003801$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240808$$CN$US$US
241873991$24187399$1$I$20240101$20240805$20240808$20240808$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024269$UNITED THERAPEUTICS$$$$$F$Y$83.9$KG$20240808$$$US$US
241874001$24187400$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003913$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240808$$CN$US$US
241874011$24187401$1$I$20240701$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004125$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240808$$CN$US$US
241874021$24187402$1$I$20240730$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004194$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240808$$CN$US$US
241874031$24187403$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004113$ELI LILLY AND CO$$63$YR$A$$Y$$$20240808$$CN$US$US
241874041$24187404$1$I$$20240731$20240808$20240808$EXP$$CO-NOVITIUMPHARMA-2024CONVP01505$NOVITIUM PHARMA$Yesid Fabian Mantilla-Florez.Fatal Calciphylaxis in Tertiary Hyperparathyroidism due to Long-Lasting End-Stage Renal Disease; A Case Report.Aging Medicine and Healthcare.30-JAN-2023;15(2):88-92$30$YR$A$F$Y$$$20240808$$HP$CO$CO
241874051$24187405$1$I$20240101$20240804$20240808$20240808$PER$$US-AMGEN-USASP2024155121$AMGEN$$$$E$F$Y$$$20240808$$CN$US$US
241874061$24187406$1$I$$20240801$20240808$20240808$EXP$$CA-CHEPLA-2024010214$CHEPLAPHARM$$70$YR$$M$Y$80$KG$20240808$$HP$COUNTRY NOT SPECIFIED$CA
241874071$24187407$1$I$20240718$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024157092$AMGEN$$74$YR$E$F$Y$$$20240808$$CN$US$US
241874101$24187410$1$I$$20240729$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR097952$VIIV$$$$$$Y$$$20240808$$HP$US$US
241874111$24187411$1$I$20240714$20240805$20240808$20240808$30DAY$$US-GSK-US2024097508$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240808$$CN$US$US
241874121$24187412$1$I$$20240802$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123285$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240808$$CN$US$US
241874141$24187414$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870313$ABBVIE$$$$$F$Y$$$20240808$$HP$US$US
241874153$24187415$3$F$$20240920$20240808$20240930$PER$$US-APOTEX-2024AP009134$APOTEX$$$$$F$Y$$$20240930$$CN$US$US
241874161$24187416$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5871221$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241874171$24187417$1$I$$20240730$20240808$20240808$PER$$US-JNJFOC-20240783312$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241874181$24187418$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870344$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241874191$24187419$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-038912$AUROBINDO$Fatima M, Gandhi ZJ, Simonetti G, Saladi L, Naik S.. Fatal Case of Cryptococcal Arthritis. Am-JRespir-Crit-Care-Med. 2023$57$YR$$F$Y$$$20240808$$HP$US$US
241874201$24187420$1$I$20240729$20240807$20240808$20240808$PER$$US-JNJFOC-20240818127$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240808$$CN$US$US
241874213$24187421$3$F$20240501$20240830$20240808$20240904$EXP$$CA-JNJFOC-20240581562$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240904$$HP$CA$CA
241874225$24187422$5$F$20240801$20240906$20240808$20240920$30DAY$$US-JNJFOC-20240802357$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240920$$CN$US$US
241874232$24187423$2$F$20240805$20240826$20240808$20240902$EXP$$FR-JNJFOC-20240817113$JOHNSON AND JOHNSON$$70$YR$E$M$Y$94$KG$20240902$$MD$FR$FR
241874241$24187424$1$I$20240806$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156345$AMGEN$$46$YR$A$M$Y$$$20240808$$HP$US$US
241874252$24187425$2$F$$20240809$20240808$20240816$EXP$$US-CELLTRION INC.-2024US018659$CELLTRION$$$$$$Y$$$20240816$$MD$US$US
241874261$24187426$1$I$$20240806$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044510$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240808$$MD$US$US
241874273$24187427$3$F$$20240908$20240808$20240918$PER$$NVSC2024US160744$NOVARTIS$$$$$$Y$$$20240918$$CN$US$US
241874281$24187428$1$I$$20240729$20240808$20240808$EXP$$US-GSK-US2024AMR095497$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241874291$24187429$1$I$20240801$20240802$20240808$20240808$EXP$$US-GSK-US2024097031$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
241874302$24187430$2$F$$20240920$20240808$20240927$EXP$$US-GSK-US2024096938$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
241874311$24187431$1$I$20240724$20240725$20240808$20240808$EXP$$CA-GSK-CA2024089997$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$HP$CA$CA
241874321$24187432$1$I$$20240730$20240808$20240808$PER$$US-ABBVIE-5871714$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241874342$24187434$2$F$$20240827$20240808$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124589$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$75.3$KG$20240904$$CN$US$US
241874351$24187435$1$I$$20240801$20240808$20240808$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-122157$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$65.32$KG$20240808$$CN$PR$PR
241874363$24187436$3$F$20240320$20240806$20240808$20240910$EXP$$US-ROCHE-10000048026$ROCHE$$26$YR$A$M$Y$72.57$KG$20240910$$MD$US$US
241874371$24187437$1$I$$20240802$20240808$20240808$PER$$NVSC2024US159510$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241874381$24187438$1$I$20231230$20240713$20240808$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05016$LUPIN$$$$$$Y$$$20240808$$CN$US$US
241874391$24187439$1$I$$20240801$20240808$20240808$PER$$US-ABBVIE-5871636$ABBVIE$$$$$F$Y$$$20240808$$HP$US$US
241874404$24187440$4$F$20220205$20240819$20240808$20240902$EXP$$CA-CELLTRION INC.-2021CA019516$CELLTRION$$$$$$Y$$$20240902$$MD$CA$CA
241874411$24187441$1$I$$20240801$20240808$20240808$EXP$$AU-BIOGEN-2024BI01276688$BIOGEN$$$$$F$Y$$$20240808$$HP$AU$AU
241874421$24187442$1$I$20170101$20240730$20240808$20240808$EXP$$ZA-SA-2023SA183691$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240808$$MD$ZA$ZA
241874431$24187443$1$I$$20240802$20240808$20240808$EXP$$CN-ABBVIE-5866487$ABBVIE$Wang X zhu, Gao X min, Wang J mei, Cai H, Li J, Cao X xin. Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations. Ann Hematol. 2024;103(8):3229-3233.$65$YR$$M$Y$$$20240808$$HP$CN$CN
241874441$24187444$1$I$20240603$20240801$20240808$20240808$EXP$$CN-009507513-2408CHN001293$MERCK$$60$YR$$M$Y$71$KG$20240808$$HP$CN$CN
241874451$24187445$1$I$$20240805$20240808$20240808$PER$$US-JNJFOC-20240813656$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$LW$US$US
241874461$24187446$1$I$$20240726$20240808$20240808$EXP$$US-LUPIN HEALTHCARE (UK) LIMITED-2024-07707$LUPIN$Martino J, Elfessi Z, Szaflarska K, Suh M, Antonishina K. Take it easy! serotonin syndrome precipitated by the rapid titration of Sertraline and trazodone in the setting of risperidone use. Journal of Pharmacy Practice. 2024;0 (0):1-4$25$YR$$M$Y$$$20240808$$MD$US$US
241874471$24187447$1$I$$20240805$20240808$20240808$PER$$US-JNJFOC-20240814614$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$HP$US$US
241874481$24187448$1$I$20240327$20240802$20240808$20240808$EXP$$DE-JNJFOC-20240811823$JOHNSON AND JOHNSON$$$$A$F$Y$60$KG$20240808$$MD$DE$DE
241874491$24187449$1$I$$20240725$20240808$20240808$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092869$GLENMARK$Attieh RM, Brumble L, Elwasila SM, Wadei HM.. Disseminated monkeypox infection in a kidney transplant recipient a case report.. Transplantation proceedings.. 2023;55 (3):667-71$$$$$Y$$$20240808$$MD$US$US
241874501$24187450$1$I$$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124904$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240808$$CN$US$US
241874512$24187451$2$F$20240801$20240826$20240808$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124714$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240829$$PH$US$US
241874531$24187453$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124950$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240808$$CN$US$US
241874543$24187454$3$F$20240806$20240919$20240808$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125025$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$94.8$KG$20240924$$PH$US$US
241874551$24187455$1$I$$20240729$20240808$20240808$EXP$$US-ACORDA-ACO_177695_2024$ACORDA$$$$$M$Y$82.086$KG$20240808$$CN$US$US
241874561$24187456$1$I$$20240731$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125295$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$69.9$KG$20240808$$CN$US$US
241874571$24187457$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870560$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241874581$24187458$1$I$$20240806$20240808$20240808$EXP$$PL-ABBVIE-5871440$ABBVIE$$$$$M$Y$$$20240808$$HP$PL$PL
241874591$24187459$1$I$20220501$20240726$20240808$20240808$EXP$$KP-AZURITY PHARMACEUTICALS, INC.-AZR202407-000206$AZURITY PHARMACEUTICALS$Song SH, Jo E.. Primary peritoneal carcinoma presented with  abdominal pain in patient with kidney transplantation. Korean J Intern Med. 2024;39:693-4$54$YR$$F$Y$$$20240808$$MD$KP$KP
241874601$24187460$1$I$$20240805$20240808$20240808$EXP$$US-BIOGEN-2024BI01273011$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241874611$24187461$1$I$20240701$20240729$20240808$20240808$PER$$US-JNJFOC-20240783737$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241874622$24187462$2$F$20240101$20240814$20240808$20240816$PER$$US-AMGEN-USASP2024156100$AMGEN$$$$$F$Y$$$20240816$$CN$US$US
241874631$24187463$1$I$20240801$20240807$20240808$20240808$PER$$US-AMGEN-USASP2024157497$AMGEN$$74$YR$E$M$Y$$$20240808$$CN$US$US
241874642$24187464$2$F$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683409$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241874651$24187465$1$I$$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122919$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240808$$HP$US$US
241874661$24187466$1$I$$20240731$20240808$20240808$EXP$$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-07456$HIKMA$$72$YR$$F$Y$$$20240808$$PH$GB$GB
241874672$24187467$2$F$$20240911$20240808$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124297$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240912$$CN$US$US
241874681$24187468$1$I$20240629$20240710$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-035588$AUROBINDO$$5$YR$$F$Y$22.67$KG$20240808$$CN$US$US
241874691$24187469$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002812$ELI LILLY AND CO$$$$$F$Y$$$20240808$$PH$US$US
241874701$24187470$1$I$$20240805$20240808$20240808$EXP$$US-HALEON-2190686$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241874711$24187471$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004260$ELI LILLY AND CO$$34$YR$A$$Y$$$20240808$$CN$US$US
241874722$24187472$2$F$$20240806$20240808$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004205$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240809$$CN$US$US
241874731$24187473$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003851$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240808$$CN$US$US
241874741$24187474$1$I$20240802$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003979$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240808$$CN$US$US
241874751$24187475$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004118$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240808$$CN$US$US
241874761$24187476$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003846$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240808$$CN$US$US
241874771$24187477$1$I$$20240716$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407010494$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240808$$CN$US$US
241874781$24187478$1$I$20240806$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004807$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240808$$CN$US$US
241874791$24187479$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004182$ELI LILLY AND CO$$$$A$M$Y$$$20240808$$CN$US$US
241874802$24187480$2$F$$20240807$20240808$20240808$EXP$$US-GILEAD-2024-0683404$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241874811$24187481$1$I$$20240713$20240808$20240808$PER$23447091$US-LUPIN PHARMACEUTICALS INC.-2024-04971$LUPIN$$$$$$Y$$$20240808$$CN$US$US
241874821$24187482$1$I$20240319$20240724$20240808$20240808$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461195$RANBAXY$$47$YR$$M$Y$$$20240808$$HP$IT$IT
241874831$24187483$1$I$20240717$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461399$RANBAXY$$55$YR$$M$Y$91$KG$20240808$$PH$GB$GB
241874841$24187484$1$I$$20240724$20240808$20240808$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461396$RANBAXY$Alshamrani HM, Alsaedi M, Alaradati H. Second generation Tyrosine Kinase Inhibitors Nilotinib and Dasatinib induced Keratosis Pilaris: A Case Report and Review of the Literature. Journal of Dermatology and Dermatologic Surgery. 2024;28 (1):55-57$41$YR$$M$Y$$$20240808$$HP$SA$SA
241874851$24187485$1$I$20240718$20240724$20240808$20240808$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460827$RANBAXY$$$$E$M$Y$$$20240808$$CN$IT$IT
241874861$24187486$1$I$20240411$20240724$20240808$20240808$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461339$RANBAXY$$73$YR$$M$Y$$$20240808$$MD$IT$IT
241874871$24187487$1$I$$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460474$RANBAXY$$89$YR$$M$Y$$$20240808$$PH$GB$GB
241874881$24187488$1$I$$20240724$20240808$20240808$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461026$RANBAXY$Bandali T, Kim Y, Khodadoust M, Rieger K, Fernandez-Pol S, Saleem A, et al.. Polatuzumab vedotin-piiq for treatment of primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCL-LT) in older adults. J Invest Dermatol. 2024;144 (8):S49$83$YR$$F$Y$$$20240808$$HP$US$US
241874891$24187489$1$I$$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460471$RANBAXY$$81$YR$$F$Y$$$20240808$$HP$GB$GB
241874901$24187490$1$I$$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460467$RANBAXY$$$$$F$Y$$$20240808$$CN$GB$GB
241874911$24187491$1$I$20240501$20240724$20240808$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461208$RANBAXY$$44$YR$$M$Y$$$20240808$$MD$FR$FR
241874921$24187492$1$I$20240514$20240724$20240808$20240808$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461133$RANBAXY$$17$YR$$F$Y$$$20240808$$PH$ES$ES
241874931$24187493$1$I$20200101$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460466$RANBAXY$$$$$$Y$$$20240808$$CN$GB$GB
241874941$24187494$1$I$20220531$20240724$20240808$20240808$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461448$RANBAXY$$70$YR$$M$Y$$$20240808$$PH$ES$ES
241874952$24187495$2$F$20240715$20240802$20240808$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461363$RANBAXY$$60$YR$$M$Y$68$KG$20240816$$CN$GB$GB
241874961$24187496$1$I$20240305$20240724$20240808$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461231$RANBAXY$$64$YR$$F$Y$41$KG$20240808$$MD$FR$FR
241874971$24187497$1$I$20240301$20240724$20240808$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461226$RANBAXY$$35$YR$$F$Y$$$20240808$$PH$FR$FR
241874981$24187498$1$I$$20240724$20240808$20240808$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461788$RANBAXY$Brumley C, Arora P, Neeley A, Hylwa S. Allergic contact dermatitis to salicylic acid: A case series of relevant sensitization. Contact Dermatitis. 2024;91:133-138$41$YR$$F$Y$$$20240808$$HP$US$US
241874991$24187499$1$I$20240724$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460472$RANBAXY$$25$YR$$F$Y$47$KG$20240808$$HP$GB$GB
241875001$24187500$1$I$$20240724$20240808$20240808$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461349$RANBAXY$Anonymous. Cerebral venous thromboses complicated with hemorrhagic cerebral infarction after administration of oral contraception: Case report. [Chinese]. Chin J Med Imag Tech. 2023;39 (9):1437-1438$$$$F$Y$$$20240808$$HP$CN$CN
241875011$24187501$1$I$20240509$20240724$20240808$20240808$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461459$RANBAXY$$84$YR$$M$Y$70$KG$20240808$$MD$IT$IT
241875021$24187502$1$I$$20240724$20240808$20240808$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461027$RANBAXY$Del Castillo NB, Salaberri- Comesaha M, gocanegra- Munoz C, Naranjo-Velasco V. febrile syndrome. beyond covid in pandemic times. Eur J Case Rep Intern Med. 2023;10 (S1):273 (575)$52$YR$$M$Y$$$20240808$$HP$ES$ES
241875031$24187503$1$I$$20240724$20240808$20240808$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461036$RANBAXY$Elahi A, Mateo RCI. Racing Hearts: A Closer Look At The Connection Between Hyperthyroidism And Coronary Vasospasm. J Endocr Soc. 2023;7 (Suppl.):A950/THU657/bvad114.1780$62$YR$$M$Y$$$20240808$$MD$US$US
241875041$24187504$1$I$$20240724$20240808$20240808$EXP$$QA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461075$RANBAXY$Madawi D, Mobayed H. Pityriasis lichenoides presented with skin rash mimicking Urticaria: A case report. Qatar Med J. 2023;ART 7:1-2$64$YR$$M$Y$$$20240808$$HP$QA$QA
241875052$24187505$2$F$$20240906$20240808$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461071$RANBAXY$Higgins C, Petrushkin H, Solebo AL, Moore W, Boyle S, Arslan Z, et al. Epstein-barr virus anterior uveitis in a paediatric kidney transplant recipient. Pediatr Nephrol. 2023;38 (Suppl.):S155/Fr-P 060$7$YR$$F$Y$$$20240920$$HP$GB$GB
241875061$24187506$1$I$20240720$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460463$RANBAXY$$59$YR$$M$Y$72$KG$20240808$$CN$GB$GB
241875071$24187507$1$I$20240422$20240724$20240808$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461137$RANBAXY$$69$YR$$M$Y$$$20240808$$PH$FR$FR
241875081$24187508$1$I$$20240724$20240808$20240808$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461057$RANBAXY$George MN, Seervai RNH, Chon SY. Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series. JAAD Case Rep. 2024;47(0):72-79$66$YR$$M$Y$$$20240808$$HP$US$US
241875091$24187509$1$I$20240229$20240724$20240808$20240808$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461405$RANBAXY$$72$YR$$F$Y$$$20240808$$MD$ES$ES
241875101$24187510$1$I$20240123$20240724$20240808$20240808$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460417$RANBAXY$$47$YR$$M$Y$$$20240808$$HP$IT$IT
241875111$24187511$1$I$$20240724$20240808$20240808$EXP$$HU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461050$RANBAXY$Gabor I, Tampu-Kiss T, Balazs D, Zsofia M, Arpad I, Gabor M. Complications of systemic cytomegalovirus infection in therapy refracter Hodgkin^s lymphoma. Orv Hetil. 2012;153(19):751-755$$$$F$Y$$$20240808$$HP$HU$HU
241875121$24187512$1$I$$20240724$20240808$20240808$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459001$RANBAXY$Vorob yovskiy DA, Kozlov KL, Vlasenko SV, Shcherbak SG, Lazakovich DN. Intravascular Imaging of Spontaneous Coronary Artery Dissection in a Patient with Acute Coronary Syndrome. Science of the young. Eruditio Juvenium. 2024;12(2):243-250$60$YR$$M$Y$$$20240808$$HP$RU$RU
241875131$24187513$1$I$20231206$20240724$20240808$20240808$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461360$RANBAXY$$40$YR$$F$Y$$$20240808$$PH$IT$IT
241875141$24187514$1$I$20221231$20240724$20240808$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461451$RANBAXY$$61$YR$$M$Y$$$20240808$$MD$FR$FR
241875151$24187515$1$I$$20240724$20240808$20240808$EXP$$CG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461292$RANBAXY$Imani-Musimwa P, Grant E, Feza-Malira M, Mbala-Kingebeni P, Buhoro-Baabo G, Zawadi-Endanda E, et al. A premature newborn born to an adolescent girl with acute Ebola virus disease and malaria survives in a resource-limited setting in an Ebola treatment unit in DR Congo: ^A case report^. Clin Case Rep. 2023;11:e8253;1-6$$$N$F$Y$1.85$KG$20240808$$HP$CG$CG
241875161$24187516$1$I$$20240724$20240808$20240808$EXP$$CG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461273$RANBAXY$Imani-Musimwa P, Grant E, Feza-Malira M, Mbala-Kingebeni P, Buhoro-Baabo G, Zawadi-Endanda E, et al. A premature newborn born to an adolescent girl with acute Ebola virus disease and malaria survives in a resource-limited setting in an Ebola treatment unit in DR Congo: ^A case report^. Clin Case Rep. 2023;11:e8253;1-6$17$YR$$F$Y$45$KG$20240808$$HP$CG$CG
241875171$24187517$1$I$20190901$20240724$20240808$20240808$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461051$RANBAXY$Szymanska-garbacz E, Czupryniak L. Type 2 diabetes comes in many forms - when gliclazide MR is a good solution. Swiat Medycyny i Farmacji. 2024;36(5):39-44$77$YR$$M$Y$83$KG$20240808$$MD$PL$PL
241875181$24187518$1$I$$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461072$RANBAXY$Mehmood T, Elaidy K, Ogunbambi O. A rare case of TEN-like acute cutaneous lupus. Clin Med London. 2024;24 (Suppl.):33$32$YR$$F$Y$$$20240808$$HP$GB$GB
241875191$24187519$1$I$20240301$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461084$RANBAXY$$21$YR$$M$Y$$$20240808$$CN$GB$GB
241875201$24187520$1$I$20240328$20240724$20240808$20240808$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461441$RANBAXY$$38$YR$$F$Y$$$20240808$$MD$ES$ES
241875212$24187521$2$F$$20240805$20240808$20240820$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460875$RANBAXY$Taniguchi SH, Komine K, Takenaga N, Yoshida Y, Sasaki K, Kawamura Y, et al. FOLFIRI Chemotherapy for Patients With Metastatic Urachal Carcinoma. Anticancer Res. 2023;43 (12):5699-5704$37$YR$$F$Y$$$20240820$$HP$JP$JP
241875221$24187522$1$I$$20240724$20240808$20240808$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461512$RANBAXY$Kaneko J, Kiuchi R, Takinami M, Ohnishi I, Ito J, Jindo O, et al. Successful intrahepatic  cholangiocarcinoma conversion surgery after administration of fibroblast growth factor receptor inhibitor. Clin J Gastroenterol. 2024;0 (0):7 pages$47$YR$$M$Y$$$20240808$$HP$JP$JP
241875231$24187523$1$I$20240711$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460464$RANBAXY$$$$$M$Y$$$20240808$$MD$GB$GB
241875241$24187524$1$I$20150630$20240724$20240808$20240808$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461473$RANBAXY$$64$YR$$F$Y$59$KG$20240808$$MD$DE$DE
241875251$24187525$1$I$$20240724$20240808$20240808$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461029$RANBAXY$Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwari A. OVERWHELMING CYTOCHROME P450 ISOENZYME ACTIVITY GENERATING DRUGINDUCED LIVER INJURY RESULTING IN FULMINANT LIVER FAILURE. Hepatology. 2023;78 (Suppl.):S643-S644 (1714-A)$41$YR$$F$Y$$$20240808$$HP$US$US
241875261$24187526$1$I$20231129$20240724$20240808$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460187$RANBAXY$$32$YR$$F$Y$$$20240808$$MD$FR$FR
241875271$24187527$1$I$20240118$20240724$20240808$20240808$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461197$RANBAXY$$34$YR$$F$Y$$$20240808$$PH$IT$IT
241875282$24187528$2$F$20240101$20240904$20240808$20240909$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-108347$REGENERON$$74$YR$$F$Y$$$20240909$$MD$JP$JP
241875291$24187529$1$I$$20240805$20240808$20240808$EXP$$GB-JNJFOC-20240812815$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$MD$GB$GB
241875301$24187530$1$I$20240421$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038009$AUROBINDO$$64$YR$$M$Y$$$20240808$$MD$FR$FR
241875311$24187531$1$I$20240206$20240807$20240808$20240808$EXP$$SG-ROCHE-10000050779$ROCHE$$$$$F$Y$$$20240808$$CN$SG$SG
241875321$24187532$1$I$$20240731$20240808$20240808$EXP$$VE-ROCHE-10000048046$ROCHE$$$$$$Y$$$20240808$$MD$VE$VE
241875332$24187533$2$F$$20240903$20240808$20240913$EXP$$US-TEVA-VS-3228185$TEVA$Dillon J, Bernik S, Zeizafoun N, Balija T. Benign phyllodes tumour in a transgender woman receiving hormonal therapy. BMJ-Case-Rep 2024; 17 (3):.; Dillon J, Bernik S, Zeizafoun N, Balija T. Benign phyllodes tumour in a transgender woman receiving hormonal therapy. BMJ-Case-Rep 2024; 17 (3):.$$$A$M$Y$$$20240913$$MD$US$US
241875341$24187534$1$I$$20240802$20240808$20240808$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00405$VELOXIS PHARMACEUTICALS$Bae E K, Chandran M M, Everitt M D, Benz E, Bock M.. LCP-tacrolimus extended-release (Envarsus XR) use in adolescent and young adult solid organ transplant recipients.. Clinical Transplantation. 2024;38:e15417:1-7$11$YR$$M$Y$$$20240808$$HP$US$US
241875351$24187535$1$I$$20240729$20240808$20240808$EXP$$CN-ROCHE-RCA5211336$ROCHE$Shan X, Ge Y. Interstitial Lung Disease in Patients with Mixed Connective Tissue Disease: A Retrospective Study. International Journal of General Medicine. 2024-May-13;17:2091-9. doi:10.2147/IJGM.S464704.$$$$$Y$$$20240808$$HP$CN$CN
241875361$24187536$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229570$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$76$YR$$F$Y$$$20240808$$HP$FR$FR
241875371$24187537$1$I$$20240725$20240808$20240808$EXP$$FR-INSMED, INC.-2024-03048-FR$INSMED$$$$$M$Y$70$KG$20240808$$MD$FR$FR
241875381$24187538$1$I$20240624$20240730$20240808$20240808$EXP$FR-AFSSAPS-PC2024000574$FR-TEVA-VS-3228524$TEVA$$51$YR$$F$Y$57$KG$20240808$$MD$FR$FR
241875391$24187539$1$I$$20240805$20240808$20240808$PER$$US-ABBVIE-5867581$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241875403$24187540$3$F$20230101$20240821$20240808$20240822$EXP$$NVSC2024ES160954$NOVARTIS$$55$YR$$F$Y$$$20240822$$MD$ES$ES
241875422$24187542$2$F$20240101$20240925$20240808$20240930$EXP$$CA-UCBSA-2024035776$UCB$$$$$F$Y$$$20240930$$CN$CA$CA
241875441$24187544$1$I$$20240724$20240808$20240808$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461008$RANBAXY$Patel R, Awad A, Purdy J. Inhalation Without Ignition: A Case of Severe Asthma Exacerbation From Occupational Cannabis Exposure. Am J Respir Crit Care Med. 2023;207:A1852/A52$60$YR$$M$Y$$$20240808$$HP$US$US
241875451$24187545$1$I$$20240724$20240808$20240808$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460990$RANBAXY$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D. Rhabdomyolysis Risk: The Dangers of Tribulus terrestris, an Over-the-Counter Supplement. Am J Case Rep. 2024;25 (0):e943492$71$YR$$M$Y$$$20240808$$HP$US$US
241875461$24187546$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A174328$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241875471$24187547$1$I$$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461022$RANBAXY$Katarki P, Nod L, Ahmad N. Persistent sweet taste dysgeusia diagnosed with probable SIADH: Unmasking underlying lung cancer in a high-risk individual: A case report. Clin Med London. 2024;24 (Suppl.):100041; 49$66$YR$$F$Y$$$20240808$$HP$GB$GB
241875491$24187549$1$I$$20240731$20240808$20240808$EXP$$ZA-AstraZeneca-2024A174737$ASTRAZENECA$$77$YR$$M$Y$$$20240808$$CN$ZA$
241875501$24187550$1$I$$20240724$20240808$20240808$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460997$RANBAXY$Yildirim EA, Adisen E. Livedo Reticularis in Association with Fingolimod: A Case Report. Indian J Dermatol. 2024;69(1):97-9$43$YR$$F$Y$$$20240808$$HP$TR$TR
241875511$24187551$1$I$$20240724$20240808$20240808$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460928$RANBAXY$Guo Y, Liu Y, Li D, Wang X, Huang S, Yang L. Clinical observation and analysis of rash caused by lacosamide in children with epilepsy. Seizure. 2024;117 (0):105-110$4$YR$$M$Y$$$20240808$$HP$CN$CN
241875521$24187552$1$I$$20240724$20240808$20240808$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461025$RANBAXY$Bandali T, Kim Y, Khodadoust M, Rieger K, Fernandez-Pol S, Saleem A, et al. Polatuzumab vedotin-piiq for treatment of primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCL-LT) in older adults. J-Invest-Dermatol. 2024;144 (8):S49 (282)$92$YR$$M$Y$$$20240808$$HP$US$US
241875531$24187553$1$I$$20240724$20240808$20240808$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460897$RANBAXY$Bombardi LM, Scorza CA, Finsterer J, Scorza FA.. NXP-2 positive dermatomyositis with marked dysphagia following an insect bite. Clinics. 2024;79$$$$M$Y$$$20240808$$HP$BR$BR
241875541$24187554$1$I$$20240724$20240808$20240808$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459468$RANBAXY$E.B. Shakhov,  E.V. Chebotar, A.D.Ljamaev, M.Y. Novikov, A.V.Lastochkin,  E.V. Zharikova. A CASE WHERE THE USE OF SYSTEMIC AND LOCAL AUXILIARY BLOOD SUPPLY TECHNIQUES WAS COMBINED TO RELIEVE CARDIOGENIC SHOCK. MA. 2024;2 (79):1-12$62$YR$$$Y$$$20240808$$HP$RU$RU
241875551$24187555$1$I$$20240724$20240808$20240808$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459607$RANBAXY$Roberto G, Aloini ME, Biondo I, Ricci F, Maggio R, Lardo P et al. Ectopic Cushing^s Syndrome in Pediatric Age. Endocr Metab Immune Disord Drug Targets. 2024;Jul 22:Online ahead of print$17$YR$$F$Y$$$20240808$$HP$IT$IT
241875562$24187556$2$F$$20240812$20240808$20240827$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460954$RANBAXY$Olisova OY, Teplyuk NP, Ignatiev DV, Dunaeva ER. Development of scalded skin syndrome in an adult patient with acquired epidermolysis bullosa after long-term treatment with methotrexate. Russ J Skin Vener Dis. 2023;26(1):41-49$47$YR$$M$Y$$$20240827$$MD$RU$RU
241875571$24187557$1$I$$20240724$20240808$20240808$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460977$RANBAXY$Yadav SM. DRESS: When saviours break bad. Indian J Rheumatol. 2023;18 (Suppl.):S384(CAS163)$20$YR$$F$Y$$$20240808$$HP$IN$IN
241875581$24187558$1$I$$20240724$20240808$20240808$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460985$RANBAXY$Kanno J, Miura A, Kawashima S, Shima H, Suzuki D, Kamimura M, et al. A case of 49,XXXYY followed-up from infancy to adulthood with review of literature. Ednocr J. 2024;71 (7):721-727$$$$M$Y$$$20240808$$HP$JP$JP
241875591$24187559$1$I$$20240724$20240808$20240808$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459489$RANBAXY$Toshina YK, Bolotnikova IV, Gorkin AE, Smirnova AY,Dinikina YV. Neurotrophic keratitis concomitant to CNS tumor in a child: a clinical case. Vopr Onkol. 2024;70(2):390-396.(UDC 616-006.48)$$$$F$Y$$$20240808$$HP$RU$RU
241875602$24187560$2$F$$20240802$20240808$20240816$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460961$RANBAXY$Aydin S, Cevizoglu M. Drug-induced Hemolytic Anemia: Isotretinoin. J Pediatr Hematol Oncol. 2024;Aug; 46 (6):328-329$17$YR$$F$Y$$$20240816$$MD$TR$TR
241875611$24187561$1$I$$20240724$20240808$20240808$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460988$RANBAXY$Naysadorai KA, Bellary S. Bottle gourd (Lagenaria siceraria) toxicity: A rare case report. Clin Med London. 2024;24 (Suppl.):21-23$62$YR$$M$Y$$$20240808$$HP$IN$IN
241875621$24187562$1$I$$20240724$20240808$20240808$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457123$RANBAXY$Xie J, Li M, Li P, Wang Y, Pang N. Acute Myeloid Leukemia Secondary to Treatment with Oxaliplatin Combined with Capecitabine for Colorectal Cancer. Clin Lab. 2024;70 (3):622-625$73$YR$$F$Y$$$20240808$$HP$CN$CN
241875631$24187563$1$I$$20240724$20240808$20240808$EXP$$EG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460964$RANBAXY$Alnahas Z, Horani M. Pure Aldosterone-secreting Adrenocortical Carcinoma Causing Resistant Hypertension In A Patient With Previously Controlled Longstanding Hypertension: A Case Report. J Endocr Soc. 2024;6 (Suppl.):LBSAT61/A46$48$YR$$M$Y$$$20240808$$MD$EG$EG
241875641$24187564$1$I$$20240724$20240808$20240808$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460936$RANBAXY$Guo Y, Liu Y, Li D, Wang X, Huang S, Yang L. Clinical observation and analysis of rash caused by lacosamide in children with epilepsy. Seizure. 2024;117 (0):105-110$5$YR$$M$Y$$$20240808$$HP$CN$CN
241875651$24187565$1$I$$20240724$20240808$20240808$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460962$RANBAXY$Kamath A. An intriguing case of multiple brown tumors. Indian J Rheumatol. 2023;18 (Suppl.2):S354-S355;CAS119$36$YR$$F$Y$$$20240808$$HP$IN$IN
241875661$24187566$1$I$$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461272$RANBAXY$$$$$$Y$$$20240808$$CN$GB$GB
241875671$24187567$1$I$$20230328$20240808$20240808$EXP$$CA-AstraZeneca-2023A076739$ASTRAZENECA$$$$$F$Y$$$20240808$$HP$CA$
241875681$24187568$1$I$$20240724$20240808$20240808$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460804$RANBAXY$Mentese IB, Tugcu M, Nazli I, Filinte D, Asicioglu E, Arikan H, et al. A case of Alport syndrome with pregnancy-related atypical hemolytic uremic syndrome and crescentic glomerulonephritis. Clin Nephrol Case Stud. 2023;11 (1):50-54$21$YR$$F$Y$$$20240808$$MD$TR$TR
241875691$24187569$1$I$$20240724$20240808$20240808$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460920$RANBAXY$Guo Y, Liu Y, Li D, Wang X, Huang S, Yang L. Clinical observation and analysis of rash caused by lacosamide in children with epilepsy. Seizure. 2024;117 (0):105-110$10$YR$$F$Y$$$20240808$$HP$CN$CN
241875711$24187571$1$I$$20240724$20240808$20240808$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460944$RANBAXY$Zhang Q, Xie P, Hou X, Zhao C, Duan L, Qiao H. Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report. J Chemother. 2024;36(4):334-342$52$YR$$M$Y$$$20240808$$HP$CN$CN
241875721$24187572$1$I$$20240724$20240808$20240808$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460772$RANBAXY$Katagiri H, Sato N, Inoue Y, Muto K, Tanaka H, Hirose Y.. Life-threatening hyperkalemia following low-dose trimethoprim sulfamethoxazole: a case report.. Case Rep Acute Med. 2023;6 (1):1-8$80$YR$$F$Y$48$KG$20240808$$HP$JP$JP
241875731$24187573$1$I$20240412$20240724$20240808$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461510$RANBAXY$$15$YR$$F$Y$83$KG$20240808$$MD$FR$FR
241875741$24187574$1$I$$20211209$20240808$20240808$EXP$$US-AstraZeneca-2021A867386$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241875751$24187575$1$I$$20230822$20240808$20240808$EXP$$US-AstraZeneca-2023A157923$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241875761$24187576$1$I$$20200129$20240808$20240808$EXP$$US-AstraZeneca-2020SE16499$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241875771$24187577$1$I$$20240722$20240808$20240808$PER$$US-JNJFOC-20240763178$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241875781$24187578$1$I$20060101$20240805$20240808$20240808$PER$$US-JNJFOC-20240812834$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240808$$HP$US$US
241875791$24187579$1$I$$20240731$20240808$20240808$EXP$$KR-NOVITIUMPHARMA-2024KRNVP01529$NOVITIUM PHARMA$Sangmin Ahn.Within-host Viral Evolution and Neutralizing Antibody Response in Immunocompromised Patients with Persistent SARS-CoV-2 Infection Receiving B Cell Depleting Treatment.Open Forum Infectious Diseases.27-NOV-2023;10(2):S278-S279$53$YR$A$M$Y$$$20240808$$HP$KR$KR
241875801$24187580$1$I$$20240806$20240808$20240808$EXP$$JP-ASTELLAS-2024JP005740$ASTELLAS$$9$DEC$$F$Y$$$20240808$$MD$JP$JP
241875811$24187581$1$I$$20240806$20240808$20240808$EXP$$JP-ASTELLAS-2024JP005759$ASTELLAS$$87$YR$$M$Y$$$20240808$$PH$JP$JP
241875821$24187582$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229793$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$82$YR$$M$Y$$$20240808$$HP$FR$FR
241875831$24187583$1$I$20240803$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156853$AMGEN$$65$YR$E$F$Y$$$20240808$$CN$US$US
241875841$24187584$1$I$20240726$20240807$20240808$20240808$PER$$US-AMGEN-USASP2024157236$AMGEN$$63$YR$A$M$Y$$$20240808$$HP$US$US
241875853$24187585$3$F$20240724$20240821$20240808$20240826$EXP$$CA-AMGEN-CANSP2024154787$AMGEN$$59$YR$A$F$Y$$$20240826$$MD$CA$CA
241875861$24187586$1$I$$20240729$20240808$20240808$30DAY$$US-GSK-US2024AMR095582$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
241875872$24187587$2$F$20240727$20240813$20240808$20240822$EXP$$US-HETERO-HET2024US02558$HETERO$$31$YR$$M$Y$81.6$KG$20240822$$CN$US$US
241875881$24187588$1$I$20240702$20240730$20240808$20240808$EXP$PT-INFARMED-R202407-240$PT-TEVA-VS-3227995$TEVA$$38$YR$$F$Y$$$20240808$$PH$PT$PT
241875891$24187589$1$I$$20240801$20240808$20240808$EXP$$US-ROCHE-10000047239$ROCHE$$71$YR$E$F$Y$$$20240808$$CN$US$US
241875901$24187590$1$I$20240708$20240722$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116818$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$49.9$KG$20240808$$HP$US$US
241875911$24187591$1$I$$20240806$20240808$20240808$PER$$NVSC2024US161457$NOVARTIS$$$$$$Y$$$20240808$$MD$US$US
241875921$24187592$1$I$$20240802$20240808$20240808$EXP$$NVSC2024BR160291$NOVARTIS$$$$$F$Y$$$20240808$$CN$BR$BR
241875931$24187593$1$I$20240612$20240730$20240808$20240808$EXP$ES-AEMPS-1551741$ES-TEVA-VS-3228132$TEVA$$35$YR$$M$Y$$$20240808$$PH$ES$ES
241875941$24187594$1$I$20220418$20220422$20240808$20240808$EXP$$US-AstraZeneca-2022A162141$ASTRAZENECA$$25540$DY$$M$Y$$$20240808$$CN$US$
241875951$24187595$1$I$20060101$20200310$20240808$20240808$EXP$$US-AstraZeneca-2020SE25776$ASTRAZENECA$$58$YR$$F$Y$114.8$KG$20240808$$MD$US$
241875961$24187596$1$I$$20210511$20240808$20240808$EXP$$US-AstraZeneca-2021A436693$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241875981$24187598$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229794$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$64$YR$$M$Y$$$20240808$$HP$FR$FR
241875991$24187599$1$I$20240615$20240724$20240808$20240808$EXP$$TR-SUNPHARMA-2024R1-458880AA$RANBAXY$$24$YR$$F$Y$59$KG$20240808$$CN$TR$TR
241876001$24187600$1$I$$20240724$20240808$20240808$EXP$$CL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461280$RANBAXY$Soto J, Weissglas B, Von Plessing-Pierry G, Del Solar MP, Pena-Villa C, Flores X, et al. Fetal Hyperthyroidism Secondary to Maternal Basedow-Graves Disease. AJP Rep. 2024;14 (2):176-183$29$YR$$F$Y$$$20240808$$MD$CL$CL
241876011$24187601$1$I$20240501$20240724$20240808$20240808$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461321$RANBAXY$$69$YR$$F$Y$61$KG$20240808$$MD$GB$GB
241876021$24187602$1$I$20240101$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156854$AMGEN$$56$YR$A$F$Y$$$20240808$$CN$US$US
241876031$24187603$1$I$$20240801$20240808$20240808$EXP$$JP-009507513-2405JPN001927J$MERCK$$8$DEC$$M$Y$$$20240808$$MD$JP$JP
241876041$24187604$1$I$$20240724$20240808$20240808$EXP$$CL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461304$RANBAXY$Soto J, Weissglas B, Von Plessing-Pierry G, Del Solar MP, Pena-Villa C, Flores X, et al. Fetal Hyperthyroidism Secondary to Maternal Basedow-Graves Disease. AJP Rep. 2024;14 (2):176-183$$$N$F$Y$2.66$KG$20240808$$MD$CL$CL
241876051$24187605$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229795$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$67$YR$$F$Y$$$20240808$$HP$FR$FR
241876062$24187606$2$F$$20240809$20240808$20240821$EXP$$CA-AUROBINDO-AUR-APL-2024-038829$AUROBINDO$Sahly AN, Sierra-Marquez J, Bungert-Plumke S, Franzen A, Mougharbel L, Berrahmoune S, et al. Genotype-phenotype correlation in CLCN4-related developmental and epileptic encephalopathy. Hum-Genet. 2024;143:667-681$$$$M$Y$$$20240821$$HP$CA$CA
241876071$24187607$1$I$$20240730$20240808$20240808$EXP$GB-MHRA-MED-202407251205535180-QZRPB$GB-TEVA-VS-3228326$TEVA$$$$$$Y$75$KG$20240808$$CN$GB$GB
241876081$24187608$1$I$20240423$20240724$20240808$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461243$RANBAXY$$63$YR$$M$Y$73$KG$20240808$$MD$FR$FR
241876091$24187609$1$I$$20240731$20240808$20240808$EXP$$ES-ROCHE-3194641$ROCHE$Martinez Iturriaga S,  Sepsis secondary to acute diverticulitis associated with the use of tocilizumab. CLINICAL CASES. 2024;34 (2):189-91. doi:10.4321/S1699-714X2024000200018.$80$YR$E$F$Y$$$20240808$$PH$ES$ES
241876101$24187610$1$I$20240701$20240731$20240808$20240808$PER$$US-ABBVIE-5863245$ABBVIE$$27$YR$$$Y$$$20240808$$CN$US$US
241876112$24187611$2$F$$20240802$20240808$20240808$EXP$$BR-BIOGEN-2024BI01277042$BIOGEN$$$$$F$Y$66$KG$20240808$$CN$BR$BR
241876121$24187612$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229781$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$71$YR$$F$Y$$$20240808$$HP$FR$FR
241876131$24187613$1$I$$20240804$20240808$20240808$EXP$$US-JNJFOC-20240811824$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241876141$24187614$1$I$$20240712$20240808$20240808$PER$$US-JNJFOC-20240748112$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241876151$24187615$1$I$$20240801$20240808$20240808$EXP$$TH-ASTELLAS-2024US022022$ASTELLAS$$$$A$$Y$64$KG$20240808$$CN$TH$TH
241876162$24187616$2$F$$20240813$20240808$20240820$PER$$US-JNJFOC-20240813325$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$HP$US$US
241876171$24187617$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229782$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$75$YR$$F$Y$$$20240808$$HP$FR$FR
241876181$24187618$1$I$$20240805$20240808$20240808$EXP$$AU-ASTELLAS-2024US022304$ASTELLAS$$$$N$F$Y$$$20240808$$CN$AU$AU
241876191$24187619$1$I$20240725$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125547$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240808$$MD$US$US
241876202$24187620$2$F$$20240805$20240808$20240812$EXP$$SE-BIOVITRUM-2024-SE-010613$BIOVITRUM$$$$C$F$Y$$$20240812$$MD$SE$SE
241876211$24187621$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229789$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$75$YR$$M$Y$$$20240808$$HP$FR$FR
241876221$24187622$1$I$$20240805$20240808$20240808$EXP$$BR-ASTELLAS-2024US013464$ASTELLAS$$$$E$M$Y$$$20240808$$CN$BR$BR
241876231$24187623$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229790$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$71$YR$$M$Y$$$20240808$$HP$FR$FR
241876241$24187624$1$I$20240414$20240730$20240808$20240808$EXP$FR-AFSSAPS-RE2024000747$FR-TEVA-VS-3228426$TEVA$$78$YR$$M$Y$83$KG$20240808$$MD$FR$FR
241876251$24187625$1$I$$20240730$20240808$20240808$EXP$$CN-STERISCIENCE B.V.-2024-ST-001151$Steriscience PTE$Hu R, Qiu W, Zhao X, Zhang L, Liu L, Xie J, et al.. Management of immunocompromised renal transplant patients infected with coronavirus disease 2019. [Chinese].. Zhonghua-Wei-Zhong-Bing-Ji-Jiu-Yi-Xue. 2022;34 (5):492-496.$49$YR$$M$Y$$$20240808$$HP$CN$CN
241876261$24187626$1$I$$20240729$20240808$20240808$EXP$$JP-ROCHE-10000048502$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$54$YR$A$M$Y$$$20240808$$HP$JP$JP
241876301$24187630$1$I$$20240806$20240808$20240808$PER$$US-BIOVITRUM-2024-US-010677$BIOVITRUM$$$$$M$Y$$$20240808$$CN$US$US
241876312$24187631$2$F$20240530$20240813$20240808$20240821$EXP$IT-PFIZER INC-PV202400092359$IT-ROCHE-10000044868$ROCHE$$57$YR$A$F$Y$70$KG$20240821$$HP$IT$IT
241876321$24187632$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA232105$SANOFI AVENTIS$$$$A$F$Y$88$KG$20240808$$MD$US$US
241876331$24187633$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA232111$SANOFI AVENTIS$$$$A$M$Y$75.7$KG$20240808$$MD$US$US
241876351$24187635$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA231287$SANOFI AVENTIS$$$$A$M$Y$$$20240808$$MD$US$US
241876361$24187636$1$I$$20240801$20240808$20240808$EXP$$CA-Amarin Pharma, Inc-2024AMR000399$AMARIN$$65$YR$E$M$Y$$$20240808$$CN$CA$CA
241876371$24187637$1$I$$20240801$20240808$20240808$EXP$$CN-TAKEDA-2024TUS077685$TAKEDA$$$$$M$Y$$$20240808$$CN$CN$CN
241876381$24187638$1$I$20240701$20240730$20240808$20240808$PER$$US-SA-2024SA232099$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240808$$MD$US$US
241876391$24187639$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA231653$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240808$$MD$US$US
241876401$24187640$1$I$$20240731$20240808$20240808$PER$$US-SA-2023SA329402$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240808$$MD$US$US
241876411$24187641$1$I$20240731$20240731$20240808$20240808$PER$$US-SA-2024SA232170$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240808$$MD$US$US
241876421$24187642$1$I$20240730$20240731$20240808$20240808$PER$$US-SA-2024SA232163$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240808$$MD$US$US
241876432$24187643$2$F$$20240807$20240808$20240816$PER$$US-SA-2024SA229394$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240816$$MD$US$US
241876441$24187644$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA231565$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240808$$MD$US$US
241876451$24187645$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA231817$SANOFI AVENTIS$$37$YR$A$F$Y$75.29$KG$20240808$$MD$US$US
241876462$24187646$2$F$20240726$20240828$20240808$20240923$PER$$US-SA-2024SA232125$SANOFI AVENTIS$$43$YR$A$F$Y$95.45$KG$20240923$$MD$US$US
241876472$24187647$2$F$20240801$20240820$20240808$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044473$BOEHRINGER INGELHEIM$$87$YR$E$M$Y$$$20240820$$CN$US$US
241876491$24187649$1$I$20240716$20240730$20240808$20240808$PER$$US-SA-2024SA229937$SANOFI AVENTIS$$16$YR$T$M$Y$79$KG$20240808$$MD$US$US
241876501$24187650$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA229976$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240808$$MD$US$US
241876521$24187652$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA229889$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240808$$MD$US$US
241876541$24187654$1$I$20240701$20240730$20240808$20240808$PER$$US-SA-2024SA229377$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240808$$MD$US$US
241876551$24187655$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA230639$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240808$$CN$US$US
241876561$24187656$1$I$20240701$20240730$20240808$20240808$PER$$US-SA-2024SA231499$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240808$$MD$US$US
241876571$24187657$1$I$20240701$20240801$20240808$20240808$PER$$US-SA-2024SA231886$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240808$$MD$US$US
241876592$24187659$2$F$$20240823$20240808$20240918$PER$$US-SA-2024SA231344$SANOFI AVENTIS$$$$A$F$Y$90.26$KG$20240918$$MD$US$US
241876601$24187660$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231472$SANOFI AVENTIS$$$$$F$Y$$$20240808$$CN$US$US
241876611$24187661$1$I$$20240805$20240808$20240808$PER$$US-SA-2024SA233236$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240808$$CN$US$US
241876621$24187662$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA151101$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240808$$CN$US$US
241876631$24187663$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA232005$SANOFI AVENTIS$$$$A$F$Y$88.4$KG$20240808$$MD$US$US
241876641$24187664$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231440$SANOFI AVENTIS$$$$C$F$Y$$$20240808$$MD$US$US
241876651$24187665$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231997$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240808$$MD$US$US
241876661$24187666$1$I$$20240730$20240808$20240808$PER$$US-SA-2022SA270485$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240808$$MD$US$US
241876672$24187667$2$F$20240722$20240913$20240808$20240923$PER$$US-SA-2024SA230770$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240923$$MD$US$US
241876681$24187668$1$I$20240701$20240730$20240808$20240808$PER$$US-SA-2024SA228066$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240808$$MD$US$US
241876691$24187669$1$I$20240701$20240801$20240808$20240808$PER$$US-SA-2024SA231900$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240808$$MD$US$US
241876701$24187670$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231844$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240808$$MD$US$US
241876711$24187671$1$I$20240701$20240730$20240808$20240808$PER$$US-SA-2024SA232133$SANOFI AVENTIS$$62$YR$A$M$Y$90.7$KG$20240808$$MD$US$US
241876721$24187672$1$I$20231214$20240801$20240808$20240808$PER$$US-SA-2024SA231933$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240808$$HP$US$US
241876731$24187673$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA230042$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240808$$CN$US$US
241876755$24187675$5$F$$20240916$20240808$20240923$PER$$US-SA-2024SA233326$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240923$$CN$US$US
241876762$24187676$2$F$20240101$20240814$20240808$20240821$PER$$US-SA-2024SA231853$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240821$$MD$US$US
241876772$24187677$2$F$$20240823$20240808$20240916$PER$$US-SA-2024SA230375$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240916$$MD$US$US
241876781$24187678$1$I$20240728$20240730$20240808$20240808$PER$$US-SA-2024SA230308$SANOFI AVENTIS$$59$YR$A$F$Y$140.59$KG$20240808$$HP$US$US
241876791$24187679$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA230656$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240808$$MD$US$US
241876801$24187680$1$I$20240701$20240730$20240808$20240808$PER$$US-SA-2024SA230804$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240808$$MD$US$US
241876811$24187681$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231925$SANOFI AVENTIS$$$$C$F$Y$$$20240808$$MD$US$US
241876821$24187682$1$I$20240601$20240801$20240808$20240808$PER$$US-SA-2024SA229809$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240808$$CN$US$US
241876831$24187683$1$I$20240604$20240801$20240808$20240808$PER$$US-SA-2024SA230493$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240808$$MD$US$US
241876841$24187684$1$I$20240701$20240801$20240808$20240808$PER$$US-SA-2024SA232011$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240808$$MD$US$US
241876851$24187685$1$I$20240802$20240802$20240808$20240808$PER$$US-SA-2024SA232199$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240808$$HP$US$US
241876861$24187686$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231517$SANOFI AVENTIS$$$$A$F$Y$52$KG$20240808$$MD$US$US
241876872$24187687$2$F$20240101$20240824$20240808$20240914$PER$$US-SA-2024SA232261$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240914$$CN$US$US
241876881$24187688$1$I$20230601$20240731$20240808$20240808$PER$$US-SA-2024SA230061$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240808$$MD$US$US
241876891$24187689$1$I$20240701$20240801$20240808$20240808$PER$$US-SA-2024SA231879$SANOFI AVENTIS$$60$YR$A$M$Y$70$KG$20240808$$MD$US$US
241876901$24187690$1$I$20240601$20240725$20240808$20240808$EXP$GB-MHRA-MED-202407251954289030-TDJPC$GB-UCBSA-2024037703$UCB$$12$YR$$F$Y$$$20240808$$CN$GB$GB
241876911$24187691$1$I$20220723$20240726$20240808$20240808$EXP$$US-UCBSA-2024029017$UCB$$27$YR$$F$Y$$$20240808$$HP$US$US
241876921$24187692$1$I$$20240729$20240808$20240808$EXP$$CA-TEVA-VS-3227758$TEVA$$40$YR$$F$Y$104.33$KG$20240808$$CN$CA$CA
241876931$24187693$1$I$$20240806$20240808$20240808$PER$$US-HALEON-2190737$Haleon PLC$$74$YR$$$Y$$$20240808$$CN$US$US
241876941$24187694$1$I$$20240801$20240808$20240808$EXP$$US-SANDOZ INC.-SDZ2024US071322$SANDOZ$$$$$$Y$$$20240808$$PH$US$US
241876951$24187695$1$I$$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038661$AUROBINDO$$57$YR$$F$Y$$$20240808$$HP$FR$FR
241876962$24187696$2$F$$20240807$20240808$20240808$EXP$$US-GILEAD-2024-0683358$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241876971$24187697$1$I$20230401$20240730$20240808$20240808$EXP$$AT-ROCHE-10000047896$ROCHE$$70$YR$E$F$Y$60$KG$20240808$$MD$AT$AT
241876981$24187698$1$I$$20240802$20240808$20240808$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00403$VELOXIS PHARMACEUTICALS$Bae E K, Chandran M M, Everitt M D, Benz E, Bock M.. LCP-tacrolimus extended-release (Envarsus XR) use in adolescent and young adult solid organ transplant recipients.. Clinical Transplantation. 2024;38:e15417:1-7$15$YR$$M$Y$$$20240808$$HP$US$US
241876991$24187699$1$I$$20240715$20240808$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05115$LUPIN$$$$$$Y$$$20240808$$CN$US$US
241877001$24187700$1$I$20240709$20240807$20240808$20240808$EXP$$CA-SANDOZ INC.-SDZ2024CA071302$SANDOZ$$92$YR$$M$Y$$$20240808$$MD$CA$CA
241877011$24187701$1$I$$20240807$20240808$20240808$EXP$$US-SANDOZ INC.-SDZ2024US071307$SANDOZ$$$$$F$Y$$$20240808$$HP$US$US
241877021$24187702$1$I$$20240806$20240808$20240808$30DAY$$US-SANDOZ INC.-SDZ2024US071282$SANDOZ$$$$$F$Y$$$20240808$$CN$US$US
241877031$24187703$1$I$20240721$20240806$20240808$20240808$EXP$$CA-SANDOZ INC.-NVSC2022CA177353$SANDOZ$$74$YR$$M$Y$$$20240808$$CN$CA$CA
241877041$24187704$1$I$20240804$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155672$AMGEN$$74$YR$E$F$Y$$$20240808$$CN$US$US
241877051$24187705$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231935$SANOFI AVENTIS$$$$A$F$Y$99.79$KG$20240808$$MD$US$US
241877061$24187706$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231885$SANOFI AVENTIS$$$$A$M$Y$$$20240808$$MD$US$US
241877071$24187707$1$I$20240725$20240731$20240808$20240808$PER$$US-SA-2024SA231715$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240808$$MD$US$US
241877081$24187708$1$I$20240601$20240731$20240808$20240808$PER$$US-SA-2024SA232358$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240808$$HP$US$US
241877091$24187709$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231791$SANOFI AVENTIS$$$$T$M$Y$$$20240808$$MD$US$US
241877101$24187710$1$I$20240701$20240731$20240808$20240808$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00802$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240808$$CN$US$US
241877111$24187711$1$I$$20240806$20240808$20240808$30DAY$GB-MHRA-ADR 26674302$GB-SANDOZ INC.-NVSC2022GB049194$SANDOZ$$$$$F$Y$$$20240808$$CN$GB$GB
241877122$24187712$2$F$$20240809$20240808$20240816$EXP$$JP-CELLTRION INC.-2024JP018693$CELLTRION$Andou M., Nishikawa S., Garamatsu S.. EP-1196 A case in which cytokine storm was caused by trastuzumab and pertuzumab.. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;476$$$$$Y$$$20240816$$MD$JP$JP
241877131$24187713$1$I$$20240802$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123596$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$108.86$KG$20240808$$CN$US$US
241877141$24187714$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123960$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$58.97$KG$20240808$$HP$US$US
241877151$24187715$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124026$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$58.06$KG$20240808$$HP$US$US
241877171$24187717$1$I$20240701$20240801$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122418$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$77.56$KG$20240808$$CN$US$US
241877181$24187718$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA227752$SANOFI AVENTIS$$$$A$M$Y$$$20240808$$MD$US$US
241877191$24187719$1$I$20240601$20240731$20240808$20240808$PER$$US-SA-2024SA230769$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240808$$MD$US$US
241877201$24187720$1$I$20211103$20220419$20240808$20240808$EXP$$CO-AstraZeneca-2022A134124$ASTRAZENECA$$22591$DY$$M$Y$52$KG$20240808$$CN$CO$
241877211$24187721$1$I$$20201119$20240808$20240808$EXP$$AU-AstraZeneca-2020SF55105$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$AU$
241877221$24187722$1$I$$20240806$20240808$20240808$EXP$$US-SANDOZ INC.-SDZ2024US071027$SANDOZ$$$$$M$Y$$$20240808$$CN$US$US
241877231$24187723$1$I$20240730$20240731$20240808$20240808$EXP$$DE-ALXN-202407EEA002121DE$ALEXION PHARMACEUTICALS$$61$YR$$F$Y$$$20240808$$MD$DE$DE
241877241$24187724$1$I$20200604$20240805$20240808$20240808$EXP$PL-URPL-1-1551-2020$PL-SA-2024SA231210$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240808$$MD$PL$PL
241877251$24187725$1$I$$20210730$20240808$20240808$EXP$$CA-AstraZeneca-2021A645940$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$CA$
241877261$24187726$1$I$$20240801$20240808$20240808$PER$$US-ALXN-202408USA000053US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240808$$CN$US$US
241877271$24187727$1$I$20240717$20240730$20240808$20240808$EXP$$CN-ROCHE-10000043028$ROCHE$$63$YR$A$M$Y$67$KG$20240808$$HP$CN$CN
241877282$24187728$2$F$$20240823$20240808$20240902$30DAY$$US-GSK-US2024094874$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$CN$US$US
241877291$24187729$1$I$$20240805$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044476$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240808$$CN$US$US
241877301$24187730$1$I$20240101$20240730$20240808$20240808$PER$$US-TEVA-VS-3228700$TEVA$$$$$M$Y$$$20240808$$CN$US$US
241877313$24187731$3$F$20231201$20240813$20240808$20240821$EXP$$CA-CELLTRION INC.-2023CA025711$CELLTRION$$$$$$Y$$$20240821$$CN$CA$CA
241877331$24187733$1$I$20240101$20240807$20240808$20240808$PER$$US-AMGEN-USASP2024157522$AMGEN$$65$YR$E$M$Y$$$20240808$$CN$US$US
241877342$24187734$2$F$20240804$20240808$20240808$20240812$PER$$US-AMGEN-USASP2024157149$AMGEN$$58$YR$A$F$Y$$$20240812$$CN$US$US
241877352$24187735$2$F$20240807$20240813$20240808$20240822$PER$$US-AMGEN-USASP2024156692$AMGEN$$52$YR$A$F$Y$$$20240822$$CN$US$US
241877361$24187736$1$I$$20240725$20240808$20240808$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-110497$ZYDUS PHARM$Pathania S, Rai A, Kumar S, Tyagi V, Agrawal T, Suvirya S.. Inadvertent intra-arterial injection: Cutaneous complications and management.. Indian-J-Dermatol-Venereol-Leprol. 2024;90(4):496-498$$$$$Y$$$20240808$$HP$IN$IN
241877371$24187737$1$I$$20240805$20240808$20240808$EXP$$PT-HALEON-2190717$Haleon PLC$Vasconcelos AL, Da Silva LN, Ferreira PC, Pinto  RR, Monteiro M, Ara?jo R.. S?ndrome  serotonin?rgico: uma longa lista de agentes  causais.. Medicina Interna. 2024;30(Sup 1 ):279$80$YR$$F$Y$$$20240808$$MD$PT$PT
241877381$24187738$1$I$$20240730$20240808$20240808$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005651$BIOCON$$$$$$Y$$$20240808$$HP$CA$CA
241877391$24187739$1$I$$20240726$20240808$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-038979$AUROBINDO$$40$YR$$F$Y$$$20240808$$HP$CA$CA
241877421$24187742$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA230814$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240808$$HP$US$US
241877431$24187743$1$I$20240506$20240806$20240808$20240808$30DAY$$US-SANDOZ INC.-SDZ2024US071023$SANDOZ$$75$YR$$F$Y$$$20240808$$HP$US$US
241877441$24187744$1$I$$20240807$20240808$20240808$30DAY$$US-SANDOZ INC.-SDZ2024US071346$SANDOZ$$$$$F$Y$$$20240808$$CN$US$US
241877451$24187745$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA195897$SANOFI AVENTIS$$59$YR$A$F$Y$58$KG$20240808$$MD$US$US
241877461$24187746$1$I$$20240729$20240808$20240808$EXP$$MY-STERISCIENCE B.V.-2024-ST-001143$Steriscience PTE$Nee TS, Shuan CT, Nurliyana W, Karunakan R, Sulaiman H.. A synergy test to assess the activity of the Ceftazidime-Avibactam and Aztreonam combination: An experience from a single centre in Malaysia.. Open-Forum-Infect-Dis. 2023;10 (Suppl.):S1242$69$YR$$M$Y$$$20240808$$HP$MY$MY
241877472$24187747$2$F$20240710$20240731$20240808$20240812$EXP$$CO-BIOVITRUM-2024-CO-010714$BIOVITRUM$$262$DY$$F$Y$$$20240812$$CN$CO$CO
241877481$24187748$1$I$$20240802$20240808$20240808$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00406$VELOXIS PHARMACEUTICALS$Bae E K, Chandran M M, Everitt M D, Benz E, Bock M.. LCP-tacrolimus extended-release (Envarsus XR) use in adolescent and young adult solid organ transplant recipients.. Clinical Transplantation. 2024;38:e15417:1-7$19$YR$$M$Y$$$20240808$$HP$US$US
241877491$24187749$1$I$20240725$20240729$20240808$20240808$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095197$VIIV$$46$YR$$F$Y$$$20240808$$HP$US$US
241877501$24187750$1$I$$20240801$20240808$20240808$EXP$$US-CHIESI-2024CHF04800$CHIESI$$$$$$Y$$$20240808$$MD$US$US
241877513$24187751$3$F$20231108$20240910$20240808$20240917$EXP$$CA-GSK-CA2023165125$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$CA$CA
241877521$24187752$1$I$$20240801$20240808$20240808$EXP$$US-JNJFOC-20240809503$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241877531$24187753$1$I$$20240729$20240808$20240808$EXP$$US-AMGEN-USASP2024154273$AMGEN$Laches R.; Hall R.J.; Chaffin J. et al.. Omission of etoposide in the treatment of haemophagocytic lymphohistiocytosis secondary to primary central nervous system lymphoma with satisfactory response. BMJ Case Reports. 2024;17 (7):1-5$$$A$F$Y$$$20240808$$HP$US$US
241877541$24187754$1$I$$20240716$20240808$20240808$PER$$US-JNJFOC-20240747133$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241877551$24187755$1$I$$20240801$20240808$20240808$EXP$$NVSC2024US158229$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241877581$24187758$1$I$$20240806$20240808$20240808$EXP$$NVSJ2024JP009490$NOVARTIS$$$$$$Y$$$20240808$$PH$JP$JP
241877591$24187759$1$I$$20240730$20240808$20240808$30DAY$$US-GSK-US2024AMR095636$GLAXOSMITHKLINE$$$$$M$Y$$$20240808$$CN$US$US
241877611$24187761$1$I$$20240729$20240808$20240808$EXP$$CN-ROCHE-10000040657$ROCHE$$33$YR$A$F$Y$$$20240808$$CN$CN$CN
241877621$24187762$1$I$$20240805$20240808$20240808$PER$$US-ROCHE-10000049934$ROCHE$$$$$$Y$$$20240808$$CN$US$US
241877631$24187763$1$I$$20240806$20240808$20240808$30DAY$$US-UCBSA-2024032988$UCB$$$$$F$Y$$$20240808$$CN$US$US
241877641$24187764$1$I$$20240729$20240808$20240808$EXP$$US-MYLANLABS-2024M1071995$MYLAN$Daccache A, Albright J, Malmberg M, Braun J, Lemley K. Intracranial Hypertension as an Initial Sign of Adrenal Insufficiency Secondary to Inhaled Corticosteroids in a Child With Asthma. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.$7$YR$$F$Y$$$20240808$$HP$US$US
241877651$24187765$1$I$$20240729$20240808$20240808$EXP$$US-MYLANLABS-2024M1072108$MYLAN$Abdelsalam M, Sleem M, Islam A. High dose dexamethasone for edema associated with brain tumor leading to acute sigmoid diverticular perforation. Am-J-Med-Sci 2024; 367 (Suppl.) S41.$65$YR$$F$Y$$$20240808$$HP$US$US
241877661$24187766$1$I$$20240729$20240808$20240808$EXP$$JP-MYLANLABS-2024M1072685$MYLAN$Kakeshita K, Imamura T, Noguchi A, Murai S, Fujioka H, Yamazaki H, et al. Nephrotic syndrome induced by aortic regurgitation with Takayasu arteritis: an autopsy case with long-term clinical follow-up. CEN-Case-Rep 2023; 13 154-160.. 2023;13:154-160$$$A$F$Y$$$20240808$$HP$JP$JP
241877671$24187767$1$I$$20240729$20240808$20240808$EXP$$JP-MYE-2024M1072694AA$MYLAN$Kondo S, Kurihara M, Higashihara M, Hara M, Nishina Y, Iwakiri R, et al. Successful treatment with reduced oral steroid dosage in an 81-year-old woman with statin-induced anti-HMGCR immune-mediated necrotizing myopathy. Geriatr-Gerontol-Int 2024; 24 (7): 739-742.. 2024;24 (7):739-742$81$YR$$F$Y$$$20240808$$HP$JP$JP
241877681$24187768$1$I$$20240729$20240808$20240808$EXP$$US-MYLANLABS-2024M1072805$MYLAN$Das S, Ailawadhi S, Sher T, Roy V, Fernandez A, Parrondo RD. Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety. Curr-Oncol 2023; 30 9627-9633.$33$YR$$M$Y$$$20240808$$HP$US$US
241877691$24187769$1$I$20240730$20240731$20240808$20240808$EXP$$BR-RDY-SPO/BRA/24/0011320$DR REDDYS$$75$YR$E$M$Y$$$20240808$$PH$BR$BR
241877711$24187771$1$I$$20240729$20240808$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-039468$AUROBINDO$$52$YR$$F$Y$50$KG$20240808$$HP$CA$CA
241877722$24187772$2$F$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683410$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241877732$24187773$2$F$$20240809$20240808$20240815$EXP$$JP-CELLTRION INC.-2024JP018822$CELLTRION$Matono R, Takurou K, Yasui D. EP-0626 Two cases in which tumor lysis syndrome developed after chemotherapy for advanced breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;334$$$$$Y$$$20240815$$MD$JP$JP
241877741$24187774$1$I$$20240729$20240808$20240808$EXP$$JP-ROCHE-10000048480$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$54$YR$A$M$Y$$$20240808$$HP$JP$JP
241877751$24187775$1$I$$20240730$20240808$20240808$EXP$$US-SP-2024-38992815$SUNNY PHARMTECH$Literature reference: Beckham AJ et. al. Robotic-assisted evacuation of retained placenta in a patient with a fibroid uterus. Am J Obstet Gynecol. 2024 Jul 9:S0002-9378(24)00748-8. doi: 10.1016/j.ajog.2024.07.005.$30$YR$$F$Y$$$20240808$$MD$US$US
241877762$24187776$2$F$20240801$20240906$20240808$20240913$30DAY$$AR-JNJFOC-20240809995$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$AR$AR
241877771$24187777$1$I$20240606$20240730$20240808$20240808$EXP$FR-AFSSAPS-LY2024001033$FR-TEVA-VS-3228386$TEVA$$79$YR$$M$Y$84$KG$20240808$$PH$FR$FR
241877781$24187778$1$I$$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038836$AUROBINDO$Lacampagne T, Guillotin V, Peuchant O, Belloir A, Sibon I, Bebear C, et al.. Current Mycoplasma pneumoniae outbreak: Don^t forget its role in Bickerstaff encephalitis. Diagn-Microbiol-Infect-Dis. 2024;110No:1$16$YR$$M$Y$$$20240808$$HP$FR$FR
241877792$24187779$2$F$20180201$20240918$20240808$20240919$PER$$US-GILEAD-2024-0683408$GILEAD$$53$YR$A$M$Y$$$20240919$$LW$US$US
241877801$24187780$1$I$20240712$20240725$20240808$20240808$EXP$GB-MHRA-MED-202407251503395980-STHPD$GB-GLENMARK PHARMACEUTICALS-2024GMK092880$GLENMARK$$$$$$Y$$$20240808$$CN$GB$GB
241877811$24187781$1$I$20240709$20240731$20240808$20240808$EXP$ES-AEMPS-1552166$ES-TEVA-VS-3228731$TEVA$$79$YR$$F$Y$$$20240808$$MD$ES$ES
241877821$24187782$1$I$20230101$20240802$20240808$20240808$PER$$US-AMGEN-USASP2024154716$AMGEN$$90$YR$E$M$Y$$$20240808$$MD$US$US
241877842$24187784$2$F$20240806$20240829$20240808$20240902$PER$$US-AMGEN-USASP2024157157$AMGEN$$68$YR$E$M$Y$$$20240902$$CN$US$US
241877851$24187785$1$I$$20240731$20240808$20240808$EXP$$IN-AstraZeneca-2024A174429$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$IN$
241877861$24187786$1$I$20240711$20240806$20240808$20240808$EXP$$CN-HALEON-2190694$Haleon PLC$$61$YR$$M$Y$65$KG$20240808$$HP$CN$CN
241877871$24187787$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A178038$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241877881$24187788$1$I$$20230829$20240808$20240808$EXP$$US-AstraZeneca-2023A162442$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241877891$24187789$1$I$$20230306$20240808$20240808$EXP$$IE-AstraZeneca-2021A008386$ASTRAZENECA$$$$$F$Y$$$20240808$$HP$IE$
241877901$24187790$1$I$$20230228$20240808$20240808$EXP$$US-AstraZeneca-2023A050512$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241877914$24187791$4$F$$20240913$20240808$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-037821$AUROBINDO$Kopernicka G, Chew J. Acute urinary retention and constipation caused by multi-dermatomal herpes zoster in an immunosuppressed patient.. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24$71$YR$$F$Y$$$20240926$$MD$GB$GB
241877921$24187792$1$I$$20220525$20240808$20240808$EXP$$US-AstraZeneca-2022A199539$ASTRAZENECA$$$$$$Y$78$KG$20240808$$CN$US$
241877931$24187793$1$I$20211001$20220314$20240808$20240808$EXP$$US-AstraZeneca-2022A114381$ASTRAZENECA$$805$MON$$F$Y$$$20240808$$CN$US$
241877941$24187794$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004197$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240808$$CN$US$US
241877951$24187795$1$I$20240601$20240802$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004110$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240808$$CN$US$US
241877961$24187796$1$I$$20240730$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407019899$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$US$US
241877971$24187797$1$I$$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004694$ELI LILLY AND CO$$$$$$Y$$$20240808$$MD$US$US
241877991$24187799$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004053$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240808$$CN$US$US
241878001$24187800$1$I$20240729$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004089$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240808$$PH$US$US
241878011$24187801$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003279$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240808$$CN$US$US
241878031$24187803$1$I$20240806$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004439$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240808$$CN$US$US
241878041$24187804$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003798$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240808$$CN$US$US
241878051$24187805$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004139$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240808$$HP$US$US
241878061$24187806$1$I$$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004791$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240808$$CN$US$US
241878071$24187807$1$I$20240806$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003946$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240808$$CN$US$US
241878081$24187808$1$I$20240730$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003934$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240808$$CN$US$US
241878091$24187809$1$I$20240701$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004233$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240808$$CN$US$US
241878101$24187810$1$I$20240805$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003281$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240808$$CN$US$US
241878111$24187811$1$I$20240801$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004841$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240808$$CN$US$US
241878121$24187812$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003830$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$US$US
241878131$24187813$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004133$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240808$$CN$US$US
241878141$24187814$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003975$ELI LILLY AND CO$$43$YR$A$$Y$$$20240808$$LW$US$US
241878151$24187815$1$I$20240701$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003647$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240808$$CN$US$US
241878161$24187816$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003870$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240808$$CN$US$US
241878181$24187818$1$I$$20240717$20240808$20240808$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15271$IPSEN$$$$$F$Y$$$20240808$$CN$US$US
241878201$24187820$1$I$20190301$20240805$20240808$20240808$PER$$US-BIOGEN-2019BI00721427$BIOGEN$$33$YR$$F$Y$$$20240808$$CN$US$US
241878221$24187822$1$I$20240101$20240804$20240808$20240808$EXP$$IE-MYLANLABS-2024M1072749$MYLAN$$$$$M$Y$$$20240808$$PH$IE$IE
241878231$24187823$1$I$$20240729$20240808$20240808$EXP$$NO-AUROBINDO-AUR-APL-2024-038481$AUROBINDO$Wenche Rodseth B, Hege-Merete K, Lisbeth Solem M, Harald A, John-Petter J, and Lars S.. A Wolf in Sheep?s Clothing. Journal of Analytical Toxicology. 2018;1-2$27$YR$$M$Y$$$20240808$$HP$NO$NO
241878241$24187824$1$I$20240701$20240725$20240808$20240808$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01239$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240808$$HP$US$US
241878251$24187825$1$I$$20240725$20240808$20240808$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01233$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240808$$HP$US$US
241878271$24187827$1$I$$20240730$20240808$20240808$EXP$US-MLMSERVICE-20240723-PI140518-00200-1$US-STRIDES ARCOLAB LIMITED-2024SP009818$STRIDES$Bally K, Trusty R, Naher K. A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone.. Cureus. 2024;16(6):e62695$95$YR$$F$Y$$$20240808$$MD$US$US
241878281$24187828$1$I$$20240802$20240808$20240808$EXP$$US-ROCHE-10000049903$ROCHE$$33$YR$A$M$Y$$$20240808$$CN$US$US
241878321$24187832$1$I$20240728$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125081$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240808$$CN$US$US
241878331$24187833$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124939$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$HP$US$US
241878352$24187835$2$F$20240101$20240828$20240808$20240911$PER$$US-SA-2024SA228248$SANOFI AVENTIS$$20$YR$A$M$Y$92.971$KG$20240911$$MD$US$US
241878361$24187836$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA231158$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240808$$MD$US$US
241878371$24187837$1$I$20240101$20240801$20240808$20240808$PER$$US-SA-2024SA231583$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240808$$MD$US$US
241878381$24187838$1$I$$20240718$20240808$20240808$PER$$US-BEH-2024176157$CSL BEHRING$$51$YR$A$M$Y$$$20240808$$HP$US$US
241878391$24187839$1$I$$20240730$20240808$20240808$EXP$$JP-ROCHE-10000049670$ROCHE$$6$DEC$A$$Y$$$20240808$$MD$JP$JP
241878402$24187840$2$F$20240701$20240729$20240808$20240812$EXP$$AU-ROCHE-10000040490$ROCHE$$23$YR$A$M$Y$$$20240812$$HP$AU$AU
241878411$24187841$1$I$$20240806$20240808$20240808$PER$$US-ABBVIE-5870275$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241878422$24187842$2$F$$20240809$20240808$20240820$EXP$$PL-AUROBINDO-AUR-APL-2024-038679$AUROBINDO$$21$YR$$M$Y$75$KG$20240820$$MD$PL$PL
241878431$24187843$1$I$$20240731$20240808$20240808$PER$$US-ABBVIE-5863378$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241878451$24187845$1$I$20240717$20240805$20240808$20240808$EXP$$AR-BIOGEN-2024BI01277225$BIOGEN$$47$YR$$M$Y$$$20240808$$CN$AR$AR
241878462$24187846$2$F$$20240807$20240808$20240812$PER$$US-BIOGEN-2024BI01276889$BIOGEN$$$$$M$Y$$$20240812$$CN$US$US
241878471$24187847$1$I$$20240802$20240808$20240808$EXP$$US-BIOGEN-2024BI01276876$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241878491$24187849$1$I$$20240729$20240808$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-039465$AUROBINDO$$81$YR$$F$Y$72$KG$20240808$$CN$CA$CA
241878511$24187851$1$I$20240712$20240729$20240808$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-038652$AUROBINDO$$49$YR$$F$Y$50$KG$20240808$$MD$PT$PT
241878521$24187852$1$I$$20240729$20240808$20240808$EXP$$IT-AUROBINDO-AUR-APL-2024-038524$AUROBINDO$Di Renzo N, Dargenio NM, Sgherza N, Federico PV, Fina MP, Matera R, et al.. REAL-WORLD DATA WITH LENALIDOMIDE AS MAINTENANCE THERAPY FOR PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: THE EXPERIENCE OF THE RETE EMATOLOGICA PUGLIESE (REP).. Haematologica. 2024;109:26-27$$$$$Y$$$20240808$$HP$IT$IT
241878542$24187854$2$F$20240720$20240813$20240808$20240816$EXP$DE-BFARM-24005464$DE-ORGANON-O2408DEU000437$ORGANON$$73$YR$$M$Y$91$KG$20240816$$MD$DE$DE
241878552$24187855$2$F$20240803$20240910$20240808$20240911$PER$$US-JNJFOC-20240810111$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240911$$CN$US$US
241878561$24187856$1$I$20240101$20240802$20240808$20240808$EXP$$BR-JNJFOC-20240811195$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240808$$CN$BR$BR
241878581$24187858$1$I$$20240725$20240808$20240808$EXP$$SY-MEDEXUS PHARMA, INC.-2024MED00328$MEDEXUS PHARMA$Aldrea F, Klib M, Jalal S, Najak A, Aji W.. Case report: Methotrexate^s role as a potential inducer of macrophage activation syndrome in Still^s disease.. Int J Rheum Dis.. 2024;27(5):e15183$26$YR$$F$Y$$$20240808$$HP$SY$SY
241878591$24187859$1$I$$20240711$20240808$20240808$30DAY$$US-VEROBIOTECH-2024USVEROSPO00165$VERO BIOTECH$$$$$$Y$$$20240808$$CN$US$US
241878601$24187860$1$I$$20240801$20240808$20240808$EXP$$US-AMGEN-USASP2024153371$AMGEN$Shah N.N.; Lambe A.J.; Kovach A.E.. How I treat post-immunotherapy relapsed B-ALL. Blood. 2024;1-24$21$YR$A$$Y$$$20240808$$HP$US$US
241878612$24187861$2$F$20240626$20240919$20240808$20240924$EXP$$DE-BAYER-2024A109637$BAYER$$72$YR$E$M$Y$100$KG$20240924$$MD$DE$DE
241878622$24187862$2$F$$20240829$20240808$20240906$EXP$$US-AMGEN-USASP2024153233$AMGEN$$68$YR$E$M$Y$$$20240905$$LW$US$US
241878632$24187863$2$F$$20240729$20240808$20240808$EXP$CA-MHPD-E2B_07183866$CA-Accord-439178$ACCORD$$73$YR$E$M$Y$$$20240808$$CN$CA$CA
241878641$24187864$1$I$$20240728$20240808$20240808$EXP$AU-TGA-809291$AU-Accord-438685$ACCORD$$$$$M$Y$$$20240808$$HP$AU$AU
241878651$24187865$1$I$$20240728$20240808$20240808$EXP$AU-TGA-810595$AU-Accord-438688$ACCORD$$85$YR$E$F$Y$$$20240808$$HP$AU$AU
241878671$24187867$1$I$20240614$20240805$20240808$20240808$EXP$GB-MHRA-MED-202408051235400280-NKCHF$GB-MYLANLABS-2024M1072991$MYLAN$$56$YR$$F$Y$$$20240808$$PH$GB$GB
241878681$24187868$1$I$$20240729$20240808$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-038830$AUROBINDO$Sahly AN, Sierra-Marquez J, Bungert-Plumke S, Franzen A, Mougharbel L, Berrahmoune S, et al. Genotype-phenotype correlation in CLCN4-related developmental and epileptic encephalopathy. Hum-Genet. 2024;143:667-681$$$$M$Y$$$20240808$$HP$CA$CA
241878691$24187869$1$I$20240724$20240806$20240808$20240808$EXP$GB-MHRA-MED-202408060826128380-YSHNW$GB-MYLANLABS-2024M1073614$MYLAN$$37$YR$$F$Y$$$20240808$$HP$GB$GB
241878701$24187870$1$I$$20240731$20240808$20240808$EXP$$CO-MYLANLABS-2024M1072866$MYLAN$Buendia ME, Duenas-Meza EM, Valderrama MA, Mendez M, Baron Puentes OU, Pulido SA, et al. Initiation of Triple Therapy in a Pediatric Patient Diagnosed With Severe Pulmonary Hypertension. A Case Report. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A6205.$10$YR$$F$Y$$$20240808$$HP$CO$CO
241878711$24187871$1$I$$20240729$20240808$20240808$EXP$CA-MHPD-E2B_001093719$CA-Accord-439249$ACCORD$$3$YR$C$M$Y$$$20240808$$HP$CA$CA
241878721$24187872$1$I$20240113$20240807$20240808$20240808$EXP$GB-MHRA-MIDB-fadd5e0d-e13f-46d0-b5ec-a270925b4c91$GB-MYLANLABS-2024M1069120$MYLAN$$41$YR$$M$Y$$$20240808$$PH$GB$GB
241878731$24187873$1$I$20240501$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024156884$AMGEN$$22$YR$A$F$Y$$$20240808$$CN$US$US
241878741$24187874$1$I$20240228$20240228$20240808$20240808$PER$$US-Techdow-2024Techdow000090$SHENZHEN TECHDOW PHARMACEUTICAL$$$$$$Y$$$20240806$$PH$US$US
241878751$24187875$1$I$$20231122$20240808$20240808$PER$$US-Techdow-2023Techdow000269$SHENZHEN TECHDOW PHARMACEUTICAL$$$$$$Y$75$KG$20240807$$PH$US$US
241878761$24187876$1$I$$20240730$20240808$20240808$EXP$$GB-Accord-439390$ACCORD$$$$E$M$Y$$$20240808$$CN$GB$GB
241878771$24187877$1$I$20240726$20240729$20240808$20240808$EXP$$US-Accord-439162$ACCORD$$58$YR$A$M$Y$$$20240808$$HP$US$US
241878782$24187878$2$F$20240716$20240812$20240808$20240823$EXP$$CN-Accord-440305$ACCORD$$62$YR$A$F$Y$64$KG$20240823$$MD$CN$CN
241878791$24187879$1$I$20240701$20240731$20240808$20240808$PER$$US-ABBVIE-5862800$ABBVIE$$$$$F$Y$$$20240808$$HP$US$US
241878801$24187880$1$I$20240723$20240802$20240808$20240808$EXP$$SG-JNJFOC-20240813404$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240808$$HP$SG$SG
241878811$24187881$1$I$$20240801$20240808$20240808$EXP$$GB-JNJFOC-20240780512$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$HP$GB$GB
241878831$24187883$1$I$20240731$20240806$20240808$20240808$EXP$$CN-ROCHE-10000050432$ROCHE$$65$YR$E$F$Y$51$KG$20240808$$HP$CN$CN
241878841$24187884$1$I$$20240801$20240808$20240808$EXP$$US-BIOGEN-2024BI01276908$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241878941$24187894$1$I$$20231016$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66438$HIKMA$$54$YR$$F$Y$$$20240808$$CN$US$US
241878951$24187895$1$I$20240306$20240806$20240808$20240808$EXP$$CA-GSK-CA2024098052$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$MD$CA$CA
241878961$24187896$1$I$20170101$20240806$20240808$20240808$EXP$$US-ABBVIE-5870585$ABBVIE$$$$$F$Y$78.017$KG$20240808$$CN$US$US
241878971$24187897$1$I$$20240729$20240808$20240808$EXP$$US-MACLEODS PHARMA-MAC2024048621$MACLEODS$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J..Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure.Journal of Neonatal-Perinatal Medicine.23-JUL-2024;1-6$$$$$Y$$$20240808$$MD$US$US
241878981$24187898$1$I$$20240729$20240808$20240808$EXP$$US-MACLEODS PHARMA-MAC2024048624$MACLEODS$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J..Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure.Journal of Neonatal-Perinatal Medicine.2024$$$$$Y$$$20240808$$MD$US$US
241878991$24187899$1$I$$20240729$20240808$20240808$EXP$$US-MACLEODS PHARMA-MAC2024048622$MACLEODS$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J..Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure..Journal of Neonatal-Perinatal Medicine.2024;1-6.$$$$$Y$$$20240808$$MD$US$US
241879002$24187900$2$F$$20240805$20240808$20240816$EXP$$FR-MACLEODS PHARMA-MAC2024048617$MACLEODS$Chouchana M, Pinel S, Colboc H, Soria A, Buard G, Delage C. et. al.Donepezil as a safe alternative treatment after maculo-papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data.Psychogeriatrics.2024$$$$$Y$$$20240816$$MD$FR$FR
241879011$24187901$1$I$20240101$20240731$20240808$20240808$PER$$US-UNITED THERAPEUTICS-UNT-2024-005395$UNITED THERAPEUTICS$$$$$M$Y$131.52$KG$20240808$$$US$US
241879021$24187902$1$I$$20240729$20240808$20240808$EXP$$ZA-MACLEODS PHARMA-MAC2024048592$MACLEODS$$$$$$Y$$$20240808$$CN$ZA$ZA
241879031$24187903$1$I$$20240729$20240808$20240808$EXP$$US-MACLEODS PHARMA-MAC2024048625$MACLEODS$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure.Journal of Neonatal-Perinatal Medicine:.2024$$$$$Y$$$20240808$$MD$US$US
241879041$24187904$1$I$$20240729$20240808$20240808$EXP$$US-MACLEODS PHARMA-MAC2024048620$MACLEODS$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J..Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure.Journal of Neonatal-Perinatal Medicine.23 JUL 2024$$$$$Y$$$20240808$$MD$US$US
241879051$24187905$1$I$20240727$20240727$20240808$20240808$EXP$GB-MHRA-MED-202407270917104810-QPYZV$GB-MACLEODS PHARMA-MAC2024048644$MACLEODS$$$$$$Y$$$20240808$$MD$GB$GB
241879061$24187906$1$I$$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124041$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240808$$CN$US$US
241879071$24187907$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125090$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$64.86$KG$20240808$$CN$US$US
241879081$24187908$1$I$20240701$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123522$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$55.79$KG$20240808$$HP$US$US
241879091$24187909$1$I$$20240711$20240808$20240808$PER$$US-009507513-2407USA008115$MERCK$Arosemena A, Tanaka G, Boese E, Huang M, Mardelli M, Krishna R, et al. Open-angle glaucoma and Fuchs dystrophy. Journal of Cataract and Refractive Surgery. 2024;50(7):777-84$62$YR$$F$Y$$$20240808$$MD$US$US
241879101$24187910$1$I$$20240725$20240808$20240808$EXP$$US-BEH-2024176526$CSL BEHRING$$$$E$M$Y$94.331$KG$20240808$$HP$US$US
241879111$24187911$1$I$$20240729$20240808$20240808$EXP$$AU-LUPIN EUROPE GMBH-2024-07588$LUPIN$$$$$M$Y$$$20240808$$CN$AU$AU
241879122$24187912$2$F$$20240812$20240808$20240822$EXP$$ES-TEVA-VS-3228687$TEVA$Lizondo Lopez T, Font I Barcelo A, Garcia Gutierrez C, Blasco M, Grafia I, Bastida C, et al. Clopidogrel-induced thrombotic microangiopathy: A case report. Eur-J-Hosp-Pharm 2024; 0 (0): no pagination; Lizondo Lopez T, Font I Barcelo A, Garcia Gutierrez C, Blasco M, Grafia I, Bastida C, et al. Clopidogrel-induced thrombotic microangiopathy: A case report. Eur-J-Hosp-Pharm 2024; 0 (0): no pagination.; Lizondo Lopez T, Font I Barcelo A, Garcia Gutierrez C, Blasco M, Grafia I, Bastida C, et al. C...$75$YR$$M$Y$$$20240822$$HP$ES$ES
241879141$24187914$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA232630$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240808$$MD$US$US
241879151$24187915$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231649$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240808$$MD$US$US
241879161$24187916$1$I$20240701$20240730$20240808$20240808$PER$$US-SA-2024SA232351$SANOFI AVENTIS$$69$YR$E$M$Y$90.7$KG$20240808$$MD$US$US
241879171$24187917$1$I$$20230928$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65758$HIKMA$$$$$M$Y$$$20240808$$CN$US$US
241879181$24187918$1$I$20240101$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155527$AMGEN$$$$$F$Y$$$20240808$$CN$US$US
241879191$24187919$1$I$$20231127$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67828$HIKMA$$$$$M$Y$$$20240808$$CN$US$US
241879201$24187920$1$I$$20240806$20240808$20240808$EXP$$US-TAKEDA-2024TUS019234$TAKEDA$$$$$M$Y$56$KG$20240808$$HP$US$US
241879211$24187921$1$I$$20240802$20240808$20240808$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00401$VELOXIS PHARMACEUTICALS$Bae E K, Chandran M M, Everitt M D, Benz E, Bock M.. LCP-tacrolimus extended-release (Envarsus XR) use in adolescent and young adult solid organ transplant recipients.. Clinical Transplantation. 2024;38:e15417:1-7$15$YR$$M$Y$$$20240808$$HP$US$US
241879221$24187922$1$I$$20221212$20240808$20240808$EXP$$IN-AstraZeneca-2022A407749$ASTRAZENECA$$55$YR$$F$Y$$$20240808$$CN$IN$
241879231$24187923$1$I$20240701$20240802$20240808$20240808$PER$$US-SA-2024SA230955$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240808$$HP$US$US
241879242$24187924$2$F$20231101$20240802$20240808$20240813$PER$$US-SA-2024SA231797$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240814$$CN$US$US
241879252$24187925$2$F$20240730$20240822$20240808$20240906$PER$$US-SA-2024SA229611$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240906$$CN$US$US
241879261$24187926$1$I$20211201$20240803$20240808$20240808$PER$$US-SA-2024SA233982$SANOFI AVENTIS$$59$YR$A$M$Y$40.36$KG$20240808$$CN$US$US
241879271$24187927$1$I$$20240803$20240808$20240808$PER$$US-SA-2024SA233094$SANOFI AVENTIS$$$$$M$Y$$$20240808$$CN$US$US
241879291$24187929$1$I$20240720$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038557$AUROBINDO$$68$YR$$F$Y$45$KG$20240808$$MD$FR$FR
241879301$24187930$1$I$$20211227$20240808$20240808$EXP$$US-AstraZeneca-2021A904901$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241879311$24187931$1$I$$20231117$20240808$20240808$EXP$$US-AstraZeneca-2023A263508$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241879321$24187932$1$I$20191209$20191230$20240808$20240808$EXP$$CO-AstraZeneca-2020SE00392$ASTRAZENECA$$29881$DY$$M$Y$$$20240808$$CN$CO$
241879331$24187933$1$I$$20220314$20240808$20240808$EXP$$US-AstraZeneca-2022A114394$ASTRAZENECA$$$$$F$Y$90.7$KG$20240808$$CN$US$
241879341$24187934$1$I$$20230925$20240808$20240808$EXP$$US-AstraZeneca-2023A220578$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241879351$24187935$1$I$$20230105$20240808$20240808$EXP$$US-AstraZeneca-2023A004133$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241879361$24187936$1$I$$20240424$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03695$HIKMA$$$$$F$Y$$$20240808$$CN$US$US
241879381$24187938$1$I$20230223$20240802$20240808$20240808$EXP$$BR-TAKEDA-2023TUS027552$TAKEDA$$45$YR$$F$Y$$$20240808$$CN$BR$BR
241879401$24187940$1$I$$20240805$20240808$20240808$EXP$GB-MHRA-MED-202408051501385540-PMWCN$GB-HALEON-2190631$Haleon PLC$$$$$M$Y$$$20240808$$MD$GB$GB
241879411$24187941$1$I$$20240510$20240807$20240807$DIR$FDA-CDER-CTU-2024-54391$$FDA-CTU$$$$$$N$$$20240510$N$HP$US$
241879421$24187942$1$I$$20240515$20240807$20240807$DIR$FDA-CDER-CTU-2024-54398$$FDA-CTU$$$$$$N$$$20240515$N$PH$US$
241879431$24187943$1$I$$20240806$20240808$20240808$PER$$US-HALEON-2190738$Haleon PLC$$74$YR$$$Y$$$20240808$$CN$US$US
241879441$24187944$1$I$20240806$20240807$20240808$20240808$PER$$US-AMGEN-USASP2024157241$AMGEN$$$$$M$Y$$$20240808$$CN$US$US
241879452$24187945$2$F$20240723$20240805$20240808$20240814$EXP$$PL-BAYER-2024A113252$BAYER$$$$$F$Y$$$20240814$$MD$PL$PL
241879461$24187946$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125052$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240808$$CN$US$US
241879471$24187947$1$I$20231001$20240805$20240808$20240808$EXP$$AU-TAKEDA-2023TUS096380$TAKEDA$$44$YR$$F$Y$$$20240808$$CN$AU$AU
241879481$24187948$1$I$$20240801$20240808$20240808$PER$$US-ALXN-202408USA000042US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$HP$US$US
241879492$24187949$2$F$20240501$20240819$20240808$20240826$EXP$$GB-JNJFOC-20240575139$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240826$$CN$GB$GB
241879501$24187950$1$I$$20231005$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS-US-H14001-23-65908$HIKMA$$$$$$Y$$$20240808$$CN$US$US
241879511$24187951$1$I$$20231016$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66437$HIKMA$$$$$$Y$$$20240808$$HP$US$US
241879521$24187952$1$I$$20231204$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2023-078209$AUROBINDO$$$$$F$Y$$$20240808$$CN$US$US
241879531$24187953$1$I$$20230815$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2023-054970$AUROBINDO$$95$YR$$F$Y$46.7$KG$20240808$$CN$US$US
241879541$24187954$1$I$$20231026$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2023-049591$AUROBINDO$$68$YR$$F$Y$54.4$KG$20240808$$CN$US$US
241879551$24187955$1$I$$20230802$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2023-052750$AUROBINDO$$75$YR$$M$Y$97$KG$20240808$$CN$US$US
241879561$24187956$1$I$$20231107$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66597$HIKMA$$$$$$Y$$$20240808$$PH$US$US
241879571$24187957$1$I$$20231125$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2023-062647$AUROBINDO$$56$YR$$F$Y$50$KG$20240808$$CN$US$US
241879581$24187958$1$I$20240731$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003274$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240808$$CN$US$US
241879591$24187959$1$I$20231013$20231106$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS-US-H14001-23-67043$HIKMA$$$$$$Y$$$20240808$$HP$US$US
241879601$24187960$1$I$20240804$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004914$ELI LILLY AND CO$$$$$M$Y$$$20240808$$CN$US$US
241879612$24187961$2$F$$20240830$20240808$20240906$PER$$US-MYLANLABS-2024M1073187$MYLAN$$85$YR$$M$Y$84.82$KG$20240906$$CN$US$US
241879621$24187962$1$I$20240805$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004708$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240808$$CN$US$US
241879631$24187963$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003937$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240808$$CN$US$US
241879641$24187964$1$I$20240723$20240731$20240808$20240808$EXP$FI-FIMEA-202402678$FI-BAYER-2024A110656$BAYER$$38$YR$A$F$Y$$$20240808$$HP$FI$FI
241879651$24187965$1$I$20231209$20231209$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2023-078614$AUROBINDO$$$$$F$Y$$$20240808$$CN$US$US
241879661$24187966$1$I$$20240129$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-002871$AUROBINDO$$73$YR$$F$Y$$$20240808$$CN$US$US
241879671$24187967$1$I$20240122$20240122$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-004534$AUROBINDO$$76$YR$$M$Y$66$KG$20240808$$CN$US$US
241879681$24187968$1$I$$20240122$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-004115$AUROBINDO$$$$$M$Y$$$20240808$$CN$US$US
241879691$24187969$1$I$$20240801$20240808$20240808$EXP$$US-SA-2024SA233375$SANOFI AVENTIS$$$$T$F$Y$$$20240808$$MD$US$US
241879701$24187970$1$I$$20231223$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2023-081710$AUROBINDO$$$$$$Y$$$20240808$$CN$US$US
241879711$24187971$1$I$$20240805$20240808$20240808$EXP$$CA-PFIZER INC-202400231133$PFIZER$$7$DEC$$F$Y$$$20240808$$HP$CA$CA
241879721$24187972$1$I$20240601$20240725$20240808$20240808$EXP$GB-MHRA-MED-202407250739342500-QMYNB$GB-GLENMARK PHARMACEUTICALS-2024GMK092881$GLENMARK$$$$$$Y$$$20240808$$CN$GB$GB
241879731$24187973$1$I$$20240805$20240808$20240808$EXP$$CA-PFIZER INC-202400231120$PFIZER$$$$$F$Y$$$20240808$$HP$CA$CA
241879741$24187974$1$I$20240128$20240220$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-009469$AUROBINDO$$69$YR$$M$Y$81.646$KG$20240808$$CN$US$US
241879751$24187975$1$I$$20240127$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-005140$AUROBINDO$$$$$F$Y$$$20240808$$CN$US$US
241879761$24187976$1$I$$20240320$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-014433$AUROBINDO$$77$YR$$F$Y$$$20240808$$HP$US$US
241879771$24187977$1$I$$20240205$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-006454$AUROBINDO$$$$$F$Y$$$20240808$$MD$US$US
241879781$24187978$1$I$20150101$20240130$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-005768$AUROBINDO$$54$YR$$F$Y$$$20240808$$HP$US$US
241879791$24187979$1$I$$20240103$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS-US-H14001-24-00253$HIKMA$$$$$F$Y$$$20240808$$CN$US$US
241879801$24187980$1$I$$20240102$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00273$HIKMA$$$$$$Y$$$20240808$$CN$US$US
241879812$24187981$2$F$$20240802$20240808$20240808$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009858$STRIDES$Arai M, Kataoka Y, Tsukamoto Y, Ohta-Ogo K.. Giant cell myocarditis attributable to myositis: Therapeutic management under the guidance of serial endomyocardial biopsy - A case report. Eur-Heart-J-Case-Rep. 2024;8 (7)$76$YR$$M$Y$$$20240808$$HP$JP$JP
241879821$24187982$1$I$$20240802$20240808$20240808$EXP$$US-GSK-US2024097040$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
241879831$24187983$1$I$$20240110$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00442$HIKMA$$$$$F$Y$$$20240808$$CN$US$US
241879841$24187984$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231781$SANOFI AVENTIS$$$$A$F$Y$$$20240808$$MD$US$US
241879851$24187985$1$I$20240701$20240730$20240808$20240808$PER$$US-SA-2024SA232350$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240808$$MD$US$US
241879861$24187986$1$I$$20240802$20240808$20240808$PER$$US-SA-2024SA232270$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240808$$HP$US$US
241879871$24187987$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA232127$SANOFI AVENTIS$$$$A$F$Y$67.13$KG$20240808$$MD$US$US
241879881$24187988$1$I$$20240621$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-022586$AUROBINDO$$81$YR$$M$Y$$$20240808$$CN$US$US
241879891$24187989$1$I$$20240429$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-022270$AUROBINDO$$$$$M$Y$$$20240808$$CN$US$US
241879901$24187990$1$I$$20240422$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-021124$AUROBINDO$$$$$M$Y$$$20240808$$CN$US$US
241879911$24187991$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125017$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240808$$MD$US$US
241879921$24187992$1$I$20240509$20240520$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-026113$AUROBINDO$$83$YR$$F$Y$54.4$KG$20240808$$CN$US$US
241879931$24187993$1$I$20240101$20240802$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123769$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240808$$HP$US$US
241879951$24187995$1$I$$20240607$20240808$20240808$PER$$US-AUROBINDO-AUR-APL-2024-029498$AUROBINDO$$74$YR$$F$Y$72.5$KG$20240808$$CN$US$US
241879961$24187996$1$I$20240731$20240731$20240808$20240808$EXP$$US-JNJFOC-20240802123$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$PH$US$US
241879971$24187997$1$I$$20240805$20240808$20240808$EXP$$US-JNJFOC-20240811151$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240808$$CN$US$US
241879981$24187998$1$I$20070101$20240805$20240808$20240808$PER$$US-JNJFOC-20240813305$JOHNSON AND JOHNSON$$3$YR$C$M$Y$$$20240808$$HP$US$US
241879991$24187999$1$I$20211201$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-037893$AUROBINDO$Allami N, O^Connor K, Bagley SM.. A case of severe opioid and methamphetamine use disorder in a 14 year old.  Allami et al. Addiction Science + Clinical Practice. 2024;19:54$14$YR$$F$Y$$$20240808$$HP$US$US
241880002$24188000$2$F$$20240806$20240808$20240817$PER$$US-SA-2024SA211261$SANOFI AVENTIS$$$$$F$Y$$$20240817$$CN$US$US
241880011$24188001$1$I$$20240802$20240808$20240808$PER$$US-SA-2024SA231455$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240808$$HP$US$US
241880021$24188002$1$I$$20240115$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00601$HIKMA$$$$$F$Y$$$20240808$$MD$US$US
241880031$24188003$1$I$$20240805$20240808$20240808$EXP$GB-MYLANLABS-2024M1009582$GB-STRIDES ARCOLAB LIMITED-2024SP009836$STRIDES$$59$YR$$F$Y$$$20240808$$HP$GB$GB
241880041$24188004$1$I$$20240517$20240807$20240807$DIR$FDA-CDER-CTU-2024-54387$$FDA-CTU$$$$$$N$$$20240517$N$HP$US$
241880051$24188005$1$I$$20240517$20240807$20240807$DIR$FDA-CDER-CTU-2024-54386$$FDA-CTU$$$$$$N$$$20240517$N$$US$
241880071$24188007$1$I$$20240118$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00769$HIKMA$$$$$F$Y$$$20240808$$CN$US$US
241880081$24188008$1$I$$20240328$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-02949$HIKMA$$$$$F$Y$$$20240808$$CN$US$US
241880091$24188009$1$I$$20240516$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-04411$HIKMA$$$$$F$Y$$$20240808$$CN$US$US
241880101$24188010$1$I$$20240621$20240808$20240808$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05787$HIKMA$$$$$$Y$$$20240808$$CN$US$US
241880111$24188011$1$I$20240801$20240802$20240808$20240808$PER$$US-AMGEN-USASP2024154529$AMGEN$$69$YR$E$F$Y$$$20240808$$PH$US$US
241880122$24188012$2$F$$20240911$20240808$20240925$EXP$$JP-AMGEN-JPNSP2024156827$AMGEN$$$$$$Y$$$20240925$$PH$JP$JP
241880131$24188013$1$I$20240728$20240805$20240808$20240808$EXP$GB-MHRA-MED-202408010921363440-NPMWC$GB-STRIDES ARCOLAB LIMITED-2024SP009842$STRIDES$$70$YR$$F$Y$117$KG$20240808$$CN$GB$GB
241880141$24188014$1$I$$20240731$20240808$20240808$PER$$US-MYLANLABS-2024M1072823$MYLAN$$$$$M$Y$$$20240808$$CN$US$US
241880161$24188016$1$I$$20240801$20240808$20240808$PER$$US-BEH-2024176765$CSL BEHRING$$$$A$F$Y$$$20240808$$HP$US$US
241880171$24188017$1$I$$20240807$20240808$20240808$PER$$US-HALEON-2190796$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241880181$24188018$1$I$$20240801$20240808$20240808$EXP$$CA-GSK-CA2023163111$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$HP$CA$CA
241880194$24188019$4$F$$20240808$20240808$20240813$PER$$NVSC2024US161218$NOVARTIS$$$$$F$Y$$$20240813$$CN$US$US
241880201$24188020$1$I$$20240515$20240807$20240807$DIR$FDA-CDER-CTU-2024-54397$$FDA-CTU$$$$$$N$$$20240515$N$PH$US$
241880221$24188022$1$I$$20240729$20240808$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-039460$AUROBINDO$$87$YR$$F$Y$80$KG$20240808$$PH$CA$CA
241880231$24188023$1$I$$20240805$20240808$20240808$PER$$US-HALEON-2190933$Haleon PLC$$86$YR$$F$Y$$$20240808$$HP$US$US
241880262$24188026$2$F$20240802$20240903$20240808$20240910$30DAY$$US-AMGEN-USASP2024155827$AMGEN$$48$YR$A$M$Y$83$KG$20240910$$PH$US$US
241880271$24188027$1$I$$20240731$20240808$20240808$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP009841$STRIDES$Patel PS, Krishna A, Singh PP, Bansal SB, Archana.. Histoplasmosis Disguised as Pyrexia of Unknown Origin in Kidney Transplant Recipients: Bone Marrow Biopsy was Key to Diagnosis.. Indian-J-Transplant. 2023;17 (4):453-456$34$YR$$M$Y$$$20240808$$HP$IN$IN
241880281$24188028$1$I$20240101$20240806$20240808$20240808$EXP$$CA-JNJFOC-20240728919$JOHNSON AND JOHNSON$$67$YR$E$M$Y$102$KG$20240808$$HP$CA$CA
241880291$24188029$1$I$$20240728$20240808$20240808$EXP$AU-TGA-808395$AU-Accord-438954$ACCORD$$$$$F$Y$$$20240808$$HP$AU$AU
241880301$24188030$1$I$$20240731$20240808$20240808$PER$$US-ALXN-202407USA002282US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241880311$24188031$1$I$$20240729$20240808$20240808$EXP$CA-MHPD-001088779$CA-Accord-439280$ACCORD$$75$YR$E$M$Y$73$KG$20240808$$HP$CA$CA
241880321$24188032$1$I$20220101$20240730$20240808$20240808$EXP$$CN-Accord-439191$ACCORD$Zhang R, He Y, Liu Y, Li H, Zhao F. Small cell lung carcinoma with KIF5B-RET fusion partially responded to the 4th-line therapy with anlotinib: A case report. World Journal of Clinical Cases. 2024;12(23):5410-5.$65$YR$E$M$Y$$$20240808$$MD$CN$CN
241880331$24188033$1$I$$20240729$20240808$20240808$EXP$NL-LRB-00993349$NL-Accord-439294$ACCORD$$53$YR$A$F$Y$84.5$KG$20240808$$MD$NL$NL
241880341$24188034$1$I$20240726$20240729$20240808$20240808$EXP$$US-Accord-439612$ACCORD$$42$YR$A$M$Y$$$20240808$$MD$US$US
241880351$24188035$1$I$20240710$20240729$20240808$20240808$EXP$$US-Accord-439614$ACCORD$$24$YR$A$F$Y$$$20240808$$MD$US$US
241880361$24188036$1$I$20231227$20240727$20240808$20240808$EXP$FR-AFSSAPS-NY2024000829$FR-Accord-438772$ACCORD$$58$YR$A$F$Y$77$KG$20240808$$HP$FR$FR
241880371$24188037$1$I$20230831$20240730$20240808$20240808$EXP$FR-AFSSAPS-TO2024000667$FR-Accord-422137$ACCORD$$78$YR$E$M$Y$$$20240808$$MD$FR$FR
241880381$24188038$1$I$20231025$20240729$20240808$20240808$EXP$FR-AFSSAPS-DJ2024000861$FR-Accord-439219$ACCORD$$72$YR$E$M$Y$$$20240808$$MD$FR$FR
241880391$24188039$1$I$20240614$20240729$20240808$20240808$EXP$FR-AFSSAPS-NC2024000893$FR-Accord-439277$ACCORD$$69$YR$E$M$Y$60$KG$20240808$$MD$FR$FR
241880401$24188040$1$I$20220912$20240729$20240808$20240808$EXP$FR-AFSSAPS-CN2024000715$FR-Accord-439290$ACCORD$$69$YR$E$M$Y$$$20240808$$MD$FR$FR
241880412$24188041$2$F$$20240808$20240808$20240813$EXP$$US-DSJP-DSU-2024-139695$DAIICHI$$$$$M$Y$$$20240813$$HP$US$US
241880421$24188042$1$I$$20220318$20240808$20240808$EXP$$CA-AstraZeneca-2022A122917$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$CA$
241880431$24188043$1$I$20220601$20220707$20240808$20240808$EXP$$US-AstraZeneca-2022A249884$ASTRAZENECA$$210$MON$$F$Y$72.4$KG$20240808$$CN$US$
241880441$24188044$1$I$20211117$20240729$20240808$20240808$EXP$$PL-AUROBINDO-AUR-APL-2024-038682$AUROBINDO$$72$YR$$M$Y$$$20240808$$MD$PL$PL
241880451$24188045$1$I$$20240729$20240808$20240808$EXP$$JP-ROCHE-10000048723$ROCHE$Anto M, Nishikawa S, Karamatsu S.. EP-1196 A case of cytokine storm due to trastuzumab and pertuzumab. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;476$71$YR$E$F$Y$$$20240808$$MD$JP$JP
241880461$24188046$1$I$$20230301$20240808$20240808$EXP$$US-AstraZeneca-2023A051332$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241880471$24188047$1$I$$20230718$20240808$20240808$EXP$$US-AstraZeneca-2023A131332$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241880481$24188048$1$I$20240101$20240805$20240808$20240808$EXP$$US-ABBVIE-5868284$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241880491$24188049$1$I$20240806$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124830$BRISTOL MYERS SQUIBB$$96$YR$E$M$Y$$$20240808$$CN$US$US
241880501$24188050$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125289$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240808$$HP$US$US
241880511$24188051$1$I$$20240801$20240808$20240808$EXP$$DK-STRIDES ARCOLAB LIMITED-2024SP009741$STRIDES$Nielsen MKK, Johansen SS, Linnet K.. Evaluation of poly-drug use in methadone-related fatalities using segmental hair analysis. Forensic-Sci-Int. 2015;248:134-139$$$$$Y$$$20240808$$HP$DK$DK
241880531$24188053$1$I$20240708$20240729$20240808$20240808$EXP$DE-BFARM-24005203$DE-Accord-439018$ACCORD$$39$YR$A$M$Y$80$KG$20240808$$PH$DE$DE
241880551$24188055$1$I$$20240728$20240808$20240808$EXP$$TR-Accord-439506$ACCORD$Sarper N, Tachsin I, Aylan Gelen S, Zengin E. The outcome in pediatric acute myeloblastic leukemia; results of the first-line treatment and contribution of hematopoietic stem cell transplantation to survival of relapsed patients. Turk J Med Sci. 2023 Dec 11;54(2):411-418.$$$$$Y$$$20240808$$HP$TR$TR
241880561$24188056$1$I$$20240728$20240808$20240808$EXP$$TR-Accord-439504$ACCORD$Sarper N, Tachsin I, Aylan Gelen S, Zengin E. The outcome in pediatric acute myeloblastic leukemia; results of the first-line treatment and contribution of hematopoietic stem cell transplantation to survival of relapsed patients. Turk J Med Sci. 2023 Dec 11;54(2):411-418.$$$$F$Y$$$20240808$$HP$TR$TR
241880571$24188057$1$I$20240726$20240729$20240808$20240808$EXP$$US-Accord-440169$ACCORD$$82$YR$E$F$Y$$$20240808$$HP$US$US
241880581$24188058$1$I$$20240729$20240808$20240808$EXP$GB-MHRA-MED-202407291713297290-SHVRB$GB-Accord-439330$ACCORD$$18$YR$A$M$Y$$$20240808$$MD$GB$GB
241880591$24188059$1$I$20240501$20240729$20240808$20240808$EXP$GB-MHRA-MED-202407292333319350-NVPFD$GB-Accord-439331$ACCORD$$18$YR$A$F$Y$52$KG$20240808$$CN$GB$GB
241880601$24188060$1$I$20240516$20240729$20240808$20240808$EXP$FR-AFSSAPS-LY2024000958$FR-Accord-439308$ACCORD$$86$YR$E$F$Y$56$KG$20240808$$CN$FR$FR
241880611$24188061$1$I$20240709$20240729$20240808$20240808$EXP$FR-AFSSAPS-GR2024000944$FR-Accord-439013$ACCORD$$43$YR$A$F$Y$110$KG$20240808$$PH$FR$FR
241880622$24188062$2$F$$20240826$20240808$20240905$30DAY$$US-GSK-US2024094844$GLAXOSMITHKLINE$$$$$M$Y$$$20240905$$CN$US$US
241880631$24188063$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124712$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$62.6$KG$20240808$$HP$US$US
241880641$24188064$1$I$$20240801$20240808$20240808$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009894$STRIDES$Abbasi F, Garcia SN, Dean J.. Disseminated Cryptococcosis in an Hiv Negative Patient on Hemodialysis.. Am-J-Respir-Crit-Care-Med. 2024;209$67$YR$$M$Y$$$20240808$$HP$US$US
241880651$24188065$1$I$$20240710$20240808$20240808$PER$$US-009507513-2407USA004868$MERCK$$$$$$Y$$$20240808$$HP$US$US
241880661$24188066$1$I$$20240729$20240808$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-038687$AUROBINDO$Mosca AM, Garcia D, Martins JJ, Araujo R, E Silva AO. A CASE REPORT OF A COMPLICATED INFECTIVE ENDOCARDITIS. Eur-J-Case-Rep-Intern-Med. 2019;6 (Suppl.1):461 abstr. 1042$65$YR$$M$Y$$$20240808$$HP$PT$PT
241880672$24188067$2$F$20240701$20240901$20240808$20240910$EXP$$IL-UNITED THERAPEUTICS-UNT-2024-024208$UNITED THERAPEUTICS$$50$YR$$F$Y$$$20240910$$MD$IL$IL
241880681$24188068$1$I$$20240806$20240808$20240808$EXP$$US-JNJFOC-20240816389$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240808$$MD$US$US
241880691$24188069$1$I$$20240802$20240808$20240808$PER$$US-UNITED THERAPEUTICS-UNT-2024-023795$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240808$$$US$US
241880701$24188070$1$I$$20240729$20240808$20240808$EXP$$IT-AUROBINDO-AUR-APL-2024-038835$AUROBINDO$La Manna G, Busutti M, Baraldi O, Porcu CV, Samele G, Campus A, et al. Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn?s Disease. Kidney-Int-Rep. 2023;8(8):1676- 1679$50$YR$$M$Y$$$20240808$$HP$IT$IT
241880711$24188071$1$I$20240224$20240805$20240808$20240808$EXP$$FR-AFSSAPS-LY2024000353$Haleon PLC$$43$YR$$M$Y$88$KG$20240808$$PH$FR$FR
241880731$24188073$1$I$20120507$20240805$20240808$20240808$PER$$US-JNJFOC-20240813384$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20240808$$HP$US$US
241880741$24188074$1$I$20240718$20240801$20240808$20240808$PER$$US-SA-2024SA233658$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240808$$MD$US$US
241880751$24188075$1$I$20240613$20240724$20240808$20240808$EXP$$CN-VALIDUS PHARMACEUTICALS LLC-CN-VDP-2024-019345$VALIDUS$$$$$$Y$$$20240808$$HP$CN$CN
241880761$24188076$1$I$20231201$20240724$20240808$20240808$EXP$$FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2024-019346$VALIDUS$$$$$$Y$$$20240808$$HP$FR$FR
241880771$24188077$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA230710$SANOFI AVENTIS$$$$$M$Y$$$20240808$$CN$US$US
241880782$24188078$2$F$20240701$20240827$20240808$20240904$PER$$US-AMGEN-USASP2024149503$AMGEN$$65$YR$E$F$Y$132.9$KG$20240904$$CN$US$US
241880801$24188080$1$I$$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024157172$AMGEN$$$$$$Y$$$20240808$$HP$US$US
241880821$24188082$1$I$$20240730$20240808$20240808$PER$$US-UNITED THERAPEUTICS-UNT-2024-023734$UNITED THERAPEUTICS$$$$$F$Y$87.075$KG$20240808$$$US$US
241880851$24188085$1$I$$20240802$20240808$20240808$EXP$IT-MLMSERVICE-20240725-PI142868-00117-1$IT-STRIDES ARCOLAB LIMITED-2024SP009849$STRIDES$Romano A, Gasparro R, Campana MD, Pinchera B, Di Crescenzo RM, Del Guercio D, et al.. COVID-19 as a critical risk factor for osteonecrosis of the jaw: diagnostic challenge and surgical treatment.. Curr-Probl-Surg. 2024;61 (9)$74$YR$$M$Y$$$20240808$$MD$IT$IT
241880861$24188086$1$I$$20240806$20240808$20240808$PER$$US-ABBVIE-5871215$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241880871$24188087$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125139$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240808$$CN$US$US
241880881$24188088$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125071$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240808$$CN$US$US
241880891$24188089$1$I$20240802$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124423$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$108.86$KG$20240808$$CN$US$US
241880912$24188091$2$F$$20240911$20240808$20240918$30DAY$$JP-JNJFOC-20240815589$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$MD$JP$JP
241880941$24188094$1$I$20240720$20240724$20240808$20240808$PER$$US-PURACAP-US-2024EPCSPO00925$PURACAP$$56$YR$A$M$Y$180$KG$20240808$$CN$US$US
241880951$24188095$1$I$20240726$20240729$20240808$20240808$EXP$$US-VIIV HEALTHCARE LIMITED-US2024094792$VIIV$$20$YR$$M$Y$$$20240808$$CN$US$US
241880962$24188096$2$F$$20240812$20240808$20240820$EXP$$FR-TEVA-VS-3229583$TEVA$Vatignez T, Lemee L, Morisse-Pradier H, Carvalho-Lallement P, Alexandre K, Artaud-Macari E. A 52-year-old immunocompromised man with an unusual cause of infectious lung cavitary inducing acute respiratory failure. Respir-Med-Res 2024; 86 101101.; Vatignez T, Lemee L, Morisse-Pradier H, Carvalho-Lallement P, Alexandre K, Artaud-Macari E. A 52-year-old immunocompromised man with an unusual cause of infectious lung cavitary inducing acute respiratory failure. Respir-Med-Res 2024; 86 101101.$52$YR$$M$Y$$$20240820$$HP$FR$FR
241880973$24188097$3$F$20240731$20240912$20240808$20240919$30DAY$$US-AMGEN-USASP2024152869$AMGEN$$61$YR$A$M$Y$$$20240919$$HP$US$US
241880981$24188098$1$I$$20240803$20240808$20240808$EXP$$AU-AMGEN-AUSSP2024155078$AMGEN$$35$YR$A$M$Y$$$20240808$$MD$AU$AU
241880991$24188099$1$I$$20240725$20240808$20240808$EXP$$KR-Axellia-005302$XELLIA PHARMACEUTICALS$Kim Y, Bae S, Huh KY, Joo JS, Lee J, Song SH, et.al. Coadministration of Voriconazole and Rifabutin Can Increase the Risk of Adverse Drug Reactions in Patients with Multiple Infections. Ther Drug Monit. 2024 Jul 16.$57$YR$A$F$Y$$$20240808$$MD$KR$KP
241881003$24188100$3$F$20221128$20240919$20240808$20240930$EXP$$US-TAKEDA-2022TUS095615$TAKEDA$$70$YR$$F$Y$96$KG$20240930$$HP$US$US
241881011$24188101$1$I$$20240725$20240808$20240808$EXP$$KR-Axellia-005303$XELLIA PHARMACEUTICALS$Kim Y, Bae S, Huh KY, Joo JS, Lee J, Song SH, et.al. Coadministration of Voriconazole and Rifabutin Can Increase the Risk of Adverse Drug Reactions in Patients with Multiple Infections. Ther Drug Monit. 2024 Jul 16.$83$YR$E$M$Y$$$20240808$$MD$KR$KP
241881021$24188102$1$I$20180527$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038609$AUROBINDO$$93$YR$$F$Y$44$KG$20240808$$PH$FR$FR
241881031$24188103$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003983$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240808$$CN$US$US
241881041$24188104$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003780$ELI LILLY AND CO$$48$YR$A$$Y$$$20240808$$LW$US$US
241881051$24188105$1$I$20240807$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004792$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241881061$24188106$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002737$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240808$$CN$US$US
241881071$24188107$1$I$$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408005006$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240808$$CN$US$US
241881081$24188108$1$I$$20240731$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408000455$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241881091$24188109$1$I$$20240807$20240808$20240808$EXP$$JP-BAYER-2024A049950$BAYER$$$$$M$Y$$$20240808$$MD$JP$JP
241881101$24188110$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA232124$SANOFI AVENTIS$$40$YR$A$F$Y$55.79$KG$20240808$$MD$US$US
241881112$24188111$2$F$$20240725$20240808$20240809$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092887$GLENMARK$$$$$$Y$$$20240809$$CN$US$US
241881121$24188112$1$I$$20240807$20240808$20240808$EXP$$US-SANDOZ INC.-SDZ2024US071357$SANDOZ$$$$$$Y$$$20240808$$MD$US$US
241881131$24188113$1$I$$20240729$20240808$20240808$PER$$US-IDORSIA-008325-2024-US$IDORSIA PHARMACEUTICALS$$$$$$Y$$$20240808$$CN$US$US
241881141$24188114$1$I$$20240801$20240808$20240808$PER$$US-IDORSIA-008334-2024-US$IDORSIA PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241881151$24188115$1$I$20240729$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038208$AUROBINDO$$32$YR$$F$Y$101$KG$20240808$$CN$GB$GB
241881161$24188116$1$I$$20240801$20240808$20240808$PER$$US-ALXN-202408USA000052US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
241881171$24188117$1$I$20240716$20240729$20240808$20240808$EXP$IT-MINISAL02-996339$IT-Accord-439045$ACCORD$$70$YR$E$F$Y$$$20240808$$MD$IT$IT
241881181$24188118$1$I$20240726$20240730$20240808$20240808$EXP$GB-MHRA-MED-202407300134326310-DVYRP$GB-Accord-439752$ACCORD$$22$YR$A$F$Y$70$KG$20240808$$CN$GB$GB
241881191$24188119$1$I$20201119$20240729$20240808$20240808$EXP$PL-URPL-1-3479-2020$PL-Accord-439440$ACCORD$$77$YR$E$M$Y$69$KG$20240808$$MD$PL$PL
241881211$24188121$1$I$$20240802$20240808$20240808$PER$$NVSC2024US160922$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241881221$24188122$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124996$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240808$$HP$US$US
241881231$24188123$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125110$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240808$$CN$US$US
241881241$24188124$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125076$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240808$$CN$US$US
241881251$24188125$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125015$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$75.75$KG$20240808$$CN$US$US
241881271$24188127$1$I$$20240724$20240808$20240808$PER$$US-EPICPHARMA-US-2024EPCSPO00927$EPIC PHARM$$$$$F$Y$$$20240808$$CN$US$US
241881281$24188128$1$I$$20240509$20240807$20240807$DIR$FDA-CDER-CTU-2024-54408$$FDA-CTU$$$$$$N$$$20240509$N$HP$US$
241881291$24188129$1$I$$20240729$20240808$20240808$EXP$$US-GSK-US2024AMR095272$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$HP$US$US
241881301$24188130$1$I$20220501$20240802$20240808$20240808$EXP$HR-HALMED-300086223$HR-BAYER-2024A112053$BAYER$$27$YR$A$F$Y$68$KG$20240808$$CN$HR$HR
241881311$24188131$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA233047$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240808$$MD$US$US
241881321$24188132$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231578$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240808$$MD$US$US
241881331$24188133$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA232122$SANOFI AVENTIS$$$$T$F$Y$$$20240808$$MD$US$US
241881341$24188134$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA231592$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240808$$MD$US$US
241881361$24188136$1$I$$20230308$20240808$20240808$EXP$$US-AstraZeneca-2023A057369$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241881371$24188137$1$I$$20221103$20240808$20240808$EXP$$US-AstraZeneca-2022A365577$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241881391$24188139$1$I$$20240805$20240808$20240808$EXP$$CN-AstraZeneca-2024A179022$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$CN$
241881401$24188140$1$I$$20220621$20240808$20240808$EXP$$US-AstraZeneca-2022A230655$ASTRAZENECA$$$$$F$Y$$$20240808$$HP$US$
241881421$24188142$1$I$20240712$20240730$20240808$20240808$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160173$JIANGSU HANSOH PHARMACEUTICAL$$61$YR$$M$Y$46$KG$20240808$$MD$CN$CN
241881431$24188143$1$I$20240728$20240731$20240808$20240808$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160170$JIANGSU HENGRUI MEDICINE$$54$YR$$M$Y$75$KG$20240808$$MD$CN$CN
241881441$24188144$1$I$$20240710$20240808$20240808$30DAY$$US-Amphastar Pharmaceuticals, Inc.-2160167$AMPHASTAR$$$$$$Y$$$20240808$$$US$US
241881461$24188146$1$I$$20240806$20240808$20240808$PER$$US-TAKEDA-2024TUS079017$TAKEDA$$42$YR$$F$Y$$$20240808$$HP$US$US
241881472$24188147$2$F$20240701$20240816$20240808$20240823$EXP$$US-862174955-ML2024-04285$Unknown Manufacturer$$87$YR$E$F$Y$63$KG$20240823$$CN$US$US
241881481$24188148$1$I$$20240708$20240808$20240808$30DAY$$US-Amphastar Pharmaceuticals, Inc.-2160163$AMPHASTAR$$$$$$Y$$$20240808$$PH$US$US
241881491$24188149$1$I$$20240729$20240808$20240808$EXP$$US-STERISCIENCE B.V.-2024-ST-001144$Steriscience PTE$Cohen P, Kudchadkar S, Schultz B, Schuette J.. REPEATED HEMODIALYSIS AFTER EXTENDED-RELEASE ACETAMINOPHEN INGESTION.. Crit-Care-Med. 2024;52 (Suppl.) (1):S301 abstr. 657$15$YR$$M$Y$$$20240808$$HP$US$US
241881501$24188150$1$I$$20240806$20240808$20240808$EXP$$AU-ABBVIE-5870829$ABBVIE$$$$$M$Y$$$20240808$$CN$AU$AU
241881521$24188152$1$I$20240710$20240723$20240808$20240808$EXP$$US-AnazaoHealth Corporation-2160160$ANAZAOHEALTH CORPORATION$$60$YR$$F$Y$78.636$KG$20240808$$$US$US
241881531$24188153$1$I$20240701$20240731$20240808$20240808$EXP$$CA-CELLTRION INC.-2024CA018857$CELLTRION$$$$$$Y$$$20240808$$HP$CA$CA
241881541$24188154$1$I$20240426$20240725$20240808$20240808$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160175$JIANGSU HANSOH PHARMACEUTICAL$$71$YR$$M$Y$$$20240808$$MD$CN$CN
241881551$24188155$1$I$$20240724$20240808$20240808$PER$$US-LGM Pharma Solutions, LLC-2160157$LGM PHARMA$$52$YR$$M$Y$$$20240808$$$US$US
241881561$24188156$1$I$$20240723$20240808$20240808$EXP$$US-AnazaoHealth Corporation-2160161$ANAZAOHEALTH CORPORATION$$70$YR$$F$Y$70.455$KG$20240808$$$US$US
241881571$24188157$1$I$$20240726$20240808$20240808$EXP$$ES-B.Braun Medical Inc.-2160176$B BRAUN$$66$YR$$F$Y$$$20240808$$$ES$ES
241881581$24188158$1$I$$20240709$20240808$20240808$30DAY$$US-Amphastar Pharmaceuticals, Inc.-2160165$AMPHASTAR$$$$$$Y$$$20240808$$$US$US
241881591$24188159$1$I$20240721$20240729$20240808$20240808$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160171$JIANGSU HENGRUI MEDICINE$$49$YR$$F$Y$$$20240808$$MD$CN$CN
241881602$24188160$2$F$20240318$20240805$20240808$20240828$EXP$$US-GSK-US2024097517$GLAXOSMITHKLINE$$68$YR$$F$Y$87.54$KG$20240828$$MD$US$US
241881611$24188161$1$I$$20240802$20240808$20240808$EXP$$US-GSK-US2024097029$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241881621$24188162$1$I$20240729$20240729$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024094786$VIIV$$38$YR$$M$Y$$$20240808$$HP$US$US
241881631$24188163$1$I$$20240802$20240808$20240808$EXP$$US-BAYER-2024A112708$BAYER$$63$YR$A$F$Y$$$20240808$$MD$US$US
241881651$24188165$1$I$$20240509$20240807$20240807$DIR$FDA-CDER-CTU-2024-54403$$FDA-CTU$$$$$$N$$$20240509$N$PH$US$
241881661$24188166$1$I$$20240805$20240808$20240808$EXP$$US-JNJFOC-20240815788$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241881671$24188167$1$I$$20240806$20240808$20240808$PER$$US-JNJFOC-20240816530$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$HP$US$US
241881682$24188168$2$F$$20240917$20240808$20240924$EXP$$US-BAUSCHBL-2024BNL030773$BAUSCH AND LOMB$$98$YR$$F$Y$$$20240924$$CN$US$US
241881691$24188169$1$I$20240320$20240731$20240808$20240808$EXP$FR-AFSSAPS-TO2024001389$FR-TEVA-VS-3229004$TEVA$$82$YR$$M$Y$$$20240808$$PH$FR$FR
241881702$24188170$2$F$20240721$20240909$20240808$20240911$PER$$US-AMGEN-USASP2024154420$AMGEN$$60$YR$A$F$Y$$$20240910$$CN$US$US
241881711$24188171$1$I$20221001$20240803$20240808$20240808$EXP$$GB-AMGEN-GBRSP2024155118$AMGEN$$$$$F$Y$$$20240808$$HP$GB$GB
241881722$24188172$2$F$20240806$20240806$20240808$20240812$PER$$US-AMGEN-USASP2024156697$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241881731$24188173$1$I$$20240730$20240808$20240808$EXP$$IT-MYLANLABS-2024M1072752$MYLAN$Conversano E, Debiec H, Colucci M, Emma F, Ronco P, Vivarelli M. A child with semaphorin 3B-associated membranous nephropathy effectivelly treared with obinutuzumab. Pediatr-Nephrol 2023; 38 (Suppl. 2) S123-S124 abstr. Su-3MP 147.$9$YR$$M$Y$$$20240808$$HP$IT$IT
241881741$24188174$1$I$$20240730$20240808$20240808$EXP$$DE-MYLANLABS-2024M1071913$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$8$YR$$F$Y$$$20240808$$HP$DE$DE
241881751$24188175$1$I$$20240730$20240808$20240808$EXP$$JP-MYLANLABS-2024M1072695$MYLAN$Azuma N, Natsuaki M, Hashimoto N, Abe T, Ueda S, Ohno Y, et al. Efficacy of anifrolumab in long-term intractable alopecia due to discoid lupus erythematosus. Mod-Rheumatol-Case-Rep 2024; 8 (2): 267-271.. 2024;8 (2):267-271$$$A$F$Y$$$20240808$$HP$JP$JP
241881761$24188176$1$I$$20240730$20240808$20240808$EXP$$US-MYLANLABS-2024M1072815$MYLAN$Seltzer J, Schneir A. Case Files from the University of California San Diego Medical Toxicology Fellowship: Neonatal Flecainide Toxicity from an Accidental Dosing Error. J-Med-Toxicol 2024; 20 (3): 314-323.$2$WK$$M$Y$$$20240808$$HP$US$US
241881771$24188177$1$I$$20240730$20240808$20240808$EXP$$US-MYLANLABS-2024M1072748$MYLAN$Sood N, Kushnir M, Jayavelu B. Acute renal thrombotic microangiopathy caused by Eltrombopag and Romiplostim in a patient with myelodysplastic syndromes (MDS) and underlying antiphospholipid syndrome. Eur-J-Case-Rep-Intern-Med 2024; 11 (7).$80$YR$$M$Y$$$20240808$$HP$US$US
241881781$24188178$1$I$$20240730$20240808$20240808$EXP$$DE-MYLANLABS-2024M1071917$MYLAN$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$4$YR$$M$Y$$$20240808$$HP$DE$DE
241881791$24188179$1$I$$20240730$20240808$20240808$EXP$$US-MYLANLABS-2024M1072272$MYLAN$Zouridis S, Oo YH, Syn W-K. Role of Sirolimus and Rituximab in the Treatment of Autoimmune Hepatitis. ACG-Case-Rep-J 2024; 11 (7): e01414.$$$$F$Y$$$20240808$$MD$US$US
241881801$24188180$1$I$$20240730$20240808$20240808$EXP$$US-MYLANLABS-2024M1072275$MYLAN$Adimora I, Zhang B, Idowu M. Recurrent Strokes in a Woman with a History of Thrombotic Thrombocytopenic Purpura. Case-Rep-Med 2023; 2023.$53$YR$$F$Y$$$20240808$$HP$US$US
241881811$24188181$1$I$$20240730$20240808$20240808$EXP$$DE-MYLANLABS-2024M1072263$MYLAN$Wiedenmayer N, Vollmer AS, Winkler JK, Enk AH. Successful Treatment of Severe Pemphigus Vulgaris with Reduced Side Effects Using a Novel IVIg Preparation. Dermatol-Ther-(Heidelb) 2024; 14 1969 -1974.$73$YR$$F$Y$$$20240808$$HP$DE$DE
241881821$24188182$1$I$20240701$20240801$20240808$20240808$EXP$$US-SA-2024SA231883$SANOFI AVENTIS$$92$YR$E$F$Y$66$KG$20240808$$MD$US$US
241881831$24188183$1$I$20240717$20240729$20240808$20240808$EXP$$US-Accord-439628$ACCORD$$59$YR$A$M$Y$$$20240808$$HP$US$US
241881851$24188185$1$I$20240624$20240729$20240808$20240808$EXP$FR-AFSSAPS-RE2024000734$FR-Accord-439276$ACCORD$$75$YR$E$M$Y$97$KG$20240808$$MD$FR$FR
241881861$24188186$1$I$$20240729$20240808$20240808$EXP$CA-MHPD-001089923$CA-Accord-439254$ACCORD$$52$YR$A$F$Y$69$KG$20240808$$HP$CA$CA
241881871$24188187$1$I$20240724$20240729$20240808$20240808$EXP$$US-Accord-439239$ACCORD$$17$YR$T$M$Y$$$20240808$$HP$US$US
241881881$24188188$1$I$20240727$20240729$20240808$20240808$EXP$$US-Accord-439243$ACCORD$$17$YR$T$M$Y$$$20240808$$HP$US$US
241881891$24188189$1$I$20240720$20240729$20240808$20240808$EXP$IT-MINISAL02-996425$IT-Accord-439022$ACCORD$$81$YR$E$M$Y$$$20240808$$MD$IT$IT
241881901$24188190$1$I$$20240729$20240808$20240808$EXP$CA-MHPD-001088329$CA-Accord-439268$ACCORD$$70$YR$E$$Y$67$KG$20240808$$HP$CA$CA
241881912$24188191$2$F$20210201$20240821$20240808$20240902$EXP$$JP-Accord-438952$ACCORD$Tokuyama N, Ikeda S, Ishida R, Futai R, Tobimatsu K, Kodama Y. Impaired Consciousness Due to Hyperammonemia During S-1 Administration for Unresectable Pancreatic Cancer. Intern Med. 2024 Jul 25. doi: 10.2169/internalmedicine.3771-24.$72$YR$E$F$Y$50$KG$20240902$$MD$JP$JP
241881921$24188192$1$I$20240717$20240729$20240808$20240808$EXP$$US-Accord-439158$ACCORD$$57$YR$A$M$Y$$$20240808$$HP$US$US
241881931$24188193$1$I$$20240508$20240807$20240807$DIR$FDA-CDER-CTU-2024-54402$$FDA-CTU$$$$$$N$$$20240508$N$HP$US$
241881941$24188194$1$I$20240201$20240729$20240808$20240808$EXP$SE-SEMPA-2024-001497$SE-Accord-439445$ACCORD$$81$YR$E$F$Y$$$20240808$$PH$SE$SE
241881951$24188195$1$I$20240606$20240729$20240808$20240808$EXP$FR-AFSSAPS-TO2024001133$FR-Accord-432058$ACCORD$$70$YR$E$F$Y$$$20240808$$PH$FR$GB
241881961$24188196$1$I$20221118$20230118$20240808$20240808$EXP$BE-FAMHP-DHH-N2023-119722$BE-Accord-419437$ACCORD$$69$YR$E$F$Y$68.2$KG$20240808$$PH$BE$BE
241881981$24188198$1$I$20240701$20240729$20240808$20240808$PER$$US-BAUSCHBL-2024BNL030874$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240808$$CN$US$US
241882012$24188201$2$F$$20240826$20240808$20240826$PER$$US-ALXN-202408USA000041US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241882021$24188202$1$I$$20240730$20240808$20240808$EXP$$JP-STERISCIENCE B.V.-2024-ST-001148$Steriscience PTE$Soejima Y, Fujiwara T, Fujii M, Tsushima H, Yamaguchi R, Nakashima Y.. Arthroscopic Treatment of Septic Arthritis of the Ankle Caused by Group B Streptococcus: A Case Report.. Am-J-Case-Rep. 2023;24$60$YR$$F$Y$$$20240808$$HP$JP$JP
241882031$24188203$1$I$20220101$20240729$20240808$20240808$EXP$$US-MYLANLABS-2024M1072826$MYLAN$Olowoyo O, Sanghi P. ^Doc, My Head Pounds^ -A Rare Cause Of Headache In A Kidney Transplant Patient -A Case Report. Am-J-Kidney-Dis 2024; 83 (Suppl. 2) (4): S148 abstr. 480.$46$YR$$F$Y$$$20240808$$HP$US$US
241882041$24188204$1$I$20240101$20240730$20240808$20240808$PER$$US-BAUSCHBL-2024BNL030884$BAUSCH AND LOMB$$83$YR$$F$Y$$$20240808$$CN$US$US
241882051$24188205$1$I$20240101$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124938$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240808$$CN$US$US
241882061$24188206$1$I$20240701$20240731$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124549$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240808$$PH$US$US
241882071$24188207$1$I$20240701$20240806$20240808$20240808$EXP$$US-ABBVIE-5870705$ABBVIE$$68$YR$$F$Y$$$20240808$$CN$US$US
241882081$24188208$1$I$$20240516$20240807$20240807$DIR$FDA-CDER-CTU-2024-54382$$FDA-CTU$$$$$$N$$$20240516$N$PH$US$
241882091$24188209$1$I$$20240304$20240808$20240808$PER$$US-OTSUKA-2024_005963$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241882101$24188210$1$I$20230906$20231109$20240808$20240808$PER$$US-OTSUKA-2023_023838$OTSUKA$$17$YR$$F$Y$$$20240808$$HP$US$US
241882111$24188211$1$I$20240326$20240528$20240808$20240808$PER$$US-OTSUKA-2024_008181$OTSUKA$$33$YR$$M$Y$$$20240808$$HP$US$US
241882121$24188212$1$I$$20230721$20240808$20240808$PER$$US-OTSUKA-2023_019734$OTSUKA$$$$$F$Y$77.11$KG$20240808$$HP$US$US
241882131$24188213$1$I$$20240328$20240808$20240808$PER$$US-OTSUKA-2024_008521$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241882141$24188214$1$I$20230801$20230829$20240808$20240808$PER$$US-OTSUKA-2023_023038$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241882151$24188215$1$I$$20240304$20240808$20240808$PER$$US-OTSUKA-2024_005948$OTSUKA$$$$$F$Y$83.91$KG$20240808$$CN$US$US
241882161$24188216$1$I$$20231003$20240808$20240808$PER$$US-OTSUKA-2023_019900$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241882171$24188217$1$I$20230829$20231029$20240808$20240808$PER$$US-OTSUKA-2023_023050$OTSUKA$$59$YR$$F$Y$73.48$KG$20240808$$CN$US$US
241882181$24188218$1$I$$20240523$20240808$20240808$PER$$US-OTSUKA-2024_007844$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241882191$24188219$1$I$$20240326$20240808$20240808$PER$$US-OTSUKA-2024_008281$OTSUKA$$9$YR$$M$Y$$$20240808$$MD$US$US
241882201$24188220$1$I$$20230828$20240808$20240808$PER$$US-OTSUKA-2023_022928$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241882211$24188221$1$I$$20240523$20240808$20240808$PER$$US-OTSUKA-2024_007732$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241882221$24188222$1$I$20230905$20231107$20240808$20240808$PER$$US-OTSUKA-2023_023606$OTSUKA$$64$YR$$F$Y$$$20240808$$HP$US$US
241882231$24188223$1$I$$20231031$20240808$20240808$PER$$US-OTSUKA-2023_022931$OTSUKA$$$$$M$Y$66.68$KG$20240808$$CN$US$US
241882241$24188224$1$I$20230824$20231108$20240808$20240808$PER$$US-OTSUKA-2023_023697$OTSUKA$$55$YR$$F$Y$78.02$KG$20240808$$MD$US$US
241882251$24188225$1$I$$20230826$20240808$20240808$PER$$US-OTSUKA-2023_022848$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241882261$24188226$1$I$$20230906$20240808$20240808$PER$$US-OTSUKA-2023_023693$OTSUKA$$75$YR$$M$Y$$$20240808$$HP$US$US
241882271$24188227$1$I$$20240326$20240808$20240808$PER$$US-OTSUKA-2024_008302$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241882281$24188228$1$I$$20240410$20240808$20240808$EXP$$US-OTSUKA-2024_010554$OTSUKA$$83$YR$$F$Y$$$20240808$$MD$US$US
241882291$24188229$1$I$$20240401$20240808$20240808$PER$$US-OTSUKA-2024_008747$OTSUKA$$$$$F$Y$63.96$KG$20240808$$CN$US$US
241882301$24188230$1$I$$20231107$20240808$20240808$PER$$US-OTSUKA-2023_023599$OTSUKA$$$$$M$Y$$$20240808$$PH$US$US
241882311$24188231$1$I$$20230830$20240808$20240808$PER$$US-OTSUKA-2023_023224$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241882321$24188232$1$I$$20240404$20240808$20240808$PER$$US-OTSUKA-2024_009399$OTSUKA$$6$DEC$$F$Y$$$20240808$$HP$US$US
241882331$24188233$1$I$$20240409$20240808$20240808$PER$$US-OTSUKA-2024_010453$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241882341$24188234$1$I$$20230905$20240808$20240808$PER$$US-OTSUKA-2023_023604$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241882351$24188235$1$I$$20230905$20240808$20240808$EXP$$US-OTSUKA-2023_023564$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241882361$24188236$1$I$20230820$20230905$20240808$20240808$PER$$US-OTSUKA-2023_023598$OTSUKA$$30$YR$$F$Y$$$20240808$$CN$US$US
241882371$24188237$1$I$$20230825$20240808$20240808$PER$$US-OTSUKA-2023_022754$OTSUKA$$19$YR$$F$Y$$$20240808$$HP$US$US
241882381$24188238$1$I$$20231031$20240808$20240808$PER$$US-OTSUKA-2023_020074$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241882391$24188239$1$I$$20240610$20240808$20240808$PER$$US-OTSUKA-2024_010369$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241882401$24188240$1$I$$20230814$20240808$20240808$PER$$US-OTSUKA-2023_021765$OTSUKA$$$$$M$Y$74.84$KG$20240808$$CN$US$US
241882411$24188241$1$I$$20240326$20240808$20240808$PER$$US-OTSUKA-2024_008221$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241882421$24188242$1$I$$20240404$20240808$20240808$PER$$US-OTSUKA-2024_009364$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241882431$24188243$1$I$$20240304$20240808$20240808$PER$$US-OTSUKA-2024_005942$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241882441$24188244$1$I$$20240326$20240808$20240808$PER$$US-OTSUKA-2024_008241$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241882451$24188245$1$I$20230711$20230921$20240808$20240808$EXP$$US-OTSUKA-2023_021838$OTSUKA$$18$YR$$F$Y$102.49$KG$20240808$$HP$US$US
241882461$24188246$1$I$$20240705$20240808$20240808$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06942$LUPIN$$$$$$Y$$$20240808$$CN$US$US
241882471$24188247$1$I$$20240807$20240808$20240808$EXP$$US-BAUSCH-BL-2024-012010$BAUSCH AND LOMB$$82$YR$$M$Y$$$20240808$$CN$US$US
241882481$24188248$1$I$20240601$20240807$20240808$20240808$EXP$$US-BAUSCH-BL-2024-012036$BAUSCH AND LOMB$$57$YR$$$Y$$$20240808$$CN$US$US
241882491$24188249$1$I$20240718$20240805$20240808$20240808$EXP$$CO-JNJFOC-20240818138$JOHNSON AND JOHNSON$$72$YR$E$F$Y$110$KG$20240808$$HP$CO$CO
241882511$24188251$1$I$$20240729$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024094813$VIIV$$$$$M$Y$$$20240808$$CN$US$US
241882521$24188252$1$I$$20240804$20240808$20240808$EXP$GB-MHRA-MED-202408042322104450-DZMQV$GB-ABBVIE-5869528$ABBVIE$$21$YR$$F$Y$$$20240808$$CN$GB$GB
241882531$24188253$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA231964$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240808$$MD$US$US
241882541$24188254$1$I$20240628$20240805$20240808$20240808$EXP$ES-AEMPS-1555532$ES-SA-2024SA231384$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240808$$PH$ES$ES
241882551$24188255$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231986$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240808$$MD$US$US
241882561$24188256$1$I$$20240802$20240808$20240808$EXP$NL-LRB-00990247$NL-SA-2024SA231222$SANOFI AVENTIS$$44$YR$A$M$Y$86$KG$20240808$$CN$NL$NL
241882572$24188257$2$F$20200101$20240809$20240808$20240812$EXP$$RO-SA-2024SA233219$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$RO$RO
241882606$24188260$6$F$20240701$20240918$20240808$20240923$30DAY$$GT-PFIZER INC-PV202400098645$PFIZER$$5$YR$$M$Y$$$20240923$$HP$GT$GT
241882611$24188261$1$I$$20240724$20240808$20240808$30DAY$$BR-PFIZER INC-202400226072$PFIZER$$$$$$Y$$$20240808$$CN$BR$US
241882621$24188262$1$I$$20230724$20240808$20240808$PER$$US-OTSUKA-2023_019983$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241882631$24188263$1$I$$20230725$20240808$20240808$PER$$US-OTSUKA-2023_020051$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241882641$24188264$1$I$$20230728$20240808$20240808$PER$$US-OTSUKA-2023_020363$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241882651$24188265$1$I$$20230727$20240808$20240808$PER$$US-OTSUKA-2023_020213$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241882661$24188266$1$I$$20230719$20240808$20240808$EXP$$US-OTSUKA-2023_019414$OTSUKA$$4$DEC$$F$Y$136.08$KG$20240808$$MD$US$US
241882671$24188267$1$I$$20230720$20240808$20240808$PER$$CA-OTSUKA-2023_019585$OTSUKA$$$$$$Y$$$20240808$$CN$CA$US
241882681$24188268$1$I$$20230720$20240808$20240808$EXP$$CA-OTSUKA-2023_019581$OTSUKA$$$$$M$Y$45.36$KG$20240808$$CN$CA$US
241882691$24188269$1$I$$20240509$20240807$20240807$DIR$FDA-CDER-CTU-2024-54409$$FDA-CTU$$$$$$N$$$20240509$N$PH$US$
241882701$24188270$1$I$$20230710$20240808$20240808$PER$$US-OTSUKA-2023_021271$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241882711$24188271$1$I$$20230726$20240808$20240808$PER$$US-OTSUKA-2023_020045$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241882721$24188272$1$I$$20240508$20240807$20240807$DIR$FDA-CDER-CTU-2024-54401$$FDA-CTU$$$$$$N$$$20240508$N$HP$US$
241882741$24188274$1$I$$20240515$20240807$20240807$DIR$FDA-CDER-CTU-2024-54399$$FDA-CTU$$$$$$N$$$20240515$N$PH$US$
241882751$24188275$1$I$$20230724$20240808$20240808$PER$$US-OTSUKA-2023_019891$OTSUKA$$34$YR$$F$Y$45.3$KG$20240808$$CN$US$US
241882761$24188276$1$I$20230717$20230718$20240808$20240808$PER$$US-OTSUKA-2023_019366$OTSUKA$$52$YR$$F$Y$$$20240808$$PH$US$US
241882771$24188277$1$I$$20240514$20240807$20240807$DIR$FDA-CDER-CTU-2024-54396$$FDA-CTU$$$$$$N$$$20240514$N$PH$US$
241882791$24188279$1$I$$20230728$20240808$20240808$PER$$US-OTSUKA-2023_020324$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241882801$24188280$1$I$$20230727$20240808$20240808$PER$$US-OTSUKA-2023_020184$OTSUKA$$$$$M$Y$$$20240808$$MD$US$US
241882811$24188281$1$I$$20230727$20240808$20240808$PER$$US-OTSUKA-2023_020216$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241882821$24188282$1$I$$20230721$20240808$20240808$PER$$US-OTSUKA-2023_019703$OTSUKA$$$$$F$Y$79.38$KG$20240808$$CN$US$US
241882831$24188283$1$I$$20230725$20240808$20240808$PER$$US-OTSUKA-2023_019952$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241882841$24188284$1$I$$20230728$20240808$20240808$PER$$US-OTSUKA-2023_020338$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241882851$24188285$1$I$20230725$20230726$20240808$20240808$PER$$US-OTSUKA-2023_020073$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241882861$24188286$1$I$$20230727$20240808$20240808$PER$$US-OTSUKA-2023_020206$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241882871$24188287$1$I$$20230718$20240808$20240808$PER$$US-OTSUKA-2023_019319$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241882891$24188289$1$I$20230517$20230719$20240808$20240808$PER$$US-OTSUKA-2023_019446$OTSUKA$$28$YR$$F$Y$107.05$KG$20240808$$PH$US$US
241882901$24188290$1$I$$20230727$20240808$20240808$EXP$$US-OTSUKA-2023_020312$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241882911$24188291$1$I$20240802$20240802$20240808$20240808$PER$$US-AMGEN-USASP2024154800$AMGEN$$61$YR$A$F$Y$$$20240808$$CN$US$US
241882921$24188292$1$I$20240806$20240807$20240808$20240808$EXP$$US-BAUSCH-BL-2024-012022$BAUSCH AND LOMB$$69$YR$$F$Y$$$20240808$$CN$US$US
241882931$24188293$1$I$20220101$20240729$20240808$20240808$EXP$$GB-ASPEN-GLO2024GB005309$ASPEN$Williams H, Thoppuram N, Law KY, Simms J.. Post-operative Post-cognitive dysfunction: Progressive multifocal leukoencephalopathy (PML), an unexpected finding in an elderly patient.. Clinical Medicine, Journal of the Royal College of Physicians of London.. 2024;24:100041$$$$$Y$$$20240808$$MD$GB$GB
241882941$24188294$1$I$20240731$20240807$20240808$20240808$EXP$$US-BAUSCH-BL-2024-012026$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240808$$CN$US$US
241882951$24188295$1$I$$20240807$20240808$20240808$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044533$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240808$$CN$GB$GB
241882961$24188296$1$I$$20240802$20240808$20240808$EXP$US-MLMSERVICE-20240726-PI144064-00192-1$US-RDY-SPO/USA/24/0011504$DR REDDYS$Xia YU, Blecher NA, Custer PL, Sieck EG. Optimizing topical drop efficacy with proper eyelid positioning. American Journal of Ophthalmology Case Reports. 2024;36:102111. DOI: 10.1016/j.ajoc.2024.102111.$71$YR$E$M$Y$$$20240808$$MD$US$US
241882971$24188297$1$I$20230723$20230822$20240808$20240808$PER$$US-OTSUKA-2023_022160$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241882981$24188298$1$I$$20230816$20240808$20240808$PER$$US-OTSUKA-2023_021938$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241882991$24188299$1$I$$20230914$20240808$20240808$PER$$US-OTSUKA-2023_024367$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241883001$24188300$1$I$$20230822$20240808$20240808$PER$$US-OTSUKA-2023_022415$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241883011$24188301$1$I$20090101$20230922$20240808$20240808$PER$$US-OTSUKA-2023_025111$OTSUKA$$$$$M$Y$53.98$KG$20240808$$CN$US$US
241883021$24188302$1$I$$20230818$20240808$20240808$EXP$$US-OTSUKA-2023_022153$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241883031$24188303$1$I$$20230823$20240808$20240808$EXP$$US-OTSUKA-2023_022506$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241883041$24188304$1$I$$20230811$20240808$20240808$PER$$US-OTSUKA-2023_021664$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241883051$24188305$1$I$$20230920$20240808$20240808$PER$$US-OTSUKA-2023_024864$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241883061$24188306$1$I$$20230815$20240808$20240808$PER$$US-OTSUKA-2023_021976$OTSUKA$$53$YR$$$Y$$$20240808$$CN$US$US
241883071$24188307$1$I$$20230809$20240808$20240808$PER$$US-OTSUKA-2023_021358$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241883081$24188308$1$I$20221101$20230821$20240808$20240808$PER$$US-OTSUKA-2023_022302$OTSUKA$$28$YR$$M$Y$63.05$KG$20240808$$CN$US$US
241883091$24188309$1$I$20230914$20230914$20240808$20240808$PER$$US-OTSUKA-2023_024502$OTSUKA$$$$$M$Y$$$20240808$$PH$US$US
241883101$24188310$1$I$$20230810$20240808$20240808$PER$$US-OTSUKA-2023_021490$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241883121$24188312$1$I$$20230904$20240808$20240808$EXP$$US-OTSUKA-2023_019417$OTSUKA$$35$YR$$M$Y$$$20240808$$HP$US$US
241883131$24188313$1$I$$20230811$20240808$20240808$PER$$US-OTSUKA-2023_021666$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241883141$24188314$1$I$$20230904$20240808$20240808$PER$$US-OTSUKA-2023_019529$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241883151$24188315$1$I$$20240509$20240807$20240807$DIR$FDA-CDER-CTU-2024-54404$$FDA-CTU$$$$$$N$$$20240509$N$PH$US$
241883161$24188316$1$I$$20240520$20240807$20240807$DIR$FDA-CDER-CTU-2024-54388$$FDA-CTU$$$$$$N$$$20240520$N$PH$US$
241883171$24188317$1$I$$20230731$20240808$20240808$PER$$US-OTSUKA-2023_020613$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241883181$24188318$1$I$$20230907$20240808$20240808$PER$$US-OTSUKA-2023_023842$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241883191$24188319$1$I$20230811$20230811$20240808$20240808$PER$$US-OTSUKA-2023_021662$OTSUKA$$$$$M$Y$$$20240808$$MD$US$US
241883201$24188320$1$I$$20230823$20240808$20240808$PER$$US-OTSUKA-2023_022553$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241883211$24188321$1$I$$20230824$20240808$20240808$PER$$US-OTSUKA-2023_022620$OTSUKA$$$$$M$Y$80.9$KG$20240808$$HP$US$US
241883221$24188322$1$I$$20230818$20240808$20240808$PER$$US-OTSUKA-2023_022103$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241883231$24188323$1$I$$20240509$20240807$20240807$DIR$FDA-CDER-CTU-2024-54406$$FDA-CTU$$$$$$N$$$20240509$N$HP$US$
241883241$24188324$1$I$$20240514$20240807$20240807$DIR$FDA-CDER-CTU-2024-54395$$FDA-CTU$$$$$$N$$$20240514$N$PH$US$
241883251$24188325$1$I$$20230810$20240808$20240808$PER$$US-OTSUKA-2023_021663$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241883271$24188327$1$I$$20230816$20240808$20240808$PER$$US-OTSUKA-2023_021923$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241883281$24188328$1$I$$20230915$20240808$20240808$PER$$US-OTSUKA-2023_024599$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241883291$24188329$1$I$20230608$20230914$20240808$20240808$PER$$US-OTSUKA-2023_019574$OTSUKA$$25$YR$$F$Y$$$20240808$$MD$US$US
241883301$24188330$1$I$$20230802$20240808$20240808$PER$$US-OTSUKA-2023_020742$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241883311$24188331$1$I$$20230830$20240808$20240808$PER$$US-OTSUKA-2023_021381$OTSUKA$$$$$M$Y$22.68$KG$20240808$$CN$US$US
241883321$24188332$1$I$20180101$20230814$20240808$20240808$EXP$$US-OTSUKA-2023_021741$OTSUKA$$$$$F$Y$68.04$KG$20240808$$MD$US$US
241883331$24188333$1$I$20230609$20230808$20240808$20240808$PER$$CA-OTSUKA-2023_020657$OTSUKA$$22$YR$$M$Y$7.71$KG$20240808$$CN$CA$US
241883341$24188334$1$I$$20230908$20240808$20240808$PER$$US-OTSUKA-2023_023969$OTSUKA$$$$C$$Y$$$20240808$$CN$US$US
241883351$24188335$1$I$$20230908$20240808$20240808$PER$$US-OTSUKA-2023_023956$OTSUKA$$$$$F$Y$56.7$KG$20240808$$CN$US$US
241883361$24188336$1$I$$20230908$20240808$20240808$PER$$US-OTSUKA-2023_023968$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241883371$24188337$1$I$$20230821$20240808$20240808$PER$$US-OTSUKA-2023_022317$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241883381$24188338$1$I$$20230815$20240808$20240808$PER$$US-OTSUKA-2023_021852$OTSUKA$$$$$F$Y$61.2$KG$20240808$$CN$US$US
241883391$24188339$1$I$$20230821$20240808$20240808$PER$$US-OTSUKA-2023_022430$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241883401$24188340$1$I$$20230802$20240808$20240808$PER$$US-OTSUKA-2023_020668$OTSUKA$$$$$F$Y$90.72$KG$20240808$$HP$US$US
241883411$24188341$1$I$$20230814$20240808$20240808$PER$$US-OTSUKA-2023_021737$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241883421$24188342$1$I$$20230808$20240808$20240808$PER$$US-OTSUKA-2023_021211$OTSUKA$$$$$M$Y$$$20240808$$PH$US$US
241883431$24188343$1$I$$20230818$20240808$20240808$PER$$US-OTSUKA-2023_022203$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241883441$24188344$1$I$$20230823$20240808$20240808$PER$$US-OTSUKA-2023_022530$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241883451$24188345$1$I$20230427$20230809$20240808$20240808$PER$$US-OTSUKA-2023_021512$OTSUKA$$38$YR$$F$Y$95.24$KG$20240808$$CN$US$US
241883461$24188346$1$I$20230908$20230908$20240808$20240808$EXP$$US-OTSUKA-2023_023958$OTSUKA$$25$YR$$M$Y$$$20240808$$HP$US$US
241883471$24188347$1$I$$20230817$20240808$20240808$PER$$US-OTSUKA-2023_022080$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241883481$24188348$1$I$$20230824$20240808$20240808$PER$$US-OTSUKA-2023_022676$OTSUKA$$$$$F$Y$63.5$KG$20240808$$PH$US$US
241883491$24188349$1$I$$20230816$20240808$20240808$PER$$US-OTSUKA-2023_021922$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241883501$24188350$1$I$$20230908$20240808$20240808$PER$$US-OTSUKA-2023_025059$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241883511$24188351$1$I$$20230807$20240808$20240808$PER$$US-OTSUKA-2023_021142$OTSUKA$$$$$F$Y$85.73$KG$20240808$$CN$US$US
241883521$24188352$1$I$20200201$20230923$20240808$20240808$PER$$US-OTSUKA-2023_025174$OTSUKA$$48$YR$$F$Y$$$20240808$$CN$US$US
241883531$24188353$1$I$$20230823$20240808$20240808$PER$$US-OTSUKA-2023_022644$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241883541$24188354$1$I$$20230823$20240808$20240808$PER$$US-OTSUKA-2023_022512$OTSUKA$$69$YR$$F$Y$$$20240808$$HP$US$US
241883552$24188355$2$F$$20240909$20240808$20240920$EXP$$JP-AMGEN-JPNSP2024156703$AMGEN$8 A case of acquired aplasia pure red cell with severe anemia progression while using erythropoietin. The 301st Hokkaido Regional Meeting of the Japanese Society of Internal Medicine$8$DEC$E$F$Y$$$20240920$$MD$JP$JP
241883561$24188356$1$I$20220901$20240729$20240808$20240808$EXP$$JP-ROCHE-10000047775$ROCHE$Kozaki K. EP-0838 A case of systemic chemotherapy for breast cancer recurrent in a patient on chronic maintenance dialysis. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;387$8$DEC$E$F$Y$$$20240808$$MD$JP$JP
241883572$24188357$2$F$$20240916$20240808$20240917$30DAY$$DE-UCBSA-2024039297$UCB$$$$$$Y$$$20240917$$CN$DE$DE
241883581$24188358$1$I$$20230929$20240808$20240808$PER$$US-OTSUKA-2023_020362$OTSUKA$$$$$M$Y$108.86$KG$20240808$$HP$US$US
241883591$24188359$1$I$$20231003$20240808$20240808$PER$$US-OTSUKA-2023_020523$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241883601$24188360$1$I$$20231018$20240808$20240808$PER$$US-OTSUKA-2023_021943$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241883611$24188361$1$I$$20231018$20240808$20240808$PER$$US-OTSUKA-2023_027484$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241883621$24188362$1$I$$20231020$20240808$20240808$PER$$US-OTSUKA-2023_027578$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241883631$24188363$1$I$$20231005$20240808$20240808$PER$$US-OTSUKA-2023_026239$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241883641$24188364$1$I$$20231024$20240808$20240808$PER$$US-OTSUKA-2023_027940$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241883651$24188365$1$I$$20231020$20240808$20240808$PER$$US-OTSUKA-2023_027649$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241883661$24188366$1$I$$20231003$20240808$20240808$PER$$US-OTSUKA-2023_027083$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241883671$24188367$1$I$20231019$20231025$20240808$20240808$PER$$US-OTSUKA-2023_028058$OTSUKA$$31$YR$$M$Y$91.17$KG$20240808$$CN$US$US
241883681$24188368$1$I$$20231027$20240808$20240808$PER$$US-OTSUKA-2023_028321$OTSUKA$$19$YR$$M$Y$$$20240808$$HP$US$US
241883691$24188369$1$I$$20231006$20240808$20240808$PER$$US-OTSUKA-2023_026319$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241883701$24188370$1$I$$20231004$20240808$20240808$PER$$US-OTSUKA-2023_026048$OTSUKA$$$$$F$Y$$$20240808$$PH$US$US
241883711$24188371$1$I$20230925$20230929$20240808$20240808$PER$$US-OTSUKA-2023_025739$OTSUKA$$23$YR$$F$Y$117.93$KG$20240808$$HP$US$US
241883721$24188372$1$I$$20231020$20240808$20240808$EXP$$US-OTSUKA-2023_027580$OTSUKA$$$$$M$Y$$$20240808$$MD$US$US
241883731$24188373$1$I$$20231016$20240808$20240808$PER$$US-OTSUKA-2023_013149$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241883741$24188374$1$I$$20230925$20240808$20240808$PER$$US-OTSUKA-2023_019844$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241883751$24188375$1$I$20231004$20231006$20240808$20240808$PER$$US-OTSUKA-2023_026334$OTSUKA$$$$$F$Y$$$20240808$$PH$US$US
241883761$24188376$1$I$$20230926$20240808$20240808$PER$$US-OTSUKA-2023_019979$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241883771$24188377$1$I$20230701$20231009$20240808$20240808$PER$$US-OTSUKA-2023_026441$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241883781$24188378$1$I$20230728$20231002$20240808$20240808$PER$$US-OTSUKA-2023_020446$OTSUKA$$36$YR$$F$Y$89.36$KG$20240808$$PH$US$US
241883791$24188379$1$I$$20231025$20240808$20240808$PER$$US-OTSUKA-2023_028030$OTSUKA$$6$YR$$M$Y$$$20240808$$CN$US$US
241883801$24188380$1$I$$20231102$20240808$20240808$PER$$US-OTSUKA-2023_028839$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241883811$24188381$1$I$$20230926$20240808$20240808$PER$$US-OTSUKA-2023_025393$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241883821$24188382$1$I$$20231017$20240808$20240808$PER$$US-OTSUKA-2023_027231$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241883831$24188383$1$I$$20230927$20240808$20240808$PER$$US-OTSUKA-2023_025510$OTSUKA$$$$$M$Y$$$20240808$$PH$US$US
241883841$24188384$1$I$20230810$20231026$20240808$20240808$PER$$US-OTSUKA-2023_022753$OTSUKA$$27$YR$$M$Y$$$20240808$$MD$US$US
241883851$24188385$1$I$$20231024$20240808$20240808$PER$$US-OTSUKA-2023_028033$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241883861$24188386$1$I$$20231009$20240808$20240808$PER$$US-OTSUKA-2023_026418$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241883871$24188387$1$I$$20230929$20240808$20240808$PER$$US-OTSUKA-2023_020200$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241883881$24188388$1$I$20220101$20231025$20240808$20240808$PER$$US-OTSUKA-2023_028043$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241883891$24188389$1$I$$20231010$20240808$20240808$PER$$US-OTSUKA-2023_026865$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241883901$24188390$1$I$20230727$20230929$20240808$20240808$PER$$US-OTSUKA-2023_020339$OTSUKA$$23$YR$$F$Y$$$20240808$$HP$US$US
241883911$24188391$1$I$$20231022$20240808$20240808$PER$$US-OTSUKA-2023_027679$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241883921$24188392$1$I$20231026$20231026$20240808$20240808$PER$$US-OTSUKA-2023_028170$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241883931$24188393$1$I$$20231012$20240808$20240808$PER$$US-OTSUKA-2023_026841$OTSUKA$$33$YR$$M$Y$$$20240808$$CN$US$US
241883941$24188394$1$I$$20230926$20240808$20240808$PER$$US-OTSUKA-2023_019978$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241883951$24188395$1$I$$20230927$20240808$20240808$PER$$US-OTSUKA-2023_020090$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241883961$24188396$1$I$$20231027$20240808$20240808$PER$$US-OTSUKA-2023_028363$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241883971$24188397$1$I$$20231101$20240808$20240808$EXP$$US-OTSUKA-2023_028686$OTSUKA$$5$DEC$$M$Y$$$20240808$$MD$US$US
241883981$24188398$1$I$$20231101$20240808$20240808$PER$$US-OTSUKA-2023_028727$OTSUKA$$$$$M$Y$$$20240808$$MD$US$US
241883991$24188399$1$I$$20231012$20240808$20240808$PER$$US-OTSUKA-2023_026822$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884001$24188400$1$I$$20231016$20240808$20240808$PER$$US-OTSUKA-2023_027071$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884011$24188401$1$I$$20231010$20240808$20240808$PER$$US-OTSUKA-2023_026568$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884021$24188402$1$I$$20231012$20240808$20240808$PER$$US-OTSUKA-2023_026850$OTSUKA$$$$$F$Y$61.23$KG$20240808$$CN$US$US
241884031$24188403$1$I$$20231002$20240808$20240808$PER$$US-OTSUKA-2023_025859$OTSUKA$$$$$F$Y$$$20240808$$PH$US$US
241884041$24188404$1$I$20230621$20230926$20240808$20240808$PER$$US-OTSUKA-2023_025331$OTSUKA$$30$YR$$F$Y$$$20240808$$CN$US$US
241884051$24188405$1$I$$20231010$20240808$20240808$PER$$US-OTSUKA-2023_027789$OTSUKA$$34$YR$$F$Y$$$20240808$$HP$US$US
241884061$24188406$1$I$$20231025$20240808$20240808$PER$$US-OTSUKA-2023_028036$OTSUKA$$22$YR$$M$Y$$$20240808$$HP$US$US
241884071$24188407$1$I$$20230929$20240808$20240808$PER$$US-OTSUKA-2023_020223$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241884081$24188408$1$I$$20231010$20240808$20240808$PER$$US-OTSUKA-2023_026545$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241884091$24188409$1$I$$20231024$20240808$20240808$PER$$US-OTSUKA-2023_027935$OTSUKA$$$$$F$Y$$$20240808$$PH$US$US
241884101$24188410$1$I$$20231004$20240808$20240808$PER$$US-OTSUKA-2023_026061$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884121$24188412$1$I$$20231019$20240808$20240808$PER$$US-OTSUKA-2023_027490$OTSUKA$$$$$$Y$52.16$KG$20240808$$HP$US$US
241884131$24188413$1$I$$20231017$20240808$20240808$PER$$US-OTSUKA-2023_021734$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884141$24188414$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA122209$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240808$$MD$US$US
241884162$24188416$2$F$$20240819$20240808$20240826$EXP$$EG-GSK-EG2024EME098236$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$EG$EG
241884181$24188418$1$I$$20230911$20240808$20240808$PER$$US-OTSUKA-2023_024109$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241884191$24188419$1$I$$20231009$20240808$20240808$PER$$US-OTSUKA-2023_026442$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241884201$24188420$1$I$$20231009$20240808$20240808$PER$$US-OTSUKA-2023_026444$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884211$24188421$1$I$$20231009$20240808$20240808$PER$$US-OTSUKA-2023_026528$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884221$24188422$1$I$$20231004$20240808$20240808$PER$$US-OTSUKA-2023_026046$OTSUKA$$4$DEC$$M$Y$$$20240808$$HP$US$US
241884231$24188423$1$I$20230101$20230908$20240808$20240808$PER$$US-OTSUKA-2023_024112$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241884241$24188424$1$I$$20230922$20240808$20240808$PER$$US-OTSUKA-2023_025150$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884251$24188425$1$I$$20231006$20240808$20240808$PER$$US-OTSUKA-2023_026314$OTSUKA$$$$$M$Y$$$20240808$$PH$US$US
241884261$24188426$1$I$20230909$20230911$20240808$20240808$PER$$US-OTSUKA-2023_024100$OTSUKA$$$$$F$Y$72.12$KG$20240808$$HP$US$US
241884271$24188427$1$I$20230801$20231007$20240808$20240808$PER$$US-OTSUKA-2023_026358$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884281$24188428$1$I$$20230926$20240808$20240808$PER$$US-OTSUKA-2023_025508$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241884291$24188429$1$I$$20230926$20240808$20240808$PER$$US-OTSUKA-2023_025336$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241884301$24188430$1$I$20230925$20231009$20240808$20240808$PER$$US-OTSUKA-2023_026427$OTSUKA$$34$YR$$F$Y$56.7$KG$20240808$$CN$US$US
241884311$24188431$1$I$$20230911$20240808$20240808$PER$$US-OTSUKA-2023_024134$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884321$24188432$1$I$20230921$20230921$20240808$20240808$PER$$US-OTSUKA-2023_025005$OTSUKA$$$$$M$Y$$$20240808$$PH$US$US
241884331$24188433$1$I$20230901$20230920$20240808$20240808$PER$$US-OTSUKA-2023_024884$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241884341$24188434$1$I$20230601$20230922$20240808$20240808$PER$$US-OTSUKA-2023_025110$OTSUKA$$13$YR$$F$Y$90$KG$20240808$$MD$US$US
241884351$24188435$1$I$$20231011$20240808$20240808$PER$$US-OTSUKA-2023_026853$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884361$24188436$1$I$$20231003$20240808$20240808$PER$$US-OTSUKA-2023_025972$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241884371$24188437$1$I$$20230925$20240808$20240808$PER$$US-OTSUKA-2023_025235$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884381$24188438$1$I$$20231010$20240808$20240808$PER$$US-OTSUKA-2023_026570$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884391$24188439$1$I$$20230921$20240808$20240808$PER$$US-OTSUKA-2023_025044$OTSUKA$$17$YR$$M$Y$$$20240808$$HP$US$US
241884401$24188440$1$I$$20230925$20240808$20240808$PER$$US-OTSUKA-2023_025266$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241884411$24188441$1$I$$20231010$20240808$20240808$PER$$US-OTSUKA-2023_026580$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241884421$24188442$1$I$$20240731$20240808$20240808$EXP$$CA-ABBVIE-5870579$ABBVIE$$$$$F$Y$$$20240808$$MD$CA$CA
241884431$24188443$1$I$$20230130$20240808$20240808$EXP$$US-AstraZeneca-2023A027348$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241884441$24188444$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A175992$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241884451$24188445$1$I$$20240510$20240807$20240807$DIR$FDA-CDER-CTU-2024-54390$$FDA-CTU$$$$$$N$$$20240510$N$PH$US$
241884461$24188446$1$I$$20240516$20240807$20240807$DIR$FDA-CDER-CTU-2024-54380$$FDA-CTU$$$$$$N$$$20240516$N$PH$US$
241884471$24188447$1$I$20190101$20240730$20240808$20240808$EXP$$PT-ASPEN-GLO2024PT005282$ASPEN$Neves AS, Viegas JF, Pinheiro D, Vilas AP.. PO-0042 - (2857) - Avascular bone necrosis in multiple myeloma ... can the thalassemic trait contribute?. Congressos da Sociedade Portuguesa de Medicina Interna: 30. Congresso Nacional de Medicina Interna - Livro de resumos.. 2024$$$$$Y$$$20240808$$MD$PT$PT
241884481$24188448$1$I$$20240516$20240807$20240807$DIR$FDA-CDER-CTU-2024-54383$$FDA-CTU$$$$$$N$$$20240516$N$PH$US$
241884491$24188449$1$I$$20240509$20240807$20240807$DIR$FDA-CDER-CTU-2024-54407$$FDA-CTU$$$$$$N$$$20240509$N$HP$US$
241884511$24188451$1$I$20240804$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004111$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240808$$CN$US$US
241884521$24188452$1$I$20240705$20240725$20240808$20240808$EXP$$AT-AMNEAL PHARMACEUTICALS-2024-AMRX-02883$AMNEAL$$$$$M$Y$83$KG$20240808$$MD$AT$AT
241884531$24188453$1$I$$20231129$20240808$20240808$PER$$US-OTSUKA-2023_026672$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884541$24188454$1$I$$20231208$20240808$20240808$PER$$US-OTSUKA-2023_026695$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241884551$24188455$1$I$$20231030$20240808$20240808$PER$$US-OTSUKA-2023_028455$OTSUKA$$$$$M$Y$$$20240808$$MD$US$US
241884561$24188456$1$I$$20231206$20240808$20240808$PER$$US-OTSUKA-2023_031850$OTSUKA$$$$$M$Y$79.83$KG$20240808$$PH$US$US
241884571$24188457$1$I$$20231211$20240808$20240808$PER$$US-OTSUKA-2023_032305$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884581$24188458$1$I$$20231107$20240808$20240808$PER$$US-OTSUKA-2023_029224$OTSUKA$$$$$M$Y$97.52$KG$20240808$$CN$US$US
241884591$24188459$1$I$$20231127$20240808$20240808$PER$$US-OTSUKA-2023_026308$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241884601$24188460$1$I$$20231208$20240808$20240808$PER$$US-OTSUKA-2023_032105$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241884611$24188461$1$I$$20231110$20240808$20240808$PER$$US-OTSUKA-2023_029575$OTSUKA$$$$$F$Y$89.81$KG$20240808$$CN$US$US
241884621$24188462$1$I$$20231110$20240808$20240808$PER$$US-OTSUKA-2023_029562$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884631$24188463$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029687$OTSUKA$$17$YR$$M$Y$$$20240808$$CN$US$US
241884641$24188464$1$I$$20231208$20240808$20240808$PER$$US-OTSUKA-2023_032160$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884651$24188465$1$I$$20231018$20240808$20240808$PER$$US-OTSUKA-2023_027482$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884661$24188466$1$I$20231114$20231114$20240808$20240808$PER$$US-OTSUKA-2023_029809$OTSUKA$$21$YR$$M$Y$$$20240808$$PH$US$US
241884671$24188467$1$I$$20231107$20240808$20240808$PER$$US-OTSUKA-2023_029427$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241884681$24188468$1$I$20230908$20231206$20240808$20240808$PER$$US-OTSUKA-2023_032049$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241884691$24188469$1$I$$20231106$20240808$20240808$PER$$US-OTSUKA-2023_029103$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241884701$24188470$1$I$$20231106$20240808$20240808$PER$$US-OTSUKA-2023_029079$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241884711$24188471$1$I$$20231211$20240808$20240808$PER$$US-OTSUKA-2023_027790$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884721$24188472$1$I$$20231102$20240808$20240808$PER$$US-OTSUKA-2023_028858$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241884731$24188473$1$I$$20231206$20240808$20240808$PER$$US-OTSUKA-2023_031810$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241884741$24188474$1$I$20230301$20231122$20240808$20240808$PER$$US-OTSUKA-2023_026710$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884751$24188475$1$I$20230928$20231127$20240808$20240808$PER$$US-OTSUKA-2023_025612$OTSUKA$$35$YR$$M$Y$$$20240808$$HP$US$US
241884761$24188476$1$I$20231017$20231108$20240808$20240808$PER$$US-OTSUKA-2023_029337$OTSUKA$$21$YR$$M$Y$$$20240808$$MD$US$US
241884771$24188477$1$I$$20231207$20240808$20240808$PER$$US-OTSUKA-2023_032048$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241884781$24188478$1$I$$20231107$20240808$20240808$PER$$US-OTSUKA-2023_029188$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884791$24188479$1$I$$20231116$20240808$20240808$PER$$US-OTSUKA-2023_024420$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241884801$24188480$1$I$$20231012$20240808$20240808$PER$$US-OTSUKA-2023_026846$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884811$24188481$1$I$$20231212$20240808$20240808$PER$$US-OTSUKA-2023_032535$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884821$24188482$1$I$$20231207$20240808$20240808$PER$$US-OTSUKA-2023_032008$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884831$24188483$1$I$20231016$20231030$20240808$20240808$EXP$$US-OTSUKA-2023_028517$OTSUKA$$24$YR$$F$Y$90.72$KG$20240808$$CN$US$US
241884841$24188484$1$I$$20231031$20240808$20240808$EXP$$US-OTSUKA-2023_028620$OTSUKA$$4$DEC$$F$Y$$$20240808$$HP$US$US
241884851$24188485$1$I$$20231110$20240808$20240808$PER$$US-OTSUKA-2023_029555$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884861$24188486$1$I$$20231103$20240808$20240808$PER$$CA-OTSUKA-2023_028967$OTSUKA$$$$$$Y$$$20240808$$PH$CA$US
241884871$24188487$1$I$20231101$20231114$20240808$20240808$PER$$US-OTSUKA-2023_029825$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884881$24188488$1$I$$20231211$20240808$20240808$PER$$US-OTSUKA-2023_028178$OTSUKA$$34$YR$$F$Y$$$20240808$$MD$US$US
241884891$24188489$1$I$20230920$20231211$20240808$20240808$PER$$US-OTSUKA-2023_027908$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884901$24188490$1$I$$20231204$20240808$20240808$PER$$US-OTSUKA-2023_031586$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241884911$24188491$1$I$20231019$20231212$20240808$20240808$PER$$US-OTSUKA-2023_027648$OTSUKA$$58$YR$$M$Y$$$20240808$$PH$US$US
241884921$24188492$1$I$$20231212$20240808$20240808$PER$$US-OTSUKA-2023_032522$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241884931$24188493$1$I$$20231031$20240808$20240808$PER$$US-OTSUKA-2023_028603$OTSUKA$$$$$M$Y$89.81$KG$20240808$$CN$US$US
241884941$24188494$1$I$$20231213$20240808$20240808$PER$$US-OTSUKA-2023_032620$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241884951$24188495$1$I$$20231106$20240808$20240808$EXP$$US-OTSUKA-2023_029090$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241884961$24188496$1$I$20230918$20231120$20240808$20240808$PER$$US-OTSUKA-2023_024766$OTSUKA$$42$YR$$F$Y$$$20240808$$PH$US$US
241884981$24188498$1$I$20230918$20231208$20240808$20240808$PER$$US-OTSUKA-2023_024890$OTSUKA$$35$YR$$M$Y$$$20240808$$HP$US$US
241884991$24188499$1$I$$20231201$20240808$20240808$PER$$US-OTSUKA-2023_031467$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241885001$24188500$1$I$$20231109$20240808$20240808$PER$$US-OTSUKA-2023_023996$OTSUKA$$$$$M$Y$80.74$KG$20240808$$CN$US$US
241885011$24188501$1$I$$20231031$20240808$20240808$PER$$US-OTSUKA-2023_028619$OTSUKA$$$$$M$Y$81.65$KG$20240808$$CN$US$US
241885021$24188502$1$I$20231004$20231205$20240808$20240808$PER$$US-OTSUKA-2023_026288$OTSUKA$$25$YR$$F$Y$$$20240808$$PH$US$US
241885031$24188503$1$I$$20231213$20240808$20240808$PER$$US-OTSUKA-2023_032645$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241885041$24188504$1$I$$20231207$20240808$20240808$PER$$US-OTSUKA-2023_032052$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885051$24188505$1$I$20230912$20231114$20240808$20240808$PER$$US-OTSUKA-2023_024213$OTSUKA$$$$$F$Y$$$20240808$$PH$US$US
241885061$24188506$1$I$$20231205$20240808$20240808$PER$$US-OTSUKA-2023_031745$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241885071$24188507$1$I$20230913$20231116$20240808$20240808$PER$$US-OTSUKA-2023_024313$OTSUKA$$63$YR$$M$Y$$$20240808$$HP$US$US
241885081$24188508$1$I$20231002$20231121$20240808$20240808$PER$$US-OTSUKA-2023_025825$OTSUKA$$35$YR$$F$Y$88.45$KG$20240808$$CN$US$US
241885091$24188509$1$I$$20231205$20240808$20240808$PER$$US-OTSUKA-2023_031714$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241885101$24188510$1$I$$20231109$20240808$20240808$PER$$US-OTSUKA-2023_023979$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241885111$24188511$1$I$$20231109$20240808$20240808$PER$$US-OTSUKA-2023_029430$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241885131$24188513$1$I$$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54358$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
241885141$24188514$1$I$20150101$20231017$20240808$20240808$PER$$US-OTSUKA-2023_027253$OTSUKA$$26$YR$$F$Y$$$20240808$$CN$US$US
241885151$24188515$1$I$$20231122$20240808$20240808$PER$$US-OTSUKA-2023_024771$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885161$24188516$1$I$$20231211$20240808$20240808$PER$$IE-OTSUKA-2023_032302$OTSUKA$$$$$M$Y$$$20240808$$CN$IE$US
241885181$24188518$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54439$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
241885191$24188519$1$I$$20231201$20240808$20240808$PER$$US-OTSUKA-2023_031472$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241885201$24188520$1$I$20231006$20231204$20240808$20240808$PER$$US-OTSUKA-2023_026447$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241885211$24188521$1$I$$20231207$20240808$20240808$PER$$US-OTSUKA-2023_032034$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241885221$24188522$1$I$$20231111$20240808$20240808$PER$$US-OTSUKA-2023_029613$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241885231$24188523$1$I$$20231016$20240808$20240808$PER$$US-OTSUKA-2023_027123$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241885241$24188524$1$I$$20231103$20240808$20240808$PER$$US-OTSUKA-2023_028964$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241885251$24188525$1$I$20231205$20231205$20240808$20240808$PER$$US-OTSUKA-2023_032718$OTSUKA$$64$YR$$M$Y$$$20240808$$HP$US$US
241885261$24188526$1$I$$20231106$20240808$20240808$PER$$US-OTSUKA-2023_029068$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241885271$24188527$1$I$$20231111$20240808$20240808$PER$$US-OTSUKA-2023_029696$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241885281$24188528$1$I$20231007$20231030$20240808$20240808$PER$$US-OTSUKA-2023_028468$OTSUKA$$$$$F$Y$$$20240808$$PH$US$US
241885291$24188529$1$I$20240806$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156954$AMGEN$$68$YR$E$M$Y$$$20240808$$CN$US$US
241885301$24188530$1$I$20240804$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155589$AMGEN$$66$YR$E$F$Y$$$20240808$$PH$US$US
241885312$24188531$2$F$$20240823$20240808$20240902$EXP$$US-TEVA-VS-3228021$TEVA$Ocasio V, Kapoor S, Atteih S, Sadreameli SC, Mogayzel PJ. A Case of Trimethoprim-sulfamethoxazole Associated Fulminant Respiratory Failure in a 15- year-old Male. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Ocasio V, Kapoor S, Atteih S, Sadreameli SC, Mogayzel PJ. A Case of Trimethoprim-sulfamethoxazole Associated Fulminant Respiratory Failure in a 15- year-old Male. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$15$YR$$M$Y$$$20240902$$HP$US$US
241885324$24188532$4$F$20180718$20240925$20240808$20240927$PER$$US-GILEAD-2024-0683387$GILEAD$$55$YR$A$M$Y$$$20240927$$LW$US$US
241885331$24188533$1$I$$20240111$20240808$20240808$PER$$US-OTSUKA-2024_001025$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885341$24188534$1$I$$20240116$20240808$20240808$PER$$US-OTSUKA-2024_001372$OTSUKA$$$$$F$Y$48.99$KG$20240808$$CN$US$US
241885351$24188535$1$I$$20240219$20240808$20240808$PER$$US-OTSUKA-2024_004459$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241885361$24188536$1$I$20231026$20240112$20240808$20240808$PER$$US-OTSUKA-2023_029686$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241885371$24188537$1$I$$20240222$20240808$20240808$EXP$$US-OTSUKA-2023_034112$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241885381$24188538$1$I$$20240207$20240808$20240808$PER$$US-OTSUKA-2024_003325$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241885391$24188539$1$I$$20231214$20240808$20240808$PER$$US-OTSUKA-2023_032740$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885401$24188540$1$I$$20240108$20240808$20240808$PER$$US-OTSUKA-2023_029204$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241885411$24188541$1$I$$20240111$20240808$20240808$PER$$US-OTSUKA-2024_000985$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241885421$24188542$1$I$$20240201$20240808$20240808$PER$$US-OTSUKA-2024_002858$OTSUKA$$40$YR$$F$Y$$$20240808$$MD$US$US
241885431$24188543$1$I$$20240306$20240808$20240808$PER$$US-OTSUKA-2024_006207$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885441$24188544$1$I$$20240116$20240808$20240808$PER$$US-OTSUKA-2024_001367$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241885451$24188545$1$I$20231212$20240213$20240808$20240808$PER$$US-OTSUKA-2023_032475$OTSUKA$$32$YR$$F$Y$$$20240808$$CN$US$US
241885461$24188546$1$I$$20231214$20240808$20240808$PER$$US-OTSUKA-2023_032717$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885471$24188547$1$I$20120101$20240306$20240808$20240808$PER$$US-OTSUKA-2024_006187$OTSUKA$$$$$F$Y$111.13$KG$20240808$$CN$US$US
241885481$24188548$1$I$20231121$20240115$20240808$20240808$PER$$US-OTSUKA-2024_001249$OTSUKA$$48$YR$$F$Y$126.1$KG$20240808$$CN$US$US
241885491$24188549$1$I$$20240110$20240808$20240808$PER$$US-OTSUKA-2023_031904$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241885501$24188550$1$I$20231028$20231215$20240808$20240808$PER$$US-OTSUKA-2023_028480$OTSUKA$$30$YR$$F$Y$$$20240808$$PH$US$US
241885511$24188551$1$I$$20240205$20240808$20240808$PER$$US-OTSUKA-2023_031784$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241885521$24188552$1$I$$20240229$20240808$20240808$PER$$US-OTSUKA-2024_005611$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241885531$24188553$1$I$20231213$20231215$20240808$20240808$PER$$US-OTSUKA-2023_032857$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885541$24188554$1$I$20240305$20240306$20240808$20240808$EXP$$US-OTSUKA-2024_006183$OTSUKA$$31$YR$$F$Y$$$20240808$$HP$US$US
241885551$24188555$1$I$$20240206$20240808$20240808$EXP$$US-OTSUKA-2024_003290$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241885561$24188556$1$I$20150101$20240227$20240808$20240808$PER$$US-OTSUKA-2024_001267$OTSUKA$$$$$F$Y$111.13$KG$20240808$$HP$US$US
241885571$24188557$1$I$$20240215$20240808$20240808$EXP$$US-OTSUKA-2024_004379$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241885581$24188558$1$I$$20240209$20240808$20240808$PER$$US-OTSUKA-2023_032101$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241885591$24188559$1$I$20240101$20240202$20240808$20240808$PER$$US-OTSUKA-2024_003048$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241885601$24188560$1$I$20240114$20240116$20240808$20240808$PER$$US-OTSUKA-2024_001324$OTSUKA$$53$YR$$F$Y$72.57$KG$20240808$$CN$US$US
241885611$24188561$1$I$$20240301$20240808$20240808$PER$$US-OTSUKA-2024_005717$OTSUKA$$$$$M$Y$62.6$KG$20240808$$CN$US$US
241885621$24188562$1$I$$20240305$20240808$20240808$PER$$US-OTSUKA-2024_006070$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241885631$24188563$1$I$$20240116$20240808$20240808$PER$$US-OTSUKA-2024_001315$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241885641$24188564$1$I$$20240214$20240808$20240808$EXP$$US-OTSUKA-2024_004368$OTSUKA$$$$$F$Y$60.59$KG$20240808$$CN$US$US
241885651$24188565$1$I$$20240115$20240808$20240808$PER$$US-OTSUKA-2024_001266$OTSUKA$$$$$F$Y$63.5$KG$20240808$$CN$US$US
241885661$24188566$1$I$$20240304$20240808$20240808$PER$$US-OTSUKA-2024_005879$OTSUKA$$54$YR$$F$Y$$$20240808$$HP$US$US
241885671$24188567$1$I$$20240202$20240808$20240808$PER$$US-OTSUKA-2024_003002$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241885681$24188568$1$I$$20240229$20240808$20240808$PER$$US-OTSUKA-2024_005752$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241885691$24188569$1$I$$20240109$20240808$20240808$PER$$US-OTSUKA-2023_029166$OTSUKA$$$$$M$Y$145.13$KG$20240808$$CN$US$US
241885701$24188570$1$I$$20240228$20240808$20240808$PER$$US-OTSUKA-2024_005508$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885711$24188571$1$I$20231101$20240216$20240808$20240808$PER$$US-OTSUKA-2024_004380$OTSUKA$$60$YR$$M$Y$$$20240808$$HP$US$US
241885721$24188572$1$I$$20240229$20240808$20240808$EXP$$US-OTSUKA-2024_005586$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241885731$24188573$1$I$20230401$20231226$20240808$20240808$PER$$US-OTSUKA-2024_000898$OTSUKA$$79$YR$$F$Y$$$20240808$$MD$US$US
241885741$24188574$1$I$$20240202$20240808$20240808$PER$$US-OTSUKA-2024_002995$OTSUKA$$24$YR$$F$Y$$$20240808$$HP$US$US
241885751$24188575$1$I$$20240131$20240808$20240808$PER$$US-OTSUKA-2024_002759$OTSUKA$$$$$M$Y$94.35$KG$20240808$$HP$US$US
241885761$24188576$1$I$20230101$20231214$20240808$20240808$PER$$US-OTSUKA-2023_032743$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241885771$24188577$1$I$$20240215$20240808$20240808$PER$$US-OTSUKA-2024_004339$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885781$24188578$1$I$$20240229$20240808$20240808$PER$$US-OTSUKA-2024_005585$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885791$24188579$1$I$$20240122$20240808$20240808$PER$$US-OTSUKA-2024_002997$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241885801$24188580$1$I$$20231214$20240808$20240808$PER$$US-OTSUKA-2023_028217$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241885811$24188581$1$I$$20240205$20240808$20240808$PER$$US-OTSUKA-2023_031805$OTSUKA$$$$$M$Y$$$20240808$$MD$US$US
241885821$24188582$1$I$$20240116$20240808$20240808$PER$$US-OTSUKA-2024_001328$OTSUKA$$$$$M$Y$70.94$KG$20240808$$PH$US$US
241885831$24188583$1$I$20230101$20240130$20240808$20240808$PER$$US-OTSUKA-2024_003195$OTSUKA$$$$$F$Y$72.56$KG$20240808$$CN$US$US
241885841$24188584$1$I$$20240208$20240808$20240808$PER$$US-OTSUKA-2024_003523$OTSUKA$$$$$F$Y$54.88$KG$20240808$$HP$US$US
241885851$24188585$1$I$20240217$20240227$20240808$20240808$EXP$$US-OTSUKA-2024_005333$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241885861$24188586$1$I$$20240229$20240808$20240808$PER$$US-OTSUKA-2024_005587$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885871$24188587$1$I$20240301$20240301$20240808$20240808$PER$$US-OTSUKA-2024_005734$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885881$24188588$1$I$$20240229$20240808$20240808$PER$$US-OTSUKA-2024_005703$OTSUKA$$$$$F$Y$63$KG$20240808$$CN$US$US
241885891$24188589$1$I$$20240201$20240808$20240808$PER$$US-OTSUKA-2024_002851$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885901$24188590$1$I$20240306$20240306$20240808$20240808$PER$$US-OTSUKA-2024_006209$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241885911$24188591$1$I$20240806$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54333$$FDA-CTU$$62$YR$$F$N$$$20240807$N$PH$US$
241885921$24188592$1$I$20240807$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54362$$FDA-CTU$$57$YR$$F$N$79.83$KG$20240807$Y$HP$US$
241885931$24188593$1$I$$20240731$20240808$20240808$EXP$$PT-NORDICGR-057084$NORDIC PHARMA$Desir?e F, Matilde C, Jo?o B, Carolina G, Monica Reis. MIOPATIA IMUNOMEDIADA  POR ANTICORPOS ANTI-HMGCR -  RELATO DE UM CASO CL?NICO (MYOPATHY IMMUNMEDIATED BY ANTI-HMGCR ANTIBODIES - REPORT OF A CLINICAL CASE). Autoimmune, rheumatological diseases and vasculitis Clinical case. 853$69$YR$$M$Y$$$20240808$$HP$PT$PT
241885941$24188594$1$I$$20240731$20240808$20240808$EXP$$GB-NORDICGR-057086$NORDIC PHARMA$Kopernicka G, Chew J. Acute urinary retention and constipation caused by multi-dermatomal herpes zoster in an immunosuppressed patient. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24. DOI:10.1016/j.clinme.2024.100053; Kopernicka G, Chew J. Acute urinary retention and constipation caused by multi-dermatomal herpes zoster in an immunosuppressed patient. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24. DOI:10.1016/j.clinme.2024.1...$71$YR$$F$Y$$$20240808$$MD$GB$
241885951$24188595$1$I$$20240730$20240808$20240808$PER$$US-MYLANLABS-2024M1071894$MYLAN$$$$$F$Y$$$20240808$$CN$US$US
241885961$24188596$1$I$20240101$20240327$20240808$20240808$PER$$US-OTSUKA-2024_008069$OTSUKA$$32$YR$$M$Y$$$20240808$$PH$US$US
241885971$24188597$1$I$$20240411$20240808$20240808$PER$$US-OTSUKA-2024_010699$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241885981$24188598$1$I$$20240509$20240808$20240808$EXP$$US-OTSUKA-2024_013407$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241885991$24188599$1$I$20240310$20240310$20240808$20240808$PER$$US-OTSUKA-2024_006469$OTSUKA$$71$YR$$F$Y$$$20240808$$HP$US$US
241886001$24188600$1$I$$20240327$20240808$20240808$PER$$US-OTSUKA-2024_006397$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241886011$24188601$1$I$$20240311$20240808$20240808$PER$$US-OTSUKA-2024_006530$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241886021$24188602$1$I$20240228$20240501$20240808$20240808$PER$$US-OTSUKA-2024_005455$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241886031$24188603$1$I$$20240311$20240808$20240808$PER$$US-OTSUKA-2024_006593$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241886041$24188604$1$I$$20240503$20240808$20240808$PER$$US-OTSUKA-2024_006218$OTSUKA$$23$YR$$M$Y$$$20240808$$PH$US$US
241886051$24188605$1$I$$20240417$20240808$20240808$EXP$$US-OTSUKA-2024_006776$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241886062$24188606$2$F$$20240823$20240808$20240828$EXP$$AT-NORDICGR-057085$NORDIC PHARMA$$66$YR$$F$Y$$$20240828$$MD$AT$AT
241886071$24188607$1$I$$20240509$20240808$20240808$PER$$US-OTSUKA-2024_013539$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241886081$24188608$1$I$$20240319$20240808$20240808$PER$$US-OTSUKA-2024_007528$OTSUKA$$58$YR$$F$Y$$$20240808$$HP$US$US
241886091$24188609$1$I$$20240425$20240808$20240808$PER$$US-OTSUKA-2024_012174$OTSUKA$$$$A$M$Y$$$20240808$$CN$US$US
241886101$24188610$1$I$$20240403$20240808$20240808$PER$$US-OTSUKA-2024_009195$OTSUKA$$39$YR$$M$Y$$$20240808$$HP$US$US
241886111$24188611$1$I$$20240319$20240808$20240808$PER$$US-OTSUKA-2024_007518$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241886121$24188612$1$I$$20240308$20240808$20240808$PER$$US-OTSUKA-2024_006422$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241886131$24188613$1$I$20240401$20240415$20240808$20240808$PER$$US-OTSUKA-2024_012127$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241886141$24188614$1$I$$20240501$20240808$20240808$PER$$US-OTSUKA-2024_012160$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241886151$24188615$1$I$$20240513$20240808$20240808$PER$$US-OTSUKA-2024_013774$OTSUKA$$25$YR$$F$Y$$$20240808$$HP$US$US
241886161$24188616$1$I$$20240326$20240808$20240808$PER$$US-OTSUKA-2024_008287$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241886171$24188617$1$I$$20240322$20240808$20240808$PER$$CA-OTSUKA-2024_007834$OTSUKA$$$$$$Y$$$20240808$$PH$CA$US
241886181$24188618$1$I$$20240327$20240808$20240808$PER$$US-OTSUKA-2024_008482$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241886191$24188619$1$I$$20240307$20240808$20240808$PER$$US-OTSUKA-2024_001125$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241886201$24188620$1$I$$20240426$20240808$20240808$PER$$US-OTSUKA-2024_012270$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241886211$24188621$1$I$$20240404$20240808$20240808$PER$$US-OTSUKA-2024_009406$OTSUKA$$6$DEC$$F$Y$$$20240808$$HP$US$US
241886221$24188622$1$I$$20240513$20240808$20240808$PER$$US-OTSUKA-2024_013952$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241886231$24188623$1$I$$20240308$20240808$20240808$PER$$US-OTSUKA-2024_006426$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241886241$24188624$1$I$20230914$20240321$20240808$20240808$PER$$US-OTSUKA-2024_007693$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241886251$24188625$1$I$$20240326$20240808$20240808$PER$$US-OTSUKA-2024_008267$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241886261$24188626$1$I$$20240508$20240808$20240808$PER$$US-OTSUKA-2024_013332$OTSUKA$$$$$M$Y$83.91$KG$20240808$$CN$US$US
241886271$24188627$1$I$$20240313$20240808$20240808$PER$$US-OTSUKA-2024_006917$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241886281$24188628$1$I$20240101$20240318$20240808$20240808$EXP$$US-OTSUKA-2024_007303$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241886291$24188629$1$I$$20240320$20240808$20240808$PER$$US-OTSUKA-2024_007609$OTSUKA$$19$YR$$M$Y$$$20240808$$MD$US$US
241886301$24188630$1$I$20240401$20240403$20240808$20240808$PER$$US-OTSUKA-2024_009176$OTSUKA$$65$YR$$F$Y$$$20240808$$PH$US$US
241886311$24188631$1$I$$20240403$20240808$20240808$PER$$US-OTSUKA-2024_009152$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241886321$24188632$1$I$$20240312$20240808$20240808$PER$$US-OTSUKA-2024_006754$OTSUKA$$28$YR$$F$Y$$$20240808$$HP$US$US
241886331$24188633$1$I$$20240509$20240808$20240808$PER$$US-OTSUKA-2024_013441$OTSUKA$$$$$F$Y$81.65$KG$20240808$$CN$US$US
241886341$24188634$1$I$20240426$20240426$20240808$20240808$PER$$US-OTSUKA-2024_012258$OTSUKA$$52$YR$$M$Y$$$20240808$$PH$US$US
241886351$24188635$1$I$$20240401$20240808$20240808$PER$$US-OTSUKA-2024_010470$OTSUKA$$52$YR$$F$Y$$$20240808$$HP$US$US
241886361$24188636$1$I$20240403$20240403$20240808$20240808$PER$$US-OTSUKA-2024_009196$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241886371$24188637$1$I$20210501$20240315$20240808$20240808$PER$$US-OTSUKA-2024_007153$OTSUKA$$22$YR$$F$Y$$$20240808$$HP$US$US
241886381$24188638$1$I$$20240501$20240808$20240808$PER$$US-OTSUKA-2024_012693$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241886391$24188639$1$I$20230401$20240321$20240808$20240808$EXP$$US-OTSUKA-2024_007708$OTSUKA$$19$YR$$M$Y$$$20240808$$MD$US$US
241886401$24188640$1$I$$20240429$20240808$20240808$EXP$$US-OTSUKA-2024_012480$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241886411$24188641$1$I$$20240402$20240808$20240808$PER$$US-OTSUKA-2024_009011$OTSUKA$$$$$F$Y$113.4$KG$20240808$$HP$US$US
241886421$24188642$1$I$$20240424$20240808$20240808$EXP$$US-OTSUKA-2024_011999$OTSUKA$$50$YR$$M$Y$$$20240808$$HP$US$US
241886431$24188643$1$I$$20240424$20240808$20240808$PER$$US-OTSUKA-2024_012056$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241886441$24188644$1$I$$20240326$20240808$20240808$PER$$US-OTSUKA-2024_008211$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241886451$24188645$1$I$$20240410$20240808$20240808$EXP$$US-OTSUKA-2024_010600$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241886461$24188646$1$I$$20240502$20240808$20240808$PER$$US-OTSUKA-2024_005633$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241886471$24188647$1$I$20240429$20240429$20240808$20240808$PER$$US-OTSUKA-2024_012446$OTSUKA$$19$YR$$F$Y$$$20240808$$HP$US$US
241886481$24188648$1$I$$20240429$20240808$20240808$PER$$US-OTSUKA-2024_012505$OTSUKA$$$$$F$Y$58.97$KG$20240808$$CN$US$US
241886491$24188649$1$I$20190101$20240401$20240808$20240808$PER$$US-OTSUKA-2024_008754$OTSUKA$$$$$F$Y$111.13$KG$20240808$$CN$US$US
241886501$24188650$1$I$$20240403$20240808$20240808$PER$$US-OTSUKA-2024_009226$OTSUKA$$26$YR$$M$Y$61.23$KG$20240808$$PH$US$US
241886511$24188651$1$I$$20240426$20240808$20240808$PER$$US-OTSUKA-2024_012296$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241886521$24188652$1$I$$20240425$20240808$20240808$PER$$US-OTSUKA-2024_012148$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241886531$24188653$1$I$$20240510$20240808$20240808$PER$$US-OTSUKA-2024_006888$OTSUKA$$$$$M$Y$$$20240808$$MD$US$US
241886541$24188654$1$I$$20240315$20240808$20240808$PER$$US-OTSUKA-2024_007157$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241886551$24188655$1$I$20230101$20240326$20240808$20240808$PER$$US-OTSUKA-2024_008234$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241886561$24188656$1$I$$20240321$20240808$20240808$PER$$US-OTSUKA-2024_007705$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241886571$24188657$1$I$20240301$20240330$20240808$20240808$PER$$US-OTSUKA-2024_008711$OTSUKA$$67$YR$$M$Y$113.4$KG$20240808$$CN$US$US
241886581$24188658$1$I$20240303$20240503$20240808$20240808$PER$$US-OTSUKA-2024_005773$OTSUKA$$45$YR$$F$Y$$$20240808$$CN$US$US
241886591$24188659$1$I$$20240508$20240808$20240808$PER$$US-OTSUKA-2024_012563$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241886601$24188660$1$I$$20240308$20240808$20240808$PER$$US-OTSUKA-2024_006447$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241886611$24188661$1$I$$20240313$20240808$20240808$EXP$$US-OTSUKA-2024_006894$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241886621$24188662$1$I$$20240403$20240808$20240808$EXP$$US-OTSUKA-2024_009180$OTSUKA$$$$$F$Y$54.43$KG$20240808$$CN$US$US
241886631$24188663$1$I$$20240429$20240808$20240808$PER$$US-OTSUKA-2024_012419$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241886641$24188664$1$I$$20240312$20240808$20240808$PER$$US-OTSUKA-2024_006778$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241886651$24188665$1$I$$20240408$20240808$20240808$PER$$US-OTSUKA-2024_010478$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241886661$24188666$1$I$20230106$20240424$20240808$20240808$PER$$US-OTSUKA-2024_011987$OTSUKA$$42$YR$$F$Y$$$20240808$$HP$US$US
241886671$24188667$1$I$$20240401$20240808$20240808$PER$$US-OTSUKA-2024_002773$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241886681$24188668$1$I$$20240313$20240808$20240808$PER$$US-OTSUKA-2024_006912$OTSUKA$$$$$F$Y$$$20240808$$PH$US$US
241886701$24188670$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124321$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240808$$HP$US$US
241886721$24188672$1$I$20240802$20240802$20240808$20240808$PER$$US-LEO Pharma-372559$LEO PHARM$$70$YR$$F$Y$$$20240808$$CN$US$US
241886741$24188674$1$I$$20240731$20240808$20240808$EXP$$US-GSK-US2024095721$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241886751$24188675$1$I$$20231121$20240808$20240808$PER$$US-OTSUKA-2023_030465$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241886761$24188676$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029793$OTSUKA$Oldak SE, Parrish MS, Cruz A, Bez Y, Jerath A, Coffey BJ. Cannibalistic Ideation in a 14-Year-Old Girl: Psychosis or Trauma?. Journal of child and adolescent psychopharmacology. 2023;33(6):255-58$14$YR$$F$Y$$$20240808$$MD$US$US
241886771$24188677$1$I$$20240531$20240808$20240808$PER$$US-OTSUKA-2024_015683$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241886781$24188678$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029771$OTSUKA$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. Journal of child and adolescent psychopharmacology. 2023;1-6$17$YR$$F$Y$$$20240808$$HP$US$US
241886791$24188679$1$I$20230907$20240621$20240808$20240808$PER$$US-OTSUKA-2024_009001$OTSUKA$$37$YR$$F$Y$$$20240808$$CN$US$US
241886801$24188680$1$I$$20231122$20240808$20240808$PER$$US-OTSUKA-2023_030617$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241886811$24188681$1$I$$20231114$20240808$20240808$PER$$US-OTSUKA-2023_029844$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241886821$24188682$1$I$$20240716$20240808$20240808$PER$$US-OTSUKA-2024_013937$OTSUKA$$$$$M$Y$119.29$KG$20240808$$CN$US$US
241886831$24188683$1$I$$20231120$20240808$20240808$PER$$US-OTSUKA-2023_030356$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241886841$24188684$1$I$20240403$20240605$20240808$20240808$PER$$US-OTSUKA-2024_009218$OTSUKA$$30$YR$$F$Y$97.98$KG$20240808$$HP$US$US
241886851$24188685$1$I$$20240531$20240808$20240808$EXP$$US-OTSUKA-2024_015704$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241886861$24188686$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029773$OTSUKA$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. J Child Adolesc Psychopharmacol.. 2023;1-6$16$YR$$F$Y$$$20240808$$HP$US$US
241886871$24188687$1$I$$20240531$20240808$20240808$PER$$US-OTSUKA-2024_015676$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241886881$24188688$1$I$$20240724$20240808$20240808$PER$$US-OTSUKA-2024_014760$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241886891$24188689$1$I$$20231116$20240808$20240808$PER$$US-OTSUKA-2023_024402$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241886901$24188690$1$I$$20231116$20240808$20240808$PER$$US-OTSUKA-2023_031158$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241886911$24188691$1$I$$20240711$20240808$20240808$PER$$US-OTSUKA-2024_013570$OTSUKA$$28$YR$$F$Y$$$20240808$$HP$US$US
241886921$24188692$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_030126$OTSUKA$Mahdavi KD, Jordan SE, Jordan KG, Rinder ES, Haroon JM, Habelhah B et.al. A pilot study of low-intensity focused ultrasound for treatment-resistant generalized anxiety disorder. J Psychiatr Res.. 2023;168:125-32$40$YR$$M$Y$$$20240808$$HP$US$US
241886931$24188693$1$I$20231121$20231121$20240808$20240808$PER$$US-OTSUKA-2023_030475$OTSUKA$$63$YR$$F$Y$$$20240808$$PH$US$US
241886941$24188694$1$I$$20240523$20240808$20240808$PER$$US-OTSUKA-2024_014944$OTSUKA$$$$$F$Y$72.57$KG$20240808$$CN$US$US
241886951$24188695$1$I$20240416$20240514$20240808$20240808$PER$$US-OTSUKA-2024_013977$OTSUKA$$46$YR$$F$Y$$$20240808$$CN$US$US
241886961$24188696$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029769$OTSUKA$Moon E, Kim E, Williams A. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. J Child Adolesc Psychopharmacol. 2023;1-6$17$YR$$F$Y$$$20240808$$PH$US$US
241886971$24188697$1$I$20240529$20240802$20240808$20240808$PER$$US-OTSUKA-2024_015957$OTSUKA$$36$YR$$F$Y$$$20240808$$PH$US$US
241886981$24188698$1$I$$20240611$20240808$20240808$PER$$US-OTSUKA-2024_010371$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241886991$24188699$1$I$$20240604$20240808$20240808$PER$$US-OTSUKA-2024_016111$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241887001$24188700$1$I$20240401$20240515$20240808$20240808$PER$$US-OTSUKA-2024_014089$OTSUKA$$36$YR$$M$Y$95.25$KG$20240808$$CN$US$US
241887011$24188701$1$I$20220701$20240627$20240808$20240808$PER$$US-OTSUKA-2024_006466$OTSUKA$$76$YR$$F$Y$$$20240808$$CN$US$US
241887021$24188702$1$I$$20231116$20240808$20240808$PER$$US-OTSUKA-2023_030108$OTSUKA$$$$C$$Y$$$20240808$$MD$US$US
241887031$24188703$1$I$$20231115$20240808$20240808$PER$$US-OTSUKA-2023_030105$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241887041$24188704$1$I$$20240516$20240808$20240808$PER$$US-OTSUKA-2024_014171$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241887051$24188705$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029772$OTSUKA$Moon E, Kim E, Williams A. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. J Child Adolesc Psychopharmacol.. 2023;1-6$16$YR$$M$Y$$$20240808$$PH$US$US
241887061$24188706$1$I$$20240521$20240808$20240808$PER$$US-OTSUKA-2024_014635$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241887071$24188707$1$I$$20231120$20240808$20240808$PER$$US-OTSUKA-2023_030355$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241887081$24188708$1$I$$20240521$20240808$20240808$PER$$US-OTSUKA-2024_007602$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241887091$24188709$1$I$$20231114$20240808$20240808$PER$$US-OTSUKA-2023_029848$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241887101$24188710$1$I$20231116$20231117$20240808$20240808$PER$$US-OTSUKA-2023_030190$OTSUKA$$93$YR$$M$Y$86.7$KG$20240808$$PH$US$US
241887111$24188711$1$I$$20231115$20240808$20240808$PER$$US-OTSUKA-2023_029907$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241887121$24188712$1$I$$20240529$20240808$20240808$PER$$US-OTSUKA-2024_015513$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241887131$24188713$1$I$$20240515$20240808$20240808$PER$$US-OTSUKA-2024_006953$OTSUKA$$$$E$M$Y$$$20240808$$CN$US$US
241887141$24188714$1$I$$20240603$20240808$20240808$PER$$US-OTSUKA-2024_015857$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241887151$24188715$1$I$$20231116$20240808$20240808$PER$$US-OTSUKA-2023_030143$OTSUKA$Eremija J, Patel S, Rice S, Daines M. Intravenous immunoglobulin treatment improves multiple neuropsychiatric outcomes in patients with pediatric acute-onset neuropsychiatric syndrome. Front Pediatr. 2023;11:01-06$11$YR$$F$Y$$$20240808$$HP$US$US
241887161$24188716$1$I$$20231116$20240808$20240808$PER$$US-OTSUKA-2023_024343$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241887171$24188717$1$I$$20231117$20240808$20240808$PER$$US-OTSUKA-2023_030227$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241887181$24188718$1$I$$20240530$20240808$20240808$PER$$US-OTSUKA-2024_015541$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241887191$24188719$1$I$$20231116$20240808$20240808$PER$$US-OTSUKA-2023_030144$OTSUKA$Eremija J, Patel S, Rice S, Daines M. Intravenous immunoglobulin treatment improves multiple neuropsychiatric outcomes in patients with pediatric acute-onset neuropsychiatric syndrome. Front Pediatr. 2023;11:01-06$12$YR$$F$Y$$$20240808$$HP$US$US
241887201$24188720$1$I$$20240514$20240808$20240808$PER$$US-OTSUKA-2024_013885$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241887211$24188721$1$I$$20240530$20240808$20240808$PER$$US-OTSUKA-2024_015578$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241887221$24188722$1$I$$20231116$20240808$20240808$PER$$US-OTSUKA-2023_031202$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241887231$24188723$1$I$20210601$20231114$20240808$20240808$PER$$US-OTSUKA-2023_024220$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241887241$24188724$1$I$20030101$20240604$20240808$20240808$PER$$US-OTSUKA-2024_016081$OTSUKA$$$$$F$Y$69.4$KG$20240808$$CN$US$US
241887251$24188725$1$I$$20240726$20240808$20240808$PER$$US-OTSUKA-2023_032733$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241887261$24188726$1$I$$20240604$20240808$20240808$PER$$US-OTSUKA-2024_016072$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241887271$24188727$1$I$$20240530$20240808$20240808$EXP$$US-OTSUKA-2024_015584$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241887281$24188728$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029774$OTSUKA$Moon E, Kim E, Williams A. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. Journal of child and adolescent psychopharmacology. 2023;1-6$17$YR$$M$Y$$$20240808$$HP$US$US
241887291$24188729$1$I$$20231121$20240808$20240808$PER$$US-OTSUKA-2023_030533$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241887301$24188730$1$I$$20231122$20240808$20240808$PER$$US-OTSUKA-2023_030594$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241887311$24188731$1$I$$20231120$20240808$20240808$PER$$US-OTSUKA-2023_030444$OTSUKA$Santore LA, Mandava S, Lee G, Chacko M. Nesidioblastosis with delayed diagnosis and post-operative complications in a patient with complex psychiatric history. BJPsych Open. 2023;9 (6)$22$YR$$F$Y$$$20240808$$HP$US$US
241887323$24188732$3$F$20240723$20240822$20240808$20240829$EXP$$CO-RECORDATI-2024006022$RECORDATI$$$$$$Y$$$20240829$$CN$CO$CO
241887332$24188733$2$F$$20240813$20240808$20240823$EXP$$FR-TEVA-VS-3229894$TEVA$Lacampagne T, Guillotin V, Peuchant O, Belloir A, Sibon I, Bebear C, et al. Current Mycoplasma pneumoniae outbreak: Don^t forget its role in Bickerstaff encephalitis. Diagn-Microbiol-Infect-Dis 2024; 110 (1):.; Lacampagne T, Guillotin V, Peuchant O, Belloir A, Sibon I, Bebear C, et al. Current Mycoplasma pneumoniae outbreak: Don^t forget its role in Bickerstaff encephalitis. Diagn-Microbiol-Infect-Dis 2024; 110 (1):.; Lacampagne T, Guillotin V, Peuchant O, Belloir A, Sibon I, Bebear C, et al....$16$YR$$M$Y$$$20240823$$HP$FR$FR
241887342$24188734$2$F$20210101$20240918$20240808$20240924$EXP$$US-ROCHE-10000009260$ROCHE$$88$YR$E$F$Y$$$20240924$$HP$US$US
241887351$24188735$1$I$$20231221$20240808$20240808$PER$$US-OTSUKA-2024_001467$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241887361$24188736$1$I$$20231126$20240808$20240808$PER$$US-OTSUKA-2023_030926$OTSUKA$$70$YR$$M$Y$$$20240808$$CN$US$US
241887371$24188737$1$I$20231001$20240126$20240808$20240808$EXP$$US-OTSUKA-2024_002364$OTSUKA$$20$YR$$M$Y$$$20240808$$HP$US$US
241887381$24188738$1$I$$20231128$20240808$20240808$PER$$US-OTSUKA-2023_031066$OTSUKA$$$$$M$Y$74.84$KG$20240808$$CN$US$US
241887391$24188739$1$I$20231211$20231215$20240808$20240808$PER$$US-OTSUKA-2023_032876$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241887401$24188740$1$I$$20240118$20240808$20240808$PER$$US-OTSUKA-2024_001632$OTSUKA$$$$$M$Y$$$20240808$$PH$US$US
241887411$24188741$1$I$20240806$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54316$$FDA-CTU$$65$YR$$F$N$127.91$KG$20240806$N$HP$US$
241887421$24188742$1$I$$20240116$20240808$20240808$PER$$US-OTSUKA-2024_001375$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241887431$24188743$1$I$$20231215$20240808$20240808$PER$$US-OTSUKA-2023_033045$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241887441$24188744$1$I$$20231128$20240808$20240808$PER$$US-OTSUKA-2023_031075$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241887471$24188747$1$I$$20240111$20240808$20240808$PER$$US-OTSUKA-2024_001058$OTSUKA$West T, Ajibade O, Fontanetta A, Munir S. No Little Feet: Managing Pseudocyesis in a Homeless, Acutely Manic Patient with Schizoaffective Disorder Bipolar Type. Case Reports in Psychiatry. 2023;2023$35$YR$$F$Y$$$20240808$$HP$US$US
241887481$24188748$1$I$$20231127$20240808$20240808$PER$$US-OTSUKA-2023_030983$OTSUKA$Termini K, Anand E, Hickox T, Richter LD, Smith JR.. Manifestation of Catatonia in an Adolescent With 22q11.2 Syndrome. Journal of the American Academy of Child and Adolescent Psychiatry. 2023;62:1281-86$14$YR$$F$Y$$$20240808$$MD$US$US
241887491$24188749$1$I$$20240207$20240808$20240808$PER$$US-OTSUKA-2024_003601$OTSUKA$$17$YR$$F$Y$$$20240808$$MD$US$US
241887501$24188750$1$I$$20240103$20240808$20240808$PER$$US-OTSUKA-2024_000225$OTSUKA$$17$YR$$F$Y$$$20240808$$MD$US$US
241887511$24188751$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54324$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
241887521$24188752$1$I$$20240207$20240808$20240808$PER$$US-OTSUKA-2024_003736$OTSUKA$$$$$F$Y$108.84$KG$20240808$$CN$US$US
241887531$24188753$1$I$20240722$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54429$$FDA-CTU$$56$YR$$M$N$82.1$KG$20240806$N$HP$US$
241887541$24188754$1$I$$20240108$20240808$20240808$EXP$$US-OTSUKA-2024_000716$OTSUKA$Roccaforte Z, Daghighi P, Findley JC, Zeni C. An Atypical Presentation of Tardive Dyskinesia in an Adolescent Patient with Complex Neuropsychiatric History: A Case Report. ANNALS OF NEUROLOGY. 2023;94 (Supp. 30):S168-69$13$YR$$M$Y$$$20240808$$HP$US$US
241887551$24188755$1$I$20210101$20240126$20240808$20240808$PER$$US-OTSUKA-2024_002362$OTSUKA$$$$$F$Y$$$20240808$$PH$US$US
241887561$24188756$1$I$$20231221$20240808$20240808$PER$$US-OTSUKA-2023_033489$OTSUKA$$$$C$M$Y$$$20240808$$MD$US$US
241887571$24188757$1$I$$20240208$20240808$20240808$PER$$US-OTSUKA-2024_004707$OTSUKA$$$$E$F$Y$$$20240808$$MD$US$US
241887581$24188758$1$I$$20240208$20240808$20240808$PER$$US-OTSUKA-2024_003588$OTSUKA$$$$$M$Y$86.18$KG$20240808$$CN$US$US
241887591$24188759$1$I$$20231218$20240808$20240808$PER$$US-OTSUKA-2023_032991$OTSUKA$$$$A$M$Y$$$20240808$$HP$US$US
241887601$24188760$1$I$$20240129$20240808$20240808$PER$$US-OTSUKA-2024_002559$OTSUKA$Lester EG, Vitolo OV, Flaherty A, Beaussant Y, Cramer M, Harley R et al.. When Will All of This End?^: A 65-Year-Old Man With Amyotrophic Lateral Sclerosis and Psychiatric Distress. J Clin Psychiatry. 2024;85(1):1-7$65$YR$$M$Y$$$20240808$$MD$US$US
241887611$24188761$1$I$$20231220$20240808$20240808$EXP$$US-OTSUKA-2024_000106$OTSUKA$Compton J, Miller MG. Aripiprazole-Induced Neutropenia in a Patient With Early Psychosis Complicated by Catatonia. American Psychiatric Association. 2023;1-2$26$YR$$F$Y$$$20240808$$MD$US$US
241887621$24188762$1$I$$20240118$20240808$20240808$PER$$US-OTSUKA-2024_000295$OTSUKA$Sreevalsam AS, TM, WJ.. A case of phentermine-induced psychosis: the need for caution for drug-drug interactions. European Psychiatry. 2023;S1015-S1016$61$YR$$F$Y$$$20240808$$HP$US$US
241887631$24188763$1$I$$20231128$20240808$20240808$PER$$US-OTSUKA-2023_031056$OTSUKA$$3$DEC$$F$Y$$$20240808$$HP$US$US
241887641$24188764$1$I$$20231128$20240808$20240808$PER$$US-OTSUKA-2023_031161$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241887651$24188765$1$I$20240101$20240118$20240808$20240808$PER$$US-OTSUKA-2024_001642$OTSUKA$$29$YR$$M$Y$51.71$KG$20240808$$CN$US$US
241887661$24188766$1$I$$20231211$20240808$20240808$PER$$US-OTSUKA-2023_032402$OTSUKA$Reinfeld S,Gill P. Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: A case series. CNS Spectrums. 2023;28(5):587-91$12$YR$$F$Y$$$20240808$$HP$US$US
241887671$24188767$1$I$$20231204$20240808$20240808$PER$$US-OTSUKA-2023_031682$OTSUKA$Weinstock LB, Nelson RM, Blitshteyn S.. Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed  Treatment: A Case Series. J Pers Med. 2023;13(11):1562$37$YR$$F$Y$$$20240808$$HP$US$US
241887681$24188768$1$I$$20240208$20240808$20240808$PER$$US-OTSUKA-2024_003694$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241887691$24188769$1$I$20240102$20240103$20240808$20240808$PER$$US-OTSUKA-2024_000235$OTSUKA$$$$$F$Y$$$20240808$$PH$US$US
241887701$24188770$1$I$$20240122$20240808$20240808$PER$$US-OTSUKA-2024_001844$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241887711$24188771$1$I$$20231218$20240808$20240808$PER$$US-OTSUKA-2023_033040$OTSUKA$Jerath AU, Oldak SE, Parrish MS, Zaydlin M, Martin S, Brown K et.al. Ketamine and Transcranial Magnetic Stimulation in an Adolescent with Treatment-Resistant Depression. J Child Adolesc Psychopharmacol.. 2023;33(7):297-303$16$YR$$F$Y$$$20240808$$MD$US$US
241887721$24188772$1$I$$20231127$20240808$20240808$PER$$US-OTSUKA-2023_030985$OTSUKA$Langone S, Dever K., Ricciardi JN, Sherak, DL.. An Integrated Behavioral-Neuropsychiatric Treatment Plan Reduces Severe Challenging Behavior in an Adolescent With Neurobehavioral Complications of Neonatal Brain Injury. Clinical Case Studies. 2023;22(6):503-17$15$YR$$M$Y$$$20240808$$HP$US$US
241887731$24188773$1$I$20210101$20240103$20240808$20240808$PER$$US-OTSUKA-2024_000209$OTSUKA$$44$YR$$M$Y$122.47$KG$20240808$$PH$US$US
241887741$24188774$1$I$$20231128$20240808$20240808$EXP$$US-OTSUKA-2023_031040$OTSUKA$$$$$F$Y$56.7$KG$20240808$$HP$US$US
241887751$24188775$1$I$$20240122$20240808$20240808$PER$$US-OTSUKA-2023_030080$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241887761$24188776$1$I$$20231228$20240808$20240808$PER$$US-OTSUKA-2023_034107$OTSUKA$Patel S, Sivananthan M.. Hypersensitivity to Psychotropic Medications in a Patient With 17q12 Microdeletion Syndrome: A Case Report. J Clin Psychopharmacol. 2024;44(1):69-71$29$YR$$M$Y$$$20240808$$MD$US$US
241887771$24188777$1$I$$20240106$20240808$20240808$PER$$US-OTSUKA-2024_000647$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241887781$24188778$1$I$$20231228$20240808$20240808$PER$$US-OTSUKA-2023_034037$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241887791$24188779$1$I$$20240118$20240808$20240808$PER$$US-OTSUKA-2024_001674$OTSUKA$Risi E, Bagla P, Allen L, Das A. Charles Bonnet Syndrome Leading to Delusional and Ocular Delusional Parasitosis. Primary Care Companion for CNS Disorders. 2023;25(6)$78$YR$$M$Y$$$20240808$$HP$US$US
241887801$24188780$1$I$$20231201$20240808$20240808$PER$$US-OTSUKA-2023_031454$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241887811$24188781$1$I$$20231212$20240808$20240808$PER$$US-OTSUKA-2023_032518$OTSUKA$King-Nakaoka EA, Beasley HM, Kessinger SR, Pfeiffer DC.. Postpartum subarachnoid hemorrhage - questions on gestational hypertension diagnosis and treatment threshold: A case report. Case Reports in Women^s Health. 2023;40$37$YR$$F$Y$$$20240808$$HP$US$US
241887821$24188782$1$I$$20231218$20240808$20240808$EXP$$US-OTSUKA-2023_032919$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241887831$24188783$1$I$20231121$20240129$20240808$20240808$PER$$US-OTSUKA-2023_030466$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241887841$24188784$1$I$$20240124$20240808$20240808$PER$$US-OTSUKA-2024_002224$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241887851$24188785$1$I$20220801$20240125$20240808$20240808$PER$$US-OTSUKA-2024_002532$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241887861$24188786$1$I$$20231128$20240808$20240808$PER$$US-OTSUKA-2023_031154$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241887871$24188787$1$I$$20231130$20240808$20240808$PER$$US-OTSUKA-2023_031304$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241887881$24188788$1$I$$20231211$20240808$20240808$PER$$US-OTSUKA-2023_032366$OTSUKA$Chang AN. Visual and Auditory Hallucinations in Anxious Preadolescent Children. Prim Care Companion CNS Disord. 2023;25(5)$10$YR$$M$Y$$$20240808$$MD$US$US
241887891$24188789$1$I$$20231211$20240808$20240808$PER$$US-OTSUKA-2023_032375$OTSUKA$Patterson EM, Lim J, Fuchs P, Smith JR, Moussa-Tooks A, Ward HB.. Use of First-Generation Antipsychotics in an Adolescent Male with Catatonic Schizophrenia. Harvard Review of Psychiatry. 2023;31(6):267-273$15$YR$$M$Y$$$20240808$$MD$US$US
241887901$24188790$1$I$$20240122$20240808$20240808$PER$$US-OTSUKA-2024_001962$OTSUKA$Weyhaupt M, Hardcastle S, Jesse N, Almeida M, Ward HB, Brady R. Diagnosis and Management of Perimenstrual Cycloid Motility Psychosis. Harv Rev Psychiatry.. 2024;32(1):33-39$23$YR$$F$Y$$$20240808$$MD$US$US
241887911$24188791$1$I$20240105$20240105$20240808$20240808$PER$$US-OTSUKA-2024_000550$OTSUKA$$43$YR$$F$Y$98.88$KG$20240808$$HP$US$US
241887921$24188792$1$I$20231001$20231214$20240808$20240808$PER$$US-OTSUKA-2023_030942$OTSUKA$$53$YR$$M$Y$$$20240808$$PH$US$US
241887931$24188793$1$I$$20240104$20240808$20240808$EXP$$US-OTSUKA-2024_000496$OTSUKA$Schmidt M, Marrone L, Hadler NL. A Case of Exquisite Sensitivity To Neuroleptics In a Young Active Duty Service Member With First Episode Psychosis. 2023$20$YR$$M$Y$$$20240808$$MD$US$US
241887941$24188794$1$I$$20231220$20240808$20240808$EXP$$US-OTSUKA-2023_032374$OTSUKA$Gude J, Bisen V, Fujii K. Medication-induced rhabdomyolysis in a patient with bipolar disorder. Current Psychiatry. 2023;22(2):39-40$32$YR$$F$Y$$$20240808$$MD$US$US
241887951$24188795$1$I$$20240124$20240808$20240808$PER$$US-OTSUKA-2024_002196$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241887961$24188796$1$I$$20231218$20240808$20240808$PER$$US-OTSUKA-2023_033003$OTSUKA$$8$DEC$$F$Y$$$20240808$$HP$US$US
241887971$24188797$1$I$$20240103$20240808$20240808$EXP$$US-OTSUKA-2024_000233$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241887981$24188798$1$I$20221201$20240125$20240808$20240808$PER$$US-OTSUKA-2024_002255$OTSUKA$$18$YR$$M$Y$77.11$KG$20240808$$CN$US$US
241887991$24188799$1$I$$20240108$20240808$20240808$PER$$US-OTSUKA-2024_000700$OTSUKA$Margolis M, Wong TL, Shmuts R, Taylor JB. Consultation-Liaison Case Conference: A Case of Factitious Disorder Imposed on Self.. J Acad Consult Liaison Psychiatry. 2023;64(6):562-70$30$YR$$F$Y$$$20240808$$MD$US$US
241888001$24188800$1$I$$20231226$20240808$20240808$PER$$US-OTSUKA-2023_033861$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241888011$24188801$1$I$$20240108$20240808$20240808$PER$$US-OTSUKA-2024_000844$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241888021$24188802$1$I$20231001$20240129$20240808$20240808$EXP$$US-OTSUKA-2024_002469$OTSUKA$$3$DEC$$F$Y$$$20240808$$HP$US$US
241888031$24188803$1$I$$20231201$20240808$20240808$PER$$US-OTSUKA-2023_031463$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241888041$24188804$1$I$$20240102$20240808$20240808$EXP$$US-OTSUKA-2024_000169$OTSUKA$D. Jacob A. Metabolic Concerns in a Patient on Long Acting Injectable Aripiprazole. American Psychiatric Association. 2023$$$$M$Y$$$20240808$$MD$US$US
241888051$24188805$1$I$$20231201$20240808$20240808$PER$$US-OTSUKA-2023_031465$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241888061$24188806$1$I$$20240131$20240808$20240808$EXP$$US-OTSUKA-2024_002726$OTSUKA$$3$DEC$$M$Y$$$20240808$$HP$US$US
241888071$24188807$1$I$20230101$20240124$20240808$20240808$PER$$US-OTSUKA-2024_002107$OTSUKA$$$$$M$Y$77.11$KG$20240808$$CN$US$US
241888081$24188808$1$I$$20240208$20240808$20240808$PER$$US-OTSUKA-2024_003575$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241888091$24188809$1$I$$20240122$20240808$20240808$PER$$US-OTSUKA-2024_001951$OTSUKA$Wang J, Abu-Hamad SJ, Jennings M, Blackburn K, Robinson DM.. Hero or Antagonist: A Case Series on the Tolerability of Memantine as Salvage Therapy for Catatonia from Anti-NMDA Receptor Encephalitis. HARVARD REVIEW OF PSYCHIATRY. 2023;31(6):281-86$3$DEC$$F$Y$$$20240808$$HP$US$US
241888101$24188810$1$I$$20231128$20240808$20240808$PER$$US-OTSUKA-2023_031055$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241888111$24188811$1$I$$20240103$20240808$20240808$PER$$US-OTSUKA-2024_000216$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241888121$24188812$1$I$$20240129$20240808$20240808$PER$$US-OTSUKA-2024_002569$OTSUKA$Goldstein S, Jooryabi D, Ammon K, Delaney J, Rodulfo A.. An Unusual Presentation of Delusional Companion Syndrome: A Case Report and Review of the Literature. Cureus. 2023;15(12):1-4$29$YR$$F$Y$$$20240808$$HP$US$US
241888131$24188813$1$I$$20231127$20240808$20240808$PER$$US-OTSUKA-2023_030987$OTSUKA$Volmrich A, Alvarez G. Moving forward: A case report on the successful treatment of movement disorder after anoxic brain injury. Brain Injury. 2023;37:19-20$32$YR$$F$Y$$$20240808$$HP$US$US
241888141$24188814$1$I$$20240126$20240808$20240808$PER$$US-OTSUKA-2024_002392$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241888151$24188815$1$I$$20240125$20240808$20240808$PER$$US-OTSUKA-2024_002235$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241888161$24188816$1$I$$20240117$20240808$20240808$PER$$US-OTSUKA-2024_001508$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241888171$24188817$1$I$$20231225$20240808$20240808$PER$$US-OTSUKA-2023_033829$OTSUKA$Espiridion ED, Saxena S.. Priapism in a 31-Year-Old Male With Paranoid Schizophrenia. Cureus. 2023;15(11):e48978$31$YR$$M$Y$$$20240808$$HP$US$US
241888181$24188818$1$I$$20240117$20240808$20240808$PER$$US-OTSUKA-2024_001540$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241888191$24188819$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683417$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241888201$24188820$1$I$$20240730$20240808$20240808$30DAY$$US-GSK-US2024095250$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$MD$US$US
241888211$24188821$1$I$$20231204$20240808$20240808$PER$$US-OTSUKA-2023_031675$OTSUKA$Lillig M, Reyes Pinzon SH. Rathke^s Cleft Cyst and Psychiatric Symptoms in an Adolescent. Prim Care Companion CNS Disord. 2023;25(5):e1-e2$12$YR$$M$Y$$$20240808$$MD$US$US
241888223$24188822$3$F$20240401$20240920$20240808$20240923$PER$$US-AMGEN-USASP2024155026$AMGEN$$70$YR$E$M$Y$$$20240923$$CN$US$US
241888231$24188823$1$I$$20240415$20240808$20240808$PER$$US-OTSUKA-2024_011094$OTSUKA$Laudon S, Duncanson L, Sandercock K, Morales-Ortiz M, Ramos A, Pishko S et al. The complexities of care in a teenager with neuropsychiatric lupus. American Journal of the Medical Sciences. 2024;367(S1):S265$16$YR$$F$Y$$$20240808$$HP$US$US
241888241$24188824$1$I$$20240220$20240808$20240808$PER$$US-OTSUKA-2024_004666$OTSUKA$$$$$M$Y$$$20240808$$PH$US$US
241888251$24188825$1$I$$20240502$20240808$20240808$PER$$US-OTSUKA-2024_011845$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241888261$24188826$1$I$$20240321$20240808$20240808$EXP$$US-OTSUKA-2024_007829$OTSUKA$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ et. al. 2022 Annual Report of the National Poison Data System+REG; (NPDS) from America^s Poison Centers+REG;: 40th Annual Report. CLINICAL TOXICOLOGY. 2023;61 (10):717-939$51$YR$$F$Y$$$20240808$$MD$US$US
241888271$24188827$1$I$$20240219$20240808$20240808$PER$$US-OTSUKA-2024_004484$OTSUKA$$$$$F$Y$88.9$KG$20240808$$CN$US$US
241888281$24188828$1$I$$20240314$20240808$20240808$PER$$US-OTSUKA-2024_007150$OTSUKA$Sterina E.. Cognitive Decline in Older Adults with Schizophrenia-Bipolar Spectrum Disorder. American Journal of Geriatric Psychiatry. 2024;32(4):S36-37$67$YR$$M$Y$$$20240808$$MD$US$US
241888291$24188829$1$I$20240501$20240502$20240808$20240808$PER$$US-OTSUKA-2024_012789$OTSUKA$$15$YR$$M$Y$52.62$KG$20240808$$MD$US$US
241888301$24188830$1$I$$20240321$20240808$20240808$EXP$$US-OTSUKA-2024_007828$OTSUKA$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al.. 2022 Annual Report of the National Poison Data System+REG; (NPDS) from America^s Poison Centers+REG;: 40th Annual Report. CLINICAL TOXICOLOGY. 2023;61(10):717-939$39$YR$$M$Y$$$20240808$$MD$US$US
241888311$24188831$1$I$20240221$20240222$20240808$20240808$PER$$US-OTSUKA-2024_004943$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241888321$24188832$1$I$$20240321$20240808$20240808$EXP$$US-OTSUKA-2024_007832$OTSUKA$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ et. al.. 2022 Annual Report of the National Poison Data System+REG; (NPDS) from America^s Poison Centers+REG;: 40th Annual Report. CLINICAL TOXICOLOGY. 2023;61(10):717-939$69$YR$$F$Y$$$20240808$$MD$US$US
241888331$24188833$1$I$$20240411$20240808$20240808$PER$$US-OTSUKA-2024_010726$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241888351$24188835$1$I$$20240321$20240808$20240808$PER$$US-OTSUKA-2024_007791$OTSUKA$Romanowicz M, Croarkin KS, Elmaghraby R, Skime M, Croarkin PE, Voort JV et. al.. Machine Learning Identifies Smartwatch-Based Physiological Biomarker for Predicting Disruptive Behavior in Children: A Feasibility Study. J Child Adolesc Psychopharmacol. 2023;33(9):387-92$10$YR$$M$Y$$$20240808$$MD$US$US
241888361$24188836$1$I$$20240213$20240808$20240808$PER$$US-OTSUKA-2024_003996$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241888371$24188837$1$I$20240220$20240423$20240808$20240808$PER$$US-OTSUKA-2024_004695$OTSUKA$$29$YR$$M$Y$122.02$KG$20240808$$HP$US$US
241888381$24188838$1$I$$20240423$20240808$20240808$PER$$US-OTSUKA-2024_011847$OTSUKA$$48$YR$$$Y$$$20240808$$HP$US$US
241888391$24188839$1$I$20231101$20240313$20240808$20240808$PER$$US-OTSUKA-2024_002363$OTSUKA$$17$YR$$M$Y$$$20240808$$MD$US$US
241888401$24188840$1$I$$20240223$20240808$20240808$PER$$US-OTSUKA-2024_019543$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241888411$24188841$1$I$$20240418$20240808$20240808$PER$$US-OTSUKA-2024_011473$OTSUKA$Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, et.al.. Psychedelic Therapy: A Primer for Primary Care Clinicians - Psilocybin. American Journal of Therapeutics. 2024;31(2):e121-E32$37$YR$$F$Y$$$20240808$$MD$US$US
241888421$24188842$1$I$$20240401$20240808$20240808$PER$$US-OTSUKA-2024_002731$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241888431$24188843$1$I$$20240223$20240808$20240808$PER$$US-OTSUKA-2024_003552$OTSUKA$$$$$M$Y$89.8$KG$20240808$$HP$US$US
241888441$24188844$1$I$20230101$20240221$20240808$20240808$PER$$US-OTSUKA-2024_004834$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241888451$24188845$1$I$20240220$20240423$20240808$20240808$PER$$US-OTSUKA-2024_004835$OTSUKA$$25$YR$$F$Y$68.04$KG$20240808$$CN$US$US
241888461$24188846$1$I$$20240226$20240808$20240808$PER$$US-OTSUKA-2024_005156$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241888471$24188847$1$I$$20240401$20240808$20240808$PER$$US-OTSUKA-2023_030529$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241888481$24188848$1$I$20240220$20240220$20240808$20240808$PER$$US-OTSUKA-2024_004660$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241888491$24188849$1$I$$20240215$20240808$20240808$PER$$US-OTSUKA-2024_004242$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241888501$24188850$1$I$$20240321$20240808$20240808$EXP$$US-OTSUKA-2024_007825$OTSUKA$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al.. 2022 Annual Report of the National Poison Data System+REG; (NPDS) from America^s Poison Centers+REG;: 40th Annual Report. CLINICAL TOXICOLOGY. 2023;61(10):717-939$54$YR$$F$Y$$$20240808$$MD$US$US
241888511$24188851$1$I$$20240501$20240808$20240808$EXP$$US-OTSUKA-2024_012694$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241888521$24188852$1$I$$20240429$20240808$20240808$PER$$US-OTSUKA-2024_012573$OTSUKA$Soin A, Zhang E, Gershengoren L. Management of Immunosuppressant-Induced Psychosis Across the Lifespan. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64:S129-S130$60$YR$$F$Y$$$20240808$$HP$US$US
241888531$24188853$1$I$$20240422$20240808$20240808$PER$$US-OTSUKA-2024_011656$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241888541$24188854$1$I$$20240422$20240808$20240808$PER$$US-OTSUKA-2024_011762$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241888551$24188855$1$I$$20240212$20240808$20240808$PER$$US-OTSUKA-2023_032860$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241888561$24188856$1$I$$20240321$20240808$20240808$EXP$$US-OTSUKA-2024_007822$OTSUKA$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al.. 2022 Annual Report of the National Poison Data System+REG; (NPDS) from America^s Poison Centers+REG;:40th Annual Report. CLINICAL TOXICOLOGY. 2023;61(10):717-939$52$YR$$F$Y$$$20240808$$MD$US$US
241888571$24188857$1$I$$20240220$20240808$20240808$PER$$US-OTSUKA-2024_004662$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241888581$24188858$1$I$$20240209$20240808$20240808$PER$$US-OTSUKA-2024_003724$OTSUKA$$21$YR$$M$Y$$$20240808$$CN$US$US
241888591$24188859$1$I$$20240412$20240808$20240808$PER$$US-OTSUKA-2024_001376$OTSUKA$$$$$F$Y$90.7$KG$20240808$$CN$US$US
241888601$24188860$1$I$20240401$20240429$20240808$20240808$PER$$US-OTSUKA-2024_012417$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241888611$24188861$1$I$$20240221$20240808$20240808$PER$$US-OTSUKA-2024_004809$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241888621$24188862$1$I$20231221$20240222$20240808$20240808$PER$$US-OTSUKA-2023_033491$OTSUKA$$26$YR$$M$Y$131.54$KG$20240808$$CN$US$US
241888631$24188863$1$I$$20240416$20240808$20240808$PER$$US-OTSUKA-2024_004081$OTSUKA$$$$$M$Y$$$20240808$$MD$US$US
241888641$24188864$1$I$$20240307$20240808$20240808$PER$$US-OTSUKA-2024_001819$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241888651$24188865$1$I$20231215$20240226$20240808$20240808$PER$$US-OTSUKA-2023_032973$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241888661$24188866$1$I$$20240410$20240808$20240808$PER$$US-OTSUKA-2024_010750$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241888671$24188867$1$I$$20240423$20240808$20240808$PER$$US-OTSUKA-2024_004782$OTSUKA$$$$$F$Y$$$20240808$$PH$US$US
241888681$24188868$1$I$$20240329$20240808$20240808$PER$$US-OTSUKA-2024_002475$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241888691$24188869$1$I$$20240429$20240808$20240808$PER$$US-OTSUKA-2024_005342$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241888701$24188870$1$I$20240401$20240501$20240808$20240808$PER$$US-OTSUKA-2024_012695$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241888711$24188871$1$I$$20240430$20240808$20240808$PER$$US-OTSUKA-2024_013112$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241888721$24188872$1$I$$20240223$20240808$20240808$PER$$US-OTSUKA-2024_005027$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241888731$24188873$1$I$$20240429$20240808$20240808$PER$$US-OTSUKA-2024_012569$OTSUKA$Kang M, Ramasubramani RS, Ilaria S, Tobia A, Trenton A.. Delusional Parasitosis and the Urgent Need for a Ventricular Assist Device. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64:S2-S3$67$YR$$M$Y$$$20240808$$HP$US$US
241888741$24188874$1$I$$20240223$20240808$20240808$EXP$$US-OTSUKA-2024_005268$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241888751$24188875$1$I$20240322$20240411$20240808$20240808$EXP$$US-OTSUKA-2024_010725$OTSUKA$$46$YR$$M$Y$95.25$KG$20240808$$CN$US$US
241888761$24188876$1$I$20240429$20240429$20240808$20240808$PER$$US-OTSUKA-2024_012491$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241888771$24188877$1$I$$20240226$20240808$20240808$PER$$US-OTSUKA-2024_005225$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241888781$24188878$1$I$$20240307$20240808$20240808$PER$$US-OTSUKA-2024_003767$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241888791$24188879$1$I$$20240220$20240808$20240808$PER$$US-OTSUKA-2024_004925$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241888801$24188880$1$I$$20240430$20240808$20240808$PER$$US-OTSUKA-2024_012616$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241888811$24188881$1$I$$20240416$20240808$20240808$PER$$US-OTSUKA-2024_011176$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241888821$24188882$1$I$$20240321$20240808$20240808$EXP$$US-OTSUKA-2024_007827$OTSUKA$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al.. 2022 Annual Report of the National Poison Data System+REG; (NPDS) from America^s Poison Centers+REG;:40th Annual Report. CLINICAL TOXICOLOGY. 2023;61(10):717-939$15$YR$$M$Y$$$20240808$$MD$US$US
241888831$24188883$1$I$$20240327$20240808$20240808$PER$$US-OTSUKA-2024_002168$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241888841$24188884$1$I$$20240410$20240808$20240808$PER$$US-OTSUKA-2024_003592$OTSUKA$$$$$F$Y$$$20240808$$PH$US$US
241888851$24188885$1$I$$20240214$20240808$20240808$PER$$US-OTSUKA-2024_004083$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241888861$24188886$1$I$20240805$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54416$$FDA-CTU$$77$YR$$$N$118.84$KG$20240806$N$$US$
241888871$24188887$1$I$$20240417$20240808$20240808$PER$$US-OTSUKA-2024_011282$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241888881$24188888$1$I$$20240729$20240807$20240807$DIR$FDA-CDER-CTU-2024-54344$$FDA-CTU$$$$$F$N$$$20240729$N$HP$US$
241888891$24188889$1$I$$20240325$20240808$20240808$PER$$US-OTSUKA-2024_008164$OTSUKA$Park JH, Sarwar S, Hassett LC, Staab JP, Fipps DC.. Clinical Characterization, Course, and Treatment of Othello Syndrome: A Case Series and Systematic Review of the Literature. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65(1):89-105$67$YR$$F$Y$$$20240808$$MD$US$US
241888901$24188890$1$I$$20240422$20240808$20240808$PER$$US-OTSUKA-2024_011681$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241888911$24188891$1$I$20240803$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54445$$FDA-CTU$$94$YR$$M$N$$$20240806$N$$US$
241888921$24188892$1$I$$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54420$$FDA-CTU$$63$YR$$M$N$$$20240806$N$$US$
241888931$24188893$1$I$$20240415$20240808$20240808$PER$$US-OTSUKA-2024_010986$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241888941$24188894$1$I$20231114$20240401$20240808$20240808$PER$$US-OTSUKA-2023_029922$OTSUKA$$53$YR$$F$Y$83.46$KG$20240808$$CN$US$US
241888951$24188895$1$I$$20240219$20240808$20240808$PER$$US-OTSUKA-2024_004516$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241888961$24188896$1$I$$20240429$20240808$20240808$PER$$US-OTSUKA-2024_012514$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241888971$24188897$1$I$$20240321$20240808$20240808$EXP$$US-OTSUKA-2024_007803$OTSUKA$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al.. 2022 Annual Report of the National Poison Data System+REG; (NPDS) from America^s Poison Centers+REG;: 40th Annual Report. CLINICAL TOXICOLOGY. 2023;61(10):717-939$31$YR$$F$Y$$$20240808$$MD$US$US
241888981$24188898$1$I$20230701$20240426$20240808$20240808$PER$$US-OTSUKA-2024_004980$OTSUKA$$36$YR$$F$Y$53.52$KG$20240808$$PH$US$US
241888991$24188899$1$I$$20240220$20240808$20240808$PER$$US-OTSUKA-2024_004687$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889005$24188900$5$F$20230301$20240925$20240808$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-039331$AUROBINDO$Chouchana M, Pinel S, Colboc H, Soria A, Buard G, Delage C ,et al. Donepezil as a safe alternative treatment after maculo-papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data.. Psychogeriatrics: the official journal of the Japanese Psychogeriatric Society. 2024;1-4$79$YR$$M$Y$66$KG$20240928$$MD$FR$FR
241889011$24188901$1$I$$20240730$20240808$20240808$EXP$$ES-AUROBINDO-AUR-APL-2024-038843$AUROBINDO$Pitarch CG, Macia MS, Simon J, Mosca L, Conter C, Rejano-Gordillo CM, et al. Neddylation inhibition prevents acetaminopheninduced liver damage by enhancing the anabolic cardiolipin pathway. Cell Reports Medicine. 2024;5(7)$$$A$F$Y$$$20240808$$HP$ES$ES
241889021$24188902$1$I$$20240506$20240808$20240808$PER$$US-OTSUKA-2024_013005$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889031$24188903$1$I$$20240523$20240808$20240808$PER$$US-OTSUKA-2024_014893$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241889041$24188904$1$I$$20240502$20240808$20240808$PER$$US-OTSUKA-2024_012790$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889051$24188905$1$I$$20240514$20240808$20240808$PER$$US-OTSUKA-2024_013930$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889061$24188906$1$I$$20240708$20240808$20240808$PER$$US-OTSUKA-2024_019279$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889071$24188907$1$I$20030101$20240710$20240808$20240808$PER$$US-OTSUKA-2024_019560$OTSUKA$$63$YR$$F$Y$83.91$KG$20240808$$CN$US$US
241889081$24188908$1$I$$20240304$20240808$20240808$PER$$US-OTSUKA-2024_006002$OTSUKA$Hickox T, Brahmbhatt K, Smith JR, Fuchs C, Tanguturi Y.. Consultation-Liaison Case Conference: Systemic Challenges in Management of Aggression in a Pediatric Patient With Seronegative Autoimmune Encephalitis. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65(1):66-75$9$YR$$F$Y$$$20240808$$HP$US$US
241889091$24188909$1$I$$20240513$20240808$20240808$PER$$US-OTSUKA-2024_013796$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241889101$24188910$1$I$$20240617$20240808$20240808$PER$$US-OTSUKA-2024_010958$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889111$24188911$1$I$20240506$20240627$20240808$20240808$PER$$US-OTSUKA-2024_013022$OTSUKA$$41$YR$$M$Y$$$20240808$$PH$US$US
241889121$24188912$1$I$$20240314$20240808$20240808$PER$$US-OTSUKA-2024_007147$OTSUKA$McQuilla J,Cinderella M,Steiner J. Outside the Lines: A Case Report Highlighting the Difficulties Faced Treating a Female Geriatric Patient with Anorexia Nervosa. American Journal of Geriatric Psychiatry. 2024;32(4):S78-S79$63$YR$$F$Y$$$20240808$$MD$US$US
241889131$24188913$1$I$$20240507$20240808$20240808$PER$$US-OTSUKA-2024_013217$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889141$24188914$1$I$$20240708$20240808$20240808$PER$$US-OTSUKA-2024_019305$OTSUKA$$$$$M$Y$99.79$KG$20240808$$CN$US$US
241889151$24188915$1$I$20240506$20240506$20240808$20240808$PER$$US-OTSUKA-2024_013024$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889161$24188916$1$I$20240221$20240523$20240808$20240808$PER$$US-OTSUKA-2024_004842$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241889171$24188917$1$I$$20240521$20240808$20240808$PER$$US-OTSUKA-2024_014638$OTSUKA$$$$$M$Y$90.72$KG$20240808$$CN$US$US
241889181$24188918$1$I$$20240627$20240808$20240808$PER$$US-OTSUKA-2024_018925$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889191$24188919$1$I$20240401$20240531$20240808$20240808$PER$$US-OTSUKA-2024_015715$OTSUKA$$24$YR$$M$Y$$$20240808$$CN$US$US
241889201$24188920$1$I$20240506$20240627$20240808$20240808$PER$$US-OTSUKA-2024_013037$OTSUKA$$22$YR$$F$Y$69.85$KG$20240808$$HP$US$US
241889211$24188921$1$I$$20240506$20240808$20240808$PER$$US-OTSUKA-2024_013018$OTSUKA$$$$A$F$Y$$$20240808$$HP$US$US
241889221$24188922$1$I$20240501$20240524$20240808$20240808$EXP$$US-OTSUKA-2024_015050$OTSUKA$$84$YR$$M$Y$77.56$KG$20240808$$CN$US$US
241889231$24188923$1$I$$20240517$20240808$20240808$PER$$US-OTSUKA-2024_014297$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241889241$24188924$1$I$20240530$20240530$20240808$20240808$PER$$US-OTSUKA-2024_015561$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241889251$24188925$1$I$20240529$20240529$20240808$20240808$PER$$US-OTSUKA-2024_015458$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241889261$24188926$1$I$$20240528$20240808$20240808$PER$$US-OTSUKA-2024_015299$OTSUKA$$$$$M$Y$49.9$KG$20240808$$CN$US$US
241889271$24188927$1$I$$20240514$20240808$20240808$PER$$US-OTSUKA-2024_013945$OTSUKA$$60$YR$$F$Y$$$20240808$$HP$US$US
241889281$24188928$1$I$20200101$20240605$20240808$20240808$PER$$US-OTSUKA-2024_014096$OTSUKA$$$$$F$Y$97.52$KG$20240808$$CN$US$US
241889291$24188929$1$I$$20240604$20240808$20240808$PER$$US-OTSUKA-2024_016110$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241889301$24188930$1$I$$20240507$20240808$20240808$PER$$US-OTSUKA-2024_013215$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889311$24188931$1$I$$20240531$20240808$20240808$EXP$$US-OTSUKA-2024_015678$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241889321$24188932$1$I$20240703$20240703$20240808$20240808$PER$$US-OTSUKA-2024_019000$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241889331$24188933$1$I$$20240607$20240808$20240808$PER$$US-OTSUKA-2024_015346$OTSUKA$$$$$F$Y$54.43$KG$20240808$$CN$US$US
241889341$24188934$1$I$$20240701$20240808$20240808$PER$$US-OTSUKA-2024_012808$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889351$24188935$1$I$$20240520$20240808$20240808$PER$$US-OTSUKA-2023_033914$OTSUKA$Free M, Pathare A, Mahgoub Y.. Unintended Weight Gain After Treatment of Catatonia With ECT in Autism. Journal of ECT. 2023;39(4):269-70$36$YR$$F$Y$$$20240808$$MD$US$US
241889361$24188936$1$I$$20240515$20240808$20240808$PER$$US-OTSUKA-2024_014045$OTSUKA$$16$YR$$F$Y$$$20240808$$CN$US$US
241889371$24188937$1$I$$20240502$20240808$20240808$PER$$US-OTSUKA-2024_012811$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241889381$24188938$1$I$$20240709$20240808$20240808$PER$$US-OTSUKA-2024_019472$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241889391$24188939$1$I$$20240521$20240808$20240808$PER$$US-OTSUKA-2024_014628$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241889401$24188940$1$I$$20240521$20240808$20240808$PER$$US-OTSUKA-2024_015047$OTSUKA$Greene EM. The Mental Health Industrial Complex: A Study in Three Cases. J Humanist Psychol.. 2023;63 (1):84-102$46$YR$$M$Y$$$20240808$$HP$US$US
241889411$24188941$1$I$$20240710$20240808$20240808$PER$$US-OTSUKA-2024_019556$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889421$24188942$1$I$$20240708$20240808$20240808$PER$$US-OTSUKA-2024_019297$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889431$24188943$1$I$$20240516$20240808$20240808$PER$$US-OTSUKA-2024_014200$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889441$24188944$1$I$20240705$20240705$20240808$20240808$PER$$US-OTSUKA-2024_019185$OTSUKA$$27$YR$$F$Y$99.79$KG$20240808$$CN$US$US
241889451$24188945$1$I$20220201$20240517$20240808$20240808$PER$$US-OTSUKA-2024_014319$OTSUKA$$22$YR$$M$Y$92.99$KG$20240808$$CN$US$US
241889461$24188946$1$I$$20240605$20240808$20240808$PER$$US-OTSUKA-2024_016183$OTSUKA$$$$$F$Y$65.77$KG$20240808$$CN$US$US
241889471$24188947$1$I$20230101$20240603$20240808$20240808$PER$$US-OTSUKA-2024_015974$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889481$24188948$1$I$$20240508$20240808$20240808$PER$$US-OTSUKA-2024_013433$OTSUKA$$5$DEC$$F$Y$$$20240808$$MD$US$US
241889491$24188949$1$I$$20240529$20240808$20240808$PER$$US-OTSUKA-2024_015488$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889501$24188950$1$I$$20240529$20240808$20240808$PER$$US-OTSUKA-2024_014424$OTSUKA$$$$$F$Y$97.98$KG$20240808$$CN$US$US
241889511$24188951$1$I$$20240623$20240808$20240808$EXP$$US-OTSUKA-2024_013561$OTSUKA$$$$A$M$Y$$$20240808$$MD$US$US
241889521$24188952$1$I$$20240708$20240808$20240808$PER$$US-OTSUKA-2024_019309$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889531$24188953$1$I$$20240708$20240808$20240808$PER$$US-OTSUKA-2024_019312$OTSUKA$$39$YR$$F$Y$$$20240808$$CN$US$US
241889541$24188954$1$I$$20240604$20240808$20240808$PER$$US-OTSUKA-2024_016073$OTSUKA$$3$DEC$$F$Y$$$20240808$$HP$US$US
241889551$24188955$1$I$$20240509$20240808$20240808$PER$$US-OTSUKA-2024_013466$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241889561$24188956$1$I$$20240618$20240808$20240808$PER$$US-OTSUKA-2024_011121$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889571$24188957$1$I$$20240709$20240808$20240808$PER$$US-OTSUKA-2024_019421$OTSUKA$$$$$M$Y$99.79$KG$20240808$$CN$US$US
241889581$24188958$1$I$$20240603$20240808$20240808$PER$$US-OTSUKA-2024_015925$OTSUKA$$$$$M$Y$83.91$KG$20240808$$CN$US$US
241889591$24188959$1$I$$20240513$20240808$20240808$PER$$US-OTSUKA-2024_012717$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889601$24188960$1$I$$20240702$20240808$20240808$PER$$US-OTSUKA-2024_018979$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889611$24188961$1$I$$20240502$20240808$20240808$PER$$US-OTSUKA-2024_012793$OTSUKA$$$$$M$Y$102.06$KG$20240808$$HP$US$US
241889621$24188962$1$I$20240530$20240607$20240808$20240808$PER$$US-OTSUKA-2024_016501$OTSUKA$$28$YR$$M$Y$$$20240808$$HP$US$US
241889631$24188963$1$I$$20240610$20240808$20240808$PER$$US-OTSUKA-2024_016780$OTSUKA$Falleni A, Abelleira A, Hieber R. It^s been a long time since I drank like that: A case report of binge drinking associated with aripiprazole. Ment Health Clin.. 2024;14(3):212-214$29$YR$$M$Y$$$20240808$$PH$US$US
241889641$24188964$1$I$$20240625$20240808$20240808$PER$$US-OTSUKA-2024_018164$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889651$24188965$1$I$20240705$20240708$20240808$20240808$PER$$US-OTSUKA-2024_019165$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241889661$24188966$1$I$$20240517$20240808$20240808$PER$$US-OTSUKA-2024_014315$OTSUKA$$14$YR$$F$Y$$$20240808$$HP$US$US
241889671$24188967$1$I$$20240705$20240808$20240808$PER$$US-OTSUKA-2024_019164$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889681$24188968$1$I$$20240516$20240808$20240808$PER$$US-OTSUKA-2024_014193$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889691$24188969$1$I$20240619$20240705$20240808$20240808$PER$$US-OTSUKA-2024_019184$OTSUKA$$$$$M$Y$$$20240808$$PH$US$US
241889701$24188970$1$I$$20240603$20240808$20240808$PER$$US-OTSUKA-2024_014172$OTSUKA$$$$$F$Y$68.04$KG$20240808$$CN$US$US
241889711$24188971$1$I$$20240626$20240808$20240808$PER$$US-OTSUKA-2023_031058$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889721$24188972$1$I$$20240610$20240808$20240808$PER$$US-OTSUKA-2024_016588$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889731$24188973$1$I$$20240709$20240808$20240808$PER$$US-OTSUKA-2024_019447$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889741$24188974$1$I$20240401$20240618$20240808$20240808$PER$$US-OTSUKA-2024_011280$OTSUKA$$52$YR$$F$Y$96.16$KG$20240808$$CN$US$US
241889751$24188975$1$I$$20240521$20240808$20240808$PER$$US-OTSUKA-2024_014590$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889761$24188976$1$I$$20240520$20240808$20240808$PER$$US-OTSUKA-2024_014413$OTSUKA$$21$YR$$M$Y$$$20240808$$CN$US$US
241889771$24188977$1$I$$20240521$20240808$20240808$PER$$US-OTSUKA-2024_014717$OTSUKA$Greene EM. The Mental Health Industrial Complex: A Study in Three Cases. JOURNAL OF HUMANISTIC PSYCHOLOGY. 2023;63(1):84-102$8$YR$$M$Y$$$20240808$$MD$US$US
241889781$24188978$1$I$$20240613$20240808$20240808$PER$$US-OTSUKA-2024_017026$OTSUKA$$$$$M$Y$62.14$KG$20240808$$CN$US$US
241889791$24188979$1$I$20240122$20240522$20240808$20240808$PER$$US-OTSUKA-2024_002470$OTSUKA$$35$YR$$M$Y$$$20240808$$PH$US$US
241889801$24188980$1$I$$20240520$20240808$20240808$PER$$US-OTSUKA-2024_014447$OTSUKA$$4$DEC$$M$Y$$$20240808$$CN$US$US
241889811$24188981$1$I$$20240708$20240808$20240808$PER$$US-OTSUKA-2024_019302$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889821$24188982$1$I$$20240709$20240808$20240808$PER$$US-OTSUKA-2024_019417$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889831$24188983$1$I$$20240510$20240808$20240808$PER$$US-OTSUKA-2024_013631$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241889841$24188984$1$I$20240422$20240516$20240808$20240808$PER$$US-OTSUKA-2024_014185$OTSUKA$$44$YR$$M$Y$$$20240808$$PH$US$US
241889851$24188985$1$I$$20240528$20240808$20240808$PER$$US-OTSUKA-2024_015306$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241889861$24188986$1$I$$20240731$20240808$20240808$EXP$$JP-ROCHE-10000049526$ROCHE$$$$$$Y$$$20240808$$PH$JP$JP
241889871$24188987$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029748$OTSUKA$Estevez TP, Casasnovas CE, Aslanova M, Rizk D, Safin DS. Diagnosis of Wernicke^s Encephalopathy in Patients With a Psychiatric History: A Case Series and Literature Review. Prim Care Companion CNS Disord. 2023;25(4):e1-e6$53$YR$$M$Y$$$20240808$$MD$US$US
241889881$24188988$1$I$$20231009$20240808$20240808$EXP$$US-OTSUKA-2023_026510$OTSUKA$Chawla S, Makadia B, Krishnan V. The rise after a fall. Chest. 2023;164(4):A6353-54$47$YR$$F$Y$$$20240808$$HP$US$US
241889891$24188989$1$I$$20240308$20240808$20240808$PER$$US-OTSUKA-2023_028553$OTSUKA$Reisch A, Gerety G, Ding A, Narapareddy L, Narapareddy BR.. Increasing awareness of rare PSP-F, where rehabilitation is the primary treatment: A case report. NeuroRehabilitation. 2023;53(2):239-47$60$YR$$M$Y$$$20240808$$HP$US$US
241889901$24188990$1$I$$20230831$20240808$20240808$PER$$US-OTSUKA-2023_023304$OTSUKA$Yang M, Rubin A, Wondimu R, Grebe T, Ritfeld G.. Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with Shine syndrome: a case report. BMC Psychiatry. 2023;23(1):0077-81$$$T$F$Y$$$20240808$$HP$US$US
241889911$24188991$1$I$$20240711$20240808$20240808$PER$$US-OTSUKA-2024_019600$OTSUKA$$19$YR$$M$Y$$$20240808$$HP$US$US
241889921$24188992$1$I$$20240711$20240808$20240808$PER$$US-OTSUKA-2024_019627$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241889931$24188993$1$I$$20240122$20240808$20240808$PER$$US-OTSUKA-2023_000065$OTSUKA$Wang J, Abu-Hamad SJ, Jennings M, Blackburn K, Robinson DM. Hero or Antagonist: A Case Series on the Tolerability of Memantine as Salvage Therapy for Catatonia from Anti-NMDA Receptor Encephalitis. Harv Rev Psychiatry. 2023;31(6):281-86$25$YR$$M$Y$$$20240808$$HP$US$US
241889941$24188994$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029720$OTSUKA$Mahdavi KD, Jordan SE, Jordan KG, Rinder ES, Haroon JM, Habelhah B, et.al.. A pilot study of low-intensity focused ultrasound for treatment-resistant generalized anxiety disorder. J. Psychiatr. Res.. 2023;168:125-32$47$YR$$M$Y$$$20240808$$HP$US$US
241889951$24188995$1$I$$20231030$20240808$20240808$PER$$US-OTSUKA-2023_028544$OTSUKA$Kalla P, Namerow LB, Walker SA, Ruano G, Malik S. Contrasting ABCB1 pharmacogenetics and psychotropic responses in child and adolescent psychiatry: a case comparison. Pharmacogenomics. 2023;24(3):131-39$9$YR$$M$Y$$$20240808$$HP$US$US
241889961$24188996$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029760$OTSUKA$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. J Child Adolesc Psychopharmacol. 2023;1-6$17$YR$$F$Y$$$20240808$$PH$US$US
241889971$24188997$1$I$$20240712$20240808$20240808$PER$$US-OTSUKA-2024_019749$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241889981$24188998$1$I$$20230725$20240808$20240808$PER$$US-OTSUKA-2023_020346$OTSUKA$Kaur J, Singh T. Wernickes encephalopathy presenting as sepsis MIMIC$65$YR$$F$Y$$$20240808$$HP$US$US
241889991$24188999$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029735$OTSUKA$Mahdavi KD,Jordan SE, Jordan KG, Rinder ES, Haroon JM, Habelhah B.. A pilot study of low-intensity focused ultrasound for treatment-resistant generalized anxiety disorder. Journal of Psychiatric Research. 2023;168:125-32$20$YR$$M$Y$$$20240808$$HP$US$US
241890001$24189000$1$I$$20240715$20240808$20240808$PER$$US-OTSUKA-2024_019883$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241890011$24189001$1$I$20240624$20240806$20240806$20240806$DIR$FDA-CDER-CTU-2024-54318$$FDA-CTU$$18$YR$$F$N$55.34$KG$20240806$N$CN$US$
241890021$24189002$1$I$$20240715$20240808$20240808$PER$$US-OTSUKA-2024_019908$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241890031$24189003$1$I$20240805$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54377$$FDA-CTU$$67$YR$$F$N$$$20240807$N$HP$US$
241890041$24189004$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54330$$FDA-CTU$$67$YR$$F$N$$$20240807$N$$US$
241890051$24189005$1$I$$20240715$20240808$20240808$PER$$US-OTSUKA-2024_019899$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241890061$24189006$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029761$OTSUKA$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. J Child Adolesc Psychopharmacol.. 2023;1-6$15$YR$$M$Y$$$20240808$$HP$US$US
241890071$24189007$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029730$OTSUKA$Mahdavi KD, Jordan SE, Jordan KG, Rinder ES, Haroon JM, Habelhah B et.al. A pilot study of low-intensity focused ultrasound for treatment-resistant generalized anxiety disorder. J Psychiatr Res.. 2023;168:125-32$53$YR$$M$Y$$$20240808$$HP$US$US
241890081$24189008$1$I$20240604$20240807$20240808$20240808$PER$$US-OTSUKA-2024_016191$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241890091$24189009$1$I$$20230807$20240808$20240808$EXP$$US-OTSUKA-2023_021194$OTSUKA$Kasetty VM, Desai TU, Desai UR.. Benign yellow-dot maculopathy: case report and review of the literature. Canadian Journal of Ophthalmology. 2023;58(4):e191-4$17$YR$$M$Y$$$20240808$$MD$US$US
241890101$24189010$1$I$$20230928$20240808$20240808$PER$$US-OTSUKA-2023_025663$OTSUKA$Marshall R, Valle K, Sheridan D, Kothari J.. Ketamine for Treatment-Resistant Depression and Suicidality in Adolescents: An Observational Study of 3 Cases. Journal of Clinical Psychopharmacology. 2023;43(5):460-62$15$YR$$M$Y$$$20240808$$MD$US$US
241890111$24189011$1$I$$20230717$20240808$20240808$PER$$US-OTSUKA-2023_019297$OTSUKA$Zaydlin M, Gershman M, Coppa A, Leuchter JD, Bez Y, Coffey BJ.. Navigating Pharmacological Treatment in an Adolescent with New Onset Psychosis: Clinical, Pharmacological, and Cultural Challenges. J Child Adolesc Psychopharmacol. 2023;33(3):118-22$14$YR$$M$Y$$$20240808$$MD$US$US
241890121$24189012$1$I$$20240321$20240808$20240808$EXP$$US-OTSUKA-2024_008155$OTSUKA$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al.. 2022 Annual Report of the National Poison Data System+REG; (NPDS) from America^s Poison Centers+REG;:40th Annual Report. Clin Toxicol. 2023;61(10):717-939$30$YR$$F$Y$$$20240808$$MD$US$US
241890131$24189013$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029719$OTSUKA$Mahdavi KD, Jordan SE, Jordan KG, Rinder ES, Haroon JM, Habelhah B et. al.. A pilot study of low-intensity focused ultrasound for treatment-resistant generalized anxiety disorder. J. Psychiatr. Res. 2023;168:125-32$29$YR$$M$Y$$$20240808$$HP$US$US
241890141$24189014$1$I$$20230911$20240808$20240808$PER$$US-OTSUKA-2023_024147$OTSUKA$Raad SA, Karam VY, Chouery E, Mehawej C, Megarbane A. CHAMP1-Related Disorder: Sharing 20 Years of thorough Clinical Follow-Up and Review of the Literature. Genes. 2023;14(8):1-9$21$YR$$F$Y$84$KG$20240808$$HP$US$US
241890151$24189015$1$I$$20240724$20240808$20240808$PER$$US-OTSUKA-2024_015426$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241890161$24189016$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029768$OTSUKA$Moon E, Kim E, Williams A. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. Journal of child and adolescent psychopharmacology. 2023;1-6$15$YR$$F$Y$$$20240808$$PH$US$US
241890171$24189017$1$I$$20230928$20240808$20240808$PER$$US-OTSUKA-2023_025656$OTSUKA$Marshall R, Valle K, Sheridan D, Kothari J.. Ketamine for Treatment-Resistant Depression and Suicidality in Adolescents: An Observational Study of 3 Cases. J Clin Psychopharmacol.. 2023;43(5):460-62$13$YR$$F$Y$$$20240808$$MD$US$US
241890181$24189018$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029717$OTSUKA$Mahdavi KD,Jordan SE, Jordan KG, Rinder ES, Haroon JM, Habelhah B et.al. A pilot study of low-intensity focused ultrasound for treatment-resistant generalized anxiety disorder. J Psychiatr Res.. 2023;168:125-32$39$YR$$F$Y$$$20240808$$HP$US$US
241890191$24189019$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029727$OTSUKA$Mahdavi KD, Jordan SE, Jordan KG, Rinder ES, Haroon JM, Habelhah B et.al. A pilot study of low-intensity focused ultrasound for treatment-resistant generalized anxiety disorder. J Psychiatr Res. 2023;168:125-32$20$YR$$M$Y$$$20240808$$HP$US$US
241890201$24189020$1$I$$20230731$20240808$20240808$PER$$US-OTSUKA-2023_020508$OTSUKA$Kramkowski J, Rath S.. Efficacious retrial of electroconvulsive therapy for major depressive disorder after a prolonged seizure in an older adult. BMJ Case Rep. 2023;16(5):e247633$8$DEC$$F$Y$$$20240808$$HP$US$US
241890211$24189021$1$I$$20230828$20240808$20240808$PER$$US-OTSUKA-2023_022949$OTSUKA$Abbas Z, Mahmood T, Bellman V, Koirala P, Myers T.. Relationship Between Pericallosal Lipoma and Neuropsychiatric Symptoms: A Case Report. J Nerv Ment Dis. 2023;211(8):639-40$15$YR$$M$Y$$$20240808$$MD$US$US
241890221$24189022$1$I$$20240321$20240808$20240808$EXP$$US-OTSUKA-2024_008156$OTSUKA$Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al.. 2022 Annual Report of the National Poison Data System+REG; (NPDS) from America^s Poison Centers+REG;: 40th Annual Report. CLINICAL TOXICOLOGY. 2023;61 (10):717-939$25$YR$$F$Y$$$20240808$$HP$US$US
241890231$24189023$1$I$$20231106$20240808$20240808$EXP$$US-OTSUKA-2023_029143$OTSUKA$Schultz AR, Singh S, Linek-Rajapaksha CE, Goode HR, Fusick AJ.. A Case of Neuroleptic Malignant Syndrome in the Context of Lithium Toxicity and Aripiprazole Use. Clin Neuropharmacol. 2023;00:1-4$60$YR$$M$Y$$$20240808$$MD$US$US
241890241$24189024$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029765$OTSUKA$Moon E, Kim E, Williams A. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. Journal of child and adolescent psychopharmacology. 2023;1-6$15$YR$$F$Y$$$20240808$$HP$US$US
241890251$24189025$1$I$$20240712$20240808$20240808$PER$$US-OTSUKA-2024_019752$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241890261$24189026$1$I$$20230828$20240808$20240808$PER$$US-OTSUKA-2023_022960$OTSUKA$Barnett BS, Balaji D, Weleff J, Carroll BT. Catatonia and Neuroleptic Malignant Syndrome in Patients With Cerebral Palsy: Two Case Reports and a Systematic Review of the Literature. J Acad Consult Liaison Psychiatry. 2023;64(3):277-93$32$YR$$F$Y$$$20240808$$MD$US$US
241890271$24189027$1$I$$20230821$20240808$20240808$EXP$$US-OTSUKA-2023_022357$OTSUKA$Ramsey, B., Yazdi, L., Laiwala, R., Srinivasan, S.. Neuroleptic Malignant-Like Syndrome as a Potential Etiology for Donepezil Related Rhabdomyolysis. Current Geriatrics Reports. 2023;12(3):112-16$6$DEC$$$Y$$$20240808$$HP$US$US
241890281$24189028$1$I$$20231009$20240808$20240808$EXP$$US-OTSUKA-2023_026511$OTSUKA$Ray AS, Ghosh M, Wittenberg ZL, Sahasranaman V. Neuroleptic Malignant Syndrome and Serotonin Syndrome: A tale of two etiologies of hyperpyrexia. Chest. 2023;164(4):A2002-3$64$YR$$F$Y$$$20240808$$HP$US$US
241890291$24189029$1$I$$20230905$20240808$20240808$PER$$US-OTSUKA-2023_023633$OTSUKA$Meshram A, Sevy S.. Delusional parasitosis successfully controlled with lurasidone: A case report. Ann Clin Psychiatry. 2022;34(4):281-282$59$YR$$M$Y$$$20240808$$MD$US$US
241890301$24189030$1$I$$20230928$20240808$20240808$PER$$US-OTSUKA-2023_025661$OTSUKA$Zaydlin M, Cruz A, Bez Y, Coffey BJ.. A Targeted Combined Pharmacotherapy Approach for Aggressive Behavior in a Child with Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2023;33(5):195-199$11$YR$$F$Y$$$20240808$$MD$US$US
241890311$24189031$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029721$OTSUKA$Mahdavi KD, Jordan SE, Jordan KG, Rinder ES, Haroon JM, Habelhah B et.al. A pilot study of low-intensity focused ultrasound for treatment-resistant generalized anxiety disorder. J Psychiatr Res.. 2023;168:125-32$64$YR$$M$Y$$$20240808$$HP$US$US
241890321$24189032$1$I$20200609$20230717$20240808$20240808$PER$$US-OTSUKA-2023_019290$OTSUKA$Repas SJ, Schmeusser BN, McCullough WP, Lehrer DS, Travers JB, McCullough PJ. Normal 24-hour urine calcium concentrations after long-term daily oral intake of vitamin D in doses ranging from 5000 to 50,000 international units in 14 adult hospitalized psychiatric patients. J Steroid Biochem Mol Biol. 2023;231$$$$$Y$$$20240808$$HP$US$US
241890331$24189033$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029759$OTSUKA$Moon E, Kim E, Williams A. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. Journal of child and adolescent psychopharmacology. 2023;1-6$15$YR$$M$Y$$$20240808$$HP$US$US
241890341$24189034$1$I$20200610$20230717$20240808$20240808$PER$$US-OTSUKA-2023_019292$OTSUKA$Repas SJ, Schmeusser BN, McCullough WP, Lehrer DS, Travers JB, McCullough PJ. Normal 24-hour urine calcium concentrations after long-term daily oral intake of vitamin D in doses ranging from 5000 to 50,000 international units in 14 adult hospitalized psychiatric patients. J Steroid Biochem Mol Biol. 2023;231$$$$$Y$$$20240808$$HP$US$US
241890351$24189035$1$I$$20240325$20240808$20240808$PER$$US-OTSUKA-2024_008163$OTSUKA$Brown K, Bez Y, Truong K, Saaraswat M, Coffey BJ. Understanding and Managing New Onset Homicidal Ideation in an Adolescent with Depression. J Child Adolesc Psychopharmacol.. 2023;33(9):393-97$15$YR$$M$Y$$$20240808$$MD$US$US
241890361$24189036$1$I$$20240325$20240808$20240808$PER$$US-OTSUKA-2024_008177$OTSUKA$Chen KW , Schultz L, Hughes N.. A Case of Postpartum Obsessive-Compulsive Disorder in a First-Time Father. Cureus. 2024;16(2):e54547$33$YR$$M$Y$$$20240808$$HP$US$US
241890371$24189037$1$I$$20230727$20240808$20240808$PER$$US-OTSUKA-2023_020242$OTSUKA$Richardson C, Yuh J, Su J, Forsberg M. Case series: Continued remission of PTSD symptoms after discontinuation of prazosin. Front Psychiatry. 2023;14$6$DEC$$F$Y$$$20240808$$HP$US$US
241890391$24189039$1$I$$20231113$20240808$20240808$PER$$US-OTSUKA-2023_029766$OTSUKA$Moon E, Kim E, Williams A. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. Journal of Child and Adolescent Psychopharmacology. 2023;1-6$14$YR$$F$Y$$$20240808$$HP$US$US
241890402$24189040$2$F$$20240805$20240808$20240813$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123678$BRISTOL MYERS SQUIBB$$$$C$$Y$$$20240813$$MD$JP$JP
241890411$24189041$1$I$$20240731$20240808$20240808$EXP$$IN-MYLANLABS-2024M1073044$MYLAN$Patel PS, Krishna A, Singh PP, Bansal SB, Archana. Histoplasmosis Disguised as Pyrexia of Unknown Origin in Kidney Transplant Recipients: Bone Marrow Biopsy was Key to Diagnosis. Indian-J-Transplant 2023; 17 (4): 453-456.$34$YR$$M$Y$$$20240808$$HP$IN$IN
241890421$24189042$1$I$20240724$20240724$20240808$20240808$PER$$US-GRANULES-US-2024GRASPO00317$GRANULES INDIA$$91$YR$$F$Y$$$20240808$$CN$US$US
241890431$24189043$1$I$$20240731$20240808$20240808$EXP$$US-MYLANLABS-2024M1072868$MYLAN$Nieves C, Zambrano R, Velez MC. Malignant peripheral nerve sheath tumor, a malignant transformation from a plexiform neurofibroma in a pediatric patient; a case report. Am-J-Med-Sci 2024; 367 (Suppl.) S180.$5$YR$$M$Y$$$20240808$$HP$US$US
241890441$24189044$1$I$$20240731$20240808$20240808$EXP$$US-MYLANLABS-2024M1072861$MYLAN$Mansour M, Mohamed A, Zalt M. A Very Rare Case of an Immunocompetent Patient With Concomitant M. Avium Complex, M. Abscessus, and M. Shimoidei Lung Infection. Am-J-Respir-Crit-Care-Med 2024; 209.$58$YR$$F$Y$$$20240808$$HP$US$US
241890451$24189045$1$I$$20240731$20240808$20240808$EXP$$US-MYLANLABS-2024M1072769$MYLAN$Stewart MA, Rives TA, Blanton K, Baldwin L. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecol-Oncol-Rep 2024; 54.$33$YR$$F$Y$$$20240808$$HP$US$US
241890461$24189046$1$I$20240615$20240723$20240808$20240808$PER$$US-OTSUKA-2024_016226$OTSUKA$$22$YR$$F$Y$65.77$KG$20240808$$CN$US$US
241890471$24189047$1$I$$20240628$20240808$20240808$PER$$US-OTSUKA-2024_018591$OTSUKA$$$$$$Y$$$20240808$$HP$US$US
241890481$24189048$1$I$$20240610$20240808$20240808$PER$$US-OTSUKA-2024_016838$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241890491$24189049$1$I$20240101$20240626$20240808$20240808$PER$$US-OTSUKA-2024_018420$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241890501$24189050$1$I$$20240614$20240808$20240808$PER$$US-OTSUKA-2024_017161$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241890511$24189051$1$I$$20240618$20240808$20240808$PER$$US-OTSUKA-2024_017423$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241890521$24189052$1$I$$20240611$20240808$20240808$PER$$US-OTSUKA-2024_016888$OTSUKA$$$$$F$Y$$$20240808$$PH$US$US
241890531$24189053$1$I$20240604$20240627$20240808$20240808$PER$$US-OTSUKA-2024_018411$OTSUKA$$68$YR$$M$Y$51.71$KG$20240808$$CN$US$US
241890541$24189054$1$I$20070101$20240610$20240808$20240808$PER$$US-OTSUKA-2024_016785$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241890551$24189055$1$I$$20240626$20240808$20240808$PER$$US-OTSUKA-2024_018347$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241890561$24189056$1$I$$20240617$20240808$20240808$PER$$US-OTSUKA-2024_017251$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241890571$24189057$1$I$$20240612$20240808$20240808$PER$$US-OTSUKA-2024_016955$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241890581$24189058$1$I$$20240612$20240808$20240808$PER$$US-OTSUKA-2024_016966$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241890591$24189059$1$I$$20240624$20240808$20240808$PER$$US-OTSUKA-2024_018034$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241890601$24189060$1$I$$20240701$20240808$20240808$PER$$US-OTSUKA-2024_018823$OTSUKA$$17$YR$$F$Y$$$20240808$$HP$US$US
241890611$24189061$1$I$$20240610$20240808$20240808$PER$$US-OTSUKA-2024_016612$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241890621$24189062$1$I$$20240625$20240808$20240808$PER$$US-OTSUKA-2024_018828$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241890631$24189063$1$I$$20240702$20240808$20240808$EXP$$US-OTSUKA-2024_018831$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241890641$24189064$1$I$$20240621$20240808$20240808$PER$$US-OTSUKA-2024_017765$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241890651$24189065$1$I$$20240605$20240808$20240808$PER$$US-OTSUKA-2024_016256$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241890661$24189066$1$I$20140101$20240607$20240808$20240808$PER$$US-OTSUKA-2024_016449$OTSUKA$$35$YR$$M$Y$$$20240808$$CN$US$US
241890671$24189067$1$I$$20240625$20240808$20240808$PER$$US-OTSUKA-2024_018170$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241890681$24189068$1$I$$20240702$20240808$20240808$PER$$US-OTSUKA-2024_018902$OTSUKA$$$$$M$Y$$$20240808$$HP$US$US
241890691$24189069$1$I$$20240408$20240808$20240808$PER$$US-OTSUKA-2024_010349$OTSUKA$Smith JR, Hopkins CE, Xiong J, Luccarelli J, Shultz E, Vandekar S. Use of ECT in Autism Spectrum Disorder and/or Intellectual Disability: A Single Site Retrospective Analysis. Journal of Autism and Developmental Disorders. 2024;54 (3):963-982$16$YR$$F$Y$$$20240808$$HP$US$US
241890701$24189070$1$I$$20240606$20240808$20240808$PER$$US-OTSUKA-2024_016444$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241890721$24189072$1$I$$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54366$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
241890731$24189073$1$I$$20240605$20240808$20240808$PER$$US-OTSUKA-2024_016222$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241890741$24189074$1$I$$20240626$20240808$20240808$PER$$US-OTSUKA-2024_018321$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241890751$24189075$1$I$20240501$20240610$20240808$20240808$EXP$$US-OTSUKA-2024_016598$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241890761$24189076$1$I$$20240611$20240808$20240808$PER$$US-OTSUKA-2024_016982$OTSUKA$$$$$$Y$$$20240808$$MD$US$US
241890771$24189077$1$I$20240101$20240617$20240808$20240808$PER$$US-OTSUKA-2024_017250$OTSUKA$$$$$F$Y$113.4$KG$20240808$$CN$US$US
241890781$24189078$1$I$$20240626$20240808$20240808$PER$$US-OTSUKA-2024_018312$OTSUKA$$$$$M$Y$136.08$KG$20240808$$CN$US$US
241890791$24189079$1$I$$20240401$20240808$20240808$PER$$US-OTSUKA-2024_008966$OTSUKA$Khanal P, Khanal P, Paudel S, Pokhrel A, Chapagain S.. Paraneoplastic movement disorder due to suspected metastatic Leiomyosarcoma of tongue: A case report. Clinical Case Reports. 2024;12(3):e8648$88$YR$$M$Y$$$20240808$$HP$US$US
241890801$24189080$1$I$20070101$20240613$20240808$20240808$PER$$US-OTSUKA-2024_017157$OTSUKA$$$$A$M$Y$$$20240808$$CN$US$US
241890811$24189081$1$I$$20240617$20240808$20240808$PER$$US-OTSUKA-2024_017328$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241890821$24189082$1$I$20120101$20240614$20240808$20240808$PER$$US-OTSUKA-2024_017159$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241890831$24189083$1$I$$20240429$20240808$20240808$PER$$US-OTSUKA-2024_010507$OTSUKA$Ruppert R, Bryant C, Lifland B, Cho S. Use of Long-Acting Injectable Paliperidone to Increase Medication Compliance in Individuals with ESRD and Schizophrenia. J Acad Consult Liaison Psychiatry. 2023;64:S100-S101$61$YR$$M$Y$$$20240808$$HP$US$US
241890841$24189084$1$I$$20240702$20240808$20240808$PER$$US-OTSUKA-2024_018817$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241890851$24189085$1$I$$20240617$20240808$20240808$PER$$US-OTSUKA-2024_017369$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241890861$24189086$1$I$$20240626$20240808$20240808$PER$$US-OTSUKA-2024_018290$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241890871$24189087$1$I$$20240612$20240808$20240808$PER$$US-OTSUKA-2024_016935$OTSUKA$$$$$F$Y$58.97$KG$20240808$$MD$US$US
241890881$24189088$1$I$$20240429$20240808$20240808$PER$$US-OTSUKA-2024_010506$OTSUKA$Varghese R, Czuma R, Jiang S.. Mirtazapine Induced Musical Hallucinations: Does Glutamate Play a Role?. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64$75$YR$$M$Y$$$20240808$$HP$US$US
241890891$24189089$1$I$$20240429$20240808$20240808$PER$$US-OTSUKA-2024_010505$OTSUKA$Mosteller L, Swanson B, Schott M. Ten-Year-Old Tongue Twists Tardive in Two Days Withdrawal Emergent Syndrome in the Complex Child. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64:S70-S70$10$YR$$M$Y$$$20240808$$HP$US$US
241890901$24189090$1$I$$20240606$20240808$20240808$PER$$US-OTSUKA-2024_016439$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241890911$24189091$1$I$$20240617$20240808$20240808$PER$$US-OTSUKA-2024_017781$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241890921$24189092$1$I$20240601$20240618$20240808$20240808$PER$$US-OTSUKA-2024_017670$OTSUKA$$$$$F$Y$$$20240808$$HP$US$US
241890931$24189093$1$I$$20240619$20240808$20240808$PER$$US-OTSUKA-2024_017520$OTSUKA$$$$$F$Y$$$20240808$$MD$US$US
241890941$24189094$1$I$$20240618$20240808$20240808$PER$$US-OTSUKA-2024_017782$OTSUKA$$64$YR$$$Y$$$20240808$$HP$US$US
241890951$24189095$1$I$$20240624$20240808$20240808$PER$$US-OTSUKA-2024_018021$OTSUKA$$$$$M$Y$111.13$KG$20240808$$CN$US$US
241890961$24189096$1$I$$20240625$20240808$20240808$PER$$US-OTSUKA-2024_016599$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241890971$24189097$1$I$20240621$20240624$20240808$20240808$PER$$US-OTSUKA-2024_017948$OTSUKA$$27$YR$$F$Y$$$20240808$$HP$US$US
241890981$24189098$1$I$$20240626$20240808$20240808$PER$$US-OTSUKA-2024_018326$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241890991$24189099$1$I$$20240606$20240808$20240808$EXP$$US-OTSUKA-2024_016351$OTSUKA$$$$A$F$Y$$$20240808$$HP$US$US
241891001$24189100$1$I$$20240611$20240808$20240808$PER$$US-OTSUKA-2024_016788$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241891011$24189101$1$I$20030101$20240613$20240808$20240808$PER$$US-OTSUKA-2024_017037$OTSUKA$$$$$M$Y$104.33$KG$20240808$$CN$US$US
241891021$24189102$1$I$$20240618$20240808$20240808$PER$$US-OTSUKA-2024_017455$OTSUKA$$$$$F$Y$49.9$KG$20240808$$HP$US$US
241891031$24189103$1$I$$20240611$20240808$20240808$PER$$US-OTSUKA-2024_016807$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241891041$24189104$1$I$$20240624$20240808$20240808$PER$$US-OTSUKA-2024_017937$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241891051$24189105$1$I$$20240612$20240808$20240808$PER$$US-OTSUKA-2024_017022$OTSUKA$$25$YR$$M$Y$$$20240808$$HP$US$US
241891061$24189106$1$I$$20240408$20240808$20240808$PER$$US-OTSUKA-2024_010350$OTSUKA$Smith JR, Hopkins CE, Xiong J, Luccarelli J, Shultz E, Vandekar S. Use of ECT in Autism Spectrum Disorder and/or Intellectual Disability: A Single Site Retrospective Analysis. Journal of Autism and Developmental Disorders. 2024;54(3):963-82$24$YR$$F$Y$$$20240808$$HP$US$US
241891071$24189107$1$I$$20240626$20240808$20240808$PER$$US-OTSUKA-2024_018310$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241891081$24189108$1$I$$20240617$20240808$20240808$PER$$US-OTSUKA-2024_017373$OTSUKA$$$$$$Y$$$20240808$$CN$US$US
241891091$24189109$1$I$$20240610$20240808$20240808$PER$$US-OTSUKA-2024_016589$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241891101$24189110$1$I$$20240611$20240808$20240808$PER$$US-OTSUKA-2024_016883$OTSUKA$$$$$M$Y$$$20240808$$CN$US$US
241891111$24189111$1$I$$20240621$20240808$20240808$PER$$US-OTSUKA-2024_017759$OTSUKA$$$$$$Y$$$20240808$$PH$US$US
241891121$24189112$1$I$$20240804$20240808$20240808$EXP$$US-JNJFOC-20240812152$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241891131$24189113$1$I$$20240401$20240808$20240808$PER$$US-OTSUKA-2024_008976$OTSUKA$Moon YM, Park SE, Smith-Hicks C, Hauptman A.. Resolution of severe neurobehavioral difficulties in an individual with Primrose syndrome with sertraline. American journal of medical genetics. Part A. 2024;e63610$17$YR$$M$Y$$$20240808$$HP$US$US
241891142$24189114$2$F$20240728$20240814$20240808$20240822$EXP$$BR-CELLTRION INC.-2024BR018634$CELLTRION$$$$$$Y$$$20240822$$CN$BR$BR
241891151$24189115$1$I$20020124$20240805$20240808$20240808$PER$$US-JNJFOC-20240813136$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240808$$HP$US$US
241891171$24189117$1$I$$20240806$20240808$20240808$EXP$$JP-BAYER-2024A108691$BAYER$$$$A$F$Y$$$20240808$$PH$JP$JP
241891181$24189118$1$I$$20240729$20240808$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-038827$AUROBINDO$Sahly AN, Sierra-Marquez J, Bungert-Plumke S, Franzen A, Mougharbel L, Berrahmoune S, et al.. Genotype-phenotype correlation in CLCN4-related developmental and epileptic encephalopathy.. Hum-Genet. 2024;143:667-681$$$$M$Y$$$20240808$$HP$CA$CA
241891192$24189119$2$F$20240306$20240805$20240808$20240817$EXP$$SE-AUROBINDO-AUR-APL-2024-038822$AUROBINDO$$19$YR$$M$Y$$$20240817$$MD$SE$SE
241891201$24189120$1$I$20240627$20240805$20240808$20240808$EXP$$ES-AUROBINDO-AUR-APL-2024-039500$AUROBINDO$$48$YR$$F$Y$$$20240808$$MD$ES$ES
241891214$24189121$4$F$20210101$20240925$20240808$20240927$PER$$US-GILEAD-2024-0683389$GILEAD$$45$YR$A$M$Y$$$20240927$$LW$US$US
241891221$24189122$1$I$$20240729$20240808$20240808$PER$$US-ABBVIE-5861408$ABBVIE$$$$$$Y$$$20240808$$HP$US$US
241891241$24189124$1$I$20240724$20240730$20240808$20240808$EXP$CN-NMPACDR-4507011023714202401084$CN-BAXTER-2024BAX022567$BAXTER$$20$YR$$M$Y$53$KG$20240808$$MD$CN$CN
241891251$24189125$1$I$$20240806$20240808$20240808$EXP$$US-GILEAD-2024-0683420$GILEAD$$$$A$F$Y$$$20240808$$CN$US$US
241891261$24189126$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683432$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241891271$24189127$1$I$20240730$20240731$20240808$20240808$EXP$$MX-AMGEN-MEXSP2024154675$AMGEN$$$$$M$Y$$$20240808$$CN$MX$MX
241891291$24189129$1$I$$20240805$20240808$20240808$EXP$$IT-ABBVIE-5867489$ABBVIE$$$$$F$Y$$$20240808$$CN$IT$IT
241891301$24189130$1$I$20240716$20240807$20240808$20240808$EXP$GB-MHRA-MED-202408071056017800-NFWJH$GB-LUNDBECK-DKLU4002664$LUNDBECK$$$$$$Y$$$20240808$$MD$GB$GB
241891311$24189131$1$I$$20240729$20240808$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-039448$AUROBINDO$$$$$F$Y$198$KG$20240808$$HP$CA$CA
241891331$24189133$1$I$20230101$20240801$20240808$20240808$EXP$$CA-GSK-CA2023121569$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$CA$CA
241891341$24189134$1$I$$20240801$20240808$20240808$EXP$$US-TAKEDA-2024TUS077757$TAKEDA$$$$$F$Y$$$20240808$$CN$US$US
241891351$24189135$1$I$$20240729$20240808$20240808$EXP$IE-EMA-DD-20240723-7482647-080025$IE-Accord-439226$ACCORD$$$$$F$Y$$$20240808$$MD$IE$IE
241891361$24189136$1$I$20141210$20240728$20240808$20240808$EXP$GB-MHRA-MED-202407281102397300-SCHFT$GB-Accord-439169$ACCORD$$60$YR$A$M$Y$77$KG$20240808$$CN$GB$GB
241891371$24189137$1$I$$20240728$20240808$20240808$EXP$$TR-Accord-439683$ACCORD$Sarper N, Tachsin I, Aylan Gelen S, Zengin E. The outcome in pediatric acute myeloblastic leukemia; results of the first-line treatment and contribution of hematopoietic stem cell transplantation to survival of relapsed patients. Turk J Med Sci. 2023 Dec 11;54(2):411-418.$$$$$Y$$$20240808$$HP$TR$TR
241891381$24189138$1$I$$20240727$20240808$20240808$EXP$CA-MHPD-001087528$CA-Accord-438919$ACCORD$$50$YR$A$M$Y$$$20240808$$HP$CA$CA
241891391$24189139$1$I$20220101$20240728$20240808$20240808$EXP$$CN-Accord-439457$ACCORD$Zhu L, Wang H, Cheng D, Wang W, Lei Y, Yang N, et al. Case report: Pyrotinib in the treatment of advanced scrotal EMPD combined with sweat gland carcinoma. Frontiers in oncology. 2024; 14:1382376$79$YR$E$M$Y$$$20240808$$HP$CN$CN
241891402$24189140$2$F$20200101$20240805$20240808$20240816$EXP$$RO-Accord-438965$ACCORD$Georgescu D, Lighezan DF, Lascu A, Buzas R, Faur A, Ionita I, et al. Hepatic Veno-Occlusive Disease and Colorectal Cancer: Expect the Unexpected. Life (Basel). 2024 Jul 4;14(7):845. doi: 10.3390/life14070845.$65$YR$E$F$Y$$$20240816$$HP$RO$RO
241891411$24189141$1$I$$20240729$20240808$20240808$EXP$FR-AFSSAPS-RE2024000752$FR-Accord-439286$ACCORD$$74$YR$E$F$Y$$$20240808$$HP$FR$FR
241891421$24189142$1$I$20240711$20240729$20240808$20240808$EXP$$US-Accord-439161$ACCORD$$49$YR$A$M$Y$$$20240808$$HP$US$US
241891431$24189143$1$I$$20240730$20240808$20240808$EXP$$CA-ROCHE-10000047133$ROCHE$$29$YR$A$F$Y$$$20240808$$MD$CA$CA
241891441$24189144$1$I$20240201$20240727$20240808$20240808$EXP$DE-BFARM-24005156$DE-Accord-439061$ACCORD$$1$DY$N$M$Y$3.905$KG$20240808$$MD$DE$DE
241891461$24189146$1$I$$20240729$20240808$20240808$EXP$$CA-TEVA-VS-3227814$TEVA$$74$YR$$F$Y$$$20240808$$CN$CA$CA
241891471$24189147$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161530$NOVARTIS$$48$YR$$F$Y$83.9$KG$20240808$$CN$US$US
241891481$24189148$1$I$20240217$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038601$AUROBINDO$$26$YR$$F$Y$61.9$KG$20240808$$MD$FR$FR
241891491$24189149$1$I$$20240729$20240808$20240808$EXP$$CA-TEVA-VS-3227526$TEVA$$54$YR$$M$Y$$$20240808$$MD$CA$CA
241891501$24189150$1$I$$20240802$20240808$20240808$EXP$$CA-TAKEDA-2021TUS069776$TAKEDA$$$$$M$Y$$$20240808$$CN$CA$CA
241891511$24189151$1$I$$20240725$20240808$20240808$EXP$$KR-Axellia-005304$XELLIA PHARMACEUTICALS$Kim Y, Bae S, Huh KY, Joo JS, Lee J, Song SH, et.al. Coadministration of Voriconazole and Rifabutin Can Increase the Risk of Adverse Drug Reactions in Patients with Multiple Infections. Ther Drug Monit. 2024 Jul 16.$46$YR$A$M$Y$$$20240808$$MD$KR$KP
241891521$24189152$1$I$$20240729$20240808$20240808$EXP$$NL-AUROBINDO-AUR-APL-2024-038814$AUROBINDO$$44$YR$$M$Y$$$20240808$$HP$NL$NL
241891533$24189153$3$F$20240501$20240821$20240808$20240829$EXP$$SG-Eisai-EC-2024-171414$EISAI$$$$$M$Y$$$20240829$$MD$SG$SG
241891541$24189154$1$I$20230101$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038755$AUROBINDO$Antoine Baudriller, Chadi Abbara, Marie Briet, et al.,. D?c?s en lien ? avec des pharmacob?zoards: ? propos de deux cas. TOXICOLOGIE ANALYTIQUE + CLINIQUE$55$YR$$F$Y$$$20240808$$MD$FR$FR
241891553$24189155$3$F$20240807$20240905$20240808$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124883$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240916$$CN$US$US
241891561$24189156$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-038914$AUROBINDO$Pokharel G, Alkhatatneh H, Fleischer J, Janosky M, Terner S. AN UNUSUAL ELEVATION IN INTERNATIONAL NORMALIZED RATIO IN THE SETTING OF APIXABAN USE. J-Invest-Med. 2023;71:135-136$67$YR$$M$Y$$$20240808$$HP$US$US
241891571$24189157$1$I$20240703$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038625$AUROBINDO$$17$YR$$$Y$$$20240808$$CN$GB$GB
241891591$24189159$1$I$$20240725$20240808$20240808$PER$$US-APOTEX-2024AP009020$APOTEX$Ward C, DePalo D, Patel N, Carr M, Longbottom B, Cunningham K, et al.. Assessing the Efficacy of Imiquimod Use in Patients With Persistent Locally Advanced Melanoma In Situ. Journal of Drugs in Dermatology. 2023;22(5):457-464$73$YR$$F$Y$$$20240808$$HP$US$US
241891601$24189160$1$I$$20240729$20240808$20240808$EXP$$CA-TEVA-VS-3227817$TEVA$$45$YR$$F$Y$$$20240808$$CN$CA$CA
241891611$24189161$1$I$20240806$20240806$20240808$20240808$PER$$US-JNJFOC-20240813581$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$HP$US$US
241891621$24189162$1$I$20230101$20240805$20240808$20240808$EXP$FR-AFSSAPS-AVBX2024000432$FR-INDIVIOR UK LIMITED-INDV-153341-2024$RECKITT BENCKISER$$$$$$Y$$$20240808$$MD$FR$FR
241891631$24189163$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-039155$AUROBINDO$Jamil A, Ali R, Paige A, Miller R, Mistry N, Abbas A, et al.. ATYPICAL PULMONARY METASTASIS OF PROSTATE ADENOCARCINOMA: A RARE PHENOMENON.. Eur-J-Case-Rep-Intern-Med. 2024;11:No. 5$64$YR$$M$Y$$$20240808$$HP$US$US
241891641$24189164$1$I$$20240715$20240808$20240808$PER$22625205$US-LUPIN PHARMACEUTICALS INC.-2024-05095$LUPIN$$$$$$Y$$$20240808$$CN$US$US
241891651$24189165$1$I$20240719$20240805$20240808$20240808$EXP$FR-AFSSAPS-LM2024000430$FR-GRUNENTHAL-2024-123809$AVERITAS$$71$YR$$M$Y$86$KG$20240807$$HP$FR$FR
241891671$24189167$1$I$20240627$20240731$20240808$20240808$EXP$ES-AEMPS-1551441$ES-TEVA-VS-3228717$TEVA$$76$YR$$M$Y$$$20240808$$MD$ES$ES
241891681$24189168$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004161$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240808$$CN$US$US
241891711$24189171$1$I$$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038272$AUROBINDO$$$$$F$Y$$$20240808$$CN$GB$GB
241891721$24189172$1$I$$20240729$20240808$20240808$EXP$$CA-TEVA-VS-3227819$TEVA$$5$YR$$M$Y$$$20240808$$CN$CA$CA
241891732$24189173$2$F$$20240826$20240808$20240910$EXP$$US-TRIGEN LABORATORIES-2024ALO00369$Alora Pharma$$50$YR$$M$Y$$$20240910$$CN$US$US
241891741$24189174$1$I$$20240725$20240808$20240808$EXP$$US-TRIGEN LABORATORIES-2024ALO00370$Unknown Manufacturer$$$$C$M$Y$$$20240808$$CN$US$US
241891751$24189175$1$I$20240317$20240801$20240808$20240808$EXP$$TH-ROCHE-10000038357$ROCHE$$68$YR$E$F$Y$$$20240808$$MD$TH$TH
241891761$24189176$1$I$20240603$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54441$$FDA-CTU$$81$YR$$F$N$$$20240807$N$MD$US$
241891771$24189177$1$I$20240726$20240802$20240808$20240808$EXP$$US-VANTIVE-2024VAN018813$Vantive US Healthcare$$75$YR$$M$Y$$$20240808$$CN$US$US
241891781$24189178$1$I$20240604$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54349$$FDA-CTU$$38$YR$$M$N$$$20240807$N$PH$US$
241891801$24189180$1$I$$20240801$20240808$20240808$EXP$$US-VANTIVE-2024VAN018849$Vantive US Healthcare$$$$$M$Y$121$KG$20240808$$HP$US$US
241891811$24189181$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683419$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241891821$24189182$1$I$20240101$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156750$AMGEN$$57$YR$A$F$Y$$$20240808$$CN$US$US
241891831$24189183$1$I$$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024156819$AMGEN$$$$$F$Y$$$20240808$$CN$US$US
241891841$24189184$1$I$20240723$20240801$20240808$20240808$EXP$$CO-VANTIVE-2024VAN018613$Vantive US Healthcare$$69$YR$$M$Y$82.5$KG$20240808$$HP$CO$CO
241891851$24189185$1$I$$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54335$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
241891861$24189186$1$I$20240726$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156360$AMGEN$$79$YR$E$M$Y$$$20240808$$CN$US$US
241891871$24189187$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54340$$FDA-CTU$$54$YR$$M$N$$$20240807$N$$US$
241891881$24189188$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54347$$FDA-CTU$$88$YR$$M$N$$$20240807$N$$US$
241891901$24189190$1$I$20230706$20240801$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122406$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240808$$CN$US$US
241891911$24189191$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54426$$FDA-CTU$$$$$$N$$$20240807$N$CN$US$
241891931$24189193$1$I$20240806$20240807$20240808$20240808$PER$$US-BAYER-2024A114108$BAYER$$16$YR$T$M$Y$$$20240808$$CN$US$US
241891941$24189194$1$I$$20240729$20240808$20240808$EXP$$US-VIIV HEALTHCARE LIMITED-US2024094840$VIIV$$$$$M$Y$$$20240808$$CN$US$US
241891951$24189195$1$I$$20240730$20240808$20240808$30DAY$$US-GSK-US2024095388$GLAXOSMITHKLINE$$$$$M$Y$$$20240808$$CN$US$US
241891962$24189196$2$F$$20240729$20240808$20240808$30DAY$$US-GSK-US2024094802$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241891971$24189197$1$I$20240701$20240805$20240808$20240808$30DAY$$US-GSK-US2024097556$GLAXOSMITHKLINE$$61$YR$$M$Y$$$20240808$$CN$US$US
241891981$24189198$1$I$$20240725$20240808$20240808$PER$$US-APOTEX-2024AP009022$APOTEX$Ward C, DePalo D, Patel N, Carr M, Longbottom B, Cunningham K, et al.. Assessing the Efficacy of Imiquimod Use in Patients With Persistent Locally Advanced Melanoma In Situ. Journal of Drugs in Dermatology. 2023;22(5):457-464$71$YR$$M$Y$$$20240808$$HP$US$US
241891991$24189199$1$I$$20240729$20240808$20240808$EXP$$NL-AUROBINDO-AUR-APL-2024-038610$AUROBINDO$$61$YR$$F$Y$$$20240808$$PH$NL$NL
241892002$24189200$2$F$20210908$20240919$20240808$20240920$PER$$US-GILEAD-2024-0683427$GILEAD$$53$YR$A$M$Y$$$20240920$$LW$US$US
241892011$24189201$1$I$20240715$20240730$20240808$20240808$PER$$CN-IGSA-BIG0030116$GRIFOLS$$31$YR$$F$Y$45$KG$20240808$$HP$CN$CN
241892021$24189202$1$I$$20240730$20240808$20240808$EXP$$TR-TAKEDA-2024TUS079102$TAKEDA$$$$$$Y$$$20240808$$MD$TR$TR
241892031$24189203$1$I$20240401$20240806$20240808$20240808$30DAY$$US-SANDOZ INC.-SDZ2024US071155$SANDOZ$$69$YR$$F$Y$$$20240808$$HP$US$US
241892051$24189205$1$I$20240804$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54343$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
241892061$24189206$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54400$$FDA-CTU$$45$YR$$M$N$$$20240807$N$$US$
241892071$24189207$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54334$$FDA-CTU$$28$YR$$F$N$$$20240807$N$$US$
241892081$24189208$1$I$20240805$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54369$$FDA-CTU$$67$YR$$F$N$$$20240806$N$HP$US$
241892091$24189209$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54346$$FDA-CTU$$73$YR$$F$N$$$20240807$N$$US$
241892101$24189210$1$I$$20240806$20240808$20240808$PER$$US-JNJFOC-20240816558$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241892111$24189211$1$I$$20240806$20240808$20240808$PER$$US-HALEON-2190942$Haleon PLC$$60$YR$$M$Y$$$20240808$$CN$US$US
241892121$24189212$1$I$20240802$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024156912$AMGEN$$68$YR$E$F$Y$$$20240808$$CN$US$US
241892131$24189213$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54427$$FDA-CTU$$$$$$N$$$20240807$N$CN$US$
241892142$24189214$2$F$20240805$20240808$20240808$20240812$PER$$US-AMGEN-USASP2024155427$AMGEN$$78$YR$E$M$Y$$$20240812$$MD$US$US
241892151$24189215$1$I$$20240801$20240808$20240808$EXP$$US-ALXN-202408USA000033US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
241892163$24189216$3$F$20240101$20240908$20240808$20240923$EXP$$CA-UCBSA-2024026734$UCB$$$$$F$Y$$$20240923$$CN$CA$CA
241892171$24189217$1$I$$20240725$20240808$20240808$EXP$$JP-UCBSA-2024038197$UCB$$$$$F$Y$$$20240808$$HP$JP$JP
241892181$24189218$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A174683$ASTRAZENECA$$$$$M$Y$$$20240808$$HP$US$
241892191$24189219$1$I$$20240805$20240808$20240808$EXP$$CN-AstraZeneca-2024A159960$ASTRAZENECA$$$$$$Y$$$20240808$$CN$CN$
241892201$24189220$1$I$$20240731$20240808$20240808$EXP$$JP-AstraZeneca-2024A175640$ASTRAZENECA$$90$YR$$F$Y$$$20240808$$MD$JP$
241892211$24189221$1$I$20220701$20240804$20240808$20240808$EXP$$EU-BAUSCHBL-2024BNL031066$BAUSCH AND LOMB$$56$YR$$F$Y$$$20240808$$MD$EU$EU
241892221$24189222$1$I$20150201$20240729$20240808$20240808$EXP$$NL-AUROBINDO-AUR-APL-2024-038507$AUROBINDO$$54$YR$$F$Y$83$KG$20240808$$HP$NL$NL
241892231$24189223$1$I$$20210927$20240808$20240808$EXP$$JP-AstraZeneca-2021A754586$ASTRAZENECA$$$$$$Y$$$20240808$$MD$JP$
241892241$24189224$1$I$$20240726$20240808$20240808$PER$$US-AstraZeneca-2024A174891$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241892255$24189225$5$F$20240913$20240924$20240808$20240930$EXP$$CA-ROCHE-3496456$ROCHE$$63$YR$A$M$Y$$$20240930$$CN$CA$CA
241892262$24189226$2$F$20240729$20240814$20240808$20240819$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004353$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
241892271$24189227$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA095473$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240808$$MD$US$US
241892281$24189228$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA229370$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240808$$MD$US$US
241892291$24189229$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA096687$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240808$$MD$US$US
241892301$24189230$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA230995$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240808$$MD$US$US
241892311$24189231$1$I$$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122981$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240808$$HP$US$US
241892334$24189233$4$F$20240801$20240830$20240808$20240904$EXP$$JP-OTSUKA-2024_021622$OTSUKA$$54$YR$$M$Y$63.5$KG$20240904$$MD$JP$JP
241892342$24189234$2$F$20150126$20240925$20240808$20240927$PER$$US-GILEAD-2024-0683398$GILEAD$$34$YR$A$M$Y$$$20240927$$LW$US$US
241892351$24189235$1$I$$20240806$20240808$20240808$PER$$US-ABBVIE-5870625$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241892361$24189236$1$I$$20240725$20240808$20240808$PER$$US-APOTEX-2024AP009021$APOTEX$Ward C, DePalo D, Patel N, Carr M, Longbottom B, Cunningham K, et al.. Assessing the Efficacy of Imiquimod Use in Patients With Persistent Locally Advanced Melanoma In Situ. Journal of Drugs in Dermatology. 2023;22(5):457-464$83$YR$$F$Y$$$20240808$$HP$US$US
241892381$24189238$1$I$$20240729$20240808$20240808$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR097954$VIIV$$$$$$Y$$$20240808$$HP$US$US
241892392$24189239$2$F$$20240910$20240808$20240919$EXP$$US-AUROBINDO-AUR-APL-2024-038638$AUROBINDO$Bollam RR, Reddy VK. Persistent Pseudomonas Aeruginosa Pneumonia Due to Antimicrobial Resistance Development Requiring Lobectomy. Am-J-Respir-Crit-Care-Med. 2024$56$YR$$F$Y$$$20240919$$HP$US$US
241892401$24189240$1$I$20240725$20240730$20240808$20240808$PER$$US-BAYER-2024A111015$BAYER$$74$YR$E$F$Y$$$20240808$$CN$US$US
241892411$24189241$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-038915$AUROBINDO$Gillespie M, Wert MJ. Airway Obstruction Due to Invasive Tracheobronchial Aspergillosis. Am-JRespir-Crit-Care-Med. 2023;207:A6069$50$YR$$M$Y$$$20240808$$HP$US$US
241892421$24189242$1$I$$20240806$20240808$20240808$EXP$$US-KYOWAKIRIN-2024KK018842$KYOWA$$$$$$Y$$$20240808$$HP$US$US
241892432$24189243$2$F$$20240813$20240808$20240823$EXP$$US-TEVA-VS-3229845$TEVA$Ortiz Velez I, Gener Huertas E, Roman Velez N, Ramirez J, Perez Mitchell MC, Torrech C, Quiles-Cruz C, Feneque J, Fernandez R. The Challenge of Multi-organism Lung Infection With Human Immunodeficiency Virus. American Journal of Respiratory and Critical Care Medicine 207: (plus Poster), 2023; Ortiz Velez I, Gener E, Quiles-Cruz C, Roman-Velez N, Rodriguez KP, Rosado-Jimenez M, et al. The Challenge of multi-organism lung infection with human immunodeficiency virus. Am-J-Med-Sci 2023; 365 (Supp...$57$YR$$M$Y$$$20240823$$HP$US$US
241892441$24189244$1$I$$20211027$20240808$20240808$EXP$$US-AstraZeneca-2021A789819$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241892451$24189245$1$I$$20240730$20240808$20240808$PER$$US-AstraZeneca-2024A175182$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241892461$24189246$1$I$$20230505$20240808$20240808$EXP$$US-AstraZeneca-2023A106487$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241892471$24189247$1$I$$20240731$20240808$20240808$EXP$$ZA-AstraZeneca-2024A174385$ASTRAZENECA$$57$YR$$F$Y$$$20240808$$CN$ZA$
241892491$24189249$1$I$$20240802$20240808$20240808$EXP$$US-SA-2024SA232400$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240808$$MD$US$US
241892501$24189250$1$I$$20240712$20240808$20240808$EXP$$NG-ROCHE-10000027714$ROCHE$$$$A$F$Y$$$20240808$$MD$NG$NG
241892513$24189251$3$F$$20240828$20240808$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06943$LUPIN$$$$$$Y$$$20240918$$PH$US$US
241892521$24189252$1$I$$20240725$20240808$20240808$PER$$US-APOTEX-2024AP009023$APOTEX$Ward C, DePalo D, Patel N, Carr M, Longbottom B, Cunningham K, et al.. Assessing the Efficacy of Imiquimod Use in Patients With Persistent Locally Advanced Melanoma In Situ. Journal of Drugs in Dermatology. 2023;22(5):457-464$83$YR$$M$Y$$$20240808$$HP$US$US
241892531$24189253$1$I$$20240802$20240808$20240808$EXP$$US-THE RITEDOSE CORPORATION-2024RIT000102$THE RITEDOSE CORP$$$$$$Y$$$20240808$$CN$US$US
241892541$24189254$1$I$$20240808$20240808$20240808$EXP$$DE-BAYER-2024A114524$BAYER$$76$YR$E$F$Y$$$20240808$$CN$DE$DE
241892551$24189255$1$I$$20240728$20240808$20240808$EXP$$US-VKT-000577$VKT PHARMA PRIVATE LIMITED$$86$YR$E$F$Y$$$20240730$$MD$US$US
241892561$24189256$1$I$$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156952$AMGEN$$$$$$Y$$$20240808$$MD$US$US
241892571$24189257$1$I$$20240806$20240808$20240808$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004384$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240808$$CN$US$US
241892592$24189259$2$F$20240806$20240913$20240808$20240913$PER$$US-AMGEN-USASP2024156942$AMGEN$$51$YR$A$F$Y$$$20240913$$CN$US$US
241892602$24189260$2$F$$20240813$20240808$20240819$EXP$$US-GILEAD-2024-0683261$GILEAD$$$$E$F$Y$$$20240819$$CN$US$US
241892611$24189261$1$I$$20240805$20240808$20240808$PER$$US-LEO Pharma-372579$LEO PHARM$$76$YR$$F$Y$$$20240808$$CN$US$US
241892621$24189262$1$I$20240718$20240729$20240808$20240808$EXP$$CA-BAYER-2024A110373$BAYER$$50$YR$A$F$Y$$$20240808$$CN$CA$CA
241892631$24189263$1$I$20230912$20240731$20240808$20240808$PER$$US-BAYER-2024A111698$BAYER$$18$YR$A$F$Y$$$20240808$$HP$US$US
241892641$24189264$1$I$$20240729$20240808$20240808$EXP$$PL-AUROBINDO-AUR-APL-2024-033331$AUROBINDO$Kolczynska N, Masajtis-Zagajewska A, Jagodzinska M, Nowicki M.. Bilateral renal arteries stenosis in a patient with treatment-resistant hypertension and acute kidney injury. Polish Nephrology and Dialysis Therapy. 2024;28(2):27-28$49$YR$$M$Y$$$20240808$$HP$PL$PL
241892652$24189265$2$F$20240802$20240904$20240808$20240909$30DAY$$US-MYLANLABS-2024M1072910$MYLAN$$7$YR$$F$Y$$$20240909$$CN$US$US
241892671$24189267$1$I$20240730$20240802$20240808$20240808$PER$$US-BAYER-2024A112288$BAYER$$$$$F$Y$$$20240808$$MD$US$US
241892682$24189268$2$F$20240705$20240822$20240808$20240912$EXP$$CA-HALEON-2187780$Haleon PLC$$51$YR$$F$Y$$$20240912$$CN$CA$CA
241892691$24189269$1$I$$20240730$20240808$20240808$EXP$$US-LANTHEUS-LMI-2024-00957$LANTHEUS MEDICAL IMAGING$$$$$$Y$$$20240808$$HP$US$US
241892701$24189270$1$I$20240423$20240726$20240808$20240808$EXP$GB-MHRA-MED-202407251459411040-CZMBR$GB-OCTA-HAPL02324$OCTAPHARMA$$77$YR$$M$Y$82$KG$20240807$$PH$GB$GB
241892711$24189271$1$I$20240805$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155549$AMGEN$$75$YR$E$M$Y$$$20240808$$CN$US$US
241892722$24189272$2$F$20240725$20240912$20240808$20240921$30DAY$$US-AMGEN-USASP2024149603$AMGEN$$15$YR$T$M$Y$55.011$KG$20240921$$HP$US$US
241892731$24189273$1$I$20240614$20240731$20240808$20240808$EXP$FR-AFSSAPS-TO2024001123$FR-TEVA-VS-3229150$TEVA$$58$YR$$M$Y$100$KG$20240808$$PH$FR$FR
241892751$24189275$1$I$$20240803$20240808$20240808$PER$$NVSC2024US159393$NOVARTIS$$$$$M$Y$$$20240808$$CN$US$US
241892761$24189276$1$I$$20240729$20240808$20240808$PER$$US-BAYER-2024A112842$BAYER$$$$$$Y$$$20240808$$CN$US$US
241892771$24189277$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161487$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241892781$24189278$1$I$$20240725$20240808$20240808$PER$$US-APOTEX-2024AP008944$APOTEX$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. The Journal of Allergy and Clinical Immunology- Pract. 2024;12 (6):1663-1665$36$YR$$F$Y$$$20240808$$MD$US$US
241892791$24189279$1$I$$20240729$20240808$20240808$EXP$$JP-ROCHE-10000047783$ROCHE$Takahashi M, Iwai K, Tabata Y, Kadoya M.. EP-1119 Two cases of patients who presented with aortitis after administration of G-CSF preparation during postoperative adjuvant chemotherapy for breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;457$72$YR$E$F$Y$$$20240808$$MD$JP$JP
241892801$24189280$1$I$20240604$20240804$20240808$20240808$EXP$GB-MHRA-WEBRADR-202408041109247600-DCMKP$GB-RDY-SPO/GBR/24/0011475$DR REDDYS$$85$YR$E$F$Y$76$KG$20240808$$CN$GB$GB
241892811$24189281$1$I$$20240802$20240808$20240808$PER$$US-ALXN-202408USA000185US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241892821$24189282$1$I$$20240805$20240808$20240808$EXP$NL-LRB-00985383$NL-UCBSA-2024039119$UCB$$61$YR$$F$Y$$$20240808$$PH$NL$NL
241892831$24189283$1$I$20240701$20240730$20240808$20240808$EXP$$ZA-INDIVIOR EUROPE LIMITED-INDV-153353-2024$RECKITT BENCKISER$$$$$$Y$$$20240808$$CN$ZA$ZA
241892841$24189284$1$I$$20240805$20240808$20240808$EXP$$US-EMD Serono-2024042530$EMD SERONO INC$$$$A$F$Y$$$20240808$$CN$US$US
241892856$24189285$6$F$20240301$20240812$20240808$20240814$PER$$US-ROCHE-10000051581$ROCHE$$2$YR$C$M$Y$$$20240814$$CN$US$US
241892862$24189286$2$F$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683443$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241892881$24189288$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA227620$SANOFI AVENTIS$$50$YR$A$F$Y$166.26$KG$20240808$$CN$US$US
241892891$24189289$1$I$20240701$20240802$20240808$20240808$PER$$US-SA-2024SA009395$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240808$$CN$US$US
241892901$24189290$1$I$$20240731$20240808$20240808$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004455$BLUEPRINT MEDICINES$$$$$$Y$$$20240808$$CN$US$US
241892911$24189291$1$I$$20240807$20240807$20240807$DIR$713317$$FDA-CTU$$$$$UNK$N$$$20240807$N$CN$US$
241892921$24189292$1$I$$20240807$20240807$20240807$DIR$713319$$FDA-CTU$$$$$UNK$N$$$20240807$N$CN$US$
241892932$24189293$2$F$$20240912$20240808$20240919$30DAY$$JP-JNJFOC-20240815043$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$PH$JP$JP
241892941$24189294$1$I$20230101$20240716$20240808$20240808$PER$$US-JNJFOC-20240747657$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240808$$CN$US$US
241892951$24189295$1$I$20240709$20240730$20240808$20240808$EXP$FR-AFSSAPS-BR2024000606$FR-BAYER-2024A109832$BAYER$$74$YR$E$M$Y$60$KG$20240808$$PH$FR$FR
241892961$24189296$1$I$$20240802$20240808$20240808$PER$$US-BAYER-2024A112339$BAYER$$24$YR$A$F$Y$$$20240808$$MD$US$US
241892971$24189297$1$I$$20240802$20240808$20240808$PER$$US-BAYER-2024A112338$BAYER$$28$YR$A$F$Y$$$20240808$$CN$US$US
241892991$24189299$1$I$20240501$20240805$20240808$20240808$EXP$$NVSC2024DO161039$NOVARTIS$$94$YR$$M$Y$$$20240808$$CN$DO$DO
241893003$24189300$3$F$20240101$20240913$20240808$20240924$EXP$$BG-AKCEA THERAPEUTICS, INC.-2024IS006175$AKCEA THERAPEUTICS$$$$$$Y$$$20240923$$CN$BG$BG
241893011$24189301$1$I$20240101$20240801$20240808$20240808$PER$$US-SA-2024SA231769$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240808$$MD$US$US
241893023$24189302$3$F$20231101$20240919$20240808$20240925$PER$$US-ROCHE-10000049414$ROCHE$$51$YR$A$M$Y$$$20240925$$CN$US$US
241893034$24189303$4$F$20170516$20240924$20240808$20240926$PER$$US-GILEAD-2024-0683360$GILEAD$$67$YR$E$M$Y$$$20240926$$LW$US$US
241893041$24189304$1$I$$20240801$20240808$20240808$PER$$US-BAYER-2024A112402$BAYER$$43$YR$A$F$Y$$$20240808$$HP$US$US
241893051$24189305$1$I$$20240807$20240808$20240808$PER$$US-BAYER-2024A114375$BAYER$$$$$M$Y$$$20240808$$CN$US$US
241893061$24189306$1$I$$20240725$20240808$20240808$PER$$US-APOTEX-2024AP009053$APOTEX$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. The Journal of Allergy and Clinical Immunology- Pract. 2024;12 (6):1663-1665$32$YR$$F$Y$$$20240808$$MD$US$US
241893081$24189308$1$I$20201211$20240805$20240808$20240808$EXP$$CO-UCBSA-2024039679$UCB$$64$YR$$M$Y$$$20240808$$CN$CO$CO
241893091$24189309$1$I$$20240802$20240808$20240808$PER$$US-BAYER-2024A112358$BAYER$$47$YR$A$F$Y$$$20240808$$CN$US$US
241893101$24189310$1$I$$20240808$20240808$20240808$PER$$US-BAYER-2024A114390$BAYER$$$$$F$Y$$$20240808$$CN$US$US
241893111$24189311$1$I$20240804$20240806$20240808$20240808$EXP$$CA-GILEAD-2024-0683394$GILEAD$$63$YR$A$M$Y$$$20240808$$CN$CA$CA
241893124$24189312$4$F$20160929$20240924$20240808$20240925$EXP$$US-GILEAD-2024-0683423$GILEAD$$45$YR$A$M$Y$$$20240925$$LW$US$US
241893131$24189313$1$I$20240601$20240801$20240808$20240808$EXP$$JP-009507513-2406JPN003024J$MERCK$$75$YR$$M$Y$$$20240808$$MD$JP$JP
241893151$24189315$1$I$20230617$20240731$20240808$20240808$EXP$$JP-AstraZeneca-2024A174933$ASTRAZENECA$$63$YR$$M$Y$80$KG$20240808$$MD$JP$
241893161$24189316$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A174525$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241893171$24189317$1$I$$20240729$20240808$20240808$EXP$$JP-ROCHE-10000048719$ROCHE$Ogawa T, Okumura M, Koike E, Koike K. EP-0715 A case of Basedow^s disease that developed during treatment with trastuzumab emtansine for metastatic breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;356$63$YR$A$F$Y$$$20240808$$MD$JP$JP
241893181$24189318$1$I$$20220208$20240808$20240808$EXP$$US-AstraZeneca-2022A066966$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241893191$24189319$1$I$$20240806$20240808$20240808$EXP$$US-JNJFOC-20240816885$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$HP$US$US
241893202$24189320$2$F$20240724$20240916$20240808$20240923$EXP$$IE-JNJFOC-20240802215$JOHNSON AND JOHNSON$$72$YR$E$M$Y$90$KG$20240924$$CN$IE$IE
241893212$24189321$2$F$$20240923$20240808$20240924$PER$$US-BAYER-2024A111709$BAYER$$55$YR$A$F$Y$$$20240924$$CN$US$US
241893221$24189322$1$I$$20240802$20240808$20240808$PER$$US-BAYER-2024A112315$BAYER$$$$$$Y$$$20240808$$CN$US$US
241893231$24189323$1$I$20240701$20240805$20240808$20240808$EXP$DE-PEI-CADR2024329701$DE-ROCHE-10000050623$ROCHE$$32$YR$A$M$Y$$$20240808$$MD$DE$DE
241893253$24189325$3$F$20240801$20240819$20240808$20240823$PER$$US-AMGEN-USASP2024154186$AMGEN$$82$YR$E$M$Y$$$20240823$$MD$US$US
241893271$24189327$1$I$$20240731$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122727$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240808$$CN$US$US
241893281$24189328$1$I$$20240730$20240808$20240808$PER$$US-BAYER-2024A110924$BAYER$$$$$$Y$$$20240808$$CN$US$US
241893291$24189329$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161612$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241893301$24189330$1$I$20230101$20240730$20240808$20240808$EXP$US-MLMSERVICE-20240723-PI140053-00030-1$US-RDY-SPO/USA/24/0011310$DR REDDYS$Longobardi SA, Alkowati H, Kang G, Slade C, Oyesanmi O. Ibuprofen-Induced Pancytopenia and Erythema Multiforme in an Elderly Female Patient. Cureus. 2024;16(6):e62785. DOI: 10.7759/cureus.62785.$75$YR$E$F$Y$$$20240808$$MD$US$US
241893311$24189331$1$I$$20240805$20240808$20240808$EXP$$MX-ROCHE-10000051242$ROCHE$$8$MON$I$F$Y$$$20240808$$HP$MX$MX
241893321$24189332$1$I$$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024157026$AMGEN$$$$$$Y$$$20240808$$CN$US$US
241893331$24189333$1$I$$20240801$20240808$20240808$EXP$$FR-MYLANLABS-2024M1072192$MYLAN$$50$YR$$M$Y$$$20240808$$MD$FR$FR
241893341$24189334$1$I$$20240801$20240808$20240808$EXP$$US-MYLANLABS-2024M1073480$MYLAN$Nguyen A, Norman M, O^reilly E, Robinson CL, Fonseca A, Madabhushi S, et al. Case Series: Spinal Cord Stimulator Therapy Alleviates Neuropathic Pain in Patients with Failed Back Surgery Syndrome in the Setting of Spinal Cord Injury. Pain-Med-Case-Rep 2023; 7 (7): 337-340.$50$YR$$M$Y$$$20240808$$MD$US$US
241893351$24189335$1$I$20240628$20240801$20240808$20240808$EXP$FR-AFSSAPS-PV2024000655$FR-MYLANLABS-2024M1072146$MYLAN$$86$YR$$F$Y$47.2$KG$20240808$$HP$FR$FR
241893361$24189336$1$I$$20240806$20240808$20240808$EXP$$GB-MYLANLABS-2024M1073503$MYLAN$$$$$M$Y$$$20240808$$MD$GB$GB
241893373$24189337$3$F$20231101$20240814$20240808$20240822$EXP$$NVSC2024MX046221$NOVARTIS$$84$YR$$F$Y$61$KG$20240822$$CN$MX$MX
241893381$24189338$1$I$$20240801$20240808$20240808$EXP$$US-MYLANLABS-2024M1073477$MYLAN$Sevella P, Khan S, Shah S. A Devastating Case of Septic Pulmonary Emboli. Am-J-Respir-Crit-Care-Med 2024; 209.$73$YR$$M$Y$$$20240808$$HP$US$US
241893391$24189339$1$I$$20240801$20240808$20240808$EXP$$US-MYLANLABS-2024M1073514$MYLAN$Qadir N, Rulka K, Shirazi I, Durgun A, Trehan M. A Day on the Beach, a Risk for Vibrio Vulnificus Septicemia. Am-J-Respir-Crit-Care-Med 2024; 209.$61$YR$$M$Y$$$20240808$$HP$US$US
241893401$24189340$1$I$$20240801$20240808$20240808$EXP$$ID-MYLANLABS-2024M1073469$MYLAN$Niryana IW, Tombeng MA, Lauren C, Maliawan S, Golden N, Mahadewa TGB, et al. Secondary Trigeminal Neuralgia Caused by Cerebellopontine Angle Arachnoid Cyst in A 27-Year-Old Female: A Case Report. Acta-Neurol-Taiwan 2024; 33 71-75.$27$YR$$F$Y$$$20240808$$MD$ID$ID
241893411$24189341$1$I$$20240718$20240808$20240808$PER$$US-BAYER-2024A106002$BAYER$$$$$$Y$$$20240808$$CN$US$US
241893421$24189342$1$I$20220312$20240729$20240808$20240808$EXP$$PL-AUROBINDO-AUR-APL-2024-038670$AUROBINDO$$64$YR$$F$Y$$$20240808$$PH$PL$PL
241893432$24189343$2$F$$20240806$20240808$20240819$EXP$GB-MHRA-MED-202408061515580660-ZSMPB$GB-MYLANLABS-2024M1073574$MYLAN$$89$YR$$F$Y$$$20240819$$PH$GB$GB
241893441$24189344$1$I$$20240801$20240808$20240808$EXP$$US-MYLANLABS-2024M1073517$MYLAN$Nguyen A, Norman M, O^reilly E, Robinson CL, Fonseca A, Madabhushi S, et al. Case Series: Spinal Cord Stimulator Therapy Alleviates Neuropathic Pain in Patients with Failed Back Surgery Syndrome in the Setting of Spinal Cord Injury. Pain-Med-Case-Rep 2023; 7 (7): 337-340.$49$YR$$M$Y$$$20240808$$MD$US$US
241893453$24189345$3$F$$20240821$20240808$20240822$EXP$$MA-PFIZER INC-202400230034$PFIZER$Tariqi, R.. A rare case of metastatic prostatic rhabdomyosarcoma in a young adult: Clinical challenges and therapeutic perspectives. Urology Case Reports. 2024;56:10.1016/j.eucr.2024.102811$23$YR$$M$Y$$$20240822$$MD$MA$MA
241893461$24189346$1$I$20210101$20240802$20240808$20240808$EXP$$CN-PFIZER INC-PV202400101658$PFIZER$Li, Z.. Intrathecal Injection of Tigecycline and Polymyxin B in the Treatment of Extensively Drug-Resistant Intracranial Acinetobacter baumannii Infection: A Case Report and Review of the Literature. Infection and Drug Resistance. 2022;15:1411-1423$31$YR$$M$Y$$$20240808$$HP$CN$CN
241893472$24189347$2$F$$20240807$20240808$20240814$EXP$$US-PFIZER INC-202400230866$PFIZER$Thor, D.. Navigation of a New-Onset Pulmonary Embolism in a Patient Receiving Female-to-Male Gender-Affirming Care: A Case Report. Cureus. 2024;16(6):e63101$21$YR$$F$Y$$$20240814$$MD$US$US
241893481$24189348$1$I$$20240805$20240808$20240808$EXP$$GR-PFIZER INC-PV202400101628$PFIZER$Keffes, N.. PENETRATING BRAIN INJURY THROUGH A PRE-EXISTING SKULL DEFECT. 37th ANNUAL CONGRESS OF THE HELLENIC NEUROSURGICAL SOCIETY. 2024$44$YR$$M$Y$$$20240808$$MD$GR$GR
241893491$24189349$1$I$$20240806$20240808$20240808$EXP$$CA-PFIZER INC-202400231338$PFIZER$$$$$$Y$$$20240808$$HP$CA$CA
241893501$24189350$1$I$$20240805$20240808$20240808$EXP$$US-PFIZER INC-202400230728$PFIZER$Jones, A.. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024;36:10.1016/j.ajoc.2024.102131$$$I$F$Y$0.57$KG$20240808$$HP$US$US
241893511$24189351$1$I$$20240805$20240808$20240808$EXP$$US-PFIZER INC-202400230727$PFIZER$Jones, A.. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024;36:10.1016/j.ajoc.2024.102131$$$I$M$Y$$$20240808$$HP$US$US
241893521$24189352$1$I$$20240805$20240808$20240808$EXP$$CA-PFIZER INC-202400230456$PFIZER$$6$DEC$$F$Y$$$20240808$$HP$CA$CA
241893531$24189353$1$I$20210909$20240731$20240808$20240808$EXP$$GB-PFIZER INC-202400228030$PFIZER$Benjamin, A.. Disseminated Mycobacterium abscessus with bone and central nervous system (CNS) involvement - a case report and review of the literature. Clinical Infection in Practice. 2024;23:10.1016/j.clinpr.2024.100372.$64$YR$$M$Y$$$20240808$$MD$GB$GB
241893542$24189354$2$F$$20240808$20240808$20240813$EXP$$US-PFIZER INC-PV202400101050$PFIZER$Rechdan, M.. Acute vesiculobullous eruption in lupus patient on trimethoprim-sulfamethoxazole. JAAD Case Reports. 2024;50:126-128$48$YR$$F$Y$$$20240813$$HP$US$US
241893551$24189355$1$I$20240724$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54332$$FDA-CTU$$74$YR$$M$N$$$20240807$Y$PH$US$
241893561$24189356$1$I$$20240807$20240807$20240807$DIR$713324$$FDA-CTU$$$$$UNK$N$$$20240807$N$CN$US$
241893571$24189357$1$I$20240807$20240807$20240807$20240807$DIR$713315$$FDA-CTU$$65$YR$$F$N$$$20240807$N$HP$US$
241893581$24189358$1$I$20240805$20240807$20240808$20240808$PER$$US-BAYER-2024A114050$BAYER$$32$YR$A$F$Y$$$20240808$$CN$US$US
241893591$24189359$1$I$20230701$20240731$20240808$20240808$PER$$US-SA-2024SA231683$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240808$$MD$US$US
241893602$24189360$2$F$20240701$20240827$20240808$20240904$PER$$US-SA-2024SA232197$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240904$$MD$US$US
241893611$24189361$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA230851$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240808$$CN$US$US
241893631$24189363$1$I$$20240722$20240808$20240808$PER$$US-APOTEX-2024AP008707$APOTEX$$$$$F$Y$$$20240808$$CN$US$US
241893641$24189364$1$I$20240730$20240801$20240808$20240808$EXP$$US-009507513-2408USA000803$MERCK$$49$YR$$F$Y$$$20240808$$HP$US$US
241893651$24189365$1$I$$20240807$20240808$20240808$30DAY$$US-SANDOZ INC.-NVSC2023US072518$SANDOZ$$$$$M$Y$40$KG$20240808$$CN$US$US
241893661$24189366$1$I$20240805$20240805$20240808$20240808$EXP$GB-MHRA-MED-202408050806323860-MLQNV$GB-ABBVIE-5869486$ABBVIE$$63$YR$$M$Y$$$20240808$$MD$GB$GB
241893671$24189367$1$I$$20240806$20240808$20240808$PER$$NVSC2024US161151$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241893682$24189368$2$F$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683456$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241893691$24189369$1$I$$20240802$20240808$20240808$PER$$US-BAYER-2024A112598$BAYER$$45$YR$A$F$Y$$$20240808$$CN$US$US
241893701$24189370$1$I$$20240729$20240808$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-039463$AUROBINDO$$47$YR$$F$Y$$$20240808$$HP$CA$CA
241893711$24189371$1$I$20220705$20240806$20240808$20240808$EXP$$GB-MYLANLABS-2024M1061217$MYLAN$$43$YR$$F$Y$$$20240808$$HP$GB$GB
241893721$24189372$1$I$$20240730$20240808$20240808$30DAY$$US-GSK-US2024AMR096084$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241893731$24189373$1$I$20240101$20240729$20240808$20240808$EXP$$SE-AUROBINDO-AUR-APL-2024-038473$AUROBINDO$$70$YR$$F$Y$$$20240808$$MD$SE$SE
241893742$24189374$2$F$20240101$20240907$20240808$20240909$PER$$US-PFIZER INC-202400229928$PFIZER$$18$YR$$F$Y$$$20240909$$CN$US$US
241893751$24189375$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-PV202400102794$PFIZER$$$$$F$Y$$$20240808$$CN$US$US
241893763$24189376$3$F$20240101$20240912$20240808$20240912$PER$$US-PFIZER INC-202400231228$PFIZER$$10$YR$$M$Y$27.7$KG$20240912$$MD$US$US
241893781$24189378$1$I$20240628$20240806$20240808$20240808$EXP$PT-INFARMED-J202406-717$PT-BAYER-2024A100534$BAYER$$72$YR$E$F$Y$72$KG$20240808$$HP$PT$PT
241893791$24189379$1$I$20240701$20240731$20240808$20240808$EXP$FR-AFSSAPS-AM2024000576$FR-INSUD PHARMA-2407FR06127$INSUD PHARMA$$31$YR$$F$Y$56$KG$20240808$$MD$FR$FR
241893801$24189380$1$I$20200711$20240731$20240808$20240808$EXP$PL-URPL-1-2126-2020$PL-INSUD PHARMA-2007PL03084$INSUD PHARMA$$48$YR$$F$Y$70$KG$20240808$$MD$PL$PL
241893811$24189381$1$I$20240101$20240724$20240808$20240808$PER$$US-INSUD PHARMA-2407US05941$INSUD PHARMA$$$$$$Y$$$20240808$$CN$US$US
241893821$24189382$1$I$20240702$20240730$20240808$20240808$EXP$$AU-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2407AU06098$INSUD PHARMA$$21$YR$$F$Y$$$20240808$$HP$AU$AU
241893831$24189383$1$I$20240701$20240724$20240808$20240808$PER$$US-INSUD PHARMA-2407US05943$INSUD PHARMA$$$$$$Y$$$20240808$$CN$US$US
241893842$24189384$2$F$20230301$20240813$20240808$20240826$PER$$US-INSUD PHARMA-2407US05944$INSUD PHARMA$$$$$$Y$$$20240826$$HP$US$US
241893851$24189385$1$I$20240724$20240807$20240808$20240808$EXP$$US-SANDOZ INC.-SDZ2024US071300$SANDOZ$$64$YR$$F$Y$$$20240808$$HP$US$US
241893862$24189386$2$F$$20240904$20240808$20240904$PER$$US-ALXN-202408USA000022US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
241893871$24189387$1$I$20080801$20240724$20240808$20240808$EXP$$US-COOPERSURGICAL, INC.-2024CPS002289$COOPERSURGICAL$$$$$F$Y$$$20240807$$LW$US$US
241893891$24189389$1$I$$20240724$20240808$20240808$EXP$$TR-JUBILANT CADISTA PHARMACEUTICALS-2024JUB00062$JUBILANT$Izci F., Izci S.,. Third-Degree Atrioventricular Block With High-Dose Lamotrigine Use. Primary Care Companion for CNS Disorders. 2023;25(3)$55$YR$$F$Y$$$20240807$$MD$TR$TR
241893901$24189390$1$I$$20240724$20240808$20240808$EXP$$CA-TASMAN PHARMA, INC.-2024TSM00220$TASMAN PHARMA$Reyes N.G.D, Bendahan N, Swinkin E, Lang A.E, Bassett A.S. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurol. Sci.. 2024$48$YR$$F$Y$$$20240807$$HP$CA$CA
241893911$24189391$1$I$$20240801$20240808$20240808$PER$$US-ALXN-202408USA000039US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240808$$HP$US$US
241893921$24189392$1$I$20240101$20240724$20240808$20240808$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01300$AVADEL CNS PHARMA$$$$$F$Y$81.633$KG$20240807$$CN$US$US
241893932$24189393$2$F$20240729$20240814$20240808$20240823$PER$$US-BAYER-2024A112677$BAYER$$72$YR$E$F$Y$$$20240823$$CN$US$US
241893941$24189394$1$I$$20240803$20240808$20240808$EXP$$US-SA-2024SA233470$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240808$$CN$US$US
241893951$24189395$1$I$$20230811$20240808$20240808$EXP$$CA-CELLTRION INC.-2022CA022767$CELLTRION$$$$$$Y$$$20240808$$MD$CA$CA
241893971$24189397$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230586$PFIZER$$23$YR$$F$Y$$$20240808$$MD$US$US
241893982$24189398$2$F$20240806$20240806$20240808$20240812$PER$$US-AMGEN-USASP2024156586$AMGEN$$60$YR$A$F$Y$$$20240811$$HP$US$US
241893991$24189399$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-039115$AUROBINDO$Hochfeld U, Heyer M, Mohammed A, Baig M, Barmaimon G, Omidvari K. Non-ARDS Chloramine Induced Lung Injury Managed by Venovenous Extracorporeal Membrane Oxygenation (ECMO): A Novel Approach. Am-J-Respir-Crit-Care-Med. 2023;207:A3205$65$YR$$M$Y$$$20240808$$HP$US$US
241894001$24189400$1$I$20240805$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155958$AMGEN$$$$$F$Y$$$20240808$$CN$US$US
241894011$24189401$1$I$20240726$20240807$20240808$20240808$PER$$US-BAYER-2024A114184$BAYER$$25$YR$A$F$Y$$$20240808$$MD$US$US
241894021$24189402$1$I$$20240729$20240808$20240808$PER$$NVSC2024US155609$NOVARTIS$$$$$F$Y$43.5$KG$20240808$$CN$US$US
241894031$24189403$1$I$20240616$20240802$20240808$20240808$EXP$FR-AFSSAPS-MA2024001110$FR-MYLANLABS-2024M1072603$MYLAN$$69$YR$$M$Y$$$20240808$$MD$FR$FR
241894041$24189404$1$I$$20240802$20240808$20240808$EXP$$GB-MYLANLABS-2024M1073754$MYLAN$Teoh PJ, McGuire E, Borman AM, Gorton R, Wilson AJ, Merrion C, et al. Invasive Trichoderma longibrachiatum infection in a neutropaenic patient. Med-Mycol-Case-Reports 2024; 45.$51$YR$$F$Y$$$20240808$$HP$GB$GB
241894051$24189405$1$I$$20240802$20240808$20240808$EXP$$US-MYLANLABS-2024M1073100$MYLAN$Tidwell J, Thakkar B, Nguyen MTT, Parker S, Schoenfeld A. Primary Hepatic Neuroendocrine Carcinoma: A Rare Entity. ACG-Case-Rep-J 2024; 11 (7).$65$YR$$M$Y$$$20240808$$HP$US$US
241894061$24189406$1$I$$20210901$20240808$20240808$EXP$$US-AstraZeneca-2021A712006$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241894081$24189408$1$I$$20240807$20240807$20240807$DIR$713311$$FDA-CTU$$$$$UNK$N$$$20240807$$CN$US$
241894091$24189409$1$I$$20211018$20240808$20240808$EXP$$US-AstraZeneca-2021A780510$ASTRAZENECA$$$$$F$Y$96.2$KG$20240808$$HP$US$
241894101$24189410$1$I$$20230330$20240808$20240808$EXP$$US-AstraZeneca-2023A076159$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241894111$24189411$1$I$$20230502$20240808$20240808$EXP$$US-AstraZeneca-2023A104016$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241894123$24189412$3$F$$20240826$20240808$20240828$EXP$$AT-ELI_LILLY_AND_COMPANY-AT202407020322$ELI LILLY AND CO$$82$YR$E$F$Y$69$KG$20240828$$HP$AT$AT
241894131$24189413$1$I$$20240224$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004215$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241894141$24189414$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54379$$FDA-CTU$$77$YR$$F$N$$$20240807$N$$US$
241894151$24189415$1$I$20230401$20240807$20240807$20240807$DIR$713325$$FDA-CTU$$48$YR$$F$N$69.75$KG$20240807$N$CN$US$
241894161$24189416$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54354$$FDA-CTU$$54$YR$$M$N$$$20240807$N$$US$
241894171$24189417$1$I$$20240728$20240808$20240808$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408002868$ELI LILLY AND CO$Yamada Y, et al..Longitudinal CT, MRI, and 18F-FDG PET/CT Imaging Findings of Peliosis Hepatis: A Case Report..Cureus 2024;16(6):e62997.$73$YR$E$F$Y$$$20240808$$MD$JP$JP
241894182$24189418$2$F$$20240828$20240808$20240830$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408002931$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240830$$CN$JP$JP
241894211$24189421$1$I$$20240807$20240808$20240808$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044526$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240808$$MD$US$US
241894221$24189422$1$I$$20231122$20240808$20240808$PER$$US-Techdow-2023Techdow000226$SHENZHEN TECHDOW PHARMACEUTICAL$$$$$$Y$68$KG$20240808$$PH$US$US
241894231$24189423$1$I$$20231122$20240808$20240808$PER$$US-Techdow-2023Techdow000268$SHENZHEN TECHDOW PHARMACEUTICAL$$$$$$Y$101$KG$20240808$$PH$US$US
241894241$24189424$1$I$$20231122$20240808$20240808$PER$$US-Techdow-2023Techdow000270$SHENZHEN TECHDOW PHARMACEUTICAL$$$$$$Y$80$KG$20240808$$PH$US$US
241894252$24189425$2$F$$20240813$20240808$20240816$EXP$$GB-MYLANLABS-2024M1054468$MYLAN$$$$$M$Y$$$20240816$$MD$GB$GB
241894261$24189426$1$I$20230829$20240805$20240808$20240808$EXP$CH-SM-2024-14532$CH-MYLANLABS-2024M1072969$MYLAN$$21$YR$$M$Y$$$20240808$$PH$CH$CH
241894272$24189427$2$F$20231009$20240912$20240808$20240919$EXP$$GB-MYLANLABS-2023M1110500$MYLAN$$74$YR$$M$Y$$$20240919$$MD$GB$GB
241894282$24189428$2$F$20170816$20240924$20240808$20240926$PER$$US-GILEAD-2024-0683386$GILEAD$$63$YR$A$M$Y$$$20240926$$LW$US$US
241894292$24189429$2$F$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683459$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241894311$24189431$1$I$20240718$20240730$20240808$20240808$EXP$$CN-GE HEALTHCARE-2024CSU008738$GE HEALTHCARE$$47$YR$$F$Y$$$20240808$$HP$CN$CN
241894331$24189433$1$I$20240411$20240802$20240808$20240808$EXP$FR-AFSSAPS-TO2024001422$FR-MYLANLABS-2024M1072581$MYLAN$$73$YR$$M$Y$$$20240808$$MD$FR$FR
241894341$24189434$1$I$20240611$20240802$20240808$20240808$EXP$FR-AFSSAPS-NC2024000900$FR-MYLANLABS-2024M1072592$MYLAN$$88$YR$$F$Y$52$KG$20240808$$MD$FR$FR
241894351$24189435$1$I$$20240802$20240808$20240808$EXP$$PT-MYLANLABS-2024M1072810$MYLAN$Veiga C, Anjo C, Albergaria I, Nunes A, Atanasio G, Nascimento E. Dermatomyositis SAE1- a case report. Congresses of the Portuguese Society of Internal Medicine: 30th National Congres. 2024;990$62$YR$$F$Y$$$20240808$$MD$PT$PT
241894361$24189436$1$I$$20240729$20240808$20240808$EXP$$US-TEVA-VS-3228350$TEVA$Shakir M, Mohamed N, Vietor N, Mai V, Hoang T. Acute Cardiovascular Complications FromTestosterone Therapy. J-Endocr-Soc 2019; 3 (Suppl. 1) 1-2 abstr. SUN-206.$48$YR$$M$Y$$$20240808$$MD$US$US
241894372$24189437$2$F$$20240827$20240808$20240828$PER$$US-ALXN-202408USA000068US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241894382$24189438$2$F$$20240829$20240808$20240829$PER$$US-ALXN-202408USA000337US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$MD$US$US
241894392$24189439$2$F$$20240903$20240808$20240913$EXP$$US-TEVA-VS-3228348$TEVA$Shakir M, Mohamed N, Vietor N, Mai V, Hoang T. Acute Cardiovascular Complications FromTestosterone Therapy. J-Endocr-Soc 2019; 3 (Suppl. 1) 1-2 abstr. SUN-206.; Shakir M, Mohamed N, Vietor N, Mai V, Hoang T. Acute Cardiovascular Complications FromTestosterone Therapy. J-Endocr-Soc 2019; 3 (Suppl. 1) 1-2 abstr. SUN-206.$43$YR$$M$Y$$$20240913$$MD$US$US
241894401$24189440$1$I$$20240807$20240808$20240808$EXP$$US-GILEAD-2024-0683436$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241894411$24189441$1$I$20240729$20240806$20240808$20240808$EXP$$CN-BAYER-2024A113664$BAYER$$38$YR$A$F$Y$$$20240808$$HP$CN$CN
241894421$24189442$1$I$20240717$20240806$20240808$20240808$EXP$$NVSC2024US160382$NOVARTIS$$95$YR$$M$Y$$$20240808$$CN$US$US
241894431$24189443$1$I$$20240805$20240808$20240808$PER$$US-BIOGEN-2024BI01277030$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241894441$24189444$1$I$$20240805$20240808$20240808$PER$$US-BIOGEN-2024BI01277070$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241894451$24189445$1$I$20240101$20240805$20240808$20240808$EXP$$US-ASTELLAS-2024US022414$ASTELLAS$$7$DEC$$M$Y$$$20240808$$CN$US$US
241894461$24189446$1$I$$20240805$20240808$20240808$PER$$US-BIOGEN-2020BI00933131$BIOGEN$$$$$M$Y$$$20240808$$CN$US$US
241894471$24189447$1$I$20230324$20240802$20240808$20240808$EXP$GB-MHRA-TPP24300188C1956549YC1722526678809$GB-RDY-SPO/GBR/24/0011457$DR REDDYS$$50$YR$A$F$Y$80$KG$20240808$$MD$GB$GB
241894481$24189448$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231913$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240808$$MD$US$US
241894491$24189449$1$I$20240701$20240801$20240808$20240808$PER$$US-SA-2024SA232054$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240808$$MD$US$US
241894511$24189451$1$I$20240730$20240801$20240808$20240808$PER$$US-SA-2024SA231362$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240808$$MD$US$US
241894521$24189452$1$I$$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54339$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
241894531$24189453$1$I$20240721$20240807$20240807$20240807$DIR$713313$$FDA-CTU$$28$YR$$F$N$$$20240807$Y$HP$US$
241894541$24189454$1$I$20240101$20240801$20240808$20240808$PER$$US-SA-2024SA231285$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240808$$MD$US$US
241894551$24189455$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA227133$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240808$$MD$US$US
241894561$24189456$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231697$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240808$$MD$US$US
241894571$24189457$1$I$$20240807$20240808$20240808$PER$$US-HALEON-2190889$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241894581$24189458$1$I$$20240729$20240808$20240808$EXP$$CA-TEVA-VS-3227831$TEVA$$$$C$F$Y$$$20240808$$MD$CA$CA
241894591$24189459$1$I$20240805$20240807$20240807$20240807$DIR$713329$$FDA-CTU$$16$YR$$F$N$73$KG$20240807$N$HP$US$
241894601$24189460$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54338$$FDA-CTU$$$$$F$N$$$20240807$N$HP$US$
241894621$24189462$1$I$$20240805$20240808$20240808$EXP$$TR-ASTELLAS-2024US022418$ASTELLAS$$62$YR$$$Y$$$20240808$$CN$TR$TR
241894631$24189463$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54353$$FDA-CTU$$51$YR$$F$N$83.91$KG$20240807$N$$US$
241894653$24189465$3$F$20240601$20240829$20240808$20240909$EXP$$US-ASTELLAS-2022US034107$ASTELLAS$$81$YR$E$M$Y$$$20240909$$CN$US$US
241894661$24189466$1$I$20240701$20240807$20240808$20240808$EXP$$US-TAKEDA-2024TUS079300$TAKEDA$$73$YR$$F$Y$$$20240808$$MD$US$US
241894671$24189467$1$I$20220101$20240805$20240808$20240808$EXP$$US-TAKEDA-2024TUS078947$TAKEDA$$56$YR$$F$Y$$$20240808$$MD$US$US
241894681$24189468$1$I$$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024157099$AMGEN$$$$$M$Y$$$20240808$$CN$US$US
241894691$24189469$1$I$$20240801$20240808$20240808$PER$$US-AMGEN-USASP2024153892$AMGEN$$$$A$M$Y$$$20240808$$HP$US$US
241894711$24189471$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54357$$FDA-CTU$$66$YR$$M$N$$$20240807$N$$US$
241894721$24189472$1$I$20240802$20240807$20240807$20240807$DIR$713303$$FDA-CTU$$72$YR$$M$N$86$KG$20240807$N$HP$US$
241894731$24189473$1$I$$20240725$20240808$20240808$EXP$$IN-ROCHE-10000040009$ROCHE$$69$YR$E$M$Y$71$KG$20240808$$MD$IN$IN
241894741$24189474$1$I$$20231114$20240808$20240808$EXP$$AU-ORGANON-O2311AUS001821$ORGANON$$$$$F$Y$$$20240808$$CN$AU$AU
241894751$24189475$1$I$$20240730$20240808$20240808$EXP$$US-PROGENICS PHARMACEUTICALS, INC.-LMI-2024-00977$PROGENICS PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
241894761$24189476$1$I$20240806$20240806$20240808$20240808$EXP$$AR-BAYER-2024A114002$BAYER$$81$YR$E$F$Y$$$20240808$$MD$AR$AR
241894791$24189479$1$I$20230818$20240807$20240808$20240808$EXP$$CH-TAKEDA-2024TUS079139$TAKEDA$$51$YR$$F$Y$$$20240808$$HP$CH$CH
241894811$24189481$1$I$20240530$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54336$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
241894821$24189482$1$I$$20240807$20240807$20240807$DIR$713339$$FDA-CTU$$$$$UNK$N$$$20240807$$CN$US$
241894841$24189484$1$I$$20240806$20240808$20240808$EXP$$NVSC2024AU104330$NOVARTIS$$$$$F$Y$$$20240808$$CN$AU$AU
241894852$24189485$2$F$$20240911$20240808$20240925$30DAY$$JP-JNJFOC-20240815012$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$PH$JP$JP
241894861$24189486$1$I$$20240807$20240808$20240808$PER$$US-BAYER-2024A114403$BAYER$$55$YR$A$F$Y$$$20240808$$CN$US$US
241894871$24189487$1$I$$20240806$20240808$20240808$EXP$$US-JNJFOC-20240817216$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240808$$MD$US$US
241894881$24189488$1$I$$20240805$20240808$20240808$EXP$$JP-JNJFOC-20240819439$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$PH$JP$JP
241894901$24189490$1$I$20240803$20240805$20240808$20240808$EXP$$US-TAKEDA-2022TUS010482$TAKEDA$$61$YR$$F$Y$103$KG$20240808$$CN$US$US
241894911$24189491$1$I$20240629$20240731$20240808$20240808$EXP$$IR-EMD Serono-2024041551$EMD SERONO INC$$45$YR$A$F$Y$60$KG$20240808$$CN$IR$IR
241894921$24189492$1$I$$20240805$20240808$20240808$PER$$US-BIOGEN-2024BI01277018$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241894931$24189493$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683388$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241894941$24189494$1$I$$20240807$20240808$20240808$PER$$US-AMGEN-USASP2024157312$AMGEN$$$$$M$Y$$$20240808$$HP$US$US
241894951$24189495$1$I$20231126$20240802$20240808$20240808$EXP$$CA-TAKEDA-2023TUS114108$TAKEDA$$45$YR$$F$Y$$$20240808$$CN$CA$CA
241894961$24189496$1$I$20231221$20240805$20240808$20240808$EXP$FR-AFSSAPS-ST2024001261$FR-TAKEDA-2024TUS079066$TAKEDA$$63$YR$$F$Y$105$KG$20240808$$HP$FR$FR
241894972$24189497$2$F$20240806$20240815$20240808$20240821$PER$$US-AMGEN-USASP2024156356$AMGEN$$72$YR$E$F$Y$$$20240820$$CN$US$US
241894993$24189499$3$F$$20240830$20240808$20240905$EXP$$US-TAKEDA-2024TUS073617$TAKEDA$$$$$M$Y$$$20240905$$CN$US$US
241895001$24189500$1$I$$20240729$20240808$20240808$EXP$$US-RECORDATI-2024006030$RECORDATI$$$$$$Y$$$20240808$$CN$US$US
241895011$24189501$1$I$20240714$20240805$20240808$20240808$EXP$$CN-PFIZER INC-PV202400101836$PFIZER$$51$YR$$F$Y$72$KG$20240808$$HP$CN$CN
241895021$24189502$1$I$20240724$20240807$20240808$20240808$EXP$$US-PFIZER INC-202400232141$PFIZER$$73$YR$$M$Y$$$20240808$$CN$US$US
241895031$24189503$1$I$$20240806$20240808$20240808$EXP$$US-PFIZER INC-202400231345$PFIZER$$78$YR$$F$Y$$$20240808$$CN$US$US
241895041$24189504$1$I$20121009$20240801$20240808$20240808$EXP$$FR-PFIZER INC-202400228001$PFIZER$$60$YR$$M$Y$$$20240808$$HP$FR$FR
241895052$24189505$2$F$$20240823$20240808$20240902$EXP$$US-TEVA-VS-3228027$TEVA$Thompson C, Barrett K, Scott D, Lofters J, Rastogi N. OH, WHAT A STORM: A CASE OF BLINATUMOMAB-INDUCED CYTOKINE RELEASE SYNDROME. J-Invest-Med 2023; 71 (7): 140-141.; Thompson C, Barrett K, Scott D, Lofters J, Rastogi N. OH, WHAT A STORM: A CASE OF BLINATUMOMAB-INDUCED CYTOKINE RELEASE SYNDROME. J-Invest-Med 2023; 71 (7): 140-141.$72$YR$$F$Y$$$20240902$$HP$US$US
241895061$24189506$1$I$20240621$20240805$20240808$20240808$EXP$FR-AFSSAPS-RN2024000846$FR-PFIZER INC-202400229863$PFIZER$$26$YR$$M$Y$$$20240808$$MD$FR$FR
241895072$24189507$2$F$20230101$20240809$20240808$20240814$EXP$$US-ROCHE-10000048467$ROCHE$$46$YR$A$M$Y$$$20240814$$CN$US$US
241895081$24189508$1$I$$20240806$20240808$20240808$EXP$$MA-PFIZER INC-202400231829$PFIZER$$$$$F$Y$$$20240808$$CN$MA$MA
241895091$24189509$1$I$20240630$20240806$20240808$20240808$EXP$IT-MINISAL02-997294$IT-PFIZER INC-202400230975$PFIZER$$21$YR$$M$Y$74$KG$20240808$$MD$IT$IT
241895101$24189510$1$I$$20240806$20240808$20240808$EXP$$US-PFIZER INC-202400231346$PFIZER$$83$YR$$F$Y$$$20240808$$CN$US$US
241895111$24189511$1$I$$20240802$20240808$20240808$EXP$$CA-PFIZER INC-202400230339$PFIZER$$73$YR$$F$Y$$$20240808$$MD$CA$CA
241895121$24189512$1$I$$20240806$20240808$20240808$EXP$GB-MHRA-MED-202408061624494640-SDVLZ$GB-PFIZER INC-202400231314$PFIZER$$54$YR$$M$Y$$$20240808$$PH$GB$GB
241895133$24189513$3$F$$20240918$20240808$20240923$EXP$$US-PFIZER INC-PV202400102155$PFIZER$$64$YR$$F$Y$$$20240923$$HP$US$US
241895141$24189514$1$I$$20240802$20240808$20240808$30DAY$$CL-PFIZER INC-202400226793$PFIZER$$$$$$Y$$$20240808$$CN$CL$CL
241895151$24189515$1$I$$20240805$20240808$20240808$EXP$$US-PFIZER INC-202400230417$PFIZER$$$$A$$Y$$$20240808$$HP$US$US
241895161$24189516$1$I$$20240805$20240808$20240808$EXP$$CA-PFIZER INC-202400231288$PFIZER$$$$$M$Y$$$20240808$$MD$CA$CA
241895171$24189517$1$I$$20240802$20240808$20240808$EXP$$CA-PFIZER INC-202400230349$PFIZER$$35$YR$$M$Y$$$20240808$$HP$CA$CA
241895181$24189518$1$I$20240701$20240805$20240808$20240808$EXP$FR-AFSSAPS-MA2024001288$FR-PFIZER INC-202400229929$PFIZER$$45$YR$$M$Y$$$20240808$$MD$FR$FR
241895191$24189519$1$I$$20240805$20240808$20240808$EXP$$CA-PFIZER INC-202400231269$PFIZER$$32$YR$$F$Y$$$20240808$$HP$CA$CA
241895212$24189521$2$F$$20240827$20240808$20240828$PER$$US-ALXN-202408USA000148US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241895222$24189522$2$F$20221012$20240813$20240808$20240816$EXP$$US-PFIZER INC-PV202400101950$PFIZER$$65$YR$$M$Y$82.81$KG$20240816$$MD$US$US
241895244$24189524$4$F$20190731$20240917$20240808$20240918$EXP$$US-GILEAD-2024-0683437$GILEAD$$58$YR$A$M$Y$$$20240918$$LW$US$US
241895251$24189525$1$I$$20220408$20240808$20240808$EXP$$CA-AstraZeneca-2020SF25928$ASTRAZENECA$$59$YR$$F$Y$$$20240808$$MD$CA$
241895261$24189526$1$I$$20240806$20240808$20240808$EXP$$IT-SANDOZ INC.-NVSC2021IT278696$SANDOZ$$25$YR$$F$Y$$$20240808$$MD$IT$IT
241895271$24189527$1$I$20240807$20240807$20240808$20240808$EXP$$CN-SANDOZ INC.-SDZ2024CN071292$SANDOZ$$$$$$Y$$$20240808$$CN$CN$CN
241895281$24189528$1$I$$20240723$20240808$20240808$PER$$US-INSUD PHARMA-2407US05935$INSUD PHARMA$$$$$$Y$$$20240808$$CN$US$US
241895291$24189529$1$I$20240101$20240723$20240808$20240808$PER$$US-INSUD PHARMA-2407US05937$INSUD PHARMA$$$$$$Y$$$20240808$$CN$US$US
241895301$24189530$1$I$20240101$20240723$20240808$20240808$PER$$US-INSUD PHARMA-2407US05936$INSUD PHARMA$$$$$$Y$$$20240808$$CN$US$US
241895324$24189532$4$F$20240701$20240923$20240808$20240926$30DAY$$US-PFIZER INC-202400229771$PFIZER$$14$YR$$M$Y$37.642$KG$20240926$$CN$US$US
241895332$24189533$2$F$$20240905$20240808$20240909$30DAY$$DE-PFIZER INC-202400228929$PFIZER$$$$$$Y$$$20240909$$HP$DE$DE
241895351$24189535$1$I$20240425$20240807$20240808$20240808$EXP$$US-TAKEDA-2024TUS050953$TAKEDA$$51$YR$$M$Y$$$20240808$$CN$US$US
241895371$24189537$1$I$20240718$20240806$20240808$20240808$EXP$$UA-MYLANLABS-2024M1073713$MYLAN$$48$YR$$M$Y$$$20240808$$HP$UA$UA
241895382$24189538$2$F$$20240823$20240808$20240902$EXP$$US-TEVA-VS-3228063$TEVA$Curtis TM, Sady KM, Randall JT, Kervin P, Mosher DM, Dailey MW. 18-Month-Old with Lethargy and Accelerated Idioventricular Rhythm in Prehospital Setting: A Case Report. Prehosp-Emerg-Care 2024; 1-4; Curtis TM, Sady KM, Randall JT, Kervin P, Mosher DM, Dailey MW. 18-Month-Old with Lethargy and Accelerated Idioventricular Rhythm in Prehospital Setting: A Case Report. Prehosp-Emerg-Care 2024; 1-4.$18$MON$$M$Y$$$20240902$$HP$US$US
241895391$24189539$1$I$$20240729$20240808$20240808$EXP$$CA-TEVA-VS-3227734$TEVA$$6$YR$$F$Y$$$20240808$$PH$CA$CA
241895401$24189540$1$I$$20240729$20240808$20240808$EXP$$CA-TEVA-VS-3227685$TEVA$$$$$M$Y$$$20240808$$MD$CA$CA
241895411$24189541$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54356$$FDA-CTU$$63$YR$$M$N$162.84$KG$20240807$N$HP$US$
241895421$24189542$1$I$20240607$20240710$20240808$20240808$EXP$$US-NEBO-663978$PHARMACOSMOS$$36$YR$$M$Y$98$KG$20240808$$HP$US$US
241895431$24189543$1$I$$20240807$20240807$20240807$DIR$713336$$FDA-CTU$$$$$M$N$84.6$KG$20240807$$CN$US$
241895441$24189544$1$I$20240806$20240807$20240807$20240807$DIR$713333$$FDA-CTU$$55$YR$$M$N$$$20240807$Y$PH$US$
241895452$24189545$2$F$$20240905$20240808$20240913$EXP$$US-TEVA-VS-3228606$TEVA$Zhang Y, Chakraborti MD C. REFINING PAIN MANAGEMENT IN CRYPTOCOCCAL IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME. South-Med-J 2022; 115 560.; Zhang Y, Chakraborti MD C. REFINING PAIN MANAGEMENT IN CRYPTOCOCCAL IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME. South-Med-J 2022; 115 560.$28$YR$$M$Y$$$20240913$$HP$US$US
241895461$24189546$1$I$20240101$20240802$20240808$20240808$EXP$$CA-ABBVIE-5865895$ABBVIE$$79$YR$$M$Y$$$20240808$$MD$CA$CA
241895471$24189547$1$I$20240802$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156927$AMGEN$$60$YR$A$F$Y$$$20240808$$CN$US$US
241895481$24189548$1$I$20240807$20240807$20240807$20240807$DIR$713320$$FDA-CTU$$66$YR$$F$N$$$20240807$N$CN$US$
241895491$24189549$1$I$20240731$20240807$20240807$20240807$DIR$713343$$FDA-CTU$$30$YR$$M$N$74.7$KG$20240807$N$$US$
241895501$24189550$1$I$$20240807$20240807$20240807$DIR$713316$$FDA-CTU$$$$$UNK$N$$$20240807$$CN$US$
241895512$24189551$2$F$20230928$20240807$20240808$20240808$EXP$$NVSC2024IN160869$NOVARTIS$$31$YR$$M$Y$$$20240808$$CN$IN$IN
241895524$24189552$4$F$20220101$20240902$20240808$20240909$EXP$$NVSC2024LK159822$NOVARTIS$$56$YR$$M$Y$$$20240909$$MD$LK$LK
241895531$24189553$1$I$$20240807$20240807$20240807$DIR$713327$$FDA-CTU$$$$$UNK$N$$$20240807$$CN$US$
241895551$24189555$1$I$20240806$20240807$20240807$20240807$DIR$713347$$FDA-CTU$$77$YR$$UNK$N$$$20240807$N$HP$US$
241895561$24189556$1$I$20240220$20240806$20240808$20240808$PER$$US-009507513-2408USA002010$MERCK$$69$YR$$M$Y$$$20240808$$MD$US$US
241895573$24189557$3$F$20240731$20240919$20240808$20240923$30DAY$$US-PFIZER INC-202400229694$PFIZER$$18$YR$$M$Y$97.52$KG$20240923$$CN$US$US
241895583$24189558$3$F$$20240911$20240808$20240911$30DAY$$US-PFIZER INC-202400225006$PFIZER$$8$YR$$M$Y$$$20240911$$CN$US$US
241895592$24189559$2$F$$20240907$20240808$20240909$30DAY$$US-PFIZER INC-202400227970$PFIZER$$11$YR$$M$Y$$$20240909$$CN$US$US
241895602$24189560$2$F$$20240913$20240808$20240913$30DAY$$CL-PFIZER INC-202400227628$PFIZER$$$$$M$Y$$$20240913$$CN$CL$CL
241895613$24189561$3$F$20240101$20240929$20240808$20240930$EXP$$CA-PFIZER INC-202400230290$PFIZER$$17$YR$$F$Y$$$20240930$$HP$CA$CA
241895622$24189562$2$F$$20240907$20240808$20240909$30DAY$$US-PFIZER INC-202400229211$PFIZER$$7$YR$$M$Y$$$20240909$$CN$US$US
241895644$24189564$4$F$20240725$20240925$20240808$20240927$EXP$$CA-PFIZER INC-202400204379$PFIZER$$71$YR$$M$Y$$$20240927$$MD$CA$CA
241895652$24189565$2$F$$20240914$20240808$20240916$30DAY$$HN-PFIZER INC-PV202400095575$PFIZER$$16$YR$$M$Y$$$20240916$$HP$HN$HN
241895663$24189566$3$F$$20240821$20240808$20240823$30DAY$$US-PFIZER INC-PV202400044132$PFIZER$$$$$$Y$$$20240823$$HP$US$US
241895672$24189567$2$F$20240101$20240813$20240808$20240816$30DAY$$CO-PFIZER INC-202400225759$PFIZER$$13$YR$$M$Y$39$KG$20240816$$CN$CO$CO
241895681$24189568$1$I$$20240725$20240808$20240808$EXP$$CA-PFIZER INC-202400223976$PFIZER$$$$$F$Y$$$20240808$$HP$CA$CA
241895691$24189569$1$I$20240801$20240805$20240808$20240808$EXP$$AR-MYLANLABS-2024M1073625$MYLAN$$54$YR$$F$Y$$$20240808$$MD$AR$AR
241895701$24189570$1$I$20240706$20240729$20240808$20240808$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000727$PAREXEL$$$$$$Y$$$20240808$$HP$CN$CN
241895711$24189571$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004220$ELI LILLY AND CO$$62$YR$A$$Y$$$20240808$$CN$US$US
241895721$24189572$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004230$ELI LILLY AND CO$$78$YR$E$$Y$$$20240808$$CN$US$US
241895731$24189573$1$I$20240104$20240729$20240808$20240808$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000728$PAREXEL$$67$YR$$M$Y$$$20240808$$HP$CN$CN
241895741$24189574$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004226$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240808$$CN$US$US
241895751$24189575$1$I$20240701$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004315$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240808$$CN$US$US
241895761$24189576$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003166$ELI LILLY AND CO$$66$YR$E$$Y$$$20240808$$CN$US$US
241895771$24189577$1$I$20240501$20240611$20240808$20240808$PER$$US-JNJFOC-20240817310$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$PH$US$US
241895782$24189578$2$F$$20240816$20240808$20240828$PER$$US-JNJFOC-20240780063$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
241895794$24189579$4$F$20240806$20240827$20240808$20240829$PER$$US-AMGEN-USASP2024157456$AMGEN$$76$YR$E$M$Y$$$20240828$$CN$US$US
241895801$24189580$1$I$$20240731$20240808$20240808$EXP$$GB-AMGEN-GBRSP2024153940$AMGEN$Taylor P.C.; Schett G.; Huizinga T.W. et.al.. Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy- results from the phase 2a IRIS-RA study. RMD Open. 2024;10 (2):1-12$$$$$Y$$$20240808$$HP$GB$GB
241895811$24189581$1$I$$20240801$20240808$20240808$EXP$$US-AMGEN-USASP2024153852$AMGEN$$$$A$F$Y$$$20240808$$HP$US$US
241895822$24189582$2$F$$20240913$20240808$20240913$30DAY$$GB-PFIZER INC-PV202400101057$PFIZER$$$$$M$Y$$$20240913$$HP$GB$GB
241895831$24189583$1$I$20240725$20240726$20240808$20240808$30DAY$$CL-PFIZER INC-202400227462$PFIZER$$15$YR$$$Y$$$20240808$$CN$CL$CL
241895851$24189585$1$I$$20240731$20240808$20240808$EXP$$US-AMGEN-USASP2024153105$AMGEN$Engen R.M.; Keyser M.; Jiang Z et.al.. Norovirus Management and Outcomes in a Multicenter Pediatric Kidney Transplant Population. Pediatric transplantation. 2024;28 (5):1-8$$$$$Y$$$20240808$$HP$US$US
241895862$24189586$2$F$20240801$20240823$20240808$20240830$EXP$$US-Vifor (International) Inc.-VIT-2024-06982$VIFOR$$$$E$F$Y$$$20240830$$CN$US$US
241895871$24189587$1$I$$20240730$20240808$20240808$PER$$US-AMGEN-USASP2024157254$AMGEN$$$$$M$Y$$$20240808$$CN$US$US
241895881$24189588$1$I$20240802$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155407$AMGEN$$56$YR$A$F$Y$$$20240808$$HP$US$US
241895901$24189590$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54351$$FDA-CTU$$57$YR$$F$N$$$20240807$N$$US$
241895911$24189591$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54363$$FDA-CTU$$86$YR$$F$N$$$20240807$N$$US$
241895921$24189592$1$I$20240101$20240805$20240808$20240808$EXP$$US-ABBVIE-5868384$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241895931$24189593$1$I$20240805$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54345$$FDA-CTU$$67$YR$$M$N$$$20240807$N$$US$
241895941$24189594$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54352$$FDA-CTU$$38$YR$$F$N$147$LBS$20240807$N$$US$
241895954$24189595$4$F$$20240916$20240808$20240921$EXP$$NL-ABBVIE-5867588$ABBVIE$$$$E$M$Y$$$20240921$$HP$NL$NL
241895961$24189596$1$I$20240801$20240801$20240808$20240808$EXP$$US-GSK-US2024096418$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$MD$US$US
241895971$24189597$1$I$$20240730$20240808$20240808$30DAY$$US-GSK-US2024AMR095672$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$PH$US$US
241895981$24189598$1$I$$20240712$20240808$20240808$EXP$$US-Vifor (International) Inc.-VIT-2024-06280$VIFOR$$$$$M$Y$$$20240808$$CN$US$US
241895991$24189599$1$I$$20240802$20240808$20240808$EXP$$CA-TAKEDA-2024TUS078837$TAKEDA$$$$$M$Y$$$20240808$$MD$CA$CA
241896002$24189600$2$F$$20240826$20240808$20240826$PER$$US-ALXN-202408USA000150US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
241896011$24189601$1$I$20240719$20240805$20240808$20240808$EXP$FR-AFSSAPS-NT2024000997$FR-PFIZER INC-202400229963$PFIZER$$71$YR$$M$Y$$$20240808$$MD$FR$FR
241896021$24189602$1$I$$20240805$20240808$20240808$EXP$$IN-PFIZER INC-PV202400083479$PFIZER$$51$YR$$M$Y$$$20240808$$CN$IN$IN
241896031$24189603$1$I$20240724$20240805$20240808$20240808$EXP$$CN-PFIZER INC-PV202400101828$PFIZER$$62$YR$$F$Y$$$20240808$$HP$CN$CN
241896041$24189604$1$I$$20240802$20240808$20240808$EXP$$US-PFIZER INC-PV202400101754$PFIZER$$76$YR$$M$Y$$$20240808$$MD$US$US
241896051$24189605$1$I$20140101$20240806$20240808$20240808$EXP$FR-AFSSAPS-RS2024000750$FR-PFIZER INC-202400230837$PFIZER$$61$YR$$F$Y$51$KG$20240808$$MD$FR$FR
241896061$24189606$1$I$$20240802$20240808$20240808$EXP$$KR-PFIZER INC-PV202400102256$PFIZER$Oh, D.. Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer. NEJM Evidence. 2022;1(8):10.1056/EVIDoa2200015$$$A$$Y$$$20240808$$MD$KR$KR
241896071$24189607$1$I$20180101$20240805$20240808$20240808$EXP$FR-AFSSAPS-RS2024000768$FR-PFIZER INC-202400229921$PFIZER$$69$YR$$F$Y$$$20240808$$MD$FR$FR
241896081$24189608$1$I$20240802$20240805$20240808$20240808$EXP$$US-PFIZER INC-202400230471$PFIZER$$$$$F$Y$$$20240808$$MD$US$US
241896091$24189609$1$I$20240801$20240806$20240808$20240808$EXP$$RU-PFIZER INC-PV202400102212$PFIZER$$50$YR$$M$Y$$$20240808$$MD$RU$RU
241896101$24189610$1$I$20240630$20240805$20240808$20240808$EXP$FR-AFSSAPS-DJ2024000874$FR-PFIZER INC-202400229937$PFIZER$$68$YR$$F$Y$$$20240808$$MD$FR$FR
241896121$24189612$1$I$20180101$20240805$20240808$20240808$EXP$$US-PFIZER INC-PV202400102783$PFIZER$$$$$F$Y$$$20240808$$CN$US$US
241896131$24189613$1$I$20240717$20240805$20240808$20240808$EXP$IT-MINISAL02-996981$IT-PFIZER INC-202400229878$PFIZER$$80$YR$$F$Y$73$KG$20240808$$MD$IT$IT
241896142$24189614$2$F$$20240808$20240808$20240813$EXP$$US-PFIZER INC-202400231341$PFIZER$$82$YR$$F$Y$$$20240813$$CN$US$US
241896151$24189615$1$I$$20240805$20240808$20240808$EXP$$US-PFIZER INC-202400230453$PFIZER$$93$YR$$M$Y$76.2$KG$20240808$$CN$US$US
241896161$24189616$1$I$$20240806$20240808$20240808$EXP$$US-PFIZER INC-202400231427$PFIZER$$69$YR$$F$Y$$$20240808$$MD$US$US
241896171$24189617$1$I$20240728$20240807$20240808$20240808$EXP$$CN-PFIZER INC-PV202400102968$PFIZER$$39$YR$$F$Y$55$KG$20240808$$HP$CN$CN
241896182$24189618$2$F$20240801$20240808$20240808$20240813$EXP$$US-PFIZER INC-202400231282$PFIZER$$61$YR$$F$Y$$$20240813$$HP$US$US
241896191$24189619$1$I$$20240807$20240808$20240808$EXP$$US-PFIZER INC-202400232088$PFIZER$$55$YR$$F$Y$$$20240808$$CN$US$US
241896201$24189620$1$I$$20240802$20240808$20240808$EXP$$KR-PFIZER INC-202400231095$PFIZER$Oh, D.. Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer. NEJM Evidence. 2022;1(8):10.1056/EVIDoa2200015$$$A$$Y$$$20240808$$MD$KR$KR
241896211$24189621$1$I$$20240806$20240808$20240808$EXP$$IT-PFIZER INC-202400230971$PFIZER$$9$YR$$M$Y$$$20240808$$HP$IT$IT
241896221$24189622$1$I$$20240806$20240808$20240808$EXP$$IN-PFIZER INC-PV202400102760$PFIZER$$50$YR$$$Y$$$20240808$$CN$IN$IN
241896241$24189624$1$I$20240727$20240806$20240808$20240808$EXP$$CN-PFIZER INC-PV202400102454$PFIZER$$30$YR$$F$Y$61.5$KG$20240808$$HP$CN$CN
241896251$24189625$1$I$$20240806$20240808$20240808$EXP$$IN-PFIZER INC-PV202400102729$PFIZER$$78$YR$$M$Y$$$20240808$$CN$IN$IN
241896261$24189626$1$I$20240705$20240805$20240808$20240808$EXP$LU-ALMPS-202404275$LU-PFIZER INC-202400229847$PFIZER$$59$YR$$M$Y$72$KG$20240808$$PH$LU$LU
241896271$24189627$1$I$20240625$20240805$20240808$20240808$EXP$FR-AFSSAPS-PP2024000852$FR-PFIZER INC-202400229871$PFIZER$$43$YR$$M$Y$100$KG$20240808$$MD$FR$FR
241896281$24189628$1$I$20240806$20240807$20240808$20240808$EXP$$US-PFIZER INC-PV202400102886$PFIZER$$74$YR$$M$Y$$$20240808$$CN$US$US
241896291$24189629$1$I$$20240710$20240808$20240808$PER$$GB-Marksans Pharma Limited-2160178$MARKSANS$$$$$F$Y$$$20240808$$$GB$GB
241896301$24189630$1$I$20240719$20240729$20240808$20240808$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000732$PAREXEL$$$$$$Y$$$20240808$$HP$CN$CN
241896312$24189631$2$F$20200115$20240807$20240808$20240813$EXP$$TR-PFIZER INC-202400231454$PFIZER$Atalar, B.. Myonecrosis as a rare side effect of stereotactic body radiotherapy for bone metastases: Report of two cases and a comprehensive literature review. Cancer/Radiotherapie. 2024;28(3):275-279$58$YR$$F$Y$68$KG$20240813$$MD$TR$TR
241896321$24189632$1$I$20240729$20240806$20240808$20240808$EXP$$CN-PFIZER INC-PV202400102468$PFIZER$$26$YR$$F$Y$75$KG$20240808$$HP$CN$CN
241896331$24189633$1$I$20240101$20240723$20240808$20240808$PER$$US-INSUD PHARMA-2407US05933$INSUD PHARMA$$$$$$Y$$$20240808$$CN$US$US
241896341$24189634$1$I$20240101$20240723$20240808$20240808$PER$$US-INSUD PHARMA-2407US05934$INSUD PHARMA$$$$$$Y$$$20240808$$CN$US$US
241896351$24189635$1$I$$20240730$20240808$20240808$PER$$US-JNJFOC-20240816370$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241896382$24189638$2$F$20240805$20240805$20240808$20240813$PER$$US-SA-2024SA232898$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240814$$MD$US$US
241896391$24189639$1$I$20240515$20240802$20240808$20240808$EXP$$US-RDY-SPO/USA/24/0011448$DR REDDYS$$70$YR$E$F$Y$$$20240808$$PH$US$US
241896401$24189640$1$I$20240512$20240807$20240808$20240808$EXP$ES-AEMPS-1557515$NVSC2024ES160550$NOVARTIS$$66$YR$$M$Y$$$20240808$$HP$ES$ES
241896412$24189641$2$F$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683469$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241896421$24189642$1$I$$20240805$20240808$20240808$EXP$$GB-TAKEDA-2024TUS078900$TAKEDA$$$$E$M$Y$$$20240808$$CN$GB$GB
241896431$24189643$1$I$$20240729$20240808$20240808$30DAY$$US-GSK-US2024AMR095047$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241896441$24189644$1$I$$20240729$20240808$20240808$30DAY$$US-GSK-US2024AMR095928$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241896451$24189645$1$I$20240101$20240729$20240808$20240808$30DAY$$US-GSK-US2024094854$GLAXOSMITHKLINE$$88$YR$$F$Y$$$20240808$$CN$US$US
241896462$24189646$2$F$$20240926$20240808$20240927$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044467$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240927$$CN$JP$JP
241896471$24189647$1$I$$20240725$20240808$20240808$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07416$LUPIN$Beesley S, Lanspa MJ. Calcium channel overdose and insulin therapy dosing. American Journal of Respiratory and Critical Care Medicine. 2024;209$28$YR$$M$Y$$$20240808$$HP$US$US
241896482$24189648$2$F$20240101$20240905$20240808$20240910$EXP$$AT-PFIZER INC-PV202400102032$PFIZER$$70$YR$$F$Y$60$KG$20240910$$MD$AT$AT
241896491$24189649$1$I$$20240729$20240808$20240808$EXP$$US-GSK-US2024AMR095623$GLAXOSMITHKLINE$$$$$F$Y$65.77$KG$20240808$$CN$US$US
241896501$24189650$1$I$$20240807$20240808$20240808$EXP$$MA-PFIZER INC-PV202400103284$PFIZER$$$$$F$Y$$$20240808$$CN$MA$MA
241896531$24189653$1$I$20221106$20240805$20240808$20240808$EXP$ES-AEMPS-1551210$ES-PFIZER INC-202400230374$PFIZER$$48$YR$$F$Y$$$20240808$$MD$ES$ES
241896541$24189654$1$I$20240717$20240729$20240808$20240808$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000724$PAREXEL$$$$$$Y$$$20240808$$HP$CN$CN
241896551$24189655$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54350$$FDA-CTU$$47$YR$$F$N$$$20240807$N$$US$
241896561$24189656$1$I$20240711$20240806$20240808$20240808$EXP$$CA-PFIZER INC-202400231326$PFIZER$$85$YR$$M$Y$$$20240808$$CN$CA$CA
241896571$24189657$1$I$20240722$20240805$20240808$20240808$EXP$IT-MINISAL02-996951$IT-PFIZER INC-202400229868$PFIZER$$74$YR$$F$Y$$$20240808$$MD$IT$IT
241896581$24189658$1$I$20240625$20240801$20240808$20240808$EXP$FR-AFSSAPS-NT2024000968$FR-PFIZER INC-202400227996$PFIZER$$83$YR$$F$Y$$$20240808$$MD$FR$FR
241896591$24189659$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54355$$FDA-CTU$$73$YR$$M$N$139$LBS$20240807$N$$US$
241896611$24189661$1$I$20240101$20240805$20240808$20240808$EXP$$CA-PFIZER INC-202400192343$PFIZER$$67$YR$$M$Y$$$20240808$$MD$CA$CA
241896621$24189662$1$I$20240628$20240805$20240808$20240808$EXP$$CN-PFIZER INC-PV202400101869$PFIZER$$69$YR$$M$Y$50$KG$20240808$$HP$CN$CN
241896632$24189663$2$F$20240609$20240905$20240808$20240910$EXP$$JP-PFIZER INC-PV202400077499$PFIZER$$7$DEC$$F$Y$$$20240910$$PH$JP$JP
241896641$24189664$1$I$$20240806$20240808$20240808$EXP$$US-PFIZER INC-202400231711$PFIZER$$81$YR$$M$Y$$$20240808$$CN$US$US
241896651$24189665$1$I$20210301$20240805$20240808$20240808$EXP$$GB-PFIZER INC-202400189821$PFIZER$$88$YR$$M$Y$68$KG$20240808$$MD$GB$GB
241896661$24189666$1$I$$20240807$20240808$20240808$EXP$$CN-PFIZER INC-PV202400102581$PFIZER$$$$A$F$Y$$$20240808$$CN$CN$CN
241896671$24189667$1$I$$20240807$20240808$20240808$EXP$$US-PFIZER INC-202400232273$PFIZER$$$$$$Y$$$20240808$$CN$US$US
241896681$24189668$1$I$$20240806$20240808$20240808$EXP$$US-PFIZER INC-PV202400102578$PFIZER$$69$YR$$F$Y$$$20240808$$HP$US$US
241896691$24189669$1$I$20240607$20240805$20240808$20240808$EXP$FR-AFSSAPS-LY2024000956$FR-PFIZER INC-202400229919$PFIZER$$66$YR$$F$Y$47.6$KG$20240808$$PH$FR$FR
241896702$24189670$2$F$20240806$20240807$20240808$20240814$EXP$$PE-JNJFOC-20240817799$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240814$$CN$PE$PE
241896711$24189671$1$I$$20240807$20240808$20240808$PER$$US-AMGEN-USASP2024157215$AMGEN$$$$$M$Y$$$20240808$$HP$US$US
241896721$24189672$1$I$$20240731$20240808$20240808$EXP$$VN-AstraZeneca-2024A177561$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$VN$
241896731$24189673$1$I$$20240731$20240808$20240808$EXP$$AU-AstraZeneca-2024A174392$ASTRAZENECA$$$$$F$Y$$$20240808$$HP$AU$
241896741$24189674$1$I$$20240731$20240808$20240808$EXP$$CO-AstraZeneca-2024A176392$ASTRAZENECA$$75$YR$$M$Y$$$20240808$$CN$CO$
241896751$24189675$1$I$$20240731$20240808$20240808$EXP$$VN-AstraZeneca-2024A177642$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$VN$
241896761$24189676$1$I$20240708$20240806$20240808$20240808$EXP$$US-ABBVIE-5870209$ABBVIE$$50$YR$$F$Y$$$20240808$$CN$US$US
241896782$24189678$2$F$20181204$20240918$20240808$20240919$PER$$US-GILEAD-2024-0683485$GILEAD$$59$YR$A$M$Y$$$20240919$$LW$US$US
241896791$24189679$1$I$$20240730$20240808$20240808$EXP$GB-MHRA-MED-202407301334377580-FHGQY$GB-TEVA-VS-3228522$TEVA$$$$$F$Y$$$20240808$$MD$GB$GB
241896801$24189680$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870192$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241896811$24189681$1$I$$20240802$20240808$20240808$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00407$VELOXIS PHARMACEUTICALS$Bae E K, Chandran M M, Everitt M D, Benz E, Bock M.. LCP-tacrolimus extended-release (Envarsus XR) use in adolescent and young adult solid organ transplant recipients.. Clinical Transplantation. 2024;38:e15417:1-7$$$$$Y$$$20240808$$HP$US$US
241896821$24189682$1$I$20240726$20240801$20240808$20240808$EXP$$AR-AMGEN-ARGSP2024156249$AMGEN$$79$YR$E$F$Y$$$20240808$$CN$AR$AR
241896831$24189683$1$I$$20240729$20240808$20240808$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023596$UNITED THERAPEUTICS$Kim U, Sumarli A, Choi J, Wong V, Aluzri N, Pineda L, et al.. Cesarean section in a group 1 pulmonary hypertension parturient patient: a case report. Cureus. 2024;16(6):e63390$31$YR$$F$Y$$$20240808$$$US$US
241896841$24189684$1$I$$20240806$20240808$20240808$EXP$$NVSC2024AU160086$NOVARTIS$$$$$F$Y$$$20240808$$MD$AU$AU
241896852$24189685$2$F$$20240815$20240808$20240822$PER$$US-BIOGEN-2024BI01276794$BIOGEN$$$$$M$Y$$$20240822$$CN$US$US
241896861$24189686$1$I$$20240729$20240808$20240808$EXP$$JP-ROCHE-10000048501$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$81$YR$E$F$Y$$$20240808$$HP$JP$JP
241896871$24189687$1$I$$20240730$20240808$20240808$EXP$$TR-TAKEDA-2024TUS079087$TAKEDA$$$$$$Y$$$20240808$$MD$TR$TR
241896881$24189688$1$I$$20240729$20240808$20240808$EXP$$AU-LUPIN EUROPE GMBH-2024-07574$LUPIN$$$$$M$Y$$$20240808$$CN$AU$AU
241896892$24189689$2$F$20240101$20240809$20240808$20240816$EXP$$US-ABBVIE-5871019$ABBVIE$$$$$M$Y$89$KG$20240816$$CN$US$US
241896901$24189690$1$I$$20240807$20240808$20240808$EXP$$US-BAYER-2024A114311$BAYER$$83$YR$E$F$Y$$$20240808$$HP$US$US
241896921$24189692$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA201626$SANOFI AVENTIS$$$$A$F$Y$63.5$KG$20240808$$MD$US$US
241896931$24189693$1$I$20240501$20240731$20240808$20240808$PER$$US-SA-2023SA091591$SANOFI AVENTIS$$$$E$M$Y$$$20240808$$MD$US$US
241896941$24189694$1$I$20240715$20240801$20240808$20240808$EXP$$CN-ROCHE-10000047081$ROCHE$$78$YR$E$F$Y$51$KG$20240808$$HP$CN$CN
241896951$24189695$1$I$20201211$20240805$20240808$20240808$EXP$$CO-UCBSA-2024039681$UCB$$64$YR$$M$Y$$$20240808$$CN$CO$CO
241896962$24189696$2$F$20240728$20240907$20240808$20240909$30DAY$$US-PFIZER INC-202400226071$PFIZER$$14$YR$$M$Y$$$20240909$$CN$US$US
241896972$24189697$2$F$$20240905$20240808$20240913$EXP$$US-TEVA-VS-3228597$TEVA$Patel S, Tsai C, Slampak-Cindric A. When in Doubt, Examine the Medication List: A Rare Case of Daptomycin-Induced Lung Injury. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Patel S, Tsai C, Slampak-Cindric A. When in Doubt, Examine the Medication List: A Rare Case of Daptomycin-Induced Lung Injury. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$75$YR$$F$Y$$$20240913$$HP$US$US
241896981$24189698$1$I$20240319$20240730$20240808$20240808$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000725$PAREXEL$$$$$$Y$$$20240808$$HP$CN$CN
241896991$24189699$1$I$$20240730$20240808$20240808$30DAY$$FR-PFIZER INC-202400226723$PFIZER$$$$$M$Y$$$20240808$$CN$FR$FR
241897002$24189700$2$F$$20240830$20240808$20240905$30DAY$$CA-PFIZER INC-202400232197$PFIZER$$$$$$Y$$$20240905$$HP$CA$CA
241897021$24189702$1$I$$20240807$20240808$20240808$PER$$US-BAYER-2024A114315$BAYER$$$$$F$Y$$$20240808$$MD$US$US
241897032$24189703$2$F$20240729$20240917$20240808$20240920$30DAY$$KR-PFIZER INC-PV202400100384$PFIZER$$13$YR$$M$Y$$$20240920$$CN$KR$KR
241897041$24189704$1$I$20240801$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54365$$FDA-CTU$$56$YR$$M$N$80.7$KG$20240807$N$PH$US$
241897061$24189706$1$I$20240708$20240807$20240807$20240807$DIR$713346$$FDA-CTU$$73$YR$$F$N$72.9$KG$20240807$N$CN$US$
241897071$24189707$1$I$$20240807$20240807$20240807$DIR$713344$$FDA-CTU$$$$$UNK$N$$$20240807$$CN$US$
241897081$24189708$1$I$20220830$20240807$20240807$20240807$DIR$713373$$FDA-CTU$$75$YR$$M$N$107.1$KG$20240807$N$CN$US$
241897091$24189709$1$I$$20240730$20240808$20240808$EXP$$US-EMD Serono-2024041488$EMD SERONO INC$Wagle L, Pant HN, Regmi DR, Regmi R, Poudel S. Metformin Toxicity Leading to Severe Refractory Hyperkalemia and Metabolic Acidosis: A Case Report. Cureus. 2024 Jun 25;16(6): 1-6. doi:DOI: 10.7759/cureus.63130.$74$YR$E$M$Y$$$20240808$$MD$US$US
241897101$24189710$1$I$20240805$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54331$$FDA-CTU$$63$YR$$M$N$97$KG$20240807$N$PH$US$
241897111$24189711$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54360$$FDA-CTU$$22$YR$$M$N$$$20240807$N$$US$
241897131$24189713$1$I$20240611$20240726$20240808$20240808$EXP$$JP-ROCHE-10000033810$ROCHE$$51$YR$A$F$Y$60$KG$20240808$$MD$JP$JP
241897141$24189714$1$I$$20240731$20240808$20240808$EXP$DE-BFARM-24005167$DE-TEVA-VS-3228997$TEVA$$61$YR$$M$Y$$$20240808$$CN$DE$DE
241897154$24189715$4$F$$20240830$20240808$20240903$30DAY$$US-PFIZER INC-202400088305$PFIZER$$51$YR$$F$Y$91.63$KG$20240903$$CN$US$US
241897162$24189716$2$F$20240806$20240819$20240808$20240820$EXP$$JP-JNJFOC-20240819033$JOHNSON AND JOHNSON$$19$YR$A$F$Y$$$20240820$$PH$JP$JP
241897171$24189717$1$I$$20240206$20240808$20240808$EXP$$NVSC2024US027333$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241897181$24189718$1$I$$20240730$20240808$20240808$EXP$$JP-ROCHE-10000048738$ROCHE$$7$DEC$E$F$Y$$$20240808$$MD$JP$JP
241897191$24189719$1$I$20240801$20240801$20240808$20240808$PER$$US-BAYER-2024A112082$BAYER$$69$YR$E$M$Y$$$20240808$$CN$US$US
241897201$24189720$1$I$$20240806$20240808$20240808$PER$$US-BIOGEN-2024BI01273497$BIOGEN$$$$$M$Y$$$20240808$$CN$US$US
241897215$24189721$5$F$20240101$20240925$20240808$20240930$PER$$US-BIOGEN-2024BI01276987$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
241897231$24189723$1$I$$20240729$20240808$20240808$EXP$$US-VKT-000578$VKT PHARMA PRIVATE LIMITED$$40$YR$A$F$Y$57$KG$20240731$$PH$US$US
241897242$24189724$2$F$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683475$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241897251$24189725$1$I$$20240728$20240808$20240808$EXP$$US-GTI-000258$Granulation Technology, INC$$73$YR$E$M$Y$$$20240730$$MD$US$US
241897261$24189726$1$I$20240801$20240801$20240808$20240808$EXP$$CA-OTSUKA-2024_021558$OTSUKA$$40$YR$$M$Y$$$20240808$$HP$CA$CA
241897271$24189727$1$I$$20240729$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407019753$ELI LILLY AND CO$$49$YR$A$$Y$$$20240808$$LW$US$US
241897281$24189728$1$I$$20240801$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408001063$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240808$$CN$US$US
241897291$24189729$1$I$$20240729$20240808$20240808$EXP$$CA-TEVA-VS-3227660$TEVA$$61$YR$$M$Y$113$KG$20240808$$HP$CA$CA
241897301$24189730$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003370$ELI LILLY AND CO$$$$A$M$Y$$$20240808$$CN$US$US
241897311$24189731$1$I$$20240801$20240808$20240808$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06936$VIFOR$$$$A$M$Y$$$20240808$$CN$ZA$ZA
241897321$24189732$1$I$$20240729$20240808$20240808$PER$$US-JNJFOC-20240782660$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241897331$24189733$1$I$$20240729$20240808$20240808$EXP$$JP-ROCHE-10000048491$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$81$YR$E$M$Y$$$20240808$$HP$JP$JP
241897341$24189734$1$I$$20240502$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00570$TARO$$$$$$Y$$$20240808$$CN$US$US
241897351$24189735$1$I$$20240503$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00568$TARO$$15$YR$$M$Y$$$20240808$$CN$US$US
241897361$24189736$1$I$$20240506$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00588$TARO$$$$$$Y$$$20240808$$CN$US$US
241897371$24189737$1$I$$20240503$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00567$TARO$$$$$$Y$$$20240808$$CN$US$US
241897381$24189738$1$I$20240425$20240506$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00589$TARO$$$$$$Y$$$20240808$$CN$US$US
241897391$24189739$1$I$$20240506$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00590$TARO$$$$$$Y$$$20240808$$CN$US$US
241897401$24189740$1$I$20240101$20240506$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00591$TARO$$14$YR$$F$Y$$$20240808$$CN$US$US
241897411$24189741$1$I$$20240506$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00593$TARO$$$$$$Y$$$20240808$$CN$US$US
241897421$24189742$1$I$20240401$20240508$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00596$TARO$$$$$$Y$$$20240808$$CN$US$US
241897431$24189743$1$I$$20240508$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00597$TARO$$$$$$Y$$$20240808$$CN$US$US
241897441$24189744$1$I$$20240509$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00599$TARO$$$$$$Y$$$20240808$$CN$US$US
241897451$24189745$1$I$$20240510$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00606$TARO$$$$$$Y$$$20240808$$CN$US$US
241897461$24189746$1$I$$20240513$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00618$TARO$$$$$$Y$$$20240808$$CN$US$US
241897471$24189747$1$I$$20240513$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00619$TARO$$$$$$Y$$$20240808$$CN$US$US
241897481$24189748$1$I$$20240513$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00620$TARO$$$$$M$Y$$$20240808$$CN$US$US
241897491$24189749$1$I$$20240513$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00621$TARO$$$$$$Y$$$20240808$$CN$US$US
241897501$24189750$1$I$20240401$20240514$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00632$TARO$$$$$$Y$$$20240808$$CN$US$US
241897511$24189751$1$I$20240401$20240514$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00633$TARO$$$$$$Y$$$20240808$$CN$US$US
241897521$24189752$1$I$20240401$20240514$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00634$TARO$$15$YR$$F$Y$$$20240808$$CN$US$US
241897531$24189753$1$I$$20240514$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00635$TARO$$$$$$Y$$$20240808$$CN$US$US
241897541$24189754$1$I$20240422$20240802$20240808$20240808$EXP$FR-AFSSAPS-AVMA2024000339$FR-MYLANLABS-2024M1072480$MYLAN$$30$YR$$M$Y$$$20240808$$MD$FR$FR
241897551$24189755$1$I$20240322$20240802$20240808$20240808$EXP$FR-AFSSAPS-RN2024000835$FR-MYLANLABS-2024M1072407$MYLAN$$76$YR$$M$Y$76$KG$20240808$$MD$FR$FR
241897561$24189756$1$I$20240223$20240802$20240808$20240808$EXP$$DE-MYLANLABS-2024M1072538$MYLAN$$58$YR$$F$Y$$$20240808$$MD$DE$DE
241897571$24189757$1$I$$20240801$20240808$20240808$EXP$$RU-BAYER-2024A113956$BAYER$$48$YR$A$F$Y$$$20240808$$MD$RU$RU
241897581$24189758$1$I$20240708$20240802$20240808$20240808$EXP$FR-AFSSAPS-LY2024001163$FR-MYLANLABS-2024M1072482$MYLAN$$93$YR$$F$Y$68$KG$20240808$$PH$FR$FR
241897591$24189759$1$I$20240624$20240730$20240808$20240808$EXP$$JP-ROCHE-10000048774$ROCHE$$68$YR$E$M$Y$$$20240808$$MD$JP$JP
241897601$24189760$1$I$$20240725$20240808$20240808$EXP$$TR-INGENUS PHARMACEUTICALS, LLC-2024INF000034$INGENUS$Calis Karanfil F, Gunduz AK, Atilla H, Sahli E.. Varied toxicity profile of intravitreal melphalan in two retinoblastoma eyes.. Anticancer Drugs. 2024$7$YR$$M$Y$$$20240808$$MD$TR$TR
241897622$24189762$2$F$20240701$20240826$20240808$20240906$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07623$LUPIN$$$$$$Y$$$20240906$$CN$US$US
241897631$24189763$1$I$$20240731$20240808$20240808$PER$$US-ALXN-202407USA002193US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240808$$CN$US$US
241897642$24189764$2$F$$20240807$20240808$20240808$EXP$$US-GILEAD-2024-0683486$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241897651$24189765$1$I$20220101$20230405$20240808$20240808$EXP$$BR-AstraZeneca-2023A081493$Unknown Manufacturer$$$$$$Y$$$20240808$$CN$BR$BR
241897661$24189766$1$I$20240531$20240802$20240808$20240808$EXP$$PH-OTSUKA-2024_007375$OTSUKA$$68$YR$$M$Y$$$20240808$$MD$PH$PH
241897671$24189767$1$I$$20240729$20240808$20240808$EXP$$CA-TEVA-VS-3227669$TEVA$$64$YR$$M$Y$$$20240808$$HP$CA$CA
241897681$24189768$1$I$$20240801$20240808$20240808$EXP$GB-MHRA-31354159$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-07460$HIKMA$$75$YR$$M$Y$$$20240808$$CN$GB$GB
241897691$24189769$1$I$20240215$20240801$20240808$20240808$EXP$$JP-AstraZeneca-2024A174958$ASTRAZENECA$$79$YR$$F$Y$35$KG$20240808$$MD$JP$
241897701$24189770$1$I$20240712$20240807$20240808$20240808$PER$$NVSC2024US161580$NOVARTIS$$$$$$Y$$$20240808$$MD$US$US
241897712$24189771$2$F$$20240807$20240808$20240814$EXP$$US-AMGEN-USASL2024156528$AMGEN$$29$YR$A$F$Y$$$20240814$$CN$US$US
241897723$24189772$3$F$20240723$20240902$20240808$20240904$PER$$US-JNJFOC-20240807120$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240904$$PH$US$US
241897741$24189774$1$I$20240501$20240612$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00808$TARO$$$$$$Y$$$20240808$$CN$US$US
241897751$24189775$1$I$20240501$20240612$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00810$TARO$$$$$$Y$$$20240808$$CN$US$US
241897761$24189776$1$I$$20240612$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00811$TARO$$$$$$Y$$$20240808$$CN$US$US
241897771$24189777$1$I$20240601$20240613$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00812$TARO$$$$$$Y$$$20240808$$CN$US$US
241897781$24189778$1$I$$20240613$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00813$TARO$$$$$$Y$$$20240808$$CN$US$US
241897791$24189779$1$I$20240501$20240614$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00816$TARO$$$$$$Y$$$20240808$$CN$US$US
241897801$24189780$1$I$$20240614$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00817$TARO$$$$$F$Y$$$20240808$$CN$US$US
241897811$24189781$1$I$$20240612$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00821$TARO$$$$$F$Y$$$20240808$$CN$US$US
241897821$24189782$1$I$$20240617$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00855$TARO$$$$$$Y$$$20240808$$CN$US$US
241897831$24189783$1$I$$20240617$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00856$TARO$$$$$$Y$$$20240808$$CN$US$US
241897841$24189784$1$I$$20240617$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00857$TARO$$$$$$Y$$$20240808$$CN$US$US
241897851$24189785$1$I$$20240618$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00863$TARO$$$$$F$Y$$$20240808$$CN$US$US
241897861$24189786$1$I$$20240619$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00871$TARO$$$$$M$Y$$$20240808$$CN$US$US
241897871$24189787$1$I$$20240621$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00876$TARO$$$$$$Y$$$20240808$$CN$US$US
241897881$24189788$1$I$$20240621$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00877$TARO$$$$$M$Y$$$20240808$$CN$US$US
241897891$24189789$1$I$$20240621$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00878$TARO$$$$$$Y$$$20240808$$CN$US$US
241897901$24189790$1$I$$20240621$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00879$TARO$$$$$$Y$$$20240808$$CN$US$US
241897911$24189791$1$I$$20240611$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00799$TARO$$$$$$Y$$$20240808$$CN$US$US
241897921$24189792$1$I$$20240611$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00800$TARO$$$$$$Y$$$20240808$$CN$US$US
241897931$24189793$1$I$20240101$20240612$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00807$TARO$$$$$$Y$$$20240808$$CN$US$US
241897941$24189794$1$I$$20240515$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00643$TARO$$$$$$Y$$$20240808$$CN$US$US
241897951$24189795$1$I$$20240516$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00644$TARO$$$$$$Y$$$20240808$$CN$US$US
241897961$24189796$1$I$20240401$20240515$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00641$TARO$$15$YR$$M$Y$$$20240808$$CN$US$US
241897971$24189797$1$I$$20240515$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00642$TARO$$$$$$Y$$$20240808$$CN$US$US
241897981$24189798$1$I$20240401$20240523$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00662$TARO$$$$$$Y$$$20240808$$CN$US$US
241897991$24189799$1$I$$20240528$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00691$TARO$$$$$$Y$$$20240808$$CN$US$US
241898001$24189800$1$I$$20240528$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00694$TARO$$$$$F$Y$$$20240808$$CN$US$US
241898011$24189801$1$I$$20240529$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00699$TARO$$$$$$Y$$$20240808$$CN$US$US
241898021$24189802$1$I$$20240529$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00700$TARO$$$$$$Y$$$20240808$$CN$US$US
241898031$24189803$1$I$20240520$20240529$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00701$TARO$$$$$$Y$$$20240808$$CN$US$US
241898041$24189804$1$I$$20240531$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00710$TARO$$$$$F$Y$$$20240808$$CN$US$US
241898051$24189805$1$I$$20240603$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00726$TARO$$$$$M$Y$$$20240808$$CN$US$US
241898061$24189806$1$I$$20240603$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00728$TARO$$$$$F$Y$$$20240808$$CN$US$US
241898071$24189807$1$I$$20240603$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00747$TARO$$$$$$Y$$$20240808$$CN$US$US
241898081$24189808$1$I$$20240604$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00767$TARO$$$$$$Y$$$20240808$$CN$US$US
241898091$24189809$1$I$$20240605$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00771$TARO$$$$$$Y$$$20240808$$CN$US$US
241898101$24189810$1$I$$20240605$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00773$TARO$$$$$$Y$$$20240808$$CN$US$US
241898111$24189811$1$I$20240501$20240606$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00775$TARO$$$$$$Y$$$20240808$$CN$US$US
241898121$24189812$1$I$$20240606$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00777$TARO$$$$$$Y$$$20240808$$CN$US$US
241898131$24189813$1$I$20240201$20240610$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00798$TARO$$$$$$Y$$$20240808$$CN$US$US
241898142$24189814$2$F$20240713$20240809$20240808$20240812$EXP$$JP-009507513-2408JPN000192J$MERCK$$77$YR$$M$Y$$$20240812$$MD$JP$JP
241898151$24189815$1$I$$20240806$20240808$20240808$PER$$US-ROCHE-10000051026$ROCHE$$77$YR$E$M$Y$$$20240808$$CN$US$US
241898161$24189816$1$I$20240723$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54370$$FDA-CTU$$65$YR$$F$N$$$20240807$N$PH$US$
241898171$24189817$1$I$20240616$20240728$20240808$20240808$EXP$$IL-NOVOPROD-1262764$NOVO NORDISK$$$$$M$Y$$$20240808$$CN$IL$IL
241898181$24189818$1$I$20220301$20240728$20240808$20240808$EXP$$US-NOVOPROD-1262745$NOVO NORDISK$$49$YR$$$Y$$$20240808$$CN$US$US
241898191$24189819$1$I$20220701$20240728$20240808$20240808$EXP$$US-NOVOPROD-1263344$NOVO NORDISK$$50$YR$$F$Y$$$20240808$$CN$US$US
241898201$24189820$1$I$20230801$20240728$20240808$20240808$EXP$$US-NOVOPROD-1263990$NOVO NORDISK$$64$YR$$F$Y$$$20240808$$CN$US$US
241898211$24189821$1$I$20240411$20240807$20240807$20240807$DIR$713349$$FDA-CTU$$16$YR$$F$N$54$KG$20240807$N$CN$US$
241898221$24189822$1$I$$20240807$20240807$20240807$DIR$713342$$FDA-CTU$$$$$UNK$N$$$20240807$$CN$US$
241898231$24189823$1$I$20240807$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54329$$FDA-CTU$$53$YR$$M$N$$$20240807$N$PH$US$
241898242$24189824$2$F$20240726$20240910$20240808$20240913$PER$$US-ROCHE-10000042345$ROCHE$$60$YR$A$M$Y$$$20240913$$CN$US$US
241898251$24189825$1$I$20240721$20240729$20240808$20240808$PER$$US-ROCHE-10000042181$ROCHE$$85$YR$E$F$Y$$$20240808$$CN$US$US
241898261$24189826$1$I$$20240805$20240808$20240808$EXP$$NVSC2024CZ160571$NOVARTIS$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al.. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study. NEOPLASMA. 2017;64(5):762-9$28$YR$$M$Y$$$20240808$$HP$CZ$CZ
241898271$24189827$1$I$20240308$20240807$20240808$20240808$EXP$$JP-BAYER-2024A114471$BAYER$$$$$$Y$$$20240808$$MD$JP$JP
241898281$24189828$1$I$20240224$20240807$20240807$20240807$DIR$713357$$FDA-CTU$$59$YR$$F$N$82.35$KG$20240807$N$CN$US$
241898291$24189829$1$I$$20240807$20240807$20240807$DIR$713363$$FDA-CTU$$$$$UNK$N$$$20240807$N$CN$US$
241898301$24189830$1$I$$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54361$$FDA-CTU$$$$$F$N$$$20240806$N$$US$
241898311$24189831$1$I$20240715$20240807$20240808$20240808$EXP$$CH-GILEAD-2024-0683416$GILEAD$$71$YR$E$F$Y$$$20240808$$MD$CH$CH
241898321$24189832$1$I$$20240802$20240808$20240808$PER$$US-SA-2024SA230759$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240808$$CN$US$US
241898331$24189833$1$I$$20240725$20240808$20240808$EXP$$TR-INGENUS PHARMACEUTICALS, LLC-2024INF000035$INGENUS$Calis Karanfil F, Gunduz AK, Atilla H, Sahli E.. Varied toxicity profile of intravitreal melphalan in two retinoblastoma eyes. Anticancer Drugs.. 2024$6$YR$$F$Y$$$20240808$$MD$TR$TR
241898341$24189834$1$I$$20240807$20240808$20240808$EXP$$JP-BAYER-2024A114518$BAYER$$$$$M$Y$$$20240808$$MD$JP$JP
241898351$24189835$1$I$20240607$20240807$20240807$20240807$DIR$713358$$FDA-CTU$$$$$M$N$$$20240807$N$CN$US$
241898361$24189836$1$I$$20240806$20240807$20240807$DIR$FDA-CDER-CTU-2024-54373$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
241898371$24189837$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54341$$FDA-CTU$$54$YR$$M$N$$$20240807$N$$US$
241898381$24189838$1$I$20221201$20240728$20240808$20240808$EXP$$US-NOVOPROD-1264018$NOVO NORDISK$$39$YR$$F$Y$$$20240808$$CN$US$US
241898391$24189839$1$I$20230101$20240728$20240808$20240808$EXP$$US-NOVOPROD-1264017$NOVO NORDISK$$41$YR$$$Y$$$20240808$$CN$US$US
241898401$24189840$1$I$20240624$20240731$20240808$20240808$EXP$FR-AFSSAPS-TS2024000848$FR-TEVA-VS-3229242$TEVA$$71$YR$$F$Y$94$KG$20240808$$MD$FR$FR
241898411$24189841$1$I$20240726$20240806$20240808$20240808$EXP$RU-RZN-2499237$RU-SANDOZ INC.-SDZ2024RU071103$SANDOZ$$$$$M$Y$82$KG$20240808$$HP$RU$RU
241898421$24189842$1$I$20240101$20240625$20240808$20240808$EXP$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00922$TARO$$$$$$Y$$$20240808$$CN$US$US
241898431$24189843$1$I$$20240807$20240808$20240808$EXP$$US-KYOWAKIRIN-2024KK018925$KYOWA$$$$$$Y$$$20240808$$HP$US$US
241898441$24189844$1$I$$20240701$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00951$TARO$$$$$$Y$$$20240808$$CN$US$US
241898451$24189845$1$I$$20240701$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00952$TARO$$$$$$Y$$$20240808$$CN$US$US
241898461$24189846$1$I$$20240628$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00938$TARO$$$$$$Y$$$20240808$$CN$US$US
241898471$24189847$1$I$$20240628$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00940$TARO$$$$$$Y$$$20240808$$CN$US$US
241898481$24189848$1$I$$20240701$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00953$TARO$$$$$M$Y$$$20240808$$CN$US$US
241898491$24189849$1$I$$20240701$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00954$TARO$$$$$M$Y$$$20240808$$CN$US$US
241898501$24189850$1$I$20240201$20240702$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00977$TARO$$13$YR$$M$Y$$$20240808$$CN$US$US
241898511$24189851$1$I$20240601$20240702$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00978$TARO$$$$$$Y$$$20240808$$CN$US$US
241898521$24189852$1$I$$20240702$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00980$TARO$$$$$$Y$$$20240808$$CN$US$US
241898531$24189853$1$I$$20240702$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00981$TARO$$$$$M$Y$$$20240808$$CN$US$US
241898541$24189854$1$I$$20240702$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00982$TARO$$$$$$Y$$$20240808$$CN$US$US
241898551$24189855$1$I$$20240705$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00985$TARO$$$$$M$Y$$$20240808$$CN$US$US
241898561$24189856$1$I$$20240705$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00986$TARO$$14$YR$$F$Y$$$20240808$$CN$US$US
241898571$24189857$1$I$$20240705$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00987$TARO$$13$YR$$F$Y$$$20240808$$CN$US$US
241898581$24189858$1$I$$20240705$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00988$TARO$$$$$$Y$$$20240808$$CN$US$US
241898591$24189859$1$I$$20240705$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00989$TARO$$$$$$Y$$$20240808$$CN$US$US
241898601$24189860$1$I$$20240705$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01011$TARO$$$$$F$Y$$$20240808$$CN$US$US
241898611$24189861$1$I$$20240705$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01012$TARO$$$$$F$Y$$$20240808$$CN$US$US
241898621$24189862$1$I$$20240705$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01013$TARO$$$$$$Y$$$20240808$$CN$US$US
241898631$24189863$1$I$$20240705$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01014$TARO$$$$$$Y$$$20240808$$CN$US$US
241898641$24189864$1$I$$20240621$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00880$TARO$$$$$F$Y$$$20240808$$CN$US$US
241898651$24189865$1$I$$20240617$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00889$TARO$$$$$$Y$$$20240808$$CN$US$US
241898661$24189866$1$I$$20240621$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00891$TARO$$$$$$Y$$$20240808$$CN$US$US
241898671$24189867$1$I$$20240624$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00894$TARO$$$$$$Y$$$20240808$$CN$US$US
241898681$24189868$1$I$$20240624$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00895$TARO$$$$$F$Y$$$20240808$$CN$US$US
241898691$24189869$1$I$$20240624$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00896$TARO$$$$$$Y$$$20240808$$CN$US$US
241898701$24189870$1$I$$20240624$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00897$TARO$$$$$$Y$$$20240808$$CN$US$US
241898711$24189871$1$I$$20240624$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00899$TARO$$12$YR$$F$Y$$$20240808$$CN$US$US
241898721$24189872$1$I$$20240624$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00900$TARO$$$$$M$Y$$$20240808$$CN$US$US
241898731$24189873$1$I$$20240624$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00902$TARO$$$$$M$Y$$$20240808$$CN$US$US
241898741$24189874$1$I$$20240625$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00921$TARO$$$$$M$Y$$$20240808$$CN$US$US
241898751$24189875$1$I$$20240625$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00923$TARO$$$$$$Y$$$20240808$$CN$US$US
241898761$24189876$1$I$$20240626$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00928$TARO$$$$$$Y$$$20240808$$CN$US$US
241898771$24189877$1$I$$20240626$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00929$TARO$$$$$$Y$$$20240808$$CN$US$US
241898781$24189878$1$I$20240101$20240627$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00930$TARO$$$$$$Y$$$20240808$$CN$US$US
241898791$24189879$1$I$20240601$20240627$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00931$TARO$$$$$$Y$$$20240808$$CN$US$US
241898801$24189880$1$I$20240601$20240627$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00932$TARO$$$$$$Y$$$20240808$$CN$US$US
241898811$24189881$1$I$$20240627$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00933$TARO$$$$$M$Y$$$20240808$$CN$US$US
241898821$24189882$1$I$$20240627$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00934$TARO$$$$$M$Y$$$20240808$$CN$US$US
241898831$24189883$1$I$20240806$20240806$20240808$20240808$PER$$NVSC2024US160536$NOVARTIS$$77$YR$$F$Y$65.306$KG$20240808$$PH$US$US
241898841$24189884$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5868440$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241898851$24189885$1$I$$20240730$20240808$20240808$30DAY$$US-GSK-US2024095380$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241898861$24189886$1$I$$20240730$20240808$20240808$EXP$$IN-EMD Serono-2024041448$EMD SERONO INC$Ali SS, Bhat S, Salih HA, Naseer A, Rajaratnam A. A bumpy ride-Acute recurrent pancreatitis in pregnancy in a Type 2 diabetic, presenting with euglycemic diabetic ketoacidosis: A case report. International Journal of Gynecology and Obstetrics. 2024 Jan 28;166(2): 897-898. doi:10.1002/ijgo.15403.$34$YR$A$F$Y$$$20240808$$HP$IN$IN
241898872$24189887$2$F$20240101$20240801$20240808$20240827$PER$$US-CHIESI-2024CHF03777$CHIESI$$42$YR$$F$Y$$$20240827$$CN$US$US
241898882$24189888$2$F$$20240827$20240808$20240905$EXP$$US-TEVA-VS-3227989$TEVA$Kundu S, Mehra I, Stevasarova A, Chahal K. Anticonvulsant Hypersensitivity Syndrome in a Patient with Phenytoin Toxicity. South-Med-J 2022; 115 (7): 571.; Kundu S, Mehra I, Stevasarova A, Chahal K. Anticonvulsant Hypersensitivity Syndrome in a Patient with Phenytoin Toxicity. South-Med-J 2022; 115 (7): 571.$53$YR$$F$Y$$$20240905$$MD$US$US
241898892$24189889$2$F$20190716$20240827$20240808$20240829$EXP$$JP-BAYER-2024A110275$BAYER$$25$YR$A$F$Y$$$20240829$$MD$JP$JP
241898901$24189890$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161676$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241898912$24189891$2$F$20240612$20240806$20240808$20240813$EXP$$JP-PFIZER INC-PV202400078018$PFIZER$$76$YR$$F$Y$46$KG$20240813$$MD$JP$JP
241898932$24189893$2$F$$20240919$20240808$20240924$EXP$$CA-JNJFOC-20240817725$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240924$$HP$CA$CA
241898942$24189894$2$F$20240629$20240806$20240808$20240812$30DAY$$PE-JNJFOC-20240784526$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240812$$CN$PE$PE
241898951$24189895$1$I$20240710$20240802$20240808$20240808$EXP$GB-MHRA-MED-202408020016238690-BYRJM$GB-RDY-SPO/GBR/24/0011469$DR REDDYS$$48$YR$A$M$Y$127$KG$20240808$$CN$GB$GB
241898961$24189896$1$I$$20240708$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01032$TARO$$$$$$Y$$$20240808$$CN$US$US
241898971$24189897$1$I$$20240708$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01033$TARO$$$$$$Y$$$20240808$$CN$US$US
241898981$24189898$1$I$20240501$20240709$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01039$TARO$$$$$$Y$$$20240808$$CN$US$US
241898991$24189899$1$I$$20240708$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01034$TARO$$$$$$Y$$$20240808$$CN$US$US
241899001$24189900$1$I$$20240709$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01036$TARO$$$$$M$Y$$$20240808$$CN$US$US
241899011$24189901$1$I$$20240709$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01038$TARO$$13$YR$$M$Y$$$20240808$$CN$US$US
241899021$24189902$1$I$$20240709$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01041$TARO$$$$$$Y$$$20240808$$CN$US$US
241899031$24189903$1$I$$20240708$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01052$TARO$$$$$M$Y$$$20240808$$CN$US$US
241899041$24189904$1$I$20240601$20240710$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01053$TARO$$$$$$Y$$$20240808$$CN$US$US
241899051$24189905$1$I$$20240710$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01054$TARO$$$$$$Y$$$20240808$$CN$US$US
241899061$24189906$1$I$$20240710$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01055$TARO$$$$$$Y$$$20240808$$CN$US$US
241899071$24189907$1$I$$20240710$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01056$TARO$$$$$$Y$$$20240808$$CN$US$US
241899081$24189908$1$I$20240601$20240710$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01057$TARO$$$$$$Y$$$20240808$$CN$US$US
241899091$24189909$1$I$$20240710$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01058$TARO$$$$$F$Y$$$20240808$$CN$US$US
241899101$24189910$1$I$$20240711$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01060$TARO$$$$$M$Y$$$20240808$$CN$US$US
241899111$24189911$1$I$$20240711$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01061$TARO$$$$$$Y$$$20240808$$CN$US$US
241899121$24189912$1$I$$20240711$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01062$TARO$$$$$$Y$$$20240808$$CN$US$US
241899131$24189913$1$I$20240707$20240708$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01017$TARO$$$$$$Y$$$20240808$$CN$US$US
241899141$24189914$1$I$$20240708$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01031$TARO$$$$$$Y$$$20240808$$CN$US$US
241899151$24189915$1$I$20240601$20240712$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01073$TARO$$$$$$Y$$$20240808$$CN$US$US
241899161$24189916$1$I$20220509$20240802$20240808$20240808$EXP$$ZA-SA-2024SA232497$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240808$$HP$ZA$ZA
241899171$24189917$1$I$$20240730$20240808$20240808$EXP$$IN-EMD Serono-2024041737$EMD SERONO INC$Ali SS, Bhat S, Salih HA, Naseer A, Rajaratnam A. A bumpy ride-Acute recurrent pancreatitis in pregnancy in a Type 2 diabetic, presenting with euglycemic diabetic ketoacidosis: A case report. International Journal of Gynecology and Obstetrics. 2024 Jan 28;166(2): 897-898. doi:10.1002/ijgo.15403.$$$N$F$Y$2$KG$20240808$$HP$IN$IN
241899181$24189918$1$I$20240701$20240730$20240808$20240808$EXP$$ZA-INDIVIOR EUROPE LIMITED-INDV-153354-2024$RECKITT BENCKISER$$$$$$Y$$$20240808$$CN$ZA$ZA
241899191$24189919$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA232171$SANOFI AVENTIS$$5$YR$C$M$Y$16.78$KG$20240808$$MD$US$US
241899201$24189920$1$I$$20240801$20240808$20240808$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-107604$REGENERON$$$$$F$Y$$$20240808$$MD$JP$JP
241899215$24189921$5$F$20230401$20240830$20240808$20240831$EXP$GR-SEATTLE GENETICS-2023SGN04870$GR-ROCHE-10000048766$ROCHE$$49$YR$A$F$Y$$$20240831$$MD$GR$GR
241899222$24189922$2$F$$20240909$20240808$20240917$EXP$$AU-AstraZeneca-2024A175691$ASTRAZENECA$$$$$F$Y$$$20240917$$HP$AU$
241899241$24189924$1$I$$20240730$20240808$20240808$EXP$$IN-EMD Serono-2024041735$EMD SERONO INC$Ali SS, Bhat S, Salih HA, Naseer A, Rajaratnam A. A bumpy ride-Acute recurrent pancreatitis in pregnancy in a Type 2 diabetic, presenting with euglycemic diabetic ketoacidosis: A case report. International Journal of Gynecology and Obstetrics. 2024 Jan 28;166(2): 897-898. doi:10.1002/ijgo.15403.$$$$F$Y$$$20240808$$HP$IN$IN
241899252$24189925$2$F$20240725$20240819$20240808$20240821$EXP$$US-BIOVITRUM-2024-US-010706$BIOVITRUM$$71$YR$$M$Y$$$20240821$$CN$US$US
241899261$24189926$1$I$20240414$20240731$20240808$20240808$EXP$$FR-AstraZeneca-2024A173979$ASTRAZENECA$$64$YR$$M$Y$93$KG$20240808$$MD$FR$
241899271$24189927$1$I$20240802$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003214$ELI LILLY AND CO$$40$YR$A$$Y$$$20240808$$CN$US$US
241899281$24189928$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003061$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240808$$CN$US$US
241899291$24189929$1$I$20240806$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004322$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240808$$CN$US$US
241899301$24189930$1$I$20231201$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004214$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240808$$CN$US$US
241899312$24189931$2$F$$20240807$20240808$20240808$EXP$$US-GILEAD-2024-0683478$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241899322$24189932$2$F$$20240805$20240808$20240814$EXP$$BR-JNJFOC-20240813097$JOHNSON AND JOHNSON$$76$YR$E$F$Y$73$KG$20240814$$CN$BR$BR
241899332$24189933$2$F$$20240812$20240808$20240819$EXP$$EC-EMD Serono-2024042577$EMD SERONO INC$$$$A$F$Y$$$20240819$$CN$EC$EC
241899341$24189934$1$I$20240504$20240807$20240808$20240808$PER$$US-BIOVITRUM-2024-US-009477$BIOVITRUM$$77$YR$$M$Y$$$20240808$$CN$US$US
241899371$24189937$1$I$20240702$20240807$20240807$20240807$DIR$713374$$FDA-CTU$$74$YR$$F$N$55.4$KG$20240807$N$HP$US$
241899381$24189938$1$I$$20240801$20240808$20240808$EXP$$US-SA-2024SA233539$SANOFI AVENTIS$$$$E$F$Y$$$20240808$$MD$US$US
241899391$24189939$1$I$$20240729$20240808$20240808$EXP$$JP-ROCHE-10000048737$ROCHE$Ota N, Amemiya T, Arai T, Uemura N, Ito T, Tsukahara T et al.. EP-0599 Case study of drug-induced interstitial pneumonia in breast cancer patients at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;327$$$$F$Y$$$20240808$$MD$JP$JP
241899401$24189940$1$I$$20240726$20240808$20240808$PER$$US-SA-2024SA222798$SANOFI AVENTIS$$$$$$Y$22$KG$20240808$$PH$US$US
241899411$24189941$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA234306$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240808$$MD$US$US
241899422$24189942$2$F$$20240812$20240808$20240820$EXP$$GB-TEVA-VS-3228689$TEVA$: Miletic SP, Ahmed SRB. Analysis of events from sudden isolated dysarthria to diagnosis of myasthenic crisis: myasthenia gravis mimicking acute lacunar stroke-a case report. J-Med-Case-Rep 2024; 18 (1):.; Miletic SP, Ahmed SRB. Analysis of events from sudden isolated dysarthria to diagnosis of myasthenic crisis: myasthenia gravis mimicking acute lacunar stroke-a case report. J-Med-Case-Rep 2024; 18 (1):.; Miletic SP, Ahmed SRB. Analysis of events from sudden isolated dysarthria to diagnosis ...$73$YR$$F$Y$$$20240820$$HP$GB$GB
241899451$24189945$1$I$$20240730$20240808$20240808$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005696$BIOCON$$$$$$Y$$$20240808$$MD$CA$CA
241899461$24189946$1$I$20240712$20240726$20240808$20240808$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00188$OPKO HEALTH$$98$YR$$M$Y$$$20240806$$PH$US$US
241899472$24189947$2$F$20231101$20240808$20240808$20240821$EXP$$US-THEA-2024001697$Thea Pharma$$80$YR$$F$Y$$$20240821$$HP$US$US
241899482$24189948$2$F$$20240903$20240808$20240913$EXP$$US-TEVA-VS-3228086$TEVA$Wilson P, Rosenstengle C, Spak C. Underrecognized cause diarrhea in solid organ transplant: a report of astroviridae enteritis in liver transplant. Transpl-Infect-Dis 2024; 26 (2):.; Wilson P, Rosenstengle C, Spak C. Underrecognized cause diarrhea in solid organ transplant: a report of astroviridae enteritis in liver transplant. Transpl-Infect-Dis 2024; 26 (2):.$72$YR$$M$Y$$$20240913$$MD$US$US
241899491$24189949$1$I$$20240802$20240808$20240808$EXP$$PH-OTSUKA-2024_021679$OTSUKA$$$$$F$Y$$$20240808$$CN$PH$PH
241899501$24189950$1$I$$20240802$20240808$20240808$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07414$HIKMA$$71$YR$$F$Y$$$20240808$$MD$CA$CA
241899511$24189951$1$I$$20240806$20240808$20240808$EXP$$CA-SANDOZ INC.-NVSC2022CA011078$SANDOZ$$$$$F$Y$$$20240808$$CN$CA$CA
241899522$24189952$2$F$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683487$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241899531$24189953$1$I$20240705$20240725$20240808$20240808$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00378$RIBON THERAPEUTICS$$$$$$Y$$$20240808$$MD$CN$CN
241899541$24189954$1$I$$20240726$20240808$20240808$PER$$US-JNJFOC-20240816439$JOHNSON AND JOHNSON$$$$A$F$Y$82.4$KG$20240808$$MD$US$US
241899552$24189955$2$F$20240625$20240815$20240808$20240820$PER$$US-AMGEN-USASP2024153530$AMGEN$$47$YR$A$F$Y$150$KG$20240820$$PH$US$US
241899561$24189956$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA232072$SANOFI AVENTIS$$$$A$F$Y$$$20240808$$MD$US$US
241899571$24189957$1$I$$20240807$20240808$20240808$PER$$US-HALEON-2191026$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241899581$24189958$1$I$20240531$20240729$20240808$20240808$PER$$US-MYLANLABS-2024M1071331$MYLAN$$76$YR$$F$Y$$$20240808$$CN$US$US
241899591$24189959$1$I$$20240806$20240808$20240808$EXP$$TW-TAKEDA-2024TUS078677$TAKEDA$$$$$$Y$$$20240808$$MD$TW$TW
241899611$24189961$1$I$$20240803$20240808$20240808$EXP$$HU-OTSUKA-2024_021638$OTSUKA$Sudden cardiac death of a patient who has basically low profile. Does psychiatric treatment modify risk?. Cardiologia Hungarica. C 309$18$YR$$M$Y$$$20240808$$HP$HU$HU
241899621$24189962$1$I$20231001$20240731$20240808$20240808$EXP$$US-BIOVITRUM-2024-US-010686$BIOVITRUM$$48$YR$A$F$Y$$$20240808$$CN$US$US
241899643$24189964$3$F$20240101$20240910$20240808$20240913$EXP$$US-PFIZER INC-202400231310$PFIZER$$75$YR$$M$Y$65.8$KG$20240913$$HP$US$US
241899651$24189965$1$I$$20240802$20240808$20240808$EXP$$US-PFIZER INC-PV202400101969$PFIZER$$70$YR$$F$Y$81.374$KG$20240808$$MD$US$US
241899661$24189966$1$I$$20240805$20240808$20240808$EXP$$US-PFIZER INC-202400231219$PFIZER$$79$YR$$F$Y$$$20240808$$HP$US$US
241899671$24189967$1$I$$20240807$20240808$20240808$EXP$$CN-PFIZER INC-PV202400102590$PFIZER$$$$E$M$Y$$$20240808$$CN$CN$CN
241899691$24189969$1$I$$20240806$20240808$20240808$EXP$$US-PFIZER INC-202400232086$PFIZER$$45$YR$$F$Y$$$20240808$$HP$US$US
241899701$24189970$1$I$$20240807$20240808$20240808$EXP$$MA-PFIZER INC-PV202400103410$PFIZER$$$$$F$Y$$$20240808$$CN$MA$MA
241899712$24189971$2$F$20231227$20240809$20240808$20240813$EXP$FR-AFSSAPS-NY2024000890$FR-PFIZER INC-202400229932$PFIZER$$95$YR$$M$Y$70.4$KG$20240813$$MD$FR$FR
241899721$24189972$1$I$20240701$20240805$20240808$20240808$EXP$$IN-PFIZER INC-PV202200058093$PFIZER$$70$YR$$F$Y$$$20240808$$CN$IN$IN
241899733$24189973$3$F$20240101$20240927$20240808$20240927$EXP$$CA-PFIZER INC-2021574547$PFIZER$$47$YR$$M$Y$$$20240927$$MD$CA$CA
241899742$24189974$2$F$$20240829$20240808$20240902$EXP$$IN-PFIZER INC-PV202400101991$PFIZER$$52$YR$$M$Y$$$20240902$$CN$IN$IN
241899751$24189975$1$I$$20240802$20240808$20240808$EXP$$US-PFIZER INC-202400229631$PFIZER$$$$$F$Y$$$20240808$$CN$US$US
241899761$24189976$1$I$20240711$20240805$20240808$20240808$EXP$FR-AFSSAPS-NT2024000980$FR-PFIZER INC-202400229885$PFIZER$$75$YR$$M$Y$74$KG$20240808$$MD$FR$FR
241899773$24189977$3$F$20240101$20240923$20240808$20240926$EXP$$CA-PFIZER INC-202400068641$PFIZER$$47$YR$$M$Y$$$20240926$$MD$CA$CA
241899781$24189978$1$I$$20240806$20240808$20240808$EXP$$US-PFIZER INC-PV202400102836$PFIZER$$61$YR$$F$Y$$$20240808$$HP$US$US
241899791$24189979$1$I$$20240806$20240808$20240808$EXP$GB-MHRA-MED-202408061509490660-QSLHD$GB-PFIZER INC-202400231304$PFIZER$$49$YR$$F$Y$73$KG$20240808$$PH$GB$GB
241899801$24189980$1$I$20240807$20240807$20240807$20240807$DIR$713366$$FDA-CTU$$82$YR$$F$N$$$20240807$Y$$US$
241899812$24189981$2$F$20220602$20240802$20240808$20240809$EXP$$DE-PFIZER INC-202400231434$PFIZER$$64$YR$$M$Y$$$20240809$$HP$DE$DE
241899821$24189982$1$I$$20240807$20240808$20240808$EXP$$JP-PFIZER INC-202400231783$PFIZER$$$$$$Y$$$20240808$$PH$JP$JP
241899831$24189983$1$I$$20240807$20240808$20240808$EXP$GB-MHRA-EMIS-1444-cccb10b0-493d-46c2-96e4-e397899df535$GB-PFIZER INC-202400232144$PFIZER$$66$YR$$F$Y$87$KG$20240808$$PH$GB$GB
241899841$24189984$1$I$$20240807$20240808$20240808$EXP$$US-PFIZER INC-202400232287$PFIZER$$48$YR$$F$Y$$$20240808$$HP$US$US
241899851$24189985$1$I$20240805$20240807$20240807$20240807$DIR$713390$$FDA-CTU$$46$YR$$F$N$58.5$KG$20240807$N$CN$US$
241899861$24189986$1$I$$20240807$20240807$20240807$DIR$713340$$FDA-CTU$$$$$UNK$N$$$20240807$$CN$US$
241899871$24189987$1$I$20240101$20240806$20240808$20240808$EXP$$JP-PFIZER INC-PV202400102391$PFIZER$$93$YR$$M$Y$$$20240808$$PH$JP$JP
241899881$24189988$1$I$20240805$20240805$20240808$20240808$EXP$$DE-PFIZER INC-202400232103$PFIZER$$61$YR$$F$Y$$$20240808$$MD$DE$DE
241899901$24189990$1$I$20240807$20240807$20240807$20240807$DIR$713348$$FDA-CTU$$65$YR$$F$N$$$20240807$N$$US$
241899911$24189991$1$I$20240807$20240807$20240807$20240807$DIR$713375$$FDA-CTU$$75$YR$$F$N$$$20240807$Y$$US$
241899922$24189992$2$F$20240730$20240902$20240808$20240904$EXP$PT-INFARMED-V202407-1130$PT-PFIZER INC-202400230820$PFIZER$$67$YR$$F$Y$$$20240904$$PH$PT$PT
241899931$24189993$1$I$20240807$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54375$$FDA-CTU$$69$YR$$M$N$125.1$KG$20240807$N$$US$
241899941$24189994$1$I$20240805$20240807$20240807$20240807$DIR$713397$$FDA-CTU$$72$YR$$F$N$$$20240807$N$CN$US$
241899951$24189995$1$I$20240615$20240807$20240807$20240807$DIR$713371$$FDA-CTU$$75$YR$$F$N$80.2$KG$20240807$N$HP$US$
241899961$24189996$1$I$20240715$20240805$20240808$20240808$EXP$IT-MINISAL02-997439$IT-PFIZER INC-202400230002$PFIZER$$68$YR$$F$Y$$$20240808$$MD$IT$IT
241899981$24189998$1$I$20170808$20240730$20240808$20240808$EXP$$BE-PFIZER INC-202300455243$PFIZER$$41$YR$$F$Y$66$KG$20240808$$MD$BE$BE
241899991$24189999$1$I$$20240807$20240808$20240808$EXP$$US-PFIZER INC-202400232318$PFIZER$$67$YR$$F$Y$$$20240808$$CN$US$US
241900013$24190001$3$F$20240408$20240928$20240808$20240930$EXP$$US-PFIZER INC-202400230494$PFIZER$$75$YR$$M$Y$$$20240930$$HP$US$US
241900021$24190002$1$I$$20240806$20240808$20240808$EXP$$JP-PFIZER INC-202400231149$PFIZER$$$$E$$Y$$$20240808$$MD$JP$JP
241900031$24190003$1$I$$20240807$20240808$20240808$EXP$$MA-PFIZER INC-PV202400103408$PFIZER$$$$$F$Y$$$20240808$$CN$MA$MA
241900041$24190004$1$I$20240601$20240801$20240808$20240808$EXP$$PH-PFIZER INC-2023SGN13621$PFIZER$$31$YR$$M$Y$$$20240808$$CN$PH$PH
241900051$24190005$1$I$20201226$20240806$20240808$20240808$EXP$FR-AFSSAPS-PV2024000673$FR-PFIZER INC-202400230854$PFIZER$$15$DY$$M$Y$0.8$KG$20240808$$MD$FR$FR
241900063$24190006$3$F$20240101$20240927$20240808$20240927$EXP$$CA-PFIZER INC-202400010730$PFIZER$$61$YR$$F$Y$$$20240927$$HP$CA$CA
241900073$24190007$3$F$20240101$20240828$20240808$20240903$EXP$$CA-PFIZER INC-202400230130$PFIZER$$74$YR$$F$Y$$$20240903$$HP$CA$CA
241900081$24190008$1$I$20240721$20240806$20240808$20240808$EXP$IT-MINISAL02-997917$IT-PFIZER INC-202400230924$PFIZER$$17$YR$$F$Y$$$20240808$$MD$IT$IT
241900091$24190009$1$I$20240119$20240806$20240808$20240808$EXP$FR-AFSSAPS-NY2024000912$FR-PFIZER INC-202400230807$PFIZER$$68$YR$$M$Y$61$KG$20240808$$MD$FR$FR
241900101$24190010$1$I$$20240807$20240808$20240808$EXP$$AU-PFIZER INC-PV202400102879$PFIZER$$79$YR$$M$Y$$$20240808$$HP$AU$AU
241900111$24190011$1$I$$20240807$20240808$20240808$EXP$$US-PFIZER INC-PV202400090968$PFIZER$$77$YR$$F$Y$$$20240808$$CN$US$US
241900124$24190012$4$F$20240430$20240916$20240808$20240918$EXP$IT-MINISAL02-997033$IT-PFIZER INC-202400229882$PFIZER$$66$YR$$F$Y$48$KG$20240918$$MD$IT$IT
241900131$24190013$1$I$20240317$20240806$20240808$20240808$EXP$$GB-PFIZER INC-202400231021$PFIZER$$78$YR$$M$Y$85$KG$20240808$$MD$GB$GB
241900141$24190014$1$I$20240711$20240806$20240808$20240808$EXP$$CN-PFIZER INC-PV202400102466$PFIZER$$40$YR$$F$Y$73$KG$20240808$$HP$CN$CN
241900151$24190015$1$I$20240626$20240802$20240808$20240808$EXP$FR-AFSSAPS-AN2024001028$FR-PFIZER INC-202400228811$PFIZER$$64$YR$$M$Y$53.4$KG$20240808$$MD$FR$FR
241900162$24190016$2$F$20240701$20240829$20240808$20240903$EXP$$JP-PFIZER INC-PV202400091264$PFIZER$$54$YR$$F$Y$40$KG$20240903$$MD$JP$JP
241900172$24190017$2$F$20240101$20240816$20240808$20240821$EXP$$CA-PFIZER INC-202400231785$PFIZER$$54$YR$$F$Y$$$20240821$$HP$CA$CA
241900181$24190018$1$I$20240527$20240731$20240808$20240808$EXP$FR-AFSSAPS-MA2024001231$FR-SA-2024SA228280$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240808$$MD$FR$FR
241900191$24190019$1$I$$20240805$20240808$20240808$PER$$US-ROCHE-10000049957$ROCHE$$$$$$Y$$$20240808$$MD$US$US
241900201$24190020$1$I$20240501$20240802$20240808$20240808$EXP$NL-LRB-00993900$NL-SA-2024SA233570$SANOFI AVENTIS$$75$YR$E$F$Y$68$KG$20240808$$CN$NL$NL
241900211$24190021$1$I$20240611$20240802$20240808$20240808$EXP$$US-ROCHE-10000048225$ROCHE$$63$YR$A$F$Y$$$20240808$$CN$US$US
241900221$24190022$1$I$$20240801$20240808$20240808$EXP$$US-AMGEN-USASP2024153374$AMGEN$Shah N.N.; Lambe A.J.; Kovach A.E.. How I treat post-immunotherapy relapsed B-ALL. Blood. 2024;1-24$3$YR$C$$Y$$$20240808$$MD$US$US
241900231$24190023$1$I$$20240730$20240808$20240808$EXP$GB-MHRA-31193571$GB-TEVA-VS-3228261$TEVA$$$$$M$Y$$$20240808$$CN$GB$GB
241900242$24190024$2$F$20240101$20240805$20240808$20240813$EXP$$US-UNITED THERAPEUTICS-UNT-2024-010708$UNITED THERAPEUTICS$$$$$M$Y$70.295$KG$20240813$$$US$US
241900251$24190025$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161526$NOVARTIS$$$$$M$Y$$$20240808$$CN$US$US
241900262$24190026$2$F$$20240820$20240808$20240826$EXP$$US-ROCHE-10000051703$ROCHE$$$$E$M$Y$$$20240826$$CN$US$US
241900281$24190028$1$I$$20240729$20240808$20240808$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07587$LUPIN$$65$YR$$M$Y$$$20240808$$CN$AU$AU
241900303$24190030$3$F$20240718$20240821$20240808$20240822$EXP$$CH-PFIZER INC-PV202400103181$PFIZER$$87$YR$$F$Y$$$20240822$$CN$CH$CH
241900311$24190031$1$I$$20240729$20240808$20240808$EXP$$US-GSK-US2024094702$GLAXOSMITHKLINE$$$$$M$Y$$$20240808$$CN$US$US
241900321$24190032$1$I$20240501$20240611$20240808$20240808$PER$$US-JNJFOC-20240816971$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240808$$PH$US$US
241900331$24190033$1$I$20240501$20240611$20240808$20240808$PER$$US-JNJFOC-20240817702$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240808$$PH$US$US
241900341$24190034$1$I$$20240807$20240808$20240808$EXP$$ZA-ROCHE-10000052047$ROCHE$$$$$$Y$$$20240808$$MD$ZA$ZA
241900352$24190035$2$F$20240805$20240807$20240808$20240810$PER$$US-AMGEN-USASP2024156548$AMGEN$$78$YR$E$F$Y$$$20240810$$PH$US$US
241900361$24190036$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA227890$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240808$$CN$US$US
241900371$24190037$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA232062$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240808$$MD$US$US
241900381$24190038$1$I$$20240805$20240808$20240808$PER$$US-SA-2024SA234390$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240808$$CN$US$US
241900391$24190039$1$I$20240301$20240801$20240808$20240808$PER$$US-SA-2024SA231637$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240808$$MD$US$US
241900401$24190040$1$I$$20240729$20240808$20240808$EXP$$US-RDY-LIT/USA/24/0011439$DR REDDYS$Das S, Ailawadhi S, Sher T, Roy V, Fernandez A, Parrondo RD. Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety. Current Oncology. 2023;30: 9627-9633. doi:10.3390/curroncol30110697.$33$YR$A$M$Y$$$20240808$$HP$US$US
241900411$24190041$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003140$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241900421$24190042$1$I$$20240805$20240808$20240808$30DAY$$US-GSK-US2024097589$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241900431$24190043$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004339$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240808$$CN$US$US
241900441$24190044$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003295$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241900452$24190045$2$F$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683488$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241900462$24190046$2$F$20240806$20240806$20240808$20240820$PER$$US-AMGEN-USASP2024156633$AMGEN$$79$YR$E$F$Y$$$20240820$$HP$US$US
241900471$24190047$1$I$$20240802$20240808$20240808$PER$$US-SA-2024SA230998$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240808$$CN$US$US
241900491$24190049$1$I$$20240802$20240808$20240808$EXP$$IN-PFIZER INC-PV202400101444$PFIZER$Singh, P.. A Rare Case of Hemolysis Following Antithymocyte Globulin in a Pediatric Patient With Aplastic Anemia Receiving Immunosuppressive Therapy. Journal of Pediatric Hematology/Oncology. 2024;46(6):e480$7$YR$$M$Y$$$20240808$$MD$IN$IN
241900501$24190050$1$I$$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123319$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240808$$CN$US$US
241900512$24190051$2$F$20240722$20240820$20240808$20240820$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-121918$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$47.8$KG$20240820$$MD$DE$DE
241900522$24190052$2$F$20240715$20240828$20240808$20240903$EXP$$DE-MYLANLABS-2024M1072656$MYLAN$$$$$F$Y$$$20240903$$CN$DE$DE
241900531$24190053$1$I$$20240730$20240808$20240808$EXP$$US-MYLANLABS-2024M1072107$MYLAN$Aijaz W, Sohail E, Jabeen R. Abstract #1607914: A Case of Empty Sella Syndrome Secondary to Pituitary Hypoplasia Revealed by Adrenal Insufficiency. Endocr-Pract 2023; 29 (Suppl.) (12): S164.$55$YR$$F$Y$$$20240808$$HP$US$US
241900551$24190055$1$I$20240701$20240730$20240808$20240808$PER$$US-MYLANLABS-2024M1071438$MYLAN$$72$YR$$F$Y$73.48$KG$20240808$$CN$US$US
241900561$24190056$1$I$20240805$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54376$$FDA-CTU$$77$YR$$M$N$65.9$KG$20240807$N$$US$
241900572$24190057$2$F$$20240925$20240808$20240930$EXP$$GB-MYLANLABS-2024M1070139$MYLAN$$$$$M$Y$$$20240930$$CN$GB$GB
241900581$24190058$1$I$20240604$20240801$20240808$20240808$EXP$$NVSC2024FR131523$NOVARTIS$$$$$$Y$$$20240808$$MD$FR$FR
241900591$24190059$1$I$20240719$20240807$20240807$20240807$DIR$713392$$FDA-CTU$$82$YR$$F$N$67.7$KG$20240807$Y$CN$US$
241900601$24190060$1$I$20240306$20240802$20240808$20240808$EXP$SE-SEMPA-2024-005754$SE-MYLANLABS-2024M1072606$MYLAN$$19$YR$$M$Y$$$20240808$$MD$SE$SE
241900611$24190061$1$I$20230525$20240802$20240808$20240808$EXP$FR-AFSSAPS-AM2024000615$FR-MYLANLABS-2024M1072666$MYLAN$$72$YR$$F$Y$70$KG$20240808$$MD$FR$FR
241900621$24190062$1$I$20240705$20240807$20240807$20240807$DIR$713389$$FDA-CTU$$82$YR$$F$N$67.7$KG$20240807$Y$CN$US$
241900631$24190063$1$I$$20240726$20240808$20240808$EXP$$AU-PERRIGO-24AU007383$PERRIGO$Dhaliwal N, Roberts DM. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clin-Toxicol-(Phila) 2024; 0 (0): 1-6.$$$$$Y$$$20240808$$HP$AU$AU
241900641$24190064$1$I$20210915$20240806$20240808$20240808$EXP$$US-BAYER-2024A113774$BAYER$$84$YR$E$F$Y$$$20240808$$CN$US$US
241900651$24190065$1$I$20240701$20240731$20240808$20240808$PER$$US-ABBVIE-5863025$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241900661$24190066$1$I$20240803$20240806$20240808$20240808$DIR$FDA-CDER-CTU-2024-54378$$FDA-CTU$$68$YR$$M$N$89.9$KG$20240806$N$$US$
241900681$24190068$1$I$$20240801$20240808$20240808$EXP$$US-ROCHE-10000046464$ROCHE$$$$$$Y$$$20240808$$CN$US$US
241900701$24190070$1$I$20200831$20240807$20240808$20240808$EXP$$US-TAKEDA-US202028314$TAKEDA$$59$YR$$F$Y$$$20240808$$MD$US$US
241900711$24190071$1$I$$20240731$20240808$20240808$PER$$US-AstraZeneca-2024A174865$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241900721$24190072$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A174364$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241900731$24190073$1$I$20231027$20240801$20240808$20240808$PER$$US-ABBVIE-5864850$ABBVIE$$63$YR$$F$Y$66$KG$20240808$$CN$US$US
241900742$24190074$2$F$20240716$20240807$20240808$20240815$PER$$US-Eisai-EC-2024-170724$EISAI$$77$YR$E$F$Y$59.9$KG$20240815$$CN$US$US
241900751$24190075$1$I$20240417$20240802$20240808$20240808$PER$$JP-Eisai-EC-2024-169153$EISAI$$75$YR$E$F$Y$$$20240808$$MD$JP$JP
241900771$24190077$1$I$$20240731$20240808$20240808$EXP$$DE-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00807$BIOCRYST PHARMACEUTICALS$$35$YR$$F$Y$$$20240808$$MD$DE$DE
241900781$24190078$1$I$20240501$20240611$20240808$20240808$PER$$US-JNJFOC-20240816970$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240808$$PH$US$US
241900792$24190079$2$F$$20240819$20240808$20240822$EXP$$PT-NORDICGR-057101$NORDIC PHARMA$Literature Reference: Mariana Moura Portugal; Ana Carolina Martins; Carla Serodio I: PO-0118 - (4088) - ACUTE METHOTREXATE POISONING, Emergency, intermediate care and critically ill patients | Clinical case$85$YR$$F$Y$$$20240822$$MD$PT$PT
241900801$24190080$1$I$20230601$20240802$20240808$20240808$EXP$RO-NMA-2024-SP0493$RO-NORDICGR-057100$NORDIC PHARMA$$47$YR$$F$Y$$$20240808$$MD$RO$RO
241900811$24190081$1$I$20230215$20240802$20240808$20240808$EXP$$DE-NORDICGR-054208$NORDIC PHARMA$$$$E$F$Y$$$20240808$$HP$DE$DE
241900821$24190082$1$I$$20240729$20240808$20240808$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07610$LUPIN$$86$YR$$F$Y$$$20240808$$CN$AU$AU
241900841$24190084$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A174504$ASTRAZENECA$$$$$F$Y$$$20240808$$MD$US$
241900852$24190085$2$F$$20240828$20240808$20240903$EXP$$EE-AstraZeneca-2024A177395$ASTRAZENECA$$84$YR$$F$Y$$$20240903$$MD$EE$
241900861$24190086$1$I$$20210902$20240808$20240808$EXP$$PH-AstraZeneca-2021A711612$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$PH$
241900871$24190087$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A174551$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241900881$24190088$1$I$$20240805$20240808$20240808$EXP$$CN-AstraZeneca-2024A178745$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$CN$
241900892$24190089$2$F$$20240827$20240808$20240909$EXP$$US-SMPA-2024SPA000358$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
241900912$24190091$2$F$20240724$20240911$20240808$20240926$EXP$$US-SMPA-2024SPA000321$SUNOVION$$$$$$Y$$$20240926$$CN$US$US
241900921$24190092$1$I$$20240729$20240808$20240808$EXP$$US-SMPA-2024SPA000315$SUNOVION$$$$$$Y$$$20240808$$CN$US$US
241900941$24190094$1$I$20240713$20240729$20240808$20240808$EXP$$US-SMPA-2024SPA000325$SUNOVION$$$$$$Y$$$20240808$$CN$US$US
241900951$24190095$1$I$$20240731$20240808$20240808$EXP$$US-ALXN-202407USA002216US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$MD$US$US
241900961$24190096$1$I$20240803$20240805$20240808$20240808$EXP$$AU-AMGEN-AUSSP2024155130$AMGEN$$91$YR$E$F$Y$$$20240808$$CN$AU$AU
241900972$24190097$2$F$$20240827$20240808$20240905$EXP$$US-TEVA-VS-3228008$TEVA$Alam RM, Espinoza J, Coches K. Steroid Induced Diabetic Ketoacidosis in End Stage Renal Disease with Suspected Vasculitis Induced Stroke. South-Med-J 2022; 115 443-444.; Alam RM, Espinoza J, Coches K. Steroid Induced Diabetic Ketoacidosis in End Stage Renal Disease with Suspected Vasculitis Induced Stroke. South-Med-J 2022; 115 443-444.$71$YR$$F$Y$$$20240905$$MD$US$US
241900981$24190098$1$I$20230911$20240805$20240808$20240808$EXP$CH-SM-2024-14534$CH-MYLANLABS-2024M1072958$MYLAN$$42$YR$$F$Y$$$20240808$$PH$CH$CH
241900992$24190099$2$F$20231227$20240821$20240808$20240826$EXP$$GB-MYLANLABS-2023M1138707$MYLAN$$43$YR$$M$Y$$$20240826$$MD$GB$GB
241901002$24190100$2$F$20230101$20240801$20240808$20240814$EXP$$PL-009507513-2408POL001562$MERCK$Czarnecki L. Pembrolizumab plus chemotherapy in a patient with lung cancer (adenocarcinoma) and below 1% PD-L1 expression.. Oncology in Clinical Practise-Education. 2024;10(C):10-4$56$YR$$M$Y$$$20240814$$MD$PL$PL
241901011$24190101$1$I$20240619$20240802$20240808$20240808$EXP$IT-MINISAL02-996798$IT-MYLANLABS-2024M1072421$MYLAN$$51$YR$$M$Y$$$20240808$$PH$IT$IT
241901021$24190102$1$I$20240601$20240802$20240808$20240808$EXP$FR-AFSSAPS-LM2024000425$FR-MYLANLABS-2024M1072440$MYLAN$$30$YR$$M$Y$73$KG$20240808$$MD$FR$FR
241901031$24190103$1$I$$20240808$20240808$20240808$PER$$US-HALEON-2191037$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241901041$24190104$1$I$$20240724$20240808$20240808$EXP$$US-TASMAN PHARMA, INC.-2024TSM00219$TASMAN PHARMA$Bayless S.L., Walker N.V, Scott M.M, Leo R.J.. Clozapine-Related Cecal Volvulus. Prim Care Companion CNS Disord. 2024;26:4$58$YR$$F$Y$$$20240808$$MD$US$US
241901061$24190106$1$I$$20240724$20240808$20240808$PER$$US-GRANULES-US-2024GRASPO00315$GRANULES INDIA$$8$YR$C$M$Y$$$20240808$$PH$US$US
241901071$24190107$1$I$$20240806$20240808$20240808$PER$$US-TAKEDA-2024TUS079021$TAKEDA$$$$$F$Y$$$20240808$$CN$US$US
241901081$24190108$1$I$$20240730$20240808$20240808$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005681$BIOCON$$$$$$Y$$$20240808$$MD$CA$CA
241901092$24190109$2$F$$20240813$20240808$20240823$EXP$$US-TEVA-VS-3229895$TEVA$Quo SW, Mederos N, Parianos M, Idrisov E. SIGNIFICANT ESOPHAGEAL AND INTESTIINAL ULCERATIONS IN THE SETTING OF RECENT CHEMOTHERAPY FOR PANCREATIC ADENOCARCINOMA. Gastroenterology 2023; 164 (Suppl.) (6): S-1209-S-1210 abstr. EP84.; Quo SW, Mederos N, Parianos M, Idrisov E. SIGNIFICANT ESOPHAGEAL AND INTESTIINAL ULCERATIONS IN THE SETTING OF RECENT CHEMOTHERAPY FOR PANCREATIC ADENOCARCINOMA. Gastroenterology 2023; 164 (Suppl.) (6): S-1209-S-1210 abstr. EP84.$72$YR$$M$Y$$$20240823$$HP$US$US
241901111$24190111$1$I$20240619$20240731$20240808$20240808$EXP$IT-MINISAL02-996798$IT-SA-2024SA227927$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240808$$PH$IT$IT
241901121$24190112$1$I$$20240808$20240808$20240808$PER$$US-HALEON-2191011$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241901132$24190113$2$F$20240701$20240917$20240808$20240925$EXP$$JP-ROCHE-10000048582$ROCHE$$9$DEC$E$M$Y$$$20240925$$MD$JP$JP
241901141$24190114$1$I$$20240801$20240808$20240808$EXP$$MO-JNJFOC-20240809128$JOHNSON AND JOHNSON$$70$YR$E$$Y$$$20240808$$MD$MO$MO
241901151$24190115$1$I$20240713$20240729$20240808$20240808$PER$$US-JNJFOC-20240780782$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240808$$CN$US$US
241901161$24190116$1$I$$20240808$20240808$20240808$PER$$US-BAYER-2024A114671$BAYER$$$$$$Y$$$20240808$$CN$US$US
241901181$24190118$1$I$$20240807$20240808$20240808$PER$$US-HALEON-2190879$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241901191$24190119$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683513$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241901201$24190120$1$I$$20240724$20240808$20240808$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00371$APHENA PHARMA SOLUTIONS$$$$$$Y$$$20240808$$CN$BR$BR
241901211$24190121$1$I$20240802$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003288$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240808$$CN$US$US
241901221$24190122$1$I$$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004693$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240808$$CN$US$US
241901231$24190123$1$I$$20240729$20240808$20240808$PER$$US-BAYER-2024A111879$BAYER$$$$$$Y$$$20240808$$CN$US$US
241901241$24190124$1$I$20240722$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003854$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240808$$CN$US$US
241901251$24190125$1$I$$20240730$20240808$20240808$30DAY$$US-GSK-US2024095415$GLAXOSMITHKLINE$$$$$M$Y$$$20240808$$CN$US$US
241901271$24190127$1$I$20240729$20240730$20240808$20240808$PER$$US-SA-2024SA230661$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240808$$MD$US$US
241901281$24190128$1$I$$20240807$20240808$20240808$EXP$GB-MHRA-MED-202407261500390560-SWBPF$GB-MYLANLABS-2024M1070091$MYLAN$$$$$$Y$$$20240808$$MD$GB$GB
241901291$24190129$1$I$20240725$20240806$20240808$20240808$EXP$$US-BAYER-2024A113763$BAYER$$26$YR$A$M$Y$$$20240808$$CN$US$US
241901301$24190130$1$I$20240606$20240727$20240808$20240808$EXP$$IN-ROCHE-10000041063$ROCHE$$38$YR$A$M$Y$$$20240808$$CN$IN$IN
241901311$24190131$1$I$$20240807$20240808$20240808$PER$$US-HALEON-2191008$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241901321$24190132$1$I$$20240729$20240808$20240808$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005627$BIOCON$$$$$$Y$$$20240808$$CN$CA$CA
241901332$24190133$2$F$$20240729$20240808$20240809$EXP$$AU-BAYER-2024A110029$BAYER$$52$YR$A$$Y$$$20240809$$HP$AU$AU
241901341$24190134$1$I$20240701$20240801$20240808$20240808$EXP$$AU-AstraZeneca-2024A177383$ASTRAZENECA$$774$MON$$F$Y$$$20240808$$CN$AU$
241901351$24190135$1$I$20240724$20240731$20240808$20240808$EXP$$CN-AstraZeneca-2024A176454$ASTRAZENECA$$20434$DY$$M$Y$65$KG$20240808$$MD$CN$
241901382$24190138$2$F$$20240812$20240808$20240822$EXP$$IT-TEVA-VS-3228691$TEVA$Perlato M, Mecheri V, Vivarelli E, Accinno M, Vultaggio A, Matucci A. ^Patient remodeling^ as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend. J-Asthma 2024; 61 (1): 72-75.; Perlato M, Mecheri V, Vivarelli E, Accinno M, Vultaggio A, Matucci A. ^Patient remodeling^ as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend. J-Asthma 2024; 61 (1): 72-75.; Per...$28$YR$$F$Y$$$20240822$$MD$IT$IT
241901391$24190139$1$I$20240806$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232330$PFIZER$$39$YR$$F$Y$$$20240808$$CN$US$US
241901401$24190140$1$I$20240802$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232236$PFIZER$$65$YR$$M$Y$$$20240808$$CN$US$US
241901411$24190141$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-PV202400102049$PFIZER$$81$YR$$M$Y$$$20240808$$HP$US$US
241901421$24190142$1$I$20240806$20240806$20240808$20240808$PER$$JP-PFIZER INC-202400230933$PFIZER$$$$$$Y$$$20240808$$PH$JP$JP
241901431$24190143$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-PV202400102514$PFIZER$$$$$$Y$$$20240808$$CN$US$US
241901441$24190144$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-PV202400102351$PFIZER$$$$$$Y$$$20240808$$HP$US$US
241901453$24190145$3$F$20240726$20240910$20240808$20240911$PER$$US-PFIZER INC-202400232235$PFIZER$$84$YR$$M$Y$83.9$KG$20240911$$CN$US$US
241901462$24190146$2$F$20240729$20240823$20240808$20240827$PER$$US-PFIZER INC-202400229741$PFIZER$$57$YR$$M$Y$74.8$KG$20240827$$CN$US$US
241901471$24190147$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231707$PFIZER$$$$$$Y$$$20240808$$CN$US$US
241901481$24190148$1$I$20240804$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232332$PFIZER$$65$YR$$F$Y$$$20240808$$CN$US$US
241901492$24190149$2$F$$20240808$20240808$20240809$PER$$US-PFIZER INC-202400232285$PFIZER$$70$YR$$M$Y$$$20240809$$CN$US$US
241901501$24190150$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-PV202400102029$PFIZER$$57$YR$$M$Y$$$20240808$$HP$US$US
241901511$24190151$1$I$$20240807$20240808$20240808$PER$$US-PFIZER INC-PV202400103247$PFIZER$$96$YR$$F$Y$$$20240808$$CN$US$US
241901522$24190152$2$F$20240805$20240918$20240808$20240919$PER$$US-PFIZER INC-202400231302$PFIZER$$34$YR$$F$Y$60.317$KG$20240919$$HP$US$US
241901533$24190153$3$F$20240801$20240820$20240808$20240822$PER$$FR-PFIZER INC-202400231191$PFIZER$$71$YR$$F$Y$$$20240822$$CN$FR$FR
241901542$24190154$2$F$$20240808$20240808$20240809$EXP$$US-PFIZER INC-PV202400102010$PFIZER$$62$YR$$F$Y$$$20240809$$CN$US$US
241901551$24190155$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230696$PFIZER$$$$$$Y$$$20240808$$CN$US$US
241901561$24190156$1$I$$20240802$20240808$20240808$PER$$US-PFIZER INC-202400229306$PFIZER$$52$YR$$F$Y$$$20240808$$MD$US$US
241901571$24190157$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231247$PFIZER$$$$$F$Y$$$20240808$$CN$US$US
241901581$24190158$1$I$20240730$20240803$20240808$20240808$PER$$US-PFIZER INC-202400229737$PFIZER$$52$YR$$M$Y$$$20240808$$CN$US$US
241901591$24190159$1$I$20240701$20240803$20240808$20240808$PER$$US-PFIZER INC-202400229562$PFIZER$$54$YR$$F$Y$$$20240808$$CN$US$US
241901601$24190160$1$I$20240701$20240805$20240808$20240808$PER$$US-PFIZER INC-PV202400102800$PFIZER$$65$YR$$M$Y$$$20240808$$HP$US$US
241901611$24190161$1$I$20201001$20240805$20240808$20240808$PER$$US-PFIZER INC-PV202400102774$PFIZER$$$$$F$Y$$$20240808$$CN$US$US
241901621$24190162$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231241$PFIZER$$55$YR$$F$Y$$$20240808$$CN$US$US
241901631$24190163$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-PV202400101980$PFIZER$$79$YR$$M$Y$$$20240808$$CN$US$US
241901642$24190164$2$F$$20240819$20240808$20240822$PER$$US-PFIZER INC-202400231906$PFIZER$$65$YR$$F$Y$$$20240822$$CN$US$US
241901652$24190165$2$F$$20240813$20240808$20240814$PER$$US-PFIZER INC-202400231518$PFIZER$$68$YR$$F$Y$$$20240814$$HP$US$US
241901662$24190166$2$F$$20240801$20240808$20240812$PER$$US-PFIZER INC-202400228377$PFIZER$$73$YR$$M$Y$81.65$KG$20240812$$CN$US$US
241901671$24190167$1$I$20240803$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230364$PFIZER$$66$YR$$M$Y$$$20240808$$CN$US$US
241901681$24190168$1$I$20240804$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230467$PFIZER$$66$YR$$F$Y$$$20240808$$CN$US$US
241901691$24190169$1$I$20240101$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231379$PFIZER$$62$YR$$M$Y$$$20240808$$MD$US$US
241901701$24190170$1$I$$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232095$PFIZER$$85$YR$$F$Y$$$20240808$$CN$US$US
241901711$24190171$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230452$PFIZER$$$$$F$Y$$$20240808$$CN$US$US
241901721$24190172$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231717$PFIZER$$65$YR$$F$Y$153.29$KG$20240808$$CN$US$US
241901741$24190174$1$I$20240801$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232523$PFIZER$$30$YR$$F$Y$$$20240808$$CN$US$US
241901752$24190175$2$F$$20240919$20240808$20240924$PER$$US-PFIZER INC-PV202400102797$PFIZER$$60$YR$$M$Y$$$20240924$$HP$US$US
241901761$24190176$1$I$20240728$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230965$PFIZER$$70$YR$$F$Y$$$20240808$$CN$US$US
241901771$24190177$1$I$20240101$20240806$20240808$20240808$PER$$US-PFIZER INC-PV202400102662$PFIZER$$83$YR$$M$Y$$$20240808$$CN$US$US
241901781$24190178$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-PV202400102009$PFIZER$$70$YR$$F$Y$$$20240808$$HP$US$US
241901792$24190179$2$F$20240801$20240826$20240808$20240828$PER$$US-PFIZER INC-202400229955$PFIZER$$53$YR$$F$Y$48.98$KG$20240828$$CN$US$US
241901801$24190180$1$I$$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232368$PFIZER$$$$$M$Y$$$20240808$$HP$US$US
241901811$24190181$1$I$20240803$20240803$20240808$20240808$PER$$US-PFIZER INC-202400229700$PFIZER$$68$YR$$F$Y$$$20240808$$CN$US$US
241901821$24190182$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231747$PFIZER$$$$$$Y$$$20240808$$HP$US$US
241901831$24190183$1$I$20240807$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232383$PFIZER$$$$$F$Y$$$20240808$$CN$US$US
241901842$24190184$2$F$$20240909$20240808$20240910$PER$$US-PFIZER INC-202400175910$PFIZER$$46$YR$$F$Y$$$20240910$$CN$US$US
241901851$24190185$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230441$PFIZER$$$$$F$Y$$$20240808$$MD$US$US
241901861$24190186$1$I$20240731$20240803$20240808$20240808$PER$$US-PFIZER INC-202400229560$PFIZER$$67$YR$$M$Y$$$20240808$$CN$US$US
241901871$24190187$1$I$$20240801$20240808$20240808$PER$$US-PFIZER INC-PV202400101310$PFIZER$$17$YR$$F$Y$$$20240808$$HP$US$US
241901893$24190189$3$F$$20240813$20240808$20240821$EXP$$US-PFIZER INC-202400232115$PFIZER$$68$YR$$M$Y$$$20240820$$CN$US$US
241901901$24190190$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-PV202400102124$PFIZER$$41$YR$$F$Y$$$20240808$$CN$US$US
241901911$24190191$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230716$PFIZER$$20$YR$$F$Y$$$20240808$$MD$US$US
241901922$24190192$2$F$$20240916$20240808$20240918$PER$$US-PFIZER INC-PV202400102126$PFIZER$$85$YR$$M$Y$$$20240918$$HP$US$US
241901931$24190193$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230400$PFIZER$$73$YR$$F$Y$$$20240808$$PH$US$US
241901941$24190194$1$I$20240806$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231804$PFIZER$$46$YR$$M$Y$$$20240808$$CN$US$US
241901951$24190195$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230876$PFIZER$$42$YR$$$Y$$$20240808$$CN$US$US
241901961$24190196$1$I$20240805$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231762$PFIZER$$49$YR$$M$Y$$$20240808$$CN$US$US
241901972$24190197$2$F$20240803$20240819$20240808$20240822$PER$$US-PFIZER INC-202400230603$PFIZER$$43$YR$$F$Y$58.97$KG$20240822$$CN$US$US
241901982$24190198$2$F$$20240805$20240808$20240809$PER$$US-PFIZER INC-202400231257$PFIZER$$68$YR$$F$Y$$$20240809$$CN$US$US
241901992$24190199$2$F$20240101$20240805$20240808$20240814$PER$$US-PFIZER INC-202400195537$PFIZER$$6$YR$$M$Y$$$20240814$$MD$US$US
241902001$24190200$1$I$$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232307$PFIZER$$69$YR$$F$Y$$$20240808$$CN$US$US
241902011$24190201$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230610$PFIZER$$$$$M$Y$$$20240808$$CN$US$US
241902021$24190202$1$I$$20240807$20240808$20240808$PER$$US-PFIZER INC-PV202400103389$PFIZER$$$$$M$Y$$$20240808$$HP$US$US
241902032$24190203$2$F$20240805$20240826$20240808$20240829$PER$$US-PFIZER INC-202400230590$PFIZER$$43$YR$$F$Y$78.471$KG$20240829$$CN$US$US
241902041$24190204$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-PV202400102025$PFIZER$$61$YR$$F$Y$$$20240808$$HP$US$US
241902061$24190206$1$I$$20240730$20240808$20240808$EXP$US-MLMSERVICE-20240723-PI140490-00217-1$US-RDY-SPO/USA/24/0011311$DR REDDYS$Jain S, Sekhon S, Leo Pradeep Chandran AS, Gummadi J, Patel P, Nakka R, et al. Metformin-associated lactic acidosis in an older adult: A case report and review. Cureus. 2024;16(6):e62729. DOI: 10.7759/cureus.62729.$82$YR$E$M$Y$$$20240808$$MD$US$US
241902071$24190207$1$I$$20240806$20240808$20240808$PER$$US-JNJFOC-20240813505$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241902081$24190208$1$I$$20240729$20240808$20240808$EXP$$US-RDY-LIT/USA/24/0011438$DR REDDYS$Das S, Ailawadhi S, Sher T, Roy V, Fernandez A, Parrondo RD. Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety. Current Oncology. 2023;30: 9627-9633. doi:10.3390/curroncol30110697.$62$YR$A$F$Y$$$20240808$$HP$US$US
241902091$24190209$1$I$20240731$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54413$$FDA-CTU$$76$YR$$M$N$85.7$KG$20240807$N$$US$
241902111$24190211$1$I$$20240807$20240808$20240808$PER$$US-TAKEDA-2024TUS079333$TAKEDA$$31$YR$$F$Y$$$20240808$$CN$US$US
241902121$24190212$1$I$$20240807$20240808$20240808$EXP$PT-TEVA-VS-3222734$PT-ROCHE-10000051360$ROCHE$Vasconcelos C, Magalh?es RT, Relvas R, Monteiro NF, Cruz D. PO-0019 - (2483) - SEVERE IATROGENIC NEUTROPENIA - AN UNUSUAL CULPRIT. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional de Medicina Interna - Livro de resumos [CNMI]. 2024 May; 394.$81$YR$E$M$Y$$$20240808$$MD$PT$PT
241902131$24190213$1$I$$20240731$20240808$20240808$EXP$$JP-PERRIGO-24JP007301$PERRIGO$Nagao S, Yabuuchi Y, Tanaka K, Morihisa Y, Kobayashi T, Akiyama S, et al. Multiple Gastric Neuroendocrine Tumors Associated with Long-term Use of a Proton Pump Inhibitor and a Potassium-competitive Acid Blocker. Internal Medicine. 2024;63(14):2001-10. DOI:10.2169/internalmedicine.2857-23.$$$A$M$Y$$$20240808$$MD$JP$JP
241902151$24190215$1$I$20240730$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231371$PFIZER$$$$$M$Y$$$20240808$$MD$US$US
241902161$24190216$1$I$20240806$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231561$PFIZER$$72$YR$$F$Y$$$20240808$$CN$US$US
241902171$24190217$1$I$20240726$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54414$$FDA-CTU$$61$YR$$F$N$50.3$KG$20240807$N$$US$
241902181$24190218$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231599$PFIZER$$34$YR$$F$Y$54.43$KG$20240808$$HP$US$US
241902191$24190219$1$I$20240804$20240806$20240808$20240808$PER$$US-PFIZER INC-202400232101$PFIZER$$83$YR$$F$Y$$$20240808$$HP$US$US
241902201$24190220$1$I$$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54491$$FDA-CTU$$$$$M$N$$$20240807$N$HP$US$
241902211$24190221$1$I$$20240807$20240808$20240808$PER$$US-PFIZER INC-202300359518$PFIZER$$34$YR$$F$Y$$$20240808$$MD$US$US
241902221$24190222$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-PV202400102731$PFIZER$$52$YR$$M$Y$$$20240808$$HP$US$US
241902231$24190223$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231580$PFIZER$$$$$$Y$$$20240808$$CN$US$US
241902241$24190224$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-PV202400102843$PFIZER$$57$YR$$F$Y$$$20240808$$HP$US$US
241902252$24190225$2$F$$20240813$20240808$20240814$PER$$US-PFIZER INC-202400232244$PFIZER$$$$$$Y$$$20240814$$CN$US$US
241902262$24190226$2$F$$20240919$20240808$20240920$PER$$NVSC2024US161664$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
241902272$24190227$2$F$$20240829$20240808$20240902$PER$$US-ROCHE-10000048350$ROCHE$$$$$F$Y$$$20240902$$HP$US$US
241902281$24190228$1$I$20240701$20240730$20240808$20240808$PER$$US-INCYTE CORPORATION-2024IN007995$INCYTE$$$$$$Y$$$20240808$$MD$US$US
241902293$24190229$3$F$20240424$20240921$20240808$20240924$EXP$$NVSC2024CO057726$NOVARTIS$$34$YR$$F$Y$73$KG$20240924$$CN$CO$CO
241902301$24190230$1$I$$20240724$20240808$20240808$EXP$$NO-AZURITY PHARMACEUTICALS, INC.-AZR202407-000198$AZURITY PHARMACEUTICALS$Dalaker VM, Furuhaugen H, Brekke M, Bjornaas MA, Oiestad EL, Vallersnes OM et al.. Drugs in blood and urine samples from victims of suspected exposure to drink spiking: A prospective observational study from Oslo, Norway. PLoS ONE. 2024;19 (7):1-14$21$YR$$F$Y$$$20240808$$HP$NO$NO
241902311$24190231$1$I$$20240805$20240808$20240808$PER$$US-ROCHE-10000049953$ROCHE$$$$$$Y$$$20240808$$CN$US$US
241902321$24190232$1$I$$20240805$20240808$20240808$PER$$US-ROCHE-RCA4901388$ROCHE$$24$YR$A$F$Y$$$20240808$$CN$US$US
241902333$24190233$3$F$$20240729$20240808$20240813$PER$$NVSC2024US156755$NOVARTIS$$$$$F$Y$57$KG$20240813$$CN$US$US
241902341$24190234$1$I$20240327$20240808$20240808$20240808$EXP$FR-AFSSAPS-LY2024000808$NVSC2024FR161364$NOVARTIS$$8$YR$$F$Y$40$KG$20240808$$PH$FR$FR
241902351$24190235$1$I$20240729$20240730$20240808$20240808$PER$$US-FARMAPROD-202408-2790$DOMPE FARMACEUTICI$$5$YR$C$F$Y$$$20240808$$CN$US$US
241902361$24190236$1$I$$20240530$20240808$20240808$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000217$Tarsus Pharmaceuticals$$$$$M$Y$$$20240808$$PH$US$US
241902371$24190237$1$I$20240101$20240708$20240808$20240808$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000305$Tarsus Pharmaceuticals$$$$$M$Y$$$20240808$$CN$US$US
241902382$24190238$2$F$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683489$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241902393$24190239$3$F$20240101$20240917$20240808$20240923$EXP$$CO-ABBVIE-5870188$ABBVIE$$$$$M$Y$65$KG$20240923$$CN$CO$CO
241902401$24190240$1$I$20240617$20240807$20240808$20240808$EXP$DE-DCGMA-24203706$DE-ROCHE-10000051103$ROCHE$$64$YR$A$M$Y$$$20240808$$MD$DE$DE
241902411$24190241$1$I$$20240807$20240808$20240808$PER$$US-ROCHE-10000051959$ROCHE$$$$A$F$Y$$$20240808$$MD$US$US
241902421$24190242$1$I$20240720$20240805$20240808$20240808$EXP$FR-AFSSAPS-LY2024001178$FR-TAKEDA-2024TUS077963$TAKEDA$$22$YR$$M$Y$67$KG$20240808$$HP$FR$FR
241902432$24190243$2$F$$20240905$20240808$20240913$EXP$$US-TEVA-VS-3228602$TEVA$Churchill AB, Nguyen AD, Xia J, Nguyen VD, Agrawal N, Durant CE, et al. To Bite or Not to Bite: A Case of Non-bite Pasteurella Multicoda Resulting in Severe Septic Shock. Am-J-Respir-Crit-Care-Med 2024; 209 A1679.; Churchill AB, Nguyen AD, Xia J, Nguyen VD, Agrawal N, Durant CE, et al. To Bite or Not to Bite: A Case of Non-bite Pasteurella Multicoda Resulting in Severe Septic Shock. Am-J-Respir-Crit-Care-Med 2024; 209 A1679.$68$YR$$M$Y$$$20240913$$HP$US$US
241902441$24190244$1$I$$20240729$20240808$20240808$EXP$$RU-AMGEN-RUSSP2024150751$AMGEN$Sagilova E. R.; Kuchma G. B.; Kozlova L. K. et al.. Clinical case of isolated thrombocytopenia in the debut of systemic lupus erythematosus. Practical medicine. 2024;22 (3):116-119$$$$F$Y$$$20240808$$HP$RU$RU
241902451$24190245$1$I$20240520$20240731$20240808$20240808$EXP$$CN-009507513-2408CHN000812$MERCK$$65$YR$$M$Y$75$KG$20240808$$HP$CN$CN
241902461$24190246$1$I$20240601$20240722$20240808$20240808$PER$$BR-TOLMAR, INC.-24BR051252$TOLMAR$$10$YR$$F$Y$$$20240807$$CN$BR$BR
241902471$24190247$1$I$$20240722$20240808$20240808$PER$$CA-TOLMAR, INC.-24CA050909$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
241902481$24190248$1$I$20240319$20240722$20240808$20240808$PER$$CA-TOLMAR, INC.-24CA051206$TOLMAR$$77$YR$$M$Y$$$20240807$$CN$CA$CA
241902491$24190249$1$I$$20240801$20240808$20240808$EXP$$CA-TOLMAR, INC.-24CA050950$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
241902501$24190250$1$I$$20240722$20240808$20240808$PER$$CA-TOLMAR, INC.-24CA051234$TOLMAR$$$$$M$Y$$$20240807$$CN$CA$CA
241902512$24190251$2$F$$20240812$20240808$20240905$PER$$CA-TOLMAR, INC.-24CA051232$TOLMAR$$$$$M$Y$$$20240905$$CN$CA$CA
241902521$24190252$1$I$20240201$20240802$20240808$20240808$PER$$CA-TOLMAR, INC.-24CA051213$TOLMAR$$51$YR$$M$Y$$$20240808$$CN$CA$CA
241902532$24190253$2$F$20240209$20240819$20240808$20240823$EXP$FR-AFSSAPS-TO2024001468$FR-FreseniusKabi-FK202412198$FRESENIUS KABI$$69$YR$E$M$Y$106$KG$20240823$$PH$FR$FR
241902541$24190254$1$I$20240715$20240802$20240808$20240808$EXP$GB-MHRA-MED-202407240808085920-WDRBP$GB-RDY-SPO/GBR/24/0011025$DR REDDYS$$60$YR$A$M$Y$68$KG$20240808$$CN$GB$GB
241902551$24190255$1$I$20240107$20240805$20240808$20240808$EXP$FR-AFSSAPS-TO2024001399$FR-FreseniusKabi-FK202412192$FRESENIUS KABI$$66$YR$E$M$Y$$$20240808$$PH$FR$FR
241902562$24190256$2$F$20240709$20240809$20240808$20240813$EXP$IT-MINISAL02-996785$IT-ROCHE-10000051465$ROCHE$$60$YR$A$M$Y$$$20240813$$MD$IT$IT
241902571$24190257$1$I$20240722$20240729$20240808$20240808$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00189$OPKO HEALTH$$77$YR$$F$Y$$$20240806$$PH$US$US
241902581$24190258$1$I$20240705$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54531$$FDA-CTU$$78$YR$$F$N$$$20240807$N$HP$US$
241902591$24190259$1$I$$20240729$20240808$20240808$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07618$LUPIN$$53$YR$$M$Y$$$20240808$$CN$AU$AU
241902602$24190260$2$F$20240501$20240826$20240808$20240905$EXP$$AU-BEH-2024176537$CSL BEHRING$$70$YR$E$F$Y$$$20240905$$HP$AU$AU
241902613$24190261$3$F$20230101$20240828$20240808$20240905$EXP$$CA-AstraZeneca-2024A178123$ASTRAZENECA$$15$YR$$M$Y$$$20240905$$CN$CA$
241902621$24190262$1$I$20230801$20240729$20240808$20240808$EXP$$US-TEVA-VS-3228360$TEVA$$59$YR$$F$Y$48.53$KG$20240808$$HP$US$US
241902631$24190263$1$I$$20240806$20240808$20240808$EXP$$CA-PFIZER INC-202400231320$PFIZER$$61$YR$$F$Y$$$20240808$$HP$CA$CA
241902641$24190264$1$I$$20240620$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407019449$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241902651$24190265$1$I$$20240801$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408001278$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240808$$CN$US$US
241902661$24190266$1$I$$20240806$20240808$20240808$EXP$$US-PFIZER INC-202400231340$PFIZER$$52$YR$$F$Y$$$20240808$$CN$US$US
241902681$24190268$1$I$20240619$20240805$20240808$20240808$EXP$$NVSC2024KR160911$NOVARTIS$$62$YR$$M$Y$$$20240808$$MD$KR$KR
241902691$24190269$1$I$$20240730$20240808$20240808$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005669$BIOCON$$$$$$Y$$$20240808$$HP$CA$CA
241902701$24190270$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A174617$ASTRAZENECA$$$$$M$Y$83$KG$20240808$$CN$US$
241902711$24190271$1$I$$20231013$20240808$20240808$EXP$$US-AstraZeneca-2023A234559$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241902721$24190272$1$I$$20230413$20240808$20240808$EXP$$US-AstraZeneca-2023A087440$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241902731$24190273$1$I$20210301$20221209$20240808$20240808$EXP$$US-AstraZeneca-2022A404183$ASTRAZENECA$$840$MON$$M$Y$$$20240808$$CN$US$
241902742$24190274$2$F$$20240812$20240808$20240813$PER$$US-HALEON-2191001$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
241902751$24190275$1$I$$20240807$20240808$20240808$30DAY$$US-SANDOZ INC.-SDZ2024US071376$SANDOZ$$65$YR$$$Y$62.14$KG$20240808$$CN$US$US
241902761$24190276$1$I$$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54537$$FDA-CTU$$53$YR$$M$N$$$20240807$Y$$US$
241902781$24190278$1$I$$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54536$$FDA-CTU$$$$$F$N$$$20240807$N$HP$US$
241902791$24190279$1$I$$20240807$20240807$20240807$DIR$713369$$FDA-CTU$$$$$UNK$N$$$20240807$$CN$US$
241902801$24190280$1$I$20240807$20240807$20240807$20240807$DIR$713372$$FDA-CTU$$35$YR$$F$N$80.82$KG$20240807$N$MD$US$
241902811$24190281$1$I$20240221$20240807$20240807$20240807$DIR$713367$$FDA-CTU$$44$YR$$F$N$218.25$KG$20240807$N$HP$US$
241902823$24190282$3$F$20240101$20240917$20240808$20240920$EXP$$CA-PFIZER INC-PV202300209493$PFIZER$$56$YR$$F$Y$54.5$KG$20240920$$HP$CA$CA
241902831$24190283$1$I$$20240806$20240808$20240808$EXP$$US-PFIZER INC-202400231348$PFIZER$$73$YR$$F$Y$$$20240808$$CN$US$US
241902841$24190284$1$I$20210904$20240806$20240808$20240808$EXP$SK-SUKLSK-20219252$SK-PFIZER INC-202400230810$PFIZER$$20$YR$$F$Y$85$KG$20240808$$MD$SK$SK
241902851$24190285$1$I$20240404$20240805$20240808$20240808$EXP$FR-AFSSAPS-AN2024001003$FR-PFIZER INC-202400229924$PFIZER$$60$YR$$M$Y$$$20240808$$PH$FR$FR
241902862$24190286$2$F$$20240806$20240808$20240814$PER$$US-AMGEN-USASP2024157096$AMGEN$$$$$$Y$$$20240814$$MD$US$US
241902871$24190287$1$I$$20240802$20240808$20240808$PER$$US-AMGEN-USASP2024155634$AMGEN$Caldera F.; Roiak S.; Farraye F. A. et al.. Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy. Clinical and Translational Gastroenterology. 2024;15(4):1-9$$$$$Y$$$20240808$$MD$US$US
241902881$24190288$1$I$20240601$20240731$20240808$20240808$EXP$$AU-AMGEN-AUSSP2024155101$AMGEN$$47$YR$A$F$Y$$$20240808$$MD$AU$AU
241902891$24190289$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161574$NOVARTIS$$$$$$Y$$$20240808$$PH$US$US
241902901$24190290$1$I$20240710$20240802$20240808$20240808$EXP$GB-MHRA-MED-202408021930281890-FPRZV$GB-BAYER-2024A112278$BAYER$$44$YR$A$$Y$$$20240808$$PH$GB$GB
241902911$24190291$1$I$20240601$20240723$20240808$20240808$PER$$US-INSUD PHARMA-2407US05932$INSUD PHARMA$$$$$$Y$$$20240808$$MD$US$US
241902921$24190292$1$I$20170504$20240729$20240808$20240808$EXP$$US-GSK-US2024AMR095505$GLAXOSMITHKLINE$$26$YR$$M$Y$$$20240808$$HP$US$US
241902931$24190293$1$I$$20240806$20240808$20240808$EXP$$IN-JNJFOC-20240814977$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$IN$IN
241902941$24190294$1$I$20240101$20240805$20240808$20240808$EXP$$US-JNJFOC-20240812229$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240808$$CN$US$US
241902951$24190295$1$I$20190915$20240724$20240808$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461579$RANBAXY$$64$YR$$M$Y$$$20240808$$MD$FR$FR
241902961$24190296$1$I$20240421$20240724$20240808$20240808$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461631$RANBAXY$$31$YR$$F$Y$$$20240808$$MD$ES$ES
241902971$24190297$1$I$20240603$20240724$20240808$20240808$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461560$RANBAXY$$$$E$M$Y$$$20240808$$CN$IT$IT
241902981$24190298$1$I$20240730$20240731$20240808$20240808$EXP$$GR-ARGENX-2024-ARGX-GR006202$ARGENX BVBA$$$$$$Y$$$20240808$$MD$GR$GR
241902991$24190299$1$I$$20240806$20240808$20240808$PER$$US-JNJFOC-20240813390$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241903001$24190300$1$I$20160101$20240725$20240808$20240808$PER$$US-JNJFOC-20240775935$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241903011$24190301$1$I$$20240728$20240808$20240808$EXP$$CN-GE HEALTHCARE-2024CSU008843$GE HEALTHCARE$$$$A$F$Y$$$20240808$$HP$CN$CN
241903021$24190302$1$I$$20240806$20240808$20240808$EXP$GB-MHRA-MED-202408061728378870-SHCJK$GB-MYLANLABS-2024M1073468$MYLAN$$$$$M$Y$$$20240808$$CN$GB$GB
241903031$24190303$1$I$$20240805$20240808$20240808$EXP$$NVSC2024GB160104$NOVARTIS$$$$$M$Y$$$20240808$$CN$GB$GB
241903041$24190304$1$I$20200101$20240724$20240808$20240808$EXP$IT-EMA-DD-20240517-7482691-072512$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461632$RANBAXY$$51$YR$$F$Y$$$20240808$$HP$IT$IT
241903051$24190305$1$I$$20240724$20240808$20240808$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461633$RANBAXY$$17$YR$$F$Y$$$20240808$$HP$PT$PT
241903061$24190306$1$I$$20240807$20240808$20240808$EXP$GB-MHRA-MED-202408071426044480-YFBQK$GB-SANDOZ INC.-SDZ2024GB071197$SANDOZ$$$$$$Y$$$20240808$$CN$GB$GB
241903071$24190307$1$I$20240701$20240801$20240808$20240808$EXP$$ZA-ROCHE-10000047268$ROCHE$$1$YR$I$M$Y$$$20240808$$MD$ZA$ZA
241903081$24190308$1$I$$20240801$20240808$20240808$EXP$$US-FreseniusKabi-FK202412254$FRESENIUS KABI$Shivarajpur A, Valentin RG. Intramuscular Progesterone: A Cause of Acute Eosinophilic Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 2024 May;209(0):$35$YR$A$F$Y$$$20240808$$HP$US$US
241903092$24190309$2$F$$20240820$20240808$20240830$EXP$$US-GSK-US2024AMR097334$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
241903101$24190310$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA233360$SANOFI AVENTIS$$$$A$F$Y$90.7$KG$20240808$$MD$US$US
241903111$24190311$1$I$20240701$20240802$20240808$20240808$PER$$US-SA-2024SA231859$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240808$$CN$US$US
241903122$24190312$2$F$$20240806$20240808$20240816$EXP$$NVSC2024US131849$NOVARTIS$$$$$M$Y$127.27$KG$20240816$$CN$US$US
241903141$24190314$1$I$$20230801$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00870$TARO$$$$$$Y$$$20240808$$CN$US$US
241903151$24190315$1$I$20240319$20240724$20240808$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461539$RANBAXY$$67$YR$$M$Y$72.9$KG$20240808$$PH$FR$FR
241903161$24190316$1$I$$20240724$20240808$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461563$RANBAXY$$25$YR$$F$Y$$$20240808$$MD$FR$FR
241903171$24190317$1$I$20231009$20240724$20240808$20240808$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461534$RANBAXY$$69$YR$$F$Y$$$20240808$$MD$FR$FR
241903181$24190318$1$I$$20240802$20240808$20240808$EXP$$DE-DSJP-DSE-2024-139150$DAIICHI$$82$YR$$M$Y$$$20240808$$MD$DE$DE
241903191$24190319$1$I$$20240711$20240808$20240808$PER$$US-SMPA-2024MYSCI0700494$SUNOVION$$$$$$Y$$$20240808$$HP$US$US
241903202$24190320$2$F$$20240906$20240808$20240923$PER$$US-SMPA-2024SPA000377$SUNOVION$$$$$$Y$$$20240923$$HP$US$US
241903211$24190321$1$I$20240716$20240807$20240807$20240807$DIR$713388$$FDA-CTU$$44$YR$$F$N$82.35$KG$20240807$N$CN$US$
241903221$24190322$1$I$20240701$20240807$20240807$20240807$DIR$713377$$FDA-CTU$$53$YR$$F$N$91.8$KG$20240807$Y$CN$US$
241903231$24190323$1$I$20240701$20240712$20240808$20240808$PER$$US-SMPA-2024MYSCI0700514$SUNOVION$$$$$$Y$$$20240808$$CN$US$US
241903241$24190324$1$I$$20240712$20240808$20240808$PER$$US-SMPA-2024MYSCI0700538$SUNOVION$$$$$$Y$$$20240808$$CN$US$US
241903251$24190325$1$I$20240721$20240807$20240807$20240807$DIR$713364$$FDA-CTU$$52$YR$$F$N$94.5$KG$20240807$N$CN$US$
241903261$24190326$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54563$$FDA-CTU$$52$YR$$M$N$$$20240808$N$$US$
241903271$24190327$1$I$$20240726$20240808$20240808$PER$$US-SMPA-2024SPA000248$SUNOVION$$$$$$Y$$$20240808$$CN$US$US
241903281$24190328$1$I$$20240730$20240808$20240808$EXP$$CA-TEVA-VS-3227572$TEVA$$69$YR$$F$Y$$$20240808$$PH$CA$CA
241903291$24190329$1$I$20240401$20240711$20240808$20240808$PER$$US-SMPA-2024MYSCI0400899$SUNOVION$$$$$$Y$$$20240808$$CN$US$US
241903301$24190330$1$I$$20240729$20240808$20240808$PER$$US-SMPA-2024SPA000509$SUNOVION$$$$$$Y$$$20240808$$CN$US$US
241903311$24190331$1$I$20240807$20240807$20240807$20240807$DIR$713385$$FDA-CTU$$45$YR$$F$N$119.25$KG$20240807$N$CN$US$
241903321$24190332$1$I$20240720$20240807$20240807$20240807$DIR$713400$$FDA-CTU$$27$YR$$F$N$78.75$KG$20240807$N$HP$US$
241903331$24190333$1$I$20240805$20240805$20240808$20240808$DIR$FDA-CDER-CTU-2024-54573$$FDA-CTU$$94$YR$$F$N$$$20240805$N$HP$US$
241903341$24190334$1$I$20240628$20240807$20240807$20240807$DIR$713337$$FDA-CTU$$68$YR$$F$N$86.4$KG$20240807$Y$CN$US$
241903351$24190335$1$I$20240101$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156348$AMGEN$$41$YR$A$F$Y$$$20240808$$CN$US$US
241903361$24190336$1$I$20240805$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024156057$AMGEN$$$$$M$Y$$$20240808$$PH$US$US
241903381$24190338$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54579$$FDA-CTU$$62$YR$$F$N$$$20240808$N$$US$
241903401$24190340$1$I$$20240807$20240807$20240807$DIR$713330$$FDA-CTU$$$$$UNK$N$$$20240807$N$PH$US$
241903411$24190341$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54556$$FDA-CTU$$19$YR$$M$N$55.79$KG$20240808$N$$US$
241903421$24190342$1$I$20240717$20240807$20240807$20240807$DIR$713360$$FDA-CTU$$65$YR$$M$N$72.31$KG$20240807$N$HP$US$
241903441$24190344$1$I$20240718$20240807$20240807$20240807$DIR$713383$$FDA-CTU$$68$YR$$F$N$54$KG$20240807$N$CN$US$
241903451$24190345$1$I$20240802$20240807$20240807$20240807$DIR$713381$$FDA-CTU$$65$YR$$F$N$79.65$KG$20240807$N$CN$US$
241903511$24190351$1$I$$20240728$20240808$20240808$EXP$$US-Prasco Laboratories-PRAS20241068$PRASCO$Kesari S, Barron C, Cohen L, Regelmann M, Baer T. Dexamethasone swish and spit: A cause of iatrogenic adrenal insufficiency. Pediatric Blood + Cancer. 2024;71:E31138:1-2. doi:10.1002/pbc.31138$14$YR$T$M$Y$$$20240808$$HP$US$US
241903521$24190352$1$I$$20240806$20240808$20240808$EXP$$US-TAKEDA-2024TUS078791$TAKEDA$$$$$M$Y$$$20240808$$CN$US$US
241903531$24190353$1$I$$20240806$20240808$20240808$PER$$NVSC2024US160842$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241903541$24190354$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54561$$FDA-CTU$$57$YR$$F$N$$$20240808$N$$US$
241903562$24190356$2$F$20240101$20240814$20240808$20240819$EXP$$US-ORGANON-O2408USA000569$ORGANON$$$$$F$Y$56.69$KG$20240819$$CN$US$US
241903572$24190357$2$F$20240701$20240815$20240808$20240823$EXP$$US-BAYER-2024A112297$BAYER$$61$YR$A$M$Y$$$20240823$$CN$US$US
241903582$24190358$2$F$$20240917$20240808$20240926$EXP$$US-TAKEDA-2023TUS014236$TAKEDA$$$$$F$Y$$$20240926$$CN$US$US
241903592$24190359$2$F$20240101$20240809$20240808$20240815$PER$$US-AMGEN-USASP2024157154$AMGEN$$80$YR$E$F$Y$$$20240815$$CN$US$US
241903601$24190360$1$I$20240701$20240726$20240808$20240808$PER$$US-SA-2024SA223501$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240808$$MD$US$US
241903611$24190361$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA232090$SANOFI AVENTIS$$$$A$M$Y$110$KG$20240808$$MD$US$US
241903621$24190362$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA230751$SANOFI AVENTIS$$$$A$M$Y$131.54$KG$20240808$$MD$US$US
241903631$24190363$1$I$20230101$20240805$20240808$20240808$EXP$$HU-SA-2024SA230025$SANOFI AVENTIS$Kurgyis EH.. Special considerations in the management of mixed graft rejection.. Cardiologia Hungarica. Unk;Unk:C353$35$YR$A$M$Y$$$20240808$$HP$HU$HU
241903641$24190364$1$I$20240624$20240802$20240808$20240808$EXP$FR-AFSSAPS-RS2024000756$FR-SA-2024SA229746$SANOFI AVENTIS$$65$YR$E$F$Y$48$KG$20240808$$PH$FR$FR
241903651$24190365$1$I$$20240723$20240808$20240808$EXP$$US-Nostrum Laboratories, Inc.-2160182$NOSTRUM$$$$$M$Y$$$20240808$$$US$US
241903661$24190366$1$I$20240501$20240805$20240808$20240808$EXP$$US-ABBVIE-5868174$ABBVIE$$70$YR$$M$Y$$$20240808$$CN$US$US
241903671$24190367$1$I$20210214$20240805$20240808$20240808$EXP$FR-AFSSAPS-NC2024000931$FR-OTSUKA-2024_021611$OTSUKA$$$$N$M$Y$2.82$KG$20240808$$MD$FR$FR
241903691$24190369$1$I$$20231025$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2023AST000483$ASSERTIO THERAPEUTICS$$$$$F$Y$$$20240808$$PH$US$US
241903701$24190370$1$I$$20221206$20240808$20240808$EXP$$US-AstraZeneca-2022A400624$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241903712$24190371$2$F$20240101$20240823$20240808$20240830$EXP$$US-ABBVIE-5868321$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
241903721$24190372$1$I$20230624$20230628$20240808$20240808$EXP$$US-AstraZeneca-2023A149799$ASTRAZENECA$$30647$DY$$F$Y$$$20240808$$CN$US$
241903731$24190373$1$I$20240707$20240730$20240808$20240808$EXP$$ES-BAUSCH-BL-2024-012002$BAUSCH AND LOMB$$22$YR$$F$Y$44$KG$20240808$$CN$ES$ES
241903751$24190375$1$I$20240703$20240731$20240808$20240808$EXP$$JP-AstraZeneca-2024A179492$ASTRAZENECA$$60$YR$$M$Y$$$20240808$$PH$JP$
241903761$24190376$1$I$20240721$20240731$20240808$20240808$EXP$$CN-AstraZeneca-2024A176031$ASTRAZENECA$$3796$WK$$F$Y$56$KG$20240808$$MD$CN$
241903771$24190377$1$I$$20230425$20240808$20240808$EXP$$US-AstraZeneca-2023A096810$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241903781$24190378$1$I$$20240731$20240808$20240808$EXP$$ZA-AstraZeneca-2024A175453$ASTRAZENECA$$28124$DY$$F$Y$$$20240808$$CN$ZA$
241903791$24190379$1$I$$20240807$20240808$20240808$EXP$$US-TAKEDA-2024TUS079070$TAKEDA$$$$$M$Y$$$20240808$$CN$US$US
241903801$24190380$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA232178$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240808$$MD$US$US
241903811$24190381$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA230758$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240808$$MD$US$US
241903822$24190382$2$F$20240731$20240826$20240808$20240903$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-012143$JAZZ$$79$YR$$$Y$$$20240903$$MD$JP$JP
241903831$24190383$1$I$$20240805$20240808$20240808$EXP$$DE-FreseniusKabi-FK202412241$FRESENIUS KABI$$$$$F$Y$$$20240808$$CN$DE$DE
241903842$24190384$2$F$$20240903$20240808$20240913$EXP$$US-TEVA-VS-3228273$TEVA$Carranza Morales A, Blanco Jimenez JA, Madhavan A. A Painful Case of Asthma. Am-J-Respir-Crit-Care-Med 2024; 209.; Carranza Morales A, Blanco Jimenez JA, Madhavan A. A Painful Case of Asthma. Am-J-Respir-Crit-Care-Med 2024; 209.$43$YR$$F$Y$$$20240913$$HP$US$US
241903851$24190385$1$I$20231110$20240731$20240808$20240808$EXP$GB-MHRA-MED-202407311500587460-NJPSH$GB-TEVA-VS-3229501$TEVA$$41$YR$$F$Y$$$20240808$$CN$GB$GB
241903861$24190386$1$I$$20240801$20240808$20240808$PER$$US-AMGEN-USASP2024153747$AMGEN$$$$$F$Y$$$20240808$$MD$US$US
241903871$24190387$1$I$20240725$20240802$20240808$20240808$PER$$US-BAYER-2024A112188$BAYER$$$$$F$Y$$$20240808$$MD$US$US
241903882$24190388$2$F$20240701$20240815$20240808$20240827$EXP$$US-BIOGEN-2024BI01276220$BIOGEN$$42$YR$$F$Y$$$20240827$$CN$US$US
241903891$24190389$1$I$20230301$20240807$20240808$20240808$EXP$GB-MHRA-TPP20285240C8148605YC1722845879499$GB-SANDOZ INC.-SDZ2024GB071198$SANDOZ$$72$YR$$F$Y$80$KG$20240808$$MD$GB$GB
241903901$24190390$1$I$$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004869$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240808$$CN$US$US
241903912$24190391$2$F$$20240913$20240808$20240913$30DAY$$CL-PFIZER INC-PV202400102318$PFIZER$$4$YR$$M$Y$$$20240913$$CN$CL$CL
241903931$24190393$1$I$$20240730$20240808$20240808$EXP$$CA-TEVA-VS-3227575$TEVA$$61$YR$$M$Y$$$20240808$$CN$CA$CA
241903941$24190394$1$I$20240101$20240729$20240808$20240808$EXP$$US-ARDELYX-2024ARDX004313$ARDELYX$$$$$M$Y$$$20240808$$CN$US$US
241903952$24190395$2$F$20240418$20240825$20240808$20240829$EXP$$CN-PFIZER INC-PV202400056183$PFIZER$$45$YR$$M$Y$$$20240829$$CN$CN$CN
241903961$24190396$1$I$$20240808$20240808$20240808$EXP$$MA-PFIZER INC-PV202400103448$PFIZER$$$$$F$Y$$$20240808$$CN$MA$MA
241903973$24190397$3$F$20240701$20240806$20240808$20240819$PER$$US-ABBVIE-5867307$ABBVIE$$72$YR$$M$Y$$$20240819$$CN$US$US
241903981$24190398$1$I$$20240729$20240808$20240808$EXP$$JP-TAKEDA-2024TUS079069$TAKEDA$$53$YR$$M$Y$$$20240808$$MD$JP$JP
241903991$24190399$1$I$$20240802$20240808$20240808$30DAY$$US-GSK-US2024AMR097680$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241904003$24190400$3$F$$20240810$20240808$20240822$EXP$$NVSC2024US159380$NOVARTIS$$$$N$$Y$$$20240822$$CN$US$US
241904011$24190401$1$I$20231201$20240801$20240808$20240808$PER$$US-SA-2024SA232430$SANOFI AVENTIS$$67$YR$E$F$Y$106$KG$20240808$$MD$US$US
241904022$24190402$2$F$20240310$20240805$20240808$20240814$EXP$FR-AFSSAPS-AN2024000995$FR-TAKEDA-2024TUS077995$TAKEDA$$69$YR$$M$Y$50$KG$20240814$$HP$FR$FR
241904031$24190403$1$I$20240801$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156764$AMGEN$$74$YR$E$F$Y$$$20240808$$PH$US$US
241904041$24190404$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683490$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241904053$24190405$3$F$$20240918$20240808$20240919$PER$$US-JNJFOC-20240814069$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$HP$US$US
241904061$24190406$1$I$$20240725$20240808$20240808$EXP$$PL-INCYTE CORPORATION-2024IN008290$INCYTE$Richert-Przygonska M, Milewska M, Debski R, Cisek J, Czyzewski K.. Sclerodermatous manifestation of chronic graft-versus-host disease: therapy challenges. ACTA HAEMATOLOGICA POLONICA. 2023;54(5):308-12$$$$$Y$$$20240808$$HP$PL$PL
241904072$24190407$2$F$$20240802$20240808$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07158$LUPIN$$$$$$Y$$$20240828$$CN$US$US
241904093$24190409$3$F$$20240921$20240808$20240924$PER$$US-TAKEDA-2024TUS079306$TAKEDA$$$$$$Y$$$20240924$$CN$US$US
241904111$24190411$1$I$20240525$20240802$20240808$20240808$EXP$ES-AEMPS-1554544$ES-009507513-2408ESP001098$MERCK$$64$YR$$M$Y$$$20240808$$MD$ES$ES
241904121$24190412$1$I$20240601$20240807$20240808$20240808$PER$$US-TAKEDA-2024TUS079163$TAKEDA$$$$$F$Y$$$20240808$$CN$US$US
241904142$24190414$2$F$$20240727$20240808$20240814$EXP$$ID-BEH-2024176618$CSL BEHRING$$$$$$Y$$$20240814$$MD$ID$ID
241904151$24190415$1$I$$20240808$20240808$20240808$EXP$$BG-SANDOZ INC.-SDZ2024BG071335$SANDOZ$$64$YR$$F$Y$$$20240808$$HP$BG$BG
241904162$24190416$2$F$$20240809$20240808$20240813$30DAY$$US-SANDOZ INC.-SDZ2024US043611$SANDOZ$$$$$F$Y$$$20240813$$CN$US$US
241904171$24190417$1$I$20240731$20240807$20240808$20240808$PER$$US-ROCHE-10000051250$ROCHE$$34$YR$A$M$Y$$$20240808$$CN$US$US
241904181$24190418$1$I$$20240801$20240808$20240808$EXP$$US-AMGEN-USASP2024153890$AMGEN$$$$$$Y$$$20240808$$PH$US$US
241904191$24190419$1$I$$20240730$20240808$20240808$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005671$BIOCON$$$$$$Y$$$20240808$$HP$CA$CA
241904201$24190420$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A175221$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241904211$24190421$1$I$20240805$20240806$20240808$20240808$EXP$GB-MHRA-MED-202408061437381510-DCKQS$GB-SANDOZ INC.-SDZ2024GB071118$SANDOZ$$55$YR$$F$Y$60$KG$20240808$$CN$GB$GB
241904221$24190422$1$I$$20240807$20240808$20240808$PER$$US-HALEON-2191043$Haleon PLC$$$$$F$Y$$$20240808$$CN$US$US
241904231$24190423$1$I$$20240729$20240808$20240808$30DAY$$US-GSK-US2024094845$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241904241$24190424$1$I$20240705$20240730$20240808$20240808$EXP$RU-RZN-2487988$RU-VERTEX PHARMACEUTICALS-2024-012637$VERTEX$$2$YR$$F$Y$11.2$KG$20240808$$HP$RU$RU
241904251$24190425$1$I$$20240731$20240808$20240808$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012627$VERTEX$$$$A$M$Y$$$20240808$$CN$GB$GB
241904261$24190426$1$I$$20240801$20240808$20240808$EXP$$US-VERTEX PHARMACEUTICALS-2024-012733$VERTEX$$18$YR$$F$Y$$$20240808$$PH$US$US
241904273$24190427$3$F$20240701$20240828$20240808$20240905$EXP$$NO-VERTEX PHARMACEUTICALS-2024-012772$VERTEX$$5$YR$$F$Y$$$20240905$$MD$NO$NO
241904284$24190428$4$F$20240101$20240823$20240808$20240828$EXP$$US-VERTEX PHARMACEUTICALS-2024-012462$VERTEX$$$$$M$Y$$$20240828$$MD$US$US
241904292$24190429$2$F$$20240822$20240808$20240830$PER$$US-VERTEX PHARMACEUTICALS-2024-012644$VERTEX$$$$$$Y$$$20240830$$CN$US$US
241904301$24190430$1$I$20240101$20240805$20240808$20240808$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012212$VERTEX$$$$A$M$Y$$$20240808$$CN$GB$GB
241904311$24190431$1$I$$20240724$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00622$TARO$$$$$$Y$$$20240808$$CN$US$US
241904321$24190432$1$I$$20240516$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00645$TARO$$$$$F$Y$$$20240808$$CN$US$US
241904331$24190433$1$I$$20240506$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00592$TARO$$$$$F$Y$$$20240808$$CN$US$US
241904341$24190434$1$I$20240508$20240509$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00598$TARO$$$$$$Y$$$20240808$$CN$US$US
241904351$24190435$1$I$$20240524$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00663$TARO$$$$$$Y$$$20240808$$CN$US$US
241904361$24190436$1$I$$20240528$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00692$TARO$$$$$$Y$$$20240808$$CN$US$US
241904371$24190437$1$I$20240501$20240715$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00698$TARO$$$$$$Y$$$20240808$$CN$US$US
241904381$24190438$1$I$20240528$20240531$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00723$TARO$$$$$$Y$$$20240808$$CN$US$US
241904391$24190439$1$I$$20240703$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00725$TARO$$$$$$Y$$$20240808$$CN$US$US
241904401$24190440$1$I$$20240603$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00727$TARO$$$$$M$Y$$$20240808$$CN$US$US
241904411$24190441$1$I$20240101$20240710$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00729$TARO$$$$$$Y$$$20240808$$CN$US$US
241904421$24190442$1$I$$20240625$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00766$TARO$$$$$$Y$$$20240808$$CN$US$US
241904431$24190443$1$I$20240501$20240605$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00772$TARO$$$$$$Y$$$20240808$$CN$US$US
241904441$24190444$1$I$$20240729$20240808$20240808$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07592$LUPIN$$53$YR$$M$Y$$$20240808$$CN$AU$AU
241904451$24190445$1$I$20240101$20240805$20240808$20240808$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012825$VERTEX$$$$A$F$Y$$$20240808$$CN$GB$GB
241904461$24190446$1$I$20240101$20240805$20240808$20240808$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012802$VERTEX$$$$A$F$Y$$$20240808$$CN$GB$GB
241904471$24190447$1$I$$20240801$20240808$20240808$PER$$US-VERTEX PHARMACEUTICALS-2024-012713$VERTEX$$2$YR$$F$Y$$$20240808$$CN$US$US
241904481$24190448$1$I$$20240801$20240808$20240808$PER$$US-VERTEX PHARMACEUTICALS-2024-003062$VERTEX$$$$I$F$Y$$$20240808$$CN$US$US
241904491$24190449$1$I$20240724$20240802$20240808$20240808$PER$$US-VERTEX PHARMACEUTICALS-2024-012373$VERTEX$$34$YR$$M$Y$$$20240808$$CN$US$US
241904501$24190450$1$I$$20240801$20240808$20240808$PER$$US-VERTEX PHARMACEUTICALS-2024-012732$VERTEX$$21$YR$$F$Y$$$20240808$$HP$US$US
241904512$24190451$2$F$$20240812$20240808$20240816$PER$$US-VERTEX PHARMACEUTICALS-2024-012714$VERTEX$$2$YR$$M$Y$$$20240816$$CN$US$US
241904521$24190452$1$I$$20240805$20240808$20240808$PER$$US-VERTEX PHARMACEUTICALS-2024-012836$VERTEX$$$$$$Y$$$20240808$$PH$US$US
241904531$24190453$1$I$$20240802$20240808$20240808$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012781$VERTEX$$$$$M$Y$$$20240808$$CN$GB$GB
241904541$24190454$1$I$20240101$20240805$20240808$20240808$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012847$VERTEX$$$$$M$Y$$$20240808$$CN$GB$GB
241904552$24190455$2$F$$20240813$20240808$20240823$EXP$$US-TEVA-VS-3229896$TEVA$Liu Z, Oktaei H. A Rare Case of Necrotizing Myopathy after Statin Use. J-Endocr-Soc 2022; 6 (Suppl. 1) A237-A238 abstr. ODP136.; Liu Z, Oktaei H. A Rare Case of Necrotizing Myopathy after Statin Use. J-Endocr-Soc 2022; 6 (Suppl. 1) A237-A238 abstr. ODP136.$35$YR$$M$Y$$$20240823$$MD$US$US
241904561$24190456$1$I$20240215$20240805$20240808$20240808$EXP$SE-SEMPA-2024-005787$SE-TAKEDA-2024TUS078132$TAKEDA$$14$YR$$M$Y$98$KG$20240808$$HP$SE$SE
241904572$24190457$2$F$$20240813$20240808$20240823$EXP$$IE-TEVA-VS-3229778$TEVA$O^Brien S, Griffin B, Dorman AM. Interesting Biopsy of a Patient with AKI on a Background of Systemic Mastocytosis. J-Am-Soc-Nephrol 2023; 34 110-111.; O^Brien S, Griffin B, Dorman AM. Interesting Biopsy of a Patient with AKI on a Background of Systemic Mastocytosis. J-Am-Soc-Nephrol 2023; 34 110-111.$$$E$F$Y$$$20240823$$HP$IE$IE
241904581$24190458$1$I$$20240805$20240808$20240808$PER$$NVSC2024US160465$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241904592$24190459$2$F$$20240812$20240808$20240822$EXP$$IT-TEVA-VS-3229226$TEVA$Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al. Pickering Syndrome: An Overlooked Renovascular Cause of Recurrent Heart Failure. J-Am-Heart-Assoc 2023; 12 (19):.; Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al. Pickering Syndrome: An Overlooked Renovascular Cause of Recurrent Heart Failure. J-Am-Heart-Assoc 2023; 12 (19):.; Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al. Pickering Syndrome: An Overlooked Renovascular Caus...$79$YR$$M$Y$$$20240822$$MD$IT$IT
241904603$24190460$3$F$20240730$20240822$20240808$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023848$UNITED THERAPEUTICS$$70$YR$$F$Y$$$20240831$$$US$US
241904622$24190462$2$F$$20240908$20240808$20240909$30DAY$$US-PFIZER INC-202400224972$PFIZER$$48$YR$$M$Y$$$20240909$$CN$US$US
241904641$24190464$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54608$$FDA-CTU$$60$YR$$F$N$85.28$KG$20240808$N$$US$
241904651$24190465$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54611$$FDA-CTU$$79$YR$$F$N$64.41$KG$20240808$N$$US$
241904661$24190466$1$I$$20240806$20240808$20240808$PER$$NVSC2024US160880$NOVARTIS$$$$$M$Y$$$20240808$$HP$US$US
241904671$24190467$1$I$20240601$20240605$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00774$TARO$$$$$$Y$$$20240808$$CN$US$US
241904681$24190468$1$I$$20240612$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00809$TARO$$$$$$Y$$$20240808$$CN$US$US
241904691$24190469$1$I$$20240613$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00814$TARO$$$$$F$Y$$$20240808$$CN$US$US
241904701$24190470$1$I$$20240614$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00815$TARO$$16$YR$$M$Y$$$20240808$$CN$US$US
241904711$24190471$1$I$20240101$20240730$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00820$TARO$$$$$$Y$$$20240808$$CN$US$US
241904721$24190472$1$I$20240501$20240620$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00872$TARO$$$$$$Y$$$20240808$$CN$US$US
241904731$24190473$1$I$$20240621$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00875$TARO$$$$$$Y$$$20240808$$CN$US$US
241904741$24190474$1$I$20240501$20240624$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00898$TARO$$$$$$Y$$$20240808$$CN$US$US
241904751$24190475$1$I$$20240624$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00901$TARO$$$$$F$Y$$$20240808$$CN$US$US
241904761$24190476$1$I$20240601$20240628$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00937$TARO$$$$$$Y$$$20240808$$CN$US$US
241904771$24190477$1$I$$20240628$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00939$TARO$$$$$F$Y$$$20240808$$CN$US$US
241904781$24190478$1$I$$20240702$20240808$20240808$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00979$TARO$$$$$$Y$$$20240808$$CN$US$US
241904791$24190479$1$I$$20240807$20240808$20240808$PER$$US-AMGEN-USASP2024157402$AMGEN$$$$$F$Y$$$20240808$$CN$US$US
241904801$24190480$1$I$20240617$20240729$20240808$20240808$EXP$$US-VIIV HEALTHCARE LIMITED-US2024094822$VIIV$$25$YR$$F$Y$$$20240808$$PH$US$US
241904811$24190481$1$I$$20240802$20240808$20240808$EXP$$IE-JNJFOC-20240816243$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240808$$CN$IE$IE
241904821$24190482$1$I$$20240806$20240808$20240808$PER$$US-JNJFOC-20240814753$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241904831$24190483$1$I$20240601$20240729$20240808$20240808$EXP$$US-TEVA-VS-3228228$TEVA$$59$YR$$F$Y$$$20240808$$CN$US$US
241904842$24190484$2$F$20230213$20240818$20240808$20240823$EXP$$PL-009507513-2408POL001252$MERCK$Kurek K. Long-term response in an adenocarcinoma patient treated with chemoimmunotherapy with pembrolizumab. Oncology in Clinical Practice. 2024;10 (Supl C):C50-4$63$YR$$M$Y$80$KG$20240823$$MD$PL$PL
241904851$24190485$1$I$20240802$20240802$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002662$ELI LILLY AND CO$$44$YR$A$$Y$$$20240808$$CN$US$US
241904861$24190486$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003196$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240808$$CN$US$US
241904872$24190487$2$F$$20240801$20240808$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408002232$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240816$$CN$US$US
241904882$24190488$2$F$$20240905$20240808$20240913$EXP$$US-TEVA-VS-3228404$TEVA$Literature Reference: Khan S, Yetiskul E, Khattar G, Ghada A, Afif S, Khan MWZ, et al. FAILURE OF THE PD-1 BLOCKING AGENT PEMBROLIZUMAB TO BENEFIT A PATIENT WITH RENAL SQUAMOUS CELL CANCER. Eur-J-Case-Rep-Intern-Med 2024; 11 (7):.; Khan S, Yetiskul E, Khattar G, Ghada A, Afif S, Khan MWZ, et al. FAILURE OF THE PD-1 BLOCKING AGENT PEMBROLIZUMAB TO BENEFIT A PATIENT WITH RENAL SQUAMOUS CELL CANCER. Eur-J-Case-Rep-Intern-Med 2024; 11 (7):.$80$YR$$F$Y$$$20240913$$HP$US$US
241904891$24190489$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54565$$FDA-CTU$$61$YR$$M$N$$$20240808$N$$US$
241904901$24190490$1$I$$20240730$20240808$20240808$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005664$BIOCON$$$$$$Y$$$20240808$$HP$CA$CA
241904911$24190491$1$I$$20240728$20240808$20240808$EXP$$US-JNJFOC-20240804574$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240808$$HP$US$US
241904921$24190492$1$I$$20240802$20240808$20240808$EXP$$US-OTSUKA-2024_016216$OTSUKA$$$$$F$Y$$$20240808$$CN$US$US
241904931$24190493$1$I$$20240801$20240808$20240808$EXP$$NVSC2024CR159367$NOVARTIS$$$$$F$Y$$$20240808$$CN$CR$CR
241904951$24190495$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683491$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241904961$24190496$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54609$$FDA-CTU$$61$YR$$F$N$77.11$KG$20240808$N$$US$
241904971$24190497$1$I$20240515$20240729$20240808$20240808$EXP$$BR-Eisai-EC-2024-171252$EISAI$$80$YR$E$F$Y$75$KG$20240808$$CN$BR$BR
241904981$24190498$1$I$$20240726$20240808$20240808$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07698$LUPIN$Abdelal Q, Isern S, Najjar N. Azith and the myth. American Journal of Respiratory and Critical Care Medicine. 2024;209$73$YR$$F$Y$$$20240808$$HP$US$US
241904991$24190499$1$I$$20240807$20240808$20240808$PER$$US-HALEON-2191036$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241905003$24190500$3$F$$20240828$20240808$20240828$PER$$US-ALXN-202408USA000112US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241905011$24190501$1$I$$20240730$20240808$20240808$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005665$BIOCON$$$$$$Y$$$20240808$$HP$CA$CA
241905021$24190502$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54597$$FDA-CTU$$67$YR$$F$N$81.65$KG$20240808$N$$US$
241905032$24190503$2$F$$20240904$20240808$20240904$PER$$US-ALXN-202408USA000040US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
241905041$24190504$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54614$$FDA-CTU$$70$YR$$F$N$45.09$KG$20240808$N$$US$
241905052$24190505$2$F$20240801$20240820$20240808$20240827$PER$$US-BIOGEN-2024BI01276182$BIOGEN$$49$YR$$F$Y$$$20240827$$CN$US$US
241905061$24190506$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5868569$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241905071$24190507$1$I$20240501$20240611$20240808$20240808$PER$$US-JNJFOC-20240817736$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240808$$PH$US$US
241905081$24190508$1$I$$20240802$20240808$20240808$PER$$US-ABBVIE-5866304$ABBVIE$$$$$$Y$$$20240808$$MD$US$US
241905093$24190509$3$F$$20240904$20240808$20240916$30DAY$$CA-JNJFOC-20240779688$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$HP$CA$CA
241905101$24190510$1$I$20191120$20240807$20240808$20240808$EXP$$AT-SANDOZ INC.-SDZ2024AT071223$SANDOZ$$9$YR$$F$Y$30$KG$20240808$$CN$AT$AT
241905112$24190511$2$F$20210101$20240808$20240808$20240810$EXP$$US-ABBVIE-5868779$ABBVIE$$$$$M$Y$104$KG$20240810$$CN$US$US
241905121$24190512$1$I$$20240801$20240808$20240808$EXP$$US-GSK-US2024096301$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
241905131$24190513$1$I$$20240805$20240808$20240808$EXP$$GB-ABBVIE-5837175$ABBVIE$$$$E$F$Y$$$20240808$$CN$GB$GB
241905141$24190514$1$I$20240805$20240806$20240808$20240808$EXP$$US-ABBVIE-5870105$ABBVIE$$26$YR$$F$Y$$$20240808$$CN$US$US
241905152$24190515$2$F$20240330$20240916$20240808$20240916$EXP$$US-PROD-AS2-212756134-RB-086703-2024$RECKITT BENCKISER$$23$YR$$F$Y$$$20240916$$CN$US$US
241905161$24190516$1$I$20240101$20240730$20240808$20240808$EXP$$CA-ABBVIE-5869789$ABBVIE$$65$YR$$M$Y$$$20240808$$CN$CA$CA
241905171$24190517$1$I$20240207$20240730$20240808$20240808$EXP$FR-AFSSAPS-RE2024000769$FR-BAXTER-2024BAX022671$BAXTER$$53$YR$$F$Y$59$KG$20240808$$MD$FR$FR
241905181$24190518$1$I$$20240801$20240808$20240808$EXP$$US-GSK-US2024096252$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
241905191$24190519$1$I$20240501$20240611$20240808$20240808$PER$$US-JNJFOC-20240817186$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240808$$PH$US$US
241905201$24190520$1$I$20240707$20240730$20240808$20240808$EXP$CN-NMPACDR-4602001068793202400099$CN-BAXTER-2024BAX022569$BAXTER$$7$YR$$M$Y$26$KG$20240808$$MD$CN$CN
241905211$24190521$1$I$20240501$20240611$20240808$20240808$PER$$US-JNJFOC-20240817843$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240808$$PH$US$US
241905221$24190522$1$I$20240802$20240802$20240808$20240808$PER$$US-BAYER-2024A112615$BAYER$$$$$F$Y$$$20240808$$CN$US$US
241905231$24190523$1$I$$20240731$20240808$20240808$EXP$NL-LRB-00990664$NL-TEVA-VS-3228986$TEVA$$30$YR$$F$Y$$$20240808$$MD$NL$NL
241905241$24190524$1$I$20240422$20240729$20240808$20240808$EXP$$JP-ABBVIE-5867801$ABBVIE$$$$$$Y$$$20240806$$MD$JP$JP
241905251$24190525$1$I$20200501$20240730$20240808$20240808$EXP$$JP-ABBVIE-5873046$ABBVIE$$81$YR$$M$Y$$$20240808$$PH$JP$JP
241905261$24190526$1$I$20240628$20240805$20240808$20240808$PER$$US-KARYOPHARM-2024KPT001408$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240808$$CN$US$US
241905271$24190527$1$I$20240628$20240805$20240808$20240808$EXP$FR-AFSSAPS-RS2024000778$FR-FreseniusKabi-FK202412200$FRESENIUS KABI$$47$YR$A$F$Y$72$KG$20240808$$MD$FR$FR
241905281$24190528$1$I$20240702$20240805$20240808$20240808$EXP$FR-AFSSAPS-BX2024001511$FR-FreseniusKabi-FK202412159$FRESENIUS KABI$$51$YR$A$F$Y$105$KG$20240808$$PH$FR$FR
241905291$24190529$1$I$$20240802$20240808$20240808$EXP$$CA-SA-2024SA230931$SANOFI AVENTIS$$$$A$F$Y$$$20240808$$CN$CA$CA
241905311$24190531$1$I$$20240731$20240808$20240808$EXP$$GB-TEVA-VS-3228590$TEVA$$$$$M$Y$$$20240808$$CN$GB$GB
241905321$24190532$1$I$20240529$20240730$20240808$20240808$EXP$$CO-UCBSA-2024039602$UCB$$13$YR$$M$Y$$$20240808$$CN$CO$CO
241905331$24190533$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870014$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241905344$24190534$4$F$20150425$20240923$20240808$20240925$PER$$US-GILEAD-2024-0683516$GILEAD$$51$YR$A$M$Y$$$20240925$$LW$US$US
241905351$24190535$1$I$$20240802$20240808$20240808$PER$$US-ABBVIE-5867019$ABBVIE$$$$$$Y$$$20240808$$HP$US$US
241905362$24190536$2$F$20240730$20240731$20240808$20240812$EXP$$CN-JNJFOC-20240802313$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$CN$CN
241905371$24190537$1$I$$20240805$20240808$20240808$EXP$$VN-AstraZeneca-2024A178435$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$VN$
241905392$24190539$2$F$20240101$20240814$20240808$20240819$EXP$$CA-AstraZeneca-2024A172914$ASTRAZENECA$$640$MON$$F$Y$$$20240819$$CN$CA$
241905403$24190540$3$F$$20240904$20240808$20240911$EXP$$NVSC2024AU157551$NOVARTIS$$29$YR$$F$Y$$$20240911$$MD$AU$AU
241905411$24190541$1$I$20240213$20240808$20240808$20240808$EXP$$TH-BAYER-2024A089700$BAYER$$64$YR$A$M$Y$$$20240808$$CN$TH$TH
241905423$24190542$3$F$$20240922$20240808$20240924$EXP$$NVSC2024US161636$NOVARTIS$$$$A$$Y$$$20240924$$CN$US$US
241905431$24190543$1$I$$20240805$20240808$20240808$PER$$NVSC2024US160592$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241905441$24190544$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54615$$FDA-CTU$$75$YR$$M$N$$$20240808$N$$US$
241905451$24190545$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54616$$FDA-CTU$$4$YR$$M$N$$$20240808$N$$US$
241905462$24190546$2$F$$20240920$20240808$20240920$PER$$NVSC2024US156236$NOVARTIS$$$$$F$Y$$$20240920$$HP$US$US
241905491$24190549$1$I$$20240806$20240808$20240808$EXP$$US-KARYOPHARM-2024KPT001402$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240808$$CN$US$US
241905501$24190550$1$I$$20240801$20240808$20240808$EXP$$US-SA-2024SA230579$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240808$$HP$US$US
241905512$24190551$2$F$20240101$20240827$20240808$20240830$PER$$US-SA-2024SA232140$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240830$$MD$US$US
241905521$24190552$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA232115$SANOFI AVENTIS$$43$YR$A$F$Y$72.562$KG$20240808$$MD$US$US
241905531$24190553$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA231406$SANOFI AVENTIS$$$$T$F$Y$88.4$KG$20240808$$MD$US$US
241905541$24190554$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA230843$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240808$$MD$US$US
241905551$24190555$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA230671$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240808$$MD$US$US
241905561$24190556$1$I$20240101$20240801$20240808$20240808$PER$$US-SA-2024SA230180$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240808$$CN$US$US
241905571$24190557$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231608$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240808$$CN$US$US
241905581$24190558$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA231339$SANOFI AVENTIS$$30$YR$A$F$Y$77.11$KG$20240808$$MD$US$US
241905591$24190559$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231348$SANOFI AVENTIS$$$$A$F$Y$$$20240808$$MD$US$US
241905601$24190560$1$I$20240701$20240801$20240808$20240808$PER$$US-SA-2024SA229839$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240808$$MD$US$US
241905611$24190561$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231662$SANOFI AVENTIS$$$$$M$Y$$$20240808$$MD$US$US
241905622$24190562$2$F$$20240903$20240808$20240913$EXP$$US-TEVA-VS-3228156$TEVA$Cheng TW, Colakovic RN, Pearson DR, Sio TT, Fiessinger LA. Treatment of sclerotic chronic graft-versus-host disease with injections of hyaluronidase. JAAD-Case-Rep 2023; 38 55-58.; Cheng TW, Colakovic RN, Pearson DR, Sio TT, Fiessinger LA. Treatment of sclerotic chronic graft-versus-host disease with injections of hyaluronidase. JAAD-Case-Rep 2023; 38 55-58.; Cheng TW, Colakovic RN, Pearson DR, Sio TT, Fiessinger LA. Treatment of sclerotic chronic graft-versus-host disease with injections of ...$35$YR$$M$Y$$$20240913$$MD$US$US
241905631$24190563$1$I$$20240805$20240808$20240808$EXP$$US-JNJFOC-20240810248$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241905641$24190564$1$I$$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54612$$FDA-CTU$$$$$M$N$$$20240807$N$HP$US$
241905651$24190565$1$I$$20240802$20240808$20240808$PER$$US-GILEAD-2024-0682845$GILEAD$$$$$M$Y$$$20240808$$PH$US$US
241905661$24190566$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54546$$FDA-CTU$$71$YR$$F$N$$$20240808$N$$US$
241905671$24190567$1$I$$20240805$20240808$20240808$EXP$$NVSC2024VN161492$NOVARTIS$$66$YR$$F$Y$$$20240808$$MD$VN$VN
241905681$24190568$1$I$20240610$20240805$20240808$20240808$PER$$US-BAYER-2024A113306$BAYER$$78$YR$E$M$Y$$$20240808$$CN$US$US
241905691$24190569$1$I$$20240731$20240808$20240808$PER$$US-INCYTE CORPORATION-2024IN008024$INCYTE$$$$$$Y$$$20240808$$CN$US$US
241905702$24190570$2$F$$20240813$20240808$20240823$EXP$$PT-TEVA-VS-3229801$TEVA$Medeiros T, Sequeira S, Mendes M, Hierro F, Duarte S. PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA COMPLICATED BY CEREBRAL VENOUS SINUS THROMBOSIS: A CASE REPORT. Eur-J-Case-Rep-Intern-Med 2023; 10 (8): 1-5.; Medeiros T, Sequeira S, Mendes M, Hierro F, Duarte S. PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA COMPLICATED BY CEREBRAL VENOUS SINUS THROMBOSIS: A CASE REPORT. Eur-J-Case-Rep-Intern-Med 2023; 10 (8): 1-5.$64$YR$$F$Y$$$20240823$$HP$PT$PT
241905711$24190571$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54568$$FDA-CTU$$69$YR$$F$N$$$20240808$N$$US$
241905721$24190572$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54610$$FDA-CTU$$47$YR$$F$N$$$20240808$N$$US$
241905742$24190574$2$F$$20240806$20240808$20240813$EXP$$JP-PFIZER INC-202400230861$PFIZER$Marunaka, Y.. Dropped head syndrome suspected due to oxaliplatin used in adjuvant chemotherapy for gastric cancer: a case report. Surgical case reports. 2024;10(1):10.1186/s40792-024-01976-w$72$YR$$M$Y$60.7$KG$20240813$$MD$JP$JP
241905751$24190575$1$I$20240730$20240806$20240808$20240808$EXP$$SG-FreseniusKabi-FK202412177$FRESENIUS KABI$$69$YR$E$F$Y$$$20240808$$HP$SG$SG
241905762$24190576$2$F$20240101$20240729$20240808$20240809$PER$$JP-Eisai-EC-2024-171201$EISAI$$8$DEC$E$F$Y$$$20240809$$MD$JP$JP
241905772$24190577$2$F$$20240808$20240808$20240817$EXP$GB-MHRA-MED-202407301345582370-YRLZB$GB-TEVA-VS-3228372$TEVA$$$$$F$Y$$$20240817$$MD$GB$GB
241905781$24190578$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54582$$FDA-CTU$$52$YR$$F$N$99.79$KG$20240808$N$$US$
241905791$24190579$1$I$20240703$20240801$20240808$20240808$EXP$$CN-GSK-CN2024GSK097841$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$HP$CN$CN
241905801$24190580$1$I$$20240807$20240808$20240808$PER$$US-AMGEN-USASP2024157120$AMGEN$$$$A$F$Y$120$KG$20240808$$PH$US$US
241905812$24190581$2$F$20240806$20240808$20240808$20240809$PER$$US-AMGEN-USASP2024157430$AMGEN$$74$YR$E$F$Y$$$20240809$$CN$US$US
241905841$24190584$1$I$20160923$20160923$20240808$20240808$EXP$$NVSC2016LK016552$NOVARTIS$$$$$$Y$$$20240808$$MD$LK$LK
241905851$24190585$1$I$20240727$20240801$20240808$20240808$PER$$US-ALXN-202408USA000028US$ALEXION PHARMACEUTICALS$$70$YR$$F$Y$$$20240808$$CN$US$US
241905862$24190586$2$F$20240803$20240809$20240808$20240815$EXP$$CO-TAKEDA-2024TUS078784$TAKEDA$$83$YR$$F$Y$52$KG$20240815$$HP$CO$CO
241905871$24190587$1$I$20240713$20240731$20240808$20240808$EXP$IT-MINISAL02-996108$IT-TEVA-VS-3228657$TEVA$$71$YR$$F$Y$$$20240808$$PH$IT$IT
241905881$24190588$1$I$20230715$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54598$$FDA-CTU$$44$YR$$F$N$$$20240808$N$PH$US$
241905891$24190589$1$I$20240805$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54623$$FDA-CTU$$67$YR$$M$N$$$20240808$Y$PH$US$
241905901$24190590$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54625$$FDA-CTU$$35$YR$$F$N$59.87$KG$20240808$N$$US$
241905911$24190591$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54613$$FDA-CTU$$4$YR$$M$N$$$20240808$N$$US$
241905931$24190593$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54562$$FDA-CTU$$82$YR$$M$N$$$20240808$N$$US$
241905941$24190594$1$I$20240603$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54626$$FDA-CTU$$62$YR$$F$N$$$20240808$N$$US$
241905951$24190595$1$I$$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54570$$FDA-CTU$$$$$F$N$$$20240807$N$HP$US$
241905961$24190596$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54585$$FDA-CTU$$70$YR$$M$N$$$20240808$N$$US$
241905971$24190597$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54627$$FDA-CTU$$69$YR$$F$N$$$20240808$N$$US$
241905991$24190599$1$I$20240731$20240807$20240808$20240808$PER$$US-BAYER-2024A114284$BAYER$$30$YR$A$F$Y$$$20240808$$MD$US$US
241906001$24190600$1$I$$20240801$20240808$20240808$EXP$$US-GSK-US2024096998$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
241906011$24190601$1$I$20240401$20240802$20240808$20240808$EXP$$US-GSK-US2024096971$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
241906021$24190602$1$I$$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54532$$FDA-CTU$$$$$M$N$$$20240807$N$HP$US$
241906031$24190603$1$I$$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54552$$FDA-CTU$$$$$F$N$$$20240807$N$HP$US$
241906041$24190604$1$I$20240101$20240805$20240808$20240808$PER$$US-ABBVIE-5867783$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241906053$24190605$3$F$20240115$20240827$20240808$20240905$EXP$$CO-MYLANLABS-2024M1073348$MYLAN$$3$YR$$F$Y$7$KG$20240905$$CN$CO$CO
241906061$24190606$1$I$20240806$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156341$AMGEN$$63$YR$A$M$Y$$$20240808$$CN$US$US
241906071$24190607$1$I$$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54559$$FDA-CTU$$$$$M$N$$$20240807$N$HP$US$
241906081$24190608$1$I$$20240808$20240808$20240808$DIR$713412$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241906092$24190609$2$F$$20240816$20240808$20240822$EXP$$US-AMGEN-USASP2024155365$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
241906102$24190610$2$F$20240801$20240808$20240808$20240813$PER$$US-FreseniusKabi-FK202412189$FRESENIUS KABI$$25$YR$A$F$Y$66.68$KG$20240813$$CN$US$US
241906111$24190611$1$I$$20240807$20240808$20240808$EXP$$US-ABBVIE-5871437$ABBVIE$$$$$M$Y$$$20240808$$HP$US$US
241906122$24190612$2$F$20240130$20240807$20240808$20240814$EXP$$US-GSK-US2024096250$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$US$US
241906141$24190614$1$I$$20240729$20240808$20240808$EXP$$CA-TEVA-VS-3229564$TEVA$$57$YR$$F$Y$$$20240808$$CN$CA$CA
241906151$24190615$1$I$$20240731$20240808$20240808$EXP$NL-LRB-00990264$NL-TEVA-VS-3229363$TEVA$$71$YR$$F$Y$82$KG$20240808$$CN$NL$NL
241906161$24190616$1$I$20220101$20240805$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043931$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240808$$CN$US$US
241906171$24190617$1$I$$20240807$20240808$20240808$PER$$US-HALEON-2191023$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241906181$24190618$1$I$20240101$20240724$20240808$20240808$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0885$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240808$$CN$US$US
241906191$24190619$1$I$$20240725$20240808$20240808$EXP$$CA-MYLANLABS-2024M1071906$MYLAN$$72$YR$$M$Y$$$20240808$$CN$CA$CA
241906201$24190620$1$I$20240710$20240724$20240808$20240808$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0864$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240808$$HP$US$US
241906211$24190621$1$I$20240208$20240802$20240808$20240808$PER$$US-ALXN-202408USA000184US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
241906222$24190622$2$F$20240801$20240814$20240808$20240819$30DAY$$US-SANDOZ INC.-SDZ2024US071291$SANDOZ$$55$YR$$M$Y$$$20240819$$CN$US$US
241906231$24190623$1$I$20240704$20240730$20240808$20240808$EXP$FR-AFSSAPS-LL2024001386$FR-TEVA-VS-3227957$TEVA$$46$YR$$F$Y$63$KG$20240808$$MD$FR$FR
241906243$24190624$3$F$$20240917$20240808$20240924$EXP$$US-GSK-US2024096248$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$US$US
241906251$24190625$1$I$20240805$20240805$20240808$20240808$EXP$$NVSC2024DE160728$NOVARTIS$$$$A$F$Y$71$KG$20240808$$MD$DE$DE
241906261$24190626$1$I$20230201$20240801$20240808$20240808$EXP$$CA-GSK-CA2023133175$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$CA$CA
241906271$24190627$1$I$$20240801$20240808$20240808$EXP$$BG-009507513-2408BGR000675$MERCK$$$$$M$Y$$$20240808$$CN$BG$BG
241906281$24190628$1$I$20240801$20240801$20240808$20240808$EXP$$US-GSK-US2024AMR097821$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$MD$US$US
241906301$24190630$1$I$20240807$20240808$20240808$20240808$DIR$713403$$FDA-CTU$$24$YR$$F$N$51.75$KG$20240808$N$CN$US$
241906311$24190631$1$I$20240410$20240808$20240808$20240808$DIR$713411$$FDA-CTU$$47$YR$$M$N$60$KG$20240808$N$PH$US$
241906321$24190632$1$I$$20240808$20240808$20240808$DIR$713413$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241906331$24190633$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54584$$FDA-CTU$$50$YR$$F$N$$$20240808$N$$US$
241906351$24190635$1$I$$20240808$20240808$20240808$DIR$713416$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241906361$24190636$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54622$$FDA-CTU$$54$YR$$F$N$63.5$KG$20240808$N$$US$
241906371$24190637$1$I$$20240808$20240808$20240808$DIR$713419$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241906381$24190638$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54549$$FDA-CTU$$55$YR$$M$N$$$20240808$N$$US$
241906391$24190639$1$I$$20240808$20240808$20240808$DIR$713415$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241906401$24190640$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54578$$FDA-CTU$$46$YR$$F$N$79.38$KG$20240808$N$$US$
241906411$24190641$1$I$$20240808$20240808$20240808$DIR$713414$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241906441$24190644$1$I$20240731$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683445$GILEAD$$63$YR$A$M$Y$$$20240808$$CN$US$US
241906451$24190645$1$I$$20240802$20240808$20240808$EXP$$US-JNJFOC-20240778725$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241906461$24190646$1$I$20240613$20240806$20240808$20240808$EXP$$US-JNJFOC-20240816600$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240808$$HP$US$US
241906471$24190647$1$I$20240605$20240807$20240808$20240808$EXP$PT-INFARMED-F202408-6$PT-ASTELLAS-2024EU007831$ASTELLAS$$71$YR$$M$Y$$$20240808$$CN$PT$PT
241906481$24190648$1$I$20210101$20240729$20240808$20240808$EXP$DE-AMK-278399$DE-SA-2024SA226540$SANOFI AVENTIS$$65$YR$E$M$Y$96$KG$20240808$$PH$DE$DE
241906491$24190649$1$I$20220101$20240802$20240808$20240808$EXP$FI-FIMEA-202402589$FI-MYLANLABS-2024M1072419$MYLAN$$39$YR$$M$Y$$$20240808$$CN$FI$FI
241906502$24190650$2$F$20220401$20240902$20240808$20240906$EXP$$PT-MYLANLABS-2024M1072422$MYLAN$Henriques C, Melo J, Vasconcelos S, Ramos R, Costa MM.. Respiratory infections: when looks can be deceiving.. Congresses of the Portuguese Society of Internal Medicine: 30th National Congres. 2024;905-905$60$YR$$F$Y$$$20240906$$HP$PT$PT
241906511$24190651$1$I$20240101$20240802$20240808$20240808$EXP$SE-SEMPA-2024-005601$SE-MYLANLABS-2024M1072788$MYLAN$$70$YR$$F$Y$$$20240808$$MD$SE$SE
241906521$24190652$1$I$20240709$20240802$20240808$20240808$EXP$FR-AFSSAPS-MP2024001210$FR-MYLANLABS-2024M1072478$MYLAN$$88$YR$$F$Y$$$20240808$$MD$FR$FR
241906531$24190653$1$I$20240808$20240808$20240808$20240808$DIR$713426$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241906541$24190654$1$I$20240708$20240808$20240808$20240808$DIR$713420$$FDA-CTU$$58$YR$$F$N$69.75$KG$20240808$N$CN$US$
241906551$24190655$1$I$20240708$20240808$20240808$20240808$DIR$713422$$FDA-CTU$$81$YR$$F$N$95$KG$20240808$N$PH$US$
241906561$24190656$1$I$$20240802$20240808$20240808$EXP$$GR-MYLANLABS-2024M1072433$MYLAN$Not reported. DIABETIC KETOACIDOSIS DUE TO TYPE 3C DIABETES AS THE INITIAL MANIFESTATION OF PANCREATIC HEAD ADENOCARCINOMA IN A PATIENT WITH PSYCHOSIS. 50th ANNUAL PANHELLENIC MEDICAL CONGRESS. 2024;25-27$61$YR$$F$Y$$$20240808$$MD$GR$GR
241906571$24190657$1$I$20171001$20240802$20240808$20240808$EXP$ES-AEMPS-1550112$ES-MYLANLABS-2024M1072401$MYLAN$$74$YR$$F$Y$65$KG$20240808$$CN$ES$ES
241906583$24190658$3$F$$20240906$20240808$20240913$EXP$$PT-MYLANLABS-2024M1072436$MYLAN$Lopes T, Antas J, Melo B, Gon?alves F, Cruz C. Organizing pneumonia due to human metapneumovirus in a lung transplant recipient. Congresses of the Portuguese Society of Internal Medicine: 30th National Congres. 2024;331$25$YR$$M$Y$$$20240913$$HP$PT$PT
241906601$24190660$1$I$$20240808$20240808$20240808$DIR$713428$$FDA-CTU$$$$$F$N$$$20240808$Y$PH$US$
241906611$24190661$1$I$$20240801$20240808$20240808$PER$$US-ABBVIE-5865165$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241906631$24190663$1$I$20200101$20240730$20240808$20240808$EXP$FR-AFSSAPS-AN2024000957$FR-Eisai-EC-2024-171131$EISAI$$62$YR$A$M$Y$$$20240808$$MD$FR$FR
241906641$24190664$1$I$$20240729$20240808$20240808$EXP$$VN-ROCHE-10000048592$ROCHE$Hang V, Hao H, Tien D. Effectiveness of carboplatin/paclitaxel regimen with or without bevacizumab in the treatment of advanced stage ovarian epithelial cancer. Vietnam Medical Journal. 2024-Mar;536:$$$$$Y$$$20240808$$HP$VN$VN
241906661$24190666$1$I$$20240808$20240808$20240808$DIR$713433$$FDA-CTU$$$$$F$N$$$20240808$Y$HP$US$
241906671$24190667$1$I$20240703$20240805$20240808$20240808$EXP$FR-AFSSAPS-LL2024001513$FR-PFIZER INC-202400229887$PFIZER$$69$YR$$F$Y$73$KG$20240808$$MD$FR$FR
241906681$24190668$1$I$$20240807$20240808$20240808$EXP$$AR-PFIZER INC-202400232131$PFIZER$$79$YR$$M$Y$$$20240808$$CN$AR$AR
241906691$24190669$1$I$20240101$20240806$20240808$20240808$EXP$$CA-PFIZER INC-202400232476$PFIZER$$21$YR$$F$Y$$$20240808$$PH$CA$CA
241906701$24190670$1$I$$20240729$20240808$20240808$DIR$FDA-CDER-CTU-2024-54599$$FDA-CTU$$$$$M$N$$$20240729$N$HP$US$
241906714$24190671$4$F$$20240826$20240808$20240904$EXP$$AT-AMGEN-AUTSP2024154608$AMGEN$$66$YR$E$F$Y$$$20240904$$MD$AT$AT
241906722$24190672$2$F$20240101$20240927$20240808$20240927$EXP$$CA-PFIZER INC-202300170360$PFIZER$$69$YR$$F$Y$$$20240927$$HP$CA$CA
241906731$24190673$1$I$20240221$20240805$20240808$20240808$EXP$$IN-PFIZER INC-PV202400025590$PFIZER$$56$YR$$F$Y$$$20240808$$CN$IN$IN
241906741$24190674$1$I$20240712$20240806$20240808$20240808$EXP$GB-MHRA-MED-202408061930558780-YCLPJ$GB-PFIZER INC-202400231353$PFIZER$$72$YR$$F$Y$76$KG$20240808$$CN$GB$GB
241906751$24190675$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA232205$SANOFI AVENTIS$$7$YR$C$M$Y$22.222$KG$20240808$$MD$US$US
241906761$24190676$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125391$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$CN$US$US
241906771$24190677$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124860$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240808$$CN$US$US
241906791$24190679$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124500$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240808$$HP$US$US
241906801$24190680$1$I$20240101$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125594$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240808$$HP$US$US
241906811$24190681$1$I$$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123957$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240808$$HP$US$US
241906821$24190682$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125755$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240808$$CN$US$US
241906831$24190683$1$I$$20240731$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122049$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240808$$CN$US$US
241906841$24190684$1$I$20240730$20240805$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124923$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240808$$CN$US$US
241906851$24190685$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124240$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240808$$CN$US$US
241906861$24190686$1$I$20240807$20240807$20240808$20240808$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-125378$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$83.46$KG$20240808$$CN$PR$PR
241906871$24190687$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124403$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240808$$CN$US$US
241906881$24190688$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125202$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$CN$US$US
241906892$24190689$2$F$$20240903$20240808$20240911$EXP$$JP-AstraZeneca-2024A161654$ASTRAZENECA$$88$YR$$M$Y$$$20240911$$PH$JP$
241906901$24190690$1$I$$20240731$20240808$20240808$EXP$$NL-AstraZeneca-2024A178748$ASTRAZENECA$$68$YR$$M$Y$91.2$KG$20240808$$MD$NL$
241906911$24190691$1$I$20240731$20240805$20240808$20240808$EXP$$ZA-AstraZeneca-2024A180101$ASTRAZENECA$$89$YR$$F$Y$$$20240808$$CN$ZA$
241906921$24190692$1$I$$20240731$20240808$20240808$EXP$$ZA-AstraZeneca-2024A174524$ASTRAZENECA$$24837$DY$$F$Y$$$20240808$$CN$ZA$
241906931$24190693$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A175121$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241906941$24190694$1$I$20231127$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A093260$ASTRAZENECA$$70$YR$$M$Y$$$20240808$$HP$US$
241906951$24190695$1$I$$20240806$20240808$20240808$EXP$$NVSC2024CA122124$NOVARTIS$$79$YR$$F$Y$$$20240808$$CN$CA$CA
241906961$24190696$1$I$$20240123$20240808$20240808$EXP$$NVSC2023TH249323$NOVARTIS$$$$$F$Y$$$20240808$$CN$TH$TH
241906972$24190697$2$F$$20240816$20240808$20240824$EXP$$US-AstraZeneca-2024A179502$ASTRAZENECA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure.. Journal of Neonatal-Perinatal Medicine 2024;1-6.$38$WK$$F$Y$$$20240823$$MD$US$
241906983$24190698$3$F$$20240830$20240808$20240903$PER$$US-Taiho Oncology Inc-2024-007521$TAIHO ONCOLOGY INC$$$$$$Y$$$20240903$$CN$US$US
241906991$24190699$1$I$20240719$20240801$20240808$20240808$EXP$$CN-GSK-CN2024APC090354$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$CN$CN
241907001$24190700$1$I$$20240805$20240808$20240808$EXP$$SE-ABBVIE-5870569$ABBVIE$$$$$M$Y$$$20240808$$HP$SE$SE
241907011$24190701$1$I$20240701$20240730$20240808$20240808$PER$$US-SA-2024SA231254$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240808$$MD$US$US
241907021$24190702$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA232106$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240808$$MD$US$US
241907041$24190704$1$I$$20240725$20240808$20240808$PER$$US-009507513-2407USA015013$MERCK$$72$YR$$F$Y$$$20240808$$CN$US$US
241907051$24190705$1$I$20240701$20240730$20240808$20240808$PER$$US-SA-2024SA232361$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240808$$MD$US$US
241907063$24190706$3$F$$20240815$20240808$20240819$PER$$US-GILEAD-2024-0682936$GILEAD$$$$$F$Y$$$20240819$$CN$US$US
241907071$24190707$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161429$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241907081$24190708$1$I$$20240806$20240808$20240808$30DAY$$CO-PFIZER INC-PV202400098585$PFIZER$$$$$F$Y$$$20240808$$CN$CO$CO
241907091$24190709$1$I$20240721$20240731$20240808$20240808$EXP$$CN-AstraZeneca-2024A177335$ASTRAZENECA$$28047$DY$$F$Y$$$20240808$$MD$CN$
241907101$24190710$1$I$$20240802$20240808$20240808$EXP$$DE-MYLANLABS-2024M1072578$MYLAN$$$$A$F$Y$95$KG$20240808$$MD$DE$DE
241907111$24190711$1$I$20230714$20240802$20240808$20240808$EXP$$US-MYLANLABS-2024M1073342$MYLAN$$21$YR$$F$Y$$$20240808$$MD$US$US
241907121$24190712$1$I$20180527$20240802$20240808$20240808$EXP$FR-AFSSAPS-PC2024000602$FR-MYLANLABS-2024M1072643$MYLAN$$93$YR$$F$Y$44$KG$20240808$$PH$FR$FR
241907131$24190713$1$I$$20240802$20240808$20240808$EXP$$PL-MYLANLABS-2024M1072846$MYLAN$Kolczynska N, Masajtis-Zagajewska A, Jagodzinska M, Nowicki M.. Bilateral renal arteries stenosis in a patient with treatment-resistant hypertension and acute kidney injury. POL NEPHROL DIAL. 2024;28 (2):27-28$49$YR$$M$Y$$$20240808$$HP$PL$PL
241907142$24190714$2$F$20240217$20240805$20240808$20240812$EXP$$DE-AstraZeneca-2024A042524$ASTRAZENECA$$85$YR$$F$Y$53.4$KG$20240812$$MD$DE$
241907151$24190715$1$I$20240601$20240807$20240808$20240808$EXP$$GB-AstraZeneca-2024A179188$ASTRAZENECA$$73$YR$$M$Y$77$KG$20240808$$MD$GB$
241907161$24190716$1$I$$20240731$20240808$20240808$EXP$$CN-AstraZeneca-2024A161117$ASTRAZENECA$$55$YR$$M$Y$$$20240808$$CN$CN$
241907171$24190717$1$I$20240701$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123295$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240808$$HP$US$US
241907181$24190718$1$I$$20240801$20240808$20240808$EXP$$CA-GSK-CA2024096309$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$CA$CA
241907203$24190720$3$F$$20240908$20240808$20240909$30DAY$$US-PFIZER INC-PV202400099659$PFIZER$$11$YR$$M$Y$$$20240909$$CN$US$US
241907214$24190721$4$F$20240802$20240819$20240808$20240821$30DAY$$CO-PFIZER INC-PV202400102262$PFIZER$$13$YR$$M$Y$44$KG$20240821$$CN$CO$CO
241907221$24190722$1$I$20240726$20240803$20240808$20240808$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000729$PAREXEL$$$$$$Y$$$20240808$$HP$CN$CN
241907231$24190723$1$I$20240704$20240731$20240808$20240808$EXP$FR-AFSSAPS-PC2024000579$FR-TEVA-VS-3228966$TEVA$$16$YR$$M$Y$60$KG$20240808$$MD$FR$FR
241907241$24190724$1$I$$20240729$20240808$20240808$EXP$$BG-AMGEN-BGRSP2024150837$AMGEN$Chilingirova N.; Samardzieva M.; Petrusheva V. et al.. CARDIO-ONCOLOGY IN REAL PRACTICE: FACTS AND CHALLENGES IN THE TREATMENT OF METASTATIC LUNG CANCER. Cardio-oncology in real practice.. 2024;7 (1):3-20$74$YR$E$M$Y$$$20240808$$MD$BG$BG
241907251$24190725$1$I$$20240805$20240808$20240808$PER$$US-FreseniusKabi-FK202412218$FRESENIUS KABI$$$$$$Y$$$20240808$$HP$US$US
241907261$24190726$1$I$$20240801$20240808$20240808$EXP$$US-SA-2024SA233853$SANOFI AVENTIS$$92$YR$E$M$Y$81.6$KG$20240808$$MD$US$US
241907301$24190730$1$I$20240726$20240808$20240808$20240808$DIR$713452$$FDA-CTU$$77$YR$$F$N$90$KG$20240808$N$CN$US$
241907312$24190731$2$F$20240713$20240912$20240808$20240913$PER$$US-AMGEN-USASP2024157486$AMGEN$$88$YR$E$M$Y$$$20240913$$CN$US$US
241907322$24190732$2$F$20240726$20240807$20240808$20240812$30DAY$$US-AMGEN-USASP2024149636$AMGEN$$55$YR$A$M$Y$$$20240812$$CN$US$US
241907331$24190733$1$I$$20240807$20240808$20240808$PER$$US-HALEON-2191000$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241907342$24190734$2$F$20240725$20240731$20240808$20240813$PER$$US-BIOMARINAP-US-2024-159624$BIOMARIN$$$$$$Y$$$20240813$$CN$US$US
241907351$24190735$1$I$$20240808$20240808$20240808$PER$$US-HALEON-2191030$Haleon PLC$$$$$$Y$$$20240808$$CN$US$US
241907361$24190736$1$I$20201106$20240731$20240808$20240808$EXP$$KR-DSJP-DSJ-2024-139240$DAIICHI$$70$YR$$F$Y$$$20240808$$MD$KR$KR
241907371$24190737$1$I$20210507$20240731$20240808$20240808$EXP$$KR-DSJP-DSJ-2024-138964$DAIICHI$$61$YR$$M$Y$$$20240808$$MD$KR$KR
241907381$24190738$1$I$20211004$20240731$20240808$20240808$EXP$$KR-DSJP-DSJ-2024-139262AA$DAIICHI$$75$YR$$M$Y$$$20240808$$MD$KR$KR
241907391$24190739$1$I$20210918$20240731$20240808$20240808$EXP$$KR-DSJP-DSJ-2024-139062$DAIICHI$$61$YR$$M$Y$$$20240808$$MD$KR$KR
241907401$24190740$1$I$20210731$20240731$20240808$20240808$EXP$$KR-DSJP-DSJ-2024-139272$DAIICHI$$76$YR$$M$Y$$$20240808$$MD$KR$KR
241907411$24190741$1$I$20210309$20240731$20240808$20240808$EXP$$KR-DSJP-DSJ-2024-139389$DAIICHI$$72$YR$$M$Y$$$20240808$$MD$KR$KR
241907421$24190742$1$I$$20240731$20240808$20240808$EXP$$BE-TEVA-VS-3229371$TEVA$$54$YR$$F$Y$$$20240808$$MD$BE$BE
241907431$24190743$1$I$20240714$20240805$20240808$20240808$EXP$FR-AFSSAPS-AN2024000977$FR-009507513-2408FRA001442$MERCK$$69$YR$$M$Y$150$KG$20240808$$MD$FR$FR
241907441$24190744$1$I$20240420$20240731$20240808$20240808$EXP$FR-AFSSAPS-PO2024000809$FR-TEVA-VS-3229253$TEVA$$53$YR$$M$Y$$$20240808$$MD$FR$FR
241907453$24190745$3$F$$20240916$20240808$20240917$PER$$US-PFIZER INC-PV202400102531$PFIZER$$74$YR$$M$Y$$$20240917$$HP$US$US
241907472$24190747$2$F$$20240808$20240808$20240809$PER$$US-PFIZER INC-PV202400102281$PFIZER$$17$YR$$M$Y$$$20240809$$HP$US$US
241907481$24190748$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400232057$PFIZER$$69$YR$$F$Y$$$20240808$$HP$US$US
241907501$24190750$1$I$$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232322$PFIZER$$39$YR$$M$Y$$$20240808$$CN$US$US
241907511$24190751$1$I$20240701$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232215$PFIZER$$$$$F$Y$$$20240808$$PH$US$US
241907521$24190752$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-PV202400102045$PFIZER$$62$YR$$F$Y$$$20240808$$CN$US$US
241907531$24190753$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231226$PFIZER$$56$YR$$F$Y$$$20240808$$CN$US$US
241907561$24190756$1$I$$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232241$PFIZER$$$$A$F$Y$$$20240808$$MD$US$US
241907571$24190757$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231700$PFIZER$$$$$$Y$$$20240808$$MD$US$US
241907581$24190758$1$I$20211001$20240806$20240808$20240808$EXP$$CA-PFIZER INC-202400232331$PFIZER$$56$YR$$M$Y$$$20240808$$MD$CA$CA
241907594$24190759$4$F$20240805$20240829$20240808$20240904$EXP$$US-PFIZER INC-202400231352$PFIZER$$82$YR$$M$Y$62.6$KG$20240904$$HP$US$US
241907601$24190760$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54553$$FDA-CTU$$60$YR$$F$N$60.33$KG$20240808$N$$US$
241907611$24190761$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54594$$FDA-CTU$$65$YR$$F$N$$$20240808$N$$US$
241907621$24190762$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54620$$FDA-CTU$$72$YR$$F$N$$$20240808$N$$US$
241907631$24190763$1$I$20240712$20240802$20240808$20240808$EXP$$CN-PFIZER INC-PV202400101223$PFIZER$$52$YR$$F$Y$56$KG$20240808$$HP$CN$CN
241907641$24190764$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231229$PFIZER$$77$YR$$F$Y$$$20240808$$CN$US$US
241907651$24190765$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54596$$FDA-CTU$$55$YR$$F$N$$$20240808$N$$US$
241907661$24190766$1$I$$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232313$PFIZER$$$$$F$Y$$$20240808$$MD$US$US
241907671$24190767$1$I$$20240807$20240808$20240808$PER$$US-PFIZER INC-PV202400102908$PFIZER$$$$$M$Y$102$KG$20240808$$CN$US$US
241907691$24190769$1$I$20231101$20231116$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2023AST000684$ASSERTIO THERAPEUTICS$$30$YR$$M$Y$$$20240808$$CN$US$US
241907701$24190770$1$I$$20240307$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2024AST000072$ASSERTIO THERAPEUTICS$$$$$F$Y$$$20240808$$CN$US$US
241907711$24190771$1$I$$20240303$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2024AST000069$ASSERTIO THERAPEUTICS$$$$$$Y$$$20240808$$CN$US$US
241907721$24190772$1$I$$20231206$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2023AST000709$ASSERTIO THERAPEUTICS$$$$$F$Y$$$20240808$$HP$US$US
241907731$24190773$1$I$$20231109$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2023AST000488$ASSERTIO THERAPEUTICS$$$$$F$Y$$$20240808$$HP$US$US
241907741$24190774$1$I$$20231001$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2023AST000474$ASSERTIO THERAPEUTICS$$$$$$Y$$$20240808$$CN$US$US
241907751$24190775$1$I$$20231220$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2023AST000712$ASSERTIO THERAPEUTICS$$$$$F$Y$$$20240808$$HP$US$US
241907761$24190776$1$I$$20240427$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2024AST000075$ASSERTIO THERAPEUTICS$$$$$$Y$$$20240808$$CN$US$US
241907771$24190777$1$I$$20240118$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2024AST000036$ASSERTIO THERAPEUTICS$$$$$M$Y$$$20240808$$HP$US$US
241907781$24190778$1$I$$20240402$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2024AST000080$ASSERTIO THERAPEUTICS$$$$$F$Y$$$20240808$$CN$US$US
241907791$24190779$1$I$$20240108$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2024AST000001$ASSERTIO THERAPEUTICS$$$$$F$Y$$$20240808$$HP$US$US
241907802$24190780$2$F$20240730$20240812$20240808$20240816$PER$$US-BAYER-2024A112593$BAYER$$36$YR$A$F$Y$89$KG$20240816$$HP$US$US
241907831$24190783$1$I$20240729$20240801$20240808$20240808$PER$$US-SA-2024SA231553$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240808$$MD$US$US
241907841$24190784$1$I$20211015$20240731$20240808$20240808$EXP$$KR-DSJP-DSJ-2024-139443$DAIICHI$$83$YR$$M$Y$$$20240808$$MD$KR$KR
241907851$24190785$1$I$$20240731$20240808$20240808$EXP$GB-MHRA-31372529$GB-TEVA-VS-3229112$TEVA$$72$YR$$F$Y$$$20240808$$PH$GB$GB
241907872$24190787$2$F$20240101$20240806$20240808$20240810$EXP$$US-ABBVIE-5868126$ABBVIE$$$$$F$Y$61$KG$20240810$$CN$US$US
241907881$24190788$1$I$20140714$20240802$20240808$20240808$EXP$$CH-GSK-CH2024EME090990$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$MD$CH$CH
241907892$24190789$2$F$$20240806$20240808$20240816$EXP$$CN-ABBVIE-5870871$ABBVIE$Hu L, Liu G, Chen X. Rhinocerebral mucormycosis and Trichosporon asahii fungemia in a pediatric patient with acute lymphoblastic leukemia: a rare coinfection. Rev Inst Med trop S Paulo. 2024;66:1-5.$14$MON$$M$Y$$$20240816$$HP$CN$CN
241907902$24190790$2$F$20240625$20240816$20240808$20240821$EXP$$FR-AMERICAN REGENT INC-2024003009$AMERICAN REGENT$$71$YR$$M$Y$108$KG$20240821$$PH$FR$FR
241907911$24190791$1$I$$20230908$20240808$20240808$PER$$US-ASSERTIO THERAPEUTICS, INC.-US-2023AST000469$ASSERTIO THERAPEUTICS$$$$$$Y$$$20240808$$CN$US$US
241907921$24190792$1$I$20240610$20240730$20240808$20240808$EXP$$GB-TEVA-VS-3228356$TEVA$$60$YR$$M$Y$97$KG$20240808$$MD$GB$GB
241907932$24190793$2$F$20240728$20240823$20240808$20240903$PER$$US-JNJFOC-20240804663$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240903$$CN$US$US
241907941$24190794$1$I$20240712$20240807$20240808$20240808$EXP$ES-AEMPS-1556364$ES-JNJFOC-20240818984$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240808$$PH$ES$ES
241907962$24190796$2$F$20190610$20240805$20240808$20240811$EXP$$CA-JNJFOC-20210504389$JOHNSON AND JOHNSON$$49$YR$A$F$Y$97.5$KG$20240811$$HP$CA$CA
241907971$24190797$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A176431$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241907981$24190798$1$I$$20240801$20240808$20240808$EXP$FR-EMA-20170209-gdhingrap-155720719$FR-RDY-SPO/FRA/21/0142207$DR REDDYS$Guitard J, Guilbeau-Frugier C, Roussel M, Kamar N. An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis. Clin-Nephrol 2014; 82(6):392-396.$58$YR$A$F$Y$$$20240808$$MD$FR$FR
241907991$24190799$1$I$20240722$20240802$20240808$20240808$EXP$$NVSC2024ZA158134$NOVARTIS$$63$YR$$F$Y$$$20240808$$HP$ZA$ZA
241908001$24190800$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA232096$SANOFI AVENTIS$$$$A$M$Y$84$KG$20240808$$MD$US$US
241908011$24190801$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA230441$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240808$$MD$US$US
241908021$24190802$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA230527$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240808$$MD$US$US
241908032$24190803$2$F$20230101$20240812$20240808$20240821$PER$$US-SA-2024SA230707$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240821$$MD$US$US
241908041$24190804$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA231189$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240808$$MD$US$US
241908051$24190805$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA230592$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240808$$MD$US$US
241908062$24190806$2$F$20240702$20240829$20240808$20240923$PER$$US-SA-2024SA229849$SANOFI AVENTIS$$21$YR$A$F$Y$64.4$KG$20240923$$MD$US$US
241908073$24190807$3$F$20240101$20240801$20240808$20240814$PER$$US-SA-2024SA229626$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240814$$MD$US$US
241908081$24190808$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA230491$SANOFI AVENTIS$$$$$F$Y$$$20240808$$HP$US$US
241908091$24190809$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231575$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240808$$MD$US$US
241908102$24190810$2$F$20240730$20240805$20240808$20240814$PER$$US-SA-2024SA232661$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240814$$CN$US$US
241908111$24190811$1$I$20240401$20240731$20240808$20240808$PER$$US-SA-2024SA230946$SANOFI AVENTIS$$14$YR$T$M$Y$70.3$KG$20240808$$MD$US$US
241908121$24190812$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54641$$FDA-CTU$$78$YR$$M$N$$$20240808$N$$US$
241908131$24190813$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54642$$FDA-CTU$$38$YR$$F$N$44$KG$20240808$N$$US$
241908151$24190815$1$I$20240801$20240805$20240808$20240808$PER$$US-BIOGEN-2024BI01277088$BIOGEN$$25$YR$$F$Y$$$20240808$$CN$US$US
241908171$24190817$1$I$$20240805$20240808$20240808$PER$$US-BIOGEN-2024BI01277058$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241908181$24190818$1$I$20240504$20240730$20240808$20240808$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000726$PAREXEL$$$$$$Y$$$20240808$$HP$CN$CN
241908192$24190819$2$F$$20240804$20240808$20240809$EXP$$IT-JNJFOC-20240779930$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240809$$HP$IT$IT
241908201$24190820$1$I$$20240806$20240808$20240808$EXP$$SA-AMERICAN REGENT INC-2024003029$AMERICAN REGENT$$35$YR$$F$Y$$$20240808$$MD$SA$SA
241908221$24190822$1$I$20231108$20240806$20240808$20240808$EXP$IT-MINISAL02-995766$IT-ORGANON-O2407ITA002410$ORGANON$$86$YR$$F$Y$$$20240808$$MD$IT$IT
241908232$24190823$2$F$$20240805$20240808$20240809$PER$$NVSC2024US160568$NOVARTIS$$$$$F$Y$$$20240809$$PH$US$US
241908241$24190824$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161723$NOVARTIS$$$$$M$Y$$$20240808$$CN$US$US
241908251$24190825$1$I$20240208$20240215$20240808$20240808$EXP$$NVSC2024IL026380$NOVARTIS$$61$YR$$F$Y$$$20240808$$HP$IL$IL
241908261$24190826$1$I$$20240808$20240808$20240808$PER$$US-BAYER-2024A114721$BAYER$$$$$F$Y$$$20240808$$CN$US$US
241908271$24190827$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54558$$FDA-CTU$$39$YR$$F$N$$$20240808$N$$US$
241908282$24190828$2$F$20240219$20240919$20240808$20240923$EXP$$NVSC2024DE046404$NOVARTIS$$$$A$F$Y$$$20240923$$MD$DE$DE
241908291$24190829$1$I$$20240808$20240808$20240808$DIR$713431$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241908311$24190831$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54643$$FDA-CTU$$69$YR$$F$N$$$20240808$N$$US$
241908321$24190832$1$I$$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024157067$AMGEN$$$$$$Y$$$20240808$$PH$US$US
241908332$24190833$2$F$20240716$20240808$20240808$20240818$EXP$IT-MINISAL02-996230$IT-TEVA-VS-3228914$TEVA$$77$YR$$M$Y$$$20240818$$MD$IT$IT
241908341$24190834$1$I$20240808$20240808$20240808$20240808$DIR$713409$$FDA-CTU$$89$YR$$F$N$53.1$KG$20240808$N$CN$US$
241908361$24190836$1$I$$20240730$20240808$20240808$EXP$$CA-TEVA-VS-3227554$TEVA$$81$YR$$M$Y$90$KG$20240808$$PH$CA$CA
241908371$24190837$1$I$20240807$20240808$20240808$20240808$DIR$713418$$FDA-CTU$$60$YR$$M$N$85.3$KG$20240808$N$PH$US$
241908382$24190838$2$F$20240701$20240830$20240808$20240909$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001068$ALEMBIC$$$$$$Y$$$20240909$$CN$US$US
241908392$24190839$2$F$$20240814$20240808$20240828$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001074$ALEMBIC$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of neonatal-perinatal medicine. 2024;1-6$$$$$Y$$$20240828$$HP$US$US
241908411$24190841$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54644$$FDA-CTU$$78$YR$$F$N$$$20240808$N$$US$
241908422$24190842$2$F$$20240814$20240808$20240828$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001076$ALEMBIC$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of neonatal-perinatal medicine. 2024;1-6$$$$$Y$$$20240828$$MD$US$US
241908431$24190843$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54560$$FDA-CTU$$83$YR$$F$N$$$20240808$N$$US$
241908441$24190844$1$I$20240101$20240731$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122765$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240808$$CN$US$US
241908451$24190845$1$I$$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124952$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240808$$HP$US$US
241908461$24190846$1$I$20240806$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124733$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240808$$CN$US$US
241908471$24190847$1$I$20240718$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123364$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240808$$PH$US$US
241908481$24190848$1$I$20240701$20240730$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121310$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240808$$PH$US$US
241908491$24190849$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125167$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240808$$HP$US$US
241908501$24190850$1$I$$20240806$20240808$20240808$PER$$US-ABBVIE-5871265$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241908522$24190852$2$F$20240712$20240924$20240808$20240930$EXP$$NVSC2024FR151851$NOVARTIS$$$$E$F$Y$59$KG$20240930$$MD$FR$FR
241908531$24190853$1$I$$20240805$20240808$20240808$EXP$$CN-AstraZeneca-2024A178666$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$CN$
241908541$24190854$1$I$20240725$20240805$20240808$20240808$PER$$NVSC2024US160879$NOVARTIS$$60$YR$$M$Y$108.86$KG$20240808$$CN$US$US
241908552$24190855$2$F$20240725$20240731$20240808$20240812$EXP$$CN-AstraZeneca-2024A176322$ASTRAZENECA$$21948$DY$$F$Y$55$KG$20240812$$MD$CN$
241908561$24190856$1$I$$20240731$20240808$20240808$EXP$$VN-AstraZeneca-2024A176550$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$VN$
241908571$24190857$1$I$$20240801$20240808$20240808$EXP$$US-ABBVIE-5864797$ABBVIE$$$$$F$Y$92$KG$20240808$$CN$US$US
241908581$24190858$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54637$$FDA-CTU$$69$YR$$F$N$$$20240808$N$$US$
241908591$24190859$1$I$20240723$20240808$20240808$20240808$DIR$713444$$FDA-CTU$$32$YR$$F$N$100.8$KG$20240808$N$CN$US$
241908601$24190860$1$I$20240727$20240808$20240808$20240808$DIR$713438$$FDA-CTU$$82$YR$$M$N$68$KG$20240808$N$PH$US$
241908611$24190861$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54640$$FDA-CTU$$42$YR$$F$N$$$20240808$N$$US$
241908621$24190862$1$I$20240801$20240808$20240808$20240808$DIR$713424$$FDA-CTU$$42$YR$$F$N$$$20240808$N$CN$US$
241908631$24190863$1$I$$20240806$20240808$20240808$DIR$FDA-CDER-CTU-2024-54554$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
241908641$24190864$1$I$$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004903$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240808$$CN$US$US
241908651$24190865$1$I$20240701$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004933$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240808$$CN$US$US
241908661$24190866$1$I$20240808$20240808$20240808$20240808$DIR$713427$$FDA-CTU$$68$YR$$M$N$126$KG$20240808$N$CN$US$
241908681$24190868$1$I$20231208$20240807$20240808$20240808$EXP$FR-AFSSAPS-LY2024001191$FR-JNJFOC-20240818978$JOHNSON AND JOHNSON$$51$YR$A$M$Y$91$KG$20240808$$MD$FR$FR
241908691$24190869$1$I$$20240730$20240808$20240808$PER$$US-SA-2024SA229358$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240808$$MD$US$US
241908701$24190870$1$I$$20240709$20240808$20240808$PER$$US-009507513-2407USA004594$MERCK$Shah S, Clark L, Davis MW, Topal JE, Shields RK. Clinical manifestations and treatment outcomes for patients with Pseudomonas endocarditis. Journal of Antimicrobial Chemotherapy 2024 Online Ahead of Print. 2024;1-5$62$YR$$M$Y$$$20240808$$HP$US$US
241908712$24190871$2$F$20240101$20240802$20240808$20240813$PER$$US-SA-2024SA231007$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240813$$MD$US$US
241908721$24190872$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA231203$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240808$$CN$US$US
241908731$24190873$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231984$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240808$$MD$US$US
241908741$24190874$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA231525$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240808$$MD$US$US
241908751$24190875$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231546$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240808$$MD$US$US
241908763$24190876$3$F$20240801$20240814$20240808$20240828$PER$$US-SA-2024SA232217$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240828$$MD$US$US
241908771$24190877$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231249$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240808$$MD$US$US
241908781$24190878$1$I$20240417$20240731$20240808$20240808$PER$$US-SA-2024SA231507$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240808$$MD$US$US
241908791$24190879$1$I$$20240731$20240808$20240808$PER$$US-AMGEN-USASP2024156928$AMGEN$$$$$F$Y$$$20240808$$HP$US$US
241908801$24190880$1$I$20240806$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024157103$AMGEN$$83$YR$E$F$Y$$$20240808$$PH$US$US
241908811$24190881$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA229521$SANOFI AVENTIS$$$$$F$Y$$$20240808$$CN$US$US
241908821$24190882$1$I$$20240618$20240808$20240808$PER$$US-LUNDBECK-DKLU4001144$LUNDBECK$$$$$$Y$$$20240808$$CN$US$US
241908831$24190883$1$I$20230101$20240801$20240808$20240808$EXP$$BR-TAKEDA-2023TUS014553$TAKEDA$$$$$F$Y$$$20240808$$CN$BR$BR
241908841$24190884$1$I$$20240805$20240808$20240808$EXP$$US-AMGEN-USASP2024155424$AMGEN$$$$$F$Y$$$20240808$$CN$US$US
241908852$24190885$2$F$20240606$20240816$20240808$20240824$EXP$$US-ABBVIE-5866409$ABBVIE$$$$$$Y$$$20240824$$MD$US$US
241908861$24190886$1$I$$20240807$20240808$20240808$EXP$$CN-TAKEDA-2024TUS079388$TAKEDA$$$$$M$Y$$$20240808$$CN$CN$CN
241908871$24190887$1$I$$20240807$20240808$20240808$EXP$$US-TAKEDA-2024TUS079206$TAKEDA$$$$$M$Y$$$20240808$$CN$US$US
241908881$24190888$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5868473$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241908891$24190889$1$I$$20240806$20240808$20240808$EXP$$BE-ABBVIE-5871363$ABBVIE$De Corte L. In one week, I lost 5 kilos. Zinnia (25) suffers from an incurable intestinal disease. Auxipress. 2024;1-3$$$A$F$Y$$$20240808$$CN$BE$BE
241908901$24190890$1$I$$20240801$20240808$20240808$PER$$US-ALXN-202408USA000094US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
241908911$24190891$1$I$$20240730$20240808$20240808$EXP$$US-RDY-LIT/USA/24/0011442$DR REDDYS$Adimora I, Zhang B, Idowu M. Recurrent Strokes in a Woman with a History of Thrombotic Thrombocytopenic Purpura. Case Reports in Medicine. 2023;doi:10.1155/2023/7070189.$$$A$F$Y$$$20240808$$HP$US$US
241908921$24190892$1$I$$20240802$20240808$20240808$EXP$$NVSC2024US160717$NOVARTIS$Homiack DR, Yan LE, Petry LG, Lloyd JR, Najjar F, Cook EH.. Successful Electroconvulsive Therapy in a Patient with Catatonia and Maternal Duplication 15q11-13 Syndrome. J-ECT. 2024;0(0):1-2.$24$YR$$M$Y$$$20240808$$HP$US$US
241908931$24190893$1$I$$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156695$AMGEN$$$$$$Y$$$20240808$$CN$US$US
241908943$24190894$3$F$$20240825$20240808$20240902$EXP$$CL-TAKEDA-2024TUS078800$TAKEDA$$22$YR$$F$Y$$$20240902$$MD$CL$CL
241908951$24190895$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683449$GILEAD$$$$$F$Y$$$20240808$$HP$US$US
241908961$24190896$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54634$$FDA-CTU$$19$YR$$M$N$$$20240808$N$$US$
241908971$24190897$1$I$20240808$20240808$20240808$20240808$DIR$713447$$FDA-CTU$$87$YR$$F$N$$$20240808$$CN$US$
241908981$24190898$1$I$20240801$20240808$20240808$20240808$DIR$713450$$FDA-CTU$$50$YR$$UNK$N$$$20240808$N$PH$US$
241908991$24190899$1$I$$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54649$$FDA-CTU$$$$$M$N$$$20240807$N$HP$US$
241909001$24190900$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA231656$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240808$$MD$US$US
241909011$24190901$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA231327$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240808$$MD$US$US
241909021$24190902$1$I$$20240802$20240808$20240808$PER$$US-SA-2024SA231902$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240808$$MD$US$US
241909031$24190903$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231617$SANOFI AVENTIS$$$$A$F$Y$53.52$KG$20240808$$MD$US$US
241909041$24190904$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA231672$SANOFI AVENTIS$$33$YR$A$F$Y$63.049$KG$20240808$$HP$US$US
241909061$24190906$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54638$$FDA-CTU$$34$YR$$F$N$$$20240808$N$$US$
241909071$24190907$1$I$$20240808$20240808$20240808$DIR$713449$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
241909081$24190908$1$I$20240701$20240701$20240808$20240808$DIR$FDA-CDER-CTU-2024-54650$$FDA-CTU$$$$$$N$$$20240701$N$$US$
241909091$24190909$1$I$$20240807$20240808$20240808$DIR$FDA-CDER-CTU-2024-54593$$FDA-CTU$$$$$F$N$$$20240807$N$HP$US$
241909111$24190911$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683453$GILEAD$$7$DEC$E$M$Y$$$20240808$$HP$US$US
241909122$24190912$2$F$$20240913$20240808$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-024315$UNITED THERAPEUTICS$$$$$M$Y$142.86$KG$20240921$$$US$US
241909131$24190913$1$I$20240806$20240807$20240808$20240808$EXP$GB-MHRA-MED-202408071524406360-QPGCL$GB-VIIV HEALTHCARE LIMITED-GB2024098527$VIIV$$$$$$Y$$$20240808$$MD$GB$GB
241909141$24190914$1$I$20240627$20240806$20240808$20240808$EXP$FR-AFSSAPS-NC2024000937$FR-GSK-FR2024097915$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$FR$FR
241909151$24190915$1$I$20240806$20240807$20240808$20240808$EXP$GB-MHRA-MED-202408071524406360-QPGCL$GB-GSK-GB2024098527$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$MD$GB$GB
241909171$24190917$1$I$20210407$20210416$20240808$20240808$EXP$$US-AstraZeneca-2021A335093$ASTRAZENECA$$22312$DY$$M$Y$$$20240808$$CN$US$
241909181$24190918$1$I$20230101$20230330$20240808$20240808$EXP$$US-AstraZeneca-2023A076185$ASTRAZENECA$$791$MON$$F$Y$$$20240808$$CN$US$
241909191$24190919$1$I$$20221109$20240808$20240808$EXP$$US-AstraZeneca-2022A371430$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241909201$24190920$1$I$$20210914$20240808$20240808$EXP$$US-AstraZeneca-2021A728055$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241909211$24190921$1$I$20240715$20240731$20240808$20240808$EXP$$DE-AstraZeneca-2024A180233$ASTRAZENECA$$80$YR$$F$Y$$$20240808$$MD$DE$
241909221$24190922$1$I$20220224$20220304$20240808$20240808$EXP$$US-AstraZeneca-2022A105345$ASTRAZENECA$$19033$DY$$M$Y$$$20240808$$CN$US$
241909231$24190923$1$I$$20231207$20240808$20240808$EXP$$US-AstraZeneca-2023A231593$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241909242$24190924$2$F$20240101$20240812$20240808$20240821$PER$$US-SA-2024SA231796$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240821$$MD$US$US
241909253$24190925$3$F$20240101$20240826$20240808$20240828$EXP$$US-Eisai-EC-2024-171111$EISAI$$62$YR$A$F$Y$90.7$KG$20240828$$CN$US$US
241909261$24190926$1$I$20240101$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156684$AMGEN$$$$$F$Y$$$20240808$$CN$US$US
241909272$24190927$2$F$$20240822$20240808$20240823$PER$$NVSC2024US161710$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
241909282$24190928$2$F$$20240808$20240808$20240814$EXP$$CN-SA-2024SA232892$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240814$$MD$CN$CN
241909292$24190929$2$F$20240604$20240813$20240808$20240816$EXP$$US-ABBVIE-5870870$ABBVIE$$63$YR$$M$Y$104$KG$20240816$$CN$US$US
241909301$24190930$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870965$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241909312$24190931$2$F$20240807$20240807$20240808$20240816$PER$$US-ALXN-202408USA000371US$ALEXION PHARMACEUTICALS$$47$YR$$F$Y$$$20240816$$HP$US$US
241909321$24190932$1$I$$20240806$20240808$20240808$EXP$GB-MHRA-MED-202408062309026040-FTDPN$GB-TAKEDA-2024TUS078832$TAKEDA$$$$$F$Y$$$20240808$$HP$GB$GB
241909331$24190933$1$I$20240701$20240729$20240808$20240808$EXP$$IT-TEVA-VS-3228718$TEVA$$49$YR$$F$Y$59$KG$20240808$$MD$IT$IT
241909341$24190934$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5871096$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241909351$24190935$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004316$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240808$$CN$US$US
241909361$24190936$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003868$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240808$$CN$US$US
241909371$24190937$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231988$SANOFI AVENTIS$$$$E$F$Y$$$20240808$$MD$US$US
241909381$24190938$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA232352$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240808$$MD$US$US
241909391$24190939$1$I$20240501$20240801$20240808$20240808$PER$$US-SA-2024SA231915$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240808$$MD$US$US
241909401$24190940$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54595$$FDA-CTU$$57$YR$$F$N$$$20240808$N$$US$
241909411$24190941$1$I$$20240801$20240808$20240808$PER$$US-ABBVIE-5866482$ABBVIE$$$$$F$Y$$$20240808$$HP$US$US
241909421$24190942$1$I$$20240807$20240808$20240808$EXP$$NVSC2024GR160523$NOVARTIS$$33$YR$$M$Y$$$20240808$$MD$GR$GR
241909431$24190943$1$I$$20240731$20240808$20240808$EXP$$CA-MYLANLABS-2024M1071382$MYLAN$$57$YR$$M$Y$$$20240808$$CN$CA$CA
241909441$24190944$1$I$20240628$20240801$20240808$20240808$EXP$$US-JNJFOC-20240803666$JOHNSON AND JOHNSON$$79$YR$E$M$Y$54.3$KG$20240808$$HP$US$US
241909451$24190945$1$I$$20240725$20240808$20240808$PER$$US-NORIDC PHARMA, INC-2024US002541$PAREXEL$Boleyn J, McLaury M, Wieman S.. Suspected Pseudocholinesterase De?ciency During Left Thyroid Lobectomy and Isthmusectomy: A Case Report. S D Med. 2024;77:6:266-269$$$$$Y$$$20240808$$MD$US$US
241909461$24190946$1$I$$20240618$20240808$20240808$PER$$US-LUNDBECK-DKLU4000677$LUNDBECK$$$$$$Y$$$20240808$$HP$US$US
241909471$24190947$1$I$$20240807$20240808$20240808$EXP$$AU-WAYLIS-2024-AU-000320$Waylis$$$$$M$Y$$$20240808$$PH$AU$AU
241909481$24190948$1$I$20240729$20240801$20240808$20240808$EXP$$US-ABBVIE-5871205$ABBVIE$$82$YR$$F$Y$$$20240808$$CN$US$US
241909491$24190949$1$I$$20240619$20240808$20240808$PER$$US-LUNDBECK-DKLU4001156$LUNDBECK$$$$$$Y$$$20240808$$CN$US$US
241909501$24190950$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5868707$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241909511$24190951$1$I$20240101$20240806$20240808$20240808$EXP$$US-ABBVIE-5870741$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241909522$24190952$2$F$20240101$20240815$20240808$20240823$EXP$$CO-ABBVIE-5870111$ABBVIE$$$$$F$Y$59$KG$20240823$$CN$CO$CO
241909531$24190953$1$I$$20240801$20240808$20240808$PER$$US-ALXN-202408USA000060US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240808$$HP$US$US
241909542$24190954$2$F$$20240826$20240808$20240826$PER$$US-ALXN-202408USA000103US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241909551$24190955$1$I$20240501$20240806$20240808$20240808$EXP$$DE-ABBVIE-5867994$ABBVIE$$74$YR$$M$Y$$$20240808$$MD$DE$DE
241909561$24190956$1$I$$20240801$20240808$20240808$EXP$$US-TAKEDA-2024TUS077925$TAKEDA$$10$YR$$M$Y$40$KG$20240808$$MD$US$US
241909571$24190957$1$I$$20240731$20240808$20240808$PER$$US-AstraZeneca-2024A174541$ASTRAZENECA$$$$$$Y$$$20240808$$HP$US$
241909581$24190958$1$I$$20211210$20240808$20240808$EXP$$US-AstraZeneca-2021A872469$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241909591$24190959$1$I$20240805$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155578$AMGEN$$56$YR$A$F$Y$$$20240808$$HP$US$US
241909611$24190961$1$I$$20221213$20240808$20240808$EXP$$US-AstraZeneca-2022A407839$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241909621$24190962$1$I$$20240730$20240808$20240808$EXP$$CA-AstraZeneca-2024A179350$ASTRAZENECA$Reyes NG, Bendahan N, Swinkin E, Lang AE, Bassett AS.. Levodopa-responsive dystonia, parkinsonism, and treatmentresistant schizoaffective disorder in Williams syndrome.. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical 2024;1-6.$47$YR$$F$Y$$$20240808$$HP$CA$
241909631$24190963$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A175105$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241909641$24190964$1$I$$20240729$20240808$20240808$EXP$$US-AstraZeneca-2024A179491$ASTRAZENECA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure.. Journal of Neonatal-Perinatal Medicine 2024;1-6.$$$N$M$Y$$$20240808$$HP$US$
241909651$24190965$1$I$20230731$20240802$20240808$20240808$EXP$ES-AEMPS-1553800$ES-MYLANLABS-2024M1072618$MYLAN$$76$YR$$F$Y$$$20240808$$MD$ES$ES
241909661$24190966$1$I$20240709$20240802$20240808$20240808$EXP$SE-SEMPA-2024-005709$SE-MYLANLABS-2024M1072612$MYLAN$$73$YR$$M$Y$$$20240808$$MD$SE$SE
241909671$24190967$1$I$20240703$20240802$20240808$20240808$EXP$FR-AFSSAPS-TS2024000863$FR-MYLANLABS-2024M1072822$MYLAN$$89$YR$$M$Y$103$KG$20240808$$MD$FR$FR
241909681$24190968$1$I$20240101$20240802$20240808$20240808$EXP$FR-AFSSAPS-AVMP2024000215$FR-MYLANLABS-2024M1072586$MYLAN$$35$YR$$M$Y$$$20240808$$HP$FR$FR
241909691$24190969$1$I$20240419$20240802$20240808$20240808$EXP$$DE-MYLANLABS-2024M1072856$MYLAN$$53$YR$$F$Y$$$20240808$$MD$DE$DE
241909701$24190970$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA232007$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240808$$MD$US$US
241909711$24190971$1$I$$20240802$20240808$20240808$EXP$$US-MYLANLABS-2024M1073970$MYLAN$Tang CJ, Balu R, Thomas CA, King CS, Shlobin OA, Aryal S, et al. Spinal Cord Infarction Associated With VA-ECMO Support. Am-J-Respir-Crit-Care-Med 2024; 209.$46$YR$$F$Y$$$20240808$$HP$US$US
241909721$24190972$1$I$20230525$20240802$20240808$20240808$EXP$FR-AFSSAPS-AM2024000614$FR-MYLANLABS-2024M1072667$MYLAN$$72$YR$$F$Y$70$KG$20240808$$MD$FR$FR
241909731$24190973$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA231921$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240808$$MD$US$US
241909741$24190974$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA229359$SANOFI AVENTIS$$$$A$F$Y$$$20240808$$MD$US$US
241909751$24190975$1$I$20240701$20240731$20240808$20240808$PER$$US-SA-2024SA178447$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240808$$MD$US$US
241909761$24190976$1$I$20240101$20240802$20240808$20240808$PER$$US-SA-2024SA231938$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240808$$MD$US$US
241909772$24190977$2$F$$20240802$20240808$20240813$PER$$US-SA-2024SA233442$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240814$$MD$US$US
241909781$24190978$1$I$$20240806$20240808$20240808$EXP$$NVSC2024GB139497$NOVARTIS$$$$$F$Y$$$20240808$$CN$GB$GB
241909791$24190979$1$I$$20240801$20240808$20240808$EXP$$US-GSK-US2024096369$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$US$US
241909801$24190980$1$I$$20211228$20240808$20240808$EXP$$NL-BIOVITRUM-2022NL00010$BIOVITRUM$$$$I$M$Y$6.2$KG$20240808$$CN$NL$NL
241909811$24190981$1$I$20211230$20220104$20240808$20240808$EXP$$ES-BIOVITRUM-2022ES00159$BIOVITRUM$$349$DY$$$Y$$$20240808$$CN$ES$ES
241909822$24190982$2$F$$20240802$20240808$20240809$EXP$$ES-BIOVITRUM-2024-ES-010545$BIOVITRUM$$$$A$F$Y$$$20240809$$MD$ES$ES
241909831$24190983$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229540$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$73$YR$$M$Y$$$20240808$$HP$FR$FR
241909841$24190984$1$I$20180101$20240802$20240808$20240808$EXP$FR-AFSSAPS-AVMP2024000216$FR-MYLANLABS-2024M1072580$MYLAN$$25$YR$$M$Y$$$20240808$$MD$FR$FR
241909851$24190985$1$I$20180620$20240802$20240808$20240808$EXP$FR-AFSSAPS-PC2024000603$FR-MYLANLABS-2024M1072639$MYLAN$$93$YR$$F$Y$44$KG$20240808$$PH$FR$FR
241909862$24190986$2$F$$20240816$20240808$20240829$PER$$US-Calliditas-2024CAL01015$CALLIDITAS THERAPEUTICS$$62$YR$A$M$Y$$$20240829$$CN$US$US
241909871$24190987$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125794$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240808$$CN$US$US
241909881$24190988$1$I$20240803$20240805$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125031$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240808$$CN$US$US
241909891$24190989$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125271$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$MD$US$US
241909903$24190990$3$F$$20240917$20240808$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125091$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240924$$MD$JP$JP
241909911$24190991$1$I$20240730$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125730$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240808$$CN$US$US
241909921$24190992$1$I$$20240730$20240808$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123643$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$PH$JP$JP
241909931$24190993$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125634$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240808$$CN$US$US
241909942$24190994$2$F$20240101$20240819$20240808$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125596$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$60.33$KG$20240828$$CN$US$US
241909951$24190995$1$I$20240702$20240801$20240808$20240808$EXP$$DK-FERRINGPH-2024FE04199$FERRING$$$$$$Y$$$20240808$$CN$DK$DK
241909961$24190996$1$I$20221201$20240802$20240808$20240808$EXP$$DE-MYLANLABS-2024M1072496$MYLAN$$$$E$F$Y$71$KG$20240808$$CN$DE$DE
241909971$24190997$1$I$20231117$20240801$20240808$20240808$EXP$$FR-FERRINGPH-2023FE06602$FERRING$$$$$$Y$$$20240808$$MD$FR$FR
241909981$24190998$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003898$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241909991$24190999$1$I$$20240801$20240808$20240808$PER$$US-ALXN-202408USA000048US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240808$$CN$US$US
241910002$24191000$2$F$$20240808$20240808$20240812$PER$$NVSC2024US161008$NOVARTIS$$$$$M$Y$$$20240812$$CN$US$US
241910011$24191001$1$I$$20240801$20240808$20240808$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-124604$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240808$$HP$CA$CA
241910021$24191002$1$I$$20240801$20240808$20240808$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-124602$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240808$$HP$CA$CA
241910031$24191003$1$I$20240101$20240725$20240808$20240808$EXP$$GB-TEVA-VS-3226867$TEVA$$45$YR$$F$Y$$$20240808$$CN$GB$GB
241910041$24191004$1$I$$20240802$20240808$20240808$EXP$$US-JNJFOC-20240809551$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$CN$US$US
241910054$24191005$4$F$20240804$20240909$20240808$20240923$30DAY$$US-JNJFOC-20240811561$JOHNSON AND JOHNSON$$59$YR$A$$Y$$$20240924$$PH$US$US
241910061$24191006$1$I$$20240731$20240808$20240808$PER$$US-INCYTE CORPORATION-2024IN008026$INCYTE$$$$$$Y$$$20240808$$CN$US$US
241910082$24191008$2$F$$20240913$20240808$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125260$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240916$$HP$US$US
241910091$24191009$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124770$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240808$$CN$US$US
241910102$24191010$2$F$20240731$20240812$20240808$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024251$UNITED THERAPEUTICS$$91$YR$$F$Y$41.723$KG$20240821$$$US$US
241910111$24191011$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870957$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241910121$24191012$1$I$$20240802$20240808$20240808$EXP$$HU-MYLANLABS-2024M1065637$MYLAN$Gabriella Mezei, P?ter Bat?r, ?rp?d Ill?s, R?bert Sz?sz.. Differential diagnosis of hemorrhagic colitis Ph+ our patients with acute lymphoblastic leukaemia  have several years of treatment with dasatinib. Can we stop giving TKI Ph+ ALL?. Hematology-Transfusology. 2023;49$58$YR$$F$Y$$$20240808$$MD$HU$HU
241910131$24191013$1$I$20230603$20240802$20240808$20240808$EXP$DK-DKMA-30736598$DK-MYLANLABS-2024M1072412$MYLAN$$35$YR$$F$Y$75$KG$20240808$$CN$DK$DK
241910144$24191014$4$F$20240502$20240905$20240808$20240913$EXP$$US-GILEAD-2024-0682947$GILEAD$$30$YR$A$F$Y$75.6$KG$20240913$$HP$US$US
241910151$24191015$1$I$20240701$20240731$20240808$20240808$PER$$US-EMD Serono-2024042525$EMD SERONO INC$$53$YR$A$F$Y$$$20240808$$MD$US$US
241910161$24191016$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A174925$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241910171$24191017$1$I$20230725$20240808$20240808$20240808$DIR$713437$$FDA-CTU$$77$YR$$F$N$72.45$KG$20240808$Y$CN$US$
241910181$24191018$1$I$$20240731$20240808$20240808$EXP$$DE-AstraZeneca-2024A180475$ASTRAZENECA$$35$YR$$F$Y$100$KG$20240808$$MD$DE$
241910191$24191019$1$I$20240101$20240806$20240808$20240808$EXP$$US-JNJFOC-20240816327$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240808$$HP$US$US
241910211$24191021$1$I$20240101$20240806$20240808$20240808$EXP$$CL-ABBVIE-5871441$ABBVIE$$$$$F$Y$$$20240808$$CN$CL$CL
241910222$24191022$2$F$$20240905$20240808$20240911$EXP$$IT-MYLANLABS-2024M1072638$MYLAN$Musone D, Nicosia V, D^Alessandro R, Andrietti M, Steri PF, Ruosi C et. al. Therapeutic plasmapheresis in idiopathic membranous nephropathy anti-PLA2R-related: A case series. J Clin Apher. 2024;39(3):e22134$69$YR$$M$Y$$$20240911$$HP$IT$IT
241910231$24191023$1$I$20240108$20240801$20240808$20240808$EXP$$CN-JNJFOC-20240805242$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20240808$$HP$CN$CN
241910251$24191025$1$I$20240101$20240805$20240808$20240808$PER$$US-PFIZER INC-202400231394$PFIZER$$64$YR$$F$Y$$$20240808$$HP$US$US
241910262$24191026$2$F$$20240806$20240808$20240809$PER$$US-PFIZER INC-PV202400102828$PFIZER$$66$YR$$F$Y$$$20240809$$CN$US$US
241910272$24191027$2$F$$20240904$20240808$20240906$PER$$US-PFIZER INC-PV202400103397$PFIZER$$47$YR$$F$Y$$$20240906$$HP$US$US
241910281$24191028$1$I$20240808$20240808$20240808$20240808$PER$$US-PFIZER INC-202400232929$PFIZER$$63$YR$$F$Y$$$20240808$$CN$US$US
241910291$24191029$1$I$20240623$20240807$20240808$20240808$PER$$US-PFIZER INC-PV202400102997$PFIZER$$40$YR$$F$Y$$$20240808$$PH$US$US
241910301$24191030$1$I$$20240805$20240808$20240808$PER$$US-PFIZER INC-202400231415$PFIZER$$$$E$M$Y$$$20240808$$CN$US$US
241910311$24191031$1$I$20240601$20240802$20240808$20240808$PER$$US-PFIZER INC-PV202400101360$PFIZER$$30$YR$$F$Y$$$20240808$$CN$US$US
241910321$24191032$1$I$$20240807$20240808$20240808$PER$$US-PFIZER INC-202400232174$PFIZER$$$$$F$Y$$$20240808$$MD$US$US
241910331$24191033$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231721$PFIZER$$49$YR$$F$Y$$$20240808$$HP$US$US
241910341$24191034$1$I$20240805$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230621$PFIZER$$51$YR$$M$Y$$$20240808$$MD$US$US
241910351$24191035$1$I$20240801$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231396$PFIZER$$68$YR$$F$Y$70.76$KG$20240808$$CN$US$US
241910361$24191036$1$I$19961125$20240807$20240808$20240808$PER$$US-PFIZER INC-PV202400102849$PFIZER$$47$YR$$F$Y$$$20240808$$MD$US$US
241910371$24191037$1$I$20240515$20240515$20240808$20240808$PER$$US-GE HEALTHCARE-2024CSU005235$GE HEALTHCARE$$70$YR$$M$Y$$$20240808$$HP$US$US
241910381$24191038$1$I$20240515$20240515$20240808$20240808$PER$$US-GE HEALTHCARE-2024CSU005253$GE HEALTHCARE$$82$YR$$F$Y$110$KG$20240808$$HP$US$US
241910391$24191039$1$I$20220816$20240726$20240808$20240808$EXP$AU-TGA-0000801560$AU-COLLEGIUM PHARMACEUTICAL, INC.-20240700565$COLLEGIUM PHARMACEUTICAL$$40$YR$$M$Y$$$20240808$$CN$AU$AU
241910401$24191040$1$I$20240601$20240806$20240808$20240808$EXP$$CL-ABBVIE-5870186$ABBVIE$$51$YR$$M$Y$$$20240808$$CN$CL$CL
241910411$24191041$1$I$20240710$20240808$20240808$20240808$DIR$713436$$FDA-CTU$$59$YR$$M$N$$$20240808$N$PH$US$
241910421$24191042$1$I$$20240805$20240808$20240808$EXP$$US-GILEAD-2024-0683007$GILEAD$$58$YR$A$M$Y$$$20240808$$CN$US$US
241910431$24191043$1$I$$20210204$20240808$20240808$EXP$$FR-DSJP-DSJ-2021-104525$DAIICHI$$$$E$F$Y$$$20240808$$MD$FR$FR
241910441$24191044$1$I$$20210204$20240808$20240808$EXP$$FR-DSJP-DSJ-2021-104539$DAIICHI$$$$$F$Y$$$20240808$$MD$FR$FR
241910452$24191045$2$F$$20240726$20240808$20240812$PER$$US-Calliditas-2024CAL01061$CALLIDITAS THERAPEUTICS$$27$YR$A$M$Y$98.8$KG$20240812$$CN$US$US
241910461$24191046$1$I$20240216$20240731$20240808$20240808$EXP$$JP-APELLIS-2024-APL-0000642$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240807$$MD$JP$JP
241910471$24191047$1$I$20230101$20240731$20240808$20240808$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023278$UNITED THERAPEUTICS$$$$$F$Y$51.701$KG$20240808$$$US$US
241910482$24191048$2$F$20190101$20240809$20240808$20240816$EXP$$US-ABBVIE-5870385$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
241910491$24191049$1$I$20220101$20221020$20240808$20240808$EXP$$CA-DSJP-DSJ-2022-137165AA$DAIICHI$$$$$F$Y$26.7$KG$20240808$$PH$CA$CA
241910501$24191050$1$I$20240702$20240807$20240808$20240808$EXP$$US-GILEAD-2024-0683334$GILEAD$$72$YR$E$F$Y$$$20240808$$CN$US$US
241910511$24191051$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161764$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241910521$24191052$1$I$$20240803$20240808$20240808$EXP$$NVSC2024US158991$NOVARTIS$$$$$M$Y$$$20240808$$CN$US$US
241910541$24191054$1$I$$20240808$20240808$20240808$PER$$NVSC2024US161746$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241910551$24191055$1$I$20240803$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125662$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240808$$HP$US$US
241910561$24191056$1$I$$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125703$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240808$$CN$US$US
241910571$24191057$1$I$$20240801$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122401$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$81.19$KG$20240808$$CN$US$US
241910581$24191058$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124891$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240808$$CN$US$US
241910591$24191059$1$I$$20240805$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125140$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240808$$CN$US$US
241910601$24191060$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124796$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240808$$CN$US$US
241910611$24191061$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5871092$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241910621$24191062$1$I$20221123$20221123$20240808$20240808$EXP$$CA-DSJP-DSJ-2022-143718$DAIICHI$$48$YR$$F$Y$71$KG$20240808$$HP$CA$CA
241910631$24191063$1$I$$20240801$20240808$20240808$EXP$DE-EMA-DD-20240425-7482650-113624$DE-MYLANLABS-2024M1042348$MYLAN$Spangemacher M, Hart X, Saalfrank E, Gr?nder G, Reinwald J, Sartorius A.. Elevation of alpha-1 acid glycoprotein during acute infection increases clozapine levels without signs of intoxication. Pharmacopsychiatry.. 2024;54(2):92-3$58$YR$$M$Y$$$20240808$$HP$DE$DE
241910641$24191064$1$I$$20240801$20240808$20240808$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-23939$SAMSUNG BIOEPIS$$27$YR$A$M$Y$$$20240808$$CN$GB$GB
241910651$24191065$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA231523$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240808$$MD$US$US
241910661$24191066$1$I$$20240731$20240808$20240808$PER$$US-SA-2023SA137041$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240808$$MD$US$US
241910671$24191067$1$I$$20240808$20240808$20240808$DIR$713453$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
241910682$24191068$2$F$$20240806$20240808$20240815$PER$$US-SA-2024SA233747$SANOFI AVENTIS$$$$$M$Y$$$20240815$$CN$US$US
241910693$24191069$3$F$20240101$20240820$20240808$20240912$PER$$US-SA-2024SA232817$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240912$$MD$US$US
241910701$24191070$1$I$$20240731$20240808$20240808$PER$$US-SA-2024SA232009$SANOFI AVENTIS$$$$T$M$Y$43.7$KG$20240808$$MD$US$US
241910711$24191071$1$I$20240623$20240801$20240808$20240808$PER$$US-SA-2024SA233347$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240808$$MD$US$US
241910721$24191072$1$I$20240101$20240731$20240808$20240808$PER$$US-SA-2024SA231882$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240808$$MD$US$US
241910731$24191073$1$I$20240701$20240801$20240808$20240808$PER$$US-SA-2024SA231924$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240808$$MD$US$US
241910741$24191074$1$I$$20240805$20240808$20240808$PER$$US-SA-2024SA233753$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240808$$CN$US$US
241910751$24191075$1$I$20240701$20240801$20240808$20240808$PER$$US-SA-2024SA231989$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240808$$MD$US$US
241910761$24191076$1$I$$20240807$20240808$20240808$EXP$$US-TAKEDA-2024TUS079297$TAKEDA$$$$$F$Y$$$20240808$$CN$US$US
241910773$24191077$3$F$20240719$20240814$20240808$20240821$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-23472$SAMSUNG BIOEPIS$$67$YR$E$F$Y$$$20240821$$CN$AU$AU
241910781$24191078$1$I$20230101$20240802$20240808$20240808$EXP$$GR-MYLANLABS-2024M1072549$MYLAN$$69$YR$$M$Y$85$KG$20240808$$CN$GR$GR
241910791$24191079$1$I$$20240802$20240808$20240808$EXP$$BE-MYLANLABS-2024M1072653$MYLAN$$15$YR$$F$Y$$$20240808$$MD$BE$BE
241910801$24191080$1$I$20240316$20240326$20240808$20240808$EXP$$NVSC2024GB065411$NOVARTIS$$$$$F$Y$$$20240808$$CN$GB$GB
241910811$24191081$1$I$$20240806$20240808$20240808$PER$$US-ABBVIE-5871579$ABBVIE$$$$$$Y$$$20240808$$HP$US$US
241910821$24191082$1$I$20240713$20240807$20240808$20240808$EXP$$US-PFIZER INC-PV202400103366$PFIZER$$60$YR$$F$Y$$$20240808$$HP$US$US
241910841$24191084$1$I$20240723$20240808$20240808$20240808$EXP$GB-MHRA-MED-202408081155210080-FYCZN$GB-PFIZER INC-202400232901$PFIZER$$73$YR$$F$Y$65$KG$20240808$$PH$GB$GB
241910851$24191085$1$I$20230107$20240807$20240808$20240808$EXP$$JP-PFIZER INC-PV202400088053$PFIZER$$40$YR$$M$Y$68$KG$20240808$$MD$JP$JP
241910862$24191086$2$F$20230701$20240905$20240808$20240905$EXP$FR-AFSSAPS-BS2024000475$FR-PFIZER INC-202400229841$PFIZER$$24$YR$$F$Y$72$KG$20240905$$MD$FR$FR
241910871$24191087$1$I$20240729$20240805$20240808$20240808$EXP$FR-AFSSAPS-MA2024001305$FR-PFIZER INC-202400229936$PFIZER$$71$YR$$F$Y$$$20240808$$PH$FR$FR
241910882$24191088$2$F$$20240806$20240808$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408003602$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240812$$CN$US$US
241910891$24191089$1$I$20240401$20240802$20240808$20240808$EXP$FR-AFSSAPS-AN2024000959$FR-MYLANLABS-2024M1072623$MYLAN$$66$YR$$M$Y$$$20240808$$MD$FR$FR
241910901$24191090$1$I$20240730$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003534$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240808$$CN$US$US
241910911$24191091$1$I$$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004778$ELI LILLY AND CO$$$$$M$Y$$$20240808$$CN$US$US
241910922$24191092$2$F$$20240731$20240808$20240812$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407016673$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$BR$BR
241910941$24191094$1$I$$20240808$20240808$20240808$DIR$713457$$FDA-CTU$$36$YR$$F$N$83.7$KG$20240808$N$MD$US$
241910952$24191095$2$F$20240723$20240828$20240808$20240903$PER$$US-BELCHER PHARMACEUTICALS, LLC-2024US002518$PAREXEL$$$$$$Y$$$20240902$$HP$US$US
241910962$24191096$2$F$$20240812$20240808$20240822$EXP$$FR-TEVA-VS-3229229$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.; Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$75$YR$$M$Y$$$20240822$$HP$FR$FR
241910971$24191097$1$I$$20240619$20240808$20240808$PER$$US-LUNDBECK-DKLU4001157$LUNDBECK$$$$$$Y$$$20240808$$HP$US$US
241910981$24191098$1$I$$20240805$20240808$20240808$PER$$US-SA-2024SA233751$SANOFI AVENTIS$$$$$F$Y$$$20240808$$CN$US$US
241910991$24191099$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA233359$SANOFI AVENTIS$$$$C$M$Y$14.1$KG$20240808$$MD$US$US
241911011$24191101$1$I$20240430$20240729$20240808$20240808$EXP$FR-AFSSAPS-AN2024000825$FR-TEVA-VS-3229499$TEVA$$77$YR$$M$Y$$$20240808$$PH$FR$FR
241911021$24191102$1$I$20240101$20240802$20240808$20240808$EXP$$GB-AMGEN-GBRSL2024154316$AMGEN$$43$YR$A$M$Y$$$20240808$$CN$GB$GB
241911031$24191103$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161610$NOVARTIS$$$$$M$Y$$$20240808$$MD$US$US
241911041$24191104$1$I$$20240807$20240808$20240808$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044459$BOEHRINGER INGELHEIM$$$$$$Y$$$20240808$$MD$US$US
241911051$24191105$1$I$$20240801$20240808$20240808$PER$$US-INCYTE CORPORATION-2024IN008079$INCYTE$$$$$$Y$$$20240808$$CN$US$US
241911062$24191106$2$F$$20240908$20240808$20240909$30DAY$$US-PFIZER INC-202400227093$PFIZER$$53$YR$$F$Y$$$20240909$$CN$US$US
241911072$24191107$2$F$$20240908$20240808$20240909$30DAY$$US-PFIZER INC-202400227886$PFIZER$$11$YR$$F$Y$$$20240909$$CN$US$US
241911081$24191108$1$I$20240731$20240801$20240808$20240808$PER$$US-INCYTE CORPORATION-2024IN008082$INCYTE$$$$$$Y$$$20240808$$CN$US$US
241911091$24191109$1$I$$20240807$20240808$20240808$PER$$US-JNJFOC-20240817948$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240808$$HP$US$US
241911102$24191110$2$F$20240417$20240919$20240808$20240926$EXP$$NVSC2024NL159228$NOVARTIS$$$$E$F$Y$52$KG$20240926$$CN$NL$NL
241911111$24191111$1$I$20240701$20240801$20240808$20240808$PER$$US-INCYTE CORPORATION-2024IN008090$INCYTE$$$$$$Y$$$20240808$$CN$US$US
241911121$24191112$1$I$$20240806$20240808$20240808$PER$$US-ABBVIE-5870035$ABBVIE$$$$$$Y$$$20240808$$HP$US$US
241911131$24191113$1$I$20240807$20240808$20240808$20240808$DIR$713425$$FDA-CTU$$84$YR$$F$N$50.1$KG$20240808$N$PH$US$
241911141$24191114$1$I$$20240802$20240808$20240808$EXP$$BR-MYLANLABS-2024M1072998$MYLAN$$$$$M$Y$73$KG$20240808$$CN$BR$BR
241911152$24191115$2$F$20240304$20240802$20240808$20240813$EXP$ES-AEMPS-1553737$ES-MYLANLABS-2024M1072608$MYLAN$$76$YR$$F$Y$$$20240813$$MD$ES$ES
241911161$24191116$1$I$$20240719$20240808$20240808$EXP$$JP-OTSUKA-2020_024339$OTSUKA$$$$$F$Y$$$20240808$$CN$JP$JP
241911191$24191119$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229539$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$58$YR$$M$Y$$$20240808$$HP$FR$FR
241911205$24191120$5$F$20240101$20240830$20240808$20240903$PER$$US-SA-2024SA233451$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240903$$CN$US$US
241911211$24191121$1$I$20240701$20240802$20240808$20240808$EXP$PT-INFARMED-T202407-374$PT-MYLANLABS-2024M1072511$MYLAN$$84$YR$$F$Y$60$KG$20240808$$MD$PT$PT
241911231$24191123$1$I$$20240730$20240808$20240808$PER$$US-ABBVIE-5862647$ABBVIE$$$$$$Y$$$20240808$$MD$US$US
241911241$24191124$1$I$$20240802$20240808$20240808$EXP$$DE-PFIZER INC-2007050945$MYLAN$Lange-Asschenfeldt, C.. Bipolar Switching after Carbamazepine Withdrawal. Pharmacopsychiatry. 2007;40/2:86-87$74$YR$$M$Y$$$20240808$$HP$DE$DE
241911251$24191125$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229542$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$73$YR$$M$Y$$$20240808$$HP$FR$FR
241911261$24191126$1$I$20240727$20240730$20240808$20240808$EXP$$CN-INCYTE CORPORATION-2024IN008133$INCYTE$$$$$$Y$$$20240808$$HP$CN$CN
241911271$24191127$1$I$20240801$20240808$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044605$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240808$$CN$US$US
241911281$24191128$1$I$20230901$20240729$20240808$20240808$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000702$ELI LILLY AND CO$Tucker JM,Ritchie J.The Tirzepatide Drop: Beware of Slimmer s Paralysis.Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-7.DOI:https://doi.org/10.1177/23247096241264635$77$YR$E$M$Y$$$20240808$$MD$US$US
241911291$24191129$1$I$$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004782$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240808$$CN$US$US
241911301$24191130$1$I$20240802$20240805$20240808$20240808$PER$$US-ABBVIE-5867737$ABBVIE$$79$YR$$F$Y$58.059$KG$20240808$$CN$US$US
241911311$24191131$1$I$$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004773$ELI LILLY AND CO$$87$YR$E$F$Y$$$20240808$$CN$US$US
241911321$24191132$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003881$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241911331$24191133$1$I$$20240802$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408005342$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240808$$CN$US$US
241911341$24191134$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003887$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240808$$CN$US$US
241911351$24191135$1$I$20240601$20240802$20240808$20240808$PER$$US-SA-2024SA231302$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240808$$MD$US$US
241911361$24191136$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229569$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$79$YR$$M$Y$$$20240808$$HP$FR$FR
241911381$24191138$1$I$$20240801$20240808$20240808$PER$$US-ABBVIE-5865738$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241911391$24191139$1$I$$20240730$20240808$20240808$PER$$US-ABBVIE-5864072$ABBVIE$$$$$$Y$$$20240808$$HP$US$US
241911401$24191140$1$I$20220312$20240802$20240808$20240808$EXP$PL-URPL-DML-MLP.4401.1.757.2022$PL-MYLANLABS-2024M1072659$MYLAN$$64$YR$$F$Y$$$20240808$$PH$PL$PL
241911412$24191141$2$F$$20240823$20240808$20240902$EXP$$US-TEVA-VS-3228069$TEVA$Martin G, Narvaez-Guerra O, Aurigemma G, Kovell L. Peripartum ventricular tachycardia and PVC-induced cardiomyopathy: delivering optimal care when it^s time to deliver. BMJ-Case-Rep 2024; 17; Martin G, Narvaez-Guerra O, Aurigemma G, Kovell L. Peripartum ventricular tachycardia and PVC-induced cardiomyopathy: delivering optimal care when it^s time to deliver. BMJ-Case-Rep 2024; 17.; Martin G, Narvaez-Guerra O, Aurigemma G, Kovell L. Peripartum ventricular tachycardia and PVC-induced cardiomyop...$$$A$F$Y$$$20240902$$HP$US$US
241911431$24191143$1$I$20240611$20240802$20240808$20240808$EXP$FR-AFSSAPS-LL2024001483$FR-MYLANLABS-2024M1072781$MYLAN$$46$YR$$F$Y$$$20240808$$CN$FR$FR
241911452$24191145$2$F$20240804$20240823$20240808$20240828$EXP$$US-INCYTE CORPORATION-2024IN008188$INCYTE$$$$$$Y$$$20240828$$CN$US$US
241911461$24191146$1$I$20240514$20240805$20240808$20240808$EXP$$US-MYLANLABS-2024M1073180$MYLAN$$21$YR$$F$Y$52$KG$20240808$$MD$US$US
241911471$24191147$1$I$20240807$20240808$20240808$20240808$DIR$713454$$FDA-CTU$$74$YR$$M$N$$$20240808$N$PH$US$
241911481$24191148$1$I$$20240802$20240808$20240808$EXP$$AR-TAKEDA-2024TUS079198$TAKEDA$$$$$F$Y$$$20240808$$CN$AR$AR
241911491$24191149$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229532$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$76$YR$$M$Y$$$20240808$$HP$FR$FR
241911501$24191150$1$I$$20240802$20240808$20240808$PER$$US-SA-2024SA231168$SANOFI AVENTIS$$$$$F$Y$$$20240808$$HP$US$US
241911511$24191151$1$I$20240701$20240805$20240808$20240808$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043938$BOEHRINGER INGELHEIM$$17$YR$T$F$Y$$$20240808$$HP$FR$FR
241911521$24191152$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870228$ABBVIE$$$$A$F$Y$$$20240808$$MD$US$US
241911532$24191153$2$F$20240419$20240828$20240808$20240918$PER$$US-SA-2024SA229354$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240918$$MD$US$US
241911542$24191154$2$F$$20240808$20240808$20240809$EXP$$TW-AstraZeneca-2024A178741$ASTRAZENECA$Su C.-S., Kao C.-L.. Stevens-Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report. Journal of medical case reports 2024;18(1):344.$82$YR$$F$Y$$$20240809$$HP$TW$
241911552$24191155$2$F$$20240816$20240808$20240824$EXP$$US-AstraZeneca-2024A179419$ASTRAZENECA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure.. Journal of Neonatal-Perinatal Medicine 2024;1-6.$35$WK$$F$Y$$$20240823$$HP$US$
241911561$24191156$1$I$$20240802$20240808$20240808$EXP$$FR-MYLANLABS-2024M1072576$MYLAN$$25$YR$$$Y$52$KG$20240808$$CN$FR$FR
241911572$24191157$2$F$$20240918$20240808$20240927$30DAY$$AT-MYLANLABS-2024M1073001$MYLAN$$$$$$Y$$$20240927$$PH$AT$AT
241911581$24191158$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229549$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$42$YR$$M$Y$$$20240808$$HP$FR$FR
241911591$24191159$1$I$$20240805$20240808$20240808$EXP$$US-INCYTE CORPORATION-2024IN008239$INCYTE$$$$$$Y$$$20240808$$CN$US$US
241911601$24191160$1$I$20240101$20240729$20240808$20240808$PER$$US-MYLANLABS-2024M1071337$MYLAN$$$$$F$Y$61.23$KG$20240808$$CN$US$US
241911611$24191161$1$I$$20240806$20240808$20240808$EXP$$JP-JNJFOC-20240820656$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$PH$JP$JP
241911621$24191162$1$I$$20240731$20240808$20240808$PER$$US-MYLANLABS-2024M1072570$MYLAN$$55$YR$$F$Y$$$20240808$$CN$US$US
241911632$24191163$2$F$20210101$20240828$20240808$20240909$EXP$$JP-AMGEN-JPNSP2024156680$AMGEN$EP-0624 A case of Pegfilgrastim-induced splenic infarction during chemotherapy for Stage IV breast cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society (11, 12, and 13 JU. 333$57$YR$A$F$Y$$$20240909$$MD$JP$JP
241911641$24191164$1$I$20230220$20240806$20240808$20240808$PER$$US-GILEAD-2024-0680425$GILEAD$$62$YR$A$M$Y$84$KG$20240808$$MD$US$US
241911651$24191165$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229550$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$$$$F$Y$$$20240808$$HP$FR$FR
241911661$24191166$1$I$$20220927$20240808$20240808$EXP$$US-AstraZeneca-2022A333594$ASTRAZENECA$$$$$F$Y$70.3$KG$20240808$$CN$US$
241911671$24191167$1$I$$20220728$20240808$20240808$EXP$$US-AstraZeneca-2022A270831$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241911681$24191168$1$I$$20221101$20240808$20240808$EXP$$US-AstraZeneca-2022A363352$ASTRAZENECA$$$$$$Y$$$20240808$$CN$US$
241911691$24191169$1$I$$20240528$20240808$20240808$EXP$$US-MYLANLABS-2024M1072617$MYLAN$$$$$M$Y$$$20240808$$CN$US$US
241911701$24191170$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229551$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$$$$F$Y$$$20240808$$HP$FR$FR
241911711$24191171$1$I$20240729$20240807$20240808$20240808$PER$$CN-Eisai-EC-2024-171717$EISAI$$54$YR$A$F$Y$56$KG$20240808$$HP$CN$CN
241911722$24191172$2$F$20240716$20240821$20240808$20240826$PER$$JP-Eisai-EC-2024-170410$EISAI$$$$A$M$Y$$$20240826$$MD$JP$JP
241911732$24191173$2$F$$20240731$20240808$20240809$EXP$$NVSC2024TH156262$NOVARTIS$$49$YR$$M$Y$96$KG$20240809$$MD$TH$TH
241911741$24191174$1$I$20240808$20240808$20240808$20240808$DIR$713421$$FDA-CTU$$67$YR$$M$N$87.75$KG$20240808$N$CN$US$
241911751$24191175$1$I$20240801$20240802$20240808$20240808$PER$$US-ALXN-202408USA000142US$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240808$$CN$US$US
241911761$24191176$1$I$$20240801$20240808$20240808$EXP$$US-JAZZ-2021-US-025493$JAZZ$$$$$M$Y$$$20240808$$MD$US$US
241911771$24191177$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229534$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$53$YR$$M$Y$$$20240808$$HP$FR$FR
241911781$24191178$1$I$20240530$20240801$20240808$20240808$EXP$$JP-JNJFOC-20240673549$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240808$$PH$JP$JP
241911791$24191179$1$I$$20240729$20240808$20240808$EXP$$FR-TEVA-VS-3229568$TEVA$Trenque T, Hadjoudj J, Trenque A, Tralongo F, Martin S, Azzouz B. Statins and immune-mediated necrotizing myopathy: Variability in the risk. Therapie 2024; 79 (3): 365-370.$$$$F$Y$$$20240808$$HP$FR$FR
241911801$24191180$1$I$$20240805$20240808$20240808$EXP$$JP-PFIZER INC-PV202400101979$PFIZER$Shina, K.. A case of Ramsay-Hunt syndrome with multiple cranial nerve disorders. The 47th Annual Meeting of the Japanese Society of Facial Nerve Research. 2024;47th:104$30$YR$$M$Y$$$20240808$$HP$JP$JP
241911811$24191181$1$I$$20240807$20240808$20240808$EXP$$US-PAIPHARMA-2024-US-042478$PHARMACEUTICAL ASSOC$Carranza Morales A, Blanco Jimenez JA, Madhavan A.A painful case of asthma..American Journal of Respiratory and Critical Care Medicine.2024;209A5999.$43$YR$$F$Y$$$20240808$$HP$US$US
241911821$24191182$1$I$20240722$20240806$20240808$20240808$PER$$US-ABBVIE-5872012$ABBVIE$$46$YR$$F$Y$$$20240808$$HP$US$US
241911831$24191183$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161051$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241911842$24191184$2$F$$20240913$20240808$20240918$EXP$$US-TAKEDA-2024TUS078137$TAKEDA$$$$$F$Y$$$20240918$$MD$US$US
241911851$24191185$1$I$$20220819$20240808$20240808$EXP$$US-AstraZeneca-2022A292785$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241911861$24191186$1$I$$20230215$20240808$20240808$EXP$$US-AstraZeneca-2023A040132$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241911871$24191187$1$I$$20230519$20240808$20240808$EXP$$US-AstraZeneca-2023A117815$ASTRAZENECA$$$$$F$Y$$$20240808$$CN$US$
241911881$24191188$1$I$$20240806$20240808$20240808$PER$$US-PFIZER INC-202400231658$PFIZER$$50$YR$$F$Y$$$20240808$$CN$US$US
241911891$24191189$1$I$20240701$20240805$20240808$20240808$PER$$US-PFIZER INC-202400230429$PFIZER$$$$A$F$Y$$$20240808$$MD$US$US
241911901$24191190$1$I$$20240807$20240808$20240808$PER$$US-PFIZER INC-PV202400103382$PFIZER$$77$YR$$F$Y$$$20240808$$CN$US$US
241911912$24191191$2$F$$20240808$20240808$20240821$EXP$$US-ALXN-202408USA000074US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$MD$US$US
241911931$24191193$1$I$$20240730$20240808$20240808$EXP$$US-AMGEN-USASP2024151125$AMGEN$Moffaft, C:. Mucosal emphysematous head and neck infections:Scoping review and a case of emphysematous tonsillitis. Laryngoscope Investigative Otolaryngology. 2024;9 (3):1-8$38$YR$A$M$Y$$$20240808$$HP$US$US
241911941$24191194$1$I$$20240806$20240808$20240808$EXP$$GB-MYLANLABS-2024M1073730$MYLAN$$$$$F$Y$$$20240808$$MD$GB$GB
241911952$24191195$2$F$$20240903$20240808$20240913$EXP$$US-TEVA-VS-3228268$TEVA$Afriyie F, Gilani N, Fanous M, Mansoor A, Shah K, Waller AH. CHASING THE HIGH TOWARDS DEATH, A CASE OF LOPERAMIDE INDUCED CARDIAC ARREST. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 2941 (plus Poster) abstr. 1200-074.; Afriyie F, Gilani N, Fanous M, Mansoor A, Shah K, Waller AH. CHASING THE HIGH TOWARDS DEATH, A CASE OF LOPERAMIDE INDUCED CARDIAC ARREST. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 2941 (plus Poster) abstr. 1200-074.$49$YR$$M$Y$$$20240913$$HP$US$US
241911971$24191197$1$I$20240101$20240801$20240808$20240808$PER$$CA-Eisai-EC-2024-171745$EISAI$$68$YR$E$F$Y$$$20240808$$CN$CA$CA
241911983$24191198$3$F$20231218$20240824$20240808$20240829$EXP$$EG-SANDOZ INC.-SDZ2024EG071172$SANDOZ$$26$YR$$F$Y$90$KG$20240829$$CN$EG$EG
241911992$24191199$2$F$20200609$20240917$20240808$20240926$EXP$$DE-SANDOZ INC.-NVSC2020DE172839$SANDOZ$$$$E$F$Y$60.4$KG$20240926$$MD$DE$DE
241912001$24191200$1$I$20240801$20240806$20240808$20240808$EXP$GB-MHRA-31414899$GB-SANDOZ INC.-SDZ2024GB071160$SANDOZ$$94$YR$$M$Y$$$20240808$$CN$GB$GB
241912022$24191202$2$F$$20240903$20240808$20240913$EXP$$US-TEVA-VS-3228270$TEVA$Gwiazdowski M, Niraula S, Bewley B. A Unique Case Presentation of Takotsubo Cardiomyopathy After Cardiac Arrest and Resuscitation Without CPR. Am-J-Respir-Crit-Care-Med 2023; 207 no pagination.; Gwiazdowski M, Niraula S, Bewley B. A Unique Case Presentation of Takotsubo Cardiomyopathy After Cardiac Arrest and Resuscitation Without CPR. Am-J-Respir-Crit-Care-Med 2023; 207 no pagination.$81$YR$$F$Y$$$20240913$$HP$US$US
241912041$24191204$1$I$$20240806$20240808$20240808$EXP$$NVSC2024RU159165$NOVARTIS$Golubovskaya DP, Dren EV, Yurkina AV, Pecherina TB, Barbarash OA. ??????????? ?????? ????????????????? ?????????? (ATTR- ?????????) ? ?????????????? ???????? ??????????? ????????? ???????????????. ??????????? ?????? (Clinical case of generalized amyloidosis (ATTR-amyloidosis) with a progressive course of chronic heart failure. Case report). TERAPEVTICHESKII ARKHIV. 2024;96 (7):695-700$45$YR$$M$Y$$$20240808$$HP$RU$RU
241912051$24191205$1$I$$20240726$20240808$20240808$EXP$GB-MHRA-MED-202407261041489380-GRVLC$GB-ELI_LILLY_AND_COMPANY-GB202407018270$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$GB$GB
241912061$24191206$1$I$20240103$20240731$20240808$20240808$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000532$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240808$$CN$US$US
241912071$24191207$1$I$$20240729$20240808$20240808$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407020452$ELI LILLY AND CO$$$$$M$Y$$$20240808$$CN$JP$JP
241912081$24191208$1$I$20240715$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003860$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$US$US
241912091$24191209$1$I$20240705$20240728$20240808$20240808$EXP$GB-MHRA-MED-202407281948543020-TDLQB$GB-ELI_LILLY_AND_COMPANY-GB202407018211$ELI LILLY AND CO$$38$YR$A$F$Y$88$KG$20240808$$CN$GB$GB
241912101$24191210$1$I$$20240726$20240808$20240808$EXP$GB-MHRA-MED-202407261233149830-GZMBK$GB-ELI_LILLY_AND_COMPANY-GB202407018189$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240808$$CN$GB$GB
241912111$24191211$1$I$$20240727$20240808$20240808$EXP$GB-MHRA-MED-202407271406040560-GNLRP$GB-ELI_LILLY_AND_COMPANY-GB202407018188$ELI LILLY AND CO$$22$YR$A$M$Y$97$KG$20240808$$CN$GB$GB
241912121$24191212$1$I$$20240807$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004750$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240808$$CN$US$US
241912131$24191213$1$I$20211201$20240806$20240808$20240808$EXP$CA-002147023-NVSC2020CA349669$CA-SANDOZ INC.-NVSC2020CA349669$SANDOZ$$40$YR$$F$Y$$$20240808$$CN$CA$CA
241912141$24191214$1$I$20240716$20240726$20240808$20240808$EXP$GB-MHRA-MED-202407261112443980-YWVCP$GB-ELI_LILLY_AND_COMPANY-GB202407018274$ELI LILLY AND CO$$33$YR$A$F$Y$82$KG$20240808$$CN$GB$GB
241912152$24191215$2$F$20240617$20240920$20240808$20240924$EXP$$DE-SANDOZ INC.-SDZ2024DE071273$SANDOZ$$76$YR$$M$Y$$$20240924$$MD$DE$DE
241912161$24191216$1$I$$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003540$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240808$$CN$US$US
241912171$24191217$1$I$20240712$20240726$20240808$20240808$EXP$GB-MHRA-MED-202407261101472300-RTLPK$GB-ELI_LILLY_AND_COMPANY-GB202407018272$ELI LILLY AND CO$$59$YR$A$F$Y$144$KG$20240808$$CN$GB$GB
241912181$24191218$1$I$$20240801$20240808$20240808$PER$$US-ABBVIE-5866101$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241912191$24191219$1$I$$20240731$20240808$20240808$EXP$$PL-AstraZeneca-2024A154663$ASTRAZENECA$Kolczynska N, Masajtis-Zagajewska A, Jagodzinska M, Nowicki M.. Bilateral renal arteries stenosis in a patient with treatment-resistant hypertension and acute kidney injury.. POL NEPHROL DIAL. 2024;28(2):27-28.$49$YR$$M$Y$$$20240808$$MD$PL$
241912201$24191220$1$I$$20240806$20240808$20240808$EXP$$CN-PFIZER INC-PV202400102021$PFIZER$$$$E$M$Y$$$20240808$$CN$CN$CN
241912211$24191221$1$I$$20240807$20240808$20240808$EXP$$GB-PFIZER INC-PV202400103402$PFIZER$$85$YR$$M$Y$$$20240808$$CN$GB$GB
241912232$24191223$2$F$$20240813$20240808$20240823$EXP$$IT-TEVA-VS-3229938$TEVA$Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports. J-Pediatr-Hematol-Oncol 2024; 0 (0): 1-4.; Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatr...$15$YR$$M$Y$$$20240823$$MD$IT$IT
241912241$24191224$1$I$$20240807$20240808$20240808$30DAY$$US-SANDOZ INC.-SDZ2024US008906$SANDOZ$$$$$F$Y$$$20240808$$CN$US$US
241912251$24191225$1$I$20240722$20240807$20240808$20240808$EXP$$NO-GILEAD-2024-0683336$GILEAD$$72$YR$E$M$Y$80$KG$20240808$$MD$NO$NO
241912271$24191227$1$I$$20240802$20240808$20240808$EXP$$US-ABBVIE-5867417$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241912281$24191228$1$I$20240704$20240730$20240808$20240808$EXP$FR-AFSSAPS-NT2024000909$FR-TEVA-VS-3228406$TEVA$$82$YR$$M$Y$$$20240808$$PH$FR$FR
241912292$24191229$2$F$20230101$20240731$20240808$20240904$EXP$$US-SA-2024SA226680$SANOFI AVENTIS$$$$A$F$Y$$$20240904$$MD$US$US
241912302$24191230$2$F$$20240813$20240808$20240823$EXP$$PT-TEVA-VS-3229775$TEVA$Tavares JA, Carvalho J, Carneiro P, Emidio C, Palma C, Pereira R, et al. DISTRIBUTIVE SHOCK IS NOT ALWAYS A SEPTIC SHOCK - A CLINICAL CASE. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl. 1) 219.; Tavares JA, Carvalho J, Carneiro P, Emidio C, Palma C, Pereira R, et al. DISTRIBUTIVE SHOCK IS NOT ALWAYS A SEPTIC SHOCK - A CLINICAL CASE. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl. 1) 219.$47$YR$$F$Y$$$20240823$$HP$PT$PT
241912311$24191231$1$I$$20240807$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044574$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$$$20240808$$HP$US$US
241912321$24191232$1$I$20231001$20240731$20240808$20240808$EXP$$DE-TEVA-VS-3228949$TEVA$$1$DY$$M$Y$2.13$KG$20240808$$MD$DE$DE
241912332$24191233$2$F$20240516$20240903$20240808$20240919$EXP$$CO-MYLANLABS-2024M1073345$MYLAN$$15$YR$$M$Y$15$KG$20240919$$CN$CO$CO
241912342$24191234$2$F$$20240904$20240808$20240904$PER$$US-ALXN-202408USA000167US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
241912353$24191235$3$F$$20240909$20240808$20240909$PER$$US-ALXN-202408USA000166US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
241912361$24191236$1$I$$20240731$20240808$20240808$PER$$US-ABBVIE-5863354$ABBVIE$$$$$$Y$$$20240808$$HP$US$US
241912371$24191237$1$I$$20240730$20240808$20240808$EXP$$CA-TEVA-VS-3227560$TEVA$$80$YR$$F$Y$$$20240808$$PH$CA$CA
241912382$24191238$2$F$$20240813$20240808$20240823$EXP$$PT-TEVA-VS-3229891$TEVA$Real LL, Rodrigues AC, Araujo PS, Iashchuk M, Silva D, Quelhas M, et al. FEVER IN COVID-19 TIMES. Eur-J-Case-Rep-Intern-Med 2022; 9 (Suppl.) 378.; Real LL, Rodrigues AC, Araujo PS, Iashchuk M, Silva D, Quelhas M, et al. FEVER IN COVID-19 TIMES. Eur-J-Case-Rep-Intern-Med 2022; 9 (Suppl.) 378.$68$YR$$F$Y$$$20240823$$HP$PT$PT
241912391$24191239$1$I$$20240731$20240808$20240808$EXP$$FR-BAUSCH-BL-2024-011664$BAUSCH AND LOMB$Dollo I, Menu E, Dudouet P, Aubry C, L^Ollivier C, Ranque S. Cryptococcosis at the university hospital of Marseille: A case series. Journal of Medical Mycology. 2024;34:1-8. doi:10.1016/j.mycmed.2024.101500$19$YR$$M$Y$$$20240808$$HP$FR$FR
241912401$24191240$1$I$$20240729$20240808$20240808$EXP$$RU-TEVA-VS-3229772$TEVA$Gantsgorn EV, Archakova MA, Manvelyan RM, Malleev IM, Antonyan BG, Dzangiev II, et al. A CLINICAL CASE OF CARBAMAZEPINE-INDUCED HEPATITIS. [Russian]. Eksp-Klin-Farmakol 2024; 87 (1): 21-24.$31$YR$$F$Y$$$20240808$$HP$RU$RU
241912411$24191241$1$I$$20240805$20240808$20240808$PER$$US-ABBVIE-5867687$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241912421$24191242$1$I$$20240801$20240808$20240808$EXP$$US-BAUSCH-BL-2024-011935$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240808$$CN$US$US
241912432$24191243$2$F$20240501$20240830$20240808$20240905$EXP$FR-AFSSAPS-RE2024000754$FR-009507513-2408FRA000822$MERCK$$46$YR$$F$Y$$$20240905$$HP$FR$FR
241912442$24191244$2$F$20170101$20240812$20240808$20240822$EXP$$IT-TEVA-VS-3229166$TEVA$Busutti M, Baraldi O, Porcu CV, Samele G, Campus A, Grandinetti V, et al. Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn^s Disease. Kidney-Int-Rep 2023; 8 (8): 1676-1679.; Busutti M, Baraldi O, Porcu CV, Samele G, Campus A, Grandinetti V, et al. Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn^s Disease. Kidney-Int-Rep 2023; 8 (8): 1676-1679.; Busutti M, Baraldi O, Porcu CV, Samele G, Campus A, Grandinetti V, et al. Safety and Effica...$$$$M$Y$$$20240822$$HP$IT$IT
241912451$24191245$1$I$$20240806$20240808$20240808$EXP$$GB-MYLANLABS-2024M1073502$MYLAN$$$$$M$Y$$$20240808$$HP$GB$GB
241912462$24191246$2$F$$20240829$20240808$20240906$EXP$$CA-TEVA-VS-3227625$TEVA$$73$YR$$F$Y$$$20240906$$HP$CA$CA
241912472$24191247$2$F$20240509$20240809$20240808$20240814$EXP$$NVSC2024US099519$NOVARTIS$$33$YR$$M$Y$$$20240814$$CN$US$US
241912481$24191248$1$I$$20240802$20240808$20240808$EXP$$DE-MYLANLABS-2024M1073883$MYLAN$Zielinski N, Baiceanu D, Dragomir A, Heyckendorf J, Ibraim E, Kohler N, et al. A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis. Pathog-Immun 2024; 9 (2): 25-42.$$$A$$Y$$$20240808$$MD$DE$DE
241912491$24191249$1$I$$20240731$20240808$20240808$EXP$$GB-Karo Pharma-2160188$Karo Pharma$$$$$F$Y$$$20240808$$$GB$GB
241912501$24191250$1$I$$20240726$20240808$20240808$EXP$$GB-B.Braun Medical Inc.-2160189$B BRAUN$$$$$$Y$$$20240808$$$GB$GB
241912511$24191251$1$I$$20240725$20240808$20240808$PER$$US-PharmaLex US Corporation-2160191$PHARMALEX$$61$YR$$F$Y$$$20240808$$MD$US$US
241912521$24191252$1$I$$20240730$20240808$20240808$PER$$US-Karo Pharma-2160190$Karo Pharma$$40$YR$$F$Y$$$20240808$$$US$US
241912531$24191253$1$I$$20240726$20240808$20240808$PER$$US-PharmaLex US Corporation-2160192$PHARMALEX$$62$YR$$M$Y$$$20240808$$MD$US$US
241912542$24191254$2$F$$20240826$20240808$20240826$PER$$US-ALXN-202408USA000122US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241912552$24191255$2$F$20240701$20240827$20240808$20240828$PER$$US-ALXN-202408USA000164US$ALEXION PHARMACEUTICALS$$42$YR$$F$Y$$$20240828$$CN$US$US
241912561$24191256$1$I$$20240806$20240808$20240808$PER$$US-JNJFOC-20240816986$JOHNSON AND JOHNSON$$$$$$Y$$$20240808$$PH$US$US
241912574$24191257$4$F$20240716$20240912$20240808$20240920$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004913$SAREPTA THERAPEUTICS$$4$YR$$M$Y$20.9$KG$20240920$$HP$US$US
241912582$24191258$2$F$20240819$20240820$20240808$20240826$EXP$$GB-MYLANLABS-2024M1069253$MYLAN$$$$$M$Y$$$20240826$$CN$GB$GB
241912592$24191259$2$F$$20240829$20240808$20240906$EXP$$CA-TEVA-VS-3227618$TEVA$$86$YR$$M$Y$$$20240906$$HP$CA$CA
241912601$24191260$1$I$20240802$20240806$20240808$20240808$EXP$$US-Taiho Oncology Inc-2024-007589$TAIHO ONCOLOGY INC$$59$YR$A$F$Y$$$20240808$$CN$US$US
241912611$24191261$1$I$20200501$20240731$20240808$20240808$EXP$PL-URPL-1-3710-2020$PL-TEVA-VS-3228971$TEVA$$57$YR$$F$Y$75$KG$20240808$$MD$PL$PL
241912621$24191262$1$I$$20240806$20240808$20240808$EXP$GB-MHRA-MED-202408061607072160-KTSDZ$GB-MYLANLABS-2024M1073865$MYLAN$$$$$M$Y$$$20240808$$CN$GB$GB
241912632$24191263$2$F$20180101$20240812$20240808$20240822$EXP$$PL-TEVA-VS-3229768$TEVA$Kolodziejczyk B, Gazda A, Naishtetik I, Gietka P, Kmiec T. Linear scleroderma of the head, face and rasmusen syndrome-case report. Pediatr-Rheumatol 2023; 21 (Suppl. 2) 143 abstr. P145.; Kolodziejczyk B, Gazda A, Naishtetik I, Gietka P, Kmiec T. Linear scleroderma of the head, face and rasmusen syndrome-case report. Pediatr-Rheumatol 2023; 21 (Suppl. 2) 143 abstr. P145.; Kolodziejczyk B, Gazda A, Naishtetik I, Gietka P, Kmiec T. Linear scleroderma of the head, face and rasmusen syndrome-case ...$8$YR$$M$Y$$$20240822$$HP$PL$PL
241912643$24191264$3$F$20240320$20240828$20240808$20240828$EXP$$US-ALXN-202408USA000114US$ALEXION PHARMACEUTICALS$$7$YR$$F$Y$26.6$KG$20240828$$MD$US$US
241912651$24191265$1$I$20240707$20240731$20240808$20240808$EXP$FR-AFSSAPS-AN2024000947$FR-TAKEDA-2024TUS079065$TAKEDA$$71$YR$$M$Y$73$KG$20240808$$HP$FR$FR
241912662$24191266$2$F$$20240920$20240808$20240920$PER$$NVSC2024US161766$NOVARTIS$$$$$F$Y$$$20240920$$HP$US$US
241912671$24191267$1$I$20240723$20240808$20240808$20240808$EXP$FR-AFSSAPS-LY2024001216$NVSC2024FR161525$NOVARTIS$$61$YR$$F$Y$65$KG$20240808$$PH$FR$FR
241912681$24191268$1$I$$20240730$20240808$20240808$EXP$$CA-TEVA-VS-3227601$TEVA$$3$YR$$M$Y$17$KG$20240808$$HP$CA$CA
241912691$24191269$1$I$20240601$20240806$20240808$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008592$JAZZ$$66$YR$$F$Y$$$20240808$$CN$US$US
241912711$24191271$1$I$20240101$20240731$20240808$20240808$EXP$$CN-009507513-2407CHN015805$MERCK$$62$YR$$M$Y$$$20240808$$CN$CN$CN
241912725$24191272$5$F$20220601$20240906$20240808$20240914$EXP$$US-ABBVIE-5869465$ABBVIE$$71$YR$$M$Y$83$KG$20240914$$CN$US$US
241912731$24191273$1$I$20240805$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125687$BRISTOL MYERS SQUIBB$$71$YR$E$$Y$$$20240808$$PH$US$US
241912741$24191274$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125109$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240808$$CN$US$US
241912751$24191275$1$I$$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125532$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240808$$HP$US$US
241912762$24191276$2$F$$20240816$20240808$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124220$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240827$$HP$US$US
241912771$24191277$1$I$20240727$20240805$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124867$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240808$$CN$US$US
241912781$24191278$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125043$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240808$$CN$US$US
241912791$24191279$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125407$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$109.77$KG$20240808$$CN$US$US
241912801$24191280$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125797$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240808$$CN$US$US
241912811$24191281$1$I$20240806$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125827$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240808$$CN$US$US
241912821$24191282$1$I$$20240731$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122013$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240808$$MD$US$US
241912841$24191284$1$I$20240726$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123569$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240808$$CN$US$US
241912851$24191285$1$I$$20240801$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122031$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240808$$HP$US$US
241912871$24191287$1$I$$20240806$20240808$20240808$EXP$$AU-PURDUE-USA-2024-0311244$PURDUE$Syrjanen R, Schumann JL, Castle JW, Sharp L, Griffiths A, Blakey K, Dutch M, Maplesden J, Greene SL.. Protonitazene detection in two cases of opioid toxicity following the use of tetrahydrocannabinol vape products in Australia. Clinical Toxicology. 2024$$$T$M$Y$$$20240808$$HP$AU$AU
241912882$24191288$2$F$$20240904$20240808$20240911$EXP$$US-ANIPHARMA-2024-US-042028$ANI$$56$YR$$F$Y$$$20240911$$CN$US$US
241912891$24191289$1$I$$20240729$20240808$20240808$PER$$US-JNJFOC-20240820476$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241912901$24191290$1$I$$20240807$20240808$20240808$PER$$US-JNJFOC-20240820211$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241912911$24191291$1$I$20240729$20240729$20240808$20240808$PER$$US-JNJFOC-20240820570$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240808$$HP$US$US
241912922$24191292$2$F$$20240924$20240808$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125555$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$49.9$KG$20240925$$CN$US$US
241912931$24191293$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124608$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240808$$HP$US$US
241912941$24191294$1$I$20240801$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125054$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$69.4$KG$20240808$$CN$US$US
241912951$24191295$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124931$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240808$$PH$US$US
241912971$24191297$1$I$$20240806$20240808$20240808$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-125299$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240808$$HP$TW$TW
241912983$24191298$3$F$20240701$20240828$20240808$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125595$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$68.4$KG$20240902$$PH$US$US
241912991$24191299$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125723$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240808$$CN$US$US
241913003$24191300$3$F$20240801$20240830$20240808$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123892$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240903$$CN$US$US
241913012$24191301$2$F$$20240913$20240808$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125692$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240919$$CN$US$US
241913021$24191302$1$I$$20240805$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125067$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240808$$CN$US$US
241913031$24191303$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125839$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240808$$CN$US$US
241913041$24191304$1$I$$20240730$20240808$20240808$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-121909$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240808$$MD$GB$GB
241913051$24191305$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124851$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$CN$US$US
241913071$24191307$1$I$$20240805$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125304$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$70$KG$20240808$$MD$US$US
241913081$24191308$1$I$$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124154$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$57.61$KG$20240808$$CN$US$US
241913091$24191309$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125467$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240808$$HP$US$US
241913101$24191310$1$I$$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124749$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240808$$CN$US$US
241913111$24191311$1$I$$20240731$20240808$20240808$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-122643$BRISTOL MYERS SQUIBB$Weinbergerova B, Mayer J, Kabut T, Sperr WR, Stevkova J, Jonasova A, et al. Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis. British Journal of Haematology. 2024 Jul 23;1-5.doi:10.1111/ bjh.19670.$65$YR$E$$Y$$$20240808$$HP$CZ$CZ
241913122$24191312$2$F$$20240906$20240808$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125483$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$73.48$KG$20240909$$CN$US$US
241913131$24191313$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125550$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240808$$CN$US$US
241913141$24191314$1$I$$20240730$20240808$20240808$EXP$$CA-TEVA-VS-3227587$TEVA$$89$YR$$F$Y$52$KG$20240808$$PH$CA$CA
241913151$24191315$1$I$$20240802$20240808$20240808$PER$$US-ABBVIE-5867434$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241913161$24191316$1$I$$20240730$20240808$20240808$EXP$$CA-TEVA-VS-3227549$TEVA$$88$YR$$M$Y$$$20240808$$HP$CA$CA
241913171$24191317$1$I$$20240806$20240808$20240808$EXP$$NVSC2024US112590$NOVARTIS$$$$$F$Y$$$20240808$$CN$US$US
241913182$24191318$2$F$$20240814$20240808$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125505$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240826$$CN$US$US
241913191$24191319$1$I$20240731$20240731$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121716$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240808$$HP$US$US
241913201$24191320$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124962$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240808$$HP$US$US
241913211$24191321$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123990$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240808$$CN$US$US
241913221$24191322$1$I$20240630$20240731$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122350$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240808$$CN$US$US
241913231$24191323$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124718$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240808$$CN$US$US
241913241$24191324$1$I$20240731$20240807$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125041$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240808$$HP$US$US
241913251$24191325$1$I$$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123286$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240808$$MD$US$US
241913271$24191327$1$I$$20240729$20240808$20240808$EXP$$IT-TEVA-VS-3229939$TEVA$Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports. J-Pediatr-Hematol-Oncol 2024; 0 (0): 1-4.; Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatr...$13$YR$$M$Y$$$20240808$$MD$IT$IT
241913281$24191328$1$I$20240722$20240729$20240808$20240808$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07589$NEUROCRINE BIOSCIENCES$$49$YR$$M$Y$$$20240808$$CN$US$US
241913291$24191329$1$I$$20240619$20240808$20240808$PER$$US-LUNDBECK-DKLU4001155$LUNDBECK$$$$$$Y$$$20240808$$CN$US$US
241913301$24191330$1$I$$20240807$20240808$20240808$PER$$US-PURDUE PHARMA-USA-2024-0311204$PURDUE$$32$YR$$F$Y$$$20240808$$CN$US$US
241913314$24191331$4$F$$20240903$20240808$20240910$PER$$US-PURDUE-USA-2024-0311203$PURDUE$$$$$F$Y$72.57$KG$20240910$$CN$US$US
241913322$24191332$2$F$$20240808$20240808$20240812$EXP$$US-PURDUE PHARMA-USA-2024-0311201$PURDUE$$28$YR$$M$Y$$$20240812$$CN$US$US
241913331$24191333$1$I$$20240807$20240808$20240808$PER$$US-PURDUE PHARMA-USA-2024-0311206$PURDUE$$$$$F$Y$$$20240808$$CN$US$US
241913341$24191334$1$I$$20240807$20240808$20240808$PER$$US-PURDUE PHARMA-USA-2024-0311205$PURDUE$$35$YR$$F$Y$$$20240808$$CN$US$US
241913351$24191335$1$I$$20240807$20240808$20240808$PER$$US-PURDUE PHARMA-USA-2024-0311208$PURDUE$$$$$M$Y$$$20240808$$CN$US$US
241913361$24191336$1$I$20230303$20240807$20240808$20240808$PER$$US-PURDUE PHARMA-USA-2024-0311202$PURDUE$$27$YR$$M$Y$$$20240808$$CN$US$US
241913371$24191337$1$I$$20240731$20240808$20240808$EXP$CZ-CZSUKL-24002123$CZ-TEVA-VS-3229350$TEVA$$39$YR$$F$Y$71$KG$20240808$$CN$CZ$CZ
241913391$24191339$1$I$$20240805$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125112$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240808$$HP$US$US
241913401$24191340$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125214$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240808$$CN$US$US
241913411$24191341$1$I$$20240806$20240808$20240808$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125126$BRISTOL MYERS SQUIBB$$96$YR$E$M$Y$$$20240808$$CN$US$US
241913431$24191343$1$I$20240525$20240802$20240808$20240808$EXP$PT-INFARMED-F202407-700$PT-MYLANLABS-2024M1072841$MYLAN$$40$YR$$F$Y$$$20240808$$PH$PT$PT
241913441$24191344$1$I$$20240730$20240808$20240808$EXP$$CA-TEVA-VS-3227632$TEVA$$$$A$$Y$$$20240808$$HP$CA$CA
241913461$24191346$1$I$20221201$20240801$20240808$20240808$PER$$US-JNJFOC-20240804447$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240808$$CN$US$US
241913471$24191347$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125499$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240808$$CN$US$US
241913482$24191348$2$F$$20240829$20240808$20240831$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125397$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240831$$HP$US$US
241913491$24191349$1$I$20240501$20240726$20240808$20240808$PER$$US-JNJFOC-20240816048$JOHNSON AND JOHNSON$$$$$M$Y$$$20240808$$CN$US$US
241913501$24191350$1$I$$20240806$20240808$20240808$PER$$US-BIOMARINAP-US-2024-159669$BIOMARIN$$$$$$Y$$$20240808$$CN$US$US
241913511$24191351$1$I$$20240803$20240808$20240808$PER$$US-BIOMARINAP-US-2024-159645$BIOMARIN$$$$$$Y$$$20240808$$CN$US$US
241913521$24191352$1$I$$20240805$20240808$20240808$PER$$US-BIOMARINAP-US-2024-159660$BIOMARIN$$$$$$Y$$$20240808$$CN$US$US
241913531$24191353$1$I$$20240805$20240808$20240808$PER$$US-BIOMARINAP-US-2024-159657$BIOMARIN$$$$$$Y$$$20240808$$CN$US$US
241913541$24191354$1$I$$20240806$20240808$20240808$PER$$US-BIOMARINAP-US-2024-159663$BIOMARIN$$$$$$Y$$$20240808$$CN$US$US
241913551$24191355$1$I$$20240805$20240808$20240808$PER$$US-BIOMARINAP-US-2024-159662$BIOMARIN$$$$$$Y$$$20240808$$CN$US$US
241913561$24191356$1$I$20240802$20240805$20240808$20240808$EXP$$US-BAYER-2024A113528$BAYER$$71$YR$E$F$Y$$$20240808$$CN$US$US
241913571$24191357$1$I$$20221125$20240808$20240808$EXP$$US-AstraZeneca-2022A394481$ASTRAZENECA$$$$$F$Y$$$20240808$$HP$US$
241913582$24191358$2$F$$20240731$20240808$20240813$EXP$$IE-Hugel Aesthetics-2160194$Hugel Aesthetics$$35$YR$$F$Y$$$20240813$$$IE$IE
241913592$24191359$2$F$20240730$20240806$20240808$20240813$EXP$$CO-BIOMARINAP-CO-2024-159635$BIOMARIN$$$$$$Y$$$20240813$$CN$CO$CO
241913601$24191360$1$I$$20240801$20240808$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012074$JAZZ$$$$$F$Y$$$20240808$$CN$US$US
241913611$24191361$1$I$$20240805$20240808$20240808$EXP$$US-BIOMARINAP-US-2024-159668$BIOMARIN$$$$$$Y$$$20240808$$CN$US$US
241913622$24191362$2$F$$20240826$20240808$20240826$PER$$US-ALXN-202408USA000176US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
241913631$24191363$1$I$20231013$20240807$20240808$20240808$EXP$$US-GILEAD-2024-0683338$GILEAD$$$$$M$Y$$$20240808$$HP$US$US
241913662$24191366$2$F$$20240821$20240808$20240822$EXP$$NVSC2024CN161509$NOVARTIS$$38$YR$$F$Y$$$20240822$$CN$CN$CN
241913671$24191367$1$I$20240615$20240731$20240808$20240808$EXP$FR-AFSSAPS-MA2024001180$FR-009507513-2408FRA000283$MERCK$$18$YR$$F$Y$68$KG$20240808$$MD$FR$FR
241913681$24191368$1$I$20240601$20240731$20240808$20240808$EXP$$BR-TAKEDA-2024TUS078155$TAKEDA$$42$YR$$M$Y$$$20240808$$CN$BR$BR
241913691$24191369$1$I$20240701$20240801$20240808$20240808$PER$$US-BAUSCHBL-2024BNL031040$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240808$$MD$US$US
241913701$24191370$1$I$$20240808$20240808$20240808$PER$$NVSC2024US161747$NOVARTIS$$$$$$Y$$$20240808$$HP$US$US
241913711$24191371$1$I$20240801$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125782$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240808$$CN$US$US
241913721$24191372$1$I$20240701$20240801$20240808$20240808$PER$$US-BAUSCHBL-2024BNL031039$BAUSCH AND LOMB$$78$YR$$F$Y$$$20240808$$CN$US$US
241913732$24191373$2$F$20240727$20240808$20240808$20240812$EXP$FR-AFSSAPS-PB2024000860$FR-ABBVIE-5871405$ABBVIE$$67$YR$$M$Y$66$KG$20240812$$PH$FR$FR
241913741$24191374$1$I$20240625$20240730$20240808$20240808$EXP$FR-AFSSAPS-TO2024001356$FR-TEVA-VS-3228363$TEVA$$67$YR$$M$Y$68$KG$20240808$$PH$FR$FR
241913751$24191375$1$I$20240729$20240731$20240808$20240808$PER$$US-009507513-2408USA000309$MERCK$$69$YR$$M$Y$$$20240808$$CN$US$US
241913762$24191376$2$F$$20240825$20240808$20240828$EXP$$BR-TAKEDA-2024TUS069908$TAKEDA$$$$$F$Y$56$KG$20240828$$MD$BR$BR
241913771$24191377$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125170$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240808$$HP$US$US
241913781$24191378$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125575$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$51.26$KG$20240808$$CN$US$US
241913791$24191379$1$I$20240515$20240801$20240808$20240808$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-107502$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$86$KG$20240808$$MD$FR$FR
241913801$24191380$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125834$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240808$$CN$US$US
241913811$24191381$1$I$$20240729$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407019357$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240808$$CN$US$US
241913821$24191382$1$I$20231206$20240726$20240808$20240808$EXP$$GB-MAYNE PHARMA-2024MYN000326$MAYNE$$$$$$Y$$$20240808$$CN$GB$GB
241913841$24191384$1$I$$20240808$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-026983$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240808$$CN$US$US
241913854$24191385$4$F$20240402$20240910$20240808$20240915$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-022954$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240915$$CN$US$US
241913861$24191386$1$I$20240701$20240808$20240808$20240808$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044593$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240808$$CN$US$US
241913871$24191387$1$I$$20240806$20240808$20240808$PER$$US-ABBVIE-5871147$ABBVIE$$$$$$Y$$$20240808$$HP$US$US
241913882$24191388$2$F$$20240805$20240808$20240812$EXP$GB-MHRA-MED-202408051436201010-PNQJC$GB-009507513-2408GBR001654$MERCK$$$$$$Y$$$20240812$$PH$GB$GB
241913891$24191389$1$I$20240701$20240730$20240808$20240808$EXP$FR-AFSSAPS-LL2024001385$FR-TEVA-VS-3227887$TEVA$$49$YR$$F$Y$52.5$KG$20240808$$MD$FR$FR
241913901$24191390$1$I$20240619$20240730$20240808$20240808$EXP$FR-AFSSAPS-GR2024000923$FR-TEVA-VS-3228400$TEVA$$36$YR$$F$Y$$$20240808$$PH$FR$FR
241913911$24191391$1$I$20240718$20240730$20240808$20240808$PER$$CN-Eisai-EC-2024-171184$EISAI$$55$YR$A$F$Y$$$20240808$$HP$CN$CN
241913922$24191392$2$F$$20240826$20240808$20240827$PER$$NVSC2024US161765$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
241913931$24191393$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125402$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240808$$HP$US$US
241913941$24191394$1$I$20240716$20240730$20240808$20240808$EXP$$CN-GE HEALTHCARE-2024CSU008763$GE HEALTHCARE$$73$YR$$F$Y$60$KG$20240808$$HP$CN$CN
241913951$24191395$1$I$20240715$20240807$20240808$20240808$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036293$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$$$20240808$$CN$CA$CA
241913961$24191396$1$I$20240701$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125559$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$113.4$KG$20240808$$CN$US$US
241913971$24191397$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161520$NOVARTIS$$$$$$Y$$$20240808$$MD$US$US
241913981$24191398$1$I$20240614$20240730$20240808$20240808$EXP$FR-AFSSAPS-MA2024001107$FR-TEVA-VS-3228450$TEVA$$76$YR$$F$Y$$$20240808$$MD$FR$FR
241914002$24191400$2$F$$20240826$20240808$20240826$PER$$US-ALXN-202408USA000172US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241914011$24191401$1$I$20240602$20240724$20240808$20240808$EXP$$US-HLS-202400530$HLS THERAPEUTICS$$63$YR$A$M$Y$$$20240808$$HP$US$US
241914021$24191402$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125412$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240808$$CN$US$US
241914031$24191403$1$I$$20240808$20240808$20240808$PER$$NVSC2024US161777$NOVARTIS$$$$$$Y$$$20240808$$CN$US$US
241914041$24191404$1$I$$20240724$20240808$20240808$EXP$$CA-HLS-202401865$HLS THERAPEUTICS$$$$A$F$Y$$$20240808$$HP$CA$CA
241914051$24191405$1$I$$20240806$20240808$20240808$PER$$US-ABBVIE-5871020$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241914061$24191406$1$I$20240606$20240801$20240808$20240808$PER$$US-009507513-2408USA000724$MERCK$$68$YR$$F$Y$$$20240808$$CN$US$US
241914071$24191407$1$I$$20240730$20240808$20240808$EXP$$JP-009507513-2404JPN000320J$MERCK$$7$DEC$$F$Y$$$20240808$$MD$JP$JP
241914082$24191408$2$F$20240101$20240809$20240808$20240813$PER$$US-JNJFOC-20240776223$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240813$$CN$US$US
241914092$24191409$2$F$$20240812$20240808$20240822$EXP$$IE-TEVA-VS-3228782$TEVA$Murphy D, Waldron D, Kennedy G, Molony J. Central anticholinergic syndrome from hyoscine hydrobromide in an unresponsive patient. BMJ-Support-Palliat-Care 2023; 13 (3): e953-e956.; Murphy D, Waldron D, Kennedy G, Molony J. Central anticholinergic syndrome from hyoscine hydrobromide in an unresponsive patient. BMJ-Support-Palliat-Care 2023; 13 (3): e953-e956.$$$$F$Y$$$20240822$$MD$IE$IE
241914111$24191411$1$I$20240711$20240802$20240808$20240808$EXP$$JP-009507513-2408JPN000198J$MERCK$$74$YR$$F$Y$$$20240808$$MD$JP$JP
241914121$24191412$1$I$20230101$20240729$20240808$20240808$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240800025$RIGEL PHARMACEUTICALS$$76$YR$$M$Y$62.7$KG$20240808$$MD$JP$JP
241914131$24191413$1$I$20240101$20240801$20240808$20240808$PER$$US-SA-2024SA232079$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240809$$MD$US$US
241914142$24191414$2$F$$20240806$20240808$20240817$EXP$$ES-GILEAD-2024-0683106$GILEAD$$$$$M$Y$$$20240817$$CN$ES$ES
241914151$24191415$1$I$$20240731$20240808$20240808$EXP$$US-AstraZeneca-2024A175482$ASTRAZENECA$$$$$M$Y$$$20240808$$CN$US$
241914162$24191416$2$F$20240607$20240910$20240808$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-094443$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$56$KG$20240910$$MD$JP$JP
241914171$24191417$1$I$20240701$20240731$20240808$20240808$EXP$$JP-009507513-2407JPN005666J$MERCK$$75$YR$$F$Y$$$20240808$$PH$JP$JP
241914181$24191418$1$I$$20240729$20240808$20240808$EXP$$US-TEVA-VS-3228834$TEVA$Woods HB, Bharathidasan K, Yang M, Nichols J, Nugent K. Delayed onset graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency virus: a case series. Am-J-Med-Sci 2024; 367 (Suppl. 1) S9-S10.$49$YR$$M$Y$$$20240808$$HP$US$US
241914191$24191419$1$I$$20240808$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044640$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240808$$CN$US$US
241914201$24191420$1$I$$20240729$20240808$20240808$PER$$US-JNJFOC-20240783437$JOHNSON AND JOHNSON$$$$$F$Y$$$20240808$$CN$US$US
241914212$24191421$2$F$20240726$20240730$20240808$20240816$PER$$US-JNJFOC-20240783646$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240816$$CN$US$US
241914221$24191422$1$I$$20240808$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044642$BOEHRINGER INGELHEIM$$$$$$Y$$$20240808$$CN$US$US
241914232$24191423$2$F$$20240812$20240808$20240820$EXP$$US-TEVA-VS-3228835$TEVA$Woods HB, Bharathidasan K, Yang M, Nichols J, Nugent K. Delayed onset graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency virus: a case series. Am-J-Med-Sci 2024; 367 (Suppl. 1) S9-S10.; Woods HB, Bharathidasan K, Yang M, Nichols J, Nugent K. Delayed onset graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency virus: a case series. Am-J-Med-Sci 2024; 367 (Suppl. 1) S9-S10.$51$YR$$F$Y$$$20240820$$HP$US$US
241914241$24191424$1$I$20240101$20240807$20240808$20240808$EXP$$US-TAKEDA-2024TUS074521$TAKEDA$$41$YR$$M$Y$$$20240808$$CN$US$US
241914251$24191425$1$I$20240226$20240731$20240808$20240808$EXP$FR-AFSSAPS-DJ2024000857$FR-TEVA-VS-3229212$TEVA$$43$YR$$M$Y$73$KG$20240808$$MD$FR$FR
241914261$24191426$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161783$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
241914271$24191427$1$I$20240726$20240801$20240808$20240808$PER$$US-JNJFOC-20240803330$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240808$$PH$US$US
241914281$24191428$1$I$20240805$20240805$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408002663$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240808$$CN$US$US
241914291$24191429$1$I$$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156941$AMGEN$$$$$$Y$$$20240808$$PH$US$US
241914302$24191430$2$F$$20240827$20240808$20240906$EXP$$US-ASTELLAS-2024EU007437$ASTELLAS$$$$E$M$Y$$$20240906$$CN$US$US
241914311$24191431$1$I$$20240712$20240808$20240808$PER$$US-009507513-2407USA009228$MERCK$$$$$M$Y$$$20240808$$CN$US$US
241914322$24191432$2$F$$20240806$20240808$20240812$PER$$US-AMGEN-USASP2024157054$AMGEN$$$$$$Y$$$20240812$$PH$US$US
241914331$24191433$1$I$20240730$20240730$20240808$20240808$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202408002212$ELI LILLY AND CO$$$$$M$Y$$$20240808$$MD$AE$AE
241914341$24191434$1$I$$20240802$20240808$20240808$EXP$GB-MHRA-MED-202408011535595350-BNHQR$GB-ELI_LILLY_AND_COMPANY-GB202408002619$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$GB$GB
241914351$24191435$1$I$20230101$20240729$20240808$20240808$EXP$DE-CADRBFARM-2024329551$DE-ELI_LILLY_AND_COMPANY-DE202407018380$ELI LILLY AND CO$$27$YR$A$M$Y$206$KG$20240808$$CN$DE$DE
241914361$24191436$1$I$$20240802$20240808$20240808$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202408002672$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$MX$MX
241914371$24191437$1$I$$20240802$20240808$20240808$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408001829$ELI LILLY AND CO$$$$$M$Y$$$20240808$$CN$JP$JP
241914381$24191438$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408003601$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240808$$CN$US$US
241914391$24191439$1$I$$20240804$20240808$20240808$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002913$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$US$US
241914401$24191440$1$I$$20240731$20240808$20240808$EXP$GB-MHRA-MED-202407291302446020-JGYTP$GB-ELI_LILLY_AND_COMPANY-GB202408000858$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240808$$CN$GB$GB
241914411$24191441$1$I$20240620$20240729$20240808$20240808$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407019185$ELI LILLY AND CO$$63$YR$A$M$Y$123$KG$20240808$$CN$GB$GB
241914421$24191442$1$I$$20240725$20240808$20240808$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07540$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240808$$PH$US$US
241914432$24191443$2$F$$20240726$20240808$20240930$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07553$NEUROCRINE BIOSCIENCES$$83$YR$$F$Y$$$20240930$$HP$US$US
241914441$24191444$1$I$$20240802$20240808$20240808$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-106939$REGENERON$$$$$M$Y$$$20240808$$CN$US$US
241914451$24191445$1$I$$20240725$20240808$20240808$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07562$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240808$$PH$US$US
241914461$24191446$1$I$$20240801$20240808$20240808$PER$$US-SA-2024SA231813$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240809$$MD$US$US
241914471$24191447$1$I$20240101$20240808$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044647$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240808$$CN$US$US
241914481$24191448$1$I$20240101$20240808$20240808$20240808$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044636$BOEHRINGER INGELHEIM$$92$YR$E$F$Y$$$20240808$$CN$US$US
241914491$24191449$1$I$$20240725$20240808$20240808$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07597$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240808$$HP$US$US
241914502$24191450$2$F$20240806$20240815$20240808$20240906$PER$$US-009507513-2408USA002086$MERCK$$67$YR$$M$Y$$$20240906$$CN$US$US
241914511$24191451$1$I$$20240725$20240808$20240808$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07607$NEUROCRINE BIOSCIENCES$$66$YR$$$Y$$$20240808$$HP$US$US
241914521$24191452$1$I$$20240802$20240808$20240808$EXP$$CA-TAKEDA-2024TUS075518$TAKEDA$$$$$F$Y$$$20240808$$CN$CA$CA
241914531$24191453$1$I$20240716$20240717$20240808$20240808$PER$$US-JNJFOC-20240749171$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240808$$CN$US$US
241914541$24191454$1$I$$20240731$20240808$20240808$EXP$$CA-TAKEDA-2024TUS077844$TAKEDA$$$$$M$Y$$$20240808$$CN$CA$CA
241914552$24191455$2$F$$20240829$20240808$20240906$EXP$$CA-GILEAD-2024-0683246$GILEAD$$55$YR$A$M$Y$$$20240906$$CN$CA$CA
241914562$24191456$2$F$$20240812$20240808$20240821$EXP$$IT-TEVA-VS-3229771$TEVA$Farina F, Ferla V, Canziani L, Dell^Acqua R, Perini T, Clerici D, et al. HIGH RATE OF RESPIRATORY TRACT INFECTIONS AFTER COVID19 WAVES IN TRANSPLANT ELEGIBLE MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMAB. Haematologica 2024; 109 29 abstr. P22.; Farina F, Ferla V, Canziani L, Dell^Acqua R, Perini T, Clerici D, et al. HIGH RATE OF RESPIRATORY TRACT INFECTIONS AFTER COVID19 WAVES IN TRANSPLANT ELEGIBLE MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMAB. Haematologica 2024; 109 29 abstr. P22.$$$$$Y$$$20240821$$HP$IT$IT
241914571$24191457$1$I$$20240805$20240808$20240808$EXP$$DE-009507513-2408DEU001619$MERCK$$$$E$M$Y$$$20240808$$MD$DE$DE
241914583$24191458$3$F$20240701$20240819$20240808$20240827$EXP$$JP-009507513-2408JPN000342J$MERCK$$60$YR$$M$Y$$$20240827$$MD$JP$JP
241914592$24191459$2$F$$20240813$20240808$20240823$EXP$$MY-TEVA-VS-3229890$TEVA$Muniandy S, Khalid A, Hamzah ML, Ahmad HH. Neuroleptic Malignant Syndrome in Puerperalwomen - Frozen in Summer. Akad-Acil-Tip-Olgu-Sunum-Dergisi 2024; 15 (2): 56-58.; Muniandy S, Khalid A, Hamzah ML, Ahmad HH. Neuroleptic Malignant Syndrome in Puerperalwomen - Frozen in Summer. Akad-Acil-Tip-Olgu-Sunum-Dergisi 2024; 15 (2): 56-58.$21$YR$$F$Y$$$20240823$$HP$MY$MY
241914601$24191460$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125023$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240808$$HP$US$US
241914612$24191461$2$F$$20240822$20240808$20240904$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07698$NEUROCRINE BIOSCIENCES$$53$YR$$F$Y$$$20240904$$HP$US$US
241914622$24191462$2$F$$20240813$20240808$20240823$EXP$$US-TEVA-VS-3230080$TEVA$Abdelrahim B, Alam M, Horani MH. Iatrogenic Thyroid Storm Treated with Plasmapheresis. J-Endocr-Soc 2022; 6 (Suppl.) A768-A769 abstr. ODP487.; Abdelrahim B, Alam M, Horani MH. Iatrogenic Thyroid Storm Treated with Plasmapheresis. J-Endocr-Soc 2022; 6 (Suppl.) A768-A769 abstr. ODP487.$32$YR$$M$Y$$$20240823$$HP$US$US
241914631$24191463$1$I$20240320$20240730$20240808$20240808$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI06500$NEUROCRINE BIOSCIENCES$$70$YR$$F$Y$$$20240808$$HP$US$US
241914641$24191464$1$I$$20240730$20240808$20240808$EXP$$JP-EMD Serono-2024041928$EMD SERONO INC$$$$$$Y$$$20240809$$MD$JP$JP
241914652$24191465$2$F$$20240814$20240808$20240822$PER$$US-BIOGEN-2024BI01277076$BIOGEN$$$$$M$Y$$$20240822$$CN$US$US
241914661$24191466$1$I$$20240731$20240808$20240808$EXP$$NVSC2024CA159910$NOVARTIS$$40$YR$$F$Y$$$20240809$$HP$CA$CA
241914671$24191467$1$I$20240101$20240730$20240808$20240808$PER$$US-SA-2024SA228386$SANOFI AVENTIS$$78$YR$E$F$Y$71$KG$20240809$$MD$US$US
241914681$24191468$1$I$$20240801$20240808$20240808$PER$$NVSC2024US158292$NOVARTIS$$$$$$Y$$$20240809$$CN$US$US
241914691$24191469$1$I$$20240731$20240808$20240808$EXP$$AU-JNJFOC-20240784561$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240809$$CN$AU$AU
241914702$24191470$2$F$20240720$20240904$20240808$20240908$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-124664$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$54.43$KG$20240909$$CN$PR$PR
241914716$24191471$6$F$20240806$20240917$20240808$20240925$EXP$$CA-JNJFOC-20240756215$JOHNSON AND JOHNSON$$5$YR$C$F$Y$19$KG$20240925$$HP$CA$CA
241914724$24191472$4$F$$20240909$20240808$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123690$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$HP$JP$JP
241914731$24191473$1$I$20240102$20240729$20240808$20240808$EXP$$FR-JNJFOC-20240509366$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240809$$MD$FR$FR
241914743$24191474$3$F$$20240829$20240808$20240907$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-124569$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240907$$PH$JP$JP
241914751$24191475$1$I$20240727$20240731$20240808$20240808$EXP$$CN-JNJFOC-20240784155$JOHNSON AND JOHNSON$$50$YR$A$M$Y$51$KG$20240809$$HP$CN$CN
241914761$24191476$1$I$$20240801$20240808$20240808$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001571$BLUEPRINT MEDICINES$$$$$F$Y$$$20240809$$CN$US$US
241914771$24191477$1$I$$20240729$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407019829$ELI LILLY AND CO$$64$YR$A$$Y$$$20240808$$LW$US$US
241914781$24191478$1$I$$20240729$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202407019955$ELI LILLY AND CO$$56$YR$A$$Y$$$20240808$$LW$US$US
241914791$24191479$1$I$20240703$20240731$20240808$20240808$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001559$BLUEPRINT MEDICINES$$78$YR$E$M$Y$$$20240809$$CN$US$US
241914801$24191480$1$I$20231011$20240806$20240808$20240808$EXP$$NVSJ2023JP018633$NOVARTIS$$39$YR$$F$Y$49.2$KG$20240809$$MD$JP$JP
241914811$24191481$1$I$$20240808$20240808$20240808$PER$$NVSC2024US161815$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241914821$24191482$1$I$20240805$20240806$20240808$20240808$PER$$US-009507513-2408USA002221$MERCK$$74$YR$$$Y$$$20240808$$MD$US$US
241914832$24191483$2$F$20240803$20240826$20240808$20240827$PER$$US-AMGEN-USASP2024155703$AMGEN$$73$YR$E$F$Y$$$20240827$$PH$US$US
241914841$24191484$1$I$20240806$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024156758$AMGEN$$73$YR$E$M$Y$$$20240808$$CN$US$US
241914851$24191485$1$I$$20240808$20240808$20240808$PER$$NVSC2024US161817$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241914862$24191486$2$F$20240101$20240815$20240808$20240820$EXP$$MX-JNJFOC-20240723014$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240820$$CN$MX$MX
241914871$24191487$1$I$$20240715$20240808$20240808$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003594$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241914882$24191488$2$F$20240801$20240917$20240808$20240924$EXP$$US-ABBVIE-5870877$ABBVIE$$43$YR$$F$Y$147$KG$20240924$$CN$US$US
241914892$24191489$2$F$20230101$20240808$20240808$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002951$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
241914901$24191490$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870845$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241914911$24191491$1$I$$20240715$20240808$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003601$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241914921$24191492$1$I$$20240806$20240808$20240808$EXP$$US-JNJFOC-20240816301$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240809$$HP$US$US
241914931$24191493$1$I$$20240715$20240808$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003602$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241914942$24191494$2$F$$20240917$20240808$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-124674$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$PH$JP$JP
241914952$24191495$2$F$$20240809$20240808$20240815$EXP$$NVSJ2024JP009526$NOVARTIS$$78$YR$$F$Y$$$20240816$$PH$JP$JP
241914962$24191496$2$F$$20240812$20240808$20240819$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001579$BLUEPRINT MEDICINES$$$$$M$Y$$$20240819$$CN$US$US
241914971$24191497$1$I$$20240711$20240808$20240808$PER$$US-AstraZeneca-2024A159270$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241914981$24191498$1$I$$20240715$20240808$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003604$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241914992$24191499$2$F$$20240901$20240808$20240904$EXP$$TW-009507513-2408TWN000880$MERCK$$59$YR$$F$Y$$$20240904$$MD$TW$TW
241915001$24191500$1$I$$20240715$20240808$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003605$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241915012$24191501$2$F$$20240902$20240808$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-124428$BRISTOL MYERS SQUIBB$$8$DEC$E$$Y$$$20240910$$PH$JP$JP
241915021$24191502$1$I$$20240805$20240808$20240808$EXP$JP-MMM-ORXU6EDN$JP-GSK-JP2024097307$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$MD$JP$JP
241915031$24191503$1$I$$20240805$20240808$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125292$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240809$$PH$JP$JP
241915043$24191504$3$F$20240614$20240814$20240808$20240816$EXP$$US-JNJFOC-20240821210$JOHNSON AND JOHNSON$$86$YR$E$M$Y$104.3$KG$20240816$$MD$US$US
241915051$24191505$1$I$20240401$20240731$20240808$20240808$EXP$$ES-JNJFOC-20240670178$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240809$$CN$ES$ES
241915061$24191506$1$I$20240730$20240802$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012067$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241915071$24191507$1$I$20240724$20240802$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012130$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241915101$24191510$1$I$$20240715$20240808$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003606$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241915121$24191512$1$I$20240805$20240806$20240808$20240808$PER$$US-AMGEN-USASP2024157015$AMGEN$$72$YR$E$M$Y$$$20240808$$CN$US$US
241915131$24191513$1$I$20240711$20240715$20240808$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003608$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240809$$CN$US$US
241915141$24191514$1$I$$20240730$20240808$20240808$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019560$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240808$$HP$US$US
241915151$24191515$1$I$$20240801$20240808$20240808$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408000330$ELI LILLY AND CO$$$$$F$Y$$$20240808$$PH$JP$JP
241915161$24191516$1$I$20240728$20240730$20240808$20240808$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408002365$ELI LILLY AND CO$$69$YR$E$M$Y$80$KG$20240808$$CN$DE$CN
241915171$24191517$1$I$20240701$20240730$20240808$20240808$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000279$ELI LILLY AND CO$$45$YR$A$F$Y$83$KG$20240808$$CN$US$US
241915181$24191518$1$I$20240808$20240808$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408005406$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240808$$CN$US$US
241915191$24191519$1$I$20240508$20240731$20240808$20240808$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408004037$ELI LILLY AND CO$$59$YR$A$M$Y$60$KG$20240808$$CN$DE$CN
241915222$24191522$2$F$$20240805$20240808$20240814$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202407020307$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240814$$CN$ES$ES
241915231$24191523$1$I$20240617$20240731$20240808$20240808$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408004031$ELI LILLY AND CO$$75$YR$E$M$Y$58$KG$20240808$$CN$DE$CN
241915241$24191524$1$I$$20240729$20240808$20240808$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407019425$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$AU$AU
241915251$24191525$1$I$$20240802$20240808$20240808$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003727$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240808$$HP$US$US
241915261$24191526$1$I$20240201$20240729$20240808$20240808$EXP$PT-INFARMED-R202407-663$PT-ELI_LILLY_AND_COMPANY-PT202407018170$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240808$$CN$PT$PT
241915271$24191527$1$I$$20240805$20240808$20240808$EXP$NL-LRB-00994580$NL-ELI_LILLY_AND_COMPANY-NL202408003596$ELI LILLY AND CO$$77$YR$E$F$Y$71.7$KG$20240808$$CN$NL$NL
241915281$24191528$1$I$20240627$20240729$20240808$20240808$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408002348$ELI LILLY AND CO$$58$YR$A$M$Y$84$KG$20240808$$CN$DE$CN
241915291$24191529$1$I$20240625$20240730$20240808$20240808$EXP$FR-AFSSAPS-NT2024000968$FR-ELI_LILLY_AND_COMPANY-FR202407020292$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240808$$CN$FR$FR
241915301$24191530$1$I$20230824$20240729$20240808$20240808$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202407019358$ELI LILLY AND CO$$69$YR$E$M$Y$77$KG$20240808$$MD$DE$DE
241915311$24191531$1$I$20240603$20240729$20240808$20240808$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408001522$ELI LILLY AND CO$$65$YR$E$M$Y$47$KG$20240808$$CN$DE$CN
241915321$24191532$1$I$$20240729$20240808$20240808$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407019418$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$AU$AU
241915331$24191533$1$I$$20240729$20240808$20240808$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408000177AA$ELI LILLY AND CO$$92$YR$E$M$Y$$$20240808$$CN$JP$JP
241915341$24191534$1$I$$20240729$20240808$20240808$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407019758AA$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240808$$CN$JP$JP
241915351$24191535$1$I$$20240801$20240808$20240808$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000898$ELI LILLY AND CO$$$$$M$Y$$$20240808$$CN$US$US
241915361$24191536$1$I$$20240715$20240808$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003612$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241915372$24191537$2$F$$20240903$20240808$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001580$BLUEPRINT MEDICINES$$$$$F$Y$$$20240911$$CN$US$US
241915381$24191538$1$I$$20240716$20240808$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003638$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241915391$24191539$1$I$$20240802$20240808$20240808$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00402$VELOXIS PHARMACEUTICALS$Bae E K, Chandran M M, Everitt M D, Benz E, Bock M.. LCP-tacrolimus extended-release (Envarsus XR) use in adolescent and young adult solid organ transplant recipients.. Clinical Transplantation. 2024;38:e15417:1-7$20$YR$$F$Y$$$20240808$$HP$US$US
241915402$24191540$2$F$20240613$20240819$20240808$20240821$EXP$$DE-JNJFOC-20240821118$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240822$$CN$DE$DE
241915411$24191541$1$I$$20240729$20240808$20240808$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407019428$ELI LILLY AND CO$$$$$F$Y$$$20240808$$CN$AU$AU
241915421$24191542$1$I$20240807$20240808$20240808$20240808$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044594$BOEHRINGER INGELHEIM$$$$$$Y$$$20240809$$CN$US$US
241915433$24191543$3$F$20240728$20240731$20240808$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123837$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240815$$MD$JP$JP
241915441$24191544$1$I$20230502$20240515$20240808$20240808$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125613$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$49$KG$20240809$$MD$JP$JP
241915451$24191545$1$I$20240101$20240806$20240808$20240808$PER$$US-ABBVIE-5871006$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241915461$24191546$1$I$$20240716$20240808$20240808$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003639$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241915473$24191547$3$F$20240131$20240820$20240808$20240822$EXP$$NVSJ2024JP006052$NOVARTIS$$85$YR$$M$Y$$$20240823$$MD$JP$JP
241915482$24191548$2$F$20240101$20240901$20240808$20240905$EXP$$CA-JNJFOC-20240723817$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240905$$HP$CA$CA
241915491$24191549$1$I$$20240731$20240808$20240808$PER$$US-ABBVIE-5862906$ABBVIE$$74$YR$$F$Y$$$20240808$$HP$US$US
241915501$24191550$1$I$$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155269$AMGEN$$$$$M$Y$$$20240808$$CN$US$US
241915512$24191551$2$F$20240723$20240911$20240808$20240916$30DAY$$US-AMGEN-USASP2024155684$AMGEN$$76$YR$E$M$Y$94$KG$20240916$$PH$US$US
241915521$24191552$1$I$$20240716$20240808$20240808$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003640$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241915531$24191553$1$I$$20240716$20240808$20240808$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003641$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241915541$24191554$1$I$$20240731$20240808$20240808$PER$$US-BAUSCHBL-2024BNL031050$BAUSCH AND LOMB$$$$$F$Y$$$20240809$$HP$US$US
241915551$24191555$1$I$$20240731$20240808$20240808$PER$$US-BAUSCHBL-2024BNL031082$BAUSCH AND LOMB$$$$$F$Y$$$20240809$$CN$US$US
241915561$24191556$1$I$$20240716$20240808$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003642$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$MD$US$US
241915572$24191557$2$F$20240803$20240813$20240808$20240821$30DAY$$US-AMGEN-USASP2024155700$AMGEN$$73$YR$E$M$Y$83.8$KG$20240821$$HP$US$US
241915585$24191558$5$F$$20240829$20240808$20240907$EXP$$PT-AUROBINDO-AUR-APL-2024-037370$AUROBINDO$Andrade J; Lopes D; Oliveira Sim?es FD; Martins AF;Carvalho A; ?ngela C. POSA-192 - (4960) - PNEUMONIA NECROSANTE POR PARVIMONAS MICRA: DESAFIO DIAGN?STICO. Doen?as infeciosas e parasit?rias | Caso cl?nico. 1269$48$YR$$F$Y$$$20240907$$MD$PT$PT
241915591$24191559$1$I$20240122$20240805$20240808$20240808$EXP$$US-JNJFOC-20240813026$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240809$$HP$US$US
241915602$24191560$2$F$$20240830$20240808$20240908$PER$$US-BAUSCHBL-2024BNL030929$BAUSCH AND LOMB$$$$$M$Y$$$20240909$$CN$US$US
241915611$24191561$1$I$$20240801$20240808$20240808$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001566$BLUEPRINT MEDICINES$$$$$F$Y$$$20240809$$CN$US$US
241915622$24191562$2$F$20240701$20240808$20240808$20240812$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-040746$BOEHRINGER INGELHEIM$$92$YR$E$F$Y$$$20240812$$CN$US$US
241915631$24191563$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-037828$AUROBINDO$Howell J, Maughan B, Fluchel M, Poppe M.. Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor:A case report. Urology Case Reports. 2024;56:102799$62$YR$$F$Y$$$20240809$$MD$US$US
241915642$24191564$2$F$20240101$20240805$20240808$20240813$EXP$$US-ABBVIE-5868220$ABBVIE$$$$$M$Y$$$20240813$$HP$US$US
241915651$24191565$1$I$20240725$20240802$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012065$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241915661$24191566$1$I$$20240805$20240808$20240808$PER$$US-ABBVIE-5867894$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241915671$24191567$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-037845$AUROBINDO$Majid S, Hamzavi-Abedi Y. Correction to Dose Dependent: A Case report of NSAID-induced urticaria and angioedema in an otherwise asymptomatic individual M058. Ann Allergy Asthma Immunol. 2023;131(5S1):S114$71$YR$$F$Y$$$20240809$$MD$US$US
241915681$24191568$1$I$20240701$20240805$20240808$20240808$EXP$$CO-ABBVIE-5870150$ABBVIE$$74$YR$$M$Y$74$KG$20240808$$CN$CO$CO
241915691$24191569$1$I$$20240716$20240808$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003646$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241915701$24191570$1$I$20240101$20240806$20240808$20240808$EXP$$US-AMGEN-USASP2024156826$AMGEN$$$$$$Y$$$20240808$$MD$US$US
241915711$24191571$1$I$20240618$20240729$20240808$20240808$EXP$$FR-AUROBINDO-AUR-APL-2024-038584$AUROBINDO$$52$YR$$F$Y$73.5$KG$20240809$$PH$FR$FR
241915721$24191572$1$I$20240626$20240802$20240808$20240808$PER$$US-SA-2024SA233217$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240809$$MD$US$US
241915731$24191573$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5871260$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241915742$24191574$2$F$$20240808$20240808$20240815$EXP$$CA-TAKEDA-2024TUS079355$TAKEDA$$$$$M$Y$$$20240815$$MD$CA$CA
241915751$24191575$1$I$$20240716$20240808$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003648$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241915763$24191576$3$F$20100101$20240909$20240808$20240912$EXP$$US-ABBVIE-5866931$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
241915771$24191577$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683368$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241915781$24191578$1$I$20240804$20240805$20240808$20240808$PER$$US-AMGEN-USASP2024155418$AMGEN$$69$YR$E$F$Y$$$20240808$$CN$US$US
241915791$24191579$1$I$20240718$20240802$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012131$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241915802$24191580$2$F$$20240904$20240808$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003651$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241915812$24191581$2$F$$20240802$20240808$20240809$EXP$$CA-BEIGENE-BGN-2024-012312$BEIGENE$$$$$$Y$$$20240809$$CN$CA$CA
241915821$24191582$1$I$20240730$20240730$20240808$20240808$PER$$US-ABBVIE-5862853$ABBVIE$$59$YR$$F$Y$$$20240808$$CN$US$US
241915832$24191583$2$F$$20240903$20240808$20240909$EXP$$TR-TAKEDA-2024TUS079086$TAKEDA$$$$$$Y$$$20240909$$MD$TR$TR
241915841$24191584$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-038632$AUROBINDO$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al.. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia. Am-J-Respir-CritCare-Med. 2024;209:A3706$31$YR$$F$Y$$$20240809$$HP$US$US
241915861$24191586$1$I$$20240729$20240808$20240808$EXP$$PL-AUROBINDO-AUR-APL-2024-038817$AUROBINDO$$55$YR$$F$Y$$$20240809$$PH$PL$PL
241915872$24191587$2$F$$20240819$20240808$20240831$EXP$$US-AUROBINDO-AUR-APL-2024-038821$AUROBINDO$Woods HB, Bharathidasan K, Yang M, Nichols J, Nugent K.. Delayed onset graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency virus: a case series. Am-J-Med-Sci. 2024;367 (Suppl. 1):S9-S10$51$YR$$F$Y$$$20240831$$MD$US$US
241915881$24191588$1$I$20240726$20240805$20240808$20240808$EXP$$US-BIOGEN-2024BI01277109$BIOGEN$$61$YR$$M$Y$$$20240808$$CN$US$US
241915891$24191589$1$I$$20240716$20240808$20240808$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003656$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241915901$24191590$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-038868$AUROBINDO$Daniels Z, Walczak AB, Lloyd EA, Deitemeyer M, Duffy V, Kistler IS, et al. Breaking Tradition: The Bivalirudin Advantage in Pediatric Mechanical Circulatory Support.. ASAIO-J. 2024;70 (Suppl.):84-85$$$$$Y$$$20240809$$HP$US$US
241915911$24191591$1$I$$20240802$20240808$20240808$EXP$$US-BIOGEN-2024BI01276727$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241915921$24191592$1$I$$20240807$20240808$20240808$EXP$$US-GILEAD-2024-0683376$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241915931$24191593$1$I$$20240730$20240808$20240808$EXP$$TR-TAKEDA-2024TUS079182$TAKEDA$$$$$$Y$$$20240808$$MD$TR$TR
241915941$24191594$1$I$$20240729$20240808$20240808$EXP$$GB-AUROBINDO-AUR-APL-2024-038908$AUROBINDO$Anand A, Brown L, Smith R, Nouri B, Powell F, Mabrok M, et al.. Donor Derived Myelodysplastic Syndrome after Sex Matched Haploidentical Allograft for AML with Monosomy 7 in Both Diseases: Importance of Donor Chimerism Assessment By Two Independent Techniques. Blood. 2022;140 (Suppl.):13029-13030$39$YR$$M$Y$$$20240809$$HP$GB$GB
241915951$24191595$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-038874$AUROBINDO$Sohal A, Kowdley KV.. Complete Biochemical Remission with Oral Vancomycin in a Patient with Primary Sclerosing Cholangitis and High Serum Immunoglobulin G4 Levels. ACG-Case-Rep-J. 2024;11(1):E01256$20$YR$$M$Y$$$20240809$$MD$US$US
241915961$24191596$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-038919$AUROBINDO$Street N, Dougherty P, Urbina E, Tosonian S, Soto FJ, Branca P. A Mass of Fungus. Am-J-RespirCrit-Care-Med. 2023$36$YR$$M$Y$$$20240809$$HP$US$US
241915971$24191597$1$I$$20240806$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125843$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240809$$CN$US$US
241915982$24191598$2$F$20240803$20240819$20240808$20240823$PER$$US-AMGEN-USASP2024157167$AMGEN$$82$YR$E$F$Y$$$20240823$$CN$US$US
241915991$24191599$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-039149$AUROBINDO$Kulkarni R, Abdelrahman A, Ghesani M, Ghesani N, Wolin E, Oh W, et al.. Management Of Concomitant Prostate Cancer and Pancreatic Neuroendocrine Tumour: Role of Nuclear Medicine in therapeutic decision making.. J-Nucl-Med. 2023;64 (Suppl. 1):1440$71$YR$$M$Y$$$20240809$$HP$US$US
241916001$24191600$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-039152$AUROBINDO$Joshi A, Ghnaima H, Nader G, Alattal S.. A Trifecta of Challenges: A Case Report of Triple Valve Endocarditis.. Am-J-Respir-Crit-Care-Med. 2024;209$37$YR$$M$Y$$$20240809$$HP$US$US
241916012$24191601$2$F$20240513$20240903$20240808$20240906$EXP$$JP-TAKEDA-2024TJP006959$TAKEDA$$60$YR$$F$Y$$$20240906$$MD$JP$JP
241916031$24191603$1$I$20240518$20240805$20240808$20240808$EXP$$US-BIOGEN-2024BI01277085$BIOGEN$$87$YR$$F$Y$$$20240808$$CN$US$US
241916041$24191604$1$I$$20240807$20240808$20240808$PER$$US-AMGEN-USASP2024157964$AMGEN$$$$$F$Y$$$20240808$$HP$US$US
241916051$24191605$1$I$$20240729$20240808$20240808$EXP$$US-AUROBINDO-AUR-APL-2024-039154$AUROBINDO$Pepin A, Lee V, O^Brien S, Mulugeta P, Taunk NK. Management of Dry Eye Toxicity After Treatment With 177Lu-PSMA-617 Radioligand Therapy. Prac-Radiat-Oncol. 2024;14(4):301-304$82$YR$$M$Y$$$20240809$$HP$US$US
241916062$24191606$2$F$20240716$20240822$20240808$20240828$EXP$$JP-SA-2024SA221144$SANOFI AVENTIS$$76$YR$E$M$Y$67$KG$20240828$$MD$JP$JP
241916071$24191607$1$I$$20240729$20240808$20240808$EXP$$IT-AUROBINDO-AUR-APL-2024-039166$AUROBINDO$Perlato M, Mecheri V, Vivarelli E, Accinno M, Vultaggio A, Matucci A.. ^Patient remodeling^ as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend.. J-Asthma. 2024;61(1):72-75$28$YR$$F$Y$$$20240809$$HP$IT$IT
241916082$24191608$2$F$20210924$20240925$20240808$20240927$PER$$US-GILEAD-2024-0683377$GILEAD$$51$YR$A$F$Y$$$20240927$$LW$US$US
241916091$24191609$1$I$$20240729$20240808$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-039455$AUROBINDO$$76$YR$$M$Y$$$20240809$$PH$CA$CA
241916101$24191610$1$I$$20240729$20240808$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-039440$AUROBINDO$$86$YR$$F$Y$61$KG$20240809$$PH$CA$CA
241916111$24191611$1$I$$20240729$20240808$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-039434$AUROBINDO$$79$YR$$M$Y$100$KG$20240809$$PH$CA$CA
241916121$24191612$1$I$$20240807$20240808$20240808$EXP$$US-BIOGEN-2024BI01277516$BIOGEN$$$$$F$Y$$$20240808$$CN$US$US
241916131$24191613$1$I$20240725$20240802$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012069$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241916141$24191614$1$I$20220101$20240802$20240808$20240808$EXP$$NVSC2024MX015379$NOVARTIS$$$$$F$Y$65$KG$20240809$$CN$MX$MX
241916151$24191615$1$I$$20240806$20240808$20240808$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-125526$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240809$$HP$TW$TW
241916161$24191616$1$I$$20240729$20240808$20240808$EXP$$PT-AUROBINDO-AUR-APL-2024-039751$AUROBINDO$Tavares JA, Carvalho J, Carneiro P, Emidio C, Palma C, Pereira R, et al. DISTRIBUTIVE SHOCK IS NOT ALWAYS A SEPTIC SHOCK - A CLINICAL CASE.. Eur-J-Case-Rep-Intern-Med. 2019;6 (Suppl. 1):219$47$YR$$F$Y$$$20240809$$HP$PT$PT
241916171$24191617$1$I$$20240729$20240808$20240808$EXP$$CA-AUROBINDO-AUR-APL-2024-039470$AUROBINDO$$70$YR$$F$Y$59$KG$20240809$$HP$CA$CA
241916181$24191618$1$I$$20240808$20240808$20240808$PER$$NVSC2024US161820$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241916191$24191619$1$I$20240806$20240806$20240808$20240808$EXP$$US-ABBVIE-5870353$ABBVIE$$77$YR$$M$Y$$$20240808$$CN$US$US
241916201$24191620$1$I$$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004023$ELI LILLY AND CO$$$$$$Y$$$20240808$$CN$US$US
241916211$24191621$1$I$20230101$20240806$20240808$20240808$EXP$$US-ABBVIE-5870365$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241916222$24191622$2$F$20240708$20240904$20240808$20240906$EXP$$JP-TAKEDA-2024TJP010272$TAKEDA$$5$DEC$$M$Y$$$20240906$$MD$JP$JP
241916231$24191623$1$I$20240301$20240806$20240808$20240808$EXP$FR-AFSSAPS-BX2024001576$FR-BIOGEN-2024BI01277300$BIOGEN$$53$YR$$F$Y$$$20240808$$MD$FR$FR
241916241$24191624$1$I$20220101$20240802$20240808$20240808$EXP$$US-BIOGEN-2024BI01276939$BIOGEN$$$$$M$Y$$$20240808$$CN$US$US
241916251$24191625$1$I$20221001$20240802$20240808$20240808$EXP$$BR-BIOGEN-2023BI01182166$BIOGEN$$33$YR$$F$Y$70$KG$20240808$$HP$BR$BR
241916261$24191626$1$I$20240420$20240802$20240808$20240808$EXP$$US-BIOGEN-2024BI01276728$BIOGEN$$50$YR$$F$Y$$$20240808$$$US$US
241916271$24191627$1$I$$20240807$20240808$20240808$EXP$$CN-SANDOZ INC.-SDZ2023CN019667$SANDOZ$Yin J, Tian H, Kong DQ, Li Y, Gu CY, Wu DP et al. A Combined Regimen Based on Bortezomib and Glucocorticoids in 6 Cases With Recurrent/Refractory Immune Thrombotic Thrombocytopenic Purpura. Chin J Hematol. 2023;44:413-418$68$YR$$F$Y$$$20240808$$HP$CN$CN
241916282$24191628$2$F$$20240806$20240808$20240808$30DAY$$US-SANDOZ INC.-NVSC2023US001587$SANDOZ$$$$$F$Y$$$20240808$$CN$US$US
241916291$24191629$1$I$20240407$20240802$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012126$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241916301$24191630$1$I$20240806$20240808$20240808$20240808$EXP$$JP-TAKEDA-2024TJP011816$TAKEDA$$8$DEC$$F$Y$$$20240808$$MD$JP$JP
241916311$24191631$1$I$20240101$20240805$20240808$20240808$EXP$$US-JNJFOC-20240812599$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240809$$HP$US$US
241916321$24191632$1$I$$20240725$20240808$20240808$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202408-000984$UNICHEM$$6$YR$C$F$Y$24.5$KG$20240809$$HP$US$
241916331$24191633$1$I$$20240725$20240808$20240808$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202408-000985$UNICHEM$$15$YR$T$F$Y$55$KG$20240809$$HP$US$
241916341$24191634$1$I$$20240725$20240808$20240808$EXP$$JP-Unichem Pharmaceuticals (USA) Inc-UCM202408-000987$UNICHEM$$$$$$Y$$$20240809$$$COUNTRY NOT SPECIFIED$
241916352$24191635$2$F$20120101$20240912$20240808$20240919$EXP$$US-ABBVIE-5871124$ABBVIE$$$$$F$Y$78.471$KG$20240919$$CN$US$US
241916361$24191636$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683482$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241916371$24191637$1$I$20240101$20240801$20240808$20240808$PER$$US-AMGEN-USASP2024153654$AMGEN$$52$YR$A$M$Y$$$20240808$$HP$US$US
241916382$24191638$2$F$20240801$20240829$20240808$20240902$PER$$US-AMGEN-USASP2024154609$AMGEN$$65$YR$E$M$Y$$$20240902$$CN$US$US
241916391$24191639$1$I$$20240806$20240808$20240808$EXP$$IT-SANDOZ INC.-SDZ2024IT070853$SANDOZ$$108$MON$$F$Y$$$20240808$$HP$IT$IT
241916401$24191640$1$I$20240101$20240806$20240808$20240808$EXP$$GB-ABBVIE-5870064$ABBVIE$$31$YR$$M$Y$$$20240808$$HP$GB$GB
241916411$24191641$1$I$20240715$20240807$20240808$20240808$EXP$$US-ABBVIE-5872573$ABBVIE$$83$YR$$F$Y$$$20240808$$CN$US$US
241916423$24191642$3$F$20210101$20240904$20240808$20240911$EXP$$ES-ABBVIE-5869602$ABBVIE$$$$$F$Y$58$KG$20240911$$HP$ES$ES
241916431$24191643$1$I$20240601$20240805$20240808$20240808$EXP$$BR-ABBVIE-5867719$ABBVIE$$86$YR$$F$Y$$$20240808$$CN$BR$BR
241916442$24191644$2$F$20240101$20240813$20240808$20240820$EXP$$US-BIOGEN-2024BI01277303$BIOGEN$$$$$F$Y$$$20240820$$CN$US$US
241916471$24191647$1$I$20240803$20240806$20240808$20240808$EXP$$CA-ABBVIE-5871505$ABBVIE$$57$YR$$M$Y$$$20240808$$HP$CA$CA
241916481$24191648$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683483$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241916491$24191649$1$I$20240804$20240805$20240808$20240808$EXP$$FR-ABBVIE-5871468$ABBVIE$$77$YR$$F$Y$$$20240808$$CN$FR$FR
241916501$24191650$1$I$20240715$20240805$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012190$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241916511$24191651$1$I$20240601$20240802$20240808$20240808$EXP$$US-ABBVIE-5865959$ABBVIE$$71$YR$$F$Y$$$20240808$$CN$US$US
241916522$24191652$2$F$20230101$20240807$20240808$20240924$EXP$$DE-ABBVIE-5872508$ABBVIE$$$$$F$Y$$$20240924$$CN$DE$DE
241916531$24191653$1$I$$20240801$20240808$20240808$PER$$US-ABBVIE-5864829$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241916541$24191654$1$I$20240802$20240802$20240808$20240808$EXP$$CN-BEIGENE-BGN-2024-012070$BEIGENE$$$$$$Y$$$20240808$$HP$CN$CN
241916551$24191655$1$I$$20240807$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125789$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$67.8$KG$20240809$$PH$US$US
241916561$24191656$1$I$20240101$20240801$20240808$20240808$EXP$$US-ABBVIE-5863319$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241916572$24191657$2$F$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683484$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241916581$24191658$1$I$$20240801$20240808$20240808$EXP$$US-ABBVIE-5870095$ABBVIE$$$$$M$Y$$$20240808$$MD$US$US
241916591$24191659$1$I$$20240724$20240808$20240808$PER$$US-TEVA-VS-3227408$TEVA$$63$YR$$M$Y$$$20240808$$CN$US$US
241916601$24191660$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870317$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241916611$24191661$1$I$20240731$20240806$20240808$20240808$EXP$$US-ABBVIE-5870510$ABBVIE$$66$YR$$F$Y$$$20240808$$CN$US$US
241916622$24191662$2$F$$20240808$20240808$20240814$PER$$US-LEO Pharma-372569$LEO PHARM$$54$YR$$M$Y$$$20240814$$PH$US$US
241916631$24191663$1$I$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683495$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241916641$24191664$1$I$$20240801$20240808$20240808$PER$$US-AMGEN-USASP2024153636$AMGEN$$$$$F$Y$$$20240808$$CN$US$US
241916651$24191665$1$I$$20240805$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124315$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240809$$CN$US$US
241916661$24191666$1$I$20240731$20240802$20240808$20240808$EXP$$US-ABBVIE-5865720$ABBVIE$$71$YR$$M$Y$$$20240808$$CN$US$US
241916671$24191667$1$I$20240807$20240807$20240808$20240808$PER$$US-AMGEN-USASP2024157308$AMGEN$$65$YR$E$F$Y$$$20240808$$PH$US$US
241916681$24191668$1$I$20240805$20240806$20240808$20240808$EXP$$US-ABBVIE-5870179$ABBVIE$$54$YR$$F$Y$$$20240808$$CN$US$US
241916692$24191669$2$F$$20240730$20240808$20240812$PER$$NVSC2024US156502$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
241916703$24191670$3$F$$20240910$20240808$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124065$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240911$$HP$US$US
241916711$24191671$1$I$$20240724$20240808$20240808$EXP$$DO-ABBVIE-5859201$ABBVIE$$$$$F$Y$$$20240808$$CN$DO$DO
241916731$24191673$1$I$20240805$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004176$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240808$$CN$US$US
241916743$24191674$3$F$20231001$20240812$20240808$20240820$EXP$$DE-ABBVIE-5869895$ABBVIE$$80$YR$$F$Y$$$20240820$$CN$DE$DE
241916751$24191675$1$I$$20240805$20240808$20240808$PER$$US-LEO Pharma-372566$LEO PHARM$$78$YR$$F$Y$$$20240809$$PH$US$US
241916761$24191676$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5871069$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241916773$24191677$3$F$$20240821$20240808$20240824$EXP$$US-ABBVIE-5870274$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
241916781$24191678$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5871223$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241916791$24191679$1$I$20240601$20240806$20240808$20240808$EXP$$US-ABBVIE-5870860$ABBVIE$$22$YR$$F$Y$$$20240808$$CN$US$US
241916801$24191680$1$I$20240216$20240801$20240808$20240808$EXP$$BR-ABBVIE-5871102$ABBVIE$$77$YR$$M$Y$68$KG$20240808$$MD$BR$BR
241916811$24191681$1$I$$20240807$20240808$20240808$EXP$$US-GILEAD-2024-0683378$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241916821$24191682$1$I$20240701$20240806$20240808$20240808$EXP$$AR-ABBVIE-5870290$ABBVIE$$79$YR$$M$Y$$$20240808$$CN$AR$AR
241916832$24191683$2$F$$20240924$20240808$20240928$EXP$$US-ABBVIE-5870312$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
241916841$24191684$1$I$$20240807$20240808$20240808$EXP$$US-ABBVIE-5871751$ABBVIE$$$$$M$Y$$$20240808$$CN$US$US
241916851$24191685$1$I$20240716$20240729$20240808$20240808$EXP$$BR-JNJFOC-20240785120$JOHNSON AND JOHNSON$$66$YR$E$M$Y$63$KG$20240809$$CN$BR$BR
241916861$24191686$1$I$$20240806$20240808$20240808$30DAY$$US-SANDOZ INC.-SDZ2023US021642$SANDOZ$$$$$M$Y$$$20240808$$CN$US$US
241916871$24191687$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870800$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241916881$24191688$1$I$$20240807$20240808$20240808$PER$$NVSC2024US161871$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241916902$24191690$2$F$20240806$20240919$20240808$20240923$EXP$$GB-ABBVIE-5871392$ABBVIE$$75$YR$$M$Y$$$20240923$$CN$GB$GB
241916911$24191691$1$I$$20240808$20240808$20240808$EXP$$US-SANDOZ INC.-SDZ2024US071472$SANDOZ$$$$$F$Y$$$20240808$$CN$US$US
241916921$24191692$1$I$20240618$20240806$20240808$20240808$EXP$$US-ABBVIE-5870233$ABBVIE$$59$YR$$M$Y$$$20240808$$CN$US$US
241916931$24191693$1$I$$20240806$20240808$20240808$EXP$$US-ABBVIE-5870524$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241916941$24191694$1$I$$20240805$20240808$20240808$EXP$$US-ABBVIE-5871715$ABBVIE$$$$$M$Y$$$20240808$$HP$US$US
241916951$24191695$1$I$20240101$20240807$20240808$20240808$EXP$$US-ABBVIE-5872324$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241916961$24191696$1$I$$20240729$20240808$20240808$EXP$$US-ABBVIE-5871945$ABBVIE$$$$$F$Y$$$20240808$$CN$US$US
241916972$24191697$2$F$$20240807$20240808$20240808$PER$$US-GILEAD-2024-0683380$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241916981$24191698$1$I$$20240806$20240808$20240808$EXP$$CZ-ABBVIE-5872516$ABBVIE$$$$$M$Y$$$20240808$$HP$CZ$CZ
241916991$24191699$1$I$20240723$20240806$20240808$20240808$EXP$$SA-GSK-SA2024EME098254$GLAXOSMITHKLINE$$$$$$Y$$$20240808$$CN$SA$SA
241917001$24191700$1$I$$20240801$20240808$20240808$PER$$US-ABBVIE-5864776$ABBVIE$$$$$$Y$$$20240808$$CN$US$US
241917011$24191701$1$I$20240803$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004174$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240808$$CN$US$US
241917021$24191702$1$I$20240806$20240806$20240808$20240808$PER$$US-ELI_LILLY_AND_COMPANY-US202408004614$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240808$$CN$US$US
241917032$24191703$2$F$$20240827$20240808$20240903$EXP$$JP-ASTELLAS-2024JP005776$ASTELLAS$$77$YR$E$M$Y$$$20240903$$MD$JP$JP
241917041$24191704$1$I$$20240807$20240808$20240808$EXP$$US-ASTELLAS-2024US022516$ASTELLAS$$$$$F$Y$$$20240809$$CN$US$US
241917051$24191705$1$I$20240501$20240805$20240808$20240808$EXP$$US-ABBVIE-5827633$ABBVIE$$64$YR$$M$Y$$$20240808$$CN$US$US
241917064$24191706$4$F$20221011$20240927$20240808$20240930$EXP$FR-AFSSAPS-PV2024000678$FR-JNJFOC-20240819569$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240930$$MD$FR$FR
241917071$24191707$1$I$$20240807$20240808$20240808$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012168$JAZZ$$$$$F$Y$$$20240808$$CN$US$US
241917083$24191708$3$F$$20240828$20240808$20240829$PER$$NVSC2024US160646$NOVARTIS$$$$$$Y$$$20240829$$CN$US$US
241917091$24191709$1$I$$20240802$20240808$20240808$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125576$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240809$$CN$US$US
241917102$24191710$2$F$20240718$20240807$20240808$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125440$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240813$$PH$US$US
241917113$24191711$3$F$20240804$20240808$20240808$20240810$PER$$US-AMGEN-USASP2024157691$AMGEN$$65$YR$E$M$Y$$$20240810$$CN$US$US
241917121$24191712$1$I$$20240730$20240808$20240808$30DAY$$US-GSK-US2024095426$GLAXOSMITHKLINE$$$$$F$Y$$$20240808$$CN$US$US
241917131$24191713$1$I$20240426$20240807$20240808$20240808$30DAY$$US-SANDOZ INC.-SDZ2024US043796$SANDOZ$$53$YR$$F$Y$$$20240808$$HP$US$US
241917141$24191714$1$I$$20240808$20240809$20240809$PER$$NVSC2024US161869$NOVARTIS$$$$$F$Y$100$KG$20240809$$CN$US$US
241917152$24191715$2$F$20240726$20240826$20240809$20240902$PER$$US-AstraZeneca-2024A172445$ASTRAZENECA$$65$YR$$F$Y$140.6$KG$20240902$$CN$US$
241917161$24191716$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157678$AMGEN$$$$$$Y$$$20240808$$PH$US$US
241917171$24191717$1$I$20240719$20240802$20240809$20240809$PER$$US-AMGEN-USASP2024155033$AMGEN$$$$$$Y$$$20240808$$PH$US$US
241917181$24191718$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125437$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240809$$HP$US$US
241917191$24191719$1$I$$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124511$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$104.33$KG$20240809$$HP$US$US
241917201$24191720$1$I$$20240806$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2024IN071456$SANDOZ$$$$$M$Y$$$20240809$$CN$US$IN
241917211$24191721$1$I$$20240731$20240809$20240809$EXP$$US-GSK-US2024095777$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241917221$24191722$1$I$20220101$20240806$20240809$20240809$EXP$$SG-GSK-SG2024APC097966$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$HP$SG$SG
241917231$24191723$1$I$20240608$20240802$20240809$20240809$EXP$$US-ABBVIE-5865639$ABBVIE$$54$YR$$M$Y$$$20240809$$CN$US$US
241917241$24191724$1$I$$20240805$20240809$20240809$PER$$US-ABBVIE-5868510$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241917251$24191725$1$I$20240101$20240802$20240809$20240809$EXP$$US-ABBVIE-5867345$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241917262$24191726$2$F$$20240804$20240809$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408003018$ELI LILLY AND CO$$50$YR$A$$Y$$$20240814$$LW$US$US
241917271$24191727$1$I$$20240805$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202404016830$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240808$$CN$US$US
241917282$24191728$2$F$20220528$20240820$20240809$20240829$EXP$FR-AFSSAPS-PV2024000719$FR-JNJFOC-20240818921$JOHNSON AND JOHNSON$$0$DY$N$M$Y$0.157$KG$20240829$$MD$FR$FR
241917292$24191729$2$F$20240731$20240911$20240809$20240920$PER$$US-JNJFOC-20240803140$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240920$$CN$US$US
241917301$24191730$1$I$$20240801$20240809$20240809$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-001330$Alvotech$$29$YR$$M$Y$$$20240809$$MD$CA$CA
241917311$24191731$1$I$20240201$20240805$20240809$20240809$EXP$$AU-ABBVIE-5869620$ABBVIE$$76$YR$$M$Y$$$20240809$$CN$AU$AU
241917322$24191732$2$F$$20240809$20240809$20240814$EXP$$US-ABBVIE-5868355$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
241917331$24191733$1$I$$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125118$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240809$$CN$US$US
241917341$24191734$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125509$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$49.9$KG$20240809$$HP$US$US
241917351$24191735$1$I$20240722$20240805$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124027$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240809$$PH$US$US
241917361$24191736$1$I$$20240805$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125435$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$69$KG$20240809$$PH$US$US
241917371$24191737$1$I$$20240806$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125540$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240809$$CN$US$US
241917381$24191738$1$I$$20240715$20240809$20240809$PER$$US-TOLMAR, INC.-24US050254$TOLMAR$$$$$$Y$$$20240809$$HP$US$US
241917391$24191739$1$I$$20240715$20240809$20240809$PER$$US-TOLMAR, INC.-24US050573$TOLMAR$$$$$$Y$$$20240809$$HP$US$US
241917401$24191740$1$I$$20240715$20240809$20240809$PER$$US-TOLMAR, INC.-24US050697$TOLMAR$$$$$M$Y$$$20240809$$CN$US$US
241917412$24191741$2$F$20240701$20240820$20240809$20240909$PER$$US-TOLMAR, INC.-24US050885$TOLMAR$$86$YR$$M$Y$$$20240909$$PH$US$US
241917421$24191742$1$I$20240101$20240802$20240809$20240809$EXP$$CA-ABBVIE-5871504$ABBVIE$$$$A$M$Y$$$20240809$$CN$CA$CA
241917432$24191743$2$F$$20240809$20240809$20240815$EXP$$US-ABBVIE-5868939$ABBVIE$$$$$F$Y$$$20240815$$HP$US$US
241917441$24191744$1$I$20240719$20240726$20240809$20240809$EXP$$DE-CIPLA LTD.-2024DE08222$CIPLA$$$$$$Y$$$20240809$$MD$DE$DE
241917451$24191745$1$I$$20240726$20240809$20240809$EXP$$US-CIPLA LTD.-2024US08288$CIPLA$Jones DT, Srinivasmurthy R, Pandit M, Tovar R, Ho L, Wairimu K. Raoultella ornithinolytica urinary tract infection in a patient with triple-negative breast cancer. Cureus. 2024;16 (7):e64742$$$$$Y$$$20240809$$HP$US$US
241917461$24191746$1$I$$20240805$20240809$20240809$PER$$US-ABBVIE-5870838$ABBVIE$$$$$$Y$$$20240809$$CN$US$US
241917471$24191747$1$I$20240715$20240730$20240809$20240809$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095328$VIIV$$45$YR$$M$Y$$$20240809$$CN$US$US
241917482$24191748$2$F$20240701$20240826$20240809$20240905$30DAY$$US-GSK-US2024095344$GLAXOSMITHKLINE$$71$YR$$M$Y$$$20240905$$MD$US$US
241917491$24191749$1$I$$20240806$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2024US071414$SANDOZ$$$$E$F$Y$$$20240809$$MD$US$US
241917502$24191750$2$F$$20240909$20240809$20240909$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035562$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240910$$CN$CA$CA
241917511$24191751$1$I$20240401$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A177993$ASTRAZENECA$$838$MON$$$Y$$$20240809$$MD$US$
241917521$24191752$1$I$$20240802$20240809$20240809$EXP$$US-ABBVIE-5865902$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241917531$24191753$1$I$20240805$20240807$20240809$20240809$EXP$$JP-TAKEDA-2024TJP011799$TAKEDA$$$$A$M$Y$$$20240809$$MD$JP$JP
241917551$24191755$1$I$20240722$20240807$20240809$20240809$EXP$$CN-BEIGENE-BGN-2024-012344$BEIGENE$$$$$$Y$$$20240809$$HP$CN$CN
241917561$24191756$1$I$$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024157013$AMGEN$$77$YR$E$F$Y$$$20240808$$MD$US$US
241917571$24191757$1$I$$20240807$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2024US069789$SANDOZ$Sheth S, Matthia E, Naik D.. Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer. Journal of clinical lipidology. 2024$57$YR$$F$Y$$$20240809$$HP$US$US
241917581$24191758$1$I$$20240802$20240809$20240809$EXP$DE-BFARM-24005331$DE-ESPERIONTHERAPEUTICS-2024DEU01244$ESPERION THERAPEUTICS$$$$A$M$Y$$$20240809$$MD$DE$DE
241917591$24191759$1$I$$20240730$20240809$20240809$PER$$US-SA-2024SA229479$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241917601$24191760$1$I$20240101$20240806$20240809$20240809$EXP$$SE-ABBVIE-5869522$ABBVIE$$78$YR$$F$Y$$$20240809$$MD$SE$SE
241917611$24191761$1$I$$20240808$20240809$20240809$PER$$NVSC2024US161873$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
241917621$24191762$1$I$20240719$20240806$20240809$20240809$EXP$$CA-JNJFOC-20240819062$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240809$$HP$CA$CA
241917631$24191763$1$I$$20240806$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125635$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240809$$CN$US$US
241917651$24191765$1$I$$20240807$20240809$20240809$EXP$$NVSC2024NP161745$NOVARTIS$$$$$F$Y$$$20240809$$CN$IN$NP
241917664$24191766$4$F$20240401$20240911$20240809$20240913$EXP$$US-ABBVIE-5870136$ABBVIE$$78$YR$$F$Y$63$KG$20240913$$CN$US$US
241917671$24191767$1$I$$20240805$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002994$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240809$$CN$US$US
241917681$24191768$1$I$20240618$20240726$20240809$20240809$EXP$$JP-UCBSA-2024039524$UCB$$73$YR$$F$Y$$$20240809$$PH$JP$JP
241917692$24191769$2$F$$20240816$20240809$20240827$EXP$$JP-BEH-2024176859$CSL BEHRING$$$$N$M$Y$0.133$KG$20240827$$HP$JP$JP
241917701$24191770$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125787$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240809$$CN$US$US
241917711$24191771$1$I$$20240805$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124306$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240809$$CN$US$US
241917721$24191772$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232043$SANOFI AVENTIS$$$$E$F$Y$$$20240809$$MD$US$US
241917731$24191773$1$I$20240801$20240803$20240809$20240809$EXP$$CN-SA-2024SA233251$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240809$$HP$CN$CN
241917741$24191774$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5871001$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241917751$24191775$1$I$20240605$20240806$20240809$20240809$EXP$$US-ABBVIE-5870208$ABBVIE$$65$YR$$F$Y$$$20240809$$CN$US$US
241917761$24191776$1$I$20240805$20240806$20240809$20240809$EXP$$US-ABBVIE-5870311$ABBVIE$$37$YR$$M$Y$$$20240809$$CN$US$US
241917772$24191777$2$F$20240101$20240812$20240809$20240821$PER$$US-SA-2024SA234537$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240821$$MD$US$US
241917781$24191778$1$I$20220304$20220419$20240809$20240809$EXP$$ZA-BIOVITRUM-2022ZA03565$BIOVITRUM$$95$DY$$F$Y$2.8$KG$20240809$$CN$ZA$ZA
241917792$24191779$2$F$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683381$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241917801$24191780$1$I$$20240802$20240809$20240809$EXP$$GB-CELLTRION INC.-2024GB018806$CELLTRION$$$$$$Y$$$20240809$$CN$GB$GB
241917811$24191781$1$I$20211227$20220118$20240809$20240809$EXP$$NL-BIOVITRUM-2022NL01054$BIOVITRUM$$138$DY$$F$Y$4.9$KG$20240809$$CN$NL$NL
241917821$24191782$1$I$20231015$20240807$20240809$20240809$EXP$$GB-ABBVIE-5871473$ABBVIE$$74$YR$$M$Y$81$KG$20240809$$HP$GB$GB
241917831$24191783$1$I$$20240806$20240809$20240809$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012123$JAZZ$$$$$M$Y$$$20240808$$CN$US$US
241917841$24191784$1$I$$20240725$20240809$20240809$PER$$US-APOTEX-2024AP009054$APOTEX$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. The Journal of Allergy and Clinical Immunology- Pract. 2024;12 (6):1663-1665$57$YR$$M$Y$$$20240809$$MD$US$US
241917851$24191785$1$I$20240705$20240806$20240809$20240809$EXP$$US-ABBVIE-5870281$ABBVIE$$66$YR$$F$Y$$$20240809$$CN$US$US
241917861$24191786$1$I$$20240802$20240809$20240809$EXP$$AT-VIIV HEALTHCARE LIMITED-AT2024EME097533$VIIV$$$$$$Y$$$20240809$$MD$AT$AT
241917871$24191787$1$I$20240101$20240806$20240809$20240809$EXP$$US-ABBVIE-5871007$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241917881$24191788$1$I$20240101$20240802$20240809$20240809$PER$$US-AMGEN-USASP2024154936$AMGEN$$73$YR$E$M$Y$$$20240808$$CN$US$US
241917901$24191790$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5865542$ABBVIE$$67$YR$$M$Y$$$20240809$$MD$US$US
241917911$24191791$1$I$$20240724$20240809$20240809$PER$$US-JNJFOC-20240772502$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241917921$24191792$1$I$20240701$20240807$20240809$20240809$EXP$IT-MINISAL02-997790$IT-JNJFOC-20240819058$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240809$$MD$IT$IT
241917942$24191794$2$F$$20240905$20240809$20240911$EXP$$JP-JNJFOC-20240820085$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240911$$MD$JP$JP
241917951$24191795$1$I$$20240730$20240809$20240809$30DAY$$US-GSK-US2024AMR096068$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241917961$24191796$1$I$$20221123$20240809$20240809$EXP$$ZA-AstraZeneca-2022A388694$ASTRAZENECA$$79$YR$$F$Y$$$20240809$$CN$ZA$
241917971$24191797$1$I$$20230814$20240809$20240809$EXP$$IN-AstraZeneca-2023A185531$ASTRAZENECA$$62$YR$$F$Y$$$20240809$$CN$IN$
241917981$24191798$1$I$20240503$20240730$20240809$20240809$EXP$FR-AFSSAPS-LL2024001380$FR-TEVA-VS-3228354$TEVA$$54$YR$$F$Y$71$KG$20240809$$MD$FR$FR
241917991$24191799$1$I$$20230630$20240809$20240809$PER$$US-Axellia-004813$XELLIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$MD$US$US
241918002$24191800$2$F$20240716$20240814$20240809$20240819$PER$$US-AMGEN-USASP2024157173$AMGEN$$66$YR$E$M$Y$102.49$KG$20240819$$HP$US$US
241918011$24191801$1$I$20240726$20240806$20240809$20240809$EXP$$CN-HALEON-2190675$Haleon PLC$$76$YR$$F$Y$52$KG$20240808$$HP$CN$CN
241918021$24191802$1$I$$20240807$20240809$20240809$EXP$$RU-ABBVIE-5871463$ABBVIE$$67$YR$$F$Y$$$20240809$$MD$RU$RU
241918031$24191803$1$I$20240101$20240805$20240809$20240809$EXP$$US-ABBVIE-5868252$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241918041$24191804$1$I$20240701$20240731$20240809$20240809$PER$$US-SA-2024SA232147$SANOFI AVENTIS$$47$YR$A$F$Y$58.967$KG$20240809$$MD$US$US
241918061$24191806$1$I$20240101$20240731$20240809$20240809$PER$$US-SA-2024SA232145$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240809$$MD$US$US
241918071$24191807$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232032$SANOFI AVENTIS$$$$$M$Y$$$20240809$$HP$US$US
241918081$24191808$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA232318$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240809$$CN$US$US
241918092$24191809$2$F$$20240906$20240809$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003566$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241918102$24191810$2$F$20240701$20240904$20240809$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003530$ACADIA PHARMACEUTICALS$$11$YR$$F$Y$$$20240926$$CN$US$US
241918111$24191811$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003565$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241918123$24191812$3$F$$20240905$20240809$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003568$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241918131$24191813$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157909$AMGEN$$$$$$Y$$$20240808$$PH$US$US
241918141$24191814$1$I$20230912$20240808$20240809$20240809$EXP$GB-MHRA-MED-202408081241349270-WTSMG$GB-JNJFOC-20240820734$JOHNSON AND JOHNSON$$21$YR$A$M$Y$70$KG$20240809$$MD$GB$GB
241918152$24191815$2$F$20240701$20240911$20240809$20240917$EXP$$JP-TAKEDA-2024TJP011815$TAKEDA$$8$DEC$$$Y$$$20240917$$MD$JP$JP
241918161$24191816$1$I$20201123$20240806$20240809$20240809$EXP$PL-URPL-1-4248-2020$PL-HALEON-2190739$Haleon PLC$$19$YR$$F$Y$70$KG$20240808$$MD$PL$PL
241918171$24191817$1$I$$20240806$20240809$20240809$PER$$NVSC2024US161782$NOVARTIS$$$$$M$Y$$$20240809$$HP$US$US
241918181$24191818$1$I$20240701$20240805$20240809$20240809$EXP$$US-ABBVIE-5870364$ABBVIE$$62$YR$$M$Y$$$20240809$$CN$US$US
241918191$24191819$1$I$$20240806$20240809$20240809$EXP$$IT-ABBVIE-5871506$ABBVIE$$74$YR$$M$Y$$$20240809$$HP$IT$IT
241918201$24191820$1$I$20240802$20240805$20240809$20240809$EXP$$ES-ABBVIE-5871380$ABBVIE$$78$YR$$M$Y$62$KG$20240809$$CN$ES$ES
241918211$24191821$1$I$20240712$20240715$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003571$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240809$$HP$US$US
241918221$24191822$1$I$$20240805$20240809$20240809$EXP$$CA-GSK-CA2024048802$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$CA$CA
241918232$24191823$2$F$$20240910$20240809$20240910$EXP$$FI-JNJFOC-20240802121$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240910$$PH$FI$FI
241918241$24191824$1$I$20240711$20240806$20240809$20240809$EXP$$US-ABBVIE-5870338$ABBVIE$$58$YR$$F$Y$$$20240809$$CN$US$US
241918251$24191825$1$I$20240620$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003688$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240809$$CN$US$US
241918262$24191826$2$F$$20240829$20240809$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123902$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240830$$CN$US$US
241918272$24191827$2$F$$20240808$20240809$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003572$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
241918281$24191828$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232036$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240809$$MD$US$US
241918291$24191829$1$I$$20240801$20240809$20240809$PER$$US-TAKEDA-2024TUS077775$TAKEDA$$$$$M$Y$12.6$KG$20240809$$MD$US$US
241918301$24191830$1$I$20240727$20240730$20240809$20240809$PER$$US-ABBVIE-5862736$ABBVIE$$50$YR$$F$Y$$$20240809$$CN$US$US
241918312$24191831$2$F$20160101$20240904$20240809$20240910$EXP$$CH-TAKEDA-2024TUS079503$TAKEDA$$$$$M$Y$$$20240910$$CN$CH$CH
241918321$24191832$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003575$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241918351$24191835$1$I$20240101$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157656$AMGEN$$49$YR$A$F$Y$$$20240808$$CN$US$US
241918361$24191836$1$I$$20240421$20240809$20240809$EXP$$US-Apnar-000173$APNAR PHARMA$Bruss P, Hartle R, Astacio J, Chauhdri AF. Electrocardiographic Effects of Bupropion Toxicity Suggesting Dysfunction of the Gap Junction or Connexin 43. Cureus. 2024 Mar 16;16(3):e56288$20$YR$A$F$Y$$$20240504$$HP$US$US
241918381$24191838$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003577$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241918392$24191839$2$F$20240802$20240913$20240809$20240915$PER$$US-JNJFOC-20240809958$JOHNSON AND JOHNSON$$60$YR$A$$Y$$$20240915$$CN$US$US
241918401$24191840$1$I$$20240807$20240809$20240809$EXP$$NVSC2024NP161698$NOVARTIS$$$$$F$Y$$$20240809$$CN$NP$NP
241918421$24191842$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA230064$SANOFI AVENTIS$$$$C$M$Y$$$20240809$$MD$US$US
241918431$24191843$1$I$$20240701$20240809$20240809$EXP$$US-ABBVIE-5872591$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241918441$24191844$1$I$$20240705$20240809$20240809$PER$$BE-TOLMAR, INC.-24BE051620$TOLMAR$$$$$$Y$$$20240809$$HP$BE$BE
241918452$24191845$2$F$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683508$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241918462$24191846$2$F$20240701$20240909$20240809$20240913$EXP$$JP-AMGEN-JPNSP2024153223$AMGEN$$$$$$Y$$$20240913$$MD$JP$JP
241918473$24191847$3$F$20240731$20240918$20240809$20240930$PER$$US-AMGEN-USASP2024154453$AMGEN$$69$YR$E$$Y$$$20240930$$PH$US$US
241918481$24191848$1$I$$20240719$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407013626$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240809$$CN$US$US
241918491$24191849$1$I$$20240718$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407012714$ELI LILLY AND CO$$74$YR$E$F$Y$34.9$KG$20240809$$CN$US$US
241918501$24191850$1$I$20240301$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004652$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241918521$24191852$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004623$ELI LILLY AND CO$$69$YR$E$$Y$$$20240809$$CN$US$US
241918531$24191853$1$I$$20240805$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003847$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240809$$CN$US$US
241918541$24191854$1$I$$20240722$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407014491$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241918551$24191855$1$I$$20240807$20240809$20240809$EXP$$NVSC2024IN161707$NOVARTIS$$$$$F$Y$$$20240809$$CN$IN$IN
241918563$24191856$3$F$$20240904$20240809$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003582$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
241918572$24191857$2$F$$20240808$20240809$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003580$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
241918581$24191858$1$I$20240701$20240731$20240809$20240809$PER$$US-ABBVIE-5863046$ABBVIE$$45$YR$$F$Y$$$20240809$$HP$US$US
241918591$24191859$1$I$$20230406$20240809$20240809$EXP$$US-AstraZeneca-2023A082326$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241918602$24191860$2$F$20240616$20240913$20240809$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003690$ACADIA PHARMACEUTICALS$$87$YR$$F$Y$$$20240923$$CN$US$US
241918611$24191861$1$I$20230318$20230616$20240809$20240809$EXP$$US-AstraZeneca-2023A104291$ASTRAZENECA$$22990$DY$$F$Y$$$20240809$$CN$US$
241918621$24191862$1$I$20220916$20240802$20240809$20240809$EXP$$CO-UCBSA-2024039865$UCB$$34$YR$$F$Y$$$20240809$$CN$CO$CO
241918631$24191863$1$I$$20240806$20240809$20240809$PER$$US-AstraZeneca-2024A179378$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241918641$24191864$1$I$$20230724$20240809$20240809$EXP$$US-AstraZeneca-2023A169461$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241918652$24191865$2$F$$20240820$20240809$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003694$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
241918662$24191866$2$F$20240726$20240809$20240809$20240815$30DAY$$US-AMGEN-USASP2024151689$AMGEN$$$$$$Y$$$20240815$$PH$US$US
241918673$24191867$3$F$20240731$20240822$20240809$20240828$30DAY$$US-AMGEN-USASP2024155658$AMGEN$$67$YR$E$F$Y$$$20240828$$HP$US$US
241918681$24191868$1$I$$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155570$AMGEN$$$$$$Y$$$20240808$$CN$US$US
241918691$24191869$1$I$$20240802$20240809$20240809$EXP$$GB-AMGEN-GBRSP2024155164$AMGEN$$$$$M$Y$$$20240808$$CN$GB$GB
241918701$24191870$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125577$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240809$$CN$US$US
241918712$24191871$2$F$$20240821$20240809$20240825$EXP$$JP-TAKEDA-2024TJP011777$TAKEDA$$5$DEC$$F$Y$$$20240825$$HP$JP$JP
241918721$24191872$1$I$20240703$20240717$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003697$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240809$$CN$US$US
241918731$24191873$1$I$20240805$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125629$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240809$$CN$US$US
241918741$24191874$1$I$$20240807$20240809$20240809$PER$$US-JNJFOC-20240817992$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$HP$US$US
241918754$24191875$4$F$20240601$20240913$20240809$20240920$EXP$$CA-JNJFOC-20240816264$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240920$$HP$CA$CA
241918761$24191876$1$I$$20240807$20240809$20240809$PER$$US-JNJFOC-20240817559$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$MD$US$US
241918771$24191877$1$I$20231001$20240725$20240809$20240809$EXP$CA-SA-2024SA138025$CA-SA-2024SA138025$SANOFI AVENTIS$$73$YR$E$F$Y$83$KG$20240809$$MD$CA$CA
241918792$24191879$2$F$20231001$20240805$20240809$20240819$PER$$US-SA-2024SA231787$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240819$$HP$US$US
241918801$24191880$1$I$20230325$20230522$20240809$20240809$EXP$$CO-BIOVITRUM-2023-CO-008955$BIOVITRUM$$229$DY$$M$Y$7.9$KG$20240809$$CN$CO$CO
241918811$24191881$1$I$$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A175807$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241918821$24191882$1$I$20211203$20211207$20240809$20240809$EXP$$US-AstraZeneca-2021A859797$ASTRAZENECA$$20751$DY$$F$Y$$$20240809$$CN$US$
241918831$24191883$1$I$$20240801$20240809$20240809$PER$$US-ALXN-202408USA000084US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241918851$24191885$1$I$$20240730$20240809$20240809$PER$$US-CHATTEMPRD-2024OHG026231$CHATTEM$$$$$$Y$$$20240809$$CN$US$US
241918862$24191886$2$F$$20240822$20240809$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003531$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
241918871$24191887$1$I$20240501$20240520$20240809$20240809$EXP$$DE-AUROBINDO-AUR-APL-2024-026135$AUROBINDO$$65$YR$$F$Y$60$KG$20240809$$CN$DE$DE
241918881$24191888$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003708$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241918891$24191889$1$I$$20240801$20240809$20240809$PER$$US-CHATTEMPRD-2024OHG026184$CHATTEM$$$$$$Y$$$20240809$$CN$US$US
241918901$24191890$1$I$20240719$20240729$20240809$20240809$EXP$GB-MHRA-31319370$GB-NOVOPROD-1262208$NOVO NORDISK$$49$YR$$F$Y$99$KG$20240809$$CN$GB$GB
241918911$24191891$1$I$20240522$20240727$20240809$20240809$EXP$$EG-NOVOPROD-1262292$NOVO NORDISK$$732$MON$$F$Y$76$KG$20240809$$CN$EG$EG
241918921$24191892$1$I$20220101$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263379$NOVO NORDISK$$63$YR$$F$Y$$$20240809$$CN$US$US
241918931$24191893$1$I$$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263566$NOVO NORDISK$$$$$M$Y$$$20240809$$CN$US$US
241918942$24191894$2$F$20240728$20240816$20240809$20240820$EXP$$US-JNJFOC-20240781263$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240820$$CN$US$US
241918951$24191895$1$I$20240730$20240730$20240809$20240809$PER$$US-JNJFOC-20240783955$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240809$$CN$US$US
241918961$24191896$1$I$$20240801$20240809$20240809$EXP$$JP-JNJFOC-20240821680$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$PH$JP$JP
241918982$24191898$2$F$20240807$20240809$20240809$20240812$PER$$US-AMGEN-USASP2024158073$AMGEN$$35$YR$A$F$Y$$$20240812$$CN$US$US
241918991$24191899$1$I$20240803$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024157849$AMGEN$$85$YR$E$F$Y$$$20240808$$CN$US$US
241919001$24191900$1$I$20240723$20240729$20240809$20240809$EXP$CN-NMPA-4202011046745202400210$CN-NOVOPROD-1262347$NOVO NORDISK$$56$YR$$M$Y$$$20240809$$HP$CN$CN
241919011$24191901$1$I$20240721$20240726$20240809$20240809$EXP$$TW-NOVOPROD-1265674$NOVO NORDISK$$53$YR$$F$Y$62$KG$20240809$$MD$TW$TW
241919021$24191902$1$I$20240724$20240729$20240809$20240809$EXP$SE-SEMPA-2024-005727$SE-NOVOPROD-1263574$NOVO NORDISK$$56$YR$$F$Y$88$KG$20240809$$CN$SE$SE
241919031$24191903$1$I$20240711$20240729$20240809$20240809$EXP$GB-MHRA-MED-202407291620171350-QRKVL$GB-NOVOPROD-1262203$NOVO NORDISK$$54$YR$$F$Y$88$KG$20240809$$HP$GB$GB
241919041$24191904$1$I$20240601$20240729$20240809$20240809$EXP$$CA-NOVOPROD-1263373$NOVO NORDISK$$58$YR$$F$Y$$$20240809$$CN$CA$CA
241919051$24191905$1$I$$20240729$20240809$20240809$EXP$$CN-NOVOPROD-1262272$NOVO NORDISK$$76$YR$$F$Y$60$KG$20240809$$CN$CN$CN
241919061$24191906$1$I$$20240729$20240809$20240809$EXP$$EG-NOVOPROD-1262270$NOVO NORDISK$$$$$M$Y$$$20240809$$CN$EG$EG
241919071$24191907$1$I$$20240729$20240809$20240809$EXP$$JP-NOVOPROD-1263389$NOVO NORDISK$$78$YR$$F$Y$$$20240809$$CN$JP$JP
241919081$24191908$1$I$20230101$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263422$NOVO NORDISK$$$$$F$Y$$$20240809$$CN$US$US
241919091$24191909$1$I$20240401$20240729$20240809$20240809$EXP$$GB-NOVOPROD-1262210$NOVO NORDISK$$63$YR$$M$Y$112$KG$20240809$$MD$GB$GB
241919101$24191910$1$I$$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263565$NOVO NORDISK$$75$YR$$F$Y$$$20240809$$CN$US$US
241919111$24191911$1$I$$20240729$20240809$20240809$EXP$GB-MHRA-MED-202407291259435040-SKWLJ$GB-NOVOPROD-1262193$NOVO NORDISK$$$$$F$Y$$$20240809$$CN$GB$GB
241919121$24191912$1$I$$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263270$NOVO NORDISK$$$$$F$Y$$$20240809$$CN$US$US
241919131$24191913$1$I$20230701$20240729$20240809$20240809$EXP$FR-AFSSAPS-BR2024000615$FR-NOVOPROD-1263212$NOVO NORDISK$$58$YR$$F$Y$115$KG$20240809$$MD$FR$FR
241919141$24191914$1$I$20211001$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263570$NOVO NORDISK$$57$YR$$F$Y$$$20240809$$CN$US$US
241919151$24191915$1$I$$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263418$NOVO NORDISK$$$$A$F$Y$$$20240809$$MD$US$US
241919161$24191916$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003543$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$HP$US$US
241919171$24191917$1$I$$20240729$20240809$20240809$EXP$$IL-NOVOPROD-1262788$NOVO NORDISK$$81$YR$$F$Y$$$20240809$$PH$IL$IL
241919181$24191918$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003539$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241919191$24191919$1$I$20240629$20240715$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003545$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240809$$CN$US$US
241919201$24191920$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003536$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241919212$24191921$2$F$$20240816$20240809$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003544$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
241919221$24191922$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003717$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241919231$24191923$1$I$$20240805$20240809$20240809$PER$$US-CHATTEMPRD-2024OHG026314$CHATTEM$$$$$$Y$$$20240809$$CN$US$US
241919241$24191924$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003540$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241919251$24191925$1$I$$20240804$20240809$20240809$PER$$US-CHATTEMPRD-2024OHG026305$CHATTEM$$$$$$Y$$$20240809$$CN$US$US
241919261$24191926$1$I$20240701$20240801$20240809$20240809$PER$$US-SA-2024SA233401$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240809$$MD$US$US
241919271$24191927$1$I$20240702$20240715$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003548$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240809$$CN$US$US
241919281$24191928$1$I$20240628$20240715$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003546$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240809$$CN$US$US
241919291$24191929$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003655$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241919301$24191930$1$I$$20240715$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003547$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241919311$24191931$1$I$20240711$20240716$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003627$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240809$$CN$US$US
241919321$24191932$1$I$$20240802$20240809$20240809$PER$$US-AMGEN-USASP2024154841$AMGEN$$$$$F$Y$$$20240808$$CN$US$US
241919331$24191933$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004626$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240809$$CN$US$US
241919342$24191934$2$F$$20240920$20240809$20240920$PER$$NVSC2024US161775$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
241919351$24191935$1$I$$20240801$20240809$20240809$30DAY$$US-GSK-US2024AMR097622$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241919361$24191936$1$I$$20240731$20240809$20240809$EXP$$US-Rigel Pharmaceuticals, Inc.-20240800010$RIGEL PHARMACEUTICALS$$$$$F$Y$73.936$KG$20240809$$CN$US$US
241919372$24191937$2$F$$20240823$20240809$20240829$PER$$US-ALXN-202408USA000212US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
241919383$24191938$3$F$20240806$20240816$20240809$20240819$EXP$$JP-009507513-2408JPN000784J$MERCK$$82$YR$$M$Y$$$20240819$$PH$JP$JP
241919391$24191939$1$I$$20240805$20240809$20240809$PER$$US-CHATTEMPRD-2024OHG026213$CHATTEM$$$$A$$Y$$$20240809$$CN$US$US
241919401$24191940$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003631$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241919411$24191941$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA232114$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241919421$24191942$1$I$$20240716$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003629$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241919435$24191943$5$F$20240731$20240830$20240809$20240906$PER$$US-SA-2024SA232893$SANOFI AVENTIS$$48$YR$A$F$Y$172$KG$20240906$$MD$US$US
241919441$24191944$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA231951$SANOFI AVENTIS$$$$C$F$Y$$$20240809$$MD$US$US
241919451$24191945$1$I$20240701$20240801$20240809$20240809$PER$$US-SA-2024SA232187$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240809$$MD$US$US
241919461$24191946$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA232104$SANOFI AVENTIS$$$$A$M$Y$131$KG$20240809$$MD$US$US
241919472$24191947$2$F$$20240828$20240809$20240829$EXP$$JP-SANDOZ INC.-SDZ2024JP070985$SANDOZ$$57$YR$$F$Y$$$20240829$$MD$JP$JP
241919482$24191948$2$F$20240101$20240806$20240809$20240812$PER$$US-ABBVIE-5870071$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241919491$24191949$1$I$20210318$20210624$20240809$20240809$EXP$$HU-AstraZeneca-2021A358823$ASTRAZENECA$$66$YR$$$Y$$$20240809$$MD$HU$
241919501$24191950$1$I$20240716$20240806$20240809$20240809$EXP$$US-AstraZeneca-2024A178599$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241919511$24191951$1$I$$20220406$20240809$20240809$EXP$$CA-AstraZeneca-2022A115828$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$CA$
241919521$24191952$1$I$$20230419$20240809$20240809$EXP$$MY-AstraZeneca-2023A094366$ASTRAZENECA$$74$YR$$M$Y$$$20240809$$MD$MY$
241919541$24191954$1$I$$20230324$20240809$20240809$EXP$$US-AstraZeneca-2023A073450$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241919551$24191955$1$I$20240701$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003653$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240809$$CN$US$US
241919561$24191956$1$I$20240101$20240731$20240809$20240809$PER$$US-SA-2024SA232059$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240809$$MD$US$US
241919573$24191957$3$F$20240722$20240830$20240809$20240913$30DAY$$CA-JNJFOC-20240809465$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240913$$HP$CA$CA
241919581$24191958$1$I$$20240806$20240809$20240809$PER$$US-ABBVIE-5870155$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241919591$24191959$1$I$$20240729$20240809$20240809$EXP$$MK-STRIDES ARCOLAB LIMITED-2024SP009877$STRIDES$Livrinova V, Purrini R.. Macrohematuria due to SARS-CoV-2 infection in pregnant patient.. J-Perinat-Med. 2021;49 (6):eA38 (plus Poster)$32$YR$$F$Y$$$20240809$$HP$MK$MK
241919601$24191960$1$I$20231201$20240726$20240809$20240809$EXP$$US-UCBSA-2024001159$UCB$$61$YR$$F$Y$$$20240809$$CN$US$US
241919611$24191961$1$I$20230207$20230213$20240809$20240809$EXP$$HU-BIOVITRUM-2023HU02729$BIOVITRUM$$186$DY$$M$Y$$$20240809$$CN$HU$HU
241919621$24191962$1$I$$20240726$20240809$20240809$EXP$$US-FDC-2024USLIT00599$FDC LIMITED$J Baez Gonzalez.Fluoroquinolone-Induced Seizure in a Patient Receiving End-of-Life Care: A Case Report..Journal of Palliative Medicine.11-JAN-2023;26:1590-1592$$$$F$Y$$$20240809$$HP$US$US
241919631$24191963$1$I$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683510$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241919642$24191964$2$F$$20240927$20240809$20240927$PER$$NVSC2024US161529$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
241919651$24191965$1$I$$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155305$AMGEN$$$$A$M$Y$$$20240808$$CN$US$US
241919661$24191966$1$I$20230101$20240801$20240809$20240809$PER$$US-AMGEN-USASP2024154991$AMGEN$$$$$F$Y$$$20240808$$MD$US$US
241919671$24191967$1$I$20240806$20240806$20240809$20240809$EXP$$US-ABBVIE-5870914$ABBVIE$$50$YR$$F$Y$$$20240809$$CN$US$US
241919684$24191968$4$F$20240801$20240829$20240809$20240905$30DAY$$US-AMGEN-USASP2024154636$AMGEN$$44$YR$A$F$Y$170.07$KG$20240904$$HP$US$US
241919692$24191969$2$F$20240101$20240808$20240809$20240812$PER$$US-AMGEN-USASP2024157500$AMGEN$$53$YR$A$F$Y$$$20240812$$CN$US$US
241919701$24191970$1$I$$20240730$20240809$20240809$EXP$$JP-ROCHE-10000049768$ROCHE$$49$YR$A$F$Y$$$20240809$$PH$JP$JP
241919711$24191971$1$I$$20240729$20240809$20240809$EXP$GR-SEATTLE GENETICS-2023SGN13186$GR-ROCHE-10000048609$ROCHE$$$$$F$Y$$$20240809$$MD$GR$GR
241919721$24191972$1$I$$20240729$20240809$20240809$EXP$$JP-ROCHE-10000048885$ROCHE$Tanaka Y, Sumi Y, Takagi M. S31-7 Gastric perforation in a patient with COVID-19. The 79th General Meeting of the Japanese Society of Gastroenterological Surgery. 2024;2503$56$YR$A$M$Y$$$20240809$$MD$JP$JP
241919731$24191973$1$I$$20240805$20240809$20240809$PER$$US-SA-2024SA234254$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240809$$CN$US$US
241919741$24191974$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA231746$SANOFI AVENTIS$$$$A$M$Y$$$20240809$$MD$US$US
241919751$24191975$1$I$$20240722$20240809$20240809$PER$$US-JNJFOC-20240817018$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241919771$24191977$1$I$20220516$20220704$20240809$20240809$EXP$$ZA-BIOVITRUM-2022ZA07048$BIOVITRUM$$11$WK$$M$Y$1.8$KG$20240809$$CN$ZA$ZA
241919781$24191978$1$I$$20240802$20240809$20240809$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02855$AMNEAL$$$$$M$Y$12.063$KG$20240809$$CN$US$US
241919791$24191979$1$I$20230101$20240730$20240809$20240809$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP009761$STRIDES$Castelli M, Betelli M, Valenti A, Merelli B, Loglio A, Vigano M, et al.. A CASE OF POLYSEROSITIS, CHYLOUS ASCITES AND HEPATITIS INDUCED BY IMMUNE CHECKPOINT INHIBITORS.. Eur-J-Case-Rep-Intern-Med. 2024;11 (7)$39$YR$$M$Y$$$20240809$$HP$IT$IT
241919801$24191980$1$I$$20220719$20240809$20240809$EXP$$ES-AstraZeneca-2022A264818$ASTRAZENECA$$$$$$Y$$$20240809$$MD$ES$
241919811$24191981$1$I$$20240801$20240809$20240809$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP009878$STRIDES$Ameri M, Aleebrahim-Dehkordi E, Soveyzi F, Rashed MM.. Intracardiac and Pericardial Hydatid Cyst Concurrent with Multi-Organ Involvement: A Case Report.. Curr-Med-Imaging-Rev. 2024;20 (1)$12$YR$$F$Y$$$20240809$$HP$IR$IR
241919821$24191982$1$I$$20220107$20240809$20240809$EXP$$CA-AstraZeneca-2021A729873$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$CA$
241919831$24191983$1$I$20240801$20240801$20240809$20240809$EXP$$CN-AstraZeneca-2024A176479$ASTRAZENECA$$3523$WK$$F$Y$60$KG$20240809$$MD$CN$
241919841$24191984$1$I$$20240730$20240809$20240809$EXP$$IN-KOANAAP-SML-IN-2024-00783$Unknown Manufacturer$Dhangar S, Shanmukhaiah C, Sawant L, Ghatanatti J, Shah A, Mathan LP, et al. Synergeticeffect of Azacitidine and Sorafenib in treatment of a case of myeloid neoplasm with solechromosomal abnormality t(8;22)(p11.2;q11.2)/BCR-FGFR1 rearrangement.. Cancer Genetics. 2023 Jun;274^-275: 26-29. doi:10.1016/j.cancergen.2023.03.004.$48$YR$A$F$Y$$$20240809$$MD$IN$IN
241919851$24191985$1$I$$20230508$20240809$20240809$EXP$$US-AstraZeneca-2023A107788$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241919861$24191986$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004959$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240809$$CN$US$US
241919871$24191987$1$I$20240701$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005262$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240809$$HP$US$US
241919881$24191988$1$I$$20240805$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002895$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241919891$24191989$1$I$$20240730$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408000074$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240809$$CN$US$US
241919911$24191991$1$I$20240710$20240716$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003630$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240809$$CN$US$US
241919921$24191992$1$I$$20240801$20240809$20240809$EXP$$US-ABBVIE-5871889$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241919942$24191994$2$F$$20240815$20240809$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003671$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
241919951$24191995$1$I$$20240725$20240809$20240809$EXP$$US-Renata Limited-2160203$RENATA LIMITED$Full text$84$YR$$F$Y$$$20240809$$$US$US
241919961$24191996$1$I$$20240801$20240809$20240809$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP009906$STRIDES$Otiniano A, Tassin C, Serris A, Guennouni N, Lanternier F, Servais A, et al.. Emphysematous pyelonephritis in a diabetic patient.. J-Nephrol. 2023;36:2621-2624$56$YR$$M$Y$$$20240809$$HP$FR$FR
241919971$24191997$1$I$$20231108$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00572$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240730$$PH$US$US
241919981$24191998$1$I$$20240125$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00039$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240730$$CN$US$US
241919991$24191999$1$I$20230101$20240214$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00077$PRINSTON PHARMACEUTICAL$$$$$F$Y$59.874$KG$20240730$$CN$US$US
241920001$24192000$1$I$20240201$20240219$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00083$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240730$$CN$US$US
241920011$24192001$1$I$20240302$20240304$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00104$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240730$$CN$US$US
241920021$24192002$1$I$20240422$20240423$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00193$PRINSTON PHARMACEUTICAL$$75$YR$$F$Y$$$20240730$$CN$US$US
241920031$24192003$1$I$$20240618$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00248$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240730$$CN$US$US
241920041$24192004$1$I$20240101$20240726$20240809$20240809$EXP$$US-UCBSA-2024038205$UCB$$$$$F$Y$$$20240809$$HP$US$US
241920051$24192005$1$I$$20240422$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00190$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240730$$PH$US$US
241920061$24192006$1$I$20230918$20230922$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00477$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240730$$PH$US$US
241920071$24192007$1$I$$20240208$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00067$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240730$$HP$US$US
241920081$24192008$1$I$$20240807$20240809$20240809$PER$$US-TAKEDA-2024TUS079430$TAKEDA$$$$E$F$Y$$$20240809$$CN$US$US
241920092$24192009$2$F$20240701$20240820$20240809$20240829$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000677$DECIPHERA PHARMACEUTICALS$$76$YR$E$M$Y$$$20240829$$CN$US$US
241920101$24192010$1$I$$20240730$20240809$20240809$30DAY$$US-GSK-US2024095311$GLAXOSMITHKLINE$$$$$M$Y$$$20240809$$CN$US$US
241920112$24192011$2$F$$20240801$20240809$20240816$30DAY$$US-GSK-US2024096857$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$HP$US$US
241920122$24192012$2$F$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683511$GILEAD$$$$$$Y$$$20240808$$LW$US$US
241920131$24192013$1$I$20240701$20240729$20240809$20240809$EXP$DK-DKMA-30736274$DK-NOVOPROD-1263591$NOVO NORDISK$$55$YR$$F$Y$79$KG$20240809$$CN$DK$DK
241920141$24192014$1$I$$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263669$NOVO NORDISK$$$$$M$Y$$$20240809$$CN$US$US
241920151$24192015$1$I$20220101$20240729$20240809$20240809$EXP$DK-DKMA-30736394$DK-NOVOPROD-1263580$NOVO NORDISK$$54$YR$$M$Y$85$KG$20240809$$MD$DK$DK
241920161$24192016$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125622$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$115.21$KG$20240809$$CN$US$US
241920171$24192017$1$I$20240801$20240806$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124776$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$89.36$KG$20240809$$PH$US$US
241920181$24192018$1$I$20240805$20240805$20240809$20240809$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02877$AMNEAL$$67$YR$$F$Y$$$20240809$$CN$US$US
241920192$24192019$2$F$20240730$20240807$20240809$20240815$EXP$$DE-JNJFOC-20240807151$JOHNSON AND JOHNSON$$54$YR$A$M$Y$86$KG$20240815$$MD$DE$DE
241920203$24192020$3$F$$20240820$20240809$20240826$30DAY$$SE-JNJFOC-20240805844$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$SE$SE
241920211$24192021$1$I$$20240808$20240809$20240809$EXP$NL-LRB-00994665$NL-JNJFOC-20240820817$JOHNSON AND JOHNSON$$6$YR$C$F$Y$39.2$KG$20240809$$MD$NL$NL
241920221$24192022$1$I$$20230417$20240809$20240809$EXP$$BR-AstraZeneca-2023A090382$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$BR$
241920231$24192023$1$I$$20240802$20240809$20240809$PER$$US-ALXN-202408USA000160US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241920242$24192024$2$F$20240803$20240827$20240809$20240828$PER$$US-ALXN-202408USA000226US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241920252$24192025$2$F$$20240822$20240809$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003589$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
241920261$24192026$1$I$$20200831$20240809$20240809$EXP$$US-AstraZeneca-2020SF12208$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241920271$24192027$1$I$$20240729$20240809$20240809$EXP$$US-NOVOPROD-1264108$NOVO NORDISK$$$$$F$Y$$$20240809$$CN$US$US
241920281$24192028$1$I$20240717$20240730$20240809$20240809$EXP$CN-NMPA-3419001529681202400222$CN-NOVOPROD-1263115$NOVO NORDISK$$53$YR$$F$Y$62$KG$20240809$$HP$CN$CN
241920291$24192029$1$I$20210621$20240730$20240809$20240809$EXP$$BE-NOVOPROD-1251144$NOVO NORDISK$$56$YR$$F$Y$69$KG$20240809$$MD$BE$BE
241920303$24192030$3$F$20200101$20240820$20240809$20240830$EXP$$CO-NOVOPROD-1263383$NOVO NORDISK$$60$YR$$M$Y$$$20240830$$CN$CO$CO
241920311$24192031$1$I$20240708$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263759$NOVO NORDISK$$$$$M$Y$$$20240809$$CN$US$US
241920321$24192032$1$I$20240701$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263874$NOVO NORDISK$$66$YR$$F$Y$$$20240809$$CN$US$US
241920331$24192033$1$I$20240510$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263691$NOVO NORDISK$$84$YR$$M$Y$$$20240809$$CN$US$US
241920341$24192034$1$I$20210101$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263710$NOVO NORDISK$$$$$M$Y$$$20240809$$CN$US$US
241920351$24192035$1$I$20240726$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407300930552600-LVNBC$GB-NOVOPROD-1262301$NOVO NORDISK$$44$YR$$F$Y$81$KG$20240809$$MD$GB$GB
241920362$24192036$2$F$$20240919$20240809$20240926$EXP$$US-NOVOPROD-1264264$NOVO NORDISK$$72$YR$$F$Y$$$20240926$$CN$US$US
241920371$24192037$1$I$20240722$20240730$20240809$20240809$EXP$$DE-NOVOPROD-1262659$NOVO NORDISK$$$$A$F$Y$75$KG$20240809$$PH$DE$DE
241920382$24192038$2$F$20231225$20240912$20240809$20240923$EXP$$CO-NOVOPROD-1263391$NOVO NORDISK$$83$YR$$M$Y$89$KG$20240923$$CN$CO$CO
241920391$24192039$1$I$20240709$20240729$20240809$20240809$EXP$$US-NOVOPROD-1264069$NOVO NORDISK$$$$$$Y$$$20240809$$MD$US$US
241920401$24192040$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407302000264370-BVZRH$GB-NOVOPROD-1262298$NOVO NORDISK$$24$YR$$F$Y$$$20240809$$CN$GB$GB
241920411$24192041$1$I$$20240729$20240809$20240809$EXP$$US-NOVOPROD-1263745$NOVO NORDISK$$$$$F$Y$$$20240809$$CN$US$US
241920421$24192042$1$I$20240101$20240729$20240809$20240809$EXP$$US-NOVOPROD-1264444$NOVO NORDISK$$54$YR$$M$Y$$$20240809$$CN$US$US
241920431$24192043$1$I$$20240729$20240809$20240809$EXP$$US-NOVOPROD-1264447$NOVO NORDISK$$$$$F$Y$$$20240809$$CN$US$US
241920441$24192044$1$I$$20240729$20240809$20240809$EXP$$US-NOVOPROD-1264091$NOVO NORDISK$$$$A$F$Y$$$20240809$$CN$US$US
241920451$24192045$1$I$20240806$20240806$20240809$20240809$EXP$$RO-ABBVIE-5871398$ABBVIE$$73$YR$$F$Y$$$20240809$$CN$RO$RO
241920461$24192046$1$I$20240703$20240730$20240809$20240809$EXP$CN-NMPA-3310021059352202400185$CN-NOVOPROD-1263213$NOVO NORDISK$$80$YR$$F$Y$40$KG$20240809$$HP$CN$CN
241920472$24192047$2$F$20240101$20240812$20240809$20240816$EXP$$US-ABBVIE-5870180$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
241920481$24192048$1$I$20240628$20240717$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003672$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240809$$CN$US$US
241920491$24192049$1$I$$20240807$20240809$20240809$EXP$$US-ABBVIE-5871681$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241920501$24192050$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125481$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240809$$HP$US$US
241920511$24192051$1$I$$20240725$20240809$20240809$EXP$$IT-Renata Limited-2160205$RENATA LIMITED$Full text$15$YR$$F$Y$48$KG$20240809$$$IT$IT
241920521$24192052$1$I$20240713$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125823$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$92.08$KG$20240809$$PH$US$US
241920531$24192053$1$I$$20240805$20240809$20240809$EXP$$CA-ABBVIE-5871381$ABBVIE$$$$E$M$Y$$$20240809$$CN$CA$CA
241920541$24192054$1$I$20220101$20240730$20240809$20240809$EXP$$US-SPECGX-T202401656$SPECGX$$$$$M$Y$136$KG$20240809$$CN$US$US
241920551$24192055$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003673$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241920561$24192056$1$I$20240807$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004958$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240809$$CN$US$US
241920571$24192057$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004278$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240809$$CN$US$US
241920581$24192058$1$I$20240805$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005065$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240809$$CN$US$US
241920592$24192059$2$F$$20240806$20240809$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408005090$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240815$$CN$US$US
241920601$24192060$1$I$20240701$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004844$ELI LILLY AND CO$$$$$$Y$$$20240809$$HP$US$US
241920611$24192061$1$I$20240805$20240805$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003104$ELI LILLY AND CO$$91$YR$E$M$Y$$$20240809$$CN$US$US
241920621$24192062$1$I$$20240801$20240809$20240809$EXP$$AU-EXELIXIS-CABO-24074497$EXELIXIS$$$$$M$Y$$$20240808$$MD$AU$AU
241920631$24192063$1$I$20240805$20240805$20240809$20240809$EXP$$JP-EXELIXIS-CABO-24080355$EXELIXIS$$7$DEC$$M$Y$$$20240808$$PH$JP$JP
241920643$24192064$3$F$20240101$20240812$20240809$20240822$PER$$US-AMGEN-USASP2024157396$AMGEN$$78$YR$E$F$Y$$$20240822$$CN$US$US
241920651$24192065$1$I$20240715$20240801$20240809$20240809$EXP$$CL-BIOGEN-2024BI01277142$BIOGEN$$33$YR$$F$Y$$$20240809$$CN$CL$CL
241920662$24192066$2$F$$20240807$20240809$20240818$EXP$$IT-AUROBINDO-AUR-APL-2024-038594$AUROBINDO$Borotti E, Ronda E, Guidotti S, Scarpa A, Schiro A, Cortellazzi P, et al. GENETIC MOLECULAR PROFILE IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENT FROM ONSET TO POST-TRANSPLANT RELAPSE A CASE REPORT. Haematologica. 2024;109 (Suppl.)90:abstr. P067$57$YR$$F$Y$$$20240818$$HP$IT$IT
241920671$24192067$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003676$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241920681$24192068$1$I$$20240802$20240809$20240809$PER$$US-ALXN-202408USA000162US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241920691$24192069$1$I$20240220$20240729$20240809$20240809$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000723$PAREXEL$$$$$$Y$$$20240809$$HP$CN$CN
241920702$24192070$2$F$20240617$20240808$20240809$20240816$EXP$$JP-ROCHE-10000033151$ROCHE$$86$YR$E$F$Y$$$20240816$$MD$JP$JP
241920711$24192071$1$I$$20240730$20240809$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-031216$AUROBINDO$Chittal A, Disilvio BE, Dumont T. Amiodarone Not the Only Anti-arrhythmic Wreaking Havoc on the Lung: A Case of Flecainide Induced Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2028$69$YR$$F$Y$$$20240809$$MD$US$US
241920721$24192072$1$I$20240716$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003679$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240809$$CN$US$US
241920731$24192073$1$I$20240101$20240730$20240809$20240809$PER$$US-SA-2024SA232360$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241920741$24192074$1$I$20240101$20240731$20240809$20240809$PER$$US-SA-2024SA232038$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240809$$MD$US$US
241920751$24192075$1$I$$20240725$20240809$20240809$EXP$$TR-Renata Limited-2160208$RENATA LIMITED$Full text$17$YR$$F$Y$$$20240809$$MD$TR$TR
241920761$24192076$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA232006$SANOFI AVENTIS$$$$A$F$Y$79$KG$20240809$$MD$US$US
241920771$24192077$1$I$$20240806$20240809$20240809$PER$$US-SA-2024SA235195$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240809$$CN$US$US
241920781$24192078$1$I$20240727$20240801$20240809$20240809$PER$$US-SA-2024SA232092$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240809$$MD$US$US
241920791$24192079$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA231945$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240809$$MD$US$US
241920801$24192080$1$I$20231211$20240805$20240809$20240809$PER$$US-SA-2024SA234445$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240809$$MD$US$US
241920811$24192081$1$I$$20240806$20240809$20240809$PER$$US-SA-2024SA235150$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240809$$CN$US$US
241920821$24192082$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA231108$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240809$$CN$US$US
241920831$24192083$1$I$$20240730$20240809$20240809$PER$$US-SA-2024SA229386$SANOFI AVENTIS$$$$T$M$Y$$$20240809$$MD$US$US
241920842$24192084$2$F$$20240910$20240809$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003680$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
241920852$24192085$2$F$$20240805$20240809$20240829$PER$$US-AstraZeneca-2024A165621$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
241920861$24192086$1$I$$20240806$20240809$20240809$PER$$US-LEO Pharma-372617$LEO PHARM$$35$YR$$F$Y$$$20240809$$PH$US$US
241920871$24192087$1$I$$20240731$20240809$20240809$PER$$US-AstraZeneca-2024A175149$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
241920881$24192088$1$I$20240722$20240805$20240809$20240809$EXP$$IT-AstraZeneca-2024A177190$ASTRAZENECA$$81$YR$$M$Y$$$20240809$$MD$IT$
241920891$24192089$1$I$20220224$20220523$20240809$20240809$EXP$$US-AstraZeneca-2022A142920$ASTRAZENECA$$20645$DY$$M$Y$$$20240809$$CN$US$
241920901$24192090$1$I$$20200814$20240809$20240809$EXP$$US-AstraZeneca-2020SF04720$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241920911$24192091$1$I$$20240801$20240809$20240809$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-125688$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$68$KG$20240809$$HP$CA$CA
241920921$24192092$1$I$$20240802$20240809$20240809$EXP$$NVSC2024US160560$NOVARTIS$$48$YR$$M$Y$$$20240809$$MD$US$US
241920931$24192093$1$I$20240601$20240725$20240809$20240809$EXP$$BR-CHEPLA-2024008714$CHEPLAPHARM$$46$YR$A$M$Y$$$20240809$$HP$COUNTRY NOT SPECIFIED$BR
241920941$24192094$1$I$$20240807$20240809$20240809$PER$$US-ROCHE-10000051646$ROCHE$$$$$F$Y$$$20240809$$CN$US$US
241920953$24192095$3$F$$20240916$20240809$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003683$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
241920961$24192096$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003681$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$HP$US$US
241920971$24192097$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003591$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241920981$24192098$1$I$20231201$20240730$20240809$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-039006$AUROBINDO$$61$YR$$M$Y$110$KG$20240809$$MD$FR$FR
241920991$24192099$1$I$$20240805$20240809$20240809$EXP$$US-ABBVIE-5868533$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241921002$24192100$2$F$$20240828$20240809$20240907$30DAY$$US-GSK-US2024095876$GLAXOSMITHKLINE$$$$$M$Y$$$20240907$$CN$US$US
241921011$24192101$1$I$20240101$20240731$20240809$20240809$EXP$$US-RIGEL-20240800008$RIGEL PHARMACEUTICALS$$$$$F$Y$65.771$KG$20240809$$CN$US$US
241921022$24192102$2$F$$20240911$20240809$20240923$EXP$$ES-AUROBINDO-AUR-APL-2024-038957$AUROBINDO$Martinez-chantar ML, Gil-pitarch C, Serrano-macia M, Simon J, Mosca L, Conter C, et al. Neddylation inhibition prevents acetaminopheninduced liver damage by enhancing the anabolic cardiolipin pathway. Cell Reports Medicine. 2024;5(7):1-18$$$A$M$Y$$$20240923$$HP$ES$ES
241921031$24192103$1$I$$20240801$20240809$20240809$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009908$STRIDES$Qadir N, Rulka K, Shirazi I, Durgun A, Trehan M.. A Day on the Beach, a Risk for Vibrio Vulnificus Septicemia.. Am-J-Respir-Crit-Care-Med. 2024;209$61$YR$$M$Y$$$20240809$$HP$US$US
241921041$24192104$1$I$20240805$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024157128$AMGEN$$$$$F$Y$$$20240808$$CN$US$US
241921051$24192105$1$I$$20240730$20240809$20240809$EXP$$US-NOVOPROD-1266208$NOVO NORDISK$$$$A$F$Y$$$20240809$$CN$US$US
241921061$24192106$1$I$20240729$20240731$20240809$20240809$EXP$$GB-NOVOPROD-1262804$NOVO NORDISK$$31$YR$$F$Y$$$20240809$$HP$GB$GB
241921081$24192108$1$I$$20240730$20240809$20240809$EXP$$US-NOVOPROD-1264693$NOVO NORDISK$$$$$$Y$$$20240809$$CN$US$US
241921091$24192109$1$I$$20240731$20240809$20240809$EXP$$CN-NOVOPROD-1256609$NOVO NORDISK$$65$YR$$M$Y$72$KG$20240809$$CN$CN$CN
241921101$24192110$1$I$$20240731$20240809$20240809$EXP$$GB-NOVOPROD-1262769$NOVO NORDISK$$$$$$Y$$$20240809$$CN$GB$GB
241921111$24192111$1$I$20230205$20240730$20240809$20240809$EXP$$US-NOVOPROD-1264093$NOVO NORDISK$$68$YR$$F$Y$$$20240809$$CN$US$US
241921122$24192112$2$F$20240501$20240918$20240809$20240930$EXP$$US-NOVOPROD-1263577$NOVO NORDISK$$73$YR$$F$Y$$$20240930$$CN$US$US
241921131$24192113$1$I$$20240731$20240809$20240809$EXP$GB-MHRA-MED-202407311858529170-PHKBV$GB-NOVOPROD-1262854$NOVO NORDISK$$$$$F$Y$$$20240809$$CN$GB$GB
241921141$24192114$1$I$$20240730$20240809$20240809$EXP$$US-NOVOPROD-1263660$NOVO NORDISK$$$$A$F$Y$$$20240809$$HP$US$US
241921151$24192115$1$I$$20240730$20240809$20240809$EXP$$CA-NOVOPROD-1264600$NOVO NORDISK$$55$YR$$M$Y$$$20240809$$MD$CA$CA
241921161$24192116$1$I$$20240730$20240809$20240809$EXP$$TR-NOVOPROD-1264506$NOVO NORDISK$$$$$F$Y$$$20240809$$CN$TR$TR
241921171$24192117$1$I$$20240730$20240809$20240809$EXP$$DE-NOVOPROD-1264515$NOVO NORDISK$$62$YR$$M$Y$$$20240809$$MD$DE$DE
241921182$24192118$2$F$20240722$20240816$20240809$20240827$EXP$$MX-NOVOPROD-1262979$NOVO NORDISK$$64$YR$$M$Y$70$KG$20240827$$CN$MX$MX
241921192$24192119$2$F$$20240826$20240809$20240826$PER$$US-ALXN-202408USA000191US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241921212$24192121$2$F$20240803$20240815$20240809$20240816$PER$$US-AMGEN-USASP2024156132$AMGEN$$75$YR$E$F$Y$$$20240816$$CN$US$US
241921221$24192122$1$I$20240806$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024156833$AMGEN$$59$YR$A$M$Y$$$20240808$$CN$US$US
241921231$24192123$1$I$20240805$20240808$20240809$20240809$PER$$US-AMGEN-USASP2024157997$AMGEN$$$$$F$Y$$$20240808$$CN$US$US
241921251$24192125$1$I$$20240801$20240809$20240809$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP009916$STRIDES$Ito H, Hirano Y.. Long-term clinical course of two rare cases of synovitis-acne-pustulosis-hyperostosis-osteomyelitis syndrome involving only unilateral femur.. Mod-Rheumatol-Case-Rep. 2024;8 (2):373-377.$35$YR$$M$Y$$$20240809$$HP$JP$JP
241921261$24192126$1$I$$20240807$20240809$20240809$PER$$US-ROCHE-10000052021$ROCHE$$23$YR$A$F$Y$$$20240809$$CN$US$US
241921271$24192127$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005088$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240809$$CN$US$US
241921281$24192128$1$I$20230901$20240730$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408000387$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240809$$CN$US$US
241921291$24192129$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004758$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240809$$CN$US$US
241921302$24192130$2$F$$20240813$20240809$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408004769$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240815$$CN$US$US
241921311$24192131$1$I$$20240806$20240809$20240809$EXP$$US-JNJFOC-20240816394$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240809$$HP$US$US
241921321$24192132$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004947$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240809$$CN$US$US
241921332$24192133$2$F$20240801$20240821$20240809$20240827$EXP$$US-JNJFOC-20240812928$JOHNSON AND JOHNSON$$32$YR$A$M$Y$99.88$KG$20240827$$HP$US$US
241921341$24192134$1$I$20240624$20240731$20240809$20240809$PER$$US-AMGEN-USASL2024152576$AMGEN$$$$$$Y$$$20240808$$CN$US$US
241921351$24192135$1$I$20240708$20240805$20240809$20240809$EXP$ES-AEMPS-1552523$ES-UCBSA-2024039117$UCB$$62$YR$$M$Y$$$20240809$$MD$ES$ES
241921361$24192136$1$I$$20240805$20240809$20240809$EXP$$US-GSK-US2024GSK097802$GLAXOSMITHKLINE$Rink DE, Abramson RH, Johnson NJ, Lee RY. Diagnostic Confounders in Brain Death: A Woman with Unexplained Coma and Brainstem Areflexia. Annals of the American Thoracic Society. 2024;21(8):1204-1208$$$$$Y$$$20240809$$MD$US$US
241921372$24192137$2$F$20240701$20240827$20240809$20240911$PER$$US-APOTEX-2024AP009006$APOTEX$$$$$F$Y$$$20240911$$CN$US$US
241921381$24192138$1$I$$20240726$20240809$20240809$PER$$US-APOTEX-2024AP009008$APOTEX$$$$$$Y$$$20240809$$PH$US$US
241921391$24192139$1$I$20240729$20240806$20240809$20240809$EXP$GB-MHRA-MED-202408042011333650-DLCHB$GB-STRIDES ARCOLAB LIMITED-2024SP009892$STRIDES$$33$YR$$F$Y$54$KG$20240809$$CN$GB$GB
241921401$24192140$1$I$$20240729$20240809$20240809$EXP$$US-PBT-009603$PANACEA BIOTEC$Park RB, Djalilian AR. Resolution of Plaque Keratopathy in a Patient with Atopic Keratoconjunctivitis After Treatment with Leflunomide. Ocul Immunol Inflamm. 2024 Jul 25:1-3. doi: 10.1080/09273948.2024.2379022.$57$YR$A$M$Y$$$20240809$$MD$US$US
241921411$24192141$1$I$$20240715$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003584$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241921421$24192142$1$I$$20240729$20240809$20240809$EXP$$CN-PBT-009617$PANACEA BIOTEC$Li C, Lin L, Pu T, Teng J, Shen Z. Immunosuppressant-resistant nephrotic syndrome and primary amenorrhea: A case report of adult Frasier syndrome and literature review. Clin Nephrol. 2024 Jul 22. doi: 10.5414/CN111432.$19$YR$A$$Y$$$20240809$$HP$CN$CN
241921432$24192143$2$F$$20240905$20240809$20240910$PER$$US-AstraZeneca-2024A173855$ASTRAZENECA$$$$$F$Y$$$20240910$$MD$US$
241921442$24192144$2$F$20240226$20240809$20240809$20240816$EXP$$GB-AstraZeneca-2024A178817$ASTRAZENECA$$51$YR$$$Y$115.5$KG$20240816$$PH$GB$
241921451$24192145$1$I$$20231122$20240809$20240809$EXP$$US-AstraZeneca-2023A268390$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241921461$24192146$1$I$20240205$20240805$20240809$20240809$EXP$IT-MINISAL02-996931$NVSC2024IT159156$NOVARTIS$$64$YR$$M$Y$85$KG$20240809$$MD$IT$IT
241921472$24192147$2$F$20230728$20240821$20240809$20240826$EXP$$NVSJ2024JP008900$NOVARTIS$$82$YR$$M$Y$$$20240826$$MD$JP$JP
241921481$24192148$1$I$$20240807$20240809$20240809$EXP$$NVSC2024AU148409$NOVARTIS$$$$$F$Y$$$20240809$$HP$AU$AU
241921491$24192149$1$I$$20240715$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003551$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$HP$US$US
241921501$24192150$1$I$$20240731$20240809$20240809$30DAY$$US-GSK-US2024095865$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$MD$US$US
241921511$24192151$1$I$$20240802$20240809$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-110704$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240809$$PH$JP$JP
241921521$24192152$1$I$$20240807$20240809$20240809$30DAY$$US-SANDOZ INC.-SDZ2024US071301$SANDOZ$$$$$F$Y$$$20240809$$CN$US$US
241921531$24192153$1$I$$20240731$20240809$20240809$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-121584$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$87$KG$20240809$$HP$CA$CA
241921541$24192154$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003552$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241921551$24192155$1$I$$20240715$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003617$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241921562$24192156$2$F$20240710$20240822$20240809$20240823$EXP$$US-ORGANON-O2408USA000627$ORGANON$$23$YR$$F$Y$$$20240823$$HP$US$US
241921572$24192157$2$F$20240731$20240814$20240809$20240819$EXP$$US-SA-2024SA234699$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240819$$MD$US$US
241921581$24192158$1$I$20240723$20240802$20240809$20240809$EXP$$US-SA-2024SA234321$SANOFI AVENTIS$$12$YR$T$M$Y$45.813$KG$20240809$$MD$US$US
241921592$24192159$2$F$20230321$20240820$20240809$20240827$EXP$$CA-JNJFOC-20230313402$JOHNSON AND JOHNSON$$11$YR$C$M$Y$30$KG$20240827$$HP$CA$CA
241921603$24192160$3$F$20240718$20240821$20240809$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024095433$VIIV$$31$YR$$M$Y$$$20240831$$HP$US$US
241921611$24192161$1$I$$20240805$20240809$20240809$EXP$$NVSJ2024JP009446$NOVARTIS$$74$YR$$F$Y$34$KG$20240809$$MD$JP$JP
241921621$24192162$1$I$20240806$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024156716$AMGEN$$71$YR$E$M$Y$$$20240808$$CN$US$US
241921631$24192163$1$I$$20240729$20240809$20240809$PER$$US-APOTEX-2024AP009007$APOTEX$$$$$M$Y$$$20240809$$CN$US$US
241921641$24192164$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003554$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241921651$24192165$1$I$$20240715$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003618$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241921661$24192166$1$I$20220214$20240806$20240809$20240809$EXP$$GB-ROCHE-10000050889$ROCHE$$47$YR$A$F$Y$98.4$KG$20240809$$MD$GB$GB
241921671$24192167$1$I$$20240717$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114664$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240809$$MD$US$US
241921681$24192168$1$I$$20240802$20240809$20240809$EXP$$ZA-ROCHE-10000048613$ROCHE$$$$A$M$Y$$$20240809$$CN$ZA$ZA
241921691$24192169$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003556$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241921701$24192170$1$I$$20240806$20240809$20240809$EXP$$CA-ROCHE-10000051382$ROCHE$$93$YR$E$F$Y$$$20240809$$CN$CA$CA
241921711$24192171$1$I$$20240806$20240809$20240809$30DAY$$US-GSK-US2024AMR097855$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241921723$24192172$3$F$$20240905$20240809$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003557$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241921732$24192173$2$F$20240814$20240814$20240809$20240821$EXP$$CA-GSK-CA2024097490$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$CA$CA
241921741$24192174$1$I$20240719$20240731$20240809$20240809$EXP$$CN-SPECGX-T202401670$SPECGX$$32$YR$$F$Y$48$KG$20240809$$CN$CN$CN
241921751$24192175$1$I$$20240806$20240809$20240809$EXP$$GB-ABBVIE-5870070$ABBVIE$Taylor D, Vallianatou K, Gandhi S, Casetta C, Howes O, MacCabe J. Severe neutropenia unrelated to clozapine in patients receiving clozapine. Journal of Psychopharmacology. 2024;38(7):624-635.$$$A$M$Y$$$20240809$$HP$GB$GB
241921761$24192176$1$I$$20240731$20240809$20240809$EXP$$US-NOVOPROD-1265818$NOVO NORDISK$$44$YR$$$Y$$$20240809$$CN$US$US
241921773$24192177$3$F$20240724$20240913$20240809$20240927$EXP$$GR-NOVOPROD-1263448$NOVO NORDISK$$20$YR$$M$Y$160$KG$20240927$$CN$GR$GR
241921782$24192178$2$F$20240721$20240816$20240809$20240827$EXP$$GB-NOVOPROD-1263371$NOVO NORDISK$$66$YR$$F$Y$$$20240827$$CN$GB$GB
241921791$24192179$1$I$20240722$20240731$20240809$20240809$EXP$GB-MHRA-MED-202407311015061050-LYGHT$GB-NOVOPROD-1263148$NOVO NORDISK$$69$YR$$F$Y$160$KG$20240809$$MD$GB$GB
241921801$24192180$1$I$$20240801$20240809$20240809$EXP$$EG-NOVOPROD-1264554$NOVO NORDISK$$$$$F$Y$$$20240809$$CN$EG$EG
241921821$24192182$1$I$$20240731$20240809$20240809$EXP$$AU-NOVOPROD-1264501$NOVO NORDISK$$$$A$F$Y$$$20240809$$HP$AU$AU
241921831$24192183$1$I$20200101$20240731$20240809$20240809$EXP$$CO-NOVOPROD-1264508$NOVO NORDISK$$64$YR$$M$Y$100$KG$20240809$$CN$CO$CO
241921842$24192184$2$F$20240615$20240913$20240809$20240924$EXP$$MX-NOVOPROD-1263436$NOVO NORDISK$$75$YR$$F$Y$61$KG$20240924$$CN$MX$MX
241921851$24192185$1$I$20210101$20240731$20240809$20240809$EXP$$EG-NOVOPROD-1263376$NOVO NORDISK$$47$YR$$M$Y$123$KG$20240809$$CN$EG$EG
241921873$24192187$3$F$$20240829$20240809$20240907$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125280$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240907$$PH$JP$JP
241921881$24192188$1$I$$20240726$20240809$20240809$PER$$US-TEVA-VS-3228194$TEVA$$53$YR$$F$Y$$$20240809$$CN$US$US
241921892$24192189$2$F$$20240906$20240809$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003558$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
241921901$24192190$1$I$$20240805$20240809$20240809$PER$$US-ROCHE-10000049838$ROCHE$$$$A$F$Y$$$20240809$$CN$US$US
241921911$24192191$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000050607$ROCHE$$$$$$Y$$$20240809$$PH$US$US
241921922$24192192$2$F$20240418$20240808$20240809$20240814$EXP$DK-DKMA-30730583$DK-ROCHE-10000047113$ROCHE$$64$YR$A$F$Y$91$KG$20240814$$MD$DK$DK
241921941$24192194$1$I$20240729$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A177808$ASTRAZENECA$$$$$F$Y$$$20240809$$MD$US$
241921951$24192195$1$I$$20230808$20240809$20240809$EXP$$US-AstraZeneca-2023A182692$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241921961$24192196$1$I$$20200312$20240809$20240809$EXP$$US-AstraZeneca-2020SE39667$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241921972$24192197$2$F$$20240823$20240809$20240902$PER$$US-AstraZeneca-2024A166699$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
241921981$24192198$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004954$ELI LILLY AND CO$$$$A$F$Y$$$20240809$$CN$US$US
241921991$24192199$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003956$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240809$$CN$US$US
241922001$24192200$1$I$$20240807$20240809$20240809$PER$$US-HALEON-2191041$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241922011$24192201$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003559$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$HP$US$US
241922022$24192202$2$F$20230901$20240911$20240809$20240920$EXP$$US-ABBVIE-5868027$ABBVIE$$88$YR$$F$Y$60$KG$20240920$$CN$US$US
241922031$24192203$1$I$20240602$20240730$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024095470$VIIV$$38$YR$$M$Y$$$20240809$$HP$US$US
241922041$24192204$1$I$20240610$20240730$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024095834$VIIV$$$$$$Y$$$20240809$$HP$US$US
241922061$24192206$1$I$20240401$20240807$20240809$20240809$EXP$FR-AFSSAPS-AN2024000959$FR-ROCHE-10000051706$ROCHE$$66$YR$E$M$Y$$$20240809$$MD$FR$FR
241922072$24192207$2$F$20240802$20240809$20240809$20240812$PER$$US-AMGEN-USASP2024158182$AMGEN$$49$YR$A$F$Y$$$20240812$$CN$US$US
241922081$24192208$1$I$$20240808$20240809$20240809$PER$$NVSC2024US161768$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241922091$24192209$1$I$20240101$20240722$20240809$20240809$PER$$US-TEVA-VS-3223806$TEVA$$74$YR$$M$Y$$$20240809$$PH$US$US
241922102$24192210$2$F$$20240830$20240809$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003650$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
241922111$24192211$1$I$20240529$20240806$20240809$20240809$EXP$$CN-JNJFOC-20240820142$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240809$$HP$CN$CN
241922121$24192212$1$I$$20240717$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003649$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241922132$24192213$2$F$$20240816$20240809$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003647$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
241922141$24192214$1$I$$20240801$20240809$20240809$EXP$$US-APOTEX-2024AP009122$APOTEX$Kim J, Prasad S, Roshan NS, Hasan BF, Gill G, Gunturu S.. Sleep disruptions and the pathway to psychosis: An in-depth case and literature review. Clinical case reports. 2024;12(6):e9108$20$YR$$M$Y$$$20240809$$HP$US$US
241922151$24192215$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157927$AMGEN$$$$$$Y$$$20240808$$HP$US$US
241922161$24192216$1$I$$20240807$20240809$20240809$PER$$NVSC2024US161589$NOVARTIS$$67$YR$$F$Y$$$20240809$$CN$US$US
241922171$24192217$1$I$$20240805$20240809$20240809$PER$$NVSC2024US160407$NOVARTIS$$$$$M$Y$$$20240809$$MD$US$US
241922191$24192219$1$I$20240510$20240717$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003645$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240809$$CN$US$US
241922201$24192220$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003622$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241922211$24192221$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003636$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241922221$24192222$1$I$20240710$20240805$20240809$20240809$PER$$PR-BIOGEN-2024BI01277090$BIOGEN$$64$YR$$F$Y$99.88$KG$20240809$$CN$PR$PR
241922232$24192223$2$F$$20240830$20240809$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003625$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
241922241$24192224$1$I$$20240801$20240809$20240809$EXP$$JP-ALXN-202408JPN000015JP$ALEXION PHARMACEUTICALS$$$$E$F$Y$$$20240809$$MD$JP$JP
241922252$24192225$2$F$20240725$20240903$20240809$20240905$EXP$$DE-ROCHE-10000051313$ROCHE$$61$YR$A$M$Y$63$KG$20240905$$MD$DE$DE
241922261$24192226$1$I$20240419$20240730$20240809$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-038853$AUROBINDO$$69$YR$$F$Y$78$KG$20240809$$MD$FR$FR
241922271$24192227$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003560$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241922281$24192228$1$I$20240729$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125463$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$61.23$KG$20240809$$CN$US$US
241922291$24192229$1$I$20190101$20240730$20240809$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-124495$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240809$$MD$JP$JP
241922301$24192230$1$I$20240101$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157219$AMGEN$$80$YR$E$F$Y$$$20240808$$PH$US$US
241922311$24192231$1$I$$20240801$20240809$20240809$PER$$NVSC2024US158166$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
241922321$24192232$1$I$$20240805$20240809$20240809$PER$$US-BIOGEN-2024BI01277151$BIOGEN$$$$$$Y$$$20240809$$CN$US$US
241922331$24192233$1$I$$20240807$20240809$20240809$EXP$$US-ROCHE-10000051377$ROCHE$$$$$$Y$$$20240809$$MD$US$US
241922341$24192234$1$I$20240703$20240730$20240809$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-038808$AUROBINDO$$84$YR$$M$Y$$$20240809$$MD$FR$FR
241922351$24192235$1$I$20240425$20240805$20240809$20240809$EXP$FR-AFSSAPS-CN2024000524$FR-TAKEDA-2024TUS078830$TAKEDA$$89$YR$$M$Y$$$20240809$$HP$FR$FR
241922361$24192236$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003633$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241922371$24192237$1$I$$20240805$20240809$20240809$PER$$US-JNJFOC-20240811215$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$CN$US$US
241922383$24192238$3$F$20240101$20240812$20240809$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023980$UNITED THERAPEUTICS$$$$$M$Y$147.85$KG$20240821$$$US$US
241922391$24192239$1$I$20240101$20240726$20240809$20240809$EXP$$US-UCBSA-2024038148$UCB$$$$$F$Y$$$20240809$$HP$US$US
241922401$24192240$1$I$$20240730$20240809$20240809$EXP$$ES-AUROBINDO-AUR-APL-2024-038992$AUROBINDO$Pitarch CG, Macia MS, Simon J, Mosca L, Conter C, Rejano-Gordillo CM, et al.. Neddylation inhibition prevents acetaminopheninduced liver damage by enhancing the anabolic cardiolipin pathway.. Cell Reports Medicine. 2024;5(7)$$$A$M$Y$$$20240809$$HP$ES$ES
241922411$24192241$1$I$20240701$20240805$20240809$20240809$EXP$$US-GSK-US2024097515$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$US$US
241922421$24192242$1$I$$20240807$20240809$20240809$PER$$US-ROCHE-10000051298$ROCHE$$$$$$Y$$$20240809$$CN$US$US
241922432$24192243$2$F$20240805$20240821$20240809$20240823$PER$$US-AMGEN-USASP2024157569$AMGEN$$56$YR$A$M$Y$$$20240823$$CN$US$US
241922441$24192244$1$I$20240506$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024156505$AMGEN$$81$YR$E$F$Y$$$20240809$$CN$US$US
241922451$24192245$1$I$$20240605$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00239$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240801$$CN$US$US
241922461$24192246$1$I$$20240424$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00197$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240801$$CN$US$US
241922491$24192249$1$I$$20240806$20240809$20240809$PER$$US-BIOGEN-2024BI01276833$BIOGEN$$$$$F$Y$$$20240809$$CN$US$US
241922501$24192250$1$I$$20240806$20240809$20240809$PER$$US-BIOGEN-2024BI01277125$BIOGEN$$$$$F$Y$$$20240809$$CN$US$US
241922511$24192251$1$I$$20240715$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003675$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241922521$24192252$1$I$$20230727$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00367$PRINSTON PHARMACEUTICAL$$$$$F$Y$90.703$KG$20240730$$CN$US$US
241922531$24192253$1$I$20230801$20230825$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00416$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240730$$CN$US$US
241922541$24192254$1$I$$20230828$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00418$PRINSTON PHARMACEUTICAL$$65$YR$$F$Y$56.689$KG$20240730$$CN$US$US
241922551$24192255$1$I$$20231010$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00535$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240730$$CN$US$US
241922561$24192256$1$I$$20240214$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00079$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240730$$CN$US$US
241922571$24192257$1$I$$20240221$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00094$PRINSTON PHARMACEUTICAL$$$$$F$Y$84.807$KG$20240730$$CN$US$US
241922581$24192258$1$I$20230101$20231010$20240809$20240809$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00530$PRINSTON PHARMACEUTICAL$$74$YR$$F$Y$$$20240730$$CN$US$US
241922591$24192259$1$I$$20231110$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00582$PRINSTON PHARMACEUTICAL$$46$YR$$F$Y$$$20240730$$CN$US$US
241922601$24192260$1$I$20210101$20231219$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00636$PRINSTON PHARMACEUTICAL$$75$YR$$F$Y$$$20240730$$CN$US$US
241922611$24192261$1$I$$20240429$20240809$20240809$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00204$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240730$$CN$US$US
241922621$24192262$1$I$$20240807$20240809$20240809$PER$$US-ROCHE-10000051510$ROCHE$$27$YR$A$F$Y$$$20240809$$CN$US$US
241922632$24192263$2$F$$20240806$20240809$20240809$PER$$US-GILEAD-2024-0683157$GILEAD$$67$YR$E$M$Y$$$20240809$$PH$US$US
241922641$24192264$1$I$$20240731$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002473$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241922652$24192265$2$F$20240501$20240731$20240809$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202407012725$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240813$$CN$US$US
241922661$24192266$1$I$$20240722$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407014490$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241922671$24192267$1$I$$20240804$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004169$ELI LILLY AND CO$$$$A$F$Y$$$20240809$$CN$US$US
241922681$24192268$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004898$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240809$$CN$US$US
241922691$24192269$1$I$$20240719$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407013486$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241922701$24192270$1$I$$20240802$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002156$ELI LILLY AND CO$$71$YR$E$$Y$$$20240809$$CN$US$US
241922721$24192272$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157932$AMGEN$$$$$$Y$$$20240809$$HP$US$US
241922732$24192273$2$F$20240803$20240830$20240809$20240831$PER$$US-AMGEN-USASP2024157798$AMGEN$$71$YR$E$M$Y$$$20240831$$CN$US$US
241922742$24192274$2$F$20240806$20240808$20240809$20240810$PER$$US-AMGEN-USASP2024156620$AMGEN$$70$YR$E$F$Y$$$20240810$$HP$US$US
241922753$24192275$3$F$$20240909$20240809$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003562$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241922761$24192276$1$I$20240702$20240725$20240809$20240809$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000753$PAREXEL$$$$$$Y$$$20240809$$MD$CN$CN
241922771$24192277$1$I$20240320$20240807$20240809$20240809$EXP$$DE-ROCHE-3532259$ROCHE$$39$YR$A$F$Y$$$20240809$$CN$DE$DE
241922783$24192278$3$F$$20240920$20240809$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003563$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241922791$24192279$1$I$20240716$20240730$20240809$20240809$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095330$VIIV$$47$YR$$M$Y$$$20240809$$CN$US$US
241922803$24192280$3$F$$20240903$20240809$20240904$EXP$$JP-TAKEDA-2024TJP011810$TAKEDA$$$$A$M$Y$$$20240904$$MD$JP$JP
241922811$24192281$1$I$$20240725$20240809$20240809$PER$$US-COSETTE-CP2024US000191$COSETTE PHARMACEUTICALS$$31$YR$A$F$Y$$$20240809$$PH$US$US
241922825$24192282$5$F$20240101$20240918$20240809$20240920$PER$$US-BIOGEN-2024BI01277048$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
241922831$24192283$1$I$$20240806$20240809$20240809$EXP$$US-AstraZeneca-2024A180039$ASTRAZENECA$$$$$M$Y$$$20240809$$MD$US$
241922841$24192284$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003775$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241922851$24192285$1$I$$20240729$20240809$20240809$EXP$$CN-PBT-009619$PANACEA BIOTEC$Li X, Luo K, Yang D, Hou C. A case report of systemic lupus erythematosus complicating interstitial lung disease and thickened pericardium treated with tofacitinib. Medicine (Baltimore). 2024 Jul 26;103(30):e39129. doi: 10.1097/MD.0000000000039129.$35$YR$A$F$Y$$$20240809$$MD$CN$CN
241922862$24192286$2$F$$20240807$20240809$20240812$PER$$NVSC2024US161538$NOVARTIS$$$$$M$Y$$$20240812$$HP$US$US
241922871$24192287$1$I$$20240808$20240809$20240809$PER$$NVSC2024US161743$NOVARTIS$$$$$F$Y$$$20240809$$HP$US$US
241922881$24192288$1$I$$20240808$20240809$20240809$PER$$NVSC2024US162095$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241922894$24192289$4$F$20200602$20240923$20240809$20240925$PER$$US-GILEAD-2024-0683382$GILEAD$$35$YR$A$M$Y$$$20240925$$LW$US$US
241922902$24192290$2$F$$20240730$20240809$20240809$PER$$US-ROCHE-10000046248$ROCHE$$$$E$M$Y$$$20240809$$CN$US$US
241922911$24192291$1$I$$20240801$20240809$20240809$EXP$$US-APOTEX-2024AP009119$APOTEX$Pang S, Saleh H, Ailawadhi S, Edgar M, Pang M. Acute esophageal stricture after bone marrow transplant. Clinical Journal of Gastroenterology. 2024;17:1-5$58$YR$$M$Y$$$20240809$$HP$US$US
241922922$24192292$2$F$20220101$20240802$20240809$20240812$EXP$KR-MLMSERVICE-20240725-PI143233-00232-1$KR-STRIDES ARCOLAB LIMITED-2024SP009867$STRIDES$Jo E, Song SH.. Primary peritoneal carcinoma presented with abdominal pain in patient with kidney transplantation.. The Korean Journal of Internal Medicine.. 2024;39(4):693-694$54$YR$$F$Y$$$20240812$$MD$KR$KR
241922931$24192293$1$I$$20240730$20240809$20240809$30DAY$$US-GSK-US2024095212$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241922941$24192294$1$I$$20240730$20240809$20240809$30DAY$$US-GSK-US2024095247$GLAXOSMITHKLINE$$$$$M$Y$$$20240809$$CN$US$US
241922951$24192295$1$I$20240215$20240807$20240809$20240809$EXP$$JP-TAKEDA-2024TJP011751$TAKEDA$$11$YR$$M$Y$32.7$KG$20240809$$MD$JP$JP
241922971$24192297$1$I$$20240730$20240809$20240809$EXP$$GB-TAKEDA-2022TUS089936$TAKEDA$$$$$M$Y$$$20240809$$CN$GB$GB
241922981$24192298$1$I$$20240802$20240809$20240809$PER$$US-AMGEN-USASP2024154967$AMGEN$$$$A$M$Y$$$20240809$$CN$US$US
241922991$24192299$1$I$$20240805$20240809$20240809$EXP$$US-AMGEN-USASP2024155329$AMGEN$$$$$F$Y$$$20240809$$HP$US$US
241923001$24192300$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157255$AMGEN$$$$$M$Y$$$20240809$$CN$US$US
241923011$24192301$1$I$$20240726$20240809$20240809$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-17557$ALKEM$Capparelli FJ, Diaz MF, Hlavnika A, et al.. Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function. Neurology. 2005;65(11):1840$$$$$Y$$$20240809$$HP$ES$ES
241923021$24192302$1$I$$20240726$20240809$20240809$EXP$GB-MHRA-MED-202407251004357380-PQSYK$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17068$ALKEM$$$$$M$Y$$$20240809$$CN$GB$GB
241923031$24192303$1$I$$20240726$20240809$20240809$EXP$GB-MHRA-MED-202407251011475310-VZQYH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17072$ALKEM$$$$$M$Y$$$20240809$$CN$GB$GB
241923041$24192304$1$I$$20240726$20240809$20240809$EXP$GB-MHRA-MED-202407251012454120-CJPMW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17073$ALKEM$$$$$M$Y$$$20240809$$CN$GB$GB
241923051$24192305$1$I$$20240726$20240809$20240809$EXP$$FI-ALKEM LABORATORIES LIMITED-FI-ALKEM-2024-17384$ALKEM$Wilenius M, Jernman J, Hietaharju A, Salonen T, Helasjoki T, Martikainen I, Nevalainen PI.. Swollen eyelids caused by polyvinylpyrrolidone histiocytosis with intravenous methylphenidate. Lancet. 2024;403:1574-1575$26$YR$$F$Y$$$20240809$$MD$FI$FI
241923061$24192306$1$I$$20240726$20240809$20240809$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16814$ALKEM$Bentley BH, Cecil AE, Lippert WC. Atypical Intrahepatic Cholestasis of Pregnancy: A Red Herring. ACG Case Reports Journal. 2024;11:e01339$20$YR$$F$Y$$$20240809$$MD$US$US
241923072$24192307$2$F$$20240805$20240809$20240820$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-17712$ALKEM$Nakatani Y, Suto Y, Fukuma K, Yamawaki M, Sakata R, Takahashi S, Nakayasu H, Nakashima K.. Intrathecal Isoniazid for Refractory Tuberculous Meningitis with Cerebral Infarction. Internal Medicine. 2017;56:953-957$30$YR$$F$Y$52$KG$20240820$$HP$JP$JP
241923081$24192308$1$I$$20240726$20240809$20240809$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17459$ALKEM$Behar D, Schaller JL.. Topiramate leukopenia on clozapine. Europ Child Adol Psychiatr. 2004;13(1):51-52$$$$$Y$$$20240809$$HP$US$US
241923091$24192309$1$I$$20240726$20240809$20240809$EXP$$US-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-17754$ALKEM$Shelton C, Ruan CJ, Ertugrul A, Cotes RO, De Leon J.. Should we routinely add CRP to clozapine titrations? - Learning from three cases. Neuropsychopharmacologia hungarica. 2022;24(4):153-161$19$YR$$F$Y$$$20240809$$HP$US$TR
241923101$24192310$1$I$$20240802$20240809$20240809$PER$$US-JNJFOC-20240809369$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$CN$US$US
241923111$24192311$1$I$20240717$20240726$20240809$20240809$EXP$GB-MHRA-MED-202407251534042050-RVYPW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17075$ALKEM$$$$$F$Y$53$KG$20240809$$PH$GB$GB
241923121$24192312$1$I$$20240726$20240809$20240809$EXP$PT-EMA-DD-20240726-7482655-085920$PT-IPCA LABORATORIES LIMITED-IPC-2024-PT-001996$IPCA$Patr?cia Silva, Marta Ferreira, Ana Grilo et al.. Serotonin syndrome: the purpose of a clinical case. Congresses of the Portuguese Society of Internal Medicine. 481$$$$$Y$$$20240809$$MD$PT$PT
241923131$24192313$1$I$$20240805$20240809$20240809$EXP$$NVSC2024US125866$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
241923141$24192314$1$I$20240717$20240805$20240809$20240809$EXP$$NVSC2024US160490$NOVARTIS$$51$YR$$F$Y$$$20240809$$CN$US$US
241923152$24192315$2$F$20240101$20240819$20240809$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-022389$UNITED THERAPEUTICS$$$$$F$Y$$$20240824$$$US$US
241923161$24192316$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003739$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241923172$24192317$2$F$20240313$20240918$20240809$20240924$EXP$$US-TAKEDA-2024TUS024948$TAKEDA$$62$YR$$F$Y$$$20240924$$MD$US$US
241923181$24192318$1$I$$20240802$20240809$20240809$EXP$$RU-AstraZeneca-2024A178702$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$RU$
241923191$24192319$1$I$20240730$20240731$20240809$20240809$30DAY$$US-GSK-US2024095806$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240809$$CN$US$US
241923202$24192320$2$F$20230101$20240918$20240809$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024201$UNITED THERAPEUTICS$$$$$F$Y$45.351$KG$20240926$$$US$US
241923211$24192321$1$I$20240624$20240802$20240809$20240809$EXP$$JP-AstraZeneca-2024A177578$ASTRAZENECA$$66$YR$$M$Y$$$20240809$$MD$JP$
241923221$24192322$1$I$$20240802$20240809$20240809$EXP$$CA-AstraZeneca-2024A177973$ASTRAZENECA$$$$$F$Y$$$20240809$$HP$CA$
241923241$24192324$1$I$$20240805$20240809$20240809$PER$$US-ROCHE-10000050030$ROCHE$$7$YR$C$M$Y$$$20240809$$CN$US$US
241923251$24192325$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191118$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241923261$24192326$1$I$20240101$20240801$20240809$20240809$EXP$$US-RIGEL-20240800017$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240809$$HP$US$US
241923271$24192327$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003738$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241923282$24192328$2$F$20240805$20240904$20240809$20240909$EXP$$JP-TAKEDA-2024TJP011812$TAKEDA$$8$DEC$$M$Y$$$20240908$$MD$JP$JP
241923291$24192329$1$I$20230101$20240801$20240809$20240809$EXP$$CA-CELLTRION INC.-2024CA007012$CELLTRION$$$$$$Y$$$20240809$$HP$CA$CA
241923301$24192330$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000051281$ROCHE$$38$YR$A$F$Y$$$20240809$$CN$US$US
241923311$24192331$1$I$$20240725$20240809$20240809$PER$$US-COSETTE-CP2024US000192$COSETTE PHARMACEUTICALS$$27$YR$A$F$Y$$$20240809$$PH$US$US
241923321$24192332$1$I$20240701$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155374$AMGEN$$75$YR$E$F$Y$$$20240809$$CN$US$US
241923331$24192333$1$I$$20240708$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06978$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241923341$24192334$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003740$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241923352$24192335$2$F$20240807$20240808$20240809$20240812$EXP$$IE-ROCHE-10000052107$ROCHE$$$$$F$Y$$$20240812$$CN$IE$IE
241923361$24192336$1$I$$20240725$20240809$20240809$PER$$US-APOTEX-2024AP009055$APOTEX$Patel G, Khan DA. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria. The Journal of Allergy and Clinical Immunology- Pract. 2024;12 (6):1663-1665$46$YR$$F$Y$$$20240809$$MD$US$US
241923372$24192337$2$F$20240731$20240827$20240809$20240906$30DAY$$US-GSK-US2024098478$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240906$$CN$US$US
241923381$24192338$1$I$$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125495$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240809$$HP$US$US
241923392$24192339$2$F$$20240903$20240809$20240913$EXP$$JP-AMGEN-JPNSP2024158006$AMGEN$$$$$$Y$$$20240913$$PH$JP$JP
241923401$24192340$1$I$20240709$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003687$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240809$$CN$US$US
241923411$24192341$1$I$$20240806$20240809$20240809$EXP$$US-BIOGEN-2024BI01277112$BIOGEN$$$$$F$Y$$$20240809$$HP$US$US
241923422$24192342$2$F$$20240913$20240809$20240923$PER$$US-ROCHE-10000047420$ROCHE$$40$YR$A$F$Y$$$20240923$$CN$US$US
241923431$24192343$1$I$20240807$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004799$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240809$$CN$US$US
241923441$24192344$1$I$20240802$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003960$ELI LILLY AND CO$$48$YR$A$$Y$$$20240809$$CN$US$US
241923451$24192345$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004236$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240809$$CN$US$US
241923461$24192346$1$I$20240731$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004762$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240809$$CN$US$US
241923471$24192347$1$I$20240723$20240807$20240809$20240809$EXP$GB-MHRA-MED-202408071606547360-YTDNH$GB-SANDOZ INC.-SDZ2024GB071447$SANDOZ$$$$$M$Y$$$20240809$$PH$GB$GB
241923481$24192348$1$I$20240701$20240731$20240809$20240809$PER$$US-ABBVIE-5863731$ABBVIE$$$$A$M$Y$$$20240809$$HP$US$US
241923493$24192349$3$F$20240101$20240909$20240809$20240918$30DAY$$TR-JNJFOC-20240801271$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$PH$TR$TR
241923501$24192350$1$I$$20240708$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06983$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241923512$24192351$2$F$$20240903$20240809$20240909$EXP$$TR-TAKEDA-2024TUS079120$TAKEDA$$$$$$Y$$$20240909$$MD$TR$TR
241923521$24192352$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000050675$ROCHE$$$$T$F$Y$$$20240809$$CN$US$US
241923533$24192353$3$F$20240201$20240910$20240809$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003862$ACADIA PHARMACEUTICALS$$32$YR$$F$Y$$$20240920$$MD$US$US
241923541$24192354$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000050894$ROCHE$$$$A$F$Y$$$20240809$$CN$US$US
241923551$24192355$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000051415$ROCHE$$$$A$F$Y$$$20240809$$CN$US$US
241923561$24192356$1$I$$20240730$20240809$20240809$30DAY$$US-GSK-US2024095399$GLAXOSMITHKLINE$$$$$M$Y$$$20240809$$CN$US$US
241923571$24192357$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000051506$ROCHE$$$$E$F$Y$$$20240809$$CN$US$US
241923581$24192358$1$I$20240527$20240801$20240809$20240809$EXP$$HR-CELLTRION INC.-2024HR016495$CELLTRION$$$$$$Y$$$20240809$$MD$HR$HR
241923592$24192359$2$F$$20240814$20240809$20240819$EXP$$US-ABBVIE-5871138$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
241923606$24192360$6$F$20240101$20240828$20240809$20240905$EXP$$US-UCBSA-2024038174$UCB$$$$$F$Y$$$20240905$$HP$US$US
241923611$24192361$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125973$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$69.63$KG$20240809$$CN$US$US
241923621$24192362$1$I$20240701$20240802$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124165$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$84.37$KG$20240809$$CN$US$US
241923631$24192363$1$I$$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125754$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240809$$CN$US$US
241923641$24192364$1$I$20230919$20240621$20240809$20240809$EXP$$CA-CELLTRION INC.-2023CA025731$CELLTRION$$$$$$Y$$$20240809$$MD$CA$CA
241923651$24192365$1$I$20240101$20240726$20240809$20240809$EXP$$US-UCBSA-2024038146$UCB$$$$$F$Y$$$20240809$$HP$US$US
241923662$24192366$2$F$$20240826$20240809$20240826$PER$$US-ALXN-202408USA000025US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
241923672$24192367$2$F$$20240807$20240809$20240809$EXP$$US-GILEAD-2024-0683357$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241923691$24192369$1$I$$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024156822$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241923711$24192371$1$I$$20240806$20240809$20240809$PER$$PR-JNJFOC-20240817373$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$MD$PR$PR
241923721$24192372$1$I$$20220201$20240809$20240809$EXP$$US-AstraZeneca-2022A056806$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
241923731$24192373$1$I$20240701$20240806$20240809$20240809$EXP$$US-ABBVIE-5870381$ABBVIE$$61$YR$$F$Y$$$20240809$$CN$US$US
241923741$24192374$1$I$$20240805$20240809$20240809$EXP$$AU-ROCHE-10000049762$ROCHE$$$$$$Y$$$20240809$$PH$AU$AU
241923752$24192375$2$F$$20240909$20240809$20240911$PER$$US-ROCHE-10000050851$ROCHE$$$$A$F$Y$78.47$KG$20240911$$CN$US$US
241923761$24192376$1$I$$20240729$20240809$20240809$EXP$$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-001965$IPCA$Benjamin Plumb, Alex Parker and Paul Wong. Feeling blue with metformin-associated lactic acidosis. BMJ Case Rep. 2013;1-4$$$$$Y$$$20240809$$MD$GB$GB
241923773$24192377$3$F$$20240923$20240809$20240923$PER$$NVSC2024US161513$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
241923781$24192378$1$I$$20240806$20240809$20240809$EXP$$US-AstraZeneca-2024A178544$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241923791$24192379$1$I$20240807$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683476$GILEAD$$$$$F$Y$$$20240809$$HP$US$US
241923801$24192380$1$I$$20240807$20240809$20240809$PER$$US-ROCHE-10000051758$ROCHE$$$$A$F$Y$$$20240809$$CN$US$US
241923811$24192381$1$I$$20231030$20240809$20240809$EXP$$US-AstraZeneca-2023A246847$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
241923821$24192382$1$I$20240805$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157391$AMGEN$$70$YR$E$F$Y$$$20240809$$CN$US$US
241923831$24192383$1$I$20240415$20240801$20240809$20240809$PER$$US-AMGEN-USASP2024153776$AMGEN$$$$$F$Y$81$KG$20240809$$MD$US$US
241923841$24192384$1$I$$20240708$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06982$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241923851$24192385$1$I$20220117$20220311$20240809$20240809$EXP$$IT-AstraZeneca-2022A087266$ASTRAZENECA$$20$YR$$M$Y$57$KG$20240809$$MD$IT$
241923861$24192386$1$I$$20240731$20240809$20240809$PER$$US-ABBVIE-5864933$ABBVIE$$$$A$F$Y$$$20240809$$MD$US$US
241923871$24192387$1$I$$20240808$20240809$20240809$EXP$$PR-JNJFOC-20240821273$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$CN$PR$PR
241923882$24192388$2$F$20240719$20240819$20240809$20240821$EXP$FR-AFSSAPS-DJ2024000895$FR-JNJFOC-20240822248$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240821$$PH$FR$FR
241923892$24192389$2$F$20240101$20240926$20240809$20240930$PER$$US-JNJFOC-20240741371$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240930$$CN$US$US
241923901$24192390$1$I$20211216$20220412$20240809$20240809$EXP$$US-AstraZeneca-2022A149270$ASTRAZENECA$$25145$DY$$M$Y$88$KG$20240809$$MD$US$
241923911$24192391$1$I$$20240730$20240809$20240809$EXP$NL-LRB-00993315$NL-JUBILANT CADISTA PHARMACEUTICALS-2024NL001112$JUBILANT$$33$YR$$F$Y$70$KG$20240809$$CN$NL$NL
241923921$24192392$1$I$$20240801$20240809$20240809$EXP$$BR-TAKEDA-2023TUS061816$TAKEDA$$$$$M$Y$$$20240809$$CN$BR$BR
241923931$24192393$1$I$20230101$20240806$20240809$20240809$EXP$$CO-ABBVIE-5870992$ABBVIE$Gonzalez C, Rengifo J, Macias-Arias P, Duque-Clavijo V, Norena-Rengifo BD. High-resolution ultrasound for complications of botulinum toxin use: a case series and literature review. Cureus. 2024.$61$YR$$F$Y$$$20240809$$HP$CO$CO
241923942$24192394$2$F$$20240815$20240809$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003743$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
241923952$24192395$2$F$$20240808$20240809$20240823$EXP$$US-ALVOGEN-2024095243$ALVOGEN$Stolear A, Dulgher M, Bae JY, Kaminsky L, Jeyashanmugaraja GP, Emerenini U. Wide Spectrum of Flecainide Toxicity: A Case Report and Literature Review. Cureus. 2024 Jun;16(6):e62923. doi:https://dx.doi.org/10.7759/cureus.62923$79$YR$$F$Y$$$20240823$$HP$US$US
241923962$24192396$2$F$$20240916$20240809$20240925$PER$$US-GSK-US2024095856$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
241923971$24192397$1$I$$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125424$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240809$$CN$US$US
241923981$24192398$1$I$20240805$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125061$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240809$$PH$US$US
241923991$24192399$1$I$$20240711$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07039$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241924001$24192400$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191093$Haleon PLC$$$$$M$Y$$$20240809$$CN$US$US
241924011$24192401$1$I$20240131$20240801$20240809$20240809$EXP$$US-INTERCEPT-PM2024001556$INTERCEPT PHARMACEUTICALS$$85$YR$$M$Y$81.179$KG$20240809$$CN$US$US
241924021$24192402$1$I$$20240731$20240809$20240809$PER$$US-ABBVIE-5866159$ABBVIE$$$$$$Y$$$20240809$$HP$US$US
241924031$24192403$1$I$$20240802$20240809$20240809$PER$$US-ROCHE-10000046579$ROCHE$$$$A$F$Y$$$20240809$$CN$US$US
241924042$24192404$2$F$$20240807$20240809$20240814$PER$$US-ROCHE-10000051302$ROCHE$$$$A$M$Y$$$20240814$$CN$US$US
241924053$24192405$3$F$$20240830$20240809$20240830$PER$$US-ALXN-202408USA000252US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240830$$HP$US$US
241924061$24192406$1$I$20240731$20240807$20240809$20240809$EXP$GB-MHRA-TPP6939755C9945216YC1722971583338$GB-SANDOZ INC.-SDZ2024GB071449$SANDOZ$$74$YR$$F$Y$103$KG$20240809$$HP$GB$GB
241924071$24192407$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003748$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241924081$24192408$1$I$$20240802$20240809$20240809$PER$$US-ABBVIE-5868497$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241924091$24192409$1$I$$20240803$20240809$20240809$PER$$US-ABBVIE-5867751$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241924101$24192410$1$I$$20240319$20240809$20240809$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439411$RANBAXY$$66$YR$$F$Y$$$20240809$$CN$US$US
241924111$24192411$1$I$20240524$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003586$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240809$$CN$US$US
241924121$24192412$1$I$$20240802$20240809$20240809$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07447$HIKMA$$82$YR$$M$Y$54$KG$20240809$$HP$CA$CA
241924131$24192413$1$I$$20240708$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07054$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241924141$24192414$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5870599$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241924151$24192415$1$I$20240801$20240802$20240809$20240809$30DAY$$IT-SANDOZ INC.-SDZ2024IT071238$SANDOZ$$11$YR$$F$Y$27$KG$20240809$$CN$IT$IT
241924161$24192416$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MIDB-0c2b3b54-7b6e-4663-8697-7781a448c749$GB-TEVA-VS-3228489$TEVA$$80$YR$$$Y$$$20240809$$PH$GB$GB
241924171$24192417$1$I$$20240803$20240809$20240809$PER$$NVSC2024US159640$NOVARTIS$$38$YR$$M$Y$$$20240809$$CN$US$US
241924181$24192418$1$I$$20240730$20240809$20240809$EXP$$GB-TEVA-VS-3227905$TEVA$$73$YR$$F$Y$$$20240809$$MD$GB$GB
241924193$24192419$3$F$$20240905$20240809$20240912$EXP$$JP-BEH-2024176504$CSL BEHRING$$$$$$Y$$$20240912$$PH$JP$JP
241924201$24192420$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004257$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240809$$CN$US$US
241924211$24192421$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003660$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241924221$24192422$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003920$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240809$$CN$US$US
241924231$24192423$1$I$$20240731$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408000339$ELI LILLY AND CO$$51$YR$A$$Y$$$20240809$$LW$US$US
241924241$24192424$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004713$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241924251$24192425$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004643$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240809$$CN$US$US
241924261$24192426$1$I$20240725$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004794$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241924271$24192427$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004698$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241924284$24192428$4$F$20240805$20240912$20240809$20240918$30DAY$$US-JNJFOC-20240817937$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240918$$HP$US$US
241924292$24192429$2$F$20240101$20240903$20240809$20240913$EXP$$US-JNJFOC-20240811546$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240913$$CN$US$US
241924301$24192430$1$I$$20240717$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003734$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241924311$24192431$1$I$$20230822$20240809$20240809$EXP$$US-AstraZeneca-2023A192154$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241924331$24192433$1$I$20240607$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003661$ACADIA PHARMACEUTICALS$$65$YR$$F$Y$$$20240809$$CN$US$US
241924341$24192434$1$I$20240801$20240802$20240809$20240809$PER$$US-BEH-2024176950$CSL BEHRING$$33$YR$A$M$Y$$$20240809$$MD$US$US
241924361$24192436$1$I$$20240730$20240809$20240809$EXP$$US-ALVOGEN-2024095259$ALVOGEN$$$$$F$Y$$$20240809$$CN$US$US
241924371$24192437$1$I$20240628$20240716$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003615$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240809$$CN$US$US
241924382$24192438$2$F$20240401$20240808$20240809$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003762$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240829$$HP$US$US
241924401$24192440$1$I$$20240710$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07021$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241924411$24192441$1$I$$20240801$20240809$20240809$EXP$$US-AMGEN-USASP2024154960$AMGEN$Knight R. J.; Ye Y.; Graviss E.A. et.al. The Impact of Kidney/Pancreas Transplantation on Peripheral Arterial Disease. Clinical Transplantation. 2024;38 (7):1-8$$$$$Y$$$20240809$$HP$US$US
241924421$24192442$1$I$$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024156089$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241924431$24192443$1$I$20210212$20220125$20240809$20240809$EXP$$CA-AstraZeneca-2021A580552$ASTRAZENECA$$60$YR$$M$Y$$$20240809$$MD$CA$
241924441$24192444$1$I$$20240807$20240809$20240809$EXP$$US-AMGEN-USASP2024157419$AMGEN$$$$$$Y$$$20240809$$HP$US$US
241924452$24192445$2$F$20240101$20240808$20240809$20240814$EXP$$BR-AMGEN-BRASP2024154606$AMGEN$$70$YR$E$$Y$$$20240814$$PH$BR$BR
241924461$24192446$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003662$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241924471$24192447$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A177822$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241924481$24192448$1$I$$20240727$20240809$20240809$EXP$GB-MHRA-MED-202407262113594890-VKHFP$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17223$ALKEM$$63$YR$$M$Y$78$KG$20240809$$CN$GB$GB
241924491$24192449$1$I$20180727$20240728$20240809$20240809$EXP$GB-MHRA-WEBRADR-202407271514074320-MDRFC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17353$ALKEM$$31$YR$$M$Y$79$KG$20240809$$CN$GB$GB
241924501$24192450$1$I$$20240727$20240809$20240809$EXP$GB-MHRA-MED-202407261307507540-CDNYM$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17217$ALKEM$$71$YR$$M$Y$$$20240809$$PH$GB$GB
241924512$24192451$2$F$20240301$20240918$20240809$20240924$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-012799$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240924$$CN$CA$CA
241924521$24192452$1$I$20240713$20240716$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003616$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240809$$CN$US$US
241924531$24192453$1$I$$20240727$20240809$20240809$EXP$GB-MHRA-TPP23805112C10759389YC1721636223740$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17230$ALKEM$$33$YR$$F$Y$115$KG$20240809$$MD$GB$GB
241924541$24192454$1$I$20240612$20240716$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003664$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240809$$CN$US$US
241924551$24192455$1$I$20240101$20240802$20240809$20240809$EXP$GB-MHRA-MED-202408021625427840-YDNVS$GB-ABBVIE-5865651$ABBVIE$$36$YR$$F$Y$$$20240809$$HP$GB$GB
241924561$24192456$1$I$20240301$20240731$20240809$20240809$30DAY$$US-GSK-US2024095679$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240809$$CN$US$US
241924572$24192457$2$F$$20240820$20240809$20240828$EXP$$US-TAKEDA-2024TUS079348$TAKEDA$$$$$M$Y$59$KG$20240828$$HP$US$US
241924582$24192458$2$F$20240716$20240802$20240809$20240814$EXP$$NVSC2024GB147484$NOVARTIS$$45$YR$$F$Y$$$20240814$$CN$GB$GB
241924591$24192459$1$I$$20240806$20240809$20240809$PER$$NVSC2024US161027$NOVARTIS$$$$$$Y$$$20240809$$CN$US$US
241924601$24192460$1$I$20240227$20240806$20240809$20240809$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043933$BOEHRINGER INGELHEIM$$69$YR$E$F$Y$$$20240809$$PH$AU$AU
241924611$24192461$1$I$$20240806$20240809$20240809$PER$$NVSC2024US160901$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
241924621$24192462$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003667$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241924631$24192463$1$I$$20240806$20240809$20240809$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044691$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240809$$CN$US$US
241924641$24192464$1$I$20240101$20240805$20240809$20240809$EXP$$US-ABBVIE-5868373$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241924651$24192465$1$I$$20240802$20240809$20240809$PER$$US-AMGEN-USASP2024155443$AMGEN$$$$A$F$Y$$$20240809$$CN$US$US
241924661$24192466$1$I$20240804$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155666$AMGEN$$73$YR$E$F$Y$$$20240809$$CN$US$US
241924673$24192467$3$F$$20240823$20240809$20240827$PER$$US-AMGEN-USASP2024158198$AMGEN$$$$A$M$Y$$$20240827$$CN$US$US
241924681$24192468$1$I$$20240808$20240809$20240809$EXP$$CA-ROCHE-10000051713$ROCHE$$36$YR$A$F$Y$81$KG$20240809$$MD$CA$CA
241924691$24192469$1$I$20220609$20240807$20240809$20240809$EXP$$US-UCBSA-2022037985$UCB$$90$YR$$F$Y$$$20240809$$CN$US$US
241924702$24192470$2$F$20240716$20240912$20240809$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003654$ACADIA PHARMACEUTICALS$$64$YR$$F$Y$$$20240930$$CN$US$US
241924711$24192471$1$I$$20240807$20240809$20240809$PER$$US-ROCHE-10000052015$ROCHE$$$$$$Y$$$20240809$$PH$US$US
241924722$24192472$2$F$20240706$20240910$20240809$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003619$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240920$$CN$US$US
241924731$24192473$1$I$$20240805$20240809$20240809$EXP$$CA-JNJFOC-20240821270$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240809$$MD$CA$CA
241924741$24192474$1$I$20240802$20240808$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2024US071533$SANDOZ$$7$YR$$$Y$$$20240809$$CN$US$US
241924751$24192475$1$I$20240618$20240716$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003620$ACADIA PHARMACEUTICALS$$89$YR$$M$Y$$$20240809$$CN$US$US
241924761$24192476$1$I$$20210703$20240809$20240809$EXP$$US-AstraZeneca-2021A612036$ASTRAZENECA$$78$YR$$M$Y$$$20240809$$MD$US$
241924771$24192477$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003669$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241924781$24192478$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003621$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241924791$24192479$1$I$$20240809$20240809$20240809$EXP$$JP-JNJFOC-20240822291$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$JP$JP
241924801$24192480$1$I$20240627$20240806$20240809$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-039656$AUROBINDO$$80$YR$$F$Y$70$KG$20240809$$PH$FR$FR
241924812$24192481$2$F$$20240905$20240809$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003623$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
241924822$24192482$2$F$20240801$20240820$20240809$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125389$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240828$$PH$JP$JP
241924831$24192483$1$I$$20240807$20240809$20240809$PER$$US-ROCHE-10000052282$ROCHE$$83$YR$E$F$Y$$$20240809$$MD$US$US
241924841$24192484$1$I$$20240731$20240809$20240809$EXP$NL-LRB-00993360$NL-TEVA-VS-3228849$TEVA$$23$YR$$M$Y$70$KG$20240809$$MD$NL$NL
241924851$24192485$1$I$$20240807$20240809$20240809$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001584$BLUEPRINT MEDICINES$$$$$F$Y$$$20240809$$CN$US$US
241924861$24192486$1$I$20240607$20240716$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003603$ACADIA PHARMACEUTICALS$$88$YR$$F$Y$$$20240809$$CN$US$US
241924871$24192487$1$I$20231201$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003598$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240809$$CN$US$US
241924882$24192488$2$F$$20240910$20240809$20240917$EXP$$RO-ROCHE-10000046450$ROCHE$$48$YR$A$M$Y$88$KG$20240917$$MD$RO$RO
241924902$24192490$2$F$$20240731$20240809$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202407014317$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240815$$CN$US$US
241924911$24192491$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005218$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241924921$24192492$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004955$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240809$$CN$US$US
241924931$24192493$1$I$20240804$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004892$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240809$$CN$US$US
241924941$24192494$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005379$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240809$$CN$US$US
241924951$24192495$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003593$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241924962$24192496$2$F$$20240807$20240809$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005147$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240812$$PH$US$US
241924971$24192497$1$I$20240806$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005402$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240809$$CN$US$US
241924981$24192498$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004672$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240809$$CN$US$US
241924991$24192499$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003701$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241925002$24192500$2$F$$20240821$20240809$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003599$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
241925011$24192501$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003610$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241925021$24192502$1$I$20240701$20240716$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003607$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240809$$CN$US$US
241925031$24192503$1$I$20240704$20240716$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003609$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240809$$CN$US$US
241925042$24192504$2$F$20240801$20240906$20240809$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003624$ACADIA PHARMACEUTICALS$$5$YR$$F$Y$$$20240927$$CN$US$US
241925051$24192505$1$I$$20240806$20240809$20240809$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-107956$REGENERON$$$$$F$Y$$$20240809$$CN$US$US
241925061$24192506$1$I$$20240730$20240809$20240809$EXP$$CA-TEVA-VS-3227588$TEVA$$49$YR$$F$Y$$$20240809$$HP$CA$CA
241925071$24192507$1$I$20200101$20240802$20240809$20240809$EXP$FR-AFSSAPS-AN2024000957$FR-TEVA-VS-3230098$TEVA$$62$YR$$M$Y$$$20240809$$MD$FR$FR
241925082$24192508$2$F$$20240809$20240809$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003613$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
241925091$24192509$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003611$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241925101$24192510$1$I$$20240716$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003614$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241925111$24192511$1$I$20240806$20240806$20240809$20240809$EXP$$US-ABBVIE-5871040$ABBVIE$$60$YR$$F$Y$$$20240809$$MD$US$US
241925121$24192512$1$I$$20240730$20240809$20240809$EXP$$CA-TEVA-VS-3227683$TEVA$$$$$F$Y$$$20240809$$HP$CA$CA
241925131$24192513$1$I$$20240802$20240809$20240809$EXP$$CA-ABBVIE-5873048$ABBVIE$$$$E$F$Y$$$20240809$$CN$CA$CA
241925143$24192514$3$F$20240101$20240816$20240809$20240826$PER$$US-AMGEN-USASP2024158013$AMGEN$$19$YR$A$M$Y$$$20240826$$HP$US$US
241925152$24192515$2$F$20240805$20240814$20240809$20240905$PER$$US-AMGEN-USASP2024158185$AMGEN$$26$YR$A$F$Y$$$20240905$$CN$US$US
241925161$24192516$1$I$$20240807$20240809$20240809$PER$$US-ROCHE-10000052389$ROCHE$$$$E$F$Y$$$20240809$$MD$US$US
241925174$24192517$4$F$$20240920$20240809$20240926$PER$$NVSC2024US161023$NOVARTIS$$$$$$Y$$$20240927$$CN$US$US
241925181$24192518$1$I$$20240731$20240809$20240809$PER$$US-ABBVIE-5863110$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241925191$24192519$1$I$$20240730$20240809$20240809$EXP$$CA-TEVA-VS-3227668$TEVA$$83$YR$$M$Y$$$20240809$$HP$CA$CA
241925212$24192521$2$F$20240101$20240828$20240809$20240903$EXP$$JP-JNJFOC-20240821713$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240903$$PH$JP$JP
241925221$24192522$1$I$$20240801$20240809$20240809$PER$$US-RDY-SPO/USA/24/0011483$DR REDDYS$$55$YR$E$$Y$$$20240809$$MD$US$US
241925241$24192524$1$I$20240716$20240806$20240809$20240809$EXP$$US-ABBVIE-5870661$ABBVIE$$55$YR$$M$Y$$$20240809$$CN$US$US
241925252$24192525$2$F$20240801$20240916$20240809$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003724$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240926$$CN$US$US
241925261$24192526$1$I$$20240806$20240809$20240809$EXP$$AU-GSK-AU2024APC066738$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$HP$AU$AU
241925272$24192527$2$F$$20240814$20240809$20240827$EXP$$PT-AUROBINDO-AUR-APL-2024-038903$AUROBINDO$Tenreiro A., Alfaiate F., Figueira J., Cala?a S., Carvalho S.. PO-0116 - (4016) - Quetiapine drug poisoning - beyond the anamnesis. PO-0119 - (4141) - Lyell syndrome: about a case.. Congresses of the Portuguese Society of Internal Medicine:30th National Congress. 2024;489$81$YR$$M$Y$$$20240827$$MD$PT$PT
241925281$24192528$1$I$$20220328$20240809$20240809$EXP$$US-AstraZeneca-2022A130685$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
241925291$24192529$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003728$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241925301$24192530$1$I$20240330$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A177803$ASTRAZENECA$$$$$M$Y$$$20240809$$MD$US$
241925311$24192531$1$I$$20240802$20240809$20240809$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00400$VELOXIS PHARMACEUTICALS$Bae E K, Chandran M M, Everitt M D, Benz E, Bock M.. LCP-tacrolimus extended-release (Envarsus XR) use in adolescent and young adult solid organ transplant recipients.. Clinical Transplantation. 2024;38:e15417:1-7$19$YR$$F$Y$$$20240809$$HP$US$US
241925321$24192532$1$I$$20240729$20240809$20240809$EXP$$IT-PADAGIS-2024PAD01240$PADAGIS$Mancini M., Di Nardo G., Casciani E., Feudi M.L., Bargiacchi L., Petraroli A.,e.al. The Multifaceted Complexity of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS): A Case Report Highlighting Atypical Gastrointestinal Manifestations. Diagnostics. 2024;14(3):1337$$$$$Y$$$20240809$$HP$IT$IT
241925331$24192533$1$I$$20240724$20240809$20240809$EXP$$US-PADAGIS-2024PAD01237$PADAGIS$$$$$$Y$$$20240809$$CN$US$US
241925341$24192534$1$I$$20240730$20240809$20240809$EXP$$US-PADAGIS-2024PAD01263$PADAGIS$$$$$$Y$$$20240809$$CN$US$US
241925351$24192535$1$I$$20240731$20240809$20240809$EXP$$US-PADAGIS-2024PAD01270$PADAGIS$$$$$$Y$$$20240809$$CN$US$US
241925361$24192536$1$I$20231007$20240731$20240809$20240809$EXP$$US-PADAGIS-2024PAD01272$PADAGIS$$$$$$Y$$$20240809$$CN$US$US
241925371$24192537$1$I$$20240731$20240809$20240809$EXP$$US-PADAGIS-2024PAD01264$PADAGIS$$$$$$Y$$$20240809$$CN$US$US
241925381$24192538$1$I$$20240801$20240809$20240809$EXP$$US-PADAGIS-2024PAD01273$PADAGIS$Sood N., Vadnerkar A., Kodali M., Hamacher L.K.. Cutaneous Pneumocystis Jirovecii Infection in An Allogeneic Stem Cell Transplant Recipient. European Journal of Case Reports in Internal Medicine. 2024;11(7):004615$$$$$Y$$$20240809$$HP$US$US
241925391$24192539$1$I$20240601$20240731$20240809$20240809$EXP$$US-PADAGIS-2024PAD01271$PADAGIS$$$$$$Y$$$20240809$$CN$US$US
241925401$24192540$1$I$$20240802$20240809$20240809$EXP$$US-PADAGIS-2024PAD01279$PADAGIS$$$$$$Y$$$20240809$$MD$US$US
241925411$24192541$1$I$$20240801$20240809$20240809$EXP$$US-PADAGIS-2024PAD01276$PADAGIS$Min M, Dulai A S, Sivamani R K. Recalcitrant multi-variant lichen planus successfully treated with oral baricitinib and topical ruxolitinib cream. Dermatology Online Journal. 2024;30(3):4$$$$$Y$$$20240809$$HP$US$US
241925421$24192542$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003726$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241925431$24192543$1$I$20240618$20240729$20240809$20240809$EXP$IT-MINISAL02-995287$IT-ROCHE-10000041701$ROCHE$$68$YR$E$M$Y$65$KG$20240809$$MD$IT$IT
241925442$24192544$2$F$20240806$20240912$20240809$20240917$PER$$US-JNJFOC-20240815834$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240917$$HP$US$US
241925451$24192545$1$I$$20240725$20240809$20240809$PER$$US-NOVITIUMPHARMA-2024USNVP01462$NOVITIUM PHARMA$$$$$M$Y$$$20240809$$CN$US$US
241925462$24192546$2$F$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683492$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241925472$24192547$2$F$20240701$20240814$20240809$20240818$PER$$US-AMGEN-USASP2024155952$AMGEN$$64$YR$A$F$Y$$$20240817$$MD$US$US
241925481$24192548$1$I$20240615$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155307$AMGEN$$73$YR$E$M$Y$$$20240809$$CN$US$US
241925492$24192549$2$F$20240802$20240819$20240809$20240821$EXP$$JP-TAKEDA-2024TJP011814$TAKEDA$$4$DEC$$F$Y$$$20240820$$MD$JP$JP
241925501$24192550$1$I$20211222$20240805$20240809$20240809$EXP$$DK-TAKEDA-2024TUS078439$TAKEDA$$$$T$M$Y$63.3$KG$20240809$$HP$DK$DK
241925512$24192551$2$F$20240702$20240814$20240809$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003732$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240830$$CN$US$US
241925521$24192552$1$I$20240702$20240717$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003733$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240809$$CN$US$US
241925531$24192553$1$I$$20240802$20240809$20240809$PER$$US-ADVANZ PHARMA-202408006550$ADVANZ PHARMA$$$$$$Y$$$20240809$$CN$US$US
241925541$24192554$1$I$20221101$20240730$20240809$20240809$EXP$FR-AFSSAPS-LY2024001083$FR-TEVA-VS-3228458$TEVA$$63$YR$$F$Y$70$KG$20240809$$CN$FR$FR
241925551$24192555$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000051073$ROCHE$$49$YR$A$M$Y$$$20240809$$CN$US$US
241925561$24192556$1$I$20240801$20240801$20240809$20240809$EXP$$US-JNJFOC-20240815523$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240809$$CN$US$US
241925571$24192557$1$I$$20240708$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06990$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241925591$24192559$1$I$20230510$20240729$20240809$20240809$EXP$FR-AFSSAPS-AM2024000612$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110549$ZYDUS PHARM$$$$$$Y$$$20240809$$MD$FR$FR
241925601$24192560$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125766$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240809$$HP$US$US
241925611$24192561$1$I$$20240805$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125846$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240809$$MD$US$US
241925621$24192562$1$I$$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124732$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240809$$CN$US$US
241925631$24192563$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125967$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$80.29$KG$20240809$$CN$US$US
241925641$24192564$1$I$20240802$20240805$20240809$20240809$EXP$$US-ABBVIE-5867450$ABBVIE$$37$YR$$M$Y$$$20240809$$CN$US$US
241925652$24192565$2$F$20240101$20240813$20240809$20240819$EXP$$TW-ABBVIE-5870523$ABBVIE$$$$$M$Y$55$KG$20240819$$CN$TW$TW
241925662$24192566$2$F$20240101$20240820$20240809$20240823$EXP$$US-ABBVIE-5871105$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
241925671$24192567$1$I$$20240802$20240809$20240809$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00399$VELOXIS PHARMACEUTICALS$Bae E K, Chandran M M, Everitt M D, Benz E, Bock M.. LCP-tacrolimus extended-release (Envarsus XR) use in adolescent and young adult solid organ transplant recipients.. Clinical Transplantation. 2024;38:e15417:1-7$17$YR$$F$Y$$$20240809$$HP$US$US
241925681$24192568$1$I$20240530$20240806$20240809$20240809$EXP$$US-ABBVIE-5871259$ABBVIE$$47$YR$$M$Y$$$20240809$$CN$US$US
241925692$24192569$2$F$$20240828$20240809$20240828$PER$$US-ALXN-202408USA000120US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
241925701$24192570$1$I$20230101$20240801$20240809$20240809$EXP$$CA-CELLTRION INC.-2023CA020097$CELLTRION$$$$$$Y$$$20240809$$CN$CA$CA
241925711$24192571$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004654$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240809$$CN$US$US
241925721$24192572$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004970$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240809$$CN$US$US
241925731$24192573$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004627$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240809$$CN$US$US
241925741$24192574$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004951$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240809$$CN$US$US
241925751$24192575$1$I$20240716$20240717$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003689$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240809$$CN$US$US
241925761$24192576$1$I$$20240805$20240809$20240809$PER$$US-ABBVIE-5868113$ABBVIE$$$$$$Y$$$20240809$$CN$US$US
241925771$24192577$1$I$20200509$20240809$20240809$20240809$EXP$PL-URPL-1-1579-2020$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044725$BOEHRINGER INGELHEIM$$91$YR$E$M$Y$70$KG$20240809$$MD$PL$PL
241925781$24192578$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003742$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241925793$24192579$3$F$20240809$20240903$20240809$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003658$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240913$$CN$US$US
241925811$24192581$1$I$$20240806$20240809$20240809$EXP$$CA-ABBVIE-5871382$ABBVIE$$$$A$M$Y$$$20240809$$MD$CA$CA
241925822$24192582$2$F$20240710$20240820$20240809$20240828$EXP$$AR-ROCHE-10000050495$ROCHE$$74$YR$E$F$Y$$$20240828$$CN$AR$AR
241925831$24192583$1$I$$20240806$20240809$20240809$EXP$$US-GSK-US2024098116$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241925841$24192584$1$I$20231101$20240806$20240809$20240809$EXP$$SA-GSK-SA2023EME152648$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$SA$SA
241925861$24192586$1$I$$20220314$20240809$20240809$EXP$$CA-AstraZeneca-2022A117721$ASTRAZENECA$$$$$$Y$$$20240809$$MD$CA$
241925871$24192587$1$I$$20240709$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07084$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241925881$24192588$1$I$20240101$20240801$20240809$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-024011$UNITED THERAPEUTICS$$$$$F$Y$92.971$KG$20240809$$$US$US
241925891$24192589$1$I$$20240802$20240809$20240809$EXP$$CA-AstraZeneca-2024A177846$ASTRAZENECA$$60$YR$$F$Y$$$20240809$$MD$CA$
241925903$24192590$3$F$$20240813$20240809$20240820$PER$$NVSC2024US161774$NOVARTIS$$$$$$Y$$$20240820$$CN$US$US
241925911$24192591$1$I$20200207$20240805$20240809$20240809$EXP$$DE-SANDOZ INC.-NVSC2020DE083867$SANDOZ$$$$E$F$Y$68$KG$20240809$$HP$DE$DE
241925921$24192592$1$I$20240101$20240804$20240809$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-024066$UNITED THERAPEUTICS$$$$$F$Y$66.667$KG$20240809$$$US$US
241925932$24192593$2$F$$20240814$20240809$20240816$EXP$$US-JNJFOC-20240819462$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240816$$CN$US$US
241925941$24192594$1$I$20240804$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157733$AMGEN$$52$YR$A$F$Y$$$20240809$$CN$US$US
241925951$24192595$1$I$$20240731$20240809$20240809$EXP$GB-MHRA-MED-202407251205574320-RQCGB$GB-AMAROX PHARMA-AMR2024GB02533$HETERO$$$$$$Y$$$20240809$$CN$GB$GB
241925961$24192596$1$I$20240101$20240802$20240809$20240809$PER$$US-ABBVIE-5866875$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241925971$24192597$1$I$$20240730$20240809$20240809$EXP$$CN-RDY-LIT/CHN/24/0011511$DR REDDYS$Zhu H, Zhuang Z, Wang W, Zhao D, Zhang W, Zhou D, et al. Three cases of late-onset post CAR-T therapy isolated CNS relapse in R/R large B-cell lymphoma. European Journal of Haematology. 2024 Feb;112(2): 310-313. doi:10.1111/ejh.14078.$64$YR$A$M$Y$$$20240809$$HP$CN$CN
241925982$24192598$2$F$$20240925$20240809$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-024162$UNITED THERAPEUTICS$$$$$F$Y$86.168$KG$20240928$$$US$US
241925991$24192599$1$I$20240723$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125151$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$74.84$KG$20240809$$CN$US$US
241926001$24192600$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125751$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240809$$HP$US$US
241926011$24192601$1$I$$20240805$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125803$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240809$$CN$US$US
241926022$24192602$2$F$$20240808$20240809$20240810$EXP$$IN-ROCHE-10000051187$ROCHE$$68$YR$E$M$Y$$$20240810$$MD$IN$IN
241926031$24192603$1$I$20240705$20240729$20240809$20240809$EXP$IT-MINISAL02-995288$IT-ROCHE-10000041676$ROCHE$$86$YR$E$F$Y$67$KG$20240809$$MD$IT$IT
241926041$24192604$1$I$20240429$20240807$20240809$20240809$EXP$FR-AFSSAPS-AM2024000634$FR-GSK-FR2024098781$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$MD$FR$FR
241926051$24192605$1$I$$20240710$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07008$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241926061$24192606$1$I$20230101$20240727$20240809$20240809$EXP$$IN-CIPLA LTD.-2024IN06727$CIPLA$$$$$$Y$$$20240809$$MD$IN$IN
241926072$24192607$2$F$$20240814$20240809$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003657$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
241926081$24192608$1$I$$20240805$20240809$20240809$EXP$$JP-GILEAD-2024-0683179$GILEAD$Fujieda K, Okamori S, Yoshida K, Nakano R, Kanzawa A, Kamei R, et al.. 16?A case of cytomegalovirus pneumonia complicated by severe COVID-19 pneumonia. The 260th Kanto Regional Meeting of the Japanese Respiratory Society. unk;unk:14$75$YR$E$M$Y$$$20240809$$MD$JP$JP
241926091$24192609$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5871080$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241926101$24192610$1$I$$20240808$20240809$20240809$PER$$US-AMGEN-USASP2024158233$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241926113$24192611$3$F$20211215$20240828$20240809$20240916$EXP$$DE-AMGEN-DEUSP2024157091$AMGEN$$81$YR$E$F$Y$57.6$KG$20240916$$MD$DE$DE
241926121$24192612$1$I$$20240805$20240809$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-021977$UNITED THERAPEUTICS$$$$$F$Y$73.016$KG$20240809$$$US$US
241926141$24192614$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003663$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241926151$24192615$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003665$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241926161$24192616$1$I$20240101$20240805$20240809$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-024281$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240809$$$US$US
241926171$24192617$1$I$$20240729$20240809$20240809$EXP$$JP-ROCHE-10000047976$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$81$YR$E$F$Y$$$20240809$$HP$JP$JP
241926181$24192618$1$I$$20240710$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07014$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241926191$24192619$1$I$20240214$20240801$20240809$20240809$PER$$US-ABBVIE-5865475$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241926201$24192620$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003666$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241926211$24192621$1$I$$20240808$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2024US071539$SANDOZ$$$$$F$Y$$$20240809$$CN$US$US
241926221$24192622$1$I$$20240731$20240809$20240809$EXP$$US-ABBVIE-5871072$ABBVIE$Hamdan A, Sharma S, Baynes K, Hajj Ali RA, Lowder CY, Srivastava SK. Management of uveitis patients on anti-tnf agents who develop demyelinating disease - a case series. J Ophthal Inflamm Infect. 2024;14(1):35.$$$$F$Y$$$20240809$$MD$US$US
241926231$24192623$1$I$20240101$20240805$20240809$20240809$EXP$$US-BIOGEN-2024BI01277092$BIOGEN$$$$$M$Y$$$20240809$$CN$US$US
241926241$24192624$1$I$$20240731$20240809$20240809$PER$$US-CHATTEMPRD-2024OHG026224$CHATTEM$$$$A$$Y$$$20240809$$CN$US$US
241926251$24192625$1$I$$20240802$20240809$20240809$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00409$VELOXIS PHARMACEUTICALS$Bae E K, Chandran M M, Everitt M D, Benz E, Bock M.. LCP-tacrolimus extended-release (Envarsus XR) use in adolescent and young adult solid organ transplant recipients.. Clinical Transplantation. 2024;38:e15417:1-7$$$$$Y$$$20240809$$HP$US$US
241926261$24192626$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003668$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241926271$24192627$1$I$$20240711$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07091$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241926281$24192628$1$I$$20240806$20240809$20240809$PER$$US-JNJFOC-20240813378$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240809$$MD$US$US
241926301$24192630$1$I$$20240729$20240809$20240809$EXP$$DE-RDY-LIT/DEU/24/0011353$DR REDDYS$Hoeltzenbein M, Slimi S, Fietz A, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023 Apr;107: 107-113. doi:10.1016/j.seizure.2023.02.015.$$$N$$Y$$$20240809$$HP$DE$DE
241926312$24192631$2$F$$20240826$20240809$20240830$EXP$DE-GERMAN-LIT/DEU/24/0011356$DE-RDY-LIT/DEU/24/0011356$DR REDDYS$Hoeltzenbein M, Slimi S, Fietz A, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023 Apr;107: 107-113. doi:10.1016/j.seizure.2023.02.015.$3$DY$N$$Y$$$20240830$$MD$DE$DE
241926321$24192632$1$I$$20240729$20240809$20240809$EXP$$DE-RDY-LIT/DEU/24/0011354$DR REDDYS$Hoeltzenbein M, Slimi S, Fietz A, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023 Apr;107: 107-113. doi:10.1016/j.seizure.2023.02.015.$$$$F$Y$$$20240809$$HP$DE$DE
241926331$24192633$1$I$$20240729$20240809$20240809$EXP$$DE-RDY-LIT/DEU/24/0011352$DR REDDYS$Hoeltzenbein M, Slimi S, Fietz A, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023 Apr;107: 107-113. doi:10.1016/j.seizure.2023.02.015.$$$$F$Y$$$20240809$$HP$DE$DE
241926342$24192634$2$F$20240116$20240912$20240809$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003670$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240930$$CN$US$US
241926351$24192635$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125805$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240809$$CN$US$US
241926361$24192636$1$I$$20240729$20240809$20240809$EXP$$JP-ROCHE-10000048499$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$39$YR$A$M$Y$$$20240809$$HP$JP$JP
241926372$24192637$2$F$$20240829$20240809$20240911$PER$$US-APOTEX-2024AP009073$APOTEX$$$$$F$Y$$$20240911$$CN$US$US
241926382$24192638$2$F$$20240807$20240809$20240809$EXP$$US-GILEAD-2024-0683529$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241926391$24192639$1$I$$20231115$20240809$20240809$EXP$$PK-UCBSA-2021002061$UCB$Kumar D, Iltaf S, Umer A, Fatima M, Zaheer M, Waqar K, et al. The Frequency of Catamenial Epilepsy in Female Epileptic Patients of Reproductive Age Group Presented to the Tertiary Care Hospital. Cureus. 2020;12(11):1-8$$$$F$Y$$$20240809$$MD$PK$PK
241926402$24192640$2$F$$20240804$20240809$20240812$PER$$NVSC2024US159258$NOVARTIS$$27$YR$$F$Y$$$20240812$$CN$US$US
241926411$24192641$1$I$20240613$20240802$20240809$20240809$EXP$$CN-BEIGENE-BGN-2024-012125$BEIGENE$$$$$$Y$$$20240809$$HP$CN$CN
241926421$24192642$1$I$$20230620$20240809$20240809$EXP$$US-AstraZeneca-2023A106235$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241926443$24192644$3$F$20240101$20240913$20240809$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-023911$UNITED THERAPEUTICS$$$$$M$Y$70.748$KG$20240921$$$US$US
241926451$24192645$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004663$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240809$$CN$US$US
241926461$24192646$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004901$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240809$$CN$US$US
241926471$24192647$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005383$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240809$$CN$US$US
241926481$24192648$1$I$20240701$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004029$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241926491$24192649$1$I$$20240710$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407007229$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241926502$24192650$2$F$20240717$20240815$20240809$20240821$PER$$US-AMGEN-USASP2024152664$AMGEN$$67$YR$E$F$Y$62.4$KG$20240821$$HP$US$US
241926511$24192651$1$I$$20240730$20240809$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-038345$AUROBINDO$$$$$M$Y$$$20240809$$PH$GB$GB
241926521$24192652$1$I$20240501$20240731$20240809$20240809$EXP$$DE-JNJFOC-20240802066$JOHNSON AND JOHNSON$$56$YR$A$M$Y$99$KG$20240809$$MD$DE$DE
241926531$24192653$1$I$20240725$20240805$20240809$20240809$EXP$$CO-JNJFOC-20240746521$JOHNSON AND JOHNSON$$57$YR$A$F$Y$47$KG$20240809$$HP$CO$CO
241926544$24192654$4$F$$20240910$20240809$20240915$EXP$$JP-ALXN-202408JPN000013JP$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$MD$JP$JP
241926552$24192655$2$F$20240401$20240731$20240809$20240828$EXP$$CA-CELLTRION INC.-2024CA014858$CELLTRION$$$$$$Y$$$20240828$$HP$CA$CA
241926561$24192656$1$I$20240530$20240730$20240809$20240809$EXP$FR-AFSSAPS-AVLY2024000103$FR-TEVA-VS-3228610$TEVA$$16$YR$$M$Y$$$20240809$$MD$FR$FR
241926571$24192657$1$I$$20240730$20240809$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-038349$AUROBINDO$$27$YR$$F$Y$$$20240809$$HP$GB$GB
241926581$24192658$1$I$20240711$20240730$20240809$20240809$EXP$FR-AFSSAPS-RE2024000751$FR-TEVA-VS-3228509$TEVA$$88$YR$$F$Y$40$KG$20240809$$MD$FR$FR
241926591$24192659$1$I$$20240801$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2024US069595$SANDOZ$Park RB, Djalilian AR. Resolution of plaque keratopathy in a patient with Atopic keratoconjunctivitis after treatment with Leflunomide. Ocular Immunology and Inflammation. 2024;1-3$57$YR$$M$Y$$$20240809$$HP$US$US
241926602$24192660$2$F$20240101$20240809$20240809$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-023491$UNITED THERAPEUTICS$$$$$M$Y$87.982$KG$20240817$$$US$US
241926611$24192661$1$I$$20240730$20240809$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-038170$AUROBINDO$$$$$$Y$75$KG$20240809$$CN$GB$GB
241926621$24192662$1$I$$20240806$20240809$20240809$PER$$US-JNJFOC-20240818989$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$CN$US$US
241926631$24192663$1$I$$20240730$20240809$20240809$EXP$$ES-AUROBINDO-AUR-APL-2024-038985$AUROBINDO$Pitarch CG, Macia MS, Simon J, Mosca L, Conter C, Rejano-Gordillo CM, et al.. Neddylation inhibition prevents acetaminopheninduced liver damage by enhancing the anabolic cardiolipin pathway. Cell Reports Medicine. 2024;5(7)$$$A$M$Y$$$20240809$$HP$ES$ES
241926641$24192664$1$I$$20240801$20240809$20240809$EXP$$US-EMD Serono-2024042148$EMD SERONO INC$$74$YR$E$F$Y$$$20240809$$CN$US$US
241926651$24192665$1$I$$20240707$20240809$20240809$PER$$US-WW-2024-e02021$WOODWARD PHARMA SERVICES$Denton J, et al. Musculoskeletal and CNS coccidiomycosis in an individual with multiple sclerosis on fingolimod - A case report. IDCases. 2024. DOI: https://doi.org/10.1016/j.idcr.2024.e02021$56$YR$$F$Y$$$20240809$$HP$US$US
241926671$24192667$1$I$$20240806$20240809$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-014235$UNITED THERAPEUTICS$$$$$F$Y$55.329$KG$20240809$$$US$US
241926682$24192668$2$F$$20240902$20240809$20240917$EXP$$PT-COSETTE-CP2024PT000198$COSETTE PHARMACEUTICALS$$88$YR$E$F$Y$$$20240917$$MD$PT$PT
241926691$24192669$1$I$$20240801$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125574$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240809$$CN$US$US
241926701$24192670$1$I$$20240802$20240809$20240809$PER$$US-JNJFOC-20240809270$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241926711$24192671$1$I$20240101$20240802$20240809$20240809$EXP$$US-009507513-2408USA001291$MERCK$$$$$F$Y$$$20240809$$CN$US$US
241926721$24192672$1$I$20240731$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125841$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240809$$PH$US$US
241926731$24192673$1$I$20240807$20240807$20240809$20240809$PER$$US-JNJFOC-20240818032$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$MD$US$US
241926741$24192674$1$I$$20240806$20240809$20240809$EXP$$EG-SANDOZ INC.-SDZ2024EG071390$SANDOZ$$$$$F$Y$$$20240809$$HP$EG$EG
241926751$24192675$1$I$$20240730$20240809$20240809$EXP$$CA-TEVA-VS-3227579$TEVA$$$$$F$Y$$$20240809$$HP$CA$CA
241926771$24192677$1$I$20240507$20240730$20240809$20240809$EXP$$BG-AUROBINDO-AUR-APL-2024-038759$AUROBINDO$NEYKOVA L, ANGELOV Y, IVANOVA M.. Intralipids and their role in the management of antipsychotic and neuroleptic drug intoxications (a clinical case).. MILITARY MEDICINE. 2024;LXXVI(2):29-33$46$YR$$F$Y$$$20240809$$HP$BG$BG
241926781$24192678$1$I$$20240729$20240809$20240809$EXP$$JP-PBT-009607$PANACEA BIOTEC$Nakamura K, Goto T, Shiraishi K, Yonekawa A, Eriguchi Y, Akashi K, et al. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications. BMC Infect Dis. 2024 Jul 25;24(1):736. doi: 10.1186/s12879-024-09633-1.$38$YR$A$F$Y$$$20240809$$HP$JP$JP
241926791$24192679$1$I$$20240729$20240809$20240809$EXP$$JP-PBT-009606$PANACEA BIOTEC$Nakamura K, Goto T, Shiraishi K, Yonekawa A, Eriguchi Y, Akashi K, et al. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications. BMC Infect Dis. 2024 Jul 25;24(1):736. doi: 10.1186/s12879-024-09633-1.$71$YR$E$M$Y$$$20240809$$HP$JP$JP
241926801$24192680$1$I$$20240729$20240809$20240809$EXP$$JP-PBT-009602$PANACEA BIOTEC$Nakamura K, Goto T, Shiraishi K, Yonekawa A, Eriguchi Y, Akashi K, et al. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications. BMC Infect Dis. 2024 Jul 25;24(1):736. doi: 10.1186/s12879-024-09633-1.$53$YR$A$F$Y$$$20240809$$HP$JP$JP
241926811$24192681$1$I$$20240729$20240809$20240809$EXP$$JP-PBT-009608$PANACEA BIOTEC$Nakamura K, Goto T, Shiraishi K, Yonekawa A, Eriguchi Y, Akashi K, et al. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications. BMC Infect Dis. 2024 Jul 25;24(1):736. doi: 10.1186/s12879-024-09633-1.$74$YR$E$F$Y$$$20240809$$HP$JP$JP
241926821$24192682$1$I$$20240729$20240809$20240809$EXP$$JP-PBT-009610$PANACEA BIOTEC$Nakamura K, Goto T, Shiraishi K, Yonekawa A, Eriguchi Y, Akashi K, et al. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications. BMC Infect Dis. 2024 Jul 25;24(1):736. doi: 10.1186/s12879-024-09633-1.$46$YR$A$F$Y$$$20240809$$HP$JP$JP
241926832$24192683$2$F$20240101$20240815$20240809$20240822$EXP$$CA-CELLTRION INC.-2024CA018993$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
241926841$24192684$1$I$$20240729$20240809$20240809$EXP$$JP-PBT-009609$PANACEA BIOTEC$Nakamura K, Goto T, Shiraishi K, Yonekawa A, Eriguchi Y, Akashi K, et al. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications. BMC Infect Dis. 2024 Jul 25;24(1):736. doi: 10.1186/s12879-024-09633-1.$41$YR$A$M$Y$$$20240809$$HP$JP$JP
241926851$24192685$1$I$$20240729$20240809$20240809$EXP$$JP-PBT-009614$PANACEA BIOTEC$Nakamura K, Goto T, Shiraishi K, Yonekawa A, Eriguchi Y, Akashi K, et al. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications. BMC Infect Dis. 2024 Jul 25;24(1):736. doi: 10.1186/s12879-024-09633-1.$60$YR$A$M$Y$$$20240809$$HP$JP$JP
241926861$24192686$1$I$$20240729$20240809$20240809$EXP$$JP-PBT-009611$PANACEA BIOTEC$Nakamura K, Goto T, Shiraishi K, Yonekawa A, Eriguchi Y, Akashi K, et al. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications. BMC Infect Dis. 2024 Jul 25;24(1):736. doi: 10.1186/s12879-024-09633-1.$25$YR$A$M$Y$$$20240809$$HP$JP$JP
241926871$24192687$1$I$$20240729$20240809$20240809$EXP$$JP-PBT-009615$PANACEA BIOTEC$Nakamura K, Goto T, Shiraishi K, Yonekawa A, Eriguchi Y, Akashi K, et al. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications. BMC Infect Dis. 2024 Jul 25;24(1):736. doi: 10.1186/s12879-024-09633-1.$64$YR$A$M$Y$$$20240809$$HP$JP$JP
241926881$24192688$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157785$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241926891$24192689$1$I$$20240729$20240809$20240809$EXP$$JP-PBT-009616$PANACEA BIOTEC$Nakamura K, Goto T, Shiraishi K, Yonekawa A, Eriguchi Y, Akashi K, et al. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications. BMC Infect Dis. 2024 Jul 25;24(1):736. doi: 10.1186/s12879-024-09633-1.$55$YR$A$F$Y$$$20240809$$HP$JP$JP
241926901$24192690$1$I$$20240729$20240809$20240809$EXP$$JP-PBT-009612$PANACEA BIOTEC$Nakamura K, Goto T, Shiraishi K, Yonekawa A, Eriguchi Y, Akashi K, et al. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications. BMC Infect Dis. 2024 Jul 25;24(1):736. doi: 10.1186/s12879-024-09633-1.$42$YR$A$M$Y$$$20240809$$HP$JP$JP
241926911$24192691$1$I$$20240731$20240809$20240809$EXP$$CN-ROCHE-RCA5213035$ROCHE$Li X, Wu D, Tang J, Wu Y. The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort.. Journal of Cancer Research and Clinical Oncology. 2024-May;150 (5):1-8. doi:10.1007/s00432-024-05808-0.$$$$$Y$$$20240809$$HP$CN$CN
241926921$24192692$1$I$$20240805$20240809$20240809$PER$$US-ORGANON-O2408USA000414$ORGANON$$43$YR$$F$Y$$$20240809$$CN$US$US
241926941$24192694$1$I$20240703$20240807$20240809$20240809$EXP$$US-ABBVIE-5872088$ABBVIE$$15$YR$$F$Y$$$20240809$$CN$US$US
241926951$24192695$1$I$20240722$20240802$20240809$20240809$EXP$$CN-BEIGENE-BGN-2024-012117$BEIGENE$$$$$$Y$$$20240809$$HP$CN$CN
241926961$24192696$1$I$20240731$20240731$20240809$20240809$EXP$$US-JNJFOC-20240800886$JOHNSON AND JOHNSON$$7$DEC$E$F$Y$$$20240809$$PH$US$US
241926973$24192697$3$F$20240101$20240917$20240809$20240924$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022083$UNITED THERAPEUTICS$$$$$F$Y$$$20240924$$$US$US
241926981$24192698$1$I$$20240726$20240809$20240809$EXP$$US-QUAGEN-2024QUALIT00236$QUAGEN PHARMACEUTICALS$B Van Noord.A Case of Delayed and Immediate Hypersensitivity Reactions Induced by Corticosteroids.Dermatitis.JAN-2024;35:191-192$71$YR$E$M$Y$$$20240809$$HP$US$US
241926991$24192699$1$I$$20240730$20240809$20240809$EXP$$NL-AUROBINDO-AUR-APL-2024-038744$AUROBINDO$$33$YR$$F$Y$70$KG$20240809$$CN$NL$NL
241927001$24192700$1$I$20240701$20240730$20240809$20240809$EXP$$FR-TEVA-VS-3228868$TEVA$$82$YR$$F$Y$$$20240809$$PH$FR$FR
241927011$24192701$1$I$$20240802$20240809$20240809$EXP$$US-ABBVIE-5867154$ABBVIE$Tsai SYC, Phipatanakul W, Hawryluk EB, Oyoshi MK, Schneider LC, Ma KSK. Comparative safety of oral Janus kinase inhibitors and dupilumab in patients with atopic dermatitis: a population-based cohort study. Journal of Allergy and Clinical Immunology. 2024;S0091674924007760.$16$YR$$M$Y$$$20240809$$HP$US$US
241927031$24192703$1$I$20240701$20240801$20240809$20240809$PER$$US-ALXN-202408USA000111US$ALEXION PHARMACEUTICALS$$68$YR$$F$Y$$$20240809$$CN$US$US
241927041$24192704$1$I$$20240730$20240809$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-038203$AUROBINDO$$60$YR$$F$Y$$$20240809$$MD$GB$GB
241927051$24192705$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5865174$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241927061$24192706$1$I$20240617$20240725$20240809$20240809$EXP$$US-HLS-202400559$HLS THERAPEUTICS$$65$YR$E$M$Y$$$20240809$$CN$CA$US
241927071$24192707$1$I$$20240725$20240809$20240809$EXP$$US-HLS-202400561$HLS THERAPEUTICS$$21$YR$A$M$Y$$$20240809$$CN$US$US
241927081$24192708$1$I$$20240726$20240809$20240809$EXP$$US-QUAGEN-2024QUALIT00235$QUAGEN PHARMACEUTICALS$Cardona Quinones RA.A neuropsychiatric case of delayed post-hypoxic leukoencephalopathy from opioid intoxication resulting in Anton-Babinski syndrome and quadriplegia.Neurocase.JAN-2023;29 (5):160-166$26$YR$A$M$Y$$$20240809$$HP$US$US
241927092$24192709$2$F$$20240911$20240809$20240924$EXP$$ES-AUROBINDO-AUR-APL-2024-038841$AUROBINDO$Martinez-chantar ML, Gil-pitarch C, Serrano-macia M, Simon J, Mosca L, Conter C, et al. Neddylation inhibition prevents acetaminopheninduced liver damage by enhancing the anabolic cardiolipin pathway. Cell Reports Medicine. 2024;5(7):1-18 (e1-e11)$$$A$F$Y$$$20240924$$HP$ES$ES
241927121$24192712$1$I$$20240805$20240809$20240809$EXP$$US-CHIESI-2024CHF04835$CHIESI$$$$N$M$Y$$$20240809$$MD$US$US
241927131$24192713$1$I$$20240729$20240809$20240809$EXP$$US-RDY-LIT/USA/24/0011403$DR REDDYS$Kaur S, Issac S, Westerman J. Life threatening hematologic emergency from low dose methrotrexate. Southern Medical Journal. 2023 Apr 20;116: 641-642.$63$YR$A$F$Y$$$20240809$$MD$US$US
241927141$24192714$1$I$20240708$20240807$20240809$20240809$EXP$$CN-ROCHE-10000051533$ROCHE$$42$YR$A$M$Y$60.7$KG$20240809$$HP$CN$CN
241927151$24192715$1$I$$20240805$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125073$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240809$$MD$US$US
241927161$24192716$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125392$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240809$$HP$US$US
241927173$24192717$3$F$$20240810$20240809$20240819$EXP$$US-JNJFOC-20240722108$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240819$$HP$US$US
241927181$24192718$1$I$$20240801$20240809$20240809$EXP$$US-STERISCIENCE B.V.-2024-ST-001164$Steriscience PTE$Sevella P, Khan S, Shah S.. A Devastating Case of Septic Pulmonary Emboli.. Am-J-Respir-Crit-Care-Med. 2024;209$73$YR$$M$Y$$$20240809$$HP$US$US
241927191$24192719$1$I$$20240731$20240809$20240809$EXP$$US-GSK-US2024AMR096792$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241927202$24192720$2$F$20240701$20240904$20240809$20240912$EXP$$CA-CELLTRION INC.-2024CA018937$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
241927211$24192721$1$I$$20240808$20240809$20240809$PER$$NVSC2024US162191$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241927221$24192722$1$I$$20240808$20240809$20240809$PER$$NVSC2024US162195$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241927231$24192723$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003794$ELI LILLY AND CO$$58$YR$A$$Y$$$20240809$$LW$US$US
241927241$24192724$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004208$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241927252$24192725$2$F$20130202$20240919$20240809$20240923$PER$$US-GILEAD-2024-0683535$GILEAD$$25$YR$A$F$Y$$$20240923$$LW$US$US
241927261$24192726$1$I$$20240805$20240809$20240809$EXP$$US-ABBVIE-5870920$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241927271$24192727$1$I$20240101$20240729$20240809$20240809$PER$$US-APOTEX-2024AP008984$APOTEX$$$$$F$Y$$$20240809$$CN$US$US
241927281$24192728$1$I$20240701$20240731$20240809$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-038761$AUROBINDO$$$$$M$Y$$$20240809$$MD$GB$GB
241927292$24192729$2$F$20240805$20240805$20240809$20240814$PER$$US-AMGEN-USASP2024155691$AMGEN$$77$YR$E$M$Y$$$20240814$$CN$US$US
241927301$24192730$1$I$20240101$20240806$20240809$20240809$EXP$CH-SM-2024-14335$CH-JNJFOC-20240822536$JOHNSON AND JOHNSON$$82$YR$E$F$Y$73$KG$20240809$$MD$CH$CH
241927312$24192731$2$F$$20240816$20240809$20240830$EXP$$PT-AUROBINDO-AUR-APL-2024-038400$AUROBINDO$Brito-Santana L, Medinas RL, Neves A, Gago J. Steroid-induced psychosis: a spectrum of neuropsychiatric glucocorticoid side effects. BMJ case reports. 2024;17(7):e259134, 1-5$5$DEC$$M$Y$$$20240830$$MD$PT$PT
241927321$24192732$1$I$$20240805$20240809$20240809$EXP$$US-ABBVIE-5868775$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241927331$24192733$1$I$20240705$20240726$20240809$20240809$EXP$$CN-ROCHE-10000040287$ROCHE$$69$YR$E$M$Y$$$20240809$$HP$CN$CN
241927341$24192734$1$I$$20240807$20240809$20240809$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-108318$REGENERON$$$$$$Y$$$20240809$$MD$US$US
241927361$24192736$1$I$20240722$20240806$20240809$20240809$EXP$$US-ABBVIE-5870462$ABBVIE$$35$YR$$M$Y$$$20240809$$CN$US$US
241927381$24192738$1$I$20170101$20211216$20240809$20240809$EXP$$US-AstraZeneca-2021A882531$ASTRAZENECA$$76$YR$$F$Y$$$20240809$$CN$US$
241927391$24192739$1$I$20240412$20240806$20240809$20240809$EXP$DK-DKMA-30735612$DK-HALEON-2190724$Haleon PLC$$84$YR$$F$Y$95$KG$20240809$$MD$DK$DK
241927401$24192740$1$I$$20240726$20240809$20240809$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01383$AVADEL CNS PHARMA$$$$$F$Y$$$20240809$$CN$US$US
241927412$24192741$2$F$$20240826$20240809$20240829$EXP$$UY-ROCHE-10000050081$ROCHE$$$$A$$Y$$$20240829$$MD$UY$UY
241927421$24192742$1$I$$20240729$20240809$20240809$EXP$$FR-ROCHE-10000045193$ROCHE$Lamy D, Mouillota P, Marietb A, Barnesteina R, Quilota F, Fraisse C, et al. Real-world comparison of chemo-immunotherapy and chemotherapy alone in the treatment of extensive-stage small-cell lung cancer. Respiratory Medicine and Research. 2024-Nov;86:1-7. doi:10.1016/j.resmer.2024.101125.$$$$$Y$$$20240809$$HP$FR$FR
241927431$24192743$1$I$$20240808$20240809$20240809$PER$$NVSC2024US162197$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241927441$24192744$1$I$$20240731$20240809$20240809$EXP$$US-GSK-US2024095812$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$MD$US$US
241927451$24192745$1$I$$20240731$20240809$20240809$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02849$AMNEAL$Jones A.A, Martin J.S, Giangiacomo A.L, Costakos D.M.. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. Am J Ophthalmol Case Rep. 2024;36$12$WK$$M$Y$0.549$KG$20240809$$HP$US$US
241927472$24192747$2$F$$20240904$20240809$20240909$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-14983$IPSEN$$$$$F$Y$$$20240909$$CN$GB$GB
241927492$24192749$2$F$20230726$20240829$20240809$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US071537$SANDOZ$$6$YR$$F$Y$14$KG$20240902$$CN$US$US
241927511$24192751$1$I$20240805$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157799$AMGEN$$31$YR$A$F$Y$$$20240809$$CN$US$US
241927521$24192752$1$I$$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024156977$AMGEN$$$$A$F$Y$$$20240809$$PH$US$US
241927531$24192753$1$I$$20240806$20240809$20240809$EXP$$JP-ABBVIE-5870742$ABBVIE$$$$$M$Y$$$20240809$$MD$JP$JP
241927542$24192754$2$F$20240101$20240828$20240809$20240911$PER$$US-APOTEX-2024AP008985$APOTEX$$$$$M$Y$$$20240911$$CN$US$US
241927551$24192755$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125812$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240809$$CN$US$US
241927562$24192756$2$F$20240101$20240909$20240809$20240918$PER$$US-UNITED THERAPEUTICS-UNT-2024-024181$UNITED THERAPEUTICS$$$$$M$Y$97.506$KG$20240918$$$US$US
241927571$24192757$1$I$$20240430$20240809$20240809$PER$$US-ROCHE-10000051554$ROCHE$$$$$$Y$$$20240809$$CN$US$US
241927581$24192758$1$I$20240701$20240805$20240809$20240809$EXP$$CA-JNJFOC-20240815548$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240809$$HP$CA$CA
241927591$24192759$1$I$20240805$20240805$20240809$20240809$PER$$US-JNJFOC-20240811699$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$HP$US$US
241927601$24192760$1$I$20240101$20240807$20240809$20240809$EXP$$AR-JNJFOC-20240821493$JOHNSON AND JOHNSON$$55$YR$A$F$Y$70$KG$20240809$$CN$AR$AR
241927611$24192761$1$I$$20240802$20240809$20240809$EXP$$AU-JNJFOC-20240814017$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$MD$AU$AU
241927621$24192762$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A177181$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241927631$24192763$1$I$$20210521$20240809$20240809$EXP$$AU-AstraZeneca-2021A026663$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$AU$
241927645$24192764$5$F$20240101$20240916$20240809$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-023992$UNITED THERAPEUTICS$$$$$M$Y$54.422$KG$20240921$$$US$US
241927651$24192765$1$I$$20220506$20240809$20240809$EXP$$US-AstraZeneca-2022A128031$ASTRAZENECA$$$$$F$Y$$$20240809$$HP$US$
241927661$24192766$1$I$20201118$20220310$20240809$20240809$EXP$$FR-AstraZeneca-2021A008687$ASTRAZENECA$$25762$DY$$F$Y$$$20240809$$HP$FR$
241927672$24192767$2$F$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683536$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241927681$24192768$1$I$$20221205$20240809$20240809$EXP$$AU-AstraZeneca-2022A402940$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$AU$
241927691$24192769$1$I$$20240802$20240809$20240809$PER$$US-ABBVIE-5867213$ABBVIE$$$$$F$Y$$$20240809$$MD$US$US
241927711$24192771$1$I$$20240726$20240809$20240809$EXP$$US-QUAGEN-2024QUALIT00232$QUAGEN PHARMACEUTICALS$B Van Noord.A Case of Delayed and Immediate Hypersensitivity Reactions Induced by Corticosteroids.Dermatitis.JAN-2024;35:191-192$71$YR$E$M$Y$$$20240809$$HP$US$US
241927721$24192772$1$I$$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125220$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$71.67$KG$20240809$$CN$US$US
241927732$24192773$2$F$20240808$20240903$20240809$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125206$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240909$$CN$US$US
241927744$24192774$4$F$20240813$20240912$20240809$20240925$EXP$$US-UCBSA-2024040026$UCB$$67$YR$$F$Y$$$20240926$$CN$US$US
241927751$24192775$1$I$20230823$20240729$20240809$20240809$EXP$$CO-UCBSA-2024039471$UCB$$85$YR$$F$Y$$$20240809$$CN$CO$CO
241927762$24192776$2$F$20240726$20240812$20240809$20240817$EXP$$CO-AMGEN-COLSL2024152150$AMGEN$$21$YR$A$F$Y$$$20240817$$MD$CO$CO
241927772$24192777$2$F$20230701$20240729$20240809$20240830$EXP$$US-ROCHE-3393365$ROCHE$$47$YR$A$M$Y$$$20240830$$MD$US$US
241927783$24192778$3$F$20220101$20240913$20240809$20240914$EXP$$JP-ABBVIE-5872458$ABBVIE$Irita H, Sonobe S. A case of death due to prolonged bone marrow failure after chemotherapy for multiple myeloma and acute myeloid leukemia. Journal of the Medical Society of Toho University/The 77th Annual Meeting of the Medical Society of Toho University (2023). 2024;71(2):91.; Irita H, Sonobe S. 20. A case of death due to prolonged bone marrow failure after chemotherapy for multiple myeloma and acute myeloid leukemia. Journal of the Medical Society of Toho University/The 77th Annual Meeting...$$$$$Y$$$20240914$$MD$JP$JP
241927791$24192779$1$I$$20240730$20240809$20240809$30DAY$$US-GSK-US2024095404$GLAXOSMITHKLINE$$63$YR$$M$Y$$$20240809$$CN$US$US
241927801$24192780$1$I$$20240808$20240809$20240809$PER$$NVSC2024US162199$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241927811$24192781$1$I$$20240726$20240809$20240809$PER$$US-TEVA-VS-3227169$TEVA$$20$YR$$F$Y$$$20240809$$PH$US$US
241927821$24192782$1$I$20231001$20240806$20240809$20240809$EXP$$US-ABBVIE-5870622$ABBVIE$$47$YR$$$Y$$$20240809$$CN$US$US
241927831$24192783$1$I$20240712$20240806$20240809$20240809$EXP$$US-ABBVIE-5871036$ABBVIE$$59$YR$$M$Y$$$20240809$$CN$US$US
241927841$24192784$1$I$20240727$20240802$20240809$20240809$EXP$$JP-VANTIVE-2024VAN018722$Vantive US Healthcare$$70$YR$$M$Y$$$20240809$$MD$JP$JP
241927851$24192785$1$I$20240515$20240807$20240809$20240809$EXP$$US-ABBVIE-5871892$ABBVIE$$65$YR$$F$Y$$$20240809$$CN$US$US
241927861$24192786$1$I$20240807$20240807$20240809$20240809$EXP$$AU-ABBVIE-5872299$ABBVIE$$74$YR$$F$Y$$$20240809$$CN$AU$AU
241927871$24192787$1$I$$20240731$20240809$20240809$EXP$$PL-AUROBINDO-AUR-APL-2024-039205$AUROBINDO$$92$YR$$F$Y$40$KG$20240809$$MD$PL$PL
241927882$24192788$2$F$$20240827$20240809$20240912$PER$$US-APOTEX-2024AP008986$APOTEX$$$$$$Y$$$20240912$$CN$US$US
241927891$24192789$1$I$$20240726$20240809$20240809$EXP$$CA-QUAGEN-2024QUALIT00233$QUAGEN PHARMACEUTICALS$H Wu.Serotonin Syndrome and Catatonia in the Absence of a Serotonergic Agent Following Abrupt Withdrawal of Clozapine.Canadian Journal of Hospital Pharmacy.JAN-2024;77$47$YR$A$M$Y$$$20240809$$HP$CA$CA
241927901$24192790$1$I$20210721$20240806$20240809$20240809$EXP$$US-ABBVIE-5870795$ABBVIE$$50$YR$$F$Y$$$20240809$$CN$US$US
241927911$24192791$1$I$20240717$20240806$20240809$20240809$EXP$$US-ABBVIE-5871025$ABBVIE$$59$YR$$F$Y$$$20240809$$CN$US$US
241927923$24192792$3$F$$20240902$20240809$20240905$EXP$$FR-AMGEN-FRASP2024155219$AMGEN$$$$$M$Y$$$20240905$$HP$FR$FR
241927931$24192793$1$I$$20240729$20240809$20240809$EXP$$JP-AMGEN-JPNSP2024157114$AMGEN$EP-1080 A case in which drug-induced pneumonia was complicated during neoadjuvant EC therapy in combination with Pegfilgrastim for breast cancer.The 32nd Annual Meeting of the Japanese Breast Cancer Society (11, 12, 13 JUL 20. 447$65$YR$E$F$Y$$$20240809$$MD$JP$JP
241927941$24192794$1$I$$20240731$20240809$20240809$PER$$US-AMGEN-USASP2024152764$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241927951$24192795$1$I$20240101$20240806$20240809$20240809$EXP$$US-ABBVIE-5870667$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241927961$24192796$1$I$20240601$20240802$20240809$20240809$EXP$FR-AFSSAPS-NT2024000953$FR-Merck Healthcare KGaA-2024042004$MERCK KGAA$$$$A$M$Y$$$20240808$$MD$FR$FR
241927971$24192797$1$I$$20240730$20240809$20240809$PER$$US-TEVA-VS-3229411$TEVA$$52$YR$$F$Y$$$20240809$$MD$US$US
241927982$24192798$2$F$$20240911$20240809$20240912$PER$$US-JNJFOC-20240815785$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
241928001$24192800$1$I$$20240731$20240809$20240809$EXP$$PT-AUROBINDO-AUR-APL-2024-039147$AUROBINDO$Araujo M, Santos S, Viana J, Marques S. Metformin-associated lactic acidosis (MALA) - 4-year series at a university hospital. Congresses of the Portuguese Society of Internal Medicine. 2024;212$$$E$$Y$$$20240809$$MD$PT$PT
241928021$24192802$1$I$20240725$20240731$20240809$20240809$EXP$$CN-ROCHE-10000046247$ROCHE$$61$YR$A$F$Y$70$KG$20240809$$HP$CN$CN
241928031$24192803$1$I$20240401$20240731$20240809$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-038963$AUROBINDO$$23$YR$$F$Y$$$20240809$$PH$FR$FR
241928041$24192804$1$I$20240806$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004811$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240809$$CN$US$US
241928051$24192805$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005465$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240809$$CN$US$US
241928061$24192806$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004716$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240809$$CN$US$US
241928071$24192807$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004645$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240809$$CN$US$US
241928081$24192808$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004193$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240809$$CN$US$US
241928091$24192809$1$I$$20240731$20240809$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-039140$AUROBINDO$$34$YR$$F$Y$$$20240809$$MD$FR$FR
241928101$24192810$1$I$20240805$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125641$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240809$$PH$US$US
241928112$24192811$2$F$20240101$20240828$20240809$20240904$EXP$$US-ABBVIE-5870971$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
241928121$24192812$1$I$$20240705$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06973$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241928131$24192813$1$I$20190201$20240801$20240809$20240809$EXP$$US-ABBVIE-5865614$ABBVIE$$43$YR$$F$Y$81$KG$20240809$$MD$US$US
241928141$24192814$1$I$20240717$20240801$20240809$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-039411$AUROBINDO$$81$YR$$F$Y$49$KG$20240809$$PH$FR$FR
241928161$24192816$1$I$20240802$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155656$AMGEN$$79$YR$E$F$Y$$$20240809$$HP$US$US
241928171$24192817$1$I$$20240803$20240809$20240809$EXP$$US-AstraZeneca-2024A176782$ASTRAZENECA$$$$$M$Y$84.4$KG$20240809$$CN$US$
241928181$24192818$1$I$$20220826$20240809$20240809$EXP$$FR-AstraZeneca-2022A301942$ASTRAZENECA$$$$$$Y$$$20240809$$HP$FR$
241928191$24192819$1$I$20190101$20230215$20240809$20240809$EXP$$US-AstraZeneca-2023A039793$ASTRAZENECA$$67$YR$$F$Y$$$20240809$$CN$US$
241928201$24192820$1$I$20220328$20220425$20240809$20240809$EXP$$CA-AstraZeneca-2022A088869$ASTRAZENECA$$26858$DY$$M$Y$$$20240809$$CN$CA$
241928211$24192821$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A177644$ASTRAZENECA$$$$$F$Y$59$KG$20240809$$CN$US$
241928221$24192822$1$I$$20230816$20240809$20240809$EXP$$US-AstraZeneca-2023A187550$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241928231$24192823$1$I$20230101$20230814$20240809$20240809$EXP$$CO-AstraZeneca-2023A187741$ASTRAZENECA$$947$MON$$M$Y$75$KG$20240809$$CN$CO$
241928241$24192824$1$I$20240101$20240802$20240809$20240809$EXP$$FR-AstraZeneca-2024A175755$ASTRAZENECA$$74$YR$$M$Y$$$20240809$$MD$FR$
241928251$24192825$1$I$$20240801$20240809$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-038690$AUROBINDO$$42$YR$$F$Y$$$20240809$$CN$GB$GB
241928261$24192826$1$I$$20240730$20240809$20240809$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095281$VIIV$$$$$M$Y$$$20240809$$CN$US$US
241928271$24192827$1$I$$20240730$20240809$20240809$30DAY$$US-GSK-US2024AMR096951$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$US$US
241928281$24192828$1$I$$20240807$20240809$20240809$EXP$$US-GSK-US2024098638$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240809$$HP$US$US
241928291$24192829$1$I$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683539$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241928303$24192830$3$F$20231201$20240912$20240809$20240916$EXP$$FR-VIIV HEALTHCARE LIMITED-FR2024EME089958$VIIV$$$$$$Y$$$20240916$$MD$FR$FR
241928311$24192831$1$I$$20240801$20240809$20240809$EXP$$CA-CELLTRION INC.-2024CA018706$CELLTRION$$$$$$Y$$$20240809$$CN$CA$CA
241928321$24192832$1$I$20240714$20240806$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125676$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240809$$CN$US$US
241928331$24192833$1$I$$20240625$20240809$20240809$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00904$TARO$$$$$$Y$$$20240809$$CN$US$US
241928341$24192834$1$I$20240510$20240731$20240809$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-039079$AUROBINDO$$53$YR$$M$Y$$$20240809$$PH$FR$FR
241928351$24192835$1$I$$20240726$20240809$20240809$EXP$$US-QUAGEN-2024QUALIT00234$QUAGEN PHARMACEUTICALS$C Siler.Polypharmacy in Older Adults: A Case Study.South Dakota Medicine.MAR-2023;76:124-127$64$YR$A$F$Y$$$20240809$$HP$US$US
241928361$24192836$1$I$$20240730$20240809$20240809$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005676$BIOCON$$$$$$Y$$$20240809$$HP$CA$CA
241928371$24192837$1$I$$20240805$20240809$20240809$EXP$$CR-JNJFOC-20240816788$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240809$$MD$CR$CR
241928381$24192838$1$I$$20231115$20240809$20240809$EXP$$US-MIRUM PHARMACEUTICALS, INC.-2023TVT00770$MIRUM PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241928392$24192839$2$F$$20240801$20240809$20240814$EXP$$IN-ROCHE-10000042592$ROCHE$$38$YR$A$F$Y$$$20240814$$CN$IN$IN
241928401$24192840$1$I$20240718$20240805$20240809$20240809$PER$$US-ABBVIE-5871495$ABBVIE$$41$YR$$F$Y$$$20240809$$HP$US$US
241928411$24192841$1$I$20240720$20240802$20240809$20240809$EXP$$CN-BEIGENE-BGN-2024-012132$BEIGENE$$$$$$Y$$$20240809$$HP$CN$CN
241928421$24192842$1$I$20240101$20240731$20240809$20240809$EXP$$US-RECORDATI-2024006025$RECORDATI$$$$$$Y$$$20240809$$CN$US$US
241928441$24192844$1$I$$20240708$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06994$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241928451$24192845$1$I$$20240801$20240809$20240809$EXP$$PT-AUROBINDO-AUR-APL-2024-039521$AUROBINDO$Monterio IDA, Silva AM, Silva S, Silverio B, Lopes ARA, Miranda LO, et al.. Sdrife - uma rea??o at?pica a antibioterapia. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI.. 2024;1403$88$YR$$M$Y$$$20240809$$MD$PT$PT
241928461$24192846$1$I$$20240710$20240809$20240809$30DAY$$US-VEROBIOTECH-2024USVEROSPO00166$VERO BIOTECH$$$$$$Y$$$20240809$$HP$US$US
241928471$24192847$1$I$$20240802$20240809$20240809$EXP$$CA-ABBVIE-5871515$ABBVIE$$$$A$M$Y$$$20240809$$CN$CA$CA
241928481$24192848$1$I$20240729$20240807$20240809$20240809$EXP$$CN-ABBVIE-5870749$ABBVIE$$50$YR$$F$Y$41$KG$20240809$$MD$CN$CN
241928491$24192849$1$I$$20240730$20240809$20240809$EXP$$HR-TEVA-VS-3229023$TEVA$$$$$F$Y$$$20240809$$MD$HR$HR
241928501$24192850$1$I$$20240731$20240809$20240809$PER$$US-APOTEX-2024AP009096$APOTEX$Sheth S, Matthia E, Naik D.. Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer. Journal of Clinical Lipidology. 2024;18 (suppl 4):e555-e556$57$YR$$F$Y$$$20240809$$HP$US$US
241928511$24192851$1$I$$20240806$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125008$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$66.8$KG$20240809$$PH$US$US
241928521$24192852$1$I$$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125968$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240809$$HP$US$US
241928531$24192853$1$I$20240721$20240807$20240809$20240809$EXP$$US-ABBVIE-5871977$ABBVIE$$49$YR$$F$Y$$$20240809$$HP$US$US
241928541$24192854$1$I$20240727$20240807$20240809$20240809$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-125777$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$95$KG$20240809$$MD$DE$DE
241928551$24192855$1$I$20240726$20240802$20240809$20240809$EXP$$CN-BEIGENE-BGN-2024-012109$BEIGENE$$$$$$Y$$$20240809$$HP$CN$CN
241928561$24192856$1$I$20240807$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157790$AMGEN$$78$YR$E$M$Y$$$20240809$$CN$US$US
241928571$24192857$1$I$20240101$20240731$20240809$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021838$UNITED THERAPEUTICS$$$$$M$Y$93.424$KG$20240809$$$US$US
241928581$24192858$1$I$20240214$20240808$20240809$20240809$PER$$NVSC2024US162179$NOVARTIS$$$$$$Y$$$20240809$$MD$US$US
241928591$24192859$1$I$$20240731$20240809$20240809$EXP$$PT-AUROBINDO-AUR-APL-2024-038928$AUROBINDO$Araujo M, Santos S, Viana J, Marques S. Metformin-associated lactic acidosis (MALA) - 4-year series at a university hospital. Congresses of the Portuguese Society of Internal Medicine. 2024;212$$$E$$Y$$$20240809$$MD$PT$PT
241928601$24192860$1$I$$20240807$20240809$20240809$EXP$$US-ABBVIE-5872332$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241928611$24192861$1$I$$20240725$20240809$20240809$PER$$US-EPICPHARMA-US-2024EPCSPO00926$EPIC PHARM$$$$$F$Y$$$20240809$$CN$US$US
241928621$24192862$1$I$$20240710$20240809$20240809$30DAY$$US-VEROBIOTECH-2024USVEROSPO00167$VERO BIOTECH$$$$$$Y$$$20240809$$HP$US$US
241928633$24192863$3$F$$20240912$20240809$20240912$PER$$US-ALXN-202408USA000233US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
241928641$24192864$1$I$$20240730$20240809$20240809$EXP$$US-JNJFOC-20240801041$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$MD$US$US
241928651$24192865$1$I$20240712$20240805$20240809$20240809$EXP$$US-ROCHE-10000049654$ROCHE$$59$YR$A$F$Y$$$20240809$$CN$US$US
241928661$24192866$1$I$$20240801$20240809$20240809$PER$$US-JNJFOC-20240815809$JOHNSON AND JOHNSON$$$$E$M$Y$68.2$KG$20240809$$MD$US$US
241928672$24192867$2$F$20240101$20240906$20240809$20240912$EXP$$JP-JNJFOC-20240819575$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240913$$PH$JP$JP
241928682$24192868$2$F$$20240917$20240809$20240918$EXP$$US-AstraZeneca-2024A176691$ASTRAZENECA$$60$YR$$M$Y$$$20240918$$CN$US$
241928691$24192869$1$I$20240805$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024156497$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241928702$24192870$2$F$20240803$20240814$20240809$20240816$PER$$US-AMGEN-USASP2024155294$AMGEN$$$$$F$Y$$$20240816$$CN$US$US
241928711$24192871$1$I$20240807$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157446$AMGEN$$71$YR$E$M$Y$$$20240809$$CN$US$US
241928721$24192872$1$I$$20240802$20240809$20240809$EXP$$IE-AstraZeneca-2024A176444$ASTRAZENECA$$$$$M$Y$$$20240809$$HP$IE$
241928732$24192873$2$F$$20240918$20240809$20240927$EXP$$DE-TEVA-VS-3228861$TEVA$$19$YR$$F$Y$$$20240927$$MD$DE$DE
241928741$24192874$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A177074$ASTRAZENECA$$$$$$Y$$$20240809$$MD$US$
241928751$24192875$1$I$$20240806$20240809$20240809$EXP$$US-AstraZeneca-2024A179201$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241928761$24192876$1$I$20130101$20240806$20240809$20240809$EXP$$PH-AstraZeneca-2024A178625$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$PH$
241928771$24192877$1$I$$20240730$20240809$20240809$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005660$BIOCON$$$$$$Y$$$20240809$$HP$CA$CA
241928782$24192878$2$F$$20240904$20240809$20240910$EXP$$JP-GSK-JP2024JPN097207$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$PH$JP$JP
241928791$24192879$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004836$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240809$$CN$US$US
241928801$24192880$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004831$ELI LILLY AND CO$$$$$M$Y$$$20240809$$CN$US$US
241928811$24192881$1$I$$20240804$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002903$ELI LILLY AND CO$$42$YR$A$$Y$$$20240809$$LW$US$US
241928821$24192882$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004128$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241928831$24192883$1$I$20240601$20240729$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004202$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240809$$HP$US$US
241928841$24192884$1$I$20240401$20240807$20240809$20240809$EXP$$US-UCBSA-2024039973$UCB$$82$YR$$F$Y$$$20240809$$CN$US$US
241928854$24192885$4$F$20180101$20240920$20240809$20240923$EXP$$US-GILEAD-2024-0683609$GILEAD$$58$YR$A$F$Y$$$20240923$$LW$US$US
241928861$24192886$1$I$20240718$20240802$20240809$20240809$EXP$$CN-ALCON LABORATORIES-ALC2024CN003693$ALCON$$62$YR$$F$Y$45$KG$20240809$$HP$CN$CN
241928871$24192887$1$I$$20240807$20240809$20240809$PER$$US-ROCHE-10000052001$ROCHE$$$$$F$Y$$$20240809$$CN$US$US
241928881$24192888$1$I$$20240726$20240809$20240809$EXP$$US-UCBSA-2024038173$UCB$$$$$F$Y$$$20240809$$HP$US$US
241928891$24192889$1$I$20240701$20240803$20240809$20240809$EXP$$AR-ROCHE-10000051643$ROCHE$$23$YR$A$F$Y$60$KG$20240809$$MD$AR$AR
241928901$24192890$1$I$20240601$20240806$20240809$20240809$EXP$$US-ABBVIE-5870989$ABBVIE$$43$YR$$M$Y$$$20240809$$CN$US$US
241928911$24192891$1$I$$20240710$20240809$20240809$30DAY$$US-VEROBIOTECH-2024USVEROSPO00170$VERO BIOTECH$$$$$$Y$$$20240809$$HP$US$US
241928923$24192892$3$F$20240711$20240910$20240809$20240911$EXP$$CN-JNJFOC-20240784340$JOHNSON AND JOHNSON$$24$YR$A$F$Y$49$KG$20240911$$HP$CN$CN
241928931$24192893$1$I$20240701$20240806$20240809$20240809$EXP$$US-AMGEN-USASL2024156402$AMGEN$$79$YR$E$F$Y$$$20240809$$CN$US$US
241928941$24192894$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5871374$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241928951$24192895$1$I$$20240802$20240809$20240809$EXP$$AU-TOLMAR, INC.-24AU051557$TOLMAR$$$$$M$Y$$$20240809$$CN$AU$AU
241928961$24192896$1$I$$20240802$20240809$20240809$EXP$$NL-TOLMAR, INC.-24NL051533$TOLMAR$$$$$M$Y$$$20240809$$CN$NL$NL
241928971$24192897$1$I$$20240730$20240809$20240809$EXP$$US-TEVA-VS-3228486$TEVA$$$$$$Y$$$20240809$$CN$US$US
241928982$24192898$2$F$20240101$20230920$20240809$20240812$EXP$$CA-CELLTRION INC.-2023CA025540$CELLTRION$$$$$$Y$$$20240812$$MD$CA$CA
241928992$24192899$2$F$20240701$20240809$20240809$20240820$EXP$$US-TOLMAR, INC.-24US051485$TOLMAR$$$$$M$Y$$$20240820$$CN$US$US
241929001$24192900$1$I$$20240726$20240809$20240809$PER$$US-EPICPHARMA-US-2024EPCSPO00937$EPIC PHARM$$$$$F$Y$$$20240809$$CN$US$US
241929011$24192901$1$I$20230719$20240726$20240809$20240809$EXP$GB-MHRA-MED-202407261151270130-JRCGN$GB-GLENMARK PHARMACEUTICALS-2024GMK092899$GLENMARK$$$$$$Y$$$20240809$$MD$GB$GB
241929021$24192902$1$I$$20240806$20240809$20240809$PER$$US-TAKEDA-2024TUS078996$TAKEDA$$$$$F$Y$$$20240809$$CN$US$US
241929034$24192903$4$F$20240701$20240830$20240809$20240909$EXP$$AT-GALDERMA-AT2024012337$GALDERMA$$$$$$Y$$$20240909$$HP$AT$AT
241929041$24192904$1$I$20240701$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125278$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240809$$CN$US$US
241929051$24192905$1$I$20240801$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125573$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$89.36$KG$20240809$$PH$US$US
241929062$24192906$2$F$20240711$20240828$20240809$20240902$EXP$$JP-009507513-2408JPN000812J$MERCK$$79$YR$$F$Y$$$20240902$$MD$JP$JP
241929071$24192907$1$I$20240708$20240805$20240809$20240809$EXP$$CA-JNJFOC-20240767283$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240809$$HP$CA$CA
241929081$24192908$1$I$$20240807$20240809$20240809$PER$$US-JNJFOC-20240818073$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$CN$US$US
241929091$24192909$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157807$AMGEN$$$$$$Y$$$20240809$$HP$US$US
241929102$24192910$2$F$$20240827$20240809$20240828$PER$$US-ALXN-202408USA000214US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241929111$24192911$1$I$$20240708$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06985$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241929121$24192912$1$I$20171227$20240806$20240809$20240809$EXP$$CA-TAKEDA-2017TUS024752$TAKEDA$$42$YR$$F$Y$$$20240809$$CN$CA$CA
241929131$24192913$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000051985$ROCHE$$40$YR$A$F$Y$$$20240809$$MD$US$US
241929141$24192914$1$I$$20240731$20240809$20240809$EXP$$GB-GALDERMA-GB2024012294$GALDERMA$Jesudason DI, Appalanaidu N, Khan A. Symptomatic bradycardia associated with topical brimonidine gel (Mirvaso) administration: a case report.. European Heart Journal - Case Reports. 2024;8(7):ytae329$$$$$Y$$$20240809$$HP$GB$GB
241929151$24192915$1$I$20240601$20240802$20240809$20240809$EXP$$US-SA-2024SA233208$SANOFI AVENTIS$$98$YR$E$F$Y$$$20240809$$MD$US$US
241929161$24192916$1$I$20190222$20240806$20240809$20240809$EXP$$CA-TAKEDA-2023TUS017495$TAKEDA$$62$YR$$F$Y$$$20240809$$MD$CA$CA
241929171$24192917$1$I$20200207$20240805$20240809$20240809$EXP$$US-TAKEDA-US202008559$TAKEDA$$57$YR$$F$Y$145$KG$20240809$$MD$US$US
241929181$24192918$1$I$20240723$20240802$20240809$20240809$EXP$$SG-SA-2024SA233768$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240809$$HP$SG$SG
241929191$24192919$1$I$$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024156515$AMGEN$$$$$F$Y$$$20240809$$PH$US$US
241929201$24192920$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157256$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241929211$24192921$1$I$$20240806$20240809$20240809$EXP$$US-AMGEN-USASL2024156378$AMGEN$$62$YR$A$M$Y$$$20240809$$CN$US$US
241929222$24192922$2$F$$20240808$20240809$20240814$EXP$$BR-AMGEN-BRASP2024154588$AMGEN$$61$YR$A$$Y$$$20240814$$PH$BR$BR
241929241$24192924$1$I$$20240805$20240809$20240809$EXP$$JP-GILEAD-2024-0683172$GILEAD$Yamamoto T, Hamada K, Kawachi H, Yamoto M, Fukao A, Sakamori Y, et al.. 3 A case of an immunocompromised patient suspected of having aggravation due to COVID-19 relapse during treatment of post-COVID-19 organising pneumonia. The 132nd Kinki Branch Mtg of the Jap Society for TB and Non-TB Mycobacteriosis. 2024;unk:53$5$DEC$A$F$Y$$$20240809$$MD$JP$JP
241929251$24192925$1$I$$20240731$20240809$20240809$PER$$US-APOTEX-2024AP009099$APOTEX$Gianos E. Donahoe S. Davila C. Bimal T.. A Patient who is Nonresponsive to PSCK9 Inhibition by both mAb and RNAi. Journal of Clinical Lipidology. 2024;18:4:e507$68$YR$$F$Y$$$20240809$$HP$US$US
241929261$24192926$1$I$$20230530$20240809$20240809$EXP$$US-AstraZeneca-2023A126121$ASTRAZENECA$$30516$DY$$F$Y$$$20240809$$CN$US$
241929271$24192927$1$I$20240101$20240807$20240809$20240809$EXP$$JP-AstraZeneca-2024A179758$ASTRAZENECA$$60$YR$$M$Y$$$20240809$$MD$JP$
241929281$24192928$1$I$$20240801$20240809$20240809$EXP$$CA-AstraZeneca-2024A177033$ASTRAZENECA$$$$$F$Y$$$20240809$$HP$CA$
241929291$24192929$1$I$$20230201$20240809$20240809$EXP$$US-AstraZeneca-2023A028194$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241929302$24192930$2$F$$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A176875$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241929311$24192931$1$I$$20240109$20240809$20240809$EXP$$US-AstraZeneca-2023A270663$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241929321$24192932$1$I$$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A176291$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241929331$24192933$1$I$$20221207$20240809$20240809$EXP$$US-AstraZeneca-2022A403164$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241929351$24192935$1$I$20240101$20240723$20240809$20240809$PER$$US-TEVA-VS-3226119$TEVA$$$$$$Y$$$20240809$$CN$US$US
241929361$24192936$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A177917$ASTRAZENECA$$$$$F$Y$102.1$KG$20240809$$CN$US$
241929372$24192937$2$F$20240726$20240730$20240809$20240813$PER$$NVSC2024US161785$NOVARTIS$$64$YR$$M$Y$$$20240813$$CN$US$US
241929381$24192938$1$I$$20240804$20240809$20240809$PER$$NVSC2024US159535$NOVARTIS$$41$YR$$F$Y$77.1$KG$20240809$$CN$US$US
241929392$24192939$2$F$20230101$20240809$20240809$20240813$EXP$$NVSC2023PE273023$NOVARTIS$$$$$F$Y$$$20240813$$CN$PE$PE
241929401$24192940$1$I$$20240802$20240809$20240809$EXP$$US-GSK-US2024096956$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$US$US
241929411$24192941$1$I$20240101$20240807$20240809$20240809$EXP$$US-ABBVIE-5871957$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241929421$24192942$1$I$$20240710$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07013$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241929431$24192943$1$I$20240715$20240715$20240809$20240809$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000629$PAREXEL$$$$$$Y$$$20240809$$PH$US$US
241929441$24192944$1$I$20240701$20240805$20240809$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-023841$UNITED THERAPEUTICS$$50$YR$$F$Y$72.562$KG$20240809$$$US$US
241929451$24192945$1$I$$20240807$20240809$20240809$PER$$NVSC2024US162192$NOVARTIS$$$$$$Y$$$20240809$$MD$US$US
241929461$24192946$1$I$$20240802$20240809$20240809$EXP$$US-009507513-2408USA000565$MERCK$$$$E$F$Y$$$20240809$$MD$US$US
241929472$24192947$2$F$20230101$20240805$20240809$20240904$EXP$$US-ROCHE-10000049461$ROCHE$$66$YR$E$M$Y$109.77$KG$20240904$$CN$US$US
241929482$24192948$2$F$$20240808$20240809$20240816$EXP$$BD-Vifor (International) Inc.-VIT-2024-06938$VIFOR$$73$YR$$F$Y$$$20240816$$CN$BD$BD
241929491$24192949$1$I$$20240802$20240809$20240809$EXP$$IE-JNJFOC-20240808034$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$MD$IE$IE
241929502$24192950$2$F$20240805$20240812$20240809$20240816$PER$$US-AMGEN-USASP2024157017$AMGEN$$21$YR$A$F$Y$$$20240816$$CN$US$US
241929522$24192952$2$F$20240701$20240826$20240809$20240902$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044282$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240902$$CN$US$US
241929532$24192953$2$F$20240101$20240820$20240809$20240828$EXP$$CA-Vifor (International) Inc.-VIT-2024-06974$VIFOR$$91$YR$$F$Y$$$20240828$$CN$CA$CA
241929541$24192954$1$I$20240606$20240806$20240809$20240809$EXP$IT-MINISAL02-997272$IT-AMGEN-ITASP2024156230$AMGEN$$48$YR$A$M$Y$85$KG$20240809$$PH$IT$IT
241929552$24192955$2$F$$20240910$20240809$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202408004664$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240915$$CN$US$US
241929561$24192956$1$I$$20240801$20240809$20240809$EXP$$GB-AMGEN-GBRSP2024153293$AMGEN$$75$YR$E$$Y$$$20240809$$PH$GB$GB
241929571$24192957$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003968$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240809$$CN$US$US
241929581$24192958$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005058$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240809$$CN$US$US
241929591$24192959$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004809$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240809$$MD$US$US
241929601$24192960$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005159$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240809$$HP$US$US
241929611$24192961$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004706$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240809$$CN$US$US
241929622$24192962$2$F$$20240827$20240809$20240828$PER$$US-ALXN-202408USA000220US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241929631$24192963$1$I$20240701$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004295$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240809$$CN$US$US
241929641$24192964$1$I$$20240803$20240809$20240809$EXP$$NVSC2024US159384$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
241929651$24192965$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5864338$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241929661$24192966$1$I$20200301$20240730$20240809$20240809$EXP$FR-AFSSAPS-PC2024000587$FR-TEVA-VS-3227973$TEVA$$32$YR$$M$Y$81$KG$20240809$$PH$FR$FR
241929671$24192967$1$I$$20240801$20240809$20240809$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001570$BLUEPRINT MEDICINES$$$$$F$Y$$$20240809$$CN$US$US
241929681$24192968$1$I$20240101$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157489$AMGEN$$80$YR$E$M$Y$$$20240809$$MD$US$US
241929691$24192969$1$I$20200801$20240802$20240809$20240809$EXP$$US-CHIESI-2024CHF04834$CHIESI$$34$YR$$F$Y$$$20240809$$MD$US$US
241929701$24192970$1$I$20240101$20240802$20240809$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-009610$UNITED THERAPEUTICS$$$$$M$Y$94.331$KG$20240809$$$US$US
241929721$24192972$1$I$$20240806$20240809$20240809$EXP$$NVSC2024DE161771$NOVARTIS$$$$$F$Y$$$20240809$$MD$DE$DE
241929731$24192973$1$I$$20240802$20240809$20240809$EXP$$GB-CELLTRION INC.-2024GB018785$CELLTRION$$$$$$Y$$$20240809$$CN$GB$GB
241929741$24192974$1$I$20240802$20240805$20240809$20240809$PER$$US-ROCHE-10000049425$ROCHE$$$$$$Y$$$20240809$$HP$US$US
241929751$24192975$1$I$$20240807$20240809$20240809$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044702$BOEHRINGER INGELHEIM$$$$$$Y$$$20240809$$CN$US$US
241929761$24192976$1$I$$20240730$20240809$20240809$EXP$$CA-TEVA-VS-3227529$TEVA$$85$YR$$F$Y$$$20240809$$HP$CA$CA
241929772$24192977$2$F$$20240802$20240809$20240814$EXP$$US-GSK-US2024AMR098233$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$US$US
241929781$24192978$1$I$$20240806$20240809$20240809$EXP$$US-ROCHE-10000051676$ROCHE$$64$YR$A$F$Y$$$20240809$$MD$US$US
241929791$24192979$1$I$20240201$20240729$20240809$20240809$EXP$FR-AFSSAPS-GR2024000939$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110569$ZYDUS PHARM$$$$$$Y$$$20240809$$PH$FR$FR
241929801$24192980$1$I$20230419$20240729$20240809$20240809$EXP$FR-AFSSAPS-AM2024000595$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110639$ZYDUS PHARM$$$$$$Y$$$20240809$$MD$FR$FR
241929811$24192981$1$I$20231025$20240729$20240809$20240809$EXP$FR-AFSSAPS-DJ2024000861$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110570$ZYDUS PHARM$$$$$$Y$$$20240809$$MD$FR$FR
241929823$24192982$3$F$20240729$20240904$20240809$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125560$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$65$KG$20240911$$PH$US$US
241929831$24192983$1$I$20230901$20240806$20240809$20240809$EXP$$US-GILEAD-2024-0683310$GILEAD$$62$YR$A$F$Y$$$20240809$$CN$US$US
241929841$24192984$1$I$20240624$20240729$20240809$20240809$EXP$FR-AFSSAPS-TS2024000848$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110533$ZYDUS PHARM$$$$$$Y$$$20240809$$MD$FR$FR
241929851$24192985$1$I$$20240726$20240809$20240809$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-110630$ZYDUS PHARM$Saxena G, Upreti S, Neogi S, Ratan SK.. Iatrogenic Radial Artery injury in a Pediatric Patient on Steroid Medication: Case Report, Management Strategy and Review of Existing Literature.. European Journal of Cardiovascular Medicine. 2024;14(2):79-81$$$$$Y$$$20240809$$MD$IN$IN
241929861$24192986$1$I$$20240726$20240809$20240809$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110494$ZYDUS PHARM$Lapiano K, Roto D.. Case Report: Nelarabine Neurotoxicity Induced Respiratory Failure. Am-J-Respir-Crit-Care-Med. 2024;209:A5696$$$$$Y$$$20240809$$HP$US$US
241929871$24192987$1$I$$20240729$20240809$20240809$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110508$ZYDUS PHARM$Gwiazdowski M, Niraula S, Bewley B.. A Unique Case Presentation of Takotsubo Cardiomyopathy After Cardiac Arrest and Resuscitation Without CPR.. Am-J-Respir-Crit-Care-Med. 2023;207:no pagination$$$$$Y$$$20240809$$HP$US$US
241929881$24192988$1$I$$20240726$20240809$20240809$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110473$ZYDUS PHARM$Alam RM, Espinoza J, Coches K. Steroid Induced Diabetic Ketoacidosis in End Stage Renal Disease with Suspected Vasculitis Induced Stroke. South-Med-J. 2022;115:443-444$$$$$Y$$$20240809$$MD$US$US
241929891$24192989$1$I$$20240726$20240809$20240809$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110623$ZYDUS PHARM$Kretovics E, Keegan K, Burg G, Von Allmen D, Chima R, Benscoter D, et al.. Prolonged High-Dose Steroid Use in an Infant With Surfactant Protein-C Deficiency and Multiple Complications. Am-JRespir- Crit-Care-Med. 2024;209:A2307$$$$$Y$$$20240809$$HP$US$US
241929901$24192990$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191101$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241929911$24192991$1$I$20240807$20240808$20240809$20240809$PER$$US-JNJFOC-20240821140$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240809$$CN$US$US
241929921$24192992$1$I$$20240802$20240809$20240809$EXP$$PK-ROCHE-10000048600$ROCHE$$56$YR$A$F$Y$$$20240809$$CN$PK$PK
241929931$24192993$1$I$20240702$20240801$20240809$20240809$PER$$US-ROCHE-10000047921$ROCHE$$$$E$F$Y$$$20240809$$CN$US$US
241929941$24192994$1$I$$20240729$20240809$20240809$EXP$$IN-ROCHE-10000040998$ROCHE$$36$YR$A$F$Y$$$20240809$$CN$IN$IN
241929951$24192995$1$I$$20230215$20240809$20240809$EXP$$US-AstraZeneca-2023A039516$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241929961$24192996$1$I$$20211216$20240809$20240809$EXP$$US-AstraZeneca-2021A886734$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241929971$24192997$1$I$$20230816$20240809$20240809$EXP$$US-AstraZeneca-2023A189909$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241929981$24192998$1$I$$20230612$20240809$20240809$EXP$$US-AstraZeneca-2023A137031$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241929991$24192999$1$I$$20240731$20240809$20240809$PER$$US-ABBVIE-5863944$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241930001$24193000$1$I$$20220131$20240809$20240809$EXP$$US-AstraZeneca-2021A900251$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241930011$24193001$1$I$20211101$20220617$20240809$20240809$EXP$$US-AstraZeneca-2022A226298$ASTRAZENECA$$742$MON$$F$Y$$$20240809$$CN$US$
241930021$24193002$1$I$$20240806$20240809$20240809$EXP$$US-AstraZeneca-2024A178632$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241930031$24193003$1$I$20240606$20240801$20240809$20240809$EXP$$IT-AUROBINDO-AUR-APL-2024-039443$AUROBINDO$$85$YR$$F$Y$$$20240809$$MD$IT$IT
241930042$24193004$2$F$20240701$20240827$20240809$20240905$EXP$$CA-TEVA-VS-3229145$TEVA$$53$YR$$M$Y$$$20240905$$CN$CA$CA
241930051$24193005$1$I$$20240725$20240809$20240809$PER$$US-TEVA-VS-3226444$TEVA$$76$YR$$F$Y$$$20240809$$CN$US$US
241930061$24193006$1$I$$20240802$20240809$20240809$PER$$US-ALXN-202408USA000163US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241930071$24193007$1$I$$20240807$20240809$20240809$PER$$US-TAKEDA-2024TUS079570$TAKEDA$$$$$M$Y$$$20240809$$CN$US$US
241930081$24193008$1$I$$20240806$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124879$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240809$$CN$US$US
241930091$24193009$1$I$$20240807$20240809$20240809$PER$$US-ROCHE-10000052161$ROCHE$$$$E$F$Y$$$20240809$$CN$US$US
241930101$24193010$1$I$20240101$20240805$20240809$20240809$EXP$$AU-ABBVIE-5871782$ABBVIE$$38$YR$$F$Y$$$20240809$$MD$AU$AU
241930111$24193011$1$I$$20240730$20240809$20240809$EXP$$US-ROCHE-10000052746$ROCHE$$39$YR$A$F$Y$$$20240809$$MD$US$US
241930122$24193012$2$F$$20240807$20240809$20240821$EXP$$US-BEH-2024176787$CSL BEHRING$$37$YR$A$F$Y$58.503$KG$20240821$$CN$US$US
241930131$24193013$1$I$$20240808$20240809$20240809$PER$$US-JNJFOC-20240820729$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240809$$CN$US$US
241930141$24193014$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191148$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241930151$24193015$1$I$$20240805$20240809$20240809$EXP$$JP-GSK-JP2024JPN097628$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$PH$JP$JP
241930161$24193016$1$I$$20240729$20240809$20240809$EXP$815388$AU-LUPIN PHARMACEUTICALS INC.-2024-07585$LUPIN$$$$$$Y$$$20240809$$CN$AU$AU
241930171$24193017$1$I$$20240730$20240809$20240809$30DAY$$US-GSK-US2024095389$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$US$US
241930181$24193018$1$I$$20240730$20240809$20240809$30DAY$$US-GSK-US2024AMR095586$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241930191$24193019$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5864818$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241930201$24193020$1$I$$20240808$20240809$20240809$PER$$US-GILEAD-2024-0683607$GILEAD$$$$A$M$Y$$$20240809$$MD$US$US
241930211$24193021$1$I$$20240806$20240809$20240809$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-107779$REGENERON$$$$$F$Y$$$20240809$$CN$US$US
241930221$24193022$1$I$$20240730$20240809$20240809$EXP$$GB-TEVA-VS-3228278$TEVA$$79$YR$$F$Y$77$KG$20240809$$MD$GB$GB
241930231$24193023$1$I$$20240805$20240809$20240809$PER$$US-ROCHE-10000049527$ROCHE$$$$$$Y$$$20240809$$MD$US$US
241930241$24193024$1$I$$20240730$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407019742$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240809$$CN$US$US
241930251$24193025$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004350$ELI LILLY AND CO$$67$YR$E$$Y$$$20240809$$LW$US$US
241930262$24193026$2$F$$20240912$20240809$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202408005824$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240916$$CN$US$US
241930272$24193027$2$F$$20240809$20240809$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408000375$ELI LILLY AND CO$$50$YR$A$$Y$$$20240816$$LW$US$US
241930281$24193028$1$I$20240801$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004656$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240809$$CN$US$US
241930291$24193029$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004178$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240809$$CN$US$US
241930301$24193030$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005122$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240809$$HP$US$US
241930311$24193031$1$I$$20240801$20240809$20240809$PER$$US-JNJFOC-20240809296$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241930321$24193032$1$I$20200902$20240808$20240809$20240809$PER$$US-AMGEN-USASP2024158214$AMGEN$$74$YR$E$F$Y$$$20240809$$CN$US$US
241930331$24193033$1$I$$20240805$20240809$20240809$EXP$$GB-JNJFOC-20240820688$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240809$$CN$GB$GB
241930341$24193034$1$I$20240730$20240730$20240809$20240809$30DAY$$US-GSK-US2024095417$GLAXOSMITHKLINE$$38$YR$$F$Y$$$20240809$$CN$US$US
241930351$24193035$1$I$$20240712$20240809$20240809$PER$$US-009507513-2407USA009546$MERCK$$$$T$M$Y$$$20240809$$CN$US$US
241930361$24193036$1$I$$20240802$20240809$20240809$EXP$$CA-GSK-CA2024096988$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$HP$CA$CA
241930371$24193037$1$I$20240201$20240728$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024094765$VIIV$$4$DEC$$M$Y$$$20240809$$CN$US$US
241930381$24193038$1$I$20240101$20240807$20240809$20240809$EXP$$CA-UCBSA-2024039964$UCB$$$$$F$Y$$$20240809$$CN$CA$CA
241930391$24193039$1$I$$20240729$20240809$20240809$PER$$US-ABBVIE-5862702$ABBVIE$$$$$M$Y$$$20240809$$MD$US$US
241930403$24193040$3$F$$20240822$20240809$20240828$EXP$$NVSC2024US161264$NOVARTIS$$$$$F$Y$$$20240828$$HP$US$US
241930412$24193041$2$F$$20240827$20240809$20240828$PER$$US-ALXN-202408USA000216US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241930421$24193042$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000050419$ROCHE$$$$$$Y$$$20240809$$CN$US$US
241930432$24193043$2$F$$20240801$20240809$20240809$EXP$$US-ROCHE-10000047398$ROCHE$$$$$F$Y$$$20240809$$CN$US$US
241930441$24193044$1$I$20240513$20240730$20240809$20240809$EXP$FR-AFSSAPS-LY2024000793$FR-TEVA-VS-3228423$TEVA$$89$YR$$M$Y$55$KG$20240809$$PH$FR$FR
241930451$24193045$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000050394$ROCHE$$$$$$Y$$$20240809$$CN$US$US
241930461$24193046$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A176967$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241930471$24193047$1$I$$20230314$20240809$20240809$EXP$$US-AstraZeneca-2023A062174$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241930481$24193048$1$I$$20220620$20240809$20240809$EXP$$US-AstraZeneca-2022A228137$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241930491$24193049$1$I$$20240707$20240809$20240809$PER$$US-WW-2024-e02026P1$WOODWARD PHARMA SERVICES$Price N.B. et al. Chronic paronychia associated with fluconazole use in two pediatric patients with coccidioidomycosis. IDCases. 2024. DOI: https://doi.org/10.1016/j.idcr.2024.e02026$13$YR$$M$Y$$$20240809$$MD$US$US
241930501$24193050$1$I$$20220525$20240809$20240809$EXP$$US-AstraZeneca-2022A200845$ASTRAZENECA$$$$$F$Y$$$20240809$$HP$US$
241930511$24193051$1$I$$20240801$20240809$20240809$EXP$$ZA-AstraZeneca-2024A175463$ASTRAZENECA$$18993$DY$$F$Y$$$20240809$$CN$ZA$
241930521$24193052$1$I$$20240805$20240809$20240809$EXP$$US-JNJFOC-20240812534$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$CN$US$US
241930531$24193053$1$I$20240411$20240802$20240809$20240809$EXP$$GB-AstraZeneca-2024A175970$ASTRAZENECA$$43$YR$$F$Y$44$KG$20240809$$MD$GB$
241930541$24193054$1$I$$20240805$20240809$20240809$PER$$US-JNJFOC-20240815843$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$HP$US$US
241930551$24193055$1$I$20240623$20240731$20240809$20240809$EXP$$ZA-Vifor (International) Inc.-VIT-2024-06883$VIFOR$$44$YR$$M$Y$$$20240809$$HP$ZA$ZA
241930561$24193056$1$I$$20240729$20240809$20240809$EXP$$JP-ROCHE-10000048790$ROCHE$Mamori T, Tsukioki T, Mimata A, Nakamoto S, Iwatani Y, Takahashi Y. EP-1210 Study of two cases of serious drug-induced cardiac failure which required long-term hospitalisation treatment. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;480.$53$YR$A$F$Y$$$20240809$$MD$JP$JP
241930571$24193057$1$I$$20240729$20240809$20240809$EXP$$JP-ROCHE-10000048791$ROCHE$Okada K,  EP-1250 A case of foreign body granuloma that occurred after breast cancer surgery and required differentiation from breast implant-associated anaplastic large cell lymphoma. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;490.$49$YR$A$F$Y$$$20240809$$MD$JP$JP
241930591$24193059$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000050636$ROCHE$$78$YR$E$F$Y$$$20240809$$CN$US$US
241930601$24193060$1$I$$20240805$20240809$20240809$PER$$US-ABBVIE-5872893$ABBVIE$$$$A$M$Y$$$20240809$$CN$US$US
241930611$24193061$1$I$$20240729$20240809$20240809$EXP$$IT-AUROBINDO-AUR-APL-2024-038944$AUROBINDO$Tolino E, Proietti I, Skroza N, Di Guardo A, Di Fraia M, Dybala A, et al.. Atopic Dermatitis Onset in a Melanoma Patient Under Pembrolizumab Therapy: A Case of Successful Treatment with Dupilumab. Indian-J-Dermatol. 2024;69(3):268-269$82$YR$$M$Y$$$20240809$$HP$IT$IT
241930621$24193062$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000051094$ROCHE$$46$YR$A$M$Y$$$20240809$$MD$US$US
241930631$24193063$1$I$$20240807$20240809$20240809$EXP$$CA-UCBSA-2024039969$UCB$$$$$M$Y$$$20240809$$CN$CA$CA
241930641$24193064$1$I$$20240729$20240809$20240809$EXP$DE-SEATTLE GENETICS-2024SGN00172$DE-ROCHE-10000048404$ROCHE$$34$YR$A$F$Y$$$20240809$$MD$DE$DE
241930651$24193065$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5865101$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241930661$24193066$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000051007$ROCHE$$$$A$F$Y$$$20240809$$CN$US$US
241930672$24193067$2$F$$20240820$20240809$20240828$EXP$$AT-UNITED THERAPEUTICS-UNT-2024-023823$UNITED THERAPEUTICS$$42$YR$$$Y$75$KG$20240828$$$AT$AT
241930681$24193068$1$I$$20240729$20240809$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-039100$AUROBINDO$Simpson T, Aljareh A, Shah U, Yoon S, Petrovic Elbaz M, Khan Z, et al. Atypical Presentation of Rhinovirus Infection With Rapid Deterioration Requiring Mechanical Ventilation. Am-J-Respir-CritCare-Med. 2023;207:A1369$45$YR$$M$Y$$$20240809$$HP$US$US
241930692$24193069$2$F$20240101$20240813$20240809$20240816$EXP$$CA-UCBSA-2024033651$UCB$$$$$M$Y$$$20240816$$CN$CA$CA
241930701$24193070$1$I$20240101$20240807$20240809$20240809$EXP$$US-ABBVIE-5872570$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241930711$24193071$1$I$$20240801$20240809$20240809$EXP$$GB-ASPEN-GLO2024GB005306$ASPEN$$$$$$Y$$$20240809$$MD$GB$GB
241930722$24193072$2$F$$20240812$20240809$20240821$EXP$$PT-ASPEN-GLO2024PT005356$ASPEN$Carrilho M, Nobre MB, Santos MC, Silva RC, Martins JR.. CO-0062 - (4147) - MYOCARDITIS A CMV .Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts [CNMI].. Infectious and parasitic diseases.. 2024;162$$$$$Y$$$20240821$$HP$PT$PT
241930731$24193073$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5871184$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241930741$24193074$1$I$$20240731$20240809$20240809$EXP$$PT-ASPEN-GLO2024PT005381$ASPEN$Brito-Santana L, Medinas RL, Neves A, Gago J. Steroid-induced psychosis: a spectrum of neuropsychiatric glucocorticoid side effects.. BMJ case reports. 2024;17(7):e259134$$$$$Y$$$20240809$$MD$PT$PT
241930751$24193075$1$I$$20240807$20240809$20240809$PER$$US-JNJFOC-20240820871$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$CN$US$US
241930761$24193076$1$I$$20240727$20240809$20240809$PER$$US-JNJFOC-20240784126$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$CN$US$US
241930771$24193077$1$I$20240101$20240805$20240809$20240809$EXP$$US-ABBVIE-5868447$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241930782$24193078$2$F$$20240802$20240809$20240813$EXP$$TH-ROCHE-10000047550$ROCHE$$69$YR$E$F$Y$$$20240813$$MD$TH$TH
241930791$24193079$1$I$20240701$20240806$20240809$20240809$EXP$$US-ABBVIE-5870575$ABBVIE$$34$YR$$F$Y$$$20240809$$CN$US$US
241930801$24193080$1$I$20240101$20240806$20240809$20240809$EXP$$US-ABBVIE-5870090$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241930812$24193081$2$F$20240101$20240826$20240809$20240904$EXP$$CA-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00817$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240904$$MD$CA$CA
241930821$24193082$1$I$$20240729$20240809$20240809$EXP$$CA-AUROBINDO-AUR-APL-2024-039402$AUROBINDO$Lavigne V, Mitrea I, Usereau M, Viau AM.. Misoprostol et angine vasospastique : une association est-elle  possible? (Misoprostol and vasospastic angina: is a possible combination?). Pharmactuel.. 2023;56(4):140-144.$69$YR$$M$Y$$$20240809$$HP$CA$CA
241930831$24193083$1$I$$20240619$20240809$20240809$PER$$US-AMGEN-USASP2024157413$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241930841$24193084$1$I$$20240729$20240809$20240809$EXP$$GB-NOVAST LABORATORIES INC.-2024NOV000285$NOVAST$Fadden EJ, Longley C, Mahambrey T.. Metformin-associated lactic acidosis. BMJ Case Rep. 2021;14$58$YR$$F$Y$$$20240809$$MD$GB$GB
241930851$24193085$1$I$$20240729$20240809$20240809$EXP$$SE-NOVAST LABORATORIES INC.-2024NOV000287$NOVAST$Johansson EK, Krynitz B, Holmsten M, Klockhoff K, Isaksson Friman E, Xie H.. Severe Photo Toxicity Recalled by Docetaxel. Case Rep Oncol. 2018;11:751-755$56$YR$$F$Y$$$20240809$$HP$SE$SE
241930861$24193086$1$I$20240701$20240806$20240809$20240809$EXP$$US-ABBVIE-5871308$ABBVIE$$61$YR$$F$Y$$$20240809$$CN$US$US
241930871$24193087$1$I$20240719$20240805$20240809$20240809$EXP$$NVSC2024CO012776$NOVARTIS$$56$YR$$M$Y$74$KG$20240809$$CN$CO$CO
241930881$24193088$1$I$20240720$20240729$20240809$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-038153$AUROBINDO$$47$YR$$F$Y$75$KG$20240809$$MD$GB$GB
241930891$24193089$1$I$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683613$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241930912$24193091$2$F$20230101$20240809$20240809$20240819$EXP$$DE-009507513-2408DEU001866$MERCK$$$$$F$Y$$$20240819$$CN$DE$DE
241930921$24193092$1$I$$20240806$20240809$20240809$PER$$US-ABBVIE-5870145$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241930931$24193093$1$I$20190101$20240730$20240809$20240809$EXP$$IN-ENDO USA, INC.-2024-003098$ENDO$Majumder AK, Majumder PD.. When Tuberculin Stings: A Case of Panophthalmitis Following Tuberculin Skin Test. Retinal Cases and Brief Reports. 2024$38$YR$$F$Y$$$20240809$$MD$IN$IN
241930951$24193095$1$I$20240101$20240802$20240809$20240809$EXP$$BR-CELLTRION INC.-2024BR018777$CELLTRION$$$$$$Y$$$20240809$$CN$BR$BR
241930972$24193097$2$F$20240723$20240808$20240809$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-023656$UNITED THERAPEUTICS$$48$YR$$F$Y$$$20240816$$$US$US
241930981$24193098$1$I$$20240729$20240809$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-039153$AUROBINDO$Usman S, Ashraf A, Badar F, Iftikhar A. Evidence Based Management of Right Heart Failure in Intensive Care Unit: A Case Report. Am-J-Respir-Crit-Care-Med. 2023;207:A1785$93$YR$$F$Y$$$20240809$$HP$US$US
241930991$24193099$1$I$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683615$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241931001$24193100$1$I$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683614$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241931012$24193101$2$F$20230101$20240826$20240809$20240828$PER$$US-ROCHE-10000052430$ROCHE$$38$YR$A$F$Y$113.39$KG$20240828$$CN$US$US
241931022$24193102$2$F$20240705$20240829$20240809$20240905$EXP$$JP-ROCHE-10000029918$ROCHE$$2$DEC$A$F$Y$$$20240905$$MD$JP$JP
241931032$24193103$2$F$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683616$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241931041$24193104$1$I$20240807$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157505$AMGEN$$79$YR$E$M$Y$$$20240809$$CN$US$US
241931051$24193105$1$I$20240729$20240730$20240809$20240809$PER$$US-AMGEN-USASP2024157817$AMGEN$$$$$$Y$$$20240809$$HP$US$US
241931061$24193106$1$I$20240726$20240806$20240809$20240809$EXP$$CN-AMGEN-CHNSP2024156932$AMGEN$$58$YR$A$M$Y$$$20240809$$HP$CN$CN
241931071$24193107$1$I$20230612$20240110$20240809$20240809$EXP$$US-GRAVITIPHARMA-GRA-2401-US-SPO-0003$GRAVITI PHARMACEUTICALS$$63$YR$E$M$Y$90$KG$20240809$$CN$US$US
241931083$24193108$3$F$20220316$20240918$20240809$20240927$EXP$$CA-ROCHE-3054504$ROCHE$$32$YR$A$F$Y$$$20240928$$CN$CA$CA
241931091$24193109$1$I$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683617$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241931102$24193110$2$F$20240701$20240807$20240809$20240823$PER$$US-Encube-000853$ENCUBE ETHICALS$$77$YR$E$M$Y$$$20240822$$CN$US$
241931111$24193111$1$I$$20240725$20240809$20240809$EXP$NL-LRB-00985652$NL-TEVA-VS-3226342$TEVA$$$$N$$Y$$$20240809$$MD$NL$NL
241931121$24193112$1$I$$20240729$20240809$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-039148$AUROBINDO$Fortich M, Reddy N, Bellinghausen A. Meth, PCP or Both? A Case of Diffuse Alveolar Hemorrhage in the Setting of Combined Amphetamine and Phencyclidine Use. Am-J-Respir-Crit-Care-Med. 2024$37$YR$$M$Y$$$20240809$$HP$US$US
241931131$24193113$1$I$$20220527$20240809$20240809$EXP$$US-AstraZeneca-2022A145083$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241931141$24193114$1$I$$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024156324$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241931152$24193115$2$F$20240807$20240916$20240809$20240920$PER$$US-AMGEN-USASP2024157398$AMGEN$$76$YR$E$F$Y$$$20240920$$CN$US$US
241931161$24193116$1$I$$20230330$20240809$20240809$EXP$$US-AstraZeneca-2023A076146$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241931171$24193117$1$I$$20220304$20240809$20240809$EXP$$US-AstraZeneca-2022A030796$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241931181$24193118$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005080$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241931191$24193119$1$I$$20240808$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005574$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240809$$CN$US$US
241931201$24193120$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005208$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240809$$CN$US$US
241931211$24193121$1$I$20231201$20240717$20240809$20240809$PER$$US-JNJFOC-20240748639$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240809$$CN$US$US
241931222$24193122$2$F$20240620$20240812$20240809$20240819$EXP$$BR-JNJFOC-20240811427$JOHNSON AND JOHNSON$$49$YR$A$M$Y$80$KG$20240819$$CN$BR$BR
241931232$24193123$2$F$20240101$20240904$20240809$20240910$EXP$$CA-APOTEX-2024AP009129$APOTEX$$$$E$M$Y$$$20240910$$PH$CA$CA
241931241$24193124$1$I$20240115$20240120$20240809$20240809$PER$$US-GRAVITIPHARMA-GRA-2401-US-SPO-0007$GRAVITI PHARMACEUTICALS$$62$YR$A$F$Y$74.8$KG$20240809$$CN$US$US
241931251$24193125$1$I$$20240807$20240809$20240809$EXP$$US-ABBVIE-5872636$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241931262$24193126$2$F$20240803$20240827$20240809$20240902$EXP$$JP-GSK-JP2024097377$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$JP$JP
241931271$24193127$1$I$$20240807$20240809$20240809$30DAY$$US-GSK-US2024098532$GLAXOSMITHKLINE$$$$$M$Y$$$20240809$$HP$US$US
241931281$24193128$1$I$20240701$20240806$20240809$20240809$EXP$$CA-ABBVIE-5871654$ABBVIE$$73$YR$$$Y$$$20240809$$HP$CA$CA
241931291$24193129$1$I$$20240707$20240809$20240809$PER$$US-WW-2024-e02026P2$WOODWARD PHARMA SERVICES$Price N.B. et al. Chronic paronychia associated with fluconazole use in two pediatric patients with coccidioidomycosis. IDCases. 2024. DOI: https://doi.org/10.1016/j.idcr.2024.e02026$11$YR$$F$Y$$$20240809$$MD$US$US
241931301$24193130$1$I$20240701$20240807$20240809$20240809$EXP$$US-ABBVIE-5872160$ABBVIE$$73$YR$$M$Y$$$20240809$$CN$US$US
241931311$24193131$1$I$20240506$20240509$20240809$20240809$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-10461$ALKEM$$72$YR$$F$Y$43.991$KG$20240809$$CN$US$US
241931321$24193132$1$I$20240729$20240802$20240809$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-024170$UNITED THERAPEUTICS$$56$YR$$F$Y$77.098$KG$20240809$$$US$US
241931331$24193133$1$I$$20240613$20240809$20240809$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-13378$ALKEM$Scavone C, Mascolo A, Bernardi FF, Aiezza ML, Saturnino P, Morra G, Simonelli M, Massa M, Pomicino A, Minei G, Pisapia R, Spatarella M, Trama U, Guglielmi G, Capuano A, Perrella A.. Hypernatremia during intravenous treatment with fosfomycin: a retrospective medical record review study and an analysis of spontaneous reports in the eudravigilance database. Frontiers in Pharmacology. 2022;13:844122$$$$F$Y$$$20240809$$HP$IT$IT
241931341$24193134$1$I$$20240613$20240809$20240809$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-13377$ALKEM$Scavone C, Mascolo A, Bernardi FF, Aiezza ML, Saturnino P, Morra G, Simonelli M, Massa M, Pomicino A, Minei G, Pisapia R, Spatarella M, Trama U, Guglielmi G, Capuano A, Perrella A. Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database. Frontiers in Pharmacology. 2022;13:844122$$$$M$Y$$$20240809$$HP$IT$IT
241931351$24193135$1$I$$20240613$20240809$20240809$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-13374$ALKEM$Scavone C, Mascolo A, Bernardi FF, Aiezza ML, Saturnino P, Morra G, Simonelli M, Massa M, Pomicino A, Minei G, Pisapia R, Spatarella M, Trama U, Guglielmi G, Capuano A, Perrella A.. Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database. Frontiers in Pharmacology. 2022;13:844122$$$$M$Y$$$20240809$$HP$IT$IT
241931361$24193136$1$I$$20240613$20240809$20240809$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-13373$ALKEM$Scavone C, Mascolo A, Bernardi FF, Aiezza ML, Saturnino P, Morra G, Simonelli M, Massa M, Pomicino A, Minei G, Pisapia R, Spatarella M, Trama U, Guglielmi G, Capuano A, Perrella A.. Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database. Frontiers in Pharmacology. 2022;13:844122$$$$M$Y$$$20240809$$HP$IT$IT
241931371$24193137$1$I$$20240715$20240809$20240809$PER$$US-JNJFOC-20240748362$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240809$$CN$US$US
241931381$24193138$1$I$$20240517$20240809$20240809$EXP$$PL-ALKEM LABORATORIES LIMITED-PL-ALKEM-2024-11288$ALKEM$Kakareko K, Rydzewska-Rosolowska A, Glowinska I, Samocik P, Kozlowski R, Hryszko T.. Post-Transplant Nephroptosis as a Cause of Recurrent Urinary Tract Infections: A Case Report. Transplantation Proceedings. 2024;000:1-3$32$YR$$F$Y$$$20240809$$HP$PL$PL
241931392$24193139$2$F$$20240813$20240809$20240825$30DAY$$TR-JNJFOC-20240819831$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$TR$TR
241931401$24193140$1$I$$20240805$20240809$20240809$EXP$$UA-TAKEDA-2024TUS079326$TAKEDA$$$$$M$Y$$$20240809$$CN$UA$UA
241931411$24193141$1$I$$20240729$20240809$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-039146$AUROBINDO$Liu Z, Oktaei H. A Rare Case of Necrotizing Myopathy after Statin Use. J-Endocr-Soc. 2022;6 (Suppl. 1):A237-A238$35$YR$$M$Y$$$20240809$$MD$US$US
241931421$24193142$1$I$$20240715$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003583$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241931431$24193143$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191153$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241931441$24193144$1$I$20240101$20240731$20240809$20240809$EXP$$JP-ROCHE-3549240$ROCHE$$7$DEC$E$F$Y$$$20240809$$PH$JP$JP
241931451$24193145$1$I$$20240406$20240809$20240809$EXP$$US-GRAVITIPHARMA-GRA-2403-US-SPO-0047$GRAVITI PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241931462$24193146$2$F$$20240829$20240809$20240830$EXP$$JP-GILEAD-2024-0683175$GILEAD$Tonai K, Ohta-Ogo K, Kainuma S, Tadokoro N, Tsukamoto Y, Hatakeyama K, et al.. Case series: successful salvage from refractory cardiogenic shock caused by COVID-19-associated myocardial injury with temporary ventricular assist devices. European Heart Journal - Case Reports. 2024;8(7):unk. doi:10.1093/ehjcr/ytae308$65$YR$E$M$Y$$$20240830$$MD$JP$JP
241931472$24193147$2$F$$20240903$20240809$20240906$EXP$$TR-TAKEDA-2024TUS079322$TAKEDA$$$$$$Y$$$20240906$$MD$TR$TR
241931481$24193148$1$I$$20240729$20240809$20240809$EXP$$CA-AUROBINDO-AUR-APL-2024-039408$AUROBINDO$$75$YR$$M$Y$56$KG$20240809$$HP$CA$CA
241931491$24193149$1$I$20240711$20240802$20240809$20240809$EXP$DE-BFARM-24005368$DE-SERVIER-S24009773$SERVIER$$$$$$Y$$$20240809$$MD$DE$DE
241931502$24193150$2$F$20240905$20240905$20240809$20240911$EXP$$CA-TAKEDA-2022TUS021663$TAKEDA$$76$YR$$M$Y$$$20240911$$CN$CA$CA
241931511$24193151$1$I$$20240808$20240809$20240809$PER$$US-ROCHE-10000052991$ROCHE$$23$YR$A$F$Y$$$20240809$$MD$US$US
241931521$24193152$1$I$$20240808$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2023US011474$SANDOZ$Sarker MR.. Severe cholestasis?associated coagulopathy diagnosed by routine screening: a case report.. AJOG Global Reports. 2023;3:3$$$N$F$Y$2.25$KG$20240809$$MD$US$US
241931531$24193153$1$I$20240730$20240730$20240809$20240809$PER$$US-ABBVIE-5862832$ABBVIE$$40$YR$$F$Y$$$20240809$$CN$US$US
241931541$24193154$1$I$$20240801$20240809$20240809$EXP$$JP-CELLTRION INC.-2024JP018087$CELLTRION$Masayuki M., Akira K., Kazushi U., Daichi H., Munakata M., Tadamichi M., et. al. A case in which a paradoxical reaction occurred during treatment with a tumor necrosis factor-alpha inhibitor and treatment with eppikajutsuto proved effective in a patient with psoriasis vulgaris.. The 2024 Fukushima Prefectural General Meeting of the Japan Society for Oriental. 2024$$$$$Y$$$20240809$$MD$JP$JP
241931551$24193155$1$I$$20240801$20240809$20240809$PER$$US-JNJFOC-20240809309$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241931561$24193156$1$I$$20240729$20240809$20240809$EXP$$JP-ROCHE-10000047979$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$79$YR$E$F$Y$$$20240809$$HP$JP$JP
241931571$24193157$1$I$$20230705$20240809$20240809$EXP$$US-GRAVITIPHARMA-GRA-2306-US-SPO-0028$GRAVITI PHARMACEUTICALS$$$$$$Y$$$20240809$$CN$US$US
241931581$24193158$1$I$$20240730$20240809$20240809$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005678$BIOCON$$$$$$Y$$$20240809$$HP$CA$CA
241931621$24193162$1$I$$20240808$20240809$20240809$PER$$NVSC2024US162136$NOVARTIS$$$$$$Y$$$20240809$$CN$US$US
241931632$24193163$2$F$20221201$20240813$20240809$20240820$EXP$$NVSC2024HK119585$NOVARTIS$$27$YR$$F$Y$$$20240820$$MD$HK$HK
241931644$24193164$4$F$20240818$20240905$20240809$20240918$PER$$US-BEH-2024176943$CSL BEHRING$$67$YR$E$F$Y$$$20240918$$MD$US$US
241931653$24193165$3$F$20240721$20240906$20240809$20240917$EXP$$JP-ROCHE-10000051049$ROCHE$$4$DEC$A$M$Y$$$20240917$$MD$JP$JP
241931662$24193166$2$F$20240701$20240820$20240809$20240828$EXP$$EG-BIOGEN-2024BI01277022$BIOGEN$$25$YR$$F$Y$$$20240828$$CN$EG$EG
241931671$24193167$1$I$$20230717$20240809$20240809$PER$$US-GRAVITIPHARMA-GRA-2307-US-SPO-0031$GRAVITI PHARMACEUTICALS$$95$YR$E$F$Y$53.5$KG$20240809$$CN$US$US
241931682$24193168$2$F$20160101$20240816$20240809$20240821$EXP$$TR-SA-2024SA232279$SANOFI AVENTIS$Caliskan A, Erdogan M.. Leflunomide induced fatal dress syndrome need liver transplantation ? A case report.. Hepatology Forum. 2024;5(4):unk$36$YR$A$F$Y$$$20240821$$MD$TR$TR
241931691$24193169$1$I$$20240805$20240809$20240809$PER$$US-BEH-2024176881$CSL BEHRING$$$$A$M$Y$$$20240809$$HP$US$US
241931701$24193170$1$I$$20240731$20240809$20240809$EXP$NL-LRB-00993341$NL-TEVA-VS-3228815$TEVA$$58$YR$$F$Y$80$KG$20240809$$CN$NL$NL
241931711$24193171$1$I$20240804$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155641$AMGEN$$83$YR$E$M$Y$$$20240809$$CN$US$US
241931721$24193172$1$I$$20240730$20240809$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-038393$AUROBINDO$$$$$M$Y$$$20240809$$PH$GB$GB
241931731$24193173$1$I$20240726$20240807$20240809$20240809$EXP$$US-ABBVIE-5872796$ABBVIE$$91$YR$$M$Y$$$20240809$$CN$US$US
241931751$24193175$1$I$20240530$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125372$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240809$$HP$US$US
241931772$24193177$2$F$$20240807$20240809$20240809$EXP$$US-GILEAD-2024-0683517$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241931781$24193178$1$I$$20240429$20240809$20240809$EXP$$US-GRAVITIPHARMA-GRA-2404-US-SPO-0147$GRAVITI PHARMACEUTICALS$$$$$$Y$$$20240809$$CN$US$US
241931791$24193179$1$I$$20240804$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002932$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240809$$CN$US$US
241931802$24193180$2$F$20240701$20240813$20240809$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408004848$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240815$$CN$US$US
241931822$24193182$2$F$20240805$20240827$20240809$20240827$PER$$US-AMGEN-USASP2024157493$AMGEN$$80$YR$E$F$Y$$$20240827$$CN$US$US
241931833$24193183$3$F$$20240909$20240809$20240911$PER$$US-AMGEN-USASP2024157168$AMGEN$$$$$M$Y$$$20240910$$CN$US$US
241931841$24193184$1$I$$20240728$20240809$20240809$PER$$US-AMGEN-USASP2024154248$AMGEN$Silverman S.L.; Reginster J.; Czerwinski E. et al.. Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis International. 2024;1-12$$$$F$Y$$$20240809$$HP$US$US
241931851$24193185$1$I$20240807$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157491$AMGEN$$75$YR$E$M$Y$$$20240809$$CN$US$US
241931861$24193186$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004795$ELI LILLY AND CO$$54$YR$A$$Y$$$20240809$$CN$US$US
241931871$24193187$1$I$20240601$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004729$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240809$$CN$US$US
241931881$24193188$1$I$20240601$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004852$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240809$$CN$US$US
241931891$24193189$1$I$20240618$20240731$20240809$20240809$EXP$FR-AFSSAPS-MA2024001093$FR-TEVA-VS-3229156$TEVA$$33$YR$$F$Y$$$20240809$$CN$FR$FR
241931901$24193190$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5870293$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241931914$24193191$4$F$20240101$20240916$20240809$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-024084$UNITED THERAPEUTICS$$$$$F$Y$$$20240921$$$US$US
241931921$24193192$1$I$20201108$20240731$20240809$20240809$EXP$$FI-ROCHE-10000009220$ROCHE$$60$YR$A$F$Y$$$20240809$$MD$FI$FI
241931931$24193193$1$I$20240101$20240806$20240809$20240809$EXP$$CA-ABBVIE-5831178$ABBVIE$$77$YR$$F$Y$$$20240809$$CN$CA$CA
241931941$24193194$1$I$$20240731$20240809$20240809$EXP$$IN-ROCHE-10000013168$ROCHE$$57$YR$A$F$Y$$$20240809$$MD$IN$IN
241931952$24193195$2$F$$20240910$20240809$20240911$PER$$US-JNJFOC-20240812455$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$HP$US$US
241931961$24193196$1$I$20240101$20240801$20240809$20240809$EXP$$US-UCBSA-2024037381$UCB$$$$$F$Y$$$20240809$$CN$US$US
241931971$24193197$1$I$$20240803$20240809$20240809$EXP$$BR-AstraZeneca-2024A179961$ASTRAZENECA$$65$YR$$M$Y$$$20240809$$MD$BR$
241931981$24193198$1$I$20240101$20240802$20240809$20240809$EXP$$JP-AstraZeneca-2024A177582$ASTRAZENECA$$68$YR$$F$Y$$$20240809$$MD$JP$
241931991$24193199$1$I$$20240731$20240809$20240809$PER$$US-AstraZeneca-2024A175838$ASTRAZENECA$$$$$$Y$$$20240809$$MD$US$
241932001$24193200$1$I$$20230209$20240809$20240809$EXP$$US-AstraZeneca-2023A037761$ASTRAZENECA$$$$$F$Y$$$20240809$$MD$US$
241932011$24193201$1$I$$20230504$20240809$20240809$EXP$$US-AstraZeneca-2023A104951$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241932022$24193202$2$F$$20240808$20240809$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-038515$AUROBINDO$$$$$F$Y$$$20240817$$MD$GB$GB
241932031$24193203$1$I$$20240724$20240809$20240809$PER$$US-JNJFOC-20240772268$JOHNSON AND JOHNSON$$29$YR$A$M$Y$63.5$KG$20240809$$CN$US$US
241932041$24193204$1$I$20210901$20211028$20240809$20240809$EXP$$US-AstraZeneca-2021A790828$ASTRAZENECA$$747$MON$$F$Y$$$20240809$$CN$US$
241932051$24193205$1$I$$20230810$20240809$20240809$EXP$$US-AstraZeneca-2023A183626$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241932061$24193206$1$I$$20240729$20240809$20240809$EXP$$GB-ADVANZ PHARMA-202407006345$ADVANZ PHARMA$$$$$$Y$$$20240809$$MD$GB$GB
241932071$24193207$1$I$$20240802$20240809$20240809$EXP$$JP-AstraZeneca-2024A177523$ASTRAZENECA$$$$E$F$Y$$$20240809$$MD$JP$
241932091$24193209$1$I$20220604$20220624$20240809$20240809$EXP$$TW-AstraZeneca-2022A235750$ASTRAZENECA$$70$YR$$F$Y$$$20240809$$CN$TW$
241932101$24193210$1$I$$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A176287$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241932113$24193211$3$F$20230101$20240828$20240809$20240912$EXP$$DE-AMGEN-DEUSP2024156661$AMGEN$$75$YR$E$F$Y$66$KG$20240912$$MD$DE$DE
241932121$24193212$1$I$$20240730$20240809$20240809$EXP$$ZA-MACLEODS PHARMA-MAC2024048593$MACLEODS$$$$$$Y$$$20240809$$CN$ZA$ZA
241932132$24193213$2$F$$20240805$20240809$20240816$EXP$$JP-MACLEODS PHARMA-MAC2024048627$MACLEODS$Kuzume D, Ohturu S, Yosida T, Morimoto Y, Yamasaki M, Hosomi N.A case of a young woman with bilateral medial medullary infarcts caused by varicella-zoster virus vasculopathy without skin rash.Rinsho Shinkeigaku (Clinical Neurology).2024$$$$$Y$$$20240816$$MD$JP$JP
241932141$24193214$1$I$$20240730$20240809$20240809$EXP$$TR-MACLEODS PHARMA-MAC2024048601$MACLEODS$Kirsavoglu B, Odabasi O, Avci IE.Solifenacin-induced acute psychosis: a case report.General Psychiatry.12-OCT-2021;34(5):e100586$$$$$Y$$$20240809$$HP$TR$TR
241932151$24193215$1$I$$20240730$20240809$20240809$EXP$$US-MACLEODS PHARMA-MAC2024048650$MACLEODS$Surineni K, Le VY, Jones D..A Case of Oral-Buccal-Lingual Dyskinesia and Neuropsychiatric Symptoms After Prolonged Levetiracetam Exposure.Cureus.2024;16(6):e62692$86$YR$E$F$Y$$$20240809$$MD$US$US
241932161$24193216$1$I$20240708$20240729$20240809$20240809$EXP$GB-MHRA-MED-202407291049014540-PFWRM$GB-MACLEODS PHARMA-MAC2024048653$MACLEODS$$77$YR$E$M$Y$64$KG$20240809$$CN$GB$GB
241932171$24193217$1$I$$20240730$20240809$20240809$EXP$$US-MACLEODS PHARMA-MAC2024048651$MACLEODS$Elwood KF, Warner EJ, Chang JS, Kopplin LJ..Aspergillus Endophthalmitis Secondary to Infectious Scleritis: Utility of Diagnostic PCR.Retinal cases + brief reports.2024$$$$$Y$$$20240809$$MD$US$US
241932182$24193218$2$F$$20240805$20240809$20240816$EXP$$IN-MACLEODS PHARMA-MAC2024048668$MACLEODS$$$$$$Y$$$20240816$$MD$IN$IN
241932191$24193219$1$I$$20240730$20240809$20240809$EXP$$BR-MACLEODS PHARMA-MAC2024048666$MACLEODS$Scorza CA, Scorza FA, Finsterer J.Daytime bruxism, tardive orofacial dyskinesia, and dysphagia as side effects to duloxetine use over nine years in an octogenarian.Clinics (Sao Paulo).2024;79:100438$$$$$Y$$$20240809$$HP$BR$BR
241932202$24193220$2$F$$20240805$20240809$20240816$EXP$$US-MACLEODS PHARMA-MAC2024048656$MACLEODS$Wagle L, Regmi D R, Regmi R, Poudel  S, Pant HN..Metformin Toxicity Leading to Severe Refractory Hyperkalemia and Metabolic Acidosis: A Case Report.Cureus.2024;16(6):e63130$$$$$Y$$$20240816$$MD$US$US
241932211$24193221$1$I$$20240730$20240809$20240809$EXP$$US-MACLEODS PHARMA-MAC2024048658$MACLEODS$Allonce J, Khan S, Pulford B..Atypical Presentation of Ziprasidone-Induced Neuroleptic Malignant Syndrome: A Case Report.Journal of investigative medicine high impact case reports..2024;12:1-4$$$$$Y$$$20240809$$MD$US$US
241932221$24193222$1$I$20240729$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407300939162530-DVYZT$GB-MACLEODS PHARMA-MAC2024048676$MACLEODS$$$$$$Y$$$20240809$$CN$GB$GB
241932232$24193223$2$F$$20240806$20240809$20240817$EXP$$CN-MACLEODS PHARMA-MAC2024048673$MACLEODS$Su CS, Kao CL.Stevens-Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report..Journal of Medical Case Reports..28-JUL-2024;18(1):344$$$$$Y$$$20240817$$PH$CN$CN
241932242$24193224$2$F$20240805$20240806$20240809$20240813$PER$$US-AMGEN-USASP2024157010$AMGEN$$65$YR$E$M$Y$$$20240813$$CN$US$US
241932251$24193225$1$I$20231107$20240731$20240809$20240809$EXP$ES-AEMPS-1548582$ES-TEVA-VS-3228723$TEVA$$72$YR$$M$Y$$$20240809$$MD$ES$ES
241932261$24193226$1$I$20220924$20240807$20240809$20240809$EXP$$GB-ROCHE-10000051880$ROCHE$$55$YR$A$F$Y$51.4$KG$20240809$$MD$GB$GB
241932271$24193227$1$I$20240731$20240805$20240809$20240809$EXP$$JP-009507513-2408JPN000396J$MERCK$$9$DEC$$F$Y$$$20240809$$PH$JP$JP
241932282$24193228$2$F$20240701$20240813$20240809$20240827$EXP$$EG-BIOGEN-2024BI01276935$BIOGEN$$23$YR$$F$Y$$$20240827$$CN$EG$EG
241932291$24193229$1$I$20240111$20240725$20240809$20240809$EXP$$IT-AstraZeneca-2024A011541$ASTRAZENECA$$16379$DY$$F$Y$72$KG$20240809$$MD$IT$
241932301$24193230$1$I$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683519$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241932312$24193231$2$F$$20240805$20240809$20240812$EXP$$US-AstraZeneca-2024A177889$ASTRAZENECA$$$$$M$Y$$$20240812$$MD$US$
241932321$24193232$1$I$$20240801$20240809$20240809$EXP$$BR-AstraZeneca-2024A177666$ASTRAZENECA$$60$YR$$M$Y$$$20240809$$MD$BR$
241932341$24193234$1$I$20240723$20240806$20240809$20240809$EXP$$US-AstraZeneca-2024A178682$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241932351$24193235$1$I$$20240730$20240809$20240809$PER$$US-AstraZeneca-2024A180133$ASTRAZENECA$$79$YR$$M$Y$$$20240809$$CN$US$
241932361$24193236$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024158023$AMGEN$$$$$$Y$$$20240809$$HP$US$US
241932371$24193237$1$I$20240803$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024156573$AMGEN$$74$YR$E$F$Y$$$20240809$$CN$US$US
241932381$24193238$1$I$$20240730$20240809$20240809$EXP$$CO-ROCHE-10000051920$ROCHE$$$$$F$Y$70$KG$20240809$$CN$CO$CO
241932391$24193239$1$I$20240807$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157518$AMGEN$$72$YR$E$F$Y$$$20240809$$CN$US$US
241932401$24193240$1$I$20200501$20240730$20240809$20240809$EXP$$PK-ROCHE-10000047397$ROCHE$$40$YR$A$M$Y$$$20240809$$MD$PK$PK
241932411$24193241$1$I$20230907$20240730$20240809$20240809$EXP$IT-MINISAL02-996018$IT-TEVA-VS-3227893$TEVA$$92$YR$$M$Y$$$20240809$$MD$IT$IT
241932422$24193242$2$F$$20240807$20240809$20240811$EXP$$AU-ROCHE-10000049872$ROCHE$$31$YR$A$M$Y$$$20240811$$HP$AU$AU
241932431$24193243$1$I$20240724$20240724$20240809$20240809$PER$$US-TEVA-VS-3225555$TEVA$$$$$F$Y$$$20240809$$CN$US$US
241932441$24193244$1$I$$20240730$20240809$20240809$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005677$BIOCON$$$$$$Y$$$20240809$$HP$CA$CA
241932452$24193245$2$F$$20240830$20240809$20240912$EXP$$US-AMAROX PHARMA-HET2024US02631$HETERO$$$$$F$Y$$$20240909$$HP$US$US
241932461$24193246$1$I$$20240806$20240809$20240809$PER$$US-ABBVIE-5870215$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241932471$24193247$1$I$$20240806$20240809$20240809$EXP$$CA-JNJFOC-20240816585$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$HP$CA$CA
241932491$24193249$1$I$$20240802$20240809$20240809$30DAY$$US-AMGEN-USASP2024154629$AMGEN$$$$$$Y$$$20240809$$PH$US$US
241932501$24193250$1$I$$20240731$20240809$20240809$EXP$FR-AFSSAPS-AVMA2024000323$FR-TEVA-VS-3229098$TEVA$$50$YR$$F$Y$$$20240809$$PH$FR$FR
241932521$24193252$1$I$$20240729$20240809$20240809$EXP$$PL-AUROBINDO-AUR-APL-2024-038677$AUROBINDO$$58$YR$$F$Y$$$20240809$$PH$PL$PL
241932531$24193253$1$I$20240624$20240807$20240809$20240809$EXP$$ZA-ABBVIE-5872761$ABBVIE$$71$YR$$F$Y$$$20240809$$MD$ZA$ZA
241932541$24193254$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157537$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241932551$24193255$1$I$20240717$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157602$AMGEN$$71$YR$E$F$Y$$$20240809$$CN$US$US
241932563$24193256$3$F$20240807$20240827$20240809$20240829$PER$$US-AMGEN-USASP2024157474$AMGEN$$77$YR$E$F$Y$$$20240829$$HP$US$US
241932571$24193257$1$I$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683521$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241932661$24193266$1$I$20240501$20240802$20240809$20240809$EXP$$AR-GSK-AR2024AMR097285$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$AR$AR
241932672$24193267$2$F$$20240809$20240809$20240819$PER$$US-ABBVIE-5872809$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
241932681$24193268$1$I$$20240805$20240809$20240809$EXP$$CA-GSK-CA2024024277$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$PH$CA$CA
241932691$24193269$1$I$20240701$20240731$20240809$20240809$EXP$$JP-ROCHE-10000050456$ROCHE$$7$DEC$E$M$Y$$$20240809$$MD$JP$JP
241932701$24193270$1$I$20240603$20240801$20240809$20240809$EXP$FR-AFSSAPS-PA2024001415$FR-ROCHE-10000048390$ROCHE$$62$YR$A$M$Y$64$KG$20240809$$PH$FR$FR
241932721$24193272$1$I$20240707$20240801$20240809$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023953$UNITED THERAPEUTICS$$61$YR$$F$Y$90.703$KG$20240809$$$US$US
241932731$24193273$1$I$$20240729$20240809$20240809$EXP$$US-MYLANLABS-2024M1071618$MYLAN$Cohen P, Kudchadkar S, Schultz B, Schuette J. Repeated hemodialysis after extended-release acetaminophen ingestion. Crit-Care-Med 2024; 52 (Suppl.) (1): S301 abstr. 657.$15$YR$$M$Y$$$20240809$$HP$US$US
241932741$24193274$1$I$$20240729$20240809$20240809$EXP$$US-MYLANLABS-2024M1072751$MYLAN$Pinchman E, Moore A, Barrett L, Pianka JP, Bhullar R. Buprenorphine Microinduction to Mitigate Withdrawal Symptoms During Abrupt Discontinuation of Intrathecal Fentanyl: A Case Report. Pain-Med-Case-Rep 2024; 8 (1): 13-15.$56$YR$$F$Y$$$20240809$$HP$US$US
241932751$24193275$1$I$$20240731$20240809$20240809$EXP$$US-MYLANLABS-2024M1072860$MYLAN$Mccreary DL, Talon A, Young K, Suliman SA. Acute Pulmonary Manifestations and Management of Idiopathic Inflammatory Myopathies. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$44$YR$$M$Y$$$20240809$$HP$US$US
241932761$24193276$1$I$20240601$20240726$20240809$20240809$EXP$$US-UCBSA-2024038167$UCB$$30$YR$$F$Y$$$20240809$$HP$US$US
241932771$24193277$1$I$$20240731$20240809$20240809$EXP$$US-MYLANLABS-2024M1073548$MYLAN$Dajani KA, Davis B, Ghabra H, Harrell-Mohamed J, Carrillo CO, Eustis HS. Methadone for Emergence Delirium in Ambulatory Pediatric Strabismus Surgery. Ochsner-J 2024; 24 (1): 31-35.$$$C$$Y$$$20240809$$MD$US$US
241932782$24193278$2$F$20240803$20240820$20240809$20240822$EXP$$CA-ROCHE-10000050350$ROCHE$$40$YR$A$F$Y$$$20240822$$CN$CA$CA
241932791$24193279$1$I$20221201$20240729$20240809$20240809$EXP$$GR-ROCHE-10000048399$ROCHE$$47$YR$A$F$Y$$$20240809$$MD$GR$GR
241932801$24193280$1$I$$20240802$20240809$20240809$EXP$$US-ROCHE-10000050174$ROCHE$$14$YR$T$M$Y$$$20240809$$CN$US$US
241932811$24193281$1$I$20220323$20240725$20240809$20240809$PER$$KG-3M-2024-KG-000001$Solventum$Mukashev MS, Turganbaev AE, Toktosun Uulu, Asanov BA, Kalybeikova GM, Ibragimov AB.Medical Poisoning with Chlorhexidine and its consequences, forsensic evaluation (expert case).Bulletin of Kyrgyz State Medical Academy.2024;67(3):54-58.$$$$F$Y$$$20240809$$HP$KG$KG
241932821$24193282$1$I$$20240730$20240809$20240809$PER$$US-ROCHE-10000029553$ROCHE$$69$YR$E$M$Y$83.91$KG$20240809$$CN$US$US
241932831$24193283$1$I$$20240805$20240809$20240809$PER$$US-ROCHE-10000051433$ROCHE$$66$YR$E$F$Y$$$20240809$$CN$US$US
241932841$24193284$1$I$20240715$20240730$20240809$20240809$EXP$$US-ACORDA-ACO_177206_2024$ACORDA$$71$YR$$M$Y$$$20240809$$CN$US$US
241932861$24193286$1$I$$20240730$20240809$20240809$EXP$$ES-AUROBINDO-AUR-APL-2024-038816$AUROBINDO$Pitarch CG, Macia MS, Simon J, Mosca L, Conter C, Rejano-Gordillo CM, et al.. Neddylation inhibition prevents acetaminopheninduced liver damage by enhancing the anabolic cardiolipin pathway.. Cell Reports Medicine. 2024;5(7)$$$A$M$Y$$$20240809$$HP$ES$ES
241932871$24193287$1$I$20240714$20240730$20240809$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-038936$AUROBINDO$$21$YR$$M$Y$$$20240809$$MD$FR$FR
241932881$24193288$1$I$20240719$20240730$20240809$20240809$EXP$$MX-ROCHE-10000045821$ROCHE$$69$YR$E$F$Y$55$KG$20240809$$MD$MX$MX
241932891$24193289$1$I$$20240808$20240809$20240809$PER$$US-AMGEN-USASP2024158169$AMGEN$$$$$$Y$$$20240809$$PH$US$US
241932901$24193290$1$I$$20240808$20240809$20240809$PER$$US-AMGEN-USASP2024158110$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241932911$24193291$1$I$20200711$20240731$20240809$20240809$EXP$PL-URPL-1-2126-2020$PL-TEVA-VS-3228794$TEVA$$48$YR$$F$Y$70$KG$20240809$$MD$PL$PL
241932921$24193292$1$I$$20240802$20240809$20240809$EXP$$US-ROCHE-10000048258$ROCHE$$74$YR$E$F$Y$$$20240809$$CN$US$US
241932933$24193293$3$F$20240801$20240906$20240809$20240915$30DAY$$US-AMGEN-USASL2024156009$AMGEN$$76$YR$E$F$Y$$$20240915$$HP$US$US
241932941$24193294$1$I$$20240731$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004311$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241932961$24193296$1$I$$20240807$20240809$20240809$PER$$US-BAYER-2024A114476$BAYER$$63$YR$A$F$Y$$$20240809$$CN$US$US
241932972$24193297$2$F$$20240819$20240809$20240820$PER$$NVSC2024US162024$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
241932981$24193298$1$I$$20240731$20240809$20240809$EXP$$US-NOVITIUMPHARMA-2024USNVP01510$NOVITIUM PHARMA$E. D. Pollack.Meningoencephalitis With Transverse Myelitis in a Patient With West Nile Virus - Clinical Insights and Awareness.American Journal of Respiratory and Critical Care Medicine.21-MAY-2024;209:A5619$42$YR$A$M$Y$$$20240809$$HP$US$US
241932991$24193299$1$I$$20240728$20240809$20240809$EXP$$PK-Indoco-000597$INDOCO$Gul F, Shah M, Waqar M, Bassi R, Shah S, Sethi N. Severe Central Nervous System and Respiratory Depression in a Neonate Following Accidental Oral Ingestion of Brimonidine Tartrate. Cureus. 2024 Jun 25;16(6):e63124.$27$DY$N$M$Y$4$KG$20240809$$HP$PK$PK
241933001$24193300$1$I$$20230413$20240809$20240809$EXP$$US-AstraZeneca-2023A087438$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241933011$24193301$1$I$$20240709$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07088$LUPIN$$$$$$Y$$$20240809$$MD$US$US
241933021$24193302$1$I$$20240731$20240809$20240809$PER$$US-AstraZeneca-2024A174556$ASTRAZENECA$$$$$M$Y$$$20240809$$MD$US$
241933031$24193303$1$I$$20240730$20240809$20240809$EXP$$CA-AUROBINDO-AUR-APL-2024-039598$AUROBINDO$$93$YR$$M$Y$57$KG$20240809$$HP$CA$CA
241933041$24193304$1$I$$20240728$20240809$20240809$EXP$$US-Apnar-000189$APNAR PHARMA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$$$I$M$Y$$$20240809$$MD$US$US
241933051$24193305$1$I$$20220525$20240809$20240809$EXP$$US-AstraZeneca-2022A166594$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241933061$24193306$1$I$$20230302$20240809$20240809$EXP$$ZA-AstraZeneca-2023A052718$ASTRAZENECA$$58$YR$$M$Y$$$20240809$$CN$ZA$
241933071$24193307$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5870475$ABBVIE$$$$$M$Y$$$20240809$$HP$US$US
241933081$24193308$1$I$$20240731$20240809$20240809$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011661$JAZZ$$$$$M$Y$$$20240809$$CN$US$US
241933092$24193309$2$F$20240806$20240809$20240809$20240821$PER$$US-AMGEN-USASP2024157237$AMGEN$$50$YR$A$F$Y$$$20240820$$CN$US$US
241933102$24193310$2$F$20230101$20240829$20240809$20240903$EXP$$US-ABBVIE-5871087$ABBVIE$$$$$M$Y$85.275$KG$20240903$$CN$US$US
241933111$24193311$1$I$$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024156322$AMGEN$$$$$F$Y$$$20240809$$HP$US$US
241933122$24193312$2$F$$20240810$20240809$20240812$PER$$US-AMGEN-USASP2024155993$AMGEN$$$$A$M$Y$$$20240812$$CN$US$US
241933131$24193313$1$I$$20240730$20240809$20240809$30DAY$$DE-JNJFOC-20240819762$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$PH$DE$DE
241933141$24193314$1$I$20240722$20240726$20240809$20240809$EXP$$ES-TEVA-VS-3227675$TEVA$$69$YR$$F$Y$$$20240809$$CN$ES$ES
241933151$24193315$1$I$$20240802$20240809$20240809$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07422$HIKMA$$$$$$Y$$$20240809$$HP$CA$CA
241933203$24193320$3$F$$20240927$20240809$20240927$EXP$$US-ABBVIE-5873235$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
241933212$24193321$2$F$20240711$20240816$20240809$20240820$EXP$$NVSC2024IT148489$NOVARTIS$$25$YR$$M$Y$$$20240820$$MD$IT$IT
241933221$24193322$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191223$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241933232$24193323$2$F$$20240807$20240809$20240809$PER$$US-ROCHE-10000052431$ROCHE$$$$A$M$Y$$$20240809$$CN$US$US
241933241$24193324$1$I$$20240711$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07111$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241933251$24193325$1$I$$20240711$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07191$LUPIN$$$$$$Y$$$20240809$$MD$US$US
241933261$24193326$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5871003$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241933271$24193327$1$I$$20240808$20240809$20240809$PER$$US-BAYER-2024A114654$BAYER$$$$$$Y$$$20240809$$CN$US$US
241933282$24193328$2$F$$20240803$20240809$20240809$EXP$$US-ROCHE-10000051654$ROCHE$$$$$$Y$$$20240809$$CN$US$US
241933291$24193329$1$I$20230715$20230715$20240809$20240809$PER$$US-PERRIGO-23US008083$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241933301$24193330$1$I$20230718$20230718$20240809$20240809$PER$$US-PERRIGO-23US008114$PERRIGO$$73$YR$$F$Y$44.444$KG$20240809$$CN$US$US
241933331$24193333$1$I$$20240808$20240809$20240809$PER$$US-BAYER-2024A115090$BAYER$$$$$$Y$$$20240809$$CN$US$US
241933341$24193334$1$I$$20240802$20240809$20240809$EXP$$US-APOTEX-2024AP009125$APOTEX$Brown AC, Evans DD, Tucker P.. Is Ketamine an Effective Treatment of Acute Agitation in the Emergency Department? Implications for APRN Practice. Advanced Emergency Nursing Journal. 2023;45(4):253-259$37$YR$$M$Y$$$20240809$$HP$US$US
241933351$24193335$1$I$$20240126$20240809$20240809$PER$$US-PERRIGO-24US001003$PERRIGO$$$$$$Y$$$20240809$$CN$US$US
241933361$24193336$1$I$$20231108$20240809$20240809$PER$$US-PERRIGO-23US013047$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241933381$24193338$1$I$20230901$20230906$20240809$20240809$PER$$US-PERRIGO-23US010734$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241933391$24193339$1$I$20220101$20240124$20240809$20240809$PER$$US-PERRIGO-24US000864$PERRIGO$$$$$M$Y$95.238$KG$20240809$$CN$US$US
241933401$24193340$1$I$20230911$20231127$20240809$20240809$PER$$US-PERRIGO-23US013586$PERRIGO$$65$YR$$M$Y$84.807$KG$20240809$$CN$US$US
241933411$24193341$1$I$20240515$20240516$20240809$20240809$PER$$US-PERRIGO-24US004811$PERRIGO$$43$YR$$F$Y$99.773$KG$20240809$$CN$US$US
241933421$24193342$1$I$20240522$20240523$20240809$20240809$PER$$US-PERRIGO-24US005091$PERRIGO$$32$YR$$M$Y$72.562$KG$20240809$$CN$US$US
241933431$24193343$1$I$$20240321$20240809$20240809$PER$$US-PERRIGO-24US002990$PERRIGO$$$$$F$Y$$$20240809$$CN$US$US
241933441$24193344$1$I$$20240327$20240809$20240809$PER$$US-PERRIGO-24US003163$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241933451$24193345$1$I$20230901$20231102$20240809$20240809$PER$$US-PERRIGO-23US012703$PERRIGO$$65$YR$$F$Y$81.633$KG$20240809$$CN$US$US
241933461$24193346$1$I$20231001$20231015$20240809$20240809$PER$$US-PERRIGO-23US012118$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241933471$24193347$1$I$$20240419$20240809$20240809$PER$$US-PERRIGO-24US003959$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241933481$24193348$1$I$20230901$20230921$20240809$20240809$PER$$US-PERRIGO-23US011317$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241933491$24193349$1$I$20231006$20231020$20240809$20240809$PER$$US-PERRIGO-23US012263$PERRIGO$$74$YR$$M$Y$77.098$KG$20240809$$CN$US$US
241933501$24193350$1$I$$20240215$20240809$20240809$PER$$US-PERRIGO-24US001748$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241933511$24193351$1$I$$20240418$20240809$20240809$PER$$US-PERRIGO-24US003911$PERRIGO$$$$$F$Y$$$20240809$$CN$US$US
241933521$24193352$1$I$20221107$20221206$20240809$20240809$EXP$$NL-TERSERA THERAPEUTICS LLC-2022TRS005744$TERSERA THERAPEUTICS$$$$$$Y$$$20240809$$CN$NL$NL
241933531$24193353$1$I$$20230124$20240809$20240809$EXP$$NL-TERSERA THERAPEUTICS LLC-2023TRS000450$TERSERA THERAPEUTICS$$$$$$Y$$$20240809$$CN$NL$NL
241933541$24193354$1$I$20210601$20210701$20240809$20240809$EXP$$NL-TERSERA THERAPEUTICS LLC-2021TRS003256$TERSERA THERAPEUTICS$$$$$$Y$$$20240809$$HP$NL$NL
241933551$24193355$1$I$20230313$20230413$20240809$20240809$EXP$$NL-TERSERA THERAPEUTICS LLC-2023TRS001786$TERSERA THERAPEUTICS$$$$$$Y$$$20240809$$CN$NL$NL
241933571$24193357$1$I$$20240730$20240809$20240809$EXP$$ES-AUROBINDO-AUR-APL-2024-039160$AUROBINDO$Pitarch CG, Macia MS, Simon J, Mosca L, Conter C, Rejano-Gordillo CM, et al.. Neddylation inhibition prevents acetaminopheninduced liver damage by enhancing the anabolic cardiolipin pathway.. Cell Reports Medicine.. 2024;Jul 16:5(7)$$$A$M$Y$$$20240809$$HP$ES$ES
241933581$24193358$1$I$20240601$20240807$20240809$20240809$EXP$$NVSC2024JO161671$NOVARTIS$$47$YR$$F$Y$$$20240809$$MD$JO$JO
241933591$24193359$1$I$$20240524$20240809$20240809$PER$$US-PERRIGO-24US005139$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241933601$24193360$1$I$$20240615$20240809$20240809$PER$$US-PERRIGO-24US005855$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241933611$24193361$1$I$$20240805$20240809$20240809$EXP$$US-FDC-2024USLIT00601$FDC LIMITED$$71$YR$E$M$Y$$$20240809$$MD$US$US
241933621$24193362$1$I$20240604$20240611$20240809$20240809$PER$$US-PERRIGO-24US005690$PERRIGO$$60$YR$$F$Y$65.76$KG$20240809$$CN$US$US
241933632$24193363$2$F$$20240830$20240809$20240907$EXP$$IT-AMGEN-ITASP2024155075$AMGEN$Gaio M.; Vastarella M.; Sullo M. et al.. Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis. Pharmaceuticals. 2024;17 (7):1-15$$$$$Y$$$20240907$$HP$IT$IT
241933641$24193364$1$I$$20240808$20240809$20240809$PER$$US-BAYER-2024A115136$BAYER$$87$YR$E$$Y$$$20240809$$CN$US$US
241933652$24193365$2$F$20240727$20240816$20240809$20240822$EXP$$US-BEH-2024176696$CSL BEHRING$$15$YR$T$M$Y$$$20240822$$PH$US$US
241933671$24193367$1$I$$20240805$20240809$20240809$PER$$US-BAYER-2024A112919$BAYER$$$$$F$Y$$$20240809$$CN$US$US
241933681$24193368$1$I$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683522$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241933691$24193369$1$I$$20240730$20240809$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-038901$AUROBINDO$Pollack ED, Richardson C, Powell B, Patel K.. Meningoencephalitis With Transverse Myelitis in a Patient With West Nile Virus - Clinical Insights and Awareness.. Am-J-Respir-Crit-Care-Med. 2024;209:A5619$42$YR$$M$Y$$$20240809$$HP$US$US
241933701$24193370$1$I$$20240726$20240809$20240809$EXP$NL-LRB-00993217$NL-GLENMARK PHARMACEUTICALS-2024GMK092914$GLENMARK$$$$$$Y$$$20240809$$MD$NL$NL
241933711$24193371$1$I$$20240805$20240809$20240809$EXP$$US-AMGEN-USASP2024155579$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241933721$24193372$1$I$$20240805$20240809$20240809$PER$$US-BAYER-2024A112920$BAYER$$$$$$Y$$$20240809$$CN$US$US
241933732$24193373$2$F$20240701$20240809$20240809$20240816$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010821$JAZZ$$33$YR$$F$Y$$$20240816$$CN$US$US
241933741$24193374$1$I$$20240806$20240809$20240809$EXP$$US-MYLANLABS-2024M1073829$MYLAN$$$$$M$Y$$$20240809$$PH$US$US
241933751$24193375$1$I$$20240805$20240809$20240809$EXP$$GB-MYLANLABS-2024M1073562$MYLAN$$$$$M$Y$$$20240809$$PH$GB$GB
241933761$24193376$1$I$$20240808$20240809$20240809$EXP$$GB-MYLANLABS-2024M1074205$MYLAN$$$$$M$Y$$$20240809$$CN$GB$GB
241933771$24193377$1$I$$20240731$20240809$20240809$EXP$$US-MYLANLABS-2024M1072859$MYLAN$Sheth S, Matthia E, Naik D. Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer. J-Clin-Lipidol 2024; 18 (Suppl.) (4): e555-e556.$57$YR$$F$Y$$$20240809$$HP$US$US
241933791$24193379$1$I$20240711$20240808$20240809$20240809$PER$$US-AMGEN-USASP2024158142$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241933801$24193380$1$I$$20240807$20240809$20240809$EXP$$US-ROCHE-10000051704$ROCHE$$$$$M$Y$$$20240809$$CN$US$US
241933811$24193381$1$I$$20240729$20240809$20240809$EXP$$BR-ROCHE-RCA5211096$ROCHE$Gagliato D, Reinert T, Rocha C, Tavares M, Pimentel S, Fuzita W, et al. Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population. Oncology and therapy. 2024-Jun-05;1-13. doi:10.1007/s40487-024-00284-5.$$$$$Y$$$20240809$$HP$BR$BR
241933823$24193382$3$F$20240730$20240909$20240809$20240917$PER$$US-ROCHE-10000048904$ROCHE$$46$YR$A$F$Y$83.91$KG$20240917$$CN$US$US
241933831$24193383$1$I$20240529$20240731$20240809$20240809$EXP$DE-CADRBFARM-2024329528$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-07387$HIKMA$$63$YR$$F$Y$63$KG$20240809$$MD$DE$DE
241933841$24193384$1$I$20210818$20221013$20240809$20240809$EXP$$TW-AstraZeneca-2022A348241$ASTRAZENECA$$70$YR$$M$Y$$$20240809$$HP$TW$
241933851$24193385$1$I$$20220830$20240809$20240809$EXP$$US-AstraZeneca-2022A304664$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
241933861$24193386$1$I$$20230818$20240809$20240809$EXP$$CA-AstraZeneca-2023A148844$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$CA$
241933871$24193387$1$I$20220401$20220616$20240809$20240809$EXP$$ES-AstraZeneca-2022A223766$ASTRAZENECA$$742$MON$$M$Y$$$20240809$$CN$ES$
241933882$24193388$2$F$$20240821$20240809$20240826$EXP$$CA-AstraZeneca-2024A178209$ASTRAZENECA$$$$$F$Y$$$20240826$$CN$CA$
241933891$24193389$1$I$$20240731$20240809$20240809$EXP$$US-NOVITIUMPHARMA-2024USNVP01512$NOVITIUM PHARMA$John Larson.A 66-Year-Old Man with Persistent Altered Mental Status and New Rash.Annals of the American Thoracic Society.MAR-2023;20:466-469$66$YR$A$M$Y$$$20240809$$HP$US$US
241933911$24193391$1$I$20240806$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004040$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240809$$CN$US$US
241933921$24193392$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004657$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240809$$CN$US$US
241933931$24193393$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004008$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241933942$24193394$2$F$$20240808$20240809$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408004634$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240813$$CN$US$US
241933951$24193395$1$I$$20240730$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408000392$ELI LILLY AND CO$$51$YR$A$$Y$$$20240809$$CN$US$US
241933961$24193396$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005534$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241933971$24193397$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005229$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240809$$CN$US$US
241933981$24193398$1$I$$20240730$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408000378$ELI LILLY AND CO$$57$YR$A$$Y$$$20240809$$LW$US$US
241933991$24193399$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004617$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240809$$CN$US$US
241934001$24193400$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004956$ELI LILLY AND CO$$20$YR$A$M$Y$$$20240809$$CN$US$US
241934011$24193401$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005512$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240809$$CN$US$US
241934021$24193402$1$I$$20240731$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004695$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240809$$CN$US$US
241934032$24193403$2$F$$20240827$20240809$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408004905$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240828$$CN$US$US
241934041$24193404$1$I$$20240725$20240809$20240809$PER$$US-TEVA-VS-3225265$TEVA$$$$$F$Y$$$20240809$$CN$US$US
241934051$24193405$1$I$20080101$20240805$20240809$20240809$PER$$US-JNJFOC-20240813886$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240809$$LW$US$US
241934061$24193406$1$I$20240619$20240805$20240809$20240809$EXP$$IT-JNJFOC-20240815705$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240809$$PH$IT$IT
241934071$24193407$1$I$20240625$20240730$20240809$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-038426$AUROBINDO$$83$YR$$F$Y$$$20240809$$MD$FR$FR
241934081$24193408$1$I$20230717$20240807$20240809$20240809$EXP$$GB-UCBSA-2024039652$UCB$$32$YR$$F$Y$73.7$KG$20240809$$MD$GB$GB
241934091$24193409$1$I$20230301$20240805$20240809$20240809$PER$$US-DSJP-DSU-2024-139709$DAIICHI$$47$YR$$F$Y$$$20240809$$CN$US$US
241934101$24193410$1$I$20240730$20240806$20240809$20240809$EXP$$US-GSK-US2024098064$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$HP$US$US
241934111$24193411$1$I$$20240711$20240809$20240809$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15893$ALKEM$Ghamasaee P, Carr K, Johnson J, Grandhi R.. Malignant stroke in a ticagrelor non-responder as a complication following aneurysm treatment with the Pipeline Embolization DeviceT. Intervent Neuroradiol. 2017;23(3):297-300$$$$$Y$$$20240809$$HP$US$US
241934131$24193413$1$I$$20240429$20240809$20240809$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-09575$ALKEM$Mair H, Ulrich S, Rosenzweig D, Goeppl J, Jurma C, Vogt F, Baumer B, Vogel F, Lamm P.. Antithrombotic drug removal with hemoadsorption during off-pump coronary artery bypass grafting. Journal of Cardiothoracic Surgery. 2024;19:246$74$YR$$F$Y$$$20240809$$HP$DE$DE
241934141$24193414$1$I$$20240711$20240809$20240809$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15780$ALKEM$Kuhn AL, Singh J, Puri AS.. Dual Antiplatelet Non-Responder: Resistance to Clopidogrel and Ticagrelor. The Neurohospitalist. 2024;14(3):312-315$74$YR$$F$Y$$$20240809$$MD$US$US
241934151$24193415$1$I$$20240124$20240809$20240809$EXP$$CA-MYLANLABS-2024M1073344$MYLAN$$$$$$Y$$$20240809$$HP$CA$CA
241934161$24193416$1$I$20240723$20240807$20240809$20240809$EXP$$US-GILEAD-2024-0683422$GILEAD$$79$YR$E$F$Y$$$20240809$$HP$US$US
241934171$24193417$1$I$$20240807$20240809$20240809$EXP$$NVSC2024TW161620$NOVARTIS$$72$YR$$M$Y$$$20240809$$MD$TW$TW
241934182$24193418$2$F$20240415$20240805$20240809$20240817$EXP$$NVSC2024US048995$NOVARTIS$$58$YR$$F$Y$$$20240817$$CN$US$US
241934201$24193420$1$I$$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024157066$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241934211$24193421$1$I$$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024156916$AMGEN$$$$$F$Y$$$20240809$$HP$US$US
241934221$24193422$1$I$$20240730$20240809$20240809$EXP$$US-TEVA-VS-3229426$TEVA$$62$YR$$F$Y$$$20240809$$CN$US$US
241934232$24193423$2$F$20240808$20240812$20240809$20240819$PER$$US-BAYER-2024A112886$BAYER$$66$YR$E$$Y$$$20240819$$CN$US$US
241934241$24193424$1$I$$20240731$20240809$20240809$EXP$$PT-AUROBINDO-AUR-APL-2024-039363$AUROBINDO$Araujo M, Santos S, Viana J, Marques S. Metformin-associated lactic acidosis (MALA) - 4-year series at a university hospital. Congresses of the Portuguese Society of Internal Medicine. 2024;212$$$E$$Y$$$20240809$$MD$PT$PT
241934253$24193425$3$F$$20240805$20240809$20240820$EXP$$EU-UNITED THERAPEUTICS-UNT-2024-024275$UNITED THERAPEUTICS$$48$YR$$$Y$$$20240820$$MD$EU$EU
241934261$24193426$1$I$$20240731$20240809$20240809$EXP$$PT-AUROBINDO-AUR-APL-2024-039163$AUROBINDO$Araujo M, Santos S, Viana J, Marques S. Metformin-associated lactic acidosis (MALA) - 4-year series at a university hospital. Congresses of the Portuguese Society of Internal Medicine. 2024;212$$$E$$Y$$$20240809$$MD$PT$PT
241934271$24193427$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11171$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$36$YR$$F$Y$$$20240809$$MD$BR$BR
241934281$24193428$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11173$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$52$YR$$F$Y$$$20240809$$MD$BR$BR
241934291$24193429$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11180$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$27$YR$$F$Y$$$20240809$$MD$BR$BR
241934301$24193430$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11185$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$17$YR$$F$Y$$$20240809$$MD$BR$BR
241934311$24193431$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11175$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$45$YR$$F$Y$$$20240809$$MD$BR$BR
241934321$24193432$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11166$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$37$YR$$F$Y$$$20240809$$MD$BR$BR
241934331$24193433$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11169$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$30$YR$$M$Y$$$20240809$$MD$BR$BR
241934341$24193434$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11170$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2 (4):414-420$44$YR$$M$Y$$$20240809$$MD$BR$BR
241934351$24193435$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11176$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$45$YR$$F$Y$$$20240809$$MD$BR$BR
241934361$24193436$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11172$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$21$YR$$M$Y$$$20240809$$MD$BR$BR
241934371$24193437$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11167$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$63$YR$$F$Y$$$20240809$$MD$BR$BR
241934381$24193438$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11165$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2 (4):414-420$40$YR$$F$Y$$$20240809$$MD$BR$BR
241934391$24193439$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11191$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$32$YR$$F$Y$$$20240809$$MD$BR$BR
241934401$24193440$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11197$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$35$YR$$F$Y$$$20240809$$MD$BR$BR
241934411$24193441$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11179$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$36$YR$$F$Y$$$20240809$$MD$BR$BR
241934421$24193442$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11193$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$34$YR$$M$Y$$$20240809$$MD$BR$BR
241934431$24193443$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11184$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$21$YR$$F$Y$$$20240809$$MD$BR$BR
241934441$24193444$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11186$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$59$YR$$F$Y$$$20240809$$MD$BR$BR
241934451$24193445$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11190$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$52$YR$$F$Y$$$20240809$$MD$BR$BR
241934461$24193446$1$I$$20240517$20240809$20240809$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-10990$ALKEM$Shetty SR, Chatra L, Shenai P, Rao PK.. Stevens-Johnson syndrome: a case report. J Oral Sci. 2010;52:343-346$$$$$Y$$$20240809$$HP$IN$IN
241934471$24193447$1$I$$20240610$20240809$20240809$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12853$ALKEM$Bonkovsky HL, Ghabril M, Nicoletti P, Dellinger A, Fontana RJ, Barnhart H, Gu J, Daly AK, Aithal GP, Phillips EJ, Kleiner DE.. Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlations. Liver International. 2024;44:1409-1421$$$$$Y$$$20240809$$HP$US$US
241934481$24193448$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11226$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$64$YR$$M$Y$$$20240809$$MD$BR$BR
241934491$24193449$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11213$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$44$YR$$F$Y$$$20240809$$MD$BR$BR
241934501$24193450$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11200$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$54$YR$$F$Y$$$20240809$$MD$BR$BR
241934511$24193451$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11187$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2 (4):414-420$29$YR$$F$Y$$$20240809$$MD$BR$BR
241934521$24193452$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11220$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$48$YR$$F$Y$$$20240809$$MD$BR$BR
241934531$24193453$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11222$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$15$YR$$M$Y$$$20240809$$MD$BR$BR
241934541$24193454$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11199$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$51$YR$$F$Y$$$20240809$$MD$BR$BR
241934551$24193455$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11215$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$34$YR$$F$Y$$$20240809$$MD$BR$BR
241934561$24193456$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11216$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$18$YR$$F$Y$$$20240809$$MD$BR$BR
241934571$24193457$1$I$$20240523$20240809$20240809$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-10756$ALKEM$Faraji N, Goli R, Mohsennezhad P, Mohammadpour Y, Parizad N, Salamat E, Pourbahram R, Bazbandi S.. NSAID (nonsteroidal anti-inflammatory drugs) Induced Stevens Johnson Syndrome in a 50-year-old woman: A case study. Toxicology Reports. 2024;12:289-291$50$YR$$F$Y$$$20240809$$HP$IR$IR
241934581$24193458$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11224$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$32$YR$$F$Y$$$20240809$$MD$BR$BR
241934591$24193459$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11223$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$25$YR$$M$Y$$$20240809$$MD$BR$BR
241934601$24193460$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11214$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$34$YR$$F$Y$$$20240809$$MD$BR$BR
241934611$24193461$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11219$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$40$YR$$M$Y$$$20240809$$MD$BR$BR
241934621$24193462$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11217$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2 (4):414-420$27$YR$$F$Y$$$20240809$$MD$BR$BR
241934631$24193463$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11209$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$33$YR$$M$Y$$$20240809$$MD$BR$BR
241934641$24193464$1$I$$20240717$20240809$20240809$EXP$$SE-ALKEM LABORATORIES LIMITED-SE-ALKEM-2024-16235$ALKEM$Antelmi A, Theodosiou G, Mowitz M, Bruze M. Acute photoallergic contact dermatitis from diclofenac mimicking bullous pemphigoid. Contact Dermatitis. 2024;unk:1-3$56$YR$$M$Y$$$20240809$$HP$SE$SE
241934651$24193465$1$I$$20240506$20240809$20240809$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-09877$ALKEM$$$$$M$Y$$$20240809$$CN$AU$AU
241934661$24193466$1$I$$20240715$20240809$20240809$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-16083$ALKEM$Bhatti Z, Patel S, Shah S, Shah N, Savani R, Chauhan S.. Is Diclofenac Transbuccal Mucoadhesive Patch Superior to Oral Diclofenac for the Management of Postoperative Sequelae After Third Molar Surgery?. J Oral Maxillofac Surg. 2024;82(7):840-851$$$A$$Y$$$20240809$$HP$IN$IN
241934671$24193467$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11212$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$27$YR$$F$Y$$$20240809$$MD$BR$BR
241934681$24193468$1$I$$20240717$20240809$20240809$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-16487$ALKEM$Fernandez-Jorge B, Goday-Bujan JJ, Murga M, Molina FP, Perez-Varela L, Fonseca E.. Photoallergic contact dermatitis due to diclofenac with cross-reaction to aceclofenac: two case reports. Contact Dermatitis. 2009;61(4):236-237$$$$$Y$$$20240809$$HP$ES$ES
241934691$24193469$1$I$$20240715$20240809$20240809$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-16082$ALKEM$Bhatti Z, Patel S, Shah S, Shah N, Savani R, Chauhan S.. Is Diclofenac Transbuccal Mucoadhesive Patch Superior to Oral Diclofenac for the Management of Postoperative Sequelae After Third Molar Surgery?. J Oral Maxillofac Surg. 2024;82(7):840-851$$$A$$Y$$$20240809$$HP$IN$IN
241934701$24193470$1$I$$20240717$20240809$20240809$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-16485$ALKEM$Fernandez-Jorge B, Goday-Buj?n JJ, Murga M, Molina FP, Perez-Varela L, Fonseca E.. Photoallergic contact dermatitis due to diclofenac with cross-reaction to aceclofenac: two case reports. Contact Dermatitis. 2009;61(4):236-237$$$$$Y$$$20240809$$HP$ES$ES
241934711$24193471$1$I$$20240703$20240809$20240809$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14293$ALKEM$$$$$M$Y$$$20240809$$HP$AU$AU
241934721$24193472$1$I$$20240725$20240809$20240809$EXP$$HR-ALKEM LABORATORIES LIMITED-HR-ALKEM-2024-16729$ALKEM$Gulin SJ, Chiriac A.. Diclofenac-Induced Allergic Contact Dermatitis: A Series of Four Patients. Drug Saf Case Rep. 2016;3:15$62$YR$$F$Y$$$20240809$$HP$HR$HR
241934731$24193473$1$I$$20240531$20240809$20240809$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-12299$ALKEM$Van Velzen A, van Riel A, de Vries I, Meulenbelt J.. The dangers of metformin: Fatal lactic acidosis with therapeutic use due to renal failure. Toxicol Lett 180S. 2008;C57:S32-S246$$$$$Y$$$20240809$$HP$NL$NL
241934741$24193474$1$I$$20240806$20240809$20240809$30DAY$$US-GSK-US2024098106$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241934752$24193475$2$F$$20240830$20240809$20240902$PER$$US-AMGEN-USASP2024157164$AMGEN$$$$$F$Y$$$20240902$$HP$US$US
241934761$24193476$1$I$$20240801$20240809$20240809$EXP$$JP-009507513-2408JPN000155J$MERCK$Kurokawa M, Ikarashi D, Kato R, Kanehira M, Fukagai T, Obara W. A case of postoperative pancreatitis in patients with renal cell carcinoma with an inferior vena cava tumor thrombus treated by presurgical lenvatinib plus pembrolizumab. International Cancer Conference Journal. 2024$59$YR$$M$Y$$$20240809$$MD$JP$JP
241934771$24193477$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11164$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420$62$YR$$F$Y$$$20240809$$MD$BR$BR
241934781$24193478$1$I$$20240517$20240809$20240809$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-11163$ALKEM$Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract.. 2014;2(4):414-420$57$YR$$F$Y$$$20240809$$MD$BR$BR
241934791$24193479$1$I$20230626$20240807$20240809$20240809$EXP$$US-TAKEDA-2023TUS063825$TAKEDA$$58$YR$$F$Y$$$20240809$$CN$US$US
241934801$24193480$1$I$20240731$20240731$20240809$20240809$PER$$US-ABBVIE-5864491$ABBVIE$$29$YR$$F$Y$74.842$KG$20240809$$CN$US$US
241934811$24193481$1$I$$20240730$20240809$20240809$EXP$$US-MYLANLABS-2024M1072680$MYLAN$Moore M, King SI, Aschner Y. Endobronchial Mucormycosis Presenting as Stridor in a Diabetic Adult. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A7420.$49$YR$$M$Y$$$20240809$$HP$US$US
241934821$24193482$1$I$$20240730$20240809$20240809$EXP$$US-MYLANLABS-2024M1072277$MYLAN$Mathias P, Epstein E. Iatrogenic Cushing^s Syndrome following Epidural Steroid Injections in an HIV-Infected Patient on Treatment with Genvoya. J-Endocr-Soc 2019; 3 (Suppl. 1).$76$YR$$F$Y$$$20240809$$MD$US$US
241934831$24193483$1$I$$20240730$20240809$20240809$EXP$$JP-VIATRISJAPAN-2024M1070658AA$MYLAN$$$$A$$Y$$$20240809$$MD$JP$JP
241934841$24193484$1$I$$20240730$20240809$20240809$EXP$$GB-MYLANLABS-2024M1072777$MYLAN$Ugwoke A, Hall F. CURING THE NAIL. Rheumatol-Adv-Pract 2023; 7 (Suppl. 2) ii28-ii29 (plus Poster) abstr. P23.$41$YR$$F$Y$$$20240809$$HP$GB$GB
241934852$24193485$2$F$20240523$20240730$20240809$20240814$EXP$$NL-MYLANLABS-2024M1071061$MYLAN$$52$YR$$F$Y$$$20240814$$CN$NL$NL
241934861$24193486$1$I$$20240808$20240809$20240809$EXP$$TH-ROCHE-10000051859$ROCHE$$78$YR$E$M$Y$$$20240809$$CN$TH$TH
241934881$24193488$1$I$$20240731$20240809$20240809$EXP$NL-LRB-00993357$NL-TEVA-VS-3228991$TEVA$$68$YR$$M$Y$91.2$KG$20240809$$MD$NL$NL
241934891$24193489$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191220$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241934902$24193490$2$F$$20240819$20240809$20240821$PER$$US-AMGEN-USASP2024155944$AMGEN$$$$$M$Y$$$20240821$$CN$US$US
241935021$24193502$1$I$$20240711$20240809$20240809$PER$$US-ALVOTECHPMS-2024-ALVOTECHPMS-002029$Alvotech$$$$$M$Y$$$20240809$$CN$US$
241935031$24193503$1$I$$20240731$20240809$20240809$EXP$$LK-AJANTA-2024AJA00139$AJANTA PHARMA$Yahathugoda TC, De Silva NL, Ruben J, Gunawardena S, Weerasooriya MV, Horton J et.al.LEDoxy-SL: A Placebo-Controlled, Double-Blind, Randomized, 24-Month Trial of Six Weeks of Daily Doxycycline Plus Hygiene-Based Essential Care for Reducing Progression of Filarial Lymphedema in Sri Lanka.The American Journal of Tropical Medicine and Hygiene.23-JUL-2024;00(00):1-14$53$YR$A$F$Y$$$20240809$$HP$LK$LK
241935042$24193504$2$F$20240701$20240814$20240809$20240820$EXP$$US-TAKEDA-2024TUS077900$TAKEDA$$67$YR$$F$Y$$$20240820$$HP$US$US
241935052$24193505$2$F$$20240812$20240809$20240816$EXP$$DE-GSK-DE2024EME098738$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$PH$DE$DE
241935061$24193506$1$I$$20240711$20240809$20240809$EXP$$SG-ROCHE-10000032138$ROCHE$$61$YR$A$F$Y$$$20240809$$CN$SG$SG
241935071$24193507$1$I$$20240726$20240809$20240809$EXP$$US-UCBSA-2024038654$UCB$$$$$M$Y$$$20240809$$CN$US$US
241935081$24193508$1$I$$20240725$20240809$20240809$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461212$RANBAXY$Witton-Davies TL, Gerdsmeier-Petz W, Meier O, Schulte-Altedorneburg G. Acute Glaucoma Following Internal Carotid Artery Stenting: A Rare But Serious Complication of Ocular Ischemic Syndrome. Neurol India. 2024;Apr;72 (2):408-410$71$YR$$F$Y$$$20240809$$HP$DE$DE
241935091$24193509$1$I$$20240730$20240809$20240809$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP009759$STRIDES$Dormans T, Zandijk E, Stals F.. LATE TUBERCULOSIS REACTIVATION AFTER SEVERE COVID-19.. Eur-J-Case-Rep-Intern-Med. 2024;11(5)$8$DEC$$F$Y$$$20240809$$HP$NL$NL
241935101$24193510$1$I$$20240725$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461207$RANBAXY$$65$YR$$M$Y$83$KG$20240809$$CN$GB$GB
241935111$24193511$1$I$$20240725$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461140$RANBAXY$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al. Venetoclax plus dose?adjusted R?EPOCH (VR?DA?EPOCH) or G?EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience. Ann Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240809$$HP$CN$CN
241935121$24193512$1$I$$20240726$20240809$20240809$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461776$RANBAXY$$16$YR$$F$Y$$$20240809$$HP$ES$ES
241935131$24193513$1$I$$20240726$20240809$20240809$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461521$RANBAXY$$47$YR$$F$Y$74$KG$20240809$$CN$NL$NL
241935141$24193514$1$I$$20240725$20240809$20240809$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461983$RANBAXY$Hierl F, Luke F, Keil F, Heudobler D, Einhell S, Klier-Richter M, et al. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. Br J Cancer. 2023;128 (6):1134-1147$$$$$Y$$$20240809$$HP$DE$DE
241935151$24193515$1$I$$20240725$20240809$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461896$RANBAXY$Yan A, Ford KS, Faloye AO. Superior Vena Cava Rupture Complicated by Cardiac Tamponade. J Cardiothorac Vasc Anesth. 2024;38:788-791$55$YR$$F$Y$$$20240809$$MD$US$US
241935161$24193516$1$I$$20240725$20240809$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461319$RANBAXY$Yoo M, Shah S, Gill AE, Hawkins CM, Kasi AS, Guglani L. Management of Refractory Type 1 Plastic Bronchitis Airway Cast With Selective Lymphatic Embolization. Am J Respir Crit Care Med. 2023;207:A2634/A105$17$YR$$M$Y$$$20240809$$HP$US$US
241935181$24193518$1$I$$20240725$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461294$RANBAXY$Pang C, Wu X, Nikuze L, Wei H. Analysis of clinical characteristics and treatment efficacy in two pediatric cases of ANKRD26-related thrombocytopenia. Platelets. 2023;34:1-8$24$MON$$F$Y$$$20240809$$HP$CN$CN
241935191$24193519$1$I$$20240725$20240809$20240809$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461269$RANBAXY$Chou MY, Wu WC, Chu PY, Tai SK, Chang PMH, Lee TL, et al. Paclitaxel-Ifosfamide-based Therapy as Salvage Treatment in Platinum-resistant Recurrent/Metastatic Head and Neck Cancer. In Vivo. 2024;38 (4):1891-1899$71$YR$$M$Y$$$20240809$$HP$TW$TW
241935201$24193520$1$I$$20240725$20240809$20240809$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461156$RANBAXY$Baskurt D, Dogan PE, Mericoz CA, Demirkesen C, Vural S. Inverse psoriasis on pre-existing hidradenitis suppurativa lesions: Reply to ^A case series of tumor necrosis factor inhibitor-induced psoriasis in patients with hidradenitis suppurativa^. Dermatol Online J. 2024;30 (3):21$41$YR$$M$Y$$$20240809$$MD$TR$TR
241935212$24193521$2$F$20240722$20240909$20240809$20240924$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460702$RANBAXY$$$$A$F$Y$$$20240924$$CN$IT$IT
241935222$24193522$2$F$$20240802$20240809$20240816$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461334$RANBAXY$Raksha KNS, David VG, Thomas A, Raj SS. Disseminated histoplasmosis with obscure gastrointestinal bleeding in a renal allograft recipient: are we lurking in the dark?. Indian J Nephrol. 2023;33 (Suppl.):S137 (277)$45$YR$$M$Y$$$20240816$$HP$IN$IN
241935231$24193523$1$I$$20240725$20240809$20240809$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461464$RANBAXY$Yeoh K, Lass-Florl C, Lamoth F, Slavin MA, Williams E, Neofytos D. Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual. Transpl Infect Dis. 2024;0(0):no pagination$53$YR$$F$Y$$$20240809$$HP$AU$AU
241935241$24193524$1$I$$20240725$20240809$20240809$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460960$RANBAXY$Somoza-Fernandez B, Escudero-Vilaplana V, Collado-Borrell R, Perez-Ram?rez S, Villanueva-Bueno C, Montero-Anton MDP et al. Severe neutropenia probably caused by enzalutamide and abiraterone in aprostate cancer patient. J Oncol Pharm Pract. 2024;Jul 23:Online ahead of print$$$$M$Y$$$20240809$$HP$ES$ES
241935251$24193525$1$I$20240803$20240808$20240809$20240809$EXP$$CN-ROCHE-10000051930$ROCHE$$63$YR$A$F$Y$59.2$KG$20240809$$HP$CN$CN
241935261$24193526$1$I$$20240725$20240809$20240809$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461652$RANBAXY$Hierl F, Luke F, Keil F, Heudobler D, Einhell S, Klier-Richter M, et al. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. British Journal of Cancer. 2023;128 (6):1134-1147$$$$$Y$$$20240809$$HP$DE$DE
241935271$24193527$1$I$$20240726$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461646$RANBAXY$$23$YR$$$Y$$$20240809$$CN$GB$GB
241935281$24193528$1$I$$20240725$20240809$20240809$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461989$RANBAXY$Hierl F, Luke F, Keil F, Heudobler D, Einhell S, Klier-Richter M, et al. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. Br J Cancer. 2023;128 (6):1134-1147$$$$$Y$$$20240809$$HP$DE$DE
241935291$24193529$1$I$$20240725$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461530$RANBAXY$$73$YR$$F$Y$98$KG$20240809$$MD$GB$GB
241935311$24193531$1$I$$20240726$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461446$RANBAXY$$$$$F$Y$$$20240809$$HP$GB$GB
241935321$24193532$1$I$20240503$20240726$20240809$20240809$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461570$RANBAXY$$78$YR$$F$Y$$$20240809$$PH$ES$ES
241935331$24193533$1$I$20240502$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461657$RANBAXY$$91$YR$$F$Y$$$20240809$$MD$FR$FR
241935341$24193534$1$I$$20240725$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459102$RANBAXY$Liu H, Xue F, Zhou R, Tian H, Mao J, Wu T. Chidamide in combination with azacitidine for an elderly patient with peripheral T cell lymphoma-not otherwise specified: A case report. Oncol Lett. 2024;28 (2):1-6$71$YR$$M$Y$$$20240809$$HP$CN$CN
241935351$24193535$1$I$20240415$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461796$RANBAXY$$72$YR$$M$Y$62.2$KG$20240809$$PH$FR$FR
241935361$24193536$1$I$$20240725$20240809$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461348$RANBAXY$Beesley S, Lanspa MJ. Calcium channel overdose and insulin therapy dosing. Am J Respir Crit Care Med. 2024;209 (0):A7313$28$YR$$M$Y$$$20240809$$HP$US$US
241935371$24193537$1$I$20190201$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461612$RANBAXY$$86$YR$$M$Y$52$KG$20240809$$PH$FR$FR
241935382$24193538$2$F$20240101$20240809$20240809$20240823$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461695$RANBAXY$$71$YR$$M$Y$$$20240823$$MD$SE$SE
241935391$24193539$1$I$$20240725$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461287$RANBAXY$Pang C, Wu X, Nikuze L, Wei H. Analysis of clinical characteristics and treatment efficacy in two pediatric cases of ANKRD26-related thrombocytopenia. Platelets. 2023;34:1-8$24$MON$$M$Y$$$20240809$$HP$CN$CN
241935401$24193540$1$I$20230508$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461844$RANBAXY$$31$YR$$M$Y$$$20240809$$MD$FR$FR
241935411$24193541$1$I$$20240726$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461734$RANBAXY$D^arienzo PD, Macdonald AR, Patel V, Ma YT, Pihlak R, Starling N. Prolonged Clinical Benefit with Futibatinib in a Patient with FGFR Inhibitor-Pretreated FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma: Case Report. OncoTargets Therap. 2024;17 (0):489-496$50$YR$$F$Y$$$20240809$$HP$GB$GB
241935421$24193542$1$I$$20240726$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461444$RANBAXY$$$$$F$Y$$$20240809$$HP$GB$GB
241935431$24193543$1$I$$20240726$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461634$RANBAXY$$44$YR$$F$Y$$$20240809$$PH$GB$GB
241935441$24193544$1$I$20240422$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461838$RANBAXY$$41$YR$$F$Y$$$20240809$$PH$FR$FR
241935451$24193545$1$I$20240203$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461842$RANBAXY$$61$YR$$F$Y$80$KG$20240809$$MD$FR$FR
241935461$24193546$1$I$$20240726$20240809$20240809$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461733$RANBAXY$$43$YR$$M$Y$138$KG$20240809$$CN$NL$NL
241935471$24193547$1$I$20240426$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461832$RANBAXY$$72$YR$$M$Y$$$20240809$$PH$FR$FR
241935481$24193548$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54700$$FDA-CTU$$48$YR$$F$N$$$20240808$N$$US$
241935491$24193549$1$I$$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461770$RANBAXY$$29$YR$$M$Y$$$20240809$$HP$FR$FR
241935501$24193550$1$I$$20240725$20240809$20240809$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460956$RANBAXY$Gupta R, Gunasekaran KP, Choudhary B, Choudhary GR. Case Report: Scorpion Envenomation with Delayed Ischemic Priapism in a Preadolescent- An Unusual Presentation. Am J Trop Med Hyg. 2024;Jul 23:online ahead of print$8$YR$$M$Y$$$20240809$$HP$IN$IN
241935511$24193551$1$I$$20240725$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461136$RANBAXY$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al. Venetoclax plus dose?adjusted R?EPOCH (VR?DA?EPOCH) or G?EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience. Ann Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240809$$HP$CN$CN
241935521$24193552$1$I$$20240725$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461124$RANBAXY$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al. Venetoclax plus dose?adjusted R?EPOCH (VR?DA?EPOCH) or G?EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience. Ann Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240809$$HP$CN$CN
241935531$24193553$1$I$$20240725$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461424$RANBAXY$Tatarinova OS, Furness CL, Borman AM, Barber J, Muthialu N, Ferreras-Antolin L.. Neosartorya udagawae pulmonary infection requiring a surgical treatment in a paediatric haematopoietic progenitor cell recipient. Med Mycol Case Reports. 2024;44:1-4$3$YR$$M$Y$$$20240809$$HP$GB$GB
241935541$24193554$1$I$$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461583$RANBAXY$$55$YR$$M$Y$$$20240809$$MD$FR$FR
241935551$24193555$1$I$20240414$20240726$20240809$20240809$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461593$RANBAXY$$73$YR$$M$Y$87$KG$20240809$$CN$DE$DE
241935561$24193556$1$I$$20240725$20240809$20240809$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461134$RANBAXY$Lichtenberg I, Dal S. A PERFECT MINI-STORM: UNCOMMON AETIOLOGY FOR A COMMON PRESENTATION OF BELL?S PALSY. BMJ Neurol Open. 2023;5(Suppl 1):A1-A63$32$YR$$F$Y$$$20240809$$HP$AU$AU
241935571$24193557$1$I$20240719$20240726$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461712$RANBAXY$$89$YR$$F$Y$82$KG$20240809$$CN$GB$GB
241935581$24193558$1$I$20240405$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461996$RANBAXY$$76$YR$$F$Y$$$20240809$$PH$FR$FR
241935591$24193559$1$I$20240721$20240726$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461709$RANBAXY$$89$YR$$F$Y$$$20240809$$CN$GB$GB
241935601$24193560$1$I$$20240725$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461146$RANBAXY$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al. Venetoclax plus dose?adjusted R?EPOCH (VR?DA?EPOCH) or G?EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience. Ann Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240809$$HP$CN$CN
241935611$24193561$1$I$$20240729$20240808$20240808$DIR$FDA-CDER-CTU-2024-54721$$FDA-CTU$$$$$F$N$$$20240729$N$HP$US$
241935621$24193562$1$I$$20240725$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461139$RANBAXY$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al. Venetoclax plus dose?adjusted R?EPOCH (VR?DA?EPOCH) or G?EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience. Ann Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240809$$HP$CN$CN
241935631$24193563$1$I$$20240726$20240809$20240809$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461528$RANBAXY$Hush JM, Steffens D, Solomon MJ. A patient-designed integrative oncology intervention for stage IV locally recurrent rectal cancer: A case report. EXPLORE NY. 2024;20 (5):no pagination$59$YR$$F$Y$$$20240809$$HP$AU$AU
241935641$24193564$1$I$20240508$20240726$20240809$20240809$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461519$RANBAXY$$76$YR$$M$Y$75$KG$20240809$$MD$DE$DE
241935651$24193565$1$I$$20240726$20240809$20240809$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461641$RANBAXY$Imai Y, Hirooka M, Sunago K, Yukimoto A, Nakamura Y, Tanaka T, et al. A case of refractory liver abscess due to hypermucoviscous klebsiella pneumoniae resolved by hepatectomy. Kanzo. 2019;60 (11):427-432$65$YR$$F$Y$$$20240809$$HP$JP$JP
241935661$24193566$1$I$$20240725$20240809$20240809$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461676$RANBAXY$Torii S, Narita T, Homma T, Kinoshita T, Torii-Goto A, Esaki H, et al. Successful pre-surgical treatment with carboplatin and gemcitabine chemotherapy for a patient with muscle-invasive bladder cancer and severe renal dysfunction. Int Canc Conf J. 2024;13:230?234$72$YR$$M$Y$$$20240809$$HP$JP$JP
241935671$24193567$1$I$20200418$20240726$20240809$20240809$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461711$RANBAXY$$35$YR$$F$Y$45$KG$20240809$$MD$PL$PL
241935681$24193568$1$I$20200101$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461614$RANBAXY$$87$YR$$M$Y$53.3$KG$20240809$$PH$FR$FR
241935691$24193569$1$I$$20240725$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461142$RANBAXY$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al. Venetoclax plus dose?adjusted R?EPOCH (VR?DA?EPOCH) or G?EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience. Ann Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240809$$HP$CN$CN
241935701$24193570$1$I$$20240725$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461141$RANBAXY$Qin S, Jiang R, Dai L, Miao Y, Sha Y, Qiu T, et al. Venetoclax plus dose?adjusted R?EPOCH (VR?DA?EPOCH) or G?EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience. Ann Hematol. 2024;103 (5):1635-1642$$$$$Y$$$20240809$$HP$CN$CN
241935711$24193571$1$I$$20240802$20240809$20240809$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009937$STRIDES$Lindsay A, Niccum DE.. An Underestimated Toxin: The Case of Intentional Benzonatate Overdose Resulting in Seizure and Cardiac Arrest.. Am-J-Respir-Crit-Care-Med. 2024;209(plusPoster)$41$YR$$F$Y$$$20240809$$HP$US$US
241935721$24193572$1$I$$20240630$20240809$20240809$EXP$$JP-AstraZeneca-2024A180447$ASTRAZENECA$Matsui R. et al.. P-210 Experience with the use of dapagliflozin for treatments other than diabetes mellitus treatment at our hospital. The Japanese Journal of Nephrology 2024;66(4):664-.$$$$$Y$$$20240809$$MD$JP$
241935731$24193573$1$I$20200120$20230818$20240809$20240809$EXP$$FR-AstraZeneca-2023A190435$ASTRAZENECA$$$$$$Y$$$20240809$$MD$FR$
241935741$24193574$1$I$20240729$20240730$20240809$20240809$EXP$CN-HENLIUS-24CN016193$CN-Accord-440494$ACCORD$$60$YR$A$F$Y$67.5$KG$20240809$$MD$CN$CN
241935761$24193576$1$I$20240724$20240730$20240809$20240809$EXP$$US-Accord-439456$ACCORD$$30$YR$A$F$Y$$$20240809$$HP$US$US
241935781$24193578$1$I$20240729$20240730$20240809$20240809$EXP$$US-Accord-439933$ACCORD$$41$YR$A$F$Y$$$20240809$$HP$US$US
241935791$24193579$1$I$20181201$20240726$20240809$20240809$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461786$RANBAXY$$75$YR$$F$Y$71.7$KG$20240809$$CN$DE$DE
241935802$24193580$2$F$20240717$20240819$20240809$20240830$EXP$GB-MHRA-MED-202407251204342300-HMTGD$GB-Accord-439753$ACCORD$$25$YR$A$M$Y$85$KG$20240830$$CN$GB$GB
241935812$24193581$2$F$20240415$20240729$20240809$20240906$EXP$$FR-Accord-440085$ACCORD$$2$YR$C$F$Y$15.7$KG$20240906$$PH$FR$FR
241935821$24193582$1$I$20240729$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A176759$ASTRAZENECA$$65$YR$$F$Y$$$20240809$$CN$US$
241935831$24193583$1$I$$20240805$20240809$20240809$EXP$$ZA-AstraZeneca-2024A177583$ASTRAZENECA$$57$YR$$M$Y$$$20240809$$CN$ZA$
241935841$24193584$1$I$20240701$20240805$20240809$20240809$EXP$$GB-MYLANLABS-2024M1073526$MYLAN$$$$$F$Y$$$20240809$$PH$GB$GB
241935851$24193585$1$I$20240601$20240806$20240809$20240809$EXP$$IE-MYLANLABS-2024M1068807$MYLAN$$$$A$M$Y$$$20240809$$MD$IE$IE
241935861$24193586$1$I$20240704$20240805$20240809$20240809$EXP$$NZ-MYLANLABS-2024M1073039$MYLAN$$53$YR$$F$Y$$$20240809$$HP$NZ$NZ
241935871$24193587$1$I$$20240806$20240809$20240809$EXP$$NVSJ2024JP009473$NOVARTIS$$$$$$Y$$$20240809$$MD$JP$JP
241935881$24193588$1$I$20211007$20240806$20240809$20240809$EXP$$NVSC2024GT161706$NOVARTIS$$$$$F$Y$$$20240809$$CN$GT$GT
241935891$24193589$1$I$$20240807$20240809$20240809$EXP$$NVSC2024GB161010$NOVARTIS$$$$$F$Y$$$20240809$$CN$GB$GB
241935901$24193590$1$I$$20240726$20240809$20240809$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461576$RANBAXY$Akin G, Avci C, Akarsu S. The Significance of Eosinophil?to?Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series. Indian J Dermatol. 2024;69 (1):81-85$75$YR$$M$Y$$$20240809$$MD$TR$TR
241935912$24193591$2$F$$20240806$20240809$20240821$EXP$$MY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461616$RANBAXY$Masiran R, Ilias MNA, Yubbu P. Methylphenidate-associated chest pain in a child. Drug Ther Bull. 2024;62 (7):108-111$$$C$M$Y$$$20240821$$HP$MY$MY
241935921$24193592$1$I$$20240726$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461443$RANBAXY$Wang Z, Jiang B, Song L, Sun M, Li C, Li X, et al. Patients with acquired pure red cell aplasia respond to PI3Kdelta inhibitor rapidly. Am J Hematol. 2024;99 (7):1431-1433$48$YR$$F$Y$$$20240809$$HP$CN$CN
241935931$24193593$1$I$$20240726$20240809$20240809$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461787$RANBAXY$Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, et al. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series. J Neurol. 2024;271 (7):4028-4038$25$MON$$M$Y$$$20240809$$HP$NL$NL
241935941$24193594$1$I$$20240726$20240809$20240809$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461425$RANBAXY$$$$A$M$Y$87$KG$20240809$$MD$DE$DE
241935951$24193595$1$I$$20240726$20240809$20240809$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461552$RANBAXY$Sandhu JK, Singh S, Basu S. Severe meibomian gland loss in polycystic ovarian syndrome patients on estrogen-progesterone therapy: A case series. F1000Res. 2023;12(0):1154/1-8$29$YR$$F$Y$$$20240809$$HP$IN$IN
241935961$24193596$1$I$$20240727$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461754$RANBAXY$$67$YR$$F$Y$66$KG$20240809$$CN$GB$GB
241935971$24193597$1$I$$20240726$20240809$20240809$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461575$RANBAXY$Akin G, Avci C, Akarsu S. The Significance of Eosinophil?to?Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series. Indian J Dermatol. 2024;69 (1):81-85$66$YR$$M$Y$$$20240809$$MD$TR$TR
241935981$24193598$1$I$$20240726$20240809$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461627$RANBAXY$Virupakshaiah A, Moseley CE, Elicegui S, Gerwitz LM, Spencer CM, George E, et al. Life-Threatening MOG Antibody-Associated Hemorrhagic ADEM With Elevated CSF IL-6. Neurol Neuroimmunol Neuroinflamm. 2024;11(4):1-6$35$YR$$M$Y$$$20240809$$MD$US$US
241935991$24193599$1$I$$20240726$20240809$20240809$EXP$$ID-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461607$RANBAXY$Susanto AJ, Yusman FA, Wati FA, Pratama YS. High-Dose Vitamin D3 and Tonsillectomy as Therapeutic Management in Henoch?Sch?nlein Purpura Following Hepatitis B Vaccination: A Rare Case Report. Acta Med Indones-Indones J Intern Med. 2024;Apr; 56(2):218-226$19$YR$$F$Y$$$20240809$$MD$ID$ID
241936002$24193600$2$F$20240701$20240913$20240809$20240918$EXP$$NVSJ2024JP009533$NOVARTIS$$$$E$$Y$$$20240918$$MD$JP$JP
241936011$24193601$1$I$20240414$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460822$RANBAXY$$61$YR$$F$Y$$$20240809$$PH$FR$FR
241936021$24193602$1$I$$20240726$20240809$20240809$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461382$RANBAXY$Di Paolo M, Maiese A, Scatena A, Bonaso M, Marcacci I, Convertino I, et al. Fat overload syndrome following intravenous lipid emulsion administration as antidote in suspected anesthetic intoxication insights from a clinical and forensic case experience. :. Clin Ter. 2024;175 (4):211-215$30$YR$$F$Y$$$20240809$$HP$IT$IT
241936031$24193603$1$I$$20240726$20240809$20240809$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461471$RANBAXY$Grijo C, Madureira S, Monteiro C, Faustino C, Almeida J. When the Cure Is the Problem. Eur J Case Rep Intern Med. 2023;10(Suppl.):571-572/1246$47$YR$$M$Y$$$20240809$$HP$PT$PT
241936042$24193604$2$F$$20240802$20240809$20240816$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461562$RANBAXY$Agarwal A, Saha SC, Kaur A, Naganur S. Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum. BMJ Case Rep. 2023;16(12):1-5(e255808)$$$A$F$Y$$$20240816$$HP$IN$IN
241936051$24193605$1$I$20240625$20240726$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460938$RANBAXY$$70$YR$$F$Y$76.95$KG$20240809$$HP$GB$GB
241936061$24193606$1$I$20180727$20240727$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461966$RANBAXY$$31$YR$$M$Y$79$KG$20240809$$CN$GB$GB
241936071$24193607$1$I$$20240726$20240809$20240809$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461573$RANBAXY$Akin G, Avci C, Akarsu S. The Significance of Eosinophil?to?Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series. Indian J Dermatol. 2024;69 (1):81-85$75$YR$$M$Y$$$20240809$$MD$TR$TR
241936081$24193608$1$I$$20240727$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462010$RANBAXY$Lacampagne T, Guillotin V, Peuchant O, Belloir A, Sibon I, Bebear C, et al.. Current mycoplasma pneumoniae outbreak: don^t forget its role in bickerstaff encephalitis. Diagn microbiol infect dis. 2024;110(1):1-3$16$YR$$M$Y$$$20240809$$HP$FR$FR
241936091$24193609$1$I$$20240726$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461394$RANBAXY$Kong C, Zong L, Ji S, Liu Y, Li M. Case report: Disseminated mucormycosis misdiagnosed as malignancy developed from allergic bronchopulmonary mycosis caused by Rhizopus microsporus following SARS-CoV-2 infection in a woman. Front Med. 2024;11 (0):1394500;01-07$60$YR$$F$Y$53$KG$20240809$$HP$CN$CN
241936101$24193610$1$I$$20240726$20240809$20240809$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461586$RANBAXY$Akin G, Avci C, Akarsu S. The Significance of Eosinophil?to?Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series. Indian J Dermatol. 2024;69 (1):81-85$76$YR$$M$Y$$$20240809$$MD$TR$TR
241936111$24193611$1$I$$20240726$20240809$20240809$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461584$RANBAXY$Akin G, Avci C, Akarsu S. The Significance of Eosinophil?to?Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series. Indian J Dermatol. 2024;69 (1):81-85$76$YR$$F$Y$$$20240809$$MD$TR$TR
241936121$24193612$1$I$20240723$20240727$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461752$RANBAXY$$60$YR$$M$Y$64$KG$20240809$$CN$GB$GB
241936132$24193613$2$F$$20240806$20240809$20240821$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461619$RANBAXY$Murt A, Bayram B, Yllmaz U, Seyahi N, Eskazan AE. Chronic Myeloid Leukemia in Renal Transplantation Patients in the Era of Tyrosine Kinase Inhibitors : A Case Report and Review of the Literature. Nephron. 2024;148:563-568$63$YR$$F$Y$$$20240821$$HP$TR$TR
241936141$24193614$1$I$$20240726$20240809$20240809$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461516$RANBAXY$Akin G, Avci C, Akarsu S. The Significance of Eosinophil?to?Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series. Indian J Dermatol. 2024;69 (1):81-85$72$YR$$M$Y$$$20240809$$MD$TR$TR
241936151$24193615$1$I$$20240726$20240809$20240809$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461582$RANBAXY$Akin G, Avci C, Akarsu S. The Significance of Eosinophil?to?Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series. Indian J Dermatol. 2024;69 (1):81-85$73$YR$$M$Y$$$20240809$$MD$TR$TR
241936161$24193616$1$I$$20240726$20240809$20240809$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461587$RANBAXY$Akin G, Avci C, Akarsu S. The Significance of Eosinophil?to?Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series. Indian J Dermatol. 2024;69 (1):81-85$77$YR$$M$Y$$$20240809$$MD$TR$TR
241936171$24193617$1$I$$20240726$20240809$20240809$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452950$RANBAXY$$$$$F$Y$$$20240809$$MD$JP$JP
241936181$24193618$1$I$$20240726$20240809$20240809$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461578$RANBAXY$Akin G, Avci C, Akarsu S. The Significance of Eosinophil?to?Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series. Indian J Dermatol. 2024;69 (1):81-85$79$YR$$F$Y$$$20240809$$MD$TR$TR
241936193$24193619$3$F$$20240812$20240809$20240819$EXP$$NVSC2023FR120944$NOVARTIS$Delbet J, Hogan J, Parmentier C, Ulinski T, Dossier C. Successful global anti-B-cell strategy with daratumumab in a patient with post-transplant nephrotic syndrome recurrence unresponsive to immunoadsorption and obinutuzumab. PEDIATRIC TRANSPLANTATION. 2023;27:1-4$2$YR$$F$Y$$$20240819$$HP$FR$FR
241936201$24193620$1$I$$20240727$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461978$RANBAXY$$39$YR$$M$Y$59$KG$20240809$$CN$GB$GB
241936211$24193621$1$I$$20240726$20240809$20240809$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461374$RANBAXY$Herms Q, Fuster-Anglada C, Juanola A. Pembrolizumab-Induced Liver Injury: Beyond Immune-Mediated Hepatitis. Gastroenterology. 2024;167 (3):443-445$43$YR$$M$Y$$$20240809$$HP$ES$ES
241936221$24193622$1$I$$20240726$20240809$20240809$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461426$RANBAXY$Skiljic S, Neskovic N, Kristek G, Milic M, Vinkovic H, Kedacic K, et al. POINT-OF-CARE DIAGNOSTIC APPROACH IN A CRITICALLY ILL PATIENT WITH SEVERE BLEEDING FROM URINARY TRACT. Acta Clin Croat. 2023;62(Suppl.2):138-142$73$YR$$M$Y$$$20240809$$MD$HR$HR
241936231$24193623$1$I$$20240726$20240809$20240809$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461574$RANBAXY$Akin G, Avci C, Akarsu S. The Significance of Eosinophil?to?Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series. Indian J Dermatol. 2024;69 (1):81-85$76$YR$$M$Y$$$20240809$$MD$TR$TR
241936241$24193624$1$I$$20240726$20240809$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461598$RANBAXY$Martin G,Narvaez-Guerra O, Aurigemma G, Kovell L. Peripartum ventricular tachycardia and PVC-induced cardiomyopathy: delivering optimal care when it?s time to deliver. BMJ Case Rep. 2024;17 (6):e259075$20$YR$$F$Y$$$20240809$$HP$US$US
241936251$24193625$1$I$$20240726$20240809$20240809$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460741$RANBAXY$Teixeira AM, Fontes CP, Fonseca S. STRESS CARDIOMYOPATHY - THE GREAT IMITATOR. Eur J Case Rep Intern Med. 2019;6 (Suppl.):133-134; 2214$70$YR$$M$Y$$$20240809$$HP$PT$PT
241936261$24193626$1$I$$20240726$20240809$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461602$RANBAXY$Martin G,Narvaez-Guerra O, Aurigemma G, Kovell L. Peripartum ventricular tachycardia and PVC-induced cardiomyopathy: delivering optimal care when it?s time to deliver. BMJ Case Rep. 2024;17 (6):e259075$$$N$$Y$$$20240809$$HP$US$US
241936271$24193627$1$I$$20240726$20240809$20240809$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461762$RANBAXY$Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, et al. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series. J Neurol. 2024;271 (7):4028-4038$23$MON$$F$Y$$$20240809$$HP$NL$NL
241936281$24193628$1$I$$20240726$20240809$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461438$RANBAXY$Rudy M, Donaldson K, Biederman L, Ahmed S. A Case of Steroid-Resistant Focal Segmental Glomerulosclerosis in a Patient with a Heterozygous Mutation of COL4A3 Gene Variant of Uncertain Significance. J Am Soc Nephrol. 2023;34:1013(SA-PO1016 P)$21$YR$$M$Y$$$20240809$$HP$US$US
241936291$24193629$1$I$$20240726$20240809$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459771$RANBAXY$Applegarth J, Finn D, Tolkacz M, Robinson H, Iacco A. Calcium Channel Blocker Overdose and ECMO: A Rare Presentation of Harlequin Syndrome. ASAIO J. 2023;May 16-19;70(S):151$18$YR$$F$Y$$$20240809$$HP$US$US
241936302$24193630$2$F$20150101$20240817$20240809$20240823$EXP$$US-SHIRE-US201835517$TAKEDA$$$$$F$Y$$$20240823$$CN$US$US
241936311$24193631$1$I$$20240802$20240809$20240809$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009938$STRIDES$Singh AD, Kurin M.. An Unusual Case of Refractory Esophagitis and Esophageal Diverticulum.. Dig-Dis-Sci. 2024;69 (6):1913-1914$76$YR$$F$Y$$$20240809$$HP$US$US
241936331$24193633$1$I$$20240701$20240809$20240809$EXP$$US-TEVA-VS-3216377$TEVA$$$$$F$Y$$$20240809$$LW$US$US
241936341$24193634$1$I$$20240731$20240809$20240809$30DAY$$US-GSK-US2024095874$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241936351$24193635$1$I$$20240801$20240809$20240809$EXP$$US-JNJFOC-20240805037$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$HP$US$US
241936371$24193637$1$I$$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155557$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241936381$24193638$1$I$20240701$20240802$20240809$20240809$EXP$$US-SA-2024SA234357$SANOFI AVENTIS$$58$YR$A$F$Y$87$KG$20240809$$MD$US$US
241936391$24193639$1$I$20240702$20240807$20240809$20240809$EXP$$NVSC2024CA139280$NOVARTIS$$41$YR$$F$Y$55$KG$20240809$$MD$CA$CA
241936402$24193640$2$F$20240716$20240807$20240809$20240813$PER$$NVSC2024US161623$NOVARTIS$$66$YR$$F$Y$$$20240813$$MD$US$US
241936411$24193641$1$I$20240714$20240801$20240809$20240809$EXP$$JP-009507513-2407JPN005458J$MERCK$$6$DEC$$F$Y$$$20240809$$MD$JP$JP
241936421$24193642$1$I$$20240731$20240809$20240809$EXP$$US-MPL-000055$MLV PHARMA$$52$YR$A$M$Y$$$20240801$$HP$US$US
241936431$24193643$1$I$$20240731$20240809$20240809$EXP$$TR-MEDLEY-000019$MEDLEY PHARMACEUTICALS$$34$YR$A$M$Y$$$20240802$$MD$TR$TR
241936441$24193644$1$I$$20240725$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460787$RANBAXY$$$$$$Y$$$20240809$$HP$GB$GB
241936451$24193645$1$I$$20240729$20240809$20240809$EXP$$ES-VKT-000579$VKT PHARMA PRIVATE LIMITED$$65$YR$E$M$Y$$$20240731$$MD$ES$ES
241936461$24193646$1$I$$20240725$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461508$RANBAXY$Okkar Kyaw, Rhiannon Morris, Maya Leibowitz. Hashimoto?s encephalitis: A case report. Clinical Medicine. 2024;24 (Suppl.):6$50$YR$$F$Y$$$20240809$$HP$GB$GB
241936471$24193647$1$I$20240407$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461611$RANBAXY$$66$YR$$F$Y$$$20240809$$MD$FR$FR
241936481$24193648$1$I$$20240725$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461174$RANBAXY$Torche E, Cao R, Mattar A, Laubacher M, Riva R, Eker OF. Ultra?Early ^Fishmouth stenosis^ and thrombosis of a Surpass Evolve flow diversion device following  treatment of multiples right siphon aneurysms. Neuroradiology. 2023;65:1803-1807$44$YR$$M$Y$$$20240809$$HP$FR$FR
241936491$24193649$1$I$$20240725$20240809$20240809$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461660$RANBAXY$Hierl F, Luke F, Keil F, Heudobler D, Einhell S, Klier-Richter M, et al. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. British Journal of Cancer. 2023;128 (6):1134-1147$$$$$Y$$$20240809$$HP$DE$DE
241936501$24193650$1$I$$20240725$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461104$RANBAXY$Ghaffar MT, Warda M, Afsar M, Damodar M. A case of skin rash associated with spontaneous pneumomediastinum. Clin Med London. 2024;24 (Suppl.):17-18$81$YR$$F$Y$$$20240809$$HP$GB$GB
241936511$24193651$1$I$$20240725$20240809$20240809$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461235$RANBAXY$$$$$F$Y$$$20240809$$PH$GB$GB
241936521$24193652$1$I$$20240725$20240809$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461390$RANBAXY$Fiske HW, Saeed F, Ward C, Sinayuk B, Ulici V, Curry M, et al. Coexisting Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Overlapping Challenges in Diagnosis and Treatment. Case Rep Gastroenterol. 2024;18:167-175$30$YR$$F$Y$$$20240809$$HP$US$US
241936531$24193653$1$I$$20240805$20240809$20240809$EXP$$JP-GSK-JP2024JPN097682$GLAXOSMITHKLINE$Miyashita R, Okada N, Shimizu M, Minegishi Y. 20 - A case in which pulmonary tuberculosis developed after introduction of a biological agent for SLE. The 260th Kanto Regional Meeting of the Japanese Respiratory Society. 15$$$$$Y$$$20240809$$MD$JP$JP
241936541$24193654$1$I$20240418$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461748$RANBAXY$$70$YR$$M$Y$73$KG$20240809$$MD$FR$FR
241936551$24193655$1$I$$20240725$20240809$20240809$EXP$$LK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461729$RANBAXY$Jayaweera J, Ranasinghe G. Actinotignum schaalii pyelonephritis in a young adult with ureteric calculus: case report. Germs. 2024;Vol. 14, No. 1:101-104$24$YR$$M$Y$$$20240809$$HP$LK$LK
241936562$24193656$2$F$$20240905$20240809$20240912$EXP$$JP-GSK-JP2024JPN097683$GLAXOSMITHKLINE$Kitamura T, Moriya M. (3) A case of patient with MELAS who presented with agammaglobulinaemia during lamotrigine administration. The 17th Tohoku Regional Meeting of the Japan Epilepsy Society. 7$$$$$Y$$$20240912$$MD$JP$JP
241936581$24193658$1$I$20240804$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005389$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240809$$CN$US$US
241936601$24193660$1$I$20240806$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004929$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240809$$CN$US$US
241936611$24193661$1$I$20240801$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004944$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240809$$CN$US$US
241936621$24193662$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005047$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240809$$CN$US$US
241936631$24193663$1$I$20240501$20240730$20240809$20240809$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019506$JAZZ$$34$YR$$F$Y$$$20240809$$MD$US$US
241936641$24193664$1$I$20240717$20240805$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003343$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240809$$CN$US$US
241936651$24193665$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005584$ELI LILLY AND CO$$42$YR$A$$Y$$$20240809$$CN$US$US
241936661$24193666$1$I$$20240729$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407019821$ELI LILLY AND CO$$53$YR$A$$Y$$$20240809$$LW$US$US
241936671$24193667$1$I$$20240726$20240809$20240809$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461809$RANBAXY$Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, et al. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series. J Neurol. 2024;271 (7):4028-4038$14$YR$$F$Y$$$20240809$$HP$NL$NL
241936681$24193668$1$I$$20240726$20240809$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461594$RANBAXY$Robertson IJ, Robbins QC, Li PC. Case of metastatic clear cell odontogenic carcinoma with response to chemoimmunotherapy. BMJ case Rep. 2024;17 (4):e259568(1-4)$8$DEC$$F$Y$$$20240809$$HP$US$US
241936701$24193670$1$I$$20240726$20240809$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461449$RANBAXY$Curtis TM, Sady KM, Randall JT, Kervin P, Mosher DM, Dailey MW. 18-Month-Old with Lethargy and Accelerated Idioventricular Rhythm in Prehospital Setting: A Case Report. Prehosp Emerg Care. 2024;0(0):1-4$18$MON$$M$Y$$$20240809$$HP$US$US
241936711$24193671$1$I$$20240726$20240809$20240809$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461623$RANBAXY$Gupta NY, Al Diffalha S, Russ KB. An Unusual Case of Colitis in a Bone Marrow Transplant Patient. Gastroenterology. 2024;167(3):e1-e4$65$YR$$M$Y$$$20240809$$HP$US$US
241936721$24193672$1$I$20240503$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461428$RANBAXY$$56$YR$$M$Y$$$20240809$$MD$FR$FR
241936731$24193673$1$I$20240516$20240726$20240809$20240809$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460821$RANBAXY$$85$YR$$F$Y$$$20240809$$MD$IT$IT
241936742$24193674$2$F$20230101$20240808$20240809$20240812$EXP$$US-ABBVIE-5867904$ABBVIE$$$$$F$Y$63$KG$20240812$$CN$US$US
241936751$24193675$1$I$$20240726$20240809$20240809$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461408$RANBAXY$Qiu Z, Ji J, Zhang S, Wang S. Case report: Drug-eluting bead transcatheter arterial chemoembolization in liver metastasis and retroperitoneal lymph node metastases of renal cell carcinoma: effective local therapy with the first report. Front Oncol. 2024;14:1371414$52$YR$$M$Y$$$20240809$$HP$CN$CN
241936761$24193676$1$I$20240805$20240805$20240809$20240809$EXP$$US-JNJFOC-20240812589$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240809$$CN$US$US
241936783$24193678$3$F$$20240909$20240809$20240918$30DAY$$TR-JNJFOC-20240818895$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$TR$TR
241936801$24193680$1$I$$20240729$20240809$20240809$PER$$US-ROCHE-10000047746$ROCHE$Godfrey J, Gao L, Shouse G, Song J, Pak S, Lee B, et al. Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood. 2024-Jul-25;144 (4):457-461. doi:10.1182/blood.2024024168.$82$YR$E$M$Y$$$20240809$$HP$US$US
241936811$24193681$1$I$$20240806$20240809$20240809$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140055$DAIICHI$$$$$F$Y$$$20240809$$CN$US$US
241936822$24193682$2$F$20240501$20240911$20240809$20240912$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-139910$DAIICHI$$63$YR$$F$Y$$$20240912$$CN$US$US
241936831$24193683$1$I$$20240727$20240809$20240809$EXP$GB-MHRA-MED-202407270735169410-MQLDJ$GB-GLENMARK PHARMACEUTICALS-2024GMK092906$GLENMARK$$$$$$Y$$$20240809$$CN$GB$GB
241936841$24193684$1$I$$20240729$20240809$20240809$EXP$$CN-PBT-009605$PANACEA BIOTEC$Zhang N, Chen X, Ye T, Ge H, Zhai X, Wu J, et al. Successful Treatment of Generalized Facial Verrucae Vulgaris with a Combination of Curettage and Photodynamic Therapy in an Adolescent: A Case Report. Clin Cosmet Investig Dermatol. 2024 Jul 22;17:1695-1699. doi: 10.2147/CCID.S470435.$17$YR$T$M$Y$$$20240809$$HP$CN$CN
241936851$24193685$1$I$$20240729$20240809$20240809$EXP$$JP-PBT-009622$PANACEA BIOTEC$Yoshida H, Umemura T, Ito S, Mizuno T, Mutoh Y, Yamada T, et al. Abnormally Elevated Blood Tacrolimus Level Following the Concomitant Use of Nirmatrelvir/Ritonavir With Extended-Release Tacrolimus in a Post-lung Transplant Patient: A Case Report and a Literature Review. Cureus. 2024 Jun 21;16(6):e62868. doi: 10.7759/cureus.62868.$$$$F$Y$$$20240809$$HP$JP$JP
241936861$24193686$1$I$20240101$20240729$20240809$20240809$EXP$$DE-BAYER-2024A111103$BAYER$$27$YR$A$F$Y$$$20240809$$HP$DE$ES
241936881$24193688$1$I$20240627$20240808$20240809$20240809$EXP$FR-AFSSAPS-GR2024000971$NVSC2024FR161449$NOVARTIS$$80$YR$$F$Y$70$KG$20240809$$PH$FR$FR
241936891$24193689$1$I$$20240730$20240809$20240809$PER$$NVSC2024US156751$NOVARTIS$$$$A$M$Y$$$20240809$$CN$US$US
241936901$24193690$1$I$$20240729$20240809$20240809$EXP$$JP-ROCHE-10000048503$ROCHE$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024-Dec;24 (1):1-10. doi:10.1186/s12879-024-09631-3.$75$YR$E$M$Y$$$20240809$$HP$JP$JP
241936911$24193691$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407300937007270-RCZYJ$GB-Accord-439787$ACCORD$$75$YR$E$$Y$$$20240809$$HP$GB$GB
241936921$24193692$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407251205574320-RQCGB$GB-Accord-439652$ACCORD$$$$$$Y$$$20240809$$CN$GB$GB
241936931$24193693$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407301909068180-JCTHZ$GB-Accord-439751$ACCORD$$19$YR$A$F$Y$63$KG$20240809$$CN$GB$GB
241936941$24193694$1$I$20230127$20240730$20240809$20240809$EXP$FR-AFSSAPS-PV2023000166$FR-Accord-439304$ACCORD$$10$YR$C$F$Y$54$KG$20240809$$MD$FR$FR
241936951$24193695$1$I$$20240728$20240809$20240809$EXP$$US-Accord-440445$ACCORD$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$1$HR$N$M$Y$$$20240809$$MD$US$US
241936962$24193696$2$F$20120101$20240807$20240809$20240818$EXP$$CZ-Accord-439318$ACCORD$Lukac A. Individualized therapy for patient with prostatic cancer. Oncology (Czech Republic). 2024;18(3):216-8.$52$YR$A$M$Y$$$20240818$$MD$CZ$CZ
241936981$24193698$1$I$20240624$20240730$20240809$20240809$EXP$FR-AFSSAPS-NT2024000933$FR-Accord-439409$ACCORD$$79$YR$E$F$Y$55$KG$20240809$$PH$FR$FR
241936991$24193699$1$I$$20240728$20240809$20240809$EXP$$US-Accord-440444$ACCORD$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$1$HR$N$M$Y$$$20240809$$MD$US$US
241937001$24193700$1$I$20240229$20240731$20240809$20240809$EXP$BE-FAMHP-DHH-N2024-122275$BE-ABBVIE-5871855$ABBVIE$$$$$$Y$$$20240809$$MD$BE$BE
241937011$24193701$1$I$$20240726$20240809$20240809$PER$$US-TEVA-VS-3227797$TEVA$$84$YR$$F$Y$$$20240809$$CN$US$US
241937021$24193702$1$I$$20240731$20240809$20240809$EXP$GB-MHRA-MED-202407311157498130-FKZLG$GB-Accord-440004$ACCORD$$$$$$Y$$$20240809$$PH$GB$GB
241937031$24193703$1$I$$20240728$20240809$20240809$EXP$$US-Accord-439393$ACCORD$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$1$HR$N$M$Y$$$20240809$$MD$US$US
241937041$24193704$1$I$$20240807$20240809$20240809$PER$$US-ROCHE-10000053060$ROCHE$$$$$F$Y$$$20240809$$CN$US$US
241937051$24193705$1$I$$20240731$20240809$20240809$EXP$$US-GSK-US2024AMR096132$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241937061$24193706$1$I$20240730$20240730$20240809$20240809$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095367$VIIV$$57$YR$$$Y$$$20240809$$CN$US$US
241937071$24193707$1$I$$20240731$20240809$20240809$EXP$$US-MYLANLABS-2024M1073062$MYLAN$El Labban M, Oluic S, Guleid H, Hassan M, Diab R, Rida MA. POLYMYALGIA RHEUMATICA FOLLOWING RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINATION. Eur-J-Case-Rep-Intern-Med 2024; 11 (7):.$72$YR$$M$Y$$$20240809$$HP$US$US
241937082$24193708$2$F$$20240829$20240809$20240903$EXP$$NVSC2024US161070$NOVARTIS$$$$$$Y$$$20240903$$CN$US$US
241937091$24193709$1$I$$20240728$20240809$20240809$EXP$$US-Indoco-000598$INDOCO$Latif R, Aloqaily M, Rabadi A, Arshad K, Kurian AI, Obeidat I, et.al. Apixaban-Induced Hemopericardium in a Post-TAVR Patient: A Case Report Highlighting Diagnostic and Management Challenges. Am J Case Rep. 2024 Jul 26;25:e944173.$66$YR$E$M$Y$$$20240809$$HP$US$US
241937101$24193710$1$I$$20240728$20240809$20240809$EXP$$US-Apnar-000188$APNAR PHARMA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$$$$F$Y$$$20240809$$MD$US$US
241937111$24193711$1$I$$20240728$20240809$20240809$EXP$$US-Apnar-000191$APNAR PHARMA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$$$N$F$Y$$$20240809$$MD$US$US
241937121$24193712$1$I$20240422$20240729$20240809$20240809$EXP$FR-AFSSAPS-AVMA2024000337$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110556$ZYDUS PHARM$$$$$$Y$$$20240809$$MD$FR$FR
241937131$24193713$1$I$20240803$20240805$20240809$20240809$EXP$$US-ABBVIE-5868622$ABBVIE$$42$YR$$F$Y$$$20240809$$CN$US$US
241937141$24193714$1$I$$20240728$20240809$20240809$EXP$$US-Nexus Pharma-000298$NEXUS PHARMACEUTICALS$Surineni K, Le V, Jones D. A Case of Oral-Buccal-Lingual Dyskinesia and Neuropsychiatric Symptoms After Prolonged Levetiracetam Exposure. Cureus. 2024 Jun 19;16(6):e62692.$86$YR$E$F$Y$$$20240809$$HP$US$US
241937151$24193715$1$I$20240705$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A178115$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241937161$24193716$1$I$$20240804$20240809$20240809$PER$$US-BAYER-2024A112940$BAYER$$$$$$Y$$$20240809$$CN$US$US
241937171$24193717$1$I$$20240802$20240809$20240809$EXP$$ZA-AstraZeneca-2024A177631$ASTRAZENECA$$77$YR$$M$Y$$$20240809$$CN$ZA$
241937181$24193718$1$I$20240806$20240806$20240809$20240809$EXP$$US-AstraZeneca-2024A178541$ASTRAZENECA$$29998$DY$$F$Y$$$20240809$$CN$US$
241937191$24193719$1$I$$20240802$20240809$20240809$EXP$$JP-AstraZeneca-2023A293711$ASTRAZENECA$Yano M, et al. 36 A case of hepatocellular carcinoma in which a single dose of durvalumab and tremelimumab demonstrated a remarkable antitumor effect. The 253rd Tokai Regional Meeting of the Japanese Society of Internal Medicine 2024;$90$YR$$M$Y$$$20240809$$MD$JP$
241937201$24193720$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A177659$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241937211$24193721$1$I$$20231004$20240809$20240809$EXP$$CA-CELLTRION INC.-2023CA018967$CELLTRION$$$$$$Y$$$20240809$$MD$CA$CA
241937221$24193722$1$I$$20240730$20240809$20240809$EXP$$CA-TEVA-VS-3227852$TEVA$$65$YR$$F$Y$97$KG$20240809$$HP$CA$CA
241937241$24193724$1$I$20240701$20240802$20240809$20240809$EXP$$US-AMGEN-USASP2024154740$AMGEN$$72$YR$E$F$Y$$$20240809$$CN$US$US
241937251$24193725$1$I$$20240806$20240809$20240809$EXP$$JP-ASTELLAS-2024JP005703$ASTELLAS$$69$YR$$M$Y$$$20240809$$PH$JP$JP
241937261$24193726$1$I$20240101$20240806$20240809$20240809$EXP$$GB-ORGANON-O2408GBR000640$ORGANON$$28$YR$$F$Y$$$20240809$$HP$GB$GB
241937271$24193727$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157894$AMGEN$$$$$$Y$$$20240809$$PH$US$US
241937281$24193728$1$I$$20240802$20240809$20240809$EXP$$US-AMGEN-USASP2024154828$AMGEN$$$$$$Y$$$20240809$$LW$US$US
241937291$24193729$1$I$20231017$20240730$20240809$20240809$EXP$IT-MINISAL02-996002$IT-TEVA-VS-3228204$TEVA$$54$YR$$F$Y$$$20240809$$MD$IT$IT
241937301$24193730$1$I$20240627$20240731$20240809$20240809$EXP$FR-AFSSAPS-AN2024000951$FR-BAYER-2024A110782$BAYER$$83$YR$E$M$Y$67.5$KG$20240809$$PH$FR$FR
241937312$24193731$2$F$$20240827$20240809$20240903$EXP$$JP-ASTELLAS-2024JP005822$ASTELLAS$$$$$M$Y$$$20240904$$MD$JP$JP
241937321$24193732$1$I$$20240807$20240809$20240809$EXP$$US-ASTELLAS-2024US022539$ASTELLAS$$$$$M$Y$$$20240809$$CN$US$US
241937331$24193733$1$I$$20240802$20240809$20240809$PER$$US-ALXN-202408USA000109US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241937342$24193734$2$F$20240801$20240827$20240809$20240828$PER$$US-ALXN-202408USA000170US$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240828$$CN$US$US
241937361$24193736$1$I$$20240801$20240809$20240809$EXP$$US-MYLANLABS-2024M1072683$MYLAN$Khan S, Reggio C, Shoukat U, Lalwani A, Yousaf Z. Avoiding Premature Brain Death Declaration in Patients With Suspected Baclofen Overdose. Am-J-Respir-Crit-Care-Med 2024; 209.$58$YR$$M$Y$$$20240809$$HP$US$US
241937371$24193737$1$I$20240729$20240806$20240809$20240809$EXP$$JP-ASTELLAS-2024JP005781$ASTELLAS$$9$DEC$$F$Y$$$20240809$$MD$JP$JP
241937383$24193738$3$F$20240621$20240823$20240809$20240904$EXP$$US-ASTELLAS-2024US022555$ASTELLAS$$74$YR$E$M$Y$$$20240904$$CN$US$US
241937392$24193739$2$F$20240802$20240920$20240809$20240925$EXP$$JP-ASTELLAS-2024JP005766$ASTELLAS$$8$DEC$E$M$Y$$$20240925$$MD$JP$JP
241937401$24193740$1$I$$20240808$20240809$20240809$EXP$$JP-ASTELLAS-2024JP005835$ASTELLAS$$92$YR$$F$Y$$$20240809$$PH$JP$JP
241937411$24193741$1$I$$20240806$20240809$20240809$EXP$$US-ASTELLAS-2024US022494$ASTELLAS$$$$$F$Y$$$20240809$$HP$US$US
241937421$24193742$1$I$$20240726$20240809$20240809$PER$$US-JNJFOC-20240775868$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$CN$US$US
241937461$24193746$1$I$20240807$20240808$20240808$20240808$DIR$713459$$FDA-CTU$$63$YR$$M$N$$$20240808$N$HP$US$
241937481$24193748$1$I$20240701$20240726$20240809$20240809$EXP$FR-AFSSAPS-LL2024001385$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07204$HIKMA$$49$YR$$F$Y$52.5$KG$20240809$$MD$FR$FR
241937491$24193749$1$I$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683608$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241937502$24193750$2$F$$20240909$20240809$20240918$30DAY$$US-GSK-US2024AMR098340$GLAXOSMITHKLINE$$$$$M$Y$$$20240918$$CN$US$US
241937521$24193752$1$I$$20240731$20240809$20240809$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095800$VIIV$$$$$M$Y$$$20240809$$CN$US$US
241937531$24193753$1$I$20240730$20240730$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024095397$VIIV$$62$YR$$M$Y$$$20240809$$HP$US$US
241937541$24193754$1$I$$20240805$20240809$20240809$EXP$DE-AMGEN-DEUSP2024142587$DE-ROCHE-10000049214$ROCHE$Bitterer F.; Zhou J.Y.; Eder D. et.al.. Case report: Predictability of clinical response and rejection risk after immune checkpoint inhibition in liver transplantation. Frontiers in transplantation. 2023;2:1-9. doi:10.3389/frtra.2023.1211916$62$YR$A$M$Y$$$20240809$$HP$DE$DE
241937561$24193756$1$I$$20240808$20240809$20240809$PER$$US-ABBVIE-5873380$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241937571$24193757$1$I$$20240807$20240809$20240809$PER$$US-BAYER-2024A114177$BAYER$$46$YR$A$F$Y$$$20240809$$HP$US$US
241937591$24193759$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003766$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240809$$MD$US$US
241937601$24193760$1$I$20240728$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004819$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240809$$CN$US$US
241937611$24193761$1$I$$20240807$20240809$20240809$PER$$US-BAYER-2024A114422$BAYER$$$$$$Y$$$20240809$$HP$US$US
241937631$24193763$1$I$$20240726$20240809$20240809$EXP$$TR-ACI HealthCare Limited-2160213$ACI HEALTHCARE$Full text$17$YR$$F$Y$$$20240809$$MD$TR$TR
241937641$24193764$1$I$$20240807$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2024US071377$SANDOZ$$$$$F$Y$$$20240809$$MD$US$US
241937651$24193765$1$I$$20240724$20240809$20240809$EXP$$US-SERB S.A.S.-2160222$LABORATOIRES SERB$$$$$M$Y$$$20240809$$PH$US$US
241937661$24193766$1$I$$20240731$20240809$20240809$EXP$$CN-Appco Pharma LLC-2160229$APPCO PHARMA$Initial$24$YR$$F$Y$$$20240809$$$CN$CN
241937672$24193767$2$F$$20240810$20240809$20240822$EXP$$IN-Appco Pharma LLC-2160224$APPCO PHARMA$Follow up$28$YR$$F$Y$$$20240822$$$IN$IN
241937683$24193768$3$F$20240802$20240828$20240809$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024064$UNITED THERAPEUTICS$$46$YR$$F$Y$77.098$KG$20240905$$PH$US$US
241937691$24193769$1$I$$20240731$20240809$20240809$EXP$$TR-Appco Pharma LLC-2160220$APPCO PHARMA$Initial$81$YR$$M$Y$$$20240809$$$TR$TR
241937701$24193770$1$I$$20240725$20240809$20240809$EXP$$IT-Creekwood Pharmaceuticals LLC-2160216$CREEKWOOD PHARMACEUTICALS$Full text$15$YR$$F$Y$48$KG$20240809$$$IT$IT
241937711$24193771$1$I$$20240725$20240809$20240809$EXP$$CN-Nuvo Pharmaceuticals Inc-2160225$NUVO PHARMACEUTICALS$Source document (Abstract).$40$YR$$F$Y$$$20240809$$$CN$CN
241937721$24193772$1$I$$20240731$20240809$20240809$EXP$$PT-Appco Pharma LLC-2160232$APPCO PHARMA$Initial$74$YR$$M$Y$$$20240809$$$PT$PT
241937732$24193773$2$F$20240701$20240905$20240809$20240909$EXP$$CA-JNJFOC-20240816804$JOHNSON AND JOHNSON$$14$YR$T$M$Y$47$KG$20240909$$HP$CA$CA
241937741$24193774$1$I$20240723$20240801$20240809$20240809$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160219$JIANGSU HENGRUI MEDICINE$$65$YR$$F$Y$70$KG$20240809$$MD$CN$CN
241937751$24193775$1$I$$20240807$20240809$20240809$EXP$$US-JNJFOC-20240821007$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240809$$MD$US$US
241937761$24193776$1$I$$20240725$20240809$20240809$EXP$$US-Nuvo Pharmaceuticals Inc-2160230$NUVO PHARMACEUTICALS$Source document (Full text article).$48$YR$$F$Y$$$20240809$$MD$US$US
241937771$24193777$1$I$$20240725$20240809$20240809$EXP$$US-Nuvo Pharmaceuticals Inc-2160227$NUVO PHARMACEUTICALS$Source document (Abstract).$64$YR$$F$Y$$$20240809$$$US$US
241937782$24193778$2$F$20240807$20240913$20240809$20240914$PER$$US-AMGEN-USASP2024157942$AMGEN$$69$YR$E$M$Y$$$20240914$$CN$US$US
241937793$24193779$3$F$20240802$20240823$20240809$20240830$PER$$US-AMGEN-USASP2024156007$AMGEN$$92$YR$E$F$Y$$$20240830$$CN$US$US
241937801$24193780$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54672$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
241937811$24193781$1$I$$20240726$20240809$20240809$EXP$$CN-The ACME Laboratories Ltd-2160233$THE ACME LABORATORIES$Full text$40$YR$$M$Y$$$20240809$$$CN$CN
241937821$24193782$1$I$$20220506$20240809$20240809$EXP$$US-AstraZeneca-2022A179799$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241937831$24193783$1$I$20230101$20240730$20240809$20240809$EXP$$IL-TEVA-VS-3213088$TEVA$$74$YR$$F$Y$$$20240809$$HP$IL$IL
241937842$24193784$2$F$20240716$20240911$20240809$20240926$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000472$BECTON DICKINSON$$$$$$Y$$$20240926$$CN$GB$GB
241937851$24193785$1$I$$20240725$20240809$20240809$EXP$$US-Nuvo Pharmaceuticals Inc-2160226$NUVO PHARMACEUTICALS$Source document (Abstract).$26$YR$$M$Y$$$20240809$$$US$US
241937861$24193786$1$I$20240601$20240801$20240809$20240809$EXP$$FR-AstraZeneca-2024A174885$ASTRAZENECA$$$$A$M$Y$$$20240809$$MD$FR$
241937871$24193787$1$I$$20240725$20240809$20240809$EXP$$KR-Nuvo Pharmaceuticals Inc-2160228$NUVO PHARMACEUTICALS$Source document (Abstract).$38$YR$$M$Y$$$20240809$$MD$KR$KR
241937881$24193788$1$I$$20240726$20240809$20240809$EXP$$IT-ACI HealthCare Limited-2160211$ACI HEALTHCARE$Full text$15$YR$$F$Y$48$KG$20240809$$$IT$IT
241937891$24193789$1$I$$20240808$20240809$20240809$PER$$US-BAYER-2024A114778$BAYER$$32$YR$A$F$Y$$$20240809$$CN$US$US
241937901$24193790$1$I$20240101$20240731$20240809$20240809$PER$$US-SA-2024SA232184$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240809$$MD$US$US
241937911$24193791$1$I$$20240725$20240809$20240809$PER$$US-SA-2024SA222551$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$CN$US$US
241937931$24193793$1$I$$20240726$20240809$20240809$EXP$$US-MYLANLABS-2024M1071517$MYLAN$Fenner EG, Simpson CE. An adult patient with pulmonary arterial hypertension, a NOTCH3 mutation, and leflunomide exposure. Pulm-Circ 2024; 14 (3):.$39$YR$$F$Y$$$20240809$$HP$US$US
241937941$24193794$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA232101$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240809$$MD$US$US
241937951$24193795$1$I$20240701$20240731$20240809$20240809$PER$$US-SA-2023SA201700$SANOFI AVENTIS$$59$YR$A$M$Y$106$KG$20240809$$MD$US$US
241937961$24193796$1$I$20240601$20240731$20240809$20240809$PER$$US-SA-2024SA231812$SANOFI AVENTIS$$76$YR$E$M$Y$72.57$KG$20240809$$MD$US$US
241937972$24193797$2$F$20240101$20240826$20240809$20240905$PER$$US-SA-2024SA231774$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240905$$MD$US$US
241937981$24193798$1$I$20240501$20240731$20240809$20240809$PER$$US-SA-2024SA232224$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240809$$MD$US$US
241937991$24193799$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA231598$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240809$$HP$US$US
241938002$24193800$2$F$20240101$20240830$20240809$20240923$PER$$US-SA-2024SA230263$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240923$$CN$US$US
241938011$24193801$1$I$20240126$20240731$20240809$20240809$PER$$US-SA-2024SA231957$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240809$$MD$US$US
241938021$24193802$1$I$20240727$20240806$20240809$20240809$EXP$DK-DKMA-30737193$DK-ABBVIE-5869580$ABBVIE$$52$YR$$M$Y$$$20240809$$MD$DK$DK
241938031$24193803$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA230580$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240809$$CN$US$US
241938041$24193804$1$I$20240701$20240731$20240809$20240809$PER$$US-SA-2024SA219358$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240809$$MD$US$US
241938062$24193806$2$F$$20240820$20240809$20240903$PER$$US-SA-2024SA230919$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240903$$MD$US$US
241938071$24193807$1$I$20240701$20240731$20240809$20240809$PER$$US-SA-2024SA232173$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240809$$MD$US$US
241938081$24193808$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA231558$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241938091$24193809$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA230839$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240809$$MD$US$US
241938101$24193810$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA230816$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240809$$MD$US$US
241938111$24193811$1$I$20240730$20240731$20240809$20240809$PER$$US-SA-2024SA231331$SANOFI AVENTIS$$64$YR$A$F$Y$107.5$KG$20240809$$MD$US$US
241938123$24193812$3$F$$20240820$20240809$20240830$EXP$$US-BEH-2024176914$CSL BEHRING$$$$A$F$Y$$$20240830$$CN$US$US
241938131$24193813$1$I$$20240730$20240809$20240809$PER$$US-SA-2024SA231931$SANOFI AVENTIS$$$$A$$Y$$$20240809$$CN$US$US
241938141$24193814$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA231509$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241938151$24193815$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA231529$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240809$$MD$US$US
241938161$24193816$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA233925$SANOFI AVENTIS$$$$A$F$Y$65.77$KG$20240809$$MD$US$US
241938171$24193817$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232000$SANOFI AVENTIS$$$$$F$Y$$$20240809$$MD$US$US
241938181$24193818$1$I$20240401$20240801$20240809$20240809$PER$$US-SA-2024SA231975$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240809$$MD$US$US
241938191$24193819$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA231983$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240809$$MD$US$US
241938202$24193820$2$F$$20240828$20240809$20240830$30DAY$$AU-JNJFOC-20240818874$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$PH$AU$AU
241938211$24193821$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232232$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240809$$MD$US$US
241938222$24193822$2$F$20240726$20240823$20240809$20240829$PER$$US-SA-2024SA233293$SANOFI AVENTIS$$48$YR$A$F$Y$97.5$KG$20240829$$MD$US$US
241938231$24193823$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA231959$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240809$$MD$US$US
241938241$24193824$1$I$20240731$20240801$20240809$20240809$PER$$US-SA-2024SA231456$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240809$$MD$US$US
241938251$24193825$1$I$20240401$20240801$20240809$20240809$PER$$US-SA-2024SA232521$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240809$$MD$US$US
241938261$24193826$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA235213$SANOFI AVENTIS$$$$C$M$Y$25.67$KG$20240809$$MD$US$US
241938271$24193827$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA233136$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240809$$MD$US$US
241938281$24193828$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA235577$SANOFI AVENTIS$$$$E$F$Y$57$KG$20240809$$MD$US$US
241938291$24193829$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA231985$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240809$$MD$US$US
241938301$24193830$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA231982$SANOFI AVENTIS$$$$E$F$Y$$$20240809$$MD$US$US
241938311$24193831$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA233597$SANOFI AVENTIS$$$$E$M$Y$78.017$KG$20240809$$MD$US$US
241938321$24193832$1$I$20240701$20240801$20240809$20240809$PER$$US-SA-2024SA118423$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240809$$MD$US$US
241938331$24193833$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA231907$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240809$$MD$US$US
241938341$24193834$1$I$20240806$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54669$$FDA-CTU$$69$YR$$F$N$$$20240808$N$$US$
241938351$24193835$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232077$SANOFI AVENTIS$$$$$$Y$$$20240809$$HP$US$US
241938361$24193836$1$I$20240720$20240801$20240809$20240809$PER$$US-SA-2024SA232117$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240809$$MD$US$US
241938373$24193837$3$F$$20240904$20240809$20240917$PER$$US-SA-2024SA232260$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240918$$MD$US$US
241938381$24193838$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54663$$FDA-CTU$$74$YR$$M$N$$$20240808$N$$US$
241938391$24193839$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232010$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240809$$MD$US$US
241938402$24193840$2$F$20240101$20240806$20240809$20240817$PER$$US-SA-2024SA233628$SANOFI AVENTIS$$52$YR$A$F$Y$72.57$KG$20240817$$MD$US$US
241938411$24193841$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA232940$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240809$$MD$US$US
241938421$24193842$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA233593$SANOFI AVENTIS$$$$E$M$Y$$$20240809$$MD$US$US
241938431$24193843$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA233981$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240809$$MD$US$US
241938442$24193844$2$F$20240101$20240809$20240809$20240819$PER$$US-SA-2024SA232201$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240819$$MD$US$US
241938451$24193845$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54670$$FDA-CTU$$72$YR$$F$N$$$20240808$N$$US$
241938461$24193846$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54707$$FDA-CTU$$87$YR$$F$N$$$20240808$N$$US$
241938473$24193847$3$F$20240301$20240904$20240809$20240919$PER$$US-SA-2024SA232555$SANOFI AVENTIS$$45$YR$A$M$Y$84.8$KG$20240919$$MD$US$US
241938481$24193848$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232068$SANOFI AVENTIS$$$$A$F$Y$65.77$KG$20240809$$MD$US$US
241938493$24193849$3$F$20240101$20240905$20240809$20240914$PER$$US-SA-2024SA234019$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240914$$MD$US$US
241938501$24193850$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA229735$SANOFI AVENTIS$$$$$F$Y$$$20240809$$CN$US$US
241938511$24193851$1$I$20240701$20240801$20240809$20240809$PER$$US-SA-2024SA232244$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240809$$MD$US$US
241938521$24193852$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA231976$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240809$$MD$US$US
241938531$24193853$1$I$20240612$20240801$20240809$20240809$PER$$US-SA-2024SA232024$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240809$$HP$US$US
241938541$24193854$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA229853$SANOFI AVENTIS$$$$$F$Y$$$20240809$$CN$US$US
241938551$24193855$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA233728$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241938571$24193857$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA231995$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240809$$MD$US$US
241938581$24193858$1$I$20240731$20240808$20240809$20240809$PER$$US-BAYER-2024A114845$BAYER$$2$YR$C$M$Y$$$20240809$$CN$US$US
241938591$24193859$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232065$SANOFI AVENTIS$$$$A$M$Y$$$20240809$$MD$US$US
241938601$24193860$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA233272$SANOFI AVENTIS$$$$$F$Y$$$20240809$$CN$US$US
241938611$24193861$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA231733$SANOFI AVENTIS$$$$$$Y$$$20240809$$MD$US$US
241938621$24193862$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232095$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241938631$24193863$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232050$SANOFI AVENTIS$$6$YR$C$M$Y$20$KG$20240809$$MD$US$US
241938641$24193864$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA233662$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240809$$MD$US$US
241938651$24193865$1$I$20240731$20240801$20240809$20240809$PER$$US-SA-2024SA232262$SANOFI AVENTIS$$77$YR$E$M$Y$87.08$KG$20240809$$MD$US$US
241938661$24193866$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA231595$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240809$$MD$US$US
241938671$24193867$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA231498$SANOFI AVENTIS$$$$$F$Y$$$20240809$$HP$US$US
241938681$24193868$1$I$20240802$20240802$20240809$20240809$PER$$US-SA-2024SA231089$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240809$$CN$US$US
241938691$24193869$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA233123$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240809$$HP$US$US
241938702$24193870$2$F$$20240806$20240809$20240816$PER$$US-SA-2024SA232084$SANOFI AVENTIS$$$$A$M$Y$104$KG$20240816$$MD$US$US
241938711$24193871$1$I$20240101$20240802$20240809$20240809$PER$$US-SA-2024SA235432$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240809$$CN$US$US
241938721$24193872$1$I$20240605$20240731$20240809$20240809$EXP$$ES-AUROBINDO-AUR-APL-2024-038924$AUROBINDO$$86$YR$$M$Y$$$20240809$$MD$ES$ES
241938731$24193873$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA233953$SANOFI AVENTIS$$$$A$F$Y$79$KG$20240809$$MD$US$US
241938741$24193874$1$I$$20240806$20240809$20240809$PER$$US-SA-2024SA235381$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240809$$CN$US$US
241938751$24193875$1$I$$20240805$20240809$20240809$PER$$US-SA-2024SA232925$SANOFI AVENTIS$$$$A$$Y$$$20240809$$MD$US$US
241938762$24193876$2$F$$20240913$20240809$20240923$PER$$US-SA-2024SA233872$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240923$$MD$US$US
241938771$24193877$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA232942$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240809$$MD$US$US
241938781$24193878$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA235386$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241938791$24193879$1$I$20230802$20240802$20240809$20240809$PER$$US-SA-2023SA249138$SANOFI AVENTIS$$63$YR$A$F$Y$47$KG$20240809$$MD$US$US
241938801$24193880$1$I$20240101$20240802$20240809$20240809$PER$$US-SA-2024SA232784$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240809$$MD$US$US
241938811$24193881$1$I$20240101$20240802$20240809$20240809$PER$$US-SA-2024SA231162$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240809$$HP$US$US
241938821$24193882$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA233670$SANOFI AVENTIS$$$$A$M$Y$$$20240809$$CN$US$US
241938831$24193883$1$I$20240601$20240802$20240809$20240809$PER$$US-SA-2024SA232900$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240809$$MD$US$US
241938841$24193884$1$I$20240101$20240802$20240809$20240809$PER$$US-SA-2024SA231903$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240809$$MD$US$US
241938851$24193885$1$I$20240701$20240802$20240809$20240809$PER$$US-SA-2022SA326398$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240809$$MD$US$US
241938862$24193886$2$F$20240101$20240828$20240809$20240918$PER$$US-SA-2024SA235156$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240918$$MD$US$US
241938871$24193887$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA231340$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240809$$MD$US$US
241938882$24193888$2$F$$20240807$20240809$20240816$PER$$US-SA-2024SA235013$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240816$$CN$US$US
241938913$24193891$3$F$20230101$20240826$20240809$20240903$EXP$$CA-CELLTRION INC.-2023CA024631$CELLTRION$$$$$$Y$$$20240903$$CN$CA$CA
241938922$24193892$2$F$$20240813$20240809$20240821$EXP$$IN-VANTIVE-2024VAN018881$Vantive US Healthcare$$26$YR$$M$Y$$$20240821$$CN$IN$IN
241938931$24193893$1$I$$20240808$20240809$20240809$PER$$US-BAYER-2024A114853$BAYER$$20$YR$A$F$Y$$$20240809$$MD$US$US
241938941$24193894$1$I$20240503$20240726$20240809$20240809$EXP$FR-AFSSAPS-LL2024001380$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07205$HIKMA$$54$YR$$F$Y$71$KG$20240809$$MD$FR$FR
241938951$24193895$1$I$20240804$20240806$20240809$20240809$EXP$$IN-ROCHE-3519586$ROCHE$$78$YR$E$M$Y$46.9$KG$20240809$$MD$IN$IN
241938961$24193896$1$I$20240701$20240805$20240809$20240809$EXP$$FR-EXELIXIS-CABO-24080366$EXELIXIS$$13$YR$$F$Y$50$KG$20240809$$MD$FR$FR
241938972$24193897$2$F$20240524$20240821$20240809$20240827$EXP$$FR-EXELIXIS-CABO-24080362$EXELIXIS$$80$YR$$M$Y$76$KG$20240827$$PH$FR$FR
241938981$24193898$1$I$$20240805$20240809$20240809$EXP$$JP-EXELIXIS-CABO-24080295$EXELIXIS$$7$DEC$$M$Y$$$20240809$$MD$JP$JP
241938991$24193899$1$I$20240808$20240808$20240809$20240809$EXP$$AU-SANDOZ INC.-SDZ2024AU071457$SANDOZ$$35$YR$$M$Y$$$20240809$$MD$AU$AU
241939002$24193900$2$F$20240731$20240820$20240809$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023859$UNITED THERAPEUTICS$$35$YR$$M$Y$67.12$KG$20240828$$PH$US$US
241939011$24193901$1$I$20240101$20240801$20240809$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023989$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240809$$$US$US
241939021$24193902$1$I$20240512$20240730$20240809$20240809$EXP$FR-AFSSAPS-LL2024001396$FR-TEVA-VS-3228342$TEVA$$6$YR$$M$Y$$$20240809$$CN$FR$FR
241939031$24193903$1$I$$20240731$20240809$20240809$EXP$$PT-AUROBINDO-AUR-APL-2024-039295$AUROBINDO$Lobo Oliveira M, Peixoto AC, Alves L, Mendes Piedade N, Nogueira Silva L, Almeida J et,al. PO-0126 ? (3983) ?Pneumonia necrotizante, uma complica??o rara. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Naciona. 2024$48$YR$$F$Y$$$20240809$$MD$PT$PT
241939041$24193904$1$I$$20240802$20240809$20240809$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006417$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241939062$24193906$2$F$20240101$20240827$20240809$20240904$EXP$$CA-CELLTRION INC.-2024CA006243$CELLTRION$$$$$$Y$$$20240904$$MD$CA$CA
241939071$24193907$1$I$$20240807$20240809$20240809$PER$$US-BAYER-2024A115045$BAYER$$$$$$Y$$$20240809$$CN$US$US
241939081$24193908$1$I$$20240730$20240809$20240809$EXP$$CA-TEVA-VS-3227603$TEVA$$82$YR$$M$Y$$$20240809$$HP$CA$CA
241939092$24193909$2$F$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683610$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241939102$24193910$2$F$20240805$20240809$20240809$20240820$PER$$CN-BRACCO-2024CN04871$BRACCO$$62$YR$$M$Y$$$20240820$$HP$CN$CN
241939111$24193911$1$I$20240226$20240303$20240809$20240809$EXP$$NVSC2024IL048093$NOVARTIS$$58$YR$$F$Y$$$20240809$$HP$IL$IL
241939121$24193912$1$I$$20240731$20240809$20240809$EXP$CA-MHPD-E2B_07144306$CA-Accord-439723$ACCORD$$46$YR$A$M$Y$$$20240809$$CN$CA$CA
241939131$24193913$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54651$$FDA-CTU$$70$YR$$F$N$$$20240808$N$$US$
241939142$24193914$2$F$20190218$20240815$20240809$20240827$EXP$DE-EMA-2024723-AUTODUP-1721768647274$DE-Accord-439262$ACCORD$$$$A$F$Y$63.5$KG$20240827$$MD$DE$DE
241939151$24193915$1$I$20240101$20240730$20240809$20240809$EXP$FI-FIMEA-202402681$FI-Accord-439315$ACCORD$$73$YR$E$F$Y$$$20240809$$HP$FI$FI
241939161$24193916$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54718$$FDA-CTU$$65$YR$$F$N$83.91$KG$20240808$N$$US$
241939171$24193917$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54702$$FDA-CTU$$62$YR$$F$N$104.33$KG$20240808$N$$US$
241939181$24193918$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54711$$FDA-CTU$$59$YR$$F$N$$$20240808$N$$US$
241939201$24193920$1$I$$20240805$20240809$20240809$PER$$US-BAYER-2024A112996$BAYER$$30$YR$A$F$Y$$$20240809$$MD$US$US
241939211$24193921$1$I$$20240726$20240809$20240809$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110453$ZYDUS PHARM$Beavin S, Ahmed S.. Mind the Gap: Pyroglutamic Acidosis as a Not-so-Rare Cause of High Anion Gap Metabolic Acidosis (HAGMA).. J-Am-Soc-Nephrol. 2023;34(11):202$$$$$Y$$$20240809$$HP$US$US
241939221$24193922$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54732$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
241939231$24193923$1$I$$20240730$20240809$20240809$EXP$$US-Accord-439939$ACCORD$$42$YR$A$M$Y$$$20240809$$HP$US$US
241939241$24193924$1$I$$20240729$20240809$20240809$EXP$$GB-Accord-438934$ACCORD$Ameli R. Interesting case of Strongyloides hyperinfection syndrome in an immunocompromised patient. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24(Supplement):100043.$42$YR$A$F$Y$$$20240809$$MD$GB$GB
241939251$24193925$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407251205535180-QZRPB$GB-Accord-439656$ACCORD$$$$$$Y$75$KG$20240809$$CN$GB$GB
241939261$24193926$1$I$20240731$20240731$20240809$20240809$EXP$GB-MHRA-TPP36479158C6663697YC1722424768133$GB-Accord-440011$ACCORD$$81$YR$E$M$Y$91$KG$20240809$$PH$GB$GB
241939271$24193927$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407260753521180-LKRTB$GB-Accord-439532$ACCORD$$60$YR$A$F$Y$$$20240809$$MD$GB$GB
241939282$24193928$2$F$20240722$20240822$20240809$20240903$EXP$$US-Accord-440532$ACCORD$$32$YR$A$M$Y$$$20240903$$HP$US$US
241939301$24193930$1$I$20240401$20240801$20240809$20240809$PER$$PR-ABBVIE-5864873$ABBVIE$$$$A$F$Y$$$20240809$$MD$PR$PR
241939311$24193931$1$I$$20240805$20240809$20240809$PER$$US-BAYER-2024A113037$BAYER$$37$YR$A$F$Y$$$20240809$$HP$US$US
241939321$24193932$1$I$20240706$20240730$20240809$20240809$EXP$GB-MHRA-31322883$GB-Accord-439764$ACCORD$$50$YR$A$F$Y$65$KG$20240809$$MD$GB$GB
241939331$24193933$1$I$20240610$20240802$20240809$20240809$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-108420$REGENERON$$80$YR$$M$Y$$$20240809$$MD$JP$JP
241939341$24193934$1$I$$20240801$20240809$20240809$EXP$$US-SA-2024SA235206$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240809$$MD$US$US
241939351$24193935$1$I$$20240806$20240809$20240809$EXP$$BR-TAKEDA-2024TUS079465$TAKEDA$$$$$M$Y$$$20240809$$CN$BR$BR
241939361$24193936$1$I$$20240804$20240809$20240809$PER$$US-BAYER-2024A113040$BAYER$$$$$F$Y$$$20240809$$CN$US$US
241939371$24193937$1$I$20240621$20240730$20240809$20240809$EXP$FR-AFSSAPS-GR2024000922$FR-TEVA-VS-3227965$TEVA$$51$YR$$F$Y$$$20240809$$PH$FR$FR
241939381$24193938$1$I$$20240807$20240809$20240809$EXP$$ES-SANDOZ INC.-SDZ2024ES071478$SANDOZ$Laiseca Garcia, J, Moreno Mata, E, Garcia Rodriguez, C, Gonzalez Munoz, M, Barrios Albajar, M, Burgos Montero, A M, Gonzalez Sanchez, L A. Drug-Induced Enterocolitis Syndrome due to Acetaminophen in an Adult: A Call for Diagnostic Tools and Accurate Management. J Investig Allergol Clin Immunol. 2024;34:1-5$45$YR$$M$Y$$$20240809$$MD$ES$ES
241939391$24193939$1$I$20240101$20240802$20240809$20240809$PER$$US-JNJFOC-20240806994$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$CN$US$IN
241939401$24193940$1$I$$20240805$20240809$20240809$EXP$GB-MHRA-TPP17742326C576475YC1722345779072$GB-MYLANLABS-2024M1073438$MYLAN$$56$YR$$M$Y$125$KG$20240809$$HP$GB$GB
241939411$24193941$1$I$$20240807$20240809$20240809$EXP$$US-JNJFOC-20240821028$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240809$$CN$US$US
241939421$24193942$1$I$20240517$20240806$20240809$20240809$EXP$$US-ROCHE-10000051314$ROCHE$$100$YR$E$F$Y$$$20240809$$CN$US$US
241939431$24193943$1$I$$20240731$20240809$20240809$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07452$HIKMA$Cardenas JM, Borasino S, Timpa J, Hawkins J, McBride M, Rushton W, et al.. Cardenas JM, Borasino S, Timpa J, Hawkins J, McBride M, Rushton W et al. Central ECMO cannulation for severe dihydropyridine calcium channel blocker overdose. The journal of extra-corporeal technology. 2023;55(4):206-8$12$YR$$F$Y$63$KG$20240809$$MD$US$US
241939441$24193944$1$I$$20240730$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR098015$VIIV$$$$$$Y$$$20240809$$HP$US$US
241939452$24193945$2$F$$20240809$20240809$20240819$30DAY$$US-GSK-US2024095381$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
241939461$24193946$1$I$$20240731$20240809$20240809$30DAY$$US-GSK-US2024095897$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241939471$24193947$1$I$20240730$20240730$20240809$20240809$EXP$$US-Accord-439734$ACCORD$$20$YR$A$M$Y$$$20240809$$HP$US$US
241939481$24193948$1$I$20210713$20240731$20240809$20240809$EXP$PL-URPL-DML-MLP.4401.1.4964.2021$PL-Accord-439597$ACCORD$$63$YR$A$F$Y$78$KG$20240809$$MD$PL$PL
241939491$24193949$1$I$20231025$20240730$20240809$20240809$EXP$FR-AFSSAPS-AM2024000563$FR-Accord-439264$ACCORD$$64$YR$A$M$Y$85$KG$20240809$$MD$FR$FR
241939501$24193950$1$I$$20240731$20240809$20240809$EXP$CA-MHPD-E2B_07144300$CA-Accord-439770$ACCORD$$68$YR$E$F$Y$$$20240809$$HP$CA$CA
241939511$24193951$1$I$20240729$20240730$20240809$20240809$EXP$$US-Accord-439627$ACCORD$$63$YR$A$M$Y$$$20240809$$MD$US$US
241939521$24193952$1$I$20240727$20240730$20240809$20240809$EXP$$US-Accord-439622$ACCORD$$59$YR$$M$Y$$$20240809$$HP$US$US
241939531$24193953$1$I$$20240729$20240809$20240809$EXP$IE-EMA-DD-20240723-7482831-074841$IE-Accord-439233$ACCORD$$$$$$Y$$$20240809$$PH$IE$IE
241939541$24193954$1$I$$20240730$20240809$20240809$EXP$$US-Accord-439707$ACCORD$$40$YR$A$M$Y$$$20240809$$MD$US$US
241939551$24193955$1$I$20230701$20240730$20240809$20240809$EXP$FR-AFSSAPS-TS2024000855$FR-Accord-439338$ACCORD$$57$YR$A$M$Y$68$KG$20240809$$MD$FR$FR
241939561$24193956$1$I$20240729$20240730$20240809$20240809$EXP$$US-Accord-439731$ACCORD$$64$YR$$M$Y$$$20240809$$HP$US$US
241939571$24193957$1$I$$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54786$$FDA-CTU$$$$$$N$$$20240808$N$$US$
241939581$24193958$1$I$20210401$20240728$20240809$20240809$EXP$$CN-Accord-438956$ACCORD$Qian Y, Chen H, Ren G. Acute therapy-related myelodysplastic syndromes following capecitabine and oxaliplatin therapy in gastric malignant tumor: A case report. Medicine. 2024;103(30):e39049.$60$YR$A$M$Y$$$20240809$$HP$CN$CN
241939591$24193959$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407301512567220-TMCRW$GB-Accord-439695$ACCORD$$$$$M$Y$$$20240809$$PH$GB$GB
241939601$24193960$1$I$20240209$20240730$20240809$20240809$EXP$FR-AFSSAPS-LM2024000159$FR-Accord-439237$ACCORD$$80$YR$E$M$Y$59$KG$20240809$$MD$FR$FR
241939611$24193961$1$I$20240628$20240801$20240809$20240809$EXP$FR-AFSSAPS-RS2024000778$FR-BIOCON BIOLOGICS LIMITED-BBL2024005712$BIOCON$$$$$$Y$$$20240809$$MD$FR$FR
241939621$24193962$1$I$$20240731$20240809$20240809$EXP$$TR-MSNLABS-2024MSNLIT01738$MSN LABORATORIES$Gurbuz AF, Eryilmaz MK, Yildiz O, Kilinc F, Araz M, Artac M.Rare case of myelodysplastic syndrome with excess blasts 2 developing after adjuvant chemoradiotherapy for triple-negative breast cancer in a patient with Bloom syndrome..Strahlentherapie und Onkologie.2024$$$$$Y$$$20240809$$MD$TR$TR
241939632$24193963$2$F$$20240911$20240809$20240913$EXP$$DE-GSK-DE2024EME098964$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$DE$DE
241939641$24193964$1$I$$20230906$20240809$20240809$EXP$$US-AstraZeneca-2023A204663$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
241939651$24193965$1$I$$20240731$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR097962$VIIV$$$$$F$Y$$$20240809$$HP$US$US
241939661$24193966$1$I$$20230306$20240809$20240809$EXP$$US-AstraZeneca-2023A055131$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
241939671$24193967$1$I$$20220419$20240809$20240809$EXP$$CA-AstraZeneca-2022A158872$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$CA$
241939681$24193968$1$I$20240726$20240806$20240809$20240809$EXP$$US-AstraZeneca-2024A178518$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241939692$24193969$2$F$$20240809$20240809$20240813$EXP$$GB-AstraZeneca-2024A178905$ASTRAZENECA$$43$YR$$F$Y$43.9$KG$20240813$$PH$GB$
241939701$24193970$1$I$$20240730$20240809$20240809$EXP$$CA-TEVA-VS-3227639$TEVA$$$$A$$Y$$$20240809$$HP$CA$CA
241939711$24193971$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004158$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240809$$CN$US$US
241939721$24193972$1$I$$20240730$20240809$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408002723$ELI LILLY AND CO$Toyama S, et al..EP-1361 A case of immune checkpoint inhibitor-induced liver injury triggered by abemaciclib administration.The 32nd Annual Meeting of the Japanese Breast Cancer Association 2024;:518.$56$YR$A$F$Y$$$20240809$$MD$JP$JP
241939732$24193973$2$F$$20240924$20240809$20240930$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408004669$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240930$$CN$JP$JP
241939741$24193974$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005460$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241939751$24193975$1$I$20240807$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004921$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241939761$24193976$1$I$$20240730$20240809$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408001944$ELI LILLY AND CO$Otsu K, et al..Two cases of delayed hepatic function disorder caused by abemaciclib.The 32nd Annual Meeting of the Japanese Breast Cancer Society 2024;:461.$56$YR$A$F$Y$$$20240809$$MD$JP$JP
241939771$24193977$1$I$20240808$20240808$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005695$ELI LILLY AND CO$$$$$M$Y$$$20240809$$CN$US$US
241939782$24193978$2$F$$20240808$20240809$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005731$ELI LILLY AND CO$$76$YR$E$$Y$$$20240812$$CN$US$US
241939791$24193979$1$I$$20240805$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002883$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240809$$HP$US$US
241939801$24193980$1$I$$20240730$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408000384$ELI LILLY AND CO$$69$YR$E$$Y$$$20240809$$LW$US$US
241939811$24193981$1$I$$20240729$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407019968$ELI LILLY AND CO$$56$YR$A$$Y$$$20240809$$LW$US$US
241939821$24193982$1$I$$20240730$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408000447$ELI LILLY AND CO$$44$YR$A$$Y$$$20240809$$LW$US$US
241939841$24193984$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005083$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240809$$CN$US$US
241939861$24193986$1$I$$20240808$20240808$20240808$DIR$713460$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241939881$24193988$1$I$$20240808$20240808$20240808$DIR$713469$$FDA-CTU$$70$YR$$M$N$$$20240808$N$HP$US$
241939902$24193990$2$F$$20240903$20240809$20240909$EXP$$CA-APOTEX-2024AP009137$APOTEX$$$$E$F$Y$$$20240909$$PH$CA$CA
241939913$24193991$3$F$20240803$20240829$20240809$20240903$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-108907$REGENERON$$83$YR$$M$Y$$$20240903$$MD$JP$JP
241939921$24193992$1$I$$20240730$20240809$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-038258$AUROBINDO$Levin S, Houser JN, Siblini H, Marshall M, Wolf J. Persistent Listeria monocytogenes Cerebritis Mimicking Cerebral Metastases Due to Melanoma. Cureus. 2024;16 (6):e62634$8$DEC$$F$Y$$$20240809$$MD$US$US
241939931$24193993$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5865482$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241939941$24193994$1$I$20240701$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024156363$AMGEN$$$$$$Y$$$20240809$$PH$US$US
241939951$24193995$1$I$$20240731$20240809$20240809$PER$$US-BAYER-2024A111324$BAYER$$33$YR$A$F$Y$$$20240809$$HP$US$US
241939961$24193996$1$I$$20240806$20240809$20240809$PER$$NVSC2024US162188$NOVARTIS$$$$$M$Y$$$20240809$$CN$US$US
241939982$24193998$2$F$20240701$20240828$20240809$20240911$PER$$US-APOTEX-2024AP009077$APOTEX$$$$$M$Y$$$20240911$$CN$US$US
241940001$24194000$1$I$20240514$20240802$20240809$20240809$EXP$$US-BAYER-2024A084313$BAYER$$88$YR$E$F$Y$73.016$KG$20240809$$CN$US$US
241940011$24194001$1$I$$20240801$20240809$20240809$EXP$$US-JNJFOC-20240820357$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241940021$24194002$1$I$20240726$20240801$20240809$20240809$30DAY$$US-GSK-US2024096331$GLAXOSMITHKLINE$$$$$F$Y$65.77$KG$20240809$$CN$US$US
241940031$24194003$1$I$$20240805$20240809$20240809$EXP$$US-MYLANLABS-2024M1074207$MYLAN$Belmore L, Ahn T, Nguyen E, Lenz T. Acute non-ST segment elevation myocardial infarction following intravenous injection of sublingual Suboxone. Prehosp-Emerg-Care 2024; 0 (0):.$41$YR$$M$Y$$$20240809$$HP$US$US
241940041$24194004$1$I$$20240801$20240809$20240809$EXP$$US-JNJFOC-20240809238$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241940051$24194005$1$I$20130101$20240806$20240809$20240809$EXP$FR-AFSSAPS-AVCN2024000586$FR-ORGANON-O2408FRA000408$ORGANON$$18$YR$$F$Y$$$20240809$$MD$FR$FR
241940061$24194006$1$I$$20231022$20240809$20240809$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016294$STRIDES$Garafola S, Shiferaw E, Dev V.. Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data.. Drugs-Real-World-Outc. 2023;10(3):351-356.$22$YR$$F$Y$$$20240809$$HP$US$US
241940071$24194007$1$I$$20240808$20240809$20240809$EXP$GB-MHRA-MED-202408072348525630-ZFNMG$GB-ORGANON-O2408GBR000603$ORGANON$$$$$M$Y$$$20240809$$CN$GB$GB
241940082$24194008$2$F$$20240806$20240809$20240816$30DAY$$US-GSK-US2024097600$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
241940091$24194009$1$I$$20240731$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR098293$VIIV$$$$$$Y$$$20240809$$HP$US$US
241940101$24194010$1$I$20240625$20240730$20240809$20240809$EXP$FR-AFSSAPS-GR2024000926$FR-TEVA-VS-3228394$TEVA$$74$YR$$F$Y$$$20240809$$PH$FR$FR
241940113$24194011$3$F$20230710$20240905$20240809$20240925$EXP$$JP-009507513-2406JPN001398J$MERCK$Tanaka Y, Toyosawa Y, Kaneko T, Takamori K, Suga Y.. [A Case of Pemphigoid with Marked Pigmentation on the Skin Eruption Lesion after Administration of Minocycline Hydrochloride]. The Japanese Journal of Dermatology/The 909th Annual Meeting of The Tokyo Divisi. 2024;134(6):1684$72$YR$$M$Y$61$KG$20240925$$MD$JP$JP
241940121$24194012$1$I$$20240801$20240809$20240809$PER$$US-BAYER-2024A112407$BAYER$$33$YR$A$F$Y$$$20240809$$MD$US$US
241940131$24194013$1$I$20240701$20240801$20240809$20240809$PER$$US-SA-2024SA234365$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240809$$MD$US$US
241940141$24194014$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA229671$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240809$$MD$US$US
241940152$24194015$2$F$20240804$20240808$20240809$20240816$PER$$US-SA-2024SA233606$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240816$$CN$US$US
241940161$24194016$1$I$20240801$20240806$20240809$20240809$PER$$US-SA-2024SA235266$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240809$$CN$US$US
241940171$24194017$1$I$$20240730$20240809$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-038134$AUROBINDO$$69$YR$$M$Y$64$KG$20240809$$MD$GB$GB
241940181$24194018$1$I$20240730$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024157624$AMGEN$$55$YR$A$M$Y$$$20240809$$PH$US$US
241940193$24194019$3$F$20240725$20240828$20240809$20240903$30DAY$$US-AMGEN-USASP2024154595$AMGEN$$52$YR$A$F$Y$83$KG$20240903$$PH$US$US
241940222$24194022$2$F$20240802$20240829$20240809$20240908$30DAY$$US-GSK-US2024097474$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240908$$CN$US$US
241940231$24194023$1$I$20240727$20240731$20240809$20240809$EXP$$CN-SA-2024SA231453$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240809$$HP$CN$CN
241940241$24194024$1$I$$20240322$20240809$20240809$EXP$$NVSC2024BR063712$NOVARTIS$$$$$F$Y$$$20240809$$CN$BR$BR
241940251$24194025$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA230818$SANOFI AVENTIS$$16$YR$T$$Y$$$20240809$$MD$US$US
241940271$24194027$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA233778$SANOFI AVENTIS$$$$A$M$Y$$$20240809$$MD$US$US
241940292$24194029$2$F$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683527$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241940301$24194030$1$I$20240101$20240725$20240809$20240809$PER$$US-TEVA-VS-3226498$TEVA$$61$YR$$F$Y$$$20240809$$CN$US$US
241940311$24194031$1$I$20240101$20240805$20240809$20240809$EXP$$US-ABBVIE-5769823$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241940321$24194032$1$I$20240604$20240802$20240809$20240809$PER$$US-BAYER-2024A112828$BAYER$$19$YR$A$F$Y$$$20240809$$HP$US$US
241940331$24194033$1$I$$20240730$20240809$20240809$EXP$$PT-AUROBINDO-AUR-APL-2024-038889$AUROBINDO$Mariana Caetano Coelho.. ABSTRACTS OF ORAL COMMUNICATIONS AND POSTERS PRESENTED AT THE 18TH PORTUGUESE CONGRESS OF HYPERTENSION AND GLOBAL CARDIOVASCULAR RISK. PORTUGUESE JOURNAL OF HYPERTENSION AND CARDIOVASCULAR$78$YR$$M$Y$$$20240809$$HP$PT$PT
241940341$24194034$1$I$20240607$20240801$20240809$20240809$EXP$FR-AFSSAPS-NT2024000943$FR-BAYER-2024A111358$BAYER$$76$YR$E$F$Y$$$20240809$$MD$FR$FR
241940351$24194035$1$I$$20240807$20240809$20240809$PER$$US-ABBVIE-5873202$ABBVIE$$$$$$Y$$$20240809$$HP$US$US
241940361$24194036$1$I$$20240805$20240809$20240809$EXP$$US-ABBVIE-5868770$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241940371$24194037$1$I$20240717$20240801$20240809$20240809$PER$$US-AMGEN-USASP2024153771$AMGEN$$$$$$Y$$$20240809$$PH$US$US
241940391$24194039$1$I$$20240729$20240809$20240809$PER$$US-MSNLABS-2024MSNSPO01701$MSN LABORATORIES$$$$$$Y$$$20240809$$CN$US$US
241940401$24194040$1$I$$20240806$20240809$20240809$PER$$US-009507513-2408USA002350$MERCK$$67$YR$$F$Y$$$20240809$$CN$US$US
241940411$24194041$1$I$$20240801$20240809$20240809$EXP$$US-009507513-2408USA000397$MERCK$$93$YR$$M$Y$$$20240809$$HP$US$US
241940421$24194042$1$I$20240712$20240712$20240809$20240809$PER$$US-009507513-2407USA009570$MERCK$$79$YR$$M$Y$$$20240809$$CN$US$US
241940431$24194043$1$I$20240731$20240805$20240809$20240809$EXP$$JP-009507513-2408JPN000425J$MERCK$$95$YR$$F$Y$$$20240809$$PH$JP$JP
241940441$24194044$1$I$$20240729$20240809$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-038581$AUROBINDO$Kwon L. Portable Percussive Massage Device-Related Rectus Sheath Hematoma and Obstructive Uropathy: A Case Report. Biomed-Hub. 2024;9(1):89-93$$$A$M$Y$$$20240809$$HP$US$US
241940451$24194045$1$I$$20240808$20240809$20240809$EXP$$CN-TAKEDA-2024TUS079600$TAKEDA$$$$$M$Y$$$20240809$$CN$CN$CN
241940461$24194046$1$I$$20240807$20240809$20240809$EXP$$US-TAKEDA-US201902834$TAKEDA$$$$$F$Y$$$20240809$$HP$US$US
241940471$24194047$1$I$20240301$20240730$20240809$20240809$EXP$$FR-AUROBINDO-AUR-APL-2024-038902$AUROBINDO$$41$YR$$F$Y$88$KG$20240809$$MD$FR$FR
241940481$24194048$1$I$$20240731$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR097957$VIIV$$$$$$Y$$$20240809$$HP$US$US
241940493$24194049$3$F$20200101$20240819$20240809$20240826$EXP$$DE-SANDOZ INC.-NVSC2021DE051785$SANDOZ$$42$YR$$F$Y$$$20240826$$MD$DE$DE
241940501$24194050$1$I$$20240805$20240809$20240809$EXP$$GR-MYLANLABS-2024M1072873$MYLAN$Zografidou P, Papagiannopoulou O, Grigoriou I, Spanopoulos K, Koraki E. Perioperative management of emergent cesarean section in a patient with peripartum cardiomyopathy: A case report. Greek e j Perioper Med. 2024;23(b):16-21$$$N$$Y$$$20240809$$MD$GR$GR
241940511$24194051$1$I$$20240730$20240809$20240809$EXP$$CA-TEVA-VS-3227608$TEVA$$66$YR$$F$Y$$$20240809$$HP$CA$CA
241940521$24194052$1$I$20240807$20240808$20240808$20240808$DIR$713467$$FDA-CTU$$56$YR$$F$N$88.2$KG$20240808$N$CN$US$
241940531$24194053$1$I$20240728$20240808$20240808$20240808$DIR$713474$$FDA-CTU$$72$YR$$M$N$$$20240808$Y$HP$US$
241940541$24194054$1$I$$20240726$20240809$20240809$EXP$$US-LUPIN HEALTHCARE (UK) LIMITED-2024-07702$LUPIN$Rafeq R, Salzman M. Use of concentrated insulin in the management of calcium channel blocker overdose: A case report. Journal of Pharmacy Practice. 2023;36 (6):1519-1522$73$YR$$F$Y$69.9$KG$20240809$$PH$US$US
241940551$24194055$1$I$$20240808$20240808$20240808$DIR$713475$$FDA-CTU$$$$$UNK$N$$$20240808$$CN$US$
241940571$24194057$1$I$$20240808$20240808$20240808$DIR$713480$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241940591$24194059$1$I$$20240808$20240808$20240808$DIR$713481$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241940601$24194060$1$I$$20240808$20240808$20240808$DIR$713477$$FDA-CTU$$18$YR$$F$N$$$20240808$N$PH$US$
241940611$24194061$1$I$$20240808$20240808$20240808$DIR$713489$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241940621$24194062$1$I$$20240808$20240808$20240808$DIR$713482$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241940631$24194063$1$I$20240212$20240808$20240808$20240808$DIR$713468$$FDA-CTU$$43$YR$$F$N$72$KG$20240808$N$CN$US$
241940641$24194064$1$I$20240804$20240808$20240808$20240808$DIR$713473$$FDA-CTU$$64$YR$$F$N$99.3$KG$20240808$N$HP$US$
241940662$24194066$2$F$$20240905$20240809$20240911$30DAY$$US-JNJFOC-20240818831$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
241940671$24194067$1$I$$20240805$20240809$20240809$EXP$$US-JNJFOC-20240812460$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241940681$24194068$1$I$20240704$20240726$20240809$20240809$EXP$GB-MHRA-MED-202407261545577700-MVBWC$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-07296$HIKMA$$76$YR$$F$Y$73$KG$20240809$$CN$GB$GB
241940691$24194069$1$I$20240409$20240806$20240809$20240809$EXP$$FR-SANDOZ INC.-SDZ2024FR071400$SANDOZ$$15$YR$$F$Y$55.8$KG$20240809$$MD$FR$FR
241940701$24194070$1$I$$20240731$20240809$20240809$PER$$US-MSNLABS-2024MSNSPO01711$MSN LABORATORIES$$$$$$Y$$$20240809$$CN$US$US
241940712$24194071$2$F$20240719$20240909$20240809$20240911$EXP$$JP-009507513-2408JPN000145J$MERCK$$90$YR$$M$Y$$$20240911$$MD$JP$JP
241940721$24194072$1$I$20240101$20240729$20240809$20240809$PER$$US-009507513-2407USA015980$MERCK$$$$$F$Y$95.5$KG$20240809$$MD$US$US
241940731$24194073$1$I$$20240730$20240809$20240809$EXP$$ES-AUROBINDO-AUR-APL-2024-038846$AUROBINDO$Pitarch CG, Macia MS, Simon J, Mosca L, Conter C, Rejano-Gordillo CM, et al.. Neddylation inhibition prevents acetaminopheninduced liver damage by enhancing the anabolic cardiolipin pathway. Cell Reports Medicine. 2024;5(7):16$$$A$F$Y$$$20240809$$HP$ES$ES
241940741$24194074$1$I$20240601$20240618$20240809$20240809$PER$$US-KARYOPHARM-2024KPT001201$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240809$$CN$US$US
241940751$24194075$1$I$20240609$20240710$20240809$20240809$PER$$US-AstraZeneca-2024A161859$ASTRAZENECA$$48$YR$$F$Y$65.9$KG$20240809$$CN$US$
241940763$24194076$3$F$20240813$20240822$20240809$20240827$EXP$$GB-MYLANLABS-2024M1073542$MYLAN$$$$$M$Y$$$20240827$$HP$GB$GB
241940771$24194077$1$I$$20230815$20240809$20240809$EXP$$US-AstraZeneca-2023A186925$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241940781$24194078$1$I$20220330$20220404$20240809$20240809$EXP$$US-AstraZeneca-2022A138375$ASTRAZENECA$$16780$DY$$F$Y$$$20240809$$CN$US$
241940791$24194079$1$I$$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A179203$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241940801$24194080$1$I$20221014$20230206$20240809$20240809$EXP$$US-AstraZeneca-2022A411724$ASTRAZENECA$$27484$DY$$F$Y$$$20240809$$CN$US$
241940821$24194082$1$I$$20240730$20240809$20240809$PER$$US-AstraZeneca-2024A174244$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241940831$24194083$1$I$$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155387$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241940841$24194084$1$I$20240626$20240729$20240809$20240809$PER$$US-AMGEN-USASP2024150719$AMGEN$$$$$$Y$$$20240809$$PH$US$US
241940852$24194085$2$F$20240722$20240905$20240809$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-038305$AUROBINDO$$65$YR$$F$Y$65$KG$20240910$$HP$FR$FR
241940861$24194086$1$I$$20230913$20240809$20240809$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65330$HIKMA$$$$$$Y$$$20240809$$HP$US$US
241940871$24194087$1$I$20240627$20240730$20240809$20240809$EXP$FR-AFSSAPS-LY2024001106$FR-TEVA-VS-3228370$TEVA$$81$YR$$F$Y$63.5$KG$20240809$$PH$FR$FR
241940891$24194089$1$I$20240728$20240808$20240808$20240808$DIR$713470$$FDA-CTU$$67$YR$$F$N$95$KG$20240808$N$CN$PL$
241940901$24194090$1$I$20240422$20240805$20240809$20240809$EXP$IT-MINISAL02-987416$IT-AMGEN-ITASP2024155487$AMGEN$$81$YR$E$M$Y$$$20240809$$MD$IT$IT
241940921$24194092$1$I$$20240729$20240809$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-038633$AUROBINDO$Gomez RF, Lin G, Golts E, Lin CM, Kafi A, Yung G, et al.. Do Eosinophils Predict Mortality? A Case Series of Lung Transplant Recipients With Acute Fibrinous Organizing Pneumonia. Am-J-Respir-CritCare-Med. 2024;56(3):1902292$38$YR$$M$Y$$$20240809$$HP$US$US
241940932$24194093$2$F$$20240801$20240809$20240917$EXP$$AU-BAYER-2024A111512$BAYER$$77$YR$E$M$Y$$$20240917$$HP$AU$AU
241940941$24194094$1$I$$20240808$20240809$20240809$PER$$US-TAKEDA-2024TUS079580$TAKEDA$$70$YR$$F$Y$$$20240809$$PH$US$US
241940951$24194095$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA233182$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240809$$MD$US$US
241940962$24194096$2$F$20240101$20240804$20240809$20240817$PER$$US-SA-2024SA233614$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240817$$MD$US$US
241940971$24194097$1$I$$20240730$20240809$20240809$EXP$$US-TEVA-VS-3229870$TEVA$$56$YR$$F$Y$$$20240809$$CN$US$US
241940981$24194098$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA066226$SANOFI AVENTIS$$64$YR$A$F$Y$55.33$KG$20240809$$MD$US$US
241940991$24194099$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232157$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241941001$24194100$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232227$SANOFI AVENTIS$$$$A$M$Y$$$20240809$$MD$US$US
241941011$24194101$1$I$20240805$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024156279$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241941021$24194102$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA233852$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240809$$MD$US$US
241941031$24194103$1$I$$20240729$20240809$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-038920$AUROBINDO$Khezri N, Servider J, Mastrogiacomo C, Seidman R, Peyster R, Dashti R.. Aggressive Sphenoid Sinus Aspergillosis with Invasion of Bilateral Internal Carotid Arteries.. J-Neurol-Surg-B-Skull-Base. 2023;84(S 01):S1-S344$78$YR$$M$Y$$$20240809$$HP$US$US
241941041$24194104$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA234121$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240809$$MD$US$US
241941051$24194105$1$I$$20240730$20240809$20240809$EXP$$ES-AUROBINDO-AUR-APL-2024-038840$AUROBINDO$Pitarch CG, Macia MS, Simon J, Mosca L, Conter C, Rejano-Gordillo CM, et al.. Neddylation inhibition prevents acetaminopheninduced liver damage by enhancing the anabolic cardiolipin pathway. Cell Reports Medicine. 2024;5(7)$$$A$M$Y$$$20240809$$HP$ES$ES
241941061$24194106$1$I$$20240804$20240809$20240809$PER$$US-ABBVIE-5867294$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241941071$24194107$1$I$$20240802$20240809$20240809$EXP$$US-MYLANLABS-2024M1073867$MYLAN$Shuster A, Peng C. Neisseria Flavescens Bacteremia in an Otherwise Immunocompetent Host. Am-J-Respir-Crit-Care-Med 2024; 209 A1655.$62$YR$$F$Y$$$20240809$$HP$US$US
241941081$24194108$1$I$$20240802$20240809$20240809$EXP$$DE-MYLANLABS-2024M1073882$MYLAN$Zielinski N, Baiceanu D, Dragomir A, Heyckendorf J, Ibraim E, Kohler N, et al. A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis. Pathog-Immun 2024; 9 (2): 25-42.$$$A$$Y$$$20240809$$MD$DE$DE
241941091$24194109$1$I$$20240802$20240809$20240809$EXP$$US-MYLANLABS-2024M1073756$MYLAN$Mccormack L, Budnick I, Kearns MT. Lemierre^s Syndrome Secondary to a Fusobacterium Necrophorum Superinfection Following Influenza B Pharyngitis. Am-J-Respir-Crit-Care-Med 2024; 209 A7325.$43$YR$$M$Y$$$20240809$$HP$US$US
241941101$24194110$1$I$$20240802$20240809$20240809$EXP$$US-MYLANLABS-2024M1073757$MYLAN$Singh AD, Kurin M. An Unusual Case of Refractory Esophagitis and Esophageal Diverticulum. Dig-Dis-Sci 2024; 69 (6): 1913-1914.$76$YR$$F$Y$$$20240809$$HP$US$US
241941111$24194111$1$I$$20240802$20240809$20240809$EXP$$US-MYLANLABS-2024M1073755$MYLAN$Cohen NT, Buraniqi E, Smith JD, Vezina LG, Gaillard WD. Ictal Arterial Spin Labeling-Magnetic Resonance Imaging Identifies Seizure Onset Zone in Epilepsia Partialis Continua. Ann-Neurol 2024; 95 (4): 760-761.$7$YR$$M$Y$$$20240809$$MD$US$US
241941121$24194112$1$I$20231114$20240802$20240809$20240809$EXP$$GR-MYLANLABS-2024M1073094$MYLAN$Karamanakos, G.. Patient with lower extremity osteomyelitis from Acinetobacter Baumanii. CLINICAL GUIDELINES: FROM DEVELOPMENT TO IMPLEMENTATION. 2024;28-30$70$YR$$M$Y$$$20240809$$MD$GR$GR
241941131$24194113$1$I$20240701$20240731$20240809$20240809$EXP$FR-AFSSAPS-SE2024000595$FR-TEVA-VS-3229296$TEVA$$18$YR$$M$Y$66$KG$20240809$$MD$FR$FR
241941141$24194114$1$I$$20240802$20240809$20240809$EXP$$US-MYLANLABS-2024M1073761$MYLAN$Sreekumar S, Rubin R. A Case of Pulmonary Mucormycosis Leading to Non-hepatic Hyperammonemia. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$31$YR$$F$Y$$$20240809$$HP$US$US
241941151$24194115$1$I$20220101$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461900$RANBAXY$$7$YR$$M$Y$$$20240809$$PH$FR$FR
241941161$24194116$1$I$$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461921$RANBAXY$$51$YR$$M$Y$$$20240809$$HP$FR$FR
241941171$24194117$1$I$20240120$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461990$RANBAXY$$70$YR$$F$Y$$$20240809$$MD$FR$FR
241941181$24194118$1$I$$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461908$RANBAXY$$46$YR$$M$Y$$$20240809$$HP$FR$FR
241941191$24194119$1$I$20240701$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024156287$AMGEN$$73$YR$E$$Y$$$20240809$$CN$US$US
241941202$24194120$2$F$20240511$20240816$20240809$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461843$RANBAXY$$72$YR$$F$Y$57$KG$20240830$$MD$FR$FR
241941211$24194121$1$I$20240707$20240801$20240809$20240809$PER$$US-SA-2024SA233438$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240809$$MD$US$US
241941233$24194123$3$F$20240101$20240829$20240809$20240913$PER$$US-SA-2024SA231699$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240913$$CN$US$US
241941241$24194124$1$I$$20240807$20240809$20240809$EXP$$US-GILEAD-2024-0683611$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241941251$24194125$1$I$20240418$20240726$20240809$20240809$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461926$RANBAXY$$82$YR$$M$Y$112.5$KG$20240809$$MD$FR$FR
241941261$24194126$1$I$20240806$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004675$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240809$$CN$US$US
241941272$24194127$2$F$20240701$20240823$20240809$20240902$EXP$$JP-ROCHE-10000052861$ROCHE$$8$DEC$E$M$Y$$$20240902$$MD$JP$JP
241941282$24194128$2$F$20240802$20240823$20240809$20240902$EXP$$JP-ROCHE-10000052811$ROCHE$$8$DEC$E$M$Y$$$20240902$$MD$JP$JP
241941291$24194129$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005170$ELI LILLY AND CO$$18$YR$A$F$Y$$$20240809$$CN$US$US
241941301$24194130$1$I$20240806$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004083$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240809$$CN$US$US
241941311$24194131$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005076$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240809$$CN$US$US
241941322$24194132$2$F$20240613$20240821$20240809$20240822$EXP$$FI-AMERICAN REGENT INC-2024003074$AMERICAN REGENT$$81$YR$$F$Y$$$20240822$$PH$FI$FI
241941331$24194133$1$I$$20240730$20240809$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-039069$AUROBINDO$Chittal A, Kumar K, Rao S, Baydarian M.. Herpes Simplex Virus 1 Meningitis Presenting as Status Epilepticus. Am-J-Respir-Crit-Care-Med. 2023;207:A1743$54$YR$$M$Y$$$20240809$$HP$US$US
241941342$24194134$2$F$20240603$20240815$20240809$20240822$PER$$US-BAYER-2024A111595$BAYER$$24$YR$A$F$Y$82.55$KG$20240822$$MD$US$US
241941351$24194135$1$I$$20240731$20240809$20240809$EXP$$US-GSK-US2024095825$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$MD$US$US
241941361$24194136$1$I$20240710$20240807$20240809$20240809$EXP$$US-KYOWAKIRIN-2024KK018970$KYOWA$$$$$$Y$$$20240809$$CN$US$US
241941381$24194138$1$I$$20240807$20240809$20240809$EXP$$US-JNJFOC-20240820303$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$CN$US$US
241941391$24194139$1$I$$20240708$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06892$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241941401$24194140$1$I$20240711$20240711$20240809$20240809$PER$$US-009507513-2407USA008984$MERCK$$17$YR$$F$Y$$$20240809$$HP$US$US
241941421$24194142$1$I$20230717$20240807$20240809$20240809$EXP$$GB-UCBSA-2024039878$UCB$$0$YR$$$Y$$$20240809$$MD$GB$GB
241941432$24194143$2$F$20220329$20240819$20240809$20240826$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-104715$REGENERON$Ando T, Kubota M, Yasukawa T, Miyase T, Ishiguro K, Esaki Y, et al.. Macular hole with retinal pigment epithelium tear after anti-VEGF therapy in an eye with neovascular age-related macular degeneration.. American Journal of Ophthalmology Case Reports.. 2024;36:102126$73$YR$$M$Y$$$20240826$$HP$JP$JP
241941441$24194144$1$I$$20240726$20240809$20240809$EXP$IT-EMA-20160227-ashishvp-105437182$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461977$RANBAXY$$45$MON$$F$Y$$$20240809$$HP$IT$IT
241941451$24194145$1$I$20240101$20240801$20240809$20240809$EXP$$US-HBP-2024US030489$HELSINN HEALTHCARE$$$$$M$Y$$$20240809$$CN$US$US
241941461$24194146$1$I$20240807$20240808$20240808$20240808$DIR$713476$$FDA-CTU$$17$YR$$F$N$74$KG$20240808$N$PH$US$
241941481$24194148$1$I$20240725$20240808$20240809$20240809$EXP$$RO-ABBVIE-5873226$ABBVIE$$72$YR$$F$Y$$$20240809$$CN$RO$RO
241941491$24194149$1$I$20240604$20240804$20240809$20240809$EXP$GB-MHRA-WEBRADR-202408041109247600-DCMKP$GB-TORRENT-00037513$TORRENT$$85$YR$E$F$Y$76$KG$20240809$$CN$GB$GB
241941501$24194150$1$I$20240805$20240805$20240809$20240809$EXP$GB-MHRA-MED-202408050806323860-MLQNV$GB-TORRENT-00037524$TORRENT$$63$YR$A$M$Y$80$KG$20240809$$MD$GB$GB
241941511$24194151$1$I$20240804$20240804$20240809$20240809$EXP$GB-MHRA-MED-202408042128201700-CMYWR$GB-TORRENT-00037517$TORRENT$$39$YR$A$F$Y$$$20240809$$CN$GB$GB
241941521$24194152$1$I$$20240805$20240809$20240809$EXP$GB-MHRA-TPP17742326C576475YC1722345779072$GB-TORRENT-00037527$TORRENT$$56$YR$A$M$Y$125$KG$20240809$$HP$GB$GB
241941531$24194153$1$I$$20240808$20240809$20240809$EXP$$CA-ROCHE-10000052103$ROCHE$$45$YR$A$$Y$$$20240809$$MD$CA$CA
241941551$24194155$1$I$20240629$20240805$20240809$20240809$EXP$GB-MHRA-MED-202408050942328210-TYRHD$GB-TORRENT-00037529$TORRENT$$53$YR$A$F$Y$$$20240809$$MD$GB$GB
241941563$24194156$3$F$$20240809$20240809$20240820$EXP$$RU-TORRENT-00000091$TORRENT$$74$YR$E$M$Y$$$20240820$$HP$RU$RU
241941571$24194157$1$I$20240801$20240808$20240808$20240808$DIR$713496$$FDA-CTU$$63$YR$$M$N$66.15$KG$20240808$Y$CN$US$
241941581$24194158$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2023SA002614$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240809$$MD$US$US
241941591$24194159$1$I$20240808$20240808$20240808$20240808$DIR$713498$$FDA-CTU$$82$YR$$F$N$$$20240808$N$HP$US$
241941602$24194160$2$F$$20240916$20240809$20240927$EXP$$US-TORRENT-00013700$TORRENT$$$$I$M$Y$$$20240927$$HP$US$US
241941611$24194161$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA233885$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241941621$24194162$1$I$20240101$20240731$20240809$20240809$PER$$US-SA-2024SA223512$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240809$$MD$US$US
241941632$24194163$2$F$$20240817$20240809$20240829$EXP$$NL-AUROBINDO-AUR-APL-2024-038749$AUROBINDO$$69$YR$$F$Y$44$KG$20240829$$MD$NL$NL
241941651$24194165$1$I$20240801$20240801$20240809$20240809$PER$$US-BAYER-2024A111757$BAYER$$$$$F$Y$$$20240809$$MD$US$US
241941661$24194166$1$I$20230101$20240806$20240809$20240809$EXP$$US-ABBVIE-5863329$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241941671$24194167$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157560$AMGEN$$$$$F$Y$$$20240809$$MD$US$US
241941681$24194168$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157950$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241941691$24194169$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157991$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241941701$24194170$1$I$20240807$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157702$AMGEN$$65$YR$E$F$Y$$$20240809$$CN$US$US
241941711$24194171$1$I$20240701$20240731$20240809$20240809$EXP$FR-AFSSAPS-GR2024000930$FR-TEVA-VS-3228897$TEVA$$74$YR$$F$Y$$$20240809$$PH$FR$FR
241941722$24194172$2$F$20240601$20240806$20240809$20240815$EXP$$US-MYLANLABS-2024M1032283$MYLAN$$30$YR$$F$Y$76.2$KG$20240815$$CN$US$US
241941741$24194174$1$I$$20240806$20240809$20240809$EXP$$CA-JNJFOC-20240771750$JOHNSON AND JOHNSON$$$$$M$Y$73$KG$20240809$$HP$CA$CA
241941751$24194175$1$I$20240101$20240731$20240809$20240809$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07408$HIKMA$Stolear A, Dulgher M, Bae JY, Kaminsky L, Jeyashanmugaraja GP, Emerenini U.. Stolear A, Dulgher M, Bae JY, Kaminsky L, Jeyashanmugaraja GP, Emerenini U. Wide Spectrum of Flecainide Toxicity: A Case Report and Literature Review. Cureus. 2024;16(6):e62923$79$YR$$F$Y$$$20240809$$MD$US$US
241941772$24194177$2$F$$20240912$20240809$20240922$PER$$US-GSK-US2024GSK097402$GLAXOSMITHKLINE$$$$$F$Y$$$20240922$$HP$US$US
241941781$24194178$1$I$$20240731$20240809$20240809$EXP$$US-GSK-US2024095867$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$MD$US$US
241941791$24194179$1$I$$20240801$20240809$20240809$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-023863$UNITED THERAPEUTICS$$$$$F$Y$$$20240809$$$CA$CA
241941801$24194180$1$I$$20240730$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024095818$VIIV$$$$$M$Y$$$20240809$$HP$US$US
241941811$24194181$1$I$$20240717$20240809$20240809$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003705$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241941821$24194182$1$I$20240801$20240808$20240809$20240809$PER$$US-AMGEN-USASP2024158389$AMGEN$$$$$F$Y$$$20240809$$HP$US$US
241941831$24194183$1$I$$20240730$20240809$20240809$EXP$$US-AUROBINDO-AUR-APL-2024-039168$AUROBINDO$Masumy M, Munoz A, Rao A. A Case of Thyroid Eye Disease in a Hypothyroid Patient. Endocr-Pract. 2024;30 (Suppl.)(5):S144-S145$64$YR$$M$Y$$$20240809$$MD$US$US
241941841$24194184$1$I$$20210917$20240809$20240809$EXP$$ES-AstraZeneca-2021A730845$ASTRAZENECA$$80$YR$$F$Y$$$20240809$$MD$ES$
241941851$24194185$1$I$$20231009$20240809$20240809$EXP$$US-AstraZeneca-2023A229758$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241941861$24194186$1$I$$20230213$20240809$20240809$EXP$$CA-AstraZeneca-2023A040105$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$CA$
241941871$24194187$1$I$20240615$20240730$20240809$20240809$EXP$FR-AFSSAPS-PB2024000800$FR-TEVA-VS-3228503$TEVA$$39$YR$$F$Y$59$KG$20240809$$MD$FR$FR
241941881$24194188$1$I$20240301$20240801$20240809$20240809$EXP$FR-AFSSAPS-RS2024000768$FR-BIOCON BIOLOGICS LIMITED-BBL2024005661$BIOCON$$$$$$Y$$$20240809$$MD$FR$FR
241941894$24194189$4$F$20230615$20240828$20240809$20240911$EXP$$FR-UCBSA-2024033512$UCB$$75$YR$$M$Y$80$KG$20240911$$MD$FR$FR
241941902$24194190$2$F$20240701$20240905$20240809$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-038420$AUROBINDO$$66$YR$$M$Y$71$KG$20240917$$HP$FR$FR
241941911$24194191$1$I$20240703$20240731$20240809$20240809$EXP$$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07395$HIKMA$$87$YR$$M$Y$69$KG$20240809$$HP$FR$FR
241941922$24194192$2$F$20240605$20240731$20240809$20240813$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS003992$TERSERA THERAPEUTICS$$$$$$Y$$$20240813$$CN$NL$NL
241941931$24194193$1$I$20240702$20240731$20240809$20240809$EXP$$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-07386$HIKMA$$30$YR$$M$Y$82.4$KG$20240809$$PH$DE$DE
241941941$24194194$1$I$$20240730$20240809$20240809$EXP$$GB-AUROBINDO-AUR-APL-2024-038405$AUROBINDO$$80$YR$$$Y$$$20240809$$PH$GB$GB
241941961$24194196$1$I$20240404$20240802$20240809$20240809$EXP$$CA-TAKEDA-2024TUS077455$TAKEDA$$40$YR$$F$Y$$$20240809$$CN$CA$CA
241941971$24194197$1$I$$20240802$20240809$20240809$EXP$$US-BAYER-2024A112429$BAYER$$$$$F$Y$$$20240809$$CN$US$US
241941981$24194198$1$I$20200604$20240806$20240809$20240809$EXP$PL-URPL-1-1551-2020$PL-MYLANLABS-2024M1073160$MYLAN$$56$YR$$M$Y$$$20240809$$MD$PL$PL
241941991$24194199$1$I$20240712$20240806$20240809$20240809$EXP$GB-MHRA-MED-202408061930558780-YCLPJ$GB-MYLANLABS-2024M1073657$MYLAN$$72$YR$$F$Y$76$KG$20240809$$CN$GB$GB
241942001$24194200$1$I$20240626$20240806$20240809$20240809$EXP$FR-AFSSAPS-AN2024001028$FR-MYLANLABS-2024M1073164$MYLAN$$64$YR$$M$Y$53.4$KG$20240809$$MD$FR$FR
241942011$24194201$1$I$20240706$20240729$20240809$20240809$EXP$$CN-JNJFOC-20240805873$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20240809$$HP$CN$CN
241942021$24194202$1$I$20240729$20240730$20240809$20240809$EXP$$US-Accord-439210$ACCORD$$58$YR$A$F$Y$$$20240809$$HP$US$US
241942031$24194203$1$I$$20240730$20240809$20240809$EXP$$CA-TEVA-VS-3227555$TEVA$$66$YR$$F$Y$$$20240809$$HP$CA$CA
241942041$24194204$1$I$20230101$20240730$20240809$20240809$EXP$FR-AFSSAPS-NT2024000937$FR-Accord-439324$ACCORD$$74$YR$E$M$Y$$$20240809$$MD$FR$FR
241942051$24194205$1$I$$20240728$20240809$20240809$EXP$$JP-Accord-440094$ACCORD$Tasaki Y, Yamazaki T, Miyazaki S, Takeda T, Nakatake M, Nakamura D, et al. Additional chemoradiotherapy for superficial esophageal squamous cell carcinoma after near-circumferential or full-circumferential noncurative endoscopic submucosal dissection: a retrospective study. BMC Gastroenterol. 2024 Jul 23;24(1):232.$$$$$Y$$$20240809$$HP$JP$JP
241942061$24194206$1$I$20240712$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407300948537410-TKMFV$GB-Accord-439757$ACCORD$$35$YR$A$M$Y$60$KG$20240809$$PH$GB$GB
241942071$24194207$1$I$$20240729$20240809$20240809$EXP$CA-MHPD-001092569$CA-Accord-439255$ACCORD$$66$YR$E$F$Y$62$KG$20240809$$HP$CA$CA
241942081$24194208$1$I$$20240730$20240809$20240809$EXP$$US-Accord-439625$ACCORD$$$$$F$Y$72.12$KG$20240809$$HP$US$US
241942091$24194209$1$I$$20240729$20240809$20240809$EXP$CA-MHPD-001092620$CA-Accord-439285$ACCORD$$80$YR$E$M$Y$59$KG$20240809$$HP$CA$CA
241942103$24194210$3$F$20240424$20240910$20240809$20240912$EXP$$JP-ABBVIE-5871722$ABBVIE$$61$YR$$M$Y$$$20240912$$MD$JP$JP
241942111$24194211$1$I$$20240808$20240809$20240809$EXP$$US-TAKEDA-2024TUS079586$TAKEDA$$$$$F$Y$$$20240809$$CN$US$US
241942121$24194212$1$I$20240801$20240805$20240809$20240809$PER$$US-ABBVIE-5871132$ABBVIE$$25$YR$$F$Y$$$20240809$$MD$US$US
241942131$24194213$1$I$$20240808$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2024US071399$SANDOZ$$73$YR$$F$Y$$$20240809$$MD$US$US
241942141$24194214$1$I$$20240808$20240809$20240809$EXP$$DK-SANDOZ INC.-SDZ2024DK071396$SANDOZ$$21$YR$$F$Y$$$20240809$$CN$DK$DK
241942151$24194215$1$I$20240808$20240808$20240808$20240808$DIR$713487$$FDA-CTU$$87$YR$$F$N$$$20240808$N$$US$
241942161$24194216$1$I$$20240808$20240808$20240808$DIR$713502$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
241942171$24194217$1$I$$20240808$20240808$20240808$DIR$713491$$FDA-CTU$$$$$UNK$N$$$20240808$N$CN$US$
241942181$24194218$1$I$$20240808$20240808$20240808$DIR$713503$$FDA-CTU$$$$$M$N$$$20240808$N$HP$US$
241942202$24194220$2$F$20240731$20240807$20240809$20240815$EXP$$JP-009507513-2407JPN005662J$MERCK$$75$YR$$M$Y$$$20240815$$MD$JP$JP
241942211$24194221$1$I$20240101$20240802$20240809$20240809$EXP$$CO-SA-2024SA232477$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240809$$CN$CO$CO
241942221$24194222$1$I$$20240808$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2024US071547$SANDOZ$$$$$$Y$$$20240809$$CN$US$US
241942241$24194224$1$I$$20240808$20240809$20240809$EXP$$NVSC2024CN162277$NOVARTIS$$75$YR$$M$Y$$$20240809$$CN$CN$CN
241942251$24194225$1$I$20240501$20240802$20240809$20240809$EXP$ES-AEMPS-1553074$ES-MYLANLABS-2024M1072611$MYLAN$$83$YR$$M$Y$$$20240809$$PH$ES$ES
241942261$24194226$1$I$$20240802$20240809$20240809$EXP$$ES-MYLANLABS-2024M1073055$MYLAN$Vargas Osorio K, Calatayud-Cubes A, Diaz-Lopez EJ, Barbaran-Corral C, Lazare-Iglesias H, Anido-Herranz U, et al. Expression of somatostatin receptors in radioiodine refractory follicular cell derived thyroid carcinomas detected with [68Ga] Ga-DOTA-TOC. Virchows-Arch 2023; 483 (Suppl. 1) S251 abstr. E-PS-09-026.$41$YR$$M$Y$$$20240809$$HP$ES$ES
241942271$24194227$1$I$$20240802$20240809$20240809$EXP$$AU-MYLANLABS-2024M1073030$MYLAN$Estabrooks KL, DeSilva K, Survela L, Stevenson WS. Haemophagocytic lymphohistiocytosis due to leishmaniasis following anti-tumour necrosis factor-alpha therapy. Br-J-Haematol 2023; 203 (4): 497-498.$56$YR$$M$Y$$$20240809$$HP$AU$AU
241942291$24194229$1$I$20240731$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005358$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241942301$24194230$1$I$$20240807$20240809$20240809$EXP$FR-AFSSAPS-RS2024000780$FR-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2407FR06272$INSUD PHARMA$$22$YR$$F$Y$68$KG$20240809$$CN$FR$FR
241942311$24194231$1$I$$20240730$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408000437$ELI LILLY AND CO$$42$YR$A$$Y$$$20240809$$CN$US$US
241942321$24194232$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003895$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241942331$24194233$1$I$20240701$20240803$20240809$20240809$EXP$$US-INSUD PHARMA-2408US06205$INSUD PHARMA$$$$$$Y$$$20240809$$CN$US$US
241942341$24194234$1$I$$20240806$20240809$20240809$EXP$GB-MHRA-MED-202405131339048220-TYRGZ$GB-LABORATORIOS LICONSA S.A.-2408GB06276$INSUD PHARMA$$$$$F$Y$102$KG$20240809$$CN$GB$GB
241942351$24194235$1$I$$20240731$20240809$20240809$EXP$$PT-AUROBINDO-AUR-APL-2024-039142$AUROBINDO$Araujo M, Santos S, Viana J, Marques S. Metformin-associated lactic acidosis (MALA) - 4-year series at a university hospital. Congresses of the Portuguese Society of Internal Medicine. 2024;212$$$E$$Y$$$20240809$$MD$PT$PT
241942361$24194236$1$I$$20240729$20240809$20240809$EXP$815044$AU-LUPIN PHARMACEUTICALS INC.-2024-07579$LUPIN$$65$YR$$M$Y$$$20240809$$CN$AU$AU
241942371$24194237$1$I$$20240731$20240809$20240809$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00303$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240809$$CN$US$US
241942382$24194238$2$F$$20240807$20240809$20240809$EXP$$US-GILEAD-2024-0683612$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241942391$24194239$1$I$$20240801$20240809$20240809$EXP$$US-AMGEN-USASP2024157464$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241942401$24194240$1$I$$20240801$20240809$20240809$EXP$$US-AMGEN-USASP2024157471$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241942411$24194241$1$I$20220101$20240807$20240809$20240809$EXP$$FR-AMGEN-FRASP2024156964$AMGEN$$74$YR$E$M$Y$$$20240809$$CN$FR$FR
241942421$24194242$1$I$20240404$20240731$20240809$20240809$EXP$FR-AFSSAPS-LM2024000419$FR-TEVA-VS-3228972$TEVA$$83$YR$$F$Y$62$KG$20240809$$MD$FR$FR
241942431$24194243$1$I$$20240805$20240809$20240809$PER$$US-ALXN-A202314064$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241942441$24194244$1$I$20240502$20240807$20240809$20240809$EXP$$JP-ALXN-202408JPN000280JP$ALEXION PHARMACEUTICALS$$77$YR$$F$Y$$$20240809$$MD$JP$JP
241942451$24194245$1$I$20240618$20240711$20240809$20240809$PER$$US-SLATERUN-2024SRSPO00130$SLATE RUN$$67$YR$E$F$Y$215$KG$20240809$$CN$US$US
241942471$24194247$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5865405$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241942481$24194248$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191100$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241942492$24194249$2$F$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683540$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241942501$24194250$1$I$$20240806$20240809$20240809$EXP$$ZA-ABBVIE-5871402$ABBVIE$$$$E$F$Y$$$20240809$$MD$ZA$ZA
241942511$24194251$1$I$$20240731$20240809$20240809$EXP$$US-GSK-US2024095743$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$MD$US$US
241942521$24194252$1$I$$20240730$20240809$20240809$EXP$$US-GSK-US2024AMR095662$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$US$US
241942532$24194253$2$F$20230729$20240813$20240809$20240822$EXP$$JP-ROCHE-10000049660$ROCHE$$78$YR$E$F$Y$45.75$KG$20240822$$MD$JP$JP
241942541$24194254$1$I$$20240729$20240809$20240809$EXP$$PT-INSUD PHARMA-2407PT06163$INSUD PHARMA$Reis C, Dias F, Grijo C, Ribeiro A, Almeida J. PSEUDOMEMBRANOUS COLITIS FOLLOWING HELICOBACTER PILORY ERADICATION WITH THE BISMUTH-BASED QUADRUPLE THERAPY. European Journal of Case Reports in Internal Medicine. 2023;237$$$$$Y$$$20240809$$HP$PT$PT
241942551$24194255$1$I$$20240802$20240809$20240809$EXP$$BR-AstraZeneca-2024A179903$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$BR$
241942561$24194256$1$I$$20220420$20240809$20240809$EXP$$US-AstraZeneca-2022A160009$ASTRAZENECA$$$$$F$Y$68$KG$20240809$$CN$US$
241942571$24194257$1$I$$20240808$20240808$20240808$DIR$713506$$FDA-CTU$$48$YR$$M$N$$$20240808$N$HP$US$
241942581$24194258$1$I$$20240730$20240809$20240809$EXP$$CA-MYLANLABS-202101110578$MYLAN$$22$YR$$M$Y$$$20240809$$CN$CA$CA
241942591$24194259$1$I$20240101$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A124559$ASTRAZENECA$$1021$MON$$M$Y$45.4$KG$20240809$$CN$US$
241942602$24194260$2$F$$20240808$20240809$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07009$LUPIN$$$$$$Y$$$20240822$$PH$US$US
241942611$24194261$1$I$$20230605$20240809$20240809$EXP$$US-AstraZeneca-2023A091749$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241942621$24194262$1$I$$20221012$20240809$20240809$EXP$$BE-AstraZeneca-2022A345651$ASTRAZENECA$$$$$$Y$$$20240809$$MD$BE$
241942631$24194263$1$I$$20230407$20240809$20240809$EXP$$US-AstraZeneca-2023A082852$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241942641$24194264$1$I$20240801$20240805$20240809$20240809$PER$$US-PFIZER INC-202400230691$PFIZER$$$$$M$Y$$$20240809$$CN$US$US
241942661$24194266$1$I$$20240729$20240809$20240809$PER$$US-PFIZER INC-202400233010$PFIZER$$66$YR$$F$Y$$$20240809$$CN$US$US
241942671$24194267$1$I$$20240805$20240809$20240809$PER$$US-PFIZER INC-PV202400102524$PFIZER$$$$$F$Y$$$20240809$$CN$US$US
241942691$24194269$1$I$20240805$20240805$20240809$20240809$PER$$US-PFIZER INC-202400230534$PFIZER$$71$YR$$F$Y$$$20240809$$CN$US$US
241942701$24194270$1$I$20240804$20240805$20240809$20240809$PER$$US-PFIZER INC-202400230344$PFIZER$$76$YR$$F$Y$72.57$KG$20240809$$CN$US$US
241942712$24194271$2$F$$20240729$20240809$20240820$EXP$$RU-TEVA-VS-3229164$TEVA$Olisova OY, Teplyuk NP, Ignatiev DV, Dunaeva ER. Development of scalded skin syndrome in an adult patient with acquired epidermolysis bullosa after long-term treatment with methotrexate. [Russian]. Russ-J-Skin-Vener-Dis 2023; 26 (1): 41-49.$47$YR$$M$Y$$$20240820$$HP$RU$RU
241942721$24194272$1$I$$20240801$20240809$20240809$PER$$US-PFIZER INC-202400108751$PFIZER$$67$YR$$M$Y$72.12$KG$20240809$$CN$US$US
241942731$24194273$1$I$20240731$20240807$20240809$20240809$EXP$$GB-MYLANLABS-2024M1073905$MYLAN$$74$YR$$F$Y$103$KG$20240809$$HP$GB$GB
241942741$24194274$1$I$20240422$20240802$20240809$20240809$EXP$FR-AFSSAPS-NY2024000876$FR-MYLANLABS-2024M1072585$MYLAN$$52$YR$$F$Y$61$KG$20240809$$PH$FR$FR
241942751$24194275$1$I$$20240801$20240809$20240809$EXP$$US-BAYER-2024A115003$BAYER$$63$YR$A$F$Y$$$20240809$$CN$US$US
241942761$24194276$1$I$20240705$20240730$20240809$20240809$EXP$FR-AFSSAPS-PB2024000801$FR-TEVA-VS-3228420$TEVA$$60$YR$$F$Y$72$KG$20240809$$MD$FR$FR
241942771$24194277$1$I$20240101$20240730$20240809$20240809$EXP$FR-AFSSAPS-BS2024000451$FR-TEVA-VS-3228607$TEVA$$45$YR$$F$Y$60$KG$20240809$$MD$FR$FR
241942781$24194278$1$I$$20240731$20240809$20240809$EXP$$US-ABBVIE-5871060$ABBVIE$Hamdan A, Sharma S, Baynes K, Hajj Ali RA, Lowder CY, Srivastava SK. Management of uveitis patients on anti-tnf agents who develop demyelinating disease - a case series. J Ophthal Inflamm Infect. 2024;14(1):35.$$$$F$Y$$$20240809$$MD$US$US
241942791$24194279$1$I$20240619$20240807$20240809$20240809$EXP$GB-MHRA-MED-202407030823125260-LZMNC$GB-MYLANLABS-2024M1062320$MYLAN$$$$$F$Y$$$20240809$$CN$GB$GB
241942801$24194280$1$I$$20240731$20240809$20240809$EXP$$PL-AUROBINDO-AUR-APL-2024-039210$AUROBINDO$$54$YR$$F$Y$70$KG$20240809$$MD$PL$PL
241942811$24194281$1$I$$20240726$20240809$20240809$EXP$GB-MHRA-31113737$GB-GLENMARK PHARMACEUTICALS-2024GMK092898$GLENMARK$$$$$$Y$$$20240809$$PH$GB$GB
241942821$24194282$1$I$20240713$20240808$20240808$20240808$DIR$713478$$FDA-CTU$$19$YR$$F$N$58.5$KG$20240808$N$CN$US$
241942831$24194283$1$I$20240807$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54698$$FDA-CTU$$47$YR$$M$N$83.1$KG$20240808$N$CN$US$
241942841$24194284$1$I$$20240801$20240809$20240809$EXP$$IR-AMICI-2024AMILIT00005$AMICI PHARMACEUTICALS$$51$YR$A$M$Y$$$20240805$$HP$IR$IR
241942851$24194285$1$I$$20240715$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07216$LUPIN$$$$$$Y$$$20240809$$MD$US$US
241942861$24194286$1$I$$20240801$20240809$20240809$EXP$$MX-AMICI-2024AMILIT00006$AMICI PHARMACEUTICALS$Lopez-Vidal WL, Enriquez-Montes MF, Meza-Martinez DA, Gallardo-Cantua LM, Hernandez-Guedea MA.Anaphylaxis as an Unusual Cause of Shock in the Trauma Setting: A Case Report.Cureus.16-JUL-2024;16(7):e64696$51$YR$A$M$Y$$$20240805$$HP$MX$MX
241942871$24194287$1$I$20240801$20240801$20240809$20240809$EXP$$JP-009507513-2407JPN005670J$MERCK$$50$YR$$$Y$$$20240809$$PH$JP$JP
241942882$24194288$2$F$20240801$20240815$20240809$20240820$PER$$US-AMGEN-USASP2024158115$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
241942891$24194289$1$I$20240807$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157516$AMGEN$$65$YR$E$F$Y$$$20240809$$CN$US$US
241942901$24194290$1$I$$20240807$20240809$20240809$PER$$US-SA-2024SA231968$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240809$$CN$US$US
241942911$24194291$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA235114$SANOFI AVENTIS$$$$A$F$Y$99.79$KG$20240809$$MD$US$US
241942921$24194292$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA234129$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240809$$MD$US$US
241942931$24194293$1$I$20240702$20240802$20240809$20240809$PER$$US-SA-2024SA232688$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240809$$MD$US$US
241942951$24194295$1$I$20240505$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54665$$FDA-CTU$$62$YR$$F$N$51.71$KG$20240808$N$$US$
241942962$24194296$2$F$20240729$20240821$20240809$20240830$PER$$US-INCYTE CORPORATION-2024IN008023$INCYTE$$$$$$Y$$$20240830$$CN$US$US
241942971$24194297$1$I$$20240807$20240809$20240809$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140090$DAIICHI$$$$$F$Y$$$20240809$$CN$US$US
241942981$24194298$1$I$20240806$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125677$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240809$$CN$US$US
241943001$24194300$1$I$$20240802$20240809$20240809$EXP$$DE-MYLANLABS-2024M1072514$MYLAN$Trabert J, Pullen R.. Polymedication and deprescribing in the elderly Polypharmacy and potentially inadequate drugs. Hessian medical journal. 2024;85(7-8):412-15$89$YR$$F$Y$$$20240809$$MD$DE$DE
241943011$24194301$1$I$20240607$20240802$20240809$20240809$EXP$FR-AFSSAPS-NT2024000943$FR-MYLANLABS-2024M1072625$MYLAN$$76$YR$$F$Y$$$20240809$$MD$FR$FR
241943022$24194302$2$F$$20240815$20240809$20240821$EXP$$PT-MYLANLABS-2024M1066787$MYLAN$Nunes AP, Jardim M, Gomes S, Almada S, Fernandes AC, Pestana A et al. CO-0177 - (4798) Drifting withdrawal. Congresses of the Portuguese Society of Internal Medicine. 2024;277$63$YR$$F$Y$$$20240821$$MD$PT$PT
241943031$24194303$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54664$$FDA-CTU$$63$YR$$F$N$$$20240808$N$$US$
241943041$24194304$1$I$20240101$20240807$20240809$20240809$EXP$GB-MHRA-30702762$GB-MYLANLABS-2024M1073839$MYLAN$$78$YR$$F$Y$57$KG$20240809$$CN$GB$GB
241943051$24194305$1$I$$20240730$20240809$20240809$EXP$$US-GSK-US2024AMR096085$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241943061$24194306$1$I$$20240801$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR098276$VIIV$$$$$$Y$$$20240809$$HP$US$US
241943071$24194307$1$I$$20240807$20240809$20240809$EXP$$US-GILEAD-2024-0680033$GILEAD$$$$A$M$Y$$$20240809$$CN$US$US
241943081$24194308$1$I$20190901$20240729$20240809$20240809$EXP$$RU-DSJP-DSJ-2024-139404$DAIICHI$Lubennikova EV, Ganshina IP, Manukyan MSH, Tyurin IE, Artamonova EV.. Expanding the treatment options for HER2-low metastatic breast cancer: Experience with trastuzumab deruxtecan in aggressive luminal HER2-low breast cancer. Meditsinskiy Sovet. 2024;18(10):66?73$45$YR$$F$Y$$$20240809$$HP$RU$RU
241943091$24194309$1$I$20240618$20240802$20240809$20240809$EXP$FR-AFSSAPS-AN2024000972$FR-MYLANLABS-2024M1072569$MYLAN$$52$YR$$F$Y$73.5$KG$20240809$$PH$FR$FR
241943101$24194310$1$I$20240401$20240808$20240808$20240808$DIR$713508$$FDA-CTU$$51$YR$$F$N$57.15$KG$20240808$N$CN$US$
241943111$24194311$1$I$$20240805$20240809$20240809$EXP$FR-EMA-20170209-gdhingrap-155720719$FR-PFIZER INC-202400231195$PFIZER$Guitard, J.. An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis.. Clin-Nephrol. 2014;82(6):392-396.$58$YR$$F$Y$$$20240809$$MD$FR$FR
241943121$24194312$1$I$$20240807$20240809$20240809$EXP$$CA-PFIZER INC-202400232202$PFIZER$$72$YR$$M$Y$$$20240809$$MD$CA$CA
241943131$24194313$1$I$20240721$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155769$AMGEN$$79$YR$E$F$Y$$$20240809$$CN$US$US
241943141$24194314$1$I$20240716$20240808$20240808$20240808$DIR$713510$$FDA-CTU$$78$YR$$M$N$$$20240808$Y$HP$US$
241943152$24194315$2$F$20240712$20240821$20240809$20240830$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007306$AEGERION$$$$$$Y$$$20240830$$HP$US$US
241943163$24194316$3$F$20240101$20240913$20240809$20240927$PER$$US-APOTEX-2024AP008771$APOTEX$$$$E$F$Y$$$20240927$$CN$US$US
241943171$24194317$1$I$$20240326$20240809$20240809$EXP$$NVSC2023AR198330$NOVARTIS$$$$$F$Y$$$20240809$$CN$AR$AR
241943181$24194318$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA078157$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240809$$MD$US$US
241943191$24194319$1$I$20240731$20240731$20240809$20240809$PER$$US-SA-2024SA230825$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240809$$CN$US$US
241943201$24194320$1$I$20240804$20240806$20240809$20240809$EXP$$CA-SANDOZ INC.-SDZ2024CA071311$SANDOZ$$60$YR$$M$Y$$$20240809$$CN$CA$CA
241943221$24194322$1$I$20240301$20240801$20240809$20240809$PER$$US-SA-2024SA233406$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240809$$MD$US$US
241943231$24194323$1$I$20240701$20240802$20240809$20240809$PER$$US-SA-2024SA132038$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240809$$CN$US$US
241943241$24194324$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54657$$FDA-CTU$$60$YR$$F$N$$$20240808$N$$US$
241943251$24194325$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232733$SANOFI AVENTIS$$$$E$F$Y$72$KG$20240809$$MD$US$US
241943261$24194326$1$I$$20240801$20240809$20240809$EXP$$US-GSK-US2024096249$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$MD$US$US
241943271$24194327$1$I$$20240802$20240809$20240809$EXP$$US-GSK-US2024096888$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241943281$24194328$1$I$$20240802$20240809$20240809$EXP$$PL-MYLANLABS-2024M1072428$MYLAN$Jarocki M, Florek K, Wietrzyk W, Modrzejewska K, Kuliczkowski W, Blaziak M. Eisenmenger syndrome complicated by the presence of an aneurysm of the pulmonary trunk and compression of the left main coronary artery. Postepy w Kardiologii Interwencyjnej$45$YR$$F$Y$$$20240809$$HP$PL$PL
241943291$24194329$1$I$20240808$20240808$20240808$20240808$DIR$713509$$FDA-CTU$$46$YR$$F$N$77.85$KG$20240808$N$$US$
241943301$24194330$1$I$$20240802$20240809$20240809$EXP$$HU-MYLANLABS-2024M1072536$MYLAN$$$$$$Y$$$20240809$$CN$HU$HU
241943311$24194331$1$I$$20240711$20240809$20240809$30DAY$$US-VEROBIOTECH-2024USVEROSPO00169$VERO BIOTECH$$$$$$Y$$$20240809$$CN$US$US
241943321$24194332$1$I$$20240802$20240809$20240809$EXP$$AU-BAUSCHBL-2024BNL030983$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240809$$CN$AU$AU
241943331$24194333$1$I$$20240802$20240809$20240809$EXP$$AU-BAUSCHBL-2024BNL030985$BAUSCH AND LOMB$$$$$M$Y$$$20240809$$CN$AU$AU
241943351$24194335$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A176266$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241943361$24194336$1$I$$20240806$20240809$20240809$EXP$$VN-AstraZeneca-2024A180701$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$VN$
241943371$24194337$1$I$20240724$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A178024$ASTRAZENECA$$31909$DY$$F$Y$$$20240809$$HP$US$
241943391$24194339$1$I$20240601$20240716$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003652$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240809$$CN$US$US
241943401$24194340$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-31296553$GB-NOVOPROD-1262325$NOVO NORDISK$$47$YR$$F$Y$$$20240809$$PH$GB$GB
241943411$24194341$1$I$$20240315$20240809$20240809$EXP$$CN-AstraZeneca-2024A180979$ASTRAZENECA$$$$$M$Y$$$20240809$$MD$CN$
241943421$24194342$1$I$$20240802$20240809$20240809$EXP$$CA-AstraZeneca-2024A177869$ASTRAZENECA$$49$YR$$F$Y$$$20240809$$MD$CA$
241943431$24194343$1$I$$20240801$20240809$20240809$EXP$$BR-JNJFOC-20240806420$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$MD$BR$BR
241943452$24194345$2$F$$20240928$20240809$20240930$EXP$$CA-PFIZER INC-202400230546$PFIZER$$13$YR$$F$Y$$$20240930$$HP$CA$CA
241943462$24194346$2$F$$20240929$20240809$20240930$EXP$$US-PFIZER INC-202400231478$PFIZER$$58$YR$$M$Y$$$20240930$$CN$US$US
241943471$24194347$1$I$$20240802$20240809$20240809$EXP$$FR-PFIZER INC-PV202400102205$PFIZER$$8$YR$$M$Y$$$20240809$$MD$FR$FR
241943481$24194348$1$I$$20240726$20240809$20240809$EXP$GB-MHRA-MIDB-2febd9d7-3b66-453e-bebb-fba455297ab9$GB-GLENMARK PHARMACEUTICALS-2024GMK092902$GLENMARK$$$$$$Y$$$20240809$$PH$GB$GB
241943491$24194349$1$I$$20240806$20240809$20240809$PER$$US-SA-2024SA235786$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240809$$MD$US$US
241943502$24194350$2$F$20240209$20240819$20240809$20240821$EXP$FR-AFSSAPS-TO2024001468$FR-SA-2024SA232821$SANOFI AVENTIS$$69$YR$E$M$Y$106$KG$20240821$$PH$FR$FR
241943512$24194351$2$F$$20240823$20240809$20240830$EXP$$US-ALXN-202408USA000051US$ALEXION PHARMACEUTICALS$$$$$F$Y$138.6$KG$20240830$$CN$US$US
241943521$24194352$1$I$20240715$20240730$20240809$20240809$EXP$CN-NMPACDR-3601301025637202400665$CN-BAXTER-2024BAX022556$BAXTER$$54$YR$$F$Y$50$KG$20240809$$MD$CN$CN
241943531$24194353$1$I$20240721$20240730$20240809$20240809$EXP$CN-NMPACDR-4501031911191202400019$CN-BAXTER-2024BAX022564$BAXTER$$11$YR$$F$Y$42.5$KG$20240809$$MD$CN$CN
241943541$24194354$1$I$20240725$20240731$20240809$20240809$EXP$CN-NMPACDR-6523011569378202400069$CN-BAXTER-2024BAX022654$BAXTER$$52$YR$$F$Y$55$KG$20240809$$MD$CN$CN
241943561$24194356$1$I$$20220531$20240809$20240809$EXP$$US-AstraZeneca-2022A153713$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241943571$24194357$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005388$ELI LILLY AND CO$$$$$M$Y$$$20240809$$CN$US$US
241943581$24194358$1$I$20240729$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004777$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240809$$CN$US$US
241943591$24194359$1$I$$20240730$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408000369$ELI LILLY AND CO$$51$YR$A$$Y$$$20240809$$CN$US$US
241943601$24194360$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004854$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240809$$CN$US$US
241943611$24194361$1$I$$20240808$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005741$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240809$$CN$US$US
241943621$24194362$1$I$20240717$20240802$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002149$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240809$$CN$US$US
241943631$24194363$1$I$20240706$20240730$20240809$20240809$EXP$SE-SEMPA-2024-005724$SE-BAXTER-2024BAX022672$BAXTER$$46$YR$$F$Y$$$20240809$$MD$SE$SE
241943641$24194364$1$I$20240618$20240730$20240809$20240809$EXP$FR-AFSSAPS-AN2024000972$FR-BAXTER-2024BAX022624$BAXTER$$52$YR$$F$Y$73.5$KG$20240809$$PH$FR$FR
241943651$24194365$1$I$$20240807$20240809$20240809$PER$$US-GILEAD-2024-0683541$GILEAD$$$$$$Y$$$20240809$$LW$US$US
241943671$24194367$1$I$$20240802$20240809$20240809$EXP$$AU-BAUSCHBL-2024BNL030986$BAUSCH AND LOMB$$68$YR$$F$Y$$$20240809$$CN$AU$AU
241943681$24194368$1$I$$20240711$20240809$20240809$30DAY$$US-VEROBIOTECH-2024USVEROSPO00172$VERO BIOTECH$$$$$$Y$$$20240809$$HP$US$US
241943691$24194369$1$I$20240522$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157770$AMGEN$$87$YR$E$F$Y$$$20240809$$CN$US$US
241943701$24194370$1$I$$20240802$20240809$20240809$EXP$$AU-BAUSCHBL-2024BNL030997$BAUSCH AND LOMB$$41$YR$$M$Y$$$20240809$$CN$AU$AU
241943711$24194371$1$I$$20240808$20240809$20240809$PER$$NVSC2024US162429$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
241943721$24194372$1$I$20210202$20240411$20240809$20240809$EXP$$NVSC2024RU070795$NOVARTIS$$70$YR$$F$Y$$$20240809$$MD$RU$RU
241943731$24194373$1$I$20240725$20240730$20240809$20240809$EXP$$CN-GE HEALTHCARE-2024CSU008748$GE HEALTHCARE$$57$YR$$F$Y$65$KG$20240809$$HP$CN$CN
241943741$24194374$1$I$20240705$20240801$20240809$20240809$EXP$$CN-GE HEALTHCARE-2024CSU008910$GE HEALTHCARE$$58$YR$$M$Y$$$20240809$$HP$CN$CN
241943752$24194375$2$F$20240101$20240904$20240809$20240913$EXP$$DE-TEVA-VS-3229044$TEVA$$54$YR$$M$Y$$$20240913$$CN$DE$DE
241943772$24194377$2$F$20240711$20240812$20240809$20240821$EXP$$MY-VANTIVE-2024VAN018643$Vantive US Healthcare$$70$YR$$M$Y$$$20240821$$HP$MY$MY
241943782$24194378$2$F$$20240805$20240809$20240814$EXP$$FR-SANDOZ INC.-PHHY2014FR151235$SANDOZ$$16$YR$$M$Y$$$20240814$$MD$FR$FR
241943791$24194379$1$I$$20240731$20240809$20240809$PER$$US-BAUSCHBL-2024BNL030999$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240809$$CN$US$US
241943801$24194380$1$I$$20240802$20240809$20240809$EXP$$AU-BAUSCHBL-2024BNL031002$BAUSCH AND LOMB$$$$$F$Y$$$20240809$$CN$AU$AU
241943811$24194381$1$I$$20240711$20240809$20240809$30DAY$$US-VEROBIOTECH-2024USVEROSPO00168$VERO BIOTECH$$$$$$Y$$$20240809$$HP$US$US
241943821$24194382$1$I$$20240808$20240809$20240809$PER$$US-BAYER-2024A114816$BAYER$$17$YR$T$F$Y$$$20240809$$MD$US$US
241943831$24194383$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54709$$FDA-CTU$$72$YR$$F$N$$$20240808$N$$US$
241943843$24194384$3$F$20240801$20240813$20240809$20240816$PER$$US-AMGEN-USASP2024157189$AMGEN$$72$YR$E$M$Y$$$20240816$$CN$US$US
241943851$24194385$1$I$$20240808$20240809$20240809$PER$$US-AMGEN-USASP2024157886$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241943861$24194386$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54659$$FDA-CTU$$52$YR$$M$N$$$20240808$N$$US$
241943871$24194387$1$I$$20240801$20240809$20240809$EXP$$EU-BAUSCHBL-2024BNL031048$BAUSCH AND LOMB$$$$E$M$Y$$$20240809$$MD$EU$EU
241943881$24194388$1$I$20240101$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024156625$AMGEN$$71$YR$E$F$Y$$$20240809$$CN$US$US
241943892$24194389$2$F$$20240816$20240809$20240821$PER$$US-AMGEN-USASP2024157763$AMGEN$$$$$F$Y$$$20240821$$PH$US$US
241943901$24194390$1$I$20240807$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157938$AMGEN$$78$YR$E$F$Y$$$20240809$$PH$US$US
241943911$24194391$1$I$20240101$20240802$20240809$20240809$PER$$US-SA-2024SA233927$SANOFI AVENTIS$$$$A$M$Y$83$KG$20240809$$MD$US$US
241943921$24194392$1$I$$20240711$20240809$20240809$30DAY$$US-VEROBIOTECH-2024USVEROSPO00171$VERO BIOTECH$$$$$$Y$$$20240809$$HP$US$US
241943931$24194393$1$I$20240711$20240730$20240809$20240809$EXP$FR-AFSSAPS-PB2024000805$FR-TEVA-VS-3228195$TEVA$$26$YR$$F$Y$$$20240809$$MD$FR$FR
241943951$24194395$1$I$$20240731$20240809$20240809$EXP$$US-TEVA-VS-3228852$TEVA$$66$YR$$F$Y$$$20240809$$HP$US$US
241943961$24194396$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54655$$FDA-CTU$$72$YR$$F$N$$$20240808$N$$US$
241943971$24194397$1$I$20231001$20240808$20240808$20240808$DIR$713514$$FDA-CTU$$69$YR$$F$N$58.5$KG$20240808$N$CN$US$
241943981$24194398$1$I$20240615$20240808$20240808$20240808$DIR$713507$$FDA-CTU$$73$YR$$F$N$77.85$KG$20240808$N$CN$US$
241943991$24194399$1$I$20180104$20240808$20240808$20240808$DIR$713497$$FDA-CTU$$68$YR$$F$N$59.4$KG$20240808$N$CN$US$
241944011$24194401$1$I$20240801$20240808$20240808$20240808$DIR$713513$$FDA-CTU$$31$YR$$M$N$$$20240808$N$$US$
241944041$24194404$1$I$20240807$20240808$20240808$20240808$DIR$713536$$FDA-CTU$$41$YR$$F$N$87.75$KG$20240808$N$CN$US$
241944051$24194405$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54736$$FDA-CTU$$61$YR$$F$N$$$20240808$N$$US$
241944071$24194407$1$I$20240804$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54689$$FDA-CTU$$76$YR$$M$N$$$20240808$Y$HP$US$
241944081$24194408$1$I$20240808$20240808$20240808$20240808$DIR$713542$$FDA-CTU$$33$YR$$F$N$86.85$KG$20240808$N$CN$US$
241944091$24194409$1$I$20240715$20240808$20240808$20240808$DIR$713538$$FDA-CTU$$33$YR$$F$N$70.65$KG$20240808$Y$CN$US$
241944141$24194414$1$I$20240421$20240808$20240808$20240808$DIR$713515$$FDA-CTU$$23$YR$$F$N$54$KG$20240808$N$CN$US$
241944151$24194415$1$I$20240806$20240808$20240808$20240808$DIR$713499$$FDA-CTU$$58$YR$$F$N$44.5$KG$20240808$N$PH$US$
241944161$24194416$1$I$20240512$20240808$20240808$20240808$DIR$713534$$FDA-CTU$$32$MON$$M$N$10$KG$20240808$N$HP$US$
241944171$24194417$1$I$20240712$20240808$20240808$20240808$DIR$713540$$FDA-CTU$$46$YR$$F$N$78.75$KG$20240808$N$CN$US$
241944191$24194419$1$I$20231201$20240808$20240808$20240808$DIR$713535$$FDA-CTU$$26$YR$$F$N$65.7$KG$20240808$N$CN$US$
241944201$24194420$1$I$20240406$20240808$20240808$20240808$DIR$713543$$FDA-CTU$$28$YR$$F$N$73$KG$20240808$N$MD$US$
241944211$24194421$1$I$20150120$20240805$20240809$20240809$EXP$$AU-TAKEDA-2024TUS079383$TAKEDA$$58$YR$$M$Y$$$20240809$$MD$AU$AU
241944221$24194422$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54704$$FDA-CTU$$48$YR$$F$N$$$20240808$N$$US$
241944231$24194423$1$I$$20240802$20240808$20240808$DIR$FDA-CDER-CTU-2024-54692$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
241944251$24194425$1$I$20230727$20240806$20240809$20240809$EXP$$KR-009507513-2408KOR001497$MERCK$$$$$M$Y$50$KG$20240809$$PH$KR$KR
241944261$24194426$1$I$20240510$20240806$20240809$20240809$EXP$ES-AEMPS-1555777$ES-ORGANON-O2408ESP000464$ORGANON$$83$YR$$F$Y$$$20240809$$MD$ES$ES
241944271$24194427$1$I$$20240730$20240809$20240809$EXP$$TR-TAKEDA-2024TUS079330$TAKEDA$$$$$$Y$$$20240809$$MD$TR$TR
241944281$24194428$1$I$20240101$20240730$20240809$20240809$EXP$$US-009507513-2408USA000247$MERCK$$$$$F$Y$$$20240809$$MD$US$US
241944291$24194429$1$I$20240626$20240807$20240809$20240809$EXP$PT-INFARMED-B202407-752$PT-JNJFOC-20240821906$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240809$$MD$PT$PT
241944301$24194430$1$I$$20240719$20240809$20240809$PER$$US-AMGEN-USASP2024156645$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241944311$24194431$1$I$$20240729$20240809$20240809$EXP$$ES-VKT-000580$VKT PHARMA PRIVATE LIMITED$$54$YR$A$M$Y$$$20240731$$MD$ES$ES
241944321$24194432$1$I$20231001$20231007$20240809$20240809$PER$$US-PERRIGO-23US011869$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241944331$24194433$1$I$$20240505$20240809$20240809$PER$$US-PERRIGO-24US004437$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241944341$24194434$1$I$20240222$20240228$20240809$20240809$PER$$US-PERRIGO-24US002208$PERRIGO$$59$YR$$F$Y$99.773$KG$20240809$$CN$US$US
241944351$24194435$1$I$$20240110$20240809$20240809$PER$$US-PERRIGO-24US000405$PERRIGO$$$$$M$Y$$$20240809$$CN$US$US
241944361$24194436$1$I$$20240515$20240809$20240809$PER$$US-PERRIGO-24US004800$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241944371$24194437$1$I$20240423$20240502$20240809$20240809$PER$$US-PERRIGO-24US004341$PERRIGO$$55$YR$$F$Y$74.83$KG$20240809$$CN$US$US
241944381$24194438$1$I$$20240529$20240809$20240809$PER$$US-PERRIGO-24US005293$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241944391$24194439$1$I$20231001$20231025$20240809$20240809$PER$$US-PERRIGO-23US012480$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241944401$24194440$1$I$20240519$20240522$20240809$20240809$PER$$US-PERRIGO-24US005013$PERRIGO$$23$YR$$M$Y$70.295$KG$20240809$$CN$US$US
241944411$24194441$1$I$$20240606$20240809$20240809$PER$$US-PERRIGO-24US005526$PERRIGO$$$$A$$Y$$$20240809$$CN$US$US
241944421$24194442$1$I$20230701$20230727$20240809$20240809$PER$$US-PERRIGO-23US008530$PERRIGO$$$$$F$Y$$$20240809$$CN$US$US
241944431$24194443$1$I$$20240129$20240809$20240809$PER$$US-PERRIGO-24US001100$PERRIGO$$$$$F$Y$$$20240809$$CN$US$US
241944441$24194444$1$I$20230101$20230727$20240809$20240809$PER$$US-PERRIGO-23US008495$PERRIGO$$$$$M$Y$60.771$KG$20240809$$CN$US$US
241944451$24194445$1$I$20210101$20240802$20240809$20240809$EXP$$US-TAKEDA-2024TUS078053$TAKEDA$$$$$F$Y$55.5$KG$20240809$$MD$US$US
241944462$24194446$2$F$$20240917$20240809$20240920$30DAY$$US-PFIZER INC-202400229423$PFIZER$$12$YR$$M$Y$$$20240920$$CN$US$US
241944472$24194447$2$F$20240801$20240908$20240809$20240909$30DAY$$US-PFIZER INC-202400229709$PFIZER$$12$YR$$M$Y$$$20240909$$HP$US$US
241944484$24194448$4$F$$20240813$20240809$20240820$30DAY$$US-PFIZER INC-202400230059$PFIZER$$19$YR$$M$Y$68.49$KG$20240820$$CN$US$US
241944512$24194451$2$F$$20240812$20240809$20240812$30DAY$$US-PFIZER INC-202400229315$PFIZER$$$$$M$Y$$$20240812$$CN$US$US
241944522$24194452$2$F$20240802$20240823$20240809$20240829$PER$$US-EMD Serono-2024042091$EMD SERONO INC$$48$YR$A$F$Y$$$20240829$$HP$US$US
241944531$24194453$1$I$$20240806$20240809$20240809$PER$$US-SA-2024SA235703$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240809$$CN$US$US
241944551$24194455$1$I$20240717$20240729$20240809$20240809$30DAY$$US-GSK-US2024098597$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240809$$PH$US$US
241944561$24194456$1$I$$20240730$20240809$20240809$30DAY$$US-GSK-US2024AMR095598$GLAXOSMITHKLINE$$$$$M$Y$$$20240809$$CN$US$US
241944571$24194457$1$I$20240808$20240808$20240809$20240809$PER$$US-AMGEN-USASP2024158186$AMGEN$$$$$$Y$$$20240809$$PH$US$US
241944582$24194458$2$F$$20240809$20240809$20240812$PER$$US-AMGEN-USASP2024158399$AMGEN$$$$$F$Y$$$20240811$$PH$US$US
241944591$24194459$1$I$$20240806$20240809$20240809$EXP$$CA-AMGEN-CANSL2024156517$AMGEN$$69$YR$E$M$Y$$$20240809$$MD$CA$CA
241944601$24194460$1$I$$20240805$20240809$20240809$EXP$$NVSC2024TR161787$NOVARTIS$$19$YR$$F$Y$$$20240809$$CN$TR$TR
241944611$24194461$1$I$20240222$20240730$20240809$20240809$EXP$CH-SM-2024-13907$CH-TEVA-VS-3228649$TEVA$$68$YR$$M$Y$$$20240809$$PH$CH$CH
241944621$24194462$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004184$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241944631$24194463$1$I$$20240801$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002622$ELI LILLY AND CO$$76$YR$E$$Y$$$20240809$$CN$US$US
241944651$24194465$1$I$20240701$20240731$20240809$20240809$PER$$US-BAUSCHBL-2024BNL031062$BAUSCH AND LOMB$$78$YR$$F$Y$$$20240809$$CN$US$US
241944661$24194466$1$I$20240727$20240806$20240809$20240809$EXP$$VN-BAYER-2024A111990$BAYER$$50$YR$A$M$Y$$$20240809$$HP$VN$VN
241944671$24194467$1$I$20240511$20240726$20240809$20240809$EXP$FR-AFSSAPS-AM2024000586$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07208$HIKMA$$$$$$Y$$$20240809$$PH$FR$FR
241944682$24194468$2$F$$20240908$20240809$20240909$30DAY$$US-PFIZER INC-202400231059$PFIZER$$17$YR$$M$Y$$$20240909$$CN$US$US
241944707$24194470$7$F$20240801$20240920$20240809$20240926$30DAY$$CO-PFIZER INC-PV202400101655$PFIZER$$13$YR$$M$Y$$$20240926$$CN$CO$CO
241944711$24194471$1$I$$20240806$20240809$20240809$EXP$FR-AFSSAPS-PV2024000679$FR-PFIZER INC-202400230846$PFIZER$$$$$$Y$$$20240809$$MD$FR$FR
241944721$24194472$1$I$$20240806$20240809$20240809$30DAY$$CO-PFIZER INC-202400231178$PFIZER$$10$YR$$F$Y$$$20240809$$CN$CO$CO
241944733$24194473$3$F$20240101$20240917$20240809$20240920$30DAY$$US-PFIZER INC-202400230602$PFIZER$$13$YR$$F$Y$$$20240920$$CN$US$US
241944742$24194474$2$F$$20240920$20240809$20240924$30DAY$$US-PFIZER INC-PV202400101934$PFIZER$$$$$F$Y$$$20240924$$CN$US$US
241944765$24194476$5$F$$20240916$20240809$20240916$30DAY$$US-PFIZER INC-202400231078$PFIZER$$30$YR$$M$Y$$$20240916$$HP$US$US
241944773$24194477$3$F$$20240813$20240809$20240814$30DAY$$CL-PFIZER INC-PV202400083561$PFIZER$$1$YR$$F$Y$$$20240814$$CN$CL$CL
241944781$24194478$1$I$$20240801$20240809$20240809$30DAY$$US-PFIZER INC-PV202400044121$PFIZER$$$$$$Y$$$20240809$$HP$US$US
241944802$24194480$2$F$$20240912$20240809$20240912$30DAY$$US-PFIZER INC-202400230608$PFIZER$$14$YR$$M$Y$$$20240912$$CN$US$US
241944812$24194481$2$F$$20240908$20240809$20240909$30DAY$$US-PFIZER INC-202400229576$PFIZER$$11$YR$$M$Y$$$20240909$$CN$US$US
241944822$24194482$2$F$20240805$20240911$20240809$20240911$30DAY$$US-PFIZER INC-202400230916$PFIZER$$$$$M$Y$$$20240911$$CN$US$US
241944832$24194483$2$F$20240801$20240806$20240809$20240813$EXP$$US-PFIZER INC-202400230460$PFIZER$$83$YR$$F$Y$56.7$KG$20240813$$MD$US$US
241944841$24194484$1$I$$20240805$20240809$20240809$EXP$$CA-PFIZER INC-202400231221$PFIZER$$52$YR$$M$Y$$$20240809$$HP$CA$CA
241944851$24194485$1$I$$20240805$20240809$20240809$EXP$$CA-PFIZER INC-202400230463$PFIZER$$81$YR$$M$Y$$$20240809$$HP$CA$CA
241944874$24194487$4$F$20240802$20240926$20240809$20240930$30DAY$$US-PFIZER INC-PV202400046938$PFIZER$$71$YR$$M$Y$102.06$KG$20240930$$MD$US$US
241944882$24194488$2$F$$20240904$20240809$20240909$EXP$$KR-PFIZER INC-202400231081$PFIZER$Kim, H.. Severe acquired hemophilia A associated with COVID-19 vaccination: A case report and literature review. Medicine. 2024;103(31):10.1097/MD.0000000000039166$56$YR$$M$Y$$$20240909$$MD$KR$KR
241944891$24194489$1$I$$20240805$20240809$20240809$EXP$$CA-PFIZER INC-202400230454$PFIZER$$69$YR$$M$Y$$$20240809$$HP$CA$CA
241944902$24194490$2$F$$20240908$20240809$20240909$30DAY$$US-PFIZER INC-PV202400102125$PFIZER$$$$$M$Y$$$20240909$$CN$US$US
241944911$24194491$1$I$$20240805$20240809$20240809$30DAY$$KR-PFIZER INC-PV202400101933$PFIZER$$$$$$Y$$$20240809$$CN$KR$KR
241944941$24194494$1$I$20240710$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54656$$FDA-CTU$$72$YR$$F$N$74.84$KG$20240808$N$HP$US$
241944954$24194495$4$F$$20240916$20240809$20240916$30DAY$$US-PFIZER INC-202400229782$PFIZER$$14$YR$$M$Y$$$20240916$$CN$US$US
241944961$24194496$1$I$$20240805$20240809$20240809$EXP$$JP-PFIZER INC-PV202400102051$PFIZER$Fujimoto, Y.. A case of ROS1 fusion gene-positive metastases to lung from lung adenocarcinoma showing ground-glass opacity in both lungs during rheumatoid arthritis treatment, leading to the diagnosis. 132nd Annual Meeting of Kinki Chapter of the Japanese Society for Tuberculosis. 2024;132nd:55$79$YR$$F$Y$$$20240809$$HP$JP$JP
241944972$24194497$2$F$$20240908$20240809$20240909$30DAY$$US-PFIZER INC-202400228807$PFIZER$$6$YR$$F$Y$$$20240909$$CN$US$US
241944992$24194499$2$F$$20240807$20240809$20240813$EXP$$CZ-MYLANLABS-2023M1039575$MYLAN$Holanek M.. Treatment of metastatic lobular breast carcinoma with an aromatase inhibitor and ribociclib combination. ACTA MEDICINAE. 2023;12:11-12$58$YR$$F$Y$$$20240813$$HP$CZ$CZ
241945021$24194502$1$I$$20240729$20240809$20240809$EXP$$US-B.Braun Medical Inc.-2160236$B BRAUN$Literature Article$53$YR$$F$Y$$$20240809$$$US$US
241945032$24194503$2$F$$20240813$20240809$20240821$PER$$US-BIOGEN-2024BI01274891$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
241945041$24194504$1$I$$20240808$20240809$20240809$EXP$$JP-BAYER-2024A114469$BAYER$$$$$F$Y$$$20240809$$PH$JP$JP
241945051$24194505$1$I$$20240805$20240809$20240809$EXP$$US-APOTEX-2024AP009148$APOTEX$Kesari S, Barron C, Cohen LE, Regelmann MO, Baer TG. Dexamethasone swish and spit: A cause of iatrogenic adrenal insufficiency. Pediatric Blood Cancer. 2024;71(9)(e31138):1-2$14$YR$$M$Y$$$20240809$$HP$US$US
241945061$24194506$1$I$$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024158104$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241945072$24194507$2$F$20240804$20240808$20240809$20240821$PER$$US-AMGEN-USASP2024156312$AMGEN$$71$YR$E$F$Y$$$20240821$$CN$US$US
241945081$24194508$1$I$$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024157176$AMGEN$$$$$$Y$$$20240809$$PH$US$US
241945091$24194509$1$I$20240401$20240726$20240809$20240809$EXP$$DE-UCBSA-2024039805$UCB$$$$A$M$Y$85$KG$20240809$$MD$DE$DE
241945101$24194510$1$I$20240730$20240730$20240809$20240809$30DAY$$US-GSK-US2024095875$GLAXOSMITHKLINE$$40$YR$$F$Y$$$20240809$$PH$US$US
241945111$24194511$1$I$20200301$20240731$20240809$20240809$EXP$$ES-SAMSUNG BIOEPIS-SB-2024-23036$SAMSUNG BIOEPIS$Montero S. IgA nephropathy after long-term treatment with infliximab for Crohn^s disease: A review of two cases. Nefrologia. 2024;44 (4):582-613. doi:10.1016/j.nefro.2023.02.007$51$YR$A$F$Y$$$20240809$$HP$ES$ES
241945131$24194513$1$I$20240725$20240806$20240809$20240809$EXP$$CN-ABBVIE-5873521$ABBVIE$$58$YR$$M$Y$$$20240809$$HP$CN$CN
241945141$24194514$1$I$20240806$20240806$20240809$20240809$EXP$$AR-BAYER-2024A114006$BAYER$$35$YR$A$F$Y$$$20240809$$MD$AR$AR
241945151$24194515$1$I$$20240806$20240809$20240809$EXP$$IN-PFIZER INC-PV202400038976$PFIZER$$73$YR$$F$Y$$$20240809$$CN$IN$IN
241945162$24194516$2$F$20240701$20240902$20240809$20240905$EXP$$CL-PFIZER INC-PV202400102840$PFIZER$$43$YR$$F$Y$65$KG$20240905$$CN$CL$CL
241945191$24194519$1$I$$20240806$20240809$20240809$30DAY$$US-PFIZER INC-PV202400100750$PFIZER$$14$YR$$F$Y$40.82$KG$20240809$$CN$US$US
241945201$24194520$1$I$$20240806$20240809$20240809$EXP$$CA-PFIZER INC-202400232000$PFIZER$$$$$$Y$$$20240809$$CN$CA$CA
241945211$24194521$1$I$20240607$20240806$20240809$20240809$EXP$ES-AEMPS-1557143$ES-PFIZER INC-202400230835$PFIZER$$73$YR$$M$Y$$$20240809$$PH$ES$ES
241945221$24194522$1$I$20240727$20240806$20240809$20240809$EXP$FR-AFSSAPS-BR2024000636$FR-PFIZER INC-202400230877$PFIZER$$68$YR$$M$Y$66$KG$20240809$$MD$FR$FR
241945232$24194523$2$F$$20240924$20240809$20240927$30DAY$$US-PFIZER INC-PV202400044166$PFIZER$$$$$$Y$$$20240927$$HP$US$US
241945251$24194525$1$I$$20240803$20240809$20240809$EXP$$TR-AstraZeneca-2024A177635$ASTRAZENECA$$37$YR$$M$Y$$$20240809$$CN$TR$
241945272$24194527$2$F$$20240807$20240809$20240813$30DAY$$US-PFIZER INC-PV202400044350$PFIZER$$$$$$Y$$$20240813$$HP$US$US
241945284$24194528$4$F$$20240918$20240809$20240923$EXP$$JP-PFIZER INC-PV202400101953$PFIZER$$$$$M$Y$$$20240923$$CN$JP$JP
241945291$24194529$1$I$20231030$20240806$20240809$20240809$EXP$FR-AFSSAPS-PV2024000703$FR-PFIZER INC-202400230816$PFIZER$$16$YR$$F$Y$94$KG$20240809$$MD$FR$FR
241945302$24194530$2$F$$20240813$20240809$20240814$PER$$US-AstraZeneca-2024A158305$ASTRAZENECA$$$$$$Y$$$20240814$$MD$US$
241945311$24194531$1$I$$20240806$20240809$20240809$PER$$US-BIOGEN-2024BI01277170$BIOGEN$$$$$F$Y$$$20240809$$CN$US$US
241945322$24194532$2$F$$20240812$20240809$20240820$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-22221$SAMSUNG BIOEPIS$$73$YR$E$F$Y$$$20240820$$CN$GB$GB
241945331$24194533$1$I$20240706$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54662$$FDA-CTU$$56$YR$$M$N$$$20240808$N$$US$
241945341$24194534$1$I$20170714$20240729$20240809$20240809$EXP$$DK-Nova Laboratories Limited-2160239$NOVA LABORATORIES$$19$YR$$M$Y$56$KG$20240809$$MD$DK$DK
241945351$24194535$1$I$20240724$20240807$20240809$20240809$EXP$$CN-BAYER-2024A114325$BAYER$$60$YR$A$M$Y$50$KG$20240809$$HP$CN$CN
241945362$24194536$2$F$20240731$20240807$20240809$20240813$PER$$US-AMGEN-USASP2024157286$AMGEN$$71$YR$E$F$Y$$$20240813$$CN$US$US
241945391$24194539$1$I$$20240805$20240809$20240809$PER$$US-BIOGEN-2014BI045536$BIOGEN$$$$$M$Y$$$20240809$$CN$US$US
241945401$24194540$1$I$$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A178284$ASTRAZENECA$$$$$M$Y$$$20240809$$MD$US$
241945411$24194541$1$I$$20240729$20240809$20240809$EXP$$AU-LUPIN HEALTHCARE (UK) LIMITED-2024-07612$LUPIN$$37$YR$$M$Y$$$20240809$$CN$AU$AU
241945421$24194542$1$I$$20240805$20240809$20240809$EXP$$US-AMERICAN REGENT INC-2024003018$AMERICAN REGENT$$$$$M$Y$$$20240809$$CN$US$US
241945431$24194543$1$I$$20240725$20240809$20240809$PER$$US-TEVA-VS-3227482$TEVA$$48$YR$$F$Y$$$20240809$$MD$US$US
241945441$24194544$1$I$20240505$20240801$20240809$20240809$EXP$$OM-AMRYT PHARMACEUTICALS DAC-AEGR007314$AEGERION$$$$$$Y$$$20240809$$MD$OM$OM
241945451$24194545$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5864704$ABBVIE$$$$$$Y$$$20240809$$CN$US$US
241945462$24194546$2$F$$20240828$20240809$20240902$PER$$US-TAKEDA-2024TUS079524$TAKEDA$$$$$F$Y$50.794$KG$20240902$$HP$US$US
241945471$24194547$1$I$$20240730$20240809$20240809$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07409$HIKMA$Bally K, Trusty R, Naher K.. Bally K, Trusty R, Naher K. A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone. Cureus. 2024;16(6):e62695$95$YR$$F$Y$$$20240809$$MD$US$US
241945501$24194550$1$I$20240101$20240806$20240809$20240809$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012869$VERTEX$$$$A$F$Y$$$20240809$$CN$GB$GB
241945521$24194552$1$I$20240101$20240806$20240809$20240809$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012871$VERTEX$$$$A$M$Y$$$20240809$$CN$GB$GB
241945531$24194553$1$I$20240101$20240807$20240809$20240809$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012968$VERTEX$$$$$F$Y$$$20240809$$CN$GB$GB
241945541$24194554$1$I$20240101$20240806$20240809$20240809$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012900$VERTEX$$$$$F$Y$$$20240809$$CN$GB$GB
241945561$24194556$1$I$20190101$20240730$20240809$20240809$EXP$$JP-AMRYT PHARMACEUTICALS DAC-AEGR006737$AEGERION$$$$$$Y$$$20240809$$MD$JP$JP
241945572$24194557$2$F$20240611$20240814$20240809$20240821$EXP$$US-TAKEDA-2024TUS041182$TAKEDA$$72$YR$$F$Y$$$20240821$$CN$US$US
241945581$24194558$1$I$$20240805$20240809$20240809$PER$$US-BIOGEN-2021BI00968249$BIOGEN$$$$$F$Y$$$20240809$$CN$US$US
241945591$24194559$1$I$20240701$20240801$20240809$20240809$PER$$US-MYLANLABS-2024M1072361$MYLAN$$$$$M$Y$$$20240809$$CN$US$US
241945603$24194560$3$F$$20240919$20240809$20240927$PER$$US-VERTEX PHARMACEUTICALS-2024-012705$VERTEX$$$$$F$Y$$$20240927$$CN$US$US
241945611$24194561$1$I$$20240807$20240809$20240809$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012932$VERTEX$$$$A$M$Y$$$20240809$$CN$GB$GB
241945631$24194563$1$I$20240725$20240725$20240809$20240809$EXP$$US-Time-Cap Labs, Inc.-2160240$TIME CAPS$$$$$F$Y$$$20240809$$$US$US
241945641$24194564$1$I$$20240805$20240809$20240809$PER$$US-VERTEX PHARMACEUTICALS-2024-012843$VERTEX$$$$$F$Y$$$20240809$$CN$US$US
241945651$24194565$1$I$20230625$20240805$20240809$20240809$EXP$FR-AFSSAPS-PV2024000593$FR-Waylis Therapeutics LLC-ATNAHS20240802263$Waylis$$1$DY$I$M$Y$0.28$KG$20240809$$MD$FR$FR
241945671$24194567$1$I$20240101$20240625$20240809$20240809$PER$$US-KARYOPHARM-2024KPT001227$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240809$$MD$US$US
241945681$24194568$1$I$20240101$20240620$20240809$20240809$PER$$US-KARYOPHARM-2024KPT001208$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240809$$CN$US$US
241945692$24194569$2$F$20240101$20240905$20240809$20240920$PER$$US-KARYOPHARM-2024KPT001339$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240920$$CN$US$US
241945701$24194570$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157860$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241945711$24194571$1$I$$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155296$AMGEN$$$$$M$Y$$$20240809$$CN$US$US
241945731$24194573$1$I$$20240808$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005671$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240809$$CN$US$US
241945741$24194574$1$I$$20240805$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003024$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240809$$CN$US$US
241945751$24194575$1$I$20240701$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004659$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240809$$CN$US$US
241945761$24194576$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004788$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240809$$CN$US$US
241945771$24194577$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004964$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240809$$CN$US$US
241945781$24194578$1$I$20231215$20240805$20240809$20240809$EXP$$JP-SANDOZ INC.-SDZ2024JP071575$SANDOZ$$93$YR$$F$Y$$$20240809$$CN$JP$JP
241945791$24194579$1$I$20240608$20240801$20240809$20240809$EXP$$BR-BIOVITRUM-2024-BR-010761$BIOVITRUM$$15$WK$$M$Y$4.4$KG$20240809$$CN$BR$BR
241945801$24194580$1$I$$20240802$20240809$20240809$PER$$US-APOTEX-2024AP009128$APOTEX$Allonce J, Khan S, Pulford B.. Atypical Presentation of Ziprasidone Induced Neuroleptic Malignant Syndrome: A Case Report. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-4$43$YR$$M$Y$$$20240809$$MD$US$US
241945811$24194581$1$I$$20240806$20240809$20240809$EXP$$PK-PFIZER INC-PV202400102278$PFIZER$Ali, M.. An Unusual Case of Phagocytic Histiocytes on Peripheral Blood Smear of a Patient With Methicillin-Resistant Staphylococcus aureus (MRSA) Endocarditis. Cureus. 2023;15(11):10.7759/cureus.49042$7$YR$$F$Y$15$KG$20240809$$HP$PK$PK
241945821$24194582$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA231805$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240809$$MD$US$US
241945831$24194583$1$I$20240601$20240802$20240809$20240809$PER$$US-SA-2024SA233214$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240809$$MD$US$US
241945841$24194584$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191247$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241945851$24194585$1$I$20240710$20240807$20240809$20240809$EXP$CH-SM-2024-14812$CH-BAYER-2024A114237$BAYER$$67$YR$E$M$Y$110$KG$20240809$$HP$CH$CH
241945861$24194586$1$I$20240701$20240729$20240809$20240809$EXP$$US-INSMED, INC.-2024-02707-US$INSMED$$90$YR$$F$Y$$$20240809$$CN$US$US
241945871$24194587$1$I$20240731$20240801$20240809$20240809$PER$$US-ABBVIE-5866034$ABBVIE$$40$YR$$M$Y$$$20240809$$CN$US$AU
241945881$24194588$1$I$20240730$20240802$20240809$20240809$PER$$US-EMD Serono-2024042080$EMD SERONO INC$$67$YR$E$F$Y$$$20240809$$HP$US$US
241945892$24194589$2$F$20240715$20240816$20240809$20240830$EXP$$US-SMITH AND NEPHEW, INC-2024SMT00039$SMITH AND NEPHEW$$64$YR$$F$Y$131.52$KG$20240830$$CN$US$US
241945901$24194590$1$I$20240725$20240725$20240809$20240809$EXP$$US-PHOTOCURE ASA-PHCUS2024000007$PHOTOCURE$$$$$$Y$$$20240809$$MD$US$US
241945911$24194591$1$I$$20220425$20240809$20240809$EXP$$US-AstraZeneca-2022A108108$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241945931$24194593$1$I$20240629$20240805$20240809$20240809$EXP$GB-MHRA-MED-202408050942328210-TYRHD$GB-OTSUKA-2024_021669$OTSUKA$$53$YR$$F$Y$$$20240809$$MD$GB$GB
241945941$24194594$1$I$20240701$20240801$20240809$20240809$PER$$US-SA-2024SA080464$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240809$$MD$US$US
241945951$24194595$1$I$20240802$20240802$20240809$20240809$PER$$US-SA-2024SA233413$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240809$$MD$US$US
241945962$24194596$2$F$20240520$20240905$20240809$20240912$EXP$DE-PEI-CADR2024329417$DE-TEVA-VS-3228295$TEVA$$66$YR$$M$Y$84$KG$20240912$$MD$DE$DE
241945971$24194597$1$I$$20240807$20240809$20240809$PER$$NVSC2024US161533$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
241945981$24194598$1$I$$20240731$20240809$20240809$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02850$AMNEAL$Jones AA, Martin JS, Giangiacomo AL, Costakos DM.. Secondary Glaucoma After Bevacizumab Injection in Type-1 Retinopathy of Prematurity. Am J Ophthalmol Case Rep.. 2024;36$$$I$F$Y$0.57$KG$20240809$$HP$US$US
241945991$24194599$1$I$20240729$20240807$20240809$20240809$EXP$DE-BFARM-24005525$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-125811$BRISTOL MYERS SQUIBB$$65$YR$A$M$Y$82$KG$20240809$$MD$DE$DE
241946001$24194600$1$I$20240808$20240808$20240809$20240809$EXP$$CH-GILEAD-2024-0683568$GILEAD$$2$MON$I$F$Y$$$20240809$$MD$CH$CH
241946011$24194601$1$I$$20240806$20240809$20240809$PER$$US-ALXN-202408USA000385US$ALEXION PHARMACEUTICALS$$$$$M$Y$58.957$KG$20240809$$CN$US$US
241946021$24194602$1$I$20240709$20240731$20240809$20240809$EXP$FR-AFSSAPS-PV2024000689$FR-ROCHE-10000050482$ROCHE$$71$YR$E$F$Y$64$KG$20240809$$MD$FR$FR
241946031$24194603$1$I$20240722$20240807$20240809$20240809$EXP$$US-BAYER-2024A114645$BAYER$$70$YR$E$M$Y$$$20240809$$HP$US$US
241946051$24194605$1$I$$20240730$20240809$20240809$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005654$BIOCON$$$$$$Y$$$20240809$$MD$CA$CA
241946061$24194606$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157287$AMGEN$$$$$M$Y$$$20240809$$HP$US$US
241946071$24194607$1$I$$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155464$AMGEN$$$$A$F$Y$$$20240809$$CN$US$US
241946081$24194608$1$I$20240802$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157854$AMGEN$$$$$M$Y$$$20240809$$CN$US$US
241946101$24194610$1$I$20240804$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024156338$AMGEN$$60$YR$A$F$Y$$$20240809$$CN$US$US
241946111$24194611$1$I$$20240727$20240809$20240809$PER$$US-Calliditas-2024CAL01423$CALLIDITAS THERAPEUTICS$$$$$M$Y$$$20240809$$CN$US$US
241946121$24194612$1$I$$20240806$20240809$20240809$EXP$$NVSC2024GB160822$NOVARTIS$$$$$F$Y$$$20240809$$CN$GB$GB
241946131$24194613$1$I$20240601$20240807$20240809$20240809$EXP$$US-GILEAD-2024-0683553$GILEAD$$49$YR$A$F$Y$$$20240809$$CN$US$US
241946141$24194614$1$I$$20240730$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024095251$VIIV$$$$$F$Y$$$20240809$$CN$US$US
241946151$24194615$1$I$$20240807$20240809$20240809$PER$$US-DSJP-DSU-2024-140092$DAIICHI$$$$$F$Y$$$20240809$$CN$US$US
241946161$24194616$1$I$$20240807$20240809$20240809$EXP$$JP-BAYER-2024A085668$BAYER$$7$DEC$E$M$Y$$$20240809$$MD$JP$JP
241946171$24194617$1$I$20240615$20240731$20240809$20240809$EXP$$EG-ROCHE-10000046204$ROCHE$$20$YR$A$F$Y$70$KG$20240809$$CN$EG$EG
241946181$24194618$1$I$$20240802$20240809$20240809$EXP$FR-AFSSAPS-AVMA2024000341$FR-SA-2024SA229784$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240809$$MD$FR$FR
241946191$24194619$1$I$$20240731$20240809$20240809$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02875$AMNEAL$Jones A.A, Martin J.S, Giangiacomo A.L, Costakos D.M.. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. Am J Ophthalmol Case Rep.. 2024;36$16$WK$$M$Y$0.48$KG$20240809$$HP$US$US
241946201$24194620$1$I$$20240802$20240809$20240809$EXP$$IN-ROCHE-10000049169$ROCHE$$73$YR$E$M$Y$$$20240809$$CN$IN$IN
241946211$24194621$1$I$20210601$20240801$20240809$20240809$EXP$DE-CADRBFARM-2024329492$DE-TEVA-VS-3229215$TEVA$$63$YR$$F$Y$62$KG$20240809$$CN$DE$DE
241946222$24194622$2$F$$20240819$20240809$20240826$EXP$PL-EMA-DD-20240802-7483181-104002$PL-SANDOZ INC.-SDZ2024PL070827$SANDOZ$$17$YR$$F$Y$$$20240826$$MD$PL$PL
241946231$24194623$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA235157$SANOFI AVENTIS$$$$C$M$Y$$$20240809$$MD$US$US
241946242$24194624$2$F$20240807$20240826$20240809$20240827$PER$$US-AMGEN-USASP2024157528$AMGEN$$52$YR$A$M$Y$$$20240827$$CN$US$US
241946261$24194626$1$I$$20240731$20240809$20240809$EXP$$VE-ROCHE-10000048089$ROCHE$$$$$$Y$$$20240809$$MD$VE$VE
241946271$24194627$1$I$$20240807$20240809$20240809$PER$$US-ORGANON-O2408USA000642$ORGANON$$17$YR$$F$Y$$$20240809$$CN$US$US
241946281$24194628$1$I$20180101$20240727$20240809$20240809$PER$$US-TEVA-VS-3228887$TEVA$$$$A$F$Y$$$20240809$$HP$US$US
241946291$24194629$1$I$$20240807$20240809$20240809$EXP$$US-JNJFOC-20240677750$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240809$$HP$US$US
241946301$24194630$1$I$20240101$20240731$20240809$20240809$PER$$US-SA-2024SA230185$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240809$$MD$US$US
241946311$24194631$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA232992$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240809$$MD$US$US
241946321$24194632$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA231060$SANOFI AVENTIS$$$$$M$Y$$$20240809$$CN$US$US
241946341$24194634$1$I$$20240729$20240809$20240809$EXP$$US-FreseniusKabi-FK202412166$FRESENIUS KABI$Benes L, Nelson N, Sloane M. Lemierre^s Syndrome Complicated by Tension Hemothorax in the Setting of the Concomitant Use of Intrapleural Fibrinolytics and Systemic Anticoagulation. American Journal of Respiratory and Critical Care Medicine. 2023 May;207: A5017. doi:10.1164/ajrccm-conference.2023.C41.$20$YR$A$M$Y$$$20240809$$HP$US$US
241946351$24194635$1$I$20240701$20240801$20240809$20240809$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000305$THERATECHNOLOGIES$$$$$$Y$$$20240809$$CN$US$US
241946361$24194636$1$I$$20240729$20240809$20240809$PER$$US-MYLANLABS-2024M1071243$MYLAN$$$$$F$Y$102.06$KG$20240809$$CN$US$US
241946372$24194637$2$F$$20240827$20240809$20240828$PER$$US-ALXN-202408USA000228US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241946381$24194638$1$I$$20240806$20240809$20240809$PER$$US-BAUSCH-BL-2024-011958$BAUSCH AND LOMB$$$$$F$Y$$$20240809$$MD$US$US
241946392$24194639$2$F$$20240827$20240809$20240830$PER$$US-ROCHE-10000044331$ROCHE$$$$$$Y$$$20240830$$HP$US$US
241946403$24194640$3$F$20230101$20240823$20240809$20240829$EXP$$IT-VERTEX PHARMACEUTICALS-2024-012801$VERTEX$Lanfranchi C, Rizza C, Russo MC, Borzani I, Angileri SA, Nazzari E, et al.. A case of severe pulmonary exacerbation in a young patient with cystic fibrosis in the era of CFTR modulators. Int J Infect Dis. 2024$20$YR$$F$Y$$$20240829$$HP$IT$IT
241946411$24194641$1$I$$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A175816$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241946421$24194642$1$I$20240614$20240729$20240809$20240809$EXP$FR-AFSSAPS-TO2024001123$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07288$HIKMA$$58$YR$$M$Y$100$KG$20240809$$PH$FR$FR
241946431$24194643$1$I$20240101$20240729$20240809$20240809$PER$$US-BEH-2024177030$CSL BEHRING$$$$$F$Y$$$20240809$$CN$US$US
241946441$24194644$1$I$$20240731$20240809$20240809$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02880$AMNEAL$Patel R, Elghawy O, Gibbs A, Gupta S, Kaur V.. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer Rep (Hoboken). 2024;7$84$YR$$M$Y$$$20240809$$HP$US$US
241946462$24194646$2$F$$20240820$20240809$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07030$LUPIN$$$$$$Y$$$20240906$$CN$US$US
241946471$24194647$1$I$$20240807$20240809$20240809$EXP$$US-BAYER-2024A115075$BAYER$$74$YR$E$F$Y$$$20240809$$HP$US$US
241946481$24194648$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000052397$ROCHE$$$$A$F$Y$$$20240809$$CN$US$US
241946491$24194649$1$I$20240730$20240731$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122048$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$103.87$KG$20240809$$HP$US$US
241946501$24194650$1$I$20240101$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125504$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$73.03$KG$20240809$$CN$US$US
241946511$24194651$1$I$$20240808$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125864$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240809$$CN$US$US
241946521$24194652$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125578$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240809$$HP$US$US
241946531$24194653$1$I$$20240807$20240809$20240809$EXP$$US-MYLANLABS-2024M1073740$MYLAN$$$$$M$Y$$$20240809$$CN$US$US
241946541$24194654$1$I$$20240729$20240809$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-122497$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240809$$MD$JP$JP
241946551$24194655$1$I$20240806$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54747$$FDA-CTU$$34$YR$$F$N$$$20240808$N$HP$US$
241946561$24194656$1$I$$20240730$20240809$20240809$EXP$$US-CIPLA LTD.-2024US08408$CIPLA$Bally K, Trusty R, Naher K.. A case report of myxedema coma in the setting of normal thyroid stimulating hormone.. Cureus. 2024;16 (6): e62695$$$$$Y$$$20240809$$MD$US$US
241946571$24194657$1$I$$20240729$20240809$20240809$EXP$$US-INSMED, INC.-2024-03122-US$INSMED$$$$$$Y$$$20240809$$CN$US$US
241946592$24194659$2$F$$20240903$20240809$20240907$EXP$$TR-TAKEDA-2024TUS079485$TAKEDA$$$$$$Y$$$20240907$$MD$TR$TR
241946601$24194660$1$I$$20240801$20240809$20240809$EXP$$US-JNJFOC-20240806144$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$MD$US$US
241946612$24194661$2$F$$20240902$20240809$20240913$EXP$$HU-ROCHE-10000048347$ROCHE$$$$$M$Y$$$20240913$$MD$HU$HU
241946622$24194662$2$F$20240618$20240807$20240809$20240821$EXP$$CN-ORGANON-O2407CHN003030$ORGANON$$76$YR$$M$Y$51.2$KG$20240821$$MD$CN$CN
241946631$24194663$1$I$20240101$20240805$20240809$20240809$30DAY$$US-PFIZER INC-202400230375$PFIZER$$12$YR$$M$Y$39.2$KG$20240809$$PH$US$US
241946642$24194664$2$F$$20240925$20240809$20240925$30DAY$$CO-PFIZER INC-202400229180$PFIZER$$12$YR$$M$Y$$$20240925$$CN$CO$CO
241946651$24194665$1$I$$20240806$20240809$20240809$30DAY$$CO-PFIZER INC-202400231189$PFIZER$$$$$M$Y$$$20240809$$CN$CO$CO
241946661$24194666$1$I$20240101$20240802$20240809$20240809$EXP$$NVSC2024DE160175$NOVARTIS$$$$A$F$Y$$$20240809$$CN$DE$DE
241946674$24194667$4$F$20240301$20240924$20240809$20240930$EXP$$US-ABBVIE-5870514$ABBVIE$$61$YR$$F$Y$$$20240929$$CN$US$US
241946683$24194668$3$F$20240727$20240823$20240809$20240827$EXP$$GB-MYLANLABS-2024M1073976$MYLAN$$34$YR$$M$Y$$$20240827$$MD$GB$GB
241946692$24194669$2$F$20240101$20240808$20240809$20240812$EXP$$US-ABBVIE-5870999$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241946701$24194670$1$I$20240521$20240805$20240809$20240809$EXP$FR-AFSSAPS-NC2024000916$FR-FreseniusKabi-FK202412174$FRESENIUS KABI$$68$YR$E$F$Y$$$20240809$$MD$FR$FR
241946711$24194671$1$I$20240519$20240805$20240809$20240809$EXP$FR-AFSSAPS-SE2024000622$FR-FreseniusKabi-FK202412209$FRESENIUS KABI$$64$YR$A$F$Y$60$KG$20240809$$HP$FR$FR
241946721$24194672$1$I$20240719$20240805$20240809$20240809$EXP$FR-AFSSAPS-NT2024000997$FR-FreseniusKabi-FK202412206$FRESENIUS KABI$$71$YR$E$M$Y$$$20240809$$MD$FR$FR
241946731$24194673$1$I$20240730$20240801$20240809$20240809$PER$$US-SA-2023SA326612$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240809$$MD$US$US
241946741$24194674$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA234047$SANOFI AVENTIS$$$$A$M$Y$$$20240809$$CN$US$US
241946751$24194675$1$I$20240611$20240617$20240809$20240809$PER$$US-KARYOPHARM-2024KPT001200$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240809$$CN$US$US
241946762$24194676$2$F$20240804$20240809$20240809$20240813$PER$$NVSC2024US162381$NOVARTIS$$29$YR$$F$Y$$$20240813$$CN$US$US
241946771$24194677$1$I$20240629$20240802$20240809$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125222$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240809$$PH$JP$JP
241946781$24194678$1$I$$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125802$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240809$$HP$US$US
241946801$24194680$1$I$20240701$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54661$$FDA-CTU$$35$YR$$F$N$$$20240808$Y$HP$US$
241946811$24194681$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54666$$FDA-CTU$$65$YR$$M$N$83.46$KG$20240808$N$$US$
241946821$24194682$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54652$$FDA-CTU$$48$YR$$F$N$$$20240808$N$$US$
241946831$24194683$1$I$20240727$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54722$$FDA-CTU$$71$YR$$F$N$$$20240808$Y$HP$US$
241946841$24194684$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54687$$FDA-CTU$$59$YR$$F$N$133.36$KG$20240808$N$$US$
241946871$24194687$1$I$$20240729$20240809$20240809$EXP$$IN-B.Braun Medical Inc.-2160241$B BRAUN$Literature Article$61$YR$$M$Y$$$20240809$$$IN$IN
241946881$24194688$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5865396$ABBVIE$$$$$$Y$$$20240809$$CN$US$US
241946891$24194689$1$I$20240808$20240808$20240809$20240809$EXP$$ZA-BAYER-2024A114628$BAYER$$64$YR$A$F$Y$$$20240809$$HP$ZA$ZA
241946901$24194690$1$I$20240711$20240808$20240809$20240809$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044753$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240809$$CN$GB$GB
241946911$24194691$1$I$20221209$20240731$20240809$20240809$EXP$FR-AFSSAPS-PC2024000593$FR-TEVA-VS-3228697$TEVA$$45$YR$$F$Y$$$20240809$$PH$FR$FR
241946921$24194692$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54660$$FDA-CTU$$72$YR$$F$N$$$20240808$N$$US$
241946931$24194693$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54679$$FDA-CTU$$63$YR$$F$N$$$20240808$N$$US$
241946941$24194694$1$I$20240704$20240704$20240808$20240808$DIR$FDA-CDER-CTU-2024-54729$$FDA-CTU$$69$YR$$M$N$$$20240704$Y$$US$
241946951$24194695$1$I$20240101$20240730$20240809$20240809$PER$$US-ABBVIE-5861818$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241946961$24194696$1$I$20221101$20240808$20240809$20240809$EXP$$US-TAKEDA-US202020720$TAKEDA$$74$YR$$F$Y$$$20240809$$MD$US$US
241946971$24194697$1$I$20240807$20240808$20240809$20240809$PER$$US-AMGEN-USASP2024158297$AMGEN$$43$YR$A$F$Y$$$20240809$$CN$US$US
241946982$24194698$2$F$$20240807$20240809$20240816$EXP$$RU-TAKEDA-2024TUS079502$TAKEDA$$$$$$Y$$$20240816$$MD$RU$RU
241946991$24194699$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASL2024157581$AMGEN$$$$$M$Y$$$20240809$$CN$US$US
241947002$24194700$2$F$$20240902$20240809$20240906$EXP$$JP-AMGEN-JPNSP2024155949$AMGEN$$84$YR$E$F$Y$$$20240906$$PH$JP$JP
241947011$24194701$1$I$$20240730$20240809$20240809$PER$$US-ROCHE-10000044314$ROCHE$$$$A$M$Y$$$20240809$$CN$US$US
241947021$24194702$1$I$20240423$20240729$20240809$20240809$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000721$PAREXEL$$$$$$Y$$$20240809$$HP$CN$CN
241947032$24194703$2$F$20240610$20240905$20240809$20240913$EXP$FR-AFSSAPS-LY2024001136$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07484$HIKMA$$53$YR$$F$Y$62$KG$20240913$$PH$FR$FR
241947041$24194704$1$I$20240101$20240805$20240809$20240809$PER$$US-ABBVIE-5870883$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241947051$24194705$1$I$$20240805$20240809$20240809$EXP$$IR-MYLANLABS-2024M1074214$MYLAN$Mohammad AP, Noroozi E, Mesgarha MG, Shayanfar N, Goodarzi A. Interesting Mucocutaneous Manifestations in COVID-19 Infection or Vaccination Confirmed by Histopathology: A Case Series. Case-Rep-Dermatol 2024; 16 (1): 21-34.$51$YR$$F$Y$$$20240809$$HP$IR$IR
241947062$24194706$2$F$$20240903$20240809$20240906$EXP$$TR-TAKEDA-2024TUS079323$TAKEDA$$$$$$Y$$$20240906$$MD$TR$TR
241947072$24194707$2$F$20240813$20240813$20240809$20240821$EXP$$AU-TAKEDA-2024TUS079356$TAKEDA$$53$YR$$M$Y$$$20240821$$CN$AU$AU
241947082$24194708$2$F$$20240905$20240809$20240911$PER$$US-ROCHE-10000042053$ROCHE$$70$YR$E$F$Y$$$20240911$$HP$US$US
241947091$24194709$1$I$$20240726$20240809$20240809$PER$$US-TEVA-VS-3227749$TEVA$$63$YR$$F$Y$$$20240809$$HP$US$US
241947101$24194710$1$I$$20240805$20240809$20240809$PER$$US-ROCHE-10000049518$ROCHE$Yuen C, Bao S, Kong X. A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient. Biomarkers in Medicine. 2024-Jan;18 (9):433-41. doi:10.1080/17520363.2024.2342231.$75$YR$E$F$Y$$$20240809$$HP$US$US
241947111$24194711$1$I$$20240806$20240809$20240809$PER$$US-BIOGEN-2024BI01262188$BIOGEN$$$$$F$Y$$$20240809$$CN$US$US
241947121$24194712$1$I$$20240801$20240809$20240809$EXP$GB-MHRA-MED-202407251406226410-SCNBF$GB-BAXTER-2024BAX022611$BAXTER$$$$$F$Y$$$20240809$$CN$GB$GB
241947132$24194713$2$F$20240616$20240809$20240809$20240812$EXP$$ES-TAKEDA-2024TUS079542$TAKEDA$$71$YR$$F$Y$$$20240812$$HP$ES$ES
241947142$24194714$2$F$20240719$20240826$20240809$20240904$EXP$$CN-BAXTER-2024BAX022605$BAXTER$$68$YR$$F$Y$56.69$KG$20240904$$MD$CN$CN
241947151$24194715$1$I$$20240801$20240809$20240809$EXP$$CA-BAXTER-2024BAX022603$BAXTER$$18$YR$$F$Y$49$KG$20240809$$HP$CA$CA
241947161$24194716$1$I$$20240806$20240809$20240809$EXP$$US-AstraZeneca-2024A179365$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241947171$24194717$1$I$$20240726$20240809$20240809$EXP$$GB-MDD US Operations-E2B_00006396$MDD OPERATIONS$$64$YR$$F$Y$$$20240809$$HP$GB$GB
241947181$24194718$1$I$$20240715$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07300$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241947191$24194719$1$I$20240303$20240801$20240809$20240809$EXP$CN-NMPACDR-3301051028618202400152$CN-BAXTER-2024BAX022732$BAXTER$$5$YR$$M$Y$23$KG$20240809$$MD$CN$CN
241947201$24194720$1$I$$20240731$20240809$20240809$EXP$$CA-BAXTER-2024BAX022534$BAXTER$$32$YR$$F$Y$$$20240809$$CN$CA$CA
241947211$24194721$1$I$20220410$20240805$20240809$20240809$EXP$FR-AFSSAPS-RE2024000801$FR-FreseniusKabi-FK202412207$FRESENIUS KABI$$40$YR$A$M$Y$70$KG$20240809$$MD$FR$FR
241947222$24194722$2$F$20240807$20240827$20240809$20240829$PER$$US-AMGEN-USASP2024157502$AMGEN$$72$YR$E$F$Y$$$20240828$$CN$US$US
241947232$24194723$2$F$20240806$20240917$20240809$20240920$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-108905$REGENERON$$$$$M$Y$$$20240920$$MD$JP$JP
241947243$24194724$3$F$$20240923$20240809$20240924$EXP$$PH-TAKEDA-2024TUS079650$TAKEDA$$$$$F$Y$$$20240924$$MD$PH$PH
241947261$24194726$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA232866$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240809$$MD$US$US
241947271$24194727$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA147631$SANOFI AVENTIS$$$$C$M$Y$$$20240809$$MD$US$US
241947281$24194728$1$I$20220813$20240731$20240809$20240809$PER$$US-SA-2024SA232304$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240809$$CN$US$US
241947291$24194729$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA232880$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240809$$MD$US$US
241947301$24194730$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA232245$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241947311$24194731$1$I$20230701$20240801$20240809$20240809$PER$$US-SA-2023SA250285$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240809$$MD$US$US
241947321$24194732$1$I$$20240801$20240809$20240809$EXP$DE-CADRBFARM-2024329508$DE-TEVA-VS-3229195$TEVA$$60$YR$$F$Y$$$20240809$$CN$DE$DE
241947331$24194733$1$I$20210501$20240729$20240809$20240809$EXP$$FR-CIPLA LTD.-2024FR08297$CIPLA$$$$$$Y$$$20240809$$MD$FR$FR
241947341$24194734$1$I$20240109$20240112$20240809$20240809$EXP$GB-MHRA-MED-202401111110206140-HCMFV$GB-ELI_LILLY_AND_COMPANY-GB202401007280$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240809$$CN$GB$GB
241947352$24194735$2$F$$20240920$20240809$20240920$PER$$NVSC2024US162481$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
241947361$24194736$1$I$$20240807$20240809$20240809$EXP$$NVSC2024US161796$NOVARTIS$$$$$F$Y$$$20240809$$HP$US$US
241947371$24194737$1$I$$20240727$20240809$20240809$PER$$US-Calliditas-2024CAL01422$CALLIDITAS THERAPEUTICS$$$$$F$Y$$$20240809$$CN$US$US
241947382$24194738$2$F$$20240813$20240809$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408003069$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240817$$CN$US$US
241947391$24194739$1$I$$20240807$20240809$20240809$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140093$DAIICHI$$$$$F$Y$$$20240809$$CN$US$US
241947421$24194742$1$I$20240601$20240802$20240809$20240809$PER$$US-MYLANLABS-2024M1073215$MYLAN$$68$YR$$M$Y$92.99$KG$20240809$$CN$US$US
241947431$24194743$1$I$20240724$20240724$20240809$20240809$PER$$US-KARYOPHARM-2024KPT001359$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240809$$CN$US$US
241947441$24194744$1$I$20220101$20240730$20240809$20240809$PER$$US-ABBVIE-5861348$ABBVIE$$$$$$Y$$$20240809$$CN$US$US
241947451$24194745$1$I$$20240729$20240809$20240809$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2024-001752$SK LIFE SCIENCE$Clarissa Corniello, Fedele Dono, Giacomo Evangelista, Sara Cipollone, Stefano Consoli, Stefano L. Sensi. Safety and effectiveness of cenobamate in down syndrome: a case  report. Neurological Sciences. 2024$$$$$Y$$$20240809$$MD$IT$IT
241947461$24194746$1$I$20231101$20240729$20240809$20240809$EXP$FR-AFSSAPS-LM2024000417$FR-SK LIFE SCIENCE, INC-SKPVG-2024-001831$SK LIFE SCIENCE$$$$$$Y$$$20240809$$MD$FR$FR
241947481$24194748$1$I$20240618$20240621$20240808$20240808$DIR$FDA-CDER-CTU-2024-54743$$FDA-CTU$$41$YR$$F$N$$$20240621$N$HP$US$
241947491$24194749$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54724$$FDA-CTU$$$$$M$N$$$20240808$N$HP$US$
241947511$24194751$1$I$20240801$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54742$$FDA-CTU$$63$YR$$F$N$$$20240808$N$$US$
241947531$24194753$1$I$$20240802$20240809$20240809$EXP$$CH-AMGEN-CHESP2024155770$AMGEN$$$$$M$Y$$$20240809$$MD$CH$CH
241947541$24194754$1$I$20240806$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157150$AMGEN$$$$$M$Y$$$20240809$$CN$US$US
241947551$24194755$1$I$$20240805$20240809$20240809$PER$$US-ALXN-202408USA000230US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241947562$24194756$2$F$$20240827$20240809$20240828$PER$$US-ALXN-202408USA000259US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241947571$24194757$1$I$$20240802$20240809$20240809$EXP$$US-SA-2024SA231766$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240809$$MD$US$US
241947591$24194759$1$I$20240805$20240806$20240809$20240809$EXP$$CN-PFIZER INC-PV202400102424$PFIZER$$44$YR$$F$Y$83.1$KG$20240809$$HP$CN$CN
241947601$24194760$1$I$$20240806$20240809$20240809$EXP$$CA-PFIZER INC-202400231983$PFIZER$$66$YR$$M$Y$122$KG$20240809$$HP$CA$CA
241947611$24194761$1$I$20240714$20240805$20240809$20240809$EXP$ES-AEMPS-1556166$ES-PFIZER INC-202400229926$PFIZER$$78$YR$$M$Y$74$KG$20240809$$HP$ES$ES
241947621$24194762$1$I$$20240805$20240809$20240809$EXP$$HK-PFIZER INC-PV202400101453$PFIZER$$80$YR$$M$Y$$$20240809$$MD$HK$HK
241947631$24194763$1$I$$20240806$20240809$20240809$EXP$$US-PFIZER INC-202400232087$PFIZER$$20$YR$$M$Y$$$20240809$$CN$US$US
241947641$24194764$1$I$20240130$20240730$20240809$20240809$EXP$$BG-PFIZER INC-202400225349$PFIZER$Gerasimov, A.. Toxicity in treatment of malignant skin melanoma with braf/mek inhibitors - a clinical case. 1(2):85-90$58$YR$$M$Y$$$20240809$$MD$BG$BG
241947651$24194765$1$I$$20240807$20240809$20240809$EXP$$US-PFIZER INC-PV202400103314$PFIZER$$$$$F$Y$$$20240809$$CN$US$US
241947661$24194766$1$I$20230620$20240801$20240809$20240809$EXP$$CN-PFIZER INC-2023SGN07079$PFIZER$$69$YR$$M$Y$59$KG$20240809$$MD$CN$CN
241947671$24194767$1$I$$20240807$20240809$20240809$EXP$$CA-PFIZER INC-202400232061$PFIZER$$73$YR$$F$Y$$$20240809$$HP$CA$CA
241947681$24194768$1$I$20230101$20240806$20240809$20240809$EXP$$US-PFIZER INC-PV202400102844$PFIZER$$67$YR$$F$Y$$$20240809$$HP$US$US
241947691$24194769$1$I$20240129$20240805$20240809$20240809$EXP$AT-BASGAGES-2024-005678$AT-PFIZER INC-202400229874$PFIZER$$26$YR$$F$Y$$$20240809$$PH$AT$AT
241947701$24194770$1$I$$20240806$20240809$20240809$EXP$$CN-PFIZER INC-202400231171$PFIZER$Li, R.. Three pediatric cases of Staphylococcus aureus associated hemophagocytic lymphohistiocytosis. Pedia Neonatol. 2023;10.1016/j.pedneo.2023.09.006$12$YR$$M$Y$$$20240809$$HP$CN$CN
241947711$24194771$1$I$$20240806$20240809$20240809$EXP$$CA-PFIZER INC-202400232001$PFIZER$$72$YR$$M$Y$$$20240809$$HP$CA$CA
241947721$24194772$1$I$$20240807$20240809$20240809$EXP$$AR-PFIZER INC-202400232020$PFIZER$$78$YR$$M$Y$$$20240809$$CN$AR$AR
241947731$24194773$1$I$20240101$20240808$20240809$20240809$EXP$$CL-PFIZER INC-PV202400103565$PFIZER$$52$YR$$F$Y$$$20240809$$CN$CL$CL
241947741$24194774$1$I$20230330$20240806$20240809$20240809$EXP$FR-AFSSAPS-LL2024001529$FR-PFIZER INC-202400230895$PFIZER$$65$YR$$F$Y$$$20240809$$MD$FR$FR
241947751$24194775$1$I$20240715$20240801$20240809$20240809$EXP$$BE-PFIZER INC-2024SGN03975$PFIZER$$72$YR$$M$Y$58$KG$20240809$$MD$BE$BE
241947761$24194776$1$I$$20240806$20240809$20240809$EXP$$JP-PFIZER INC-202400232254$PFIZER$$$$$$Y$$$20240809$$PH$JP$JP
241947772$24194777$2$F$20240801$20240924$20240809$20240925$EXP$$CA-PFIZER INC-PV202400096696$PFIZER$$41$YR$$F$Y$$$20240925$$CN$CA$CA
241947783$24194778$3$F$20240727$20240903$20240809$20240906$EXP$$JP-PFIZER INC-PV202400101975$PFIZER$$69$YR$$M$Y$59$KG$20240906$$MD$JP$JP
241947791$24194779$1$I$$20240805$20240809$20240809$EXP$$CA-PFIZER INC-202400231210$PFIZER$$$$$M$Y$$$20240809$$HP$CA$CA
241947802$24194780$2$F$20240701$20240821$20240809$20240826$EXP$$CA-PFIZER INC-PV202400103570$PFIZER$$61$YR$$F$Y$59.3$KG$20240826$$CN$CA$CA
241947812$24194781$2$F$20220826$20240812$20240809$20240814$EXP$$CN-PFIZER INC-202400233041$PFIZER$Hu, L.. Rhinocerebral mucormycosis and Trichosporon asahii fungemia in a pediatric patient with acute lymphoblastic leukemia: a rare coinfection. Journal of the Sao Paulo Institute of Tropical Medicine. 2024;66:10.1590/S1678-9946202466041$14$MON$$M$Y$$$20240814$$HP$CN$CN
241947821$24194782$1$I$$20240806$20240809$20240809$EXP$$US-PFIZER INC-202400232309$PFIZER$$54$YR$$F$Y$$$20240809$$HP$US$US
241947831$24194783$1$I$20240722$20240806$20240809$20240809$EXP$$CN-PFIZER INC-PV202400102423$PFIZER$$47$YR$$F$Y$68$KG$20240809$$HP$CN$CN
241947842$24194784$2$F$20240101$20240816$20240809$20240820$EXP$$CA-PFIZER INC-202400222038$PFIZER$$55$YR$$F$Y$$$20240820$$HP$CA$CA
241947851$24194785$1$I$20231029$20240805$20240809$20240809$EXP$$FR-PFIZER INC-202400229950$PFIZER$$50$YR$$M$Y$66$KG$20240809$$MD$FR$FR
241947861$24194786$1$I$20240708$20240806$20240809$20240809$EXP$FR-AFSSAPS-LL2024001525$FR-PFIZER INC-202400230800$PFIZER$$55$YR$$F$Y$$$20240809$$MD$FR$FR
241947874$24194787$4$F$$20240914$20240809$20240916$PER$$US-PFIZER INC-202400233118$PFIZER$$81$YR$$F$Y$$$20240916$$CN$US$US
241947881$24194788$1$I$$20240806$20240809$20240809$EXP$$CA-PFIZER INC-202400231971$PFIZER$$78$YR$$F$Y$$$20240809$$HP$CA$CA
241947891$24194789$1$I$20240801$20240807$20240809$20240809$EXP$$TH-PFIZER INC-PV202400103372$PFIZER$$$$E$F$Y$$$20240809$$MD$TH$TH
241947902$24194790$2$F$20210826$20240826$20240809$20240829$EXP$$CA-PFIZER INC-202101117199$PFIZER$$64$YR$$F$Y$$$20240829$$MD$CA$CA
241947911$24194791$1$I$$20240806$20240809$20240809$EXP$$FR-PFIZER INC-202400232935$PFIZER$$$$$$Y$$$20240809$$MD$FR$FR
241947922$24194792$2$F$20230101$20240919$20240809$20240923$EXP$$US-PFIZER INC-PV202400103563$PFIZER$$26$YR$$F$Y$$$20240923$$HP$US$US
241947931$24194793$1$I$$20240807$20240809$20240809$EXP$$US-PFIZER INC-202400232389$PFIZER$$56$YR$$F$Y$99.79$KG$20240809$$CN$US$US
241947941$24194794$1$I$20230101$20240807$20240809$20240809$EXP$$US-PFIZER INC-202400232435$PFIZER$$66$YR$$F$Y$90.72$KG$20240809$$CN$US$US
241947951$24194795$1$I$20240103$20240806$20240809$20240809$EXP$FR-AFSSAPS-LY2024000767$FR-PFIZER INC-202400230878$PFIZER$$59$YR$$F$Y$$$20240809$$PH$FR$FR
241947961$24194796$1$I$20240701$20240808$20240809$20240809$EXP$$JP-PFIZER INC-PV202400103584$PFIZER$$70$YR$$F$Y$$$20240809$$MD$JP$JP
241947981$24194798$1$I$$20240729$20240808$20240808$DIR$FDA-CDER-CTU-2024-54727$$FDA-CTU$$$$$F$N$$$20240729$N$$US$
241947991$24194799$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54683$$FDA-CTU$$82$YR$$M$N$$$20240808$N$$US$
241948001$24194800$1$I$20240806$20240807$20240809$20240809$EXP$GB-MHRA-MED-202408071637296490-LSPMT$GB-PFIZER INC-202400232145$PFIZER$$75$YR$$M$Y$92$KG$20240809$$HP$GB$GB
241948011$24194801$1$I$$20240805$20240809$20240809$EXP$$US-PFIZER INC-202400231158$PFIZER$Ra, O.. Transient recurrence of chemotherapy-induced peripheral neuropathy in the immediate postoperative period following gynaecological surgery under general anaesthesia. Anaesthesia Reports. 2024;12(2):10.1002/anr3.12315$57$YR$$F$Y$$$20240809$$HP$US$US
241948021$24194802$1$I$20240806$20240807$20240809$20240809$EXP$GB-MHRA-MED-202408071120063820-BMTVY$GB-PFIZER INC-202400232002$PFIZER$$40$YR$$M$Y$77$KG$20240809$$HP$GB$GB
241948032$24194803$2$F$20240801$20240815$20240809$20240820$EXP$$TW-PFIZER INC-PV202400103774$PFIZER$$$$E$F$Y$$$20240820$$HP$TW$TW
241948051$24194805$1$I$$20240807$20240809$20240809$EXP$$AU-PFIZER INC-PV202400102866$PFIZER$$83$YR$$M$Y$$$20240809$$MD$AU$AU
241948061$24194806$1$I$20240711$20240805$20240809$20240809$EXP$$US-LEX-000420$LEXICON PHARMACEUTICALS$$95$YR$$F$Y$$$20240809$$CN$US$US
241948071$24194807$1$I$$20240806$20240809$20240809$EXP$$RU-PFIZER INC-202400231083$PFIZER$$66$YR$$F$Y$$$20240809$$MD$RU$RU
241948081$24194808$1$I$$20240809$20240809$20240809$DIR$713552$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241948091$24194809$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54693$$FDA-CTU$$64$YR$$F$N$$$20240808$N$$US$
241948101$24194810$1$I$20220501$20240807$20240809$20240809$EXP$$US-PFIZER INC-202400233117$PFIZER$$63$YR$$F$Y$$$20240809$$HP$US$US
241948111$24194811$1$I$$20240808$20240808$20240808$DIR$FDA-CDER-CTU-2024-54667$$FDA-CTU$$63$YR$$F$N$$$20240808$N$$US$
241948121$24194812$1$I$$20240808$20240809$20240809$EXP$$US-PFIZER INC-202400233230$PFIZER$$81$YR$$F$Y$$$20240809$$CN$US$US
241948131$24194813$1$I$20210101$20240807$20240809$20240809$EXP$$US-PFIZER INC-202400232961$PFIZER$$54$YR$$F$Y$$$20240809$$MD$US$US
241948141$24194814$1$I$$20240806$20240809$20240809$EXP$$US-PFIZER INC-202400232116$PFIZER$$5$YR$$F$Y$$$20240809$$CN$US$US
241948151$24194815$1$I$20240726$20240808$20240809$20240809$EXP$$IN-PFIZER INC-PV202400103949$PFIZER$$50$YR$$F$Y$$$20240809$$CN$IN$IN
241948162$24194816$2$F$$20240812$20240809$20240813$EXP$$DE-PFIZER INC-202400229889$PFIZER$$60$YR$$F$Y$$$20240813$$CN$DE$DE
241948172$24194817$2$F$$20240826$20240809$20240829$EXP$$US-PFIZER INC-PV202400102393$PFIZER$$67$YR$$F$Y$57.143$KG$20240829$$CN$US$US
241948181$24194818$1$I$20240101$20240807$20240809$20240809$EXP$$CA-PFIZER INC-202400218276$PFIZER$$49$YR$$M$Y$$$20240809$$MD$CA$CA
241948192$24194819$2$F$20240209$20240816$20240809$20240820$EXP$FR-AFSSAPS-TO2024001468$FR-PFIZER INC-202400229933$PFIZER$$69$YR$$M$Y$106$KG$20240820$$PH$FR$FR
241948211$24194821$1$I$$20240802$20240809$20240809$EXP$$KR-PFIZER INC-202400232965$PFIZER$Oh, D.. Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer. NEJM Evidence. 2022;1(8):10.1056/EVIDoa2200015$$$A$$Y$$$20240809$$MD$KR$KR
241948222$24194822$2$F$20240619$20240913$20240809$20240917$EXP$FR-AFSSAPS-PV2024000099$FR-PFIZER INC-202400230802$PFIZER$$1$DY$$M$Y$0.327$KG$20240917$$MD$FR$FR
241948231$24194823$1$I$20240804$20240807$20240809$20240809$EXP$$US-DSJP-DSU-2024-139908$DAIICHI$$67$YR$$F$Y$$$20240809$$HP$US$US
241948241$24194824$1$I$20240802$20240802$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124077$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240809$$CN$US$US
241948252$24194825$2$F$20240518$20240909$20240809$20240912$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-125056$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$53.6$KG$20240912$$MD$ES$ES
241948262$24194826$2$F$$20240920$20240809$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123731$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240923$$HP$US$US
241948281$24194828$1$I$20231205$20240806$20240809$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125927$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240809$$PH$JP$JP
241948292$24194829$2$F$$20240805$20240809$20240818$EXP$$US-CIPLA LTD.-2024US08432$CIPLA$Cheng JJ, Shen J, Suresh Y, Akopyan NA, Kapoor NS.. Synchronous metastatic prostate cancer and male breast cancer while on Testosterone replacement therapy: Case report. International Journal of Surgery. 2024;122:110050$$$$$Y$$$20240818$$MD$US$US
241948301$24194830$1$I$$20240731$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123626$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240809$$HP$US$US
241948312$24194831$2$F$20240101$20240823$20240809$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008932$UNITED THERAPEUTICS$$$$$F$Y$58.957$KG$20240831$$$US$US
241948321$24194832$1$I$20240716$20240731$20240809$20240809$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001561$BLUEPRINT MEDICINES$$27$YR$A$F$Y$$$20240809$$CN$US$US
241948331$24194833$1$I$20240724$20240802$20240809$20240809$EXP$$BR-GILEAD-2024-0682018$GILEAD$$54$YR$A$M$Y$88.9$KG$20240809$$PH$BR$BR
241948341$24194834$1$I$20200101$20240807$20240809$20240809$EXP$FR-AFSSAPS-LL2024001021$FR-ABBVIE-5872733$ABBVIE$$31$YR$$M$Y$$$20240809$$MD$FR$FR
241948352$24194835$2$F$20240701$20240822$20240809$20240826$PER$$US-AMGEN-USASP2024157501$AMGEN$$39$YR$A$F$Y$$$20240826$$CN$US$US
241948362$24194836$2$F$$20240819$20240809$20240820$PER$$US-TAKEDA-2024TUS078750$TAKEDA$$$$$M$Y$103$KG$20240820$$MD$US$US
241948383$24194838$3$F$$20240905$20240809$20240909$EXP$$JP-GILEAD-2024-0682963$GILEAD$$63$YR$A$M$Y$$$20240909$$MD$JP$JP
241948391$24194839$1$I$20240730$20240731$20240809$20240809$30DAY$$US-GSK-US2024095879$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240809$$CN$US$US
241948401$24194840$1$I$20201207$20240807$20240809$20240809$EXP$$US-TAKEDA-US201830738$TAKEDA$$64$YR$$F$Y$$$20240809$$MD$US$US
241948411$24194841$1$I$$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A176128$ASTRAZENECA$$$$$F$Y$88$KG$20240809$$CN$US$
241948421$24194842$1$I$$20240808$20240809$20240809$EXP$$FR-JNJFOC-20240819983$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240809$$PH$FR$FR
241948432$24194843$2$F$$20240813$20240809$20240823$30DAY$$TW-JNJFOC-20240817369$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$PH$TW$TW
241948441$24194844$1$I$20240731$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A177534$ASTRAZENECA$$76$YR$$F$Y$47.2$KG$20240809$$CN$US$
241948452$24194845$2$F$20240718$20240910$20240809$20240913$EXP$$JP-AstraZeneca-2024A178567$ASTRAZENECA$$71$YR$$M$Y$$$20240913$$MD$JP$
241948461$24194846$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A176713$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241948471$24194847$1$I$$20240805$20240809$20240809$EXP$$MX-ASTELLAS-2024US022441$ASTELLAS$$65$YR$$M$Y$$$20240809$$CN$MX$MX
241948484$24194848$4$F$$20240903$20240809$20240913$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004393$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240913$$CN$FR$FR
241948492$24194849$2$F$$20240903$20240809$20240906$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004392$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240906$$CN$US$US
241948502$24194850$2$F$20240101$20240805$20240809$20240812$EXP$$EG-009507513-2408EGY001805$MERCK$$$$E$F$Y$$$20240812$$CN$EG$EG
241948511$24194851$1$I$$20240730$20240809$20240809$EXP$$GB-CIPLA LTD.-2024GB08345$CIPLA$$$$$$Y$$$20240809$$CN$GB$GB
241948522$24194852$2$F$$20240813$20240809$20240816$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004377$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240816$$MD$US$US
241948532$24194853$2$F$20230620$20240814$20240809$20240825$EXP$$CN-JNJFOC-20240776667$JOHNSON AND JOHNSON$$90$YR$E$M$Y$56$KG$20240826$$HP$CN$CN
241948541$24194854$1$I$$20240802$20240809$20240809$EXP$$CH-MYLANLABS-2024M1073752$MYLAN$Miedl M, Baumgartner P, Disse LR, Weber KP, Pohl H, Wegener S. Harlequin syndrome in a patient with probable hemicrania continua and exertional headache - is there a link? a case report. BMC-Neurol 2024; 24 1-6.$42$YR$$F$Y$$$20240809$$HP$CH$CH
241948551$24194855$1$I$20240809$20240809$20240809$20240809$DIR$713547$$FDA-CTU$$23$YR$$F$N$60.75$KG$20240809$N$CN$US$
241948561$24194856$1$I$$20240809$20240809$20240809$DIR$713563$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241948571$24194857$1$I$20231228$20240809$20240809$20240809$DIR$713560$$FDA-CTU$$74$YR$$F$N$60$KG$20240809$N$CN$IL$
241948582$24194858$2$F$20220101$20240802$20240809$20240812$EXP$$PL-AMGEN-POLSP2024154281$AMGEN$$38$YR$A$F$Y$$$20240812$$MD$PL$PL
241948591$24194859$1$I$20240725$20240804$20240809$20240809$EXP$$CN-Eisai-EC-2024-171432$EISAI$$61$YR$A$F$Y$55$KG$20240809$$HP$CN$CN
241948601$24194860$1$I$20210801$20240715$20240809$20240809$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003587$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240809$$CN$US$US
241948611$24194861$1$I$$20240807$20240809$20240809$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-125383$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$66.22$KG$20240809$$CN$PR$PR
241948621$24194862$1$I$20240802$20240805$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124147$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240809$$PH$US$US
241948631$24194863$1$I$20240801$20240802$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124018$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240809$$CN$US$US
241948641$24194864$1$I$$20240610$20240809$20240809$PER$$US-ASTELLAS-2024US016799$ASTELLAS$$$$$F$Y$$$20240809$$CN$US$US
241948651$24194865$1$I$$20240520$20240809$20240809$PER$$US-ASTELLAS-2024US014699$ASTELLAS$$$$$$Y$$$20240809$$CN$US$US
241948661$24194866$1$I$20240627$20240628$20240809$20240809$PER$$US-ASTELLAS-2024US018676$ASTELLAS$$83$YR$$F$Y$$$20240809$$CN$US$US
241948681$24194868$1$I$$20240809$20240809$20240809$DIR$713546$$FDA-CTU$$54$YR$$F$N$67.5$KG$20240809$N$CN$US$
241948691$24194869$1$I$$20240809$20240809$20240809$DIR$713572$$FDA-CTU$$$$$UNK$N$$$20240809$N$$US$
241948701$24194870$1$I$20240413$20240719$20240809$20240809$PER$$US-ASTELLAS-2024US017335$ASTELLAS$$92$YR$$M$Y$$$20240809$$MD$US$US
241948711$24194871$1$I$20240701$20240731$20240809$20240809$EXP$$CA-Vifor (International) Inc.-VIT-2024-06933$VIFOR$$85$YR$$M$Y$$$20240809$$CN$CA$CA
241948721$24194872$1$I$20240625$20240807$20240809$20240809$EXP$GB-MHRA-MED-202408071137307850-HQDSF$GB-MYLANLABS-2024M1073940$MYLAN$$$$$M$Y$$$20240809$$MD$GB$GB
241948731$24194873$1$I$20240711$20240712$20240809$20240809$PER$$US-ASTELLAS-2024US020310$ASTELLAS$$89$YR$$F$Y$$$20240809$$CN$US$US
241948741$24194874$1$I$$20240719$20240809$20240809$PER$$US-ASTELLAS-2024US020786$ASTELLAS$$$$$M$Y$$$20240809$$CN$US$US
241948753$24194875$3$F$$20240828$20240809$20240909$30DAY$$TR-JNJFOC-20240817221$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$TR$TR
241948761$24194876$1$I$$20240806$20240809$20240809$EXP$$BE-JNJFOC-20240818699$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$MD$BE$BE
241948771$24194877$1$I$$20240808$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2024US071649$SANDOZ$$$$$F$Y$$$20240809$$CN$US$US
241948781$24194878$1$I$$20240729$20240809$20240809$EXP$$GB-B.Braun Medical Inc.-2160244$B BRAUN$$32$YR$$F$Y$101$KG$20240809$$$GB$GB
241948791$24194879$1$I$$20240801$20240809$20240809$EXP$CA-EMA-DD-20221006-7180169-075726$NVSC2024CA159937$NOVARTIS$$$$A$F$Y$68$KG$20240809$$HP$CA$CA
241948802$24194880$2$F$$20240718$20240809$20240819$PER$$ES-TOLMAR, INC.-24ES051540$TOLMAR$$$$$$Y$$$20240814$$HP$ES$ES
241948811$24194881$1$I$$20240729$20240809$20240809$EXP$$US-Standard Homeopathic-2160243$STANDARD HOMEOPATHIC$$23$MON$$F$Y$$$20240809$$$US$US
241948821$24194882$1$I$20240614$20240731$20240809$20240809$EXP$FR-AFSSAPS-MA2024001095$FR-TEVA-VS-3228880$TEVA$$56$YR$$F$Y$$$20240809$$MD$FR$FR
241948831$24194883$1$I$20240701$20240807$20240809$20240809$EXP$$NVSC2024CA162365$NOVARTIS$$$$$M$Y$$$20240809$$CN$CA$CA
241948841$24194884$1$I$$20240730$20240809$20240809$PER$$NVSC2024US162473$NOVARTIS$$$$$F$Y$$$20240809$$HP$US$US
241948851$24194885$1$I$$20240801$20240809$20240809$EXP$$JP-009507513-2408JPN000153J$MERCK$$56$YR$$F$Y$$$20240809$$MD$JP$JP
241948861$24194886$1$I$$20240720$20240809$20240809$PER$$US-TEVA-VS-3193193$TEVA$$$$$$Y$$$20240809$$CN$US$US
241948871$24194887$1$I$20240729$20240805$20240809$20240809$EXP$$US-LEX-000419$LEXICON PHARMACEUTICALS$$81$YR$$M$Y$$$20240809$$CN$US$US
241948881$24194888$1$I$$20240807$20240809$20240809$PER$$US-BAYER-2024A114414$BAYER$$$$$$Y$$$20240809$$CN$US$US
241948891$24194889$1$I$$20240801$20240809$20240809$EXP$$US-EMD Serono-2024041840$EMD SERONO INC$$$$$F$Y$$$20240809$$HP$US$US
241948901$24194890$1$I$$20240712$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07162$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241948911$24194891$1$I$$20240730$20240809$20240809$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07446$HIKMA$Surineni K, Le VY, Jones D.. Surineni K, Le VY, Jones D. A Case of Oral-Buccal-Lingual Dyskinesia and Neuropsychiatric Symptoms After Prolonged Levetiracetam Exposure.. Cureus. 2024;16(6):e62692$86$YR$$F$Y$$$20240809$$MD$US$US
241948921$24194892$1$I$$20240801$20240809$20240809$EXP$$GB-GILEAD-2024-0682625$GILEAD$$45$YR$A$F$Y$$$20240809$$MD$GB$GB
241948931$24194893$1$I$20240613$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A178083$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241948942$24194894$2$F$20240701$20240806$20240809$20240814$EXP$$US-AstraZeneca-2024A178410$ASTRAZENECA$$24397$DY$$F$Y$$$20240814$$CN$US$
241948951$24194895$1$I$$20240802$20240809$20240809$PER$$US-ALXN-202408USA000151US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240809$$CN$US$US
241948962$24194896$2$F$20240722$20240830$20240809$20240906$EXP$$US-AstraZeneca-2024A176325$ASTRAZENECA$$23570$DY$$M$Y$106.6$KG$20240906$$MD$US$
241948974$24194897$4$F$20240730$20240821$20240809$20240829$EXP$$US-JNJFOC-20240816000$JOHNSON AND JOHNSON$$48$YR$A$F$Y$103.3$KG$20240829$$HP$US$US
241948982$24194898$2$F$$20240904$20240809$20240910$30DAY$$AU-JNJFOC-20240782256$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$AU$AU
241948993$24194899$3$F$$20240830$20240809$20240903$PER$$US-BAYER-2024A115004$BAYER$$77$YR$E$M$Y$$$20240903$$CN$US$US
241949001$24194900$1$I$20240502$20240808$20240809$20240809$PER$$US-BIOVITRUM-2024-US-007237$BIOVITRUM$$69$YR$$F$Y$$$20240809$$CN$US$US
241949011$24194901$1$I$20240728$20240802$20240809$20240809$PER$$US-BAYER-2024A112240$BAYER$$25$YR$A$F$Y$$$20240809$$CN$US$US
241949031$24194903$1$I$$20240809$20240809$20240809$DIR$713553$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241949041$24194904$1$I$$20240809$20240809$20240809$DIR$713554$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241949061$24194906$1$I$$20240805$20240809$20240809$EXP$$NVSC2024US160455$NOVARTIS$$$$$F$Y$$$20240809$$HP$US$US
241949071$24194907$1$I$$20240726$20240809$20240809$EXP$$HK-ROCHE-10000038311$ROCHE$$$$$F$Y$$$20240809$$CN$HK$HK
241949081$24194908$1$I$$20240715$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07213$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241949092$24194909$2$F$$20240528$20240809$20240813$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000516$AZURITY PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241949102$24194910$2$F$$20240508$20240809$20240813$PER$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000566$AZURITY PHARMACEUTICALS$$$$$F$Y$$$20240812$$HP$US$US
241949112$24194911$2$F$20240101$20240826$20240809$20240828$EXP$$JP-ABBVIE-5863293$ABBVIE$$73$YR$$F$Y$$$20240828$$PH$JP$JP
241949121$24194912$1$I$$20240806$20240809$20240809$EXP$$US-ASTELLAS-2024US022367$ASTELLAS$$$$$F$Y$$$20240809$$CN$US$US
241949131$24194913$1$I$$20240808$20240809$20240809$EXP$$TH-BAYER-2024A115041$BAYER$$$$$M$Y$$$20240809$$HP$TH$TH
241949142$24194914$2$F$20240701$20240730$20240809$20240809$EXP$$US-TEVA-VS-3228663$TEVA$$26$YR$$F$Y$81.65$KG$20240809$$CN$US$US
241949151$24194915$1$I$$20240731$20240809$20240809$PER$$US-MYLANLABS-2024M1072357$MYLAN$$$$$$Y$$$20240809$$CN$US$US
241949173$24194917$3$F$20240728$20240917$20240809$20240919$30DAY$$CO-PFIZER INC-202400227593$PFIZER$$12$YR$$$Y$$$20240919$$MD$CO$CO
241949191$24194919$1$I$$20240807$20240809$20240809$EXP$$US-GILEAD-2024-0683565$GILEAD$$$$C$M$Y$$$20240809$$CN$US$US
241949212$24194921$2$F$20240603$20240830$20240809$20240905$EXP$$JP-009507513-2406JPN004156J$MERCK$$6$DEC$$M$Y$$$20240905$$MD$JP$JP
241949222$24194922$2$F$20240701$20240906$20240809$20240913$EXP$$JP-009507513-2408JPN000195J$MERCK$$77$YR$$F$Y$$$20240913$$MD$JP$JP
241949231$24194923$1$I$$20240807$20240809$20240809$EXP$$JP-BAYER-2024A085670$BAYER$$7$DEC$E$M$Y$$$20240809$$MD$JP$JP
241949241$24194924$1$I$20240710$20240805$20240809$20240809$PER$$US-MYLANLABS-2024M1073385$MYLAN$$$$$$Y$$$20240809$$CN$US$US
241949252$24194925$2$F$20240720$20240809$20240809$20240814$EXP$DE-BFARM-24005464$DE-RDY-SPO/DEU/24/0011550$DR REDDYS$$73$YR$E$M$Y$91$KG$20240814$$MD$DE$DE
241949261$24194926$1$I$$20240806$20240809$20240809$EXP$$JP-GILEAD-2024-0683170$GILEAD$$73$YR$E$F$Y$$$20240809$$MD$JP$JP
241949291$24194929$1$I$20240601$20240726$20240809$20240809$EXP$$CA-RECORDATI RARE DISEASE INC.-2024006104$RECORDATI$$$$$$Y$$$20240809$$MD$CA$CA
241949301$24194930$1$I$$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A177739$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241949311$24194931$1$I$$20240806$20240809$20240809$EXP$$JP-AstraZeneca-2024A179723$ASTRAZENECA$Fujiya M, et al. OS4-6 Investigation of irAE enterocolitis cases induced by durvalumab and tremelimumab combination therapy for advanced hepatocellular carcinoma. The 30th Japan Association of Systemic Therapy for HCC 2024;104.$$$A$$Y$$$20240809$$MD$JP$
241949322$24194932$2$F$20240101$20240813$20240809$20240815$EXP$$IT-AstraZeneca-2024A180350$ASTRAZENECA$$49$YR$$F$Y$45$KG$20240815$$MD$IT$
241949331$24194933$1$I$20240313$20240731$20240809$20240809$EXP$FR-AFSSAPS-TO2024001378$FR-TEVA-VS-3228859$TEVA$$80$YR$$F$Y$$$20240809$$PH$FR$FR
241949342$24194934$2$F$$20240809$20240809$20240816$EXP$$AU-AstraZeneca-2024A181298$ASTRAZENECA$Dhaliwal N, Roberts D.. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study.. Clinical Toxicology 2024;62(3):168-173.$$$$$Y$$$20240816$$HP$AU$
241949351$24194935$1$I$$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A176190$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241949361$24194936$1$I$$20240630$20240809$20240809$EXP$$JP-AstraZeneca-2024A180450$ASTRAZENECA$Matsui R. et al.. P-210 Experience with the use of dapagliflozin for treatments other than diabetes mellitus treatment at our hospital. The Japanese Journal of Nephrology 2024;66(4):664-.$$$$$Y$$$20240809$$MD$JP$
241949371$24194937$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A177896$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241949381$24194938$1$I$$20240725$20240809$20240809$EXP$$US-Standard Homeopathic-2160245$STANDARD HOMEOPATHIC$$9$MON$$M$Y$$$20240809$$$US$US
241949391$24194939$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005258$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240809$$CN$US$US
241949401$24194940$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005479$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241949411$24194941$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004783$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240809$$CN$US$US
241949441$24194944$1$I$$20240806$20240809$20240809$EXP$$ZA-AstraZeneca-2024A178869$ASTRAZENECA$$25932$DY$$M$Y$$$20240809$$CN$ZA$
241949452$24194945$2$F$$20240815$20240809$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07304$LUPIN$$$$$$Y$$$20240905$$CN$US$US
241949461$24194946$1$I$$20240716$20240809$20240809$PER$$US-009507513-2407USA011086$MERCK$$74$YR$$M$Y$$$20240809$$CN$US$US
241949471$24194947$1$I$20240806$20240807$20240809$20240809$EXP$$US-009507513-2408USA002477$MERCK$$57$YR$$M$Y$$$20240809$$PH$US$US
241949481$24194948$1$I$$20240729$20240809$20240809$30DAY$$FR-PFIZER INC-202400225760$PFIZER$$11$YR$$F$Y$$$20240809$$PH$FR$FR
241949493$24194949$3$F$$20240920$20240809$20240924$30DAY$$CH-PFIZER INC-202400230194$PFIZER$$$$$F$Y$$$20240924$$CN$CH$CH
241949502$24194950$2$F$20240729$20240917$20240809$20240920$30DAY$$JP-PFIZER INC-PV202400098269$PFIZER$$$$$$Y$$$20240920$$HP$JP$JP
241949512$24194951$2$F$20240601$20240925$20240809$20240926$30DAY$$CA-PFIZER INC-202400227158$PFIZER$$61$YR$$F$Y$$$20240926$$HP$CA$CA
241949523$24194952$3$F$20240731$20240924$20240809$20240926$30DAY$$US-PFIZER INC-202400228144$PFIZER$$10$YR$$M$Y$$$20240926$$CN$US$US
241949531$24194953$1$I$$20240808$20240809$20240809$EXP$$US-PFIZER INC-PV202400103760$PFIZER$$$$$$Y$$$20240809$$CN$US$US
241949542$24194954$2$F$$20240915$20240809$20240916$30DAY$$RO-PFIZER INC-202400224602$PFIZER$$$$$$Y$$$20240916$$CN$RO$RO
241949552$24194955$2$F$$20240917$20240809$20240920$30DAY$$FR-PFIZER INC-202400232031$PFIZER$$$$$$Y$$$20240920$$HP$FR$FR
241949561$24194956$1$I$20230401$20240802$20240809$20240809$EXP$$NVSC2024DE160903$NOVARTIS$$$$C$F$Y$$$20240809$$MD$DE$DE
241949571$24194957$1$I$$20231117$20240809$20240809$EXP$$AU-SANDOZ INC.-SDZ2023AU076657$SANDOZ$$$$$$Y$$$20240809$$HP$AU$AU
241949581$24194958$1$I$$20240801$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR097955$VIIV$$$$$$Y$$$20240809$$HP$US$US
241949591$24194959$1$I$20240101$20240808$20240809$20240809$EXP$$CN-BAYER-2024A115091$BAYER$$92$YR$E$M$Y$$$20240809$$HP$CN$CN
241949601$24194960$1$I$20220423$20240805$20240809$20240809$EXP$$PHHY2017AR100969$NOVARTIS$$83$YR$$M$Y$$$20240809$$CN$AR$AR
241949611$24194961$1$I$$20240801$20240809$20240809$EXP$$JP-CARA THERAPEUTICS, INC.-2024-00353-JP$CARA THERAPEUTICS$$$$$$Y$$$20240809$$MD$JP$JP
241949621$24194962$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024158376$AMGEN$$$$A$F$Y$$$20240809$$HP$US$US
241949631$24194963$1$I$$20240808$20240809$20240809$EXP$$US-JNJFOC-20240820913$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$HP$US$US
241949641$24194964$1$I$$20240806$20240809$20240809$EXP$$JP-PFIZER INC-PV202400102522$PFIZER$$$$$$Y$$$20240809$$MD$JP$JP
241949651$24194965$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-PV202400102869$PFIZER$$$$$$Y$$$20240809$$MD$US$US
241949661$24194966$1$I$20240620$20240806$20240809$20240809$PER$$US-PFIZER INC-PV202400081524$PFIZER$$77$YR$$$Y$$$20240809$$MD$US$US
241949671$24194967$1$I$20240728$20240806$20240809$20240809$EXP$$CA-PFIZER INC-202400232182$PFIZER$$88$YR$$M$Y$$$20240809$$CN$CA$CA
241949681$24194968$1$I$20240804$20240806$20240809$20240809$PER$$US-PFIZER INC-PV202400020571$PFIZER$$70$YR$$F$Y$$$20240809$$CN$US$US
241949691$24194969$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400231704$PFIZER$$$$$$Y$$$20240809$$CN$US$US
241949711$24194971$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400231318$PFIZER$$$$A$$Y$$$20240809$$MD$US$US
241949722$24194972$2$F$$20240812$20240809$20240814$EXP$$AU-PFIZER INC-202400233614$PFIZER$$71$YR$$M$Y$$$20240814$$MD$AU$AU
241949742$24194974$2$F$$20240813$20240809$20240815$PER$$US-PFIZER INC-202400231273$PFIZER$$30$YR$$M$Y$$$20240815$$HP$US$US
241949751$24194975$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400231335$PFIZER$$$$$M$Y$$$20240809$$CN$US$US
241949761$24194976$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400232206$PFIZER$$86$YR$$F$Y$$$20240809$$HP$US$US
241949772$24194977$2$F$20240101$20240812$20240809$20240813$PER$$US-PFIZER INC-202400231483$PFIZER$$$$$M$Y$$$20240813$$CN$US$US
241949781$24194978$1$I$20240729$20240806$20240809$20240809$PER$$US-PFIZER INC-202400231362$PFIZER$$74$YR$$F$Y$$$20240809$$CN$US$US
241949791$24194979$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400231609$PFIZER$$22$YR$$F$Y$$$20240809$$CN$US$US
241949801$24194980$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-PV202400102571$PFIZER$$55$YR$$F$Y$$$20240809$$HP$US$US
241949811$24194981$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-PV202400102712$PFIZER$$$$$F$Y$$$20240809$$CN$US$US
241949821$24194982$1$I$20240806$20240807$20240809$20240809$EXP$$DO-PFIZER INC-PV202400079459$PFIZER$$59$YR$$F$Y$$$20240809$$CN$DO$DO
241949831$24194983$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-PV202400102868$PFIZER$$$$$$Y$$$20240809$$MD$US$US
241949841$24194984$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-PV202400102857$PFIZER$$68$YR$$F$Y$$$20240809$$HP$US$US
241949851$24194985$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400232390$PFIZER$$$$$$Y$$$20240809$$CN$US$US
241949861$24194986$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400231343$PFIZER$$50$YR$$F$Y$$$20240809$$CN$US$US
241949871$24194987$1$I$$20240808$20240809$20240809$EXP$$US-PFIZER INC-PV202400103835$PFIZER$$44$YR$$F$Y$$$20240809$$CN$US$US
241949881$24194988$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400231240$PFIZER$$72$YR$$F$Y$$$20240809$$CN$US$US
241949891$24194989$1$I$20230101$20240806$20240809$20240809$PER$$US-PFIZER INC-PV202300196323$PFIZER$$45$YR$$F$Y$$$20240809$$HP$US$US
241949901$24194990$1$I$20240701$20240806$20240809$20240809$PER$$US-PFIZER INC-202400232260$PFIZER$$47$YR$$F$Y$$$20240809$$HP$US$US
241949911$24194991$1$I$$20240805$20240809$20240809$PER$$US-PFIZER INC-PV202400102211$PFIZER$$65$YR$$F$Y$$$20240809$$CN$US$US
241949921$24194992$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400231744$PFIZER$$$$$$Y$$$20240809$$CN$US$US
241949935$24194993$5$F$20220701$20240828$20240809$20240830$EXP$$JP-PFIZER INC-202300203426$PFIZER$Ishimaru, S.. Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial. International Journal of Clinical Oncology. 2024;29(2):89-95$31$YR$$M$Y$96$KG$20240830$$MD$JP$JP
241949941$24194994$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400232267$PFIZER$$$$$$Y$$$20240809$$MD$US$US
241949961$24194996$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400232350$PFIZER$$$$$F$Y$$$20240809$$CN$US$US
241949971$24194997$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400231365$PFIZER$$$$A$F$Y$$$20240809$$MD$US$US
241949981$24194998$1$I$$20240805$20240809$20240809$PER$$US-PFIZER INC-202400230648$PFIZER$$69$YR$$M$Y$$$20240809$$CN$US$US
241949991$24194999$1$I$20211222$20240806$20240809$20240809$EXP$$FR-PFIZER INC-202400230888$PFIZER$$51$YR$$M$Y$64$KG$20240809$$MD$FR$FR
241950001$24195000$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400231715$PFIZER$$63$YR$$M$Y$$$20240809$$CN$US$US
241950011$24195001$1$I$20240101$20240806$20240809$20240809$PER$$US-PFIZER INC-202400231592$PFIZER$$72$YR$$M$Y$$$20240809$$CN$US$US
241950021$24195002$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-202400231631$PFIZER$$37$YR$$F$Y$$$20240809$$HP$US$US
241950034$24195003$4$F$20240804$20240919$20240809$20240924$PER$$US-PFIZER INC-202400224027$PFIZER$$49$YR$$M$Y$$$20240924$$MD$US$US
241950041$24195004$1$I$20220101$20240806$20240809$20240809$PER$$US-PFIZER INC-PV202400102859$PFIZER$$69$YR$$F$Y$$$20240809$$HP$US$US
241950052$24195005$2$F$20240722$20240828$20240809$20240829$EXP$$JP-PFIZER INC-PV202400103626$PFIZER$$80$YR$$F$Y$48.3$KG$20240829$$MD$JP$JP
241950061$24195006$1$I$$20240806$20240809$20240809$PER$$US-PFIZER INC-PV202400102863$PFIZER$$$$$F$Y$$$20240809$$HP$US$US
241950071$24195007$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191263$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241950081$24195008$1$I$20240101$20240806$20240809$20240809$EXP$$US-SA-2024SA233199$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240809$$MD$US$US
241950092$24195009$2$F$$20240808$20240809$20240816$PER$$US-SA-2024SA236207$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$CN$US$US
241950102$24195010$2$F$20240701$20240812$20240809$20240813$PER$$US-BAYER-2024A112699$BAYER$$74$YR$E$M$Y$$$20240813$$CN$US$US
241950121$24195012$1$I$$20240809$20240809$20240809$DIR$713580$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241950181$24195018$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191183$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241950191$24195019$1$I$$20240729$20240809$20240809$EXP$$CN-MEITHEAL-2024MPLIT00229$MEITHEAL PHARMACEUTICALS$Lu P and Zhang Y, Zhang W, Ji Y, Sun Y, Zhi K. Et.al.Case report: a cataract induced by bleomycin in a patient with testicular cancerYana Zhang.Frontiers in Pharmacology.20-JUN-2024;15 (1):1-6$22$YR$A$M$Y$$$20240809$$HP$CN$CN
241950201$24195020$1$I$$20240807$20240809$20240809$EXP$$GB-MYLANLABS-2024M1074201$MYLAN$$$$$M$Y$$$20240809$$MD$GB$GB
241950211$24195021$1$I$20240724$20240802$20240809$20240809$EXP$$SK-IMMUNOCORE, LTD.-2024-IMC-002909$IMMUNOCORE$$$$$$Y$$$20240809$$MD$SK$SK
241950223$24195022$3$F$20240620$20240815$20240809$20240829$PER$$US-ASTELLAS-2024US021986$ASTELLAS$$78$YR$E$F$Y$$$20240829$$MD$US$US
241950231$24195023$1$I$20240808$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54757$$FDA-CTU$$$$$M$N$7.5$KG$20240808$N$$US$
241950241$24195024$1$I$20240807$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54765$$FDA-CTU$$$$$F$N$71.1$KG$20240808$N$$US$
241950251$24195025$1$I$20240806$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54769$$FDA-CTU$$67$YR$$F$N$63.5$KG$20240808$N$$US$
241950261$24195026$1$I$20240801$20240807$20240809$20240809$EXP$$GB-BAYER-2024A114986$BAYER$$75$YR$E$M$Y$$$20240809$$HP$GB$GB
241950274$24195027$4$F$$20240924$20240809$20240930$EXP$$US-TAKEDA-2024TUS041304$TAKEDA$$$$$M$Y$135.6$KG$20240930$$CN$US$US
241950281$24195028$1$I$$20240729$20240809$20240809$EXP$$PT-MEITHEAL-2024MPLIT00234$MEITHEAL PHARMACEUTICALS$Campos-Lopes S, Monteiro AM, Marques O, et al..Pulmonary Embolism in Adipsic DI: Can Desmopressin Be a Contributing Factor?.Journal of the Endocrine Society.MAY-2021;5 (1):A605-6$51$YR$A$F$Y$$$20240809$$MD$PT$PT
241950291$24195029$1$I$$20240730$20240809$20240809$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095315$VIIV$$$$$$Y$$$20240809$$HP$US$US
241950301$24195030$1$I$$20240802$20240809$20240809$EXP$$NVSC2024BR161993$NOVARTIS$$$$$F$Y$$$20240809$$CN$BR$BR
241950311$24195031$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227794$TEVA$$14$YR$$F$Y$$$20240809$$PH$CA$CA
241950321$24195032$1$I$20240714$20240805$20240809$20240809$EXP$FR-AFSSAPS-BS2024000474$FR-MYLANLABS-2024M1072855$MYLAN$$21$YR$$M$Y$$$20240809$$MD$FR$FR
241950331$24195033$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227798$TEVA$$25$YR$$M$Y$72$KG$20240809$$HP$CA$CA
241950341$24195034$1$I$20240228$20240320$20240809$20240809$PER$$US-AMERICAN REGENT INC-2024000797$AMERICAN REGENT$$68$YR$$F$Y$$$20240809$$CN$US$US
241950351$24195035$1$I$20240101$20240723$20240809$20240809$PER$$US-AMERICAN REGENT INC-2024002847$AMERICAN REGENT$$$$$F$Y$$$20240809$$CN$US$US
241950371$24195037$1$I$$20240729$20240809$20240809$EXP$$IN-MEITHEAL-2024MPLIT00232$MEITHEAL PHARMACEUTICALS$Sivagnanam, et al..Mucormycosis-Associated Colon Perforation in the Early Postrenal Transplant Period.Indian Journal of Transplantation .28-JUN-2024;18 (2):189-93$32$YR$A$M$Y$$$20240809$$MD$IN$IN
241950381$24195038$1$I$$20240729$20240809$20240809$EXP$$US-MEITHEAL-2024MPLIT00237$MEITHEAL PHARMACEUTICALS$Lapiano K, et al..Case Report: Nelarabine Neurotoxicity Induced Respiratory Failure.American Journal of Respiratory and Critical Care Medicine.JAN-2024;209 (1):A5696$30$YR$A$F$Y$$$20240809$$HP$US$US
241950391$24195039$1$I$20240715$20240801$20240809$20240809$PER$$US-MYLANLABS-2024M1072376$MYLAN$$46$YR$$F$Y$66.22$KG$20240809$$HP$US$US
241950401$24195040$1$I$$20240805$20240809$20240809$EXP$$DE-MYLANLABS-2024M1072939$MYLAN$Schott-Seidenschwanz I, Wille H, Muehlbauer B.. Metamizole - a death trap?. Bremen Medical Journal. 2011;64(20)$70$YR$$F$Y$$$20240809$$MD$DE$DE
241950412$24195041$2$F$20240720$20240812$20240809$20240814$EXP$CH-SM-2024-14978$CH-GILEAD-2024-0683520$GILEAD$$58$YR$A$F$Y$$$20240814$$MD$CH$CH
241950421$24195042$1$I$$20240805$20240809$20240809$EXP$$GR-MYLANLABS-2024M1072909$MYLAN$Zografidou P, Papagiannopoulou O, Grigoriou I, Spanopoulos K, Koraki E.. Perioperative management of emergent cesarean section in a patient with peripartum cardiomyopathy: A case report. Greek e j Perioper Med. 2024;23(b):16-21$$$N$$Y$$$20240809$$MD$GR$GR
241950432$24195043$2$F$20240601$20240809$20240809$20240815$EXP$$JP-AstraZeneca-2024A176186$ASTRAZENECA$$79$YR$$F$Y$$$20240815$$PH$JP$
241950441$24195044$1$I$$20240802$20240809$20240809$EXP$$AU-PFIZER INC-2024SGN05916$PFIZER$$89$YR$$$Y$$$20240809$$MD$AU$AU
241950451$24195045$1$I$$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A178731$ASTRAZENECA$$$$$$Y$$$20240809$$MD$US$
241950462$24195046$2$F$20240701$20240829$20240809$20240906$EXP$$JP-AstraZeneca-2024A177521$ASTRAZENECA$$60$YR$$M$Y$$$20240906$$MD$JP$
241950471$24195047$1$I$20240806$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157481$AMGEN$$41$YR$A$F$Y$$$20240809$$HP$US$US
241950481$24195048$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024158379$AMGEN$$$$$M$Y$$$20240809$$MD$US$US
241950492$24195049$2$F$20231105$20240808$20240809$20240812$EXP$$US-AstraZeneca-2024A180955$ASTRAZENECA$$23875$DY$$M$Y$$$20240812$$CN$US$
241950501$24195050$1$I$$20240806$20240809$20240809$PER$$US-JNJFOC-20240815218$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$CN$US$US
241950511$24195051$1$I$$20240802$20240809$20240809$EXP$$IE-BAYER-2024A112286$BAYER$$73$YR$E$M$Y$$$20240809$$HP$IE$IE
241950521$24195052$1$I$$20240806$20240809$20240809$EXP$$JP-009507513-2408JPN002373$MERCK$$8$DEC$$F$Y$$$20240809$$MD$JP$JP
241950532$24195053$2$F$20240719$20240830$20240809$20240905$EXP$$JP-Eisai-EC-2024-171289$EISAI$$79$YR$E$F$Y$$$20240905$$MD$JP$JP
241950541$24195054$1$I$$20240729$20240809$20240809$EXP$$US-MEITHEAL-2024MPLIT00231$MEITHEAL PHARMACEUTICALS$Alam RM, Espinoza J, Coches K..Steroid Induced Diabetic Ketoacidosis in End Stage Renal Disease with  Suspected Vasculitis Induced Stroke.Southern Medical Journal.JUL-2022;115 (7):443-4$71$YR$E$F$Y$$$20240809$$MD$US$US
241950562$24195056$2$F$$20240923$20240809$20240930$EXP$$US-LUNDBECK-DKLU4002567$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
241950571$24195057$1$I$20240708$20240805$20240809$20240809$PER$$US-REGENERON PHARMACEUTICALS, INC.-2024-107547$REGENERON$$$$$F$Y$$$20240809$$CN$US$US
241950581$24195058$1$I$$20240729$20240809$20240809$EXP$$US-MEITHEAL-2024MPLIT00233$MEITHEAL PHARMACEUTICALS$Rozenbaum Lerner G, et al.Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209 (1):A3531$68$YR$A$M$Y$$$20240809$$HP$US$US
241950591$24195059$1$I$$20240729$20240809$20240809$EXP$$JP-MEITHEAL-2024MPLIT00238$MEITHEAL PHARMACEUTICALS$Nakamoto K, et al..Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases.Internal Medicine.JUN-2024;63 (12):1783-7$88$YR$E$M$Y$$$20240809$$MD$JP$JP
241950601$24195060$1$I$$20240729$20240809$20240809$EXP$$JP-MEITHEAL-2024MPLIT00239$MEITHEAL PHARMACEUTICALS$Nakamoto K, et al..Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases.Internal Medicine.JUN-2024;63 (12):1783-7$63$YR$A$M$Y$$$20240809$$MD$JP$JP
241950611$24195061$1$I$$20240729$20240809$20240809$EXP$$CN-MEITHEAL-2024MPLIT00236$MEITHEAL PHARMACEUTICALS$Liu H, et al..Chidamide in combination with azacitidine for an elderly patient with peripheral T cell lymphoma-not otherwise specified: A case report.Oncology Letters.28-MAY-2024;28 (2):1-6$71$YR$E$M$Y$$$20240809$$MD$CN$CN
241950622$24195062$2$F$20240601$20240806$20240809$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408003223$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240813$$CN$US$US
241950631$24195063$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004908$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240809$$CN$US$US
241950641$24195064$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004812$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240809$$HP$US$US
241950652$24195065$2$F$20240805$20240807$20240809$20240812$PER$$US-PFIZER INC-202400232090$PFIZER$$27$YR$$F$Y$63.05$KG$20240812$$HP$US$US
241950663$24195066$3$F$20240101$20240929$20240809$20240930$PER$$US-PFIZER INC-202400232394$PFIZER$$16$YR$$M$Y$$$20240930$$HP$US$US
241950671$24195067$1$I$$20240803$20240809$20240809$PER$$US-PFIZER INC-PV202300014451$PFIZER$$$$$$Y$$$20240809$$CN$US$US
241950693$24195069$3$F$20240503$20240911$20240809$20240916$30DAY$$US-PFIZER INC-PV202400047082$PFIZER$$13$YR$$M$Y$45.36$KG$20240916$$MD$US$US
241950702$24195070$2$F$$20240807$20240809$20240809$PER$$US-PFIZER INC-PV202400103243$PFIZER$$72$YR$$F$Y$$$20240809$$HP$US$US
241950711$24195071$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-PV202400103317$PFIZER$$18$YR$$$Y$$$20240809$$CN$US$US
241950721$24195072$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232345$PFIZER$$78$YR$$M$Y$$$20240809$$CN$US$US
241950741$24195074$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-PV202400103465$PFIZER$$17$YR$$F$Y$$$20240809$$CN$US$US
241950752$24195075$2$F$$20240908$20240809$20240909$PER$$US-PFIZER INC-202400231575$PFIZER$$35$YR$$F$Y$$$20240909$$CN$US$US
241950761$24195076$1$I$20240101$20240806$20240809$20240809$PER$$US-SA-2024SA235743$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240809$$MD$US$US
241950771$24195077$1$I$20240715$20240801$20240809$20240809$EXP$$US-SA-2024SA230973$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240809$$MD$US$US
241950791$24195079$1$I$20240723$20240806$20240809$20240809$EXP$$AR-UCBSA-2024040165$UCB$$70$YR$$M$Y$$$20240809$$CN$AR$AR
241950801$24195080$1$I$$20240710$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07042$LUPIN$$$$$$Y$$$20240809$$MD$US$US
241950811$24195081$1$I$$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024157549$AMGEN$$$$$$Y$$$20240809$$PH$US$US
241950821$24195082$1$I$$20240808$20240809$20240809$EXP$$US-ROCHE-10000052897$ROCHE$$50$YR$A$F$Y$70$KG$20240809$$PH$US$US
241950831$24195083$1$I$$20240731$20240809$20240809$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095885$VIIV$$$$$$Y$$$20240809$$HP$US$US
241950861$24195086$1$I$20240731$20240805$20240809$20240809$EXP$$US-OTSUKA-2024_021779$OTSUKA$$$$$M$Y$$$20240809$$CN$US$US
241950871$24195087$1$I$20240726$20240808$20240809$20240809$EXP$$US-UCBSA-2024040158$UCB$$48$YR$$F$Y$$$20240809$$HP$US$US
241950881$24195088$1$I$20240101$20240806$20240809$20240809$EXP$$DE-ORGANON-O2407DEU002276$ORGANON$$43$YR$$F$Y$$$20240809$$MD$DE$DE
241950891$24195089$1$I$$20240716$20240809$20240809$EXP$$BR-SA-2024SA214544$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240809$$MD$BR$BR
241950911$24195091$1$I$$20240806$20240809$20240809$EXP$$SK-ROCHE-10000051421$ROCHE$$$$$F$Y$$$20240809$$PH$SK$SK
241950932$24195093$2$F$20231102$20240920$20240809$20240924$EXP$$NVSC2024US062842$NOVARTIS$$54$YR$$F$Y$$$20240924$$CN$US$US
241950942$24195094$2$F$$20240912$20240809$20240919$EXP$$NVSC2024DE160083$NOVARTIS$$$$A$F$Y$$$20240919$$HP$DE$DE
241950951$24195095$1$I$$20240429$20240809$20240809$PER$$US-ANIPHARMA-2024-US-025104$ANI$$65$YR$$F$Y$$$20240809$$HP$US$US
241950961$24195096$1$I$20240327$20240501$20240809$20240809$PER$$US-ANIPHARMA-2024-US-025588$ANI$$57$YR$$F$Y$$$20240809$$HP$US$US
241950971$24195097$1$I$$20240503$20240809$20240809$PER$$US-ANIPHARMA-2024-US-025916$ANI$$$$$F$Y$$$20240809$$CN$US$US
241950981$24195098$1$I$$20240506$20240809$20240809$PER$$US-ANIPHARMA-2024-US-026759$ANI$$$$$UNK$Y$$$20240809$$MD$US$US
241950991$24195099$1$I$20240410$20240514$20240809$20240809$PER$$US-ANIPHARMA-2024-US-028128$ANI$$47$YR$$F$Y$$$20240809$$HP$US$US
241951001$24195100$1$I$$20240514$20240809$20240809$PER$$US-ANIPHARMA-2024-US-028141$ANI$$54$YR$$F$Y$$$20240809$$HP$US$US
241951011$24195101$1$I$20240401$20240514$20240809$20240809$PER$$US-ANIPHARMA-2024-US-028242$ANI$$40$YR$$F$Y$$$20240809$$HP$US$US
241951021$24195102$1$I$$20240515$20240809$20240809$PER$$US-ANIPHARMA-2024-US-028410$ANI$$$$$M$Y$$$20240809$$HP$US$US
241951031$24195103$1$I$20240514$20240516$20240809$20240809$PER$$US-ANIPHARMA-2024-US-028479$ANI$$62$YR$$F$Y$$$20240809$$HP$US$US
241951041$24195104$1$I$20240426$20240521$20240809$20240809$PER$$US-ANIPHARMA-2024-US-029371$ANI$$62$YR$$F$Y$$$20240809$$HP$US$US
241951051$24195105$1$I$$20240522$20240809$20240809$PER$$US-ANIPHARMA-2024-US-029644$ANI$$69$YR$$F$Y$$$20240809$$HP$US$US
241951061$24195106$1$I$$20240523$20240809$20240809$PER$$US-ANIPHARMA-2024-US-029824$ANI$$$$$F$Y$$$20240809$$HP$US$US
241951071$24195107$1$I$20240508$20240527$20240809$20240809$PER$$US-ANIPHARMA-2024-US-030424$ANI$$82$YR$$F$Y$$$20240809$$HP$US$US
241951081$24195108$1$I$20240501$20240525$20240809$20240809$PER$$US-ANIPHARMA-2024-US-030433$ANI$$60$YR$$F$Y$$$20240809$$HP$US$US
241951091$24195109$1$I$20240531$20240530$20240809$20240809$PER$$US-ANIPHARMA-2024-US-030939$ANI$$36$YR$$F$Y$88.45$KG$20240809$$HP$US$US
241951101$24195110$1$I$$20240530$20240809$20240809$PER$$US-ANIPHARMA-2024-US-031048$ANI$$80$YR$$F$Y$$$20240809$$CN$US$US
241951111$24195111$1$I$20240101$20240531$20240809$20240809$PER$$US-ANIPHARMA-2024-US-031182$ANI$$48$YR$$F$Y$$$20240809$$HP$US$US
241951121$24195112$1$I$20240301$20240513$20240809$20240809$PER$$US-ANIPHARMA-2024-US-027869$ANI$$52$YR$$M$Y$$$20240809$$HP$US$US
241951131$24195113$1$I$20240501$20240603$20240809$20240809$PER$$US-ANIPHARMA-2024-US-031442$ANI$$40$YR$$F$Y$$$20240809$$HP$US$US
241951141$24195114$1$I$$20240521$20240809$20240809$PER$$US-ANIPHARMA-2024-US-029351$ANI$$$$$F$Y$$$20240809$$HP$US$US
241951151$24195115$1$I$20240501$20240603$20240809$20240809$PER$$US-ANIPHARMA-2024-US-031446$ANI$$91$YR$$F$Y$$$20240809$$HP$US$US
241951161$24195116$1$I$20240501$20240605$20240809$20240809$PER$$US-ANIPHARMA-2024-US-031928$ANI$$41$YR$$M$Y$$$20240809$$HP$US$US
241951171$24195117$1$I$$20240523$20240809$20240809$PER$$US-ANIPHARMA-2024-US-029857$ANI$$$$$F$Y$$$20240809$$HP$US$US
241951181$24195118$1$I$$20240606$20240809$20240809$PER$$US-ANIPHARMA-2024-US-032147$ANI$$$$$F$Y$$$20240809$$HP$US$US
241951191$24195119$1$I$20240607$20240607$20240809$20240809$PER$$US-ANIPHARMA-2024-US-032445$ANI$$24$YR$$M$Y$$$20240809$$HP$US$US
241951201$24195120$1$I$$20240502$20240809$20240809$PER$$US-ANIPHARMA-2024-US-025840$ANI$$70$YR$$F$Y$$$20240809$$HP$US$US
241951211$24195121$1$I$20240531$20240610$20240809$20240809$PER$$US-ANIPHARMA-2024-US-032626$ANI$$70$YR$$F$Y$$$20240809$$CN$US$US
241951221$24195122$1$I$20240607$20240611$20240809$20240809$PER$$US-ANIPHARMA-2024-US-032914$ANI$$74$YR$$F$Y$$$20240809$$CN$US$US
241951231$24195123$1$I$$20240611$20240809$20240809$PER$$US-ANIPHARMA-2024-US-033020$ANI$$$$$M$Y$$$20240809$$CN$US$US
241951241$24195124$1$I$$20240611$20240809$20240809$PER$$US-ANIPHARMA-2024-US-033082$ANI$$59$YR$$F$Y$$$20240809$$HP$US$US
241951251$24195125$1$I$$20240517$20240809$20240809$PER$$US-ANIPHARMA-2024-US-028959$ANI$$63$YR$$F$Y$$$20240809$$HP$US$US
241951261$24195126$1$I$20240316$20240529$20240809$20240809$PER$$US-ANIPHARMA-2024-US-030854$ANI$$81$YR$$F$Y$$$20240809$$HP$US$US
241951271$24195127$1$I$$20240521$20240809$20240809$PER$$US-ANIPHARMA-2024-US-029475$ANI$$$$$F$Y$$$20240809$$HP$US$US
241951281$24195128$1$I$$20240523$20240809$20240809$PER$$US-ANIPHARMA-2024-US-029870$ANI$$$$$M$Y$$$20240809$$HP$US$US
241951291$24195129$1$I$$20240612$20240809$20240809$PER$$US-ANIPHARMA-2024-US-033226$ANI$$$$$F$Y$$$20240809$$HP$US$US
241951301$24195130$1$I$$20240520$20240809$20240809$PER$$US-ANIPHARMA-2024-US-029106$ANI$$$$$F$Y$$$20240809$$HP$US$US
241951311$24195131$1$I$20240502$20240603$20240809$20240809$PER$$US-ANIPHARMA-2024-US-031544$ANI$$61$YR$$F$Y$77.11$KG$20240809$$HP$US$US
241951321$24195132$1$I$$20240612$20240809$20240809$PER$$US-ANIPHARMA-2024-US-033205$ANI$$$$$F$Y$74.39$KG$20240809$$CN$US$US
241951331$24195133$1$I$20240427$20240430$20240809$20240809$PER$$US-ANIPHARMA-2024-US-025366$ANI$$60$YR$$M$Y$$$20240809$$HP$US$US
241951342$24195134$2$F$20240501$20240919$20240809$20240926$EXP$$US-ANIPHARMA-2024-US-028201$ANI$$60$YR$$F$Y$$$20240926$$HP$US$US
241951351$24195135$1$I$$20240530$20240809$20240809$PER$$US-ANIPHARMA-2024-US-031018$ANI$$$$$F$Y$$$20240809$$HP$US$US
241951361$24195136$1$I$$20240531$20240809$20240809$PER$$US-ANIPHARMA-2024-US-031191$ANI$$$$$M$Y$$$20240809$$HP$US$US
241951371$24195137$1$I$$20240611$20240809$20240809$PER$$US-ANIPHARMA-2024-US-033061$ANI$$66$YR$$F$Y$$$20240809$$HP$US$US
241951381$24195138$1$I$$20240611$20240809$20240809$PER$$US-ANIPHARMA-2024-US-033054$ANI$$56$YR$$M$Y$$$20240809$$HP$US$US
241951401$24195140$1$I$20240101$20240801$20240809$20240809$EXP$$DE-LUNDBECK-DKLU4002726$LUNDBECK$$$$$$Y$$$20240809$$CN$DE$DE
241951411$24195141$1$I$$20240730$20240809$20240809$EXP$$TR-TAKEDA-2024TUS079332$TAKEDA$Elver O, Erol V, Kendir I, Gueler N, Aslan N.. Multipl miyelomda Anti-CD38 monoklonal antikoru daratumumab tedavisi genelyanit oranini arttirir. Pam Med J. 2024;17:448-455.$$$$$Y$$$20240809$$MD$TR$TR
241951422$24195142$2$F$20240801$20240808$20240809$20240813$PER$$US-ABBVIE-5873455$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
241951431$24195143$1$I$$20240805$20240809$20240809$EXP$$AU-TAKEDA-2024TUS079655$TAKEDA$$$$$F$Y$$$20240809$$CN$GB$GB
241951441$24195144$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5864365$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241951451$24195145$1$I$20240719$20240806$20240809$20240809$EXP$$US-AstraZeneca-2024A178633$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241951461$24195146$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A170416$ASTRAZENECA$$61$YR$$F$Y$74.7$KG$20240809$$PH$US$
241951471$24195147$1$I$20240725$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A177643$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241951482$24195148$2$F$$20240906$20240809$20240913$EXP$$JP-AstraZeneca-2024A176179$ASTRAZENECA$$$$$F$Y$$$20240913$$PH$JP$
241951491$24195149$1$I$$20240802$20240809$20240809$EXP$$AR-AstraZeneca-2024A179124$ASTRAZENECA$$$$$F$Y$$$20240809$$MD$AR$
241951501$24195150$1$I$$20240802$20240809$20240809$EXP$$ZA-AstraZeneca-2024A176312$ASTRAZENECA$$82$YR$$M$Y$$$20240809$$CN$ZA$
241951511$24195151$1$I$20240701$20240731$20240809$20240809$PER$$US-SA-2024SA231024$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240809$$MD$US$US
241951521$24195152$1$I$20240101$20240731$20240809$20240809$PER$$US-SA-2024SA231180$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240809$$MD$US$US
241951531$24195153$1$I$20240101$20240731$20240809$20240809$PER$$US-SA-2024SA230573$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240809$$MD$US$US
241951541$24195154$1$I$$20240726$20240809$20240809$EXP$$CO-LUNDBECK-DKLU4002529$LUNDBECK$$$$$$Y$$$20240809$$MD$CO$CO
241951551$24195155$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA231386$SANOFI AVENTIS$$$$A$M$Y$$$20240809$$MD$US$US
241951561$24195156$1$I$$20240801$20240809$20240809$PER$$US-ALXN-202408USA000093US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241951571$24195157$1$I$$20240716$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07291$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241951581$24195158$1$I$20230801$20230920$20240809$20240809$PER$$US-AMERICAN REGENT INC-2023002027$AMERICAN REGENT$$$$$F$Y$$$20240809$$CN$US$US
241951591$24195159$1$I$$20240712$20240809$20240809$PER$$US-AMERICAN REGENT INC-2024002429$AMERICAN REGENT$$70$YR$$F$Y$$$20240809$$CN$US$US
241951601$24195160$1$I$$20240715$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07214$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241951611$24195161$1$I$20240101$20240731$20240809$20240809$PER$$US-ABBVIE-5864485$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241951622$24195162$2$F$$20240807$20240809$20240812$EXP$$US-JNJFOC-20240721417$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240813$$CN$US$US
241951631$24195163$1$I$20240701$20240801$20240809$20240809$PER$$US-SA-2024SA233046$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240809$$CN$US$US
241951641$24195164$1$I$$20240807$20240809$20240809$PER$$US-SA-2024SA236064$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240809$$CN$US$US
241951651$24195165$1$I$20240701$20240801$20240809$20240809$PER$$US-SA-2024SA232229$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240809$$MD$US$US
241951661$24195166$1$I$20240507$20240805$20240809$20240809$EXP$$BG-MYLANLABS-2024M1073108$MYLAN$Neykova L, Angelov Y, Ivanova M, Notev A.. Intralipids and their role in the management of antipsychotic and neuroleptic drug intoxications (a clinical case). MILITARY MEDICINE. 2024;LXXVI(2):29-33$46$YR$$F$Y$$$20240809$$HP$BG$BG
241951671$24195167$1$I$20240804$20240805$20240809$20240809$EXP$$US-BAYER-2024A115295$BAYER$$31$YR$A$F$Y$102.04$KG$20240809$$CN$US$US
241951681$24195168$1$I$20240727$20240729$20240809$20240809$DIR$FDA-CDER-CTU-2024-54774$$FDA-CTU$$83$YR$$M$N$51.9$KG$20240729$N$$US$
241951691$24195169$1$I$20240723$20240726$20240809$20240809$DIR$FDA-CDER-CTU-2024-54758$$FDA-CTU$$66$YR$$M$N$91.4$KG$20240726$N$$US$
241951701$24195170$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191221$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241951721$24195172$1$I$20240701$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024155355$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241951731$24195173$1$I$$20240729$20240809$20240809$EXP$$CN-SLATERUN-2024SRLIT00136$SLATE RUN$Ruze R, et al. .Liver autotransplantation and atrial reconstruction on a patient with multiorgan alveolar echinococcosis: a case report.BMC Infectious Diseases.02-JUL-2024;24 (1):1-10$59$YR$A$F$Y$$$20240809$$HP$CN$CN
241951741$24195174$1$I$20240601$20240730$20240809$20240809$PER$$PR-ABBVIE-5866054$ABBVIE$$51$YR$$F$Y$71.667$KG$20240809$$CN$PR$PR
241951751$24195175$1$I$$20240730$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019790$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240809$$CN$US$US
241951761$24195176$1$I$20231118$20240802$20240809$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202312015193$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240809$$CN$JP$JP
241951771$24195177$1$I$$20240731$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002113$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240809$$CN$US$US
241951781$24195178$1$I$$20240806$20240809$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408004011$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$JP$JP
241951791$24195179$1$I$20240805$20240805$20240809$20240809$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202408003665$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240809$$MD$CA$CA
241951801$24195180$1$I$$20240730$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000343$ELI LILLY AND CO$$$$$M$Y$$$20240809$$CN$US$US
241951811$24195181$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004895$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240809$$CN$US$US
241951821$24195182$1$I$20240716$20240730$20240809$20240809$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408004857$ELI LILLY AND CO$$89$YR$E$F$Y$47$KG$20240809$$CN$DE$CN
241951831$24195183$1$I$$20240731$20240809$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408004553$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240809$$CN$JP$JP
241951841$24195184$1$I$20240729$20240802$20240809$20240809$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-108584$REGENERON$$65$YR$$F$Y$$$20240809$$HP$CO$CO
241951851$24195185$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA233223$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241951861$24195186$1$I$$20240712$20240809$20240809$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000017$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240809$$PH$US$US
241951871$24195187$1$I$$20240802$20240809$20240809$EXP$$KR-AstraZeneca-2024A178465$ASTRAZENECA$$71$YR$$F$Y$$$20240809$$MD$KR$
241951881$24195188$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A177007$ASTRAZENECA$$$$$M$Y$68.5$KG$20240809$$MD$US$
241951891$24195189$1$I$$20240805$20240809$20240809$EXP$$CN-AstraZeneca-2024A179657$ASTRAZENECA$$$$$$Y$$$20240809$$MD$CN$
241951902$24195190$2$F$$20240809$20240809$20240816$EXP$$AU-AstraZeneca-2024A181122$ASTRAZENECA$Dhaliwal N, Roberts D.. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study.. CLINICAL TOXICOLOGY 2024;62(3):168-173.$$$$$Y$$$20240816$$HP$AU$
241951911$24195191$1$I$20240101$20240806$20240809$20240809$EXP$$CA-AstraZeneca-2024A178758$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$CA$
241951921$24195192$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A176706$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241951931$24195193$1$I$$20240807$20240809$20240809$EXP$$FR-AstraZeneca-2024A180715$ASTRAZENECA$$90$YR$$F$Y$$$20240809$$MD$FR$
241951941$24195194$1$I$20200101$20240808$20240809$20240809$EXP$$FR-WAYLIS-2024-FR-000129$Waylis$$62$YR$$M$Y$$$20240809$$HP$FR$FR
241951951$24195195$1$I$20240601$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A177628$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241951962$24195196$2$F$$20240809$20240809$20240816$EXP$$AU-AstraZeneca-2024A181160$ASTRAZENECA$Dhaliwal N, Roberts D.. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study.. CLINICAL TOXICOLOGY 2024;62(3):168?173.$$$$$Y$$$20240816$$MD$AU$
241951971$24195197$1$I$$20240708$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06980$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241951981$24195198$1$I$20240319$20240731$20240809$20240809$PER$$US-SA-2024SA232357$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240809$$MD$US$US
241951991$24195199$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA232246$SANOFI AVENTIS$$$$A$F$Y$83.9$KG$20240809$$MD$US$US
241952011$24195201$1$I$20240101$20240801$20240809$20240809$EXP$$CN-SA-2024SA230979$SANOFI AVENTIS$$$$T$$Y$$$20240809$$MD$CN$CN
241952021$24195202$1$I$20240101$20240731$20240809$20240809$PER$$US-SA-2024SA231961$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240809$$MD$US$US
241952031$24195203$1$I$$20240802$20240809$20240809$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-108935$REGENERON$$$$$$Y$$$20240809$$PH$JP$JP
241952041$24195204$1$I$20240711$20240730$20240809$20240809$EXP$FR-AFSSAPS-RE2024000745$FR-TEVA-VS-3228514$TEVA$$73$YR$$F$Y$108.5$KG$20240809$$MD$FR$FR
241952051$24195205$1$I$$20240802$20240809$20240809$EXP$$AT-AMERICAN REGENT INC-2024002991$AMERICAN REGENT$$21$YR$$F$Y$$$20240809$$MD$AT$AT
241952062$24195206$2$F$20240624$20240812$20240809$20240821$EXP$$CN-Blueprint Medicines Corporation-SP-CN-2024-001597$BLUEPRINT MEDICINES$$35$YR$A$M$Y$$$20240821$$CN$CN$CN
241952071$24195207$1$I$20230101$20240730$20240809$20240809$EXP$$US-RDY-LIT/USA/24/0011444$DR REDDYS$Chalker C, Yilmaz B, Trone K, Parecki G, Chen A, Lim JY, et al. Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule. npj Precision Oncology. 2024;8(1): 1-6. doi:10.1038/s41698-024-00619-5.$70$YR$E$M$Y$$$20240809$$HP$US$US
241952091$24195209$1$I$20240101$20240730$20240809$20240809$EXP$$US-INSMED-2024-00806-USAA$INSMED$$$$$F$Y$$$20240809$$CN$US$US
241952101$24195210$1$I$$20240712$20240809$20240809$PER$$US-SCIEGENP-2024SCSPO00339$SCIEGEN$$$$$M$Y$$$20240809$$CN$US$US
241952111$24195211$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125726$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$77.56$KG$20240809$$CN$US$US
241952151$24195215$1$I$$20240808$20240809$20240809$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044696$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240809$$CN$US$US
241952171$24195217$1$I$20200721$20240806$20240809$20240809$EXP$PL-URPL-1-1923-2020$PL-MYLANLABS-2024M1073171$MYLAN$$48$YR$$F$Y$80$KG$20240809$$MD$PL$PL
241952181$24195218$1$I$$20240805$20240809$20240809$EXP$$HU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043776$BOEHRINGER INGELHEIM$Gerges G, Toth F, Sebo N, Balint O, Peter A, Szanto A, et al. A bumpy road from Borsod to Vienna, or from deep vein thrombosis to pulmonary thrombendarterectomy. Cardiologia Hungarica Supplementum. 2024;(3): 352-352.$25$YR$A$M$Y$$$20240809$$MD$HU$HU
241952191$24195219$1$I$$20240802$20240809$20240809$EXP$$AT-ROCHE-10000048122$ROCHE$$40$YR$A$F$Y$$$20240809$$MD$AT$AT
241952201$24195220$1$I$$20240730$20240809$20240809$EXP$$TR-TAKEDA-2024TUS079334$TAKEDA$Elver O, Erol V, Kendir I, Guler N, Aslan N.. Multipl miyelomda anti-CD38 monoklonal antikoru daratumumab tedavisi genel yanit oranini arttirir. Pam Med J. 2024;17(3):448-455$$$$$Y$$$20240809$$MD$TR$TR
241952223$24195222$3$F$20230327$20240805$20240809$20240917$EXP$$FR-ROCHE-10000049634$ROCHE$$39$YR$A$F$Y$110$KG$20240917$$MD$FR$FR
241952231$24195223$1$I$$20240731$20240809$20240809$PER$$US-ABBVIE-5863827$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241952241$24195224$1$I$20240301$20240809$20240809$20240809$EXP$FR-AFSSAPS-TO2024000455$FR-BAYER-2024A115103$BAYER$$69$YR$E$F$Y$63$KG$20240809$$MD$FR$FR
241952252$24195225$2$F$20240101$20240808$20240809$20240814$PER$$US-AMGEN-USASP2024158084$AMGEN$$80$YR$E$F$Y$$$20240814$$CN$US$US
241952261$24195226$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191252$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241952281$24195228$1$I$$20240731$20240809$20240809$EXP$NL-LRB-00993217$NL-TEVA-VS-3228994$TEVA$$91$YR$$M$Y$$$20240809$$MD$NL$NL
241952301$24195230$1$I$20240704$20240808$20240809$20240809$EXP$FR-AFSSAPS-PB2024000856$NVSC2024FR161454$NOVARTIS$$51$YR$$M$Y$$$20240809$$PH$FR$FR
241952311$24195231$1$I$$20240808$20240809$20240809$EXP$$NVSC2024KR162318$NOVARTIS$$$$$$Y$$$20240809$$MD$KR$KR
241952321$24195232$1$I$20240601$20240802$20240809$20240809$EXP$$US-SA-2024SA234596$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240809$$MD$US$US
241952331$24195233$1$I$20240701$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125836$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240809$$CN$US$US
241952341$24195234$1$I$20240601$20240801$20240809$20240809$30DAY$$US-GSK-US2024096330$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240809$$CN$US$US
241952351$24195235$1$I$$20240731$20240809$20240809$EXP$$US-GSK-US2024AMR096072$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241952361$24195236$1$I$$20240730$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024095820$VIIV$$$$$M$Y$$$20240809$$HP$US$US
241952371$24195237$1$I$$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125747$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240809$$CN$US$US
241952381$24195238$1$I$20240101$20240802$20240809$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125390$BRISTOL MYERS SQUIBB$$4$DEC$A$M$Y$$$20240809$$MD$JP$JP
241952391$24195239$1$I$$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125738$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240809$$CN$US$US
241952401$24195240$1$I$20240805$20240807$20240809$20240809$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-125380$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240809$$PH$PR$PR
241952411$24195241$1$I$$20240807$20240809$20240809$EXP$$US-JNJFOC-20240817869$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$HP$US$US
241952421$24195242$1$I$$20240730$20240809$20240809$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005673$BIOCON$$$$$$Y$$$20240809$$HP$CA$CA
241952431$24195243$1$I$20240703$20240802$20240809$20240809$EXP$$AU-GSK-AU2024APC098226$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$PH$AU$AU
241952441$24195244$1$I$20230819$20230822$20240809$20240809$PER$$US-PAIPHARMA-2023-US-026117$PHARMACEUTICAL ASSOC$$80$YR$$M$Y$63.5$KG$20240809$$CN$US$US
241952451$24195245$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232259$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241952461$24195246$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232275$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240809$$MD$US$US
241952471$24195247$1$I$20240624$20240805$20240809$20240809$PER$$US-FreseniusKabi-FK202412216$FRESENIUS KABI$$$$$$Y$$$20240809$$HP$US$US
241952481$24195248$1$I$20231115$20231206$20240809$20240809$PER$$US-PAIPHARMA-2023-US-041658$PHARMACEUTICAL ASSOC$$76$YR$$M$Y$53.52$KG$20240809$$CN$US$US
241952491$24195249$1$I$20231101$20231228$20240809$20240809$PER$$US-PAIPHARMA-2023-US-044596$PHARMACEUTICAL ASSOC$$77$YR$$M$Y$81.65$KG$20240809$$CN$US$US
241952503$24195250$3$F$20240530$20240820$20240809$20240827$PER$$US-SA-2024SA231790$SANOFI AVENTIS$$50$YR$A$M$Y$135$KG$20240827$$CN$US$US
241952511$24195251$1$I$20240730$20240805$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124305$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240809$$CN$US$US
241952521$24195252$1$I$20240801$20240804$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124858$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240809$$MD$US$US
241952531$24195253$1$I$$20240805$20240809$20240809$PER$$US-FreseniusKabi-FK202412217$FRESENIUS KABI$$$$$$Y$$$20240809$$HP$US$US
241952541$24195254$1$I$$20240805$20240809$20240809$PER$$US-FreseniusKabi-FK202412219$FRESENIUS KABI$$$$$$Y$$$20240809$$HP$US$US
241952551$24195255$1$I$20240101$20240730$20240809$20240809$PER$$US-BAYER-2024A111389$BAYER$$$$$M$Y$$$20240809$$CN$US$US
241952562$24195256$2$F$$20240814$20240809$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125546$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240821$$CN$US$US
241952571$24195257$1$I$$20240805$20240809$20240809$EXP$$IN-ASTELLAS-2024US022331$ASTELLAS$Gupta D, Singh L, Kumar S, Singh K, Mendonca S, Chatterjee T. Rare complications of heart transplant: Autopsy findings. Indian Journal of Pathology and Microbiology. 2024;67(3):624-7$33$YR$$M$Y$$$20240809$$HP$IN$IN
241952581$24195258$1$I$$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125678$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240809$$CN$US$US
241952591$24195259$1$I$$20240805$20240809$20240809$PER$$US-AMGEN-USASP2024156590$AMGEN$$$$$$Y$$$20240809$$HP$US$US
241952611$24195261$1$I$20240708$20240802$20240809$20240809$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-012250$JAZZ$$75$YR$$M$Y$$$20240809$$MD$JP$JP
241952621$24195262$1$I$20240729$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A179224$ASTRAZENECA$$17681$DY$$M$Y$$$20240809$$CN$US$
241952631$24195263$1$I$$20240809$20240809$20240809$DIR$713582$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241952641$24195264$1$I$20240701$20240807$20240809$20240809$EXP$$JP-AstraZeneca-2024A180166$ASTRAZENECA$$$$E$M$Y$$$20240809$$MD$JP$
241952651$24195265$1$I$20240118$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A177581$ASTRAZENECA$$27590$DY$$F$Y$$$20240809$$CN$US$
241952661$24195266$1$I$$20240617$20240809$20240809$EXP$$HU-TEVA-VS-3212122$TEVA$Radeleczki S, Vir?g ?, Szab? I, V?radi T, Bajk? N, Szeberin Z, Szab? G, Jacz? Zs, Farkas K, Kolossv?ry E. A case of aortic free floating thrombus associated with a malignant disease. ?rbetegs?gek. 2024; 31(2): 74.$61$YR$$F$Y$$$20240809$$MD$HU$HU
241952671$24195267$1$I$20240803$20240803$20240809$20240809$EXP$$CN-AstraZeneca-2024A180503$ASTRAZENECA$$1124$WK$$M$Y$61$KG$20240809$$MD$CN$
241952681$24195268$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A179195$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241952691$24195269$1$I$20240701$20240730$20240809$20240809$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007300$AEGERION$$$$$$Y$$$20240809$$MD$DE$DE
241952701$24195270$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003939$ELI LILLY AND CO$$50$YR$A$$Y$$$20240809$$LW$US$US
241952711$24195271$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004815$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240809$$CN$US$US
241952721$24195272$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005267$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241952732$24195273$2$F$20230701$20240826$20240809$20240904$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007312$AEGERION$$54$YR$$F$Y$58.005$KG$20240904$$HP$US$US
241952741$24195274$1$I$$20240730$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408000456$ELI LILLY AND CO$$64$YR$A$$Y$$$20240809$$LW$US$US
241952761$24195276$1$I$20240804$20240809$20240809$20240809$DIR$713575$$FDA-CTU$$46$YR$$F$N$$$20240809$N$HP$US$
241952771$24195277$1$I$20220902$20240731$20240809$20240809$EXP$IT-MINISAL02-996159$IT-TEVA-VS-3228710$TEVA$$76$YR$$F$Y$62$KG$20240809$$MD$IT$IT
241952781$24195278$1$I$20240802$20240805$20240809$20240809$EXP$$US-AMGEN-USASP2024155731$AMGEN$$55$YR$A$F$Y$$$20240809$$CN$US$US
241952791$24195279$1$I$$20240726$20240809$20240809$PER$$US-SMPA-2024SPA000304$SUNOVION$$$$$$Y$$$20240809$$CN$US$US
241952801$24195280$1$I$$20240214$20240809$20240809$EXP$$NVSC2023US261499$NOVARTIS$$$$$F$Y$$$20240809$$CN$US$US
241952811$24195281$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227799$TEVA$$72$YR$$F$Y$125$KG$20240809$$HP$CA$CA
241952821$24195282$1$I$$20240711$20240809$20240809$PER$$US-SMPA-2024MYSCI0700469$SUNOVION$$$$$$Y$$$20240809$$CN$US$US
241952831$24195283$1$I$$20240729$20240809$20240809$PER$$US-SMPA-2024SPA000437$SUNOVION$$$$$$Y$$$20240809$$CN$US$US
241952841$24195284$1$I$$20240801$20240809$20240809$PER$$US-SMPA-2024SPA000631$SUNOVION$$$$$$Y$$$20240809$$CN$US$US
241952851$24195285$1$I$$20240711$20240809$20240809$PER$$US-SMPA-2024MYSCI0700428$SUNOVION$$$$$$Y$$$20240809$$MD$US$US
241952861$24195286$1$I$$20240712$20240809$20240809$PER$$US-SMPA-2024MYSCI0700495$SUNOVION$$$$$$Y$$$20240809$$CN$US$US
241952871$24195287$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227801$TEVA$$57$YR$$F$Y$64$KG$20240809$$HP$CA$CA
241952881$24195288$1$I$$20240805$20240809$20240809$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24059$SAMSUNG BIOEPIS$$52$YR$A$F$Y$$$20240809$$CN$GB$GB
241952892$24195289$2$F$$20240731$20240809$20240911$PER$$US-SMPA-202407-URV-001102$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
241952901$24195290$1$I$$20240712$20240809$20240809$PER$$US-SMPA-2024MYSCI0700491$SUNOVION$$$$$$Y$$$20240809$$CN$US$US
241952911$24195291$1$I$$20240724$20240809$20240809$PER$$US-SMPA-202407-URV-001109$SUNOVION$$$$$$Y$$$20240809$$CN$US$US
241952921$24195292$1$I$$20240711$20240809$20240809$PER$$US-SMPA-2024MYSCI0700453$SUNOVION$$$$$$Y$$$20240809$$CN$US$US
241952931$24195293$1$I$$20240723$20240809$20240809$PER$$US-SMPA-2024SPA000442$SUNOVION$$$$$$Y$$$20240809$$CN$US$US
241952943$24195294$3$F$20240701$20240801$20240809$20240913$PER$$US-LUNDBECK-DKLU4002037$LUNDBECK$$$$$$Y$$$20240913$$CN$US$US
241952951$24195295$1$I$$20240729$20240809$20240809$EXP$$JP-JNJFOC-20240764232$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$MD$JP$JP
241952971$24195297$1$I$20221104$20240802$20240809$20240809$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012210$JAZZ$$58$YR$$F$Y$$$20240809$$HP$US$US
241952981$24195298$1$I$20240101$20240709$20240809$20240809$EXP$$JP-JNJFOC-20240727568$JOHNSON AND JOHNSON$$7$DEC$E$F$Y$$$20240809$$MD$JP$JP
241952991$24195299$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227807$TEVA$$83$YR$$F$Y$63$KG$20240809$$HP$CA$CA
241953001$24195300$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227841$TEVA$$82$YR$$F$Y$72$KG$20240809$$HP$CA$CA
241953013$24195301$3$F$20230403$20240822$20240809$20240829$EXP$FR-AFSSAPS-LM2024000423$FR-TAKEDA-2024TUS079517$TAKEDA$$$$A$F$Y$$$20240829$$HP$FR$FR
241953021$24195302$1$I$$20240805$20240809$20240809$PER$$US-FreseniusKabi-FK202412220$FRESENIUS KABI$$$$$$Y$$$20240809$$HP$US$US
241953031$24195303$1$I$20240805$20240805$20240809$20240809$PER$$US-FreseniusKabi-FK202412221$FRESENIUS KABI$$$$$$Y$$$20240809$$HP$US$US
241953051$24195305$1$I$20240805$20240805$20240809$20240809$EXP$$US-JNJFOC-20240816390$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240809$$MD$US$US
241953061$24195306$1$I$20230517$20240802$20240809$20240809$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012204$JAZZ$$69$YR$$M$Y$$$20240809$$HP$US$US
241953072$24195307$2$F$$20240801$20240809$20240913$PER$$US-LUNDBECK-DKLU4001290$LUNDBECK$$$$$$Y$$$20240913$$CN$US$US
241953081$24195308$1$I$20240806$20240809$20240809$20240809$DIR$713557$$FDA-CTU$$41$YR$$F$N$$$20240809$N$PH$US$
241953091$24195309$1$I$20240716$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54761$$FDA-CTU$$82$YR$$M$N$81.3$KG$20240808$N$$US$
241953101$24195310$1$I$$20240801$20240809$20240809$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122304$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240809$$HP$CA$CA
241953111$24195311$1$I$$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54780$$FDA-CTU$$$$$M$N$$$20240808$N$HP$US$
241953131$24195313$1$I$$20240809$20240809$20240809$DIR$713586$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241953141$24195314$1$I$20240510$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54764$$FDA-CTU$$77$YR$$M$N$89.36$KG$20240808$N$$US$
241953151$24195315$1$I$$20240809$20240809$20240809$DIR$713587$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241953161$24195316$1$I$20240723$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54788$$FDA-CTU$$52$YR$$M$N$$$20240808$N$PH$US$
241953171$24195317$1$I$20240801$20240809$20240809$20240809$DIR$713559$$FDA-CTU$$55$YR$$F$N$96.8$KG$20240809$N$HP$US$
241953201$24195320$1$I$20240601$20240809$20240809$20240809$DIR$713592$$FDA-CTU$$41$YR$$F$N$118$KG$20240809$N$$US$
241953231$24195323$1$I$20240803$20240806$20240809$20240809$DIR$FDA-CDER-CTU-2024-54797$$FDA-CTU$$77$YR$$F$N$$$20240806$N$HP$US$
241953241$24195324$1$I$$20240809$20240809$20240809$DIR$713593$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241953251$24195325$1$I$20240806$20240807$20240809$20240809$DIR$FDA-CDER-CTU-2024-54803$$FDA-CTU$$62$YR$$F$N$$$20240807$N$HP$US$
241953261$24195326$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191262$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241953271$24195327$1$I$$20240806$20240809$20240809$EXP$$PH-OTSUKA-2024_021918$OTSUKA$$$$$F$Y$$$20240809$$CN$PH$PH
241953281$24195328$1$I$$20240118$20240809$20240809$PER$$US-PAIPHARMA-2024-US-003306$PHARMACEUTICAL ASSOC$$$$$M$Y$$$20240809$$CN$US$US
241953291$24195329$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA232239$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240809$$CN$US$US
241953301$24195330$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA232385$SANOFI AVENTIS$$$$A$F$Y$61$KG$20240809$$MD$US$US
241953312$24195331$2$F$20240320$20240812$20240809$20240815$EXP$$FR-ANIPHARMA-2024-FR-000130$ANI$$84$YR$$M$Y$70$KG$20240815$$MD$FR$FR
241953321$24195332$1$I$20230101$20240731$20240809$20240809$EXP$DE-EMA-DD-20240730-7482715-081833$DE-BIOCON BIOLOGICS LIMITED-BBL2024005679$BIOCON$Abu Rached N, Gambichler T, Ocker L, Schultheis B, Susok L, Schmidt W et al.. Upadacitinib treatment associated with varicella zoster infection complicated by  haemophagocytic lymphohistiocytosis in a patient with severe hidradenitis  suppurativa.. Journal of the European Academy of Dermatology and Venereology.. 2024;38(2)$$$$$Y$$$20240809$$MD$DE$DE
241953351$24195335$1$I$$20240803$20240809$20240809$PER$$US-JNJFOC-20240809361$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241953361$24195336$1$I$20240418$20240730$20240809$20240809$EXP$$GR-TEVA-VS-3228538$TEVA$$68$YR$$M$Y$74.3$KG$20240809$$MD$GR$GR
241953373$24195337$3$F$20230522$20240923$20240809$20240926$EXP$$NL-SANDOZ INC.-NVSC2023NL144101$SANDOZ$$9$YR$$M$Y$$$20240926$$CN$NL$NL
241953381$24195338$1$I$$20240801$20240809$20240809$EXP$$DK-BAYER-2024A112834$BAYER$$$$$$Y$98$KG$20240809$$MD$DK$DK
241953391$24195339$1$I$20240603$20240806$20240809$20240809$EXP$$PH-OTSUKA-2024_021882$OTSUKA$$83$YR$$F$Y$$$20240809$$CN$PH$PH
241953402$24195340$2$F$$20240808$20240809$20240813$EXP$$CA-GSK-CA2023131559$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$MD$CA$CA
241953411$24195341$1$I$20240722$20240801$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122137$BRISTOL MYERS SQUIBB$$18$YR$A$M$Y$$$20240809$$HP$US$US
241953422$24195342$2$F$$20240829$20240809$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124034$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240905$$CN$US$US
241953431$24195343$1$I$$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125694$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240809$$CN$US$US
241953441$24195344$1$I$20240101$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157795$AMGEN$$59$YR$A$F$Y$$$20240809$$CN$US$US
241953451$24195345$1$I$20210601$20240606$20240809$20240809$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2022-017112$BRISTOL MYERS SQUIBB$Dai L, Jin X, Wang L, Wang H, Yan Z, Wang G, et al. Efficacy of disitamab vedotin in treating HER22+/FISH-gastric cancer. OncoTargets and Therapy. 2022 Mar 16;15:267-75. doi:10.2147/OTT.S349096.$56$YR$A$F$Y$$$20240809$$HP$CN$CN
241953461$24195346$1$I$$20240802$20240809$20240809$EXP$$CN-PFIZER INC-PV202400100959$PFIZER$Zhu, F.. Clinical characteristics and risk factors of complications after kidney transplantation in children at a single-center. Chinese Journal of Organ Transplantation. 2024;45(6):391-398$$$$$Y$$$20240809$$HP$CN$CN
241953471$24195347$1$I$$20240801$20240809$20240809$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122725$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240809$$HP$CA$CA
241953482$24195348$2$F$20240411$20240918$20240809$20240926$EXP$$US-GENMAB-2024-02708$GENMAB$$74$YR$$F$Y$$$20240926$$MD$US$US
241953491$24195349$1$I$$20240730$20240809$20240809$EXP$$TH-BAYER-2024A110686$BAYER$$69$YR$E$F$Y$$$20240809$$HP$TH$TH
241953501$24195350$1$I$20240101$20240731$20240809$20240809$PER$$US-SA-2024SA232086$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240809$$MD$US$US
241953511$24195351$1$I$20170101$20240801$20240809$20240809$PER$$US-SA-2024SA231690$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240809$$HP$US$US
241953521$24195352$1$I$20240720$20240802$20240809$20240809$PER$$US-SA-2024SA232274$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240809$$CN$US$US
241953532$24195353$2$F$20240701$20240822$20240809$20240906$PER$$US-SA-2024SA230819$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240906$$MD$US$US
241953541$24195354$1$I$20240614$20240804$20240809$20240809$EXP$$CN-SA-2024SA234568$SANOFI AVENTIS$$48$YR$A$F$Y$60$KG$20240809$$HP$CN$CN
241953551$24195355$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA232395$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240809$$MD$US$US
241953562$24195356$2$F$20240805$20240805$20240809$20240814$PER$$US-SA-2024SA232495$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240814$$CN$US$US
241953571$24195357$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA230785$SANOFI AVENTIS$$$$$$Y$$$20240809$$CN$US$US
241953582$24195358$2$F$20080101$20240809$20240809$20240815$EXP$FR-AFSSAPS-TS2024000881$FR-OTSUKA-2024_021753$OTSUKA$$42$YR$$M$Y$97$KG$20240815$$CN$FR$FR
241953592$24195359$2$F$20240101$20240827$20240809$20240911$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00353$Alora Pharma$$$$$F$Y$56.689$KG$20240911$$CN$US$US
241953601$24195360$1$I$$20240807$20240809$20240809$PER$$US-JNJFOC-20240818436$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$MD$US$US
241953621$24195362$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125433$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$97.07$KG$20240809$$HP$US$US
241953631$24195363$1$I$20240801$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125828$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240809$$HP$US$US
241953641$24195364$1$I$20240101$20240725$20240809$20240809$PER$$US-JNJFOC-20240782816$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241953651$24195365$1$I$$20240731$20240809$20240809$EXP$$US-BAYER-2024A104929$BAYER$$81$YR$E$M$Y$$$20240809$$CN$US$US
241953661$24195366$1$I$$20240729$20240809$20240809$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07591$LUPIN$$$$$$Y$$$20240809$$CN$AU$AU
241953671$24195367$1$I$$20240731$20240809$20240809$EXP$$PE-BIOVITRUM-2024-PE-010733$BIOVITRUM$$$$$F$Y$$$20240809$$MD$PE$PE
241953681$24195368$1$I$$20240729$20240809$20240809$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202407017486$ELI LILLY AND CO$$16$YR$T$F$Y$$$20240809$$CN$AU$AU
241953691$24195369$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54817$$FDA-CTU$$60$YR$$F$N$$$20240809$N$$US$
241953701$24195370$1$I$$20240809$20240809$20240809$DIR$713596$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241953711$24195371$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003905$ELI LILLY AND CO$$37$YR$A$$Y$$$20240809$$LW$US$US
241953722$24195372$2$F$20240807$20240812$20240809$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408004709$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240816$$CN$US$US
241953731$24195373$1$I$$20240729$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202407019951$ELI LILLY AND CO$$44$YR$A$$Y$$$20240809$$LW$US$US
241953741$24195374$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004144$ELI LILLY AND CO$$55$YR$A$$Y$$$20240809$$LW$US$US
241953751$24195375$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004980$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241953771$24195377$1$I$$20240729$20240809$20240809$DIR$FDA-CDER-CTU-2024-54790$$FDA-CTU$$$$$F$N$$$20240729$N$HP$US$
241953781$24195378$1$I$$20240801$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408001253$ELI LILLY AND CO$$29$YR$A$$Y$$$20240809$$LW$US$US
241953791$24195379$1$I$$20240808$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005818$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241953801$24195380$1$I$$20240801$20240809$20240809$EXP$$JP-ROCHE-10000052180$ROCHE$$8$DEC$E$F$Y$$$20240809$$MD$JP$JP
241953811$24195381$1$I$$20240808$20240809$20240809$EXP$$SK-SANDOZ INC.-NVSC2020SK313313$SANDOZ$$44$YR$$M$Y$145$KG$20240809$$MD$SK$SK
241953821$24195382$1$I$$20240807$20240809$20240809$EXP$$JP-ABBVIE-5872340$ABBVIE$$$$$$Y$$$20240809$$MD$JP$JP
241953841$24195384$1$I$20240701$20240802$20240809$20240809$EXP$$JP-ROCHE-10000052349$ROCHE$$71$YR$E$M$Y$$$20240809$$MD$JP$JP
241953851$24195385$1$I$20240101$20240806$20240809$20240809$EXP$$JP-OTSUKA-2024_021699$OTSUKA$$6$DEC$$M$Y$$$20240809$$MD$JP$JP
241953861$24195386$1$I$$20240807$20240809$20240809$EXP$$CA-TAKEDA-2024TUS079675$TAKEDA$$$$$F$Y$$$20240809$$CN$CA$CA
241953874$24195387$4$F$20240731$20240822$20240809$20240828$EXP$$AT-TAKEDA-2024TUS078981$TAKEDA$$66$YR$$M$Y$$$20240828$$CN$AT$AT
241953881$24195388$1$I$$20240806$20240809$20240809$EXP$$NL-AUROBINDO-AUR-APL-2024-039669$AUROBINDO$$69$YR$$M$Y$$$20240809$$MD$NL$NL
241953891$24195389$1$I$20230707$20240803$20240809$20240809$PER$$US-GILEAD-2024-0682836$GILEAD$$28$YR$A$M$Y$$$20240809$$CN$US$US
241953901$24195390$1$I$$20240806$20240809$20240809$EXP$$JP-OTSUKA-2024_018599$OTSUKA$$$$E$M$Y$$$20240809$$PH$JP$JP
241953912$24195391$2$F$$20240916$20240809$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125727$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240918$$CN$US$US
241953921$24195392$1$I$$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125800$BRISTOL MYERS SQUIBB$$80$YR$E$$Y$$$20240809$$CN$US$US
241953931$24195393$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125605$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240809$$HP$US$US
241953943$24195394$3$F$20240528$20240816$20240809$20240819$EXP$PT-INFARMED-J202408-71$PT-BIOVITRUM-2024-PT-010752$BIOVITRUM$$24$YR$$F$Y$$$20240819$$PH$PT$PT
241953951$24195395$1$I$20240730$20240801$20240809$20240809$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00663$PARATEK PHARMACEUTICALS$$89$YR$$M$Y$75$KG$20240809$$HP$CN$CN
241953961$24195396$1$I$20240725$20240803$20240809$20240809$EXP$IT-MINISAL02-997534$IT-GE HEALTHCARE-2024CSU008939$GE HEALTHCARE$$74$YR$$M$Y$$$20240809$$HP$IT$IT
241953981$24195398$1$I$20240722$20240803$20240809$20240809$EXP$FR-AFSSAPS-MA2024001300$FR-GE HEALTHCARE-2024CSU008940$GE HEALTHCARE$$79$YR$$M$Y$58.6$KG$20240809$$HP$FR$FR
241953991$24195399$1$I$$20240807$20240809$20240809$EXP$$CA-TAKEDA-2024TUS058667$TAKEDA$$$$$F$Y$$$20240809$$CN$CA$CA
241954001$24195400$1$I$20240622$20240805$20240809$20240809$EXP$$GB-MYLANLABS-2024M1072867$MYLAN$$74$YR$$M$Y$$$20240809$$HP$GB$GB
241954011$24195401$1$I$$20240619$20240809$20240809$PER$$US-LUNDBECK-DKLU4000793$LUNDBECK$$$$$$Y$$$20240809$$HP$US$US
241954021$24195402$1$I$$20240731$20240809$20240809$PER$$US-EMD Serono-2024041611$EMD SERONO INC$$50$YR$A$M$Y$$$20240809$$CN$US$US
241954031$24195403$1$I$$20240807$20240809$20240809$EXP$GB-MHRA-30702762$GB-SANDOZ INC.-SDZ2024GB071406$SANDOZ$$78$YR$$F$Y$57$KG$20240809$$CN$GB$GB
241954051$24195405$1$I$20240725$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54836$$FDA-CTU$$84$YR$$M$N$90.2$KG$20240809$N$PH$US$
241954061$24195406$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54793$$FDA-CTU$$54$YR$$F$N$106.14$KG$20240809$N$$US$
241954071$24195407$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54875$$FDA-CTU$$77$YR$$M$N$72.57$KG$20240809$N$$US$
241954081$24195408$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54854$$FDA-CTU$$76$YR$$F$N$63.5$KG$20240809$N$$US$
241954091$24195409$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54798$$FDA-CTU$$40$YR$$F$N$$$20240809$N$$US$
241954111$24195411$1$I$20240806$20240806$20240809$20240809$EXP$$US-AstraZeneca-2024A178522$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
241954122$24195412$2$F$20240124$20240902$20240809$20240909$EXP$$CA-GSK-CA2024012306$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$HP$CA$CA
241954131$24195413$1$I$$20240802$20240809$20240809$PER$$US-ALXN-202408USA000177US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241954141$24195414$1$I$20240723$20240807$20240809$20240809$EXP$GB-MHRA-MED-202408071606547360-YTDNH$GB-MYLANLABS-2024M1073925$MYLAN$$$$$M$Y$$$20240809$$PH$GB$GB
241954151$24195415$1$I$$20240730$20240809$20240809$PER$$US-ABBVIE-5864267$ABBVIE$$$$$M$Y$$$20240809$$MD$US$US
241954161$24195416$1$I$20220419$20220512$20240809$20240809$EXP$$CO-BIOVITRUM-2022CO06942$BIOVITRUM$$215$DY$$F$Y$6$KG$20240809$$CN$CO$CO
241954171$24195417$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227833$TEVA$$$$$$Y$$$20240809$$HP$CA$CA
241954181$24195418$1$I$$20240802$20240809$20240809$EXP$$BR-JNJFOC-20240811498$JOHNSON AND JOHNSON$$58$YR$A$F$Y$85$KG$20240809$$CN$BR$BR
241954191$24195419$1$I$20240201$20240801$20240809$20240809$EXP$SE-SEMPA-2024-001497$SE-TEVA-VS-3229304$TEVA$$81$YR$$F$Y$$$20240809$$PH$SE$SE
241954201$24195420$1$I$$20220308$20240809$20240809$EXP$$NL-BIOVITRUM-2022NL03853$BIOVITRUM$$$$I$M$Y$9.7$KG$20240809$$HP$NL$NL
241954211$24195421$1$I$20240808$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54828$$FDA-CTU$$75$YR$$M$N$79.83$KG$20240809$N$$US$
241954221$24195422$1$I$20240719$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54829$$FDA-CTU$$62$YR$$F$N$$$20240809$N$$US$
241954232$24195423$2$F$$20240823$20240809$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07041$LUPIN$$$$E$M$Y$$$20240912$$PH$US$US
241954241$24195424$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-PV202300159230$PFIZER$$66$YR$$F$Y$$$20240809$$MD$US$US
241954251$24195425$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54806$$FDA-CTU$$57$YR$$M$N$68.04$KG$20240809$N$$US$
241954261$24195426$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54805$$FDA-CTU$$56$YR$$F$N$109.32$KG$20240809$N$$US$
241954271$24195427$1$I$20240801$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54848$$FDA-CTU$$77$YR$$F$N$$$20240809$N$HP$US$
241954281$24195428$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54850$$FDA-CTU$$39$YR$$F$N$$$20240809$N$$US$
241954301$24195430$1$I$20240731$20240807$20240809$20240809$PER$$US-PFIZER INC-202400233167$PFIZER$$47$YR$$M$Y$$$20240809$$HP$US$US
241954311$24195431$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232872$PFIZER$$$$A$M$Y$$$20240809$$MD$US$US
241954322$24195432$2$F$$20240808$20240809$20240812$PER$$US-PFIZER INC-202400232139$PFIZER$$$$$F$Y$$$20240812$$CN$US$US
241954331$24195433$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-PV202400103529$PFIZER$$$$$$Y$$$20240809$$MD$US$US
241954341$24195434$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-202400233004$PFIZER$$$$$F$Y$$$20240809$$CN$US$US
241954361$24195436$1$I$20240804$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232509$PFIZER$$45$YR$$F$Y$$$20240809$$CN$US$US
241954371$24195437$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-202400233462$PFIZER$$54$YR$$F$Y$$$20240809$$HP$US$US
241954382$24195438$2$F$20240805$20240807$20240809$20240812$PER$$US-PFIZER INC-202400232432$PFIZER$$65$YR$$F$Y$53.52$KG$20240812$$CN$US$US
241954391$24195439$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-202400233150$PFIZER$$68$YR$$F$Y$$$20240809$$HP$US$US
241954401$24195440$1$I$20240101$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232173$PFIZER$$60$YR$$F$Y$$$20240809$$HP$US$US
241954411$24195441$1$I$20240726$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232240$PFIZER$$77$YR$$F$Y$$$20240809$$CN$US$US
241954421$24195442$1$I$20240802$20240807$20240809$20240809$PER$$US-PFIZER INC-PV202400103288$PFIZER$$67$YR$$F$Y$$$20240809$$PH$US$US
241954431$24195443$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232964$PFIZER$$51$YR$$F$Y$$$20240809$$HP$US$US
241954441$24195444$1$I$20240728$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232571$PFIZER$$52$YR$$F$Y$$$20240809$$MD$US$US
241954451$24195445$1$I$20231201$20240807$20240809$20240809$PER$$US-PFIZER INC-202400233145$PFIZER$$67$YR$$F$Y$$$20240809$$HP$US$US
241954461$24195446$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-202400233151$PFIZER$$63$YR$$M$Y$$$20240809$$HP$US$US
241954471$24195447$1$I$20240802$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232243$PFIZER$$57$YR$$F$Y$$$20240809$$CN$US$US
241954491$24195449$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-PV202400103164$PFIZER$$37$YR$$M$Y$$$20240809$$HP$US$US
241954501$24195450$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232407$PFIZER$$78$YR$$F$Y$73.1$KG$20240809$$HP$US$US
241954511$24195451$1$I$$20240807$20240809$20240809$PER$$JP-PFIZER INC-202400231550$PFIZER$$$$$$Y$$$20240809$$PH$JP$JP
241954523$24195452$3$F$$20240826$20240809$20240829$PER$$US-PFIZER INC-202400232732$PFIZER$$87$YR$$F$Y$$$20240829$$CN$US$US
241954541$24195454$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232156$PFIZER$$68$YR$$F$Y$$$20240809$$HP$US$US
241954551$24195455$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232481$PFIZER$$$$$$Y$$$20240809$$HP$US$US
241954561$24195456$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232388$PFIZER$$$$$$Y$$$20240809$$CN$US$US
241954571$24195457$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232382$PFIZER$$39$YR$$M$Y$$$20240809$$HP$US$US
241954581$24195458$1$I$20240807$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232367$PFIZER$$30$YR$$F$Y$$$20240809$$CN$US$US
241954591$24195459$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-2021261542$PFIZER$$71$YR$$F$Y$$$20240809$$MD$US$US
241954611$24195461$1$I$20240731$20240807$20240809$20240809$PER$$US-009507513-2408USA002457$MERCK$$67$YR$$M$Y$$$20240809$$CN$US$US
241954621$24195462$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA233990$SANOFI AVENTIS$$$$$$Y$$$20240809$$MD$US$US
241954631$24195463$1$I$20240730$20240806$20240809$20240809$PER$$US-SA-2024SA235556$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240809$$CN$US$US
241954641$24195464$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232323$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240809$$MD$US$US
241954652$24195465$2$F$$20240807$20240809$20240809$EXP$$US-GILEAD-2024-0683397$GILEAD$$60$YR$A$M$Y$$$20240809$$CN$US$US
241954661$24195466$1$I$20240719$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157441$AMGEN$$$$$$Y$$$20240809$$HP$US$US
241954671$24195467$1$I$$20240802$20240809$20240809$EXP$$CA-TAKEDA-2024TUS078827$TAKEDA$$$$$M$Y$$$20240809$$MD$CA$CA
241954681$24195468$1$I$20240629$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125826$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240809$$CN$US$US
241954691$24195469$1$I$$20240802$20240809$20240809$EXP$$CA-AstraZeneca-2024A175937$ASTRAZENECA$$$$$M$Y$110.7$KG$20240809$$CN$CA$
241954701$24195470$1$I$$20240715$20240809$20240809$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07212$LUPIN$$$$$$Y$$$20240809$$CN$US$US
241954711$24195471$1$I$$20240806$20240809$20240809$EXP$$US-AstraZeneca-2024A178527$ASTRAZENECA$$$$$F$Y$$$20240809$$MD$US$
241954721$24195472$1$I$$20240630$20240809$20240809$EXP$$JP-AstraZeneca-2024A180448$ASTRAZENECA$Matsui R. et al.. P-210 Experience with the use of dapagliflozin for treatments other than diabetes mellitus treatment at our hospital. The Japanese Journal of Nephrology 2024;66(4):664-.$$$$$Y$$$20240809$$MD$JP$
241954731$24195473$1$I$$20240803$20240809$20240809$EXP$$US-AstraZeneca-2024A178193$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241954741$24195474$1$I$20240611$20240726$20240809$20240809$EXP$$CN-ROCHE-10000038170$ROCHE$$69$YR$E$M$Y$$$20240809$$HP$CN$CN
241954751$24195475$1$I$$20240807$20240809$20240809$EXP$$US-OTSUKA-2024_021902$OTSUKA$$$$$$Y$$$20240809$$HP$US$US
241954761$24195476$1$I$$20240802$20240809$20240809$EXP$$AU-AstraZeneca-2024A181302$ASTRAZENECA$Kamsani S, Middeldorp M, Chiang G, Stefil M, Evans S, Nguyen M, et al.. Safety of outpatient commencement of sotalol.. Heart rhythm O2 2024;5(6):341-350..$78$YR$$F$Y$$$20240809$$MD$AU$
241954771$24195477$1$I$20240802$20240807$20240809$20240809$PER$$US-JNJFOC-20240818609$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240809$$HP$US$US
241954781$24195478$1$I$$20240802$20240809$20240809$EXP$$ZA-AstraZeneca-2024A177629$ASTRAZENECA$$66$YR$$F$Y$$$20240809$$CN$ZA$
241954791$24195479$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A176860$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241954801$24195480$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A176843$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
241954811$24195481$1$I$20240615$20240729$20240809$20240809$EXP$$GB-BAXTER-2024BAX020393$BAXTER$$49$YR$$F$Y$56$KG$20240809$$HP$GB$GB
241954821$24195482$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA231542$SANOFI AVENTIS$$$$A$M$Y$68$KG$20240809$$MD$US$US
241954831$24195483$1$I$$20240729$20240809$20240809$EXP$$GB-BAXTER-2024BAX022482$BAXTER$$$$$M$Y$$$20240809$$HP$GB$GB
241954851$24195485$1$I$20240601$20240807$20240809$20240809$PER$$US-ABBVIE-5871920$ABBVIE$$55$YR$$F$Y$$$20240809$$MD$US$US
241954861$24195486$1$I$20240101$20240802$20240809$20240809$PER$$US-SA-2024SA231830$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240809$$MD$US$US
241954871$24195487$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA231642$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240809$$MD$US$US
241954882$24195488$2$F$20240729$20240807$20240809$20240814$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-123469$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$74$KG$20240814$$HP$DE$DE
241954891$24195489$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA231661$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240809$$MD$US$US
241954901$24195490$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA231484$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240809$$MD$US$US
241954911$24195491$1$I$$20240809$20240809$20240809$DIR$713589$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241954922$24195492$2$F$20230402$20240823$20240809$20240902$EXP$$US-BAXTER-2024BAX022544$BAXTER$$60$YR$$M$Y$95.5$KG$20240902$$HP$US$US
241954931$24195493$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54801$$FDA-CTU$$54$YR$$F$N$71.67$KG$20240809$N$HP$US$
241954941$24195494$1$I$$20240809$20240809$20240809$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044776$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240809$$CN$US$US
241954961$24195496$1$I$20240805$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54811$$FDA-CTU$$67$YR$$F$N$79.38$KG$20240809$N$MD$US$
241954981$24195498$1$I$20230715$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54787$$FDA-CTU$$44$YR$$F$N$$$20240808$N$HP$US$
241954991$24195499$1$I$20240730$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54882$$FDA-CTU$$74$YR$$F$N$$$20240809$N$HP$US$
241955001$24195500$1$I$$20240809$20240809$20240809$DIR$713588$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241955011$24195501$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54880$$FDA-CTU$$52$YR$$F$N$99.79$KG$20240809$N$HP$US$
241955021$24195502$1$I$$20240809$20240809$20240809$DIR$713597$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241955031$24195503$1$I$20240708$20240801$20240809$20240809$EXP$$US-Eisai-EC-2024-171389$EISAI$$79$YR$E$F$Y$$$20240809$$CN$US$US
241955041$24195504$1$I$20240719$20240807$20240809$20240809$PER$$IN-Eisai-EC-2024-171765$EISAI$$60$YR$A$F$Y$$$20240809$$CN$IN$IN
241955051$24195505$1$I$20240701$20240802$20240809$20240809$EXP$$US-Eisai-EC-2024-171489$EISAI$$67$YR$E$M$Y$100$KG$20240809$$CN$US$US
241955061$24195506$1$I$20240701$20240806$20240809$20240809$DIR$FDA-CDER-CTU-2024-54881$$FDA-CTU$$63$YR$$F$N$$$20240806$N$HP$US$
241955072$24195507$2$F$20240101$20240804$20240809$20240815$EXP$$DE-ABBVIE-5869605$ABBVIE$$$$$F$Y$$$20240815$$CN$DE$DE
241955081$24195508$1$I$$20240728$20240809$20240809$EXP$$US-Accord-440447$ACCORD$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$1$HR$N$M$Y$$$20240809$$MD$US$US
241955091$24195509$1$I$20240726$20240730$20240809$20240809$EXP$$US-Accord-439616$ACCORD$$57$YR$A$F$Y$$$20240809$$HP$US$US
241955101$24195510$1$I$$20240729$20240809$20240809$EXP$CA-MHPD-E2B_07143503$CA-Accord-439174$ACCORD$$15$YR$T$F$Y$$$20240809$$HP$CA$CA
241955111$24195511$1$I$$20240728$20240809$20240809$EXP$$US-Accord-440446$ACCORD$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$$$$F$Y$$$20240809$$MD$US$US
241955121$24195512$1$I$$20240730$20240809$20240809$EXP$$CA-ABBVIE-5867529$ABBVIE$$$$E$M$Y$$$20240809$$CN$CA$CA
241955132$24195513$2$F$$20240819$20240809$20240822$EXP$$CA-JNJFOC-20240808415$JOHNSON AND JOHNSON$$33$YR$A$F$Y$150.59$KG$20240822$$HP$CA$CA
241955141$24195514$1$I$$20240725$20240809$20240809$PER$$US-IMPEL PHARMACEUTICALS, LLC-2024-SPO-TR-0433$IMPEL NEUROPHARMA$$$$$$Y$$$20240809$$PH$US$US
241955151$24195515$1$I$20240101$20240725$20240809$20240809$PER$$US-IMPEL PHARMACEUTICALS, LLC-2024-SPO-TR-0432$IMPEL NEUROPHARMA$$$$$$Y$$$20240809$$PH$US$US
241955161$24195516$1$I$$20240711$20240809$20240809$PER$$US-IMPEL PHARMACEUTICALS, LLC-2024-SPO-TR-0430$IMPEL NEUROPHARMA$$$$$$Y$$$20240809$$PH$US$US
241955172$24195517$2$F$20240101$20240814$20240809$20240823$EXP$$CA-UCBSA-2024017707$UCB$$$$$F$Y$$$20240823$$CN$CA$CA
241955181$24195518$1$I$$20240806$20240809$20240809$PER$$US-GILEAD-2024-0683197$GILEAD$$56$YR$A$M$Y$$$20240809$$PH$US$US
241955191$24195519$1$I$$20240805$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003799$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240809$$CN$US$US
241955202$24195520$2$F$$20240929$20240809$20240930$EXP$$US-PFIZER INC-202400230830$PFIZER$$70$YR$$M$Y$$$20240930$$CN$US$US
241955212$24195521$2$F$$20240918$20240809$20240920$30DAY$$CO-PFIZER INC-202400228306$PFIZER$$11$YR$$M$Y$$$20240920$$CN$CO$CO
241955222$24195522$2$F$20240801$20240827$20240809$20240830$EXP$$PR-ABBVIE-5869495$ABBVIE$$69$YR$$F$Y$$$20240830$$CN$PR$PR
241955232$24195523$2$F$$20240905$20240809$20240909$30DAY$$SI-PFIZER INC-PV202400103390$PFIZER$$$$$$Y$$$20240909$$HP$SI$SI
241955244$24195524$4$F$20240813$20240924$20240809$20240930$30DAY$$CR-PFIZER INC-PV202400098647$PFIZER$$17$YR$$M$Y$$$20240930$$MD$CR$CR
241955251$24195525$1$I$20240226$20240313$20240809$20240809$PER$$US-PAIPHARMA-2024-US-015617$PHARMACEUTICAL ASSOC$$66$YR$$F$Y$$$20240809$$CN$US$US
241955263$24195526$3$F$20200217$20240823$20240809$20240830$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007317$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240830$$MD$DE$DE
241955281$24195528$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5870588$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241955292$24195529$2$F$20240601$20240904$20240809$20240910$EXP$$US-ABBVIE-5867451$ABBVIE$$61$YR$$M$Y$$$20240910$$CN$US$US
241955303$24195530$3$F$$20240814$20240809$20240814$EXP$$GB-JNJFOC-20240809000$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20240814$$CN$GB$GB
241955312$24195531$2$F$$20240802$20240809$20240820$EXP$$CA-AstraZeneca-2024A171946$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$CA$
241955322$24195532$2$F$$20240809$20240809$20240816$EXP$$AU-AstraZeneca-2024A181215$ASTRAZENECA$Dhaliwal N, Roberts D.. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study.. Clinical Toxicology 2024;62(3):168-173.$$$$$Y$$$20240816$$HP$AU$
241955331$24195533$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A170246$ASTRAZENECA$$$$$F$Y$$$20240809$$HP$US$
241955341$24195534$1$I$$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A175973$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241955351$24195535$1$I$20240101$20240807$20240809$20240809$PER$$US-ABBVIE-5871731$ABBVIE$$14$YR$$F$Y$$$20240809$$HP$US$US
241955361$24195536$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A176919$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
241955371$24195537$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A176984$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241955381$24195538$1$I$20240801$20240802$20240809$20240809$EXP$$PH-AstraZeneca-2024A176245$ASTRAZENECA$$$$$M$Y$$$20240809$$MD$PH$
241955391$24195539$1$I$20240728$20240801$20240809$20240809$EXP$$US-AstraZeneca-2024A178063$ASTRAZENECA$$21896$DY$$F$Y$$$20240809$$CN$US$
241955401$24195540$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A176133$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241955411$24195541$1$I$$20240809$20240809$20240809$DIR$713594$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241955421$24195542$1$I$$20240809$20240809$20240809$DIR$713602$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241955431$24195543$1$I$$20240807$20240809$20240809$EXP$$US-AstraZeneca-2024A181596$ASTRAZENECA$Thomas, Anisha M.; Lu, Angela C.; Lin, Kyaw, D.O.. Tramadol for Pain Management Associated with Serotonin Syndrome. National Conference on Pain for Frontline Practitioners - Pain Week 2024;$63$YR$$M$Y$$$20240809$$HP$US$
241955441$24195544$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5871021$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241955452$24195545$2$F$20240101$20240917$20240809$20240923$EXP$$JP-AMGEN-JPNSP2024155725$AMGEN$$$$$$Y$$$20240923$$PH$JP$JP
241955461$24195546$1$I$$20240809$20240809$20240809$DIR$713603$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241955471$24195547$1$I$$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54827$$FDA-CTU$$77$YR$$F$N$$$20240808$N$$US$
241955481$24195548$1$I$$20240806$20240809$20240809$DIR$FDA-CDER-CTU-2024-54831$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
241955492$24195549$2$F$$20240807$20240809$20240813$PER$$US-AMGEN-USASP2024157110$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
241955501$24195550$1$I$$20240802$20240809$20240809$EXP$$CA-ABBVIE-5871436$ABBVIE$$$$E$M$Y$$$20240809$$CN$CA$CA
241955511$24195551$1$I$$20240729$20240809$20240809$EXP$$US-RDY-LIT/USA/24/0011399$DR REDDYS$On S, Domingo W, Cheung E, Johnston L. Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen with Methotrexate-Based GvHD Prophylaxis. Blood. 2023 Nov 02;142: doi:10.1182/blood-2023-182983.$$$$$Y$$$20240809$$HP$US$US
241955521$24195552$1$I$$20240731$20240809$20240809$PER$$TW-Eisai-EC-2024-171331$EISAI$$49$YR$A$M$Y$$$20240809$$MD$TW$TW
241955531$24195553$1$I$20240520$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125516$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240809$$CN$US$US
241955541$24195554$1$I$$20240809$20240809$20240809$DIR$713595$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241955551$24195555$1$I$$20240809$20240809$20240809$DIR$713605$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241955561$24195556$1$I$$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54845$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
241955571$24195557$1$I$$20240808$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125856$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240809$$HP$US$US
241955581$24195558$1$I$$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125492$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240809$$CN$US$US
241955591$24195559$1$I$$20240731$20240809$20240809$PER$$US-GILEAD-2024-0682943$GILEAD$$85$YR$E$F$Y$$$20240809$$MD$US$US
241955601$24195560$1$I$$20240809$20240809$20240809$DIR$713607$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241955641$24195564$1$I$20240809$20240809$20240809$20240809$DIR$713571$$FDA-CTU$$13$MON$$M$N$9.45$KG$20240809$N$CN$US$
241955651$24195565$1$I$$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54823$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
241955661$24195566$1$I$$20240805$20240809$20240809$DIR$FDA-CDER-CTU-2024-54886$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
241955671$24195567$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54865$$FDA-CTU$$35$YR$$M$N$70.31$KG$20240809$N$HP$US$
241955681$24195568$1$I$20230101$20240806$20240809$20240809$EXP$$JP-OTSUKA-2024_021737$OTSUKA$Nakamura N, Mizumoto C, Sugimoto A, Fujimoto M, Ayaki T, Takaori-kondo A. Severe consciousness disturbance after cord blood transplantation for relapsed T lymphoblastic lymphoma. The Japanese journal of clinical hematology. 2024;65(1):47-51$50$YR$$M$Y$$$20240809$$MD$JP$JP
241955692$24195569$2$F$$20240809$20240809$20240812$PER$$NVSC2024US162302$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
241955702$24195570$2$F$$20240806$20240809$20240813$EXP$$BE-JNJFOC-20240810124$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$BE$BE
241955711$24195571$1$I$20240101$20240802$20240809$20240809$EXP$$AU-AMGEN-AUSSP2024121663$AMGEN$$$$$F$Y$$$20240809$$CN$AU$AU
241955722$24195572$2$F$20230101$20240805$20240809$20240813$PER$$US-AMGEN-USASP2024156061$AMGEN$$84$YR$E$F$Y$$$20240813$$CN$US$US
241955731$24195573$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA233943$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240809$$MD$US$US
241955741$24195574$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA230709$SANOFI AVENTIS$$$$C$F$Y$$$20240809$$MD$US$US
241955751$24195575$1$I$20230101$20240731$20240809$20240809$EXP$$US-TEVA-VS-3230141$TEVA$$21$YR$$F$Y$$$20240809$$HP$US$US
241955761$24195576$1$I$20230903$20240808$20240809$20240809$EXP$FR-AFSSAPS-LY2023001486$FR-ROCHE-3436583$ROCHE$$34$YR$A$F$Y$$$20240809$$MD$FR$FR
241955771$24195577$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA234345$SANOFI AVENTIS$$$$C$M$Y$$$20240809$$MD$US$US
241955781$24195578$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232692$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241955803$24195580$3$F$$20240828$20240809$20240901$EXP$$US-ABBVIE-5871897$ABBVIE$$$$$F$Y$$$20240901$$CN$US$US
241955811$24195581$1$I$20240101$20240806$20240809$20240809$EXP$$CA-ABBVIE-5871507$ABBVIE$$$$E$M$Y$$$20240809$$CN$CA$CA
241955821$24195582$1$I$20240201$20240728$20240809$20240809$PER$$US-JNJFOC-20240823044$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240809$$CN$US$US
241955832$24195583$2$F$20230805$20240807$20240809$20240814$EXP$$NVSC2024RU160613$NOVARTIS$$0$YR$$F$Y$7.7$KG$20240814$$CN$RU$RU
241955841$24195584$1$I$$20240808$20240809$20240809$EXP$$NVSC2021IT178368$NOVARTIS$Giaimo M, Prezioso L, Rinaldi A, Falcioni F, Palma BD, Cambo B et al. EBV colitis post hematopoietic stem cell transplantation in patient with aplastic anemia. BONE MARROW TRANSPLANTATION. 2021;56:250-1$46$YR$$M$Y$$$20240809$$HP$IT$IT
241955861$24195586$1$I$20240801$20240805$20240809$20240809$EXP$$KR-MALLINCKRODT-MNK202405006$MALLINCKRODT$$0$YR$N$$Y$0.63$KG$20240809$$HP$KR$KR
241955872$24195587$2$F$20240107$20240819$20240809$20240827$EXP$$JP-MALLINCKRODT-MNK202405005$MALLINCKRODT$$50$YR$A$$Y$$$20240827$$HP$JP$JP
241955881$24195588$1$I$$20240807$20240809$20240809$EXP$$GB-MYLANLABS-2024M1039288$MYLAN$$$$$M$Y$$$20240809$$PH$GB$GB
241955901$24195590$1$I$$20240401$20240809$20240809$PER$$US-PAIPHARMA-2024-US-019242$PHARMACEUTICAL ASSOC$$$$$F$Y$$$20240809$$CN$US$US
241955911$24195591$1$I$$20240514$20240809$20240809$PER$$US-PAIPHARMA-2024-US-028076$PHARMACEUTICAL ASSOC$$$$$F$Y$$$20240809$$CN$US$US
241955921$24195592$1$I$$20240528$20240809$20240809$PER$$US-PAIPHARMA-2024-US-030515$PHARMACEUTICAL ASSOC$$$$$UNK$Y$$$20240809$$CN$US$US
241955931$24195593$1$I$20230103$20240801$20240809$20240809$EXP$$DE-BIOCON BIOLOGICS LIMITED-BBL2024005775$BIOCON$$$$$$Y$$$20240809$$HP$DE$DE
241955941$24195594$1$I$20240801$20240807$20240809$20240809$DIR$FDA-CDER-CTU-2024-54891$$FDA-CTU$$$$$F$N$$$20240807$N$HP$US$
241955971$24195597$1$I$20230101$20240731$20240809$20240809$EXP$$JP-TAKEDA-2024TUS079506$TAKEDA$$26$YR$$F$Y$$$20240809$$MD$JP$JP
241955981$24195598$1$I$$20240808$20240809$20240809$PER$$NVSC2024US162555$NOVARTIS$$$$$$Y$$$20240809$$MD$US$US
241955991$24195599$1$I$20240803$20240805$20240809$20240809$EXP$$NVSC2024IN161870$NOVARTIS$$71$YR$$M$Y$$$20240809$$CN$IN$IN
241956011$24195601$1$I$20240619$20240809$20240809$20240809$DIR$713609$$FDA-CTU$$48$YR$$F$N$131.4$KG$20240809$N$HP$US$
241956021$24195602$1$I$$20240809$20240809$20240809$DIR$713604$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241956031$24195603$1$I$20240201$20240731$20240809$20240809$EXP$FR-AFSSAPS-PO2024000805$FR-TEVA-VS-3228939$TEVA$$26$YR$$F$Y$$$20240809$$MD$FR$FR
241956041$24195604$1$I$20240101$20240805$20240809$20240809$EXP$$US-ABBVIE-5869773$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241956051$24195605$1$I$$20240729$20240809$20240809$EXP$$DE-RDY-LIT/DEU/24/0011355$DR REDDYS$Hoeltzenbein M, Slimi S, Fietz A, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023 Apr;107: 107-113. doi:10.1016/j.seizure.2023.02.015.$4$DY$N$$Y$$$20240809$$HP$DE$DE
241956062$24195606$2$F$$20240822$20240809$20240828$EXP$NL-LRB-00993461$NL-MYLANLABS-2024M1072975$MYLAN$$69$YR$$F$Y$44$KG$20240828$$MD$NL$NL
241956071$24195607$1$I$$20240730$20240809$20240809$PER$$US-JNJFOC-20240824011$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241956081$24195608$1$I$20220801$20240801$20240809$20240809$EXP$$US-JNJFOC-20240803807$JOHNSON AND JOHNSON$$63$YR$$F$Y$$$20240809$$MD$US$US
241956091$24195609$1$I$20240730$20240730$20240809$20240809$PER$$US-JNJFOC-20240823769$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240809$$HP$US$US
241956111$24195611$1$I$20240101$20240807$20240809$20240809$PER$$US-JNJFOC-20240818397$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$CN$US$US
241956131$24195613$1$I$20240801$20240801$20240809$20240809$EXP$$US-JNJFOC-20240823130$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$HP$US$US
241956141$24195614$1$I$$20240806$20240809$20240809$EXP$$VN-AstraZeneca-2024A180755$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$VN$
241956151$24195615$1$I$20240101$20240730$20240809$20240809$EXP$$US-TEVA-VS-3229249$TEVA$$$$A$F$Y$$$20240809$$HP$US$US
241956161$24195616$1$I$20240730$20240803$20240809$20240809$EXP$$FR-AstraZeneca-2024A178626$ASTRAZENECA$$74$YR$$M$Y$$$20240809$$CN$FR$
241956171$24195617$1$I$$20240803$20240809$20240809$EXP$$ES-AstraZeneca-2024A177831$ASTRAZENECA$Villanueva I., C?vico J., Lled? G.M., Matas A., Aldecoa I., Milisenda J., Espinosa G.. Systemic sclerosis and inflammatory myopathy after treatment with durvalumab in a patient with rectal neoplasm. Clinical and Experimental Rheumatology 2024;$74$YR$$M$Y$$$20240809$$MD$ES$
241956181$24195618$1$I$$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024157020$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241956191$24195619$1$I$20240701$20240716$20240809$20240809$PER$$US-AMGEN-USASP2024157638$AMGEN$$54$YR$A$F$Y$$$20240809$$CN$US$US
241956201$24195620$1$I$$20240803$20240809$20240809$PER$$US-AMGEN-USASP2024157570$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241956211$24195621$1$I$20240411$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A176522$ASTRAZENECA$$22660$DY$$F$Y$49.9$KG$20240809$$HP$US$
241956221$24195622$1$I$20240201$20240731$20240809$20240809$EXP$$DE-AstraZeneca-2024A180478$ASTRAZENECA$$1$DY$$M$Y$3.9$KG$20240809$$MD$DE$
241956231$24195623$1$I$$20240801$20240809$20240809$EXP$$ZA-AstraZeneca-2024A175601$ASTRAZENECA$$62$YR$$F$Y$$$20240809$$CN$ZA$
241956241$24195624$1$I$20200428$20240805$20240809$20240809$EXP$PL-URPL-1-1641-2020$PL-SA-2024SA231396$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240809$$MD$PL$PL
241956251$24195625$1$I$$20240806$20240809$20240809$EXP$$JP-AstraZeneca-2024A178945$ASTRAZENECA$Ushida K, et al.. Study 5 A case of pegfilgrastim-induced aortitis during chemotherapy including immune checkpoint inhibitors.. The 260th Kanto Regional Meeting of the Japanese Respiratory Society 2024;9-.$66$YR$$M$Y$$$20240809$$MD$JP$
241956261$24195626$1$I$20240501$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005567$ELI LILLY AND CO$$$$A$M$Y$$$20240809$$CN$US$US
241956271$24195627$1$I$$20240803$20240809$20240809$EXP$$US-AstraZeneca-2024A177837$ASTRAZENECA$Gikandi A., Connors J.M., Nabzdyk C.G., Zenati M.A.. Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest. Perfusion (United Kingdom) 2024;0(0):1-4.$67$YR$$M$Y$$$20240809$$MD$US$
241956281$24195628$1$I$$20240805$20240809$20240809$PER$$US-ALXN-202408USA000338US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240809$$CN$US$US
241956291$24195629$1$I$20240715$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005202$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241956301$24195630$1$I$$20240806$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005199$ELI LILLY AND CO$$$$A$M$Y$$$20240809$$CN$US$US
241956311$24195631$1$I$$20240806$20240809$20240809$EXP$$JP-AstraZeneca-2024A180159$ASTRAZENECA$Fujiya M, et al. OS4-6 Investigation of irAE enterocolitis cases induced by durvalumab and tremelimumab combination therapy for advanced hepatocellular carcinoma. The 30th Japan Association of Systemic Therapy for HCC 2024;104.$$$A$$Y$$$20240809$$MD$JP$
241956341$24195634$1$I$20240101$20240729$20240809$20240809$PER$$US-009507513-2407USA015993$MERCK$$$$$M$Y$120.5$KG$20240809$$MD$US$US
241956351$24195635$1$I$20240801$20240809$20240809$20240809$DIR$713612$$FDA-CTU$$58$YR$$M$N$104.4$KG$20240809$Y$HP$US$
241956361$24195636$1$I$$20240809$20240809$20240809$DIR$713601$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241956371$24195637$1$I$20240806$20240809$20240809$20240809$DIR$713614$$FDA-CTU$$$$$M$N$87.3$KG$20240809$N$HP$US$
241956381$24195638$1$I$$20240805$20240809$20240809$PER$$US-009507513-2408USA001740$MERCK$$13$MON$$$Y$$$20240809$$CN$US$US
241956391$24195639$1$I$20240701$20240806$20240809$20240809$EXP$$CA-ABBVIE-5871604$ABBVIE$$51$YR$$F$Y$$$20240809$$CN$CA$CA
241956401$24195640$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54796$$FDA-CTU$$55$YR$$F$N$$$20240809$N$HP$US$
241956421$24195642$1$I$$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54824$$FDA-CTU$$$$$M$N$$$20240808$N$HP$US$
241956431$24195643$1$I$20230101$20240807$20240809$20240809$EXP$$CA-ROCHE-3272300$ROCHE$$38$YR$A$F$Y$$$20240809$$CN$CA$CA
241956441$24195644$1$I$20240722$20240809$20240809$20240809$DIR$713615$$FDA-CTU$$68$YR$$F$N$83.25$KG$20240809$N$HP$US$
241956451$24195645$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54879$$FDA-CTU$$59$YR$$M$N$$$20240809$N$$US$
241956461$24195646$1$I$20240808$20240809$20240809$20240809$DIR$713574$$FDA-CTU$$26$YR$$F$N$$$20240809$N$PH$US$
241956471$24195647$1$I$20240601$20240730$20240809$20240809$EXP$$JP-009507513-2407JPN005305J$MERCK$$74$YR$$F$Y$$$20240809$$MD$JP$JP
241956482$24195648$2$F$20240201$20240812$20240809$20240816$EXP$$US-ABBVIE-5623543$ABBVIE$$78$YR$$M$Y$65$KG$20240816$$CN$US$US
241956491$24195649$1$I$20240721$20240804$20240809$20240809$EXP$$CO-BAYER-2024A113378$BAYER$$29$YR$A$F$Y$$$20240809$$CN$CO$CO
241956501$24195650$1$I$$20240807$20240809$20240809$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-108375$REGENERON$$$$$M$Y$$$20240809$$CN$JP$JP
241956511$24195651$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA232214$SANOFI AVENTIS$$$$E$F$Y$108$KG$20240809$$MD$US$US
241956521$24195652$1$I$20240101$20240802$20240809$20240809$PER$$US-009507513-2408USA000692$MERCK$$70$YR$$M$Y$$$20240809$$CN$US$US
241956531$24195653$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227849$TEVA$$$$$M$Y$$$20240809$$MD$CA$CA
241956541$24195654$1$I$20240805$20240806$20240809$20240809$EXP$$US-ABBVIE-5870893$ABBVIE$$53$YR$$M$Y$$$20240809$$CN$US$US
241956552$24195655$2$F$20240801$20240826$20240809$20240830$EXP$$NL-ABBVIE-5871935$ABBVIE$$$$E$F$Y$$$20240830$$CN$NL$NL
241956561$24195656$1$I$20240701$20240806$20240809$20240809$EXP$$IT-ABBVIE-5871491$ABBVIE$$77$YR$$F$Y$$$20240809$$HP$IT$IT
241956572$24195657$2$F$$20240821$20240809$20240828$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007318$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240828$$MD$DE$DE
241956581$24195658$1$I$$20240730$20240809$20240809$EXP$US-MLMSERVICE-20240723-PI140518-00200-1$US-RDY-SPO/USA/24/0011315$DR REDDYS$Bally K, Trusty R, Naher K. A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone. Cureus. 2024;16(6):e62695. DOI:10.7759/cureus.62695.$95$YR$E$F$Y$$$20240809$$MD$US$US
241956595$24195659$5$F$20240524$20240821$20240809$20240828$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-123929$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$76$KG$20240828$$PH$FR$FR
241956601$24195660$1$I$20240701$20240808$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126005$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240809$$HP$US$US
241956612$24195661$2$F$$20240808$20240809$20240814$PER$$NVSC2024US162498$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
241956621$24195662$1$I$20240701$20240801$20240809$20240809$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15448$IPSEN$$$$$F$Y$$$20240809$$MD$US$US
241956631$24195663$1$I$$20240804$20240809$20240809$EXP$$KR-JNJFOC-20240809427$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$HP$KR$KR
241956651$24195665$1$I$20240710$20240808$20240809$20240809$EXP$FR-AFSSAPS-BX2024001509$FR-ROCHE-10000052427$ROCHE$$43$YR$A$F$Y$73$KG$20240809$$MD$FR$FR
241956662$24195666$2$F$20240101$20240814$20240809$20240820$EXP$$US-ABBVIE-5872754$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
241956671$24195667$1$I$$20240807$20240809$20240809$EXP$$BR-ABBVIE-5873229$ABBVIE$$68$YR$$M$Y$$$20240809$$MD$BR$BR
241956681$24195668$1$I$$20240726$20240809$20240809$PER$$US-TEVA-VS-3227936$TEVA$$$$$F$Y$$$20240809$$MD$US$US
241956691$24195669$1$I$$20240807$20240809$20240809$EXP$$US-ABBVIE-5872935$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241956701$24195670$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227764$TEVA$$12$YR$$M$Y$$$20240809$$HP$CA$CA
241956711$24195671$1$I$20240101$20240807$20240809$20240809$EXP$$GB-ABBVIE-5873365$ABBVIE$$63$YR$$F$Y$$$20240809$$HP$GB$GB
241956721$24195672$1$I$$20240730$20240809$20240809$PER$$US-SA-2024SA229361$SANOFI AVENTIS$$$$T$M$Y$$$20240809$$MD$US$US
241956731$24195673$1$I$20240804$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157765$AMGEN$$62$YR$A$M$Y$$$20240809$$CN$US$US
241956741$24195674$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA229140$SANOFI AVENTIS$$$$A$$Y$$$20240809$$CN$US$US
241956752$24195675$2$F$20240101$20240816$20240809$20240821$EXP$$RO-ABBVIE-5871817$ABBVIE$$83$YR$$M$Y$$$20240821$$CN$RO$RO
241956781$24195678$1$I$20240808$20240809$20240809$20240809$DIR$713616$$FDA-CTU$$43$YR$$F$N$$$20240809$N$HP$US$
241956791$24195679$1$I$$20240809$20240809$20240809$DIR$713584$$FDA-CTU$$53$YR$$F$N$65.25$KG$20240809$N$CN$US$
241956811$24195681$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54849$$FDA-CTU$$39$YR$$F$N$$$20240809$N$$US$
241956831$24195683$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54818$$FDA-CTU$$58$YR$$F$N$$$20240809$N$$US$
241956841$24195684$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54892$$FDA-CTU$$45$YR$$F$N$$$20240809$N$$US$
241956851$24195685$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54844$$FDA-CTU$$$$$$N$$$20240809$N$$US$
241956861$24195686$1$I$20240101$20240807$20240809$20240809$EXP$$US-ABBVIE-5871932$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241956872$24195687$2$F$20240701$20240807$20240809$20240822$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0913$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240821$$HP$US$US
241956881$24195688$1$I$$20240731$20240809$20240809$EXP$$PT-JNJFOC-20240805050$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240809$$HP$PT$PT
241956891$24195689$1$I$20240101$20240807$20240809$20240809$EXP$$US-JNJFOC-20240819476$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240809$$HP$US$US
241956902$24195690$2$F$20240101$20240809$20240809$20240813$PER$$US-AMGEN-USASP2024157953$AMGEN$$67$YR$E$F$Y$$$20240812$$PH$US$US
241956911$24195691$1$I$$20240731$20240809$20240809$EXP$$US-Alcon Laboratories-ALC2024US003627$ALCON$$$$$M$Y$$$20240809$$CN$US$US
241956921$24195692$1$I$20240802$20240806$20240809$20240809$EXP$$CA-MYLANLABS-2024M1073775$MYLAN$$83$YR$$M$Y$$$20240809$$CN$CA$CA
241956931$24195693$1$I$$20240808$20240809$20240809$PER$$US-PFIZER INC-202400099347$PFIZER$$39$YR$$M$Y$$$20240809$$MD$US$US
241956943$24195694$3$F$$20240822$20240809$20240827$PER$$US-PFIZER INC-202400233095$PFIZER$$$$$$Y$$$20240827$$MD$US$US
241956951$24195695$1$I$$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233160$PFIZER$$65$YR$$F$Y$$$20240809$$CN$US$US
241956961$24195696$1$I$$20240808$20240809$20240809$PER$$US-PFIZER INC-202200167619$PFIZER$$72$YR$$F$Y$$$20240809$$CN$US$US
241956972$24195697$2$F$20240101$20240924$20240809$20240926$PER$$US-PFIZER INC-PV202400103588$PFIZER$$57$YR$$F$Y$73.923$KG$20240926$$HP$US$US
241956981$24195698$1$I$20240803$20240807$20240809$20240809$PER$$US-PFIZER INC-202400232317$PFIZER$$79$YR$$F$Y$$$20240809$$CN$US$US
241956992$24195699$2$F$$20240908$20240809$20240909$PER$$US-PFIZER INC-PV202400103336$PFIZER$$66$YR$$F$Y$$$20240909$$CN$US$US
241957001$24195700$1$I$$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233147$PFIZER$$67$YR$$F$Y$$$20240809$$CN$US$US
241957011$24195701$1$I$20240731$20240807$20240809$20240809$EXP$$ID-AstraZeneca-2024A180943$ASTRAZENECA$$28896$DY$$M$Y$$$20240809$$CN$ID$
241957031$24195703$1$I$20240701$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A178112$ASTRAZENECA$$1048$MON$$F$Y$$$20240809$$HP$US$
241957042$24195704$2$F$$20240821$20240809$20240829$EXP$$JP-AstraZeneca-2024A178590$ASTRAZENECA$$$$$$Y$$$20240829$$MD$JP$
241957052$24195705$2$F$$20240820$20240809$20240828$EXP$$JP-AstraZeneca-2024A176900$ASTRAZENECA$$88$YR$$F$Y$$$20240828$$PH$JP$
241957061$24195706$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA233448$SANOFI AVENTIS$$$$T$M$Y$63.5$KG$20240809$$MD$US$US
241957072$24195707$2$F$$20240802$20240809$20240819$EXP$$US-AstraZeneca-2024A109260$ASTRAZENECA$$67$YR$$F$Y$79.8$KG$20240819$$PH$US$
241957082$24195708$2$F$$20240917$20240809$20240920$EXP$$US-TAKEDA-2024TUS079107$TAKEDA$$$$$M$Y$$$20240920$$CN$US$US
241957092$24195709$2$F$$20240913$20240809$20240918$EXP$$JP-AstraZeneca-2024A177806$ASTRAZENECA$$82$YR$$F$Y$$$20240918$$PH$JP$
241957101$24195710$1$I$$20240805$20240809$20240809$EXP$$US-AstraZeneca-2024A178022$ASTRAZENECA$$$$$M$Y$$$20240809$$HP$US$
241957111$24195711$1$I$20231201$20240801$20240809$20240809$EXP$$JP-AstraZeneca-2024A176582$ASTRAZENECA$$65$YR$$F$Y$45$KG$20240809$$MD$JP$
241957121$24195712$1$I$$20240802$20240809$20240809$EXP$$JP-AstraZeneca-2024A177515$ASTRAZENECA$$$$E$F$Y$$$20240809$$MD$JP$
241957132$24195713$2$F$20230101$20240807$20240809$20240814$EXP$$JP-AstraZeneca-2023A263332$ASTRAZENECA$$58$YR$$F$Y$54$KG$20240814$$MD$JP$
241957141$24195714$1$I$20240711$20240801$20240809$20240809$EXP$$US-Eisai-EC-2024-171390$EISAI$$77$YR$E$F$Y$$$20240809$$HP$US$US
241957151$24195715$1$I$20240719$20240801$20240809$20240809$PER$$CN-Eisai-EC-2024-171377$EISAI$$51$YR$A$F$Y$45.5$KG$20240809$$HP$CN$CN
241957161$24195716$1$I$20240101$20240802$20240809$20240809$EXP$$US-ABBVIE-5865939$ABBVIE$$$$$M$Y$$$20240809$$MD$US$US
241957171$24195717$1$I$$20240730$20240809$20240809$30DAY$$US-GSK-US2024095343$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241957181$24195718$1$I$20240701$20240806$20240809$20240809$EXP$$CL-ABBVIE-5871438$ABBVIE$$76$YR$$F$Y$$$20240809$$CN$CL$CL
241957192$24195719$2$F$20240705$20240917$20240809$20240923$EXP$$US-ABBVIE-5871968$ABBVIE$$32$YR$$F$Y$$$20240923$$CN$US$US
241957201$24195720$1$I$$20240801$20240809$20240809$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-124672$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240809$$HP$CA$CA
241957211$24195721$1$I$$20240807$20240809$20240809$EXP$$AT-ABBVIE-5872370$ABBVIE$$$$E$F$Y$$$20240809$$CN$AT$AT
241957221$24195722$1$I$20240215$20240806$20240809$20240809$EXP$$DE-SANDOZ INC.-SDZ2024DE071480$SANDOZ$$$$A$F$Y$$$20240809$$HP$DE$DE
241957232$24195723$2$F$20240806$20240828$20240809$20240904$PER$$US-PFIZER INC-202400233237$PFIZER$$66$YR$$F$Y$65.76$KG$20240904$$CN$US$US
241957241$24195724$1$I$$20240807$20240809$20240809$EXP$$US-TAKEDA-2024TUS079312$TAKEDA$$$$$M$Y$$$20240809$$CN$US$US
241957251$24195725$1$I$20240731$20240801$20240809$20240809$30DAY$$CL-PFIZER INC-202400229224$PFIZER$$7$YR$$$Y$$$20240809$$CN$CL$CL
241957261$24195726$1$I$$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233491$PFIZER$$58$YR$$F$Y$$$20240809$$MD$US$US
241957281$24195728$1$I$20240806$20240807$20240809$20240809$PER$$US-PFIZER INC-PV202400103330$PFIZER$$$$$F$Y$$$20240809$$CN$US$US
241957291$24195729$1$I$$20240808$20240809$20240809$PER$$US-PFIZER INC-2020289349$PFIZER$$70$YR$$F$Y$$$20240809$$CN$US$US
241957302$24195730$2$F$20240701$20240918$20240809$20240923$PER$$US-PFIZER INC-202400233305$PFIZER$$62$YR$$F$Y$50.34$KG$20240923$$CN$US$US
241957311$24195731$1$I$$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233013$PFIZER$$70$YR$$F$Y$$$20240809$$CN$US$US
241957321$24195732$1$I$$20240807$20240809$20240809$PER$$US-PFIZER INC-PV202400103308$PFIZER$$$$$M$Y$$$20240809$$CN$US$US
241957332$24195733$2$F$$20240809$20240809$20240813$PER$$US-PFIZER INC-PV202400103555$PFIZER$$$$$F$Y$$$20240813$$CN$US$US
241957341$24195734$1$I$$20240808$20240809$20240809$PER$$US-PFIZER INC-PV202400060224$PFIZER$$54$YR$$F$Y$$$20240809$$HP$US$US
241957351$24195735$1$I$20240807$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233243$PFIZER$$67$YR$$F$Y$$$20240809$$CN$US$US
241957361$24195736$1$I$20240807$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233342$PFIZER$$67$YR$$M$Y$$$20240809$$CN$US$US
241957371$24195737$1$I$$20240802$20240809$20240809$PER$$US-PFIZER INC-202400229543$PFIZER$$$$$F$Y$$$20240809$$CN$US$US
241957381$24195738$1$I$20240807$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233262$PFIZER$$71$YR$$M$Y$$$20240809$$CN$US$US
241957391$24195739$1$I$20240801$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233036$PFIZER$$32$YR$$M$Y$$$20240809$$CN$US$US
241957401$24195740$1$I$20240807$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233454$PFIZER$$60$YR$$F$Y$$$20240809$$CN$US$US
241957422$24195742$2$F$20240701$20240816$20240809$20240821$PER$$US-PFIZER INC-202400232588$PFIZER$$$$$$Y$$$20240821$$PH$US$US
241957431$24195743$1$I$20220101$20240807$20240809$20240809$PER$$US-PFIZER INC-PV202400103323$PFIZER$$56$YR$$$Y$$$20240809$$CN$US$US
241957441$24195744$1$I$20240807$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233332$PFIZER$$68$YR$$F$Y$$$20240809$$CN$US$US
241957481$24195748$1$I$$20240808$20240809$20240809$PER$$US-PFIZER INC-PV202400103548$PFIZER$$54$YR$$F$Y$$$20240809$$CN$US$US
241957491$24195749$1$I$20240807$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233456$PFIZER$$51$YR$$M$Y$$$20240809$$CN$US$US
241957502$24195750$2$F$20240730$20240921$20240809$20240923$30DAY$$CO-PFIZER INC-PV202400100476$PFIZER$$11$YR$$F$Y$$$20240923$$CN$CO$CO
241957511$24195751$1$I$$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233283$PFIZER$$82$YR$$M$Y$$$20240809$$CN$US$US
241957521$24195752$1$I$20240804$20240808$20240809$20240809$PER$$US-PFIZER INC-202400233242$PFIZER$$53$YR$$M$Y$$$20240809$$CN$US$US
241957531$24195753$1$I$20240501$20240613$20240809$20240809$EXP$$FI-NOVOPROD-1235480$NOVO NORDISK$$900$MON$$F$Y$$$20240809$$HP$FI$FI
241957553$24195755$3$F$20240726$20240912$20240809$20240919$EXP$$AR-TAKEDA-2024TUS078654$TAKEDA$$49$YR$$F$Y$70$KG$20240919$$CN$AR$AR
241957571$24195757$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125816$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$63.5$KG$20240809$$CN$US$US
241957583$24195758$3$F$20240826$20240911$20240809$20240911$PER$$US-ALXN-202408USA000308US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
241957591$24195759$1$I$20240803$20240808$20240809$20240809$EXP$$US-ABBVIE-5874070$ABBVIE$$85$YR$$M$Y$$$20240809$$CN$US$US
241957601$24195760$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227783$TEVA$$25$YR$$M$Y$77$KG$20240809$$HP$CA$CA
241957611$24195761$1$I$20240705$20240806$20240809$20240809$EXP$$US-GSK-US2024098129$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$HP$US$US
241957621$24195762$1$I$20240704$20240806$20240809$20240809$EXP$$US-GSK-US2024AMR098840$GLAXOSMITHKLINE$$$$$$Y$$$20240809$$CN$US$US
241957631$24195763$1$I$20240701$20240806$20240809$20240809$PER$$US-009507513-2408USA002154$MERCK$$$$$F$Y$$$20240809$$CN$US$US
241957641$24195764$1$I$20240619$20240710$20240809$20240809$PER$$US-009507513-2407USA005134$MERCK$$$$$F$Y$$$20240809$$CN$US$US
241957651$24195765$1$I$20240712$20240801$20240809$20240809$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024010$UNITED THERAPEUTICS$$84$YR$$F$Y$47.619$KG$20240809$$$US$US
241957671$24195767$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54807$$FDA-CTU$$73$YR$$F$N$180$LBS$20240809$N$$US$
241957681$24195768$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54799$$FDA-CTU$$57$YR$$F$N$$$20240809$N$$US$
241957691$24195769$1$I$20240107$20240801$20240809$20240809$EXP$$NL-MYLANLABS-2024M1068472$MYLAN$$69$YR$$M$Y$$$20240809$$HP$NL$NL
241957701$24195770$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54876$$FDA-CTU$$47$YR$$M$N$332$LBS$20240809$N$$US$
241957721$24195772$1$I$20240801$20240802$20240809$20240809$PER$$US-AMGEN-USASP2024155007$AMGEN$$$$$M$Y$$$20240809$$CN$US$US
241957731$24195773$1$I$$20240808$20240809$20240809$EXP$$US-ABBVIE-5874136$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241957741$24195774$1$I$20240101$20240802$20240809$20240809$EXP$$US-SA-2024SA236369$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240809$$MD$US$US
241957751$24195775$1$I$20240101$20240808$20240809$20240809$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044789$BOEHRINGER INGELHEIM$$57$YR$A$M$Y$$$20240809$$CN$GB$GB
241957761$24195776$1$I$$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125644$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240809$$CN$US$US
241957771$24195777$1$I$$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125121$BRISTOL MYERS SQUIBB$$30$YR$A$$Y$$$20240809$$MD$US$US
241957781$24195778$1$I$20240730$20240802$20240809$20240809$PER$$US-SA-2024SA232281$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240809$$MD$US$US
241957791$24195779$1$I$20240101$20240802$20240809$20240809$PER$$US-SA-2024SA232530$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240809$$MD$US$US
241957801$24195780$1$I$$20240807$20240809$20240809$EXP$$GB-ABBVIE-5873251$ABBVIE$$$$E$F$Y$$$20240809$$CN$GB$GB
241957811$24195781$1$I$20230101$20240731$20240809$20240809$PER$$US-ABBVIE-5865650$ABBVIE$$$$$F$Y$$$20240809$$HP$US$US
241957821$24195782$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3231216$TEVA$$74$YR$$F$Y$$$20240809$$HP$CA$CA
241957831$24195783$1$I$20240101$20240806$20240809$20240809$EXP$$CO-ABBVIE-5871983$ABBVIE$$$$$F$Y$53$KG$20240809$$CN$CO$CO
241957841$24195784$1$I$20240101$20240805$20240809$20240809$EXP$$US-ABBVIE-5868180$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241957851$24195785$1$I$20240717$20240807$20240809$20240809$EXP$$US-ABBVIE-5873019$ABBVIE$$53$YR$$M$Y$$$20240809$$CN$US$US
241957863$24195786$3$F$20191101$20240824$20240809$20240829$EXP$$CA-PFIZER INC-202400231597$PFIZER$Raphael, J.. Durable Response to Atezolizumab in Extensive-Stage Small-Cell Lung Cancer Leading to 60 Months Overall Survival: A Case Report. Current oncology (Toronto, Ont.). 2024;31(7):3682-3689$58$YR$$M$Y$$$20240829$$MD$CA$CA
241957881$24195788$1$I$20240730$20240805$20240809$20240809$PER$$US-EMD Serono-2024042335$EMD SERONO INC$$73$YR$E$F$Y$$$20240809$$CN$US$US
241957891$24195789$1$I$$20240801$20240809$20240809$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-123126$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$68$KG$20240809$$HP$CA$CA
241957901$24195790$1$I$20240606$20240730$20240809$20240809$EXP$$US-JNJFOC-20240784179$JOHNSON AND JOHNSON$$63$YR$A$F$Y$96.4$KG$20240809$$HP$US$US
241957911$24195791$1$I$20220101$20240805$20240809$20240809$EXP$$US-009507513-2408USA001788$MERCK$$$$$F$Y$$$20240809$$CN$US$US
241957922$24195792$2$F$$20240905$20240809$20240917$PER$$US-BIOMARINAP-US-2024-159547$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
241957932$24195793$2$F$20240802$20240809$20240809$20240814$PER$$US-BIOMARINAP-US-2024-159549$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
241957941$24195794$1$I$20240805$20240807$20240809$20240809$PER$$US-BIOMARINAP-US-2024-159712$BIOMARIN$$$$$$Y$$$20240809$$CN$US$US
241957951$24195795$1$I$20240730$20240802$20240809$20240809$EXP$$IT-MYLANLABS-2024M1073082$MYLAN$$12$YR$$M$Y$$$20240809$$MD$IT$IT
241957961$24195796$1$I$$20240802$20240809$20240809$PER$$US-ABBVIE-5866876$ABBVIE$$$$$$Y$$$20240809$$CN$US$US
241957972$24195797$2$F$20230101$20240828$20240809$20240905$EXP$$CA-AstraZeneca-2024A177934$ASTRAZENECA$$$$$$Y$$$20240905$$CN$CA$
241957981$24195798$1$I$20231101$20240731$20240809$20240809$EXP$$FR-AstraZeneca-2024A181105$ASTRAZENECA$$50$YR$$M$Y$64$KG$20240809$$MD$FR$
241957991$24195799$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A176285$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241958001$24195800$1$I$$20240802$20240809$20240809$EXP$$US-AstraZeneca-2024A177108$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$US$
241958011$24195801$1$I$20240621$20240801$20240809$20240809$EXP$$NVSC2024CN159127$NOVARTIS$$61$YR$$M$Y$$$20240809$$HP$CN$CN
241958022$24195802$2$F$20221130$20240815$20240809$20240821$EXP$IE-HPRA-2024-114389$IE-MYLANLABS-2024M1073332$MYLAN$$5$YR$$F$Y$$$20240821$$CN$IE$IE
241958031$24195803$1$I$$20240729$20240809$20240809$PER$$US-MYLANLABS-2024M1071768$MYLAN$$$$$F$Y$66.22$KG$20240809$$CN$US$US
241958042$24195804$2$F$$20240906$20240809$20240910$PER$$US-ALXN-202408USA000256US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$HP$US$US
241958051$24195805$1$I$20240805$20240807$20240809$20240809$EXP$$US-JNJFOC-20240820252$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240809$$HP$US$US
241958061$24195806$1$I$20240716$20240731$20240809$20240809$EXP$IT-MINISAL02-996836$IT-009507513-2408ITA000180$MERCK$$45$YR$$M$Y$90$KG$20240809$$MD$IT$IT
241958071$24195807$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54814$$FDA-CTU$$44$YR$$F$N$$$20240809$N$$US$
241958081$24195808$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54872$$FDA-CTU$$64$YR$$M$N$$$20240809$N$$US$
241958091$24195809$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54804$$FDA-CTU$$73$YR$$F$N$190$LBS$20240809$N$HP$US$
241958101$24195810$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54792$$FDA-CTU$$81$YR$$F$N$$$20240809$N$$US$
241958111$24195811$1$I$20240807$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54884$$FDA-CTU$$71$YR$$M$N$$$20240809$N$HP$US$
241958121$24195812$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54846$$FDA-CTU$$58$YR$$M$N$$$20240809$N$$US$
241958133$24195813$3$F$20240805$20240812$20240809$20240817$PER$$US-AMGEN-USASP2024156872$AMGEN$$53$YR$A$M$Y$$$20240816$$CN$US$US
241958141$24195814$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54889$$FDA-CTU$$78$YR$$F$N$$$20240809$N$$US$
241958151$24195815$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54800$$FDA-CTU$$56$YR$$F$N$$$20240809$N$$US$
241958161$24195816$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227869$TEVA$$69$YR$$F$Y$60$KG$20240809$$MD$CA$CA
241958171$24195817$1$I$$20240801$20240809$20240809$PER$$US-RDY-SPO/USA/24/0011451$DR REDDYS$$23$YR$A$F$Y$$$20240809$$MD$US$US
241958181$24195818$1$I$$20240729$20240809$20240809$EXP$$US-RDY-LIT/USA/24/0011401$DR REDDYS$On S, Domingo W, Cheung E, Johnston L. Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen with Methotrexate-Based GvHD Prophylaxis. Blood. 2023 Nov 02;142: doi:10.1182/blood-2023-182983.$$$$$Y$$$20240809$$HP$US$US
241958191$24195819$1$I$$20240801$20240809$20240809$PER$$US-RDY-SPO/USA/24/0011449$DR REDDYS$$20$YR$A$F$Y$$$20240809$$MD$US$US
241958231$24195823$1$I$20240712$20240726$20240809$20240809$EXP$SE-SEMPA-2024-005603$SE-TEVA-VS-3227023$TEVA$$33$YR$$F$Y$$$20240809$$MD$SE$SE
241958241$24195824$1$I$20240201$20240731$20240809$20240809$EXP$$TN-BIOCON BIOLOGICS LIMITED-BBL2024005727$BIOCON$$$$$$Y$$$20240809$$HP$TN$TN
241958251$24195825$1$I$$20240802$20240809$20240809$EXP$$NVSC2024US158542$NOVARTIS$$54$YR$$F$Y$$$20240809$$MD$US$US
241958261$24195826$1$I$$20240807$20240809$20240809$PER$$US-DSJP-DSU-2024-140228$DAIICHI$$$$$F$Y$$$20240809$$CN$US$US
241958271$24195827$1$I$20240805$20240807$20240809$20240809$EXP$$CN-ROCHE-10000052772$ROCHE$$73$YR$E$M$Y$84$KG$20240809$$HP$CN$CN
241958281$24195828$1$I$$20240806$20240809$20240809$EXP$$US-JNJFOC-20240820402$JOHNSON AND JOHNSON$$$$$M$Y$$$20240809$$HP$US$US
241958291$24195829$1$I$$20240731$20240809$20240809$PER$$US-JNJFOC-20240819453$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240809$$CN$US$US
241958301$24195830$1$I$$20240730$20240809$20240809$PER$$US-JNJFOC-20240783039$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241958311$24195831$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227788$TEVA$$16$YR$$M$Y$61$KG$20240809$$PH$CA$CA
241958321$24195832$1$I$20240701$20240801$20240809$20240809$PER$$US-SA-2024SA233052$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240809$$MD$US$US
241958331$24195833$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232999$SANOFI AVENTIS$$$$T$F$Y$$$20240809$$MD$US$US
241958341$24195834$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA232212$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$MD$US$US
241958351$24195835$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA233439$SANOFI AVENTIS$$82$YR$E$M$Y$52.1$KG$20240809$$MD$US$US
241958361$24195836$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA233527$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240809$$MD$US$US
241958371$24195837$1$I$$20240809$20240809$20240809$PER$$NVSC2024US162582$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241958381$24195838$1$I$20240418$20240731$20240809$20240809$EXP$CN-NMPACDR-4602001068793202400102$CN-BAXTER-2024BAX022645$BAXTER$$30$YR$$F$Y$52$KG$20240809$$MD$CN$CN
241958391$24195839$1$I$$20240801$20240809$20240809$EXP$$US-HISAMITSU PHARMACEUTICAL CO., INC.-2024-NOV-US001021$PAREXEL$$$$$F$Y$$$20240809$$CN$US$US
241958401$24195840$1$I$20240423$20240807$20240809$20240809$EXP$FR-AFSSAPS-TO2024001408$FR-PURDUE-USA-2024-0311258$PURDUE$$49$YR$$F$Y$$$20240809$$PH$FR$FR
241958411$24195841$1$I$$20240806$20240809$20240809$EXP$$JP-PURDUE PHARMA-USA-2024-0311242$PURDUE$Ogawa S., Amaya F.. A peripherally acting ?-opioid receptor antagonist for treating opioid-associated tinnitus: A case report. Palliative Medicine. 2024;1-4$74$YR$$M$Y$$$20240809$$HP$JP$JP
241958421$24195842$1$I$$20240806$20240809$20240809$EXP$$AU-PURDUE-USA-2024-0311243$PURDUE$Syrjanen R, Schumann JL, Castle JW, Sharp L, Griffiths A, Blakey K, Dutch M, Maplesden J, Greene SL.. Protonitazene detection in two cases of opioid toxicity following the use of tetrahydrocannabinol vape products in Australia. Clinical Toxicology. 2024$3$DEC$$M$Y$$$20240809$$HP$AU$AU
241958431$24195843$1$I$$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157709$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241958441$24195844$1$I$20240730$20240730$20240809$20240809$EXP$$US-GSK-US2024095329$GLAXOSMITHKLINE$$$$E$F$Y$$$20240809$$CN$US$US
241958451$24195845$1$I$$20240808$20240809$20240809$PER$$US-ROCHE-10000052854$ROCHE$$$$$$Y$$$20240809$$CN$US$US
241958481$24195848$1$I$$20240808$20240809$20240809$PER$$NVSC2024US162265$NOVARTIS$$$$$M$Y$$$20240809$$MD$US$US
241958491$24195849$1$I$$20240731$20240809$20240809$PER$$US-ABBVIE-5866157$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241958501$24195850$1$I$$20231024$20240809$20240809$EXP$$US-NOVOPROD-1247865$NOVO NORDISK$$$$$$Y$$$20240809$$CN$US$US
241958511$24195851$1$I$$20230331$20240809$20240809$EXP$$US-NOVOPROD-1248279$NOVO NORDISK$$$$$M$Y$$$20240809$$CN$US$US
241958521$24195852$1$I$$20230511$20240809$20240809$EXP$$US-NOVOPROD-1246278$NOVO NORDISK$$$$$$Y$$$20240809$$CN$US$US
241958531$24195853$1$I$$20230314$20240809$20240809$EXP$$US-NOVOPROD-1245705$NOVO NORDISK$$$$$$Y$$$20240809$$CN$US$US
241958541$24195854$1$I$$20230316$20240809$20240809$EXP$$US-NOVOPROD-1245702$NOVO NORDISK$$$$$$Y$$$20240809$$CN$US$US
241958551$24195855$1$I$$20230320$20240809$20240809$EXP$$US-NOVOPROD-1248266$NOVO NORDISK$$84$YR$$M$Y$$$20240809$$CN$US$US
241958561$24195856$1$I$$20231110$20240809$20240809$EXP$$US-NOVOPROD-1261590$NOVO NORDISK$$$$$M$Y$$$20240809$$CN$US$US
241958571$24195857$1$I$$20230323$20240809$20240809$EXP$$US-NOVOPROD-1246559$NOVO NORDISK$$$$$$Y$$$20240809$$CN$US$US
241958581$24195858$1$I$$20240802$20240809$20240809$EXP$$US-TAKEDA-2024TUS078428$TAKEDA$$$$$F$Y$95$KG$20240809$$MD$US$US
241958591$24195859$1$I$$20240807$20240809$20240809$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-139855$DAIICHI$$75$YR$$$Y$$$20240809$$MD$JP$JP
241958601$24195860$1$I$$20240806$20240809$20240809$PER$$US-AMGEN-USASP2024157547$AMGEN$$$$$$Y$$$20240809$$PH$US$US
241958612$24195861$2$F$$20240913$20240809$20240916$PER$$NVSC2024US162581$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
241958621$24195862$1$I$20240718$20240809$20240809$20240809$EXP$BE-FAMHP-DHH-N2024-122456$NVSC2024BE162281$NOVARTIS$$84$YR$$F$Y$67$KG$20240809$$MD$BE$BE
241958631$24195863$1$I$$20240807$20240809$20240809$EXP$$AU-TAKEDA-2024TUS079303$TAKEDA$$40$YR$$M$Y$$$20240809$$HP$AU$AU
241958641$24195864$1$I$20240720$20240804$20240804$20240804$DIR$712874$$FDA-CTU$$22$YR$$F$N$54$KG$20240804$N$CN$US$
241958661$24195866$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54810$$FDA-CTU$$79$YR$$F$N$$$20240809$N$$US$
241958671$24195867$1$I$$20240807$20240809$20240809$DIR$FDA-CDER-CTU-2024-54864$$FDA-CTU$$$$$F$N$$$20240807$N$HP$US$
241958691$24195869$1$I$$20240805$20240809$20240809$EXP$$PT-MYLANLABS-2024M1072898$MYLAN$Quadrado F, Vieira AT, Jacinto M, Ribeirinho R. PO-0292 - (2710) -Meningoencephalitis at VHS-7. Doen?as infeciosas e parasit?rias | Caso cl?nico (Infectious and parasitic disea. 657$20$YR$$F$Y$$$20240809$$HP$PT$PT
241958702$24195870$2$F$$20240905$20240809$20240909$PER$$US-MYLANLABS-2024M1073672$MYLAN$$$$$M$Y$$$20240909$$CN$US$US
241958711$24195871$1$I$20240703$20240805$20240809$20240809$EXP$FR-AFSSAPS-LL2024001511$FR-MYLANLABS-2024M1073027$MYLAN$$84$YR$$M$Y$$$20240809$$MD$FR$FR
241958721$24195872$1$I$$20240807$20240809$20240809$PER$$US-ABBVIE-5872543$ABBVIE$$$$$$Y$$$20240809$$CN$US$US
241958731$24195873$1$I$$20240805$20240809$20240809$EXP$DK-DKMA-30736400$DK-MYLANLABS-2024M1072930$MYLAN$$85$YR$$F$Y$$$20240809$$MD$DK$DK
241958741$24195874$1$I$20240301$20240717$20240809$20240809$PER$$AU-TOLMAR, INC.-24AU051056$TOLMAR$$78$YR$$M$Y$$$20240809$$CN$AU$AU
241958752$24195875$2$F$20240708$20240828$20240809$20240926$PER$$AU-TOLMAR, INC.-24AU051110$TOLMAR$$82$YR$$M$Y$$$20240926$$PH$AU$AU
241958761$24195876$1$I$$20240718$20240809$20240809$PER$$AU-TOLMAR, INC.-24AU051177$TOLMAR$$$$$M$Y$$$20240809$$HP$AU$AU
241958771$24195877$1$I$20240703$20240718$20240809$20240809$PER$$BR-TOLMAR, INC.-24BR050838$TOLMAR$$8$YR$$F$Y$$$20240809$$CN$BR$BR
241958782$24195878$2$F$$20240822$20240809$20240912$PER$$BR-TOLMAR, INC.-24BR050966$TOLMAR$$$$$$Y$$$20240912$$PH$BR$BR
241958791$24195879$1$I$20240601$20240717$20240809$20240809$PER$$BR-TOLMAR, INC.-24BR051154$TOLMAR$$9$YR$$F$Y$$$20240809$$CN$BR$BR
241958801$24195880$1$I$20240601$20240717$20240809$20240809$PER$$BR-TOLMAR, INC.-24BR051155$TOLMAR$$10$YR$$F$Y$$$20240809$$CN$BR$BR
241958811$24195881$1$I$$20240718$20240809$20240809$PER$$BR-TOLMAR, INC.-24BR051173$TOLMAR$$$$$F$Y$$$20240809$$CN$BR$BR
241958821$24195882$1$I$$20240726$20240809$20240809$PER$$US-TEVA-VS-3228082$TEVA$$58$YR$$M$Y$$$20240809$$CN$US$US
241958832$24195883$2$F$20240101$20240812$20240809$20240816$EXP$$US-PFIZER INC-202400232275$PFIZER$$58$YR$$F$Y$89.483$KG$20240816$$HP$US$US
241958841$24195884$1$I$20240101$20240805$20240809$20240809$EXP$$JP-GENMAB-2024-02848$GENMAB$$88$YR$$F$Y$$$20240809$$MD$JP$JP
241958851$24195885$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227810$TEVA$$66$YR$$M$Y$73$KG$20240809$$HP$CA$CA
241958862$24195886$2$F$20240724$20240809$20240809$20240811$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044758$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240812$$CN$US$US
241958871$24195887$1$I$20240607$20240801$20240809$20240809$EXP$$PT-DSJP-DSE-2024-139308$DAIICHI$$85$YR$$F$Y$$$20240809$$HP$PT$PT
241958891$24195889$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227792$TEVA$$51$YR$$F$Y$72$KG$20240809$$HP$CA$CA
241958901$24195890$1$I$20230831$20240802$20240809$20240809$EXP$$JP-DSJP-DSJ-2024-111831$DAIICHI$Hashimoto T. O3-2 Experience with T-Dxd in HER2-positive recurrent breast cancer cases with symptomatic multiple brain metastases meningeal dissemination. The 21st Tohoku Regional Meeting of the Japanese Breast Cancer Society. 2024;33$71$YR$$F$Y$$$20240809$$MD$JP$JP
241958911$24195891$1$I$$20240731$20240809$20240809$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004488$JAZZ$$$$$F$Y$$$20240809$$CN$US$US
241958921$24195892$1$I$$20240801$20240809$20240809$PER$$US-BAUSCH-BL-2024-011881$BAUSCH AND LOMB$$$$$F$Y$$$20240809$$CN$US$US
241958931$24195893$1$I$$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125029$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240809$$CN$US$US
241958942$24195894$2$F$20240314$20240822$20240809$20240827$EXP$$US-AMERICAN REGENT INC-2024003010$AMERICAN REGENT$$36$YR$$F$Y$78$KG$20240827$$HP$US$US
241958952$24195895$2$F$$20240806$20240809$20240909$PER$$US-BAUSCH-BL-2024-011951$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240909$$CN$US$US
241958961$24195896$1$I$20240101$20240807$20240809$20240809$EXP$$US-ABBVIE-5873020$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241958971$24195897$1$I$20230101$20240807$20240809$20240809$PER$$US-JNJFOC-20240817612$JOHNSON AND JOHNSON$$4$DEC$A$$Y$$$20240809$$MD$US$US
241958981$24195898$1$I$$20240730$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122179$BRISTOL MYERS SQUIBB$Elwood KF, Warner EJ, Chang JS, Kopplin LJ. Aspergillus endophthalmitis secondary to infectious scleritis: utility of diagnostic PCR. Retinal Cases + Brief Reports. 2024;1-15. doi:10.1097/ICB.0000000000001633.$76$YR$E$M$Y$$$20240809$$MD$US$US
241958991$24195899$1$I$20190101$20240805$20240809$20240809$EXP$PL-EMA-DD-20240805-7482831-100823$PL-PERRIGO-20PL017314$PERRIGO$$43$YR$$M$Y$100$KG$20240809$$CN$PL$PL
241959002$24195900$2$F$20180101$20240812$20240809$20240826$PER$GB-MHRA-MED-202408021518269360-JPZHR$GB-PERRIGO-24GB007275$PERRIGO$$12$YR$$F$Y$$$20240826$$CN$GB$GB
241959011$24195901$1$I$20240728$20240804$20240809$20240809$EXP$GB-MHRA-MED-202408042222420250-CLGJP$GB-PERRIGO-24GB007278$PERRIGO$$$$$F$Y$70$KG$20240809$$CN$GB$GB
241959021$24195902$1$I$$20240731$20240809$20240809$PER$$US-SA-2024SA230487$SANOFI AVENTIS$$3$YR$C$M$Y$47.6$KG$20240809$$MD$US$US
241959034$24195903$4$F$$20240923$20240809$20240930$PER$$US-ALXN-202408USA000277US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240930$$$US$US
241959041$24195904$1$I$$20240808$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126284$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240809$$CN$US$US
241959064$24195906$4$F$20231222$20240919$20240809$20240925$EXP$$US-ABBVIE-5872435$ABBVIE$$26$YR$$F$Y$70.76$KG$20240925$$CN$PR$PR
241959071$24195907$1$I$20240313$20240731$20240809$20240809$EXP$FR-AFSSAPS-NT2024000875$FR-TEVA-VS-3228906$TEVA$$23$YR$$M$Y$51$KG$20240809$$MD$FR$FR
241959081$24195908$1$I$20240624$20240805$20240809$20240809$EXP$$US-ABBVIE-5869505$ABBVIE$$43$YR$$M$Y$$$20240809$$CN$US$US
241959091$24195909$1$I$$20240806$20240809$20240809$EXP$$CA-ABBVIE-5871366$ABBVIE$$$$A$$Y$$$20240809$$HP$CA$CA
241959102$24195910$2$F$20240804$20240807$20240809$20240811$EXP$$FR-ABBVIE-5871397$ABBVIE$$72$YR$$M$Y$$$20240811$$MD$FR$FR
241959121$24195912$1$I$$20240710$20240809$20240809$PER$$US-AstraZeneca-2024A158636$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$US$
241959131$24195913$1$I$$20240724$20240809$20240809$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR094215$VIIV$$$$$F$Y$$$20240809$$HP$US$US
241959151$24195915$1$I$$20240730$20240809$20240809$30DAY$$US-GSK-US2024AMR095972$GLAXOSMITHKLINE$$$$$F$Y$$$20240809$$CN$US$US
241959161$24195916$1$I$20240301$20240806$20240809$20240809$EXP$$TR-ABBVIE-5871410$ABBVIE$$38$YR$$F$Y$$$20240809$$MD$TR$TR
241959171$24195917$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227874$TEVA$$81$YR$$M$Y$$$20240809$$HP$CA$CA
241959183$24195918$3$F$20240401$20240821$20240809$20240827$EXP$$JP-GENMAB-2024-02883$GENMAB$$51$YR$$F$Y$$$20240827$$MD$JP$JP
241959191$24195919$1$I$$20240805$20240809$20240809$EXP$$PT-AstraZeneca-2024A171645$ASTRAZENECA$Correia I, Eca R, Barbosa MJ, et al.. Dress syndrome: A rare secondary response. Congress of the Portuguese society of internal medicine. 30th national congress of internal medicine 2024;846.$30$YR$$M$Y$$$20240809$$MD$PT$
241959201$24195920$1$I$$20240807$20240809$20240809$EXP$$US-ROCHE-3517824$ROCHE$$57$YR$A$F$Y$$$20240809$$HP$US$US
241959212$24195921$2$F$$20240812$20240809$20240817$PER$$US-JAZZ PHARMACEUTICALS-2024-US-012151$JAZZ$$$$$F$Y$$$20240817$$CN$US$US
241959221$24195922$1$I$$20240801$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122354$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$78.47$KG$20240809$$CN$US$US
241959231$24195923$1$I$$20240807$20240809$20240809$PER$$US-BAYER-2024A114644$BAYER$$29$YR$A$M$Y$$$20240809$$HP$US$US
241959241$24195924$1$I$20240401$20240806$20240809$20240809$EXP$$BR-ABBVIE-5871498$ABBVIE$$63$YR$$F$Y$100$KG$20240809$$CN$BR$BR
241959251$24195925$1$I$20240101$20240802$20240809$20240809$PER$$US-SA-2024SA234136$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240809$$MD$US$US
241959261$24195926$1$I$20240101$20240731$20240809$20240809$PER$$US-SA-2024SA233432$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240809$$MD$US$US
241959271$24195927$1$I$20240601$20240731$20240809$20240809$PER$$US-SA-2024SA229926$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240809$$MD$US$US
241959281$24195928$1$I$20210104$20230805$20240809$20240809$DIR$FDA-CDER-CTU-2024-54894$$FDA-CTU$$73$YR$$F$N$130$LBS$20230805$Y$CN$US$
241959291$24195929$1$I$20240301$20240807$20240809$20240809$EXP$FR-AFSSAPS-AN2024000999$FR-SA-2024SA233157$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240809$$MD$FR$FR
241959301$24195930$1$I$20240320$20240731$20240809$20240809$EXP$FR-AFSSAPS-PP2024000820$FR-TEVA-VS-3229250$TEVA$$56$YR$$F$Y$45.5$KG$20240809$$MD$FR$FR
241959311$24195931$1$I$20240804$20240806$20240809$20240809$EXP$$CO-BIOMARINAP-CO-2024-159706$BIOMARIN$$$$$$Y$$$20240809$$CN$CO$CO
241959321$24195932$1$I$20240726$20240731$20240809$20240809$EXP$$CL-BIOMARINAP-CL-2024-159677$BIOMARIN$$$$$$Y$$$20240809$$CN$CL$CL
241959332$24195933$2$F$$20240801$20240809$20240813$EXP$$US-TEVA-VS-3229034$TEVA$$79$YR$$M$Y$$$20240813$$PH$US$US
241959341$24195934$1$I$$20240807$20240809$20240809$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140223$DAIICHI$$$$$F$Y$$$20240809$$CN$US$US
241959351$24195935$1$I$20240805$20240808$20240809$20240809$PER$$US-DSJP-DSU-2024-140095$DAIICHI$$62$YR$$F$Y$$$20240809$$CN$US$US
241959361$24195936$1$I$20240716$20240717$20240809$20240809$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000638$PAREXEL$$$$$$Y$$$20240809$$PH$US$US
241959371$24195937$1$I$$20240801$20240809$20240809$PER$$US-RDY-SPO/USA/24/0011458$DR REDDYS$$69$YR$E$F$Y$$$20240809$$HP$US$US
241959381$24195938$1$I$$20240809$20240809$20240809$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044788$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240809$$CN$US$US
241959401$24195940$1$I$20240801$20240807$20240809$20240809$EXP$$JP-GENMAB-2024-02884$GENMAB$$69$YR$$M$Y$$$20240809$$MD$JP$JP
241959411$24195941$1$I$$20240804$20240809$20240809$EXP$$DE-BAYER-2024A113891$BAYER$$$$$F$Y$$$20240809$$MD$DE$DE
241959421$24195942$1$I$$20240807$20240809$20240809$EXP$$NVSC2024RU160191$NOVARTIS$$$$A$F$Y$$$20240809$$MD$RU$RU
241959432$24195943$2$F$$20240813$20240809$20240814$EXP$$SA-BIOMARINAP-SA-2024-159727$BIOMARIN$$$$$$Y$$$20240814$$CN$SA$SA
241959442$24195944$2$F$20240729$20240929$20240809$20240930$30DAY$$CO-PFIZER INC-202400227486$PFIZER$$12$YR$$M$Y$$$20240930$$CN$CO$CO
241959452$24195945$2$F$$20240807$20240809$20240814$EXP$$CA-ABBVIE-5872517$ABBVIE$$$$E$F$Y$$$20240814$$CN$CA$CA
241959461$24195946$1$I$20220101$20240730$20240809$20240809$PER$$US-ABBVIE-5861593$ABBVIE$$$$$$Y$$$20240809$$CN$US$US
241959475$24195947$5$F$$20240909$20240809$20240912$EXP$$US-SA-2024SA232498$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240912$$CN$US$US
241959481$24195948$1$I$$20240809$20240809$20240809$PER$$NVSC2024US162583$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241959491$24195949$1$I$20240518$20240731$20240809$20240809$EXP$$US-TEVA-VS-3229590$TEVA$$52$YR$$M$Y$95.4$KG$20240809$$HP$US$US
241959503$24195950$3$F$20240723$20240815$20240809$20240822$EXP$$NVSC2024US162257$NOVARTIS$$71$YR$$M$Y$114$KG$20240822$$MD$US$US
241959511$24195951$1$I$$20240805$20240809$20240809$EXP$NL-LRB-00993315$NL-MYLANLABS-2024M1072888$MYLAN$$33$YR$$F$Y$70$KG$20240809$$CN$NL$NL
241959521$24195952$1$I$20240617$20240725$20240809$20240809$DIR$FDA-CDER-CTU-2024-54902$$FDA-CTU$$54$YR$$F$N$122$LBS$20240725$N$CN$US$
241959531$24195953$1$I$20240510$20240804$20240804$20240804$DIR$712849$$FDA-CTU$$$$$M$N$$$20240804$N$CN$US$
241959541$24195954$1$I$20240510$20240804$20240804$20240804$DIR$712849$$FDA-CTU$$55$YR$$F$N$58.5$KG$20240804$N$CN$US$
241959561$24195956$1$I$$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54890$$FDA-CTU$$$$$F$N$$$20240807$N$PH$US$
241959571$24195957$1$I$$20240809$20240809$20240809$DIR$713590$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241959591$24195959$1$I$20240101$20240806$20240809$20240809$EXP$$US-ABBVIE-5871113$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241959601$24195960$1$I$$20240716$20240809$20240809$PER$$US-JNJFOC-20240747372$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240809$$CN$US$US
241959611$24195961$1$I$$20240807$20240809$20240809$PER$$US-TAKEDA-2024TUS079294$TAKEDA$$4$DEC$$F$Y$$$20240809$$CN$US$US
241959621$24195962$1$I$$20240806$20240809$20240809$EXP$$JP-AstraZeneca-2024A179736$ASTRAZENECA$Motoyoshi Y, et al. OS11-1 Initial experience with durvalumab + tremelimumab therapy for. The 30th Japan Association of Systemic Therapy for HCC 2024;$$$A$$Y$$$20240809$$MD$JP$
241959632$24195963$2$F$$20240815$20240809$20240828$PER$$US-SA-2024SA230768$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240828$$MD$US$US
241959651$24195965$1$I$$20240625$20240809$20240809$EXP$$NVSC2024CA162442$NOVARTIS$$$$$$Y$$$20240809$$CN$CA$CA
241959661$24195966$1$I$20240618$20240807$20240809$20240809$EXP$FR-AFSSAPS-TO2024001139$FR-TAKEDA-2024TUS064226$TAKEDA$$73$YR$$M$Y$93$KG$20240809$$HP$FR$FR
241959671$24195967$1$I$$20240729$20240809$20240809$EXP$$PK-BRISTOL-MYERS SQUIBB COMPANY-2024-121105$BRISTOL MYERS SQUIBB$Akhtar MZ, Tayab GUN, Nawaz MI, Seher I. Excessive dynamic airway collapse after entecavir use in a patient with pegylated interferon-induced undifferentiated connective tissue disease and entecavir use to prevent hepatitis B virus reactivation upon giving rituximab. Cureus. 2024 Jun 21;16(6):1-7.doi:10.7759/cureus.62835.$49$YR$A$F$Y$$$20240809$$HP$PK$PK
241959681$24195968$1$I$$20240807$20240809$20240809$EXP$$US-GILEAD-2024-0683474$GILEAD$$59$YR$A$M$Y$$$20240809$$CN$US$US
241959701$24195970$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5870904$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241959712$24195971$2$F$20221206$20240906$20240809$20240912$EXP$$US-TAKEDA-2022TUS094199$TAKEDA$$71$YR$$M$Y$$$20240912$$CN$US$US
241959721$24195972$1$I$$20240722$20240809$20240809$PER$$US-TEVA-VS-3226208$TEVA$$82$YR$$F$Y$$$20240809$$HP$US$US
241959731$24195973$1$I$$20240808$20240809$20240809$EXP$$NVSC2024GB121815$NOVARTIS$$$$$$Y$$$20240809$$CN$GB$GB
241959741$24195974$1$I$20240806$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408005294$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240809$$CN$US$US
241959765$24195976$5$F$20240101$20240920$20240809$20240924$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-139907$DAIICHI$$$$$M$Y$$$20240924$$CN$US$US
241959771$24195977$1$I$20240724$20240805$20240809$20240809$EXP$IT-MINISAL02-997107$IT-REGENERON PHARMACEUTICALS, INC.-2024-108136$REGENERON$$65$YR$$M$Y$$$20240809$$MD$IT$IT
241959781$24195978$1$I$$20240808$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126036$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240809$$HP$US$US
241959791$24195979$1$I$20240710$20240809$20240809$20240809$DIR$713610$$FDA-CTU$$56$YR$$F$N$59.6$KG$20240809$N$HP$US$
241959801$24195980$1$I$20231116$20240809$20240809$20240809$DIR$713606$$FDA-CTU$$36$YR$$F$N$90$KG$20240809$N$CN$US$
241959811$24195981$1$I$20240809$20240809$20240809$20240809$DIR$713613$$FDA-CTU$$49$YR$$F$N$$$20240809$N$HP$US$
241959821$24195982$1$I$20231025$20240809$20240809$20240809$DIR$713618$$FDA-CTU$$53$YR$$F$N$119.25$KG$20240809$N$MD$US$
241959842$24195984$2$F$20240624$20240729$20240809$20240812$EXP$$US-SMPA-2024SPA000371$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
241959851$24195985$1$I$$20240731$20240809$20240809$EXP$$US-SA-2024SA231770$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240809$$MD$US$US
241959861$24195986$1$I$20240622$20240730$20240809$20240809$EXP$FR-AFSSAPS-GR2024000921$FR-TEVA-VS-3228480$TEVA$$70$YR$$M$Y$79$KG$20240809$$PH$FR$FR
241959872$24195987$2$F$20240805$20240805$20240809$20240814$PER$$US-SA-2024SA232482$SANOFI AVENTIS$$56$YR$A$M$Y$83.914$KG$20240814$$MD$US$US
241959882$24195988$2$F$$20240809$20240809$20240812$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044806$BOEHRINGER INGELHEIM$$$$$$Y$$$20240812$$MD$US$US
241959891$24195989$1$I$$20240809$20240809$20240809$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044812$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240809$$CN$US$US
241959901$24195990$1$I$20240725$20240808$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126234$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$73.94$KG$20240809$$CN$US$US
241959911$24195991$1$I$20240101$20240808$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126229$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240809$$CN$US$US
241959922$24195992$2$F$$20240829$20240809$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126133$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240902$$HP$US$US
241959931$24195993$1$I$$20240805$20240809$20240809$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125217$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240809$$PH$JP$JP
241959943$24195994$3$F$$20240815$20240809$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126192$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240821$$CN$US$US
241959951$24195995$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5865999$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241959961$24195996$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5865111$ABBVIE$$$$$M$Y$$$20240809$$HP$US$US
241959972$24195997$2$F$20230410$20240814$20240809$20240815$EXP$$ES-ROCHE-10000050253$ROCHE$$24$YR$A$F$Y$$$20240815$$MD$ES$ES
241959981$24195998$1$I$20240805$20240805$20240809$20240809$PER$$US-ALXN-202408USA000257US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
241959991$24195999$1$I$20240701$20240806$20240809$20240809$PER$$US-JNJFOC-20240814512$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$CN$US$US
241960001$24196000$1$I$20240717$20240807$20240809$20240809$EXP$$US-ABBVIE-5872863$ABBVIE$$35$YR$$M$Y$$$20240809$$CN$US$US
241960011$24196001$1$I$$20240802$20240809$20240809$PER$$NVSC2024US162604$NOVARTIS$$$$$$Y$$$20240809$$PH$US$US
241960021$24196002$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227790$TEVA$$40$YR$$F$Y$$$20240809$$HP$CA$CA
241960031$24196003$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227808$TEVA$$2$YR$$M$Y$14$KG$20240809$$HP$CA$CA
241960041$24196004$1$I$$20240730$20240809$20240809$EXP$$US-RADIUS HEALTH INC.-2024US005888$RADIUS PHARM$$$$$F$Y$$$20240809$$CN$US$US
241960051$24196005$1$I$$20240805$20240809$20240809$EXP$$NVSC2024US162266$NOVARTIS$Hernandez K, Ahmed T, Liu D, Seiter K, Steinberg A. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. BLOOD. 2023;142 (Suppl 1):7349-50$28$YR$$M$Y$$$20240809$$HP$US$US
241960061$24196006$1$I$$20240807$20240809$20240809$PER$$US-JNJFOC-20240817683$JOHNSON AND JOHNSON$$$$$$Y$$$20240809$$HP$US$US
241960071$24196007$1$I$$20240730$20240809$20240809$30DAY$$CO-PFIZER INC-202400226642$PFIZER$$$$$M$Y$$$20240809$$CN$CO$CO
241960081$24196008$1$I$20240701$20240802$20240809$20240809$EXP$FI-FIMEA-202402698$FI-BAUSCH-BL-2024-012059$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240809$$PH$FI$FI
241960091$24196009$1$I$20240805$20240807$20240809$20240809$PER$$US-JNJFOC-20240818023$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$HP$US$US
241960102$24196010$2$F$$20240809$20240809$20240812$EXP$$AU-AstraZeneca-2024A181257$ASTRAZENECA$Dhaliwal N, Roberts D.. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study.. Clin-Toxicol-(Phila). 2024;1-6.$$$$$Y$$$20240812$$HP$AU$
241960122$24196012$2$F$20240801$20240916$20240809$20240921$EXP$$US-ABBVIE-5871245$ABBVIE$$26$YR$$M$Y$$$20240921$$CN$US$US
241960131$24196013$1$I$20240101$20240806$20240809$20240809$EXP$$US-ABBVIE-5870448$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241960141$24196014$1$I$20240711$20240715$20240809$20240809$PER$$US-FMCRTG-FMC-2407-000850$FRESENIUS MEDICAL CARE$$67$YR$E$F$Y$64$KG$20240809$$HP$US$US
241960151$24196015$1$I$20220101$20240729$20240809$20240809$EXP$$GB-TAKEDA-2024TUS079083$TAKEDA$$87$YR$$F$Y$$$20240809$$HP$GB$GB
241960161$24196016$1$I$$20240708$20240809$20240809$PER$$US-FMCRTG-FMC-2407-000822$FRESENIUS MEDICAL CARE$$73$YR$E$F$Y$$$20240809$$HP$US$US
241960171$24196017$1$I$$20240715$20240809$20240809$PER$$US-FMCRTG-FMC-2407-000881$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240809$$CN$US$US
241960181$24196018$1$I$$20240714$20240809$20240809$PER$$US-FMCRTG-FMC-2407-000889$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240809$$CN$US$US
241960192$24196019$2$F$20240701$20240808$20240809$20240814$EXP$$US-BAUSCH-BL-2024-002494$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240814$$CN$US$US
241960201$24196020$1$I$20240101$20240806$20240809$20240809$EXP$$US-ABBVIE-5870738$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241960212$24196021$2$F$20240801$20240905$20240809$20240908$EXP$$BG-ABBVIE-5873373$ABBVIE$$70$YR$$F$Y$$$20240908$$CN$BG$BG
241960241$24196024$1$I$$20240802$20240809$20240809$EXP$$US-ROCHE-10000050048$ROCHE$$$$$$Y$$$20240809$$CN$US$US
241960251$24196025$1$I$$20240808$20240809$20240809$PER$$US-HALEON-2191243$Haleon PLC$$$$$$Y$$$20240809$$CN$US$US
241960261$24196026$1$I$$20240730$20240809$20240809$EXP$$CA-TEVA-202310_00014542$TEVA$$53$YR$$M$Y$72$KG$20240809$$CN$CA$CA
241960271$24196027$1$I$20240801$20240808$20240809$20240809$EXP$$IT-ABBVIE-5874633$ABBVIE$$80$YR$$M$Y$$$20240809$$CN$IT$IT
241960282$24196028$2$F$$20240805$20240809$20240814$PER$$US-SA-2024SA234158$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240814$$HP$US$US
241960291$24196029$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA232119$SANOFI AVENTIS$$$$A$$Y$127$KG$20240809$$MD$US$US
241960301$24196030$1$I$$20240805$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408003235$ELI LILLY AND CO$$87$YR$E$F$Y$$$20240809$$CN$US$US
241960321$24196032$1$I$20240101$20240807$20240809$20240809$EXP$$CA-ABBVIE-5874124$ABBVIE$$$$E$M$Y$$$20240809$$CN$CA$CA
241960332$24196033$2$F$$20240812$20240809$20240812$PER$$US-JNJFOC-20240818318$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$HP$US$US
241960341$24196034$1$I$$20240731$20240809$20240809$EXP$$PT-BAUSCH-BL-2024-011761$BAUSCH AND LOMB$Brito-Santana L, Medinas R, Neves A, Gago J. Steroid-induced psychosis: A spectrum of neuropsychiatric glucocorticoid side effects.. BMJ case reports. 2024;17(7):1-5. doi:10.1136/bcr-2023-259134$5$DEC$$M$Y$$$20240809$$MD$PT$PT
241960351$24196035$1$I$20240806$20240806$20240809$20240809$EXP$$US-ABBVIE-5870926$ABBVIE$$40$YR$$F$Y$$$20240809$$CN$US$US
241960363$24196036$3$F$20210219$20240904$20240809$20240909$EXP$$US-ABBVIE-5871744$ABBVIE$$59$YR$$F$Y$80$KG$20240909$$CN$US$US
241960371$24196037$1$I$20240701$20240806$20240809$20240809$EXP$$IT-ABBVIE-5871371$ABBVIE$$72$YR$$M$Y$$$20240809$$CN$IT$IT
241960381$24196038$1$I$20240501$20240806$20240809$20240809$EXP$$US-ABBVIE-5870818$ABBVIE$$68$YR$$F$Y$$$20240809$$CN$US$US
241960391$24196039$1$I$$20240805$20240809$20240809$EXP$$US-ABBVIE-5797787$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241960401$24196040$1$I$20230101$20240802$20240809$20240809$EXP$$US-ABBVIE-5709895$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241960411$24196041$1$I$$20240802$20240809$20240809$PER$$US-APELLIS-2024-APL-0000644$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240809$$CN$US$US
241960431$24196043$1$I$20240601$20240807$20240809$20240809$PER$$US-BAUSCH-BL-2024-012061$BAUSCH AND LOMB$$53$YR$$F$Y$$$20240809$$HP$US$US
241960442$24196044$2$F$20240517$20240909$20240809$20240920$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00192$OPKO HEALTH$$68$YR$$F$Y$107.85$KG$20240918$$PH$US$US
241960451$24196045$1$I$$20240731$20240809$20240809$PER$$US-JNJFOC-20240823475$JOHNSON AND JOHNSON$$$$$F$Y$$$20240809$$HP$US$US
241960461$24196046$1$I$$20240807$20240809$20240809$PER$$NVSC2024US161686$NOVARTIS$$$$$$Y$$$20240809$$CN$US$US
241960471$24196047$1$I$20240301$20240528$20240809$20240809$EXP$$US-PFIZER INC-PV202400070451$PFIZER$$70$YR$$M$Y$$$20240809$$CN$US$US
241960481$24196048$1$I$$20240808$20240809$20240809$EXP$$DE-BAUSCH-BL-2024-012106$BAUSCH AND LOMB$$$$$M$Y$$$20240809$$CN$DE$DE
241960501$24196050$1$I$$20240802$20240809$20240809$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-123416$BRISTOL MYERS SQUIBB$$37$YR$A$M$Y$$$20240809$$MD$PL$PL
241960511$24196051$1$I$$20240801$20240809$20240809$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122395$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240809$$MD$CA$CA
241960521$24196052$1$I$$20240805$20240809$20240809$EXP$$US-BAUSCH-BL-2024-011945$BAUSCH AND LOMB$Sheth S, Matthia E, Naik D. Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer. Journal of Clinical Lipidology. 2024 JUL 01;18(4):E555-E556. doi:10.1016/j.jacl.2024.04.091$57$YR$$F$Y$$$20240809$$HP$US$US
241960532$24196053$2$F$20240808$20240823$20240809$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126359$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$68.04$KG$20240826$$CN$US$US
241960541$24196054$1$I$20231101$20240802$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124112$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240809$$CN$US$US
241960551$24196055$1$I$20240728$20240802$20240809$20240809$EXP$GB-MHRA-MED-202408012207433700-JHTSR$GB-BAUSCH-BL-2024-012121$BAUSCH AND LOMB$$50$YR$$M$Y$86$KG$20240809$$CN$GB$GB
241960561$24196056$1$I$20240101$20240807$20240809$20240809$EXP$$US-BAUSCH-BL-2024-012021$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240809$$CN$US$US
241960571$24196057$1$I$20240807$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54949$$FDA-CTU$$53$YR$$F$N$72.57$KG$20240807$N$CN$US$
241960591$24196059$1$I$20240801$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54919$$FDA-CTU$$78$YR$$F$N$68.8$KG$20240807$N$PH$US$
241960601$24196060$1$I$20240807$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54948$$FDA-CTU$$48$YR$$F$N$$$20240807$N$HP$US$
241960611$24196061$1$I$20240807$20240807$20240807$20240807$DIR$FDA-CDER-CTU-2024-54908$$FDA-CTU$$47$YR$$F$N$109$KG$20240807$N$HP$US$
241960621$24196062$1$I$$20240807$20240809$20240809$EXP$$DE-ROCHE-10000052089$ROCHE$$$$A$F$Y$$$20240809$$MD$DE$DE
241960631$24196063$1$I$20240209$20240807$20240809$20240809$EXP$$DE-BEIGENE-BGN-2024-012455$BEIGENE$$$$$$Y$$$20240809$$MD$DE$DE
241960642$24196064$2$F$20230421$20240809$20240809$20240814$30DAY$$BR-SANDOZ INC.-NVSC2023BR099981$SANDOZ$$13$YR$$M$Y$56$KG$20240814$$CN$BR$BR
241960661$24196066$1$I$20231101$20240805$20240809$20240809$EXP$$BE-APELLIS-2024-APL-0000662$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240809$$MD$BE$BE
241960671$24196067$1$I$20240730$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125166$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240809$$HP$US$US
241960691$24196069$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125849$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240809$$CN$US$US
241960701$24196070$1$I$20240712$20240804$20240809$20240809$EXP$$CN-SANDOZ INC.-SDZ2024CN071535$SANDOZ$$9$YR$$M$Y$$$20240809$$HP$CN$CN
241960712$24196071$2$F$$20240823$20240809$20240905$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US002547$PAREXEL$$$$$$Y$$$20240904$$HP$US$US
241960721$24196072$1$I$$20240807$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2024US061051$SANDOZ$$$$$$Y$$$20240809$$CN$US$US
241960731$24196073$1$I$$20240808$20240809$20240809$PER$$NVSC2024US162304$NOVARTIS$$$$$F$Y$$$20240809$$MD$US$US
241960741$24196074$1$I$20190809$20240806$20240809$20240809$PER$$US-TAKEDA-US201926606$TAKEDA$$41$YR$$F$Y$85$KG$20240809$$MD$US$US
241960781$24196078$1$I$20240724$20240731$20240809$20240809$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095702$VIIV$$63$YR$$F$Y$$$20240809$$CN$US$US
241960791$24196079$1$I$$20240807$20240809$20240809$PER$$US-ABBVIE-5872974$ABBVIE$$$$$$Y$$$20240809$$HP$US$US
241960801$24196080$1$I$$20240808$20240809$20240809$EXP$$US-SANDOZ INC.-SDZ2024US071659$SANDOZ$$$$$M$Y$$$20240809$$CN$US$US
241960811$24196081$1$I$20240101$20240807$20240809$20240809$EXP$$US-BAUSCH-BL-2024-012064$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240809$$CN$US$US
241960821$24196082$1$I$$20240807$20240809$20240809$EXP$$US-ABBVIE-5872043$ABBVIE$$$$$$Y$$$20240809$$CN$US$US
241960832$24196083$2$F$20240804$20240830$20240809$20240904$EXP$$JP-OTSUKA-2024_021718$OTSUKA$$8$DEC$$M$Y$$$20240904$$MD$JP$JP
241960842$24196084$2$F$20240601$20240809$20240809$20240812$EXP$GB-MHRA-MED-202408041059565410-BZPCS$GB-TEVA-VS-3230432$TEVA$$21$YR$$M$Y$$$20240812$$CN$GB$GB
241960851$24196085$1$I$20240531$20240809$20240809$20240809$EXP$FR-AFSSAPS-LY2024000954$FR-SANDOZ INC.-SDZ2024FR071665$SANDOZ$$48$YR$$M$Y$85$KG$20240809$$PH$FR$FR
241960861$24196086$1$I$$20240731$20240809$20240809$PER$$US-Kiniksa Pharmaceuticals Ltd.-2024KPU001302$KINIKSA PHARMACEUTICALS$$$$$M$Y$$$20240808$$MD$US$US
241960871$24196087$1$I$$20240730$20240809$20240809$EXP$$GB-TEVA-VS-3229381$TEVA$$53$YR$$F$Y$$$20240809$$HP$GB$GB
241960881$24196088$1$I$20230101$20240809$20240809$20240809$EXP$$DE-SANDOZ INC.-SDZ2024DE071629$SANDOZ$$49$YR$$F$Y$67$KG$20240809$$CN$DE$DE
241960891$24196089$1$I$$20240808$20240809$20240809$EXP$$US-INCYTE CORPORATION-2024IN008329$INCYTE$$$$$$Y$$$20240809$$MD$US$US
241960901$24196090$1$I$20150101$20240731$20240809$20240809$EXP$FR-AFSSAPS-AVLY2024000108$FR-TEVA-VS-3229008$TEVA$$18$YR$$F$Y$55$KG$20240809$$MD$FR$FR
241960911$24196091$1$I$$20240731$20240809$20240809$PER$$US-INCYTE CORPORATION-2024IN008059$INCYTE$$$$$$Y$$$20240809$$CN$US$US
241960941$24196094$1$I$$20240730$20240809$20240809$EXP$$US-FMCRTG-FMC-2407-000924$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240809$$CN$US$US
241960951$24196095$1$I$$20240730$20240809$20240809$EXP$$US-FMCRTG-FMC-2408-000933$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240809$$HP$US$US
241960961$24196096$1$I$20240725$20240729$20240809$20240809$EXP$$US-FMCRTG-FMC-2407-000926$FRESENIUS MEDICAL CARE$$35$YR$A$M$Y$102.5$KG$20240809$$HP$US$US
241960973$24196097$3$F$$20240917$20240809$20240919$EXP$$GB-SANDOZ INC.-NVSC2021GB063714$SANDOZ$$$$$M$Y$$$20240919$$CN$GB$GB
241960981$24196098$1$I$$20240808$20240809$20240809$EXP$$US-INCYTE CORPORATION-2024IN008340$INCYTE$$$$$$Y$$$20240809$$MD$US$US
241960992$24196099$2$F$$20240823$20240809$20240905$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US002549$PAREXEL$$$$$$Y$$$20240904$$HP$US$US
241961001$24196100$1$I$$20240725$20240809$20240809$30DAY$$US-Kaleo, Inc.-2024KL000028$KALEO$$14$YR$T$M$Y$$$20240808$$CN$US$US
241961011$24196101$1$I$$20240730$20240809$20240809$30DAY$$US-Kaleo, Inc.-2024KL000029$KALEO$$27$YR$A$F$Y$$$20240808$$CN$US$US
241961021$24196102$1$I$$20240807$20240809$20240809$EXP$$GB-SANDOZ INC.-SDZ2024GB071493$SANDOZ$$$$$F$Y$$$20240809$$CN$GB$GB
241961031$24196103$1$I$20240804$20240806$20240809$20240809$EXP$$US-ABBVIE-5871004$ABBVIE$$21$YR$$F$Y$$$20240809$$CN$US$US
241961041$24196104$1$I$$20240725$20240809$20240809$PER$$US-TEVA-VS-3227490$TEVA$$67$YR$$F$Y$$$20240809$$MD$US$US
241961051$24196105$1$I$20240701$20240801$20240809$20240809$PER$$US-INCYTE CORPORATION-2024IN008105$INCYTE$$$$$$Y$$$20240809$$CN$US$US
241961061$24196106$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227872$TEVA$$72$YR$$M$Y$86$KG$20240809$$PH$CA$CA
241961072$24196107$2$F$20240301$20240821$20240809$20240822$EXP$$FR-SANDOZ INC.-SDZ2024FR069951$SANDOZ$Fidan I, Delamotte E, Colombier M, et al.. Non-surgical Treatment of Severe Drug-Influenced Gingival Enlargement: A Report of Two Cases. Cureus. 2024;16(6):e63214$58$YR$$M$Y$$$20240822$$HP$FR$FR
241961081$24196108$1$I$$20240808$20240809$20240809$PER$$NVSC2024US162628$NOVARTIS$$$$$$Y$$$20240809$$HP$US$US
241961101$24196110$1$I$$20240805$20240809$20240809$EXP$$US-INCYTE CORPORATION-2024IN008197$INCYTE$$$$$$Y$$$20240809$$CN$US$US
241961111$24196111$1$I$$20240805$20240809$20240809$EXP$$US-INCYTE CORPORATION-2024IN008203$INCYTE$$$$$$Y$$$20240809$$CN$US$US
241961122$24196112$2$F$$20240816$20240809$20240830$PER$AT-JNJFOC-20240757456$AT-RIGEL-20240800030$RIGEL PHARMACEUTICALS$$47$YR$$M$Y$$$20240830$$MD$AT$AT
241961131$24196113$1$I$20240806$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125253$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240809$$CN$US$US
241961141$24196114$1$I$$20240807$20240809$20240809$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125691$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240809$$HP$US$US
241961161$24196116$1$I$$20240729$20240809$20240809$EXP$$EU-RADIUS HEALTH, INC.-2024ES005928$RADIUS PHARM$$$$$F$Y$$$20240809$$PH$EU$ES
241961171$24196117$1$I$20170101$20240801$20240809$20240809$EXP$$DE-BIOGEN-2024BI01276725$BIOGEN$$$$$M$Y$$$20240809$$MD$DE$DE
241961181$24196118$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004522$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240809$$CN$US$US
241961191$24196119$1$I$$20240802$20240809$20240809$EXP$$US-TAKEDA-2024TUS066860$TAKEDA$$$$$F$Y$84.485$KG$20240809$$CN$US$US
241961201$24196120$1$I$$20240726$20240809$20240809$PER$$US-JNJFOC-20240777202$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240809$$CN$US$US
241961211$24196121$1$I$20240616$20240806$20240809$20240809$EXP$$CN-ASTELLAS-2024US022676$ASTELLAS$$61$YR$$M$Y$60$KG$20240809$$CN$CN$CN
241961222$24196122$2$F$20240805$20240911$20240809$20240926$EXP$$US-SA-2023SA387807$SANOFI AVENTIS$$18$YR$A$F$Y$49.895$KG$20240926$$MD$US$US
241961231$24196123$1$I$20240710$20240805$20240809$20240809$PER$$US-ROCHE-10000050360$ROCHE$$43$YR$A$F$Y$$$20240809$$CN$US$US
241961241$24196124$1$I$$20240729$20240809$20240809$EXP$$GB-CIPHER-2024-UK-000004$CIPHER$Safety update: tramadol-warfarin interaction.DRUG AND THERAPEUTICS BULLETIN.2024;0(0):1. Warfarin: be alert to the risk of drug interactions with?tramadol..Drug Safety Update.2024;17(2):.$$$$UNK$Y$$$20240809$$HP$GB$GB
241961251$24196125$1$I$$20240731$20240809$20240809$EXP$$US-RADIUS HEALTH, INC.-2024US005964$RADIUS PHARM$$$$$F$Y$$$20240809$$CN$US$US
241961262$24196126$2$F$20231101$20240805$20240809$20240819$EXP$IT-MINISAL02-997767$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-123621$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240819$$MD$IT$IT
241961271$24196127$1$I$$20240808$20240809$20240809$PER$$NVSC2024US162558$NOVARTIS$$$$$$Y$$$20240809$$MD$US$US
241961281$24196128$1$I$20240524$20240806$20240809$20240809$EXP$$US-MYLANLABS-2024M1074136$MYLAN$$16$YR$$F$Y$$$20240809$$HP$US$US
241961291$24196129$1$I$20240701$20240803$20240809$20240809$PER$$US-Millicent Holdings Ltd.-MILL20241075$MILLICENT HOLDINGS$$62$YR$A$F$Y$$$20240809$$CN$COUNTRY NOT SPECIFIED$US
241961301$24196130$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227826$TEVA$$62$YR$$F$Y$$$20240809$$MD$CA$CA
241961312$24196131$2$F$$20240807$20240809$20240817$EXP$$NL-TEVA-VS-3230067$TEVA$$38$YR$$F$Y$$$20240817$$CN$NL$NL
241961321$24196132$1$I$20000916$20240731$20240809$20240809$EXP$$GB-TEVA-VS-3146620$TEVA$$86$YR$$F$Y$56$KG$20240809$$MD$DE$DE
241961331$24196133$1$I$$20240806$20240809$20240809$EXP$$GB-TAKEDA-2024TUS079624$TAKEDA$$$$$M$Y$$$20240809$$CN$GB$GB
241961341$24196134$1$I$$20240806$20240809$20240809$EXP$$BR-ORGANON-O2408BRA000731$ORGANON$$$$$F$Y$$$20240809$$HP$BR$BR
241961351$24196135$1$I$20240522$20240801$20240809$20240809$EXP$DE-CADRBFARM-2024329507$DE-TEVA-VS-3229300$TEVA$$32$YR$$F$Y$53$KG$20240809$$CN$DE$DE
241961361$24196136$1$I$$20240805$20240809$20240809$EXP$$GB-TAKEDA-2024TUS079347$TAKEDA$$$$$F$Y$$$20240809$$CN$GB$GB
241961371$24196137$1$I$$20240806$20240809$20240809$EXP$$US-PURDUE-USA-2024-0311247$PURDUE$Nicolet N, Bhagia A, Torve M, Tribby K, Poppinga N, McKay K, Talavera-Barber MM. The Epidemic of Congenital Syphilis in the Indigenous and Rural Populations of South Dakota. Pediatrics. 2024;154(1):e2023063823$29$YR$$F$Y$$$20240809$$HP$US$US
241961381$24196138$1$I$$20240806$20240809$20240809$EXP$$US-PURDUE-USA-2024-0311246$PURDUE$Nicolet N, Bhagia A, Torve M, Tribby K, Poppinga N, McKay K, Talavera-Barber MM.. The Epidemic of Congenital Syphilis in the Indigenous and Rural Populations of South Dakota. Pediatrics. 2024;154(1):e2023063823$33$YR$$F$Y$$$20240809$$HP$US$US
241961391$24196139$1$I$$20240806$20240809$20240809$EXP$$AU-PURDUE PHARMA-USA-2024-0311245$PURDUE$Malkopoulos A., Mason R., Pillai S., Dzienis M., et al.. Immune-related colitis presenting with constipation. BMJ Case Reports. 2024;17(7):e258940$6$DEC$$M$Y$$$20240809$$MD$AU$AU
241961411$24196141$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227836$TEVA$$78$YR$$F$Y$$$20240809$$HP$CA$CA
241961421$24196142$1$I$$20240801$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408000936$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240809$$CN$US$US
241961431$24196143$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227828$TEVA$$79$YR$$M$Y$80$KG$20240809$$HP$CA$CA
241961441$24196144$1$I$$20240808$20240809$20240809$PER$$US-PURDUE PHARMA-USA-2024-0311253$PURDUE$$42$YR$$F$Y$$$20240809$$CN$US$US
241961452$24196145$2$F$20240101$20240903$20240809$20240912$PER$$US-SA-2024SA232690$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240912$$MD$US$US
241961462$24196146$2$F$20240101$20240822$20240809$20240917$PER$$US-SA-2024SA232739$SANOFI AVENTIS$$10$YR$C$M$Y$33.11$KG$20240918$$MD$US$US
241961471$24196147$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227855$TEVA$$35$YR$$F$Y$$$20240809$$HP$CA$CA
241961481$24196148$1$I$$20240730$20240809$20240809$EXP$$CO-INCYTE CORPORATION-2024IN008067$INCYTE$$$$$$Y$$$20240809$$CN$CO$CO
241961491$24196149$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227842$TEVA$$69$YR$$F$Y$$$20240809$$HP$CA$CA
241961501$24196150$1$I$$20240730$20240809$20240809$EXP$$GB-INCYTE CORPORATION-2024IN008068$INCYTE$$$$$$Y$$$20240809$$HP$GB$GB
241961511$24196151$1$I$$20240516$20240809$20240809$PER$$US-GE HEALTHCARE-2024CSU005367$GE HEALTHCARE$$$$$$Y$$$20240809$$HP$US$US
241961521$24196152$1$I$20240101$20240806$20240809$20240809$PER$$US-ALKERMES INC.-ALK-2024-002063$ALKERMES$$$$$F$Y$$$20240809$$HP$US$US
241961532$24196153$2$F$$20240807$20240809$20240820$PER$$US-GILEAD-2024-0683316$GILEAD$$56$YR$A$M$Y$$$20240820$$CN$US$US
241961541$24196154$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA232958$SANOFI AVENTIS$$$$A$F$Y$$$20240809$$CN$US$US
241961551$24196155$1$I$$20240806$20240809$20240809$PER$$US-ROCHE-10000051000$ROCHE$$34$YR$A$F$Y$$$20240809$$CN$US$US
241961561$24196156$1$I$$20240802$20240809$20240809$PER$$US-INCYTE CORPORATION-2024IN008131$INCYTE$$$$$$Y$$$20240809$$CN$US$US
241961572$24196157$2$F$20240725$20240731$20240809$20240809$EXP$$US-ALKERMES INC.-ALK-2024-002022$ALKERMES$$23$YR$$$Y$54.422$KG$20240809$$CN$US$US
241961581$24196158$1$I$20240101$20240731$20240809$20240809$EXP$$US-ALKERMES INC.-ALK-2024-002070$ALKERMES$$$$$M$Y$$$20240809$$CN$US$US
241961593$24196159$3$F$20240726$20240916$20240809$20240927$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-IBA-000292$Unknown Manufacturer$$$$$$Y$$$20240927$$MD$US$US
241961601$24196160$1$I$20240725$20240805$20240809$20240809$EXP$$US-ALKERMES INC.-ALK-2024-002065$ALKERMES$$24$YR$$M$Y$$$20240809$$HP$US$US
241961611$24196161$1$I$$20240807$20240809$20240809$EXP$$CN-AstraZeneca-2024A180644$ASTRAZENECA$$$$$M$Y$$$20240809$$CN$CN$
241961621$24196162$1$I$$20240806$20240809$20240809$PER$$US-DSJP-DSU-2024-140051$DAIICHI$$$$$F$Y$$$20240809$$MD$US$US
241961642$24196164$2$F$20240527$20240815$20240809$20240820$EXP$$CN-PFIZER INC-202400231920$PFIZER$$21$YR$$M$Y$72.5$KG$20240820$$HP$CN$CN
241961651$24196165$1$I$$20240730$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019801$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240809$$CN$US$US
241961661$24196166$1$I$20220101$20240729$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019336$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240809$$CN$US$US
241961671$24196167$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407301556389470-YKFVS$GB-ELI_LILLY_AND_COMPANY-GB202407020420$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$GB$GB
241961681$24196168$1$I$$20240729$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019170$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240809$$CN$US$US
241961691$24196169$1$I$20240719$20240730$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019928$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240809$$CN$US$US
241961701$24196170$1$I$$20240729$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019510$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241961711$24196171$1$I$20240728$20240730$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019719$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240809$$CN$US$US
241961721$24196172$1$I$20240627$20240731$20240809$20240809$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408002678$ELI LILLY AND CO$$61$YR$A$M$Y$52$KG$20240809$$CN$DE$CN
241961731$24196173$1$I$$20240802$20240809$20240809$EXP$GB-MHRA-MED-202408011630127860-BDFMK$GB-ELI_LILLY_AND_COMPANY-GB202408002626$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$GB$GB
241961741$24196174$1$I$$20240729$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407015747$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240809$$CN$DE$US
241961751$24196175$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407301118248480-HMDVR$GB-ELI_LILLY_AND_COMPANY-GB202407020204$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$GB$GB
241961761$24196176$1$I$20240715$20240730$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019704$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240809$$CN$US$US
241961771$24196177$1$I$$20240729$20240809$20240809$EXP$GB-MHRA-MED-202407291247154250-BJYPC$GB-ELI_LILLY_AND_COMPANY-GB202407019220$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$GB$GB
241961781$24196178$1$I$20240521$20240730$20240809$20240809$EXP$FR-AFSSAPS-NC2024000916$FR-ELI_LILLY_AND_COMPANY-FR202407020165$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240809$$CN$FR$FR
241961791$24196179$1$I$$20240731$20240809$20240809$EXP$GB-MHRA-MED-202407311157498130-FKZLG$GB-TEVA-VS-3228533$TEVA$$$$$$Y$$$20240809$$PH$GB$GB
241961801$24196180$1$I$$20240730$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000381$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241961811$24196181$1$I$$20240801$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002170$ELI LILLY AND CO$$$$A$F$Y$$$20240809$$CN$US$US
241961821$24196182$1$I$20240201$20240729$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019720$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240809$$CN$US$US
241961831$24196183$1$I$20240616$20240729$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407018800$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240809$$CN$US$US
241961841$24196184$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407251314235980-SKGJW$GB-ELI_LILLY_AND_COMPANY-GB202407019259$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$GB$GB
241961851$24196185$1$I$$20240730$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019910$ELI LILLY AND CO$$$$$$Y$$$20240809$$CN$US$US
241961861$24196186$1$I$$20240730$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019802$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240809$$CN$US$US
241961871$24196187$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407301600574960-SWVLB$GB-ELI_LILLY_AND_COMPANY-GB202407020431$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$GB$GB
241961881$24196188$1$I$$20240729$20240809$20240809$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202407019251$ELI LILLY AND CO$$$$$F$Y$$$20240809$$MD$GB$GB
241961901$24196190$1$I$$20240730$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001061$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241961911$24196191$1$I$20240729$20240729$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019202$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240809$$CN$US$US
241961921$24196192$1$I$$20240729$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019923$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240809$$CN$US$US
241961931$24196193$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407301352589980-GJYHL$GB-ELI_LILLY_AND_COMPANY-GB202407020288$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$GB$GB
241961941$24196194$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407301452157790-MZKYT$GB-ELI_LILLY_AND_COMPANY-GB202407020403$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$GB$GB
241961951$24196195$1$I$20240726$20240805$20240809$20240809$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408003391$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240809$$CN$CN$CN
241961961$24196196$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407301350507210-TCHWZ$GB-ELI_LILLY_AND_COMPANY-GB202407020285$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$GB$GB
241961981$24196198$1$I$$20240730$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000363$ELI LILLY AND CO$$35$YR$A$$Y$$$20240809$$LW$US$US
241961991$24196199$1$I$$20240730$20240809$20240809$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408000627$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240809$$CN$FR$FR
241962001$24196200$1$I$$20240730$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000422$ELI LILLY AND CO$$41$YR$A$$Y$$$20240809$$LW$US$US
241962011$24196201$1$I$$20240729$20240809$20240809$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407019313$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240809$$CN$FR$FR
241962021$24196202$1$I$$20240730$20240809$20240809$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407020017$ELI LILLY AND CO$$55$YR$A$F$Y$56.5$KG$20240809$$CN$CN$CN
241962032$24196203$2$F$$20240729$20240809$20240813$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407018383$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240813$$CN$FR$FR
241962041$24196204$1$I$$20240806$20240809$20240809$EXP$$CN-AstraZeneca-2024A179615$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$CN$
241962051$24196205$1$I$$20240807$20240809$20240809$EXP$$CN-AstraZeneca-2024A180623$ASTRAZENECA$$$$$F$Y$$$20240809$$CN$CN$
241962061$24196206$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407301154578060-LDSZY$GB-ELI_LILLY_AND_COMPANY-GB202407020228$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$GB$GB
241962071$24196207$1$I$$20240731$20240809$20240809$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408000947$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240809$$CN$JP$JP
241962081$24196208$1$I$$20240730$20240809$20240809$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202406001551$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240809$$MD$ES$ES
241962092$24196209$2$F$20240722$20240903$20240809$20240912$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408002547$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240912$$CN$DE$GB
241962101$24196210$1$I$20240728$20240729$20240809$20240809$EXP$GB-MHRA-MED-202407291259328580-WLZVF$GB-ELI_LILLY_AND_COMPANY-GB202407019413$ELI LILLY AND CO$$31$YR$A$F$Y$99$KG$20240809$$CN$GB$GB
241962111$24196211$1$I$$20240729$20240809$20240809$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019167$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240809$$CN$US$US
241962121$24196212$1$I$20240628$20240731$20240809$20240809$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408003940$ELI LILLY AND CO$$42$YR$A$M$Y$52$KG$20240809$$CN$DE$CN
241962131$24196213$1$I$$20240730$20240809$20240809$EXP$GB-MHRA-MED-202407301145488700-VCGKS$GB-ELI_LILLY_AND_COMPANY-GB202407020216$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$GB$GB
241962141$24196214$1$I$$20240807$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408004465$ELI LILLY AND CO$$$$$F$Y$$$20240809$$CN$US$US
241962151$24196215$1$I$20240730$20240807$20240809$20240809$EXP$$JP-ABBVIE-5861002$ABBVIE$$58$YR$$M$Y$$$20240809$$PH$JP$JP
241962161$24196216$1$I$20240806$20240807$20240809$20240809$PER$$US-AMGEN-USASP2024157787$AMGEN$$80$YR$E$M$Y$$$20240809$$CN$US$US
241962171$24196217$1$I$20240731$20240801$20240809$20240809$PER$$US-ABBVIE-5866035$ABBVIE$$49$YR$$F$Y$$$20240809$$CN$US$US
241962181$24196218$1$I$20240718$20240802$20240809$20240809$EXP$FR-AFSSAPS-LL2024001479$FR-009507513-2408FRA001251$MERCK$$56$YR$$M$Y$$$20240809$$MD$FR$FR
241962191$24196219$1$I$20240725$20240731$20240809$20240809$PER$$US-APELLIS-2024-APL-0000611$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240809$$CN$US$US
241962201$24196220$1$I$$20240807$20240809$20240809$EXP$$US-VISTAPHARM-2024-US-042537$VISTAPHARM$Kalsoom S, Khan M, Zaman MA, Vitellas M.A silent inferior wall st segment elevation myocardial infarction..Arteriosclerosis, Thrombosis, and Vascular Biology.2023;43(1):A671.$36$YR$$M$Y$$$20240809$$HP$US$US
241962211$24196221$1$I$$20240807$20240809$20240809$PER$$US-ABBVIE-5873541$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241962221$24196222$1$I$$20240801$20240809$20240809$EXP$$JP-TAKEDA-2024TUS079558$TAKEDA$$$$$$Y$$$20240809$$PH$JP$JP
241962231$24196223$1$I$$20240807$20240809$20240809$EXP$$US-ABBVIE-5871878$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241962242$24196224$2$F$$20240816$20240809$20240820$EXP$$US-ALXN-202408USA000159US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
241962251$24196225$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5866795$ABBVIE$$$$A$$Y$$$20240809$$HP$US$US
241962261$24196226$1$I$$20240801$20240809$20240809$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122787$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240809$$HP$CA$CA
241962283$24196228$3$F$$20240827$20240809$20240829$EXP$$FR-TAKEDA-2024TUS080025$TAKEDA$$$$A$M$Y$$$20240829$$CN$FR$FR
241962291$24196229$1$I$$20240807$20240809$20240809$EXP$$IN-VISTAPHARM-2024-IN-000138$VISTAPHARM$Ancilla LC, Sundaram B, Pathak N, Raj A.Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy..Journal of Nephropharmacology.2024;13(2):1-5.$55$YR$$M$Y$$$20240809$$HP$IN$IN
241962301$24196230$1$I$$20240807$20240809$20240809$EXP$$IN-VISTAPHARM-2024-IN-000139$VISTAPHARM$Ancilla LC, Sundaram B, Pathak N, Raj A.Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy..Journal of Nephropharmacology.2024;13(2):1-5.$58$YR$$M$Y$$$20240809$$HP$IN$IN
241962311$24196231$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126215$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240809$$CN$US$US
241962321$24196232$1$I$20240101$20240806$20240809$20240809$PER$$US-009507513-2408USA001793$MERCK$$$$$$Y$$$20240809$$CN$US$US
241962331$24196233$1$I$$20240807$20240809$20240809$EXP$$US-VISTAPHARM-2024-US-042496$VISTAPHARM$Carranza Morales A, Blanco Jimenez JA, Madhavan A.A painful case of asthma..American Journal of Respiratory and Critical Care Medicine.2024;209A5999.$43$YR$$F$Y$$$20240809$$HP$US$US
241962341$24196234$1$I$$20240729$20240809$20240809$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07974$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240809$$HP$US$US
241962351$24196235$1$I$20240514$20240805$20240809$20240809$EXP$$CN-009507513-2408CHN002992$MERCK$$43$YR$$M$Y$53.4$KG$20240809$$HP$CN$CN
241962361$24196236$1$I$20240501$20240802$20240809$20240809$PER$$US-SA-2024SA234100$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240809$$CN$US$US
241962371$24196237$1$I$20240201$20240731$20240809$20240809$EXP$$DE-TEVA-VS-3228808$TEVA$$1$DY$$M$Y$3.905$KG$20240809$$MD$DE$DE
241962381$24196238$1$I$$20240802$20240809$20240809$EXP$$AU-BAUSCHBL-2024BNL030994$BAUSCH AND LOMB$$87$YR$$M$Y$$$20240809$$CN$AU$AU
241962391$24196239$1$I$$20240802$20240809$20240809$EXP$$AU-BAUSCHBL-2024BNL030996$BAUSCH AND LOMB$$30$YR$$M$Y$$$20240809$$CN$AU$AU
241962401$24196240$1$I$$20240802$20240809$20240809$EXP$$AU-BAUSCHBL-2024BNL030998$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240809$$CN$AU$AU
241962411$24196241$1$I$20240101$20240801$20240809$20240809$PER$$US-SA-2024SA232800$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240809$$MD$US$US
241962422$24196242$2$F$$20240824$20240809$20240827$PER$$NVSC2024US158531$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
241962431$24196243$1$I$$20240802$20240809$20240809$EXP$$AU-BAUSCHBL-2024BNL031003$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240809$$CN$AU$AU
241962442$24196244$2$F$20240412$20240920$20240809$20240928$30DAY$$US-TAKEDA-2024TUS035992$TAKEDA$$13$YR$$M$Y$$$20240928$$MD$US$US
241962451$24196245$1$I$20240521$20240807$20240809$20240809$EXP$$BR-GILEAD-2024-0674349$GILEAD$$36$YR$A$F$Y$$$20240809$$MD$BR$BR
241962461$24196246$1$I$$20240619$20240809$20240809$PER$$US-LUNDBECK-DKLU4001160$LUNDBECK$$$$$$Y$$$20240809$$HP$US$US
241962471$24196247$1$I$$20240619$20240809$20240809$PER$$US-LUNDBECK-DKLU4000732$LUNDBECK$$$$$$Y$$$20240809$$CN$US$US
241962481$24196248$1$I$$20240802$20240809$20240809$EXP$$US-ANIPHARMA-2024-US-041859$ANI$Khachatryan A, Isseh I, Vavilin I, et al.Recurrent perimyocarditis associated with long-term methylphenidate use..Journal of the American College of Cardiology.2024;83(Suppl2):3543.$19$YR$$M$Y$$$20240809$$HP$US$US
241962491$24196249$1$I$$20240619$20240809$20240809$PER$$US-LUNDBECK-DKLU4000788$LUNDBECK$$$$$$Y$$$20240809$$CN$US$US
241962502$24196250$2$F$$20240806$20240809$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408004507$ELI LILLY AND CO$$13$YR$T$M$Y$$$20240830$$CN$US$US
241962511$24196251$1$I$20240101$20240715$20240809$20240809$PER$$US-009507513-2407USA009816$MERCK$$$$$F$Y$$$20240809$$CN$US$US
241962521$24196252$1$I$20200401$20240731$20240809$20240809$EXP$$ES-SAMSUNG BIOEPIS-SB-2024-23803$SAMSUNG BIOEPIS$Montero S. IgA nephropathy after long-term treatment with infliximab for Crohn^s disease: A review of two cases. Nefrolog?a. doi:10.1016/j.nefro.2023.02.007$20$YR$A$M$Y$$$20240809$$HP$ES$ES
241962531$24196253$1$I$$20240729$20240809$20240809$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-23493$SAMSUNG BIOEPIS$$15$YR$T$M$Y$49.7$KG$20240809$$PH$CA$CA
241962542$24196254$2$F$20240730$20240905$20240809$20240917$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-24201$SAMSUNG BIOEPIS$$61$YR$A$F$Y$58.8$KG$20240917$$MD$DE$DE
241962551$24196255$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA233084$SANOFI AVENTIS$$25$YR$A$M$Y$68$KG$20240809$$MD$US$US
241962561$24196256$1$I$20240701$20240802$20240809$20240809$PER$$US-SA-2024SA234134$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240809$$MD$US$US
241962571$24196257$1$I$$20240619$20240809$20240809$PER$$US-LUNDBECK-DKLU4000796$LUNDBECK$$$$$$Y$$$20240809$$HP$US$US
241962582$24196258$2$F$20240613$20240812$20240809$20240822$PER$$US-Eisai-EC-2024-171484$EISAI$$68$YR$E$F$Y$84$KG$20240822$$MD$US$US
241962593$24196259$3$F$$20240911$20240809$20240918$EXP$$US-LUNDBECK-DKLU4002708$LUNDBECK$$$$$$Y$$$20240918$$CN$US$US
241962601$24196260$1$I$20240317$20240619$20240809$20240809$PER$$US-LUNDBECK-DKLU4001149$LUNDBECK$$$$$$Y$$$20240809$$HP$US$US
241962612$24196261$2$F$$20240808$20240809$20240812$EXP$$US-JNJFOC-20240821009$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240812$$MD$US$US
241962622$24196262$2$F$$20240809$20240809$20240815$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001601$BLUEPRINT MEDICINES$$$$$F$Y$$$20240816$$CN$US$US
241962641$24196264$1$I$$20240801$20240809$20240809$PER$$US-ABBVIE-5865141$ABBVIE$$$$$$Y$$$20240809$$MD$US$US
241962652$24196265$2$F$20240701$20240822$20240809$20240906$PER$$US-JNJFOC-20240812856$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240906$$CN$US$US
241962661$24196266$1$I$$20240729$20240809$20240809$EXP$$US-IMP-2024000573$Harrow Health$Kevin F. Elwood, Evan J. Warner, Jonathan S. Chang, Laura J. Kopplin. Aspergillus Endophthalmitis Secondary to Infectious Scleritis: Utility of Diagnostic PCR. 2024 Jul 19; doi:10.1097/ICB.0000000000001633$76$YR$E$M$Y$$$20240810$$HP$US$US
241962671$24196267$1$I$$20240807$20240809$20240809$PER$$US-AstraZeneca-2024A180679$ASTRAZENECA$$$$$$Y$$$20240809$$CN$US$
241962681$24196268$1$I$20240724$20240725$20240809$20240809$EXP$$US-HLS-202400545$HLS THERAPEUTICS$$72$YR$E$F$Y$$$20240809$$PH$US$US
241962691$24196269$1$I$$20240806$20240809$20240809$EXP$$US-009507513-2408USA002143$MERCK$$$$$F$Y$$$20240809$$HP$US$US
241962703$24196270$3$F$20240807$20240809$20240809$20240823$PER$$NVSC2024US162196$NOVARTIS$$65$YR$$F$Y$$$20240823$$CN$US$US
241962711$24196271$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA232905$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240810$$MD$US$US
241962721$24196272$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA232826$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240810$$MD$US$US
241962731$24196273$1$I$20240101$20240725$20240809$20240809$PER$$US-009507513-2407USA014214$MERCK$$$$$F$Y$58.957$KG$20240809$$HP$US$US
241962742$24196274$2$F$$20240731$20240809$20240826$PER$$US-INCYTE CORPORATION-2024IN008029$INCYTE$$$$$$Y$$$20240826$$CN$US$US
241962751$24196275$1$I$$20240725$20240809$20240809$EXP$$CA-HLS-202401869$HLS THERAPEUTICS$$$$A$F$Y$$$20240809$$MD$CA$CA
241962775$24196277$5$F$20240731$20240920$20240809$20240930$EXP$$US-ROCHE-10000053041$ROCHE$$71$YR$E$F$Y$111.13$KG$20240930$$CN$US$US
241962782$24196278$2$F$$20240807$20240809$20240816$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07661$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240816$$MD$US$US
241962791$24196279$1$I$$20240806$20240809$20240809$EXP$$US-ROCHE-10000050392$ROCHE$$86$YR$E$M$Y$$$20240809$$CN$US$US
241962801$24196280$1$I$$20240725$20240809$20240809$EXP$$US-HLS-202400562$HLS THERAPEUTICS$$$$A$M$Y$$$20240809$$MD$US$US
241962811$24196281$1$I$$20240205$20240809$20240809$EXP$$US-ROCHE-10000052629$ROCHE$$15$YR$T$M$Y$$$20240809$$MD$US$US
241962821$24196282$1$I$20240723$20240725$20240809$20240809$EXP$$US-HLS-202400569$HLS THERAPEUTICS$$77$YR$E$$Y$$$20240809$$MD$US$US
241962831$24196283$1$I$20240709$20240807$20240809$20240809$EXP$$CN-ROCHE-10000051856$ROCHE$$87$YR$E$M$Y$39$KG$20240809$$HP$CN$CN
241962841$24196284$1$I$$20240805$20240809$20240809$EXP$$BR-BIOMARINAP-BR-2024-159732$BIOMARIN$$$$$$Y$$$20240809$$CN$BR$BR
241962852$24196285$2$F$$20240820$20240809$20240826$EXP$$JP-BIOMARINAP-JP-2024-159750$BIOMARIN$$$$$$Y$$$20240826$$CN$JP$JP
241962861$24196286$1$I$$20240802$20240809$20240809$EXP$$JP-ROCHE-10000051903$ROCHE$$8$DEC$E$M$Y$$$20240809$$PH$JP$JP
241962872$24196287$2$F$$20240816$20240809$20240820$EXP$$NVSC2024ZA159764$NOVARTIS$$64$YR$$F$Y$$$20240820$$CN$ZA$ZA
241962881$24196288$1$I$20240401$20240802$20240809$20240809$PER$$US-ELI_LILLY_AND_COMPANY-US202408002673$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240809$$CN$US$US
241962891$24196289$1$I$20240101$20240801$20240809$20240809$EXP$$US-RADIUS HEALTH INC.-2024US005954$RADIUS PHARM$$$$$F$Y$$$20240809$$CN$US$US
241962931$24196293$1$I$20240720$20240805$20240809$20240809$EXP$$CN-ROCHE-10000049279$ROCHE$$55$YR$A$F$Y$53$KG$20240810$$HP$CN$CN
241962941$24196294$1$I$$20240805$20240809$20240809$EXP$$US-Bion-013632$BIONPHARMA$$$$$M$Y$$$20240810$$CN$US$
241962951$24196295$1$I$20240723$20240725$20240809$20240809$EXP$$US-HLS-202400574$HLS THERAPEUTICS$$59$YR$A$$Y$$$20240809$$PH$US$US
241962972$24196297$2$F$20240719$20240823$20240809$20240829$EXP$$JP-RADIUS HEALTH INC.-2024JP005583$RADIUS PHARM$$8$DEC$$F$Y$$$20240829$$PH$JP$JP
241962981$24196298$1$I$20240127$20240807$20240809$20240809$EXP$DE-CADRBFARM-2024329055$DE-ABBVIE-5872738$ABBVIE$$69$YR$$M$Y$$$20240809$$CN$DE$DE
241962994$24196299$4$F$20240101$20240917$20240809$20240927$EXP$$JP-RADIUS HEALTH INC.-2024JP005782$RADIUS PHARM$$79$YR$$F$Y$$$20240927$$MD$JP$JP
241963002$24196300$2$F$20240720$20240823$20240809$20240830$EXP$$JP-RADIUS HEALTH, INC.-2024JP005783$RADIUS PHARM$$78$YR$$F$Y$$$20240830$$MD$JP$JP
241963021$24196302$1$I$$20240718$20240809$20240809$PER$$US-009507513-2407USA011864$MERCK$$$$$F$Y$195$KG$20240809$$CN$US$US
241963031$24196303$1$I$$20240806$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125087$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$64.86$KG$20240810$$CN$US$US
241963041$24196304$1$I$20240601$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125168$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$86.64$KG$20240810$$CN$US$US
241963051$24196305$1$I$$20240807$20240809$20240809$EXP$$US-BEH-2024176958$CSL BEHRING$$$$A$F$Y$$$20240809$$CN$US$US
241963061$24196306$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227779$TEVA$$$$$F$Y$58$KG$20240809$$HP$CA$CA
241963071$24196307$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227859$TEVA$$$$$F$Y$$$20240809$$HP$CA$CA
241963081$24196308$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125039$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240810$$CN$US$US
241963094$24196309$4$F$20040101$20240918$20240809$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-024091$UNITED THERAPEUTICS$$$$$M$Y$$$20240921$$$US$US
241963101$24196310$1$I$$20240804$20240809$20240809$PER$$US-JNJFOC-20240811804$JOHNSON AND JOHNSON$$$$$$Y$$$20240810$$CN$US$US
241963112$24196311$2$F$$20240809$20240809$20240813$EXP$$JP-BEH-2024177006$CSL BEHRING$$59$YR$A$M$Y$$$20240813$$PH$JP$JP
241963121$24196312$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227782$TEVA$$64$YR$$F$Y$$$20240809$$HP$CA$CA
241963131$24196313$1$I$20240101$20240802$20240809$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-024068$UNITED THERAPEUTICS$$$$$F$Y$50.34$KG$20240809$$$US$US
241963144$24196314$4$F$20240101$20240913$20240809$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-022545$UNITED THERAPEUTICS$$$$$F$Y$68.481$KG$20240919$$$US$US
241963151$24196315$1$I$$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125461$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240810$$HP$US$US
241963171$24196317$1$I$$20240808$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126294$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240810$$HP$US$US
241963181$24196318$1$I$$20240731$20240809$20240809$EXP$$CA-TEVA-VS-3227787$TEVA$$66$YR$$F$Y$$$20240809$$HP$CA$CA
241963191$24196319$1$I$$20240805$20240809$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-024277$UNITED THERAPEUTICS$$$$$F$Y$68.481$KG$20240809$$$US$US
241963201$24196320$1$I$$20240805$20240809$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-024342$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240809$$$US$US
241963211$24196321$1$I$$20240726$20240809$20240809$EXP$$US-HLS-202400597$HLS THERAPEUTICS$$$$A$$Y$$$20240809$$PH$US$US
241963221$24196322$1$I$20240501$20240806$20240809$20240809$PER$$US-UNITED THERAPEUTICS-UNT-2024-017145$UNITED THERAPEUTICS$$48$YR$$F$Y$56.689$KG$20240809$$$US$US
241963231$24196323$1$I$20240701$20240807$20240809$20240809$EXP$$CA-ABBVIE-5874113$ABBVIE$$44$YR$$M$Y$$$20240809$$HP$CA$CA
241963241$24196324$1$I$20240701$20240808$20240809$20240809$EXP$$FR-ABBVIE-5874615$ABBVIE$$73$YR$$M$Y$$$20240809$$CN$FR$FR
241963251$24196325$1$I$$20240808$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126235$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240810$$HP$US$US
241963261$24196326$1$I$$20240801$20240809$20240809$PER$$US-SA-2024SA235623$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240810$$CN$US$US
241963271$24196327$1$I$20240806$20240807$20240809$20240809$EXP$$US-ABBVIE-5871780$ABBVIE$$75$YR$$M$Y$$$20240809$$CN$US$US
241963281$24196328$1$I$20240430$20240724$20240809$20240809$PER$$US-009507513-2407USA014679$MERCK$$68$YR$$F$Y$$$20240809$$CN$US$US
241963291$24196329$1$I$20240501$20240805$20240809$20240809$EXP$$US-ABBVIE-5868062$ABBVIE$$67$YR$$M$Y$$$20240809$$CN$US$US
241963301$24196330$1$I$20240101$20240807$20240809$20240809$EXP$$US-ABBVIE-5872007$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241963311$24196331$1$I$20240804$20240806$20240809$20240809$EXP$$CA-ABBVIE-5871399$ABBVIE$$52$YR$$$Y$$$20240809$$CN$CA$CA
241963321$24196332$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5872971$ABBVIE$$$$$M$Y$$$20240809$$HP$US$US
241963331$24196333$1$I$$20240806$20240809$20240809$EXP$$US-ABBVIE-5871083$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241963341$24196334$1$I$$20240807$20240809$20240809$EXP$$US-ROCHE-10000052436$ROCHE$$$$E$M$Y$$$20240810$$CN$US$US
241963352$24196335$2$F$20240101$20240829$20240809$20240906$EXP$$US-ABBVIE-5870945$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
241963361$24196336$1$I$20240101$20240806$20240809$20240809$EXP$$US-ABBVIE-5871125$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241963373$24196337$3$F$20240101$20240903$20240809$20240911$PER$$US-AMGEN-USASP2024156339$AMGEN$$69$YR$E$M$Y$$$20240911$$CN$US$US
241963381$24196338$1$I$20240612$20240807$20240809$20240809$EXP$$CA-ABBVIE-5874123$ABBVIE$$92$YR$$M$Y$$$20240809$$HP$CA$CA
241963391$24196339$1$I$$20240801$20240809$20240809$EXP$$CA-TEVA-VS-3230888$TEVA$$5$YR$$F$Y$$$20240809$$HP$CA$CA
241963401$24196340$1$I$$20240801$20240809$20240809$EXP$$CA-TEVA-VS-3230916$TEVA$$10$YR$$F$Y$$$20240809$$HP$CA$CA
241963411$24196341$1$I$20240701$20240807$20240809$20240809$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125381$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240810$$HP$US$US
241963421$24196342$1$I$$20240807$20240809$20240809$EXP$$ES-ROCHE-10000049788$ROCHE$$$$E$$Y$$$20240810$$MD$ES$ES
241963431$24196343$1$I$$20240801$20240809$20240809$EXP$$CA-TEVA-VS-3230443$TEVA$$6$YR$$M$Y$17$KG$20240809$$HP$CA$CA
241963441$24196344$1$I$$20240801$20240809$20240809$EXP$$CA-TEVA-VS-3230446$TEVA$$3$YR$$M$Y$14$KG$20240809$$PH$CA$CA
241963451$24196345$1$I$20240101$20240804$20240809$20240809$PER$$US-SA-2024SA234087$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240810$$MD$US$US
241963461$24196346$1$I$$20240807$20240809$20240809$EXP$$IN-ROCHE-10000052591$ROCHE$$85$YR$E$M$Y$$$20240810$$CN$IN$IN
241963471$24196347$1$I$$20240712$20240809$20240809$30DAY$$US-VEROBIOTECH-2024USVEROSPO00173$VERO BIOTECH$$$$$M$Y$$$20240810$$HP$US$US
241963481$24196348$1$I$20230101$20240802$20240809$20240809$EXP$$US-ABBVIE-5865919$ABBVIE$$$$$M$Y$50.8$KG$20240809$$CN$US$US
241963491$24196349$1$I$20240724$20240804$20240809$20240809$EXP$$PT-ABBVIE-5859035$ABBVIE$$57$YR$$M$Y$$$20240809$$CN$PT$PT
241963501$24196350$1$I$20240701$20240805$20240809$20240809$EXP$$US-ABBVIE-5848666$ABBVIE$$53$YR$$F$Y$$$20240809$$MD$US$US
241963512$24196351$2$F$20240101$20240822$20240809$20240917$PER$$US-SA-2024SA230438$SANOFI AVENTIS$$65$YR$E$F$Y$50.45$KG$20240918$$MD$US$US
241963521$24196352$1$I$20230101$20240802$20240809$20240809$EXP$$US-ABBVIE-5865638$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241963531$24196353$1$I$$20240801$20240809$20240809$EXP$$CA-TEVA-VS-3230449$TEVA$$4$YR$$F$Y$11$KG$20240809$$PH$CA$CA
241963541$24196354$1$I$20240101$20240802$20240809$20240809$PER$$US-SA-2024SA182163$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240810$$CN$US$US
241963551$24196355$1$I$20240101$20240801$20240809$20240809$EXP$$US-ABBVIE-5871351$ABBVIE$$$$$M$Y$$$20240809$$MD$US$US
241963563$24196356$3$F$20210501$20240909$20240809$20240916$EXP$$US-ABBVIE-5871946$ABBVIE$$69$YR$$M$Y$93$KG$20240916$$HP$US$US
241963571$24196357$1$I$$20240801$20240809$20240809$EXP$$CA-TEVA-VS-3230451$TEVA$$3$YR$$M$Y$15$KG$20240809$$PH$CA$CA
241963581$24196358$1$I$20240701$20240806$20240809$20240809$EXP$$US-ABBVIE-5870949$ABBVIE$$69$YR$$F$Y$$$20240809$$CN$US$US
241963591$24196359$1$I$$20240808$20240809$20240809$EXP$$ZA-ROCHE-10000052899$ROCHE$$$$E$F$Y$$$20240810$$MD$ZA$ZA
241963603$24196360$3$F$20240101$20240919$20240809$20240926$EXP$$US-ABBVIE-5871926$ABBVIE$$52$YR$$F$Y$85$KG$20240926$$CN$US$US
241963611$24196361$1$I$$20240807$20240809$20240809$EXP$$CA-ROCHE-10000050843$ROCHE$$$$$$Y$$$20240810$$CN$CA$CA
241963622$24196362$2$F$20240101$20240902$20240809$20240906$PER$$US-009507513-2408USA000005$MERCK$$$$$F$Y$50.8$KG$20240906$$CN$US$US
241963631$24196363$1$I$$20240808$20240809$20240809$EXP$$US-ABBVIE-5873339$ABBVIE$$$$$$Y$$$20240809$$CN$US$US
241963642$24196364$2$F$20240101$20240726$20240809$20240812$EXP$$US-009507513-2407USA015676$MERCK$$$$$M$Y$$$20240812$$HP$US$US
241963652$24196365$2$F$20240101$20240806$20240809$20240819$EXP$$CA-ABBVIE-5871379$ABBVIE$$21$YR$$F$Y$$$20240819$$CN$CA$CA
241963661$24196366$1$I$$20240802$20240809$20240809$EXP$$US-ABBVIE-5865833$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241963671$24196367$1$I$20240613$20240806$20240809$20240809$EXP$FR-AFSSAPS-GR2024000946$FR-ROCHE-10000051074$ROCHE$$80$YR$E$M$Y$81$KG$20240810$$HP$FR$FR
241963681$24196368$1$I$20240802$20240806$20240809$20240809$EXP$$CN-ROCHE-10000050376$ROCHE$$67$YR$E$M$Y$65$KG$20240810$$HP$CN$CN
241963691$24196369$1$I$20240731$20240731$20240809$20240809$EXP$$JP-ROCHE-10000050677$ROCHE$$8$DEC$E$M$Y$$$20240810$$MD$JP$JP
241963702$24196370$2$F$$20240805$20240809$20240814$PER$$US-SA-2024SA234165$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240814$$MD$US$US
241963711$24196371$1$I$$20240731$20240809$20240809$EXP$GB-MHRA-MIDB-a4467771-ce51-4dcf-a6ae-aef332cfa0d3$GB-TEVA-VS-3228593$TEVA$$82$YR$$F$Y$$$20240809$$HP$GB$GB
241963721$24196372$1$I$20240629$20240807$20240809$20240809$EXP$$CN-ABBVIE-5871376$ABBVIE$$64$YR$$F$Y$57$KG$20240809$$MD$CN$CN
241963731$24196373$1$I$20240101$20240806$20240809$20240809$EXP$$CA-ABBVIE-5843913$ABBVIE$$60$YR$$F$Y$$$20240809$$CN$CA$CA
241963741$24196374$1$I$20240805$20240807$20240809$20240809$EXP$$US-ABBVIE-5871976$ABBVIE$$60$YR$$M$Y$$$20240809$$CN$US$US
241963751$24196375$1$I$$20240802$20240809$20240809$PER$$US-SA-2024SA232881$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$MD$US$US
241963761$24196376$1$I$20240101$20240807$20240809$20240809$EXP$$CA-ABBVIE-5872425$ABBVIE$$57$YR$$M$Y$$$20240809$$CN$CA$CA
241963771$24196377$1$I$$20240801$20240809$20240809$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01520$NOVITIUM PHARMA$Kazutaka Oda.Thiamylal serum concentration for refractory convulsive status epilepticus while associated decreased concentrations of concomitant antiepileptics: a case report.Journal of Pharmaceutical Health Care and Sciences.12-JUL-2024;NA:1-4$72$YR$E$M$Y$71.4$KG$20240810$$HP$JP$JP
241963782$24196378$2$F$20240807$20240807$20240809$20240813$PER$$US-AMGEN-USASP2024157260$AMGEN$$69$YR$E$F$Y$$$20240813$$CN$US$US
241963791$24196379$1$I$$20240805$20240809$20240809$EXP$$US-ABBVIE-5869536$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241963801$24196380$1$I$20230801$20240805$20240809$20240809$EXP$PT-AMGEN-PRTSP2024141418$PT-ROCHE-10000049112$ROCHE$Henriques C.; Melo J.; Vasconcelos S et al. PO-0552 - (4842) - RESPIRATORY INFECTIONS: WHEN APPEARANCES ARE DECEPTIVE. 30th National Congress of Internal Medicine (CNMI). 905$60$YR$A$F$Y$$$20240810$$HP$PT$PT
241963812$24196381$2$F$20210101$20240825$20240809$20240828$EXP$$US-ABBVIE-5871168$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
241963821$24196382$1$I$$20240802$20240809$20240809$EXP$$JP-ROCHE-10000052045$ROCHE$$$$$F$Y$$$20240810$$PH$JP$JP
241963831$24196383$1$I$$20240809$20240809$20240809$EXP$$IT-ABBVIE-5874619$ABBVIE$$84$YR$$F$Y$$$20240809$$CN$IT$IT
241963842$24196384$2$F$$20240911$20240809$20240918$EXP$$JP-AMGEN-JPNSP2024156866$AMGEN$$83$YR$E$M$Y$$$20240918$$MD$JP$JP
241963851$24196385$1$I$$20240717$20240809$20240809$PER$$US-009507513-2407USA011498$MERCK$$$$$F$Y$$$20240809$$CN$US$US
241963862$24196386$2$F$20240729$20240809$20240809$20240816$EXP$$JP-ROCHE-10000049657$ROCHE$$8$DEC$E$M$Y$$$20240817$$MD$JP$JP
241963871$24196387$1$I$20240706$20240805$20240809$20240809$EXP$$PK-ROCHE-10000049531$ROCHE$$66$YR$E$M$Y$$$20240810$$CN$PK$PK
241963882$24196388$2$F$20240522$20240920$20240809$20240926$EXP$$PK-ROCHE-10000049539$ROCHE$$67$YR$E$M$Y$$$20240926$$CN$PK$PK
241963891$24196389$1$I$$20240801$20240809$20240809$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01518$NOVITIUM PHARMA$Tadashi Nishio.A case of lacosamide and mirtazapine self-poisoning.Legal Medicine.JUL-2024;69:1-7$$$$F$Y$$$20240810$$HP$JP$JP
241963901$24196390$1$I$20240801$20240802$20240809$20240809$EXP$GB-MHRA-MED-202408021433080450-YVPGZ$GB-ROCHE-10000048583$ROCHE$$35$YR$A$F$Y$$$20240810$$MD$GB$GB
241963911$24196391$1$I$$20240802$20240809$20240809$PER$$US-EMD Serono-2024042254$EMD SERONO INC$$$$$M$Y$$$20240810$$CN$US$US
241963921$24196392$1$I$20240806$20240807$20240809$20240809$EXP$GB-MHRA-MED-202408071637296490-LSPMT$GB-ROCHE-10000051743$ROCHE$$75$YR$E$M$Y$92$KG$20240810$$HP$GB$GB
241963931$24196393$1$I$20240101$20240806$20240809$20240809$EXP$$US-ABBVIE-5871772$ABBVIE$$$$$F$Y$$$20240809$$CN$US$US
241963941$24196394$1$I$$20240804$20240809$20240809$PER$$US-SA-2024SA233623$SANOFI AVENTIS$$93$YR$E$F$Y$$$20240810$$MD$US$US
241963951$24196395$1$I$20240701$20240807$20240809$20240809$EXP$$US-ABBVIE-5795672$ABBVIE$$22$YR$$F$Y$$$20240809$$CN$US$US
241963961$24196396$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872436$ABBVIE$$$$$M$Y$$$20240809$$HP$US$US
241963971$24196397$1$I$$20240805$20240810$20240810$EXP$$US-ABBVIE-5868424$ABBVIE$$$$$M$Y$$$20240809$$CN$US$US
241963982$24196398$2$F$20240101$20240807$20240810$20240812$EXP$$CA-ABBVIE-5872895$ABBVIE$$50$YR$$F$Y$$$20240812$$CN$CA$CA
241963991$24196399$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872711$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241964003$24196400$3$F$20240710$20240906$20240810$20240912$30DAY$$US-AMGEN-USASP2024155354$AMGEN$$64$YR$A$F$Y$83.6$KG$20240912$$PH$US$US
241964011$24196401$1$I$$20240801$20240810$20240810$EXP$$US-APOTEX-2024AP009126$APOTEX$Khan S, Reggio C, Shoukat U, Lalwani A, Yousaf Z. Avoiding Premature Brain Death Declaration in Patients With Suspected Baclofen Overdose. American Journal of Respiratory and Critical Care Medicine. 2024;209:A7027$58$YR$$M$Y$$$20240810$$HP$US$US
241964021$24196402$1$I$$20240805$20240810$20240810$PER$$US-ROCHE-10000048633$ROCHE$Dejenie R, Wong M, Love N, He Y, Fung M, Tartar D. Granulomatosis with polyangiitis with pyoderma gangrenosum, acne, hidradenitis suppurativa-like features. JAAD Case Reports. 2024-Sep;51:30-33. doi:10.1016/j.jdcr.2024.05.040.$16$YR$T$M$Y$$$20240810$$HP$US$US
241964031$24196403$1$I$20240804$20240808$20240810$20240810$EXP$$US-ABBVIE-5873701$ABBVIE$$74$YR$$F$Y$$$20240810$$CN$US$US
241964041$24196404$1$I$20240804$20240807$20240810$20240810$EXP$$US-ABBVIE-5872843$ABBVIE$$73$YR$$M$Y$$$20240810$$CN$US$US
241964062$24196406$2$F$$20240809$20240810$20240813$EXP$$US-ABBVIE-5872275$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
241964071$24196407$1$I$20240101$20240805$20240810$20240810$EXP$$MX-ABBVIE-5867606$ABBVIE$$$$$F$Y$56$KG$20240810$$CN$MX$MX
241964081$24196408$1$I$20240701$20240802$20240810$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-024026$UNITED THERAPEUTICS$$60$YR$$F$Y$$$20240810$$$US$US
241964091$24196409$1$I$20240701$20240807$20240810$20240810$EXP$$GB-ABBVIE-5874356$ABBVIE$$$$A$F$Y$$$20240810$$CN$GB$GB
241964101$24196410$1$I$$20240805$20240810$20240810$EXP$$GB-ABBVIE-5871427$ABBVIE$$$$A$M$Y$$$20240810$$CN$GB$GB
241964111$24196411$1$I$20240701$20240807$20240810$20240810$EXP$$GB-ABBVIE-5873209$ABBVIE$$61$YR$$M$Y$$$20240810$$CN$GB$GB
241964131$24196413$1$I$20240101$20240807$20240810$20240810$EXP$$US-ABBVIE-5872515$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241964151$24196415$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA232983$SANOFI AVENTIS$$$$T$F$Y$101$KG$20240810$$HP$US$US
241964161$24196416$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233653$SANOFI AVENTIS$$$$A$M$Y$$$20240810$$MD$US$US
241964182$24196418$2$F$$20240807$20240810$20240814$EXP$$US-ABBVIE-5872763$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
241964191$24196419$1$I$$20240802$20240810$20240810$EXP$$US-APOTEX-2024AP009127$APOTEX$Homiack DR, Yan LE, Petry LG, Lloyd JR, Najjar F, Cook EH.. Successful Electroconvulsive Therapy in a Patient with Catatonia and Maternal Duplication 15q11-13 Syndrome. Journal of ECT. 2024;0 (0):1-3$24$YR$$M$Y$$$20240810$$MD$US$US
241964201$24196420$1$I$20240701$20240807$20240810$20240810$EXP$FR-AFSSAPS-PB2024000842$FR-009507513-2408FRA002218$MERCK$$71$YR$$F$Y$$$20240810$$MD$FR$FR
241964211$24196421$1$I$20240801$20240807$20240810$20240810$EXP$$CA-ABBVIE-5873142$ABBVIE$$$$A$F$Y$$$20240810$$CN$CA$CA
241964221$24196422$1$I$$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024156301$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241964231$24196423$1$I$$20240806$20240810$20240810$PER$$US-ABBVIE-5870458$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241964241$24196424$1$I$$20240801$20240810$20240810$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01514$NOVITIUM PHARMA$Lucas Armange.The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review. European Journal of Clinical Microbiology + Infectious Diseases.16-FEB-2023;42(4):413-422$33$YR$A$F$Y$$$20240810$$HP$FR$FR
241964251$24196425$1$I$$20240802$20240810$20240810$PER$$US-APOTEX-2024AP009149$APOTEX$Zayat N, Arora A, O^Brien J, Bal J, Sugarman R, Rivera L, et al.. Pregnancy-Associated Onset of Adult-Onset Still^s Disease. American Journal of Perinatology Reports. 2024;14(2):e145-e155$29$YR$$F$Y$$$20240810$$MD$US$US
241964261$24196426$1$I$20240713$20240730$20240810$20240810$EXP$GB-MHRA-MED-202407251347497920-ZJSKB$GB-ELI_LILLY_AND_COMPANY-GB202407020097$ELI LILLY AND CO$$37$YR$A$F$Y$109$KG$20240810$$CN$GB$GB
241964282$24196428$2$F$20240701$20240820$20240810$20240828$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407020453$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240828$$CN$JP$JP
241964291$24196429$1$I$20230101$20240730$20240810$20240810$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407020278$ELI LILLY AND CO$$$$$$Y$$$20240810$$CN$CN$CN
241964304$24196430$4$F$$20240828$20240810$20240911$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408000580$ELI LILLY AND CO$$$$$M$Y$$$20240911$$HP$BR$BR
241964311$24196431$1$I$20240101$20240730$20240810$20240810$EXP$GB-MHRA-MED-202407250929525710-KSRWF$GB-ELI_LILLY_AND_COMPANY-GB202407019257$ELI LILLY AND CO$$63$YR$A$F$Y$103$KG$20240810$$CN$GB$GB
241964321$24196432$1$I$20230401$20240729$20240810$20240810$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002671$ELI LILLY AND CO$Tucker JM,Ritchie J.The Tirzepatide Drop: Beware of Slimmer s Paralysis.Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-7.DOI:https://doi.org/10.1177/23247096241264635$56$YR$A$F$Y$$$20240810$$MD$US$US
241964332$24196433$2$F$$20240823$20240810$20240904$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408002728$ELI LILLY AND CO$$$$E$$Y$$$20240904$$CN$JP$JP
241964341$24196434$1$I$20240501$20240729$20240810$20240810$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019491$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240810$$CN$US$US
241964351$24196435$1$I$20221101$20240730$20240810$20240810$EXP$$US-ELI_LILLY_AND_COMPANY-US202407020314$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240810$$CN$US$US
241964361$24196436$1$I$$20240730$20240810$20240810$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019837$ELI LILLY AND CO$$$$$M$Y$$$20240810$$CN$US$US
241964371$24196437$1$I$$20240729$20240810$20240810$EXP$$US-ELI_LILLY_AND_COMPANY-US202407019800$ELI LILLY AND CO$$69$YR$E$$Y$$$20240810$$LW$US$US
241964381$24196438$1$I$20240101$20240807$20240810$20240810$EXP$$CA-ABBVIE-5873245$ABBVIE$$60$YR$$M$Y$$$20240810$$CN$CA$CA
241964391$24196439$1$I$$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024157946$AMGEN$$$$$M$Y$$$20240809$$CN$US$US
241964401$24196440$1$I$20240715$20240807$20240810$20240810$EXP$$CA-ABBVIE-5873499$ABBVIE$$24$YR$$M$Y$$$20240810$$CN$CA$CA
241964411$24196441$1$I$20240802$20240806$20240810$20240810$EXP$$US-ABBVIE-5870052$ABBVIE$$67$YR$$M$Y$$$20240810$$CN$US$US
241964421$24196442$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5727569$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241964431$24196443$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5761780$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241964441$24196444$1$I$20150201$20240801$20240810$20240810$EXP$$NL-AMGEN-NLDSL2015039792$AMGEN$$54$YR$A$F$Y$83$KG$20240809$$HP$NL$NL
241964451$24196445$1$I$$20240801$20240810$20240810$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01525$NOVITIUM PHARMA$Lucas Armange.The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review. European Journal of Clinical Microbiology + Infectious Diseases.16-FEB-2023;42(4):413-422$26$YR$A$F$Y$$$20240810$$HP$FR$FR
241964461$24196446$1$I$$20240801$20240810$20240810$PER$$US-ABBVIE-5865067$ABBVIE$$$$$F$Y$$$20240810$$HP$US$US
241964473$24196447$3$F$$20240909$20240810$20240913$EXP$$CA-ABBVIE-5873170$ABBVIE$$$$A$F$Y$$$20240913$$CN$CA$CA
241964492$24196449$2$F$20240501$20240827$20240810$20240830$EXP$$US-ABBVIE-5872221$ABBVIE$$39$YR$$F$Y$$$20240830$$CN$US$US
241964501$24196450$1$I$$20240807$20240810$20240810$EXP$$CN-ROCHE-10000047243$ROCHE$Bai G, Bai Y, Guan H, Ren H, Li H, Wang Y. A case report of lymphoproliferative disease in brain following therapies with mycophenolate Mofetil and Fingolimod and literature review. Journal of neuroimmunology. 2024;394:1-5. doi:10.1016/j.jneuroim.2024.578410.$32$YR$A$M$Y$$$20240810$$HP$CN$CN
241964511$24196451$1$I$$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024156979$AMGEN$$$$$$Y$$$20240809$$PH$US$US
241964521$24196452$1$I$20220101$20240806$20240810$20240810$EXP$$CL-ABBVIE-22K-034-4305710-00$ABBVIE$$$$$M$Y$$$20240810$$CN$CL$CL
241964531$24196453$1$I$20240101$20240807$20240810$20240810$EXP$$US-ABBVIE-5859066$ABBVIE$$$$$F$Y$91$KG$20240810$$CN$US$US
241964541$24196454$1$I$20240101$20240807$20240810$20240810$EXP$$US-ABBVIE-5872981$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241964551$24196455$1$I$$20240801$20240810$20240810$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01526$NOVITIUM PHARMA$Lucas Armange.The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review. European Journal of Clinical Microbiology + Infectious Diseases.16-FEB-2023;42(4):413-422$61$YR$A$F$Y$$$20240810$$HP$FR$FR
241964562$24196456$2$F$20220309$20240905$20240810$20240911$EXP$$FR-ABBVIE-5873940$ABBVIE$$48$YR$$F$Y$104$KG$20240911$$MD$FR$FR
241964571$24196457$1$I$$20240807$20240810$20240810$EXP$$NG-ROCHE-10000051886$ROCHE$$$$$$Y$$$20240810$$MD$NG$NG
241964581$24196458$1$I$$20240806$20240810$20240810$EXP$$US-ABBVIE-5871058$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241964591$24196459$1$I$$20240806$20240810$20240810$EXP$$US-ABBVIE-5870959$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241964601$24196460$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872408$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241964611$24196461$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872622$ABBVIE$$$$$$Y$$$20240810$$HP$US$US
241964621$24196462$1$I$20240101$20240807$20240810$20240810$EXP$$US-AMGEN-USASP2024157414$AMGEN$$$$$M$Y$$$20240809$$MD$US$US
241964632$24196463$2$F$20240101$20240813$20240810$20240819$EXP$$US-ABBVIE-5872267$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
241964641$24196464$1$I$20240101$20240806$20240810$20240810$PER$$US-ABBVIE-5870119$ABBVIE$$63$YR$$M$Y$82$KG$20240810$$CN$US$US
241964651$24196465$1$I$20240101$20240807$20240810$20240810$EXP$$US-ABBVIE-5871985$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241964661$24196466$1$I$20240804$20240806$20240810$20240810$EXP$$IN-ROCHE-10000051174$ROCHE$$61$YR$A$M$Y$$$20240810$$CN$IN$IN
241964671$24196467$1$I$$20240808$20240810$20240810$EXP$$SK-ABBVIE-5874127$ABBVIE$$75$YR$$M$Y$$$20240810$$CN$SK$SK
241964681$24196468$1$I$20240101$20240807$20240810$20240810$EXP$$DE-ABBVIE-5873090$ABBVIE$$64$YR$$F$Y$$$20240810$$MD$DE$DE
241964691$24196469$1$I$$20240719$20240810$20240810$PER$$US-JNJFOC-20240759068$JOHNSON AND JOHNSON$$$$$F$Y$$$20240810$$CN$US$US
241964701$24196470$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872225$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241964711$24196471$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA234500$SANOFI AVENTIS$$$$E$F$Y$65.77$KG$20240810$$MD$US$US
241964721$24196472$1$I$20240802$20240802$20240810$20240810$PER$$US-SA-2024SA233632$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240810$$MD$US$US
241964731$24196473$1$I$20240501$20240802$20240810$20240810$PER$$US-SA-2024SA220519$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240810$$CN$US$US
241964741$24196474$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA233919$SANOFI AVENTIS$$$$T$F$Y$86.18$KG$20240810$$MD$US$US
241964761$24196476$1$I$$20240806$20240810$20240810$PER$$US-ABBVIE-5873454$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241964771$24196477$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA231942$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240810$$MD$US$US
241964781$24196478$1$I$$20240806$20240810$20240810$PER$$US-ABBVIE-5870194$ABBVIE$$$$$$Y$$$20240810$$CN$US$US
241964791$24196479$1$I$$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024158852$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241964802$24196480$2$F$$20240816$20240810$20240823$EXP$$US-ABBVIE-5872422$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
241964811$24196481$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233830$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$HP$US$US
241964821$24196482$1$I$20240801$20240805$20240810$20240810$EXP$$US-SA-2024SA234468$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240810$$MD$US$US
241964831$24196483$1$I$20230801$20240801$20240810$20240810$PER$$US-SA-2024SA231760$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240810$$MD$US$US
241964841$24196484$1$I$20240731$20240801$20240810$20240810$PER$$US-SA-2024SA230498$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240810$$PH$US$US
241964861$24196486$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872712$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241964871$24196487$1$I$$20240801$20240810$20240810$EXP$$TN-ABBVIE-5754889$ABBVIE$Ouni B, Mansour K, Sassi M, Sriha B, Bensayed N, Fathallah N, et al. Silodosin-induced leukocytoclastic vasculitis: a first case report. European Journal of Dermatology. 2024;34(1): 92-3.$68$YR$$M$Y$$$20240810$$HP$TN$TN
241964881$24196488$1$I$20240722$20240806$20240810$20240810$EXP$$CN-ABBVIE-5870731$ABBVIE$$66$YR$$F$Y$72$KG$20240810$$MD$CN$CN
241964891$24196489$1$I$20240718$20240807$20240810$20240810$EXP$$US-ABBVIE-5872680$ABBVIE$$47$YR$$F$Y$$$20240810$$CN$US$US
241964901$24196490$1$I$20240627$20240807$20240810$20240810$EXP$$NVSC2024US080993$NOVARTIS$$62$YR$$F$Y$$$20240810$$CN$US$US
241964911$24196491$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA233947$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$MD$US$US
241964921$24196492$1$I$20240701$20240802$20240810$20240810$PER$$US-ABBVIE-5866554$ABBVIE$$32$YR$$M$Y$$$20240810$$HP$US$US
241964931$24196493$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA231873$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240810$$MD$US$US
241964942$24196494$2$F$20240101$20240806$20240810$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024160$UNITED THERAPEUTICS$$$$$F$Y$70.295$KG$20240816$$$US$US
241964951$24196495$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA231566$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240810$$CN$US$US
241964961$24196496$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA233246$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240810$$MD$US$US
241964971$24196497$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233940$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240810$$MD$US$US
241964981$24196498$1$I$20240801$20240802$20240810$20240810$PER$$US-SA-2024SA234435$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240810$$MD$US$US
241964991$24196499$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA231496$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240810$$MD$US$US
241965001$24196500$1$I$$20240724$20240810$20240810$PER$$US-JNJFOC-20240772335$JOHNSON AND JOHNSON$$$$$F$Y$$$20240810$$CN$US$US
241965011$24196501$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA234397$SANOFI AVENTIS$$$$E$M$Y$79.38$KG$20240810$$MD$US$US
241965022$24196502$2$F$20240101$20240827$20240810$20240917$PER$$US-SA-2024SA233010$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
241965031$24196503$1$I$20240301$20240808$20240810$20240810$EXP$FR-AFSSAPS-TS2024000869$FR-ROCHE-10000052562$ROCHE$$41$YR$A$F$Y$88$KG$20240810$$MD$FR$FR
241965042$24196504$2$F$$20240910$20240810$20240917$EXP$$IN-ROCHE-10000050122$ROCHE$$78$YR$E$M$Y$$$20240917$$CN$IN$IN
241965051$24196505$1$I$$20240801$20240810$20240810$EXP$$US-NOVITIUMPHARMA-2024USNVP01522$NOVITIUM PHARMA$$$$$M$Y$12.57$KG$20240808$$CN$US$US
241965061$24196506$1$I$$20240806$20240810$20240810$PER$$US-ABBVIE-5872700$ABBVIE$$$$$$Y$$$20240810$$HP$US$US
241965071$24196507$1$I$20200101$20240806$20240810$20240810$EXP$$JP-ROCHE-10000053232$ROCHE$$8$DEC$E$M$Y$$$20240810$$MD$JP$JP
241965101$24196510$1$I$$20240807$20240810$20240810$PER$$US-ABBVIE-5873725$ABBVIE$$$$$F$Y$$$20240810$$HP$US$US
241965111$24196511$1$I$$20240809$20240810$20240810$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044826$BOEHRINGER INGELHEIM$$$$$$Y$$$20240810$$CN$US$US
241965121$24196512$1$I$$20240801$20240810$20240810$PER$$US-ABBVIE-5866323$ABBVIE$$$$$$Y$$$20240810$$CN$US$US
241965131$24196513$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233849$SANOFI AVENTIS$$53$YR$A$F$Y$77.11$KG$20240810$$MD$US$US
241965141$24196514$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA235175$SANOFI AVENTIS$$$$A$M$Y$$$20240810$$MD$US$US
241965151$24196515$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA232138$SANOFI AVENTIS$$$$A$M$Y$$$20240810$$MD$US$US
241965161$24196516$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA232100$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240810$$MD$US$US
241965171$24196517$1$I$20240805$20240806$20240810$20240810$PER$$US-SA-2024SA235518$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240810$$MD$US$US
241965181$24196518$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA232507$SANOFI AVENTIS$$$$$F$Y$$$20240810$$HP$US$US
241965191$24196519$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA232064$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240810$$MD$US$US
241965201$24196520$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA232186$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240810$$CN$US$US
241965211$24196521$1$I$20240401$20240801$20240810$20240810$PER$$US-SA-2024SA233709$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240810$$MD$US$US
241965221$24196522$1$I$$20240809$20240810$20240810$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044844$BOEHRINGER INGELHEIM$$$$$$Y$$$20240810$$CN$US$US
241965233$24196523$3$F$$20240828$20240810$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-024369$UNITED THERAPEUTICS$$$$$M$Y$63.492$KG$20240904$$$US$US
241965241$24196524$1$I$$20240805$20240810$20240810$EXP$$RU-ROCHE-10000050322$ROCHE$$$$$$Y$$$20240810$$MD$RU$RU
241965251$24196525$1$I$20230101$20240802$20240810$20240810$EXP$$US-AMGEN-USASL2024001351$AMGEN$$71$YR$E$F$Y$$$20240809$$CN$US$US
241965271$24196527$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233446$SANOFI AVENTIS$$$$T$F$Y$46.3$KG$20240810$$MD$US$US
241965281$24196528$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA231914$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240810$$CN$US$US
241965291$24196529$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233072$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240810$$MD$US$US
241965301$24196530$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA233218$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240810$$MD$US$US
241965312$24196531$2$F$$20240904$20240810$20240919$PER$$US-SA-2024SA235275$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240919$$MD$US$US
241965321$24196532$1$I$20240603$20240808$20240810$20240810$EXP$$PK-ROCHE-10000052461$ROCHE$$51$YR$A$M$Y$$$20240810$$CN$PK$PK
241965331$24196533$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126326$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$87.54$KG$20240810$$CN$US$US
241965341$24196534$1$I$$20240802$20240810$20240810$EXP$$JP-ROCHE-3539059$ROCHE$$8$DEC$E$M$Y$$$20240810$$MD$JP$JP
241965351$24196535$1$I$20240802$20240808$20240810$20240810$EXP$$CN-ROCHE-10000051931$ROCHE$$38$YR$A$F$Y$64$KG$20240810$$HP$CN$CN
241965362$24196536$2$F$$20240726$20240810$20240822$PER$$US-ABBVIE-5874669$ABBVIE$$$$T$M$Y$$$20240822$$MD$US$US
241965372$24196537$2$F$$20240911$20240810$20240917$PER$$US-AMGEN-USASP2024159000$AMGEN$$$$$F$Y$$$20240917$$CN$US$US
241965381$24196538$1$I$20240726$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024157865$AMGEN$$36$YR$A$F$Y$$$20240809$$CN$US$US
241965392$24196539$2$F$$20240816$20240810$20240821$PER$$US-AMGEN-USASP2024157719$AMGEN$$$$$F$Y$$$20240820$$MD$US$US
241965401$24196540$1$I$20240724$20240802$20240810$20240810$EXP$$JP-ROCHE-10000051926$ROCHE$$69$YR$E$M$Y$$$20240810$$MD$JP$JP
241965411$24196541$1$I$$20240802$20240810$20240810$PER$$US-JNJFOC-20240809336$JOHNSON AND JOHNSON$$$$$$Y$$$20240810$$CN$US$US
241965421$24196542$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872579$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241965431$24196543$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA232058$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240810$$MD$US$US
241965441$24196544$1$I$20240501$20240801$20240810$20240810$PER$$US-SA-2024SA233133$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240810$$MD$US$US
241965451$24196545$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233315$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240810$$HP$US$US
241965461$24196546$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA230647$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240810$$CN$US$US
241965471$24196547$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA235457$SANOFI AVENTIS$$$$C$F$Y$37$KG$20240810$$MD$US$US
241965481$24196548$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA232046$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240810$$MD$US$US
241965491$24196549$1$I$$20240802$20240810$20240810$EXP$$JP-ROCHE-10000052123$ROCHE$$8$DEC$E$M$Y$$$20240810$$MD$JP$JP
241965501$24196550$1$I$$20240807$20240810$20240810$PER$$US-ABBVIE-5874742$ABBVIE$$$$$$Y$$$20240810$$CN$US$US
241965521$24196552$1$I$$20240712$20240810$20240810$30DAY$$US-VEROBIOTECH-2024USVEROSPO00174$VERO BIOTECH$$5$MON$N$$Y$$$20240810$$HP$US$US
241965541$24196554$1$I$20240802$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024157262$AMGEN$$42$YR$A$M$Y$$$20240809$$CN$US$US
241965551$24196555$1$I$$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024157716$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241965561$24196556$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA233467$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240810$$CN$US$US
241965573$24196557$3$F$20240805$20240827$20240810$20240829$PER$$US-SA-2024SA234099$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240829$$MD$US$US
241965581$24196558$1$I$20240701$20240801$20240810$20240810$PER$$US-SA-2024SA233535$SANOFI AVENTIS$$46$YR$A$M$Y$104$KG$20240810$$MD$US$US
241965593$24196559$3$F$20240101$20240813$20240810$20240911$PER$$US-009507513-2408USA002245$MERCK$$$$$M$Y$$$20240911$$HP$US$US
241965601$24196560$1$I$20240711$20240802$20240810$20240810$EXP$$HU-ROCHE-10000049209$ROCHE$$73$YR$E$F$Y$$$20240810$$MD$HU$HU
241965611$24196561$1$I$20240607$20240731$20240810$20240810$EXP$FR-AFSSAPS-PP2024000800$FR-ROCHE-10000044414$ROCHE$$81$YR$E$M$Y$$$20240810$$MD$FR$FR
241965621$24196562$1$I$$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158793$AMGEN$$$$$$Y$$$20240809$$HP$US$US
241965631$24196563$1$I$$20240808$20240810$20240810$PER$$US-ABBVIE-5874293$ABBVIE$$$$$$Y$$$20240810$$CN$US$US
241965641$24196564$1$I$$20240802$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124139$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240810$$MD$US$US
241965651$24196565$1$I$20240729$20240806$20240810$20240810$PER$$US-ABBVIE-5871384$ABBVIE$$44$YR$$F$Y$$$20240810$$HP$US$US
241965661$24196566$1$I$20240401$20240805$20240810$20240810$EXP$$UY-AMGEN-URYSP2024156647$AMGEN$$66$YR$E$M$Y$$$20240809$$MD$UY$UY
241965671$24196567$1$I$$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158722$AMGEN$$$$$$Y$$$20240809$$HP$US$US
241965681$24196568$1$I$$20240805$20240810$20240810$EXP$IT-AMGEN-ITASP2024141843$IT-ROCHE-10000048718$ROCHE$Casartelli C, Tommasi C. Functional HRD by RAD51 identifies BRCAl VUS associated with loss of gene function and response to DNA-damaging agents.. ESMO Open. 2024;9 (7):103629. doi:10.1016/j.esmoop.2024.103629.$66$YR$E$F$Y$$$20240810$$HP$IT$IT
241965691$24196569$1$I$20240720$20240801$20240810$20240810$PER$$US-SA-2024SA232071$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240810$$MD$US$US
241965701$24196570$1$I$20240801$20240802$20240810$20240810$PER$$US-SA-2024SA235270$SANOFI AVENTIS$$84$YR$E$F$Y$36.2$KG$20240810$$MD$US$US
241965711$24196571$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA235189$SANOFI AVENTIS$$$$A$F$Y$77.11$KG$20240810$$MD$US$US
241965721$24196572$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA233731$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240810$$MD$US$US
241965732$24196573$2$F$20240701$20240821$20240810$20240902$EXP$$JP-ROCHE-10000020902$ROCHE$$86$YR$E$M$Y$$$20240902$$MD$JP$JP
241965741$24196574$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126303$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240810$$CN$US$US
241965761$24196576$1$I$$20240801$20240810$20240810$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01524$NOVITIUM PHARMA$Lucas Armange.The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review. European Journal of Clinical Microbiology + Infectious Diseases.16-FEB-2023;42(4):413-422$27$YR$A$M$Y$$$20240810$$HP$FR$FR
241965771$24196577$1$I$20240701$20240731$20240810$20240810$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095754$VIIV$$67$YR$$M$Y$$$20240810$$HP$US$US
241965781$24196578$1$I$$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158719$AMGEN$$$$$$Y$$$20240809$$CN$US$US
241965792$24196579$2$F$$20240911$20240810$20240913$PER$$US-AMGEN-USASP2024157449$AMGEN$$$$$F$Y$$$20240913$$CN$US$US
241965801$24196580$1$I$20240703$20240729$20240810$20240810$EXP$FR-AFSSAPS-GR2024000951$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110604$ZYDUS PHARM$$$$$$Y$$$20240810$$PH$FR$FR
241965811$24196581$1$I$20200101$20240729$20240810$20240810$EXP$FR-AFSSAPS-AN2024000957$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110600$ZYDUS PHARM$$$$$$Y$$$20240810$$MD$FR$FR
241965821$24196582$1$I$20240409$20240729$20240810$20240810$EXP$FR-AFSSAPS-NT2024000908$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110607$ZYDUS PHARM$$$$$$Y$$$20240810$$MD$FR$FR
241965831$24196583$1$I$20240601$20240729$20240810$20240810$EXP$FR-AFSSAPS-NT2024000942$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110539$ZYDUS PHARM$$$$$$Y$$$20240810$$MD$FR$FR
241965841$24196584$1$I$20171001$20240729$20240810$20240810$EXP$ES-AEMPS-1550112$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-110628$ZYDUS PHARM$$$$$$Y$$$20240810$$CN$ES$ES
241965851$24196585$1$I$20240501$20240807$20240810$20240810$EXP$$US-ABBVIE-5872962$ABBVIE$$81$YR$$F$Y$$$20240810$$CN$US$US
241965861$24196586$1$I$$20240806$20240810$20240810$PER$$US-ABBVIE-5870374$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241965871$24196587$1$I$20240726$20240801$20240810$20240810$PER$$US-ABBVIE-5865653$ABBVIE$$27$YR$$F$Y$$$20240810$$CN$US$US
241965881$24196588$1$I$20240608$20240729$20240810$20240810$EXP$FR-AFSSAPS-NY2024000839$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110573$ZYDUS PHARM$$$$$$Y$$$20240810$$MD$FR$FR
241965891$24196589$1$I$20240719$20240805$20240810$20240810$EXP$$CN-ABBVIE-5873270$ABBVIE$$74$YR$$F$Y$$$20240810$$HP$CN$CN
241965901$24196590$1$I$20240401$20240729$20240810$20240810$EXP$FR-AFSSAPS-AN2024000959$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110537$ZYDUS PHARM$$$$$$Y$$$20240810$$MD$FR$FR
241965911$24196591$1$I$$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158707$AMGEN$$$$$$Y$$$20240809$$MD$US$US
241965921$24196592$1$I$20240701$20240731$20240810$20240810$PER$$US-SA-2024SA229883$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240810$$MD$US$US
241965931$24196593$1$I$20240422$20240807$20240810$20240810$30DAY$$US-SANDOZ INC.-SDZ2024US043753$SANDOZ$$12$YR$$F$Y$$$20240810$$HP$US$US
241965941$24196594$1$I$$20240731$20240810$20240810$PER$$US-SA-2024SA229887$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240810$$MD$US$US
241965952$24196595$2$F$20210301$20240805$20240810$20240814$PER$$US-SA-2024SA231950$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240814$$MD$US$US
241965972$24196597$2$F$$20240828$20240810$20240912$PER$$US-SA-2024SA229315$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240912$$MD$US$US
241965981$24196598$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA232150$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240810$$MD$US$US
241965991$24196599$1$I$20240806$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158452$AMGEN$$42$YR$A$F$Y$$$20240809$$CN$US$US
241966001$24196600$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126101$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240810$$CN$US$US
241966011$24196601$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126257$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240810$$CN$US$US
241966021$24196602$1$I$20240801$20240806$20240810$20240810$PER$$US-ABBVIE-5870210$ABBVIE$$20$YR$$$Y$$$20240810$$CN$US$US
241966042$24196604$2$F$20240712$20240916$20240810$20240919$EXP$$DE-ABBVIE-5866505$ABBVIE$$63$YR$$F$Y$65$KG$20240919$$MD$DE$DE
241966051$24196605$1$I$20231227$20240731$20240810$20240810$EXP$FR-AFSSAPS-NY2024000829$FR-TEVA-VS-3228920$TEVA$$58$YR$$F$Y$77$KG$20240810$$HP$FR$FR
241966061$24196606$1$I$20240421$20240805$20240810$20240810$EXP$FR-AFSSAPS-BR2024000611$FR-ROCHE-10000048943$ROCHE$$33$YR$A$F$Y$54$KG$20240810$$MD$FR$FR
241966071$24196607$1$I$$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158481$AMGEN$$$$$F$Y$$$20240809$$CN$US$US
241966082$24196608$2$F$20240806$20240829$20240810$20240926$PER$$US-AMGEN-USASP2024157397$AMGEN$$86$YR$E$F$Y$$$20240926$$CN$US$US
241966091$24196609$1$I$$20240802$20240810$20240810$PER$$US-ABBVIE-5866458$ABBVIE$$$$$M$Y$$$20240810$$HP$US$US
241966101$24196610$1$I$$20240806$20240810$20240810$PER$$US-SA-2024SA236077$SANOFI AVENTIS$$$$E$M$Y$$$20240810$$CN$US$US
241966111$24196611$1$I$$20240801$20240810$20240810$PER$$US-ABBVIE-5866000$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241966122$24196612$2$F$$20240906$20240810$20240910$PER$$US-AMGEN-USASP2024158616$AMGEN$$$$$M$Y$$$20240909$$HP$US$US
241966132$24196613$2$F$20240703$20240729$20240810$20240816$EXP$$US-GILEAD-2024-0680339$GILEAD$$74$YR$E$F$Y$47.2$KG$20240816$$HP$US$US
241966141$24196614$1$I$20240711$20240808$20240810$20240810$EXP$$US-ABBVIE-5874543$ABBVIE$$85$YR$$M$Y$$$20240810$$CN$US$US
241966151$24196615$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA235426$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240810$$MD$US$US
241966161$24196616$1$I$20240606$20240801$20240810$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-011920$UNITED THERAPEUTICS$$66$YR$$M$Y$74.83$KG$20240810$$$US$US
241966171$24196617$1$I$$20240731$20240810$20240810$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR095995$VIIV$$$$$M$Y$$$20240810$$CN$US$US
241966181$24196618$1$I$$20240808$20240810$20240810$EXP$$CA-ABBVIE-5874125$ABBVIE$$$$A$F$Y$$$20240810$$PH$CA$CA
241966192$24196619$2$F$20240101$20240809$20240810$20240815$EXP$$CA-CELLTRION INC.-2024CA014163$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
241966201$24196620$1$I$$20240807$20240810$20240810$PER$$US-ELI_LILLY_AND_COMPANY-US202408004806$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240810$$CN$US$US
241966212$24196621$2$F$20240806$20240808$20240810$20240813$30DAY$$FR-SANDOZ INC.-SDZ2024FR071766$SANDOZ$$14$YR$$M$Y$$$20240813$$HP$FR$FR
241966241$24196624$1$I$$20240806$20240810$20240810$PER$$US-SA-2024SA235781$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240810$$CN$US$US
241966252$24196625$2$F$20220101$20240812$20240810$20240821$EXP$$US-ABBVIE-5870248$ABBVIE$$$$$F$Y$81$KG$20240821$$CN$US$US
241966261$24196626$1$I$$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158627$AMGEN$$$$$$Y$$$20240810$$CN$US$US
241966271$24196627$1$I$20240201$20240805$20240810$20240810$EXP$$US-SA-2024SA234794$SANOFI AVENTIS$$62$YR$A$F$Y$124$KG$20240810$$MD$US$US
241966281$24196628$1$I$$20240805$20240810$20240810$EXP$$US-SA-2024SA234939$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240810$$CN$US$US
241966291$24196629$1$I$20240201$20240801$20240810$20240810$PER$$US-SA-2024SA233559$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240810$$MD$US$US
241966301$24196630$1$I$20240101$20240805$20240810$20240810$PER$$US-SA-2024SA234261$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240810$$CN$US$US
241966311$24196631$1$I$$20240805$20240810$20240810$EXP$$JP-Square Pharmaceuticals PLC-000044$SQUARE PHARMACEUTICALS$JP-Square Pharmaceuticals PLC-000044-01_Initial Source Document$36$YR$A$F$Y$66.8$KG$20240809$$MD$JP$
241966321$24196632$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872104$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241966331$24196633$1$I$$20240807$20240810$20240810$EXP$$ZA-ROCHE-10000052435$ROCHE$$$$E$M$Y$$$20240810$$MD$ZA$ZA
241966342$24196634$2$F$$20240812$20240810$20240813$EXP$$JP-ABBVIE-5872191$ABBVIE$Matsuoka T, Tomioka H, Kobayashi H, Miyamoto K, Masamichi Ri, Yokota S, et al. 100: A case of diagnosed adalimumab-induced lung injury due to re-administration. Joint meeting of the 132nd Kinki Branch Meeting of the Japanese Society for Tuberculosis and Nontuberculous Mycobacteriosis/The 103rd Kinki Branch Meeting of the Japanese Respiratory Society (2024);77.; Matsuoka T, Tomioka H, Kobayashi Y. et al. 100: A case of drug-induced lung injury due to adalimumab diagnosed by re-administration. ...$71$YR$$F$Y$$$20240813$$MD$JP$JP
241966351$24196635$1$I$20240719$20240801$20240810$20240810$EXP$FR-AFSSAPS-DJ2024000862$FR-TEVA-VS-3229209$TEVA$$62$YR$$F$Y$$$20240810$$MD$FR$FR
241966361$24196636$1$I$$20240801$20240810$20240810$EXP$$US-VIIV HEALTHCARE LIMITED-US2024096295$VIIV$$$$$M$Y$$$20240810$$CN$US$US
241966371$24196637$1$I$$20240802$20240810$20240810$EXP$$NL-KOANAAP-SML-NL-2024-00830$SHILPA MEDICARE$Meerten TV, Kuruvilla J, Song KW, Thieblemont C, Minnema MC, Forcade E, et al. Impact of debulking therapy on the clinical outcomes of  axicabtagene ciloleucel in the treatment of relapsed  or refractory large B-cell lymphoma. American journal of cancer research. 2024;14(6):2905-20. doi:https://doi.org/10.62347/LLXR8002$$$A$$Y$$$20240810$$MD$NL$NL
241966381$24196638$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA232975$SANOFI AVENTIS$$$$$F$Y$$$20240810$$CN$US$US
241966401$24196640$1$I$$20240805$20240810$20240810$PER$$US-ABBVIE-5869785$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241966423$24196642$3$F$$20240911$20240810$20240917$EXP$$JP-ABBVIE-5872296$ABBVIE$Hirai H, Akai Y, Ogata N, et al. GK-P02-03: A case of cytomegalovirus retinitis during upadacitinib oral treatment. Ocular Infection, Inflammation and Allergy 2024 in Sapporo/The 60th Annual Meeting of Japanese Association for Ocular Infection (2024). 74.; Hirai H, Akai Y, Ogata N, et al. GK-P02-03: A case of cytomegalovirus retinitis during upadacitinib oral treatment. Ocular Infection, Inflammation and Allergy 2024 in Sapporo/The 60th Annual Meeting of Japanese Association for Ocular Infect...$79$YR$$F$Y$$$20240917$$MD$JP$JP
241966431$24196643$1$I$$20240726$20240810$20240810$PER$$US-GRANULES-US-2024GRASPO00318$GRANULES INDIA$$$$$F$Y$$$20240810$$CN$US$US
241966441$24196644$1$I$$20240731$20240810$20240810$PER$$US-JNJFOC-20240809634$JOHNSON AND JOHNSON$$$$$F$Y$131.8$KG$20240810$$CN$US$US
241966452$24196645$2$F$20240805$20240809$20240810$20240813$PER$$US-ABBVIE-5874660$ABBVIE$$30$YR$$F$Y$$$20240813$$MD$US$US
241966461$24196646$1$I$$20240807$20240810$20240810$EXP$$ZA-ROCHE-10000052536$ROCHE$$$$E$M$Y$$$20240810$$MD$ZA$ZA
241966471$24196647$1$I$20240101$20240802$20240810$20240810$PER$$US-ABBVIE-5866412$ABBVIE$$$$$$Y$$$20240810$$CN$US$US
241966481$24196648$1$I$$20240807$20240810$20240810$PER$$US-SA-2024SA236040$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240810$$CN$US$US
241966491$24196649$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA231892$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240810$$CN$US$US
241966501$24196650$1$I$$20240807$20240810$20240810$EXP$$US-SANDOZ INC.-SDZ2024US071466$SANDOZ$$$$$$Y$$$20240810$$CN$US$US
241966511$24196651$1$I$$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158765$AMGEN$$$$$$Y$$$20240810$$PH$US$US
241966521$24196652$1$I$$20240801$20240810$20240810$PER$$US-RDY-SPO/USA/24/0011460$DR REDDYS$$$$$$Y$$$20240810$$CN$US$US
241966532$24196653$2$F$$20240917$20240810$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126222$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240925$$CN$US$US
241966541$24196654$1$I$$20240807$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125510$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240810$$CN$US$US
241966551$24196655$1$I$20240101$20240806$20240810$20240810$EXP$$GB-ABBVIE-5748218$ABBVIE$$62$YR$$F$Y$$$20240810$$CN$GB$GB
241966561$24196656$1$I$$20240802$20240810$20240810$EXP$$JP-AMGEN-JPNSP2024154141$AMGEN$$$$$$Y$$$20240810$$PH$JP$JP
241966575$24196657$5$F$20221101$20240829$20240810$20240906$EXP$BG-PFIZER INC-PV202400095933$BG-ROCHE-10000051466$ROCHE$Petrusheva V, Samardzieva M, Simova I, Chilingirova N, Vekov T. Cardiotoxicity in patient with breast cancer treated with HER-2 targeted therapy - a case report. Cardiovascular diseases. 2024;2:14-23.$54$YR$A$F$Y$$$20240906$$HP$BG$BG
241966581$24196658$1$I$$20240807$20240810$20240810$PER$$US-ABBVIE-5874569$ABBVIE$$$$E$F$Y$$$20240810$$MD$US$US
241966591$24196659$1$I$$20240802$20240810$20240810$EXP$$KR-009507513-2408KOR001968$MERCK$$$$$F$Y$$$20240810$$PH$KR$KR
241966601$24196660$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872114$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241966622$24196662$2$F$20230901$20240906$20240810$20240911$EXP$$RU-ABBVIE-5874314$ABBVIE$Kantsalieva KA, Naydenov LA, Slavgorodskaya MS, Baeva DO, Dmitriev MN. Development of multiple sclerosis in a patient suffering from bipolar affective disorder. Somatoneurology, Materials of XV International Scientific and Practical Conference of Students and Young Scientists. 2024;39-57.; Kantsalieva KA, Naydenov LA, Slavgorodskaya MS, Baeva DO, Dmitriev MN. Development of multiple sclerosis in a patient suffering from bipolar affective disorder. Somatoneurology, Materials of XV Internationa...$$$$$Y$$$20240911$$HP$RU$RU
241966631$24196663$1$I$$20240806$20240810$20240810$EXP$$US-ABBVIE-5871117$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241966641$24196664$1$I$$20240805$20240810$20240810$EXP$$ZA-ABBVIE-5869533$ABBVIE$$52$YR$$F$Y$$$20240810$$CN$ZA$ZA
241966651$24196665$1$I$20240730$20240806$20240810$20240810$EXP$$BR-ROCHE-10000050326$ROCHE$$74$YR$E$F$Y$55$KG$20240810$$PH$BR$BR
241966661$24196666$1$I$$20240805$20240810$20240810$EXP$$US-SA-2024SA235731$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240810$$MD$US$US
241966671$24196667$1$I$$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024157981$AMGEN$$$$$$Y$$$20240810$$PH$US$US
241966681$24196668$1$I$20240805$20240805$20240810$20240810$EXP$$CA-ABBVIE-5871368$ABBVIE$$89$YR$$M$Y$$$20240810$$CN$CA$CA
241966691$24196669$1$I$$20240730$20240810$20240810$EXP$$CA-TEVA-VS-3227637$TEVA$$$$$F$Y$$$20240810$$HP$CA$CA
241966701$24196670$1$I$20240401$20240806$20240810$20240810$EXP$$US-ABBVIE-5701787$ABBVIE$$41$YR$$F$Y$$$20240810$$CN$US$US
241966712$24196671$2$F$20240101$20240819$20240810$20240822$PER$$US-AMGEN-USASP2024158009$AMGEN$$67$YR$E$F$Y$$$20240821$$PH$US$US
241966721$24196672$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA232298$SANOFI AVENTIS$$$$A$M$Y$$$20240810$$MD$US$US
241966731$24196673$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA235430$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240810$$MD$US$US
241966741$24196674$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA235545$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240810$$MD$US$US
241966753$24196675$3$F$20240801$20240906$20240810$20240913$PER$$US-SA-2024SA236072$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240913$$CN$US$US
241966761$24196676$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA233922$SANOFI AVENTIS$$$$E$M$Y$$$20240810$$MD$US$US
241966771$24196677$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA233356$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240810$$MD$US$US
241966782$24196678$2$F$20240701$20240812$20240810$20240816$EXP$$US-ABBVIE-5871752$ABBVIE$$83$YR$$M$Y$113.39$KG$20240816$$CN$US$US
241966791$24196679$1$I$20240730$20240731$20240810$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023659$UNITED THERAPEUTICS$$57$YR$$F$Y$77.098$KG$20240810$$PH$US$US
241966801$24196680$1$I$$20240801$20240810$20240810$EXP$IE-EMA-DD-20240723-7482831-074841$IE-TEVA-VS-3229380$TEVA$$$$$$Y$$$20240810$$PH$IE$IE
241966811$24196681$1$I$$20240806$20240810$20240810$EXP$$US-ABBVIE-5871554$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241966821$24196682$1$I$20240523$20240731$20240810$20240810$EXP$$GB-TEVA-VS-3229113$TEVA$$70$YR$$M$Y$87$KG$20240810$$MD$GB$GB
241966831$24196683$1$I$$20240808$20240810$20240810$EXP$$US-ABBVIE-5874813$ABBVIE$$8$YR$$F$Y$$$20240810$$MD$US$US
241966842$24196684$2$F$$20240822$20240810$20240829$EXP$$JP-ROCHE-10000053213$ROCHE$$48$YR$A$F$Y$$$20240829$$MD$JP$JP
241966851$24196685$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA233942$SANOFI AVENTIS$$$$C$F$Y$28$KG$20240810$$MD$US$US
241966861$24196686$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA234527$SANOFI AVENTIS$$$$$F$Y$$$20240810$$LW$US$US
241966871$24196687$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA235657$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$MD$US$US
241966881$24196688$1$I$20230901$20240805$20240810$20240810$PER$$US-SA-2024SA235434$SANOFI AVENTIS$$6$YR$C$M$Y$30.753$KG$20240810$$MD$US$US
241966891$24196689$1$I$$20240805$20240810$20240810$EXP$$NZ-ROCHE-10000049749$ROCHE$$$$E$$Y$$$20240810$$CN$NZ$NZ
241966901$24196690$1$I$$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024157151$AMGEN$$$$$$Y$$$20240810$$CN$US$US
241966911$24196691$1$I$20240725$20240809$20240810$20240810$PER$$NVSC2024US162672$NOVARTIS$$69$YR$$M$Y$$$20240810$$CN$US$US
241966921$24196692$1$I$$20240806$20240810$20240810$EXP$NL-LRB-00994137$NL-ABBVIE-5867938$ABBVIE$$21$YR$$M$Y$76$KG$20240810$$MD$NL$NL
241966931$24196693$1$I$20240301$20240807$20240810$20240810$EXP$$US-ABBVIE-5872656$ABBVIE$$23$YR$$F$Y$$$20240810$$CN$US$US
241966941$24196694$1$I$$20240807$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125599$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240810$$HP$US$US
241966951$24196695$1$I$20240523$20240807$20240810$20240810$EXP$$BR-ABBVIE-5871822$ABBVIE$$42$YR$$M$Y$69$KG$20240810$$CN$BR$BR
241966961$24196696$1$I$$20240808$20240810$20240810$EXP$$GB-ABBVIE-5874966$ABBVIE$$$$$M$Y$$$20240810$$HP$GB$GB
241966972$24196697$2$F$20240629$20240806$20240810$20240813$EXP$$NVSC2024CO150310$NOVARTIS$$35$YR$$M$Y$67$KG$20240813$$HP$CO$CO
241966981$24196698$1$I$20240101$20240806$20240810$20240810$EXP$$US-ABBVIE-5871861$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241966991$24196699$1$I$$20240807$20240810$20240810$EXP$$CA-ABBVIE-5872903$ABBVIE$$$$E$F$Y$$$20240810$$CN$CA$CA
241967011$24196701$1$I$20240701$20240807$20240810$20240810$EXP$$GB-ABBVIE-5873246$ABBVIE$$62$YR$$F$Y$$$20240810$$CN$GB$GB
241967021$24196702$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA235178$SANOFI AVENTIS$$95$YR$E$F$Y$$$20240810$$MD$US$US
241967032$24196703$2$F$20240201$20240812$20240810$20240814$EXP$$US-ABBVIE-5874391$ABBVIE$$31$YR$$M$Y$$$20240814$$CN$US$US
241967041$24196704$1$I$20240712$20240801$20240810$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022175$UNITED THERAPEUTICS$$83$YR$$F$Y$91.156$KG$20240810$$$US$US
241967061$24196706$1$I$$20240808$20240810$20240810$EXP$$CA-ABBVIE-5874129$ABBVIE$$$$E$M$Y$$$20240810$$CN$CA$CA
241967071$24196707$1$I$$20240731$20240810$20240810$PER$$US-TEVA-VS-3229361$TEVA$$37$YR$$F$Y$$$20240810$$CN$US$US
241967081$24196708$1$I$20240629$20240731$20240810$20240810$EXP$$US-TEVA-VS-3229567$TEVA$$58$YR$$F$Y$$$20240810$$CN$US$US
241967091$24196709$1$I$20240101$20240731$20240810$20240810$EXP$$US-TEVA-VS-3228974$TEVA$$75$YR$$M$Y$84.37$KG$20240810$$CN$US$US
241967101$24196710$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5873021$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241967111$24196711$1$I$$20240804$20240810$20240810$EXP$$IT-ABBVIE-5873241$ABBVIE$$47$YR$$F$Y$$$20240810$$CN$IT$IT
241967121$24196712$1$I$$20240802$20240810$20240810$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07472$HIKMA$$58$YR$$M$Y$$$20240810$$HP$CA$CA
241967131$24196713$1$I$$20240731$20240810$20240810$EXP$$CA-TEVA-VS-3229927$TEVA$$35$YR$$F$Y$$$20240810$$CN$CA$CA
241967141$24196714$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA235645$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240810$$MD$US$US
241967151$24196715$1$I$$20240808$20240810$20240810$EXP$$US-ABBVIE-5873747$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241967161$24196716$1$I$20240701$20240801$20240810$20240810$PER$$US-SA-2024SA231357$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240810$$MD$US$US
241967171$24196717$1$I$20240701$20240802$20240810$20240810$PER$$US-JNJFOC-20240809254$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240810$$CN$US$US
241967181$24196718$1$I$$20240806$20240810$20240810$EXP$$ZA-ABBVIE-5874439$ABBVIE$$79$YR$$M$Y$$$20240810$$CN$ZA$ZA
241967191$24196719$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872347$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241967201$24196720$1$I$$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024156557$AMGEN$$$$$$Y$$$20240810$$CN$US$US
241967211$24196721$1$I$20240701$20240801$20240810$20240810$PER$$US-SA-2024SA232088$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240810$$MD$US$US
241967221$24196722$1$I$20240719$20240801$20240810$20240810$PER$$US-SA-2024SA234014$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240810$$MD$US$US
241967231$24196723$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA235739$SANOFI AVENTIS$$$$A$F$Y$73.9$KG$20240810$$MD$US$US
241967242$24196724$2$F$20240731$20240818$20240810$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-023996$UNITED THERAPEUTICS$$52$YR$$F$Y$76.644$KG$20240827$$$US$US
241967251$24196725$1$I$20240101$20240801$20240810$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-024405$UNITED THERAPEUTICS$$$$$F$Y$$$20240810$$$US$US
241967261$24196726$1$I$$20240807$20240810$20240810$EXP$$CA-ABBVIE-5873223$ABBVIE$$$$E$M$Y$$$20240810$$CN$CA$CA
241967281$24196728$1$I$$20240731$20240810$20240810$EXP$$CA-TEVA-VS-3227805$TEVA$$56$YR$$M$Y$109$KG$20240810$$HP$CA$CA
241967291$24196729$1$I$$20240731$20240810$20240810$EXP$$GR-CELLTRION INC.-2024GR018669$CELLTRION$$$$$$Y$$$20240810$$CN$GR$GR
241967311$24196731$1$I$$20240806$20240810$20240810$EXP$$US-SA-2024SA234203$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240810$$MD$US$US
241967322$24196732$2$F$$20240809$20240810$20240820$PER$$US-SA-2024SA236284$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240820$$CN$US$US
241967331$24196733$1$I$20230101$20240805$20240810$20240810$PER$$US-AMGEN-USASP2024155759$AMGEN$$40$YR$A$F$Y$$$20240810$$CN$US$US
241967341$24196734$1$I$$20240805$20240810$20240810$PER$$US-ALXN-202408USA000247US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240810$$CN$US$US
241967351$24196735$1$I$$20240806$20240810$20240810$EXP$$US-ABBVIE-5871068$ABBVIE$$41$YR$$M$Y$$$20240810$$MD$US$US
241967361$24196736$1$I$20240516$20240801$20240810$20240810$EXP$$CA-CELLTRION INC.-2024CA013140$CELLTRION$$$$$$Y$$$20240810$$HP$CA$CA
241967371$24196737$1$I$$20240801$20240810$20240810$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125953$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240810$$MD$JP$JP
241967391$24196739$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230455$TEVA$$5$YR$$M$Y$16$KG$20240810$$PH$CA$CA
241967401$24196740$1$I$20240715$20240802$20240810$20240810$EXP$$CA-CELLTRION INC.-2024CA014396$CELLTRION$$$$$$Y$$$20240810$$HP$CA$CA
241967411$24196741$1$I$$20240805$20240810$20240810$EXP$$JP-ROCHE-10000053243$ROCHE$$6$DEC$A$F$Y$$$20240810$$MD$JP$JP
241967421$24196742$1$I$$20240807$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126044$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240810$$PH$US$US
241967441$24196744$1$I$20240730$20240731$20240810$20240810$PER$$US-ABBVIE-5866108$ABBVIE$$30$YR$$F$Y$$$20240810$$CN$US$US
241967451$24196745$1$I$20170727$20240730$20240810$20240810$EXP$IT-EMA-2024723-AUTODUP-1721768600521$IT-Accord-439446$ACCORD$$32$YR$A$M$Y$98$KG$20240810$$MD$IT$IT
241967461$24196746$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126332$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240810$$CN$US$US
241967471$24196747$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126153$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240810$$HP$US$US
241967481$24196748$1$I$20240401$20240802$20240810$20240810$PER$$US-SA-2024SA235297$SANOFI AVENTIS$$60$YR$A$F$Y$95.2$KG$20240810$$MD$US$US
241967491$24196749$1$I$$20240729$20240810$20240810$PER$$US-ABBVIE-5862595$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241967502$24196750$2$F$$20240808$20240810$20240816$PER$$US-SA-2024SA233365$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240816$$MD$US$US
241967513$24196751$3$F$20240101$20240821$20240810$20240828$EXP$$CA-CELLTRION INC.-2024CA012017$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
241967521$24196752$1$I$$20240802$20240810$20240810$PER$$US-ABBVIE-5866900$ABBVIE$$$$$F$Y$$$20240810$$HP$US$US
241967531$24196753$1$I$20230701$20240801$20240810$20240810$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011726$JAZZ$$37$YR$$F$Y$$$20240810$$CN$US$US
241967541$24196754$1$I$20240601$20240730$20240810$20240810$PER$$PR-ABBVIE-5866242$ABBVIE$$51$YR$$F$Y$71.67$KG$20240810$$CN$PR$PR
241967551$24196755$1$I$20240331$20240807$20240810$20240810$EXP$$US-ABBVIE-5873886$ABBVIE$$65$YR$$M$Y$$$20240810$$MD$US$US
241967561$24196756$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126329$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$40.82$KG$20240810$$PH$US$US
241967571$24196757$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126402$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$73.94$KG$20240810$$CN$US$US
241967581$24196758$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230986$TEVA$$58$YR$$F$Y$58.513$KG$20240810$$HP$CA$CA
241967591$24196759$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230992$TEVA$$73$YR$$F$Y$47$KG$20240810$$HP$CA$CA
241967604$24196760$4$F$20240723$20240912$20240810$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022825$UNITED THERAPEUTICS$$68$YR$$F$Y$62.132$KG$20240921$$PH$US$US
241967611$24196761$1$I$20240101$20240802$20240810$20240810$EXP$$CO-ABBVIE-5867659$ABBVIE$$$$$F$Y$55$KG$20240810$$CN$CO$CO
241967621$24196762$1$I$$20240724$20240810$20240810$PER$$US-JNJFOC-20240775948$JOHNSON AND JOHNSON$$$$$$Y$$$20240810$$CN$US$US
241967631$24196763$1$I$20240730$20240731$20240810$20240810$EXP$$GB-TEVA-VS-3229502$TEVA$$24$YR$$F$Y$64$KG$20240810$$PH$GB$GB
241967641$24196764$1$I$20240101$20240806$20240810$20240810$EXP$$US-ABBVIE-5838627$ABBVIE$$34$YR$$M$Y$68$KG$20240810$$CN$US$US
241967651$24196765$1$I$20240101$20240805$20240810$20240810$PER$$US-ABBVIE-5874206$ABBVIE$$90$YR$$F$Y$$$20240810$$MD$US$US
241967661$24196766$1$I$$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024157478$AMGEN$$$$$$Y$$$20240810$$CN$US$US
241967673$24196767$3$F$20240101$20240911$20240810$20240920$PER$$US-SA-2024SA233649$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240920$$MD$US$US
241967681$24196768$1$I$$20240806$20240810$20240810$PER$$US-SA-2024SA236379$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240810$$CN$US$US
241967693$24196769$3$F$20240101$20240821$20240810$20240909$PER$$US-SA-2024SA235091$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240909$$MD$US$US
241967701$24196770$1$I$20240101$20240802$20240810$20240810$PER$$US-ABBVIE-5866622$ABBVIE$$$$$$Y$$$20240810$$CN$US$US
241967711$24196771$1$I$$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024157717$AMGEN$$$$A$M$Y$$$20240810$$HP$US$US
241967721$24196772$1$I$20240101$20240802$20240810$20240810$EXP$$CA-CELLTRION INC.-2024CA018878$CELLTRION$$$$$$Y$$$20240810$$HP$CA$CA
241967732$24196773$2$F$$20240909$20240810$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125963$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240912$$MD$JP$JP
241967741$24196774$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5871590$ABBVIE$$$$$$Y$83$KG$20240810$$MD$US$US
241967751$24196775$1$I$20240101$20240805$20240810$20240810$PER$$US-SA-2024SA195810$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240810$$MD$US$US
241967762$24196776$2$F$20210101$20240903$20240810$20240910$EXP$$US-ABBVIE-5874303$ABBVIE$$$$$M$Y$63$KG$20240910$$CN$US$US
241967772$24196777$2$F$20240209$20240814$20240810$20240823$EXP$FR-AFSSAPS-TO2024001468$FR-KOANAAP-SML-FR-2024-00827$Unknown Manufacturer$$69$YR$E$M$Y$106$KG$20240823$$PH$FR$FR
241967781$24196778$1$I$$20240731$20240810$20240810$PER$$US-JNJFOC-20240801582$JOHNSON AND JOHNSON$$$$$F$Y$$$20240810$$CN$US$US
241967791$24196779$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872942$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241967801$24196780$1$I$$20240801$20240810$20240810$EXP$$CO-UNITED THERAPEUTICS-UNT-2024-024012$UNITED THERAPEUTICS$$51$YR$$$Y$43$KG$20240810$$$CO$CO
241967812$24196781$2$F$20240820$20240904$20240810$20240912$EXP$$CA-CELLTRION INC.-2024CA018880$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
241967821$24196782$1$I$20220221$20220221$20240810$20240810$EXP$$IN-AstraZeneca-2022A083994$ASTRAZENECA$$68$YR$$M$Y$$$20240810$$CN$IN$
241967831$24196783$1$I$$20230726$20240810$20240810$EXP$$GB-AstraZeneca-2023A140475$ASTRAZENECA$$$$$F$Y$$$20240810$$CN$GB$
241967841$24196784$1$I$$20220815$20240810$20240810$EXP$$US-AstraZeneca-2022A241340$ASTRAZENECA$$$$$F$Y$$$20240810$$CN$US$
241967851$24196785$1$I$$20220823$20240810$20240810$EXP$$US-AstraZeneca-2022A297222$ASTRAZENECA$$$$$F$Y$$$20240810$$CN$US$
241967861$24196786$1$I$$20220415$20240810$20240810$EXP$$US-AstraZeneca-2022A155176$ASTRAZENECA$$$$$M$Y$$$20240810$$CN$US$
241967871$24196787$1$I$$20220601$20240810$20240810$EXP$$US-AstraZeneca-2022A206536$ASTRAZENECA$$$$$M$Y$$$20240810$$CN$US$
241967881$24196788$1$I$$20230830$20240810$20240810$EXP$$US-AstraZeneca-2023A200905$ASTRAZENECA$$$$$F$Y$$$20240810$$CN$US$
241967891$24196789$1$I$20230214$20230705$20240810$20240810$EXP$$US-AstraZeneca-2023A155017$ASTRAZENECA$$82$YR$$$Y$$$20240810$$CN$US$
241967902$24196790$2$F$$20240828$20240810$20240905$30DAY$$US-GSK-US2024097041$GLAXOSMITHKLINE$$$$$M$Y$$$20240905$$CN$US$US
241967914$24196791$4$F$20240802$20240906$20240810$20240916$EXP$$ZA-CELLTRION INC.-2024ZA018776$CELLTRION$$$$$$Y$$$20240916$$CN$ZA$ZA
241967921$24196792$1$I$$20240802$20240810$20240810$PER$$US-ABBVIE-5866093$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241967931$24196793$1$I$$20240805$20240810$20240810$EXP$$JP-ROCHE-10000052859$ROCHE$Taga A, Taga Y, Onishi Y, Ishida K, Nakamura A, Hoshimoto Y. Original article: Investigation of anticoagulant therapy in cases of ovarian cancer complicated by thrombosis diagnosed in our hospital in the last four years.. Obstetrical and Gynecological Practice.. 2024;73 (7):757-62.$$$$F$Y$$$20240810$$MD$JP$JP
241967941$24196794$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230433$TEVA$$75$YR$$M$Y$$$20240810$$HP$CA$CA
241967951$24196795$1$I$20240617$20240806$20240810$20240810$EXP$$US-ABBVIE-5869953$ABBVIE$$69$YR$$M$Y$$$20240810$$CN$US$US
241967961$24196796$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872563$ABBVIE$$$$$M$Y$$$20240810$$HP$US$US
241967971$24196797$1$I$20230601$20240806$20240810$20240810$EXP$$US-ABBVIE-5872538$ABBVIE$$54$YR$$F$Y$$$20240810$$CN$US$US
241967981$24196798$1$I$$20240808$20240810$20240810$EXP$$US-ABBVIE-5874253$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241967991$24196799$1$I$$20240808$20240810$20240810$PER$$US-ABBVIE-5873625$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241968001$24196800$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230428$TEVA$$74$YR$$M$Y$$$20240810$$CN$CA$CA
241968011$24196801$1$I$20150101$20240801$20240810$20240810$EXP$$US-TEVA-VS-3229429$TEVA$$42$YR$$F$Y$56.7$KG$20240810$$HP$US$US
241968021$24196802$1$I$$20240731$20240810$20240810$EXP$GB-MHRA-MED-202407311822484720-VHGSC$GB-TEVA-VS-3229504$TEVA$$69$YR$$F$Y$$$20240810$$CN$GB$GB
241968031$24196803$1$I$$20240806$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126250$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240810$$HP$US$US
241968041$24196804$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126451$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240810$$MD$US$US
241968051$24196805$1$I$20220101$20240805$20240810$20240810$EXP$$CN-ABBVIE-5870858$ABBVIE$Chen J, Jiang Y, Xie R, Gao L. Adalimumab administration caused Miller-Fisher syndrome: a case report. Journal of Neurology and Neurorehabilitation. 2024;20(1):26-32.$32$YR$$M$Y$$$20240810$$HP$CN$CN
241968062$24196806$2$F$20240804$20240813$20240810$20240817$PER$$US-AMGEN-USASP2024155377$AMGEN$$72$YR$E$F$Y$$$20240817$$CN$US$US
241968071$24196807$1$I$$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024157591$AMGEN$$$$$$Y$$$20240810$$CN$US$US
241968081$24196808$1$I$$20240731$20240810$20240810$EXP$$GB-TEVA-VS-3229500$TEVA$$$$A$M$Y$$$20240810$$MD$GB$GB
241968091$24196809$1$I$$20240806$20240810$20240810$PER$$US-SA-2024SA236383$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240810$$CN$US$US
241968101$24196810$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA233419$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240810$$MD$US$US
241968111$24196811$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233379$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$CN$US$US
241968121$24196812$1$I$$20240803$20240810$20240810$PER$$US-SA-2024SA233381$SANOFI AVENTIS$$$$E$M$Y$$$20240810$$MD$US$US
241968141$24196814$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230440$TEVA$$56$YR$$F$Y$$$20240810$$HP$CA$CA
241968151$24196815$1$I$$20240801$20240810$20240810$EXP$$US-TEVA-VS-3229325$TEVA$$76$YR$$F$Y$91.7$KG$20240810$$CN$US$US
241968161$24196816$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230471$TEVA$$105$MON$$M$Y$$$20240810$$HP$CA$CA
241968171$24196817$1$I$$20240730$20240810$20240810$PER$$PR-JNJFOC-20240804650$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240810$$CN$PR$PR
241968183$24196818$3$F$20220201$20240813$20240810$20240923$EXP$$US-ABBVIE-5872785$ABBVIE$$66$YR$$F$Y$$$20240923$$CN$US$US
241968191$24196819$1$I$20240731$20240731$20240810$20240810$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024096205$VIIV$$27$YR$$M$Y$$$20240810$$PH$US$US
241968201$24196820$1$I$$20240729$20240810$20240810$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011512$JAZZ$$$$$F$Y$$$20240810$$CN$US$US
241968211$24196821$1$I$$20240808$20240810$20240810$EXP$$TR-ABBVIE-5874825$ABBVIE$$$$$F$Y$$$20240810$$MD$TR$TR
241968221$24196822$1$I$$20240801$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122085$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240810$$HP$US$US
241968231$24196823$1$I$$20240805$20240810$20240810$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125565$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$70$KG$20240810$$MD$US$US
241968242$24196824$2$F$20240730$20240814$20240810$20240823$PER$$US-ABBVIE-5866501$ABBVIE$$55$YR$$M$Y$$$20240823$$CN$US$US
241968251$24196825$1$I$20240517$20240808$20240810$20240810$EXP$$DE-ABBVIE-5874636$ABBVIE$$$$E$M$Y$$$20240810$$CN$DE$DE
241968261$24196826$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230458$TEVA$$18$YR$$F$Y$84$KG$20240810$$HP$CA$CA
241968271$24196827$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA233404$SANOFI AVENTIS$$76$YR$E$M$Y$110.7$KG$20240810$$HP$US$US
241968281$24196828$1$I$20240101$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158562$AMGEN$$67$YR$E$F$Y$$$20240810$$CN$US$US
241968293$24196829$3$F$$20240911$20240810$20240920$EXP$$GB-TEVA-VS-3228564$TEVA$$40$YR$$F$Y$$$20240920$$HP$GB$GB
241968301$24196830$1$I$20240701$20240805$20240810$20240810$EXP$$US-ABBVIE-5854336$ABBVIE$$66$YR$$M$Y$$$20240810$$CN$US$US
241968311$24196831$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3229610$TEVA$$72$YR$$M$Y$$$20240810$$MD$CA$CA
241968321$24196832$1$I$20240807$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024157715$AMGEN$$75$YR$E$M$Y$$$20240810$$CN$US$US
241968331$24196833$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA181556$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240810$$CN$US$US
241968341$24196834$1$I$20240718$20240802$20240810$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022509$UNITED THERAPEUTICS$$64$YR$$F$Y$51.701$KG$20240810$$PH$US$US
241968351$24196835$1$I$$20240808$20240810$20240810$EXP$GB-MHRA-MED-202408081520323690-SWYNB$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044749$BOEHRINGER INGELHEIM$$57$YR$A$M$Y$$$20240810$$PH$GB$GB
241968361$24196836$1$I$20230826$20240805$20240810$20240810$PER$$US-SA-2023SA264273$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240810$$MD$US$US
241968372$24196837$2$F$$20240902$20240810$20240905$EXP$$JP-AMGEN-JPNSP2024156135$AMGEN$$$$$M$Y$$$20240905$$PH$JP$JP
241968381$24196838$1$I$20240301$20240807$20240810$20240810$EXP$$US-ABBVIE-5872126$ABBVIE$$63$YR$$M$Y$$$20240810$$CN$US$US
241968401$24196840$1$I$20240728$20240802$20240810$20240810$EXP$$PK-ROCHE-10000047911$ROCHE$$51$YR$A$F$Y$$$20240810$$CN$PK$PK
241968411$24196841$1$I$20240101$20240806$20240810$20240810$EXP$$US-009507513-2408USA002029$MERCK$$$$$M$Y$$$20240810$$HP$US$US
241968421$24196842$1$I$20240618$20240806$20240810$20240810$EXP$$US-ABBVIE-5870748$ABBVIE$$59$YR$$M$Y$$$20240810$$CN$US$US
241968431$24196843$1$I$20240805$20240807$20240810$20240810$EXP$$MX-ABBVIE-5874992$ABBVIE$$71$YR$$F$Y$$$20240810$$CN$MX$MX
241968441$24196844$1$I$$20240807$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125793$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240810$$CN$US$US
241968451$24196845$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126268$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240810$$CN$US$US
241968462$24196846$2$F$20240701$20240807$20240810$20240813$EXP$$US-ABBVIE-5872827$ABBVIE$$61$YR$$M$Y$$$20240810$$CN$US$US
241968472$24196847$2$F$20240101$20240807$20240810$20240813$EXP$$US-ABBVIE-5873000$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241968482$24196848$2$F$20240701$20240801$20240810$20240819$EXP$$US-VIIV HEALTHCARE LIMITED-US2024096413$VIIV$$60$YR$$M$Y$$$20240819$$CN$US$US
241968492$24196849$2$F$$20240822$20240810$20240906$PER$$US-SA-2024SA234107$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240906$$MD$US$US
241968501$24196850$1$I$$20240808$20240810$20240810$EXP$$US-ABBVIE-5874395$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241968511$24196851$1$I$20240408$20240729$20240810$20240810$EXP$FR-AFSSAPS-DJ2024000844$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110611$ZYDUS PHARM$$$$$$Y$$$20240810$$MD$FR$FR
241968521$24196852$1$I$20240322$20240729$20240810$20240810$EXP$FR-AFSSAPS-RN2024000835$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110583$ZYDUS PHARM$$$$$$Y$$$20240810$$MD$FR$FR
241968531$24196853$1$I$20240703$20240729$20240810$20240810$EXP$FR-AFSSAPS-TS2024000863$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110582$ZYDUS PHARM$$$$$$Y$$$20240810$$MD$FR$FR
241968541$24196854$1$I$20240706$20240729$20240810$20240810$EXP$FR-AFSSAPS-PO2024000787$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110613$ZYDUS PHARM$$$$$$Y$$$20240810$$MD$FR$FR
241968551$24196855$1$I$20240621$20240807$20240810$20240810$PER$$US-ABBVIE-5871891$ABBVIE$$32$YR$$F$Y$$$20240810$$HP$US$US
241968561$24196856$1$I$$20240802$20240810$20240810$PER$$US-JNJFOC-20240809200$JOHNSON AND JOHNSON$$$$$F$Y$$$20240810$$CN$US$US
241968571$24196857$1$I$$20240807$20240810$20240810$PER$$US-JNJFOC-20240819682$JOHNSON AND JOHNSON$$6$MON$I$M$Y$$$20240810$$CN$US$US
241968581$24196858$1$I$$20240809$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126336$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240810$$CN$US$US
241968591$24196859$1$I$$20240806$20240810$20240810$PER$$US-ABBVIE-5874834$ABBVIE$$$$$$Y$$$20240810$$CN$US$US
241968601$24196860$1$I$20231025$20240729$20240810$20240810$EXP$FR-AFSSAPS-AM2024000563$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110616$ZYDUS PHARM$$$$$$Y$$$20240810$$MD$FR$FR
241968613$24196861$3$F$$20240812$20240810$20240820$EXP$$CA-CELLTRION INC.-2024CA018709$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
241968621$24196862$1$I$20240807$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024158504$AMGEN$$$$$$Y$$$20240810$$PH$US$US
241968631$24196863$1$I$$20240805$20240810$20240810$PER$$US-SA-2023SA072969$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$MD$US$US
241968661$24196866$1$I$$20240809$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126321$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240810$$CN$US$US
241968674$24196867$4$F$20240808$20240909$20240810$20240920$PER$$US-AMGEN-USASP2024158508$AMGEN$$65$YR$E$F$Y$$$20240920$$CN$US$US
241968681$24196868$1$I$20240806$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024157796$AMGEN$$63$YR$A$F$Y$$$20240810$$CN$US$US
241968691$24196869$1$I$20240401$20240801$20240810$20240810$PER$$US-SA-2024SA229206$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240810$$MD$US$US
241968701$24196870$1$I$20240722$20240805$20240810$20240810$PER$$US-SA-2024SA233987$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240810$$HP$US$US
241968712$24196871$2$F$20240101$20240826$20240810$20240830$PER$$US-009507513-2407USA011956$MERCK$$$$$F$Y$81.633$KG$20240830$$CN$US$US
241968721$24196872$1$I$20240101$20240802$20240810$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-024163$UNITED THERAPEUTICS$$$$$F$Y$87.982$KG$20240810$$$US$US
241968731$24196873$1$I$20240630$20240805$20240810$20240810$EXP$$US-ABBVIE-5874652$ABBVIE$$66$YR$$F$Y$$$20240810$$MD$US$US
241968742$24196874$2$F$20240809$20240812$20240810$20240813$EXP$$CH-ABBVIE-5874801$ABBVIE$$74$YR$$M$Y$$$20240813$$MD$CH$CH
241968751$24196875$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3231005$TEVA$$70$YR$$F$Y$65$KG$20240810$$MD$CA$CA
241968761$24196876$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230462$TEVA$$$$$F$Y$48$KG$20240810$$HP$CA$CA
241968771$24196877$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230995$TEVA$$84$YR$$F$Y$$$20240810$$PH$CA$CA
241968781$24196878$1$I$$20240801$20240810$20240810$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR097956$VIIV$$$$$$Y$$$20240810$$HP$US$US
241968791$24196879$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230998$TEVA$$84$YR$$F$Y$29$KG$20240810$$HP$CA$CA
241968801$24196880$1$I$20240805$20240805$20240810$20240810$EXP$$KR-009507513-2408KOR001944$MERCK$$$$$F$Y$$$20240810$$CN$KR$KR
241968811$24196881$1$I$20240310$20240807$20240810$20240810$EXP$FR-AFSSAPS-AVMA2024000275$FR-ABBVIE-5872765$ABBVIE$$$$$$Y$$$20240810$$PH$FR$FR
241968822$24196882$2$F$$20240809$20240810$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024491$UNITED THERAPEUTICS$$$$$F$Y$57.143$KG$20240816$$$US$US
241968831$24196883$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3231040$TEVA$$65$YR$$F$Y$56$KG$20240810$$HP$CA$CA
241968841$24196884$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3231045$TEVA$$64$YR$$F$Y$$$20240810$$HP$CA$CA
241968851$24196885$1$I$20170510$20240731$20240810$20240810$PER$$US-TEVA-VS-3229585$TEVA$$37$YR$$F$Y$$$20240810$$HP$US$US
241968863$24196886$3$F$20240812$20240822$20240810$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-024550$UNITED THERAPEUTICS$$32$YR$$F$Y$52.154$KG$20240830$$$US$US
241968871$24196887$1$I$$20240806$20240810$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-017838$UNITED THERAPEUTICS$$$$$M$Y$101.59$KG$20240810$$$US$US
241968881$24196888$1$I$$20240802$20240810$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-024065$UNITED THERAPEUTICS$$$$$F$Y$$$20240810$$$US$US
241968891$24196889$1$I$$20240806$20240810$20240810$EXP$$US-ABBVIE-5870498$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241968901$24196890$1$I$20230706$20240808$20240810$20240810$EXP$FR-AFSSAPS-CF2024000327$FR-ABBVIE-5872087$ABBVIE$$79$YR$$F$Y$$$20240810$$MD$FR$FR
241968912$24196891$2$F$$20240808$20240810$20240812$PER$$US-ABBVIE-5874160$ABBVIE$$$$$$Y$$$20240812$$MD$US$US
241968922$24196892$2$F$20240725$20240819$20240810$20240823$PER$$US-AMGEN-USASP2024158612$AMGEN$$85$YR$E$M$Y$$$20240823$$CN$US$US
241968932$24196893$2$F$$20240912$20240810$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126311$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240913$$CN$US$US
241968941$24196894$1$I$20240101$20240806$20240810$20240810$EXP$$US-ABBVIE-5870895$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241968951$24196895$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5871912$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241968961$24196896$1$I$20230101$20240806$20240810$20240810$EXP$$CA-ABBVIE-5871576$ABBVIE$$$$A$F$Y$$$20240810$$CN$CA$CA
241968971$24196897$1$I$20240803$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024156213$AMGEN$$81$YR$E$F$Y$$$20240810$$CN$US$US
241968981$24196898$1$I$$20240805$20240810$20240810$PER$$US-AMGEN-USASP2024156080$AMGEN$$$$E$M$Y$$$20240810$$MD$US$US
241968991$24196899$1$I$20240729$20240805$20240810$20240810$PER$$US-SA-2024SA235028$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240810$$MD$US$US
241969001$24196900$1$I$$20240808$20240810$20240810$EXP$$CA-ABBVIE-5874103$ABBVIE$$$$E$M$Y$$$20240810$$HP$CA$CA
241969011$24196901$1$I$$20240730$20240810$20240810$PER$$US-ABBVIE-5861672$ABBVIE$$$$$$Y$$$20240810$$CN$US$US
241969021$24196902$1$I$20240101$20240806$20240810$20240810$EXP$$US-ABBVIE-5870235$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241969031$24196903$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5849084$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241969041$24196904$1$I$20240101$20240805$20240810$20240810$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024278$UNITED THERAPEUTICS$$$$$F$Y$63.039$KG$20240810$$$US$US
241969052$24196905$2$F$20240101$20240812$20240810$20240813$EXP$$US-ABBVIE-5873031$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
241969061$24196906$1$I$20240726$20240806$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126210$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240810$$HP$US$US
241969071$24196907$1$I$20231101$20240807$20240810$20240810$EXP$$US-ABBVIE-5872178$ABBVIE$$35$YR$$F$Y$$$20240810$$CN$US$US
241969081$24196908$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA232728$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240810$$MD$US$US
241969101$24196910$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233689$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$MD$US$US
241969121$24196912$1$I$$20240806$20240810$20240810$EXP$$CA-ABBVIE-5874059$ABBVIE$$$$E$M$Y$$$20240810$$CN$CA$CA
241969131$24196913$1$I$$20240807$20240810$20240810$PER$$US-ABBVIE-5874376$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241969151$24196915$1$I$20240709$20240807$20240810$20240810$EXP$$US-SA-2024SA236377$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240810$$MD$US$US
241969161$24196916$1$I$20221101$20240730$20240810$20240810$PER$$US-009507513-2408USA000372$MERCK$Becken B, Dousa KM, Johnson JL, Holland SM, Bonomo RA.. Dual ?-lactam for treatment of pulmonary Mycobacterium abscessus in a child. Antimicrobial Agents and Chemotherapy. 2024;68(7)$6$YR$$F$Y$$$20240810$$HP$US$US
241969172$24196917$2$F$$20240821$20240810$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126103$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240827$$HP$US$US
241969181$24196918$1$I$$20240806$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125822$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240810$$CN$US$US
241969191$24196919$1$I$$20240809$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126376$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240810$$CN$US$US
241969202$24196920$2$F$$20240815$20240810$20240828$PER$$US-SA-2024SA228695$SANOFI AVENTIS$$6$YR$C$M$Y$22.22$KG$20240828$$MD$US$US
241969211$24196921$1$I$$20240802$20240810$20240810$PER$$US-AstraZeneca-2024A176779$ASTRAZENECA$$$$$F$Y$$$20240810$$PH$US$
241969221$24196922$1$I$20230731$20240729$20240810$20240810$EXP$ES-AEMPS-1553800$ES-GLENMARK PHARMACEUTICALS-2024GMK092941$GLENMARK$$$$$$Y$$$20240810$$MD$ES$ES
241969232$24196923$2$F$20240101$20240819$20240810$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-024324$UNITED THERAPEUTICS$$$$$M$Y$83.9$KG$20240824$$$US$US
241969241$24196924$1$I$$20240806$20240810$20240810$EXP$$US-ABBVIE-5872595$ABBVIE$$$$$F$Y$$$20240810$$HP$US$US
241969251$24196925$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5873204$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241969271$24196927$1$I$20240720$20240803$20240810$20240810$EXP$$EG-ABBVIE-5867499$ABBVIE$$32$YR$$F$Y$$$20240810$$CN$EG$EG
241969281$24196928$1$I$$20240806$20240810$20240810$EXP$$US-ABBVIE-5871195$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241969291$24196929$1$I$20240101$20240807$20240810$20240810$EXP$$US-ABBVIE-5872626$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241969311$24196931$1$I$$20240731$20240810$20240810$PER$$US-SA-2024SA233619$SANOFI AVENTIS$$$$A$F$Y$58.967$KG$20240810$$MD$US$US
241969321$24196932$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872751$ABBVIE$$$$$F$Y$$$20240810$$HP$US$US
241969331$24196933$1$I$$20240806$20240810$20240810$PER$$US-ABBVIE-5872844$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241969351$24196935$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA233061$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240810$$MD$US$US
241969361$24196936$1$I$20240801$20240805$20240810$20240810$PER$$US-SA-2024SA228051$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240810$$MD$US$US
241969371$24196937$1$I$20240803$20240805$20240810$20240810$PER$$US-SA-2024SA233827$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240810$$CN$US$US
241969381$24196938$1$I$20240718$20240801$20240810$20240810$PER$$US-SA-2024SA232234$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240810$$MD$US$US
241969391$24196939$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA233056$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240810$$MD$US$US
241969402$24196940$2$F$20240626$20240806$20240810$20240820$EXP$$CO-CIPLA LTD.-2024CO08569$CIPLA$$$$$$Y$$$20240820$$MD$CO$CO
241969411$24196941$1$I$20240701$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024157459$AMGEN$$86$YR$E$F$Y$$$20240810$$CN$US$US
241969421$24196942$1$I$20240618$20240804$20240810$20240810$PER$$US-SA-2024SA233466$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240810$$MD$US$US
241969431$24196943$1$I$20240701$20240801$20240810$20240810$PER$$US-SA-2024SA232134$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$MD$US$US
241969441$24196944$1$I$$20240723$20240810$20240810$PER$$US-JNJFOC-20240767137$JOHNSON AND JOHNSON$$$$$$Y$$$20240810$$CN$US$US
241969451$24196945$1$I$$20240806$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126154$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240810$$CN$US$US
241969461$24196946$1$I$20240101$20240802$20240810$20240810$EXP$$US-ABBVIE-5866462$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241969471$24196947$1$I$20240723$20240807$20240810$20240810$EXP$FR-AFSSAPS-MA2024001259$FR-ROCHE-10000051144$ROCHE$$53$YR$A$M$Y$$$20240810$$MD$FR$FR
241969481$24196948$1$I$$20240806$20240810$20240810$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012071$JAZZ$$$$$F$Y$$$20240810$$HP$US$US
241969491$24196949$1$I$20240727$20240802$20240810$20240810$PER$$US-SA-2024SA232888$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240810$$MD$US$US
241969501$24196950$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA233533$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240810$$CN$US$US
241969511$24196951$1$I$20240715$20240807$20240810$20240810$EXP$PT-INFARMED-M202407-429$PT-ROCHE-10000051851$ROCHE$$72$YR$E$M$Y$$$20240810$$HP$PT$PT
241969521$24196952$1$I$20230615$20240806$20240810$20240810$EXP$$KR-TAKEDA-2024TUS079865$TAKEDA$$60$YR$$M$Y$83.5$KG$20240810$$MD$KR$KR
241969531$24196953$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230504$TEVA$$76$YR$$F$Y$77$KG$20240810$$MD$CA$CA
241969543$24196954$3$F$20240618$20240820$20240810$20240829$EXP$FR-AFSSAPS-AN2024000972$FR-TEVA-VS-3230569$TEVA$$52$YR$$F$Y$73.5$KG$20240829$$PH$FR$FR
241969551$24196955$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230465$TEVA$$18$YR$$F$Y$49$KG$20240810$$HP$CA$CA
241969561$24196956$1$I$$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024156735$AMGEN$$$$$M$Y$$$20240810$$HP$US$US
241969571$24196957$1$I$$20240806$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126320$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240810$$CN$US$US
241969581$24196958$1$I$20240101$20240802$20240810$20240810$EXP$$JP-009507513-2408JPN000344J$MERCK$$8$DEC$$F$Y$$$20240810$$MD$JP$JP
241969591$24196959$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA181140$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240810$$MD$US$US
241969601$24196960$1$I$20240101$20240805$20240810$20240810$PER$$US-SA-2024SA234857$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240810$$MD$US$US
241969611$24196961$1$I$20240701$20240802$20240810$20240810$PER$$US-SA-2024SA234161$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240810$$MD$US$US
241969621$24196962$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126404$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240810$$CN$US$US
241969631$24196963$1$I$$20240807$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125829$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240810$$CN$US$US
241969641$24196964$1$I$20221101$20240805$20240810$20240810$EXP$$PL-AMGEN-POLSP2024155895$AMGEN$$59$YR$A$M$Y$$$20240810$$MD$PL$PL
241969651$24196965$1$I$$20240803$20240810$20240810$EXP$NL-LRB-00994580$NL-KOANAAP-SML-NL-2024-00836$SHILPA MEDICARE$$77$YR$E$F$Y$71.7$KG$20240810$$MD$NL$NL
241969661$24196966$1$I$$20240802$20240810$20240810$PER$$US-JNJFOC-20240809217$JOHNSON AND JOHNSON$$$$$F$Y$$$20240810$$CN$US$US
241969671$24196967$1$I$$20240806$20240810$20240810$EXP$$US-ABBVIE-5870873$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241969681$24196968$1$I$20240101$20240806$20240810$20240810$EXP$$CA-ABBVIE-5828705$ABBVIE$$50$YR$$M$Y$$$20240810$$CN$CA$CA
241969691$24196969$1$I$20240801$20240806$20240810$20240810$EXP$$CA-ABBVIE-5871877$ABBVIE$$42$YR$$F$Y$$$20240810$$CN$CA$CA
241969701$24196970$1$I$$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158713$AMGEN$$$$$M$Y$$$20240810$$HP$US$US
241969711$24196971$1$I$$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024157965$AMGEN$$$$$F$Y$$$20240810$$CN$US$US
241969721$24196972$1$I$$20240807$20240810$20240810$PER$$US-ABBVIE-5873898$ABBVIE$$$$$$Y$$$20240810$$CN$US$US
241969731$24196973$1$I$$20240806$20240810$20240810$EXP$$FR-KOANAAP-SML-FR-2024-00838$SHILPA MEDICARE$$$$$$Y$$$20240810$$MD$FR$FR
241969741$24196974$1$I$$20240808$20240810$20240810$EXP$$US-ABBVIE-5874787$ABBVIE$$$$$F$Y$$$20240810$$HP$US$US
241969752$24196975$2$F$20240601$20240817$20240810$20240822$EXP$$US-ABBVIE-5833921$ABBVIE$$75$YR$$F$Y$$$20240822$$CN$US$US
241969761$24196976$1$I$20240101$20240806$20240810$20240810$EXP$$US-ABBVIE-5870886$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241969771$24196977$1$I$20240101$20240805$20240810$20240810$EXP$$ES-ABBVIE-5869460$ABBVIE$$$$$F$Y$$$20240810$$HP$ES$ES
241969781$24196978$1$I$$20240801$20240810$20240810$EXP$$BR-TAKEDA-2024TUS078448$TAKEDA$$$$$M$Y$$$20240810$$CN$BR$BR
241969791$24196979$1$I$$20240807$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126345$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240810$$CN$US$US
241969802$24196980$2$F$20240804$20240806$20240810$20240813$PER$$US-AMGEN-USASP2024157021$AMGEN$$74$YR$E$M$Y$$$20240813$$CN$US$US
241969812$24196981$2$F$20150401$20240812$20240810$20240815$EXP$$TW-ABBVIE-5872032$ABBVIE$$66$YR$$F$Y$$$20240815$$CN$TW$TW
241969821$24196982$1$I$20240729$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158723$AMGEN$$82$YR$E$F$Y$$$20240810$$HP$US$US
241969831$24196983$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230507$TEVA$$51$YR$$F$Y$$$20240810$$CN$CA$CA
241969841$24196984$1$I$20240101$20240807$20240810$20240810$EXP$$US-ABBVIE-5872395$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241969851$24196985$1$I$20240801$20240806$20240810$20240810$EXP$$US-ABBVIE-5871016$ABBVIE$$77$YR$$M$Y$$$20240810$$CN$US$US
241969861$24196986$1$I$$20240806$20240810$20240810$PER$$US-SA-2024SA234858$SANOFI AVENTIS$$$$E$F$Y$$$20240810$$CN$US$US
241969871$24196987$1$I$20240701$20240805$20240810$20240810$PER$$US-SA-2024SA234970$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240810$$MD$US$US
241969881$24196988$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872238$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241969891$24196989$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA231107$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240810$$CN$US$US
241969902$24196990$2$F$$20240820$20240810$20240822$EXP$$EG-ABBVIE-5871939$ABBVIE$$24$YR$$M$Y$59$KG$20240822$$CN$EG$EG
241969911$24196991$1$I$$20240801$20240810$20240810$EXP$$US-TEVA-VS-3230291$TEVA$$42$YR$$M$Y$$$20240810$$CN$US$US
241969921$24196992$1$I$20240729$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158700$AMGEN$$71$YR$E$F$Y$$$20240810$$HP$US$US
241969931$24196993$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126429$BRISTOL MYERS SQUIBB$$21$YR$A$F$Y$$$20240810$$CN$US$US
241969942$24196994$2$F$$20240903$20240810$20240910$EXP$$TR-TAKEDA-2024TUS079484$TAKEDA$$$$$$Y$$$20240910$$MD$TR$TR
241969951$24196995$1$I$20240807$20240807$20240810$20240810$EXP$$US-ABBVIE-5872695$ABBVIE$$45$YR$$F$Y$$$20240810$$CN$US$US
241969961$24196996$1$I$$20240805$20240810$20240810$EXP$$AT-009507513-2408AUT002389$MERCK$$$$A$M$Y$$$20240810$$MD$AT$AT
241969972$24196997$2$F$20240729$20240911$20240810$20240912$PER$$US-AMGEN-USASP2024158502$AMGEN$$67$YR$E$$Y$$$20240912$$HP$US$US
241969981$24196998$1$I$$20240804$20240810$20240810$EXP$$CA-TAKEDA-2022TUS000413$TAKEDA$$$$$F$Y$$$20240810$$CN$CA$CA
241969991$24196999$1$I$$20240808$20240810$20240810$EXP$$US-ABBVIE-5873768$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241970001$24197000$1$I$20240729$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158682$AMGEN$$78$YR$E$F$Y$$$20240810$$HP$US$US
241970012$24197001$2$F$$20240816$20240810$20240822$PER$$US-JNJFOC-20240809185$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$CN$US$US
241970022$24197002$2$F$$20240903$20240810$20240909$EXP$$TR-TAKEDA-2024TUS079329$TAKEDA$$$$$$Y$$$20240909$$MD$TR$TR
241970031$24197003$1$I$$20240805$20240810$20240810$EXP$$CN-ROCHE-10000048891$ROCHE$$69$YR$E$M$Y$$$20240810$$CN$CN$CN
241970041$24197004$1$I$20070101$20240731$20240810$20240810$EXP$$CN-BIOCON BIOLOGICS LIMITED-BBL2024005730$BIOCON$Yuan Y, Yu Z., Tong F, Zhao S, Li Y, Shi Q et al.. A retrospective study of 29 fatal cases of insulin overdose.. Forensic Science International.. 2024;361:1-7$$$$$Y$$$20240810$$HP$CN$CN
241970051$24197005$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230933$TEVA$$57$YR$$F$Y$81$KG$20240810$$HP$CA$CA
241970061$24197006$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA233350$SANOFI AVENTIS$$61$YR$A$M$Y$110$KG$20240810$$MD$US$US
241970071$24197007$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA232321$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240810$$MD$US$US
241970081$24197008$1$I$$20240806$20240810$20240810$PER$$US-SA-2024SA234480$SANOFI AVENTIS$$$$$F$Y$$$20240810$$CN$US$US
241970091$24197009$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA233312$SANOFI AVENTIS$$$$A$M$Y$97$KG$20240810$$MD$US$US
241970101$24197010$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA233485$SANOFI AVENTIS$$$$C$F$Y$34.47$KG$20240810$$MD$US$US
241970111$24197011$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA236501$SANOFI AVENTIS$$$$A$M$Y$$$20240810$$MD$US$US
241970122$24197012$2$F$20240728$20240906$20240810$20240916$PER$$US-SA-2024SA235006$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240916$$HP$US$US
241970132$24197013$2$F$$20240822$20240810$20240916$PER$$US-SA-2024SA233222$SANOFI AVENTIS$$24$YR$A$F$Y$46.2$KG$20240916$$MD$US$US
241970141$24197014$1$I$20110101$20240731$20240810$20240810$EXP$$CN-BIOCON BIOLOGICS LIMITED-BBL2024005736$BIOCON$Yuan Y,  Yu Z., Tong F,  Zhao S,  Li Y, Shi Q et al.. A retrospective study of 29 fatal cases of insulin overdose.. Forensic Science International. 2024;361$$$$$Y$$$20240810$$HP$CN$CN
241970151$24197015$1$I$20150101$20240731$20240810$20240810$EXP$$CH-BIOCON BIOLOGICS LIMITED-BBL2024005746$BIOCON$Palmiere C, Sabatasso S, Torrent C, Rey F, Werner D, Bardy D.. Post-mortem determination of insulin using chemiluminescence enzyme immunoassay: preliminary results. Drug Test. Anal.. 2015;7(9):797-803$$$$$Y$$$20240810$$HP$CH$CH
241970161$24197016$1$I$20200101$20240731$20240810$20240810$EXP$$CN-BIOCON BIOLOGICS LIMITED-BBL2024005751$BIOCON$Yuan Y, Yu Z., Tong F, Zhao S, Li Y, Shi Q et al.. A retrospective study of 29 fatal cases of insulin overdose.. Forensic Science International.. 2024;361:1-7$$$$$Y$$$20240810$$HP$CN$CN
241970171$24197017$1$I$$20240809$20240810$20240810$30DAY$$US-SANDOZ INC.-SDZ2024US071755$SANDOZ$$$$$$Y$$$20240810$$MD$US$US
241970181$24197018$1$I$$20240731$20240810$20240810$EXP$$FR-BIOCON BIOLOGICS LIMITED-BBL2024005753$BIOCON$C. Bottinelli, R. Nicoli, F. Bevalot, N. Cartiser, C. Roger, K. Chikh, et al.. Development and validation of a method for quantification of human insulin and its synthetic analogues in plasma and post-mortem sera by LC-MS/HRMS.. Talanta.. 2021;25:122047$$$$$Y$$$20240810$$HP$FR$FR
241970191$24197019$1$I$$20240731$20240810$20240810$EXP$$CN-BIOCON BIOLOGICS LIMITED-BBL2024005735$BIOCON$Yuan Y,  Yu Z,  Tong F,  Zhao S, Li Y,  Shi Q et al.. A retrospective study of 29 fatal cases of insulin overdose.. Forensic Science International. 2024;361:1-7$$$$$Y$$$20240810$$HP$CN$CN
241970201$24197020$1$I$20120101$20240731$20240810$20240810$EXP$$CN-BIOCON BIOLOGICS LIMITED-BBL2024005737$BIOCON$Yuan Y,  Yu Z., Tong F,  Zhao S,  Li Y, Shi Q et al.. A retrospective study of 29 fatal cases of insulin overdose.. Forensic Science International.. 2024;361:1-7$$$$$Y$$$20240810$$HP$CN$CN
241970211$24197021$1$I$20240628$20240801$20240810$20240810$PER$$US-SA-2024SA232483$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240810$$MD$US$US
241970221$24197022$1$I$$20240731$20240810$20240810$EXP$$CN-BIOCON BIOLOGICS LIMITED-BBL2024005745$BIOCON$Tong F, Wu R, Huang W, Yang Y, Zhang L, Zhang, B et al.. Forensic aspects of homicides by insulin overdose. Forensic Science International. 2017;278:9-15$$$$$Y$$$20240810$$HP$CN$CN
241970231$24197023$1$I$$20240731$20240810$20240810$EXP$$CN-BIOCON BIOLOGICS LIMITED-BBL2024005749$BIOCON$Yuan Y,  Yu Z., Tong F,  Zhao S,  Li Y, Shi Q et al.. A retrospective study of 29 fatal cases of insulin overdose.. Forensic Science International. 2024;361$$$$$Y$$$20240810$$HP$CN$CN
241970241$24197024$1$I$$20240731$20240810$20240810$EXP$$CN-BIOCON BIOLOGICS LIMITED-BBL2024005747$BIOCON$Tong F, Wu R, Huang W, Yang Y, Zhang L, Zhang B et al.,. Forensic aspects of homicides by insulin overdose. Forensic Science International. 2017;278:9-15$$$$$Y$$$20240810$$HP$CN$CN
241970251$24197025$1$I$$20240808$20240810$20240810$EXP$$US-SANDOZ INC.-SDZ2024US071643$SANDOZ$$$$$F$Y$$$20240810$$CN$US$US
241970261$24197026$1$I$20240731$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024157060$AMGEN$$77$YR$E$F$Y$$$20240810$$CN$US$US
241970271$24197027$1$I$20190101$20240731$20240810$20240810$EXP$$CN-BIOCON BIOLOGICS LIMITED-BBL2024005750$BIOCON$Yuan Y,  Yu Z., Tong F,  Zhao S,  Li Y, Shi Q et al.. A retrospective study of 29 fatal cases of insulin overdose.. Forensic Science International. 2024;361$$$$$Y$$$20240810$$HP$CN$CN
241970281$24197028$1$I$$20240808$20240810$20240810$PER$$US-JNJFOC-20240821335$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240810$$CN$US$US
241970291$24197029$1$I$$20240808$20240810$20240810$EXP$$JP-ABBVIE-5874119$ABBVIE$$$$$$Y$$$20240810$$MD$JP$JP
241970301$24197030$1$I$$20240731$20240810$20240810$EXP$$CN-BIOCON BIOLOGICS LIMITED-BBL2024005752$BIOCON$Yuan Y,  Yu Z., Tong F,  Zhao S,  Li Y, Shi Q et al.. A retrospective study of 29 fatal cases of insulin overdose.. Forensic Science International. 2024;361$$$$$Y$$$20240810$$HP$CN$CN
241970311$24197031$1$I$20210101$20240731$20240810$20240810$EXP$$FR-BIOCON BIOLOGICS LIMITED-BBL2024005754$BIOCON$Bottinelli C, Nicoli B, Bevalot F, Cartiser N, Roger C, Chikh K et al.. Development and validation of a method for quantification of human insulin and its synthetic analogues in plasma and post-mortem sera by LC-MS/HRMS.. Talanta.. 2021;225:122047$$$$$Y$$$20240810$$HP$FR$FR
241970322$24197032$2$F$$20240903$20240810$20240906$EXP$$TR-TAKEDA-2024TUS079497$TAKEDA$$$$$$Y$$$20240906$$MD$TR$TR
241970331$24197033$1$I$$20240806$20240810$20240810$PER$$US-ELI_LILLY_AND_COMPANY-US202408005206$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240810$$CN$US$US
241970341$24197034$1$I$$20240731$20240810$20240810$EXP$$DE-BIOCON BIOLOGICS LIMITED-BBL2024005738$BIOCON$Thevis M, Thomas A, Schanzer W, Ostman P, Ojanpera I. Measuring insulin in human vitreous humour using LC-MS/MS.. Drug testing and analysis. 2012;4 (1):53-56$$$$$Y$$$20240810$$HP$DE$DE
241970351$24197035$1$I$$20240731$20240810$20240810$EXP$$CN-BIOCON BIOLOGICS LIMITED-BBL2024005755$BIOCON$Yuan Y,  Yu Z., Tong F,  Zhao S,  Li Y, Shi Q et al.. A retrospective study of 29 fatal cases of insulin overdose.. Forensic Science International. 2024;361$$$$$Y$$$20240810$$$CN$CN
241970361$24197036$1$I$20240508$20240808$20240810$20240810$EXP$$US-ABBVIE-5874238$ABBVIE$$66$YR$$F$Y$$$20240810$$CN$US$US
241970371$24197037$1$I$20240101$20240801$20240810$20240810$EXP$$ES-TEVA-VS-3229635$TEVA$$75$YR$$F$Y$$$20240810$$CN$ES$ES
241970381$24197038$1$I$$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158795$AMGEN$$$$$$Y$$$20240810$$HP$US$US
241970392$24197039$2$F$$20240911$20240810$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126416$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$50.35$KG$20240913$$CN$US$US
241970401$24197040$1$I$20240731$20240730$20240810$20240810$PER$$US-ABBVIE-5864437$ABBVIE$$$$$$Y$$$20240810$$MD$US$US
241970411$24197041$1$I$$20240801$20240810$20240810$EXP$$GB-TEVA-VS-3228898$TEVA$$59$YR$$F$Y$$$20240810$$HP$GB$GB
241970421$24197042$1$I$20240726$20240802$20240810$20240810$EXP$$CN-AMGEN-CHNSP2024154193$AMGEN$$74$YR$E$M$Y$55$KG$20240810$$HP$CN$CN
241970432$24197043$2$F$20240806$20240909$20240810$20240911$PER$$US-AMGEN-USASP2024156457$AMGEN$$52$YR$A$F$Y$$$20240911$$CN$US$US
241970441$24197044$1$I$$20240806$20240810$20240810$EXP$$FR-KOANAAP-SML-FR-2024-00840$SHILPA MEDICARE$M V, B B, L C, H EH. Rare cas d^hyperpigmentation flexurale precoce induite par le thiotepa et le busulfan. Rev-Fr-Allergol. 2024 Apr 03;$42$YR$A$F$Y$$$20240810$$MD$FR$FR
241970452$24197045$2$F$20240101$20240815$20240810$20240820$PER$$US-SA-2024SA232623$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240820$$MD$US$US
241970462$24197046$2$F$20240101$20240910$20240810$20240916$PER$$US-SA-2024SA233073$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240916$$MD$US$US
241970471$24197047$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA167870$SANOFI AVENTIS$$$$A$M$Y$$$20240810$$MD$US$US
241970481$24197048$1$I$$20240802$20240810$20240810$PER$$US-ABBVIE-5866676$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241970491$24197049$1$I$$20240729$20240810$20240810$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092963$GLENMARK$$$$$$Y$$$20240810$$CN$US$US
241970513$24197051$3$F$20240415$20240830$20240810$20240903$EXP$$CN-ABBVIE-5733440$ABBVIE$$71$YR$$M$Y$69$KG$20240903$$MD$CN$CN
241970531$24197053$1$I$20240618$20240729$20240810$20240810$EXP$FR-AFSSAPS-AN2024000972$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110577$ZYDUS PHARM$$$$$$Y$$$20240810$$PH$FR$FR
241970541$24197054$1$I$20240422$20240729$20240810$20240810$EXP$FR-AFSSAPS-AVMA2024000339$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110597$ZYDUS PHARM$$$$$$Y$$$20240810$$MD$FR$FR
241970551$24197055$1$I$$20240729$20240810$20240810$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110644$ZYDUS PHARM$Khalil H, Cota D.. Multiorgan failure from ivermectin and deet toxicity concealed behind alcohol withdrawal.. Crit-Care-Med. 2024;52:S440$$$$$Y$$$20240810$$HP$US$US
241970562$24197056$2$F$20240801$20240924$20240810$20240930$EXP$$GB-ABBVIE-5871476$ABBVIE$$42$YR$$F$Y$$$20240930$$CN$GB$GB
241970572$24197057$2$F$20240601$20240808$20240810$20240815$PER$$US-AMGEN-USASP2024158714$AMGEN$$44$YR$A$F$Y$$$20240815$$HP$US$US
241970583$24197058$3$F$20240808$20240826$20240810$20240827$PER$$US-AMGEN-USASP2024158057$AMGEN$$44$YR$A$F$Y$$$20240827$$CN$US$US
241970591$24197059$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA232622$SANOFI AVENTIS$$$$A$$Y$$$20240810$$HP$US$US
241970601$24197060$1$I$$20240806$20240810$20240810$PER$$US-SA-2024SA126959$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240810$$CN$US$US
241970621$24197062$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233598$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240810$$MD$US$US
241970631$24197063$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA232570$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240810$$MD$US$US
241970641$24197064$1$I$$20240731$20240810$20240810$EXP$$JP-BIOCON BIOLOGICS LIMITED-BBL2024005756$BIOCON$Nagasawa S., Rutsuko Y., Fumiko, Suguru, Hirotaro I.. Identification, measurement, and evaluation of blood concentrations of insulin glargine and insulin lispro by UPLC-MS-MS in a dead body suspected of  insulin overdose.. 2022$$$$$Y$$$20240810$$$JP$JP
241970651$24197065$1$I$20240801$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024158914$AMGEN$$$$$$Y$$$20240810$$CN$US$US
241970661$24197066$1$I$$20240722$20240810$20240810$PER$$US-JNJFOC-20240763691$JOHNSON AND JOHNSON$$$$$F$Y$$$20240810$$CN$US$US
241970671$24197067$1$I$20240804$20240806$20240810$20240810$PER$$US-SA-2024SA231866$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240810$$MD$US$US
241970681$24197068$1$I$$20240731$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125429$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240810$$CN$US$US
241970691$24197069$1$I$20231024$20240807$20240810$20240810$EXP$$US-ABBVIE-5872253$ABBVIE$$$$$F$Y$$$20240810$$HP$US$US
241970702$24197070$2$F$$20240812$20240810$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125693$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240813$$CN$US$US
241970711$24197071$1$I$20240806$20240806$20240810$20240810$EXP$$US-SA-2024SA234294$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240810$$CN$US$US
241970722$24197072$2$F$$20240808$20240810$20240819$EXP$$MO-SA-2024SA232425$SANOFI AVENTIS$$$$$M$Y$$$20240819$$MD$MO$MO
241970731$24197073$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA231836$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240810$$MD$US$US
241970741$24197074$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA234575$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240810$$MD$US$US
241970751$24197075$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA232754$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240810$$CN$US$US
241970761$24197076$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA232803$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240810$$MD$US$US
241970771$24197077$1$I$20240701$20240802$20240810$20240810$PER$$US-SA-2024SA233664$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240810$$MD$US$US
241970781$24197078$1$I$20240501$20240801$20240810$20240810$PER$$US-SA-2024SA233190$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240810$$MD$US$US
241970791$24197079$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA232748$SANOFI AVENTIS$$$$E$F$Y$$$20240810$$MD$US$US
241970801$24197080$1$I$$20240805$20240810$20240810$EXP$$JP-009507513-2408JPN000436J$MERCK$$3$YR$$$Y$$$20240810$$MD$JP$JP
241970811$24197081$1$I$$20240729$20240810$20240810$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092982$GLENMARK$Yang Z, Loew T, Hammer RD.. Association of long-term tacrolimus (FK506) therapy with abnormal megakaryocytosis, bone marrow fibrosis, and dyserythropoiesis.. Clinical Case Reports.. 2015;3(7):664-668$$$$$Y$$$20240810$$MD$US$US
241970821$24197082$1$I$20230101$20240802$20240810$20240810$PER$$US-SA-2024SA233242$SANOFI AVENTIS$$22$YR$A$M$Y$97.5$KG$20240810$$MD$US$US
241970831$24197083$1$I$20240601$20240806$20240810$20240810$PER$$US-SA-2024SA235121$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240810$$MD$US$US
241970841$24197084$1$I$$20240719$20240810$20240810$PER$$US-009507513-2407USA013777$MERCK$Hernandez JM, Huff M, Nlandu Z, Vekariya B, Torres J.. Mycobacterium abscessus Infection in Left Ventricular Assist Device (LVAD): A Case Series. Cureus. 2021;13 (6):1-7$80$YR$$M$Y$$$20240810$$HP$US$US
241970851$24197085$1$I$$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024156769$AMGEN$$$$$$Y$$$20240810$$CN$US$US
241970861$24197086$1$I$$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024156795$AMGEN$$$$$$Y$$$20240810$$CN$US$US
241970871$24197087$1$I$20240807$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158598$AMGEN$$54$YR$A$F$Y$$$20240810$$MD$US$US
241970881$24197088$1$I$$20240731$20240810$20240810$PER$$US-JNJFOC-20240815347$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240810$$CN$US$US
241970891$24197089$1$I$20240605$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024156627$AMGEN$$67$YR$E$M$Y$$$20240810$$CN$US$US
241970901$24197090$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA230543$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240810$$CN$US$US
241970911$24197091$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA232666$SANOFI AVENTIS$$$$$$Y$$$20240810$$HP$US$US
241970921$24197092$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233067$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240810$$MD$US$US
241970932$24197093$2$F$20240802$20240829$20240810$20240917$PER$$US-SA-2024SA233191$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240918$$PH$US$US
241970941$24197094$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA235171$SANOFI AVENTIS$$$$$M$Y$$$20240810$$CN$US$US
241970961$24197096$1$I$$20240801$20240810$20240810$PER$$US-TEVA-VS-3230271$TEVA$$$$$$Y$$$20240810$$MD$US$US
241970971$24197097$1$I$20240419$20240807$20240810$20240810$EXP$ES-AEMPS-1555237$ES-009507513-2408ESP002224$MERCK$$24$YR$$F$Y$$$20240810$$PH$ES$ES
241970981$24197098$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126459$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240810$$CN$US$US
241970991$24197099$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126301$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240810$$CN$US$US
241971011$24197101$1$I$20240101$20240805$20240810$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-024368$UNITED THERAPEUTICS$$$$$F$Y$61.224$KG$20240810$$$US$US
241971022$24197102$2$F$20240101$20240827$20240810$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-023832$UNITED THERAPEUTICS$$$$$M$Y$58.05$KG$20240829$$$US$US
241971032$24197103$2$F$$20240820$20240810$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-014897$UNITED THERAPEUTICS$$$$$M$Y$88.435$KG$20240823$$$US$US
241971051$24197105$1$I$20240101$20240806$20240810$20240810$EXP$$US-ABBVIE-5870703$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241971061$24197106$1$I$20240101$20240805$20240810$20240810$EXP$$US-ABBVIE-5870844$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241971071$24197107$1$I$20240118$20240808$20240810$20240810$EXP$$US-TAKEDA-2024TUS006229$TAKEDA$$32$YR$$F$Y$$$20240810$$MD$US$US
241971081$24197108$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA232955$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240810$$CN$US$US
241971091$24197109$1$I$20240701$20240801$20240810$20240810$PER$$US-SA-2024SA232721$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240810$$MD$US$US
241971114$24197111$4$F$20240101$20240909$20240810$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024649$UNITED THERAPEUTICS$$$$$F$Y$$$20240919$$$US$US
241971121$24197112$1$I$$20240801$20240810$20240810$EXP$$JP-AMGEN-JPNSP2024154120$AMGEN$$$$$$Y$$$20240810$$MD$JP$JP
241971131$24197113$1$I$$20240801$20240810$20240810$EXP$$US-SA-2024SA233967$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240810$$MD$US$US
241971142$24197114$2$F$20240101$20240815$20240810$20240828$PER$$US-SA-2024SA233276$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240828$$MD$US$US
241971151$24197115$1$I$20230101$20240805$20240810$20240810$EXP$$US-AMGEN-USASP2024155406$AMGEN$$$$$M$Y$$$20240810$$CN$US$US
241971161$24197116$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126287$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240810$$CN$US$US
241971171$24197117$1$I$20240101$20240805$20240810$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-024672$UNITED THERAPEUTICS$$$$$F$Y$50.34$KG$20240810$$$US$US
241971181$24197118$1$I$$20240808$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126446$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$117.93$KG$20240810$$PH$US$US
241971191$24197119$1$I$20240101$20240806$20240810$20240810$PER$$US-UNITED THERAPEUTICS-UNT-2024-024244$UNITED THERAPEUTICS$$$$$M$Y$80.272$KG$20240810$$$US$US
241971201$24197120$1$I$$20240719$20240810$20240810$PER$$US-009507513-2408USA002622$MERCK$Hernandez JM, Huff M, Nlandu Z, Vekariya B, Torres J,. Mycobacterium abscessus Infection in Left Ventricular Assist Device (LVAD): A Case Series. Cureus. 2021;13 (6):1-7$80$YR$$M$Y$$$20240810$$HP$US$US
241971212$24197121$2$F$20240801$20240915$20240810$20240918$EXP$$PT-ABBVIE-5873162$ABBVIE$$73$YR$$F$Y$$$20240918$$HP$PT$PT
241971221$24197122$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233447$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240810$$MD$US$US
241971231$24197123$1$I$20240101$20240805$20240810$20240810$EXP$$US-ABBVIE-5861809$ABBVIE$$$$$M$Y$109$KG$20240810$$CN$US$US
241971251$24197125$1$I$20230301$20240805$20240810$20240810$EXP$$US-ABBVIE-5867651$ABBVIE$$65$YR$$F$Y$$$20240810$$CN$US$US
241971271$24197127$1$I$20240219$20240807$20240810$20240810$EXP$$US-ABBVIE-5872048$ABBVIE$$73$YR$$F$Y$$$20240810$$CN$US$US
241971281$24197128$1$I$20240710$20240731$20240810$20240810$EXP$CN-NMPACDR-6206221668758202400098$CN-BAXTER-2024BAX022658$BAXTER$$35$YR$$F$Y$$$20240810$$MD$CN$CN
241971291$24197129$1$I$20240721$20240731$20240810$20240810$EXP$CN-NMPACDR-4401041006981202400388$CN-BAXTER-2024BAX022641$BAXTER$$61$YR$$F$Y$63$KG$20240810$$MD$CN$CN
241971301$24197130$1$I$$20240807$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126155$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240810$$HP$US$US
241971311$24197131$1$I$20220505$20240731$20240810$20240810$EXP$$KR-BAXTER-2024BAX022542$BAXTER$$51$YR$$F$Y$55$KG$20240810$$MD$KR$KR
241971331$24197133$1$I$20240101$20240805$20240810$20240810$PER$$US-SA-2024SA234735$SANOFI AVENTIS$$$$E$F$Y$$$20240810$$MD$US$US
241971341$24197134$1$I$20240801$20240802$20240810$20240810$PER$$US-ABBVIE-5866056$ABBVIE$$37$YR$$F$Y$81.646$KG$20240810$$CN$US$US
241971352$24197135$2$F$20240806$20240920$20240810$20240927$EXP$$JP-ABBVIE-5874521$ABBVIE$$$$E$M$Y$$$20240927$$MD$JP$JP
241971361$24197136$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA235378$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240810$$MD$US$US
241971371$24197137$1$I$20240101$20240805$20240810$20240810$PER$$US-SA-2024SA233007$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240810$$MD$US$US
241971381$24197138$1$I$$20240719$20240810$20240810$PER$$US-009507513-2408USA002623$MERCK$Hernandez JM, Huff M, Nlandu Z, Vekariya B, Torres J,. Mycobacterium abscessus Infection in Left Ventricular Assist Device (LVAD): A Case Series. Cureus. 2021;13 (6):1-7$51$YR$$M$Y$$$20240810$$HP$US$US
241971407$24197140$7$F$20240101$20240921$20240810$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024067$UNITED THERAPEUTICS$$$$$F$Y$44.444$KG$20240928$$$US$US
241971411$24197141$1$I$$20240729$20240810$20240810$EXP$$US-UCBSA-2024038434$UCB$$$$$M$Y$$$20240810$$HP$US$US
241971421$24197142$1$I$20240101$20240805$20240810$20240810$PER$$US-SA-2024SA234495$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240810$$MD$US$US
241971431$24197143$1$I$$20240806$20240810$20240810$EXP$$GB-ABBVIE-5871483$ABBVIE$$$$A$F$Y$$$20240810$$CN$GB$GB
241971441$24197144$1$I$$20240808$20240810$20240810$EXP$$US-ABBVIE-5874425$ABBVIE$$$$$M$Y$$$20240810$$HP$US$US
241971451$24197145$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA233574$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240810$$MD$US$US
241971461$24197146$1$I$20240101$20240805$20240810$20240810$PER$$US-SA-2024SA235490$SANOFI AVENTIS$$10$YR$C$F$Y$39.9$KG$20240810$$MD$US$US
241971472$24197147$2$F$20240101$20240903$20240810$20240925$PER$$US-SA-2024SA235766$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240925$$MD$US$US
241971481$24197148$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA010554$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$MD$US$US
241971492$24197149$2$F$$20240828$20240810$20240910$PER$$US-SA-2024SA232681$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240910$$MD$US$US
241971501$24197150$1$I$20240806$20240807$20240810$20240810$EXP$$FR-SA-2024SA220922$SANOFI AVENTIS$$84$YR$E$$Y$81.6$KG$20240810$$PH$FR$FR
241971521$24197152$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA233235$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240810$$MD$US$US
241971531$24197153$1$I$20240715$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024157069$AMGEN$$80$YR$E$F$Y$$$20240810$$CN$US$US
241971541$24197154$1$I$$20240731$20240810$20240810$PER$$US-AstraZeneca-2024A175231$ASTRAZENECA$$$$$F$Y$$$20240810$$CN$US$
241971551$24197155$1$I$$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024157871$AMGEN$$$$$$Y$$$20240810$$HP$US$US
241971561$24197156$1$I$$20240801$20240810$20240810$EXP$$GB-TEVA-VS-3229033$TEVA$$75$YR$$F$Y$67$KG$20240810$$MD$GB$GB
241971571$24197157$1$I$$20240729$20240810$20240810$EXP$$FR-RDY-LIT/FRA/24/0011635$DR REDDYS$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024 Apr;117(4): 297-300. doi:10.1016/j.acvd.2024.02.003.$75$YR$E$F$Y$$$20240810$$HP$FR$FR
241971581$24197158$1$I$$20240729$20240810$20240810$EXP$$FR-RDY-LIT/FRA/24/0011633$DR REDDYS$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024 Apr;117(4): 297-300. doi:10.1016/j.acvd.2024.02.003.$67$YR$E$M$Y$$$20240810$$HP$FR$FR
241971591$24197159$1$I$$20240729$20240810$20240810$EXP$$FR-RDY-LIT/FRA/24/0011629$DR REDDYS$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024 Apr;117(4): 297-300. doi:10.1016/j.acvd.2024.02.003.$72$YR$E$M$Y$$$20240810$$HP$FR$FR
241971601$24197160$1$I$$20240729$20240810$20240810$EXP$$FR-RDY-LIT/FRA/24/0011630$DR REDDYS$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024 Apr;117(4): 297-300. doi:10.1016/j.acvd.2024.02.003.$77$YR$E$M$Y$$$20240810$$HP$FR$FR
241971611$24197161$1$I$$20240729$20240810$20240810$EXP$$FR-RDY-LIT/FRA/24/0011628$DR REDDYS$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024 Apr;117(4): 297-300. doi:10.1016/j.acvd.2024.02.003.$54$YR$A$F$Y$$$20240810$$HP$FR$FR
241971621$24197162$1$I$$20240729$20240810$20240810$EXP$$FR-RDY-LIT/FRA/24/0011634$DR REDDYS$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024 Apr;117(4): 297-300. doi:10.1016/j.acvd.2024.02.003.$71$YR$E$M$Y$$$20240810$$HP$FR$FR
241971631$24197163$1$I$$20240729$20240810$20240810$EXP$$FR-RDY-LIT/FRA/24/0011632$DR REDDYS$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024 Apr;117(4): 297-300. doi:10.1016/j.acvd.2024.02.003.$80$YR$E$F$Y$$$20240810$$HP$FR$FR
241971641$24197164$1$I$20240701$20240802$20240810$20240810$PER$$US-SA-2024SA233635$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240810$$MD$US$US
241971651$24197165$1$I$$20240807$20240810$20240810$PER$$US-ELI_LILLY_AND_COMPANY-US202408004936$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240810$$HP$US$US
241971661$24197166$1$I$$20240731$20240810$20240810$30DAY$$US-GSK-US2024095857$GLAXOSMITHKLINE$$$$$F$Y$$$20240810$$CN$US$US
241971672$24197167$2$F$$20240806$20240810$20240910$EXP$$JP-ABBVIE-5857259$ABBVIE$$70$YR$$F$Y$$$20240910$$PH$JP$JP
241971681$24197168$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872720$ABBVIE$$$$$M$Y$$$20240810$$CN$US$US
241971691$24197169$1$I$20240101$20240729$20240810$20240810$EXP$$BR-UCBSA-2024038825$UCB$$78$YR$$F$Y$$$20240810$$CN$BR$BR
241971701$24197170$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233283$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240810$$MD$US$US
241971712$24197171$2$F$$20240812$20240810$20240812$PER$$US-JNJFOC-20240815764$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$HP$US$US
241971721$24197172$1$I$$20240806$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125996$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240810$$CN$US$US
241971731$24197173$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA233961$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240810$$MD$US$US
241971741$24197174$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA233202$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240810$$MD$US$US
241971751$24197175$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA231909$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240810$$MD$US$US
241971761$24197176$1$I$20240801$20240805$20240810$20240810$PER$$US-SA-2024SA235414$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240810$$PH$US$US
241971771$24197177$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA233676$SANOFI AVENTIS$$58$YR$A$F$Y$79.3$KG$20240810$$MD$US$US
241971781$24197178$1$I$$20240730$20240810$20240810$PER$$US-JNJFOC-20240800666$JOHNSON AND JOHNSON$$$$$F$Y$$$20240810$$CN$US$US
241971794$24197179$4$F$20240729$20240815$20240810$20240910$30DAY$$US-AMGEN-USASP2024156164$AMGEN$$73$YR$E$M$Y$$$20240910$$HP$US$US
241971802$24197180$2$F$20240725$20240815$20240810$20240821$30DAY$$US-AMGEN-USASP2024155650$AMGEN$$70$YR$E$F$Y$$$20240821$$HP$US$US
241971811$24197181$1$I$$20240805$20240810$20240810$EXP$$JP-AMGEN-JPNSP2024159351$AMGEN$$8$DEC$E$F$Y$$$20240810$$MD$JP$JP
241971822$24197182$2$F$$20240805$20240810$20240812$EXP$$US-UCBSA-2024038711$UCB$$$$A$F$Y$$$20240812$$CN$US$US
241971832$24197183$2$F$$20240808$20240810$20240812$PER$$NVSC2024US162471$NOVARTIS$$$$$$Y$$$20240812$$HP$US$US
241971841$24197184$1$I$20230101$20240801$20240810$20240810$EXP$$JP-UNITED THERAPEUTICS-UNT-2023-023846$UNITED THERAPEUTICS$$54$YR$$M$Y$$$20240810$$$JP$JP
241971851$24197185$1$I$20240101$20240805$20240810$20240810$PER$$US-SA-2024SA232878$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240810$$CN$US$US
241971861$24197186$1$I$20240101$20240806$20240810$20240810$PER$$US-SA-2024SA235080$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240810$$MD$US$US
241971871$24197187$1$I$20240101$20240805$20240810$20240810$PER$$US-SA-2024SA235488$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240810$$MD$US$US
241971881$24197188$1$I$20240301$20240801$20240810$20240810$PER$$GB-TEVA-VS-3229028$TEVA$$71$YR$$M$Y$$$20240810$$CN$GB$GB
241971891$24197189$1$I$$20240731$20240810$20240810$EXP$$US-GSK-US2024AMR096251$GLAXOSMITHKLINE$$$$$M$Y$$$20240810$$HP$US$US
241971901$24197190$1$I$$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158623$AMGEN$$$$A$F$Y$$$20240810$$MD$US$US
241971912$24197191$2$F$$20240917$20240810$20240926$EXP$$US-UCBSA-2024038687$UCB$$$$$F$Y$$$20240926$$HP$US$US
241971921$24197192$1$I$$20240809$20240810$20240810$EXP$$US-TAKEDA-2024TUS080019$TAKEDA$$$$$M$Y$$$20240810$$CN$US$US
241971931$24197193$1$I$20240807$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158637$AMGEN$$63$YR$A$M$Y$$$20240810$$CN$US$US
241971941$24197194$1$I$20240701$20240801$20240810$20240810$PER$$US-SA-2024SA234030$SANOFI AVENTIS$$43$YR$A$M$Y$138$KG$20240810$$MD$US$US
241971951$24197195$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA233766$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240810$$MD$US$US
241971971$24197197$1$I$20240701$20240809$20240810$20240810$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140312$DAIICHI$$$$$F$Y$$$20240810$$HP$US$US
241971982$24197198$2$F$20240802$20240821$20240810$20240902$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-125708$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$PH$PR$PR
241971991$24197199$1$I$20231101$20240731$20240810$20240810$EXP$$US-TEVA-VS-3230332$TEVA$$14$YR$$F$Y$91.8$KG$20240810$$HP$US$US
241972001$24197200$1$I$20240223$20240801$20240810$20240810$EXP$FR-AFSSAPS-AVMA2024000329$FR-TEVA-VS-3229362$TEVA$$63$YR$$M$Y$$$20240810$$PH$FR$FR
241972011$24197201$1$I$20220101$20240731$20240810$20240810$EXP$$US-TEVA-VS-3230905$TEVA$$$$$$Y$$$20240810$$CN$US$US
241972021$24197202$1$I$20240101$20240809$20240810$20240810$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140291$DAIICHI$$$$$F$Y$$$20240810$$PH$US$US
241972031$24197203$1$I$20220101$20240731$20240810$20240810$EXP$$US-TEVA-VS-3229780$TEVA$$28$YR$$F$Y$$$20240810$$CN$US$US
241972041$24197204$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA235494$SANOFI AVENTIS$$$$A$M$Y$$$20240810$$MD$US$US
241972051$24197205$1$I$20240807$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024158234$AMGEN$$$$$F$Y$$$20240810$$CN$US$US
241972061$24197206$1$I$$20240807$20240810$20240810$PER$$US-AMGEN-USASP2024158741$AMGEN$$73$YR$E$F$Y$$$20240810$$CN$US$US
241972072$24197207$2$F$20240701$20240801$20240810$20240812$EXP$$US-AMGEN-USASP2024154628$AMGEN$$$$$F$Y$$$20240812$$MD$US$US
241972082$24197208$2$F$20240807$20240903$20240810$20240904$PER$$US-AMGEN-USASP2024158554$AMGEN$$63$YR$A$F$Y$$$20240904$$CN$US$US
241972091$24197209$1$I$20240721$20240805$20240810$20240810$EXP$$CN-SA-2024SA234900$SANOFI AVENTIS$$65$YR$E$M$Y$50$KG$20240810$$HP$CN$CN
241972101$24197210$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA230715$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240810$$CN$US$US
241972114$24197211$4$F$20240801$20240809$20240810$20240816$EXP$$US-AMGEN-USASP2024157928$AMGEN$$$$$$Y$$$20240816$$HP$US$US
241972121$24197212$1$I$$20240807$20240810$20240810$EXP$$US-AstraZeneca-2024A179963$ASTRAZENECA$$$$$M$Y$$$20240810$$CN$US$
241972133$24197213$3$F$20231128$20240918$20240810$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2023-034981$UNITED THERAPEUTICS$$66$YR$$F$Y$58.957$KG$20240926$$$US$US
241972141$24197214$1$I$$20240729$20240810$20240810$EXP$$CA-TAKEDA-2023TUS081533$TAKEDA$$$$$F$Y$$$20240810$$CN$CA$CA
241972151$24197215$1$I$$20240805$20240810$20240810$EXP$$AR-TAKEDA-2024TUS079291$TAKEDA$$$$$M$Y$$$20240810$$CN$AR$AR
241972161$24197216$1$I$$20240729$20240810$20240810$EXP$$US-UCBSA-2024038476$UCB$$$$$F$Y$98.095$KG$20240810$$HP$US$US
241972171$24197217$1$I$$20240730$20240810$20240810$PER$$US-JNJFOC-20240782973$JOHNSON AND JOHNSON$$$$$F$Y$$$20240810$$CN$US$US
241972181$24197218$1$I$20240501$20240807$20240810$20240810$EXP$$US-SA-2024SA174819$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240810$$CN$US$US
241972191$24197219$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA231502$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240810$$CN$US$US
241972202$24197220$2$F$20240728$20240902$20240810$20240912$EXP$GB-MHRA-MED-202407311150191670-TRJDL$GB-TEVA-VS-3228529$TEVA$$84$YR$$M$Y$74$KG$20240912$$PH$GB$GB
241972211$24197221$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA235147$SANOFI AVENTIS$$$$A$F$Y$68.8$KG$20240810$$MD$US$US
241972221$24197222$1$I$$20240729$20240810$20240810$EXP$$US-UCBSA-2024038462$UCB$$$$$F$Y$$$20240810$$HP$US$US
241972231$24197223$1$I$$20240806$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124978$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240810$$PH$US$US
241972241$24197224$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA233762$SANOFI AVENTIS$$$$T$F$Y$$$20240810$$MD$US$US
241972251$24197225$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA233724$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240810$$MD$US$US
241972261$24197226$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5872967$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241972281$24197228$1$I$20240701$20240801$20240810$20240810$PER$$US-SA-2024SA232165$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240810$$CN$US$US
241972291$24197229$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA231966$SANOFI AVENTIS$$$$A$F$Y$$$20240810$$MD$US$US
241972301$24197230$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA233984$SANOFI AVENTIS$$$$A$M$Y$$$20240810$$HP$US$US
241972311$24197231$1$I$$20240730$20240810$20240810$EXP$$IN-Accord-439724$ACCORD$Simon J, Saranya C,Indhumati E,Ananthakumar P.K,Sivasamy M, Bose S , et al. A case report on overlap syndrome: diagnostic and management challenges. REVISTA ROMANA DE REUMATOLOGIE. 2024;33(2):119-124.$32$YR$A$F$Y$$$20240810$$HP$IN$IN
241972321$24197232$1$I$20240808$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158335$AMGEN$$65$YR$E$F$Y$$$20240810$$CN$US$US
241972331$24197233$1$I$$20240729$20240810$20240810$EXP$$FR-RDY-LIT/FRA/24/0011440$DR REDDYS$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024 Apr;117(4): 297-300. doi:10.1016/j.acvd.2024.02.003.$78$YR$E$F$Y$$$20240810$$HP$FR$FR
241972352$24197235$2$F$$20240801$20240810$20240813$PER$$NVSC2024US157793$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
241972361$24197236$1$I$20240501$20240731$20240810$20240810$EXP$$DE-TAKEDA-2024TUS079713$TAKEDA$$56$YR$$M$Y$99$KG$20240810$$MD$DE$DE
241972371$24197237$1$I$$20240730$20240810$20240810$PER$$NVSC2024US156369$NOVARTIS$$$$$F$Y$$$20240810$$CN$US$US
241972381$24197238$1$I$20240201$20240730$20240810$20240810$PER$$US-JNJFOC-20240801072$JOHNSON AND JOHNSON$$$$$F$Y$$$20240810$$CN$US$US
241972391$24197239$1$I$20240715$20240731$20240810$20240810$EXP$DE-AMK-278462$DE-TEVA-VS-3228891$TEVA$$80$YR$$F$Y$$$20240810$$PH$DE$DE
241972411$24197241$1$I$$20240715$20240810$20240810$PER$$US-AstraZeneca-2024A161981$ASTRAZENECA$$$$$M$Y$$$20240810$$CN$US$
241972422$24197242$2$F$$20240806$20240810$20240813$PER$$US-AMGEN-USASP2024157401$AMGEN$$$$A$F$Y$$$20240813$$CN$US$US
241972431$24197243$1$I$$20240731$20240810$20240810$EXP$$US-RDY-LIT/USA/24/0011520$DR REDDYS$Gruber TA, Huang M, Jeha S, Deyell RJ, Lewis VA, Chang BH, et al. Outcome of Infants Treated on Total Therapy for Infants with Acute Lymphoblastic Leukemia I: Results from a Non-Randomized Multi-Center Study. Blood. 2023;142: 823. doi:10.1182/blood-2023-177798.$$$I$$Y$$$20240810$$MD$US$US
241972441$24197244$1$I$20240716$20240731$20240810$20240810$EXP$$GB-TEVA-VS-3228569$TEVA$$79$YR$$M$Y$100$KG$20240810$$MD$GB$GB
241972451$24197245$1$I$20240315$20240730$20240810$20240810$EXP$CN-NMPA-3503041003861202400548$CN-Ipsen Biopharmaceuticals, Inc.-2024-15778$IPSEN$$69$YR$E$F$Y$70$KG$20240810$$HP$CN$CN
241972471$24197247$1$I$20231101$20240806$20240810$20240810$EXP$$US-ABBVIE-5871748$ABBVIE$$66$YR$$F$Y$$$20240810$$CN$US$US
241972481$24197248$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA232850$SANOFI AVENTIS$$$$T$F$Y$$$20240810$$MD$US$US
241972503$24197250$3$F$$20240902$20240810$20240906$EXP$$GB-TAKEDA-2024TUS042618$TAKEDA$$$$$F$Y$$$20240906$$CN$GB$GB
241972512$24197251$2$F$20220101$20240809$20240810$20240816$EXP$$US-AMGEN-USASL2024153786$AMGEN$$56$YR$A$F$Y$111.57$KG$20240816$$HP$US$US
241972523$24197252$3$F$$20240816$20240810$20240827$PER$$US-SA-2024SA231284$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240827$$CN$US$US
241972531$24197253$1$I$20240522$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024156967$AMGEN$$66$YR$E$F$Y$$$20240810$$CN$US$US
241972541$24197254$1$I$20240101$20240803$20240810$20240810$PER$$US-SA-2024SA233997$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240810$$MD$US$US
241972551$24197255$1$I$$20240731$20240810$20240810$EXP$$GB-TEVA-VS-3229110$TEVA$$86$YR$$M$Y$$$20240810$$PH$GB$GB
241972561$24197256$1$I$$20240726$20240810$20240810$EXP$$US-HLS-202400594$HLS THERAPEUTICS$$70$YR$E$F$Y$$$20240810$$MD$US$US
241972571$24197257$1$I$$20240731$20240810$20240810$EXP$$US-RDY-LIT/USA/24/0011411$DR REDDYS$Wang J, Elghawy O, Kurpiel B, Kaur V. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors. Clinical Journal of Gastroenterology. 2023;16: 807-814. doi:10.1007/s12328-023-01853-3.$75$YR$E$F$Y$$$20240810$$HP$US$US
241972581$24197258$1$I$$20240731$20240810$20240810$EXP$$CA-TEVA-VS-3227823$TEVA$$$$$$Y$61$KG$20240810$$HP$CA$CA
241972601$24197260$1$I$20240612$20240726$20240810$20240810$EXP$$US-HLS-202400592$HLS THERAPEUTICS$$72$YR$E$M$Y$$$20240810$$HP$US$US
241972611$24197261$1$I$$20240807$20240810$20240810$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-15784$IPSEN$$$$$M$Y$$$20240810$$CN$GB$GB
241972622$24197262$2$F$20240808$20240819$20240810$20240821$PER$$US-AMGEN-USASP2024158782$AMGEN$$74$YR$E$F$Y$$$20240821$$CN$US$US
241972631$24197263$1$I$20240301$20240807$20240810$20240810$EXP$$AT-ABBVIE-5872410$ABBVIE$$57$YR$$M$Y$$$20240810$$CN$AT$AT
241972641$24197264$1$I$20240209$20240801$20240810$20240810$EXP$ES-AEMPS-1552707$ES-TEVA-VS-3229264$TEVA$$46$YR$$F$Y$$$20240810$$MD$ES$ES
241972651$24197265$1$I$20240101$20240806$20240810$20240810$PER$$US-AMGEN-USASP2024157429$AMGEN$$$$$F$Y$$$20240810$$CN$US$US
241972664$24197266$4$F$20240701$20240919$20240810$20240930$EXP$$US-UCBSA-2024034090$UCB$$54$YR$$F$Y$71.156$KG$20240930$$CN$US$US
241972671$24197267$1$I$20240730$20240806$20240810$20240810$EXP$$CA-ABBVIE-5871725$ABBVIE$$$$$F$Y$$$20240810$$HP$CA$CA
241972681$24197268$1$I$20240701$20240807$20240810$20240810$EXP$$US-ABBVIE-5872286$ABBVIE$$33$YR$$M$Y$$$20240810$$CN$US$US
241972691$24197269$1$I$$20240802$20240810$20240810$EXP$$PT-TAKEDA-2024TUS068872$TAKEDA$$$$$F$Y$$$20240810$$CN$GB$PT
241972702$24197270$2$F$20240525$20240807$20240810$20240813$EXP$$CA-ABBVIE-5874792$ABBVIE$$60$YR$$M$Y$$$20240813$$CN$CA$CA
241972712$24197271$2$F$20220531$20240813$20240810$20240815$EXP$$KR-ABBVIE-5874277$ABBVIE$$53$YR$$M$Y$$$20240815$$MD$KR$KR
241972721$24197272$1$I$$20240808$20240810$20240810$EXP$$US-ABBVIE-5874099$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241972732$24197273$2$F$$20240813$20240810$20240826$PER$$US-SA-2024SA235443$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240826$$MD$US$US
241972741$24197274$1$I$$20240801$20240810$20240810$EXP$NL-LRB-00993149$NL-TEVA-VS-3229467$TEVA$$52$YR$$F$Y$81$KG$20240810$$CN$NL$NL
241972751$24197275$1$I$$20240807$20240810$20240810$EXP$$US-ABBVIE-5871800$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241972761$24197276$1$I$$20240808$20240810$20240810$EXP$$US-ABBVIE-5874074$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241972771$24197277$1$I$20240101$20240807$20240810$20240810$EXP$$US-ABBVIE-5872762$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241972781$24197278$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA232019$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240810$$MD$US$US
241972791$24197279$1$I$$20240808$20240810$20240810$PER$$US-ABBVIE-5874954$ABBVIE$$$$$F$Y$$$20240810$$HP$US$US
241972801$24197280$1$I$$20240730$20240810$20240810$EXP$$US-RDY-LIT/USA/24/0011445$DR REDDYS$Lee K, Hussain K, Balasubramanian S, Salazar JP, Karagodin I, Levisay JP, et al. A ^VEIN^ ATTEMPT AT ANGIOPLASTY. Journal of the American College of Cardiology. 83(13): 4092. doi:10.1016/S0735-1097%2824%2906082-0.$59$YR$A$M$Y$$$20240810$$HP$US$US
241972813$24197281$3$F$20240101$20240820$20240810$20240828$PER$$US-SA-2024SA232472$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240828$$MD$US$US
241972821$24197282$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA232040$SANOFI AVENTIS$$$$C$$Y$$$20240810$$HP$US$US
241972831$24197283$1$I$20240401$20240802$20240810$20240810$PER$$US-SA-2024SA231533$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240810$$MD$US$US
241972841$24197284$1$I$20240808$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158181$AMGEN$$60$YR$A$F$Y$$$20240810$$CN$US$US
241972851$24197285$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA233645$SANOFI AVENTIS$$$$C$F$Y$$$20240810$$MD$US$US
241972861$24197286$1$I$$20240801$20240810$20240810$EXP$FR-AFSSAPS-RE2024000752$FR-TEVA-VS-3229535$TEVA$$74$YR$$F$Y$$$20240810$$HP$FR$FR
241972871$24197287$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA233979$SANOFI AVENTIS$$$$A$M$Y$99.79$KG$20240810$$MD$US$US
241972881$24197288$1$I$20240701$20240801$20240810$20240810$PER$$US-SA-2024SA233951$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240810$$MD$US$US
241972891$24197289$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA235336$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240810$$MD$US$US
241972901$24197290$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA235504$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240810$$CN$US$US
241972911$24197291$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA231784$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240810$$MD$US$US
241972921$24197292$1$I$20240731$20240802$20240810$20240810$EXP$$US-AMGEN-USASP2024155962$AMGEN$$3$YR$C$F$Y$$$20240810$$CN$US$US
241972933$24197293$3$F$20240603$20240826$20240810$20240831$EXP$$US-AMGEN-USASP2024155375$AMGEN$$70$YR$E$F$Y$$$20240831$$HP$US$US
241972941$24197294$1$I$20240807$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158402$AMGEN$$$$$$Y$$$20240810$$PH$US$US
241972952$24197295$2$F$20240722$20240916$20240810$20240918$EXP$IT-MINISAL02-997183$IT-TAKEDA-2024TUS078609$TAKEDA$$54$YR$$M$Y$65$KG$20240918$$HP$IT$IT
241972961$24197296$1$I$$20240803$20240810$20240810$PER$$US-SA-2024SA232855$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240810$$MD$US$US
241972971$24197297$1$I$20230801$20240805$20240810$20240810$EXP$$US-AMGEN-USASP2024155446$AMGEN$$53$YR$$F$Y$$$20240810$$CN$US$US
241972982$24197298$2$F$$20240911$20240810$20240917$EXP$$NVSC2024US161901$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
241972991$24197299$1$I$20240101$20240805$20240810$20240810$EXP$$US-SA-2024SA233850$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240810$$MD$US$US
241973001$24197300$1$I$20240214$20240801$20240810$20240810$EXP$FR-AFSSAPS-RE2024000755$FR-TEVA-VS-3229338$TEVA$$68$YR$$M$Y$47.5$KG$20240810$$MD$FR$FR
241973013$24197301$3$F$$20240920$20240810$20240923$PER$$NVSC2024US162677$NOVARTIS$$$$$$Y$$$20240923$$MD$US$US
241973021$24197302$1$I$20240720$20240726$20240810$20240810$EXP$$CA-HLS-202401878$HLS THERAPEUTICS$$58$YR$A$M$Y$$$20240810$$PH$CA$CA
241973031$24197303$1$I$20240805$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158328$AMGEN$$67$YR$E$M$Y$$$20240810$$CN$US$US
241973041$24197304$1$I$$20240808$20240810$20240810$PER$$US-ABBVIE-5874042$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241973052$24197305$2$F$$20240905$20240810$20240906$PER$$NVSC2024US162616$NOVARTIS$$$$$F$Y$72$KG$20240906$$CN$US$US
241973061$24197306$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230977$TEVA$$61$YR$$F$Y$$$20240810$$MD$CA$CA
241973071$24197307$1$I$$20240802$20240810$20240810$PER$$US-AstraZeneca-2024A176279$ASTRAZENECA$$$$$F$Y$$$20240810$$CN$US$
241973081$24197308$1$I$$20240801$20240810$20240810$EXP$$CA-TEVA-VS-3230509$TEVA$$34$YR$$M$Y$$$20240810$$MD$CA$CA
241973091$24197309$1$I$$20240809$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126297$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240810$$CN$US$US
241973101$24197310$1$I$20240807$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158317$AMGEN$$62$YR$A$F$Y$$$20240810$$CN$US$US
241973111$24197311$1$I$20240807$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158583$AMGEN$$85$YR$E$F$Y$$$20240810$$CN$US$US
241973121$24197312$1$I$20240726$20240726$20240810$20240810$EXP$$US-HLS-202400581$HLS THERAPEUTICS$$28$YR$A$M$Y$$$20240810$$HP$US$US
241973131$24197313$1$I$20240501$20240801$20240810$20240810$PER$$US-SA-2024SA234549$SANOFI AVENTIS$$24$YR$A$M$Y$104$KG$20240810$$MD$US$US
241973142$24197314$2$F$20240701$20240807$20240810$20240816$PER$$US-SA-2024SA233097$SANOFI AVENTIS$$65$YR$E$F$Y$95.25$KG$20240816$$MD$US$US
241973151$24197315$1$I$20240101$20240801$20240810$20240810$PER$$US-SA-2024SA234026$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240810$$MD$US$US
241973162$24197316$2$F$20240716$20240817$20240810$20240827$EXP$$US-GSK-US2024095898$GLAXOSMITHKLINE$$71$YR$$M$Y$$$20240827$$PH$US$US
241973171$24197317$1$I$20240101$20240803$20240810$20240810$PER$$US-SA-2024SA232872$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240810$$CN$US$US
241973181$24197318$1$I$20240716$20240801$20240810$20240810$EXP$IT-MINISAL02-996339$IT-TEVA-VS-3229279$TEVA$$70$YR$$F$Y$$$20240810$$MD$IT$IT
241973191$24197319$1$I$20240101$20240805$20240810$20240810$EXP$$US-SA-2024SA234720$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240810$$MD$US$US
241973201$24197320$1$I$20231025$20240801$20240810$20240810$EXP$FR-AFSSAPS-DJ2024000861$FR-TEVA-VS-3229316$TEVA$$72$YR$$M$Y$$$20240810$$MD$FR$FR
241973211$24197321$1$I$20240808$20240808$20240810$20240810$PER$$US-AMGEN-USASP2024158436$AMGEN$$53$YR$A$F$Y$$$20240810$$CN$US$US
241973221$24197322$1$I$20240626$20240727$20240810$20240810$EXP$$US-HLS-202400600$HLS THERAPEUTICS$$40$YR$A$F$Y$$$20240810$$HP$US$US
241973231$24197323$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA234571$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240810$$MD$US$US
241973241$24197324$1$I$20240615$20240809$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126411$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240810$$HP$US$US
241973251$24197325$1$I$20240803$20240805$20240810$20240810$PER$$US-SA-2024SA234094$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240810$$CN$US$US
241973261$24197326$1$I$20240628$20240801$20240810$20240810$EXP$CZ-CZSUKL-24002125$CZ-TEVA-VS-3229575$TEVA$$30$YR$$F$Y$56$KG$20240810$$CN$CZ$CZ
241973271$24197327$1$I$20240709$20240801$20240810$20240810$EXP$FR-AFSSAPS-GR2024000944$FR-TEVA-VS-3229524$TEVA$$43$YR$$F$Y$110$KG$20240810$$PH$FR$FR
241973281$24197328$1$I$$20240731$20240810$20240810$30DAY$$US-GSK-US2024095890$GLAXOSMITHKLINE$$$$$F$Y$$$20240810$$CN$US$US
241973291$24197329$1$I$20240425$20240801$20240810$20240810$EXP$FR-AFSSAPS-RE2024000738$FR-TEVA-VS-3229342$TEVA$$74$YR$$M$Y$90$KG$20240810$$PH$FR$FR
241973301$24197330$1$I$20240608$20240801$20240810$20240810$EXP$FR-AFSSAPS-NY2024000839$FR-TEVA-VS-3229322$TEVA$$37$YR$$M$Y$70$KG$20240810$$MD$FR$FR
241973311$24197331$1$I$$20240805$20240810$20240810$EXP$$ZA-SA-2024SA233787$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240810$$HP$ZA$ZA
241973321$24197332$1$I$20240501$20240806$20240810$20240810$PER$$US-AstraZeneca-2024A179101$ASTRAZENECA$$887$MON$$$Y$$$20240810$$CN$US$
241973331$24197333$1$I$$20240321$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240792$IRONSHORE PHARMA$$$$A$F$Y$$$20240810$$MD$US$US
241973341$24197334$1$I$$20240531$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240956$IRONSHORE PHARMA$$$$T$F$Y$$$20240810$$MD$US$US
241973351$24197335$1$I$20240101$20240318$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240781$IRONSHORE PHARMA$$$$$F$Y$$$20240810$$CN$US$US
241973361$24197336$1$I$20240404$20240801$20240810$20240810$EXP$FR-AFSSAPS-ST2024001218$FR-TEVA-VS-3229309$TEVA$$69$YR$$F$Y$54.6$KG$20240810$$HP$FR$FR
241973371$24197337$1$I$$20240806$20240810$20240810$EXP$$US-009507513-2408USA002146$MERCK$$$$$M$Y$$$20240810$$MD$US$US
241973381$24197338$1$I$20240708$20240806$20240810$20240810$EXP$FR-AFSSAPS-LY2024001095$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-125086$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$100$KG$20240810$$PH$FR$FR
241973391$24197339$1$I$$20240731$20240810$20240810$30DAY$$US-GSK-US2024095863$GLAXOSMITHKLINE$$$$$F$Y$$$20240810$$CN$US$US
241973401$24197340$1$I$20221001$20240801$20240810$20240810$EXP$FR-AFSSAPS-AVPO2024000143$FR-TEVA-VS-3229368$TEVA$$43$YR$$M$Y$$$20240810$$PH$FR$FR
241973411$24197341$1$I$20240719$20240802$20240810$20240810$PER$$US-SA-2024SA233995$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240810$$MD$US$US
241973421$24197342$1$I$20240419$20240801$20240810$20240810$EXP$IT-MINISAL02-996369$IT-TEVA-VS-3229456$TEVA$$55$YR$$F$Y$$$20240810$$MD$IT$IT
241973431$24197343$1$I$20240101$20240731$20240810$20240810$EXP$$US-TEVA-VS-3228951$TEVA$$67$YR$$F$Y$48.08$KG$20240810$$HP$US$US
241973441$24197344$1$I$20230101$20240722$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241051$IRONSHORE PHARMA$$12$YR$T$M$Y$$$20240810$$HP$US$US
241973451$24197345$1$I$$20240730$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241066$IRONSHORE PHARMA$$50$YR$A$F$Y$$$20240810$$HP$US$US
241973461$24197346$1$I$20240701$20240730$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241059$IRONSHORE PHARMA$$10$YR$C$M$Y$$$20240810$$HP$US$US
241973471$24197347$1$I$20240101$20240723$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241054$IRONSHORE PHARMA$$11$YR$C$M$Y$$$20240810$$MD$US$US
241973481$24197348$1$I$20240401$20240625$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241063$IRONSHORE PHARMA$$7$YR$C$M$Y$37.2$KG$20240810$$HP$US$US
241973491$24197349$1$I$$20240620$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240997$IRONSHORE PHARMA$$15$YR$T$M$Y$$$20240810$$CN$US$US
241973501$24197350$1$I$20240708$20240711$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241028$IRONSHORE PHARMA$$27$YR$A$M$Y$$$20240810$$CN$US$US
241973511$24197351$1$I$$20240722$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241048$IRONSHORE PHARMA$$$$$$Y$$$20240810$$MD$US$US
241973521$24197352$1$I$20240101$20240625$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241004$IRONSHORE PHARMA$$7$YR$C$M$Y$23$KG$20240810$$HP$US$US
241973531$24197353$1$I$20240401$20240625$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241065$IRONSHORE PHARMA$$6$YR$C$M$Y$24.4$KG$20240810$$HP$US$US
241973541$24197354$1$I$20240301$20240715$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241034$IRONSHORE PHARMA$$11$YR$$M$Y$42.7$KG$20240810$$MD$US$US
241973551$24197355$1$I$20240101$20240715$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241045$IRONSHORE PHARMA$$8$YR$C$F$Y$39.5$KG$20240810$$MD$US$US
241973561$24197356$1$I$20240101$20240718$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241040$IRONSHORE PHARMA$$16$YR$T$M$Y$$$20240810$$HP$US$US
241973571$24197357$1$I$20240101$20240625$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241064$IRONSHORE PHARMA$$6$YR$C$M$Y$25.2$KG$20240810$$HP$US$US
241973581$24197358$1$I$20240701$20240719$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241047$IRONSHORE PHARMA$$$$$$Y$$$20240810$$HP$US$US
241973592$24197359$2$F$$20240904$20240810$20240925$PER$$US-SA-2024SA235203$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
241973605$24197360$5$F$$20240916$20240810$20240925$PER$$US-GSK-US2024095741$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
241973611$24197361$1$I$$20240617$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240983$IRONSHORE PHARMA$$9$YR$C$F$Y$$$20240810$$CN$US$US
241973621$24197362$1$I$$20240806$20240810$20240810$PER$$US-ALXN-202408USA000292US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240810$$HP$US$US
241973631$24197363$1$I$$20240808$20240810$20240810$PER$$US-ELI_LILLY_AND_COMPANY-US202408005633$ELI LILLY AND CO$$$$$M$Y$$$20240810$$CN$US$US
241973642$24197364$2$F$20220101$20240916$20240810$20240925$EXP$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459142$US-SHIONOGI INC.-2023000830$SHIONOGI$$75$YR$E$F$Y$$$20240925$$PH$US$US
241973651$24197365$1$I$$20240726$20240810$20240810$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2160259$BRECKENRIDGE$$$$$$Y$$$20240810$$$ES$A1
241973661$24197366$1$I$$20240726$20240810$20240810$PER$$US-Karo Pharma-2160249$Karo Pharma$$$$$$Y$$$20240810$$$US$US
241973671$24197367$1$I$20240314$20240320$20240810$20240810$PER$$US-GREER Laboratories, Inc.-2160255$GREER$$45$YR$$M$Y$$$20240810$$$US$US
241973681$24197368$1$I$20240724$20240801$20240810$20240810$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160265$JIANGSU HANSOH PHARMACEUTICAL$$72$YR$$F$Y$$$20240810$$MD$CN$CN
241973692$24197369$2$F$$20240904$20240810$20240904$PER$$US-ALXN-202408USA000384US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
241973702$24197370$2$F$$20240827$20240810$20240828$PER$$US-ALXN-202408USA000341US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241973711$24197371$1$I$$20240731$20240810$20240810$EXP$$US-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160266$JIANGSU HANSOH PHARMACEUTICAL$The Use of Amiloride and Sodium-Glucose Cotransporter 2 Inhibitors in Cisplatin-Induced Hypomagnesemia: A Case Report and Review of the Literature$57$YR$$F$Y$$$20240810$$$US$US
241973721$24197372$1$I$20240201$20240801$20240810$20240810$EXP$FR-AFSSAPS-GR2024000939$FR-TEVA-VS-3229313$TEVA$$80$YR$$M$Y$$$20240810$$PH$FR$FR
241973731$24197373$1$I$$20240729$20240810$20240810$EXP$$US-Marksans Pharma Limited-2160253$MARKSANS$Wagle L, Regmi DR, Regmi R, Poudel S, Pant HN. Metformin Toxicity Leading to Severe Refractory Hyperkalemia and Metabolic Acidosis: A Case Report. Cureus. 2024 Jun 25;16(6):e63130. doi: 10.7759/cureus.63130. PMID: 39055480.$74$YR$$M$Y$$$20240810$$$US$US
241973741$24197374$1$I$20240420$20240801$20240810$20240810$EXP$ES-AEMPS-1552206$ES-TEVA-VS-3229438$TEVA$$75$YR$$M$Y$$$20240810$$MD$ES$ES
241973751$24197375$1$I$20240101$20240726$20240810$20240810$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241056$IRONSHORE PHARMA$$10$YR$C$F$Y$$$20240810$$CN$US$US
241973761$24197376$1$I$20231201$20240801$20240810$20240810$EXP$IT-MINISAL02-996410$IT-TEVA-VS-3229803$TEVA$$74$YR$$F$Y$$$20240810$$PH$IT$IT
241973771$24197377$1$I$$20240806$20240810$20240810$PER$$US-ALXN-202408USA000350US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240810$$CN$US$US
241973781$24197378$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA235554$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240810$$MD$US$US
241973791$24197379$1$I$20240605$20240801$20240810$20240810$EXP$FR-AFSSAPS-AVCN2024000571$FR-TEVA-VS-3229356$TEVA$$22$YR$$F$Y$$$20240810$$HP$FR$FR
241973801$24197380$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA235263$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240810$$MD$US$US
241973811$24197381$1$I$$20240806$20240810$20240810$PER$$US-ALXN-202408USA000353US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240810$$CN$US$US
241973821$24197382$1$I$20240601$20240723$20240810$20240810$PER$$US-009507513-2407USA013254$MERCK$$68$YR$$M$Y$$$20240810$$CN$US$US
241973831$24197383$1$I$$20240805$20240810$20240810$PER$$US-SA-2024SA235320$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240810$$MD$US$US
241973841$24197384$1$I$20240101$20240805$20240810$20240810$PER$$US-SA-2024SA235223$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240810$$MD$US$US
241973851$24197385$1$I$20240614$20240801$20240810$20240810$EXP$FR-AFSSAPS-NC2024000893$FR-TEVA-VS-3229525$TEVA$$69$YR$$M$Y$60$KG$20240810$$MD$FR$FR
241973862$24197386$2$F$$20240827$20240810$20240828$PER$$US-ALXN-202408USA000375US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241973871$24197387$1$I$20240516$20240801$20240810$20240810$EXP$FR-AFSSAPS-LY2024000958$FR-TEVA-VS-3229418$TEVA$$86$YR$$F$Y$56$KG$20240810$$CN$FR$FR
241973881$24197388$1$I$$20240806$20240810$20240810$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125026$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$206$KG$20240810$$HP$US$US
241973893$24197389$3$F$20240620$20240916$20240810$20240925$EXP$$US-ZENPEP LLC-2024AIMT01018$AIMMUNE$$$$$$Y$$$20240925$$HP$US$US
241973901$24197390$1$I$20231201$20240801$20240810$20240810$EXP$FR-AFSSAPS-PB2024000818$FR-TEVA-VS-3229533$TEVA$$71$YR$$F$Y$54$KG$20240810$$MD$FR$FR
241973911$24197391$1$I$$20240806$20240810$20240810$PER$$US-ALXN-202408USA000404US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240810$$CN$US$US
241973922$24197392$2$F$$20240904$20240810$20240908$PER$$US-ALXN-202408USA000290US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$CN$US$US
241973932$24197393$2$F$$20240827$20240810$20240828$PER$$US-ALXN-202408USA000330US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
241973942$24197394$2$F$$20240827$20240810$20240828$PER$$US-ALXN-202408USA000269US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241973951$24197395$1$I$$20240801$20240810$20240810$EXP$FR-AFSSAPS-AVPO2024000144$FR-TEVA-VS-3229553$TEVA$$42$YR$$M$Y$$$20240810$$PH$FR$FR
241973961$24197396$1$I$20220912$20240801$20240810$20240810$EXP$FR-AFSSAPS-CN2024000715$FR-TEVA-VS-3229348$TEVA$$69$YR$$M$Y$$$20240810$$MD$FR$FR
241973971$24197397$1$I$20240129$20240801$20240810$20240810$EXP$FR-AFSSAPS-AN2024000967$FR-TEVA-VS-3229484$TEVA$$28$YR$$F$Y$$$20240810$$PH$FR$FR
241973982$24197398$2$F$$20240827$20240810$20240828$PER$$US-ALXN-202408USA000266US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
241973991$24197399$1$I$$20240805$20240810$20240810$PER$$US-ALXN-202408USA000339US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240810$$CN$US$US
241974001$24197400$1$I$20240701$20240731$20240810$20240810$EXP$$US-GSK-US2024AMR096853$GLAXOSMITHKLINE$$57$YR$$F$Y$63.492$KG$20240810$$CN$US$US
241974011$24197401$1$I$20240428$20240801$20240810$20240810$EXP$ES-AEMPS-1552716$ES-TEVA-VS-3229273$TEVA$$50$YR$$M$Y$55$KG$20240810$$MD$ES$ES
241974021$24197402$1$I$$20240806$20240810$20240810$EXP$$CA-ABBVIE-5873126$ABBVIE$$82$YR$$F$Y$$$20240810$$HP$CA$CA
241974031$24197403$1$I$$20240805$20240810$20240810$EXP$$US-SA-2024SA236514$SANOFI AVENTIS$$$$A$F$Y$81.6$KG$20240811$$HP$US$US
241974041$24197404$1$I$20240802$20240802$20240810$20240810$PER$$US-SA-2024SA233821$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240811$$CN$US$US
241974051$24197405$1$I$20240701$20240802$20240810$20240810$PER$$US-SA-2024SA233854$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240811$$MD$US$US
241974061$24197406$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA233845$SANOFI AVENTIS$$$$A$M$Y$113$KG$20240811$$MD$US$US
241974071$24197407$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA233973$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240811$$MD$US$US
241974081$24197408$1$I$20240101$20240802$20240810$20240810$PER$$US-SA-2024SA233938$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240811$$MD$US$US
241974091$24197409$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA234004$SANOFI AVENTIS$$$$A$F$Y$$$20240811$$MD$US$US
241974101$24197410$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA234116$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240811$$MD$US$US
241974111$24197411$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233903$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240811$$MD$US$US
241974122$24197412$2$F$20240101$20240830$20240810$20240923$PER$$US-SA-2024SA233916$SANOFI AVENTIS$$36$YR$A$F$Y$131.5$KG$20240923$$CN$US$US
241974131$24197413$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA233905$SANOFI AVENTIS$$$$A$F$Y$47.1$KG$20240811$$MD$US$US
241974141$24197414$1$I$$20240801$20240810$20240810$PER$$US-SA-2024SA234311$SANOFI AVENTIS$$$$C$F$Y$$$20240811$$MD$US$US
241974152$24197415$2$F$20240101$20240820$20240810$20240902$PER$$US-SA-2024SA233954$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240902$$MD$US$US
241974161$24197416$1$I$$20240802$20240810$20240810$PER$$US-SA-2024SA235463$SANOFI AVENTIS$$$$A$M$Y$67.5$KG$20240811$$MD$US$US
241974171$24197417$1$I$20240620$20240801$20240810$20240810$PER$$US-SA-2024SA235486$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240811$$MD$US$US
241974182$24197418$2$F$20240101$20240806$20240810$20240816$PER$$US-SA-2024SA234889$SANOFI AVENTIS$$27$YR$A$M$Y$108.8$KG$20240816$$MD$US$US
241974191$24197419$1$I$$20240808$20240810$20240810$PER$$US-ABBVIE-5874808$ABBVIE$$$$$F$Y$$$20240810$$CN$US$US
241974201$24197420$1$I$$20240729$20240810$20240810$PER$$US-JNJFOC-20240816830$JOHNSON AND JOHNSON$$$$$F$Y$$$20240811$$MD$US$US
241974211$24197421$1$I$$20240808$20240810$20240810$EXP$$NVSC2024US161827$NOVARTIS$$$$$$Y$$$20240811$$HP$US$US
241974221$24197422$1$I$$20240726$20240810$20240810$EXP$$US-HLS-202400578$HLS THERAPEUTICS$$$$A$$Y$$$20240810$$PH$US$US
241974231$24197423$1$I$20240618$20240726$20240810$20240810$EXP$$CA-HLS-202401802$HLS THERAPEUTICS$$72$YR$E$M$Y$$$20240810$$PH$CA$CA
241974241$24197424$1$I$20210203$20240726$20240810$20240810$EXP$$US-HLS-202400590$HLS THERAPEUTICS$$55$YR$A$F$Y$$$20240810$$HP$US$US
241974251$24197425$1$I$$20240726$20240810$20240810$EXP$$CA-HLS-202401880$HLS THERAPEUTICS$$$$A$F$Y$$$20240810$$PH$CA$CA
241974261$24197426$1$I$$20240726$20240810$20240810$EXP$$US-HLS-202400576$HLS THERAPEUTICS$$$$E$F$Y$$$20240810$$HP$US$US
241974272$24197427$2$F$$20240811$20240810$20240821$EXP$$NVSC2024US159392$NOVARTIS$$53$YR$$M$Y$$$20240821$$CN$US$US
241974281$24197428$1$I$20240701$20240805$20240810$20240810$PER$$US-SA-2024SA235294$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240811$$MD$US$US
241974291$24197429$1$I$$20240806$20240810$20240810$PER$$US-SA-2024SA235316$SANOFI AVENTIS$$$$A$F$Y$$$20240811$$HP$US$US
241974301$24197430$1$I$$20240731$20240810$20240810$PER$$NVSC2024US157494$NOVARTIS$$$$$$Y$$$20240811$$CN$US$US
241974311$24197431$1$I$$20240806$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408004276$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240811$$CN$US$US
241974321$24197432$1$I$$20211008$20240811$20240811$EXP$$DE-TEVA-VS-3217342$TEVA$$80$YR$$M$Y$69$KG$20240811$$HP$DE$CA
241974331$24197433$1$I$$20240729$20240811$20240811$EXP$GB-MHRA-MED-202407291838413150-BHPGJ$GB-GLENMARK PHARMACEUTICALS-2024GMK092995$GLENMARK$$$$$$Y$$$20240811$$CN$GB$GB
241974341$24197434$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA234372$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240811$$MD$US$US
241974361$24197436$1$I$$20240729$20240811$20240811$EXP$GB-MHRA-MED-202407251141093720-GLVBC$GB-GLENMARK PHARMACEUTICALS-2024GMK092998$GLENMARK$$$$$$Y$$$20240811$$HP$GB$GB
241974371$24197437$1$I$$20240802$20240811$20240811$EXP$$FR-JNJFOC-20240816174$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240811$$MD$FR$FR
241974381$24197438$1$I$$20240729$20240811$20240811$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093015$GLENMARK$Darnell H, Brenner A, Kern C, Flomenhoft D, Lee E.. Sevelamer-induced ischemic enteritis. ACG Case Reports Journal. 2024;11:e01451$$$$$Y$$$20240811$$MD$US$US
241974391$24197439$1$I$$20240805$20240811$20240811$EXP$$NVSC2024US159726$NOVARTIS$$$$$M$Y$$$20240811$$CN$US$US
241974422$24197442$2$F$$20240811$20240811$20240901$EXP$$EG-JNJFOC-20240817552$JOHNSON AND JOHNSON$$37$YR$A$M$Y$90$KG$20240901$$CN$EG$EG
241974461$24197446$1$I$20240701$20240807$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408005075$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240811$$CN$US$US
241974471$24197447$1$I$$20240801$20240811$20240811$PER$$US-AstraZeneca-2024A175701$ASTRAZENECA$$$$$F$Y$$$20240811$$CN$US$
241974511$24197451$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA232885$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240811$$CN$US$US
241974521$24197452$1$I$$20240806$20240811$20240811$PER$$US-SA-2024SA235061$SANOFI AVENTIS$$$$$F$Y$$$20240811$$MD$US$US
241974531$24197453$1$I$20240715$20240801$20240811$20240811$EXP$ES-AEMPS-1552952$ES-TEVA-VS-3229439$TEVA$$68$YR$$F$Y$$$20240811$$PH$ES$ES
241974583$24197458$3$F$20240701$20240808$20240811$20240829$EXP$$PR-JNJFOC-20240822214$JOHNSON AND JOHNSON$$87$YR$E$M$Y$73.48$KG$20240829$$CN$PR$PR
241974591$24197459$1$I$20240101$20240805$20240811$20240811$PER$$US-SA-2024SA235101$SANOFI AVENTIS$$16$YR$T$F$Y$60$KG$20240811$$MD$US$US
241974631$24197463$1$I$$20240806$20240811$20240811$PER$$US-SA-2024SA235082$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240811$$MD$US$US
241974641$24197464$1$I$$20240721$20240811$20240811$EXP$$US-SA-2024SA237271$SANOFI AVENTIS$$$$T$M$Y$$$20240811$$MD$US$US
241974651$24197465$1$I$20240806$20240807$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408004886$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240811$$CN$US$US
241974684$24197468$4$F$$20240831$20240811$20240902$PER$$US-AMGEN-USASP2024155883$AMGEN$$59$YR$A$M$Y$$$20240902$$HP$US$US
241974691$24197469$1$I$$20240731$20240811$20240811$PER$$US-AstraZeneca-2024A174622$ASTRAZENECA$$$$$F$Y$85.3$KG$20240811$$CN$US$
241974702$24197470$2$F$20231101$20240814$20240811$20240827$EXP$$GB-TEVA-VS-3228669$TEVA$$$$$$Y$$$20240827$$PH$GB$GB
241974711$24197471$1$I$$20240731$20240811$20240811$PER$$US-AstraZeneca-2024A174969$ASTRAZENECA$$$$$F$Y$$$20240811$$MD$US$
241974722$24197472$2$F$$20240820$20240811$20240905$PER$$US-AstraZeneca-2024A179254$ASTRAZENECA$$$$$F$Y$$$20240905$$MD$US$
241974751$24197475$1$I$20240715$20240801$20240811$20240811$PER$$US-JNJFOC-20240804843$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240811$$CN$US$US
241974761$24197476$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA231291$SANOFI AVENTIS$$$$A$M$Y$$$20240811$$CN$US$US
241974771$24197477$1$I$20240801$20240803$20240811$20240811$PER$$US-SA-2024SA232696$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240811$$MD$US$US
241974781$24197478$1$I$$20240807$20240811$20240811$PER$$US-AstraZeneca-2024A180248$ASTRAZENECA$$$$$F$Y$$$20240811$$MD$US$
241974802$24197480$2$F$20230616$20240821$20240811$20240829$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-15888$IPSEN$$78$YR$E$F$Y$$$20240829$$PH$JP$JP
241974821$24197482$1$I$$20240803$20240811$20240811$PER$$US-SA-2024SA233371$SANOFI AVENTIS$$$$A$F$Y$$$20240811$$MD$US$US
241974861$24197486$1$I$$20240809$20240811$20240811$PER$$NVSC2024US162775$NOVARTIS$$$$$M$Y$$$20240811$$HP$US$US
241974871$24197487$1$I$20240701$20240803$20240811$20240811$PER$$US-SA-2024SA233423$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240811$$MD$US$US
241974881$24197488$1$I$20240101$20240803$20240811$20240811$PER$$US-SA-2024SA233422$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240811$$MD$US$US
241974891$24197489$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA234120$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240811$$CN$US$US
241974901$24197490$1$I$20240701$20240801$20240811$20240811$EXP$$US-TEVA-VS-3230548$TEVA$$73$YR$$$Y$$$20240811$$HP$US$US
241974911$24197491$1$I$20240501$20240805$20240811$20240811$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15764$IPSEN$$$$$F$Y$$$20240811$$CN$US$US
241974931$24197493$1$I$20210316$20240805$20240811$20240811$EXP$$BR-JNJFOC-20240820974$JOHNSON AND JOHNSON$$8$YR$C$F$Y$50$KG$20240811$$HP$BR$BR
241974941$24197494$1$I$$20240801$20240811$20240811$PER$$US-JNJFOC-20240804620$JOHNSON AND JOHNSON$$$$$F$Y$$$20240811$$CN$US$US
241974951$24197495$1$I$$20240807$20240811$20240811$PER$$US-AstraZeneca-2024A180275$ASTRAZENECA$$$$$$Y$$$20240811$$PH$US$
241974962$24197496$2$F$$20240808$20240811$20240813$PER$$NVSC2024US162769$NOVARTIS$$$$$F$Y$$$20240813$$HP$US$US
241974971$24197497$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA234920$SANOFI AVENTIS$$$$A$M$Y$77$KG$20240811$$MD$US$US
241975021$24197502$1$I$$20240806$20240811$20240811$PER$$US-SA-2024SA235079$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240811$$MD$US$US
241975031$24197503$1$I$$20240801$20240811$20240811$PER$$US-AstraZeneca-2024A176385$ASTRAZENECA$$$$$$Y$$$20240811$$PH$US$
241975051$24197505$1$I$20240724$20240805$20240811$20240811$PER$$US-JNJFOC-20240812560$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240811$$CN$US$US
241975061$24197506$1$I$20240801$20240806$20240811$20240811$PER$$US-SA-2024SA235548$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240811$$MD$US$US
241975072$24197507$2$F$$20240820$20240811$20240829$PER$$US-SA-2024SA234709$SANOFI AVENTIS$$$$E$F$Y$$$20240829$$MD$US$US
241975101$24197510$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA235535$SANOFI AVENTIS$$$$A$M$Y$$$20240811$$CN$US$US
241975111$24197511$1$I$20230522$20240801$20240811$20240811$EXP$$GB-TEVA-VS-3229182$TEVA$$79$YR$$F$Y$96$KG$20240811$$MD$GB$GB
241975132$24197513$2$F$$20240925$20240811$20240925$PER$$NVSC2024US162765$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
241975141$24197514$1$I$20240802$20240805$20240811$20240811$PER$$US-JNJFOC-20240812722$JOHNSON AND JOHNSON$$$$$M$Y$$$20240811$$CN$US$US
241975151$24197515$1$I$$20240801$20240811$20240811$EXP$GB-MHRA-31377037$GB-TEVA-VS-3228857$TEVA$$38$YR$$M$Y$$$20240811$$PH$GB$GB
241975161$24197516$1$I$$20240729$20240811$20240811$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093013$GLENMARK$Dogrul BN, Park C.. Hydralazine-Induced Visual and Auditory Hallucinations in a Kidney Transplant Patient: Case Report. Journal of the Academy of Consultation-Liaison Psychiatry. 2024$$$$$Y$$$20240811$$MD$US$US
241975201$24197520$1$I$20240501$20240801$20240811$20240811$EXP$$US-TEVA-VS-3229879$TEVA$$78$YR$$F$Y$$$20240811$$CN$US$US
241975211$24197521$1$I$20240728$20240801$20240811$20240811$EXP$GB-MHRA-MED-202408010950294290-YPCWN$GB-TEVA-VS-3228848$TEVA$$78$YR$$M$Y$102$KG$20240811$$PH$GB$GB
241975231$24197523$1$I$20240801$20240802$20240811$20240811$PER$$US-SA-2024SA235541$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240811$$MD$US$US
241975241$24197524$1$I$20240612$20240802$20240811$20240811$PER$$US-SA-2024SA229204$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240811$$CN$US$US
241975251$24197525$1$I$20240701$20240801$20240811$20240811$PER$$US-SA-2024SA234494$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240811$$CN$US$US
241975261$24197526$1$I$$20240806$20240811$20240811$EXP$$GB-AMGEN-GBRSP2024158629$AMGEN$$66$YR$E$F$Y$$$20240811$$CN$GB$GB
241975281$24197528$1$I$20240501$20240802$20240811$20240811$PER$$US-SA-2024SA235317$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240811$$MD$US$US
241975291$24197529$1$I$$20240801$20240811$20240811$EXP$GB-MHRA-31377035$GB-TEVA-VS-3229043$TEVA$$83$YR$$F$Y$$$20240811$$PH$GB$GB
241975301$24197530$1$I$$20240802$20240811$20240811$EXP$$US-SANDOZ INC.-SDZ2024US071701$SANDOZ$$$$$$Y$$$20240811$$CN$US$US
241975312$24197531$2$F$$20240828$20240811$20240909$EXP$$JP-AMGEN-JPNSP2024157781$AMGEN$$$$$$Y$$$20240909$$MD$JP$JP
241975321$24197532$1$I$$20240801$20240811$20240811$EXP$$JP-AMGEN-JPNSP2024158476$AMGEN$Hiroshi Kataoka, Kosaku Nitta, Junichi Hoshino, Terumasa Hayashi, Masaomi Nangaku, Ichiei Narita, Tatsuo Kagimura. Supplementary Material to ^Cardio-renal prognosis and therapeutic responsiveness of renal anemia: An attribute-based analysis using a cross-classification approach in the BRIGHTEN study^. Unknown$$$$$Y$$$20240811$$MD$JP$JP
241975331$24197533$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA235543$SANOFI AVENTIS$$$$E$F$Y$$$20240811$$MD$US$US
241975341$24197534$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA232265$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240811$$CN$US$US
241975351$24197535$1$I$$20240805$20240811$20240811$PER$$US-AstraZeneca-2024A177985$ASTRAZENECA$$$$$M$Y$$$20240811$$HP$US$
241975361$24197536$1$I$20240101$20240807$20240811$20240811$EXP$$US-SA-2024SA236130$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240811$$MD$US$US
241975372$24197537$2$F$20240101$20240820$20240811$20240828$PER$$US-AMGEN-USASP2024156968$AMGEN$$70$YR$E$F$Y$$$20240828$$CN$US$US
241975381$24197538$1$I$$20240801$20240811$20240811$EXP$$GB-TEVA-VS-3229027$TEVA$$$$$M$Y$$$20240811$$CN$GB$GB
241975391$24197539$1$I$20240101$20240802$20240811$20240811$PER$$US-SA-2024SA234577$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240811$$MD$US$US
241975401$24197540$1$I$$20240801$20240811$20240811$30DAY$$US-GSK-US2024096185$GLAXOSMITHKLINE$$$$$F$Y$$$20240811$$CN$US$US
241975411$24197541$1$I$20240722$20240805$20240811$20240811$PER$$US-SA-2024SA235339$SANOFI AVENTIS$$40$YR$A$F$Y$96.16$KG$20240811$$MD$US$US
241975421$24197542$1$I$$20240802$20240811$20240811$PER$$US-JNJFOC-20240812835$JOHNSON AND JOHNSON$$$$$$Y$$$20240811$$CN$US$US
241975431$24197543$1$I$$20240808$20240811$20240811$EXP$$US-AstraZeneca-2024A181214$ASTRAZENECA$$$$$F$Y$92.1$KG$20240811$$MD$US$
241975441$24197544$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA233715$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240811$$MD$US$US
241975451$24197545$1$I$20240101$20240806$20240811$20240811$PER$$US-SA-2024SA235089$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240811$$MD$US$US
241975462$24197546$2$F$$20240813$20240811$20240821$30DAY$$US-GSK-US2024096328$GLAXOSMITHKLINE$$$$$M$Y$$$20240821$$CN$US$US
241975471$24197547$1$I$$20240801$20240811$20240811$30DAY$$US-GSK-US2024AMR096954$GLAXOSMITHKLINE$$$$$F$Y$$$20240811$$CN$US$US
241975481$24197548$1$I$20240604$20240805$20240811$20240811$EXP$$US-JNJFOC-20240811961$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240811$$MD$US$US
241975491$24197549$1$I$20240806$20240807$20240811$20240811$PER$$US-AMGEN-USASP2024157646$AMGEN$$81$YR$E$F$Y$$$20240811$$CN$US$US
241975501$24197550$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA234623$SANOFI AVENTIS$$$$C$F$Y$30$KG$20240811$$MD$US$US
241975511$24197551$1$I$20240701$20240806$20240811$20240811$PER$$US-SA-2024SA235151$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240811$$CN$US$US
241975521$24197552$1$I$$20240801$20240811$20240811$EXP$GB-MHRA-MIDB-336b6b53-5264-4938-b43f-b030150d24c7$GB-TEVA-VS-3228881$TEVA$$36$YR$$F$Y$$$20240811$$PH$GB$GB
241975531$24197553$1$I$20240801$20240805$20240811$20240811$EXP$$US-JNJFOC-20240815848$JOHNSON AND JOHNSON$$$$$$Y$$$20240811$$HP$US$US
241975541$24197554$1$I$20240808$20240808$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408006234$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240811$$CN$US$US
241975551$24197555$1$I$$20240806$20240811$20240811$PER$$US-SA-2024SA235148$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240811$$MD$US$US
241975561$24197556$1$I$20240101$20240803$20240811$20240811$PER$$US-SA-2024SA233616$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240811$$MD$US$US
241975572$24197557$2$F$20240806$20240813$20240811$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044701$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240813$$CN$US$US
241975581$24197558$1$I$20220101$20240801$20240811$20240811$PER$$US-SA-2024SA233814$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240811$$MD$US$US
241975591$24197559$1$I$20240101$20240802$20240811$20240811$PER$$US-SA-2024SA233049$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240811$$CN$US$US
241975602$24197560$2$F$20240701$20240910$20240811$20240918$PER$$US-SA-2024SA234039$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240918$$MD$US$US
241975611$24197561$1$I$20240701$20240806$20240811$20240811$EXP$$US-JNJFOC-20240813432$JOHNSON AND JOHNSON$$$$$F$Y$$$20240811$$CN$US$US
241975621$24197562$1$I$$20240807$20240811$20240811$PER$$US-JNJFOC-20240820436$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240811$$CN$US$US
241975631$24197563$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA232738$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240811$$HP$US$US
241975641$24197564$1$I$20240802$20240803$20240811$20240811$EXP$GB-MHRA-MED-202408031605153050-LNKZD$GB-SA-2024SA231414$SANOFI AVENTIS$$$$$F$Y$85$KG$20240811$$CN$GB$GB
241975651$24197565$1$I$20240801$20240807$20240811$20240811$EXP$$US-SA-2024SA236339$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240811$$MD$US$US
241975661$24197566$1$I$$20240801$20240811$20240811$EXP$$US-GSK-US2024096380$GLAXOSMITHKLINE$$$$$F$Y$$$20240811$$CN$US$US
241975671$24197567$1$I$$20240801$20240811$20240811$30DAY$$US-GSK-US2024096352$GLAXOSMITHKLINE$$$$$F$Y$$$20240811$$CN$US$US
241975681$24197568$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA234513$SANOFI AVENTIS$$$$A$F$Y$60$KG$20240811$$MD$US$US
241975691$24197569$1$I$20240731$20240801$20240811$20240811$EXP$$US-GSK-US2024097016$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240811$$CN$US$US
241975701$24197570$1$I$$20240807$20240811$20240811$PER$$US-ROCHE-10000052643$ROCHE$$66$YR$E$F$Y$$$20240811$$MD$US$US
241975711$24197571$1$I$$20240807$20240811$20240811$EXP$$US-SA-2024SA235989$SANOFI AVENTIS$$$$$F$Y$$$20240811$$HP$US$US
241975722$24197572$2$F$20210203$20240920$20240811$20240925$EXP$FR-AFSSAPS-CF2024000212$FR-SA-2024SA236128$SANOFI AVENTIS$$71$YR$E$M$Y$56$KG$20240925$$MD$FR$FR
241975731$24197573$1$I$$20240807$20240811$20240811$PER$$US-JNJFOC-20240820393$JOHNSON AND JOHNSON$$$$$F$Y$$$20240811$$CN$US$US
241975743$24197574$3$F$20240802$20240827$20240811$20240905$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-012251$JAZZ$$70$YR$$M$Y$$$20240905$$PH$JP$JP
241975751$24197575$1$I$$20240806$20240811$20240811$PER$$US-SA-2024SA235279$SANOFI AVENTIS$$5$YR$C$M$Y$21.1$KG$20240811$$HP$US$US
241975761$24197576$1$I$$20240807$20240811$20240811$EXP$$US-SA-2024SA237185$SANOFI AVENTIS$$$$A$M$Y$$$20240811$$MD$US$US
241975771$24197577$1$I$20220101$20240803$20240811$20240811$PER$$US-SA-2024SA233063$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240811$$MD$US$US
241975781$24197578$1$I$20120101$20240709$20240811$20240811$EXP$$BR-JNJFOC-20240821301$JOHNSON AND JOHNSON$$56$YR$A$F$Y$59$KG$20240811$$HP$BR$BR
241975801$24197580$1$I$20231201$20240805$20240811$20240811$EXP$$US-ROCHE-10000049321$ROCHE$$63$YR$A$F$Y$$$20240811$$CN$US$US
241975811$24197581$1$I$20240101$20240803$20240811$20240811$PER$$US-SA-2024SA232890$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240811$$MD$US$US
241975821$24197582$1$I$20240101$20240807$20240811$20240811$EXP$$US-SA-2024SA236391$SANOFI AVENTIS$$$$A$$Y$$$20240811$$MD$US$US
241975831$24197583$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA234344$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240811$$MD$US$US
241975841$24197584$1$I$$20240730$20240811$20240811$30DAY$$US-GSK-US2024095394$GLAXOSMITHKLINE$$$$$F$Y$$$20240811$$CN$US$US
241975851$24197585$1$I$20240101$20240806$20240811$20240811$EXP$$US-SANDOZ INC.-SDZ2024US071387$SANDOZ$$$$E$F$Y$$$20240811$$MD$US$US
241975862$24197586$2$F$$20240821$20240811$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011518$JAZZ$$$$$F$Y$$$20240823$$CN$US$US
241975871$24197587$1$I$20240101$20240805$20240811$20240811$PER$$US-SA-2024SA235568$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240811$$MD$US$US
241975882$24197588$2$F$20231001$20240828$20240811$20240918$PER$$US-SA-2024SA233928$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240918$$MD$US$US
241975891$24197589$1$I$20170101$20240808$20240811$20240811$EXP$$US-ROCHE-10000053078$ROCHE$$39$YR$A$M$Y$87.54$KG$20240811$$CN$US$US
241975901$24197590$1$I$20240101$20240806$20240811$20240811$PER$$US-SA-2024SA235387$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240811$$CN$US$US
241975911$24197591$1$I$20240601$20240807$20240811$20240811$EXP$FR-AFSSAPS-BS2024000479$FR-SA-2024SA234763$SANOFI AVENTIS$$61$YR$A$M$Y$98$KG$20240811$$MD$FR$FR
241975921$24197592$1$I$$20240802$20240811$20240811$30DAY$$US-GSK-US2024096913$GLAXOSMITHKLINE$$$$$F$Y$68.1$KG$20240811$$MD$US$US
241975931$24197593$1$I$$20240731$20240811$20240811$EXP$$US-JNJFOC-20240800112$JOHNSON AND JOHNSON$$$$$F$Y$$$20240811$$CN$US$US
241975942$24197594$2$F$$20240903$20240811$20240911$PER$$US-AstraZeneca-2024A174350$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
241975951$24197595$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA234339$SANOFI AVENTIS$$$$A$F$Y$79.3$KG$20240811$$MD$US$US
241975961$24197596$1$I$20240101$20240805$20240811$20240811$PER$$US-SA-2024SA235956$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240811$$MD$US$US
241975971$24197597$1$I$$20240806$20240811$20240811$EXP$$GB-SA-2024SA225270$SANOFI AVENTIS$$96$YR$E$M$Y$$$20240811$$CN$GB$GB
241975982$24197598$2$F$20240101$20240829$20240811$20240917$PER$$US-SA-2024SA235481$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240918$$MD$US$US
241975991$24197599$1$I$20240101$20240805$20240811$20240811$EXP$$US-SA-2024SA236381$SANOFI AVENTIS$$85$YR$E$F$Y$68.9$KG$20240811$$MD$US$US
241976001$24197600$1$I$20231003$20240805$20240811$20240811$EXP$$US-AMGEN-USASP2024155526$AMGEN$$67$YR$E$F$Y$$$20240811$$CN$US$US
241976011$24197601$1$I$$20240804$20240811$20240811$EXP$$US-AMGEN-USASP2024156785$AMGEN$Stan M.N.; Rachmasari K.N.; Toro-tobon D. et al.. Impact of Teprotumumab on Clinical Practice in Thyroid Eye Disease. American Association of Clinical endocrinologists. 2024;1-20$77$YR$E$F$Y$$$20240811$$MD$US$US
241976021$24197602$1$I$$20240805$20240811$20240811$EXP$$US-AMGEN-USASP2024157526$AMGEN$$$$$M$Y$$$20240811$$CN$US$US
241976031$24197603$1$I$$20240804$20240811$20240811$EXP$$US-AMGEN-USASP2024156646$AMGEN$Stan M.N.; Rachmasari K.N.; Toro-tobon D. et al.. Impact of Teprotumumab on Clinical Practice in Thyroid Eye Disease. American Association of Clinical endocrinologists. 2024;1-20$73$YR$E$F$Y$$$20240811$$MD$US$US
241976041$24197604$1$I$$20240805$20240811$20240811$EXP$$US-AMGEN-USASP2024155016$AMGEN$Johnson H.J.; Rudzik K.N.; Schonder K.S. et.al. Early Conversion to Everolimus Within 180 Days of Living Donor Liver Transplantation. Clinical Transplantation. 2024;38 (7):1-8$$$$$Y$$$20240811$$HP$US$US
241976051$24197605$1$I$$20240802$20240811$20240811$30DAY$$US-GSK-US2024096922$GLAXOSMITHKLINE$$$$$F$Y$$$20240811$$CN$US$US
241976062$24197606$2$F$20240101$20240806$20240811$20240812$EXP$$US-JNJFOC-20240809001$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240812$$CN$US$US
241976071$24197607$1$I$$20240729$20240811$20240811$EXP$$JP-AMGEN-JPNSP2024156696$AMGEN$Shigehisa Kajikawa, Tomoyuki Ogisu, Toshiyuki Yonezawa, Hiroyuki Tanaka, Satoru Ito, Satsuki Murakami, Akiyoshi Takami, Akira Satou, Toyonori Tsuzuki, Akihito Kubo. [CASE REPORT]Pseudocarcinomatous Hyperplasia of the Nose and Necrotic Tracheitis Associated with Acute Myeloid Leukemia. Internal Medicine. 2024;63(14):2063-2067$29$YR$A$F$Y$$$20240811$$MD$JP$JP
241976081$24197608$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA234795$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240811$$MD$US$US
241976091$24197609$1$I$20231201$20240805$20240811$20240811$EXP$$PL-AMGEN-POLSP2024156907$AMGEN$$75$YR$E$F$Y$$$20240811$$CN$PL$PL
241976101$24197610$1$I$20240716$20240807$20240811$20240811$PER$$US-AMGEN-USASP2024157826$AMGEN$$84$YR$E$F$Y$$$20240811$$CN$US$US
241976112$24197611$2$F$20240101$20240802$20240811$20240812$EXP$$US-AMGEN-USASP2024155104$AMGEN$$$$$$Y$$$20240812$$MD$US$US
241976122$24197612$2$F$20240801$20240807$20240811$20240812$EXP$$US-AMGEN-USASP2024157891$AMGEN$$$$$$Y$$$20240812$$MD$US$US
241976131$24197613$1$I$20220620$20240731$20240811$20240811$EXP$$TH-BAXTER-2024BAX022547$BAXTER$$69$YR$$F$Y$52$KG$20240811$$HP$TH$TH
241976141$24197614$1$I$20240329$20240801$20240811$20240811$EXP$CN-NMPACDR-3301051028618202400150$CN-BAXTER-2024BAX022731$BAXTER$$6$YR$$F$Y$20.5$KG$20240811$$MD$CN$CN
241976151$24197615$1$I$20240502$20240801$20240811$20240811$EXP$CN-NMPACDR-3301051028618202400154$CN-BAXTER-2024BAX022728$BAXTER$$6$YR$$F$Y$20.4$KG$20240811$$MD$CN$CN
241976161$24197616$1$I$20240401$20240801$20240811$20240811$EXP$CN-NMPACDR-3301051028618202400153$CN-BAXTER-2024BAX022735$BAXTER$$3$YR$$M$Y$16$KG$20240811$$MD$CN$CN
241976171$24197617$1$I$20240218$20240801$20240811$20240811$EXP$CN-NMPACDR-3301051028618202400157$CN-BAXTER-2024BAX022708$BAXTER$$13$YR$$M$Y$72.8$KG$20240811$$MD$CN$CN
241976181$24197618$1$I$20240326$20240801$20240811$20240811$EXP$CN-NMPACDR-3301051028618202400156$CN-BAXTER-2024BAX022718$BAXTER$$3$YR$$F$Y$13.4$KG$20240811$$MD$CN$CN
241976191$24197619$1$I$$20240801$20240811$20240811$EXP$$CA-BAXTER-2024BAX016162$BAXTER$$74$YR$$F$Y$54$KG$20240811$$HP$CA$CA
241976202$24197620$2$F$$20240815$20240811$20240826$PER$$US-RDY-SPO/USA/24/0011305$DR REDDYS$$52$YR$A$F$Y$$$20240826$$CN$US$US
241976211$24197621$1$I$$20240801$20240811$20240811$EXP$$CA-BAXTER-2024BAX022599$BAXTER$$13$YR$$M$Y$33$KG$20240811$$HP$CA$CA
241976231$24197623$1$I$20240802$20240802$20240811$20240811$EXP$$US-JNJFOC-20240812770$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240811$$HP$US$US
241976241$24197624$1$I$$20240808$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408005887$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240811$$CN$US$US
241976251$24197625$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA235505$SANOFI AVENTIS$$$$A$F$Y$72.5$KG$20240811$$MD$US$US
241976261$24197626$1$I$$20240807$20240811$20240811$PER$$US-SA-2024SA236836$SANOFI AVENTIS$$$$$$Y$$$20240811$$HP$US$US
241976271$24197627$1$I$20240805$20240805$20240811$20240811$PER$$US-SA-2024SA235588$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240811$$MD$US$US
241976281$24197628$1$I$20240522$20240802$20240811$20240811$EXP$$US-GSK-US2024096980$GLAXOSMITHKLINE$$12$YR$$M$Y$$$20240811$$MD$US$US
241976292$24197629$2$F$$20240827$20240811$20240902$EXP$$BR-AMGEN-BRASP2024155581$AMGEN$$$$$M$Y$64$KG$20240902$$CN$BR$BR
241976301$24197630$1$I$20240101$20240807$20240811$20240811$EXP$$US-SA-2024SA222048$SANOFI AVENTIS$$46$YR$A$F$Y$163$KG$20240811$$MD$US$US
241976311$24197631$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA233183$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240811$$CN$US$US
241976321$24197632$1$I$20240610$20240730$20240811$20240811$PER$$US-JNJFOC-20240822440$JOHNSON AND JOHNSON$$$$$$Y$$$20240811$$HP$US$US
241976331$24197633$1$I$$20240806$20240811$20240811$PER$$US-JNJFOC-20240816783$JOHNSON AND JOHNSON$$$$$$Y$$$20240811$$HP$US$US
241976341$24197634$1$I$$20240806$20240811$20240811$EXP$$VN-AMGEN-VNMSP2024156824$AMGEN$$56$YR$A$F$Y$$$20240811$$MD$VN$VN
241976352$24197635$2$F$20240801$20240807$20240811$20240812$EXP$$US-AMGEN-USASP2024157919$AMGEN$$$$E$M$Y$$$20240812$$HP$US$US
241976361$24197636$1$I$$20240801$20240811$20240811$PER$$US-SA-2024SA231545$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240811$$MD$US$US
241976371$24197637$1$I$$20240805$20240811$20240811$EXP$$US-SA-2024SA235725$SANOFI AVENTIS$$$$A$F$Y$$$20240811$$MD$US$US
241976381$24197638$1$I$20240805$20240805$20240811$20240811$PER$$US-SA-2024SA235470$SANOFI AVENTIS$$32$YR$A$F$Y$68.03$KG$20240811$$MD$US$US
241976392$24197639$2$F$20240101$20240819$20240811$20240828$PER$$US-SA-2024SA233426$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240828$$MD$US$US
241976401$24197640$1$I$20240101$20240802$20240811$20240811$PER$$US-SA-2024SA233431$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240811$$MD$US$US
241976411$24197641$1$I$20240801$20240801$20240811$20240811$PER$$US-JNJFOC-20240820528$JOHNSON AND JOHNSON$$$$$$Y$$$20240811$$CN$US$US
241976421$24197642$1$I$20240802$20240802$20240811$20240811$30DAY$$US-GSK-US2024097019$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240811$$CN$US$US
241976431$24197643$1$I$20240804$20240805$20240811$20240811$PER$$US-SA-2024SA235464$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240811$$MD$US$US
241976441$24197644$1$I$$20240801$20240811$20240811$PER$$US-SA-2024SA230510$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240811$$MD$US$US
241976452$24197645$2$F$$20240820$20240811$20240902$PER$$US-SA-2024SA235172$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240902$$MD$US$US
241976461$24197646$1$I$$20240729$20240811$20240811$EXP$$US-RDY-LIT/USA/24/0011407$DR REDDYS$Zielinski R, Qureshi K, Wright Z, D^Cunha S. Worsening coronary artery disease found in a routine lung cancer screen. American Journal of the Medical Sciences. 2024 Feb;367: S104-S105. doi:10.1016/S0002-9629%2824%2900235-0.$56$YR$A$M$Y$$$20240811$$HP$US$US
241976471$24197647$1$I$$20240807$20240811$20240811$PER$$US-JNJFOC-20240820380$JOHNSON AND JOHNSON$$$$$F$Y$$$20240811$$CN$US$US
241976481$24197648$1$I$$20240807$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408004737$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240811$$CN$US$US
241976491$24197649$1$I$20240701$20240801$20240811$20240811$PER$$US-SA-2024SA232273$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240811$$MD$US$US
241976501$24197650$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA233924$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240811$$MD$US$US
241976511$24197651$1$I$$20240801$20240811$20240811$PER$$US-SA-2024SA232278$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240811$$MD$US$US
241976521$24197652$1$I$$20240807$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408004941$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240811$$CN$US$US
241976531$24197653$1$I$$20240805$20240811$20240811$EXP$$US-SA-2024SA236107$SANOFI AVENTIS$$$$E$M$Y$79$KG$20240811$$MD$US$US
241976542$24197654$2$F$20240101$20240826$20240811$20240912$EXP$$US-SA-2024SA233339$SANOFI AVENTIS$$$$E$M$Y$$$20240912$$MD$US$US
241976551$24197655$1$I$20240701$20240801$20240811$20240811$PER$$US-SA-2024SA230951$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240811$$MD$US$US
241976561$24197656$1$I$20240809$20240809$20240811$20240811$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044878$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240811$$HP$US$US
241976571$24197657$1$I$20240803$20240808$20240811$20240811$PER$$US-JNJFOC-20240821153$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240811$$CN$US$US
241976581$24197658$1$I$$20240807$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408005049$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240811$$CN$US$US
241976591$24197659$1$I$$20240807$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408004977$ELI LILLY AND CO$$$$$M$Y$$$20240811$$CN$US$US
241976602$24197660$2$F$$20240828$20240811$20240908$30DAY$$US-GSK-US2024097035$GLAXOSMITHKLINE$$$$$M$Y$$$20240908$$CN$US$US
241976611$24197661$1$I$20240808$20240808$20240811$20240811$PER$$US-AMGEN-USASP2024158678$AMGEN$$79$YR$E$F$Y$$$20240811$$CN$US$US
241976621$24197662$1$I$$20240808$20240811$20240811$PER$$PR-JNJFOC-20240821292$JOHNSON AND JOHNSON$$$$$$Y$$$20240811$$MD$PR$PR
241976631$24197663$1$I$$20240802$20240811$20240811$30DAY$$US-GSK-US2024097038$GLAXOSMITHKLINE$$$$E$F$Y$$$20240811$$CN$US$US
241976641$24197664$1$I$$20240807$20240811$20240811$PER$$US-ROCHE-3513786$ROCHE$$51$YR$A$F$Y$$$20240811$$MD$US$US
241976651$24197665$1$I$$20240803$20240811$20240811$PER$$US-SA-2024SA234600$SANOFI AVENTIS$$$$T$F$Y$$$20240811$$MD$US$US
241976661$24197666$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA234656$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240811$$MD$US$US
241976671$24197667$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA234163$SANOFI AVENTIS$$$$A$F$Y$69.7$KG$20240811$$MD$US$US
241976681$24197668$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA235629$SANOFI AVENTIS$$$$A$F$Y$$$20240811$$MD$US$US
241976701$24197670$1$I$20240701$20240802$20240811$20240811$PER$$US-SA-2024SA235689$SANOFI AVENTIS$$61$YR$A$F$Y$51$KG$20240811$$MD$US$US
241976712$24197671$2$F$20240712$20240815$20240811$20240822$EXP$$BR-JNJFOC-20240821422$JOHNSON AND JOHNSON$$75$YR$E$M$Y$61.245$KG$20240822$$MD$BR$BR
241976721$24197672$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA234849$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240811$$MD$US$US
241976731$24197673$1$I$20240729$20240806$20240811$20240811$EXP$$US-JNJFOC-20240813927$JOHNSON AND JOHNSON$$75$YR$E$M$Y$61.2$KG$20240811$$HP$US$US
241976742$24197674$2$F$20240726$20240819$20240811$20240826$PER$$US-AMGEN-USASP2024157627$AMGEN$$$$$$Y$$$20240826$$PH$US$US
241976752$24197675$2$F$20240705$20240821$20240811$20240825$30DAY$$US-AMGEN-USASP2024157563$AMGEN$$$$$$Y$$$20240825$$PH$US$US
241976761$24197676$1$I$20240726$20240806$20240811$20240811$EXP$$BR-EMD Serono-2024042551$EMD SERONO INC$$47$YR$A$F$Y$$$20240811$$CN$BR$BR
241976771$24197677$1$I$20240101$20240803$20240811$20240811$PER$$US-SA-2024SA204392$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240811$$CN$US$US
241976781$24197678$1$I$20240803$20240805$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408003344$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240811$$CN$US$US
241976791$24197679$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA233900$SANOFI AVENTIS$$67$YR$E$M$Y$96.61$KG$20240811$$MD$US$US
241976801$24197680$1$I$20240101$20240802$20240811$20240811$PER$$US-SA-2024SA233804$SANOFI AVENTIS$$64$YR$A$M$Y$113.39$KG$20240811$$MD$US$US
241976811$24197681$1$I$20240804$20240806$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408004076$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240811$$CN$US$US
241976821$24197682$1$I$20240101$20240805$20240811$20240811$PER$$US-SA-2024SA235448$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240811$$MD$US$US
241976832$24197683$2$F$20240724$20240917$20240811$20240927$EXP$$JP-AMGEN-JPNSP2024154863$AMGEN$$56$YR$A$F$Y$$$20240926$$PH$JP$JP
241976841$24197684$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA233857$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240811$$MD$US$US
241976851$24197685$1$I$20240802$20240805$20240811$20240811$PER$$US-AMGEN-USASP2024155674$AMGEN$$58$YR$A$F$Y$$$20240811$$CN$US$US
241976861$24197686$1$I$20240101$20240802$20240811$20240811$PER$$US-SA-2024SA233685$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240811$$MD$US$US
241976871$24197687$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA233686$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240811$$MD$US$US
241976881$24197688$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA232902$SANOFI AVENTIS$$$$A$F$Y$84.36$KG$20240811$$MD$US$US
241976891$24197689$1$I$20240727$20240802$20240811$20240811$PER$$US-SA-2024SA232993$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240811$$MD$US$US
241976901$24197690$1$I$$20240806$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408004216$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240811$$CN$US$US
241976911$24197691$1$I$$20240802$20240811$20240811$PER$$US-AstraZeneca-2024A176210$ASTRAZENECA$$$$$$Y$$$20240811$$HP$US$
241976921$24197692$1$I$$20240808$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408005654$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240811$$CN$US$US
241976932$24197693$2$F$20240101$20240917$20240811$20240926$PER$$US-SA-2024SA233988$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240926$$MD$US$US
241976941$24197694$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA233983$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240811$$CN$US$US
241976961$24197696$1$I$20240101$20240805$20240811$20240811$PER$$US-SA-2024SA234558$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240811$$CN$US$US
241976971$24197697$1$I$$20240802$20240811$20240811$PER$$US-SA-2024SA233955$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240811$$MD$US$US
241976981$24197698$1$I$20240101$20240805$20240811$20240811$PER$$US-SA-2024SA235446$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240811$$MD$US$US
241976991$24197699$1$I$$20240801$20240811$20240811$PER$$US-AstraZeneca-2024A177135$ASTRAZENECA$$$$$M$Y$$$20240811$$HP$US$
241977001$24197700$1$I$$20240808$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408005754$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240811$$CN$US$US
241977012$24197701$2$F$20240101$20240920$20240811$20240927$EXP$$US-SA-2024SA234334$SANOFI AVENTIS$$67$YR$E$F$Y$74$KG$20240927$$MD$US$US
241977021$24197702$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA232870$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240811$$CN$US$US
241977031$24197703$1$I$$20240806$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408004845$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240811$$CN$US$US
241977042$24197704$2$F$$20240807$20240811$20240811$PER$$US-ROCHE-10000052254$ROCHE$$$$A$F$Y$$$20240811$$CN$US$US
241977051$24197705$1$I$$20240805$20240811$20240811$PER$$US-RDY-SPO/USA/24/0011524$DR REDDYS$$65$YR$E$M$Y$$$20240811$$CN$US$US
241977061$24197706$1$I$$20240801$20240811$20240811$PER$$US-RDY-SPO/USA/24/0011450$DR REDDYS$$15$YR$T$$Y$$$20240811$$MD$US$US
241977071$24197707$1$I$20210301$20240805$20240811$20240811$PER$$US-RDY-SPO/USA/24/0011589$DR REDDYS$$17$YR$T$F$Y$$$20240811$$CN$US$US
241977081$24197708$1$I$$20240805$20240811$20240811$PER$$US-RDY-SPO/USA/24/0011591$DR REDDYS$$$$$F$Y$$$20240811$$MD$US$US
241977091$24197709$1$I$20240701$20240726$20240811$20240811$PER$$US-TEVA-VS-3227115$TEVA$$62$YR$$F$Y$$$20240811$$PH$US$US
241977101$24197710$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA232879$SANOFI AVENTIS$$$$$M$Y$$$20240811$$CN$US$US
241977111$24197711$1$I$20240701$20240807$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408005277$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240811$$CN$US$US
241977121$24197712$1$I$20240501$20240808$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408005611$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240811$$CN$US$US
241977131$24197713$1$I$$20240806$20240811$20240811$PER$$US-JNJFOC-20240815869$JOHNSON AND JOHNSON$$$$$M$Y$$$20240811$$MD$US$US
241977142$24197714$2$F$$20240820$20240811$20240820$PER$$US-JNJFOC-20240817475$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$US$US
241977153$24197715$3$F$20240807$20240904$20240811$20240906$PER$$US-JNJFOC-20240818385$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240906$$HP$US$US
241977161$24197716$1$I$$20240807$20240811$20240811$PER$$US-JNJFOC-20240820934$JOHNSON AND JOHNSON$$$$$F$Y$$$20240811$$HP$US$US
241977171$24197717$1$I$$20240808$20240811$20240811$PER$$US-JNJFOC-20240821149$JOHNSON AND JOHNSON$$$$$$Y$$$20240811$$HP$US$US
241977181$24197718$1$I$20180531$20240807$20240811$20240811$PER$$US-HALEON-2191048$Haleon PLC$$80$YR$$M$Y$$$20240811$$MD$US$US
241977191$24197719$1$I$$20240727$20240811$20240811$PER$$US-TEVA-VS-3228375$TEVA$$49$YR$$F$Y$$$20240811$$HP$US$US
241977202$24197720$2$F$20240101$20240823$20240811$20240913$PER$$US-SA-2024SA233450$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240913$$MD$US$US
241977221$24197722$1$I$20240101$20240802$20240811$20240811$PER$$US-SA-2024SA233537$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240811$$MD$US$US
241977232$24197723$2$F$20240801$20240828$20240811$20240923$PER$$US-SA-2024SA235408$SANOFI AVENTIS$$67$YR$E$F$Y$90.91$KG$20240923$$MD$US$US
241977242$24197724$2$F$$20240819$20240811$20240903$PER$$US-JNJFOC-20240815967$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240903$$CN$US$US
241977251$24197725$1$I$$20240730$20240811$20240811$PER$$US-JNJFOC-20240823557$JOHNSON AND JOHNSON$$$$$M$Y$$$20240811$$HP$US$US
241977261$24197726$1$I$20240625$20240731$20240811$20240811$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024095782$VIIV$$52$YR$$F$Y$$$20240811$$CN$US$US
241977271$24197727$1$I$$20240731$20240811$20240811$EXP$$US-VIIV HEALTHCARE LIMITED-US2024095844$VIIV$$$$$$Y$$$20240811$$PH$US$US
241977281$24197728$1$I$$20240731$20240811$20240811$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024095887$VIIV$$$$$M$Y$$$20240811$$CN$US$US
241977292$24197729$2$F$$20240829$20240811$20240906$EXP$$JP-ROCHE-10000048756$ROCHE$Furuta M, Watanabe S, Aizu K, Kobayashi S, Sato F, Hayashi Y. EP-0733 Two cases of HER2 positive hormone-sensitive negative de novo stage IV breast cancer in which a long-term survival was obtained by multidisciplinary treatment. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;361.$42$YR$A$F$Y$$$20240906$$MD$JP$JP
241977301$24197730$1$I$$20240725$20240811$20240811$PER$$US-JNJFOC-20240772327$JOHNSON AND JOHNSON$$$$$$Y$$$20240811$$CN$US$US
241977311$24197731$1$I$$20240731$20240811$20240811$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024096198$VIIV$$$$$M$Y$$$20240811$$CN$US$US
241977321$24197732$1$I$20240805$20240807$20240811$20240811$PER$$US-JNJFOC-20240820488$JOHNSON AND JOHNSON$$$$$$Y$$$20240811$$HP$US$US
241977331$24197733$1$I$20240201$20240805$20240811$20240811$PER$$US-SA-2024SA234153$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240811$$CN$US$US
241977341$24197734$1$I$$20240806$20240811$20240811$PER$$US-ROCHE-10000050652$ROCHE$$$$A$F$Y$$$20240811$$CN$US$US
241977352$24197735$2$F$$20240808$20240811$20240817$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024096329$VIIV$$$$$M$Y$$$20240817$$PH$US$US
241977361$24197736$1$I$20240601$20240801$20240811$20240811$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024096948$VIIV$$35$YR$$M$Y$74.84$KG$20240811$$CN$US$US
241977371$24197737$1$I$$20240807$20240811$20240811$PER$$US-ROCHE-10000051078$ROCHE$$$$A$F$Y$$$20240811$$CN$US$US
241977381$24197738$1$I$20240701$20240807$20240811$20240811$EXP$$DE-ROCHE-10000052454$ROCHE$$56$YR$A$F$Y$65$KG$20240811$$MD$DE$DE
241977391$24197739$1$I$$20240729$20240811$20240811$EXP$$CA-ROCHE-10000047002$ROCHE$Paczkowski F, Raphael J, Browne C. Durable Response to Atezolizumab in Extensive-Stage Small-Cell Lung Cancer Leading to 60 Months Overall Survival: A Case Report. Current oncology. 2024-Jun-27;31 (7):3682-3689. doi:10.3390/curroncol31070271.$58$YR$A$M$Y$$$20240811$$HP$CA$CA
241977401$24197740$1$I$$20240807$20240811$20240811$PER$$US-ROCHE-10000052160$ROCHE$$$$$$Y$$$20240811$$PH$US$US
241977411$24197741$1$I$20240710$20240806$20240811$20240811$PER$$US-ROCHE-10000050572$ROCHE$$64$YR$A$F$Y$68.22$KG$20240811$$HP$US$US
241977421$24197742$1$I$20240101$20240807$20240811$20240811$PER$$US-ROCHE-10000052354$ROCHE$$$$$$Y$$$20240811$$HP$US$US
241977431$24197743$1$I$$20240806$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408004790$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240811$$PH$US$US
241977441$24197744$1$I$20240101$20240802$20240811$20240811$PER$$US-SA-2024SA233231$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240811$$MD$US$US
241977451$24197745$1$I$$20240729$20240811$20240811$EXP$$CN-ROCHE-3578032$ROCHE$Gu Q, Zhu M, Wang Y and Gu Y. Retrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab. Doi:10.2147/BCTT.S457845. Breast cancer 2024 May 25;16:253-68.$$$$$Y$$$20240811$$HP$CN$CN
241977461$24197746$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA233742$SANOFI AVENTIS$$$$A$F$Y$$$20240811$$CN$US$US
241977472$24197747$2$F$20240501$20240827$20240811$20240828$PER$$US-ALXN-202408USA000255US$ALEXION PHARMACEUTICALS$$66$YR$$F$Y$$$20240828$$CN$US$US
241977481$24197748$1$I$$20240801$20240811$20240811$EXP$$US-ZENPEP LLC-2024AIMT01181$AIMMUNE$$$$$$Y$$$20240811$$CN$US$US
241977491$24197749$1$I$$20240718$20240811$20240811$PER$$US-009507513-2407USA011843$MERCK$Saleh A, D^amico A, Hasnie A, Clarkson S, Heindl B. Atrial arrhythmias and acute pericarditis triggered by bleach ingestion-associated oesophageal perforation: a case report. Eur Heart J Case Rep. 2024;8:1-5$36$YR$$M$Y$$$20240811$$HP$US$US
241977501$24197750$1$I$$20240805$20240811$20240811$PER$$US-ALXN-202408USA000276US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240811$$HP$US$US
241977511$24197751$1$I$$20240729$20240811$20240811$EXP$GR-SEATTLE GENETICS-2023SGN11095$GR-ROCHE-10000048622$ROCHE$$$$$F$Y$$$20240811$$MD$GR$GR
241977521$24197752$1$I$$20240805$20240811$20240811$PER$$US-ALXN-202406USA001656US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240811$$CN$US$US
241977531$24197753$1$I$20240625$20240730$20240811$20240811$EXP$DE-SAMSUNG BIOEPIS-SB-2024-20902$DE-ROCHE-10000041801$ROCHE$$$$$M$Y$79$KG$20240811$$MD$DE$DE
241977541$24197754$1$I$$20240802$20240811$20240811$EXP$$US-ZENPEP LLC-2024AIMT01201$AIMMUNE$$$$$$Y$$$20240811$$CN$US$US
241977551$24197755$1$I$$20240806$20240811$20240811$PER$$US-AMGEN-USASP2024156724$AMGEN$$69$YR$E$M$Y$$$20240811$$HP$US$US
241977562$24197756$2$F$$20240820$20240811$20240823$EXP$$GR-ROCHE-10000052187$ROCHE$$$$$F$Y$$$20240823$$MD$GR$GR
241977571$24197757$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA235165$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240812$$MD$US$US
241977581$24197758$1$I$$20240806$20240811$20240811$PER$$US-009507513-2408USA002166$MERCK$$$$$F$Y$$$20240811$$CN$US$US
241977591$24197759$1$I$$20240809$20240811$20240811$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044879$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240811$$MD$US$US
241977601$24197760$1$I$20240701$20240807$20240811$20240811$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044884$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240811$$CN$US$US
241977611$24197761$1$I$20240101$20240803$20240811$20240811$PER$$US-SA-2024SA232939$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240812$$MD$US$US
241977621$24197762$1$I$$20240806$20240811$20240811$PER$$US-009507513-2408USA002138$MERCK$$$$$M$Y$$$20240811$$CN$US$US
241977631$24197763$1$I$$20240805$20240811$20240811$PER$$US-AMGEN-USASP2024156688$AMGEN$$$$$$Y$$$20240811$$HP$US$US
241977641$24197764$1$I$$20240805$20240811$20240811$PER$$US-AMGEN-USASP2024156353$AMGEN$$$$$$Y$$$20240811$$HP$US$US
241977651$24197765$1$I$$20240807$20240811$20240811$EXP$$US-SANDOZ INC.-SDZ2024US071334$SANDOZ$$$$$F$Y$$$20240811$$MD$US$US
241977661$24197766$1$I$20240701$20240805$20240811$20240811$EXP$$CA-JNJFOC-20240812831$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240812$$HP$CA$CA
241977672$24197767$2$F$$20240917$20240811$20240917$PER$$PR-JNJFOC-20240802439$JOHNSON AND JOHNSON$$$$$M$Y$64.468$KG$20240917$$CN$PR$PR
241977682$24197768$2$F$20240101$20240812$20240811$20240819$EXP$IT-MINISAL02-997830$IT-AMGEN-ITASP2024157178$AMGEN$$57$YR$A$M$Y$85$KG$20240819$$MD$IT$IT
241977691$24197769$1$I$20240514$20240809$20240811$20240811$EXP$FR-AFSSAPS-LM2024000439$FR-AMGEN-FRASP2024158487$AMGEN$$72$YR$E$M$Y$101$KG$20240811$$MD$FR$FR
241977702$24197770$2$F$20240101$20240904$20240811$20240910$EXP$$US-JNJFOC-20240821466$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$CN$US$US
241977711$24197771$1$I$20240315$20240806$20240811$20240811$EXP$$US-ABBVIE-5716767$ABBVIE$$79$YR$$F$Y$$$20240811$$CN$US$US
241977721$24197772$1$I$$20240808$20240811$20240811$EXP$$DE-ABBVIE-5874545$ABBVIE$$78$YR$$M$Y$$$20240811$$MD$DE$DE
241977731$24197773$1$I$$20240808$20240811$20240811$EXP$$US-ABBVIE-5874605$ABBVIE$$$$$M$Y$$$20240811$$CN$US$US
241977741$24197774$1$I$20240101$20240807$20240811$20240811$EXP$$US-ABBVIE-5872183$ABBVIE$$57$YR$$F$Y$51$KG$20240811$$CN$US$US
241977751$24197775$1$I$20210101$20240802$20240811$20240811$EXP$$US-JNJFOC-20240823667$JOHNSON AND JOHNSON$$66$YR$E$F$Y$55.5$KG$20240812$$MD$US$US
241977761$24197776$1$I$$20240801$20240811$20240811$PER$$US-JNJFOC-20240803243$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$HP$US$US
241977771$24197777$1$I$$20240808$20240811$20240811$PER$$US-JNJFOC-20240822140$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
241977781$24197778$1$I$20240101$20240808$20240811$20240811$EXP$$US-ABBVIE-5874358$ABBVIE$$$$$M$Y$$$20240811$$CN$US$US
241977791$24197779$1$I$$20240807$20240811$20240811$EXP$$US-ABBVIE-5873617$ABBVIE$$$$$$Y$$$20240811$$PH$US$US
241977801$24197780$1$I$20240501$20240808$20240811$20240811$EXP$$US-ABBVIE-5874345$ABBVIE$$53$YR$$M$Y$$$20240811$$CN$US$US
241977811$24197781$1$I$20240728$20240801$20240811$20240811$PER$$US-BAUSCHBL-2024BNL030992$BAUSCH AND LOMB$$$$$F$Y$$$20240812$$CN$US$US
241977821$24197782$1$I$$20240808$20240811$20240811$EXP$$US-ABBVIE-5874272$ABBVIE$$$$$M$Y$$$20240811$$CN$US$US
241977831$24197783$1$I$20240701$20240807$20240811$20240811$EXP$$CL-ABBVIE-5873618$ABBVIE$$45$YR$$F$Y$$$20240811$$CN$CL$CL
241977842$24197784$2$F$$20240830$20240811$20240909$PER$$US-BAUSCHBL-2024BNL031029$BAUSCH AND LOMB$$$$$M$Y$$$20240909$$CN$US$US
241977852$24197785$2$F$$20240731$20240811$20240822$PER$$US-BAUSCHBL-2024BNL030970$BAUSCH AND LOMB$$$$$F$Y$$$20240823$$CN$US$US
241977861$24197786$1$I$20240101$20240805$20240811$20240811$EXP$FR-AFSSAPS-TS2024000872$FR-PFIZER INC-202400233027$PFIZER$$71$YR$$M$Y$98$KG$20240811$$MD$FR$FR
241977871$24197787$1$I$20240101$20240806$20240811$20240811$EXP$$US-PFIZER INC-PV202400103447$PFIZER$$83$YR$$M$Y$$$20240811$$HP$US$US
241977881$24197788$1$I$$20240807$20240811$20240811$EXP$$US-PFIZER INC-202400232096$PFIZER$$55$YR$$F$Y$$$20240811$$HP$US$US
241977891$24197789$1$I$20240730$20240806$20240811$20240811$EXP$$CN-PFIZER INC-PV202400102402$PFIZER$$33$YR$$F$Y$65.5$KG$20240811$$HP$CN$CN
241977901$24197790$1$I$$20240807$20240811$20240811$EXP$$CA-PFIZER INC-202400232207$PFIZER$$43$YR$$F$Y$$$20240811$$MD$CA$CA
241977914$24197791$4$F$20240101$20240918$20240811$20240924$EXP$$CA-PFIZER INC-202400018281$PFIZER$$75$YR$$M$Y$$$20240924$$CN$CA$CA
241977921$24197792$1$I$20240806$20240807$20240811$20240811$EXP$$CA-PFIZER INC-202400215036$PFIZER$$64$YR$$M$Y$85$KG$20240811$$MD$CA$CA
241977931$24197793$1$I$20240601$20240808$20240811$20240811$EXP$$NZ-BRISTOL-MYERS SQUIBB COMPANY-2024-108665$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240812$$PH$NZ$NZ
241977941$24197794$1$I$20130101$20240807$20240811$20240811$PER$$US-JNJFOC-20240823172$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240812$$HP$US$US
241977952$24197795$2$F$20220908$20240730$20240811$20240812$EXP$$CN-009507513-2408CHN003365$MERCK$$49$YR$$M$Y$$$20240812$$HP$CN$CN
241977961$24197796$1$I$20240701$20240807$20240811$20240811$EXP$$CA-ABBVIE-5873244$ABBVIE$$37$YR$$M$Y$$$20240811$$CN$CA$CA
241977971$24197797$1$I$$20240805$20240811$20240811$PER$$US-SA-2023SA055950$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240812$$MD$US$US
241977981$24197798$1$I$20240101$20240808$20240811$20240811$EXP$$US-ABBVIE-5874171$ABBVIE$$$$$M$Y$$$20240811$$CN$US$US
241977991$24197799$1$I$20240101$20240806$20240811$20240811$EXP$$US-ABBVIE-5873024$ABBVIE$$$$$M$Y$$$20240811$$CN$US$US
241978001$24197800$1$I$20240101$20240802$20240811$20240811$EXP$$JP-009507513-2404JPN003188J$MERCK$$8$DEC$$M$Y$$$20240811$$MD$JP$JP
241978011$24197801$1$I$20240424$20240807$20240811$20240811$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125833$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240812$$CN$US$US
241978022$24197802$2$F$$20240815$20240811$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125731$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240819$$CN$US$US
241978031$24197803$1$I$20240805$20240808$20240811$20240811$EXP$$CO-ABBVIE-5873382$ABBVIE$$54$YR$$F$Y$74$KG$20240811$$CN$CO$CO
241978041$24197804$1$I$20201230$20240809$20240811$20240811$EXP$SK-SUKLSK-20214337$SK-JNJFOC-20240823798$JOHNSON AND JOHNSON$$86$YR$E$F$Y$78$KG$20240812$$MD$SK$SK
241978051$24197805$1$I$$20240808$20240811$20240811$EXP$$US-JNJFOC-20240821630$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$US$US
241978061$24197806$1$I$$20240806$20240811$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125746$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240812$$CN$US$US
241978071$24197807$1$I$$20240802$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408001953$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240811$$CN$US$US
241978081$24197808$1$I$20230709$20240806$20240811$20240811$EXP$$US-ABBVIE-5853520$ABBVIE$$71$YR$$M$Y$97$KG$20240811$$HP$US$US
241978091$24197809$1$I$20240804$20240808$20240811$20240811$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126423$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$40.82$KG$20240812$$CN$US$US
241978101$24197810$1$I$$20240807$20240811$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125593$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240812$$HP$US$US
241978111$24197811$1$I$20240101$20240806$20240811$20240811$EXP$$US-ABBVIE-5871064$ABBVIE$$$$$M$Y$$$20240811$$CN$US$US
241978121$24197812$1$I$20240101$20240807$20240811$20240811$EXP$$US-ABBVIE-5872594$ABBVIE$$$$$F$Y$$$20240811$$CN$US$US
241978142$24197814$2$F$20240601$20240820$20240811$20240824$EXP$$EG-ABBVIE-5873086$ABBVIE$$62$YR$$M$Y$80$KG$20240824$$CN$EG$EG
241978161$24197816$1$I$20230101$20240802$20240811$20240811$EXP$$NVSC2023BR131925$NOVARTIS$$$$$F$Y$$$20240812$$CN$BR$BR
241978172$24197817$2$F$20240601$20240812$20240811$20240815$EXP$$US-ABBVIE-5874332$ABBVIE$$95$YR$$F$Y$$$20240815$$CN$US$US
241978181$24197818$1$I$$20240806$20240811$20240811$EXP$$BR-JNJFOC-20240823517$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$BR$BR
241978191$24197819$1$I$$20240806$20240811$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125861$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240812$$CN$US$US
241978201$24197820$1$I$20240801$20240806$20240811$20240811$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124757$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$68.04$KG$20240812$$CN$US$US
241978211$24197821$1$I$20240701$20240806$20240811$20240811$EXP$$CA-ABBVIE-5873091$ABBVIE$$$$E$M$Y$$$20240811$$CN$CA$CA
241978221$24197822$1$I$$20240807$20240811$20240811$PER$$US-JNJFOC-20240817282$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
241978231$24197823$1$I$20240730$20240808$20240811$20240811$EXP$FR-AFSSAPS-RS2024000795$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-126552$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$70$KG$20240812$$PH$FR$FR
241978241$24197824$1$I$20240806$20240806$20240811$20240811$EXP$$US-JNJFOC-20240820542$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240812$$HP$US$US
241978251$24197825$1$I$20240101$20240806$20240811$20240811$EXP$$US-ABBVIE-5871229$ABBVIE$$$$$M$Y$$$20240811$$CN$US$US
241978261$24197826$1$I$$20240806$20240811$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125394$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240812$$HP$US$US
241978271$24197827$1$I$20240510$20240808$20240811$20240811$EXP$$CN-JNJFOC-20240822893$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240812$$HP$CN$CN
241978282$24197828$2$F$20240805$20240823$20240811$20240828$EXP$$RO-ABBVIE-5873150$ABBVIE$$62$YR$$M$Y$$$20240828$$CN$RO$RO
241978291$24197829$1$I$20240731$20240807$20240811$20240811$PER$$US-AMGEN-USASP2024157943$AMGEN$$84$YR$E$F$Y$$$20240811$$CN$US$US
241978302$24197830$2$F$20240401$20240813$20240811$20240815$EXP$$US-ABBVIE-5872612$ABBVIE$$66$YR$$M$Y$83.914$KG$20240815$$CN$US$US
241978311$24197831$1$I$$20240808$20240811$20240811$EXP$$JP-ABBVIE-5873798$ABBVIE$$77$YR$$M$Y$$$20240811$$CN$JP$JP
241978322$24197832$2$F$20240730$20240814$20240811$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126117$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240821$$CN$US$US
241978331$24197833$1$I$20240804$20240808$20240811$20240811$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126269$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240812$$CN$US$US
241978342$24197834$2$F$$20240827$20240811$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125566$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240904$$CN$US$US
241978351$24197835$1$I$20240730$20240805$20240811$20240811$PER$$US-SA-2024SA234369$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240812$$MD$US$US
241978371$24197837$1$I$$20240805$20240811$20240811$EXP$$AR-AMGEN-ARGSP2024158025$AMGEN$$64$YR$A$F$Y$$$20240811$$CN$AR$AR
241978381$24197838$1$I$$20240807$20240811$20240811$EXP$$BG-ABBVIE-5873386$ABBVIE$$56$YR$$F$Y$$$20240811$$CN$BG$BG
241978391$24197839$1$I$$20240806$20240811$20240811$EXP$$BE-JNJFOC-20240821653$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$BE$BE
241978411$24197841$1$I$20240601$20240809$20240811$20240811$EXP$SE-SEMPA-2024-005910$SE-JNJFOC-20240826012$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240812$$MD$SE$SE
241978421$24197842$1$I$$20240802$20240811$20240811$PER$$US-ABBVIE-5866713$ABBVIE$$$$$M$Y$$$20240811$$CN$US$US
241978431$24197843$1$I$$20240725$20240811$20240811$EXP$$JP-JNJFOC-20240825655$JOHNSON AND JOHNSON$Ohtsubo H. Hepatic fibrosis and renal impairment during MTX use.$$$$$Y$$$20240812$$HP$JP$JP
241978441$24197844$1$I$20240501$20240807$20240811$20240811$EXP$$US-ABBVIE-5872301$ABBVIE$$69$YR$$M$Y$$$20240811$$CN$US$US
241978451$24197845$1$I$$20240809$20240811$20240811$EXP$$US-ABBVIE-5875377$ABBVIE$$$$$M$Y$$$20240811$$CN$US$US
241978463$24197846$3$F$20240726$20240909$20240811$20240916$PER$$US-AMGEN-USASP2024150810$AMGEN$$68$YR$E$M$Y$$$20240916$$CN$US$US
241978473$24197847$3$F$$20240904$20240811$20240906$EXP$$JP-ABBVIE-5870191$ABBVIE$Nagayama M, Funayama Y, Taniguchi O, Hatano K, Oguro K, Owada J, et al. Biologic therapy for ulcerative colitis associated with immune thrombocytopenia. Clin J Gastroenterol. 2024.$51$YR$$M$Y$$$20240906$$HP$JP$JP
241978482$24197848$2$F$20240729$20240809$20240811$20240820$PER$$US-JNJFOC-20240826278$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240820$$HP$US$US
241978492$24197849$2$F$20240802$20240904$20240811$20240909$PER$$US-JNJFOC-20240810904$JOHNSON AND JOHNSON$$56$YR$A$$Y$$$20240909$$CN$US$US
241978501$24197850$1$I$20240601$20240807$20240811$20240811$EXP$$AR-JNJFOC-20240822657$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240812$$CN$AR$AR
241978511$24197851$1$I$20240731$20240731$20240811$20240811$PER$$US-JNJFOC-20240826211$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240812$$PH$US$US
241978521$24197852$1$I$20240101$20240805$20240811$20240811$PER$$US-SA-2024SA234647$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240812$$MD$US$US
241978531$24197853$1$I$20240711$20240808$20240811$20240811$EXP$$US-TAKEDA-2024TUS076446$TAKEDA$$63$YR$$M$Y$$$20240811$$CN$US$US
241978541$24197854$1$I$$20240806$20240811$20240811$EXP$$MX-JNJFOC-20240821163$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240812$$CN$MX$MX
241978552$24197855$2$F$$20240817$20240811$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126424$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$38.1$KG$20240828$$CN$US$US
241978562$24197856$2$F$20240805$20240930$20240811$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125079$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240930$$PH$US$US
241978571$24197857$1$I$20231220$20240802$20240811$20240811$EXP$GB-MHRA-MED-202408011848076220-KWQZD$GB-TEVA-VS-3229251$TEVA$$26$YR$$F$Y$$$20240811$$CN$GB$GB
241978582$24197858$2$F$20220416$20240904$20240811$20240913$EXP$$IT-CELLTRION INC.-2024IT018626$CELLTRION$$$$$$Y$$$20240913$$MD$IT$IT
241978591$24197859$1$I$$20240805$20240811$20240811$PER$$US-SA-2024SA234906$SANOFI AVENTIS$$$$C$M$Y$$$20240812$$MD$US$US
241978601$24197860$1$I$20240701$20240805$20240811$20240811$PER$$US-SA-2024SA234848$SANOFI AVENTIS$$23$YR$A$F$Y$122.47$KG$20240812$$MD$US$US
241978612$24197861$2$F$20240601$20240821$20240811$20240827$EXP$$PT-ABBVIE-5864029$ABBVIE$$$$E$M$Y$$$20240827$$CN$PT$PT
241978621$24197862$1$I$20240606$20240729$20240811$20240811$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160281$JIANGSU HANSOH PHARMACEUTICAL$$58$YR$$M$Y$62$KG$20240811$$MD$CN$CN
241978641$24197864$1$I$20240408$20240731$20240811$20240811$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160282$JIANGSU HANSOH PHARMACEUTICAL$$44$YR$$M$Y$63$KG$20240811$$MD$CN$CN
241978651$24197865$1$I$$20240807$20240811$20240811$EXP$$RU-ORGANON-O2408RUS000730$ORGANON$$64$YR$$F$Y$$$20240811$$MD$RU$RU
241978661$24197866$1$I$$20240805$20240811$20240811$EXP$$US-BIOGEN-2024BI01277113$BIOGEN$$$$$F$Y$$$20240811$$CN$US$US
241978671$24197867$1$I$$20240802$20240811$20240811$EXP$$JP-BIOGEN-2024BI01277445$BIOGEN$$$$A$M$Y$$$20240811$$MD$JP$JP
241978681$24197868$1$I$$20240729$20240811$20240811$EXP$$US-AUROBINDO-AUR-APL-2024-039156$AUROBINDO$Jamil A, Ali R, Paige A, Miller R, Mistry N, Abbas A, et al.. ATYPICAL PULMONARY METASTASIS OF PROSTATE ADENOCARCINOMA: A RARE PHENOMENON.. Eur-J-Case-Rep-Intern-Med. 2024;11:No. 5$64$YR$$M$Y$$$20240812$$HP$US$US
241978691$24197869$1$I$$20240805$20240811$20240811$PER$$US-ABBVIE-5867922$ABBVIE$$$$$F$Y$$$20240811$$HP$US$US
241978701$24197870$1$I$20240507$20240809$20240811$20240811$EXP$DK-DKMA-30730545$NVSC2024DK162173$NOVARTIS$$14$DY$$M$Y$3.4$KG$20240812$$MD$DK$DK
241978721$24197872$1$I$20240101$20240807$20240811$20240811$EXP$$US-ABBVIE-5874326$ABBVIE$$$$$F$Y$$$20240811$$CN$US$US
241978731$24197873$1$I$$20240808$20240811$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126003$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240812$$HP$US$US
241978741$24197874$1$I$$20240807$20240811$20240811$PER$$US-ELI_LILLY_AND_COMPANY-US202408005025$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240811$$CN$US$US
241978751$24197875$1$I$$20240808$20240811$20240811$EXP$$US-ABBVIE-5875414$ABBVIE$$$$$F$Y$$$20240811$$CN$US$US
241978761$24197876$1$I$20240101$20240805$20240811$20240811$PER$$US-SA-2024SA234507$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240812$$MD$US$US
241978772$24197877$2$F$20240101$20240820$20240811$20240902$PER$$US-SA-2024SA234548$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240902$$MD$US$US
241978781$24197878$1$I$$20240803$20240811$20240811$PER$$US-ABBVIE-5866837$ABBVIE$$$$$F$Y$57$KG$20240811$$CN$US$US
241978791$24197879$1$I$20240101$20240805$20240811$20240811$PER$$US-SA-2024SA234607$SANOFI AVENTIS$$1$YR$I$M$Y$13.6$KG$20240812$$MD$US$US
241978801$24197880$1$I$20240423$20240802$20240811$20240811$EXP$GB-MHRA-MED-202408012055539780-NRLTM$GB-TEVA-VS-3229285$TEVA$$72$YR$$F$Y$53$KG$20240811$$CN$GB$GB
241978811$24197881$1$I$$20240809$20240811$20240811$PER$$US-JNJFOC-20240826688$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$MD$US$US
241978821$24197882$1$I$$20240806$20240811$20240811$EXP$$CA-JNJFOC-20240823962$JOHNSON AND JOHNSON$$$$$F$Y$47$KG$20240812$$HP$CA$CA
241978831$24197883$1$I$20240726$20240808$20240811$20240811$PER$$US-HALEON-2191115$Haleon PLC$$57$YR$$F$Y$$$20240811$$CN$US$US
241978841$24197884$1$I$20240809$20240809$20240811$20240811$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044922$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240812$$CN$US$US
241978851$24197885$1$I$20240804$20240805$20240811$20240811$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123898$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240812$$CN$US$US
241978861$24197886$1$I$20240706$20240730$20240811$20240811$EXP$$GB-AUROBINDO-AUR-APL-2024-038332$AUROBINDO$$50$YR$$F$Y$65$KG$20240812$$MD$GB$GB
241978871$24197887$1$I$$20240730$20240811$20240811$EXP$$GB-AUROBINDO-AUR-APL-2024-038157$AUROBINDO$$79$YR$$F$Y$77$KG$20240812$$MD$GB$GB
241978881$24197888$1$I$20221029$20240807$20240811$20240811$EXP$SE-SEMPA-2024-005874$SE-GSK-SE2024098758$GLAXOSMITHKLINE$$$$$$Y$$$20240811$$CN$SE$SE
241978892$24197889$2$F$$20240911$20240811$20240923$EXP$$ES-AUROBINDO-AUR-APL-2024-038839$AUROBINDO$Mart?nez-Chantar ML, Gil-pitarch C, Macia MS, Simon J, Mosca L, Conter C, et al.. Neddylation inhibition prevents acetaminopheninduced liver damage by enhancing the anabolic cardiolipin pathway. Cell Reports Medicine. 2024;16:5(7)$$$A$F$Y$$$20240923$$HP$ES$ES
241978901$24197890$1$I$20240701$20240807$20240811$20240811$EXP$FR-AFSSAPS-PV2024000699$FR-GSK-FR2024098778$GLAXOSMITHKLINE$$$$$$Y$$$20240811$$PH$FR$FR
241978911$24197891$1$I$20240107$20240731$20240811$20240811$EXP$$FR-AUROBINDO-AUR-APL-2024-038955$AUROBINDO$$66$YR$$M$Y$$$20240812$$PH$FR$FR
241978923$24197892$3$F$$20240906$20240811$20240916$30DAY$$US-JNJFOC-20240780859$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240916$$CN$US$US
241978931$24197893$1$I$$20240808$20240811$20240811$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126275$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240812$$CN$US$US
241978941$24197894$1$I$$20240806$20240811$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124575$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240812$$HP$US$US
241978951$24197895$1$I$$20240807$20240811$20240811$EXP$$US-BIOGEN-2024BI01277528$BIOGEN$$$$$M$Y$$$20240811$$CN$US$US
241978961$24197896$1$I$20240525$20240731$20240811$20240811$EXP$$FR-AUROBINDO-AUR-APL-2024-039022$AUROBINDO$$67$YR$$M$Y$83$KG$20240812$$MD$FR$FR
241978971$24197897$1$I$20200608$20240731$20240811$20240811$EXP$$PL-AUROBINDO-AUR-APL-2024-039203$AUROBINDO$$47$YR$$F$Y$75$KG$20240812$$MD$PL$PL
241978981$24197898$1$I$20240716$20240731$20240811$20240811$EXP$$ES-AUROBINDO-AUR-APL-2024-039039$AUROBINDO$$51$YR$$F$Y$$$20240812$$PH$ES$ES
241978991$24197899$1$I$20200604$20240731$20240811$20240811$EXP$$PL-AUROBINDO-AUR-APL-2024-039200$AUROBINDO$$56$YR$$M$Y$$$20240812$$MD$PL$PL
241979001$24197900$1$I$$20240731$20240811$20240811$EXP$$PL-AUROBINDO-AUR-APL-2024-039215$AUROBINDO$$26$YR$$M$Y$80$KG$20240812$$MD$PL$PL
241979011$24197901$1$I$$20240802$20240811$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123479$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240812$$CN$US$US
241979021$24197902$1$I$$20240805$20240811$20240811$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123908$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$77.11$KG$20240812$$HP$US$US
241979031$24197903$1$I$$20240731$20240811$20240811$EXP$$PL-AUROBINDO-AUR-APL-2024-039232$AUROBINDO$$45$YR$$F$Y$75$KG$20240812$$MD$PL$PL
241979041$24197904$1$I$$20240718$20240811$20240811$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003760$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241979051$24197905$1$I$$20240806$20240811$20240811$30DAY$$US-GSK-US2024098095$GLAXOSMITHKLINE$$$$$F$Y$$$20240811$$CN$US$US
241979061$24197906$1$I$20240701$20240715$20240812$20240812$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003597$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240812$$CN$US$US
241979072$24197907$2$F$$20240808$20240812$20240815$PER$$US-AMGEN-USASP2024158041$AMGEN$$$$$F$Y$$$20240815$$CN$US$US
241979082$24197908$2$F$$20240902$20240812$20240910$EXP$$JP-AMGEN-JPNSP2024157852$AMGEN$$$$$$Y$$$20240910$$PH$JP$JP
241979091$24197909$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126633$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$77.11$KG$20240812$$CN$US$US
241979101$24197910$1$I$20240515$20240808$20240812$20240812$EXP$FR-AFSSAPS-TS2024000896$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-126261$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$58$KG$20240812$$MD$FR$FR
241979111$24197911$1$I$$20240718$20240812$20240812$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003018$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240812$$HP$US$US
241979121$24197912$1$I$20240805$20240808$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126105$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240812$$HP$US$US
241979131$24197913$1$I$20240728$20240807$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125561$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240812$$HP$US$US
241979142$24197914$2$F$$20240919$20240812$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003767$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
241979151$24197915$1$I$20240701$20240718$20240812$20240812$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003768$ACADIA PHARMACEUTICALS$$93$YR$$M$Y$$$20240812$$CN$US$US
241979161$24197916$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA234836$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240812$$MD$US$US
241979171$24197917$1$I$$20240729$20240812$20240812$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202408000322$ELI LILLY AND CO$$$$$M$Y$$$20240811$$MD$SA$SA
241979181$24197918$1$I$$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003763$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241979191$24197919$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA234441$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240812$$MD$US$US
241979201$24197920$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA234703$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240812$$CN$US$US
241979221$24197922$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235615$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240812$$CN$US$US
241979232$24197923$2$F$$20240814$20240812$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003730$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
241979241$24197924$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236364$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240812$$MD$US$US
241979251$24197925$1$I$$20240809$20240812$20240812$PER$$NVSC2024US162895$NOVARTIS$$$$$$Y$$$20240812$$HP$US$US
241979261$24197926$1$I$20240101$20240805$20240812$20240812$EXP$$US-ABBVIE-5867969$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241979271$24197927$1$I$$20240809$20240812$20240812$EXP$$US-ABBVIE-5875551$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241979281$24197928$1$I$$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003788$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241979291$24197929$1$I$20240411$20240808$20240812$20240812$EXP$$US-ABBVIE-5874173$ABBVIE$$82$YR$$M$Y$$$20240812$$CN$US$US
241979303$24197930$3$F$20240624$20240820$20240812$20240823$EXP$$US-ABBVIE-5874128$ABBVIE$$30$YR$$F$Y$$$20240823$$CN$US$US
241979311$24197931$1$I$20240808$20240808$20240812$20240812$EXP$$US-ABBVIE-5874752$ABBVIE$$64$YR$$F$Y$$$20240812$$CN$US$US
241979321$24197932$1$I$$20240807$20240812$20240812$EXP$$JP-SANDOZ INC.-SDZ2024JP071275$SANDOZ$$65$YR$$F$Y$$$20240812$$MD$JP$JP
241979331$24197933$1$I$$20240802$20240812$20240812$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01532$NOVITIUM PHARMA$Francois Lescarbotte.Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases.Annales de Chirurgie Plastique Esthetique.05-JAN-2024;69:27-33$55$YR$A$F$Y$$$20240812$$HP$FR$FR
241979341$24197934$1$I$$20240806$20240812$20240812$EXP$$CA-JNJFOC-20240823257$JOHNSON AND JOHNSON$$$$$F$Y$72$KG$20240812$$MD$CA$CA
241979351$24197935$1$I$20240401$20240805$20240812$20240812$EXP$$JP-009507513-2408JPN000563J$MERCK$$$$$F$Y$$$20240812$$MD$JP$JP
241979361$24197936$1$I$$20240729$20240812$20240812$EXP$$JP-ROCHE-10000048855$ROCHE$Yamaguchi K, Ueno A, Imai S. EP-1145 A case of cervical lymph node metastasis of HER2 positive breast cancer with tracheal stenosis that responded to trastuzumab deruxtecan. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;464$39$YR$A$F$Y$$$20240812$$MD$JP$JP
241979371$24197937$1$I$20240101$20240802$20240812$20240812$PER$$US-ABBVIE-5865982$ABBVIE$$$$$F$Y$68$KG$20240812$$CN$US$US
241979381$24197938$1$I$20240101$20240807$20240812$20240812$EXP$$CN-ABBVIE-5871373$ABBVIE$$$$$M$Y$$$20240812$$MD$CN$CN
241979391$24197939$1$I$20240801$20240808$20240812$20240812$EXP$$TR-ABBVIE-5874121$ABBVIE$$68$YR$$F$Y$$$20240812$$CN$TR$TR
241979411$24197941$1$I$20240701$20240807$20240812$20240812$EXP$$US-ABBVIE-5872716$ABBVIE$$75$YR$$F$Y$$$20240812$$CN$US$US
241979421$24197942$1$I$20240701$20240802$20240812$20240812$PER$$US-SA-2024SA233162$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240812$$MD$US$US
241979431$24197943$1$I$20240701$20240722$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202407014483$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240812$$CN$US$US
241979441$24197944$1$I$$20240731$20240812$20240812$PER$$US-009507513-2408USA000355$MERCK$$68$YR$$M$Y$$$20240812$$HP$US$US
241979451$24197945$1$I$$20240805$20240812$20240812$PER$$US-JNJFOC-20240816841$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$US$US
241979461$24197946$1$I$20240401$20240808$20240812$20240812$EXP$$US-ABBVIE-5873675$ABBVIE$$45$YR$$M$Y$$$20240812$$CN$US$US
241979471$24197947$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA236014$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240812$$MD$US$US
241979481$24197948$1$I$20240801$20240809$20240812$20240812$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044925$BOEHRINGER INGELHEIM$$88$YR$E$F$Y$$$20240812$$CN$US$US
241979491$24197949$1$I$20240803$20240809$20240812$20240812$EXP$$US-ABBVIE-5875362$ABBVIE$$83$YR$$F$Y$$$20240812$$CN$US$US
241979501$24197950$1$I$20240807$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158352$AMGEN$$$$$F$Y$$$20240811$$PH$US$US
241979511$24197951$1$I$$20240802$20240812$20240812$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01545$NOVITIUM PHARMA$Francois Lescarbotte.Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases.Annales de Chirurgie Plastique Esthetique.05-JAN-2024;69:27-33$76$YR$E$F$Y$$$20240812$$HP$FR$FR
241979521$24197952$1$I$20240723$20240804$20240812$20240812$EXP$$GB-CELLTRION INC.-2024GB018759$CELLTRION$$$$$$Y$$$20240812$$CN$GB$GB
241979531$24197953$1$I$$20240730$20240812$20240812$EXP$$CN-JNJFOC-20240816935$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$HP$CN$CN
241979543$24197954$3$F$$20240909$20240812$20240916$30DAY$$TR-JNJFOC-20240818920$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$TR$TR
241979552$24197955$2$F$$20240731$20240812$20240812$PER$$US-ROCHE-10000047393$ROCHE$$91$YR$E$M$Y$$$20240812$$MD$US$US
241979561$24197956$1$I$20240101$20240808$20240812$20240812$EXP$$US-ABBVIE-5874203$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241979571$24197957$1$I$20240805$20240808$20240812$20240812$EXP$$US-TAKEDA-2024TUS079701$TAKEDA$$56$YR$$F$Y$$$20240812$$CN$US$US
241979581$24197958$1$I$20240101$20240703$20240812$20240812$PER$$US-AMGEN-USASP2024158904$AMGEN$$$$$M$Y$$$20240811$$CN$US$US
241979592$24197959$2$F$$20240916$20240812$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125767$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240919$$CN$US$US
241979601$24197960$1$I$$20240806$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126077$BRISTOL MYERS SQUIBB$$96$YR$E$M$Y$$$20240812$$CN$US$US
241979611$24197961$1$I$$20240802$20240812$20240812$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009950$STRIDES$Garofalo V, Walgamage M, Cuello LN, Wester K, Robinson S, Gemayel CY.. ANAPLASMOSIS: FROM MULTI-SYSTEM MAYHEM TO VENTRICULAR TACHYCARDIA IN A HEARTBEAT.. J-Am-Coll-Cardiol. 2024;83(Suppl.)(13):4506 (plus Poster)$78$YR$$M$Y$$$20240812$$HP$US$US
241979621$24197962$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA233352$SANOFI AVENTIS$$$$A$F$Y$42$KG$20240812$$MD$US$US
241979631$24197963$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA235020$SANOFI AVENTIS$$3$YR$C$M$Y$14.2$KG$20240812$$MD$US$US
241979641$24197964$1$I$20240805$20240807$20240812$20240812$EXP$GB-MHRA-MED-202408051735291820-DNQTK$GB-STRIDES ARCOLAB LIMITED-2024SP009946$STRIDES$$$$$M$Y$$$20240812$$MD$GB$GB
241979651$24197965$1$I$$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408003900$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240812$$HP$US$US
241979661$24197966$1$I$$20240807$20240812$20240812$EXP$$GB-HALEON-2191066$Haleon PLC$$$$$F$Y$$$20240809$$CN$GB$GB
241979671$24197967$1$I$$20240802$20240812$20240812$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP009957$STRIDES$Qin Y, Zhang T, Du Z, Chen S, Li Y, Lv Y, et al.. Prognosis of immune checkpoint inhibitor-related myocarditis: Retrospective experience of a single institution.. Int-Immunopharmacol. 2024;136:1-9$71$YR$$F$Y$$$20240812$$HP$CN$CN
241979681$24197968$1$I$$20240802$20240812$20240812$EXP$$GE-STRIDES ARCOLAB LIMITED-2024SP009958$STRIDES$Kashibadze K, Nakashidze M, Beridze S, Shanava K, Bolkvadze R, Beridze D, et al.. Is Liver Retransplant Possible After Oropharyngeal Squamous Cell Carcinoma Development?.. Exp-Clin-Transplant. 2023;21 (7):626-629$44$YR$$M$Y$$$20240812$$HP$GE$GE
241979692$24197969$2$F$$20240802$20240812$20240813$EXP$$CO-NOVOPROD-1264547$NOVO NORDISK$$62$YR$$M$Y$$$20240813$$MD$CO$CA
241979701$24197970$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA234162$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240812$$MD$US$US
241979711$24197971$1$I$$20240801$20240812$20240812$PER$$US-SA-2024SA233643$SANOFI AVENTIS$$$$A$F$Y$72.57$KG$20240812$$MD$US$US
241979721$24197972$1$I$$20240805$20240812$20240812$EXP$$NVSC2024US160443$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
241979732$24197973$2$F$$20240906$20240812$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126041$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$79.83$KG$20240909$$CN$US$US
241979741$24197974$1$I$$20240808$20240812$20240812$EXP$SK-EMA-20171006-pbishtp-122444624$SK-JNJFOC-20240822526$JOHNSON AND JOHNSON$$46$YR$A$M$Y$80$KG$20240812$$HP$SK$SK
241979751$24197975$1$I$$20240805$20240812$20240812$EXP$$CA-HALEON-2177266$Haleon PLC$$40$YR$$F$Y$$$20240809$$HP$CA$CA
241979761$24197976$1$I$20240101$20240807$20240812$20240812$EXP$$US-ABBVIE-5871821$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241979774$24197977$4$F$20240613$20240902$20240812$20240910$EXP$$GB-BIOGEN-2024BI01277519$BIOGEN$$65$YR$$F$Y$$$20240910$$HP$GB$GB
241979781$24197978$1$I$$20240805$20240812$20240812$EXP$$US-BIOGEN-2024BI01277284$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
241979792$24197979$2$F$20240817$20240819$20240812$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US071561$SANDOZ$$54$YR$$M$Y$$$20240821$$CN$US$US
241979803$24197980$3$F$20240125$20240822$20240812$20240829$EXP$$GB-SA-2024SA035239$SANOFI AVENTIS$$69$YR$E$M$Y$61.9$KG$20240829$$HP$GB$GB
241979811$24197981$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA233917$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240812$$MD$US$US
241979821$24197982$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA235388$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$MD$US$US
241979831$24197983$1$I$20240509$20240805$20240812$20240812$EXP$$CN-HALEON-2190477$Haleon PLC$$49$YR$$F$Y$$$20240812$$HP$CN$CN
241979841$24197984$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235636$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240812$$CN$US$US
241979851$24197985$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA204912$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240812$$MD$US$US
241979861$24197986$1$I$$20240805$20240812$20240812$PER$$QA-SA-2024SA235608$SANOFI AVENTIS$$60$YR$A$$Y$$$20240812$$CN$US$QA
241979871$24197987$1$I$20240710$20240731$20240812$20240812$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160284$JIANGSU HANSOH PHARMACEUTICAL$$72$YR$$M$Y$$$20240812$$MD$CN$CN
241979881$24197988$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA235072$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240812$$MD$US$US
241979891$24197989$1$I$20230317$20240808$20240812$20240812$EXP$$US-TAKEDA-2023TUS004169$TAKEDA$$79$YR$$F$Y$$$20240812$$HP$US$US
241979901$24197990$1$I$20240719$20240801$20240812$20240812$EXP$$CN-SPECGX-T202401671$SPECGX$$50$YR$$M$Y$50$KG$20240812$$CN$CN$CN
241979911$24197991$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126104$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$79.38$KG$20240812$$CN$US$US
241979921$24197992$1$I$$20240808$20240812$20240812$EXP$$US-TAKEDA-2024TUS021169$TAKEDA$$$$$F$Y$$$20240812$$CN$US$US
241979933$24197993$3$F$20240328$20240806$20240812$20240821$EXP$$JP-UCBSA-2024017372$UCB$$6$DEC$$M$Y$110$KG$20240821$$CN$JP$JP
241979941$24197994$1$I$20240701$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158420$AMGEN$$$$$$Y$$$20240811$$PH$US$US
241979951$24197995$1$I$20240717$20240722$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202407014486$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
241979962$24197996$2$F$$20240820$20240812$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408004677$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240827$$CN$US$US
241979971$24197997$1$I$20240803$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004069$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240812$$CN$US$US
241979981$24197998$1$I$$20240801$20240812$20240812$PER$$US-AMGEN-USASP2024154168$AMGEN$$$$$F$Y$$$20240811$$HP$US$US
241979991$24197999$1$I$$20240808$20240812$20240812$EXP$$US-SANDOZ INC.-SDZ2024US071520$SANDOZ$$$$$F$Y$$$20240812$$MD$US$US
241980001$24198000$1$I$20240503$20240801$20240812$20240812$EXP$$FR-TEVA-VS-3229708$TEVA$$82$YR$$M$Y$71$KG$20240812$$MD$FR$FR
241980011$24198001$1$I$$20240807$20240812$20240812$EXP$$US-SANDOZ INC.-SDZ2024US071605$SANDOZ$$$$$F$Y$75$KG$20240812$$CN$US$US
241980021$24198002$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024159245$AMGEN$$$$$F$Y$$$20240811$$MD$US$US
241980031$24198003$1$I$20240101$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024158960$AMGEN$$$$$F$Y$$$20240811$$CN$US$US
241980041$24198004$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA233462$SANOFI AVENTIS$$$$T$F$Y$$$20240812$$MD$US$US
241980051$24198005$1$I$$20240808$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126370$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240812$$CN$US$US
241980061$24198006$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235142$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240812$$CN$US$US
241980071$24198007$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA234160$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240812$$MD$US$US
241980081$24198008$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235489$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240812$$MD$US$US
241980091$24198009$1$I$$20240805$20240812$20240812$PER$$US-AstraZeneca-2024A178262$ASTRAZENECA$$$$$M$Y$$$20240812$$MD$US$
241980102$24198010$2$F$20240909$20240909$20240812$20240912$EXP$$CA-TAKEDA-2023TUS059786$TAKEDA$$35$YR$$M$Y$$$20240912$$CN$CA$CA
241980112$24198011$2$F$20240701$20240823$20240812$20240826$PER$$US-ROCHE-10000050071$ROCHE$$82$YR$E$F$Y$$$20240826$$CN$US$US
241980121$24198012$1$I$20240729$20240807$20240812$20240812$EXP$$US-ABBVIE-5872654$ABBVIE$$75$YR$$F$Y$$$20240812$$CN$US$US
241980133$24198013$3$F$20240807$20240812$20240812$20240820$PER$$US-AMGEN-USASP2024158459$AMGEN$$67$YR$E$F$Y$$$20240820$$PH$US$US
241980141$24198014$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158865$AMGEN$$$$$$Y$$$20240811$$MD$US$US
241980151$24198015$1$I$20240808$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158368$AMGEN$$45$YR$A$F$Y$$$20240811$$CN$US$US
241980163$24198016$3$F$20240730$20240916$20240812$20240919$PER$$US-ROCHE-10000051092$ROCHE$$37$YR$A$M$Y$88.45$KG$20240919$$CN$US$US
241980171$24198017$1$I$20240601$20240805$20240812$20240812$EXP$$NVSC2024DE162035$NOVARTIS$$$$A$F$Y$$$20240812$$CN$DE$DE
241980182$24198018$2$F$20240601$20240830$20240812$20240905$EXP$$NVSC2024US160810$NOVARTIS$$20$YR$$F$Y$100.5$KG$20240905$$MD$US$US
241980193$24198019$3$F$20240720$20240916$20240812$20240921$PER$$US-ROCHE-10000051096$ROCHE$$9$YR$C$M$Y$$$20240921$$CN$US$US
241980204$24198020$4$F$$20240909$20240812$20240914$PER$$US-ROCHE-10000051874$ROCHE$$$$T$$Y$$$20240914$$PH$US$US
241980211$24198021$1$I$$20240808$20240812$20240812$PER$$US-ROCHE-10000052887$ROCHE$$$$A$F$Y$$$20240812$$CN$US$US
241980221$24198022$1$I$$20240808$20240812$20240812$PER$$US-ROCHE-10000053228$ROCHE$$$$$F$Y$$$20240812$$MD$US$US
241980241$24198024$1$I$$20240805$20240812$20240812$EXP$$US-BIOGEN-2024BI01276964$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
241980251$24198025$1$I$$20240731$20240812$20240812$EXP$$FR-AMGEN-FRASP2024159052$AMGEN$$64$YR$A$M$Y$$$20240811$$PH$FR$FR
241980262$24198026$2$F$20240730$20240812$20240812$20240813$PER$$US-AMGEN-USASP2024159321$AMGEN$$56$YR$A$F$Y$$$20240813$$HP$US$US
241980271$24198027$1$I$$20240808$20240812$20240812$PER$$US-ROCHE-10000053050$ROCHE$$$$A$F$Y$$$20240812$$CN$US$US
241980281$24198028$1$I$20240701$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125695$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240812$$HP$US$US
241980292$24198029$2$F$20240730$20240830$20240812$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126038$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$92.99$KG$20240902$$CN$US$US
241980301$24198030$1$I$$20240804$20240812$20240812$EXP$$US-JNJFOC-20240812734$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$HP$US$US
241980312$24198031$2$F$$20240802$20240812$20240813$EXP$$US-ALXN-202404USA002272US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
241980331$24198033$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA234572$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
241980342$24198034$2$F$20240101$20240813$20240812$20240826$PER$$US-SA-2024SA235990$SANOFI AVENTIS$$60$YR$A$F$Y$79$KG$20240826$$MD$US$US
241980361$24198036$1$I$$20240806$20240812$20240812$PER$$US-ROCHE-10000051068$ROCHE$$77$YR$E$F$Y$$$20240812$$CN$US$US
241980372$24198037$2$F$$20240812$20240812$20240813$PER$$US-ROCHE-10000050979$ROCHE$$$$T$M$Y$$$20240813$$CN$US$US
241980391$24198039$1$I$$20240808$20240812$20240812$PER$$US-ROCHE-10000052933$ROCHE$$$$A$M$Y$$$20240812$$CN$US$US
241980401$24198040$1$I$20240806$20240807$20240812$20240812$PER$$US-ROCHE-10000052554$ROCHE$$1$YR$I$$Y$$$20240812$$CN$US$US
241980421$24198042$1$I$$20240806$20240812$20240812$PER$$US-ROCHE-10000050968$ROCHE$$75$YR$E$M$Y$$$20240812$$CN$US$US
241980432$24198043$2$F$20240101$20240812$20240812$20240819$EXP$$BR-AMGEN-BRASP2024157461$AMGEN$$90$YR$E$F$Y$$$20240819$$CN$BR$BR
241980441$24198044$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235988$SANOFI AVENTIS$$$$A$F$Y$49.89$KG$20240812$$MD$US$US
241980451$24198045$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA188646$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240812$$MD$US$US
241980461$24198046$1$I$20240726$20240808$20240812$20240812$PER$$US-ROCHE-10000052998$ROCHE$$35$YR$A$F$Y$$$20240812$$CN$US$US
241980471$24198047$1$I$$20240807$20240812$20240812$PER$$US-ROCHE-10000052024$ROCHE$$$$A$M$Y$$$20240812$$CN$US$US
241980481$24198048$1$I$$20240808$20240812$20240812$PER$$US-ABBVIE-5874000$ABBVIE$$$$$M$Y$$$20240812$$HP$US$US
241980491$24198049$1$I$20240401$20240805$20240812$20240812$EXP$FR-AFSSAPS-BS2024000476$FR-GSK-FR2024097401$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$MD$FR$FR
241980501$24198050$1$I$20240201$20240805$20240812$20240812$EXP$$NVSC2024CN162291$NOVARTIS$$82$YR$$M$Y$69$KG$20240812$$HP$CN$CN
241980511$24198051$1$I$$20240808$20240812$20240812$PER$$US-HALEON-2191098$Haleon PLC$$$$$F$Y$$$20240812$$CN$US$US
241980522$24198052$2$F$$20240912$20240812$20240924$PER$$US-SA-2024SA233622$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240924$$MD$US$US
241980531$24198053$1$I$$20240802$20240812$20240812$EXP$$NVSC2024BR162055$NOVARTIS$$$$$F$Y$$$20240812$$CN$BR$BR
241980541$24198054$1$I$$20240805$20240812$20240812$EXP$$NVSC2024CN162512$NOVARTIS$Chen X, Liu M, Guo T, Du L, Hou J, Hou L. Efficacy evaluation in patients with gastrointestinal stromal tumors treated  with the generic or branded domestic imatinibEfficacy evaluation in patients with gastrointestinal stromal tumors treated with the generic or branded domestic imatinib. CARCINOGENESIS TERATOGENESIS AND MUTAGENESIS. 2024;36 (4):256-60$$$$$Y$$$20240812$$HP$CN$CN
241980551$24198055$1$I$$20240809$20240812$20240812$PER$$NVSC2024US162730$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
241980561$24198056$1$I$$20240802$20240812$20240812$PER$$US-ABBVIE-5874540$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241980572$24198057$2$F$20230101$20240822$20240812$20240826$EXP$FR-AFSSAPS-RN2024000867$FR-ABBVIE-5872279$ABBVIE$$27$YR$$F$Y$78$KG$20240826$$MD$FR$FR
241980581$24198058$1$I$$20240801$20240812$20240812$EXP$$KR-ROCHE-10000051970$ROCHE$Chun S, Kim K, Kim Y, Paek S, Lee K, Song J, et al. Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery. Radiotherapy and Oncology. 2024-Oct;199:1-8. doi:10.1016/j.radonc.2024.110461.$75$YR$E$$Y$$$20240812$$HP$KR$KR
241980591$24198059$1$I$$20240805$20240812$20240812$EXP$$GB-AMGEN-GBRSP2024156064$AMGEN$$$$$M$Y$$$20240811$$HP$GB$GB
241980601$24198060$1$I$20240101$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159227$AMGEN$$71$YR$E$F$Y$$$20240811$$CN$US$US
241980611$24198061$1$I$$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003727$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241980621$24198062$1$I$20231221$20240731$20240812$20240812$EXP$$KR-AMNEAL PHARMACEUTICALS-2024-AMRX-02901$AMNEAL$$78$YR$$F$Y$$$20240812$$HP$KR$KR
241980634$24198063$4$F$$20240903$20240812$20240912$EXP$$PT-AUROBINDO-AUR-APL-2024-037305$AUROBINDO$Velho RM, Maia M, P?scoa F, Paix?o J, Silva F, Teixeira AS et al.,. PO-0097 - (4625) - HIPONATR?MIA GRAVE SECUND?RIA ? CIPROFLOXACIN (PO-0097 - (4625) - SEVERE HYPONATREMIA SECONDARY TO CIPROFLOXACIN). Doen?as end?crinas, metab?licas e nutricionais | Caso cl?nico. 2024;30:469$84$YR$$M$Y$$$20240912$$MD$PT$PT
241980641$24198064$1$I$$20240729$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-038712$AUROBINDO$Ortiz Velez I, Gener Huertas E, Roman Velez N, Ramirez J, Perez Mitchell MC, Torrech C, et al.. The Challenge of multi-organism lung infection with human immunodeficiency virus.. Am-J-Med-Sci. 2023$57$YR$$M$Y$$$20240812$$HP$US$US
241980651$24198065$1$I$$20240724$20240812$20240812$PER$$US-AstraZeneca-2024A169534$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241980661$24198066$1$I$20240728$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179702$ASTRAZENECA$$$$$F$Y$$$20240812$$HP$US$
241980671$24198067$1$I$$20240807$20240812$20240812$PER$$US-ABBVIE-5873153$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241980681$24198068$1$I$20240101$20240729$20240812$20240812$EXP$$GB-UCBSA-2024038424$UCB$$$$$M$Y$$$20240812$$HP$GB$GB
241980691$24198069$1$I$20240808$20240808$20240812$20240812$EXP$$JP-SANDOZ INC.-SDZ2024JP071654$SANDOZ$$$$$F$Y$$$20240812$$CN$JP$JP
241980701$24198070$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004949$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240812$$CN$US$US
241980711$24198071$1$I$$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408003916$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240812$$CN$US$US
241980721$24198072$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004861$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240812$$CN$US$US
241980731$24198073$1$I$20240701$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004938$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240812$$CN$US$US
241980741$24198074$1$I$$20240801$20240812$20240812$EXP$$KR-ROCHE-10000051969$ROCHE$Chun S, Kim K, Kim Y, Paek S, Lee K, Song J, et al. Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery. Radiotherapy and Oncology. 2024-Oct;199:1-8. doi:10.1016/j.radonc.2024.110461.$44$YR$A$$Y$$$20240812$$HP$KR$KR
241980751$24198075$1$I$$20240808$20240812$20240812$PER$$US-GILEAD-2024-0683567$GILEAD$$$$A$$Y$$$20240811$$HP$US$US
241980762$24198076$2$F$$20240823$20240812$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003729$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
241980771$24198077$1$I$$20240806$20240812$20240812$PER$$US-AMGEN-USASP2024158780$AMGEN$$$$A$F$Y$$$20240811$$HP$US$US
241980781$24198078$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA233705$SANOFI AVENTIS$$$$C$F$Y$29.98$KG$20240812$$MD$US$US
241980791$24198079$1$I$20240101$20240806$20240812$20240812$EXP$$US-009507513-2408USA002634$MERCK$$$$$M$Y$$$20240812$$CN$US$US
241980801$24198080$1$I$$20240729$20240812$20240812$EXP$$CA-AUROBINDO-AUR-APL-2024-039346$AUROBINDO$$72$YR$$F$Y$$$20240812$$CN$CA$CA
241980811$24198081$1$I$$20240808$20240812$20240812$PER$$US-JNJFOC-20240824446$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240812$$HP$US$US
241980821$24198082$1$I$$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003736$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241980831$24198083$1$I$20240715$20240718$20240812$20240812$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003731$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240812$$CN$US$US
241980841$24198084$1$I$$20240801$20240812$20240812$EXP$$KR-ROCHE-10000051968$ROCHE$Chun S, Kim K, Kim Y, Paek S, Lee K, Song J, et al. Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery. Radiotherapy and Oncology. 2024-Oct;199:1-8. doi:10.1016/j.radonc.2024.110461.$70$YR$E$$Y$$$20240812$$HP$KR$KR
241980852$24198085$2$F$20240610$20240912$20240812$20240913$EXP$$NVSC2024US162673$NOVARTIS$$75$YR$$M$Y$$$20240913$$HP$US$US
241980862$24198086$2$F$20240101$20240906$20240812$20240913$EXP$$US-TAKEDA-2024TUS079135$TAKEDA$$$$$F$Y$62$KG$20240913$$CN$US$US
241980872$24198087$2$F$$20240827$20240812$20240828$PER$$US-ALXN-202408USA000302US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
241980883$24198088$3$F$$20240912$20240812$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003720$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
241980891$24198089$1$I$$20240807$20240812$20240812$PER$$US-ABBVIE-5872172$ABBVIE$$$$$M$Y$$$20240812$$HP$US$US
241980903$24198090$3$F$20240718$20240909$20240812$20240917$PER$$US-ABBVIE-5874784$ABBVIE$$27$YR$$$Y$$$20240917$$MD$US$US
241980911$24198091$1$I$20240623$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003741$ACADIA PHARMACEUTICALS$$91$YR$$F$Y$$$20240812$$CN$US$US
241980921$24198092$1$I$20240101$20240805$20240812$20240812$EXP$$US-ABBVIE-4701495$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241980932$24198093$2$F$$20240809$20240812$20240813$PER$$US-TAKEDA-2024TUS079750$TAKEDA$$$$$F$Y$$$20240813$$CN$US$US
241980941$24198094$1$I$$20240807$20240812$20240812$EXP$$US-ABBVIE-5871955$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241980951$24198095$1$I$20240101$20240729$20240812$20240812$EXP$$US-UniquePharma-US-2024UPLSPO00025$UNIQUE PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241980961$24198096$1$I$$20240801$20240812$20240812$EXP$$KR-ROCHE-10000051967$ROCHE$Chun S, Kim K, Kim Y, Paek S, Lee K, Song J, et al. Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery. Radiotherapy and Oncology. 2024-Oct;199:1-8. doi:10.1016/j.radonc.2024.110461.$50$YR$A$$Y$$$20240812$$HP$KR$KR
241980971$24198097$1$I$20240101$20240807$20240812$20240812$EXP$$US-ABBVIE-5871823$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241980981$24198098$1$I$$20240731$20240812$20240812$PER$$US-ROCHE-10000046270$ROCHE$$$$A$F$Y$$$20240812$$HP$US$US
241980991$24198099$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126343$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240812$$PH$US$US
241981001$24198100$1$I$$20240807$20240812$20240812$PER$$US-ABBVIE-5873161$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241981013$24198101$3$F$$20240912$20240812$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003744$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241981021$24198102$1$I$$20240807$20240812$20240812$EXP$$CL-SANDOZ INC.-SDZ2024CL071484$SANDOZ$$$$$F$Y$$$20240812$$CN$CL$CL
241981032$24198103$2$F$20231201$20240830$20240812$20240904$EXP$$US-ABBVIE-5873037$ABBVIE$$58$YR$$F$Y$81$KG$20240904$$CN$US$US
241981041$24198104$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5874035$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241981052$24198105$2$F$20220101$20240807$20240812$20240820$EXP$$US-UCBSA-2024038407$UCB$$57$YR$$F$Y$$$20240820$$HP$US$US
241981062$24198106$2$F$20240723$20240806$20240812$20240814$PER$$US-AMGEN-USASP2024156572$AMGEN$$67$YR$E$F$Y$$$20240814$$CN$US$US
241981071$24198107$1$I$$20240801$20240812$20240812$EXP$$KR-ROCHE-10000051966$ROCHE$Chun S, Kim K, Kim Y, Paek S, Lee K, Song J, et al. Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery. Radiotherapy and Oncology. 2024-Oct;199:1-8. doi:10.1016/j.radonc.2024.110461.$37$YR$A$$Y$$$20240812$$HP$KR$KR
241981081$24198108$1$I$20240101$20240808$20240812$20240812$EXP$$US-ABBVIE-5874038$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241981091$24198109$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5874101$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241981102$24198110$2$F$20230801$20240821$20240812$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003745$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240913$$CN$US$US
241981111$24198111$1$I$$20240731$20240812$20240812$EXP$$PT-MSNLABS-2024MSNLIT01737$MSN LABORATORIES$Cabreira V.Anti-Hu Encephalitis in an Adolescent With a Mediastinal Seminoma.Child Neurology.2023$$$$$Y$$$20240812$$MD$PT$PT
241981121$24198112$1$I$$20240805$20240812$20240812$EXP$$US-SA-2024SA233865$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$HP$US$US
241981131$24198113$1$I$$20240801$20240812$20240812$EXP$$KR-ROCHE-10000051965$ROCHE$Chun S, Kim K, Kim Y, Paek S, Lee K, Song J, et al. Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery. Radiotherapy and Oncology. 2024-Oct;199:1-8. doi:10.1016/j.radonc.2024.110461.$41$YR$A$$Y$$$20240812$$HP$KR$KR
241981141$24198114$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA233966$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240812$$MD$US$US
241981151$24198115$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA234095$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240812$$MD$US$US
241981161$24198116$1$I$20240726$20240801$20240812$20240812$PER$$US-SA-2024SA231706$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240812$$CN$US$US
241981171$24198117$1$I$20240728$20240802$20240812$20240812$EXP$$GB-CELLTRION INC.-2024GB018801$CELLTRION$$$$$$Y$$$20240812$$CN$GB$GB
241981181$24198118$1$I$20240404$20240807$20240812$20240812$EXP$FR-AFSSAPS-AN2024001003$FR-SA-2024SA234751$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240812$$PH$FR$FR
241981191$24198119$1$I$$20240806$20240812$20240812$PER$$US-ABBVIE-5872820$ABBVIE$$$$$F$Y$$$20240812$$HP$US$US
241981203$24198120$3$F$$20240806$20240812$20240922$EXP$$BE-UCBSA-2024038386$UCB$$$$$F$Y$$$20240923$$MD$BE$BE
241981211$24198121$1$I$$20240731$20240812$20240812$PER$$US-MSNLABS-2024MSNSPO01712$MSN LABORATORIES$$$$$$Y$$$20240812$$CN$US$US
241981221$24198122$1$I$20240802$20240805$20240812$20240812$PER$$US-BIOGEN-2024BI01276925$BIOGEN$$42$YR$$F$Y$$$20240812$$CN$US$US
241981232$24198123$2$F$$20240829$20240812$20240829$PER$$US-ALXN-202408USA000396US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
241981241$24198124$1$I$20240724$20240802$20240812$20240812$EXP$$BR-EMD Serono-2024042398$EMD SERONO INC$$0$DY$N$F$Y$2$KG$20240812$$PH$BR$BR
241981261$24198126$1$I$$20240801$20240812$20240812$EXP$$KR-ROCHE-10000051964$ROCHE$Chun S, Kim K, Kim Y, Paek S, Lee K, Song J, et al. Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery. Radiotherapy and Oncology. 2024-Oct;199:1-8. doi:10.1016/j.radonc.2024.110461.$57$YR$A$$Y$$$20240812$$HP$KR$KR
241981271$24198127$1$I$$20240802$20240812$20240812$30DAY$$US-GSK-US2024097044$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
241981282$24198128$2$F$$20240909$20240812$20240916$30DAY$$FR-JNJFOC-20240819866$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$PH$FR$FR
241981291$24198129$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004927$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240812$$CN$US$US
241981301$24198130$1$I$$20240724$20240812$20240812$PER$$US-UniquePharma-US-2024UPLSPO00022$UNIQUE PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241981311$24198131$1$I$20210101$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005936$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240812$$HP$US$US
241981321$24198132$1$I$$20240801$20240812$20240812$EXP$$KR-ROCHE-10000051963$ROCHE$Chun S, Kim K, Kim Y, Paek S, Lee K, Song J, et al. Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery. Radiotherapy and Oncology. 2024-Oct;199:1-8. doi:10.1016/j.radonc.2024.110461.$57$YR$A$$Y$$$20240812$$HP$KR$KR
241981334$24198133$4$F$20240601$20240822$20240812$20240902$PER$$US-AMGEN-USASP2024158991$AMGEN$$76$YR$E$F$Y$$$20240902$$CN$US$US
241981341$24198134$1$I$20231001$20240802$20240812$20240812$EXP$$BR-EMD Serono-2024007198$EMD SERONO INC$$30$YR$A$F$Y$$$20240812$$PH$BR$BR
241981352$24198135$2$F$20240601$20240823$20240812$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003712$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240916$$CN$US$US
241981362$24198136$2$F$20240622$20240814$20240812$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003677$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240906$$CN$US$US
241981371$24198137$1$I$$20240801$20240812$20240812$EXP$$KR-ROCHE-10000051961$ROCHE$Chun S, Kim K, Kim Y, Paek S, Lee K, Song J, et al. Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery. Radiotherapy and Oncology. 2024-Oct;199:1-8. doi:10.1016/j.radonc.2024.110461.$$$$$Y$$$20240812$$HP$KR$KR
241981392$24198139$2$F$20240807$20240812$20240812$20240813$PER$$US-AMGEN-USASP2024159153$AMGEN$$59$YR$A$F$Y$$$20240812$$CN$US$US
241981402$24198140$2$F$$20240829$20240812$20240905$PER$$US-SA-2024SA234096$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240905$$MD$US$US
241981411$24198141$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236027$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240812$$MD$US$US
241981421$24198142$1$I$20240601$20240802$20240812$20240812$PER$$US-SA-2024SA233380$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240812$$MD$US$US
241981431$24198143$1$I$$20211013$20240812$20240812$EXP$$US-AstraZeneca-2021A775347$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241981441$24198144$1$I$20211114$20211129$20240812$20240812$EXP$$US-AstraZeneca-2021A850389$ASTRAZENECA$$27684$DY$$F$Y$$$20240812$$CN$US$
241981453$24198145$3$F$$20240831$20240812$20240925$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003713$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
241981461$24198146$1$I$$20240801$20240812$20240812$EXP$$KR-ROCHE-10000048352$ROCHE$Chun S, Kim K, Kim Y, Paek S, Lee K, Song J, et al. Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery. Radiotherapy and Oncology. 2024-Oct;199:1-8. doi:10.1016/j.radonc.2024.110461.$57$YR$A$$Y$$$20240812$$HP$KR$KR
241981471$24198147$1$I$$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003714$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241981481$24198148$1$I$20240714$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003706$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240812$$CN$US$US
241981491$24198149$1$I$$20240803$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124081$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$87.54$KG$20240812$$CN$US$US
241981501$24198150$1$I$20240501$20240806$20240812$20240812$30DAY$$US-GSK-US2024097982$GLAXOSMITHKLINE$$72$YR$$M$Y$$$20240812$$CN$US$US
241981511$24198151$1$I$20240725$20240802$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124351$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$98.88$KG$20240812$$CN$US$US
241981522$24198152$2$F$$20240815$20240812$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003715$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
241981531$24198153$1$I$20240601$20240725$20240812$20240812$PER$$US-UniquePharma-US-2024UPLSPO00023$UNIQUE PHARMACEUTICALS$$75$YR$E$F$Y$175$KG$20240812$$CN$US$US
241981541$24198154$1$I$20230628$20240806$20240812$20240812$EXP$$US-AMGEN-USASP2024156503$AMGEN$$85$YR$E$M$Y$$$20240811$$CN$US$US
241981552$24198155$2$F$$20240815$20240812$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003719$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
241981562$24198156$2$F$$20240909$20240812$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003721$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241981571$24198157$1$I$20211001$20220128$20240812$20240812$EXP$$US-AstraZeneca-2021A864065$ASTRAZENECA$$18050$DY$$F$Y$$$20240812$$CN$US$
241981581$24198158$1$I$20240722$20240808$20240812$20240812$PER$$US-ABBVIE-5874284$ABBVIE$$24$YR$$F$Y$$$20240812$$MD$US$US
241981591$24198159$1$I$$20210707$20240812$20240812$EXP$$BR-AstraZeneca-2021A606743$ASTRAZENECA$$$$$F$Y$60$KG$20240812$$HP$BR$
241981601$24198160$1$I$$20220120$20240812$20240812$EXP$$CA-AstraZeneca-2021A340213$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$CA$
241981612$24198161$2$F$$20240906$20240812$20240912$30DAY$$CA-JNJFOC-20240821664$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$PH$CA$CA
241981622$24198162$2$F$$20240729$20240812$20240821$PER$$US-AMGEN-USASP2024157600$AMGEN$$$$$M$Y$$$20240821$$MD$US$US
241981631$24198163$1$I$20240804$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159003$AMGEN$$65$YR$E$F$Y$$$20240811$$CN$US$US
241981643$24198164$3$F$$20240913$20240812$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003722$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
241981651$24198165$1$I$20240723$20240802$20240812$20240812$EXP$$US-EMD Serono-2024042092$EMD SERONO INC$$48$YR$A$F$Y$$$20240812$$MD$US$US
241981662$24198166$2$F$$20240823$20240812$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003723$ACADIA PHARMACEUTICALS$$$$$F$Y$12.1$KG$20240916$$CN$US$US
241981681$24198168$1$I$$20240731$20240812$20240812$EXP$GB-MHRA-MIDB-a4467771-ce51-4dcf-a6ae-aef332cfa0d3$GB-ADVANZ PHARMA-202407006480$ADVANZ PHARMA$$$$$$Y$$$20240812$$HP$GB$GB
241981691$24198169$1$I$$20240806$20240812$20240812$PER$$US-ROCHE-10000050665$ROCHE$$53$YR$A$F$Y$$$20240812$$HP$US$US
241981721$24198172$1$I$20240401$20240805$20240812$20240812$EXP$$US-SA-2024SA233550$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240812$$MD$US$US
241981731$24198173$1$I$20240701$20240731$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408001320$ELI LILLY AND CO$$$$$M$Y$$$20240812$$CN$US$US
241981741$24198174$1$I$$20240805$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005380$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
241981751$24198175$1$I$20240807$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005716$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240812$$CN$US$US
241981761$24198176$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005953$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240812$$CN$US$US
241981771$24198177$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005717$ELI LILLY AND CO$$$$$F$Y$$$20240812$$HP$US$US
241981784$24198178$4$F$$20240910$20240812$20240916$PER$$US-BIOGEN-2024BI01277257$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
241981791$24198179$1$I$$20240806$20240812$20240812$PER$$US-BIOGEN-2024BI01244410$BIOGEN$$$$$M$Y$$$20240812$$CN$US$US
241981801$24198180$1$I$$20240806$20240812$20240812$PER$$US-BIOGEN-2024BI01277245$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
241981811$24198181$1$I$$20240806$20240812$20240812$PER$$US-BIOGEN-2024BI01277256$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
241981821$24198182$1$I$$20240806$20240812$20240812$PER$$US-BIOGEN-2024BI01265698$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
241981831$24198183$1$I$20240729$20240805$20240812$20240812$PER$$US-BIOGEN-2024BI01277144$BIOGEN$$55$YR$$M$Y$$$20240812$$CN$US$US
241981841$24198184$1$I$$20240730$20240812$20240812$EXP$$CN-NOVOPROD-1262759$NOVO NORDISK$$85$YR$$M$Y$$$20240812$$CN$CN$CN
241981851$24198185$1$I$20240726$20240730$20240812$20240812$EXP$$TR-NOVOPROD-1264535$NOVO NORDISK$$$$$M$Y$$$20240812$$CN$TR$TR
241981861$24198186$1$I$20240712$20240730$20240812$20240812$EXP$$US-NOVOPROD-1263727$NOVO NORDISK$$42$YR$$F$Y$$$20240812$$CN$US$US
241981871$24198187$1$I$20240122$20240730$20240812$20240812$EXP$GB-MHRA-MED-202407301520026330-ZYRWJ$GB-NOVOPROD-1262300$NOVO NORDISK$$25$YR$$F$Y$$$20240812$$CN$GB$GB
241981881$24198188$1$I$20240601$20240730$20240812$20240812$EXP$$PE-UCBSA-2024040126$UCB$$73$YR$$F$Y$$$20240812$$CN$PE$PE
241981891$24198189$1$I$$20240808$20240812$20240812$PER$$US-HALEON-2191109$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
241981902$24198190$2$F$20240808$20240815$20240812$20240820$PER$$US-AMGEN-USASP2024159343$AMGEN$$77$YR$E$M$Y$$$20240820$$CN$US$US
241981912$24198191$2$F$$20240813$20240812$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06984$LUPIN$$$$$$Y$$$20240901$$CN$US$US
241981931$24198193$1$I$20220107$20220110$20240812$20240812$EXP$$CA-AstraZeneca-2022A019451$ASTRAZENECA$$29407$DY$$M$Y$$$20240812$$CN$CA$
241981941$24198194$1$I$$20210701$20240812$20240812$EXP$$US-AstraZeneca-2021A596307$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
241981951$24198195$1$I$$20211007$20240812$20240812$EXP$$US-AstraZeneca-2021A765526$ASTRAZENECA$$$$$$Y$$$20240812$$CN$US$
241981961$24198196$1$I$20230101$20240730$20240812$20240812$EXP$$US-NOVOPROD-1265064$NOVO NORDISK$$53$YR$$F$Y$$$20240812$$CN$US$US
241981971$24198197$1$I$$20240730$20240812$20240812$EXP$$US-NOVOPROD-1264859$NOVO NORDISK$$$$A$F$Y$$$20240812$$CN$US$US
241981981$24198198$1$I$20170101$20240730$20240812$20240812$EXP$$US-NOVOPROD-1264966$NOVO NORDISK$$$$$F$Y$$$20240812$$CN$US$US
241981991$24198199$1$I$20210531$20240730$20240812$20240812$EXP$$US-NOVOPROD-1265750$NOVO NORDISK$$70$YR$$M$Y$$$20240812$$CN$US$US
241982001$24198200$1$I$20231201$20240730$20240812$20240812$EXP$FI-FIMEA-202402722$FI-NOVOPROD-1264647$NOVO NORDISK$$68$YR$$F$Y$$$20240812$$CN$FI$FI
241982011$24198201$1$I$20240723$20240731$20240812$20240812$EXP$CN-NMPA-2306011003936202400193$CN-NOVOPROD-1263687$NOVO NORDISK$$60$YR$$F$Y$64$KG$20240812$$HP$CN$CN
241982021$24198202$1$I$$20240731$20240812$20240812$EXP$$DE-NOVOPROD-1264497$NOVO NORDISK$$55$YR$$F$Y$$$20240812$$CN$DE$DE
241982031$24198203$1$I$20240725$20240731$20240812$20240812$EXP$$JP-NOVOPROD-1264516$NOVO NORDISK$$7$DEC$$M$Y$$$20240812$$MD$JP$JP
241982041$24198204$1$I$20210101$20240730$20240812$20240812$EXP$$US-NOVOPROD-1265999$NOVO NORDISK$$$$$F$Y$$$20240812$$CN$US$US
241982051$24198205$1$I$20200201$20240730$20240812$20240812$EXP$$US-NOVOPROD-1265061$NOVO NORDISK$$78$YR$$F$Y$$$20240812$$CN$US$US
241982061$24198206$1$I$$20240730$20240812$20240812$EXP$$US-NOVOPROD-1264833$NOVO NORDISK$$$$A$F$Y$$$20240812$$CN$US$US
241982071$24198207$1$I$$20240730$20240812$20240812$EXP$$US-NOVOPROD-1265665$NOVO NORDISK$$$$E$F$Y$$$20240812$$CN$US$US
241982081$24198208$1$I$20240731$20240731$20240812$20240812$PER$$US-SA-2024SA227179$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240812$$MD$US$US
241982091$24198209$1$I$20240701$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003725$ACADIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240812$$CN$US$US
241982101$24198210$1$I$20240211$20240805$20240812$20240812$EXP$FR-AFSSAPS-NT2024000979$FR-EXELIXIS-CABO-24080299$EXELIXIS$$87$YR$$F$Y$57$KG$20240811$$MD$FR$FR
241982113$24198211$3$F$20240124$20240909$20240812$20240912$EXP$$JP-EXELIXIS-CABO-24080413$EXELIXIS$$59$YR$$F$Y$53$KG$20240912$$MD$JP$JP
241982121$24198212$1$I$$20240801$20240812$20240812$PER$$US-JNJFOC-20240804618$JOHNSON AND JOHNSON$$1$YR$I$F$Y$$$20240812$$CN$US$US
241982131$24198213$1$I$20240801$20240806$20240812$20240812$EXP$$JP-EXELIXIS-CABO-24080341$EXELIXIS$$6$DEC$$M$Y$$$20240811$$MD$JP$JP
241982143$24198214$3$F$$20240906$20240812$20240911$EXP$$JP-EXELIXIS-CABO-24080395$EXELIXIS$$8$DEC$$M$Y$$$20240911$$MD$JP$JP
241982152$24198215$2$F$$20240829$20240812$20240902$EXP$$JP-EXELIXIS-CABO-24080398$EXELIXIS$$9$DEC$$M$Y$$$20240902$$MD$JP$JP
241982163$24198216$3$F$20240606$20240909$20240812$20240912$EXP$$US-JNJFOC-20240816485$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240913$$HP$US$US
241982171$24198217$1$I$$20240808$20240812$20240812$PER$$US-GILEAD-2024-0683569$GILEAD$$$$A$$Y$$$20240811$$HP$US$US
241982181$24198218$1$I$$20240806$20240812$20240812$PER$$US-AMGEN-USASP2024157436$AMGEN$$$$$$Y$$$20240811$$CN$US$US
241982192$24198219$2$F$$20240814$20240812$20240822$EXP$$US-EMD Serono-2024042332$EMD SERONO INC$$55$YR$A$F$Y$$$20240822$$MD$US$US
241982201$24198220$1$I$20240808$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158371$AMGEN$$64$YR$A$F$Y$$$20240811$$CN$US$US
241982212$24198221$2$F$20240101$20240829$20240812$20240912$PER$$US-SA-2024SA233901$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240912$$MD$US$US
241982221$24198222$1$I$20240701$20240806$20240812$20240812$PER$$US-SA-2024SA235453$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240812$$MD$US$US
241982242$24198224$2$F$$20240807$20240812$20240816$PER$$US-SA-2024SA237048$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240816$$CN$US$US
241982251$24198225$1$I$20240801$20240806$20240812$20240812$PER$$US-SA-2024SA236657$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240812$$MD$US$US
241982271$24198227$1$I$$20240724$20240812$20240812$PER$$US-RDY-CLI/USA/24/0011012$DR REDDYS$$8$YR$C$M$Y$$$20240812$$HP$US$US
241982281$24198228$1$I$$20240731$20240812$20240812$EXP$$US-RDY-SPO/USA/24/0011515$DR REDDYS$$$$I$M$Y$$$20240812$$HP$US$US
241982291$24198229$1$I$$20240731$20240812$20240812$EXP$$US-NOVOPROD-1264845$NOVO NORDISK$$$$A$M$Y$$$20240812$$MD$US$US
241982301$24198230$1$I$20231117$20240731$20240812$20240812$EXP$$US-NOVOPROD-1264731$NOVO NORDISK$$74$YR$$F$Y$$$20240812$$CN$US$US
241982311$24198231$1$I$20240719$20240731$20240812$20240812$EXP$DE-CADRBFARM-2024329519$DE-MSNLABS-2024MSNSPO01731$MSN LABORATORIES$$$$$$Y$$$20240812$$MD$DE$DE
241982321$24198232$1$I$$20240731$20240812$20240812$EXP$$CO-NOVOPROD-1264528$NOVO NORDISK$$64$YR$$M$Y$100$KG$20240812$$CN$CO$CO
241982341$24198234$1$I$20240418$20240808$20240812$20240812$EXP$FR-AFSSAPS-SE2024000641$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-126265$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$57$KG$20240812$$MD$FR$FR
241982352$24198235$2$F$20240724$20240807$20240812$20240813$PER$$US-AMGEN-USASP2024157295$AMGEN$$73$YR$E$M$Y$$$20240813$$CN$US$US
241982362$24198236$2$F$20240805$20240905$20240812$20240905$EXP$$US-ALXN-202408USA000398US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$HP$US$US
241982381$24198238$1$I$20240513$20240809$20240812$20240812$EXP$FR-AFSSAPS-BR2024000642$FR-SANDOZ INC.-SDZ2024FR071692$SANDOZ$$85$YR$$F$Y$72$KG$20240812$$MD$FR$FR
241982391$24198239$1$I$$20240809$20240812$20240812$EXP$$DE-SANDOZ INC.-PHHY2017DE184444$SANDOZ$$66$YR$$F$Y$$$20240812$$MD$DE$DE
241982401$24198240$1$I$20240101$20240805$20240812$20240812$EXP$$CA-CELLTRION INC.-2024CA018911$CELLTRION$$$$$$Y$$$20240812$$HP$CA$CA
241982412$24198241$2$F$$20240603$20240812$20240902$PER$$US-ASTELLAS-2024US014225$ASTELLAS$$68$YR$E$F$Y$$$20240830$$MD$US$US
241982422$24198242$2$F$$20240524$20240812$20240902$PER$$US-ASTELLAS-2024US014149$ASTELLAS$$$$A$F$Y$$$20240830$$MD$US$US
241982432$24198243$2$F$$20240513$20240812$20240902$PER$$US-ASTELLAS-2024US014055$ASTELLAS$$54$YR$A$F$Y$$$20240830$$HP$US$US
241982442$24198244$2$F$$20240514$20240812$20240902$PER$$US-ASTELLAS-2024US014018$ASTELLAS$$6$DEC$A$F$Y$$$20240830$$HP$US$US
241982452$24198245$2$F$$20240519$20240812$20240902$PER$$US-ASTELLAS-2024US014424$ASTELLAS$$59$YR$A$F$Y$$$20240830$$HP$US$US
241982461$24198246$1$I$20240101$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159365$AMGEN$$72$YR$E$M$Y$$$20240811$$CN$US$US
241982472$24198247$2$F$$20240812$20240812$20240812$PER$$US-AMGEN-USASP2024159238$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
241982482$24198248$2$F$$20240528$20240812$20240902$PER$$US-ASTELLAS-2024US015257$ASTELLAS$$76$YR$E$F$Y$$$20240830$$CN$US$US
241982492$24198249$2$F$$20240529$20240812$20240902$PER$$US-ASTELLAS-2024US015682$ASTELLAS$$58$YR$A$F$Y$$$20240830$$CN$US$US
241982502$24198250$2$F$$20240613$20240812$20240902$PER$$US-ASTELLAS-2024US015768$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241982512$24198251$2$F$$20240522$20240812$20240902$PER$$US-ASTELLAS-2024US014887$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241982522$24198252$2$F$$20240611$20240812$20240902$PER$$US-ASTELLAS-2024US015577$ASTELLAS$$61$YR$A$F$Y$$$20240830$$CN$US$US
241982532$24198253$2$F$$20240604$20240812$20240902$PER$$US-ASTELLAS-2024US015798$ASTELLAS$$81$YR$E$F$Y$$$20240830$$HP$US$US
241982542$24198254$2$F$$20240529$20240812$20240902$PER$$US-ASTELLAS-2024US015602$ASTELLAS$$49$YR$A$F$Y$$$20240830$$MD$US$US
241982552$24198255$2$F$$20240529$20240812$20240902$PER$$US-ASTELLAS-2024US015732$ASTELLAS$$$$$$Y$$$20240830$$MD$US$US
241982562$24198256$2$F$$20240809$20240812$20240902$PER$$US-ASTELLAS-2024US015684$ASTELLAS$$68$YR$E$F$Y$$$20240830$$CN$US$US
241982572$24198257$2$F$20240501$20240520$20240812$20240902$PER$$US-ASTELLAS-2024US014683$ASTELLAS$$64$YR$A$F$Y$$$20240830$$CN$US$US
241982582$24198258$2$F$$20240522$20240812$20240902$PER$$US-ASTELLAS-2024US014849$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241982592$24198259$2$F$$20240530$20240812$20240902$PER$$US-ASTELLAS-2024US014871$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241982601$24198260$1$I$20240702$20240801$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-039412$AUROBINDO$$15$YR$$F$Y$59$KG$20240812$$PH$FR$FR
241982611$24198261$1$I$$20240706$20240812$20240812$PER$$US-AUROBINDO-AUR-APL-2024-026639$AUROBINDO$$$$$M$Y$$$20240812$$CN$US$US
241982621$24198262$1$I$20240421$20240723$20240812$20240812$PER$$US-AUROBINDO-AUR-APL-2024-021099$AUROBINDO$$56$YR$$M$Y$82.55$KG$20240812$$CN$US$US
241982631$24198263$1$I$$20240805$20240812$20240812$EXP$GB-MHRA-MED-202408051005127000-JCLST$GB-RDY-SPO/GBR/24/0011530$DR REDDYS$$34$YR$A$M$Y$$$20240812$$CN$GB$GB
241982641$24198264$1$I$$20240807$20240812$20240812$EXP$$GB-SANDOZ INC.-NVSC2020GB025062$SANDOZ$$$$$F$Y$$$20240812$$CN$GB$GB
241982652$24198265$2$F$$20240531$20240812$20240902$PER$$US-ASTELLAS-2024US015971$ASTELLAS$$57$YR$A$F$Y$$$20240830$$HP$US$US
241982662$24198266$2$F$$20240604$20240812$20240902$PER$$US-ASTELLAS-2024US016320$ASTELLAS$$51$YR$A$F$Y$$$20240830$$CN$US$US
241982672$24198267$2$F$20240501$20240529$20240812$20240902$PER$$US-ASTELLAS-2024US015883$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241982682$24198268$2$F$$20240612$20240812$20240902$PER$$US-ASTELLAS-2024US015804$ASTELLAS$$$$A$F$Y$$$20240830$$CN$US$US
241982692$24198269$2$F$$20240602$20240812$20240902$PER$$US-ASTELLAS-2024US015959$ASTELLAS$$6$DEC$A$F$Y$$$20240830$$CN$US$US
241982702$24198270$2$F$$20240610$20240812$20240902$PER$$US-ASTELLAS-2024US016827$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241982712$24198271$2$F$20240604$20240708$20240812$20240902$PER$$US-ASTELLAS-2024US016715$ASTELLAS$$50$YR$A$F$Y$$$20240830$$CN$US$US
241982722$24198272$2$F$$20240606$20240812$20240902$PER$$US-ASTELLAS-2024US016719$ASTELLAS$$78$YR$E$F$Y$$$20240830$$CN$US$US
241982732$24198273$2$F$$20240611$20240812$20240902$PER$$US-ASTELLAS-2024US016925$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241982742$24198274$2$F$20240501$20240703$20240812$20240902$PER$$US-ASTELLAS-2024US016858$ASTELLAS$$$$A$F$Y$$$20240830$$CN$US$US
241982751$24198275$1$I$$20240708$20240812$20240812$PER$$US-AUROBINDO-AUR-APL-2024-032024$AUROBINDO$$$$$$Y$$$20240812$$HP$US$US
241982762$24198276$2$F$20240501$20240605$20240812$20240902$PER$$US-ASTELLAS-2024US015966$ASTELLAS$$42$YR$A$F$Y$$$20240830$$MD$US$US
241982772$24198277$2$F$$20240603$20240812$20240902$PER$$US-ASTELLAS-2024US016109$ASTELLAS$$63$YR$A$F$Y$$$20240830$$MD$US$US
241982781$24198278$1$I$20240209$20240801$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-039429$AUROBINDO$$69$YR$$M$Y$106$KG$20240812$$PH$FR$FR
241982791$24198279$1$I$20240802$20240807$20240812$20240812$EXP$SE-SEMPA-2024-005969$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-125845$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$92$KG$20240812$$HP$SE$SE
241982801$24198280$1$I$20240101$20240802$20240812$20240812$PER$$US-ABBVIE-5867008$ABBVIE$$$$$$Y$$$20240812$$HP$US$US
241982812$24198281$2$F$$20240611$20240812$20240902$PER$$US-ASTELLAS-2024US016731$ASTELLAS$$52$YR$A$F$Y$$$20240830$$HP$US$US
241982822$24198282$2$F$$20240711$20240812$20240902$PER$$US-ASTELLAS-2024US017106$ASTELLAS$$$$A$F$Y$$$20240830$$HP$US$US
241982835$24198283$5$F$20240507$20240909$20240812$20240919$PER$$US-ASTELLAS-2024US017913$ASTELLAS$$80$YR$E$F$Y$$$20240919$$CN$US$US
241982842$24198284$2$F$$20240708$20240812$20240902$PER$$US-ASTELLAS-2024US017334$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241982852$24198285$2$F$$20240620$20240812$20240902$PER$$US-ASTELLAS-2024US017900$ASTELLAS$$54$YR$A$F$Y$$$20240830$$MD$US$US
241982862$24198286$2$F$$20240619$20240812$20240902$PER$$US-ASTELLAS-2024US017799$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241982872$24198287$2$F$20240501$20240619$20240812$20240902$PER$$US-ASTELLAS-2024US016785$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241982882$24198288$2$F$$20240626$20240812$20240902$PER$$US-ASTELLAS-2024US017698$ASTELLAS$$58$YR$A$F$Y$$$20240830$$CN$US$US
241982892$24198289$2$F$20240616$20240716$20240812$20240902$PER$$US-ASTELLAS-2024US017526$ASTELLAS$$49$YR$A$F$Y$$$20240830$$CN$US$US
241982902$24198290$2$F$$20240619$20240812$20240902$PER$$US-ASTELLAS-2024US017060$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241982912$24198291$2$F$$20240624$20240812$20240902$PER$$US-ASTELLAS-2024US018015$ASTELLAS$$57$YR$A$F$Y$$$20240830$$CN$US$US
241982922$24198292$2$F$20240610$20240613$20240812$20240902$PER$$US-ASTELLAS-2024US017432$ASTELLAS$$$$A$F$Y$$$20240830$$CN$US$US
241982932$24198293$2$F$$20240620$20240812$20240902$PER$$US-ASTELLAS-2024US017571$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241982942$24198294$2$F$20240601$20240718$20240812$20240902$PER$$US-ASTELLAS-2024US017620$ASTELLAS$$62$YR$A$F$Y$$$20240830$$CN$US$US
241982951$24198295$1$I$$20240801$20240812$20240812$PER$$US-SA-2023SA378125$SANOFI AVENTIS$$$$T$M$Y$$$20240812$$MD$US$US
241982961$24198296$1$I$$20240803$20240812$20240812$EXP$$CA-ROCHE-10000048223$ROCHE$$53$YR$A$F$Y$$$20240812$$HP$CA$CA
241982973$24198297$3$F$20240808$20240812$20240812$20240820$PER$$US-AMGEN-USASP2024158676$AMGEN$$70$YR$E$F$Y$$$20240820$$CN$US$US
241982981$24198298$1$I$$20240808$20240812$20240812$EXP$$US-TAKEDA-2024TUS079464$TAKEDA$$$$$F$Y$75$KG$20240812$$MD$US$US
241982992$24198299$2$F$20240726$20240821$20240812$20240902$PER$$US-AstraZeneca-2024A174669$ASTRAZENECA$$26470$DY$$M$Y$$$20240902$$CN$US$
241983001$24198300$1$I$$20220913$20240812$20240812$EXP$$CA-AstraZeneca-2021A565497$ASTRAZENECA$$$$$M$Y$$$20240812$$HP$CA$
241983011$24198301$1$I$20240808$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158378$AMGEN$$77$YR$E$F$Y$$$20240811$$CN$US$US
241983021$24198302$1$I$20240101$20240808$20240812$20240812$EXP$$AU-AMGEN-AUSSP2024157776$AMGEN$$42$YR$A$M$Y$$$20240811$$MD$AU$AU
241983031$24198303$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005640$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240812$$CN$US$US
241983041$24198304$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005722$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240812$$CN$US$US
241983051$24198305$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006039$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240812$$CN$US$US
241983061$24198306$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005726$ELI LILLY AND CO$$73$YR$E$$Y$$$20240812$$CN$US$US
241983071$24198307$1$I$20240808$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005781$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240812$$CN$US$US
241983081$24198308$1$I$20240804$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005224$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240812$$CN$US$US
241983091$24198309$1$I$20240806$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005343$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240812$$CN$US$US
241983101$24198310$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005669$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240812$$CN$US$US
241983112$24198311$2$F$$20240627$20240812$20240902$PER$$US-ASTELLAS-2024US018454$ASTELLAS$$75$YR$E$F$Y$$$20240830$$HP$US$US
241983122$24198312$2$F$$20240624$20240812$20240902$PER$$US-ASTELLAS-2024US018165$ASTELLAS$$$$A$F$Y$$$20240830$$HP$US$US
241983132$24198313$2$F$$20240628$20240812$20240902$PER$$US-ASTELLAS-2024US018757$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241983142$24198314$2$F$20240202$20240716$20240812$20240902$PER$$US-ASTELLAS-2024US018155$ASTELLAS$$$$A$F$Y$$$20240830$$MD$US$US
241983152$24198315$2$F$20240702$20240711$20240812$20240902$PER$$US-ASTELLAS-2024US018914$ASTELLAS$$52$YR$A$F$Y$$$20240830$$MD$US$US
241983162$24198316$2$F$$20240625$20240812$20240902$PER$$US-ASTELLAS-2024US018192$ASTELLAS$$50$YR$A$F$Y$$$20240830$$HP$US$US
241983172$24198317$2$F$$20240625$20240812$20240902$PER$$US-ASTELLAS-2024US018219$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241983182$24198318$2$F$$20240703$20240812$20240902$PER$$US-ASTELLAS-2024US018993$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241983192$24198319$2$F$$20240705$20240812$20240902$PER$$US-ASTELLAS-2024US019009$ASTELLAS$$68$YR$E$F$Y$$$20240830$$MD$US$US
241983202$24198320$2$F$$20240628$20240812$20240902$PER$$US-ASTELLAS-2024US018685$ASTELLAS$$31$YR$A$F$Y$$$20240830$$PH$US$US
241983211$24198321$1$I$$20240809$20240812$20240812$PER$$NVSC2024US162997$NOVARTIS$$$$$$Y$$$20240812$$HP$US$US
241983221$24198322$1$I$$20240807$20240812$20240812$PER$$US-JNJFOC-20240818515$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
241983232$24198323$2$F$20240409$20240806$20240812$20240828$EXP$$US-GSK-US2024098044$GLAXOSMITHKLINE$$67$YR$$M$Y$$$20240828$$MD$US$US
241983242$24198324$2$F$20240617$20240725$20240812$20240902$PER$$US-ASTELLAS-2024US018268$ASTELLAS$$59$YR$A$F$Y$$$20240830$$CN$US$US
241983252$24198325$2$F$$20240701$20240812$20240902$PER$$US-ASTELLAS-2024US018907$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241983262$24198326$2$F$$20240627$20240812$20240902$PER$$US-ASTELLAS-2024US018299$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241983272$24198327$2$F$$20240718$20240812$20240902$PER$$US-ASTELLAS-2024US020789$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983282$24198328$2$F$$20240716$20240812$20240902$PER$$US-ASTELLAS-2024US020422$ASTELLAS$$$$$F$Y$$$20240830$$CN$US$US
241983292$24198329$2$F$$20240723$20240812$20240902$PER$$US-ASTELLAS-2024US021020$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983305$24198330$5$F$20230101$20240906$20240812$20240918$PER$$US-ASTELLAS-2024US020852$ASTELLAS$$$$E$F$Y$$$20240918$$MD$US$US
241983312$24198331$2$F$$20240731$20240812$20240903$PER$$US-ASTELLAS-2024US020400$ASTELLAS$$48$YR$A$F$Y$$$20240830$$CN$US$US
241983322$24198332$2$F$$20240716$20240812$20240902$PER$$US-ASTELLAS-2024US020632$ASTELLAS$$59$YR$A$F$Y$$$20240830$$MD$US$US
241983332$24198333$2$F$$20240718$20240812$20240902$PER$$US-ASTELLAS-2024US020978$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983344$24198334$4$F$20240601$20240812$20240812$20240902$PER$$US-ASTELLAS-2024US020976$ASTELLAS$$52$YR$A$F$Y$$$20240830$$MD$US$US
241983352$24198335$2$F$$20240722$20240812$20240902$PER$$US-ASTELLAS-2024US020792$ASTELLAS$$8$DEC$E$F$Y$$$20240830$$MD$US$US
241983363$24198336$3$F$$20240826$20240812$20240903$EXP$$US-ASTELLAS-2024US020029$ASTELLAS$$$$A$F$Y$$$20240903$$CN$US$US
241983372$24198337$2$F$$20240715$20240812$20240902$PER$$US-ASTELLAS-2024US020581$ASTELLAS$$69$YR$E$F$Y$$$20240830$$MD$US$US
241983381$24198338$1$I$$20240806$20240812$20240812$EXP$$CZ-ROCHE-10000052036$ROCHE$$$$A$F$Y$$$20240812$$MD$CZ$CZ
241983392$24198339$2$F$$20240715$20240812$20240902$PER$$US-ASTELLAS-2024US020380$ASTELLAS$$$$$$Y$$$20240830$$CN$US$US
241983402$24198340$2$F$$20240724$20240812$20240902$PER$$US-ASTELLAS-2024US021093$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983412$24198341$2$F$$20240715$20240812$20240903$PER$$US-ASTELLAS-2024US020490$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983422$24198342$2$F$20240131$20240725$20240812$20240902$PER$$US-ASTELLAS-2024US019498$ASTELLAS$$52$YR$A$F$Y$$$20240830$$HP$US$US
241983432$24198343$2$F$$20240715$20240812$20240902$PER$$US-ASTELLAS-2024US020184$ASTELLAS$$58$YR$A$F$Y$$$20240830$$MD$US$US
241983442$24198344$2$F$$20240715$20240812$20240902$PER$$US-ASTELLAS-2024US020577$ASTELLAS$$59$YR$A$F$Y$$$20240830$$CN$US$US
241983452$24198345$2$F$$20240722$20240812$20240902$PER$$US-ASTELLAS-2024US020767$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983462$24198346$2$F$$20240717$20240812$20240902$PER$$US-ASTELLAS-2024US019663$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983472$24198347$2$F$20240501$20240724$20240812$20240902$PER$$US-ASTELLAS-2024US020014$ASTELLAS$$63$YR$A$F$Y$$$20240830$$MD$US$US
241983482$24198348$2$F$$20240723$20240812$20240902$PER$$US-ASTELLAS-2024US021039$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241983492$24198349$2$F$$20240723$20240812$20240902$PER$$US-ASTELLAS-2024US021167$ASTELLAS$$8$DEC$E$F$Y$$$20240830$$MD$US$US
241983502$24198350$2$F$$20240708$20240812$20240902$PER$$US-ASTELLAS-2024US019499$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241983512$24198351$2$F$$20240718$20240812$20240902$PER$$US-ASTELLAS-2024US020713$ASTELLAS$$48$YR$A$F$Y$$$20240830$$HP$US$US
241983523$24198352$3$F$20240730$20240829$20240812$20240904$EXP$$US-SA-2024SA233529$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240904$$MD$US$US
241983532$24198353$2$F$20240101$20240903$20240812$20240910$EXP$$CA-CELLTRION INC.-2024CA018966$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
241983542$24198354$2$F$$20240814$20240812$20240902$PER$$US-ASTELLAS-2024US022346$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983552$24198355$2$F$$20240806$20240812$20240902$PER$$US-ASTELLAS-2024US022365$ASTELLAS$$68$YR$E$F$Y$$$20240830$$MD$US$US
241983562$24198356$2$F$$20240805$20240812$20240903$PER$$US-ASTELLAS-2024US021537$ASTELLAS$$85$YR$E$M$Y$$$20240830$$CN$US$US
241983572$24198357$2$F$$20240810$20240812$20240902$PER$$US-ASTELLAS-2024US022140$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983582$24198358$2$F$$20240729$20240812$20240902$PER$$US-ASTELLAS-2024US021643$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983592$24198359$2$F$$20240809$20240812$20240902$PER$$US-ASTELLAS-2024US021947$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983602$24198360$2$F$$20240807$20240812$20240902$PER$$US-ASTELLAS-2024US022545$ASTELLAS$$6$DEC$A$F$Y$$$20240830$$MD$US$US
241983612$24198361$2$F$20240101$20240806$20240812$20240902$PER$$US-ASTELLAS-2024US022521$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241983622$24198362$2$F$$20240805$20240812$20240902$PER$$US-ASTELLAS-2024US022259$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983631$24198363$1$I$$20240807$20240812$20240812$PER$$US-ASTELLAS-2024US022538$ASTELLAS$$$$$F$Y$$$20240812$$CN$US$US
241983644$24198364$4$F$20240101$20240915$20240812$20240927$PER$$US-ASTELLAS-2024US022520$ASTELLAS$$74$YR$E$F$Y$$$20240927$$CN$US$US
241983652$24198365$2$F$20240501$20240724$20240812$20240902$PER$$US-ASTELLAS-2024US021370$ASTELLAS$$64$YR$A$F$Y$$$20240830$$CN$US$US
241983662$24198366$2$F$$20240806$20240812$20240902$PER$$US-ASTELLAS-2024US022343$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
241983682$24198368$2$F$$20240729$20240812$20240902$PER$$US-ASTELLAS-2024US021658$ASTELLAS$$60$YR$A$F$Y$$$20240830$$HP$US$US
241983692$24198369$2$F$$20240806$20240812$20240902$PER$$US-ASTELLAS-2024US022369$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241983702$24198370$2$F$$20240807$20240812$20240902$PER$$US-ASTELLAS-2024US022410$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241983711$24198371$1$I$$20240808$20240812$20240812$PER$$US-ASTELLAS-2024US022598$ASTELLAS$$$$A$$Y$$$20240812$$CN$US$US
241983722$24198372$2$F$$20240730$20240812$20240902$PER$$US-ASTELLAS-2024US021175$ASTELLAS$$61$YR$A$F$Y$$$20240830$$MD$US$US
241983732$24198373$2$F$$20240808$20240812$20240902$PER$$US-ASTELLAS-2024US022600$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
241983742$24198374$2$F$20240722$20240731$20240812$20240902$PER$$US-ASTELLAS-2024US021869$ASTELLAS$$57$YR$A$F$Y$$$20240830$$HP$US$US
241983753$24198375$3$F$20240509$20240830$20240812$20240904$EXP$$US-JNJFOC-20240820434$JOHNSON AND JOHNSON$$67$YR$E$M$Y$79.45$KG$20240904$$HP$US$US
241983761$24198376$1$I$$20240809$20240812$20240812$EXP$$US-JNJFOC-20240824510$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$HP$US$US
241983772$24198377$2$F$$20240905$20240812$20240909$EXP$$LB-JNJFOC-20240822679$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$CN$LB$LB
241983781$24198378$1$I$$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265560$NOVO NORDISK$$$$$F$Y$$$20240812$$MD$US$US
241983791$24198379$1$I$$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265623$NOVO NORDISK$$47$YR$$F$Y$$$20240812$$HP$US$US
241983801$24198380$1$I$$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265629$NOVO NORDISK$$$$$F$Y$$$20240812$$CN$US$US
241983811$24198381$1$I$20220101$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265685$NOVO NORDISK$$$$$M$Y$$$20240812$$CN$US$US
241983821$24198382$1$I$20240101$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265557$NOVO NORDISK$$76$YR$$F$Y$$$20240812$$CN$US$US
241983841$24198384$1$I$$20240731$20240812$20240812$EXP$$BR-NOVOPROD-1265344$NOVO NORDISK$$$$$F$Y$$$20240812$$CN$BR$BR
241983851$24198385$1$I$$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265654$NOVO NORDISK$$$$E$$Y$$$20240812$$CN$US$US
241983861$24198386$1$I$20240725$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265492$NOVO NORDISK$$68$YR$$F$Y$$$20240812$$CN$US$US
241983873$24198387$3$F$$20240827$20240812$20240903$EXP$$US-ASTELLAS-2024US022871$ASTELLAS$$$$$F$Y$$$20240903$$MD$US$US
241983882$24198388$2$F$20240701$20240812$20240812$20240902$PER$$US-ASTELLAS-2024US022679$ASTELLAS$$51$YR$A$F$Y$$$20240830$$CN$US$US
241983891$24198389$1$I$20240725$20240805$20240812$20240812$PER$$US-009507513-2408USA001285$MERCK$$73$YR$$F$Y$$$20240812$$CN$US$US
241983901$24198390$1$I$20240530$20240805$20240812$20240812$EXP$FR-AFSSAPS-PB2024000834$FR-SA-2024SA234761$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240812$$MD$FR$FR
241983911$24198391$1$I$20240628$20240801$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-039476$AUROBINDO$$29$YR$$F$Y$65$KG$20240812$$MD$FR$FR
241983921$24198392$1$I$20230401$20240805$20240812$20240812$PER$$US-SA-2024SA235373$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240812$$HP$US$US
241983931$24198393$1$I$20240725$20240806$20240812$20240812$PER$$US-ABBVIE-5872306$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241983941$24198394$1$I$20240801$20240801$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123444$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240812$$HP$US$US
241983951$24198395$1$I$$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265080$NOVO NORDISK$$$$$$Y$$$20240812$$CN$US$US
241983961$24198396$1$I$$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265703$NOVO NORDISK$$$$$$Y$$$20240812$$CN$US$US
241983971$24198397$1$I$20240501$20240731$20240812$20240812$EXP$$US-NOVOPROD-1264896$NOVO NORDISK$$$$A$M$Y$$$20240812$$CN$US$US
241983981$24198398$1$I$20190101$20240731$20240812$20240812$EXP$$US-NOVOPROD-1264858$NOVO NORDISK$$$$$M$Y$$$20240812$$CN$US$US
241983991$24198399$1$I$$20240807$20240812$20240812$EXP$$AR-JNJFOC-20240821088$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$67$KG$20240812$$CN$AR$AR
241984001$24198400$1$I$$20240729$20240812$20240812$EXP$$US-VIIV HEALTHCARE LIMITED-US2024094906$VIIV$$$$$M$Y$$$20240812$$CN$US$US
241984011$24198401$1$I$$20240708$20240812$20240812$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06992$LUPIN$$$$$$Y$$$20240812$$CN$US$US
241984022$24198402$2$F$20240805$20240812$20240812$20240812$PER$$US-AMGEN-USASP2024159394$AMGEN$$67$YR$E$M$Y$$$20240812$$CN$US$US
241984031$24198403$1$I$20230923$20240805$20240812$20240812$EXP$$CO-UCBSA-2024040203$UCB$$41$YR$$F$Y$$$20240812$$CN$CO$CO
241984044$24198404$4$F$20240809$20240904$20240812$20240905$PER$$US-AMGEN-USASP2024159009$AMGEN$$41$YR$A$M$Y$$$20240904$$HP$US$US
241984051$24198405$1$I$20240101$20240801$20240812$20240812$PER$$US-SA-2024SA232849$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240812$$MD$US$US
241984061$24198406$1$I$$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003791$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241984071$24198407$1$I$20240301$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265767$NOVO NORDISK$$62$YR$$F$Y$$$20240812$$PH$US$US
241984081$24198408$1$I$$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265733$NOVO NORDISK$$$$$F$Y$$$20240812$$CN$US$US
241984091$24198409$1$I$20240701$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265749$NOVO NORDISK$$67$YR$$M$Y$$$20240812$$CN$US$US
241984101$24198410$1$I$$20240806$20240812$20240812$PER$$US-ALXN-202408USA000412US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240812$$MD$US$US
241984112$24198411$2$F$$20240816$20240812$20240819$EXP$AT-JNJFOC-20240757456$AT-ROCHE-10000052654$ROCHE$$47$YR$A$$Y$$$20240819$$MD$AT$AT
241984131$24198413$1$I$20240718$20240731$20240812$20240812$EXP$$CN-Shanghai Hengrui Pharmaceutical Co., Ltd.-2160286$SHANGHAI HENGRUI PHARMACEUTICAL$$48$YR$$M$Y$76.5$KG$20240812$$MD$CN$CN
241984142$24198414$2$F$$20240813$20240812$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06995$LUPIN$$$$$$Y$$$20240901$$CN$US$US
241984151$24198415$1$I$$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003888$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241984161$24198416$1$I$20240806$20240807$20240812$20240812$PER$$US-JNJFOC-20240819151$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240812$$CN$US$US
241984181$24198418$1$I$20240726$20240807$20240812$20240812$EXP$DE-DCGMA-24203746$DE-RDY-SPO/DEU/24/0011608$DR REDDYS$$66$YR$E$F$Y$$$20240812$$MD$DE$DE
241984191$24198419$1$I$$20240806$20240812$20240812$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125269$BRISTOL MYERS SQUIBB$$2$DEC$A$$Y$$$20240812$$PH$JP$JP
241984201$24198420$1$I$20240727$20240807$20240812$20240812$EXP$IT-MINISAL02-998215$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-126289$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$77$KG$20240812$$MD$IT$IT
241984211$24198421$1$I$$20240708$20240812$20240812$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06991$LUPIN$$$$$$Y$$$20240812$$CN$US$US
241984222$24198422$2$F$20240715$20240808$20240812$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125741$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$88.45$KG$20240819$$PH$US$US
241984231$24198423$1$I$$20240806$20240812$20240812$EXP$$CA-TAKEDA-2024TUS028785$TAKEDA$$$$$F$Y$$$20240812$$CN$CA$CA
241984241$24198424$1$I$20240808$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158465$AMGEN$$71$YR$E$F$Y$$$20240812$$CN$US$US
241984252$24198425$2$F$20240804$20240815$20240812$20240821$PER$$US-AMGEN-USASP2024155344$AMGEN$$68$YR$E$$Y$$$20240821$$CN$US$US
241984261$24198426$1$I$$20240805$20240812$20240812$EXP$$US-GSK-US2024097540$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
241984271$24198427$1$I$$20240802$20240812$20240812$EXP$$US-GSK-US2024096957$GLAXOSMITHKLINE$$$$$M$Y$$$20240812$$CN$US$US
241984281$24198428$1$I$20171214$20240802$20240812$20240812$EXP$$CA-TAKEDA-2024TUS078869$TAKEDA$$47$YR$$F$Y$$$20240812$$CN$CA$CA
241984291$24198429$1$I$$20240729$20240812$20240812$EXP$$AU-LUPIN EUROPE GMBH-2024-07617$LUPIN$$$$$$Y$$$20240812$$CN$AU$AU
241984301$24198430$1$I$$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004309$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240812$$CN$US$US
241984312$24198431$2$F$$20240812$20240812$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006042$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240813$$CN$US$US
241984321$24198432$1$I$20240805$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005853$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240812$$CN$US$US
241984331$24198433$1$I$20240730$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005729$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240812$$CN$US$US
241984341$24198434$1$I$$20240807$20240812$20240812$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001588$BLUEPRINT MEDICINES$$$$$F$Y$$$20240812$$CN$US$US
241984351$24198435$1$I$$20240805$20240812$20240812$PER$$US-ROCHE-10000050067$ROCHE$$71$YR$E$F$Y$$$20240812$$CN$US$US
241984361$24198436$1$I$$20240802$20240812$20240812$EXP$$BR-TAKEDA-2024TUS078878$TAKEDA$$$$$M$Y$$$20240812$$HP$BR$BR
241984371$24198437$1$I$20240729$20240806$20240812$20240812$PER$$US-AMGEN-USASP2024157104$AMGEN$$54$YR$A$M$Y$$$20240812$$CN$US$US
241984381$24198438$1$I$20240807$20240806$20240812$20240812$PER$$US-AMGEN-USASP2024157147$AMGEN$$74$YR$E$F$Y$$$20240812$$CN$US$US
241984392$24198439$2$F$20240808$20240812$20240812$20240813$PER$$US-AMGEN-USASP2024158995$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241984402$24198440$2$F$20240801$20240905$20240812$20240911$EXP$$CA-TAKEDA-2024TUS079136$TAKEDA$$76$YR$$F$Y$$$20240911$$CN$CA$CA
241984411$24198441$1$I$$20240808$20240812$20240812$PER$$US-ROCHE-10000053546$ROCHE$$$$E$F$Y$$$20240812$$CN$US$US
241984422$24198442$2$F$20240701$20240823$20240812$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003749$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240916$$CN$US$US
241984431$24198443$1$I$20240101$20240807$20240812$20240812$EXP$$MX-JNJFOC-20240821638$JOHNSON AND JOHNSON$$74$YR$E$F$Y$70$KG$20240812$$CN$MX$MX
241984441$24198444$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235401$SANOFI AVENTIS$$2$YR$C$$Y$$$20240812$$HP$US$US
241984451$24198445$1$I$20240101$20240806$20240812$20240812$EXP$$US-SA-2024SA235471$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240812$$MD$US$US
241984464$24198446$4$F$$20240827$20240812$20240904$PER$$US-ROCHE-10000052846$ROCHE$$$$A$M$Y$$$20240904$$CN$US$US
241984471$24198447$1$I$$20240803$20240812$20240812$EXP$$US-VANTIVE-2024VAN018812$Vantive US Healthcare$$$$$M$Y$$$20240812$$HP$US$US
241984481$24198448$1$I$$20240801$20240812$20240812$PER$$US-EMD Serono-2024041980$EMD SERONO INC$$59$YR$A$F$Y$$$20240812$$CN$US$US
241984491$24198449$1$I$$20240806$20240812$20240812$EXP$$CA-TAKEDA-2024TUS079149$TAKEDA$$$$$F$Y$$$20240812$$CN$CA$CA
241984502$24198450$2$F$$20240808$20240812$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003993$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
241984511$24198451$1$I$$20240802$20240812$20240812$PER$$US-AstraZeneca-2024A176645$ASTRAZENECA$$$$$F$Y$$$20240812$$MD$US$
241984521$24198452$1$I$20230101$20240805$20240812$20240812$EXP$$CL-UCBSA-2024040276$UCB$$$$$M$Y$$$20240812$$CN$CL$CL
241984531$24198453$1$I$$20211110$20240812$20240812$EXP$$US-AstraZeneca-2021A734007$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241984541$24198454$1$I$20240723$20240808$20240812$20240812$EXP$FR-AFSSAPS-LY2024001216$FR-GSK-FR2024099428$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$PH$FR$FR
241984551$24198455$1$I$$20240806$20240812$20240812$EXP$$US-GSK-US2024098082$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$HP$US$US
241984561$24198456$1$I$20230301$20240801$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-039422$AUROBINDO$$25$YR$$M$Y$$$20240812$$MD$FR$FR
241984571$24198457$1$I$20240701$20240805$20240812$20240812$EXP$$RO-TAKEDA-2024TUS079557$TAKEDA$$56$YR$$M$Y$$$20240812$$CN$RO$RO
241984581$24198458$1$I$$20240801$20240812$20240812$EXP$$PT-AUROBINDO-AUR-APL-2024-039380$AUROBINDO$I. De Albuquerque Monteiro, J. Correira Cardoso, F. Guedes, S. Festa, P. Macedo Neves, J. Salomao, et al,. An infection never comes alone - about a clinical case.. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional$76$YR$$M$Y$$$20240812$$MD$PT$PT
241984601$24198460$1$I$20240726$20240727$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120114$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$79.38$KG$20240812$$CN$US$US
241984612$24198461$2$F$20231101$20240814$20240812$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-038709$AUROBINDO$$37$YR$$F$Y$67$KG$20240827$$PH$GB$GB
241984621$24198462$1$I$$20240807$20240812$20240812$EXP$IT-CELLTRION INC.-2024IT017803$IT-ROCHE-10000052523$ROCHE$Musone D, Nicosia V, D^Alessandro R, Andrietti M, Steri P, Ruosi C. Therapeutic plasmapheresis in idiopathic membranous nephropathy anti-PLA2Rrelated: A case series. J Clin Apher. 2024;39 (3):e22134. doi:10.1002/jca.22134.$71$YR$E$F$Y$$$20240812$$HP$IT$IT
241984632$24198463$2$F$20240101$20240822$20240812$20240916$PER$$US-SA-2024SA235749$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240916$$MD$US$US
241984641$24198464$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA235845$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240812$$MD$US$US
241984651$24198465$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA235529$SANOFI AVENTIS$$8$YR$C$M$Y$30.39$KG$20240812$$MD$US$US
241984661$24198466$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA224442$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240812$$CN$US$US
241984671$24198467$1$I$$20240806$20240812$20240812$EXP$$US-JNJFOC-20240817918$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$HP$US$US
241984682$24198468$2$F$20240101$20240826$20240812$20240924$PER$$US-SA-2024SA235864$SANOFI AVENTIS$$44$YR$A$F$Y$56$KG$20240924$$MD$US$US
241984702$24198470$2$F$$20240812$20240812$20240812$PER$$US-AMGEN-USASP2024158984$AMGEN$$$$$$Y$$$20240812$$CN$US$US
241984711$24198471$1$I$20240808$20240808$20240812$20240812$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099185$VIIV$$$$$$Y$$$20240812$$PH$US$US
241984721$24198472$1$I$$20240806$20240812$20240812$EXP$$CA-JNJFOC-20240823935$JOHNSON AND JOHNSON$$18$YR$A$$Y$$$20240812$$MD$CA$CA
241984731$24198473$1$I$20240718$20240807$20240812$20240812$EXP$$CN-ROCHE-10000051553$ROCHE$$49$YR$A$F$Y$74$KG$20240812$$HP$CN$CN
241984741$24198474$1$I$20240720$20240807$20240812$20240812$EXP$$CN-ROCHE-10000052850$ROCHE$$87$YR$E$F$Y$50$KG$20240812$$HP$CN$CN
241984751$24198475$1$I$$20240802$20240812$20240812$30DAY$$US-GSK-US2024097030$GLAXOSMITHKLINE$$$$E$F$Y$$$20240812$$CN$US$US
241984761$24198476$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005702$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
241984771$24198477$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004734$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240812$$CN$US$US
241984792$24198479$2$F$$20240814$20240812$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408005466$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240825$$CN$US$US
241984801$24198480$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005720$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
241984811$24198481$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005857$ELI LILLY AND CO$$$$A$F$Y$$$20240812$$CN$US$US
241984821$24198482$1$I$20240807$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005773$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240812$$CN$US$US
241984831$24198483$1$I$$20240807$20240812$20240812$EXP$$GB-JNJFOC-20240825172$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20240812$$CN$GB$GB
241984841$24198484$1$I$$20240802$20240812$20240812$EXP$$IT-AUROBINDO-AUR-APL-2024-039785$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P,. Surgical treatment of invasive fungal infection in pediatric oncology.. Eur-J-Haematol. 2024;113 (1):90-98$4$YR$$M$Y$$$20240812$$HP$IT$IT
241984852$24198485$2$F$20240809$20240812$20240812$20240813$PER$$US-AMGEN-USASP2024159117$AMGEN$$70$YR$E$M$Y$$$20240812$$CN$US$US
241984861$24198486$1$I$$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159395$AMGEN$$$$$$Y$$$20240812$$CN$US$US
241984871$24198487$1$I$20240113$20240802$20240812$20240812$EXP$$ES-AUROBINDO-AUR-APL-2024-039556$AUROBINDO$$56$YR$$M$Y$72.1$KG$20240812$$MD$ES$ES
241984881$24198488$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158757$AMGEN$$$$$$Y$$$20240812$$HP$US$US
241984891$24198489$1$I$20240804$20240804$20240812$20240812$PER$$US-AMGEN-USASP2024155158$AMGEN$$46$YR$A$$Y$$$20240812$$HP$US$US
241984901$24198490$1$I$$20210830$20240812$20240812$EXP$$US-AstraZeneca-2021A704670$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
241984911$24198491$1$I$$20210709$20240812$20240812$EXP$$PH-AstraZeneca-2021A611837$ASTRAZENECA$$54$YR$$M$Y$$$20240812$$CN$PH$
241984924$24198492$4$F$20240801$20240910$20240812$20240919$PER$$US-ROCHE-10000049729$ROCHE$$46$YR$A$F$Y$$$20240919$$CN$US$US
241984931$24198493$1$I$20240712$20240802$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-039631$AUROBINDO$$34$YR$$M$Y$$$20240812$$MD$FR$FR
241984941$24198494$1$I$$20240806$20240812$20240812$PER$$US-ALXN-202408USA000400US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241984951$24198495$1$I$$20240808$20240812$20240812$EXP$$US-JNJFOC-20240823526$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240812$$HP$US$US
241984964$24198496$4$F$$20240910$20240812$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US071391$SANDOZ$$$$$F$Y$$$20240913$$CN$US$US
241984981$24198498$1$I$20240717$20240802$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-039604$AUROBINDO$$78$YR$$F$Y$$$20240812$$HP$FR$FR
241984991$24198499$1$I$20240701$20240802$20240812$20240812$PER$$US-SA-2024SA234098$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240812$$MD$US$US
241985002$24198500$2$F$20240809$20240812$20240812$20240813$PER$$US-AMGEN-USASP2024159018$AMGEN$$68$YR$E$M$Y$$$20240812$$CN$US$US
241985011$24198501$1$I$20240226$20240805$20240812$20240812$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044260$BOEHRINGER INGELHEIM$$11$YR$C$F$Y$33.9$KG$20240812$$HP$FR$FR
241985021$24198502$1$I$$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159391$AMGEN$$$$$$Y$$$20240812$$CN$US$US
241985032$24198503$2$F$$20240809$20240812$20240815$PER$$US-AMGEN-USASP2024157411$AMGEN$$67$YR$E$F$Y$49.05$KG$20240814$$CN$US$US
241985043$24198504$3$F$$20240911$20240812$20240916$PER$$US-SA-2024SA233135$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240916$$CN$US$US
241985052$24198505$2$F$20240608$20240815$20240812$20240819$PER$$US-AMGEN-USASP2024159400$AMGEN$$38$YR$A$F$Y$$$20240818$$CN$US$US
241985062$24198506$2$F$$20240906$20240812$20240909$EXP$$NVSC2024US162375$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
241985071$24198507$1$I$20240719$20240802$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-039576$AUROBINDO$$71$YR$$M$Y$$$20240812$$MD$FR$FR
241985081$24198508$1$I$$20240731$20240812$20240812$PER$$US-RDY-LIT/USA/24/0011512$DR REDDYS$Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. blood. 2023 Nov;142: 5898. doi:10.1182/blood-2023-188298.$$$A$$Y$$$20240812$$MD$US$US
241985091$24198509$1$I$$20240808$20240812$20240812$EXP$$CN-TAKEDA-2024TUS079770$TAKEDA$$$$$M$Y$$$20240812$$CN$CN$CN
241985101$24198510$1$I$20220101$20240727$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126719$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$79.38$KG$20240812$$CN$US$US
241985111$24198511$1$I$20240725$20240802$20240812$20240812$EXP$$ES-AUROBINDO-AUR-APL-2024-039557$AUROBINDO$$80$YR$$F$Y$35$KG$20240812$$MD$ES$ES
241985121$24198512$1$I$$20240731$20240812$20240812$EXP$PT-MLMSERVICE-20240724-PI141748-00285-2$PT-JUBILANT CADISTA PHARMACEUTICALS-2024PT001124$JUBILANT$Brito-Santana L, Medinas RL, Neves A, Gago J. Steroid-induced psychosis: a spectrum of neuropsychiatric glucocorticoid side effects.. BMJ case reports.. 2024;17(7):$5$DEC$$M$Y$$$20240812$$MD$PT$PT
241985132$24198513$2$F$$20240806$20240812$20240816$EXP$$CN-JUBILANT CADISTA PHARMACEUTICALS-2024CN001127$JUBILANT$Su C, Kao C. Stevens-Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report. Journal of Medical Case Reports. 2024;18:344$82$YR$$F$Y$$$20240816$$PH$CN$CN
241985141$24198514$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163041$NOVARTIS$$$$$$Y$$$20240812$$MD$US$US
241985152$24198515$2$F$20240625$20240904$20240812$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-039536$AUROBINDO$$84$YR$$F$Y$67$KG$20240910$$PH$FR$FR
241985161$24198516$1$I$$20240808$20240812$20240812$PER$$US-HALEON-2191281$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
241985173$24198517$3$F$20240701$20240820$20240812$20240904$EXP$$BG-UCBSA-2024038242$UCB$$5$YR$$M$Y$$$20240904$$MD$BG$BG
241985191$24198519$1$I$$20230823$20240812$20240812$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00902$TARO$$$$$$Y$$$20240812$$CN$US$US
241985201$24198520$1$I$$20240429$20240812$20240812$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00552$TARO$$$$$$Y$$$20240812$$CN$US$US
241985211$24198521$1$I$20240101$20240808$20240812$20240812$EXP$$US-UCBSA-2024039980$UCB$$$$$M$Y$$$20240812$$CN$US$US
241985221$24198522$1$I$$20231025$20240812$20240812$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01144$TARO$$$$$$Y$$$20240812$$CN$US$US
241985231$24198523$1$I$20231101$20240112$20240812$20240812$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00081$TARO$$$$$$Y$$$20240812$$CN$US$US
241985241$24198524$1$I$20210101$20240215$20240812$20240812$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00152$TARO$$$$$$Y$$$20240812$$CN$US$US
241985251$24198525$1$I$20231130$20240104$20240812$20240812$EXP$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01280$TARO$$$$$$Y$$$20240812$$CN$US$US
241985261$24198526$1$I$20220801$20240807$20240812$20240812$EXP$$CA-SANDOZ INC.-NVSC2022CA199344$SANDOZ$$49$YR$$F$Y$$$20240812$$CN$CA$CA
241985271$24198527$1$I$$20240730$20240812$20240812$EXP$$CZ-AUROBINDO-AUR-APL-2024-039158$AUROBINDO$Zpracovala R, Viktorova K.. Development of osteology in the Czech Republic, denosumab and romosozumab in the treatment of osteoporosis.. Remedia.. 2024;34:247-252$$$$F$Y$61.5$KG$20240812$$PH$CZ$CZ
241985281$24198528$1$I$$20230817$20240812$20240812$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00882$TARO$$$$$$Y$$$20240812$$CN$US$US
241985292$24198529$2$F$$20240827$20240812$20240828$PER$$US-ALXN-202408USA000291US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$US$US
241985301$24198530$1$I$$20240328$20240812$20240812$PER$$US-ENDO USA, INC.-2024-001572$ENDO$$$$$M$Y$$$20240812$$CN$US$US
241985311$24198531$1$I$$20231221$20240812$20240812$PER$$US-ENDO PHARMACEUTICALS INC-2023-006272$ENDO$$$$$M$Y$$$20240812$$CN$US$US
241985322$24198532$2$F$20230901$20240813$20240812$20240820$EXP$$CA-GSK-CA2023177215$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$HP$CA$CA
241985331$24198533$1$I$$20240805$20240812$20240812$EXP$$JP-ROCHE-10000049151$ROCHE$Tajima T, Hata K, Tanaka K, Iyama N, Kusakabe J, Kageyama S, et al. Chronological alterations in de novo malignancies after living-donor liver transplantation: A cohort study of 1781 recipients using annual comparisons of standardized incidence ratios. Journal of Hepato-Biliary-Pancreatic Sciences. 2024-Jul;31 (7):455-67. doi:10.1002/jhbp.12002.$$$$$Y$$$20240812$$MD$JP$JP
241985341$24198534$1$I$20230101$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005736$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240812$$CN$US$US
241985351$24198535$1$I$20240414$20240415$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005037$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
241985361$24198536$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005760$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
241985371$24198537$1$I$$20240731$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408000962$ELI LILLY AND CO$$$$A$M$Y$$$20240812$$CN$US$US
241985381$24198538$1$I$20240807$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005928$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240812$$CN$US$US
241985391$24198539$1$I$20240802$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005753$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240812$$CN$US$US
241985401$24198540$1$I$20240730$20240809$20240812$20240812$EXP$$CA-JNJFOC-20240826299$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240812$$CN$CA$CA
241985413$24198541$3$F$20240819$20240822$20240812$20240829$EXP$$CA-TAKEDA-2024TUS080141$TAKEDA$$71$YR$$F$Y$$$20240829$$CN$CA$CA
241985421$24198542$1$I$$20240808$20240812$20240812$PER$$US-GILEAD-2024-0683631$GILEAD$$53$YR$A$F$Y$$$20240812$$PH$US$US
241985431$24198543$1$I$20120101$20240730$20240812$20240812$PER$$US-JNJFOC-20240783102$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240812$$CN$US$US
241985452$24198545$2$F$$20240910$20240812$20240917$PER$$US-BAUSCHBL-2024BNL031080$BAUSCH AND LOMB$$$$$F$Y$$$20240917$$CN$US$US
241985461$24198546$1$I$$20240715$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003696$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241985481$24198548$1$I$$20240802$20240812$20240812$30DAY$$US-GSK-US2024AMR097486$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
241985501$24198550$1$I$20240601$20240806$20240812$20240812$EXP$$AR-JNJFOC-20240817663$JOHNSON AND JOHNSON$$78$YR$E$M$Y$105$KG$20240812$$CN$AR$AR
241985511$24198551$1$I$20240806$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158120$AMGEN$$47$YR$A$F$Y$$$20240812$$CN$US$US
241985522$24198552$2$F$20240808$20240812$20240812$20240813$PER$$US-AMGEN-USASP2024158697$AMGEN$$44$YR$A$F$Y$$$20240813$$CN$US$US
241985531$24198553$1$I$$20240717$20240812$20240812$PER$$US-ALK-ABELLO A/S-2024AA002941$ALK-ABELLO$$$$$$Y$$$20240812$$MD$US$US
241985541$24198554$1$I$$20240808$20240812$20240812$PER$$US-HALEON-2191272$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
241985551$24198555$1$I$20240717$20240718$20240812$20240812$PER$$US-ALK-ABELLO A/S-2024AA002952$ALK-ABELLO$$$$$$Y$$$20240812$$HP$US$US
241985561$24198556$1$I$$20240805$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126334$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$113.4$KG$20240812$$MD$US$US
241985571$24198557$1$I$$20240805$20240812$20240812$EXP$$EU-BAUSCHBL-2024BNL031098$BAUSCH AND LOMB$$$$$M$Y$$$20240812$$CN$EU$EU
241985582$24198558$2$F$$20240813$20240812$20240819$PER$$US-ALXN-202408USA000386US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
241985591$24198559$1$I$$20240806$20240812$20240812$PER$$US-ALXN-202408USA000347US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241985601$24198560$1$I$$20240809$20240812$20240812$EXP$$IT-SANDOZ INC.-SDZ2024IT071683$SANDOZ$$33$MON$$F$Y$$$20240812$$HP$IT$IT
241985611$24198561$1$I$$20240808$20240812$20240812$PER$$US-HALEON-2191362$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
241985621$24198562$1$I$20240724$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024157162$AMGEN$$77$YR$E$M$Y$$$20240812$$HP$US$US
241985632$24198563$2$F$$20240827$20240812$20240916$PER$$US-Novugen Pharma Sdn. Bhd.-2160288$NOVUGEN PHARMA MALAYSIA$$$$$$Y$$$20240916$$$US$US
241985642$24198564$2$F$20240722$20240830$20240812$20240909$EXP$$US-ORG100014127-2024000222$HRA PHARMA$$49$YR$$F$Y$$$20240909$$CN$US$US
241985652$24198565$2$F$20220301$20240809$20240812$20240817$EXP$$RU-SA-2024SA233739$SANOFI AVENTIS$$21$YR$A$F$Y$65$KG$20240817$$MD$RU$RU
241985662$24198566$2$F$20240801$20240816$20240812$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003685$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240910$$CN$US$US
241985672$24198567$2$F$20240701$20240812$20240812$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003479$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240830$$CN$US$US
241985681$24198568$1$I$20240722$20240806$20240812$20240812$EXP$$US-GSK-US2024AMR098983$GLAXOSMITHKLINE$$$$$F$Y$53.515$KG$20240812$$CN$US$US
241985691$24198569$1$I$$20240805$20240812$20240812$EXP$$US-SANDOZ INC.-SDZ2024US071830$SANDOZ$$$$$F$Y$$$20240812$$MD$US$US
241985701$24198570$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158094$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241985711$24198571$1$I$20240701$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003710$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240812$$CN$US$US
241985721$24198572$1$I$20240613$20240802$20240812$20240812$EXP$$CH-VANTIVE-2024VAN018743$Vantive US Healthcare$$$$$M$Y$$$20240812$$CN$CH$CH
241985732$24198573$2$F$$20240903$20240812$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003703$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
241985741$24198574$1$I$$20240805$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123984$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240812$$CN$US$US
241985752$24198575$2$F$20240201$20240906$20240812$20240910$EXP$$US-TAKEDA-2024TUS078517$TAKEDA$$57$YR$$F$Y$$$20240910$$MD$US$US
241985761$24198576$1$I$20240627$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158438$AMGEN$$75$YR$E$F$Y$$$20240812$$CN$US$US
241985772$24198577$2$F$20240101$20240812$20240812$20240813$PER$$US-AMGEN-USASP2024158709$AMGEN$$72$YR$E$F$Y$$$20240813$$CN$US$US
241985781$24198578$1$I$20240806$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159399$AMGEN$$$$$F$Y$$$20240812$$PH$US$US
241985791$24198579$1$I$$20240806$20240812$20240812$PER$$US-ALXN-202408USA000394US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241985812$24198581$2$F$$20240814$20240812$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003711$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
241985821$24198582$1$I$$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003707$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241985833$24198583$3$F$20240101$20240822$20240812$20240827$PER$$US-AMGEN-USASP2024156310$AMGEN$$$$$M$Y$$$20240826$$CN$US$US
241985841$24198584$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408003047$ELI LILLY AND CO$$32$YR$A$M$Y$$$20240812$$CN$US$US
241985851$24198585$1$I$$20240804$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408003031$ELI LILLY AND CO$$31$YR$A$$Y$$$20240812$$LW$US$US
241985861$24198586$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005381$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240812$$CN$US$US
241985871$24198587$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005553$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
241985881$24198588$1$I$20240718$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005752$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240812$$CN$US$US
241985891$24198589$1$I$20240724$20240806$20240812$20240812$30DAY$$US-GSK-US2024098055$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240812$$CN$US$US
241985903$24198590$3$F$20240806$20240920$20240812$20240927$30DAY$$US-JNJFOC-20240819215$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240927$$PH$US$US
241985911$24198591$1$I$$20240809$20240812$20240812$EXP$$PL-SANDOZ INC.-NVSC2020PL035984$SANDOZ$$43$YR$$M$Y$$$20240812$$MD$PL$PL
241985922$24198592$2$F$20240717$20240917$20240812$20240925$EXP$$CO-JNJFOC-20240824741$JOHNSON AND JOHNSON$$67$YR$E$F$Y$59$KG$20240925$$HP$CO$CO
241985932$24198593$2$F$$20240809$20240812$20240814$PER$$US-AMGEN-USASP2024159389$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
241985941$24198594$1$I$$20240731$20240812$20240812$EXP$$TR-NOVOPROD-1266437$NOVO NORDISK$$$$$F$Y$66$KG$20240812$$CN$TR$TR
241985951$24198595$1$I$$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265889$NOVO NORDISK$$$$$F$Y$$$20240812$$HP$US$US
241985961$24198596$1$I$$20240731$20240812$20240812$EXP$$TR-NOVOPROD-1266837$NOVO NORDISK$$$$$M$Y$$$20240812$$CN$TR$TR
241985971$24198597$1$I$$20240731$20240812$20240812$EXP$$US-NOVOPROD-1265773$NOVO NORDISK$$35$YR$$M$Y$$$20240812$$CN$US$US
241985981$24198598$1$I$$20240729$20240812$20240812$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07620$LUPIN$$$$$$Y$$$20240812$$CN$AU$AU
241985991$24198599$1$I$$20240802$20240812$20240812$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR096929$VIIV$$$$A$M$Y$$$20240812$$CN$US$US
241986001$24198600$1$I$20240101$20240807$20240812$20240812$PER$$US-SA-2024SA236352$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240812$$MD$US$US
241986012$24198601$2$F$$20240916$20240812$20240926$PER$$US-GSK-US2024097025$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
241986021$24198602$1$I$$20240807$20240812$20240812$30DAY$$US-GSK-US2024AMR098850$GLAXOSMITHKLINE$$$$$M$Y$$$20240812$$CN$US$US
241986031$24198603$1$I$$20240802$20240812$20240812$PER$$US-SA-2022SA312656$SANOFI AVENTIS$$11$MON$I$M$Y$13$KG$20240812$$MD$US$US
241986041$24198604$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236649$SANOFI AVENTIS$$$$A$F$Y$74.843$KG$20240812$$MD$US$US
241986051$24198605$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235460$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240812$$MD$US$US
241986061$24198606$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA234157$SANOFI AVENTIS$$19$YR$A$F$Y$57.06$KG$20240812$$MD$US$US
241986071$24198607$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA233600$SANOFI AVENTIS$$$$E$F$Y$$$20240812$$MD$US$US
241986081$24198608$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA236562$SANOFI AVENTIS$$$$E$M$Y$$$20240812$$MD$US$US
241986091$24198609$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA234114$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240812$$MD$US$US
241986102$24198610$2$F$20240501$20240820$20240812$20240830$PER$$US-SA-2024SA233196$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240830$$MD$US$US
241986111$24198611$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA234102$SANOFI AVENTIS$$43$YR$A$F$Y$68.04$KG$20240812$$MD$US$US
241986121$24198612$1$I$20240717$20240802$20240812$20240812$PER$$US-SA-2024SA234127$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240812$$MD$US$US
241986131$24198613$1$I$20221201$20240803$20240812$20240812$PER$$US-SA-2024SA233590$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240812$$MD$US$US
241986141$24198614$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA236336$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240812$$MD$US$US
241986151$24198615$1$I$20240501$20240807$20240812$20240812$PER$$US-SA-2024SA236650$SANOFI AVENTIS$$$$$M$Y$$$20240812$$HP$US$US
241986161$24198616$1$I$$20240802$20240812$20240812$PER$$US-RDY-SPO/USA/24/0011517$DR REDDYS$$15$YR$T$F$Y$$$20240812$$MD$US$US
241986171$24198617$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA235123$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240812$$MD$US$US
241986181$24198618$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235284$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240812$$MD$US$US
241986191$24198619$1$I$20240519$20240802$20240812$20240812$PER$$US-HETERO-HET2024US02594$HETERO$$56$YR$$M$Y$$$20240812$$CN$US$US
241986201$24198620$1$I$20240731$20240801$20240812$20240812$EXP$$ZA-BIOVITRUM-2024-ZA-010773$BIOVITRUM$$92$DY$$F$Y$$$20240812$$CN$ZA$ZA
241986222$24198622$2$F$20240805$20240819$20240812$20240821$PER$$US-AMGEN-USASP2024158287$AMGEN$$84$YR$E$F$Y$$$20240821$$HP$US$US
241986231$24198623$1$I$20230819$20240722$20240812$20240812$PER$$US-009507513-2407USA012597$MERCK$$$$$F$Y$$$20240812$$CN$US$US
241986241$24198624$1$I$$20240806$20240812$20240812$EXP$$US-GSK-US2024097951$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
241986253$24198625$3$F$20240726$20240819$20240812$20240827$EXP$$CA-ROCHE-10000052778$ROCHE$$32$YR$A$F$Y$$$20240827$$CN$CA$CA
241986261$24198626$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163094$NOVARTIS$$$$$$Y$$$20240812$$HP$US$US
241986271$24198627$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235485$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240812$$MD$US$US
241986281$24198628$1$I$20240701$20240805$20240812$20240812$PER$$US-SA-2024SA236678$SANOFI AVENTIS$$58$YR$A$F$Y$77.11$KG$20240812$$MD$US$US
241986291$24198629$1$I$$20240805$20240812$20240812$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-109259$REGENERON$$$$$M$Y$$$20240812$$CN$DE$DE
241986301$24198630$1$I$$20240807$20240812$20240812$EXP$$US-JNJFOC-20240820991$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$CN$US$US
241986312$24198631$2$F$20240101$20240820$20240812$20240821$EXP$$US-UCBSA-2024040331$UCB$$$$$F$Y$$$20240821$$CN$US$US
241986322$24198632$2$F$20240101$20240812$20240812$20240813$PER$$US-AMGEN-USASP2024158359$AMGEN$$84$YR$E$F$Y$$$20240813$$CN$US$US
241986341$24198634$1$I$20240806$20240806$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125254$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$79$KG$20240812$$PH$US$US
241986351$24198635$1$I$20240801$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158762$AMGEN$$77$YR$E$F$Y$$$20240812$$CN$US$US
241986362$24198636$2$F$20240802$20240812$20240812$20240814$PER$$US-AMGEN-USASP2024159212$AMGEN$$69$YR$E$M$Y$$$20240813$$PH$US$US
241986371$24198637$1$I$20171106$20240805$20240812$20240812$EXP$$US-GSK-US2024098113$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
241986381$24198638$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163007$NOVARTIS$$$$$M$Y$$$20240812$$CN$US$US
241986391$24198639$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005859$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240812$$CN$US$US
241986401$24198640$1$I$20240801$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408001785$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240812$$CN$US$US
241986412$24198641$2$F$$20240807$20240812$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408005418$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240815$$CN$US$US
241986421$24198642$1$I$$20240731$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408000283$ELI LILLY AND CO$$56$YR$A$$Y$$$20240812$$LW$US$US
241986431$24198643$1$I$20240807$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005749$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240812$$CN$US$US
241986441$24198644$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005673$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240812$$CN$US$US
241986451$24198645$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004726$ELI LILLY AND CO$$38$YR$A$$Y$$$20240812$$LW$US$US
241986461$24198646$1$I$20240804$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004604$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240812$$CN$US$US
241986471$24198647$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005477$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240812$$CN$US$US
241986481$24198648$1$I$20240802$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005468$ELI LILLY AND CO$$58$YR$A$$Y$$$20240812$$CN$US$US
241986491$24198649$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006339$ELI LILLY AND CO$$46$YR$A$$Y$$$20240812$$CN$US$US
241986501$24198650$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005007$ELI LILLY AND CO$$75$YR$E$$Y$$$20240812$$CN$US$US
241986521$24198652$1$I$$20240805$20240812$20240812$PER$$US-ALXN-202408USA000296US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241986531$24198653$1$I$$20240801$20240812$20240812$EXP$$GB-NOVOPROD-1264534$NOVO NORDISK$$$$$F$Y$$$20240812$$CN$GB$GB
241986541$24198654$1$I$20240601$20240801$20240812$20240812$EXP$$US-NOVOPROD-1264114$NOVO NORDISK$$78$YR$$F$Y$$$20240812$$CN$US$US
241986551$24198655$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235467$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240812$$MD$US$US
241986562$24198656$2$F$20240801$20240911$20240812$20240924$PER$$US-SA-2024SA235684$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240924$$MD$US$US
241986571$24198657$1$I$$20240801$20240812$20240812$EXP$$GB-NOVOPROD-1263443$NOVO NORDISK$$47$YR$$F$Y$$$20240812$$HP$GB$GB
241986581$24198658$1$I$$20240718$20240812$20240812$EXP$$US-ABBVIE-5875356$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241986591$24198659$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163085$NOVARTIS$$$$$$Y$$$20240812$$HP$US$US
241986601$24198660$1$I$$20240801$20240812$20240812$EXP$$CN-NOVOPROD-1264838$NOVO NORDISK$$$$$M$Y$$$20240812$$CN$CN$CN
241986611$24198661$1$I$20240724$20240801$20240812$20240812$EXP$CN-NMPA-5110021035768202400113$CN-NOVOPROD-1264589$NOVO NORDISK$$49$YR$$F$Y$60$KG$20240812$$HP$CN$CN
241986621$24198662$1$I$20240715$20240801$20240812$20240812$EXP$CN-NMPA-5329001570801202400777$CN-NOVOPROD-1264884$NOVO NORDISK$$70$YR$$M$Y$73.2$KG$20240812$$HP$CN$CN
241986631$24198663$1$I$20240806$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158384$AMGEN$$68$YR$E$M$Y$$$20240812$$CN$US$US
241986651$24198665$1$I$20240601$20240801$20240812$20240812$EXP$CN-NMPA-3508021010953202400509$CN-NOVOPROD-1264892$NOVO NORDISK$$68$YR$$F$Y$60$KG$20240812$$HP$CN$CN
241986661$24198666$1$I$$20240801$20240812$20240812$EXP$$IL-NOVOPROD-1265314$NOVO NORDISK$$$$$F$Y$$$20240812$$MD$IL$IL
241986671$24198667$1$I$20240726$20240801$20240812$20240812$EXP$CN-NMPA-3202841025955202400600$CN-NOVOPROD-1264581$NOVO NORDISK$$67$YR$$M$Y$50$KG$20240812$$HP$CN$CN
241986681$24198668$1$I$20231201$20240801$20240812$20240812$EXP$$BR-NOVOPROD-1264903$NOVO NORDISK$$58$YR$$F$Y$115$KG$20240812$$CN$BR$BR
241986691$24198669$1$I$$20240801$20240812$20240812$EXP$$AT-NOVOPROD-1265071$NOVO NORDISK$$60$YR$$F$Y$$$20240812$$MD$AT$AT
241986701$24198670$1$I$20240701$20240806$20240812$20240812$EXP$$US-SA-2024SA235779$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240812$$MD$US$US
241986711$24198671$1$I$$20240806$20240812$20240812$EXP$$US-SA-2024SA236530$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$MD$US$US
241986722$24198672$2$F$20240729$20240816$20240812$20240822$EXP$$CA-JNJFOC-20240768113$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240822$$HP$CA$CA
241986731$24198673$1$I$$20240806$20240812$20240812$EXP$$US-TAKEDA-2024TUS078868$TAKEDA$$$$$F$Y$$$20240812$$CN$US$US
241986742$24198674$2$F$20240101$20240823$20240812$20240904$PER$$US-SA-2024SA235478$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240904$$MD$US$US
241986751$24198675$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235482$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240812$$MD$US$US
241986761$24198676$1$I$$20240805$20240812$20240812$EXP$$JP-ADVANZ PHARMA-202408006691$ADVANZ PHARMA$$$$$$Y$$$20240812$$MD$JP$JP
241986771$24198677$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA203633$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240812$$MD$US$US
241986781$24198678$1$I$20240806$20240809$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126707$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240812$$CN$US$US
241986792$24198679$2$F$20240712$20240826$20240812$20240904$EXP$$JP-ROCHE-10000031907$ROCHE$$8$DEC$E$M$Y$$$20240904$$MD$JP$JP
241986821$24198682$1$I$$20240729$20240812$20240812$PER$$US-ROCHE-10000041943$ROCHE$$$$E$F$Y$$$20240812$$CN$US$US
241986833$24198683$3$F$20240701$20240904$20240812$20240911$EXP$$US-009507513-2408USA001386$MERCK$$36$YR$$F$Y$$$20240911$$HP$US$US
241986841$24198684$1$I$20210621$20210705$20240812$20240812$EXP$$NL-TERSERA THERAPEUTICS LLC-2021TRS003285$TERSERA THERAPEUTICS$$$$$$Y$$$20240812$$CN$NL$NL
241986851$24198685$1$I$$20240808$20240812$20240812$PER$$US-JNJFOC-20240821702$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$MD$US$US
241986861$24198686$1$I$$20240730$20240812$20240812$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092985$GLENMARK$Elwood KF, Warner EJ, Chang JS, Kopplin LJ.. Aspergillus Endophthalmitis Secondary to Infectious Scleritis: Utility of Diagnostic PCR.. Retinal cases + brief reports.. 2024$$$$$Y$$$20240812$$MD$US$US
241986871$24198687$1$I$20240806$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024157652$AMGEN$$70$YR$E$F$Y$$$20240812$$CN$US$US
241986881$24198688$1$I$20240301$20240807$20240812$20240812$PER$$US-ALXN-202408USA000458US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$MD$US$US
241986891$24198689$1$I$20240729$20240801$20240812$20240812$EXP$$CN-ROCHE-10000047080$ROCHE$$64$YR$A$F$Y$59$KG$20240812$$HP$CN$CN
241986901$24198690$1$I$20240611$20240801$20240812$20240812$EXP$CN-NMPACDR-3301051028618202400158$CN-BAXTER-2024BAX022704$BAXTER$$4$YR$$M$Y$17$KG$20240812$$MD$CN$CN
241986911$24198691$1$I$20240705$20240801$20240812$20240812$EXP$CN-NMPACDR-4409021008661202400725$CN-BAXTER-2024BAX022733$BAXTER$$65$YR$$F$Y$$$20240812$$MD$CN$CN
241986921$24198692$1$I$$20240801$20240812$20240812$EXP$$CA-BAXTER-2024BAX022680$BAXTER$$74$YR$$F$Y$54$KG$20240812$$HP$CA$CA
241986931$24198693$1$I$20240629$20240802$20240812$20240812$EXP$CN-NMPACDR-3701031012442202400239$CN-BAXTER-2024BAX022782$BAXTER$$56$YR$$F$Y$55$KG$20240812$$MD$CN$CN
241986941$24198694$1$I$$20240801$20240812$20240812$EXP$$CA-BAXTER-2024BAX022601$BAXTER$$74$YR$$F$Y$54$KG$20240812$$HP$CA$CA
241986952$24198695$2$F$20240726$20240813$20240812$20240819$EXP$$US-SANDOZ INC.-SDZ2024US071295$SANDOZ$$50$YR$$F$Y$$$20240819$$HP$US$US
241986961$24198696$1$I$$20240801$20240812$20240812$EXP$$JP-ROCHE-10000051649$ROCHE$$8$DEC$E$F$Y$$$20240812$$MD$JP$JP
241986971$24198697$1$I$$20240807$20240812$20240812$PER$$US-BEH-2024177032$CSL BEHRING$$20$YR$A$M$Y$$$20240810$$CN$US$US
241986981$24198698$1$I$$20240729$20240812$20240812$EXP$$AU-STERISCIENCE B.V.-2024-ST-001141$Steriscience PTE$Donnan M, Siemienowicz M, Tay HS, McLean C, Philpot S, Mason C, et al.. Trimethoprim-sulfamethoxazole acute respiratory distress syndrome requiring lung transplantation.. Respirol-Case-Rep. 2024;12(7)$18$YR$$F$Y$$$20240812$$HP$AU$AU
241986991$24198699$1$I$$20240807$20240812$20240812$PER$$US-BEH-2024176984$CSL BEHRING$$$$E$$Y$$$20240810$$CN$US$US
241987003$24198700$3$F$$20240807$20240812$20240823$PER$$US-BEH-2024177019$CSL BEHRING$$$$$F$Y$$$20240823$$CN$US$US
241987022$24198702$2$F$$20240829$20240812$20240903$EXP$$JP-BEH-2024176813$CSL BEHRING$$9$YR$C$M$Y$$$20240903$$MD$JP$JP
241987031$24198703$1$I$20240804$20240807$20240812$20240812$EXP$$US-BEH-2024176981$CSL BEHRING$$71$YR$E$F$Y$37.642$KG$20240812$$CN$US$US
241987041$24198704$1$I$$20240806$20240812$20240812$PER$$US-BEH-2024177028$CSL BEHRING$$$$A$M$Y$$$20240810$$MD$US$US
241987051$24198705$1$I$20240803$20240809$20240812$20240812$EXP$$US-UCBSA-2024040402$UCB$$34$YR$$M$Y$$$20240812$$CN$US$US
241987061$24198706$1$I$20240601$20240805$20240812$20240812$PER$$US-SA-2024SA235227$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240812$$MD$US$US
241987071$24198707$1$I$$20240805$20240812$20240812$EXP$$NVSC2024US160908$NOVARTIS$$48$YR$$M$Y$$$20240812$$HP$US$US
241987081$24198708$1$I$20220101$20240807$20240812$20240812$PER$$US-SA-2024SA237062$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240812$$CN$US$US
241987091$24198709$1$I$20240701$20240807$20240812$20240812$PER$$US-SA-2024SA236668$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240812$$MD$US$US
241987101$24198710$1$I$$20240805$20240812$20240812$PER$$US-ABBVIE-5868525$ABBVIE$$$$$$Y$$$20240812$$HP$US$US
241987111$24198711$1$I$20240601$20240805$20240812$20240812$PER$$US-SA-2024SA236573$SANOFI AVENTIS$$62$YR$A$F$Y$78.01$KG$20240812$$MD$US$US
241987121$24198712$1$I$$20240731$20240812$20240812$EXP$$US-RDY-LIT/USA/24/0011627$DR REDDYS$Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. blood. 2023 Nov;142: 5898. doi:10.1182/blood-2023-188298.$$$A$$Y$$$20240812$$MD$US$US
241987132$24198713$2$F$20240725$20240905$20240812$20240911$EXP$$JP-009507513-2408JPN000964J$MERCK$$75$YR$$F$Y$$$20240911$$MD$JP$JP
241987141$24198714$1$I$$20240806$20240812$20240812$EXP$$NVSC2024DE162444$NOVARTIS$$$$$F$Y$$$20240812$$MD$DE$DE
241987151$24198715$1$I$$20240805$20240812$20240812$EXP$$CN-ROCHE-10000048970$ROCHE$$47$YR$A$F$Y$$$20240812$$MD$CN$CN
241987172$24198717$2$F$20240101$20240809$20240812$20240814$PER$$US-AMGEN-USASP2024158971$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
241987181$24198718$1$I$$20240802$20240812$20240812$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009951$STRIDES$Shuster A, Peng C.. Neisseria Flavescens Bacteremia in an Otherwise Immunocompetent Host.. Am-J-Respir-Crit-Care-Med. 2024;209:A1655$$$$$Y$$$20240812$$HP$US$US
241987191$24198719$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024159094$AMGEN$$$$$$Y$$$20240812$$HP$US$US
241987201$24198720$1$I$20240118$20240807$20240812$20240812$EXP$FI-FIMEA-202402311$FI-TAKEDA-2024TUS079400$TAKEDA$$25$YR$$F$Y$$$20240812$$HP$FI$FI
241987211$24198721$1$I$20240711$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006390$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240812$$CN$US$US
241987221$24198722$1$I$$20240805$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408002786$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240812$$CN$US$US
241987231$24198723$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004982$ELI LILLY AND CO$$60$YR$A$$Y$$$20240812$$LW$US$US
241987241$24198724$1$I$$20240731$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408000357$ELI LILLY AND CO$$54$YR$A$$Y$$$20240812$$LW$US$US
241987251$24198725$1$I$$20240731$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005469$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
241987261$24198726$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005891$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
241987271$24198727$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005506$ELI LILLY AND CO$$$$A$F$Y$$$20240812$$CN$US$US
241987281$24198728$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004966$ELI LILLY AND CO$$66$YR$E$$Y$$$20240812$$LW$US$US
241987291$24198729$1$I$$20240801$20240812$20240812$PER$$US-MTPC-MTDA2024-0016373$MITSUBISHI TANABE PHARMA$$65$YR$$F$Y$$$20240812$$CN$US$US
241987303$24198730$3$F$20240807$20240819$20240812$20240821$PER$$US-AMGEN-USASP2024157955$AMGEN$$58$YR$A$M$Y$$$20240821$$CN$US$US
241987313$24198731$3$F$20240101$20240820$20240812$20240823$PER$$US-AMGEN-USASP2024159403$AMGEN$$88$YR$E$F$Y$$$20240823$$PH$US$US
241987321$24198732$1$I$$20240807$20240812$20240812$EXP$$US-AMGEN-USASP2024157589$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241987331$24198733$1$I$$20240808$20240812$20240812$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-108928$REGENERON$$$$$F$Y$$$20240812$$CN$US$US
241987341$24198734$1$I$$20240806$20240812$20240812$EXP$$CN-INDOCO-IND-2024-CN-LIT-00021$INDOCO$Zhai W, Liu H, Li J, Xin H.Pregabalin-induced rhabdomyolysis: a case series and literature analysis.Journal of International Medical Reasearch.JUN-2024;52(6):1-8$90$YR$E$F$Y$$$20240812$$HP$CN$CN
241987351$24198735$1$I$$20240807$20240812$20240812$PER$$US-ABBVIE-5872499$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241987363$24198736$3$F$20211201$20240806$20240812$20240821$EXP$$CA-TAKEDA-2022TUS011763$TAKEDA$$33$YR$$M$Y$$$20240821$$MD$CA$CA
241987371$24198737$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191374$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
241987382$24198738$2$F$$20240816$20240812$20240830$PER$$US-SA-2024SA234619$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240830$$MD$US$US
241987391$24198739$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA236672$SANOFI AVENTIS$$60$YR$A$M$Y$113.39$KG$20240812$$MD$US$US
241987401$24198740$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA236227$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240812$$MD$US$US
241987411$24198741$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA233180$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240812$$CN$US$US
241987421$24198742$1$I$20240805$20240805$20240812$20240812$EXP$$JP-AMGEN-JPNSP2024158581$AMGEN$$8$DEC$E$F$Y$$$20240812$$PH$JP$JP
241987431$24198743$1$I$$20240730$20240812$20240812$EXP$$GB-AUROBINDO-AUR-APL-2024-038404$AUROBINDO$$$$$M$Y$$$20240812$$MD$GB$GB
241987442$24198744$2$F$20240101$20240827$20240812$20240903$EXP$$US-ABBVIE-5873942$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
241987451$24198745$1$I$20240501$20240802$20240812$20240812$EXP$$JP-009507513-2408JPN000340J$MERCK$$67$YR$$M$Y$$$20240812$$MD$JP$JP
241987461$24198746$1$I$20240320$20240729$20240812$20240812$PER$$US-JNJFOC-20240782862$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240812$$CN$US$US
241987471$24198747$1$I$20240806$20240807$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125719$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240812$$CN$US$US
241987482$24198748$2$F$$20240903$20240812$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125939$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$64.86$KG$20240906$$CN$US$US
241987491$24198749$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126823$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240812$$CN$US$US
241987502$24198750$2$F$20240729$20240808$20240812$20240819$EXP$$JP-RECORDATI-2024006081$RECORDATI$$$$$$Y$$$20240819$$MD$JP$JP
241987511$24198751$1$I$20240705$20240803$20240812$20240812$EXP$$IN-ROCHE-10000049051$ROCHE$$60$YR$A$F$Y$$$20240812$$CN$IN$IN
241987521$24198752$1$I$20240807$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158067$AMGEN$$76$YR$E$F$Y$$$20240812$$CN$US$US
241987542$24198754$2$F$$20240911$20240812$20240923$EXP$$ES-AUROBINDO-AUR-APL-2024-038838$AUROBINDO$Martinez-chantar ML, Gil-pitarch C, Serrano-macia M, Simon J, Mosca L, Conter C, et al. Neddylation inhibition prevents acetaminopheninduced liver damage by enhancing the anabolic cardiolipin pathway. Cell Reports Medicine. 2024;5(7):1-18$$$A$F$Y$$$20240923$$HP$ES$ES
241987551$24198755$1$I$$20240807$20240812$20240812$EXP$$CA-GILEAD-2024-0683655$GILEAD$$$$A$M$Y$$$20240812$$CN$CA$CA
241987571$24198757$1$I$20240101$20240805$20240812$20240812$EXP$$US-SA-2024SA236166$SANOFI AVENTIS$$59$YR$A$M$Y$88.45$KG$20240812$$MD$US$US
241987581$24198758$1$I$$20240809$20240812$20240812$EXP$$US-JNJFOC-20240825010$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240812$$HP$US$US
241987595$24198759$5$F$20221101$20240911$20240812$20240912$EXP$$NVSC2024AU159318$NOVARTIS$$43$YR$$F$Y$$$20240912$$HP$AU$AU
241987612$24198761$2$F$20240501$20240828$20240812$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07724$LUPIN$$$$$$Y$$$20240906$$CN$US$US
241987624$24198762$4$F$$20240901$20240812$20240906$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001589$BLUEPRINT MEDICINES$$$$$F$Y$$$20240906$$HP$US$US
241987631$24198763$1$I$20240725$20240809$20240812$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US071833$SANDOZ$$56$YR$$F$Y$$$20240812$$HP$US$US
241987641$24198764$1$I$$20240801$20240812$20240812$EXP$$TR-NOVOPROD-1265854$NOVO NORDISK$$$$$F$Y$$$20240812$$HP$TR$TR
241987651$24198765$1$I$$20240801$20240812$20240812$EXP$$US-NOVOPROD-1265693$NOVO NORDISK$$$$$M$Y$$$20240812$$CN$US$US
241987661$24198766$1$I$$20240801$20240812$20240812$EXP$$IL-NOVOPROD-1265462$NOVO NORDISK$$77$YR$$F$Y$$$20240812$$MD$IL$IL
241987671$24198767$1$I$$20240801$20240812$20240812$EXP$$US-NOVOPROD-1266401$NOVO NORDISK$$$$$M$Y$$$20240812$$CN$US$US
241987681$24198768$1$I$$20240801$20240812$20240812$EXP$$US-NOVOPROD-1266411$NOVO NORDISK$$41$YR$$$Y$$$20240812$$CN$US$US
241987691$24198769$1$I$$20240801$20240812$20240812$EXP$$US-NOVOPROD-1265406$NOVO NORDISK$$$$$F$Y$$$20240812$$CN$US$US
241987701$24198770$1$I$$20240801$20240812$20240812$EXP$$US-NOVOPROD-1266322$NOVO NORDISK$$59$YR$$$Y$$$20240812$$CN$US$US
241987712$24198771$2$F$20240601$20240807$20240812$20240819$EXP$$US-NOVOPROD-1266428$NOVO NORDISK$$49$YR$$$Y$$$20240819$$CN$US$US
241987721$24198772$1$I$$20240801$20240812$20240812$EXP$$US-NOVOPROD-1265569$NOVO NORDISK$$$$$F$Y$$$20240812$$MD$US$US
241987731$24198773$1$I$$20240801$20240812$20240812$EXP$$US-NOVOPROD-1266425$NOVO NORDISK$$51$YR$$$Y$$$20240812$$CN$US$US
241987741$24198774$1$I$$20240801$20240812$20240812$EXP$$US-NOVOPROD-1266366$NOVO NORDISK$$68$YR$$$Y$$$20240812$$CN$US$US
241987751$24198775$1$I$20230501$20240801$20240812$20240812$EXP$$US-NOVOPROD-1266012$NOVO NORDISK$$83$YR$$M$Y$$$20240812$$CN$US$US
241987761$24198776$1$I$$20240801$20240812$20240812$EXP$$US-NOVOPROD-1266417$NOVO NORDISK$$46$YR$$$Y$$$20240812$$CN$US$US
241987771$24198777$1$I$$20240801$20240812$20240812$EXP$$US-NOVOPROD-1266423$NOVO NORDISK$$49$YR$$$Y$$$20240812$$CN$US$US
241987782$24198778$2$F$$20240904$20240812$20240904$PER$$US-ALXN-202408USA000405US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
241987792$24198779$2$F$$20240828$20240812$20240828$PER$$US-ALXN-202408USA000417US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241987803$24198780$3$F$$20240821$20240812$20240828$EXP$$US-ALXN-202408USA000248US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241987813$24198781$3$F$$20240909$20240812$20240911$30DAY$$US-ROCHE-10000050667$ROCHE$$$$$$Y$$$20240911$$MD$US$US
241987821$24198782$1$I$20240415$20240805$20240812$20240812$EXP$FR-AFSSAPS-BS2024000454$FR-ROCHE-10000048772$ROCHE$$85$YR$E$M$Y$72$KG$20240812$$MD$FR$FR
241987831$24198783$1$I$$20240804$20240812$20240812$EXP$$BR-ROCHE-10000049266$ROCHE$$80$YR$E$F$Y$$$20240812$$MD$BR$BR
241987842$24198784$2$F$20240805$20240813$20240812$20240820$PER$$US-SA-2024SA232504$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240820$$MD$US$US
241987851$24198785$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA234913$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240812$$CN$US$US
241987861$24198786$1$I$20240101$20240803$20240812$20240812$PER$$US-SA-2024SA232846$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240812$$MD$US$US
241987871$24198787$1$I$20240601$20240805$20240812$20240812$PER$$US-SA-2024SA235487$SANOFI AVENTIS$$37$YR$A$M$Y$136$KG$20240812$$MD$US$US
241987881$24198788$1$I$20240412$20240801$20240812$20240812$EXP$$CA-TAKEDA-2023TUS077908$TAKEDA$$48$YR$$F$Y$$$20240812$$HP$CA$CA
241987891$24198789$1$I$$20240805$20240812$20240812$30DAY$$US-GSK-US2024097608$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
241987911$24198791$1$I$$20240801$20240812$20240812$EXP$$US-NOVOPROD-1265512$NOVO NORDISK$$$$$F$Y$$$20240812$$CN$US$US
241987921$24198792$1$I$20240101$20240808$20240812$20240812$EXP$$US-ABBVIE-5875579$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241987931$24198793$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125912$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240812$$CN$US$US
241987941$24198794$1$I$$20240730$20240812$20240812$EXP$GB-MHRA-MED-202407300742060690-TMPNY$GB-ADVANZ PHARMA-202407006462$ADVANZ PHARMA$$$$$$Y$$$20240812$$HP$GB$GB
241987951$24198795$1$I$$20240806$20240812$20240812$PER$$US-ABBVIE-5872520$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241987961$24198796$1$I$20240610$20240730$20240812$20240812$EXP$$GB-ADVANZ PHARMA-202407006464$ADVANZ PHARMA$$$$$$Y$$$20240812$$MD$GB$GB
241987971$24198797$1$I$$20240809$20240812$20240812$PER$$US-GILEAD-2024-0683666$GILEAD$$38$YR$A$F$Y$$$20240812$$PH$US$US
241987981$24198798$1$I$20240729$20240730$20240812$20240812$EXP$$US-ROCHE-10000044060$ROCHE$$54$YR$A$F$Y$$$20240812$$CN$US$US
241987991$24198799$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024159390$AMGEN$$$$$$Y$$$20240812$$CN$US$US
241988001$24198800$1$I$$20240808$20240812$20240812$EXP$$US-GILEAD-2024-0682777$GILEAD$$$$E$M$Y$$$20240812$$PH$US$US
241988011$24198801$1$I$$20240802$20240812$20240812$PER$$US-ROCHE-10000047589$ROCHE$Li X, Kumar D, Bo A, Le J, Ellis A, Young K, et al. A Case of Disseminated Mycobacterium Haemophilum in a Kidney Transplant Recipient Presenting With Subcutaneous Nodules. Wisconsin Medical Journal. 2024-Jul;123 (3):233-7.$63$YR$A$M$Y$$$20240812$$MD$US$US
241988021$24198802$1$I$$20240807$20240812$20240812$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001590$BLUEPRINT MEDICINES$$$$$F$Y$$$20240812$$HP$US$US
241988031$24198803$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004628$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
241988042$24198804$2$F$20240809$20240816$20240812$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408006392$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240819$$CN$US$US
241988052$24198805$2$F$20240803$20240815$20240812$20240826$EXP$$US-ROCHE-10000051293$ROCHE$$82$YR$E$F$Y$$$20240826$$MD$US$US
241988061$24198806$1$I$$20240802$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408001995$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
241988071$24198807$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005522$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
241988081$24198808$1$I$20240726$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005865$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240812$$PH$US$US
241988091$24198809$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004986$ELI LILLY AND CO$$47$YR$A$$Y$$$20240812$$LW$US$US
241988101$24198810$1$I$20240805$20240808$20240812$20240812$EXP$$CA-APOTEX-2024AP009181$APOTEX$$86$YR$E$M$Y$$$20240812$$HP$CA$CA
241988112$24198811$2$F$$20240815$20240812$20240820$EXP$$US-ABBVIE-5874133$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
241988121$24198812$1$I$$20240805$20240812$20240812$PER$$US-BIOGEN-2024BI01277277$BIOGEN$$$$$M$Y$$$20240812$$MD$US$US
241988132$24198813$2$F$$20240830$20240812$20240902$30DAY$$DE-UCBSA-2024039099$UCB$$$$$F$Y$$$20240902$$CN$DE$DE
241988141$24198814$1$I$$20240808$20240812$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US071523$SANDOZ$$$$$F$Y$$$20240812$$CN$US$US
241988151$24198815$1$I$$20240729$20240812$20240812$PER$$US-JNJFOC-20240780006$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$MD$US$US
241988161$24198816$1$I$$20240806$20240812$20240812$PER$$US-JNJFOC-20240821839$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240812$$CN$US$US
241988181$24198818$1$I$20240708$20240730$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-038303$AUROBINDO$$58$YR$$F$Y$$$20240812$$MD$FR$FR
241988191$24198819$1$I$20240804$20240808$20240812$20240812$EXP$$US-ABBVIE-5874448$ABBVIE$$46$YR$$F$Y$$$20240812$$CN$US$US
241988201$24198820$1$I$$20240807$20240812$20240812$EXP$$US-SA-2024SA236541$SANOFI AVENTIS$$$$$$Y$$$20240812$$HP$US$US
241988211$24198821$1$I$20240806$20240807$20240812$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US071284$SANDOZ$$$$$M$Y$$$20240812$$HP$US$US
241988221$24198822$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA236841$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240812$$MD$US$US
241988232$24198823$2$F$20240101$20240820$20240812$20240917$PER$$US-SA-2024SA236389$SANOFI AVENTIS$$63$YR$A$F$Y$70.3$KG$20240918$$MD$US$US
241988241$24198824$1$I$20240731$20240805$20240812$20240812$PER$$US-SA-2024SA235499$SANOFI AVENTIS$$27$YR$A$F$Y$74$KG$20240812$$MD$US$US
241988251$24198825$1$I$20240618$20240801$20240812$20240812$EXP$$CA-CELLTRION INC.-2024CA016385$CELLTRION$$$$$$Y$$$20240812$$PH$CA$CA
241988261$24198826$1$I$20220908$20240806$20240812$20240812$EXP$$BR-CELLTRION INC.-2022BR019343$CELLTRION$$$$$$Y$$$20240812$$CN$BR$BR
241988271$24198827$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA233176$SANOFI AVENTIS$$$$E$M$Y$$$20240812$$MD$US$US
241988281$24198828$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235522$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240812$$MD$US$US
241988301$24198830$1$I$$20240802$20240812$20240812$EXP$$US-ROCHE-10000046096$ROCHE$$$$E$M$Y$$$20240812$$CN$US$US
241988311$24198831$1$I$$20240805$20240812$20240812$EXP$$US-GSK-US2024097472$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
241988321$24198832$1$I$$20240801$20240812$20240812$EXP$$BR-IPCA LABORATORIES LIMITED-IPC-2024-BR-001992$IPCA$Eneida Machado Alves, Vanessa Fonseca, Carlos Antonio Moura et al.. Bilateral outer foveal microdefect in a patient with systemic lupus erythematosus using hydroxychloroquine - A case report. Lupus. 2024;0(0):1-3$$$$$Y$$$20240812$$HP$BR$BR
241988331$24198833$1$I$$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024157138$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
241988341$24198834$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-039058$AUROBINDO$Garg A, Joong A, Gambetta K, Monge M, Thrush P.. To VAD or Not VAD? How to Get to Heart Transplant in a Child with Duchenne Muscular Dystrophy. J-Heart-Lung-Transplant. 2024;43 (Suppl.) (4):S633 abstr. 1376$9$YR$$M$Y$$$20240812$$HP$US$US
241988352$24198835$2$F$$20240815$20240812$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125900$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240821$$HP$US$US
241988361$24198836$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126696$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240812$$HP$US$US
241988371$24198837$1$I$$20240805$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124474$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240812$$CN$US$US
241988381$24198838$1$I$20240803$20240805$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125175$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$84.37$KG$20240812$$CN$US$US
241988391$24198839$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125928$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240812$$HP$US$US
241988401$24198840$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125753$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240812$$CN$US$US
241988411$24198841$1$I$20240701$20240730$20240812$20240812$EXP$$DE-AUROBINDO-AUR-APL-2024-038412$AUROBINDO$$83$YR$$M$Y$60$KG$20240812$$MD$DE$DE
241988421$24198842$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-038935$AUROBINDO$Pesantez M, Perez C, Gra S.. THE ROLE OF MEK INHIBITORS IN PAPILLARY THYROID CANCER: A CASE REPORT.. Thyroid. 2023;33 (1):A109-A110$62$YR$$M$Y$$$20240812$$HP$US$US
241988431$24198843$1$I$20240717$20240803$20240812$20240812$EXP$$IN-ROCHE-10000049568$ROCHE$$72$YR$E$M$Y$$$20240812$$CN$IN$IN
241988442$24198844$2$F$20240730$20240807$20240812$20240821$EXP$$GB-TERSERA THERAPEUTICS LLC-2024TRS004018$TERSERA THERAPEUTICS$$$$$$Y$$$20240821$$MD$GB$GB
241988451$24198845$1$I$20240101$20240808$20240812$20240812$EXP$$CA-UCBSA-2024040282$UCB$$$$$F$Y$$$20240812$$CN$CA$CA
241988461$24198846$1$I$20221130$20240730$20240812$20240812$EXP$$IE-AUROBINDO-AUR-APL-2024-038865$AUROBINDO$$5$YR$$F$Y$$$20240812$$CN$IE$IE
241988471$24198847$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA233348$SANOFI AVENTIS$$$$$F$Y$$$20240812$$CN$US$US
241988481$24198848$1$I$$20240806$20240812$20240812$EXP$$US-SA-2024SA235814$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240812$$MD$US$US
241988491$24198849$1$I$$20240801$20240812$20240812$PER$$US-SA-2024SA231626$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240812$$CN$US$US
241988501$24198850$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA236363$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
241988511$24198851$1$I$$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159522$AMGEN$$$$$$Y$$$20240812$$PH$US$US
241988521$24198852$1$I$20200101$20240807$20240812$20240812$EXP$$US-JNJFOC-20240817257$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240812$$HP$US$US
241988531$24198853$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A180010$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241988541$24198854$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179946$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241988553$24198855$3$F$$20240821$20240812$20240826$EXP$$CA-ROCHE-3383757$ROCHE$$28$YR$A$F$Y$$$20240826$$CN$CA$CA
241988562$24198856$2$F$20240101$20240820$20240812$20240822$EXP$$US-SA-2024SA235293$SANOFI AVENTIS$$2$YR$C$M$Y$11.7$KG$20240822$$MD$US$US
241988571$24198857$1$I$$20240801$20240812$20240812$EXP$$GB-MSNLABS-2024MSNSPO01720$MSN LABORATORIES$$$$$$Y$$$20240812$$CN$GB$GB
241988582$24198858$2$F$$20240731$20240812$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462141$RANBAXY$Barsoum G, Talal A. MATERNAL MONITORING FOR MULTI-DRUG REGRACTORY FETAL SUPRAVENTRICULAR TACHYCARDIA: A MANAGEMENT CHALLENGE. J Invest Med. 2023;71:35-36$38$YR$$F$Y$$$20240814$$HP$US$US
241988591$24198859$1$I$$20240809$20240812$20240812$EXP$$GR-ABBVIE-5874988$ABBVIE$$81$YR$$F$Y$$$20240812$$CN$GR$GR
241988602$24198860$2$F$$20240731$20240812$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461960$RANBAXY$Cohen P, Kudchadkar S, Schultz B, Schuette J. Repeated hemodialysis after extended release acetaminophen ingestion. Crit Care Med. 2024;52 (Suppl.) (1):S301 (657)$15$YR$$M$Y$$$20240814$$HP$US$US
241988611$24198861$1$I$$20240731$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-039192$AUROBINDO$Gargues P, SuC, Navarro M, Paillous P, Janin C, Mathieu A.. Hypomagnesemia induced by proton pump inhibitors: a metabolic disorder not to be misunderstood.. The Journal of Internal Medicine.. 2017;38:A150-1$93$YR$$M$Y$$$20240812$$HP$FR$FR
241988622$24198862$2$F$20240727$20240819$20240812$20240827$PER$$US-ABBVIE-5867654$ABBVIE$$30$YR$$M$Y$78.017$KG$20240827$$CN$US$US
241988631$24198863$1$I$$20240808$20240812$20240812$PER$$US-ALXN-202408USA000451US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
241988642$24198864$2$F$$20240812$20240812$20240814$PER$$US-AMGEN-USASP2024159221$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
241988653$24198865$3$F$20240801$20240923$20240812$20240924$PER$$US-AMGEN-USASP2024159353$AMGEN$$67$YR$E$F$Y$$$20240924$$CN$US$US
241988661$24198866$1$I$20210501$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159290$AMGEN$Krause P.J.; Vannier E.; Rogers R. et al.. Tafenoquine for Relapsing Babesiosis: A Case Series. Clinical Infectious Diseases. 2024;79 (1):130-137$80$YR$E$M$Y$$$20240812$$HP$US$US
241988671$24198867$1$I$20220801$20240809$20240812$20240812$EXP$$US-AMGEN-USASP2024159299$AMGEN$Krause P.J.; Vannier E.; Rogers R. et al.. Tafenoquine for Relapsing Babesiosis: A Case Series. Clinical Infectious Diseases. 2024;79 (1):130-137$70$YR$E$F$Y$$$20240812$$HP$US$US
241988681$24198868$1$I$20240702$20240730$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-038711$AUROBINDO$$51$YR$$F$Y$105$KG$20240812$$PH$FR$FR
241988691$24198869$1$I$20240403$20240731$20240812$20240812$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004650$JAZZ$$30$YR$$F$Y$$$20240812$$CN$US$US
241988701$24198870$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005688$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240812$$CN$US$US
241988711$24198871$1$I$20240805$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005077$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
241988721$24198872$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006423$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240812$$CN$US$US
241988731$24198873$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004876$ELI LILLY AND CO$$65$YR$E$$Y$$$20240812$$LW$US$US
241988741$24198874$1$I$20240808$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005656$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240812$$CN$US$US
241988752$24198875$2$F$20240808$20240808$20240812$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408005922$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$US$US
241988761$24198876$1$I$20240806$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159199$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241988771$24198877$1$I$$20240803$20240812$20240812$EXP$$IN-ROCHE-10000014023$ROCHE$$41$YR$A$M$Y$$$20240812$$MD$IN$IN
241988781$24198878$1$I$20231031$20240805$20240812$20240812$EXP$$AU-009507513-2408AUS002709$MERCK$$77$YR$$F$Y$$$20240812$$HP$AU$AU
241988801$24198880$1$I$$20240731$20240812$20240812$EXP$$US-APOTEX-2024AP009078$APOTEX$$$$$M$Y$$$20240812$$CN$US$US
241988811$24198881$1$I$20240728$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179967$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241988821$24198882$1$I$$20240807$20240812$20240812$PER$$US-ROCHE-10000053370$ROCHE$$$$$$Y$$$20240812$$CN$US$US
241988833$24198883$3$F$20240809$20240923$20240812$20240924$PER$$US-AMGEN-USASP2024159373$AMGEN$$50$YR$A$F$Y$$$20240924$$PH$US$US
241988843$24198884$3$F$20230427$20240902$20240812$20240910$EXP$FR-AFSSAPS-CF2024000243$FR-SA-2024SA236138$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240910$$MD$FR$FR
241988851$24198885$1$I$$20240805$20240812$20240812$EXP$US-MLMSERVICE-20240729-PI146473-00312-1$US-RDY-SPO/USA/24/0011553$DR REDDYS$Thor DC, Patel K, Singh M. Navigation of a New-Onset Pulmonary Embolism in a Patient Receiving Female-to-Male Gender-Affirming Care: A Case Report. Cureus. 2024;16(6):e63101. DOI: 10.7759/cureus.63101.$21$YR$A$F$Y$$$20240812$$MD$US$US
241988862$24198886$2$F$20240814$20240814$20240812$20240821$PER$$US-SA-2024SA234006$SANOFI AVENTIS$$10$YR$C$M$Y$45$KG$20240821$$HP$US$US
241988881$24198888$1$I$20240701$20240805$20240812$20240812$PER$$US-SA-2024SA236033$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240812$$MD$US$US
241988891$24198889$1$I$$20240730$20240812$20240812$EXP$$US-862174955-ML2024-04361$MICRO LABS$SEVELAMER ASSOCIATED COLITIS: A TRIGGER TO CHANGE TREATMENT APPROACH. American Journal of Kidney disease. 2024 Apr;Vol 83(4 Suppl 2): S74-S74.$63$YR$A$F$Y$$$20240812$$HP$US$US
241988901$24198890$1$I$20240423$20240802$20240812$20240812$EXP$GB-MHRA-MED-202408012055539780-NRLTM$GB-862174955-ML2024-04344$MICRO LABS$$72$YR$E$F$Y$53$KG$20240812$$CN$GB$GB
241988911$24198891$1$I$$20240730$20240812$20240812$EXP$$IN-862174955-ML2024-04372$MICRO LABS$Ancilla LC, Sundaram B, Pathak N, Raj A. Twin neurological enigmas radiological and medicalinsight into a dual encounter with metformin induced encephalopathy. Journal of nephropharmacology. 2024 Jun 29;Vol 13(2): 1-5. doi:10.34172/npj.2024.11681.$58$YR$A$M$Y$$$20240812$$HP$IN$IN
241988921$24198892$1$I$$20240730$20240812$20240812$EXP$$US-862174955-ML2024-04316$MICRO LABS$Jain S, Sekhon S, Leo Pradeep Chandran AS, Gummadi J, Patel P, Nakka R, et al. Metformin-associated lactic acidosis in an older adult: A case report and review. Cureus. 2024;16(6): 1-6. DOI: 10.7759/cureus.62729.$82$YR$E$M$Y$$$20240812$$MD$US$US
241988931$24198893$1$I$$20240802$20240812$20240812$EXP$GB-MHRA-MED-202408022127263100-JYQWK$GB-862174955-ML2024-04348$MICRO LABS$$$$$F$Y$$$20240812$$CN$GB$GB
241988941$24198894$1$I$$20240730$20240812$20240812$EXP$$US-862174955-ML2024-04317$MICRO LABS$Bally K, Trusty R, Naher K. A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone. Cureus. 2024 Jun 19;16(6): 1-3. doi:10.7759/cureus.62695.$95$YR$E$F$Y$$$20240812$$MD$US$US
241988952$24198895$2$F$$20240911$20240812$20240918$EXP$$US-862174955-ML2024-04191$Unknown Manufacturer$$88$YR$E$F$Y$62$KG$20240918$$CN$US$US
241988961$24198896$1$I$20231201$20240802$20240812$20240812$EXP$DE-CADRBFARM-2024329481$DE-862174955-ML2024-04352$MICRO LABS$$79$YR$E$M$Y$80$KG$20240812$$CN$DE$DE
241988972$24198897$2$F$$20240903$20240812$20240911$EXP$$MA-862174955-ML2024-04376$MICRO LABS$Mourabiti H, Esayh G, Hoummani H, Hanchi SA, Chaouche I, Achour S. Paraparesis secondary to metformin: A rare condition to be aware of, with characteristic MRI images. Toxic-Analyt-Clinique. 2024;1-6.$63$YR$A$F$Y$$$20240911$$HP$MA$MA
241988981$24198898$1$I$$20240730$20240812$20240812$EXP$$IN-862174955-ML2024-04367$MICRO LABS$Ancilla LC, Sundaram B, Pathak N, Raj A. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy.. Journal of nephropharmacology. 2024 Jun 29;Vol 13(2): 1-5. doi:10.34172/npj.2024.11681.$55$YR$A$M$Y$$$20240812$$HP$IN$IN
241988991$24198899$1$I$$20240730$20240812$20240812$EXP$$US-862174955-ML2024-04363$MICRO LABS$Shultz J, Antar-Shultz M, Taha M, Zervogiannis P, Lazcano G, Lamarche J. SEVELAMER-ASSOCIATED COLITIS: A TRIGGER TO CHANGE TREATMENT APPROACH.. American journal of kidney disease. 2024 Apr;(4): S74-S74.$63$YR$A$M$Y$$$20240812$$HP$US$US
241989001$24198900$1$I$$20240730$20240812$20240812$EXP$$JP-862174955-ML2024-04371$MICRO LABS$Takahashi Y, Nakano H, Motoki M, Wakimoto Y, Ikechi D, Koyama Y, et al. Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review. Acute Medicine and Surgery. 2024;11: 1-5. doi:10.1002/ams2.981.$45$YR$A$F$Y$90$KG$20240812$$HP$JP$JP
241989011$24198901$1$I$$20240730$20240812$20240812$EXP$$US-862174955-ML2024-01885$MICRO LABS$Le V, Surineni K, Elias G. A Case of Partially Reversible Oral-buccal-lingual Dyskinesia after Prolonged Levetiracetam Exposure. American Journal of Geriatric Psychiatry, 2024;32(4):S106. DOI:10.1016/j.jagp.2024.01.190.$86$YR$E$F$Y$$$20240812$$MD$US$US
241989031$24198903$1$I$20210101$20240726$20240812$20240812$PER$$US-JNJFOC-20240776136$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240812$$CN$US$US
241989042$24198904$2$F$20240808$20240809$20240812$20240813$PER$$US-ABBVIE-5874105$ABBVIE$$42$YR$$F$Y$$$20240813$$HP$US$US
241989051$24198905$1$I$$20240806$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125944$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240812$$HP$US$US
241989061$24198906$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126721$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240812$$CN$US$US
241989071$24198907$1$I$20240802$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126068$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240812$$CN$US$US
241989082$24198908$2$F$20240806$20240828$20240812$20240828$PER$$US-ALXN-202408USA000452US$ALEXION PHARMACEUTICALS$$56$YR$$F$Y$$$20240828$$CN$US$US
241989101$24198910$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA182404$SANOFI AVENTIS$$18$YR$A$M$Y$58.96$KG$20240812$$MD$US$US
241989111$24198911$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA233408$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240812$$MD$US$US
241989121$24198912$1$I$20240701$20240805$20240812$20240812$PER$$US-SA-2024SA233428$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240812$$CN$US$US
241989131$24198913$1$I$20240701$20240802$20240812$20240812$PER$$US-SA-2024SA235369$SANOFI AVENTIS$$20$YR$A$M$Y$55.247$KG$20240812$$MD$US$US
241989141$24198914$1$I$20240501$20240805$20240812$20240812$PER$$US-SA-2024SA235559$SANOFI AVENTIS$$57$YR$A$F$Y$61$KG$20240812$$MD$US$US
241989151$24198915$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA233369$SANOFI AVENTIS$$$$E$M$Y$$$20240812$$MD$US$US
241989161$24198916$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA236881$SANOFI AVENTIS$$$$E$M$Y$104.32$KG$20240812$$MD$US$US
241989171$24198917$1$I$20240201$20240805$20240812$20240812$PER$$US-SA-2024SA235958$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240812$$MD$US$US
241989181$24198918$1$I$$20240803$20240812$20240812$EXP$$US-GSK-US2024097527$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
241989192$24198919$2$F$20210101$20240820$20240812$20240821$EXP$$US-UCBSA-2024040338$UCB$$$$$M$Y$$$20240821$$CN$US$US
241989211$24198921$1$I$20240602$20240808$20240812$20240812$EXP$$CZ-ABBVIE-5874525$ABBVIE$$63$YR$$F$Y$$$20240812$$MD$CZ$CZ
241989221$24198922$1$I$$20240808$20240812$20240812$EXP$$CO-JNJFOC-20240824508$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$HP$CO$CO
241989231$24198923$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA233427$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240812$$MD$US$US
241989241$24198924$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA235660$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240812$$CN$US$US
241989251$24198925$1$I$$20240803$20240812$20240812$EXP$$IN-ROCHE-3559160$ROCHE$$53$YR$A$M$Y$$$20240812$$MD$IN$IN
241989261$24198926$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5874359$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241989271$24198927$1$I$$20240802$20240812$20240812$EXP$$PK-ROCHE-10000048579$ROCHE$$54$YR$A$F$Y$$$20240812$$CN$PK$PK
241989291$24198929$1$I$20240101$20240808$20240812$20240812$EXP$$NVSC2024SK162356$NOVARTIS$$$$$F$Y$$$20240812$$MD$SK$SK
241989302$24198930$2$F$20240613$20240917$20240812$20240927$PER$$US-GSK-US2024098192$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240927$$HP$US$US
241989311$24198931$1$I$20240808$20240809$20240812$20240812$EXP$$US-UCBSA-2024040293$UCB$$28$YR$$F$Y$$$20240812$$CN$US$US
241989321$24198932$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5874271$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241989331$24198933$1$I$$20240806$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125590$BRISTOL MYERS SQUIBB$$33$YR$A$M$Y$$$20240812$$CN$US$US
241989343$24198934$3$F$20240705$20240813$20240812$20240819$30DAY$$IE-JNJFOC-20240739485$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240819$$CN$IE$IE
241989352$24198935$2$F$20240601$20240917$20240812$20240924$EXP$$CO-JNJFOC-20240824761$JOHNSON AND JOHNSON$$82$YR$E$F$Y$50$KG$20240924$$HP$CO$CO
241989362$24198936$2$F$$20240808$20240812$20240814$EXP$$US-ABBVIE-5874288$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
241989371$24198937$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179898$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241989381$24198938$1$I$20240429$20240808$20240812$20240812$EXP$$US-AstraZeneca-2024A181022$ASTRAZENECA$$31425$DY$$M$Y$$$20240812$$MD$US$
241989393$24198939$3$F$20240806$20240828$20240812$20240828$PER$$US-ALXN-202408USA000462US$ALEXION PHARMACEUTICALS$$9$YR$$M$Y$22.676$KG$20240828$$CN$US$US
241989401$24198940$1$I$20240709$20240808$20240812$20240812$EXP$$US-ABBVIE-5874197$ABBVIE$$28$YR$$M$Y$$$20240812$$CN$US$US
241989411$24198941$1$I$20240701$20240805$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408003142$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240812$$CN$US$US
241989421$24198942$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004888$ELI LILLY AND CO$$65$YR$E$$Y$$$20240812$$LW$US$US
241989431$24198943$1$I$20240807$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005540$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240812$$CN$US$US
241989441$24198944$1$I$20240807$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005547$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
241989452$24198945$2$F$20240201$20240812$20240812$20240816$EXP$$US-ABBVIE-5874823$ABBVIE$$63$YR$$F$Y$104.32$KG$20240816$$CN$US$US
241989461$24198946$1$I$20240423$20240803$20240812$20240812$EXP$GB-MHRA-MED-202408012055539780-NRLTM$GB-MSNLABS-2024MSNSPO01742$MSN LABORATORIES$$$$$$Y$$$20240812$$CN$GB$GB
241989471$24198947$1$I$$20240807$20240812$20240812$30DAY$$US-GSK-US2024098584$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
241989481$24198948$1$I$20240722$20240805$20240812$20240812$PER$$US-ABBVIE-5867547$ABBVIE$$71$YR$$F$Y$$$20240812$$CN$US$US
241989491$24198949$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5875043$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241989501$24198950$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158772$AMGEN$$$$$M$Y$$$20240812$$HP$US$US
241989511$24198951$1$I$20240705$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125438$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$70.76$KG$20240812$$PH$US$US
241989521$24198952$1$I$20240720$20240730$20240812$20240812$EXP$$US-UCBSA-2024039232$UCB$$69$YR$$M$Y$$$20240812$$CN$US$US
241989531$24198953$1$I$$20240809$20240812$20240812$EXP$$US-ABBVIE-5875587$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241989541$24198954$1$I$20240101$20240802$20240812$20240812$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00814$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
241989551$24198955$1$I$20240706$20240802$20240812$20240812$EXP$ES-AEMPS-1552944$ES-TEVA-VS-3230043$TEVA$$90$YR$$M$Y$$$20240812$$MD$ES$ES
241989561$24198956$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158905$AMGEN$$$$$$Y$$$20240812$$CN$US$US
241989571$24198957$1$I$$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024157175$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
241989581$24198958$1$I$$20240805$20240812$20240812$PER$$US-ABBVIE-5870036$ABBVIE$$29$YR$$F$Y$$$20240812$$HP$US$US
241989591$24198959$1$I$20240702$20240807$20240812$20240812$PER$$US-ABBVIE-5872005$ABBVIE$$32$YR$$F$Y$$$20240812$$MD$US$US
241989602$24198960$2$F$20201120$20240827$20240812$20240830$EXP$$NVSC2024US159666$NOVARTIS$$77$YR$$M$Y$$$20240830$$CN$US$US
241989611$24198961$1$I$$20240805$20240812$20240812$EXP$$US-GSK-US2024097481$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
241989621$24198962$1$I$$20240806$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125502$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240812$$CN$US$US
241989631$24198963$1$I$$20240806$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125758$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240812$$CN$US$US
241989641$24198964$1$I$$20240806$20240812$20240812$EXP$$DE-ROCHE-10000051028$ROCHE$$37$YR$A$$Y$$$20240812$$CN$DE$DE
241989651$24198965$1$I$20240730$20240802$20240812$20240812$EXP$$US-VIIV HEALTHCARE LIMITED-US2024096935$VIIV$$61$YR$$M$Y$$$20240812$$CN$US$US
241989661$24198966$1$I$$20240730$20240812$20240812$EXP$$GB-AUROBINDO-AUR-APL-2024-038140$AUROBINDO$$$$$$Y$$$20240812$$CN$GB$GB
241989681$24198968$1$I$$20240805$20240812$20240812$EXP$$EE-IMMUNOCORE, LTD-2024-IMC-002938$IMMUNOCORE$$$$$$Y$$$20240812$$CN$EE$EE
241989691$24198969$1$I$$20240808$20240812$20240812$EXP$$UM-JNJFOC-20240821669$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$UM$UM
241989701$24198970$1$I$20240714$20240808$20240812$20240812$PER$$US-ABBVIE-5875337$ABBVIE$$46$YR$$F$Y$$$20240812$$HP$US$US
241989721$24198972$1$I$$20240807$20240812$20240812$PER$$US-LEO Pharma-372630$LEO PHARM$$53$YR$$M$Y$$$20240812$$CN$US$US
241989732$24198973$2$F$20201127$20240813$20240812$20240816$EXP$$NVSC2023DE074741$NOVARTIS$$$$E$F$Y$82$KG$20240816$$MD$DE$DE
241989741$24198974$1$I$$20240807$20240812$20240812$EXP$$US-TAKEDA-2024TUS079725$TAKEDA$$$$$M$Y$$$20240812$$CN$US$US
241989752$24198975$2$F$20240712$20240903$20240812$20240911$EXP$FR-AFSSAPS-PV2024000724$FR-SA-2024SA236136$SANOFI AVENTIS$$24$YR$A$F$Y$79$KG$20240911$$MD$FR$FR
241989761$24198976$1$I$$20240807$20240812$20240812$PER$$US-SA-2020SA205532$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240812$$CN$US$US
241989771$24198977$1$I$$20240809$20240812$20240812$EXP$$JP-ABBVIE-5874541$ABBVIE$$$$$$Y$$$20240812$$PH$JP$JP
241989781$24198978$1$I$$20240808$20240812$20240812$PER$$US-HALEON-2191365$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
241989791$24198979$1$I$20240701$20240731$20240812$20240812$EXP$$JP-ROCHE-10000050468$ROCHE$$8$DEC$E$F$Y$$$20240812$$PH$JP$JP
241989801$24198980$1$I$20230109$20240808$20240812$20240812$EXP$$EU-BAUSCHBL-2023BNL000386$BAUSCH AND LOMB$$66$YR$$M$Y$101$KG$20240812$$MD$EU$EU
241989812$24198981$2$F$20240802$20240809$20240812$20240815$PER$$US-AMGEN-USASP2024159652$AMGEN$$69$YR$E$F$Y$$$20240815$$CN$US$US
241989821$24198982$1$I$20240716$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125375$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$99.79$KG$20240812$$CN$US$US
241989831$24198983$1$I$20240624$20240808$20240812$20240812$EXP$FR-AFSSAPS-TS2024000893$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-126324$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$64$KG$20240812$$MD$FR$FR
241989841$24198984$1$I$$20240809$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126744$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240812$$HP$US$US
241989853$24198985$3$F$20240710$20240903$20240812$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126571$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240910$$PH$US$US
241989861$24198986$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125401$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240812$$PH$US$US
241989881$24198988$1$I$$20240808$20240812$20240812$PER$$US-JNJFOC-20240821511$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$US$US
241989891$24198989$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-038959$AUROBINDO$Beshay L, Thakkar A.. A Case Of Mature Onset Diabetes Of The Young. J-Endocr-Soc. 2023;7 (Suppl. 1):A513$21$YR$$F$Y$$$20240812$$MD$US$US
241989901$24198990$1$I$$20240801$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408001162$ELI LILLY AND CO$$53$YR$A$$Y$$$20240812$$LW$US$US
241989911$24198991$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005638$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240812$$HP$US$US
241989921$24198992$1$I$20240712$20240801$20240812$20240812$EXP$$JP-ROCHE-10000052299$ROCHE$$60$YR$A$M$Y$$$20240812$$MD$JP$JP
241989931$24198993$1$I$$20240729$20240812$20240812$PER$$US-TEVA-VS-3228946$TEVA$$67$YR$$F$Y$$$20240812$$CN$US$US
241989941$24198994$1$I$$20240808$20240812$20240812$PER$$NVSC2024US162831$NOVARTIS$$$$$$Y$$$20240812$$HP$US$US
241989951$24198995$1$I$$20240805$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408003836$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
241989961$24198996$1$I$$20240715$20240812$20240812$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00746$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
241989971$24198997$1$I$$20240806$20240812$20240812$PER$$US-LEO Pharma-372609$LEO PHARM$$37$YR$$M$Y$$$20240812$$CN$US$US
241989981$24198998$1$I$$20240805$20240812$20240812$EXP$$US-TAKEDA-2024TUS061726$TAKEDA$$$$$F$Y$$$20240812$$CN$US$US
241989991$24198999$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235331$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240812$$MD$US$US
241990001$24199000$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA234337$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240812$$CN$US$US
241990011$24199001$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA233980$SANOFI AVENTIS$$$$$M$Y$$$20240812$$CN$US$US
241990021$24199002$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236534$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240812$$MD$US$US
241990031$24199003$1$I$20220315$20240809$20240812$20240812$EXP$FR-AFSSAPS-PB2024000848$FR-SA-2024SA236686$SANOFI AVENTIS$$76$YR$E$F$Y$88$KG$20240812$$HP$FR$FR
241990041$24199004$1$I$20220617$20240805$20240812$20240812$PER$$US-SA-2023SA248628$SANOFI AVENTIS$$11$YR$C$M$Y$36.7$KG$20240812$$MD$US$US
241990051$24199005$1$I$$20240808$20240812$20240812$EXP$$US-GSK-US2024099260$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$PH$US$US
241990061$24199006$1$I$20240804$20240806$20240812$20240812$30DAY$$US-GSK-US2024098080$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240812$$CN$US$US
241990072$24199007$2$F$$20240911$20240812$20240920$EXP$$US-GSK-US2024AMR097665$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
241990082$24199008$2$F$20240101$20240820$20240812$20240902$EXP$$CA-UCBSA-2024040306$UCB$$$$$F$Y$$$20240902$$CN$CA$CA
241990092$24199009$2$F$$20240816$20240812$20240823$EXP$$JP-UCBSA-2024038915$UCB$Goda S, Ohta T, Ohno R, Tani H, Tsuboi F, Ono H et al.. A male case of congenital nephrotic syndrome caused by ARHGDIA gene mutation. Japanese Journal of Pediatric Nephrology. 2024;37:9-14$3$MON$$M$Y$$$20240823$$MD$JP$JP
241990101$24199010$1$I$$20240808$20240812$20240812$PER$$US-JNJFOC-20240823021$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$US$US
241990111$24199011$1$I$$20240802$20240812$20240812$EXP$$AU-BAUSCHBL-2024BNL030984$BAUSCH AND LOMB$$30$YR$$M$Y$$$20240812$$CN$AU$AU
241990122$24199012$2$F$20240306$20240924$20240812$20240926$EXP$PL-AstraZeneca-2024A121272$PL-ROCHE-10000048785$ROCHE$$71$YR$E$F$Y$$$20240926$$MD$PL$PL
241990162$24199016$2$F$20240715$20240812$20240812$20240814$PER$$US-AMGEN-USASP2024158559$AMGEN$$49$YR$A$F$Y$$$20240814$$CN$US$US
241990171$24199017$1$I$20240101$20240807$20240812$20240812$EXP$$CA-AstraZeneca-2024A179907$ASTRAZENECA$$64$YR$$F$Y$$$20240812$$CN$CA$
241990181$24199018$1$I$20240628$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A180316$ASTRAZENECA$$27908$DY$$F$Y$$$20240812$$MD$US$
241990191$24199019$1$I$$20240807$20240812$20240812$EXP$$ZA-AstraZeneca-2024A180822$ASTRAZENECA$$44$YR$$M$Y$$$20240812$$CN$ZA$
241990201$24199020$1$I$$20240730$20240812$20240812$EXP$$TR-TAKEDA-2024TUS079526$TAKEDA$$$$$$Y$$$20240812$$MD$TR$TR
241990211$24199021$1$I$$20240807$20240812$20240812$PER$$US-ABBVIE-5872625$ABBVIE$$$$$$Y$$$20240812$$MD$US$US
241990221$24199022$1$I$20240715$20240731$20240812$20240812$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15603$IPSEN$$39$YR$A$F$Y$$$20240812$$HP$US$US
241990231$24199023$1$I$20200521$20240802$20240812$20240812$EXP$PL-URPL-1-3864-2020$PL-TEVA-VS-3229639$TEVA$$39$YR$$M$Y$76$KG$20240812$$MD$PL$PL
241990241$24199024$1$I$$20240802$20240812$20240812$EXP$$AU-BAUSCHBL-2024BNL031004$BAUSCH AND LOMB$$91$YR$$F$Y$$$20240812$$CN$AU$AU
241990251$24199025$1$I$$20240802$20240812$20240812$EXP$$AU-BAUSCHBL-2024BNL031001$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240812$$CN$AU$AU
241990261$24199026$1$I$$20240802$20240812$20240812$EXP$$AU-BAUSCHBL-2024BNL031005$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240812$$CN$AU$AU
241990271$24199027$1$I$20230821$20240803$20240812$20240812$EXP$$PL-TAKEDA-2024TUS079044$TAKEDA$$$$$$Y$$$20240812$$CN$PL$PL
241990281$24199028$1$I$20240701$20240807$20240812$20240812$EXP$$US-ABBVIE-5872717$ABBVIE$$52$YR$$M$Y$$$20240812$$CN$US$US
241990291$24199029$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5873822$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241990301$24199030$1$I$$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159439$AMGEN$$$$$$Y$$$20240812$$MD$US$US
241990311$24199031$1$I$$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159248$AMGEN$$31$YR$A$F$Y$$$20240812$$HP$US$US
241990321$24199032$1$I$20240601$20240809$20240812$20240812$EXP$$US-ABBVIE-5875370$ABBVIE$$73$YR$$M$Y$$$20240812$$CN$US$US
241990331$24199033$1$I$20230901$20240809$20240812$20240812$EXP$$US-ABBVIE-5860535$ABBVIE$$70$YR$$F$Y$127$KG$20240812$$CN$US$US
241990342$24199034$2$F$20240801$20240827$20240812$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126237$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240903$$CN$US$US
241990351$24199035$1$I$20230821$20240803$20240812$20240812$EXP$$PL-TAKEDA-2024TUS079043$TAKEDA$$$$$$Y$$$20240812$$CN$PL$PL
241990361$24199036$1$I$$20230830$20240812$20240812$EXP$$US-AstraZeneca-2023A198927$ASTRAZENECA$$$$$$Y$$$20240812$$CN$US$
241990371$24199037$1$I$$20240730$20240812$20240812$EXP$$ES-AUROBINDO-AUR-APL-2024-038966$AUROBINDO$De La Rosa Valero VD, Del Carmen Hernandez Murciano M, Del Carmen Martinez Canovas E, Perez-Crespo CB, Alcazar II-P, Palao GP, et al.. A FATAL STRONGYLOIDES STERCORALIS HYPERINFECTION SYNDROME IN A HIVINFECTED PATIENT. Eur-J-Case-Rep-Intern-Med. 2019;6 (Suppl. 1):410$46$YR$$M$Y$$$20240812$$HP$ES$ES
241990381$24199038$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179914$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241990391$24199039$1$I$20240501$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179699$ASTRAZENECA$$$$$$Y$$$20240812$$CN$US$
241990401$24199040$1$I$20240804$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A180232$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241990421$24199042$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024159362$AMGEN$$$$A$$Y$$$20240812$$HP$US$US
241990431$24199043$1$I$$20231113$20240812$20240812$EXP$$US-AstraZeneca-2023A258932$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241990441$24199044$1$I$$20240801$20240812$20240812$EXP$$JP-ROCHE-10000051945$ROCHE$$$$E$$Y$$$20240812$$MD$JP$JP
241990453$24199045$3$F$$20240819$20240812$20240822$EXP$$US-ABBVIE-5868593$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
241990461$24199046$1$I$$20240807$20240812$20240812$EXP$$CN-TAKEDA-2024TUS080186$TAKEDA$Ye S, Diao Z, L Hua, Xu Y, Wu J, Mao T et.al. A case report of interstitial pneumonia induced by vedolizumab in a patient with ulcerative colitis. Medicine. 2024;31:103$39$YR$$M$Y$$$20240812$$MD$CN$CN
241990471$24199047$1$I$$20240806$20240812$20240812$EXP$$US-ABBVIE-5870934$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241990481$24199048$1$I$$20240801$20240812$20240812$EXP$$US-STERISCIENCE B.V.-2024-ST-001166$Steriscience PTE$Davis RE, Skinner M, Carlberg C, Talbot J.. Aerococcus Urinae: A Rare Urinary Bacterium With Fatal Cardiac Complications.. Am-J-Respir-Crit-Care-Med. 2024;209$72$YR$$M$Y$$$20240812$$HP$US$US
241990491$24199049$1$I$$20240715$20240812$20240812$EXP$$US-ROCHE-10000053116$ROCHE$$$$$$Y$$$20240812$$HP$US$US
241990501$24199050$1$I$20220501$20240806$20240812$20240812$PER$$US-JNJFOC-20240817504$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240812$$CN$US$US
241990512$24199051$2$F$$20240828$20240812$20240828$PER$$US-ALXN-202408USA000419US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
241990531$24199053$1$I$20240725$20240808$20240812$20240812$EXP$$US-ABBVIE-5873962$ABBVIE$$43$YR$$F$Y$$$20240812$$CN$US$US
241990542$24199054$2$F$$20240802$20240812$20240813$PER$$US-ROCHE-10000044553$ROCHE$$$$A$M$Y$$$20240813$$MD$US$US
241990551$24199055$1$I$$20240531$20240812$20240812$EXP$$US-BAUSCHBL-2024BNL031353$BAUSCH AND LOMB$$$$$$Y$$$20240812$$CN$US$US
241990562$24199056$2$F$20240101$20240905$20240812$20240910$EXP$$BG-ABBVIE-5875064$ABBVIE$$71$YR$$F$Y$$$20240910$$CN$BG$BG
241990571$24199057$1$I$20240803$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159645$AMGEN$$64$YR$A$M$Y$$$20240812$$CN$US$US
241990581$24199058$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158871$AMGEN$$$$$$Y$$$20240812$$PH$US$US
241990591$24199059$1$I$$20240730$20240812$20240812$EXP$$IR-862174955-ML2024-04362$MICRO LABS$Ghazavi M, Allameh Z. Levofloxacin-Induced Oromandibular Dystonia in a 9-Year-Old Patient.. Iranian Journal of Child neurology. 2024 Jun 22;Vol 18(3): 151-157. doi://doi.org/10.22037/ijcn.v18i3.18054.$9$YR$C$M$Y$$$20240812$$MD$IR$IR
241990601$24199060$1$I$20240101$20240801$20240812$20240812$EXP$$CA-862174955-ML2024-04382$MICRO LABS$$70$YR$E$M$Y$$$20240812$$HP$CA$CA
241990642$24199064$2$F$20221201$20240910$20240812$20240916$EXP$$CA-TAKEDA-2022TUS083302$TAKEDA$$64$YR$$F$Y$$$20240916$$HP$CA$CA
241990651$24199065$1$I$$20240809$20240812$20240812$PER$$US-ROCHE-10000053307$ROCHE$$49$YR$A$F$Y$$$20240812$$HP$US$US
241990661$24199066$1$I$$20240805$20240812$20240812$PER$$US-ABBVIE-5867784$ABBVIE$$$$$$Y$$$20240812$$HP$US$US
241990671$24199067$1$I$20240801$20240805$20240812$20240812$30DAY$$US-GSK-US2024097542$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240812$$CN$US$US
241990681$24199068$1$I$$20240802$20240812$20240812$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024096883$VIIV$$$$$F$Y$$$20240812$$PH$US$US
241990691$24199069$1$I$20240617$20240808$20240812$20240812$EXP$FR-AFSSAPS-PO2024000890$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-126545$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240812$$PH$FR$FR
241990701$24199070$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126514$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240812$$HP$US$US
241990721$24199072$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125775$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240812$$CN$US$US
241990731$24199073$1$I$$20240802$20240812$20240812$EXP$$US-STERISCIENCE B.V.-2024-ST-001173$Steriscience PTE$Sreekumar S, Rubin R. A Case of Pulmonary Mucormycosis Leading to Non-hepatic Hyperammonemia.. Am-J-Respir-Crit-Care-Med. 2024;209:(plus Poster)$31$YR$$F$Y$$$20240812$$HP$US$US
241990741$24199074$1$I$$20240802$20240812$20240812$EXP$$US-STERISCIENCE B.V.-2024-ST-001170$Steriscience PTE$Mccormack L, Budnick I, Kearns MT.. Lemierre^s Syndrome Secondary to a Fusobacterium Necrophorum Superinfection Following Influenza B Pharyngitis.. Am-J-Respir-Crit-Care-Med. 2024;209:A7325$43$YR$$M$Y$$$20240812$$HP$US$US
241990751$24199075$1$I$$20240808$20240812$20240812$EXP$$US-AMGEN-USASP2024158109$AMGEN$$$$$F$Y$$$20240812$$MD$US$US
241990761$24199076$1$I$$20240801$20240812$20240812$EXP$$US-STERISCIENCE B.V.-2024-ST-001167$Steriscience PTE$Malik S, Brucato MF, Faiver L, Phan T, Yassin MH, Bishop JM, et al.. Severe Fatal ARDS Due to Untreated Human Granulocytic Anaplasmosis in a 67-Year-Old Man: A Case Report.. Am-J-Case-Rep. 2024;25 (0)$67$YR$$M$Y$$$20240812$$HP$US$US
241990771$24199077$1$I$$20240801$20240812$20240812$EXP$$US-STERISCIENCE B.V.-2024-ST-001168$Steriscience PTE$Qadir N, Rulka K, Shirazi I, Durgun A, Trehan M.. A Day on the Beach, a Risk for Vibrio Vulnificus Septicemia.. Am-J-Respir-Crit-Care-Med. 2024;209$61$YR$$M$Y$$$20240812$$HP$US$US
241990782$24199078$2$F$$20240821$20240812$20240827$EXP$$BR-JNJFOC-20240820506$JOHNSON AND JOHNSON$$12$YR$T$F$Y$29$KG$20240828$$CN$BR$BR
241990791$24199079$1$I$$20240802$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408002148$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240812$$CN$US$US
241990811$24199081$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004721$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240812$$CN$US$US
241990821$24199082$1$I$20240705$20240802$20240812$20240812$EXP$IT-MINISAL02-996613$IT-TEVA-VS-3230015$TEVA$$68$YR$$M$Y$$$20240812$$MD$IT$IT
241990831$24199083$1$I$$20240802$20240812$20240812$EXP$$JP-EMD Serono-2024042393$EMD SERONO INC$$75$YR$E$F$Y$$$20240812$$HP$JP$JP
241990841$24199084$1$I$20240101$20240807$20240812$20240812$EXP$$US-ABBVIE-5872870$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241990851$24199085$1$I$$20240718$20240812$20240812$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003747$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241990861$24199086$1$I$20220201$20240731$20240812$20240812$EXP$$PT-ASPEN-GLO2024PT005355$ASPEN$Silva MI, Santos P, Viegas D, Miranda M, Montes V, Pita F, et al.. Neurolymphomatosis as primary presentation of extra-nodal NK/T-cell lymphoma, nasal type. Neurological Sciences.. 2024;45(8):4003-6$$$$$Y$$$20240812$$MD$PT$PT
241990872$24199087$2$F$20240101$20240813$20240812$20240815$EXP$$US-ABBVIE-5873255$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
241990882$24199088$2$F$20240319$20240906$20240812$20240912$EXP$$US-ABBVIE-5501546$ABBVIE$$24$YR$$F$Y$$$20240912$$CN$US$US
241990891$24199089$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5839964$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241990901$24199090$1$I$20240608$20240808$20240812$20240812$EXP$$NVSC2024US162576$NOVARTIS$$34$YR$$F$Y$$$20240812$$HP$US$US
241990921$24199092$1$I$$20240808$20240812$20240812$PER$$US-JNJFOC-20240821780$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$HP$US$US
241990931$24199093$1$I$20240701$20240808$20240812$20240812$EXP$$US-ABBVIE-5873976$ABBVIE$$72$YR$$F$Y$$$20240812$$CN$US$US
241990941$24199094$1$I$20230310$20230320$20240812$20240812$EXP$$US-AstraZeneca-2023A068071$ASTRAZENECA$$26115$DY$$F$Y$$$20240812$$CN$US$
241990951$24199095$1$I$$20240801$20240812$20240812$EXP$$RU-ROCHE-10000047884$ROCHE$$57$YR$A$F$Y$$$20240812$$MD$RU$RU
241990961$24199096$1$I$$20221004$20240812$20240812$EXP$$US-AstraZeneca-2022A338188$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241990973$24199097$3$F$$20240916$20240812$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003750$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
241990982$24199098$2$F$$20240809$20240812$20240814$PER$$US-ALXN-202408USA000460US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240814$$CN$US$US
241991001$24199100$1$I$$20240808$20240812$20240812$PER$$US-ABBVIE-5875183$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241991011$24199101$1$I$$20240808$20240812$20240812$PER$$US-TAKEDA-2024TUS079834$TAKEDA$$29$YR$$F$Y$$$20240812$$CN$US$US
241991021$24199102$1$I$20240401$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003751$ACADIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240812$$CN$US$US
241991031$24199103$1$I$$20240730$20240812$20240812$EXP$$US-JUBILANT PHARMA LTD-2024US001122$JUBILANT$Bally K, Trusty R, Naher K.. A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone. Cureus. 2024;16(6)$95$YR$$F$Y$$$20240812$$MD$US$US
241991041$24199104$1$I$20240724$20240806$20240812$20240812$EXP$IT-MINISAL02-997032$IT-SA-2024SA233595$SANOFI AVENTIS$$97$YR$E$F$Y$$$20240812$$MD$IT$IT
241991051$24199105$1$I$20240701$20240807$20240812$20240812$EXP$$US-SA-2024SA236544$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240812$$MD$US$US
241991061$24199106$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA235325$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240812$$MD$US$US
241991073$24199107$3$F$20240101$20240826$20240812$20240909$EXP$$US-SA-2024SA159419$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240909$$MD$US$US
241991083$24199108$3$F$$20240923$20240812$20240926$EXP$$ZA-TAKEDA-2023TUS004321$TAKEDA$$$$$F$Y$$$20240926$$MD$ZA$ZA
241991091$24199109$1$I$$20240802$20240812$20240812$PER$$US-ABBVIE-5868966$ABBVIE$$$$$F$Y$$$20240812$$MD$US$US
241991101$24199110$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-039174$AUROBINDO$Satta T, Papadopoulos EB, Gyurkocza B, Susman P, Singh A, Calafiore M, et al.. Use of a TissueTargeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GIAcute Gvhd. Blood. 2023;142 (Suppl. 1):7019$70$YR$$$Y$$$20240812$$MD$US$US
241991121$24199112$1$I$$20240801$20240812$20240812$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024095918$VIIV$$$$$M$Y$$$20240812$$HP$US$US
241991131$24199113$1$I$20240730$20240809$20240812$20240812$EXP$$US-ABBVIE-5875416$ABBVIE$$57$YR$$M$Y$$$20240812$$CN$US$US
241991141$24199114$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126585$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240812$$HP$US$US
241991151$24199115$1$I$$20240807$20240812$20240812$PER$$US-JNJFOC-20240822408$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
241991162$24199116$2$F$20240808$20240923$20240812$20240924$PER$$US-AMGEN-USASP2024158505$AMGEN$$47$YR$A$M$Y$$$20240924$$CN$US$US
241991171$24199117$1$I$20240715$20240809$20240812$20240812$EXP$$US-UCBSA-2024040292$UCB$$69$YR$$M$Y$$$20240812$$CN$US$US
241991181$24199118$1$I$20240521$20240730$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-038429$AUROBINDO$$68$YR$$F$Y$$$20240812$$MD$FR$FR
241991191$24199119$1$I$$20240807$20240812$20240812$EXP$$US-SA-2024SA236382$SANOFI AVENTIS$$$$$$Y$$$20240812$$CN$US$US
241991201$24199120$1$I$20240301$20240806$20240812$20240812$PER$$US-SA-2024SA236790$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240812$$MD$US$US
241991212$24199121$2$F$$20240808$20240812$20240815$PER$$US-ABBVIE-5875812$ABBVIE$$$$$$Y$$$20240815$$CN$US$US
241991221$24199122$1$I$$20240801$20240812$20240812$EXP$$PE-ROCHE-10000048033$ROCHE$$89$YR$E$F$Y$$$20240812$$CN$PE$PE
241991231$24199123$1$I$$20240808$20240812$20240812$PER$$US-TAKEDA-2024TUS080158$TAKEDA$$$$$F$Y$$$20240812$$CN$US$US
241991241$24199124$1$I$$20240729$20240812$20240812$EXP$$NO-ROCHE-10000040717$ROCHE$Rekeland I, Sorland K, Neteland L, Fossa A, Alme K, Risa K, et al. Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. PloS one. 2024-Jul-23;19 (7):e0307484. doi:10.1371/journal.pone.0307484.$$$$$Y$$$20240812$$HP$NO$NO
241991251$24199125$1$I$$20240808$20240812$20240812$PER$$US-JNJFOC-20240825371$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240812$$MD$US$US
241991261$24199126$1$I$20240530$20240809$20240812$20240812$EXP$ES-AEMPS-1558104$ES-JNJFOC-20240827812$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240812$$MD$ES$ES
241991271$24199127$1$I$20240611$20240806$20240812$20240812$EXP$$IE-JNJFOC-20240819741$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240812$$HP$IE$IE
241991281$24199128$1$I$$20240806$20240812$20240812$EXP$$BR-TAKEDA-2024TUS079598$TAKEDA$$33$YR$$$Y$$$20240812$$CN$BR$BR
241991291$24199129$1$I$$20240806$20240812$20240812$PER$$US-ALXN-202408USA000340US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241991301$24199130$1$I$$20240801$20240812$20240812$EXP$$US-SA-2024SA229741$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240812$$PH$US$US
241991312$24199131$2$F$$20240809$20240812$20240816$PER$$US-ALXN-202408USA000449US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240817$$CN$US$US
241991321$24199132$1$I$$20240729$20240812$20240812$PER$$US-ROCHE-10000049817$ROCHE$Godfrey J, Gao L S. Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood. 2024-Jul-25;144 (4):457-461. doi:10.1182/blood.2024024168.$41$YR$A$F$Y$$$20240812$$HP$US$US
241991332$24199133$2$F$$20240819$20240812$20240828$PER$$US-SA-2024SA233678$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240828$$MD$US$US
241991341$24199134$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA234470$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240812$$MD$US$US
241991351$24199135$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA235269$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240812$$MD$US$US
241991361$24199136$1$I$20240710$20240731$20240812$20240812$PER$$ES-IGSA-BIG0030127$GRIFOLS$$9$YR$$F$Y$31.4$KG$20240812$$MD$ES$ES
241991372$24199137$2$F$$20240807$20240812$20240823$EXP$$NVSC2024KR162229$NOVARTIS$$$$$F$Y$$$20240823$$MD$KR$KR
241991391$24199139$1$I$20240801$20240805$20240812$20240812$PER$$US-SA-2024SA234461$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240812$$MD$US$US
241991401$24199140$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126484$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$83.91$KG$20240812$$CN$US$US
241991421$24199142$1$I$20240501$20240808$20240812$20240812$PER$$US-AstraZeneca-2024A181251$ASTRAZENECA$$$$$M$Y$$$20240812$$MD$US$
241991431$24199143$1$I$$20230405$20240812$20240812$EXP$$US-AstraZeneca-2023A081302$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241991441$24199144$1$I$20240701$20240802$20240812$20240812$EXP$FR-AFSSAPS-MA2024001219$FR-TEVA-VS-3230024$TEVA$$46$YR$$M$Y$$$20240812$$MD$FR$FR
241991451$24199145$1$I$20220425$20220428$20240812$20240812$EXP$$US-AstraZeneca-2022A167905$ASTRAZENECA$$26247$DY$$F$Y$$$20240812$$CN$US$
241991461$24199146$1$I$20240731$20240806$20240812$20240812$EXP$$CN-AstraZeneca-2024A181796$ASTRAZENECA$$16$YR$$F$Y$50$KG$20240812$$MD$CN$
241991472$24199147$2$F$20240501$20240827$20240812$20240829$EXP$$US-GILEAD-2024-0681384$GILEAD$$34$YR$A$F$Y$$$20240829$$CN$US$US
241991481$24199148$1$I$$20231127$20240812$20240812$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04212$AMNEAL$$$$$M$Y$$$20240812$$CN$US$US
241991491$24199149$1$I$$20240422$20240812$20240812$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01396$AMNEAL$$$$$M$Y$$$20240812$$CN$US$US
241991501$24199150$1$I$$20240131$20240812$20240812$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00480$AMNEAL$$$$$M$Y$$$20240812$$PH$US$US
241991511$24199151$1$I$$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004152$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240812$$CN$US$US
241991521$24199152$1$I$20240223$20240304$20240812$20240812$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00785$AMNEAL$$78$YR$$M$Y$68.934$KG$20240812$$CN$US$US
241991531$24199153$1$I$20240808$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006312$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240812$$CN$US$US
241991541$24199154$1$I$$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004774$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240812$$CN$US$US
241991551$24199155$1$I$20240728$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408003965$ELI LILLY AND CO$$22$YR$A$M$Y$$$20240812$$HP$US$US
241991562$24199156$2$F$$20240823$20240812$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408004747$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240826$$CN$US$US
241991571$24199157$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005696$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240812$$CN$US$US
241991581$24199158$1$I$20240806$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004763$ELI LILLY AND CO$$$$$M$Y$$$20240812$$CN$US$US
241991591$24199159$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005548$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240812$$CN$US$US
241991601$24199160$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006326$ELI LILLY AND CO$$51$YR$A$$Y$$$20240812$$LW$US$US
241991611$24199161$1$I$20240804$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005748$ELI LILLY AND CO$$70$YR$E$$Y$$$20240812$$CN$US$US
241991625$24199162$5$F$20240808$20240829$20240812$20240830$PER$$US-AMGEN-USASP2024158969$AMGEN$$30$YR$A$F$Y$$$20240830$$CN$US$US
241991632$24199163$2$F$20240803$20240809$20240812$20240815$PER$$US-AMGEN-USASP2024159557$AMGEN$$57$YR$A$F$Y$$$20240815$$CN$US$US
241991641$24199164$1$I$20240101$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158045$AMGEN$$82$YR$E$M$Y$$$20240812$$CN$US$US
241991661$24199166$1$I$20240601$20240807$20240812$20240812$PER$$US-ABBVIE-5875682$ABBVIE$$$$A$F$Y$$$20240812$$HP$US$US
241991681$24199168$1$I$20220101$20240729$20240812$20240812$EXP$$NL-AUROBINDO-AUR-APL-2024-038925$AUROBINDO$Conradi PM, Heidendael JF, Lucas CMHB, Yazdi MT, Handoko ML.. A classical case report of constrictive pericarditis, highlighting the role of magnetic resonance imaging and haemodynamic assessment.. Eur-Heart-J-Case-Rep. 2024;8 (2)$67$YR$$M$Y$$$20240812$$HP$NL$NL
241991691$24199169$1$I$20240802$20240802$20240812$20240812$PER$$US-ABBVIE-5868051$ABBVIE$$71$YR$$F$Y$$$20240812$$CN$US$US
241991711$24199171$1$I$20231001$20240805$20240812$20240812$EXP$$US-GSK-US2024098072$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
241991731$24199173$1$I$$20240802$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126849$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240812$$CN$US$US
241991741$24199174$1$I$20240725$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158393$AMGEN$$42$YR$A$M$Y$$$20240812$$CN$US$US
241991753$24199175$3$F$20240716$20240821$20240812$20240827$PER$$US-AMGEN-USASP2024155713$AMGEN$$61$YR$A$F$Y$66.213$KG$20240827$$PH$US$US
241991763$24199176$3$F$20240722$20240913$20240812$20240924$EXP$$US-BEH-2024176715$CSL BEHRING$$11$YR$C$F$Y$$$20240924$$HP$US$US
241991772$24199177$2$F$$20240823$20240812$20240830$EXP$$BR-TAKEDA-2024TUS011261$TAKEDA$$$$$F$Y$65$KG$20240830$$CN$BR$BR
241991781$24199178$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236497$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
241991791$24199179$1$I$20210201$20240803$20240812$20240812$PER$$US-SA-2024SA234748$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240812$$MD$US$US
241991801$24199180$1$I$20240723$20240805$20240812$20240812$PER$$US-SA-2024SA233840$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240812$$CN$US$US
241991811$24199181$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA235069$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240812$$MD$US$US
241991821$24199182$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA236821$SANOFI AVENTIS$$$$A$F$Y$56.6$KG$20240812$$HP$US$US
241991832$24199183$2$F$$20240815$20240812$20240821$PER$$US-LEO Pharma-372639$LEO PHARM$$$$$M$Y$$$20240821$$CN$US$US
241991841$24199184$1$I$$20240807$20240812$20240812$EXP$$NL-REGENERON PHARMACEUTICALS, INC.-2024-109986$REGENERON$$$$$$Y$$$20240812$$HP$NL$NL
241991852$24199185$2$F$20240807$20240809$20240812$20240906$PER$$US-AMGEN-USASP2024158264$AMGEN$$65$YR$E$M$Y$$$20240906$$CN$US$US
241991861$24199186$1$I$20240101$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158040$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241991872$24199187$2$F$$20240808$20240812$20240814$PER$$US-AMGEN-USASP2024159359$AMGEN$$$$A$M$Y$$$20240814$$HP$US$US
241991882$24199188$2$F$$20240909$20240812$20240912$PER$$US-AMGEN-USASP2024149604$AMGEN$$67$YR$E$F$Y$49.433$KG$20240912$$CN$US$US
241991891$24199189$1$I$$20240808$20240812$20240812$EXP$$NVSC2024PT162773$NOVARTIS$$$$E$F$Y$$$20240812$$MD$PT$PT
241991901$24199190$1$I$$20240805$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124093$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240812$$CN$US$US
241991911$24199191$1$I$$20240802$20240812$20240812$EXP$$US-GSK-US2024AMR096942$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
241991921$24199192$1$I$20240808$20240809$20240812$20240812$EXP$$US-UCBSA-2024040297$UCB$$49$YR$$F$Y$$$20240812$$CN$US$US
241991931$24199193$1$I$$20240809$20240812$20240812$PER$$US-JNJFOC-20240825294$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240812$$MD$US$US
241991941$24199194$1$I$$20240805$20240812$20240812$EXP$$GB-009507513-2408GBR002913$MERCK$$$$$M$Y$$$20240812$$HP$GB$GB
241991953$24199195$3$F$20240903$20240925$20240812$20240930$EXP$$IN-ROCHE-10000010774$ROCHE$$70$YR$E$F$Y$$$20240930$$CN$IN$IN
241991961$24199196$1$I$$20240802$20240812$20240812$EXP$$TW-HETERO-HET2024TW02595$HETERO$Chung S, Liu Y, Huang S, Sung M, Wu AY. Secondary hemophagocytic lymphohistiocytosis triggered by Staphylococcus aureus bacteremia:A case report and systemic review. IDCases. 2024;37:e02031$86$YR$$F$Y$$$20240812$$MD$TW$TW
241991972$24199197$2$F$20240101$20240807$20240812$20240814$EXP$$US-ABBVIE-5875603$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
241991981$24199198$1$I$$20240809$20240812$20240812$EXP$$GR-SANDOZ INC.-PHHY2018GR060445$SANDOZ$$51$YR$$F$Y$$$20240812$$MD$GR$GR
241992012$24199201$2$F$$20240821$20240812$20240831$30DAY$$US-GSK-US2024AMR097785$GLAXOSMITHKLINE$$$$$F$Y$$$20240831$$HP$US$US
241992021$24199202$1$I$20240804$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024158315$AMGEN$$85$YR$E$F$Y$$$20240812$$CN$US$US
241992031$24199203$1$I$20240701$20240805$20240812$20240812$EXP$$US-SA-2024SA236042$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240812$$MD$US$US
241992052$24199205$2$F$20230626$20240903$20240812$20240909$EXP$$US-TAKEDA-2023TUS065003$TAKEDA$$58$YR$$F$Y$43$KG$20240909$$HP$US$US
241992061$24199206$1$I$$20240805$20240812$20240812$PER$$NVSC2024US160522$NOVARTIS$$$$$M$Y$102$KG$20240812$$CN$US$US
241992081$24199208$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235625$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240812$$MD$US$US
241992101$24199210$1$I$$20240806$20240812$20240812$PER$$US-SA-2023SA172388$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240812$$MD$US$US
241992111$24199211$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA236550$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240812$$MD$US$US
241992121$24199212$1$I$20230719$20240802$20240812$20240812$EXP$$US-RDY-CLI/USA/24/0011446$DR REDDYS$$35$YR$A$F$Y$63.5$KG$20240812$$CN$US$US
241992133$24199213$3$F$$20240902$20240812$20240913$EXP$$DE-LUPIN HEALTHCARE (UK) LIMITED-2024-07708$LUPIN$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$N$$Y$$$20240913$$HP$DE$DE
241992151$24199215$1$I$20240716$20240730$20240812$20240812$EXP$RU-RZN-2493122$RU-SERVIER-S24009722$SERVIER$$$$$$Y$$$20240812$$MD$RU$RU
241992162$24199216$2$F$$20240827$20240812$20240828$PER$$US-ALXN-202408USA000364US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241992171$24199217$1$I$20240728$20240808$20240812$20240812$EXP$FR-AFSSAPS-AN2024001087$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-126253$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$83$KG$20240812$$MD$FR$FR
241992181$24199218$1$I$20240802$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126418$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240812$$HP$US$US
241992193$24199219$3$F$20160818$20240904$20240812$20240910$EXP$$ES-ABBVIE-5875785$ABBVIE$$$$$$Y$$$20240910$$MD$ES$ES
241992201$24199220$1$I$$20240806$20240812$20240812$EXP$$CA-TAKEDA-2024TUS079245$TAKEDA$$$$$F$Y$$$20240812$$CN$CA$CA
241992211$24199221$1$I$$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003752$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240812$$HP$US$US
241992221$24199222$1$I$20240808$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005569$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240812$$CN$US$US
241992232$24199223$2$F$$20240812$20240812$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006328$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240814$$CN$US$US
241992241$24199224$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005565$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240812$$CN$US$US
241992251$24199225$1$I$$20240806$20240812$20240812$EXP$$US-APOTEX-2024AP009167$APOTEX$Nelson N, Masih D, Sabri A, Monika F, Mirza M. Isolated Myeloid Sarcoma Masquerading as Scattered Abscesses in a Septic Patient: A Case Report and Literature Review.. Case Reports in Oncology. 2024;17(1):39-48$76$YR$$F$Y$$$20240812$$HP$US$US
241992261$24199226$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005776$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240812$$CN$US$US
241992271$24199227$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006343$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240812$$CN$US$US
241992281$24199228$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006314$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240812$$CN$US$US
241992291$24199229$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006374$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240812$$CN$US$US
241992301$24199230$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004864$ELI LILLY AND CO$$74$YR$E$$Y$$$20240812$$CN$US$US
241992312$24199231$2$F$$20240808$20240812$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005854$ELI LILLY AND CO$$15$YR$T$M$Y$$$20240816$$CN$US$US
241992321$24199232$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005571$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240812$$HP$US$US
241992331$24199233$1$I$20240808$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005923$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240812$$CN$US$US
241992341$24199234$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006466$ELI LILLY AND CO$$55$YR$A$$Y$$$20240812$$CN$US$US
241992351$24199235$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004953$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240812$$CN$US$US
241992361$24199236$1$I$20240719$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024158380$AMGEN$$$$$$Y$$$20240812$$CN$US$US
241992372$24199237$2$F$20240701$20240812$20240812$20240814$PER$$US-JNJFOC-20240819863$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20240814$$CN$US$US
241992382$24199238$2$F$$20240828$20240812$20240910$EXP$$CA-UCBSA-2024040039$UCB$$$$$F$Y$$$20240910$$HP$CA$CA
241992391$24199239$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005788$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240812$$CN$US$US
241992401$24199240$1$I$20240803$20240806$20240812$20240812$EXP$$CN-JNJFOC-20240816177$JOHNSON AND JOHNSON$$77$YR$E$F$Y$46$KG$20240812$$HP$CN$CN
241992441$24199244$1$I$20240713$20240802$20240812$20240812$EXP$ES-AEMPS-1553311$ES-TEVA-VS-3229707$TEVA$$89$YR$$M$Y$90$KG$20240812$$MD$ES$ES
241992451$24199245$1$I$$20240807$20240812$20240812$EXP$$US-SA-2024SA237193$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240812$$MD$US$US
241992461$24199246$1$I$20240805$20240806$20240812$20240812$EXP$$US-SA-2024SA236140$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240812$$MD$US$US
241992471$24199247$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA236286$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240812$$CN$US$US
241992491$24199249$1$I$20240716$20240718$20240812$20240812$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003754$ACADIA PHARMACEUTICALS$$89$YR$$M$Y$$$20240812$$CN$US$US
241992501$24199250$1$I$20240806$20240806$20240812$20240812$PER$$US-SA-2024SA235936$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240812$$MD$US$US
241992511$24199251$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236940$SANOFI AVENTIS$$$$E$F$Y$65.77$KG$20240812$$MD$US$US
241992521$24199252$1$I$$20240725$20240812$20240812$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07855$LUPIN$$$$$$Y$$$20240812$$HP$US$US
241992531$24199253$1$I$20240806$20240806$20240812$20240812$PER$$US-SA-2024SA234378$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240812$$HP$US$US
241992551$24199255$1$I$$20240802$20240812$20240812$30DAY$$US-GSK-US2024AMR097668$GLAXOSMITHKLINE$$$$$M$Y$$$20240812$$PH$US$US
241992561$24199256$1$I$20240701$20240805$20240812$20240812$PER$$US-SA-2024SA235439$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240812$$MD$US$US
241992571$24199257$1$I$$20240809$20240812$20240812$PER$$US-ROCHE-10000054270$ROCHE$$$$$$Y$$$20240812$$MD$US$US
241992581$24199258$1$I$20240706$20240718$20240812$20240812$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003755$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240812$$CN$US$US
241992591$24199259$1$I$20240804$20240806$20240812$20240812$PER$$US-SA-2024SA236947$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240812$$MD$US$US
241992601$24199260$1$I$20240624$20240730$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-038716$AUROBINDO$$62$YR$$F$Y$54$KG$20240812$$PH$FR$FR
241992613$24199261$3$F$20240714$20240905$20240812$20240916$PER$$US-AstraZeneca-2024A173500$ASTRAZENECA$$22031$DY$$F$Y$$$20240916$$CN$US$
241992621$24199262$1$I$20240804$20240807$20240812$20240812$EXP$$JP-AstraZeneca-2024A180389$ASTRAZENECA$$$$E$F$Y$$$20240812$$MD$JP$
241992631$24199263$1$I$20230801$20240807$20240812$20240812$EXP$$US-SA-2024SA235787$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240812$$CN$US$US
241992641$24199264$1$I$20240808$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158548$AMGEN$$$$$$Y$$$20240812$$HP$US$US
241992652$24199265$2$F$20240701$20240812$20240812$20240813$PER$$US-AMGEN-USASP2024159357$AMGEN$$76$YR$E$F$Y$$$20240812$$CN$US$US
241992661$24199266$1$I$$20240806$20240812$20240812$PER$$US-JNJFOC-20240819591$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$US$US
241992671$24199267$1$I$20220901$20240731$20240812$20240812$EXP$$US-862174955-ML2024-04360$MICRO LABS$Shah N, Dib EG, Joseph N, Fontana RJ. Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits? Clinical Liver Disease. 2024;23(1):e0125.1-5. DOI: 10.1097/CLD.0000000000000125.$76$YR$E$F$Y$$$20240812$$MD$US$US
241992681$24199268$1$I$20240805$20240805$20240812$20240812$PER$$US-SA-2024SA233555$SANOFI AVENTIS$$$$$$Y$$$20240812$$MD$US$US
241992691$24199269$1$I$20240701$20240801$20240812$20240812$PER$$US-SA-2024SA233081$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
241992701$24199270$1$I$20230101$20240806$20240812$20240812$PER$$US-SA-2024SA236967$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$MD$US$US
241992712$24199271$2$F$20240101$20240910$20240812$20240918$PER$$US-SA-2024SA234091$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240918$$MD$US$US
241992721$24199272$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163192$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
241992731$24199273$1$I$20240802$20240805$20240812$20240812$PER$$US-SA-2024SA236578$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240812$$MD$US$US
241992742$24199274$2$F$$20240916$20240812$20240918$PER$$NVSC2024US163208$NOVARTIS$$$$$M$Y$$$20240918$$MD$US$US
241992751$24199275$1$I$$20240701$20240812$20240812$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099143$VIIV$$$$$M$Y$$$20240812$$CN$US$US
241992761$24199276$1$I$$20240730$20240812$20240812$EXP$$PT-AUROBINDO-AUR-APL-2024-039008$AUROBINDO$Ferreira AI, Carreira MS, Enes J, Pacheco M, Silva C, Flores L.. CAN IT BE AN ALLERGIC ANGINA CAUSED BYAN ANTI-INFLAMMATORY DRUG?. Eur-J-Case-Rep-Intern-Med. 2021;8 (Suppl. 1)47:PV072$37$YR$$F$Y$$$20240812$$HP$PT$PT
241992771$24199277$1$I$$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003756$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241992781$24199278$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125925$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240812$$CN$US$US
241992791$24199279$1$I$$20240805$20240812$20240812$PER$US-MLMSERVICE-20240731-PI144681-00246-1$US-RDY-SPO/USA/24/0011560$DR REDDYS$Sheth S, Matthia E, Naik D. Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer. Journal of Clinical Lipidology. 2024;18(4):e555-6. DOI:10.1016/j.jacl.2024.04.091$57$YR$A$F$Y$$$20240812$$HP$US$US
241992801$24199280$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126296$BRISTOL MYERS SQUIBB$$66$YR$E$$Y$$$20240812$$HP$US$US
241992811$24199281$1$I$$20240806$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124480$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240812$$HP$US$US
241992821$24199282$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126183$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240812$$HP$US$US
241992831$24199283$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126485$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$81.19$KG$20240812$$CN$US$US
241992842$24199284$2$F$$20240808$20240812$20240813$EXP$$GB-MYLANLABS-2024M1074240$MYLAN$$$$$F$Y$$$20240813$$PH$GB$GB
241992854$24199285$4$F$$20240909$20240812$20240911$EXP$$GB-MYLANLABS-2024M1074364$MYLAN$$$$$F$Y$$$20240911$$HP$GB$GB
241992862$24199286$2$F$20240805$20240812$20240812$20240812$PER$$US-AMGEN-USASP2024159370$AMGEN$$85$YR$E$F$Y$$$20240812$$CN$US$US
241992871$24199287$1$I$$20240807$20240812$20240812$PER$$US-ALXN-202408USA000444US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$HP$US$US
241992881$24199288$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-039177$AUROBINDO$Satta T, Papadopoulos EB, Gyurkocza B, Susman P, Singh A, Calafiore M, et al.. Use of a TissueTargeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GIAcute Gvhd. Blood. 2023;142 (Suppl. 1):7019$46$YR$$$Y$$$20240812$$MD$US$US
241992891$24199289$1$I$$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003758$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241992905$24199290$5$F$20240809$20240913$20240812$20240916$PER$$US-AMGEN-USASP2024159456$AMGEN$$72$YR$E$F$Y$$$20240915$$CN$US$US
241992913$24199291$3$F$20240301$20240826$20240812$20240903$PER$$US-AMGEN-USASP2024158493$AMGEN$$76$YR$E$F$Y$$$20240903$$CN$US$US
241992921$24199292$1$I$$20240805$20240812$20240812$PER$$US-JNJFOC-20240816077$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$CN$US$US
241992932$24199293$2$F$$20240830$20240812$20240913$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-07613$LUPIN$$78$YR$$F$Y$$$20240913$$MD$AU$AU
241992951$24199295$1$I$$20240730$20240812$20240812$PER$$US-ROCHE-10000046447$ROCHE$$$$$$Y$$$20240812$$HP$US$US
241992961$24199296$1$I$$20240718$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003759$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241992971$24199297$1$I$$20240808$20240812$20240812$EXP$$CN-AstraZeneca-2024A182077$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$CN$
241992981$24199298$1$I$$20221024$20240812$20240812$EXP$$US-AstraZeneca-2022A355520$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
241992991$24199299$1$I$20230101$20230121$20240812$20240812$EXP$$US-AstraZeneca-2023A021646$ASTRAZENECA$$62$YR$$F$Y$$$20240812$$CN$US$
241993001$24199300$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A180330$ASTRAZENECA$$$$$F$Y$$$20240812$$HP$US$
241993011$24199301$1$I$$20240807$20240812$20240812$EXP$$VN-AstraZeneca-2024A180893$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$VN$
241993022$24199302$2$F$20240807$20240809$20240812$20240814$EXP$$CA-AstraZeneca-2024A180140$ASTRAZENECA$$22701$DY$$M$Y$$$20240814$$CN$CA$
241993031$24199303$1$I$20240220$20240806$20240812$20240812$EXP$$MX-EMD Serono-2024042694$EMD SERONO INC$$12$YR$T$F$Y$$$20240812$$CN$MX$MX
241993041$24199304$1$I$$20240730$20240812$20240812$EXP$$NL-AUROBINDO-AUR-APL-2024-038892$AUROBINDO$$44$YR$$M$Y$86$KG$20240812$$CN$NL$NL
241993051$24199305$1$I$20221101$20240802$20240812$20240812$EXP$FR-AFSSAPS-MA2024001240$FR-TEVA-VS-3230099$TEVA$$74$YR$$M$Y$$$20240812$$MD$FR$FR
241993061$24199306$1$I$$20240807$20240812$20240812$EXP$$IL-009507513-2408ISR002896$MERCK$$$$$F$Y$$$20240812$$MD$IL$IL
241993072$24199307$2$F$20240606$20240813$20240812$20240822$EXP$PT-INFARMED-F202407-634$PT-Vifor (International) Inc.-VIT-2024-07009$VIFOR$$58$YR$$M$Y$60$KG$20240822$$PH$PT$PT
241993081$24199308$1$I$$20240807$20240812$20240812$PER$$US-ABBVIE-5872377$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241993091$24199309$1$I$$20240808$20240812$20240812$PER$$US-ROCHE-10000053269$ROCHE$$$$$$Y$$$20240812$$HP$US$US
241993101$24199310$1$I$$20240807$20240812$20240812$PER$$US-ABBVIE-5873125$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241993111$24199311$1$I$20240701$20240807$20240812$20240812$PER$$US-SA-2024SA182064$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240812$$MD$US$US
241993121$24199312$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA232486$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240812$$CN$US$US
241993131$24199313$1$I$20240717$20240801$20240812$20240812$EXP$$CN-ROCHE-10000050029$ROCHE$$59$YR$A$M$Y$68$KG$20240812$$HP$CN$CN
241993141$24199314$1$I$$20240805$20240812$20240812$PER$$US-JNJFOC-20240812205$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
241993152$24199315$2$F$$20240819$20240812$20240821$PER$$US-JNJFOC-20240823039$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
241993162$24199316$2$F$20220519$20240823$20240812$20240828$EXP$$IL-JNJFOC-20240813454$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240828$$HP$IL$IL
241993172$24199317$2$F$20231101$20240828$20240812$20240916$EXP$$US-SA-2024SA234750$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240916$$MD$US$US
241993221$24199322$1$I$20240720$20240807$20240812$20240812$30DAY$$US-AMGEN-USASP2024157607$AMGEN$$$$$$Y$$$20240812$$PH$US$US
241993233$24199323$3$F$20240727$20240906$20240812$20240912$EXP$$CO-AMGEN-COLSP2024155981$AMGEN$$53$YR$A$F$Y$58$KG$20240912$$PH$CO$CO
241993241$24199324$1$I$20240612$20240803$20240812$20240812$PER$$US-RDY-SPO/USA/24/0011529$DR REDDYS$$19$YR$A$F$Y$$$20240812$$MD$US$US
241993261$24199326$1$I$20240807$20240809$20240812$20240812$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-126724$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240812$$MD$BR$BR
241993271$24199327$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126534$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240812$$CN$US$US
241993281$24199328$1$I$20240704$20240730$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-038852$AUROBINDO$$41$YR$$F$Y$$$20240812$$PH$FR$FR
241993291$24199329$1$I$$20240808$20240812$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US071699$SANDOZ$$76$YR$$F$Y$$$20240812$$HP$US$US
241993302$24199330$2$F$$20240910$20240812$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07048$LUPIN$$$$$$Y$$$20240925$$CN$US$US
241993311$24199331$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005774$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240812$$CN$US$US
241993321$24199332$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005627$ELI LILLY AND CO$$37$YR$A$$Y$$$20240812$$CN$US$US
241993341$24199334$1$I$$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006093$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240812$$CN$US$US
241993351$24199335$1$I$20240806$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005387$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240812$$CN$US$US
241993362$24199336$2$F$$20240813$20240812$20240814$PER$$US-JNJFOC-20240777185$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$US$US
241993381$24199338$1$I$$20240806$20240812$20240812$PER$$US-ALXN-202408USA000406US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
241993391$24199339$1$I$$20240806$20240812$20240812$PER$$US-ALXN-202408USA000414US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241993412$24199341$2$F$20240101$20240819$20240812$20240822$PER$$US-AMGEN-USASP2024158619$AMGEN$$82$YR$E$F$Y$$$20240822$$CN$US$US
241993421$24199342$1$I$20240101$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159165$AMGEN$$49$YR$A$F$Y$$$20240812$$CN$US$US
241993432$24199343$2$F$20240809$20240812$20240812$20240813$PER$$US-AMGEN-USASP2024159388$AMGEN$$68$YR$E$F$Y$$$20240813$$HP$US$US
241993441$24199344$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158103$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241993451$24199345$1$I$20190101$20240805$20240812$20240812$EXP$$AU-AMGEN-AUSSP2024156499$AMGEN$$75$YR$E$F$Y$$$20240812$$HP$AU$AU
241993461$24199346$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA235321$SANOFI AVENTIS$$61$YR$A$$Y$$$20240812$$HP$US$US
241993471$24199347$1$I$20230101$20240805$20240812$20240812$PER$$US-SA-2024SA236706$SANOFI AVENTIS$$58$YR$A$M$Y$78$KG$20240812$$MD$US$US
241993481$24199348$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235626$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$MD$US$US
241993491$24199349$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA236922$SANOFI AVENTIS$$$$A$F$Y$76.2$KG$20240812$$MD$US$US
241993501$24199350$1$I$20240725$20240805$20240812$20240812$PER$$US-SA-2024SA233370$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240812$$MD$US$US
241993511$24199351$1$I$20240729$20240805$20240812$20240812$PER$$US-SA-2024SA234213$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240812$$MD$US$US
241993523$24199352$3$F$20240721$20240903$20240812$20240925$PER$$US-SA-2024SA236406$SANOFI AVENTIS$$54$YR$A$F$Y$81.64$KG$20240925$$MD$US$US
241993531$24199353$1$I$20240808$20240808$20240812$20240812$EXP$$US-GILEAD-2024-0683266$GILEAD$$71$YR$E$M$Y$$$20240812$$CN$US$US
241993541$24199354$1$I$20220728$20240805$20240812$20240812$EXP$$DE-AstraZeneca-2024A178271$ASTRAZENECA$$67$YR$$F$Y$105$KG$20240812$$MD$DE$
241993555$24199355$5$F$20240710$20240916$20240812$20240925$EXP$$DE-UCBSA-2024038423$UCB$$42$YR$$M$Y$120$KG$20240925$$MD$DE$DE
241993561$24199356$1$I$20240630$20240802$20240812$20240812$EXP$PT-INFARMED-T202407-382$PT-TEVA-VS-3229964$TEVA$$72$YR$$F$Y$$$20240812$$PH$PT$PT
241993571$24199357$1$I$$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024157824$AMGEN$$$$$$Y$$$20240812$$HP$US$US
241993581$24199358$1$I$$20240808$20240812$20240812$EXP$$NVSC2024US162724$NOVARTIS$$82$YR$$F$Y$$$20240812$$CN$US$US
241993593$24199359$3$F$20180521$20240903$20240812$20240910$EXP$$PHHY2018CO030602$NOVARTIS$$38$YR$$M$Y$108$KG$20240910$$CN$CO$CO
241993601$24199360$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-038227$AUROBINDO$Bally K, Trusty R, Naher K.. A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone.. Cureus. 2024;16(6):e62695$95$YR$$F$Y$$$20240812$$MD$US$US
241993611$24199361$1$I$20240101$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126824$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240812$$CN$US$US
241993621$24199362$1$I$$20240729$20240812$20240812$EXP$814325$AU-LUPIN PHARMACEUTICALS INC.-2024-07599$LUPIN$$$$$$Y$$$20240812$$CN$AU$AU
241993631$24199363$1$I$$20240731$20240812$20240812$EXP$$US-SCIEGENP-2024SCLIT00347$SCIEGEN$Golob.S, et al..Bupropion Overdose Requiring Veno-Arterial Extracorporeal Membrane Oxygenation.Circulation.06-NOV-2023;148 (1):A15659$32$YR$A$$Y$$$20240812$$HP$US$US
241993655$24199365$5$F$20231027$20240909$20240812$20240919$EXP$$JP-UCBSA-2024038930$UCB$Sugiyama J, Ryuge A, Mitsubayashi K, Ito M, Matsumoto N, Takeuchi R, et al.. Dapagliflozin induced hypernatremia via osmotic diuresis: a case report. CEN Case Reports. 2024;13(1):9-13$65$YR$$F$Y$77$KG$20240919$$MD$JP$JP
241993661$24199366$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126441$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240812$$CN$US$US
241993671$24199367$1$I$$20240805$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124632$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240812$$CN$US$US
241993681$24199368$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126495$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240812$$HP$US$US
241993691$24199369$1$I$20220824$20240809$20240812$20240812$EXP$FR-AFSSAPS-LY2024001256$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-126384$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240812$$PH$FR$FR
241993721$24199372$1$I$$20240808$20240812$20240812$30DAY$$US-GSK-US2024099140$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
241993744$24199374$4$F$$20240827$20240812$20240830$EXP$$US-GILEAD-2024-0683651$GILEAD$$45$YR$A$M$Y$$$20240830$$CN$US$US
241993752$24199375$2$F$$20240807$20240812$20240813$EXP$$US-JNJFOC-20240822136$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$CN$US$US
241993762$24199376$2$F$20240808$20240917$20240812$20240919$PER$$US-AMGEN-USASP2024158589$AMGEN$$88$YR$E$F$Y$$$20240919$$HP$US$US
241993771$24199377$1$I$$20240808$20240812$20240812$EXP$$TH-UCBSA-2024040242$UCB$Saengow VE.. Efficacy of Levetiracetam versus Phenytoin in Neonatal Seizure in Rural Area of Thailand.. Journal of the Medical Association of Thailand. 2023;106(8):791-94$$$N$$Y$$$20240812$$MD$TH$TH
241993781$24199378$1$I$$20240802$20240812$20240812$EXP$$US-RIGEL-20240800018$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241993812$24199381$2$F$20240808$20240819$20240812$20240827$EXP$$NVSC2024CH162393$NOVARTIS$$$$E$M$Y$$$20240827$$PH$CH$CH
241993821$24199382$1$I$$20240806$20240812$20240812$EXP$$US-BIOGEN-2024BI01277279$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
241993831$24199383$1$I$20240805$20240805$20240812$20240812$EXP$$CA-BIOGEN-2024BI01277249$BIOGEN$$66$YR$$M$Y$$$20240812$$CN$CA$CA
241993841$24199384$1$I$20230101$20240805$20240812$20240812$EXP$$US-BIOGEN-2023BI01225602$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
241993851$24199385$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191491$Haleon PLC$$$$$F$Y$$$20240812$$CN$US$US
241993862$24199386$2$F$$20240902$20240812$20240913$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2024-07704$LUPIN$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$N$$Y$$$20240913$$HP$DE$DE
241993873$24199387$3$F$20240626$20240819$20240812$20240823$EXP$FR-AFSSAPS-BR2024000548$FR-ROCHE-10000051493$ROCHE$$58$YR$A$M$Y$$$20240823$$MD$FR$FR
241993881$24199388$1$I$$20240802$20240812$20240812$EXP$FR-AFSSAPS-AVPO2024000146$FR-TEVA-VS-3230113$TEVA$$23$YR$$M$Y$$$20240812$$PH$FR$FR
241993922$24199392$2$F$20240808$20240809$20240812$20240816$PER$$US-AMGEN-USASP2024159374$AMGEN$$$$$$Y$$$20240816$$PH$US$US
241993931$24199393$1$I$$20240805$20240812$20240812$EXP$$CN-AMGEN-CHNSP2024156546$AMGEN$$$$A$$Y$$$20240812$$MD$CN$CN
241993941$24199394$1$I$20240520$20240805$20240812$20240812$EXP$$CN-AMGEN-CHNSP2024156940$AMGEN$$70$YR$E$F$Y$$$20240812$$HP$CN$CN
241993951$24199395$1$I$$20240802$20240812$20240812$EXP$$GB-VANTIVE-2024VAN018824$Vantive US Healthcare$$$$$M$Y$94.9$KG$20240812$$CN$GB$GB
241993961$24199396$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126566$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240812$$HP$US$US
241993973$24199397$3$F$20240101$20240830$20240812$20240905$EXP$$US-AMGEN-USASP2024159454$AMGEN$$69$YR$E$F$Y$$$20240904$$HP$US$US
241993983$24199398$3$F$20240729$20240812$20240812$20240820$PER$$US-AMGEN-USASP2024158271$AMGEN$$80$YR$E$M$Y$$$20240820$$HP$US$US
241993991$24199399$1$I$20220417$20220418$20240812$20240812$EXP$$US-AstraZeneca-2022A155453$ASTRAZENECA$$16242$DY$$F$Y$$$20240812$$CN$US$
241994001$24199400$1$I$20240730$20240808$20240812$20240812$EXP$$ID-AstraZeneca-2024A182050$ASTRAZENECA$$24904$DY$$M$Y$$$20240812$$CN$ID$
241994014$24199401$4$F$$20240827$20240812$20240828$EXP$GR-SEATTLE GENETICS-2024SGN00521$GR-ROCHE-10000054172$ROCHE$$$$$F$Y$$$20240828$$MD$GR$GR
241994021$24199402$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005217$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240812$$CN$US$US
241994031$24199403$1$I$$20240613$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006298$ELI LILLY AND CO$$$$A$F$Y$$$20240812$$CN$US$US
241994041$24199404$1$I$20240109$20240112$20240812$20240812$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202401010236$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240812$$CN$JP$JP
241994051$24199405$1$I$$20240808$20240812$20240812$PER$$NVSC2024US162947$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
241994071$24199407$1$I$$20240811$20240812$20240812$PER$$US-BAYER-2024A115422$BAYER$$$$$$Y$$$20240812$$CN$US$US
241994082$24199408$2$F$20240101$20240904$20240812$20240913$EXP$$CA-APOTEX-2024AP009143$APOTEX$$$$A$M$Y$$$20240913$$PH$CA$CA
241994101$24199410$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191379$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
241994111$24199411$1$I$20240701$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005614$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240812$$CN$US$US
241994121$24199412$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA236192$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$HP$US$US
241994131$24199413$1$I$$20240804$20240812$20240812$EXP$$US-ROCHE-10000049935$ROCHE$$$$$$Y$$$20240812$$CN$US$US
241994141$24199414$1$I$$20240810$20240812$20240812$PER$$US-BAYER-2024A115424$BAYER$$$$$$Y$$$20240812$$CN$US$US
241994151$24199415$1$I$20190101$20240730$20240812$20240812$EXP$$US-MYLANLABS-2024M1072211$MYLAN$Chalker C, Yilmaz B, Trone K, Parecki G, Chen A, Lim JY, et al. Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule. NPJ-Precis-Oncol 2024; 8 (1): 01-06.$70$YR$$M$Y$$$20240812$$HP$US$US
241994161$24199416$1$I$$20240729$20240812$20240812$EXP$$FR-MYLANLABS-2024M1071834$MYLAN$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2023; 35 (1): 54-59.$60$YR$$F$Y$$$20240812$$HP$FR$FR
241994171$24199417$1$I$$20240730$20240812$20240812$EXP$$IT-MYLANLABS-2024M1072775$MYLAN$Castelli M, Betelli M, Valenti A, Merelli B, Loglio A, Vigano M, et al. A case of polyserositis, chylous ascites and hepatitis induced by immune checkpoint inhibitors. Eur-J-Case-Rep-Intern-Med 2024; 11 (7):.$39$YR$$M$Y$$$20240812$$HP$IT$IT
241994181$24199418$1$I$$20240730$20240812$20240812$EXP$$IT-MYLANLABS-2024M1072742$MYLAN$Fiori L, Tagi VM, Montanari C, Gambino M, Carlevatti V, Zizzo C, et al. Desensitization of olipudase alfa-induced anaphylaxis in a child with chronic neurovisceral acid sphingomyelinase deficiency. Mol-Genet-Metab-Rep 2024; 40.$2$YR$$M$Y$$$20240812$$HP$IT$IT
241994191$24199419$1$I$$20240730$20240812$20240812$EXP$$US-MYLANLABS-2024M1072812$MYLAN$Kumar R, Sadek A. The effects of glucagon-like peptide-1 receptor agonist therapy on diuretic resistant fluid retention in a patient with pulmonary hypertension and right heart failure. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 2802.$59$YR$$M$Y$$$20240812$$HP$US$US
241994201$24199420$1$I$$20231026$20240812$20240812$PER$$US-Accord-387326$ACCORD$$$$$F$Y$63.5$KG$20240812$$CN$US$US
241994211$24199421$1$I$$20240112$20240812$20240812$PER$$US-Accord-402307$ACCORD$$$$$F$Y$$$20240812$$CN$US$US
241994221$24199422$1$I$$20240808$20240812$20240812$PER$$US-HALEON-2191288$Haleon PLC$$92$YR$$F$Y$$$20240812$$CN$US$US
241994232$24199423$2$F$$20240828$20240812$20240828$PER$$US-ALXN-202408USA000411US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
241994241$24199424$1$I$$20240729$20240812$20240812$EXP$$BR-UCBSA-2024038816$UCB$$$$$F$Y$$$20240812$$CN$BR$BR
241994251$24199425$1$I$20240101$20240808$20240812$20240812$EXP$$CO-ABBVIE-5875125$ABBVIE$$57$YR$$F$Y$85$KG$20240812$$CN$CO$CO
241994261$24199426$1$I$$20240810$20240812$20240812$PER$$US-BAYER-2024A115448$BAYER$$$$$$Y$$$20240812$$CN$US$US
241994271$24199427$1$I$$20240731$20240812$20240812$EXP$$US-MYLANLABS-2024M1073095$MYLAN$Graham J, Cosnahan M, Wynn C. False negative antibody testing in SRA-Positive Heparin-Induced thrombocytopenia. Am-J-Med-Sci 2024; 367 (Suppl. 1) S172.$56$YR$$F$Y$$$20240812$$HP$US$US
241994281$24199428$1$I$$20240731$20240812$20240812$EXP$$IE-MYLANLABS-2024M1073045$MYLAN$Kelliher J, Rahmani G, Carey JJ, Bergin D. Severe atypical iliac wing fracture associated with long-term bisphosphonate use. Skel-Radiol 2024; 0 (0):.$63$YR$$F$Y$$$20240812$$HP$IE$IE
241994311$24199431$1$I$$20240809$20240812$20240812$PER$$US-BAYER-2024A115404$BAYER$$73$YR$E$M$Y$$$20240812$$CN$US$US
241994321$24199432$1$I$20240806$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024157814$AMGEN$$$$$$Y$$$20240812$$PH$US$US
241994331$24199433$1$I$20240702$20240802$20240812$20240812$EXP$FR-AFSSAPS-AVMA2024000333$FR-TEVA-VS-3229618$TEVA$$23$YR$$F$Y$$$20240812$$CN$FR$FR
241994341$24199434$1$I$20240801$20240801$20240812$20240812$EXP$$US-JNJFOC-20240808169$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$HP$US$US
241994351$24199435$1$I$$20240809$20240812$20240812$PER$$US-BAYER-2024A115496$BAYER$$24$YR$A$M$Y$$$20240812$$CN$US$US
241994361$24199436$1$I$$20240807$20240812$20240812$PER$$US-ROCHE-10000051687$ROCHE$$78$YR$E$M$Y$$$20240812$$HP$US$US
241994371$24199437$1$I$$20240807$20240812$20240812$EXP$$DE-ASTELLAS-2024EU007936$ASTELLAS$Husain-Syed F, Rangaswami J, Nunez J, Skrzypek S, Jux C, Grone H et al. Histopathology of congestive nephropathy: a case description and literature review. ESC Heart Failure. 2024;11(4):2395-8$23$YR$$M$Y$$$20240812$$MD$DE$DE
241994391$24199439$1$I$$20240807$20240812$20240812$EXP$$GB-ASTELLAS-2024EU007880$ASTELLAS$Mohidin B, Needleman A, Fernando R, Lowe DM, Wechalekar A, Sheaff M et al. Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab. Journal of Clinical Medicine. 2024;13(14):1-10$$$A$M$Y$$$20240812$$HP$GB$GB
241994402$24199440$2$F$$20240919$20240812$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126528$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240920$$CN$US$US
241994411$24199441$1$I$$20240806$20240812$20240812$EXP$$US-GSK-US2024098153$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$HP$US$US
241994421$24199442$1$I$$20240614$20240812$20240812$EXP$$US-GRAVITIPHARMA-GRA-2406-US-SPO-0182$GRAVITI PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241994431$24199443$1$I$$20240808$20240812$20240812$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099273$VIIV$$$$$$Y$$$20240812$$HP$US$US
241994441$24199444$1$I$$20240808$20240812$20240812$PER$$US-BAYER-2024A115425$BAYER$$$$$$Y$$$20240812$$CN$US$US
241994451$24199445$1$I$$20240809$20240812$20240812$PER$$US-ROCHE-10000054479$ROCHE$$66$YR$E$F$Y$$$20240812$$CN$US$US
241994462$24199446$2$F$$20240812$20240812$20240814$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-15785$IPSEN$$$$$M$Y$$$20240814$$CN$GB$GB
241994471$24199447$1$I$$20240807$20240812$20240812$EXP$$US-BEH-2024176978$CSL BEHRING$$$$A$F$Y$$$20240812$$CN$US$US
241994481$24199448$1$I$$20240731$20240812$20240812$EXP$$OM-Appco Pharma LLC-2160292$APPCO PHARMA$Initial$73$YR$$F$Y$$$20240812$$MD$OM$OM
241994491$24199449$1$I$$20240730$20240812$20240812$EXP$$US-MACLEODS PHARMA-MAC2024048594$MACLEODS$$$$$$Y$$$20240812$$CN$US$US
241994501$24199450$1$I$$20240730$20240812$20240812$EXP$$US-MACLEODS PHARMA-MAC2024048647$MACLEODS$Bally K, Trusty R, Naher K..A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone.Cureus.2024;16(6):e62695$$$$$Y$$$20240812$$MD$US$US
241994511$24199451$1$I$$20240731$20240812$20240812$EXP$$US-MACLEODS PHARMA-MAC2024048713$MACLEODS$Moshfeghi DM, Lowder CY, Roth DB, Kaiser PK..Retinal and choroidal vascular occlusion after posterior sub-tenon triamcinolone injection.American journal of ophthalmology.2002;134(1):132-4$$$$$Y$$$20240812$$MD$US$US
241994521$24199452$1$I$$20240731$20240812$20240812$EXP$$US-MACLEODS PHARMA-MAC2024048707$MACLEODS$Bansal V, D^Souza G, Aladade E, McFarlane DM, Agarwal R..Postdural Puncture Headaches in Pediatric Patients: A Review of Options When Repeated Epidural Blood  Patches Do Not Work.Cureus.2024;16(6):e62833$$$$$Y$$$20240812$$MD$US$US
241994531$24199453$1$I$20120101$20240731$20240812$20240812$EXP$$CZ-MACLEODS PHARMA-MAC2024048706$MACLEODS$Lukac A..Individualised therapy for patient with prostatic cancer..Onkologie (CzechRepublic).2024;18(3):216-8$52$YR$A$M$Y$$$20240812$$MD$CZ$CZ
241994551$24199455$1$I$$20240730$20240812$20240812$EXP$$US-UCBSA-2024038686$UCB$$$$$M$Y$$$20240812$$HP$US$US
241994561$24199456$1$I$20220901$20240731$20240812$20240812$EXP$$US-MACLEODS PHARMA-MAC2024048705$MACLEODS$Shah N, Dib EG, Joseph N, Fontana RJ..Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits.Clinical Liver Disease..2024;23(1):e0125$$$$$Y$$$20240812$$MD$US$US
241994571$24199457$1$I$20240101$20240805$20240812$20240812$EXP$$DO-ASTELLAS-2024US022741$ASTELLAS$$83$YR$$F$Y$$$20240812$$CN$DO$DO
241994581$24199458$1$I$20240712$20240802$20240812$20240812$EXP$$HR-ASTELLAS-2024US022829$ASTELLAS$$65$YR$$F$Y$56$KG$20240812$$CN$CH$HR
241994591$24199459$1$I$20240715$20240801$20240812$20240812$EXP$$CN-ROCHE-10000047072$ROCHE$$42$YR$A$F$Y$64.7$KG$20240812$$HP$CN$CN
241994601$24199460$1$I$20240101$20240806$20240812$20240812$EXP$$CO-ASTELLAS-2024US022647$ASTELLAS$$$$$M$Y$$$20240812$$CN$CO$CO
241994622$24199462$2$F$20240711$20240910$20240812$20240920$EXP$$FR-ASTELLAS-2024US022851$ASTELLAS$$81$YR$E$M$Y$85$KG$20240920$$PH$FR$FR
241994632$24199463$2$F$20240603$20240816$20240812$20240829$EXP$$BR-ASTELLAS-2024US022850$ASTELLAS$$65$YR$E$F$Y$79$KG$20240829$$PH$BR$BR
241994652$24199465$2$F$$20240808$20240812$20240823$EXP$$IT-ALVOGEN-2024095262$ALVOGEN$Marano M, Goffredo BM, Faraci S, Torroni F, Gowda SH, Perdichizzi S, Di Nardo M. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars. Toxicology Reports. 2024 Dec;13:101683. doi:https://dx.doi.org/10.1016/j.toxrep.2024.101683$15$YR$$F$Y$48$KG$20240823$$HP$IT$IT
241994661$24199466$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55050$$FDA-CTU$$65$YR$$M$N$$$20240809$N$$US$
241994671$24199467$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55049$$FDA-CTU$$52$YR$$F$N$70.76$KG$20240809$N$$US$
241994731$24199473$1$I$20240701$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54967$$FDA-CTU$$82$YR$$$N$$$20240809$N$HP$US$
241994741$24199474$1$I$20240701$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55045$$FDA-CTU$$82$YR$$M$N$$$20240809$N$HP$US$
241994751$24199475$1$I$20240720$20240806$20240809$20240809$DIR$FDA-CDER-CTU-2024-54971$$FDA-CTU$$47$YR$$M$N$$$20240806$N$HP$US$
241994761$24199476$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54987$$FDA-CTU$$81$YR$$M$N$$$20240809$N$PH$US$
241994772$24199477$2$F$20240801$20240822$20240812$20240829$EXP$$JP-ASTELLAS-2024JP005600$ASTELLAS$$7$DEC$E$F$Y$$$20240828$$MD$JP$JP
241994791$24199479$1$I$20240801$20240808$20240812$20240812$EXP$$JP-ASTELLAS-2024JP005823$ASTELLAS$$58$YR$$M$Y$$$20240812$$MD$JP$JP
241994802$24199480$2$F$$20240819$20240812$20240829$EXP$$JP-ASTELLAS-2024JP005852$ASTELLAS$$96$YR$E$M$Y$$$20240828$$CN$JP$JP
241994812$24199481$2$F$20240806$20240829$20240812$20240909$EXP$$JP-ASTELLAS-2024JP005853$ASTELLAS$$8$DEC$E$F$Y$$$20240909$$MD$JP$JP
241994821$24199482$1$I$$20240808$20240812$20240812$EXP$$ZA-ASTELLAS-2024EU007891$ASTELLAS$$70$YR$$F$Y$$$20240812$$HP$GB$ZA
241994841$24199484$1$I$$20240807$20240812$20240812$PER$$US-GILEAD-2024-0683673$GILEAD$$60$YR$A$M$Y$$$20240812$$CN$US$US
241994852$24199485$2$F$20240601$20240813$20240812$20240820$30DAY$$US-AMGEN-USASP2024152746$AMGEN$$49$YR$A$F$Y$181$KG$20240820$$PH$US$US
241994861$24199486$1$I$$20240809$20240812$20240812$EXP$$DE-ASTELLAS-2024EU007922$ASTELLAS$$$$$F$Y$3.015$KG$20240812$$CN$DE$DE
241994872$24199487$2$F$20240711$20240912$20240812$20240920$EXP$$US-ASTELLAS-2024US021609$ASTELLAS$$80$YR$E$M$Y$$$20240920$$CN$US$US
241994881$24199488$1$I$20240224$20240809$20240812$20240812$EXP$$JP-ASTELLAS-2024JP001730$ASTELLAS$$7$DEC$$M$Y$$$20240812$$MD$JP$JP
241994891$24199489$1$I$$20240809$20240812$20240812$EXP$$JP-ASTELLAS-2024JP005866$ASTELLAS$$83$YR$$F$Y$$$20240812$$PH$JP$JP
241994901$24199490$1$I$$20240809$20240812$20240812$EXP$$JP-ASTELLAS-2024JP005877$ASTELLAS$$8$DEC$$F$Y$$$20240812$$HP$JP$JP
241994913$24199491$3$F$20240620$20240911$20240812$20240918$EXP$$JP-ASTELLAS-2024JP004368$ASTELLAS$$8$DEC$E$M$Y$$$20240918$$MD$JP$JP
241994921$24199492$1$I$20240501$20240809$20240812$20240812$EXP$$CO-ASTELLAS-2024US022776$ASTELLAS$$$$$M$Y$$$20240812$$CN$CO$CO
241994931$24199493$1$I$20240727$20240809$20240812$20240812$EXP$$CN-ASTELLAS-2024US022879$ASTELLAS$$61$YR$$M$Y$60$KG$20240812$$CN$CN$CN
241994941$24199494$1$I$$20240809$20240812$20240812$EXP$$US-ASTELLAS-2024US022860$ASTELLAS$$64$YR$$M$Y$$$20240812$$CN$US$US
241994951$24199495$1$I$$20240806$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125749$BRISTOL MYERS SQUIBB$$96$YR$E$M$Y$$$20240812$$CN$US$US
241994961$24199496$1$I$$20240806$20240812$20240812$PER$$US-ALXN-202408USA000446US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241994971$24199497$1$I$20211225$20240809$20240812$20240812$EXP$$AU-ASTELLAS-2024US022720$ASTELLAS$$$$$M$Y$$$20240812$$CN$AU$AU
241994981$24199498$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235506$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240812$$MD$US$US
241994991$24199499$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA238169$SANOFI AVENTIS$$$$$$Y$$$20240812$$PH$US$US
241995001$24199500$1$I$20240401$20240807$20240812$20240812$PER$$US-SA-2024SA236446$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240812$$HP$US$US
241995012$24199501$2$F$20240730$20240806$20240812$20240819$PER$$US-SA-2024SA232810$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240819$$CN$US$US
241995021$24199502$1$I$20240724$20240807$20240812$20240812$PER$$US-SA-2024SA236302$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240812$$CN$US$US
241995031$24199503$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235001$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240812$$CN$US$US
241995041$24199504$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163247$NOVARTIS$$$$$M$Y$$$20240812$$HP$US$US
241995051$24199505$1$I$$20240808$20240812$20240812$EXP$$US-AMGEN-USASP2024158424$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241995061$24199506$1$I$$20240730$20240812$20240812$EXP$$CO-ROCHE-10000045377$ROCHE$$$$$$Y$$$20240812$$MD$CO$CO
241995071$24199507$1$I$20240716$20240802$20240812$20240812$EXP$$CN-ROCHE-10000048419$ROCHE$$52$YR$A$F$Y$79.6$KG$20240812$$HP$CN$CN
241995091$24199509$1$I$$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159197$AMGEN$$$$A$F$Y$$$20240812$$HP$US$US
241995102$24199510$2$F$20240809$20240812$20240812$20240813$PER$$US-AMGEN-USASP2024158893$AMGEN$$53$YR$A$F$Y$$$20240813$$CN$US$US
241995111$24199511$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA236880$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240812$$MD$US$US
241995121$24199512$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA233399$SANOFI AVENTIS$$$$E$F$Y$$$20240812$$CN$US$US
241995131$24199513$1$I$20231001$20240806$20240812$20240812$PER$$US-SA-2024SA236626$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240812$$MD$US$US
241995142$24199514$2$F$$20240912$20240812$20240923$PER$$US-SA-2024SA236421$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240923$$MD$US$US
241995153$24199515$3$F$20240807$20240812$20240812$20240817$PER$$US-AMGEN-USASP2024159781$AMGEN$$75$YR$E$F$Y$$$20240816$$CN$US$US
241995163$24199516$3$F$20240807$20240918$20240812$20240920$EXP$$US-AMGEN-USASP2024157385$AMGEN$$69$YR$E$F$Y$$$20240919$$HP$US$US
241995171$24199517$1$I$$20240730$20240812$20240812$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15314$IPSEN$$32$YR$A$F$Y$$$20240812$$CN$US$US
241995181$24199518$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126677$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240812$$HP$US$US
241995201$24199520$1$I$$20240802$20240812$20240812$EXP$$US-ZENPEP LLC-2024AIMT01193$AIMMUNE$$$$$$Y$$$20240812$$CN$US$US
241995211$24199521$1$I$$20240801$20240812$20240812$PER$$US-MSNLABS-2024MSNSPO01724$MSN LABORATORIES$$$$$$Y$$$20240812$$CN$US$US
241995221$24199522$1$I$$20240729$20240812$20240812$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07558$LUPIN$Allami N, O^Connor K, Bagley SM. A case of severe opioid and methamphetamine use disorder in a 14 year old. Addiction Science + Clinical Practice. 2024;19:54:1-4$14$YR$$F$Y$$$20240812$$HP$US$US
241995231$24199523$1$I$$20240802$20240812$20240812$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP009961$STRIDES$Luque-Paz D, Lalanne S, Besombes J, Dorel M, Maamar A, Revest M.. Absence of maribavir penetration into the central nervous system: confirmation by multiple cerebrospinal fluid dosages in a solid organ transplant recipient.. J-Antimicrob-Chemother. 2024;79 (6):1462-1463.$59$YR$$F$Y$$$20240812$$HP$FR$FR
241995241$24199524$1$I$$20240802$20240812$20240812$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009952$STRIDES$Sreekumar S, Rubin R.. A Case of Pulmonary Mucormycosis Leading to Non-hepatic Hyperammonemia.. Am-J-Respir-Crit-Care-Med. 2024;209(plus Poster$31$YR$$F$Y$$$20240812$$HP$US$US
241995251$24199525$1$I$20240718$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55060$$FDA-CTU$$78$YR$$F$N$$$20240809$Y$PH$US$
241995261$24199526$1$I$$20240802$20240812$20240812$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024096949$VIIV$$$$$M$Y$$$20240812$$CN$US$US
241995271$24199527$1$I$20240601$20240806$20240809$20240809$DIR$FDA-CDER-CTU-2024-54982$$FDA-CTU$$65$YR$$F$N$$$20240806$N$HP$US$
241995281$24199528$1$I$20240730$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54955$$FDA-CTU$$53$YR$$F$N$$$20240809$Y$HP$US$
241995291$24199529$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005525$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240812$$CN$US$US
241995301$24199530$1$I$20240808$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005951$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240812$$CN$US$US
241995311$24199531$1$I$20240807$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005605$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240812$$CN$US$US
241995321$24199532$1$I$20240805$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005944$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240812$$CN$US$US
241995331$24199533$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55047$$FDA-CTU$$36$YR$$F$N$151$LBS$20240809$N$$US$
241995341$24199534$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236506$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240812$$MD$US$US
241995351$24199535$1$I$20240524$20240802$20240812$20240812$EXP$$JP-ROCHE-10000051662$ROCHE$$73$YR$E$M$Y$52.4$KG$20240812$$PH$JP$JP
241995362$24199536$2$F$$20240902$20240812$20240913$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2024-07706$LUPIN$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$C$$Y$$$20240913$$HP$DE$DE
241995371$24199537$1$I$20240716$20240808$20240812$20240812$EXP$$CA-JNJFOC-20240824185$JOHNSON AND JOHNSON$$17$YR$T$M$Y$49$KG$20240812$$HP$CA$CA
241995381$24199538$1$I$$20240804$20240812$20240812$EXP$$US-JNJFOC-20240809727$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$US$US
241995391$24199539$1$I$$20240729$20240812$20240812$PER$$US-ROCHE-10000049816$ROCHE$Godfrey J, Gao L, Shouse G, Song J, Pak S, Lee B, et al. Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood. 2024-Jul-25;144 (4):457-461. doi:10.1182/blood.2024024168.$56$YR$A$F$Y$$$20240812$$HP$US$US
241995401$24199540$1$I$20240712$20240801$20240812$20240812$PER$$US-JNJFOC-20240809795$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240812$$CN$US$US
241995421$24199542$1$I$$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024157984$AMGEN$$$$$$Y$$$20240812$$PH$US$US
241995442$24199544$2$F$20240731$20240731$20240812$20240819$30DAY$$US-AMGEN-USASL2024154169$AMGEN$$$$$$Y$$$20240819$$PH$US$US
241995451$24199545$1$I$20240808$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158783$AMGEN$$75$YR$E$F$Y$$$20240812$$HP$US$US
241995461$24199546$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125895$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240812$$HP$US$US
241995473$24199547$3$F$$20240822$20240812$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123307$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$76$KG$20240827$$HP$US$US
241995481$24199548$1$I$$20240806$20240812$20240812$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009963$STRIDES$Dantas MAS, Graneiro AL, Cavalcante R, Felipez LM.. A Challenging Case of Oral Ulcers and Gastrointestinal Bleeding: Crohn^s or Beh?et^s Disease.. Case Reports in Pediatrics. 2023;2023:Article ID 4705638, 1-6$8$YR$$M$Y$$$20240812$$HP$US$US
241995491$24199549$1$I$$20240730$20240812$20240812$30DAY$$FR-UCBSA-2024039112$UCB$$53$YR$$F$Y$$$20240812$$PH$FR$FR
241995501$24199550$1$I$20230501$20240806$20240812$20240812$30DAY$$US-GSK-US2024098078$GLAXOSMITHKLINE$$19$YR$$F$Y$$$20240812$$CN$US$US
241995511$24199551$1$I$$20240806$20240812$20240812$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP009920$STRIDES$Amaral A, Ferreira da Silva D, Sampaio MB, Salvado C.. Colchicine Poisoning: A Rare Case. Cureus. 2023;15(11):e48933$50$YR$$F$Y$$$20240812$$HP$PT$PT
241995524$24199552$4$F$20240707$20240913$20240812$20240924$EXP$$US-ORGANON-O2408USA000543$ORGANON$$63$YR$$F$Y$60$KG$20240924$$HP$US$US
241995531$24199553$1$I$20240325$20240809$20240812$20240812$EXP$FR-AFSSAPS-AN2024000987$FR-ROCHE-10000054013$ROCHE$$66$YR$E$M$Y$$$20240812$$MD$FR$FR
241995541$24199554$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54945$$FDA-CTU$$$$$$N$$$20240809$N$CN$US$
241995551$24199555$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55046$$FDA-CTU$$36$YR$$F$N$151$LBS$20240809$N$$US$
241995561$24199556$1$I$$20240805$20240809$20240809$DIR$FDA-CDER-CTU-2024-55044$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
241995571$24199557$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54941$$FDA-CTU$$$$$M$N$$$20240809$N$HP$US$
241995612$24199561$2$F$20240101$20240928$20240812$20240930$EXP$$CA-PFIZER INC-202400233163$PFIZER$$19$YR$$M$Y$$$20240930$$HP$CA$CA
241995621$24199562$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-038279$AUROBINDO$Bangolo A, Tesoro N, Onyeka S, Bangura M, Shrestha R, Nagesh VK, et al.. A Rare Case Report of Hypoketotic Hypoglycemia Induced Seizures Due to Secondary Carnitine Deficiency in a 44-year-old Female.. Journal of community hospital internal medicine perspectives.. 2024;14(3):68-71$44$YR$$F$Y$$$20240812$$MD$US$US
241995642$24199564$2$F$$20240929$20240812$20240930$EXP$$US-PFIZER INC-202400232328$PFIZER$$81$YR$$F$Y$$$20240930$$CN$US$US
241995651$24199565$1$I$$20240729$20240812$20240812$PER$$US-ASTELLAS-2024US021683$ASTELLAS$$$$$F$Y$$$20240812$$CN$US$US
241995661$24199566$1$I$$20240426$20240812$20240812$PER$$US-ASTELLAS-2024US012810$ASTELLAS$$38$YR$$F$Y$150$KG$20240812$$HP$US$US
241995681$24199568$1$I$20230705$20240805$20240812$20240812$PER$$US-ALXN-A202308648$ALEXION PHARMACEUTICALS$$59$YR$$F$Y$$$20240812$$CN$US$US
241995691$24199569$1$I$$20240503$20240812$20240812$PER$$US-ASTELLAS-2024US013362$ASTELLAS$$18$YR$$F$Y$$$20240812$$HP$US$US
241995701$24199570$1$I$20240627$20240802$20240812$20240812$EXP$FR-AFSSAPS-AM2024000598$FR-TEVA-VS-3230114$TEVA$$62$YR$$M$Y$90$KG$20240812$$PH$FR$FR
241995721$24199572$1$I$$20240713$20240812$20240812$30DAY$$US-VEROBIOTECH-2024USVEROSPO00175$VERO BIOTECH$$$$$$Y$$$20240812$$HP$US$US
241995731$24199573$1$I$20240801$20240805$20240812$20240812$EXP$$JP-AstraZeneca-2024A180259$ASTRAZENECA$$$$$F$Y$$$20240812$$MD$JP$
241995741$24199574$1$I$20220407$20220513$20240812$20240812$EXP$$US-AstraZeneca-2022A147167$ASTRAZENECA$$48$YR$$F$Y$93.4$KG$20240812$$HP$US$
241995761$24199576$1$I$$20240808$20240812$20240812$EXP$$GB-MYLANLABS-2024M1074211$MYLAN$$$$$M$Y$$$20240812$$CN$GB$GB
241995771$24199577$1$I$$20240809$20240812$20240812$EXP$$GB-MYLANLABS-2024M1074532$MYLAN$$35$YR$$F$Y$73$KG$20240812$$PH$GB$GB
241995781$24199578$1$I$20240701$20240802$20240812$20240812$EXP$$US-TEVA-VS-3230930$TEVA$$66$YR$$M$Y$$$20240812$$CN$US$US
241995792$24199579$2$F$20240626$20240903$20240812$20240904$EXP$$NZ-MYLANLABS-2024M1074622$MYLAN$$50$YR$$F$Y$$$20240904$$HP$NZ$NZ
241995801$24199580$1$I$20240624$20240812$20240812$20240812$EXP$$AU-MYLANLABS-2024M1074683$MYLAN$$70$YR$$M$Y$$$20240812$$HP$AU$AU
241995811$24199581$1$I$$20240808$20240812$20240812$EXP$GB-MHRA-MED-202408081140126560-YGFTN$GB-MYLANLABS-2024M1074300$MYLAN$$58$YR$$M$Y$$$20240812$$PH$GB$GB
241995822$24199582$2$F$$20240916$20240812$20240917$EXP$$GB-MYLANLABS-2024M1074685$MYLAN$$$$$M$Y$$$20240917$$HP$GB$GB
241995831$24199583$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54916$$FDA-CTU$$$$$$N$$$20240809$N$CN$US$
241995851$24199585$1$I$$20240808$20240812$20240812$EXP$$GB-MYLANLABS-2024M1074226$MYLAN$$$$$M$Y$$$20240812$$HP$GB$GB
241995881$24199588$1$I$20231204$20231204$20240812$20240812$PER$$US-ASTELLAS-2023US036774$ASTELLAS$$86$YR$$M$Y$$$20240812$$HP$US$US
241995891$24199589$1$I$$20231110$20240812$20240812$PER$$US-ASTELLAS-2023US034635$ASTELLAS$$$$$M$Y$$$20240812$$CN$US$US
241995901$24199590$1$I$$20240802$20240812$20240812$EXP$$NL-RDY-LIT/NLD/24/0011647$DR REDDYS$Hutten EM, Roeloffzen WW, Lambeck AJ, van den TB, Oude HE, van de AV. Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization. Journal of Investigational Allergology and Clinical Immunology. 34(3): 214-216. doi:10.18176/jiaci.0990.$52$YR$A$F$Y$$$20240812$$HP$NL$NL
241995911$24199591$1$I$20240408$20240408$20240812$20240812$PER$$US-ASTELLAS-2024US011154$ASTELLAS$$61$YR$$M$Y$$$20240812$$PH$US$US
241995921$24199592$1$I$20231118$20231202$20240812$20240812$PER$$US-ASTELLAS-2023US035310$ASTELLAS$$73$YR$$M$Y$$$20240812$$PH$US$US
241995931$24199593$1$I$$20240304$20240812$20240812$PER$$US-ASTELLAS-2024US007080$ASTELLAS$$$$$$Y$$$20240812$$CN$US$US
241995941$24199594$1$I$20240307$20240319$20240812$20240812$PER$$US-ASTELLAS-2024US007860$ASTELLAS$$89$YR$$F$Y$$$20240812$$PH$US$US
241995951$24199595$1$I$$20240730$20240812$20240812$PER$$US-ASTELLAS-2024EU007765$ASTELLAS$$22$YR$$M$Y$$$20240812$$HP$US$US
241995961$24199596$1$I$$20240809$20240812$20240812$PER$$US-ABBVIE-5876260$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241995973$24199597$3$F$20240101$20240827$20240812$20240903$PER$$US-JNJFOC-20240809601$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240903$$HP$US$US
241995991$24199599$1$I$20231001$20240807$20240812$20240812$EXP$$US-JNJFOC-20240818189$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240812$$MD$US$US
241996001$24199600$1$I$20240722$20240803$20240812$20240812$PER$$CN-Eisai-EC-2024-171430$EISAI$$54$YR$A$F$Y$50$KG$20240812$$HP$CN$CN
241996011$24199601$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-039040$AUROBINDO$Churchill AB, Nguyen AD, Xia J, Nguyen VD, Agrawal N, Durant CE, et al.. To Bite or Not to Bite: A Case of Non-bite Pasteurella Multicoda Resulting in Severe Septic Shock. Am-J-Respir-Crit-CareMed. 2024;209:A1679$68$YR$$M$Y$$$20240812$$HP$US$US
241996021$24199602$1$I$20240101$20240807$20240812$20240812$EXP$$US-AMGEN-USASL2024157334$AMGEN$$72$YR$E$M$Y$$$20240812$$CN$US$US
241996031$24199603$1$I$20240718$20240719$20240812$20240812$EXP$$US-NEBO-664778$PHARMACOSMOS$$$$$F$Y$$$20240812$$CN$US$US
241996041$24199604$1$I$$20240731$20240812$20240812$PER$$US-HALEON-2191261$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
241996051$24199605$1$I$$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024158354$AMGEN$$$$$$Y$$$20240812$$PH$US$US
241996063$24199606$3$F$20240806$20240812$20240812$20240816$PER$$US-AMGEN-USASP2024159410$AMGEN$$74$YR$E$F$Y$$$20240816$$CN$US$US
241996072$24199607$2$F$20240809$20240812$20240812$20240815$PER$$US-AMGEN-USASP2024159459$AMGEN$$56$YR$A$F$Y$$$20240814$$CN$US$US
241996081$24199608$1$I$$20240808$20240812$20240812$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-126636$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240812$$MD$JP$JP
241996102$24199610$2$F$20240713$20240812$20240812$20240819$EXP$$PL-MYLANLABS-2024M1072545$MYLAN$$85$YR$$M$Y$$$20240819$$CN$PL$PL
241996111$24199611$1$I$20240701$20240802$20240812$20240812$EXP$$US-VIIV HEALTHCARE LIMITED-US2024096924$VIIV$$62$YR$$F$Y$$$20240812$$CN$US$US
241996121$24199612$1$I$20240725$20240731$20240812$20240812$EXP$$CN-ROCHE-10000046306$ROCHE$$39$YR$A$F$Y$64$KG$20240812$$HP$CN$CN
241996131$24199613$1$I$$20240715$20240812$20240812$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003581$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241996141$24199614$1$I$$20240714$20240812$20240812$30DAY$$US-VEROBIOTECH-2024USVEROSPO00176$VERO BIOTECH$$$$$$Y$$$20240812$$HP$US$US
241996151$24199615$1$I$$20240730$20240812$20240812$EXP$$BR-AUROBINDO-AUR-APL-2024-038998$AUROBINDO$Nobre L, Rosas C, Kalichsztein B, Nobre G, Kalichsztein M, Marinho A, et al. Recurrent Pulmonary Hemorrhage in a Young Adult. Am-J-Respir-Crit-Care-Med. 2024;209:A7055$48$YR$$F$Y$$$20240812$$HP$BR$BR
241996161$24199616$1$I$$20240802$20240812$20240812$EXP$GR-SEATTLE GENETICS-2024SGN00446$GR-ROCHE-10000052132$ROCHE$$$$$F$Y$$$20240812$$MD$GR$GR
241996171$24199617$1$I$$20240731$20240812$20240812$EXP$$IT-EMD Serono-2024041757$EMD SERONO INC$Brunoni B, Zadek F, Fumagalli R, Protti A, Cecconi M, Langer T. Uncomplicated Calcium-Citrate Anticoagulation during Continuous Renal Replacement Therapy in 2 Other Patients with Metformin Accumulation. Blood Purification. 2024 Feb 12;53(7): 591-593. doi:DOI: 10.1159/000537712.$73$YR$E$M$Y$$$20240812$$HP$IT$IT
241996191$24199619$1$I$$20240806$20240812$20240812$EXP$$GB-MYLANLABS-2024M1073914$MYLAN$$$$$F$Y$$$20240812$$CN$GB$GB
241996201$24199620$1$I$20240603$20240806$20240812$20240812$EXP$FR-AFSSAPS-AN2024001000$FR-MYLANLABS-2024M1073191$MYLAN$$88$YR$$F$Y$49.2$KG$20240812$$MD$FR$FR
241996211$24199621$1$I$20240609$20240802$20240812$20240812$EXP$DE-CADRBFARM-2024329453$DE-TEVA-VS-3230102$TEVA$$34$YR$$M$Y$117$KG$20240812$$CN$DE$DE
241996222$24199622$2$F$$20240816$20240812$20240829$EXP$$IT-AUROBINDO-AUR-APL-2024-038187$AUROBINDO$Contu N, Gallus R, Profice P, Lucchetti D, Degni E, Rizzo D, et al. Vocal Fold Paralysis After Spinal and Epidural Anesthesia: A Case Report and Scoping Review. Laryngoscope. 2024;134(8):3477-84$38$YR$$F$Y$$$20240829$$MD$IT$IT
241996231$24199623$1$I$20240124$20240806$20240812$20240812$EXP$$ZA-MYLANLABS-2024M1073442$MYLAN$$62$YR$$M$Y$$$20240812$$HP$ZA$ZA
241996241$24199624$1$I$$20230612$20240812$20240812$EXP$$US-AstraZeneca-2023A136696$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241996251$24199625$1$I$20240612$20240614$20240812$20240812$EXP$$US-GRAVITIPHARMA-GRA-2406-US-SPO-0183$GRAVITI PHARMACEUTICALS$$78$YR$E$M$Y$81.64$KG$20240812$$CN$US$US
241996261$24199626$1$I$$20240730$20240812$20240812$EXP$$GB-AUROBINDO-AUR-APL-2024-038403$AUROBINDO$$$$$F$Y$$$20240812$$MD$GB$GB
241996271$24199627$1$I$$20230705$20240812$20240812$EXP$$US-AstraZeneca-2023A154846$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
241996281$24199628$1$I$20240803$20240805$20240812$20240812$EXP$$US-VANTIVE-2024VAN018903$Vantive US Healthcare$$65$YR$$F$Y$$$20240812$$HP$US$US
241996291$24199629$1$I$$20240808$20240812$20240812$EXP$$US-AMGEN-USASL2024158211$AMGEN$$57$YR$A$F$Y$$$20240812$$CN$US$US
241996301$24199630$1$I$$20240731$20240812$20240812$EXP$$IT-EMD Serono-2024042213$EMD SERONO INC$Brunoni B, Zadek F, Protti A, Cecconi M, Fumagalli R, Langer T. Uncomplicated Calcium-Citrate Anticoagulation during Continuous Renal Replacement Therapy in 2 Other Patients with Metformin Accumulation. Blood Purification. 2024 Feb 12;53(7): 591-593. doi:DOI:10.1159/000537712.$77$YR$E$M$Y$$$20240812$$HP$IT$IT
241996311$24199631$1$I$20240801$20240806$20240812$20240812$PER$$US-AMGEN-USASP2024157671$AMGEN$$$$$F$Y$$$20240812$$HP$US$US
241996321$24199632$1$I$20240809$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159035$AMGEN$$51$YR$A$F$Y$$$20240812$$CN$US$US
241996331$24199633$1$I$$20240805$20240812$20240812$PER$$US-ABBVIE-5868781$ABBVIE$$$$$$Y$$$20240812$$CN$US$US
241996341$24199634$1$I$$20240802$20240812$20240812$EXP$$IN-SANDOZ INC.-SDZ2024IN071746$SANDOZ$$$$$M$Y$$$20240812$$CN$IN$IN
241996351$24199635$1$I$$20240809$20240812$20240812$PER$$US-ROCHE-10000054485$ROCHE$$68$YR$E$M$Y$$$20240812$$HP$US$US
241996361$24199636$1$I$$20240802$20240812$20240812$PER$$NVSC2024US162790$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
241996371$24199637$1$I$20170101$20240809$20240812$20240812$EXP$$DE-SANDOZ INC.-NVSC2020DE286062$SANDOZ$$33$YR$$M$Y$$$20240812$$MD$DE$DE
241996381$24199638$1$I$$20240729$20240812$20240812$EXP$$US-NKFPHARMA-2024MPLIT00240$NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL$Weigle DP, et al..Uncommon and Unfavorable: Heparin-Induced Hyperkalemia. Journal of Cardiothoracic and Vascular Anesthesia.26-APR-2024;1(1):01-4$56$YR$A$M$Y$$$20240812$$MD$US$US
241996391$24199639$1$I$20240718$20240809$20240812$20240812$EXP$RO-NMA-2024-SP0488$RO-ROCHE-10000054023$ROCHE$$65$YR$E$M$Y$$$20240812$$MD$RO$RO
241996401$24199640$1$I$$20240730$20240812$20240812$EXP$$GB-AUROBINDO-AUR-APL-2024-038124$AUROBINDO$$$$$F$Y$$$20240812$$MD$GB$GB
241996421$24199642$1$I$$20240809$20240809$20240809$DIR$713689$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
241996451$24199645$1$I$$20240809$20240809$20240809$DIR$713668$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241996461$24199646$1$I$$20240701$20240812$20240812$PER$$US-TRAVERE-2024TVT00668$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240812$$CN$US$US
241996471$24199647$1$I$$20240809$20240809$20240809$DIR$713674$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241996481$24199648$1$I$20240729$20240809$20240809$20240809$DIR$713703$$FDA-CTU$$21$YR$$F$N$80.55$KG$20240809$N$CN$US$
241996502$24199650$2$F$20240609$20240705$20240812$20240815$PER$$US-TRAVERE-2024TVT00667$TRAVERE THERAPEUTICS$$61$YR$A$F$Y$$$20240815$$CN$US$US
241996512$24199651$2$F$20240101$20240727$20240812$20240828$PER$$ES-TRAVERE-2024TVT00757$TRAVERE THERAPEUTICS$$$$A$M$Y$$$20240828$$HP$ES$ES
241996521$24199652$1$I$20200501$20240729$20240812$20240812$EXP$$US-ENDO USA, INC.-2024-003081$ENDO$$$$$F$Y$$$20240812$$CN$US$US
241996531$24199653$1$I$$20240808$20240812$20240812$EXP$$GB-SANDOZ INC.-SDZ2024GB071783$SANDOZ$$$$$F$Y$$$20240812$$CN$GB$GB
241996541$24199654$1$I$20240416$20240806$20240812$20240812$EXP$FR-AFSSAPS-PA2024001277$FR-RDY-SPO/FRA/24/0011546$DR REDDYS$$79$YR$E$F$Y$75$KG$20240812$$PH$FR$FR
241996551$24199655$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191388$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
241996561$24199656$1$I$$20240805$20240812$20240812$EXP$BE-FAMHP-DHH-N2024-122426$BE-MYLANLABS-2024M1073113$MYLAN$$48$YR$$F$Y$$$20240812$$MD$BE$BE
241996571$24199657$1$I$$20240805$20240812$20240812$EXP$FR-AFSSAPS-AVNT2024000572$FR-MYLANLABS-2024M1073247$MYLAN$$31$YR$$M$Y$$$20240812$$MD$FR$FR
241996581$24199658$1$I$20240723$20240805$20240812$20240812$EXP$DE-CADRBFARM-2024329591$DE-MYLANLABS-2024M1073170$MYLAN$$2$DY$$M$Y$3$KG$20240812$$MD$DE$DE
241996592$24199659$2$F$20240701$20240911$20240812$20240917$EXP$FR-AFSSAPS-MP2024001211$FR-MYLANLABS-2024M1073880$MYLAN$$66$YR$$M$Y$71$KG$20240917$$HP$FR$FR
241996611$24199661$1$I$20240731$20240808$20240812$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US071628$SANDOZ$$49$YR$$F$Y$$$20240812$$HP$US$US
241996622$24199662$2$F$20240805$20240808$20240812$20240823$30DAY$$US-SANDOZ INC.-SDZ2024US071748$SANDOZ$$54$YR$$M$Y$$$20240823$$CN$US$US
241996631$24199663$1$I$20230101$20240801$20240812$20240812$EXP$$US-NOVOPROD-1266296$NOVO NORDISK$$64$YR$$$Y$$$20240812$$CN$US$US
241996641$24199664$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA236636$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240812$$MD$US$US
241996651$24199665$1$I$$20240801$20240812$20240812$PER$$US-SA-2024SA234000$SANOFI AVENTIS$$$$A$F$Y$63.5$KG$20240812$$MD$US$US
241996661$24199666$1$I$20240101$20240801$20240812$20240812$PER$$US-SA-2024SA233912$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240812$$MD$US$US
241996671$24199667$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA236452$SANOFI AVENTIS$$$$E$M$Y$$$20240812$$CN$US$US
241996681$24199668$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163283$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
241996691$24199669$1$I$20240401$20240806$20240812$20240812$PER$$US-SA-2024SA236631$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240812$$MD$US$US
241996701$24199670$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235351$SANOFI AVENTIS$$$$T$M$Y$$$20240812$$MD$US$US
241996711$24199671$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA169743$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240812$$MD$US$US
241996721$24199672$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA235422$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240812$$MD$US$US
241996731$24199673$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235567$SANOFI AVENTIS$$$$E$F$Y$$$20240812$$MD$US$US
241996742$24199674$2$F$$20240903$20240812$20240913$30DAY$$US-GSK-US2024097607$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
241996761$24199676$1$I$20240805$20240805$20240812$20240812$PER$$US-SA-2024SA235271$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240812$$MD$US$US
241996771$24199677$1$I$$20240730$20240812$20240812$EXP$$IT-AUROBINDO-AUR-APL-2024-038993$AUROBINDO$Schierz IAM, Giuffre M, Piro E, La Placa S, Corsello G. A Case of Cardiomyopathy Due to Premature Ductus Arteriosus Closure: The Flip Side of Paracetamol. Pediatrics. 2018;141 (2):e20163850$$$$F$Y$$$20240812$$MD$IT$IT
241996781$24199678$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006657$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240812$$CN$US$US
241996811$24199681$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA234438$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240812$$CN$US$US
241996821$24199682$1$I$$20240731$20240812$20240812$EXP$$PT-EMD Serono-2024041734$EMD SERONO INC$Novais C. Unexpected challenges: Recognize the serious adverse effects of oral antidiabetics. Portuguese Journal of Family Medicine and General Practice. 2024;40(Supplem 13): S21-S21.$80$YR$E$F$Y$$$20240812$$MD$PT$PT
241996831$24199683$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006294$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240812$$CN$US$US
241996842$24199684$2$F$20240717$20240905$20240812$20240914$EXP$PT-INFARMED-F202407-487$PT-TEVA-VS-3229710$TEVA$$67$YR$$M$Y$$$20240914$$PH$PT$PT
241996852$24199685$2$F$$20240806$20240812$20240816$EXP$$GB-TEVA-VS-3230083$TEVA$$$$$F$Y$$$20240816$$HP$GB$GB
241996863$24199686$3$F$$20240924$20240812$20240927$EXP$$US-TAKEDA-2024TUS063239$TAKEDA$$$$$M$Y$$$20240927$$HP$US$US
241996881$24199688$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158943$AMGEN$$$$$$Y$$$20240812$$MD$US$US
241996891$24199689$1$I$$20240730$20240812$20240812$EXP$$JP-UCBSA-2024038698$UCB$$65$YR$$M$Y$$$20240812$$PH$JP$JP
241996902$24199690$2$F$$20240814$20240812$20240817$EXP$$SK-SA-2024SA236819$SANOFI AVENTIS$Sykora T, Horakova J, Buzzasyova D, Sladekova M, Poczova M, Sufliarska S.. Protothecal peritonitis in child after bone marrow transplantation: case report and literature review of paediatric cases.. New Microbe and New Infect.. 2014;2:156-60$3$YR$C$M$Y$$$20240817$$HP$SK$SK
241996911$24199691$1$I$$20240808$20240812$20240812$PER$$US-ABBVIE-5875166$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241996921$24199692$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236642$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240812$$MD$US$US
241996931$24199693$1$I$20240730$20240805$20240812$20240812$PER$$US-SA-2024SA235655$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240812$$MD$US$US
241996942$24199694$2$F$$20240820$20240812$20240830$PER$$US-SA-2024SA236551$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240830$$MD$US$US
241996951$24199695$1$I$20240724$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125972$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240812$$CN$US$US
241996961$24199696$1$I$20240401$20240805$20240812$20240812$EXP$$FR-ASTELLAS-2024US010981$ASTELLAS$$73$YR$$M$Y$100$KG$20240812$$CN$FR$FR
241996971$24199697$1$I$$20240812$20240812$20240812$EXP$$ES-SANDOZ INC.-SDZ2024ES071859$SANDOZ$$24$YR$$F$Y$$$20240812$$HP$ES$ES
241996981$24199698$1$I$$20220812$20240812$20240812$EXP$$US-AstraZeneca-2022A286764$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241996991$24199699$1$I$$20230705$20240812$20240812$EXP$$US-AstraZeneca-2023A155510$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241997001$24199700$1$I$$20221207$20240812$20240812$EXP$$US-AstraZeneca-2022A401582$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241997011$24199701$1$I$$20240809$20240809$20240809$DIR$713664$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241997021$24199702$1$I$$20230705$20240812$20240812$EXP$$US-AstraZeneca-2023A157211$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
241997031$24199703$1$I$$20240808$20240812$20240812$EXP$$DE-SANDOZ INC.-SDZ2024DE071709$SANDOZ$$$$$F$Y$$$20240812$$CN$DE$DE
241997041$24199704$1$I$20240725$20240802$20240812$20240812$EXP$$CN-SA-2024SA235046$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240812$$HP$CN$CN
241997052$24199705$2$F$20240805$20240918$20240812$20240926$EXP$$US-TAKEDA-2024TUS079564$TAKEDA$$75$YR$$M$Y$76$KG$20240926$$MD$US$US
241997061$24199706$1$I$20220901$20240802$20240812$20240812$EXP$$TH-BAYER-2024A112671$BAYER$$72$YR$E$F$Y$$$20240812$$MD$TH$TH
241997091$24199709$1$I$20240808$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158807$AMGEN$$74$YR$E$F$Y$$$20240812$$CN$US$US
241997101$24199710$1$I$20240809$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024158954$AMGEN$$$$$$Y$$$20240812$$CN$US$US
241997112$24199711$2$F$$20240726$20240812$20240815$PER$$US-TRAVERE-2024TVT00670$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240815$$CN$US$US
241997122$24199712$2$F$$20240807$20240812$20240815$PER$$US-TRAVERE-2024TVT00673$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240815$$CN$US$US
241997132$24199713$2$F$20240704$20240705$20240812$20240815$PER$$US-TRAVERE-2024TVT00672$TRAVERE THERAPEUTICS$$76$YR$E$F$Y$$$20240815$$CN$US$US
241997141$24199714$1$I$20240801$20240806$20240812$20240812$EXP$$US-JNJFOC-20240820631$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$HP$US$US
241997151$24199715$1$I$$20240729$20240812$20240812$EXP$$AU-LUPIN EUROPE GMBH-2024-07572$LUPIN$$$$$M$Y$$$20240812$$CN$AU$AU
241997161$24199716$1$I$$20240801$20240812$20240812$EXP$$US-JNJFOC-20240805736$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240812$$MD$US$US
241997171$24199717$1$I$20201009$20240806$20240812$20240812$EXP$PL-URPL-1-3173-2020$PL-MYLANLABS-2024M1073136$MYLAN$$40$YR$$F$Y$85$KG$20240812$$HP$PL$PL
241997181$24199718$1$I$$20240806$20240812$20240812$EXP$$HN-MYLANLABS-2024M1074012$MYLAN$$$$$F$Y$59.87$KG$20240812$$CN$HN$HN
241997191$24199719$1$I$$20240808$20240812$20240812$PER$$NVSC2024US162766$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
241997201$24199720$1$I$20240101$20240808$20240812$20240812$EXP$$CA-UCBSA-2024040394$UCB$$$$$M$Y$$$20240812$$CN$CA$CA
241997211$24199721$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA237064$SANOFI AVENTIS$$$$$F$Y$$$20240812$$CN$US$US
241997221$24199722$1$I$20240801$20240806$20240812$20240812$PER$$US-SA-2024SA236729$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240812$$MD$US$US
241997231$24199723$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA233238$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240812$$MD$US$US
241997241$24199724$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA236842$SANOFI AVENTIS$$$$A$F$Y$68.03$KG$20240812$$MD$US$US
241997252$24199725$2$F$20240701$20240814$20240812$20240816$PER$$US-JNJFOC-20240771065$JOHNSON AND JOHNSON$$41$YR$A$F$Y$93$KG$20240816$$HP$US$US
241997271$24199727$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235528$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240812$$MD$US$US
241997281$24199728$1$I$$20240730$20240812$20240812$EXP$$DE-AMICUS THERAPEUTICS, INC.-AMI_3295$AMICUS THERAPEUTICS$$$$$F$Y$$$20240812$$MD$DE$DE
241997301$24199730$1$I$20240705$20240731$20240809$20240809$DIR$FDA-CDER-CTU-2024-55036$$FDA-CTU$$63$YR$$M$N$$$20240731$N$HP$US$
241997311$24199731$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55040$$FDA-CTU$$81$YR$$F$N$140$LBS$20240809$N$$US$
241997321$24199732$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54966$$FDA-CTU$$19$YR$$F$N$105$LBS$20240809$N$$US$
241997331$24199733$1$I$$20240807$20240812$20240812$PER$$US-ALXN-202408USA000454US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
241997341$24199734$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163144$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
241997351$24199735$1$I$$20240810$20240812$20240812$PER$$NVSC2024US163196$NOVARTIS$$$$$M$Y$$$20240812$$CN$US$US
241997361$24199736$1$I$$20240802$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124341$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240812$$CN$US$US
241997381$24199738$1$I$20240802$20240806$20240812$20240812$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-124697$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$70.76$KG$20240812$$CN$PR$PR
241997392$24199739$2$F$$20240826$20240812$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124174$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240902$$CN$US$US
241997421$24199742$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127030$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240812$$CN$US$US
241997433$24199743$3$F$20240717$20240905$20240812$20240911$30DAY$$US-AMGEN-USASP2024156639$AMGEN$$78$YR$E$M$Y$73.48$KG$20240910$$PH$US$US
241997441$24199744$1$I$20240101$20240805$20240812$20240812$PER$$US-ABBVIE-5868385$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241997452$24199745$2$F$$20240807$20240812$20240829$PER$$US-BEH-2024177021$CSL BEHRING$$13$YR$T$F$Y$$$20240829$$PH$US$US
241997462$24199746$2$F$20240621$20240913$20240812$20240919$EXP$FR-AFSSAPS-TO2024001497$NVSC2024FR161422$NOVARTIS$$60$YR$$M$Y$100$KG$20240919$$PH$FR$FR
241997471$24199747$1$I$$20240809$20240812$20240812$EXP$SK-EMA-20171006-pbishtp-122444624$SK-SANDOZ INC.-SDZ2024SK071678$SANDOZ$$46$YR$$M$Y$80$KG$20240812$$MD$SK$SK
241997482$24199748$2$F$20240115$20240919$20240812$20240926$EXP$$NVSC2024DE009399$NOVARTIS$$$$E$F$Y$$$20240926$$MD$DE$DE
241997491$24199749$1$I$$20240808$20240812$20240812$EXP$$NVSC2024US162483$NOVARTIS$$$$$M$Y$$$20240812$$CN$US$US
241997501$24199750$1$I$$20240808$20240812$20240812$EXP$$US-SANDOZ INC.-SDZ2024US071639$SANDOZ$$$$$$Y$$$20240812$$CN$US$US
241997511$24199751$1$I$$20240730$20240812$20240812$EXP$$US-ELITEPHARMA-2024ELLIT00202$ELITE$R. Vaidya et al..Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure.Journal of Neonatal-Perinatal Medicine.2024;1 (1):1-6$$$N$M$Y$$$20240812$$MD$US$US
241997521$24199752$1$I$$20240730$20240812$20240812$EXP$$US-ELITEPHARMA-2024ELLIT00203$ELITE$R. Vaidya et al..Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure.Journal of Neonatal-Perinatal Medicine.2024;1 (1):01-6$$$$M$Y$$$20240812$$MD$US$US
241997542$24199754$2$F$20240801$20240806$20240812$20240828$EXP$$AU-BEH-2024176908$CSL BEHRING$$92$YR$E$F$Y$67$KG$20240828$$HP$AU$AU
241997551$24199755$1$I$$20240809$20240809$20240809$DIR$713644$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241997561$24199756$1$I$$20240810$20240812$20240812$EXP$GB-MHRA-MED-202408100658253420-HDTFK$GB-SANDOZ INC.-SDZ2024GB071856$SANDOZ$$$$$M$Y$$$20240812$$CN$GB$GB
241997571$24199757$1$I$$20240809$20240812$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US071890$SANDOZ$$$$$$Y$$$20240812$$HP$US$US
241997581$24199758$1$I$20210430$20240806$20240812$20240812$EXP$$CA-TAKEDA-2024TUS079427$TAKEDA$$37$YR$$F$Y$$$20240812$$CN$CA$CA
241997591$24199759$1$I$$20240809$20240809$20240809$DIR$713682$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241997601$24199760$1$I$$20240806$20240812$20240812$EXP$$FR-UCBSA-2024039581$UCB$Hagenkotter B, Zayet S, Poloni S, Gendrin V, Zanusso M, Stancescu S, et al.. Posterior reversible encephalopathy syndrome in early lyme neuroborreliosis. Ticks and Tick-borne Diseases. 2024;15(6):1-4$69$YR$$M$Y$$$20240812$$HP$FR$FR
241997611$24199761$1$I$$20240805$20240812$20240812$EXP$$JP-BAYER-2024A113104$BAYER$$$$$F$Y$$$20240812$$CN$JP$JP
241997621$24199762$1$I$20240101$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158445$AMGEN$$$$$F$Y$$$20240812$$MD$US$US
241997631$24199763$1$I$$20240809$20240809$20240809$DIR$713642$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
241997652$24199765$2$F$20240601$20240807$20240812$20240816$EXP$FR-AFSSAPS-NT2024000953$FR-TEVA-VS-3230241$TEVA$$$$A$M$Y$$$20240816$$MD$FR$FR
241997663$24199766$3$F$20231001$20240910$20240812$20240912$EXP$$NVSC2024GB160946$NOVARTIS$$57$YR$$M$Y$88$KG$20240912$$MD$GB$GB
241997671$24199767$1$I$$20240807$20240812$20240812$EXP$$NVSC2024GB105101$NOVARTIS$$$$E$F$Y$$$20240812$$CN$GB$GB
241997701$24199770$1$I$20240314$20240802$20240812$20240812$EXP$PL-URPL-DML-MLP.4401.1.162.2024$PL-TEVA-VS-3229867$TEVA$$74$YR$$M$Y$52$KG$20240812$$MD$PL$PL
241997712$24199771$2$F$20240704$20240906$20240812$20240909$EXP$$DE-SANDOZ INC.-SDZ2024DE071657$SANDOZ$$61$YR$$M$Y$64$KG$20240909$$MD$DE$DE
241997721$24199772$1$I$$20240808$20240812$20240812$PER$$US-TAKEDA-2024TUS079764$TAKEDA$$$$$$Y$$$20240812$$CN$US$US
241997732$24199773$2$F$20240802$20240813$20240812$20240820$PER$$IT-Eisai-EC-2024-171806$EISAI$$80$YR$E$$Y$$$20240820$$MD$IT$IT
241997741$24199774$1$I$20240720$20240812$20240812$20240812$EXP$FR-AFSSAPS-TO2024001537$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044956$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$125$KG$20240812$$MD$FR$FR
241997751$24199775$1$I$19920101$20240806$20240812$20240812$EXP$GB-MHRA-MED-202405131339048220-TYRGZ$GB-TAKEDA-2024TUS079519$TAKEDA$$$$A$F$Y$102$KG$20240812$$HP$GB$GB
241997762$24199776$2$F$20240717$20240814$20240812$20240823$EXP$$DZ-EMD Serono-2024042915$EMD SERONO INC$$25$YR$A$F$Y$$$20240823$$CN$DZ$DZ
241997771$24199777$1$I$$20240808$20240812$20240812$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140281$DAIICHI$$$$$F$Y$$$20240812$$CN$US$US
241997781$24199778$1$I$$20240801$20240812$20240812$EXP$GB-MYLANLABS-2024M1009582$GB-RDY-SPO/GBR/24/0011415$DR REDDYS$$59$YR$A$F$Y$$$20240812$$HP$GB$GB
241997792$24199779$2$F$$20240813$20240812$20240819$EXP$$ES-AUROBINDO-AUR-APL-2024-040159$AUROBINDO$Carrasco-Sanchez, M. Carrillo-Hernandez-Rubio J, LlopisPastor E, Garcia-Salmones-Martin M.. From clarinet notes to critical care: dual antifungal therapy in an immunocompetent patient with a diagnosis of invasive pulmonary aspergilosis. Case report. Revista de Patologia Respiratoria. 2024;27(2):91-94$65$YR$$M$Y$$$20240819$$HP$ES$ES
241997801$24199780$1$I$20240801$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125813$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$90.6$KG$20240812$$PH$US$US
241997813$24199781$3$F$20240201$20240806$20240812$20240925$EXP$$CA-BEH-2024176975$CSL BEHRING$$38$YR$A$M$Y$94$KG$20240925$$CN$CA$CA
241997831$24199783$1$I$$20240807$20240812$20240812$EXP$$IE-MYLANLABS-2024M1073843$MYLAN$$$$$F$Y$$$20240812$$HP$IE$IE
241997841$24199784$1$I$20240805$20240807$20240812$20240812$EXP$$AU-MYLANLABS-2024M1073877$MYLAN$$64$YR$$F$Y$$$20240812$$HP$AU$AU
241997851$24199785$1$I$20240731$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179826$ASTRAZENECA$$$$$F$Y$$$20240812$$HP$US$
241997861$24199786$1$I$$20240801$20240812$20240812$EXP$$US-MYLANLABS-2024M1073509$MYLAN$Pang S, Saleh H, Ailawadhi S, Edgar M, Pang M. Acute esophageal stricture after bone marrow transplant. Clin-J-Gastroenterol 2024; 17 1-5.$58$YR$$M$Y$$$20240812$$HP$US$US
241997871$24199787$1$I$$20240802$20240812$20240812$EXP$$US-MYLANLABS-2024M1073067$MYLAN$Elsayed M. An Interesting Case of Drug-Induced Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Pulmonary and Renal Involvement. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$75$YR$$M$Y$$$20240812$$HP$US$US
241997881$24199788$1$I$$20240801$20240812$20240812$EXP$$US-MYLANLABS-2024M1073520$MYLAN$Fakhraie S, Chovatiya R. Janus Kinase Inhibition in the Treatment of Prurigo Nodularis. Dermatitis 2023; 35 (3): 299-300.$45$YR$$F$Y$$$20240812$$MD$US$US
241997891$24199789$1$I$$20230124$20240812$20240812$EXP$$US-AstraZeneca-2023A020882$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
241997901$24199790$1$I$20240519$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179900$ASTRAZENECA$$$$$$Y$$$20240812$$CN$US$
241997911$24199791$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179682$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
241997921$24199792$1$I$$20230808$20240812$20240812$EXP$$US-AstraZeneca-2023A182088$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
241997931$24199793$1$I$20240803$20240805$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004334$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
241997941$24199794$1$I$20240807$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005985$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240812$$CN$US$US
241997951$24199795$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005601$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240812$$CN$US$US
241997961$24199796$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005961$ELI LILLY AND CO$$50$YR$A$$Y$$$20240812$$CN$US$US
241997971$24199797$1$I$20240805$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004200$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240812$$CN$US$US
241997981$24199798$1$I$20240808$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005595$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240812$$CN$US$US
241997991$24199799$1$I$$20240809$20240812$20240812$PER$$NVSC2024US162679$NOVARTIS$$$$$F$Y$$$20240812$$MD$US$US
241998001$24199800$1$I$$20240802$20240812$20240812$EXP$$US-GSK-US2024096887$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$MD$US$US
241998011$24199801$1$I$20240602$20240809$20240812$20240812$PER$$US-ABBVIE-5875311$ABBVIE$$42$YR$$F$Y$64$KG$20240812$$CN$US$US
241998021$24199802$1$I$$20240806$20240812$20240812$EXP$$US-BAYER-2024A113581$BAYER$$78$YR$E$F$Y$$$20240812$$CN$US$US
241998031$24199803$1$I$$20240807$20240812$20240812$EXP$$BR-TAKEDA-2024TUS080061$TAKEDA$$22$YR$$$Y$$$20240812$$CN$BR$BR
241998041$24199804$1$I$20230130$20230328$20240812$20240812$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044897$BOEHRINGER INGELHEIM$$48$YR$A$F$Y$89.5$KG$20240812$$HP$US$US
241998052$24199805$2$F$$20240822$20240812$20240826$PER$$US-TAKEDA-2024TUS079676$TAKEDA$$$$$M$Y$141$KG$20240826$$MD$US$US
241998061$24199806$1$I$20180101$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-038271$AUROBINDO$Greenman M, Bellone S, Demirkiran C, Hartwich TMP, Santin AD. Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer.. Gynecologic Oncology Reports. 2024;54:101459$69$YR$$F$Y$$$20240812$$MD$US$US
241998071$24199807$1$I$20240731$20240731$20240812$20240812$PER$$US-JNJFOC-20240801501$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$US$US
241998082$24199808$2$F$$20240826$20240812$20240830$EXP$$JP-UCBSA-2024038917$UCB$Taka R, Tanaka H, Machimoto T. A case report of FNH mimicking hepatocellular adenoma during long-term antiepileptic medication. The 79th General Meeting of the Japanese Society of Gastroenterological Surgery. 2024$18$YR$$F$Y$$$20240830$$MD$JP$JP
241998091$24199809$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-038859$AUROBINDO$Puthumana RM, Koch AL, Schettino C, Vehar SJ. Asymptomatic and slowly progressive antiMDA5 ILD: A report of three cases deviating from a notoriously rapidly progressive ILD. Respiratory Medicine Case Reports. 2024;51:102072$54$YR$$F$Y$$$20240812$$HP$US$US
241998101$24199810$1$I$$20240731$20240812$20240812$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-02882$AMNEAL$Ikejima S, Okubo H, Fukuo Y, Yamashina S, Ikejima K. A case of dermatomyositis associated with atezolizumab plus bevacizumab therapy for advanced hepatocellular carcinoma. Acta Hepatol Jpn. 2024;65 (7):327-35$$$$M$Y$$$20240812$$HP$JP$JP
241998112$24199811$2$F$20240809$20240812$20240812$20240815$PER$$US-AMGEN-USASP2024159471$AMGEN$$74$YR$E$F$Y$$$20240815$$CN$US$US
241998121$24199812$1$I$20240805$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024157637$AMGEN$$65$YR$E$F$Y$$$20240812$$PH$US$US
241998131$24199813$1$I$$20240807$20240812$20240812$EXP$$US-009507513-2408USA002853$MERCK$$$$$F$Y$$$20240812$$MD$US$US
241998141$24199814$1$I$$20240807$20240812$20240812$EXP$$GB-SA-2024SA238322$SANOFI AVENTIS$Grantham H, Best K, Weatherhead S.. Peripheral blood flow cytometry reveals heterogeneous but benign T-cell changes in patients with severe eczema undergoing dupilumab therapy.. British Journal of Dermatology.. 2024;192:i31$$$$$Y$$$20240812$$HP$GB$GB
241998151$24199815$1$I$20240601$20240730$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-038667$AUROBINDO$$$$A$M$Y$$$20240812$$MD$FR$FR
241998161$24199816$1$I$20230802$20240731$20240812$20240812$EXP$ES-AEMPS-1554205$ES-Accord-439693$ACCORD$$16$YR$T$M$Y$$$20240812$$PH$ES$ES
241998171$24199817$1$I$20240724$20240731$20240812$20240812$EXP$$US-Accord-439938$ACCORD$$63$YR$A$M$Y$$$20240812$$HP$US$US
241998182$24199818$2$F$20240731$20240806$20240812$20240817$EXP$GB-MHRA-MED-202407311046435960-GSYJP$GB-Accord-439956$ACCORD$$39$YR$A$F$Y$$$20240817$$CN$GB$GB
241998191$24199819$1$I$20240501$20240731$20240812$20240812$EXP$ES-AEMPS-1553074$ES-Accord-439710$ACCORD$$83$YR$E$M$Y$$$20240812$$PH$ES$ES
241998211$24199821$1$I$20240730$20240731$20240812$20240812$EXP$$US-Accord-440131$ACCORD$$68$YR$E$F$Y$$$20240812$$HP$US$US
241998221$24199822$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-E2B_07138765$CA-Accord-439778$ACCORD$$78$YR$E$F$Y$$$20240812$$HP$CA$CA
241998231$24199823$1$I$20240603$20240731$20240812$20240812$EXP$PL-URPL-DML-MLP.4401.1.163.2024$PL-Accord-439598$ACCORD$$74$YR$E$M$Y$70$KG$20240812$$PH$PL$PL
241998241$24199824$1$I$20240501$20240731$20240812$20240812$EXP$SE-SEMPA-2024-005705$SE-Accord-439747$ACCORD$$94$YR$E$F$Y$$$20240812$$MD$SE$SE
241998251$24199825$1$I$$20240731$20240812$20240812$EXP$GB-MHRA-MIDB-2e957c43-01ee-4abe-8676-d258493bd95a$GB-Accord-439984$ACCORD$$72$YR$E$M$Y$$$20240812$$PH$GB$GB
241998261$24199826$1$I$20240716$20240731$20240812$20240812$EXP$GB-MHRA-TPP20640899C6519831YC1722347811120$GB-Accord-439986$ACCORD$$79$YR$E$M$Y$100$KG$20240812$$MD$GB$GB
241998271$24199827$1$I$$20240731$20240812$20240812$EXP$GB-MHRA-31372200$GB-Accord-440006$ACCORD$$$$$M$Y$$$20240812$$CN$GB$GB
241998281$24199828$1$I$$20240731$20240812$20240812$EXP$GB-MHRA-31372440$GB-Accord-439991$ACCORD$$86$YR$E$M$Y$$$20240812$$PH$GB$GB
241998291$24199829$1$I$$20240731$20240812$20240812$EXP$GB-MHRA-31372529$GB-Accord-440280$ACCORD$$72$YR$E$F$Y$$$20240812$$PH$GB$GB
241998301$24199830$1$I$20240607$20240731$20240812$20240812$EXP$ES-AEMPS-1553165$ES-Accord-439570$ACCORD$$57$YR$A$F$Y$$$20240812$$MD$ES$ES
241998311$24199831$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA236899$SANOFI AVENTIS$$$$E$F$Y$81$KG$20240812$$MD$US$US
241998322$24199832$2$F$20240101$20240829$20240812$20240923$PER$$US-SA-2024SA234803$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240923$$CN$US$US
241998331$24199833$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA236773$SANOFI AVENTIS$$$$A$M$Y$87.54$KG$20240812$$MD$US$US
241998341$24199834$1$I$$20240805$20240812$20240812$EXP$$US-GSK-US2024097545$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
241998351$24199835$1$I$$20240806$20240812$20240812$30DAY$$US-GSK-US2024098185$GLAXOSMITHKLINE$$$$E$F$Y$$$20240812$$CN$US$US
241998361$24199836$1$I$20240601$20240802$20240812$20240812$EXP$$CN-Eisai-EC-2024-171431$EISAI$$56$YR$A$M$Y$73$KG$20240812$$HP$CN$CN
241998381$24199838$1$I$$20240806$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124906$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240812$$PH$US$US
241998391$24199839$1$I$20240101$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125360$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240812$$HP$US$US
241998401$24199840$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125655$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240812$$MD$US$US
241998411$24199841$1$I$$20240807$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126066$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240812$$CN$US$US
241998451$24199845$1$I$20240608$20240809$20240809$20240809$DIR$713620$$FDA-CTU$$52$YR$$F$N$69.75$KG$20240809$Y$CN$CA$
241998461$24199846$1$I$20240802$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54978$$FDA-CTU$$73$YR$$M$N$$$20240809$Y$PH$US$
241998471$24199847$1$I$$20240808$20240812$20240812$PER$$US-ROCHE-10000053979$ROCHE$$$$A$M$Y$$$20240812$$CN$US$US
241998481$24199848$1$I$$20240808$20240812$20240812$PER$$US-ROCHE-10000052883$ROCHE$$$$A$F$Y$$$20240812$$CN$US$US
241998491$24199849$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191394$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
241998511$24199851$1$I$20240201$20240730$20240812$20240812$EXP$$BR-UCBSA-2024039259$UCB$$53$YR$$F$Y$94$KG$20240812$$CN$BR$BR
241998521$24199852$1$I$20240722$20240809$20240812$20240812$EXP$$IE-ROCHE-10000053680$ROCHE$$$$$F$Y$$$20240812$$CN$IE$IE
241998533$24199853$3$F$20240405$20240816$20240812$20240821$EXP$FR-AFSSAPS-ST2024001270$FR-EXELIXIS-CABO-24080442$EXELIXIS$$80$YR$$M$Y$76$KG$20240821$$HP$FR$FR
241998541$24199854$1$I$$20240805$20240812$20240812$EXP$$CA-BAYER-2024A113902$BAYER$$30$YR$A$F$Y$90$KG$20240812$$CN$CA$CA
241998552$24199855$2$F$$20240828$20240812$20240828$PER$$US-ALXN-202408USA000383US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
241998561$24199856$1$I$$20240801$20240812$20240812$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-02881$AMNEAL$Nishio T, Toukairin Y, Hoshi T, Arai T, Nogami M.. A case of lacosamide and mirtazapine self-poisoning. Leg.Med. 2024;69$$$$$Y$$$20240812$$HP$JP$JP
241998585$24199858$5$F$20240502$20240911$20240812$20240920$EXP$$XI-TEVA-VS-3230109$TEVA$$74$YR$$F$Y$$$20240920$$MD$GB$GB
241998591$24199859$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400233148$PFIZER$$49$YR$$F$Y$$$20240812$$MD$US$US
241998615$24199861$5$F$$20240925$20240812$20240925$30DAY$$US-PFIZER INC-202400226018$PFIZER$$16$YR$$M$Y$63.5$KG$20240925$$CN$US$US
241998623$24199862$3$F$$20240923$20240812$20240926$PER$$US-PFIZER INC-202400232380$PFIZER$$11$YR$$M$Y$$$20240926$$HP$US$US
241998631$24199863$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-PV202400103509$PFIZER$$44$YR$$M$Y$$$20240812$$HP$US$US
241998641$24199864$1$I$$20240808$20240812$20240812$EXP$$CO-ROCHE-10000053889$ROCHE$$33$YR$A$M$Y$$$20240812$$CN$CO$CO
241998651$24199865$1$I$20240708$20240802$20240812$20240812$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024097015$VIIV$$60$YR$$M$Y$$$20240812$$CN$US$US
241998661$24199866$1$I$$20240802$20240812$20240812$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR098384$VIIV$$$$$$Y$$$20240812$$CN$US$US
241998671$24199867$1$I$$20240802$20240812$20240812$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024097046$VIIV$$$$$$Y$$$20240812$$PH$US$US
241998681$24199868$1$I$20240712$20240730$20240812$20240812$EXP$$FR-AUROBINDO-AUR-APL-2024-038422$AUROBINDO$$69$YR$$M$Y$73$KG$20240812$$PH$FR$FR
241998691$24199869$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158270$AMGEN$$$$$$Y$$$20240812$$CN$US$US
241998701$24199870$1$I$20210101$20240806$20240812$20240812$PER$$US-AMGEN-USASP2024157551$AMGEN$$$$$F$Y$$$20240812$$LW$US$US
241998711$24199871$1$I$20240601$20240806$20240812$20240812$PER$$US-AMGEN-USASP2024156798$AMGEN$$67$YR$E$M$Y$$$20240812$$CN$US$US
241998721$24199872$1$I$$20240806$20240812$20240812$EXP$$NVSC2024CN162373$NOVARTIS$Bai G, Bai Y, Guan H, Ren H, Li H, Wang Y. A case report of lymphoproliferative disease in brain following therapies with mycophenolate Mofetil and Fingolimod and literature review. JOURNAL OF NEUROIMMUNOLOGY. 2024;394:1-5$32$YR$$M$Y$$$20240812$$HP$CN$CN
241998731$24199873$1$I$20240101$20240807$20240812$20240812$PER$$US-BAYER-2024A114187$BAYER$$41$YR$A$F$Y$$$20240812$$MD$US$US
241998741$24199874$1$I$20240807$20240807$20240812$20240812$PER$$US-BAYER-2024A114342$BAYER$$22$YR$A$F$Y$$$20240812$$HP$US$US
241998761$24199876$1$I$$20240808$20240812$20240812$PER$$US-GILEAD-2024-0683685$GILEAD$$$$$M$Y$$$20240812$$HP$US$US
241998782$24199878$2$F$$20240905$20240812$20240913$30DAY$$AR-JNJFOC-20240822616$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$AR$AR
241998791$24199879$1$I$20240719$20240809$20240812$20240812$EXP$$US-ABBVIE-5875387$ABBVIE$$77$YR$$M$Y$$$20240812$$CN$US$US
241998801$24199880$1$I$$20240730$20240812$20240812$EXP$$CA-AUROBINDO-AUR-APL-2024-039532$AUROBINDO$$87$YR$$F$Y$59$KG$20240812$$PH$CA$CA
241998811$24199881$1$I$$20240807$20240812$20240812$5DAY$$US-ASTELLAS-2024US022517$ASTELLAS$$$$$$Y$$$20240812$$CN$US$US
241998821$24199882$1$I$$20240801$20240812$20240812$EXP$$CY-AMNEAL PHARMACEUTICALS-2024-AMRX-02915$AMNEAL$Liveri K, Constantinou M.A, Afxentiou M, Kanari P.. A fatal intoxication related to MDPV and pentedrone combined with antipsychotic and antidepressant substances in Cyprus. Forensic Sci Int.. 2016;265:160-165$42$YR$$M$Y$$$20240812$$HP$CY$CY
241998831$24199883$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158669$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241998841$24199884$1$I$20240101$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158092$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
241998852$24199885$2$F$20240330$20240830$20240812$20240909$EXP$$JP-AMGEN-JPNSP2024158370$AMGEN$$65$YR$E$F$Y$$$20240908$$MD$JP$JP
241998861$24199886$1$I$20240505$20240807$20240812$20240812$EXP$GB-MHRA-MED-202405171218264050-YSZMJ$GB-MYLANLABS-2024M1063821$MYLAN$$15$YR$$F$Y$$$20240812$$MD$GB$GB
241998872$24199887$2$F$20240627$20240815$20240812$20240820$PER$$US-BAYER-2024A114437$BAYER$$22$YR$A$F$Y$58$KG$20240820$$MD$US$US
241998882$24199888$2$F$20240701$20240815$20240812$20240820$EXP$$RU-BAYER-2024A114402$BAYER$$27$YR$A$F$Y$$$20240820$$MD$RU$RU
241998891$24199889$1$I$$20240401$20240812$20240812$EXP$$NVSC2024US070089$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
241998901$24199890$1$I$20240101$20240809$20240812$20240812$EXP$$US-ABBVIE-5875889$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
241998911$24199891$1$I$20240601$20240808$20240812$20240812$EXP$$CA-SANDOZ INC.-SDZ2024CA071564$SANDOZ$$71$YR$$M$Y$$$20240812$$MD$CA$CA
241998921$24199892$1$I$20240807$20240807$20240812$20240812$PER$$US-BAYER-2024A114485$BAYER$$50$YR$A$$Y$$$20240812$$HP$US$US
241998931$24199893$1$I$20240705$20240806$20240812$20240812$EXP$IT-MINISAL02-997096$IT-SA-2024SA234696$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240812$$MD$IT$IT
241998941$24199894$1$I$$20240809$20240812$20240812$EXP$$BR-PFIZER INC-PV202400104076$PFIZER$$$$$M$Y$$$20240812$$MD$BR$BR
241998955$24199895$5$F$20240923$20240925$20240812$20240927$EXP$$US-PFIZER INC-202400234034$PFIZER$$46$YR$$F$Y$$$20240927$$MD$US$US
241998966$24199896$6$F$20230201$20240929$20240812$20240930$EXP$$CA-PFIZER INC-202300008100$PFIZER$$66$YR$$M$Y$134$KG$20240930$$MD$CA$CA
241998971$24199897$1$I$20230825$20240808$20240812$20240812$EXP$$DE-PFIZER INC-202400232645$PFIZER$$74$YR$$F$Y$$$20240812$$MD$DE$DE
241998982$24199898$2$F$20240101$20240927$20240812$20240927$EXP$$CA-PFIZER INC-202300439797$PFIZER$$67$YR$$M$Y$$$20240927$$MD$CA$CA
241998991$24199899$1$I$$20240809$20240812$20240812$EXP$$MA-PFIZER INC-PV202400104548$PFIZER$$$$$F$Y$$$20240812$$CN$MA$MA
241999003$24199900$3$F$20240801$20240911$20240812$20240912$EXP$$AU-PFIZER INC-202400233471$PFIZER$$60$YR$$M$Y$$$20240912$$CN$AU$AU
241999011$24199901$1$I$20240214$20240808$20240812$20240812$EXP$PL-URPL-DML-MLP.4401.1.165.2024$PL-PFIZER INC-202400232616$PFIZER$$5$MON$$F$Y$6.8$KG$20240812$$PH$PL$PL
241999024$24199902$4$F$20240802$20240902$20240812$20240905$EXP$$CN-PFIZER INC-PV202400102666$PFIZER$$79$YR$$F$Y$65$KG$20240905$$HP$CN$CN
241999031$24199903$1$I$$20240809$20240812$20240812$EXP$$MA-PFIZER INC-PV202400104541$PFIZER$$$$$F$Y$$$20240812$$CN$MA$MA
241999041$24199904$1$I$$20240809$20240812$20240812$EXP$$JP-PFIZER INC-202400233355$PFIZER$$$$$$Y$$$20240812$$PH$JP$JP
241999051$24199905$1$I$$20240809$20240812$20240812$EXP$$US-PFIZER INC-202400234018$PFIZER$$78$YR$$F$Y$$$20240812$$CN$US$US
241999101$24199910$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55035$$FDA-CTU$$52$YR$$F$N$$$20240809$N$$US$
241999111$24199911$1$I$20240807$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126046$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240812$$CN$US$US
241999121$24199912$1$I$20240720$20240806$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124781$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240812$$CN$US$US
241999131$24199913$1$I$20240301$20240809$20240812$20240812$EXP$$US-GILEAD-2024-0683756$GILEAD$$78$YR$E$F$Y$$$20240812$$CN$US$US
241999141$24199914$1$I$$20240807$20240812$20240812$PER$$US-JNJFOC-20240820215$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
241999151$24199915$1$I$$20240805$20240812$20240812$EXP$$CA-PFIZER INC-202400231175$PFIZER$$62$YR$$F$Y$85$KG$20240812$$HP$CA$CA
241999161$24199916$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA236745$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240812$$CN$US$US
241999172$24199917$2$F$20240201$20240815$20240812$20240821$PER$$US-BAYER-2024A114646$BAYER$$40$YR$A$F$Y$94.785$KG$20240821$$MD$US$US
241999182$24199918$2$F$20240804$20240814$20240812$20240821$PER$$US-SA-2024SA234532$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240821$$MD$US$US
241999191$24199919$1$I$20240801$20240806$20240812$20240812$PER$$US-ALXN-202408USA000421US$ALEXION PHARMACEUTICALS$$72$YR$$F$Y$$$20240812$$CN$US$US
241999201$24199920$1$I$20240805$20240805$20240812$20240812$PER$$US-ALXN-202408USA000447US$ALEXION PHARMACEUTICALS$$58$YR$$F$Y$$$20240812$$CN$US$US
241999212$24199921$2$F$$20240828$20240812$20240828$EXP$$US-ALXN-202408USA000194US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240828$$MD$US$US
241999221$24199922$1$I$$20240808$20240812$20240812$EXP$$US-UCBSA-2024021948$UCB$$$$$F$Y$$$20240812$$CN$US$US
241999241$24199924$1$I$$20240730$20240812$20240812$EXP$$JP-UCBSA-2024038938$UCB$$$$$$Y$$$20240812$$MD$JP$JP
241999251$24199925$1$I$20240804$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004354$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240812$$CN$US$US
241999261$24199926$1$I$$20240731$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408000571$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
241999271$24199927$1$I$20240201$20240805$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004394$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240812$$CN$US$US
241999281$24199928$1$I$20240701$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004265$ELI LILLY AND CO$$$$$M$Y$$$20240812$$CN$US$US
241999291$24199929$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005520$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240812$$MD$US$US
241999301$24199930$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005579$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240812$$CN$US$US
241999311$24199931$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006378$ELI LILLY AND CO$$64$YR$A$$Y$$$20240812$$LW$US$US
241999321$24199932$1$I$$20240805$20240812$20240812$EXP$$NVSC2024TW161696$NOVARTIS$Leong PY, Shih PC, Huo AP. Is low-dose tumor necrosis factor inhibitor effective and safe in patients with ankylosing spondylitis flare-up after renal transplantation? A case report and literature review. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2024;27:e14877 (1-4)$55$YR$$M$Y$$$20240812$$HP$TW$TW
241999331$24199933$1$I$20240410$20240410$20240812$20240812$EXP$$NVSC2024US077472$NOVARTIS$$$$$$Y$$$20240812$$MD$US$US
241999341$24199934$1$I$20220401$20240802$20240812$20240812$EXP$$BR-TAKEDA-2024TUS079399$TAKEDA$$42$YR$$F$Y$$$20240812$$CN$BR$BR
241999352$24199935$2$F$$20240905$20240812$20240906$PER$$US-BAYER-2024A115032$BAYER$$50$YR$A$M$Y$$$20240906$$CN$US$US
241999361$24199936$1$I$$20240801$20240812$20240812$EXP$$AU-AMNEAL PHARMACEUTICALS-2024-AMRX-02918$AMNEAL$Adamson A, Michael A, Patel S, Brown M.. First case of Drug-Induced Pulmonary Arterial Hypertension: Teriflunomide. Heart Lung Circ. 2024;33(4):S353$45$YR$$F$Y$$$20240812$$HP$AU$AU
241999372$24199937$2$F$$20240812$20240812$20240814$PER$$US-AMGEN-USASP2024159457$AMGEN$$$$$$Y$$$20240813$$CN$US$US
241999381$24199938$1$I$20240605$20240802$20240812$20240812$EXP$SE-SEMPA-2024-005702$SE-TEVA-VS-3229868$TEVA$$87$YR$$M$Y$$$20240812$$MD$SE$SE
241999391$24199939$1$I$20240101$20240808$20240812$20240812$EXP$$US-ABBVIE-5874342$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
241999401$24199940$1$I$$20240807$20240812$20240812$EXP$$GB-SA-2024SA238326$SANOFI AVENTIS$Grantham H, Best K, Weatherhead S.. Peripheral blood flow cytometry reveals heterogeneous but benign T-cell changes in patients with severe eczema undergoing dupilumab therapy.. British Journal of Dermatology.. 2024;192:i31$$$$$Y$$$20240812$$HP$GB$GB
241999411$24199941$1$I$20240401$20240809$20240812$20240812$EXP$GB-MHRA-MED-202408091020594970-KFVBM$GB-SANDOZ INC.-SDZ2024GB071815$SANDOZ$$59$YR$$M$Y$$$20240812$$HP$GB$GB
241999421$24199942$1$I$20240726$20240809$20240812$20240812$PER$$US-BAYER-2024A115491$BAYER$$67$YR$E$M$Y$$$20240812$$CN$US$US
241999431$24199943$1$I$$20240807$20240812$20240812$EXP$$JP-009507513-2408JPN000803J$MERCK$$70$YR$$M$Y$$$20240812$$PH$JP$JP
241999451$24199945$1$I$20220101$20240809$20240812$20240812$EXP$$PL-SANDOZ INC.-SDZ2024PL071706$SANDOZ$$68$YR$$M$Y$$$20240812$$MD$PL$PL
241999462$24199946$2$F$20240713$20240822$20240812$20240830$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02837$AMNEAL$$77$YR$$F$Y$90.249$KG$20240830$$CN$US$US
241999471$24199947$1$I$$20240729$20240812$20240812$PER$$US-TEVA-VS-3228403$TEVA$$88$YR$$F$Y$$$20240812$$CN$US$US
241999481$24199948$1$I$$20240808$20240812$20240812$EXP$$DE-PFIZER INC-202400232845$PFIZER$$$$E$M$Y$$$20240812$$MD$DE$DE
241999491$24199949$1$I$20240720$20240805$20240812$20240812$EXP$FR-AFSSAPS-LY2024001178$FR-PFIZER INC-202400232974$PFIZER$$22$YR$$M$Y$67$KG$20240812$$PH$FR$FR
241999502$24199950$2$F$20240507$20240807$20240812$20240813$EXP$$US-PFIZER INC-PV202400103050$PFIZER$$75$YR$$M$Y$83.447$KG$20240813$$MD$US$US
241999541$24199954$1$I$$20240807$20240812$20240812$EXP$$US-PFIZER INC-202400232266$PFIZER$$56$YR$$F$Y$99.79$KG$20240812$$CN$US$US
241999551$24199955$1$I$20240715$20240807$20240812$20240812$EXP$$CN-PFIZER INC-PV202400102936$PFIZER$$62$YR$$M$Y$55$KG$20240812$$HP$CN$CN
241999561$24199956$1$I$$20240807$20240812$20240812$EXP$$BR-AMGEN-BRASP2024159320$AMGEN$Breviglieri C.; Ginani V.C.; Gouveia R.V. et al.. BLINATUMOMAB + DONOR LEUKOCYTE INFUSIONS (DLI) CAN BE USED TO PREVENT THE RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT). JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 2024;5 (SUPPL_1):82-83$$$$$Y$$$20240812$$HP$BR$BR
241999571$24199957$1$I$$20240806$20240812$20240812$PER$$US-AMGEN-USASP2024156278$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
241999582$24199958$2$F$20240806$20240808$20240812$20240816$PER$$US-AMGEN-USASP2024158621$AMGEN$$70$YR$E$F$Y$$$20240816$$CN$US$US
241999591$24199959$1$I$20240730$20240805$20240809$20240809$DIR$FDA-CDER-CTU-2024-54963$$FDA-CTU$$70$YR$$M$N$$$20240805$N$HP$US$
241999601$24199960$1$I$20240521$20240807$20240812$20240812$EXP$FR-AFSSAPS-AVPO2024000148$FR-MYLANLABS-2024M1073633$MYLAN$$17$YR$$M$Y$$$20240812$$PH$FR$FR
241999611$24199961$1$I$20240604$20240807$20240812$20240812$EXP$FR-AFSSAPS-AVPO2024000149$FR-MYLANLABS-2024M1073590$MYLAN$$17$YR$$M$Y$$$20240812$$PH$FR$FR
241999621$24199962$1$I$20240309$20240807$20240812$20240812$EXP$FR-AFSSAPS-AVMA2024000343$FR-MYLANLABS-2024M1073563$MYLAN$$39$YR$$F$Y$140$KG$20240812$$PH$FR$FR
241999631$24199963$1$I$20240621$20240807$20240812$20240812$EXP$FR-AFSSAPS-RN2024000846$FR-MYLANLABS-2024M1073583$MYLAN$$26$YR$$M$Y$$$20240812$$MD$FR$FR
241999642$24199964$2$F$$20240821$20240812$20240823$EXP$$PT-MYLANLABS-2024M1073603$MYLAN$$70$YR$$F$Y$$$20240823$$MD$PT$PT
241999651$24199965$1$I$$20240808$20240812$20240812$EXP$$JP-AstraZeneca-2024A180694$ASTRAZENECA$$68$YR$$M$Y$$$20240812$$MD$JP$
241999662$24199966$2$F$$20240809$20240812$20240816$EXP$$US-AstraZeneca-2024A180971$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
241999671$24199967$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A180284$ASTRAZENECA$$$$$$Y$$$20240812$$MD$US$
241999682$24199968$2$F$20240729$20240809$20240812$20240816$EXP$$GB-AstraZeneca-2024A181876$ASTRAZENECA$$39$YR$$F$Y$$$20240816$$MD$GB$
241999691$24199969$1$I$20240630$20240730$20240812$20240812$EXP$$DE-AUROBINDO-AUR-APL-2024-038758$AUROBINDO$$$$E$F$Y$$$20240812$$HP$DE$DE
241999702$24199970$2$F$20230710$20240813$20240812$20240820$EXP$$BR-CELLTRION INC.-2023BR014752$CELLTRION$$$$$$Y$$$20240820$$CN$BR$BR
241999712$24199971$2$F$20240805$20240911$20240812$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125711$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240913$$CN$US$US
241999721$24199972$1$I$$20240808$20240812$20240812$EXP$$CA-PFIZER INC-202400233761$PFIZER$$15$YR$$F$Y$$$20240812$$PH$CA$CA
241999731$24199973$1$I$20240101$20240806$20240812$20240812$EXP$$US-PFIZER INC-202400232035$PFIZER$$60$YR$$$Y$$$20240812$$CN$US$US
241999741$24199974$1$I$$20240807$20240812$20240812$EXP$$US-PFIZER INC-202400232968$PFIZER$$82$YR$$F$Y$$$20240812$$HP$US$US
241999751$24199975$1$I$20240101$20240807$20240812$20240812$EXP$$US-PFIZER INC-PV202300069417$PFIZER$$62$YR$$F$Y$$$20240812$$CN$US$US
241999761$24199976$1$I$20240701$20240808$20240812$20240812$EXP$GB-MHRA-MED-202408081056022780-PSZCD$GB-PFIZER INC-202400232856$PFIZER$$$$$M$Y$$$20240812$$PH$GB$GB
241999771$24199977$1$I$$20240806$20240812$20240812$EXP$FR-AFSSAPS-PV2024000722$FR-PFIZER INC-202400230827$PFIZER$$$$N$M$Y$0.32$KG$20240812$$MD$FR$FR
241999782$24199978$2$F$$20240826$20240812$20240829$PER$$US-PFIZER INC-202400232171$PFIZER$$$$$F$Y$$$20240829$$CN$US$US
241999791$24199979$1$I$$20240808$20240812$20240812$EXP$$CA-PFIZER INC-202400233756$PFIZER$$14$YR$$M$Y$$$20240812$$HP$CA$CA
241999801$24199980$1$I$20240509$20240806$20240812$20240812$EXP$JP-PMDA-i2410002184001$JP-PFIZER INC-PV202400102520$PFIZER$$82$YR$$M$Y$52$KG$20240812$$PH$JP$JP
241999812$24199981$2$F$20240101$20240929$20240812$20240930$EXP$$US-PFIZER INC-202400214127$PFIZER$$38$YR$$F$Y$$$20240930$$CN$US$US
241999821$24199982$1$I$$20240807$20240812$20240812$EXP$$CA-PFIZER INC-202400232125$PFIZER$$$$$F$Y$$$20240812$$HP$CA$CA
241999831$24199983$1$I$$20240806$20240812$20240812$EXP$$CA-PFIZER INC-2020270161$PFIZER$$79$YR$$F$Y$$$20240812$$CN$CA$CA
241999841$24199984$1$I$20240601$20240806$20240812$20240812$EXP$IT-MINISAL02-997766$IT-PFIZER INC-202400230795$PFIZER$$67$YR$$M$Y$80$KG$20240812$$MD$IT$IT
241999851$24199985$1$I$20240419$20240808$20240812$20240812$EXP$$US-PFIZER INC-202400233534$PFIZER$$81$YR$$M$Y$$$20240812$$HP$US$US
241999861$24199986$1$I$20240519$20240805$20240812$20240812$EXP$FR-AFSSAPS-SE2024000622$FR-PFIZER INC-202400229940$PFIZER$$64$YR$$F$Y$60$KG$20240812$$HP$FR$FR
241999871$24199987$1$I$$20240808$20240812$20240812$30DAY$$US-PFIZER INC-PV202400044230$PFIZER$$$$$$Y$$$20240812$$HP$US$US
241999881$24199988$1$I$20230413$20240808$20240812$20240812$EXP$$US-PFIZER INC-202400233065$PFIZER$$48$YR$$M$Y$$$20240812$$CN$US$US
241999892$24199989$2$F$$20240813$20240812$20240814$EXP$$US-PFIZER INC-202400233902$PFIZER$$70$YR$$M$Y$120.2$KG$20240814$$CN$US$US
241999901$24199990$1$I$20230101$20240806$20240812$20240812$EXP$$CA-PFIZER INC-202300237579$PFIZER$$82$YR$$M$Y$$$20240812$$CN$CA$CA
241999911$24199991$1$I$$20240808$20240812$20240812$EXP$$CN-PFIZER INC-PV202400103286$PFIZER$$$$A$M$Y$$$20240812$$CN$CN$CN
241999921$24199992$1$I$20240731$20240808$20240812$20240812$EXP$$CN-PFIZER INC-PV202400103702$PFIZER$$67$YR$$F$Y$51$KG$20240812$$HP$CN$CN
241999931$24199993$1$I$20240701$20240808$20240812$20240812$EXP$$US-PFIZER INC-202400233988$PFIZER$$69$YR$$F$Y$$$20240812$$HP$US$US
241999943$24199994$3$F$$20240820$20240812$20240822$EXP$$US-PFIZER INC-PV202400103979$PFIZER$$50$YR$$F$Y$$$20240822$$CN$US$US
241999954$24199995$4$F$20231001$20240906$20240812$20240911$EXP$$CA-PFIZER INC-PV202300184707$PFIZER$$39$YR$$F$Y$58$KG$20240911$$HP$CA$CA
241999961$24199996$1$I$$20240807$20240812$20240812$EXP$$CA-PFIZER INC-202400232151$PFIZER$$$$$F$Y$$$20240812$$HP$CA$CA
241999972$24199997$2$F$20240701$20240812$20240812$20240816$EXP$$US-BAYER-2024A110884$BAYER$$69$YR$E$M$Y$$$20240816$$HP$US$US
241999981$24199998$1$I$$20240522$20240812$20240812$EXP$$NVSC2024DE161702$NOVARTIS$$$$$F$Y$$$20240812$$MD$DE$DE
241999992$24199999$2$F$20240101$20240909$20240812$20240923$EXP$$US-UCBSA-2024034828$UCB$$$$$M$Y$$$20240923$$CN$US$US
242000002$24200000$2$F$$20240912$20240812$20240919$30DAY$$JP-JNJFOC-20240822598$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$PH$JP$JP
242000011$24200001$1$I$$20240807$20240812$20240812$PER$$US-ALXN-202408USA000370US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
242000021$24200002$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-039088$AUROBINDO$Sinha Ray A, Ghosh M, Plambeck R. Intractable Pain and Digital Ulceration From Severe Digital Ischemia With Raynauds- How to ^Cut It^?. Am-J-Respir-Crit-Care-Med. 2023;207:A1728$60$YR$$F$Y$$$20240812$$HP$US$US
242000031$24200003$1$I$$20240717$20240812$20240812$PER$$US-009507513-2407USA010955$MERCK$$60$YR$$F$Y$$$20240812$$CN$US$US
242000041$24200004$1$I$$20240808$20240812$20240812$EXP$$US-GILEAD-2024-0683752$GILEAD$$$$E$F$Y$$$20240812$$CN$US$US
242000051$24200005$1$I$$20240729$20240812$20240812$EXP$$JP-PFIZER INC-PV202400103748$PFIZER$Kiyama, T.. A 13-year-old boy who came to the hospital as a walk-in patient after a seizure in the bathtub but required mechanical ventilation due to progression of respiratory failure. The 37th Annual Meeting of Japanese Society of Emergency Pediatrics$13$YR$$M$Y$$$20240812$$HP$JP$JP
242000061$24200006$1$I$$20240808$20240812$20240812$EXP$$CA-PFIZER INC-202400233740$PFIZER$$60$YR$$M$Y$$$20240812$$HP$CA$CA
242000071$24200007$1$I$$20240801$20240812$20240812$EXP$$CO-EXELIXIS-CABO-23066118$EXELIXIS$$$$$M$Y$$$20240812$$PH$CO$CO
242000081$24200008$1$I$$20240806$20240812$20240812$EXP$$US-AMGEN-USASP2024156587$AMGEN$Weiland G.; Lester D.; Kotay M.; et al.. Exercise in Clinical Reasoning- Getting a Foothold on Lower Extremity Weakness. Journal of General Internal Medicine. 2024;39 (9):1756-1761$88$YR$E$M$Y$$$20240812$$MD$US$US
242000091$24200009$1$I$$20240802$20240812$20240812$PER$$US-AMGEN-USASP2024154443$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
242000101$24200010$1$I$$20240807$20240812$20240812$EXP$GB-MHRA-MED-202408072348525630-ZFNMG$GB-MYLANLABS-2024M1073938$MYLAN$$$$$M$Y$$$20240812$$CN$GB$GB
242000111$24200011$1$I$$20240804$20240812$20240812$EXP$$TR-MYLANLABS-2024M1074118$MYLAN$Ceylan ME, Unsalver BO, Ceylan HZ. A Bell^s Palsy Case Probably Related to Sertraline Use. Psychopharmacol-Bull 2024; 54 (2): 51-52.$53$YR$$M$Y$$$20240812$$HP$TR$TR
242000121$24200012$1$I$$20240802$20240812$20240812$EXP$$US-MYLANLABS-2024M1073759$MYLAN$Venkatraman S, Mehta T, Deng F. A Rare Neurotoxicity Syndrome Following Opioid Intoxication. Ann-Neurol 2024; 96 (2): 412-415.$55$YR$$F$Y$$$20240812$$HP$US$US
242000131$24200013$1$I$20240805$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55037$$FDA-CTU$$72$YR$$F$N$$$20240809$Y$HP$US$
242000141$24200014$1$I$$20240806$20240809$20240809$DIR$FDA-CDER-CTU-2024-55039$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
242000151$24200015$1$I$$20240807$20240812$20240812$EXP$GB-MHRA-MED-202408070917555000-DHZVC$GB-MYLANLABS-2024M1073868$MYLAN$$$$$F$Y$$$20240812$$CN$GB$GB
242000161$24200016$1$I$$20240731$20240812$20240812$EXP$$US-MYLANLABS-2024M1073092$MYLAN$Singh A, Chidharla A, Jain N, Debnath N, Dawoodi I, Kukreja G. IgD Multiple Myeloma, Does It Still Have a Poor Prognosis?. Blood 2022; 140 (Suppl. 1).$63$YR$$F$Y$$$20240812$$HP$US$US
242000173$24200017$3$F$$20240925$20240812$20240927$PER$$NVSC2024US162767$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
242000191$24200019$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163335$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
242000201$24200020$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55041$$FDA-CTU$$68$YR$$F$N$$$20240809$N$$US$
242000211$24200021$1$I$$20240809$20240809$20240809$DIR$713621$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
242000225$24200022$5$F$$20240920$20240812$20240926$EXP$$NVSC2024US160895$NOVARTIS$$$$$F$Y$68.027$KG$20240926$$MD$US$US
242000231$24200023$1$I$$20240805$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127049$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$81.19$KG$20240812$$MD$US$US
242000244$24200024$4$F$20240101$20240821$20240812$20240827$PER$$US-AMGEN-USASP2024158543$AMGEN$$79$YR$E$F$Y$$$20240827$$CN$US$US
242000255$24200025$5$F$20240801$20240928$20240812$20240930$30DAY$$US-PFIZER INC-202400230726$PFIZER$$12$YR$$M$Y$$$20240930$$MD$US$US
242000261$24200026$1$I$20240609$20240806$20240812$20240812$EXP$FR-AFSSAPS-NT2024000972$FR-BAYER-2024A113312$BAYER$$13$YR$T$F$Y$$$20240812$$MD$FR$FR
242000271$24200027$1$I$20240805$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159464$AMGEN$$76$YR$E$F$Y$$$20240812$$CN$US$US
242000281$24200028$1$I$$20240807$20240812$20240812$EXP$$US-TAKEDA-2022TUS062923$TAKEDA$$$$$M$Y$$$20240812$$MD$US$US
242000291$24200029$1$I$20240805$20240806$20240812$20240812$EXP$$US-ASTELLAS-2024US022471$ASTELLAS$$37$YR$$F$Y$$$20240812$$HP$US$US
242000301$24200030$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA234557$SANOFI AVENTIS$$$$$M$Y$$$20240812$$HP$US$US
242000311$24200031$1$I$20240801$20240806$20240812$20240812$PER$$US-SA-2024SA236510$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240812$$CN$US$US
242000322$24200032$2$F$$20240816$20240812$20240830$PER$$US-SA-2024SA234670$SANOFI AVENTIS$$$$A$M$Y$136$KG$20240830$$MD$US$US
242000331$24200033$1$I$$20240802$20240812$20240812$EXP$$CA-TEVA-202206_00013171$TEVA$$$$$F$Y$$$20240812$$HP$CA$CA
242000341$24200034$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191386$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
242000351$24200035$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA232868$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$CN$US$US
242000362$24200036$2$F$20240806$20240806$20240812$20240817$PER$$US-SA-2024SA234918$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240817$$MD$US$US
242000371$24200037$1$I$20240719$20240802$20240812$20240812$EXP$DE-CADRBFARM-2024329519$DE-TEVA-VS-3230117$TEVA$$71$YR$$F$Y$70$KG$20240812$$MD$DE$DE
242000381$24200038$1$I$$20240805$20240812$20240812$EXP$$DE-GILEAD-2024-0682938$GILEAD$$38$YR$A$F$Y$$$20240812$$MD$DE$DE
242000392$24200039$2$F$$20240808$20240812$20240815$PER$$US-AMGEN-USASP2024158664$AMGEN$$$$$M$Y$$$20240814$$PH$US$US
242000402$24200040$2$F$20240808$20240809$20240812$20240814$PER$$US-AMGEN-USASP2024159512$AMGEN$$75$YR$E$M$Y$$$20240814$$CN$US$US
242000422$24200042$2$F$20240528$20240911$20240812$20240911$30DAY$$US-PFIZER INC-202400228958$PFIZER$$15$YR$$M$Y$$$20240911$$MD$US$US
242000431$24200043$1$I$20240329$20240808$20240812$20240812$30DAY$$US-PFIZER INC-PV202400044201$PFIZER$$$$$$Y$$$20240812$$HP$US$US
242000451$24200045$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-038256$AUROBINDO$Surineni K, Le VY, Jones D.. A Case of Oral-Buccal-Lingual Dyskinesia and Neuropsychiatric Symptoms After Prolonged Levetiracetam Exposure. Cureus. 2024;16(6):e62692$86$YR$$F$Y$$$20240812$$MD$US$US
242000472$24200047$2$F$20240731$20240906$20240812$20240912$PER$$US-AstraZeneca-2024A175215$ASTRAZENECA$$26322$DY$$F$Y$$$20240912$$CN$US$
242000481$24200048$1$I$$20240801$20240812$20240812$EXP$$US-AMGEN-USASL2024049909$AMGEN$$50$YR$A$F$Y$$$20240812$$MD$US$US
242000491$24200049$1$I$$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159249$AMGEN$$$$$$Y$$$20240812$$MD$US$US
242000501$24200050$1$I$$20240809$20240809$20240809$DIR$713631$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
242000511$24200051$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179947$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
242000523$24200052$3$F$20240101$20240812$20240812$20240816$EXP$$AT-ABBVIE-5874872$ABBVIE$$$$$$Y$$$20240816$$MD$AT$AT
242000541$24200054$1$I$20240712$20240809$20240809$20240809$DIR$713624$$FDA-CTU$$69$YR$$F$N$$$20240809$N$CN$US$
242000562$24200056$2$F$20240716$20240809$20240812$20240911$PER$$US-Eisai-EC-2024-170470$EISAI$$82$YR$E$M$Y$87.5$KG$20240911$$MD$US$US
242000571$24200057$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126660$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240812$$HP$US$US
242000581$24200058$1$I$20240201$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126694$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240812$$HP$US$US
242000603$24200060$3$F$$20240912$20240812$20240912$30DAY$$US-PFIZER INC-202400227767$PFIZER$$18$YR$$F$Y$$$20240912$$CN$US$US
242000622$24200062$2$F$20240101$20240926$20240812$20240926$30DAY$$GB-PFIZER INC-PV202400098565$PFIZER$$83$YR$$F$Y$$$20240926$$CN$GB$GB
242000631$24200063$1$I$20240802$20240805$20240812$20240812$30DAY$$US-PFIZER INC-202400230919$PFIZER$$14$YR$$M$Y$41.28$KG$20240812$$CN$US$US
242000654$24200065$4$F$20240804$20240905$20240812$20240910$30DAY$$US-PFIZER INC-202400230458$PFIZER$$12$YR$$F$Y$$$20240910$$HP$US$US
242000662$24200066$2$F$$20240827$20240812$20240903$30DAY$$US-PFIZER INC-PV202400044494$PFIZER$$$$$$Y$$$20240903$$HP$US$US
242000673$24200067$3$F$20240804$20240912$20240812$20240918$30DAY$$US-PFIZER INC-202400230535$PFIZER$$12$YR$$M$Y$$$20240918$$CN$US$US
242000682$24200068$2$F$20240701$20240730$20240812$20240812$PER$$US-ROCHE-10000045256$ROCHE$$70$YR$E$F$Y$$$20240812$$CN$US$US
242000692$24200069$2$F$$20240813$20240812$20240823$EXP$$PT-AUROBINDO-AUR-APL-2024-038900$AUROBINDO$Lopes T, Antes J, Melo B, Gon?alves F, Cruz C.. CO-0237 - (4707) - Organizing pneumonia due to human Metapneumovirus in a lung transplant recipient. Congresses of the Portuguese Society of Internal Medicine.. 30th National Congress of Internal Medicine - Book of abstracts [CNMI].. 2024;331$25$YR$$M$Y$$$20240823$$MD$PT$PT
242000701$24200070$1$I$$20240804$20240812$20240812$EXP$$US-MYLANLABS-2024M1074301$MYLAN$Dutcher D, Hicks S, Hoppe M, Whitten S, Falk K. 10021 Combined Robotic and Hysteroscopic Repair of Isthmocele Containing Retained Products of Conception. J-Minim-Invasive-Gynecol 2023; 30 (Suppl.) (11): S99 abstr. 10021.$31$YR$$F$Y$$$20240812$$HP$US$US
242000721$24200072$1$I$$20240807$20240812$20240812$EXP$$GB-SA-2024SA235711$SANOFI AVENTIS$Grantham H, Best K, Weatherhead S.. Peripheral blood flow cytometry reveals heterogeneous but benign T-cell changes in patients with severe eczema undergoing dupilumab therapy.. British Journal of Dermatology.. 2024;192:i31$$$$$Y$$$20240812$$HP$GB$GB
242000731$24200073$1$I$$20240806$20240812$20240812$PER$$US-ALXN-202408USA000236US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
242000741$24200074$1$I$$20240807$20240812$20240812$EXP$$BR-AMGEN-BRASP2024159306$AMGEN$Breviglieri C. N.; Ginani V. C.; Gouveia R. V. et al.. BLINATUMOMAB + DONOR LEUKOCYTE INFUSIONS (DLI) CAN BE USED TO PREVENT THE  RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT). JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 2024;5 (SUPPL_1):82-83$$$$$Y$$$20240812$$HP$BR$BR
242000751$24200075$1$I$20240808$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158307$AMGEN$$$$$$Y$$$20240812$$HP$US$US
242000762$24200076$2$F$$20240828$20240812$20240828$PER$$US-ALXN-202408USA000463US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242000773$24200077$3$F$$20240808$20240812$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-038343$AUROBINDO$$$$$F$Y$$$20240820$$MD$GB$GB
242000782$24200078$2$F$$20240805$20240812$20240819$EXP$$NVSC2024DE161853$NOVARTIS$$$$A$F$Y$$$20240819$$MD$DE$DE
242000792$24200079$2$F$20240101$20240829$20240812$20240923$PER$$US-SA-2024SA235315$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240923$$MD$US$US
242000801$24200080$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235605$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240812$$CN$US$US
242000811$24200081$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA236080$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240812$$CN$US$US
242000821$24200082$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA235495$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240812$$MD$US$US
242000831$24200083$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA235702$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240812$$CN$US$US
242000844$24200084$4$F$20240805$20240820$20240812$20240826$PER$$US-AMGEN-USASP2024159192$AMGEN$$77$YR$E$F$Y$$$20240825$$PH$US$US
242000851$24200085$1$I$20240601$20240806$20240809$20240809$DIR$FDA-CDER-CTU-2024-54984$$FDA-CTU$$65$YR$$F$N$$$20240806$N$HP$US$
242000861$24200086$1$I$$20240809$20240809$20240809$DIR$713639$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
242000871$24200087$1$I$20240701$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54965$$FDA-CTU$$74$YR$$F$N$$$20240809$N$$US$
242000881$24200088$1$I$$20240809$20240809$20240809$DIR$713636$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
242000894$24200089$4$F$20240703$20240902$20240812$20240912$EXP$FR-AFSSAPS-TS2024000863$FR-TEVA-VS-3230574$TEVA$$89$YR$$M$Y$103$KG$20240912$$MD$FR$FR
242000901$24200090$1$I$$20240807$20240812$20240812$EXP$$BR-AMGEN-BRASP2024159327$AMGEN$Breviglieri C. N.; Ginani V. C.; Gouveia R. V. et al.. BLINATUMOMAB + DONOR LEUKOCYTE INFUSIONS (DLI) CAN BE USED TO PREVENT THE RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT). JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAP. 2024;5 (SUPPL_1):82-83$$$$$Y$$$20240812$$HP$BR$BR
242000911$24200091$1$I$20240616$20240731$20240812$20240812$EXP$$US-Accord-439671$ACCORD$$72$YR$E$F$Y$$$20240812$$HP$US$US
242000921$24200092$1$I$20200717$20240731$20240812$20240812$EXP$PL-URPL-1-3866-2020$PL-Accord-439997$ACCORD$$59$YR$A$F$Y$50$KG$20240812$$MD$PL$PL
242000931$24200093$1$I$20240730$20240731$20240812$20240812$EXP$$US-Accord-439856$ACCORD$$39$YR$A$F$Y$$$20240812$$HP$US$US
242000941$24200094$1$I$20240730$20240731$20240812$20240812$EXP$$US-Accord-439854$ACCORD$$58$YR$A$F$Y$$$20240812$$HP$US$US
242000951$24200095$1$I$$20240731$20240812$20240812$EXP$$IN-Accord-438723$ACCORD$Seth NH, Raghuveer R, Qureshi MI. Integrating Physiotherapy in Neuroleptic Malignant Syndrome Management: A Case Report. Cureus. 2024 Jun 21;16(6):e62808.$70$YR$E$F$Y$$$20240812$$HP$IN$IN
242000961$24200096$1$I$$20240801$20240812$20240812$EXP$CA-MHPD-001089025$CA-Accord-440307$ACCORD$$7$YR$C$F$Y$33$KG$20240812$$HP$CA$CA
242000971$24200097$1$I$$20240731$20240812$20240812$EXP$$US-Accord-440168$ACCORD$$56$YR$A$M$Y$$$20240812$$HP$US$US
242000981$24200098$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-E2B_07141155$CA-Accord-439514$ACCORD$$28$YR$A$M$Y$$$20240812$$HP$CA$CA
242000991$24200099$1$I$$20240809$20240812$20240812$EXP$$GB-TEVA-VS-3232003$TEVA$$35$YR$$F$Y$73$KG$20240812$$PH$GB$GB
242001001$24200100$1$I$$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004612$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240812$$CN$US$US
242001011$24200101$1$I$20240719$20240801$20240812$20240812$EXP$CN-HENLIUS-24CN016256$CN-Accord-440996$ACCORD$$61$YR$A$F$Y$$$20240812$$MD$CN$CN
242001021$24200102$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-001087509$CA-Accord-440066$ACCORD$$53$YR$A$M$Y$$$20240812$$HP$CA$CA
242001033$24200103$3$F$$20240918$20240812$20240930$EXP$CA-MHPD-E2B_07160758$CA-Accord-440036$ACCORD$$17$YR$T$F$Y$$$20240930$$MD$CA$CA
242001041$24200104$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006630$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240812$$CN$US$US
242001051$24200105$1$I$20240408$20240802$20240812$20240812$EXP$FR-AFSSAPS-DJ2024000844$FR-TEVA-VS-3229786$TEVA$$51$YR$$M$Y$108$KG$20240812$$MD$FR$FR
242001061$24200106$1$I$20240101$20240807$20240812$20240812$PER$$US-ABBVIE-5873005$ABBVIE$$$$$$Y$$$20240812$$CN$US$US
242001071$24200107$1$I$20230809$20240802$20240812$20240812$EXP$SE-SEMPA-2024-005790$SE-TAKEDA-2024TUS077724$TAKEDA$$50$YR$$F$Y$60$KG$20240812$$HP$SE$SE
242001081$24200108$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-001092248$CA-Accord-439511$ACCORD$$69$YR$E$F$Y$75$KG$20240812$$HP$CA$CA
242001091$24200109$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-039001$AUROBINDO$Kaur K, Othman AR, Dalbah RMR, Erpenwar S, Hoskere GV. Candida Empyema in a Patient With Adenocarcinoma of Gastroesophageal Junction. Am-J-Respir-Crit-Care-Med. 2023;207:A5020$81$YR$$M$Y$$$20240812$$HP$US$US
242001101$24200110$1$I$20240727$20240806$20240812$20240812$EXP$$US-BAYER-2024A114412$BAYER$$5$YR$C$M$Y$$$20240812$$CN$US$US
242001111$24200111$1$I$$20240806$20240812$20240812$PER$$US-JNJFOC-20240819143$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
242001131$24200113$1$I$20240729$20240808$20240812$20240812$EXP$IT-MINISAL02-998157$IT-SHIONOGI, INC-2024002051$SHIONOGI$$$$$$Y$$$20240812$$MD$IT$IT
242001142$24200114$2$F$20240101$20240912$20240812$20240912$30DAY$$US-PFIZER INC-202400231316$PFIZER$$14$YR$$M$Y$$$20240912$$HP$US$US
242001161$24200116$1$I$20230101$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-038249$AUROBINDO$Longobardi SA, Alkowati H, Kang G, Slade C, Oyesanmi O.. Ibuprofen-Induced Pancytopenia and Erythema Multiforme in an Elderly Female Patient.. Cureus.. 2024;16(6):e62785$75$YR$$F$Y$$$20240812$$MD$US$US
242001172$24200117$2$F$$20240903$20240812$20240906$30DAY$$US-PFIZER INC-PV202400044120$PFIZER$$$$$$Y$$$20240906$$HP$US$US
242001182$24200118$2$F$20240806$20240920$20240812$20240925$30DAY$$GR-PFIZER INC-PV202400103368$PFIZER$$14$YR$$M$Y$41$KG$20240925$$CN$GR$GR
242001194$24200119$4$F$20240701$20240919$20240812$20240919$30DAY$$US-PFIZER INC-202400224061$PFIZER$$10$YR$$M$Y$$$20240919$$CN$US$US
242001214$24200121$4$F$$20240917$20240812$20240920$30DAY$$GB-PFIZER INC-PV202400102263$PFIZER$$45$YR$$F$Y$$$20240920$$CN$GB$GB
242001223$24200122$3$F$20240101$20240924$20240812$20240925$30DAY$$FI-PFIZER INC-202400229951$PFIZER$$50$YR$$F$Y$$$20240925$$PH$FI$FI
242001231$24200123$1$I$20210101$20240807$20240812$20240812$PER$$US-BIOGEN-2024BI01277472$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
242001242$24200124$2$F$$20240830$20240812$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-038284$AUROBINDO$Cheng JJ, Shen J, Suresh Y, Akopyan NA, Kapoor NS.. Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy: Case report. International journal of surgery case reports. 2024;122:110050$72$YR$$M$Y$88.9$KG$20240910$$MD$US$US
242001272$24200127$2$F$20240416$20240917$20240812$20240920$30DAY$ES-AEMPS-1557092$ES-PFIZER INC-202400230803$PFIZER$$1$YR$$F$Y$$$20240920$$PH$ES$ES
242001301$24200130$1$I$20240610$20240805$20240812$20240812$EXP$HR-HALMED-300086195$HR-TAKEDA-2024TUS078444$TAKEDA$$40$YR$$M$Y$$$20240812$$HP$HR$HR
242001311$24200131$1$I$$20240729$20240812$20240812$EXP$US-ALVOGEN-2024094966$US-ALVOGEN-2024094966$ALVOGEN$$$$A$$Y$$$20240812$$CN$US$US
242001321$24200132$1$I$$20240801$20240812$20240812$EXP$$US-ALVOGEN-2024095189$ALVOGEN$Chebrolu S, Mayl J, Bhave P. Flecainide Toxicity in a Patient with a Functioning Pacemaker. The Journal of Innovations in Cardiac Rhythm Management. 2024-Jul;15(7):5951-5954. doi: https://dx.doi.Org/1 0.1 91 02/icrm.2024.15075$75$YR$$M$Y$$$20240812$$MD$US$US
242001333$24200133$3$F$$20240916$20240812$20240917$30DAY$$US-PFIZER INC-PV202400088220$PFIZER$$14$YR$$M$Y$$$20240917$$MD$US$US
242001341$24200134$1$I$20240806$20240806$20240812$20240812$PER$$US-BAYER-2024A113793$BAYER$$35$YR$A$F$Y$$$20240812$$HP$US$US
242001351$24200135$1$I$$20240806$20240812$20240812$PER$$US-BAYER-2024A113808$BAYER$$$$$F$Y$$$20240812$$CN$US$US
242001361$24200136$1$I$20240729$20240802$20240812$20240812$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024094258$VIIV$$24$YR$$$Y$$$20240812$$HP$US$US
242001371$24200137$1$I$20230101$20240729$20240812$20240812$EXP$$JP-ROCHE-10000048825$ROCHE$$$$$F$Y$43$KG$20240812$$CN$JP$JP
242001382$24200138$2$F$$20240826$20240812$20240903$EXP$$JP-AMGEN-JPNSP2024159166$AMGEN$$88$YR$E$F$Y$$$20240903$$PH$JP$JP
242001392$24200139$2$F$20240806$20240903$20240812$20240905$EXP$$IE-MYLANLABS-2024M1074038$MYLAN$$$$$M$Y$$$20240905$$MD$IE$IE
242001402$24200140$2$F$$20240730$20240812$20240814$EXP$$US-AUROBINDO-AUR-APL-2024-012501$AUROBINDO$Le V, Surineni K, Elias G.. A Case of Partially Reversible Oral-buccal-lingual Dyskinesia after Prolonged Levetiracetam Exposure.. American Journal of Geriatric Psychiatry. 2024;32(4):S106$86$YR$$F$Y$$$20240814$$MD$US$US
242001421$24200142$1$I$$20240809$20240812$20240812$EXP$$NVSC2024US162678$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
242001441$24200144$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126726$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240812$$HP$US$US
242001451$24200145$1$I$$20240807$20240812$20240812$30DAY$$KR-PFIZER INC-PV202400103024$PFIZER$$$$C$$Y$$$20240812$$CN$KR$KR
242001461$24200146$1$I$$20240709$20240812$20240812$DIR$FDA-CDER-CTU-2024-55106$$FDA-CTU$$$$$$N$$$20240709$N$$US$
242001472$24200147$2$F$20240701$20240910$20240812$20240920$EXP$FR-AFSSAPS-MP2024001211$FR-TEVA-VS-3230511$TEVA$$66$YR$$M$Y$71$KG$20240920$$HP$FR$FR
242001482$24200148$2$F$$20240906$20240812$20240912$30DAY$$TW-JNJFOC-20240822396$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$TW$TW
242001491$24200149$1$I$$20240805$20240812$20240812$PER$$US-ABBVIE-5869905$ABBVIE$$22$YR$$M$Y$$$20240812$$HP$US$US
242001501$24200150$1$I$$20240807$20240812$20240812$EXP$$BR-TAKEDA-2024TUS080208$TAKEDA$$9$YR$$$Y$$$20240812$$CN$BR$BR
242001511$24200151$1$I$$20240806$20240812$20240812$PER$$US-BAYER-2024A113827$BAYER$$$$$F$Y$$$20240812$$CN$US$US
242001521$24200152$1$I$$20240731$20240812$20240812$EXP$$KR-ROCHE-10000044607$ROCHE$Kim J, Lee J, Lee S, Kim K. Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report. Medicina. 2024-Jun-17;60 (6):1-5. doi:10.3390/ medicina60060992.$79$YR$E$M$Y$$$20240812$$HP$KR$US
242001531$24200153$1$I$20240101$20240808$20240812$20240812$EXP$$US-UCBSA-2024040148$UCB$$$$$F$Y$$$20240812$$CN$US$US
242001541$24200154$1$I$$20240730$20240812$20240812$EXP$$IT-AUROBINDO-AUR-APL-2024-039042$AUROBINDO$Farina F, Ferla V, Canziani L, Dell^Acqua R, Perini T, Clerici D, et al. HIGH RATE OF RESPIRATORYTRACT INFECTIONS AFTER COVID19 WAVES IN TRANSPLANT ELEGIBLE MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMAB. Haematologica. 2024;109 (29):abstr. P22$$$$$Y$$$20240812$$HP$IT$IT
242001551$24200155$1$I$20220501$20240802$20240812$20240812$EXP$FR-AFSSAPS-AVPO2024000145$FR-TEVA-VS-3229908$TEVA$$42$YR$$F$Y$$$20240812$$PH$FR$FR
242001561$24200156$1$I$20240806$20240806$20240812$20240812$PER$$US-BAYER-2024A113878$BAYER$$$$$F$Y$$$20240812$$MD$US$US
242001571$24200157$1$I$20240808$20240808$20240812$20240812$PER$$US-ABBVIE-5875170$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242001581$24200158$1$I$20240501$20240729$20240812$20240812$EXP$$DE-EMD Serono-2024041474$EMD SERONO INC$$54$YR$A$F$Y$$$20240812$$CN$DE$DE
242001591$24200159$1$I$$20240805$20240812$20240812$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-124690$BRISTOL MYERS SQUIBB$Haschka D. Azacitidin-behandlung eines patienten mit vexas-syndrom und neuer, ursachlicher UBA1-mutation. Fakten Der Rheumatologie. 2024;(02):45-6.$$$$M$Y$$$20240812$$MD$AT$AT
242001601$24200160$1$I$$20240801$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122092$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240812$$HP$US$US
242001611$24200161$1$I$$20240801$20240812$20240812$EXP$$US-BRAEBURN-US-BRA-24-000720$BRAEBURN PHARMACEUTICALS$$$$A$M$Y$$$20240812$$HP$US$US
242001621$24200162$1$I$20240701$20240806$20240812$20240812$EXP$$US-SA-2024SA235975$SANOFI AVENTIS$$25$YR$A$M$Y$97.06$KG$20240812$$MD$US$US
242001631$24200163$1$I$20240806$20240806$20240812$20240812$PER$$US-BAYER-2024A113966$BAYER$$45$YR$A$F$Y$$$20240812$$CN$US$US
242001642$24200164$2$F$$20240902$20240812$20240913$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2024-07705$LUPIN$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$4$DY$$$Y$$$20240913$$HP$DE$DE
242001651$24200165$1$I$$20240809$20240809$20240809$DIR$713635$$FDA-CTU$$$$$F$N$$$20240809$$CN$US$
242001661$24200166$1$I$20240807$20240809$20240809$20240809$DIR$713693$$FDA-CTU$$66$YR$$F$N$$$20240809$N$$US$
242001671$24200167$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA177246$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240812$$MD$US$US
242001681$24200168$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA086046$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240812$$MD$US$US
242001711$24200171$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA233335$SANOFI AVENTIS$$$$$M$Y$$$20240812$$CN$US$US
242001721$24200172$1$I$$20240730$20240812$20240812$EXP$$PT-AUROBINDO-AUR-APL-2024-038996$AUROBINDO$Tavares M, Pereira I, Nicolau M, Mendes AC, Ferreira C. BURKHOLDERIA CEPACIA COMPLEX: A RARE PERITONITIS CASE REPORT. Clin-Chem-Lab-Med. 2024;62(6):eA175-eA176$87$YR$$F$Y$$$20240812$$HP$PT$PT
242001731$24200173$1$I$$20240806$20240812$20240812$PER$$US-BAYER-2024A114356$BAYER$$50$YR$A$F$Y$$$20240812$$CN$US$US
242001741$24200174$1$I$20210801$20240807$20240812$20240812$EXP$$US-PFIZER INC-PV202400103290$PFIZER$$50$YR$$F$Y$$$20240812$$CN$US$US
242001752$24200175$2$F$$20240812$20240812$20240815$EXP$$US-PFIZER INC-PV202400102000$PFIZER$Bulleit, C.. Treating Malignant Catatonia With Liquid Amantadine: A Case Report and Literature Review. Journal of Psychiatric Practice. 2024;30(4):308-310$51$YR$$F$Y$$$20240815$$MD$US$US
242001761$24200176$1$I$20240721$20240802$20240812$20240812$EXP$$US-VIIV HEALTHCARE LIMITED-US2024098070$VIIV$$65$YR$$M$Y$$$20240812$$HP$US$US
242001771$24200177$1$I$20240802$20240806$20240812$20240812$PER$$US-BAYER-2024A114433$BAYER$$52$YR$A$F$Y$$$20240812$$HP$US$US
242001781$24200178$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-039044$AUROBINDO$Schambach S, Esteitie R, Nader A.. Diffuse Disseminated Demyelination: A Detrimental Outcome.. Am-J-Respir-Crit-Care-Med. 2023;207:A1742$27$YR$$M$Y$$$20240812$$HP$US$US
242001791$24200179$1$I$20240806$20240808$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126921$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240812$$CN$US$US
242001801$24200180$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126689$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240812$$CN$US$US
242001812$24200181$2$F$20240703$20240807$20240812$20240817$EXP$FR-AFSSAPS-LL2024001511$FR-TEVA-VS-3230453$TEVA$$84$YR$$M$Y$$$20240817$$MD$FR$FR
242001821$24200182$1$I$$20240806$20240812$20240812$PER$$US-BAYER-2024A114539$BAYER$$$$$F$Y$$$20240812$$CN$US$US
242001831$24200183$1$I$20240603$20240806$20240812$20240812$EXP$$BE-ABBVIE-5875052$ABBVIE$$57$YR$$M$Y$$$20240812$$CN$BE$BE
242001841$24200184$1$I$20240805$20240805$20240812$20240812$PER$$US-009507513-2408USA001898$MERCK$$$$$F$Y$$$20240812$$CN$US$US
242001851$24200185$1$I$20240722$20240806$20240812$20240812$EXP$FR-AFSSAPS-TO2024001487$FR-ARGENX-2024-ARGX-FR006311$ARGENX BVBA$$$$$$Y$$$20240812$$MD$FR$FR
242001861$24200186$1$I$20240713$20240806$20240812$20240812$PER$$US-JNJFOC-20240816135$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240812$$CN$US$US
242001871$24200187$1$I$20240101$20240808$20240812$20240812$EXP$$CA-JNJFOC-20240824259$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240812$$HP$CA$CA
242001882$24200188$2$F$20240101$20240919$20240812$20240926$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00151$CATALYST PHARMA$$$$$F$Y$43.084$KG$20240926$$HP$US$US
242001891$24200189$1$I$20240710$20240807$20240812$20240812$EXP$ES-AEMPS-1556063$ES-BAYER-2024A113745$BAYER$$46$YR$A$F$Y$$$20240812$$MD$ES$ES
242001901$24200190$1$I$20240129$20240730$20240812$20240812$EXP$$DE-AUROBINDO-AUR-APL-2024-038845$AUROBINDO$$57$YR$$M$Y$$$20240812$$MD$DE$DE
242001911$24200191$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006445$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240812$$CN$US$US
242001921$24200192$1$I$20240724$20240809$20240809$20240809$DIR$713688$$FDA-CTU$$67$YR$$F$N$$$20240809$Y$PH$US$
242001931$24200193$1$I$$20240809$20240809$20240809$DIR$713628$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
242001951$24200195$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004945$ELI LILLY AND CO$$68$YR$E$$Y$$$20240812$$LW$US$US
242001961$24200196$1$I$$20240801$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408001880$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240812$$CN$US$US
242001971$24200197$1$I$20240802$20240809$20240809$20240809$DIR$713709$$FDA-CTU$$26$YR$$M$N$$$20240809$Y$PH$US$
242001981$24200198$1$I$20240807$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005582$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240812$$CN$US$US
242001991$24200199$1$I$$20240809$20240809$20240809$DIR$713673$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
242002001$24200200$1$I$20240809$20240809$20240809$20240809$DIR$713656$$FDA-CTU$$36$YR$$M$N$$$20240809$N$PH$US$
242002011$24200201$1$I$20240808$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005991$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240812$$CN$US$US
242002021$24200202$1$I$$20240731$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408000247$ELI LILLY AND CO$$55$YR$A$$Y$$$20240812$$CN$US$US
242002031$24200203$1$I$20240725$20240805$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004741$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
242002041$24200204$1$I$$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005410$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240812$$CN$US$US
242002051$24200205$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005739$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240812$$CN$US$US
242002061$24200206$1$I$20240711$20240808$20240812$20240812$EXP$$US-AstraZeneca-2024A180733$ASTRAZENECA$$$$$M$Y$$$20240812$$MD$US$
242002071$24200207$1$I$$20240731$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408000271$ELI LILLY AND CO$$59$YR$A$$Y$$$20240812$$CN$US$US
242002082$24200208$2$F$$20240807$20240812$20240815$EXP$$US-AstraZeneca-2024A180483$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242002091$24200209$1$I$$20240808$20240812$20240812$PER$$US-AstraZeneca-2024A181333$ASTRAZENECA$$55$YR$$F$Y$$$20240812$$MD$US$
242002102$24200210$2$F$$20240812$20240812$20240814$PER$$US-AMGEN-USASP2024158962$AMGEN$$$$$$Y$$$20240813$$CN$US$US
242002111$24200211$1$I$20240801$20240805$20240812$20240812$EXP$$CA-AMGEN-CANSL2024156309$AMGEN$$77$YR$E$M$Y$$$20240812$$CN$CA$CA
242002121$24200212$1$I$20240502$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158579$AMGEN$$77$YR$E$M$Y$$$20240812$$CN$US$US
242002131$24200213$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASL2024158796$AMGEN$$$$$$Y$$$20240812$$CN$US$US
242002141$24200214$1$I$20230812$20240812$20240812$20240812$EXP$GB-MHRA-WEBRADR-202408120742157310-GKVSR$GB-SANDOZ INC.-SDZ2024GB071886$SANDOZ$$62$YR$$M$Y$$$20240812$$CN$GB$GB
242002151$24200215$1$I$$20240809$20240812$20240812$EXP$$US-JNJFOC-20240827322$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$CN$US$US
242002161$24200216$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA234979$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
242002171$24200217$1$I$20240731$20240807$20240812$20240812$EXP$$CN-BAYER-2024A113923$BAYER$$71$YR$E$F$Y$$$20240812$$MD$CN$CN
242002181$24200218$1$I$$20240805$20240812$20240812$EXP$$US-PFIZER INC-PV202400101965$PFIZER$Jones, A.. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024;36:10.1016/j.ajoc.2024.102131$$$I$M$Y$0.55$KG$20240812$$HP$US$US
242002192$24200219$2$F$$20240819$20240812$20240823$EXP$$KR-PFIZER INC-PV202400102991$PFIZER$Park, D.. Pneumatosis cystoides intestinalis induced by sunitinib therapy in a patient with metastatic renal cell carcinoma A case report. Medicine. 2024;103(30):e39075$57$YR$$F$Y$$$20240823$$MD$KR$KR
242002202$24200220$2$F$$20240809$20240812$20240815$EXP$$JP-PFIZER INC-202400233426$PFIZER$Shinohara, K.. Micafungin-breakthrough Coniochaeta hoffmannii (Lecythophora hoffmannii) fungemia following cord blood transplant in a patient with acute myeloid leukemia successfully treated with voriconazole. Journal of Infection and Chemotherapy. 2024;30(9):934-937$48$YR$$F$Y$$$20240815$$MD$JP$JP
242002211$24200221$1$I$20240411$20240731$20240812$20240812$PER$$US-INCYTE CORPORATION-2024IN008058$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242002222$24200222$2$F$$20240808$20240812$20240814$EXP$$PT-PFIZER INC-202400232314$PFIZER$Freitas, J.. When ^Myeloma^ is not a Myeloma: a case report of malignant bone lymphoma.. Porto Biomedical Journal. 2024;9(4):10.1097/j.pbj.0000000000000261$63$YR$$F$Y$$$20240814$$MD$PT$PT
242002231$24200223$1$I$$20240805$20240812$20240812$EXP$FR-EMA-20150317-AUTODUP-408608$FR-PFIZER INC-202400231765$PFIZER$Pontoizeau, C.. Ruling out false-positive urinary legionella pneumophila serogroup 1 and streptococcus pneumoniae antigen test results by heating urine.. Journal of Clinical Microbiology. 2014;52 (12):4347-4349$16$YR$$M$Y$$$20240812$$HP$FR$FR
242002241$24200224$1$I$20240101$20240717$20240812$20240812$PER$$US-JNJFOC-20240751269$JOHNSON AND JOHNSON$$61$YR$A$F$Y$101.1$KG$20240812$$CN$US$US
242002254$24200225$4$F$$20240829$20240812$20240909$EXP$$PT-AUROBINDO-AUR-APL-2024-038875$AUROBINDO$Monteiro AS, Reboredo P, Domingos R, et al. Exuberante hematoma da parede abdominal secund?rio ? admnistra??o de enoxaparina. Congressos da Sociedade Portuguesa de Medicina Interna:. Congresso Nacional de Medicina Interna - Livro de resumos. 2024;30:487$71$YR$$F$Y$$$20240909$$MD$PT$PT
242002261$24200226$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-E2B_07147192$CA-Accord-439750$ACCORD$$63$YR$A$F$Y$$$20240812$$HP$CA$CA
242002271$24200227$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-001085762$CA-Accord-439454$ACCORD$$56$YR$A$F$Y$69$KG$20240812$$MD$CA$CA
242002281$24200228$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-E2B_07116389$CA-Accord-439527$ACCORD$$64$YR$A$F$Y$$$20240812$$HP$CA$CA
242002291$24200229$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-001088752$CA-Accord-440071$ACCORD$$73$YR$E$F$Y$$$20240812$$CN$CA$CA
242002301$24200230$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-E2B_07144302$CA-Accord-439643$ACCORD$$38$YR$A$M$Y$83$KG$20240812$$HP$CA$CA
242002311$24200231$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-E2B_07142265$CA-Accord-439641$ACCORD$$27$YR$$M$Y$$$20240812$$MD$CA$CA
242002321$24200232$1$I$20240405$20240731$20240812$20240812$EXP$GB-MHRA-MED-202407311618410910-TCYNP$GB-Accord-439992$ACCORD$$90$YR$E$F$Y$66$KG$20240812$$MD$GB$GB
242002331$24200233$1$I$20240513$20240731$20240812$20240812$EXP$FR-AFSSAPS-PB2024000814$FR-Accord-439559$ACCORD$$73$YR$E$F$Y$61$KG$20240812$$MD$FR$FR
242002341$24200234$1$I$20240505$20240801$20240812$20240812$EXP$GB-MHRA-MED-202408011054318720-KGNWR$GB-Accord-440072$ACCORD$$77$YR$E$F$Y$60$KG$20240812$$CN$GB$GB
242002351$24200235$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-E2B_07142574$CA-Accord-439645$ACCORD$$41$YR$A$F$Y$$$20240812$$HP$CA$CA
242002361$24200236$1$I$20240702$20240731$20240812$20240812$EXP$$US-Accord-440122$ACCORD$$83$YR$E$F$Y$$$20240812$$PH$US$US
242002371$24200237$1$I$20240611$20240731$20240812$20240812$EXP$FR-AFSSAPS-NC2024000900$FR-Accord-439558$ACCORD$$88$YR$E$F$Y$52$KG$20240812$$MD$FR$FR
242002391$24200239$1$I$$20240731$20240812$20240812$EXP$FR-AFSSAPS-AN2024000959$FR-Accord-439660$ACCORD$$66$YR$E$M$Y$$$20240812$$MD$FR$FR
242002401$24200240$1$I$20240601$20240805$20240812$20240812$PER$$US-BAYER-2024A113042$BAYER$$45$YR$A$F$Y$$$20240812$$MD$US$US
242002411$24200241$1$I$$20240807$20240812$20240812$EXP$$AU-BAYER-2024A114354$BAYER$$$$$M$Y$$$20240812$$MD$AU$AU
242002421$24200242$1$I$20240615$20240809$20240812$20240812$EXP$$US-INCYTE CORPORATION-2024IN008385$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242002431$24200243$1$I$$20240731$20240812$20240812$PER$$US-INCYTE CORPORATION-2024IN008022$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242002441$24200244$1$I$$20240808$20240812$20240812$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012985$VERTEX$$$$E$F$Y$$$20240812$$CN$GB$GB
242002451$24200245$1$I$20240730$20240802$20240812$20240812$EXP$$CN-009507513-2408CHN001875$MERCK$$59$YR$$F$Y$50$KG$20240812$$HP$CN$CN
242002462$24200246$2$F$20240101$20240816$20240812$20240822$EXP$$CA-VERTEX PHARMACEUTICALS-2024-011973$VERTEX$$5$YR$$M$Y$$$20240822$$MD$CA$CA
242002471$24200247$1$I$$20240808$20240812$20240812$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012970$VERTEX$$$$A$F$Y$$$20240812$$CN$GB$GB
242002481$24200248$1$I$20240701$20240808$20240812$20240812$EXP$$US-VERTEX PHARMACEUTICALS-2024-012681$VERTEX$$43$YR$$M$Y$146$KG$20240812$$MD$US$US
242002492$24200249$2$F$$20240829$20240812$20240829$PER$$US-ALXN-202408USA000466US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242002501$24200250$1$I$$20240806$20240812$20240812$EXP$$CA-TEVA-VS-3231117$TEVA$$77$YR$$F$Y$$$20240812$$HP$CA$CA
242002512$24200251$2$F$20240801$20240913$20240812$20240920$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006419$AURINIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240920$$CN$US$US
242002521$24200252$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126208$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240812$$CN$US$US
242002532$24200253$2$F$$20240826$20240812$20240904$EXP$$DE-AUROBINDO-AUR-APL-2024-039023$AUROBINDO$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D.. Paul.Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology.. 2024;48:299-313$32$YR$$M$Y$$$20240904$$HP$DE$DE
242002541$24200254$1$I$20240701$20240801$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122375$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240812$$HP$US$US
242002552$24200255$2$F$$20240828$20240812$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126842$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240904$$CN$US$US
242002561$24200256$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA232904$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240812$$MD$US$US
242002571$24200257$1$I$20240701$20240805$20240812$20240812$PER$$US-SA-2024SA235892$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240812$$MD$US$US
242002581$24200258$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA234540$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240812$$MD$US$US
242002591$24200259$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA235716$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240812$$MD$US$US
242002601$24200260$1$I$$20240805$20240812$20240812$PER$$US-BAYER-2024A114568$BAYER$$$$$F$Y$$$20240812$$CN$US$US
242002611$24200261$1$I$20240619$20240807$20240812$20240812$EXP$GB-MHRA-MED-202408061816175830-GHPJL$GB-LEO Pharma-372618$LEO PHARM$$43$YR$$F$Y$$$20240812$$CN$GB$GB
242002622$24200262$2$F$$20240826$20240812$20240827$EXP$$BR-JNJFOC-20240821497$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240828$$MD$BR$BR
242002631$24200263$1$I$20240723$20240808$20240812$20240812$EXP$$KR-DAIICHI SANKYO, INC.-DSJ-2024-140012$DAIICHI$$48$YR$$F$Y$$$20240812$$CN$KR$KR
242002651$24200265$1$I$$20240801$20240812$20240812$PER$$US-INCYTE CORPORATION-2024IN008230$INCYTE$$$$$$Y$$$20240812$$HP$US$US
242002661$24200266$1$I$20240724$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55054$$FDA-CTU$$77$YR$$M$N$$$20240809$Y$HP$US$
242002671$24200267$1$I$20240801$20240809$20240809$20240809$DIR$713661$$FDA-CTU$$26$YR$$M$N$$$20240809$Y$$US$
242002691$24200269$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55051$$FDA-CTU$$74$YR$$F$N$$$20240809$N$$US$
242002711$24200271$1$I$20240808$20240809$20240809$20240809$DIR$713715$$FDA-CTU$$55$YR$$F$N$72$KG$20240809$N$CN$US$
242002721$24200272$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55056$$FDA-CTU$$74$YR$$F$N$$$20240809$N$$US$
242002731$24200273$1$I$20240807$20240809$20240809$20240809$DIR$713712$$FDA-CTU$$45$YR$$M$N$119.25$KG$20240809$Y$CN$US$
242002741$24200274$1$I$20240808$20240809$20240809$20240809$DIR$713670$$FDA-CTU$$69$YR$$M$N$65.25$KG$20240809$N$$US$
242002751$24200275$1$I$$20240809$20240809$20240809$DIR$713671$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
242002761$24200276$1$I$20240730$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54954$$FDA-CTU$$53$YR$$F$N$$$20240809$Y$PH$US$
242002771$24200277$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54969$$FDA-CTU$$50$YR$$M$N$$$20240809$N$$US$
242002791$24200279$1$I$20240806$20240809$20240809$20240809$DIR$713672$$FDA-CTU$$73$YR$$F$N$72$KG$20240809$N$CN$US$
242002802$24200280$2$F$20240602$20240904$20240812$20240905$EXP$$JP-PFIZER INC-PV202400072277$PFIZER$$65$YR$$F$Y$41.2$KG$20240905$$PH$JP$JP
242002812$24200281$2$F$20240101$20240929$20240812$20240930$EXP$$CA-PFIZER INC-202400087837$PFIZER$$69$YR$$M$Y$$$20240930$$MD$CA$CA
242002821$24200282$1$I$20231101$20240812$20240812$20240812$EXP$$NP-PFIZER INC-PV202400104425$PFIZER$$53$YR$$M$Y$$$20240812$$CN$NP$NP
242002832$24200283$2$F$$20240925$20240812$20240926$EXP$$MA-PFIZER INC-PV202400104656$PFIZER$$$$$M$Y$$$20240926$$CN$MA$MA
242002841$24200284$1$I$$20240809$20240812$20240812$EXP$$MA-PFIZER INC-PV202400104655$PFIZER$$$$$M$Y$$$20240812$$CN$MA$MA
242002851$24200285$1$I$$20240806$20240812$20240812$EXP$$US-INCYTE CORPORATION-2024IN008266$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242002862$24200286$2$F$20240826$20240827$20240812$20240903$EXP$$US-INCYTE CORPORATION-2024IN008259$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242002871$24200287$1$I$20240101$20240808$20240812$20240812$EXP$$US-UCBSA-2024040194$UCB$$$$$M$Y$$$20240812$$CN$US$US
242002881$24200288$1$I$$20240730$20240812$20240812$EXP$$ES-AUROBINDO-AUR-APL-2024-039091$AUROBINDO$Solaz-Ruiz MG, Perez LA, Cauto-Picazo C, Barranco-Gonzalez H, Pascual-Camps I, EspanaGregori E.. Toxicity to intravitreal melphalan in a patient with retinoblastoma.. Rom-J-Ophthalmol. 2023;67(3):305-308$3$YR$$M$Y$$$20240812$$MD$ES$ES
242002891$24200289$1$I$20240101$20240809$20240812$20240812$EXP$$US-BAUSCH-BL-2024-012135$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240812$$HP$US$US
242002901$24200290$1$I$20240807$20240807$20240812$20240812$PER$$US-BAUSCH-BL-2024-012016$BAUSCH AND LOMB$$$$$F$Y$$$20240812$$CN$US$US
242002911$24200291$1$I$20240726$20240808$20240812$20240812$EXP$FR-AFSSAPS-RN2024000864$FR-BAUSCH-BL-2024-012111$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240812$$PH$FR$FR
242002922$24200292$2$F$$20240917$20240812$20240925$EXP$$ZA-ROCHE-10000053419$ROCHE$$$$E$M$Y$$$20240925$$CN$ZA$ZA
242002931$24200293$1$I$$20240806$20240812$20240812$EXP$$US-INCYTE CORPORATION-2024IN008249$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242002952$24200295$2$F$20240101$20240820$20240812$20240828$EXP$$JP-BAUSCH-BL-2024-012117$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240828$$PH$JP$JP
242002961$24200296$1$I$$20240806$20240812$20240812$EXP$$GB-BAUSCH-BL-2024-012118$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240812$$CN$GB$GB
242002971$24200297$1$I$$20240808$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126382$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240812$$CN$US$US
242002981$24200298$1$I$20240101$20240806$20240812$20240812$EXP$$CN-009507513-2408CHN003187$MERCK$$80$YR$$M$Y$72$KG$20240812$$HP$CN$CN
242002991$24200299$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235234$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$MD$US$US
242003001$24200300$1$I$20240101$20240808$20240812$20240812$EXP$CH-SM-2024-14861$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-126779$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$73$KG$20240812$$PH$CH$CH
242003022$24200302$2$F$$20240904$20240812$20240911$30DAY$$BR-JNJFOC-20240821834$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$PH$BR$BR
242003031$24200303$1$I$$20240804$20240812$20240812$PER$$US-BAYER-2024A113045$BAYER$$$$$F$Y$$$20240812$$CN$US$US
242003041$24200304$1$I$20240726$20240809$20240812$20240812$EXP$$DE-BAUSCH-BL-2024-012145$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240812$$MD$DE$DE
242003051$24200305$1$I$$20240806$20240812$20240812$EXP$$US-INCYTE CORPORATION-2024IN008246$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242003061$24200306$1$I$$20240729$20240812$20240812$EXP$814588$AU-LUPIN PHARMACEUTICALS INC.-2024-07596$LUPIN$$$$$$Y$$$20240812$$CN$AU$AU
242003071$24200307$1$I$$20240801$20240812$20240812$EXP$$AU-OTSUKA-2024_021866$OTSUKA$$$$$$Y$$$20240812$$MD$AU$AU
242003094$24200309$4$F$20210101$20240819$20240812$20240830$EXP$$PT-DSJP-DSE-2024-139701$DAIICHI$$61$YR$$M$Y$88$KG$20240830$$CN$PT$PT
242003102$24200310$2$F$$20240816$20240812$20240822$PER$$US-ALXN-202408USA000481US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242003111$24200311$1$I$$20240728$20240812$20240812$PER$$US-QUAGEN-2024QUASPO00237$QUAGEN PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
242003124$24200312$4$F$20231213$20240916$20240812$20240924$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00041$CATALYST PHARMA$$30$YR$$F$Y$56.689$KG$20240924$$CN$US$US
242003131$24200313$1$I$20240101$20240808$20240812$20240812$EXP$$US-BAYER-2024A019334$BAYER$$54$YR$A$M$Y$$$20240812$$CN$US$US
242003142$24200314$2$F$$20240816$20240812$20240822$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006412$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242003151$24200315$1$I$20240329$20240515$20240812$20240812$PER$$US-ASTELLAS-2024US013659$ASTELLAS$$74$YR$$F$Y$$$20240812$$CN$US$US
242003161$24200316$1$I$$20240807$20240812$20240812$EXP$DE-EMA-DD-20240806-7482663-105013$DE-RDY-SPO/DEU/24/0011616$DR REDDYS$$14$MON$I$M$Y$$$20240812$$MD$DE$DE
242003171$24200317$1$I$$20240806$20240812$20240812$EXP$DE-GERMAN-SPO/DEU/24/0003427$DE-RDY-SPO/DEU/24/0003427$DR REDDYS$$68$YR$E$M$Y$$$20240812$$HP$DE$DE
242003181$24200318$1$I$$20240805$20240812$20240812$PER$$US-ABBVIE-5870038$ABBVIE$$24$YR$$M$Y$$$20240812$$HP$US$US
242003196$24200319$6$F$20240701$20240812$20240812$20240821$PER$$US-BIOGEN-2024BI01277557$BIOGEN$$37$YR$$F$Y$$$20240821$$CN$US$US
242003201$24200320$1$I$20240118$20240530$20240812$20240812$PER$$US-ASTELLAS-2024US013777$ASTELLAS$$93$YR$$F$Y$$$20240812$$HP$US$US
242003211$24200321$1$I$20240730$20240812$20240812$20240812$EXP$IT-MINISAL02-997969$IT-BAYER-2024A115765$BAYER$$32$YR$A$M$Y$$$20240812$$MD$IT$IT
242003231$24200323$1$I$20240701$20240809$20240812$20240812$EXP$$AR-PFIZER INC-PV202400104095$PFIZER$$$$$$Y$$$20240812$$MD$AR$AR
242003241$24200324$1$I$$20240805$20240812$20240812$PER$$US-009507513-2408USA001759$MERCK$$$$$M$Y$$$20240812$$CN$US$US
242003251$24200325$1$I$20240729$20240808$20240809$20240809$DIR$FDA-CDER-CTU-2024-54968$$FDA-CTU$$42$YR$$F$N$$$20240808$N$HP$US$
242003261$24200326$1$I$$20240730$20240812$20240812$EXP$$GB-B.Braun Medical Inc.-2160295$B BRAUN$$$$$M$Y$$$20240812$$$GB$GB
242003271$24200327$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55052$$FDA-CTU$$55$YR$$F$N$$$20240809$N$$US$
242003281$24200328$1$I$20240806$20240806$20240812$20240812$PER$$US-SA-2024SA236355$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240812$$CN$US$US
242003292$24200329$2$F$20240807$20240807$20240812$20240815$PER$$US-SA-2024SA236633$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240815$$MD$US$US
242003301$24200330$1$I$20240807$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005456$ELI LILLY AND CO$$$$$$Y$$$20240812$$MD$US$US
242003321$24200332$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005858$ELI LILLY AND CO$$$$$$Y$$$20240812$$MD$US$US
242003331$24200333$1$I$20240708$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005996$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240812$$CN$US$US
242003341$24200334$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005629$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240812$$CN$US$US
242003351$24200335$1$I$20240809$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006376$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240812$$CN$US$US
242003361$24200336$1$I$20240722$20240808$20240812$20240812$EXP$$US-BAYER-2024A114851$BAYER$$66$YR$E$F$Y$$$20240812$$HP$US$US
242003381$24200338$1$I$20240801$20240809$20240809$20240809$DIR$713676$$FDA-CTU$$32$YR$$F$N$59.4$KG$20240809$N$CN$US$
242003391$24200339$1$I$$20240805$20240812$20240812$EXP$$MA-BRISTOL-MYERS SQUIBB COMPANY-2024-124713$BRISTOL MYERS SQUIBB$Adjade G, Haag K, Meunier J, El Fadli M, Essadi I, Belbaraka R. Giant cell arteritis and therapeutic response: a dual facet of immunotherapy in metastatic clear cell renal carcinoma. Oxford Medical Case Reports. 2024 Jul 30;7:324-6. doi:10.1093/omcr/omae082.$80$YR$E$M$Y$$$20240812$$HP$MA$MA
242003401$24200340$1$I$$20240809$20240809$20240809$DIR$713626$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
242003411$24200341$1$I$$20240812$20240812$20240812$EXP$$DE-SANDOZ INC.-SDZ2024DE071888$SANDOZ$$$$$M$Y$$$20240812$$HP$DE$DE
242003422$24200342$2$F$20240801$20240807$20240812$20240816$EXP$$MX-SA-2024SA233115$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240816$$CN$MX$MX
242003432$24200343$2$F$20240803$20240809$20240812$20240813$EXP$$CA-ROCHE-10000053833$ROCHE$$38$YR$A$M$Y$$$20240813$$CN$CA$CA
242003441$24200344$1$I$20240808$20240809$20240809$20240809$DIR$713707$$FDA-CTU$$48$YR$$F$N$65.25$KG$20240809$N$CN$US$
242003451$24200345$1$I$20240806$20240809$20240809$20240809$DIR$713702$$FDA-CTU$$57$YR$$M$N$134$KG$20240809$N$HP$US$
242003461$24200346$1$I$$20240809$20240809$20240809$DIR$713685$$FDA-CTU$$$$$UNK$N$$$20240809$N$CN$US$
242003491$24200349$1$I$$20240805$20240812$20240812$PER$$US-TAKEDA-2024TUS078201$TAKEDA$$$$$F$Y$$$20240812$$HP$US$US
242003503$24200350$3$F$20240601$20240906$20240812$20240920$EXP$$US-UCBSA-2024039934$UCB$$49$YR$$F$Y$$$20240920$$CN$US$US
242003511$24200351$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235405$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240812$$CN$US$US
242003521$24200352$1$I$$20240806$20240812$20240812$EXP$$US-APOTEX-2024AP009133$APOTEX$$$$C$$Y$$$20240812$$CN$US$US
242003531$24200353$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235451$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240812$$MD$US$US
242003541$24200354$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235512$SANOFI AVENTIS$$$$E$M$Y$$$20240812$$MD$US$US
242003551$24200355$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA235836$SANOFI AVENTIS$$73$YR$E$M$Y$78$KG$20240812$$MD$US$US
242003561$24200356$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA233165$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240812$$MD$US$US
242003571$24200357$1$I$20240724$20240802$20240812$20240812$EXP$$US-VANTIVE-2024VAN018820$Vantive US Healthcare$$59$YR$$F$Y$$$20240812$$HP$US$US
242003582$24200358$2$F$$20240913$20240812$20240919$EXP$$US-BAYER-2024A115386$BAYER$$22$YR$A$M$Y$$$20240919$$HP$US$US
242003593$24200359$3$F$$20240926$20240812$20240930$PER$$US-PFIZER INC-PV202400103991$PFIZER$$82$YR$$F$Y$$$20240930$$HP$US$US
242003601$24200360$1$I$$20240808$20240812$20240812$PER$$US-PFIZER INC-PV202400103927$PFIZER$$73$YR$$F$Y$$$20240812$$CN$US$US
242003611$24200361$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-PV202400104488$PFIZER$$45$YR$$F$Y$$$20240812$$HP$US$US
242003631$24200363$1$I$20240807$20240808$20240812$20240812$PER$$US-PFIZER INC-202400232994$PFIZER$$71$YR$$F$Y$$$20240812$$CN$US$US
242003642$24200364$2$F$$20240911$20240812$20240911$PER$$US-PFIZER INC-202400232158$PFIZER$$$$$M$Y$$$20240911$$MD$US$US
242003651$24200365$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234130$PFIZER$$$$T$F$Y$$$20240812$$MD$US$US
242003661$24200366$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234007$PFIZER$$72$YR$$F$Y$$$20240812$$CN$US$US
242003671$24200367$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-PV202400104402$PFIZER$$58$YR$$F$Y$$$20240812$$HP$US$US
242003682$24200368$2$F$20210101$20240918$20240812$20240920$EXP$$US-PFIZER INC-PV202400102820$PFIZER$$66$YR$$F$Y$65.76$KG$20240920$$CN$US$US
242003691$24200369$1$I$$20240809$20240809$20240809$DIR$713643$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
242003701$24200370$1$I$20240730$20240807$20240812$20240812$PER$$US-PFIZER INC-202400232127$PFIZER$$69$YR$$F$Y$$$20240812$$CN$US$US
242003712$24200371$2$F$20240807$20240827$20240812$20240830$PER$$US-PFIZER INC-202400232283$PFIZER$$43$YR$$M$Y$71.67$KG$20240830$$CN$US$US
242003721$24200372$1$I$$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233907$PFIZER$$62$YR$$F$Y$$$20240812$$HP$US$US
242003731$24200373$1$I$$20240809$20240809$20240809$DIR$713694$$FDA-CTU$$70$YR$$M$N$$$20240809$N$HP$US$
242003751$24200375$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400233263$PFIZER$$62$YR$$M$Y$$$20240812$$HP$US$US
242003761$24200376$1$I$20240101$20240807$20240812$20240812$PER$$US-PFIZER INC-PV202400103560$PFIZER$$51$YR$$M$Y$$$20240812$$HP$US$US
242003771$24200377$1$I$$20240809$20240809$20240809$DIR$713699$$FDA-CTU$$$$$F$N$$$20240809$N$HP$US$
242003781$24200378$1$I$20240701$20240808$20240812$20240812$PER$$US-PFIZER INC-PV202400103836$PFIZER$$26$YR$$M$Y$$$20240812$$HP$US$US
242003791$24200379$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400233776$PFIZER$$60$YR$$F$Y$$$20240812$$CN$US$US
242003801$24200380$1$I$20240806$20240807$20240812$20240812$PER$$US-PFIZER INC-202400232561$PFIZER$$69$YR$$F$Y$$$20240812$$CN$US$US
242003811$24200381$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-PV202400087847$PFIZER$$72$YR$$F$Y$$$20240812$$MD$US$US
242003821$24200382$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400233521$PFIZER$$55$YR$$M$Y$$$20240812$$HP$US$US
242003831$24200383$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400233236$PFIZER$$63$YR$$F$Y$$$20240812$$HP$US$US
242003842$24200384$2$F$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400233131$PFIZER$$53$YR$$F$Y$$$20240812$$HP$US$US
242003851$24200385$1$I$20240807$20240807$20240812$20240812$PER$$US-PFIZER INC-202400232478$PFIZER$$70$YR$$F$Y$$$20240812$$CN$US$US
242003862$24200386$2$F$20170101$20240916$20240812$20240926$PER$$US-ROCHE-10000053127$ROCHE$$43$YR$A$F$Y$53.52$KG$20240926$$CN$US$US
242003871$24200387$1$I$20240725$20240729$20240812$20240812$PER$$US-AMGEN-USASP2024150293$AMGEN$$48$YR$A$M$Y$$$20240812$$HP$US$US
242003882$24200388$2$F$20240809$20240812$20240812$20240813$PER$$US-AMGEN-USASP2024159378$AMGEN$$50$YR$A$F$Y$$$20240812$$CN$US$US
242003891$24200389$1$I$20220629$20240808$20240812$20240812$EXP$$GB-ROCHE-10000053625$ROCHE$$58$YR$A$F$Y$$$20240812$$MD$GB$GB
242003902$24200390$2$F$20240723$20240823$20240812$20240926$EXP$$US-BEH-2024176662$CSL BEHRING$$33$YR$A$F$Y$74.842$KG$20240926$$HP$US$US
242003911$24200391$1$I$$20240805$20240812$20240812$PER$$US-ABBVIE-5868396$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
242003921$24200392$1$I$$20240806$20240812$20240812$PER$$US-PFIZER INC-PV202400103484$PFIZER$$$$$F$Y$$$20240812$$CN$US$US
242003931$24200393$1$I$$20240808$20240812$20240812$EXP$$US-OTSUKA-2024_022060$OTSUKA$$$$$F$Y$$$20240812$$MD$US$US
242003941$24200394$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400233877$PFIZER$$$$$F$Y$$$20240812$$CN$US$US
242003951$24200395$1$I$20240810$20240810$20240812$20240812$PER$$US-PFIZER INC-202400233944$PFIZER$$51$YR$$M$Y$$$20240812$$CN$US$US
242003961$24200396$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400233775$PFIZER$$82$YR$$F$Y$$$20240812$$CN$US$US
242003971$24200397$1$I$20240129$20240808$20240812$20240812$PER$$US-PFIZER INC-202400234041$PFIZER$$58$YR$$M$Y$$$20240812$$HP$US$US
242003981$24200398$1$I$20240101$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233286$PFIZER$$58$YR$$M$Y$$$20240812$$CN$US$US
242004001$24200400$1$I$20240810$20240811$20240812$20240812$PER$$US-PFIZER INC-202400234255$PFIZER$$56$YR$$M$Y$$$20240812$$CN$US$US
242004011$24200401$1$I$20240807$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233465$PFIZER$$70$YR$$F$Y$$$20240812$$CN$US$US
242004021$24200402$1$I$20240723$20240805$20240812$20240812$PER$$US-SA-2024SA235289$SANOFI AVENTIS$$26$YR$A$F$Y$81.64$KG$20240812$$MD$US$US
242004031$24200403$1$I$$20240801$20240812$20240812$PER$$US-RDY-LIT/USA/24/0011577$DR REDDYS$Nguyen A, Norman M, O^Reilly E, Robinson CL, Fonseca A, Madabhushi S, et al. Case Series: Spinal Cord Stimulator Therapy Alleviates Neuropathic Pain in Patients with Failed Back Surgery Syndrome in the Setting of Spinal Cord Injury. Pain Medicine Case Reports. 2023;7(7): 337-340.$49$YR$A$M$Y$$$20240812$$HP$US$US
242004041$24200404$1$I$20240808$20240810$20240812$20240812$PER$$US-PFIZER INC-202400233935$PFIZER$$$$E$F$Y$$$20240812$$CN$US$US
242004051$24200405$1$I$20240801$20240807$20240812$20240812$PER$$US-SA-2024SA236833$SANOFI AVENTIS$$$$$F$Y$$$20240812$$CN$US$US
242004061$24200406$1$I$20240501$20240729$20240812$20240812$EXP$$FR-ROCHE-RCA5186818$ROCHE$$86$YR$E$F$Y$$$20240812$$MD$FR$FR
242004071$24200407$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236893$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240812$$CN$US$US
242004081$24200408$1$I$20240801$20240807$20240812$20240812$PER$$US-SA-2024SA236966$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240812$$CN$US$US
242004091$24200409$1$I$20240601$20240808$20240812$20240812$EXP$$US-ROCHE-10000053125$ROCHE$$62$YR$A$F$Y$57.6$KG$20240812$$CN$US$US
242004101$24200410$1$I$$20240809$20240812$20240812$EXP$GB-MHRA-MED-202408091357405630-NYPSK$GB-ABBVIE-5874861$ABBVIE$$32$YR$$M$Y$$$20240812$$HP$GB$GB
242004111$24200411$1$I$$20240808$20240812$20240812$EXP$$IT-009507513-2408ITA002923$MERCK$$81$YR$$F$Y$$$20240812$$MD$IT$IT
242004121$24200412$1$I$20240508$20240805$20240812$20240812$EXP$$CO-UCBSA-2024040069$UCB$$72$YR$$M$Y$$$20240812$$CN$CO$CO
242004132$24200413$2$F$20240101$20240808$20240812$20240814$PER$$US-009507513-2408USA002068$MERCK$$$$$F$Y$132.43$KG$20240814$$CN$US$US
242004142$24200414$2$F$$20240809$20240812$20240815$PER$$US-ROCHE-10000053470$ROCHE$$$$$$Y$$$20240815$$CN$US$US
242004151$24200415$1$I$20240530$20240805$20240812$20240812$PER$$US-Nobelpharma America, LLC-NPA-2024-01365$NOBELPHARMA$$21$YR$$M$Y$$$20240812$$PH$US$US
242004181$24200418$1$I$$20240806$20240812$20240812$PER$$US-BAYER-2024A114179$BAYER$$35$YR$A$F$Y$$$20240812$$MD$US$US
242004191$24200419$1$I$$20240809$20240812$20240812$EXP$$US-TAKEDA-2023TUS106213$TAKEDA$$$$$F$Y$$$20240812$$MD$US$US
242004201$24200420$1$I$$20240801$20240812$20240812$PER$$US-SA-2024SA234001$SANOFI AVENTIS$$$$A$F$Y$90$KG$20240812$$MD$US$US
242004212$24200421$2$F$20211004$20240808$20240812$20240813$EXP$$SK-SA-2024SA236041$SANOFI AVENTIS$$15$YR$T$M$Y$52$KG$20240813$$MD$SK$SK
242004222$24200422$2$F$20240101$20240904$20240812$20240911$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00848$CATALYST PHARMA$$$$$F$Y$60.29$KG$20240911$$CN$US$US
242004231$24200423$1$I$$20240806$20240812$20240812$EXP$$CA-TEVA-VS-3231122$TEVA$$68$YR$$F$Y$$$20240812$$CN$CA$CA
242004241$24200424$1$I$20240807$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158044$AMGEN$$68$YR$E$M$Y$$$20240812$$CN$US$US
242004251$24200425$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA233003$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240812$$HP$US$US
242004261$24200426$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA232689$SANOFI AVENTIS$$3$YR$C$$Y$$$20240812$$HP$US$US
242004271$24200427$1$I$$20240802$20240812$20240812$EXP$$IT-ROVI-20240809$ROVIPHARM SAS$$66$YR$E$M$Y$$$20240812$$MD$IT$IT
242004281$24200428$1$I$$20230711$20240812$20240812$PER$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-23-00398$MELINTA THERAPEUTICS$$$$$F$Y$$$20240730$$MD$US$US
242004291$24200429$1$I$$20240807$20240812$20240812$EXP$$US-MYLANLABS-2024M1074389$MYLAN$$$$$F$Y$$$20240812$$PH$US$US
242004301$24200430$1$I$$20240807$20240812$20240812$EXP$$US-MYLANLABS-2024M1074357$MYLAN$Cheng J, Harney S, Toner K, Kube P, Gong S, Ozdemirli M, et al. Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment. Pediatr-Blood-Cancer 2024; 71 (8): 1-4.$9$YR$$M$Y$$$20240812$$HP$US$US
242004311$24200431$1$I$20181009$20240731$20240812$20240812$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2023US001729$JUBILANT$Miao J, Gibson LE, Craici IM.. Levofloxacin-Associated Bullous Pemphigoid in a Hemodialysis Patient After Kidney Transplant Failure.. The American journal of case reports.. 2022;23:e938476$27$YR$$F$Y$66$KG$20240812$$HP$US$US
242004321$24200432$1$I$$20240809$20240809$20240809$DIR$713658$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
242004331$24200433$1$I$$20240809$20240809$20240809$DIR$713625$$FDA-CTU$$$$$UNK$N$$$20240809$$CN$US$
242004351$24200435$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55014$$FDA-CTU$$64$YR$$F$N$$$20240809$N$$US$
242004361$24200436$1$I$$20240809$20240812$20240812$EXP$$US-OTSUKA-2024_022128$OTSUKA$$$$$M$Y$$$20240812$$HP$US$US
242004371$24200437$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54993$$FDA-CTU$$64$YR$$M$N$$$20240809$N$$US$
242004381$24200438$1$I$20240804$20240809$20240809$20240809$DIR$713659$$FDA-CTU$$48$YR$$F$N$58.5$KG$20240809$Y$CN$US$
242004405$24200440$5$F$20240322$20240819$20240812$20240820$EXP$$US-PFIZER INC-PV202400100834$PFIZER$$29$YR$$F$Y$86.3$KG$20240820$$MD$US$US
242004411$24200441$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54952$$FDA-CTU$$75$YR$$M$N$$$20240809$N$$US$
242004424$24200442$4$F$20240101$20240905$20240812$20240912$PER$$US-AMGEN-USASP2024159266$AMGEN$$72$YR$E$F$Y$$$20240911$$HP$US$US
242004433$24200443$3$F$20240806$20240905$20240812$20240906$EXP$$US-BAYER-2024A114825$BAYER$$51$YR$A$F$Y$$$20240906$$CN$US$US
242004441$24200444$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158921$AMGEN$$$$$$Y$$$20240812$$PH$US$US
242004461$24200446$1$I$20240806$20240806$20240812$20240812$EXP$$AU-TAKEDA-2021TUS038415$TAKEDA$$27$YR$$F$Y$$$20240812$$MD$AU$AU
242004471$24200447$1$I$$20240809$20240812$20240812$EXP$$JP-JNJFOC-20240827965$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$PH$JP$JP
242004481$24200448$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005975$ELI LILLY AND CO$$66$YR$E$$Y$$$20240812$$LW$US$US
242004491$24200449$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005870$ELI LILLY AND CO$$$$$$Y$$$20240812$$MD$US$US
242004501$24200450$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006269$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240812$$CN$US$US
242004512$24200451$2$F$20240808$20240808$20240812$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408005793$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242004521$24200452$1$I$20240808$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006336$ELI LILLY AND CO$$18$YR$A$F$Y$$$20240812$$CN$US$US
242004531$24200453$1$I$$20240806$20240812$20240812$EXP$$VN-TAKEDA-2024TUS059236$TAKEDA$$46$YR$$F$Y$50$KG$20240812$$CN$VN$VN
242004541$24200454$1$I$$20240809$20240812$20240812$EXP$$US-GILEAD-2024-0683703$GILEAD$$$$A$M$Y$$$20240812$$CN$US$US
242004552$24200455$2$F$20240723$20240809$20240812$20240814$EXP$IT-MINISAL02-997797$IT-BAYER-2024A115062$BAYER$$77$YR$E$F$Y$$$20240814$$PH$IT$IT
242004562$24200456$2$F$$20240729$20240812$20240813$EXP$$GB-BAYER-2024A109928$BAYER$$$$$F$Y$$$20240813$$CN$GB$GB
242004582$24200458$2$F$$20240816$20240812$20240821$EXP$$US-TAKEDA-2024TUS079148$TAKEDA$$$$$M$Y$$$20240821$$CN$US$US
242004591$24200459$1$I$20240408$20240726$20240812$20240812$EXP$$US-NEBO-665284$PHARMACOSMOS$$40$YR$$F$Y$$$20240812$$HP$US$US
242004601$24200460$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA235022$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240812$$MD$US$US
242004613$24200461$3$F$20240603$20240820$20240812$20240826$PER$$US-SA-2024SA177910$SANOFI AVENTIS$$35$YR$A$M$Y$84.36$KG$20240826$$CN$US$US
242004621$24200462$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235630$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240812$$MD$US$US
242004631$24200463$1$I$20240701$20240801$20240812$20240812$PER$$US-SA-2024SA233963$SANOFI AVENTIS$$64$YR$A$M$Y$93.893$KG$20240812$$MD$US$US
242004641$24200464$1$I$20240501$20240802$20240812$20240812$PER$$US-SA-2024SA233870$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240812$$MD$US$US
242004651$24200465$1$I$20240201$20240807$20240812$20240812$EXP$$GB-ROCHE-10000054081$ROCHE$$54$YR$A$F$Y$63.5$KG$20240812$$MD$GB$GB
242004661$24200466$1$I$$20240726$20240812$20240812$PER$$US-TEVA-VS-3227134$TEVA$$74$YR$$F$Y$$$20240812$$PH$US$US
242004671$24200467$1$I$$20240802$20240812$20240812$EXP$$TR-OTSUKA-BMS-2016-022003$OTSUKA$Tuman TC, Arslan D, Cakir U. Effect of Aripiprazole on INR in a patient using warfarin: case report. Poster Bildiriler. 41$32$YR$$F$Y$$$20240812$$MD$TR$TR
242004682$24200468$2$F$20240718$20240829$20240812$20240830$PER$$US-AMGEN-USASP2024157684$AMGEN$$63$YR$A$M$Y$$$20240830$$CN$US$US
242004691$24200469$1$I$20240101$20240731$20240812$20240812$EXP$$US-INSMED-2024-01469-USAA$INSMED$$$$$F$Y$$$20240812$$CN$US$US
242004701$24200470$1$I$$20240802$20240812$20240812$EXP$$IT-ROVI-20240570$ROVIPHARM SAS$$20$YR$A$M$Y$$$20240812$$MD$IT$IT
242004711$24200471$1$I$20240101$20240728$20240812$20240812$PER$$US-TEVA-VS-3228846$TEVA$$$$$F$Y$$$20240812$$HP$US$US
242004721$24200472$1$I$20240803$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024157732$AMGEN$$52$YR$A$F$Y$$$20240812$$CN$US$US
242004731$24200473$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158403$AMGEN$$$$A$$Y$$$20240812$$HP$US$US
242004741$24200474$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A182194$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242004751$24200475$1$I$$20240807$20240812$20240812$PER$$US-ROCHE-10000024420$ROCHE$$$$A$F$Y$$$20240812$$CN$US$US
242004772$24200477$2$F$$20240805$20240812$20240820$EXP$$CZ-MYLANLABS-2024M1072918$MYLAN$Zpracovala R, Viktorova K.. Development of osteology in the Czech Republic, denosumab and romosozumab in the treatment of osteoporosis.. Remedia. 2024;34:247-252$$$$F$Y$61.5$KG$20240820$$PH$CZ$CZ
242004781$24200478$1$I$$20240805$20240812$20240812$EXP$$DE-MYLANLABS-2024M1073105$MYLAN$$$$$F$Y$$$20240812$$MD$DE$DE
242004791$24200479$1$I$$20240805$20240812$20240812$EXP$FR-AFSSAPS-AVMA2024000342$FR-MYLANLABS-2024M1073007$MYLAN$$22$YR$$M$Y$$$20240812$$MD$FR$FR
242004802$24200480$2$F$20240701$20240909$20240812$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011930$JAZZ$$38$YR$$M$Y$$$20240912$$CN$US$US
242004811$24200481$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126836$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240812$$CN$US$US
242004821$24200482$1$I$20240726$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54953$$FDA-CTU$$71$YR$$M$N$$$20240809$N$HP$US$
242004831$24200483$1$I$20240530$20240809$20240809$20240809$DIR$713692$$FDA-CTU$$88$YR$$M$N$76.5$KG$20240809$N$CN$US$
242004841$24200484$1$I$20070608$20240805$20240812$20240812$EXP$$FR-MYLANLABS-2024M1072978$MYLAN$$56$YR$$F$Y$$$20240812$$HP$FR$FR
242004852$24200485$2$F$$20240805$20240812$20240814$EXP$NL-LRB-00990247$NL-MYLANLABS-2024M1073389$MYLAN$$44$YR$$M$Y$86$KG$20240814$$CN$NL$NL
242004861$24200486$1$I$20240725$20240729$20240809$20240809$DIR$FDA-CDER-CTU-2024-54956$$FDA-CTU$$71$YR$$M$N$$$20240729$N$HP$US$
242004871$24200487$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126692$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240812$$HP$US$US
242004882$24200488$2$F$$20240816$20240812$20240822$EXP$$DE-MYLANLABS-2024M1073135$MYLAN$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$43$YR$$M$Y$$$20240822$$HP$DE$DE
242004891$24200489$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126690$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240812$$HP$US$US
242004902$24200490$2$F$$20240813$20240812$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126851$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240814$$CN$US$US
242004931$24200493$1$I$20240809$20240809$20240809$20240809$DIR$713691$$FDA-CTU$$73$YR$$M$N$88.5$KG$20240809$Y$PH$US$
242004941$24200494$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-54951$$FDA-CTU$$$$$F$N$$$20240809$N$HP$US$
242004951$24200495$1$I$20240707$20240810$20240810$20240810$DIR$713727$$FDA-CTU$$32$YR$$M$N$63$KG$20240810$N$CN$US$
242004961$24200496$1$I$$20240802$20240812$20240812$EXP$GB-MHRA-31304927$GB-BAYER-2024A112276$BAYER$$$$$F$Y$$$20240812$$CN$GB$GB
242004971$24200497$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158879$AMGEN$$$$$$Y$$$20240812$$PH$US$US
242004981$24200498$1$I$$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159467$AMGEN$$$$$$Y$$$20240812$$HP$US$US
242004991$24200499$1$I$$20240808$20240812$20240812$EXP$$US-SANDOZ INC.-SDZ2024US071640$SANDOZ$$$$$F$Y$$$20240812$$LW$US$US
242005001$24200500$1$I$20240610$20240805$20240812$20240812$EXP$$US-MYLANLABS-2024M1053831$MYLAN$$40$YR$$F$Y$74.83$KG$20240812$$CN$US$US
242005011$24200501$1$I$$20240805$20240812$20240812$EXP$$FR-MYLANLABS-2024M1072882$MYLAN$$57$YR$$F$Y$$$20240812$$HP$FR$FR
242005021$24200502$1$I$$20240729$20240812$20240812$EXP$$FR-COLLEGIUM PHARMACEUTICAL, INC.-20240800593$COLLEGIUM PHARMACEUTICAL$A. Baudriller, C. Abbara, M. Briet et al.. Deaths linked to pharmacobezoars: About two cases. Analytical Clinical Toxicology$$$$$Y$$$20240811$$HP$FR$FR
242005031$24200503$1$I$$20240808$20240812$20240812$EXP$$US-KYOWAKIRIN-2024KK018969$KYOWA$$$$$$Y$$$20240812$$HP$US$US
242005042$24200504$2$F$$20240729$20240812$20240831$PER$$US-TEVA-VS-3228271$TEVA$$$$$M$Y$$$20240831$$HP$US$US
242005051$24200505$1$I$$20240802$20240812$20240812$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-003074$JAZZ$$$$$M$Y$117.9$KG$20240812$$CN$US$US
242005071$24200507$1$I$$20240808$20240812$20240812$30DAY$$US-GSK-US2024099269$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
242005081$24200508$1$I$20240401$20240806$20240812$20240812$EXP$FR-AFSSAPS-TS2024000872$FR-MYLANLABS-2024M1073372$MYLAN$$71$YR$$M$Y$98$KG$20240812$$MD$FR$FR
242005091$24200509$1$I$20240629$20240806$20240812$20240812$EXP$FR-AFSSAPS-AVCF2024000495$FR-MYLANLABS-2024M1073317$MYLAN$$23$YR$$F$Y$$$20240812$$HP$FR$FR
242005101$24200510$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235162$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240812$$MD$US$US
242005111$24200511$1$I$20240529$20240730$20240809$20240809$DIR$FDA-CDER-CTU-2024-54979$$FDA-CTU$$84$YR$$F$N$57.61$KG$20240730$N$CN$US$
242005121$24200512$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA235096$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240812$$MD$US$US
242005141$24200514$1$I$20240701$20240802$20240812$20240812$EXP$FR-AFSSAPS-PP2024000832$FR-BAYER-2024A112018$BAYER$$36$YR$A$F$Y$78$KG$20240812$$MD$FR$FR
242005151$24200515$1$I$20180921$20240808$20240812$20240812$EXP$$CN-SA-2024SA238569$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240812$$HP$CN$CN
242005163$24200516$3$F$20240101$20240828$20240812$20240902$EXP$$US-JNJFOC-20240675437$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$CN$US$US
242005171$24200517$1$I$$20240805$20240812$20240812$PER$$US-AMGEN-USASP2024155419$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
242005181$24200518$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191532$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
242005192$24200519$2$F$20240101$20240817$20240812$20240919$PER$$US-KARYOPHARM-2024KPT001397$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240919$$CN$US$US
242005211$24200521$1$I$20230101$20240805$20240812$20240812$EXP$$AU-009507513-2408AUS002986$MERCK$$67$YR$$F$Y$46.7$KG$20240812$$MD$AU$AU
242005222$24200522$2$F$20240801$20240815$20240812$20240823$EXP$$DE-TEVA-VS-3230997$TEVA$$65$YR$$F$Y$$$20240823$$PH$DE$DE
242005231$24200523$1$I$$20240614$20240812$20240812$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090906$GLENMARK$$$$$$Y$$$20240812$$CN$US$US
242005241$24200524$1$I$$20240508$20240812$20240812$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090760$GLENMARK$$$$$$Y$$$20240812$$PH$US$US
242005251$24200525$1$I$$20240306$20240812$20240812$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089360$GLENMARK$$$$$$Y$$$20240812$$PH$US$US
242005261$24200526$1$I$$20240507$20240812$20240812$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090703$GLENMARK$$$$$$Y$$$20240812$$PH$US$US
242005271$24200527$1$I$$20240520$20240812$20240812$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091013$GLENMARK$$$$$$Y$$$20240812$$PH$US$US
242005281$24200528$1$I$$20240502$20240812$20240812$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090244$GLENMARK$$$$$$Y$$$20240812$$CN$US$US
242005291$24200529$1$I$20240728$20240802$20240812$20240812$EXP$$US-ETON PHARMACEUTICALS, INC-2024ETO000178$ETON PHARMACEUTICALS$$$$$$Y$$$20240812$$HP$US$US
242005301$24200530$1$I$$20240729$20240812$20240812$PER$$US-RDY-SPO/USA/24/0011303$DR REDDYS$$$$$$Y$$$20240812$$CN$US$US
242005311$24200531$1$I$$20240729$20240812$20240812$PER$$US-RDY-SPO/USA/24/0011429$DR REDDYS$$$$$$Y$$$20240812$$CN$US$US
242005321$24200532$1$I$$20240808$20240812$20240812$PER$$US-PFIZER INC-PV202400098628$PFIZER$$73$YR$$M$Y$89.4$KG$20240812$$HP$US$US
242005331$24200533$1$I$20240729$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233239$PFIZER$$70$YR$$F$Y$$$20240812$$HP$US$US
242005341$24200534$1$I$$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233780$PFIZER$$28$YR$$F$Y$$$20240812$$CN$US$US
242005352$24200535$2$F$20240201$20240905$20240812$20240909$PER$$US-PFIZER INC-202400232385$PFIZER$$73$YR$$F$Y$54.43$KG$20240909$$CN$US$US
242005361$24200536$1$I$20240501$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233893$PFIZER$$54$YR$$F$Y$$$20240812$$HP$US$US
242005372$24200537$2$F$$20240910$20240812$20240912$PER$$US-PFIZER INC-PV202400102894$PFIZER$$49$YR$$F$Y$$$20240912$$CN$US$US
242005381$24200538$1$I$$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233722$PFIZER$$$$$F$Y$$$20240812$$HP$US$US
242005391$24200539$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400233216$PFIZER$$46$YR$$F$Y$$$20240812$$HP$US$US
242005401$24200540$1$I$20240101$20240807$20240812$20240812$PER$$US-PFIZER INC-202400233213$PFIZER$$59$YR$$M$Y$$$20240812$$HP$US$US
242005411$24200541$1$I$20240212$20240807$20240812$20240812$PER$$US-PFIZER INC-202400233205$PFIZER$$48$YR$$M$Y$$$20240812$$HP$US$US
242005421$24200542$1$I$$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233385$PFIZER$$75$YR$$F$Y$$$20240812$$CN$US$US
242005431$24200543$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400050007$PFIZER$$20$YR$$F$Y$$$20240812$$HP$US$US
242005441$24200544$1$I$$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233285$PFIZER$$39$YR$$F$Y$$$20240812$$MD$US$US
242005451$24200545$1$I$20240703$20240807$20240812$20240812$PER$$US-PFIZER INC-PV202400103455$PFIZER$$69$YR$$F$Y$$$20240812$$HP$US$US
242005461$24200546$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400233235$PFIZER$$63$YR$$F$Y$$$20240812$$HP$US$US
242005472$24200547$2$F$$20240814$20240812$20240816$PER$$US-PFIZER INC-202400232251$PFIZER$$56$YR$$F$Y$$$20240816$$MD$US$US
242005482$24200548$2$F$$20240827$20240812$20240830$PER$$US-PFIZER INC-PV202400083231$PFIZER$$79$YR$$F$Y$$$20240830$$CN$US$US
242005492$24200549$2$F$20240101$20240823$20240812$20240829$PER$$US-PFIZER INC-202400233481$PFIZER$$63$YR$$F$Y$$$20240829$$HP$US$US
242005501$24200550$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400232905$PFIZER$$66$YR$$F$Y$$$20240812$$HP$US$US
242005512$24200551$2$F$$20240912$20240812$20240918$PER$$US-PFIZER INC-202400233281$PFIZER$$73$YR$$F$Y$$$20240918$$HP$US$US
242005521$24200552$1$I$20240805$20240807$20240812$20240812$PER$$US-PFIZER INC-202400232570$PFIZER$$80$YR$$F$Y$$$20240812$$CN$US$US
242005531$24200553$1$I$$20240807$20240812$20240812$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-126664$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240812$$MD$JP$JP
242005542$24200554$2$F$$20240807$20240812$20240819$PER$$US-AMGEN-USASP2024157820$AMGEN$$$$$M$Y$$$20240818$$MD$US$US
242005563$24200556$3$F$20240808$20240906$20240812$20240909$PER$$US-AMGEN-USASP2024159483$AMGEN$$$$$M$Y$$$20240909$$CN$US$US
242005571$24200557$1$I$$20240802$20240812$20240812$PER$$US-ABBVIE-5866632$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242005581$24200558$1$I$20240701$20240702$20240812$20240812$EXP$$LB-AMGEN-LBNSP2024156618$AMGEN$$$$$M$Y$$$20240812$$HP$LB$LB
242005591$24200559$1$I$20240101$20240807$20240812$20240812$PER$$US-BIOGEN-2024BI01271482$BIOGEN$$$$$M$Y$$$20240812$$CN$US$US
242005601$24200560$1$I$20240101$20240808$20240812$20240812$EXP$$PR-BAYER-2024A115428$BAYER$$51$YR$A$F$Y$$$20240812$$HP$PR$PR
242005612$24200561$2$F$20240802$20240815$20240812$20240820$PER$$US-AMGEN-USASP2024159291$AMGEN$$31$YR$A$F$Y$$$20240820$$HP$US$US
242005621$24200562$1$I$20240804$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159303$AMGEN$$$$$$Y$$$20240812$$PH$US$US
242005631$24200563$1$I$20240101$20240731$20240812$20240812$EXP$$US-ARDELYX-2024ARDX003689$ARDELYX$$$$$M$Y$$$20240811$$MD$US$US
242005641$24200564$1$I$$20240802$20240812$20240812$EXP$$CA-TEVA-202206_00013167$TEVA$$46$YR$$F$Y$$$20240812$$CN$CA$CA
242005651$24200565$1$I$$20240808$20240812$20240812$EXP$$US-JNJFOC-20240822202$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240812$$HP$US$US
242005661$24200566$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006470$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
242005671$24200567$1$I$20240802$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006531$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240812$$CN$US$US
242005681$24200568$1$I$20240808$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006335$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240812$$CN$US$US
242005691$24200569$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005826$ELI LILLY AND CO$$46$YR$A$F$Y$64$KG$20240812$$CN$US$US
242005701$24200570$1$I$20240101$20240731$20240812$20240812$EXP$$US-ARDELYX-2024ARDX000878$ARDELYX$$$$$F$Y$86.16$KG$20240811$$CN$US$US
242005711$24200571$1$I$20240707$20240731$20240812$20240812$EXP$$US-ETON PHARMACEUTICALS, INC-2024ETO000155$ETON PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
242005721$24200572$1$I$20240630$20240802$20240812$20240812$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00670$PARATEK PHARMACEUTICALS$$79$YR$$F$Y$$$20240812$$HP$CN$CN
242005731$24200573$1$I$20240704$20240802$20240812$20240812$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00669$PARATEK PHARMACEUTICALS$$78$YR$$M$Y$60$KG$20240812$$HP$CN$CN
242005741$24200574$1$I$20240101$20240729$20240812$20240812$EXP$$US-TRIGEN LABORATORIES-2024ALO00376$Alora Pharma$$$$$M$Y$$$20240812$$CN$US$US
242005751$24200575$1$I$20240724$20240809$20240812$20240812$EXP$$CN-BAYER-2024A115782$BAYER$$64$YR$A$F$Y$55$KG$20240812$$HP$CN$CN
242005761$24200576$1$I$20231227$20240807$20240812$20240812$EXP$FR-AFSSAPS-NY2024000890$FR-MYLANLABS-2024M1073628$MYLAN$$95$YR$$M$Y$70.4$KG$20240812$$MD$FR$FR
242005771$24200577$1$I$$20240807$20240812$20240812$EXP$$GR-MYLANLABS-2024M1073601$MYLAN$$$$E$F$Y$75$KG$20240812$$MD$GR$GR
242005781$24200578$1$I$$20240802$20240812$20240812$EXP$NL-LRB-00993543$NL-TEVA-VS-3229750$TEVA$$72$YR$$F$Y$60$KG$20240812$$CN$NL$NL
242005791$24200579$1$I$20200601$20240807$20240812$20240812$EXP$$CA-MYLANLABS-2024M1074133$MYLAN$$80$YR$$M$Y$69$KG$20240812$$MD$CA$CA
242005801$24200580$1$I$$20240807$20240812$20240812$EXP$$FR-MYLANLABS-2024M1073915$MYLAN$Pontoizeau C, Dangers L, Jarlier V, Luyt CE, Guiller E, Brossier F, et al. Ruling out false-positive urinary legionella pneumophila serogroup 1 and streptococcus pneumoniae antigen test results by heating urine. Clinical Microbiology. 2014;52(12):4347-4349$16$YR$$M$Y$$$20240812$$HP$FR$FR
242005811$24200581$1$I$$20231018$20240812$20240812$PER$$US-AYTU BIOPHARMA, INC.-2023AYT000043$AYTU BIOSCIENCE$$$$$$Y$$$20240812$$CN$US$US
242005821$24200582$1$I$$20240304$20240812$20240812$PER$$US-AYTU BIOPHARMA, INC.-2024AYT000013$AYTU BIOSCIENCE$$$$$$Y$$$20240812$$CN$US$US
242005831$24200583$1$I$$20240302$20240812$20240812$PER$$US-AYTU BIOPHARMA, INC.-2024AYT000015$AYTU BIOSCIENCE$$$$$$Y$$$20240812$$CN$US$US
242005841$24200584$1$I$$20240304$20240812$20240812$PER$$US-AYTU BIOPHARMA, INC.-2024AYT000016$AYTU BIOSCIENCE$$$$$M$Y$$$20240812$$CN$US$US
242005851$24200585$1$I$20240301$20240320$20240812$20240812$PER$$US-AYTU BIOPHARMA, INC.-2024AYT000017$AYTU BIOSCIENCE$$$$$$Y$$$20240812$$CN$US$US
242005861$24200586$1$I$20240101$20240401$20240812$20240812$PER$$US-AYTU BIOPHARMA, INC.-2024AYT000025$AYTU BIOSCIENCE$$$$$$Y$$$20240812$$CN$US$US
242005871$24200587$1$I$20240502$20240514$20240812$20240812$PER$$US-AYTU BIOPHARMA, INC.-2024AYT000044$AYTU BIOSCIENCE$$$$$$Y$$$20240812$$CN$US$US
242005881$24200588$1$I$20230703$20230703$20240812$20240812$PER$$US-AYTU BIOPHARMA, INC.-2023AYT000032$AYTU BIOSCIENCE$$$$$$Y$$$20240812$$CN$US$US
242005892$24200589$2$F$20240806$20240812$20240812$20240814$PER$$US-AMGEN-USASP2024159223$AMGEN$$74$YR$E$M$Y$$$20240813$$CN$US$US
242005911$24200591$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA236481$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240812$$MD$US$US
242005921$24200592$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA231624$SANOFI AVENTIS$$$$$F$Y$$$20240812$$CN$US$US
242005931$24200593$1$I$20240801$20240808$20240812$20240812$EXP$$US-JNJFOC-20240822761$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$HP$US$US
242005942$24200594$2$F$20240719$20240827$20240812$20240904$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00836$CATALYST PHARMA$$15$YR$$M$Y$52.154$KG$20240904$$CN$US$US
242005951$24200595$1$I$20240730$20240730$20240812$20240812$EXP$$JP-UCBSA-2024038910$UCB$$8$DEC$$F$Y$$$20240812$$MD$JP$JP
242005961$24200596$1$I$$20240805$20240812$20240812$EXP$$IN-ROCHE-3470425$ROCHE$$75$YR$E$M$Y$$$20240812$$MD$IN$IN
242005971$24200597$1$I$$20240731$20240812$20240812$EXP$$US-CIPLA LTD.-2024US08434$CIPLA$$$$$$Y$$$20240812$$CN$US$US
242005982$24200598$2$F$20240605$20240731$20240812$20240812$PER$$DE-TRAVERE-2024TVT00666$TRAVERE THERAPEUTICS$$30$YR$A$M$Y$73$KG$20240812$$MD$DE$DE
242005992$24200599$2$F$20240728$20240823$20240812$20240830$EXP$$US-Axsome Therapeutics, Inc.-AXS202408-001166$AXSOME THERAPEUTICS$$43$YR$A$F$Y$86$KG$20240830$$$US$
242006001$24200600$1$I$20240801$20240802$20240812$20240812$EXP$GB-MHRA-MED-202408020939225370-RYQNG$GB-TEVA-VS-3229278$TEVA$$74$YR$$M$Y$74$KG$20240812$$CN$GB$GB
242006011$24200601$1$I$$20240805$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124134$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240812$$HP$US$US
242006021$24200602$1$I$20240702$20240802$20240812$20240812$EXP$FR-AFSSAPS-PA2024001389$FR-TEVA-VS-3230028$TEVA$$21$YR$$M$Y$71.4$KG$20240812$$MD$FR$FR
242006031$24200603$1$I$20240101$20240802$20240812$20240812$EXP$$GB-TEVA-VS-3229836$TEVA$$61$YR$$F$Y$84$KG$20240812$$PH$GB$GB
242006041$24200604$1$I$20240702$20240802$20240812$20240812$EXP$GB-MHRA-MED-202408011123548920-DHFBL$GB-TEVA-VS-3229831$TEVA$$71$YR$$M$Y$71$KG$20240812$$MD$GB$GB
242006051$24200605$1$I$$20240808$20240812$20240812$PER$$US-GILEAD-2024-0683634$GILEAD$$63$YR$A$M$Y$$$20240812$$CN$US$US
242006061$24200606$1$I$$20240802$20240812$20240812$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00840$CATALYST PHARMA$$$$$M$Y$$$20240812$$CN$US$US
242006081$24200608$1$I$20240511$20240612$20240812$20240812$PER$$US-ANIPHARMA-2024-US-033357$ANI$$76$YR$$F$Y$$$20240812$$HP$US$US
242006091$24200609$1$I$20231201$20240617$20240812$20240812$PER$$US-ANIPHARMA-2024-US-034068$ANI$$59$YR$$F$Y$71.67$KG$20240812$$HP$US$US
242006101$24200610$1$I$$20240618$20240812$20240812$PER$$US-ANIPHARMA-2024-US-034152$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006111$24200611$1$I$$20240618$20240812$20240812$PER$$US-ANIPHARMA-2024-US-034283$ANI$$$$$M$Y$$$20240812$$CN$US$US
242006121$24200612$1$I$$20240619$20240812$20240812$PER$$US-ANIPHARMA-2024-US-034387$ANI$$55$YR$$F$Y$$$20240812$$HP$US$US
242006131$24200613$1$I$$20240617$20240812$20240812$PER$$US-ANIPHARMA-2024-US-034311$ANI$$$$$F$Y$$$20240812$$HP$US$US
242006141$24200614$1$I$$20240620$20240812$20240812$PER$$US-ANIPHARMA-2024-US-034753$ANI$$$$$F$Y$$$20240812$$CN$US$US
242006151$24200615$1$I$$20240624$20240812$20240812$PER$$US-ANIPHARMA-2024-US-035118$ANI$$65$YR$$F$Y$$$20240812$$HP$US$US
242006161$24200616$1$I$20240601$20240630$20240812$20240812$PER$$US-ANIPHARMA-2024-US-036218$ANI$$58$YR$$M$Y$102.06$KG$20240812$$CN$US$US
242006171$24200617$1$I$20240610$20240618$20240812$20240812$PER$$US-ANIPHARMA-2024-US-034175$ANI$$34$YR$$F$Y$$$20240812$$CN$US$US
242006181$24200618$1$I$20240625$20240701$20240812$20240812$PER$$US-ANIPHARMA-2024-US-036353$ANI$$$$$F$Y$$$20240812$$CN$US$US
242006201$24200620$1$I$20240501$20240703$20240812$20240812$PER$$US-ANIPHARMA-2024-US-036776$ANI$$75$YR$$F$Y$68.04$KG$20240812$$HP$US$US
242006211$24200621$1$I$20240401$20240703$20240812$20240812$PER$$US-ANIPHARMA-2024-US-036782$ANI$$53$YR$$F$Y$$$20240812$$HP$US$US
242006221$24200622$1$I$20230101$20240703$20240812$20240812$PER$$US-ANIPHARMA-2024-US-036810$ANI$$80$YR$$F$Y$68.95$KG$20240812$$CN$US$US
242006231$24200623$1$I$$20240628$20240812$20240812$PER$$US-ANIPHARMA-2024-US-035990$ANI$$57$YR$$M$Y$98.43$KG$20240812$$HP$US$US
242006241$24200624$1$I$20240706$20240709$20240812$20240812$PER$$US-ANIPHARMA-2024-US-037681$ANI$$47$YR$$F$Y$$$20240812$$HP$US$US
242006251$24200625$1$I$$20240701$20240812$20240812$PER$$US-ANIPHARMA-2024-US-036342$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006261$24200626$1$I$$20240702$20240812$20240812$PER$$US-ANIPHARMA-2024-US-036710$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006271$24200627$1$I$20240623$20240710$20240812$20240812$PER$$US-ANIPHARMA-2024-US-037902$ANI$$63$YR$$F$Y$$$20240812$$HP$US$US
242006281$24200628$1$I$$20240612$20240812$20240812$PER$$US-ANIPHARMA-2024-US-033298$ANI$$$$$F$Y$$$20240812$$HP$US$US
242006291$24200629$1$I$$20240709$20240812$20240812$PER$$US-ANIPHARMA-2024-US-037581$ANI$$$$$F$Y$$$20240812$$HP$US$US
242006301$24200630$1$I$$20240611$20240812$20240812$PER$$US-ANIPHARMA-2024-US-033228$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006311$24200631$1$I$$20240709$20240812$20240812$PER$$US-ANIPHARMA-2024-US-037925$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006321$24200632$1$I$20240601$20240705$20240812$20240812$PER$$US-ANIPHARMA-2024-US-037217$ANI$$49$YR$$F$Y$75.3$KG$20240812$$HP$US$US
242006331$24200633$1$I$$20240711$20240812$20240812$PER$$US-ANIPHARMA-2024-US-038417$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006341$24200634$1$I$$20240712$20240812$20240812$PER$$US-ANIPHARMA-2024-US-038472$ANI$$73$YR$$M$Y$$$20240812$$HP$US$US
242006351$24200635$1$I$20240715$20240715$20240812$20240812$PER$$US-ANIPHARMA-2024-US-038678$ANI$$50$YR$$F$Y$$$20240812$$HP$US$US
242006361$24200636$1$I$$20240620$20240812$20240812$PER$$US-ANIPHARMA-2024-US-034559$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006371$24200637$1$I$$20240701$20240812$20240812$PER$$US-ANIPHARMA-2024-US-036350$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006381$24200638$1$I$20240710$20240717$20240812$20240812$PER$$US-ANIPHARMA-2024-US-039054$ANI$$76$YR$$F$Y$81.65$KG$20240812$$CN$US$US
242006391$24200639$1$I$$20240722$20240812$20240812$PER$$US-ANIPHARMA-2024-US-039808$ANI$$$$$M$Y$$$20240812$$CN$US$US
242006401$24200640$1$I$$20240620$20240812$20240812$PER$$US-ANIPHARMA-2024-US-034707$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006411$24200641$1$I$$20240716$20240812$20240812$PER$$US-ANIPHARMA-2024-US-038812$ANI$$58$YR$$M$Y$$$20240812$$HP$US$US
242006421$24200642$1$I$$20240711$20240812$20240812$PER$$US-ANIPHARMA-2024-US-038060$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006431$24200643$1$I$$20240709$20240812$20240812$PER$$US-ANIPHARMA-2024-US-037598$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006441$24200644$1$I$$20240710$20240812$20240812$PER$$US-ANIPHARMA-2024-US-037848$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006451$24200645$1$I$20240701$20240725$20240812$20240812$PER$$US-ANIPHARMA-2024-US-040368$ANI$$52$YR$$F$Y$$$20240812$$CN$US$US
242006461$24200646$1$I$$20240620$20240812$20240812$PER$$US-ANIPHARMA-2024-US-034698$ANI$$$$$F$Y$$$20240812$$HP$US$US
242006471$24200647$1$I$$20240710$20240812$20240812$PER$$US-ANIPHARMA-2024-US-037865$ANI$$$$$F$Y$$$20240812$$HP$US$US
242006481$24200648$1$I$$20240725$20240812$20240812$PER$$US-ANIPHARMA-2024-US-040483$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006491$24200649$1$I$$20240802$20240812$20240812$EXP$$IT-ROVI-20240574$ROVIPHARM SAS$$20$YR$A$F$Y$$$20240812$$MD$IT$IT
242006501$24200650$1$I$$20240718$20240812$20240812$PER$$US-ANIPHARMA-2024-US-039349$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006511$24200651$1$I$$20240726$20240812$20240812$PER$$US-ANIPHARMA-2024-US-040687$ANI$$$$$F$Y$$$20240812$$HP$US$US
242006521$24200652$1$I$$20240618$20240812$20240812$PER$$US-ANIPHARMA-2024-US-034319$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006531$24200653$1$I$$20240711$20240812$20240812$PER$$US-ANIPHARMA-2024-US-038258$ANI$$$$$M$Y$$$20240812$$CN$US$US
242006541$24200654$1$I$$20240723$20240812$20240812$PER$$US-ANIPHARMA-2024-US-039952$ANI$$$$$F$Y$$$20240812$$HP$US$US
242006551$24200655$1$I$$20240802$20240812$20240812$EXP$$IT-ROVI-20240571$ROVIPHARM SAS$$30$YR$A$M$Y$$$20240812$$MD$IT$IT
242006561$24200656$1$I$$20240802$20240812$20240812$EXP$$PT-CTRS-202400161$ADDMEDICA$Patr?cio J, Modesto F, Caldeira V, Fernandes I. Patr?cio J, Modesto F, et al.. quando o tratamento despoleta a doen?a - Um caso clinico. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI. 2024;:495.$76$YR$$M$Y$$$20240812$$MD$PT$
242006571$24200657$1$I$$20240802$20240812$20240812$EXP$$US-ROCHE-10000048232$ROCHE$$72$YR$E$M$Y$$$20240812$$CN$US$US
242006581$24200658$1$I$$20240722$20240812$20240812$PER$$US-ANIPHARMA-2024-US-039708$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006591$24200659$1$I$$20240726$20240812$20240812$PER$$US-ANIPHARMA-2024-US-040696$ANI$$$$$M$Y$$$20240812$$HP$US$US
242006602$24200660$2$F$20240515$20240826$20240812$20240903$EXP$FR-AFSSAPS-TS2024000856$FR-TEVA-VS-3229783$TEVA$$64$YR$$M$Y$82$KG$20240903$$MD$FR$FR
242006611$24200661$1$I$$20240618$20240812$20240812$PER$$US-ANIPHARMA-2024-US-034335$ANI$$$$$F$Y$$$20240812$$HP$US$US
242006621$24200662$1$I$20240704$20240708$20240812$20240812$PER$$US-ANIPHARMA-2024-US-037392$ANI$$76$YR$$F$Y$$$20240812$$HP$US$US
242006631$24200663$1$I$20240421$20240726$20240812$20240812$PER$$PR-ANIPHARMA-2024-PR-000018$ANI$$67$YR$$F$Y$$$20240812$$CN$PR$PR
242006651$24200665$1$I$20240722$20240724$20240812$20240812$PER$$US-ANIPHARMA-2024-US-040224$ANI$$60$YR$$F$Y$$$20240812$$HP$US$US
242006662$24200666$2$F$$20240826$20240812$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011809$JAZZ$$$$$F$Y$$$20240828$$CN$US$US
242006682$24200668$2$F$20240404$20240909$20240812$20240919$EXP$$US-ANIPHARMA-2024-US-038861$ANI$$54$YR$$F$Y$154.22$KG$20240919$$CN$US$US
242006691$24200669$1$I$20240718$20240724$20240812$20240812$PER$$US-ANIPHARMA-2024-US-040234$ANI$$29$YR$$M$Y$$$20240812$$HP$US$US
242006711$24200671$1$I$20220101$20240731$20240812$20240812$EXP$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00051$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240808$$CN$US$US
242006721$24200672$1$I$20230101$20240810$20240810$20240810$DIR$713744$$FDA-CTU$$67$YR$$F$N$63$KG$20240810$N$CN$US$
242006732$24200673$2$F$$20240808$20240812$20240820$EXP$$US-ARDELYX-2024ARDX005878$ARDELYX$$$$$M$Y$$$20240820$$HP$US$US
242006741$24200674$1$I$$20240805$20240812$20240812$EXP$$AU-ROCHE-10000049804$ROCHE$$$$$$Y$$$20240812$$PH$AU$AU
242006751$24200675$1$I$20240701$20240731$20240812$20240812$EXP$$US-ARDELYX-2024ARDX005881$ARDELYX$$66$YR$$M$Y$$$20240811$$HP$US$US
242006761$24200676$1$I$20240701$20240731$20240812$20240812$EXP$$US-ARDELYX-2024ARDX005889$ARDELYX$$81$YR$$F$Y$$$20240811$$CN$US$US
242006772$24200677$2$F$20240725$20240812$20240812$20240822$EXP$$US-ARDELYX-2024ARDX005907$ARDELYX$$85$YR$$M$Y$$$20240822$$HP$US$US
242006781$24200678$1$I$$20240810$20240810$20240810$DIR$713741$$FDA-CTU$$66$YR$$M$N$91.8$KG$20240810$N$CN$US$
242006791$24200679$1$I$20240423$20240806$20240812$20240812$EXP$$JP-009507513-2408JPN000789J$MERCK$$$$E$F$Y$$$20240812$$MD$JP$JP
242006801$24200680$1$I$20240727$20240806$20240812$20240812$EXP$$CN-JNJFOC-20240816099$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240812$$HP$CN$CN
242006811$24200681$1$I$20240101$20240802$20240812$20240812$EXP$$US-ARDELYX-2024ARDX005943$ARDELYX$$86$YR$$M$Y$$$20240811$$CN$US$US
242006821$24200682$1$I$20240724$20240805$20240812$20240812$EXP$$US-ABBVIE-5871012$ABBVIE$$74$YR$$M$Y$$$20240812$$CN$US$US
242006842$24200684$2$F$$20240920$20240812$20240930$EXP$$JP-ARDELYX-2024ARDX006069$ARDELYX$$$$$M$Y$$$20241001$$MD$JP$JP
242006851$24200685$1$I$$20240802$20240812$20240812$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000083$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
242006862$24200686$2$F$$20240812$20240812$20240822$EXP$$US-FARMAPROD-202408-2798$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240822$$MD$US$US
242006871$24200687$1$I$20231209$20240808$20240812$20240812$EXP$GB-MHRA-31448231$GB-PFIZER INC-202400232926$PFIZER$$4$YR$$$Y$$$20240812$$HP$GB$GB
242006891$24200689$1$I$20240601$20240731$20240812$20240812$PER$$US-RDY-SPO/USA/24/0011400$DR REDDYS$$30$YR$A$F$Y$$$20240812$$CN$US$US
242006901$24200690$1$I$$20240809$20240812$20240812$PER$$US-ROCHE-10000054269$ROCHE$$$$$$Y$$$20240812$$CN$US$US
242006911$24200691$1$I$20240301$20240807$20240812$20240812$EXP$$US-TAKEDA-2024TUS030603$TAKEDA$$78$YR$$F$Y$$$20240812$$CN$US$US
242006921$24200692$1$I$$20240808$20240812$20240812$EXP$$NVSC2024AT162574$NOVARTIS$$$$$F$Y$$$20240812$$MD$AT$AT
242006932$24200693$2$F$20201013$20240808$20240812$20240821$EXP$$NVSC2024CN162408$NOVARTIS$$18$YR$$M$Y$60$KG$20240821$$HP$CN$CN
242006942$24200694$2$F$$20240815$20240812$20240828$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000301$Unknown Manufacturer$$$$$$Y$$$20240828$$CN$US$US
242006952$24200695$2$F$$20240809$20240812$20240821$EXP$PL-EMA-DD-20240806-7482827-094215$NVSC2024PL162211$NOVARTIS$Jankowski J, Jedynak P, Pazik J.. Pregnant woman with primary membranous nephropathy - case report.. POLSKI MERKURIUSZ LEKARSKI: ORGAN POLSKIEGO TOWARZYSTWA LEKARSKIEGO. 2020;48(284):105-7$21$YR$$F$Y$$$20240821$$HP$PL$PL
242006971$24200697$1$I$$20240808$20240812$20240812$PER$$NVSC2024US162770$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
242006981$24200698$1$I$$20240809$20240812$20240812$EXP$$NVSC2024US163191$NOVARTIS$$$$$$Y$$$20240812$$HP$US$US
242007002$24200700$2$F$20240717$20240905$20240812$20240911$EXP$$NVSC2024US162475$NOVARTIS$$60$YR$$M$Y$55.2$KG$20240911$$MD$US$US
242007021$24200702$1$I$20240801$20240805$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123746$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240812$$HP$US$US
242007031$24200703$1$I$$20240805$20240812$20240812$PER$$US-ABBVIE-5867941$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242007041$24200704$1$I$$20240808$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126379$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240812$$CN$US$US
242007051$24200705$1$I$$20240808$20240812$20240812$EXP$$FR-DAIICHI SANKYO, INC.-DSE-2024-140262$DAIICHI$$$$E$F$Y$70$KG$20240812$$MD$FR$FR
242007061$24200706$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA235078$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240812$$MD$US$US
242007071$24200707$1$I$20240701$20240806$20240812$20240812$PER$$US-SA-2024SA235087$SANOFI AVENTIS$$$$$$Y$$$20240812$$CN$US$US
242007081$24200708$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA234601$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240812$$MD$US$US
242007091$24200709$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235565$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240812$$MD$US$US
242007101$24200710$1$I$$20240801$20240812$20240812$PER$$US-SA-2024SA234123$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$MD$US$US
242007111$24200711$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA235126$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240812$$MD$US$US
242007131$24200713$1$I$20230628$20240808$20240812$20240812$EXP$$HR-MYLANLABS-2024M1074485$MYLAN$$91$YR$$F$Y$$$20240812$$CN$HR$DE
242007142$24200714$2$F$20240728$20240814$20240812$20240826$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00845$CATALYST PHARMA$$12$YR$$M$Y$63.946$KG$20240826$$CN$US$US
242007151$24200715$1$I$$20240808$20240812$20240812$EXP$$NL-MYLANLABS-2024M1074003$MYLAN$Meerten TV, Kuruvilla J, Song KW, Thieblemont C, Minnema MC, Forcade E, et al.. Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma.. American journal of cancer research.. 2024;14(6):2905-20$$$A$$Y$$$20240812$$MD$NL$NL
242007161$24200716$1$I$20220410$20240808$20240812$20240812$EXP$FR-AFSSAPS-RE2024000801$FR-MYLANLABS-2024M1073997$MYLAN$$40$YR$$M$Y$70$KG$20240812$$MD$FR$FR
242007171$24200717$1$I$$20240808$20240812$20240812$EXP$GB-MHRA-MED-202408081058109930-HGRMQ$GB-MYLANLABS-2024M1074104$MYLAN$$79$YR$$F$Y$$$20240812$$HP$GB$GB
242007181$24200718$1$I$20240808$20240808$20240812$20240812$EXP$$GB-MYLANLABS-2024M1074030$MYLAN$$52$YR$$F$Y$81$KG$20240812$$HP$GB$GB
242007192$24200719$2$F$20240628$20240912$20240812$20240916$EXP$FR-AFSSAPS-NY2024000897$FR-009507513-2408FRA001380$MERCK$$64$YR$$M$Y$$$20240916$$MD$FR$FR
242007202$24200720$2$F$20200917$20240808$20240812$20240821$EXP$$NVSC2024CN162389$NOVARTIS$$25$YR$$F$Y$$$20240821$$HP$CN$CN
242007211$24200721$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005787$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240812$$CN$US$US
242007221$24200722$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005892$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240812$$CN$US$US
242007231$24200723$1$I$$20240810$20240812$20240812$PER$$NVSC2024US163379$NOVARTIS$$$$$$Y$$$20240812$$CN$US$US
242007241$24200724$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006249$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
242007251$24200725$1$I$20240506$20240805$20240812$20240812$EXP$$US-OTSUKA-2024_021696$OTSUKA$$40$YR$$F$Y$70.75$KG$20240812$$CN$US$US
242007261$24200726$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191481$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
242007274$24200727$4$F$20240808$20240830$20240812$20240905$EXP$$ES-ABBVIE-5874912$ABBVIE$$57$YR$$M$Y$$$20240905$$MD$ES$ES
242007281$24200728$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA235248$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240812$$MD$US$US
242007292$24200729$2$F$$20240815$20240812$20240820$EXP$$ZA-TAKEDA-2024TUS064221$TAKEDA$$$$$F$Y$$$20240820$$MD$ZA$ZA
242007301$24200730$1$I$20240611$20240805$20240812$20240812$PER$$US-SA-2024SA235220$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240812$$MD$US$US
242007313$24200731$3$F$$20240909$20240812$20240913$EXP$$FR-ABBVIE-5874913$ABBVIE$$59$YR$$M$Y$$$20240913$$HP$FR$FR
242007323$24200732$3$F$20240101$20240909$20240812$20240919$EXP$$NL-UCBSA-2024023118$UCB$$$$$M$Y$34.5$KG$20240919$$CN$NL$NL
242007332$24200733$2$F$20240808$20240822$20240812$20240826$PER$$US-AMGEN-USASP2024158760$AMGEN$$78$YR$E$M$Y$$$20240826$$CN$US$US
242007341$24200734$1$I$20240501$20240805$20240812$20240812$EXP$FR-AFSSAPS-BS2024000475$FR-GSK-FR2024097400$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$MD$FR$FR
242007361$24200736$1$I$20240723$20240810$20240810$20240810$DIR$713755$$FDA-CTU$$56$YR$$F$N$42.75$KG$20240810$N$CN$US$
242007371$24200737$1$I$$20240807$20240812$20240812$EXP$$NL-Bion-013652$BIONPHARMA$$7$DEC$E$F$Y$$$20240812$$HP$NL$NL
242007381$24200738$1$I$$20240807$20240812$20240812$EXP$$US-Bion-013650$BIONPHARMA$$65$YR$E$F$Y$$$20240812$$HP$US$US
242007391$24200739$1$I$20240808$20240809$20240812$20240812$EXP$$US-ABBVIE-5875552$ABBVIE$$78$YR$$M$Y$$$20240812$$CN$US$US
242007401$24200740$1$I$$20240808$20240812$20240812$PER$$US-JNJFOC-20240825319$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240812$$MD$US$US
242007413$24200741$3$F$$20240909$20240812$20240913$EXP$$US-SANDOZ INC.-SDZ2024US071515$SANDOZ$$$$$M$Y$$$20240913$$CN$US$US
242007421$24200742$1$I$$20240806$20240812$20240812$EXP$$US-MYLANLABS-2024M1070184$MYLAN$$$$$F$Y$72.57$KG$20240812$$CN$US$US
242007431$24200743$1$I$$20240806$20240812$20240812$EXP$$US-MYLANLABS-2024M1073722$MYLAN$$$$$M$Y$$$20240812$$CN$US$US
242007441$24200744$1$I$$20240729$20240812$20240812$PER$$US-Nuvo Pharmaceuticals Inc-2160300$NUVO PHARMACEUTICALS$$$$$$Y$$$20240812$$$US$US
242007451$24200745$1$I$20240703$20240710$20240812$20240812$PER$$US-Eisai-EC-2024-170387$EISAI$$82$YR$E$M$Y$$$20240812$$CN$US$US
242007462$24200746$2$F$$20240812$20240812$20240822$30DAY$$US-GSK-US2024099188$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242007471$24200747$1$I$$20240805$20240812$20240812$EXP$GB-MHRA-TPP17742326C576475YC1722345779072$GB-RDY-SPO/GBR/24/0011565$DR REDDYS$$56$YR$A$M$Y$125$KG$20240812$$HP$GB$GB
242007492$24200749$2$F$$20240821$20240812$20240827$EXP$$NVSC2024IL160792$NOVARTIS$$68$YR$$F$Y$$$20240827$$HP$IL$IL
242007501$24200750$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126985$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240812$$CN$US$US
242007511$24200751$1$I$$20240807$20240812$20240812$EXP$$US-SA-2024SA236119$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240812$$HP$US$US
242007531$24200753$1$I$$20240807$20240812$20240812$PER$$US-ROCHE-10000053587$ROCHE$$$$$F$Y$$$20240812$$HP$US$US
242007541$24200754$1$I$$20240803$20240812$20240812$EXP$$US-Bion-013656$BIONPHARMA$$$$$F$Y$$$20240812$$CN$US$US
242007551$24200755$1$I$20240101$20240807$20240812$20240812$PER$$US-SA-2024SA236630$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240812$$HP$US$US
242007561$24200756$1$I$$20240806$20240812$20240812$EXP$$SE-MYLANLABS-2024M1074820$MYLAN$Zilg B, Alkass K, Berg S, Druid H. Interpretation of postmortem vitreous concentrations of sodium and chloride. Forensic-Sci-Int 2016; 263 107-113.$55$YR$$F$Y$$$20240812$$HP$SE$SE
242007571$24200757$1$I$20240803$20240810$20240810$20240810$DIR$713732$$FDA-CTU$$58$YR$$F$N$77.85$KG$20240810$N$CN$US$
242007581$24200758$1$I$20240615$20240804$20240812$20240812$EXP$GB-MHRA-MED-202408042148217470-WLNZK$GB-TORRENT-00037508$TORRENT$$39$YR$A$F$Y$$$20240812$$CN$GB$GB
242007591$24200759$1$I$$20240805$20240812$20240812$EXP$GB-MHRA-MED-202408051535024400-VQSNR$GB-TORRENT-00037537$TORRENT$$39$YR$A$F$Y$$$20240812$$CN$GB$GB
242007601$24200760$1$I$20240802$20240807$20240812$20240812$EXP$GB-MHRA-MED-202408031331012830-YMSRD$GB-TORRENT-00037548$TORRENT$$39$YR$A$F$Y$$$20240812$$CN$GB$GB
242007612$24200761$2$F$20240808$20240812$20240812$20240821$EXP$GB-MHRA-MED-202408081451583880-WYCHS$GB-TORRENT-00037549$TORRENT$$39$YR$A$F$Y$$$20240821$$CN$GB$GB
242007621$24200762$1$I$$20240807$20240812$20240812$EXP$GB-MHRA-MED-202408070917555000-DHZVC$GB-TORRENT-00037544$TORRENT$$$$$F$Y$$$20240812$$CN$GB$GB
242007631$24200763$1$I$$20240807$20240812$20240812$EXP$$US-TORRENT-00013708$TORRENT$$40$YR$A$M$Y$$$20240812$$CN$US$US
242007642$24200764$2$F$20240720$20240819$20240812$20240823$EXP$$US-TORRENT-00013709$TORRENT$$33$YR$A$F$Y$88$KG$20240823$$HP$US$US
242007651$24200765$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5874310$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242007671$24200767$1$I$20240720$20240812$20240812$20240812$EXP$FR-AFSSAPS-SE2024000643$NVSC2024FR163249$NOVARTIS$$54$YR$$F$Y$$$20240812$$MD$FR$FR
242007681$24200768$1$I$20240101$20240808$20240812$20240812$EXP$$US-ABBVIE-5874740$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
242007691$24200769$1$I$20240729$20240808$20240812$20240812$EXP$$CA-ABBVIE-5875834$ABBVIE$$78$YR$$M$Y$$$20240812$$HP$CA$CA
242007701$24200770$1$I$$20240808$20240812$20240812$PER$$NVSC2024US162246$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
242007711$24200771$1$I$20231201$20240802$20240812$20240812$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00224$CATALYST PHARMA$$82$YR$$M$Y$115.65$KG$20240812$$CN$US$US
242007721$24200772$1$I$20190101$20240802$20240812$20240812$EXP$FR-AFSSAPS-AN2024000948$FR-TEVA-VS-3229777$TEVA$$51$YR$$M$Y$98$KG$20240812$$PH$FR$FR
242007732$24200773$2$F$20240701$20240815$20240812$20240819$PER$$US-AMGEN-USASP2024158520$AMGEN$$78$YR$E$F$Y$$$20240819$$PH$US$US
242007741$24200774$1$I$20240627$20240802$20240812$20240812$EXP$FR-AFSSAPS-AN2024000951$FR-TEVA-VS-3230017$TEVA$$83$YR$$M$Y$67.5$KG$20240812$$PH$FR$FR
242007751$24200775$1$I$20220520$20240802$20240812$20240812$EXP$$JP-EMD Serono-9324324$EMD SERONO INC$$82$YR$E$M$Y$60$KG$20240812$$MD$JP$JP
242007761$24200776$1$I$$20240722$20240812$20240812$PER$$US-TOLMAR, INC.-24US050969$TOLMAR$$$$$M$Y$$$20240812$$HP$US$US
242007771$24200777$1$I$$20240722$20240812$20240812$PER$$US-TOLMAR, INC.-24US051115$TOLMAR$$$$$M$Y$$$20240812$$CN$US$US
242007781$24200778$1$I$20240625$20240731$20240812$20240812$PER$$US-FARMAPROD-202407-2493$DOMPE FARMACEUTICI$$83$YR$E$F$Y$$$20240812$$CN$US$US
242007792$24200779$2$F$$20240829$20240812$20240917$PER$$US-TOLMAR, INC.-24US051201$TOLMAR$$$$$M$Y$$$20240917$$HP$US$US
242007801$24200780$1$I$20240717$20240722$20240812$20240812$PER$$US-TOLMAR, INC.-24US051230$TOLMAR$$43$YR$$F$Y$$$20240812$$HP$US$US
242007812$24200781$2$F$20240722$20240722$20240812$20240913$PER$$US-TOLMAR, INC.-24US051224$TOLMAR$$72$YR$$M$Y$$$20240912$$PH$US$US
242007823$24200782$3$F$$20240904$20240812$20240906$EXP$$US-INCYTE CORPORATION-2024IN008167$INCYTE$$$$$$Y$$$20240906$$MD$US$US
242007831$24200783$1$I$20240131$20240805$20240812$20240812$EXP$$FR-AstraZeneca-2024A181754$ASTRAZENECA$$2$MON$$M$Y$5.2$KG$20240812$$MD$FR$
242007841$24200784$1$I$$20240802$20240812$20240812$PER$$US-AstraZeneca-2024A177000$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242007851$24200785$1$I$$20240806$20240812$20240812$PER$$US-BAYER-2024A113882$BAYER$$45$YR$A$F$Y$$$20240812$$CN$US$US
242007861$24200786$1$I$20240701$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158180$AMGEN$$68$YR$E$F$Y$$$20240812$$HP$US$US
242007871$24200787$1$I$20240807$20240807$20240812$20240812$EXP$$US-JNJFOC-20240822088$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$MD$US$US
242007881$24200788$1$I$$20240806$20240812$20240812$EXP$$PH-OTSUKA-2024_015789$OTSUKA$$$$$M$Y$$$20240812$$CN$PH$PH
242007892$24200789$2$F$20230101$20240815$20240812$20240829$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00855$CATALYST PHARMA$$$$$F$Y$92.971$KG$20240829$$CN$US$US
242007921$24200792$1$I$20240510$20240810$20240810$20240810$DIR$713774$$FDA-CTU$$24$YR$$M$N$76.5$KG$20240810$N$CN$US$
242007931$24200793$1$I$20240703$20240810$20240810$20240810$DIR$713746$$FDA-CTU$$67$YR$$F$N$76.5$KG$20240810$N$CN$US$
242007941$24200794$1$I$20240808$20240810$20240810$20240810$DIR$713753$$FDA-CTU$$78$YR$$M$N$121.5$KG$20240810$N$CN$US$
242007981$24200798$1$I$20240809$20240810$20240810$20240810$DIR$713776$$FDA-CTU$$$$$UNK$N$$$20240810$$CN$US$
242007992$24200799$2$F$$20240806$20240812$20240816$PER$$US-ROCHE-10000050749$ROCHE$$$$$$Y$$$20240816$$CN$US$US
242008031$24200803$1$I$20240721$20240810$20240810$20240810$DIR$713781$$FDA-CTU$$51$WK$$F$N$61.65$KG$20240810$N$CN$US$
242008042$24200804$2$F$20240804$20240821$20240812$20240828$PER$$JP-Eisai-EC-2024-171632$EISAI$$75$YR$E$F$Y$42.2$KG$20240828$$MD$JP$JP
242008061$24200806$1$I$20240726$20240810$20240810$20240810$DIR$713773$$FDA-CTU$$38$YR$$F$N$69.75$KG$20240810$N$CN$US$
242008071$24200807$1$I$20240101$20240810$20240810$20240810$DIR$713772$$FDA-CTU$$22$YR$$F$N$51.75$KG$20240810$N$CN$US$
242008082$24200808$2$F$$20240911$20240812$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126966$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$78.02$KG$20240916$$CN$US$US
242008091$24200809$1$I$$20240806$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124929$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240812$$HP$US$US
242008101$24200810$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA235176$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240812$$MD$US$US
242008111$24200811$1$I$20240701$20240805$20240812$20240812$PER$$US-SA-2024SA235154$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240812$$MD$US$US
242008121$24200812$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235718$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
242008131$24200813$1$I$$20240805$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125351$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$63.96$KG$20240812$$CN$US$US
242008141$24200814$1$I$20240805$20240805$20240812$20240812$PER$$US-SA-2024SA235218$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240812$$MD$US$US
242008151$24200815$1$I$20240801$20240805$20240812$20240812$PER$$US-SA-2024SA235093$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$MD$US$US
242008162$24200816$2$F$$20240912$20240812$20240912$30DAY$$AR-PFIZER INC-202400230307$PFIZER$$13$YR$$M$Y$$$20240912$$CN$AR$AR
242008182$24200818$2$F$20240806$20240918$20240812$20240918$30DAY$$CL-PFIZER INC-PV202400103513$PFIZER$$8$YR$$M$Y$$$20240918$$CN$CL$CL
242008192$24200819$2$F$$20240906$20240812$20240913$EXP$$JP-009507513-2408JPN000562J$MERCK$$8$DEC$$M$Y$$$20240913$$MD$JP$JP
242008211$24200821$1$I$$20240806$20240812$20240812$EXP$$FR-MYLANLABS-2024M1073680$MYLAN$$12$YR$$F$Y$$$20240812$$HP$FR$FR
242008221$24200822$1$I$20240603$20240806$20240812$20240812$EXP$FR-AFSSAPS-TS2024000875$FR-MYLANLABS-2024M1073333$MYLAN$$56$YR$$M$Y$66$KG$20240812$$MD$FR$FR
242008231$24200823$1$I$20200412$20240806$20240812$20240812$EXP$PL-URPL-1-2217-2020$PL-MYLANLABS-2024M1073219$MYLAN$$31$YR$$M$Y$93$KG$20240812$$MD$PL$PL
242008241$24200824$1$I$$20240806$20240812$20240812$EXP$$DE-MYLANLABS-2024M1073519$MYLAN$$$$$F$Y$$$20240812$$MD$DE$DE
242008261$24200826$1$I$20240604$20240806$20240812$20240812$EXP$$UA-MYLANLABS-2024M1073806$MYLAN$$56$YR$$M$Y$$$20240812$$HP$UA$UA
242008271$24200827$1$I$20200725$20240806$20240812$20240812$EXP$PL-URPL-1-1716-2020$PL-MYLANLABS-2024M1073325$MYLAN$$39$YR$$F$Y$95$KG$20240812$$MD$PL$PL
242008291$24200829$1$I$20240622$20240802$20240812$20240812$EXP$FR-AFSSAPS-PV2024000686$FR-TEVA-VS-3229792$TEVA$$5$YR$$F$Y$19$KG$20240812$$MD$FR$FR
242008301$24200830$1$I$$20240807$20240812$20240812$PER$$US-LEO Pharma-372641$LEO PHARM$$51$YR$$M$Y$$$20240812$$PH$US$US
242008311$24200831$1$I$20231211$20240806$20240812$20240812$EXP$FR-AFSSAPS-NC2024000949$FR-ABBVIE-5869572$ABBVIE$$41$YR$$F$Y$63$KG$20240812$$MD$FR$FR
242008321$24200832$1$I$20240522$20240806$20240812$20240812$EXP$FR-AFSSAPS-DJ2024000871$FR-VERTEX PHARMACEUTICALS-2024-012827$VERTEX$$$$N$M$Y$$$20240812$$MD$FR$FR
242008331$24200833$1$I$$20240725$20240812$20240812$PER$$US-JNJFOC-20240773776$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$HP$US$US
242008341$24200834$1$I$20240808$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006558$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240812$$CN$US$US
242008351$24200835$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006260$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240812$$CN$US$US
242008361$24200836$1$I$$20240807$20240812$20240812$EXP$$CA-GILEAD-2024-0683598$GILEAD$$$$A$F$Y$$$20240812$$CN$CA$CA
242008371$24200837$1$I$20240502$20240731$20240812$20240812$EXP$$DE-BEH-2024174766$CSL BEHRING$$82$YR$E$M$Y$99$KG$20240812$$MD$DE$DE
242008381$24200838$1$I$20210101$20240806$20240812$20240812$EXP$RO-EMA-DD-20240730-7483181-075742$RO-MYLANLABS-2024M1073216$MYLAN$Cavasi A, Stoleru I, Buzias M, Rusu I.. Challenges in the management of checkpoint inhibitor induced liver injury.. J Gastrointestin Liver Dis.. 2023;32(4):560-562$52$YR$$F$Y$$$20240812$$HP$RO$RO
242008392$24200839$2$F$20240506$20240911$20240812$20240913$EXP$GB-MHRA-MED-202408072019074410-NTCRP$NVSC2024GB163068$NOVARTIS$$68$YR$$F$Y$51$KG$20240913$$MD$GB$GB
242008401$24200840$1$I$20231025$20240802$20240812$20240812$EXP$FR-AFSSAPS-AM2024000563$FR-TEVA-VS-3229687$TEVA$$64$YR$$M$Y$85$KG$20240812$$MD$FR$FR
242008411$24200841$1$I$$20240808$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126786$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240812$$CN$US$US
242008421$24200842$1$I$$20240801$20240812$20240812$PER$$US-SA-2024SA233594$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
242008431$24200843$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA234645$SANOFI AVENTIS$$$$A$F$Y$129$KG$20240812$$MD$US$US
242008441$24200844$1$I$$20240809$20240812$20240812$EXP$GB-MHRA-MED-202408091843549660-ZLBWM$GB-MYLANLABS-2024M1074554$MYLAN$$$$$M$Y$$$20240812$$CN$GB$GB
242008451$24200845$1$I$$20240809$20240812$20240812$EXP$GB-MHRA-MED-202408091852555040-WQTBF$GB-MYLANLABS-2024M1074555$MYLAN$$$$$M$Y$$$20240812$$CN$GB$GB
242008461$24200846$1$I$$20240809$20240812$20240812$EXP$GB-MHRA-MED-202408091442060030-DQZMP$GB-MYLANLABS-2024M1074558$MYLAN$$$$$M$Y$$$20240812$$CN$GB$GB
242008471$24200847$1$I$$20240807$20240812$20240812$PER$$US-AstraZeneca-2024A180360$ASTRAZENECA$$70$YR$$M$Y$$$20240812$$HP$US$
242008481$24200848$1$I$$20230530$20240812$20240812$EXP$$US-AstraZeneca-2023A126214$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242008491$24200849$1$I$20240624$20240807$20240812$20240812$EXP$$BE-AstraZeneca-2024A179308$ASTRAZENECA$$85$YR$$M$Y$$$20240812$$MD$BE$
242008501$24200850$1$I$20211209$20220628$20240812$20240812$EXP$$US-AstraZeneca-2022A238877$ASTRAZENECA$$57$YR$$F$Y$$$20240812$$CN$US$
242008511$24200851$1$I$20240620$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179844$ASTRAZENECA$$27452$DY$$F$Y$$$20240812$$CN$US$
242008521$24200852$1$I$20240801$20240810$20240810$20240810$DIR$713782$$FDA-CTU$$77$YR$$F$N$$$20240810$Y$CN$US$
242008532$24200853$2$F$$20240904$20240812$20240911$EXP$$HU-ROCHE-10000048980$ROCHE$Rajj R, Schaadt N, Bezsila K, Balazs O, Jancso M, Auer M, et al. Survey of Potential Drug Interactions, Use of Non-Medical Health Products, and Immunization Status among Patients Receiving Targeted Therapies. Pharmaceuticals. 2024-Jul;17 (7):1-19. doi:10.3390/ph17070942.$$$$$Y$$$20240911$$HP$HU$HU
242008541$24200854$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179819$ASTRAZENECA$$$$$M$Y$$$20240812$$HP$US$
242008551$24200855$1$I$20240427$20240812$20240812$20240812$EXP$FR-AFSSAPS-PC2024000638$NVSC2024FR163072$NOVARTIS$$66$YR$$M$Y$78$KG$20240812$$MD$FR$FR
242008562$24200856$2$F$$20240917$20240812$20240923$EXP$$JP-009507513-2408JPN000565J$MERCK$$72$YR$$M$Y$$$20240923$$MD$JP$JP
242008571$24200857$1$I$$20240805$20240812$20240812$EXP$$AT-FreseniusKabi-FK202412186$FRESENIUS KABI$$47$YR$A$F$Y$$$20240812$$MD$AT$AT
242008581$24200858$1$I$20240330$20240808$20240812$20240812$EXP$$US-ORGANON-O2408USA000707$ORGANON$$42$YR$$F$Y$$$20240812$$CN$US$US
242008591$24200859$1$I$$20240806$20240812$20240812$EXP$$US-INCYTE CORPORATION-2024IN006896$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242008603$24200860$3$F$20220101$20240819$20240812$20240829$EXP$$GR-MYLANLABS-2024M1074103$MYLAN$$69$YR$$F$Y$63$KG$20240829$$CN$GR$GR
242008621$24200862$1$I$$20240805$20240812$20240812$EXP$$PT-MYLANLABS-2024M1073334$MYLAN$Jessica O, Martim B, Mariana C, Duarte C.. Unlikely foot of MRSA bacteremia. Rare diseases I Imaging in Internal. 1299$73$YR$$M$Y$$$20240812$$HP$PT$PT
242008631$24200863$1$I$$20240801$20240812$20240812$EXP$$US-MYLANLABS-2024M1073233$MYLAN$Wang AW, Steed K, Mundi PS, Greenberg P, Saul SR. Hunt for Hypercalcemia. J-Endocr-Soc 2022; 6 (Suppl.) A163-A164.$71$YR$$M$Y$$$20240812$$MD$US$US
242008641$24200864$1$I$$20240805$20240812$20240812$EXP$$IN-MYLANLABS-2024M1074115$MYLAN$Suryapraba S, Nivethitha L, Mooventhan A. Role of yoga and naturopathy in polycystic ovarian syndrome with complex hemorrhagic para-ovarian cyst: A case report. J-Bodyw-Mov-Ther 2024; 40 868-871.$24$YR$$F$Y$$$20240812$$HP$IN$IN
242008651$24200865$1$I$20210101$20240805$20240812$20240812$EXP$$US-MYLANLABS-2024M1073405$MYLAN$$$$$F$Y$$$20240812$$CN$US$US
242008662$24200866$2$F$$20240822$20240812$20240828$EXP$$PT-MYLANLABS-2024M1073876$MYLAN$Ol?mpia Varela, Bruna Malheiro, Ana Paula Castro, Jos? Ant?nio Carvalho, Eliana Costa. PLASMA CELL LEUKEMIA ? CLINICAL CASE. XIII NATIONAL CONGRESS OF CLINICAL. 2024;5:141-145$71$YR$$F$Y$$$20240828$$MD$PT$PT
242008671$24200867$1$I$20201110$20240805$20240812$20240812$EXP$$US-MYLANLABS-2024M1073689$MYLAN$$19$YR$$F$Y$$$20240812$$HP$US$US
242008681$24200868$1$I$20240710$20240805$20240812$20240812$EXP$MT-ADM-07072024$MT-MYLANLABS-2024M1073360$MYLAN$$71$YR$$M$Y$$$20240812$$PH$MT$MT
242008692$24200869$2$F$20240506$20240911$20240812$20240913$EXP$GB-MHRA-MED-202408072019074410-NTCRP$GB-MYLANLABS-2024M1074749$MYLAN$$68$YR$$F$Y$68$KG$20240913$$MD$GB$GB
242008701$24200870$1$I$$20240805$20240812$20240812$EXP$$PT-MYLANLABS-2024M1073330$MYLAN$De Albuquerque Monteiro I, Cardoso JC, Guedes F, Party S, Neves PM, Solomon J, Esteves M. An infection never comes only ? for the purpose of a clinical case. Infectious and parasitic diseases. 530$76$YR$$F$Y$$$20240812$$HP$PT$PT
242008711$24200871$1$I$20240709$20240805$20240812$20240812$EXP$FR-AFSSAPS-AM2024000618$FR-MYLANLABS-2024M1073736$MYLAN$$90$YR$$F$Y$52$KG$20240812$$PH$FR$FR
242008721$24200872$1$I$$20240805$20240812$20240812$EXP$$FR-MYLANLABS-2024M1073991$MYLAN$Larue M, Moulis G, Rueter M, Audia S, Terriou L, Viallard J-F, et al. Efficacy and Safety of Dapsone in Primary Immune Thrombocytopenia. Results of a Randomized, Placebo-Controlled Multicenter Trial and of a Single-Arm, Emulated Trial in the Prospective, Multicenter Carmen-France Registry. Blood 2023; 142 (Suppl. 1) 3983-3984.$$$A$$Y$$$20240812$$HP$FR$FR
242008733$24200873$3$F$20240802$20240821$20240812$20240829$EXP$$US-MYLANLABS-2024M1073774$MYLAN$$34$YR$$F$Y$$$20240829$$CN$US$US
242008741$24200874$1$I$20240601$20240715$20240812$20240812$PER$$US-Eisai-EC-2024-170371$EISAI$$$$E$F$Y$$$20240812$$MD$US$US
242008751$24200875$1$I$20240101$20240709$20240812$20240812$PER$$US-Eisai-EC-2024-170232$EISAI$$77$YR$E$M$Y$$$20240812$$MD$US$US
242008761$24200876$1$I$$20240805$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124434$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$65.77$KG$20240812$$CN$US$US
242008771$24200877$1$I$20240701$20240805$20240812$20240812$PER$$US-SA-2024SA235177$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240812$$MD$US$US
242008781$24200878$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA236610$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240812$$MD$US$US
242008791$24200879$1$I$20230701$20240805$20240812$20240812$PER$$US-SA-2024SA235229$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$MD$US$US
242008831$24200883$1$I$$20240809$20240812$20240812$EXP$$US-AMGEN-USASP2024159193$AMGEN$Sokol L.; Yun S.; Chan O. et al.. Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant. Blood Advances. 2020;4 (14):3435-3442$$$$$Y$$$20240812$$HP$US$US
242008841$24200884$1$I$20240728$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159063$AMGEN$$68$YR$E$F$Y$$$20240812$$CN$US$US
242008851$24200885$1$I$20240807$20240807$20240812$20240812$PER$$US-BIOGEN-2024BI01263024$BIOGEN$$52$YR$$F$Y$$$20240812$$CN$US$US
242008862$24200886$2$F$$20240828$20240812$20240828$PER$$US-ALXN-202408USA000408US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242008871$24200887$1$I$$20240807$20240812$20240812$EXP$$BR-TAKEDA-2024TUS080054$TAKEDA$$25$YR$$$Y$$$20240812$$CN$BR$BR
242008881$24200888$1$I$$20240805$20240812$20240812$PER$$US-MYLANLABS-2024M1073796$MYLAN$$65$YR$$M$Y$$$20240812$$CN$US$US
242008891$24200889$1$I$20240101$20240807$20240812$20240812$EXP$FR-AFSSAPS-BX2024001472$FR-SA-2024SA220749$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240812$$MD$FR$FR
242008901$24200890$1$I$$20240805$20240812$20240812$EXP$$NVSC2024CL162867$NOVARTIS$$59$YR$$M$Y$$$20240812$$CN$CL$CL
242008911$24200891$1$I$20070616$20240731$20240809$20240809$DIR$FDA-CDER-CTU-2024-54977$$FDA-CTU$$54$YR$$M$N$104.33$KG$20240731$Y$CN$US$
242008921$24200892$1$I$20240101$20240801$20240812$20240812$PER$$US-SA-2024SA233771$SANOFI AVENTIS$$$$A$F$Y$89$KG$20240812$$MD$US$US
242008931$24200893$1$I$20240601$20240802$20240812$20240812$PER$$US-SA-2024SA231674$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240812$$HP$US$US
242008941$24200894$1$I$20240101$20240803$20240812$20240812$PER$$US-SA-2024SA238217$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240812$$CN$US$US
242008951$24200895$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA233546$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240812$$MD$US$US
242008961$24200896$1$I$$20240803$20240812$20240812$PER$$US-AMGEN-USASP2024156066$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
242008971$24200897$1$I$$20240809$20240812$20240812$EXP$$US-AMGEN-USASP2024159201$AMGEN$Sokol L.; Yun S.; Chan O. et al.. Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant. Blood Advances. 2020;4 (14):3435-3442$$$$$Y$$$20240812$$HP$US$US
242008982$24200898$2$F$20240808$20240812$20240812$20240814$PER$$US-AMGEN-USASP2024159475$AMGEN$$71$YR$E$M$Y$$$20240813$$CN$US$US
242008991$24200899$1$I$$20240807$20240812$20240812$EXP$$BR-TAKEDA-2024TUS080240$TAKEDA$$21$YR$$$Y$$$20240812$$CN$BR$BR
242009001$24200900$1$I$20230115$20240805$20240812$20240812$EXP$DE-CADRBFARM-2024329682$DE-RDY-SPO/DEU/24/0011500$DR REDDYS$$37$YR$A$M$Y$65$KG$20240812$$CN$DE$DE
242009021$24200902$1$I$$20240805$20240812$20240812$EXP$NL-LRB-00994580$NL-FreseniusKabi-FK202412113$FRESENIUS KABI$$77$YR$E$F$Y$71.7$KG$20240812$$MD$NL$NL
242009032$24200903$2$F$20240101$20240816$20240812$20240916$PER$$US-Eisai-EC-2024-170744$EISAI$$79$YR$E$M$Y$$$20240916$$CN$US$US
242009041$24200904$1$I$$20240801$20240812$20240812$EXP$$US-FreseniusKabi-FK202412269$FRESENIUS KABI$Pang S, Saleh H, Ailawadhi S, Edgar M, Pang M. Acute esophageal stricture after bone marrow transplant. Clinical Journal of Gastroenterology. 2024 Feb;17: 1-5. doi:10.1007/s12328-023-01879-7.$58$YR$A$M$Y$$$20240812$$HP$US$US
242009052$24200905$2$F$$20240809$20240812$20240814$PER$$NVSC2024US162768$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
242009061$24200906$1$I$$20240729$20240812$20240812$EXP$NL-LRB-00990106$HU-SMPA-2024SPA000389$SUNOVION$$$$$$Y$$$20240812$$CN$NL$NL
242009071$24200907$1$I$$20240506$20240812$20240812$EXP$$US-SMPA-2024SPA000637$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242009082$24200908$2$F$20230101$20240816$20240812$20240828$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-124379$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240828$$MD$DE$DE
242009091$24200909$1$I$$20240729$20240812$20240812$EXP$$US-SMPA-2024SPA000395$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242009101$24200910$1$I$$20240729$20240812$20240812$PER$$US-TEVA-VS-3227677$TEVA$$75$YR$$F$Y$$$20240812$$CN$US$US
242009111$24200911$1$I$$20220610$20240812$20240812$EXP$$US-AstraZeneca-2022A219278$ASTRAZENECA$$$$$F$Y$77.1$KG$20240812$$HP$US$
242009121$24200912$1$I$$20240808$20240812$20240812$EXP$$US-AstraZeneca-2024A180964$ASTRAZENECA$$$$$F$Y$$$20240812$$MD$US$
242009131$24200913$1$I$$20240805$20240812$20240812$PER$$US-MYLANLABS-2024M1074097$MYLAN$$$$$F$Y$77.11$KG$20240812$$CN$US$US
242009141$24200914$1$I$$20220908$20240812$20240812$EXP$$US-AstraZeneca-2022A315217$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
242009151$24200915$1$I$20221101$20230313$20240812$20240812$EXP$$US-AstraZeneca-2023A060815$ASTRAZENECA$$906$MON$$F$Y$$$20240812$$CN$US$
242009161$24200916$1$I$20240321$20240808$20240812$20240812$EXP$$US-AstraZeneca-2024A181370$ASTRAZENECA$$29350$DY$$M$Y$$$20240812$$HP$US$
242009171$24200917$1$I$$20240805$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408003160$ELI LILLY AND CO$$$$$M$Y$$$20240812$$CN$US$US
242009181$24200918$1$I$$20240806$20240812$20240812$PER$$US-ALXN-202408USA000390US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240812$$CN$US$US
242009191$24200919$1$I$$20240809$20240812$20240812$EXP$$AU-JNJFOC-20240824141$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$MD$AU$AU
242009201$24200920$1$I$$20240807$20240812$20240812$PER$$US-JNJFOC-20240821938$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$US$US
242009211$24200921$1$I$20240614$20240806$20240812$20240812$EXP$ES-AEMPS-1556398$ES-JNJFOC-20240815815$JOHNSON AND JOHNSON$$46$YR$A$M$Y$83.9$KG$20240812$$MD$ES$ES
242009231$24200923$1$I$20240621$20240731$20240812$20240812$EXP$$CA-TAKEDA-2024TUS077741$TAKEDA$$37$YR$$M$Y$$$20240812$$MD$CA$CA
242009241$24200924$1$I$$20240731$20240812$20240812$PER$$US-MYLANLABS-2024M1074145$MYLAN$$$$$F$Y$$$20240812$$CN$US$US
242009254$24200925$4$F$20240731$20240918$20240812$20240923$EXP$$PT-MYLANLABS-2024M1074170$MYLAN$$75$YR$$F$Y$$$20240923$$PH$PT$PT
242009261$24200926$1$I$20240802$20240802$20240812$20240812$EXP$GB-MHRA-TPP61165852C16984943YC1722595283227$GB-PERRIGO-24GB007277$PERRIGO$$27$YR$$M$Y$82$KG$20240812$$HP$GB$GB
242009271$24200927$1$I$20240712$20240808$20240812$20240812$EXP$$US-PFIZER INC-202400215319$PFIZER$$45$YR$$F$Y$$$20240812$$HP$US$US
242009281$24200928$1$I$20240510$20240802$20240812$20240812$EXP$$FR-PFIZER INC-202400181190$PFIZER$$56$YR$$M$Y$$$20240812$$PH$FR$FR
242009292$24200929$2$F$20240205$20240813$20240812$20240814$EXP$$FR-PFIZER INC-PV202300186836$PFIZER$$16$YR$$F$Y$49.5$KG$20240814$$PH$FR$FR
242009301$24200930$1$I$$20240806$20240812$20240812$EXP$$GB-TAKEDA-2024TUS080003$TAKEDA$$$$$F$Y$$$20240812$$CN$GB$GB
242009321$24200932$1$I$20240715$20240802$20240812$20240812$EXP$GB-MHRA-MED-202407240808085920-WDRBP$GB-TEVA-VS-3225241$TEVA$$60$YR$$M$Y$68$KG$20240812$$CN$GB$GB
242009331$24200933$1$I$$20240808$20240812$20240812$EXP$$AM-TAKEDA-2024TUS080152$TAKEDA$$$$$F$Y$$$20240812$$CN$AM$AM
242009341$24200934$1$I$20240722$20240805$20240812$20240812$EXP$$CN-ROCHE-10000049282$ROCHE$$71$YR$E$F$Y$56$KG$20240812$$HP$CN$CN
242009351$24200935$1$I$$20240811$20240812$20240812$PER$$US-BAYER-2024A115931$BAYER$$$$$$Y$$$20240812$$CN$US$US
242009361$24200936$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158911$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
242009372$24200937$2$F$20221001$20240902$20240812$20240910$EXP$ES-AEMPS-1553029$ES-FreseniusKabi-FK202412154$FRESENIUS KABI$$67$YR$E$F$Y$$$20240910$$MD$ES$ES
242009381$24200938$1$I$20240808$20240808$20240812$20240812$PER$$US-JNJFOC-20240827739$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
242009391$24200939$1$I$20240803$20240806$20240812$20240812$PER$$US-BAYER-2024A113815$BAYER$$$$$$Y$$$20240812$$CN$US$US
242009401$24200940$1$I$$20240729$20240812$20240812$PER$$US-COSETTE-CP2024US000196$COSETTE PHARMACEUTICALS$$48$YR$A$F$Y$$$20240812$$PH$US$US
242009411$24200941$1$I$$20240806$20240812$20240812$EXP$$CA-TEVA-VS-3231958$TEVA$$$$$M$Y$$$20240812$$HP$CA$CA
242009421$24200942$1$I$$20240729$20240812$20240812$PER$$US-TEVA-VS-3228916$TEVA$$35$YR$$F$Y$$$20240812$$CN$US$US
242009432$24200943$2$F$20231206$20240906$20240812$20240911$EXP$$US-TAKEDA-2023TUS124033$TAKEDA$$56$YR$$M$Y$$$20240911$$HP$US$US
242009441$24200944$1$I$20240515$20240731$20240812$20240812$PER$$US-MYLANLABS-2024M1072373$MYLAN$$48$YR$$$Y$113.4$KG$20240812$$CN$US$US
242009451$24200945$1$I$$20240802$20240812$20240812$EXP$$NVSC2024TR160653$NOVARTIS$Yorulmaz A, Bal Bayazitli EC, Orman U, Tamer E, Orhun HS.. Bir Kad?n Olguda Coklu ?lac Maruziyeti Sonras? Gelisen Siddetli Kutanoz  Erupsiyon: Stevens-Johnson Sendromu/Toksik Epidermal Nekroliz Benzeri  Lupus Eritematozusun Nadir Bir Prezentasyonu [Severe Cutaneous Eruption in a Woman after Ingesting Multiple Drugs: A Rare Presentation of Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis-Like Lupus Erythematosus]. TURKIYE KLINIKLERI JOURNAL OF DERMATOLOGY. 2024;34 (1):32-6$40$YR$$F$Y$$$20240812$$HP$TR$TR
242009461$24200946$1$I$$20240809$20240812$20240812$PER$$US-Karo Pharma-2160304$Karo Pharma$$$$$F$Y$$$20240812$$$US$US
242009471$24200947$1$I$20240808$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158105$AMGEN$$84$YR$E$$Y$$$20240812$$CN$US$US
242009481$24200948$1$I$20240626$20240808$20240812$20240812$EXP$FR-AFSSAPS-PO2024000866$FR-AMGEN-FRASP2024158537$AMGEN$$72$YR$E$F$Y$46.2$KG$20240812$$MD$FR$FR
242009493$24200949$3$F$20240724$20240815$20240812$20240823$PER$$US-ALXN-202408USA000484US$ALEXION PHARMACEUTICALS$$11$YR$$M$Y$$$20240824$$CN$US$US
242009511$24200951$1$I$$20240805$20240812$20240812$PER$$US-MYLANLABS-2024M1074127$MYLAN$$$$C$M$Y$$$20240812$$PH$US$US
242009531$24200953$1$I$$20240807$20240812$20240812$EXP$$CA-GSK-CA2024056294$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$CA$CA
242009541$24200954$1$I$20230601$20240808$20240812$20240812$EXP$$NVSC2024AT047512$NOVARTIS$$31$YR$$F$Y$$$20240812$$MD$AT$AT
242009551$24200955$1$I$$20240807$20240812$20240812$EXP$$US-JNJFOC-20240827461$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$CN$US$US
242009571$24200957$1$I$20240731$20240802$20240812$20240812$EXP$$TW-JNJFOC-20240805822$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240812$$CN$TW$TW
242009581$24200958$1$I$20240720$20240730$20240809$20240809$DIR$FDA-CDER-CTU-2024-54983$$FDA-CTU$$68$YR$$F$N$99.79$KG$20240730$N$CN$US$
242009591$24200959$1$I$20240705$20240805$20240812$20240812$EXP$$CN-SA-2024SA236766$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240812$$HP$CN$CN
242009611$24200961$1$I$20240730$20240810$20240810$20240810$DIR$713728$$FDA-CTU$$40$YR$$F$N$54$KG$20240810$Y$CN$US$
242009631$24200963$1$I$20240809$20240810$20240810$20240810$DIR$713779$$FDA-CTU$$52$YR$$F$N$72$KG$20240810$N$CN$US$
242009661$24200966$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236872$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$CN$US$US
242009671$24200967$1$I$20220901$20240801$20240812$20240812$PER$$US-SA-2024SA233604$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240812$$MD$US$US
242009681$24200968$1$I$$20240802$20240812$20240812$PER$$US-MYLANLABS-2024M1072654$MYLAN$$$$$F$Y$67.13$KG$20240812$$CN$US$US
242009693$24200969$3$F$20240801$20240816$20240812$20240823$PER$$US-PFIZER INC-202400233084$PFIZER$$$$$$Y$$$20240823$$CN$US$US
242009701$24200970$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400233779$PFIZER$$61$YR$$F$Y$$$20240812$$CN$US$US
242009711$24200971$1$I$20240701$20240729$20240812$20240812$PER$$US-COSETTE-CP2024US000197$COSETTE PHARMACEUTICALS$$73$YR$$M$Y$81.64$KG$20240812$$CN$US$US
242009721$24200972$1$I$$20240808$20240812$20240812$PER$$US-PFIZER INC-PV202400104137$PFIZER$$62$YR$$F$Y$$$20240812$$CN$US$US
242009731$24200973$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-PV202400104341$PFIZER$$54$YR$$F$Y$$$20240812$$HP$US$US
242009761$24200976$1$I$20240807$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233054$PFIZER$$69$YR$$F$Y$$$20240812$$CN$US$US
242009772$24200977$2$F$$20240816$20240812$20240820$PER$$US-PFIZER INC-PV202400104118$PFIZER$$$$$F$Y$$$20240820$$MD$US$US
242009781$24200978$1$I$$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233903$PFIZER$$75$YR$$F$Y$$$20240812$$CN$US$US
242009791$24200979$1$I$$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233798$PFIZER$$46$YR$$F$Y$$$20240812$$CN$US$US
242009801$24200980$1$I$$20240808$20240812$20240812$PER$$KR-PFIZER INC-202400232955$PFIZER$$$$$$Y$$$20240812$$PH$KR$KR
242009811$24200981$1$I$$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233899$PFIZER$$63$YR$$F$Y$$$20240812$$HP$US$US
242009821$24200982$1$I$20240807$20240808$20240812$20240812$PER$$US-PFIZER INC-202400233067$PFIZER$$51$YR$$F$Y$$$20240812$$CN$US$US
242009831$24200983$1$I$$20240808$20240812$20240812$PER$$US-PFIZER INC-PV202400103452$PFIZER$$$$$$Y$$$20240812$$CN$US$US
242009841$24200984$1$I$$20240805$20240812$20240812$EXP$$RU-FreseniusKabi-FK202412287$FRESENIUS KABI$Guzovskiy E, Belikov V, Fetisov V, Lebedinskii K. Anaesthesiological risk assessment and anesthesia-related medical errors: analysis of commission forensic examinations. Russian Journal of Anesthesiology and Reanimatology. 2024;(3): 6-11. doi:https://doi.org/10.17116/anaesthesiology20240316.$19$YR$A$M$Y$$$20240812$$HP$RU$RU
242009851$24200985$1$I$20240718$20240805$20240812$20240812$EXP$PT-INFARMED-E202407-586$PT-FreseniusKabi-FK202412183$FRESENIUS KABI$$75$YR$E$F$Y$$$20240812$$PH$PT$PT
242009861$24200986$1$I$$20240806$20240812$20240812$EXP$$CA-TAKEDA-2024TUS079184$TAKEDA$$$$$F$Y$$$20240812$$CN$CA$CA
242009871$24200987$1$I$$20240807$20240812$20240812$PER$$US-ABBVIE-5875503$ABBVIE$$40$YR$$F$Y$$$20240812$$HP$US$US
242009881$24200988$1$I$20240701$20240805$20240812$20240812$EXP$DE-CADRBFARM-2024329606$DE-MYLANLABS-2024M1073099$MYLAN$$83$YR$$M$Y$60$KG$20240812$$MD$DE$DE
242009892$24200989$2$F$20140101$20240816$20240812$20240822$EXP$$FR-MYLANLABS-2024M1073096$MYLAN$$$$E$F$Y$$$20240822$$CN$FR$FR
242009901$24200990$1$I$$20240805$20240812$20240812$EXP$$DE-MYLANLABS-2024M1073115$MYLAN$$$$$F$Y$$$20240812$$CN$DE$DE
242009911$24200991$1$I$$20240805$20240812$20240812$EXP$$IT-MYLANLABS-2024M1073237$MYLAN$$$$$F$Y$$$20240812$$MD$IT$IT
242009921$24200992$1$I$$20240805$20240812$20240812$EXP$$PT-MYLANLABS-2024M1073255$MYLAN$Ribeiro M, Damaso F, Oliveira J, Medeiros I, Eliseu A, Duarte J... POSA-073 - (2757) - unexpected iatrogenies. Other | Clinical case. 1145$74$YR$$M$Y$$$20240812$$HP$PT$PT
242009931$24200993$1$I$$20240805$20240812$20240812$EXP$$GR-MYLANLABS-2024M1073061$MYLAN$Pastras, P. A remarkable clinical case of metastasis in rectal adenocarcinoma. 50th annual panhellenic medical congress. 2024;238$44$YR$$F$Y$$$20240812$$MD$GR$GR
242009941$24200994$1$I$$20240804$20240812$20240812$PER$$US-MYLANLABS-2024M1073288$MYLAN$$$$$$Y$$$20240812$$CN$US$US
242009951$24200995$1$I$20240701$20240805$20240812$20240812$EXP$FR-AFSSAPS-PP2024000827$FR-MYLANLABS-2024M1073229$MYLAN$$75$YR$$M$Y$$$20240812$$PH$FR$FR
242009961$24200996$1$I$$20240805$20240812$20240812$EXP$$DE-MYLANLABS-2024M1073085$MYLAN$$25$YR$$M$Y$$$20240812$$CN$DE$DE
242009981$24200998$1$I$$20240805$20240812$20240812$EXP$$DE-MYLANLABS-2024M1073107$MYLAN$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$28$YR$$M$Y$$$20240812$$HP$DE$DE
242009992$24200999$2$F$$20240814$20240812$20240820$PER$$US-JNJFOC-20240801115$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
242010001$24201000$1$I$$20240805$20240812$20240812$EXP$$US-MYLANLABS-2024M1074228$MYLAN$Hernandez K, Ahmed T, Liu D, Seiter K, Steinberg A. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. Blood 2023; 142 (Suppl. 1) 7349-7350.$28$YR$$M$Y$$$20240812$$HP$US$US
242010012$24201001$2$F$$20240820$20240812$20240822$EXP$$CN-ROCHE-10000054500$ROCHE$$58$YR$A$F$Y$$$20240822$$MD$CN$CN
242010021$24201002$1$I$20240601$20240805$20240812$20240812$EXP$FR-AFSSAPS-NT2024000953$FR-MYLANLABS-2024M1073272$MYLAN$$$$A$M$Y$$$20240812$$MD$FR$FR
242010031$24201003$1$I$$20240806$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125897$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240812$$MD$US$US
242010041$24201004$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125535$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240812$$HP$US$US
242010051$24201005$1$I$20240801$20240804$20240812$20240812$PER$$US-AMGEN-USASP2024155265$AMGEN$$75$YR$E$F$Y$$$20240812$$HP$US$US
242010061$24201006$1$I$20240101$20240802$20240812$20240812$PER$$US-BIOGEN-2024BI01276800$BIOGEN$$$$$F$Y$$$20240812$$MD$US$US
242010071$24201007$1$I$$20240805$20240812$20240812$EXP$$AU-GSK-AU2023159646$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$AU$AU
242010081$24201008$1$I$20240804$20240805$20240812$20240812$PER$$US-ABBVIE-5867603$ABBVIE$$75$YR$$F$Y$45$KG$20240812$$CN$US$US
242010091$24201009$1$I$$20240808$20240812$20240812$PER$$US-ROCHE-10000053583$ROCHE$$53$YR$A$M$Y$$$20240812$$HP$US$US
242010101$24201010$1$I$20240805$20240808$20240812$20240812$EXP$$PR-BAYER-2024A115435$BAYER$$68$YR$E$M$Y$$$20240812$$CN$PR$PR
242010111$24201011$1$I$20210618$20240729$20240812$20240812$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202407019086$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240812$$CN$KR$KR
242010121$24201012$1$I$$20240731$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000896$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240812$$CN$US$US
242010131$24201013$1$I$$20240807$20240812$20240812$PER$$US-ABBVIE-5876058$ABBVIE$$$$$$Y$$$20240812$$CN$US$US
242010141$24201014$1$I$20240601$20240731$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000553$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240812$$CN$US$US
242010151$24201015$1$I$$20240806$20240812$20240812$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202408004167$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240812$$CN$KR$KR
242010161$24201016$1$I$20240705$20240729$20240812$20240812$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407019120$ELI LILLY AND CO$$55$YR$A$M$Y$72.5$KG$20240812$$CN$CN$CN
242010171$24201017$1$I$$20240731$20240812$20240812$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408000621$ELI LILLY AND CO$$$$$F$Y$$$20240812$$MD$FR$FR
242010181$24201018$1$I$20240804$20240806$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004094$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240812$$HP$US$US
242010191$24201019$1$I$20230501$20240801$20240812$20240812$EXP$$VN-ELI_LILLY_AND_COMPANY-VN202408004879$ELI LILLY AND CO$$$$$M$Y$$$20240812$$PH$VN$VN
242010201$24201020$1$I$20240719$20240731$20240812$20240812$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408003656$ELI LILLY AND CO$$59$YR$A$M$Y$60$KG$20240812$$CN$DE$CN
242010211$24201021$1$I$20240731$20240731$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000157$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
242010221$24201022$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006545$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240812$$CN$US$US
242010231$24201023$1$I$20240709$20240730$20240812$20240812$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407020052$ELI LILLY AND CO$$38$YR$A$F$Y$62$KG$20240812$$CN$CN$CN
242010241$24201024$1$I$20240723$20240731$20240812$20240812$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408000938$ELI LILLY AND CO$$27$YR$A$F$Y$44$KG$20240812$$CN$CN$CN
242010251$24201025$1$I$$20240802$20240812$20240812$EXP$$US-TEVA-VS-3230589$TEVA$$$$E$F$Y$$$20240812$$MD$US$US
242010274$24201027$4$F$$20240906$20240812$20240919$EXP$$PT-COSETTE-CP2024PT000201$COSETTE PHARMACEUTICALS$$30$YR$A$M$Y$$$20240919$$MD$PT$PT
242010281$24201028$1$I$$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159038$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
242010291$24201029$1$I$$20240807$20240812$20240812$EXP$$PT-JNJFOC-20240828186$JOHNSON AND JOHNSON$Capitao M,Almeida M, Ferreira B, Trindade M, Carmo M. A STRANGE CASE OF INTERMITTENT COMA IN THE ELDERLY. PORTUGUESE JOURNAL OF FAMILY MEDICINE AND GENERAL PRACTICE. 2024;40;Supple 13:S21$77$YR$E$F$Y$$$20240812$$HP$PT$PT
242010301$24201030$1$I$$20240731$20240812$20240812$PER$$US-JNJFOC-20240827457$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$CN$US$US
242010311$24201031$1$I$20240801$20240809$20240812$20240812$EXP$$US-JNJFOC-20240827459$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240812$$HP$US$US
242010321$24201032$1$I$20240101$20240801$20240812$20240812$PER$$US-SA-2024SA233785$SANOFI AVENTIS$$63$YR$A$M$Y$104.3$KG$20240812$$MD$US$US
242010331$24201033$1$I$20240802$20240805$20240812$20240812$PER$$US-BIOGEN-2024BI01276966$BIOGEN$$5$YR$$F$Y$$$20240812$$HP$US$US
242010341$24201034$1$I$20050101$20240727$20240809$20240809$DIR$FDA-CDER-CTU-2024-54975$$FDA-CTU$$68$YR$$M$N$76.2$KG$20240727$N$CN$US$
242010362$24201036$2$F$$20240814$20240812$20240819$30DAY$$US-PFIZER INC-PV202400044527$PFIZER$$$$$$Y$$$20240819$$HP$US$US
242010371$24201037$1$I$$20240724$20240812$20240812$30DAY$$CL-PFIZER INC-202400224605$PFIZER$$$$$$Y$$$20240812$$CN$CL$CL
242010401$24201040$1$I$20240806$20240808$20240812$20240812$EXP$$CN-BAYER-2024A114389$BAYER$$65$YR$E$F$Y$$$20240812$$CN$CN$CN
242010411$24201041$1$I$$20240806$20240812$20240812$EXP$$NL-CIVICARX-2024-NL-000032$CIVICA$Herijgers A, Van Dyck L, Le Roy I, Dobbels L, Van De Putte P..Bupivacaine pleural effusion mimicking a hemothorax after a thoracoscopic microdiscetomy with epidural anesthesia.Acta Neurochirurgica.2024;166(284):.$42$YR$$F$Y$$$20240812$$HP$NL$NL
242010421$24201042$1$I$20240701$20240703$20240812$20240812$PER$$US-TRAVERE-2024TVT00675$TRAVERE THERAPEUTICS$$26$YR$A$M$Y$$$20240812$$CN$US$US
242010432$24201043$2$F$20240626$20240717$20240812$20240815$PER$$US-TRAVERE-2024TVT00674$TRAVERE THERAPEUTICS$$76$YR$E$F$Y$$$20240815$$CN$US$US
242010441$24201044$1$I$20240701$20240805$20240812$20240812$PER$$US-MYLANLABS-2024M1073404$MYLAN$$47$YR$$F$Y$74.83$KG$20240812$$CN$US$US
242010451$24201045$1$I$20240728$20240805$20240812$20240812$EXP$MT-ADM-08072024$MT-GSK-MT2024097734$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$MD$MT$MT
242010462$24201046$2$F$20240806$20240820$20240812$20240827$EXP$$US-OTSUKA-2024_021804$OTSUKA$$$$$M$Y$$$20240827$$PH$US$US
242010471$24201047$1$I$20240220$20240731$20240812$20240812$EXP$GB-MHRA-MED-202407301404319610-BGTPS$GB-THEA-2024001675$Thea Pharma$$77$YR$$F$Y$70$KG$20240812$$CN$GB$GB
242010481$24201048$1$I$$20240805$20240812$20240812$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125012$BRISTOL MYERS SQUIBB$Oyake T, Maeta T, Takahata T, Tamai Y, Kameoka Y, Takahashi N, et al. Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory hodgkin^s lymphoma. Journal of Clinical and Experimental Hematopathology. 2024 Jul 31;1-12. doi:10.3960/jslrt.24021.$63$YR$A$M$Y$$$20240812$$MD$JP$JP
242010491$24201049$1$I$$20240801$20240812$20240812$PER$$US-SA-2024SA232196$SANOFI AVENTIS$$$$$$Y$$$20240812$$CN$US$US
242010501$24201050$1$I$20240725$20240805$20240812$20240812$EXP$$CN-SA-2024SA236396$SANOFI AVENTIS$$47$YR$A$M$Y$72$KG$20240812$$HP$CN$CN
242010512$24201051$2$F$$20240827$20240812$20240902$EXP$$US-AMGEN-USASP2024158485$AMGEN$$$$A$F$Y$$$20240902$$HP$US$US
242010521$24201052$1$I$20230101$20240802$20240812$20240812$EXP$FR-AFSSAPS-NT2024000937$FR-TEVA-VS-3229779$TEVA$$74$YR$$M$Y$$$20240812$$MD$FR$FR
242010531$24201053$1$I$$20230106$20240812$20240812$EXP$$US-AstraZeneca-2023A005058$ASTRAZENECA$$$$$$Y$$$20240812$$CN$US$
242010541$24201054$1$I$$20240802$20240812$20240812$PER$$US-AstraZeneca-2024A176196$ASTRAZENECA$$$$$$Y$$$20240812$$MD$US$
242010551$24201055$1$I$$20230228$20240812$20240812$EXP$$US-AstraZeneca-2023A050139$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242010571$24201057$1$I$20240411$20240802$20240812$20240812$EXP$FR-AFSSAPS-MP2024001204$FR-TEVA-VS-3230609$TEVA$$56$YR$$F$Y$$$20240812$$PH$FR$FR
242010582$24201058$2$F$$20240820$20240812$20240826$EXP$$FR-Karo Pharma-2160305$Karo Pharma$$64$YR$$F$Y$$$20240826$$MD$FR$FR
242010591$24201059$1$I$$20240811$20240812$20240812$PER$$NVSC2024US163442$NOVARTIS$$$$$$Y$$$20240812$$HP$US$US
242010601$24201060$1$I$$20240808$20240812$20240812$EXP$$US-PURDUE-USA-2024-0311249$PURDUE$$29$YR$$M$Y$$$20240812$$CN$US$US
242010611$24201061$1$I$$20240806$20240812$20240812$EXP$$US-PURDUE-USA-2024-0311250$PURDUE$Nicolet N, Bhagia A, Torve M, Tribby K, Poppinga N, McKay K, Talavera-Barber MM.. The Epidemic of Congenital Syphilis in the Indigenous and Rural Populations of South Dakota. Pediatrics. 2024;154(1):e2023063823$$$N$$Y$$$20240812$$HP$US$US
242010621$24201062$1$I$20240801$20240803$20240812$20240812$EXP$$BR-PURDUE-USA-2024-0311279$PURDUE$$44$YR$$F$Y$78$KG$20240812$$CN$BR$BR
242010632$24201063$2$F$$20240809$20240812$20240814$EXP$$US-PURDUE PHARMA-USA-2024-0311280$PURDUE$$57$YR$$F$Y$$$20240814$$CN$US$US
242010641$24201064$1$I$20240730$20240802$20240812$20240812$EXP$$CN-PURDUE-USA-2024-0311254$PURDUE$$58$YR$$F$Y$55$KG$20240812$$HP$CN$CN
242010651$24201065$1$I$20100319$20240809$20240812$20240812$EXP$$US-PURDUE PHARMA-USA-2024-0311278$PURDUE$$48$YR$$F$Y$75.4$KG$20240812$$MD$US$US
242010662$24201066$2$F$$20240806$20240812$20240813$EXP$$US-PURDUE-USA-2024-0311252$PURDUE$Nicolet N., Bhagia A., Torve M., Tribby K., Poppinga N., McKay K., Talavera-Barber M.M.. The Epidemic of Congenital Syphilis in the Indigenous and Rural Populations of South Dakota. Pediatrics. 2024;154(1):e2023063823$$$N$$Y$1.97$KG$20240813$$HP$US$US
242010671$24201067$1$I$20240625$20240808$20240812$20240812$EXP$FR-AFSSAPS-NT2024000968$FR-ROCHE-10000053361$ROCHE$$83$YR$E$F$Y$$$20240812$$MD$FR$FR
242010682$24201068$2$F$20240101$20240812$20240812$20240813$EXP$$US-JNJFOC-20240827468$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240813$$HP$US$US
242010691$24201069$1$I$$20240807$20240812$20240812$EXP$$BR-TAKEDA-2024TUS080220$TAKEDA$$38$YR$$$Y$$$20240812$$CN$BR$BR
242010701$24201070$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235575$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$CN$US$US
242010712$24201071$2$F$$20240812$20240812$20240813$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127112$BRISTOL MYERS SQUIBB$Sueoka S, et al. A case of successful SOX + nivolumab therapy for recurrent peritoneal dissemination from primary gastric adenocarcinoma with enteroblastic differentiation. Gastric Cancer. 2024;96:406.$72$YR$E$M$Y$$$20240814$$MD$JP$JP
242010721$24201072$1$I$20220101$20240802$20240812$20240812$PER$$US-SA-2024SA233944$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240812$$MD$US$US
242010731$24201073$1$I$$20240809$20240812$20240812$PER$$US-ABBVIE-5876732$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242010741$24201074$1$I$$20240808$20240812$20240812$EXP$$US-OTSUKA-2024_022023$OTSUKA$$$$$F$Y$$$20240812$$CN$US$US
242010752$24201075$2$F$$20240809$20240812$20240819$PER$$US-ABBVIE-5875629$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242010761$24201076$1$I$$20240807$20240812$20240812$PER$$US-MYLANLABS-2024M1074117$MYLAN$$$$$F$Y$$$20240812$$CN$US$US
242010772$24201077$2$F$$20240904$20240812$20240911$EXP$$NVSC2024AR162737$NOVARTIS$$34$YR$$F$Y$$$20240911$$MD$AR$AR
242010781$24201078$1$I$20240510$20240806$20240812$20240812$EXP$FR-AFSSAPS-NT2024000965$FR-MYLANLABS-2024M1073228$MYLAN$$53$YR$$M$Y$$$20240812$$PH$FR$FR
242010791$24201079$1$I$$20231006$20240812$20240812$EXP$$US-AstraZeneca-2023A193055$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242010801$24201080$1$I$$20230123$20240812$20240812$EXP$$GB-AstraZeneca-2023A019828$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$GB$
242010811$24201081$1$I$20240101$20240807$20240812$20240812$EXP$$US-JNJFOC-20240819224$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240812$$CN$US$US
242010823$24201082$3$F$$20240809$20240812$20240819$30DAY$$CA-JNJFOC-20240772915$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$HP$CA$CA
242010831$24201083$1$I$$20221011$20240812$20240812$EXP$$TW-AstraZeneca-2022A345357$ASTRAZENECA$$59$YR$$M$Y$$$20240812$$HP$TW$
242010841$24201084$1$I$$20240809$20240812$20240812$PER$$US-JNJFOC-20240824686$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$HP$US$US
242010851$24201085$1$I$$20240705$20240812$20240812$PER$$US-TRAVERE-2024TVT00678$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240812$$CN$US$US
242010863$24201086$3$F$20240101$20240919$20240812$20240920$EXP$$US-JNJFOC-20240827469$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240920$$HP$US$US
242010891$24201089$1$I$$20240731$20240809$20240809$DIR$FDA-CDER-CTU-2024-54976$$FDA-CTU$$71$YR$$F$N$74.84$KG$20240731$N$CN$US$
242010921$24201092$1$I$$20240703$20240809$20240809$DIR$FDA-CDER-CTU-2024-54990$$FDA-CTU$$$$$F$N$77.11$KG$20240703$N$CN$US$
242010931$24201093$1$I$$20240807$20240812$20240812$EXP$$RS-ROCHE-10000053703$ROCHE$$$$$$Y$$$20240812$$MD$RS$RS
242010941$24201094$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236862$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240812$$MD$US$US
242010951$24201095$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA237052$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240812$$CN$US$US
242010961$24201096$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127178$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240812$$CN$US$US
242010972$24201097$2$F$20220401$20240919$20240812$20240926$EXP$$US-ABBVIE-2232420US$ABBVIE$$68$YR$$F$Y$$$20240926$$CN$US$US
242010981$24201098$1$I$$20240806$20240812$20240812$PER$$US-LEO Pharma-372621$LEO PHARM$$81$YR$$F$Y$$$20240812$$CN$US$US
242010991$24201099$1$I$$20240807$20240812$20240812$PER$$US-BIOGEN-2024BI01277426$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
242011002$24201100$2$F$$20240905$20240812$20240909$PER$$US-BIOGEN-2024BI01277448$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
242011011$24201101$1$I$$20240806$20240812$20240812$PER$$US-BIOGEN-2024BI01276642$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
242011021$24201102$1$I$20240712$20240807$20240812$20240812$EXP$$NVSC2024CN162427$NOVARTIS$$38$YR$$F$Y$60$KG$20240812$$HP$CN$CN
242011031$24201103$1$I$20240501$20240802$20240812$20240812$EXP$FR-AFSSAPS-PV2024000687$FR-TEVA-VS-3229992$TEVA$$43$YR$$F$Y$93$KG$20240812$$MD$FR$FR
242011042$24201104$2$F$$20240904$20240812$20240910$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR097202$VIIV$$$$$$Y$$$20240910$$MD$US$US
242011051$24201105$1$I$$20240726$20240812$20240812$PER$$US-INSUD PHARMA-2407US06091$INSUD PHARMA$$$$$$Y$$$20240812$$CN$US$US
242011061$24201106$1$I$$20240727$20240812$20240812$PER$$US-INSUD PHARMA-2407US06023$INSUD PHARMA$$$$$$Y$$$20240812$$CN$US$US
242011071$24201107$1$I$20240701$20240726$20240812$20240812$PER$$US-INSUD PHARMA-2407US06024$INSUD PHARMA$$$$$$Y$$$20240812$$CN$US$US
242011081$24201108$1$I$$20240717$20240812$20240812$PER$$US-MYLANLABS-2024M1067344$MYLAN$$$$$F$Y$$$20240812$$CN$US$US
242011091$24201109$1$I$$20240806$20240812$20240812$PER$$NVSC2024US162849$NOVARTIS$$$$$F$Y$$$20240812$$MD$US$US
242011111$24201111$1$I$$20240805$20240812$20240812$EXP$$JP-ROCHE-10000053390$ROCHE$Masuda Y, Honda A, Yasunaga Y, Kurokawa M. 42 A case of intestinal perforation which occurred after administration of tisagenlecleucel for recurrent/refractory follicular lymphoma. The 21st Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology. 2024;38$81$YR$E$F$Y$$$20240812$$MD$JP$JP
242011121$24201112$1$I$$20240807$20240812$20240812$PER$$US-BIOGEN-2024BI01277492$BIOGEN$$$$$M$Y$$$20240812$$CN$US$US
242011131$24201113$1$I$$20240807$20240812$20240812$PER$$US-BIOGEN-2024BI01252125$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
242011141$24201114$1$I$$20240807$20240812$20240812$PER$$US-BIOGEN-2024BI01277379$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
242011151$24201115$1$I$20230101$20240807$20240812$20240812$EXP$$US-ABBVIE-5872920$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242011161$24201116$1$I$$20240718$20240812$20240812$PER$$US-MYLANLABS-2024M1067539$MYLAN$$$$$F$Y$$$20240812$$CN$US$US
242011171$24201117$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A180181$ASTRAZENECA$$$$$$Y$$$20240812$$CN$US$
242011181$24201118$1$I$$20240808$20240812$20240812$PER$$US-AstraZeneca-2024A181768$ASTRAZENECA$$50$YR$$F$Y$82.1$KG$20240812$$MD$US$
242011191$24201119$1$I$20220401$20240807$20240812$20240812$EXP$$US-OTSUKA-2024_021961$OTSUKA$$56$YR$$F$Y$$$20240812$$MD$US$US
242011202$24201120$2$F$20210701$20240812$20240812$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR097460$VIIV$$43$YR$$M$Y$$$20240816$$CN$US$US
242011211$24201121$1$I$20240716$20240802$20240812$20240812$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR097708$VIIV$$30$YR$$M$Y$$$20240812$$CN$US$US
242011221$24201122$1$I$$20240708$20240812$20240812$PER$$US-TRAVERE-2024TVT00682$TRAVERE THERAPEUTICS$$30$YR$A$F$Y$$$20240812$$CN$US$US
242011231$24201123$1$I$$20240708$20240812$20240812$PER$$US-TRAVERE-2024TVT00684$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240812$$CN$US$US
242011243$24201124$3$F$$20240903$20240812$20240930$PER$$US-TRAVERE-2024TVT00686$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
242011251$24201125$1$I$$20240708$20240812$20240812$PER$$US-TRAVERE-2024TVT00683$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240812$$CN$US$US
242011262$24201126$2$F$$20240715$20240812$20240815$PER$$US-TRAVERE-2024TVT00685$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$CN$US$US
242011271$24201127$1$I$$20240708$20240812$20240812$PER$$US-TRAVERE-2024TVT00691$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240812$$CN$US$US
242011281$24201128$1$I$$20240708$20240812$20240812$PER$$US-TRAVERE-2024TVT00688$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240812$$CN$US$US
242011293$24201129$3$F$$20240821$20240812$20240826$30DAY$$US-AMGEN-USASL2024156355$AMGEN$$$$$$Y$$$20240826$$CN$US$US
242011302$24201130$2$F$$20240812$20240812$20240815$PER$$US-ROCHE-10000054514$ROCHE$$$$E$M$Y$$$20240815$$HP$US$US
242011311$24201131$1$I$20240805$20240805$20240812$20240812$PER$$US-RDY-SPO/USA/24/0011592$DR REDDYS$$88$YR$E$$Y$$$20240812$$HP$US$US
242011321$24201132$1$I$20240701$20240805$20240812$20240812$PER$$US-RDY-SPO/USA/24/0011587$DR REDDYS$$20$YR$A$F$Y$$$20240812$$CN$US$US
242011331$24201133$1$I$$20240806$20240812$20240812$PER$$US-RDY-SPO/USA/24/0011584$DR REDDYS$$65$YR$E$M$Y$$$20240812$$HP$US$US
242011341$24201134$1$I$$20240725$20240812$20240812$PER$$US-MYLANLABS-2024M1070853$MYLAN$$82$YR$$F$Y$$$20240812$$MD$US$US
242011351$24201135$1$I$20170101$20240812$20240812$20240812$EXP$IT-EMA-DD-20240807-7482655-081841$IT-SANDOZ INC.-SDZ2024IT071926$SANDOZ$$26$YR$$F$Y$$$20240812$$MD$IT$IT
242011361$24201136$1$I$$20240808$20240812$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US043663$SANDOZ$$$$$F$Y$$$20240812$$CN$US$US
242011371$24201137$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191477$Haleon PLC$$73$YR$$M$Y$$$20240812$$CN$US$US
242011381$24201138$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127237$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$49.9$KG$20240812$$HP$US$US
242011391$24201139$1$I$20090101$20240805$20240812$20240812$EXP$HR-PFIZER INC-PV202400088450$HR-ROCHE-10000048864$ROCHE$Skugor N,  Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma. Collegium Antropologicum. 2010;34 (1):241-5.$36$YR$A$F$Y$$$20240812$$HP$HR$HR
242011401$24201140$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126886$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240812$$MD$US$US
242011431$24201143$1$I$$20240807$20240812$20240812$EXP$$NVSC2024MX162750$NOVARTIS$$$$$F$Y$$$20240812$$CN$MX$MX
242011441$24201144$1$I$$20240807$20240812$20240812$PER$$US-BIOGEN-2023BI01213898$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
242011452$24201145$2$F$20240701$20240828$20240812$20240828$PER$$US-ALXN-202408USA000453US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242011461$24201146$1$I$20240712$20240808$20240812$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US071527$SANDOZ$$49$YR$$F$Y$$$20240812$$HP$US$US
242011471$24201147$1$I$20240624$20240806$20240812$20240812$PER$$US-Vifor (International) Inc.-VIT-2024-07053$VIFOR$$27$YR$$M$Y$74$KG$20240812$$HP$US$US
242011481$24201148$1$I$$20240806$20240812$20240812$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07019$VIFOR$$$$A$M$Y$$$20240812$$CN$ZA$ZA
242011491$24201149$1$I$20200502$20240806$20240812$20240812$EXP$PL-URPL-1-1643-2020$PL-MYLANLABS-2024M1073448$MYLAN$$18$YR$$F$Y$$$20240812$$MD$PL$PL
242011501$24201150$1$I$20240806$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234119$PFIZER$$28$YR$$F$Y$$$20240812$$CN$US$US
242011512$24201151$2$F$20240808$20240829$20240812$20240904$PER$$US-PFIZER INC-202400234054$PFIZER$$56$YR$$M$Y$86.18$KG$20240904$$CN$US$US
242011521$24201152$1$I$20240701$20240807$20240812$20240812$PER$$US-PFIZER INC-PV202400103508$PFIZER$$63$YR$$M$Y$$$20240812$$HP$US$US
242011531$24201153$1$I$20240701$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234498$PFIZER$$25$YR$$F$Y$$$20240812$$MD$US$US
242011541$24201154$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234337$PFIZER$$82$YR$$F$Y$$$20240812$$CN$US$US
242011551$24201155$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400233835$PFIZER$$78$YR$$F$Y$$$20240812$$CN$US$US
242011562$24201156$2$F$$20240912$20240812$20240912$PER$$US-PFIZER INC-PV202400104374$PFIZER$$45$YR$$$Y$$$20240912$$CN$US$US
242011572$24201157$2$F$20210625$20240812$20240812$20240814$PER$$US-PFIZER INC-202400233799$PFIZER$$78$YR$$F$Y$$$20240814$$CN$US$US
242011582$24201158$2$F$$20240814$20240812$20240819$PER$$US-PFIZER INC-202400233539$PFIZER$$36$YR$$F$Y$$$20240819$$HP$US$US
242011591$24201159$1$I$20240809$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234090$PFIZER$$$$$$Y$$$20240812$$CN$US$US
242011601$24201160$1$I$$20240807$20240812$20240812$PER$$JP-PFIZER INC-202400231530$PFIZER$$$$$$Y$$$20240812$$PH$JP$JP
242011611$24201161$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234005$PFIZER$$30$YR$$M$Y$$$20240812$$CN$US$US
242011623$24201162$3$F$20240808$20240819$20240812$20240821$PER$$KR-PFIZER INC-202400233295$PFIZER$$$$$M$Y$$$20240821$$CN$KR$KR
242011631$24201163$1$I$20240810$20240811$20240812$20240812$PER$$US-PFIZER INC-202400234513$PFIZER$$56$YR$$F$Y$$$20240812$$HP$US$US
242011641$24201164$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234105$PFIZER$$$$$$Y$$$20240812$$CN$US$US
242011651$24201165$1$I$20240101$20240809$20240812$20240812$PER$$PR-PFIZER INC-202400234151$PFIZER$$76$YR$$F$Y$$$20240812$$HP$PR$PR
242011661$24201166$1$I$20240809$20240810$20240812$20240812$PER$$US-PFIZER INC-202400234526$PFIZER$$72$YR$$M$Y$$$20240812$$CN$US$US
242011671$24201167$1$I$$20240811$20240812$20240812$PER$$US-PFIZER INC-PV202300107987$PFIZER$$82$YR$$F$Y$$$20240812$$HP$US$US
242011681$24201168$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400099308$PFIZER$$75$YR$$F$Y$$$20240812$$HP$US$US
242011691$24201169$1$I$20240808$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234084$PFIZER$$33$YR$$M$Y$$$20240812$$CN$US$US
242011702$24201170$2$F$20240701$20240809$20240812$20240813$PER$$US-PFIZER INC-202400234503$PFIZER$$42$YR$$M$Y$$$20240813$$MD$US$US
242011711$24201171$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400232180$PFIZER$$$$$F$Y$$$20240812$$CN$US$US
242011721$24201172$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234010$PFIZER$$$$$F$Y$$$20240812$$CN$US$US
242011742$24201174$2$F$$20240813$20240812$20240814$PER$$US-PFIZER INC-202400233011$PFIZER$$83$YR$$F$Y$$$20240814$$CN$US$US
242011751$24201175$1$I$20240807$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234115$PFIZER$$66$YR$$F$Y$$$20240812$$CN$US$US
242011761$24201176$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400232525$PFIZER$$49$YR$$M$Y$80.74$KG$20240812$$CN$US$US
242011771$24201177$1$I$20240808$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234099$PFIZER$$27$YR$$M$Y$$$20240812$$CN$US$US
242011781$24201178$1$I$20240101$20240806$20240812$20240812$EXP$$US-VIIV HEALTHCARE LIMITED-US2024098164$VIIV$$$$$$Y$$$20240812$$HP$US$US
242011802$24201180$2$F$$20240913$20240812$20240926$PER$$US-JNJFOC-20240821226$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
242011811$24201181$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA234561$SANOFI AVENTIS$$$$$$Y$$$20240812$$MD$US$US
242011821$24201182$1$I$20240731$20240808$20240812$20240812$EXP$$GB-MYLANLABS-2024M1074258$MYLAN$$34$YR$$F$Y$$$20240812$$MD$GB$GB
242011833$24201183$3$F$$20240813$20240812$20240816$EXP$$US-PFIZER INC-PV202400104170$PFIZER$$78$YR$$F$Y$$$20240816$$HP$US$US
242011841$24201184$1$I$20240101$20240808$20240812$20240812$EXP$$US-PFIZER INC-PV202400084555$PFIZER$$65$YR$$M$Y$$$20240812$$HP$US$US
242011851$24201185$1$I$$20240807$20240812$20240812$EXP$$DE-PFIZER INC-202400232076$PFIZER$Satirer, O.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD Open. 2024;10(3):e004381$1$YR$$M$Y$$$20240812$$MD$DE$DE
242011873$24201187$3$F$20240805$20240917$20240812$20240919$PER$$US-AMGEN-USASP2024159110$AMGEN$$65$YR$E$F$Y$$$20240919$$CN$US$US
242011883$24201188$3$F$20240717$20240918$20240812$20240924$30DAY$$US-AMGEN-USASP2024154838$AMGEN$$75$YR$E$F$Y$$$20240924$$HP$US$US
242011891$24201189$1$I$$20240726$20240812$20240812$PER$$US-TEVA-VS-3226602$TEVA$$58$YR$$F$Y$$$20240812$$HP$US$US
242011902$24201190$2$F$20240516$20240919$20240812$20240923$EXP$$NVSC2024BE161859$NOVARTIS$$$$$M$Y$$$20240923$$MD$BE$BE
242011912$24201191$2$F$20240805$20240910$20240812$20240911$PER$$US-JNJFOC-20240821396$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240911$$CN$US$US
242011921$24201192$1$I$$20240727$20240812$20240812$PER$$US-JNJFOC-20240778938$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$US$US
242011931$24201193$1$I$20240701$20240805$20240812$20240812$EXP$FR-AFSSAPS-GR2024000930$FR-ROCHE-10000048662$ROCHE$$74$YR$E$F$Y$$$20240812$$PH$FR$FR
242011941$24201194$1$I$$20240709$20240812$20240812$PER$$US-TRAVERE-2024TVT00696$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240812$$CN$US$US
242011951$24201195$1$I$20240710$20240731$20240812$20240812$EXP$CN-GUERBET / FUNDTRIP PHARMACEUTICALS-CN-20240206$CN-GUERBET / LLC-CN-20240206$GUERBET$$73$YR$E$M$Y$$$20240812$$HP$CN$CN
242011961$24201196$1$I$$20240710$20240812$20240812$PER$$US-TRAVERE-2024TVT00701$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240812$$CN$US$US
242011972$24201197$2$F$20240701$20240715$20240812$20240815$PER$$US-TRAVERE-2024TVT00695$TRAVERE THERAPEUTICS$$47$YR$A$F$Y$$$20240815$$CN$US$US
242011981$24201198$1$I$$20240709$20240812$20240812$PER$$US-TRAVERE-2024TVT00700$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240812$$HP$US$US
242011991$24201199$1$I$$20240710$20240812$20240812$PER$$US-TRAVERE-2024TVT00699$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240812$$CN$US$US
242012001$24201200$1$I$$20240711$20240812$20240812$PER$$US-TRAVERE-2024TVT00702$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240812$$CN$US$US
242012013$24201201$3$F$$20240808$20240812$20240822$PER$$US-TRAVERE-2024TVT00694$TRAVERE THERAPEUTICS$$32$YR$A$F$Y$$$20240822$$CN$US$US
242012024$24201202$4$F$$20240828$20240812$20240918$PER$$US-TRAVERE-2024TVT00698$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240918$$CN$US$US
242012031$24201203$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158745$AMGEN$$64$YR$A$F$Y$$$20240812$$HP$US$US
242012041$24201204$1$I$$20240711$20240812$20240812$PER$$US-TRAVERE-2024TVT00703$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240812$$CN$US$US
242012051$24201205$1$I$$20240805$20240812$20240812$PER$$US-AMGEN-USASP2024155894$AMGEN$$$$A$F$Y$$$20240812$$HP$US$US
242012063$24201206$3$F$20240806$20240821$20240812$20240823$PER$$US-AMGEN-USASP2024157989$AMGEN$$60$YR$A$M$Y$$$20240823$$CN$US$US
242012071$24201207$1$I$20240201$20240805$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123813$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$81.19$KG$20240812$$MD$US$US
242012082$24201208$2$F$20230101$20240904$20240812$20240912$EXP$$BR-TEVA-VS-3230262$TEVA$$47$YR$$F$Y$$$20240912$$CN$BR$BR
242012091$24201209$1$I$20230719$20240802$20240812$20240812$EXP$$US-BAXTER-2024BAX022619$BAXTER$$76$YR$$F$Y$98.4$KG$20240812$$HP$US$US
242012101$24201210$1$I$$20240802$20240812$20240812$EXP$$CA-BAXTER-2024BAX022737$BAXTER$$$$$$Y$$$20240812$$CN$CA$CA
242012111$24201211$1$I$$20240807$20240812$20240812$EXP$$DE-PFIZER INC-202400232077$PFIZER$Satirer, O.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD Open. 2024;10(3):e004381$2$YR$$F$Y$$$20240812$$MD$DE$DE
242012121$24201212$1$I$$20240801$20240812$20240812$EXP$$CA-TEVA-VS-3229612$TEVA$$72$YR$$M$Y$$$20240812$$MD$CA$CA
242012131$24201213$1$I$20240419$20240805$20240812$20240812$EXP$FR-AFSSAPS-RN2024000845$FR-MYLANLABS-2024M1072954$MYLAN$$69$YR$$F$Y$78$KG$20240812$$MD$FR$FR
242012142$24201214$2$F$$20240821$20240812$20240827$EXP$$PT-MYLANLABS-2024M1066687$MYLAN$Campos S, Conceicao V, Vieira N, Arez L. Lyell^s syndrome - a relevant adverse effect. Congresses of the Portuguese Society of Internal Medicine. 2024;30(Sup 1:637$20$YR$$M$Y$$$20240827$$MD$PT$PT
242012151$24201215$1$I$20240624$20240805$20240812$20240812$EXP$FR-AFSSAPS-AM2024000616$FR-MYLANLABS-2024M1072960$MYLAN$$90$YR$$F$Y$52$KG$20240812$$PH$FR$FR
242012161$24201216$1$I$20240301$20240805$20240812$20240812$EXP$FR-AFSSAPS-TS2024000869$FR-MYLANLABS-2024M1072887$MYLAN$$41$YR$$F$Y$88$KG$20240812$$MD$FR$FR
242012171$24201217$1$I$$20240805$20240812$20240812$EXP$$PT-MYLANLABS-2024M1072905$MYLAN$Silva P, Ferreira M, Grilo A, Gon?alves F.. SEROTONINERGIC SYNDROME: THE PURPOSE OF A CLINICAL CASE. Emergency, intermediate care. 481$48$YR$$F$Y$$$20240812$$HP$PT$PT
242012184$24201218$4$F$$20240906$20240812$20240912$EXP$$PT-MYLANLABS-2024M1067273$MYLAN$Catarina Castelo Maia; Jo?o Paulo Rocha; Teresa Antunes; Jorge Almeida. PO-0608 - (4552)-Diffuse large B-cell lymphoma ? an incidental diagnosis. Congresso Nacional de Medicina Interna. 2024;30(Sup 1):954$72$YR$$F$Y$$$20240912$$MD$PT$PT
242012191$24201219$1$I$20240601$20240805$20240812$20240812$EXP$FR-AFSSAPS-BX2024001536$FR-MYLANLABS-2024M1072935$MYLAN$$31$YR$$F$Y$50$KG$20240812$$MD$FR$FR
242012201$24201220$1$I$20150201$20240805$20240812$20240812$EXP$NL-LRB-196371$NL-MYLANLABS-2024M1072889$MYLAN$$54$YR$$F$Y$83$KG$20240812$$HP$NL$NL
242012211$24201221$1$I$$20240806$20240812$20240812$PER$$US-AstraZeneca-2024A179304$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
242012221$24201222$1$I$$20230907$20240812$20240812$EXP$$US-AstraZeneca-2023A205360$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242012231$24201223$1$I$20051117$20240805$20240812$20240812$EXP$$FR-MYLANLABS-2024M1072896$MYLAN$$69$YR$$F$Y$$$20240812$$MD$FR$FR
242012241$24201224$1$I$20240723$20240808$20240812$20240812$EXP$$US-AstraZeneca-2024A181136$ASTRAZENECA$$28245$DY$$M$Y$$$20240812$$MD$US$
242012251$24201225$1$I$20240509$20240808$20240812$20240812$EXP$$NVSC2024US162898$NOVARTIS$$41$YR$$F$Y$$$20240812$$HP$US$US
242012262$24201226$2$F$20201023$20240808$20240812$20240821$EXP$$NVSC2024CN162526$NOVARTIS$$45$YR$$M$Y$73$KG$20240821$$HP$CN$CN
242012271$24201227$1$I$$20240731$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408000429$ELI LILLY AND CO$$61$YR$A$$Y$$$20240812$$CN$US$US
242012281$24201228$1$I$20240807$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005830$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240812$$CN$US$US
242012291$24201229$1$I$$20240801$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408002182$ELI LILLY AND CO$$57$YR$A$$Y$$$20240812$$LW$US$US
242012301$24201230$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006398$ELI LILLY AND CO$$45$YR$A$$Y$$$20240812$$CN$US$US
242012311$24201231$1$I$20240808$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006350$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240812$$CN$US$US
242012322$24201232$2$F$$20240821$20240812$20240903$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001198$AKEBIA THERAPEUTICS$$77$YR$$M$Y$78.3$KG$20240903$$MD$JP$JP
242012331$24201233$1$I$$20240715$20240812$20240812$PER$$US-ALXN-202407USA000997US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
242012341$24201234$1$I$20230505$20240802$20240812$20240812$EXP$$CN-009507513-2408CHN001946$MERCK$$32$YR$$F$Y$$$20240812$$HP$CN$CN
242012351$24201235$1$I$$20240807$20240812$20240812$EXP$$US-OTSUKA-2024_021913$OTSUKA$$$$$M$Y$$$20240812$$CN$US$US
242012362$24201236$2$F$20240701$20240827$20240812$20240911$PER$$US-APOTEX-2024AP009041$APOTEX$$$$$M$Y$$$20240911$$CN$US$US
242012371$24201237$1$I$20240101$20240802$20240812$20240812$EXP$GB-MHRA-MED-202408021431075440-DHWYC$GB-BAUSCH-BL-2024-012119$BAUSCH AND LOMB$$$$$F$Y$$$20240812$$PH$GB$GB
242012382$24201238$2$F$$20240730$20240812$20240830$EXP$$IN-BAYER-2024A110543$BAYER$Tyagi M, Ahuja R, Patel V, Sahni K, Taneja N, Gupta S. Fixed Drug Eruptions Due To/Caused by Levocetirizine and Cetirizine: An Uncommon Adverse Cutaneous Drug Reaction to Commonly Used Piperazine Derivatives. Indian Dermatology Online Journal. 2024;15:80-678$28$YR$A$M$Y$$$20240830$$HP$IN$IN
242012392$24201239$2$F$$20240902$20240812$20240906$EXP$$JP-INCYTE CORPORATION-2024IN008109$INCYTE$$$$$$Y$$$20240906$$PH$JP$JP
242012401$24201240$1$I$20231108$20240812$20240812$20240812$EXP$FR-AFSSAPS-NY2024000898$NVSC2024FR163238$NOVARTIS$$57$YR$$M$Y$76$KG$20240812$$PH$FR$FR
242012411$24201241$1$I$20230101$20240806$20240812$20240812$EXP$$CA-AMGEN-CANSL2023204179$AMGEN$$60$YR$A$F$Y$$$20240812$$CN$CA$CA
242012421$24201242$1$I$$20240810$20240812$20240812$EXP$FR-AFSSAPS-TS2024000897$FR-BAUSCH-BL-2024-012168$BAUSCH AND LOMB$$86$YR$$M$Y$$$20240812$$MD$FR$FR
242012431$24201243$1$I$20211001$20240810$20240812$20240812$EXP$$DE-BAUSCH-BL-2024-012173$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240812$$MD$DE$DE
242012441$24201244$1$I$$20240805$20240812$20240812$EXP$$SG-BAUSCH-BL-2024-011949$BAUSCH AND LOMB$Wong C, Lua A, Tay Y, Tan S, Rajaratnam R. Drug reaction with eosinophilia and systemic symptoms secondary to minocycline complicated by posterior reversible encephalopathy syndrome. JAAD Case reports. 2024;51:1-3. doi:10.1016/j.jdcr.2024.06.015$71$YR$$F$Y$$$20240812$$MD$SG$SG
242012453$24201245$3$F$20240621$20240815$20240812$20240829$EXP$ES-AEMPS-1557510$ES-BAUSCH-BL-2024-012055$BAUSCH AND LOMB$$87$YR$$M$Y$57$KG$20240829$$HP$ES$ES
242012461$24201246$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191436$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
242012471$24201247$1$I$20240701$20240802$20240812$20240812$PER$$US-SA-2024SA234340$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240812$$MD$US$US
242012481$24201248$1$I$$20240730$20240812$20240812$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-07742$LUPIN$Singh D, Sarkar B, Yadav S, Sarkar K. Silent epidemic of silicotuberculosis in India and emergence of multidrug-resistant tuberculosis?. Journal of Global Antimicrobial Resistance. 2024;38:163-166$$$$$Y$$$20240812$$HP$IN$IN
242012491$24201249$1$I$20240808$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158454$AMGEN$$80$YR$E$M$Y$$$20240812$$CN$US$US
242012501$24201250$1$I$20240701$20240805$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124436$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$97.52$KG$20240812$$CN$US$US
242012511$24201251$1$I$20240623$20240806$20240812$20240812$EXP$$US-MYLANLABS-2024M1074351$MYLAN$$42$YR$$M$Y$86.18$KG$20240812$$CN$US$US
242012521$24201252$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5874172$ABBVIE$$$$$$Y$$$20240812$$MD$US$US
242012531$24201253$1$I$$20240807$20240812$20240812$EXP$$PH-OTSUKA-2024_019242$OTSUKA$$$$$M$Y$$$20240812$$CN$PH$PH
242012541$24201254$1$I$$20240731$20240812$20240812$EXP$$US-LAURUS LABS LIMITED-2024LAU000062$LAURUS LABS LIMITED$Wagle L, Regmi DR, Regmi R, Poudel S, Pant HN. Metformin Toxicity Leading to Severe Refractory Hyperkalemia and Metabolic Acidosis: A Case Report.. Cureus. 2024;16(6)$74$YR$$M$Y$$$20240812$$HP$US$US
242012551$24201255$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400233906$PFIZER$$66$YR$$F$Y$$$20240812$$HP$US$US
242012571$24201257$1$I$20240718$20240807$20240812$20240812$EXP$$US-BIOMARINAP-US-2024-159717$BIOMARIN$$$$$$Y$$$20240812$$CN$US$US
242012581$24201258$1$I$$20240806$20240812$20240812$EXP$$BE-ABBVIE-5875862$ABBVIE$$$$$$Y$$$20240812$$CN$BE$BE
242012601$24201260$1$I$20240704$20240806$20240812$20240812$EXP$FR-AFSSAPS-NY2024000863$FR-MYLANLABS-2024M1073869$MYLAN$$41$YR$$F$Y$$$20240812$$PH$FR$FR
242012611$24201261$1$I$20240101$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158265$AMGEN$$67$YR$E$F$Y$$$20240812$$HP$US$US
242012621$24201262$1$I$20240807$20240809$20240810$20240810$DIR$FDA-CDER-CTU-2024-54959$$FDA-CTU$$$$$M$N$125.1$KG$20240809$N$$US$
242012631$24201263$1$I$20240731$20240809$20240810$20240810$DIR$FDA-CDER-CTU-2024-54960$$FDA-CTU$$$$$M$N$85.7$KG$20240809$N$$US$
242012641$24201264$1$I$$20240810$20240810$20240810$DIR$FDA-CDER-CTU-2024-55062$$FDA-CTU$$77$YR$$F$N$$$20240810$N$$US$
242012651$24201265$1$I$$20240810$20240810$20240810$DIR$FDA-CDER-CTU-2024-54958$$FDA-CTU$$89$YR$$M$N$$$20240810$N$$US$
242012661$24201266$1$I$20240804$20240811$20240811$20240811$DIR$713783$$FDA-CTU$$25$YR$$F$N$74.25$KG$20240811$N$CN$US$
242012671$24201267$1$I$$20240806$20240810$20240810$DIR$FDA-CDER-CTU-2024-54957$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
242012681$24201268$1$I$20240808$20240809$20240810$20240810$DIR$FDA-CDER-CTU-2024-55063$$FDA-CTU$$47$YR$$F$N$$$20240809$N$HP$US$
242012691$24201269$1$I$$20240804$20240810$20240810$DIR$FDA-CDER-CTU-2024-54961$$FDA-CTU$$75$YR$$F$N$$$20240804$N$$US$
242012701$24201270$1$I$$20240802$20240812$20240812$EXP$$US-BEH-2024176840$CSL BEHRING$$$$A$F$Y$$$20240812$$HP$US$US
242012711$24201271$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126863$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$101.15$KG$20240812$$CN$US$US
242012731$24201273$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236844$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240812$$CN$US$US
242012741$24201274$1$I$20240701$20240802$20240812$20240812$PER$$US-SA-2024SA232642$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240812$$MD$US$US
242012751$24201275$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235137$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240812$$MD$US$US
242012761$24201276$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA234994$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240812$$MD$US$US
242012772$24201277$2$F$20141001$20240916$20240812$20240917$EXP$FR-AFSSAPS-TO2024001517$NVSC2024FR163269$NOVARTIS$$63$YR$$F$Y$61$KG$20240917$$HP$FR$FR
242012781$24201278$1$I$20240807$20240807$20240812$20240812$EXP$$NVSC2024GR161738$NOVARTIS$$$$$M$Y$$$20240812$$MD$GR$GR
242012791$24201279$1$I$20240301$20240808$20240812$20240812$EXP$IT-MINISAL02-997287$IT-MYLANLABS-2024M1073928$MYLAN$$76$YR$$F$Y$58$KG$20240812$$CN$IT$IT
242012801$24201280$1$I$$20240807$20240812$20240812$EXP$$GB-TAKEDA-2021TUS070307$TAKEDA$$$$$F$Y$$$20240812$$HP$GB$GB
242012811$24201281$1$I$$20240808$20240812$20240812$EXP$$US-ASTELLAS-2024US022627$ASTELLAS$$$$$$Y$$$20240812$$CN$US$US
242012821$24201282$1$I$$20240728$20240812$20240812$EXP$$BR-Inventia-000738$INVENTIA HEALTHCARE$Scorza CA, Scorza FA, Finsterer J. Daytime bruxism, tardive orofacial dyskinesia, and dysphagia as side effects to duloxetine use over nine years in an octogenarian. Clinics (Sao Paulo). 2024 Jul 22;79:100438.$83$YR$E$F$Y$69$KG$20240812$$HP$BR$BR
242012831$24201283$1$I$$20240728$20240812$20240812$EXP$$US-CPL-004509$CADILA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$$$$F$Y$$$20240812$$MD$US$US
242012841$24201284$1$I$$20240728$20240812$20240812$EXP$$US-CPL-004510$CADILA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$$$$M$Y$$$20240812$$MD$US$US
242012851$24201285$1$I$$20240728$20240812$20240812$EXP$$US-CPL-004515$CADILA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$$$N$F$Y$$$20240812$$MD$US$US
242012861$24201286$1$I$$20240808$20240812$20240812$PER$$NVSC2024US162536$NOVARTIS$$$$$$Y$$$20240812$$CN$US$US
242012871$24201287$1$I$$20240728$20240812$20240812$EXP$$US-Indicus Pharma-001028$INDICUS$Wagle L, Regmi DR, Regmi R, Poudel S, Pant HN. Metformin Toxicity Leading to Severe Refractory Hyperkalemia and Metabolic Acidosis: A Case Report. Cureus. 2024 Jun 25;16(6):e63130.$74$YR$E$M$Y$$$20240812$$HP$US$US
242012881$24201288$1$I$$20240802$20240812$20240812$PER$$US-ABBVIE-5867986$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242012891$24201289$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191475$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
242012901$24201290$1$I$$20240808$20240812$20240812$EXP$$US-OTSUKA-2024_022053$OTSUKA$$$$$M$Y$$$20240812$$CN$US$US
242012911$24201291$1$I$$20240728$20240812$20240812$EXP$$US-Inventia-000735$INVENTIA HEALTHCARE$Wagle L, Regmi DR, Regmi R, Poudel S, Pant HN. Metformin Toxicity Leading to Severe Refractory Hyperkalemia and Metabolic Acidosis: A Case Report. Cureus. 2024 Jun 25;16(6):e63130.$74$YR$E$M$Y$$$20240812$$HP$US$US
242012922$24201292$2$F$20240620$20240822$20240812$20240828$EXP$$NVSC2024DE161390$NOVARTIS$$$$E$F$Y$$$20240828$$MD$DE$DE
242012931$24201293$1$I$$20240728$20240812$20240812$EXP$$US-Indicus Pharma-001030$INDICUS$Jain S, Sekhon S, Leo Pradeep Chandran AS, Gummadi J, Patel P, Nakka R, et.al. Metformin-Associated Lactic Acidosis in an Older Adult: A Case Report and Review. Cureus. 2024 Jun 19;16(6):e62729.$82$YR$E$M$Y$$$20240812$$HP$US$US
242012941$24201294$1$I$$20240728$20240812$20240812$EXP$$US-Inventia-000737$INVENTIA HEALTHCARE$Jain S, Sekhon S, Leo Pradeep Chandran AS, Gummadi J, Patel P, Nakka R, et.al. Metformin-Associated Lactic Acidosis in an Older Adult: A Case Report and Review. Cureus. 2024 Jun 19;16(6):e62729.$82$YR$E$M$Y$$$20240812$$HP$US$US
242012951$24201295$1$I$20220101$20240806$20240812$20240812$EXP$$US-SA-2024SA235092$SANOFI AVENTIS$$$$C$M$Y$$$20240812$$CN$US$US
242012963$24201296$3$F$20240101$20240909$20240812$20240919$EXP$$JP-JNJFOC-20240776509$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240919$$MD$JP$JP
242012971$24201297$1$I$20240123$20240808$20240812$20240812$PER$IT-MINISAL02-998366$IT-Eisai-EC-2024-171713$EISAI$$66$YR$E$F$Y$$$20240812$$PH$IT$IT
242012981$24201298$1$I$$20240730$20240812$20240812$EXP$$NL-DENTSPLY-2024SCDP000231$DENTSPLY$Meulemans R J, Gerritse B M. Acute reversal of respiratory distress after a preoperative single-shot interscalene nerve block. Regional anesthesia and pain medicine. 2024$65$YR$$M$Y$$$20240809$$HP$NL$NL
242012992$24201299$2$F$$20240806$20240812$20240902$EXP$$BR-ORGANON-O2408BRA000700$ORGANON$$$$$F$Y$88$KG$20240902$$HP$BR$BR
242013002$24201300$2$F$20220101$20240910$20240812$20240920$EXP$$US-NOVOPROD-1263541$NOVO NORDISK$$66$YR$$F$Y$$$20240920$$CN$US$US
242013011$24201301$1$I$20230801$20240809$20240812$20240812$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044969$BOEHRINGER INGELHEIM$$46$YR$A$F$Y$35$KG$20240812$$MD$RU$RU
242013021$24201302$1$I$$20240805$20240812$20240812$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127003$BRISTOL MYERS SQUIBB$Oyake T, Maeta T, Takahata T, Tamai Y, Kameoka Y, Takahashi N, et al. Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory hodgkin^s lymphoma. Journal of Clinical and Experimental Hematopathology. 2024 Jul 31;1-12. doi:10.3960/jslrt.24021.$79$YR$E$M$Y$$$20240812$$MD$JP$JP
242013031$24201303$1$I$$20240807$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127013$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240812$$CN$US$US
242013041$24201304$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126862$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$108.4$KG$20240812$$CN$US$US
242013051$24201305$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA236853$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240812$$MD$US$US
242013061$24201306$1$I$$20240801$20240812$20240812$EXP$$US-DENTSPLY-2024SCDP000230$DENTSPLY$$14$YR$$F$Y$68$KG$20240812$$MD$US$US
242013071$24201307$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158928$AMGEN$$$$$$Y$$$20240812$$PH$US$US
242013082$24201308$2$F$20240808$20240812$20240812$20240815$PER$$US-AMGEN-USASP2024159402$AMGEN$$49$YR$A$F$Y$$$20240815$$CN$US$US
242013092$24201309$2$F$20240101$20240920$20240812$20240930$EXP$$JP-AMGEN-JPNSP2024158561$AMGEN$$$$A$F$Y$$$20240930$$PH$JP$JP
242013102$24201310$2$F$$20240830$20240812$20240907$EXP$$IT-AMGEN-ITASP2024154965$AMGEN$Gaio M.; Vastarella M.; Sullo M. et al.. Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis. Pharmaceuticals. 2024;17 (7):1-15$$$$F$Y$$$20240907$$HP$IT$IT
242013111$24201311$1$I$$20240805$20240812$20240812$PER$$US-AMGEN-USASP2024155390$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
242013121$24201312$1$I$$20240809$20240812$20240812$EXP$$US-SANDOZ INC.-SDZ2024US071946$SANDOZ$$$$$F$Y$$$20240812$$CN$US$US
242013132$24201313$2$F$20230217$20240827$20240812$20240830$EXP$$NVSC2023AR046435$NOVARTIS$$80$YR$$F$Y$$$20240830$$CN$AR$AR
242013141$24201314$1$I$$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004786$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
242013151$24201315$1$I$$20240731$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408000385$ELI LILLY AND CO$$49$YR$A$$Y$$$20240812$$LW$US$US
242013161$24201316$1$I$20240802$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004526$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240812$$CN$US$US
242013181$24201318$1$I$20240727$20240731$20240812$20240812$EXP$$US-Accord-439851$ACCORD$$13$YR$T$M$Y$$$20240812$$HP$US$US
242013191$24201319$1$I$$20240731$20240812$20240812$EXP$$US-Accord-440123$ACCORD$$28$YR$A$M$Y$$$20240812$$HP$US$US
242013201$24201320$1$I$20240719$20240731$20240812$20240812$EXP$$KR-Accord-440556$ACCORD$$65$YR$E$M$Y$$$20240812$$MD$KR$KR
242013211$24201321$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-E2B_07142972$CA-Accord-440044$ACCORD$$35$YR$A$M$Y$$$20240812$$MD$CA$CA
242013221$24201322$1$I$$20240731$20240812$20240812$EXP$CA-MHPD-E2B_07143946$CA-Accord-439538$ACCORD$$$$$M$Y$17$KG$20240812$$HP$CA$CA
242013231$24201323$1$I$20211001$20240731$20240812$20240812$EXP$$US-Accord-270347$ACCORD$$75$YR$E$M$Y$$$20240812$$CN$US$US
242013242$24201324$2$F$20240729$20240816$20240812$20240828$EXP$$US-Accord-440082$ACCORD$$55$YR$A$F$Y$$$20240828$$HP$US$US
242013251$24201325$1$I$20240630$20240731$20240812$20240812$EXP$GB-MHRA-MED-202407311453080640-YTDZS$GB-Accord-440007$ACCORD$$$$$F$Y$$$20240812$$CN$GB$GB
242013262$24201326$2$F$20240101$20240808$20240812$20240815$EXP$$CA-ABBVIE-5644497$ABBVIE$$52$YR$$F$Y$$$20240815$$CN$CA$CA
242013271$24201327$1$I$$20240809$20240812$20240812$PER$$US-TAKEDA-2024TUS080293$TAKEDA$$$$$$Y$$$20240812$$HP$US$US
242013281$24201328$1$I$20220101$20240731$20240812$20240812$EXP$$KR-Accord-439325$ACCORD$Jo E, Song SH. Primary peritoneal carcinoma presented with abdominal pain in patient with kidney transplantation. The Korean Journal of Internal Medicine. 2024;39(4):693-4.$54$YR$A$F$Y$$$20240812$$MD$KR$KR
242013291$24201329$1$I$20220901$20240731$20240812$20240812$EXP$$US-Accord-439327$ACCORD$Shah N, Dib EG, Joseph N, Fontana RJ. Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits? Clinical Liver Disease. 2024;23(1):e0125. DOI: 10.1097/CLD.0000000000000125.$76$YR$E$F$Y$$$20240812$$MD$US$US
242013301$24201330$1$I$$20240805$20240812$20240812$EXP$$NVSC2024CN162467$NOVARTIS$Chen X, Liu M, Guo T, Du L, Hou J, Huo L. Efficacy evaluation in patients with gastrointestinal stromal tumors treated with the generic or branded domestic imatinib. CARCINOGENESIS, TERATOGENESIS + MUTAGENESIS. 2024;36 (4):256-60$$$$$Y$$$20240812$$HP$CN$CN
242013311$24201331$1$I$20240810$20240811$20240811$20240811$DIR$713810$$FDA-CTU$$63$YR$$M$N$108$KG$20240811$N$CN$US$
242013321$24201332$1$I$$20240806$20240810$20240810$DIR$FDA-CDER-CTU-2024-55061$$FDA-CTU$$$$$F$N$$$20240806$N$$US$
242013331$24201333$1$I$$20240730$20240812$20240812$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202407-000244$AZURITY PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
242013351$24201335$1$I$$20240806$20240812$20240812$EXP$$US-SA-2024SA235693$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240812$$CN$US$US
242013361$24201336$1$I$20240811$20240811$20240811$20240811$DIR$713811$$FDA-CTU$$45$YR$$F$N$$$20240811$N$CN$US$
242013371$24201337$1$I$20240323$20240328$20240811$20240811$DIR$FDA-CDER-CTU-2024-54962$$FDA-CTU$$74$YR$$M$N$75.2$KG$20240328$N$$US$
242013382$24201338$2$F$20240101$20240805$20240812$20240814$PER$$US-SA-2024SA230154$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240814$$CN$US$US
242013392$24201339$2$F$20240101$20240820$20240812$20240829$PER$$US-SA-2024SA236647$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240829$$MD$US$US
242013401$24201340$1$I$20240806$20240806$20240812$20240812$PER$$US-SA-2024SA234622$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240812$$CN$US$US
242013411$24201341$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235196$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240812$$MD$US$US
242013421$24201342$1$I$20240501$20240806$20240812$20240812$PER$$US-SA-2024SA236350$SANOFI AVENTIS$$7$YR$C$M$Y$18.05$KG$20240812$$MD$US$US
242013431$24201343$1$I$$20240730$20240812$20240812$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-08014$LUPIN$Singh D, Sarkar B, Yadav S, Sarkar K. Silent epidemic of silicotuberculosis in India and emergence of multidrug-resistant tuberculosis?. Journal of Global Antimicrobial Resistance. 2024;38:163-166$$$$$Y$$$20240812$$HP$IN$IN
242013451$24201345$1$I$$20240731$20240812$20240812$EXP$$JP-WOCKHARDT BIO AG-2024WBA000016$WOCKHARDT BIO AG$Doi K, Inoue J, Ninomiya M, Sano A, Tsuruoka M, Sato K et.al.. Three consecutive cases of acute liver failure in young women due to acetaminophen overdose: insights into Japanese social issues and transplantation landscape.. Clin J Gastroenterol.. 2024$19$YR$$F$Y$$$20240808$$HP$JP$JP
242013461$24201346$1$I$$20240810$20240812$20240812$PER$$US-HALEON-2191535$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
242013472$24201347$2$F$$20240812$20240812$20240819$EXP$$CA-TAKEDA-2024TUS079133$TAKEDA$$$$$M$Y$$$20240819$$CN$CA$CA
242013481$24201348$1$I$20230822$20240731$20240812$20240812$EXP$FR-AFSSAPS-TO2024001417$FR-GUERBET / LLC-FR-20240290$GUERBET$$73$YR$E$M$Y$$$20240812$$MD$FR$FR
242013491$24201349$1$I$20240702$20240806$20240812$20240812$EXP$FR-AFSSAPS-AVCF2024000498$FR-MYLANLABS-2024M1073167$MYLAN$$41$YR$$F$Y$$$20240812$$HP$FR$FR
242013511$24201351$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA236410$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240812$$CN$US$US
242013521$24201352$1$I$20240701$20240802$20240812$20240812$PER$$US-SA-2024SA233528$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240812$$MD$US$US
242013531$24201353$1$I$20240803$20240806$20240812$20240812$EXP$$US-SA-2023SA264264$SANOFI AVENTIS$$$$$M$Y$$$20240812$$CN$US$US
242013541$24201354$1$I$20240801$20240806$20240812$20240812$PER$$US-SA-2024SA236837$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240812$$CN$US$US
242013551$24201355$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA232877$SANOFI AVENTIS$$$$$F$Y$$$20240812$$CN$US$US
242013561$24201356$1$I$20240603$20240809$20240812$20240812$EXP$$US-AstraZeneca-2024A147904$ASTRAZENECA$$$$$F$Y$$$20240812$$HP$US$
242013571$24201357$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A182295$ASTRAZENECA$$$$$M$Y$$$20240812$$MD$US$
242013581$24201358$1$I$$20240716$20240812$20240812$PER$$US-JNJFOC-20240816639$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$CN$US$US
242013592$24201359$2$F$20240727$20240904$20240812$20240906$EXP$$JP-AstraZeneca-2024A181220$ASTRAZENECA$$53$YR$$M$Y$$$20240906$$PH$JP$
242013611$24201361$1$I$$20240809$20240812$20240812$EXP$$US-AstraZeneca-2024A182305$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242013621$24201362$1$I$20240717$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A181809$ASTRAZENECA$$29926$DY$$F$Y$$$20240812$$CN$US$
242013631$24201363$1$I$20240804$20240806$20240812$20240812$PER$$US-AstraZeneca-2024A180299$ASTRAZENECA$$$$$$Y$$$20240812$$HP$US$
242013641$24201364$1$I$$20230124$20240812$20240812$EXP$$US-AstraZeneca-2023A021940$ASTRAZENECA$$$$$$Y$$$20240812$$CN$US$
242013651$24201365$1$I$$20240808$20240812$20240812$EXP$$JP-AstraZeneca-2024A180710$ASTRAZENECA$$67$YR$$M$Y$$$20240812$$MD$JP$
242013661$24201366$1$I$$20240801$20240812$20240812$EXP$$CN-AstraZeneca-2024A181849$ASTRAZENECA$$$$$$Y$$$20240812$$MD$CN$
242013671$24201367$1$I$$20240808$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126319$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$85.28$KG$20240812$$MD$US$US
242013681$24201368$1$I$$20240806$20240812$20240812$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-126723$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$71$KG$20240812$$CN$CN$CN
242013701$24201370$1$I$$20240731$20240812$20240812$EXP$$GB-LUPIN PHARMACEUTICALS INC.-2024-07639$LUPIN$$19$YR$$F$Y$63$KG$20240812$$CN$GB$GB
242013711$24201371$1$I$$20240802$20240812$20240812$EXP$$GB-TEVA-VS-3230579$TEVA$$74$YR$$M$Y$$$20240812$$CN$GB$GB
242013721$24201372$1$I$$20240806$20240812$20240812$EXP$$CA-TAKEDA-2024TUS079415$TAKEDA$$$$$F$Y$$$20240812$$MD$CA$CA
242013731$24201373$1$I$$20240806$20240812$20240812$EXP$$PT-MYLANLABS-2024M1073264$MYLAN$Fernandes R, Henriques AC, Martins C, Barreto F, Silva M, Correia MI et al.. FernandesFernandes R, Henriques AC, Martins C, Barreto F, Silva M, Correia MI, Dias G, Faria T. Neuroinfectious complexity: clinical case of otomastoiditis associated with cerebral venous thrombosis and meningitis. Congresses of the Portuguese Society of Internal Medicine. 2024$38$YR$$F$Y$$$20240812$$MD$PT$PT
242013753$24201375$3$F$20240911$20240911$20240812$20240912$PER$$US-GILEAD-2024-0683740$GILEAD$$48$YR$A$M$Y$$$20240912$$HP$US$US
242013762$24201376$2$F$20240222$20240806$20240812$20240812$EXP$$US-PFIZER INC-PV202400103005$PFIZER$$54$YR$$F$Y$$$20240812$$LW$US$US
242013772$24201377$2$F$20240808$20240827$20240812$20240906$EXP$$GB-EMD Serono-2024042151$EMD SERONO INC$$31$YR$A$F$Y$$$20240906$$CN$GB$GB
242013781$24201378$1$I$$20240807$20240812$20240812$EXP$$IL-009507513-2408ISR002888$MERCK$$$$$F$Y$$$20240812$$MD$IL$IL
242013791$24201379$1$I$$20240805$20240812$20240812$EXP$$CN-PERRIGO-24CN007401$PERRIGO$$82$YR$$F$Y$$$20240812$$MD$CN$CN
242013802$24201380$2$F$20240101$20240813$20240812$20240819$PER$$US-AMGEN-USASP2024158447$AMGEN$$84$YR$E$M$Y$$$20240819$$PH$US$US
242013811$24201381$1$I$$20240806$20240812$20240812$EXP$$CA-TAKEDA-2024TUS079210$TAKEDA$$$$$F$Y$$$20240812$$CN$CA$CA
242013821$24201382$1$I$$20240730$20240812$20240812$EXP$$US-AUROBINDO-AUR-APL-2024-039084$AUROBINDO$Abedrabo S, Rodriguez TE, Klein LM, Bitran J.. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 2023;142:7078$$$$$Y$$$20240812$$MD$US$US
242013841$24201384$1$I$$20240730$20240812$20240812$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK089418$GLENMARK$Le V, Surineni K, Elias G.. A Case of Partially Reversible Oral-buccal-lingual Dyskinesia after Prolonged Levetiracetam Exposure.. American Journal of Geriatric Psychiatry.. 2024;32 (4):S106$$$$$Y$$$20240812$$MD$US$US
242013871$24201387$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55196$$FDA-CTU$$94$YR$$M$N$$$20240812$N$$US$
242013881$24201388$1$I$20240627$20240809$20240812$20240812$DIR$FDA-CDER-CTU-2024-55194$$FDA-CTU$$37$YR$$F$N$$$20240809$N$HP$US$
242013891$24201389$1$I$20240806$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55220$$FDA-CTU$$32$YR$$F$N$$$20240812$N$$US$
242013901$24201390$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55230$$FDA-CTU$$77$YR$$M$N$$$20240812$N$$US$
242013921$24201392$1$I$20240731$20240811$20240811$20240811$DIR$713812$$FDA-CTU$$30$YR$$M$N$69.3$KG$20240811$N$CN$US$
242013931$24201393$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55218$$FDA-CTU$$58$YR$$F$N$$$20240812$N$$US$
242013941$24201394$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55228$$FDA-CTU$$29$YR$$F$N$102.06$KG$20240812$N$$US$
242013951$24201395$1$I$20240527$20240805$20240812$20240812$EXP$FR-AFSSAPS-DJ2024000884$FR-GUERBET / LLC-FR-20240297$GUERBET$$76$YR$E$M$Y$$$20240812$$MD$FR$FR
242013962$24201396$2$F$20240709$20240923$20240812$20240930$PER$$US-JNJFOC-20240822731$JOHNSON AND JOHNSON$$63$YR$A$M$Y$95.34$KG$20240930$$HP$US$US
242013971$24201397$1$I$20240501$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126532$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240812$$CN$US$US
242013982$24201398$2$F$20240724$20240827$20240812$20240827$EXP$$US-AMERICAN REGENT INC-2024003059$AMERICAN REGENT$$55$YR$$M$Y$101$KG$20240827$$HP$US$US
242013991$24201399$1$I$$20240808$20240812$20240812$EXP$$CA-PFIZER INC-202400234504$PFIZER$$65$YR$$M$Y$$$20240812$$PH$CA$CA
242014001$24201400$1$I$20230622$20230622$20240812$20240812$EXP$$US-AstraZeneca-2023A145055$ASTRAZENECA$$30918$DY$$F$Y$$$20240812$$CN$US$
242014011$24201401$1$I$$20221104$20240812$20240812$EXP$$US-AstraZeneca-2022A368875$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242014021$24201402$1$I$$20240801$20240812$20240812$PER$$US-AstraZeneca-2024A175882$ASTRAZENECA$$$$$$Y$$$20240812$$CN$US$
242014031$24201403$1$I$20231202$20240805$20240812$20240812$EXP$$FR-AstraZeneca-2024A181842$ASTRAZENECA$$22$DY$$F$Y$$$20240812$$MD$FR$
242014041$24201404$1$I$$20240806$20240812$20240812$PER$$US-AstraZeneca-2024A178952$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242014051$24201405$1$I$$20220913$20240812$20240812$EXP$$US-AstraZeneca-2022A318215$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
242014062$24201406$2$F$20240809$20240813$20240812$20240815$PER$$US-AMGEN-USASP2024159418$AMGEN$$$$$F$Y$$$20240815$$MD$US$US
242014071$24201407$1$I$20240807$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005403$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240812$$CN$US$US
242014081$24201408$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005845$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240812$$CN$US$US
242014091$24201409$1$I$$20240731$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408000323$ELI LILLY AND CO$$71$YR$E$$Y$$$20240812$$LW$US$US
242014101$24201410$1$I$20240601$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005142$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240812$$CN$US$US
242014111$24201411$1$I$20240725$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006001$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240812$$CN$US$US
242014121$24201412$1$I$$20240808$20240812$20240812$30DAY$$US-GSK-US2024099284$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
242014131$24201413$1$I$20240701$20240806$20240812$20240812$EXP$DE-CADRBFARM-2024329625$DE-MYLANLABS-2024M1073462$MYLAN$$$$E$F$Y$67$KG$20240812$$CN$DE$DE
242014141$24201414$1$I$$20240730$20240812$20240812$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-08015$LUPIN$Singh D, Sarkar B, Yadav S, Sarkar K. Silent epidemic of silicotuberculosis in India and emergence of multidrug-resistant tuberculosis?. Journal of Global Antimicrobial Resistance. 2024;38:163-166$$$$$Y$$$20240812$$HP$IN$IN
242014152$24201415$2$F$$20240827$20240812$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06927$LUPIN$$$$$$Y$$$20240918$$CN$US$US
242014161$24201416$1$I$$20240802$20240812$20240812$PER$$US-TAKEDA-2024TUS078459$TAKEDA$$$$$$Y$$$20240812$$CN$US$US
242014171$24201417$1$I$20200428$20240806$20240812$20240812$EXP$PL-URPL-1-1641-2020$PL-MYLANLABS-2024M1073522$MYLAN$$52$YR$$F$Y$$$20240812$$MD$PL$PL
242014181$24201418$1$I$$20240809$20240812$20240812$EXP$$IN-ROCHE-10000054777$ROCHE$$80$YR$E$M$Y$$$20240812$$CN$IN$IN
242014191$24201419$1$I$20240801$20240809$20240812$20240812$PER$$US-ABBVIE-5875144$ABBVIE$$61$YR$$F$Y$59$KG$20240812$$CN$US$US
242014201$24201420$1$I$$20240808$20240812$20240812$EXP$$NVSC2024BR163058$NOVARTIS$$$$$M$Y$$$20240812$$CN$BR$BR
242014211$24201421$1$I$$20240710$20240812$20240812$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07152$LUPIN$$$$$$Y$$$20240812$$CN$US$US
242014221$24201422$1$I$$20240806$20240812$20240812$PER$$US-JNJFOC-20240816815$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$HP$US$US
242014231$24201423$1$I$20240501$20240611$20240812$20240812$EXP$$NVSC2024US102882$NOVARTIS$$81$YR$$F$Y$64.8$KG$20240812$$CN$US$US
242014243$24201424$3$F$$20240828$20240812$20240903$EXP$$US-PFIZER INC-PV202400103989$PFIZER$Al-Zakhari, R.. Rare but fatal case of cavitary pneumonia caused by Alcaligenes faecalis. Cureus. 2020;12(6):e8934$66$YR$$M$Y$$$20240903$$HP$US$US
242014251$24201425$1$I$20140901$20240809$20240812$20240812$PER$$PL-SANDOZ INC.-PHHY2019PL202011$SANDOZ$$52$YR$$F$Y$$$20240812$$MD$PL$PL
242014261$24201426$1$I$20240509$20240808$20240812$20240812$EXP$RO-NMA-2024-SP0522$RO-ABBVIE-5871952$ABBVIE$$35$YR$$F$Y$49$KG$20240812$$CN$RO$RO
242014272$24201427$2$F$20240313$20240904$20240812$20240906$EXP$$DE-AstraZeneca-2024A182743$ASTRAZENECA$$83$YR$$F$Y$$$20240906$$MD$DE$
242014281$24201428$1$I$$20230922$20240812$20240812$EXP$$US-AstraZeneca-2023A183244$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242014291$24201429$1$I$$20240807$20240812$20240812$PER$$US-AstraZeneca-2024A182072$ASTRAZENECA$$$$$$Y$$$20240812$$CN$US$
242014302$24201430$2$F$$20240910$20240812$20240913$EXP$$US-GILEAD-2024-0683718$GILEAD$$$$A$F$Y$$$20240913$$CN$US$US
242014311$24201431$1$I$$20240729$20240812$20240812$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007311$AEGERION$$$$$F$Y$43.537$KG$20240812$$CN$US$US
242014321$24201432$1$I$$20240805$20240812$20240812$EXP$$CA-GSK-CA2024097626$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$CA$CA
242014331$24201433$1$I$20240612$20240801$20240812$20240812$EXP$$CN-TAKEDA-2024TUS079747$TAKEDA$$63$YR$$M$Y$$$20240812$$HP$CN$CN
242014341$24201434$1$I$$20240708$20240812$20240812$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06979$LUPIN$$$$$$Y$$$20240812$$CN$US$US
242014351$24201435$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA233280$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240812$$CN$US$US
242014362$24201436$2$F$$20240808$20240812$20240820$PER$$US-SA-2024SA184691$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240820$$CN$US$US
242014371$24201437$1$I$$20240711$20240812$20240812$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07092$LUPIN$$$$$$Y$$$20240812$$CN$US$US
242014391$24201439$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55251$$FDA-CTU$$47$YR$$F$N$$$20240812$N$$US$
242014401$24201440$1$I$$20240810$20240812$20240812$DIR$FDA-CDER-CTU-2024-55241$$FDA-CTU$$$$$F$N$$$20240810$N$$US$
242014431$24201443$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55197$$FDA-CTU$$61$YR$$F$N$102.51$KG$20240812$N$$US$
242014441$24201444$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55217$$FDA-CTU$$78$YR$$F$N$$$20240812$N$$US$
242014461$24201446$1$I$20220615$20240808$20240812$20240812$EXP$$US-009507513-2408USA003166$MERCK$$$$$F$Y$$$20240812$$CN$US$US
242014471$24201447$1$I$20230801$20240809$20240812$20240812$EXP$CH-SM-2024-14429$CH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044953$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240812$$PH$CH$CH
242014481$24201448$1$I$20240730$20240812$20240812$20240812$EXP$FR-AFSSAPS-RS2024000795$FR-SANDOZ INC.-SDZ2024FR071915$SANDOZ$$74$YR$$F$Y$70$KG$20240812$$PH$FR$FR
242014491$24201449$1$I$20240101$20240806$20240812$20240812$EXP$$US-JNJFOC-20240820887$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240812$$HP$US$US
242014501$24201450$1$I$20240703$20240802$20240812$20240812$PER$$US-ABBVIE-5867985$ABBVIE$$67$YR$$F$Y$$$20240812$$CN$US$US
242014511$24201451$1$I$20240802$20240802$20240812$20240812$EXP$$GB-TEVA-VS-3229834$TEVA$$51$YR$$F$Y$89$KG$20240812$$MD$GB$GB
242014522$24201452$2$F$$20240812$20240812$20240827$EXP$$CA-VER-202400372$VERITY PHARMACEUTICALS$$70$YR$E$M$Y$$$20240827$$HP$CA$CA
242014531$24201453$1$I$$20240730$20240812$20240812$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092986$GLENMARK$Jain S, Sekhon S, Leo Pradeep Chandran AS, Gummadi J, Patel P, Nakka R, et al.. Metformin-associated lactic acidosis in an older adult: A case report and review. Cureus.. Cureus. 2024;16(6):e62729$$$$$Y$$$20240812$$MD$US$US
242014543$24201454$3$F$20240801$20240828$20240812$20240903$EXP$$JP-009507513-2408JPN000354J$MERCK$$63$YR$$F$Y$$$20240903$$MD$JP$JP
242014552$24201455$2$F$$20240813$20240812$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06993$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242014561$24201456$1$I$$20240802$20240812$20240812$PER$$JP-Eisai-EC-2024-171448$EISAI$$82$YR$E$M$Y$$$20240812$$MD$JP$JP
242014571$24201457$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125945$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240812$$CN$US$US
242014591$24201459$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126722$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240812$$CN$US$US
242014601$24201460$1$I$$20240807$20240812$20240812$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-125183$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240812$$HP$PR$PR
242014611$24201461$1$I$20240801$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126757$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$63.96$KG$20240812$$CN$US$US
242014621$24201462$1$I$$20240805$20240812$20240812$EXP$$US-SANDOZ INC.-SDZ2024US072062$SANDOZ$$$$$$Y$$$20240812$$PH$US$US
242014631$24201463$1$I$$20240808$20240812$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US071627$SANDOZ$$$$$$Y$$$20240812$$PH$US$US
242014641$24201464$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA233318$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$CN$US$US
242014661$24201466$1$I$20240701$20240802$20240812$20240812$PER$$US-SA-2024SA233325$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240812$$MD$US$US
242014671$24201467$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA233258$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240812$$MD$US$US
242014681$24201468$1$I$$20220916$20240812$20240812$EXP$$US-AstraZeneca-2022A321753$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242014691$24201469$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA235098$SANOFI AVENTIS$$4$YR$C$M$Y$13.381$KG$20240812$$MD$US$US
242014701$24201470$1$I$$20240806$20240812$20240812$EXP$$DE-MYLANLABS-2024M1073543$MYLAN$$$$A$M$Y$$$20240812$$MD$DE$DE
242014711$24201471$1$I$20240806$20240807$20240812$20240812$PER$$US-SA-2024SA235952$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240812$$CN$US$US
242014721$24201472$1$I$20240803$20240805$20240812$20240812$PER$$US-SA-2024SA235081$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240812$$MD$US$US
242014731$24201473$1$I$$20220829$20240812$20240812$EXP$$DE-AstraZeneca-2022A301789$ASTRAZENECA$$$$$$Y$$$20240812$$HP$DE$
242014741$24201474$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA236645$SANOFI AVENTIS$$90$YR$E$M$Y$$$20240812$$CN$US$US
242014751$24201475$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55237$$FDA-CTU$$32$YR$$$N$107.95$KG$20240812$N$$US$
242014761$24201476$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55238$$FDA-CTU$$57$YR$$F$N$$$20240812$N$$US$
242014791$24201479$1$I$20240804$20240809$20240812$20240812$DIR$FDA-CDER-CTU-2024-55246$$FDA-CTU$$$$$F$N$$$20240809$N$HP$US$
242014801$24201480$1$I$$20240730$20240812$20240812$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK092987$GLENMARK$Bally K, Trusty R, Naher K.. A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone.. Cureus.. 2024;16 (6):e62695$$$$$Y$$$20240812$$MD$US$US
242014811$24201481$1$I$$20240731$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000441$ELI LILLY AND CO$$59$YR$A$$Y$$$20240812$$LW$US$US
242014821$24201482$1$I$$20240731$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001334$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240812$$CN$US$US
242014831$24201483$1$I$20240501$20240811$20240811$20240811$DIR$713803$$FDA-CTU$$33$YR$$F$N$110.7$KG$20240811$N$CN$US$
242014842$24201484$2$F$$20240905$20240812$20240916$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407016533$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$BR$BR
242014851$24201485$1$I$20240807$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005398$ELI LILLY AND CO$$31$YR$A$$Y$$$20240812$$CN$US$US
242014861$24201486$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005809$ELI LILLY AND CO$$44$YR$A$$Y$$$20240812$$CN$US$US
242014871$24201487$1$I$20240601$20240731$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000683$ELI LILLY AND CO$$$$$M$Y$$$20240812$$CN$US$US
242014891$24201489$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006405$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
242014901$24201490$1$I$$20240730$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202407020351$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240812$$CN$US$US
242014911$24201491$1$I$$20240802$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002125$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240812$$CN$US$US
242014921$24201492$1$I$$20240731$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000592$ELI LILLY AND CO$$46$YR$A$$Y$$$20240812$$LW$US$US
242014931$24201493$1$I$$20240730$20240812$20240812$EXP$GB-MHRA-MED-202407300948361960-NDZGM$GB-ELI_LILLY_AND_COMPANY-GB202407020122$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$GB$GB
242014941$24201494$1$I$$20240809$20240812$20240812$DIR$FDA-CDER-CTU-2024-55102$$FDA-CTU$$$$$F$N$$$20240809$N$HP$US$
242014951$24201495$1$I$20240722$20240731$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001480$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240812$$CN$US$US
242014961$24201496$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006420$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240812$$CN$US$US
242014971$24201497$1$I$$20240802$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002247$ELI LILLY AND CO$$47$YR$A$$Y$$$20240812$$LW$US$US
242014981$24201498$1$I$$20240806$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004275$ELI LILLY AND CO$$$$$M$Y$$$20240812$$CN$US$US
242014991$24201499$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55191$$FDA-CTU$$85$YR$$M$N$$$20240812$N$$US$
242015001$24201500$1$I$20240701$20240731$20240812$20240812$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408000541$ELI LILLY AND CO$$29$YR$A$F$Y$47$KG$20240812$$CN$CN$CN
242015011$24201501$1$I$20240601$20240802$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002025$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240812$$CN$US$US
242015021$24201502$1$I$$20240730$20240812$20240812$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202407020088$ELI LILLY AND CO$$$$$F$Y$$$20240812$$MD$SA$SA
242015031$24201503$1$I$20240722$20240731$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000251$ELI LILLY AND CO$$$$A$F$Y$$$20240812$$CN$US$US
242015041$24201504$1$I$20240801$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006661$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
242015051$24201505$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191504$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
242015061$24201506$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55256$$FDA-CTU$$67$YR$$F$N$$$20240812$N$HP$US$
242015071$24201507$1$I$$20240731$20240812$20240812$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000494$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
242015082$24201508$2$F$20240601$20240903$20240812$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000304$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240913$$CN$US$US
242015091$24201509$1$I$20240323$20240812$20240812$20240812$EXP$FR-AFSSAPS-BR2024000650$FR-SANDOZ INC.-SDZ2024FR071994$SANDOZ$$38$YR$$M$Y$97$KG$20240812$$PH$FR$FR
242015101$24201510$1$I$$20240806$20240812$20240812$EXP$$CA-TEVA-VS-3231201$TEVA$$42$YR$$F$Y$68$KG$20240812$$CN$CA$CA
242015111$24201511$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA237044$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240812$$MD$US$US
242015121$24201512$1$I$20240804$20240811$20240811$20240811$DIR$713784$$FDA-CTU$$43$YR$$F$N$94.5$KG$20240811$N$CN$US$
242015131$24201513$1$I$20240716$20240812$20240812$20240812$EXP$FR-AFSSAPS-PC2024000652$NVSC2024FR163038$NOVARTIS$$89$YR$$F$Y$$$20240812$$PH$FR$FR
242015141$24201514$1$I$20240731$20240802$20240812$20240812$PER$$US-SA-2024SA232333$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240812$$CN$US$US
242015151$24201515$1$I$20240715$20240811$20240811$20240811$DIR$713813$$FDA-CTU$$75$YR$$F$N$64.35$KG$20240811$N$CN$US$
242015161$24201516$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA233342$SANOFI AVENTIS$$15$YR$T$M$Y$61.224$KG$20240812$$MD$US$US
242015171$24201517$1$I$$20240708$20240812$20240812$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07046$LUPIN$$$$$$Y$$$20240812$$CN$US$US
242015181$24201518$1$I$20240730$20240802$20240812$20240812$EXP$$US-TEVA-VS-3229906$TEVA$$80$YR$$F$Y$$$20240812$$CN$US$US
242015192$24201519$2$F$$20240813$20240812$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07053$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242015201$24201520$1$I$$20240807$20240812$20240812$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-15821$IPSEN$$$$$M$Y$$$20240812$$CN$GB$GB
242015211$24201521$1$I$20240531$20240605$20240812$20240812$PER$$US-PERRIGO-24US005482$PERRIGO$$49$YR$$$Y$$$20240812$$CN$US$US
242015221$24201522$1$I$20240522$20240522$20240812$20240812$PER$$US-PERRIGO-24US005020$PERRIGO$$$$A$$Y$$$20240812$$CN$US$US
242015231$24201523$1$I$20240722$20240809$20240812$20240812$EXP$$NVSC2024CN151860$NOVARTIS$$$$A$M$Y$$$20240812$$CN$CN$CN
242015241$24201524$1$I$$20240730$20240812$20240812$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK093022$GLENMARK$$$$$$Y$$$20240812$$MD$GB$GB
242015252$24201525$2$F$$20240910$20240812$20240910$EXP$$US-ALXN-202408USA000469US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$MD$US$US
242015261$24201526$1$I$$20240809$20240812$20240812$EXP$$US-TAKEDA-2024TUS080246$TAKEDA$$$$$M$Y$$$20240812$$CN$US$US
242015282$24201528$2$F$20240101$20240731$20240812$20240930$PER$$US-009507513-2408USA000200$MERCK$$$$$F$Y$76.2$KG$20240930$$CN$US$US
242015291$24201529$1$I$$20240806$20240812$20240812$EXP$$US-AMGEN-USASP2024156290$AMGEN$$$$$$Y$$$20240812$$CN$US$US
242015302$24201530$2$F$20180708$20240808$20240812$20240815$EXP$$NVSC2024CN163220$NOVARTIS$$77$YR$$M$Y$$$20240815$$HP$CN$CN
242015331$24201533$1$I$20240729$20240811$20240811$20240811$DIR$713818$$FDA-CTU$$59$YR$$F$N$54$KG$20240811$N$CN$US$
242015341$24201534$1$I$20240730$20240811$20240811$20240811$DIR$713799$$FDA-CTU$$4$YR$$M$N$20.25$KG$20240811$N$CN$US$
242015351$24201535$1$I$20240808$20240811$20240811$20240811$DIR$713819$$FDA-CTU$$67$YR$$F$N$66.6$KG$20240811$N$CN$US$
242015371$24201537$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55258$$FDA-CTU$$64$YR$$F$N$68.04$KG$20240812$N$$US$
242015381$24201538$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55257$$FDA-CTU$$53$YR$$M$N$$$20240812$N$$US$
242015401$24201540$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55250$$FDA-CTU$$44$YR$$M$N$$$20240812$N$$US$
242015421$24201542$1$I$$20240809$20240812$20240812$DIR$FDA-CDER-CTU-2024-55166$$FDA-CTU$$$$$F$N$$$20240809$N$HP$US$
242015431$24201543$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55243$$FDA-CTU$$28$YR$$F$N$$$20240812$N$$US$
242015441$24201544$1$I$20240807$20240809$20240812$20240812$DIR$FDA-CDER-CTU-2024-55252$$FDA-CTU$$69$YR$$M$N$$$20240809$N$HP$US$
242015451$24201545$1$I$$20240808$20240812$20240812$EXP$$US-TAKEDA-US201408802$TAKEDA$$$$$M$Y$77$KG$20240812$$MD$US$US
242015462$24201546$2$F$$20240813$20240812$20240821$EXP$$US-GSK-US2024097562$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
242015471$24201547$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA233023$SANOFI AVENTIS$$$$T$M$Y$57.6$KG$20240812$$MD$US$US
242015481$24201548$1$I$$20240804$20240812$20240812$PER$$US-SA-2024SA235357$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
242015491$24201549$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235459$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240812$$MD$US$US
242015501$24201550$1$I$20240101$20240806$20240812$20240812$EXP$$US-SA-2024SA236434$SANOFI AVENTIS$$75$YR$E$F$Y$83.46$KG$20240812$$MD$US$US
242015511$24201551$1$I$$20240807$20240812$20240812$EXP$$US-BAYER-2024A115092$BAYER$$$$$F$Y$$$20240812$$CN$US$US
242015531$24201553$1$I$20231116$20240808$20240812$20240812$EXP$FR-AFSSAPS-NY2024000911$FR-MYLANLABS-2024M1074037$MYLAN$$62$YR$$M$Y$85.5$KG$20240812$$MD$FR$FR
242015541$24201554$1$I$$20240807$20240812$20240812$EXP$$US-MYLANLABS-2024M1074154$MYLAN$$$$$M$Y$82.5$KG$20240812$$CN$US$US
242015551$24201555$1$I$20240216$20240807$20240812$20240812$EXP$$GB-MYLANLABS-2024M1074140$MYLAN$$76$YR$$M$Y$95$KG$20240812$$MD$GB$GB
242015561$24201556$1$I$20240520$20240808$20240812$20240812$EXP$PT-INFARMED-F202405-900$PT-MYLANLABS-2024M1074110$MYLAN$$83$YR$$M$Y$92$KG$20240812$$MD$PT$PT
242015571$24201557$1$I$20240809$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159323$AMGEN$$53$YR$A$F$Y$$$20240812$$CN$US$US
242015581$24201558$1$I$20240721$20240724$20240812$20240812$PER$$US-TPU-TPU-2024-00414$TEIKOKU$$75$YR$E$F$Y$$$20240812$$CN$US$US
242015591$24201559$1$I$$20240724$20240812$20240812$PER$$US-TPU-TPU-2024-00412$TEIKOKU$$$$$F$Y$$$20240812$$CN$US$US
242015601$24201560$1$I$20240713$20240802$20240812$20240812$EXP$FR-AFSSAPS-DJ2024000863$FR-TEVA-VS-3229684$TEVA$$30$YR$$M$Y$74$KG$20240812$$CN$FR$FR
242015611$24201561$1$I$20240701$20240807$20240812$20240812$EXP$$CR-PFIZER INC-202400232054$PFIZER$$82$YR$$F$Y$$$20240812$$CN$CR$CR
242015621$24201562$1$I$20240601$20240807$20240812$20240812$EXP$$JP-FERRINGPH-2024FE04030$FERRING$$$$$$Y$$$20240812$$PH$JP$JP
242015631$24201563$1$I$$20240808$20240812$20240812$EXP$$CN-FERRINGPH-2024FE04488$FERRING$$$$$$Y$$$20240812$$CN$CN$CN
242015641$24201564$1$I$20240625$20240809$20240812$20240812$EXP$$PK-ROCHE-10000053573$ROCHE$$45$YR$A$M$Y$$$20240812$$CN$PK$PK
242015651$24201565$1$I$$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158422$AMGEN$$$$$F$Y$$$20240812$$MD$US$US
242015661$24201566$1$I$20240807$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024159280$AMGEN$$$$$$Y$$$20240812$$MD$US$US
242015671$24201567$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006096$ELI LILLY AND CO$$$$A$F$Y$$$20240812$$CN$US$US
242015682$24201568$2$F$$20240811$20240812$20240814$EXP$$AT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004396$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240814$$MD$AT$AT
242015692$24201569$2$F$20240712$20240805$20240812$20240816$EXP$$NVSC2024CN162278$NOVARTIS$$82$YR$$F$Y$$$20240816$$HP$CN$CN
242015701$24201570$1$I$20230201$20240806$20240812$20240812$EXP$$PL-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004399$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240812$$MD$PL$PL
242015711$24201571$1$I$$20240807$20240812$20240812$EXP$$JP-FERRINGPH-2024FE04483$FERRING$$$$$$Y$$$20240812$$PH$JP$JP
242015721$24201572$1$I$20240722$20240801$20240812$20240812$EXP$$US-BEH-2024176760$CSL BEHRING$$67$YR$E$F$Y$$$20240812$$HP$US$US
242015732$24201573$2$F$$20240819$20240812$20240823$EXP$$LT-SANDOZ INC.-NVSC2020LT079036$SANDOZ$$32$YR$$M$Y$$$20240823$$MD$LT$LT
242015741$24201574$1$I$$20240809$20240812$20240812$EXP$$US-ABBVIE-5876025$ABBVIE$$86$YR$$F$Y$$$20240812$$CN$US$US
242015751$24201575$1$I$20240719$20240806$20240812$20240812$EXP$$PH-OTSUKA-2024_013522$OTSUKA$$60$YR$$M$Y$$$20240812$$CN$PH$PH
242015761$24201576$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA235119$SANOFI AVENTIS$$77$YR$E$F$Y$79$KG$20240812$$HP$US$US
242015772$24201577$2$F$20240322$20240909$20240812$20240918$EXP$FR-AFSSAPS-AN2024000940$FR-TEVA-VS-3230016$TEVA$$84$YR$$M$Y$70$KG$20240918$$MD$FR$FR
242015781$24201578$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA233390$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
242015791$24201579$1$I$$20240808$20240812$20240812$PER$$US-ROCHE-10000053968$ROCHE$$$$C$M$Y$$$20240812$$HP$US$US
242015801$24201580$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125478$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240812$$HP$US$US
242015811$24201581$1$I$20240628$20240802$20240812$20240812$EXP$FR-AFSSAPS-RN2024000830$FR-TEVA-VS-3229993$TEVA$$71$YR$$F$Y$$$20240812$$MD$FR$FR
242015822$24201582$2$F$20240722$20240812$20240812$20240819$EXP$$CL-GSK-CL2024AMR098300$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$CN$CL$CL
242015831$24201583$1$I$20240729$20240802$20240812$20240812$EXP$$US-TAKEDA-2024TUS080275$TAKEDA$$57$YR$$F$Y$$$20240812$$CN$US$US
242015841$24201584$1$I$$20240807$20240812$20240812$EXP$$BR-TAKEDA-2024TUS080040$TAKEDA$$30$YR$$$Y$$$20240812$$CN$BR$BR
242015851$24201585$1$I$20240807$20240811$20240811$20240811$DIR$713828$$FDA-CTU$$$$$UNK$N$$$20240811$N$$US$
242015861$24201586$1$I$20240810$20240811$20240811$20240811$DIR$713830$$FDA-CTU$$12$YR$$F$N$48.15$KG$20240811$N$CN$US$
242015871$24201587$1$I$20240103$20240811$20240811$20240811$DIR$713809$$FDA-CTU$$58$YR$$F$N$91$KG$20240811$N$CN$US$
242015881$24201588$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55249$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242015891$24201589$1$I$20240808$20240811$20240811$20240811$DIR$713826$$FDA-CTU$$86$YR$$M$N$$$20240811$N$CN$MY$
242015901$24201590$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55253$$FDA-CTU$$70$YR$$F$N$74.84$KG$20240812$N$$US$
242015911$24201591$1$I$20240502$20240811$20240811$20240811$DIR$713815$$FDA-CTU$$52$YR$$F$N$87.75$KG$20240811$N$CN$US$
242015921$24201592$1$I$20240708$20240802$20240812$20240812$EXP$$DE-Ipsen Biopharmaceuticals, Inc.-2024-15522$IPSEN$$77$YR$E$M$Y$82$KG$20240812$$CN$DE$DE
242015931$24201593$1$I$$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159827$AMGEN$$$$$$Y$$$20240812$$CN$US$US
242015941$24201594$1$I$20240709$20240731$20240812$20240812$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000733$PAREXEL$$$$$$Y$$$20240812$$HP$CN$CN
242015951$24201595$1$I$20240708$20240730$20240812$20240812$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000745$PAREXEL$$$$$$Y$$$20240812$$HP$CN$CN
242015961$24201596$1$I$20240721$20240731$20240812$20240812$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000757$PAREXEL$$$$$$Y$$$20240812$$HP$CN$CN
242015971$24201597$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126256$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240812$$CN$US$US
242015981$24201598$1$I$$20240808$20240812$20240812$EXP$$NVSC2024GT162691$NOVARTIS$$$$$M$Y$$$20240812$$CN$GT$GT
242015991$24201599$1$I$$20240810$20240812$20240812$PER$$NVSC2024US163424$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
242016002$24201600$2$F$$20240807$20240812$20240816$EXP$$US-JNJFOC-20240822053$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$HP$US$US
242016011$24201601$1$I$20240101$20240805$20240812$20240812$PER$$US-009507513-2408USA001773$MERCK$$$$$F$Y$$$20240812$$HP$US$US
242016022$24201602$2$F$20190218$20240812$20240812$20240822$EXP$$DE-TEVA-VS-3230068$TEVA$$$$A$F$Y$63.5$KG$20240822$$MD$DE$DE
242016031$24201603$1$I$$20230310$20240812$20240812$EXP$$US-AstraZeneca-2023A001601$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
242016042$24201604$2$F$20230711$20240828$20240812$20240904$EXP$$JP-AstraZeneca-2024A145995$ASTRAZENECA$$80$YR$$M$Y$68$KG$20240904$$MD$JP$
242016061$24201606$1$I$$20240807$20240812$20240812$EXP$$US-INCYTE CORPORATION-2024IN008298$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242016071$24201607$1$I$$20240805$20240812$20240812$EXP$$US-GSK-US2024AMR098304$GLAXOSMITHKLINE$$$$$F$Y$$$20240812$$CN$US$US
242016101$24201610$1$I$20240804$20240808$20240812$20240812$EXP$$US-009507513-2408USA003102$MERCK$$$$$M$Y$$$20240812$$CN$US$US
242016111$24201611$1$I$$20240807$20240812$20240812$PER$$US-MYLANLABS-2024M1074397$MYLAN$$$$$F$Y$$$20240812$$CN$US$US
242016122$24201612$2$F$$20240808$20240812$20240819$EXP$$US-PFIZER INC-202400231805$PFIZER$Anil, V.. Gemcitabine-induced thrombotic microangiopathy in a patient with cholangiocarcinoma: An Atypical Case. Cureus. 2024;16(6):10.7759/cureus.63385$45$YR$$F$Y$$$20240819$$MD$US$US
242016141$24201614$1$I$20150202$20240811$20240811$20240811$DIR$713834$$FDA-CTU$$36$YR$$F$N$$$20240811$N$CN$US$
242016151$24201615$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55242$$FDA-CTU$$50$YR$$F$N$117.93$KG$20240812$N$$US$
242016161$24201616$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55170$$FDA-CTU$$64$YR$$F$N$67.13$KG$20240812$N$HP$US$
242016171$24201617$1$I$20240724$20240811$20240811$20240811$DIR$713825$$FDA-CTU$$41$YR$$F$N$53.1$KG$20240811$N$CN$US$
242016201$24201620$1$I$$20240810$20240812$20240812$DIR$FDA-CDER-CTU-2024-55115$$FDA-CTU$$$$$F$N$$$20240810$N$HP$US$
242016211$24201621$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55240$$FDA-CTU$$53$YR$$M$N$$$20240812$N$$US$
242016221$24201622$1$I$20240806$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55219$$FDA-CTU$$32$YR$$F$N$$$20240812$N$$US$
242016231$24201623$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55255$$FDA-CTU$$56$YR$$F$N$50.35$KG$20240812$N$$US$
242016251$24201625$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55254$$FDA-CTU$$52$YR$$M$N$$$20240812$N$$US$
242016261$24201626$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55190$$FDA-CTU$$79$YR$$F$N$$$20240812$N$HP$US$
242016271$24201627$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55239$$FDA-CTU$$65$YR$$F$N$$$20240812$N$$US$
242016281$24201628$1$I$20230701$20240802$20240812$20240812$EXP$$GB-TEVA-VS-3230070$TEVA$$61$YR$$F$Y$84$KG$20240812$$PH$GB$GB
242016291$24201629$1$I$20240101$20240806$20240812$20240812$PER$$US-Eisai-EC-2024-171823$EISAI$$50$YR$A$M$Y$$$20240812$$CN$US$US
242016301$24201630$1$I$20240801$20240802$20240812$20240812$EXP$$US-GSK-US2024AMR097706$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$CN$US$US
242016311$24201631$1$I$20240525$20240807$20240812$20240812$EXP$$US-SA-2024SA182243$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240812$$MD$US$US
242016322$24201632$2$F$20240801$20240912$20240812$20240920$PER$$US-SA-2024SA048254$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240920$$MD$US$US
242016331$24201633$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA233394$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240812$$MD$US$US
242016341$24201634$1$I$$20240807$20240812$20240812$PER$$US-MYLANLABS-2024M1074539$MYLAN$$$$$F$Y$$$20240812$$CN$US$US
242016351$24201635$1$I$20200316$20240806$20240812$20240812$EXP$PL-URPL-1-1283-2020$PL-MYLANLABS-2024M1073525$MYLAN$$50$YR$$F$Y$$$20240812$$MD$PL$PL
242016361$24201636$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55193$$FDA-CTU$$72$YR$$F$N$$$20240812$N$$US$
242016371$24201637$1$I$20240808$20240808$20240812$20240812$PER$$US-JNJFOC-20240821673$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240812$$PH$US$US
242016381$24201638$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55198$$FDA-CTU$$43$YR$$M$N$$$20240812$N$HP$US$
242016391$24201639$1$I$$20240809$20240812$20240812$EXP$$US-BAUSCH-BL-2024-012147$BAUSCH AND LOMB$$$$$M$Y$$$20240812$$CN$US$US
242016401$24201640$1$I$20240719$20240810$20240812$20240812$EXP$FR-AFSSAPS-TS2024000892$FR-BAUSCH-BL-2024-012171$BAUSCH AND LOMB$$78$YR$$F$Y$52$KG$20240812$$MD$FR$FR
242016411$24201641$1$I$20240807$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005069$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240812$$CN$US$US
242016421$24201642$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006110$ELI LILLY AND CO$$$$$M$Y$$$20240812$$CN$US$US
242016431$24201643$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005610$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240812$$CN$US$US
242016441$24201644$1$I$$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004701$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240812$$CN$US$US
242016451$24201645$1$I$20240701$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005918$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240812$$CN$US$US
242016461$24201646$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006765$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240812$$CN$US$US
242016471$24201647$1$I$20230701$20240802$20240812$20240812$EXP$FR-AFSSAPS-TS2024000855$FR-TEVA-VS-3230007$TEVA$$57$YR$$M$Y$68$KG$20240812$$MD$FR$FR
242016481$24201648$1$I$20240101$20240807$20240812$20240812$EXP$$US-INCYTE CORPORATION-2024IN008293$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242016491$24201649$1$I$$20240805$20240812$20240812$PER$$US-MYLANLABS-2024M1073400$MYLAN$$$$$F$Y$$$20240812$$CN$US$US
242016501$24201650$1$I$20240807$20240807$20240812$20240812$30DAY$$US-GSK-US2024098457$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240812$$CN$US$US
242016511$24201651$1$I$20240626$20240811$20240812$20240812$EXP$$DE-BAUSCH-BL-2024-012198$BAUSCH AND LOMB$$72$YR$$M$Y$100$KG$20240812$$MD$DE$DE
242016521$24201652$1$I$$20240809$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127023$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240812$$CN$US$US
242016531$24201653$1$I$20240801$20240805$20240812$20240812$PER$$US-SA-2024SA235337$SANOFI AVENTIS$$$$E$F$Y$$$20240812$$MD$US$US
242016541$24201654$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA234510$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240812$$MD$US$US
242016551$24201655$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA236046$SANOFI AVENTIS$$$$C$F$Y$33.38$KG$20240812$$MD$US$US
242016561$24201656$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA233644$SANOFI AVENTIS$$16$YR$T$M$Y$149$KG$20240812$$MD$US$US
242016571$24201657$1$I$$20240807$20240812$20240812$EXP$$US-INCYTE CORPORATION-2024IN008294$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242016581$24201658$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA232949$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240812$$MD$US$US
242016602$24201660$2$F$$20240830$20240812$20240905$PER$$US-SA-2024SA232987$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240905$$MD$US$US
242016611$24201661$1$I$20240701$20240805$20240812$20240812$PER$$US-SA-2024SA234526$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240812$$MD$US$US
242016622$24201662$2$F$20240101$20240916$20240812$20240925$PER$$US-SA-2024SA233978$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240925$$MD$US$US
242016631$24201663$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA233561$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240812$$MD$US$US
242016641$24201664$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA233456$SANOFI AVENTIS$$$$$$Y$$$20240812$$HP$US$US
242016651$24201665$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA236547$SANOFI AVENTIS$$$$A$F$Y$86$KG$20240812$$MD$US$US
242016661$24201666$1$I$20240807$20240807$20240812$20240812$PER$$US-APELLIS-2024-APL-0000656$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
242016671$24201667$1$I$$20240810$20240812$20240812$EXP$$IT-BAUSCH-BL-2024-012174$BAUSCH AND LOMB$$33$YR$$F$Y$90$KG$20240812$$MD$IT$IT
242016681$24201668$1$I$$20240806$20240812$20240812$EXP$$LT-MYLANLABS-2024M1073309$MYLAN$$53$YR$$F$Y$$$20240812$$HP$LT$LT
242016691$24201669$1$I$20240401$20240806$20240812$20240812$EXP$FR-AFSSAPS-AVMP2024000219$FR-MYLANLABS-2024M1073567$MYLAN$$23$YR$$F$Y$$$20240812$$PH$FR$FR
242016701$24201670$1$I$$20240730$20240812$20240812$PER$$US-JNJFOC-20240824195$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$HP$US$US
242016711$24201671$1$I$20240426$20240808$20240812$20240812$EXP$$US-AMGEN-USASP2024158125$AMGEN$$60$YR$A$F$Y$$$20240812$$PH$US$US
242016721$24201672$1$I$20240716$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158358$AMGEN$$63$YR$A$F$Y$$$20240812$$CN$US$US
242016731$24201673$1$I$20240720$20240802$20240812$20240812$EXP$AT-BASGAGES-2024-005600$AT-TEVA-VS-3230115$TEVA$$34$YR$$F$Y$$$20240812$$CN$AT$AT
242016741$24201674$1$I$$20240808$20240812$20240812$EXP$$CN-AstraZeneca-2024A182048$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$CN$
242016751$24201675$1$I$$20240809$20240812$20240812$EXP$$US-AstraZeneca-2024A182524$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242016761$24201676$1$I$20240101$20240807$20240812$20240812$EXP$$JP-Eisai-EC-2024-171807$EISAI$$75$YR$E$F$Y$$$20240812$$PH$JP$JP
242016772$24201677$2$F$20230714$20240805$20240812$20240905$EXP$$JP-AstraZeneca-2024A027572$ASTRAZENECA$$65$YR$$M$Y$72$KG$20240905$$MD$JP$
242016781$24201678$1$I$$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179942$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$US$
242016792$24201679$2$F$20240531$20240815$20240812$20240821$EXP$FR-AFSSAPS-LY2024000954$FR-SA-2024SA238416$SANOFI AVENTIS$$48$YR$A$M$Y$85$KG$20240821$$PH$FR$FR
242016801$24201680$1$I$20240101$20240802$20240812$20240812$PER$$US-SA-2024SA233400$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240812$$MD$US$US
242016811$24201681$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA233398$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$MD$US$US
242016821$24201682$1$I$20240101$20240805$20240812$20240812$PER$$US-SA-2024SA236928$SANOFI AVENTIS$$71$YR$E$F$Y$61.23$KG$20240812$$MD$US$US
242016831$24201683$1$I$$20240729$20240812$20240812$PER$$US-SA-2024SA238821$SANOFI AVENTIS$$11$YR$C$F$Y$45.99$KG$20240812$$MD$US$US
242016841$24201684$1$I$$20240808$20240812$20240812$EXP$$JP-AstraZeneca-2024A180800$ASTRAZENECA$$$$$M$Y$$$20240812$$MD$JP$
242016852$24201685$2$F$$20240812$20240812$20240813$PER$$NVSC2024US163485$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
242016871$24201687$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55192$$FDA-CTU$$75$YR$$M$N$$$20240812$N$$US$
242016881$24201688$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55245$$FDA-CTU$$75$YR$$M$N$92.99$KG$20240812$N$$US$
242016891$24201689$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55247$$FDA-CTU$$67$YR$$F$N$$$20240812$N$$US$
242016901$24201690$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55201$$FDA-CTU$$70$YR$$F$N$49.9$KG$20240812$N$$US$
242016911$24201691$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55118$$FDA-CTU$$85$YR$$M$N$63.5$KG$20240812$N$$US$
242016921$24201692$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55205$$FDA-CTU$$$$$M$N$$$20240812$N$PH$US$
242016931$24201693$1$I$20240101$20240805$20240812$20240812$PER$$US-ABBVIE-5868107$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242016941$24201694$1$I$20240729$20240802$20240812$20240812$EXP$CN-NMPACDR-3603011009578202400326$CN-BAXTER-2024BAX022777$BAXTER$$49$YR$$F$Y$47$KG$20240812$$MD$CN$CN
242016951$24201695$1$I$20240722$20240802$20240812$20240812$EXP$CN-NMPACDR-4413011012460202400345$CN-BAXTER-2024BAX022805$BAXTER$$77$YR$$M$Y$50$KG$20240812$$MD$CN$CN
242016961$24201696$1$I$$20240730$20240812$20240812$EXP$$US-PRAXGEN-2024PPLIT00047$PRAXGEN PHARMACEUTICALS$Alam RM, Espinoza J and Coches K.Steroid Induced Diabetic Ketoacidosis in End Stage Renal Disease with Suspected Vasculitis Induced Stroke.Southern Medical Journal.JUL-2022;115 (7):443-4$71$YR$E$F$Y$$$20240812$$MD$US$US
242016971$24201697$1$I$$20240730$20240812$20240812$EXP$$US-PRAXGEN-2024PPLIT00048$PRAXGEN PHARMACEUTICALS$Rozenbaum Lerner G, et al..Bilateral Lung Transplant Complicated by Cytokine Storm Syndrome Due to Hemophagocytic Lymphohistocytosis.American Journal of Respiratory and Critical Care Medicine .MAY-2024;209 (1):A3531$68$YR$A$M$Y$$$20240812$$HP$US$US
242016981$24201698$1$I$$20240806$20240812$20240812$EXP$$CA-TEVA-VS-3231189$TEVA$$9$YR$$M$Y$$$20240812$$HP$CA$CA
242016991$24201699$1$I$20240612$20240802$20240812$20240812$EXP$$ZA-BAXTER-2024BAX020334$BAXTER$$69$YR$$F$Y$91.5$KG$20240812$$MD$ZA$ZA
242017001$24201700$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA235921$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240812$$HP$US$US
242017012$24201701$2$F$$20240805$20240812$20240822$EXP$$JP-009507513-2408JPN000606J$MERCK$Tsutsumi R, Nagaya K, Okura N, Harita S. 126 A Case of Mucoepidermoid Carcinoma Treated with Combination Immunotherapy.. The Joint Meeting of the 132nd Meeting of The Japanese Society for Tuberculosis. 84$77$YR$$M$Y$$$20240822$$MD$JP$JP
242017021$24201702$1$I$20240706$20240802$20240812$20240812$EXP$FR-AFSSAPS-PO2024000787$FR-TEVA-VS-3229915$TEVA$$58$YR$$F$Y$43.8$KG$20240812$$MD$FR$FR
242017031$24201703$1$I$20240808$20240809$20240812$20240812$EXP$$RO-SANDOZ INC.-SDZ2024RO071829$SANDOZ$$$$$$Y$$$20240812$$CN$RO$RO
242017041$24201704$1$I$$20240718$20240812$20240812$PER$$US-009507513-2407USA011796$MERCK$$$$$F$Y$150$KG$20240812$$CN$US$US
242017052$24201705$2$F$20240412$20240814$20240812$20240823$EXP$$US-ASCENDIS PHARMA-2024US005367$ASCENDIS PHARMA$$$$$$Y$$$20240823$$MD$US$US
242017062$24201706$2$F$$20240926$20240812$20240926$PER$$NVSC2024US163367$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
242017071$24201707$1$I$$20240801$20240812$20240812$PER$$US-JNJFOC-20240828204$JOHNSON AND JOHNSON$$$$$M$Y$$$20240812$$HP$US$US
242017081$24201708$1$I$20230801$20240806$20240812$20240812$EXP$$FR-MYLANLABS-2024M1073445$MYLAN$$39$YR$$M$Y$$$20240812$$LW$FR$FR
242017093$24201709$3$F$$20240830$20240812$20240905$EXP$$PT-MYLANLABS-2024M1073852$MYLAN$Maia CC. DIFFUSE LARGE CELL LYMPHOMA B - AN INCIDENTAL DIAGNOSIS. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine. Book of abstracts. 2024;954$72$YR$$F$Y$$$20240905$$MD$PT$PT
242017101$24201710$1$I$20240717$20240718$20240812$20240812$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000628$PAREXEL$$$$$$Y$$$20240812$$PH$US$US
242017111$24201711$1$I$$20240809$20240812$20240812$EXP$$US-SANDOZ INC.-SDZ2024US072030$SANDOZ$$$$$F$Y$57.143$KG$20240812$$CN$US$US
242017121$24201712$1$I$$20240806$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124807$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240812$$HP$US$US
242017131$24201713$1$I$20240807$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126340$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240812$$HP$US$US
242017141$24201714$1$I$$20240807$20240812$20240812$EXP$$EG-PFIZER INC-2023SGN07435$PFIZER$$23$YR$$F$Y$$$20240812$$CN$EG$EG
242017151$24201715$1$I$$20240802$20240812$20240812$PER$$US-JNJFOC-20240828187$JOHNSON AND JOHNSON$$$$$F$Y$$$20240812$$PH$US$US
242017161$24201716$1$I$$20240802$20240812$20240812$PER$$US-JNJFOC-20240828470$JOHNSON AND JOHNSON$$$$$$Y$$$20240812$$PH$US$US
242017171$24201717$1$I$$20240802$20240812$20240812$PER$$US-JNJFOC-20240828037$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240812$$CN$US$US
242017181$24201718$1$I$20240716$20240730$20240812$20240812$PER$$US-JNJFOC-20240782967$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240812$$CN$US$US
242017191$24201719$1$I$20240708$20240802$20240812$20240812$PER$$US-JNJFOC-20240828469$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240812$$CN$US$US
242017201$24201720$1$I$20240412$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179886$ASTRAZENECA$$28961$DY$$M$Y$$$20240812$$HP$US$
242017211$24201721$1$I$20240623$20240807$20240812$20240812$EXP$$US-AstraZeneca-2024A179767$ASTRAZENECA$$31052$DY$$F$Y$$$20240812$$MD$US$
242017221$24201722$1$I$20230528$20240802$20240812$20240812$EXP$FR-AFSSAPS-LL2023001491$FR-TEVA-2023-FR-2932043$TEVA$$37$YR$$F$Y$84$KG$20240812$$CN$FR$FR
242017231$24201723$1$I$20240610$20240805$20240812$20240812$EXP$$IT-AstraZeneca-2024A177194$ASTRAZENECA$$80$YR$$F$Y$42$KG$20240812$$MD$IT$
242017241$24201724$1$I$20240807$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005295$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240812$$CN$US$US
242017251$24201725$1$I$20240601$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408004983$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240812$$CN$US$US
242017261$24201726$1$I$$20240801$20240812$20240812$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-125511$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$96$KG$20240812$$HP$CA$CA
242017271$24201727$1$I$20230709$20240802$20240812$20240812$EXP$DE-CADRBFARM-2024329513$DE-TEVA-VS-3229668$TEVA$$51$YR$$M$Y$86$KG$20240812$$CN$DE$DE
242017281$24201728$1$I$20240711$20240717$20240812$20240812$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000639$PAREXEL$$$$$$Y$$$20240812$$PH$US$US
242017291$24201729$1$I$20240629$20240806$20240812$20240812$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000640$PAREXEL$$$$$$Y$$$20240812$$PH$US$US
242017301$24201730$1$I$20240718$20240719$20240812$20240812$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000652$PAREXEL$$$$$$Y$$$20240812$$CN$US$US
242017311$24201731$1$I$20240603$20240802$20240812$20240812$EXP$FR-AFSSAPS-LY2024001007$FR-TEVA-VS-3229677$TEVA$$81$YR$$F$Y$67.2$KG$20240812$$PH$FR$FR
242017322$24201732$2$F$20240101$20240911$20240812$20240920$EXP$$US-SA-2024SA238760$SANOFI AVENTIS$$57$YR$A$F$Y$57.1$KG$20240920$$MD$US$US
242017331$24201733$1$I$20240201$20240807$20240812$20240812$EXP$$US-SA-2024SA238609$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240812$$MD$US$US
242017341$24201734$1$I$20240712$20240807$20240812$20240812$EXP$$US-SA-2024SA237223$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240812$$MD$US$US
242017361$24201736$1$I$20230726$20240808$20240812$20240812$EXP$$US-PFIZER INC-PV202300201914$PFIZER$$86$YR$$M$Y$$$20240812$$HP$US$US
242017371$24201737$1$I$20240727$20240809$20240812$20240812$EXP$$CN-PFIZER INC-PV202400104210$PFIZER$$32$YR$$F$Y$97$KG$20240812$$HP$CN$CN
242017381$24201738$1$I$$20240808$20240812$20240812$PER$$US-TAKEDA-2024TUS079872$TAKEDA$$$$$$Y$$$20240812$$PH$US$US
242017391$24201739$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA233396$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240812$$MD$US$US
242017402$24201740$2$F$20240101$20240903$20240812$20240912$PER$$US-SA-2024SA233363$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240912$$MD$US$US
242017411$24201741$1$I$20240619$20240808$20240812$20240812$EXP$$JP-SA-2024SA189054$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$MD$JP$JP
242017421$24201742$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163154$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
242017431$24201743$1$I$20230401$20240809$20240812$20240812$EXP$$NVSC2024DE162227$NOVARTIS$$1$DY$$M$Y$2.49$KG$20240812$$MD$DE$DE
242017451$24201745$1$I$$20240806$20240812$20240812$EXP$$CA-TEVA-VS-3231991$TEVA$$41$YR$$M$Y$$$20240812$$CN$CA$CA
242017461$24201746$1$I$$20240730$20240812$20240812$EXP$$US-ASCENT-2024ASLIT00020$ASCENT$Khachatryan A, et al..Recurrent Perimyocarditis Associated with Long-Term Methylphenidate Use.Journal of the American College of Cardiology.02-APR-2024;83 (13):3543$19$YR$A$M$Y$$$20240812$$HP$US$US
242017471$24201747$1$I$20210214$20240808$20240812$20240812$EXP$FR-AFSSAPS-NC2024000931$FR-MYLANLABS-2024M1073949$MYLAN$$$$N$M$Y$2.82$KG$20240812$$MD$FR$FR
242017481$24201748$1$I$$20240730$20240812$20240812$EXP$$CN-ASCENT-2024ASLIT00021$ASCENT$Sheng Su C and Lan Kao C..Stevens-johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine a case report.Journal of Medical Case Reports.2024;18 (344):1-5$82$YR$E$F$Y$$$20240812$$HP$CN$CN
242017491$24201749$1$I$20210711$20240808$20240812$20240812$EXP$SK-SUKLSK-20218481$SK-MYLANLABS-2024M1073966$MYLAN$$63$YR$$M$Y$105$KG$20240812$$MD$SK$SK
242017501$24201750$1$I$$20240808$20240812$20240812$EXP$FR-AFSSAPS-PV2024000679$FR-MYLANLABS-2024M1074173$MYLAN$$$$$$Y$$$20240812$$MD$FR$FR
242017511$24201751$1$I$20240403$20240808$20240812$20240812$EXP$FR-AFSSAPS-TS2024000885$FR-MYLANLABS-2024M1073932$MYLAN$$81$YR$$F$Y$50$KG$20240812$$MD$FR$FR
242017521$24201752$1$I$$20240805$20240812$20240812$EXP$$US-ZENPEP LLC-2024AIMT01206$AIMMUNE$$$$$$Y$$$20240812$$CN$US$US
242017531$24201753$1$I$$20240730$20240812$20240812$EXP$$US-ASCENT-2024ASLIT00022$ASCENT$Vaidya R, Hashmia N, Kakshapatib S, Changa W and Beachya J.Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure.Journal of Neonatal-Perinatal Medicine.23-jul-2023;1-6$$$N$M$Y$$$20240812$$MD$US$US
242017541$24201754$1$I$$20240730$20240812$20240812$EXP$$US-ASCENT-2024ASLIT00023$ASCENT$R. Vaidya et al..Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure.Journal of Neonatal-Perinatal Medicine.2024;1 (1):1-6$$$N$M$Y$$$20240812$$MD$US$US
242017551$24201755$1$I$20240718$20240719$20240812$20240812$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000661$PAREXEL$$$$$$Y$$$20240812$$PH$US$US
242017561$24201756$1$I$20240718$20240719$20240812$20240812$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000658$PAREXEL$$$$$$Y$$$20240812$$PH$US$US
242017572$24201757$2$F$20220309$20240731$20240812$20240813$EXP$$IN-INCYTE CORPORATION-2022IN002898$INCYTE$$$$$$Y$$$20240813$$CN$IN$IN
242017581$24201758$1$I$$20240807$20240812$20240812$PER$$US-TAKEDA-2024TUS079129$TAKEDA$$$$$$Y$$$20240812$$CN$US$US
242017591$24201759$1$I$20240425$20240809$20240812$20240812$EXP$$DE-ASTELLAS-2024EU007960$ASTELLAS$$35$YR$$F$Y$$$20240812$$CN$DE$DE
242017601$24201760$1$I$20240101$20240808$20240812$20240812$EXP$SE-SEMPA-2024-005914$SE-009507513-2408SWE003207$MERCK$$35$YR$$F$Y$$$20240812$$MD$SE$SE
242017611$24201761$1$I$20240701$20240808$20240812$20240812$PER$$US-PFIZER INC-202400232765$PFIZER$$32$YR$$F$Y$$$20240812$$CN$US$US
242017621$24201762$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-PV202400103048$PFIZER$$68$YR$$M$Y$$$20240812$$CN$US$US
242017632$24201763$2$F$$20240826$20240812$20240826$PER$$US-JNJFOC-20240821916$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$MD$US$US
242017641$24201764$1$I$20200305$20240807$20240812$20240812$EXP$$CA-TAKEDA-2024TUS079705$TAKEDA$$17$YR$$F$Y$$$20240812$$CN$CA$CA
242017651$24201765$1$I$20180307$20240808$20240812$20240812$EXP$$JP-009507513-2405JPN002704J$MERCK$$8$DEC$$M$Y$$$20240812$$MD$JP$JP
242017661$24201766$1$I$$20240802$20240812$20240812$EXP$$US-TEVA-VS-3230405$TEVA$$68$YR$$F$Y$$$20240812$$CN$US$US
242017671$24201767$1$I$$20240719$20240812$20240812$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000718$PAREXEL$$$$$$Y$$$20240812$$HP$US$US
242017681$24201768$1$I$20240716$20240731$20240812$20240812$EXP$$CN-GE HEALTHCARE-2024CSU008838$GE HEALTHCARE$$74$YR$$F$Y$60$KG$20240812$$HP$CN$CN
242017691$24201769$1$I$20240517$20240517$20240812$20240812$PER$$US-GE HEALTHCARE-2024CSU005264$GE HEALTHCARE$$88$YR$$F$Y$$$20240812$$HP$US$US
242017701$24201770$1$I$20240708$20240805$20240812$20240812$EXP$FR-AFSSAPS-LY2024001163$FR-TEVA-VS-3230491$TEVA$$93$YR$$F$Y$68$KG$20240812$$PH$FR$FR
242017711$24201771$1$I$20240728$20240805$20240812$20240812$EXP$$CN-GE HEALTHCARE-2024CSU009026$GE HEALTHCARE$$81$YR$$F$Y$68$KG$20240812$$HP$CN$CN
242017722$24201772$2$F$$20240829$20240812$20240905$EXP$$CA-GSK-CA2024098115$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$CA$CA
242017741$24201774$1$I$20240508$20240806$20240812$20240812$EXP$FR-AFSSAPS-AN2024000998$FR-MYLANLABS-2024M1073368$MYLAN$$64$YR$$M$Y$77$KG$20240812$$MD$FR$FR
242017751$24201775$1$I$20240605$20240806$20240812$20240812$EXP$ES-AEMPS-1555666$ES-MYLANLABS-2024M1073859$MYLAN$$86$YR$$M$Y$$$20240812$$MD$ES$ES
242017761$24201776$1$I$$20240806$20240812$20240812$EXP$$PT-MYLANLABS-2024M1074175$MYLAN$$79$YR$$F$Y$$$20240812$$MD$PT$PT
242017771$24201777$1$I$20240705$20240806$20240812$20240812$EXP$FR-AFSSAPS-ST2024001246$FR-MYLANLABS-2024M1073221$MYLAN$$54$YR$$M$Y$79$KG$20240812$$PH$FR$FR
242017781$24201778$1$I$$20240806$20240812$20240812$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012058$JAZZ$$$$$$Y$$$20240812$$CN$US$US
242017791$24201779$1$I$20240101$20240808$20240812$20240812$EXP$$CA-ABBVIE-5874753$ABBVIE$$43$YR$$M$Y$$$20240812$$CN$CA$CA
242017801$24201780$1$I$20240801$20240808$20240812$20240812$30DAY$$US-GSK-US2024099149$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240812$$CN$US$US
242017811$24201781$1$I$20240101$20240809$20240812$20240812$EXP$$IT-KARYOPHARM-2024KPT001417$KARYOPHARM THERAPEUTICS$$65$YR$$M$Y$71$KG$20240812$$MD$IT$IT
242017821$24201782$1$I$20240709$20240806$20240812$20240812$EXP$IE-HPRA-2024-114533$IE-MYLANLABS-2024M1073679$MYLAN$$15$YR$$F$Y$43.6$KG$20240812$$HP$IE$IE
242017831$24201783$1$I$$20240809$20240812$20240812$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044839$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240812$$CN$US$US
242017841$24201784$1$I$$20240808$20240812$20240812$EXP$$US-SHIRE-US201916232$TAKEDA$$$$$F$Y$$$20240812$$HP$US$US
242017851$24201785$1$I$20240709$20240805$20240812$20240812$EXP$IT-MINISAL02-996802$IT-TEVA-VS-3230863$TEVA$$61$YR$$M$Y$$$20240812$$PH$IT$IT
242017861$24201786$1$I$20240801$20240806$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124983$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$79.74$KG$20240812$$PH$US$US
242017871$24201787$1$I$20240802$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158567$AMGEN$$$$$$Y$$$20240812$$PH$US$US
242017881$24201788$1$I$$20240805$20240812$20240812$PER$$US-EMD Serono-2024042343$EMD SERONO INC$$53$YR$A$M$Y$$$20240812$$HP$US$US
242017891$24201789$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005361$ELI LILLY AND CO$$$$$F$Y$$$20240812$$CN$US$US
242017901$24201790$1$I$20240804$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006005$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240812$$CN$US$US
242017911$24201791$1$I$$20240806$20240812$20240812$EXP$$CA-TEVA-VS-3231197$TEVA$$69$YR$$F$Y$$$20240812$$HP$CA$CA
242017921$24201792$1$I$$20240731$20240812$20240812$EXP$$SG-BEXIMCO-2024BEX00039$BEXIMCO PHARMACEUTICALS$Wong C.J, Lua A.C.Y, Tay Y.-K, Tan S.H, Rajaratnam R.. Drug reaction with eosinophilia and systemic symptoms secondary to minocycline complicated by posterior reversible encephalopathy syndrome. Journal of the American Academy of Dermatology. 2024;51:1-3$71$YR$$F$Y$$$20240809$$HP$SG$SG
242017931$24201793$1$I$$20240802$20240812$20240812$EXP$$AU-INCYTE CORPORATION-2024IN008184$INCYTE$$$$$$Y$$$20240812$$MD$AU$AU
242017941$24201794$1$I$20240805$20240807$20240812$20240812$EXP$$CA-TAKEDA-2024TUS079839$TAKEDA$$47$YR$$M$Y$$$20240812$$CN$CA$CA
242017951$24201795$1$I$20240513$20240806$20240812$20240812$EXP$$DE-SA-2024SA235831$SANOFI AVENTIS$$69$YR$E$F$Y$108$KG$20240812$$CN$DE$DE
242017961$24201796$1$I$20240701$20240809$20240812$20240812$EXP$$NVSC2024US162889$NOVARTIS$$37$YR$$M$Y$$$20240812$$CN$US$US
242017971$24201797$1$I$$20240804$20240812$20240812$PER$$US-INCYTE CORPORATION-2024IN008145$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242017981$24201798$1$I$$20240807$20240812$20240812$EXP$$GB-ABBVIE-5873228$ABBVIE$$$$E$F$Y$$$20240812$$CN$GB$GB
242017991$24201799$1$I$$20240803$20240812$20240812$EXP$$US-AstraZeneca-2024A181242$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242018001$24201800$1$I$$20240808$20240812$20240812$EXP$$CN-AstraZeneca-2024A182374$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$CN$
242018011$24201801$1$I$$20240802$20240812$20240812$EXP$$BG-TEVA-VS-3230250$TEVA$Mahmoud I,Demcrdjicva Z, Knchcva M,Tsankov N, DRUG REACTION WITH EOSINOPHILIA AND SYSTIEMIC SYMPTOMS (DRESS) SYNDROMEINASSOCIATION WITH EPSTEIN-BARR VIRUS (EBV), LXl, 6p.4/2023$69$YR$$M$Y$$$20240812$$HP$BG$BG
242018022$24201802$2$F$$20240910$20240812$20240927$EXP$$US-SA-2024SA236320$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
242018031$24201803$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127310$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240812$$CN$US$US
242018041$24201804$1$I$20240808$20240808$20240812$20240812$PER$$US-009507513-2408USA003298$MERCK$$75$YR$$F$Y$$$20240812$$CN$US$US
242018051$24201805$1$I$$20240802$20240812$20240812$EXP$GB-MHRA-MED-202408021148323410-THRQN$GB-TEVA-VS-3229246$TEVA$$$$$F$Y$50$KG$20240812$$CN$GB$GB
242018061$24201806$1$I$$20240809$20240812$20240812$PER$$US-HALEON-2191472$Haleon PLC$$$$$$Y$$$20240812$$CN$US$US
242018081$24201808$1$I$$20240807$20240812$20240812$PER$$US-SA-2024SA236791$SANOFI AVENTIS$$$$C$M$Y$$$20240812$$CN$US$US
242018091$24201809$1$I$$20240807$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127080$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240812$$CN$US$US
242018101$24201810$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126936$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240812$$CN$US$US
242018111$24201811$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125857$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240812$$CN$US$US
242018132$24201813$2$F$$20240821$20240812$20240828$EXP$$PT-MYLANLABS-2024M1071409$MYLAN$Ferreira IP, Sousa C, Silva IF, Borges J, Sousa A, Queijo C et al.. Pauciimmune glomerulonephritis in an immunocompromised patient - about a clinical case.. Congresses of the Portuguese Society of Internal Medicine: 30th National Congres. 2024;30(Sup 1):353$70$YR$$M$Y$$$20240828$$HP$PT$PT
242018141$24201814$1$I$$20240806$20240812$20240812$EXP$DE-EMA-DD-20240730-7482689-074631$DE-MYLANLABS-2024M1073939$MYLAN$Ecker ME, Weckauf H, Tebbe S, Schuppert F. Immune-mediated gastritis in a patient with metastatic lung cancer due to therapy with the immune checkpoint inhibitor pembrolizumab - differences and similarities in comparison to ^endogenous^ autoimmune type A Gastritis and a review of literature. [Review]. Z-Gastroenterol. 2023;61(10):1385-1393$54$YR$$F$Y$$$20240812$$HP$DE$DE
242018151$24201815$1$I$$20240724$20240812$20240812$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-124380$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$96$KG$20240812$$HP$CA$CA
242018171$24201817$1$I$20201104$20240807$20240812$20240812$EXP$$FR-EMD Serono-2023467085$EMD SERONO INC$$54$YR$A$F$Y$$$20240812$$MD$FR$FR
242018182$24201818$2$F$$20240919$20240812$20240930$PER$$US-SA-2024SA235307$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240930$$MD$US$US
242018191$24201819$1$I$$20240806$20240812$20240812$EXP$$ZA-SA-2024SA236293$SANOFI AVENTIS$$$$A$M$Y$$$20240812$$HP$ZA$ZA
242018201$24201820$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163482$NOVARTIS$$$$$$Y$$$20240812$$HP$US$US
242018212$24201821$2$F$20240805$20240912$20240812$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202408006199$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240916$$CN$US$US
242018231$24201823$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005619$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240812$$CN$US$US
242018241$24201824$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005362$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240812$$CN$US$US
242018251$24201825$1$I$$20240806$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006204$ELI LILLY AND CO$$$$A$F$Y$$$20240812$$CN$US$US
242018261$24201826$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006245$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240812$$CN$US$US
242018271$24201827$1$I$20240601$20240805$20240812$20240812$EXP$FR-AFSSAPS-NT2024000942$FR-TEVA-VS-3230464$TEVA$$84$YR$$M$Y$65.7$KG$20240812$$MD$FR$FR
242018281$24201828$1$I$20240427$20240808$20240812$20240812$EXP$$NVSC2024CN163326$NOVARTIS$$61$YR$$M$Y$55$KG$20240812$$HP$CN$CN
242018291$24201829$1$I$20240804$20240807$20240812$20240812$EXP$$US-GSK-US2024098641$GLAXOSMITHKLINE$$33$YR$$F$Y$$$20240812$$CN$US$US
242018301$24201830$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126089$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240812$$HP$US$US
242018311$24201831$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126829$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$78.47$KG$20240812$$CN$US$US
242018321$24201832$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126835$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240812$$CN$US$US
242018331$24201833$1$I$$20240809$20240812$20240812$EXP$$US-PFIZER INC-202400234603$PFIZER$$44$YR$$M$Y$$$20240812$$MD$US$US
242018341$24201834$1$I$20240719$20240808$20240812$20240812$EXP$FR-AFSSAPS-LY2024001196$FR-MYLANLABS-2024M1074094$MYLAN$$91$YR$$F$Y$$$20240812$$MD$FR$FR
242018351$24201835$1$I$$20240805$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124438$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$97.52$KG$20240812$$CN$US$US
242018361$24201836$1$I$$20240806$20240812$20240812$EXP$$BR-TAKEDA-2024TUS079973$TAKEDA$$16$YR$$$Y$$$20240812$$CN$BR$BR
242018371$24201837$1$I$20230201$20240808$20240812$20240812$EXP$$US-MYLANLABS-2024M1074645$MYLAN$$72$YR$$F$Y$$$20240812$$CN$US$US
242018382$24201838$2$F$20201226$20240917$20240812$20240923$EXP$FR-AFSSAPS-PV2024000673$FR-MYLANLABS-2024M1074417$MYLAN$$15$DY$$M$Y$0.8$KG$20240923$$MD$FR$FR
242018391$24201839$1$I$20240101$20240807$20240812$20240812$EXP$$CA-JNJFOC-20240372807$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240812$$HP$CA$CA
242018401$24201840$1$I$$20240809$20240812$20240812$EXP$GB-MHRA-MED-202408091535216740-SCDBG$GB-GILEAD-2024-0683717$GILEAD$$30$YR$A$M$Y$95$KG$20240812$$CN$GB$GB
242018411$24201841$1$I$$20240808$20240812$20240812$EXP$NL-LRB-00994580$NL-009507513-2408NLD003266$MERCK$$77$YR$$F$Y$71.7$KG$20240812$$MD$NL$NL
242018421$24201842$1$I$$20240806$20240812$20240812$EXP$$US-APELLIS-2024-APL-0000652$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240809$$CN$US$US
242018432$24201843$2$F$20240730$20240815$20240812$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126914$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$88.02$KG$20240823$$PH$US$US
242018441$24201844$1$I$$20240801$20240812$20240812$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-126887$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$97$KG$20240812$$MD$CA$CA
242018462$24201846$2$F$$20240812$20240812$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127343$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240813$$CN$US$US
242018472$24201847$2$F$$20240905$20240812$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126925$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240906$$CN$US$US
242018481$24201848$1$I$20240101$20240731$20240812$20240812$30DAY$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122129$BRISTOL MYERS SQUIBB$$18$YR$A$F$Y$$$20240812$$CN$US$US
242018491$24201849$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126940$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240812$$CN$US$US
242018501$24201850$1$I$$20240811$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126877$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$76.66$KG$20240812$$CN$US$US
242018521$24201852$1$I$$20240802$20240812$20240812$EXP$GB-MHRA-MED-202408011650144590-VSCTK$GB-TEVA-VS-3229332$TEVA$$$$$$Y$$$20240812$$HP$GB$GB
242018532$24201853$2$F$20240401$20240829$20240812$20240908$EXP$$US-009507513-2407USA009701$MERCK$$36$YR$$M$Y$94.331$KG$20240908$$HP$US$US
242018542$24201854$2$F$$20240821$20240812$20240826$EXP$$JP-009507513-2407JPN013094$MERCK$$$$$M$Y$$$20240826$$PH$JP$JP
242018551$24201855$1$I$20231001$20240802$20240812$20240812$EXP$$FR-009507513-2407FRA013263$MERCK$$84$YR$$F$Y$$$20240812$$MD$FR$FR
242018562$24201856$2$F$20220101$20240806$20240812$20240815$EXP$$KR-009507513-2408KOR001501$MERCK$$71$YR$$F$Y$$$20240815$$MD$KR$KR
242018571$24201857$1$I$$20240731$20240812$20240812$PER$$US-MYLANLABS-2024M1071963$MYLAN$$$$$F$Y$101.15$KG$20240812$$CN$US$US
242018581$24201858$1$I$20240506$20240805$20240812$20240812$EXP$SE-SEMPA-2024-005743$SE-TEVA-VS-3230587$TEVA$$31$YR$$M$Y$$$20240812$$MD$SE$SE
242018592$24201859$2$F$$20240821$20240812$20240826$EXP$$JP-JNJFOC-20240826724$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240827$$MD$JP$JP
242018601$24201860$1$I$$20240304$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2024JNY00050$JOURNEY MEDICAL CORPORATION$$$$$$Y$$$20240812$$HP$US$US
242018611$24201861$1$I$$20240214$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2024JNY00035$JOURNEY MEDICAL CORPORATION$$$$$$Y$$$20240812$$CN$US$US
242018621$24201862$1$I$20240301$20240304$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2024JNY00051$JOURNEY MEDICAL CORPORATION$$$$$$Y$$$20240812$$HP$US$US
242018631$24201863$1$I$20240408$20240617$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2024JNY00070$JOURNEY MEDICAL CORPORATION$$$$$F$Y$79.365$KG$20240812$$HP$US$US
242018641$24201864$1$I$20240527$20240527$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2024JNY00103$JOURNEY MEDICAL CORPORATION$$42$YR$$F$Y$61.224$KG$20240812$$CN$US$US
242018651$24201865$1$I$20240529$20240601$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2024JNY00108$JOURNEY MEDICAL CORPORATION$$$$$F$Y$$$20240812$$CN$US$US
242018661$24201866$1$I$20240607$20240608$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2024JNY00115$JOURNEY MEDICAL CORPORATION$$$$$F$Y$$$20240812$$CN$US$US
242018671$24201867$1$I$20240101$20240618$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2024JNY00132$JOURNEY MEDICAL CORPORATION$$$$$F$Y$$$20240812$$CN$US$US
242018681$24201868$1$I$$20230801$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2023JNY00160$JOURNEY MEDICAL CORPORATION$$$$$$Y$$$20240812$$HP$US$US
242018691$24201869$1$I$20230101$20230824$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2023JNY00183$JOURNEY MEDICAL CORPORATION$$$$$F$Y$67.12$KG$20240812$$CN$US$US
242018701$24201870$1$I$$20230925$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2023JNY00205$JOURNEY MEDICAL CORPORATION$$$$$M$Y$$$20240812$$HP$US$US
242018711$24201871$1$I$20230101$20231110$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2023JNY00235$JOURNEY MEDICAL CORPORATION$$$$$F$Y$83.9$KG$20240812$$MD$US$US
242018721$24201872$1$I$20230807$20230808$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2023JNY00171$JOURNEY MEDICAL CORPORATION$$$$$F$Y$$$20240812$$CN$US$US
242018731$24201873$1$I$20231001$20231116$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2023JNY00238$JOURNEY MEDICAL CORPORATION$$13$YR$$F$Y$$$20240812$$CN$US$US
242018741$24201874$1$I$20231008$20231121$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2023JNY00243$JOURNEY MEDICAL CORPORATION$$20$YR$$M$Y$74.83$KG$20240812$$HP$US$US
242018751$24201875$1$I$20210101$20231127$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2023JNY00246$JOURNEY MEDICAL CORPORATION$$$$$M$Y$$$20240812$$CN$US$US
242018761$24201876$1$I$$20240111$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2024JNY00006$JOURNEY MEDICAL CORPORATION$$$$$M$Y$$$20240812$$CN$US$US
242018771$24201877$1$I$$20240127$20240812$20240812$PER$$US-JOURNEY MEDICAL CORPORATION-2024JNY00019$JOURNEY MEDICAL CORPORATION$$$$T$$Y$$$20240812$$MD$US$US
242018782$24201878$2$F$20240805$20240903$20240812$20240905$PER$$US-PFIZER INC-202400234293$PFIZER$$55$YR$$F$Y$55.782$KG$20240905$$CN$US$US
242018801$24201880$1$I$20240628$20240806$20240812$20240812$EXP$FR-AFSSAPS-AVNY2024000231$FR-MYLANLABS-2024M1073358$MYLAN$$29$YR$$F$Y$65$KG$20240812$$MD$FR$FR
242018851$24201885$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005363$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240812$$CN$US$US
242018861$24201886$1$I$$20240805$20240812$20240812$PER$$US-APELLIS-2024-APL-0000645$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
242018871$24201887$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127000$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240812$$CN$US$US
242018882$24201888$2$F$$20240911$20240812$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127073$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240913$$CN$US$US
242018891$24201889$1$I$20240709$20240805$20240812$20240812$EXP$SE-SEMPA-2024-005709$SE-TEVA-VS-3230838$TEVA$$73$YR$$M$Y$$$20240812$$MD$SE$SE
242018901$24201890$1$I$20240722$20240723$20240812$20240812$PER$$US-AMERICAN REGENT INC-2024002843$AMERICAN REGENT$$68$YR$$F$Y$$$20240812$$CN$US$US
242018911$24201891$1$I$$20240801$20240812$20240812$PER$$US-MYLANLABS-2024M1072652$MYLAN$$$$$$Y$$$20240812$$CN$US$US
242018921$24201892$1$I$20240711$20240730$20240812$20240812$EXP$ES-AEMPS-1549722$ES-SK LIFE SCIENCE, INC-SKPVG-2024-001811$SK LIFE SCIENCE$$$$$$Y$$$20240812$$CN$ES$ES
242018932$24201893$2$F$$20240827$20240812$20240903$EXP$$US-MYLANLABS-2024M1073645$MYLAN$$$$$F$Y$$$20240903$$MD$US$US
242018941$24201894$1$I$$20240805$20240812$20240812$EXP$$PL-REGENERON PHARMACEUTICALS, INC.-2024-108652$REGENERON$Paulina Zukowska, Katarzyna Ciepiela, Aleksandra Kudrymska, Kajetan Kielbowski, Rafal Becht. Successful Treatment of Cutaneous Squamous Cell Cancer with Cemiplimab-A Report of Two Cases Demonstrating the Management of Pseudoprogression and Adverse Events.. Journal of Clinical Medicine. 2024;13:4236$82$YR$$M$Y$$$20240812$$MD$PL$PL
242018951$24201895$1$I$20231201$20240731$20240812$20240812$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-000198$SK LIFE SCIENCE$$$$$$Y$$$20240812$$CN$US$US
242018971$24201897$1$I$$20240801$20240812$20240812$EXP$$VN-INCYTE CORPORATION-2024IN008126$INCYTE$$$$$$Y$$$20240812$$MD$VN$VN
242018982$24201898$2$F$$20240809$20240812$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126785$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240815$$CN$US$US
242018991$24201899$1$I$20130101$20240806$20240812$20240812$EXP$FR-AFSSAPS-AVCN2024000586$FR-MYLANLABS-2024M1073632$MYLAN$$18$YR$$F$Y$$$20240812$$MD$FR$FR
242019001$24201900$1$I$20240702$20240731$20240812$20240812$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-14304$IPSEN$$42$YR$A$F$Y$$$20240812$$HP$US$US
242019012$24201901$2$F$$20240808$20240812$20240815$EXP$$CA-HLS-202401978$HLS THERAPEUTICS$$$$A$M$Y$$$20240815$$HP$CA$CA
242019021$24201902$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235456$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240812$$MD$US$US
242019031$24201903$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235375$SANOFI AVENTIS$$$$A$F$Y$59.87$KG$20240812$$MD$US$US
242019041$24201904$1$I$$20240809$20240812$20240812$PER$$US-ROCHE-10000054275$ROCHE$$$$T$M$Y$$$20240812$$MD$US$US
242019051$24201905$1$I$20240502$20240805$20240812$20240812$EXP$FR-AFSSAPS-PP2024000861$FR-REGENERON PHARMACEUTICALS, INC.-2024-108166$REGENERON$$90$YR$$F$Y$$$20240812$$MD$FR$FR
242019062$24201906$2$F$20240722$20240819$20240812$20240822$PER$$JP-Eisai-EC-2024-171788$EISAI$$$$$F$Y$$$20240822$$MD$JP$JP
242019071$24201907$1$I$20240801$20240808$20240812$20240812$EXP$$GB-GSK-GB2024EME099368$GLAXOSMITHKLINE$$$$$$Y$$$20240812$$HP$GB$GB
242019082$24201908$2$F$20240519$20240903$20240812$20240909$EXP$FR-AFSSAPS-SE2024000622$FR-009507513-2408FRA002420$MERCK$$64$YR$$F$Y$60$KG$20240909$$HP$FR$FR
242019092$24201909$2$F$$20240809$20240812$20240813$PER$$NVSC2024US162726$NOVARTIS$$30$YR$$F$Y$$$20240813$$CN$US$US
242019101$24201910$1$I$$20240808$20240812$20240812$EXP$$US-GSK-US2024GSK099986$GLAXOSMITHKLINE$Preskorn SH, Masolak DD. Life-threatening Rash Due to Lamotrigine and a Failure to Understand Its Pharmacology: How Forensic Detective Work Uses Medical Knowledge and Clinical Pharmacology to Solve Cases. Journal of Psychiatric Practice. 2024;30(4):273-278$$$$$Y$$$20240812$$MD$US$US
242019111$24201911$1$I$$20240807$20240812$20240812$EXP$$NVSC2024RU162454$NOVARTIS$Zhuravleva JA, Fedorova LV, Lepik EE, Gusak AA, Popova MO, Lepik KV et al.. A clinical case of successful treatment of CD30-negative angioimmunoblastic T-cell lymphoma using brentuximab vedotin and lenalidomide followed by allogeneic hematopoietic stem cell transplantation. CELLULAR THERAPY AND TRANSPLANTATION. 2024;13(2):41-6$55$YR$$F$Y$$$20240812$$HP$RU$RU
242019131$24201913$1$I$$20240806$20240812$20240812$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408003543$ELI LILLY AND CO$Yu C.,Xu T.,Fang H.,Wang X.,Liu N.,Yang L.,Fang S..High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer.Journal of Neuro-Oncology 2024;169:203-213.DOI:10.1007/s11060-024-04716-0$49$YR$A$M$Y$$$20240812$$HP$CN$CN
242019151$24201915$1$I$$20240731$20240812$20240812$EXP$$RO-ELI_LILLY_AND_COMPANY-RO202407020323$ELI LILLY AND CO$Olimpia Simona Huluban et al.Acrocianosis in the context of oncological treatment: case presentation.Revista Romanian de Medicina Familiei 2024;7(2):17-21.$71$YR$E$F$Y$$$20240812$$MD$RO$RO
242019162$24201916$2$F$$20240801$20240812$20240814$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408003650$ELI LILLY AND CO$Xue Qidan, Liu Mei, Chen Qinda.Patient with type 2 diabetes mellitus converted to insulin degludec insulin aspart after poor blood glucose controlled by pre-mixed insulin: a case report..J Diabetes Mellitus 2024;16(Z1):46-48.DOI:10.3760/cma.j.cn115791-20240503-00245$68$YR$E$M$Y$81$KG$20240814$$HP$CN$CN
242019172$24201917$2$F$$20240828$20240812$20240828$PER$$US-ALXN-202408USA000229US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242019181$24201918$1$I$20240801$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126098$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$117.93$KG$20240812$$PH$US$US
242019191$24201919$1$I$20240807$20240807$20240812$20240812$EXP$$PH-PFIZER INC-202400232045$PFIZER$$75$YR$$M$Y$$$20240812$$CN$PH$PH
242019201$24201920$1$I$$20240805$20240812$20240812$EXP$$JP-BAUSCH-BL-2024-011891$BAUSCH AND LOMB$Kuzume D, Otsuru S, Yoshida T, Morimoto Y, Yamasaki M, Hosomi N. A case of a young woman with bilateral medial medullary infarcts caused by varicella-zoster virus vasculopathy without skin rash. Clinical Neurology. 2024 JUL 24;1-6. doi:10.5692/clinicalneurol.cn-001973$36$YR$$F$Y$66.8$KG$20240812$$HP$JP$JP
242019211$24201921$1$I$20240606$20240729$20240812$20240812$PER$$US-ALKERMES INC.-ALK-2024-002004$ALKERMES$$47$YR$$M$Y$88$KG$20240812$$HP$US$US
242019224$24201922$4$F$20240712$20240913$20240812$20240923$PER$$JP-Eisai-EC-2024-170492$EISAI$$$$E$M$Y$$$20240923$$MD$JP$JP
242019231$24201923$1$I$20240101$20240729$20240812$20240812$PER$$US-ALKERMES INC.-ALK-2024-002001$ALKERMES$$3$DEC$$M$Y$$$20240812$$HP$US$US
242019243$24201924$3$F$20230601$20240913$20240812$20240924$PER$$US-ALKERMES INC.-ALK-2024-002002$ALKERMES$$34$YR$$M$Y$87.075$KG$20240924$$PH$US$US
242019261$24201926$1$I$$20230912$20240812$20240812$EXP$$US-AstraZeneca-2023A208611$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242019271$24201927$1$I$20240509$20240809$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127129$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240812$$CN$US$US
242019282$24201928$2$F$$20240820$20240812$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126994$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240826$$CN$US$US
242019301$24201930$1$I$20240603$20240811$20240812$20240812$EXP$$CN-PFIZER INC-PV202400104307$PFIZER$$$$$M$Y$22.5$KG$20240812$$HP$CN$CN
242019311$24201931$1$I$$20240807$20240812$20240812$EXP$$US-PFIZER INC-PV202400103100$PFIZER$$43$YR$$$Y$$$20240812$$CN$US$US
242019322$24201932$2$F$20240701$20240813$20240812$20240827$EXP$$US-RADIUS HEALTH INC.-2024US006021$RADIUS PHARM$$79$YR$$F$Y$$$20240827$$CN$US$US
242019331$24201933$1$I$$20240809$20240812$20240812$EXP$$US-BAUSCH-BL-2024-001717$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240812$$MD$US$US
242019351$24201935$1$I$20090101$20240809$20240812$20240812$EXP$$US-BAUSCH-BL-2024-012143$BAUSCH AND LOMB$$92$YR$$F$Y$$$20240812$$CN$US$US
242019361$24201936$1$I$$20240805$20240812$20240812$EXP$$US-BAUSCH-BL-2024-011942$BAUSCH AND LOMB$Wagle L, Regmi D, Regmi R, Poudel S, Pant H. Metformin Toxicity Leading to Severe Refractory Hyperkalemia and Metabolic Acidosis: A Case Report.. Cureus. 2024 JUN 25;16(6):1-6. doi:10.7759/cureus.63130.$74$YR$$M$Y$$$20240812$$HP$US$US
242019371$24201937$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235547$SANOFI AVENTIS$$$$E$F$Y$58$KG$20240812$$MD$US$US
242019381$24201938$1$I$$20240807$20240812$20240812$PER$$US-TAKEDA-2024TUS079132$TAKEDA$$$$$$Y$$$20240812$$CN$US$US
242019391$24201939$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235631$SANOFI AVENTIS$$$$T$M$Y$90.71$KG$20240812$$MD$US$US
242019402$24201940$2$F$$20240809$20240812$20240820$PER$$US-SA-2024SA236849$SANOFI AVENTIS$$41$YR$A$M$Y$108$KG$20240820$$MD$US$US
242019412$24201941$2$F$20240715$20240823$20240812$20240827$EXP$$PT-AMERICAN REGENT INC-2024003082$AMERICAN REGENT$$89$YR$$F$Y$$$20240827$$HP$PT$PT
242019421$24201942$1$I$$20240804$20240812$20240812$EXP$$GB-AMGEN-GBRSL2024155956$AMGEN$$$$$F$Y$$$20240812$$CN$GB$GB
242019431$24201943$1$I$20230829$20240805$20240812$20240812$EXP$$CH-PURDUE-USA-2024-0311290$PURDUE$$21$YR$$M$Y$$$20240812$$PH$CH$CH
242019451$24201945$1$I$$20240805$20240812$20240812$EXP$$CA-PURDUE-USA-2024-0311299$PURDUE$$44$YR$$F$Y$$$20240812$$HP$CA$CA
242019461$24201946$1$I$20240802$20240802$20240812$20240812$EXP$$CN-G1 THERAPEUTICS-2024G1CN0000100$G1 THERAPEUTICS$$$$$$Y$$$20240812$$MD$CN$CN
242019481$24201948$1$I$$20230706$20240812$20240812$EXP$$US-AstraZeneca-2023A155921$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242019491$24201949$1$I$$20240809$20240812$20240812$EXP$$CN-AstraZeneca-2024A183056$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$CN$
242019501$24201950$1$I$$20240812$20240812$20240812$PER$$US-PURDUE PHARMA-USA-2024-0311302$PURDUE$$$$$M$Y$$$20240812$$CN$US$US
242019511$24201951$1$I$$20240809$20240812$20240812$PER$$US-PURDUE PHARMA-USA-2024-0311281$PURDUE$$50$YR$$M$Y$$$20240812$$CN$US$US
242019521$24201952$1$I$$20240808$20240812$20240812$PER$$US-PURDUE PHARMA-USA-2024-0311300$PURDUE$$$$N$M$Y$$$20240812$$CN$US$US
242019532$24201953$2$F$$20240810$20240812$20240813$PER$$US-PURDUE PHARMA-USA-2024-0311284$PURDUE$$48$YR$$M$Y$$$20240813$$CN$US$US
242019541$24201954$1$I$$20240809$20240812$20240812$PER$$US-PURDUE PHARMA-USA-2024-0311297$PURDUE$$$$$F$Y$$$20240812$$PH$US$US
242019551$24201955$1$I$$20240812$20240812$20240812$PER$$US-PURDUE PHARMA-USA-2024-0311301$PURDUE$$$$$F$Y$$$20240812$$HP$US$US
242019561$24201956$1$I$$20240808$20240812$20240812$PER$$US-PURDUE PHARMA-USA-2024-0311251$PURDUE$$33$YR$$F$Y$$$20240812$$CN$US$US
242019571$24201957$1$I$20240731$20240809$20240812$20240812$EXP$$US-SANDOZ INC.-SDZ2024US072060$SANDOZ$$71$YR$$F$Y$$$20240812$$CN$US$US
242019582$24201958$2$F$20150501$20240829$20240812$20240830$EXP$$IT-SANDOZ INC.-SDZ2024IT071928$SANDOZ$$17$YR$$M$Y$$$20240830$$MD$IT$IT
242019592$24201959$2$F$20140604$20240820$20240812$20240822$EXP$PL-ARISTO PHARMA-CEFU202407221$PL-SANDOZ INC.-SDZ2024PL071909$SANDOZ$$57$YR$$F$Y$$$20240822$$HP$PL$PL
242019601$24201960$1$I$$20240809$20240812$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US071941$SANDOZ$$$$$M$Y$$$20240812$$CN$US$US
242019611$24201961$1$I$20240730$20240808$20240812$20240812$PER$$NVSC2024US162567$NOVARTIS$$36$YR$$F$Y$$$20240812$$CN$US$US
242019622$24201962$2$F$20240806$20240905$20240812$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125818$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240906$$HP$US$US
242019632$24201963$2$F$20240624$20240813$20240812$20240904$PER$$US-ALXN-202408USA000420US$ALEXION PHARMACEUTICALS$$76$YR$$M$Y$$$20240904$$CN$US$US
242019641$24201964$1$I$$20240808$20240812$20240812$EXP$$US-BAUSCH-BL-2024-012046$BAUSCH AND LOMB$$28$YR$$F$Y$$$20240812$$CN$US$US
242019651$24201965$1$I$20240801$20240805$20240812$20240812$EXP$$JP-009507513-2408JPN000560J$MERCK$$78$YR$$F$Y$$$20240812$$MD$JP$JP
242019661$24201966$1$I$$20240730$20240812$20240812$PER$$US-ALKERMES INC.-ALK-2024-002009$ALKERMES$$$$$F$Y$$$20240812$$CN$US$US
242019671$24201967$1$I$20210208$20240809$20240812$20240812$EXP$$DE-AstraZeneca-2021A307727$ASTRAZENECA$$$$E$F$Y$49.5$KG$20240812$$MD$DE$
242019681$24201968$1$I$$20240806$20240812$20240812$EXP$$IT-MYLANLABS-2024M1073422$MYLAN$$$$E$M$Y$$$20240812$$CN$IT$IT
242019692$24201969$2$F$$20240816$20240812$20240821$EXP$$CA-LUNDBECK-DKLU4002795$LUNDBECK$$$$$$Y$$$20240821$$HP$CA$CA
242019711$24201971$1$I$$20240801$20240812$20240812$PER$$US-SA-2024SA234028$SANOFI AVENTIS$$$$E$F$Y$46$KG$20240812$$MD$US$US
242019721$24201972$1$I$20240523$20240801$20240812$20240812$PER$$US-SA-2024SA233929$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240812$$MD$US$US
242019731$24201973$1$I$20240704$20240731$20240812$20240812$EXP$$CN-Ipsen Biopharmaceuticals, Inc.-2024-15881$IPSEN$$48$YR$A$F$Y$$$20240812$$HP$CN$CN
242019741$24201974$1$I$20240731$20240731$20240812$20240812$PER$$US-ALKERMES INC.-ALK-2024-002027$ALKERMES$$$$$F$Y$$$20240812$$HP$US$US
242019752$24201975$2$F$$20240812$20240812$20240815$PER$$US-BIOMARINAP-US-2024-159713$BIOMARIN$$$$$$Y$$$20240815$$CN$US$US
242019762$24201976$2$F$20240803$20240809$20240812$20240823$EXP$$CA-HLS-202401997$HLS THERAPEUTICS$$44$YR$A$M$Y$$$20240823$$HP$CA$CA
242019771$24201977$1$I$$20240807$20240812$20240812$PER$$US-APELLIS-2024-APL-0000663$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
242019781$24201978$1$I$20240714$20240716$20240812$20240812$PER$$US-INCYTE CORPORATION-2024IN007662$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242019791$24201979$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400232064$PFIZER$$63$YR$$F$Y$$$20240812$$CN$US$US
242019801$24201980$1$I$$20240807$20240812$20240812$PER$$US-PFIZER INC-202400232876$PFIZER$$67$YR$$F$Y$$$20240812$$CN$US$US
242019811$24201981$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234165$PFIZER$$$$$F$Y$$$20240812$$CN$US$US
242019821$24201982$1$I$$20240807$20240812$20240812$EXP$$US-INCYTE CORPORATION-2024IN008299$INCYTE$$$$$$Y$$$20240812$$CN$US$US
242019832$24201983$2$F$$20240828$20240812$20240828$PER$$US-ALXN-202408USA000512US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242019841$24201984$1$I$$20240809$20240812$20240812$PER$$US-PFIZER INC-202400234247$PFIZER$$$$$M$Y$$$20240812$$CN$US$US
242019851$24201985$1$I$$20240731$20240812$20240812$PER$$US-ALKERMES INC.-ALK-2024-002017$ALKERMES$$29$YR$$M$Y$$$20240812$$HP$US$US
242019861$24201986$1$I$20240101$20240731$20240812$20240812$PER$$US-ALKERMES INC.-ALK-2024-002020$ALKERMES$$$$$M$Y$$$20240812$$CN$US$US
242019871$24201987$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006221$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240812$$CN$US$US
242019883$24201988$3$F$20240803$20240807$20240812$20240821$PER$$TW-Eisai-EC-2024-171893$EISAI$$87$YR$E$F$Y$51$KG$20240821$$HP$TW$TW
242019901$24201990$1$I$20240101$20240801$20240812$20240812$PER$$US-ALKERMES INC.-ALK-2024-002032$ALKERMES$$$$$M$Y$$$20240812$$CN$US$US
242019911$24201991$1$I$20240601$20240801$20240812$20240812$PER$$US-ALKERMES INC.-ALK-2024-002034$ALKERMES$$57$YR$$M$Y$$$20240812$$HP$US$US
242019922$24201992$2$F$20240807$20240812$20240812$20240813$EXP$$US-PFIZER INC-PV202400095911$PFIZER$$62$YR$$M$Y$$$20240813$$PH$US$US
242019931$24201993$1$I$$20240801$20240812$20240812$EXP$$PH-PFIZER INC-202400233891$PFIZER$$81$YR$$F$Y$$$20240812$$HP$PH$PH
242019941$24201994$1$I$20240801$20240801$20240812$20240812$PER$$US-ALKERMES INC.-ALK-2024-002039$ALKERMES$$19$YR$$F$Y$$$20240812$$PH$US$US
242019951$24201995$1$I$20240601$20240802$20240812$20240812$PER$$US-ALKERMES INC.-ALK-2024-001813$ALKERMES$$$$$M$Y$$$20240812$$CN$US$US
242019971$24201997$1$I$20240101$20240802$20240812$20240812$PER$$US-ALKERMES INC.-ALK-2024-002047$ALKERMES$$$$$M$Y$85.261$KG$20240812$$CN$US$US
242019981$24201998$1$I$$20240808$20240812$20240812$EXP$$US-ALXN-202408USA000508US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240812$$CN$US$US
242019992$24201999$2$F$20240716$20240814$20240812$20240816$EXP$$US-ABBVIE-5875842$ABBVIE$$66$YR$$F$Y$95.254$KG$20240816$$CN$US$US
242020001$24202000$1$I$20240514$20240517$20240812$20240812$PER$$US-GE HEALTHCARE-2024CSU005293$GE HEALTHCARE$$53$YR$$F$Y$72.562$KG$20240812$$HP$US$US
242020011$24202001$1$I$20240701$20240802$20240812$20240812$PER$$US-SA-2024SA234551$SANOFI AVENTIS$$52$YR$A$M$Y$127.4$KG$20240812$$MD$US$US
242020021$24202002$1$I$20230301$20240809$20240812$20240812$EXP$DE-CADRBFARM-2024329756$DE-BAUSCH-BL-2024-012156$BAUSCH AND LOMB$$28$YR$$M$Y$86$KG$20240812$$CN$DE$DE
242020031$24202003$1$I$20240501$20240802$20240812$20240812$PER$$US-SA-2024SA234683$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240812$$MD$US$US
242020041$24202004$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126393$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240812$$HP$US$US
242020051$24202005$1$I$20230924$20240808$20240812$20240812$EXP$CH-SM-2024-14886$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-126872$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240812$$PH$CH$CH
242020061$24202006$1$I$$20240805$20240812$20240812$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI03808$NEUROCRINE BIOSCIENCES$$80$YR$$M$Y$$$20240812$$PH$US$US
242020071$24202007$1$I$$20240729$20240812$20240812$EXP$$CA-HLS-202401931$HLS THERAPEUTICS$$$$A$M$Y$$$20240812$$PH$CA$CA
242020081$24202008$1$I$20231001$20240730$20240812$20240812$EXP$$US-EVOFEM BIOSCIENCES, INC.-2024-EVO-US000032$PAREXEL$$$$$$Y$$$20240812$$CN$US$US
242020101$24202010$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126915$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$74.39$KG$20240812$$HP$US$US
242020111$24202011$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127318$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$81.65$KG$20240812$$CN$US$US
242020121$24202012$1$I$$20240805$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408003922$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240812$$CN$US$US
242020132$24202013$2$F$$20240812$20240812$20240813$PER$$NVSC2024US163336$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
242020141$24202014$1$I$$20240802$20240812$20240812$EXP$$AU-BAUSCHBL-2024BNL030982$BAUSCH AND LOMB$$$$$F$Y$$$20240812$$CN$AU$AU
242020152$24202015$2$F$$20240805$20240812$20240821$EXP$$JP-009507513-2408JPN000575J$MERCK$Nakajima I, Nakaizumi T, Usui Y, Tuji H. GE-06-05 Three cases with ocular immune-related adverse events caused by immune checkpoint inhibitors. Ocular Infection, Inflammation and Allergy 2024 in Sapporo, The 57th Annual Meet. 99$45$YR$$F$Y$$$20240821$$HP$JP$JP
242020161$24202016$1$I$$20240802$20240812$20240812$EXP$$US-BAUSCHBL-2024BNL031076$BAUSCH AND LOMB$Xia Y, Blecher N, Custer P, Sieck E. Optimizing topical drop efficacy with proper eyelid positioning. American Journal of Ophthalmology Case Reports. 2024 JUL 18;36:1-3. doi:10.1016/j.ajoc.2024.102111.$71$YR$$M$Y$$$20240812$$HP$US$US
242020171$24202017$1$I$$20240802$20240812$20240812$PER$$US-SA-2024SA233033$SANOFI AVENTIS$$29$YR$A$F$Y$68$KG$20240812$$MD$US$US
242020181$24202018$1$I$$20240730$20240812$20240812$EXP$$JP-SMPA-2024SMP011737$SUNOVION$$$$$$Y$$$20240812$$CN$JP$JP
242020202$24202020$2$F$20240602$20240813$20240812$20240816$EXP$$US-PFIZER INC-2020SGN02696$PFIZER$$60$YR$$F$Y$$$20240816$$MD$US$US
242020211$24202021$1$I$$20240805$20240812$20240812$EXP$$US-BAUSCHBL-2024BNL031149$BAUSCH AND LOMB$Sheth S, Matthia E, Naik D. Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer. Journal of Clinical Lipidology. 2024;18(4S):E555-E556. doi:10.1016/j.jacl.2024.04.091$57$YR$$F$Y$$$20240812$$HP$US$US
242020221$24202022$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163451$NOVARTIS$$$$$F$Y$$$20240812$$CN$US$US
242020241$24202024$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006329$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240812$$CN$US$US
242020251$24202025$1$I$$20240802$20240812$20240812$EXP$$US-EMERGENT BIOSOLUTIONS,-24000120$EMERGENT BIOSOLUTIONS$$40$YR$$M$Y$$$20240812$$CN$US$US
242020261$24202026$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125564$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240812$$HP$US$US
242020271$24202027$1$I$$20240805$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125250$BRISTOL MYERS SQUIBB$Tan CH, Sayegh Y, Fasih-Ahmad S, Tse DT, Karp CL, Dubovy SR. Periocular granulomatous inflammatory lesions mimicking conjunctival  melanoma recurrence in the setting of systemic nivolumab treatment. American Journal of Ophthalmology Case Reports. 2024;36:1-5. doi:10.1016/j.ajoc.2024.102025.$46$YR$A$M$Y$$$20240812$$HP$US$US
242020281$24202028$1$I$$20240731$20240812$20240812$PER$$US-009507513-2408USA000304$MERCK$$$$$F$Y$$$20240812$$CN$US$US
242020291$24202029$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125657$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240812$$CN$US$US
242020301$24202030$1$I$20240315$20240710$20240812$20240812$PER$$US-ANIPHARMA-2024-US-016708$ANI$$46$YR$$M$Y$$$20240812$$HP$US$US
242020311$24202031$1$I$$20240806$20240812$20240812$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-125103$BRISTOL MYERS SQUIBB$Haschka D, Petzer V, Schmidt S, Jukic E, Duftner C, Wolf D, et al. Azacitidine treatment of a patient with vexas syndrome and a new, causative UBA1 mutation. Fakten Der Rheumatologie. 2024;02:45-6.$$$$M$Y$$$20240812$$MD$AT$AT
242020321$24202032$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125374$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240812$$CN$US$US
242020332$24202033$2$F$20240621$20240821$20240812$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125648$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240903$$MD$US$US
242020341$24202034$1$I$$20240809$20240812$20240812$EXP$$CN-AstraZeneca-2024A182993$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$CN$
242020351$24202035$1$I$$20240807$20240812$20240812$EXP$$CN-AstraZeneca-2024A182215$ASTRAZENECA$$$$$M$Y$$$20240812$$CN$CN$
242020361$24202036$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408007023$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240812$$CN$US$US
242020391$24202039$1$I$20240305$20240805$20240812$20240812$EXP$$JP-APELLIS-APL-2024-003910$APELLIS PHARMACEUTICALS$$$$$$Y$62$KG$20240809$$CN$JP$JP
242020402$24202040$2$F$20200101$20240804$20240812$20240819$EXP$$AU-OTSUKA-2024_020998$OTSUKA$$$$$$Y$$$20240819$$CN$AU$AU
242020411$24202041$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235133$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240813$$MD$US$US
242020421$24202042$1$I$20240806$20240806$20240812$20240812$PER$$US-SA-2024SA235169$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240813$$MD$US$US
242020431$24202043$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235330$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240813$$MD$US$US
242020441$24202044$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA235450$SANOFI AVENTIS$$$$A$F$Y$$$20240813$$MD$US$US
242020451$24202045$1$I$$20240805$20240812$20240812$PER$$US-SA-2024SA234988$SANOFI AVENTIS$$16$YR$T$F$Y$65.77$KG$20240813$$MD$US$US
242020462$24202046$2$F$$20240909$20240812$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125262$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240911$$CN$US$US
242020471$24202047$1$I$$20240810$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408007024$ELI LILLY AND CO$$$$$$Y$$$20240812$$CN$US$US
242020482$24202048$2$F$$20240809$20240812$20240903$EXP$$US-AstraZeneca-2024A182651$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242020491$24202049$1$I$$20240731$20240812$20240812$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07670$NEUROCRINE BIOSCIENCES$$59$YR$$F$Y$$$20240812$$HP$US$US
242020501$24202050$1$I$$20240809$20240812$20240812$EXP$GB-MHRA-MED-202408091510358050-RKVYF$GB-GILEAD-2024-0683719$GILEAD$$$$$M$Y$$$20240812$$PH$GB$GB
242020511$24202051$1$I$$20230203$20240812$20240812$EXP$$CA-AstraZeneca-2023A023920$ASTRAZENECA$$$$$F$Y$$$20240812$$HP$CA$
242020522$24202052$2$F$20240731$20240821$20240812$20240902$EXP$$JP-RIGEL-20240800031$RIGEL PHARMACEUTICALS$$86$YR$$M$Y$$$20240902$$MD$JP$JP
242020531$24202053$1$I$$20240729$20240812$20240812$EXP$$US-HLS-202400606$HLS THERAPEUTICS$$$$A$$Y$$$20240812$$MD$US$US
242020541$24202054$1$I$$20230206$20240812$20240812$EXP$$US-AstraZeneca-2023A032796$ASTRAZENECA$$$$$M$Y$$$20240812$$MD$US$
242020551$24202055$1$I$$20221014$20240812$20240812$EXP$$TW-AstraZeneca-2022A347367$ASTRAZENECA$$57$YR$$M$Y$$$20240812$$CN$TW$
242020561$24202056$1$I$$20230817$20240812$20240812$EXP$$US-AstraZeneca-2023A188494$ASTRAZENECA$$$$$F$Y$$$20240812$$CN$US$
242020572$24202057$2$F$20240812$20240903$20240812$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045123$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240905$$CN$US$US
242020581$24202058$1$I$20240802$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126125$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$73.48$KG$20240812$$CN$US$US
242020611$24202061$1$I$$20240729$20240812$20240812$EXP$$US-HLS-202400614$HLS THERAPEUTICS$$$$E$$Y$$$20240812$$HP$US$US
242020621$24202062$1$I$20150212$20240729$20240812$20240812$EXP$$US-HLS-202400613$HLS THERAPEUTICS$$52$YR$A$$Y$$$20240812$$MD$US$US
242020631$24202063$1$I$$20240804$20240812$20240812$PER$$US-APELLIS-2024-APL-0000637$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240812$$CN$US$US
242020651$24202065$1$I$20240504$20240806$20240812$20240812$EXP$$JP-BIOMARINAP-JP-2024-158901$BIOMARIN$$$$$$Y$$$20240812$$CN$JP$JP
242020661$24202066$1$I$20240718$20240809$20240812$20240812$EXP$$CL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045064$BOEHRINGER INGELHEIM$$92$YR$E$F$Y$$$20240812$$MD$CL$CL
242020672$24202067$2$F$$20240911$20240812$20240917$EXP$$US-GILEAD-2024-0683737$GILEAD$$$$A$M$Y$$$20240917$$CN$US$US
242020681$24202068$1$I$20240624$20240729$20240812$20240812$EXP$$CA-HLS-202401522$HLS THERAPEUTICS$$39$YR$A$F$Y$$$20240812$$MD$CA$CA
242020691$24202069$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127215$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240812$$CN$US$US
242020711$24202071$1$I$20240626$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126765$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240812$$CN$US$US
242020721$24202072$1$I$20240719$20240729$20240812$20240812$EXP$$US-HLS-202400615$HLS THERAPEUTICS$$40$YR$A$F$Y$$$20240812$$HP$US$US
242020731$24202073$1$I$20211225$20240806$20240812$20240812$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044182$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240812$$HP$AU$AU
242020741$24202074$1$I$$20240809$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127135$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$58.51$KG$20240812$$CN$US$US
242020754$24202075$4$F$20240802$20240919$20240812$20240920$PER$$US-JNJFOC-20240813594$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240920$$CN$US$US
242020761$24202076$1$I$$20240809$20240812$20240812$PER$$US-BIOMARINAP-US-2024-159777$BIOMARIN$$$$$$Y$$$20240812$$CN$US$US
242020771$24202077$1$I$20240710$20240805$20240812$20240812$EXP$$CN-AstraZeneca-2024A179620$ASTRAZENECA$$57$YR$$F$Y$55$KG$20240813$$MD$CN$
242020781$24202078$1$I$$20240729$20240812$20240812$EXP$$US-HLS-202400628$HLS THERAPEUTICS$$70$YR$E$F$Y$$$20240812$$MD$IN$US
242020791$24202079$1$I$20240802$20240808$20240812$20240812$EXP$$PH-ROCHE-10000054204$ROCHE$$51$YR$A$M$Y$$$20240812$$CN$PH$PH
242020801$24202080$1$I$20240804$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159539$AMGEN$$80$YR$E$M$Y$$$20240812$$CN$US$US
242020811$24202081$1$I$20221201$20240802$20240812$20240812$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-125045$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240812$$MD$PL$PL
242020821$24202082$1$I$20240802$20240807$20240812$20240812$PER$$US-009507513-2408USA002469$MERCK$$45$YR$$$Y$$$20240812$$CN$US$US
242020831$24202083$1$I$20240101$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159489$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
242020841$24202084$1$I$20240806$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159496$AMGEN$$52$YR$A$M$Y$$$20240812$$CN$US$US
242020851$24202085$1$I$20240726$20240808$20240812$20240812$EXP$$PH-ROCHE-10000054255$ROCHE$$69$YR$E$M$Y$$$20240813$$CN$PH$PH
242020861$24202086$1$I$$20240805$20240812$20240812$PER$$US-APELLIS-2024-APL-0000643$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240812$$HP$US$US
242020871$24202087$1$I$$20240808$20240812$20240812$EXP$$PH-ROCHE-10000054276$ROCHE$$$$$M$Y$$$20240813$$CN$PH$PH
242020881$24202088$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005861$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240812$$CN$US$US
242020891$24202089$1$I$20240730$20240808$20240812$20240812$EXP$$PH-ROCHE-10000054302$ROCHE$$32$YR$A$F$Y$$$20240813$$CN$PH$PH
242020901$24202090$1$I$$20240808$20240812$20240812$EXP$$PH-ROCHE-10000054219$ROCHE$$$$$F$Y$$$20240813$$CN$PH$PH
242020911$24202091$1$I$$20240807$20240812$20240812$EXP$$JP-AstraZeneca-2024A180385$ASTRAZENECA$$83$YR$$F$Y$$$20240813$$CN$JP$
242020921$24202092$1$I$20220614$20240805$20240812$20240812$EXP$$GB-009507513-2405GBR005985$MERCK$$36$YR$$F$Y$61$KG$20240812$$MD$GB$GB
242020931$24202093$1$I$20240726$20240808$20240812$20240812$EXP$$PH-ROCHE-10000054119$ROCHE$$68$YR$E$F$Y$$$20240813$$CN$PH$PH
242020941$24202094$1$I$20230506$20240729$20240812$20240812$EXP$$JP-AMGEN-JPNNI2023202864$AMGEN$$89$YR$E$M$Y$61$KG$20240812$$MD$JP$JP
242020951$24202095$1$I$20240628$20240730$20240812$20240812$EXP$$AE-AMGEN-ARENI2024158209$AMGEN$$77$YR$E$M$Y$$$20240812$$MD$AE$AE
242020961$24202096$1$I$20240802$20240811$20240812$20240812$EXP$$DZ-BIOMARINAP-DZ-2024-159794$BIOMARIN$$$$$$Y$$$20240812$$CN$DZ$DZ
242020981$24202098$1$I$$20240731$20240812$20240812$PER$$US-ROCHE-3562968$ROCHE$$13$YR$T$M$Y$32.66$KG$20240813$$CN$US$US
242020991$24202099$1$I$$20240729$20240812$20240812$PER$$US-TEVA-VS-3228836$TEVA$$$$$M$Y$$$20240812$$CN$US$US
242021002$24202100$2$F$20240803$20240812$20240812$20240814$PER$$US-AMGEN-USASP2024159194$AMGEN$$53$YR$A$F$Y$$$20240814$$CN$US$US
242021011$24202101$1$I$$20240805$20240812$20240812$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125422$BRISTOL MYERS SQUIBB$Kanno A, et al. A case of resumed anticancer drug treatment after treatment of irAE diagnosed as cachexia. Joint Meeting of the 29th Congress of the Japanese Society for Palliative Medicine. 2024;P47-9.$7$DEC$E$M$Y$$$20240813$$MD$JP$JP
242021021$24202102$1$I$20240603$20240809$20240812$20240812$EXP$$US-JNJFOC-20240824585$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240813$$CN$US$US
242021031$24202103$1$I$$20240808$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408005886$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240812$$CN$US$US
242021041$24202104$1$I$20240809$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159216$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
242021051$24202105$1$I$$20240809$20240812$20240812$30DAY$$US-SANDOZ INC.-SDZ2024US071950$SANDOZ$$$$$F$Y$12$KG$20240812$$HP$US$US
242021062$24202106$2$F$$20240807$20240812$20240813$30DAY$$US-SANDOZ INC.-SDZ2024US071910$SANDOZ$$67$YR$$$Y$$$20240813$$CN$US$US
242021071$24202107$1$I$$20240808$20240812$20240812$EXP$$US-JNJFOC-20240821095$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$PH$US$US
242021081$24202108$1$I$$20240807$20240812$20240812$EXP$$US-JNJFOC-20240818454$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
242021091$24202109$1$I$$20240809$20240812$20240812$PER$$US-JNJFOC-20240827652$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240813$$MD$US$US
242021101$24202110$1$I$20240601$20240705$20240812$20240812$PER$$US-INCYTE CORPORATION-2024IN007139$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242021111$24202111$1$I$20240101$20240807$20240812$20240812$EXP$$US-JNJFOC-20240817772$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240813$$CN$US$US
242021121$24202112$1$I$20240627$20240802$20240812$20240812$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125396$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240813$$MD$JP$JP
242021131$24202113$1$I$$20240808$20240812$20240812$EXP$$US-PFIZER INC-PV202400055353$PFIZER$$72$YR$$M$Y$$$20240812$$HP$US$US
242021152$24202115$2$F$20240101$20240815$20240812$20240820$EXP$$CA-PFIZER INC-202300452088$PFIZER$$70$YR$$F$Y$79$KG$20240820$$MD$CA$CA
242021161$24202116$1$I$20240101$20240808$20240812$20240812$EXP$$ZA-PFIZER INC-PV202400033388$PFIZER$$68$YR$$F$Y$$$20240812$$CN$ZA$ZA
242021171$24202117$1$I$$20240810$20240812$20240812$EXP$$US-PFIZER INC-202400234357$PFIZER$$$$$$Y$$$20240812$$CN$US$US
242021181$24202118$1$I$20240314$20240808$20240812$20240812$EXP$FR-AFSSAPS-PA2024001277$FR-PFIZER INC-202400232668$PFIZER$$79$YR$$F$Y$75$KG$20240812$$PH$FR$FR
242021191$24202119$1$I$20240601$20240802$20240812$20240812$PER$$US-ABBVIE-5866545$ABBVIE$$40$YR$$M$Y$$$20240812$$CN$US$US
242021201$24202120$1$I$$20240812$20240812$20240812$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045147$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240813$$CN$US$US
242021211$24202121$1$I$20240612$20240808$20240812$20240812$EXP$$US-ABBVIE-5874311$ABBVIE$$64$YR$$F$Y$$$20240812$$CN$US$US
242021221$24202122$1$I$20240727$20240805$20240812$20240812$EXP$$CN-BEIGENE-BGN-2024-012191$BEIGENE$$$$$$Y$$$20240812$$HP$CN$CN
242021231$24202123$1$I$20240601$20240809$20240812$20240812$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045124$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$$$20240813$$CN$US$US
242021241$24202124$1$I$$20240805$20240812$20240812$EXP$$US-JNJFOC-20240811392$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$CN$US$US
242021251$24202125$1$I$$20240801$20240812$20240812$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-125519$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$96$KG$20240813$$HP$CA$CA
242021261$24202126$1$I$20240101$20240802$20240812$20240812$EXP$$CA-ABBVIE-5875897$ABBVIE$$71$YR$$M$Y$$$20240812$$HP$CA$CA
242021272$24202127$2$F$$20240823$20240812$20240828$EXP$$US-ABBVIE-5875788$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242021281$24202128$1$I$20240801$20240808$20240812$20240812$EXP$$KR-ABBVIE-5872454$ABBVIE$$62$YR$$F$Y$$$20240812$$CN$KR$KR
242021291$24202129$1$I$20041201$20240807$20240812$20240812$EXP$$US-JNJFOC-20240827311$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20240813$$LW$US$US
242021301$24202130$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5874400$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242021311$24202131$1$I$20240601$20240807$20240812$20240812$EXP$$US-ABBVIE-5872721$ABBVIE$$37$YR$$F$Y$$$20240812$$CN$US$US
242021321$24202132$1$I$20181105$20240809$20240812$20240812$EXP$$US-ABBVIE-5875380$ABBVIE$$41$YR$$F$Y$$$20240812$$CN$US$US
242021331$24202133$1$I$$20240809$20240812$20240812$EXP$$US-ABBVIE-5875472$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
242021341$24202134$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5874433$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
242021351$24202135$1$I$$20240809$20240812$20240812$EXP$$US-009507513-2408USA003417$MERCK$$60$YR$$M$Y$$$20240812$$CN$US$US
242021361$24202136$1$I$$20240808$20240812$20240812$EXP$$IL-ABBVIE-5875836$ABBVIE$$$$$F$Y$$$20240812$$CN$IL$IL
242021372$24202137$2$F$20240806$20240808$20240812$20240814$PER$$US-AMGEN-USASP2024156731$AMGEN$$$$$M$Y$$$20240814$$CN$US$US
242021381$24202138$1$I$$20240801$20240812$20240812$PER$$US-SMPA-2024SPA000730$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021391$24202139$1$I$$20240801$20240812$20240812$PER$$US-SMPA-2024SPA000669$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021401$24202140$1$I$20230101$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158759$AMGEN$$58$YR$A$F$Y$$$20240812$$CN$US$US
242021411$24202141$1$I$$20240715$20240812$20240812$PER$$US-SMPA-2024MYSCI0700572$SUNOVION$$$$$$Y$$$20240812$$HP$US$US
242021421$24202142$1$I$$20240802$20240812$20240812$PER$$US-SMPA-2024SPA000784$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021441$24202144$1$I$$20240715$20240812$20240812$PER$$US-SMPA-2024MYSCI0700566$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021452$24202145$2$F$$20240815$20240812$20240911$PER$$US-SMPA-2024MYSCI0500633$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
242021461$24202146$1$I$$20240716$20240812$20240812$PER$$US-SMPA-2024MYSCI0700672$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021471$24202147$1$I$20240101$20240716$20240812$20240812$PER$$US-SMPA-2024MYSCI0700674$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021482$24202148$2$F$20240101$20240815$20240812$20240911$PER$$US-SMPA-2024MYSCI0700012$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
242021491$24202149$1$I$$20240715$20240812$20240812$PER$$US-SMPA-2024MYSCI0700581$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021501$24202150$1$I$$20240715$20240812$20240812$PER$$US-SMPA-2024MYSCI0600533$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021511$24202151$1$I$$20240715$20240812$20240812$PER$$US-SMPA-2024MYSCI0700570$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021522$24202152$2$F$20240701$20240814$20240812$20240819$EXP$$US-ABBVIE-5871734$ABBVIE$$70$YR$$M$Y$$$20240819$$CN$US$US
242021531$24202153$1$I$20240731$20240805$20240812$20240812$EXP$$CN-BEIGENE-BGN-2024-012187$BEIGENE$$$$$$Y$$$20240812$$HP$CN$CN
242021541$24202154$1$I$$20240808$20240812$20240812$EXP$$US-ASTELLAS-2024US022615$ASTELLAS$$60$YR$$F$Y$$$20240813$$CN$US$US
242021551$24202155$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127253$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240813$$CN$US$US
242021561$24202156$1$I$$20240806$20240812$20240812$EXP$$GR-JNJFOC-20240822567$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$50$KG$20240813$$CN$GR$GR
242021571$24202157$1$I$$20240807$20240812$20240812$EXP$$NVSJ2024JP009560$NOVARTIS$Tanaka R, Sato T, Umeda Y and Aoyama H. A case of angiosarcoma treated with PAZOPANIB. Nishinihon Dermatology / The 75 Ehime Regional Meeting of the Japanese Dermatolo. 2024;86(1):90$$$A$F$Y$$$20240813$$HP$JP$JP
242021581$24202158$1$I$$20240802$20240812$20240812$EXP$$JP-009507513-2408JPN000578J$MERCK$$68$YR$$F$Y$$$20240812$$MD$JP$JP
242021592$24202159$2$F$$20240822$20240812$20240826$EXP$$JP-TAKEDA-2024TJP011813$TAKEDA$$6$DEC$$F$Y$$$20240826$$MD$JP$JP
242021601$24202160$1$I$20240710$20240805$20240812$20240812$EXP$$CN-BEIGENE-BGN-2024-012196$BEIGENE$$$$$$Y$$$20240812$$HP$CN$CN
242021612$24202161$2$F$20240101$20240828$20240812$20240905$PER$$US-BAUSCHBL-2024BNL031112$BAUSCH AND LOMB$$71$YR$$F$Y$49.89$KG$20240906$$CN$US$US
242021621$24202162$1$I$20240729$20240805$20240812$20240812$EXP$$CN-BEIGENE-BGN-2024-012215$BEIGENE$$$$$$Y$$$20240812$$HP$CN$CN
242021633$24202163$3$F$20240725$20240816$20240812$20240827$30DAY$$GB-JNJFOC-20240772374$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$CN$GB$GB
242021641$24202164$1$I$$20240806$20240812$20240812$EXP$$PH-ABBVIE-5875902$ABBVIE$$$$$$Y$$$20240812$$CN$PH$PH
242021651$24202165$1$I$20240101$20240802$20240812$20240812$PER$$US-BAUSCHBL-2024BNL031188$BAUSCH AND LOMB$$79$YR$$F$Y$$$20240813$$CN$US$US
242021661$24202166$1$I$20240801$20240808$20240812$20240812$EXP$$US-ABBVIE-5873984$ABBVIE$$52$YR$$M$Y$$$20240812$$CN$US$US
242021681$24202168$1$I$$20240730$20240812$20240812$EXP$$US-SMPA-2024SPA000565$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021691$24202169$1$I$20240628$20240722$20240812$20240812$EXP$GB-MHRA-31204242$HU-SMPA-2024SPA000728$SUNOVION$$$$$$Y$$$20240812$$MD$GB$GB
242021701$24202170$1$I$$20240730$20240812$20240812$EXP$$US-SMPA-2024SPA000621$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021711$24202171$1$I$$20240730$20240812$20240812$EXP$$US-SMPA-2024SPA000525$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021721$24202172$1$I$$20240730$20240812$20240812$EXP$$US-SMPA-2024SPA000477$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021741$24202174$1$I$$20240730$20240812$20240812$EXP$$US-SMPA-2024SPA000611$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021751$24202175$1$I$$20240730$20240812$20240812$EXP$$US-SMPA-2024SPA000430$SUNOVION$$$$$$Y$$$20240812$$CN$US$US
242021761$24202176$1$I$20240101$20240808$20240812$20240812$EXP$$US-ABBVIE-5874174$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
242021771$24202177$1$I$20240715$20240805$20240812$20240812$EXP$FR-AFSSAPS-BS2024000480$FR-INCYTE CORPORATION-2024IN008192$INCYTE$$$$$$Y$$$20240813$$MD$FR$FR
242021781$24202178$1$I$$20240808$20240812$20240812$EXP$$JP-INCYTE CORPORATION-2024IN008339$INCYTE$$$$$$Y$$$20240813$$PH$JP$JP
242021791$24202179$1$I$$20240805$20240812$20240812$EXP$$RO-INCYTE CORPORATION-2024IN008289$INCYTE$$$$$$Y$$$20240813$$MD$RO$RO
242021802$24202180$2$F$20240101$20240814$20240812$20240819$EXP$$US-ABBVIE-5875988$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242021811$24202181$1$I$20240731$20240809$20240812$20240812$EXP$$CN-BEIGENE-BGN-2024-012516$BEIGENE$$$$$$Y$$$20240812$$HP$CN$CN
242021821$24202182$1$I$$20240722$20240812$20240812$PER$$US-INCYTE CORPORATION-2024IN007698$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242021832$24202183$2$F$$20240901$20240812$20240910$EXP$$US-SMPA-2023MYSCI1100260$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
242021841$24202184$1$I$20240722$20240726$20240812$20240812$PER$$US-INCYTE CORPORATION-2024IN007881$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242021851$24202185$1$I$$20240725$20240812$20240812$PER$$US-INCYTE CORPORATION-2024IN007874$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242021861$24202186$1$I$$20240726$20240812$20240812$PER$$US-INCYTE CORPORATION-2024IN007895$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242021872$24202187$2$F$$20240820$20240812$20240824$PER$$US-AMGEN-USASP2024158644$AMGEN$$$$$$Y$$$20240824$$CN$US$US
242021881$24202188$1$I$$20240731$20240812$20240812$EXP$$DE-AZURITY PHARMACEUTICALS, INC.-AZR202407-000275$AZURITY PHARMACEUTICALS$Heinz P, Schuldes S, Wolf B.. Locked-in syndrome after pontine hemorrhage in an amphetamine abuser. Dtsch Arztebl Int. 2024;121:330$37$YR$$F$Y$$$20240812$$MD$DE$DE
242021891$24202189$1$I$$20240802$20240812$20240812$PER$$US-BAUSCHBL-2024BNL031134$BAUSCH AND LOMB$$$$$F$Y$$$20240813$$CN$US$US
242021901$24202190$1$I$20240101$20240802$20240812$20240812$PER$$US-BAUSCHBL-2024BNL031125$BAUSCH AND LOMB$$96$YR$$F$Y$$$20240813$$CN$US$US
242021911$24202191$1$I$$20240726$20240812$20240812$PER$$US-INCYTE CORPORATION-2024IN007897$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242021921$24202192$1$I$20240701$20240802$20240812$20240812$PER$$US-BAUSCHBL-2024BNL031124$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240813$$CN$US$US
242021932$24202193$2$F$20240712$20240826$20240812$20240909$EXP$$JP-MDD US Operations-E2B_00006407$MDD OPERATIONS$$69$YR$$M$Y$$$20240909$$MD$JP$JP
242021942$24202194$2$F$20240805$20240912$20240812$20240918$EXP$$NVSJ2024JP009442$NOVARTIS$$80$YR$$F$Y$$$20240918$$PH$JP$JP
242021951$24202195$1$I$$20240808$20240812$20240812$EXP$$EU-BAUSCHBL-2024BNL031320$BAUSCH AND LOMB$$$$$M$Y$$$20240813$$CN$EU$EU
242021962$24202196$2$F$20240607$20240819$20240812$20240821$EXP$$JP-TAKEDA-2024TJP011870$TAKEDA$$85$YR$$M$Y$$$20240821$$MD$JP$JP
242021971$24202197$1$I$20220623$20240807$20240812$20240812$EXP$$AU-ABBVIE-5872433$ABBVIE$$77$YR$$F$Y$$$20240812$$MD$AU$AU
242021981$24202198$1$I$20240719$20240806$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125134$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$94.35$KG$20240813$$PH$US$US
242021991$24202199$1$I$20240715$20240809$20240812$20240812$EXP$$CO-ABBVIE-5875222$ABBVIE$$67$YR$$F$Y$$$20240812$$MD$CO$CO
242022001$24202200$1$I$$20240809$20240812$20240812$PER$$US-GILEAD-2024-0683675$GILEAD$$$$$F$Y$$$20240812$$HP$US$US
242022014$24202201$4$F$$20240826$20240812$20240830$EXP$$JP-GSK-JP2024097880$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$PH$JP$JP
242022021$24202202$1$I$20240101$20240806$20240812$20240812$EXP$$US-BIOGEN-2024BI01277302$BIOGEN$$$$$M$Y$$$20240812$$CN$US$US
242022033$24202203$3$F$20240801$20240920$20240812$20240926$PER$$US-ABBVIE-5872552$ABBVIE$$74$YR$$M$Y$91$KG$20240926$$CN$US$US
242022041$24202204$1$I$$20240807$20240812$20240812$EXP$$US-ABBVIE-5872303$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242022051$24202205$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163507$NOVARTIS$$$$$F$Y$$$20240813$$CN$US$US
242022061$24202206$1$I$20240801$20240805$20240812$20240812$EXP$$CN-BEIGENE-BGN-2024-012217$BEIGENE$$$$$$Y$$$20240812$$HP$CN$CN
242022071$24202207$1$I$$20240730$20240812$20240812$PER$$US-ROCHE-10000046345$ROCHE$$$$$M$Y$$$20240813$$HP$US$US
242022082$24202208$2$F$$20240827$20240812$20240904$EXP$$US-BIOGEN-2024BI01265046$BIOGEN$$$$$F$Y$$$20240904$$CN$US$US
242022091$24202209$1$I$$20240808$20240812$20240812$EXP$$US-BIOGEN-2024BI01277653$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
242022101$24202210$1$I$$20240807$20240812$20240812$PER$$US-ROCHE-10000008944$ROCHE$$$$$$Y$$$20240813$$CN$US$US
242022111$24202211$1$I$$20240807$20240812$20240812$PER$$US-ROCHE-10000053386$ROCHE$$6$YR$C$M$Y$$$20240813$$CN$US$US
242022122$24202212$2$F$$20240813$20240812$20240819$PER$$US-ROCHE-10000051678$ROCHE$$$$$F$Y$$$20240819$$CN$US$US
242022141$24202214$1$I$20240101$20240808$20240812$20240812$EXP$$US-ABBVIE-5874324$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242022152$24202215$2$F$$20240903$20240812$20240906$PER$$US-ROCHE-10000053984$ROCHE$$36$YR$A$M$Y$$$20240906$$CN$US$US
242022161$24202216$1$I$20240501$20240808$20240812$20240812$EXP$$US-ABBVIE-5874067$ABBVIE$$56$YR$$F$Y$$$20240812$$CN$US$US
242022171$24202217$1$I$$20240808$20240812$20240812$PER$$US-ROCHE-10000052898$ROCHE$$$$E$F$Y$$$20240813$$CN$US$US
242022181$24202218$1$I$$20240724$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202407016252$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240812$$CN$US$US
242022191$24202219$1$I$$20240806$20240812$20240812$EXP$$CA-JNJFOC-20240823946$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240813$$HP$CA$CA
242022202$24202220$2$F$20240806$20240813$20240812$20240821$PER$$US-ROCHE-10000052618$ROCHE$$38$YR$A$M$Y$81.65$KG$20240821$$CN$US$US
242022211$24202221$1$I$20220101$20240807$20240812$20240812$EXP$$US-ABBVIE-5754925$ABBVIE$$22$YR$$F$Y$$$20240812$$CN$US$US
242022221$24202222$1$I$20240701$20240810$20240812$20240812$EXP$$US-ABBVIE-5876037$ABBVIE$$$$A$F$Y$$$20240812$$MD$US$US
242022231$24202223$1$I$20240718$20240802$20240812$20240812$EXP$$US-BIOGEN-2024BI01277532$BIOGEN$$27$YR$$F$Y$$$20240812$$CN$US$US
242022241$24202224$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5874762$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
242022251$24202225$1$I$20240501$20240808$20240812$20240812$PER$$US-ROCHE-10000053422$ROCHE$$48$YR$A$F$Y$$$20240813$$CN$US$US
242022261$24202226$1$I$$20240808$20240812$20240812$EXP$$US-ABBVIE-5874252$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242022271$24202227$1$I$20240501$20240809$20240812$20240812$PER$$US-ROCHE-10000054580$ROCHE$$81$YR$E$M$Y$$$20240813$$CN$US$US
242022281$24202228$1$I$20240101$20240808$20240812$20240812$EXP$$US-ABBVIE-5874274$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
242022291$24202229$1$I$20240101$20240810$20240812$20240812$EXP$$US-ABBVIE-5876487$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
242022301$24202230$1$I$$20240801$20240812$20240812$PER$$US-ROCHE-10000054150$ROCHE$$$$$$Y$$$20240813$$CN$US$US
242022311$24202231$1$I$$20240809$20240812$20240812$PER$$US-ROCHE-10000054285$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
242022321$24202232$1$I$$20240809$20240812$20240812$PER$$US-ROCHE-10000054666$ROCHE$$$$E$F$Y$$$20240813$$CN$US$US
242022331$24202233$1$I$20190104$20240807$20240812$20240812$EXP$$JP-TAKEDA-2019TJP000106$TAKEDA$$6$DEC$$F$Y$$$20240812$$HP$JP$JP
242022341$24202234$1$I$$20240808$20240812$20240812$EXP$$GB-AMGEN-GBRSP2024159648$AMGEN$$88$YR$E$M$Y$$$20240812$$CN$GB$GB
242022351$24202235$1$I$20231101$20240808$20240812$20240812$EXP$$US-ABBVIE-5807636$ABBVIE$$73$YR$$F$Y$77.11$KG$20240812$$CN$US$US
242022362$24202236$2$F$20240501$20240812$20240812$20240815$EXP$$US-ABBVIE-5875420$ABBVIE$$50$YR$$F$Y$65.771$KG$20240815$$CN$US$US
242022372$24202237$2$F$20240808$20240913$20240812$20240917$EXP$$JP-TAKEDA-2024TJP011857$TAKEDA$$5$DEC$$F$Y$$$20240917$$MD$JP$JP
242022381$24202238$1$I$$20240805$20240812$20240812$PER$$US-TAKEDA-2024TUS079095$TAKEDA$$$$$$Y$$$20240812$$CN$US$US
242022391$24202239$1$I$$20240801$20240812$20240812$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-126892$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$97$KG$20240813$$MD$CA$CA
242022402$24202240$2$F$20220101$20240812$20240812$20240818$EXP$$US-ABBVIE-5875449$ABBVIE$$$$$M$Y$65.77$KG$20240818$$CN$US$US
242022411$24202241$1$I$$20240809$20240812$20240812$EXP$$US-ABBVIE-5875917$ABBVIE$$$$$F$Y$$$20240812$$HP$US$US
242022423$24202242$3$F$20240729$20240830$20240812$20240906$EXP$$BR-BIOGEN-2024BI01277687$BIOGEN$$43$YR$$M$Y$96$KG$20240906$$CN$BR$BR
242022431$24202243$1$I$20240730$20240805$20240812$20240812$EXP$$CN-BEIGENE-BGN-2024-012219$BEIGENE$$$$$$Y$$$20240812$$HP$CN$CN
242022442$24202244$2$F$$20240809$20240812$20240813$EXP$$IT-SANDOZ INC.-SDZ2024IT071703$SANDOZ$$45$MON$$F$Y$$$20240813$$HP$IT$IT
242022453$24202245$3$F$20240601$20240906$20240812$20240912$PER$$US-AMGEN-USASP2024156969$AMGEN$$77$YR$E$M$Y$$$20240912$$CN$US$US
242022461$24202246$1$I$$20240730$20240812$20240812$EXP$$CN-Unichem Pharmaceuticals (USA) Inc-UCM202408-000977$UNICHEM$$16$YR$T$M$Y$78$KG$20240813$$HP$CN$
242022471$24202247$1$I$20240802$20240808$20240812$20240812$PER$$US-AMGEN-USASP2024158433$AMGEN$$$$$$Y$$$20240812$$PH$US$US
242022482$24202248$2$F$20240228$20240807$20240812$20240815$EXP$$NVSJ2024JP005890$NOVARTIS$$54$YR$$M$Y$75$KG$20240816$$MD$JP$JP
242022491$24202249$1$I$$20240805$20240812$20240812$EXP$$NVSC2024MY160159$NOVARTIS$$$$$M$Y$$$20240813$$MD$MY$MY
242022503$24202250$3$F$20240802$20240904$20240812$20240905$PER$$US-AMGEN-USASP2024155322$AMGEN$$52$YR$A$F$Y$$$20240904$$CN$US$US
242022511$24202251$1$I$$20240804$20240812$20240812$EXP$$US-JNJFOC-20240810003$JOHNSON AND JOHNSON$$14$MON$I$$Y$$$20240813$$HP$US$US
242022521$24202252$1$I$$20240808$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126286$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$72.57$KG$20240813$$CN$US$US
242022531$24202253$1$I$20240809$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006686$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240812$$CN$US$US
242022541$24202254$1$I$20240101$20240808$20240812$20240812$EXP$$US-ABBVIE-5874193$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242022551$24202255$1$I$20240201$20240808$20240812$20240812$EXP$$US-ABBVIE-5874214$ABBVIE$$45$YR$$M$Y$$$20240812$$CN$US$US
242022571$24202257$1$I$$20240801$20240812$20240812$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-124700$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240813$$HP$CA$CA
242022581$24202258$1$I$$20240807$20240812$20240812$EXP$$CA-TAKEDA-2023TUS002549$TAKEDA$$$$$F$Y$$$20240812$$MD$CA$CA
242022591$24202259$1$I$20240801$20240801$20240812$20240812$PER$$US-JNJFOC-20240808244$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$MD$US$US
242022603$24202260$3$F$20240501$20240909$20240812$20240912$EXP$$US-JNJFOC-20240637148$JOHNSON AND JOHNSON$$71$YR$E$F$Y$57.3$KG$20240912$$HP$US$US
242022611$24202261$1$I$20240101$20240807$20240812$20240812$EXP$$DE-JNJFOC-20240822357$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240813$$MD$DE$DE
242022621$24202262$1$I$20210101$20240805$20240812$20240812$EXP$$RU-009507513-2408RUS000246$MERCK$Marina F. Ballyuzek, Sergey O. Kuzin, Dzerasa G. Khaimanova, Georgy V. Sholokhov. The Characteristics of Cardiovascular Adverse Events in Therapy with Immune Checkpoint Inhibitors: The Result of Work of the Multi-Disciplinary Team.. PROBLEMS IN ONCOLOGY.. 2024;70(3):541-49$49$YR$$F$Y$52$KG$20240812$$MD$RU$RU
242022631$24202263$1$I$$20240802$20240812$20240812$PER$$US-ROCHE-10000049443$ROCHE$$$$$$Y$$$20240813$$MD$US$US
242022642$24202264$2$F$20240101$20240924$20240812$20240928$EXP$$CA-ABBVIE-5874086$ABBVIE$$68$YR$$F$Y$$$20240928$$CN$CA$CA
242022651$24202265$1$I$20240101$20240806$20240812$20240812$PER$$US-SA-2024SA235527$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240813$$CN$US$US
242022661$24202266$1$I$$20240806$20240812$20240812$PER$$US-SA-2024SA235592$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240813$$MD$US$US
242022671$24202267$1$I$$20240801$20240812$20240812$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-124119$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240813$$MD$CA$CA
242022681$24202268$1$I$$20240806$20240812$20240812$EXP$$US-BEIGENE-BGN-2024-012395$BEIGENE$$$$$$Y$$$20240812$$CN$US$US
242022691$24202269$1$I$20240101$20240807$20240812$20240812$EXP$$US-ABBVIE-5873989$ABBVIE$$$$$M$Y$$$20240812$$CN$US$US
242022701$24202270$1$I$$20240811$20240812$20240812$PER$$US-AMGEN-USASP2024159742$AMGEN$$$$A$F$Y$$$20240812$$CN$US$US
242022711$24202271$1$I$$20240807$20240812$20240812$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126613$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240813$$CN$US$US
242022721$24202272$1$I$20240101$20240806$20240812$20240812$EXP$$US-BIOGEN-2024BI01277310$BIOGEN$$55$YR$$F$Y$$$20240812$$CN$US$US
242022731$24202273$1$I$$20240806$20240812$20240812$EXP$$MX-BIOGEN-2024BI01277510$BIOGEN$$$$$$Y$$$20240812$$MD$MX$MX
242022742$24202274$2$F$20240909$20240909$20240812$20240916$EXP$$US-BIOGEN-2024BI01277805$BIOGEN$$48$YR$$F$Y$$$20240916$$HP$US$US
242022751$24202275$1$I$$20240805$20240812$20240812$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125241$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240813$$MD$JP$JP
242022761$24202276$1$I$$20240806$20240812$20240812$EXP$$US-BIOGEN-2024BI01277669$BIOGEN$$$$$F$Y$$$20240812$$CN$US$US
242022771$24202277$1$I$$20240807$20240812$20240812$PER$$US-AMGEN-USASP2024158509$AMGEN$$$$$$Y$$$20240812$$MD$US$US
242022782$24202278$2$F$$20240911$20240812$20240922$EXP$$JP-AMGEN-JPNSP2024129529$AMGEN$$$$$$Y$$$20240922$$PH$JP$JP
242022791$24202279$1$I$20210101$20210524$20240812$20240812$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045019$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$53$KG$20240813$$CN$CN$CN
242022801$24202280$1$I$20240718$20240805$20240812$20240812$EXP$$JP-SA-2024SA212789$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240813$$MD$JP$JP
242022814$24202281$4$F$$20240917$20240812$20240919$PER$$US-JNJFOC-20240822100$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$HP$US$US
242022821$24202282$1$I$20240807$20240807$20240812$20240812$EXP$$US-JNJFOC-20240822120$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240813$$MD$US$US
242022832$24202283$2$F$20240529$20240830$20240812$20240903$EXP$FR-AFSSAPS-CF2024000334$FR-JNJFOC-20240828697$JOHNSON AND JOHNSON$$45$YR$A$M$Y$85$KG$20240903$$PH$FR$FR
242022841$24202284$1$I$20240803$20240805$20240812$20240812$EXP$$AE-TAKEDA-2024TUS078713$TAKEDA$$$$$$Y$$$20240812$$CN$AE$AE
242022851$24202285$1$I$$20240809$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006598$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240812$$CN$US$US
242022861$24202286$1$I$$20240807$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408006224$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240812$$CN$US$US
242022871$24202287$1$I$$20240808$20240812$20240812$PER$$US-ABBVIE-5874185$ABBVIE$$$$$$Y$$$20240812$$CN$US$US
242022882$24202288$2$F$20240101$20240813$20240812$20240822$EXP$$JP-SA-2024SA230877$SANOFI AVENTIS$$$$$F$Y$$$20240822$$CN$JP$JP
242022892$24202289$2$F$20240721$20240809$20240812$20240813$EXP$$US-JNJFOC-20240816388$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240814$$CN$US$US
242022901$24202290$1$I$20240628$20240805$20240812$20240812$EXP$$CN-BEIGENE-BGN-2024-012197$BEIGENE$$$$$$Y$$$20240812$$HP$CN$CN
242022921$24202292$1$I$$20240804$20240812$20240812$PER$$US-AstraZeneca-2024A178481$ASTRAZENECA$$$$$$Y$$$20240813$$CN$US$
242022931$24202293$1$I$20240618$20240809$20240812$20240812$EXP$FR-AFSSAPS-AM2024000636$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-126654$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$76.8$KG$20240813$$MD$FR$FR
242022941$24202294$1$I$20240713$20240718$20240812$20240812$PER$$FR-TOLMAR, INC.-24FR051063$TOLMAR$$71$YR$$M$Y$$$20240812$$PH$FR$FR
242022951$24202295$1$I$20240713$20240719$20240812$20240812$PER$$FR-TOLMAR, INC.-24FR051170$TOLMAR$$79$YR$$M$Y$$$20240812$$CN$FR$FR
242022961$24202296$1$I$20240718$20240718$20240812$20240812$PER$$FR-TOLMAR, INC.-24FR051179$TOLMAR$$70$YR$$M$Y$$$20240812$$PH$FR$FR
242022971$24202297$1$I$20240717$20240717$20240812$20240812$PER$$FR-TOLMAR, INC.-24FR051148$TOLMAR$$62$YR$$M$Y$$$20240812$$PH$FR$FR
242022981$24202298$1$I$20230101$20240806$20240812$20240812$EXP$$US-ABBVIE-5505183$ABBVIE$$$$$F$Y$72.6$KG$20240812$$CN$US$US
242022991$24202299$1$I$20240701$20240718$20240812$20240812$PER$$NI-TOLMAR, INC.-24NI051194$TOLMAR$$8$YR$$F$Y$$$20240812$$CN$NI$NI
242023001$24202300$1$I$$20240719$20240812$20240812$PER$$NI-TOLMAR, INC.-24NI051233$TOLMAR$$$$$F$Y$$$20240812$$CN$NI$NI
242023011$24202301$1$I$$20240717$20240812$20240812$PER$$NL-TOLMAR, INC.-24NL051093$TOLMAR$$$$$M$Y$$$20240812$$HP$NL$NL
242023021$24202302$1$I$20240804$20240809$20240812$20240812$EXP$GB-MHRA-MIDB-7c52894c-e3ed-494a-a910-37e5e84feb09$GB-ABBVIE-5874916$ABBVIE$$32$YR$$$Y$$$20240812$$PH$GB$GB
242023031$24202303$1$I$20240808$20240808$20240812$20240812$PER$$US-JNJFOC-20240824054$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
242023041$24202304$1$I$20240728$20240809$20240812$20240812$EXP$$CN-BEIGENE-BGN-2024-012515$BEIGENE$$$$$$Y$$$20240812$$HP$CN$CN
242023052$24202305$2$F$20220101$20240812$20240812$20240824$EXP$KR-MLMSERVICE-20240725-PI143233-00232-1$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-17926$ALKEM$Jo E, Song SH.. Primary peritoneal carcinoma presented with abdominal pain in patient with kidney transplantation. The Korean Journal of Internal Medicine. 2024;39(4):693-694$54$YR$$F$Y$$$20240825$$HP$KR$KR
242023061$24202306$1$I$$20240801$20240812$20240812$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18221$ALKEM$Akbari SH, Reynolds MR, Kadkhodayan Y, Cross DT 3rd, Moran CJ.. Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J NeuroIntervent Surg. 2013;5:337-343$4$DEC$$F$Y$$$20240812$$HP$US$US
242023072$24202307$2$F$20220101$20240812$20240812$20240824$EXP$JP-MLMSERVICE-20240724-PI142185-00306-1$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-17822$ALKEM$Yoshida H, Umemura T, Ito S, Mizuno T, Mutoh Y, Yamada T, Kimura T.. Abnormally Elevated Blood Tacrolimus Level Following the Concomitant Use of Nirmatrelvir/Ritonavir With Extended-Release Tacrolimus in a Post-lung Transplant Patient: A Case Report and a Literature Review. Cureus. 2024;16(6):e62868$7$DEC$$F$Y$$$20240825$$PH$JP$JP
242023081$24202308$1$I$20240731$20240801$20240812$20240812$EXP$GB-MHRA-MED-202407311634356530-WSMCH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17924$ALKEM$$32$YR$$F$Y$70$KG$20240812$$CN$GB$GB
242023091$24202309$1$I$$20240801$20240812$20240812$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18222$ALKEM$Akbari SH, Reynolds MR, Kadkhodayan Y, Cross DT 3rd, Moran CJ. Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J NeuroIntervent Surg. 2013;5:337-343$6$DEC$$M$Y$$$20240812$$HP$US$US
242023101$24202310$1$I$20240731$20240801$20240812$20240812$EXP$GB-MHRA-MED-202407311046435960-GSYJP$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17866$ALKEM$$39$YR$$F$Y$$$20240812$$CN$GB$GB
242023112$24202311$2$F$$20240809$20240812$20240823$EXP$CN-MLMSERVICE-20240730-PI147771-00142-1$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-18152$ALKEM$Su CS, Kao CL. Stevens-Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report. Journal of Medical Case Reports. 2024;18(1):344$82$YR$$F$Y$$$20240823$$PH$TW$TW
242023121$24202312$1$I$$20240730$20240812$20240812$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17916$ALKEM$Sorenson EJ.. An acute, life-threatening, hypersensitivity reaction to riluzole. Neurology. 2006;67(12):2260-2261$50$YR$$M$Y$$$20240812$$HP$US$US
242023131$24202313$1$I$$20240730$20240812$20240812$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18034$ALKEM$Crook MJ.. Isoniazid-induced anaphylaxis. J Clin Pharmacol. 2003;43:545-6$$$$$Y$$$20240812$$HP$US$US
242023141$24202314$1$I$$20240729$20240812$20240812$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17631$ALKEM$$$$$M$Y$$$20240812$$CN$US$US
242023152$24202315$2$F$$20240808$20240812$20240822$EXP$GB-MLMSERVICE-20240722-PI138634-00270-1$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17769$ALKEM$Ameli R. Interesting case of Strongyloides hyperinfection syndrome in an immunocompromised patient.. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24:100043$42$YR$$F$Y$$$20240822$$MD$GB$GB
242023162$24202316$2$F$20200101$20240808$20240812$20240822$EXP$SE-MLMSERVICE-20210614-2944632-1$SE-ALKEM LABORATORIES LIMITED-SE-ALKEM-2024-17821$ALKEM$Psaros Einberg A, Casswall T, Arnell H, Nowak G, Mirazimi A, Sundin M, Fischler B.. Iatrogenic immunosuppression can lead to prolonged viral shedding and absent immune response to COVID-19. Acta paediatrica. 2021;110:2810-2811$$$$F$Y$16.7$KG$20240822$$MD$SE$SE
242023172$24202317$2$F$$20240808$20240812$20240822$EXP$US-MLMSERVICE-20161205-0523978-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17825$ALKEM$Yang Z, Loew T, Hammer RD.. Association of long-term tacrolimus (FK506) therapy with abnormal megakaryocytosis, bone marrow fibrosis, and dyserythropoiesis. Clinical Case Reports. 2015;3(7):664-668$17$YR$$M$Y$$$20240822$$MD$US$US
242023181$24202318$1$I$$20240730$20240812$20240812$EXP$GB-MHRA-MED-202407251141093720-GLVBC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17481$ALKEM$$$$$F$Y$$$20240812$$HP$GB$GB
242023192$24202319$2$F$$20240809$20240812$20240823$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-17904$ALKEM$Ebrahimi P, Nazari R, Senobari N, Mousavinezhad SM, Ghadimi DJ, Soleimani H.. Kounis syndrome type I induced by an intramuscular injection of diclofenac: A literature review based on a case report. Clinical Case Reports. 2024;12(7):e9198$51$YR$$M$Y$$$20240823$$HP$IR$IR
242023201$24202320$1$I$$20240730$20240812$20240812$EXP$$AT-ALKEM LABORATORIES LIMITED-AT-ALKEM-2024-18029$ALKEM$Bodner T, Jenner C, Benke T, et al.. Intoxication with riluzole in Huntington^s disease. Neurology. 2001;57(6):1141-1143$38$YR$$F$Y$$$20240812$$HP$AT$AT
242023211$24202321$1$I$$20240730$20240812$20240812$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2024-17829$ALKEM$Miodownik C, Alkatnany A, Frolova K and Lerner V. Delirium associated with lithium-quetiapine combination. Clin Neuropharmacol. 2008;31:176-179$$$$$Y$$$20240812$$HP$IL$IL
242023221$24202322$1$I$20240708$20240730$20240812$20240812$EXP$GB-MHRA-MED-202407291049014540-PFWRM$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17483$ALKEM$$77$YR$$M$Y$64$KG$20240812$$CN$GB$GB
242023232$24202323$2$F$$20240809$20240812$20240823$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-17949$ALKEM$Zheng Li, Li G, Zhang L.. A case study of impaired consciousness caused by alcohol consumption in a pediatric patient taking high-dose cefixime. Int J Clin Pharmacol Ther. 2024;62:427-430$14$YR$$F$Y$$$20240823$$HP$CN$CN
242023241$24202324$1$I$$20240731$20240812$20240812$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-18494$ALKEM$$59$YR$$F$Y$$$20240812$$MD$DE$DE
242023251$24202325$1$I$20240726$20240730$20240812$20240812$EXP$GB-MHRA-MED-202407300134326310-DVYRP$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17513$ALKEM$$22$YR$$F$Y$70$KG$20240812$$CN$GB$GB
242023261$24202326$1$I$20240503$20240730$20240812$20240812$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-17526$ALKEM$$56$YR$$F$Y$$$20240812$$CN$DE$DE
242023271$24202327$1$I$$20240731$20240812$20240812$EXP$GB-MHRA-MED-202407251205574320-RQCGB$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17694$ALKEM$$$$$$Y$$$20240812$$CN$GB$GB
242023282$24202328$2$F$$20240809$20240812$20240823$EXP$IT-MLMSERVICE-20240723-PI140266-00232-1$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17658$ALKEM$Azzimonti M, Esposito F, Poliani PL, Gagliardi F, Anzalone N, Panni P, Giordano A, Martinelli V, Rocca MA, Filippi M. Teaching NeuroImage: Spontaneously Resolving Ring-Enhancing Lesions Due to Immunodeficiency-Associated CNS Lymphoma: A Case of ^Vanishing Lymphoma^. Neurology. 2024;103(3):e209644$57$YR$$F$Y$65$KG$20240823$$MD$IT$IT
242023293$24202329$3$F$20220515$20240823$20240812$20240828$EXP$$IL-JNJFOC-20220601367$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240828$$HP$IL$IL
242023301$24202330$1$I$$20240805$20240812$20240812$PER$$US-JNJFOC-20240816471$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
242023311$24202331$1$I$$20240812$20240812$20240812$PER$$US-ELI_LILLY_AND_COMPANY-US202408007027$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240812$$CN$US$US
242023321$24202332$1$I$$20240810$20240812$20240812$PER$$NVSC2024US163448$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242023331$24202333$1$I$$20240731$20240812$20240812$EXP$GB-MHRA-TPP19250208C9433810YC1721401292676$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17637$ALKEM$$69$YR$$M$Y$64$KG$20240812$$MD$GB$GB
242023341$24202334$1$I$$20240810$20240812$20240812$PER$$NVSC2024US163437$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242023351$24202335$1$I$$20240730$20240812$20240812$EXP$$BE-ALKEM LABORATORIES LIMITED-BE-ALKEM-2024-17918$ALKEM$De Schryver N, Wittebole X, Van den Bergh P, Haufroid V, Goffin E, Hantson P.. Severe rhabdomyolysis associated with simvastatin and role of ciprofloxacin and amlodipine coadministration. Case Reports in Nephrology. 2015;2015(761393):1-4$41$YR$$F$Y$$$20240812$$HP$BE$BE
242023362$24202336$2$F$$20240810$20240812$20240823$EXP$US-MLMSERVICE-20240723-PI140518-00200-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17651$ALKEM$Bally K, Trusty R, Naher K.. A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone. Cureus. 2024;16(6):e62695$95$YR$$F$Y$$$20240823$$MD$US$US
242023371$24202337$1$I$20240726$20240731$20240812$20240812$EXP$GB-MHRA-TPP27735692C23117855YC1722010764663$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-17644$ALKEM$$29$YR$$F$Y$78$KG$20240812$$MD$GB$GB
242023382$24202338$2$F$20230101$20240810$20240812$20240823$EXP$US-MLMSERVICE-20240723-PI140053-00030-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17647$ALKEM$Longobardi SA, Alkowati H, Kang G, Slade C, Oyesanmi O.. Ibuprofen-Induced Pancytopenia and Erythema Multiforme in an Elderly Female Patient. Cureus. 2024;16(6):e62785$75$YR$$F$Y$$$20240823$$MD$US$US
242023391$24202339$1$I$$20240807$20240812$20240812$EXP$$IE-ABBVIE-5874702$ABBVIE$Grechin C, Doheny J, Pilson K, Howard D, Roche M. Tumour necrosis factor- -induced lupus panniculi-tis: one case report and literature review. Br J Dermatol. 2024;192(Supplement 1):i17.$62$YR$$F$Y$$$20240812$$HP$IE$IE
242023401$24202340$1$I$20240807$20240808$20240812$20240812$EXP$$US-ABBVIE-5874036$ABBVIE$$77$YR$$F$Y$$$20240812$$CN$US$US
242023412$24202341$2$F$20150101$20240806$20240812$20240820$PER$$US-ABBVIE-5867553$ABBVIE$$$$$M$Y$99.79$KG$20240820$$CN$US$US
242023421$24202342$1$I$20240527$20240808$20240812$20240812$EXP$$US-ABBVIE-5874436$ABBVIE$$63$YR$$F$Y$$$20240812$$CN$US$US
242023431$24202343$1$I$20240731$20240809$20240812$20240812$EXP$$US-ABBVIE-5875592$ABBVIE$$75$YR$$F$Y$$$20240812$$CN$US$US
242023441$24202344$1$I$20200101$20240802$20240812$20240812$EXP$$CA-ABBVIE-5874871$ABBVIE$$$$A$M$Y$$$20240812$$MD$CA$CA
242023451$24202345$1$I$$20240809$20240812$20240812$EXP$$US-ABBVIE-5875533$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242023462$24202346$2$F$20230403$20240827$20240812$20240830$EXP$$JP-TAKEDA-SH202311497$TAKEDA$$8$YR$$M$Y$26.4$KG$20240830$$MD$JP$JP
242023471$24202347$1$I$20240101$20240809$20240812$20240812$EXP$$US-ABBVIE-5875810$ABBVIE$$$$$F$Y$$$20240812$$CN$US$US
242023482$24202348$2$F$20240731$20240909$20240812$20240920$30DAY$$GB-JNJFOC-20240805841$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240920$$CN$GB$GB
242023492$24202349$2$F$20230501$20240827$20240812$20240901$EXP$$JP-SA-2024SA228030$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240902$$MD$JP$JP
242023501$24202350$1$I$$20240809$20240812$20240812$EXP$$BR-ABBVIE-5874970$ABBVIE$$$$$M$Y$$$20240812$$CN$BR$BR
242023511$24202351$1$I$$20240807$20240812$20240812$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125832$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240813$$HP$US$US
242023521$24202352$1$I$$20240809$20240812$20240812$PER$$US-AMGEN-USASP2024159866$AMGEN$$$$$$Y$$$20240812$$CN$US$US
242023532$24202353$2$F$$20240815$20240812$20240819$EXP$$JP-JNJFOC-20240829990$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240820$$MD$JP$JP
242023541$24202354$1$I$$20240809$20240812$20240812$PER$$NVSC2024US163452$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242023552$24202355$2$F$20240101$20240814$20240813$20240819$EXP$$US-CIPLA LTD.-2024US08492$CIPLA$$$$$$Y$$$20240819$$CN$US$US
242023561$24202356$1$I$$20240811$20240813$20240813$PER$$US-HALEON-2191559$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242023581$24202358$1$I$20240101$20240801$20240813$20240813$EXP$$US-CIPLA LTD.-2024US08497$CIPLA$$$$$$Y$$$20240813$$CN$US$US
242023592$24202359$2$F$$20240816$20240813$20240822$EXP$$US-JNJFOC-20240822617$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$HP$US$US
242023602$24202360$2$F$$20240911$20240813$20240918$30DAY$$ZA-JNJFOC-20240823534$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$ZA$ZA
242023611$24202361$1$I$20240730$20240731$20240813$20240813$PER$$US-JNJFOC-20240823904$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
242023621$24202362$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA233374$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240813$$MD$US$US
242023631$24202363$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA235706$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240813$$CN$US$US
242023641$24202364$1$I$$20240806$20240813$20240813$EXP$$US-SA-2024SA236035$SANOFI AVENTIS$$$$A$F$Y$89.81$KG$20240813$$MD$US$US
242023651$24202365$1$I$20220801$20240807$20240813$20240813$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-126652$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240813$$MD$JP$JP
242023671$24202367$1$I$20240620$20240730$20240813$20240813$EXP$$IN-CIPLA LTD.-2024IN08565$CIPLA$$$$$$Y$$$20240813$$CN$IN$IN
242023681$24202368$1$I$$20240806$20240813$20240813$PER$$US-JNJFOC-20240816863$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
242023691$24202369$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006333$ELI LILLY AND CO$$72$YR$E$$Y$$$20240812$$LW$US$US
242023702$24202370$2$F$20240603$20240927$20240813$20240930$EXP$$JP-TAKEDA-2024TJP011875$TAKEDA$$5$DEC$$M$Y$$$20240930$$MD$JP$JP
242023711$24202371$1$I$$20240812$20240813$20240813$PER$$NVSC2024US163679$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
242023721$24202372$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005764$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240812$$CN$US$US
242023732$24202373$2$F$20240618$20240813$20240813$20240821$EXP$$US-ABBVIE-5875797$ABBVIE$$71$YR$$F$Y$83.46$KG$20240821$$CN$US$US
242023741$24202374$1$I$20240806$20240808$20240813$20240813$EXP$$ES-ABBVIE-5874641$ABBVIE$$77$YR$$M$Y$$$20240813$$CN$ES$ES
242023751$24202375$1$I$$20240807$20240813$20240813$EXP$$US-ABBVIE-5870408$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242023761$24202376$1$I$20240101$20240807$20240813$20240813$EXP$$US-ABBVIE-5872167$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242023771$24202377$1$I$20240101$20240805$20240813$20240813$EXP$$US-ABBVIE-5833210$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242023781$24202378$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A181194$ASTRAZENECA$$$$$M$Y$$$20240813$$HP$US$
242023791$24202379$1$I$20240724$20240807$20240813$20240813$EXP$$US-ABBVIE-5803983$ABBVIE$$57$YR$$M$Y$$$20240813$$CN$US$US
242023802$24202380$2$F$$20240913$20240813$20240923$30DAY$$CA-JNJFOC-20240827052$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$CA$CA
242023811$24202381$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5875792$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242023821$24202382$1$I$$20240804$20240813$20240813$EXP$$CA-JNJFOC-20240809396$JOHNSON AND JOHNSON$$$$I$$Y$$$20240813$$HP$CA$CA
242023831$24202383$1$I$20240101$20240808$20240813$20240813$EXP$$US-ABBVIE-5811758$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242023841$24202384$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126505$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240813$$HP$US$US
242023851$24202385$1$I$20240601$20240807$20240813$20240813$PER$$US-ABBVIE-5875457$ABBVIE$$$$A$F$Y$$$20240813$$HP$US$US
242023861$24202386$1$I$20240623$20240806$20240813$20240813$EXP$$DE-ABBVIE-5871532$ABBVIE$$37$YR$$F$Y$102$KG$20240813$$CN$DE$DE
242023871$24202387$1$I$$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158230$AMGEN$$32$YR$A$F$Y$$$20240812$$CN$US$US
242023882$24202388$2$F$20240803$20240906$20240813$20240912$30DAY$$US-AMGEN-USASP2024156534$AMGEN$$$$$M$Y$$$20240912$$HP$US$US
242023893$24202389$3$F$$20240829$20240813$20240904$EXP$$US-ABBVIE-5871947$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242023901$24202390$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5874371$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242023911$24202391$1$I$$20240802$20240813$20240813$PER$$US-SA-2024SA237676$SANOFI AVENTIS$$$$$M$Y$$$20240813$$CN$US$US
242023931$24202393$1$I$20190101$20240729$20240813$20240813$EXP$FR-AFSSAPS-AN2024000948$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110605$ZYDUS PHARM$$$$$$Y$$$20240812$$PH$FR$FR
242023941$24202394$1$I$20231002$20240729$20240813$20240813$EXP$FR-AFSSAPS-AM2024000583$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110638$ZYDUS PHARM$$$$$$Y$$$20240812$$MD$FR$FR
242023951$24202395$1$I$$20240729$20240813$20240813$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110505$ZYDUS PHARM$Alam M, Abdelrahim B, Horani MH. Iatrogenic Thyroid Storm Treated with Plasmapheresis. J-Endocr- Soc. 2022;6 (Suppl.):A768-A769 abstr. ODP487$$$$$Y$$$20240812$$HP$US$US
242023961$24202396$1$I$20240401$20240809$20240813$20240813$EXP$$CO-ABBVIE-5817765$ABBVIE$$79$YR$$M$Y$64$KG$20240813$$CN$CO$CO
242023971$24202397$1$I$$20240801$20240813$20240813$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110778$ZYDUS PHARM$Fenner EG, Simpson CE. An adult patient with pulmonary arterial hypertension, a NOTCH3 mutation, and leflunomide exposure. Pulm-Circ. 2024;14 No. 3:e12411$$$$$Y$$$20240812$$HP$US$US
242023981$24202398$1$I$$20240731$20240813$20240813$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110774$ZYDUS PHARM$Gaur D, Michalopulos MG, Drake KA, Gattineni J.. Acetaminophen induced high anion gap metabolic acidosis: a potentially under-recognized consequence from a common medication.. Pediatr-Nephrol. 2024$$$$$Y$$$20240812$$HP$US$US
242023991$24202399$1$I$20240624$20240730$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-038883$AUROBINDO$$90$YR$$F$Y$52$KG$20240813$$PH$FR$FR
242024001$24202400$1$I$20240709$20240806$20240813$20240813$PER$$US-JNJFOC-20240814178$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
242024011$24202401$1$I$20240420$20240729$20240813$20240813$EXP$ES-AEMPS-1552206$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-110624$ZYDUS PHARM$$$$$$Y$$$20240812$$MD$ES$ES
242024021$24202402$1$I$20240501$20240729$20240813$20240813$EXP$ES-AEMPS-1553074$ES-ZYDUS PHARMACEUTICALS UK LTD-ES-ZYDUS-110627$ZYDUS PHARM$$$$$$Y$$$20240812$$PH$ES$ES
242024031$24202403$1$I$20231003$20240729$20240813$20240813$EXP$ES-AEMPS-1554122$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-110633$ZYDUS PHARM$$$$$$Y$$$20240812$$MD$ES$ES
242024041$24202404$1$I$20240703$20240729$20240813$20240813$EXP$FR-AFSSAPS-PV2024000680$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110543$ZYDUS PHARM$$$$$$Y$$$20240812$$MD$FR$FR
242024051$24202405$1$I$20240408$20240729$20240813$20240813$EXP$FR-AFSSAPS-AVMA2024000338$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110557$ZYDUS PHARM$$$$$$Y$$$20240812$$MD$FR$FR
242024061$24202406$1$I$20240208$20240729$20240813$20240813$EXP$FR-AFSSAPS-AN2024000952$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110601$ZYDUS PHARM$$$$$$Y$$$20240812$$PH$FR$FR
242024071$24202407$1$I$$20240805$20240813$20240813$EXP$$US-PADAGIS-2024PAD01291$PADAGIS$$$$$$Y$$$20240812$$CN$US$US
242024081$24202408$1$I$20240802$20240802$20240813$20240813$EXP$$US-PADAGIS-2024PAD01280$PADAGIS$$$$$$Y$$$20240812$$CN$US$US
242024094$24202409$4$F$20240731$20240816$20240813$20240826$30DAY$$US-AMGEN-USASP2024156523$AMGEN$$$$$M$Y$$$20240826$$HP$US$US
242024102$24202410$2$F$$20240808$20240813$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127335$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240819$$CN$US$US
242024111$24202411$1$I$$20240807$20240813$20240813$EXP$$BR-TAKEDA-2024TUS080189$TAKEDA$$32$YR$$$Y$$$20240813$$CN$BR$BR
242024121$24202412$1$I$20240701$20240809$20240813$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045163$BOEHRINGER INGELHEIM$$60$YR$A$M$Y$$$20240813$$CN$US$US
242024131$24202413$1$I$$20240806$20240813$20240813$EXP$$CA-JNJFOC-20240823955$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240813$$HP$CA$CA
242024141$24202414$1$I$$20230303$20240813$20240813$EXP$$US-AstraZeneca-2023A053714$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242024152$24202415$2$F$20001020$20240812$20240813$20240816$EXP$$US-AstraZeneca-2024A180970$ASTRAZENECA$$18857$DY$$M$Y$$$20240816$$HP$US$
242024161$24202416$1$I$$20230221$20240813$20240813$EXP$$US-AstraZeneca-2023A044617$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242024171$24202417$1$I$$20220425$20240813$20240813$EXP$$US-AstraZeneca-2022A108152$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242024182$24202418$2$F$20240804$20240910$20240813$20240913$PER$$US-AMGEN-USASP2024155308$AMGEN$$77$YR$E$F$Y$$$20240912$$CN$US$US
242024191$24202419$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA235635$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240813$$CN$US$US
242024211$24202421$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA233889$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240813$$MD$US$US
242024221$24202422$1$I$20240806$20240808$20240813$20240813$PER$$US-ABBVIE-5874821$ABBVIE$$36$YR$$F$Y$$$20240813$$HP$US$US
242024231$24202423$1$I$20240101$20240806$20240813$20240813$EXP$$US-BIOGEN-2024BI01277319$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
242024251$24202425$1$I$$20240808$20240813$20240813$EXP$$US-BIOGEN-2024BI01277609$BIOGEN$$$$$M$Y$$$20240813$$CN$US$US
242024261$24202426$1$I$$20240809$20240813$20240813$PER$$US-HALEON-2191543$Haleon PLC$$50$YR$$F$Y$$$20240813$$CN$US$US
242024271$24202427$1$I$$20240804$20240813$20240813$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000281$EMCURE$Sheth K, Lee C, Srinivas N, Hasan Y, Myat K.. Hydrochlorothiazide-Induced Exfoliative Rash and Sepsis. Cureus. 2024;16(7):e63655$86$YR$$M$Y$$$20240813$$HP$US$US
242024282$24202428$2$F$$20240918$20240813$20240924$EXP$$JP-SANDOZ INC.-SDZ2024JP071077$SANDOZ$Kusano C, Otsuka M, Kuwahara Y. A Case of Takotsubo Cardiomyopathy Caused by Adrenaline-Containing Local Anesthetic in an Infant. The 60th Annual Meeting of the Japanese Society of Pediatric Cardiology (Program. 2024;II-P01-6-08$22$MON$$M$Y$$$20240924$$MD$JP$JP
242024292$24202429$2$F$20240101$20240812$20240813$20240816$EXP$$US-ABBVIE-5873285$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242024301$24202430$1$I$20220321$20220407$20240813$20240813$EXP$$ZA-BIOVITRUM-2022ZA04724$BIOVITRUM$$221$DY$$M$Y$4.9$KG$20240813$$CN$ZA$ZA
242024311$24202431$1$I$$20240806$20240813$20240813$EXP$$US-GSK-US2024098126$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
242024321$24202432$1$I$$20240807$20240813$20240813$EXP$$US-BIOGEN-2024BI01272036$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
242024331$24202433$1$I$20240724$20240807$20240813$20240813$EXP$$NL-BIOGEN-2024BI01277692$BIOGEN$$65$YR$$M$Y$$$20240813$$CN$NL$NL
242024341$24202434$1$I$$20240730$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-038974$AUROBINDO$Shih J, Hamera L. Multiorgan Failure in the Aftermath of Pre-eclampsia With Intracerebral Hemorrhage and HELLP Syndrome. Am-J-Respir-Crit-Care-Med. 2023;207:A4354$18$YR$$F$Y$$$20240813$$HP$US$US
242024351$24202435$1$I$20221220$20221220$20240813$20240813$EXP$$KW-BIOVITRUM-2022KW15645$BIOVITRUM$$209$DY$$F$Y$$$20240813$$CN$KW$KW
242024361$24202436$1$I$$20240730$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-039075$AUROBINDO$Gorbonos A, Kamat A, Williams B, Rodriguez G, Bahtiyar G. Pheochromocytoma in a Pregnant Woman with VHL leading to First Trimester Fetal Demise.. Journal of the Endocrine Society. 2022;6 (Suppl. 1):A93$39$YR$$F$Y$$$20240813$$MD$US$US
242024371$24202437$1$I$20220901$20220920$20240813$20240813$EXP$$TW-AstraZeneca-2022A324871$ASTRAZENECA$$59$YR$$M$Y$$$20240813$$CN$TW$
242024381$24202438$1$I$$20230517$20240813$20240813$EXP$$US-AstraZeneca-2023A115687$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242024391$24202439$1$I$$20240809$20240813$20240813$30DAY$$US-SANDOZ INC.-SDZ2024US071841$SANDOZ$$$$$M$Y$$$20240813$$CN$US$US
242024401$24202440$1$I$$20240807$20240813$20240813$EXP$$US-AstraZeneca-2024A180525$ASTRAZENECA$$50$YR$$F$Y$$$20240813$$MD$US$
242024411$24202441$1$I$$20221019$20240813$20240813$EXP$$US-AstraZeneca-2022A353424$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242024421$24202442$1$I$$20220502$20240813$20240813$EXP$$US-AstraZeneca-2022A174842$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242024431$24202443$1$I$$20240730$20240813$20240813$EXP$$GB-AUROBINDO-AUR-APL-2024-039080$AUROBINDO$Del Mundo JS, Khan H.. A rare presentation of geriatric non-epileptic seizures due to carotid artery encasement of a diffuse large B-cell lymphoma: A case report.. Clinical Medicine-London. 2024;24 (Suppl.):34-35$75$YR$$M$Y$$$20240813$$HP$GB$GB
242024441$24202444$1$I$20240806$20240808$20240813$20240813$30DAY$$IT-SANDOZ INC.-SDZ2024IT072064$SANDOZ$$13$YR$$M$Y$55$KG$20240813$$CN$IT$IT
242024451$24202445$1$I$$20240809$20240813$20240813$EXP$$IT-ABBVIE-5874965$ABBVIE$$80$YR$$F$Y$$$20240813$$CN$IT$IT
242024461$24202446$1$I$$20240805$20240813$20240813$EXP$$IT-CHEPLA-2024010315$CHEPLAPHARM$Castelli M, Betelli M, Valenti A, Merelli B, Loglio A, Vigan? M, Benetti A. A Case of Polyserositis, Chylous Ascites and Hepatitis Induced by Immune Checkpoint Inhibitors. Eur J Case Rep Intern Med. 2024 May 31;11(7):004237. doi: 10.12890/2024_004237. PMID: 38984185; PMCID: PMC11229460.$39$YR$$M$Y$$$20240812$$HP$COUNTRY NOT SPECIFIED$IT
242024471$24202447$1$I$$20240805$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US072075$SANDOZ$$58$YR$$F$Y$$$20240813$$CN$US$US
242024481$24202448$1$I$$20240812$20240813$20240813$EXP$GB-MHRA-MED-202408121500517630-NJZBD$GB-SANDOZ INC.-SDZ2024GB072096$SANDOZ$$66$YR$$F$Y$$$20240813$$HP$GB$GB
242024493$24202449$3$F$20240101$20240808$20240813$20240814$EXP$$US-ABBVIE-5875794$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242024502$24202450$2$F$20240101$20240828$20240813$20240906$PER$$US-SA-2024SA233896$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240906$$MD$US$US
242024515$24202451$5$F$20240806$20240823$20240813$20240905$PER$$US-SA-2024SA238238$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240905$$MD$US$US
242024521$24202452$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA237033$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240813$$CN$US$US
242024541$24202454$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA234007$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240813$$MD$US$US
242024551$24202455$1$I$20240729$20240805$20240813$20240813$PER$$US-SA-2024SA236575$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240813$$MD$US$US
242024561$24202456$1$I$20240809$20240809$20240813$20240813$PER$$NVSC2024US163504$NOVARTIS$$51$YR$$F$Y$$$20240813$$HP$US$US
242024572$24202457$2$F$20240803$20240904$20240813$20240908$EXP$$US-ABBVIE-5875605$ABBVIE$$73$YR$$M$Y$$$20240908$$CN$US$US
242024581$24202458$1$I$20240101$20240809$20240813$20240813$EXP$$US-ABBVIE-5875813$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242024591$24202459$1$I$$20240812$20240813$20240813$PER$$NVSC2024US163625$NOVARTIS$$$$$F$Y$$$20240813$$MD$US$US
242024601$24202460$1$I$$20240730$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-038861$AUROBINDO$Puthumana RM, Koch AL, Schettino C, Vehar SJ. Asymptomatic and slowly progressive antiMDA5 ILD: A report of three cases deviating from a notoriously rapidly progressive ILD. RespiratMed-Case-Report. 2024;51102072$80$YR$$M$Y$$$20240813$$HP$US$US
242024611$24202461$1$I$$20240806$20240813$20240813$EXP$$GR-CHEPLA-2024010169$CHEPLAPHARM$$$$$F$Y$$$20240812$$MD$COUNTRY NOT SPECIFIED$GR
242024622$24202462$2$F$20231013$20240819$20240813$20240830$EXP$$US-UCBSA-2024038824$UCB$$22$YR$$F$Y$79$KG$20240830$$HP$US$US
242024632$24202463$2$F$20240726$20240828$20240813$20240911$EXP$$US-MDD US Operations-MDD202408-002817$MDD OPERATIONS$$88$YR$$F$Y$$$20240912$$CN$US$
242024641$24202464$1$I$$20221114$20240813$20240813$EXP$$US-AstraZeneca-2022A377080$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242024651$24202465$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A181326$ASTRAZENECA$$$$$$Y$$$20240813$$HP$US$
242024661$24202466$1$I$20240705$20240806$20240813$20240813$EXP$FR-AFSSAPS-ST2024001246$FR-CHEPLA-2024010278$CHEPLAPHARM$$54$YR$$M$Y$79$KG$20240812$$PH$COUNTRY NOT SPECIFIED$FR
242024671$24202467$1$I$20240616$20240717$20240813$20240813$EXP$FR-AFSSAPS-RN2024000808$FR-DEXPHARM-2024-2657$DEXCEL$$51$YR$A$M$Y$$$20240811$$HP$FR$FR
242024682$24202468$2$F$$20240809$20240813$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006535$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240814$$CN$US$US
242024691$24202469$1$I$20240507$20240806$20240813$20240813$EXP$BG-EGIS-HUN-2024-0922$BG-CHEPLA-2024010260$CHEPLAPHARM$Neykova L, Angelov Y, Ivanova M. Intralipids and their role in the management of antipsychotic and neuroleptic drug intoxications (a clinical case). MILITARY MEDICINE. 2024;LXXVI(2): 29-33.$46$YR$$F$Y$$$20240812$$HP$COUNTRY NOT SPECIFIED$BG
242024701$24202470$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5874535$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242024711$24202471$1$I$$20240805$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408003261$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242024721$24202472$1$I$$20240730$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-039176$AUROBINDO$Satta T, Papadopoulos EB, Gyurkocza B, Susman P, Singh A, Calafiore M, et al.. Use of a TissueTargeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GIAcute Gvhd.. Blood. 2023;142 (Suppl. 1):7019$37$YR$$$Y$$$20240813$$MD$US$US
242024731$24202473$1$I$$20240805$20240813$20240813$EXP$$TR-JNJFOC-20240754524$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$PH$TR$TR
242024741$24202474$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875778$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242024751$24202475$1$I$20240101$20240809$20240813$20240813$EXP$$US-ABBVIE-5875775$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242024762$24202476$2$F$$20240829$20240813$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA071860$SANDOZ$$$$$M$Y$$$20240902$$MD$CA$CA
242024781$24202478$1$I$20240607$20240805$20240813$20240813$EXP$$BE-ABBVIE-5875037$ABBVIE$$34$YR$$F$Y$$$20240813$$CN$BE$BE
242024791$24202479$1$I$20240503$20240730$20240813$20240813$EXP$$DE-AUROBINDO-AUR-APL-2024-038717$AUROBINDO$$56$YR$$F$Y$$$20240813$$CN$DE$DE
242024802$24202480$2$F$$20240808$20240813$20240820$EXP$$PT-AUROBINDO-AUR-APL-2024-038884$AUROBINDO$Carrilho M, Nobre MB, Santos MC, Silva RC, Martins JR.. CMV MYOCARDITIS.. Infectious and parasitic diseases.. 2024;162$72$YR$$F$Y$$$20240820$$MD$PT$PT
242024811$24202481$1$I$$20240812$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045158$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240813$$CN$US$US
242024821$24202482$1$I$20240809$20240809$20240813$20240813$PER$$US-GRUNENTHAL-2024-124027$AVERITAS$$60$YR$$M$Y$$$20240812$$CN$US$US
242024831$24202483$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003773$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242024841$24202484$1$I$20240716$20240808$20240813$20240813$EXP$$AR-ABBVIE-5875106$ABBVIE$$59$YR$$F$Y$$$20240813$$CN$AR$AR
242024851$24202485$1$I$20240801$20240806$20240813$20240813$PER$$US-AMGEN-USASP2024156327$AMGEN$$51$YR$A$M$Y$$$20240812$$CN$US$US
242024861$24202486$1$I$20240805$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024159342$AMGEN$$55$YR$A$F$Y$$$20240812$$PH$US$US
242024871$24202487$1$I$$20240808$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126729$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240813$$CN$US$US
242024881$24202488$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126422$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240813$$CN$US$US
242024891$24202489$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003774$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242024901$24202490$1$I$20240801$20240807$20240813$20240813$EXP$$DE-ABBVIE-5873338$ABBVIE$$54$YR$$F$Y$$$20240813$$CN$DE$DE
242024922$24202492$2$F$20240101$20240823$20240813$20240828$EXP$$CA-ABBVIE-5875927$ABBVIE$$56$YR$$F$Y$$$20240828$$CN$CA$CA
242024932$24202493$2$F$20240724$20240827$20240813$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003764$ACADIA PHARMACEUTICALS$$5$YR$$F$Y$$$20240919$$CN$US$US
242024941$24202494$1$I$$20240808$20240813$20240813$EXP$$NVSC2024SI162440$NOVARTIS$$$$$M$Y$$$20240813$$MD$SI$SI
242024951$24202495$1$I$$20240731$20240813$20240813$EXP$$ES-AUROBINDO-AUR-APL-2024-039046$AUROBINDO$Condom Esteve M, Roig Buscato C. Paciente con lesiones ampollosas generalizadas (Patient with generalized bullous lesions). AMF. 2024;20(6):1$77$YR$$F$Y$$$20240813$$MD$ES$ES
242024961$24202496$1$I$$20240805$20240813$20240813$EXP$$CO-TOLMAR, INC.-24CO051637$TOLMAR$$$$$M$Y$$$20240813$$CN$CO$CO
242024971$24202497$1$I$20240720$20240805$20240813$20240813$EXP$FR-AFSSAPS-PB2024000828$FR-TOLMAR, INC.-24FR051584$TOLMAR$$$$$M$Y$$$20240813$$MD$FR$FR
242024981$24202498$1$I$$20240805$20240813$20240813$EXP$$ES-TOLMAR, INC.-24ES051581$TOLMAR$$60$YR$$M$Y$$$20240813$$HP$ES$ES
242024991$24202499$1$I$20240702$20240812$20240813$20240813$EXP$GB-MHRA-MED-202408120822242000-NMZJL$GB-JNJFOC-20240828072$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240813$$PH$GB$GB
242025003$24202500$3$F$20240708$20240907$20240813$20240909$EXP$$JP-TAKEDA-2024TJP010361$TAKEDA$$15$YR$$F$Y$$$20240909$$MD$JP$JP
242025011$24202501$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875520$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242025031$24202503$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA234054$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240813$$MD$US$US
242025041$24202504$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039738$AUROBINDO$$79$YR$$F$Y$$$20240813$$PH$CA$CA
242025051$24202505$1$I$$20240808$20240813$20240813$EXP$$US-GSK-US2024AMR099851$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242025061$24202506$1$I$$20240321$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089639$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242025071$24202507$1$I$$20240515$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090980$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242025081$24202508$1$I$$20240807$20240813$20240813$EXP$$US-ABBVIE-5872418$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242025091$24202509$1$I$$20240805$20240813$20240813$EXP$$DE-EMD Serono-2024042415$EMD SERONO INC$$$$A$F$Y$$$20240813$$CN$DE$DE
242025101$24202510$1$I$20240725$20240806$20240813$20240813$EXP$HR-HALMEDAPP-202407271408117650-TNSZG$HR-ORGANON-O2408HRV000443$ORGANON$$36$YR$$F$Y$66$KG$20240812$$CN$HR$HR
242025111$24202511$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039755$AUROBINDO$$13$YR$$F$Y$55.338$KG$20240813$$CN$CA$CA
242025121$24202512$1$I$20230101$20240807$20240813$20240813$EXP$$RU-ORGANON-O2408RUS000681$ORGANON$$93$YR$$F$Y$$$20240812$$CN$RU$RU
242025131$24202513$1$I$$20240810$20240813$20240813$EXP$GB-MHRA-MED-202408091852555040-WQTBF$GB-ORGANON-O2408GBR000829$ORGANON$$$$$M$Y$$$20240812$$CN$GB$GB
242025141$24202514$1$I$$20240806$20240813$20240813$EXP$$US-ORGANON-O2408USA000638$ORGANON$$$$$M$Y$$$20240812$$CN$US$US
242025151$24202515$1$I$$20240810$20240813$20240813$EXP$GB-MHRA-MED-202408091843549660-ZLBWM$GB-ORGANON-O2408GBR000805$ORGANON$$$$$M$Y$$$20240812$$CN$GB$GB
242025161$24202516$1$I$$20240718$20240813$20240813$PER$$PH-TOLMAR, INC.-24PH051388$TOLMAR$$$$$M$Y$$$20240812$$MD$PH$PH
242025171$24202517$1$I$20240718$20240718$20240813$20240813$PER$$TR-TOLMAR, INC.-24TR051131$TOLMAR$$$$$M$Y$$$20240812$$MD$TR$TR
242025181$24202518$1$I$20240628$20240718$20240813$20240813$PER$$TR-TOLMAR, INC.-24TR050920$TOLMAR$$84$YR$$M$Y$$$20240812$$PH$TR$TR
242025191$24202519$1$I$20240718$20240718$20240813$20240813$PER$$TR-TOLMAR, INC.-24TR051150$TOLMAR$$59$YR$$M$Y$$$20240812$$HP$TR$TR
242025201$24202520$1$I$20240717$20240717$20240813$20240813$PER$$TR-TOLMAR, INC.-24TR051136$TOLMAR$$78$YR$$M$Y$$$20240812$$MD$TR$TR
242025211$24202521$1$I$20240718$20240718$20240813$20240813$PER$$TR-TOLMAR, INC.-24TR051149$TOLMAR$$65$YR$$M$Y$$$20240812$$HP$TR$TR
242025221$24202522$1$I$20240716$20240717$20240813$20240813$PER$$US-TOLMAR, INC.-24US051113$TOLMAR$$31$YR$$F$Y$$$20240812$$PH$US$US
242025232$24202523$2$F$$20240820$20240813$20240909$PER$$US-TOLMAR, INC.-24US050902$TOLMAR$$$$$$Y$$$20240909$$PH$US$US
242025242$24202524$2$F$20240711$20240823$20240813$20240911$PER$$US-TOLMAR, INC.-24US050995$TOLMAR$$66$YR$$M$Y$$$20240911$$HP$US$US
242025252$24202525$2$F$$20240828$20240813$20240917$PER$$US-TOLMAR, INC.-24US051123$TOLMAR$$$$$M$Y$$$20240917$$HP$US$US
242025261$24202526$1$I$20240702$20240718$20240813$20240813$PER$$US-TOLMAR, INC.-24US051124$TOLMAR$$76$YR$$M$Y$$$20240812$$HP$US$US
242025272$24202527$2$F$20240718$20240828$20240813$20240917$PER$$US-TOLMAR, INC.-24US051143$TOLMAR$$62$YR$$M$Y$$$20240917$$PH$US$US
242025281$24202528$1$I$20240101$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159480$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
242025291$24202529$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039856$AUROBINDO$$24$YR$$F$Y$65$KG$20240813$$HP$CA$CA
242025313$24202531$3$F$20240801$20240814$20240813$20240822$30DAY$$US-AMGEN-USASL2024155918$AMGEN$$76$YR$E$M$Y$69.1$KG$20240822$$PH$US$US
242025321$24202532$1$I$20240701$20240808$20240813$20240813$EXP$$JP-TAKEDA-2024TJP011862$TAKEDA$$4$DEC$$M$Y$$$20240813$$HP$JP$JP
242025341$24202534$1$I$$20240803$20240813$20240813$30DAY$$US-GSK-US2024AMR097330$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242025351$24202535$1$I$20240806$20240808$20240813$20240813$30DAY$$IT-SANDOZ INC.-SDZ2024IT072048$SANDOZ$$6$YR$$$Y$15$KG$20240813$$CN$IT$IT
242025361$24202536$1$I$$20240806$20240813$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-024551$UNITED THERAPEUTICS$$$$$F$Y$50.794$KG$20240813$$$US$US
242025371$24202537$1$I$$20240806$20240813$20240813$EXP$$CA-ABBVIE-5875051$ABBVIE$$$$A$F$Y$$$20240813$$CN$CA$CA
242025381$24202538$1$I$20240715$20240805$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002600$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240813$$CN$US$US
242025391$24202539$1$I$20240301$20240806$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408004102$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240813$$CN$US$US
242025412$24202541$2$F$20200101$20240811$20240813$20240816$EXP$$EG-JNJFOC-20240815628$JOHNSON AND JOHNSON$$34$YR$A$M$Y$60$KG$20240816$$CN$EG$EG
242025421$24202542$1$I$$20240811$20240813$20240813$PER$$NVSC2024US163645$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242025431$24202543$1$I$20240701$20240809$20240813$20240813$EXP$$NVSC2024US162976$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242025441$24202544$1$I$$20240801$20240813$20240813$PER$$US-SA-2024SA231651$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240813$$CN$US$US
242025451$24202545$1$I$$20240730$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-038211$AUROBINDO$Jain S, Sekhon S, Leo Pradeep Chandran AS, Gummadi J, Patel P, Nakka R, et al.. Metformin-associated lactic acidosis in an older adult: A case report and review.. Cureus. 2024;16(6):e62729$82$YR$$M$Y$$$20240813$$MD$US$US
242025461$24202546$1$I$20240501$20240806$20240813$20240813$EXP$NO-NOMAADVRE-PASRAPP-2024-V375k5$NO-CHATTEMPRD-2024OHG026325$CHATTEM$$51$YR$A$F$Y$72$KG$20240813$$CN$NO$NO
242025471$24202547$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236570$SANOFI AVENTIS$$$$$$Y$$$20240813$$HP$US$US
242025482$24202548$2$F$20240101$20240814$20240813$20240822$EXP$$CO-SA-2024SA229893$SANOFI AVENTIS$$22$YR$A$F$Y$100$KG$20240822$$CN$CO$CO
242025492$24202549$2$F$20240718$20240808$20240813$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126436$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240814$$CN$US$US
242025501$24202550$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA234462$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240813$$CN$US$US
242025511$24202551$1$I$$20240801$20240813$20240813$PER$$US-SA-2024SA233532$SANOFI AVENTIS$$$$A$F$Y$136.07$KG$20240813$$MD$US$US
242025521$24202552$1$I$20240705$20240731$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-039089$AUROBINDO$$54$YR$$M$Y$79$KG$20240813$$PH$FR$FR
242025531$24202553$1$I$$20240801$20240813$20240813$PER$$US-SA-2024SA233351$SANOFI AVENTIS$$63$YR$A$F$Y$77$KG$20240813$$MD$US$US
242025541$24202554$1$I$20240101$20240807$20240813$20240813$EXP$$AU-ABBVIE-5872001$ABBVIE$$$$$M$Y$$$20240813$$CN$AU$AU
242025551$24202555$1$I$$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158617$AMGEN$$$$A$M$Y$$$20240812$$HP$US$US
242025561$24202556$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A181065$ASTRAZENECA$$$$$M$Y$$$20240813$$HP$US$
242025573$24202557$3$F$$20240809$20240813$20240913$EXP$$US-AstraZeneca-2024A179888$ASTRAZENECA$$$$$F$Y$$$20240913$$PH$US$
242025581$24202558$1$I$$20231018$20240813$20240813$EXP$$HN-AstraZeneca-2023A238804$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$HN$
242025591$24202559$1$I$20220615$20220624$20240813$20240813$EXP$$US-AstraZeneca-2022A235901$ASTRAZENECA$$28746$DY$$M$Y$$$20240813$$CN$US$
242025601$24202560$1$I$$20230822$20240813$20240813$EXP$$US-AstraZeneca-2023A194432$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242025611$24202561$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039899$AUROBINDO$$71$YR$$M$Y$$$20240813$$PH$CA$CA
242025622$24202562$2$F$20240809$20240815$20240813$20240820$PER$$US-AMGEN-USASP2024159182$AMGEN$$78$YR$E$F$Y$$$20240820$$PH$US$US
242025631$24202563$1$I$20240729$20240807$20240813$20240813$EXP$GB-MHRA-MED-202408080001449660-BFJYD$GB-CHATTEMPRD-2024OHG026591$CHATTEM$$29$YR$A$F$Y$96$KG$20240813$$CN$GB$GB
242025641$24202564$1$I$20240730$20240808$20240813$20240813$EXP$$US-BEH-2024177002$CSL BEHRING$$91$YR$E$F$Y$$$20240813$$CN$US$US
242025651$24202565$1$I$20240725$20240805$20240813$20240813$PER$$US-SA-2024SA235574$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240813$$MD$US$US
242025661$24202566$1$I$20231106$20240731$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-039092$AUROBINDO$$49$YR$$M$Y$$$20240813$$MD$FR$FR
242025671$24202567$1$I$20240701$20240805$20240813$20240813$PER$$US-SA-2024SA235407$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240813$$MD$US$US
242025681$24202568$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA235342$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240813$$MD$US$US
242025691$24202569$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236038$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240813$$HP$US$US
242025701$24202570$1$I$$20240801$20240813$20240813$EXP$$US-CHATTEMPRD-2024OHG026054$CHATTEM$Ehsan E, Wei EX, Georgesen C. Histopathologic Features of Drug Reaction With Eosinophilia and Systemic Symptoms. American Journal of Dermatopathology. 2024 46:8 (1-6)$$$A$$Y$$$20240813$$HP$US$US
242025711$24202571$1$I$20240701$20240805$20240813$20240813$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024501$UNITED THERAPEUTICS$$76$YR$$M$Y$96.145$KG$20240813$$$US$US
242025721$24202572$1$I$$20240811$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US071944$SANDOZ$$$$$M$Y$$$20240813$$CN$US$US
242025731$24202573$1$I$$20240730$20240813$20240813$EXP$$ES-AUROBINDO-AUR-APL-2024-039063$AUROBINDO$de la Flor JC, Cruzado L, Deira J, Valga F, Sualdea B, Zamora R, et al.. Management of refractory pruritus with difelikefalin in a patient on incremental hemodialysis one day a week: Is it safe and effective?. Nefrologia. 2024;44(3):437-439$62$YR$$F$Y$$$20240813$$HP$ES$ES
242025741$24202574$1$I$20240101$20240807$20240813$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-020140$UNITED THERAPEUTICS$$$$$M$Y$78.912$KG$20240813$$$US$US
242025751$24202575$1$I$$20240730$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-039067$AUROBINDO$Abdelrahim B, Alam M, Horani MH.. Iatrogenic Thyroid Storm Treated with Plasmapheresis. JEndocr-Soc. 2022;6$25$YR$$M$Y$$$20240813$$MD$US$US
242025762$24202576$2$F$$20240903$20240813$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-024668$UNITED THERAPEUTICS$$$$$M$Y$117.91$KG$20240906$$MD$US$US
242025772$24202577$2$F$$20240814$20240813$20240828$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001080$ALEMBIC$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of neonatal-perinatal medicine. 2024;1-6$$$$$Y$$$20240828$$MD$US$US
242025782$24202578$2$F$20240823$20240828$20240813$20240923$EXP$$IT-STEMLINE THERAPEUTICS, INC-2024-STML-IT000003$PAREXEL$$$$$$Y$$$20240923$$MD$IT$IT
242025791$24202579$1$I$20240101$20240807$20240813$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-024652$UNITED THERAPEUTICS$$$$$M$Y$93.878$KG$20240813$$$US$US
242025801$24202580$1$I$$20240806$20240813$20240813$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001090$ALEMBIC$Shanks K.G, Kurtz S.A.K, Behonick G.S.. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of analytical toxicology. 2024;00:1-9$$$$$Y$$$20240812$$HP$US$US
242025811$24202581$1$I$$20240730$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-038926$AUROBINDO$Alam RM, Espinoza J, Coches K. Steroid Induced Diabetic Ketoacidosis in End Stage Renal Disease with Suspected Vasculitis Induced Stroke. South-Med-J. 2022;115:443-444$71$YR$$F$Y$$$20240813$$MD$US$US
242025821$24202582$1$I$20240806$20240806$20240813$20240813$30DAY$$US-GSK-US2024097993$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240813$$CN$US$US
242025832$24202583$2$F$$20240911$20240813$20240918$EXP$$IN-VANTIVE-2024VAN018910$Vantive US Healthcare$$55$YR$$F$Y$$$20240918$$CN$IN$IN
242025842$24202584$2$F$20240805$20240816$20240813$20240823$EXP$$IN-VANTIVE-2024VAN018911$Vantive US Healthcare$$14$YR$$M$Y$$$20240823$$CN$IN$IN
242025853$24202585$3$F$20240805$20240816$20240813$20240823$EXP$$IN-VANTIVE-2024VAN018941$Vantive US Healthcare$$53$YR$$M$Y$$$20240823$$CN$IN$IN
242025861$24202586$1$I$$20240806$20240813$20240813$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001091$ALEMBIC$Shanks K.G, Kurtz S.A.K, Behonick G.S. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of analytical toxicology. 2024;00:1-9$$$$$Y$$$20240812$$HP$US$US
242025871$24202587$1$I$20240701$20240807$20240813$20240813$PER$$US-SA-2024SA237962$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240813$$CN$US$US
242025881$24202588$1$I$$20240807$20240813$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-024715$UNITED THERAPEUTICS$$$$$M$Y$89.342$KG$20240813$$$US$US
242025891$24202589$1$I$$20220703$20240813$20240813$EXP$$US-AstraZeneca-2022A243985$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242025901$24202590$1$I$$20230830$20240813$20240813$EXP$$US-AstraZeneca-2023A200667$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242025911$24202591$1$I$$20240806$20240813$20240813$PER$$US-AstraZeneca-2024A179582$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242025921$24202592$1$I$20240614$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A181109$ASTRAZENECA$$27835$DY$$F$Y$$$20240813$$CN$US$
242025931$24202593$1$I$$20240731$20240813$20240813$EXP$$US-ChurchDwight-2024-CDW-01255$CHURCH + DWIGHT$$$$$F$Y$$$20240812$$CN$US$US
242025941$24202594$1$I$20120227$20240805$20240813$20240813$PER$$US-JNJFOC-20240826557$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240813$$LW$US$US
242025961$24202596$1$I$$20220519$20240813$20240813$EXP$$US-AstraZeneca-2022A192424$ASTRAZENECA$$$$$F$Y$88$KG$20240813$$CN$US$
242025971$24202597$1$I$$20240812$20240813$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045146$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240813$$CN$US$US
242025982$24202598$2$F$$20240809$20240813$20240821$EXP$$PL-AUROBINDO-AUR-APL-2024-038873$AUROBINDO$Koper K. Metastasis of colorectal cancer to the ovary in a patient treated with panitumumab and FOLFOX4 chemotherapy after achieving complete remission in imaging tests$67$YR$$F$Y$$$20240821$$MD$PL$PL
242025991$24202599$1$I$20240716$20240801$20240813$20240813$EXP$$CA-CELLTRION INC.-2024CA006206$CELLTRION$$$$$$Y$$$20240813$$MD$CA$CA
242026001$24202600$1$I$20240715$20240730$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-038418$AUROBINDO$$56$YR$$F$Y$53.6$KG$20240813$$HP$FR$FR
242026012$24202601$2$F$$20240906$20240813$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202408006266$ELI LILLY AND CO$$89$YR$E$F$Y$$$20240911$$MD$US$US
242026021$24202602$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006277$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240813$$CN$US$US
242026031$24202603$1$I$$20240806$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005130$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240813$$CN$US$US
242026041$24202604$1$I$20240809$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006487$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240813$$CN$US$US
242026052$24202605$2$F$20240101$20240918$20240813$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-024809$UNITED THERAPEUTICS$$$$$F$Y$53.515$KG$20240927$$$US$US
242026061$24202606$1$I$$20240719$20240813$20240813$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003777$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242026071$24202607$1$I$$20240808$20240813$20240813$PER$$US-JNJFOC-20240823629$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$CN$US$US
242026084$24202608$4$F$20240101$20240924$20240813$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-024100$UNITED THERAPEUTICS$$$$$M$Y$93.424$KG$20240928$$$US$US
242026091$24202609$1$I$20230901$20240809$20240813$20240813$EXP$IT-MINISAL02-997008$IT-ROCHE-10000054680$ROCHE$$55$YR$A$M$Y$$$20240813$$MD$IT$IT
242026101$24202610$1$I$20240802$20240802$20240813$20240813$PER$$US-SA-2024SA233957$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240813$$MD$US$US
242026111$24202611$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA234582$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240813$$HP$US$US
242026121$24202612$1$I$$20240802$20240813$20240813$PER$$US-SA-2024SA234522$SANOFI AVENTIS$$$$A$M$Y$83.91$KG$20240813$$MD$US$US
242026132$24202613$2$F$20240802$20240826$20240813$20240830$30DAY$$US-AMGEN-USASP2024157424$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242026141$24202614$1$I$$20240801$20240813$20240813$PER$$US-AMGEN-USASL2024155039$AMGEN$$$$$$Y$$$20240812$$PH$US$US
242026151$24202615$1$I$$20240809$20240813$20240813$PER$$US-GILEAD-2024-0683712$GILEAD$$$$$M$Y$$$20240812$$CN$US$US
242026161$24202616$1$I$$20220831$20240813$20240813$EXP$$GB-AstraZeneca-2022A296976$ASTRAZENECA$$$$$$Y$$$20240813$$MD$GB$
242026182$24202618$2$F$$20240816$20240813$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003778$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
242026191$24202619$1$I$$20221230$20240813$20240813$EXP$$US-AstraZeneca-2023A000168$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242026201$24202620$1$I$$20240806$20240813$20240813$EXP$$CA-CELLTRION INC.-2023CA020860$CELLTRION$$$$$$Y$$$20240813$$CN$CA$CA
242026211$24202621$1$I$$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127238$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240813$$HP$US$US
242026221$24202622$1$I$20221123$20230110$20240813$20240813$EXP$$US-AstraZeneca-2022A408158$ASTRAZENECA$$27283$DY$$M$Y$83.6$KG$20240813$$HP$US$
242026241$24202624$1$I$$20240808$20240813$20240813$PER$$US-ROCHE-10000053058$ROCHE$$$$C$M$Y$$$20240813$$CN$US$US
242026252$24202625$2$F$20231201$20240828$20240813$20240903$EXP$$CA-TAKEDA-2024TUS070377$TAKEDA$$26$YR$$F$Y$$$20240903$$CN$CA$CA
242026262$24202626$2$F$$20240917$20240813$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003783$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$HP$US$US
242026281$24202628$1$I$20240801$20240809$20240813$20240813$PER$$US-ROCHE-10000053423$ROCHE$$29$YR$A$M$Y$$$20240813$$CN$US$US
242026292$24202629$2$F$$20240814$20240813$20240827$EXP$$IN-ROCHE-10000046831$ROCHE$$$$$$Y$$$20240827$$CN$IN$IN
242026301$24202630$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003784$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242026311$24202631$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003779$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242026321$24202632$1$I$$20240801$20240813$20240813$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-001167$Alvotech$$71$YR$$F$Y$$$20240813$$PH$CA$CA
242026331$24202633$1$I$$20240808$20240813$20240813$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-108917$REGENERON$$$$$F$Y$$$20240813$$CN$US$US
242026351$24202635$1$I$$20240808$20240813$20240813$EXP$$NVSC2024US162741$NOVARTIS$$44$YR$$M$Y$$$20240813$$MD$US$US
242026361$24202636$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003785$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242026371$24202637$1$I$20240806$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158685$AMGEN$$64$YR$A$F$Y$$$20240812$$CN$US$US
242026381$24202638$1$I$20240801$20240809$20240813$20240813$PER$$US-ROCHE-10000053478$ROCHE$$18$YR$A$M$Y$58.97$KG$20240813$$CN$US$US
242026402$24202640$2$F$$20240903$20240813$20240904$PER$$US-ROCHE-10000053760$ROCHE$$$$A$M$Y$$$20240904$$CN$US$US
242026411$24202641$1$I$$20240806$20240813$20240813$EXP$$US-ALXN-202408USA000423US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$HP$US$US
242026421$24202642$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000053676$ROCHE$$$$E$M$Y$$$20240813$$CN$US$US
242026431$24202643$1$I$20221001$20240802$20240813$20240813$EXP$$US-NOVOPROD-1267361$NOVO NORDISK$$57$YR$$M$Y$$$20240813$$CN$US$US
242026441$24202644$1$I$$20240802$20240813$20240813$EXP$$US-NOVOPROD-1266814$NOVO NORDISK$$$$$F$Y$$$20240813$$CN$US$US
242026451$24202645$1$I$20210809$20240802$20240813$20240813$EXP$$US-NOVOPROD-1266956$NOVO NORDISK$$51$YR$$M$Y$$$20240813$$CN$US$US
242026461$24202646$1$I$$20240802$20240813$20240813$EXP$$US-NOVOPROD-1266948$NOVO NORDISK$$69$YR$$$Y$$$20240813$$CN$US$US
242026471$24202647$1$I$$20240802$20240813$20240813$EXP$$US-NOVOPROD-1267431$NOVO NORDISK$$$$A$M$Y$$$20240813$$CN$US$US
242026482$24202648$2$F$20240701$20240904$20240813$20240913$EXP$ES-AEMPS-1556288$ES-NOVOPROD-1266941$NOVO NORDISK$$20$YR$$F$Y$74$KG$20240913$$MD$ES$ES
242026491$24202649$1$I$20230421$20240802$20240813$20240813$EXP$$US-NOVOPROD-1266982$NOVO NORDISK$$47$YR$$$Y$$$20240813$$CN$US$US
242026501$24202650$1$I$$20240802$20240813$20240813$EXP$$US-NOVOPROD-1266410$NOVO NORDISK$$64$YR$$$Y$$$20240813$$CN$US$US
242026511$24202651$1$I$20240401$20240802$20240813$20240813$EXP$DE-AMK-276960$DE-NOVOPROD-1266955$NOVO NORDISK$$45$YR$$F$Y$120$KG$20240813$$PH$DE$DE
242026541$24202654$1$I$$20231228$20240813$20240813$EXP$$US-SPECGX-T202302458$SPECGX$$$$$M$Y$$$20240813$$CN$US$US
242026551$24202655$1$I$$20230731$20240813$20240813$EXP$$US-SPECGX-T202301625$SPECGX$$$$$$Y$$$20240813$$CN$US$US
242026561$24202656$1$I$$20230822$20240813$20240813$EXP$$US-SPECGX-T202301752$SPECGX$$$$$F$Y$$$20240813$$CN$US$US
242026571$24202657$1$I$$20230925$20240813$20240813$EXP$$US-SPECGX-T202301931$SPECGX$$$$$F$Y$$$20240813$$CN$US$US
242026581$24202658$1$I$$20240514$20240813$20240813$EXP$$US-SPECGX-T202401133$SPECGX$$62$YR$$M$Y$$$20240813$$MD$US$US
242026591$24202659$1$I$20240221$20240322$20240813$20240813$EXP$$US-SPECGX-T202400786$SPECGX$$$$$M$Y$$$20240813$$CN$US$US
242026611$24202661$1$I$$20230801$20240813$20240813$EXP$$US-SPECGX-T202301631$SPECGX$$$$$$Y$$$20240813$$CN$US$US
242026621$24202662$1$I$$20240114$20240813$20240813$EXP$$US-SPECGX-T202400480$SPECGX$$$$$F$Y$$$20240813$$CN$US$US
242026631$24202663$1$I$20200101$20240222$20240813$20240813$EXP$$US-SPECGX-T202400552$SPECGX$$$$$F$Y$$$20240813$$CN$US$US
242026651$24202665$1$I$20240507$20240806$20240813$20240813$PER$$US-SA-2024SA235208$SANOFI AVENTIS$$$$$M$Y$$$20240813$$CN$US$US
242026661$24202666$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003790$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242026671$24202667$1$I$20240601$20240802$20240813$20240813$EXP$$US-NOVOPROD-1242445$NOVO NORDISK$$66$YR$$M$Y$$$20240813$$HP$US$US
242026681$24202668$1$I$20231001$20240802$20240813$20240813$EXP$$US-NOVOPROD-1265970$NOVO NORDISK$$72$YR$$M$Y$115.19$KG$20240813$$CN$US$US
242026691$24202669$1$I$$20240802$20240813$20240813$EXP$$US-NOVOPROD-1266605$NOVO NORDISK$$$$$$Y$$$20240813$$CN$US$US
242026711$24202671$1$I$20150101$20240802$20240813$20240813$EXP$$CN-NOVOPROD-1265442$NOVO NORDISK$$70$YR$$M$Y$62$KG$20240813$$CN$CN$CN
242026721$24202672$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003787$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240813$$HP$US$US
242026731$24202673$1$I$20240101$20240802$20240813$20240813$EXP$$US-NOVOPROD-1266237$NOVO NORDISK$$$$$M$Y$$$20240813$$CN$US$US
242026741$24202674$1$I$20240801$20240802$20240813$20240813$EXP$$ES-NOVOPROD-1264542$NOVO NORDISK$$39$YR$$M$Y$$$20240813$$CN$ES$ES
242026751$24202675$1$I$20240530$20240802$20240813$20240813$EXP$$GB-NOVOPROD-1264591$NOVO NORDISK$$67$YR$$M$Y$100$KG$20240813$$HP$GB$GB
242026761$24202676$1$I$20240731$20240802$20240813$20240813$EXP$GB-MHRA-MED-202408021956271770-VBFKW$GB-NOVOPROD-1264616$NOVO NORDISK$$25$YR$$F$Y$105$KG$20240813$$CN$GB$GB
242026771$24202677$1$I$$20240802$20240813$20240813$EXP$$US-NOVOPROD-1266427$NOVO NORDISK$$48$YR$$$Y$$$20240813$$CN$US$US
242026781$24202678$1$I$$20240802$20240813$20240813$EXP$$US-NOVOPROD-1266412$NOVO NORDISK$$40$YR$$$Y$$$20240813$$CN$US$US
242026791$24202679$1$I$20231228$20240801$20240813$20240813$EXP$$US-NOVOPROD-1266380$NOVO NORDISK$$70$YR$$F$Y$$$20240813$$CN$US$US
242026801$24202680$1$I$20210101$20240802$20240813$20240813$EXP$$US-NOVOPROD-1266463$NOVO NORDISK$$73$YR$$F$Y$$$20240813$$CN$US$US
242026811$24202681$1$I$20240730$20240802$20240813$20240813$EXP$$AR-NOVOPROD-1265242$NOVO NORDISK$$1$YR$$M$Y$$$20240813$$CN$AR$AR
242026821$24202682$1$I$$20240802$20240813$20240813$EXP$$US-NOVOPROD-1266650$NOVO NORDISK$$$$$F$Y$$$20240813$$HP$US$US
242026831$24202683$1$I$20240721$20240802$20240813$20240813$EXP$$US-NOVOPROD-1265955$NOVO NORDISK$$64$YR$$F$Y$$$20240813$$CN$US$US
242026841$24202684$1$I$$20240802$20240813$20240813$EXP$$BR-NOVOPROD-1265247$NOVO NORDISK$$20$YR$$F$Y$$$20240813$$MD$BR$BR
242026851$24202685$1$I$20240617$20240802$20240813$20240813$EXP$$CN-NOVOPROD-1265400$NOVO NORDISK$$65$YR$$M$Y$78$KG$20240813$$CN$CN$CN
242026862$24202686$2$F$$20240912$20240813$20240923$EXP$$AU-NOVOPROD-1264540$NOVO NORDISK$$$$A$F$Y$$$20240923$$HP$AU$AU
242026871$24202687$1$I$20240701$20240802$20240813$20240813$EXP$CN-NMPA-5201011979493202400081$CN-NOVOPROD-1266447$NOVO NORDISK$$45$YR$$F$Y$55$KG$20240813$$HP$CN$CN
242026881$24202688$1$I$$20240802$20240813$20240813$EXP$$NZ-NOVOPROD-1265364$NOVO NORDISK$$$$$$Y$$$20240813$$CN$NZ$NZ
242026891$24202689$1$I$20220301$20240802$20240813$20240813$EXP$RU-RZN-2492870$RU-NOVOPROD-1265987$NOVO NORDISK$$21$YR$$F$Y$65$KG$20240813$$HP$RU$RU
242026901$24202690$1$I$$20240802$20240813$20240813$EXP$$US-NOVOPROD-1266287$NOVO NORDISK$$$$$F$Y$$$20240813$$CN$US$US
242026911$24202691$1$I$$20240802$20240813$20240813$EXP$$BR-NOVOPROD-1264549$NOVO NORDISK$$62$YR$$M$Y$$$20240813$$MD$BR$BR
242026922$24202692$2$F$20240701$20240813$20240813$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125148$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240814$$CN$US$US
242026931$24202693$1$I$20220101$20221006$20240813$20240813$EXP$$US-AstraZeneca-2022A340847$ASTRAZENECA$$596$MON$$F$Y$$$20240813$$CN$US$
242026941$24202694$1$I$$20220926$20240813$20240813$EXP$$US-AstraZeneca-2022A330950$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242026951$24202695$1$I$$20230523$20240813$20240813$EXP$$US-AstraZeneca-2023A120512$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242026961$24202696$1$I$20200311$20200311$20240813$20240813$EXP$$CO-AstraZeneca-2020SE37978$ASTRAZENECA$$20239$DY$$F$Y$$$20240813$$CN$CO$
242026971$24202697$1$I$$20240807$20240813$20240813$EXP$$US-AstraZeneca-2024A180441$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242026981$24202698$1$I$$20220206$20240813$20240813$EXP$$US-AstraZeneca-2022A064813$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242026992$24202699$2$F$$20240918$20240813$20240925$EXP$$AU-NOVOPROD-1262285$NOVO NORDISK$$$$$F$Y$$$20240925$$PH$AU$AU
242027001$24202700$1$I$$20240806$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005562$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240813$$CN$US$US
242027011$24202701$1$I$$20240812$20240813$20240813$EXP$$CZ-SANDOZ INC.-SDZ2024CZ072066$SANDOZ$$32$YR$$M$Y$$$20240813$$HP$CZ$CZ
242027021$24202702$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006499$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240813$$CN$US$US
242027031$24202703$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006560$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240813$$CN$US$US
242027042$24202704$2$F$$20240819$20240813$20240826$EXP$$JP-TEVA-VS-3230167$TEVA$Katagiri H, Sato N, Inoue Y, Muto K, Tanaka H, Hirose Y. Life-Threatening Hyperkalemia following Low-Dose Trimethoprim-Sulfamethoxazole: A Case Report. Case-Rep-Acute-Med 2023; 6 (1): 1-8.; Katagiri H, Sato N, Inoue Y, Muto K, Tanaka H, Hirose Y. Life-Threatening Hyperkalemia following Low-Dose Trimethoprim-Sulfamethoxazole: A Case Report. Case-Rep-Acute-Med 2023; 6 (1): 1-8.$80$YR$$F$Y$$$20240826$$HP$JP$JP
242027052$24202705$2$F$$20240823$20240813$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003789$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
242027061$24202706$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003792$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242027071$24202707$1$I$$20240809$20240813$20240813$PER$$NVSC2024US163587$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
242027081$24202708$1$I$20240401$20240729$20240813$20240813$PER$$US-TEVA-VS-3227661$TEVA$$35$YR$$F$Y$77.11$KG$20240813$$CN$US$US
242027092$24202709$2$F$20240806$20240819$20240813$20240822$PER$$US-AMGEN-USASP2024157800$AMGEN$$5$YR$C$$Y$$$20240822$$PH$US$US
242027104$24202710$4$F$20240704$20240910$20240813$20240921$30DAY$$US-AMGEN-USASP2024156350$AMGEN$$74$YR$E$F$Y$$$20240920$$HP$US$US
242027111$24202711$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159870$AMGEN$$$$$$Y$$$20240812$$PH$US$US
242027121$24202712$1$I$$20240720$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003772$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242027131$24202713$1$I$$20240807$20240813$20240813$PER$$US-ROCHE-10000054288$ROCHE$$$$$$Y$$$20240813$$PH$US$US
242027141$24202714$1$I$$20240805$20240813$20240813$PER$$US-CHATTEMPRD-2024OHG026573$CHATTEM$$$$A$$Y$$$20240813$$CN$US$US
242027151$24202715$1$I$20240601$20240802$20240813$20240813$EXP$$US-MDD US Operations-MDD202408-002868$MDD OPERATIONS$$73$YR$$M$Y$$$20240811$$HP$US$
242027161$24202716$1$I$$20240326$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089850$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027171$24202717$1$I$$20240329$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089848$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027181$24202718$1$I$$20240228$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089381$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027191$24202719$1$I$20240329$20240405$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089894$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027201$24202720$1$I$$20240220$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089110$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027211$24202721$1$I$$20240314$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089537$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027221$24202722$1$I$$20240426$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089916$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027231$24202723$1$I$$20240319$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089642$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027241$24202724$1$I$$20240426$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090016$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027251$24202725$1$I$$20240326$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090143$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027261$24202726$1$I$$20230713$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083543$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027271$24202727$1$I$$20230727$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083974$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027281$24202728$1$I$20230401$20230706$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083369$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027291$24202729$1$I$$20230712$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083544$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027301$24202730$1$I$$20230720$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083896$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027311$24202731$1$I$$20230724$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083847$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027321$24202732$1$I$$20240201$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088090$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027331$24202733$1$I$$20240124$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088695$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027341$24202734$1$I$$20240202$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088164$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027351$24202735$1$I$$20240216$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088646$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027361$24202736$1$I$$20240129$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088776$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027371$24202737$1$I$$20240213$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088968$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027381$24202738$1$I$$20240201$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088815$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027391$24202739$1$I$$20240126$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088750$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027401$24202740$1$I$$20240212$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089063$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027411$24202741$1$I$$20240220$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089105$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027421$24202742$1$I$$20240129$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088859$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027431$24202743$1$I$$20240214$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089051$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027441$24202744$1$I$$20240223$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089427$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027451$24202745$1$I$$20240726$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092119$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027461$24202746$1$I$$20240604$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091414$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027471$24202747$1$I$$20240426$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090065$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027481$24202748$1$I$$20240406$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090056$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027491$24202749$1$I$$20240703$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091402$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027501$24202750$1$I$$20240523$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091108$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027511$24202751$1$I$$20240513$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090837$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027521$24202752$1$I$20240418$20240531$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090523$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027531$24202753$1$I$$20240524$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091229$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027541$24202754$1$I$$20240411$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090191$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027551$24202755$1$I$$20240802$20240813$20240813$PER$$US-TAKEDA-2024TUS078978$TAKEDA$$$$$F$Y$$$20240813$$CN$US$US
242027561$24202756$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003801$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242027571$24202757$1$I$$20240520$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091012$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027582$24202758$2$F$$20240919$20240813$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126291$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240920$$CN$US$US
242027591$24202759$1$I$$20240730$20240813$20240813$EXP$$US-ENDO USA, INC.-2024-003121$ENDO$$$$$M$Y$$$20240813$$CN$US$US
242027602$24202760$2$F$20231122$20240904$20240813$20240915$EXP$$JP-AMGEN-JPNSP2024159729$AMGEN$Study 5 A case of drug-induced aortitis caused by Pegfilgrastim (PEG-rhG-CSF) during chemotherapy containing immune checkpoint inhibitors. The 260th Kanto Branch Meeting of the Japanese Respiratory Society (06 JUL 2024). 2024;9$66$YR$E$M$Y$$$20240915$$MD$JP$JP
242027612$24202761$2$F$$20240807$20240813$20240816$PER$$US-CHATTEMPRD-2024OHG026468$CHATTEM$$$$$F$Y$$$20240816$$CN$US$US
242027622$24202762$2$F$20240701$20240813$20240813$20240819$EXP$$US-LEO Pharma-372619$LEO PHARM$$66$YR$$M$Y$$$20240819$$CN$US$US
242027631$24202763$1$I$20240713$20240809$20240813$20240813$EXP$FR-AFSSAPS-NC2024000954$FR-SANDOZ INC.-SDZ2024FR071705$SANDOZ$$15$YR$$F$Y$57$KG$20240813$$MD$FR$FR
242027641$24202764$1$I$$20240719$20240813$20240813$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091871$GLENMARK$$$$$$Y$$$20240813$$CN$US$US
242027651$24202765$1$I$$20240807$20240813$20240813$30DAY$$US-GSK-US2024098624$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242027661$24202766$1$I$20240731$20240806$20240813$20240813$PER$$US-ROCHE-10000051169$ROCHE$$$$$$Y$$$20240813$$PH$US$US
242027672$24202767$2$F$$20240807$20240813$20240814$PER$$US-CHATTEMPRD-2024OHG026607$CHATTEM$$$$$M$Y$$$20240814$$CN$US$US
242027681$24202768$1$I$20240701$20240730$20240813$20240813$PER$$US-Encube-001174$ENCUBE ETHICALS$$$$$F$Y$$$20240812$$CN$US$
242027692$24202769$2$F$20240701$20240903$20240813$20240911$EXP$$GB-JNJFOC-20240818969$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20240911$$CN$GB$GB
242027701$24202770$1$I$20240808$20240809$20240813$20240813$EXP$$US-JNJFOC-20240827462$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240813$$MD$US$US
242027711$24202771$1$I$$20240805$20240813$20240813$PER$$US-CHATTEMPRD-2024OHG026429$CHATTEM$$$$$M$Y$$$20240813$$CN$US$US
242027731$24202773$1$I$$20240808$20240813$20240813$PER$$US-TAKEDA-2024TUS080140$TAKEDA$$$$$$Y$$$20240813$$CN$US$US
242027741$24202774$1$I$$20240812$20240813$20240813$EXP$PL-EMA-20130614-AUTODUP-355587$PL-SANDOZ INC.-SDZ2024PL072058$SANDOZ$$35$YR$$F$Y$$$20240813$$MD$PL$PL
242027751$24202775$1$I$20240718$20240719$20240813$20240813$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003802$ACADIA PHARMACEUTICALS$$88$YR$$M$Y$$$20240813$$CN$US$US
242027761$24202776$1$I$$20240812$20240813$20240813$EXP$$RO-SANDOZ INC.-SDZ2024RO071891$SANDOZ$$37$YR$$F$Y$$$20240813$$HP$RO$RO
242027773$24202777$3$F$20240330$20240813$20240813$20240823$PER$$US-CHATTEMPRD-2024OHG026603$CHATTEM$$43$YR$A$M$Y$$$20240823$$CN$US$US
242027781$24202778$1$I$$20240806$20240813$20240813$PER$$US-CHATTEMPRD-2024OHG026593$CHATTEM$$$$$$Y$$$20240813$$CN$US$US
242027792$24202779$2$F$$20240822$20240813$20240902$EXP$$JP-AMGEN-JPNSP2024159274$AMGEN$$6$DEC$A$M$Y$$$20240902$$MD$JP$JP
242027801$24202780$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159270$AMGEN$$$$$M$Y$$$20240812$$HP$US$US
242027811$24202781$1$I$$20240807$20240813$20240813$PER$$US-AMGEN-USASP2024157729$AMGEN$$$$$F$Y$$$20240812$$CN$US$US
242027821$24202782$1$I$$20240810$20240813$20240813$PER$$NVSC2024US163439$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242027831$24202783$1$I$$20240808$20240813$20240813$EXP$$NVSJ2024JP009604$NOVARTIS$$$$$$Y$$$20240813$$MD$JP$JP
242027841$24202784$1$I$20240728$20240805$20240813$20240813$EXP$$CN-BEIGENE-BGN-2024-012193$BEIGENE$$$$$$Y$$$20240813$$HP$CN$CN
242027852$24202785$2$F$20240605$20240902$20240813$20240905$EXP$$IL-UCBSA-2024040040$UCB$$38$YR$$F$Y$49$KG$20240905$$HP$IL$IL
242027862$24202786$2$F$20240509$20240829$20240813$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003804$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240923$$CN$US$US
242027872$24202787$2$F$$20240808$20240813$20240813$EXP$$US-ROCHE-10000048476$ROCHE$$$$$$Y$$$20240813$$CN$US$US
242027881$24202788$1$I$$20240712$20240813$20240813$PER$$US-TRAVERE-2024TVT00704$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240813$$CN$US$US
242027891$24202789$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127445$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$117.93$KG$20240813$$CN$US$US
242027902$24202790$2$F$20240101$20240822$20240813$20240828$PER$$US-BIOGEN-2024BI01272234$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
242027911$24202791$1$I$20240305$20240801$20240813$20240813$EXP$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000712$PAREXEL$$$$$$Y$$$20240813$$CN$US$US
242027921$24202792$1$I$20240806$20240808$20240813$20240813$EXP$$NVSJ2024JP009607$NOVARTIS$$$$$$Y$$$20240813$$MD$JP$JP
242027931$24202793$1$I$$20240808$20240813$20240813$EXP$$US-TAKEDA-2024TUS022346$TAKEDA$$$$$M$Y$$$20240813$$CN$US$US
242027941$24202794$1$I$$20240810$20240813$20240813$PER$$US-GILEAD-2024-0683818$GILEAD$$$$$M$Y$$$20240812$$MD$US$US
242027951$24202795$1$I$$20240805$20240813$20240813$PER$$US-JNJFOC-20240816829$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$CN$US$US
242027961$24202796$1$I$$20240809$20240813$20240813$EXP$GB-MHRA-MED-202408081308279350-GDTFN$GB-ROCHE-10000054472$ROCHE$$32$YR$A$F$Y$$$20240813$$HP$GB$GB
242027971$24202797$1$I$20240731$20240802$20240813$20240813$EXP$$GB-BAXTER-2024BAX022699$BAXTER$$65$YR$$M$Y$$$20240813$$CN$GB$GB
242027981$24202798$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006573$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240813$$CN$US$US
242027991$24202799$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006288$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240813$$CN$US$US
242028001$24202800$1$I$20240808$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006282$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240813$$CN$US$US
242028011$24202801$1$I$20240627$20240802$20240813$20240813$EXP$CN-NMPACDR-4403061004832202400274$CN-BAXTER-2024BAX022808$BAXTER$$80$YR$$F$Y$40$KG$20240813$$MD$CN$CN
242028021$24202802$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006793$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240813$$CN$US$US
242028031$24202803$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006692$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242028041$24202804$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006504$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240813$$CN$US$US
242028051$24202805$1$I$$20240809$20240813$20240813$EXP$$NVSC2024US163454$NOVARTIS$$60$YR$$M$Y$$$20240813$$HP$US$US
242028062$24202806$2$F$$20240815$20240813$20240821$PER$$US-ROCHE-10000033250$ROCHE$$$$$F$Y$$$20240821$$CN$US$US
242028071$24202807$1$I$$20240807$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408004636$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240813$$CN$US$US
242028081$24202808$1$I$20240809$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006501$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240813$$CN$US$US
242028092$24202809$2$F$$20240819$20240813$20240827$EXP$$CA-ROCHE-10000053436$ROCHE$$$$A$M$Y$$$20240827$$CN$CA$CA
242028101$24202810$1$I$$20240808$20240813$20240813$30DAY$$ES-SANDOZ INC.-SDZ2024ES071489$SANDOZ$$$$$M$Y$$$20240813$$PH$ES$ES
242028111$24202811$1$I$20240717$20240719$20240813$20240813$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003806$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240813$$CN$US$US
242028121$24202812$1$I$20240717$20240717$20240813$20240813$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000637$PAREXEL$$$$$$Y$$$20240813$$CN$US$US
242028131$24202813$1$I$$20240808$20240813$20240813$PER$$US-BIOGEN-2024BI01277564$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
242028151$24202815$1$I$$20240808$20240813$20240813$PER$$US-BIOGEN-2024BI01277679$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
242028171$24202817$1$I$$20230705$20240813$20240813$EXP$$US-AstraZeneca-2023A155025$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242028181$24202818$1$I$20240507$20240808$20240813$20240813$EXP$$JP-TAKEDA-2024TJP007183$TAKEDA$$3$DEC$$M$Y$$$20240813$$MD$JP$JP
242028191$24202819$1$I$20240806$20240807$20240813$20240813$EXP$$US-TAKEDA-2024TUS075251$TAKEDA$$41$YR$$M$Y$$$20240813$$CN$US$US
242028201$24202820$1$I$$20221110$20240813$20240813$EXP$$US-AstraZeneca-2022A375174$ASTRAZENECA$$$$$M$Y$99.8$KG$20240813$$CN$US$
242028211$24202821$1$I$$20220727$20240813$20240813$EXP$$US-AstraZeneca-2022A269398$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242028221$24202822$1$I$20240614$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180860$ASTRAZENECA$$27835$DY$$F$Y$$$20240813$$CN$US$
242028231$24202823$1$I$$20220614$20240813$20240813$EXP$$US-AstraZeneca-2022A222119$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242028241$24202824$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003816$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242028251$24202825$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A177550$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242028262$24202826$2$F$$20240912$20240813$20240919$EXP$$JP-AMGEN-JPNSP2024156136$AMGEN$$$$$$Y$$$20240919$$PH$JP$JP
242028271$24202827$1$I$$20240807$20240813$20240813$EXP$$JP-AMGEN-JPNSP2024159735$AMGEN$$$$$$Y$$$20240812$$MD$JP$JP
242028281$24202828$1$I$$20240712$20240813$20240813$PER$$US-TRAVERE-2024TVT00706$TRAVERE THERAPEUTICS$$27$YR$A$M$Y$$$20240813$$CN$US$US
242028291$24202829$1$I$$20240807$20240813$20240813$PER$$US-ROCHE-10000052255$ROCHE$$$$$$Y$$$20240813$$MD$US$US
242028302$24202830$2$F$$20240909$20240813$20240911$PER$$US-ROCHE-10000051018$ROCHE$$$$$$Y$$$20240911$$CN$US$US
242028311$24202831$1$I$20240716$20240716$20240813$20240813$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000635$PAREXEL$$$$$$Y$$$20240813$$CN$US$US
242028321$24202832$1$I$20231005$20240802$20240813$20240813$EXP$$US-RDY-CLI/USA/24/0011668$DR REDDYS$$0$DY$N$M$Y$2.49$KG$20240813$$CN$US$US
242028331$24202833$1$I$$20240807$20240813$20240813$PER$$US-BIOGEN-2024BI01277373$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
242028341$24202834$1$I$20240621$20240806$20240813$20240813$EXP$$CA-JNJFOC-20240806693$JOHNSON AND JOHNSON$$62$YR$A$F$Y$60$KG$20240813$$HP$CA$CA
242028351$24202835$1$I$20240101$20240807$20240813$20240813$PER$$US-BIOGEN-2024BI01277461$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
242028361$24202836$1$I$$20240712$20240813$20240813$PER$$US-TRAVERE-2024TVT00707$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240813$$CN$US$US
242028372$24202837$2$F$$20240812$20240813$20240814$PER$$US-AMGEN-USASP2024159019$AMGEN$$$$$$Y$$$20240814$$CN$US$US
242028381$24202838$1$I$$20240807$20240813$20240813$30DAY$$US-GSK-US2024098627$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242028391$24202839$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003817$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242028402$24202840$2$F$20240701$20240822$20240813$20240829$PER$$US-ROCHE-10000050793$ROCHE$$71$YR$E$M$Y$81.64$KG$20240829$$CN$US$US
242028411$24202841$1$I$$20240805$20240813$20240813$PER$$US-ABBVIE-5868200$ABBVIE$$$$$F$Y$$$20240813$$MD$US$US
242028431$24202843$1$I$$20240719$20240813$20240813$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003809$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242028441$24202844$1$I$20240102$20240812$20240813$20240813$EXP$FR-AFSSAPS-NC2024000982$FR-ABBVIE-5876693$ABBVIE$$38$YR$$M$Y$$$20240813$$MD$FR$FR
242028452$24202845$2$F$20240806$20240808$20240813$20240821$EXP$$AU-BEH-2024176996$CSL BEHRING$$37$YR$A$M$Y$101.2$KG$20240821$$HP$AU$AU
242028461$24202846$1$I$20231201$20240805$20240813$20240813$EXP$FR-AFSSAPS-TS2024000867$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110856$ZYDUS PHARM$$$$$$Y$$$20240813$$MD$FR$FR
242028471$24202847$1$I$20240101$20240807$20240813$20240813$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110921$ZYDUS PHARM$$$$$$Y$$$20240813$$PH$US$US
242028481$24202848$1$I$$20240731$20240813$20240813$EXP$GB-MHRA-MIDB-2e957c43-01ee-4abe-8676-d258493bd95a$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-110651$ZYDUS PHARM$$$$$$Y$$$20240813$$PH$GB$GB
242028491$24202849$1$I$$20240731$20240813$20240813$EXP$$ES-WOCKHARDT BIO AG-2024WBA000017$WOCKHARDT BIO AG$Somoza-Fernandez B, Escudero-Vilaplana V, Collado-Borrell R, Perez-Ramirez S, Villanueva-Bueno C, Montero-Anton MDP et.al.. Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient.. J Oncol Pharm Pract.. 2024$60$YR$$M$Y$$$20240808$$HP$ES$ES
242028501$24202850$1$I$$20230123$20240813$20240813$EXP$$US-AstraZeneca-2023A019850$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242028511$24202851$1$I$20200106$20200129$20240813$20240813$EXP$$CO-AstraZeneca-2020SE12454$ASTRAZENECA$$24462$DY$$F$Y$$$20240813$$CN$CO$
242028521$24202852$1$I$$20240807$20240813$20240813$EXP$$US-AstraZeneca-2024A180523$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242028531$24202853$1$I$$20240807$20240813$20240813$EXP$$US-AstraZeneca-2024A180408$ASTRAZENECA$$$$$F$Y$54$KG$20240813$$CN$US$
242028541$24202854$1$I$$20200122$20240813$20240813$EXP$$US-AstraZeneca-2020SE11472$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242028551$24202855$1$I$20240711$20240719$20240813$20240813$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003819$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240813$$CN$US$US
242028561$24202856$1$I$20240708$20240719$20240813$20240813$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003821$ACADIA PHARMACEUTICALS$$87$YR$$F$Y$$$20240813$$HP$US$US
242028571$24202857$1$I$$20240806$20240813$20240813$PER$$US-ROCHE-10000053653$ROCHE$$$$$$Y$$$20240813$$CN$US$US
242028582$24202858$2$F$$20240924$20240813$20240926$PER$$US-ROCHE-10000050785$ROCHE$$$$E$M$Y$$$20240926$$CN$US$US
242028591$24202859$1$I$$20240809$20240813$20240813$EXP$$US-ROCHE-10000052916$ROCHE$$$$A$M$Y$$$20240813$$CN$US$US
242028601$24202860$1$I$$20240804$20240813$20240813$30DAY$$US-GSK-US2024097586$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242028612$24202861$2$F$20230101$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024159319$AMGEN$$70$YR$E$F$Y$$$20240813$$CN$US$US
242028621$24202862$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159050$AMGEN$$$$$M$Y$$$20240812$$CN$US$US
242028632$24202863$2$F$$20240808$20240813$20240822$PER$$US-TRAVERE-2024TVT00710$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242028643$24202864$3$F$20220911$20240812$20240813$20240816$EXP$$IT-SANDOZ INC.-NVSC2022IT222927$SANDOZ$$68$YR$$M$Y$80$KG$20240816$$MD$IT$IT
242028651$24202865$1$I$20240616$20240808$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127048$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240813$$CN$US$US
242028661$24202866$1$I$$20240808$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127233$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240813$$CN$US$US
242028671$24202867$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003818$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242028681$24202868$1$I$$20240809$20240813$20240813$EXP$$DE-JNJFOC-20240830764$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240813$$MD$DE$DE
242028691$24202869$1$I$$20240806$20240813$20240813$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043945$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240813$$MD$AU$AU
242028701$24202870$1$I$$20240808$20240813$20240813$PER$$US-ROCHE-10000052841$ROCHE$$78$YR$E$F$Y$$$20240813$$CN$US$US
242028711$24202871$1$I$$20240805$20240813$20240813$PER$$US-ROCHE-10000050545$ROCHE$Salih N, Chirakkara S, Shatila A. First Three NMOSD Case Series Started on IV Ravulizumab in UAE [Abstract: MSC2023-A-1075]. Multiple Sclerosis and Related Disorders. 2023-Dec;80:39. doi:10.1016/j.msard.2023.105256.$42$YR$A$F$Y$$$20240813$$HP$US$US
242028721$24202872$1$I$$20240808$20240813$20240813$PER$$US-ROCHE-10000053194$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
242028731$24202873$1$I$20190101$20240809$20240813$20240813$EXP$$US-ROCHE-10000054390$ROCHE$$41$YR$A$F$Y$70.3$KG$20240813$$CN$US$US
242028741$24202874$1$I$20240701$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003822$ACADIA PHARMACEUTICALS$$61$YR$$M$Y$$$20240813$$CN$US$US
242028761$24202876$1$I$20200326$20240802$20240813$20240813$EXP$DE-BoehringerIngelheim-2020-BI-024596$DE-KOANAAP-SML-DE-2021-01081$SHILPA MEDICARE$$62$YR$A$F$Y$77.7$KG$20240813$$MD$DE$DE
242028771$24202877$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006419$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240813$$CN$US$US
242028781$24202878$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006575$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240813$$CN$US$US
242028792$24202879$2$F$20240808$20240917$20240813$20240919$PER$$US-AMGEN-USASP2024158843$AMGEN$$65$YR$E$F$Y$$$20240919$$CN$US$US
242028802$24202880$2$F$$20240828$20240813$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003831$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
242028812$24202881$2$F$20240101$20240902$20240813$20240910$EXP$$CA-CELLTRION INC.-2024CA006434$CELLTRION$$$$$$Y$$$20240910$$CN$CA$CA
242028823$24202882$3$F$20240101$20240909$20240813$20240914$EXP$$BE-JNJFOC-20240822366$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240914$$MD$BE$BE
242028832$24202883$2$F$20240704$20240912$20240813$20240919$EXP$$MX-ROCHE-10000053783$ROCHE$$33$YR$A$M$Y$89$KG$20240919$$CN$MX$MX
242028841$24202884$1$I$$20240812$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US072191$SANDOZ$$$$$F$Y$$$20240813$$CN$US$US
242028852$24202885$2$F$$20240813$20240813$20240819$EXP$DE-EMA-DD-20240806-7482677-114853$DE-SANDOZ INC.-SDZ2024DE071927$SANDOZ$$11$YR$$F$Y$$$20240819$$MD$DE$DE
242028861$24202886$1$I$$20240720$20240813$20240813$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003833$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242028871$24202887$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003827$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242028881$24202888$1$I$20240113$20240805$20240813$20240813$EXP$$ES-EXELIXIS-CABO-24080383$EXELIXIS$$52$YR$$M$Y$61$KG$20240812$$MD$ES$ES
242028891$24202889$1$I$$20221024$20240813$20240813$EXP$$US-AstraZeneca-2022A355775$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242028901$24202890$1$I$20230603$20230628$20240813$20240813$EXP$$US-AstraZeneca-2023A151167$ASTRAZENECA$$27760$DY$$F$Y$$$20240813$$CN$US$
242028911$24202891$1$I$$20221031$20240813$20240813$EXP$$US-AstraZeneca-2022A362482$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242028931$24202893$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127312$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240813$$CN$US$US
242028941$24202894$1$I$20240717$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003800$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240813$$CN$US$US
242028951$24202895$1$I$$20240806$20240813$20240813$EXP$$FR-Orion Corporation ORION PHARMA-TREX2024-0208$ORION$$83$YR$E$M$Y$$$20240813$$MD$FR$
242028961$24202896$1$I$20220224$20240806$20240813$20240813$EXP$$CA-TAKEDA-2022TUS014577$TAKEDA$$72$YR$$M$Y$$$20240813$$CN$CA$CA
242028972$24202897$2$F$20240731$20240809$20240813$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003644$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240830$$CN$US$US
242028981$24202898$1$I$20240730$20240808$20240813$20240813$EXP$$CN-ROCHE-10000052141$ROCHE$$38$YR$A$F$Y$58$KG$20240813$$HP$CN$CN
242028992$24202899$2$F$20240826$20240826$20240813$20240828$EXP$$CA-TAKEDA-2024TUS040556$TAKEDA$$63$YR$$F$Y$$$20240828$$CN$CA$CA
242029001$24202900$1$I$$20240807$20240813$20240813$EXP$$GB-AMGEN-GBRSP2024159350$AMGEN$$74$YR$E$F$Y$$$20240812$$CN$GB$GB
242029013$24202901$3$F$20240808$20240830$20240813$20240831$PER$$US-AMGEN-USASP2024158689$AMGEN$$76$YR$E$M$Y$$$20240831$$MD$US$US
242029021$24202902$1$I$20240808$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158536$AMGEN$$33$YR$A$F$Y$$$20240812$$CN$US$US
242029031$24202903$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159922$AMGEN$$$$$$Y$$$20240812$$PH$US$US
242029041$24202904$1$I$$20240808$20240813$20240813$EXP$$BR-JNJFOC-20240823718$JOHNSON AND JOHNSON$$82$YR$E$M$Y$67$KG$20240813$$CN$BR$BR
242029051$24202905$1$I$$20240719$20240813$20240813$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003771$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242029061$24202906$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003770$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242029082$24202908$2$F$$20240821$20240813$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003757$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
242029091$24202909$1$I$20240601$20240719$20240813$20240813$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003753$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240813$$CN$US$US
242029101$24202910$1$I$20240101$20240807$20240813$20240813$PER$$US-AMGEN-USASP2024157925$AMGEN$$73$YR$E$F$Y$$$20240812$$HP$US$US
242029111$24202911$1$I$$20240806$20240813$20240813$EXP$$BE-ABBVIE-5876834$ABBVIE$$$$$$Y$$$20240813$$CN$BE$BE
242029121$24202912$1$I$20240401$20240805$20240813$20240813$EXP$$US-AMGEN-USASL2024155598$AMGEN$$79$YR$E$M$Y$$$20240812$$CN$US$US
242029131$24202913$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003761$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242029141$24202914$1$I$20240722$20240722$20240813$20240813$PER$$CA-TOLMAR, INC.-24CA051236$TOLMAR$$71$YR$$M$Y$$$20240812$$CN$CA$CA
242029151$24202915$1$I$20240722$20240722$20240813$20240813$PER$$CA-TOLMAR, INC.-24CA051242$TOLMAR$$83$YR$$M$Y$$$20240812$$CN$CA$CA
242029161$24202916$1$I$20240721$20240722$20240813$20240813$PER$$CA-TOLMAR, INC.-24CA051235$TOLMAR$$89$YR$$M$Y$$$20240812$$CN$CA$CA
242029171$24202917$1$I$$20240722$20240813$20240813$PER$$CA-TOLMAR, INC.-24CA051275$TOLMAR$$$$$M$Y$$$20240812$$CN$CA$CA
242029181$24202918$1$I$$20240722$20240813$20240813$PER$$CA-TOLMAR, INC.-24CA051274$TOLMAR$$$$$M$Y$$$20240812$$CN$CA$CA
242029191$24202919$1$I$20240722$20240722$20240813$20240813$PER$$CA-TOLMAR, INC.-24CA051243$TOLMAR$$58$YR$$M$Y$$$20240812$$CN$CA$CA
242029201$24202920$1$I$20240719$20240719$20240813$20240813$PER$$US-TOLMAR, INC.-24US051175$TOLMAR$$60$YR$$M$Y$$$20240812$$HP$US$US
242029211$24202921$1$I$20240309$20240718$20240813$20240813$PER$$US-TOLMAR, INC.-24US051153$TOLMAR$$50$YR$$F$Y$$$20240812$$HP$US$US
242029222$24202922$2$F$20240718$20240828$20240813$20240917$PER$$US-TOLMAR, INC.-24US051171$TOLMAR$$82$YR$$M$Y$$$20240917$$HP$US$US
242029232$24202923$2$F$20240718$20240718$20240813$20240905$PER$$US-TOLMAR, INC.-24US051180$TOLMAR$$83$YR$$M$Y$$$20240905$$HP$US$US
242029241$24202924$1$I$$20240731$20240813$20240813$EXP$$US-RDY-LIT/USA/24/0011523$DR REDDYS$Allami N, O^Connor K, Bagley SM. A case of severe opioid and methamphetamine use disorder in a 14 year old. Addiction science and clinical practice. 19(1): 54. doi:10.1186/s13722-024-00487-1.$14$YR$T$F$Y$$$20240813$$HP$US$US
242029251$24202925$1$I$20200101$20240811$20240813$20240813$EXP$$IL-ABBVIE-5877119$ABBVIE$$44$YR$$M$Y$$$20240813$$CN$IL$IL
242029261$24202926$1$I$$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125699$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240813$$HP$US$US
242029271$24202927$1$I$$20240808$20240813$20240813$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-126637$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240813$$MD$JP$JP
242029281$24202928$1$I$$20240730$20240813$20240813$EXP$$US-GRAVITIPHARMA-GRA-2407-US-LIT-0306$GRAVITI PHARMACEUTICALS$Carranza Morales A, Blanco Jimenez JA, Madhavan A.A Painful Case of Asthma.Am J Respir Crit Care Med.30-07-2024;209:A5999$43$YR$A$F$Y$$$20240813$$HP$US$US
242029291$24202929$1$I$20240701$20240808$20240813$20240813$EXP$$US-JNJFOC-20240821635$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240813$$HP$US$US
242029311$24202931$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000053410$ROCHE$$63$YR$A$M$Y$$$20240813$$MD$US$US
242029321$24202932$1$I$$20240805$20240813$20240813$PER$$US-GILEAD-2024-0683066$GILEAD$$$$$M$Y$$$20240812$$HP$US$US
242029331$24202933$1$I$$20230120$20240813$20240813$EXP$$US-AstraZeneca-2022A401413$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242029341$24202934$1$I$20240724$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A181485$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242029351$24202935$1$I$$20220526$20240813$20240813$EXP$$US-AstraZeneca-2022A201700$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242029361$24202936$1$I$$20240805$20240813$20240813$EXP$$AU-ALXN-202408OCE000189AU$ALEXION PHARMACEUTICALS$$25$YR$$F$Y$$$20240813$$CN$AU$AU
242029371$24202937$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006247$ELI LILLY AND CO$$18$YR$A$F$Y$$$20240813$$CN$US$US
242029381$24202938$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006287$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240813$$CN$US$US
242029391$24202939$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007237$ELI LILLY AND CO$$12$YR$C$F$Y$$$20240813$$CN$US$US
242029401$24202940$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006541$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240813$$CN$US$US
242029411$24202941$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006337$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240813$$CN$US$US
242029421$24202942$1$I$20240701$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006546$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240813$$CN$US$US
242029431$24202943$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006699$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240813$$CN$US$US
242029441$24202944$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006540$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240813$$CN$US$US
242029452$24202945$2$F$20240101$20240822$20240813$20240830$EXP$$IT-MIRUM PHARMACEUTICALS INTERNATIONAL B.V.-IT-MIR-24-00601$MIRUM PHARMACEUTICALS$$$$$$Y$$$20240830$$MD$IT$IT
242029481$24202948$1$I$20240804$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158453$AMGEN$$61$YR$A$M$Y$$$20240812$$CN$US$US
242029491$24202949$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5874223$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242029501$24202950$1$I$20230815$20240808$20240813$20240813$EXP$$CO-UCBSA-2024040660$UCB$$21$YR$$F$Y$$$20240813$$CN$CO$CO
242029512$24202951$2$F$$20240808$20240813$20240823$EXP$$TR-JNJFOC-20240822653$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240823$$MD$TR$TR
242029521$24202952$1$I$$20240808$20240813$20240813$EXP$$US-JNJFOC-20240822852$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240813$$HP$US$US
242029542$24202954$2$F$20240808$20240814$20240813$20240817$PER$$US-AMGEN-USASP2024159294$AMGEN$$78$YR$E$M$Y$$$20240817$$HP$US$US
242029551$24202955$1$I$$20240808$20240813$20240813$EXP$$CA-ROCHE-10000053715$ROCHE$$$$A$F$Y$$$20240813$$CN$CA$CA
242029561$24202956$1$I$20230101$20240731$20240813$20240813$EXP$$US-ROCHE-10000045946$ROCHE$$68$YR$E$F$Y$89.81$KG$20240813$$CN$US$US
242029571$24202957$1$I$20240720$20240809$20240813$20240813$EXP$$CA-ABBVIE-5876031$ABBVIE$$81$YR$$M$Y$$$20240813$$CN$CA$CA
242029581$24202958$1$I$20240805$20240812$20240813$20240813$PER$$US-HALEON-2191630$Haleon PLC$$76$YR$$M$Y$$$20240813$$CN$US$US
242029591$24202959$1$I$20240101$20240119$20240813$20240813$PER$$US-SPECGX-T202400501$SPECGX$$$$$F$Y$$$20240813$$CN$US$US
242029601$24202960$1$I$$20230720$20240813$20240813$PER$$US-SPECGX-T202301585$SPECGX$$$$$$Y$$$20240813$$CN$US$US
242029611$24202961$1$I$20240410$20240411$20240813$20240813$PER$$US-SPECGX-T202400921$SPECGX$$71$YR$$M$Y$64$KG$20240813$$CN$US$US
242029621$24202962$1$I$20231001$20240122$20240813$20240813$PER$$US-SPECGX-T202400525$SPECGX$$84$YR$$M$Y$$$20240813$$CN$US$US
242029631$24202963$1$I$$20230810$20240813$20240813$PER$$US-SPECGX-T202301692$SPECGX$$$$$$Y$$$20240813$$PH$US$US
242029641$24202964$1$I$$20230808$20240813$20240813$PER$$US-SPECGX-T202301681$SPECGX$$$$$F$Y$$$20240813$$CN$US$US
242029651$24202965$1$I$20090101$20240701$20240813$20240813$PER$$US-SPECGX-T202401370$SPECGX$$$$$F$Y$$$20240813$$CN$US$US
242029661$24202966$1$I$20231101$20240617$20240813$20240813$PER$$US-SPECGX-T202401369$SPECGX$$83$YR$$F$Y$$$20240813$$CN$US$US
242029671$24202967$1$I$20231101$20240322$20240813$20240813$PER$$US-SPECGX-T202400787$SPECGX$$67$YR$$F$Y$100$KG$20240813$$CN$US$US
242029681$24202968$1$I$$20240307$20240813$20240813$PER$$US-SPECGX-T202400736$SPECGX$$$$$$Y$$$20240813$$CN$US$US
242029691$24202969$1$I$20230101$20231106$20240813$20240813$PER$$US-SPECGX-T202302172$SPECGX$$$$$M$Y$104$KG$20240813$$CN$US$US
242029701$24202970$1$I$20240601$20240624$20240813$20240813$PER$$US-SPECGX-T202401277$SPECGX$$65$YR$$M$Y$100$KG$20240813$$PH$US$US
242029711$24202971$1$I$20230101$20230922$20240813$20240813$PER$$US-SPECGX-T202301845$SPECGX$$$$$F$Y$68$KG$20240813$$CN$US$US
242029721$24202972$1$I$20240329$20240331$20240813$20240813$PER$$US-SPECGX-T202400824$SPECGX$$$$$F$Y$$$20240813$$CN$US$US
242029732$24202973$2$F$20230701$20230823$20240813$20240814$PER$$US-SPECGX-T202301675$SPECGX$$78$YR$$F$Y$54$KG$20240814$$CN$US$US
242029741$24202974$1$I$20230801$20230922$20240813$20240813$PER$$US-SPECGX-T202301856$SPECGX$$39$YR$$F$Y$66$KG$20240813$$CN$US$US
242029751$24202975$1$I$20230801$20231004$20240813$20240813$PER$$US-SPECGX-T202301983$SPECGX$$39$YR$$F$Y$70$KG$20240813$$CN$US$US
242029761$24202976$1$I$$20230818$20240813$20240813$PER$$US-SPECGX-T202301735$SPECGX$$$$$M$Y$$$20240813$$CN$US$US
242029771$24202977$1$I$$20240212$20240813$20240813$PER$$US-SPECGX-T202400606$SPECGX$$$$$F$Y$91$KG$20240813$$CN$US$US
242029781$24202978$1$I$$20240808$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125993$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240813$$CN$US$US
242029791$24202979$1$I$$20240812$20240813$20240813$PER$$NVSC2024US163837$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
242029801$24202980$1$I$20240101$20240730$20240813$20240813$PER$$US-SERVIER-S24009758$SERVIER$$$$$$Y$$$20240813$$HP$US$US
242029812$24202981$2$F$$20240812$20240813$20240816$PER$$NVSC2024US163318$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
242029822$24202982$2$F$$20240809$20240813$20240820$EXP$$CA-INTERCEPT-PM2024001595$INTERCEPT PHARMACEUTICALS$$72$YR$$F$Y$$$20240820$$CN$CA$CA
242029833$24202983$3$F$20230101$20240913$20240813$20240924$EXP$$CA-INTERCEPT-PM2024001599$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$CA$CA
242029841$24202984$1$I$20160101$20240724$20240813$20240813$PER$$US-TEVA-VS-3225317$TEVA$$69$YR$$F$Y$39.92$KG$20240813$$CN$US$US
242029854$24202985$4$F$$20240828$20240813$20240829$PER$$US-AMGEN-USASP2024159971$AMGEN$$$$$F$Y$$$20240829$$CN$US$US
242029861$24202986$1$I$$20240806$20240813$20240813$PER$$US-ROCHE-10000052968$ROCHE$$76$YR$E$F$Y$$$20240813$$CN$US$US
242029871$24202987$1$I$$20240806$20240813$20240813$PER$$US-ROCHE-10000053044$ROCHE$$43$YR$A$F$Y$$$20240813$$CN$US$US
242029881$24202988$1$I$$20240806$20240813$20240813$PER$$US-ROCHE-10000052903$ROCHE$$57$YR$A$F$Y$$$20240813$$CN$US$US
242029891$24202989$1$I$20240806$20240806$20240813$20240813$30DAY$$US-GSK-US2024098118$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240813$$CN$US$US
242029901$24202990$1$I$$20240112$20240813$20240813$PER$$CA-USP-004886$USPHARMA$$$$$M$Y$$$20240812$$CN$CA$CA
242029911$24202991$1$I$$20240113$20240813$20240813$PER$$CA-USP-004887$USPHARMA$$$$$M$Y$$$20240812$$CN$CA$CA
242029921$24202992$1$I$20100101$20240730$20240813$20240813$PER$$US-JNJFOC-20240800649$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240813$$CN$US$US
242029931$24202993$1$I$20211201$20240731$20240813$20240813$EXP$$IN-SPC-000467$SOLARIS PHARMA$Modi D, Dessureault S, Greene J. Diagnosis and Treatment Challenges of Candida guilliermondii in Immunocompromised Patients: A Case Study in a Neutropenic AML Patient. Case Rep Infect Dis. 2024 Jul 22;2024:7806235. doi: 10.1155/2024/7806235.$30$YR$A$F$Y$$$20240812$$CN$IN$IN
242029941$24202994$1$I$20240801$20240807$20240813$20240813$EXP$$US-JNJFOC-20240820430$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240813$$MD$US$US
242029951$24202995$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000054327$ROCHE$$$$E$F$Y$$$20240813$$CN$US$US
242029961$24202996$1$I$20240212$20240808$20240813$20240813$EXP$$US-UCBSA-2024033290$UCB$$43$YR$$F$Y$40.363$KG$20240813$$MD$US$US
242029972$24202997$2$F$20240506$20240816$20240813$20240822$EXP$$DE-AUROBINDO-AUR-APL-2024-036033$AUROBINDO$$88$YR$$M$Y$68$KG$20240822$$MD$DE$DE
242029981$24202998$1$I$20230506$20240731$20240813$20240813$EXP$$US-UCBSA-2024017780$UCB$$32$YR$$F$Y$139.68$KG$20240813$$CN$US$US
242029992$24202999$2$F$$20240816$20240813$20240820$PER$$US-AMGEN-USASP2024157485$AMGEN$$$$$F$Y$133.35$KG$20240820$$HP$US$US
242030001$24203000$1$I$$20240801$20240813$20240813$EXP$$JP-BIOCON BIOLOGICS LIMITED-BBL2024005911$BIOCON$$$$$$Y$$$20240813$$PH$JP$JP
242030021$24203002$1$I$$20240801$20240813$20240813$EXP$$US-RDY-LIT/USA/24/0011576$DR REDDYS$Qadir N, Rulka K, Shirazi I, Durgun A, Trehan M. A Day on the Beach, a Risk for Vibrio Vulnificus Septicemia. American Journal of Respiratory and Critical Care Medicine. 2024;209: doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1667.$61$YR$A$M$Y$$$20240813$$HP$US$US
242030031$24203003$1$I$20240612$20240807$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045008$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240813$$CN$US$US
242030041$24203004$1$I$20240101$20240731$20240813$20240813$EXP$$US-UCBSA-2024028453$UCB$$$$$F$Y$75.74$KG$20240813$$HP$US$US
242030051$24203005$1$I$$20240801$20240813$20240813$PER$$US-RDY-LIT/USA/24/0011578$DR REDDYS$Nguyen A, Norman M, O^Reilly E, Robinson CL, Fonseca A, Madabhushi S, et al. Case Series: Spinal Cord Stimulator Therapy Alleviates Neuropathic Pain in Patients with Failed Back Surgery Syndrome in the Setting of Spinal Cord Injury. Pain Medicine Case Reports. 2023;7(7): 337-340.$50$YR$A$M$Y$$$20240813$$HP$US$US
242030061$24203006$1$I$20240725$20240802$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124057$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240813$$CN$US$US
242030072$24203007$2$F$20240501$20240907$20240813$20240913$EXP$$US-BEIGENE-BGN-2024-012457$BEIGENE$$$$$$Y$$$20240913$$MD$US$US
242030081$24203008$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003837$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242030091$24203009$1$I$20240501$20240806$20240813$20240813$EXP$$AR-GSK-AR2024AMR055708$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$AR$AR
242030101$24203010$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07425$HIKMA$$$$$$Y$$$20240812$$MD$CA$CA
242030112$24203011$2$F$20231201$20240805$20240813$20240828$EXP$$US-GSK-US2024097532$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240828$$CN$US$US
242030121$24203012$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159111$AMGEN$$$$$$Y$$$20240813$$CN$US$US
242030131$24203013$1$I$$20240807$20240813$20240813$EXP$$ES-AUROBINDO-AUR-APL-2024-039184$AUROBINDO$Ros-Sanchez E, Oliver-Gutierrez D, Buck P, Goncharova T, Distefano L, Kirkegaard-Biosca E.. Purpureocillium lilacinum-related endophthalmitis: case report. Journal of Ophthalmic Inflammation and Infection. 2024;14:27:1-5$64$YR$$M$Y$$$20240813$$HP$ES$ES
242030151$24203015$1$I$$20240806$20240813$20240813$PER$$US-JNJFOC-20240822210$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$HP$US$US
242030171$24203017$1$I$20240101$20240809$20240813$20240813$EXP$$US-ABBVIE-5875347$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242030181$24203018$1$I$20240805$20240810$20240813$20240813$EXP$$US-KYOWAKIRIN-2024KK019074$KYOWA$$$$$$Y$$$20240813$$HP$US$US
242030191$24203019$1$I$$20240807$20240813$20240813$EXP$$US-AstraZeneca-2024A179817$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242030202$24203020$2$F$20240816$20240816$20240813$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003838$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240910$$CN$US$US
242030211$24203021$1$I$$20220527$20240813$20240813$EXP$$CA-AstraZeneca-2022A204199$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$CA$
242030221$24203022$1$I$$20240807$20240813$20240813$EXP$$CN-AstraZeneca-2024A180978$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$CN$
242030231$24203023$1$I$$20220513$20240813$20240813$EXP$$US-AstraZeneca-2022A186627$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242030241$24203024$1$I$$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127113$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240813$$CN$US$US
242030254$24203025$4$F$20240801$20240816$20240813$20240821$EXP$$ES-ABBVIE-5874685$ABBVIE$$78$YR$$M$Y$$$20240821$$CN$ES$ES
242030261$24203026$1$I$20240705$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127170$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240813$$CN$US$US
242030271$24203027$1$I$$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125835$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240813$$HP$US$US
242030281$24203028$1$I$20240808$20240809$20240813$20240813$PER$$US-JNJFOC-20240827373$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240813$$CN$US$US
242030292$24203029$2$F$$20240906$20240813$20240918$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24231$SAMSUNG BIOEPIS$$57$YR$A$F$Y$$$20240918$$CN$GB$GB
242030301$24203030$1$I$20220625$20220630$20240813$20240813$EXP$$CO-BIOVITRUM-2022CO08538$BIOVITRUM$$148$DY$$F$Y$$$20240813$$CN$CO$CO
242030312$24203031$2$F$$20240903$20240813$20240910$30DAY$$EG-JNJFOC-20240826091$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$PH$EG$EG
242030321$24203032$1$I$$20240809$20240813$20240813$EXP$$JP-JNJFOC-20240828786$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$PH$JP$JP
242030331$24203033$1$I$$20230125$20240813$20240813$EXP$$NL-BIOVITRUM-2023NL01806$BIOVITRUM$$$$I$M$Y$5.8$KG$20240813$$HP$NL$NL
242030341$24203034$1$I$$20240802$20240813$20240813$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-24069$SAMSUNG BIOEPIS$$22$YR$A$M$Y$56.5$KG$20240813$$HP$CA$CA
242030352$24203035$2$F$$20240828$20240813$20240901$EXP$$US-ABBVIE-5873383$ABBVIE$$$$$F$Y$$$20240901$$CN$US$US
242030361$24203036$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039740$AUROBINDO$$23$YR$$F$Y$$$20240813$$HP$CA$CA
242030381$24203038$1$I$$20240806$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-039845$AUROBINDO$$$$$$Y$$$20240813$$CN$US$US
242030391$24203039$1$I$$20230104$20240813$20240813$EXP$$US-AstraZeneca-2023A002663$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242030401$24203040$1$I$20211001$20220829$20240813$20240813$EXP$$US-AstraZeneca-2022A301610$ASTRAZENECA$$746$MON$$F$Y$$$20240813$$CN$US$
242030411$24203041$1$I$$20221219$20240813$20240813$EXP$$US-AstraZeneca-2022A411713$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242030421$24203042$1$I$20240801$20240803$20240813$20240813$EXP$GB-MHRA-MED-202408031643076480-NRGQW$GB-TEVA-VS-3230081$TEVA$$56$YR$$M$Y$100$KG$20240813$$CN$GB$GB
242030431$24203043$1$I$20240201$20240808$20240813$20240813$EXP$$PL-ABBVIE-5874673$ABBVIE$$35$YR$$M$Y$$$20240813$$MD$PL$PL
242030441$24203044$1$I$$20221206$20240813$20240813$EXP$$US-AstraZeneca-2022A401238$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242030451$24203045$1$I$$20240812$20240813$20240813$PER$$US-HALEON-2191628$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242030461$24203046$1$I$20240802$20240805$20240813$20240813$EXP$$US-GSK-US2024097552$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$PH$US$US
242030471$24203047$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039904$AUROBINDO$$45$YR$$F$Y$$$20240813$$MD$CA$CA
242030481$24203048$1$I$20240620$20240805$20240813$20240813$EXP$$CN-BEIGENE-BGN-2024-012216$BEIGENE$$$$$$Y$$$20240813$$HP$CN$CN
242030492$24203049$2$F$20240805$20240809$20240813$20240820$PER$$US-AMGEN-USASP2024159740$AMGEN$$58$YR$A$M$Y$$$20240820$$PH$US$US
242030501$24203050$1$I$20230601$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159002$AMGEN$$41$YR$A$F$Y$$$20240813$$CN$US$US
242030511$24203051$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126935$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240813$$CN$US$US
242030521$24203052$1$I$20220530$20231129$20240813$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044900$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$87.53$KG$20240813$$HP$US$US
242030531$24203053$1$I$$20240807$20240813$20240813$EXP$$US-ROCHE-10000051989$ROCHE$$5$YR$C$M$Y$$$20240813$$CN$US$US
242030541$24203054$1$I$$20240811$20240813$20240813$PER$$US-HALEON-2191546$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242030551$24203055$1$I$20240101$20240731$20240813$20240813$EXP$$US-UCBSA-2024038804$UCB$$$$$F$Y$$$20240813$$HP$US$US
242030561$24203056$1$I$20240724$20240808$20240813$20240813$EXP$$RO-ABBVIE-5855460$ABBVIE$$64$YR$$F$Y$$$20240810$$CN$RO$RO
242030571$24203057$1$I$20240806$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005599$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240813$$CN$US$US
242030581$24203058$1$I$20240808$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006292$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240813$$CN$US$US
242030591$24203059$1$I$20240809$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006520$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240813$$CN$US$US
242030601$24203060$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005467$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240813$$CN$US$US
242030611$24203061$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202406012708$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240813$$CN$US$US
242030622$24203062$2$F$$20240823$20240813$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408006677$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240827$$CN$US$US
242030631$24203063$1$I$20240809$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006521$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240813$$CN$US$US
242030641$24203064$1$I$20240808$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006787$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240813$$CN$US$US
242030651$24203065$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006289$ELI LILLY AND CO$$$$$F$Y$$$20240813$$PH$US$US
242030661$24203066$1$I$20240807$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158564$AMGEN$$$$$$Y$$$20240813$$PH$US$US
242030671$24203067$1$I$20240701$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006442$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240813$$CN$US$US
242030681$24203068$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006666$ELI LILLY AND CO$$$$$$Y$$$20240813$$CN$US$US
242030691$24203069$1$I$$20240807$20240813$20240813$EXP$$FR-AMGEN-FRASP2024157361$AMGEN$$$$E$F$Y$$$20240813$$CN$FR$FR
242030701$24203070$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159356$AMGEN$$$$$$Y$$$20240813$$CN$US$US
242030711$24203071$1$I$20240101$20240809$20240813$20240813$EXP$$CA-ABBVIE-5876081$ABBVIE$$54$YR$$F$Y$$$20240813$$CN$CA$CA
242030721$24203072$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002089$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242030731$24203073$1$I$20240101$20240812$20240813$20240813$EXP$$IL-ABBVIE-5877213$ABBVIE$$58$YR$$M$Y$$$20240813$$PH$IL$IL
242030742$24203074$2$F$20240701$20240813$20240813$20240819$EXP$$IE-ABBVIE-5859251$ABBVIE$$74$YR$$M$Y$$$20240819$$CN$IE$IE
242030752$24203075$2$F$20240223$20240816$20240813$20240821$EXP$$US-ABBVIE-5875482$ABBVIE$$41$YR$$F$Y$$$20240821$$CN$US$US
242030761$24203076$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875655$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242030771$24203077$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000054630$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
242030781$24203078$1$I$$20240802$20240813$20240813$EXP$$FR-GlaxoSmithKline-B0678878A$Haleon PLC$Yameogo TM et al. Organ damage and prognosis during Lyell^s syndrome. Two case reports. Letters to the editor/French anesthesia and resuscitation annals 2010; 29:592-598.; Yameogo TM, Tchaou B, Azon-Kouanou A et al. Lyell^ disease, visceral damage and evolution. About two cases Annales Francaises d^Anesthesie et de Reanimation 2010 29 (7-8) 597-598; Yameogo TM et al. Organ damage and prognosis during Lyell^s syndrome. Two case reports. Lettres a la redaction/annales francaises d-anesthesia et...$21$YR$$M$Y$$$20240812$$MD$FR$FR
242030791$24203079$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000054246$ROCHE$$$$$$Y$$$20240813$$CN$US$US
242030801$24203080$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5873983$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242030811$24203081$1$I$$20220815$20240813$20240813$EXP$$US-AstraZeneca-2022A287717$ASTRAZENECA$$$$$$Y$$$20240813$$MD$US$
242030821$24203082$1$I$20240807$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180703$ASTRAZENECA$$31010$DY$$M$Y$$$20240813$$HP$US$
242030831$24203083$1$I$$20220715$20240813$20240813$EXP$$US-AstraZeneca-2022A206604$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242030851$24203085$1$I$20220421$20220530$20240813$20240813$EXP$$US-AstraZeneca-2022A161916$ASTRAZENECA$$18188$DY$$F$Y$$$20240813$$CN$US$
242030861$24203086$1$I$20220212$20220502$20240813$20240813$EXP$$US-AstraZeneca-2022A119075$ASTRAZENECA$$$$$$Y$$$20240813$$CN$US$
242030872$24203087$2$F$$20240828$20240813$20240828$PER$$US-ALXN-202408USA000425US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242030881$24203088$1$I$$20221007$20240813$20240813$EXP$$US-AstraZeneca-2022A296533$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242030891$24203089$1$I$20240601$20240731$20240813$20240813$EXP$$US-UCBSA-2024038817$UCB$$35$YR$$F$Y$$$20240813$$HP$US$US
242030901$24203090$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875653$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242030912$24203091$2$F$20240101$20240812$20240813$20240820$EXP$$GB-INSMED, INC.-2024-03187-GB$INSMED$$$$$F$Y$$$20240820$$HP$GB$GB
242030921$24203092$1$I$20200423$20240731$20240813$20240813$EXP$$PL-AUROBINDO-AUR-APL-2024-039106$AUROBINDO$$14$YR$$F$Y$92$KG$20240813$$MD$PL$PL
242030931$24203093$1$I$$20240812$20240813$20240813$EXP$GB-MHRA-MED-202408112206023550-QKDCN$GB-ORGANON-O2408GBR000883$ORGANON$$2$YR$$M$Y$$$20240813$$CN$GB$GB
242030941$24203094$1$I$20130101$20240731$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-039113$AUROBINDO$$18$YR$$F$Y$$$20240813$$MD$FR$FR
242030951$24203095$1$I$20240701$20240809$20240813$20240813$EXP$$US-ABBVIE-5875781$ABBVIE$$70$YR$$M$Y$$$20240813$$CN$US$US
242030961$24203096$1$I$$20240802$20240813$20240813$EXP$$ES-RDY-LIT/ESP/24/0011527$DR REDDYS$Osorio KV, Calatayud-Cubes A, Diaz-Lopez EJ, Barbaran-Corral C, Lazare-Iglesias H, Anido-Herranz U, et al. Expression of somatostatin receptors in radioiodine refractory follicular cell derived thyroid carcinomas detected with [68Ga] Ga-DOTA-TOC. Virchows Archiv. 2023;483: S251. doi:10.1007/s00428-023-03602-w.$41$YR$A$M$Y$$$20240813$$HP$ES$ES
242030971$24203097$1$I$$20240719$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004002$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242030981$24203098$1$I$20240808$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158130$AMGEN$$77$YR$E$M$Y$$$20240813$$CN$US$US
242030991$24203099$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000054635$ROCHE$$71$YR$E$F$Y$$$20240813$$CN$US$US
242031001$24203100$1$I$20240808$20240809$20240813$20240813$PER$$US-JNJFOC-20240825214$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240813$$CN$US$US
242031022$24203102$2$F$$20240814$20240813$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07070$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242031031$24203103$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000054381$ROCHE$$58$YR$A$F$Y$$$20240813$$HP$US$US
242031042$24203104$2$F$$20240813$20240813$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004240$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242031051$24203105$1$I$$20240805$20240813$20240813$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP009981$STRIDES$Grewal TS, Soni D, Nada R, Sharma N, Pannu AK.. A young boy with severe pulmonary-renal syndrome: Will you suspect IgA nephropathy?.. Turk-J-Emerg-Med. 2023;23 (1):52-56$15$YR$$M$Y$$$20240813$$HP$IN$IN
242031061$24203106$1$I$$20240805$20240813$20240813$EXP$$TW-STRIDES ARCOLAB LIMITED-2024SP009998$STRIDES$Leong PY, Shih PC, Huo AP.. Is low-dose tumor necrosis factor inhibitor effective and safe in patients with ankylosing spondylitis flare-up after renal transplantation? A case report and literature review. [Review].. Int-J-Rheum-Diseases. 2023;27:e14877$55$YR$$M$Y$$$20240813$$HP$TW$TW
242031071$24203107$1$I$$20240805$20240813$20240813$EXP$$US-STRIDES PHARMA UK LTD.-2024SP009995$STRIDES$Mullis CE, Heldman M, Bahr NC, Minamoto GY, Puius YA, Malinis M.. Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient.. Transpl-Infect-Dis. 2024;26 (3)$$$$$Y$$$20240813$$HP$US$US
242031091$24203109$1$I$20200721$20240731$20240813$20240813$EXP$$PL-AUROBINDO-AUR-APL-2024-039218$AUROBINDO$$48$YR$$F$Y$80$KG$20240813$$MD$PL$PL
242031101$24203110$1$I$20230101$20240731$20240813$20240813$EXP$$NL-AUROBINDO-AUR-APL-2024-014926$AUROBINDO$$$$E$M$Y$$$20240813$$HP$NL$NL
242031111$24203111$1$I$20230301$20240730$20240813$20240813$EXP$$BR-UCBSA-2024039557$UCB$$64$YR$$M$Y$67$KG$20240813$$CN$BR$BR
242031121$24203112$1$I$20240401$20240731$20240813$20240813$EXP$$FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2024-019353$VALIDUS$$$$$$Y$$$20240813$$PH$FR$FR
242031131$24203113$1$I$$20240711$20240813$20240813$PER$$DE-TOLMAR, INC.-24DE051626$TOLMAR$$$$$$Y$$$20240813$$HP$DE$DE
242031141$24203114$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875844$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242031151$24203115$1$I$$20240720$20240813$20240813$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003823$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242031161$24203116$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000055163$ROCHE$$$$$$Y$$$20240813$$CN$US$US
242031172$24203117$2$F$20230309$20240816$20240813$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003839$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240830$$CN$US$US
242031182$24203118$2$F$20240101$20240919$20240813$20240927$EXP$$NVSC2024CN137962$NOVARTIS$$$$$F$Y$$$20240927$$CN$CN$CN
242031194$24203119$4$F$20240808$20240814$20240813$20240816$EXP$$CA-ROCHE-10000055168$ROCHE$$43$YR$A$F$Y$$$20240816$$CN$CA$CA
242031201$24203120$1$I$$20240808$20240813$20240813$EXP$GB-MHRA-MED-202408061032103830-KCFHY$GB-STRIDES ARCOLAB LIMITED-2024SP009974$STRIDES$$37$YR$$F$Y$$$20240813$$PH$GB$GB
242031211$24203121$1$I$$20240805$20240813$20240813$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP009984$STRIDES$Mohammad AP, Noroozi E, Mesgarha MG, Shayanfar N, Goodarzi A.. Interesting Mucocutaneous Manifestations in COVID-19 Infection or Vaccination Confirmed by Histopathology: A Case Series.. Case-Rep-Dermatol. 2024;16 (1):21-34$51$YR$$F$Y$$$20240813$$HP$IR$IR
242031221$24203122$1$I$20240801$20240808$20240813$20240813$EXP$$US-ABBVIE-5874285$ABBVIE$$67$YR$$F$Y$$$20240813$$CN$US$US
242031231$24203123$1$I$$20240811$20240813$20240813$PER$$US-HALEON-2191621$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242031241$24203124$1$I$20240701$20240724$20240813$20240813$PER$$US-TEVA-VS-3226166$TEVA$$66$YR$$F$Y$$$20240813$$CN$US$US
242031251$24203125$1$I$$20240808$20240813$20240813$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099192$VIIV$$$$$M$Y$$$20240813$$HP$US$US
242031261$24203126$1$I$20210525$20240806$20240813$20240813$EXP$$CA-GSK-CA2021AMR136202$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CA$CA
242031281$24203128$1$I$$20240807$20240813$20240813$EXP$$CA-GSK-CA2020AMR248469$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$MD$CA$CA
242031291$24203129$1$I$20200412$20240731$20240813$20240813$EXP$$PL-AUROBINDO-AUR-APL-2024-039220$AUROBINDO$$31$YR$$M$Y$93$KG$20240813$$MD$PL$PL
242031301$24203130$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000054667$ROCHE$$23$YR$A$F$Y$$$20240813$$MD$US$US
242031311$24203131$1$I$20240801$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159061$AMGEN$$45$YR$A$$Y$$$20240813$$HP$US$US
242031321$24203132$1$I$$20240730$20240813$20240813$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-08013$LUPIN$Singh D, Sarkar B, Yadav S, Sarkar K. Silent epidemic of silicotuberculosis in India and emergence of multidrug-resistant tuberculosis?. Journal of Global Antimicrobial Resistance. 2024;38:163-166$$$$$Y$$$20240813$$HP$IN$IN
242031331$24203133$1$I$$20240805$20240813$20240813$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024317$UNITED THERAPEUTICS$$$$$F$Y$67.12$KG$20240813$$$US$US
242031341$24203134$1$I$$20240614$20240813$20240813$EXP$$US-ROCHE-10000006384$ROCHE$$37$YR$A$M$Y$$$20240813$$MD$US$US
242031351$24203135$1$I$$20240808$20240813$20240813$EXP$GB-TORRENT-00036216$GB-STRIDES ARCOLAB LIMITED-2024SP009975$STRIDES$$$$T$M$Y$$$20240813$$MD$GB$GB
242031361$24203136$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005642$ELI LILLY AND CO$$23$YR$A$M$Y$$$20240813$$CN$US$US
242031371$24203137$1$I$20240804$20240805$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408003242$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240813$$CN$US$US
242031381$24203138$1$I$20220101$20240802$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002175$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240813$$CN$US$US
242031391$24203139$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005666$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240813$$CN$US$US
242031401$24203140$1$I$20240807$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006426$ELI LILLY AND CO$$45$YR$A$$Y$$$20240813$$PH$US$US
242031412$24203141$2$F$$20240812$20240813$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408006313$ELI LILLY AND CO$$$$$F$Y$$$20240815$$CN$US$US
242031421$24203142$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006525$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242031431$24203143$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006360$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240813$$CN$US$US
242031441$24203144$1$I$20240701$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006632$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240813$$CN$US$US
242031451$24203145$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006418$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240813$$CN$US$US
242031461$24203146$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006458$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240813$$CN$US$US
242031471$24203147$1$I$$20240725$20240813$20240813$PER$$US-JNJFOC-20240776013$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$CN$US$US
242031481$24203148$1$I$20231101$20240808$20240813$20240813$EXP$$CO-JNJFOC-20240825041$JOHNSON AND JOHNSON$$43$YR$A$M$Y$70$KG$20240813$$HP$CO$CO
242031491$24203149$1$I$20230101$20230512$20240813$20240813$EXP$$US-AstraZeneca-2023A074815$ASTRAZENECA$$65$YR$$F$Y$$$20240813$$CN$US$
242031501$24203150$1$I$$20240809$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US071947$SANDOZ$$$$$M$Y$$$20240813$$CN$US$US
242031511$24203151$1$I$$20240807$20240813$20240813$EXP$$CA-ROCHE-10000051190$ROCHE$Unknown U,  UNKNOWN.$5$YR$C$F$Y$$$20240813$$HP$CA$CA
242031521$24203152$1$I$20240807$20240808$20240813$20240813$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-15944$IPSEN$$67$YR$E$M$Y$$$20240813$$HP$GB$GB
242031532$24203153$2$F$20240729$20240807$20240813$20240821$EXP$$JP-UCBSA-2024039198$UCB$$62$YR$$$Y$$$20240821$$PH$JP$JP
242031541$24203154$1$I$$20240805$20240813$20240813$EXP$$ZA-AstraZeneca-2024A178076$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$ZA$
242031551$24203155$1$I$20220323$20220328$20240813$20240813$EXP$$ES-AstraZeneca-2022A125782$ASTRAZENECA$$17422$DY$$F$Y$$$20240813$$CN$ES$
242031561$24203156$1$I$20240808$20240808$20240813$20240813$PER$$US-ABBVIE-5875346$ABBVIE$$39$YR$$F$Y$$$20240813$$HP$US$US
242031571$24203157$1$I$20240504$20240808$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US046945$SANDOZ$$59$YR$$M$Y$$$20240813$$CN$US$US
242031581$24203158$1$I$$20240801$20240813$20240813$EXP$$PT-ASPEN-GLO2024PT005354$ASPEN$Carrilho M, Nobre MB, Santos MC, Silva RC, Martins JR.. CO-0062 - (4147) - MYOCARDITIS A CMV.. Congresses of the Portuguese Society of Internal Medicine: 30th National Congres. 2024;162$$$$$Y$$$20240813$$MD$PT$PT
242031591$24203159$1$I$20221001$20240803$20240813$20240813$EXP$$GB-ASPEN-GLO2024GB005395$ASPEN$$$$$$Y$$$20240813$$HP$GB$GB
242031601$24203160$1$I$$20240805$20240813$20240813$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR098934$VIIV$$$$$M$Y$$$20240813$$CN$US$US
242031611$24203161$1$I$20240804$20240806$20240813$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044149$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240813$$CN$US$US
242031621$24203162$1$I$20240802$20240807$20240813$20240813$EXP$$BG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043995$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$85$KG$20240813$$PH$BG$BG
242031631$24203163$1$I$20240426$20240806$20240813$20240813$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043942$BOEHRINGER INGELHEIM$$51$YR$A$M$Y$$$20240813$$HP$AU$AU
242031642$24203164$2$F$$20240813$20240813$20240819$EXP$GB-MHRA-MED-202408051436201010-PNQJC$GB-RDY-SPO/GBR/24/0011536$DR REDDYS$$$$$$Y$$$20240819$$PH$GB$GB
242031651$24203165$1$I$$20240708$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06996$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242031661$24203166$1$I$$20240808$20240813$20240813$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044940$BOEHRINGER INGELHEIM$$$$$$Y$$$20240813$$MD$DE$DE
242031671$24203167$1$I$$20240729$20240813$20240813$PER$$US-TEVA-VS-3228136$TEVA$$$$$M$Y$$$20240813$$CN$US$US
242031691$24203169$1$I$$20240720$20240813$20240813$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003795$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242031701$24203170$1$I$$20240731$20240813$20240813$EXP$$US-OCTA-LIT05924$OCTAPHARMA$Nishimura, H.; Kore, S.; Chugh, S. (2024): 126 A rare case of Minimal Change Disease in an elderly patient with Chronic Inflammatory Demyelinating Polyneuropathy on intravenous immunoglobulin. In American Journal of Kidney Diseases 83 (4), S37-S38. DOI: 10.1053/j.ajkd.2024.01.129.$78$YR$E$M$Y$$$20240812$$HP$US$US
242031711$24203171$1$I$$20240803$20240813$20240813$EXP$$GB-ASPEN-GLO2024GB005394$ASPEN$$$$$$Y$$$20240813$$HP$GB$GB
242031721$24203172$1$I$$20240812$20240813$20240813$PER$$NVSC2024US163832$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
242031732$24203173$2$F$$20240809$20240813$20240813$EXP$$US-AMGEN-USASP2024159264$AMGEN$$$$A$$Y$$$20240813$$HP$US$US
242031741$24203174$1$I$20240731$20240731$20240813$20240813$EXP$$US-OCTA-GAM24324$OCTAPHARMA$$$$A$F$Y$81$KG$20240812$$HP$US$US
242031753$24203175$3$F$20231201$20240912$20240813$20240919$EXP$$FR-JNJFOC-20240774987$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240919$$MD$FR$FR
242031764$24203176$4$F$20240801$20240820$20240813$20240828$EXP$$CA-JNJFOC-20240463583$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240828$$HP$CA$CA
242031771$24203177$1$I$20240803$20240806$20240813$20240813$EXP$$US-PADAGIS-2024PAD01289$PADAGIS$$$$$$Y$$$20240813$$CN$US$US
242031784$24203178$4$F$20240730$20240823$20240813$20240830$PER$$US-ROCHE-10000050672$ROCHE$$8$YR$C$M$Y$38.1$KG$20240830$$PH$US$US
242031791$24203179$1$I$$20240808$20240813$20240813$30DAY$$US-GSK-US2024099246$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242031801$24203180$1$I$$20240805$20240813$20240813$EXP$$US-GSK-US2024AMR098270$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242031821$24203182$1$I$$20240606$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000247$Tarsus Pharmaceuticals$$$$$$Y$$$20240813$$CN$US$US
242031831$24203183$1$I$$20240804$20240813$20240813$EXP$$GB-ASPEN-GLO2024GB005420$ASPEN$$$$$$Y$$$20240813$$HP$GB$GB
242031841$24203184$1$I$$20240527$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000226$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$CN$US$US
242031851$24203185$1$I$20240501$20240621$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000224$Tarsus Pharmaceuticals$$66$YR$$F$Y$$$20240813$$PH$US$US
242031861$24203186$1$I$$20240621$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000248$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$PH$US$US
242031871$24203187$1$I$$20240612$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000257$Tarsus Pharmaceuticals$$$$$$Y$$$20240813$$MD$US$US
242031881$24203188$1$I$20240613$20240621$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000246$Tarsus Pharmaceuticals$$19$YR$$M$Y$$$20240813$$PH$US$US
242031891$24203189$1$I$$20240723$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000241$Tarsus Pharmaceuticals$$62$YR$$M$Y$$$20240813$$PH$US$US
242031901$24203190$1$I$$20240607$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000249$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$MD$US$US
242031911$24203191$1$I$$20240604$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000242$Tarsus Pharmaceuticals$$69$YR$$F$Y$$$20240813$$PH$US$US
242031921$24203192$1$I$$20240609$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000253$Tarsus Pharmaceuticals$$$$$M$Y$$$20240813$$CN$US$US
242031931$24203193$1$I$20240101$20240603$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000238$Tarsus Pharmaceuticals$$70$YR$$M$Y$$$20240813$$PH$US$US
242031941$24203194$1$I$$20240605$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000244$Tarsus Pharmaceuticals$$64$YR$$F$Y$$$20240813$$PH$US$US
242031951$24203195$1$I$20240501$20240530$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000233$Tarsus Pharmaceuticals$$76$YR$$F$Y$$$20240813$$MD$US$US
242031961$24203196$1$I$$20240530$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000231$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$MD$US$US
242031971$24203197$1$I$$20240612$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000260$Tarsus Pharmaceuticals$$$$$$Y$$$20240813$$MD$US$US
242031981$24203198$1$I$20240529$20240531$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000236$Tarsus Pharmaceuticals$$30$YR$$M$Y$$$20240813$$PH$US$US
242031991$24203199$1$I$20240101$20240611$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000234$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$CN$US$US
242032001$24203200$1$I$$20240611$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000258$Tarsus Pharmaceuticals$$$$$M$Y$$$20240813$$PH$US$US
242032011$24203201$1$I$$20240610$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000255$Tarsus Pharmaceuticals$$$$$$Y$$$20240813$$PH$US$US
242032021$24203202$1$I$20240101$20240530$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000230$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$MD$US$US
242032031$24203203$1$I$20240501$20240620$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000227$Tarsus Pharmaceuticals$$73$YR$$M$Y$$$20240813$$CN$US$US
242032041$24203204$1$I$$20240605$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000243$Tarsus Pharmaceuticals$$$$$$Y$$$20240813$$MD$US$US
242032051$24203205$1$I$20240528$20240619$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000228$Tarsus Pharmaceuticals$$56$YR$$F$Y$$$20240813$$PH$US$US
242032061$24203206$1$I$$20240606$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000251$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$CN$US$US
242032071$24203207$1$I$20240501$20240523$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000222$Tarsus Pharmaceuticals$$71$YR$$F$Y$$$20240813$$CN$US$US
242032081$24203208$1$I$$20240529$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000229$Tarsus Pharmaceuticals$$12$YR$$M$Y$$$20240813$$PH$US$US
242032091$24203209$1$I$20240101$20240607$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000237$Tarsus Pharmaceuticals$$70$YR$$F$Y$$$20240813$$CN$US$US
242032101$24203210$1$I$$20240606$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000240$Tarsus Pharmaceuticals$$71$YR$$M$Y$$$20240813$$PH$US$US
242032111$24203211$1$I$$20240621$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000225$Tarsus Pharmaceuticals$$40$YR$$M$Y$$$20240813$$CN$US$US
242032121$24203212$1$I$20240513$20240607$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000223$Tarsus Pharmaceuticals$$26$YR$$F$Y$$$20240813$$MD$US$US
242032131$24203213$1$I$$20240712$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000232$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$CN$US$US
242032141$24203214$1$I$20240607$20240610$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000254$Tarsus Pharmaceuticals$$68$YR$$F$Y$$$20240813$$CN$US$US
242032151$24203215$1$I$$20240610$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000252$Tarsus Pharmaceuticals$$58$YR$$F$Y$$$20240813$$PH$US$US
242032161$24203216$1$I$20240802$20240810$20240813$20240813$EXP$$CO-JNJFOC-20240829490$JOHNSON AND JOHNSON$$30$YR$A$M$Y$77$KG$20240813$$HP$CO$CO
242032171$24203217$1$I$20240520$20240614$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000220$Tarsus Pharmaceuticals$$77$YR$$M$Y$$$20240813$$PH$US$US
242032181$24203218$1$I$$20240603$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000239$Tarsus Pharmaceuticals$$81$YR$$F$Y$$$20240813$$PH$US$US
242032191$24203219$1$I$20240601$20240731$20240813$20240813$EXP$$US-UCBSA-2024038862$UCB$$35$YR$$F$Y$$$20240813$$HP$US$US
242032201$24203220$1$I$20240301$20240731$20240813$20240813$EXP$$BR-UCBSA-2024039265$UCB$$41$YR$$M$Y$$$20240813$$CN$BR$BR
242032211$24203221$1$I$$20240801$20240813$20240813$EXP$$RU-MELINTA THERAPEUTICS, LLC-RU-MLNT-24-00379$MELINTA THERAPEUTICS$$$$$$Y$$$20240813$$MD$RU$RU
242032221$24203222$1$I$20240812$20240812$20240813$20240813$EXP$GB-MHRA-MED-202408120914571210-MTQRH$GB-ORGANON-O2408GBR000885$ORGANON$$62$YR$$F$Y$90$KG$20240813$$CN$GB$GB
242032231$24203223$1$I$$20240622$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000284$Tarsus Pharmaceuticals$$59$YR$$F$Y$$$20240813$$PH$US$US
242032241$24203224$1$I$20240613$20240715$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000268$Tarsus Pharmaceuticals$$81$YR$$F$Y$$$20240813$$PH$US$US
242032251$24203225$1$I$20240601$20240715$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000272$Tarsus Pharmaceuticals$$55$YR$$M$Y$$$20240813$$PH$US$US
242032261$24203226$1$I$$20240617$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000267$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$CN$US$US
242032271$24203227$1$I$20240101$20240619$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000283$Tarsus Pharmaceuticals$$62$YR$$F$Y$$$20240813$$MD$US$US
242032281$24203228$1$I$20240529$20240625$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000262$Tarsus Pharmaceuticals$$52$YR$$F$Y$$$20240813$$PH$US$US
242032291$24203229$1$I$20240612$20240711$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000275$Tarsus Pharmaceuticals$$61$YR$$F$Y$$$20240813$$MD$US$US
242032301$24203230$1$I$$20240625$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000286$Tarsus Pharmaceuticals$$71$YR$$F$Y$$$20240813$$PH$US$US
242032311$24203231$1$I$$20240621$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000280$Tarsus Pharmaceuticals$$75$YR$$M$Y$$$20240813$$PH$US$US
242032321$24203232$1$I$20240501$20240702$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000281$Tarsus Pharmaceuticals$$$$$M$Y$$$20240813$$MD$US$US
242032331$24203233$1$I$20240623$20240710$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000266$Tarsus Pharmaceuticals$$92$YR$$F$Y$$$20240813$$PH$US$US
242032341$24203234$1$I$$20240619$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000277$Tarsus Pharmaceuticals$$84$YR$$F$Y$$$20240813$$CN$US$US
242032351$24203235$1$I$20240609$20240717$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000276$Tarsus Pharmaceuticals$$79$YR$$M$Y$$$20240813$$MD$US$US
242032361$24203236$1$I$20240101$20240614$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000265$Tarsus Pharmaceuticals$$48$YR$$F$Y$$$20240813$$PH$US$US
242032371$24203237$1$I$20240529$20240625$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000263$Tarsus Pharmaceuticals$$78$YR$$F$Y$$$20240813$$PH$US$US
242032381$24203238$1$I$$20240716$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000264$Tarsus Pharmaceuticals$$$$$M$Y$$$20240813$$CN$US$US
242032391$24203239$1$I$20240601$20240702$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000285$Tarsus Pharmaceuticals$$68$YR$$M$Y$$$20240813$$CN$US$US
242032401$24203240$1$I$20240101$20240618$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000273$Tarsus Pharmaceuticals$$78$YR$$F$Y$$$20240813$$PH$US$US
242032411$24203241$1$I$$20240618$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000274$Tarsus Pharmaceuticals$$84$YR$$F$Y$$$20240813$$PH$US$US
242032421$24203242$1$I$$20240617$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000279$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$CN$US$US
242032431$24203243$1$I$20240101$20240617$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000271$Tarsus Pharmaceuticals$$$$$M$Y$$$20240813$$CN$US$US
242032441$24203244$1$I$$20240618$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000278$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$MD$US$US
242032451$24203245$1$I$20240101$20240701$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000282$Tarsus Pharmaceuticals$$82$YR$$M$Y$$$20240813$$PH$US$US
242032471$24203247$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006724$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240813$$CN$US$US
242032481$24203248$1$I$20240807$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005659$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240813$$CN$US$US
242032491$24203249$1$I$20240808$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006421$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240813$$CN$US$US
242032501$24203250$1$I$$20240712$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000313$Tarsus Pharmaceuticals$$63$YR$$F$Y$$$20240813$$PH$US$US
242032511$24203251$1$I$$20240718$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000322$Tarsus Pharmaceuticals$$$$$$Y$$$20240813$$MD$US$US
242032521$24203252$1$I$$20240711$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000310$Tarsus Pharmaceuticals$$36$YR$$M$Y$$$20240813$$MD$US$US
242032531$24203253$1$I$20240719$20240719$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000323$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$CN$US$US
242032541$24203254$1$I$20240708$20240718$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000320$Tarsus Pharmaceuticals$$85$YR$$M$Y$$$20240813$$CN$US$US
242032551$24203255$1$I$20240101$20240710$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000308$Tarsus Pharmaceuticals$$84$YR$$F$Y$$$20240813$$CN$US$US
242032561$24203256$1$I$$20240717$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000321$Tarsus Pharmaceuticals$$$$$M$Y$$$20240813$$CN$US$US
242032571$24203257$1$I$$20240717$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000318$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$MD$US$US
242032581$24203258$1$I$$20240717$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000316$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$MD$US$US
242032591$24203259$1$I$$20240711$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000309$Tarsus Pharmaceuticals$$82$YR$$F$Y$$$20240813$$PH$US$US
242032601$24203260$1$I$$20240713$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000314$Tarsus Pharmaceuticals$$$$$$Y$$$20240813$$MD$US$US
242032611$24203261$1$I$$20240716$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000315$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$MD$US$US
242032621$24203262$1$I$$20240805$20240813$20240813$EXP$$PT-CELLTRION INC.-2024PT019211$CELLTRION$Schon M., Rato ML., Fernandes SR., Correia LA., Ferreira J.. CC-22- RATIONAL THERAPY IN MULTIPLE SCLEROSIS OVERLAP SYNDROME AND INFLAMMATORY BOWEL DISEASE.. Sinapse Suplemento 1. 2023;1(23):110-111$$$$$Y$$$20240813$$HP$PT$PT
242032631$24203263$1$I$20240607$20240805$20240813$20240813$EXP$ES-AEMPS-1553165$ES-TEVA-VS-3231099$TEVA$$57$YR$$F$Y$$$20240813$$MD$ES$ES
242032653$24203265$3$F$20240101$20240916$20240813$20240925$EXP$$US-UCBSA-2024035493$UCB$$$$$F$Y$$$20240925$$CN$US$US
242032661$24203266$1$I$$20240806$20240813$20240813$EXP$$CA-CELLTRION INC.-2024CA018847$CELLTRION$$$$$$Y$$$20240813$$CN$CA$CA
242032691$24203269$1$I$$20240731$20240813$20240813$EXP$$CA-ROCHE-3576859$ROCHE$$70$YR$E$F$Y$$$20240813$$PH$CA$CA
242032701$24203270$1$I$$20240807$20240813$20240813$EXP$$DE-JNJFOC-20240821567$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$MD$DE$DE
242032711$24203271$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159412$AMGEN$$$$$$Y$$$20240813$$PH$US$US
242032721$24203272$1$I$$20240731$20240813$20240813$EXP$$AU-PBT-009629$PANACEA BIOTEC$Xian E, Morrison T, Wong J. Hyperacute in-Stent Thrombosis Causing Large Vessel Occlusion after Stent-Assisted Aneurysm Coiling Secondary to Complete Clopidogrel and Prasugrel Resistance: a Case Report. J Neurol Surg A Cent Eur Neurosurg. 2024 Sep;85(5):531-533. doi: 10.1055/a-1877-0421.$$$$$Y$$$20240813$$HP$AU$AU
242032731$24203273$1$I$$20240806$20240813$20240813$EXP$$US-AMGEN-USASL2024156397$AMGEN$$70$YR$E$F$Y$$$20240813$$CN$US$US
242032744$24203274$4$F$$20240911$20240813$20240923$EXP$$US-TAKEDA-2024TUS079696$TAKEDA$$$$$M$Y$$$20240923$$CN$US$US
242032751$24203275$1$I$20240611$20240805$20240813$20240813$EXP$FR-AFSSAPS-NC2024000900$FR-TEVA-VS-3230459$TEVA$$88$YR$$F$Y$52$KG$20240813$$MD$FR$FR
242032761$24203276$1$I$$20240812$20240813$20240813$PER$$NVSC2024US163931$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242032772$24203277$2$F$$20240819$20240813$20240822$EXP$$US-TAKEDA-2024TUS079405$TAKEDA$$$$$M$Y$$$20240822$$MD$US$US
242032782$24203278$2$F$20240701$20240808$20240813$20240820$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004458$BLUEPRINT MEDICINES$$$$$$Y$$$20240816$$CN$CN$CN
242032802$24203280$2$F$$20240919$20240813$20240927$EXP$$NVSJ2024JP009589$NOVARTIS$$80$YR$$M$Y$$$20240927$$PH$JP$JP
242032813$24203281$3$F$$20240926$20240813$20240930$PER$$NVSC2024US163435$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
242032821$24203282$1$I$20221001$20240803$20240813$20240813$EXP$$GB-TEVA-VS-3229922$TEVA$$$$$F$Y$$$20240813$$HP$GB$GB
242032831$24203283$1$I$$20240806$20240813$20240813$EXP$$AU-CELLTRION INC.-2024AU018883$CELLTRION$$$$$$Y$$$20240813$$HP$AU$AU
242032842$24203284$2$F$$20240819$20240813$20240827$EXP$$JP-TEVA-VS-3230247$TEVA$Azuma N, Natsuaki M, Hashimoto N, Abe T, Ueda S, Ohno Y, et al. Efficacy of anifrolumab in long-term intractable alopecia due to discoid lupus erythematosus. Mod-Rheumatol-Case-Rep 2024; 8 (2): 267-271.; Azuma N, Natsuaki M, Hashimoto N, Abe T, Ueda S, Ohno Y, et al. Efficacy of anifrolumab in long-term intractable alopecia due to discoid lupus erythematosus. Mod-Rheumatol-Case-Rep 2024; 8 (2): 267-271.$$$A$F$Y$$$20240827$$HP$JP$JP
242032851$24203285$1$I$$20240805$20240813$20240813$PER$$US-ABBVIE-5869921$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242032861$24203286$1$I$20240529$20240812$20240813$20240813$EXP$FR-AFSSAPS-LY2024000987$FR-ROCHE-10000054692$ROCHE$$33$YR$A$F$Y$57$KG$20240813$$PH$FR$FR
242032872$24203287$2$F$20230101$20240902$20240813$20240906$EXP$$IT-AstraZeneca-2024A178719$ASTRAZENECA$$79$YR$$F$Y$$$20240906$$MD$IT$
242032881$24203288$1$I$20240601$20240731$20240813$20240813$EXP$$US-UCBSA-2024038853$UCB$$28$YR$$F$Y$$$20240813$$HP$US$US
242032891$24203289$1$I$20221014$20240812$20240813$20240813$EXP$$US-UCBSA-2024040651$UCB$$67$YR$$F$Y$$$20240813$$HP$US$US
242032901$24203290$1$I$$20230117$20240813$20240813$EXP$$US-AstraZeneca-2022A397228$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242032911$24203291$1$I$$20230215$20240813$20240813$EXP$$US-AstraZeneca-2023A040220$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242032921$24203292$1$I$$20220810$20240813$20240813$EXP$$AU-AstraZeneca-2022A284974$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$AU$
242032932$24203293$2$F$$20240917$20240813$20240918$EXP$$US-AstraZeneca-2024A177862$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
242032941$24203294$1$I$$20240731$20240813$20240813$EXP$$OM-ROCHE-10000046804$ROCHE$$67$YR$E$$Y$$$20240813$$MD$OM$OM
242032951$24203295$1$I$$20240709$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07028$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242032961$24203296$1$I$20200824$20210907$20240813$20240813$EXP$$NL-TERSERA THERAPEUTICS LLC-2021TRS004411$TERSERA THERAPEUTICS$$$$$$Y$$$20240813$$CN$NL$NL
242032971$24203297$1$I$20210101$20240809$20240813$20240813$EXP$GB-MEN-2024-107925$GB-MEN-2024-107925$MENARINI$$75$YR$$F$Y$83$KG$20240813$$CN$GB$GB
242032982$24203298$2$F$20210901$20240822$20240813$20240904$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004459$Unknown Manufacturer$$$$$$Y$$$20240830$$CN$CN$CN
242032991$24203299$1$I$$20240807$20240813$20240813$EXP$$US-JNJFOC-20240817043$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
242033001$24203300$1$I$20240101$20240802$20240813$20240813$EXP$$JP-INSMED, INC.-2024-03167-JP$INSMED$$$$$F$Y$$$20240813$$MD$JP$JP
242033011$24203301$1$I$20240101$20240809$20240813$20240813$EXP$GB-MEN-2024-107927$GB-MEN-2024-107927$MENARINI$$$$E$F$Y$$$20240813$$CN$GB$GB
242033021$24203302$1$I$$20240730$20240813$20240813$EXP$$CN-RISINGPHARMA-CN-2024RISLIT00280$RISING PHARMACEUTICALS$Chi-Sheng Su.Stevens-Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report .Journal of Medical Case Reports.2024;18:1-5$82$YR$E$F$Y$$$20240813$$HP$CN$CN
242033041$24203304$1$I$$20240803$20240813$20240813$EXP$$CA-ROCHE-10000048182$ROCHE$$44$YR$A$F$Y$$$20240813$$HP$CA$CA
242033051$24203305$1$I$$20240514$20240813$20240813$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06849$HIKMA$Chan BL, Wang T.. Chan BL, Wang T. Capecitabine-induced genital hand-foot syndrome treated with topical tacrolimus.. Cureus.. 2024;16(4):e57570$$$$$Y$$$20240813$$MD$US$US
242033061$24203306$1$I$20240808$20240809$20240813$20240813$EXP$$NVSC2024US162787$NOVARTIS$$76$YR$$F$Y$$$20240813$$CN$US$US
242033071$24203307$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07440$HIKMA$$63$YR$$M$Y$$$20240813$$HP$CA$CA
242033081$24203308$1$I$20240808$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006456$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242033091$24203309$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006432$ELI LILLY AND CO$$63$YR$A$$Y$$$20240813$$CN$US$US
242033101$24203310$1$I$20240809$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006717$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240813$$CN$US$US
242033111$24203311$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006729$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240813$$CN$US$US
242033121$24203312$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005834$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240813$$CN$US$US
242033141$24203314$1$I$$20240805$20240813$20240813$EXP$$US-Sprout Pharmaceuticals, Inc.-2024SP000237$SPROUT PHARMACEUTICALS$$$$A$F$Y$$$20240809$$CN$US$US
242033151$24203315$1$I$$20240730$20240813$20240813$EXP$$US-RISINGPHARMA-US-2024RISLIT00278$RISING PHARMACEUTICALS$Alexandra Dennee.Sinus Arrest Related to Dexmedetomidine Infusion in an Infant; a Case Report and Review of Current Literature.Journal of Pharmacy Practice.2024;37(4):1026-1031$11$MON$N$F$Y$$$20240813$$MD$US$US
242033161$24203316$1$I$$20240808$20240813$20240813$PER$$US-HALEON-2191258$Haleon PLC$$$$$F$Y$$$20240813$$CN$US$US
242033171$24203317$1$I$$20240805$20240813$20240813$EXP$$FR-AKCEA THERAPEUTICS, INC.-2024IS006220$AKCEA THERAPEUTICS$$$$$$Y$$$20240809$$HP$FR$FR
242033181$24203318$1$I$20240704$20240805$20240813$20240813$EXP$FR-AFSSAPS-NY2024000863$FR-TAKEDA-2024TUS078118$TAKEDA$$41$YR$$F$Y$$$20240813$$HP$FR$FR
242033191$24203319$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06345$HIKMA$$52$YR$$M$Y$$$20240813$$HP$CA$CA
242033201$24203320$1$I$20230901$20240812$20240813$20240813$EXP$FR-AFSSAPS-TS2024000888$FR-JNJFOC-20240830429$JOHNSON AND JOHNSON$$70$YR$E$M$Y$89$KG$20240813$$CN$FR$FR
242033211$24203321$1$I$$20240804$20240813$20240813$EXP$$KG-JNJFOC-20240813231$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$KG$KG
242033222$24203322$2$F$20240614$20240819$20240813$20240903$PER$$US-AstraZeneca-2024A148878$ASTRAZENECA$$1826$DY$$F$Y$$$20240903$$CN$US$
242033231$24203323$1$I$20240704$20240805$20240813$20240813$EXP$$CN-AstraZeneca-2024A179600$ASTRAZENECA$$20827$DY$$F$Y$60$KG$20240813$$MD$CN$
242033241$24203324$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180757$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242033251$24203325$1$I$$20240805$20240813$20240813$PER$$US-AstraZeneca-2024A179607$ASTRAZENECA$$$$$$Y$$$20240813$$CN$US$
242033261$24203326$1$I$$20240723$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000327$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$MD$US$US
242033271$24203327$1$I$$20240718$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000333$Tarsus Pharmaceuticals$$$$$$Y$$$20240813$$CN$US$US
242033281$24203328$1$I$$20240627$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000291$Tarsus Pharmaceuticals$$$$$$Y$$$20240813$$MD$US$US
242033291$24203329$1$I$20240624$20240625$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000287$Tarsus Pharmaceuticals$$61$YR$$M$Y$$$20240813$$PH$US$US
242033301$24203330$1$I$20240601$20240627$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000290$Tarsus Pharmaceuticals$$75$YR$$M$Y$$$20240813$$CN$US$US
242033311$24203331$1$I$20240701$20240722$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000325$Tarsus Pharmaceuticals$$75$YR$$F$Y$$$20240813$$PH$US$US
242033321$24203332$1$I$20240601$20240626$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000288$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$CN$US$US
242033331$24203333$1$I$20240721$20240723$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000326$Tarsus Pharmaceuticals$$$$$F$Y$$$20240813$$CN$US$US
242033341$24203334$1$I$20240625$20240626$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000289$Tarsus Pharmaceuticals$$56$YR$$F$Y$43.991$KG$20240813$$CN$US$US
242033351$24203335$1$I$$20240808$20240813$20240813$PER$$US-HALEON-2191669$Haleon PLC$$$$$M$Y$$$20240813$$CN$US$US
242033361$24203336$1$I$$20240805$20240813$20240813$PER$$US-ABBVIE-5867569$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242033371$24203337$1$I$$20240802$20240813$20240813$EXP$$US-RDY-LIT/USA/24/0011642$DR REDDYS$Tang CJ, Balu R, Thomas CA, King CS, Shlobin OA, Aryal S, et al. Spinal Cord Infarction Associated With VA-ECMO Support. American Journal of Respiratory and Critical Care Medicine. 2024;209: doi:10.1164/ajrccm conference.2024.209.1_MeetingAbstracts.A7037?download=true.$46$YR$A$F$Y$$$20240813$$HP$US$US
242033381$24203338$1$I$$20240802$20240813$20240813$EXP$$US-RDY-LIT/USA/24/0011643$DR REDDYS$Cohen NT, Buraniqi E, Smith JD, Vezina LG, Gaillard WD. Ictal Arterial Spin Labeling-Magnetic Resonance Imaging Identifies Seizure Onset Zone in Epilepsia Partialis Continua. Annals of Neurology. 2024 Apr;95(4): 760-761. doi:10.1002/ana.26865.$7$YR$C$M$Y$$$20240813$$MD$US$US
242033402$24203340$2$F$$20240926$20240813$20240926$PER$$NVSC2024US163580$NOVARTIS$$$$$M$Y$$$20240926$$HP$US$US
242033411$24203341$1$I$$20240807$20240813$20240813$EXP$$JP-SANDOZ INC.-SDZ2024JP071569$SANDOZ$Nagata M, Arai T, Mikami K, Matsuoka Y, Hasegawa T, Akitaya K, et al.. A Case of Ruptured Oesophageal Varices Caused by Portal Hypertension due to Oxaliplatin. The 171st Annual Meeting of the Tohoku Branch of the Japan Society for Gastroent. 2024;PL-01$74$YR$$M$Y$$$20240813$$MD$JP$JP
242033421$24203342$1$I$20240101$20240802$20240813$20240813$EXP$$US-RECORDATI-2024006056$RECORDATI$$$$$$Y$$$20240813$$CN$US$US
242033431$24203343$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07437$HIKMA$$46$YR$$M$Y$$$20240812$$CN$CA$CA
242033441$24203344$1$I$$20240731$20240813$20240813$EXP$$GB-AUROBINDO-AUR-APL-2024-038432$AUROBINDO$$16$YR$$F$Y$$$20240813$$HP$GB$GB
242033452$24203345$2$F$$20240916$20240813$20240926$EXP$$PT-AUROBINDO-AUR-APL-2024-038999$AUROBINDO$Quelhas MB, Silva DN, Bravo JB, Mozzer R, Gomes DM, Jaime LB, etal.. S?ndrome confusional aguda e desequil?brio da marcha como apresenta??o de neoplasia pulmonar. Congressos da Sociedade Portuguesa de Medicina Interna: 30.?. Congresso Nacional. 2024;838$68$YR$$M$Y$$$20240926$$MD$PT$PT
242033461$24203346$1$I$$20240730$20240813$20240813$EXP$$CN-RISINGPHARMA-CN-2024RISLIT00279$RISING PHARMACEUTICALS$Guo-fei Ren.Acute therapy-related myelodysplastic syndromes following capecitabine and oxaliplatin therapy in gastric malignant tumor: A case report.Medicine .2024;103:30:1-4$60$YR$A$M$Y$$$20240813$$HP$CN$CN
242033471$24203347$1$I$20240807$20240809$20240813$20240813$EXP$$US-ABBVIE-5875848$ABBVIE$$47$YR$$F$Y$$$20240813$$CN$US$US
242033481$24203348$1$I$$20240809$20240813$20240813$PER$$NVSC2024US163614$NOVARTIS$$41$YR$$M$Y$$$20240813$$CN$US$US
242033491$24203349$1$I$$20240807$20240813$20240813$EXP$$US-ABBVIE-5568522$ABBVIE$$$$$M$Y$$$20240813$$MD$US$US
242033501$24203350$1$I$$20240809$20240813$20240813$EXP$$NVSC2024AT162202$NOVARTIS$$$$$F$Y$$$20240813$$MD$AT$AT
242033511$24203351$1$I$20240808$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159168$AMGEN$$66$YR$E$F$Y$$$20240813$$CN$US$US
242033522$24203352$2$F$$20240911$20240813$20240911$PER$$US-AMGEN-USASP2024160000$AMGEN$$$$$$Y$$$20240911$$CN$US$US
242033531$24203353$1$I$$20240805$20240813$20240813$PER$$US-ABBVIE-5868426$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242033541$24203354$1$I$20240708$20240807$20240813$20240813$EXP$FR-AFSSAPS-LM2024000422$FR-ROCHE-10000051319$ROCHE$$54$YR$A$F$Y$46.8$KG$20240813$$MD$FR$FR
242033551$24203355$1$I$$20240731$20240813$20240813$EXP$$SG-ROCHE-10000047577$ROCHE$$60$YR$A$M$Y$$$20240813$$CN$SG$SG
242033561$24203356$1$I$$20240806$20240813$20240813$EXP$$IN-ROCHE-10000051178$ROCHE$$77$YR$E$M$Y$$$20240813$$MD$IN$IN
242033571$24203357$1$I$20230802$20240805$20240813$20240813$EXP$ES-AEMPS-1554205$ES-TEVA-VS-3231064$TEVA$$16$YR$$M$Y$$$20240813$$PH$ES$ES
242033581$24203358$1$I$$20230417$20240813$20240813$EXP$$US-AstraZeneca-2023A102215$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242033601$24203360$1$I$20240702$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A181127$ASTRAZENECA$$28913$DY$$M$Y$$$20240813$$CN$US$
242033611$24203361$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024160244$AMGEN$$$$$$Y$$$20240813$$MD$US$US
242033621$24203362$1$I$20240806$20240806$20240813$20240813$EXP$$JP-AMGEN-JPNSP2024156103$AMGEN$$$$$$Y$$$20240813$$CN$JP$JP
242033631$24203363$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039823$AUROBINDO$$65$YR$$F$Y$97$KG$20240813$$HP$CA$CA
242033641$24203364$1$I$20240808$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006459$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240813$$HP$US$US
242033651$24203365$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006433$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240813$$CN$US$US
242033661$24203366$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006441$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240813$$CN$US$US
242033671$24203367$1$I$20240730$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005663$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240813$$CN$US$US
242033681$24203368$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006600$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240813$$CN$US$US
242033691$24203369$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005905$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240813$$CN$US$US
242033702$24203370$2$F$$20240807$20240813$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005811$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240816$$CN$US$US
242033711$24203371$1$I$20240808$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006323$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240813$$CN$US$US
242033721$24203372$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006483$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240813$$CN$US$US
242033731$24203373$1$I$20240809$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006697$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240813$$CN$US$US
242033741$24203374$1$I$$20240808$20240813$20240813$EXP$$ID-ROCHE-10000052529$ROCHE$$$$$$Y$$$20240813$$MD$ID$ID
242033752$24203375$2$F$$20240822$20240813$20240826$PER$$US-LEO Pharma-372638$LEO PHARM$$$$$M$Y$$$20240826$$CN$US$US
242033761$24203376$1$I$20240101$20240808$20240813$20240813$EXP$$US-CHIESI-2024CHF04964$CHIESI$$$$$F$Y$54$KG$20240813$$HP$US$US
242033771$24203377$1$I$20240101$20240805$20240813$20240813$EXP$$US-CHIESI-2024CHF04895$CHIESI$$$$$F$Y$35$KG$20240813$$HP$US$US
242033782$24203378$2$F$20240601$20240822$20240813$20240902$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-02912$AMNEAL$$$$$$Y$$$20240902$$HP$JP$JP
242033791$24203379$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039759$AUROBINDO$$58$YR$$F$Y$$$20240813$$HP$CA$CA
242033801$24203380$1$I$20240327$20240731$20240813$20240813$EXP$$DE-AUROBINDO-AUR-APL-2024-039183$AUROBINDO$$$$A$F$Y$60$KG$20240813$$MD$DE$DE
242033811$24203381$1$I$20230814$20240805$20240813$20240813$EXP$$BR-SA-2023SA253986$SANOFI AVENTIS$$21$YR$A$M$Y$90$KG$20240813$$CN$BR$BR
242033821$24203382$1$I$20240724$20240731$20240813$20240813$PER$$US-ALXN-202407USA002281US$ALEXION PHARMACEUTICALS$$21$YR$$F$Y$$$20240813$$CN$US$US
242033832$24203383$2$F$$20240815$20240813$20240822$PER$$US-AMGEN-USASP2024158121$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242033843$24203384$3$F$20240731$20240821$20240813$20240910$PER$$US-AMGEN-USASP2024157579$AMGEN$$66$YR$E$F$Y$$$20240910$$HP$US$US
242033852$24203385$2$F$20240101$20240813$20240813$20240819$PER$$US-AMGEN-USASP2024160014$AMGEN$$77$YR$E$F$Y$$$20240818$$CN$US$US
242033861$24203386$1$I$$20240804$20240813$20240813$EXP$$TH-ROCHE-10000049418$ROCHE$$64$YR$A$M$Y$$$20240813$$CN$TH$TH
242033871$24203387$1$I$20180621$20240807$20240813$20240813$EXP$$US-BIOGEN-2024BI01277712$BIOGEN$$41$YR$$F$Y$99.019$KG$20240813$$MD$US$US
242033881$24203388$1$I$20240603$20240731$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-039032$AUROBINDO$$88$YR$$F$Y$49.2$KG$20240813$$MD$FR$FR
242033903$24203390$3$F$20240101$20240906$20240813$20240920$EXP$$CA-UCBSA-2024040679$UCB$$$$$F$Y$$$20240920$$CN$CA$CA
242033911$24203391$1$I$$20240811$20240813$20240813$EXP$GB-MHRA-MED-202408112206023550-QKDCN$GB-SANDOZ INC.-SDZ2024GB071905$SANDOZ$$2$YR$$M$Y$$$20240813$$CN$GB$GB
242033921$24203392$1$I$20240101$20240805$20240813$20240813$EXP$$US-SA-2024SA234230$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240813$$MD$US$US
242033931$24203393$1$I$20240101$20240805$20240813$20240813$EXP$$US-SA-2024SA122828$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240813$$MD$US$US
242033941$24203394$1$I$20210701$20240801$20240813$20240813$EXP$FR-AFSSAPS-BX2023000003$FR-RECORDATI RARE DISEASE INC.-2024006006$RECORDATI$$$$$$Y$$$20240813$$MD$FR$FR
242033951$24203395$1$I$$20240809$20240813$20240813$EXP$GB-MHRA-MED-202408091442060030-DQZMP$GB-ORGANON-O2408GBR000815$ORGANON$$$$$M$Y$$$20240813$$CN$GB$GB
242033961$24203396$1$I$$20240806$20240813$20240813$EXP$$DE-JNJFOC-20240813222$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$CN$DE$DE
242033971$24203397$1$I$$20240708$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07045$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242033981$24203398$1$I$20240501$20240523$20240813$20240813$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000221$Tarsus Pharmaceuticals$$59$YR$$F$Y$$$20240813$$CN$US$US
242033991$24203399$1$I$$20240805$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125044$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240813$$MD$US$US
242034001$24203400$1$I$20240701$20240801$20240813$20240813$EXP$$CL-ROCHE-10000048133$ROCHE$$75$YR$E$F$Y$58$KG$20240813$$CN$CL$CL
242034011$24203401$1$I$$20240731$20240813$20240813$EXP$$PT-AUROBINDO-AUR-APL-2024-039275$AUROBINDO$$79$YR$$F$Y$$$20240813$$MD$PT$PT
242034021$24203402$1$I$$20240806$20240813$20240813$EXP$$BR-SANDOZ INC.-SDZ2024BR072007$SANDOZ$$$$$F$Y$$$20240813$$CN$BR$BR
242034042$24203404$2$F$20240808$20240813$20240813$20240814$PER$$US-AMGEN-USASP2024158114$AMGEN$$71$YR$E$M$Y$$$20240813$$CN$US$US
242034051$24203405$1$I$$20240731$20240813$20240813$EXP$$GB-AUROBINDO-AUR-APL-2024-038490$AUROBINDO$$72$YR$$M$Y$$$20240813$$PH$GB$GB
242034061$24203406$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5874367$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242034072$24203407$2$F$$20240808$20240813$20240816$PER$$NVSC2024US163204$NOVARTIS$$73$YR$$$Y$$$20240816$$CN$US$US
242034081$24203408$1$I$$20240709$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07082$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242034092$24203409$2$F$20240101$20240812$20240813$20240816$EXP$$US-ABBVIE-5874704$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242034102$24203410$2$F$20240724$20240813$20240813$20240815$EXP$$US-ABBVIE-5872598$ABBVIE$$70$YR$$M$Y$$$20240815$$CN$US$US
242034111$24203411$1$I$$20240805$20240813$20240813$PER$$US-ROCHE-10000049852$ROCHE$Jones A, Martin J, Giangiacomo A, Costakos D. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024-Dec;36:1-4. doi:10.1016/j.ajoc.2024.102131.$$$I$M$Y$$$20240813$$HP$US$US
242034121$24203412$1$I$20240717$20240806$20240813$20240813$EXP$$CN-BEIGENE-BGN-2024-012266$BEIGENE$$$$$$Y$$$20240813$$HP$CN$CN
242034131$24203413$1$I$20240101$20240808$20240813$20240813$EXP$$US-ABBVIE-5874375$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242034141$24203414$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126986$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240813$$HP$US$US
242034151$24203415$1$I$20240101$20240807$20240813$20240813$EXP$$GB-ABBVIE-5871849$ABBVIE$$67$YR$$M$Y$$$20240813$$CN$GB$GB
242034161$24203416$1$I$20240101$20240808$20240813$20240813$EXP$$CA-ABBVIE-5874707$ABBVIE$$77$YR$$M$Y$$$20240813$$CN$CA$CA
242034171$24203417$1$I$20240809$20240809$20240813$20240813$PER$$US-ABBVIE-5876592$ABBVIE$$30$YR$$F$Y$$$20240813$$MD$US$US
242034182$24203418$2$F$20230103$20240903$20240813$20240911$EXP$$IE-BEH-2023154069$CSL BEHRING$$68$YR$E$M$Y$80$KG$20240911$$CN$IE$IE
242034191$24203419$1$I$20240809$20240809$20240813$20240813$EXP$$US-ABBVIE-5875415$ABBVIE$$38$YR$$F$Y$$$20240813$$CN$US$US
242034201$24203420$1$I$$20240730$20240813$20240813$EXP$$CA-HLS-202401907$HLS THERAPEUTICS$$$$E$M$Y$$$20240813$$HP$CA$CA
242034211$24203421$1$I$20240809$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159857$AMGEN$$$$$$Y$$$20240813$$CN$US$US
242034221$24203422$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039877$AUROBINDO$$89$YR$$F$Y$55$KG$20240813$$PH$CA$CA
242034231$24203423$1$I$$20240810$20240813$20240813$EXP$$IN-ROCHE-10000054927$ROCHE$$34$YR$A$F$Y$$$20240813$$CN$IN$IN
242034241$24203424$1$I$20220401$20240730$20240813$20240813$EXP$$JP-JNJFOC-20240800737$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240813$$MD$JP$JP
242034251$24203425$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039824$AUROBINDO$$80$YR$$M$Y$78$KG$20240813$$MD$CA$CA
242034261$24203426$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127057$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240813$$PH$US$US
242034271$24203427$1$I$$20240804$20240813$20240813$EXP$$IL-EMD Serono-2024042182$EMD SERONO INC$$16$YR$T$F$Y$$$20240813$$CN$IL$IL
242034291$24203429$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07439$HIKMA$$51$YR$$M$Y$$$20240813$$CN$CA$CA
242034301$24203430$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A181020$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242034311$24203431$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039840$AUROBINDO$$54$YR$$F$Y$$$20240813$$HP$CA$CA
242034321$24203432$1$I$$20240731$20240813$20240813$PER$$US-ROCHE-10000047189$ROCHE$$50$YR$A$F$Y$$$20240813$$MD$US$US
242034331$24203433$1$I$$20240805$20240813$20240813$PER$$US-AstraZeneca-2024A177927$ASTRAZENECA$$$$$M$Y$$$20240813$$MD$US$
242034341$24203434$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039769$AUROBINDO$$$$$M$Y$$$20240813$$HP$CA$CA
242034351$24203435$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039870$AUROBINDO$$90$YR$$M$Y$64$KG$20240813$$HP$CA$CA
242034363$24203436$3$F$20240701$20240911$20240813$20240917$EXP$$JP-EMD Serono-2024042662$EMD SERONO INC$$79$YR$E$F$Y$$$20240917$$HP$JP$JP
242034371$24203437$1$I$$20240802$20240813$20240813$PER$$US-AstraZeneca-2024A177269$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242034381$24203438$1$I$20230804$20230823$20240813$20240813$EXP$$CO-AstraZeneca-2023A194337$ASTRAZENECA$$3559$WK$$M$Y$$$20240813$$CN$CO$
242034392$24203439$2$F$20240808$20240809$20240813$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408006651$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240815$$CN$US$US
242034401$24203440$1$I$20240807$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006794$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242034411$24203441$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007448$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240813$$HP$US$US
242034421$24203442$1$I$$20240802$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002070$ELI LILLY AND CO$$$$$$Y$$$20240813$$CN$US$US
242034432$24203443$2$F$$20240809$20240813$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408006743$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240815$$CN$US$US
242034441$24203444$1$I$20240101$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006713$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240813$$CN$US$US
242034451$24203445$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006461$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240813$$CN$US$US
242034461$24203446$1$I$$20240804$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408003051$ELI LILLY AND CO$$52$YR$A$$Y$$$20240813$$CN$US$US
242034471$24203447$1$I$20240808$20240809$20240813$20240813$EXP$$CA-JNJFOC-20240736616$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240813$$HP$CA$CA
242034481$24203448$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039744$AUROBINDO$$77$YR$$M$Y$$$20240813$$HP$CA$CA
242034491$24203449$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5874634$ABBVIE$$$$$F$Y$$$20240813$$HP$US$US
242034501$24203450$1$I$20240701$20240808$20240813$20240813$EXP$$US-ABBVIE-5821529$ABBVIE$$92$YR$$M$Y$$$20240813$$CN$US$US
242034511$24203451$1$I$20240615$20240803$20240813$20240813$PER$$US-ABBVIE-5866623$ABBVIE$$18$YR$$F$Y$56.699$KG$20240813$$CN$US$US
242034521$24203452$1$I$$20240531$20240813$20240813$EXP$$US-BAUSCHBL-2024BNL031356$BAUSCH AND LOMB$$$$N$$Y$$$20240813$$CN$US$US
242034531$24203453$1$I$$20240531$20240813$20240813$EXP$$US-BAUSCHBL-2024BNL031348$BAUSCH AND LOMB$$$$N$$Y$$$20240813$$CN$US$US
242034545$24203454$5$F$20240101$20240904$20240813$20240905$PER$$US-AMGEN-USASP2024158033$AMGEN$$69$YR$E$F$Y$$$20240905$$CN$US$US
242034551$24203455$1$I$20240510$20240805$20240813$20240813$EXP$ES-AEMPS-1555777$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-110878$ZYDUS PHARM$$$$$$Y$$$20240813$$MD$ES$ES
242034562$24203456$2$F$20240809$20240813$20240813$20240821$PER$$US-AMGEN-USASP2024160066$AMGEN$$79$YR$E$M$Y$$$20240821$$CN$US$US
242034571$24203457$1$I$$20240730$20240813$20240813$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110733$ZYDUS PHARM$Afriyie F, Gilani N, Fanous M, Mansoor A, Shah K, Waller AH. Chasing the high towards death, a case of loperamide induced cardiac arrest. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):2941 abstr. 1200-074$$$$$Y$$$20240813$$HP$US$US
242034581$24203458$1$I$20240701$20240810$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127012$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$74.39$KG$20240813$$CN$US$US
242034591$24203459$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126448$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$117.93$KG$20240813$$CN$US$US
242034601$24203460$1$I$20240802$20240802$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123289$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$96.3$KG$20240813$$PH$US$US
242034612$24203461$2$F$20240730$20240827$20240813$20240902$EXP$$JP-EXELIXIS-CABO-24080431$EXELIXIS$$8$DEC$$M$Y$$$20240902$$MD$JP$JP
242034621$24203462$1$I$$20240807$20240813$20240813$PER$$CZ-Blueprint Medicines Corporation-SP-CZ-2024-001598$BLUEPRINT MEDICINES$$$$$F$Y$$$20240813$$MD$CZ$CZ
242034631$24203463$1$I$20240601$20240805$20240813$20240813$PER$$NVSC2024US138464$NOVARTIS$$56$YR$$F$Y$117.48$KG$20240813$$CN$US$US
242034641$24203464$1$I$20240708$20240730$20240813$20240813$EXP$$US-MDD US Operations-MDD202407-002804$MDD OPERATIONS$$81$YR$$M$Y$$$20240813$$CN$US$
242034651$24203465$1$I$20240731$20240731$20240813$20240813$EXP$$GB-AUROBINDO-AUR-APL-2024-038764$AUROBINDO$$32$YR$$F$Y$70$KG$20240813$$CN$GB$GB
242034662$24203466$2$F$20220421$20240916$20240813$20240924$EXP$$CA-CELLTRION INC.-2022CA008442$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
242034672$24203467$2$F$20240721$20240920$20240813$20240925$EXP$$PK-ROCHE-10000048566$ROCHE$$66$YR$E$F$Y$$$20240925$$CN$PK$PK
242034681$24203468$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039814$AUROBINDO$$85$YR$$F$Y$$$20240813$$PH$CA$CA
242034692$24203469$2$F$20240712$20240822$20240813$20240830$EXP$$AU-CELLTRION INC.-2024AU019148$CELLTRION$$$$$$Y$$$20240830$$HP$AU$AU
242034703$24203470$3$F$$20240827$20240813$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123032$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$PH$JP$JP
242034711$24203471$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126989$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240813$$CN$US$US
242034721$24203472$1$I$$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126407$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240813$$PH$US$US
242034731$24203473$1$I$20240101$20240808$20240813$20240813$EXP$$US-ABBVIE-5874292$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242034742$24203474$2$F$20240701$20240826$20240813$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012004$JAZZ$$20$YR$$F$Y$$$20240828$$CN$US$US
242034751$24203475$1$I$$20240803$20240813$20240813$EXP$$CA-ROCHE-10000048261$ROCHE$$74$YR$E$F$Y$54$KG$20240813$$HP$CA$CA
242034761$24203476$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5874711$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242034771$24203477$1$I$20240101$20240808$20240813$20240813$EXP$$US-SA-2024SA238099$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240813$$MD$US$US
242034781$24203478$1$I$20240521$20240812$20240813$20240813$EXP$$US-GILEAD-2024-0683881$GILEAD$$53$YR$A$M$Y$$$20240813$$CN$US$US
242034791$24203479$1$I$$20240809$20240813$20240813$EXP$$US-KYOWAKIRIN-2024KK019069$KYOWA$$$$$$Y$$$20240813$$HP$US$US
242034811$24203481$1$I$$20220620$20240813$20240813$EXP$$US-AstraZeneca-2022A227890$ASTRAZENECA$$$$$$Y$$$20240813$$HP$US$
242034821$24203482$1$I$20240301$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A179196$ASTRAZENECA$$757$MON$$M$Y$$$20240813$$CN$US$
242034831$24203483$1$I$$20240805$20240813$20240813$EXP$$ZA-AstraZeneca-2024A180032$ASTRAZENECA$$39$YR$$M$Y$$$20240813$$CN$ZA$
242034841$24203484$1$I$$20240802$20240813$20240813$PER$$US-AstraZeneca-2024A176781$ASTRAZENECA$$$$$$Y$$$20240813$$MD$US$
242034851$24203485$1$I$$20240805$20240813$20240813$EXP$$ZA-AstraZeneca-2024A177735$ASTRAZENECA$$75$YR$$M$Y$$$20240813$$CN$ZA$
242034861$24203486$1$I$20221101$20240808$20240813$20240813$EXP$$CA-ABBVIE-5874767$ABBVIE$$$$E$M$Y$$$20240813$$CN$CA$CA
242034872$24203487$2$F$20240807$20240920$20240813$20240923$PER$$US-ROCHE-10000052097$ROCHE$$75$YR$E$F$Y$47.62$KG$20240923$$CN$US$US
242034881$24203488$1$I$20240712$20240812$20240813$20240813$PER$$NVSC2024US163631$NOVARTIS$$62$YR$$F$Y$$$20240813$$HP$US$US
242034891$24203489$1$I$20240709$20240731$20240813$20240813$EXP$$IE-AUROBINDO-AUR-APL-2024-039197$AUROBINDO$$15$YR$$F$Y$43.6$KG$20240813$$HP$IE$IE
242034901$24203490$1$I$$20240731$20240813$20240813$EXP$$PT-AUROBINDO-AUR-APL-2024-039309$AUROBINDO$Fernandes R, Henriques AC, Martins C, Barreto F, Silva M, Correia MI et al.. FernandesFernandes R, Henriques AC, Martins C, Barreto F, Silva M, Correia MI, Dias G, Faria T CO-0010 - (2128). Complexidade neuroinfecciosa: caso cl?nico de otomastoidite associada a trombose venosa cerebral e meningite. (Neuroinfectious complexity: clinical case of otomastoiditis associated with cerebral venous thrombosis and meningitis.). Congressos da Sociedade Portuguesa de Medicina Interna (Congresses of the Port$38$YR$$F$Y$$$20240813$$MD$PT$PT
242034912$24203491$2$F$20240730$20240919$20240813$20240920$PER$$US-AMGEN-USASP2024160010$AMGEN$$74$YR$E$F$Y$$$20240920$$CN$US$US
242034922$24203492$2$F$20220810$20240815$20240813$20240826$EXP$PT-INFARMED-M202211-311$PT-GILEAD-2024-0683833$GILEAD$$72$YR$E$M$Y$$$20240826$$MD$PT$PT
242034932$24203493$2$F$$20240821$20240813$20240902$EXP$$JP-ADVANZ PHARMA-202408006634$ADVANZ PHARMA$$$$$$Y$$$20240902$$PH$JP$JP
242034941$24203494$1$I$$20240729$20240813$20240813$PER$$US-TEVA-VS-3228701$TEVA$$$$$$Y$$$20240813$$CN$US$US
242034951$24203495$1$I$$20240808$20240813$20240813$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001594$BLUEPRINT MEDICINES$$$$$M$Y$$$20240813$$CN$US$US
242034961$24203496$1$I$20240709$20240806$20240813$20240813$EXP$IE-HPRA-2024-114533$IE-CHEPLA-2024010293$CHEPLAPHARM$$15$YR$$F$Y$43.599$KG$20240813$$HP$COUNTRY NOT SPECIFIED$IE
242034971$24203497$1$I$20200412$20240806$20240813$20240813$EXP$PL-URPL-1-2217-2020$PL-CHEPLA-2024010307$CHEPLAPHARM$$31$YR$A$M$Y$93$KG$20240813$$MD$COUNTRY NOT SPECIFIED$PL
242034981$24203498$1$I$20230401$20240806$20240813$20240813$EXP$$CN-CHEPLA-2024010272$CHEPLAPHARM$Sun M, Xu G, Cai L, He S. Misdiagnosis of severe and atypical oxaliplatin-related hypersensitivity reaction following chemotherapy combined with PD-1 inhibitor: A case report and literature review. Oncol Lett. 2024 Jul 23;28(4):452. doi: 10.3892/ol.2024.14586. PMID: 39101001; PMCID: PMC11292463.$67$YR$$M$Y$$$20240813$$HP$COUNTRY NOT SPECIFIED$CN
242034991$24203499$1$I$20240101$20240809$20240813$20240813$EXP$$US-ABBVIE-5875050$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242035001$24203500$1$I$20240401$20240809$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US071851$SANDOZ$$83$YR$$F$Y$$$20240813$$CN$US$US
242035011$24203501$1$I$$20240805$20240813$20240813$EXP$$GB-AMGEN-GBRSP2024159164$AMGEN$$64$YR$A$M$Y$$$20240813$$CN$GB$GB
242035022$24203502$2$F$20240808$20240813$20240813$20240820$PER$$US-AMGEN-USASP2024159796$AMGEN$$50$YR$A$F$Y$$$20240820$$CN$US$US
242035031$24203503$1$I$20240310$20240731$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-039110$AUROBINDO$$69$YR$$M$Y$50$KG$20240813$$MD$FR$FR
242035041$24203504$1$I$$20240812$20240813$20240813$EXP$$US-JNJFOC-20240831053$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
242035051$24203505$1$I$$20240731$20240813$20240813$EXP$$US-RDY-LIT/USA/24/0011725$DR REDDYS$Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. blood. 2023 Nov;142: 5898. doi:10.1182/blood-2023-188298.$$$A$$Y$$$20240813$$MD$US$US
242035062$24203506$2$F$$20240828$20240813$20240828$PER$$US-ALXN-202408USA000456US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242035071$24203507$1$I$$20240731$20240813$20240813$EXP$$US-RDY-LIT/USA/24/0011723$DR REDDYS$Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. blood. 2023 Nov;142: 5898. doi:10.1182/blood-2023-188298.$$$A$$Y$$$20240813$$MD$US$US
242035081$24203508$1$I$$20240731$20240813$20240813$EXP$$US-RDY-LIT/USA/24/0011724$DR REDDYS$Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. blood. 2023 Nov;142: 5898. doi:10.1182/blood-2023-188298.$$$A$$Y$$$20240813$$MD$US$US
242035091$24203509$1$I$$20240803$20240813$20240813$EXP$$IN-IPCA LABORATORIES LIMITED-IPC-2024-IN-001990$IPCA$Ranjan Kumar Patel, Taraprasad Tripathy, Srikant Behera, et.al.. Paraplegia from warfarin-induced spinal epidural hematoma. J Vasc Interv Radiol. 2024;35:1248-1249$$$$$Y$$$20240813$$MD$IN$IN
242035102$24203510$2$F$$20240812$20240813$20240820$PER$$US-APOTEX-2024AP009145$APOTEX$Mess SA, Stephanos KN.. Temperance With Tranexamic Acid: Increased Risk of Venous Thromboembolism in Abdominoplasty. Aesthetic Surgery Journal Open Forum. 2024;6 (ojae044):1-6$52$YR$$F$Y$$$20240820$$MD$US$US
242035111$24203511$1$I$$20240805$20240813$20240813$EXP$$JP-GENMAB-2024-02836$GENMAB$$8$DEC$$F$Y$$$20240813$$MD$JP$JP
242035121$24203512$1$I$20170815$20240807$20240813$20240813$EXP$$CA-TAKEDA-2017TUS017388$TAKEDA$$42$YR$$M$Y$$$20240813$$MD$CA$CA
242035131$24203513$1$I$20230101$20240806$20240813$20240813$EXP$$US-ARGENX-2024-ARGX-US006321$ARGENX BVBA$$$$$$Y$$$20240813$$HP$US$US
242035141$24203514$1$I$20240802$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006533$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240813$$HP$US$US
242035151$24203515$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006766$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240813$$CN$US$US
242035161$24203516$1$I$20240811$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007404$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240813$$CN$US$US
242035171$24203517$1$I$20240809$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006807$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240813$$CN$US$US
242035181$24203518$1$I$$20240801$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408001069$ELI LILLY AND CO$$54$YR$A$$Y$$$20240813$$LW$US$US
242035191$24203519$1$I$$20240807$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005125$ELI LILLY AND CO$$$$$F$Y$$$20240813$$MD$US$US
242035201$24203520$1$I$$20240809$20240813$20240813$EXP$$CA-ORGANON-O2405CAN001050$ORGANON$$36$YR$$F$Y$$$20240813$$HP$CA$CA
242035212$24203521$2$F$20240101$20240829$20240813$20240905$EXP$$US-ABBVIE-5875368$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242035221$24203522$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875433$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242035231$24203523$1$I$$20240808$20240813$20240813$EXP$$US-JNJFOC-20240825995$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240813$$CN$US$US
242035241$24203524$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07521$HIKMA$$86$YR$$M$Y$$$20240813$$PH$CA$CA
242035251$24203525$1$I$20240607$20240805$20240813$20240813$EXP$FR-AFSSAPS-NT2024000943$FR-TEVA-VS-3230469$TEVA$$76$YR$$F$Y$$$20240813$$MD$FR$FR
242035263$24203526$3$F$20240801$20240903$20240813$20240906$EXP$$US-ABBVIE-5875511$ABBVIE$$86$YR$$M$Y$$$20240906$$CN$US$US
242035271$24203527$1$I$$20240731$20240813$20240813$EXP$$GB-AUROBINDO-AUR-APL-2024-038756$AUROBINDO$$72$YR$$F$Y$$$20240813$$PH$GB$GB
242035281$24203528$1$I$20240801$20240807$20240813$20240813$PER$$US-AMGEN-USASP2024158641$AMGEN$$$$$$Y$$$20240813$$PH$US$US
242035291$24203529$1$I$$20240812$20240813$20240813$PER$$NVSC2024US163827$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
242035301$24203530$1$I$$20240805$20240813$20240813$EXP$$ZA-AstraZeneca-2024A177769$ASTRAZENECA$$83$YR$$F$Y$$$20240813$$CN$ZA$
242035311$24203531$1$I$$20240805$20240813$20240813$EXP$$ZA-AstraZeneca-2024A177714$ASTRAZENECA$$54$YR$$F$Y$$$20240813$$CN$ZA$
242035321$24203532$1$I$20240101$20240808$20240813$20240813$EXP$$US-ABBVIE-5874347$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242035331$24203533$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5874393$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242035344$24203534$4$F$20240806$20240912$20240813$20240921$PER$$US-ROCHE-10000051197$ROCHE$$53$YR$A$F$Y$86.18$KG$20240921$$CN$US$US
242035352$24203535$2$F$20231103$20240916$20240813$20240926$EXP$$IT-AUROBINDO-AUR-APL-2023-081798$AUROBINDO$$46$YR$$M$Y$$$20240926$$MD$IT$IT
242035361$24203536$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875448$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242035372$24203537$2$F$20240812$20240813$20240813$20240814$PER$$US-AMGEN-USASP2024159991$AMGEN$$68$YR$E$M$Y$$$20240814$$CN$US$US
242035382$24203538$2$F$20240807$20240816$20240813$20240821$EXP$$FR-ABBVIE-5877023$ABBVIE$$78$YR$$F$Y$$$20240821$$HP$FR$FR
242035391$24203539$1$I$20240101$20240730$20240813$20240813$EXP$$US-UCBSA-2024033505$UCB$$$$$F$Y$77.56$KG$20240813$$HP$US$US
242035401$24203540$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127056$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240813$$CN$US$US
242035411$24203541$1$I$$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125464$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$49.9$KG$20240813$$HP$US$US
242035421$24203542$1$I$$20230705$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-63081$HIKMA$$$$$$Y$$$20240812$$HP$US$US
242035432$24203543$2$F$$20240812$20240813$20240819$PER$$US-APOTEX-2024AP009177$APOTEX$Mess SA, Stephanos KN.. Temperance With Tranexamic Acid: Increased Risk of Venous Thromboembolism in Abdominoplasty. Aesthetic Surgery Journal Open Forum. 2024;6 (ojae044):1-6$44$YR$$F$Y$$$20240819$$MD$US$US
242035441$24203544$1$I$$20230802$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-63989$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242035451$24203545$1$I$$20230814$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64438$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242035461$24203546$1$I$$20230814$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64491$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242035471$24203547$1$I$$20230819$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64592$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242035481$24203548$1$I$$20230907$20240813$20240813$EXP$$CA-CELLTRION INC.-2023CA025586$CELLTRION$$$$$$Y$$$20240813$$MD$CA$CA
242035492$24203549$2$F$$20240814$20240813$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07017$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242035501$24203550$1$I$20240721$20240805$20240813$20240813$EXP$$US-RIGEL-20240700109$RIGEL PHARMACEUTICALS$$72$YR$$M$Y$99.79$KG$20240813$$CN$US$US
242035511$24203551$1$I$$20240731$20240813$20240813$EXP$$DE-AUROBINDO-AUR-APL-2024-039239$AUROBINDO$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S, et al.. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. British Journal of Cancer. 2023;128(6):1134-1147$$$$F$Y$$$20240813$$HP$DE$DE
242035521$24203552$1$I$20230617$20240705$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64657$HIKMA$$67$YR$$M$Y$$$20240812$$PH$US$US
242035531$24203553$1$I$$20240806$20240813$20240813$EXP$$CN-JNJFOC-20240818768$JOHNSON AND JOHNSON$$78$YR$E$F$Y$59$KG$20240813$$HP$CN$CN
242035541$24203554$1$I$$20230906$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65038$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242035551$24203555$1$I$20240515$20240725$20240813$20240813$EXP$$CO-UCBSA-2024040629$UCB$$69$YR$$F$Y$$$20240813$$CN$CO$CO
242035561$24203556$1$I$$20230907$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65139$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242035572$24203557$2$F$$20240812$20240813$20240820$PER$$US-APOTEX-2024AP009180$APOTEX$Mess SA, Stephanos KN.. Temperance With Tranexamic Acid: Increased Risk of Venous Thromboembolism in Abdominoplasty. Aesthetic Surgery Journal Open Forum. 2024;6 (ojae044):1-6$53$YR$$F$Y$$$20240820$$MD$US$US
242035581$24203558$1$I$$20230908$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65152$HIKMA$$$$$$Y$$$20240812$$HP$US$US
242035591$24203559$1$I$20240618$20240729$20240813$20240813$EXP$CH-SM-2024-14376$CH-UCBSA-2024038033$UCB$$75$YR$$F$Y$$$20240813$$HP$CH$CH
242035602$24203560$2$F$20240401$20240919$20240813$20240927$EXP$$GT-EMD Serono-2024027062$EMD SERONO INC$$10$YR$C$M$Y$$$20240927$$CN$GT$GT
242035611$24203561$1$I$20240802$20240805$20240813$20240813$EXP$$JP-009507513-2408JPN000397J$MERCK$$77$YR$$F$Y$$$20240813$$PH$JP$JP
242035621$24203562$1$I$20240804$20240808$20240813$20240813$EXP$$US-009507513-2408USA002752$MERCK$$61$YR$$M$Y$$$20240813$$CN$US$US
242035632$24203563$2$F$$20240815$20240813$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07015$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242035643$24203564$3$F$20240730$20240916$20240813$20240924$EXP$$US-AUROBINDO-AUR-APL-2024-039263$AUROBINDO$$$$$F$Y$$$20240924$$CN$US$US
242035651$24203565$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039894$AUROBINDO$$46$YR$$F$Y$$$20240813$$HP$CA$CA
242035661$24203566$1$I$$20240806$20240813$20240813$EXP$$GB-CELLTRION INC.-2024GB019033$CELLTRION$$$$$$Y$$$20240813$$CN$GB$GB
242035671$24203567$1$I$20230811$20240731$20240813$20240813$EXP$$US-UCBSA-2023042617$UCB$$13$YR$$M$Y$$$20240813$$CN$US$US
242035681$24203568$1$I$20200101$20240806$20240813$20240813$EXP$DE-EMA-DD-20240805-7482675-093431$DE-RDY-SPO/DEU/24/0011545$DR REDDYS$Hollein A., Bojko P., Schulz S., Neitz J., Stotzer O., Pihusch R., et al. Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study. Acta Oncol. 2021 60:1 (24-27).$42$YR$A$F$Y$$$20240813$$MD$DE$DE
242035691$24203569$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039928$AUROBINDO$$$$$M$Y$$$20240813$$MD$CA$CA
242035701$24203570$1$I$$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125621$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240813$$HP$US$US
242035711$24203571$1$I$20240729$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125810$BRISTOL MYERS SQUIBB$$28$YR$A$F$Y$$$20240813$$CN$US$US
242035721$24203572$1$I$$20240726$20240813$20240813$PER$$US-UniquePharma-US-2024UPLSPO00024$UNIQUE PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242035732$24203573$2$F$$20240814$20240813$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07148$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242035741$24203574$1$I$$20230816$20240813$20240813$EXP$$US-AstraZeneca-2023A187519$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242035751$24203575$1$I$$20220329$20240813$20240813$EXP$$US-AstraZeneca-2022A073032$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242035761$24203576$1$I$$20240805$20240813$20240813$EXP$$GB-AstraZeneca-2024A177213$ASTRAZENECA$$71$YR$$M$Y$112$KG$20240813$$MD$GB$
242035771$24203577$1$I$20230808$20230810$20240813$20240813$EXP$$US-AstraZeneca-2023A183640$ASTRAZENECA$$25752$DY$$F$Y$$$20240813$$CN$US$
242035781$24203578$1$I$$20240807$20240813$20240813$EXP$$US-AstraZeneca-2024A180134$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242035791$24203579$1$I$$20240731$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-038995$AUROBINDO$Shultz J, Antar-Shultz M, Taha M, Zervogiannis P, Lazcano G, Lamarche J.. SEVELAMERASSOCIATED COLITIS: A TRIGGER TO CHANGE TREATMENT APPROACH. Am-J-Kidney-Dis. 2024;83 (Suppl.)(4):S74 abstr. 242$63$YR$$M$Y$$$20240813$$HP$US$US
242035801$24203580$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005864$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240813$$CN$US$US
242035811$24203581$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007327$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240813$$CN$US$US
242035821$24203582$1$I$$20240801$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002173$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240813$$CN$US$US
242035831$24203583$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007294$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240813$$CN$US$US
242035841$24203584$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006330$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240813$$CN$US$US
242035851$24203585$1$I$20220101$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006824$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240813$$CN$US$US
242035861$24203586$1$I$$20240806$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006463$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240813$$CN$US$US
242035871$24203587$1$I$20240302$20240805$20240813$20240813$EXP$FR-AFSSAPS-TO2024001427$FR-TEVA-VS-3230592$TEVA$$60$YR$$M$Y$$$20240813$$MD$FR$FR
242035881$24203588$1$I$$20240808$20240813$20240813$EXP$$US-ROCHE-10000053973$ROCHE$$24$YR$A$F$Y$$$20240813$$CN$US$US
242035892$24203589$2$F$20231201$20240910$20240813$20240913$PER$$US-ROCHE-10000049871$ROCHE$$69$YR$E$M$Y$103.42$KG$20240913$$CN$US$US
242035901$24203590$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024160293$AMGEN$$$$$$Y$$$20240813$$MD$US$US
242035911$24203591$1$I$$20230908$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65175$HIKMA$$$$$$Y$$$20240812$$HP$US$US
242035921$24203592$1$I$$20240731$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-038572$AUROBINDO$Allonce J, Khan S, Pulford B. Atypical Presentation of Ziprasidone-Induced Neuroleptic Malignant Syndrome: A Case Report.. Journal of investigative medicine high impact case reports. 2024;12:1-4$43$YR$$M$Y$$$20240813$$MD$US$US
242035931$24203593$1$I$20240410$20240411$20240813$20240813$PER$$US-ABBVIE-5875678$ABBVIE$$23$YR$$F$Y$$$20240813$$HP$US$US
242035941$24203594$1$I$$20230909$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65278$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242035951$24203595$1$I$20240729$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160065$AMGEN$$$$$M$Y$$$20240813$$PH$US$US
242035961$24203596$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024158842$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242035971$24203597$1$I$$20230912$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65283$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242035981$24203598$1$I$20200502$20240731$20240813$20240813$EXP$$PL-AUROBINDO-AUR-APL-2024-039201$AUROBINDO$$18$YR$$F$Y$$$20240813$$MD$PL$PL
242035991$24203599$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07523$HIKMA$$54$YR$$F$Y$$$20240813$$CN$CA$CA
242036001$24203600$1$I$$20240710$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07016$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242036011$24203601$1$I$$20230919$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65468$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242036021$24203602$1$I$20230301$20240801$20240813$20240813$EXP$$US-INSMED-2023-01671-USAA$INSMED$$82$YR$$M$Y$$$20240813$$CN$US$US
242036031$24203603$1$I$$20240731$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-039258$AUROBINDO$Bandali T, Kim Y, Khodadoust M, Rieger K, Fernandez-Pol S, Saleem A, et al. Polatuzumab vedotin-piiq for treatment of primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCLLT) in older adults. J-Invest-Dermatol. 2024;144 (Suppl.)(8):S49 abstr. 282$83$YR$$F$Y$$$20240813$$HP$US$US
242036041$24203604$1$I$20231218$20240805$20240813$20240813$EXP$FR-AFSSAPS-TO2024001424$FR-TEVA-VS-3230591$TEVA$$56$YR$$F$Y$$$20240813$$MD$FR$FR
242036051$24203605$1$I$$20230919$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65469$HIKMA$$$$$$Y$$$20240812$$HP$US$US
242036061$24203606$1$I$20240101$20240805$20240813$20240813$EXP$$JP-GENMAB-2024-02840$GENMAB$$72$YR$$F$Y$$$20240813$$MD$JP$JP
242036071$24203607$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039749$AUROBINDO$$56$YR$$F$Y$$$20240813$$HP$CA$CA
242036082$24203608$2$F$20240712$20240821$20240813$20240827$EXP$$NVSC2024AR162744$NOVARTIS$$75$YR$$F$Y$$$20240827$$CN$AR$AR
242036091$24203609$1$I$20240618$20240812$20240813$20240813$EXP$FR-AFSSAPS-AN2024001089$FR-SANDOZ INC.-SDZ2024FR071923$SANDOZ$$69$YR$$F$Y$87$KG$20240813$$PH$FR$FR
242036102$24203610$2$F$$20240816$20240813$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-038428$AUROBINDO$$5$DEC$$F$Y$$$20240828$$HP$GB$GB
242036111$24203611$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039766$AUROBINDO$$88$YR$$M$Y$77$KG$20240813$$PH$CA$CA
242036121$24203612$1$I$$20240731$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-039256$AUROBINDO$Bandali T, Kim Y, Khodadoust M, Rieger K, Fernandez-Pol S, Saleem A, et al. Polatuzumab vedotin-piiq for treatment of primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCLLT) in older adults. J-Invest-Dermatol. 2024;144 (Suppl.)(8):S49 abstr. 282$92$YR$$M$Y$$$20240813$$HP$US$US
242036131$24203613$1$I$$20240809$20240813$20240813$EXP$$CA-JNJFOC-20240826775$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240813$$HP$CA$CA
242036141$24203614$1$I$$20240812$20240813$20240813$EXP$$CA-ADIENNEP-2024AD000641$ADIENNE PHARMA + BIOTECH$$34$YR$$M$Y$176$KG$20240812$$HP$CA$
242036151$24203615$1$I$$20240802$20240813$20240813$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18664$ALKEM$Prosser JM, Mills A, Rhim ES, Perrone J.. Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus. Int J Emerg Med. 2008;1:217-220$$$$$Y$$$20240813$$HP$US$US
242036161$24203616$1$I$$20240802$20240813$20240813$EXP$$JO-ALKEM LABORATORIES LIMITED-JO-ALKEM-2024-18628$ALKEM$Al-Husseini A, Wazaify M, Van Hout MC. Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User Experiences. Int J Ment Health Addict. 2018;16:642-654$22$YR$$M$Y$$$20240813$$HP$JO$JO
242036172$24203617$2$F$$20240813$20240813$20240825$EXP$US-MLMSERVICE-20190314-1664104-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17456$ALKEM$Yeddi A, Adam O, Khalid M, Benjaram S, Abu-Heija A, Abdallah MA, Shah P. Myoclonus and Altered Mental Status Induced by Single Dose of Gabapentin in a Patient With End-Stage Renal Disease: A Case Report and Literature Review. American Journal of Therapeutics. 2019;26(6):e768-e770$62$YR$$F$Y$$$20240825$$MD$US$US
242036181$24203618$1$I$$20240802$20240813$20240813$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18640$ALKEM$Asrani SK, Wiesner RH, Trotter JF, Klintmalm G, Katz E, Maller E, Roberts J, Kneteman N, Teperman L, Fung JJ, Millis JM.. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. American Journal of Transplantation. 2014;14:356-366$52$YR$$M$Y$$$20240813$$HP$US$US
242036192$24203619$2$F$$20240813$20240813$20240825$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-18032$ALKEM$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. Rheumatic and Muskuloskeletal Diseases Open. 2024;10:e004381$20$YR$$M$Y$$$20240825$$HP$DE$DE
242036201$24203620$1$I$$20240802$20240813$20240813$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18637$ALKEM$Asrani SK, Wiesner RH, Trotter JF, Klintmalm G, Katz E, Maller E, Roberts J, Kneteman N, Teperman L, Fung JJ, Millis JM.. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. American Journal of Transplantation. 2014;14:356-366$48$YR$$M$Y$$$20240813$$HP$US$US
242036211$24203621$1$I$$20240802$20240813$20240813$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18629$ALKEM$Asrani SK, Wiesner RH, Trotter JF, Klintmalm G, Katz E, Maller E, Roberts J, Kneteman N, Teperman L, Fung JJ, Millis JM.. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. American Journal of Transplantation. 2014;14:356-366$60$YR$$M$Y$$$20240813$$HP$US$US
242036221$24203622$1$I$$20240802$20240813$20240813$EXP$$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-18669$ALKEM$Lee HY, Li JH, Wu LT, Wu JS, Yen CF, Tang HP. Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. Substance Abuse Treatment, Prevention, and Policy. 2012;7:11$41$YR$$M$Y$$$20240813$$HP$TW$TW
242036232$24203623$2$F$$20240813$20240813$20240825$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-18031$ALKEM$Satirer O, Henes J, D?ring M, Lesk T, Benseler S, Kuemmerle-Deschner J.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. Rheumatic and musculoskeletal diseases open. 2024;10 (3):e004381$29$YR$$F$Y$$$20240825$$HP$DE$DE
242036241$24203624$1$I$$20240802$20240813$20240813$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18662$ALKEM$Fahey T, Law F, Cottee H, Astley P. Sudden death in an adult taking methadone: lessons for general practice. Br J Gen Pract .. 2003;53:471-472$$$A$$Y$$$20240813$$HP$GB$GB
242036251$24203625$1$I$$20240802$20240813$20240813$EXP$GB-MHRA-31354159$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18006$ALKEM$$75$YR$$M$Y$$$20240813$$CN$GB$GB
242036261$24203626$1$I$$20231011$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65503$HIKMA$$$$$$Y$$$20240812$$CN$US$US
242036271$24203627$1$I$$20240806$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125853$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240813$$HP$US$US
242036281$24203628$1$I$$20240802$20240813$20240813$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18660$ALKEM$Hendra TJ, Gerrish SP, Forrest AR. Fatal methadone overdose. BMJ .. 1996;313:481-482$$$$$Y$$$20240813$$HP$GB$GB
242036291$24203629$1$I$$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127315$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240813$$CN$US$US
242036301$24203630$1$I$20240812$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127331$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240813$$CN$US$US
242036312$24203631$2$F$$20240923$20240813$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126928$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240925$$CN$US$US
242036321$24203632$1$I$$20230928$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65789$HIKMA$$$$$$Y$$$20240812$$HP$US$US
242036331$24203633$1$I$$20240802$20240813$20240813$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-17993$ALKEM$$$$$F$Y$$$20240813$$CN$DE$DE
242036341$24203634$1$I$$20240802$20240813$20240813$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-18045$ALKEM$$69$YR$$M$Y$$$20240813$$MD$DE$DE
242036352$24203635$2$F$$20240815$20240813$20240827$EXP$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-18393$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-18393$ALKEM$Latief M, Bhat M, Wani M, Shafi O, Goud L, Abbas F, Wani M. Gabapentin Toxicity and Role of Dialysis: Case Series and Literature Review. Journal of Renal and Hepatic Disorders. 2022;6(1):7-9$32$YR$$M$Y$$$20240827$$MD$IN$IN
242036361$24203636$1$I$20230101$20240809$20240813$20240813$EXP$$CA-ABBVIE-5875961$ABBVIE$$$$E$M$Y$$$20240813$$CN$CA$CA
242036371$24203637$1$I$$20240802$20240813$20240813$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17436$ALKEM$Khan M, Khalid S, Marwat A, Aldergash S, Joshi M, Malhotra V. Myoclonus in a Patient with Acute Kidney Injury: A Rare Presentation of Gabapentin Toxicity. American Journal of Medical Case Reports. 2017;5(8):232-233$55$YR$$F$Y$$$20240813$$HP$US$US
242036381$24203638$1$I$$20240802$20240813$20240813$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18625$ALKEM$Asrani SK, Wiesner RH, Trotter JF, Klintmalm G, Katz E, Maller E, Roberts J, Kneteman N, Teperman L, Fung JJ, Millis JM.. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. American Journal of Transplantation. 2014;14:356-366$53$YR$$M$Y$$$20240813$$HP$US$US
242036391$24203639$1$I$$20240802$20240813$20240813$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18624$ALKEM$Asrani SK, Wiesner RH, Trotter JF, Klintmalm G, Katz E, Maller E, Roberts J, Kneteman N, Teperman L, Fung JJ, Millis JM.. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. American Journal of Transplantation. 2014;14:356-366$40$YR$$M$Y$$$20240813$$HP$US$US
242036401$24203640$1$I$$20240802$20240813$20240813$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18626$ALKEM$Asrani SK, Wiesner RH, Trotter JF, Klintmalm G, Katz E, Maller E, Roberts J, Kneteman N, Teperman L, Fung JJ, Millis JM.. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. American Journal of Transplantation. 2014;14:356-366$49$YR$$M$Y$$$20240813$$HP$US$US
242036411$24203641$1$I$$20240802$20240813$20240813$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-17958$ALKEM$Kampf C, Benecke R, Roesche J.. Provocation of Myoclonic Seizures and Generalized Electroencephalographic Epileptic Patterns in a Patient with Renal Failure and Gabapentin Intoxication. Epileptologia. 2011;19:159-163$40$YR$$F$Y$$$20240813$$MD$DE$DE
242036421$24203642$1$I$$20240802$20240813$20240813$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-17792$ALKEM$De Sousa A.. Pregabalin misuse in a 75-year-old woman. Journal of Geriatric Mental Health. 2018;6:26-27$75$YR$$F$Y$$$20240813$$HP$IN$IN
242036431$24203643$1$I$$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158318$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242036442$24203644$2$F$$20240828$20240813$20240902$EXP$ES-EMA-DD-20240808-7482643-110601$ES-ADIENNEP-2024AD000639$ADIENNE PHARMA + BIOTECH$Quintero V, Bueno-Sanchez D, Mozo-Del-Castillo Y, Urtasun-Erburu A, Sisinni L, Lopez-Duarte M et al. Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow Failure. Transplant Cell Ther. 2023;29(10):621.e1-6. DOI: 10.1016/j.jtct.2023.07.011.$9$YR$$M$Y$$$20240829$$MD$ES$ES
242036451$24203645$1$I$$20231025$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66578$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242036461$24203646$1$I$$20231106$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66929$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242036472$24203647$2$F$$20240815$20240813$20240819$PER$$US-AMGEN-USASP2024159007$AMGEN$$$$$F$Y$$$20240818$$HP$US$US
242036481$24203648$1$I$$20231109$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67058$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242036491$24203649$1$I$20240709$20240808$20240813$20240813$EXP$$CO-ABBVIE-5877349$ABBVIE$$65$YR$$M$Y$79$KG$20240813$$HP$CO$CO
242036501$24203650$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875868$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242036512$24203651$2$F$20240730$20240910$20240813$20240919$EXP$$US-TAKEDA-2023TUS122843$TAKEDA$$80$YR$$M$Y$$$20240919$$MD$US$US
242036521$24203652$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039897$AUROBINDO$$66$YR$$M$Y$$$20240813$$HP$CA$CA
242036532$24203653$2$F$20240101$20240812$20240813$20240821$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00870$CATALYST PHARMA$$$$$M$Y$$$20240821$$CN$US$US
242036542$24203654$2$F$$20240814$20240813$20240819$EXP$$US-GILEAD-2024-0683811$GILEAD$$$$A$F$Y$$$20240819$$CN$US$US
242036551$24203655$1$I$$20240808$20240813$20240813$EXP$$US-TAKEDA-2024TUS060255$TAKEDA$$$$$F$Y$83$KG$20240813$$HP$US$US
242036561$24203656$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039875$AUROBINDO$$66$YR$$F$Y$$$20240813$$HP$CA$CA
242036571$24203657$1$I$20240701$20240807$20240813$20240813$EXP$$CL-JNJFOC-20240769533$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240813$$CN$CL$CL
242036581$24203658$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240828350$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$HP$US$US
242036591$24203659$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039789$AUROBINDO$$87$YR$$M$Y$91$KG$20240813$$PH$CA$CA
242036601$24203660$1$I$20240802$20240802$20240813$20240813$EXP$GB-MHRA-MED-202408020906084330-PFLRZ$GB-LUPIN PHARMACEUTICALS INC.-2024-07810$LUPIN$$$$$$Y$$$20240813$$CN$GB$GB
242036611$24203661$1$I$20240805$20240807$20240813$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012029$JAZZ$$18$YR$$M$Y$48.1$KG$20240813$$HP$US$US
242036621$24203662$1$I$$20240731$20240813$20240813$EXP$$GB-AUROBINDO-AUR-APL-2024-038452$AUROBINDO$$$$$M$Y$$$20240813$$CN$GB$GB
242036651$24203665$1$I$20240312$20240809$20240813$20240813$EXP$IT-MINISAL02-998478$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-127206$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240813$$MD$IT$IT
242036661$24203666$1$I$$20240805$20240813$20240813$EXP$$FR-SA-2024SA235117$SANOFI AVENTIS$$$$E$$Y$$$20240813$$HP$FR$FR
242036672$24203667$2$F$20230101$20240806$20240813$20240828$EXP$$US-CHIESI-2024CHF04892$CHIESI$$34$YR$$M$Y$$$20240828$$CN$US$US
242036682$24203668$2$F$20230101$20240806$20240813$20240903$EXP$$US-CHIESI-2024CHF04898$CHIESI$$39$YR$$F$Y$$$20240903$$CN$US$US
242036692$24203669$2$F$$20240819$20240813$20240827$EXP$$JP-TEVA-VS-3230243$TEVA$Nakai K, Sato K, Nohara N, Takagi M, Kihara M, Ueda S, et al. Successful Pregnancy and Delivery in a Chronic Renal Failure Patient with Membranoproliferative Glomerulonephritis and Preeclampsia-related Nephrotic Syndrome. Intern-Med 2024; 63 (14): 2035-2042.; Nakai K, Sato K, Nohara N, Takagi M, Kihara M, Ueda S, et al. Successful Pregnancy and Delivery in a Chronic Renal Failure Patient with Membranoproliferative Glomerulonephritis and Preeclampsia-related Nephrotic Syndrome. Intern-Med 2024...$37$YR$$F$Y$$$20240827$$HP$JP$JP
242036702$24203670$2$F$20240701$20240821$20240813$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003798$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240913$$CN$US$US
242036711$24203671$1$I$20230801$20240807$20240813$20240813$EXP$$BR-TAKEDA-2023TUS090491$TAKEDA$$50$YR$$F$Y$$$20240813$$CN$BR$BR
242036721$24203672$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000055161$ROCHE$$$$$F$Y$$$20240813$$CN$US$US
242036731$24203673$1$I$20240401$20240809$20240813$20240813$EXP$$US-ROCHE-10000054236$ROCHE$$58$YR$A$F$Y$99.79$KG$20240813$$CN$US$US
242036741$24203674$1$I$20240508$20240731$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-038945$AUROBINDO$$64$YR$$M$Y$77$KG$20240813$$MD$FR$FR
242036751$24203675$1$I$$20240802$20240813$20240813$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07429$HIKMA$$$$$F$Y$$$20240813$$CN$US$US
242036771$24203677$1$I$$20240807$20240813$20240813$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15948$IPSEN$$$$$F$Y$$$20240813$$HP$US$US
242036781$24203678$1$I$20240808$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006746$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240813$$CN$US$US
242036791$24203679$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007324$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240813$$CN$US$US
242036802$24203680$2$F$$20240813$20240813$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006683$ELI LILLY AND CO$$52$YR$A$$Y$$$20240814$$HP$US$US
242036811$24203681$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006714$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242036821$24203682$1$I$20240701$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006605$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240813$$CN$US$US
242036831$24203683$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006588$ELI LILLY AND CO$$60$YR$A$$Y$$$20240813$$CN$US$US
242036841$24203684$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006596$ELI LILLY AND CO$$$$$M$Y$$$20240813$$CN$US$US
242036851$24203685$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006467$ELI LILLY AND CO$$$$$F$Y$$$20240813$$PH$US$US
242036861$24203686$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006464$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242036871$24203687$1$I$$20240807$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005270$ELI LILLY AND CO$$$$$$Y$$$20240813$$CN$US$US
242036881$24203688$1$I$$20240807$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005687$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240813$$HP$US$US
242036891$24203689$1$I$$20231110$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67138$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242036901$24203690$1$I$$20231116$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67335$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242036911$24203691$1$I$$20231011$20240813$20240813$PER$$US-APOTEX-2023AP015461$APOTEX$Rodriguez A, Jarrett ZS, Officer L, Kiley J. NONCONVULSIVE STATUS EPILEPTICUS: AN IMPORTANT PRESENTATION OF CEFEPIME-INDUCED NEUROTOXICITY. Chest. 2023;164:4:A2760-A2761$82$YR$$F$Y$$$20240813$$HP$US$US
242036922$24203692$2$F$20240701$20240830$20240813$20240830$PER$$US-ALXN-202408USA000480US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$HP$US$US
242036931$24203693$1$I$20240423$20240802$20240813$20240813$EXP$GB-MHRA-MED-202408012055539780-NRLTM$GB-Accord-440190$ACCORD$$72$YR$E$F$Y$53$KG$20240813$$CN$GB$GB
242036942$24203694$2$F$20230824$20240806$20240813$20240817$EXP$$DE-AUROBINDO-AUR-APL-2024-039187$AUROBINDO$$68$YR$$M$Y$75$KG$20240817$$MD$DE$DE
242036951$24203695$1$I$$20231129$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67784$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242036964$24203696$4$F$20240101$20240904$20240813$20240910$PER$$US-AMGEN-USASP2024160434$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
242036971$24203697$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126926$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240813$$PH$US$US
242036981$24203698$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_07149156$CA-Accord-440142$ACCORD$$14$YR$T$F$Y$$$20240813$$MD$CA$CA
242036991$24203699$1$I$$20240802$20240813$20240813$EXP$GB-MHRA-MIDB-270dfa52-6779-47c6-8a75-d932d3aa103c$GB-Accord-440213$ACCORD$$85$YR$E$$Y$$$20240813$$PH$GB$GB
242037001$24203700$1$I$$20240807$20240813$20240813$EXP$$CA-JAZZ PHARMACEUTICALS-2024-CA-012139$JAZZ$$$$$M$Y$$$20240813$$HP$CA$CA
242037011$24203701$1$I$$20231205$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67899$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242037021$24203702$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000055162$ROCHE$$$$$F$Y$$$20240813$$CN$US$US
242037031$24203703$1$I$$20231205$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67900$HIKMA$$$$$$Y$$$20240812$$MD$US$US
242037041$24203704$1$I$20240630$20240805$20240813$20240813$EXP$$US-JNJFOC-20240812368$JOHNSON AND JOHNSON$$60$YR$A$F$Y$66.2$KG$20240813$$PH$US$US
242037051$24203705$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164005$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
242037061$24203706$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039842$AUROBINDO$$78$YR$$M$Y$$$20240813$$CN$CA$CA
242037081$24203708$1$I$20240517$20240805$20240813$20240813$EXP$FR-AFSSAPS-LL2024001440$FR-TEVA-VS-3230598$TEVA$$76$YR$$M$Y$$$20240813$$PH$FR$FR
242037091$24203709$1$I$$20240807$20240813$20240813$EXP$$AU-TAKEDA-2024TUS079073$TAKEDA$$40$YR$$M$Y$$$20240813$$HP$AU$AU
242037102$24203710$2$F$20240101$20240808$20240813$20240814$EXP$$CA-ABBVIE-5875009$ABBVIE$$56$YR$$M$Y$$$20240814$$CN$CA$CA
242037111$24203711$1$I$$20240807$20240813$20240813$EXP$$CA-ROCHE-10000051233$ROCHE$$$$$$Y$$$20240813$$HP$CA$CA
242037121$24203712$1$I$20240101$20240805$20240813$20240813$PER$$US-ABBVIE-5868550$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242037131$24203713$1$I$20230701$20240805$20240813$20240813$EXP$$PL-TAKEDA-2024TUS079925$TAKEDA$$$$$$Y$$$20240813$$CN$PL$PL
242037141$24203714$1$I$20220101$20240809$20240813$20240813$EXP$$TN-ABBVIE-5875012$ABBVIE$$$$A$F$Y$$$20240813$$CN$TN$TN
242037151$24203715$1$I$$20231226$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-68502$HIKMA$$60$YR$$F$Y$$$20240812$$MD$US$US
242037161$24203716$1$I$$20211228$20240813$20240813$EXP$$CA-AstraZeneca-2022A005559$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$CA$
242037171$24203717$1$I$20240804$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A177580$ASTRAZENECA$$$$$F$Y$$$20240813$$MD$US$
242037191$24203719$1$I$20240703$20240808$20240813$20240813$EXP$$ID-AstraZeneca-2024A182074$ASTRAZENECA$$21998$DY$$M$Y$$$20240813$$CN$ID$
242037201$24203720$1$I$$20240808$20240813$20240813$EXP$$GB-AMGEN-GBRSP2024159524$AMGEN$$59$YR$A$F$Y$$$20240813$$CN$GB$GB
242037212$24203721$2$F$$20240826$20240813$20240904$EXP$$DE-AUROBINDO-AUR-APL-2024-039189$AUROBINDO$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul.. Paul.Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology.. 2024;48 (5):299-313$30$YR$$M$Y$$$20240904$$HP$DE$DE
242037221$24203722$1$I$20240617$20240808$20240813$20240813$EXP$FR-AFSSAPS-PO2024000890$FR-RDY-SPO/FRA/24/0011676$DR REDDYS$$47$YR$A$F$Y$$$20240813$$PH$FR$FR
242037231$24203723$1$I$$20240731$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-039254$AUROBINDO$Antony M, Chaurasia A, Gopal N, Kozel Z, Linehan M, Ball M. Risk of Tumor Recurrence, Functional Decline, and Metastatic Disease of Renal Transplant in Recipients with Hereditary Kidney Cancer: A Case Series. Am-J-Transplant. 2022;22 (Suppl.)965:C213$$$$$Y$$$20240813$$HP$US$US
242037251$24203725$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039848$AUROBINDO$$73$YR$$M$Y$72$KG$20240813$$HP$CA$CA
242037261$24203726$1$I$20240101$20240809$20240813$20240813$EXP$RO-NMA-2024-SP0507$RO-SA-2024SA236230$SANOFI AVENTIS$$27$YR$A$M$Y$65$KG$20240813$$MD$RO$RO
242037271$24203727$1$I$20240201$20240808$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126684$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240813$$CN$US$US
242037282$24203728$2$F$20240815$20240815$20240813$20240903$PER$$US-009507513-2407USA010992$MERCK$$$$E$M$Y$$$20240903$$MD$US$US
242037291$24203729$1$I$20240527$20240812$20240813$20240813$EXP$GB-MHRA-WEBRADR-202406092258419660-VKTJC$GB-SANDOZ INC.-SDZ2024GB056256$SANDOZ$$54$YR$$M$Y$121$KG$20240813$$CN$GB$GB
242037301$24203730$1$I$$20230105$20240813$20240813$EXP$$US-AstraZeneca-2023A003825$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242037312$24203731$2$F$$20240816$20240813$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-039305$AUROBINDO$Field J, Shah ND, Memel Z, Mahadevan U, Beck K. Exclusive Yet Effective: The Crohn^s Disease Exclusion Diet as Treatment for Medication-Refractory Disease. Digestive Diseases and Sciences. 2024;69:1608-1612$19$YR$$F$Y$$$20240829$$HP$US$US
242037321$24203732$1$I$20220531$20240808$20240813$20240813$EXP$$CA-TAKEDA-2024TUS080151$TAKEDA$$44$YR$$F$Y$$$20240813$$MD$CA$CA
242037331$24203733$1$I$20240116$20240808$20240813$20240813$EXP$$CA-TAKEDA-2024TUS005482$TAKEDA$$44$YR$$F$Y$$$20240813$$MD$CA$CA
242037341$24203734$1$I$$20240807$20240813$20240813$EXP$$CA-TAKEDA-2024TUS079544$TAKEDA$$$$$F$Y$$$20240813$$CN$CA$CA
242037351$24203735$1$I$$20230929$20240813$20240813$EXP$$US-AstraZeneca-2023A187726$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242037361$24203736$1$I$20240725$20240807$20240813$20240813$EXP$$CA-TAKEDA-2024TUS079616$TAKEDA$$51$YR$$M$Y$$$20240813$$CN$CA$CA
242037371$24203737$1$I$20240501$20240809$20240813$20240813$EXP$$US-ABBVIE-5876163$ABBVIE$$60$YR$$F$Y$$$20240813$$CN$US$US
242037381$24203738$1$I$20240804$20240806$20240813$20240813$EXP$$CN-BEIGENE-BGN-2024-012275$BEIGENE$$$$$$Y$$$20240813$$HP$CN$CN
242037391$24203739$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024160362$AMGEN$$$$$$Y$$$20240813$$HP$US$US
242037402$24203740$2$F$$20240819$20240813$20240826$EXP$$US-TEVA-VS-3230919$TEVA$Moore M, King SI, Aschner Y. Endobronchial Mucormycosis Presenting as Stridor in a Diabetic Adult. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A7420.; Moore M, King SI, Aschner Y. Endobronchial Mucormycosis Presenting as Stridor in a Diabetic Adult. Am-J-Respir-Crit-Care-Med 2024; 209 abstr. A7420.$49$YR$$M$Y$$$20240826$$HP$US$US
242037411$24203741$1$I$$20240805$20240813$20240813$EXP$$CA-TAKEDA-2024TUS078934$TAKEDA$$$$$F$Y$$$20240813$$CN$CA$CA
242037421$24203742$1$I$$20240424$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03694$HIKMA$$$$$$Y$$$20240812$$HP$US$US
242037431$24203743$1$I$$20240718$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05586$HIKMA$$$$$M$Y$$$20240812$$HP$US$US
242037441$24203744$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126903$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240813$$PH$US$US
242037452$24203745$2$F$$20240815$20240813$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126976$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240816$$CN$US$US
242037461$24203746$1$I$$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125739$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240813$$CN$US$US
242037471$24203747$1$I$$20240808$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126802$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240813$$CN$US$US
242037481$24203748$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240827650$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$MD$US$US
242037491$24203749$1$I$20230601$20240809$20240813$20240813$PER$$PR-JNJFOC-20240827814$JOHNSON AND JOHNSON$$69$YR$E$M$Y$81$KG$20240813$$CN$PR$PR
242037501$24203750$1$I$$20240718$20240813$20240813$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05624$HIKMA$$$$$F$Y$$$20240812$$CN$US$US
242037511$24203751$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039806$AUROBINDO$$88$YR$$M$Y$83$KG$20240813$$PH$CA$CA
242037522$24203752$2$F$20210215$20240816$20240813$20240826$EXP$PT-INFARMED-M202210-491$PT-GILEAD-2024-0683822$GILEAD$$82$YR$E$M$Y$$$20240826$$MD$PT$PT
242037532$24203753$2$F$20240823$20240823$20240813$20240828$EXP$$CA-TAKEDA-2023TUS094241$TAKEDA$$35$YR$$M$Y$$$20240828$$CN$CA$CA
242037551$24203755$1$I$20240506$20240805$20240813$20240813$EXP$SE-SEMPA-2024-005742$SE-TEVA-VS-3230588$TEVA$$31$YR$$M$Y$$$20240813$$MD$SE$SE
242037561$24203756$1$I$20240706$20240803$20240813$20240813$EXP$GB-MHRA-MED-202408032339429080-BFPVN$GB-TEVA-VS-3229934$TEVA$$13$YR$$F$Y$40$KG$20240813$$CN$GB$GB
242037571$24203757$1$I$$20240806$20240813$20240813$EXP$$BR-TAKEDA-2024TUS079992$TAKEDA$$$$$$Y$$$20240813$$CN$BR$BR
242037581$24203758$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07441$HIKMA$$$$$$Y$$$20240813$$CN$CA$CA
242037591$24203759$1$I$$20240730$20240813$20240813$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-02316$HIKMA$$86$YR$$F$Y$$$20240813$$MD$US$US
242037602$24203760$2$F$20240101$20240820$20240813$20240830$PER$$US-ABBVIE-5868337$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242037611$24203761$1$I$$20240806$20240813$20240813$EXP$$BR-TAKEDA-2024TUS079660$TAKEDA$$$$E$M$Y$$$20240813$$CN$BR$BR
242037622$24203762$2$F$20240726$20240812$20240813$20240816$EXP$FR-AFSSAPS-PO2024000865$NVSC2024FR163265$NOVARTIS$$54$YR$$M$Y$52$KG$20240816$$MD$FR$FR
242037635$24203763$5$F$$20240923$20240813$20240924$PER$$NVSC2024US163292$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
242037641$24203764$1$I$20230101$20240808$20240813$20240813$PER$$US-ABBVIE-5873561$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242037656$24203765$6$F$20240701$20240921$20240813$20240925$EXP$$NVSC2024CA156094$NOVARTIS$$50$YR$$F$Y$$$20240925$$CN$CA$CA
242037661$24203766$1$I$20100215$20240730$20240813$20240813$EXP$$US-ACORDA-ACO_177730_2024$ACORDA$$49$YR$$F$Y$$$20240813$$CN$US$US
242037671$24203767$1$I$$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160080$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242037681$24203768$1$I$$20240809$20240813$20240813$PER$$US-TAKEDA-2024TUS080183$TAKEDA$$$$$$Y$$$20240813$$CN$US$US
242037691$24203769$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039764$AUROBINDO$$64$YR$$M$Y$52$KG$20240813$$HP$CA$CA
242037701$24203770$1$I$$20240726$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202407018186$ELI LILLY AND CO$$57$YR$A$$Y$$$20240813$$CN$US$US
242037711$24203771$1$I$20240101$20240808$20240813$20240813$PER$$US-ABBVIE-5875394$ABBVIE$$$$$M$Y$69.399$KG$20240813$$CN$US$US
242037721$24203772$1$I$$20240806$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408004992$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240813$$CN$US$US
242037731$24203773$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039940$AUROBINDO$$56$YR$$F$Y$42$KG$20240813$$HP$CA$CA
242037741$24203774$1$I$20240401$20240807$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005523$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240813$$CN$US$US
242037751$24203775$1$I$$20240731$20240813$20240813$EXP$$GB-AUROBINDO-AUR-APL-2024-038430$AUROBINDO$$$$$F$Y$$$20240813$$CN$GB$GB
242037771$24203777$1$I$20240711$20240730$20240813$20240813$EXP$$US-ACORDA-ACO_177702_2024$ACORDA$$75$YR$$M$Y$$$20240813$$CN$US$US
242037783$24203778$3$F$$20240812$20240813$20240823$EXP$$US-FARMAPROD-202407-2741$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240823$$CN$US$US
242037791$24203779$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039893$AUROBINDO$$34$YR$$F$Y$70$KG$20240813$$HP$CA$CA
242037801$24203780$1$I$20240731$20240812$20240813$20240813$EXP$FR-AFSSAPS-ST2024001288$FR-GILEAD-2024-0683847$GILEAD$$29$YR$A$M$Y$$$20240813$$MD$FR$FR
242037811$24203781$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07559$HIKMA$$$$$$Y$$$20240813$$MD$CA$CA
242037821$24203782$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127439$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240813$$HP$US$US
242037831$24203783$1$I$$20240729$20240813$20240813$EXP$$US-PROVEPHARM, INC.-2024-APO-000075$APOLLO PHARMACEUTICALS$Chajkowski A, Rodriguez CA. Clostridium Difficile Bacteremia: Going Beyond the Gut. American Journal of Respiratory and Critical Care Medicine.. 2024;209:A1660$$$$$Y$$$20240813$$MD$US$US
242037841$24203784$1$I$$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126169$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$64.41$KG$20240813$$CN$US$US
242037851$24203785$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126543$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240813$$HP$US$US
242037861$24203786$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127148$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240813$$CN$US$US
242037871$24203787$1$I$20240806$20240809$20240813$20240813$PER$$US-JNJFOC-20240826573$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240813$$CN$US$US
242037882$24203788$2$F$20240808$20240813$20240813$20240814$PER$$US-AMGEN-USASP2024159942$AMGEN$$72$YR$E$F$Y$$$20240814$$CN$US$US
242037892$24203789$2$F$$20240812$20240813$20240819$PER$$US-APOTEX-2024AP009178$APOTEX$Mess SA, Stephanos KN.. Temperance With Tranexamic Acid: Increased Risk of Venous Thromboembolism in Abdominoplasty. Aesthetic Surgery Journal Open Forum. 2024;6 (ojae044):1-6$56$YR$$F$Y$$$20240819$$MD$US$US
242037901$24203790$1$I$$20240807$20240813$20240813$PER$$US-BAUSCHBL-2024BNL031330$BAUSCH AND LOMB$$$$$F$Y$$$20240813$$CN$US$US
242037912$24203791$2$F$$20240821$20240813$20240823$PER$$US-ROCHE-10000052245$ROCHE$$$$$$Y$$$20240823$$HP$US$US
242037921$24203792$1$I$$20240805$20240813$20240813$EXP$$IN-ROCHE-3391756$ROCHE$$60$YR$A$F$Y$$$20240813$$MD$IN$IN
242037931$24203793$1$I$$20240808$20240813$20240813$PER$$US-ROCHE-10000052975$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
242037941$24203794$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039761$AUROBINDO$$58$YR$$F$Y$$$20240813$$HP$CA$CA
242037951$24203795$1$I$$20220425$20240813$20240813$EXP$$US-AstraZeneca-2022A164603$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242037961$24203796$1$I$$20240228$20240813$20240813$EXP$$TH-AstraZeneca-2023A250949$ASTRAZENECA$$$$$M$Y$$$20240813$$HP$TH$
242037971$24203797$1$I$$20240806$20240813$20240813$EXP$$DE-AstraZeneca-2024A178655$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$DE$
242037981$24203798$1$I$$20230420$20240813$20240813$EXP$$US-AstraZeneca-2023A094835$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242037991$24203799$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A178857$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242038001$24203800$1$I$$20220816$20240813$20240813$EXP$$US-AstraZeneca-2022A290394$ASTRAZENECA$$$$$F$Y$$$20240813$$HP$US$
242038011$24203801$1$I$$20240805$20240813$20240813$EXP$$VN-AstraZeneca-2024A182202$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$VN$
242038031$24203803$1$I$$20240710$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06989$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242038042$24203804$2$F$$20240912$20240813$20240916$PER$$US-ROCHE-10000054819$ROCHE$$$$A$F$Y$$$20240916$$CN$US$US
242038051$24203805$1$I$20240715$20240808$20240813$20240813$PER$$US-ROCHE-10000053997$ROCHE$$$$$F$Y$$$20240813$$CN$US$US
242038062$24203806$2$F$20240805$20240813$20240813$20240814$EXP$$US-ROCHE-10000055239$ROCHE$$$$$F$Y$$$20240814$$CN$US$US
242038071$24203807$1$I$$20240808$20240813$20240813$PER$$US-ROCHE-10000053245$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
242038082$24203808$2$F$$20240813$20240813$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07073$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242038092$24203809$2$F$20240809$20240814$20240813$20240823$PER$$US-AMGEN-USASP2024160086$AMGEN$$56$YR$A$M$Y$$$20240822$$CN$US$US
242038101$24203810$1$I$$20240807$20240813$20240813$PER$$US-HALEON-2191139$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242038111$24203811$1$I$$20240807$20240813$20240813$PER$$US-AMGEN-USASP2024157711$AMGEN$$$$$F$Y$$$20240813$$MD$US$US
242038121$24203812$1$I$$20240809$20240813$20240813$PER$$US-TAKEDA-2024TUS080383$TAKEDA$$$$$F$Y$$$20240813$$CN$US$US
242038131$24203813$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000054291$ROCHE$$$$E$M$Y$$$20240813$$CN$US$US
242038151$24203815$1$I$$20240807$20240813$20240813$EXP$$NL-ABBVIE-5874909$ABBVIE$$$$E$M$Y$$$20240813$$CN$NL$NL
242038162$24203816$2$F$$20240812$20240813$20240813$PER$$NVSC2024US164073$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
242038171$24203817$1$I$20240802$20240806$20240813$20240813$EXP$$CN-ROCHE-10000050398$ROCHE$$50$YR$A$F$Y$61$KG$20240813$$HP$CN$CN
242038181$24203818$1$I$20240702$20240805$20240813$20240813$EXP$FR-AFSSAPS-SE2024000627$FR-ROCHE-10000049625$ROCHE$$51$YR$A$F$Y$84$KG$20240813$$MD$FR$FR
242038201$24203820$1$I$$20240810$20240813$20240813$PER$$US-JNJFOC-20240827934$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$CN$US$US
242038215$24203821$5$F$$20240828$20240813$20240907$EXP$$PT-AUROBINDO-AUR-APL-2024-039050$AUROBINDO$Almeida R, Sitari C, Patraquim A, et al.. PO-0611 - (2544) - Trombocitopenia induzida por azitromicina - a prop?sito de um caso cl?nico. Congressos da Sociedade Portuguesa de Medicina Interna: 30.?. Congresso Nacional de Medicina Interna - Livro de resumos.. 2024;957$79$YR$$F$Y$$$20240907$$MD$PT$PT
242038221$24203822$1$I$20231113$20240812$20240813$20240813$EXP$$FR-GILEAD-2024-0683820$GILEAD$$28$YR$A$M$Y$88$KG$20240813$$MD$FR$FR
242038231$24203823$1$I$20240618$20240802$20240813$20240813$EXP$$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07508$HIKMA$$52$YR$$F$Y$73.5$KG$20240813$$PH$FR$FR
242038241$24203824$1$I$20230829$20240805$20240813$20240813$EXP$CH-SM-2024-14532$CH-CHEPLA-2024010269$CHEPLAPHARM$$21$YR$$M$Y$$$20240813$$PH$COUNTRY NOT SPECIFIED$CH
242038252$24203825$2$F$$20240812$20240813$20240820$PER$$US-APOTEX-2024AP009179$APOTEX$Mess SA, Stephanos KN.. Temperance With Tranexamic Acid: Increased Risk of Venous Thromboembolism in Abdominoplasty. Aesthetic Surgery Journal Open Forum. 2024;6 (ojae044):1-6$59$YR$$F$Y$$$20240820$$MD$US$US
242038263$24203826$3$F$$20240731$20240813$20240814$EXP$$US-AUROBINDO-AUR-APL-2023-075651$AUROBINDO$Grissett B, Sosa-Pagan M, Iqbal QZ.. Topiramate causing elevation of urinary cortisol assay.. Journal of the Endocrine Society. 2022;6 (supp. 1):A66-7$69$YR$$F$Y$105$KG$20240814$$MD$US$US
242038271$24203827$1$I$20240710$20240729$20240813$20240813$EXP$$BR-PHATHOM PHARMACEUTICALS INC.-2024PHT00698$Phathom Pharmaceuticals$$57$YR$$F$Y$90$KG$20240813$$CN$BR$BR
242038282$24203828$2$F$$20240813$20240813$20240828$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462176$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$48$YR$$F$Y$$$20240828$$HP$DK$DK
242038291$24203829$1$I$$20240709$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07113$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242038301$24203830$1$I$$20240806$20240813$20240813$EXP$$CA-TEVA-VS-3231205$TEVA$$$$$$Y$$$20240813$$CN$CA$CA
242038311$24203831$1$I$$20240809$20240813$20240813$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-127212$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240813$$CN$PR$PR
242038321$24203832$1$I$20240803$20240812$20240813$20240813$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-127266$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$77.56$KG$20240813$$CN$PR$PR
242038331$24203833$1$I$$20240807$20240813$20240813$PER$$US-ROCHE-10000052488$ROCHE$$60$YR$A$F$Y$$$20240813$$MD$US$US
242038342$24203834$2$F$20240807$20240911$20240813$20240912$PER$$US-AMGEN-USASP2024158940$AMGEN$$88$YR$E$M$Y$$$20240912$$CN$US$US
242038351$24203835$1$I$$20240806$20240813$20240813$EXP$$US-ARGENX-2024-ARGX-US006447$ARGENX BVBA$$$$$$Y$$$20240813$$CN$US$US
242038362$24203836$2$F$$20240729$20240813$20240831$PER$$US-TEVA-VS-3228097$TEVA$$47$YR$$F$Y$$$20240831$$HP$US$US
242038371$24203837$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07560$HIKMA$$$$$$Y$$$20240813$$MD$CA$CA
242038383$24203838$3$F$$20240731$20240813$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-038991$AUROBINDO$Tatarinova OS, Furness CL, Borman AM, Barber J, Muthialu N, Ferreras-Antolin L. Neosartorya udagawae pulmonary infection requiring a surgical treatment in a paediatric haematopoietic progenitor cell recipient. Med-Mycol-Case-Reports. 2024;44:1-4$3$YR$$M$Y$$$20240814$$HP$GB$GB
242038391$24203839$1$I$$20240805$20240813$20240813$EXP$$FR-TEVA-VS-3231768$TEVA$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2023; 35 (1): 54-59.$18$YR$$M$Y$$$20240813$$HP$FR$FR
242038401$24203840$1$I$$20240809$20240813$20240813$PER$$US-HALEON-2191450$Haleon PLC$$19$YR$$M$Y$$$20240813$$HP$US$US
242038412$24203841$2$F$$20240821$20240813$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125182$BRISTOL MYERS SQUIBB$$7$DEC$$$Y$$$20240827$$MD$JP$JP
242038421$24203842$1$I$20220701$20240805$20240813$20240813$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-126063$BRISTOL MYERS SQUIBB$Yamada K, Nakao M, Yoshikawa K, Sadahiro H, Karita M, Manabe Y, et al. A case of palliative radiotherapy for headache due to postoperative skull metastasis of pancreatic cancer. Palliative Care Research. 2024 Jan 01;19(1):41-6.$67$YR$E$F$Y$47.8$KG$20240813$$MD$JP$JP
242038441$24203844$1$I$20240804$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158530$AMGEN$$56$YR$A$F$Y$$$20240813$$CN$US$US
242038451$24203845$1$I$20240806$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160342$AMGEN$$48$YR$A$F$Y$$$20240813$$CN$US$US
242038463$24203846$3$F$20240811$20240828$20240813$20240830$PER$$US-AMGEN-USASP2024160093$AMGEN$$70$YR$E$M$Y$$$20240829$$CN$US$US
242038472$24203847$2$F$20240809$20240813$20240813$20240814$PER$$US-AMGEN-USASP2024160022$AMGEN$$59$YR$A$F$Y$$$20240814$$CN$US$US
242038481$24203848$1$I$$20240802$20240813$20240813$PER$$US-ROCHE-10000049559$ROCHE$$$$$F$Y$$$20240813$$CN$US$US
242038491$24203849$1$I$20240701$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159255$AMGEN$$77$YR$E$F$Y$$$20240813$$HP$US$US
242038501$24203850$1$I$20240615$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180730$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242038511$24203851$1$I$$20230725$20240813$20240813$EXP$$US-AstraZeneca-2023A137167$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242038521$24203852$1$I$$20240807$20240813$20240813$EXP$$US-ABBVIE-5871786$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242038531$24203853$1$I$$20231011$20240813$20240813$EXP$$US-AstraZeneca-2023A232064$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242038541$24203854$1$I$20240201$20240806$20240813$20240813$EXP$$DE-JNJFOC-20240819386$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240813$$HP$DE$DE
242038551$24203855$1$I$$20240805$20240813$20240813$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009994$STRIDES$Patel R, Elghawy O, Gibbs A, Gupta S, Kaur V.. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma.. Cancer-Rep. 2024;7 (7):e2110$$$$$Y$$$20240813$$HP$US$US
242038561$24203856$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240827774$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$CN$US$US
242038571$24203857$1$I$$20240805$20240813$20240813$EXP$$SG-IPCA LABORATORIES LIMITED-IPC-2024-SG-002009$IPCA$Denise T.M. Au Eong , Ryan L.J. Chiew and Kah-Guan Au Eong. Delayed-onset hypnopompic visual hallucinations 20 years after initiation  of propranolol therapy for systemic hypertension: a case report. American Journal of Case Reports. 2024;25(e944342):1-4$$$$$Y$$$20240813$$HP$SG$SG
242038581$24203858$1$I$$20240801$20240813$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-127631$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$68$KG$20240813$$HP$CA$CA
242038591$24203859$1$I$$20240729$20240813$20240813$PER$$US-TEVA-VS-3228112$TEVA$$$$$$Y$$$20240813$$HP$US$US
242038601$24203860$1$I$$20240805$20240813$20240813$EXP$$NL-TEVA-VS-3231775$TEVA$Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, et al. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series. J-Neurol 2024; 271 4028-4038.; Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, et al. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series. J-Neurol 2024; 271 4028-4038.$27$MON$$M$Y$$$20240813$$HP$NL$NL
242038611$24203861$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07561$HIKMA$$$$$$Y$$$20240813$$MD$CA$CA
242038621$24203862$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006947$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240813$$CN$US$US
242038631$24203863$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006773$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240813$$CN$US$US
242038641$24203864$1$I$20240811$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007182$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240813$$CN$US$US
242038651$24203865$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005692$ELI LILLY AND CO$$55$YR$A$$Y$$$20240813$$LW$US$US
242038661$24203866$1$I$20240808$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006478$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240813$$CN$US$US
242038671$24203867$1$I$20240809$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006576$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240813$$CN$US$US
242038681$24203868$1$I$20240808$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006356$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240813$$CN$US$US
242038691$24203869$1$I$20240701$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006321$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240813$$CN$US$US
242038701$24203870$1$I$20240629$20240812$20240813$20240813$EXP$ES-AEMPS-1557772$ES-GILEAD-2024-0683835$GILEAD$$61$YR$A$F$Y$$$20240813$$MD$ES$ES
242038711$24203871$1$I$20240808$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005973$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240813$$HP$US$US
242038721$24203872$1$I$$20240802$20240813$20240813$EXP$$JP-NOVAST LABORATORIES INC.-2024NOV000288$NOVAST$Marunaka Y, Ohashi T, Kubota T, Nishibeppu K, Konishi H, Shiozaki A,et,all.. Dropped head syndrome suspected due to oxaliplatin used in adjuvant chemotherapy for gastric cancer: a case report. Surg Case Rep. 2024;10$72$YR$$M$Y$60.7$KG$20240813$$HP$JP$JP
242038731$24203873$1$I$$20240802$20240813$20240813$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000289$NOVAST$Qian YF, Chen HP, Ren GF. Acute therapy-related myelodysplastic syndromes following capecitabine and oxaliplatin therapy in gastric malignant tumor A case report. A case report. Medicine. 2024;103(30)$60$YR$$M$Y$$$20240813$$HP$CN$CN
242038742$24203874$2$F$20230101$20240806$20240813$20240903$EXP$$US-CHIESI-2024CHF04900$CHIESI$$23$YR$$M$Y$$$20240903$$CN$US$US
242038751$24203875$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5806268$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242038761$24203876$1$I$$20240806$20240813$20240813$EXP$$US-ROCHE-10000050557$ROCHE$$61$YR$A$M$Y$93.89$KG$20240813$$HP$US$US
242038772$24203877$2$F$20240725$20240916$20240813$20240920$EXP$$NVSC2024US153263$NOVARTIS$$42$YR$$F$Y$$$20240920$$CN$US$US
242038781$24203878$1$I$20240101$20240809$20240813$20240813$EXP$$US-ABBVIE-5875193$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242038791$24203879$1$I$20240718$20240801$20240813$20240813$EXP$$IT-AUROBINDO-AUR-APL-2024-039513$AUROBINDO$$65$YR$$F$Y$60$KG$20240813$$MD$IT$IT
242038812$24203881$2$F$20240806$20240911$20240813$20240917$EXP$$JP-ABBVIE-5877666$ABBVIE$$$$E$$Y$$$20240917$$MD$JP$JP
242038821$24203882$1$I$20240711$20240729$20240813$20240813$PER$$US-GRANULES-US-2024GRASPO00342$GRANULES INDIA$$$$$F$Y$$$20240813$$CN$US$US
242038831$24203883$1$I$$20240709$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07085$LUPIN$$$$$$Y$$$20240813$$HP$US$US
242038841$24203884$1$I$$20240801$20240813$20240813$EXP$$PT-AUROBINDO-AUR-APL-2024-037127$AUROBINDO$Teixeira CM, Amaro AM, Dias A, Brito A, Duarte A.. Drug-induced injury secondary to terbinafine. (Drug-induced injury secondary to terbinafine). Italian Medical Journal Archive for Medical Sciences. 2024;183(4):364-66$92$YR$$M$Y$$$20240813$$MD$PT$PT
242038851$24203885$1$I$20240702$20240806$20240813$20240813$EXP$FR-AFSSAPS-PA2024001389$FR-ROCHE-10000050838$ROCHE$$21$YR$A$M$Y$71.4$KG$20240813$$MD$FR$FR
242038861$24203886$1$I$$20240806$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125116$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240813$$CN$US$US
242038871$24203887$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126924$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240813$$CN$US$US
242038881$24203888$1$I$20240101$20240805$20240813$20240813$EXP$$US-TEVA-VS-3231308$TEVA$$15$YR$$M$Y$$$20240813$$MD$US$US
242038891$24203889$1$I$20240101$20240809$20240813$20240813$PER$$US-JNJFOC-20240828847$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240813$$CN$US$US
242038901$24203890$1$I$20240717$20240809$20240813$20240813$EXP$FR-AFSSAPS-RE2024000806$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-127085$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$74.5$KG$20240813$$PH$FR$FR
242038912$24203891$2$F$20240807$20240815$20240813$20240820$PER$$US-AMGEN-USASP2024158568$AMGEN$$66$YR$E$F$Y$46.85$KG$20240820$$PH$US$US
242038921$24203892$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024160443$AMGEN$$$$$$Y$$$20240813$$CN$US$US
242038931$24203893$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024160363$AMGEN$$$$$$Y$$$20240813$$CN$US$US
242038941$24203894$1$I$$20240812$20240813$20240813$PER$$US-ROCHE-10000054539$ROCHE$Daftary K, Zamora E, Malone J, Callen J. Cutaneous Plasmacytosis Treated with Tocilizumab. Clinical and experimental dermatology. 2024;1-13. doi:10.1093/ced/llae290.$6$DEC$A$F$Y$$$20240813$$HP$US$US
242038951$24203895$1$I$$20240731$20240813$20240813$EXP$$DE-AUROBINDO-AUR-APL-2024-039076$AUROBINDO$$$$A$M$Y$$$20240813$$MD$DE$DE
242038982$24203898$2$F$$20240823$20240813$20240828$EXP$$RO-ROCHE-10000049483$ROCHE$Chitoran E, Rotaru V, Ionescu S, Gelal A, Capsa C, Bohiltea R, et al. Bevacizumab-Based Therapies in Malignant Tumors - Real-World Data on Effectiveness, Safety, and Cost. Cancers. 2024-Jul-19;16 (14):1-20. doi:10.3390/cancers16142590.$$$$$Y$$$20240828$$HP$RO$RO
242038991$24203899$1$I$$20240731$20240813$20240813$EXP$$GB-AUROBINDO-AUR-APL-2024-038790$AUROBINDO$$$$$$Y$$$20240813$$PH$GB$GB
242039011$24203901$1$I$$20240801$20240813$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122394$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240813$$HP$CA$CA
242039033$24203903$3$F$$20240823$20240813$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07095$LUPIN$$$$$$Y$$$20240912$$CN$US$US
242039042$24203904$2$F$20240514$20240909$20240813$20240913$EXP$$NVSC2024US162698$NOVARTIS$$80$YR$$F$Y$57.15$KG$20240913$$CN$US$US
242039053$24203905$3$F$$20240916$20240813$20240923$PER$$NVSC2024US163416$NOVARTIS$$$$$M$Y$94.331$KG$20240923$$CN$US$US
242039061$24203906$1$I$$20240806$20240813$20240813$PER$$US-ABBVIE-5870723$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242039071$24203907$1$I$20240809$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024159964$AMGEN$$65$YR$E$M$Y$$$20240813$$PH$US$US
242039081$24203908$1$I$$20240808$20240813$20240813$EXP$$US-SHIRE-US202015178$TAKEDA$$$$$F$Y$$$20240813$$MD$US$US
242039091$24203909$1$I$20240101$20240805$20240813$20240813$EXP$$US-SA-2024SA234352$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240813$$MD$US$US
242039111$24203911$1$I$$20240730$20240813$20240813$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110720$ZYDUS PHARM$Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwari A. Overwhelming cytochrome p450 isoenzyme activity generating druginduced liver injury resulting in fulminant liver failure.. Hepatology. 2023;78 (Suppl.):S643-S644$$$$$Y$$$20240813$$HP$US$US
242039131$24203913$1$I$$20240730$20240813$20240813$EXP$$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-110696$ZYDUS PHARM$Garcia Velasco G. Dia 69.. Se ha movido el silencio.. AMF. 2024;20(7):1$$$$$Y$$$20240813$$MD$ES$ES
242039142$24203914$2$F$20230101$20240805$20240813$20240903$EXP$$US-CHIESI-2024CHF04869$CHIESI$$34$YR$$F$Y$$$20240903$$CN$US$US
242039151$24203915$1$I$20240807$20240808$20240813$20240813$EXP$$CN-SPECGX-T202401710$SPECGX$$23$YR$$F$Y$53$KG$20240813$$CN$CN$CN
242039161$24203916$1$I$20240201$20240806$20240813$20240813$EXP$$US-SA-2024SA238874$SANOFI AVENTIS$$60$YR$A$F$Y$84.8$KG$20240813$$MD$US$US
242039172$24203917$2$F$$20240814$20240813$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07049$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242039192$24203919$2$F$$20240819$20240813$20240826$EXP$$NL-TEVA-VS-3231774$TEVA$Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, et al. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series. J-Neurol 2024; 271 4028-4038.; Beerepoot S, Boelens JJ, Lindemans C, de Witte MA, Nierkens S, Vrancken AFJE, et al. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series. J-Neurol 2024; 271 4028-4038.; Beere...$34$MON$$F$Y$$$20240826$$HP$NL$NL
242039201$24203920$1$I$$20240805$20240813$20240813$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010001$STRIDES$Yamamoto H, Kuroda H, Hiramoto N, Hasuike T, Doi A, Nishioka H.. Successful maintenance treatment of disseminated nocardiosis with cerebral abscess in a severely immunocompromised patient allergic to trimethoprim-sulfamethoxazole using moxifloxacin and high-dose minocycline: A case report. J-Infect-Chemother. 2024$60$YR$$M$Y$$$20240813$$HP$JP$JP
242039214$24203921$4$F$$20240904$20240813$20240912$EXP$$BR-TAKEDA-BR201943849$TAKEDA$$$$$F$Y$50$KG$20240912$$MD$BR$BR
242039221$24203922$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039819$AUROBINDO$$82$YR$$F$Y$72$KG$20240813$$HP$CA$CA
242039231$24203923$1$I$20240605$20240805$20240813$20240813$EXP$IT-MINISAL02-995859$IT-TEVA-VS-3230971$TEVA$$79$YR$$F$Y$$$20240813$$MD$IT$IT
242039242$24203924$2$F$$20240819$20240813$20240826$EXP$$US-TEVA-VS-3230850$TEVA$Bharucha K. Multisystemic Sarcoidosis Culminating in Asymptomatic Complete Heart Block. Am-J-Respir-Crit-Care-Med 2024; 209.; Bharucha K. Multisystemic Sarcoidosis Culminating in Asymptomatic Complete Heart Block. Am-J-Respir-Crit-Care-Med 2024; 209.$$$$M$Y$$$20240826$$HP$US$US
242039251$24203925$1$I$20240729$20240806$20240813$20240813$EXP$$CN-ORGANON-O2408CHN000665$ORGANON$$61$YR$$M$Y$65.6$KG$20240813$$HP$CN$CN
242039261$24203926$1$I$$20240808$20240813$20240813$PER$$US-HALEON-2191187$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242039271$24203927$1$I$20220101$20240807$20240813$20240813$EXP$$CA-Orion Corporation ORION PHARMA-24_00031249$ORION$$54$YR$A$F$Y$$$20240813$$HP$CA$
242039282$24203928$2$F$20240701$20240807$20240813$20240814$EXP$$UY-BRISTOL-MYERS SQUIBB COMPANY-2024-126240$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240814$$HP$UY$UY
242039291$24203929$1$I$$20240805$20240813$20240813$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010004$STRIDES$Hernandez K, Ahmed T, Liu D, Seiter K, Steinberg A.. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients.. Blood. 2023;142 (Suppl. 1):7349-7350.$28$YR$$M$Y$$$20240813$$HP$US$US
242039301$24203930$1$I$20240723$20240808$20240813$20240813$EXP$IT-MINISAL02-997793$IT-SA-2024SA238431$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240813$$PH$IT$IT
242039313$24203931$3$F$20240821$20240830$20240813$20240910$PER$$US-AMGEN-USASP2024160075$AMGEN$$33$YR$A$F$Y$$$20240910$$CN$US$US
242039322$24203932$2$F$$20240904$20240813$20240905$30DAY$$US-ELI_LILLY_AND_COMPANY-US202408007301$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240905$$CN$US$US
242039341$24203934$1$I$$20240805$20240813$20240813$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009983$STRIDES$Lee J, Casey E, Otigbah C, Tompsett MK, Pittathankal A, Sirkova A, et al.. Hyperparathyroidism Causing life Threatening Hypercalcaemia in Pregnancy.. J-Endocr-Soc. 2022;6 (Suppl. 1):A166-A167$31$YR$$F$Y$$$20240813$$HP$US$US
242039351$24203935$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006602$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242039361$24203936$1$I$$20240807$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005001$ELI LILLY AND CO$$42$YR$A$$Y$$$20240813$$LW$US$US
242039371$24203937$1$I$$20240805$20240813$20240813$EXP$$US-TERSERA THERAPEUTICS LLC-2024TRS003953$TERSERA THERAPEUTICS$$$$$$Y$$$20240813$$MD$US$US
242039382$24203938$2$F$20240711$20240801$20240813$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010845$JAZZ$$32$YR$$F$Y$$$20240813$$CN$US$US
242039401$24203940$1$I$$20240805$20240813$20240813$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010005$STRIDES$Hernandez K, Ahmed T, Liu D, Seiter K, Steinberg A.. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients.. Blood. 2023;142 (Suppl. 1):7349-7350$37$YR$$M$Y$$$20240813$$HP$US$US
242039411$24203941$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240824627$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$MD$US$US
242039422$24203942$2$F$$20240813$20240813$20240814$PER$$US-AMGEN-USASP2024160073$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242039431$24203943$1$I$20240809$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006784$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240813$$CN$US$US
242039441$24203944$1$I$20240720$20240805$20240813$20240813$EXP$$CN-JNJFOC-20240814163$JOHNSON AND JOHNSON$$70$YR$E$F$Y$62.5$KG$20240813$$HP$CN$CN
242039451$24203945$1$I$$20240709$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07024$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242039461$24203946$1$I$$20240806$20240813$20240813$PER$$US-009507513-2408USA002365$MERCK$$$$$F$Y$$$20240813$$CN$US$US
242039471$24203947$1$I$$20240805$20240813$20240813$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009985$STRIDES$Lee J, Casey E, Otigbah C, Tompsett MK, Pittathankal A, Sirkova A, et al.. Hyperparathyroidism Causing life Threatening Hypercalcaemia in Pregnancy.. J-Endocr-Soc. 2022;6 (Suppl. 1):A166-A167$$$$M$Y$$$20240813$$HP$US$US
242039481$24203948$1$I$$20240807$20240813$20240813$EXP$$US-ABBVIE-5867153$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242039491$24203949$1$I$$20240808$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127481$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240813$$CN$US$US
242039501$24203950$1$I$$20240805$20240813$20240813$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP010086$STRIDES$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al.. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy.. Circ-Genom-Precis-Med. 2024;17 (2):E004353.$12$YR$$F$Y$$$20240813$$MD$IT$IT
242039511$24203951$1$I$$20240806$20240813$20240813$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010146$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$42$YR$$M$Y$$$20240813$$HP$NL$NL
242039521$24203952$1$I$20240101$20240807$20240813$20240813$PER$$US-AMGEN-USASP2024157809$AMGEN$$70$YR$E$F$Y$$$20240813$$HP$US$US
242039531$24203953$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039910$AUROBINDO$$$$$F$Y$$$20240813$$MD$CA$CA
242039541$24203954$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039858$AUROBINDO$$70$YR$$F$Y$97$KG$20240813$$HP$CA$CA
242039581$24203958$1$I$$20240806$20240813$20240813$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010024$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$45$YR$$M$Y$$$20240813$$HP$NL$NL
242039591$24203959$1$I$20230101$20240805$20240813$20240813$EXP$FR-AFSSAPS-AM2024000614$FR-TEVA-VS-3230418$TEVA$$72$YR$$F$Y$70$KG$20240813$$MD$FR$FR
242039604$24203960$4$F$20240104$20240913$20240813$20240919$EXP$$AR-MYLANLABS-2024M1001927$MYLAN$$38$YR$$M$Y$$$20240919$$CN$AR$AR
242039611$24203961$1$I$$20240808$20240813$20240813$PER$$US-MYLANLABS-2024M1074635$MYLAN$$$$$M$Y$$$20240813$$CN$US$US
242039621$24203962$1$I$20240515$20240805$20240813$20240813$EXP$FR-AFSSAPS-MP2024001216$FR-TEVA-VS-3230499$TEVA$$52$YR$$F$Y$$$20240813$$PH$FR$FR
242039631$24203963$1$I$20240803$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158632$AMGEN$$62$YR$A$F$Y$$$20240813$$CN$US$US
242039652$24203965$2$F$$20240813$20240813$20240821$PER$$US-PCCINC-2024-PPL-000610$PIRAMAL$$$$$$Y$$$20240821$$HP$US$US
242039661$24203966$1$I$20210101$20240731$20240813$20240813$EXP$$IT-AUROBINDO-AUR-APL-2024-038576$AUROBINDO$Romano A, Gasparro R, Campana MD, Pinchera B, Di Crescenzo RM, Del Guercio D, et al.. COVID-19 as a critical risk factor for osteonecrosis of the jaw: diagnostic challenge and surgical treatment.. Current Problems in Surgery.. 2024;61(9):101555.$74$YR$$M$Y$$$20240813$$MD$IT$IT
242039671$24203967$1$I$$20240805$20240813$20240813$EXP$$ZA-AstraZeneca-2024A177956$ASTRAZENECA$$90$YR$$F$Y$$$20240813$$CN$ZA$
242039683$24203968$3$F$20240601$20240905$20240813$20240913$EXP$$US-AstraZeneca-2024A177839$ASTRAZENECA$$1006$MON$$M$Y$$$20240913$$MD$US$
242039691$24203969$1$I$20240701$20240805$20240813$20240813$EXP$$PE-AstraZeneca-2024A180384$ASTRAZENECA$$20393$DY$$F$Y$$$20240813$$CN$PE$
242039701$24203970$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039739$AUROBINDO$$90$YR$$F$Y$$$20240813$$PH$CA$CA
242039712$24203971$2$F$20240809$20240906$20240813$20240910$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-13841$IPSEN$$88$YR$E$F$Y$$$20240910$$CN$GB$GB
242039721$24203972$1$I$$20240809$20240813$20240813$EXP$$US-AstraZeneca-2024A181975$ASTRAZENECA$$$$$M$Y$$$20240813$$MD$US$
242039733$24203973$3$F$$20240902$20240813$20240911$EXP$$GR-TEVA-VS-3230556$TEVA$$$$$F$Y$$$20240911$$MD$GR$GR
242039741$24203974$1$I$$20240709$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07149$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242039751$24203975$1$I$$20240805$20240813$20240813$EXP$$FR-TEVA-VS-3231770$TEVA$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2023; 35 (1): 54-59.$45$YR$$M$Y$$$20240813$$HP$FR$FR
242039761$24203976$1$I$$20240731$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-038994$AUROBINDO$Shultz J, Antar-Shultz M, Taha M, Zervogiannis P, Lazcano G, Lamarche J.. SEVELAMER-ASSOCIATED COLITIS: A TRIGGER TO CHANGE TREATMENT APPROACH.. Am-J-Kidney-Dis. 2024;83 (Suppl.)(4):S74$63$YR$$F$Y$$$20240813$$HP$US$US
242039774$24203977$4$F$$20240919$20240813$20240925$EXP$$ES-MYLANLABS-2024M1074029$MYLAN$Beatriz Somoza-Fernandez, Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Sara Perez-Ramirez, Cristina Villanueva-Bueno, Maria del Pilar Montero-Anton, Ana Herranz-Alonso and Maria Sanjurjo-Saez.. Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient.. Journal of oncology pharmacy practice: official publication of the International. 2024;1-6$60$YR$$M$Y$$$20240925$$HP$ES$ES
242039781$24203978$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461863$RANBAXY$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clin Toxicol (Phila). 2024;62 (5):296-302$21$YR$$F$Y$$$20240813$$HP$US$US
242039792$24203979$2$F$$20240826$20240813$20240909$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461628$RANBAXY$Nemoto H, Hino M, Aoki T, Yamashita Y, Okunushi T, Nagasawa K et al. Effectiveness of isavuconazole in invasive cerebral aspergillosis duringhematopoietic stem cell transplantation in a pediatric patient with myelodysplastic syndrome: A case report. J Infect Chemother. 2024;Jul 22:Online ahead of print$4$YR$$M$Y$$$20240909$$HP$JP$JP
242039801$24203980$1$I$$20240729$20240813$20240813$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461697$RANBAXY$Zheng S, Verjans GMGM, Evers A, van den WittenboerE, Tjhie JHT, Snoeck R, et al. CRISPR/Cas9-mediated genome editing of the thymidine kinase gene in a clinical HSV-1 isolate identifies F289S as novel acyclovir-resistant mutation. Antiviral Res. 2024;228 (0):105950$75$YR$$M$Y$$$20240813$$HP$NL$NL
242039811$24203981$1$I$$20240729$20240813$20240813$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461406$RANBAXY$Saha AK, Padhi P, Hota D, Rathore V. Neonatal Acute Kidney Injury due to Maternal Olmesartan Intake. Indian J Pediatr. 2024;Aug;91 (8):869$$$N$M$Y$1.62$KG$20240813$$HP$IN$IN
242039821$24203982$1$I$$20240729$20240813$20240813$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461403$RANBAXY$Saha AK, Padhi P, Hota D, Rathore V. Neonatal Acute Kidney Injury due to Maternal Olmesartan Intake. Indian J Pediatr. 2024;Aug;91 (8):869$$$$F$Y$$$20240813$$HP$IN$IN
242039831$24203983$1$I$20230810$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462300$RANBAXY$$$$N$F$Y$2$KG$20240813$$MD$FR$FR
242039841$24203984$1$I$$20240729$20240813$20240813$EXP$$MK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461726$RANBAXY$Livrinova V, Purrini R.. Macrohematuria due to SARS-Cov Infection in pregnant patient. J Perinat Med. 2021;49 (6):eA38$32$YR$$F$Y$$$20240813$$HP$MK$MK
242039851$24203985$1$I$$20240729$20240813$20240813$EXP$$AR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461662$RANBAXY$Komornicki M, Buttazzoni M, Diehl M, Mazzaro E, Alonso G, Varela F, et al. Primary hyperparathyroidism in pregnancy during the COVID-19 pandemic. JBMR Plus. 2021;5(Suppl.):8$$$N$M$Y$$$20240813$$HP$AR$AR
242039861$24203986$1$I$$20240729$20240813$20240813$EXP$$NP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461649$RANBAXY$Bhusal A, Shrestha M, Rayamajhi A, Bista M, Das A. Discordant exencephaly in case of a twin delivery: a case report. Ann Med Surgery. 2024;Dec,86(1):598-601$$$N$$Y$$$20240813$$MD$NP$NP
242039871$24203987$1$I$20220801$20240729$20240813$20240813$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461805$RANBAXY$Hsieh C-Y, Yu S-C, Lee J-A, Tsai TF. Nodal T?Follicular Helper Cell Lymphoma, Angioimmunoblastic?Type, Diagnosed in a Patient with Psoriasis Following COVID?19 Vaccination under Adalimumab Treatment: A Causal Association?. Indian J Dermatol. 2024;May-Jun; 69(3):264-267$66$YR$$M$Y$$$20240813$$HP$TW$TW
242039881$24203988$1$I$$20240729$20240813$20240813$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461956$RANBAXY$De Almeida Ambrioso I, Ramos MM, Guisado M, Sousa M, Gaspar V, Rodrigues F, et al. The Other Side of The Coin - Euglycemic Diabetic Ketoacidosis Associated with Sglt2 Inhibitors. Eur J Case Rep Intern Med. 2023;10(Suppl.):198/412$51$YR$$M$Y$$$20240813$$HP$PT$PT
242039891$24203989$1$I$$20240729$20240813$20240813$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462065$RANBAXY$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J ALLERGY CLIN IMMUNOL PRACT. 2024;12(7):1850-1862$$$A$$Y$$$20240813$$MD$BE$BE
242039901$24203990$1$I$$20240805$20240813$20240813$EXP$$FR-TEVA-VS-3231850$TEVA$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2023; 35 (1): 54-59.$53$YR$$F$Y$$$20240813$$HP$FR$FR
242039911$24203991$1$I$$20240729$20240813$20240813$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461482$RANBAXY$Donnan M, Siemienowicz M, Tay HS, McLean C, Philpot S, Mason C, et al.. Trimethoprim-sulfamethoxazole acute respiratory distress syndrome requiring lung transplantation. Respirol Case Rep. 2024;12 (7):1-5 e01434$18$YR$$F$Y$$$20240813$$HP$AU$AU
242039921$24203992$1$I$$20240729$20240813$20240813$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461723$RANBAXY$Oliveira VF, Silva GDD, Silva LT, Goncalves VL, Rivas PE, Marques AC, et al. Histoplasmosis in a fingolimod-treated patient: case report and scoping review. Rev Inst Med Trop Sao Paulo. 2024;66 (0):e39$30$YR$$F$Y$$$20240813$$HP$BR$BR
242039931$24203993$1$I$20240424$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461879$RANBAXY$$57$YR$$F$Y$$$20240813$$HP$FR$FR
242039941$24203994$1$I$20230719$20240729$20240813$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461882$RANBAXY$$79$YR$$F$Y$$$20240813$$MD$IT$IT
242039961$24203996$1$I$20240510$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462315$RANBAXY$$95$YR$$F$Y$50$KG$20240813$$PH$FR$FR
242039971$24203997$1$I$20240404$20240804$20240813$20240813$EXP$$CN-TAKEDA-2024TUS079748$TAKEDA$$71$YR$$F$Y$49$KG$20240813$$HP$CN$CN
242039981$24203998$1$I$$20240808$20240813$20240813$PER$$US-TAKEDA-2024TUS079656$TAKEDA$$11$YR$$$Y$$$20240813$$PH$US$US
242039991$24203999$1$I$$20240729$20240813$20240813$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462294$RANBAXY$Pham JP, Zdanska O, Selga M, Javier J, O^Grady A, Chin V, et al. Oncolytic viruses to augment PD-1 inhibition in metastatic cutaneous squamous cell carcinoma. J Dtsch Dermatol Ges. 2024;22 (7):1016-1018$62$YR$$M$Y$$$20240813$$HP$AU$AU
242040001$24204000$1$I$$20240729$20240813$20240813$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461683$RANBAXY$Santos S, Gomes S, Carmo C, Campante F.. From Primary to secondary hypertension. Eur J Case Rep Intern Med. 2019;6:37-38$39$YR$$F$Y$$$20240813$$HP$PT$PT
242040011$24204001$1$I$$20240729$20240813$20240813$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462057$RANBAXY$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J ALLERGY CLIN IMMUNOL PRACT. 2024;12(7):1850-1862$$$A$$Y$$$20240813$$MD$BE$BE
242040021$24204002$1$I$20240425$20240729$20240813$20240813$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462263$RANBAXY$$35$YR$$F$Y$49$KG$20240813$$MD$DE$DE
242040031$24204003$1$I$$20240729$20240813$20240813$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461814$RANBAXY$Doi M, Hamada M, Ishizawa K, Fushimi N, Kase Y, Ikezono T, et al. Diagnostic utility of cytology in a patient with Epstein-Barr virus-positive mucocutaneous ulcer in palatine tonsils: A case report. Diagn Cytopathol. 2024;52 (7):E154-E158$82$YR$$M$Y$$$20240813$$HP$JP$JP
242040041$24204004$1$I$20210501$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461876$RANBAXY$$76$YR$$M$Y$81$KG$20240813$$MD$FR$FR
242040051$24204005$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461887$RANBAXY$Schott C, Massad KM, Held N.. Disseminated Nocardiosis in a Sarcoidosis Patient Off Pneumocystis Pneumonia Prophylaxis. Am J Respir Crit Care Med. 2024;209(0):A2418$81$YR$$M$Y$$$20240813$$HP$US$US
242040061$24204006$1$I$$20240729$20240813$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461687$RANBAXY$Finelli C, Follo MY, Barraco M, De Maio C, Testoni N, Ottaviani E, et al.. LENALIDOMIDE THERAPY IN MYELODYSPLASTIC SYNDROMES WITH LOW-OR-INTERMEDIATE-1 IPSS RISK AND DEL(5Q): RETROSPECTIVE STUDY OF 17 PATIENTS FROM A SINGLE INSTITUTION.. Haematologica. 2016;101 (Suppl.):S119$$$$$Y$$$20240813$$HP$IT$IT
242040071$24204007$1$I$$20240729$20240813$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461689$RANBAXY$Finelli C, Follo MY, Barraco M, De Maio C, Testoni N, Ottaviani E, et al.. LENALIDOMIDE THERAPY IN MYELODYSPLASTIC SYNDROMES WITH LOW-OR-INTERMEDIATE-1 IPSS RISK AND DEL(5Q): RETROSPECTIVE STUDY OF 17 PATIENTS FROM A SINGLE INSTITUTION.. Haematologica. 2016;101 (Suppl.):S119$$$$$Y$$$20240813$$HP$IT$IT
242040081$24204008$1$I$20231018$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462280$RANBAXY$$70$YR$$M$Y$88.5$KG$20240813$$CN$FR$FR
242040091$24204009$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461892$RANBAXY$Abu Zahra M, Al-Dhmour H, Patel N, Weingarten-Arams J, Gorstein S, Michael Ushay H, et al. Is It Children^s Interstitial Lung Disease (chILD)?. Am J Respir Crit Care Med. 2024;209:A2309$$$I$M$Y$$$20240813$$HP$US$US
242040101$24204010$1$I$$20240729$20240813$20240813$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462275$RANBAXY$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J ALLERGY CLIN IMMUNOL PRACT. 2024;12(7):1850-1862$$$E$$Y$$$20240813$$MD$BE$BE
242040111$24204011$1$I$$20240729$20240813$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461681$RANBAXY$Finelli C, Follo MY, Barraco M, De Maio C, Testoni N, Ottaviani E, et al.. LENALIDOMIDE THERAPY IN MYELODYSPLASTIC SYNDROMES WITH LOW-OR-INTERMEDIATE-1 IPSS RISK AND DEL(5Q): RETROSPECTIVE STUDY OF 17 PATIENTS FROM A SINGLE INSTITUTION.. Haematologica. 2016;101 (Suppl.):S119$$$$$Y$$$20240813$$HP$IT$IT
242040121$24204012$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462172$RANBAXY$Hooda Z, Higgins SC, Pastore D, Crisafulli G, Canoles H, Alkomos M, et al. Rare case of fecaloma requiring endoscopic intervention in a 24-year-old female. J Surg Case Rep. 2024;7:rjae438$24$YR$$F$Y$$$20240813$$HP$US$US
242040131$24204013$1$I$$20240729$20240813$20240813$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461533$RANBAXY$$79$YR$$F$Y$$$20240813$$PH$GB$GB
242040141$24204014$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461889$RANBAXY$Woodard VV, Mann B, Ragland MF. Successful Use of VV ECMO for Cavitary Pneumonia in the Setting of Eosinophilic Granulomatosis With Polyangiitis. Am J Respir Crit Care Med. 2024;209 (0):A5787$32$YR$$F$Y$$$20240813$$HP$US$US
242040151$24204015$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461881$RANBAXY$Zielinski R, Qureshi K, Wright Z, D^Cunha S. Worsening coronary artery disease found in a routine lung cancer screen. Am J Med Sci. 2024;367 (Suppl.):S104-S105/182$56$YR$$M$Y$$$20240813$$HP$US$US
242040161$24204016$1$I$20240410$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461704$RANBAXY$$77$YR$$M$Y$60$KG$20240813$$MD$FR$FR
242040172$24204017$2$F$$20240807$20240813$20240822$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462098$RANBAXY$Heck K, Malinina S, Palmowski A. Scleritis and Intraorbital Inflammation following Oral and Intravenous Bisphosphonates in a 66-Year-Old Man. Klin Monatsbl Augenheilkd. 2024;241 (4):426-428$66$YR$$M$Y$$$20240822$$HP$CH$CH
242040181$24204018$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461865$RANBAXY$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clin Toxicol (Phila). 2024;62 (5):296-302$63$YR$$M$Y$$$20240813$$HP$US$US
242040191$24204019$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461880$RANBAXY$Olowoyo O, Sanghi P. ^DOC, MY HEAD POUNDS^^ - A RARE CAUSE OF HEADACHE IN A KIDNEY TRANSPLANT PATIENT -A CASE REPORT. Am J Kidney Dis. 2024;83 (Suppl.) (4):S148/480$46$YR$$F$Y$$$20240813$$HP$US$US
242040201$24204020$1$I$$20240729$20240813$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461691$RANBAXY$Finelli C, Follo MY, Barraco M, De Maio C, Testoni N, Ottaviani E, et al.. LENALIDOMIDE THERAPY IN MYELODYSPLASTIC SYNDROMES WITH LOW-OR-INTERMEDIATE-1 IPSS RISK AND DEL(5Q): RETROSPECTIVE STUDY OF 17 PATIENTS FROM A SINGLE INSTITUTION.. Haematologica. 2016;101 (Suppl.):S119$$$$$Y$$$20240813$$HP$IT$IT
242040211$24204021$1$I$$20240729$20240813$20240813$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461778$RANBAXY$Li J, Du Z, Xu T, Li C, Ba S, Zhu H. Epithelioid trophoblastic tumor with lung metastasis: A case report and literature review. Medicine. 2024;103(27):e38108$39$YR$$F$Y$$$20240813$$HP$CN$CN
242040221$24204022$1$I$$20240729$20240813$20240813$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461861$RANBAXY$Evangelou G, Vamvakaris I, Konstantopoulou I, Syrigos K. Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs. Oncology Huntingt. 2024;38 (7):264-268$62$YR$$F$Y$$$20240813$$MD$GR$GR
242040231$24204023$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462025$RANBAXY$Das S, Ailawadhi S, Sher T, Roy V, Fernandez A, Parrondo RD. Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety. Curr Oncol. 2023;30:9627-9633$33$YR$$M$Y$$$20240813$$HP$US$US
242040241$24204024$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461860$RANBAXY$Idowu D, Ezema K, Corcoran J, Farkas A. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clin Toxicol (Phila). 2024;62 (5):296-302$44$YR$$F$Y$$$20240813$$HP$US$US
242040251$24204025$1$I$20230901$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462298$RANBAXY$$61$YR$$M$Y$70$KG$20240813$$MD$FR$FR
242040261$24204026$1$I$$20240729$20240813$20240813$EXP$$MY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461098$RANBAXY$Abdullah N, Rosly N, Pauzi SHM, Mustapha AW, Arifuddin Y. Case report: Axillary lymph node metastases from primary ovarian cancer: a report of two cases and literature review. Front Oncol. 2024;21 May;14 (0):1-6$51$YR$$F$Y$$$20240813$$HP$MY$MY
242040271$24204027$1$I$$20240729$20240813$20240813$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462054$RANBAXY$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J Allergy Clin Immunol Pract. 2024;Jul; 12(7):1850-1862$$$A$$Y$$$20240813$$MD$BE$BE
242040281$24204028$1$I$20240408$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461878$RANBAXY$$14$YR$$F$Y$47$KG$20240813$$HP$FR$FR
242040291$24204029$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461888$RANBAXY$Puthumana RM, Mintz J, Perez M, Gaddipati S, Gorman D. Too Much of a Good Thing: A Case of Beta Blocker and Warfarin Toxicity. Am J Respir Crit Care Med. 2024;209 (0):A5692$38$YR$$M$Y$$$20240813$$HP$US$US
242040301$24204030$1$I$$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462002$RANBAXY$Naim G, Malissin I, Megarbane B. Cerebral microbleeds in the poisoned patient: An observational magnetic resonance imaging study. Basic Clin Pharmacol Toxicol. 2023;133:770-777$40$YR$$M$Y$$$20240813$$HP$FR$FR
242040311$24204031$1$I$$20240729$20240813$20240813$EXP$$MX-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461950$RANBAXY$Fonseca-Chavez A, Campos-Nunez G, Cano-Escobar KB, Soto-Abraham V, Madero M, Rodriguez- Castellanos FE. HISTOLOGICAL TRANSITION IN LUPUS PODOCYTOPATHY: REPORT OF TWO CASES. Eur J Case Rep Intern Med. 2023;10 (Suppl.):196/WCN24-2640$31$YR$$F$Y$$$20240813$$HP$MX$MX
242040321$24204032$1$I$$20240805$20240813$20240813$PER$$US-BAYER-2024A113162$BAYER$$$$$$Y$$$20240813$$CN$US$US
242040331$24204033$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462013$RANBAXY$Das S, Ailawadhi S, Sher T, Roy V, Fernandez A, Parrondo RD. Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety. Curr Oncol. 2023;30:9627-9633$62$YR$$F$Y$$$20240813$$HP$US$US
242040341$24204034$1$I$20240724$20240730$20240813$20240813$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000746$PAREXEL$$$$$$Y$$$20240813$$HP$CN$CN
242040351$24204035$1$I$20240402$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461873$RANBAXY$$77$YR$$F$Y$$$20240813$$MD$FR$FR
242040361$24204036$1$I$$20240729$20240813$20240813$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462120$RANBAXY$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J ALLERGY CLIN IMMUNOL PRACT. 2024;12(7):1850-1862$$$A$$Y$$$20240813$$MD$BE$SE
242040371$24204037$1$I$20240409$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461866$RANBAXY$$90$YR$$M$Y$55.8$KG$20240813$$PH$FR$FR
242040381$24204038$1$I$$20240729$20240813$20240813$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462066$RANBAXY$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J Allergy Clin Immunol Pract. 2024;Jul; 12(7):1850-1862$$$A$$Y$$$20240813$$MD$BE$BE
242040391$24204039$1$I$$20240729$20240813$20240813$EXP$$MX-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461953$RANBAXY$Fonseca-Chavez A, Campos-Nunez G, Cano-Escobar KB, Soto-Abraham V, Madero M, Rodriguez- Castellanos FE. Histological Transition in Lupus Podocytopathy: Report of Two Cases. Eur J Case Rep Intern Med. 2023;10 (Suppl.):196/WCN24-2640$32$YR$$M$Y$$$20240813$$HP$MX$MX
242040401$24204040$1$I$$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462155$RANBAXY$$32$YR$$M$Y$$$20240813$$HP$FR$FR
242040411$24204041$1$I$20240416$20240729$20240813$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462072$RANBAXY$$43$YR$$F$Y$$$20240813$$MD$IT$IT
242040421$24204042$1$I$20240101$20240729$20240813$20240813$EXP$FR-EMA-DD-20240523-7482689-065918$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461932$RANBAXY$$69$YR$$M$Y$78$KG$20240813$$CN$FR$FR
242040431$24204043$1$I$$20240729$20240813$20240813$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462028$RANBAXY$$$$$M$Y$$$20240813$$MD$GB$GB
242040441$24204044$1$I$$20240729$20240813$20240813$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462144$RANBAXY$$72$YR$$M$Y$91$KG$20240813$$PH$GB$GB
242040451$24204045$1$I$20240726$20240729$20240813$20240813$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462030$RANBAXY$$59$YR$$F$Y$$$20240813$$MD$GB$GB
242040461$24204046$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039834$AUROBINDO$$71$YR$$M$Y$$$20240813$$PH$CA$CA
242040471$24204047$1$I$$20240729$20240813$20240813$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462123$RANBAXY$$25$YR$$F$Y$$$20240813$$CN$GB$GB
242040481$24204048$1$I$20240118$20240729$20240813$20240813$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462247$RANBAXY$$77$YR$$M$Y$$$20240813$$MD$ES$ES
242040491$24204049$1$I$$20240729$20240813$20240813$EXP$$MY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461092$RANBAXY$Nee TS, Shuan CT, Nurliyana W, Karunakan R, Sulaiman H. A synergy test to assess the activity of the Ceftazidime-Avibactam and Aztreonam combination: An experience from a single centre in Malaysia. Open Forum Infect Dis. 2023;10 (Suppl. 2):S1242/ofad500.2421/2810$69$YR$$M$Y$$$20240813$$MD$MY$MY
242040501$24204050$1$I$20240320$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462039$RANBAXY$$63$YR$$F$Y$45$KG$20240813$$MD$FR$FR
242040511$24204051$1$I$20240316$20240729$20240813$20240813$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462107$RANBAXY$$77$YR$$F$Y$$$20240813$$MD$ES$ES
242040521$24204052$1$I$20230620$20240729$20240813$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462079$RANBAXY$$65$YR$$F$Y$$$20240813$$MD$IT$IT
242040531$24204053$1$I$20230625$20240729$20240813$20240813$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462069$RANBAXY$$$$$F$Y$$$20240813$$MD$DE$DE
242040542$24204054$2$F$20240729$20240808$20240813$20240823$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462119$RANBAXY$$61$YR$$M$Y$112$KG$20240823$$HP$GB$GB
242040551$24204055$1$I$20240402$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462100$RANBAXY$$78$YR$$F$Y$63$KG$20240813$$MD$FR$FR
242040571$24204057$1$I$20240514$20240729$20240813$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462089$RANBAXY$$54$YR$$F$Y$$$20240813$$HP$IT$IT
242040581$24204058$1$I$20240504$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462093$RANBAXY$$72$YR$$M$Y$66$KG$20240813$$MD$FR$FR
242040591$24204059$1$I$$20240729$20240813$20240813$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461951$RANBAXY$Merz M, Vucinic V, Wang SY, Kloetzer C, Schetschorke B, Sonntag J, et al. Rapid Response to Idecabtagene Vicleucel in a Myeloma Patient Refractory to Multiple Prior Lines of Anti-BCMA Directed Therapies. Blood. 2022;140 (Suppl.):12492-12493$54$YR$$F$Y$$$20240813$$MD$DE$DE
242040601$24204060$1$I$20240725$20240802$20240813$20240813$EXP$$US-Emmaus Medical, Inc.-EMM202408-000390$EMMAUS LIFE SCIENCES$$16$YR$T$F$Y$$$20240813$$CN$US$
242040611$24204061$1$I$$20240809$20240813$20240813$PER$$US-ABBVIE-5877000$ABBVIE$$$$$$Y$$$20240813$$CN$US$US
242040621$24204062$1$I$$20240808$20240813$20240813$PER$$US-TAKEDA-2024TUS079795$TAKEDA$$$$A$M$Y$$$20240813$$MD$US$US
242040651$24204065$1$I$$20240809$20240813$20240813$PER$$NVSC2024US163650$NOVARTIS$$$$$$Y$$$20240813$$MD$US$US
242040661$24204066$1$I$$20240731$20240813$20240813$EXP$$GB-AUROBINDO-AUR-APL-2024-038470$AUROBINDO$$80$YR$$F$Y$$$20240813$$HP$GB$GB
242040674$24204067$4$F$20240101$20240920$20240813$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023324$UNITED THERAPEUTICS$$$$$F$Y$62.132$KG$20240928$$$US$US
242040681$24204068$1$I$20240708$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159638$AMGEN$$81$YR$E$M$Y$$$20240813$$HP$US$US
242040691$24204069$1$I$$20240729$20240813$20240813$EXP$$JO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461739$RANBAXY$Abu-Hijlih R, Ismael T, Shehadeh A, Salaymeh KJ, Boheisi M, Sultan I, et al. Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better. South Asian J Cancer. 2023;12(3):290-296$9$YR$$F$Y$$$20240813$$MD$JO$JO
242040702$24204070$2$F$$20240806$20240813$20240821$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461636$RANBAXY$Cyriac S, V S, Law AD, Penny PTT, Chirayath JJ, Mullapillil R, et al. Tumor Infiltrating Lymphocytes Therapy - Report of the First TILs Therapy Infusion from India, for a Patient of Malignant Melanoma. Transplant Cell Ther. 2024;Feb; 30 (2):S304-S305(411)$42$YR$$F$Y$$$20240821$$HP$IN$IN
242040711$24204071$1$I$20240201$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462308$RANBAXY$$74$YR$$M$Y$64$KG$20240813$$MD$FR$FR
242040721$24204072$1$I$$20240729$20240813$20240813$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461743$RANBAXY$Carreira MS, Cunha A, Couto M, Ramalho P. MYXEDEMA COMA, A LATE POSTOPERATIVE COMPLICATION - THE ODDS OF RARITY. Eur J Case Rep Intern Med. 2019;6 (Suppl.):265 (1141)$85$YR$$M$Y$$$20240813$$HP$PT$PT
242040731$24204073$1$I$$20240729$20240813$20240813$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462064$RANBAXY$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J ALLERGY CLIN IMMUNOL PRACT. 2024;12(7):1850-1862$$$A$$Y$$$20240813$$MD$BE$BE
242040742$24204074$2$F$20240723$20240909$20240813$20240924$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461315$RANBAXY$$50$YR$$M$Y$71.5$KG$20240924$$HP$CN$CN
242040751$24204075$1$I$$20240729$20240813$20240813$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462548$RANBAXY$Soriano AH, Tirado A, Puchol-Rodrigo FJ, Cameo J, Madero L, Gutierrez A. Azathioprine: a rare cause of sialadenitis. Two cases report. Gastroenterology and Hepatology. 2024;0(0):502212$57$YR$$F$Y$$$20240813$$HP$ES$ES
242040761$24204076$1$I$$20240729$20240813$20240813$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461679$RANBAXY$Finelli C, Follo MY, Barraco M, De Maio C, Testoni N, Ottaviani E, et al.. LENALIDOMIDE THERAPY IN MYELODYSPLASTIC SYNDROMES WITH LOW-OR-INTERMEDIATE-1 IPSS RISK AND DEL(5Q): RETROSPECTIVE STUDY OF 17 PATIENTS FROM A SINGLE INSTITUTION.. Haematologica. 2016;101 (Suppl.):S119$$$$$Y$$$20240813$$HP$IT$IT
242040771$24204077$1$I$$20240729$20240813$20240813$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462276$RANBAXY$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J ALLERGY CLIN IMMUNOL PRACT. 2024;12(7):1850-1862$$$A$$Y$$$20240813$$MD$BE$BE
242040781$24204078$1$I$$20240729$20240813$20240813$EXP$$MK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461731$RANBAXY$Livrinova V, Purrini R.. Macrohematuria due to SARS-CoV-2 infection in pregnant patient. J Perinat Med. 2021;49 (6):eA38$$$N$$Y$2.9$KG$20240813$$HP$MK$MK
242040791$24204079$1$I$$20240729$20240813$20240813$EXP$$MK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461732$RANBAXY$Livrinova V, Purrini R.. Macrohematuria due to SARS-CoV-2 infection in pregnant patient. J Perinat Med. 2021;49(6):eA38$$$N$$Y$2.42$KG$20240813$$HP$MK$MK
242040801$24204080$1$I$$20240729$20240813$20240813$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462056$RANBAXY$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J ALLERGY CLIN IMMUNOL PRACT. 2024;12(7):1850-1862$$$A$$Y$$$20240813$$MD$BE$BE
242040821$24204082$1$I$$20240729$20240813$20240813$EXP$$AR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461659$RANBAXY$Komornicki M, Buttazzoni M, Diehl M, Mazzaro E, Alonso G, Varela F, et al. Primary hyperparathyroidism in pregnancy during the COVID-19 pandemic. JBMR Plus. 2021;5 (Suppl.):8$40$YR$$F$Y$$$20240813$$HP$AR$AR
242040831$24204083$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460810$RANBAXY$Pepin A, Lee V, O^Brien S, Mulugeta P, Taunk NK. Management of Dry Eye Toxicity After Treatment With 177Lu-PSMA-617 Radioligand Therapy. Prac Radiat Oncol. 2024;14 (4):301-304$82$YR$$M$Y$$$20240813$$MD$US$US
242040841$24204084$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461999$RANBAXY$Daccache A, Albright J, Malmberg M, Braun J, Lemley K. Intracranial Hypertension as an Initial Sign of Adrenal Insufficiency Secondary to Inhaled Corticosteroids in a Child With Asthma. Am-J-Respir-Crit-Care-Med. 2024;209(0):A6176/C64$7$YR$$F$Y$$$20240813$$HP$US$US
242040851$24204085$1$I$$20240729$20240813$20240813$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462067$RANBAXY$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J Allergy Clin Immunol Pract. 2024;Jul; 12(7):1850-1862$$$A$$Y$$$20240813$$MD$BE$BE
242040861$24204086$1$I$$20240729$20240813$20240813$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461893$RANBAXY$Kommaraju K, Pennington K, Kennedy CC, Peters SG, Wylam ME, Daly R, et al. A Case of Gastrointestinal Post-transplant Lymphoproliferative Disorder in the Early Post-lung Transplant Period. Am J Respir Crit Care Med. 2023;207:A3226$55$YR$$M$Y$$$20240813$$HP$US$US
242040871$24204087$1$I$$20240729$20240813$20240813$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462055$RANBAXY$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J Allergy Clin Immunol Pract. 2024;Jul; 12(7):1850-1862$$$A$$Y$$$20240813$$MD$BE$BE
242040881$24204088$1$I$20240122$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462259$RANBAXY$$54$YR$$F$Y$80$KG$20240813$$MD$FR$FR
242040891$24204089$1$I$$20240729$20240813$20240813$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461767$RANBAXY$Hao W, Chang R, Liu J, Wang Y, Ren M, Xin K, et al. Case report: A case of advanced gastric cancer with multiple skin metastases, with significant relief from immunotherapy. Front Immunol. 2024;15(0):1356350(1-8)$61$YR$$F$Y$$$20240813$$HP$CN$CN
242040901$24204090$1$I$20240403$20240729$20240813$20240813$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462281$RANBAXY$$41$YR$$M$Y$64$KG$20240813$$MD$FR$FR
242040911$24204091$1$I$$20240729$20240813$20240813$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461629$RANBAXY$Itoyama M, Ohara A, Yokoyama K, Yamamoto S, Kato K, Tada Y et al. An autopsy case of pulmonary tumor thrombotic microangiopathy that developed during chemotherapy for salivary duct carcinoma of the parotid gland. Auris Nasus Larynx. 2024;Jul 23;51(5):829-833$43$YR$$M$Y$$$20240813$$HP$JP$JP
242040921$24204092$1$I$20240728$20240731$20240813$20240813$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000755$PAREXEL$$$$$$Y$$$20240813$$HP$CN$CN
242040931$24204093$1$I$$20240731$20240813$20240813$EXP$$US-MYLANLABS-2024M1073097$MYLAN$Maloney N, Novoa R, Yeh JE. Chronic ulcer in a patient with essential thrombocythemia taking hydroxyurea. Dermatol-Online-J 2024; 30 (3).$82$YR$$F$Y$$$20240813$$MD$US$US
242040951$24204095$1$I$20240801$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160310$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
242040961$24204096$1$I$$20240731$20240813$20240813$EXP$$GB-AUROBINDO-AUR-APL-2024-039209$AUROBINDO$Kyaw O, Morris R, Leibowitz M. Hashimoto^s encephalitis - A case report. Clinical Medicine. 2024;24:100041$50$YR$$F$Y$$$20240813$$HP$GB$GB
242040971$24204097$1$I$$20240808$20240813$20240813$PER$$US-TAKEDA-2024TUS079790$TAKEDA$$$$$$Y$$$20240813$$PH$US$US
242040982$24204098$2$F$20240731$20240819$20240813$20240828$30DAY$$JP-JNJFOC-20240811353$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$JP$JP
242040993$24204099$3$F$20240802$20240812$20240813$20240820$EXP$$US-ROCHE-10000055126$ROCHE$$74$YR$E$M$Y$$$20240820$$HP$US$US
242041001$24204100$1$I$20240805$20240805$20240813$20240813$EXP$$EC-AstraZeneca-2024A178636$ASTRAZENECA$$$$$$Y$$$20240813$$MD$EC$
242041011$24204101$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A177880$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242041021$24204102$1$I$$20240812$20240813$20240813$PER$$US-ROCHE-10000055585$ROCHE$$32$YR$A$F$Y$$$20240813$$HP$US$US
242041031$24204103$1$I$20240720$20240806$20240813$20240813$EXP$FR-AFSSAPS-LY2024001178$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07586$HIKMA$$22$YR$$M$Y$67$KG$20240813$$PH$FR$FR
242041041$24204104$1$I$$20240730$20240813$20240813$EXP$$US-862174955-ML2024-04349$MICRO LABS$Kwon L. Portable Percussive Massage Device-Related Rectus Sheath Hematoma and Obstructive Uropathy: A Case Report. Biomedicine Hub. 2024;9(1): 89-93. doi:10.1159/000538709.$6$DEC$A$M$Y$$$20240813$$HP$US$US
242041071$24204107$1$I$$20240710$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06987$LUPIN$$$$$$Y$$$20240813$$PH$US$US
242041081$24204108$1$I$20240719$20240730$20240813$20240813$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000758$PAREXEL$$$$$$Y$$$20240813$$HP$CN$CN
242041091$24204109$1$I$20240806$20240807$20240813$20240813$EXP$$ES-VANTIVE-2024VAN018921$Vantive US Healthcare$$82$YR$$M$Y$$$20240813$$HP$ES$ES
242041101$24204110$1$I$20240401$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126977$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$83.91$KG$20240813$$HP$US$US
242041111$24204111$1$I$20240806$20240806$20240813$20240813$EXP$$US-VANTIVE-2024VAN018874$Vantive US Healthcare$$71$YR$$F$Y$$$20240813$$CN$US$US
242041121$24204112$1$I$20240802$20240807$20240813$20240813$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-125343$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240813$$HP$PR$PR
242041131$24204113$1$I$$20240710$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07027$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242041141$24204114$1$I$$20240805$20240813$20240813$EXP$NL-LRB-00993784$NL-TEVA-VS-3230726$TEVA$$73$YR$$M$Y$$$20240813$$MD$NL$NL
242041151$24204115$1$I$$20240730$20240813$20240813$EXP$NL-LRB-00985383$NL-GLENMARK PHARMACEUTICALS-2024GMK093053$GLENMARK$$$$$$Y$$$20240813$$PH$NL$NL
242041161$24204116$1$I$$20240806$20240813$20240813$EXP$$US-NOVITIUMPHARMA-2024USNVP01548$NOVITIUM PHARMA$Marc Schwartz.Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes.Blood.02-NOV-2023;142:5898-5900$$$A$$Y$$$20240813$$HP$US$US
242041171$24204117$1$I$20240323$20240810$20240813$20240813$EXP$FR-AFSSAPS-BR2024000650$FR-BAUSCH-BL-2024-012170$BAUSCH AND LOMB$$38$YR$$M$Y$97$KG$20240813$$PH$FR$FR
242041182$24204118$2$F$$20240828$20240813$20240828$PER$$US-ALXN-202408USA000281US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242041191$24204119$1$I$$20240806$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408003952$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240813$$CN$US$US
242041201$24204120$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007342$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240813$$CN$US$US
242041211$24204121$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006410$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240813$$CN$US$US
242041221$24204122$1$I$$20240804$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408003127$ELI LILLY AND CO$$62$YR$A$$Y$$$20240813$$LW$US$US
242041231$24204123$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007535$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240813$$CN$US$US
242041241$24204124$1$I$20240607$20240801$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005263$ELI LILLY AND CO$$72$YR$E$F$Y$52$KG$20240813$$CN$US$US
242041251$24204125$1$I$$20240730$20240813$20240813$EXP$$FR-JNJFOC-20240780273$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$FR$FR
242041261$24204126$1$I$20240517$20240803$20240813$20240813$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019349$VALIDUS$$$$$$Y$$$20240813$$CN$US$US
242041271$24204127$1$I$20240101$20240806$20240813$20240813$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019351$VALIDUS$$$$$$Y$$$20240813$$CN$US$US
242041281$24204128$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164079$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
242041312$24204131$2$F$$20240810$20240813$20240813$EXP$$US-ROCHE-10000054199$ROCHE$$$$$M$Y$$$20240813$$CN$US$US
242041322$24204132$2$F$20240727$20240820$20240813$20240828$30DAY$$US-AMGEN-USASP2024151564$AMGEN$$61$YR$A$M$Y$78$KG$20240828$$PH$US$US
242041331$24204133$1$I$$20240806$20240813$20240813$EXP$$US-AMGEN-USASP2024157540$AMGEN$$$$$$Y$$$20240813$$LW$US$US
242041342$24204134$2$F$20240718$20240813$20240813$20240817$30DAY$$US-AMGEN-USASP2024144226$AMGEN$$71$YR$E$M$Y$84$KG$20240817$$PH$US$US
242041351$24204135$1$I$$20240710$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07012$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242041361$24204136$1$I$20230509$20240805$20240813$20240813$EXP$$US-AMGEN-USASP2024156844$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242041372$24204137$2$F$20240801$20240816$20240813$20240821$30DAY$$US-AMGEN-USASP2024155963$AMGEN$$$$$M$Y$$$20240821$$CN$US$US
242041381$24204138$1$I$20240101$20240805$20240813$20240813$PER$$US-ABBVIE-5868551$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242041391$24204139$1$I$$20240812$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US072206$SANDOZ$$$$$F$Y$$$20240813$$CN$US$US
242041401$24204140$1$I$$20240731$20240813$20240813$EXP$$CA-HALEON-2190600$Haleon PLC$$40$YR$$F$Y$$$20240813$$HP$CA$CA
242041411$24204141$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127037$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240813$$CN$US$US
242041421$24204142$1$I$$20240805$20240813$20240813$EXP$$FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2024-019352$VALIDUS$$$$$$Y$$$20240813$$PH$FR$FR
242041431$24204143$1$I$20240801$20240805$20240813$20240813$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110748$ZYDUS PHARM$$$$$$Y$$$20240813$$HP$US$US
242041441$24204144$1$I$20240508$20240805$20240813$20240813$EXP$FR-AFSSAPS-AN2024000998$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110873$ZYDUS PHARM$$$$$$Y$$$20240813$$MD$FR$FR
242041451$24204145$1$I$$20240730$20240813$20240813$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110776$ZYDUS PHARM$Beesley S, Lanspa MJ.. Calcium Channel Overdose and Insulin Therapy Dosing.. Am-J-Respir-Crit-Care-Med. 2024;209:A7313$$$$$Y$$$20240813$$HP$US$US
242041461$24204146$1$I$20240601$20240805$20240813$20240813$EXP$FR-AFSSAPS-NT2024000953$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110855$ZYDUS PHARM$$$$$$Y$$$20240813$$MD$FR$FR
242041471$24204147$1$I$20240731$20240808$20240813$20240813$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111023$ZYDUS PHARM$$$$$$Y$$$20240813$$PH$US$US
242041481$24204148$1$I$$20240710$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07011$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242041501$24204150$1$I$20240625$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A181306$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242041511$24204151$1$I$$20240807$20240813$20240813$PER$$US-APOTEX-2024AP009191$APOTEX$Gondal MUR, Rovenstine L, Ansari F, Kiyani Z, Nair DPJR, Khan T, et al.. NAVIGATING A COMPLEX CASE OF MYCOBACTERIUM XENOPI IN A PATIENT WITH BLUE RUBBER BLEB NEVUS SYNDROME. European Journal of Case Reports in Internal Medicine. 2024;11(6)$40$YR$$F$Y$$$20240813$$HP$US$US
242041521$24204152$1$I$20240701$20240808$20240813$20240813$EXP$$CO-ABBVIE-5876796$ABBVIE$$66$YR$$F$Y$54$KG$20240813$$HP$CO$CO
242041531$24204153$1$I$20240807$20240807$20240813$20240813$PER$$US-JNJFOC-20240820010$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$HP$US$US
242041553$24204155$3$F$$20240823$20240813$20240827$PER$$US-HALEON-2191703$Haleon PLC$$$$$F$Y$$$20240827$$CN$US$US
242041561$24204156$1$I$$20240808$20240813$20240813$PER$$US-ROCHE-10000053369$ROCHE$$7$YR$C$F$Y$$$20240813$$HP$US$US
242041571$24204157$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159057$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242041583$24204158$3$F$20240101$20240826$20240813$20240830$EXP$$US-ABBVIE-5877217$ABBVIE$$$$$F$Y$83$KG$20240830$$CN$US$US
242041592$24204159$2$F$20240806$20240826$20240813$20240830$PER$$US-AMGEN-USASP2024156555$AMGEN$$59$YR$A$M$Y$60.9$KG$20240830$$PH$US$US
242041602$24204160$2$F$20240724$20240815$20240813$20240821$PER$$US-AMGEN-USASP2024156286$AMGEN$$66$YR$E$F$Y$79.5$KG$20240821$$PH$US$US
242041613$24204161$3$F$20240803$20240819$20240813$20240823$EXP$$US-AMGEN-USASP2024158311$AMGEN$$53$YR$A$F$Y$$$20240823$$CN$US$US
242041621$24204162$1$I$$20240710$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07010$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242041631$24204163$1$I$$20240809$20240813$20240813$PER$$US-ABBVIE-5876457$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242041644$24204164$4$F$20240101$20240906$20240813$20240912$EXP$$US-ABBVIE-5875440$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
242041651$24204165$1$I$20240801$20240807$20240813$20240813$EXP$$CA-ABBVIE-5874856$ABBVIE$$51$YR$$M$Y$$$20240813$$CN$CA$CA
242041662$24204166$2$F$20240806$20240814$20240813$20240829$PER$$US-AMGEN-USASP2024156556$AMGEN$$75$YR$E$M$Y$100$KG$20240829$$PH$US$US
242041671$24204167$1$I$20240806$20240806$20240813$20240813$30DAY$$US-AMGEN-USASP2024156772$AMGEN$$70$YR$E$M$Y$87.75$KG$20240813$$CN$US$US
242041684$24204168$4$F$20240810$20240829$20240813$20240903$EXP$$US-AMGEN-USASP2024159890$AMGEN$$72$YR$E$F$Y$$$20240903$$HP$US$US
242041693$24204169$3$F$20240801$20240911$20240813$20240918$PER$$US-AMGEN-USASP2024157598$AMGEN$$51$YR$A$F$Y$4$KG$20240918$$PH$US$US
242041701$24204170$1$I$20240101$20240808$20240813$20240813$EXP$$US-ABBVIE-5874445$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242041712$24204171$2$F$20230101$20240806$20240813$20240903$EXP$$US-CHIESI-2024CHF04950$CHIESI$$35$YR$$M$Y$$$20240903$$CN$US$US
242041721$24204172$1$I$20240101$20240807$20240813$20240813$EXP$$US-AMGEN-USASP2024157625$AMGEN$$$$$F$Y$$$20240813$$HP$US$US
242041731$24204173$1$I$$20240805$20240813$20240813$EXP$$FR-TEVA-VS-3231771$TEVA$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2023; 35 (1): 54-59.$60$YR$$F$Y$$$20240813$$HP$FR$FR
242041741$24204174$1$I$20240401$20240809$20240813$20240813$EXP$$US-UCBSA-2024018685$UCB$$74$YR$$M$Y$$$20240813$$MD$US$US
242041761$24204176$1$I$$20240810$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127109$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$63.96$KG$20240813$$CN$US$US
242041771$24204177$1$I$$20240810$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126950$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$69.4$KG$20240813$$CN$US$US
242041781$24204178$1$I$$20240805$20240813$20240813$EXP$$NZ-ROCHE-10000050759$ROCHE$Chow K, Keating P, Solanki K, Sapsford M, Lindsay K, ODonnell J. Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand. Seminars in Arthritis and Rheumatism. 2024-Oct;68:1-6. doi:10.1016/j.semarthrit.2024.152522.$$$$$Y$$$20240813$$HP$NZ$NZ
242041811$24204181$1$I$$20231201$20240813$20240813$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424243$RANBAXY$$$$$$Y$$$20240813$$CN$US$US
242041821$24204182$1$I$$20230825$20240813$20240813$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407777$RANBAXY$$$$E$M$Y$$$20240813$$CN$US$US
242041831$24204183$1$I$$20230823$20240813$20240813$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407363$RANBAXY$$$$E$F$Y$$$20240813$$CN$US$US
242041841$24204184$1$I$20240101$20240617$20240813$20240813$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453146$RANBAXY$$$$A$M$Y$$$20240813$$CN$US$US
242041851$24204185$1$I$$20231108$20240813$20240813$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-418626$RANBAXY$$$$$F$Y$$$20240813$$CN$US$US
242041861$24204186$1$I$$20230706$20240813$20240813$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-399732$RANBAXY$$$$$F$Y$$$20240813$$CN$US$US
242041871$24204187$1$I$$20240604$20240813$20240813$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451038$RANBAXY$$$$A$F$Y$$$20240813$$HP$US$US
242041881$24204188$1$I$$20240325$20240813$20240813$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439883$RANBAXY$$$$$F$Y$$$20240813$$CN$US$US
242041891$24204189$1$I$$20240528$20240813$20240813$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449952$RANBAXY$$67$YR$$F$Y$$$20240813$$CN$US$US
242041911$24204191$1$I$$20240711$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07178$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242041923$24204192$3$F$20240803$20240815$20240813$20240822$EXP$$US-ALXN-202408GLO000310US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240822$$MD$US$US
242041931$24204193$1$I$20240715$20240805$20240813$20240813$EXP$FR-AFSSAPS-LL2024001450$FR-TEVA-VS-3230125$TEVA$$88$YR$$$Y$$$20240813$$PH$FR$FR
242041941$24204194$1$I$$20240805$20240813$20240813$EXP$$TR-MYLANLABS-2024M1074983$MYLAN$Peksoz U, Oner U, Celik M. The effectiveness of the erector spinae plane block using methylprednisolone and bupivacaine in post-herpetic neuralgia: Case series. Agri 2023; 35 (4): 273-277.$67$YR$$F$Y$63$KG$20240813$$MD$TR$TR
242041951$24204195$1$I$20240618$20240730$20240813$20240813$EXP$FR-AFSSAPS-AN2024000972$FR-GLENMARK PHARMACEUTICALS-2024GMK093058$GLENMARK$$$$$$Y$$$20240813$$PH$FR$FR
242041961$24204196$1$I$20240801$20240808$20240813$20240813$EXP$$CN-MYLANLABS-2024M1074534$MYLAN$$53$YR$$F$Y$55$KG$20240813$$HP$CN$CN
242041971$24204197$1$I$$20240809$20240813$20240813$EXP$$AU-MYLANLABS-2024M1074348$MYLAN$$$$T$F$Y$$$20240813$$PH$AU$AU
242041981$24204198$1$I$$20240805$20240813$20240813$EXP$$TR-MYLANLABS-2024M1074985$MYLAN$Peksoz U, Oner U, Celik M. The effectiveness of the erector spinae plane block using methylprednisolone and bupivacaine in post-herpetic neuralgia: Case series. Agri 2023; 35 (4): 273-277.$65$YR$$M$Y$70$KG$20240813$$MD$TR$TR
242041992$24204199$2$F$$20240808$20240813$20240814$EXP$$DE-MYLANLABS-2024M1074844$MYLAN$Bingert R, Kolbe V, Boy D, Buttner A. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. [German]. Rechtsmedizin 2023; 33 (5): 396-402.$14$YR$$F$Y$$$20240814$$HP$DE$DE
242042001$24204200$1$I$$20240805$20240813$20240813$EXP$$TR-MYLANLABS-2024M1074992$MYLAN$Peksoz U, Oner U, Celik M. The effectiveness of the erector spinae plane block using methylprednisolone and bupivacaine in post-herpetic neuralgia: Case series. Agri 2023; 35 (4): 273-277.$52$YR$$F$Y$65$KG$20240813$$MD$TR$TR
242042011$24204201$1$I$20240710$20240809$20240813$20240813$EXP$$GB-MYLANLABS-2024M1074577$MYLAN$$80$YR$$F$Y$$$20240813$$PH$GB$GB
242042022$24204202$2$F$20230824$20240807$20240813$20240817$PER$$US-AMGEN-USASL2023154172$AMGEN$$75$YR$E$F$Y$$$20240817$$CN$US$US
242042031$24204203$1$I$20240801$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160125$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
242042041$24204204$1$I$$20240802$20240813$20240813$PER$$US-HALEON-2190999$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242042051$24204205$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127351$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240813$$CN$US$US
242042061$24204206$1$I$$20240809$20240813$20240813$PER$$NVSC2024US163445$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242042071$24204207$1$I$20240101$20240805$20240813$20240813$EXP$$US-TEVA-VS-3231221$TEVA$$18$YR$$M$Y$$$20240813$$HP$US$US
242042081$24204208$1$I$$20240807$20240813$20240813$EXP$$CN-TAKEDA-2024TUS079344$TAKEDA$Khan UZ, Yang X, Masroor M, Aziz A, Yi H, Liu H. Surgery-associated acquired hemophilia A: a report of 2 cases and review of literature. BMC Surgery. 2020;20(213):1-7$18$YR$$M$Y$54$KG$20240813$$HP$CN$CN
242042091$24204209$1$I$$20240808$20240813$20240813$PER$$US-JNJFOC-20240824528$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
242042103$24204210$3$F$20240803$20240905$20240813$20240906$PER$$US-AMGEN-USASP2024160077$AMGEN$$57$YR$A$M$Y$$$20240906$$CN$US$US
242042111$24204211$1$I$$20240810$20240813$20240813$EXP$$US-ABBVIE-5876726$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242042131$24204213$1$I$20240101$20240805$20240813$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-024399$UNITED THERAPEUTICS$$$$$F$Y$84.49$KG$20240813$$$US$US
242042141$24204214$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127463$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240813$$HP$US$US
242042152$24204215$2$F$$20240821$20240813$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127460$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240826$$HP$US$US
242042161$24204216$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127498$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240813$$CN$US$US
242042171$24204217$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127530$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240813$$CN$US$US
242042182$24204218$2$F$20240801$20240813$20240813$20240816$EXP$$IL-ABBVIE-5875826$ABBVIE$$73$YR$$M$Y$$$20240816$$CN$IL$IL
242042191$24204219$1$I$$20240805$20240813$20240813$EXP$$FR-TEVA-VS-3231767$TEVA$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2023; 35 (1): 54-59.$45$YR$$M$Y$$$20240813$$HP$FR$FR
242042201$24204220$1$I$20240730$20240806$20240813$20240813$PER$$US-ABBVIE-5870347$ABBVIE$$66$YR$$F$Y$90$KG$20240813$$CN$US$US
242042211$24204221$1$I$$20240809$20240813$20240813$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-127273$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$78.93$KG$20240813$$CN$PR$PR
242042221$24204222$1$I$20240801$20240805$20240813$20240813$EXP$$JP-AstraZeneca-2024A179005$ASTRAZENECA$$$$E$$Y$$$20240813$$MD$JP$
242042231$24204223$1$I$$20240805$20240813$20240813$EXP$$VN-AstraZeneca-2024A182525$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$VN$
242042241$24204224$1$I$$20240807$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006764$ELI LILLY AND CO$$$$A$F$Y$$$20240813$$CN$US$US
242042252$24204225$2$F$20240805$20240903$20240813$20240906$EXP$$IT-AstraZeneca-2024A182354$ASTRAZENECA$$$$$F$Y$$$20240906$$MD$IT$
242042261$24204226$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007567$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240813$$CN$US$US
242042271$24204227$1$I$$20240802$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002439$ELI LILLY AND CO$$39$YR$A$$Y$$$20240813$$LW$US$US
242042281$24204228$1$I$$20240806$20240813$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-015559$UNITED THERAPEUTICS$$$$$M$Y$86.168$KG$20240813$$$US$US
242042322$24204232$2$F$$20240828$20240813$20240909$EXP$$JP-NOVOPROD-1264532$NOVO NORDISK$$7$DEC$$F$Y$$$20240909$$MD$JP$JP
242042331$24204233$1$I$$20240807$20240813$20240813$PER$$US-TAKEDA-2024TUS079875$TAKEDA$$$$$$Y$$$20240813$$PH$US$US
242042341$24204234$1$I$20240807$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160292$AMGEN$$62$YR$A$M$Y$$$20240813$$CN$US$US
242042353$24204235$3$F$20240801$20240911$20240813$20240912$EXP$$AU-Orion Corporation ORION PHARMA-24_00031245$ORION$$60$YR$A$M$Y$$$20240912$$CN$AU$
242042361$24204236$1$I$$20240806$20240813$20240813$EXP$$US-NOVITIUMPHARMA-2024USNVP01567$NOVITIUM PHARMA$Marc Schwartz.Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes.Blood.02-NOV-2023;142:5898-5900$$$A$$Y$$$20240813$$HP$US$US
242042371$24204237$1$I$20240709$20240805$20240813$20240813$EXP$FR-AFSSAPS-MP2024001210$FR-TEVA-VS-3230496$TEVA$$88$YR$$F$Y$$$20240813$$MD$FR$FR
242042391$24204239$1$I$20231202$20240812$20240813$20240813$EXP$ES-AEMPS-1467371$ES-ABBVIE-5876514$ABBVIE$$47$YR$$F$Y$$$20240813$$MD$ES$ES
242042401$24204240$1$I$20240724$20240812$20240813$20240813$EXP$FR-AFSSAPS-CF2024000411$FR-JNJFOC-20240828357$JOHNSON AND JOHNSON$$96$YR$E$F$Y$87$KG$20240813$$PH$FR$FR
242042432$24204243$2$F$20240101$20240911$20240813$20240918$EXP$$US-862174955-ML2024-04381$MICRO LABS$$80$YR$E$F$Y$$$20240918$$CN$US$US
242042442$24204244$2$F$20240801$20240815$20240813$20240821$30DAY$$US-AMGEN-USASP2024155696$AMGEN$$38$YR$A$F$Y$$$20240821$$PH$US$US
242042451$24204245$1$I$20240520$20240805$20240813$20240813$EXP$IT-MINISAL02-996835$IT-TEVA-VS-3230129$TEVA$$58$YR$$M$Y$$$20240813$$PH$IT$IT
242042461$24204246$1$I$20240719$20240809$20240813$20240813$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045157$BOEHRINGER INGELHEIM$$86$YR$E$F$Y$$$20240813$$MD$JP$JP
242042471$24204247$1$I$$20240810$20240813$20240813$EXP$$US-ABBVIE-5876734$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242042481$24204248$1$I$$20240802$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123361$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240813$$HP$US$US
242042501$24204250$1$I$20240401$20240809$20240813$20240813$EXP$$US-ORGANON-O2408USA000856$ORGANON$$$$$M$Y$$$20240813$$CN$US$US
242042511$24204251$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164134$NOVARTIS$$$$$M$Y$$$20240813$$MD$US$US
242042521$24204252$1$I$$20240809$20240813$20240813$EXP$$NVSC2024US163468$NOVARTIS$$$$$F$Y$$$20240813$$MD$US$US
242042531$24204253$1$I$20171001$20240805$20240813$20240813$EXP$ES-AEMPS-1550112$ES-TEVA-VS-3231046$TEVA$$74$YR$$F$Y$65$KG$20240813$$CN$ES$ES
242042542$24204254$2$F$$20240813$20240813$20240817$EXP$$JP-ROCHE-10000031116$ROCHE$$51$YR$A$M$Y$$$20240817$$MD$JP$JP
242042562$24204256$2$F$20240725$20240808$20240813$20240819$PER$$US-AMGEN-USASP2024157987$AMGEN$$67$YR$E$F$Y$$$20240819$$HP$US$US
242042581$24204258$1$I$$20240730$20240813$20240813$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07406$HIKMA$Bangolo A, Tesoro N, Onyeka S, Bangura M, Shrestha R, Nagesh VK, et al. Bangolo A, Tesoro N, Onyeka S, Bangura M, Shrestha R, Nagesh VK, Alrestom R, Rathod J, Gomez EL,  Laabidi Y, Laabidi I, Erikson C, Sheikh A, Maria S, Naria M, Tabucanon EJ, Dongre JV, Auda A, Jurri M, Radhakrishnan R, Alrefai H, Weissman S. . A Rare Case Report of Hypoketotic Hypoglycemia Induced Seizures Due to Secondary Carnitine Deficiency in a 44-year-old Female.. Journal of community hospital internal medicine perspecti$44$YR$$F$Y$$$20240813$$MD$US$US
242042612$24204261$2$F$20240805$20240823$20240813$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126644$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240826$$CN$US$US
242042621$24204262$1$I$20240701$20240805$20240813$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011969$JAZZ$$45$YR$$M$Y$$$20240813$$CN$US$US
242042631$24204263$1$I$20240808$20240812$20240813$20240813$PER$$US-HALEON-2191689$Haleon PLC$$83$YR$$F$Y$$$20240813$$CN$US$US
242042641$24204264$1$I$20210308$20240613$20240813$20240813$EXP$FR-AFSSAPS-NC2024000685$FR-RECORDATI RARE DISEASES-2024004471$RECORDATI$$$$$$Y$$$20240813$$MD$FR$FR
242042651$24204265$1$I$20220101$20240805$20240813$20240813$EXP$$US-MYLANLABS-2024M1074722$MYLAN$Petras JK, Elrod MG, Ty MC, Dawson P, O^Laughlin K, Gee JE, et al. Locally Acquired Melioidosis Linked to Environment - Mississippi, 2020-2023. N-Engl-J-Med 2023; 389 2355-2362.$62$YR$$M$Y$$$20240813$$HP$US$US
242042661$24204266$1$I$$20240805$20240813$20240813$EXP$$DE-MYLANLABS-2024M1074756$MYLAN$Bienenstein E, Jakob A, Dalla PR, Fischer M, Haas N. Acute Yew-Intoxication (Taxus baccata): Lessons to Be Learned for Pediatric Cardiologists. Thorac-Cardiovasc-Surg 2024; 72 (Suppl.).$16$YR$$M$Y$$$20240813$$HP$DE$DE
242042671$24204267$1$I$$20240805$20240813$20240813$EXP$$US-MYLANLABS-2024M1074109$MYLAN$Sharma D, Bashir Hamidu R, Viana Rodriguez G, Canakis A, Chatila A, Goldberg E. Use of Over-the-Scope Clips in the Management of Refractory Postbanding Ulcer Bleed in a Patient After Liver Transplant. ACG-Case-Rep-J 2024; 11 E01241.$24$YR$$M$Y$$$20240813$$MD$US$US
242042681$24204268$1$I$$20240808$20240813$20240813$PER$$US-MYLANLABS-2024M1074131$MYLAN$$$$$M$Y$$$20240813$$CN$US$US
242042691$24204269$1$I$$20240805$20240813$20240813$EXP$$TN-MYLANLABS-2024M1074299$MYLAN$Mansour K, Chadli Z, Ghachem I, Fredj NB, Romdhane HB, Fadhel NB, et al. Seronegative acute encephalitis following COVID-19 vaccines: a case series of an overlooked diagnosis with literature review. Eur-J-Clin-Pharmacol 2023; 79 (7): 975-987.$35$YR$$F$Y$$$20240813$$HP$TN$TN
242042701$24204270$1$I$20240301$20240806$20240813$20240813$EXP$$US-SA-2024SA238773$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240813$$MD$US$US
242042711$24204271$1$I$$20240812$20240813$20240813$PER$$US-JNJFOC-20240830714$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$CN$US$US
242042721$24204272$1$I$20240714$20240803$20240813$20240813$EXP$$IN-ROCHE-3548875$ROCHE$$55$YR$A$F$Y$$$20240813$$CN$IN$IN
242042731$24204273$1$I$$20240808$20240813$20240813$PER$$US-ROCHE-10000053611$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
242042741$24204274$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875636$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242042751$24204275$1$I$$20240806$20240813$20240813$EXP$$US-SA-2024SA238534$SANOFI AVENTIS$$$$E$F$Y$82.5$KG$20240813$$MD$US$US
242042761$24204276$1$I$$20240806$20240813$20240813$EXP$$JP-ROCHE-10000052892$ROCHE$$6$DEC$A$$Y$$$20240813$$PH$JP$JP
242042771$24204277$1$I$$20240805$20240813$20240813$EXP$$CN-AMGEN-CHNSP2024155913$AMGEN$$$$A$$Y$$$20240813$$MD$CN$CN
242042781$24204278$1$I$20240710$20240802$20240813$20240813$EXP$$IN-ROCHE-3367228$ROCHE$$67$YR$E$M$Y$$$20240813$$MD$IN$IN
242042802$24204280$2$F$$20240827$20240813$20240902$EXP$$US-TAKEDA-2023TUS087568$TAKEDA$$$$$F$Y$$$20240902$$CN$US$US
242042811$24204281$1$I$20240129$20240805$20240813$20240813$EXP$FR-AFSSAPS-DJ2024000869$FR-TEVA-VS-3230457$TEVA$$60$YR$$M$Y$67$KG$20240813$$MD$FR$FR
242042821$24204282$1$I$20210101$20240801$20240813$20240813$EXP$$IT-MACLEODS PHARMA-MAC2024048710$MACLEODS$Scala M, Chiera M, Bortolotti B, Rodriguez-Jimenez R, Menchetti M.Aggressive behaviour and diabetes: A clinical case of atypical metabolic improvement during clozapine  treatment..Journal of intellectual disabilities.2024;1-8$$$$$Y$$$20240813$$MD$IT$IT
242042832$24204283$2$F$$20240813$20240813$20240823$EXP$$ZA-MACLEODS PHARMA-MAC2024048654$MACLEODS$$$$$$Y$$$20240823$$CN$ZA$ZA
242042842$24204284$2$F$20231108$20240826$20240813$20240908$EXP$IT-MINISAL02-995646$IT-MACLEODS PHARMA-MAC2024048470$MACLEODS$$$$$$Y$$$20240907$$MD$IT$IT
242042851$24204285$1$I$$20240802$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408001977$ELI LILLY AND CO$$59$YR$A$$Y$$$20240813$$LW$US$US
242042862$24204286$2$F$20240809$20240822$20240813$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408007321$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240902$$CN$US$US
242042871$24204287$1$I$$20240802$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002319$ELI LILLY AND CO$$39$YR$A$$Y$$$20240813$$LW$US$US
242042881$24204288$1$I$20240725$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006498$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242042891$24204289$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006652$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240813$$CN$US$US
242042901$24204290$1$I$$20240802$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002336$ELI LILLY AND CO$$44$YR$A$$Y$$$20240813$$LW$US$US
242042911$24204291$1$I$$20240801$20240813$20240813$EXP$$AU-MACLEODS PHARMA-MAC2024048746$MACLEODS$Ghosh D, McGann PM, Furlong TJ, Day RO.Febuxostat-associated rhabdomyolysis in chronic renal failure.Medical Journal of Australia.20-JUL-2015;203(2):107-8$68$YR$A$M$Y$$$20240813$$MD$AU$AU
242042921$24204292$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005856$ELI LILLY AND CO$$66$YR$E$$Y$$$20240813$$LW$US$US
242042931$24204293$1$I$$20240801$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408001030$ELI LILLY AND CO$$64$YR$A$$Y$$$20240813$$LW$US$US
242042941$24204294$1$I$20240701$20240807$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006299$ELI LILLY AND CO$$$$A$F$Y$$$20240813$$CN$US$US
242042951$24204295$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007282$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240813$$HP$US$US
242042961$24204296$1$I$20220101$20240809$20240813$20240813$PER$$NVSC2024US163430$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
242042974$24204297$4$F$20240622$20240823$20240813$20240906$EXP$$FR-SA-2024SA237273$SANOFI AVENTIS$$31$YR$A$F$Y$63$KG$20240906$$HP$FR$FR
242042981$24204298$1$I$$20240808$20240813$20240813$EXP$$CA-TAKEDA-2024TUS080443$TAKEDA$$$$$M$Y$$$20240813$$CN$CA$CA
242042991$24204299$1$I$$20240807$20240813$20240813$PER$$US-MYLANLABS-2024M1073985$MYLAN$$$$$F$Y$86.18$KG$20240813$$CN$US$US
242043001$24204300$1$I$20240727$20240801$20240813$20240813$EXP$$CN-OCTA-ALB13024$OCTAPHARMA$$$$A$F$Y$41$KG$20240813$$HP$CN$CN
242043011$24204301$1$I$20240810$20240809$20240813$20240813$EXP$$BR-ASTELLAS-2024US022962$ASTELLAS$$90$YR$$M$Y$$$20240813$$CN$BR$BR
242043021$24204302$1$I$$20240812$20240813$20240813$PER$$US-TAKEDA-2024TUS080428$TAKEDA$$$$$$Y$$$20240813$$CN$US$US
242043031$24204303$1$I$20230101$20240808$20240813$20240813$PER$$US-ABBVIE-5875066$ABBVIE$$$$$$Y$$$20240813$$CN$US$US
242043041$24204304$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07476$HIKMA$$65$YR$$F$Y$$$20240812$$HP$CA$CA
242043051$24204305$1$I$$20240731$20240813$20240813$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-19-04209$HIKMA$Pimentel Janiel L, Kapadia C , Newbern D , Shaibi G. Adrenal insufficiency due to combined inhaled corticosteroid and Azole agent. Hormone Research in Paediatrics. 2017;88(1):438-439$9$YR$$F$Y$$$20240813$$MD$US$US
242043061$24204306$1$I$$20240806$20240813$20240813$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01569$NOVITIUM PHARMA$Haimin Sun.Picalm::MLLT10 can Identify a New Subgroup of Acute Leukemias of Ambiguous Lineage with Unique Extramedullary Disease and Treatment Response.Blood.02-NOV-2023;142:6078-6080$34$YR$A$F$Y$$$20240813$$HP$CN$CN
242043071$24204307$1$I$20240701$20240807$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125042$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240813$$HP$US$US
242043091$24204309$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127162$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$66.3$KG$20240813$$CN$US$US
242043101$24204310$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127329$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240813$$CN$US$US
242043111$24204311$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127896$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240813$$CN$US$US
242043121$24204312$1$I$20200706$20240805$20240813$20240813$EXP$PL-URPL-1-3887-2020$PL-TEVA-VS-3230585$TEVA$$50$YR$$M$Y$130$KG$20240813$$MD$PL$PL
242043131$24204313$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039836$AUROBINDO$$95$YR$$F$Y$68$KG$20240813$$PH$CA$CA
242043141$24204314$1$I$$20240808$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126643$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240813$$CN$US$US
242043151$24204315$1$I$20220901$20240731$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-038478$AUROBINDO$Shah N, Dib EG, Joseph N, Fontana RJ.. Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits?. Clinical Liver Disease.. 2024;23(1):e0125$76$YR$$F$Y$$$20240813$$MD$US$US
242043171$24204317$1$I$20240718$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55351$$FDA-CTU$$39$YR$$F$N$$$20240812$Y$PH$US$
242043191$24204319$1$I$20240718$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55354$$FDA-CTU$$39$YR$$F$N$$$20240812$Y$PH$US$
242043221$24204322$1$I$$20240805$20240813$20240813$EXP$$US-MYLANLABS-2024M1074712$MYLAN$Kotha A, Esmail K. Inhaled doxorubicin induced cardiotoxicity in a young male. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 2814.$21$YR$$M$Y$$$20240813$$HP$US$US
242043231$24204323$1$I$$20240812$20240813$20240813$PER$$US-ROCHE-10000055460$ROCHE$$32$YR$A$M$Y$$$20240813$$HP$US$US
242043241$24204324$1$I$20240810$20240812$20240813$20240813$PER$$US-HALEON-2191692$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242043251$24204325$1$I$20240214$20240805$20240813$20240813$EXP$FR-AFSSAPS-TO2024001428$FR-TEVA-VS-3230595$TEVA$$55$YR$$F$Y$$$20240813$$MD$FR$FR
242043262$24204326$2$F$20211101$20240813$20240813$20240828$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461841$RANBAXY$$39$YR$A$M$Y$$$20240828$$HP$AU$AU
242043271$24204327$1$I$$20240730$20240813$20240813$EXP$$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111022$ZYDUS PHARM$Rascon Roig N, Gauchia Mulet C, Garrido Calvo L.. A raiz de una faringoamigdalitis: sifilis secundaria.. AMF. 2024;20(7):1$$$$$Y$$$20240813$$MD$ES$ES
242043281$24204328$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039925$AUROBINDO$$69$YR$$M$Y$$$20240813$$HP$CA$CA
242043293$24204329$3$F$20240812$20240820$20240813$20240913$PER$$US-INCYTE CORPORATION-2024IN008252$INCYTE$$$$$$Y$$$20240913$$MD$US$US
242043302$24204330$2$F$$20240822$20240813$20240826$PER$$NVSC2024US163830$NOVARTIS$$$$$M$Y$$$20240826$$MD$US$US
242043311$24204331$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039900$AUROBINDO$$$$$M$Y$$$20240813$$HP$CA$CA
242043321$24204332$1$I$$20240812$20240813$20240813$PER$$US-HALEON-2191691$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242043342$24204334$2$F$$20240822$20240813$20240903$PER$$US-INCYTE CORPORATION-2024IN008172$INCYTE$$$$$$Y$$$20240903$$MD$US$US
242043351$24204335$1$I$$20240807$20240813$20240813$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140224$DAIICHI$$$$$F$Y$$$20240813$$CN$US$US
242043361$24204336$1$I$20240701$20240808$20240813$20240813$EXP$$US-ABBVIE-5874073$ABBVIE$$71$YR$$F$Y$$$20240811$$CN$US$US
242043371$24204337$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127177$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240813$$CN$US$US
242043381$24204338$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127493$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240813$$CN$US$US
242043391$24204339$1$I$20240801$20240809$20240813$20240813$EXP$$US-ASTELLAS-2024US022986$ASTELLAS$$$$$M$Y$$$20240813$$CN$US$US
242043401$24204340$1$I$20240801$20240812$20240813$20240813$EXP$$US-UCBSA-2024040751$UCB$$83$YR$$M$Y$$$20240813$$CN$US$US
242043411$24204341$1$I$$20240805$20240813$20240813$EXP$$DE-TAKEDA-2024TUS058984$TAKEDA$$$$$M$Y$$$20240813$$CN$DE$DE
242043421$24204342$1$I$$20240805$20240813$20240813$EXP$SE-SEMPA-2024-005805$SE-TAKEDA-2024TUS078134$TAKEDA$$24$YR$$F$Y$$$20240813$$HP$SE$SE
242043431$24204343$1$I$$20240802$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN008158$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242043441$24204344$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07474$HIKMA$$50$YR$$M$Y$$$20240813$$PH$CA$CA
242043454$24204345$4$F$$20240912$20240813$20240917$EXP$$US-INCYTE CORPORATION-2024IN008165$INCYTE$$$$$$Y$$$20240917$$MD$US$US
242043461$24204346$1$I$$20240805$20240813$20240813$PER$$US-ABBVIE-5870019$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242043481$24204348$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A177762$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242043491$24204349$1$I$$20240803$20240813$20240813$PER$$US-TEVA-VS-3230908$TEVA$$64$YR$$M$Y$$$20240813$$CN$US$US
242043501$24204350$1$I$$20240731$20240813$20240813$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK093044$GLENMARK$$$$$$Y$$$20240813$$HP$GB$GB
242043511$24204351$1$I$20240715$20240809$20240813$20240813$EXP$GB-MHRA-MED-202408091453427860-LVSZW$GB-MYLANLABS-2024M1074627$MYLAN$$$$$F$Y$$$20240813$$PH$GB$GB
242043521$24204352$1$I$20240806$20240809$20240813$20240813$EXP$GB-MHRA-MED-202408071620241670-WLJRM$GB-MYLANLABS-2024M1074781$MYLAN$$50$YR$$F$Y$$$20240813$$HP$GB$GB
242043532$24204353$2$F$20240803$20240803$20240813$20240814$EXP$$US-CSL-2024-007425$CSL Plasma$$40$YR$$F$Y$$$20240814$$HP$US$US
242043541$24204354$1$I$$20240802$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN008157$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242043552$24204355$2$F$20240701$20240819$20240813$20240827$EXP$$US-AstraZeneca-2024A178700$ASTRAZENECA$$20291$DY$$F$Y$$$20240827$$CN$US$
242043562$24204356$2$F$20210114$20240816$20240813$20240826$EXP$PT-INFARMED-M202210-669$PT-GILEAD-2024-0683891$GILEAD$$79$YR$E$M$Y$$$20240826$$MD$PT$PT
242043573$24204357$3$F$$20240813$20240813$20240822$EXP$$DE-AUROBINDO-AUR-APL-2024-034786$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology.. 2024;48:299-313$43$YR$$M$Y$$$20240822$$HP$DE$DE
242043581$24204358$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164168$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
242043591$24204359$1$I$20240724$20240812$20240813$20240813$EXP$FR-AFSSAPS-CF2024000411$NVSC2024FR163268$NOVARTIS$$96$YR$$F$Y$87$KG$20240813$$PH$FR$FR
242043601$24204360$1$I$20240429$20240807$20240813$20240813$EXP$$US-ROCHE-10000033817$ROCHE$$79$YR$E$F$Y$82.1$KG$20240813$$CN$US$US
242043621$24204362$1$I$$20240802$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN008104$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242043631$24204363$1$I$$20240807$20240813$20240813$PER$$US-DSJP-DSU-2024-140226$DAIICHI$$$$$F$Y$$$20240813$$CN$US$US
242043641$24204364$1$I$20240801$20240809$20240813$20240813$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140284$DAIICHI$$57$YR$$F$Y$$$20240813$$CN$US$US
242043651$24204365$1$I$20240101$20240731$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-038467$AUROBINDO$Stolear A, Dulgher M, Bae JY, Kaminsky L, Jeyashanmugaraja GP, Emerenini U.. Wide Spectrum of Flecainide Toxicity: A Case Report and Literature Review.  2024;:. DOI:. Cureus. 2024;16(6):e62923$79$YR$$F$Y$$$20240813$$MD$US$US
242043661$24204366$1$I$20231230$20240807$20240813$20240813$EXP$$CZ-ASTELLAS-2024US014116$ASTELLAS$$73$YR$$F$Y$$$20240813$$HP$CZ$CZ
242043671$24204367$1$I$$20240802$20240813$20240813$EXP$$US-STERISCIENCE B.V.-2024-ST-001171$Steriscience PTE$Singh AD, Kurin M.. An Unusual Case of Refractory Esophagitis and Esophageal Diverticulum.. Dig-Dis-Sci. 2024;69 (6):1913-1914.$76$YR$$F$Y$$$20240813$$HP$US$US
242043681$24204368$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07563$HIKMA$$33$YR$$M$Y$$$20240813$$MD$CA$CA
242043691$24204369$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039813$AUROBINDO$$46$YR$$F$Y$138$KG$20240813$$HP$CA$CA
242043701$24204370$1$I$20240731$20240806$20240813$20240813$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023889$UNITED THERAPEUTICS$$62$YR$$F$Y$52.154$KG$20240813$$PH$US$US
242043731$24204373$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55288$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242043741$24204374$1$I$20240718$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55319$$FDA-CTU$$72$YR$$M$N$$$20240812$N$PH$US$
242043761$24204376$1$I$$20240811$20240812$20240812$DIR$FDA-CDER-CTU-2024-55324$$FDA-CTU$$$$$M$N$$$20240811$N$HP$US$
242043771$24204377$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55275$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242043791$24204379$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55357$$FDA-CTU$$25$YR$$F$N$$$20240812$N$$US$
242043801$24204380$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55339$$FDA-CTU$$48$YR$$M$N$$$20240812$N$$US$
242043821$24204382$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55348$$FDA-CTU$$80$YR$$F$N$$$20240812$N$$US$
242043831$24204383$1$I$$20240805$20240813$20240813$PER$$US-ABBVIE-5870047$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242043841$24204384$1$I$$20240805$20240813$20240813$EXP$$US-STERISCIENCE B.V.-2024-ST-001175$Steriscience PTE$Khattar G, Makram M, Rabah H, Hong C, Khan S, Mourad O, et al.. Catastrophic Convergence: Refractory Septic Shock and Multisystem Failure in a Case of Hidradenitis Suppurativa Complicated by Fournier^s Gangrene and Bilateral Pulmonary Embolism. Am-J-Respir-Crit-Care-Med. 2024;209:A1614$53$YR$$F$Y$$$20240813$$HP$US$US
242043851$24204385$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07438$HIKMA$$38$YR$$M$Y$$$20240813$$CN$CA$CA
242043872$24204387$2$F$$20240822$20240813$20240829$EXP$$NL-TEVA-VS-3231226$TEVA$Fijen LM, Petersen RS, Cohn DM. Facial swelling due to angioedema: often mast cell mediated, but not always. [Dutch]. Ned-Tijdschr-Geneeskd 2023; 167 (42):.; Fijen LM, Petersen RS, Cohn DM. Facial swelling due to angioedema: often mast cell mediated, but not always. [Dutch]. Ned-Tijdschr-Geneeskd 2023; 167 (42):.$18$YR$$F$Y$$$20240829$$HP$NL$NL
242043881$24204388$1$I$$20240805$20240813$20240813$EXP$US-MLMSERVICE-20240729-PI145381-00217-1$US-RDY-SPO/USA/24/0011559$DR REDDYS$Wagle L, Regmi DR, Regmi R, Poudel S, Pant HN. Metformin Toxicity Leading to Severe Refractory Hyperkalemia and Metabolic Acidosis: A Case Report. Cureus. 2024;16(6):e63130. DOI: 10.7759/cureus.63130.$74$YR$E$M$Y$$$20240813$$MD$US$US
242043891$24204389$1$I$20240802$20240806$20240813$20240813$PER$$US-RDY-SPO/USA/24/0011680$DR REDDYS$$50$YR$A$F$Y$$$20240813$$MD$US$US
242043901$24204390$1$I$$20240808$20240813$20240813$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140310$DAIICHI$$$$$F$Y$$$20240813$$PH$US$US
242043912$24204391$2$F$20240101$20240806$20240813$20240820$EXP$$GB-UCBSA-2024039661$UCB$$$$$F$Y$$$20240820$$CN$GB$GB
242043931$24204393$1$I$$20240731$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-038510$AUROBINDO$Wright C, Saitis F, Ayoub W, Schneegurt NR. A Case of BRASH (Bradycardia, Renal Dysfunction, Atrioventricular Node Blockade, Shock, and Hyperkalemia) Syndrome Following Initiation of a Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor and a Loop Diuretic. Cureus. 2024;16(6):e62830$73$YR$$M$Y$$$20240813$$MD$US$US
242043941$24204394$1$I$$20240807$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125712$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240813$$CN$US$US
242043951$24204395$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55358$$FDA-CTU$$57$YR$$F$N$$$20240812$N$$US$
242043961$24204396$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55280$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242043971$24204397$1$I$20240701$20240806$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125229$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240813$$HP$US$US
242043981$24204398$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125886$BRISTOL MYERS SQUIBB$$29$YR$A$M$Y$$$20240813$$HP$US$US
242043991$24204399$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55338$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242044001$24204400$1$I$20240812$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55342$$FDA-CTU$$64$YR$$F$N$$$20240812$Y$PH$US$
242044011$24204401$1$I$$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125804$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240813$$CN$US$US
242044021$24204402$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55344$$FDA-CTU$$58$YR$$M$N$$$20240812$N$$US$
242044041$24204404$1$I$20240115$20240805$20240813$20240813$EXP$FR-AFSSAPS-TO2024001431$FR-TEVA-VS-3230596$TEVA$$41$YR$$M$Y$$$20240813$$MD$FR$FR
242044051$24204405$1$I$$20240805$20240813$20240813$EXP$$CA-STERISCIENCE B.V.-2024-ST-001178$Steriscience PTE$Aboznadah W, Bond R.. CASE REPORT: UNCONTROLLED HYPERTHYROIDISM IN PREGNANCY ASSOCIATED WITH FETAL HEART MALFORMATION.. Can-J-Diab. 2023;47 (Suppl.) (7):S128.$24$YR$$F$Y$$$20240813$$HP$CA$CA
242044061$24204406$1$I$$20240812$20240813$20240813$PER$$US-ROCHE-10000055758$ROCHE$$65$YR$E$F$Y$$$20240813$$MD$US$US
242044071$24204407$1$I$20240811$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007304$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240813$$CN$US$US
242044091$24204409$1$I$20240801$20240801$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002095$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240813$$CN$US$US
242044101$24204410$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006609$ELI LILLY AND CO$$$$A$M$Y$$$20240813$$CN$US$US
242044111$24204411$1$I$20240710$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006486$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240813$$CN$US$US
242044121$24204412$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039891$AUROBINDO$$$$$F$Y$$$20240813$$CN$CA$CA
242044132$24204413$2$F$20240229$20240904$20240813$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-018652$JAZZ$$30$YR$$F$Y$$$20240906$$HP$US$US
242044141$24204414$1$I$$20240805$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408003635$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240813$$CN$US$US
242044151$24204415$1$I$20230130$20240805$20240813$20240813$EXP$$ES-AUROBINDO-AUR-APL-2024-040166$AUROBINDO$$1$HR$$F$Y$3$KG$20240813$$MD$ES$ES
242044161$24204416$1$I$20240808$20240808$20240813$20240813$PER$$US-PFIZER INC-202400233464$PFIZER$$38$YR$$F$Y$$$20240813$$MD$US$US
242044171$24204417$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-PV202400103731$PFIZER$$59$YR$$F$Y$$$20240813$$CN$US$US
242044181$24204418$1$I$$20240805$20240813$20240813$EXP$$CA-STERISCIENCE B.V.-2024-ST-001179$Steriscience PTE$Aboznadah W, Bond R.. CASE REPORT: UNCONTROLLED HYPERTHYROIDISM IN PREGNANCY ASSOCIATED WITH FETAL HEART MALFORMATION.. Can-J-Diab. 2023;47 (Suppl.) (7):S128$$$N$$Y$$$20240813$$HP$CA$CA
242044192$24204419$2$F$$20240812$20240813$20240819$EXP$$NVSC2024GB162696$NOVARTIS$$$$$M$Y$$$20240819$$CN$GB$GB
242044201$24204420$1$I$20201020$20240808$20240813$20240813$EXP$$NVSC2024CN162518$NOVARTIS$$15$YR$$M$Y$58.5$KG$20240813$$HP$CN$CN
242044211$24204421$1$I$$20240808$20240813$20240813$PER$$US-DSJP-DSU-2024-140314$DAIICHI$$$$$F$Y$$$20240813$$PH$US$US
242044221$24204422$1$I$$20240808$20240813$20240813$PER$$US-DSJP-DSU-2024-140315$DAIICHI$$$$$F$Y$$$20240813$$CN$US$US
242044232$24204423$2$F$$20240821$20240813$20240822$PER$$US-TAKEDA-2024TUS079671$TAKEDA$$$$$M$Y$68$KG$20240822$$MD$US$US
242044241$24204424$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07448$HIKMA$$69$YR$$F$Y$69$KG$20240813$$PH$CA$CA
242044253$24204425$3$F$20240801$20240918$20240813$20240926$30DAY$$US-JNJFOC-20240821437$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240926$$CN$US$US
242044261$24204426$1$I$20240730$20240807$20240813$20240813$EXP$$CN-JNJFOC-20240822038$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20240813$$HP$CN$CN
242044271$24204427$1$I$$20240812$20240813$20240813$EXP$$US-JNJFOC-20240830132$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
242044281$24204428$1$I$20200502$20240806$20240813$20240813$EXP$PL-URPL-1-1643-2020$PL-CHEPLA-2024010383$CHEPLAPHARM$$18$YR$$F$Y$$$20240813$$MD$COUNTRY NOT SPECIFIED$PL
242044291$24204429$1$I$$20240809$20240813$20240813$EXP$$US-GILEAD-2024-0683817$GILEAD$$$$A$M$Y$$$20240813$$CN$US$US
242044301$24204430$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127033$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240813$$CN$US$US
242044311$24204431$1$I$$20240812$20240813$20240813$PER$$US-TAKEDA-2024TUS080867$TAKEDA$$$$$M$Y$102$KG$20240813$$MD$US$US
242044321$24204432$1$I$$20240808$20240813$20240813$PER$$US-TAKEDA-2024TUS080417$TAKEDA$$$$$M$Y$$$20240813$$CN$US$US
242044331$24204433$1$I$$20240726$20240813$20240813$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS004035$TERSERA THERAPEUTICS$$$$$$Y$$$20240813$$CN$NL$NL
242044341$24204434$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-001088867$CA-Accord-440139$ACCORD$$11$YR$C$M$Y$53$KG$20240813$$PH$CA$CA
242044351$24204435$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180761$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242044361$24204436$1$I$20240731$20240808$20240813$20240813$EXP$$ZA-AstraZeneca-2024A182201$ASTRAZENECA$$71$YR$$F$Y$$$20240813$$CN$ZA$
242044371$24204437$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-001089008$CA-Accord-440141$ACCORD$$13$YR$T$F$Y$42$KG$20240813$$PH$CA$CA
242044381$24204438$1$I$$20240808$20240813$20240813$PER$$US-ABBVIE-5875773$ABBVIE$$$$$$Y$$$20240813$$HP$US$US
242044392$24204439$2$F$$20240814$20240813$20240821$PER$$US-ABBVIE-5874603$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242044401$24204440$1$I$20240811$20240812$20240813$20240813$PER$$US-HALEON-2191734$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242044411$24204441$1$I$20240531$20240808$20240813$20240813$EXP$$FR-AstraZeneca-2024A180451$ASTRAZENECA$$48$YR$$M$Y$85$KG$20240813$$MD$FR$
242044422$24204442$2$F$20210522$20240815$20240813$20240826$EXP$PT-INFARMED-M202210-790$PT-GILEAD-2024-0683887$GILEAD$$66$YR$E$F$Y$$$20240826$$MD$PT$PT
242044431$24204443$1$I$20240502$20240812$20240813$20240813$EXP$FR-AFSSAPS-AM2024000637$NVSC2024FR163271$NOVARTIS$$25$YR$$F$Y$72$KG$20240813$$MD$FR$FR
242044441$24204444$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039874$AUROBINDO$$$$$$Y$$$20240813$$CN$CA$CA
242044451$24204445$1$I$$20240801$20240813$20240813$EXP$$US-Accord-440132$ACCORD$$46$YR$A$M$Y$$$20240813$$HP$US$US
242044471$24204447$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-001092017$CA-Accord-440324$ACCORD$$$$$F$Y$$$20240813$$MD$CA$CA
242044481$24204448$1$I$20240723$20240801$20240813$20240813$EXP$$US-Accord-440128$ACCORD$$25$YR$A$F$Y$$$20240813$$HP$US$US
242044491$24204449$1$I$20240725$20240801$20240813$20240813$EXP$CN-HENLIUS-24CN016252$CN-Accord-441005$ACCORD$$64$YR$A$F$Y$$$20240813$$MD$CN$CN
242044501$24204450$1$I$20240731$20240801$20240813$20240813$EXP$$US-Accord-440133$ACCORD$$23$YR$A$F$Y$$$20240813$$HP$US$US
242044511$24204451$1$I$20240522$20240801$20240813$20240813$EXP$$US-Accord-440136$ACCORD$$26$YR$A$F$Y$$$20240813$$PH$US$US
242044521$24204452$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_07161708$CA-Accord-440289$ACCORD$$61$YR$A$F$Y$$$20240813$$HP$CA$CA
242044531$24204453$1$I$$20240803$20240813$20240813$EXP$CA-MHPD-E2B_07147731$CA-Accord-440522$ACCORD$$$$$M$Y$$$20240813$$CN$CA$CA
242044541$24204454$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_07115075$CA-Accord-440384$ACCORD$$$$$$Y$$$20240813$$HP$CA$CA
242044551$24204455$1$I$$20240801$20240813$20240813$EXP$GB-MHRA-MED-202408010921590110-WSPTV$GB-Accord-440032$ACCORD$$42$YR$A$F$Y$$$20240813$$CN$GB$GB
242044561$24204456$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-001092295$CA-Accord-440318$ACCORD$$8$YR$C$M$Y$30$KG$20240813$$HP$CA$CA
242044571$24204457$1$I$$20240803$20240813$20240813$EXP$CA-MHPD-001087631$CA-Accord-440471$ACCORD$$78$YR$E$F$Y$$$20240813$$HP$CA$CA
242044581$24204458$1$I$$20240731$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-038980$AUROBINDO$Shacker M, Braat JP, Arjuna A. Acute Hepatitis After Lung Transplant in a Recipient from Hep C Donor: The Chicken or the Egg Phenomenon?. J-Heart-Lung-Transplant. 2024;43(Suppl.)(4):S480$70$YR$$F$Y$$$20240813$$HP$US$US
242044591$24204459$1$I$20240701$20240809$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045378$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240813$$CN$US$US
242044601$24204460$1$I$20220901$20240731$20240813$20240813$EXP$US-MLMSERVICE-20240724-PI141983-00057-1$US-RDY-SPO/USA/24/0011340$DR REDDYS$Shah N, Dib EG, Joseph N, Fontana RJ. Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits? Clinical Liver Disease. 2024;23(1):e0125. DOI: 10.1097/CLD.0000000000000125.$76$YR$E$F$Y$$$20240813$$MD$US$US
242044612$24204461$2$F$20240614$20240912$20240813$20240918$EXP$$US-BEH-2024176709$CSL BEHRING$$71$YR$E$M$Y$$$20240918$$HP$US$US
242044623$24204462$3$F$$20240911$20240813$20240918$EXP$$US-JNJFOC-20240811553$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240918$$CN$US$US
242044631$24204463$1$I$20240603$20240802$20240813$20240813$EXP$GB-MHRA-MED-202408020916186060-VJCLR$GB-Accord-440202$ACCORD$$78$YR$E$F$Y$$$20240813$$HP$GB$GB
242044641$24204464$1$I$$20240803$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN008164$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242044651$24204465$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-001089094$CA-Accord-440309$ACCORD$$7$YR$C$M$Y$23$KG$20240813$$PH$CA$CA
242044661$24204466$1$I$$20240801$20240813$20240813$EXP$GB-MHRA-MED-202408011231456190-JCPVZ$GB-Accord-440058$ACCORD$$59$YR$A$F$Y$$$20240813$$HP$GB$GB
242044671$24204467$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_001088887$CA-Accord-440284$ACCORD$$6$YR$C$M$Y$$$20240813$$PH$CA$CA
242044681$24204468$1$I$20240802$20240802$20240813$20240813$EXP$GB-MHRA-MED-202408020906084330-PFLRZ$GB-Accord-440177$ACCORD$$62$YR$A$M$Y$65$KG$20240813$$CN$GB$GB
242044691$24204469$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_001089895$CA-Accord-440271$ACCORD$$57$YR$A$F$Y$101$KG$20240813$$HP$CA$CA
242044701$24204470$1$I$$20240801$20240813$20240813$EXP$GB-MHRA-MED-202407310048251170-KPQFY$GB-Accord-440031$ACCORD$$4$YR$C$F$Y$$$20240813$$CN$GB$GB
242044711$24204471$1$I$$20240801$20240813$20240813$EXP$$IR-Accord-440149$ACCORD$Mahmoudi H, Ramezanalipour Z, Khansari M, Meijer EFJ, Mahmoudi S, Spruijtenburg B, et al. (2024) Chromoblastomycosis caused by Alternaria infectoria, concurrent with myiasis, in a recipient of a kidney transplant: a compelling case report. Front. Med. 11:1396224.$46$YR$A$F$Y$$$20240813$$HP$IR$IR
242044721$24204472$1$I$20240702$20240801$20240813$20240813$EXP$CN-HENLIUS-24CN016221$CN-Accord-441009$ACCORD$$57$YR$A$F$Y$55$KG$20240813$$MD$CN$CN
242044731$24204473$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_07161695$CA-Accord-440265$ACCORD$$49$YR$A$$Y$$$20240813$$MD$CA$CA
242044741$24204474$1$I$$20240801$20240813$20240813$EXP$$JP-Accord-440104$ACCORD$Nonaka K, Kawase K, Takagi K, Takatsu Y, Maniwa K, Takao C, et al. Development of Fournier^s gangrene after chemotherapy for the recurrence of testicular cancer despite the absence of anorectal lesions: A case report. Medicine (Baltimore). 2024 Jul 26;103(30):e38688.$54$YR$A$M$Y$$$20240813$$MD$JP$JP
242044751$24204475$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-001088770$CA-Accord-440304$ACCORD$$7$YR$C$M$Y$35$KG$20240813$$HP$CA$CA
242044761$24204476$1$I$$20240810$20240813$20240813$PER$$US-HALEON-2191482$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242044771$24204477$1$I$20230510$20240805$20240813$20240813$EXP$FR-AFSSAPS-AM2024000612$FR-TEVA-VS-3230414$TEVA$$68$YR$$F$Y$100$KG$20240813$$MD$FR$FR
242044792$24204479$2$F$$20240823$20240813$20240829$EXP$$US-CBFLEET-202408-US-002552$CB FLEET$$66$YR$E$M$Y$$$20240829$$CN$US$US
242044801$24204480$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039801$AUROBINDO$$85$YR$$F$Y$45$KG$20240813$$PH$CA$CA
242044811$24204481$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55309$$FDA-CTU$$80$YR$$F$N$$$20240812$N$$US$
242044821$24204482$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55289$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242044831$24204483$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55265$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242044841$24204484$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55281$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242044851$24204485$1$I$20220704$20240731$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-039029$AUROBINDO$$85$YR$$M$Y$$$20240813$$MD$FR$FR
242044871$24204487$1$I$20240714$20240731$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-038949$AUROBINDO$$69$YR$$M$Y$150$KG$20240813$$MD$FR$FR
242044881$24204488$1$I$$20240809$20240813$20240813$EXP$$BE-TAKEDA-2024TUS080049$TAKEDA$$25$YR$$F$Y$$$20240813$$HP$BE$BE
242044891$24204489$1$I$$20240731$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-038461$AUROBINDO$Worth L, Khreisat A, Iacobelli A.. Successful Treatment of Relapsing Chronic Eosinophilic Pneumonia With Mepolizumab: A Case Report. Cureus.. 2024;16(7):e65097$73$YR$$M$Y$$$20240813$$MD$US$US
242044902$24204490$2$F$20240701$20240814$20240813$20240821$EXP$$US-ABBVIE-5871847$ABBVIE$$70$YR$$M$Y$127$KG$20240821$$CN$US$US
242044911$24204491$1$I$20200401$20240807$20240813$20240813$PER$$US-BIOGEN-2019BI00776989$BIOGEN$$45$YR$$M$Y$152.09$KG$20240813$$CN$US$US
242044921$24204492$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039816$AUROBINDO$$30$YR$$M$Y$$$20240813$$MD$CA$CA
242044931$24204493$1$I$20240721$20240804$20240813$20240813$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160343$JIANGSU HANSOH PHARMACEUTICAL$$79$YR$$F$Y$62$KG$20240813$$MD$CN$CN
242044941$24204494$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55273$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242044951$24204495$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55300$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242044961$24204496$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55263$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242044971$24204497$1$I$20240809$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234137$PFIZER$$66$YR$$F$Y$$$20240813$$CN$US$US
242044981$24204498$1$I$20240801$20240811$20240813$20240813$PER$$US-PFIZER INC-202400234319$PFIZER$$52$YR$$F$Y$$$20240813$$HP$US$US
242044991$24204499$1$I$20240101$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234142$PFIZER$$37$YR$$F$Y$$$20240813$$CN$US$US
242045001$24204500$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039807$AUROBINDO$$61$YR$$M$Y$$$20240813$$PH$CA$CA
242045011$24204501$1$I$20240809$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234558$PFIZER$$55$YR$$M$Y$$$20240813$$CN$US$US
242045031$24204503$1$I$20240801$20240808$20240813$20240813$PER$$US-PFIZER INC-PV202400103930$PFIZER$$68$YR$$$Y$$$20240813$$CN$US$US
242045041$24204504$1$I$20240806$20240808$20240813$20240813$PER$$US-PFIZER INC-202400233466$PFIZER$$51$YR$$F$Y$$$20240813$$CN$US$US
242045051$24204505$1$I$20230101$20240807$20240813$20240813$PER$$US-PFIZER INC-202400232552$PFIZER$$$$A$F$Y$$$20240813$$CN$US$US
242045071$24204507$1$I$$20240812$20240813$20240813$PER$$US-PFIZER INC-202400235277$PFIZER$$39$YR$$F$Y$$$20240813$$CN$US$US
242045081$24204508$1$I$$20240807$20240813$20240813$PER$$US-PFIZER INC-202400232123$PFIZER$$$$$F$Y$$$20240813$$CN$US$US
242045092$24204509$2$F$20240729$20240828$20240813$20240904$PER$$US-PFIZER INC-202400234363$PFIZER$$76$YR$$F$Y$94$KG$20240904$$CN$US$US
242045101$24204510$1$I$20240808$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234577$PFIZER$$80$YR$$M$Y$$$20240813$$CN$US$US
242045111$24204511$1$I$20240807$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234466$PFIZER$$53$YR$$F$Y$$$20240813$$CN$US$US
242045121$24204512$1$I$$20240810$20240813$20240813$PER$$US-PFIZER INC-PV202400104361$PFIZER$$26$YR$$F$Y$$$20240813$$CN$US$US
242045131$24204513$1$I$20240806$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234361$PFIZER$$59$YR$$M$Y$$$20240813$$CN$US$US
242045151$24204515$1$I$20240807$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234584$PFIZER$$75$YR$$F$Y$$$20240813$$CN$US$US
242045161$24204516$1$I$20240809$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234148$PFIZER$$21$YR$$F$Y$$$20240813$$CN$US$US
242045172$24204517$2$F$$20240912$20240813$20240912$PER$$US-PFIZER INC-202400233000$PFIZER$$65$YR$$F$Y$$$20240912$$CN$US$US
242045181$24204518$1$I$$20240809$20240813$20240813$PER$$JP-PFIZER INC-202400233320$PFIZER$$$$$$Y$$$20240813$$PH$JP$JP
242045191$24204519$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400233717$PFIZER$$96$YR$$F$Y$$$20240813$$CN$US$US
242045201$24204520$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-PV202400104651$PFIZER$$$$$$Y$$$20240813$$CN$US$US
242045211$24204521$1$I$$20240809$20240813$20240813$PER$$JP-PFIZER INC-202400233317$PFIZER$$$$$$Y$$$20240813$$PH$JP$JP
242045221$24204522$1$I$20240810$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234472$PFIZER$$42$YR$$F$Y$$$20240813$$CN$US$US
242045231$24204523$1$I$20240808$20240809$20240813$20240813$PER$$US-PFIZER INC-202400233867$PFIZER$$52$YR$$M$Y$92.99$KG$20240813$$CN$US$US
242045242$24204524$2$F$20240811$20240814$20240813$20240819$PER$$US-PFIZER INC-202400234102$PFIZER$$60$YR$$M$Y$106.57$KG$20240819$$CN$US$US
242045251$24204525$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-202400233092$PFIZER$$82$YR$$M$Y$$$20240813$$CN$US$US
242045261$24204526$1$I$$20240810$20240813$20240813$PER$$US-PFIZER INC-202400233945$PFIZER$$$$E$$Y$$$20240813$$CN$US$US
242045271$24204527$1$I$20240801$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234455$PFIZER$$$$$M$Y$$$20240813$$CN$US$US
242045281$24204528$1$I$20240809$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234477$PFIZER$$62$YR$$M$Y$$$20240813$$CN$US$US
242045292$24204529$2$F$20240809$20240919$20240813$20240920$PER$$US-PFIZER INC-202400234580$PFIZER$$71$YR$$F$Y$71.67$KG$20240920$$CN$US$US
242045301$24204530$1$I$20220101$20240809$20240813$20240813$PER$$US-PFIZER INC-PV202400104628$PFIZER$$55$YR$$$Y$$$20240813$$CN$US$US
242045311$24204531$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-202400233307$PFIZER$$$$$M$Y$$$20240813$$CN$US$US
242045322$24204532$2$F$20240809$20240828$20240813$20240830$PER$$US-PFIZER INC-202400234127$PFIZER$$68$YR$$F$Y$58.957$KG$20240830$$CN$US$US
242045341$24204534$1$I$20240626$20240730$20240813$20240813$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160331$JIANGSU HANSOH PHARMACEUTICAL$$38$YR$$M$Y$57$KG$20240813$$MD$CN$CN
242045351$24204535$1$I$$20240808$20240813$20240813$EXP$$IE-MYLANLABS-2024M1074842$MYLAN$$$$$M$Y$$$20240813$$PH$IE$IE
242045361$24204536$1$I$$20240808$20240813$20240813$EXP$$GB-MYLANLABS-2024M1055345$MYLAN$$$$$F$Y$$$20240813$$MD$GB$GB
242045391$24204539$1$I$$20240731$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039750$AUROBINDO$$76$YR$$M$Y$$$20240813$$PH$CA$CA
242045401$24204540$1$I$$20240807$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045160$BOEHRINGER INGELHEIM$$$$$$Y$$$20240813$$MD$US$US
242045411$24204541$1$I$$20240202$20240813$20240813$PER$$US-Lyne Laboratories Inc.-2160310$LYNE LABORATORIES$$66$YR$$F$Y$65.909$KG$20240813$$$US$US
242045421$24204542$1$I$$20240731$20240813$20240813$EXP$$PT-OrBion Pharmaceuticals Private Limited-2160335$ORBION PHARMACEUTICALS$Real LL, Rodrigues AC, Araujo PS, Iashchuk M, Silva D, Quelhas M, et al. FEVER IN COVID-19 TIMES. Eur J Case Rep Intern Med 2022;9 (Suppl.)378.$68$YR$$F$Y$$$20240813$$MD$PT$PT
242045431$24204543$1$I$$20240731$20240813$20240813$EXP$$US-OrBion Pharmaceuticals Private Limited-2160336$ORBION PHARMACEUTICALS$McKnight M, Nnamani I, Volberding K, Cutshall BT, Wells DA. Non-ST elevation myocardial ischemia in a patient on modafinil. Nurse Pract. 2024 Aug 1;49(8):9-12. doi: 10.1097/01.NPR.0000000000000211.$35$YR$$M$Y$$$20240813$$PH$US$US
242045441$24204544$1$I$$20240730$20240813$20240813$EXP$$GB-B.Braun Medical Inc.-2160308$B BRAUN$$$$$F$Y$$$20240813$$$GB$GB
242045451$24204545$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55279$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242045461$24204546$1$I$$20240729$20240813$20240813$EXP$$US-Nephron Sterile Compounding Center-2160317$NEPHRON STERILE COMPOUNDING CENTER, LLC (NSCC), WEST COLUMBIA, SC$$$$$$Y$$$20240813$$PH$US$US
242045471$24204547$1$I$20240725$20240731$20240813$20240813$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160337$JIANGSU HANSOH PHARMACEUTICAL$$58$YR$$M$Y$$$20240813$$MD$CN$CN
242045481$24204548$1$I$$20240810$20240813$20240813$EXP$$GB-SANDOZ INC.-SDZ2024GB011181$SANDOZ$$$$$F$Y$$$20240813$$CN$GB$GB
242045501$24204550$1$I$$20240805$20240813$20240813$PER$$US-Oxford Pharmaceuticals, LLC-2160346$OXFORD PHARMACEUTICALS$$$$$M$Y$$$20240813$$$US$US
242045511$24204551$1$I$$20240410$20240813$20240813$PER$$US-Lyne Laboratories Inc.-2160316$LYNE LABORATORIES$$80$YR$$F$Y$70.455$KG$20240813$$$US$US
242045521$24204552$1$I$$20240730$20240813$20240813$EXP$$AU-Ascend Therapeutics US, LLC-2160312$ASCEND$$25$YR$$F$Y$$$20240813$$$AU$AU
242045531$24204553$1$I$$20240805$20240813$20240813$EXP$$US-LUNDBECK-DKLU4002725$LUNDBECK$$$$$$Y$$$20240813$$HP$US$US
242045541$24204554$1$I$$20240731$20240813$20240813$EXP$$US-OrBion Pharmaceuticals Private Limited-2160333$ORBION PHARMACEUTICALS$Beesley S, Lanspa MJ. Calcium Channel Overdose and Insulin Therapy Dosing. Am J Respir Crit Care Med 2024.$28$YR$$M$Y$$$20240813$$MD$US$US
242045551$24204555$1$I$$20240801$20240813$20240813$EXP$$US-Caplin Steriles Limited-2160345$CAPLIN POINT LABORATORIES$Doka R, Neibaur S, Mohammad S, et al. (June 18, 2024) Evaluation of the Early Administration of Tranexamic Acid in Geriatric Hip Fractures in the Emergency Department: A Retrospective Study. Cureus 16(6): e62636. DOI 10.7759/cureus.62636$$$$$Y$$$20240813$$$US$US
242045561$24204556$1$I$$20240812$20240813$20240813$EXP$$CA-SANDOZ INC.-SDZ2024CA072180$SANDOZ$$15$YR$$F$Y$$$20240813$$PH$CA$CA
242045572$24204557$2$F$$20240814$20240813$20240815$EXP$$US-Mission Pharmacal Company-2160325$MISSION$$33$YR$$F$Y$$$20240815$$$US$US
242045581$24204558$1$I$$20240731$20240813$20240813$EXP$$TR-OrBion Pharmaceuticals Private Limited-2160334$ORBION PHARMACEUTICALS$Erseven F. Combined Therapy in Severe Valproic Acid Intoxication. JARSS 2023;31(3):249-251 2023;31(3):249-251, doi: 10.54875/jarss.2023.21704.$77$YR$$M$Y$$$20240813$$MD$TR$TR
242045592$24204559$2$F$$20240809$20240813$20240824$EXP$$AU-Ascend Therapeutics US, LLC-2160313$ASCEND$$25$YR$$F$Y$$$20240824$$$AU$AU
242045621$24204562$1$I$20240726$20240804$20240813$20240813$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160342$JIANGSU HANSOH PHARMACEUTICAL$$59$YR$$F$Y$60$KG$20240813$$MD$CN$CN
242045631$24204563$1$I$20240725$20240804$20240813$20240813$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160341$JIANGSU HANSOH PHARMACEUTICAL$$42$YR$$F$Y$60$KG$20240813$$MD$CN$CN
242045651$24204565$1$I$$20240812$20240813$20240813$30DAY$$US-SANDOZ INC.-SDZ2024US072237$SANDOZ$$$$$F$Y$$$20240813$$HP$US$US
242045661$24204566$1$I$$20240812$20240813$20240813$PER$$US-ROCHE-10000055551$ROCHE$$$$A$F$Y$$$20240813$$HP$US$US
242045672$24204567$2$F$$20240812$20240813$20240820$EXP$$PL-SANDOZ INC.-PHHY2014PL148992$SANDOZ$$61$YR$$F$Y$$$20240820$$MD$PL$PL
242045681$24204568$1$I$20240726$20240731$20240813$20240813$EXP$$US-The Proactiv LLC-2160347$PROACTIV$$58$YR$$F$Y$$$20240813$$$US$US
242045691$24204569$1$I$20240801$20240803$20240813$20240813$PER$$US-ALKERMES INC.-ALK-2024-002046$ALKERMES$$$$$F$Y$$$20240813$$CN$US$US
242045701$24204570$1$I$$20240731$20240813$20240813$EXP$$US-AUROBINDO-AUR-APL-2024-039252$AUROBINDO$Prednisolone: Systemic fungal infection: case report. Reactions. 2022;No. 1925$$$$$Y$$$20240813$$HP$US$US
242045711$24204571$1$I$20240501$20240808$20240813$20240813$EXP$$US-ABBVIE-5873960$ABBVIE$$60$YR$$M$Y$$$20240813$$CN$US$US
242045721$24204572$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875681$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242045732$24204573$2$F$20220220$20240815$20240813$20240826$EXP$PT-INFARMED-M202210-1043$PT-GILEAD-2024-0683886$GILEAD$$85$YR$E$F$Y$$$20240826$$MD$PT$PT
242045742$24204574$2$F$20240716$20240814$20240813$20240821$EXP$$US-ABBVIE-5875441$ABBVIE$$65$YR$$F$Y$79.832$KG$20240821$$CN$US$US
242045754$24204575$4$F$20240529$20240905$20240813$20240916$EXP$$US-ABBVIE-5875940$ABBVIE$$44$YR$$F$Y$136$KG$20240916$$CN$US$US
242045771$24204577$1$I$20240717$20240805$20240813$20240813$EXP$FR-AFSSAPS-BX2024001550$FR-FreseniusKabi-FK202412201$FRESENIUS KABI$$78$YR$E$F$Y$$$20240813$$HP$FR$FR
242045781$24204578$1$I$$20240802$20240813$20240813$PER$$US-ABBVIE-5877338$ABBVIE$$$$$M$Y$$$20240813$$MD$US$US
242045791$24204579$1$I$$20240809$20240813$20240813$EXP$$ES-AMGEN-ESPSP2024158946$AMGEN$Martinez-selles M.; Valero-Masa M.J.; Ortiz-Bautista C.D. et al.. Optimization of Hypercholesterolemia Treatment after Heart Transplant: The Role of PCSK9 Inhibitors. Current Pharmaceutical Design. 2024;30:1-4$$$$M$Y$$$20240813$$HP$ES$ES
242045802$24204580$2$F$20240809$20240816$20240813$20240820$EXP$$GB-MYLANLABS-2024M1074824$MYLAN$$$$$F$Y$$$20240820$$HP$GB$GB
242045811$24204581$1$I$20240703$20240809$20240813$20240813$EXP$$GB-MYLANLABS-2024M1074563$MYLAN$$65$YR$$M$Y$90$KG$20240813$$PH$GB$GB
242045821$24204582$1$I$$20240805$20240813$20240813$EXP$$US-LUNDBECK-DKLU4002728$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
242045831$24204583$1$I$$20240806$20240813$20240813$EXP$$US-GILEAD-2024-0683326$GILEAD$$$$A$F$Y$$$20240813$$CN$US$US
242045841$24204584$1$I$$20240725$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119082$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$72.8$KG$20240813$$MD$US$US
242045851$24204585$1$I$$20240806$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124888$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240813$$HP$US$US
242045861$24204586$1$I$$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126927$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240813$$MD$US$US
242045871$24204587$1$I$$20240806$20240813$20240813$EXP$$ZA-ROCHE-10000050540$ROCHE$$$$A$$Y$$$20240813$$MD$ZA$ZA
242045881$24204588$1$I$$20240808$20240813$20240813$EXP$$NVSC2024AU162705$NOVARTIS$$$$$M$Y$$$20240813$$MD$AU$AU
242045891$24204589$1$I$20240101$20240809$20240813$20240813$EXP$$US-ORGANON-O2408USA000836$ORGANON$$$$I$$Y$$$20240813$$HP$US$US
242045901$24204590$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A178885$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242045911$24204591$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006359$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240813$$CN$US$US
242045921$24204592$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006737$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240813$$CN$US$US
242045931$24204593$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006262$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240813$$HP$US$US
242045941$24204594$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006516$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240813$$CN$US$US
242045951$24204595$1$I$20240626$20240809$20240813$20240813$30DAY$$US-SANDOZ INC.-SDZ2024US070628$SANDOZ$$10$YR$$$Y$$$20240813$$CN$US$US
242045961$24204596$1$I$$20240808$20240813$20240813$EXP$$US-PFIZER INC-202400233097$PFIZER$$$$$M$Y$$$20240813$$HP$US$US
242045971$24204597$1$I$$20240807$20240813$20240813$EXP$$IN-PFIZER INC-PV202400058763$PFIZER$$60$YR$$M$Y$$$20240813$$CN$IN$IN
242045981$24204598$1$I$$20240805$20240813$20240813$EXP$$US-PFIZER INC-PV202400102497$PFIZER$$88$YR$$F$Y$108.2$KG$20240813$$HP$US$US
242045991$24204599$1$I$20240101$20240807$20240813$20240813$EXP$$US-PFIZER INC-202400233119$PFIZER$$50$YR$$M$Y$$$20240813$$HP$US$US
242046001$24204600$1$I$$20240808$20240813$20240813$EXP$$CA-PFIZER INC-202400233765$PFIZER$$16$YR$$F$Y$$$20240813$$PH$CA$CA
242046011$24204601$1$I$20240522$20240807$20240813$20240813$EXP$$CN-PFIZER INC-PV202400102926$PFIZER$$64$YR$$F$Y$48$KG$20240813$$HP$CN$CN
242046021$24204602$1$I$20240101$20240806$20240813$20240813$EXP$$CA-PFIZER INC-PV202400077149$PFIZER$$52$YR$$F$Y$98$KG$20240813$$HP$CA$CA
242046061$24204606$1$I$20240708$20240731$20240813$20240813$EXP$$AR-AKCEA THERAPEUTICS, INC.-2024IS006176$AKCEA THERAPEUTICS$$$$$$Y$$$20240812$$CN$AR$AR
242046071$24204607$1$I$20240805$20240805$20240813$20240813$EXP$$US-VANTIVE-2024VAN018850$Vantive US Healthcare$$70$YR$$M$Y$$$20240813$$CN$US$US
242046081$24204608$1$I$$20240812$20240813$20240813$PER$$US-HALEON-2191666$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242046091$24204609$1$I$20231101$20240808$20240813$20240813$EXP$$US-TAKEDA-2024TUS058579$TAKEDA$$76$YR$$F$Y$$$20240813$$CN$US$US
242046111$24204611$1$I$20240723$20240801$20240813$20240813$EXP$CN-HENLIUS-24CN016247$CN-Accord-440697$ACCORD$$66$YR$E$F$Y$$$20240813$$MD$CN$CN
242046122$24204612$2$F$$20240809$20240813$20240821$EXP$$CN-Accord-440151$ACCORD$Zhang L, Liu M, Xie L, Tian X. Cardiac Arrest Due to Capecitabine Toxicosis Treated With ECMO and CRRT: A Case Report. Crit Care Nurse. 2024 Aug 1;44(4):57-62.$58$YR$A$M$Y$$$20240821$$MD$CN$CN
242046131$24204613$1$I$20240731$20240802$20240813$20240813$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004456$BLUEPRINT MEDICINES$$$$$$Y$$$20240812$$CN$US$US
242046141$24204614$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_07150548$CA-Accord-440293$ACCORD$$11$YR$C$F$Y$$$20240813$$HP$CA$CA
242046151$24204615$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_07151001$CA-Accord-440385$ACCORD$$86$YR$E$F$Y$$$20240813$$HP$CA$CA
242046161$24204616$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_07161235$CA-Accord-440312$ACCORD$$72$YR$E$F$Y$$$20240813$$HP$CA$CA
242046171$24204617$1$I$20240325$20240801$20240813$20240813$EXP$GB-MHRA-MIDB-7ddc4bba-a91f-47ea-a8f7-cbcb3909585a$GB-Accord-440040$ACCORD$$47$YR$A$$Y$$$20240813$$PH$GB$GB
242046181$24204618$1$I$20240722$20240801$20240813$20240813$EXP$$US-Accord-440129$ACCORD$$50$YR$A$M$Y$$$20240813$$HP$US$US
242046191$24204619$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_07133652$CA-Accord-440377$ACCORD$$50$YR$A$F$Y$100$KG$20240813$$HP$CA$CA
242046201$24204620$1$I$$20240802$20240813$20240813$EXP$Au-TGA-811097$AU-Accord-439857$ACCORD$$$$$F$Y$$$20240813$$HP$AU$AU
242046211$24204621$1$I$20240730$20240801$20240813$20240813$EXP$$US-Accord-440908$ACCORD$$29$YR$$M$Y$$$20240813$$MD$US$US
242046221$24204622$1$I$20240710$20240802$20240813$20240813$EXP$GB-MHRA-MED-202408020016238690-BYRJM$GB-Accord-440166$ACCORD$$48$YR$A$M$Y$127$KG$20240813$$CN$GB$GB
242046231$24204623$1$I$20240606$20240802$20240813$20240813$EXP$IT-MINISAL02-997272$IT-Accord-439920$ACCORD$$48$YR$A$M$Y$85$KG$20240813$$PH$IT$IT
242046241$24204624$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-001089028$CA-Accord-440295$ACCORD$$5$YR$C$M$Y$18$KG$20240813$$PH$CA$CA
242046251$24204625$1$I$20240715$20240801$20240813$20240813$EXP$CN-HENLIUS-24CN016249$CN-Accord-441001$ACCORD$$34$YR$A$F$Y$$$20240813$$MD$CN$CN
242046262$24204626$2$F$20240801$20240809$20240813$20240816$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004436$BLUEPRINT MEDICINES$$$$$$Y$$$20240816$$CN$US$US
242046272$24204627$2$F$$20240827$20240813$20240903$EXP$$JP-AMGEN-JPNSP2024159730$AMGEN$$$$$M$Y$$$20240903$$MD$JP$JP
242046282$24204628$2$F$20240812$20240813$20240813$20240814$PER$$US-AMGEN-USASP2024160528$AMGEN$$63$YR$A$F$Y$$$20240814$$PH$US$US
242046291$24204629$1$I$20240801$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158477$AMGEN$$77$YR$E$F$Y$$$20240813$$CN$US$US
242046301$24204630$1$I$$20240809$20240813$20240813$EXP$$US-ROCHE-10000054482$ROCHE$$$$A$M$Y$$$20240813$$CN$US$US
242046312$24204631$2$F$20240725$20240910$20240813$20240912$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-110569$REGENERON$$85$YR$$M$Y$$$20240912$$MD$JP$JP
242046321$24204632$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234250$PFIZER$$87$YR$$F$Y$$$20240813$$MD$US$US
242046331$24204633$1$I$$20240812$20240813$20240813$PER$$US-PFIZER INC-202400235470$PFIZER$$72$YR$$M$Y$$$20240813$$CN$US$US
242046341$24204634$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-PV202400104122$PFIZER$$85$YR$$F$Y$90.3$KG$20240813$$MD$US$US
242046351$24204635$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-202400233905$PFIZER$$66$YR$$F$Y$$$20240813$$HP$US$US
242046361$24204636$1$I$$20240808$20240813$20240813$EXP$$CA-PFIZER INC-202400233726$PFIZER$$66$YR$$F$Y$93$KG$20240813$$HP$CA$CA
242046371$24204637$1$I$$20240808$20240813$20240813$EXP$$CA-PFIZER INC-202400233088$PFIZER$$11$YR$$M$Y$37$KG$20240813$$HP$CA$CA
242046382$24204638$2$F$20240101$20240911$20240813$20240916$PER$$US-PFIZER INC-202400234021$PFIZER$$69$YR$$F$Y$$$20240916$$HP$US$US
242046391$24204639$1$I$20240808$20240808$20240813$20240813$EXP$$JP-PFIZER INC-202400232439$PFIZER$$70$YR$$F$Y$$$20240813$$MD$JP$JP
242046402$24204640$2$F$$20240815$20240813$20240816$PER$$US-PFIZER INC-202400234904$PFIZER$$85$YR$$F$Y$$$20240816$$CN$US$US
242046411$24204641$1$I$20230316$20240808$20240813$20240813$EXP$$CA-PFIZER INC-202201375074$PFIZER$$63$YR$$F$Y$65$KG$20240813$$MD$CA$CA
242046432$24204643$2$F$20240101$20240809$20240813$20240814$EXP$$CA-PFIZER INC-202400222039$PFIZER$$33$YR$$F$Y$$$20240814$$HP$CA$CA
242046441$24204644$1$I$20240101$20240809$20240813$20240813$PER$$US-PFIZER INC-202400235002$PFIZER$$57$YR$$F$Y$$$20240813$$HP$US$US
242046451$24204645$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-PV202400104337$PFIZER$$78$YR$$$Y$$$20240813$$CN$US$US
242046461$24204646$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-202300058254$PFIZER$$73$YR$$M$Y$$$20240813$$CN$US$US
242046471$24204647$1$I$$20240808$20240813$20240813$EXP$$IN-PFIZER INC-PV202400104014$PFIZER$$64$YR$$F$Y$$$20240813$$CN$IN$IN
242046483$24204648$3$F$20240701$20240929$20240813$20240930$EXP$$CA-PFIZER INC-PV202400104691$PFIZER$$75$YR$$M$Y$76.5$KG$20240930$$HP$CA$CA
242046492$24204649$2$F$20240101$20240808$20240813$20240814$EXP$$US-PFIZER INC-202400232186$PFIZER$$78$YR$$F$Y$90.72$KG$20240814$$CN$US$US
242046501$24204650$1$I$$20240808$20240813$20240813$EXP$$IN-PFIZER INC-PV202400104167$PFIZER$$45$YR$$F$Y$$$20240813$$CN$IN$IN
242046511$24204651$1$I$$20240808$20240813$20240813$EXP$$DE-PFIZER INC-202400232776$PFIZER$$$$$$Y$$$20240813$$MD$DE$DE
242046521$24204652$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-202400233896$PFIZER$$44$YR$$F$Y$$$20240813$$HP$US$US
242046532$24204653$2$F$$20240812$20240813$20240814$EXP$$GB-PFIZER INC-PV202400103939$PFIZER$$$$$$Y$$$20240814$$PH$GB$GB
242046541$24204654$1$I$20240806$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55292$$FDA-CTU$$60$YR$$F$N$74.3$KG$20240809$N$$US$
242046551$24204655$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55343$$FDA-CTU$$67$YR$$F$N$80.29$KG$20240812$N$$US$
242046561$24204656$1$I$20220701$20240808$20240813$20240813$EXP$$CA-PFIZER INC-202201000144$PFIZER$$85$YR$$M$Y$$$20240813$$CN$CA$CA
242046571$24204657$1$I$$20240812$20240813$20240813$PER$$US-PFIZER INC-202400234918$PFIZER$$85$YR$$F$Y$$$20240813$$CN$US$US
242046581$24204658$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400233801$PFIZER$$77$YR$$F$Y$$$20240813$$CN$US$US
242046591$24204659$1$I$$20240808$20240813$20240813$EXP$$US-PFIZER INC-202400232996$PFIZER$$$$$M$Y$$$20240813$$HP$US$US
242046601$24204660$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-202400233997$PFIZER$$84$YR$$F$Y$$$20240813$$HP$US$US
242046611$24204661$1$I$20220104$20240812$20240813$20240813$PER$$US-PFIZER INC-202400234905$PFIZER$$68$YR$$F$Y$$$20240813$$CN$US$US
242046621$24204662$1$I$20240807$20240808$20240813$20240813$EXP$$IN-PFIZER INC-PV202200090256$PFIZER$$79$YR$$F$Y$$$20240813$$CN$IN$IN
242046631$24204663$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234070$PFIZER$$89$YR$$$Y$$$20240813$$CN$US$US
242046641$24204664$1$I$$20240808$20240813$20240813$EXP$$CN-PFIZER INC-PV202400103255$PFIZER$$$$E$M$Y$$$20240813$$CN$CN$CN
242046651$24204665$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400233814$PFIZER$$78$YR$$F$Y$$$20240813$$CN$US$US
242046661$24204666$1$I$20221201$20240808$20240813$20240813$PER$$US-PFIZER INC-202400072826$PFIZER$$34$YR$$M$Y$$$20240813$$CN$US$US
242046681$24204668$1$I$$20240620$20240813$20240813$PER$$US-LUNDBECK-DKLU4001094$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
242046691$24204669$1$I$20240712$20240730$20240813$20240813$EXP$$CN-EAGLE PHARMACEUTICALS, INC.-CN-2024EAG000196$EAGLE$$46$YR$$M$Y$75$KG$20240813$$HP$CN$CN
242046702$24204670$2$F$$20240805$20240813$20240819$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07345$HIKMA$Cheng JJ, Shen J, Suresh Y, Akopyan NA, Kapoor NS.. Cheng JJ, Shen J, Suresh Y, Akopyan NA, Kapoor NS. Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy: Case report.. International journal of surgery case reports. 2024;122:110050$72$YR$$M$Y$88.9$KG$20240819$$MD$US$US
242046711$24204671$1$I$$20240806$20240813$20240813$PER$$US-AMGEN-USASP2024157643$AMGEN$$$$$M$Y$$$20240813$$HP$US$US
242046722$24204672$2$F$20240811$20240813$20240813$20240814$PER$$US-AMGEN-USASP2024160516$AMGEN$$28$YR$A$F$Y$$$20240813$$CN$US$US
242046731$24204673$1$I$20240807$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159414$AMGEN$$49$YR$A$F$Y$$$20240813$$CN$US$US
242046741$24204674$1$I$20240812$20240812$20240813$20240813$EXP$$DE-SANDOZ INC.-SDZ2024DE072156$SANDOZ$$$$E$F$Y$$$20240813$$HP$DE$DE
242046762$24204676$2$F$20240803$20240813$20240813$20240814$PER$$US-AMGEN-USASP2024160400$AMGEN$$63$YR$A$F$Y$$$20240814$$CN$US$US
242046771$24204677$1$I$$20240807$20240813$20240813$EXP$$US-AMGEN-USASP2024157621$AMGEN$$75$YR$E$F$Y$$$20240813$$MD$US$US
242046781$24204678$1$I$$20240808$20240813$20240813$PER$$US-BIOGEN-2023BI01206422$BIOGEN$$$$$M$Y$$$20240813$$CN$US$US
242046791$24204679$1$I$20240101$20240808$20240813$20240813$EXP$$US-ABBVIE-5874302$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242046811$24204681$1$I$20240430$20240805$20240813$20240813$EXP$$CA-TAKEDA-2024TUS023121$TAKEDA$$66$YR$$F$Y$$$20240813$$CN$CA$CA
242046822$24204682$2$F$20240101$20240821$20240813$20240823$EXP$$NVSJ2024JP009608$NOVARTIS$$83$YR$$F$Y$$$20240823$$MD$JP$JP
242046842$24204684$2$F$20240101$20240929$20240813$20240930$EXP$$CA-PFIZER INC-202200957359$PFIZER$$61$YR$$F$Y$$$20240930$$HP$CA$CA
242046852$24204685$2$F$20240301$20240929$20240813$20240930$EXP$$CA-PFIZER INC-202400234888$PFIZER$$69$YR$$M$Y$$$20240930$$HP$CA$CA
242046862$24204686$2$F$20240729$20240914$20240813$20240916$EXP$$CA-PFIZER INC-202400230208$PFIZER$$33$YR$$F$Y$$$20240916$$MD$CA$CA
242046871$24204687$1$I$20240501$20240805$20240813$20240813$PER$$US-ABBVIE-5868057$ABBVIE$$39$YR$$M$Y$77.11$KG$20240813$$CN$US$US
242046881$24204688$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55284$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242046891$24204689$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55270$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242046901$24204690$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55329$$FDA-CTU$$65$YR$$F$N$$$20240812$N$$US$
242046911$24204691$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55283$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242046921$24204692$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55304$$FDA-CTU$$57$YR$$F$N$104.78$KG$20240812$N$$US$
242046931$24204693$1$I$$20240811$20240812$20240812$DIR$FDA-CDER-CTU-2024-55325$$FDA-CTU$$$$$F$N$$$20240811$N$HP$US$
242046941$24204694$1$I$$20240807$20240813$20240813$EXP$$US-TAKEDA-2024TUS018253$TAKEDA$$$$$F$Y$$$20240813$$MD$US$US
242046951$24204695$1$I$20221215$20240808$20240813$20240813$EXP$$GB-MYLANLABS-2024M1074144$MYLAN$$38$YR$$F$Y$$$20240813$$CN$GB$GB
242046961$24204696$1$I$20230729$20240808$20240813$20240813$EXP$$AR-MYLANLABS-2024M1074343$MYLAN$$40$YR$$M$Y$$$20240813$$CN$AR$AR
242046971$24204697$1$I$$20240808$20240813$20240813$EXP$$GB-MYLANLABS-2024M1074323$MYLAN$$63$YR$$F$Y$103$KG$20240813$$MD$GB$GB
242046981$24204698$1$I$$20240805$20240813$20240813$EXP$$IT-JNJFOC-20240818587$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$MD$IT$IT
242046991$24204699$1$I$$20240711$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07166$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242047001$24204700$1$I$20240724$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126212$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240813$$HP$US$US
242047013$24204701$3$F$20230101$20240903$20240813$20240916$PER$$US-ABBVIE-5870269$ABBVIE$$$$$F$Y$62$KG$20240916$$MD$US$US
242047021$24204702$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55301$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242047032$24204703$2$F$20240316$20240905$20240813$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125263$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$52.6$KG$20240912$$PH$US$US
242047041$24204704$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55276$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242047051$24204705$1$I$20240731$20240802$20240813$20240813$EXP$GB-MHRA-MED-202408011252467800-SZJCF$GB-Accord-440218$ACCORD$$$$$F$Y$73$KG$20240813$$CN$GB$GB
242047061$24204706$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55335$$FDA-CTU$$46$YR$$F$N$$$20240812$N$$US$
242047071$24204707$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55299$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242047081$24204708$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55308$$FDA-CTU$$65$YR$$F$N$$$20240812$N$$US$
242047091$24204709$1$I$20240726$20240801$20240813$20240813$EXP$$US-Accord-440163$ACCORD$$31$YR$A$M$Y$$$20240813$$HP$US$US
242047101$24204710$1$I$20231220$20240802$20240813$20240813$EXP$GB-MHRA-MED-202408011848076220-KWQZD$GB-Accord-440152$ACCORD$$26$YR$A$F$Y$$$20240813$$CN$GB$GB
242047112$24204711$2$F$20240101$20240820$20240813$20240826$EXP$$ES-BAYER-2024A111103$BAYER$$27$YR$A$F$Y$$$20240826$$CN$ES$ES
242047121$24204712$1$I$$20240808$20240813$20240813$PER$$US-BIOGEN-2023BI01206873$BIOGEN$$$$$M$Y$$$20240813$$CN$US$US
242047131$24204713$1$I$20230901$20240807$20240813$20240813$EXP$$CA-AMGEN-CANSP2024157366$AMGEN$$77$YR$E$F$Y$$$20240813$$CN$CA$CA
242047142$24204714$2$F$$20240827$20240813$20240830$30DAY$$GB-PFIZER INC-PV202400104584$PFIZER$$61$YR$$M$Y$$$20240830$$CN$GB$GB
242047151$24204715$1$I$20240426$20240808$20240813$20240813$EXP$$FR-PFIZER INC-202400232689$PFIZER$$$$$F$Y$$$20240813$$PH$FR$FR
242047164$24204716$4$F$$20240916$20240813$20240920$30DAY$$US-PFIZER INC-202400231411$PFIZER$$48$YR$$M$Y$$$20240920$$CN$US$US
242047171$24204717$1$I$$20240809$20240813$20240813$EXP$$BE-PFIZER INC-202400234949$PFIZER$$73$YR$$F$Y$$$20240813$$MD$BE$BE
242047182$24204718$2$F$20240804$20240913$20240813$20240919$30DAY$$US-PFIZER INC-202400230468$PFIZER$$$$C$M$Y$$$20240919$$CN$US$US
242047192$24204719$2$F$$20240807$20240813$20240815$EXP$$GB-PFIZER INC-PV202400102796$PFIZER$$7$YR$$M$Y$$$20240815$$CN$GB$GB
242047203$24204720$3$F$$20240918$20240813$20240918$30DAY$$US-PFIZER INC-202400230945$PFIZER$$4$YR$$F$Y$15.88$KG$20240918$$CN$US$US
242047211$24204721$1$I$20240104$20240808$20240813$20240813$EXP$FR-AFSSAPS-MA2024001171$FR-PFIZER INC-202400232688$PFIZER$$52$YR$$F$Y$58$KG$20240813$$PH$FR$FR
242047222$24204722$2$F$20230301$20240816$20240813$20240821$EXP$$AT-PFIZER INC-202400233509$PFIZER$$63$YR$$M$Y$$$20240821$$MD$AT$AT
242047232$24204723$2$F$$20240912$20240813$20240912$30DAY$$US-PFIZER INC-202400226330$PFIZER$$9$YR$$F$Y$$$20240912$$CN$US$US
242047245$24204724$5$F$$20240924$20240813$20240927$30DAY$$GR-PFIZER INC-PV202400103444$PFIZER$$5$YR$$F$Y$16$KG$20240927$$HP$GR$GR
242047261$24204726$1$I$$20240809$20240813$20240813$EXP$$US-PFIZER INC-PV202400104440$PFIZER$$88$YR$$M$Y$$$20240813$$CN$US$US
242047272$24204727$2$F$$20240912$20240813$20240912$30DAY$$US-PFIZER INC-202400231426$PFIZER$$$$$$Y$$$20240912$$CN$US$US
242047282$24204728$2$F$20240101$20240828$20240813$20240830$EXP$$US-PFIZER INC-202400233837$PFIZER$$50$YR$$F$Y$54.43$KG$20240830$$CN$US$US
242047291$24204729$1$I$$20240808$20240813$20240813$EXP$$CA-PFIZER INC-202400233848$PFIZER$$57$YR$$M$Y$$$20240813$$PH$CA$CA
242047301$24204730$1$I$20240704$20240809$20240813$20240813$EXP$$CN-PFIZER INC-PV202400104238$PFIZER$$33$YR$$M$Y$60$KG$20240813$$HP$CN$CN
242047311$24204731$1$I$$20240806$20240813$20240813$PER$$US-BIOGEN-2024BI01277329$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
242047321$24204732$1$I$20240807$20240809$20240813$20240813$30DAY$$US-SANDOZ INC.-SDZ2024US071949$SANDOZ$$32$YR$$F$Y$$$20240813$$CN$US$US
242047331$24204733$1$I$$20240805$20240813$20240813$EXP$$US-TAKEDA-2024TUS047812$TAKEDA$$$$$F$Y$$$20240813$$CN$US$US
242047341$24204734$1$I$$20240806$20240813$20240813$EXP$$BE-ABBVIE-5877777$ABBVIE$$$$$$Y$$$20240813$$CN$BE$BE
242047351$24204735$1$I$$20240806$20240813$20240813$EXP$$US-THE RITEDOSE CORPORATION-2024RIT000103$THE RITEDOSE CORP$$$$$$Y$$$20240813$$CN$US$US
242047361$24204736$1$I$20240528$20240805$20240813$20240813$EXP$FR-AFSSAPS-LY2024000963$FR-TEVA-VS-3230474$TEVA$$69$YR$$F$Y$69$KG$20240813$$PH$FR$FR
242047371$24204737$1$I$$20240806$20240813$20240813$EXP$GB-MHRA-MED-202408061233211950-KGVQH$GB-RDY-SPO/GBR/24/0011601$DR REDDYS$$$$$M$Y$$$20240813$$CN$GB$GB
242047383$24204738$3$F$20240101$20240816$20240813$20240830$EXP$$CN-SA-2024SA234872$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240830$$HP$CN$CN
242047391$24204739$1$I$$20240806$20240813$20240813$EXP$$US-EMD Serono-2024042784$EMD SERONO INC$$60$YR$A$F$Y$$$20240813$$CN$US$US
242047401$24204740$1$I$$20240807$20240813$20240813$EXP$$BR-AMGEN-BRASP2024159408$AMGEN$Breviglieri C.; Ginani V.C.; Gouveia R.V. et al.. BLINATUMOMAB + DONOR LEUKOCYTE INFUSIONS (DLI) CAN BE USED TO PREVENT THE RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT). JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 2024;5 (SUPPL_1):82-83$$$$$Y$$$20240813$$HP$BR$BR
242047412$24204741$2$F$$20240814$20240813$20240817$PER$$US-AMGEN-USASP2024160265$AMGEN$$$$$M$Y$$$20240816$$CN$US$US
242047421$24204742$1$I$$20240807$20240813$20240813$EXP$$BR-AMGEN-BRASP2024159314$AMGEN$Breviglieri C.; Ginani V.C.; Gouveia R.V. et al.. BLINATUMOMAB + DONOR LEUKOCYTE INFUSIONS (DLI) CAN BE USED TO PREVENT THE RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT). JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 2024;5 (SUPPL_1):82-83$$$$$Y$$$20240813$$HP$BR$BR
242047431$24204743$1$I$$20240808$20240813$20240813$EXP$$US-AMGEN-USASP2024159680$AMGEN$Phang C. R.; Farooqi A.; Sangwan Y.. Unmasking the Unusual: Cryptococcal Pericarditis in a Patient with Liver Failure - a Rare Occurrence. American Journal of Case Reports. 2024;25:1-5$47$YR$A$M$Y$$$20240813$$HP$US$US
242047441$24204744$1$I$20240807$20240807$20240813$20240813$PER$$US-AMGEN-USASP2024157780$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
242047451$24204745$1$I$20240722$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127262$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240813$$CN$US$US
242047461$24204746$1$I$20230919$20240809$20240813$20240813$EXP$$US-ORGANON-O2408USA000846$ORGANON$$32$YR$$F$Y$129.72$KG$20240813$$HP$US$US
242047474$24204747$4$F$$20240918$20240813$20240920$30DAY$$CH-PFIZER INC-202400225594$PFIZER$$$$$F$Y$$$20240920$$PH$CH$CH
242047481$24204748$1$I$$20240808$20240813$20240813$PER$$US-BIOGEN-2024BI01277681$BIOGEN$$$$$M$Y$$$20240813$$CN$US$US
242047491$24204749$1$I$20240501$20240731$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000267$ELI LILLY AND CO$$58$YR$A$$Y$$$20240813$$CN$US$US
242047501$24204750$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005622$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240813$$CN$US$US
242047511$24204751$1$I$20240301$20240731$20240813$20240813$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408005084$ELI LILLY AND CO$$77$YR$E$M$Y$85$KG$20240813$$CN$GB$GB
242047521$24204752$1$I$$20240806$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408004293$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240813$$CN$US$US
242047531$24204753$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007397$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240813$$CN$US$US
242047541$24204754$1$I$$20240731$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408000684$ELI LILLY AND CO$$$$$$Y$$$20240813$$CN$US$US
242047551$24204755$1$I$$20240806$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005336$ELI LILLY AND CO$$$$$M$Y$$$20240813$$CN$US$US
242047561$24204756$1$I$$20240731$20240813$20240813$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408000819$ELI LILLY AND CO$$29$YR$A$M$Y$109$KG$20240813$$CN$GB$GB
242047571$24204757$1$I$20240714$20240730$20240813$20240813$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202407020080$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240813$$MD$SA$SA
242047581$24204758$1$I$$20240802$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408001966$ELI LILLY AND CO$$59$YR$A$$Y$$$20240813$$LW$US$US
242047591$24204759$1$I$20240304$20240731$20240813$20240813$EXP$GB-MHRA-MED-202407311255369710-MWTYD$GB-ELI_LILLY_AND_COMPANY-GB202408000839$ELI LILLY AND CO$$70$YR$E$F$Y$114$KG$20240813$$CN$GB$GB
242047602$24204760$2$F$20240101$20240808$20240813$20240820$EXP$$US-INSMED, INC.-2024-00557-US$INSMED$$$$$F$Y$$$20240820$$CN$US$US
242047611$24204761$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55298$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242047621$24204762$1$I$20240718$20240801$20240813$20240813$EXP$$CA-TAKEDA-2024TUS077873$TAKEDA$$39$YR$$F$Y$$$20240813$$CN$CA$CA
242047641$24204764$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55294$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242047651$24204765$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55272$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242047661$24204766$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55366$$FDA-CTU$$52$YR$$F$N$83.01$KG$20240812$N$$US$
242047671$24204767$1$I$$20240802$20240813$20240813$EXP$$US-BAYER-2024A115347$BAYER$Sachdeva N, Sun LW, Young J, Chen A.. Early to late explantation of Hydrus microstent MIGS device: A case series.. American Journal of Ophthalmology Case Reports.. 2024;36:102105$71$YR$E$M$Y$$$20240813$$MD$US$US
242047681$24204768$1$I$$20240806$20240813$20240813$PER$$US-MYLANLABS-2024M1074165$MYLAN$$$$$F$Y$56.7$KG$20240813$$CN$US$US
242047691$24204769$1$I$$20240805$20240813$20240813$PER$$US-AMGEN-USASP2024156145$AMGEN$$$$$$Y$$$20240813$$CN$US$US
242047701$24204770$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55271$$FDA-CTU$$$$$$N$$$20240809$$CN$US$
242047711$24204771$1$I$$20240731$20240813$20240813$EXP$$US-MEDLEY-000017$MEDLEY PHARMACEUTICALS$$64$YR$A$M$Y$$$20240801$$HP$US$US
242047721$24204772$1$I$20240705$20240805$20240813$20240813$EXP$$US-EMD Serono-2024042585$EMD SERONO INC$$47$YR$A$F$Y$$$20240813$$CN$US$US
242047731$24204773$1$I$$20240731$20240813$20240813$EXP$$IT-MEDLEY-000021$MEDLEY PHARMACEUTICALS$$26$YR$A$F$Y$$$20240802$$MD$IT$IT
242047742$24204774$2$F$20240508$20240925$20240813$20240930$PER$$US-LUNDBECK-DKLU4002794$LUNDBECK$$$$$$Y$$$20240930$$HP$US$US
242047751$24204775$1$I$$20240731$20240813$20240813$EXP$$CN-MEDLEY-000020$MEDLEY PHARMACEUTICALS$$15$YR$T$M$Y$$$20240802$$HP$CN$CN
242047761$24204776$1$I$$20240731$20240813$20240813$EXP$$AR-MPL-000056$MLV PHARMA$$43$YR$A$M$Y$$$20240801$$MD$AR$AR
242047781$24204778$1$I$20180127$20240801$20240813$20240813$EXP$$US-TAKEDA-2024TUS077411$TAKEDA$$18$YR$$F$Y$$$20240813$$HP$US$US
242047791$24204779$1$I$$20240805$20240813$20240813$PER$$US-ABBVIE-5867909$ABBVIE$$$$$$Y$$$20240813$$MD$US$US
242047802$24204780$2$F$$20240805$20240813$20240823$PER$$US-MYLANLABS-2024M1073711$MYLAN$$$$$F$Y$$$20240823$$CN$US$US
242047821$24204782$1$I$$20240731$20240813$20240813$EXP$$PT-MEDLEY-000018$MEDLEY PHARMACEUTICALS$$15$YR$T$M$Y$$$20240802$$MD$PT$PT
242047831$24204783$1$I$$20240806$20240813$20240813$EXP$$BR-ROCHE-10000051395$ROCHE$$$$$M$Y$$$20240813$$CN$BR$BR
242047841$24204784$1$I$20240710$20240802$20240813$20240813$EXP$GB-MHRA-MED-202408021809155270-HMTVR$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-07534$HIKMA$$71$YR$$F$Y$88$KG$20240813$$MD$GB$GB
242047851$24204785$1$I$$20240806$20240813$20240813$EXP$$US-GILEAD-2024-0683324$GILEAD$$15$YR$T$M$Y$$$20240813$$CN$US$US
242047871$24204787$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55340$$FDA-CTU$$41$YR$$F$N$$$20240812$N$$US$
242047881$24204788$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55331$$FDA-CTU$$76$YR$$M$N$$$20240812$N$$US$
242047891$24204789$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55327$$FDA-CTU$$31$YR$$M$N$111.13$KG$20240812$N$$US$
242047901$24204790$1$I$20230101$20240812$20240813$20240813$EXP$GB-MHRA-MED-202408121916569840-MRGLH$GB-TAKEDA-2024TUS080689$TAKEDA$$$$$F$Y$$$20240813$$HP$GB$GB
242047911$24204791$1$I$20240703$20240808$20240813$20240813$EXP$$US-TAKEDA-2024TUS050548$TAKEDA$$71$YR$$M$Y$$$20240813$$CN$US$US
242047922$24204792$2$F$20240801$20240913$20240813$20240913$30DAY$$US-PFIZER INC-202400229413$PFIZER$$11$YR$$M$Y$$$20240913$$HP$US$US
242047932$24204793$2$F$$20240819$20240813$20240826$EXP$$US-TEVA-VS-3230924$TEVA$Gupta S, Gowda N, Shin D, Gogineni K, Bower D, Greer M. PP01.127 A rare case of pulmonary enteric adenocarcinoma in a 26-year-old female non-smoker. J-Thorac-Oncol 2024; 19 (Suppl.) (7): e55-e56 abstr. PP01.127.; Gupta S, Gowda N, Shin D, Gogineni K, Bower D, Greer M. PP01.127 A rare case of pulmonary enteric adenocarcinoma in a 26-year-old female non-smoker. J-Thorac-Oncol 2024; 19 (Suppl.) (7): e55-e56 abstr. PP01.127.$26$YR$$F$Y$$$20240826$$MD$US$US
242047941$24204794$1$I$20240721$20240807$20240813$20240813$EXP$DK-DKMA-30736495$DK-ROCHE-10000051982$ROCHE$$81$YR$E$M$Y$$$20240813$$MD$DK$DK
242047951$24204795$1$I$20240701$20240729$20240813$20240813$EXP$$US-TEVA-VS-3228707$TEVA$$62$YR$$M$Y$$$20240813$$CN$US$US
242047961$24204796$1$I$20240719$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160603$AMGEN$$$$$$Y$$$20240813$$PH$US$US
242047972$24204797$2$F$20240401$20240816$20240813$20240820$EXP$$NVSC2024RU163563$NOVARTIS$$$$A$$Y$$$20240820$$HP$RU$RU
242047981$24204798$1$I$$20240807$20240813$20240813$EXP$$NVSC2024US161116$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242047991$24204799$1$I$$20240802$20240813$20240813$PER$$US-AstraZeneca-2024A176639$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242048001$24204800$1$I$$20240805$20240813$20240813$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024097528$VIIV$$30$YR$$M$Y$$$20240813$$MD$US$US
242048013$24204801$3$F$$20240905$20240813$20240915$30DAY$$US-GSK-US2024097579$GLAXOSMITHKLINE$$$$$M$Y$$$20240915$$CN$US$US
242048021$24204802$1$I$$20240805$20240813$20240813$EXP$$US-GSK-US2024GSK098248$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242048031$24204803$1$I$$20240806$20240813$20240813$EXP$$US-GSK-US2024098110$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242048041$24204804$1$I$$20240805$20240813$20240813$30DAY$$US-GSK-US2024097610$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242048051$24204805$1$I$$20240803$20240813$20240813$30DAY$$US-GSK-US2024097580$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242048061$24204806$1$I$20231101$20240806$20240813$20240813$EXP$$IN-GSK-IN2023APC162009$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$IN$IN
242048071$24204807$1$I$$20240806$20240813$20240813$EXP$$US-GSK-US2024098632$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$MD$US$US
242048081$24204808$1$I$$20240806$20240813$20240813$EXP$$US-GSK-US2024098103$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
242048092$24204809$2$F$$20240902$20240813$20240906$EXP$$JP-GSK-JP2024JPN098716$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$PH$JP$JP
242048102$24204810$2$F$$20240902$20240813$20240906$EXP$$JP-GSK-JP2024JPN098715$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$PH$JP$JP
242048111$24204811$1$I$20240716$20240806$20240813$20240813$EXP$$US-GSK-US2024098071$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
242048122$24204812$2$F$20220408$20240823$20240813$20240829$EXP$$AR-GSK-AR2022AMR062383$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$AR$AR
242048131$24204813$1$I$$20240808$20240813$20240813$EXP$$CA-GSK-CA2022018583$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$CA$CA
242048141$24204814$1$I$20230801$20240809$20240813$20240813$EXP$$JP-GSK-JP2024100543$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$MD$JP$JP
242048151$24204815$1$I$$20240806$20240813$20240813$EXP$$CA-GSK-CA2023AMR134329$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$CA$CA
242048161$24204816$1$I$20240101$20240730$20240813$20240813$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000754$PAREXEL$$$$$$Y$$$20240813$$HP$CN$CN
242048172$24204817$2$F$20240101$20240830$20240813$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127241$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240904$$CN$US$US
242048181$24204818$1$I$20240701$20240805$20240813$20240813$EXP$$MX-LUNDBECK-DKLU4002717$LUNDBECK$$$$$$Y$$$20240813$$CN$MX$MX
242048191$24204819$1$I$20230719$20240802$20240813$20240813$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-07378$HIKMA$$76$YR$$F$Y$98.4$KG$20240813$$HP$US$US
242048201$24204820$1$I$$20240807$20240813$20240813$EXP$$BR-AMGEN-BRASP2024159416$AMGEN$Breviglieri C.; Ginani V.C.; Gouveia R.V. et al.. BLINATUMOMAB + DONOR LEUKOCYTE INFUSIONS (DLI) CAN BE USED TO PREVENT THE RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT). JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 2024;5 (SUPPL_1):82-83$$$$$Y$$$20240813$$HP$BR$BR
242048212$24204821$2$F$20240725$20240813$20240813$20240814$EXP$$US-PFIZER INC-202400234801$PFIZER$$58$YR$$M$Y$$$20240814$$CN$US$US
242048221$24204822$1$I$$20240809$20240813$20240813$EXP$$CA-PFIZER INC-202400234827$PFIZER$$66$YR$$F$Y$$$20240813$$HP$CA$CA
242048232$24204823$2$F$20240711$20240816$20240813$20240816$EXP$$CN-PFIZER INC-PV202400104273$PFIZER$$36$YR$$F$Y$$$20240816$$HP$CN$CN
242048241$24204824$1$I$20240726$20240810$20240813$20240813$EXP$$CN-PFIZER INC-PV202400104191$PFIZER$$33$YR$$F$Y$54$KG$20240813$$HP$CN$CN
242048251$24204825$1$I$$20240812$20240813$20240813$EXP$$PT-PFIZER INC-PV202400104719$PFIZER$$$$$F$Y$$$20240813$$MD$PT$PT
242048261$24204826$1$I$20240101$20240809$20240813$20240813$EXP$$CN-PFIZER INC-202400233431$PFIZER$$6$DEC$$F$Y$$$20240813$$MD$CN$CN
242048271$24204827$1$I$$20240812$20240813$20240813$EXP$$CA-PFIZER INC-202400234875$PFIZER$$63$YR$$F$Y$67$KG$20240813$$HP$CA$CA
242048281$24204828$1$I$20240101$20240812$20240813$20240813$EXP$$IE-PFIZER INC-202400234614$PFIZER$$$$$M$Y$$$20240813$$CN$IE$IE
242048301$24204830$1$I$$20240809$20240813$20240813$EXP$$DO-PFIZER INC-202400234835$PFIZER$$57$YR$$F$Y$$$20240813$$CN$DO$DO
242048311$24204831$1$I$$20240812$20240813$20240813$EXP$$CA-PFIZER INC-202400234845$PFIZER$$38$YR$$F$Y$$$20240813$$PH$CA$CA
242048321$24204832$1$I$$20240812$20240813$20240813$EXP$$US-PFIZER INC-202400235247$PFIZER$$41$YR$$F$Y$$$20240813$$CN$US$US
242048341$24204834$1$I$20240201$20240809$20240813$20240813$EXP$$US-PFIZER INC-202400234058$PFIZER$$73$YR$$F$Y$56.7$KG$20240813$$CN$US$US
242048353$24204835$3$F$20240727$20240828$20240813$20240906$30DAY$$US-GSK-US2024097484$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240906$$CN$US$US
242048361$24204836$1$I$$20240810$20240813$20240813$EXP$$US-AMGEN-USASP2024159817$AMGEN$Tribble J.T.; Johnson M.; Moon Y. et al.. Kaposi sarcoma in a men-who-have-sex-with-men patient without human immunodeficiency virus who was treated with upadacitinib for ulcerative colitis. JAAD Case Reports. 2024;50:119-122$45$YR$A$M$Y$$$20240813$$HP$US$US
242048371$24204837$1$I$$20240807$20240813$20240813$EXP$$BR-AMGEN-BRASP2024159427$AMGEN$Breviglieri C.; Ginani V.C.; Gouveia R.V. et al.. BLINATUMOMAB + DONOR LEUKOCYTE INFUSIONS (DLI) CAN BE USED TO PREVENT THE RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT). JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 2024;5 (SUPPL_1):82-83$$$$$Y$$$20240813$$HP$BR$BR
242048381$24204838$1$I$$20240807$20240813$20240813$EXP$$BR-AMGEN-BRASP2024159434$AMGEN$Breviglieri C.; Ginani V.C.; Gouveia R.V. et al.. BLINATUMOMAB + DONOR LEUKOCYTE INFUSIONS (DLI) CAN BE USED TO PREVENT THE RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT). JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 2024;5 (SUPPL_1):82-83$$$$$Y$$$20240813$$HP$BR$BR
242048391$24204839$1$I$$20240812$20240813$20240813$EXP$$CA-PFIZER INC-202400234940$PFIZER$$68$YR$$F$Y$64$KG$20240813$$HP$CA$CA
242048401$24204840$1$I$$20240810$20240813$20240813$EXP$$US-AMGEN-USASP2024159674$AMGEN$Steehler A.; Sadhar B.; Slupek D. et al.. Primary diffuse large B-cell lymphoma of the lacrimal sac with involvement of maxillary sinus: a case report and review of literature. Journal of Surgical Case Reports. 2024;7:1-3$66$YR$E$F$Y$$$20240813$$HP$US$US
242048411$24204841$1$I$20240809$20240809$20240813$20240813$EXP$GB-MHRA-MED-202408091343505770-CPDHV$GB-PFIZER INC-202400233748$PFIZER$$61$YR$$F$Y$$$20240813$$PH$GB$GB
242048421$24204842$1$I$20210818$20240716$20240813$20240813$PER$$CO-TOLMAR, INC.-21CO029773$TOLMAR$$61$YR$$M$Y$$$20240813$$CN$CO$CO
242048432$24204843$2$F$20240711$20240827$20240813$20240917$PER$$US-TOLMAR, INC.-24US051016$TOLMAR$$83$YR$$M$Y$$$20240917$$HP$US$US
242048441$24204844$1$I$20240601$20240715$20240813$20240813$PER$$US-TOLMAR, INC.-24US051038$TOLMAR$$$$$M$Y$$$20240813$$HP$US$US
242048451$24204845$1$I$$20240809$20240813$20240813$EXP$$US-JNJFOC-20240827974$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$CN$US$US
242048461$24204846$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5876902$ABBVIE$$$$$$Y$$$20240813$$CN$US$US
242048472$24204847$2$F$$20240813$20240813$20240826$EXP$$DE-AUROBINDO-AUR-APL-2024-039241$AUROBINDO$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S, et al. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. British Journal of Cancer. 2023;128(6):1134-1147$$$$F$Y$$$20240826$$HP$DE$DE
242048491$24204849$1$I$$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024159691$AMGEN$Sharf K.; Chahin N.; Do T. et.al.. Benefits of Early vs Late Initiation of IVIG in the Treatment of Anti-HMGCR Immune-Mediated Necrotizing Myopathy. Arthritis Care + Research. 2024$$$$$Y$$$20240813$$MD$US$US
242048501$24204850$1$I$$20240807$20240813$20240813$EXP$$NVSJ2024JP009557$NOVARTIS$Masuno H, Nakamura K, Sasaki T, Fujino M, Kawasaki Y and Yoshida Y et al.. Two Cases of Epstein-Barr Virus-Associated Lymphoproliferative Disorders with Cardiovascular Lesions. Journal of the Japanese Society of Pediatric Cardiology and Cardiac Surgery, The. 2024;II-P03-3-07$7$YR$$M$Y$$$20240813$$HP$JP$JP
242048511$24204851$1$I$$20240807$20240813$20240813$EXP$$NVSJ2024JP009571$NOVARTIS$Nukui J, Tachibana T, Miyazaki T, Tanaka M, Matsumoto K, Ishii Y, et al. Clinical significance of total nucleated cell count in bone marrow of patients with acute lymphoblastic leukemia who underwent allogeneic hematopoietic stem cell. International Journal of Hematology. 2024;119:62-70$61$YR$$M$Y$$$20240813$$HP$JP$JP
242048521$24204852$1$I$$20240807$20240813$20240813$EXP$$NVSJ2024JP009572$NOVARTIS$Nukui J, Tachibana T, Miyazaki T, Tanaka M, Matsumoto K, Ishii Y et al.. Clinical significance of total nucleated cell count in bone marrow of patients with acute lymphoblastic leukemia who underwent allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 2024;119:62-70$39$YR$$M$Y$$$20240813$$HP$JP$JP
242048531$24204853$1$I$$20240807$20240813$20240813$EXP$$NVSJ2024JP009559$NOVARTIS$Fujisaki T, Ishii Y, Nagano H, Hayashida Y, Mori M, Asada D, et al.. Three cases of cardiac rhabdomyoma with tuberous sclerosis with different clinical courses. The 30th Annual Meeting of Japanese Society of Fetal Cardiology (Program and Abs. 2024;O10-7$$$N$$Y$$$20240813$$HP$JP$JP
242048541$24204854$1$I$20240604$20240805$20240813$20240813$EXP$FR-AFSSAPS-AN2024000964$FR-TEVA-VS-3230472$TEVA$$73$YR$$M$Y$$$20240813$$MD$FR$FR
242048551$24204855$1$I$$20240805$20240813$20240813$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020789$UNITED THERAPEUTICS$$$$$M$Y$83.9$KG$20240813$$$US$US
242048561$24204856$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55312$$FDA-CTU$$56$YR$$F$N$$$20240812$N$$US$
242048571$24204857$1$I$$20240807$20240813$20240813$EXP$$BE-MYLANLABS-2024M1074047$MYLAN$$$$$F$Y$$$20240813$$MD$BE$BE
242048581$24204858$1$I$20240310$20240806$20240813$20240813$EXP$FR-AFSSAPS-AN2024000995$FR-MYLANLABS-2024M1073855$MYLAN$$69$YR$$M$Y$50$KG$20240813$$MD$FR$FR
242048591$24204859$1$I$$20240806$20240813$20240813$PER$$US-MYLANLABS-2024M1073794$MYLAN$$$$$M$Y$$$20240813$$CN$US$US
242048601$24204860$1$I$$20240731$20240813$20240813$EXP$$US-MYLANLABS-2024M1072587$MYLAN$$$$$F$Y$$$20240813$$HP$US$US
242048612$24204861$2$F$$20240913$20240813$20240919$EXP$$PT-MYLANLABS-2024M1073566$MYLAN$Lagarteira J, Ferreira CA, Sa S, Pera R, Carrascal A.. Lagarteira J, Ferreira CA, Sa S, Pera R, Carrascal A.. A case of cardiotoxicity due to chemotherapy. Congresses of the Portuguese Society of Internal Medicine. 2024;30:463$66$YR$$M$Y$$$20240919$$MD$PT$PT
242048621$24204862$1$I$$20240806$20240813$20240813$EXP$$US-MYLANLABS-2024M1074700$MYLAN$Gillespie L, Diaz M, Gorder K, Shaw C, Ahmad S, Hinckley W, et al. The Successful Rotor Wing Transport of 2 Patients Requiring Biventricular Impella Support: A Case Series and Review. [Review]. Air-Med-J 2023; 42 499-503.$81$YR$$F$Y$$$20240813$$HP$US$US
242048631$24204863$1$I$$20240730$20240813$20240813$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00677$Phathom Pharmaceuticals$$$$$$Y$$$20240813$$PH$JP$JP
242048641$24204864$1$I$20240701$20240730$20240813$20240813$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00676$Phathom Pharmaceuticals$$54$YR$$F$Y$$$20240813$$MD$JP$JP
242048651$24204865$1$I$20230701$20240802$20240813$20240813$EXP$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-119866$GB-RDY-SPO/GBR/24/0011421$DR REDDYS$$61$YR$A$F$Y$84$KG$20240813$$PH$GB$GB
242048661$24204866$1$I$$20240805$20240813$20240813$PER$$US-RDY-CLI/USA/24/0011606$DR REDDYS$$8$YR$T$F$Y$19$KG$20240813$$CN$US$US
242048681$24204868$1$I$$20240812$20240813$20240813$PER$$US-HALEON-2191753$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242048691$24204869$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127031$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240813$$CN$US$US
242048701$24204870$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240825469$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240813$$CN$US$US
242048711$24204871$1$I$$20240705$20240813$20240813$30DAY$$DE-UCBSA-2024035590$UCB$$$$E$M$Y$$$20240813$$PH$DE$DE
242048721$24204872$1$I$20240721$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A182337$ASTRAZENECA$$17220$DY$$F$Y$$$20240813$$CN$US$
242048731$24204873$1$I$20240729$20240805$20240813$20240813$EXP$$US-TORRENT-00013707$TORRENT$$$$$M$Y$$$20240813$$PH$US$US
242048741$24204874$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_07157223$CA-Accord-440311$ACCORD$$72$YR$E$M$Y$$$20240813$$HP$CA$CA
242048752$24204875$2$F$20240110$20240814$20240813$20240824$EXP$GB-MHRA-MED-202405161316449030-BKDSY$GB-Accord-434539$ACCORD$$13$YR$T$M$Y$$$20240824$$CN$GB$GB
242048761$24204876$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_07151016$CA-Accord-440314$ACCORD$$75$YR$E$F$Y$$$20240813$$HP$CA$CA
242048771$24204877$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-001087128$CA-Accord-440379$ACCORD$$67$YR$E$M$Y$$$20240813$$MD$CA$CA
242048781$24204878$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-001092028$CA-Accord-440272$ACCORD$$57$YR$A$F$Y$97$KG$20240813$$HP$CA$CA
242048791$24204879$1$I$20240724$20240801$20240813$20240813$EXP$CN-HENLIUS-24CN016261$CN-Accord-441007$ACCORD$$51$YR$A$F$Y$80$KG$20240813$$MD$CN$CN
242048801$24204880$1$I$$20240801$20240813$20240813$EXP$NL-LRB-00993530$NL-Accord-439894$ACCORD$$58$YR$A$F$Y$77$KG$20240813$$PH$NL$NL
242048811$24204881$1$I$20240731$20240801$20240813$20240813$EXP$$US-Accord-440137$ACCORD$$31$YR$A$F$Y$$$20240813$$HP$US$US
242048821$24204882$1$I$20210101$20240801$20240813$20240813$EXP$$CN-Accord-440390$ACCORD$Bai G, Bai Y, Guan H, Ren H, Li H, Wang Y. A case report of lymphoproliferative disease in brain following therapies with mycophenolate Mofetil and Fingolimod and literature review. J Neuroimmunol. 2024 Jul 23;394:578410.$4$DEC$A$M$Y$$$20240813$$HP$CN$CN
242048832$24204883$2$F$20210101$20240816$20240813$20240828$EXP$$IN-Accord-440926$ACCORD$Modi D, Dessureault S, Greene J. Diagnosis and Treatment Challenges of Candida guilliermondii in Immunocompromised Patients: A Case Study in a Neutropenic AML Patient. Case Rep Infect Dis. 2024 Jul 22;2024:7806235.$30$YR$A$F$Y$$$20240828$$HP$IN$IN
242048841$24204884$1$I$20240730$20240801$20240813$20240813$EXP$$US-Accord-440135$ACCORD$$73$YR$E$M$Y$$$20240813$$HP$US$US
242048851$24204885$1$I$$20240801$20240813$20240813$EXP$$US-Accord-440127$ACCORD$$34$YR$A$F$Y$$$20240813$$MD$US$US
242048862$24204886$2$F$20240722$20240812$20240813$20240919$EXP$$US-Accord-440134$ACCORD$$52$YR$A$F$Y$$$20240919$$MD$US$US
242048872$24204887$2$F$20230101$20240808$20240813$20240820$EXP$$GR-Accord-440172$ACCORD$Angelousi A, Jouinot A, Bourgioti C, Tokmakidis P, Bertherat J, Kaltsas G. Transformation of a Benign Adrenocortical Adenoma to a Metastatic Adrenocortical Carcinoma Is Rare But It Happens. JCEM case reports. 2024;2(8):luae131.$64$YR$A$M$Y$$$20240820$$HP$GR$GR
242048881$24204888$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55316$$FDA-CTU$$$$$M$N$$$20240812$N$HP$US$
242048891$24204889$1$I$$20240801$20240813$20240813$EXP$CA-MHPD-E2B_07150682$CA-Accord-440294$ACCORD$$11$YR$C$F$Y$$$20240813$$HP$CA$CA
242048903$24204890$3$F$$20240924$20240813$20240927$30DAY$$US-PFIZER INC-202400231534$PFIZER$$12$YR$$F$Y$$$20240927$$MD$US$US
242048913$24204891$3$F$$20240912$20240813$20240918$30DAY$$US-PFIZER INC-202400228851$PFIZER$$16$YR$$M$Y$$$20240918$$CN$US$US
242048921$24204892$1$I$20240705$20240801$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002484$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242048932$24204893$2$F$$20240903$20240813$20240909$EXP$$NVSJ2024JP009574$NOVARTIS$Nishijima K and Hashimoto A.. A case of pyoderma gangrenosum in the right breast. The Nishinihon Journal of Dermatology/The 87th Saga Regional Meeting of JDA. 2024;86:98$25$YR$$F$Y$$$20240909$$HP$JP$JP
242048941$24204894$1$I$20240808$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160261$AMGEN$$79$YR$E$M$Y$$$20240813$$CN$US$US
242048951$24204895$1$I$20240801$20240807$20240813$20240813$PER$$US-AMGEN-USASP2024158242$AMGEN$$$$$F$Y$$$20240813$$PH$US$US
242048961$24204896$1$I$$20240806$20240813$20240813$EXP$$AR-AMGEN-USASP2024156939$AMGEN$$$$$$Y$$$20240813$$CN$AR$AR
242048971$24204897$1$I$20240808$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159339$AMGEN$$$$$$Y$$$20240813$$PH$US$US
242048981$24204898$1$I$$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024159694$AMGEN$Sharf K.; Chahin N.; Do T. et.al.. Benefits of Early vs Late Initiation of IVIG in the Treatment of Anti-HMGCR Immune-Mediated Necrotizing Myopathy. Arthritis Care + Research. 2024$$$$$Y$$$20240813$$MD$US$US
242048991$24204899$1$I$$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024159692$AMGEN$Sharf K.; Chahin N.; Do T. et.al.. Benefits of Early vs Late Initiation of IVIG in the Treatment of Anti-HMGCR Immune-Mediated Necrotizing Myopathy. Arthritis Care + Research. 2024$$$$$Y$$$20240813$$MD$US$US
242049001$24204900$1$I$$20240731$20240813$20240813$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07431$HIKMA$Worth L, Khreisat A, Iacobelli A.. Worth L, Khreisat A, Iacobelli A. Successful Treatment of Relapsing Chronic Eosinophilic Pneumonia With Mepolizumab: A Case Report. Cureus. 2024;16(7):e65097$73$YR$$M$Y$$$20240812$$MD$US$US
242049011$24204901$1$I$20240731$20240812$20240813$20240813$EXP$$US-INCYTE CORPORATION-2024IN008438$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242049022$24204902$2$F$$20240829$20240813$20240906$EXP$$US-THEA-2024001719$Thea Pharma$Xia YU, Blecher NA, Custer PL, Sieck EG.. Optimizing topical drop efficacy with proper eyelid positioning. . American Journal of Ophthalmology Case Reports. . 2024;36:10:2111. doi:10.1016/j.ajoc.2024.102111.$71$YR$$M$Y$$$20240906$$MD$US$US
242049031$24204903$1$I$$20240812$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US072184$SANDOZ$$$$$F$Y$$$20240813$$CN$US$US
242049041$24204904$1$I$20240727$20240809$20240813$20240813$EXP$$US-INCYTE CORPORATION-2024IN008414$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242049051$24204905$1$I$$20240801$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-040219$AUROBINDO$Muram S, Mitha A.. Natural history of antiplatelet nonresponders undergoing carotid artery  stenting.. Journal of Neurosurgery.. 2023;139 ISSUE 3:661-669$$$$$Y$$$20240813$$MD$CA$CA
242049063$24204906$3$F$20220308$20240816$20240813$20240910$EXP$PT-INFARMED-M202210-1039$PT-GILEAD-2024-0683841$GILEAD$$85$YR$E$F$Y$$$20240910$$MD$PT$PT
242049071$24204907$1$I$20240701$20240729$20240813$20240813$EXP$$SE-TEVA-VS-3228787$TEVA$$87$YR$$F$Y$$$20240813$$CN$SE$SE
242049082$24204908$2$F$$20240910$20240813$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07145$LUPIN$$$$$$Y$$$20240925$$CN$US$US
242049092$24204909$2$F$20240601$20240912$20240813$20240917$EXP$$US-INCYTE CORPORATION-2024IN008407$INCYTE$$$$$$Y$$$20240917$$CN$US$US
242049101$24204910$1$I$20240326$20240805$20240813$20240813$EXP$PT-INFARMED-J202407-855$PT-TAKEDA-2024TUS078122$TAKEDA$$61$YR$$F$Y$$$20240813$$HP$PT$PT
242049112$24204911$2$F$$20240910$20240813$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07019$LUPIN$$$$$$Y$$$20240925$$CN$US$US
242049121$24204912$1$I$20240803$20240805$20240813$20240813$EXP$$US-LUNDBECK-DKLU4002729$LUNDBECK$$$$$$Y$$$20240813$$HP$US$US
242049131$24204913$1$I$20230513$20240801$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-038799$AUROBINDO$$63$YR$$M$Y$91$KG$20240813$$MD$FR$FR
242049141$24204914$1$I$$20240808$20240813$20240813$EXP$$DE-AMGEN-DEUSP2024160032$AMGEN$Schreiber S.; Cross R.K.; Panaccione R. et al.. Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn^s disease. Alimentary  Pharmacology + Therapeutics. 2024;1-10$$$$$Y$$$20240813$$HP$DE$DE
242049152$24204915$2$F$20240802$20240816$20240813$20240823$PER$$US-AMGEN-USASP2024155175$AMGEN$$$$$$Y$$$20240822$$PH$US$US
242049161$24204916$1$I$$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158096$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
242049174$24204917$4$F$20240101$20240913$20240813$20240924$EXP$$US-INSMED, INC.-2024-02614-US$INSMED$$$$$F$Y$$$20240924$$CN$US$US
242049181$24204918$1$I$$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024159696$AMGEN$Sharf K.; Chahin N.; Do T. et.al.. Benefits of Early vs Late Initiation of IVIG in the Treatment of Anti-HMGCR Immune-Mediated Necrotizing Myopathy. Arthritis Care + Research. 2024$$$$$Y$$$20240813$$MD$US$US
242049203$24204920$3$F$$20240919$20240813$20240919$30DAY$$US-PFIZER INC-202400231958$PFIZER$$14$YR$$M$Y$$$20240919$$HP$US$US
242049211$24204921$1$I$$20240730$20240813$20240813$30DAY$$DE-PFIZER INC-202400227252$PFIZER$$$$$$Y$$$20240813$$HP$DE$DE
242049222$24204922$2$F$$20240912$20240813$20240912$30DAY$$US-PFIZER INC-202400232810$PFIZER$$16$YR$$M$Y$$$20240912$$CN$US$US
242049232$24204923$2$F$20240707$20240812$20240813$20240815$EXP$$US-AMGEN-USASP2024159283$AMGEN$$87$YR$E$F$Y$$$20240815$$HP$US$US
242049241$24204924$1$I$$20240812$20240813$20240813$EXP$$CA-PFIZER INC-202400234933$PFIZER$$77$YR$$F$Y$$$20240813$$HP$CA$CA
242049251$24204925$1$I$$20240812$20240813$20240813$PER$$NVSC2024US163946$NOVARTIS$$$$$$Y$$$20240813$$PH$US$US
242049261$24204926$1$I$$20240812$20240813$20240813$PER$$US-HALEON-2191638$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242049271$24204927$1$I$20240803$20240805$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US072068$SANDOZ$$47$YR$$F$Y$$$20240813$$CN$US$US
242049281$24204928$1$I$$20240809$20240813$20240813$EXP$$JP-SANDOZ INC.-SDZ2024JP071836$SANDOZ$$$$E$F$Y$$$20240813$$MD$JP$JP
242049291$24204929$1$I$$20240715$20240813$20240813$PER$$US-TRAVERE-2024TVT00709$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240813$$CN$US$US
242049301$24204930$1$I$20240721$20240809$20240813$20240813$EXP$$US-INCYTE CORPORATION-2024IN008398$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242049311$24204931$1$I$$20240801$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-039671$AUROBINDO$Harris M, Larsen G, Montaner J.. Exacerbation of depression associated with starting  raltegravir: a report of four cases.. AIDS.. 2008;22 (14):1890-1892$40$YR$$M$Y$$$20240813$$MD$CA$CA
242049321$24204932$1$I$20240808$20240809$20240813$20240813$EXP$$CN-FreseniusKabi-FK202412350$FRESENIUS KABI$$79$YR$E$M$Y$60$KG$20240813$$HP$CN$CN
242049332$24204933$2$F$20240709$20240820$20240813$20240822$EXP$$US-INCYTE CORPORATION-2024IN008390$INCYTE$$$$$$Y$$$20240822$$HP$US$US
242049341$24204934$1$I$$20240731$20240813$20240813$EXP$$US-RDY-LIT/USA/24/0011519$DR REDDYS$Noor F, Ali M, Khan H, Cluzet V. A RARE CASE OF POLYURIA SECONDARY TO VASOPRESSIN WITHDRAWAL IN A CRITICALLY ILL PATIENT. Critical Care Medicine. 2024;52(1): S725. doi:10.1097/01.ccm.0001004188.88923.b1.$67$YR$E$M$Y$$$20240813$$HP$US$US
242049362$24204936$2$F$$20240910$20240813$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07151$LUPIN$$$$$$Y$$$20240925$$CN$US$US
242049371$24204937$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07412$HIKMA$$43$YR$$F$Y$$$20240813$$HP$CA$CA
242049381$24204938$1$I$20240412$20240730$20240813$20240813$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000735$PAREXEL$$$$$$Y$$$20240813$$HP$CN$CN
242049391$24204939$1$I$$20240801$20240813$20240813$EXP$$US-RDY-LIT/USA/24/0011669$DR REDDYS$Pang S, Saleh H, Ailawadhi S, Edgar M, Pang M. Acute esophageal stricture after bone marrow transplant. Clinical Journal of Gastroenterology. 2024;17: 1-5. doi:10.1007/s12328-023-01879-7.$58$YR$A$M$Y$$$20240813$$HP$US$US
242049402$24204940$2$F$20210103$20240819$20240813$20240826$EXP$PT-INFARMED-M202210-641$PT-GILEAD-2024-0683883$GILEAD$$88$YR$E$M$Y$$$20240826$$MD$PT$PT
242049411$24204941$1$I$20240501$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127079$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240813$$CN$US$US
242049431$24204943$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126317$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240813$$CN$US$US
242049442$24204944$2$F$$20240819$20240813$20240823$EXP$$NVSC2024CA159908$NOVARTIS$$40$YR$$F$Y$$$20240823$$HP$CA$CA
242049451$24204945$1$I$20240731$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55313$$FDA-CTU$$80$YR$$F$N$$$20240812$N$PH$US$
242049471$24204947$1$I$$20240801$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-040215$AUROBINDO$Caylie M. Poirier, Aleesa A. Carter,Yvonne Kwan, Jessica Koo,Jill M. Westlund, Fadi Alkass,Kori Leblanc.. Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic  Therapy Post-Percutaneous Coronary Intervention.. CJC Open. 2023$74$YR$$F$Y$$$20240813$$MD$CA$CA
242049482$24204948$2$F$$20240905$20240813$20240917$EXP$$IN-ROCHE-10000054234$ROCHE$$59$YR$A$F$Y$$$20240917$$CN$IN$IN
242049491$24204949$1$I$$20240808$20240813$20240813$EXP$$US-INCYTE CORPORATION-2024IN008359$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242049502$24204950$2$F$20240101$20240904$20240813$20240913$EXP$$US-TEVA-VS-3231167$TEVA$$59$YR$$F$Y$$$20240913$$CN$US$US
242049511$24204951$1$I$20240711$20240801$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-039451$AUROBINDO$$29$YR$$F$Y$53.7$KG$20240813$$PH$FR$FR
242049521$24204952$1$I$20240501$20240813$20240813$20240813$EXP$SE-SEMPA-2024-005998$SE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045403$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$$$20240813$$MD$SE$SE
242049532$24204953$2$F$$20240819$20240813$20240826$EXP$$NL-TEVA-VS-3231210$TEVA$Dormans T, Zandijk E, Stals F. LATE TUBERCULOSIS REACTIVATION AFTER SEVERE COVID-19. Eur-J-Case-Rep-Intern-Med 2024; 11 (5):.; Dormans T, Zandijk E, Stals F. LATE TUBERCULOSIS REACTIVATION AFTER SEVERE COVID-19. Eur-J-Case-Rep-Intern-Med 2024; 11 (5):.$$$E$F$Y$$$20240826$$HP$NL$NL
242049541$24204954$1$I$$20240807$20240813$20240813$PER$$US-DSJP-DSU-2024-140317$DAIICHI$$$$$F$Y$$$20240813$$CN$US$US
242049551$24204955$1$I$$20240802$20240813$20240813$EXP$$US-ROCHE-10000033768$ROCHE$$72$YR$E$M$Y$$$20240813$$CN$US$US
242049561$24204956$1$I$20240214$20240805$20240813$20240813$EXP$$JP-DSJP-DSJ-2024-116919$DAIICHI$$59$YR$$M$Y$69.5$KG$20240813$$MD$JP$JP
242049571$24204957$1$I$$20240808$20240813$20240813$EXP$$BR-AMGEN-BRASP2024158859$AMGEN$$70$YR$E$F$Y$$$20240813$$CN$BR$BR
242049581$24204958$1$I$$20240810$20240813$20240813$EXP$$NVSC2024PH163240$NOVARTIS$$$$$F$Y$$$20240813$$CN$PH$PH
242049591$24204959$1$I$$20240811$20240813$20240813$PER$$NVSC2024US163918$NOVARTIS$$60$YR$$M$Y$83.91$KG$20240813$$CN$US$US
242049602$24204960$2$F$20210713$20240815$20240813$20240826$EXP$PT-INFARMED-M202210-793$PT-GILEAD-2024-0683877$GILEAD$$55$YR$A$M$Y$$$20240826$$MD$PT$PT
242049611$24204961$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-072165$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$90.26$KG$20240813$$CN$US$US
242049621$24204962$1$I$$20240801$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-040179$AUROBINDO$$76$YR$$M$Y$$$20240813$$PH$CA$CA
242049631$24204963$1$I$20240708$20240730$20240813$20240813$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000744$PAREXEL$$$$$$Y$$$20240813$$HP$CN$CN
242049651$24204965$1$I$$20240809$20240813$20240813$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-127208$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240813$$CN$PR$PR
242049661$24204966$1$I$$20240812$20240813$20240813$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-127606$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$$$20240813$$HP$TW$TW
242049671$24204967$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127822$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240813$$MD$US$US
242049681$24204968$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127032$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240813$$HP$US$US
242049691$24204969$1$I$$20240805$20240813$20240813$30DAY$$US-GSK-US2024097588$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242049701$24204970$1$I$$20240806$20240813$20240813$EXP$$ES-MYLANLABS-2024M1073343$MYLAN$Condom Esteve M, Roig Buscato C. Patient with generalized blistering lesions. AMF. 2024;20(6):1$77$YR$$F$Y$$$20240813$$MD$ES$ES
242049711$24204971$1$I$20100111$20240806$20240813$20240813$EXP$$FR-MYLANLABS-2024M1073363$MYLAN$$22$YR$$M$Y$$$20240813$$MD$FR$FR
242049721$24204972$1$I$20240418$20240806$20240813$20240813$EXP$HR-HALMED-300085249$HR-MYLANLABS-2024M1073544$MYLAN$$$$A$M$Y$$$20240813$$MD$HR$HR
242049731$24204973$1$I$$20240805$20240813$20240813$EXP$$TW-TEVA-VS-3231203$TEVA$Tsai J-H, Lee K-T. The Real-world Experiences of Abemaciclib for Estrogen Receptor-positive Human Epidermal Growth Factor Receptor-negative-2 Metastatic Breast Cancer - Sharing from a Single Institute in Southern Taiwan. J-Cancer-Res-Pract 2024; 11 (2): 73-76.; Tsai J-H, Lee K-T. The Real-world Experiences of Abemaciclib for Estrogen Receptor-positive Human Epidermal Growth Factor Receptor-negative-2 Metastatic Breast Cancer - Sharing from a Single Institute in Southern Taiwan. J-Cancer-Res-P...$62$YR$$F$Y$$$20240813$$HP$TW$TW
242049741$24204974$1$I$$20240731$20240813$20240813$EXP$$US-MYLANLABS-2024M1073060$MYLAN$Attieh RM, Brumble L, Elwasila SM, Wadei HM. Disseminated Monkeypox Infection in a Kidney Transplant Recipient: A Case Report. Transplant-Proc 2023; 55 (3): 667-671.$44$YR$$M$Y$$$20240813$$MD$US$US
242049751$24204975$1$I$20240606$20240805$20240813$20240813$PER$$US-AMGEN-USASP2024155532$AMGEN$$67$YR$E$F$Y$$$20240813$$CN$US$US
242049764$24204976$4$F$20240712$20240905$20240813$20240909$EXP$$FR-SANDOZ INC.-SDZ2024FR071968$SANDOZ$$$$A$M$Y$93$KG$20240909$$MD$FR$FR
242049771$24204977$1$I$$20240801$20240813$20240813$EXP$$CA-AUROBINDO-AUR-APL-2024-040198$AUROBINDO$$72$YR$$M$Y$86$KG$20240813$$PH$CA$CA
242049781$24204978$1$I$20240608$20240621$20240813$20240813$PER$$US-LUNDBECK-DKLU4001075$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
242049791$24204979$1$I$$20240807$20240813$20240813$EXP$$NVSC2024TW162625$NOVARTIS$$45$YR$$F$Y$$$20240813$$MD$TW$TW
242049812$24204981$2$F$20220217$20240815$20240813$20240826$EXP$PT-INFARMED-M202210-1042$PT-GILEAD-2024-0683852$GILEAD$$85$YR$E$F$Y$$$20240826$$MD$PT$PT
242049821$24204982$1$I$20240625$20240729$20240813$20240813$EXP$ES-TEVA-VS-3220112$ES-SERVIER-S24009553$SERVIER$$$$$$Y$$$20240813$$MD$ES$ES
242049831$24204983$1$I$20240601$20240809$20240813$20240813$EXP$$JP-BAYER-2024A116211$BAYER$$$$$F$Y$$$20240813$$PH$JP$JP
242049841$24204984$1$I$20230101$20240805$20240813$20240813$EXP$FR-AFSSAPS-RN2024000815$FR-TEVA-VS-3229923$TEVA$$74$YR$$F$Y$$$20240813$$MD$FR$FR
242049851$24204985$1$I$20231001$20240731$20240813$20240813$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000761$PAREXEL$$$$$$Y$$$20240813$$HP$CN$CN
242049861$24204986$1$I$20240720$20240805$20240813$20240813$EXP$$FR-ZAMBON SWITZERLAND LTD.-2024-ZAM-FR000044$PAREXEL$$$$$$Y$$$20240813$$MD$FR$FR
242049871$24204987$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127397$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240813$$HP$US$US
242049883$24204988$3$F$$20240920$20240813$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127497$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$$$20240923$$HP$US$US
242049891$24204989$1$I$20240723$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127199$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$58.97$KG$20240813$$HP$US$US
242049901$24204990$1$I$20240101$20240806$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125256$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$98.43$KG$20240813$$PH$US$US
242049911$24204991$1$I$20240718$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126937$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240813$$CN$US$US
242049921$24204992$1$I$$20240808$20240813$20240813$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-109929$REGENERON$$$$$F$Y$$$20240813$$CN$US$US
242049931$24204993$1$I$$20240808$20240813$20240813$EXP$$US-JNJFOC-20240828349$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
242049941$24204994$1$I$$20240808$20240813$20240813$PER$$US-HALEON-2191255$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242049951$24204995$1$I$20220101$20240805$20240813$20240813$EXP$$SG-ROCHE-10000050736$ROCHE$$55$YR$A$F$Y$$$20240813$$CN$SG$SG
242049961$24204996$1$I$20240718$20240803$20240813$20240813$EXP$FR-AFSSAPS-RN2024000850$FR-LEO Pharma-372496$LEO PHARM$$25$YR$$F$Y$$$20240813$$MD$FR$FR
242049971$24204997$1$I$20240812$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55350$$FDA-CTU$$65$YR$$M$N$$$20240812$Y$PH$US$
242049981$24204998$1$I$20240812$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55333$$FDA-CTU$$73$YR$$F$N$$$20240812$Y$PH$US$
242049991$24204999$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55438$$FDA-CTU$$$$$M$N$$$20240812$N$HP$US$
242050011$24205001$1$I$20240731$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006591$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240813$$CN$US$US
242050022$24205002$2$F$$20240812$20240813$20240820$30DAY$$US-ELI_LILLY_AND_COMPANY-US202408007380$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240820$$CN$US$US
242050031$24205003$1$I$20210118$20240812$20240813$20240813$EXP$PT-INFARMED-M202210-670$PT-GILEAD-2024-0683859$GILEAD$$79$YR$E$M$Y$$$20240813$$MD$PT$PT
242050041$24205004$1$I$$20240808$20240813$20240813$EXP$$US-INCYTE CORPORATION-2024IN008342$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242050051$24205005$1$I$20240101$20240808$20240813$20240813$EXP$$CA-UCBSA-2024039721$UCB$$$$$M$Y$$$20240813$$CN$CA$CA
242050061$24205006$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024160487$AMGEN$$$$$$Y$$$20240813$$MD$US$US
242050071$24205007$1$I$20240415$20240805$20240813$20240813$EXP$FR-AFSSAPS-TO2024001421$FR-TEVA-VS-3230434$TEVA$$55$YR$$F$Y$$$20240813$$MD$FR$FR
242050082$24205008$2$F$$20240917$20240813$20240925$EXP$$US-ROCHE-10000048322$ROCHE$$67$YR$E$M$Y$$$20240925$$CN$US$US
242050091$24205009$1$I$$20240812$20240813$20240813$PER$$US-HALEON-2191729$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242050101$24205010$1$I$$20240717$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07354$LUPIN$$$$$$Y$$$20240813$$MD$US$US
242050112$24205011$2$F$$20240827$20240813$20240903$EXP$$JP-AMGEN-JPNSP2024159660$AMGEN$$$$$M$Y$$$20240903$$MD$JP$JP
242050121$24205012$1$I$$20240811$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127171$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240813$$CN$US$US
242050132$24205013$2$F$$20240819$20240813$20240826$EXP$$TW-TEVA-VS-3231202$TEVA$Tsai J-H, Lee K-T. The Real-world Experiences of Abemaciclib for Estrogen Receptor-positive Human Epidermal Growth Factor Receptor-negative-2 Metastatic Breast Cancer - Sharing from a Single Institute in Southern Taiwan. J-Cancer-Res-Pract 2024; 11 (2): 73-76.; Tsai J-H, Lee K-T. The Real-world Experiences of Abemaciclib for Estrogen Receptor-positive Human Epidermal Growth Factor Receptor-negative-2 Metastatic Breast Cancer - Sharing from a Single Institute in Southern Taiwan. J-Cancer-Res-P...$83$YR$$F$Y$$$20240826$$HP$TW$TW
242050141$24205014$1$I$$20240731$20240813$20240813$EXP$$CA-B.Braun Medical Inc.-2160348$B BRAUN$$95$YR$$F$Y$$$20240813$$$CA$CA
242050151$24205015$1$I$20240701$20240810$20240813$20240813$PER$$US-Prasco Laboratories-PRAS20241086$PRASCO$$81$YR$E$F$Y$$$20240813$$CN$US$US
242050161$24205016$1$I$$20240621$20240813$20240813$PER$$US-LUNDBECK-DKLU4001077$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
242050173$24205017$3$F$20220120$20240816$20240813$20240910$EXP$PT-INFARMED-M202210-1035$PT-GILEAD-2024-0683853$GILEAD$$90$YR$E$F$Y$$$20240910$$MD$PT$PT
242050181$24205018$1$I$20230101$20240724$20240813$20240813$PER$$US-APOTEX-2024AP008799$APOTEX$$$$E$F$Y$$$20240813$$CN$US$US
242050192$24205019$2$F$$20240805$20240813$20240829$EXP$$JP-009507513-2408JPN000596J$MERCK$Maruyama S, Adachi Y, Takahashi T, Matsuyama S, Kuroudu N, Kobayashi D, et al.. 38 A case of unilateral drug-induced lung disorder due to Pembrolizumab involving talc suspension. The 260th Kanto Regional Meeting of the Japanese Respiratory Society. 24$70$YR$$M$Y$$$20240829$$MD$JP$JP
242050203$24205020$3$F$20231201$20240906$20240813$20240910$EXP$$JP-PERRIGO-24JP007509$PERRIGO$$22$YR$$F$Y$43$KG$20240910$$MD$JP$JP
242050214$24205021$4$F$20240801$20240919$20240813$20240919$30DAY$$US-PFIZER INC-202400232500$PFIZER$$15$YR$$M$Y$$$20240919$$HP$US$US
242050232$24205023$2$F$$20240920$20240813$20240925$30DAY$$KR-PFIZER INC-PV202400102625$PFIZER$$9$YR$$M$Y$$$20240925$$CN$KR$KR
242050243$24205024$3$F$$20240925$20240813$20240930$30DAY$$US-PFIZER INC-PV202400044245$PFIZER$$$$$$Y$$$20240930$$HP$US$US
242050264$24205026$4$F$$20240905$20240813$20240909$30DAY$$US-PFIZER INC-PV202400044342$PFIZER$$$$$$Y$$$20240909$$HP$US$US
242050272$24205027$2$F$$20240814$20240813$20240816$30DAY$$US-PFIZER INC-202400232969$PFIZER$$38$YR$$F$Y$109$KG$20240816$$PH$US$US
242050283$24205028$3$F$$20240912$20240813$20240918$30DAY$$US-PFIZER INC-202400230738$PFIZER$$15$YR$$M$Y$68.04$KG$20240918$$CN$US$US
242050291$24205029$1$I$20230731$20240805$20240813$20240813$EXP$ES-AEMPS-1553800$ES-TEVA-VS-3231054$TEVA$$76$YR$$F$Y$$$20240813$$MD$ES$ES
242050301$24205030$1$I$20240731$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024159482$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242050311$24205031$1$I$20240704$20240805$20240813$20240813$EXP$$CN-ROCHE-10000049753$ROCHE$$62$YR$A$F$Y$59$KG$20240813$$HP$CN$CN
242050321$24205032$1$I$$20240806$20240813$20240813$EXP$GB-002147023-NVSC2022GB181391$GB-RDY-SPO/UKI/22/0153491$DR REDDYS$$$$E$F$Y$$$20240813$$CN$GB$GB
242050331$24205033$1$I$20240221$20240805$20240813$20240813$EXP$FR-AFSSAPS-NC2024000919$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07543$HIKMA$$48$YR$$F$Y$97$KG$20240813$$MD$FR$FR
242050341$24205034$1$I$$20240807$20240813$20240813$EXP$$BR-TAKEDA-2024TUS079928$TAKEDA$$22$YR$$$Y$$$20240813$$CN$BR$BR
242050361$24205036$1$I$$20240806$20240813$20240813$30DAY$$US-GSK-US2024098155$GLAXOSMITHKLINE$$$$$M$Y$$$20240813$$CN$US$US
242050374$24205037$4$F$$20240819$20240813$20240823$EXP$$NVSC2024CA163296$NOVARTIS$$40$YR$$F$Y$$$20240823$$HP$CA$CA
242050381$24205038$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07423$HIKMA$$12$MON$$M$Y$10$KG$20240813$$HP$CA$CA
242050391$24205039$1$I$$20240804$20240813$20240813$EXP$$PL-ROCHE-10000050273$ROCHE$$$$A$F$Y$$$20240813$$MD$PL$PL
242050402$24205040$2$F$20210529$20240815$20240813$20240826$EXP$PT-INFARMED-M202210-791$PT-GILEAD-2024-0683862$GILEAD$$74$YR$E$M$Y$$$20240826$$MD$PT$PT
242050411$24205041$1$I$$20240806$20240813$20240813$EXP$$AU-009507513-2408AUS002189$MERCK$Nguyen C, Kaur R, Vaishnav M, Kurup R. Coronary Artery Vasospasm Presenting as Myocardial Infarction With Non-obstructive Coronary Arteries (MINOCA) in a Patient on Previous Immunotherapy for Melanoma. Heart Lung and Circulation. 2024;33(4):299$65$YR$$F$Y$$$20240813$$HP$AU$AU
242050421$24205042$1$I$$20240808$20240813$20240813$PER$$US-JNJFOC-20240826015$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
242050431$24205043$1$I$$20240801$20240813$20240813$PER$CA-AstraZeneca-2023A150264$CA-LEO Pharma-372644$LEO PHARM$$52$YR$$F$Y$$$20240813$$MD$CA$CA
242050451$24205045$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55355$$FDA-CTU$$61$YR$$F$N$$$20240812$N$$US$
242050461$24205046$1$I$20230701$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55420$$FDA-CTU$$30$YR$$F$N$56$KG$20240812$N$CN$TR$
242050481$24205048$1$I$20240601$20240806$20240813$20240813$PER$$US-MYLANLABS-2024M1073355$MYLAN$$61$YR$$F$Y$67.13$KG$20240813$$CN$US$US
242050491$24205049$1$I$20240329$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55328$$FDA-CTU$$67$YR$$M$N$$$20240812$N$PH$US$
242050501$24205050$1$I$$20240810$20240813$20240813$EXP$$LB-PFIZER INC-PV202400104524$PFIZER$$$$$$Y$$$20240813$$MD$LB$LB
242050511$24205051$1$I$$20240808$20240813$20240813$EXP$$NVSC2024SK162557$NOVARTIS$$$$$F$Y$$$20240813$$MD$SK$SK
242050531$24205053$1$I$20231212$20240405$20240813$20240813$EXP$$NVSC2023TH192098$NOVARTIS$$60$YR$$F$Y$$$20240813$$CN$TH$TH
242050541$24205054$1$I$$20240614$20240813$20240813$EXP$$NVSC2024CA067021$NOVARTIS$$61$YR$$F$Y$$$20240813$$CN$CA$CA
242050552$24205055$2$F$20240807$20240808$20240813$20240816$PER$$NVSC2024US162500$NOVARTIS$$35$YR$$F$Y$$$20240816$$CN$US$US
242050582$24205058$2$F$20220215$20240815$20240813$20240826$EXP$PT-INFARMED-M202210-1041$PT-GILEAD-2024-0683845$GILEAD$$62$YR$A$M$Y$$$20240826$$MD$PT$PT
242050591$24205059$1$I$20211001$20240424$20240813$20240813$EXP$$NVSC2024RU069063$NOVARTIS$$67$YR$$F$Y$$$20240813$$MD$RU$RU
242050611$24205061$1$I$20240527$20240808$20240813$20240813$EXP$$ZA-MYLANLABS-2024M1074365$MYLAN$$$$$$Y$$$20240813$$HP$ZA$ZA
242050621$24205062$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240749044$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
242050634$24205063$4$F$20240801$20240820$20240813$20240828$PER$$US-AMGEN-USASP2024157645$AMGEN$$$$$$Y$$$20240827$$PH$US$US
242050641$24205064$1$I$$20240812$20240813$20240813$EXP$$PK-ROCHE-10000054981$ROCHE$$53$YR$A$M$Y$$$20240813$$CN$PK$PK
242050651$24205065$1$I$$20240808$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126477$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240813$$CN$US$US
242050661$24205066$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126891$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240813$$CN$US$US
242050671$24205067$1$I$$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126388$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240813$$CN$US$US
242050681$24205068$1$I$20240408$20240805$20240813$20240813$EXP$$CA-GSK-CA2024006326$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CA$CA
242050691$24205069$1$I$$20240802$20240813$20240813$EXP$$US-JNJFOC-20240806508$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
242050701$24205070$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07461$HIKMA$$60$YR$$M$Y$$$20240813$$HP$CA$CA
242050721$24205072$1$I$20230829$20240812$20240813$20240813$EXP$BE-FAMHP-DHH-N2024-122457$NVSC2024BE163286$NOVARTIS$$62$YR$$F$Y$$$20240813$$PH$BE$BE
242050732$24205073$2$F$20240810$20240813$20240813$20240814$PER$$US-AMGEN-USASP2024160492$AMGEN$$71$YR$E$M$Y$$$20240814$$CN$US$US
242050741$24205074$1$I$$20240527$20240813$20240813$EXP$$NVSC2022TH248194$NOVARTIS$$$$$F$Y$$$20240813$$CN$TH$TH
242050751$24205075$1$I$20240601$20240729$20240813$20240813$EXP$$US-BIOCODEX2-2024000873$BIOCODEX$$21$YR$$M$Y$44$KG$20240813$$MD$US$US
242050761$24205076$1$I$$20240808$20240813$20240813$EXP$$US-TAKEDA-2023TUS111053$TAKEDA$$$$$F$Y$91$KG$20240813$$CN$US$US
242050771$24205077$1$I$20240402$20240802$20240813$20240813$EXP$FR-AFSSAPS-NC2024000947$FR-Waylis Therapeutics LLC-ATNAHS20240802246$Waylis$$50$YR$A$M$Y$$$20240809$$PH$FR$FR
242050781$24205078$1$I$$20240725$20240813$20240813$PER$$US-JNJFOC-20240776378$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$CN$US$US
242050791$24205079$1$I$20240812$20240812$20240813$20240813$EXP$$US-JNJFOC-20240828960$JOHNSON AND JOHNSON$$82$YR$$M$Y$$$20240813$$CN$US$US
242050811$24205081$1$I$20240101$20240807$20240813$20240813$EXP$$US-SA-2024SA236417$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240813$$MD$US$US
242050821$24205082$1$I$20240101$20240807$20240813$20240813$EXP$$US-SA-2024SA238907$SANOFI AVENTIS$$18$YR$A$F$Y$49.8$KG$20240813$$MD$US$US
242050832$24205083$2$F$20240401$20240816$20240813$20240820$EXP$$NVSC2024RU163658$NOVARTIS$$$$A$F$Y$$$20240820$$HP$RU$RU
242050841$24205084$1$I$20240418$20240812$20240813$20240813$EXP$FR-AFSSAPS-AM2024000638$FR-DSJP-DSE-2024-140357$DAIICHI$$47$YR$$F$Y$66$KG$20240813$$PH$FR$FR
242050851$24205085$1$I$$20240807$20240813$20240813$EXP$$CA-BEH-2024177048$CSL BEHRING$$68$YR$E$F$Y$58$KG$20240813$$HP$CA$CA
242050862$24205086$2$F$$20240814$20240813$20240822$EXP$$RU-ORGANON-O2408RUS000013$ORGANON$$$$$F$Y$$$20240822$$MD$RU$RU
242050871$24205087$1$I$20230121$20240808$20240813$20240813$EXP$$NVSC2024FR163500$NOVARTIS$$81$YR$$M$Y$$$20240813$$HP$FR$FR
242050881$24205088$1$I$20240625$20240805$20240813$20240813$EXP$FR-AFSSAPS-NT2024000968$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07544$HIKMA$$$$$$Y$$$20240813$$MD$FR$FR
242050891$24205089$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006357$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240813$$CN$US$US
242050901$24205090$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007526$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240813$$CN$US$US
242050911$24205091$1$I$$20240801$20240813$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122785$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240813$$HP$CA$CA
242050921$24205092$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07449$HIKMA$$81$YR$$F$Y$62$KG$20240813$$PH$CA$CA
242050931$24205093$1$I$$20240709$20240813$20240813$EXP$$NVSC2024CA162568$NOVARTIS$$44$YR$$F$Y$$$20240813$$HP$CA$CA
242050951$24205095$1$I$$20240806$20240813$20240813$30DAY$$GB-PFIZER INC-PV202400102795$PFIZER$$7$YR$$F$Y$$$20240813$$CN$GB$GB
242050962$24205096$2$F$20240731$20240911$20240813$20240912$PER$$US-ROCHE-10000055863$ROCHE$$86$YR$E$F$Y$$$20240912$$CN$US$US
242050981$24205098$1$I$20240101$20240806$20240813$20240813$EXP$$CA-THEA-2024001772$Thea Pharma$$$$$F$Y$$$20240813$$CN$CA$CA
242051001$24205100$1$I$20210130$20240812$20240813$20240813$EXP$PT-INFARMED-M202210-671$PT-GILEAD-2024-0683898$GILEAD$$66$YR$E$M$Y$$$20240813$$MD$PT$PT
242051011$24205101$1$I$20240731$20240801$20240813$20240813$EXP$$US-AMNEAL-2024-AMRX-02822$AMNEAL$$5$YR$$M$Y$$$20240813$$MD$US$US
242051021$24205102$1$I$$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125421$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240813$$CN$US$US
242051031$24205103$1$I$$20240805$20240813$20240813$30DAY$$HU-UCBSA-2024039636$UCB$$$$$$Y$$$20240813$$CN$HU$HU
242051044$24205104$4$F$20220201$20240904$20240813$20240910$EXP$$NVSC2024CO157463$NOVARTIS$$33$YR$$M$Y$86$KG$20240910$$CN$CO$CO
242051051$24205105$1$I$$20240804$20240813$20240813$EXP$$GB-TEVA-VS-3230123$TEVA$$$$$M$Y$$$20240813$$HP$GB$GB
242051061$24205106$1$I$20240604$20240804$20240813$20240813$EXP$$GB-TEVA-VS-3229937$TEVA$$85$YR$$F$Y$76$KG$20240813$$CN$GB$GB
242051071$24205107$1$I$20240515$20240805$20240813$20240813$EXP$FR-AFSSAPS-PO2024000828$FR-TEVA-VS-3230447$TEVA$$39$YR$$F$Y$52$KG$20240813$$MD$FR$FR
242051081$24205108$1$I$$20240802$20240813$20240813$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07564$HIKMA$$49$YR$$M$Y$$$20240813$$MD$CA$CA
242051092$24205109$2$F$$20240911$20240813$20240918$EXP$$CA-TAKEDA-2024TUS080255$TAKEDA$$$$$F$Y$$$20240918$$MD$CA$CA
242051101$24205110$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55337$$FDA-CTU$$70$YR$$M$N$$$20240812$N$$US$
242051111$24205111$1$I$20240728$20240809$20240812$20240812$DIR$FDA-CDER-CTU-2024-55334$$FDA-CTU$$67$YR$$F$N$$$20240809$N$HP$US$
242051121$24205112$1$I$$20240805$20240813$20240813$EXP$PT-AMGEN-PRTSP2024142287$PT-ROCHE-10000048711$ROCHE$Costa A, Faustino C, Correia F. HEMOPHAGOCYTIC SYNDROME - WHEN SHOULD THIS ENTITY BE CONSIDERED? ABOUT A CLINICAL CASE [Abstract number: PO-0184 - (2479)]. 30th National Congress of Internal Medicine (CNMI).552.$50$YR$A$F$Y$$$20240813$$HP$PT$PT
242051131$24205113$1$I$$20240806$20240813$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-024270$UNITED THERAPEUTICS$$$$$F$Y$72.109$KG$20240813$$$US$US
242051151$24205115$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55367$$FDA-CTU$$$$$F$N$$$20240812$N$$US$
242051161$24205116$1$I$$20240729$20240813$20240813$EXP$$AR-Vista Pharmaceuticals Inc.-2160349$VISTAPHARM$Full text$15$YR$$M$Y$$$20240813$$$AR$AR
242051172$24205117$2$F$$20240913$20240813$20240913$30DAY$$US-PFIZER INC-202400230959$PFIZER$$2$YR$$M$Y$$$20240913$$CN$US$US
242051181$24205118$1$I$$20240808$20240813$20240813$30DAY$$US-PFIZER INC-PV202400044502$PFIZER$$$$$$Y$$$20240813$$HP$US$US
242051191$24205119$1$I$$20240808$20240813$20240813$PER$$US-LEO Pharma-372649$LEO PHARM$$76$YR$$M$Y$$$20240813$$CN$US$US
242051201$24205120$1$I$$20240807$20240813$20240813$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02947$AMNEAL$Enstrom C., Gast S., Church L., Heflin M.K., Moore C. et.al. Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy. US Cardiology Review. 2024;18:2$29$YR$$M$Y$$$20240813$$HP$US$US
242051223$24205122$3$F$$20240908$20240813$20240911$PER$$US-AMGEN-USASP2024159460$AMGEN$$66$YR$E$F$Y$$$20240911$$CN$US$US
242051231$24205123$1$I$$20240731$20240813$20240813$EXP$$CA-B.Braun Medical Inc.-2160350$B BRAUN$$$$$F$Y$$$20240813$$$CA$CA
242051241$24205124$1$I$$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127806$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240813$$CN$US$US
242051251$24205125$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126501$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$95.25$KG$20240813$$HP$US$US
242051261$24205126$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126503$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240813$$CN$US$US
242051271$24205127$1$I$20240401$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55362$$FDA-CTU$$92$YR$$F$N$$$20240812$N$PH$US$
242051281$24205128$1$I$$20240810$20240812$20240812$DIR$FDA-CDER-CTU-2024-55307$$FDA-CTU$$$$$F$N$$$20240810$N$HP$US$
242051291$24205129$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55314$$FDA-CTU$$65$YR$$F$N$$$20240812$N$$US$
242051301$24205130$1$I$$20240806$20240813$20240813$EXP$$MA-BRISTOL-MYERS SQUIBB COMPANY-2024-125290$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240813$$MD$MA$MA
242051312$24205131$2$F$$20240904$20240813$20240912$PER$$US-JNJFOC-20240829443$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$MD$US$US
242051322$24205132$2$F$20240703$20240815$20240813$20240819$EXP$$TR-ABBVIE-5872826$ABBVIE$$45$YR$$M$Y$92$KG$20240819$$MD$TR$TR
242051332$24205133$2$F$20240809$20240829$20240813$20240829$EXP$$KR-MYLANLABS-2024M1074855$MYLAN$$60$YR$$M$Y$$$20240829$$MD$KR$KR
242051351$24205135$1$I$20240101$20240724$20240813$20240813$PER$$US-009507513-2407USA014049$MERCK$$$$$F$Y$$$20240813$$CN$US$US
242051361$24205136$1$I$$20240806$20240813$20240813$EXP$$DE-AMGEN-DEUSP2024156898$AMGEN$$$$$$Y$$$20240813$$MD$DE$DE
242051371$24205137$1$I$$20240807$20240813$20240813$EXP$$BR-AMGEN-BRASP2024158821$AMGEN$$$$$F$Y$$$20240813$$CN$BR$BR
242051381$24205138$1$I$$20240626$20240813$20240813$PER$$US-LUNDBECK-DKLU4001010$LUNDBECK$$$$$$Y$$$20240813$$HP$US$US
242051391$24205139$1$I$$20240807$20240813$20240813$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02948$AMNEAL$Enstrom C, Gast S, Church L, Heflin M.K, Moore C et.al. Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy. US Cardiology Review. 2024;18:2$25$YR$$M$Y$$$20240813$$HP$US$US
242051402$24205140$2$F$20240807$20240812$20240813$20240815$EXP$$US-ROCHE-10000055340$ROCHE$$63$YR$A$M$Y$$$20240815$$CN$US$US
242051411$24205141$1$I$$20240805$20240813$20240813$EXP$$AU-BAYER-2024A112685$BAYER$$$$$M$Y$$$20240813$$HP$AU$AU
242051421$24205142$1$I$$20240625$20240813$20240813$PER$$US-LUNDBECK-DKLU4000973$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
242051431$24205143$1$I$20240401$20240805$20240813$20240813$PER$$US-JNJFOC-20240812007$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240813$$CN$US$US
242051441$24205144$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240830551$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$CN$US$US
242051461$24205146$1$I$$20240729$20240813$20240813$EXP$$TR-Spectra Medical Devices, LLC-2160351$Spectra Medical Devices$Abstract$18$YR$$F$Y$50$KG$20240813$$$TR$TR
242051472$24205147$2$F$20240101$20240919$20240813$20240920$EXP$$TW-BAYER-2024A102063$BAYER$$64$YR$A$M$Y$$$20240920$$HP$TW$TW
242051481$24205148$1$I$$20240812$20240813$20240813$PER$$US-HALEON-2191760$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242051492$24205149$2$F$20240726$20240808$20240813$20240823$EXP$$US-BEH-2024177066$CSL BEHRING$$56$YR$A$F$Y$76.19$KG$20240823$$CN$US$US
242051501$24205150$1$I$$20240808$20240813$20240813$PER$$US-BIOGEN-2024BI01277689$BIOGEN$$$$$$Y$$$20240813$$HP$US$US
242051511$24205151$1$I$$20240729$20240813$20240813$EXP$$MX-PURACAP-MX-2024EPCLIT00928$PURACAP$Luis E Martinez-Bravo.Pancytopenia in neuromyelitis optica spectrum disorder induced by  azathioprine-allopurinol interaction.Neuroimmunology Reports .2024;6:1-3$63$YR$A$F$Y$$$20240813$$HP$MX$MX
242051521$24205152$1$I$20240730$20240811$20240812$20240812$DIR$FDA-CDER-CTU-2024-55322$$FDA-CTU$$80$YR$$M$N$$$20240811$N$HP$US$
242051541$24205154$1$I$20240807$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55320$$FDA-CTU$$81$YR$$M$N$52.16$KG$20240812$N$PH$US$
242051551$24205155$1$I$$20240808$20240813$20240813$PER$$US-ROCHE-10000053970$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
242051561$24205156$1$I$$20240808$20240813$20240813$PER$$US-ROCHE-10000053982$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
242051571$24205157$1$I$20240701$20240731$20240813$20240813$PER$$US-Eisai-EC-2024-169782$EISAI$$48$YR$A$M$Y$$$20240813$$CN$US$US
242051581$24205158$1$I$20230811$20240805$20240813$20240813$EXP$$AU-Eisai-EC-2024-171751$EISAI$$31$YR$A$F$Y$$$20240813$$MD$AU$AU
242051591$24205159$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000052860$ROCHE$$$$E$F$Y$$$20240813$$CN$US$US
242051621$24205162$1$I$$20240808$20240813$20240813$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121628$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240813$$MD$JP$JP
242051642$24205164$2$F$$20240819$20240813$20240826$EXP$$US-TEVA-VS-3231282$TEVA$Wang J, Elghawy O, Kurpiel B, Kaur V. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors. Clin-J-Gastroenterol 2023; 16 807-814.; Wang J, Elghawy O, Kurpiel B, Kaur V. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors. Clin-J-Gastroenterol 2023; 16 807-814.; Wang J, Elghawy O, Kurpiel B, Kaur V. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors. Clin-J-Gastroenterol 2023; 16 807-814.$70$YR$$M$Y$$$20240826$$HP$US$US
242051652$24205165$2$F$20240101$20240913$20240813$20240919$EXP$$US-SANDOZ INC.-SDZ2024US072084$SANDOZ$$50$YR$$F$Y$54.42$KG$20240919$$HP$US$US
242051661$24205166$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55347$$FDA-CTU$$69$YR$$F$N$$$20240812$N$$US$
242051671$24205167$1$I$$20240729$20240813$20240813$EXP$$JP-LUNDBECK-DKLU4001469$LUNDBECK$Mihara M; Katayama N; Hayashi A; Hirawa A. O-2-12: Two infants with reduced amplitude of rod response on electroretinogram during treatment with vigabatrin. The 80th Annual Meeting of Japanese Association for Strabismus and Amblyopia (JA. UNK:83$$$$$Y$$$20240813$$MD$JP$JP
242051681$24205168$1$I$20240702$20240805$20240813$20240813$EXP$$US-OTSUKA-2024_021801$OTSUKA$$75$YR$$F$Y$97.89$KG$20240813$$CN$US$US
242051701$24205170$1$I$20240722$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55332$$FDA-CTU$$29$YR$$M$N$$$20240812$N$PH$US$
242051713$24205171$3$F$20240803$20240910$20240813$20240912$EXP$AT-BASGAGES-2024-005976$AT-GILEAD-2024-0683854$GILEAD$$45$YR$A$M$Y$83$KG$20240912$$PH$AT$AT
242051721$24205172$1$I$$20240805$20240813$20240813$30DAY$$US-GSK-US2024AMR098325$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242051742$24205174$2$F$20240717$20240827$20240813$20240906$EXP$$AU-OCTA-GAM24224$OCTAPHARMA$$$$E$F$Y$55$KG$20240905$$HP$AU$AU
242051751$24205175$1$I$$20240801$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408001336$ELI LILLY AND CO$$30$YR$A$$Y$$$20240813$$LW$US$US
242051761$24205176$1$I$20240809$20240810$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007292$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240813$$CN$US$US
242051771$24205177$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006018$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240813$$CN$US$US
242051781$24205178$1$I$20240305$20240507$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005044$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242051791$24205179$1$I$20240101$20240809$20240813$20240813$PER$$US-BIOGEN-2024BI01277754$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
242051802$24205180$2$F$20240701$20240822$20240813$20240826$EXP$$US-ABBVIE-5875662$ABBVIE$$43$YR$$F$Y$$$20240826$$CN$US$US
242051811$24205181$1$I$20240301$20240806$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN008245$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242051821$24205182$1$I$$20240807$20240813$20240813$EXP$$JP-BAYER-2024A085674$BAYER$$77$YR$E$M$Y$$$20240813$$MD$JP$JP
242051831$24205183$1$I$20240805$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158478$AMGEN$$$$$$Y$$$20240813$$PH$US$US
242051841$24205184$1$I$20240808$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159463$AMGEN$$88$YR$E$M$Y$$$20240813$$CN$US$US
242051851$24205185$1$I$20240725$20240729$20240813$20240813$EXP$$US-SERVIER-S24009697$SERVIER$$$$$$Y$$$20240813$$MD$US$US
242051861$24205186$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127202$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240813$$CN$US$US
242051871$24205187$1$I$20240619$20240730$20240813$20240813$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0968$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240812$$MD$US$US
242051881$24205188$1$I$$20240729$20240813$20240813$EXP$$CN-EPICPHARMA-CN-2024EPCLIT00944$EPIC PHARM$L Gao.Severe electrolyte disorders and rhabdomyolysis caused by long-term use of capreomycin.Adverse drug reactions journal.JAN-2020;22:44-45$53$YR$A$F$Y$$$20240813$$HP$CN$CN
242051891$24205189$1$I$20240724$20240805$20240813$20240813$PER$$US-JNJFOC-20240817141$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240813$$CN$US$US
242051902$24205190$2$F$20211116$20240821$20240813$20240828$EXP$$SE-JNJFOC-20240814897$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240828$$HP$SE$SE
242051911$24205191$1$I$20220825$20240809$20240813$20240813$EXP$FR-AFSSAPS-LY2024001261$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-127357$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240813$$PH$FR$FR
242051922$24205192$2$F$20230328$20240829$20240813$20240905$EXP$$CA-GSK-CA2023047820$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$PH$CA$CA
242051932$24205193$2$F$20240101$20240830$20240813$20240910$PER$$US-INCYTE CORPORATION-2024IN008210$INCYTE$$$$$$Y$$$20240910$$CN$US$US
242051941$24205194$1$I$$20240731$20240813$20240813$EXP$$US-MYLANLABS-2024M1073098$MYLAN$Joffe D, Rohan TZ, Mandel J, Suriano J, Banner L, Valiga A, et al. The development of 2 clonally and histologically distinct subtypes of extranodal B-cell lymphomas in the brain and skin in 1 individual. JAAD-Case-Rep 2024; 49 51-54.$61$YR$$M$Y$$$20240813$$MD$US$US
242051951$24205195$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127098$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$78.93$KG$20240813$$PH$US$US
242051961$24205196$1$I$20240701$20240806$20240813$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-001544$JAZZ$$47$YR$$F$Y$$$20240813$$CN$US$US
242051971$24205197$1$I$$20240805$20240813$20240813$EXP$$US-MYLANLABS-2024M1074707$MYLAN$Sedlacek M. Polysulfone Dialyzer Allergy in a Patient on Aquadex Hemofiltration. J-Am-Soc-Nephrol 2023; 34 (11) 1078 abstr. PUB103.$82$YR$$M$Y$$$20240813$$HP$US$US
242051981$24205198$1$I$$20240805$20240813$20240813$EXP$$IT-MYLANLABS-2024M1074835$MYLAN$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ-Genom-Precis-Med 2024; 17 (2): E004353.$14$YR$$M$Y$$$20240813$$MD$IT$IT
242051991$24205199$1$I$$20240805$20240813$20240813$EXP$$TR-MYLANLABS-2024M1074982$MYLAN$Peksoz U, Oner U, Celik M. The effectiveness of the erector spinae plane block using methylprednisolone and bupivacaine in post-herpetic neuralgia: Case series. Agri 2023; 35 (4): 273-277.$64$YR$$F$Y$58$KG$20240813$$MD$TR$TR
242052001$24205200$1$I$$20240805$20240813$20240813$EXP$$US-MYLANLABS-2024M1074757$MYLAN$Phang CR, Farooqi A, Sangwan Y. Unmasking the Unusual: Cryptococcal Pericarditis in a Patient with Liver Failure - a Rare Occurrence. Am-J-Case-Rep 2024; 25.$47$YR$$M$Y$$$20240813$$HP$US$US
242052011$24205201$1$I$$20240809$20240813$20240813$EXP$$IN-ROCHE-10000054901$ROCHE$$56$YR$A$M$Y$$$20240813$$CN$IN$IN
242052021$24205202$1$I$$20240805$20240813$20240813$EXP$$TR-MYLANLABS-2024M1074987$MYLAN$Peksoz U, Oner U, Celik M. The effectiveness of the erector spinae plane block using methylprednisolone and bupivacaine in post-herpetic neuralgia: Case series. Agri 2023; 35 (4): 273-277.$64$YR$$M$Y$70$KG$20240813$$MD$TR$TR
242052031$24205203$1$I$$20240805$20240813$20240813$EXP$$US-MYLANLABS-2024M1074215$MYLAN$Hernandez K, Ahmed T, Liu D, Seiter K, Steinberg A. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. Blood 2023; 142 (Suppl. 1) 7349-7350.$37$YR$$M$Y$$$20240813$$HP$US$US
242052041$24205204$1$I$$20240805$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN008208$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242052051$24205205$1$I$20240724$20240805$20240813$20240813$EXP$$LT-DAIICHI SANKYO, INC.-DSJ-2024-140210$DAIICHI$$$$$F$Y$$$20240813$$MD$LT$LT
242052063$24205206$3$F$20240716$20240919$20240813$20240920$EXP$$TW-BAYER-2024A106683$BAYER$$85$YR$E$M$Y$$$20240920$$HP$TW$TW
242052071$24205207$1$I$$20240807$20240813$20240813$PER$$US-ABBVIE-5877253$ABBVIE$$$$$$Y$$$20240813$$CN$US$US
242052081$24205208$1$I$20210401$20240808$20240813$20240813$PER$$US-BIOGEN-2021BI01040528$BIOGEN$$60$YR$$F$Y$$$20240813$$CN$US$US
242052102$24205210$2$F$20240806$20240814$20240813$20240819$EXP$$NVSC2024US163469$NOVARTIS$$61$YR$$F$Y$54.43$KG$20240819$$CN$US$US
242052111$24205211$1$I$$20240812$20240813$20240813$PER$$US-TAKEDA-2024TUS080387$TAKEDA$$$$$M$Y$$$20240813$$CN$US$US
242052121$24205212$1$I$$20240806$20240813$20240813$EXP$$CA-TEVA-VS-3232042$TEVA$$52$YR$$F$Y$$$20240813$$HP$CA$CA
242052131$24205213$1$I$$20240806$20240813$20240813$EXP$$JP-DSJP-DSJ-2024-139586$DAIICHI$Fujimoto A, Nakano Y, Shinoda Y. Symposium 7 Consider Pharmacotherapy for Cancer Patients with Complex Backgrounds/The Forum of Pharmaceutical Health Care and Sciences 2024 the 32nd Clinical Pharmacy Symposium. See Journal Title following Article Title. 2024;96$6$DEC$$F$Y$35.9$KG$20240813$$PH$JP$JP
242052141$24205214$1$I$$20240805$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN008206$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242052151$24205215$1$I$20240808$20240808$20240813$20240813$EXP$$JP-GILEAD-2024-0683581$GILEAD$$$$E$F$Y$$$20240813$$PH$JP$JP
242052161$24205216$1$I$$20240729$20240813$20240813$EXP$$DK-EPICPHARMA-DK-2024EPCLIT00945$EPIC PHARM$Carina Lundby.Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects.British Journal of Clinical Pharmacology.01-APR-2024;90:1741-1744$76$YR$E$F$Y$$$20240813$$HP$DK$DK
242052171$24205217$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55306$$FDA-CTU$$54$YR$$M$N$$$20240812$N$$US$
242052181$24205218$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55360$$FDA-CTU$$31$YR$$M$N$$$20240812$N$$US$
242052191$24205219$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55326$$FDA-CTU$$35$YR$$F$N$92.08$KG$20240812$N$$US$
242052201$24205220$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55336$$FDA-CTU$$42$YR$$M$N$$$20240812$N$$US$
242052231$24205223$1$I$$20240810$20240812$20240812$DIR$FDA-CDER-CTU-2024-55341$$FDA-CTU$$$$$F$N$$$20240810$N$HP$US$
242052241$24205224$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55315$$FDA-CTU$$63$YR$$M$N$$$20240812$N$$US$
242052251$24205225$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55345$$FDA-CTU$$79$YR$$M$N$$$20240812$N$$US$
242052261$24205226$1$I$20240809$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55359$$FDA-CTU$$73$YR$$M$N$$$20240812$N$HP$US$
242052271$24205227$1$I$20240808$20240809$20240812$20240812$DIR$FDA-CDER-CTU-2024-55310$$FDA-CTU$$65$YR$$F$N$$$20240809$N$HP$US$
242052281$24205228$1$I$20240725$20240806$20240813$20240813$EXP$$IN-ROCHE-10000023915$ROCHE$$72$YR$E$M$Y$$$20240813$$CN$IN$IN
242052292$24205229$2$F$20240731$20240815$20240813$20240816$PER$$US-JNJFOC-20240821058$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240816$$CN$US$US
242052311$24205231$1$I$$20240729$20240813$20240813$EXP$$KR-EPICPHARMA-KR-2024EPCLIT00931$EPIC PHARM$Kiyoung Kim.Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report.Medicina.17-JUN-2024;60:1-5$79$YR$E$M$Y$$$20240813$$HP$KR$KR
242052322$24205232$2$F$$20240913$20240813$20240913$30DAY$$US-PFIZER INC-202400232555$PFIZER$$13$YR$$M$Y$65.32$KG$20240913$$MD$US$US
242052331$24205233$1$I$20240201$20240806$20240813$20240813$EXP$$US-PFIZER INC-202400232334$PFIZER$$15$YR$$M$Y$$$20240813$$HP$US$US
242052341$24205234$1$I$20240808$20240808$20240813$20240813$EXP$GB-MHRA-MED-202408081809415130-PCBNJ$GB-PFIZER INC-202400233073$PFIZER$$$$$$Y$$$20240813$$HP$GB$GB
242052351$24205235$1$I$20240730$20240807$20240813$20240813$EXP$$JP-PFIZER INC-202400233390$PFIZER$$52$YR$$F$Y$$$20240813$$MD$JP$JP
242052361$24205236$1$I$$20240809$20240813$20240813$30DAY$$US-PFIZER INC-PV202400044302$PFIZER$$$$$$Y$$$20240813$$HP$US$US
242052372$24205237$2$F$$20240913$20240813$20240913$30DAY$$US-PFIZER INC-202400230711$PFIZER$$10$YR$$F$Y$$$20240913$$CN$US$US
242052381$24205238$1$I$20240722$20240807$20240813$20240813$PER$$US-Vifor (International) Inc.-VIT-2024-07112$VIFOR$$55$YR$$M$Y$91.5$KG$20240813$$HP$US$US
242052391$24205239$1$I$20210101$20240806$20240813$20240813$EXP$PT-INFARMED-R202407-857$PT-BAYER-2024A113220$BAYER$$29$YR$A$F$Y$65$KG$20240813$$CN$PT$PT
242052401$24205240$1$I$20240213$20240801$20240813$20240813$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240300064$UPSHER SMITH LABORATORIES$$36$YR$$F$Y$$$20240813$$$US$US
242052411$24205241$1$I$20200717$20240805$20240813$20240813$EXP$PL-URPL-1-3866-2020$PL-TEVA-VS-3230584$TEVA$$59$YR$$F$Y$50$KG$20240813$$MD$PL$PL
242052421$24205242$1$I$20240101$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158095$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
242052432$24205243$2$F$$20240819$20240813$20240826$EXP$$US-TEVA-VS-3231284$TEVA$Hung E, Face C, Yu DH. Is Osimertinib the New Medical ICU Miracle Drug? The Role of Osimertinib in Critical Illness for Patients With Metastatic EGFR Mutated Lung Cancer. Am-J-Respir-Crit-Care-Med 2024; 209.; Hung E, Face C, Yu DH. Is Osimertinib the New Medical ICU Miracle Drug? The Role of Osimertinib in Critical Illness for Patients With Metastatic EGFR Mutated Lung Cancer. Am-J-Respir-Crit-Care-Med 2024; 209.$33$YR$$F$Y$$$20240826$$HP$US$US
242052441$24205244$1$I$$20240808$20240813$20240813$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012992$VERTEX$$$$A$M$Y$$$20240813$$CN$GB$GB
242052451$24205245$1$I$$20240806$20240813$20240813$EXP$$GB-VERTEX PHARMACEUTICALS-2024-012899$VERTEX$$$$A$F$Y$$$20240813$$CN$GB$GB
242052461$24205246$1$I$$20240809$20240813$20240813$EXP$$US-VERTEX PHARMACEUTICALS-2024-013046$VERTEX$$$$$F$Y$$$20240813$$CN$US$US
242052472$24205247$2$F$20240714$20240917$20240813$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126460$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240924$$PH$US$US
242052481$24205248$1$I$$20240809$20240813$20240813$PER$$US-VERTEX PHARMACEUTICALS-2024-013053$VERTEX$$$$$$Y$76$KG$20240813$$CN$US$US
242052491$24205249$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55318$$FDA-CTU$$56$YR$$F$N$$$20240812$N$$US$
242052501$24205250$1$I$$20240806$20240813$20240813$EXP$$AU-VERTEX PHARMACEUTICALS-2024-012921$VERTEX$$$$A$F$Y$$$20240813$$PH$AU$AU
242052511$24205251$1$I$$20240729$20240813$20240813$EXP$$US-EPICPHARMA-US-2024EPCLIT00929$EPIC PHARM$Erin A. Dean.Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report..Case Reports in Oncology.09-JAN-2024;17:75-81$64$YR$A$F$Y$$$20240813$$HP$US$US
242052521$24205252$1$I$$20240801$20240813$20240813$30DAY$$AR-PFIZER INC-202400230353$PFIZER$$$$$$Y$$$20240813$$CN$AR$AR
242052531$24205253$1$I$$20240809$20240813$20240813$EXP$$US-PFIZER INC-PV202400104765$PFIZER$$52$YR$$F$Y$$$20240813$$PH$US$US
242052541$24205254$1$I$$20240809$20240813$20240813$EXP$$US-PFIZER INC-202400234052$PFIZER$$$$$$Y$$$20240813$$CN$US$US
242052561$24205256$1$I$20240812$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55356$$FDA-CTU$$55$YR$$M$N$$$20240812$Y$PH$US$
242052581$24205258$1$I$$20240810$20240813$20240813$EXP$$US-PFIZER INC-PV202400104330$PFIZER$$82$YR$$M$Y$$$20240813$$CN$US$US
242052591$24205259$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55352$$FDA-CTU$$60$YR$$F$N$$$20240812$N$$US$
242052601$24205260$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55317$$FDA-CTU$$56$YR$$F$N$$$20240812$N$$US$
242052611$24205261$1$I$$20240812$20240812$20240812$DIR$713863$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242052621$24205262$1$I$20240801$20240809$20240813$20240813$EXP$$US-PFIZER INC-202400235043$PFIZER$$71$YR$$F$Y$$$20240813$$HP$US$US
242052631$24205263$1$I$$20240809$20240813$20240813$EXP$$CN-PFIZER INC-PV202400104416$PFIZER$$75$YR$$F$Y$$$20240813$$CN$CN$CN
242052641$24205264$1$I$$20240809$20240812$20240812$DIR$FDA-CDER-CTU-2024-55330$$FDA-CTU$$$$$M$N$$$20240809$N$HP$US$
242052651$24205265$1$I$20110601$20240812$20240812$20240812$DIR$713854$$FDA-CTU$$44$YR$$F$N$67.05$KG$20240812$N$CN$US$
242052661$24205266$1$I$$20240806$20240813$20240813$PER$$US-AMGEN-USASP2024156869$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242052671$24205267$1$I$20240720$20240730$20240813$20240813$EXP$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000539$Day One Biopharmaceuticals$$12$YR$$M$Y$49.887$KG$20240805$$HP$US$US
242052681$24205268$1$I$20240701$20240806$20240813$20240813$EXP$$CA-ABBVIE-5871413$ABBVIE$$$$A$F$Y$$$20240813$$CN$CA$CA
242052691$24205269$1$I$$20240806$20240813$20240813$PER$$US-ALXN-202408USA000344US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242052702$24205270$2$F$20240708$20240806$20240813$20240822$PER$$US-TRAVERE-2024TVT00711$TRAVERE THERAPEUTICS$$38$YR$A$F$Y$$$20240822$$CN$US$US
242052712$24205271$2$F$20240401$20240816$20240813$20240819$EXP$SI-JAZMP-NCPHV-2024SI0831_0831$SI-BAYER-2024A113754$BAYER$$17$YR$T$F$Y$$$20240819$$PH$SI$SI
242052721$24205272$1$I$$20240806$20240813$20240813$EXP$$CA-TEVA-VS-3231999$TEVA$$$$E$M$Y$$$20240813$$MD$CA$CA
242052731$24205273$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180852$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242052741$24205274$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A177647$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242052751$24205275$1$I$$20240729$20240813$20240813$EXP$$US-EPICPHARMA-US-2024EPCLIT00932$EPIC PHARM$Robertson IJ.Case of metastatic clear cell odontogenic carcinoma with response to chemoimmunotherapy.BMJ Case Reports.APR-2024;17:1-4$8$DEC$E$F$Y$$$20240813$$HP$US$US
242052761$24205276$1$I$$20240806$20240813$20240813$PER$$US-UNITED THERAPEUTICS-UNT-2024-024469$UNITED THERAPEUTICS$$$$$F$Y$61.678$KG$20240813$$$US$US
242052772$24205277$2$F$$20240812$20240813$20240814$PER$$US-JNJFOC-20240827886$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242052782$24205278$2$F$20240807$20240909$20240813$20240910$PER$$US-JNJFOC-20240820728$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$CN$US$US
242052791$24205279$1$I$$20240802$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002377$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240813$$CN$US$US
242052801$24205280$1$I$$20240805$20240813$20240813$EXP$$JP-TEVA-VS-3230761$TEVA$$$$$$Y$$$20240813$$PH$JP$JP
242052811$24205281$1$I$$20240802$20240813$20240813$PER$$US-ROCHE-10000049484$ROCHE$$$$$$Y$$$20240813$$MD$US$US
242052821$24205282$1$I$$20240729$20240813$20240813$EXP$$US-ROCHE-10000014432$ROCHE$$31$YR$A$M$Y$48$KG$20240813$$MD$US$US
242052832$24205283$2$F$$20240913$20240813$20240913$30DAY$$US-PFIZER INC-202400228451$PFIZER$$9$YR$$F$Y$$$20240913$$CN$US$US
242052841$24205284$1$I$$20240809$20240813$20240813$EXP$$US-GILEAD-2024-0683755$GILEAD$$$$E$M$Y$$$20240813$$CN$US$US
242052851$24205285$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5873948$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242052861$24205286$1$I$$20240808$20240813$20240813$EXP$$US-TAKEDA-2024TUS079742$TAKEDA$$$$$M$Y$$$20240813$$CN$US$US
242052873$24205287$3$F$20240708$20240913$20240813$20240918$EXP$$US-ABBVIE-5875713$ABBVIE$$19$YR$$M$Y$119$KG$20240918$$CN$US$US
242052882$24205288$2$F$20240620$20240823$20240813$20240827$EXP$FR-AFSSAPS-NC2024000975$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-127333$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$58$KG$20240827$$MD$FR$FR
242052891$24205289$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024160501$AMGEN$$$$$M$Y$$$20240813$$MD$US$US
242052901$24205290$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55311$$FDA-CTU$$81$YR$$M$N$$$20240812$N$$US$
242052911$24205291$1$I$20240201$20240806$20240813$20240813$EXP$$US-AMGEN-USASP2024157137$AMGEN$$$$$F$Y$110.7$KG$20240813$$HP$US$US
242052921$24205292$1$I$$20240812$20240813$20240813$PER$$NVSC2024US163619$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
242052931$24205293$1$I$20220401$20240807$20240813$20240813$EXP$$PL-AMGEN-POLSP2024157523$AMGEN$Zygulska A. An elderly patient diagnosed with stage IV colon cancer. Colon Cancer. 1-3$84$YR$E$M$Y$$$20240813$$MD$PL$PL
242052941$24205294$1$I$20240711$20240806$20240813$20240813$EXP$$US-OTSUKA-2024_021887$OTSUKA$$$$$$Y$$$20240813$$CN$US$US
242052951$24205295$1$I$20240808$20240808$20240813$20240813$PER$$US-ABBVIE-5873855$ABBVIE$$$$$M$Y$$$20240813$$HP$US$US
242052961$24205296$1$I$$20240806$20240812$20240812$DIR$FDA-CDER-CTU-2024-55323$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
242052971$24205297$1$I$20240101$20240812$20240813$20240813$EXP$FI-FIMEA-202402804$FI-JNJFOC-20240830279$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240813$$CN$FI$FI
242052981$24205298$1$I$$20240812$20240812$20240812$DIR$FDA-CDER-CTU-2024-55321$$FDA-CTU$$71$YR$$M$N$$$20240812$N$$US$
242052991$24205299$1$I$$20240806$20240813$20240813$EXP$$DE-009507513-2408DEU001871$MERCK$$$$$F$Y$$$20240813$$MD$DE$DE
242053032$24205303$2$F$$20240814$20240813$20240814$EXP$$CA-PFIZER INC-PV202400103764$PFIZER$Fine, N.. Drug Development for Transthyretin Amyloidosis: Time to Fix the System?. JACC: Case Reports. 2024;29$68$YR$$M$Y$$$20240814$$MD$CA$US
242053042$24205304$2$F$$20240828$20240813$20240828$PER$$US-ALXN-202408USA000403US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242053052$24205305$2$F$$20240812$20240813$20240815$EXP$$ES-PFIZER INC-202400233598$PFIZER$Gimeno-Pitarch, L.. Leishmania infection in patients with inflammatory bowel disease: Case series and literature review. Gastroenterol-Hepatol-Barcelona. 2024;47(1):82-92$53$YR$$F$Y$$$20240815$$HP$ES$ES
242053071$24205307$1$I$$20240729$20240813$20240813$EXP$$JP-EPICPHARMA-JP-2024EPCLIT00947$EPIC PHARM$Hirohito Seki.Development of neuro-Behcet^s disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy: A case report.Breast Disease.2024;43:223-229$40$YR$A$F$Y$$$20240813$$HP$JP$JP
242053082$24205308$2$F$$20240911$20240813$20240914$EXP$$US-AMGEN-USASP2024159417$AMGEN$$58$YR$A$M$Y$$$20240914$$HP$US$US
242053092$24205309$2$F$20220101$20240830$20240813$20240902$EXP$ES-AEMPS-1559078$NVSC2024ES163290$NOVARTIS$$68$YR$$M$Y$$$20240902$$MD$ES$ES
242053102$24205310$2$F$20240701$20240815$20240813$20240820$EXP$$US-TRAVERE-2024TVT00712$TRAVERE THERAPEUTICS$$41$YR$A$M$Y$$$20240820$$CN$US$US
242053111$24205311$1$I$20240805$20240807$20240813$20240813$EXP$$US-FreseniusKabi-FK202412296$FRESENIUS KABI$$76$YR$E$F$Y$$$20240813$$PH$US$US
242053122$24205312$2$F$$20240807$20240813$20240905$PER$$US-ROCHE-10000052652$ROCHE$$$$$$Y$$$20240905$$HP$US$US
242053131$24205313$1$I$$20240730$20240813$20240813$EXP$FR-AFSSAPS-RE2024000752$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07358$HIKMA$$74$YR$$F$Y$$$20240813$$HP$FR$FR
242053141$24205314$1$I$20240628$20240802$20240812$20240812$DIR$FDA-CDER-CTU-2024-55370$$FDA-CTU$$68$YR$$M$N$200$LBS$20240802$Y$CN$US$
242053151$24205315$1$I$20240716$20240806$20240812$20240812$DIR$FDA-CDER-CTU-2024-55371$$FDA-CTU$$83$YR$$F$N$133$LBS$20240806$N$CN$US$
242053161$24205316$1$I$$20240729$20240813$20240813$EXP$$US-CorePharma LLC-2160352$COREPHARMA$Source document (Full text article).$18$YR$$F$Y$$$20240813$$$US$US
242053171$24205317$1$I$$20240808$20240813$20240813$EXP$$US-INCYTE CORPORATION-2024IN007548$INCYTE$$$$$$Y$$$20240813$$HP$US$US
242053181$24205318$1$I$$20240812$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US072290$SANDOZ$$$$$$Y$$$20240813$$MD$US$US
242053192$24205319$2$F$$20240822$20240813$20240829$30DAY$$DE-MYLANLABS-2024M1074017$MYLAN$$$$$$Y$$$20240829$$CN$DE$DE
242053201$24205320$1$I$$20240808$20240813$20240813$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004429$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240813$$CN$US$US
242053211$24205321$1$I$20240601$20240812$20240813$20240813$EXP$$NVSC2024CH151272$NOVARTIS$$$$A$M$Y$$$20240813$$MD$CH$CH
242053221$24205322$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000054122$ROCHE$$$$A$F$Y$$$20240813$$CN$US$US
242053231$24205323$1$I$$20240729$20240813$20240813$EXP$$CA-EPICPHARMA-CA-2024EPCLIT00930$EPIC PHARM$G Brin.Severe Hypotension Associated with Guanfacine: Case Report of an Unexpected Drug Reaction.Canadian Journal of Hospital Pharmacy.JAN-2024;77$15$YR$T$M$Y$$$20240813$$HP$CA$CA
242053241$24205324$1$I$20240101$20240805$20240813$20240813$EXP$FR-AFSSAPS-TO2024001429$FR-TEVA-VS-3230594$TEVA$$35$YR$$M$Y$$$20240813$$MD$FR$FR
242053262$24205326$2$F$20240710$20240910$20240813$20240920$30DAY$$GB-JNJFOC-20240776366$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240920$$HP$GB$GB
242053271$24205327$1$I$20200214$20240812$20240813$20240813$EXP$$FR-GILEAD-2024-0683821$GILEAD$$46$YR$A$M$Y$$$20240813$$MD$FR$FR
242053283$24205328$3$F$$20240912$20240813$20240919$30DAY$$US-MYLANLABS-2024M1071418$MYLAN$$$$$$Y$$$20240919$$PH$US$US
242053291$24205329$1$I$20240808$20240811$20240813$20240813$PER$$US-ROCHE-10000054346$ROCHE$$59$YR$A$F$Y$$$20240813$$CN$US$US
242053301$24205330$1$I$$20240724$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128030$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$82.55$KG$20240813$$CN$US$US
242053311$24205331$1$I$$20240801$20240813$20240813$PER$$US-009507513-2408USA000512$MERCK$$$$$M$Y$$$20240813$$CN$US$US
242053321$24205332$1$I$$20240731$20240813$20240813$EXP$$AU-AUROBINDO-AUR-APL-2024-038967$AUROBINDO$Yeoh K, Lass-Florl C, Lamoth F, Slavin MA, Williams E, Neofytos D. Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual. Transpl-Infect-Dis. 2024;e14273$53$YR$$F$Y$$$20240813$$HP$AU$AU
242053331$24205333$1$I$$20240808$20240813$20240813$EXP$$KR-VANTIVE-2024VAN018957$Vantive US Healthcare$$$$$F$Y$$$20240813$$CN$KR$KR
242053342$24205334$2$F$$20240915$20240813$20240923$EXP$$GB-VANTIVE-2024VAN018889$Vantive US Healthcare$$$$$F$Y$42.6$KG$20240923$$CN$GB$GB
242053351$24205335$1$I$$20240802$20240813$20240813$EXP$$US-JNJFOC-20240807266$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$MD$US$US
242053361$24205336$1$I$$20240806$20240813$20240813$PER$$US-ROCHE-10000053406$ROCHE$$$$$F$Y$$$20240813$$HP$US$US
242053371$24205337$1$I$$20240806$20240813$20240813$PER$$US-ALXN-202408USA000418US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242053381$24205338$1$I$$20240729$20240813$20240813$EXP$$JP-EPICPHARMA-JP-2024EPCLIT00935$EPIC PHARM$Inoue F.Giant T waves and QT interval prolongation associated with guanfacine toxicity.Clinical Toxicology.JAN-2024;62:269-271$51$YR$A$M$Y$$$20240813$$HP$JP$JP
242053391$24205339$1$I$20240606$20240808$20240813$20240813$EXP$$DE-BAYER-2024A110058$BAYER$$38$YR$A$F$Y$$$20240813$$CN$DE$DE
242053412$24205341$2$F$20240724$20240813$20240813$20240823$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00844$CATALYST PHARMA$$66$YR$$M$Y$131.52$KG$20240823$$CN$US$US
242053422$24205342$2$F$$20240924$20240813$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127885$BRISTOL MYERS SQUIBB$$$$T$F$Y$$$20240927$$PH$US$US
242053432$24205343$2$F$$20240903$20240813$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120008$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$77.11$KG$20240926$$CN$US$US
242053442$24205344$2$F$20240727$20240823$20240813$20240827$EXP$GB-LDELTA-2024000990$GB-GSK-GB2024098416$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$GB$GB
242053451$24205345$1$I$20240301$20240808$20240813$20240813$EXP$CH-SM-2024-13749$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-126170$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$90$KG$20240813$$PH$CH$CH
242053461$24205346$1$I$$20240729$20240813$20240813$PER$$US-EPICPHARMA-US-2024EPCSPO00965$EPIC PHARM$$$$$$Y$$$20240813$$CN$US$US
242053471$24205347$1$I$20240802$20240808$20240813$20240813$PER$$US-BAYER-2024A114744$BAYER$$34$YR$A$F$Y$$$20240813$$MD$US$US
242053481$24205348$1$I$20240501$20240808$20240813$20240813$EXP$$CO-SA-2024SA238872$SANOFI AVENTIS$$75$YR$E$F$Y$67$KG$20240813$$HP$CO$CO
242053491$24205349$1$I$$20240806$20240813$20240813$EXP$$GR-MYLANLABS-2023M1100314$MYLAN$Petropoulos K., Geladari E., Sarri G., Adamopoulou E., Kanari M., Balabinis C. et al. Co-administration of daptomycin with ceftaroline led to the treatment of resistant MRSA-positive bacteremia. 49th Annual Panhellenic Medical Congress. 2023;11-13$67$YR$$M$Y$$$20240813$$MD$GR$GR
242053501$24205350$1$I$$20240806$20240813$20240813$EXP$$FR-MYLANLABS-2024M1074884$MYLAN$Drouart L, Cabon M, Gominet M, Care W, Antoine M, Andriamanantena D, et al. Pseudo-erysipele secondaire a l^administration de Gemcitabine sans irradiation prealable : un diagnostic differentiel rare des dermohypodermites infectieuses. Rev-Med-Interne 2023; 44 (Suppl.) A415.$64$YR$$F$Y$$$20240813$$HP$FR$FR
242053511$24205351$1$I$$20240807$20240813$20240813$EXP$$DE-MYLANLABS-2024M1073661$MYLAN$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$30$YR$$M$Y$$$20240813$$HP$DE$DE
242053522$24205352$2$F$$20240813$20240813$20240823$EXP$$ES-AMRYT PHARMACEUTICALS DAC-AEGR006519$AEGERION$$$$$$Y$$$20240823$$MD$ES$ES
242053531$24205353$1$I$$20240809$20240813$20240813$EXP$$NVSC2024CN164093$NOVARTIS$$78$YR$$$Y$$$20240813$$MD$CN$CN
242053543$24205354$3$F$$20240828$20240813$20240903$EXP$$AT-MYLANLABS-2024M1069910$MYLAN$$66$YR$$F$Y$$$20240903$$MD$AT$AT
242053551$24205355$1$I$20231231$20240808$20240813$20240813$EXP$$BE-SA-2024SA239865$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240813$$CN$BE$BE
242053561$24205356$1$I$$20240805$20240812$20240812$DIR$FDA-CDER-CTU-2024-55372$$FDA-CTU$$64$YR$$M$N$275$LBS$20240805$N$CN$US$
242053571$24205357$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5874322$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242053581$24205358$1$I$$20240807$20240813$20240813$EXP$$US-OTSUKA-2024_021900$OTSUKA$$$$$M$Y$$$20240813$$CN$US$US
242053591$24205359$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007220$ELI LILLY AND CO$$$$$F$Y$$$20240813$$HP$US$US
242053601$24205360$1$I$20240301$20240805$20240813$20240813$EXP$FR-AFSSAPS-LM2024000205$FR-TEVA-VS-3230315$TEVA$$32$YR$$M$Y$$$20240813$$MD$FR$FR
242053611$24205361$1$I$20240810$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007437$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240813$$CN$US$US
242053621$24205362$1$I$20240601$20240807$20240813$20240813$EXP$$US-ASTELLAS-2024US022097$ASTELLAS$$50$YR$$F$Y$$$20240813$$CN$US$US
242053631$24205363$1$I$$20240812$20240813$20240813$PER$$US-BAYER-2024A116007$BAYER$$$$$F$Y$$$20240813$$CN$US$US
242053641$24205364$1$I$$20240729$20240813$20240813$EXP$$JP-EPICPHARMA-JP-2024EPCLIT00938$EPIC PHARM$F Inoue.Giant T waves and QT interval prolongation associated with guanfacine toxicity.Clinical Toxicology.JAN-2024;62:269-271$21$YR$A$F$Y$$$20240813$$HP$JP$JP
242053652$24205365$2$F$20240705$20240807$20240813$20240911$EXP$$CN-INCYTE CORPORATION-2024IN008432$INCYTE$$$$$$Y$$$20240911$$HP$CN$CN
242053661$24205366$1$I$20240613$20240808$20240813$20240813$EXP$$BR-BAYER-2024A115758$BAYER$$40$YR$A$M$Y$$$20240813$$HP$BR$BR
242053671$24205367$1$I$$20240806$20240813$20240813$PER$$US-ABBVIE-5870273$ABBVIE$$$$$F$Y$$$20240813$$HP$US$US
242053681$24205368$1$I$20240804$20240806$20240813$20240813$EXP$$CN-GSK-CN2024APC098251$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CN$CN
242053692$24205369$2$F$$20240812$20240813$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126444$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240815$$HP$US$US
242053701$24205370$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127014$BRISTOL MYERS SQUIBB$$$$E$F$Y$55.34$KG$20240813$$HP$US$US
242053711$24205371$1$I$$20240729$20240813$20240813$PER$$US-EPICPHARMA-US-2024EPCSPO00964$EPIC PHARM$$$$$$Y$150$KG$20240813$$CN$US$US
242053721$24205372$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127130$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$84.6$KG$20240813$$PH$US$US
242053731$24205373$1$I$$20240812$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US072178$SANDOZ$$$$$F$Y$$$20240813$$CN$US$US
242053741$24205374$1$I$20240710$20240812$20240813$20240813$PER$$US-BAYER-2024A116108$BAYER$$21$YR$A$F$Y$$$20240813$$MD$US$US
242053751$24205375$1$I$$20240807$20240813$20240813$PER$$US-ROCHE-10000052088$ROCHE$$67$YR$E$F$Y$$$20240813$$CN$US$US
242053761$24205376$1$I$$20240808$20240813$20240813$PER$$US-ROCHE-10000038701$ROCHE$$$$E$M$Y$$$20240813$$CN$US$US
242053771$24205377$1$I$$20240812$20240813$20240813$PER$$US-BAYER-2024A116123$BAYER$$22$YR$A$F$Y$$$20240813$$HP$US$US
242053782$24205378$2$F$$20240904$20240813$20240907$EXP$$TR-ASTELLAS-2024US023024$ASTELLAS$$74$YR$E$M$Y$$$20240907$$MD$TR$TR
242053791$24205379$1$I$$20240809$20240813$20240813$EXP$$CN-PFIZER INC-PV202400104000$PFIZER$Shang, Q.. The efficacy and safety of modified CLAG regimen for relapsed or refractory acute myeloid leukemia in children. Journal of Clinical Pediatrics. 2024;42(7):589-594,599$$$$$Y$$$20240813$$HP$CN$CN
242053801$24205380$1$I$20220512$20240808$20240813$20240813$EXP$$US-PFIZER INC-202400233044$PFIZER$$85$YR$$F$Y$$$20240813$$CN$US$US
242053813$24205381$3$F$$20240828$20240813$20240830$EXP$$US-PFIZER INC-PV202400104613$PFIZER$Green, K.. The Emergence of Bromazolam in Jefferson County AL. A Case Series. Journal of analytical toxicology. 2024;10.1093/jat/bkae067$35$YR$$F$Y$$$20240830$$MD$US$US
242053832$24205383$2$F$$20240814$20240813$20240819$EXP$$US-PFIZER INC-PV202400104344$PFIZER$Barnes, A.. Immune Checkpoint Inhibitor Use Leading to Fulminant Myocarditis with Cardiogenic Shock: A Case Series. US Cardiology Review. 2024;18(Supp 1):4$62$YR$$F$Y$$$20240819$$MD$US$US
242053841$24205384$1$I$20240710$20240809$20240813$20240813$EXP$$US-BAYER-2024A116015$BAYER$$55$YR$A$M$Y$$$20240813$$CN$US$US
242053851$24205385$1$I$$20240812$20240813$20240813$PER$$US-HALEON-2191717$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242053861$24205386$1$I$$20240805$20240813$20240813$EXP$$US-ABBVIE-5868416$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242053871$24205387$1$I$$20240812$20240813$20240813$PER$$US-BAYER-2024A116127$BAYER$$73$YR$E$F$Y$$$20240813$$CN$US$US
242053891$24205389$1$I$$20240715$20240813$20240813$PER$$US-TRAVERE-2024TVT00713$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240813$$CN$US$US
242053901$24205390$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A177879$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242053911$24205391$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180903$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242053922$24205392$2$F$20240423$20240813$20240813$20240819$EXP$$JP-DSJP-DSJ-2024-136783$DAIICHI$$80$YR$$F$Y$42$KG$20240819$$MD$JP$JP
242053931$24205393$1$I$20240809$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127590$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240813$$PH$US$US
242053941$24205394$1$I$$20240805$20240813$20240813$EXP$$ZA-AstraZeneca-2024A182153$ASTRAZENECA$$72$YR$$M$Y$$$20240813$$CN$ZA$
242053952$24205395$2$F$20240101$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159385$AMGEN$$52$YR$A$M$Y$$$20240813$$MD$US$US
242053963$24205396$3$F$20240807$20240830$20240813$20240903$PER$$US-AMGEN-USASP2024157597$AMGEN$$65$YR$E$M$Y$$$20240903$$CN$US$US
242053971$24205397$1$I$$20240805$20240813$20240813$EXP$$CN-AstraZeneca-2024A179047$ASTRAZENECA$$97$YR$$F$Y$$$20240813$$MD$CN$
242053982$24205398$2$F$20240724$20240816$20240813$20240819$30DAY$$US-AMGEN-USASP2024157296$AMGEN$$72$YR$E$M$Y$111$KG$20240819$$PH$US$US
242053991$24205399$1$I$20240807$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158269$AMGEN$$33$YR$A$F$Y$$$20240813$$CN$US$US
242054011$24205401$1$I$20240704$20240805$20240813$20240813$EXP$FR-AFSSAPS-RN2024000809$FR-TEVA-VS-3230438$TEVA$$91$YR$$F$Y$$$20240813$$MD$FR$FR
242054022$24205402$2$F$$20240812$20240813$20240819$PER$$US-TAKEDA-2024TUS080846$TAKEDA$$$$$M$Y$$$20240819$$MD$US$US
242054031$24205403$1$I$20240806$20240808$20240813$20240813$EXP$$TW-TAKEDA-2024TUS080313$TAKEDA$$56$YR$$M$Y$$$20240813$$CN$TW$TW
242054041$24205404$1$I$20240701$20240807$20240813$20240813$EXP$FR-AFSSAPS-MA2024001288$FR-MYLANLABS-2024M1073666$MYLAN$$45$YR$$M$Y$$$20240813$$MD$FR$FR
242054051$24205405$1$I$$20240809$20240813$20240813$EXP$$NVSC2024GB092743$NOVARTIS$$$$$M$Y$$$20240813$$CN$GB$GB
242054061$24205406$1$I$20240804$20240811$20240813$20240813$EXP$$CN-BAYER-2024A116419$BAYER$$66$YR$E$F$Y$$$20240813$$HP$CN$CN
242054071$24205407$1$I$$20240807$20240813$20240813$PER$$US-BAYER-2024A114181$BAYER$$47$YR$A$F$Y$$$20240813$$MD$US$US
242054082$24205408$2$F$20240805$20240821$20240813$20240828$EXP$$CA-GSK-CA2024094237$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$CA$CA
242054091$24205409$1$I$$20240812$20240813$20240813$PER$$US-JNJFOC-20240831591$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240813$$CN$US$US
242054101$24205410$1$I$20240805$20240806$20240812$20240812$DIR$FDA-CDER-CTU-2024-55373$$FDA-CTU$$67$YR$$M$N$170$LBS$20240806$N$CN$US$
242054111$24205411$1$I$20240801$20240805$20240812$20240812$DIR$FDA-CDER-CTU-2024-55376$$FDA-CTU$$22$YR$$F$N$235$LBS$20240805$N$CN$US$
242054121$24205412$1$I$$20240806$20240813$20240813$PER$$US-AGIOS-2408US03851$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242054131$24205413$1$I$$20240807$20240813$20240813$PER$$US-BAYER-2024A114434$BAYER$$$$$F$Y$$$20240813$$HP$US$US
242054141$24205414$1$I$$20240809$20240813$20240813$PER$$US-AGIOS-2408US03854$AGIOS PHARMACEUTICALS$$$$$F$Y$71.655$KG$20240813$$CN$US$US
242054151$24205415$1$I$$20240729$20240813$20240813$EXP$$JP-EPICPHARMA-JP-2024EPCLIT00936$EPIC PHARM$F Inoue.Giant T waves and QT interval prolongation associated with guanfacine toxicity.Clinical Toxicology.JAN-2024;62:269-271$17$YR$T$F$Y$$$20240813$$HP$JP$JP
242054161$24205416$1$I$20221215$20240808$20240813$20240813$EXP$$GB-OTSUKA-2024_022003$OTSUKA$$38$YR$$F$Y$$$20240813$$CN$GB$GB
242054173$24205417$3$F$20240713$20240808$20240813$20240822$PER$$US-TRAVERE-2024TVT00717$TRAVERE THERAPEUTICS$$40$YR$A$F$Y$$$20240822$$CN$US$US
242054181$24205418$1$I$20240716$20240716$20240813$20240813$PER$$US-TRAVERE-2024TVT00716$TRAVERE THERAPEUTICS$$59$YR$A$M$Y$$$20240813$$CN$US$US
242054191$24205419$1$I$$20240805$20240813$20240813$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01200$AIMMUNE$$$$$$Y$$$20240813$$HP$US$US
242054202$24205420$2$F$20240502$20240812$20240813$20240816$EXP$$KR-DSJP-DSJ-2024-139799$DAIICHI$$56$YR$$F$Y$50$KG$20240816$$MD$KR$KR
242054211$24205421$1$I$$20240812$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127249$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240813$$HP$US$US
242054221$24205422$1$I$$20240808$20240813$20240813$EXP$$CN-TAKEDA-2024TUS079429$TAKEDA$$$$$M$Y$$$20240813$$CN$CN$CN
242054231$24205423$1$I$$20240810$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126942$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$68.95$KG$20240813$$CN$US$US
242054241$24205424$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A178149$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242054251$24205425$1$I$20240711$20240801$20240813$20240813$EXP$$CN-AstraZeneca-2024A178617$ASTRAZENECA$$37$YR$$M$Y$$$20240813$$MD$CN$
242054262$24205426$2$F$$20240809$20240813$20240813$EXP$$US-AMGEN-USASP2024159421$AMGEN$$$$$F$Y$$$20240813$$MD$US$US
242054272$24205427$2$F$$20240906$20240813$20240910$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045182$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240910$$CN$US$US
242054281$24205428$1$I$20240807$20240812$20240813$20240813$EXP$$CN-BAYER-2024A116227$BAYER$$76$YR$E$M$Y$58$KG$20240813$$HP$CN$CN
242054291$24205429$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006621$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240813$$CN$US$US
242054301$24205430$1$I$20240808$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006644$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240813$$CN$US$US
242054311$24205431$1$I$20240510$20240805$20240813$20240813$EXP$FR-AFSSAPS-NT2024000965$FR-TEVA-VS-3230489$TEVA$$53$YR$$M$Y$$$20240813$$PH$FR$FR
242054322$24205432$2$F$20240101$20240819$20240813$20240820$EXP$$US-UCBSA-2024040747$UCB$$$$$F$Y$$$20240820$$CN$US$US
242054331$24205433$1$I$$20230311$20240813$20240813$EXP$$NL-BIOVITRUM-2023NL02485$BIOVITRUM$$$$I$F$Y$3.2$KG$20240813$$MD$NL$NL
242054341$24205434$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006622$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240813$$CN$US$US
242054351$24205435$1$I$$20240729$20240813$20240813$EXP$$US-EPICPHARMA-US-2024EPCLIT00939$EPIC PHARM$Stephanie Golob.Bupropion Overdose Requiring Veno-Arterial Extracorporeal Membrane Oxygenation..Circulation.06-NOV-2023;148 (1)$32$YR$A$$Y$$$20240813$$HP$US$US
242054361$24205436$1$I$$20230323$20240813$20240813$EXP$$NL-BIOVITRUM-2023-NL-008251$BIOVITRUM$$$$I$M$Y$3.9$KG$20240813$$CN$NL$NL
242054371$24205437$1$I$$20240808$20240813$20240813$PER$$US-BAYER-2024A114846$BAYER$$16$YR$T$F$Y$$$20240813$$HP$US$US
242054382$24205438$2$F$20240711$20240912$20240813$20240918$EXP$$JP-009507513-2408JPN000766J$MERCK$$71$YR$$F$Y$$$20240918$$MD$JP$JP
242054391$24205439$1$I$20240621$20240812$20240813$20240813$EXP$FR-AFSSAPS-BX2024001563$FR-GILEAD-2024-0683830$GILEAD$$51$YR$A$F$Y$42$KG$20240813$$MD$FR$FR
242054402$24205440$2$F$$20240821$20240813$20240822$EXP$$CL-UCBSA-2024040681$UCB$$$$$F$Y$$$20240822$$CN$CL$CL
242054411$24205441$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164151$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242054421$24205442$1$I$20240802$20240808$20240813$20240813$EXP$$NVSC2024MX163616$NOVARTIS$$77$YR$$F$Y$$$20240813$$MD$MX$MX
242054442$24205444$2$F$$20240917$20240813$20240918$EXP$$US-AstraZeneca-2024A177626$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
242054451$24205445$1$I$$20240812$20240813$20240813$EXP$$FR-SANDOZ INC.-NVSC2022FR256660$SANDOZ$$53$YR$$F$Y$$$20240813$$MD$FR$FR
242054461$24205446$1$I$$20240808$20240813$20240813$PER$$US-BAYER-2024A114847$BAYER$$48$YR$A$F$Y$$$20240813$$MD$US$US
242054472$24205447$2$F$$20240814$20240813$20240815$EXP$$AU-ROCHE-10000055611$ROCHE$$70$YR$E$M$Y$$$20240815$$MD$AU$AU
242054481$24205448$1$I$$20240805$20240813$20240813$EXP$$FR-TEVA-VS-3231769$TEVA$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2023; 35 (1): 54-59.$68$YR$$F$Y$$$20240813$$HP$FR$FR
242054501$24205450$1$I$20240710$20240809$20240813$20240813$EXP$GB-MHRA-MIDB-aea73cb5-b1d6-48dd-822a-8a1a84b2a87d$GB-MYLANLABS-2024M1074594$MYLAN$$68$YR$$$Y$$$20240813$$HP$GB$GB
242054521$24205452$1$I$$20240807$20240813$20240813$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004418$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240813$$CN$US$US
242054531$24205453$1$I$20240730$20240808$20240813$20240813$PER$$US-BAYER-2024A114916$BAYER$$34$YR$A$F$Y$$$20240813$$CN$US$US
242054541$24205454$1$I$$20240812$20240813$20240813$PER$$US-ABBVIE-5877630$ABBVIE$$$$$F$Y$$$20240813$$MD$US$US
242054552$24205455$2$F$$20240729$20240813$20240903$PER$$US-TEVA-VS-3228742$TEVA$$49$YR$$F$Y$$$20240903$$HP$US$US
242054562$24205456$2$F$20210101$20240813$20240813$20240822$EXP$$CA-BAUSCH-BL-2024-012241$BAUSCH AND LOMB$Baker S, Nfonsam L, Leto D, Rutherford C, Smieja M, McArthur A. Chronic COVID-19 infection in an immunosuppressed patient shows changes in lineage over time: a case report. Virology Journal. 2024 JAN 04;21 (8):1-11. doi:10.1186/s12985-023-02278-7$6$DEC$$M$Y$$$20240822$$HP$CA$CA
242054571$24205457$1$I$$20240812$20240813$20240813$EXP$$CA-BAUSCH-BL-2024-012257$BAUSCH AND LOMB$$58$YR$$M$Y$$$20240813$$HP$CA$CA
242054581$24205458$1$I$$20240703$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06599$LUPIN$$$$$F$Y$$$20240813$$CN$US$US
242054591$24205459$1$I$20240607$20240809$20240813$20240813$EXP$FR-AFSSAPS-AVTO2024000111$FR-INDIVIOR UK LIMITED-INDV-155994-2024$RECKITT BENCKISER$$$$$$Y$$$20240813$$MD$FR$FR
242054601$24205460$1$I$$20240729$20240813$20240813$EXP$$ES-EPICPHARMA-ES-2024EPCLIT00934$EPIC PHARM$M Calvo-Barcelo.Answer: Shock with electrocardiogram deterioration.European Heart Journal: Acute Cardiovascular Care.JAN-2024;13:185-186$60$YR$A$F$Y$$$20240813$$HP$ES$ES
242054611$24205461$1$I$20230918$20240810$20240813$20240813$EXP$$ES-BAUSCH-BL-2024-012169$BAUSCH AND LOMB$$82$YR$$F$Y$70$KG$20240813$$HP$ES$ES
242054621$24205462$1$I$20240802$20240812$20240813$20240813$EXP$FR-AFSSAPS-MP2024001271$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044964$BOEHRINGER INGELHEIM$$91$YR$E$F$Y$$$20240813$$PH$FR$FR
242054631$24205463$1$I$$20240716$20240813$20240813$PER$$US-TRAVERE-2024TVT00718$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240813$$CN$US$US
242054641$24205464$1$I$$20240716$20240813$20240813$PER$$US-TRAVERE-2024TVT00719$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240813$$CN$US$US
242054651$24205465$1$I$$20240810$20240813$20240813$EXP$$US-Taiho Oncology Inc-2024-007004$TAIHO ONCOLOGY INC$$68$YR$E$M$Y$85.73$KG$20240813$$CN$US$US
242054661$24205466$1$I$20240710$20240808$20240813$20240813$PER$$US-BAYER-2024A114928$BAYER$$60$YR$A$F$Y$$$20240813$$CN$US$US
242054671$24205467$1$I$20240804$20240812$20240812$20240812$DIR$713864$$FDA-CTU$$64$YR$$F$N$71$KG$20240812$Y$PH$US$
242054681$24205468$1$I$$20240812$20240812$20240812$DIR$713867$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242054691$24205469$1$I$$20240812$20240812$20240812$DIR$713866$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242054701$24205470$1$I$$20240812$20240812$20240812$DIR$713869$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242054712$24205471$2$F$20240629$20240806$20240813$20240814$EXP$CH-SM-2024-14591$CH-009507513-2408CHE003307$MERCK$$62$YR$$F$Y$51$KG$20240814$$MD$CH$CH
242054721$24205472$1$I$$20240808$20240813$20240813$EXP$$IT-MYLANLABS-2024M1074429$MYLAN$Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G, et al. Stevens-Johnson syndrome associated with drugs and vaccines in children: a case-control study. Plos One. 2013;8:7:1-8$108$MON$$F$Y$$$20240813$$HP$IT$IT
242054731$24205473$1$I$$20240807$20240813$20240813$PER$$US-PFIZER INC-202400232975$PFIZER$$36$YR$$M$Y$$$20240813$$HP$US$US
242054741$24205474$1$I$$20240701$20240813$20240813$EXP$$US-ROCHE-10000055889$ROCHE$Smith M, Cheng G, Phelan R, Brazauskas R, Strom J, Ahn K, et al. Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: incidence, risk factors, and outcomes. Frontiers in Oncology. 2024-May-29;14:1-10. doi:10.3389/fonc.2024.1415984.$$$$$Y$$$20240813$$HP$US$US
242054753$24205475$3$F$$20240809$20240813$20240822$PER$$US-PFIZER INC-PV202400104083$PFIZER$$50$YR$$F$Y$$$20240822$$CN$US$US
242054761$24205476$1$I$20240617$20240808$20240813$20240813$PER$$US-PFIZER INC-PV202400075074$PFIZER$$69$YR$$F$Y$122.44$KG$20240813$$CN$US$US
242054771$24205477$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400233886$PFIZER$$72$YR$$F$Y$$$20240813$$CN$US$US
242054781$24205478$1$I$20240812$20240812$20240813$20240813$PER$$US-PFIZER INC-202400235171$PFIZER$$19$YR$$$Y$$$20240813$$CN$US$US
242054791$24205479$1$I$20240801$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234463$PFIZER$$43$YR$$F$Y$$$20240813$$CN$US$US
242054801$24205480$1$I$20240807$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234469$PFIZER$$38$YR$$M$Y$$$20240813$$CN$US$US
242054811$24205481$1$I$20230101$20240808$20240813$20240813$PER$$US-PFIZER INC-202400074276$PFIZER$$14$YR$$F$Y$$$20240813$$CN$US$US
242054821$24205482$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-202400234766$PFIZER$$53$YR$$F$Y$$$20240813$$MD$US$US
242054831$24205483$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-PV202400103962$PFIZER$$57$YR$$F$Y$$$20240813$$CN$US$US
242054841$24205484$1$I$20240728$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234331$PFIZER$$$$A$F$Y$$$20240813$$CN$US$US
242054851$24205485$1$I$20230101$20240811$20240813$20240813$PER$$US-PFIZER INC-202400234867$PFIZER$$37$YR$$F$Y$54.43$KG$20240813$$CN$US$US
242054861$24205486$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-PV202400104328$PFIZER$$82$YR$$F$Y$$$20240813$$HP$US$US
242054873$24205487$3$F$20240101$20240911$20240813$20240913$PER$$US-PFIZER INC-202400234065$PFIZER$$46$YR$$F$Y$$$20240913$$CN$US$US
242054891$24205489$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-PV202400104614$PFIZER$$62$YR$$$Y$$$20240813$$CN$US$US
242054903$24205490$3$F$$20240809$20240813$20240819$PER$$US-PFIZER INC-202400233194$PFIZER$$51$YR$$F$Y$74.84$KG$20240819$$CN$US$US
242054911$24205491$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400233784$PFIZER$$59$YR$$F$Y$78.47$KG$20240813$$CN$US$US
242054921$24205492$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234031$PFIZER$$$$$$Y$$$20240813$$CN$US$US
242054931$24205493$1$I$$20240812$20240813$20240813$PER$$US-PFIZER INC-202400235030$PFIZER$$21$YR$$M$Y$$$20240813$$MD$US$US
242054941$24205494$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234242$PFIZER$$80$YR$$F$Y$$$20240813$$CN$US$US
242054952$24205495$2$F$$20240815$20240813$20240819$PER$$US-PFIZER INC-202400234507$PFIZER$$39$YR$$F$Y$$$20240819$$CN$US$US
242054961$24205496$1$I$20240811$20240812$20240813$20240813$PER$$US-PFIZER INC-202400235442$PFIZER$$68$YR$$M$Y$$$20240813$$CN$US$US
242054972$24205497$2$F$20240805$20240913$20240813$20240913$30DAY$$US-PFIZER INC-202400230493$PFIZER$$$$$F$Y$$$20240913$$CN$US$US
242054981$24205498$1$I$20240805$20240812$20240813$20240813$PER$$US-PFIZER INC-202400235303$PFIZER$$69$YR$$M$Y$$$20240813$$CN$US$US
242054991$24205499$1$I$20240809$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234410$PFIZER$$36$YR$$F$Y$$$20240813$$CN$US$US
242055001$24205500$1$I$20240701$20240807$20240813$20240813$PER$$US-PFIZER INC-202400232585$PFIZER$$$$$$Y$$$20240813$$PH$US$US
242055011$24205501$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234951$PFIZER$$25$YR$$F$Y$$$20240813$$CN$US$US
242055021$24205502$1$I$$20240807$20240813$20240813$PER$$US-PFIZER INC-202400232587$PFIZER$$$$$$Y$$$20240813$$PH$US$US
242055031$24205503$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234068$PFIZER$$69$YR$$F$Y$$$20240813$$HP$US$US
242055041$24205504$1$I$$20240812$20240812$20240812$DIR$713871$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242055051$24205505$1$I$$20240812$20240812$20240812$DIR$713860$$FDA-CTU$$$$$UNK$N$$$20240812$$CN$US$
242055071$24205507$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400196178$PFIZER$$62$YR$$F$Y$$$20240813$$CN$US$US
242055082$24205508$2$F$20231101$20240929$20240813$20240930$PER$$US-PFIZER INC-202400233259$PFIZER$$44$YR$$F$Y$$$20240930$$CN$US$US
242055091$24205509$1$I$$20240812$20240813$20240813$PER$$CN-PFIZER INC-202400234297$PFIZER$$$$$$Y$$$20240813$$CN$CN$CN
242055111$24205511$1$I$20240810$20240812$20240812$20240812$DIR$713877$$FDA-CTU$$66$YR$$F$N$$$20240812$N$$US$
242055121$24205512$1$I$20240809$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55364$$FDA-CTU$$$$$M$N$59.4$KG$20240812$N$$US$
242055131$24205513$1$I$20240701$20240807$20240813$20240813$PER$$US-PFIZER INC-202400232209$PFIZER$$$$$$Y$$$20240813$$PH$US$US
242055141$24205514$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-202400234083$PFIZER$$$$A$$Y$$$20240813$$MD$US$US
242055153$24205515$3$F$20240808$20240828$20240813$20240830$PER$$US-PFIZER INC-202400233639$PFIZER$$75$YR$$M$Y$88.45$KG$20240830$$CN$US$US
242055161$24205516$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-202400233046$PFIZER$$51$YR$$F$Y$$$20240813$$CN$US$US
242055172$24205517$2$F$$20240905$20240813$20240909$PER$$US-PFIZER INC-202400234426$PFIZER$$78$YR$$F$Y$58.97$KG$20240909$$HP$US$US
242055185$24205518$5$F$20180101$20240913$20240813$20240918$EXP$$US-PFIZER INC-202400234150$PFIZER$$45$YR$$F$Y$68.04$KG$20240918$$CN$US$US
242055192$24205519$2$F$$20240816$20240813$20240819$PER$$US-PFIZER INC-202400234366$PFIZER$$72$YR$$F$Y$$$20240819$$HP$US$US
242055201$24205520$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-PV202400104844$PFIZER$$56$YR$$M$Y$$$20240813$$CN$US$US
242055211$24205521$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234124$PFIZER$$$$$$Y$$$20240813$$HP$US$US
242055221$24205522$1$I$$20240801$20240813$20240813$30DAY$$KR-PFIZER INC-202400233709$PFIZER$$12$YR$$$Y$$$20240813$$CN$KR$KR
242055231$24205523$1$I$20240810$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234445$PFIZER$$44$YR$$F$Y$$$20240813$$HP$US$US
242055241$24205524$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-PV202400104477$PFIZER$$$$$$Y$$$20240813$$MD$US$US
242055251$24205525$1$I$$20240812$20240813$20240813$PER$$US-PFIZER INC-202400234890$PFIZER$$$$$M$Y$$$20240813$$HP$US$US
242055261$24205526$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-202400233383$PFIZER$$$$$F$Y$$$20240813$$CN$US$US
242055281$24205528$1$I$$20240812$20240813$20240813$PER$$US-PFIZER INC-202400234911$PFIZER$$61$YR$$F$Y$$$20240813$$CN$US$US
242055291$24205529$1$I$20240701$20240807$20240813$20240813$PER$$US-PFIZER INC-202400232586$PFIZER$$$$$$Y$$$20240813$$PH$US$US
242055301$24205530$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-PV202400104429$PFIZER$$44$YR$$F$Y$$$20240813$$HP$US$US
242055313$24205531$3$F$20231201$20240906$20240813$20240910$EXP$$JP-PERRIGO-24JP007510$PERRIGO$$19$YR$$F$Y$41$KG$20240910$$MD$JP$JP
242055321$24205532$1$I$20240801$20240812$20240813$20240813$EXP$$CN-BAYER-2024A116276$BAYER$$51$YR$A$M$Y$76$KG$20240813$$HP$CN$CN
242055332$24205533$2$F$20240731$20240813$20240813$20240820$PER$$US-BAYER-2024A115074$BAYER$$34$YR$A$F$Y$$$20240820$$MD$US$US
242055342$24205534$2$F$20231106$20240807$20240813$20240916$EXP$FR-AFSSAPS-AN2024001001$FR-TEVA-VS-3230318$TEVA$$49$YR$$M$Y$$$20240916$$MD$FR$FR
242055353$24205535$3$F$$20240913$20240813$20240919$EXP$$NVSC2023IN273244$NOVARTIS$$$$$F$Y$$$20240919$$CN$IN$IN
242055361$24205536$1$I$$20240807$20240813$20240813$PER$$US-BAYER-2024A115079$BAYER$$16$YR$T$F$Y$$$20240813$$HP$US$US
242055373$24205537$3$F$20240801$20240829$20240813$20240904$PER$$US-PFIZER INC-202400234471$PFIZER$$68$YR$$F$Y$68.481$KG$20240904$$CN$US$US
242055381$24205538$1$I$20240801$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234588$PFIZER$$68$YR$$F$Y$$$20240813$$CN$US$US
242055391$24205539$1$I$20240810$20240812$20240813$20240813$PER$$US-PFIZER INC-202400235315$PFIZER$$67$YR$$F$Y$$$20240813$$CN$US$US
242055401$24205540$1$I$20240805$20240805$20240813$20240813$PER$$US-ABBVIE-5870279$ABBVIE$$69$YR$$M$Y$$$20240813$$CN$US$US
242055411$24205541$1$I$$20240812$20240813$20240813$EXP$$CA-PFIZER INC-202400234966$PFIZER$$90$YR$$$Y$$$20240813$$PH$CA$CA
242055421$24205542$1$I$$20240807$20240813$20240813$PER$$US-PFIZER INC-PV202400103194$PFIZER$$36$YR$$F$Y$$$20240813$$CN$US$US
242055434$24205543$4$F$$20240813$20240813$20240814$EXP$$US-ROCHE-10000055461$ROCHE$$83$YR$E$F$Y$$$20240814$$HP$US$US
242055452$24205545$2$F$$20240815$20240813$20240821$PER$$US-BIOGEN-2023BI01182739$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
242055461$24205546$1$I$$20240806$20240813$20240813$EXP$$US-GSK-US2024AMR098661$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$US$US
242055472$24205547$2$F$20221101$20240826$20240813$20240902$EXP$$US-GSK-US2024098068$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$HP$US$US
242055481$24205548$1$I$$20240808$20240813$20240813$PER$$US-BIOGEN-2024BI01277651$BIOGEN$$$$$M$Y$$$20240813$$CN$US$US
242055491$24205549$1$I$$20240809$20240813$20240813$PER$$US-BIOGEN-2024BI01277749$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
242055501$24205550$1$I$20210101$20240808$20240813$20240813$PER$$US-BAYER-2024A115133$BAYER$$43$YR$A$F$Y$$$20240813$$MD$US$US
242055511$24205551$1$I$$20240716$20240813$20240813$PER$$US-TRAVERE-2024TVT00723$TRAVERE THERAPEUTICS$$64$YR$A$F$Y$$$20240813$$CN$US$US
242055521$24205552$1$I$$20240716$20240813$20240813$PER$$US-TRAVERE-2024TVT00720$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240813$$CN$US$US
242055531$24205553$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126900$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240813$$CN$US$US
242055541$24205554$1$I$$20240809$20240813$20240813$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-127176$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240813$$CN$TW$TW
242055551$24205555$1$I$$20240801$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122715$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$98$KG$20240813$$PH$US$US
242055561$24205556$1$I$20240724$20240809$20240813$20240813$EXP$$NVSC2024CN163973$NOVARTIS$$69$YR$$F$Y$64$KG$20240813$$HP$CN$CN
242055571$24205557$1$I$20240730$20240807$20240813$20240813$PER$$US-BAYER-2024A115210$BAYER$$$$$F$Y$$$20240813$$HP$US$US
242055581$24205558$1$I$$20240806$20240813$20240813$EXP$$CA-TEVA-VS-3232045$TEVA$$73$YR$$F$Y$$$20240813$$MD$CA$CA
242055591$24205559$1$I$20221001$20240729$20240813$20240813$EXP$EU-AFSSAPS-AVPO2024000143$EU-ETHYPHARM-2024002034$ETHYPHARM$$$$$$Y$$$20240813$$PH$EU$EU
242055601$24205560$1$I$20240809$20240812$20240812$20240812$DIR$713879$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242055611$24205561$1$I$20240803$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55365$$FDA-CTU$$$$$M$N$94.9$KG$20240812$N$$US$
242055621$24205562$1$I$20240812$20240812$20240812$20240812$DIR$713874$$FDA-CTU$$67$YR$$F$N$$$20240812$N$PH$US$
242055632$24205563$2$F$20240101$20240809$20240813$20240815$EXP$$US-ABBVIE-5875888$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242055641$24205564$1$I$20240729$20240808$20240813$20240813$EXP$$NO-LUNDBECK-DKLU4002793$LUNDBECK$$$$$$Y$$$20240813$$MD$NO$NO
242055651$24205565$1$I$20240409$20240808$20240813$20240813$EXP$FR-AFSSAPS-NT2024000977$FR-MYLANLABS-2024M1074520$MYLAN$$15$YR$$F$Y$55.8$KG$20240813$$MD$FR$FR
242055671$24205567$1$I$$20240502$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007672$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240813$$HP$US$US
242055682$24205568$2$F$20240806$20240828$20240813$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005474$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240909$$CN$US$US
242055691$24205569$1$I$$20240802$20240813$20240813$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408003701$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240813$$CN$JP$JP
242055701$24205570$1$I$$20240808$20240813$20240813$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408005324$ELI LILLY AND CO$$$$$F$Y$$$20240813$$MD$GB$GB
242055713$24205571$3$F$20230101$20240918$20240813$20240925$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408005704$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240925$$MD$CN$CN
242055721$24205572$1$I$$20240801$20240813$20240813$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408002726$ELI LILLY AND CO$$$$$$Y$$$20240813$$CN$JP$JP
242055731$24205573$1$I$20240725$20240808$20240813$20240813$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408005890$ELI LILLY AND CO$$57$YR$A$F$Y$52.5$KG$20240813$$CN$CN$CN
242055741$24205574$1$I$20240719$20240801$20240813$20240813$EXP$FR-AFSSAPS-NT2024000997$FR-ELI_LILLY_AND_COMPANY-FR202408001616$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240813$$CN$FR$FR
242055751$24205575$1$I$20240701$20240801$20240813$20240813$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408000915$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240813$$CN$JP$JP
242055761$24205576$1$I$20240701$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006679$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240813$$CN$US$US
242055773$24205577$3$F$20240604$20240910$20240813$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407013819$ELI LILLY AND CO$$15$YR$T$F$Y$$$20240920$$CN$JP$JP
242055792$24205579$2$F$20240517$20240805$20240813$20240816$EXP$IT-MINISAL02-997022$IT-ELI_LILLY_AND_COMPANY-IT202408000786$ELI LILLY AND CO$$13$YR$T$M$Y$$$20240816$$CN$IT$IT
242055801$24205580$1$I$20240111$20240802$20240813$20240813$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202311017850$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240813$$CN$JP$JP
242055811$24205581$1$I$20240501$20240731$20240813$20240813$EXP$$TR-ELI_LILLY_AND_COMPANY-TR202408000706$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240813$$CN$TR$TR
242055821$24205582$1$I$20240101$20240801$20240813$20240813$EXP$SE-SEMPA-2024-005806$SE-ELI_LILLY_AND_COMPANY-SE202408000660$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240813$$CN$SE$SE
242055831$24205583$1$I$20240724$20240808$20240813$20240813$PER$FR-AFSSAPS-ST2024001264$FR-BRACCO-2024FR04928$BRACCO$$33$YR$$F$Y$$$20240813$$MD$FR$FR
242055842$24205584$2$F$$20240805$20240813$20240819$EXP$$CN-JNJFOC-20240642525$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240819$$CN$CN$CN
242055852$24205585$2$F$20240801$20240814$20240813$20240820$PER$$US-JNJFOC-20240822720$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240820$$PH$US$US
242055861$24205586$1$I$$20240808$20240813$20240813$PER$$US-BAYER-2024A115485$BAYER$$37$YR$A$F$Y$$$20240813$$HP$US$US
242055872$24205587$2$F$20240101$20240809$20240813$20240819$PER$$US-AMGEN-USASP2024158980$AMGEN$$75$YR$E$F$Y$$$20240819$$CN$US$US
242055881$24205588$1$I$$20240729$20240813$20240813$EXP$$IN-EPICPHARMA-IN-2024EPCLIT00949$EPIC PHARM$Sonam Spalgais.Exfoliated dermatitis and hepatitis to first line Anti-Tubercular Therapy with treatment  of Drug-Sensitive Tuberculosis with second line Anti-Tubercular Therapy: a roller  coaster ride.Chest Disease Reports.2024;12:1-19$31$YR$A$M$Y$$$20240813$$HP$IN$IN
242055891$24205589$1$I$$20240806$20240813$20240813$EXP$$US-GSK-US2024097987$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$MD$US$US
242055902$24205590$2$F$$20240812$20240813$20240905$PER$$CA-TOLMAR, INC.-24CA051329$TOLMAR$$$$$M$Y$$$20240905$$CN$CA$CA
242055912$24205591$2$F$20240703$20240815$20240813$20240905$PER$$US-TOLMAR, INC.-24US050771$TOLMAR$$91$YR$$M$Y$$$20240905$$PH$US$US
242055921$24205592$1$I$20231006$20240810$20240813$20240813$EXP$$NVSC2024IN163610$NOVARTIS$$$$$M$Y$$$20240813$$CN$IN$IN
242055933$24205593$3$F$$20240905$20240813$20240905$PER$$US-ALXN-202408USA000225US$ALEXION PHARMACEUTICALS$$$$$M$Y$46.3$KG$20240905$$CN$US$US
242055941$24205594$1$I$20240730$20240801$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122361$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240813$$CN$US$US
242055951$24205595$1$I$20240701$20240806$20240813$20240813$PER$$US-BAYER-2024A113799$BAYER$$30$YR$A$F$Y$$$20240813$$CN$US$US
242055961$24205596$1$I$$20240809$20240813$20240813$EXP$$US-OTSUKA-2024_022125$OTSUKA$$$$$M$Y$$$20240813$$CN$US$US
242055971$24205597$1$I$20240510$20240805$20240813$20240813$EXP$FR-AFSSAPS-DJ2024000865$FR-TEVA-VS-3230454$TEVA$$65$YR$$F$Y$65$KG$20240813$$MD$FR$FR
242055982$24205598$2$F$$20240814$20240813$20240819$PER$US-MLMSERVICE-20240730-PI147104-00165-1$US-RDY-SPO/USA/24/0011624$DR REDDYS$Anil V, Alhujaily E, Grover D, Santos JP, Kanugula AK, Suleiman M, et al. Gemcitabine-induced thrombotic microangiopathy in a patient with cholangiocarcinoma: An Atypical Case. Cureus. 2024;16(6):e63385. DOI: 10.7759/cureus.63385.$45$YR$A$F$Y$$$20240819$$MD$US$US
242055991$24205599$1$I$$20240805$20240813$20240813$PER$$US-MYLANLABS-2024M1073394$MYLAN$$$$$$Y$$$20240813$$CN$US$US
242056001$24205600$1$I$20240802$20240806$20240813$20240813$PER$$US-BAYER-2024A113877$BAYER$$27$YR$A$F$Y$$$20240813$$MD$US$US
242056012$24205601$2$F$$20240906$20240813$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126996$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$38.1$KG$20240909$$CN$US$US
242056021$24205602$1$I$20240802$20240806$20240813$20240813$PER$$US-BAYER-2024A114027$BAYER$$20$YR$A$F$Y$$$20240813$$HP$US$US
242056041$24205604$1$I$20220825$20240812$20240812$20240812$DIR$713870$$FDA-CTU$$68$YR$$F$N$74.25$KG$20240812$N$CN$US$
242056052$24205605$2$F$20240805$20240902$20240813$20240902$EXP$IT-MINISAL02-998356$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045215$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$$$20240902$$MD$IT$IT
242056071$24205607$1$I$$20240729$20240813$20240813$EXP$$US-EPICPHARMA-US-2024EPCLIT00951$EPIC PHARM$Haram A. Abdelmajid.Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring.Case Reports in Perinatal Medicine.31-MAY-2024;13 (1):1-5$$$$M$Y$$$20240813$$MD$US$US
242056081$24205608$1$I$$20240812$20240812$20240812$DIR$713861$$FDA-CTU$$$$$UNK$N$$$20240812$$CN$US$
242056091$24205609$1$I$20240812$20240812$20240812$20240812$DIR$713859$$FDA-CTU$$28$YR$$F$N$75.6$KG$20240812$N$CN$US$
242056101$24205610$1$I$20240722$20240812$20240812$20240812$DIR$713888$$FDA-CTU$$75$YR$$F$N$47.25$KG$20240812$N$HP$US$
242056111$24205611$1$I$20240812$20240812$20240812$20240812$DIR$713889$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242056131$24205613$1$I$20240809$20240812$20240812$20240812$DIR$713881$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242056141$24205614$1$I$20240812$20240812$20240812$20240812$DIR$713891$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242056151$24205615$1$I$$20240812$20240813$20240813$PER$$US-HALEON-2191777$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242056162$24205616$2$F$$20240806$20240813$20240816$EXP$$NVSC2024TH159904$NOVARTIS$$75$YR$$M$Y$$$20240816$$MD$TH$TH
242056171$24205617$1$I$$20240805$20240813$20240813$EXP$$GR-TEVA-VS-3230559$TEVA$$$$$F$Y$$$20240813$$MD$GR$GR
242056181$24205618$1$I$20240701$20240812$20240813$20240813$EXP$FR-AFSSAPS-LL2024001002$FR-GILEAD-2024-0675553$GILEAD$$59$YR$A$F$Y$79$KG$20240813$$MD$FR$FR
242056191$24205619$1$I$20240628$20240807$20240813$20240813$EXP$$GB-JNJFOC-20240825182$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240813$$CN$GB$GB
242056201$24205620$1$I$$20240812$20240813$20240813$PER$$US-HALEON-2191771$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242056221$24205622$1$I$$20240810$20240813$20240813$EXP$GB-MHRA-MED-202408100658253420-HDTFK$GB-MYLANLABS-2024M1074677$MYLAN$$$$$M$Y$$$20240813$$CN$GB$GB
242056231$24205623$1$I$20240626$20240801$20240813$20240813$EXP$$US-MYLANLABS-2024M1071957$MYLAN$$$$$F$Y$$$20240813$$HP$US$US
242056241$24205624$1$I$$20240729$20240813$20240813$EXP$$JP-PURACAP-JP-2024EPCLIT00946$PURACAP$Naohito Ide.Central Nervous System Adverse Reactions to Amantadine Intoxication: A Case Report and Analysis of JADER.In Vivo.JUL-2024;38:2090-2096$63$YR$A$F$Y$36.7$KG$20240813$$HP$JP$JP
242056251$24205625$1$I$20240627$20240805$20240813$20240813$PER$$US-BAYER-2024A113038$BAYER$$26$YR$A$F$Y$$$20240813$$CN$US$US
242056262$24205626$2$F$$20240803$20240813$20240829$PER$$US-BEH-2024176819$CSL BEHRING$$$$$M$Y$$$20240829$$MD$US$US
242056271$24205627$1$I$20240809$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159033$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
242056281$24205628$1$I$$20240808$20240813$20240813$EXP$$US-AMGEN-USASP2024158523$AMGEN$$$$$$Y$$$20240813$$HP$US$US
242056291$24205629$1$I$20240811$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160040$AMGEN$$63$YR$A$M$Y$$$20240813$$CN$US$US
242056301$24205630$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164181$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242056321$24205632$1$I$$20240801$20240813$20240813$EXP$$US-AstraZeneca-2024A179361$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242056331$24205633$1$I$20240506$20240809$20240813$20240813$EXP$$NVSC2024CN163876$NOVARTIS$$72$YR$$F$Y$56$KG$20240813$$HP$CN$CN
242056341$24205634$1$I$$20170306$20240813$20240813$EXP$$CY-AstraZeneca-2024A183490$ASTRAZENECA$$$$$$Y$$$20240813$$MD$CY$
242056351$24205635$1$I$20240417$20240808$20240813$20240813$EXP$$GB-SA-2024SA237824$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240813$$CN$GB$GB
242056361$24205636$1$I$20240722$20240731$20240813$20240813$PER$$US-009507513-2408USA000100$MERCK$$69$YR$$F$Y$$$20240813$$CN$US$US
242056372$24205637$2$F$20240101$20240830$20240813$20240907$EXP$$US-JNJFOC-20240827755$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240907$$CN$US$US
242056381$24205638$1$I$$20240802$20240813$20240813$EXP$$IT-RDY-LIT/ITA/24/0011649$DR REDDYS$Diral E, Furnari G, Bruno A, Greco R, Clerici D, Marktel S, et al. Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience. Frontiers in Oncology. 2024;14: doi:10.3389/fonc.2024.1391743.$$$$$Y$$$20240813$$HP$IT$IT
242056391$24205639$1$I$20240601$20240730$20240813$20240813$EXP$$CA-RDY-SPO/CAN/24/0011799$DR REDDYS$$$$$F$Y$$$20240813$$CN$CA$CA
242056402$24205640$2$F$20240809$20240826$20240813$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128000$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240828$$HP$US$US
242056411$24205641$1$I$$20240729$20240813$20240813$EXP$$IN-EPICPHARMA-IN-2024EPCLIT00933$EPIC PHARM$Dr. Swastika Suvirya.Inadvertent intra-arterial injection: Cutaneous  complications and management.Indian Journal of Dermatology, Venereology and Leprology.JUN-2024;90(4):496-498$24$YR$A$M$Y$$$20240813$$HP$IN$IN
242056421$24205642$1$I$$20240806$20240813$20240813$EXP$$JP-009507513-2408JPN000581J$MERCK$$89$YR$$F$Y$$$20240813$$PH$JP$JP
242056431$24205643$1$I$$20240809$20240813$20240813$PER$$US-HALEON-2191457$Haleon PLC$$79$YR$$F$Y$$$20240813$$CN$US$US
242056441$24205644$1$I$20210420$20240807$20240813$20240813$EXP$$KR-009507513-2203KOR006267$MERCK$$36$YR$$F$Y$49.5$KG$20240813$$MD$KR$KR
242056451$24205645$1$I$20240711$20240812$20240813$20240813$EXP$$CN-BAYER-2024A116283$BAYER$$76$YR$E$F$Y$$$20240813$$HP$CN$CN
242056461$24205646$1$I$$20240717$20240813$20240813$30DAY$$CL-PFIZER INC-202400234947$PFIZER$$$$$$Y$$$20240813$$CN$CL$CL
242056471$24205647$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55500$$FDA-CTU$$67$YR$$M$N$$$20240813$N$$US$
242056481$24205648$1$I$20240727$20240805$20240813$20240813$DIR$FDA-CDER-CTU-2024-55369$$FDA-CTU$$9$YR$$M$N$36.6$KG$20240805$N$$US$
242056491$24205649$1$I$20240727$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55368$$FDA-CTU$$40$YR$$M$N$114.3$KG$20240812$N$$US$
242056501$24205650$1$I$$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55498$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242056511$24205651$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55528$$FDA-CTU$$70$YR$$F$N$$$20240813$N$$US$
242056521$24205652$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55525$$FDA-CTU$$64$YR$$M$N$245$LBS$20240813$N$$US$
242056531$24205653$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55529$$FDA-CTU$$50$YR$$F$N$$$20240813$N$$US$
242056541$24205654$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55554$$FDA-CTU$$58$YR$$F$N$177$LBS$20240813$N$$US$
242056561$24205656$1$I$20240501$20240807$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005360$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240813$$CN$US$US
242056572$24205657$2$F$20240624$20240808$20240813$20240820$EXP$$US-Rubicon research Pvt ltd-2024000041$RUBICON RESEARCH$$31$YR$$M$Y$$$20240814$$CN$US$US
242056582$24205658$2$F$$20240911$20240813$20240919$EXP$$US-JNJFOC-20240829986$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
242056591$24205659$1$I$$20240729$20240813$20240813$EXP$$US-PURACAP-US-2024EPCLIT00948$PURACAP$Jacob Applegarth.Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of  Harlequin Syndrome.ASAIO Journal.MAY-2024;70:P74$18$YR$T$F$Y$$$20240813$$HP$US$US
242056602$24205660$2$F$$20240809$20240813$20240814$PER$$US-BIOGEN-2024BI01277865$BIOGEN$$$$$F$Y$$$20240814$$CN$US$US
242056614$24205661$4$F$20240807$20240916$20240813$20240916$PER$$US-AMGEN-USASP2024160648$AMGEN$$71$YR$E$M$Y$$$20240916$$CN$US$US
242056623$24205662$3$F$20240729$20240820$20240813$20240903$EXP$$US-BAYER-2024A112439$BAYER$$74$YR$E$F$Y$$$20240903$$CN$US$US
242056631$24205663$1$I$$20240806$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126408$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240813$$CN$US$US
242056641$24205664$1$I$20240408$20240805$20240813$20240813$EXP$FR-AFSSAPS-AVMA2024000338$FR-TEVA-VS-3230363$TEVA$$53$YR$$M$Y$$$20240813$$MD$FR$FR
242056651$24205665$1$I$$20240806$20240813$20240813$EXP$$US-IMMUNOCORE, LTD-2024-IMC-002945$IMMUNOCORE$$$$$$Y$$$20240813$$MD$US$US
242056661$24205666$1$I$$20240809$20240813$20240813$EXP$$US-INCYTE CORPORATION-2024IN008393$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242056671$24205667$1$I$20240501$20240805$20240813$20240813$EXP$SE-SEMPA-2024-005705$SE-TEVA-VS-3230832$TEVA$$94$YR$$F$Y$$$20240813$$MD$SE$SE
242056681$24205668$1$I$20240802$20240806$20240813$20240813$PER$$US-AMGEN-USASP2024159701$AMGEN$$66$YR$E$F$Y$$$20240813$$CN$US$US
242056691$24205669$1$I$$20240812$20240813$20240813$EXP$$CA-SANDOZ INC.-SDZ2024CA072110$SANDOZ$$80$YR$$M$Y$$$20240813$$PH$CA$CA
242056701$24205670$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55485$$FDA-CTU$$96$YR$$M$N$$$20240813$N$$US$
242056711$24205671$1$I$20240101$20240807$20240813$20240813$EXP$$US-THEA-2024001618$Thea Pharma$$$$$M$Y$$$20240813$$CN$US$US
242056721$24205672$1$I$$20240802$20240813$20240813$EXP$$IT-RDY-LIT/ITA/24/0011685$DR REDDYS$Diral E, Furnari G, Bruno A, Greco R, Clerici D, Marktel S, et al. Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience. Frontiers in Oncology. 2024;14: doi:10.3389/fonc.2024.1391743.$$$$$Y$$$20240813$$HP$IT$IT
242056732$24205673$2$F$$20240801$20240813$20240822$PER$$US-TRAVERE-2024TVT00722$TRAVERE THERAPEUTICS$$30$YR$A$F$Y$$$20240822$$CN$US$US
242056742$24205674$2$F$$20240808$20240813$20240822$PER$$US-TRAVERE-2024TVT00721$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242056762$24205676$2$F$20240701$20240916$20240813$20240919$EXP$$US-ABBVIE-5877068$ABBVIE$$83$YR$$M$Y$82$KG$20240919$$CN$US$US
242056773$24205677$3$F$$20240926$20240813$20240926$PER$$NVSC2024US164156$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
242056791$24205679$1$I$$20240805$20240813$20240813$EXP$$US-LUNDBECK-DKLU4002730$LUNDBECK$$$$$$Y$$$20240813$$HP$US$US
242056811$24205681$1$I$$20240802$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN008140$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242056821$24205682$1$I$$20240729$20240813$20240813$PER$$US-ABBVIE-5877797$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242056831$24205683$1$I$20240101$20240809$20240813$20240813$EXP$$CN-ABBVIE-5876540$ABBVIE$$43$YR$$F$Y$45$KG$20240813$$MD$CN$CN
242056841$24205684$1$I$$20240809$20240813$20240813$EXP$$CN-Time-Cap Labs, Inc.-2160355$TIME CAPS$Wenyi He MMed , Xin Fu MMed, Xinyue Du MMed, Guolan Deng MMed?Diagnosis and treatment of recurrent syncope in a middle-aged women?Ann Noninvasive Electrocardiol. 2024;29:e13110.?DOI: 10.1111/anec.13110$50$YR$$F$Y$$$20240813$$$CN$CN
242056852$24205685$2$F$$20240819$20240813$20240827$EXP$$JP-TEVA-VS-3230165$TEVA$Sawada K, Kawaji T, Yamana K, Matsuhashi K, Hara Y, Kuriyama N, et al. Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory distress syndrome: a case report. J-Cardiothorac-Surg 2024; 19 (1): 1-7.; Sawada K, Kawaji T, Yamana K, Matsuhashi K, Hara Y, Kuriyama N, et al. Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory...$40$YR$$F$Y$$$20240827$$HP$JP$JP
242056861$24205686$1$I$20240726$20240731$20240813$20240813$EXP$$US-TAKEDA-2024TUS077941$TAKEDA$$20$YR$$M$Y$$$20240813$$PH$US$US
242056871$24205687$1$I$$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55378$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242056881$24205688$1$I$$20240807$20240813$20240813$EXP$$CA-TAKEDA-2023TUS078580$TAKEDA$$$$$F$Y$$$20240813$$HP$CA$CA
242056891$24205689$1$I$$20240805$20240813$20240813$PER$$US-BAYER-2024A113906$BAYER$$$$$F$Y$$$20240813$$HP$US$US
242056901$24205690$1$I$20240811$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55543$$FDA-CTU$$83$YR$$M$N$$$20240813$Y$PH$US$
242056911$24205691$1$I$$20240429$20240813$20240813$PER$$US-ENDO USA, INC.-2024-002258$ENDO$$$$$$Y$$$20240813$$CN$US$US
242056921$24205692$1$I$$20240429$20240813$20240813$PER$$US-ENDO USA, INC.-2024-002259$ENDO$$$$$$Y$$$20240813$$CN$US$US
242056931$24205693$1$I$$20240801$20240813$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-126180$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240813$$MD$CA$CA
242056942$24205694$2$F$20240726$20240909$20240813$20240910$EXP$$DE-SANDOZ INC.-SDZ2024DE071889$SANDOZ$$69$YR$$F$Y$$$20240910$$MD$DE$DE
242056951$24205695$1$I$20230314$20240809$20240813$20240813$EXP$ES-AEMPS-1556064$ES-ROCHE-10000054693$ROCHE$$34$YR$A$M$Y$$$20240813$$MD$ES$ES
242056961$24205696$1$I$$20240708$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN007177$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242056972$24205697$2$F$$20240815$20240813$20240820$PER$$US-PFIZER INC-202400235206$PFIZER$$71$YR$$F$Y$$$20240820$$CN$US$US
242056982$24205698$2$F$$20240917$20240813$20240918$PER$$US-AstraZeneca-2024A182045$ASTRAZENECA$$41$YR$$F$Y$$$20240918$$HP$US$
242056991$24205699$1$I$20240711$20240805$20240813$20240813$EXP$$CN-AstraZeneca-2024A179674$ASTRAZENECA$$74$YR$$M$Y$67$KG$20240813$$MD$CN$
242057001$24205700$1$I$$20240809$20240813$20240813$PER$$US-ORGANON-O2408USA000911$ORGANON$$$$$$Y$$$20240813$$CN$US$US
242057011$24205701$1$I$20240714$20240808$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127131$BRISTOL MYERS SQUIBB$$97$YR$E$F$Y$$$20240813$$CN$US$US
242057021$24205702$1$I$20240601$20240812$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127956$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240813$$CN$US$US
242057031$24205703$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127138$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240813$$CN$US$US
242057041$24205704$1$I$20240621$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-111841$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240813$$HP$US$US
242057051$24205705$1$I$20240618$20240809$20240813$20240813$EXP$$NVSC2024CN164096$NOVARTIS$$37$YR$$M$Y$$$20240813$$HP$CN$CN
242057061$24205706$1$I$20240502$20240807$20240813$20240813$EXP$FR-AFSSAPS-PP2024000861$FR-MYLANLABS-2024M1073687$MYLAN$$90$YR$$F$Y$$$20240813$$MD$FR$FR
242057071$24205707$1$I$20140101$20240807$20240813$20240813$EXP$FR-AFSSAPS-RS2024000775$FR-MYLANLABS-2024M1073894$MYLAN$$77$YR$$F$Y$38$KG$20240813$$MD$FR$FR
242057081$24205708$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000054411$ROCHE$$31$YR$A$F$Y$$$20240813$$HP$US$US
242057092$24205709$2$F$20230713$20240731$20240813$20240829$EXP$$US-BEH-2024176750$CSL BEHRING$$$$A$$Y$$$20240829$$CN$US$US
242057101$24205710$1$I$20240630$20240807$20240813$20240813$EXP$FR-AFSSAPS-DJ2024000874$FR-MYLANLABS-2024M1073681$MYLAN$$68$YR$$F$Y$$$20240813$$MD$FR$FR
242057111$24205711$1$I$20210101$20240805$20240813$20240813$EXP$$US-ROCHE-2824251$ROCHE$$37$YR$A$F$Y$63.5$KG$20240813$$CN$US$US
242057131$24205713$1$I$$20240801$20240813$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-127870$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240813$$HP$CA$CA
242057141$24205714$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55533$$FDA-CTU$$78$YR$$M$N$$$20240813$N$$US$
242057151$24205715$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55542$$FDA-CTU$$61$YR$$F$N$$$20240813$N$$US$
242057161$24205716$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55561$$FDA-CTU$$63$YR$$F$N$$$20240813$N$$US$
242057171$24205717$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55564$$FDA-CTU$$69$YR$$M$N$$$20240813$N$$US$
242057182$24205718$2$F$20240810$20240813$20240813$20240822$PER$$US-AMGEN-USASP2024160275$AMGEN$$64$YR$A$M$Y$$$20240822$$CN$US$US
242057191$24205719$1$I$$20240812$20240813$20240813$EXP$$CA-SANDOZ INC.-SDZ2024CA072201$SANDOZ$$45$YR$$F$Y$$$20240813$$CN$CA$CA
242057201$24205720$1$I$20240711$20240718$20240813$20240813$PER$$US-TRAVERE-2024TVT00726$TRAVERE THERAPEUTICS$$47$YR$A$F$Y$$$20240813$$CN$US$US
242057211$24205721$1$I$$20240719$20240813$20240813$PER$$US-TRAVERE-2024TVT00728$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240813$$CN$US$US
242057221$24205722$1$I$$20240718$20240813$20240813$PER$$US-TRAVERE-2024TVT00725$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240813$$CN$US$US
242057231$24205723$1$I$20240812$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55534$$FDA-CTU$$15$YR$$M$N$$$20240813$Y$PH$US$
242057241$24205724$1$I$$20240806$20240813$20240813$EXP$$US-RDY-SPO/USA/24/0011674$DR REDDYS$$26$YR$A$F$Y$$$20240813$$MD$US$US
242057251$24205725$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164305$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242057261$24205726$1$I$$20240805$20240813$20240813$EXP$FR-AFSSAPS-PV2023000738$FR-RDY-SPO/FRA/23/0179837$DR REDDYS$$$$$M$Y$0.456$KG$20240813$$MD$FR$FR
242057271$24205727$1$I$$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55540$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242057281$24205728$1$I$$20240804$20240813$20240813$EXP$$CY-STEMLINE THERAPEUTICS, INC-2024-STML-CY000053$PAREXEL$$$$$$Y$$$20240813$$MD$CY$CY
242057291$24205729$1$I$$20240709$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07087$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242057301$24205730$1$I$20240101$20240809$20240813$20240813$EXP$$CN-BAYER-2024A115746$BAYER$$72$YR$E$M$Y$50$KG$20240813$$HP$CN$CN
242057311$24205731$1$I$$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55510$$FDA-CTU$$78$YR$$F$N$$$20240812$N$HP$US$
242057322$24205732$2$F$$20240815$20240813$20240823$EXP$$JP-TAKEDA-2024TUS079880$TAKEDA$$7$DEC$$$Y$$$20240823$$PH$JP$JP
242057331$24205733$1$I$20240411$20240805$20240813$20240813$EXP$FR-AFSSAPS-TO2024001422$FR-TEVA-VS-3230431$TEVA$$73$YR$$M$Y$$$20240813$$MD$FR$FR
242057341$24205734$1$I$20240809$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160625$AMGEN$$$$$$Y$$$20240813$$PH$US$US
242057351$24205735$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55538$$FDA-CTU$$67$YR$$F$N$$$20240813$N$$US$
242057361$24205736$1$I$20220101$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007180$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240813$$CN$US$US
242057371$24205737$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006798$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242057382$24205738$2$F$$20240819$20240813$20240826$EXP$$US-TEVA-VS-3230714$TEVA$Schott C, Massad KM, Held N. Disseminated Nocardiosis in a Sarcoidosis Patient Off Pneumocystis Pneumonia Prophylaxis. Am-J-Respir-Crit-Care-Med 2024; 209.; Schott C, Massad KM, Held N. Disseminated Nocardiosis in a Sarcoidosis Patient Off Pneumocystis Pneumonia Prophylaxis. Am-J-Respir-Crit-Care-Med 2024; 209.$81$YR$$M$Y$$$20240826$$HP$US$US
242057391$24205739$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007174$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240813$$CN$US$US
242057401$24205740$1$I$$20240807$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005385$ELI LILLY AND CO$$$$$$Y$$$20240813$$MD$US$US
242057411$24205741$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007289$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240813$$CN$US$US
242057421$24205742$1$I$20230901$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006680$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240813$$CN$US$US
242057431$24205743$1$I$$20240806$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408004348$ELI LILLY AND CO$$58$YR$A$$Y$$$20240813$$CN$US$US
242057441$24205744$1$I$20240719$20240805$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408003093$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240813$$CN$US$US
242057451$24205745$1$I$$20240812$20240813$20240813$EXP$$NVSC2024VN164127$NOVARTIS$$$$$F$Y$$$20240813$$MD$VN$VN
242057462$24205746$2$F$$20240911$20240813$20240911$PER$$US-ALXN-202408USA000265US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
242057471$24205747$1$I$$20240807$20240813$20240813$EXP$$US-EXELIXIS-CABO-24080373$EXELIXIS$$$$$M$Y$66.576$KG$20240813$$CN$US$US
242057481$24205748$1$I$20230308$20240812$20240813$20240813$EXP$$KR-MYLANLABS-2024M1074970$MYLAN$$$$A$F$Y$$$20240813$$MD$KR$KR
242057491$24205749$1$I$20240628$20240807$20240813$20240813$EXP$FR-AFSSAPS-RS2024000778$FR-MYLANLABS-2024M1073890$MYLAN$$47$YR$$F$Y$72$KG$20240813$$MD$FR$FR
242057502$24205750$2$F$$20240826$20240813$20240909$EXP$$PT-ASTELLAS-2024EU008052$ASTELLAS$$$$C$F$Y$$$20240909$$PH$PT$PT
242057511$24205751$1$I$20240808$20240812$20240813$20240813$PER$$US-HALEON-2191653$Haleon PLC$$70$YR$$F$Y$$$20240813$$CN$US$US
242057522$24205752$2$F$$20240813$20240813$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127767$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240819$$HP$US$US
242057531$24205753$1$I$$20240806$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124594$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240813$$HP$US$US
242057541$24205754$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126784$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$81.65$KG$20240813$$CN$US$US
242057551$24205755$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164217$NOVARTIS$$$$$F$Y$$$20240813$$CN$US$US
242057562$24205756$2$F$20240726$20240812$20240813$20240822$PER$$US-AstraZeneca-2024A171091$ASTRAZENECA$$26095$DY$$M$Y$$$20240822$$CN$US$
242057571$24205757$1$I$$20240805$20240813$20240813$EXP$$TW-AstraZeneca-2024A181633$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$TW$
242057581$24205758$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A177489$ASTRAZENECA$$$$$F$Y$78.9$KG$20240813$$CN$US$
242057591$24205759$1$I$20240731$20240801$20240813$20240813$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000161$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240813$$CN$US$US
242057601$24205760$1$I$20190101$20240808$20240813$20240813$EXP$$AU-ABBVIE-5873891$ABBVIE$$60$YR$$M$Y$$$20240813$$MD$AU$AU
242057611$24205761$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127949$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240813$$CN$US$US
242057621$24205762$1$I$$20240807$20240813$20240813$EXP$GB-MHRA-MED-202408072348525630-ZFNMG$GB-RDY-SPO/GBR/24/0011658$DR REDDYS$$$$$M$Y$$$20240813$$CN$GB$GB
242057631$24205763$1$I$$20240806$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124935$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240813$$MD$US$US
242057641$24205764$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127276$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240813$$CN$US$US
242057651$24205765$1$I$$20240812$20240813$20240813$PER$$US-HALEON-2191694$Haleon PLC$$$$$M$Y$$$20240813$$CN$US$US
242057661$24205766$1$I$20240415$20240808$20240813$20240813$EXP$$CA-JNJFOC-20240530950$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240813$$HP$CA$CA
242057671$24205767$1$I$20240703$20240806$20240813$20240813$EXP$$US-BAYER-2024A114324$BAYER$$76$YR$E$F$Y$$$20240813$$CN$US$US
242057701$24205770$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55544$$FDA-CTU$$51$YR$$F$N$350$LBS$20240813$N$$US$
242057711$24205771$1$I$20240810$20240812$20240812$20240812$DIR$713969$$FDA-CTU$$42$YR$$F$N$56.25$KG$20240812$N$MD$US$
242057721$24205772$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55566$$FDA-CTU$$59$YR$$F$N$245$LBS$20240813$N$$US$
242057752$24205775$2$F$20240725$20240807$20240813$20240829$EXP$$CN-DSJP-DSJ-2024-139819$DAIICHI$$$$A$F$Y$70$KG$20240829$$MD$CN$CN
242057761$24205776$1$I$$20240730$20240813$20240813$EXP$$US-Nexus Pharma-000299$NEXUS PHARMACEUTICALS$Braish JS, Kugler E, Jabbour E, Woodman K, Ravandi F, Nicholas S, et.al. Incidence and Clinical Presentation of Severe Neurotoxicity from Nelarabine in Patients with T-Cell Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2024 Jun 26: S2152-2650(24)00241-6.$56$YR$A$M$Y$$$20240813$$HP$US$US
242057771$24205777$1$I$$20240805$20240813$20240813$EXP$NL-LRB-00993500$NL-TEVA-VS-3231120$TEVA$$61$YR$$M$Y$72$KG$20240813$$MD$NL$NL
242057781$24205778$1$I$$20240813$20240813$20240813$EXP$$GB-ORGANON-1912GBR007549$ORGANON$Hafouda Y, Sharma A, Li V, Yesudian PD.. Double trouble: ciclosporin-simvastatin coinduced rhabdomyolysis. BMJ case reports. 2019;12(11):e225971$73$YR$$F$Y$$$20240813$$HP$GB$GB
242057791$24205779$1$I$$20240805$20240813$20240813$30DAY$$US-GSK-US2024AMR098280$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
242057801$24205780$1$I$$20240807$20240813$20240813$PER$$US-JNJFOC-20240820891$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$HP$US$US
242057812$24205781$2$F$$20240902$20240813$20240905$EXP$$BR-JNJFOC-20240824960$JOHNSON AND JOHNSON$$$$$F$Y$50$KG$20240905$$CN$BR$BR
242057821$24205782$1$I$20240701$20240805$20240813$20240813$EXP$$FR-TEVA-VS-3231180$TEVA$$$$$F$Y$$$20240813$$CN$FR$FR
242057831$24205783$1$I$20240101$20240808$20240813$20240813$EXP$$US-ABBVIE-5871133$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242057851$24205785$1$I$$20240403$20240813$20240813$PER$$US-GALDERMA-US2024006252$GALDERMA$$$$$$Y$$$20240813$$CN$US$US
242057861$24205786$1$I$20240730$20240806$20240813$20240813$PER$$US-ABBVIE-5870750$ABBVIE$$59$YR$$M$Y$$$20240813$$CN$US$US
242057871$24205787$1$I$$20240806$20240813$20240813$EXP$$US-BAYER-2024A114467$BAYER$$70$YR$E$M$Y$$$20240813$$MD$US$US
242057881$24205788$1$I$$20240805$20240813$20240813$EXP$$US-RDY-LIT/USA/24/0011706$DR REDDYS$Khattar G, Makram M, Rabah H, Hong C, Khan S, Mourad O, et al. Catastrophic Convergence: Refractory Septic Shock and Multisystem Failure in a Case of Hidradenitis Suppurativa Complicated by Fournier^s Gangrene and Bilateral Pulmonary Embolism. American Journal of Respiratory and Critical Care Medicine. 2024;209: A1614. doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1614.$53$YR$A$F$Y$$$20240813$$HP$US$US
242057891$24205789$1$I$20240713$20240805$20240813$20240813$EXP$FR-AFSSAPS-RN2024000817$FR-TEVA-VS-3230445$TEVA$$30$YR$$F$Y$$$20240813$$MD$FR$FR
242057902$24205790$2$F$$20240818$20240813$20240826$EXP$$SE-Ipsen Biopharmaceuticals, Inc.-2024-15716$IPSEN$Aslam, Mohammad Asif, Khoschnau, Shwan ^Selective endoscopic neurotomy of the upper and lower subscapular nerves in a patient with dyskinetic cerebral palsy: a case report^, JSES Reviews, Reports, and Techniques, 01-Jan-2024, Vol. 4.0, Iss. 3.0, Pp. 511-514. doi:10.1016/j.xrrt.2024.03.004$$$$F$Y$$$20240826$$MD$SE$SE
242057911$24205791$1$I$$20240729$20240813$20240813$EXP$$TR-NOVOPROD-1266511$NOVO NORDISK$Merva Bet?l Sevin? et.al. Autoimmune Gestational Diabetes, An Uncommon Cause of Type 1 Diabetes: A Case Report. Endocrinology research and practice. 2024;188-190$19$YR$$F$Y$$$20240813$$HP$TR$TR
242057921$24205792$1$I$$20240809$20240813$20240813$EXP$$US-JNJFOC-20240828094$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240813$$HP$US$US
242057952$24205795$2$F$20230101$20240808$20240813$20240823$EXP$$US-CHIESI-2024CHF05016$CHIESI$$24$YR$$M$Y$$$20240823$$CN$US$US
242057961$24205796$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240823831$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
242057971$24205797$1$I$$20240807$20240813$20240813$PER$$US-JNJFOC-20240818404$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240813$$CN$US$US
242057981$24205798$1$I$$20240809$20240813$20240813$PER$$NVSC2024US164330$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
242057993$24205799$3$F$20231020$20240829$20240813$20240903$EXP$$US-AstraZeneca-2024A182043$ASTRAZENECA$$68$YR$$M$Y$70.8$KG$20240903$$HP$US$
242058001$24205800$1$I$$20221214$20240813$20240813$EXP$$US-AstraZeneca-2022A407688$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242058021$24205802$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55572$$FDA-CTU$$67$YR$$F$N$119$KG$20240813$N$$US$
242058041$24205804$1$I$20240806$20240806$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408003674$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240813$$PH$US$US
242058052$24205805$2$F$20240810$20240814$20240813$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408007424$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240818$$CN$US$US
242058061$24205806$1$I$20240601$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006417$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240813$$CN$US$US
242058071$24205807$1$I$$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160419$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
242058081$24205808$1$I$$20240806$20240813$20240813$30DAY$$US-GSK-US2024098141$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242058092$24205809$2$F$$20240827$20240813$20240905$EXP$$JP-ARDELYX-2024ARDX006102$ARDELYX$$7$DEC$$M$Y$$$20240904$$MD$JP$JP
242058101$24205810$1$I$20240101$20240722$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04959$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242058111$24205811$1$I$20240712$20240812$20240813$20240813$EXP$FR-AFSSAPS-AN2024001041$NVSC2024FR163083$NOVARTIS$$64$YR$$M$Y$92$KG$20240813$$PH$FR$FR
242058122$24205812$2$F$20240301$20240821$20240813$20240828$EXP$$JP-ARDELYX-2024ARDX006120$ARDELYX$$52$YR$$F$Y$$$20240828$$HP$JP$JP
242058131$24205813$1$I$$20240809$20240813$20240813$EXP$$US-JNJFOC-20240827465$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240813$$MD$US$US
242058141$24205814$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127070$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240813$$CN$US$US
242058151$24205815$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128021$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240813$$CN$US$US
242058162$24205816$2$F$$20240828$20240813$20240828$PER$$US-JNJFOC-20240806829$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$CN$US$US
242058181$24205818$1$I$$20240806$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125498$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$51.26$KG$20240813$$CN$US$US
242058191$24205819$1$I$20240501$20240809$20240813$20240813$EXP$$PR-ABBVIE-5877225$ABBVIE$$76$YR$$F$Y$$$20240813$$CN$PR$PR
242058201$24205820$1$I$$20240808$20240813$20240813$EXP$$US-GILEAD-2024-0683715$GILEAD$Aldoss, Ibrahim., et al.. Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Blood Advances. 2024;unk:unk$$$A$$Y$$$20240813$$HP$US$US
242058212$24205821$2$F$$20240812$20240813$20240821$EXP$$NVSC2024US164132$NOVARTIS$$$$$M$Y$$$20240821$$MD$US$US
242058221$24205822$1$I$20240731$20240808$20240813$20240813$EXP$GB-MHRA-TPP274383C9623330YC1723131528270$GB-INDIVIOR US-INDV-155986-2024$RECKITT BENCKISER$$$$$$Y$$$20240813$$MD$GB$GB
242058231$24205823$1$I$$20240621$20240813$20240813$PER$$US-LUNDBECK-DKLU4001644$LUNDBECK$$$$$$Y$$$20240813$$HP$US$US
242058242$24205824$2$F$20240802$20240923$20240813$20240930$EXP$$US-Vifor (International) Inc.-VIT-2024-07131$VIFOR$$61$YR$$M$Y$74$KG$20240930$$HP$US$US
242058251$24205825$1$I$$20240813$20240813$20240813$EXP$$KR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045188$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240813$$CN$KR$KR
242058261$24205826$1$I$20240101$20240809$20240813$20240813$EXP$$US-ABBVIE-5875839$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242058281$24205828$1$I$20240614$20240805$20240813$20240813$EXP$$CL-BIOGEN-2024BI01277288$BIOGEN$$6$YR$$F$Y$$$20240813$$CN$CL$CL
242058291$24205829$1$I$20240801$20240809$20240813$20240813$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004452$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240813$$HP$US$US
242058311$24205831$1$I$$20240806$20240813$20240813$30DAY$$US-GSK-US2024AMR098819$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
242058323$24205832$3$F$20230201$20240826$20240813$20240828$EXP$FR-AFSSAPS-RN2023000299$FR-SANDOZ INC.-NVSC2023FR070374$SANDOZ$$55$YR$$M$Y$$$20240828$$MD$FR$FR
242058341$24205834$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55576$$FDA-CTU$$84$YR$$F$N$126$LBS$20240813$N$$US$
242058351$24205835$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55574$$FDA-CTU$$54$YR$$F$N$$$20240813$N$$US$
242058361$24205836$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55582$$FDA-CTU$$51$YR$$F$N$233$LBS$20240813$N$$US$
242058371$24205837$1$I$$20240806$20240813$20240813$PER$$US-JNJFOC-20240816373$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$CN$US$US
242058391$24205839$1$I$$20240809$20240813$20240813$PER$$US-TAKEDA-2024TUS080878$TAKEDA$$$$$$Y$$$20240813$$CN$US$US
242058402$24205840$2$F$20230101$20240808$20240813$20240823$EXP$$US-CHIESI-2024CHF05015$CHIESI$$24$YR$$M$Y$$$20240823$$CN$US$US
242058411$24205841$1$I$20240315$20240805$20240813$20240813$EXP$CZ-CZSUKL-24002137$CZ-TEVA-VS-3231093$TEVA$$49$YR$$F$Y$78$KG$20240813$$CN$CZ$CZ
242058422$24205842$2$F$$20240808$20240813$20240819$EXP$$US-GILEAD-2024-0683716$GILEAD$Aldoss, Ibrahim., et al.. Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Blood Advances. 2024;unk:unk$$$A$$Y$$$20240819$$HP$US$US
242058431$24205843$1$I$$20240623$20240813$20240813$PER$$US-LUNDBECK-DKLU4001069$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
242058441$24205844$1$I$20220926$20221003$20240813$20240813$EXP$$CO-BIOVITRUM-2022CO11599$BIOVITRUM$$90$DY$$M$Y$$$20240813$$CN$CO$CO
242058461$24205846$1$I$20220508$20220525$20240813$20240813$EXP$$ZA-BIOVITRUM-2022ZA07363$BIOVITRUM$$278$DY$$M$Y$4.7$KG$20240813$$CN$ZA$ZA
242058471$24205847$1$I$$20240808$20240813$20240813$EXP$$NVSC2024BR163754$NOVARTIS$$$$$F$Y$$$20240813$$MD$BR$BR
242058481$24205848$1$I$$20240808$20240813$20240813$EXP$$US-GILEAD-2024-0683689$GILEAD$Aldoss, Ibrahim., et al.. Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Blood Advances. 2024;unk:unk$$$A$$Y$$$20240813$$HP$US$US
242058491$24205849$1$I$$20240808$20240813$20240813$EXP$$NVSC2024US117878$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
242058502$24205850$2$F$20240808$20240812$20240813$20240813$PER$$US-JNJFOC-20240825316$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240813$$CN$US$US
242058521$24205852$1$I$$20240812$20240812$20240812$DIR$713905$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242058551$24205855$1$I$20240809$20240812$20240812$20240812$DIR$713902$$FDA-CTU$$46$YR$$F$N$$$20240812$N$CN$US$
242058571$24205857$1$I$20240809$20240812$20240812$20240812$DIR$713914$$FDA-CTU$$77$YR$$M$N$76.05$KG$20240812$Y$PH$US$
242058581$24205858$1$I$20240605$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55537$$FDA-CTU$$61$YR$$F$N$$$20240813$N$HP$US$
242058591$24205859$1$I$20240812$20240812$20240812$20240812$DIR$713938$$FDA-CTU$$28$YR$$F$N$85.5$KG$20240812$N$CN$US$
242058611$24205861$1$I$20240801$20240812$20240812$20240812$DIR$713959$$FDA-CTU$$29$YR$$M$N$69.75$KG$20240812$N$CN$US$
242058621$24205862$1$I$20240721$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55589$$FDA-CTU$$60$YR$$F$N$$$20240813$N$$US$
242058642$24205864$2$F$$20240827$20240813$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125356$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$PH$JP$JP
242058651$24205865$1$I$$20240709$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-113334$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240813$$PH$US$US
242058661$24205866$1$I$$20240812$20240813$20240813$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-127214$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240813$$CN$TW$TW
242058671$24205867$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126272$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240813$$CN$US$US
242058683$24205868$3$F$$20240906$20240813$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127090$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240912$$MD$JP$JP
242058691$24205869$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127803$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$59.87$KG$20240813$$CN$US$US
242058701$24205870$1$I$$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126766$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240813$$HP$US$US
242058711$24205871$1$I$$20240805$20240813$20240813$EXP$$BR-TAKEDA-2024TUS079871$TAKEDA$$$$$M$Y$$$20240813$$CN$BR$BR
242058721$24205872$1$I$20240420$20240805$20240813$20240813$EXP$FR-AFSSAPS-AM2024000601$FR-TEVA-VS-3230392$TEVA$$70$YR$$M$Y$80$KG$20240813$$MD$FR$FR
242058732$24205873$2$F$$20240903$20240813$20240911$EXP$$HU-BAXTER-2024BAX022695$BAXTER$$29$YR$$F$Y$$$20240911$$HP$HU$HU
242058741$24205874$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5873986$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242058751$24205875$1$I$$20240624$20240813$20240813$PER$$US-LUNDBECK-DKLU4001062$LUNDBECK$$$$$$Y$$$20240813$$CN$US$US
242058761$24205876$1$I$$20240809$20240813$20240813$EXP$$CA-SANDOZ INC.-NVSC2022CA178138$SANDOZ$$$$$F$Y$$$20240813$$CN$CA$CA
242058771$24205877$1$I$$20240723$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05057$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242058781$24205878$1$I$20240808$20240808$20240813$20240813$30DAY$$IT-SANDOZ INC.-SDZ2024IT072016$SANDOZ$$14$YR$$M$Y$45$KG$20240813$$CN$IT$IT
242058792$24205879$2$F$$20240819$20240813$20240826$EXP$$JP-TEVA-VS-3230166$TEVA$Masuda H, Yamamoto Y, Kimura S, Matsuda K, Kobayashi K, Ae R. Spontaneous Abdominal Wall Hematoma: Early Recurrence without an Anticoagulant in an Elderly Woman Receiving Chronic Corticosteroid Treatment. Intern-Med 2024; 63 (14): 2097-2100.; Masuda H, Yamamoto Y, Kimura S, Matsuda K, Kobayashi K, Ae R. Spontaneous Abdominal Wall Hematoma: Early Recurrence without an Anticoagulant in an Elderly Woman Receiving Chronic Corticosteroid Treatment. Intern-Med 2024; 63 (14): 2097-2100.; Masuda H, Y...$73$YR$$F$Y$$$20240826$$HP$JP$JP
242058801$24205880$1$I$$20240809$20240813$20240813$EXP$$US-TAKEDA-2024TUS080245$TAKEDA$$$$$F$Y$$$20240813$$CN$US$US
242058811$24205881$1$I$20240601$20240809$20240813$20240813$EXP$$CN-BAYER-2024A115751$BAYER$$73$YR$E$M$Y$64$KG$20240813$$HP$CN$CN
242058821$24205882$1$I$20240726$20240805$20240813$20240813$EXP$CN-NMPACDR-4501031911191202400021$CN-BAXTER-2024BAX022870$BAXTER$$8$YR$$M$Y$43$KG$20240813$$MD$CN$CN
242058831$24205883$1$I$$20240808$20240813$20240813$PER$$US-ALXN-202408USA000541US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242058842$24205884$2$F$20240101$20240905$20240813$20240910$EXP$$CA-SA-2024SA234578$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240910$$MD$CA$CA
242058851$24205885$1$I$20240701$20240808$20240813$20240813$EXP$$US-SA-2024SA238932$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240813$$MD$US$US
242058861$24205886$1$I$$20240813$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045466$BOEHRINGER INGELHEIM$$$$$$Y$$$20240813$$CN$US$US
242058872$24205887$2$F$20240401$20240916$20240813$20240917$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045363$BOEHRINGER INGELHEIM$$90$YR$E$F$Y$85$KG$20240918$$MD$DE$DE
242058881$24205888$1$I$$20240722$20240813$20240813$PER$$US-TRAVERE-2024TVT00730$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240813$$CN$US$US
242058891$24205889$1$I$$20240717$20240813$20240813$PER$$US-FMCRTG-FMC-2407-000876$FRESENIUS MEDICAL CARE$$82$YR$E$F$Y$44$KG$20240813$$HP$US$US
242058901$24205890$1$I$$20240715$20240813$20240813$PER$$US-FMCRTG-FMC-2407-000866$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240813$$CN$US$US
242058911$24205891$1$I$$20240712$20240813$20240813$PER$$US-FMCRTG-FMC-2407-000862$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240813$$HP$US$US
242058921$24205892$1$I$$20240808$20240813$20240813$EXP$$US-SA-2024SA239660$SANOFI AVENTIS$$$$A$M$Y$92.99$KG$20240813$$MD$US$US
242058931$24205893$1$I$20240101$20240808$20240813$20240813$EXP$$US-SA-2024SA238993$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240813$$MD$US$US
242058941$24205894$1$I$$20240808$20240813$20240813$EXP$$US-SA-2024SA239898$SANOFI AVENTIS$$$$$$Y$$$20240813$$MD$US$US
242058951$24205895$1$I$$20240812$20240812$20240812$DIR$713896$$FDA-CTU$$$$$UNK$N$$$20240812$$CN$US$
242058961$24205896$1$I$$20240716$20240813$20240813$PER$$US-FMCRTG-FMC-2407-000864$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240813$$HP$US$US
242058971$24205897$1$I$$20240805$20240813$20240813$EXP$$US-FMCRTG-FMC-2408-000958$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240813$$HP$US$US
242058981$24205898$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126745$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240813$$HP$US$US
242058991$24205899$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126710$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240813$$CN$US$US
242059001$24205900$1$I$$20240812$20240812$20240812$DIR$713937$$FDA-CTU$$50$YR$$M$N$100$KG$20240812$N$MD$US$
242059011$24205901$1$I$20240322$20240812$20240812$20240812$DIR$713934$$FDA-CTU$$71$YR$$F$N$60.75$KG$20240812$Y$CN$US$
242059021$24205902$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127719$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240813$$HP$US$US
242059031$24205903$1$I$20240801$20240808$20240813$20240813$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127407$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240813$$MD$JP$JP
242059041$24205904$1$I$$20240812$20240813$20240813$PER$$US-JNJFOC-20240830719$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
242059051$24205905$1$I$$20240806$20240813$20240813$EXP$$CA-GSK-CA2024084477$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$CA$CA
242059061$24205906$1$I$$20240806$20240813$20240813$EXP$$CA-JNJFOC-20240823945$JOHNSON AND JOHNSON$$11$YR$C$F$Y$$$20240813$$HP$CA$CA
242059071$24205907$1$I$20240619$20240805$20240813$20240813$EXP$IT-MINISAL02-996798$IT-TEVA-VS-3230927$TEVA$$51$YR$$M$Y$$$20240813$$PH$IT$IT
242059081$24205908$1$I$$20240809$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US071961$SANDOZ$$$$$$Y$$$20240813$$CN$US$US
242059091$24205909$1$I$20240809$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006450$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240813$$CN$US$US
242059101$24205910$1$I$$20240417$20240813$20240813$EXP$$US-TEVA-VS-3224555$TEVA$$$$$$Y$$$20240813$$CN$US$US
242059113$24205911$3$F$$20240823$20240813$20240830$EXP$$AU-PFIZER INC-202400235447$PFIZER$$$$$M$Y$$$20240830$$MD$AU$AU
242059121$24205912$1$I$20240501$20240809$20240813$20240813$EXP$$US-PFIZER INC-202400223279$PFIZER$$44$YR$$F$Y$$$20240813$$CN$US$US
242059131$24205913$1$I$$20240729$20240813$20240813$EXP$$JP-PFIZER INC-202400229457$PFIZER$Tsujino, M.. A review of the usage of CDK4/6 inhibitors in patients with HR-positive, HER2-negative advanced or breast cancer recurrent at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;32nd:117$$$$$Y$$$20240813$$HP$JP$JP
242059141$24205914$1$I$$20240812$20240813$20240813$EXP$$US-PFIZER INC-PV202400105098$PFIZER$$78$YR$$F$Y$$$20240813$$CN$US$US
242059151$24205915$1$I$$20240801$20240813$20240813$30DAY$$US-PFIZER INC-PV202400044105$PFIZER$$$$$$Y$$$20240813$$HP$US$US
242059161$24205916$1$I$$20240807$20240813$20240813$EXP$$AR-TAKEDA-2024TUS080908$TAKEDA$$$$$F$Y$$$20240813$$CN$AR$AR
242059173$24205917$3$F$20240801$20240820$20240813$20240823$EXP$$GB-MYLANLABS-2024M1072290$MYLAN$$39$YR$$M$Y$$$20240823$$MD$GB$GB
242059181$24205918$1$I$20240113$20240808$20240813$20240813$EXP$FR-AFSSAPS-ST2024001273$FR-BAYER-2024A114444$BAYER$$80$YR$E$$Y$78.3$KG$20240813$$PH$FR$FR
242059191$24205919$1$I$$20240812$20240813$20240813$EXP$$US-JNJFOC-20240829459$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
242059201$24205920$1$I$20240728$20240805$20240813$20240813$EXP$$CN-ROCHE-10000049695$ROCHE$$86$YR$E$F$Y$42$KG$20240813$$HP$CN$CN
242059211$24205921$1$I$$20240806$20240813$20240813$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001092$ALEMBIC$Shanks K.G, Kurtz S.A.K, Behonick G.S.. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of analytical toxicology. 2024;00:1-9$$$$$Y$$$20240813$$HP$US$US
242059222$24205922$2$F$20240807$20240912$20240813$20240917$PER$$US-AMGEN-USASP2024160060$AMGEN$$71$YR$E$F$Y$$$20240917$$MD$US$US
242059241$24205924$1$I$20240718$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160127$AMGEN$$62$YR$A$F$Y$101.5$KG$20240813$$HP$US$US
242059251$24205925$1$I$$20240806$20240813$20240813$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001093$ALEMBIC$Shanks K.G, Kurtz S.A.K, Behonick G.S.. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of analytical toxicology. 2024;00:1-9$$$$$Y$$$20240813$$HP$US$US
242059261$24205926$1$I$$20240806$20240813$20240813$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001094$ALEMBIC$Shanks K.G, Kurtz S.A.K, Behonick G.S.. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of analytical toxicology. 2024;00:1-9$$$$$Y$$$20240813$$HP$US$US
242059271$24205927$1$I$20240812$20240812$20240812$20240812$DIR$713915$$FDA-CTU$$5$YR$$M$N$23.9$KG$20240812$N$HP$US$
242059301$24205930$1$I$20240615$20240801$20240813$20240813$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00195$OPKO HEALTH$$89$YR$$M$Y$$$20240808$$PH$US$US
242059321$24205932$1$I$$20240806$20240813$20240813$EXP$$CA-TEVA-VS-3232008$TEVA$$$$$F$Y$$$20240813$$CN$CA$CA
242059331$24205933$1$I$20240730$20240801$20240813$20240813$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00196$OPKO HEALTH$$90$YR$$M$Y$$$20240808$$PH$COUNTRY NOT SPECIFIED$US
242059363$24205936$3$F$20240807$20240829$20240813$20240829$PER$$US-ALXN-202408USA000540US$ALEXION PHARMACEUTICALS$$74$YR$$F$Y$$$20240829$$CN$US$US
242059382$24205938$2$F$20240514$20240916$20240813$20240926$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00203$OPKO HEALTH$$66$YR$$F$Y$$$20240924$$PH$US$US
242059391$24205939$1$I$$20240806$20240813$20240813$EXP$US-MLMSERVICE-20240730-PI148178-00306-1$US-RDY-SPO/USA/24/0011626$DR REDDYS$Manuel SL, Sapone J, Lin F. Tacrolimus-induced recurrent acute coronary syndrome due to an unknown mechanism. Cureus. 2024;16(6):e63266. DOI: 10.7759/cureus.63266.$74$YR$E$F$Y$$$20240813$$MD$US$US
242059401$24205940$1$I$$20240722$20240813$20240813$PER$$US-TRAVERE-2024TVT00731$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240813$$CN$US$US
242059411$24205941$1$I$20240703$20240805$20240813$20240813$EXP$FR-AFSSAPS-LY2024001144$FR-TEVA-VS-3230488$TEVA$$20$YR$$F$Y$50$KG$20240813$$PH$FR$FR
242059421$24205942$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55596$$FDA-CTU$$86$YR$$M$N$$$20240813$N$$US$
242059431$24205943$1$I$$20240812$20240812$20240812$DIR$713928$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242059443$24205944$3$F$20240723$20240815$20240813$20240824$EXP$$BR-TAKEDA-2024TUS079056$TAKEDA$$67$YR$$F$Y$$$20240824$$CN$BR$BR
242059451$24205945$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164277$NOVARTIS$$$$$$Y$$$20240813$$PH$US$US
242059461$24205946$1$I$20240401$20240812$20240812$20240812$DIR$713939$$FDA-CTU$$66$YR$$F$N$57.6$KG$20240812$Y$CN$US$
242059471$24205947$1$I$$20240805$20240813$20240813$EXP$$EG-AstraZeneca-2024A119290$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$EG$
242059481$24205948$1$I$$20240812$20240813$20240813$EXP$DE-EMA-20141104-shavetasoodp-133905501$DE-SANDOZ INC.-SDZ2024DE071963$SANDOZ$$69$YR$$M$Y$$$20240813$$HP$DE$DE
242059493$24205949$3$F$20240101$20240904$20240813$20240911$EXP$$US-AMGEN-USASP2024160021$AMGEN$$83$YR$E$F$Y$$$20240911$$HP$US$US
242059501$24205950$1$I$$20240805$20240813$20240813$EXP$$JP-AstraZeneca-2024A178935$ASTRAZENECA$$$$$$Y$$$20240813$$MD$JP$
242059511$24205951$1$I$20150401$20240805$20240813$20240813$EXP$$CN-AstraZeneca-2024A183858$ASTRAZENECA$Zhu L, Wang X. Nursing experience of a patient with bipolar disorder hypomania with severe erythema multiforme drug eruption. China Healthcare + Nutrition 2016;26(7):375.$39$YR$$F$Y$$$20240813$$HP$CN$
242059521$24205952$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A181438$ASTRAZENECA$$$$$M$Y$$$20240813$$HP$US$
242059531$24205953$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127044$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240813$$CN$US$US
242059542$24205954$2$F$20240722$20240903$20240813$20240909$EXP$$CO-AstraZeneca-2024A182254$ASTRAZENECA$$28656$DY$$M$Y$$$20240909$$CN$CO$
242059552$24205955$2$F$20230601$20240913$20240813$20240918$EXP$$US-AstraZeneca-2024A177748$ASTRAZENECA$$1024$MON$$M$Y$$$20240918$$CN$US$
242059561$24205956$1$I$$20230315$20240813$20240813$EXP$$US-AstraZeneca-2023A063772$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242059571$24205957$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127907$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240813$$CN$US$US
242059581$24205958$1$I$20160101$20200827$20240813$20240813$EXP$$DE-SANDOZ INC.-NVSC2020DE103632$SANDOZ$$49$YR$$M$Y$$$20240813$$MD$DE$DE
242059591$24205959$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5876105$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242059602$24205960$2$F$20240101$20240903$20240813$20240909$EXP$$US-ABBVIE-5873003$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242059611$24205961$1$I$$20240806$20240813$20240813$EXP$$CA-TAKEDA-2024TUS079387$TAKEDA$$$$$F$Y$$$20240813$$MD$CA$CA
242059631$24205963$1$I$$20240806$20240813$20240813$EXP$$CA-TEVA-VS-3231996$TEVA$$37$YR$$F$Y$$$20240813$$PH$CA$CA
242059641$24205964$1$I$$20220930$20240813$20240813$EXP$$EG-JNJFOC-20240828447$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$CN$EG$EG
242059651$24205965$1$I$$20240806$20240813$20240813$PER$$US-JNJFOC-20240816852$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240813$$CN$US$US
242059661$24205966$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164338$NOVARTIS$$$$A$F$Y$$$20240813$$CN$US$US
242059671$24205967$1$I$$20240809$20240813$20240813$EXP$$NVSC2024US163428$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242059681$24205968$1$I$$20240808$20240813$20240813$EXP$$US-GILEAD-2024-0683720$GILEAD$Aldoss, Ibrahim., et al.. Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Blood Advances. 2024;unk:unk$$$A$$Y$$$20240813$$HP$US$US
242059691$24205969$1$I$$20240809$20240813$20240813$PER$$US-ROCHE-10000054447$ROCHE$$$$A$F$Y$$$20240813$$HP$US$US
242059711$24205971$1$I$$20240806$20240813$20240813$EXP$$US-PFIZER INC-202400232725$PFIZER$Davitt, M.. Atypical hemolytic uremic syndrome during induction chemotherapy in neuroblastoma, a rare phenomenon or common congenital predisposition?. Pediatr Blood Cancer. 2024;71(9):10.1002/pbc.31175$13$MON$$M$Y$$$20240813$$HP$US$US
242059731$24205973$1$I$$20240812$20240813$20240813$EXP$$CA-SANDOZ INC.-SDZ2024CA072224$SANDOZ$$59$YR$$F$Y$$$20240813$$HP$CA$CA
242059741$24205974$1$I$$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55541$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242059761$24205976$1$I$$20240812$20240812$20240812$DIR$713947$$FDA-CTU$$$$$UNK$N$$$20240812$$CN$US$
242059781$24205978$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55600$$FDA-CTU$$59$YR$$F$N$$$20240813$N$$US$
242059801$24205980$1$I$20240726$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55603$$FDA-CTU$$78$YR$$M$N$$$20240813$N$$US$
242059811$24205981$1$I$20240811$20240812$20240812$20240812$DIR$713997$$FDA-CTU$$33$YR$$F$N$58.5$KG$20240812$N$CN$US$
242059821$24205982$1$I$$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55592$$FDA-CTU$$$$$M$N$$$20240812$N$HP$US$
242059841$24205984$1$I$20240807$20240812$20240812$20240812$DIR$713862$$FDA-CTU$$53$YR$$F$N$51.75$KG$20240812$N$CN$US$
242059851$24205985$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A178132$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242059871$24205987$1$I$20240601$20240723$20240813$20240813$PER$$US-TRAVERE-2024TVT00733$TRAVERE THERAPEUTICS$$30$YR$A$F$Y$$$20240813$$CN$US$US
242059891$24205989$1$I$20220608$20240807$20240813$20240813$EXP$$JP-AstraZeneca-2024A180773$ASTRAZENECA$$21$YR$$F$Y$$$20240813$$MD$JP$
242059901$24205990$1$I$$20240724$20240813$20240813$PER$$US-TRAVERE-2024TVT00735$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240813$$MD$US$US
242059913$24205991$3$F$20240815$20240816$20240813$20240822$PER$$US-TRAVERE-2024TVT00737$TRAVERE THERAPEUTICS$$31$YR$A$M$Y$$$20240822$$CN$US$US
242059921$24205992$1$I$$20240724$20240813$20240813$PER$$US-TRAVERE-2024TVT00734$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240813$$CN$US$US
242059931$24205993$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A182755$ASTRAZENECA$$$$$F$Y$$$20240813$$MD$US$
242059941$24205994$1$I$20231223$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180931$ASTRAZENECA$$27174$DY$$M$Y$$$20240813$$CN$US$
242059952$24205995$2$F$$20240909$20240813$20240917$EXP$$US-AstraZeneca-2024A169034$ASTRAZENECA$$$$$F$Y$$$20240917$$HP$US$
242059961$24205996$1$I$$20220823$20240813$20240813$EXP$$US-AstraZeneca-2022A239848$ASTRAZENECA$$$$$$Y$$$20240813$$MD$US$
242059974$24205997$4$F$20240808$20240821$20240813$20240827$EXP$$CA-AstraZeneca-2024A182588$ASTRAZENECA$$24150$DY$$F$Y$$$20240827$$CN$CA$
242059981$24205998$1$I$$20240805$20240813$20240813$EXP$$BR-AstraZeneca-2024A182331$ASTRAZENECA$$$$$F$Y$$$20240813$$MD$BR$
242059991$24205999$1$I$$20221128$20240813$20240813$EXP$$US-AstraZeneca-2022A393113$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242060002$24206000$2$F$$20240917$20240813$20240918$EXP$$US-AstraZeneca-2024A177610$ASTRAZENECA$$59$YR$$M$Y$$$20240918$$PH$US$
242060012$24206001$2$F$20240624$20240903$20240813$20240906$EXP$$JP-TAKEDA-2024TJP011552$TAKEDA$$82$YR$$F$Y$45$KG$20240906$$PH$JP$JP
242060022$24206002$2$F$$20240808$20240813$20240819$EXP$$US-GILEAD-2024-0683722$GILEAD$Aldoss, Ibrahim., et al.. Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Blood Advances. 2024;unk:unk$$$A$$Y$$$20240819$$HP$US$US
242060041$24206004$1$I$$20240809$20240813$20240813$EXP$$US-PFIZER INC-202400234164$PFIZER$$$$$F$Y$$$20240813$$CN$US$US
242060052$24206005$2$F$$20240814$20240813$20240819$EXP$$US-PFIZER INC-202400234060$PFIZER$Barnes, A.. Immune Checkpoint Inhibitor Use Leading to Fulminant Myocarditis with Cardiogenic Shock: A Case Series. US Cardiology Review. 2024;18(Supp 1):4$72$YR$$F$Y$$$20240819$$MD$US$US
242060061$24206006$1$I$$20240807$20240813$20240813$EXP$$US-PFIZER INC-PV202400103429$PFIZER$Griffith-Linsley, J.. Autologous stem cell transplantation in adults with atypical teratoid rhabdoid tumor: a case report and review. CNS Oncology. 2024;13(1):10.1080/20450907.2024.2375960$46$YR$$F$Y$$$20240813$$HP$US$US
242060074$24206007$4$F$$20240820$20240813$20240823$EXP$$US-PFIZER INC-202400233562$PFIZER$Akhdar, G.. Single Low-Dose Methotrexate and Vitamin B12 Deficiency-Induced Pancytopenia Causing Fatality: A Case Report. Cureus. 2024;16(6):e63528$71$YR$$M$Y$$$20240823$$MD$US$US
242060081$24206008$1$I$$20240808$20240813$20240813$EXP$$CA-PFIZER INC-202400233080$PFIZER$$20$MON$$M$Y$$$20240813$$HP$CA$CA
242060091$24206009$1$I$$20240801$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408001383$ELI LILLY AND CO$$$$$M$Y$$$20240813$$CN$US$US
242060103$24206010$3$F$$20240815$20240813$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408004469$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240826$$CN$US$US
242060111$24206011$1$I$20240701$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006759$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240813$$CN$US$US
242060121$24206012$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55573$$FDA-CTU$$46$YR$$F$N$97.52$KG$20240813$N$$US$
242060131$24206013$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55610$$FDA-CTU$$52$YR$$F$N$89.36$KG$20240813$N$$US$
242060141$24206014$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55565$$FDA-CTU$$60$YR$$F$N$81.65$KG$20240813$N$$US$
242060151$24206015$1$I$20240630$20240808$20240813$20240813$EXP$$PR-ABBVIE-5873652$ABBVIE$$71$YR$$M$Y$59$KG$20240813$$CN$PR$PR
242060161$24206016$1$I$20240620$20240809$20240813$20240813$EXP$$US-ABBVIE-5875684$ABBVIE$$60$YR$$F$Y$$$20240813$$CN$US$US
242060171$24206017$1$I$20240101$20240805$20240813$20240813$EXP$$NL-BAUSCH-BL-2024-012290$BAUSCH AND LOMB$$75$YR$$F$Y$64$KG$20240813$$MD$NL$NL
242060181$24206018$1$I$$20240808$20240813$20240813$EXP$$US-ABBVIE-5875677$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242060191$24206019$1$I$20231201$20240809$20240813$20240813$EXP$$US-ABBVIE-5875787$ABBVIE$$58$YR$$M$Y$$$20240813$$CN$US$US
242060201$24206020$1$I$20240801$20240808$20240813$20240813$PER$$US-ABBVIE-5874780$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242060211$24206021$1$I$20110802$20240812$20240813$20240813$EXP$GB-MHRA-MED-202408121110562550-WSNRJ$GB-ORGANON-O2408GBR000874$ORGANON$$22$YR$$M$Y$100$KG$20240813$$CN$GB$GB
242060221$24206022$1$I$20221019$20240809$20240813$20240813$EXP$$US-ABBVIE-5762580$ABBVIE$$41$YR$$F$Y$$$20240813$$CN$US$US
242060231$24206023$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5876011$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242060242$24206024$2$F$20240701$20240814$20240813$20240816$EXP$$US-ABBVIE-5873100$ABBVIE$$70$YR$$F$Y$53.07$KG$20240816$$CN$US$US
242060251$24206025$1$I$20240710$20240809$20240813$20240813$EXP$$US-ABBVIE-5875680$ABBVIE$$42$YR$$F$Y$$$20240813$$CN$US$US
242060261$24206026$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875846$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242060271$24206027$1$I$$20240808$20240813$20240813$EXP$$CN-VANTIVE-2024VAN018948$Vantive US Healthcare$$$$$M$Y$$$20240813$$CN$CN$CN
242060281$24206028$1$I$20230701$20240807$20240813$20240813$PER$$US-ABBVIE-5872329$ABBVIE$$$$$F$Y$$$20240813$$MD$US$US
242060291$24206029$1$I$20240802$20240812$20240813$20240813$EXP$$US-BAUSCH-BL-2024-012214$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240813$$CN$US$US
242060301$24206030$1$I$$20240812$20240813$20240813$EXP$$CA-BAUSCH-BL-2024-012218$BAUSCH AND LOMB$$$$$M$Y$$$20240813$$CN$CA$CA
242060321$24206032$1$I$$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126168$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240813$$CN$US$US
242060331$24206033$1$I$20240101$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126799$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240813$$CN$US$US
242060341$24206034$1$I$20240807$20240807$20240813$20240813$EXP$$US-JNJFOC-20240820986$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240813$$HP$US$US
242060363$24206036$3$F$20240807$20240912$20240813$20240918$PER$$US-AMGEN-USASP2024157258$AMGEN$$65$YR$E$F$Y$126.8$KG$20240918$$HP$US$US
242060372$24206037$2$F$20240301$20240815$20240813$20240817$PER$$US-AMGEN-USASP2024160121$AMGEN$$$$$F$Y$$$20240817$$CN$US$US
242060382$24206038$2$F$20240802$20240813$20240813$20240820$30DAY$$US-AMGEN-USASP2024158071$AMGEN$$77$YR$E$M$Y$116$KG$20240820$$PH$US$US
242060391$24206039$1$I$20240807$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126804$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240813$$HP$US$US
242060401$24206040$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A177830$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242060411$24206041$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180750$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242060421$24206042$1$I$20240731$20240808$20240813$20240813$EXP$$ZA-AstraZeneca-2024A182193$ASTRAZENECA$$91$YR$$F$Y$$$20240813$$CN$ZA$
242060431$24206043$1$I$$20240811$20240813$20240813$EXP$$AU-GILEAD-2024-0683711$GILEAD$$$$A$M$Y$$$20240813$$HP$AU$AU
242060441$24206044$1$I$20221216$20240805$20240813$20240813$EXP$$DE-AstraZeneca-2024A178280$ASTRAZENECA$$58$YR$$M$Y$124$KG$20240813$$MD$DE$
242060451$24206045$1$I$$20240809$20240813$20240813$EXP$$US-SANDOZ INC.-SDZ2024US072296$SANDOZ$$$$$F$Y$$$20240813$$HP$US$US
242060461$24206046$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A178031$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242060471$24206047$1$I$$20240801$20240813$20240813$PER$$US-RDY-LIT/USA/24/0011579$DR REDDYS$Fakhraie S, Chovatiya R. Janus Kinase Inhibition in the Treatment of Prurigo Nodularis. Dermatitis. 2023;35(3): 299-300. doi:10.1089/derm.2023.0036.$45$YR$A$F$Y$$$20240813$$HP$US$US
242060481$24206048$1$I$$20240801$20240813$20240813$PER$$US-RDY-SPO/USA/24/0011516$DR REDDYS$$18$YR$A$$Y$$$20240813$$CN$US$US
242060492$24206049$2$F$20240815$20240815$20240813$20240828$EXP$$CA-JNJFOC-20240826518$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240828$$CN$CA$CA
242060501$24206050$1$I$20240101$20240806$20240813$20240813$PER$$US-JNJFOC-20240817158$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240813$$HP$US$US
242060511$24206051$1$I$$20240806$20240813$20240813$30DAY$$US-GSK-US2024098173$GLAXOSMITHKLINE$$$$$F$Y$$$20240813$$CN$US$US
242060521$24206052$1$I$$20240808$20240813$20240813$PER$$US-ALXN-202408USA000536US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242060531$24206053$1$I$$20240801$20240813$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122926$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240813$$HP$CA$CA
242060551$24206055$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55552$$FDA-CTU$$85$YR$$F$N$72.12$KG$20240813$N$$US$
242060561$24206056$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55514$$FDA-CTU$$58$YR$$F$N$$$20240813$N$$US$
242060571$24206057$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55563$$FDA-CTU$$71$YR$$F$N$78.02$KG$20240813$N$$US$
242060581$24206058$1$I$$20240809$20240813$20240813$EXP$GB-MHRA-MED-202408091601415750-QZLBV$GB-GILEAD-2024-0683728$GILEAD$$67$YR$E$M$Y$78$KG$20240813$$CN$GB$GB
242060593$24206059$3$F$20210101$20240816$20240813$20240821$EXP$$IN-PFIZER INC-202400232654$PFIZER$Modi, D.. Diagnosis and Treatment Challenges of Candida guilliermondii in Immunocompromised Patients: A Case Study in a Neutropenic AML Patient. Case reports in infectious diseases. 2024;2024 (1):10.1155/2024/7806235$30$YR$$F$Y$$$20240821$$MD$IN$IN
242060601$24206060$1$I$20240723$20240809$20240813$20240813$EXP$$CN-PFIZER INC-PV202400104284$PFIZER$$69$YR$$F$Y$70$KG$20240813$$HP$CN$CN
242060611$24206061$1$I$$20240809$20240813$20240813$EXP$$US-PFIZER INC-202400233822$PFIZER$$77$YR$$F$Y$$$20240813$$CN$US$US
242060631$24206063$1$I$20240713$20240812$20240813$20240813$EXP$AT-BASGAGES-2024-005979$AT-PFIZER INC-202400234271$PFIZER$$65$YR$$M$Y$92$KG$20240813$$PH$AT$AT
242060642$24206064$2$F$20240604$20240816$20240813$20240819$EXP$IT-MINISAL02-998187$IT-GILEAD-2024-0683836$GILEAD$$69$YR$E$M$Y$64$KG$20240819$$MD$IT$IT
242060661$24206066$1$I$20240805$20240809$20240813$20240813$EXP$$US-ABBVIE-5876505$ABBVIE$$75$YR$$F$Y$$$20240813$$CN$US$US
242060671$24206067$1$I$20240801$20240805$20240813$20240813$EXP$$US-PERRIGO-24US007410$PERRIGO$$59$YR$$F$Y$$$20240813$$CN$US$US
242060681$24206068$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875942$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242060691$24206069$1$I$20240301$20240812$20240813$20240813$PER$$US-ABBVIE-5877718$ABBVIE$$50$YR$$F$Y$75$KG$20240813$$CN$US$US
242060701$24206070$1$I$$20240731$20240813$20240813$EXP$$IT-Ascend Therapeutics US, LLC-2160357$ASCEND$$26$YR$$M$Y$$$20240813$$$IT$IT
242060711$24206071$1$I$$20240809$20240813$20240813$PER$$US-TAKEDA-2024TUS080331$TAKEDA$$$$$M$Y$$$20240813$$CN$US$US
242060721$24206072$1$I$$20240808$20240813$20240813$PER$$US-BAYER-2024A114924$BAYER$$$$$M$Y$$$20240813$$CN$US$US
242060731$24206073$1$I$20240717$20240719$20240813$20240813$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000776$PAREXEL$$$$$$Y$$$20240813$$PH$US$US
242060742$24206074$2$F$20240726$20240814$20240813$20240821$30DAY$$AR-PFIZER INC-202400233712$PFIZER$$59$YR$$F$Y$$$20240821$$CN$AR$AR
242060752$24206075$2$F$20240710$20240819$20240813$20240819$EXP$FR-AFSSAPS-GR2024000997$FR-GILEAD-2024-0683864$GILEAD$$58$YR$A$M$Y$94$KG$20240819$$PH$FR$FR
242060761$24206076$1$I$$20240722$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN007840$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242060771$24206077$1$I$$20240801$20240813$20240813$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI07930$NEUROCRINE BIOSCIENCES$$6$DEC$$M$Y$$$20240813$$MD$JP$JP
242060781$24206078$1$I$20240101$20240806$20240813$20240813$EXP$$US-AMGEN-USASP2024156829$AMGEN$Wang, JC. Olaparib induced aplastic anemia in a patient with castrate resistant prostate cancer: A case report. Leukemia Research Reports. 2024;1-4$75$YR$E$M$Y$$$20240813$$MD$US$US
242060791$24206079$1$I$20240801$20240812$20240813$20240813$PER$$US-BAYER-2024A116028$BAYER$$31$YR$A$F$Y$$$20240813$$CN$US$US
242060801$24206080$1$I$$20240807$20240813$20240813$PER$$US-Taiho Oncology Inc-2024-007704$TAIHO ONCOLOGY INC$$$$A$M$Y$$$20240813$$CN$US$US
242060812$24206081$2$F$$20240816$20240813$20240819$EXP$$IT-GILEAD-2024-0683930$GILEAD$$55$YR$A$M$Y$$$20240819$$HP$IT$IT
242060821$24206082$1$I$20240101$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127646$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240813$$CN$US$US
242060831$24206083$1$I$$20240802$20240813$20240813$EXP$$US-RDY-LIT/USA/24/0011645$DR REDDYS$Singh AD, Kurin M. An Unusual Case of Refractory Esophagitis and Esophageal Diverticulum. Digestive Diseases and Sciences. 69(6): 1913-1914. doi:10.1007/s10620-024-08301-3.$76$YR$E$F$Y$$$20240813$$HP$US$US
242060841$24206084$1$I$20240701$20240806$20240813$20240813$30DAY$$US-GSK-US2024098136$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240813$$CN$US$US
242060851$24206085$1$I$20240101$20240807$20240813$20240813$EXP$$US-ABBVIE-5767627$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242060862$24206086$2$F$$20240829$20240813$20240829$PER$$US-ALXN-202408USA000549US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242060871$24206087$1$I$20240101$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A178121$ASTRAZENECA$$75$YR$$M$Y$$$20240813$$CN$US$
242060881$24206088$1$I$$20220729$20240813$20240813$EXP$$US-AstraZeneca-2022A272955$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242060891$24206089$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A177826$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242060901$24206090$1$I$20240727$20240806$20240813$20240813$EXP$$US-AMERICAN REGENT INC-2024003028$AMERICAN REGENT$$33$YR$$F$Y$60$KG$20240813$$HP$US$US
242060911$24206091$1$I$$20221025$20240813$20240813$EXP$$PT-AstraZeneca-2022A361697$ASTRAZENECA$$$$$$Y$$$20240813$$MD$PT$
242060921$24206092$1$I$$20240806$20240813$20240813$EXP$$CA-TEVA-VS-3231998$TEVA$$75$YR$$M$Y$56$KG$20240813$$PH$CA$CA
242060931$24206093$1$I$$20240807$20240813$20240813$EXP$$US-PFIZER INC-PV202300187577$PFIZER$$54$YR$$F$Y$$$20240813$$CN$US$US
242060941$24206094$1$I$20240628$20240710$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN007286$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242060952$24206095$2$F$$20240925$20240813$20240927$PER$$NVSC2024US164141$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
242060961$24206096$1$I$$20240808$20240813$20240813$EXP$$US-GILEAD-2024-0683721$GILEAD$Aldoss, Ibrahim., et al.. Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Blood Advances. 2024;unk:unk$$$A$$Y$$$20240813$$HP$US$US
242060971$24206097$1$I$$20240801$20240813$20240813$EXP$$US-BRAEBURN-US-BRA-24-000719$BRAEBURN PHARMACEUTICALS$$$$A$M$Y$$$20240813$$HP$US$US
242060982$24206098$2$F$20240909$20240910$20240813$20240913$EXP$$CA-FERRINGPH-2024FE03087$FERRING$$$$$$Y$$$20240913$$CN$CA$CA
242060992$24206099$2$F$20240101$20240807$20240813$20240815$EXP$$JP-FERRINGPH-2024FE04446$FERRING$$$$$$Y$$$20240815$$MD$JP$JP
242061001$24206100$1$I$20240703$20240807$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125911$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240813$$CN$US$US
242061011$24206101$1$I$$20240806$20240813$20240813$EXP$$CA-GSK-CA2024098542$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$HP$CA$CA
242061022$24206102$2$F$20240620$20240809$20240813$20240819$EXP$$CN-JNJFOC-20240828766$JOHNSON AND JOHNSON$$66$YR$E$F$Y$52$KG$20240820$$HP$CN$CN
242061031$24206103$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164220$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242061041$24206104$1$I$$20240809$20240813$20240813$PER$$US-BAYER-2024A115804$BAYER$$$$$F$Y$$$20240813$$CN$US$US
242061051$24206105$1$I$$20240731$20240813$20240813$EXP$$IT-Ascend Therapeutics US, LLC-2160359$ASCEND$$26$YR$$M$Y$$$20240813$$$IT$IT
242061061$24206106$1$I$$20240806$20240813$20240813$PER$$US-RDY-SPO/USA/24/0011681$DR REDDYS$$$$$F$Y$$$20240813$$MD$US$US
242061071$24206107$1$I$$20240806$20240813$20240813$PER$$US-RDY-SPO/USA/24/0011678$DR REDDYS$$13$YR$C$F$Y$$$20240813$$MD$US$US
242061081$24206108$1$I$20240701$20240806$20240813$20240813$PER$$US-RDY-SPO/USA/24/0011671$DR REDDYS$$20$YR$A$$Y$$$20240813$$CN$US$US
242061091$24206109$1$I$$20240808$20240813$20240813$EXP$$US-GILEAD-2024-0683723$GILEAD$Aldoss, Ibrahim., et al.. Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Blood Advances. 2024;unk:unk$$$A$$Y$$$20240813$$HP$US$US
242061102$24206110$2$F$20220118$20240816$20240813$20240826$EXP$PT-INFARMED-M202210-1034$PT-GILEAD-2024-0683855$GILEAD$$91$YR$E$M$Y$$$20240826$$MD$PT$PT
242061111$24206111$1$I$$20240809$20240813$20240813$PER$$NVSC2024US164053$NOVARTIS$$$$$F$Y$$$20240813$$HP$US$US
242061121$24206112$1$I$$20240809$20240813$20240813$EXP$$US-PFIZER INC-202400234596$PFIZER$$58$YR$$$Y$$$20240813$$CN$US$US
242061141$24206114$1$I$$20240812$20240813$20240813$EXP$$CA-PFIZER INC-202400235628$PFIZER$$12$MON$$M$Y$$$20240813$$HP$CA$CA
242061153$24206115$3$F$20240803$20240906$20240813$20240912$PER$$US-AMGEN-USASP2024158346$AMGEN$$78$YR$E$M$Y$69.6$KG$20240911$$PH$US$US
242061161$24206116$1$I$$20240808$20240813$20240813$PER$$US-BAYER-2024A115803$BAYER$$$$$F$Y$$$20240813$$CN$US$US
242061171$24206117$1$I$20230720$20230721$20240813$20240813$PER$$US-GALDERMA-US2023011149$GALDERMA$$$$$$Y$$$20240813$$CN$US$US
242061181$24206118$1$I$20221201$20240806$20240813$20240813$EXP$FR-AFSSAPS-PC2024000636$FR-ORGANON-O2408FRA000461$ORGANON$$46$YR$$M$Y$$$20240813$$CN$FR$FR
242061191$24206119$1$I$$20230725$20240813$20240813$PER$$US-GALDERMA-US2023011256$GALDERMA$$$$$$Y$$$20240813$$PH$US$US
242061201$24206120$1$I$$20240607$20240813$20240813$PER$$US-GALDERMA-US2024009634$GALDERMA$$$$$$Y$$$20240813$$CN$US$US
242061211$24206121$1$I$$20231102$20240813$20240813$PER$$US-GALDERMA-US2023016557$GALDERMA$$$$$$Y$$$20240813$$HP$US$US
242061241$24206124$1$I$$20240809$20240813$20240813$EXP$PL-EMA-20160525-AUTODUP-465144$PL-SANDOZ INC.-SDZ2024PL071677$SANDOZ$$32$YR$$M$Y$$$20240813$$HP$PL$PL
242061251$24206125$1$I$20240808$20240812$20240812$20240812$DIR$713933$$FDA-CTU$$37$YR$$M$N$99$KG$20240812$N$CN$US$
242061281$24206128$1$I$$20240812$20240813$20240813$PER$$US-TAKEDA-2024TUS080916$TAKEDA$$$$$M$Y$$$20240813$$CN$US$US
242061291$24206129$1$I$20240703$20240812$20240813$20240813$EXP$FR-AFSSAPS-BX2024001599$FR-GILEAD-2024-0683824$GILEAD$$60$YR$A$F$Y$$$20240813$$HP$FR$FR
242061302$24206130$2$F$20240808$20240920$20240813$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127142$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240924$$CN$US$US
242061313$24206131$3$F$$20240820$20240813$20240823$EXP$$PL-AUROBINDO-AUR-APL-2024-039896$AUROBINDO$Jeleniewicz R, Majdan M, Targonska-Stepniak B, Wielosz E. Selected problems of biologic therapy in rheumatoid arthritis patients-inefficacy of several biologic therapies. Case reports. Reumatologia. 2013;51/1:89-92$35$YR$$F$Y$$$20240823$$MD$PL$PL
242061321$24206132$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164373$NOVARTIS$$$$$$Y$$$20240813$$MD$US$US
242061341$24206134$1$I$20240624$20240808$20240813$20240813$EXP$$FR-AUROBINDO-AUR-APL-2024-040170$AUROBINDO$$77$YR$$M$Y$64$KG$20240813$$MD$FR$FR
242061351$24206135$1$I$$20240812$20240812$20240812$DIR$713927$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242061361$24206136$1$I$20240812$20240812$20240812$20240812$DIR$713965$$FDA-CTU$$47$YR$$F$N$61.65$KG$20240812$Y$HP$US$
242061372$24206137$2$F$20231219$20240816$20240813$20240816$EXP$PT-INFARMED-T202407-556$PT-ROCHE-10000053635$ROCHE$$48$YR$A$F$Y$57$KG$20240816$$MD$PT$PT
242061381$24206138$1$I$20240601$20240808$20240813$20240813$EXP$$US-SA-2024SA238532$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240813$$MD$US$US
242061391$24206139$1$I$20240801$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55613$$FDA-CTU$$74$YR$$F$N$71.67$KG$20240813$Y$$US$
242061401$24206140$1$I$20240101$20240807$20240813$20240813$EXP$$US-ABBVIE-5871867$ABBVIE$$$$$F$Y$$$20240813$$HP$US$US
242061411$24206141$1$I$20240602$20240805$20240813$20240813$EXP$$AU-AstraZeneca-2024A177429$ASTRAZENECA$$83$YR$$M$Y$$$20240813$$MD$AU$
242061421$24206142$1$I$$20240808$20240813$20240813$EXP$$ZA-AstraZeneca-2024A183390$ASTRAZENECA$$27759$DY$$F$Y$$$20240813$$CN$ZA$
242061431$24206143$1$I$20240812$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55609$$FDA-CTU$$69$YR$$F$N$$$20240813$N$$US$
242061441$24206144$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A182003$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242061451$24206145$1$I$$20240808$20240813$20240813$PER$$US-BAYER-2024A114875$BAYER$$$$$$Y$$$20240813$$CN$US$US
242061461$24206146$1$I$20240801$20240806$20240813$20240813$EXP$$JP-ROCHE-10000055759$ROCHE$$7$DEC$E$F$Y$$$20240813$$MD$JP$JP
242061471$24206147$1$I$$20240808$20240813$20240813$EXP$$US-TAKEDA-2024TUS080131$TAKEDA$$$$$F$Y$$$20240813$$CN$US$US
242061485$24206148$5$F$$20240923$20240813$20240926$EXP$$PT-MYLANLABS-2024M1073637$MYLAN$Moura M., Martins A C., Serodio C. PO-0118 - (4088) - Acute methotrexate poisoning. 30 CNMI Emergency, intermediate care and critically ill patient Clinical case. National Internal Medicine Congress. 2024;488$85$YR$$F$Y$$$20240926$$MD$PT$PT
242061491$24206149$1$I$20230101$20240806$20240813$20240813$EXP$$CO-Ipsen Biopharmaceuticals, Inc.-2024-15737$IPSEN$Gonzalez, Claudia, Rengifo, Jaime, Macias-Arias, Paola, et al. ^High-Resolution Ultrasound for Complications of Botulinum Toxin Use: A Case Series and Literature Review^, Cureus, 01-Jan-2024, Vol. 16.0, Iss. 6.0, Pp. e63232. doi:10.7759/cureus.63232$61$YR$A$F$Y$$$20240813$$MD$CO$CO
242061502$24206150$2$F$20240801$20240911$20240813$20240918$EXP$$US-JNJFOC-20240831094$JOHNSON AND JOHNSON$$47$YR$A$F$Y$72.64$KG$20240918$$MD$US$US
242061511$24206151$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007465$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240813$$CN$US$US
242061521$24206152$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-PV202300128059$PFIZER$$$$$F$Y$$$20240813$$CN$US$US
242061531$24206153$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-PV202400104735$PFIZER$$$$$F$Y$$$20240813$$MD$US$US
242061541$24206154$1$I$20240805$20240808$20240813$20240813$PER$$US-PFIZER INC-202400233037$PFIZER$$78$YR$$F$Y$$$20240813$$CN$US$US
242061551$24206155$1$I$20240708$20240808$20240813$20240813$PER$$US-PFIZER INC-202400232472$PFIZER$$56$YR$$M$Y$$$20240813$$HP$US$US
242061561$24206156$1$I$20210201$20240809$20240813$20240813$PER$$US-PFIZER INC-202400234057$PFIZER$$52$YR$$F$Y$$$20240813$$MD$US$US
242061571$24206157$1$I$$20240808$20240813$20240813$PER$$US-PFIZER INC-PV202400103751$PFIZER$$52$YR$$F$Y$$$20240813$$CN$US$US
242061581$24206158$1$I$20240807$20240807$20240813$20240813$PER$$US-PFIZER INC-202400232019$PFIZER$$70$YR$$F$Y$48.99$KG$20240813$$CN$US$US
242061591$24206159$1$I$$20240808$20240813$20240813$EXP$$US-GILEAD-2024-0683724$GILEAD$Aldoss, Ibrahim., et al.. Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Blood Advances. 2024;unk:unk$$$A$$Y$$$20240813$$HP$US$US
242061601$24206160$1$I$20240807$20240812$20240813$20240813$EXP$GB-MHRA-MED-202408121525422230-KCFNG$GB-SANDOZ INC.-SDZ2024GB072185$SANDOZ$$76$YR$$M$Y$$$20240813$$HP$GB$GB
242061611$24206161$1$I$20240807$20240808$20240813$20240813$PER$$US-PFIZER INC-202400233523$PFIZER$$48$YR$$F$Y$98.866$KG$20240813$$HP$US$US
242061621$24206162$1$I$20240306$20240807$20240813$20240813$PER$$US-BAYER-2024A114561$BAYER$$$$$$Y$$$20240813$$HP$US$US
242061632$24206163$2$F$$20240916$20240813$20240925$EXP$$CA-TAKEDA-2024TUS080806$TAKEDA$$$$$F$Y$$$20240925$$CN$CA$CA
242061641$24206164$1$I$20240808$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024159208$AMGEN$$$$$F$Y$$$20240813$$MD$US$US
242061651$24206165$1$I$20230916$20240810$20240813$20240813$EXP$$US-PURDUE PHARMA-USA-2024-0311309$PURDUE$$$$$$Y$$$20240813$$CN$US$US
242061661$24206166$1$I$20230416$20240810$20240813$20240813$EXP$$US-PURDUE PHARMA-USA-2024-0311308$PURDUE$$$$$$Y$$$20240813$$CN$US$US
242061671$24206167$1$I$20221219$20240810$20240813$20240813$EXP$$US-PURDUE PHARMA-USA-2024-0311306$PURDUE$$$$$$Y$$$20240813$$CN$US$US
242061681$24206168$1$I$$20240807$20240813$20240813$EXP$$CA-BAYER-2024A114945$BAYER$$71$YR$E$M$Y$$$20240813$$CN$CA$CA
242061691$24206169$1$I$20240722$20240806$20240813$20240813$EXP$$US-GSK-US2024098077$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$US$US
242061701$24206170$1$I$$20240724$20240813$20240813$PER$$US-TEVA-VS-3227038$TEVA$$10$YR$$F$Y$$$20240813$$CN$US$US
242061711$24206171$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240825592$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$PH$US$US
242061721$24206172$1$I$$20240809$20240813$20240813$EXP$$US-JNJFOC-20240829562$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
242061731$24206173$1$I$$20240806$20240813$20240813$PER$$US-ABBVIE-5870250$ABBVIE$$$$$$Y$$$20240813$$MD$US$US
242061741$24206174$1$I$$20240812$20240812$20240812$DIR$713948$$FDA-CTU$$$$$UNK$N$$$20240812$$CN$US$
242061751$24206175$1$I$20220820$20240812$20240812$20240812$DIR$713942$$FDA-CTU$$18$YR$$F$N$112.5$KG$20240812$N$CN$US$
242061761$24206176$1$I$$20240812$20240812$20240812$DIR$713930$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242061781$24206178$1$I$20240812$20240812$20240812$20240812$DIR$713951$$FDA-CTU$$27$YR$$F$N$98.55$KG$20240812$N$$US$
242061801$24206180$1$I$20240811$20240812$20240812$20240812$DIR$713941$$FDA-CTU$$53$YR$$F$N$90$KG$20240812$N$CN$US$
242061811$24206181$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55527$$FDA-CTU$$68$YR$$M$N$$$20240813$N$$US$
242061821$24206182$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240825019$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
242061831$24206183$1$I$$20240807$20240813$20240813$PER$$US-ABBVIE-5870629$ABBVIE$$75$YR$$F$Y$$$20240813$$HP$US$US
242061841$24206184$1$I$$20240710$20240813$20240813$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07022$LUPIN$$$$$$Y$$$20240813$$CN$US$US
242061851$24206185$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126432$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240813$$CN$US$US
242061861$24206186$1$I$20240605$20240806$20240813$20240813$EXP$ES-AEMPS-1554641$ES-TEVA-VS-3231076$TEVA$$54$YR$$F$Y$$$20240813$$PH$ES$ES
242061872$24206187$2$F$$20240813$20240813$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07023$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242061881$24206188$1$I$$20240808$20240813$20240813$EXP$$US-BAYER-2024A115437$BAYER$$77$YR$E$F$Y$$$20240813$$CN$US$US
242061891$24206189$1$I$$20240802$20240813$20240813$PER$$US-ABBVIE-5866556$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242061901$24206190$1$I$20240808$20240808$20240813$20240813$EXP$$JP-GSK-JP2024100457$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$MD$JP$JP
242061911$24206191$1$I$$20240808$20240813$20240813$EXP$$US-GILEAD-2024-0683725$GILEAD$Aldoss, Ibrahim., et al.. Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Blood Advances. 2024;unk:unk$$$A$$Y$$$20240813$$HP$US$US
242061921$24206192$1$I$$20240805$20240813$20240813$EXP$$FR-AstraZeneca-2024A091075$ASTRAZENECA$$$$$M$Y$$$20240813$$MD$FR$
242061931$24206193$1$I$20240628$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180917$ASTRAZENECA$$$$$$Y$$$20240813$$CN$US$
242061941$24206194$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180957$ASTRAZENECA$$$$$$Y$$$20240813$$CN$US$
242061951$24206195$1$I$20230214$20230731$20240813$20240813$EXP$$GB-AstraZeneca-2023A175266$ASTRAZENECA$$68$YR$$M$Y$72$KG$20240813$$PH$GB$
242061961$24206196$1$I$20240808$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126770$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240813$$CN$US$US
242061971$24206197$1$I$20240808$20240808$20240813$20240813$EXP$$JP-GSK-JP2024100458$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$MD$JP$JP
242061981$24206198$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55517$$FDA-CTU$$72$YR$$F$N$$$20240813$N$$US$
242061991$24206199$1$I$$20240812$20240812$20240812$DIR$713882$$FDA-CTU$$$$$UNK$N$$$20240812$$CN$US$
242062001$24206200$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55612$$FDA-CTU$$$$$M$N$$$20240813$N$HP$US$
242062021$24206202$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55608$$FDA-CTU$$75$YR$$F$N$$$20240813$N$$US$
242062031$24206203$1$I$$20240812$20240812$20240812$DIR$713900$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242062051$24206205$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55562$$FDA-CTU$$44$YR$$M$N$$$20240813$N$$US$
242062071$24206207$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55539$$FDA-CTU$$83$YR$$M$N$$$20240813$N$$US$
242062081$24206208$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55520$$FDA-CTU$$43$YR$$F$N$$$20240813$N$$US$
242062091$24206209$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55526$$FDA-CTU$$63$YR$$F$N$113.4$KG$20240813$N$$US$
242062101$24206210$1$I$$20240812$20240812$20240812$DIR$713944$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242062111$24206211$1$I$$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55499$$FDA-CTU$$$$$M$N$$$20240812$N$HP$US$
242062121$24206212$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55550$$FDA-CTU$$71$YR$$M$N$$$20240813$N$$US$
242062131$24206213$1$I$$20240812$20240812$20240812$DIR$713912$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242062141$24206214$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55584$$FDA-CTU$$67$YR$$F$N$$$20240813$N$$US$
242062151$24206215$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55518$$FDA-CTU$$51$YR$$M$N$$$20240813$N$$US$
242062161$24206216$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55551$$FDA-CTU$$75$YR$$M$N$$$20240813$N$$US$
242062171$24206217$1$I$20240810$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55457$$FDA-CTU$$66$YR$$F$N$$$20240812$N$HP$US$
242062181$24206218$1$I$$20240809$20240813$20240813$EXP$$CL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045066$BOEHRINGER INGELHEIM$$92$YR$E$F$Y$$$20240813$$MD$CL$CL
242062191$24206219$1$I$20240704$20240809$20240813$20240813$EXP$$AR-JNJFOC-20240828885$JOHNSON AND JOHNSON$$70$YR$E$F$Y$70$KG$20240813$$CN$AR$AR
242062201$24206220$1$I$20240806$20240808$20240813$20240813$PER$$US-AMGEN-USASL2024159104$AMGEN$$$$$$Y$$$20240813$$CN$US$US
242062211$24206221$1$I$$20240801$20240813$20240813$30DAY$$CN-PFIZER INC-202400233752$PFIZER$$$$$$Y$$$20240813$$CN$CN$CN
242062221$24206222$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164264$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242062231$24206223$1$I$$20240730$20240813$20240813$EXP$$AU-Ascend Therapeutics US, LLC-2160360$ASCEND$$25$YR$$F$Y$$$20240813$$$AU$AU
242062241$24206224$1$I$$20240807$20240813$20240813$EXP$$DE-MYLANLABS-2024M1073674$MYLAN$$56$YR$$M$Y$$$20240813$$CN$DE$DE
242062251$24206225$1$I$$20240805$20240813$20240813$EXP$$US-MYLANLABS-2024M1072923$MYLAN$$$$$$Y$$$20240813$$LW$US$US
242062261$24206226$1$I$20240604$20240807$20240813$20240813$EXP$FR-AFSSAPS-AVPO2024000150$FR-MYLANLABS-2024M1073947$MYLAN$$17$YR$$M$Y$$$20240813$$PH$FR$FR
242062271$24206227$1$I$20240801$20240805$20240813$20240813$PER$$US-MYLANLABS-2024M1073322$MYLAN$$62$YR$$M$Y$$$20240813$$CN$US$US
242062281$24206228$1$I$20240219$20240807$20240813$20240813$EXP$FR-AFSSAPS-SE2024000592$FR-MYLANLABS-2024M1073951$MYLAN$$71$YR$$F$Y$56$KG$20240813$$MD$FR$FR
242062294$24206229$4$F$$20240905$20240813$20240911$EXP$FR-EMA-DD-20240731-7482827-114521$FR-MYLANLABS-2024M1074256$MYLAN$Terrier B, Jachiet M, Samson M, Cottin V, Kahn JE, Guenno GE et al.. Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients. Arthritis + Rheumatology. 2016;68(9):2274-82$53$YR$$M$Y$$$20240911$$HP$FR$FR
242062302$24206230$2$F$$20240806$20240813$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121085$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240822$$HP$US$US
242062311$24206231$1$I$$20240809$20240813$20240813$EXP$$JP-BAYER-2024A115155$BAYER$$7$DEC$E$M$Y$$$20240813$$PH$JP$JP
242062323$24206232$3$F$20231201$20240906$20240813$20240912$EXP$$JP-PERRIGO-24JP007508$PERRIGO$$22$YR$$F$Y$49.1$KG$20240912$$MD$JP$JP
242062331$24206233$1$I$20230101$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180933$ASTRAZENECA$$906$MON$$F$Y$$$20240813$$CN$US$
242062341$24206234$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A182321$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242062352$24206235$2$F$$20240830$20240813$20240906$EXP$$US-AstraZeneca-2024A177965$ASTRAZENECA$$75$YR$$F$Y$$$20240906$$CN$US$
242062361$24206236$1$I$20240711$20240807$20240813$20240813$EXP$$CN-AstraZeneca-2024A181174$ASTRAZENECA$$54$YR$$F$Y$48$KG$20240813$$MD$CN$
242062371$24206237$1$I$20240806$20240807$20240813$20240813$EXP$$CA-JNJFOC-20240825377$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240813$$HP$CA$CA
242062381$24206238$1$I$20240403$20240805$20240813$20240813$EXP$$JP-AstraZeneca-2024A179289$ASTRAZENECA$$83$YR$$M$Y$$$20240813$$MD$JP$
242062391$24206239$1$I$$20240809$20240813$20240813$PER$$US-PFIZER INC-PV202400104519$PFIZER$$$$$F$Y$$$20240813$$LW$US$US
242062412$24206241$2$F$20240723$20240905$20240813$20240912$EXP$$IN-PFIZER INC-202400233667$PFIZER$$44$YR$$F$Y$56.5$KG$20240912$$CN$IN$US
242062422$24206242$2$F$$20240812$20240813$20240814$EXP$$US-PFIZER INC-PV202400061584$PFIZER$$47$YR$$M$Y$$$20240814$$CN$US$US
242062431$24206243$1$I$$20240812$20240813$20240813$PER$$US-PFIZER INC-202400235056$PFIZER$$71$YR$$F$Y$$$20240813$$HP$US$US
242062441$24206244$1$I$$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55553$$FDA-CTU$$$$$M$N$$$20240812$N$HP$US$
242062451$24206245$1$I$20240701$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55594$$FDA-CTU$$29$YR$$M$N$$$20240813$N$PH$US$
242062461$24206246$1$I$20240809$20240809$20240813$20240813$PER$$US-PFIZER INC-202400233817$PFIZER$$50$YR$$F$Y$99.79$KG$20240813$$CN$US$US
242062471$24206247$1$I$20240812$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024159919$AMGEN$$67$YR$E$F$Y$$$20240813$$CN$US$US
242062481$24206248$1$I$20240804$20240806$20240813$20240813$EXP$CN-91110000556821568D-2024DRL001460$CN-RDY-SPO/CHN/24/0011688$DR REDDYS$$23$YR$A$F$Y$46$KG$20240813$$HP$CN$CN
242062498$24206249$8$F$20240101$20240919$20240813$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-024187$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240926$$$US$US
242062501$24206250$1$I$20240101$20240806$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125124$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$95.71$KG$20240813$$CN$US$US
242062511$24206251$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55519$$FDA-CTU$$52$YR$$F$N$$$20240813$N$$US$
242062521$24206252$1$I$20240805$20240805$20240813$20240813$EXP$$US-VIIV HEALTHCARE LIMITED-US2024097498$VIIV$$64$YR$$F$Y$$$20240813$$HP$US$US
242062531$24206253$1$I$20240401$20240729$20240813$20240813$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01243$INTRA-CELLULAR THERAPIES$$34$YR$$M$Y$88.435$KG$20240813$$CN$US$US
242062542$24206254$2$F$$20240920$20240813$20240930$EXP$$CA-TEVA-VS-3231990$TEVA$$67$YR$$M$Y$$$20240930$$HP$CA$CA
242062551$24206255$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024160494$AMGEN$$$$$$Y$$$20240813$$MD$US$US
242062561$24206256$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159863$AMGEN$$$$$$Y$$$20240813$$CN$US$US
242062571$24206257$1$I$$20240808$20240813$20240813$EXP$$US-TAKEDA-2024TUS079844$TAKEDA$$$$$F$Y$$$20240813$$MD$US$US
242062582$24206258$2$F$20240806$20240820$20240813$20240822$EXP$$AU-MYLANLABS-2024M1074427$MYLAN$$45$YR$$F$Y$$$20240822$$HP$AU$AU
242062591$24206259$1$I$$20240808$20240813$20240813$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-110612$REGENERON$$$$$M$Y$$$20240813$$CN$CA$CA
242062602$24206260$2$F$20240101$20240821$20240813$20240830$EXP$$US-ABBVIE-5875274$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242062611$24206261$1$I$$20240807$20240813$20240813$EXP$$AU-BAYER-2024A113900$BAYER$$$$$M$Y$$$20240813$$MD$AU$AU
242062621$24206262$1$I$$20240808$20240813$20240813$EXP$$DE-JNJFOC-20240822412$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$MD$DE$DE
242062632$24206263$2$F$$20240808$20240813$20240820$EXP$$US-BAYER-2024A115977$BAYER$$78$YR$E$F$Y$104.99$KG$20240820$$HP$US$US
242062641$24206264$1$I$$20240809$20240813$20240813$EXP$$US-BAUSCH-BL-2024-012142$BAUSCH AND LOMB$$$$$$Y$$$20240813$$PH$US$US
242062653$24206265$3$F$20240811$20240822$20240813$20240826$PER$$US-AMGEN-USASP2024160464$AMGEN$$68$YR$E$F$Y$$$20240826$$CN$US$US
242062662$24206266$2$F$$20240814$20240813$20240821$EXP$GB-MHRA-31193571$GB-PERRIGO-24GB007534$PERRIGO$$$$$M$Y$$$20240821$$CN$GB$GB
242062671$24206267$1$I$20240101$20240808$20240813$20240813$EXP$$US-BAUSCH-BL-2024-012104$BAUSCH AND LOMB$$$$$$Y$$$20240813$$PH$US$US
242062681$24206268$1$I$$20240809$20240813$20240813$EXP$$CN-TAKEDA-2024TUS080388$TAKEDA$$$$$M$Y$$$20240813$$CN$CN$CN
242062692$24206269$2$F$20240801$20240819$20240813$20240822$EXP$$US-RDY-CLI/USA/24/0011667$DR REDDYS$$24$YR$A$F$Y$$$20240822$$MD$US$US
242062701$24206270$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024160410$AMGEN$$$$$$Y$$$20240813$$CN$US$US
242062711$24206271$1$I$20240731$20240802$20240813$20240813$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01196$AIMMUNE$$$$$$Y$$$20240813$$CN$US$US
242062731$24206273$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127948$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240813$$CN$US$US
242062741$24206274$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024160491$AMGEN$$$$$$Y$$$20240813$$HP$US$US
242062752$24206275$2$F$$20240917$20240813$20240917$EXP$$US-AstraZeneca-2024A178207$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
242062761$24206276$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A181947$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242062771$24206277$1$I$$20240812$20240813$20240813$EXP$$CA-BAUSCH-BL-2024-012285$BAUSCH AND LOMB$$82$YR$$M$Y$$$20240813$$PH$CA$CA
242062791$24206279$1$I$$20240808$20240813$20240813$EXP$$US-AstraZeneca-2024A180886$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242062802$24206280$2$F$$20240808$20240813$20240816$EXP$$US-AstraZeneca-2024A181593$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242062811$24206281$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A179072$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242062821$24206282$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A178701$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242062831$24206283$1$I$$20240805$20240813$20240813$EXP$$US-AstraZeneca-2024A179533$ASTRAZENECA$$$$$F$Y$$$20240813$$CN$US$
242062841$24206284$1$I$$20240805$20240813$20240813$EXP$$IN-AstraZeneca-2024A179614$ASTRAZENECA$$30$YR$$F$Y$$$20240813$$CN$IN$
242062851$24206285$1$I$$20240805$20240813$20240813$EXP$$GR-AstraZeneca-2024A182362$ASTRAZENECA$$14244$DY$$F$Y$$$20240813$$HP$GR$
242062861$24206286$1$I$$20240805$20240813$20240813$EXP$$PL-BAUSCH-BL-2024-011932$BAUSCH AND LOMB$Nizinska I, Gattner K. Zatrucie litem w przebiegu stosowania antagonistow receptora angiotensyny II oraz hydrochlorotiazydu. Opis dwoch przypadkow. Farmakoterapia w Psychiatrii i Neurologii. 2024;40(1):53-60. doi:10.5114/fpn.2024.141961$72$YR$$F$Y$$$20240813$$HP$PL$PL
242062881$24206288$1$I$$20240812$20240813$20240813$EXP$$US-PFIZER INC-202400235033$PFIZER$$$$T$M$Y$$$20240813$$MD$US$US
242062891$24206289$1$I$20240712$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160465$AMGEN$$$$$$Y$$$20240813$$HP$US$US
242062901$24206290$1$I$$20240812$20240813$20240813$EXP$$CA-BAUSCH-BL-2024-012245$BAUSCH AND LOMB$$80$YR$$M$Y$86$KG$20240813$$HP$CA$CA
242062913$24206291$3$F$20240101$20240828$20240813$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-024892$UNITED THERAPEUTICS$$$$$F$Y$89.342$KG$20240903$$$US$US
242062924$24206292$4$F$20240101$20240904$20240813$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127248$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240906$$HP$US$US
242062933$24206293$3$F$20240101$20240913$20240813$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-024811$UNITED THERAPEUTICS$$$$$F$Y$79.819$KG$20240920$$$US$US
242062941$24206294$1$I$20231101$20240806$20240813$20240813$EXP$ES-AEMPS-1551099$ES-TEVA-VS-3231222$TEVA$$90$YR$$M$Y$$$20240813$$MD$ES$ES
242062951$24206295$1$I$20240701$20240805$20240813$20240813$EXP$PT-INFARMED-T202407-374$PT-TEVA-VS-3231161$TEVA$$84$YR$$F$Y$60$KG$20240813$$MD$PT$PT
242062961$24206296$1$I$$20240729$20240813$20240813$EXP$$CA-SEBELA IRELAND LIMITED-2024SEB00055$SEBELA$Su S, Wang Y.M, Zaborniak K, Hamza S, Jassal D.S, Blouw M. Severe distributive shock, neutrophilic dermatosis, and ST-elevation myocardial infarction in the setting of azathioprine hypersensitivity syndrome. Allergy Asthma Clin. Immunol.. 2024;(20:1)$59$YR$$M$Y$$$20240813$$HP$CA$CA
242062971$24206297$1$I$20240322$20240806$20240813$20240813$EXP$FR-AFSSAPS-RN2024000835$FR-TEVA-VS-3230897$TEVA$$76$YR$$M$Y$76$KG$20240813$$MD$FR$FR
242062982$24206298$2$F$20240701$20240912$20240813$20240918$EXP$$US-TG THERAPEUTICS INC.-TGT003869$TG THERAPEUTICS$$$$$$Y$$$20240918$$MD$US$US
242062991$24206299$1$I$20240805$20240805$20240813$20240813$EXP$$US-TAKEDA-2024TUS079452$TAKEDA$$35$YR$$F$Y$$$20240813$$HP$US$US
242063002$24206300$2$F$20240725$20240821$20240813$20240912$PER$$US-IMP-2024000575$Harrow Health$$68$YR$E$F$Y$$$20240912$$CN$US$US
242063011$24206301$1$I$20240101$20240729$20240813$20240813$EXP$$FR-HARMONY BIOSCIENCES-2024HMY01560$HARMONY BIOSCIENCES$$$$$$Y$$$20240813$$MD$FR$FR
242063021$24206302$1$I$20240806$20240812$20240812$20240812$DIR$713995$$FDA-CTU$$59$YR$$F$N$42.75$KG$20240812$N$CN$US$
242063051$24206305$1$I$$20240802$20240813$20240813$30DAY$$AR-PFIZER INC-202400231132$PFIZER$$12$YR$$F$Y$$$20240813$$CN$AR$AR
242063063$24206306$3$F$20240115$20240902$20240813$20240903$EXP$$US-PFIZER INC-PV202400083184$PFIZER$$64$YR$$F$Y$55.782$KG$20240903$$CN$US$US
242063071$24206307$1$I$20240621$20240806$20240813$20240813$EXP$FR-AFSSAPS-RN2024000846$FR-SA-2024SA234708$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240813$$MD$FR$FR
242063082$24206308$2$F$20240101$20240812$20240813$20240816$EXP$$US-KARYOPHARM-2024KPT001410$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240816$$MD$US$US
242063091$24206309$1$I$20240716$20240730$20240813$20240813$EXP$$EG-IMP-2024000583$Harrow Health$$20$YR$A$$Y$$$20240813$$MD$EG$EG
242063101$24206310$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164366$NOVARTIS$$$$$$Y$$$20240813$$HP$US$US
242063111$24206311$1$I$20240703$20240808$20240813$20240813$PER$$US-ROCHE-10000053633$ROCHE$$43$YR$A$M$Y$136.98$KG$20240813$$CN$US$US
242063121$24206312$1$I$20200914$20240809$20240813$20240813$EXP$$US-TAKEDA-US202029987$TAKEDA$$8$YR$$M$Y$33$KG$20240813$$HP$US$US
242063131$24206313$1$I$$20240812$20240812$20240812$DIR$713940$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242063141$24206314$1$I$20240424$20240812$20240812$20240812$DIR$713908$$FDA-CTU$$65$YR$$F$N$56.7$KG$20240812$Y$CN$US$
242063151$24206315$1$I$20240806$20240812$20240812$20240812$DIR$713949$$FDA-CTU$$68$YR$$F$N$107.1$KG$20240812$N$HP$US$
242063161$24206316$1$I$20240728$20240812$20240812$20240812$DIR$713956$$FDA-CTU$$70$YR$$M$N$$$20240812$N$HP$US$
242063171$24206317$1$I$20240807$20240812$20240812$20240812$DIR$713935$$FDA-CTU$$32$YR$$F$N$99$KG$20240812$N$MD$US$
242063181$24206318$1$I$20240311$20240812$20240812$20240812$DIR$713993$$FDA-CTU$$18$YR$$M$N$54$KG$20240812$Y$CN$US$
242063191$24206319$1$I$20240101$20240812$20240812$20240812$DIR$713952$$FDA-CTU$$90$YR$$F$N$65.25$KG$20240812$N$CN$US$
242063222$24206322$2$F$$20240823$20240813$20240829$EXP$$NL-MYLANLABS-2024M1073646$MYLAN$$49$YR$$F$Y$$$20240829$$CN$NL$NL
242063231$24206323$1$I$20240717$20240807$20240813$20240813$EXP$FR-AFSSAPS-CF2024000395$FR-MYLANLABS-2024M1074216$MYLAN$$81$YR$$F$Y$49$KG$20240813$$PH$FR$FR
242063241$24206324$1$I$20240702$20240807$20240813$20240813$EXP$FR-AFSSAPS-CF2024000392$FR-MYLANLABS-2024M1074242$MYLAN$$15$YR$$F$Y$59$KG$20240813$$PH$FR$FR
242063251$24206325$1$I$$20240812$20240813$20240813$PER$$US-ROCHE-10000054816$ROCHE$$$$A$M$Y$$$20240813$$CN$US$US
242063262$24206326$2$F$20240209$20240821$20240813$20240827$EXP$FR-AFSSAPS-TO2024001468$FR-MYLANLABS-2024M1073656$MYLAN$$69$YR$$M$Y$106$KG$20240827$$PH$FR$FR
242063271$24206327$1$I$20240801$20240812$20240813$20240813$PER$$US-ROCHE-10000054852$ROCHE$$12$YR$T$M$Y$$$20240813$$CN$US$US
242063301$24206330$1$I$$20240807$20240813$20240813$EXP$$CA-TEVA-VS-3232137$TEVA$$56$YR$$F$Y$59$KG$20240813$$HP$CA$CA
242063311$24206331$1$I$$20240807$20240813$20240813$EXP$$BR-BIOMARINAP-BR-2024-159763$BIOMARIN$$$$$$Y$$$20240813$$CN$BR$BR
242063333$24206333$3$F$$20240913$20240813$20240913$PER$$US-PFIZER INC-202400235573$PFIZER$$82$YR$$F$Y$71.67$KG$20240913$$CN$US$US
242063351$24206335$1$I$20240809$20240810$20240813$20240813$PER$$US-PFIZER INC-202400234418$PFIZER$$73$YR$$M$Y$$$20240813$$CN$US$US
242063361$24206336$1$I$20240811$20240812$20240813$20240813$PER$$US-PFIZER INC-PV202400105070$PFIZER$$63$YR$$F$Y$$$20240813$$HP$US$US
242063371$24206337$1$I$20240101$20240812$20240813$20240813$PER$$US-PFIZER INC-202400235446$PFIZER$$44$YR$$M$Y$$$20240813$$HP$US$US
242063381$24206338$1$I$20240807$20240808$20240813$20240813$PER$$US-PFIZER INC-202400233102$PFIZER$$67$YR$$F$Y$70.31$KG$20240813$$CN$US$US
242063391$24206339$1$I$$20240812$20240813$20240813$PER$$US-PFIZER INC-202400234915$PFIZER$$85$YR$$F$Y$$$20240813$$CN$US$US
242063401$24206340$1$I$$20240808$20240813$20240813$EXP$$US-DSJP-DSU-2024-140309$DAIICHI$$$$$F$Y$$$20240813$$MD$US$US
242063411$24206341$1$I$$20240806$20240813$20240813$EXP$$NVSC2024BR162780$NOVARTIS$$$$$F$Y$$$20240813$$CN$BR$BR
242063431$24206343$1$I$$20240807$20240813$20240813$EXP$$CA-TEVA-VS-3232392$TEVA$$$$A$F$Y$$$20240813$$MD$CA$CA
242063441$24206344$1$I$$20240807$20240813$20240813$EXP$$JP-DSJP-DSJ-2024-139921$DAIICHI$$$$E$$Y$$$20240813$$PH$JP$JP
242063451$24206345$1$I$20240723$20240809$20240813$20240813$EXP$$US-ROCHE-10000054432$ROCHE$$62$YR$A$$Y$$$20240813$$CN$US$US
242063461$24206346$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005795$ELI LILLY AND CO$$8$YR$C$M$Y$$$20240813$$CN$US$US
242063471$24206347$1$I$$20240806$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408003933$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240813$$CN$US$US
242063491$24206349$1$I$20221130$20240806$20240813$20240813$EXP$PT-INFARMED-B202407-441$PT-TEVA-VS-3231127$TEVA$$62$YR$$F$Y$$$20240813$$MD$PT$PT
242063501$24206350$1$I$20240723$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005682$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240813$$CN$US$US
242063511$24206351$1$I$$20240806$20240813$20240813$PER$$US-BIOMARINAP-US-2024-159683$BIOMARIN$$$$$$Y$$$20240813$$CN$US$US
242063522$24206352$2$F$20240101$20240812$20240813$20240903$PER$$US-KARYOPHARM-2024KPT001418$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242063532$24206353$2$F$20240806$20240814$20240813$20240820$EXP$$MX-TAKEDA-2024TUS079286$TAKEDA$$36$YR$$M$Y$97$KG$20240820$$CN$MX$MX
242063544$24206354$4$F$$20240902$20240813$20240911$EXP$$IT-TAKEDA-2024TUS080059$TAKEDA$$$$$F$Y$$$20240911$$CN$IT$IT
242063551$24206355$1$I$20240624$20240812$20240812$20240812$DIR$713923$$FDA-CTU$$68$YR$$F$N$$$20240812$N$PH$US$
242063561$24206356$1$I$$20240805$20240813$20240813$EXP$$JP-TAKEDA-2024TUS081060$TAKEDA$$$$$$Y$$$20240813$$PH$JP$JP
242063611$24206361$1$I$$20240812$20240812$20240812$DIR$713925$$FDA-CTU$$$$$UNK$N$$$20240812$N$CN$US$
242063621$24206362$1$I$20240806$20240812$20240812$20240812$DIR$713962$$FDA-CTU$$55$YR$$F$N$81$KG$20240812$N$CN$US$
242063651$24206365$1$I$$20240812$20240812$20240812$DIR$713945$$FDA-CTU$$$$$UNK$N$$$20240812$$CN$US$
242063671$24206367$1$I$20240629$20240812$20240812$20240812$DIR$713922$$FDA-CTU$$57$YR$$M$N$92.25$KG$20240812$N$CN$US$
242063711$24206371$1$I$20240501$20240806$20240813$20240813$EXP$$BR-SANDOZ INC.-SDZ2024BR072139$SANDOZ$$$$$F$Y$64$KG$20240813$$CN$BR$BR
242063721$24206372$1$I$$20240806$20240813$20240813$EXP$$CA-TEVA-VS-3232051$TEVA$$68$YR$$F$Y$73$KG$20240813$$CN$CA$CA
242063732$24206373$2$F$$20240827$20240813$20240828$PER$$NVSC2024US163349$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242063741$24206374$1$I$$20240730$20240813$20240813$EXP$$US-HLS-202400635$HLS THERAPEUTICS$$$$A$$Y$$$20240813$$HP$US$US
242063751$24206375$1$I$$20240807$20240813$20240813$PER$$US-JNJFOC-20240829624$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$HP$US$US
242063771$24206377$1$I$$20240812$20240813$20240813$PER$$NVSC2024US163626$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242063781$24206378$1$I$20240617$20240806$20240813$20240813$EXP$FR-AFSSAPS-CN2024000726$FR-TEVA-VS-3230867$TEVA$$79$YR$$M$Y$80.4$KG$20240813$$MD$FR$FR
242063791$24206379$1$I$$20240807$20240813$20240813$EXP$$NVSC2024GB162840$NOVARTIS$$$$$F$Y$$$20240813$$CN$GB$GB
242063801$24206380$1$I$$20240809$20240813$20240813$EXP$$FR-DSJP-DSE-2024-140384$DAIICHI$$$$E$F$Y$$$20240813$$MD$FR$FR
242063811$24206381$1$I$$20240809$20240813$20240813$EXP$$US-TAKEDA-2024TUS080207$TAKEDA$$$$$F$Y$$$20240813$$MD$US$US
242063822$24206382$2$F$$20240819$20240813$20240826$EXP$$US-TEVA-VS-3230631$TEVA$Spitz A, Shi H, Panjawatanan P, Skarda C, Shahsavari S, Welch T, et al. LATE-ONSET AMIODARONE-INDUCED THYROTOXICOSIS (AIT) CAUSING RECURRENT HEART FAILURE WITH REDUCED EJECTION FRACTION. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3182.; Spitz A, Shi H, Panjawatanan P, Skarda C, Shahsavari S, Welch T, et al. LATE-ONSET AMIODARONE-INDUCED THYROTOXICOSIS (AIT) CAUSING RECURRENT HEART FAILURE WITH REDUCED EJECTION FRACTION. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3182.$58$YR$$M$Y$$$20240826$$HP$US$US
242063831$24206383$1$I$20240721$20240724$20240813$20240813$PER$$US-TEVA-VS-3225366$TEVA$$68$YR$$F$Y$67.13$KG$20240813$$CN$US$US
242063841$24206384$1$I$20120101$20240806$20240813$20240813$EXP$$BR-MYLANLABS-2017531712$MYLAN$$$$$M$Y$95$KG$20240813$$CN$BR$BR
242063861$24206386$1$I$$20240805$20240813$20240813$PER$$US-JNJFOC-20240831251$JOHNSON AND JOHNSON$$$$$M$Y$$$20240813$$CN$US$US
242063871$24206387$1$I$$20240812$20240813$20240813$PER$$US-Karo Pharma-2160366$Karo Pharma$$86$YR$$F$Y$$$20240813$$$US$US
242063895$24206389$5$F$20220101$20240909$20240813$20240913$EXP$$US-PFIZER INC-PV202400104834$PFIZER$$60$YR$$F$Y$73$KG$20240913$$MD$US$US
242063903$24206390$3$F$20140101$20240826$20240813$20240902$EXP$$NVSC2016NL006689$NOVARTIS$Hoppe BPC, de Jongh E, Griffioen-Keijzer A, Zijlstra-Baalbergen JM, Ijzerman EPF, Baboe F et al.. Human metapneumovirus in haematopoietic stem cell transplantation recipients: a case series and review of the diagnostic and therapeutic approach. THE NETHERLANDS JOURNAL OF MEDICINE. 2016;74(8):336-41$67$YR$$F$Y$$$20240902$$HP$NL$NL
242063911$24206391$1$I$20240805$20240805$20240813$20240813$EXP$$CN-AstraZeneca-2024A179742$ASTRAZENECA$$20348$DY$$M$Y$75$KG$20240813$$MD$CN$
242063921$24206392$1$I$20240716$20240807$20240813$20240813$EXP$SE-SEMPA-2024-005841$SE-MYLANLABS-2024M1074120$MYLAN$$19$YR$$F$Y$$$20240813$$MD$SE$SE
242063931$24206393$1$I$$20240807$20240813$20240813$PER$$US-AstraZeneca-2024A180653$ASTRAZENECA$$$$$$Y$$$20240813$$CN$US$
242063941$24206394$1$I$20230301$20240807$20240813$20240813$EXP$FR-AFSSAPS-AVMP2024000221$FR-MYLANLABS-2024M1073941$MYLAN$$25$YR$$M$Y$$$20240813$$MD$FR$FR
242063951$24206395$1$I$$20240809$20240813$20240813$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006142$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240813$$CN$US$US
242063961$24206396$1$I$$20240805$20240813$20240813$EXP$$RU-AstraZeneca-2024A179866$ASTRAZENECA$Sorokovikova T.V., Morozov A.M., Kryukova A.N., Naumova S.A., Mitropolskaya A.V.. Genetic prion disease-fatal familial insomnia (clinical case). Acta biomedica scientifica 2021;9(3):90-94.$$$$F$Y$$$20240813$$HP$RU$
242063971$24206397$1$I$$20240809$20240813$20240813$EXP$$ES-AMGEN-ESPSP2024158975$AMGEN$Martinez-selles M.; Valero-Masa M.J.; Ortiz-Bautista C.D. et al.. Optimization of Hypercholesterolemia Treatment after Heart Transplant: The Role of PCSK9 Inhibitors. Current Pharmaceutical Design. 2024;30:1-4$$$$M$Y$$$20240813$$HP$ES$ES
242063981$24206398$1$I$20210101$20240807$20240813$20240813$EXP$$CN-009507513-2408CHN003364$MERCK$Wang B, Qiu M. Multidisciplinary treatment and immunotherapy improved the prognosis of advanced small intestine sarcomatoid carcinoma. Precision Clinical Medicine. 2024;7:1-3$61$YR$$M$Y$$$20240813$$HP$CN$CN
242063991$24206399$1$I$20230624$20240809$20240813$20240813$EXP$IT-MINISAL02-997992$IT-009507513-2408ITA003593$MERCK$$61$YR$$M$Y$70$KG$20240813$$MD$IT$IT
242064001$24206400$1$I$20240517$20240807$20240813$20240813$EXP$$IT-BIOGEN-2024BI01269901$BIOGEN$$8$YR$$M$Y$$$20240813$$MD$IT$IT
242064011$24206401$1$I$$20240805$20240813$20240813$EXP$NL-LRB-00993393$NL-TEVA-VS-3230564$TEVA$$69$YR$$M$Y$106$KG$20240813$$CN$NL$NL
242064021$24206402$1$I$$20240808$20240813$20240813$EXP$$PHHY2014PL147926$NOVARTIS$Juczynska K, Zebrowska A.. Deep lupus erythematosus (lupus erythematosus profundus): diagnostic and therapeutic difficulties based on a case report in the light of recent literature reports$39$YR$$F$Y$$$20240813$$HP$PL$PL
242064031$24206403$1$I$20240101$20240809$20240813$20240813$EXP$$CA-PFIZER INC-202400234651$PFIZER$$65$YR$$F$Y$$$20240813$$HP$CA$CA
242064041$24206404$1$I$$20240808$20240813$20240813$EXP$$NVSC2011NL002120$NOVARTIS$Flinterman AE, Timmer-de Mik L, Canninga-van Dijk MR, Sanders CJG. Spectrum of reactive neutrophilic dermatoses in a patient with meylodysplastic syndrome: treatment with anti-TNF alpha antibodies. NEDERLANDS VOOR DEMATOLGIE EN VENEROLGIE. 2009;19:289-92$28$YR$$M$Y$$$20240813$$HP$NL$NL
242064051$24206405$1$I$$20240812$20240813$20240813$EXP$$US-PFIZER INC-PV202400105061$PFIZER$$81$YR$$F$Y$$$20240813$$CN$US$US
242064061$24206406$1$I$20240701$20240806$20240813$20240813$EXP$DK-DKMA-30736376$DK-TEVA-VS-3231059$TEVA$$65$YR$$M$Y$$$20240813$$MD$DK$DK
242064071$24206407$1$I$20240515$20240806$20240813$20240813$EXP$$CR-MYLANLABS-2024M1074157$MYLAN$$88$YR$$F$Y$59.86$KG$20240813$$CN$CR$CR
242064081$24206408$1$I$$20240812$20240813$20240813$EXP$$CA-AMERICAN REGENT INC-2024003102$AMERICAN REGENT$$36$YR$$F$Y$$$20240813$$HP$CA$CA
242064091$24206409$1$I$20230101$20240806$20240813$20240813$EXP$$US-BIOGEN-2024BI01254226$BIOGEN$$50$YR$$F$Y$$$20240813$$CN$US$US
242064101$24206410$1$I$$20240806$20240813$20240813$EXP$$US-BIOGEN-2024BI01277515$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
242064113$24206411$3$F$$20240923$20240813$20240930$PER$$US-ALXN-202408USA000557US$ALEXION PHARMACEUTICALS$$$$A$$Y$$$20240930$$$US$US
242064121$24206412$1$I$20240501$20240807$20240813$20240813$EXP$PT-INFARMED-F202407-964$PT-MYLANLABS-2024M1074237$MYLAN$$44$YR$$F$Y$70$KG$20240813$$PH$PT$PT
242064131$24206413$1$I$$20240806$20240813$20240813$EXP$$CA-TEVA-VS-3231200$TEVA$$33$YR$$F$Y$$$20240813$$PH$CA$CA
242064142$24206414$2$F$$20240926$20240813$20240926$PER$$NVSC2024US164388$NOVARTIS$$$$$$Y$$$20240926$$MD$US$US
242064152$24206415$2$F$$20240819$20240813$20240821$EXP$$GB-ABBVIE-5875930$ABBVIE$$$$$M$Y$$$20240821$$HP$GB$GB
242064161$24206416$1$I$20230101$20240806$20240813$20240813$PER$$US-ABBVIE-5870067$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242064171$24206417$1$I$20240723$20240805$20240813$20240813$EXP$IT-MINISAL02-996720$IT-TEVA-VS-3230895$TEVA$$68$YR$$F$Y$57$KG$20240813$$PH$IT$IT
242064182$24206418$2$F$20220927$20240923$20240813$20240927$EXP$$DE-ROCHE-3535747$ROCHE$$31$YR$A$F$Y$$$20240927$$CN$DE$DE
242064191$24206419$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164139$NOVARTIS$$$$$M$Y$$$20240813$$CN$US$US
242064201$24206420$1$I$$20240621$20240813$20240813$PER$$US-LUNDBECK-DKLU4001081$LUNDBECK$$$$$$Y$$$20240813$$HP$US$US
242064222$24206422$2$F$$20240809$20240813$20240925$PER$$US-LUNDBECK-DKLU4001852$LUNDBECK$$$$$$Y$$$20240925$$CN$US$US
242064231$24206423$1$I$20240725$20240805$20240813$20240813$EXP$$IT-AstraZeneca-2024A179128$ASTRAZENECA$$18708$DY$$M$Y$80$KG$20240813$$MD$IT$
242064251$24206425$1$I$$20240805$20240813$20240813$EXP$$ZA-AstraZeneca-2024A177692$ASTRAZENECA$$63$YR$$M$Y$$$20240813$$CN$ZA$
242064261$24206426$1$I$$20240625$20240813$20240813$PER$$US-LUNDBECK-DKLU4001049$LUNDBECK$$$$$$Y$$$20240813$$HP$US$US
242064271$24206427$1$I$$20240806$20240813$20240813$PER$$US-ABBVIE-5870445$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242064281$24206428$1$I$$20240730$20240813$20240813$EXP$$US-HLS-202400633$HLS THERAPEUTICS$$44$YR$A$F$Y$$$20240813$$HP$US$US
242064292$24206429$2$F$20240229$20240903$20240813$20240910$EXP$FR-AFSSAPS-RE2024000803$FR-009507513-2408FRA002476$MERCK$$66$YR$$F$Y$109$KG$20240910$$HP$FR$FR
242064311$24206431$1$I$$20240627$20240813$20240813$PER$$US-LUNDBECK-DKLU4000989$LUNDBECK$$$$$$Y$$$20240813$$HP$US$US
242064322$24206432$2$F$20240416$20240906$20240813$20240909$EXP$$DE-SANDOZ INC.-SDZ2024DE071898$SANDOZ$$68$YR$$M$Y$72$KG$20240909$$MD$DE$DE
242064331$24206433$1$I$20240201$20240806$20240813$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012089$JAZZ$$72$YR$$M$Y$$$20240813$$CN$US$US
242064342$24206434$2$F$20240812$20240814$20240813$20240821$PER$$US-AMGEN-USASP2024159955$AMGEN$$73$YR$E$F$Y$$$20240821$$CN$US$US
242064361$24206436$1$I$20240621$20240806$20240813$20240813$EXP$ES-AEMPS-1554646$ES-TEVA-VS-3231068$TEVA$$16$YR$$F$Y$$$20240813$$MD$ES$ES
242064371$24206437$1$I$$20240729$20240813$20240813$PER$$US-TEVA-VS-3228762$TEVA$$41$YR$$F$Y$$$20240813$$HP$US$US
242064392$24206439$2$F$$20240829$20240813$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126425$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240903$$CN$US$US
242064401$24206440$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128150$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240813$$CN$US$US
242064411$24206441$1$I$20240601$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127095$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240813$$CN$US$US
242064421$24206442$1$I$20221001$20240806$20240813$20240813$EXP$$JP-009507513-2408JPN000772J$MERCK$$53$YR$$F$Y$$$20240813$$MD$JP$JP
242064442$24206444$2$F$$20240808$20240813$20240815$EXP$$PT-PFIZER INC-202400232787$PFIZER$Silva, D.. Leucemia mieloide aguda: evolucao no paradigma e impacto terapeutico. Hematologia e Oncologia. 2024;12(46):18-21$28$YR$$F$Y$$$20240815$$MD$PT$PT
242064452$24206445$2$F$$20240813$20240813$20240821$EXP$$AU-BIOGEN-2024BI01277554$BIOGEN$$39$YR$$F$Y$$$20240820$$MD$AU$AU
242064462$24206446$2$F$20240808$20240906$20240813$20240912$EXP$$US-JNJFOC-20240831712$JOHNSON AND JOHNSON$$39$YR$A$M$Y$70.5$KG$20240912$$HP$US$US
242064471$24206447$1$I$20240101$20240809$20240813$20240813$EXP$$US-ABBVIE-5875919$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242064481$24206448$1$I$$20240805$20240813$20240813$PER$$US-AstraZeneca-2024A179668$ASTRAZENECA$$$$$$Y$$$20240813$$CN$US$
242064492$24206449$2$F$20240801$20240909$20240813$20240912$EXP$$NL-ABBVIE-5876947$ABBVIE$$82$YR$$M$Y$$$20240912$$MD$NL$NL
242064501$24206450$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127674$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240813$$HP$US$US
242064511$24206451$1$I$20230101$20240808$20240813$20240813$PER$$US-BAUSCH-BL-2024-012112$BAUSCH AND LOMB$$$$$M$Y$$$20240813$$CN$US$US
242064521$24206452$1$I$20240727$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127757$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$70.76$KG$20240813$$PH$US$US
242064532$24206453$2$F$$20240820$20240813$20240826$PER$$US-AMGEN-USASP2024160048$AMGEN$$$$$F$Y$$$20240825$$HP$US$US
242064542$24206454$2$F$$20240822$20240813$20240830$EXP$$DE-TEVA-VS-3231531$TEVA$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure 2023; 107 107-113.$3$DY$$$Y$$$20240830$$MD$DE$DE
242064551$24206455$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127898$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240813$$MD$US$US
242064561$24206456$1$I$20240811$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024160128$AMGEN$$57$YR$A$F$Y$$$20240813$$CN$US$US
242064571$24206457$1$I$20240701$20240801$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128162$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240813$$HP$US$US
242064581$24206458$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127555$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$66.68$KG$20240813$$CN$US$US
242064592$24206459$2$F$$20240822$20240813$20240830$EXP$$DE-TEVA-VS-3231528$TEVA$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure 2023; 107 107-113.$$$N$$Y$$$20240830$$MD$DE$DE
242064621$24206462$1$I$$20240725$20240813$20240813$PER$$US-009507513-2407USA014312$MERCK$Maliga Z, Kim DY, Bui AN, Dewan AK, Jadeja S, Murphy GF, et al. Immune Profiling of Dermatologic Adverse Events from Checkpoint Blockade Using Tissue Cyclic Immunofluorescence: A Pilot Study. Journal of Investigative Dermatology. 2024;144:1887-90$62$YR$$M$Y$$$20240813$$HP$US$US
242064631$24206463$1$I$$20240725$20240813$20240813$PER$$US-009507513-2408USA003330$MERCK$Maliga Z, Kim DY, Bui AN, Dewan AK, Jadeja S, Murphy GF, et al. Immune Profiling of Dermatologic Adverse Events from Checkpoint Blockade Using Tissue Cyclic Immunofluorescence: A Pilot Study. Journal of Investigative Dermatology. 2024;144:1887-90$51$YR$$F$Y$$$20240813$$HP$US$US
242064641$24206464$1$I$$20240813$20240813$20240813$EXP$$CA-HLS-202402057$HLS THERAPEUTICS$$52$YR$A$M$Y$$$20240813$$HP$CA$CA
242064652$24206465$2$F$20240727$20240912$20240813$20240917$EXP$$US-APELLIS-2024-APL-0000590$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240917$$CN$US$US
242064661$24206466$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127656$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240813$$HP$US$US
242064672$24206467$2$F$$20240903$20240813$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125705$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240904$$CN$US$US
242064681$24206468$1$I$20240731$20240805$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127165$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240813$$CN$US$US
242064691$24206469$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127591$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240813$$CN$US$US
242064701$24206470$1$I$20240304$20240314$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004520$JAZZ$$71$YR$$F$Y$$$20240813$$MD$US$US
242064711$24206471$1$I$20210410$20240716$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010831$JAZZ$$53$YR$$M$Y$$$20240813$$MD$US$US
242064721$24206472$1$I$$20240116$20240813$20240813$PER$$AU-JAZZ PHARMACEUTICALS-2024-AU-000828$JAZZ$$60$YR$$$Y$$$20240813$$MD$AU$AU
242064731$24206473$1$I$20240122$20240722$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011173$JAZZ$$53$YR$$M$Y$$$20240813$$HP$US$US
242064741$24206474$1$I$20230411$20240716$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011211$JAZZ$$47$YR$$M$Y$$$20240813$$MD$US$US
242064751$24206475$1$I$20210114$20240718$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010985$JAZZ$$72$YR$$M$Y$$$20240813$$HP$US$US
242064761$24206476$1$I$$20231110$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2023-US-023044$JAZZ$Guillermo B, Elias J, Kelly S. Chien, Gautam B, Zeev E, Tapan K et.al. Results of a Phase 1/2 Study of Lower Dose CPX-351 for Patients with Int-2 or High Risk IPSS Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia after Failure to Hypomethylating Agents. Br J Haematol. 2023;00:1-12$78$YR$$$Y$$$20240813$$HP$US$US
242064771$24206477$1$I$20220127$20240726$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011383$JAZZ$$65$YR$$M$Y$$$20240813$$HP$US$US
242064781$24206478$1$I$20200915$20240722$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011174$JAZZ$$57$YR$$M$Y$$$20240813$$MD$US$US
242064791$24206479$1$I$20190523$20240723$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010776$JAZZ$$67$YR$$M$Y$$$20240813$$HP$US$US
242064802$24206480$2$F$$20240816$20240813$20240821$PER$$US-PFIZER INC-202400233174$PFIZER$$70$YR$$$Y$$$20240821$$CN$US$US
242064812$24206481$2$F$20240710$20240807$20240813$20240827$PER$$US-IMP-2024000510$Harrow Health$$57$YR$A$F$Y$$$20240827$$CN$US$US
242064821$24206482$1$I$$20240805$20240813$20240813$EXP$$FR-AstraZeneca-2024A074732$ASTRAZENECA$$$$$M$Y$63$KG$20240813$$MD$FR$
242064831$24206483$1$I$$20240415$20240813$20240813$EXP$$BR-EMD Serono-2024042988$EMD SERONO INC$$$$$F$Y$$$20240813$$HP$BR$BR
242064843$24206484$3$F$$20240813$20240813$20240816$PER$$NVSC2024US164219$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
242064851$24206485$1$I$20200513$20240808$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011415$JAZZ$$69$YR$$M$Y$$$20240813$$HP$US$US
242064861$24206486$1$I$20190315$20240729$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011560$JAZZ$$69$YR$$F$Y$$$20240813$$HP$US$US
242064871$24206487$1$I$20180928$20240726$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011395$JAZZ$$67$YR$$F$Y$$$20240813$$MD$US$US
242064881$24206488$1$I$20240101$20240808$20240813$20240813$EXP$$NVSC2024US162746$NOVARTIS$$12$YR$$F$Y$91$KG$20240813$$MD$US$US
242064891$24206489$1$I$20180826$20240730$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011563$JAZZ$$68$YR$$M$Y$$$20240813$$HP$US$US
242064901$24206490$1$I$20220225$20240731$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011741$JAZZ$$67$YR$$M$Y$$$20240813$$HP$US$US
242064911$24206491$1$I$20200721$20240801$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011463$JAZZ$$73$YR$$M$Y$$$20240813$$HP$US$US
242064921$24206492$1$I$20180324$20240731$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011746$JAZZ$$70$YR$$M$Y$$$20240813$$MD$US$US
242064931$24206493$1$I$20180902$20240725$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011390$JAZZ$$34$YR$$F$Y$$$20240813$$HP$US$US
242064941$24206494$1$I$20190116$20240730$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011603$JAZZ$$58$YR$$M$Y$$$20240813$$MD$US$US
242064951$24206495$1$I$$20240808$20240813$20240813$EXP$$CA-BIOGEN-2024BI01277952$BIOGEN$$$$$F$Y$$$20240813$$HP$CA$CA
242064961$24206496$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127231$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240813$$CN$US$US
242064972$24206497$2$F$$20240818$20240813$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127653$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$67.13$KG$20240821$$CN$US$US
242064981$24206498$1$I$$20240808$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127296$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240813$$CN$US$US
242064992$24206499$2$F$$20240909$20240813$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127614$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240910$$CN$US$US
242065001$24206500$1$I$20191121$20240114$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-000887$JAZZ$$72$YR$$F$Y$$$20240813$$MD$US$US
242065011$24206501$1$I$20210622$20240501$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006968$JAZZ$$58$YR$$M$Y$$$20240813$$HP$US$US
242065021$24206502$1$I$20230208$20240229$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-001309$JAZZ$$63$YR$$M$Y$$$20240813$$HP$US$US
242065031$24206503$1$I$20200607$20240426$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006871$JAZZ$$40$YR$$M$Y$$$20240813$$HP$US$US
242065041$24206504$1$I$20180130$20240117$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-001062$JAZZ$$71$YR$$M$Y$$$20240813$$MD$US$US
242065051$24206505$1$I$20200620$20240731$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011766$JAZZ$$64$YR$$M$Y$$$20240813$$HP$US$US
242065061$24206506$1$I$20230430$20240326$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005169$JAZZ$$53$YR$$F$Y$$$20240813$$MD$US$US
242065071$24206507$1$I$20200620$20240731$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011769$JAZZ$$74$YR$$M$Y$$$20240813$$MD$US$US
242065081$24206508$1$I$20200713$20240503$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007031$JAZZ$$54$YR$$M$Y$$$20240813$$MD$US$US
242065091$24206509$1$I$20240225$20240416$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006448$JAZZ$$66$YR$$F$Y$$$20240813$$HP$US$US
242065111$24206511$1$I$$20240801$20240813$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-126179$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240813$$MD$CA$CA
242065121$24206512$1$I$20200405$20240522$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007662$JAZZ$$54$YR$$F$Y$$$20240813$$HP$US$US
242065132$24206513$2$F$$20240828$20240813$20240828$PER$$US-ALXN-202408USA000529US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242065141$24206514$1$I$20180127$20240515$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007645$JAZZ$$70$YR$$F$Y$$$20240813$$HP$US$US
242065151$24206515$1$I$20180505$20240515$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007636$JAZZ$$61$YR$$F$Y$$$20240813$$HP$US$US
242065161$24206516$1$I$20180608$20240510$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007326$JAZZ$$74$YR$$F$Y$$$20240813$$HP$US$US
242065171$24206517$1$I$20220315$20240506$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007170$JAZZ$$65$YR$$F$Y$$$20240813$$HP$US$US
242065181$24206518$1$I$20181211$20240507$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007205$JAZZ$$72$YR$$F$Y$$$20240813$$MD$US$US
242065191$24206519$1$I$20210419$20240508$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007267$JAZZ$$44$YR$$M$Y$$$20240813$$MD$US$US
242065201$24206520$1$I$20200925$20240515$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007653$JAZZ$$35$YR$$M$Y$$$20240813$$HP$US$US
242065211$24206521$1$I$20180325$20240508$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007263$JAZZ$$44$YR$$M$Y$$$20240813$$MD$US$US
242065221$24206522$1$I$20180528$20240514$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007474$JAZZ$$59$YR$$M$Y$$$20240813$$MD$US$US
242065231$24206523$1$I$$20240807$20240813$20240813$PER$$US-TRAVERE-2024TVT00785$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240813$$CN$US$US
242065241$24206524$1$I$$20240716$20240813$20240813$PER$$US-009507513-2407USA011087$MERCK$$63$YR$$$Y$81.179$KG$20240813$$CN$US$US
242065251$24206525$1$I$$20240808$20240813$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044742$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240813$$CN$US$US
242065261$24206526$1$I$$20240802$20240813$20240813$EXP$$DE-Covis Pharma GmbH-2024COV00958$COVIS PHARMA$$52$YR$A$M$Y$$$20240813$$CN$DE$DE
242065272$24206527$2$F$20240722$20240905$20240813$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127597$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240909$$CN$US$US
242065281$24206528$1$I$$20201012$20240813$20240813$EXP$$US-Covis Pharma GmbH-2024COV00973$COVIS PHARMA$$57$YR$A$M$Y$$$20240813$$$COUNTRY NOT SPECIFIED$US
242065291$24206529$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127650$BRISTOL MYERS SQUIBB$$65$YR$A$M$Y$$$20240813$$CN$US$US
242065301$24206530$1$I$20210525$20240611$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009186$JAZZ$$51$YR$$M$Y$$$20240813$$MD$US$US
242065311$24206531$1$I$20231010$20240613$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009216$JAZZ$$54$YR$$M$Y$$$20240813$$MD$US$US
242065321$24206532$1$I$20240214$20240613$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009256$JAZZ$$56$YR$$M$Y$$$20240813$$HP$US$US
242065331$24206533$1$I$20221224$20240606$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008915$JAZZ$$55$YR$$M$Y$$$20240813$$HP$US$US
242065341$24206534$1$I$20211014$20240611$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009184$JAZZ$$64$YR$$M$Y$$$20240813$$HP$US$US
242065351$24206535$1$I$20200323$20240612$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009266$JAZZ$$62$YR$$M$Y$$$20240813$$MD$US$US
242065361$24206536$1$I$20180429$20240612$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009276$JAZZ$$67$YR$$F$Y$$$20240813$$MD$US$US
242065371$24206537$1$I$20180910$20240608$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009001$JAZZ$$57$YR$$M$Y$$$20240813$$MD$US$US
242065381$24206538$1$I$20220329$20240606$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008859$JAZZ$$55$YR$$M$Y$$$20240813$$HP$US$US
242065391$24206539$1$I$20180627$20240530$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-007740$JAZZ$$59$YR$$M$Y$$$20240813$$HP$US$US
242065401$24206540$1$I$$20240725$20240813$20240813$PER$$US-009507513-2408USA003331$MERCK$Maliga Z, Kim DY, Bui AN, Dewan AK, Jadeja S, Murphy GF, et al. Immune Profiling of Dermatologic Adverse Events from Checkpoint Blockade Using Tissue Cyclic Immunofluorescence: A Pilot Study. Journal of Investigative Dermatology. 2024;144:1887-90$68$YR$$F$Y$$$20240813$$HP$US$US
242065412$24206541$2$F$20231220$20240828$20240813$20240909$EXP$FR-AFSSAPS-NC2024000956$FR-ELI_LILLY_AND_COMPANY-FR202408004506$ELI LILLY AND CO$$84$YR$E$F$Y$48$KG$20240909$$CN$FR$FR
242065421$24206542$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006225$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242065431$24206543$1$I$20220913$20240807$20240813$20240813$EXP$$RU-ELI_LILLY_AND_COMPANY-RU202408006688$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240813$$MD$RU$RU
242065441$24206544$1$I$20240726$20240802$20240813$20240813$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408005401$ELI LILLY AND CO$$25$YR$A$F$Y$33$KG$20240813$$CN$DE$CN
242065451$24206545$1$I$$20240807$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005124$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240813$$HP$US$US
242065461$24206546$1$I$20230507$20240623$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009773$JAZZ$$42$YR$$M$Y$$$20240813$$HP$US$US
242065471$24206547$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007436$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240813$$CN$US$US
242065481$24206548$1$I$20240725$20240809$20240813$20240813$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408006778$ELI LILLY AND CO$$63$YR$A$F$Y$42$KG$20240813$$CN$CN$CN
242065491$24206549$1$I$20211029$20240623$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009762$JAZZ$$59$YR$$M$Y$$$20240813$$HP$US$US
242065501$24206550$1$I$20231027$20240620$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009609$JAZZ$$27$YR$$F$Y$$$20240813$$MD$US$US
242065511$24206551$1$I$20220308$20240623$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009763$JAZZ$$64$YR$$F$Y$$$20240813$$HP$US$US
242065521$24206552$1$I$20191203$20240626$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009955$JAZZ$$71$YR$$M$Y$$$20240813$$HP$US$US
242065531$24206553$1$I$20200126$20240619$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009445$JAZZ$$68$YR$$F$Y$$$20240813$$HP$US$US
242065541$24206554$1$I$20211226$20240619$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009444$JAZZ$$71$YR$$M$Y$$$20240813$$HP$US$US
242065551$24206555$1$I$20230504$20240618$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009339$JAZZ$$64$YR$$M$Y$$$20240813$$HP$US$US
242065561$24206556$1$I$20200903$20240623$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009769$JAZZ$$69$YR$$M$Y$$$20240813$$HP$US$US
242065571$24206557$1$I$20220303$20240626$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009956$JAZZ$$65$YR$$F$Y$$$20240813$$HP$US$US
242065581$24206558$1$I$20180622$20240626$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009964$JAZZ$$61$YR$$F$Y$$$20240813$$MD$US$US
242065591$24206559$1$I$20211018$20240626$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009976$JAZZ$$59$YR$$M$Y$$$20240813$$HP$US$US
242065601$24206560$1$I$20180804$20240710$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010517$JAZZ$$68$YR$$F$Y$$$20240813$$HP$US$US
242065611$24206561$1$I$20180805$20240710$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010518$JAZZ$$68$YR$$M$Y$$$20240813$$HP$US$US
242065621$24206562$1$I$20230729$20240112$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2023-US-016622$JAZZ$$63$YR$$$Y$$$20240813$$MD$US$US
242065631$24206563$1$I$20210613$20240626$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009968$JAZZ$$60$YR$$M$Y$$$20240813$$HP$US$US
242065641$24206564$1$I$20190524$20240717$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010948$JAZZ$$75$YR$$M$Y$$$20240813$$HP$US$US
242065651$24206565$1$I$20180114$20240626$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009960$JAZZ$$56$YR$$F$Y$$$20240813$$HP$US$US
242065661$24206566$1$I$20190512$20240627$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009979$JAZZ$$72$YR$$F$Y$$$20240813$$HP$US$US
242065671$24206567$1$I$20231024$20240626$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009985$JAZZ$$64$YR$$M$Y$$$20240813$$HP$US$US
242065681$24206568$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127647$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240813$$CN$US$US
242065691$24206569$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126598$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240813$$HP$US$US
242065701$24206570$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127859$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240813$$CN$US$US
242065711$24206571$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126647$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240813$$CN$US$US
242065721$24206572$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128046$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240813$$HP$US$US
242065731$24206573$1$I$$20240806$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127423$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240813$$HP$US$US
242065741$24206574$1$I$20231202$20240808$20240813$20240813$EXP$FR-AFSSAPS-ST2024001276$FR-009507513-2408FRA002748$MERCK$$68$YR$$M$Y$72$KG$20240813$$MD$FR$FR
242065751$24206575$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126848$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$106.14$KG$20240813$$CN$US$US
242065762$24206576$2$F$20240802$20240813$20240813$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127834$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240814$$PH$US$US
242065771$24206577$1$I$20240514$20240708$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-008190$JAZZ$$51$YR$$M$Y$$$20240813$$MD$IT$IT
242065781$24206578$1$I$$20240215$20240813$20240813$PER$$GB-JAZZ PHARMACEUTICALS-2024-GB-002926$JAZZ$$68$YR$$M$Y$$$20240813$$HP$GB$GB
242065791$24206579$1$I$$20240808$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126167$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240813$$MD$US$US
242065801$24206580$1$I$20240413$20240806$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-008296$JAZZ$$69$YR$$M$Y$$$20240813$$MD$IT$IT
242065811$24206581$1$I$20240809$20240812$20240813$20240813$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-127636$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240813$$CN$GB$GB
242065821$24206582$1$I$20240709$20240723$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-010701$JAZZ$$64$YR$$M$Y$$$20240813$$HP$IT$IT
242065831$24206583$1$I$20240125$20240520$20240813$20240813$PER$$KR-JAZZ PHARMACEUTICALS-2024-KR-006744$JAZZ$$75$YR$$M$Y$60$KG$20240813$$MD$KR$KR
242065841$24206584$1$I$20231124$20240603$20240813$20240813$PER$$KR-JAZZ PHARMACEUTICALS-2024-KR-005968$JAZZ$$69$YR$$M$Y$62.1$KG$20240813$$MD$KR$KR
242065851$24206585$1$I$20240730$20240731$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-011743$JAZZ$$58$YR$$M$Y$$$20240813$$HP$IT$IT
242065861$24206586$1$I$20240420$20240728$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-008306$JAZZ$$62$YR$$M$Y$$$20240813$$HP$IT$IT
242065871$24206587$1$I$$20240108$20240813$20240813$PER$$GB-JAZZ PHARMACEUTICALS-2024-GB-000328$JAZZ$$$$$$Y$$$20240813$$CN$GB$GB
242065881$24206588$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240825122$JOHNSON AND JOHNSON$$$$$$Y$$$20240813$$HP$US$US
242065891$24206589$1$I$20240628$20240701$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-010278$JAZZ$$$$$F$Y$$$20240813$$HP$IT$IT
242065901$24206590$1$I$$20240731$20240813$20240813$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI07894$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240813$$PH$JP$JP
242065911$24206591$1$I$$20240802$20240813$20240813$EXP$$TR-INSUD PHARMA-2408TR06333$INSUD PHARMA$Yorulmaz A, Bal Bayazitli EC, Orman U, Tamer E, Orhum HS. Severe Cutaneous Eruption in a Woman After Ingesting Multiple Drug: A Rare Presentation of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-Like Lupus Erythematosus. Turkiye Klinikleri J Dermatol. 2024;34(1):32-6$$$$$Y$$$20240813$$HP$TR$TR
242065921$24206592$1$I$20150101$20240802$20240813$20240813$EXP$$US-INSUD PHARMA-2408US06306$INSUD PHARMA$Cheng JJ, Shen J, Suresh Y, Akopyan NA, Kapoor NS. Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy: Case report. International Journal of Surgery Case Reports. 2024;122:1-4$$$$$Y$$$20240813$$MD$US$US
242065931$24206593$1$I$$20240802$20240813$20240813$EXP$$JP-INSUD PHARMA-2408JP06334$INSUD PHARMA$Nagao S, Yabuuchi Y, Tanaka K, Morihisa Y, Kobayashi T, Akiyama S, Tanke G, Wada M, Morita S, Inoue S, Hobyung C, Yamashita D, Inokuma T. Multiple Gastric Neuroendocrine Tumors Associated with Long-term Use of a Proton Pump Inhibitor and a Potassium-competitive Acid Blocker. Intern Med. 2024;63:2001-2010$$$$$Y$$$20240813$$HP$JP$JP
242065941$24206594$1$I$$20240801$20240813$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-127668$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240813$$HP$CA$CA
242065951$24206595$1$I$20240617$20240618$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-009602$JAZZ$$68$YR$$F$Y$$$20240813$$MD$IT$IT
242065961$24206596$1$I$$20231213$20240813$20240813$PER$$DE-JAZZ PHARMACEUTICALS-2023-DE-024782$JAZZ$Witt M, Cichutek S, Michalowski N, Lund G, Wellbrock J, Bokemeyer C et al. Skin rash and myositis as severe side effects during CPX-351 treatment. Oncology Research and Treatment. 2023;46:264$$$$$Y$$$20240813$$HP$DE$DE
242065971$24206597$1$I$$20231018$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2023-US-021263$JAZZ$Shaikh AS, Almanza Huante E, Taherian M, Quesada AE, Jabbour EJ, Thirumurthi S, et al. Gastric Myeloid Sarcoma. ACG Case Reports Journal. 2023;10:9:1-6$68$YR$$F$Y$$$20240813$$HP$US$US
242065981$24206598$1$I$20240627$20240806$20240813$20240813$EXP$FR-AFSSAPS-GR2024000971$FR-RDY-SPO/FRA/24/0011547$DR REDDYS$$80$YR$E$F$Y$70$KG$20240813$$PH$FR$FR
242065991$24206599$1$I$20230301$20240807$20240813$20240813$EXP$DE-CADRBFARM-2024329756$DE-RDY-SPO/DEU/24/0011625$DR REDDYS$$28$YR$A$M$Y$86$KG$20240813$$CN$DE$DE
242066001$24206600$1$I$$20231213$20240813$20240813$PER$$DE-JAZZ PHARMACEUTICALS-2023-DE-024784$JAZZ$Witt M, Cichutek S, Michalowski N, Lund G, Wellbrock J, Bokemeyer C et al. Skin rash and myositis as severe side effects during CPX-351 treatment. Oncology Research and Treatment. 2023;46:264$$$$$Y$$$20240813$$HP$DE$DE
242066011$24206601$1$I$$20240228$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004094$JAZZ$Bennett J G, Gilmore D, Male H J, Byrd K P, Lin T L, Gonzalez Lugo J D, et al. Real World Outcomes with CPX 351 Induction in Adults with Newly Diagnosed Acute Myeloid Leukemia. Blood (2023) 142 Supplement 1 (5924). 2023;142:5924-5926$$$$$Y$$$20240813$$HP$US$US
242066021$24206602$1$I$$20240117$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-001008$JAZZ$Tianyu Yang, Nayyara Mahmood, Bradley Goldberg. Myeloid lymphoid neoplasm with a novel cryptic RBPMS. Leukemia and Lymphoma. 2023;64:2338-2342$58$YR$$M$Y$$$20240813$$HP$US$US
242066031$24206603$1$I$$20231108$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2023-US-022790$JAZZ$Milbar HC, Caplan A, Schwab RD, Coromilas AJ, Baumrin E, Forrestel A et al. Vitamin C deficiency in patients with acute myeloid leukemia a case series and review of the literature. Blood Advances. 2023;7:19:5780-5783$60$YR$$F$Y$$$20240813$$HP$US$US
242066043$24206604$3$F$20240407$20240918$20240813$20240923$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-008189$JAZZ$$$$$$Y$$$20240922$$MD$IT$IT
242066051$24206605$1$I$$20231108$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2023-US-022786$JAZZ$Milbar HC, Caplan A, Schwab RD, Coromilas AJ, Baumrin E, Forrestel A et al. Vitamin C deficiency in patients with acute myeloid leukemia a case series and review of the literature. Blood Advances. 2023;7:5780$57$YR$$F$Y$$$20240813$$HP$US$US
242066061$24206606$1$I$$20231115$20240813$20240813$PER$$NL-JAZZ PHARMACEUTICALS-2023-NL-023293$JAZZ$Shrestha B, Sharma Rijal S, Sherpa C, Leu J. Posaconazole induced Pseudohyperaldosteronism (PIPH) in Patient Treated for Acute Myeloid Leukemia. Journal of the Endocrine Society. 2022;6 (A720-A721):1-5$62$YR$$F$Y$$$20240813$$MD$NL$NL
242066071$24206607$1$I$$20240812$20240813$20240813$PER$$US-PURDUE PHARMA-USA-2024-0311304$PURDUE$$$$$F$Y$$$20240813$$CN$US$US
242066081$24206608$1$I$$20240810$20240813$20240813$PER$$US-PURDUE PHARMA-USA-2024-0311311$PURDUE$$$$$M$Y$$$20240813$$CN$US$US
242066091$24206609$1$I$$20240810$20240813$20240813$PER$$US-PURDUE PHARMA-USA-2024-0311312$PURDUE$$19$YR$$M$Y$$$20240813$$CN$US$US
242066101$24206610$1$I$20240401$20240810$20240813$20240813$PER$$US-PURDUE PHARMA-USA-2024-0311305$PURDUE$$20$YR$$M$Y$$$20240813$$CN$US$US
242066111$24206611$1$I$20240701$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125633$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$89.36$KG$20240813$$PH$US$US
242066121$24206612$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126997$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240813$$HP$US$US
242066131$24206613$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126982$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240813$$CN$US$US
242066141$24206614$1$I$20240730$20240810$20240813$20240813$EXP$$CN-AstraZeneca-2024A183067$ASTRAZENECA$$26082$DY$$F$Y$58$KG$20240813$$MD$CN$
242066161$24206616$1$I$$20240313$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004468$JAZZ$Martinelli M, Smith S, Levinson A, Michlitsch J, Agrawal A. Institutional experience using CPX-351 in children with relapsed/refractory myeloid malignancies$$$$$Y$$$20240813$$HP$US$US
242066181$24206618$1$I$$20240313$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004465$JAZZ$Martinelli M, Smith S, Levinson A, Michlitsch J, Agrawal A. Institutional experience using cpx 351 in children with relapsed refractory myeloid malignancies. 327$$$$$Y$$$20240813$$HP$US$US
242066191$24206619$1$I$$20240313$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004469$JAZZ$Martinelli M, Smith S, Levinson A, Michlitsch J, Agrawal A. Institutional experience using cpx 351 in children with relapsed refractory myeloid malignancies. 24$$$$$Y$$$20240813$$HP$US$US
242066201$24206620$1$I$$20240807$20240813$20240813$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012215$JAZZ$$$$$F$Y$$$20240813$$CN$US$US
242066211$24206621$1$I$$20240612$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009129$JAZZ$Madero Marroquin R, Dworkin E, Weiner H, Saygin C, Nawas M.T, Drazer M.W, et al. Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy. Leukemia and Lymphoma. 2024;65:864$$$$$Y$$$20240813$$HP$US$US
242066221$24206622$1$I$$20240313$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004470$JAZZ$Martinelli M, Smith S, Levinson A, Michlitsch J, Agrawal A. Institutional experience using cpx 351 in children with relapsed refractory myeloid malignancies. 024$$$$$Y$$$20240813$$HP$US$US
242066231$24206623$1$I$$20240313$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004466$JAZZ$Martinelli M, Smith S, Levinson A, Michlitsch J, Agrawal A. Institutional experience using cpx 351 in children with relapsed refractory myeloid malignancies. 24$$$$$Y$$$20240813$$HP$US$US
242066241$24206624$1$I$$20240313$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-004464$JAZZ$Martinelli M, Smith S, Levinson A, Michlitsch J, Agrawal A. Institutional experience using cpx 351 in children with relapsed refractory myeloid malignancies. 327$$$$$Y$$$20240813$$HP$US$US
242066252$24206625$2$F$$20240902$20240813$20240910$EXP$$GR-TEVA-VS-3230552$TEVA$$$$$F$Y$$$20240910$$MD$GR$GR
242066261$24206626$1$I$20240618$20240708$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010784$JAZZ$$7$DEC$$F$Y$$$20240813$$HP$JP$JP
242066271$24206627$1$I$$20240731$20240813$20240813$PER$$AU-JAZZ PHARMACEUTICALS-2024-AU-011624$JAZZ$$6$YR$$$Y$$$20240813$$HP$AU$AU
242066281$24206628$1$I$$20240801$20240813$20240813$PER$$FR-JAZZ PHARMACEUTICALS-2024-FR-011763$JAZZ$$$$$$Y$$$20240813$$MD$FR$FR
242066301$24206630$1$I$20240601$20240716$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-011202$JAZZ$$55$YR$$M$Y$$$20240813$$MD$JP$JP
242066311$24206631$1$I$20230616$20240129$20240813$20240813$PER$$ES-JAZZ PHARMACEUTICALS-2024-ES-001349$JAZZ$$65$YR$$M$Y$63.3$KG$20240813$$MD$ES$ES
242066322$24206632$2$F$$20240822$20240813$20240830$EXP$$DE-TEVA-VS-3231525$TEVA$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure 2023; 107 107-113.$$$A$F$Y$$$20240830$$MD$DE$DE
242066331$24206633$1$I$20240602$20240725$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-009092$JAZZ$$68$YR$$M$Y$$$20240813$$MD$JP$JP
242066341$24206634$1$I$20240625$20240716$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010272$JAZZ$$68$YR$$F$Y$$$20240813$$MD$JP$JP
242066351$24206635$1$I$$20240729$20240813$20240813$PER$$DE-JAZZ PHARMACEUTICALS-2024-DE-011471$JAZZ$$$$$$Y$$$20240813$$MD$DE$DE
242066364$24206636$4$F$20240703$20240902$20240813$20240917$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011270$JAZZ$$50$YR$$M$Y$$$20240917$$MD$JP$JP
242066371$24206637$1$I$20240620$20240805$20240813$20240813$EXP$SE-SEMPA-2024-005684$SE-TEVA-VS-3231109$TEVA$$79$YR$$M$Y$$$20240813$$MD$SE$SE
242066381$24206638$1$I$$20230810$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2023-IT-012544$JAZZ$$52$YR$$F$Y$$$20240813$$MD$IT$IT
242066391$24206639$1$I$$20230910$20240813$20240813$PER$$IL-JAZZ PHARMACEUTICALS-2023-IL-019184$JAZZ$$71$YR$$M$Y$$$20240813$$HP$IL$IL
242066401$24206640$1$I$20230718$20230814$20240813$20240813$PER$$FR-JAZZ PHARMACEUTICALS-2023-FR-017244$JAZZ$$$$$$Y$$$20240813$$PH$FR$FR
242066411$24206641$1$I$$20230928$20240813$20240813$PER$$GR-JAZZ PHARMACEUTICALS-2023-GR-020256$JAZZ$$35$YR$$M$Y$$$20240813$$MD$GR$GR
242066421$24206642$1$I$20230626$20230803$20240813$20240813$PER$$KR-JAZZ PHARMACEUTICALS-2023-KR-016545$JAZZ$$$$$$Y$$$20240813$$MD$KR$KR
242066431$24206643$1$I$$20230905$20240813$20240813$PER$$GB-JAZZ PHARMACEUTICALS-2023-GB-016989$JAZZ$$52$YR$$M$Y$97.2$KG$20240813$$PH$GB$DE
242066441$24206644$1$I$$20230920$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2023-US-019723$JAZZ$$$$$$Y$$$20240813$$MD$US$US
242066451$24206645$1$I$$20230825$20240813$20240813$PER$$GB-JAZZ PHARMACEUTICALS-2023-GB-018076$JAZZ$$$$$M$Y$$$20240813$$HP$GB$GB
242066461$24206646$1$I$20230216$20230808$20240813$20240813$PER$FR-AFSSAPS-PP2023000793$FR-JAZZ PHARMACEUTICALS-2023-FR-011223$JAZZ$$$$$$Y$$$20240813$$MD$FR$FR
242066471$24206647$1$I$20220629$20230824$20240813$20240813$PER$$PL-JAZZ PHARMACEUTICALS-2023-PL-018034$JAZZ$$63$YR$$M$Y$82$KG$20240813$$HP$PL$PL
242066481$24206648$1$I$$20231025$20240813$20240813$PER$$DE-JAZZ PHARMACEUTICALS-2023-DE-021875$JAZZ$$$$$F$Y$$$20240813$$MD$DE$DE
242066491$24206649$1$I$$20231002$20240813$20240813$PER$$GR-JAZZ PHARMACEUTICALS-2023-GR-020429$JAZZ$$49$YR$$M$Y$147$KG$20240813$$MD$GR$GR
242066501$24206650$1$I$$20231021$20240813$20240813$PER$$CA-JAZZ PHARMACEUTICALS-2023-CA-021510$JAZZ$$$$$$Y$$$20240813$$HP$CA$CA
242066511$24206651$1$I$$20231003$20240813$20240813$PER$$CA-JAZZ PHARMACEUTICALS-2023-CA-020437$JAZZ$$$$$$Y$$$20240813$$PH$CA$CA
242066521$24206652$1$I$$20231021$20240813$20240813$PER$$CA-JAZZ PHARMACEUTICALS-2023-CA-021511$JAZZ$$$$$$Y$$$20240813$$HP$CA$CA
242066531$24206653$1$I$$20231026$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2023-IT-021829$JAZZ$$8$YR$$M$Y$$$20240813$$MD$IT$IT
242066541$24206654$1$I$$20231017$20240813$20240813$PER$$GB-JAZZ PHARMACEUTICALS-2023-GB-021202$JAZZ$$54$YR$$M$Y$$$20240813$$MD$GB$GB
242066551$24206655$1$I$20231031$20231031$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2023-US-022067$JAZZ$$$$$M$Y$$$20240813$$MD$US$US
242066561$24206656$1$I$$20231002$20240813$20240813$PER$$GR-JAZZ PHARMACEUTICALS-2023-GR-011477$JAZZ$$71$YR$$M$Y$$$20240813$$MD$GR$GR
242066571$24206657$1$I$20211209$20231013$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2023-US-019724$JAZZ$$59$YR$$F$Y$$$20240813$$MD$US$US
242066581$24206658$1$I$20231018$20231031$20240813$20240813$PER$$PL-JAZZ PHARMACEUTICALS-2023-PL-024317$JAZZ$$57$YR$$M$Y$$$20240813$$HP$PL$PL
242066591$24206659$1$I$20231019$20231110$20240813$20240813$PER$IT-MINISAL02-953791$IT-JAZZ PHARMACEUTICALS-2023-IT-022849$JAZZ$$48$YR$$M$Y$$$20240813$$MD$IT$IT
242066601$24206660$1$I$20231101$20231109$20240813$20240813$PER$IT-MINISAL02-953494$IT-JAZZ PHARMACEUTICALS-2023-IT-022768$JAZZ$$19$YR$$F$Y$54$KG$20240813$$MD$IT$IT
242066611$24206661$1$I$20231030$20231117$20240813$20240813$PER$IT-MINISAL02-955042$IT-JAZZ PHARMACEUTICALS-2023-IT-023339$JAZZ$$62$YR$$F$Y$$$20240813$$PH$IT$IT
242066621$24206662$1$I$$20231101$20240813$20240813$PER$$IL-JAZZ PHARMACEUTICALS-2023-IL-022376$JAZZ$$70$YR$$F$Y$$$20240813$$MD$IL$IL
242066631$24206663$1$I$20230716$20231109$20240813$20240813$PER$IT-MINISAL02-953488$IT-JAZZ PHARMACEUTICALS-2023-IT-022803$JAZZ$$54$YR$$M$Y$113$KG$20240813$$MD$IT$IT
242066641$24206664$1$I$$20231105$20240813$20240813$PER$$IL-JAZZ PHARMACEUTICALS-2023-IL-022742$JAZZ$$72$YR$$M$Y$$$20240813$$MD$IL$IL
242066651$24206665$1$I$$20231123$20240813$20240813$PER$$FR-JAZZ PHARMACEUTICALS-2023-FR-021406$JAZZ$$$$$$Y$$$20240813$$MD$FR$FR
242066661$24206666$1$I$20231101$20231109$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2023-IT-022795$JAZZ$$63$YR$$M$Y$$$20240813$$MD$IT$IT
242066671$24206667$1$I$20231001$20231117$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2023-IT-023343$JAZZ$$64$YR$$M$Y$$$20240813$$HP$IT$IT
242066681$24206668$1$I$$20240809$20240813$20240813$EXP$$KR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044978$BOEHRINGER INGELHEIM$$$$$$Y$$$20240813$$MD$KR$KR
242066691$24206669$1$I$20231130$20231206$20240813$20240813$PER$$IL-JAZZ PHARMACEUTICALS-2023-IL-024460$JAZZ$$66$YR$$F$Y$$$20240813$$MD$IL$IL
242066701$24206670$1$I$20231125$20231129$20240813$20240813$PER$$KR-JAZZ PHARMACEUTICALS-2023-KR-023982$JAZZ$$$$$$Y$$$20240813$$MD$KR$KR
242066712$24206671$2$F$$20240926$20240813$20240926$PER$$NVSC2024US164137$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
242066721$24206672$1$I$20231120$20231127$20240813$20240813$PER$$BG-JAZZ PHARMACEUTICALS-2023-BG-023762$JAZZ$$69$YR$$F$Y$$$20240813$$MD$BG$BG
242066731$24206673$1$I$$20231127$20240813$20240813$PER$$CA-JAZZ PHARMACEUTICALS-2023-CA-023875$JAZZ$$$$$$Y$$$20240813$$PH$CA$CA
242066741$24206674$1$I$$20231205$20240813$20240813$PER$$KR-JAZZ PHARMACEUTICALS-2023-KR-024352$JAZZ$$$$$$Y$$$20240813$$MD$KR$KR
242066751$24206675$1$I$$20231126$20240813$20240813$PER$$IL-JAZZ PHARMACEUTICALS-2023-IL-023854$JAZZ$$56$YR$$F$Y$$$20240813$$MD$IL$IL
242066761$24206676$1$I$$20231205$20240813$20240813$PER$$KR-JAZZ PHARMACEUTICALS-2023-KR-024356$JAZZ$$$$$$Y$$$20240813$$MD$KR$KR
242066771$24206677$1$I$20240101$20240729$20240813$20240813$EXP$$US-TRIGEN LABORATORIES-2024ALO00382$Alora Pharma$$$$$F$Y$$$20240813$$CN$US$US
242066781$24206678$1$I$20240103$20240104$20240813$20240813$PER$$DE-JAZZ PHARMACEUTICALS-2024-DE-000283$JAZZ$$$$$$Y$$$20240813$$MD$DE$DE
242066791$24206679$1$I$$20231206$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2023-IT-024339$JAZZ$$$$$M$Y$12.7$KG$20240813$$PH$IT$IT
242066801$24206680$1$I$$20231214$20240813$20240813$PER$$CA-JAZZ PHARMACEUTICALS-2023-CA-024816$JAZZ$$67$YR$$F$Y$$$20240813$$MD$CA$CA
242066811$24206681$1$I$20240812$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007440$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240813$$CN$US$US
242066821$24206682$1$I$$20240111$20240813$20240813$PER$$GB-JAZZ PHARMACEUTICALS-2024-GB-000598$JAZZ$$62$YR$$M$Y$$$20240813$$CN$GB$GB
242066831$24206683$1$I$$20240219$20240813$20240813$PER$$HU-JAZZ PHARMACEUTICALS-2024-HU-002988$JAZZ$$$$$$Y$$$20240813$$HP$HU$HU
242066841$24206684$1$I$$20240125$20240813$20240813$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-001606$JAZZ$$$$$$Y$$$20240813$$MD$CA$CA
242066851$24206685$1$I$20230609$20240126$20240813$20240813$PER$ES-AEMPS-1478312$ES-JAZZ PHARMACEUTICALS-2024-ES-001530$JAZZ$$65$YR$$F$Y$63.3$KG$20240813$$MD$ES$ES
242066861$24206686$1$I$$20240123$20240813$20240813$PER$$GR-JAZZ PHARMACEUTICALS-2024-GR-001333$JAZZ$$62$YR$$F$Y$$$20240813$$MD$GR$GR
242066871$24206687$1$I$$20240208$20240813$20240813$PER$$DE-JAZZ PHARMACEUTICALS-2024-DE-002593$JAZZ$$$$$$Y$$$20240813$$PH$DE$DE
242066881$24206688$1$I$$20240215$20240813$20240813$PER$$CA-JAZZ PHARMACEUTICALS-2023-CA-021513$JAZZ$$$$$F$Y$$$20240813$$HP$CA$CA
242066891$24206689$1$I$20231204$20240208$20240813$20240813$PER$FR-AFSSAPS-DJ2024000196$FR-JAZZ PHARMACEUTICALS-2023-FR-025615$JAZZ$$$$$$Y$$$20240813$$MD$FR$FR
242066901$24206690$1$I$$20240112$20240813$20240813$PER$$DE-JAZZ PHARMACEUTICALS-2024-DE-000761$JAZZ$$$$$F$Y$$$20240813$$MD$DE$DE
242066911$24206691$1$I$$20240126$20240813$20240813$PER$$PL-JAZZ PHARMACEUTICALS-2024-PL-001772$JAZZ$$$$$F$Y$$$20240813$$HP$PL$PL
242066921$24206692$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126481$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240813$$HP$US$US
242066931$24206693$1$I$$20240806$20240813$20240813$EXP$$DE-TEVA-VS-3231107$TEVA$$$$$M$Y$$$20240813$$MD$DE$DE
242066941$24206694$1$I$$20240804$20240813$20240813$EXP$$US-AstraZeneca-2024A177408$ASTRAZENECA$$78$YR$$M$Y$$$20240813$$MD$US$
242066951$24206695$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127673$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$59.87$KG$20240813$$CN$US$US
242066961$24206696$1$I$$20240730$20240813$20240813$EXP$$AU-VER-202400001$VERITY PHARMACEUTICALS$$$$$M$Y$$$20240813$$MD$AU$AU
242066971$24206697$1$I$$20240813$20240813$20240813$EXP$$DE-WAYLIS-2024-DE-000105$Waylis$$$$$M$Y$$$20240813$$PH$DE$DE
242066981$24206698$1$I$20240117$20240402$20240813$20240813$PER$$BG-JAZZ PHARMACEUTICALS-2024-BG-005503$JAZZ$$39$YR$$F$Y$$$20240813$$MD$BG$BG
242066991$24206699$1$I$$20240306$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-003971$JAZZ$$65$YR$$M$Y$$$20240813$$MD$IT$IT
242067001$24206700$1$I$20240718$20240806$20240813$20240813$EXP$FR-AFSSAPS-LL2024001479$FR-TEVA-VS-3231211$TEVA$$56$YR$$M$Y$$$20240813$$MD$FR$FR
242067011$24206701$1$I$$20240304$20240813$20240813$PER$$CZ-JAZZ PHARMACEUTICALS-2024-CZ-003921$JAZZ$$$$$$Y$$$20240813$$MD$CZ$CZ
242067021$24206702$1$I$$20240328$20240813$20240813$PER$$AU-JAZZ PHARMACEUTICALS-2024-AU-005223$JAZZ$$6$YR$$$Y$$$20240813$$HP$AU$AU
242067031$24206703$1$I$20240222$20240318$20240813$20240813$PER$$FR-JAZZ PHARMACEUTICALS-2024-FR-004665$JAZZ$$$$$$Y$$$20240813$$PH$FR$FR
242067041$24206704$1$I$20240223$20240312$20240813$20240813$PER$IT-MINISAL02-974975$IT-JAZZ PHARMACEUTICALS-2024-IT-004368$JAZZ$$64$YR$$F$Y$$$20240813$$MD$IT$IT
242067051$24206705$1$I$$20240325$20240813$20240813$PER$$FR-JAZZ PHARMACEUTICALS-2023-FR-012977$JAZZ$$$$$$Y$$$20240813$$MD$FR$FR
242067061$24206706$1$I$$20240329$20240813$20240813$PER$$GR-JAZZ PHARMACEUTICALS-2024-GR-005338$JAZZ$$61$YR$$M$Y$$$20240813$$MD$GR$GR
242067071$24206707$1$I$20231002$20240225$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2023-IT-025038$JAZZ$$58$YR$$F$Y$$$20240813$$MD$IT$IT
242067081$24206708$1$I$$20240227$20240813$20240813$PER$$DE-JAZZ PHARMACEUTICALS-2024-DE-003754$JAZZ$$68$YR$$$Y$$$20240813$$HP$DE$DE
242067091$24206709$1$I$20240415$20240417$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006305$JAZZ$$$$$F$Y$$$20240813$$PH$US$US
242067101$24206710$1$I$$20240410$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-005921$JAZZ$$$$$$Y$$$20240813$$MD$US$US
242067111$24206711$1$I$$20240513$20240813$20240813$PER$$IL-JAZZ PHARMACEUTICALS-2024-IL-007677$JAZZ$$$$$M$Y$$$20240813$$MD$IL$IL
242067121$24206712$1$I$$20240423$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-006589$JAZZ$$52$YR$$M$Y$$$20240813$$MD$IT$IT
242067131$24206713$1$I$$20240513$20240813$20240813$PER$$PL-JAZZ PHARMACEUTICALS-2024-PL-007444$JAZZ$$72$YR$$F$Y$$$20240813$$HP$PL$PL
242067141$24206714$1$I$20240404$20240422$20240813$20240813$PER$IT-MINISAL02-981990$IT-JAZZ PHARMACEUTICALS-2024-IT-006457$JAZZ$$63$YR$$M$Y$$$20240813$$MD$IT$IT
242067151$24206715$1$I$$20240422$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-006439$JAZZ$$65$YR$$M$Y$$$20240813$$MD$US$US
242067161$24206716$1$I$$20240513$20240813$20240813$PER$$GB-JAZZ PHARMACEUTICALS-2024-GB-007435$JAZZ$$$$$M$Y$$$20240813$$MD$GB$GB
242067171$24206717$1$I$$20240508$20240813$20240813$PER$$KR-JAZZ PHARMACEUTICALS-2024-KR-007258$JAZZ$$$$$$Y$$$20240813$$MD$KR$KR
242067181$24206718$1$I$$20240604$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-008660$JAZZ$$70$YR$$M$Y$$$20240813$$MD$IT$IT
242067191$24206719$1$I$$20240423$20240813$20240813$PER$$IT-JAZZ PHARMACEUTICALS-2024-IT-006588$JAZZ$$57$YR$$M$Y$$$20240813$$MD$IT$IT
242067201$24206720$1$I$$20240812$20240813$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045153$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240813$$CN$US$US
242067211$24206721$1$I$20240607$20240610$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-009364$JAZZ$$73$YR$$M$Y$$$20240813$$MD$JP$JP
242067221$24206722$1$I$$20240610$20240813$20240813$PER$$US-JAZZ PHARMACEUTICALS-2024-US-008998$JAZZ$$$$$M$Y$$$20240813$$PH$US$US
242067231$24206723$1$I$$20240523$20240813$20240813$PER$$IL-JAZZ PHARMACEUTICALS-2024-IL-008122$JAZZ$$25$YR$$M$Y$$$20240813$$MD$IL$IL
242067241$24206724$1$I$$20240516$20240813$20240813$PER$$GR-JAZZ PHARMACEUTICALS-2024-GR-007617$JAZZ$$58$YR$$M$Y$$$20240813$$MD$GR$GR
242067251$24206725$1$I$$20240531$20240813$20240813$PER$$AU-JAZZ PHARMACEUTICALS-2024-AU-008401$JAZZ$$6$YR$$$Y$$$20240813$$HP$AU$AU
242067261$24206726$1$I$20240520$20240528$20240813$20240813$PER$$ES-JAZZ PHARMACEUTICALS-2024-ES-007801$JAZZ$$14$YR$$F$Y$$$20240813$$MD$ES$ES
242067271$24206727$1$I$$20240515$20240813$20240813$PER$$AT-JAZZ PHARMACEUTICALS-2024-AT-007780$JAZZ$$$$$$Y$$$20240813$$HP$AT$AT
242067281$24206728$1$I$20240605$20240611$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-009316$JAZZ$$52$YR$$M$Y$$$20240813$$MD$JP$JP
242067291$24206729$1$I$20240101$20240610$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-008924$JAZZ$$70$YR$$M$Y$$$20240813$$HP$JP$JP
242067301$24206730$1$I$20240801$20240808$20240813$20240813$EXP$$AU-ABBVIE-5874864$ABBVIE$$90$YR$$M$Y$$$20240813$$HP$AU$AU
242067311$24206731$1$I$$20240611$20240813$20240813$PER$$AT-JAZZ PHARMACEUTICALS-2024-AT-008174$JAZZ$$77$YR$$F$Y$$$20240813$$MD$AT$AT
242067321$24206732$1$I$$20240624$20240813$20240813$PER$$DE-JAZZ PHARMACEUTICALS-2024-DE-003920$JAZZ$$$$$$Y$$$20240813$$HP$DE$DE
242067332$24206733$2$F$20240101$20240913$20240813$20240920$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010141$JAZZ$$$$$$Y$$$20240920$$MD$JP$JP
242067341$24206734$1$I$$20240701$20240813$20240813$PER$$DE-JAZZ PHARMACEUTICALS-2024-DE-002311$JAZZ$$$$$M$Y$$$20240813$$HP$DE$DE
242067351$24206735$1$I$20240629$20240702$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010304$JAZZ$$49$YR$$F$Y$$$20240813$$MD$JP$JP
242067361$24206736$1$I$$20240801$20240813$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122230$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240813$$HP$CA$CA
242067371$24206737$1$I$20240621$20240621$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010015$JAZZ$$73$YR$$M$Y$$$20240813$$HP$JP$JP
242067381$24206738$1$I$20240528$20240702$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-009601$JAZZ$$$$$$Y$$$20240813$$HP$JP$JP
242067391$24206739$1$I$20240101$20240702$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010471$JAZZ$$$$$M$Y$$$20240813$$MD$JP$JP
242067401$24206740$1$I$20240616$20240625$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010208$JAZZ$$76$YR$$F$Y$$$20240813$$MD$JP$JP
242067411$24206741$1$I$20240601$20240701$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010361$JAZZ$$$$$M$Y$$$20240813$$MD$JP$JP
242067421$24206742$1$I$20240101$20240808$20240813$20240813$EXP$$GB-ABBVIE-5875816$ABBVIE$$$$E$F$Y$$$20240813$$CN$GB$GB
242067431$24206743$1$I$$20240622$20240813$20240813$PER$$US-LUNDBECK-DKLU4001078$LUNDBECK$$$$$$Y$$$20240813$$HP$US$US
242067441$24206744$1$I$20240101$20240808$20240813$20240813$EXP$$CA-ABBVIE-5875951$ABBVIE$$18$YR$$M$Y$$$20240813$$CN$CA$CA
242067452$24206745$2$F$20240101$20240805$20240813$20240814$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010561$JAZZ$$$$A$M$Y$$$20240814$$MD$JP$JP
242067461$24206746$1$I$20240625$20240708$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010786$JAZZ$$$$$$Y$$$20240813$$MD$JP$JP
242067472$24206747$2$F$20240705$20240805$20240813$20240814$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-010876$JAZZ$$72$YR$$M$Y$$$20240814$$PH$JP$JP
242067481$24206748$1$I$20240618$20240708$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010788$JAZZ$$70$YR$$$Y$$$20240813$$MD$JP$JP
242067491$24206749$1$I$20240613$20240703$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010207$JAZZ$$60$YR$$M$Y$$$20240813$$MD$JP$JP
242067501$24206750$1$I$20240625$20240708$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010785$JAZZ$$$$$$Y$$$20240813$$MD$JP$JP
242067511$24206751$1$I$20240701$20240708$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010794$JAZZ$$$$$$Y$$$20240813$$MD$JP$JP
242067521$24206752$1$I$20240606$20240709$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-009598$JAZZ$$77$YR$$M$Y$$$20240813$$MD$JP$JP
242067531$24206753$1$I$20240101$20240703$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-009310$JAZZ$$50$YR$$M$Y$$$20240813$$MD$JP$JP
242067541$24206754$1$I$20240702$20240708$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010789$JAZZ$$76$YR$$M$Y$$$20240813$$MD$JP$JP
242067551$24206755$1$I$20240101$20240805$20240813$20240813$PER$$US-009507513-2408USA001734$MERCK$$$$$M$Y$$$20240813$$CN$US$US
242067561$24206756$1$I$20240101$20240711$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010997$JAZZ$$74$YR$$F$Y$$$20240813$$MD$JP$JP
242067571$24206757$1$I$20240713$20240718$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-011345$JAZZ$$$$A$$Y$$$20240813$$MD$JP$JP
242067581$24206758$1$I$20240624$20240719$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-011340$JAZZ$$58$YR$$M$Y$$$20240813$$MD$JP$JP
242067591$24206759$1$I$$20240715$20240813$20240813$PER$$AU-JAZZ PHARMACEUTICALS-2024-AU-010727$JAZZ$$$$$$Y$$$20240813$$PH$AU$AU
242067601$24206760$1$I$20240710$20240717$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-011201$JAZZ$$6$DEC$$$Y$$$20240813$$MD$JP$JP
242067611$24206761$1$I$20240101$20240717$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-011282$JAZZ$$58$YR$$M$Y$$$20240813$$MD$JP$JP
242067631$24206763$1$I$20240713$20240718$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-011268$JAZZ$$72$YR$$M$Y$$$20240813$$PH$JP$JP
242067641$24206764$1$I$20240708$20240709$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010878$JAZZ$$60$YR$$M$Y$$$20240813$$MD$JP$JP
242067651$24206765$1$I$20240627$20240709$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010621$JAZZ$$70$YR$$F$Y$$$20240813$$MD$JP$JP
242067661$24206766$1$I$$20240806$20240813$20240813$EXP$$GR-TEVA-VS-3231121$TEVA$$$$$F$Y$$$20240813$$MD$GR$GR
242067671$24206767$1$I$$20240809$20240813$20240813$EXP$$CA-PFIZER INC-202400235775$PFIZER$$89$YR$$F$Y$$$20240813$$CN$CA$CA
242067681$24206768$1$I$20240713$20240723$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-011344$JAZZ$$73$YR$$M$Y$$$20240813$$MD$JP$JP
242067692$24206769$2$F$$20240820$20240813$20240828$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011645$JAZZ$$68$YR$$M$Y$$$20240828$$MD$JP$JP
242067702$24206770$2$F$$20240807$20240813$20240815$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011505$JAZZ$$75$YR$$M$Y$$$20240815$$HP$JP$JP
242067712$24206771$2$F$20240721$20240910$20240813$20240918$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011579$JAZZ$$$$$F$Y$$$20240918$$PH$JP$JP
242067721$24206772$1$I$20240721$20240726$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-011728$JAZZ$$64$YR$$M$Y$$$20240813$$MD$JP$JP
242067731$24206773$1$I$20240715$20240726$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-011642$JAZZ$$72$YR$$M$Y$$$20240813$$MD$JP$JP
242067741$24206774$1$I$20240721$20240725$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-011644$JAZZ$$63$YR$$M$Y$$$20240813$$MD$JP$JP
242067752$24206775$2$F$20240717$20240828$20240813$20240905$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011580$JAZZ$$64$YR$$M$Y$$$20240905$$MD$JP$JP
242067761$24206776$1$I$$20240726$20240813$20240813$PER$$ES-JAZZ PHARMACEUTICALS-2024-ES-011525$JAZZ$$$$A$F$Y$$$20240813$$HP$ES$ES
242067771$24206777$1$I$20240701$20240725$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-010556$JAZZ$$71$YR$$M$Y$$$20240813$$MD$JP$JP
242067782$24206778$2$F$20240101$20240917$20240813$20240926$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-011861$JAZZ$$73$YR$$$Y$$$20240926$$MD$JP$JP
242067791$24206779$1$I$20240731$20240802$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-012260$JAZZ$$$$$M$Y$$$20240813$$MD$JP$JP
242067801$24206780$1$I$20240720$20240729$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-011946$JAZZ$$60$YR$$$Y$$$20240813$$MD$JP$JP
242067811$24206781$1$I$20240616$20240802$20240813$20240813$PER$$RO-JAZZ PHARMACEUTICALS-2024-RO-010325$JAZZ$$54$YR$$F$Y$$$20240813$$HP$RO$RO
242067821$24206782$1$I$$20240730$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-012047$JAZZ$$$$$$Y$$$20240813$$HP$JP$JP
242067833$24206783$3$F$20240715$20240902$20240813$20240910$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-012284$JAZZ$$67$YR$$F$Y$$$20240910$$MD$JP$JP
242067841$24206784$1$I$20240805$20240801$20240813$20240813$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-012203$JAZZ$$71$YR$$M$Y$$$20240813$$MD$JP$JP
242067851$24206785$1$I$20240701$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006272$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240813$$CN$US$US
242067862$24206786$2$F$20240621$20240809$20240813$20240830$EXP$$US-009507513-2407USA004368$MERCK$$60$YR$$F$Y$75.6$KG$20240830$$MD$US$US
242067871$24206787$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007004$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240813$$CN$US$US
242067881$24206788$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007916$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240813$$CN$US$US
242067892$24206789$2$F$$20240819$20240813$20240826$EXP$$US-TEVA-VS-3230628$TEVA$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D. Rhabdomyolysis Risk: The Dangers of Tribulus Terrestris, an Over-the-Counter Supplement. Am-J-Case-Rep 2024; 25 (0): e943492.; Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D. Rhabdomyolysis Risk: The Dangers of Tribulus Terrestris, an Over-the-Counter Supplement. Am-J-Case-Rep 2024; 25 (0): e943492.$71$YR$$M$Y$$$20240826$$HP$US$US
242067903$24206790$3$F$$20240914$20240813$20240916$30DAY$$CA-PFIZER INC-202400231283$PFIZER$$11$YR$$M$Y$$$20240916$$HP$CA$CA
242067912$24206791$2$F$20240803$20240820$20240813$20240822$PER$$NVSC2024US164140$NOVARTIS$$40$YR$$F$Y$$$20240822$$PH$US$US
242067923$24206792$3$F$$20240815$20240813$20240822$PER$$NVSC2024US164160$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
242067931$24206793$1$I$$20240809$20240813$20240813$EXP$$ES-TAKEDA-2024TUS081088$TAKEDA$$$$$F$Y$$$20240813$$MD$ES$ES
242067941$24206794$1$I$$20240808$20240813$20240813$PER$$US-BIOGEN-2024BI01277715$BIOGEN$$$$$F$Y$$$20240813$$CN$US$US
242067951$24206795$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127840$BRISTOL MYERS SQUIBB$$64$YR$$F$Y$$$20240813$$CN$US$US
242067961$24206796$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127657$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240813$$CN$US$US
242067971$24206797$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128027$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$69.85$KG$20240813$$CN$US$US
242067981$24206798$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127648$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240813$$CN$US$US
242067991$24206799$1$I$$20240730$20240813$20240813$EXP$$US-HLS-202400630$HLS THERAPEUTICS$$$$A$$Y$$$20240813$$HP$US$US
242068021$24206802$1$I$20240805$20240812$20240813$20240813$PER$$NVSC2024US164447$NOVARTIS$$30$YR$$M$Y$$$20240813$$MD$US$US
242068031$24206803$1$I$$20240813$20240813$20240813$PER$$NVSC2024US164282$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242068041$24206804$1$I$20240630$20240801$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045471$BOEHRINGER INGELHEIM$$55$YR$A$F$Y$$$20240813$$CN$US$US
242068051$24206805$1$I$20240806$20240810$20240813$20240813$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-127043$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240813$$CN$PR$PR
242068061$24206806$1$I$$20240729$20240813$20240813$PER$$US-TEVA-VS-3228676$TEVA$$66$YR$$M$Y$$$20240813$$HP$US$US
242068073$24206807$3$F$$20240816$20240813$20240823$PER$$US-ALXN-202408USA000415US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242068081$24206808$1$I$20240701$20240725$20240813$20240813$PER$$US-INSUD PHARMA-2407US06015$INSUD PHARMA$$$$$$Y$$$20240813$$CN$US$US
242068091$24206809$1$I$20240727$20240731$20240813$20240813$PER$$US-INSUD PHARMA-2407US06137$INSUD PHARMA$$$$$F$Y$$$20240813$$CN$US$US
242068101$24206810$1$I$20240629$20240801$20240813$20240813$PER$$US-INSUD PHARMA-2408US06203$INSUD PHARMA$$$$$$Y$$$20240813$$CN$US$US
242068111$24206811$1$I$20240701$20240729$20240813$20240813$PER$$US-INSUD PHARMA-2407US06089$INSUD PHARMA$$$$$$Y$$$20240813$$CN$US$US
242068121$24206812$1$I$20240101$20240802$20240813$20240813$PER$$US-INSUD PHARMA-2408US06204$INSUD PHARMA$$$$$$Y$$$20240813$$CN$US$US
242068131$24206813$1$I$20240701$20240729$20240813$20240813$PER$$US-INSUD PHARMA-2407US06136$INSUD PHARMA$$$$$$Y$$$20240813$$CN$US$US
242068141$24206814$1$I$20230101$20240729$20240813$20240813$PER$$US-INSUD PHARMA-2407US06133$INSUD PHARMA$$$$$$Y$$$20240813$$CN$US$US
242068151$24206815$1$I$$20240725$20240813$20240813$PER$$US-INSUD PHARMA-2407US06008$INSUD PHARMA$$$$$$Y$$$20240813$$CN$US$US
242068161$24206816$1$I$20240701$20240729$20240813$20240813$PER$$US-INSUD PHARMA-2407US06134$INSUD PHARMA$$$$$F$Y$$$20240813$$CN$US$US
242068181$24206818$1$I$$20240809$20240813$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045036$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240813$$CN$US$US
242068191$24206819$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126885$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240813$$HP$US$US
242068201$24206820$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126789$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240813$$HP$US$US
242068211$24206821$1$I$$20240806$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125760$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240813$$HP$US$US
242068221$24206822$1$I$20240728$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126233$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$82.55$KG$20240813$$CN$US$US
242068231$24206823$1$I$20240730$20240730$20240813$20240813$PER$$US-009507513-2407USA015876$MERCK$$65$YR$$M$Y$$$20240813$$CN$US$US
242068241$24206824$1$I$$20240805$20240813$20240813$EXP$$US-ANIPHARMA-2024-US-042127$ANI$$$$$F$Y$92.53$KG$20240813$$CN$US$US
242068252$24206825$2$F$20230101$20240829$20240813$20240906$EXP$$JP-RADIUS HEALTH, INC.-2023JP004733$RADIUS PHARM$$76$YR$$F$Y$$$20240906$$CN$JP$JP
242068271$24206827$1$I$20240728$20240730$20240813$20240813$EXP$$CA-HLS-202401900$HLS THERAPEUTICS$$60$YR$A$M$Y$$$20240813$$HP$CA$CA
242068282$24206828$2$F$20240531$20240806$20240813$20240827$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-009099$JAZZ$$$$$M$Y$$$20240827$$MD$JP$JP
242068302$24206830$2$F$20240801$20240809$20240813$20240820$EXP$$KR-JAZZ PHARMACEUTICALS-2024-KR-012475$JAZZ$$68$YR$$M$Y$62.8$KG$20240820$$MD$KR$KR
242068311$24206831$1$I$20200122$20240808$20240813$20240813$PER$$US-009507513-2001USA009716$MERCK$$57$YR$$F$Y$63.8$KG$20240813$$MD$US$US
242068321$24206832$1$I$$20230912$20240813$20240813$EXP$$US-AstraZeneca-2023A175799$ASTRAZENECA$$$$$M$Y$$$20240813$$CN$US$
242068331$24206833$1$I$$20240715$20240813$20240813$PER$$US-LEX-000400$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240813$$CN$US$US
242068341$24206834$1$I$20240812$20240812$20240813$20240813$PER$$NVSC2024US164423$NOVARTIS$$63$YR$$F$Y$59$KG$20240813$$CN$US$US
242068351$24206835$1$I$$20240809$20240813$20240813$EXP$$ID-ANIPHARMA-2024-ID-000012$ANI$Putri Hazlianda C, Ridlo M.Acute generalized exanthematous pustulosis suspected induced by cefadroxil after receiving the vaccine Covid-19: A case report..Journal of Pakistan Association of Dermatologists.2024;34(3):785-789.$31$YR$$M$Y$$$20240813$$HP$ID$ID
242068361$24206836$1$I$20230101$20240731$20240813$20240813$PER$$US-009507513-2408USA001068$MERCK$$$$$$Y$$$20240813$$CN$US$US
242068371$24206837$1$I$20240701$20240730$20240813$20240813$PER$$US-INSUD PHARMA-2407US06128$INSUD PHARMA$$$$$$Y$$$20240813$$CN$US$US
242068382$24206838$2$F$20240701$20240923$20240813$20240925$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045551$BOEHRINGER INGELHEIM$$61$YR$A$F$Y$$$20240925$$CN$US$US
242068391$24206839$1$I$$20240812$20240813$20240813$PER$$NVSC2024US164421$NOVARTIS$$$$$$Y$$$20240813$$CN$US$US
242068401$24206840$1$I$20231122$20240809$20240813$20240813$EXP$$US-TAKEDA-2023TUS096236$TAKEDA$$6$YR$$M$Y$$$20240813$$HP$US$US
242068422$24206842$2$F$$20240919$20240813$20240921$PER$$US-HALEON-2191715$Haleon PLC$$$$E$F$Y$$$20240921$$CN$US$US
242068431$24206843$1$I$20240812$20240812$20240813$20240813$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045529$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$72$KG$20240813$$HP$CO$CO
242068471$24206847$1$I$20240601$20240808$20240813$20240813$EXP$$US-009507513-2408USA003147$MERCK$$71$YR$$F$Y$$$20240813$$HP$US$US
242068481$24206848$1$I$20240401$20240807$20240813$20240813$PER$$JP-Eisai-EC-2024-171985$EISAI$$71$YR$E$M$Y$$$20240813$$MD$JP$JP
242068491$24206849$1$I$$20240808$20240813$20240813$PER$$US-AMGEN-USASP2024158479$AMGEN$$$$$$Y$$$20240813$$HP$US$US
242068501$24206850$1$I$20240701$20240715$20240813$20240813$PER$$US-PFIZER INC-PV202400105300$PFIZER$$17$YR$$M$Y$$$20240813$$MD$US$US
242068531$24206853$1$I$20240801$20240807$20240813$20240813$PER$$US-AMGEN-USASP2024158237$AMGEN$$74$YR$E$M$Y$$$20240813$$PH$US$US
242068541$24206854$1$I$20240729$20240809$20240813$20240813$EXP$$JP-009507513-2408JPN000211J$MERCK$$$$$M$Y$$$20240813$$MD$JP$JP
242068551$24206855$1$I$20240729$20240808$20240813$20240813$EXP$$BR-JNJFOC-20240832807$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$BR$BR
242068561$24206856$1$I$$20240807$20240813$20240813$PER$$US-JNJFOC-20240818551$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240813$$MD$US$US
242068581$24206858$1$I$$20240807$20240813$20240813$PER$$US-JNJFOC-20240818457$JOHNSON AND JOHNSON$$$$$F$Y$$$20240813$$CN$US$US
242068602$24206860$2$F$$20240812$20240813$20240816$EXP$$US-AstraZeneca-2024A183303$ASTRAZENECA$$$$$M$Y$$$20240816$$HP$US$
242068612$24206861$2$F$$20240917$20240813$20240918$PER$$US-AstraZeneca-2024A184065$ASTRAZENECA$$$$$$Y$$$20240918$$MD$US$
242068622$24206862$2$F$$20240806$20240813$20240822$EXP$$CA-GILEAD-2021-0562670$GILEAD$$74$YR$E$F$Y$$$20240822$$HP$CA$CA
242068641$24206864$1$I$20240731$20240731$20240813$20240813$EXP$GB-MHRA-MED-202407311608552530-MTDNG$GB-ELI_LILLY_AND_COMPANY-GB202408000596$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240813$$CN$GB$GB
242068651$24206865$1$I$$20240801$20240813$20240813$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408001324$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240813$$PH$FR$FR
242068661$24206866$1$I$20200101$20240801$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001792$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240813$$CN$US$US
242068671$24206867$1$I$$20240808$20240813$20240813$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202408005689$ELI LILLY AND CO$$30$YR$A$M$Y$$$20240813$$MD$SA$SA
242068681$24206868$1$I$$20240801$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001481$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240813$$CN$US$US
242068692$24206869$2$F$$20240816$20240813$20240826$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408004251$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$CN$CN
242068702$24206870$2$F$20120101$20240918$20240813$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001774$ELI LILLY AND CO$$$$A$F$Y$$$20240930$$CN$US$US
242068711$24206871$1$I$$20240805$20240813$20240813$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407017954$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240813$$CN$JP$JP
242068721$24206872$1$I$$20240801$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001317$ELI LILLY AND CO$$61$YR$A$$Y$$$20240813$$LW$US$US
242068731$24206873$1$I$$20240801$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001291$ELI LILLY AND CO$$58$YR$A$$Y$$$20240813$$LW$US$US
242068741$24206874$1$I$20240614$20240801$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002102$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240813$$CN$US$US
242068751$24206875$1$I$$20240801$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001338$ELI LILLY AND CO$$58$YR$A$$Y$$$20240813$$CN$US$US
242068761$24206876$1$I$$20240801$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002938$ELI LILLY AND CO$$$$$M$Y$$$20240813$$HP$US$US
242068771$24206877$1$I$$20240801$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001274$ELI LILLY AND CO$$69$YR$E$$Y$$$20240813$$LW$US$US
242068782$24206878$2$F$20240801$20240806$20240813$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002335$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240816$$CN$US$US
242068792$24206879$2$F$20240801$20240821$20240813$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001406$ELI LILLY AND CO$$$$$F$Y$69.4$KG$20240830$$CN$US$US
242068801$24206880$1$I$20240724$20240801$20240813$20240813$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408001639$ELI LILLY AND CO$$38$YR$A$F$Y$49$KG$20240813$$CN$CN$CN
242068811$24206881$1$I$$20240731$20240813$20240813$EXP$GB-MHRA-MED-202407311936388570-ZBFMD$GB-ELI_LILLY_AND_COMPANY-GB202408000616$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$GB$GB
242068821$24206882$1$I$20240716$20240801$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001539$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240813$$CN$US$US
242068831$24206883$1$I$$20240802$20240813$20240813$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002100$ELI LILLY AND CO$$64$YR$A$$Y$$$20240813$$LW$US$US
242068842$24206884$2$F$20240101$20240906$20240813$20240910$PER$$US-009507513-2408USA001249$MERCK$$$$$F$Y$68.481$KG$20240910$$HP$US$US
242068861$24206886$1$I$$20240729$20240813$20240813$EXP$$US-009507513-2407USA015494$MERCK$$$$$M$Y$$$20240813$$CN$US$US
242068871$24206887$1$I$20240722$20240812$20240813$20240813$EXP$$US-TAKEDA-2024TUS020450$TAKEDA$$91$YR$$F$Y$$$20240813$$HP$US$US
242068891$24206889$1$I$20240806$20240807$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045432$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240813$$CN$US$US
242068902$24206890$2$F$20240720$20240813$20240813$20240814$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045559$BOEHRINGER INGELHEIM$$55$YR$A$M$Y$60$KG$20240814$$HP$CO$CO
242068911$24206891$1$I$$20240813$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045546$BOEHRINGER INGELHEIM$$74$HR$N$M$Y$$$20240813$$CN$US$US
242068942$24206894$2$F$20240423$20240826$20240813$20240906$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07714$NEUROCRINE BIOSCIENCES$$63$YR$$M$Y$$$20240906$$MD$US$US
242068951$24206895$1$I$20230101$20240806$20240813$20240813$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07890$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240813$$MD$US$US
242068962$24206896$2$F$$20240802$20240813$20240819$EXP$$ES-APELLIS-2024-APL-0000680$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240819$$MD$ES$ES
242068971$24206897$1$I$$20240808$20240813$20240813$PER$$US-JNJFOC-20240829366$JOHNSON AND JOHNSON$$54$YR$A$F$Y$47.6$KG$20240813$$CN$US$US
242068981$24206898$1$I$$20240731$20240813$20240813$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07671$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240813$$HP$US$US
242068991$24206899$1$I$$20240730$20240813$20240813$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07673$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240813$$HP$US$US
242069001$24206900$1$I$20240809$20240812$20240813$20240813$PER$$NVSC2024US164285$NOVARTIS$$22$YR$$F$Y$$$20240814$$PH$US$US
242069012$24206901$2$F$$20240805$20240813$20240825$EXP$$JP-009507513-2408JPN000608J$MERCK$Sogabe H, Soumiya K, Asai S, Shinomori K, Kuwano H, Yoshida O. 1 Two Cases of Liver Disorder Developed during Pembrolizumab-Lenvatinib Combination Therapy for Advanced Renal Cell Carcinoma - irAE or not. The 114th Shikoku Regional Meeting of the Japanese Urological Association. 33$56$YR$$M$Y$$$20240824$$HP$JP$JP
242069022$24206902$2$F$$20240814$20240813$20240820$EXP$$US-ABBVIE-5848544$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242069031$24206903$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5876106$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242069041$24206904$1$I$20240802$20240809$20240813$20240813$EXP$$US-ABBVIE-5875780$ABBVIE$$82$YR$$F$Y$$$20240813$$CN$US$US
242069051$24206905$1$I$$20240807$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005367$ELI LILLY AND CO$$$$$$Y$181.41$KG$20240813$$HP$US$US
242069061$24206906$1$I$20240806$20240806$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408005365$ELI LILLY AND CO$$$$A$F$Y$$$20240813$$CN$US$US
242069072$24206907$2$F$$20240814$20240813$20240821$EXP$$US-APELLIS-APL-2023-002378$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240821$$CN$US$US
242069091$24206909$1$I$$20240723$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN007730$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242069101$24206910$1$I$$20240801$20240813$20240813$PER$$US-INCYTE CORPORATION-2024IN008114$INCYTE$$$$$$Y$$$20240813$$CN$US$US
242069114$24206911$4$F$20240101$20240912$20240813$20240918$EXP$$US-INCYTE CORPORATION-2024IN008025$INCYTE$$$$$$Y$$$20240918$$MD$US$US
242069121$24206912$1$I$$20240813$20240813$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045555$BOEHRINGER INGELHEIM$$6$DEC$A$$Y$$$20240814$$HP$US$US
242069131$24206913$1$I$$20240809$20240813$20240813$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-127185$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240814$$HP$TW$TW
242069141$24206914$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408008030$ELI LILLY AND CO$$$$$$Y$$$20240813$$PH$US$US
242069151$24206915$1$I$20230101$20240806$20240813$20240813$EXP$$US-APELLIS-APL-2023-003342$APELLIS PHARMACEUTICALS$$$$$$Y$36.6$KG$20240813$$MD$US$US
242069161$24206916$1$I$20240810$20240813$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045584$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240814$$CN$US$US
242069171$24206917$1$I$$20240813$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045566$BOEHRINGER INGELHEIM$$$$$$Y$$$20240814$$CN$US$US
242069181$24206918$1$I$20240701$20240803$20240813$20240813$PER$$US-Millicent Holdings Ltd.-MILL20241089$MILLICENT HOLDINGS$$55$YR$A$F$Y$$$20240814$$CN$US$US
242069191$24206919$1$I$$20240807$20240813$20240813$EXP$$IT-Bion-013645$BIONPHARMA$$74$YR$E$M$Y$$$20240814$$HP$IT$IT
242069201$24206920$1$I$$20240807$20240813$20240813$EXP$$CN-Bion-013646$BIONPHARMA$$64$YR$A$M$Y$$$20240814$$HP$CN$CN
242069212$24206921$2$F$20240806$20240904$20240813$20240911$PER$$US-BIOMARINAP-US-2024-159707$BIOMARIN$$$$$$Y$$$20240911$$CN$US$US
242069221$24206922$1$I$20220531$20240807$20240813$20240813$EXP$$BR-JNJFOC-20240820867$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240814$$MD$BR$BR
242069231$24206923$1$I$$20240807$20240813$20240813$EXP$$US-Bion-013654$BIONPHARMA$$$$A$$Y$$$20240814$$HP$US$US
242069241$24206924$1$I$$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126865$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240814$$CN$US$US
242069251$24206925$1$I$$20240807$20240813$20240813$EXP$$US-Bion-013657$BIONPHARMA$$$$A$$Y$$$20240814$$HP$US$US
242069261$24206926$1$I$$20240807$20240813$20240813$EXP$$US-Bion-013651$BIONPHARMA$$33$YR$A$M$Y$$$20240814$$HP$US$US
242069271$24206927$1$I$$20240808$20240813$20240813$EXP$$JP-BIOMARINAP-JP-2024-159767$BIOMARIN$$$$$$Y$$$20240813$$CN$JP$JP
242069283$24206928$3$F$$20240808$20240813$20240815$PER$$US-JAZZ PHARMACEUTICALS-2024-US-012173$JAZZ$$$$$M$Y$24.5$KG$20240815$$CN$US$US
242069291$24206929$1$I$20240701$20240808$20240813$20240813$EXP$$US-ABBVIE-5875421$ABBVIE$$22$YR$$F$Y$$$20240813$$CN$US$US
242069311$24206931$1$I$$20240813$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045558$BOEHRINGER INGELHEIM$$$$$$Y$$$20240814$$CN$US$US
242069321$24206932$1$I$20240725$20240813$20240813$20240813$EXP$$UA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043729$BOEHRINGER INGELHEIM$$$$$M$Y$80$KG$20240814$$MD$UA$UA
242069332$24206933$2$F$20220101$20240913$20240813$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127793$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240918$$CN$US$US
242069341$24206934$1$I$$20240813$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045541$BOEHRINGER INGELHEIM$$$$$$Y$$$20240814$$HP$US$US
242069351$24206935$1$I$20240801$20240808$20240813$20240813$EXP$$CO-BIOMARINAP-CO-2024-159802$BIOMARIN$$$$$$Y$$$20240813$$CN$CO$CO
242069362$24206936$2$F$$20240808$20240813$20240814$PER$$US-JNJFOC-20240823367$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242069371$24206937$1$I$20240101$20240807$20240813$20240813$PER$$US-AMGEN-USASP2024159436$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242069381$24206938$1$I$$20240806$20240813$20240813$PER$$US-BIOMARINAP-US-2024-159689$BIOMARIN$$$$$$Y$$$20240813$$CN$US$US
242069391$24206939$1$I$20240606$20240807$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125729$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240814$$PH$US$US
242069401$24206940$1$I$20231025$20240806$20240813$20240813$EXP$FR-AFSSAPS-AM2024000563$FR-ROCHE-10000051053$ROCHE$$64$YR$A$M$Y$85$KG$20240814$$MD$FR$FR
242069411$24206941$1$I$$20240807$20240813$20240813$EXP$$ES-ABBVIE-5872937$ABBVIE$Serrano-Combarro A, Atienza-Mateo B, Loarce-Martos J, DEL Olmo Perez L, Garc?a-Perez S, Gonz?lez-Mozo G, et al. upadacitinib and other jak inhibitors in the treatment of rheumatoid arthritis-interstitial lung disease. National multicenter study of clinical practice. In: Scientific Abstracts. BMJ Publishing Group Ltd and European League Against Rheumatism; 2024.1529-1530.$$$$$Y$$$20240813$$HP$ES$ES
242069421$24206942$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126043$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240814$$HP$US$US
242069431$24206943$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159036$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242069441$24206944$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127961$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240814$$HP$US$US
242069452$24206945$2$F$$20240805$20240813$20240823$EXP$$CN-AMGEN-CHNNI2024159030$AMGEN$He R., Li L., Han C., An W., Liu Z., Gao J.. Effect of the combined use of ivabradine and metoprolol in patients with acute myocardial infarction early after percutaneous coronary intervention: A randomized controlled study. Heliyon. 2024;doi:10.1016/j.heliyon.2024.e33779$$$$$Y$$$20240822$$MD$CN$CN
242069461$24206946$1$I$$20240811$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007429$ELI LILLY AND CO$$55$YR$A$$Y$$$20240813$$HP$US$US
242069472$24206947$2$F$20240617$20240808$20240813$20240816$EXP$$FR-JNJFOC-20240657319$JOHNSON AND JOHNSON$$56$YR$A$F$Y$65$KG$20240816$$HP$FR$FR
242069481$24206948$1$I$20240528$20240805$20240813$20240813$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125891$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$55.8$KG$20240814$$PH$JP$JP
242069491$24206949$1$I$$20240808$20240813$20240813$PER$$US-ALXN-202408USA000556US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242069501$24206950$1$I$$20240806$20240813$20240813$PER$$US-JNJFOC-20240815006$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$US$US
242069511$24206951$1$I$$20240731$20240813$20240813$EXP$$DE-PRINSTON PHARMACEUTICAL INC.-2024PRN00304$PRINSTON PHARMACEUTICAL$Heinz P., Wolf B., Schuldes S.. Locked-in Syndrome After Pontine Hemorrhage in an Amphetamine Abuser. Deutsches ?rzteblatt International. 2021;121:10:330$37$YR$$F$Y$$$20240813$$MD$DE$DE
242069523$24206952$3$F$20240101$20240904$20240813$20240910$EXP$$US-ABBVIE-5875426$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
242069532$24206953$2$F$20240529$20240830$20240813$20240909$EXP$$US-SMPA-2024SPA000397$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242069541$24206954$1$I$$20240729$20240813$20240813$EXP$$US-SMPA-2024SPA000407$SUNOVION$$$$$$Y$$$20240813$$CN$US$US
242069551$24206955$1$I$20240809$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024159062$AMGEN$$41$YR$A$F$Y$$$20240813$$CN$US$US
242069561$24206956$1$I$$20240806$20240813$20240813$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001582$BLUEPRINT MEDICINES$$$$$F$Y$$$20240814$$CN$US$US
242069571$24206957$1$I$20240727$20240808$20240813$20240813$EXP$$CO-JNJFOC-20240824455$JOHNSON AND JOHNSON$$83$YR$E$F$Y$72$KG$20240814$$HP$CO$CO
242069582$24206958$2$F$20240811$20240814$20240813$20240821$PER$$US-AMGEN-USASP2024160090$AMGEN$$77$YR$E$M$Y$$$20240821$$CN$US$US
242069591$24206959$1$I$20230713$20240807$20240813$20240813$EXP$$PL-JNJFOC-20240831295$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240814$$MD$PL$PL
242069601$24206960$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024160009$AMGEN$$$$$$Y$$$20240813$$PH$US$US
242069611$24206961$1$I$$20240724$20240813$20240813$PER$$US-009507513-2407USA013832$MERCK$Kranyak A, Lee-Foltz MM, Salem I, Hodson E and Chapman M.. Palisaded neutrophilic granulomatous dermatitis in a patient with a history of metastatic melanoma previously treated with immune-checkpoint inhibitors. Journal of Investigative Dermatology. 2024;144:S112$83$YR$$M$Y$$$20240813$$HP$US$US
242069621$24206962$1$I$$20240730$20240813$20240813$EXP$$TW-AMGEN-TWNSP2024159446$AMGEN$Lin WC, Peng PS, Lin SL. Feasibility of Short-Term Use of Ivabradine in Critical Ill Patients Who Have Atrial Fibrillation and Tachycardia. Acta Cardiol Sin. 2024;40:373-382. doi:10.6515/ACS.202407_40 (4).20240411A$$$$$Y$$$20240813$$CN$TW$TW
242069631$24206963$1$I$$20240212$20240813$20240813$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240063$IRONSHORE PHARMA$$10$YR$C$F$Y$$$20240814$$HP$US$US
242069641$24206964$1$I$$20240806$20240813$20240813$PER$$US-ROCHE-10000051071$ROCHE$$63$YR$A$F$Y$$$20240814$$CN$US$US
242069651$24206965$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240825452$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$HP$US$US
242069661$24206966$1$I$20230821$20240809$20240813$20240813$EXP$$US-JNJFOC-20240827692$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240814$$CN$US$US
242069671$24206967$1$I$$20240807$20240813$20240813$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-128002$BRISTOL MYERS SQUIBB$Kato S, Nakashima K, Yamato G, Saito S, Taneyama Y, Yamamoto N, et al. Azacitidine treatment for myeloid leukemia associated with down syndrome: a nationwide retrospective study in japan. Pediatric Blood + Cancer. 2024 Aug 04;1-5. doi:10.1002/pbc.31244.$$$$$Y$$$20240814$$HP$JP$JP
242069681$24206968$1$I$$20240809$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128010$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240814$$HP$US$US
242069691$24206969$1$I$20240101$20240614$20240813$20240813$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240981$IRONSHORE PHARMA$$$$$F$Y$$$20240814$$CN$US$US
242069702$24206970$2$F$$20240823$20240813$20240828$EXP$$CA-JNJFOC-20240826774$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240828$$PH$CA$CA
242069721$24206972$1$I$$20240808$20240813$20240813$PER$$US-JNJFOC-20240821411$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$PH$US$US
242069731$24206973$1$I$$20240810$20240813$20240813$EXP$$US-JNJFOC-20240828066$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240814$$CN$US$US
242069741$24206974$1$I$$20240801$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122234$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240814$$HP$US$US
242069751$24206975$1$I$$20240807$20240813$20240813$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-126131$BRISTOL MYERS SQUIBB$Americo AD, Silva CC, Kerbauy MN, Arcuri LJ, Feitosa Ribeiro AA, Hamerschlak N, et al. Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome-a propensity score matched analysis. Hematology, Transfusion and Cell Therapy. 2024 May 25;1-4. doi:10.1016/j.htct.2024.03.006.$$$A$$Y$$$20240814$$HP$BR$BR
242069761$24206976$1$I$20240803$20240805$20240813$20240813$PER$$US-ABBVIE-5870393$ABBVIE$$27$YR$$F$Y$$$20240813$$CN$US$US
242069771$24206977$1$I$$20240807$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127770$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240814$$PH$US$US
242069781$24206978$1$I$$20240415$20240813$20240813$PER$$US-GALDERMA-US2024006641$GALDERMA$$$$$$Y$$$20240814$$CN$US$US
242069791$24206979$1$I$$20240809$20240813$20240813$PER$$US-AMGEN-USASP2024160431$AMGEN$$$$$$Y$$$20240813$$PH$US$US
242069802$24206980$2$F$20240701$20240812$20240813$20240818$PER$$US-AMGEN-USASP2024160627$AMGEN$$$$$F$Y$$$20240818$$HP$US$US
242069811$24206981$1$I$20240730$20240808$20240813$20240813$PER$$JP-Eisai-EC-2024-171624$EISAI$$79$YR$E$F$Y$$$20240814$$MD$JP$JP
242069822$24206982$2$F$20240101$20240806$20240813$20240819$EXP$$US-ABBVIE-5836475$ABBVIE$$$$$F$Y$104$KG$20240819$$CN$US$US
242069831$24206983$1$I$$20240812$20240813$20240813$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128108$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240814$$CN$US$US
242069851$24206985$1$I$$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007694$ELI LILLY AND CO$$$$$F$Y$$$20240813$$CN$US$US
242069861$24206986$1$I$20240101$20240809$20240813$20240813$EXP$$US-ABBVIE-5875501$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242069871$24206987$1$I$20240701$20240812$20240813$20240813$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045536$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240814$$HP$CO$CO
242069881$24206988$1$I$$20240813$20240813$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045484$BOEHRINGER INGELHEIM$$$$$$Y$$$20240814$$CN$US$US
242069891$24206989$1$I$$20240801$20240813$20240813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122676$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$68$KG$20240814$$HP$CA$CA
242069904$24206990$4$F$20240810$20240826$20240813$20240827$PER$$US-AMGEN-USASP2024160680$AMGEN$$56$YR$A$F$Y$$$20240826$$CN$US$US
242069911$24206991$1$I$20240701$20240802$20240813$20240813$PER$$US-BAUSCHBL-2024BNL031136$BAUSCH AND LOMB$$89$YR$$M$Y$$$20240814$$CN$US$US
242069921$24206992$1$I$20240723$20240808$20240813$20240813$PER$$US-ABBVIE-5874098$ABBVIE$$39$YR$$F$Y$$$20240813$$MD$US$US
242069931$24206993$1$I$20240710$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126646$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240814$$HP$US$US
242069941$24206994$1$I$$20240807$20240813$20240813$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241080$IRONSHORE PHARMA$$$$A$F$Y$$$20240814$$MD$US$US
242069951$24206995$1$I$$20240807$20240813$20240813$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241079$IRONSHORE PHARMA$$$$A$M$Y$$$20240814$$MD$US$US
242069961$24206996$1$I$$20240807$20240813$20240813$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241081$IRONSHORE PHARMA$$$$T$M$Y$$$20240814$$MD$US$US
242069971$24206997$1$I$20240801$20240805$20240813$20240813$PER$$US-BAUSCHBL-2024BNL031159$BAUSCH AND LOMB$$$$$M$Y$$$20240814$$CN$US$US
242069981$24206998$1$I$$20240813$20240813$20240813$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045543$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240814$$CN$US$US
242069991$24206999$1$I$20240201$20240809$20240813$20240813$EXP$$US-ABBVIE-5875843$ABBVIE$$74$YR$$M$Y$$$20240813$$CN$US$US
242070001$24207000$1$I$20240101$20240809$20240813$20240813$EXP$$US-ABBVIE-5875675$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242070012$24207001$2$F$$20240822$20240813$20240827$EXP$$JP-GSK-JP2024098400$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$PH$JP$JP
242070021$24207002$1$I$$20240808$20240813$20240813$EXP$$CN-BEIGENE-BGN-2024-012545$BEIGENE$$$$$$Y$$$20240813$$MD$CN$CN
242070031$24207003$1$I$$20240809$20240813$20240813$PER$$US-ABBVIE-5876969$ABBVIE$$$$$$Y$$$20240813$$CN$US$US
242070051$24207005$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126190$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240814$$CN$US$US
242070061$24207006$1$I$$20240809$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408008091$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240813$$CN$US$US
242070081$24207008$1$I$20240812$20240812$20240813$20240813$PER$$US-AMGEN-USASP2024159818$AMGEN$$$$A$F$Y$$$20240813$$CN$US$US
242070092$24207009$2$F$20240101$20240806$20240813$20240820$EXP$$US-UCBSA-2024038841$UCB$$$$$F$Y$$$20240820$$CN$US$US
242070101$24207010$1$I$$20240809$20240813$20240813$PER$$US-ORGANON-O2408USA000871$ORGANON$$$$$F$Y$$$20240813$$CN$US$US
242070111$24207011$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128083$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240814$$CN$US$US
242070161$24207016$1$I$20240101$20240809$20240813$20240813$EXP$$CO-JNJFOC-20240829191$JOHNSON AND JOHNSON$$22$YR$A$M$Y$60$KG$20240814$$HP$CO$CO
242070171$24207017$1$I$20240101$20240807$20240813$20240813$EXP$$US-AMGEN-USASP2024157844$AMGEN$$66$YR$E$F$Y$$$20240813$$CN$US$US
242070181$24207018$1$I$$20240802$20240813$20240813$PER$$US-SA-2024SA234013$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$CN$US$US
242070191$24207019$1$I$$20240801$20240813$20240813$PER$$US-SA-2024SA234746$SANOFI AVENTIS$$$$E$M$Y$85.7$KG$20240814$$MD$US$US
242070201$24207020$1$I$20240701$20240802$20240813$20240813$PER$$US-SA-2024SA233192$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240814$$MD$US$US
242070211$24207021$1$I$20240731$20240801$20240813$20240813$PER$$US-SA-2024SA233910$SANOFI AVENTIS$$36$YR$A$F$Y$40$KG$20240814$$CN$US$US
242070221$24207022$1$I$$20240801$20240813$20240813$PER$$US-SA-2024SA231491$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240814$$MD$US$US
242070231$24207023$1$I$$20240802$20240813$20240813$PER$$US-SA-2024SA233266$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240814$$MD$US$US
242070241$24207024$1$I$$20240802$20240813$20240813$PER$$US-SA-2024SA234962$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240814$$MD$US$US
242070252$24207025$2$F$$20240812$20240813$20240821$PER$$US-SA-2024SA231723$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240821$$MD$US$US
242070261$24207026$1$I$$20240802$20240813$20240813$PER$$US-SA-2024SA235403$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242070271$24207027$1$I$20240101$20240801$20240813$20240813$PER$$US-SA-2024SA235935$SANOFI AVENTIS$$17$YR$T$M$Y$52.16$KG$20240814$$MD$US$US
242070281$24207028$1$I$20240601$20240802$20240813$20240813$PER$$US-SA-2024SA235118$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240814$$MD$US$US
242070291$24207029$1$I$20240101$20240802$20240813$20240813$PER$$US-SA-2024SA236680$SANOFI AVENTIS$$59$YR$A$M$Y$113.39$KG$20240814$$MD$US$US
242070301$24207030$1$I$20240101$20240802$20240813$20240813$PER$$US-SA-2024SA235724$SANOFI AVENTIS$$60$YR$A$M$Y$108$KG$20240814$$MD$US$US
242070311$24207031$1$I$20240101$20240802$20240813$20240813$PER$$US-SA-2024SA232740$SANOFI AVENTIS$$43$YR$A$F$Y$124$KG$20240814$$MD$US$US
242070321$24207032$1$I$$20240802$20240813$20240813$PER$$US-SA-2024SA233617$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240814$$MD$US$US
242070332$24207033$2$F$20240701$20240906$20240813$20240916$PER$$US-SA-2024SA233378$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240916$$MD$US$US
242070341$24207034$1$I$20240101$20240802$20240813$20240813$PER$$US-SA-2024SA231673$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240814$$HP$US$US
242070361$24207036$1$I$$20240802$20240813$20240813$PER$$US-SA-2022SA080404$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240814$$MD$US$US
242070371$24207037$1$I$$20240802$20240813$20240813$PER$$US-SA-2024SA233630$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240814$$MD$US$US
242070381$24207038$1$I$$20240802$20240813$20240813$PER$$US-SA-2024SA232804$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240814$$MD$US$US
242070391$24207039$1$I$20240701$20240802$20240813$20240813$PER$$US-SA-2024SA234562$SANOFI AVENTIS$$35$YR$A$F$Y$105.2$KG$20240814$$MD$US$US
242070401$24207040$1$I$20240801$20240802$20240813$20240813$PER$$US-SA-2024SA230993$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240814$$CN$US$US
242070411$24207041$1$I$$20240802$20240813$20240813$PER$$US-SA-2024SA233309$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240814$$CN$US$US
242070421$24207042$1$I$$20240802$20240813$20240813$PER$$US-SA-2024SA233159$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240814$$MD$US$US
242070433$24207043$3$F$$20240905$20240813$20240919$PER$$US-SA-2024SA234434$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240919$$MD$US$US
242070441$24207044$1$I$20240701$20240802$20240813$20240813$PER$$US-SA-2024SA238134$SANOFI AVENTIS$$61$YR$A$F$Y$129$KG$20240814$$MD$US$US
242070451$24207045$1$I$20240801$20240805$20240813$20240813$PER$$US-BAUSCHBL-2024BNL031170$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240814$$CN$US$US
242070461$24207046$1$I$$20240802$20240813$20240813$PER$$US-BAUSCHBL-2024BNL031183$BAUSCH AND LOMB$$$$$F$Y$$$20240814$$CN$US$US
242070471$24207047$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236850$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240814$$MD$US$US
242070481$24207048$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA235303$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240814$$MD$US$US
242070491$24207049$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA235310$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240814$$MD$US$US
242070501$24207050$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236049$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240814$$MD$US$US
242070511$24207051$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA234499$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240814$$MD$US$US
242070521$24207052$1$I$20240801$20240806$20240813$20240813$PER$$US-SA-2024SA235516$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240814$$MD$US$US
242070531$24207053$1$I$20240101$20240804$20240813$20240813$PER$$US-SA-2023SA217226$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240814$$MD$US$US
242070541$24207054$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235285$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$CN$US$US
242070551$24207055$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236244$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240814$$CN$US$US
242070561$24207056$1$I$20240625$20240807$20240813$20240813$PER$$US-SA-2024SA236019$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240814$$MD$US$US
242070571$24207057$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235011$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240814$$CN$US$US
242070581$24207058$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA149400$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240814$$MD$US$US
242070591$24207059$1$I$20240806$20240806$20240813$20240813$PER$$US-SA-2024SA238554$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240814$$CN$US$US
242070601$24207060$1$I$20240101$20240807$20240813$20240813$PER$$US-SA-2024SA237810$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240814$$MD$US$US
242070611$24207061$1$I$20240806$20240806$20240813$20240813$PER$$US-SA-2024SA234584$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240814$$CN$US$US
242070621$24207062$1$I$$20240804$20240813$20240813$PER$$US-SA-2024SA234457$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
242070631$24207063$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236343$SANOFI AVENTIS$$5$YR$C$F$Y$18.3$KG$20240814$$HP$US$US
242070641$24207064$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA236556$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240814$$MD$US$US
242070651$24207065$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236831$SANOFI AVENTIS$$$$E$F$Y$$$20240814$$MD$US$US
242070661$24207066$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA236936$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240814$$MD$US$US
242070671$24207067$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA238712$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242070682$24207068$2$F$$20240819$20240813$20240826$EXP$$GB-TEVA-VS-3231415$TEVA$Kyaw O, Morris R, Leibowitz M. Hashimoto^s encephalitis - A case report. Clin-Med-London 2024; 24 (Suppl.).; Kyaw O, Morris R, Leibowitz M. Hashimoto^s encephalitis - A case report. Clin-Med-London 2024; 24 (Suppl.).$50$YR$$F$Y$$$20240826$$HP$GB$GB
242070692$24207069$2$F$20240701$20240816$20240813$20240830$PER$$US-SA-2024SA236411$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240830$$MD$US$US
242070701$24207070$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA238232$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240814$$MD$US$US
242070711$24207071$1$I$20240701$20240806$20240813$20240813$PER$$US-SA-2024SA235455$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240814$$MD$US$US
242070721$24207072$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA074134$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240814$$MD$US$US
242070731$24207073$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA237873$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240814$$MD$US$US
242070741$24207074$1$I$20240701$20240806$20240813$20240813$PER$$US-SA-2024SA236331$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240814$$MD$US$US
242070751$24207075$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA239544$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240814$$MD$US$US
242070761$24207076$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236892$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240814$$MD$US$US
242070771$24207077$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA235355$SANOFI AVENTIS$$$$E$F$Y$$$20240814$$MD$US$US
242070791$24207079$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA233789$SANOFI AVENTIS$$60$YR$A$F$Y$84.82$KG$20240814$$HP$US$US
242070801$24207080$1$I$$20240807$20240813$20240813$EXP$$IE-TAKEDA-2024TUS080591$TAKEDA$$$$$F$Y$$$20240813$$HP$IE$IE
242070811$24207081$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236814$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
242070821$24207082$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA238157$SANOFI AVENTIS$$$$C$F$Y$$$20240814$$CN$US$US
242070831$24207083$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235135$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240814$$MD$US$US
242070851$24207085$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA237200$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240814$$MD$US$US
242070862$24207086$2$F$20240101$20240821$20240813$20240905$PER$$US-SA-2024SA238945$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240905$$MD$US$US
242070871$24207087$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA238236$SANOFI AVENTIS$$$$A$F$Y$55$KG$20240814$$MD$US$US
242070881$24207088$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA238239$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240814$$MD$US$US
242070891$24207089$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA232322$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240814$$MD$US$US
242070901$24207090$1$I$20240701$20240805$20240813$20240813$PER$$US-SA-2024SA238295$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240814$$MD$US$US
242070911$24207091$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA234474$SANOFI AVENTIS$$$$$$Y$$$20240814$$HP$US$US
242070921$24207092$1$I$20231101$20240805$20240813$20240813$PER$$US-SA-2024SA233718$SANOFI AVENTIS$$92$YR$E$F$Y$$$20240814$$MD$US$US
242070931$24207093$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235084$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240814$$MD$US$US
242070941$24207094$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236696$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240814$$MD$US$US
242070951$24207095$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA237807$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240814$$MD$US$US
242070961$24207096$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA237466$SANOFI AVENTIS$$$$A$F$Y$49.89$KG$20240814$$MD$US$US
242070981$24207098$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA233702$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240814$$MD$US$US
242070991$24207099$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA235204$SANOFI AVENTIS$$$$$F$Y$$$20240814$$HP$US$US
242071001$24207100$1$I$20240731$20240806$20240813$20240813$PER$$US-SA-2024SA234351$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240814$$MD$US$US
242071011$24207101$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA237633$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240814$$MD$US$US
242071021$24207102$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA237050$SANOFI AVENTIS$$$$T$F$Y$49.44$KG$20240814$$MD$US$US
242071031$24207103$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875631$ABBVIE$$$$$M$Y$$$20240813$$HP$US$US
242071042$24207104$2$F$20240101$20240807$20240813$20240816$PER$$US-SA-2024SA236279$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240816$$MD$US$US
242071051$24207105$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236938$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
242071061$24207106$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA238082$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240814$$MD$US$US
242071071$24207107$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA196803$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242071081$24207108$1$I$$20240802$20240813$20240813$PER$$US-BAUSCHBL-2024BNL031177$BAUSCH AND LOMB$$$$$F$Y$$$20240814$$CN$US$US
242071091$24207109$1$I$20240730$20240802$20240813$20240813$PER$$US-BAUSCHBL-2024BNL031123$BAUSCH AND LOMB$$$$$F$Y$$$20240814$$CN$US$US
242071101$24207110$1$I$$20240809$20240813$20240813$PER$$US-ABBVIE-5877060$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242071111$24207111$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236593$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240814$$HP$US$US
242071121$24207112$1$I$20240101$20240807$20240813$20240813$EXP$$CA-ABBVIE-5873071$ABBVIE$$63$YR$$M$Y$$$20240813$$CN$CA$CA
242071131$24207113$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA237028$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242071141$24207114$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236924$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240814$$MD$US$US
242071161$24207116$1$I$20240101$20240807$20240813$20240813$PER$$US-SA-2024SA236031$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240814$$MD$US$US
242071171$24207117$1$I$20240101$20240807$20240813$20240813$PER$$US-SA-2024SA237584$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240814$$MD$US$US
242071181$24207118$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236765$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240814$$MD$US$US
242071193$24207119$3$F$$20240909$20240813$20240918$PER$$US-SA-2024SA237749$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240918$$MD$US$US
242071201$24207120$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA235633$SANOFI AVENTIS$$15$YR$T$M$Y$91$KG$20240814$$MD$US$US
242071211$24207121$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA237066$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$PH$US$US
242071221$24207122$1$I$20240701$20240805$20240813$20240813$PER$$US-SA-2024SA236600$SANOFI AVENTIS$$89$YR$E$F$Y$69.39$KG$20240814$$MD$US$US
242071231$24207123$1$I$20240801$20240805$20240813$20240813$PER$$US-SA-2024SA236939$SANOFI AVENTIS$$24$YR$A$F$Y$63$KG$20240814$$MD$US$US
242071241$24207124$1$I$20240805$20240805$20240813$20240813$PER$$US-SA-2024SA235278$SANOFI AVENTIS$$52$YR$A$M$Y$76.65$KG$20240814$$MD$US$US
242071252$24207125$2$F$20240101$20240808$20240813$20240820$PER$$US-SA-2024SA236740$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240820$$MD$US$US
242071261$24207126$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA239419$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240814$$MD$US$US
242071271$24207127$1$I$20240701$20240806$20240813$20240813$PER$$US-SA-2024SA236828$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240814$$MD$US$US
242071281$24207128$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236795$SANOFI AVENTIS$$$$A$M$Y$18.5$KG$20240814$$MD$US$US
242071291$24207129$1$I$20240801$20240806$20240813$20240813$PER$$US-SA-2024SA235193$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240814$$MD$US$US
242071301$24207130$1$I$20240801$20240806$20240813$20240813$PER$$US-SA-2024SA237762$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240814$$MD$US$US
242071311$24207131$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA235073$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240814$$MD$US$US
242071321$24207132$1$I$$20240806$20240813$20240813$PER$$US-SA-2023SA394878$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240814$$CN$US$US
242071331$24207133$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235503$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
242071341$24207134$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA235788$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240814$$CN$US$US
242071351$24207135$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA238840$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240814$$MD$US$US
242071361$24207136$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235265$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240814$$MD$US$US
242071371$24207137$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235146$SANOFI AVENTIS$$$$E$F$Y$$$20240814$$CN$US$US
242071381$24207138$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235328$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240814$$MD$US$US
242071391$24207139$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA234463$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242071401$24207140$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA238280$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240814$$MD$US$US
242071411$24207141$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA234663$SANOFI AVENTIS$$40$YR$A$F$Y$79.3$KG$20240814$$MD$US$US
242071421$24207142$1$I$20240804$20240805$20240813$20240813$PER$$US-SA-2024SA232578$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240814$$CN$US$US
242071432$24207143$2$F$$20240801$20240813$20240814$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202408-000995$UNICHEM$$38$WK$I$$Y$$$20240815$$HP$US$
242071442$24207144$2$F$$20240801$20240813$20240814$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202408-001002$UNICHEM$$34$WK$I$$Y$$$20240815$$HP$US$
242071452$24207145$2$F$$20240801$20240813$20240814$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202408-001003$UNICHEM$$35$WK$I$$Y$$$20240815$$HP$US$
242071462$24207146$2$F$$20240806$20240813$20240814$EXP$$ES-Unichem Pharmaceuticals (USA) Inc-UCM202408-001000$UNICHEM$$22$WK$I$$Y$$$20240815$$HP$ES$
242071471$24207147$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA235502$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240814$$HP$US$US
242071481$24207148$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA237761$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240814$$HP$US$US
242071491$24207149$1$I$20240802$20240807$20240813$20240813$PER$$US-SA-2024SA238439$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240814$$CN$US$US
242071501$24207150$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA237673$SANOFI AVENTIS$$$$A$M$Y$70.307$KG$20240814$$HP$US$US
242071511$24207151$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA237858$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240814$$MD$US$US
242071521$24207152$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA238572$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240814$$MD$US$US
242071531$24207153$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA237264$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240814$$MD$US$US
242071541$24207154$1$I$20240101$20240807$20240813$20240813$PER$$US-SA-2024SA237667$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240814$$MD$US$US
242071551$24207155$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA237741$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240814$$MD$US$US
242071561$24207156$1$I$20240701$20240805$20240813$20240813$PER$$US-SA-2024SA235576$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240814$$MD$US$US
242071571$24207157$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA238648$SANOFI AVENTIS$$55$YR$A$F$Y$67.5$KG$20240814$$MD$US$US
242071581$24207158$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA237220$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242071591$24207159$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA237903$SANOFI AVENTIS$$64$YR$A$F$Y$128.3$KG$20240814$$MD$US$US
242071602$24207160$2$F$20240101$20240819$20240813$20240828$PER$$US-SA-2024SA234621$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240828$$MD$US$US
242071611$24207161$1$I$20240101$20240807$20240813$20240813$PER$$US-SA-2024SA236902$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240814$$MD$US$US
242071621$24207162$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA239315$SANOFI AVENTIS$$$$T$M$Y$$$20240814$$MD$US$US
242071631$24207163$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235115$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240814$$CN$US$US
242071641$24207164$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236254$SANOFI AVENTIS$$$$E$M$Y$56.699$KG$20240814$$MD$US$US
242071651$24207165$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA236341$SANOFI AVENTIS$$$$A$F$Y$61.2$KG$20240814$$MD$US$US
242071661$24207166$1$I$20240501$20240806$20240813$20240813$PER$$US-SA-2024SA236314$SANOFI AVENTIS$$19$YR$A$M$Y$92.98$KG$20240814$$MD$US$US
242071671$24207167$1$I$20240804$20240807$20240813$20240813$PER$$US-SA-2024SA236498$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240814$$CN$US$US
242071681$24207168$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236571$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240814$$MD$US$US
242071691$24207169$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235584$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240814$$MD$US$US
242071702$24207170$2$F$20240101$20240911$20240813$20240926$PER$$US-SA-2024SA233992$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240926$$MD$US$US
242071711$24207171$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236923$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240814$$MD$US$US
242071721$24207172$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236931$SANOFI AVENTIS$$73$YR$E$M$Y$97$KG$20240814$$CN$US$US
242071731$24207173$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236028$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240814$$MD$US$US
242071741$24207174$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA237872$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240814$$MD$US$US
242071751$24207175$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA234412$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240814$$MD$US$US
242071761$24207176$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236992$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240814$$MD$US$US
242071771$24207177$1$I$20240101$20240731$20240813$20240813$EXP$$US-UCBSA-2024038908$UCB$$$$$F$Y$$$20240814$$CN$US$US
242071781$24207178$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA237859$SANOFI AVENTIS$$$$A$F$Y$82$KG$20240814$$MD$US$US
242071791$24207179$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236222$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240814$$MD$US$US
242071801$24207180$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA238715$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240814$$MD$US$US
242071811$24207181$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA237094$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242071821$24207182$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236792$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240814$$MD$US$US
242071832$24207183$2$F$20230101$20240822$20240813$20240902$PER$$US-SA-2024SA238244$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240902$$CN$US$US
242071841$24207184$1$I$20240601$20240806$20240813$20240813$PER$$US-SA-2024SA239452$SANOFI AVENTIS$$$$$F$Y$$$20240814$$CN$US$US
242071851$24207185$1$I$20240701$20240806$20240813$20240813$PER$$US-SA-2024SA239131$SANOFI AVENTIS$$63$YR$A$F$Y$64$KG$20240814$$MD$US$US
242071861$24207186$1$I$20240701$20240805$20240813$20240813$PER$$US-SA-2024SA235895$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240814$$MD$US$US
242071871$24207187$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA235493$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240814$$MD$US$US
242071881$24207188$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235346$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240814$$MD$US$US
242071891$24207189$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA236553$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240814$$MD$US$US
242071901$24207190$1$I$20220701$20240805$20240813$20240813$PER$$US-SA-2024SA235691$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240814$$MD$US$US
242071911$24207191$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA236921$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240814$$MD$US$US
242071921$24207192$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236826$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240814$$MD$US$US
242071931$24207193$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA235648$SANOFI AVENTIS$$$$E$M$Y$82.1$KG$20240814$$MD$US$US
242071941$24207194$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA234318$SANOFI AVENTIS$$$$$$Y$$$20240814$$MD$US$US
242071951$24207195$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA237850$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242071961$24207196$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236576$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240814$$MD$US$US
242071971$24207197$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA234466$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240814$$MD$US$US
242071981$24207198$1$I$20240101$20240807$20240813$20240813$PER$$US-SA-2024SA238994$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240814$$MD$US$US
242071991$24207199$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA237743$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240814$$HP$US$US
242072001$24207200$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235391$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240814$$CN$US$US
242072011$24207201$1$I$20231101$20240807$20240813$20240813$PER$$US-SA-2024SA239001$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240814$$MD$US$US
242072021$24207202$1$I$20240801$20240806$20240813$20240813$PER$$US-SA-2024SA235524$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240814$$MD$US$US
242072031$24207203$1$I$20240701$20240806$20240813$20240813$PER$$US-SA-2024SA200969$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240814$$MD$US$US
242072041$24207204$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA239340$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240814$$MD$US$US
242072052$24207205$2$F$20230501$20240828$20240813$20240918$PER$$US-SA-2024SA234404$SANOFI AVENTIS$$3$YR$C$M$Y$23.64$KG$20240918$$CN$US$US
242072061$24207206$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA238688$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240814$$MD$US$US
242072071$24207207$1$I$20240101$20240807$20240813$20240813$PER$$US-SA-2024SA236784$SANOFI AVENTIS$$61$YR$A$$Y$$$20240814$$MD$US$US
242072081$24207208$1$I$20240701$20240805$20240813$20240813$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-126703$BRISTOL MYERS SQUIBB$$13$YR$T$F$Y$50$KG$20240814$$MD$FR$FR
242072091$24207209$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA235549$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240814$$MD$US$US
242072111$24207211$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA234512$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240814$$CN$US$US
242072121$24207212$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA233355$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240814$$MD$US$US
242072131$24207213$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236888$SANOFI AVENTIS$$$$T$F$Y$$$20240814$$CN$US$US
242072141$24207214$1$I$20240701$20240806$20240813$20240813$PER$$US-SA-2024SA235253$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240814$$MD$US$US
242072151$24207215$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA234606$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240814$$MD$US$US
242072161$24207216$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235216$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240814$$MD$US$US
242072171$24207217$1$I$20240601$20240806$20240813$20240813$PER$$US-SA-2024SA235282$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240814$$MD$US$US
242072181$24207218$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA238105$SANOFI AVENTIS$$$$E$M$Y$86.2$KG$20240814$$MD$US$US
242072191$24207219$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA238817$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$CN$US$US
242072201$24207220$1$I$20240805$20240807$20240813$20240813$PER$$US-SA-2024SA237697$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240814$$HP$US$US
242072211$24207221$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA234890$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240814$$MD$US$US
242072221$24207222$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA234618$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240814$$MD$US$US
242072231$24207223$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA238138$SANOFI AVENTIS$$$$T$F$Y$$$20240814$$CN$US$US
242072241$24207224$1$I$20240804$20240807$20240813$20240813$PER$$US-SA-2024SA238283$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240814$$MD$US$US
242072251$24207225$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA236579$SANOFI AVENTIS$$67$YR$E$M$Y$92.9$KG$20240814$$MD$US$US
242072261$24207226$1$I$20240701$20240806$20240813$20240813$PER$$US-SA-2024SA221477$SANOFI AVENTIS$$77$YR$E$M$Y$79$KG$20240814$$MD$US$US
242072271$24207227$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA234289$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240814$$MD$US$US
242072291$24207229$1$I$20240501$20240807$20240813$20240813$PER$$US-SA-2024SA236346$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240814$$MD$US$US
242072301$24207230$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235038$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240814$$MD$US$US
242072311$24207231$1$I$20240301$20240805$20240813$20240813$PER$$US-SA-2024SA236788$SANOFI AVENTIS$$18$YR$A$M$Y$57.596$KG$20240814$$MD$US$US
242072321$24207232$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA235658$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240814$$MD$US$US
242072331$24207233$1$I$20240101$20240807$20240813$20240813$PER$$US-SA-2024SA238976$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240814$$MD$US$US
242072341$24207234$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA234255$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240814$$MD$US$US
242072352$24207235$2$F$$20240822$20240813$20240913$PER$$US-SA-2024SA237573$SANOFI AVENTIS$$$$A$F$Y$72.1$KG$20240913$$MD$US$US
242072361$24207236$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA237043$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240814$$MD$US$US
242072371$24207237$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA238107$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240814$$MD$US$US
242072382$24207238$2$F$20240101$20240829$20240813$20240830$PER$$US-SA-2024SA235018$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240830$$MD$US$US
242072392$24207239$2$F$20240101$20240909$20240813$20240916$PER$$US-SA-2024SA239089$SANOFI AVENTIS$$71$YR$E$M$Y$83.9$KG$20240916$$MD$US$US
242072401$24207240$1$I$20240101$20240805$20240813$20240813$EXP$$US-JNJFOC-20240811888$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240814$$HP$US$US
242072411$24207241$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA238478$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240814$$MD$US$US
242072421$24207242$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA237100$SANOFI AVENTIS$$$$A$$Y$$$20240814$$PH$US$US
242072441$24207244$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235570$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242072451$24207245$1$I$20240701$20240806$20240813$20240813$PER$$US-SA-2024SA235583$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240814$$MD$US$US
242072461$24207246$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA238296$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240814$$MD$US$US
242072471$24207247$1$I$20230101$20240806$20240813$20240813$PER$$US-SA-2024SA238284$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240814$$MD$US$US
242072481$24207248$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA236372$SANOFI AVENTIS$$$$A$F$Y$95$KG$20240814$$MD$US$US
242072491$24207249$1$I$20240806$20240807$20240813$20240813$PER$$US-SA-2024SA236022$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240814$$CN$US$US
242072502$24207250$2$F$$20240816$20240813$20240830$PER$$US-SA-2024SA235360$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240830$$MD$US$US
242072511$24207251$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA238454$SANOFI AVENTIS$$57$YR$A$F$Y$48$KG$20240814$$MD$US$US
242072522$24207252$2$F$$20240808$20240813$20240820$PER$$US-SA-2024SA238959$SANOFI AVENTIS$$$$E$F$Y$84.8$KG$20240820$$MD$US$US
242072532$24207253$2$F$$20240809$20240813$20240820$PER$$US-SA-2024SA232075$SANOFI AVENTIS$$78$YR$E$F$Y$86.18$KG$20240820$$MD$US$US
242072541$24207254$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236568$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240814$$MD$US$US
242072551$24207255$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235334$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240814$$MD$US$US
242072561$24207256$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236683$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240814$$MD$US$US
242072571$24207257$1$I$20240719$20240807$20240813$20240813$PER$$US-SA-2024SA237596$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240814$$MD$US$US
242072581$24207258$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA238222$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240814$$MD$US$US
242072591$24207259$1$I$20240701$20240805$20240813$20240813$PER$$US-SA-2024SA236801$SANOFI AVENTIS$$60$YR$A$M$Y$79$KG$20240814$$MD$US$US
242072601$24207260$1$I$20240601$20240806$20240813$20240813$PER$$US-SA-2024SA238209$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240814$$MD$US$US
242072611$24207261$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236047$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240814$$MD$US$US
242072621$24207262$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235064$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240814$$MD$US$US
242072631$24207263$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA232476$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240814$$CN$US$US
242072641$24207264$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA237752$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240814$$CN$US$US
242072651$24207265$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA238886$SANOFI AVENTIS$$$$A$M$Y$92.063$KG$20240814$$MD$US$US
242072661$24207266$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA236358$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240814$$MD$US$US
242072671$24207267$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA238433$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240814$$MD$US$US
242072681$24207268$1$I$20240801$20240806$20240813$20240813$PER$$US-SA-2024SA237049$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240814$$MD$US$US
242072691$24207269$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236736$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240814$$MD$US$US
242072701$24207270$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA232306$SANOFI AVENTIS$$17$YR$T$F$Y$54.422$KG$20240814$$CN$US$US
242072711$24207271$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA235688$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240814$$MD$US$US
242072721$24207272$1$I$20231101$20240806$20240813$20240813$PER$$US-SA-2024SA234530$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240814$$HP$US$US
242072732$24207273$2$F$$20240814$20240813$20240828$PER$$US-SA-2024SA236779$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240828$$MD$US$US
242072741$24207274$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235291$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240814$$CN$US$US
242072751$24207275$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236985$SANOFI AVENTIS$$$$A$M$Y$77$KG$20240814$$MD$US$US
242072761$24207276$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA238246$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240814$$MD$US$US
242072771$24207277$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA235304$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240814$$MD$US$US
242072781$24207278$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA236638$SANOFI AVENTIS$$$$A$F$Y$76.65$KG$20240814$$MD$US$US
242072791$24207279$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236927$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240814$$CN$US$US
242072801$24207280$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA237311$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240814$$MD$US$US
242072811$24207281$1$I$20240101$20240807$20240813$20240813$PER$$US-SA-2024SA237855$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240814$$MD$US$US
242072821$24207282$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA238701$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240814$$MD$US$US
242072831$24207283$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA233457$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242072841$24207284$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA236260$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240814$$MD$US$US
242072851$24207285$1$I$20240807$20240807$20240813$20240813$PER$$US-SA-2024SA239015$SANOFI AVENTIS$$41$YR$A$M$Y$81$KG$20240814$$MD$US$US
242072861$24207286$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236846$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240814$$MD$US$US
242072871$24207287$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA236303$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240814$$CN$US$US
242072881$24207288$1$I$20240601$20240806$20240813$20240813$PER$$US-SA-2024SA235590$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240814$$MD$US$US
242072891$24207289$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA238007$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240814$$MD$US$US
242072901$24207290$1$I$20240101$20240807$20240813$20240813$PER$$US-SA-2024SA237067$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240814$$CN$US$US
242072911$24207291$1$I$20240101$20240805$20240813$20240813$PER$$US-SA-2024SA235290$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240814$$MD$US$US
242072921$24207292$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA236185$SANOFI AVENTIS$$$$$$Y$$$20240814$$MD$US$US
242072931$24207293$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA236741$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240814$$MD$US$US
242072941$24207294$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA234565$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240814$$MD$US$US
242072951$24207295$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235163$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240814$$CN$US$US
242072962$24207296$2$F$$20240906$20240813$20240916$PER$$US-SA-2024SA234106$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240916$$MD$US$US
242072971$24207297$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235641$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240814$$MD$US$US
242072981$24207298$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA235468$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242072991$24207299$1$I$20240701$20240806$20240813$20240813$PER$$US-SA-2024SA235637$SANOFI AVENTIS$$$$$M$Y$$$20240814$$MD$US$US
242073001$24207300$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA235906$SANOFI AVENTIS$$$$A$F$Y$78.458$KG$20240814$$MD$US$US
242073012$24207301$2$F$20240604$20240823$20240813$20240829$EXP$$US-BIOGEN-2024BI01268745$BIOGEN$$43$YR$$F$Y$85.9$KG$20240829$$CN$US$US
242073022$24207302$2$F$20240101$20240903$20240813$20240913$PER$$US-SA-2024SA239414$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240913$$MD$US$US
242073031$24207303$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA236796$SANOFI AVENTIS$$$$A$F$Y$135.17$KG$20240814$$MD$US$US
242073041$24207304$1$I$20240301$20240806$20240813$20240813$PER$$US-SA-2024SA237740$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240814$$MD$US$US
242073051$24207305$1$I$20240701$20240806$20240813$20240813$PER$$US-SA-2024SA237839$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240814$$MD$US$US
242073061$24207306$1$I$$20240807$20240813$20240813$PER$$US-SA-2024SA239312$SANOFI AVENTIS$$$$E$F$Y$$$20240814$$MD$US$US
242073071$24207307$1$I$20240807$20240807$20240813$20240813$PER$$US-SA-2024SA239119$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240814$$MD$US$US
242073081$24207308$1$I$20240701$20240807$20240813$20240813$PER$$US-SA-2024SA238484$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240814$$MD$US$US
242073091$24207309$1$I$$20240808$20240813$20240813$PER$$US-SA-2024SA238772$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240814$$CN$US$US
242073101$24207310$1$I$$20240808$20240813$20240813$PER$$US-SA-2024SA238538$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240814$$CN$US$US
242073111$24207311$1$I$$20240808$20240813$20240813$PER$$US-SA-2024SA238009$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240814$$HP$US$US
242073122$24207312$2$F$$20240904$20240813$20240930$PER$$US-SA-2024SA238555$SANOFI AVENTIS$$74$YR$E$F$Y$90$KG$20240930$$MD$US$US
242073131$24207313$1$I$20220712$20240808$20240813$20240813$PER$$US-SA-2024SA238206$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240814$$MD$US$US
242073141$24207314$1$I$$20240808$20240813$20240813$PER$$US-SA-2024SA237626$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240814$$CN$US$US
242073151$24207315$1$I$20240807$20240808$20240813$20240813$PER$$US-SA-2024SA237781$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240814$$CN$US$US
242073161$24207316$1$I$$20240808$20240813$20240813$PER$$US-SA-2024SA238757$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240814$$CN$US$US
242073171$24207317$1$I$$20240806$20240813$20240813$PER$$US-SA-2024SA234839$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242073181$24207318$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA238211$SANOFI AVENTIS$$$$E$F$Y$57$KG$20240814$$MD$US$US
242073191$24207319$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA235601$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240814$$MD$US$US
242073201$24207320$1$I$$20240808$20240813$20240813$PER$$US-SA-2024SA238689$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240814$$CN$US$US
242073212$24207321$2$F$$20240813$20240813$20240820$PER$$US-SA-2024SA238311$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240820$$CN$US$US
242073231$24207323$1$I$$20240808$20240813$20240813$PER$$US-SA-2024SA237334$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240814$$MD$US$US
242073242$24207324$2$F$20240806$20240830$20240813$20240927$PER$$US-SA-2024SA235191$SANOFI AVENTIS$$59$YR$A$M$Y$103.76$KG$20240927$$HP$US$US
242073251$24207325$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA193687$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240814$$MD$US$US
242073261$24207326$1$I$20240701$20240805$20240813$20240813$PER$$US-SA-2024SA235642$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240814$$MD$US$US
242073271$24207327$1$I$20221103$20240808$20240813$20240813$PER$$US-SA-2024SA238918$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240814$$CN$US$US
242073281$24207328$1$I$$20240805$20240813$20240813$PER$$US-SA-2024SA236944$SANOFI AVENTIS$$$$E$F$Y$54.43$KG$20240814$$MD$US$US
242073291$24207329$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA224614$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240814$$MD$US$US
242073302$24207330$2$F$$20240903$20240813$20240918$PER$$US-SA-2024SA237862$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240918$$MD$US$US
242073311$24207331$1$I$20240101$20240806$20240813$20240813$PER$$US-SA-2024SA235598$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240814$$MD$US$US
242073321$24207332$1$I$20240721$20240731$20240813$20240813$EXP$$US-UCBSA-2024039072$UCB$$59$YR$$F$Y$$$20240814$$HP$US$US
242073332$24207333$2$F$$20240829$20240813$20240906$PER$$US-BAUSCHBL-2024BNL031172$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240906$$CN$US$US
242073341$24207334$1$I$$20240807$20240813$20240813$EXP$$JP-GSK-JP2024098406$GLAXOSMITHKLINE$$$$$$Y$$$20240813$$CN$JP$JP
242073351$24207335$1$I$$20240802$20240813$20240813$EXP$$JP-SMPA-2024SMP011864$SUNOVION$$$$$$Y$$$20240813$$CN$JP$JP
242073362$24207336$2$F$20240101$20240822$20240813$20240827$EXP$$US-ABBVIE-5872968$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242073371$24207337$1$I$$20240805$20240813$20240813$PER$$US-ABBVIE-5869791$ABBVIE$$$$$$Y$$$20240813$$CN$US$US
242073382$24207338$2$F$$20240813$20240813$20240820$EXP$$AU-BIOGEN-2024BI01277550$BIOGEN$$39$YR$$F$Y$$$20240820$$MD$AU$AU
242073393$24207339$3$F$20240101$20240904$20240813$20240910$EXP$$US-BIOGEN-2024BI01276467$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
242073401$24207340$1$I$$20240809$20240813$20240813$EXP$$GB-BIOGEN-2024BI01277908$BIOGEN$$$$$F$Y$$$20240813$$CN$GB$GB
242073411$24207341$1$I$$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127811$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240814$$CN$US$US
242073432$24207343$2$F$$20240813$20240813$20240816$EXP$$US-ABBVIE-5874228$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242073443$24207344$3$F$$20240829$20240813$20240906$EXP$$US-BIOGEN-2024BI01277889$BIOGEN$$$$$M$Y$$$20240906$$CN$US$US
242073451$24207345$1$I$20240712$20240807$20240813$20240813$EXP$$CN-ABBVIE-5877566$ABBVIE$$53$YR$$M$Y$44$KG$20240813$$HP$CN$CN
242073461$24207346$1$I$20240701$20240809$20240813$20240813$EXP$$US-BIOGEN-2024BI01277731$BIOGEN$$58$YR$$F$Y$$$20240813$$CN$US$US
242073471$24207347$1$I$$20240812$20240813$20240813$PER$$US-PURDUE PHARMA-USA-2024-0311303$PURDUE$$$$$$Y$$$20240814$$CN$US$US
242073481$24207348$1$I$$20240809$20240813$20240813$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024EME099932$VIIV$$$$$$Y$$$20240813$$CN$GB$GB
242073491$24207349$1$I$$20240808$20240813$20240813$EXP$$US-JNJFOC-20240821241$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242073502$24207350$2$F$$20240813$20240813$20240822$EXP$$BR-JNJFOC-20240821661$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240822$$HP$BR$BR
242073521$24207352$1$I$20240721$20240807$20240813$20240813$EXP$$US-BIOGEN-2024BI01277709$BIOGEN$$28$YR$$F$Y$$$20240813$$CN$US$US
242073531$24207353$1$I$20240701$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127679$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240814$$HP$US$US
242073541$24207354$1$I$20240802$20240806$20240813$20240813$30DAY$$US-GSK-US2024098069$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240813$$CN$US$US
242073551$24207355$1$I$$20240808$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408006416$ELI LILLY AND CO$$$$A$F$Y$$$20240813$$CN$US$US
242073561$24207356$1$I$20240701$20240730$20240813$20240813$30DAY$$US-JNJFOC-20240800885$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242073571$24207357$1$I$20230207$20240809$20240813$20240813$EXP$$US-ABBVIE-5875373$ABBVIE$$58$YR$$F$Y$$$20240813$$CN$US$US
242073581$24207358$1$I$$20240809$20240813$20240813$PER$$US-ABBVIE-5877048$ABBVIE$$$$$$Y$$$20240813$$HP$US$US
242073592$24207359$2$F$$20240919$20240813$20240926$EXP$$US-ABBVIE-5877717$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
242073601$24207360$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875890$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242073611$24207361$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5875944$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242073621$24207362$1$I$20240808$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127021$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240814$$CN$US$US
242073632$24207363$2$F$20240718$20240920$20240813$20240926$EXP$$US-ABBVIE-5877763$ABBVIE$$73$YR$$F$Y$$$20240926$$CN$US$US
242073641$24207364$1$I$20240728$20240812$20240813$20240813$EXP$$US-ABBVIE-5877861$ABBVIE$$66$YR$$F$Y$$$20240813$$HP$US$US
242073651$24207365$1$I$20240811$20240812$20240813$20240813$EXP$$US-ABBVIE-5878766$ABBVIE$$69$YR$$M$Y$$$20240813$$CN$US$US
242073661$24207366$1$I$20240809$20240812$20240813$20240813$EXP$$US-ABBVIE-5878286$ABBVIE$$77$YR$$M$Y$$$20240813$$CN$US$US
242073671$24207367$1$I$$20240802$20240813$20240813$EXP$$RU-ABBVIE-5853997$ABBVIE$Alexeeva EI, Krekhova EA, Kriulin IA, Kriulina TY, Dvoryakovskaya TM, Isaeva KB, et al. Experience with the JAK-kinase inhibitor upadacitinib in children with rheumatic diseases. Pediatrics Practice Issues. 2024;19(2):59-79.; Alexeeva EI, Krekhova EA, Kriulin IA, Kriulina TYu, Dvoryakovskaya TM, Isaeva KB, et al. Experience with the JAK-kinase inhibitor upadacitinib in children with rheumatic diseases. Vopr. prakt. pediatr. 2024;22(2):59-79.$17$YR$$F$Y$$$20240813$$MD$RU$RU
242073683$24207368$3$F$20240321$20240909$20240813$20240913$EXP$$US-ABBVIE-5873540$ABBVIE$$73$YR$$F$Y$78.47$KG$20240913$$HP$US$US
242073691$24207369$1$I$20240809$20240812$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127862$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$81.19$KG$20240814$$HP$US$US
242073701$24207370$1$I$$20240731$20240813$20240813$EXP$$US-SMPA-2024SPA000424$SUNOVION$$$$$$Y$$$20240813$$CN$US$US
242073711$24207371$1$I$20240710$20240731$20240813$20240813$EXP$$HU-SMPA-2024SPA000391$SUNOVION$$$$$$Y$$$20240813$$MD$GB$GB
242073722$24207372$2$F$20240601$20240828$20240813$20240902$EXP$$PR-ABBVIE-5877501$ABBVIE$$40$YR$$M$Y$90$KG$20240902$$CN$PR$PR
242073732$24207373$2$F$$20240910$20240813$20240924$EXP$$US-SMPA-2024SPA000425$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242073751$24207375$1$I$20230101$20240809$20240813$20240813$EXP$$US-ABBVIE-5875852$ABBVIE$$$$$F$Y$$$20240813$$CN$US$US
242073761$24207376$1$I$$20240809$20240813$20240813$EXP$$US-ABBVIE-5876151$ABBVIE$$$$$M$Y$$$20240813$$CN$US$US
242073771$24207377$1$I$20240701$20240805$20240813$20240813$EXP$$US-ABBVIE-5868250$ABBVIE$$66$YR$$F$Y$$$20240813$$CN$US$US
242073782$24207378$2$F$20240801$20240905$20240813$20240911$EXP$$JP-009507513-2408JPN000177J$MERCK$$7$DEC$$F$Y$$$20240911$$MD$JP$JP
242073801$24207380$1$I$$20240731$20240813$20240813$EXP$$US-SMPA-2024SPA000616$SUNOVION$$$$$$Y$$$20240813$$CN$US$US
242073812$24207381$2$F$20240715$20240806$20240813$20240819$EXP$$US-SMPA-2024SPA000641$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
242073821$24207382$1$I$20240512$20240731$20240813$20240813$EXP$$US-SMPA-2024SPA000663$SUNOVION$$$$$$Y$$$20240813$$CN$US$US
242073831$24207383$1$I$20240701$20240731$20240813$20240813$EXP$$US-SMPA-2024SPA000549$SUNOVION$$$$$$Y$$$20240813$$CN$US$US
242073851$24207385$1$I$20230312$20240802$20240813$20240813$EXP$$US-SMPA-2023MYSCI0300340$SUNOVION$$$$$$Y$$$20240813$$CN$US$US
242073862$24207386$2$F$20240101$20240813$20240813$20240816$EXP$$US-ABBVIE-5877520$ABBVIE$$68$YR$$M$Y$$$20240816$$HP$US$US
242073891$24207389$1$I$$20240731$20240813$20240813$PER$$US-APOTEX-2024AP009117$APOTEX$Singh A, Chidharla A, Jain N, Debnath N, Dawoodi I, Kukreja G.. IgD Multiple Myeloma, Does It Still Have a Poor Prognosis?. Blood. 2022;140 (Suppl.1):12520-12523$63$YR$$F$Y$$$20240813$$HP$US$US
242073901$24207390$1$I$20240601$20240809$20240813$20240813$EXP$$US-ABBVIE-5875464$ABBVIE$$69$YR$$F$Y$$$20240813$$CN$US$US
242073911$24207391$1$I$$20240809$20240813$20240813$PER$$US-JNJFOC-20240825013$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242073921$24207392$1$I$20240809$20240809$20240813$20240813$PER$$US-JNJFOC-20240823897$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240814$$CN$US$US
242073932$24207393$2$F$20240730$20240813$20240813$20240822$EXP$$CA-TAKEDA-2024TUS013024$TAKEDA$$62$YR$$M$Y$$$20240822$$CN$CA$CA
242073941$24207394$1$I$20230101$20240809$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128033$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240814$$CN$US$US
242073951$24207395$1$I$20240813$20240813$20240813$20240813$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045599$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240814$$CN$US$US
242073961$24207396$1$I$$20240808$20240813$20240813$PER$$US-ABBVIE-5877214$ABBVIE$$50$YR$$F$Y$$$20240813$$HP$US$US
242073971$24207397$1$I$20240701$20240806$20240813$20240813$EXP$$JP-AMGEN-JPNSP2024157179$AMGEN$$$$$F$Y$$$20240813$$MD$JP$JP
242073981$24207398$1$I$$20240731$20240813$20240813$PER$$US-APOTEX-2024AP009120$APOTEX$Thompson R, Taddei T, Kaplan D, Rabiee A.. Safety of naltrexone in patients with cirrhosis. JHEP-Repports. 2024;6 (7):1-5$$$A$$Y$$$20240813$$HP$US$US
242073991$24207399$1$I$20240805$20240805$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408002930$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240813$$CN$US$US
242074001$24207400$1$I$20240808$20240812$20240813$20240813$PER$$US-ELI_LILLY_AND_COMPANY-US202408007439$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240813$$MD$US$US
242074012$24207401$2$F$$20240918$20240813$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127197$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$76.2$KG$20240920$$CN$US$US
242074021$24207402$1$I$20240101$20240809$20240813$20240813$EXP$$DE-ABBVIE-5877021$ABBVIE$$77$YR$$M$Y$$$20240813$$HP$DE$DE
242074031$24207403$1$I$$20240812$20240813$20240813$EXP$PL-URPL-1-1310-2020$PL-ABBVIE-5878490$ABBVIE$$66$YR$$M$Y$$$20240813$$MD$PL$PL
242074041$24207404$1$I$$20240813$20240813$20240813$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045389$BOEHRINGER INGELHEIM$$39$YR$A$F$Y$100$KG$20240814$$PH$GB$GB
242074051$24207405$1$I$20240805$20240812$20240813$20240813$EXP$$US-ABBVIE-5878486$ABBVIE$$81$YR$$F$Y$$$20240813$$CN$US$US
242074061$24207406$1$I$$20240808$20240813$20240813$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128157$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240814$$HP$US$US
242074072$24207407$2$F$20240723$20240823$20240813$20240827$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-126328$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$42.64$KG$20240828$$CN$PR$PR
242074081$24207408$1$I$$20240806$20240813$20240813$EXP$$BR-TAKEDA-2024TUS080444$TAKEDA$$$$E$F$Y$37$KG$20240813$$CN$BR$BR
242074091$24207409$1$I$$20240807$20240813$20240813$EXP$$US-GSK-US2024098508$GLAXOSMITHKLINE$$$$$M$Y$$$20240813$$CN$US$US
242074101$24207410$1$I$$20231005$20240813$20240813$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240628$IRONSHORE PHARMA$$$$$M$Y$$$20240814$$HP$US$US
242074111$24207411$1$I$$20231020$20240813$20240813$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240613$IRONSHORE PHARMA$$$$$M$Y$$$20240814$$MD$US$US
242074121$24207412$1$I$$20231024$20240813$20240813$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240616$IRONSHORE PHARMA$$$$C$$Y$$$20240814$$MD$US$US
242074131$24207413$1$I$$20240731$20240813$20240813$PER$$US-APOTEX-2024AP009121$APOTEX$Soyster N, Brewer L, Scott ML.. Successful treatment of a patient with type II diabetes mellitus and familial partial lipodystrophy with glucagon-like peptide-1 agonist, hybrid closed loop pump system, and off label use of subcuatneous daily degludec due to high total daily dose of insulin. The American Journal of the Medical Sciences. 2024;367 (S1):S279-S280$18$YR$$F$Y$$$20240813$$HP$US$US
242074141$24207414$1$I$$20240806$20240813$20240813$EXP$$US-JNJFOC-20240814249$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$HP$US$US
242074151$24207415$1$I$$20231121$20240813$20240813$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240726$IRONSHORE PHARMA$$11$YR$C$F$Y$$$20240814$$HP$US$US
242074161$24207416$1$I$$20240808$20240813$20240813$PER$$US-HALEON-2191269$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242074171$24207417$1$I$20240807$20240807$20240814$20240814$PER$$US-ALXN-202408USA000505US$ALEXION PHARMACEUTICALS$$75$YR$$M$Y$$$20240814$$CN$US$US
242074181$24207418$1$I$20240101$20240807$20240814$20240814$EXP$$CA-ABBVIE-5874280$ABBVIE$$75$YR$$M$Y$$$20240814$$CN$CA$CA
242074191$24207419$1$I$$20240730$20240814$20240814$EXP$$JP-AMGEN-JPNSP2024160429$AMGEN$Sugimura N, Okamoto A, Uryu E, Miyashita M, Takao S. EP-1007 A case of luminal breast cancer with distant metastasis at first diagnosis that became HER2 positive after systemic therapy. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;429$$$$$Y$$$20240813$$MD$JP$JP
242074202$24207420$2$F$20240730$20240905$20240814$20240915$30DAY$$CA-JNJFOC-20240805638$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240916$$HP$CA$CA
242074211$24207421$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240830381$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$HP$US$US
242074231$24207423$1$I$20240725$20240812$20240814$20240814$EXP$$US-TAKEDA-2024TUS080957$TAKEDA$$73$YR$$M$Y$$$20240814$$CN$US$US
242074241$24207424$1$I$$20240805$20240814$20240814$PER$$US-APOTEX-2024AP009147$APOTEX$Parmar H, Biran N, Phull P, Vesole DH, Siegel DS.. Single-Center Experience of Car??lzomib-Based Combinations for Patients with Lymphoplasmacytic Lymphoma. blood. 2023;142:1684-1686$$$$$Y$$$20240814$$MD$US$US
242074251$24207425$1$I$20240804$20240806$20240814$20240814$PER$$US-SA-2024SA239446$SANOFI AVENTIS$$69$YR$E$F$Y$81.64$KG$20240814$$MD$US$US
242074261$24207426$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA237642$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240814$$MD$US$US
242074271$24207427$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA173057$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240814$$MD$US$US
242074281$24207428$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA238550$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240814$$HP$US$US
242074291$24207429$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA237658$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
242074302$24207430$2$F$$20240904$20240814$20240916$PER$$US-SA-2024SA238686$SANOFI AVENTIS$$$$A$M$Y$74.8$KG$20240916$$MD$US$US
242074311$24207431$1$I$20240725$20240808$20240814$20240814$EXP$$CN-ALCON LABORATORIES-ALC2024CN003737$ALCON$$40$YR$$F$Y$$$20240814$$CN$CN$CN
242074321$24207432$1$I$20240409$20240808$20240814$20240814$EXP$$NVSC2024DE091402$NOVARTIS$$$$A$F$Y$$$20240814$$MD$DE$DE
242074331$24207433$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA237980$SANOFI AVENTIS$$$$E$M$Y$98.88$KG$20240814$$MD$US$US
242074341$24207434$1$I$$20240805$20240814$20240814$PER$$US-APOTEX-2024AP009146$APOTEX$Parmar H, Biran N, Phull P, Vesole DH, Siegel DS.. Single-Center Experience of Car??lzomib-Based Combinations for Patients with Lymphoplasmacytic Lymphoma. blood. 2023;142 (Suppl. 1):1684-1686$$$$$Y$$$20240814$$MD$US$US
242074351$24207435$1$I$20240701$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126833$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240814$$CN$US$US
242074361$24207436$1$I$20240630$20240808$20240814$20240814$EXP$$GB-ABBVIE-5874898$ABBVIE$$59$YR$$M$Y$$$20240814$$HP$GB$GB
242074371$24207437$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA239383$SANOFI AVENTIS$$10$YR$C$M$Y$89.8$KG$20240814$$MD$US$US
242074381$24207438$1$I$20240601$20240807$20240814$20240814$EXP$$FR-AstraZeneca-2024A181668$ASTRAZENECA$$82$YR$$M$Y$$$20240814$$PH$FR$
242074391$24207439$1$I$$20240802$20240814$20240814$PER$$US-SA-2024SA233306$SANOFI AVENTIS$$$$E$F$Y$$$20240814$$MD$US$US
242074401$24207440$1$I$20240803$20240809$20240814$20240814$EXP$$CN-HALEON-2191428$Haleon PLC$$23$YR$$F$Y$49$KG$20240814$$HP$CN$CN
242074411$24207441$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA234413$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240814$$MD$US$US
242074432$24207443$2$F$20240811$20240812$20240814$20240819$PER$$US-AMGEN-USASP2024160496$AMGEN$$81$YR$E$F$Y$$$20240819$$CN$US$US
242074441$24207444$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA237825$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240814$$MD$US$US
242074453$24207445$3$F$20240101$20240829$20240814$20240905$EXP$$US-ABBVIE-5877549$ABBVIE$$$$$F$Y$68.945$KG$20240905$$CN$US$US
242074461$24207446$1$I$$20240808$20240814$20240814$EXP$$US-TAKEDA-2024TUS077283$TAKEDA$$$$$M$Y$$$20240814$$CN$US$US
242074472$24207447$2$F$20240501$20240819$20240814$20240822$EXP$$JP-HALEON-2190760$Haleon PLC$$8$DEC$$F$Y$$$20240822$$PH$JP$JP
242074481$24207448$1$I$$20240808$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125883$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240814$$CN$US$US
242074491$24207449$1$I$20240811$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128154$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$$$20240814$$CN$US$US
242074501$24207450$1$I$20240323$20240809$20240814$20240814$EXP$$US-ABBVIE-5876798$ABBVIE$$81$YR$$F$Y$$$20240814$$CN$US$US
242074511$24207451$1$I$20240101$20240809$20240814$20240814$EXP$$US-ABBVIE-5876849$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242074521$24207452$1$I$20240101$20240809$20240814$20240814$EXP$$US-ABBVIE-5875460$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242074531$24207453$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240830487$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242074541$24207454$1$I$$20240805$20240814$20240814$PER$$US-ABBVIE-5869790$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242074551$24207455$1$I$$20240809$20240814$20240814$EXP$$US-ABBVIE-5875845$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242074561$24207456$1$I$20240325$20240807$20240814$20240814$EXP$$US-ABBVIE-5873422$ABBVIE$$16$YR$$F$Y$54$KG$20240814$$CN$US$US
242074571$24207457$1$I$20230323$20240809$20240814$20240814$EXP$$FR-AFSSAPS-PV2023000361$Haleon PLC$$15$YR$$M$Y$60$KG$20240814$$MD$FR$FR
242074581$24207458$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164426$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
242074591$24207459$1$I$20240101$20240809$20240814$20240814$EXP$$CA-ABBVIE-5876032$ABBVIE$$48$YR$$M$Y$$$20240814$$CN$CA$CA
242074602$24207460$2$F$$20240904$20240814$20240911$PER$$US-AstraZeneca-2024A173717$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
242074611$24207461$1$I$20240101$20240809$20240814$20240814$EXP$$US-ABBVIE-5875916$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242074621$24207462$1$I$$20240806$20240814$20240814$PER$$US-APOTEX-2024AP009154$APOTEX$$$$$F$Y$$$20240814$$CN$US$US
242074631$24207463$1$I$20240601$20240812$20240814$20240814$EXP$$US-ABBVIE-5877812$ABBVIE$$74$YR$$F$Y$$$20240814$$CN$US$US
242074641$24207464$1$I$$20240812$20240814$20240814$EXP$$US-ABBVIE-5877916$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242074652$24207465$2$F$$20240904$20240814$20240909$EXP$$CN-TAKEDA-2024TUS079773$TAKEDA$$$$$F$Y$$$20240909$$CN$CN$CN
242074661$24207466$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126374$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$69.85$KG$20240814$$CN$US$US
242074671$24207467$1$I$$20240805$20240814$20240814$EXP$$RO-STERISCIENCE B.V.-2024-ST-001162$Steriscience PTE$Blaga, L. Risk factors for neonatal cholestasis in small gestational  age infants: case report and literature review. THE NEWBORN RESEARCH + REVIEWS. 2024;2(1):21-26$$$N$M$Y$$$20240814$$HP$RO$RO
242074681$24207468$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA235610$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240814$$HP$US$US
242074691$24207469$1$I$20240801$20240812$20240814$20240814$EXP$$US-ABBVIE-5877692$ABBVIE$$66$YR$$F$Y$$$20240814$$CN$US$US
242074701$24207470$1$I$$20240805$20240814$20240814$EXP$$LB-STRIDES ARCOLAB LIMITED-2024SP010159$STRIDES$Farhat M, Soutou B.. Case report: A case of resistant anti-SAE1 dermatomyositis with severe periorbital edema after hydroxychloroquine that responded to adalimumab.. Int-J-Rheum-Diseases. 2024;27 (3)$57$YR$$F$Y$$$20240814$$HP$LB$LB
242074712$24207471$2$F$$20240829$20240814$20240911$PER$$US-APOTEX-2024AP009123$APOTEX$$$$$F$Y$$$20240911$$CN$US$US
242074721$24207472$1$I$$20240806$20240814$20240814$EXP$$IN-NOVITIUMPHARMA-2024INNVP01568$NOVITIUM PHARMA$Akanksha Agarwal.Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum.BMJ case reports.28-DEC-2023;16:e255808$$$N$M$Y$$$20240814$$HP$IN$IN
242074731$24207473$1$I$$20240806$20240814$20240814$PER$$US-ALXN-202408USA000409US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242074741$24207474$1$I$$20240808$20240814$20240814$PER$$US-ROCHE-10000053130$ROCHE$$$$$M$Y$$$20240814$$CN$US$US
242074751$24207475$1$I$$20240808$20240814$20240814$EXP$$CN-TAKEDA-2024TUS079726$TAKEDA$$$$$M$Y$$$20240814$$CN$CN$CN
242074761$24207476$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA236295$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240814$$CN$US$US
242074771$24207477$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238718$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240814$$MD$US$US
242074785$24207478$5$F$20240801$20240830$20240814$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-024496$UNITED THERAPEUTICS$$61$YR$$F$Y$58.05$KG$20240906$$$US$US
242074791$24207479$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238277$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240814$$MD$US$US
242074801$24207480$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA234431$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240814$$MD$US$US
242074812$24207481$2$F$20230103$20240814$20240814$20240820$EXP$$US-ABBVIE-5877681$ABBVIE$$19$YR$$M$Y$50$KG$20240820$$CN$US$US
242074822$24207482$2$F$20240808$20240814$20240814$20240820$PER$$US-ABBVIE-5878082$ABBVIE$$31$YR$$F$Y$$$20240820$$HP$US$US
242074831$24207483$1$I$$20240812$20240814$20240814$EXP$$US-JNJFOC-20240829781$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$HP$US$US
242074841$24207484$1$I$$20240807$20240814$20240814$PER$$US-JNJFOC-20240827591$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$LW$US$US
242074851$24207485$1$I$$20240805$20240814$20240814$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP010087$STRIDES$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al.. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy.. Circ-Genom-Precis-Med. 2024;17 (2):E004353$14$YR$$M$Y$$$20240814$$MD$IT$IT
242074861$24207486$1$I$$20240805$20240814$20240814$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP010088$STRIDES$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al.. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy.. Circ-Genom-Precis-Med. 2024;17 (2):E004353$1$YR$$M$Y$$$20240814$$MD$IT$IT
242074874$24207487$4$F$$20240830$20240814$20240906$30DAY$$TR-JNJFOC-20240805087$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$PH$TR$TR
242074881$24207488$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160786$AMGEN$$$$$$Y$$$20240813$$PH$US$US
242074891$24207489$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010147$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$43$YR$$M$Y$$$20240814$$HP$NL$NL
242074901$24207490$1$I$20240801$20240812$20240814$20240814$EXP$$US-JNJFOC-20240830239$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240814$$HP$US$US
242074911$24207491$1$I$20240101$20240810$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045373$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$54.4$KG$20240814$$HP$US$US
242074921$24207492$1$I$$20240806$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US072431$SANDOZ$$$$$$Y$$$20240814$$PH$US$US
242074931$24207493$1$I$$20240801$20240814$20240814$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-122452$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240814$$HP$CA$CA
242074941$24207494$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010148$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$38$YR$$M$Y$$$20240814$$HP$NL$NL
242074951$24207495$1$I$20240714$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A182198$ASTRAZENECA$$$$$$Y$$$20240814$$CN$US$
242074961$24207496$1$I$$20240808$20240814$20240814$PER$$US-ALXN-202408USA000523US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242074971$24207497$1$I$20240404$20240807$20240814$20240814$EXP$$EG-SANDOZ INC.-SDZ2024EG013928$SANDOZ$$30$YR$$F$Y$55$KG$20240814$$PH$EG$EG
242074981$24207498$1$I$$20240806$20240814$20240814$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP010073$STRIDES$Anshu, Sinha A.. Study on Outcome of Pregnancy in Patients with Unilaterally Increased Uterine Artery Resistance in Second Trimester.. Int-J-Pharmac-Clin-Res. 2024;16 (6):1935-1939$$$$F$Y$$$20240814$$HP$IN$IN
242074993$24207499$3$F$20230101$20240821$20240814$20240829$EXP$$US-BIOGEN-2024BI01277717$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
242075001$24207500$1$I$20240801$20240808$20240814$20240814$EXP$$US-BIOGEN-2024BI01277728$BIOGEN$$65$YR$$F$Y$$$20240814$$CN$US$US
242075011$24207501$1$I$20240101$20240730$20240814$20240814$EXP$$JP-AMGEN-JPNSP2024139057$AMGEN$$$$E$F$Y$$$20240813$$MD$JP$JP
242075021$24207502$1$I$20130321$20240809$20240814$20240814$EXP$$PL-SANDOZ INC.-SDZ2024PL071671$SANDOZ$$61$YR$$F$Y$$$20240814$$HP$PL$PL
242075032$24207503$2$F$20240812$20240813$20240814$20240814$PER$$US-AMGEN-USASP2024160916$AMGEN$$61$YR$A$M$Y$$$20240814$$CN$US$US
242075042$24207504$2$F$20240809$20240820$20240814$20240826$PER$$US-AMGEN-USASP2024160490$AMGEN$$65$YR$E$F$Y$$$20240825$$CN$US$US
242075051$24207505$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010076$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$50$YR$$M$Y$$$20240814$$HP$NL$NL
242075061$24207506$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010081$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8.$39$YR$$M$Y$$$20240814$$HP$NL$NL
242075071$24207507$1$I$$20240805$20240814$20240814$EXP$$LB-PFIZER INC-202400232943$PFIZER$$82$YR$$F$Y$$$20240814$$MD$LB$LB
242075081$24207508$1$I$20240715$20240809$20240814$20240814$EXP$$CA-PFIZER INC-PV202400092568$PFIZER$$52$YR$$F$Y$83.3$KG$20240814$$HP$CA$CA
242075091$24207509$1$I$20220101$20240813$20240814$20240814$EXP$$US-PFIZER INC-202400235728$PFIZER$$$$E$$Y$$$20240814$$HP$US$US
242075101$24207510$1$I$20240701$20240808$20240814$20240814$EXP$$JP-PFIZER INC-202400235011$PFIZER$$$$$M$Y$$$20240814$$PH$JP$JP
242075112$24207511$2$F$20140801$20240813$20240814$20240821$EXP$$AU-BIOGEN-2024BI01277548$BIOGEN$$39$YR$$F$Y$$$20240821$$MD$AU$AU
242075121$24207512$1$I$$20240801$20240814$20240814$PER$$US-SA-2024SA235435$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242075131$24207513$1$I$20240807$20240812$20240814$20240814$PER$$US-ROCHE-10000055502$ROCHE$$77$YR$E$M$Y$76.8$KG$20240814$$HP$US$US
242075141$24207514$1$I$$20240808$20240814$20240814$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP010115$STRIDES$Bingert R, Kolbe V, Boy D, Buttner A.. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. [German].. Rechtsmedizin. 2023;33 (5):396-402.$17$YR$$M$Y$$$20240814$$HP$DE$DE
242075151$24207515$1$I$$20240806$20240814$20240814$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP010084$STRIDES$Majhi DN, Shetty RA, Nimonkar RA, Pardal MPS.. Clinicoepidemiological Profile of a Fatal Case of Scrub Typhus: Our Experience. Int-J-Pharmac-Clin-Res. 2024;16 (6):1116-1119.$37$YR$$F$Y$$$20240814$$HP$IN$IN
242075161$24207516$1$I$$20240807$20240814$20240814$EXP$$US-TAKEDA-2024TUS017102$TAKEDA$$$$$F$Y$$$20240814$$CN$US$US
242075171$24207517$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA239367$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
242075181$24207518$1$I$20240101$20240807$20240814$20240814$EXP$$US-ABBVIE-5872035$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242075191$24207519$1$I$$20240806$20240814$20240814$EXP$$AU-CELLTRION INC.-2024AU018820$CELLTRION$$$$$$Y$$$20240814$$HP$AU$AU
242075201$24207520$1$I$$20240805$20240814$20240814$EXP$JP-MLMSERVICE-20240729-PI146017-00270-1$JP-STRIDES ARCOLAB LIMITED-2024SP010017$STRIDES$Yoshizawa K, Yagi T, Uchida T, Moriguchi T, Moroi A, Ueki K.. Concomitant pyogenic spondylodiscitis and empyema following tongue cancer resection and wisdom tooth extraction: A case report and literature review.. Medicine. 2024;103(30):e39087$79$YR$$M$Y$$$20240814$$MD$JP$JP
242075211$24207521$1$I$20240812$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160120$AMGEN$$$$$F$Y$$$20240813$$HP$US$US
242075221$24207522$1$I$20240101$20240812$20240814$20240814$EXP$$US-JNJFOC-20240830777$JOHNSON AND JOHNSON$$24$YR$A$F$Y$$$20240814$$HP$US$US
242075231$24207523$1$I$20240705$20240806$20240814$20240814$EXP$FR-AFSSAPS-LY2024001128$FR-TEVA-VS-3230962$TEVA$$91$YR$$M$Y$65$KG$20240814$$PH$FR$FR
242075241$24207524$1$I$$20240729$20240814$20240814$PER$$US-NOVITIUMPHARMA-2024USNVP01499$NOVITIUM PHARMA$$$$$F$Y$$$20240814$$CN$US$US
242075251$24207525$1$I$$20240812$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045349$BOEHRINGER INGELHEIM$$$$$$Y$$$20240814$$CN$US$US
242075261$24207526$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236563$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240814$$MD$US$US
242075271$24207527$1$I$20240801$20240807$20240814$20240814$PER$$US-SA-2024SA236651$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240814$$MD$US$US
242075282$24207528$2$F$20240810$20240813$20240814$20240820$PER$$US-AMGEN-USASP2024160264$AMGEN$$63$YR$A$F$Y$$$20240819$$PH$US$US
242075291$24207529$1$I$20240722$20240808$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126072$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240814$$CN$US$US
242075301$24207530$1$I$$20240806$20240814$20240814$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP009888$STRIDES$Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G, et al.. Stevens-Johnson syndrome associated with drugs and vaccines in children: a case-control study.. Plos One. 2013;8:7:1-8$108$MON$$F$Y$$$20240814$$HP$IT$IT
242075311$24207531$1$I$$20240807$20240814$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001587$BLUEPRINT MEDICINES$$$$$F$Y$$$20240814$$CN$US$US
242075321$24207532$1$I$$20240810$20240814$20240814$EXP$$SA-AMGEN-SAUSP2024159672$AMGEN$Alalawi Y. F.; Alrashidi T. N.; Alshahrani E. H.. Pancreatitis with Intra abdominal Venous Thrombosis as an Initial Presentation of Parathyroid Adenoma: A Rare Clinical Presentation. The American journal of case reports. 2024;25:1-7$34$YR$A$F$Y$$$20240813$$HP$SA$SA
242075331$24207533$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160259$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242075341$24207534$1$I$$20240808$20240814$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001612$BLUEPRINT MEDICINES$$$$$M$Y$$$20240814$$CN$US$US
242075351$24207535$1$I$20240502$20240806$20240814$20240814$EXP$$RU-AstraZeneca-2024A179918$ASTRAZENECA$$15$YR$$F$Y$$$20240814$$MD$RU$
242075361$24207536$1$I$$20240806$20240814$20240814$PER$$US-AstraZeneca-2024A181933$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242075371$24207537$1$I$$20240807$20240814$20240814$EXP$$US-AstraZeneca-2024A181142$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242075381$24207538$1$I$20240810$20240810$20240814$20240814$PER$$US-AMGEN-USASP2024160928$AMGEN$$73$YR$E$M$Y$$$20240813$$CN$US$US
242075391$24207539$1$I$$20240805$20240814$20240814$EXP$$GB-MSNLABS-2024MSNLIT01755$MSN LABORATORIES$Del Mundo JS, Khan H.A rare presentation of geriatric non-epileptic seizures due to carotid artery encasement of a diffuse large B-cell lymphoma: A case report.Clinical medicine London.2024;24:100041$$$$$Y$$$20240814$$HP$GB$GB
242075401$24207540$1$I$20240801$20240807$20240814$20240814$PER$$US-SA-2024SA236770$SANOFI AVENTIS$$$$$M$Y$$$20240814$$MD$US$US
242075411$24207541$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236797$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240814$$MD$US$US
242075421$24207542$1$I$20240701$20240805$20240814$20240814$PER$$US-SA-2024SA236725$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240814$$MD$US$US
242075431$24207543$1$I$20240811$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160117$AMGEN$$74$YR$E$F$Y$$$20240813$$CN$US$US
242075441$24207544$1$I$20190101$20240807$20240814$20240814$EXP$$US-ABBVIE-5845155$ABBVIE$$$$$M$Y$113$KG$20240814$$CN$US$US
242075451$24207545$1$I$20240101$20240807$20240814$20240814$EXP$$US-ABBVIE-5872209$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242075461$24207546$1$I$$20240807$20240814$20240814$EXP$$US-AstraZeneca-2024A179785$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242075471$24207547$1$I$20240605$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A182271$ASTRAZENECA$$$$$M$Y$$$20240814$$HP$US$
242075481$24207548$1$I$$20240807$20240814$20240814$EXP$$ZA-AstraZeneca-2024A180136$ASTRAZENECA$$24106$DY$$M$Y$$$20240814$$CN$ZA$
242075491$24207549$1$I$20230101$20240807$20240814$20240814$EXP$$CA-UCBSA-2024040232$UCB$$$$$$Y$$$20240814$$CN$CA$CA
242075502$24207550$2$F$$20240828$20240814$20240911$PER$$US-APOTEX-2024AP009092$APOTEX$$$$$F$Y$$$20240911$$CN$US$US
242075511$24207551$1$I$$20240808$20240814$20240814$EXP$$US-ALXN-202408USA000558US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242075521$24207552$1$I$20230701$20240801$20240814$20240814$EXP$$US-NOVOPROD-1264977$NOVO NORDISK$$61$YR$$M$Y$$$20240814$$CN$US$US
242075531$24207553$1$I$20230101$20240807$20240814$20240814$EXP$$CA-UCBSA-2024040229$UCB$$$$$$Y$$$20240814$$CN$CA$CA
242075541$24207554$1$I$$20240807$20240814$20240814$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR098810$VIIV$$$$$F$Y$$$20240814$$HP$US$US
242075551$24207555$1$I$20240101$20240801$20240814$20240814$EXP$$US-NOVOPROD-1266883$NOVO NORDISK$$72$YR$$M$Y$$$20240814$$CN$US$US
242075561$24207556$1$I$$20240802$20240814$20240814$EXP$$US-NOVOPROD-1266977$NOVO NORDISK$$$$$F$Y$$$20240814$$CN$US$US
242075571$24207557$1$I$20240801$20240804$20240814$20240814$EXP$$GB-NOVOPROD-1264584$NOVO NORDISK$$52$YR$$M$Y$105$KG$20240814$$HP$GB$GB
242075581$24207558$1$I$$20240809$20240814$20240814$PER$$US-ROCHE-10000054237$ROCHE$$40$YR$A$M$Y$$$20240814$$HP$US$US
242075592$24207559$2$F$$20240814$20240814$20240826$EXP$$IL-NOVOPROD-1263381$NOVO NORDISK$$$$C$F$Y$14$KG$20240826$$MD$IL$IL
242075601$24207560$1$I$$20240801$20240814$20240814$EXP$$BR-NOVOPROD-1265062$NOVO NORDISK$$51$YR$$F$Y$$$20240814$$MD$BR$BR
242075611$24207561$1$I$$20240801$20240814$20240814$EXP$$US-NOVOPROD-1266635$NOVO NORDISK$$$$$F$Y$$$20240814$$HP$US$US
242075621$24207562$1$I$$20240804$20240814$20240814$EXP$$CN-NOVOPROD-1265342$NOVO NORDISK$$$$$M$Y$$$20240814$$CN$CN$CN
242075631$24207563$1$I$$20240804$20240814$20240814$EXP$$US-NOVOPROD-1267009$NOVO NORDISK$$44$YR$$$Y$$$20240814$$CN$US$US
242075641$24207564$1$I$$20240804$20240814$20240814$EXP$$US-NOVOPROD-1267331$NOVO NORDISK$$58$YR$$$Y$$$20240814$$CN$US$US
242075651$24207565$1$I$$20240804$20240814$20240814$EXP$$US-NOVOPROD-1266990$NOVO NORDISK$$$$$$Y$$$20240814$$CN$US$US
242075661$24207566$1$I$20240628$20240801$20240814$20240814$EXP$FR-AFSSAPS-RS2024000778$FR-NOVOPROD-1266852$NOVO NORDISK$$47$YR$$F$Y$72$KG$20240814$$MD$FR$FR
242075671$24207567$1$I$$20240802$20240814$20240814$EXP$$TR-NOVOPROD-1268183$NOVO NORDISK$$$$$M$Y$98$KG$20240814$$CN$TR$TR
242075692$24207569$2$F$20230101$20240731$20240814$20240821$EXP$$MX-BEH-2024177129$CSL BEHRING$$15$YR$T$M$Y$$$20240821$$CN$MX$MX
242075705$24207570$5$F$20240801$20240909$20240814$20240915$EXP$$NVSC2024KR162994$NOVARTIS$$4$MON$$F$Y$7.1$KG$20240916$$HP$KR$KR
242075711$24207571$1$I$20240721$20240808$20240814$20240814$EXP$CN-NMPA-46010511047559202400027$CN-NOVOPROD-1268208$NOVO NORDISK$$50$YR$$M$Y$$$20240814$$HP$CN$CN
242075722$24207572$2$F$20190101$20240813$20240814$20240823$EXP$$EG-NOVOPROD-1266036$NOVO NORDISK$$494$MON$$M$Y$54$KG$20240823$$CN$EG$EG
242075731$24207573$1$I$$20240805$20240814$20240814$EXP$$US-NOVOPROD-1267718$NOVO NORDISK$$$$$F$Y$$$20240814$$CN$US$US
242075741$24207574$1$I$20230101$20240807$20240814$20240814$EXP$$CA-UCBSA-2023030681$UCB$$$$$F$Y$$$20240814$$CN$CA$CA
242075751$24207575$1$I$20231030$20240805$20240814$20240814$EXP$$US-NOVOPROD-1267714$NOVO NORDISK$$39$YR$$$Y$$$20240814$$CN$US$US
242075761$24207576$1$I$$20240805$20240814$20240814$EXP$$US-NOVOPROD-1268033$NOVO NORDISK$$$$A$F$Y$$$20240814$$CN$US$US
242075772$24207577$2$F$$20240813$20240814$20240823$EXP$$EG-NOVOPROD-1265868$NOVO NORDISK$$888$MON$$M$Y$120$KG$20240823$$CN$EG$EG
242075782$24207578$2$F$$20240820$20240814$20240830$EXP$$BR-NOVOPROD-1266039$NOVO NORDISK$$50$YR$$M$Y$$$20240830$$MD$BR$BR
242075792$24207579$2$F$$20240813$20240814$20240823$EXP$$EG-NOVOPROD-1266000$NOVO NORDISK$$888$MON$$M$Y$120$KG$20240823$$CN$EG$EG
242075801$24207580$1$I$$20240804$20240814$20240814$EXP$$US-NOVOPROD-1267912$NOVO NORDISK$$52$YR$$$Y$$$20240814$$CN$US$US
242075811$24207581$1$I$$20240805$20240814$20240814$EXP$$GB-NOVOPROD-1265941$NOVO NORDISK$$$$$M$Y$$$20240814$$HP$GB$GB
242075821$24207582$1$I$20240501$20240805$20240814$20240814$EXP$$US-NOVOPROD-1267629$NOVO NORDISK$$51$YR$$M$Y$$$20240814$$CN$US$US
242075831$24207583$1$I$20240809$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007632$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240814$$CN$US$US
242075841$24207584$1$I$20240810$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007449$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240814$$CN$US$US
242075851$24207585$1$I$$20240808$20240814$20240814$PER$$US-CHATTEMPRD-2024OHG026776$CHATTEM$$$$$$Y$$$20240814$$CN$US$US
242075862$24207586$2$F$$20240909$20240814$20240924$PER$$US-APOTEX-2024AP009091$APOTEX$$$$$$Y$$$20240924$$HP$US$US
242075871$24207587$1$I$$20240806$20240814$20240814$PER$$US-CHATTEMPRD-2024OHG026581$CHATTEM$$$$E$F$Y$$$20240814$$CN$US$US
242075882$24207588$2$F$20240701$20240829$20240814$20240911$PER$$US-APOTEX-2024AP009093$APOTEX$$$$$F$Y$$$20240911$$CN$US$US
242075891$24207589$1$I$20240702$20240806$20240814$20240814$EXP$$CN-BEIGENE-BGN-2024-012272$BEIGENE$$$$$$Y$$$20240814$$HP$CN$CN
242075902$24207590$2$F$20240101$20240816$20240814$20240820$PER$$US-AMGEN-USASP2024158141$AMGEN$$65$YR$E$F$Y$$$20240820$$CN$US$US
242075911$24207591$1$I$$20240808$20240814$20240814$PER$$US-CHATTEMPRD-2024OHG026865$CHATTEM$$$$E$F$Y$$$20240814$$CN$US$US
242075923$24207592$3$F$$20240826$20240814$20240830$PER$$US-CHATTEMPRD-2024OHG026618$CHATTEM$$70$YR$E$F$Y$$$20240830$$CN$US$US
242075931$24207593$1$I$$20240807$20240814$20240814$EXP$$US-AstraZeneca-2024A179780$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242075941$24207594$1$I$20230223$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A182457$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242075951$24207595$1$I$20220710$20240813$20240814$20240814$EXP$PT-INFARMED-M202210-462$PT-ROCHE-10000055673$ROCHE$$64$YR$A$$Y$100$KG$20240814$$MD$PT$PT
242075961$24207596$1$I$$20240809$20240814$20240814$EXP$DE-EMBRYOTOX-202302242$DE-GSK-DE2024099609$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$DE$DE
242075971$24207597$1$I$$20240808$20240814$20240814$PER$$US-CHATTEMPRD-2024OHG026747$CHATTEM$$$$$F$Y$$$20240814$$CN$US$US
242075982$24207598$2$F$20240508$20240821$20240814$20240825$30DAY$$US-AMGEN-USASP2024150441$AMGEN$$63$YR$A$F$Y$84.58$KG$20240825$$PH$US$US
242075992$24207599$2$F$20240806$20240806$20240814$20240820$PER$$US-CHATTEMPRD-2024OHG026685$CHATTEM$$$$A$$Y$$$20240820$$CN$US$US
242076001$24207600$1$I$$20240808$20240814$20240814$EXP$$CA-TAKEDA-2023TUS023659$TAKEDA$$$$$F$Y$$$20240814$$CN$CA$CA
242076012$24207601$2$F$$20240815$20240814$20240820$PER$$NVSC2024US164424$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242076021$24207602$1$I$20240425$20240812$20240814$20240814$EXP$IE-HPRA-2024-114637$IE-GSK-IE2024100217$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$IE$IE
242076031$24207603$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164374$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242076043$24207604$3$F$$20240906$20240814$20240913$30DAY$$FR-JNJFOC-20240812331$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240913$$PH$FR$FR
242076051$24207605$1$I$20240727$20240805$20240814$20240814$EXP$$CN-JNJFOC-20240819432$JOHNSON AND JOHNSON$$59$YR$A$M$Y$80$KG$20240814$$HP$CN$CN
242076061$24207606$1$I$$20240807$20240814$20240814$PER$$US-JNJFOC-20240819916$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$US$US
242076071$24207607$1$I$$20240808$20240814$20240814$EXP$$US-TERSERA THERAPEUTICS LLC-2024TRS004023$TERSERA THERAPEUTICS$$$$$$Y$$$20240814$$HP$US$US
242076081$24207608$1$I$$20240807$20240814$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001591$BLUEPRINT MEDICINES$$$$$F$Y$$$20240814$$HP$US$US
242076092$24207609$2$F$$20240814$20240814$20240827$PER$$US-MSNLABS-2024MSNSPO01768$MSN LABORATORIES$$$$$$Y$$$20240827$$CN$US$US
242076113$24207611$3$F$20240811$20240904$20240814$20240905$PER$$US-AMGEN-USASP2024160911$AMGEN$$65$YR$E$F$Y$$$20240905$$PH$US$US
242076121$24207612$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160995$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242076131$24207613$1$I$$20240808$20240814$20240814$EXP$$JP-AMGEN-JPNSP2024157912$AMGEN$$$$$$Y$$$20240813$$MD$JP$JP
242076141$24207614$1$I$$20240805$20240814$20240814$EXP$$DE-CELLTRION INC.-2024DE018961$CELLTRION$Lukac S, Wenzel R, Schochter F, Friebe-Hoffmann U, Huner B, Janni W.. Pregnancy after advanced ovarian cancer with spontaneous uterine rupture in second trimester: A case report and review of the literature. International Journal of Gynecology + Obstetrics. 2024;1-6$$$$$Y$$$20240814$$HP$DE$DE
242076151$24207615$1$I$$20240809$20240814$20240814$PER$$US-JNJFOC-20240828409$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$HP$US$US
242076162$24207616$2$F$20240905$20240905$20240814$20240911$EXP$$CA-TAKEDA-2024TUS080965$TAKEDA$$52$YR$$F$Y$$$20240911$$CN$CA$CA
242076171$24207617$1$I$20240731$20240806$20240814$20240814$PER$$US-SA-2024SA235370$SANOFI AVENTIS$$$$$F$Y$$$20240814$$MD$US$US
242076191$24207619$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA236614$SANOFI AVENTIS$$$$I$$Y$$$20240814$$MD$US$US
242076201$24207620$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA237045$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240814$$MD$US$US
242076211$24207621$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA237727$SANOFI AVENTIS$$$$E$M$Y$$$20240814$$MD$US$US
242076221$24207622$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA239372$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240814$$MD$US$US
242076241$24207624$1$I$$20240730$20240814$20240814$PER$$US-AMGEN-USASP2024160296$AMGEN$$75$YR$E$F$Y$$$20240813$$CN$US$US
242076252$24207625$2$F$20240801$20240920$20240814$20240926$30DAY$$US-AMGEN-USASP2024157416$AMGEN$$66$YR$E$F$Y$43$KG$20240926$$PH$US$US
242076261$24207626$1$I$$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128175$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$$$20240814$$CN$US$US
242076272$24207627$2$F$20240801$20240819$20240814$20240826$PER$$US-AMGEN-USASP2024157417$AMGEN$$70$YR$E$M$Y$86.4$KG$20240826$$PH$US$US
242076282$24207628$2$F$20240809$20240809$20240814$20240820$PER$$US-AMGEN-USASP2024159272$AMGEN$$74$YR$E$M$Y$$$20240819$$PH$US$US
242076291$24207629$1$I$20240101$20240807$20240814$20240814$EXP$$FR-AstraZeneca-2024A179453$ASTRAZENECA$$74$YR$$F$Y$65$KG$20240814$$MD$FR$
242076301$24207630$1$I$$20240807$20240814$20240814$EXP$$ZA-AstraZeneca-2024A180325$ASTRAZENECA$$23010$DY$$F$Y$$$20240814$$CN$ZA$
242076311$24207631$1$I$20240701$20240807$20240814$20240814$EXP$$FR-AstraZeneca-2024A179145$ASTRAZENECA$$39$YR$$M$Y$$$20240814$$MD$FR$
242076321$24207632$1$I$20240101$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A182232$ASTRAZENECA$$$$$M$Y$$$20240814$$HP$US$
242076331$24207633$1$I$20240811$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007462$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242076341$24207634$1$I$$20240806$20240814$20240814$EXP$$TW-ROCHE-10000049708$ROCHE$$$$$$Y$$$20240814$$MD$TW$TW
242076351$24207635$1$I$$20240806$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408004515$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240814$$CN$US$US
242076361$24207636$1$I$20240101$20240806$20240814$20240814$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000694$DECIPHERA PHARMACEUTICALS$$76$YR$E$F$Y$$$20240814$$HP$US$US
242076372$24207637$2$F$20240801$20240909$20240814$20240917$30DAY$$AR-JNJFOC-20240814036$JOHNSON AND JOHNSON$$58$YR$A$M$Y$62$KG$20240917$$CN$AR$AR
242076381$24207638$1$I$$20240807$20240814$20240814$PER$$US-ROCHE-10000051570$ROCHE$$$$$$Y$$$20240814$$PH$US$US
242076391$24207639$1$I$$20240724$20240814$20240814$PER$$US-JNJFOC-20240772508$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240814$$CN$US$US
242076401$24207640$1$I$20240801$20240812$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045098$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$$$20240814$$CN$US$US
242076422$24207642$2$F$20240803$20240814$20240814$20240820$30DAY$$US-AMGEN-USASP2024157561$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242076431$24207643$1$I$20240627$20240809$20240814$20240814$EXP$$CA-TAKEDA-2024TUS065492$TAKEDA$$61$YR$$F$Y$$$20240814$$CN$CA$CA
242076441$24207644$1$I$$20240809$20240814$20240814$EXP$$CA-ABBVIE-5875958$ABBVIE$$$$A$F$Y$$$20240814$$CN$CA$CA
242076452$24207645$2$F$$20240912$20240814$20240912$PER$$US-ALXN-202408USA000561US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
242076461$24207646$1$I$20240624$20240808$20240814$20240814$EXP$$IE-JNJFOC-20240637736$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240814$$CN$IE$IE
242076471$24207647$1$I$20130101$20240812$20240814$20240814$EXP$$GR-JNJFOC-20240828831$JOHNSON AND JOHNSON$$23$YR$A$M$Y$14.5$KG$20240814$$HP$GR$GR
242076481$24207648$1$I$20240811$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160612$AMGEN$$79$YR$E$F$Y$$$20240813$$PH$US$US
242076491$24207649$1$I$20240811$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160289$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
242076502$24207650$2$F$$20240813$20240814$20240814$PER$$NVSC2024US164626$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242076511$24207651$1$I$$20240807$20240814$20240814$EXP$$GB-CELLTRION INC.-2024GB019157$CELLTRION$$$$$$Y$$$20240814$$HP$GB$GB
242076521$24207652$1$I$20240719$20240805$20240814$20240814$EXP$FI-FIMEA-202402676$FI-Blueprint Medicines Corporation-SP-FI-2024-001576$BLUEPRINT MEDICINES$$58$YR$A$M$Y$$$20240814$$HP$FI$FI
242076531$24207653$1$I$$20240805$20240814$20240814$EXP$$KR-SA-2024SA233843$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240814$$CN$KR$KR
242076542$24207654$2$F$$20240818$20240814$20240826$EXP$$JP-GENMAB-2024-02869$GENMAB$$84$YR$$F$Y$$$20240826$$MD$JP$JP
242076551$24207655$1$I$$20240812$20240814$20240814$EXP$$US-ABBVIE-5878039$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242076561$24207656$1$I$$20240808$20240814$20240814$PER$$US-AMGEN-USASP2024158275$AMGEN$$$$$F$Y$$$20240813$$MD$US$US
242076571$24207657$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164370$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
242076582$24207658$2$F$$20240829$20240814$20240829$PER$$US-ALXN-202408USA000563US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242076592$24207659$2$F$20230718$20240911$20240814$20240919$EXP$$CA-CELLTRION INC.-2023CA012999$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
242076601$24207660$1$I$20240810$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007634$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240814$$CN$US$US
242076611$24207661$1$I$20240809$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007886$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240814$$CN$US$US
242076621$24207662$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008045$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240814$$CN$US$US
242076631$24207663$1$I$$20240809$20240814$20240814$EXP$$US-JNJFOC-20240829000$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$MD$US$US
242076641$24207664$1$I$$20240806$20240814$20240814$PER$$US-ROCHE-10000050879$ROCHE$$77$YR$E$F$Y$$$20240814$$HP$US$US
242076652$24207665$2$F$20240804$20240905$20240814$20240909$PER$$US-ROCHE-10000050774$ROCHE$$17$YR$T$F$Y$$$20240909$$CN$US$US
242076661$24207666$1$I$$20240812$20240814$20240814$PER$$US-GILEAD-2024-0683901$GILEAD$$$$A$M$Y$$$20240813$$CN$US$US
242076671$24207667$1$I$$20240731$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039826$AUROBINDO$Lajoie C, Ghanemi A, Bourbeau K, Sidibe A, Wang YP, Desmeules S, et al. Multimodality approach to treat calciphylaxis in end-stage kidney disease patients. Ren-Fail. 2023;45 (2):2256413$82$YR$$F$Y$$$20240814$$HP$CA$CA
242076682$24207668$2$F$$20240814$20240814$20240816$PER$$US-AMGEN-USASP2024160488$AMGEN$$$$$F$Y$$$20240816$$CN$US$US
242076691$24207669$1$I$$20240806$20240814$20240814$PER$$US-ROCHE-10000052459$ROCHE$$49$YR$A$M$Y$$$20240814$$CN$US$US
242076701$24207670$1$I$$20240812$20240814$20240814$30DAY$$US-SANDOZ INC.-SDZ2024US072380$SANDOZ$$$$$F$Y$$$20240814$$CN$US$US
242076721$24207672$1$I$$20240808$20240814$20240814$PER$$US-ROCHE-10000053571$ROCHE$$$$$$Y$$$20240814$$CN$US$US
242076731$24207673$1$I$20240801$20240809$20240814$20240814$PER$$US-ROCHE-10000054431$ROCHE$$67$YR$E$F$Y$$$20240814$$CN$US$US
242076741$24207674$1$I$$20240812$20240814$20240814$PER$$US-ROCHE-10000055826$ROCHE$$23$YR$A$M$Y$$$20240814$$CN$US$US
242076751$24207675$1$I$$20240812$20240814$20240814$PER$$US-ROCHE-10000055338$ROCHE$$58$YR$A$F$Y$$$20240814$$CN$US$US
242076761$24207676$1$I$20240701$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127752$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240814$$CN$US$US
242076771$24207677$1$I$$20240810$20240814$20240814$PER$$US-JNJFOC-20240827887$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242076781$24207678$1$I$$20240805$20240814$20240814$EXP$$US-MSNLABS-2024MSNLIT01754$MSN LABORATORIES$Fenner EG, Simpson CE.An adult patient with pulmonary arterial hypertension, a NOTCH3 mutation, and leflunomide exposure.Pulmonary Circulation.2024;14:e12411$$$$$Y$$$20240814$$HP$US$US
242076791$24207679$1$I$$20240730$20240814$20240814$PER$$US-NOVITIUMPHARMA-2024USNVP01528$NOVITIUM PHARMA$$66$YR$A$M$Y$96.2$KG$20240814$$CN$US$US
242076801$24207680$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164428$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
242076811$24207681$1$I$20230811$20240811$20240814$20240814$PER$$US-AMGEN-USASP2024160321$AMGEN$$63$YR$A$F$Y$$$20240813$$CN$US$US
242076821$24207682$1$I$20240730$20240805$20240814$20240814$30DAY$$US-GSK-US2024097554$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240814$$CN$US$US
242076831$24207683$1$I$20240101$20240809$20240814$20240814$EXP$$DE-BIOGEN-2024BI01277917$BIOGEN$$$$$F$Y$$$20240814$$MD$DE$DE
242076841$24207684$1$I$20240809$20240812$20240814$20240814$EXP$$US-AstraZeneca-2024A183361$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242076851$24207685$1$I$20231201$20240807$20240814$20240814$EXP$$FR-AstraZeneca-2024A179152$ASTRAZENECA$$65$YR$$M$Y$$$20240814$$MD$FR$
242076861$24207686$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179314$ASTRAZENECA$$$$$F$Y$$$20240814$$HP$US$
242076871$24207687$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A178970$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242076891$24207689$1$I$$20240809$20240814$20240814$PER$$US-ROCHE-10000054654$ROCHE$$$$A$F$Y$$$20240814$$CN$US$US
242076901$24207690$1$I$$20240731$20240814$20240814$EXP$$CA-MIRUM PHARMACEUTICALS, INC.-CA-MIR-24-00603$MIRUM PHARMACEUTICALS$$$$$$Y$$$20240814$$CN$CA$CA
242076911$24207691$1$I$20240805$20240805$20240814$20240814$EXP$$US-GSK-US2024097538$GLAXOSMITHKLINE$$$$$M$Y$$$20240814$$CN$US$US
242076922$24207692$2$F$$20240906$20240814$20240910$PER$$US-BIOGEN-2024BI01277765$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
242076931$24207693$1$I$$20240809$20240814$20240814$EXP$$US-BIOGEN-2024BI01277904$BIOGEN$$$$$$Y$$$20240814$$CN$US$US
242076941$24207694$1$I$20240627$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003854$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240814$$CN$US$US
242076951$24207695$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164135$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
242076971$24207697$1$I$$20240801$20240814$20240814$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000683$DECIPHERA PHARMACEUTICALS$$75$YR$E$M$Y$$$20240814$$CN$US$US
242076981$24207698$1$I$20240721$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003793$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240814$$CN$US$US
242076991$24207699$1$I$$20240808$20240814$20240814$EXP$$MX-EMD Serono-2024043199$EMD SERONO INC$$$$T$F$Y$$$20240814$$CN$MX$MX
242077001$24207700$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007729$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240814$$CN$US$US
242077011$24207701$1$I$20240730$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007410$ELI LILLY AND CO$$$$$M$Y$$$20240814$$CN$US$US
242077021$24207702$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160922$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
242077032$24207703$2$F$20240601$20240809$20240814$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408005251$ELI LILLY AND CO$$89$YR$E$F$Y$$$20240818$$CN$US$US
242077041$24207704$1$I$$20240808$20240814$20240814$PER$$US-ALXN-202408USA000576US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240814$$CN$US$US
242077053$24207705$3$F$$20240910$20240814$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003807$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242077063$24207706$3$F$$20240905$20240814$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003805$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242077071$24207707$1$I$20240719$20240722$20240814$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003796$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240814$$CN$US$US
242077082$24207708$2$F$$20240822$20240814$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003799$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
242077091$24207709$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003803$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242077101$24207710$1$I$20240811$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024161167$AMGEN$$$$$F$Y$$$20240813$$CN$US$US
242077114$24207711$4$F$$20240906$20240814$20240910$PER$$US-AMGEN-USASP2024161012$AMGEN$$$$$M$Y$$$20240910$$CN$US$US
242077121$24207712$1$I$20240811$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160284$AMGEN$$47$YR$A$F$Y$$$20240813$$CN$US$US
242077131$24207713$1$I$$20240808$20240814$20240814$PER$$US-BIOGEN-2024BI01277950$BIOGEN$$$$$M$Y$$$20240814$$CN$US$US
242077142$24207714$2$F$$20240814$20240814$20240821$EXP$$US-AMGEN-USASL2024159398$AMGEN$$46$YR$A$F$Y$$$20240821$$MD$US$US
242077152$24207715$2$F$20230601$20240821$20240814$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003811$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240913$$CN$US$US
242077162$24207716$2$F$$20240904$20240814$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003810$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242077171$24207717$1$I$$20221108$20240814$20240814$EXP$$EG-JNJFOC-20240828910$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240814$$CN$EG$EG
242077181$24207718$1$I$$20240811$20240814$20240814$PER$$US-HALEON-2191793$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242077191$24207719$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179958$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242077201$24207720$1$I$$20240806$20240814$20240814$PER$$US-ABBVIE-5870521$ABBVIE$$$$$$Y$$$20240814$$CN$US$US
242077211$24207721$1$I$$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A182377$ASTRAZENECA$$$$$M$Y$$$20240814$$HP$US$
242077221$24207722$1$I$$20240806$20240814$20240814$EXP$$ZA-AstraZeneca-2024A179106$ASTRAZENECA$$59$YR$$F$Y$$$20240814$$CN$ZA$
242077232$24207723$2$F$$20240913$20240814$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003808$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
242077251$24207725$1$I$20240731$20240805$20240814$20240814$EXP$$CN-TAKEDA-2024TUS078531$TAKEDA$$76$YR$$M$Y$61.2$KG$20240814$$HP$CN$CN
242077261$24207726$1$I$20240719$20240806$20240814$20240814$EXP$$CN-BEIGENE-BGN-2024-012261$BEIGENE$$$$$$Y$$$20240814$$HP$CN$CN
242077273$24207727$3$F$20240731$20240903$20240814$20240904$PER$$US-AMGEN-USASP2024160714$AMGEN$$42$YR$A$$Y$$$20240903$$CN$US$US
242077282$24207728$2$F$20240724$20240910$20240814$20240914$PER$$US-ABBVIE-5876901$ABBVIE$$38$YR$$F$Y$79$KG$20240914$$MD$US$US
242077292$24207729$2$F$$20240819$20240814$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003812$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
242077301$24207730$1$I$$20240722$20240814$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003855$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242077311$24207731$1$I$20221130$20240807$20240814$20240814$EXP$$GB-CELLTRION INC.-2022GB020520$CELLTRION$$$$$$Y$$$20240814$$CN$GB$GB
242077321$24207732$1$I$$20240808$20240814$20240814$PER$$US-BIOGEN-2024BI01271237$BIOGEN$$$$$M$Y$$$20240814$$CN$US$US
242077331$24207733$1$I$20240721$20240801$20240814$20240814$PER$$US-IGSA-BIG0030184$GRIFOLS$$51$YR$$M$Y$$$20240814$$HP$US$US
242077342$24207734$2$F$20140101$20240827$20240814$20240903$EXP$NL-EMA-DD-20240806-7482677-163140$IE-TAKEDA-2024TUS080202$TAKEDA$$67$YR$$F$Y$$$20240903$$HP$NL$NL
242077351$24207735$1$I$$20240808$20240814$20240814$EXP$$US-TAKEDA-2024TUS046763$TAKEDA$$$$$M$Y$$$20240814$$CN$US$US
242077361$24207736$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164430$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
242077371$24207737$1$I$20240801$20240806$20240814$20240814$EXP$$CA-CELLTRION INC.-2024CA018987$CELLTRION$$$$$$Y$$$20240814$$MD$CA$CA
242077382$24207738$2$F$$20240820$20240814$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003851$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
242077401$24207740$1$I$$20240731$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039833$AUROBINDO$Albanese I, Nicolas N, Mitmaker E, Vautour L, Wing SS.. A Curious Case Of Severe Reversible PTH-mediated Hypercalcemia Of Pregnancy. Journal of the Endocrine Society. 2023;Suppl. 1(7):A265-A266$$$$$Y$$$20240814$$HP$CA$CA
242077411$24207741$1$I$20240301$20240806$20240814$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-009423$UNITED THERAPEUTICS$$64$YR$$M$Y$$$20240814$$$US$US
242077421$24207742$1$I$20240101$20240806$20240814$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-012422$UNITED THERAPEUTICS$$$$$M$Y$74.83$KG$20240814$$$US$US
242077431$24207743$1$I$20231201$20240807$20240814$20240814$EXP$FR-AFSSAPS-MP2024001191$FR-ROCHE-10000051764$ROCHE$$90$YR$E$M$Y$101$KG$20240814$$PH$FR$FR
242077441$24207744$1$I$$20240812$20240814$20240814$EXP$$CN-TAKEDA-2024TUS080934$TAKEDA$$$$$M$Y$$$20240814$$CN$CN$CN
242077451$24207745$1$I$20240721$20240722$20240814$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003856$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240814$$CN$US$US
242077461$24207746$1$I$$20240730$20240814$20240814$PER$$US-RISINGPHARMA-US-2024RISSPO00281$RISING PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242077471$24207747$1$I$$20240808$20240814$20240814$PER$$US-ABBVIE-5877618$ABBVIE$$$$$$Y$$$20240814$$CN$US$US
242077481$24207748$1$I$$20240811$20240814$20240814$PER$$NVSC2024US164367$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
242077491$24207749$1$I$20240807$20240808$20240814$20240814$EXP$$US-JNJFOC-20240827464$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240814$$HP$US$US
242077501$24207750$1$I$$20240812$20240814$20240814$EXP$$US-JNJFOC-20240830826$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240814$$HP$US$US
242077521$24207752$1$I$$20240611$20240814$20240814$EXP$$US-SPECGX-T202401328$SPECGX$$$$$$Y$$$20240814$$CN$US$US
242077531$24207753$1$I$$20240806$20240814$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-009695$UNITED THERAPEUTICS$$$$$F$Y$81.179$KG$20240814$$$US$US
242077541$24207754$1$I$$20240522$20240814$20240814$EXP$$US-SPECGX-T202401206$SPECGX$$$$$$Y$$$20240814$$CN$US$US
242077551$24207755$1$I$$20240312$20240814$20240814$EXP$$US-SPECGX-T202400745$SPECGX$$$$$F$Y$$$20240814$$CN$US$US
242077562$24207756$2$F$$20231127$20240814$20240814$EXP$$US-SPECGX-T202302286$SPECGX$$$$$F$Y$71$KG$20240814$$HP$US$US
242077571$24207757$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191838$Haleon PLC$$$$$M$Y$$$20240814$$CN$US$US
242077581$24207758$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003857$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242077591$24207759$1$I$20240807$20240807$20240814$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-024616$UNITED THERAPEUTICS$$80$YR$$M$Y$63.492$KG$20240814$$$US$US
242077601$24207760$1$I$20231210$20240802$20240814$20240814$EXP$$JP-AMGEN-JPNNI2024159926$AMGEN$$80$YR$E$M$Y$65.4$KG$20240813$$MD$JP$JP
242077612$24207761$2$F$20240809$20240821$20240814$20240823$PER$$US-AMGEN-USASP2024159345$AMGEN$$66$YR$E$F$Y$$$20240823$$CN$US$US
242077621$24207762$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003852$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242077631$24207763$1$I$20240101$20240807$20240814$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-024660$UNITED THERAPEUTICS$$$$$F$Y$61.224$KG$20240814$$$US$US
242077641$24207764$1$I$20240812$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160709$AMGEN$$76$YR$E$F$Y$$$20240813$$CN$US$US
242077653$24207765$3$F$20240812$20240906$20240814$20240910$PER$$US-AMGEN-USASP2024160955$AMGEN$$72$YR$E$F$Y$$$20240910$$CN$US$US
242077661$24207766$1$I$$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A182322$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242077671$24207767$1$I$$20230811$20240814$20240814$EXP$$US-AstraZeneca-2023A184789$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242077681$24207768$1$I$$20240807$20240814$20240814$EXP$$US-AstraZeneca-2024A180307$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242077691$24207769$1$I$20240630$20240807$20240814$20240814$EXP$$EC-AstraZeneca-2024A182558$ASTRAZENECA$$86$YR$$F$Y$$$20240814$$MD$EC$
242077701$24207770$1$I$$20240722$20240814$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003858$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240814$$HP$US$US
242077711$24207771$1$I$20240811$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007467$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240814$$CN$US$US
242077721$24207772$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007683$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240814$$CN$US$US
242077731$24207773$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006647$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240814$$CN$US$US
242077751$24207775$1$I$$20240806$20240814$20240814$EXP$$CA-JNJFOC-20240823979$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$HP$CA$CA
242077761$24207776$1$I$20240406$20240808$20240814$20240814$EXP$CH-SM-2024-14529$CH-JNJFOC-20240820208$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$PH$CH$CH
242077771$24207777$1$I$20240804$20240806$20240814$20240814$EXP$$CN-BEIGENE-BGN-2024-012263$BEIGENE$$$$$$Y$$$20240814$$HP$CN$CN
242077781$24207778$1$I$$20240812$20240814$20240814$PER$$US-ROCHE-10000055503$ROCHE$$$$$$Y$$$20240814$$CN$US$US
242077791$24207779$1$I$20240628$20240715$20240814$20240814$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR099350$VIIV$$45$YR$$M$Y$$$20240814$$CN$US$US
242077802$24207780$2$F$$20240821$20240814$20240827$EXP$$GB-TAKEDA-2024TUS076470$TAKEDA$$$$$M$Y$$$20240827$$CN$GB$GB
242077811$24207781$1$I$20240603$20240806$20240814$20240814$EXP$$CN-BEIGENE-BGN-2024-012270$BEIGENE$$$$$$Y$$$20240814$$HP$CN$CN
242077821$24207782$1$I$20240101$20240808$20240814$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-018093$UNITED THERAPEUTICS$$$$$M$Y$107.03$KG$20240814$$$US$US
242077842$24207784$2$F$20240101$20240830$20240814$20240913$PER$$US-APOTEX-2024AP009113$APOTEX$$$$$F$Y$$$20240913$$CN$US$US
242077851$24207785$1$I$20240101$20240802$20240814$20240814$EXP$$GB-ASPEN-GLO2024GB005419$ASPEN$$$$$$Y$$$20240814$$PH$GB$GB
242077861$24207786$1$I$20240720$20240809$20240814$20240814$EXP$$US-KYOWAKIRIN-2024KK019056$KYOWA$$$$$$Y$$$20240814$$HP$US$US
242077871$24207787$1$I$$20240809$20240814$20240814$PER$$US-JNJFOC-20240825465$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242077891$24207789$1$I$20240101$20240806$20240814$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-016164$UNITED THERAPEUTICS$$$$$M$Y$$$20240814$$$US$US
242077901$24207790$1$I$$20240807$20240814$20240814$EXP$$CN-RDY-LIT/CHN/24/0011792$DR REDDYS$Bao L, Lu M, Liu P, Wang Y, Zhuang J, Zhang M, et al. Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score }=2: A Prospective Multicenter Study. Blood. 2022 Nov 15;140: 12564-12565. doi:10.1182/blood-2022-168068.$$$E$$Y$$$20240814$$MD$CN$CN
242077913$24207791$3$F$20240808$20240828$20240814$20240911$PER$$US-AMGEN-USASP2024158764$AMGEN$$71$YR$E$F$Y$$$20240911$$CN$US$US
242077923$24207792$3$F$20240807$20240904$20240814$20240914$30DAY$$US-GSK-US2024099251$GLAXOSMITHKLINE$$62$YR$$M$Y$$$20240914$$PH$US$US
242077931$24207793$1$I$$20240811$20240814$20240814$PER$$US-HALEON-2191673$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242077941$24207794$1$I$20240401$20240808$20240814$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-024872$UNITED THERAPEUTICS$$$$$$Y$$$20240814$$$US$US
242077952$24207795$2$F$20240101$20240815$20240814$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-024086$UNITED THERAPEUTICS$$$$$F$Y$80.726$KG$20240824$$$US$US
242077963$24207796$3$F$20240826$20240916$20240814$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-024825$UNITED THERAPEUTICS$$49$YR$$F$Y$83.447$KG$20240920$$$US$US
242077971$24207797$1$I$$20240806$20240814$20240814$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000690$DECIPHERA PHARMACEUTICALS$$79$YR$E$F$Y$$$20240814$$CN$US$US
242077983$24207798$3$F$20240101$20240816$20240814$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-024133$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240822$$$US$US
242077991$24207799$1$I$$20240812$20240814$20240814$PER$$US-HALEON-2191742$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242078001$24207800$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160101$AMGEN$$$$$M$Y$$$20240813$$CN$US$US
242078012$24207801$2$F$20240723$20240907$20240814$20240913$EXP$$JP-GENMAB-2024-02882$GENMAB$$7$DEC$$M$Y$$$20240913$$MD$JP$JP
242078023$24207802$3$F$20240101$20240910$20240814$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-024353$UNITED THERAPEUTICS$$$$$F$Y$53.061$KG$20240917$$$US$US
242078031$24207803$1$I$20240722$20240812$20240814$20240814$EXP$$CN-ROCHE-10000055260$ROCHE$$77$YR$E$M$Y$$$20240814$$HP$CN$CN
242078043$24207804$3$F$$20240912$20240814$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003865$ACADIA PHARMACEUTICALS$$$$$F$Y$85.261$KG$20240930$$CN$US$US
242078051$24207805$1$I$20240802$20240808$20240814$20240814$PER$$US-ALXN-202408USA000504US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242078071$24207807$1$I$$20240813$20240814$20240814$PER$$US-JNJFOC-20240833858$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240814$$CN$US$US
242078081$24207808$1$I$$20240808$20240814$20240814$EXP$$US-ROCHE-10000050848$ROCHE$$21$YR$A$F$Y$$$20240814$$MD$US$US
242078091$24207809$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164729$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242078101$24207810$1$I$$20240805$20240814$20240814$PER$$US-ABBVIE-5872483$ABBVIE$$$$$M$Y$$$20240814$$HP$US$US
242078111$24207811$1$I$$20240812$20240814$20240814$PER$$US-ROCHE-10000056153$ROCHE$$29$YR$A$F$Y$$$20240814$$CN$US$US
242078121$24207812$1$I$20231101$20240806$20240814$20240814$EXP$$JP-ROCHE-10000055900$ROCHE$$67$YR$E$$Y$$$20240814$$MD$JP$JP
242078131$24207813$1$I$20240710$20240812$20240814$20240814$EXP$$US-AMGEN-USASP2024160325$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242078141$24207814$1$I$20240721$20240722$20240814$20240814$EXP$$CN-BEH-2024176271$CSL BEHRING$$51$YR$A$F$Y$52$KG$20240814$$HP$CN$CN
242078152$24207815$2$F$20240831$20240906$20240814$20240910$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-127824$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$75.3$KG$20240910$$CN$PR$PR
242078162$24207816$2$F$$20240815$20240814$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408007358$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240817$$CN$US$US
242078171$24207817$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006563$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240814$$CN$US$US
242078181$24207818$1$I$20240812$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007185$ELI LILLY AND CO$$$$$$Y$$$20240814$$CN$US$US
242078191$24207819$1$I$$20240805$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408003549$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240814$$CN$US$US
242078201$24207820$1$I$20240812$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008203$ELI LILLY AND CO$$$$$$Y$$$20240814$$CN$US$US
242078211$24207821$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007635$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242078221$24207822$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007534$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240814$$CN$US$US
242078231$24207823$1$I$$20240808$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007274$ELI LILLY AND CO$$$$$F$Y$$$20240814$$MD$US$US
242078243$24207824$3$F$20240801$20240823$20240814$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000681$DECIPHERA PHARMACEUTICALS$$67$YR$A$F$Y$$$20240905$$CN$US$US
242078251$24207825$1$I$$20240805$20240814$20240814$30DAY$$US-GSK-US2024097613$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
242078261$24207826$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164369$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
242078271$24207827$1$I$20240701$20240802$20240814$20240814$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000682$DECIPHERA PHARMACEUTICALS$$85$YR$E$M$Y$$$20240814$$CN$US$US
242078281$24207828$1$I$20240716$20240731$20240814$20240814$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK093041$GLENMARK$$$$$$Y$$$20240814$$MD$GB$GB
242078292$24207829$2$F$$20240818$20240814$20240822$EXP$$CA-BEH-2024176609$CSL BEHRING$$70$YR$E$M$Y$94.8$KG$20240822$$CN$CA$CA
242078311$24207831$1$I$$20240810$20240814$20240814$PER$$US-JNJFOC-20240827827$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242078332$24207833$2$F$20240603$20240809$20240814$20240821$EXP$DE-CADRBFARM-2024329658$DE-ESPERIONTHERAPEUTICS-2024DEU01257$ESPERION THERAPEUTICS$$77$YR$$F$Y$74$KG$20240821$$CN$DE$DE
242078341$24207834$1$I$$20240809$20240814$20240814$EXP$$US-ESPERIONTHERAPEUTICS-2024USA01265$ESPERION THERAPEUTICS$$$$$M$Y$$$20240814$$MD$US$US
242078351$24207835$1$I$$20240805$20240814$20240814$EXP$$US-AstraZeneca-2024A179659$ASTRAZENECA$$$$$$Y$$$20240814$$CN$US$
242078362$24207836$2$F$$20240829$20240814$20240829$PER$$US-ALXN-202408USA000502US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242078371$24207837$1$I$20240812$20240812$20240814$20240814$PER$$US-HALEON-2191769$Haleon PLC$$$$$F$Y$$$20240814$$CN$US$US
242078382$24207838$2$F$$20240902$20240814$20240906$EXP$$NZ-ROCHE-10000046328$ROCHE$$$$A$F$Y$$$20240906$$MD$NZ$NZ
242078391$24207839$1$I$$20240805$20240814$20240814$EXP$$JP-ROCHE-10000053225$ROCHE$Kato M, Takahashi R, Kawamura N, Higashiyama T, Ota H, Mori M et al.. 5 A case of a patient who had a treatment history with anti-CD20 antibody and COVID-19 with six-month prolonged pneumonia. Joint Congress of the 132nd Kinki Branch Meeting of the Japanese Society for Tub. 2024;54$68$YR$E$F$Y$$$20240814$$MD$JP$JP
242078402$24207840$2$F$20230522$20240801$20240814$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-038691$AUROBINDO$$79$YR$$F$Y$96$KG$20240816$$MD$GB$GB
242078411$24207841$1$I$20230510$20240813$20240814$20240814$EXP$FR-AFSSAPS-BR2024000115$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-128184$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240814$$MD$FR$FR
242078421$24207842$1$I$$20240808$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126691$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240814$$CN$US$US
242078431$24207843$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164730$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242078441$24207844$1$I$$20240806$20240814$20240814$EXP$$DE-BIOCON BIOLOGICS LIMITED-BBL2024005825$BIOCON$Ganzleben I, Geppert C, Osaba L, Hirschmann S, Nagel A, Atreya R et al.. Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY.. 2020;13:1-5$$$$$Y$$$20240814$$HP$DE$DE
242078452$24207845$2$F$20240701$20240909$20240814$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000684$DECIPHERA PHARMACEUTICALS$$72$YR$E$M$Y$198.4$KG$20240927$$CN$US$US
242078462$24207846$2$F$20240801$20240918$20240814$20240919$PER$$US-AMGEN-USASP2024160663$AMGEN$$69$YR$E$F$Y$$$20240919$$CN$US$US
242078471$24207847$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240832354$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242078481$24207848$1$I$20240812$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160602$AMGEN$$60$YR$A$F$Y$$$20240814$$CN$US$US
242078491$24207849$1$I$20240722$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039431$AUROBINDO$$79$YR$$M$Y$58.6$KG$20240814$$PH$FR$FR
242078501$24207850$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040218$AUROBINDO$Caylie M. Poirier, Aleesa A. Carter,Yvonne Kwan, Jessica Koo,Jill M. Westlund, Fadi Alkass,Kori Leblanc... Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post-Percutaneous Coronary Intervention. CJC Open. 2023;XX:1-13$71$YR$$M$Y$$$20240814$$MD$CA$CA
242078511$24207851$1$I$20240807$20240807$20240814$20240814$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240800067$UPSHER SMITH LABORATORIES$$1$YR$$F$Y$$$20240814$$$US$US
242078531$24207853$1$I$20240801$20240812$20240814$20240814$EXP$$CN-ROCHE-10000055634$ROCHE$$45$YR$A$F$Y$71$KG$20240814$$HP$CN$CN
242078551$24207855$1$I$$20240813$20240814$20240814$PER$$US-ROCHE-10000056131$ROCHE$$$$C$M$Y$$$20240814$$CN$US$US
242078582$24207858$2$F$$20240816$20240814$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07093$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242078591$24207859$1$I$$20240812$20240814$20240814$PER$$US-ROCHE-10000055806$ROCHE$$62$YR$A$F$Y$$$20240814$$CN$US$US
242078601$24207860$1$I$20240607$20240801$20240814$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-039428$AUROBINDO$$43$YR$$F$Y$$$20240814$$PH$IT$IT
242078612$24207861$2$F$20240728$20240902$20240814$20240911$EXP$GB-MHRA-MED-202407311150191670-TRJDL$GB-GLENMARK PHARMACEUTICALS-2024GMK093045$GLENMARK$$$$$$Y$$$20240911$$PH$GB$GB
242078621$24207862$1$I$20240101$20240812$20240814$20240814$EXP$AT-BASGAGES-2024-005712$AT-UCBSA-2024040572$UCB$$$$A$F$Y$$$20240814$$MD$AT$AT
242078633$24207863$3$F$$20240911$20240814$20240911$EXP$$DE-ALXN-202408EEA000366DE$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$MD$DE$DE
242078641$24207864$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040203$AUROBINDO$$81$YR$$M$Y$78$KG$20240814$$HP$CA$CA
242078651$24207865$1$I$$20240807$20240814$20240814$EXP$$JP-GENMAB-2024-02872$GENMAB$$51$YR$$M$Y$$$20240814$$MD$JP$JP
242078662$24207866$2$F$20210101$20240812$20240814$20240823$EXP$$IT-AUROBINDO-AUR-APL-2024-038751$AUROBINDO$Scala M, Chiera M, Bortolotti B, Rodriguez-Jimenez R, Menchetti M. Aggressive behaviour and diabetes: A clinical case of atypical metabolic improvement during clozapine treatment. Journal of intellectual disabilities: JOID. 2024;1-8$$$A$M$Y$$$20240823$$MD$IT$IT
242078671$24207867$1$I$$20240807$20240814$20240814$EXP$$JP-GENMAB-2024-02870$GENMAB$$64$YR$$F$Y$$$20240814$$MD$JP$JP
242078682$24207868$2$F$$20240815$20240814$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07157$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242078692$24207869$2$F$$20240815$20240814$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06763$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242078701$24207870$1$I$$20240808$20240814$20240814$EXP$$GB-ORGANON-O2408GBR000804$ORGANON$$$$$F$Y$$$20240814$$MD$GB$GB
242078711$24207871$1$I$20240701$20240806$20240814$20240814$PER$$US-APOTEX-2024AP009140$APOTEX$$$$$F$Y$$$20240814$$CN$US$US
242078721$24207872$1$I$$20240722$20240814$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003869$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242078731$24207873$1$I$20230707$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039522$AUROBINDO$$28$YR$$F$Y$50$KG$20240814$$PH$FR$FR
242078741$24207874$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040183$AUROBINDO$$78$YR$$M$Y$74$KG$20240814$$HP$CA$CA
242078752$24207875$2$F$$20240910$20240814$20240918$PER$$US-LEO Pharma-372705$LEO PHARM$$65$YR$$F$Y$$$20240918$$PH$US$US
242078761$24207876$1$I$$20240812$20240814$20240814$EXP$DE-GERMAN-LIT/DEU/24/0011328$DE-GSK-DE2024100164$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$HP$DE$DE
242078771$24207877$1$I$$20240807$20240814$20240814$EXP$$JP-GENMAB-2024-02868$GENMAB$$66$YR$$M$Y$$$20240814$$MD$JP$JP
242078781$24207878$1$I$$20240807$20240814$20240814$EXP$$JP-GENMAB-2024-02866$GENMAB$$80$YR$$F$Y$$$20240814$$MD$JP$JP
242078791$24207879$1$I$$20240809$20240814$20240814$PER$$US-JNJFOC-20240826008$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242078802$24207880$2$F$$20240815$20240814$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06331$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242078811$24207881$1$I$$20240807$20240814$20240814$EXP$$JP-GENMAB-2024-02865$GENMAB$$76$YR$$F$Y$$$20240814$$MD$JP$JP
242078831$24207883$1$I$$20240806$20240814$20240814$EXP$$DE-EMD Serono-2024042505$EMD SERONO INC$$$$C$F$Y$$$20240814$$CN$DE$DE
242078841$24207884$1$I$20240806$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160624$AMGEN$$81$YR$E$F$Y$$$20240814$$CN$US$US
242078851$24207885$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160456$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242078862$24207886$2$F$$20240920$20240814$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-040212$AUROBINDO$Poirier CM, Carter AA, Kwan Y, Koo J, Westlund JM, Alkass F, et al. Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post-Percutaneous Coronary Intervention. CJC Open. 2023;1-13$75$YR$$M$Y$$$20240930$$MD$CA$CA
242078871$24207887$1$I$$20240712$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07154$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242078881$24207888$1$I$$20240807$20240814$20240814$EXP$$JP-GENMAB-2024-02864$GENMAB$$60$YR$$F$Y$$$20240814$$MD$JP$JP
242078891$24207889$1$I$$20240807$20240814$20240814$EXP$$JP-GENMAB-2024-02863$GENMAB$$75$YR$$M$Y$$$20240814$$MD$JP$JP
242078911$24207891$1$I$$20240729$20240814$20240814$PER$$US-TEVA-VS-3227731$TEVA$$80$YR$$F$Y$$$20240814$$CN$US$US
242078922$24207892$2$F$$20240820$20240814$20240829$EXP$$US-TEVA-VS-3230859$TEVA$Abdelal Q, Isern S, Najjar N. Azith and the Myth. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Abdelal Q, Isern S, Najjar N. Azith and the Myth. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$73$YR$$F$Y$$$20240829$$HP$US$US
242078931$24207893$1$I$$20240805$20240814$20240814$PER$$US-JNJFOC-20240816715$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242078941$24207894$1$I$$20240802$20240814$20240814$EXP$$IT-RDY-LIT/ITA/24/0011651$DR REDDYS$Diral E, Furnari G, Bruno A, Greco R, Clerici D, Marktel S, et al. Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience. Frontiers in Oncology. doi:10.3389/fonc.2024.1391743.$$$$$Y$$$20240814$$HP$IT$IT
242078951$24207895$1$I$$20240802$20240814$20240814$EXP$$IT-RDY-LIT/ITA/24/0011650$DR REDDYS$Diral E, Furnari G, Bruno A, Greco R, Clerici D, Marktel S, et al. Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience. Frontiers in Oncology. 2024;14: doi:10.3389/fonc.2024.1391743.$$$$$Y$$$20240814$$HP$IT$IT
242078961$24207896$1$I$20240101$20240809$20240814$20240814$EXP$$CA-UCBSA-2024024807$UCB$$$$$F$Y$$$20240814$$CN$CA$CA
242078971$24207897$1$I$20240719$20240722$20240814$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003872$ACADIA PHARMACEUTICALS$$61$YR$$M$Y$$$20240814$$CN$US$US
242078981$24207898$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040214$AUROBINDO$Caylie M. Poirier, Aleesa A. Carter,Yvonne Kwan, Jessica Koo,Jill M. Westlund, Fadi Alkass,Kori  Leblanc.etc. Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic  Therapy Post-Percutaneous Coronary Intervention.. CJC Open. 2023;1-13$80$YR$$M$Y$$$20240814$$MD$CA$CA
242078991$24207899$1$I$20240801$20240806$20240814$20240814$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023204$UNITED THERAPEUTICS$$49$YR$$F$Y$91.61$KG$20240814$$$US$US
242079001$24207900$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003840$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242079011$24207901$1$I$$20240805$20240814$20240814$EXP$$JP-ROCHE-10000050770$ROCHE$Kitano M, Honda T, Hikita E, Masuo M, Miyazaki Y, Kobayashi M. Delayed immune-related adverse events in long-responders of immunotherapy: a single-center experience. Asia-Pacific Journal of Clinical Oncology. 2024-Aug;20 (4):463-471. doi:10.1111/ajco.14059.$$$$$Y$$$20240814$$HP$JP$JP
242079021$24207902$1$I$20240528$20240805$20240814$20240814$EXP$ES-AEMPS-1557508$ES-AMAROX PHARMA-AMR2024ES02601$HETERO$$87$YR$$F$Y$82$KG$20240814$$HP$ES$ES
242079032$24207903$2$F$$20240826$20240814$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07207$LUPIN$$$$$$Y$$$20240913$$CN$US$US
242079041$24207904$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160358$AMGEN$$$$$F$Y$$$20240814$$PH$US$US
242079051$24207905$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003847$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242079061$24207906$1$I$$20240812$20240814$20240814$EXP$$US-JNJFOC-20240831622$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242079073$24207907$3$F$$20240814$20240814$20240822$PER$$US-ROCHE-3568714$ROCHE$$$$E$F$Y$$$20240822$$CN$US$US
242079091$24207909$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164781$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242079102$24207910$2$F$20240809$20240812$20240814$20240819$PER$$US-AMGEN-USASP2024160469$AMGEN$$76$YR$E$F$Y$$$20240819$$CN$US$US
242079112$24207911$2$F$20240811$20240821$20240814$20240827$PER$$US-AMGEN-USASP2024160926$AMGEN$$65$YR$E$F$Y$$$20240827$$MD$US$US
242079121$24207912$1$I$$20240731$20240814$20240814$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093005$GLENMARK$Bansal V, D^Souza G, Aladade E, McFarlane DM, Agarwal R.. Postdural Puncture Headaches in Pediatric Patients: A Review of Options When Repeated Epidural Blood Patches Do Not Work.. Cureus.. 2024;16(6):e62833$$$$$Y$$$20240814$$MD$US$US
242079131$24207913$1$I$$20240812$20240814$20240814$PER$$US-ABBVIE-5878241$ABBVIE$$$$$$Y$$$20240814$$HP$US$US
242079151$24207915$1$I$$20240807$20240814$20240814$30DAY$$US-GSK-US2024098499$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
242079161$24207916$1$I$20240228$20240807$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126075$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$57.7$KG$20240814$$MD$US$US
242079172$24207917$2$F$$20240809$20240814$20240826$PER$$US-ALXN-202408USA000633US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242079181$24207918$1$I$$20240806$20240814$20240814$EXP$$DE-ALCON LABORATORIES-ALC2024DE003648$ALCON$$$$$$Y$$$20240814$$CN$DE$DE
242079191$24207919$1$I$20240101$20240805$20240814$20240814$EXP$NL-LRB-00993332$NL-ABBVIE-5877565$ABBVIE$$38$YR$$F$Y$70$KG$20240814$$MD$NL$NL
242079201$24207920$1$I$$20240125$20240814$20240814$PER$$US-SPECGX-T202400537$SPECGX$$$$$F$Y$$$20240814$$CN$US$US
242079211$24207921$1$I$$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A182482$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242079222$24207922$2$F$20170626$20230713$20240814$20240814$PER$$US-SPECGX-T202301548$SPECGX$$$$$$Y$$$20240814$$HP$US$US
242079231$24207923$1$I$20240301$20240329$20240814$20240814$PER$$US-SPECGX-T202400810$SPECGX$$$$$F$Y$$$20240814$$CN$US$US
242079241$24207924$1$I$20240210$20240212$20240814$20240814$PER$$US-SPECGX-T202400607$SPECGX$$63$YR$$F$Y$73$KG$20240814$$CN$US$US
242079251$24207925$1$I$20230801$20230821$20240814$20240814$PER$$US-SPECGX-T202301738$SPECGX$$$$$$Y$$$20240814$$CN$US$US
242079261$24207926$1$I$$20240512$20240814$20240814$PER$$US-SPECGX-T202401127$SPECGX$$$$$M$Y$$$20240814$$CN$US$US
242079271$24207927$1$I$20230101$20231030$20240814$20240814$PER$$US-SPECGX-T202302138$SPECGX$$$$$F$Y$53$KG$20240814$$CN$US$US
242079281$24207928$1$I$20240101$20240625$20240814$20240814$PER$$US-SPECGX-T202401214$SPECGX$$$$$F$Y$55$KG$20240814$$CN$US$US
242079291$24207929$1$I$20230903$20230905$20240814$20240814$PER$$US-SPECGX-T202301815$SPECGX$$$$$F$Y$$$20240814$$CN$US$US
242079301$24207930$1$I$20240501$20240502$20240814$20240814$PER$$US-SPECGX-T202401072$SPECGX$$61$YR$$F$Y$51$KG$20240814$$CN$US$US
242079311$24207931$1$I$$20231113$20240814$20240814$PER$$US-SPECGX-T202302219$SPECGX$$$$$F$Y$$$20240814$$PH$US$US
242079321$24207932$1$I$20230101$20240223$20240814$20240814$PER$$US-SPECGX-T202400677$SPECGX$$$$$F$Y$170$KG$20240814$$CN$US$US
242079331$24207933$1$I$20231201$20240104$20240814$20240814$PER$$US-SPECGX-T202400413$SPECGX$$58$YR$$F$Y$$$20240814$$PH$US$US
242079341$24207934$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006355$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240814$$CN$US$US
242079351$24207935$1$I$$20240808$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006972$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240814$$CN$US$US
242079361$24207936$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007706$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240814$$CN$US$US
242079371$24207937$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007853$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242079381$24207938$1$I$$20240811$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007155$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240814$$CN$US$US
242079391$24207939$1$I$20240811$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007538$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240814$$CN$US$US
242079401$24207940$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007372$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240814$$CN$US$US
242079411$24207941$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007166$ELI LILLY AND CO$$$$$M$Y$$$20240814$$PH$US$US
242079421$24207942$1$I$$20240808$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006340$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240814$$CN$US$US
242079432$24207943$2$F$$20240812$20240814$20240822$PER$$US-ROCHE-10000052084$ROCHE$$$$$$Y$$$20240822$$CN$US$US
242079443$24207944$3$F$20240101$20240813$20240814$20240820$PER$$US-AMGEN-USASP2024160181$AMGEN$$44$YR$A$F$Y$$$20240819$$CN$US$US
242079451$24207945$1$I$20240201$20240812$20240814$20240814$EXP$FR-AFSSAPS-PO2024000861$FR-AMGEN-FRASP2024159997$AMGEN$$53$YR$A$F$Y$$$20240814$$PH$FR$FR
242079461$24207946$1$I$20160315$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039405$AUROBINDO$$82$YR$$F$Y$$$20240814$$MD$FR$FR
242079472$24207947$2$F$$20240813$20240814$20240815$PER$$NVSC2024US164766$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
242079481$24207948$1$I$$20240808$20240814$20240814$PER$$US-JNJFOC-20240822624$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240814$$HP$US$US
242079491$24207949$1$I$20240610$20240722$20240814$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003860$ACADIA PHARMACEUTICALS$$89$YR$$M$Y$$$20240814$$CN$US$US
242079511$24207951$1$I$20191213$20240801$20240814$20240814$EXP$$DE-AUROBINDO-AUR-APL-2024-039325$AUROBINDO$$$$$$Y$$$20240814$$MD$DE$DE
242079521$24207952$1$I$$20240813$20240814$20240814$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045603$BOEHRINGER INGELHEIM$$90$YR$E$M$Y$$$20240814$$HP$SG$SG
242079531$24207953$1$I$$20240810$20240814$20240814$EXP$$US-HALEON-2191625$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242079541$24207954$1$I$20240701$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039475$AUROBINDO$$45$YR$$M$Y$$$20240814$$MD$FR$FR
242079551$24207955$1$I$20240718$20240809$20240814$20240814$PER$$NVSC2024US163660$NOVARTIS$$22$YR$$F$Y$$$20240814$$CN$US$US
242079561$24207956$1$I$$20240801$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-038699$AUROBINDO$$38$YR$$M$Y$$$20240814$$PH$GB$GB
242079571$24207957$1$I$$20240731$20240814$20240814$EXP$GB-MHRA-MED-202407311157498130-FKZLG$GB-GLENMARK PHARMACEUTICALS-2024GMK093040$GLENMARK$$$$$$Y$$$20240814$$PH$GB$GB
242079583$24207958$3$F$20240805$20240917$20240814$20240926$30DAY$$US-JNJFOC-20240821587$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240926$$PH$US$US
242079592$24207959$2$F$20240811$20240917$20240814$20240926$EXP$$US-JNJFOC-20240831807$JOHNSON AND JOHNSON$$70$YR$E$M$Y$89.36$KG$20240926$$HP$US$US
242079601$24207960$1$I$$20240721$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003832$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242079612$24207961$2$F$$20240819$20240814$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA071115$SANDOZ$$43$YR$$F$Y$96$KG$20240823$$HP$CA$CA
242079621$24207962$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164753$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242079631$24207963$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164813$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242079642$24207964$2$F$$20240814$20240814$20240819$PER$$US-JNJFOC-20240832533$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240819$$CN$US$US
242079651$24207965$1$I$$20240808$20240814$20240814$EXP$$US-THEA-2024001768$Thea Pharma$$$$$F$Y$$$20240814$$CN$US$US
242079661$24207966$1$I$20240811$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160151$AMGEN$$$$$M$Y$$$20240814$$CN$US$US
242079672$24207967$2$F$20240701$20240814$20240814$20240820$EXP$$US-AMGEN-USASL2024156668$AMGEN$$64$YR$A$F$Y$$$20240819$$CN$US$US
242079681$24207968$1$I$20240101$20240807$20240814$20240814$EXP$$US-SA-2024SA238917$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240814$$MD$US$US
242079691$24207969$1$I$$20240807$20240814$20240814$EXP$$US-SA-2024SA239099$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240814$$MD$US$US
242079712$24207971$2$F$20240101$20240906$20240814$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-023879$UNITED THERAPEUTICS$$$$$F$Y$113.38$KG$20240914$$$US$US
242079722$24207972$2$F$$20240830$20240814$20240912$EXP$$US-AMAROX PHARMA-HET2024US02632$HETERO$$$$$M$Y$$$20240909$$CN$US$US
242079731$24207973$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164756$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242079741$24207974$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040197$AUROBINDO$$77$YR$$M$Y$$$20240814$$PH$CA$CA
242079751$24207975$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007377$ELI LILLY AND CO$$63$YR$A$$Y$$$20240814$$LW$US$US
242079761$24207976$1$I$20240810$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007501$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240814$$CN$US$US
242079771$24207977$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006362$ELI LILLY AND CO$$77$YR$E$$Y$$$20240814$$CN$US$US
242079802$24207980$2$F$20240701$20240814$20240814$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408007754$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240817$$CN$US$US
242079811$24207981$1$I$$20240807$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408005581$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240814$$CN$US$US
242079821$24207982$1$I$20231001$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006681$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240814$$CN$US$US
242079832$24207983$2$F$$20240829$20240814$20240829$PER$$US-ALXN-202408USA000623US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242079842$24207984$2$F$20220101$20240809$20240814$20240911$EXP$$CZ-Orion Corporation ORION PHARMA-TREX2024-0209$ORION$$71$YR$E$F$Y$$$20240911$$MD$CZ$
242079851$24207985$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A180286$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242079861$24207986$1$I$20240715$20240731$20240814$20240814$EXP$GB-MHRA-MED-202407310702593170-MWYJG$GB-GLENMARK PHARMACEUTICALS-2024GMK093048$GLENMARK$$$$$$Y$$$20240814$$CN$GB$GB
242079871$24207987$1$I$$20240812$20240814$20240814$EXP$$GB-SANDOZ INC.-PHHY2019GB177888$SANDOZ$$$$$F$Y$$$20240814$$HP$GB$GB
242079883$24207988$3$F$20240101$20240911$20240814$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-022955$UNITED THERAPEUTICS$$$$$F$Y$68.481$KG$20240919$$$US$US
242079891$24207989$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160976$AMGEN$$$$$$Y$$$20240814$$HP$US$US
242079901$24207990$1$I$$20240812$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US072376$SANDOZ$$$$$F$Y$$$20240814$$CN$US$US
242079911$24207991$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164796$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242079921$24207992$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003894$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240814$$HP$US$US
242079931$24207993$1$I$20240808$20240812$20240814$20240814$EXP$$CN-ORGANON-O2408CHN000898$ORGANON$$80$YR$$F$Y$56$KG$20240814$$HP$CN$CN
242079941$24207994$1$I$20230301$20240807$20240814$20240814$EXP$$FR-Orion Corporation ORION PHARMA-TREX2024-0210$ORION$$74$YR$E$F$Y$63$KG$20240814$$PH$FR$
242079951$24207995$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164827$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242079971$24207997$1$I$20221201$20240809$20240814$20240814$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-109266$REGENERON$$$$$M$Y$$$20240814$$CN$US$US
242079983$24207998$3$F$20240811$20240909$20240814$20240910$PER$$US-AMGEN-USASP2024160616$AMGEN$$83$YR$E$F$Y$$$20240910$$CN$US$US
242079991$24207999$1$I$$20240729$20240814$20240814$PER$$US-Calliditas-2024CAL01431$CALLIDITAS THERAPEUTICS$$37$YR$A$F$Y$137$KG$20240813$$CN$US$US
242080001$24208000$1$I$$20240730$20240814$20240814$PER$$US-Calliditas-2024CAL01444$CALLIDITAS THERAPEUTICS$$53$YR$A$F$Y$$$20240813$$CN$US$US
242080012$24208001$2$F$$20240819$20240814$20240829$PER$$US-Calliditas-2024CAL01451$CALLIDITAS THERAPEUTICS$$43$YR$A$F$Y$58$KG$20240829$$CN$US$US
242080022$24208002$2$F$$20240906$20240814$20240913$EXP$$US-Calliditas-2024CAL01493$CALLIDITAS THERAPEUTICS$$53$YR$A$M$Y$77.2$KG$20240913$$CN$US$US
242080032$24208003$2$F$20240501$20240819$20240814$20240903$PER$$US-Calliditas-2024CAL01449$CALLIDITAS THERAPEUTICS$$52$YR$A$F$Y$$$20240903$$CN$US$US
242080042$24208004$2$F$20240811$20240813$20240814$20240817$PER$$US-AMGEN-USASP2024160622$AMGEN$$69$YR$E$F$Y$$$20240817$$CN$US$US
242080051$24208005$1$I$$20240807$20240814$20240814$EXP$$DE-BIOVITRUM-2024-DE-010799$ADC THERAPEUTICS$$$$$F$Y$$$20240814$$MD$DE$DE
242080061$24208006$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003922$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240814$$HP$US$US
242080081$24208008$1$I$20240614$20240812$20240814$20240814$PER$$US-PAREXEL-2024-COH-US000499$PAREXEL$$$$$$Y$$$20240814$$HP$US$US
242080091$24208009$1$I$20240101$20240802$20240814$20240814$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000679$DECIPHERA PHARMACEUTICALS$$$$$$Y$$$20240814$$PH$US$US
242080101$24208010$1$I$20210101$20240808$20240814$20240814$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-109308$REGENERON$$100$YR$$F$Y$$$20240814$$CN$US$US
242080111$24208011$1$I$$20240807$20240814$20240814$PER$$US-RDY-SPO/USA/24/0011705$DR REDDYS$$22$YR$A$F$Y$$$20240814$$CN$US$US
242080122$24208012$2$F$20240701$20240910$20240814$20240912$EXP$$NVSC2024ZA163231$NOVARTIS$$61$YR$$F$Y$$$20240912$$HP$ZA$ZA
242080132$24208013$2$F$$20240912$20240814$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128176$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240913$$CN$US$US
242080141$24208014$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004125$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242080151$24208015$1$I$20240712$20240809$20240814$20240814$EXP$$US-ROCHE-10000054976$ROCHE$$64$YR$A$F$Y$$$20240814$$CN$US$US
242080161$24208016$1$I$$20240805$20240814$20240814$EXP$$US-AMAROX PHARMA-HET2024US02664$HETERO$Fenner EG, Simpson CE. An adult patient with pulmonary arterial hypertension, a NOTCH3 mutation, and leflunomide exposure. Pulmonary Circulation. 2024;14(3):1-4$39$YR$$F$Y$$$20240814$$HP$US$US
242080171$24208017$1$I$$20240813$20240814$20240814$EXP$PT-INFARMED-M202210-457$PT-ROCHE-10000056301$ROCHE$$63$YR$A$M$Y$80$KG$20240814$$MD$PT$PT
242080181$24208018$1$I$20240717$20240807$20240814$20240814$EXP$DE-CADRBFARM-2024329725$DE-RDY-SPO/DEU/24/0011613$DR REDDYS$$75$YR$E$M$Y$75$KG$20240814$$MD$DE$DE
242080193$24208019$3$F$20240811$20240822$20240814$20240826$PER$$US-AMGEN-USASP2024160414$AMGEN$$77$YR$E$F$Y$$$20240826$$CN$US$US
242080201$24208020$1$I$$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024159352$AMGEN$$$$$M$Y$$$20240814$$CN$US$US
242080211$24208021$1$I$$20240806$20240814$20240814$EXP$$CA-BEH-2023154011$CSL BEHRING$$10$MON$I$F$Y$8$KG$20240814$$CN$CA$CA
242080221$24208022$1$I$$20240807$20240814$20240814$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR099008$VIIV$$34$YR$$F$Y$$$20240814$$HP$US$US
242080231$24208023$1$I$20231227$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039437$AUROBINDO$$95$YR$$M$Y$70.4$KG$20240814$$MD$FR$FR
242080241$24208024$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007389$ELI LILLY AND CO$$59$YR$A$$Y$$$20240814$$LW$US$US
242080252$24208025$2$F$$20240925$20240814$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202408007165$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240930$$CN$US$US
242080261$24208026$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007157$ELI LILLY AND CO$$44$YR$A$$Y$$$20240814$$LW$US$US
242080271$24208027$1$I$$20240802$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408003057$ELI LILLY AND CO$$36$YR$A$$Y$$$20240814$$LW$US$US
242080281$24208028$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007747$ELI LILLY AND CO$$$$$M$Y$$$20240814$$CN$US$US
242080291$24208029$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007249$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240814$$CN$US$US
242080301$24208030$1$I$20240728$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007797$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240814$$CN$US$US
242080311$24208031$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006529$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240814$$CN$US$US
242080321$24208032$1$I$20240601$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007466$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240814$$CN$US$US
242080331$24208033$1$I$20240813$20240813$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008308$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240814$$CN$US$US
242080341$24208034$1$I$$20240812$20240814$20240814$EXP$$CA-UCBSA-2022056942$UCB$$$$$F$Y$$$20240814$$CN$CA$CA
242080351$24208035$1$I$$20240808$20240814$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001606$BLUEPRINT MEDICINES$$$$$M$Y$$$20240814$$CN$US$US
242080371$24208037$1$I$$20240805$20240814$20240814$EXP$$IN-ROCHE-10000009580$ROCHE$$$$$$Y$$$20240814$$CN$IN$IN
242080381$24208038$1$I$$20240812$20240814$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001628$BLUEPRINT MEDICINES$$$$$F$Y$$$20240814$$CN$US$US
242080391$24208039$1$I$$20240802$20240814$20240814$EXP$$NL-AUROBINDO-AUR-APL-2024-039563$AUROBINDO$$84$YR$$M$Y$81$KG$20240814$$CN$NL$NL
242080401$24208040$1$I$$20240811$20240814$20240814$PER$$US-HALEON-2191509$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242080411$24208041$1$I$20230328$20240722$20240814$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003843$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240814$$CN$US$US
242080421$24208042$1$I$$20240813$20240814$20240814$EXP$$DE-SANDOZ INC.-SDZ2024DE072269$SANDOZ$$$$$M$Y$$$20240814$$HP$DE$DE
242080432$24208043$2$F$20240603$20240821$20240814$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012227$JAZZ$$8$YR$$F$Y$$$20240822$$CN$US$US
242080442$24208044$2$F$$20240920$20240814$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-040216$AUROBINDO$Caylie M. Poirier, Aleesa A. Carter,Yvonne Kwan, Jessica Koo,Jill M. Westlund, Fadi Alkass.et.al. Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic  Therapy Post-Percutaneous Coronary Intervention. CJC Open. 2023;5 (11):846-858$64$YR$$M$Y$$$20240928$$MD$CA$CA
242080451$24208045$1$I$$20240807$20240814$20240814$EXP$$US-AMGEN-USASL2024157317$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242080461$24208046$1$I$20240628$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003836$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240814$$CN$US$US
242080471$24208047$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240828609$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$MD$US$US
242080481$24208048$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040196$AUROBINDO$$95$YR$$F$Y$40$KG$20240814$$HP$CA$CA
242080491$24208049$1$I$20240701$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003835$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240814$$CN$US$US
242080502$24208050$2$F$$20240814$20240814$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003829$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242080511$24208051$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164841$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242080521$24208052$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003842$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240814$$CN$US$US
242080531$24208053$1$I$$20240808$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126239$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240814$$CN$US$US
242080542$24208054$2$F$$20240827$20240814$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA072209$SANDOZ$$4$YR$$M$Y$$$20240830$$HP$CA$CA
242080551$24208055$1$I$$20240809$20240814$20240814$EXP$$US-ABBVIE-5875776$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242080561$24208056$1$I$20240722$20240808$20240814$20240814$EXP$$JP-EXELIXIS-CABO-24080482$EXELIXIS$$7$DEC$$M$Y$$$20240814$$MD$JP$JP
242080572$24208057$2$F$20240522$20240912$20240814$20240917$EXP$$US-TAKEDA-2024TUS051775$TAKEDA$$40$YR$$F$Y$74.8$KG$20240917$$CN$US$US
242080582$24208058$2$F$$20240813$20240814$20240819$EXP$PL-EMA-DD-20240809-7482661-074952$PL-SANDOZ INC.-SDZ2024PL072320$SANDOZ$$7$YR$$F$Y$$$20240819$$HP$PL$PL
242080591$24208059$1$I$$20240805$20240814$20240814$EXP$$US-RECORDATI RARE DISEASE INC.-2024006114$RECORDATI$$$$$$Y$$$20240814$$CN$US$US
242080601$24208060$1$I$20240811$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160480$AMGEN$$76$YR$E$M$Y$$$20240814$$CN$US$US
242080612$24208061$2$F$20240802$20240821$20240814$20240826$PER$$US-AMGEN-USASP2024155303$AMGEN$$72$YR$E$F$Y$$$20240826$$CN$US$US
242080623$24208062$3$F$20240501$20240903$20240814$20240904$PER$$US-AMGEN-USASP2024156771$AMGEN$$18$YR$A$F$Y$48.526$KG$20240904$$MD$US$US
242080631$24208063$1$I$$20240808$20240814$20240814$EXP$$BR-AMGEN-BRASP2024158636$AMGEN$$$$$F$Y$$$20240814$$CN$BR$BR
242080642$24208064$2$F$$20240813$20240814$20240816$PER$$US-JNJFOC-20240831673$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$US$US
242080651$24208065$1$I$$20240811$20240814$20240814$PER$$US-JNJFOC-20240827872$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242080661$24208066$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240831601$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242080671$24208067$1$I$20240220$20240812$20240814$20240814$EXP$FR-AFSSAPS-TO2024001493$FR-UCBSA-2024040635$UCB$$57$YR$$F$Y$51.2$KG$20240814$$PH$FR$FR
242080681$24208068$1$I$20231003$20240801$20240814$20240814$EXP$$CA-CELLTRION INC.-2023CA025749$CELLTRION$$$$$$Y$$$20240814$$CN$CA$CA
242080691$24208069$1$I$20240505$20240808$20240814$20240814$EXP$$JP-GSK-JP2024JPN069660$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$JP$JP
242080701$24208070$1$I$20240720$20240722$20240814$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003875$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240814$$CN$US$US
242080711$24208071$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164339$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
242080721$24208072$1$I$$20240809$20240814$20240814$EXP$$US-ALXN-202408USA000628US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242080731$24208073$1$I$20240712$20240715$20240814$20240814$EXP$$GB-CELLTRION INC.-2024GB019446$CELLTRION$$$$$$Y$$$20240814$$PH$GB$GB
242080742$24208074$2$F$$20240813$20240814$20240822$EXP$$GB-BEIGENE-BGN-2024-012559$BEIGENE$$$$$$Y$$$20240822$$MD$GB$GB
242080751$24208075$1$I$20240326$20240806$20240814$20240814$EXP$$IT-JNJFOC-20240432858$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240814$$HP$IT$IT
242080761$24208076$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164836$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242080771$24208077$1$I$$20240812$20240814$20240814$EXP$$NVSC2024US164405$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
242080793$24208079$3$F$20240101$20240902$20240814$20240911$EXP$$JP-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00829$BIOCRYST PHARMACEUTICALS$$4$DEC$$F$Y$$$20240911$$MD$JP$JP
242080801$24208080$1$I$20230402$20230704$20240814$20240814$EXP$$US-AstraZeneca-2023A118726$ASTRAZENECA$$19202$DY$$F$Y$$$20240814$$CN$US$
242080811$24208081$1$I$$20240806$20240814$20240814$EXP$$JP-AstraZeneca-2024A179264$ASTRAZENECA$Katano T et al. B-01 Two cases of respiratory adverse events associated with olaparib, a poly. The 5th Tokai Regional Meeting of the Japanese Society of Allergology 2024;30.$60$YR$$F$Y$$$20240814$$MD$JP$
242080821$24208082$1$I$20240628$20240722$20240814$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003828$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240814$$CN$US$US
242080831$24208083$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003877$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242080841$24208084$1$I$20240812$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007210$ELI LILLY AND CO$$$$$$Y$$$20240814$$CN$US$US
242080851$24208085$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006415$ELI LILLY AND CO$$$$$$Y$$$20240814$$CN$US$US
242080861$24208086$1$I$20240811$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007486$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240814$$CN$US$US
242080871$24208087$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007463$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240814$$CN$US$US
242080882$24208088$2$F$20240228$20240820$20240814$20240829$EXP$$SK-EMD Serono-2024042935$EMD SERONO INC$$64$YR$A$F$Y$66$KG$20240829$$MD$SK$SK
242080893$24208089$3$F$$20240819$20240814$20240827$EXP$$JP-ROCHE-10000053181$ROCHE$Sekiguchi Y, Tsutsumi H, Gomyo A, Kudo M, Iizaki Y, Maseki N et al.. P-32 Usage experience of pola-R-mini-CHP therapy (R-mini-CHP in combination with polatuzumab vedotin) in patients aged 80 or older with diffuse large B-cell lymphoma (DLBCL): 18 case reports from single facility. The Journal of the Japanese Society for Lymphoreticular Tissue Research / The 64. 2024;64:102$$$E$M$Y$$$20240827$$MD$JP$JP
242080902$24208090$2$F$$20240822$20240814$20240831$EXP$$US-AMGEN-USASP2024159617$AMGEN$Specks U.; Falde S.D.; Lal A. et al.. Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Diffuse Alveolar Hemorrhage With Avacopan. ARC open Rheumatology. 2024;1-10$$$$$Y$$$20240831$$MD$US$US
242080911$24208091$1$I$20231030$20240807$20240814$20240814$EXP$$CA-CELLTRION INC.-2023CA021539$CELLTRION$$$$$$Y$$$20240814$$HP$CA$CA
242080922$24208092$2$F$$20240821$20240814$20240829$EXP$$IN-ROCHE-10000051177$ROCHE$$74$YR$E$M$Y$$$20240829$$CN$IN$IN
242080931$24208093$1$I$$20240812$20240814$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA072332$SANDOZ$$$$$F$Y$$$20240814$$CN$CA$CA
242080941$24208094$1$I$20240808$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024158981$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242080951$24208095$1$I$20240701$20240806$20240814$20240814$EXP$$EG-ROCHE-10000052755$ROCHE$$19$YR$A$F$Y$75$KG$20240814$$CN$EG$EG
242080962$24208096$2$F$20240701$20240910$20240814$20240917$EXP$$JP-009507513-2408JPN000765J$MERCK$$9$DEC$$M$Y$$$20240917$$MD$JP$JP
242080973$24208097$3$F$20240801$20240820$20240814$20240827$EXP$$US-ALXN-202408USA000525US$ALEXION PHARMACEUTICALS$$77$YR$$M$Y$$$20240827$$CN$US$US
242080981$24208098$1$I$$20240808$20240814$20240814$PER$$US-ALXN-202408USA000522US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242080993$24208099$3$F$20240801$20240917$20240814$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003825$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240927$$CN$US$US
242081001$24208100$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003880$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242081012$24208101$2$F$20240706$20240802$20240814$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123511$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240819$$HP$US$US
242081023$24208102$3$F$$20240903$20240814$20240910$30DAY$$GB-JNJFOC-20240804114$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$HP$GB$GB
242081031$24208103$1$I$$20240807$20240814$20240814$PER$$NVSC2024US163766$NOVARTIS$$67$YR$$$Y$$$20240814$$CN$US$US
242081041$24208104$1$I$20240701$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127575$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240814$$HP$US$US
242081052$24208105$2$F$$20240806$20240814$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-126150$BRISTOL MYERS SQUIBB$Ito Y, Inagaki K, Yamaoka K, Ishi T, Sasaki E, Fujisawa S, et al. A case of immune checkpoint inhibitor-associated hypophysitis that required a differentiation from metastasis. Folia Endocrinologica Japonica. 2023; 99(4): 31.$7$DEC$E$F$Y$$$20240821$$MD$JP$JP
242081061$24208106$1$I$$20240719$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-117924$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$77.56$KG$20240814$$CN$US$US
242081072$24208107$2$F$20240822$20240822$20240814$20240827$PER$$US-AMGEN-USASP2024160098$AMGEN$$92$YR$E$M$Y$$$20240827$$CN$US$US
242081081$24208108$1$I$$20240805$20240814$20240814$EXP$$US-ASPIRO-ASP2024US02659$ASPIRO PHARMA$Pushparaji B, Sankar PR, Achuthanandan S, Basnet A, Cordeiro N, Epstein DJ, et,all. ECMO Rescue in Fulminant Myocarditis: Taming the VT Storm. Journal of the American College of Cardiology. 2024;83(13):3851$38$YR$$F$Y$$$20240814$$HP$US$US
242081091$24208109$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040181$AUROBINDO$$95$YR$$F$Y$$$20240814$$HP$CA$CA
242081101$24208110$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040227$AUROBINDO$Gilhofer TS, Nestelberger T, Kang M, Inohara T, Alfadhel M, McAlister C, et al. Stroke Prevention With Left Atrial Appendage Closure in Patients With Atrial Fibrillation and Prior Intracranial Hemorrhage. CJC Open. 2023;5(6):404-411$$$$$Y$$$20240814$$MD$CA$CA
242081111$24208111$1$I$20240701$20240813$20240814$20240814$EXP$FR-AFSSAPS-TO2024001250$FR-ORGANON-O2408FRA000993$ORGANON$$69$YR$$F$Y$47$KG$20240814$$PH$FR$FR
242081123$24208112$3$F$$20240913$20240814$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003876$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
242081131$24208113$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003820$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242081141$24208114$1$I$$20240722$20240814$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003826$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242081151$24208115$1$I$$20240806$20240814$20240814$EXP$$US-SPECGX-T202401715$SPECGX$Enstrom C, Gast S, Church L, Heflin MK, Moore C, Cook C et al. Cardiogenic shock due to concomitant use of e-cigarettes and amphetamine/dextroamphetamine-associated cardiomyopathy. US Cardiology Review. 2024;18(1):2$25$YR$$M$Y$$$20240814$$HP$US$US
242081161$24208116$1$I$$20240806$20240814$20240814$EXP$$US-SPECGX-T202401714$SPECGX$Enstrom C, Gast S, Church L, Heflin MK, Moore C, Cook C et al. Cardiogenic shock due to concomitant use of e-cigarettes and amphetamine/dextroamphetamine-associated cardiomyopathy. US Cardiology Review. 2024;18(1):2$29$YR$$M$Y$$$20240814$$HP$US$US
242081171$24208117$1$I$$20240812$20240814$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA072323$SANDOZ$$82$YR$$M$Y$102$KG$20240814$$MD$CA$CA
242081181$24208118$1$I$$20240807$20240814$20240814$EXP$$US-BIOGEN-2024BI01277391$BIOGEN$$$$$F$Y$$$20240814$$MD$US$US
242081191$24208119$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040187$AUROBINDO$$86$YR$$M$Y$$$20240814$$HP$CA$CA
242081202$24208120$2$F$20230801$20240905$20240814$20240911$EXP$$US-SA-2024SA239223$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240911$$MD$US$US
242081211$24208121$1$I$$20240807$20240814$20240814$EXP$$US-SA-2024SA239011$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240814$$CN$US$US
242081222$24208122$2$F$$20240812$20240814$20240815$EXP$$US-BIOGEN-2024BI01277872$BIOGEN$$$$$M$Y$$$20240815$$CN$US$US
242081231$24208123$1$I$20240601$20240808$20240814$20240814$EXP$$US-BIOGEN-2024BI01276415$BIOGEN$$44$YR$$M$Y$$$20240814$$CN$US$US
242081241$24208124$1$I$$20240808$20240814$20240814$EXP$$CA-SANDOZ INC.-NVSC2022CA082911$SANDOZ$$$$$F$Y$$$20240814$$CN$CA$CA
242081251$24208125$1$I$20240101$20240807$20240814$20240814$EXP$$US-AMGEN-USASP2024158011$AMGEN$$$$$F$Y$$$20240814$$MD$US$US
242081261$24208126$1$I$20240812$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160029$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242081271$24208127$1$I$20240718$20240809$20240814$20240814$EXP$$US-SA-2024SA239938$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240814$$MD$US$US
242081281$24208128$1$I$$20240805$20240814$20240814$EXP$$US-RECORDATI RARE DISEASE INC.-2024006115$RECORDATI$$$$$$Y$$$20240814$$CN$US$US
242081291$24208129$1$I$$20240802$20240814$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-039883$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol. 2024;113 (1):90-98$10$YR$$M$Y$$$20240814$$HP$IT$IT
242081301$24208130$1$I$$20240809$20240814$20240814$EXP$$US-SA-2024SA239562$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240814$$CN$US$US
242081312$24208131$2$F$20240807$20240809$20240814$20240819$EXP$$IT-SA-2024SA239004$SANOFI AVENTIS$$54$YR$A$M$Y$77$KG$20240820$$HP$IT$IT
242081321$24208132$1$I$20240803$20240808$20240814$20240814$EXP$$US-SA-2024SA239630$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240814$$MD$US$US
242081331$24208133$1$I$20240425$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039396$AUROBINDO$$73$YR$$M$Y$55$KG$20240814$$MD$FR$FR
242081341$24208134$1$I$20240812$20240812$20240814$20240814$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045359$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$71$KG$20240814$$MD$GB$GB
242081352$24208135$2$F$20240801$20240829$20240814$20240904$EXP$$JP-SA-2024SA235672$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240904$$MD$JP$JP
242081361$24208136$1$I$$20240806$20240814$20240814$EXP$$US-SANDOZ INC.-NVSC2020US261813$SANDOZ$$$$$F$Y$$$20240814$$CN$US$US
242081372$24208137$2$F$$20240917$20240814$20240920$EXP$$NVSC2024US164236$NOVARTIS$$98$YR$$F$Y$$$20240920$$CN$US$US
242081383$24208138$3$F$20240701$20240903$20240814$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003217$ACADIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240913$$CN$US$US
242081391$24208139$1$I$20240701$20240715$20240814$20240814$EXP$$US-VIIV HEALTHCARE LIMITED-US2024088816$VIIV$$45$YR$$M$Y$$$20240814$$CN$US$US
242081401$24208140$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008374$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240814$$CN$US$US
242081412$24208141$2$F$$20240822$20240814$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408007471$ELI LILLY AND CO$$$$$M$Y$$$20240826$$CN$US$US
242081421$24208142$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007527$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240814$$CN$US$US
242081431$24208143$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007457$ELI LILLY AND CO$$53$YR$A$$Y$$$20240814$$CN$US$US
242081441$24208144$1$I$$20240811$20240814$20240814$PER$$US-JNJFOC-20240828397$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242081451$24208145$1$I$20240719$20240813$20240814$20240814$EXP$FR-AFSSAPS-GR2024001015$FR-ORGANON-O2408FRA000949$ORGANON$$53$YR$$F$Y$$$20240814$$PH$FR$FR
242081461$24208146$1$I$$20240722$20240814$20240814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003815$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242081471$24208147$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003884$ACADIA PHARMACEUTICALS$$11$YR$$F$Y$$$20240814$$MD$US$US
242081481$24208148$1$I$20240630$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039497$AUROBINDO$$68$YR$$F$Y$$$20240814$$MD$FR$FR
242081491$24208149$1$I$$20240805$20240814$20240814$EXP$$JP-ROCHE-10000052829$ROCHE$Sawada A, Okamoto T, Shimada S, Yasuda T, Sonoda S, Aoki H et al.. 35 A case of dermatomyositis-related interstitial pneumonia during administration of atezolizumab. The 260th Kanto Regional Meeting of the Japanese Respiratory Society. 2024;23$65$YR$E$M$Y$$$20240814$$MD$JP$JP
242081502$24208150$2$F$$20240903$20240814$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003814$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242081512$24208151$2$F$20240713$20240912$20240814$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003886$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240923$$CN$US$US
242081522$24208152$2$F$$20240826$20240814$20240905$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-127821$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240905$$HP$CA$CA
242081533$24208153$3$F$20240806$20240923$20240814$20240926$EXP$$US-ABBVIE-5877837$ABBVIE$$83$YR$$F$Y$$$20240926$$CN$US$US
242081542$24208154$2$F$20240807$20240827$20240814$20240829$EXP$$PL-ABBVIE-5879436$ABBVIE$$84$YR$$M$Y$$$20240829$$HP$PL$PL
242081551$24208155$1$I$$20220729$20240814$20240814$EXP$$US-AstraZeneca-2022A271960$ASTRAZENECA$$$$$$Y$$$20240814$$HP$US$
242081561$24208156$1$I$$20240806$20240814$20240814$EXP$$JP-AstraZeneca-2024A179263$ASTRAZENECA$Katano T, et al.. B-01 Two cases of respiratory adverse events associated with olaparib, a poly. The 5th Tokai Regional Meeting of the Japanese Society of Allergology 2024;30.$70$YR$$F$Y$$$20240814$$MD$JP$
242081571$24208157$1$I$$20240806$20240814$20240814$EXP$$JP-AstraZeneca-2024A180163$ASTRAZENECA$$68$YR$$F$Y$$$20240814$$MD$JP$
242081581$24208158$1$I$$20240808$20240814$20240814$EXP$$NVSC2024US162580$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
242081591$24208159$1$I$20240301$20240812$20240814$20240814$EXP$FR-AFSSAPS-GR2024000989$NVSC2024FR163278$NOVARTIS$$40$YR$$F$Y$$$20240814$$PH$FR$FR
242081601$24208160$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003887$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240814$$MD$US$US
242081611$24208161$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164882$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242081622$24208162$2$F$$20240812$20240814$20240819$EXP$$NVSC2024US163513$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242081631$24208163$1$I$20230901$20240808$20240814$20240814$EXP$FR-AFSSAPS-TS2024000888$FR-RDY-SPO/FRA/24/0011696$DR REDDYS$$70$YR$E$M$Y$89$KG$20240814$$CN$FR$FR
242081644$24208164$4$F$20240812$20240912$20240814$20240913$PER$$US-AMGEN-USASP2024161264$AMGEN$$68$YR$E$F$Y$$$20240913$$CN$US$US
242081651$24208165$1$I$$20240808$20240814$20240814$PER$$US-JNJFOC-20240822315$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$US$US
242081661$24208166$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040206$AUROBINDO$Poirier CM, Carter AA, Kwan Y, Koo J, Westlund JM, Alkass F, et al.. Experiences of patients with atrial fibrillation with combination antithrombotic therapy post-percutaneous coronary intervention. CJC Open. 2023;5:846-58$73$YR$$M$Y$$$20240814$$HP$CA$CA
242081671$24208167$1$I$$20240809$20240814$20240814$PER$$US-ROCHE-10000054642$ROCHE$$41$YR$A$F$Y$$$20240814$$HP$US$US
242081681$24208168$1$I$20231201$20240802$20240814$20240814$EXP$$US-INSMED-2023-05028-USAA$INSMED$$61$YR$$F$Y$$$20240814$$CN$US$US
242081691$24208169$1$I$20240801$20240808$20240814$20240814$EXP$$CA-BEH-2024176860$CSL BEHRING$$74$YR$E$F$Y$79.4$KG$20240814$$CN$CA$CA
242081701$24208170$1$I$$20240807$20240814$20240814$EXP$$FR-ROCHE-3466428$ROCHE$Chanson J, Bouhour F, Aube-Nathier A, Mallaret M, Vial C, Hacquard A, Petiot P, Spinazzi M, Nadaj- Pakleza A and Echaniz-Laguna A Myasthenia gravis treatment in the elderly presents with a significant iatrogenic risk: a multicentric retrospective study. DOI: 10.1007/s00415-023-11925-6. Journal of Neurology 2023;270 (12):5819-26.$78$YR$E$F$Y$$$20240814$$HP$FR$FR
242081711$24208171$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127124$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240814$$HP$US$US
242081721$24208172$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128223$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240814$$HP$US$US
242081731$24208173$1$I$$20240515$20240814$20240814$PER$$US-SPECGX-T202401152$SPECGX$$$$$M$Y$82$KG$20240814$$CN$US$US
242081742$24208174$2$F$$20240708$20240814$20240913$PER$$US-SPECGX-T202401297$SPECGX$$$$$F$Y$62$KG$20240913$$CN$US$US
242081751$24208175$1$I$$20240802$20240814$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-124489$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240814$$PH$JP$JP
242081761$24208176$1$I$20240806$20240807$20240814$20240814$EXP$$JP-ROCHE-10000055701$ROCHE$$$$A$$Y$$$20240814$$MD$JP$JP
242081774$24208177$4$F$20240425$20240918$20240814$20240925$EXP$$CN-ORGANON-O2408CHN000811$ORGANON$$76$YR$$F$Y$57$KG$20240925$$MD$CN$CN
242081782$24208178$2$F$$20240801$20240814$20240816$EXP$$CA-AUROBINDO-AUR-APL-2024-040177$AUROBINDO$$$$$F$Y$71$KG$20240816$$PH$CA$CA
242081791$24208179$1$I$20240707$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039454$AUROBINDO$$15$YR$$F$Y$57$KG$20240814$$PH$FR$FR
242081801$24208180$1$I$$20240123$20240814$20240814$PER$$US-SPECGX-T202400002$SPECGX$$$$$F$Y$51$KG$20240814$$CN$US$US
242081812$24208181$2$F$$20240822$20240814$20240828$EXP$$JP-JNJFOC-20240834683$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240828$$PH$JP$JP
242081821$24208182$1$I$20240808$20240812$20240814$20240814$EXP$$CZ-GILEAD-2024-0683470$GILEAD$$$$$F$Y$$$20240814$$MD$CZ$CZ
242081831$24208183$1$I$$20240802$20240814$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-039885$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol. 2024;113 (1):90-98$16$YR$$F$Y$$$20240814$$HP$IT$IT
242081842$24208184$2$F$$20240827$20240814$20240830$EXP$$JP-GSK-JP2024JPN100398$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$JP$JP
242081851$24208185$1$I$20240813$20240813$20240814$20240814$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-128243$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$65.32$KG$20240814$$CN$PR$PR
242081861$24208186$1$I$$20240802$20240814$20240814$EXP$$BE-AUROBINDO-AUR-APL-2024-039808$AUROBINDO$$40$YR$$M$Y$$$20240814$$PH$BE$BE
242081881$24208188$1$I$$20240802$20240814$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-039887$AUROBINDO$$19$YR$$M$Y$$$20240814$$HP$IT$IT
242081891$24208189$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179199$ASTRAZENECA$$$$$F$Y$$$20240814$$MD$US$
242081901$24208190$1$I$$20240806$20240814$20240814$EXP$$JP-AstraZeneca-2024A180258$ASTRAZENECA$Kawamura Y. et al.. OS9-7 A case in which intrahepatic disease control was finally achieved after tumour lysis syndrome, hepatocellular carcinoma imminent rupture and cytokine release syndrome during pharmacological therapy for unresectable advanced hepatocell. The 30th Japan Association of Systemic Therapy for HCC 2024;136-.$50$YR$$F$Y$$$20240814$$MD$JP$
242081911$24208191$1$I$20240205$20240806$20240814$20240814$EXP$$IT-AstraZeneca-2024A178414$ASTRAZENECA$$73$YR$$F$Y$54$KG$20240814$$MD$IT$
242081921$24208192$1$I$$20230615$20240814$20240814$EXP$$US-AstraZeneca-2023A139540$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242081931$24208193$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A178991$ASTRAZENECA$$$$$F$Y$$$20240814$$HP$US$
242081941$24208194$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179137$ASTRAZENECA$$$$$$Y$$$20240814$$CN$US$
242081953$24208195$3$F$20240501$20240905$20240814$20240912$EXP$$US-ABBVIE-5875008$ABBVIE$$71$YR$$F$Y$90.718$KG$20240912$$CN$US$US
242081961$24208196$1$I$20240101$20240809$20240814$20240814$EXP$$US-ABBVIE-5833142$ABBVIE$$$$$M$Y$66$KG$20240814$$CN$US$US
242081971$24208197$1$I$20240729$20240809$20240814$20240814$EXP$$US-ABBVIE-5875371$ABBVIE$$72$YR$$M$Y$$$20240814$$CN$US$US
242081981$24208198$1$I$$20240802$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-039217$AUROBINDO$$77$YR$$F$Y$$$20240814$$HP$GB$GB
242081991$24208199$1$I$20220718$20240806$20240814$20240814$EXP$$CN-ROCHE-10000049457$ROCHE$Wang M, Zhu P, Shi Y, Sun Q, Dong W. Returning from the afterlife? Sotorasib treatment for advanced KRAS mutant lung cancer: A case report. World Journal of Clinical Cases. 2024;12 (25):5805-13. doi:10.12998/wjcc.v12.i25.5805.$52$YR$A$F$Y$$$20240814$$HP$CN$CN
242082001$24208200$1$I$$20240809$20240814$20240814$EXP$$AE-ROCHE-10000053445$ROCHE$$$$$$Y$$$20240814$$MD$AE$AE
242082011$24208201$1$I$20240101$20240811$20240814$20240814$EXP$$US-ABBVIE-5876593$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242082022$24208202$2$F$20220203$20240815$20240814$20240827$EXP$PT-INFARMED-M202210-1036$PT-GILEAD-2024-0683860$GILEAD$$86$YR$E$M$Y$$$20240827$$MD$PT$PT
242082031$24208203$1$I$20240710$20240802$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-039244$AUROBINDO$$44$YR$$$Y$$$20240814$$PH$GB$GB
242082042$24208204$2$F$20240604$20240913$20240814$20240923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127733$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$71$KG$20240923$$PH$JP$JP
242082052$24208205$2$F$$20240909$20240814$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127389$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240910$$CN$US$US
242082061$24208206$1$I$20240701$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128160$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240814$$PH$US$US
242082071$24208207$1$I$20240309$20240806$20240814$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125909$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$65$KG$20240814$$PH$JP$JP
242082081$24208208$1$I$20240809$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127179$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240814$$HP$US$US
242082091$24208209$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127504$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240814$$CN$US$US
242082101$24208210$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127386$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$50.8$KG$20240814$$CN$US$US
242082113$24208211$3$F$20240811$20240828$20240814$20240831$PER$$US-AMGEN-USASP2024160281$AMGEN$$78$YR$E$F$Y$$$20240831$$CN$US$US
242082131$24208213$1$I$20240723$20240802$20240814$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-039541$AUROBINDO$$95$YR$$F$Y$$$20240814$$MD$IT$IT
242082141$24208214$1$I$$20240802$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040057$AUROBINDO$$78$YR$$M$Y$$$20240814$$HP$CA$CA
242082151$24208215$1$I$20240709$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007665$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242082161$24208216$1$I$20240812$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007700$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240814$$CN$US$US
242082171$24208217$1$I$$20240808$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408005719$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240814$$CN$US$US
242082181$24208218$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007762$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242082192$24208219$2$F$$20240903$20240814$20240915$30DAY$$TW-JNJFOC-20240831077$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$PH$TW$TW
242082201$24208220$1$I$$20240806$20240814$20240814$EXP$$JP-JNJFOC-20240833728$JOHNSON AND JOHNSON$Kimura O, Okada A, Iizuka M, Fujiwara T, Sato I, Inui Y, et al. [121 A case of malignant pleural mesothelioma complicated with cytomegalovirus enterocolitis during irAE therapy with nivolumab + ipilimumab] The Joint Meeting of the 132nd Kinki Branch Meeting of the Japanese Society of Tuberculosis and Nontuberculous Mycobacteriosis and the 103rd Kinki Regional Meeting of the Japanese Respiratory Society. 2024.7.20;83$84$YR$E$M$Y$$$20240814$$MD$JP$JP
242082221$24208222$1$I$$20240802$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040193$AUROBINDO$$63$YR$$M$Y$$$20240814$$HP$CA$CA
242082232$24208223$2$F$20220113$20240816$20240814$20240826$EXP$PT-INFARMED-M202210-1033$PT-GILEAD-2024-0683858$GILEAD$$86$YR$E$F$Y$$$20240826$$MD$PT$PT
242082241$24208224$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040225$AUROBINDO$Caylie MP, Aleesa AC,Yvonne K, Jessica K,Jill MW, Fadi A etal. Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic  Therapy Post-Percutaneous Coronary Intervention. CJC Open. 2023;1-13$81$YR$$M$Y$$$20240814$$MD$CA$CA
242082251$24208225$1$I$20240809$20240810$20240814$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-024975$UNITED THERAPEUTICS$$45$YR$$F$Y$77.098$KG$20240814$$$US$US
242082261$24208226$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179139$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242082271$24208227$1$I$$20240806$20240814$20240814$EXP$$ZA-AstraZeneca-2024A178672$ASTRAZENECA$$81$YR$$F$Y$$$20240814$$CN$ZA$
242082281$24208228$1$I$$20240806$20240814$20240814$EXP$$JP-AstraZeneca-2024A179162$ASTRAZENECA$Tani J, et al.. OS8-3 Initial treatment results of durvalumab + tremelimumab combination therapy for unresectable hepatocellular carcinoma at our hospital.. The 30th Japan Association of Systemic Therapy for HCC 2024;126-.$$$A$$Y$$$20240814$$MD$JP$
242082294$24208229$4$F$$20240911$20240814$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-038899$AUROBINDO$Baudriller A, Abbara C, Briet M, Jousset N, Malbranque S, Zabet D, et al.. Deaths related to pharmacobezoars: A report on two cases.. Toxicologie Analytique et Clinique.. 2024;547:9$55$YR$$F$Y$$$20240925$$MD$FR$FR
242082301$24208230$1$I$$20240802$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040067$AUROBINDO$$78$YR$$F$Y$$$20240814$$MD$CA$CA
242082311$24208231$1$I$20240607$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039492$AUROBINDO$$66$YR$$F$Y$47.6$KG$20240814$$PH$FR$FR
242082321$24208232$1$I$$20240802$20240814$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-039791$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol. 2024;113 (1):90-98$13$YR$$M$Y$$$20240814$$HP$IT$IT
242082332$24208233$2$F$20240806$20240812$20240814$20240816$EXP$$US-ABBVIE-5878001$ABBVIE$$32$YR$$F$Y$$$20240816$$CN$US$US
242082341$24208234$1$I$20240712$20240715$20240814$20240814$EXP$$GB-CELLTRION INC.-2024GB019449$CELLTRION$$$$$$Y$$$20240814$$PH$GB$GB
242082351$24208235$1$I$20240701$20240812$20240814$20240814$EXP$$US-ABBVIE-5878420$ABBVIE$$66$YR$$M$Y$$$20240814$$CN$US$US
242082362$24208236$2$F$$20240812$20240814$20240814$EXP$$US-ABBVIE-5877689$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242082371$24208237$1$I$20240601$20240801$20240814$20240814$EXP$$US-UCBSA-2024032216$UCB$$68$YR$$M$Y$96.19$KG$20240814$$HP$US$US
242082381$24208238$1$I$20240101$20240812$20240814$20240814$EXP$$ZA-ABBVIE-5877112$ABBVIE$$51$YR$$F$Y$$$20240814$$CN$ZA$ZA
242082391$24208239$1$I$20231220$20240802$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-039226$AUROBINDO$$26$YR$$F$Y$$$20240814$$CN$GB$GB
242082401$24208240$1$I$20240730$20240806$20240814$20240814$EXP$$US-VIIV HEALTHCARE LIMITED-US2024098108$VIIV$$34$YR$$M$Y$$$20240814$$CN$US$US
242082411$24208241$1$I$20240802$20240804$20240814$20240814$EXP$GB-MHRA-MED-202408040955137530-ZCWSM$GB-TEVA-VS-3229946$TEVA$$6$YR$$M$Y$20$KG$20240814$$CN$GB$GB
242082421$24208242$1$I$$20240807$20240814$20240814$EXP$$CN-RDY-LIT/CHN/24/0011793$DR REDDYS$Bao L, Lu M, Liu P, Wang Y, Zhuang J, Zhang M, et al. Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score }=2: A Prospective Multicenter Study. Blood. 2022 Nov 15;140: 12564-12565. doi:10.1182/blood-2022-168068.$$$E$$Y$$$20240814$$MD$CN$CN
242082431$24208243$1$I$20240729$20240804$20240814$20240814$EXP$GB-MHRA-MED-202408042011333650-DLCHB$GB-TEVA-VS-3230147$TEVA$$33$YR$$F$Y$54$KG$20240814$$CN$GB$GB
242082442$24208244$2$F$20240701$20240820$20240814$20240829$EXP$$FR-TEVA-VS-3230009$TEVA$$80$YR$$F$Y$$$20240829$$CN$FR$FR
242082451$24208245$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232144$TEVA$$3$YR$$M$Y$$$20240814$$HP$CA$CA
242082461$24208246$1$I$20221031$20240805$20240814$20240814$EXP$$US-TEVA-2022-US-2832048$TEVA$$63$YR$$F$Y$$$20240814$$CN$US$US
242082481$24208248$1$I$20240513$20240805$20240814$20240814$EXP$FR-AFSSAPS-PB2024000814$FR-TEVA-VS-3230442$TEVA$$73$YR$$F$Y$61$KG$20240814$$MD$FR$FR
242082491$24208249$1$I$$20240806$20240814$20240814$EXP$$CA-TEVA-VS-3231988$TEVA$$15$YR$$F$Y$$$20240814$$HP$CA$CA
242082511$24208251$1$I$$20240806$20240814$20240814$EXP$$CA-TEVA-VS-3231977$TEVA$$74$YR$$F$Y$67$KG$20240814$$HP$CA$CA
242082521$24208252$1$I$$20240807$20240814$20240814$EXP$$CA-ROCHE-10000050908$ROCHE$$52$YR$A$M$Y$$$20240814$$HP$CA$CA
242082531$24208253$1$I$$20240805$20240814$20240814$EXP$$NL-ROCHE-10000050810$ROCHE$Verkouteren B, Reyners A, Aarts M, Mosterd K. Hedgehog Pathway and Programmed Cell Death Protein-1 Inhibitors for Advanced Basal Cell Carcinoma. Case Reports in Dermatology. 2024-Jan;173-180. doi:10.1159/000539592.$68$YR$E$F$Y$$$20240814$$HP$NL$NL
242082541$24208254$1$I$20240601$20240807$20240814$20240814$PER$$US-ABBVIE-5875768$ABBVIE$$59$YR$$M$Y$$$20240814$$HP$US$US
242082552$24208255$2$F$20240725$20240802$20240814$20240816$EXP$$PT-AUROBINDO-AUR-APL-2024-039817$AUROBINDO$$66$YR$$F$Y$88.1$KG$20240816$$MD$PT$PT
242082561$24208256$1$I$20240801$20240807$20240814$20240814$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02938$AMNEAL$$26$YR$$M$Y$63$KG$20240814$$MD$US$US
242082572$24208257$2$F$$20240829$20240814$20240829$PER$$US-ALXN-202408USA000580US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242082583$24208258$3$F$20240510$20240828$20240814$20240907$EXP$$ES-AUROBINDO-AUR-APL-2024-039652$AUROBINDO$$83$YR$$M$Y$$$20240907$$MD$ES$ES
242082592$24208259$2$F$20211227$20240815$20240814$20240826$EXP$PT-INFARMED-M202210-888$PT-GILEAD-2024-0683890$GILEAD$$75$YR$E$F$Y$$$20240826$$MD$PT$PT
242082601$24208260$1$I$$20240813$20240814$20240814$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045588$BOEHRINGER INGELHEIM$$$$$$Y$$$20240814$$HP$CA$CA
242082611$24208261$1$I$20240304$20240802$20240814$20240814$EXP$$ES-AUROBINDO-AUR-APL-2024-039654$AUROBINDO$$54$YR$$F$Y$61$KG$20240814$$HP$ES$ES
242082621$24208262$1$I$$20240812$20240814$20240814$EXP$$US-GILEAD-2024-0684033$GILEAD$$30$YR$A$M$Y$$$20240814$$CN$US$US
242082632$24208263$2$F$$20240913$20240814$20240917$30DAY$$TW-JNJFOC-20240831103$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$PH$TW$TW
242082641$24208264$1$I$$20240802$20240814$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-039889$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol. 2024;113 (1):90-98$11$YR$$F$Y$$$20240814$$HP$IT$IT
242082652$24208265$2$F$20240503$20240913$20240814$20240925$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093076$GLENMARK$$$$$$Y$$$20240925$$CN$US$US
242082661$24208266$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040210$AUROBINDO$Poirier CM, Carter AA, Kwan Y, Koo J, Westlund JM, Alkass F. Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post-Percutaneous Coronary Intervention. CJC Open. 2023;1-13$67$YR$$F$Y$$$20240814$$MD$CA$CA
242082671$24208267$1$I$$20240802$20240814$20240814$EXP$$DE-AUROBINDO-AUR-APL-2024-039677$AUROBINDO$$60$YR$$F$Y$$$20240814$$CN$DE$DE
242082684$24208268$4$F$20240516$20240807$20240814$20240903$EXP$$US-ROCHE-10000052068$ROCHE$$47$YR$A$F$Y$79.37$KG$20240903$$CN$US$US
242082693$24208269$3$F$20240724$20240815$20240814$20240821$EXP$AT-BASGAGES-2024-005768$AT-009507513-2408AUT002330$MERCK$$81$YR$$M$Y$78$KG$20240821$$MD$AT$AT
242082701$24208270$1$I$$20240809$20240814$20240814$EXP$$AT-AMGEN-AUTSP2024158613$AMGEN$$$$$F$Y$$$20240814$$CN$AT$AT
242082712$24208271$2$F$$20240801$20240814$20240816$EXP$$CA-AUROBINDO-AUR-APL-2024-040186$AUROBINDO$$78$YR$$F$Y$$$20240816$$HP$CA$CA
242082721$24208272$1$I$20210430$20240812$20240814$20240814$EXP$PT-INFARMED-M202210-789$PT-GILEAD-2024-0683888$GILEAD$$74$YR$E$M$Y$$$20240814$$MD$PT$PT
242082731$24208273$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127795$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240814$$HP$US$US
242082741$24208274$1$I$20240701$20240812$20240814$20240814$EXP$LT-SMCA-4775$LT-SANDOZ INC.-SDZ2024LT072043$SANDOZ$$65$YR$$M$Y$$$20240814$$MD$LT$LT
242082751$24208275$1$I$$20240802$20240814$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-039878$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology.. Eur-J-Haematol. 2024;113 (1):90-98.$6$YR$$M$Y$$$20240814$$HP$IT$IT
242082762$24208276$2$F$$20240802$20240814$20240816$EXP$$IT-AUROBINDO-AUR-APL-2024-039582$AUROBINDO$$72$YR$$F$Y$$$20240816$$MD$IT$IT
242082772$24208277$2$F$20220131$20240816$20240814$20240826$EXP$PT-INFARMED-M202210-1037$PT-GILEAD-2024-0683857$GILEAD$$82$YR$E$F$Y$$$20240826$$MD$PT$PT
242082781$24208278$1$I$20240101$20240808$20240814$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-024812$UNITED THERAPEUTICS$$$$$$Y$$$20240814$$$US$US
242082791$24208279$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A178679$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242082802$24208280$2$F$$20240927$20240814$20240930$PER$$NVSC2024US164850$NOVARTIS$$$$$$Y$$$20240930$$HP$US$US
242082811$24208281$1$I$$20240810$20240814$20240814$PER$$US-ABBVIE-5877759$ABBVIE$$$$$$Y$$$20240814$$CN$US$US
242082821$24208282$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164895$NOVARTIS$$$$$$Y$$$20240814$$PH$US$US
242082831$24208283$1$I$20240811$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007390$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240814$$CN$US$US
242082842$24208284$2$F$20240812$20240813$20240814$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408007644$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240820$$CN$US$US
242082851$24208285$1$I$$20240802$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040070$AUROBINDO$$61$YR$$M$Y$$$20240814$$PH$CA$CA
242082861$24208286$1$I$$20240802$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408002330$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240814$$CN$US$US
242082871$24208287$1$I$20170401$20240813$20240814$20240814$EXP$$ES-ORGANON-1903ESP013134$ORGANON$Ordonez-Fernandez L, Rodriguez-Ferreras A, Carriles C, Mart?nez-Torron A, Lazaro-Lopez E, Rosado-Maria MC.. Pneumonia in a patient with kidney transplant treated with alirocumab and everolimus. Farmacia Hospitalaria. 2019;43 (2):74-6$45$YR$$M$Y$$$20240814$$HP$ES$ES
242082881$24208288$1$I$$20240808$20240814$20240814$30DAY$$US-GSK-US2024099286$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240814$$CN$US$US
242082892$24208289$2$F$$20240910$20240814$20240923$PER$$US-ROCHE-10000052399$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
242082902$24208290$2$F$20240101$20240812$20240814$20240819$EXP$GB-MHRA-MED-202408121723240630-QZMCD$GB-ABBVIE-5877573$ABBVIE$$57$YR$$M$Y$81$KG$20240819$$CN$GB$GB
242082911$24208291$1$I$$20240806$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127110$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240814$$HP$US$US
242082923$24208292$3$F$20240806$20240920$20240814$20240925$30DAY$$US-AMGEN-USASP2024158643$AMGEN$$$$$F$Y$$$20240925$$CN$US$US
242082931$24208293$1$I$20240603$20240802$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-039262$AUROBINDO$$78$YR$$F$Y$$$20240814$$HP$GB$GB
242082941$24208294$1$I$20230101$20240809$20240814$20240814$EXP$$US-ABBVIE-5404688$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242082951$24208295$1$I$$20240809$20240814$20240814$PER$$US-ROCHE-3568532$ROCHE$$85$YR$E$F$Y$$$20240814$$CN$US$US
242082961$24208296$1$I$20201101$20240812$20240814$20240814$EXP$GB-MHRA-MED-202408121641507570-NDJLF$GB-TEVA-VS-3232856$TEVA$$22$YR$$F$Y$67$KG$20240814$$CN$GB$GB
242082971$24208297$1$I$20240423$20240802$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-039236$AUROBINDO$$72$YR$$F$Y$53$KG$20240814$$CN$GB$GB
242082981$24208298$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232166$TEVA$$52$YR$$M$Y$$$20240814$$MD$CA$CA
242082991$24208299$1$I$$20240805$20240814$20240814$PER$$US-AMGEN-USASP2024155908$AMGEN$$$$A$F$Y$$$20240814$$MD$US$US
242083001$24208300$1$I$$20240805$20240814$20240814$EXP$$US-ROCHE-10000049940$ROCHE$$55$YR$A$F$Y$$$20240814$$HP$US$US
242083011$24208301$1$I$20231003$20240806$20240814$20240814$EXP$ES-AEMPS-1554122$ES-TEVA-VS-3230783$TEVA$$86$YR$$F$Y$$$20240814$$MD$ES$ES
242083022$24208302$2$F$20240101$20240813$20240814$20240822$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024748$UNITED THERAPEUTICS$$$$$F$Y$76.644$KG$20240822$$MD$US$US
242083031$24208303$1$I$$20240719$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116181$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240814$$CN$US$US
242083041$24208304$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126808$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240814$$HP$US$US
242083051$24208305$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128193$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240814$$CN$US$US
242083061$24208306$1$I$20230427$20240802$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039635$AUROBINDO$$73$YR$$M$Y$$$20240814$$MD$FR$FR
242083071$24208307$1$I$20240629$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408050942328210-TYRHD$GB-AMAROX PHARMA-AMR2024GB02605$HETERO$$53$YR$$F$Y$$$20240814$$MD$GB$GB
242083081$24208308$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164929$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242083102$24208310$2$F$$20240826$20240814$20240904$EXP$$PL-TEVA-VS-3231411$TEVA$Zimodro JM, Gasecka A, Arski P, Schwarz J, Banach M, Gouni-Berthold I. Lipoprotein (a) measurement: potential for personalized cardiovascular disease management in a patient with acute myocardial infarction. Arch-Med-Sci 2024; 20 (3): 1043-1047.; Zimodro JM, Gasecka A, Arski P, Schwarz J, Banach M, Gouni-Berthold I. Lipoprotein (a) measurement: potential for personalized cardiovascular disease management in a patient with acute myocardial infarction. Arch-Med-Sci 2024; 20 (3): 1043-1047.$58$YR$$M$Y$$$20240904$$HP$PL$PL
242083121$24208312$1$I$$20240805$20240814$20240814$PER$$RU-ORGANON-O2408RUS000616$ORGANON$$40$YR$$F$Y$$$20240814$$MD$RU$RU
242083141$24208314$1$I$$20240805$20240814$20240814$PER$$US-ROCHE-10000049990$ROCHE$$$$$$Y$$$20240814$$PH$US$US
242083151$24208315$1$I$$20240807$20240814$20240814$EXP$$US-AMGEN-USASP2024157750$AMGEN$$89$YR$E$F$Y$$$20240814$$CN$US$US
242083161$24208316$1$I$$20240807$20240814$20240814$EXP$$SE-JNJFOC-20240822194$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240814$$MD$SE$SE
242083171$24208317$1$I$20240101$20240812$20240814$20240814$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024932$UNITED THERAPEUTICS$$$$$F$Y$$$20240814$$$US$US
242083182$24208318$2$F$20240731$20240827$20240814$20240830$EXP$$US-GILEAD-2024-0681692$GILEAD$$50$YR$A$F$Y$$$20240830$$CN$US$US
242083191$24208319$1$I$$20240809$20240814$20240814$EXP$$US-SA-2024SA240090$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240814$$HP$US$US
242083201$24208320$1$I$$20240808$20240814$20240814$EXP$$US-SA-2024SA239553$SANOFI AVENTIS$$$$A$$Y$$$20240814$$CN$US$US
242083211$24208321$1$I$20240701$20240808$20240814$20240814$EXP$$US-SA-2024SA238612$SANOFI AVENTIS$$$$A$$Y$$$20240814$$MD$US$US
242083221$24208322$1$I$$20240808$20240814$20240814$EXP$$JP-VANTIVE-2024VAN018930$Vantive US Healthcare$$77$YR$$M$Y$$$20240814$$MD$JP$JP
242083231$24208323$1$I$$20240809$20240814$20240814$EXP$$JP-VANTIVE-2024VAN018868$Vantive US Healthcare$$$$$M$Y$$$20240814$$HP$JP$JP
242083242$24208324$2$F$20240805$20240813$20240814$20240820$EXP$$JP-VANTIVE-2024VAN018872$Vantive US Healthcare$$85$YR$$F$Y$$$20240820$$HP$JP$JP
242083251$24208325$1$I$$20240808$20240814$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001599$BLUEPRINT MEDICINES$$$$$F$Y$$$20240814$$CN$US$US
242083261$24208326$1$I$$20240807$20240814$20240814$PER$$US-AMGEN-USASP2024159865$AMGEN$$$$$$Y$$$20240814$$CN$US$US
242083271$24208327$1$I$20240710$20240809$20240814$20240814$EXP$IT-MINISAL02-998170$IT-AMGEN-ITASP2024159243$AMGEN$$93$YR$E$M$Y$79$KG$20240814$$CN$IT$IT
242083281$24208328$1$I$$20240731$20240814$20240814$PER$$US-JNJFOC-20240801079$JOHNSON AND JOHNSON$$2$YR$C$F$Y$$$20240814$$CN$US$US
242083291$24208329$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127800$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240814$$CN$US$US
242083301$24208330$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128138$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240814$$CN$US$US
242083311$24208331$1$I$$20240806$20240814$20240814$EXP$GB-MHRA-MED-202408061607072160-KTSDZ$GB-AMAROX PHARMA-AMR2024GB02625$HETERO$$$$$M$Y$$$20240814$$CN$GB$GB
242083321$24208332$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128173$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240814$$CN$US$US
242083331$24208333$1$I$$20240807$20240814$20240814$PER$$US-EMD Serono-2024042869$EMD SERONO INC$$34$YR$A$F$Y$$$20240814$$CN$US$US
242083341$24208334$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007645$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240814$$CN$US$US
242083351$24208335$1$I$20240811$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007432$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240814$$CN$US$US
242083361$24208336$1$I$20240813$20240813$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008345$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240814$$CN$US$US
242083372$24208337$2$F$$20240823$20240814$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408008268$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242083381$24208338$1$I$20240701$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007248$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240814$$CN$US$US
242083392$24208339$2$F$$20240812$20240814$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007403$ELI LILLY AND CO$$86$YR$E$M$Y$$$20240816$$CN$US$US
242083401$24208340$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007490$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242083411$24208341$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232193$TEVA$$12$YR$$F$Y$32$KG$20240814$$HP$CA$CA
242083421$24208342$1$I$20240506$20240813$20240814$20240814$PER$$NVSC2024US164926$NOVARTIS$$71$YR$$F$Y$$$20240814$$HP$US$US
242083431$24208343$1$I$$20240811$20240814$20240814$PER$$NVSC2024US163972$NOVARTIS$$$$A$F$Y$$$20240814$$HP$US$US
242083441$24208344$1$I$20240309$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039525$AUROBINDO$$39$YR$$F$Y$140$KG$20240814$$PH$FR$FR
242083451$24208345$1$I$20240802$20240802$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-039264$AUROBINDO$$62$YR$$M$Y$65$KG$20240814$$CN$GB$GB
242083462$24208346$2$F$$20240826$20240814$20240904$EXP$$GB-TEVA-VS-3231800$TEVA$D^arienzo PD, Macdonald AR, Patel V, Ma YT, Pihlak R, Starling N. Prolonged Clinical Benefit with Futibatinib in a Patient with FGFR Inhibitor-Pretreated FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma: Case Report. OncoTargets-Therap 2024; 17 (0): 489-496; D^arienzo PD, Macdonald AR, Patel V, Ma YT, Pihlak R, Starling N. Prolonged Clinical Benefit with Futibatinib in a Patient with FGFR Inhibitor-Pretreated FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma: Case Report. OncoTargets...$50$YR$$F$Y$$$20240904$$HP$GB$GB
242083471$24208347$1$I$20240730$20240805$20240814$20240814$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS004071$TERSERA THERAPEUTICS$$$$$$Y$$$20240814$$HP$NL$NL
242083481$24208348$1$I$$20240812$20240814$20240814$EXP$$US-JNJFOC-20240830549$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242083491$24208349$1$I$$20240808$20240814$20240814$EXP$$US-TERSERA THERAPEUTICS LLC-2024TRS004029$TERSERA THERAPEUTICS$$$$$$Y$$$20240814$$CN$US$US
242083504$24208350$4$F$20240101$20240910$20240814$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018196$UNITED THERAPEUTICS$$$$$M$Y$81.633$KG$20240918$$$US$US
242083511$24208351$1$I$$20240805$20240814$20240814$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024005794$BIOCON$$$$$$Y$$$20240814$$CN$AU$AU
242083521$24208352$1$I$$20240810$20240814$20240814$EXP$$CA-TERSERA THERAPEUTICS LLC-2024TRS004050$TERSERA THERAPEUTICS$$$$$$Y$$$20240814$$MD$CA$CA
242083531$24208353$1$I$20240729$20240805$20240814$20240814$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS003947$TERSERA THERAPEUTICS$$$$$$Y$$$20240814$$HP$NL$NL
242083541$24208354$1$I$$20240808$20240814$20240814$PER$$US-ALXN-202408USA000585US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242083551$24208355$1$I$$20240811$20240814$20240814$30DAY$$EG-SANDOZ INC.-SDZ2024EG038413$SANDOZ$$$$$M$Y$$$20240814$$CN$EG$EG
242083573$24208357$3$F$20240809$20240812$20240814$20240821$PER$$US-AMGEN-USASP2024160880$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242083581$24208358$1$I$$20240812$20240814$20240814$EXP$$US-ROCHE-10000055823$ROCHE$$87$YR$E$F$Y$$$20240814$$CN$US$US
242083591$24208359$1$I$20240812$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160819$AMGEN$$$$A$$Y$$$20240814$$HP$US$US
242083604$24208360$4$F$20230101$20240922$20240814$20240930$PER$$NVSC2024US162680$NOVARTIS$$$$$$Y$$$20240930$$CN$US$US
242083611$24208361$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164932$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242083621$24208362$1$I$$20240807$20240814$20240814$EXP$$US-IMMUNOCORE, LTD-2024-IMC-002942$IMMUNOCORE$$$$$F$Y$$$20240814$$MD$US$US
242083632$24208363$2$F$$20240813$20240814$20240818$PER$$US-AMGEN-USASP2024161159$AMGEN$$$$$F$Y$$$20240818$$CN$US$US
242083642$24208364$2$F$$20240911$20240814$20240925$30DAY$$US-JNJFOC-20240831460$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
242083651$24208365$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040475$AUROBINDO$$$$$M$Y$$$20240814$$HP$CA$CA
242083661$24208366$1$I$20240730$20240805$20240814$20240814$PER$$US-JNJFOC-20240812788$JOHNSON AND JOHNSON$$93$YR$E$F$Y$$$20240814$$CN$US$US
242083671$24208367$1$I$$20240802$20240814$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-039763$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol. 2024;113 (1):90-98$17$YR$$M$Y$$$20240814$$HP$IT$IT
242083692$24208369$2$F$20230317$20240905$20240814$20240911$EXP$$US-ABBVIE-5875251$ABBVIE$$63$YR$$F$Y$93$KG$20240911$$CN$US$US
242083701$24208370$1$I$20240614$20240802$20240814$20240814$EXP$$ES-AUROBINDO-AUR-APL-2024-039666$AUROBINDO$$46$YR$$M$Y$83.9$KG$20240814$$MD$ES$ES
242083711$24208371$1$I$20240101$20240809$20240814$20240814$EXP$$US-ABBVIE-5875784$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242083721$24208372$1$I$20240808$20240809$20240814$20240814$EXP$$US-ABBVIE-5875939$ABBVIE$$72$YR$$F$Y$$$20240814$$CN$US$US
242083731$24208373$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040204$AUROBINDO$$92$YR$$M$Y$$$20240814$$HP$CA$CA
242083742$24208374$2$F$20240722$20240815$20240814$20240819$EXP$$US-ABBVIE-5878474$ABBVIE$$71$YR$$F$Y$60$KG$20240819$$CN$US$US
242083751$24208375$1$I$$20240812$20240814$20240814$PER$$US-GILEAD-2024-0683925$GILEAD$$$$A$M$Y$$$20240814$$CN$US$US
242083764$24208376$4$F$20240322$20240913$20240814$20240923$EXP$$FR-TEVA-VS-3233021$TEVA$$84$YR$$M$Y$70$KG$20240923$$MD$FR$FR
242083771$24208377$1$I$20240424$20240802$20240814$20240814$EXP$$DE-AUROBINDO-AUR-APL-2024-039703$AUROBINDO$$74$YR$$M$Y$$$20240814$$MD$DE$DE
242083781$24208378$1$I$20240602$20240802$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-039296$AUROBINDO$$81$YR$$M$Y$64$KG$20240814$$HP$GB$GB
242083791$24208379$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039689$AUROBINDO$$76$YR$$M$Y$105$KG$20240814$$PH$CA$CA
242083812$24208381$2$F$$20240814$20240814$20240815$PER$$NVSC2024US164897$NOVARTIS$$$$$M$Y$$$20240815$$PH$US$US
242083821$24208382$1$I$$20240807$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125962$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240814$$CN$US$US
242083832$24208383$2$F$$20240913$20240814$20240925$30DAY$$JP-JNJFOC-20240831457$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$PH$JP$JP
242083841$24208384$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039628$AUROBINDO$$26$YR$$F$Y$$$20240814$$MD$CA$CA
242083852$24208385$2$F$$20240909$20240814$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003889$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242083861$24208386$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039617$AUROBINDO$$67$YR$$F$Y$$$20240814$$HP$CA$CA
242083872$24208387$2$F$$20240826$20240814$20240903$EXP$$FR-TEVA-VS-3231773$TEVA$Beigneux Y, Louapre C, Bihan K, Roux T, de Paz R, Lubetzki C, et al. Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab. Mult-Scler-J 2024; 30 (1): 131-133.; Beigneux Y, Louapre C, Bihan K, Roux T, de Paz R, Lubetzki C, et al. Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab. Mult-Scler-J 2024; 30 (1): 131-133.$38$YR$$F$Y$$$20240903$$HP$FR$FR
242083881$24208388$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040184$AUROBINDO$$83$YR$$F$Y$49$KG$20240814$$HP$CA$CA
242083901$24208390$1$I$$20240812$20240814$20240814$PER$$US-BEH-2024177145$CSL BEHRING$$$$E$F$Y$$$20240814$$HP$US$US
242083911$24208391$1$I$$20240809$20240814$20240814$EXP$$PT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044773$BOEHRINGER INGELHEIM$Miranda T, Maio Herculano M, Sousa Torres J, Das Neves Coelho F, Rebelo M. From Bronchodilation to Lactic Acidosis: A Case Report on Salbutamol^s Adverse Effect. Cureus. 2024;16(6): doi:10.7759/cureus.63213.$23$YR$A$F$Y$$$20240814$$MD$PT$PT
242083921$24208392$1$I$$20240813$20240814$20240814$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045617$BOEHRINGER INGELHEIM$$89$YR$E$M$Y$$$20240814$$HP$SG$SG
242083931$24208393$1$I$$20240805$20240814$20240814$EXP$$MX-TAKEDA-2024TUS079891$TAKEDA$$$$$$Y$$$20240814$$CN$MX$MX
242083941$24208394$1$I$$20240807$20240814$20240814$EXP$$GB-TAKEDA-2024TUS080365$TAKEDA$$$$$F$Y$$$20240814$$MD$GB$GB
242083951$24208395$1$I$$20240805$20240814$20240814$EXP$$CN-TEYRO-2024-TY-000416$Teyro Labs$Zhang L, Liu M, Xie L, Tian X. .Cardiac Arrest Due to Capecitabine Toxicosis Treated With ECMO and CRRT: A Case Report. .Crit Care Nurse.2024;44(4):57-62$58$YR$A$M$Y$$$20240814$$MD$CN$CN
242083961$24208396$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040200$AUROBINDO$$71$YR$$M$Y$73$KG$20240814$$HP$CA$CA
242083971$24208397$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128099$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$70.76$KG$20240814$$CN$US$US
242083991$24208399$1$I$20240716$20240805$20240814$20240814$PER$$US-AMGEN-USASP2024159821$AMGEN$$64$YR$A$F$Y$61$KG$20240814$$CN$US$US
242084002$24208400$2$F$20240101$20240913$20240814$20240917$PER$$US-AMGEN-USASP2024161490$AMGEN$$58$YR$A$F$Y$$$20240917$$HP$US$US
242084011$24208401$1$I$$20240801$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-038673$AUROBINDO$$75$YR$$F$Y$67$KG$20240814$$MD$GB$GB
242084021$24208402$1$I$$20240730$20240814$20240814$PER$$US-TEVA-VS-3228300$TEVA$$$$$F$Y$$$20240814$$CN$US$US
242084031$24208403$1$I$20240101$20240809$20240814$20240814$PER$$US-ABBVIE-5878890$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242084041$24208404$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006523$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240814$$CN$US$US
242084051$24208405$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007521$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240814$$CN$US$US
242084061$24208406$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007643$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240814$$CN$US$US
242084071$24208407$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007505$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240814$$CN$US$US
242084081$24208408$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007435$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240814$$CN$US$US
242084091$24208409$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007251$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240814$$CN$US$US
242084101$24208410$1$I$$20240807$20240814$20240814$PER$$US-AMGEN-USASP2024157609$AMGEN$$$$E$F$Y$$$20240814$$HP$US$US
242084111$24208411$1$I$20240730$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024161016$AMGEN$$65$YR$E$M$Y$$$20240814$$CN$US$US
242084121$24208412$1$I$20240811$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160977$AMGEN$$77$YR$E$F$Y$$$20240814$$CN$US$US
242084131$24208413$1$I$20240812$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024159990$AMGEN$$73$YR$E$F$Y$$$20240814$$CN$US$US
242084141$24208414$1$I$20240806$20240806$20240814$20240814$EXP$$US-VIIV HEALTHCARE LIMITED-US2024098057$VIIV$$56$YR$$F$Y$$$20240814$$CN$US$US
242084151$24208415$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003841$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240814$$CN$US$US
242084171$24208417$1$I$$20240730$20240814$20240814$PER$$US-NOVITIUMPHARMA-2024USNVP01484$NOVITIUM PHARMA$$2$MON$I$M$Y$$$20240814$$PH$US$US
242084181$24208418$1$I$$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A181985$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242084192$24208419$2$F$$20240903$20240814$20240911$EXP$$US-AstraZeneca-2024A179220$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
242084201$24208420$1$I$$20240807$20240814$20240814$EXP$$US-AstraZeneca-2024A181077$ASTRAZENECA$$$$$M$Y$102.5$KG$20240814$$CN$US$
242084211$24208421$1$I$20240101$20240805$20240814$20240814$EXP$SE-SEMPA-2024-005866$SE-STRIDES PHARMA UK LTD.-2024SP009887$STRIDES$$$$$M$Y$$$20240814$$CN$SE$SE
242084221$24208422$1$I$20240810$20240810$20240814$20240814$PER$$US-LEO Pharma-372694$LEO PHARM$$54$YR$$M$Y$$$20240814$$PH$US$US
242084231$24208423$1$I$20240701$20240808$20240814$20240814$PER$$US-ABBVIE-5875439$ABBVIE$$$$$$Y$$$20240814$$CN$US$US
242084243$24208424$3$F$20220101$20240910$20240814$20240916$EXP$$CA-TAKEDA-2022TUS026883$TAKEDA$$$$$F$Y$46$KG$20240916$$HP$CA$CA
242084251$24208425$1$I$$20240808$20240814$20240814$PER$$NVSC2024US162772$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
242084261$24208426$1$I$20240806$20240808$20240814$20240814$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099172$VIIV$$46$YR$$M$Y$$$20240814$$HP$US$US
242084281$24208428$1$I$20231001$20240807$20240814$20240814$EXP$DE-CADRBFARM-2024329726$DE-RDY-SPO/DEU/24/0011617$DR REDDYS$$38$YR$A$M$Y$65$KG$20240814$$CN$DE$DE
242084291$24208429$1$I$$20240809$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128106$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240814$$CN$US$US
242084301$24208430$1$I$20240801$20240809$20240814$20240814$EXP$$US-ABBVIE-5875798$ABBVIE$$70$YR$$M$Y$$$20240814$$CN$US$US
242084311$24208431$1$I$20240728$20240808$20240814$20240814$EXP$$CA-TAKEDA-2022TUS058475$TAKEDA$$32$YR$$F$Y$$$20240814$$MD$CA$CA
242084321$24208432$1$I$$20240809$20240814$20240814$PER$$US-BIOGEN-2024BI01277793$BIOGEN$$$$$F$Y$$$20240814$$CN$US$US
242084341$24208434$1$I$20240701$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128268$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240814$$HP$US$US
242084351$24208435$1$I$$20240808$20240814$20240814$EXP$$CA-ROCHE-10000052304$ROCHE$$$$$F$Y$$$20240814$$MD$CA$CA
242084362$24208436$2$F$20240812$20240812$20240814$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128191$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240820$$CN$US$US
242084371$24208437$1$I$$20240813$20240814$20240814$EXP$$US-JNJFOC-20240833917$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$HP$US$US
242084381$24208438$1$I$20240610$20240808$20240814$20240814$EXP$$FR-JNJFOC-20240827383$JOHNSON AND JOHNSON$$52$YR$A$F$Y$71$KG$20240814$$MD$FR$FR
242084393$24208439$3$F$20240717$20240905$20240814$20240906$EXP$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000431$REVANCE THERAPEUTICS$$$$$$Y$$$20240906$$CN$US$US
242084401$24208440$1$I$$20240805$20240814$20240814$PER$$US-ROCHE-10000053006$ROCHE$$66$YR$E$F$Y$$$20240814$$CN$US$US
242084411$24208441$1$I$$20240808$20240814$20240814$EXP$$US-ROCHE-10000053623$ROCHE$$56$YR$A$M$Y$$$20240814$$CN$US$US
242084421$24208442$1$I$20240701$20240808$20240814$20240814$EXP$$JP-009507513-2408JPN000959J$MERCK$$6$DEC$$F$Y$$$20240814$$MD$JP$JP
242084431$24208443$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040205$AUROBINDO$Caylie MP, Aleesa A. Carter,Yvonne Kwan, Jessica Koo,Jill M. Westlund, Fadi Alkass etal. Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic  Therapy Post-Percutaneous Coronary Intervention.. CJC Open. 2023;1-13$72$YR$$M$Y$$$20240814$$MD$CA$CA
242084441$24208444$1$I$20240805$20240807$20240814$20240814$EXP$$JP-009507513-2408JPN000802J$MERCK$$83$YR$$M$Y$$$20240814$$MD$JP$JP
242084451$24208445$1$I$20190401$20240808$20240814$20240814$EXP$$US-CHATTEMPRD-2024OHG026943$CHATTEM$$$$$M$Y$$$20240814$$CN$US$US
242084471$24208447$1$I$$20240808$20240814$20240814$EXP$$US-TAKEDA-2024TUS056426$TAKEDA$$$$$M$Y$$$20240814$$CN$US$US
242084481$24208448$1$I$20210401$20240808$20240814$20240814$PER$$US-BIOGEN-2024BI01277684$BIOGEN$$51$YR$$F$Y$$$20240814$$MD$US$US
242084491$24208449$1$I$20140826$20240812$20240814$20240814$PER$$US-BIOGEN-2017BI00423724$BIOGEN$$36$YR$$F$Y$$$20240814$$CN$US$US
242084501$24208450$1$I$20240727$20240806$20240814$20240814$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024425$UNITED THERAPEUTICS$$54$YR$$M$Y$$$20240814$$$US$US
242084511$24208451$1$I$20240610$20240809$20240814$20240814$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-109135$REGENERON$$$$$M$Y$$$20240814$$HP$US$US
242084521$24208452$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040209$AUROBINDO$Poirier CM, Carter AA, Kwan Y, Koo J, Westlund JM, Alkass F, et al.. Experiences of patients with  atrial fibrillation with combination antithrombotic therapy post-percutaneous coronary  intervention. CJC Open. 2023;5:846-58$84$YR$$M$Y$$$20240814$$MD$CA$CA
242084532$24208453$2$F$20240702$20240817$20240814$20240821$EXP$$NVSC2024EG164115$NOVARTIS$$43$YR$$F$Y$92$KG$20240821$$CN$EG$EG
242084541$24208454$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191848$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242084551$24208455$1$I$20240116$20240801$20240814$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-039496$AUROBINDO$$70$YR$$M$Y$80$KG$20240814$$MD$IT$IT
242084574$24208457$4$F$20240801$20240814$20240814$20240916$EXP$$CA-LEO Pharma-372625$LEO PHARM$$74$YR$$F$Y$$$20240917$$CN$CA$CA
242084581$24208458$1$I$$20240812$20240814$20240814$EXP$$US-UCBSA-2024040848$UCB$$$$$F$Y$$$20240814$$CN$US$US
242084591$24208459$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039623$AUROBINDO$$78$YR$$M$Y$115$KG$20240814$$PH$CA$CA
242084601$24208460$1$I$$20240812$20240814$20240814$PER$$US-BIOGEN-2024BI01266143$BIOGEN$$$$$F$Y$$$20240814$$CN$US$US
242084611$24208461$1$I$20220101$20240807$20240814$20240814$EXP$$US-ROCHE-10000051803$ROCHE$$33$YR$A$F$Y$113.4$KG$20240814$$CN$US$US
242084622$24208462$2$F$20240601$20240812$20240814$20240821$PER$$US-ABBVIE-5870762$ABBVIE$$39$YR$$F$Y$$$20240821$$CN$US$US
242084631$24208463$1$I$$20240806$20240814$20240814$PER$$US-EMD Serono-2024042888$EMD SERONO INC$$36$YR$A$M$Y$$$20240814$$CN$US$US
242084641$24208464$1$I$20240701$20240807$20240814$20240814$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024666$UNITED THERAPEUTICS$$27$YR$$F$Y$81.633$KG$20240814$$$US$US
242084651$24208465$1$I$$20240806$20240814$20240814$EXP$$RU-AstraZeneca-2024A178546$ASTRAZENECA$$63$YR$$F$Y$77$KG$20240814$$MD$RU$
242084661$24208466$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040192$AUROBINDO$$72$YR$$M$Y$75$KG$20240814$$HP$CA$CA
242084671$24208467$1$I$20190101$20240808$20240814$20240814$EXP$$CA-AMGEN-CANSL2024159662$AMGEN$$47$YR$A$M$Y$$$20240814$$CN$CA$CA
242084681$24208468$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160614$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242084692$24208469$2$F$20240811$20240814$20240814$20240817$PER$$US-AMGEN-USASP2024160597$AMGEN$$83$YR$E$F$Y$$$20240817$$CN$US$US
242084701$24208470$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160069$AMGEN$$$$$M$Y$$$20240814$$CN$US$US
242084711$24208471$1$I$$20240811$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007484$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240814$$HP$US$US
242084721$24208472$1$I$$20240807$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408004793$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242084731$24208473$1$I$$20240801$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-038675$AUROBINDO$$58$YR$$F$Y$82$KG$20240814$$MD$GB$GB
242084741$24208474$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007656$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240814$$CN$US$US
242084751$24208475$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007385$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240814$$CN$US$US
242084761$24208476$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008145$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240814$$CN$US$US
242084771$24208477$1$I$20240808$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007828$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240814$$CN$US$US
242084781$24208478$1$I$20240812$20240812$20240814$20240814$PER$$US-BEH-2024177182$CSL BEHRING$$74$YR$E$F$Y$$$20240814$$PH$US$US
242084791$24208479$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039618$AUROBINDO$$86$YR$$F$Y$$$20240814$$PH$CA$CA
242084801$24208480$1$I$20240813$20240813$20240814$20240814$PER$$US-GILEAD-2024-0684126$GILEAD$$$$$F$Y$$$20240814$$MD$US$US
242084811$24208481$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039609$AUROBINDO$$92$YR$$M$Y$70$KG$20240814$$PH$CA$CA
242084831$24208483$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127685$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$58.06$KG$20240814$$CN$US$US
242084842$24208484$2$F$$20240822$20240814$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127111$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240827$$HP$US$US
242084851$24208485$1$I$$20240808$20240814$20240814$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-126559$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240814$$MD$ES$ES
242084861$24208486$1$I$$20240805$20240814$20240814$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010066$STRIDES$Phang CR, Farooqi A, Sangwan Y.. Unmasking the Unusual: Cryptococcal Pericarditis in a Patient with Liver Failure - a Rare Occurrence.. Am-J-Case-Rep. 2024;25$$$$$Y$$$20240814$$HP$US$US
242084871$24208487$1$I$$20240807$20240814$20240814$EXP$$CA-JNJFOC-20240586040$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240814$$HP$CA$CA
242084882$24208488$2$F$20240812$20240814$20240814$20240817$PER$$US-AMGEN-USASP2024161195$AMGEN$$78$YR$E$F$Y$$$20240817$$CN$US$US
242084891$24208489$1$I$20240610$20240806$20240814$20240814$EXP$ES-AEMPS-1554443$ES-TEVA-VS-3230697$TEVA$$79$YR$$M$Y$64$KG$20240814$$MD$ES$ES
242084901$24208490$1$I$$20240805$20240814$20240814$30DAY$$US-GSK-US2024AMR098317$GLAXOSMITHKLINE$$$$A$M$Y$$$20240814$$HP$US$US
242084911$24208491$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039566$AUROBINDO$$43$YR$$F$Y$63$KG$20240814$$CN$CA$CA
242084921$24208492$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039636$AUROBINDO$$83$YR$$M$Y$54$KG$20240814$$PH$CA$CA
242084932$24208493$2$F$20240808$20240830$20240814$20240830$PER$$US-ALXN-202408USA000601US$ALEXION PHARMACEUTICALS$$77$YR$$M$Y$$$20240830$$CN$US$US
242084941$24208494$1$I$20240710$20240802$20240814$20240814$EXP$GB-MHRA-MED-202408020016238690-BYRJM$GB-LUPIN PHARMACEUTICALS INC.-2024-07809$LUPIN$$48$YR$$M$Y$127$KG$20240814$$CN$GB$GB
242084951$24208495$1$I$$20240802$20240814$20240814$EXP$$IT-AUROBINDO-AUR-APL-2024-039793$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol. 2024;113 (1):90-98$12$YR$$F$Y$$$20240814$$HP$IT$IT
242084961$24208496$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240832426$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242084971$24208497$1$I$20240701$20240808$20240814$20240814$EXP$$CA-TAKEDA-2024TUS080225$TAKEDA$$35$YR$$M$Y$$$20240814$$CN$CA$CA
242084981$24208498$1$I$20240712$20240715$20240814$20240814$EXP$$GB-CELLTRION INC.-2024GB019452$CELLTRION$$$$$$Y$$$20240814$$PH$GB$GB
242084991$24208499$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039663$AUROBINDO$$52$YR$$F$Y$$$20240814$$HP$CA$CA
242085002$24208500$2$F$20240731$20240816$20240814$20240829$EXP$$ES-AUROBINDO-AUR-APL-2024-039651$AUROBINDO$$42$YR$$F$Y$$$20240829$$PH$ES$ES
242085011$24208501$1$I$20240729$20240730$20240814$20240814$PER$$US-NOVITIUMPHARMA-2024USNVP01598$NOVITIUM PHARMA$$58$YR$A$F$Y$50.8$KG$20240814$$CN$US$US
242085031$24208503$1$I$$20240805$20240814$20240814$EXP$$US-SA-2024SA233116$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240814$$MD$US$US
242085041$24208504$1$I$20170501$20240805$20240814$20240814$EXP$$US-SA-2024SA232529$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240814$$MD$US$US
242085051$24208505$1$I$20240801$20240809$20240814$20240814$EXP$$CN-HALEON-2191380$Haleon PLC$$37$YR$$M$Y$56$KG$20240814$$HP$CN$CN
242085091$24208509$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040195$AUROBINDO$$76$YR$$F$Y$61$KG$20240814$$HP$CA$CA
242085101$24208510$1$I$$20240809$20240814$20240814$EXP$GB-MHRA-MED-202408091225388380-KBLWF$GB-TAKEDA-2024TUS080078$TAKEDA$$68$YR$$F$Y$$$20240814$$HP$GB$GB
242085111$24208511$1$I$20240807$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127344$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240814$$PH$US$US
242085121$24208512$1$I$20240719$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039472$AUROBINDO$$83$YR$$F$Y$56.9$KG$20240814$$MD$FR$FR
242085131$24208513$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127708$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$65.77$KG$20240814$$CN$US$US
242085141$24208514$1$I$20240627$20240809$20240814$20240814$EXP$$CO-JNJFOC-20240829464$JOHNSON AND JOHNSON$$43$YR$A$F$Y$59$KG$20240814$$HP$CO$CO
242085151$24208515$1$I$20240809$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160339$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242085161$24208516$1$I$20240809$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160409$AMGEN$$55$YR$A$M$Y$$$20240814$$CN$US$US
242085171$24208517$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040258$AUROBINDO$ao R, Alsaif N, Thain A, Kao V, Misener B, Chu M.. Alcohol-based hand sanitizer^s effect on  hand barrier function induced Staphylococcus lugdunensis aortic and mitral valve endocarditis: a case report.. AME Medical Journal.. 2023;8:Article Number: 26$75$YR$$F$Y$$$20240814$$HP$CA$CA
242085181$24208518$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040202$AUROBINDO$$76$YR$$M$Y$107$KG$20240814$$PH$CA$CA
242085191$24208519$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024161178$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242085202$24208520$2$F$20240701$20240905$20240814$20240912$EXP$$JP-009507513-2408JPN000942J$MERCK$$74$YR$$F$Y$$$20240912$$MD$JP$JP
242085211$24208521$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040180$AUROBINDO$$84$YR$$F$Y$53$KG$20240814$$PH$CA$CA
242085221$24208522$1$I$$20240730$20240814$20240814$EXP$$US-LEADINGPHARMA-US-2024LEALIT00338$LEADING PHARMA$Andrew Murphy.AN UNCOMMON CUASE OF COMPLETE HEART BLOCK IN A PATIENT WITH A HISTORY OF SEIZURES.Journal of the American College of Cardiology.83 (Suppl.) No. 13:2881$64$YR$A$M$Y$$$20240814$$HP$US$US
242085241$24208524$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040222$AUROBINDO$$$$$$Y$$$20240814$$MD$CA$CA
242085251$24208525$1$I$$20240808$20240814$20240814$PER$$US-RDY-SPO/USA/24/0011760$DR REDDYS$$19$YR$A$F$Y$$$20240814$$MD$US$US
242085261$24208526$1$I$$20240805$20240814$20240814$EXP$$JP-ROCHE-10000052760$ROCHE$Anzai H, Ogasawara S, Fujiya M, Sawada M, Akatsuka T, Izai R et al.. OS10-3 Four cases in which tumour control was achieved with iron heavy particle therapy as a conversion treatment after drug therapy for nonresectable hepatocellular carcinoma. The 30th Japan Association of Systemic Therapy for HCC. 2024;139$80$YR$E$M$Y$$$20240814$$MD$JP$JP
242085271$24208527$1$I$$20240807$20240814$20240814$EXP$$US-GSK-US2024098521$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$MD$US$US
242085281$24208528$1$I$$20240801$20240814$20240814$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07856$LUPIN$$$$$$Y$$$20240814$$HP$US$US
242085291$24208529$1$I$$20240809$20240814$20240814$PER$$NVSC2024US163450$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
242085311$24208531$1$I$20240701$20240806$20240814$20240814$PER$$US-ALXN-202408USA000354US$ALEXION PHARMACEUTICALS$$71$YR$$F$Y$$$20240814$$CN$US$US
242085321$24208532$1$I$$20240806$20240814$20240814$PER$$US-ROCHE-10000050414$ROCHE$$56$YR$A$M$Y$$$20240814$$CN$US$US
242085331$24208533$1$I$20240811$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007215$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240814$$CN$US$US
242085341$24208534$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007191$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240814$$CN$US$US
242085351$24208535$1$I$20240709$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007659$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242085361$24208536$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007450$ELI LILLY AND CO$$$$$M$Y$$$20240814$$HP$US$US
242085372$24208537$2$F$$20240813$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008507$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240814$$HP$US$US
242085381$24208538$1$I$$20240812$20240814$20240814$EXP$$CA-Orion Corporation ORION PHARMA-24_00031263$ORION$$66$YR$E$F$Y$$$20240814$$HP$CA$
242085391$24208539$1$I$20240208$20240803$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-040064$AUROBINDO$$87$YR$$F$Y$56.4$KG$20240814$$PH$FR$FR
242085404$24208540$4$F$20240101$20240904$20240814$20240911$PER$$US-AMGEN-USASP2024160626$AMGEN$$70$YR$E$M$Y$$$20240911$$CN$US$US
242085412$24208541$2$F$20240703$20240814$20240814$20240826$EXP$$US-UCBSA-2024039391$UCB$$61$YR$$M$Y$$$20240826$$CN$US$US
242085431$24208543$1$I$20240801$20240812$20240814$20240814$EXP$ES-AEMPS-1559706$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-128031$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240814$$MD$ES$ES
242085441$24208544$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127910$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240814$$CN$US$US
242085451$24208545$1$I$$20240805$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124131$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240814$$MD$US$US
242085461$24208546$1$I$$20240811$20240814$20240814$PER$$US-TAKEDA-2024TUS080771$TAKEDA$$$$$M$Y$$$20240814$$CN$US$US
242085471$24208547$1$I$$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128195$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240814$$CN$US$US
242085481$24208548$1$I$20231218$20240808$20240814$20240814$EXP$$CH-ABBVIE-5874708$ABBVIE$$54$YR$$F$Y$83$KG$20240814$$PH$CH$CH
242085502$24208550$2$F$20240101$20240813$20240814$20240820$EXP$$US-AMGEN-USASP2024160081$AMGEN$$84$YR$E$M$Y$$$20240820$$MD$US$US
242085511$24208551$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A178908$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242085522$24208552$2$F$$20240903$20240814$20240905$EXP$$JP-009507513-2408JPN000568J$MERCK$$88$YR$$M$Y$$$20240905$$PH$JP$JP
242085531$24208553$1$I$$20240807$20240814$20240814$30DAY$$US-GSK-US2024098633$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
242085541$24208554$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128022$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240814$$CN$US$US
242085551$24208555$1$I$$20240808$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126392$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240814$$HP$US$US
242085561$24208556$1$I$$20240805$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124153$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240814$$CN$US$US
242085572$24208557$2$F$20240701$20240814$20240814$20240816$EXP$$US-ABBVIE-5877476$ABBVIE$$86$YR$$F$Y$75$KG$20240816$$CN$US$US
242085591$24208559$1$I$20240812$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160576$AMGEN$$81$YR$E$F$Y$$$20240814$$HP$US$US
242085601$24208560$1$I$$20240813$20240814$20240814$PER$$US-TAKEDA-2024TUS081061$TAKEDA$$$$$$Y$$$20240814$$CN$US$US
242085621$24208562$1$I$20240719$20240812$20240814$20240814$PER$$US-JNJFOC-20240830383$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240814$$CN$US$US
242085631$24208563$1$I$20230131$20240806$20240814$20240814$EXP$$CA-CELLTRION INC.-2021CA019478$CELLTRION$$$$$$Y$$$20240814$$MD$CA$CA
242085641$24208564$1$I$$20240803$20240814$20240814$PER$$US-NOVITIUMPHARMA-2024USNVP01533$NOVITIUM PHARMA$$$$$F$Y$$$20240814$$CN$US$US
242085651$24208565$1$I$$20240813$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045700$BOEHRINGER INGELHEIM$$$$$$Y$$$20240814$$CN$US$US
242085662$24208566$2$F$$20240809$20240814$20240820$EXP$$SK-SANDOZ INC.-NVSC2023SK038153$SANDOZ$$10$YR$$M$Y$$$20240820$$MD$SK$SK
242085676$24208567$6$F$20240726$20240916$20240814$20240919$EXP$$CA-BIOGEN-2024BI01277447$BIOGEN$$61$YR$$F$Y$$$20240919$$CN$CA$CA
242085681$24208568$1$I$20240810$20240809$20240814$20240814$PER$$US-ABBVIE-5879380$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242085691$24208569$1$I$20220224$20240808$20240814$20240814$EXP$$NVSC2024US161855$NOVARTIS$$74$YR$$F$Y$$$20240814$$CN$US$US
242085703$24208570$3$F$20240701$20240826$20240814$20240829$EXP$$JP-009507513-2408JPN000600J$MERCK$$70$YR$$M$Y$$$20240829$$PH$JP$JP
242085712$24208571$2$F$$20240830$20240814$20240909$30DAY$$US-GSK-US2024097590$GLAXOSMITHKLINE$$76$YR$$M$Y$$$20240909$$CN$US$US
242085721$24208572$1$I$$20240805$20240814$20240814$EXP$$FR-TEVA-VS-3232028$TEVA$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2023; 35 (1): 54-59.$38$YR$$M$Y$$$20240814$$HP$FR$FR
242085731$24208573$1$I$$20240812$20240814$20240814$PER$$US-TAKEDA-2024TUS081299$TAKEDA$$$$$F$Y$88$KG$20240814$$MD$US$US
242085791$24208579$1$I$20231224$20240808$20240814$20240814$EXP$$ES-AstraZeneca-2024A183234$ASTRAZENECA$$72$DY$$F$Y$8.1$KG$20240814$$MD$ES$
242085801$24208580$1$I$$20240807$20240814$20240814$EXP$$GB-AMAROX PHARMA-AMR2024GB02652$HETERO$Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP. A case of human T-lymphotropic  virus-1-associated lichenoid dermatitis.. Clinical and Experimental Dermatology. 2024;49(8):916-18$61$YR$$F$Y$$$20240814$$MD$GB$GB
242085811$24208581$1$I$$20240808$20240814$20240814$EXP$$TR-009507513-2408TUR003114$MERCK$Kiraci M, Esen SA, Turkay DO, Kos FT. Pembrolizumab related perforated appendicitis. Journal of Oncology Pharmacy Practice. 2024;1-5$70$YR$$M$Y$$$20240814$$HP$TR$TR
242085822$24208582$2$F$$20240918$20240814$20240928$PER$$US-GSK-US2024097598$GLAXOSMITHKLINE$$$$$F$Y$$$20240928$$CN$US$US
242085831$24208583$1$I$20200101$20240724$20240814$20240814$EXP$$HN-MYLANLABS-2024M1070017$MYLAN$$$$$F$Y$73.48$KG$20240814$$CN$HN$HN
242085842$24208584$2$F$20240101$20240915$20240814$20240919$EXP$$FI-REGENERON PHARMACEUTICALS, INC.-2024-111087$REGENERON$$60$YR$$M$Y$$$20240919$$HP$FI$FI
242085851$24208585$1$I$20240101$20240813$20240814$20240814$PER$$US-AMGEN-USASP2024161227$AMGEN$$63$YR$A$F$Y$$$20240814$$HP$US$US
242085862$24208586$2$F$$20240808$20240814$20240817$PER$$US-JNJFOC-20240817790$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240817$$CN$US$US
242085873$24208587$3$F$20240811$20240913$20240814$20240914$PER$$US-JNJFOC-20240828954$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240914$$CN$US$US
242085882$24208588$2$F$$20240813$20240814$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408007657$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240821$$CN$US$US
242085891$24208589$1$I$$20240811$20240814$20240814$EXP$$US-ROCHE-10000021070$ROCHE$$$$$$Y$$$20240814$$CN$US$US
242085901$24208590$1$I$$20240806$20240814$20240814$EXP$$JP-ROCHE-10000055919$ROCHE$$8$DEC$E$M$Y$$$20240814$$MD$JP$JP
242085911$24208591$1$I$$20240809$20240814$20240814$PER$$US-ALXN-202408USA000535US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242085921$24208592$1$I$20240718$20240806$20240814$20240814$EXP$FI-FIMEA-202402681$FI-ROCHE-10000050828$ROCHE$$73$YR$E$F$Y$$$20240814$$HP$FI$FI
242085931$24208593$1$I$20240121$20240807$20240814$20240814$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024098570$VIIV$$65$YR$$M$Y$$$20240814$$HP$US$US
242085952$24208595$2$F$20240627$20240909$20240814$20240918$EXP$$JP-ROCHE-10000022962$ROCHE$$78$YR$E$F$Y$$$20240918$$MD$JP$JP
242085961$24208596$1$I$$20240810$20240814$20240814$EXP$$US-ROCHE-10000054360$ROCHE$$$$$$Y$$$20240814$$CN$US$US
242085971$24208597$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164561$NOVARTIS$$$$$M$Y$$$20240814$$MD$US$US
242085981$24208598$1$I$$20240801$20240814$20240814$EXP$$US-UCBSA-2024039223$UCB$$$$$M$Y$$$20240814$$MD$US$US
242085992$24208599$2$F$20240701$20240827$20240814$20240910$EXP$$US-UCBSA-2024039329$UCB$$66$YR$$F$Y$$$20240910$$HP$US$US
242086002$24208600$2$F$20240101$20240912$20240814$20240918$EXP$$US-ABBVIE-5876462$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
242086011$24208601$1$I$$20240304$20240814$20240814$EXP$$US-AstraZeneca-2024A184522$ASTRAZENECA$$$$$M$Y$$$20240814$$MD$US$
242086021$24208602$1$I$$20240730$20240814$20240814$PER$$US-AstraZeneca-2024A173403$ASTRAZENECA$$$$$$Y$$$20240814$$CN$US$
242086031$24208603$1$I$$20240806$20240814$20240814$EXP$$GB-AstraZeneca-2024A178239$ASTRAZENECA$$$$$M$Y$$$20240814$$MD$GB$
242086041$24208604$1$I$$20240806$20240814$20240814$EXP$$JP-AstraZeneca-2024A178933$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$JP$
242086051$24208605$1$I$$20240808$20240814$20240814$PER$$US-ROCHE-10000053988$ROCHE$$15$YR$T$F$Y$$$20240814$$CN$US$US
242086061$24208606$1$I$$20240808$20240814$20240814$PER$$US-ROCHE-10000053140$ROCHE$$34$YR$A$F$Y$$$20240814$$MD$US$US
242086071$24208607$1$I$$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A183406$ASTRAZENECA$$$$$M$Y$$$20240814$$HP$US$
242086081$24208608$1$I$20240801$20240809$20240814$20240814$EXP$$IT-ABBVIE-5877117$ABBVIE$$71$YR$$F$Y$$$20240814$$CN$IT$IT
242086091$24208609$1$I$$20240807$20240814$20240814$EXP$$KR-AstraZeneca-2024A182221$ASTRAZENECA$$$$$F$Y$$$20240814$$MD$KR$
242086101$24208610$1$I$20240101$20240809$20240814$20240814$EXP$$CN-ABBVIE-5876492$ABBVIE$$$$$M$Y$50$KG$20240814$$MD$CN$CN
242086111$24208611$1$I$$20240729$20240814$20240814$PER$$US-NOVITIUMPHARMA-2024USNVP01609$NOVITIUM PHARMA$$$$$F$Y$$$20240814$$CN$US$US
242086121$24208612$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010082$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8.$22$YR$$M$Y$$$20240814$$HP$NL$NL
242086131$24208613$1$I$$20240806$20240814$20240814$EXP$$LB-NOVITIUMPHARMA-2024LBNVP01557$NOVITIUM PHARMA$Johny Salem.Legionella lymphadenitis in immunocompetent adult: Case report.IDCases.13-JUL-2024;37:e02023$53$YR$A$F$Y$$$20240814$$HP$LB$LB
242086141$24208614$1$I$$20240807$20240814$20240814$EXP$$SG-ROCHE-10000051821$ROCHE$$61$YR$A$F$Y$$$20240814$$CN$SG$SG
242086152$24208615$2$F$20240512$20240919$20240814$20240927$EXP$$US-ABBVIE-5876563$ABBVIE$$55$YR$$F$Y$133$KG$20240927$$HP$US$US
242086161$24208616$1$I$20240101$20240809$20240814$20240814$EXP$$US-ABBVIE-5878893$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242086172$24208617$2$F$20240401$20240812$20240814$20240816$EXP$$US-ROCHE-10000054651$ROCHE$$72$YR$E$M$Y$74.84$KG$20240816$$CN$US$US
242086181$24208618$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164407$NOVARTIS$$25$YR$$F$Y$$$20240814$$CN$US$US
242086191$24208619$1$I$$20240806$20240814$20240814$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP010046$STRIDES$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al.. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies. Am-J-Reprod-Immunol. 2024;92 (1):e13898$27$YR$$F$Y$$$20240814$$HP$FR$FR
242086203$24208620$3$F$20240728$20240826$20240814$20240830$EXP$$JP-009507513-2408JPN000601J$MERCK$$66$YR$$F$Y$$$20240830$$PH$JP$JP
242086211$24208621$1$I$$20240806$20240814$20240814$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP010059$STRIDES$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.. Am-J-Reprod-Immunol. 2024;92 (1):e13898$$$$F$Y$$$20240814$$HP$FR$FR
242086221$24208622$1$I$$20240806$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124605$BRISTOL MYERS SQUIBB$$31$YR$A$M$Y$$$20240814$$CN$US$US
242086231$24208623$1$I$20240725$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127413$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240814$$CN$US$US
242086241$24208624$1$I$$20240806$20240814$20240814$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP010047$STRIDES$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al.. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.. Am-J-Reprod-Immunol. 2024;92 (1):e13898$34$YR$$F$Y$$$20240814$$HP$FR$FR
242086251$24208625$1$I$$20240812$20240814$20240814$EXP$$GB-GSK-GB2024EME100425$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$HP$GB$GB
242086261$24208626$1$I$$20240807$20240814$20240814$EXP$$GR-GSK-GR2024GSK100059$GLAXOSMITHKLINE$Koutsianas C, Tsalapaki C, Mavrea E, Dimopoulou N, Vassilopoulos D. Simultaneous use of rituximab and mepolizumab in relapsing anca negative eosinophilic granulomatosis with polyangiitis. Annals of the Rheumatic Diseases. 2024;83(S1):1967-1968$$$$$Y$$$20240814$$HP$GR$GR
242086271$24208627$1$I$$20240808$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126557$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240814$$CN$US$US
242086281$24208628$1$I$20240731$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127167$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$104.4$KG$20240814$$PH$US$US
242086291$24208629$1$I$$20240806$20240814$20240814$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP010060$STRIDES$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al.. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.. Am-J-Reprod-Immunol. 2024;92 (1):e13898.$$$$F$Y$$$20240814$$HP$FR$FR
242086331$24208633$1$I$$20240813$20240814$20240814$EXP$$US-UCBSA-2024040957$UCB$$$$$F$Y$$$20240814$$CN$US$US
242086341$24208634$1$I$$20240805$20240814$20240814$EXP$$CN-TEYRO-2024-TY-000428$Teyro Labs$Li XF, Zhang YP, Wei LL, Wang ZJ, Yang MQ. .SMARCA4 deficient uterine adnexal tumor with ascites: A case report and literature review. .Oncol Lett.2024;28(2):357$64$YR$A$F$Y$$$20240814$$HP$CN$CN
242086351$24208635$1$I$$20240808$20240814$20240814$EXP$$US-ROCHE-10000053215$ROCHE$$63$YR$A$M$Y$63.5$KG$20240814$$CN$US$US
242086361$24208636$1$I$$20240805$20240814$20240814$EXP$$US-ROCHE-10000049904$ROCHE$$58$YR$A$F$Y$$$20240814$$CN$US$US
242086371$24208637$1$I$$20240812$20240814$20240814$PER$$US-ABBVIE-5879446$ABBVIE$$$$$F$Y$$$20240814$$HP$US$US
242086381$24208638$1$I$$20240806$20240814$20240814$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP010089$STRIDES$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al.. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.. Am-J-Reprod-Immunol. 2024;92 (1)$37$YR$$F$Y$$$20240814$$HP$FR$FR
242086392$24208639$2$F$20240101$20240905$20240814$20240914$EXP$$CA-CELLTRION INC.-2024CA003255$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
242086401$24208640$1$I$$20240806$20240814$20240814$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP010128$STRIDES$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al.. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.. Am-J-Reprod-Immunol. 2024;92 (1)$$$$F$Y$$$20240814$$HP$FR$FR
242086411$24208641$1$I$20240812$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160420$AMGEN$$69$YR$E$F$Y$$$20240814$$CN$US$US
242086431$24208643$1$I$20240722$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024161019$AMGEN$$78$YR$E$F$Y$$$20240814$$CN$US$US
242086451$24208645$1$I$$20240806$20240814$20240814$PER$$US-ROCHE-10000051214$ROCHE$$$$$$Y$$$20240814$$CN$US$US
242086461$24208646$1$I$$20240806$20240814$20240814$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP010127$STRIDES$Sharma A, Mondal A, Aggarwal A, Khandpur S.. Langerhans cell histiocytosis presenting as perianal ulcers.. Indian-J-Dermatol-Venereol-Leprol. 2024;90 (4)$21$YR$$M$Y$$$20240814$$MD$IN$IN
242086471$24208647$1$I$$20240806$20240814$20240814$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010112$STRIDES$Naka M, Inaba A, Miyasaka H, Suzue K, Ishigaki J, Shibuya H, et al.. An elderly case of paraneoplastic anti-NMDA receptor encephalitis associated with large cell neuroendocrine carcinoma of the lung.. BMC-Pulm-Med. 2024;24:1-6$78$YR$$M$Y$$$20240814$$HP$JP$JP
242086481$24208648$1$I$$20240807$20240814$20240814$EXP$$TZ-STRIDES ARCOLAB LIMITED-2024SP010140$STRIDES$Mwakyula IH, Makarius E, Maro H, Ngatunga C.. Pneumoconiosis among artisanal miners in Chunya district, Mbeya, Tanzania.. BMJ-Case-Rep. 2024;17 (6)$4$DEC$$M$Y$$$20240814$$MD$TZ$TZ
242086492$24208649$2$F$$20240820$20240814$20240827$EXP$$US-AMGEN-USASP2024159778$AMGEN$Haefner H.K.; Termin D.E.; Welch K.C. et al.. Lichen planus follicularis tumidus of the vulva. American Journal of Obstetrics + Gynecology. 2024;280-282$59$YR$A$F$Y$$$20240827$$MD$US$US
242086501$24208650$1$I$$20240806$20240814$20240814$PER$$US-ROCHE-10000050647$ROCHE$$$$$$Y$$$20240814$$CN$US$US
242086511$24208651$1$I$20240101$20240806$20240814$20240814$EXP$SE-SEMPA-2024-005601$SE-TEVA-VS-3231164$TEVA$$70$YR$$F$Y$$$20240814$$MD$SE$SE
242086521$24208652$1$I$20211109$20240809$20240814$20240814$EXP$GB-MHRA-MED-202408061640361270-DZFNJ$GB-ROCHE-10000053630$ROCHE$$350$DY$I$M$Y$15$KG$20240814$$CN$GB$GB
242086532$24208653$2$F$$20240819$20240814$20240830$EXP$$US-ALVOGEN-2024095288$ALVOGEN$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024 Jul 23; doi:https://dx.doi.org/10.3233/NPM-230165$1$DY$$$Y$$$20240830$$MD$US$US
242086542$24208654$2$F$20240615$20240906$20240814$20240913$EXP$$PL-ROCHE-10000050010$ROCHE$$67$YR$E$F$Y$$$20240913$$MD$PL$PL
242086551$24208655$1$I$$20240806$20240814$20240814$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01550$NOVITIUM PHARMA$Ken Sawada.Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory distress syndrome: a case report.Journal of Cardiothoracic Surgery.24-JUN-2024;19(1):1-7$40$YR$A$F$Y$$$20240814$$HP$JP$JP
242086561$24208656$1$I$$20240807$20240814$20240814$EXP$$GB-CELLTRION INC.-2024GB019162$CELLTRION$$$$$$Y$$$20240814$$HP$GB$GB
242086571$24208657$1$I$20240728$20240808$20240814$20240814$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012233$JAZZ$$64$YR$$F$Y$$$20240814$$HP$US$US
242086581$24208658$1$I$$20240806$20240814$20240814$PER$$US-ROCHE-10000051365$ROCHE$$$$$$Y$$$20240814$$HP$US$US
242086593$24208659$3$F$20240116$20240920$20240814$20240930$EXP$$JP-ROCHE-10000052847$ROCHE$$$$$F$Y$$$20240930$$CN$JP$JP
242086601$24208660$1$I$$20240806$20240814$20240814$EXP$$US-GSK-US2024098054$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
242086611$24208661$1$I$20231201$20240809$20240814$20240814$EXP$$US-ABBVIE-5784701$ABBVIE$$56$YR$$M$Y$$$20240814$$CN$US$US
242086622$24208662$2$F$20240413$20240822$20240814$20240903$EXP$$US-AstraZeneca-2024A182236$ASTRAZENECA$$29440$DY$$M$Y$$$20240903$$HP$US$
242086631$24208663$1$I$20240803$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A182292$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242086641$24208664$1$I$$20240809$20240814$20240814$EXP$$AR-EMD Serono-2024043417$EMD SERONO INC$$$$A$F$Y$$$20240814$$CN$AR$AR
242086651$24208665$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A180217$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242086661$24208666$1$I$$20240806$20240814$20240814$EXP$$ZA-AstraZeneca-2024A179408$ASTRAZENECA$$72$YR$$F$Y$$$20240814$$CN$ZA$
242086671$24208667$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040254$AUROBINDO$Poirier CM, Carter AA, Kwan Y, Koo J, Westlund JM, Alkass F, et al.. Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy PostePercutaneous Coronary Intervention.. CJC Open.. 2023;5 (11):846-858$88$YR$$M$Y$$$20240814$$HP$CA$CA
242086681$24208668$1$I$$20240810$20240814$20240814$PER$$US-JNJFOC-20240827883$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242086702$24208670$2$F$$20240814$20240814$20240827$EXP$$US-ALVOGEN-2024095303$ALVOGEN$Akhdar G, Akpan I. Navigating the Nexus: Lenalidomide-Associated Thrombotic Thrombocytopenic Purpura. Cureus. 2024 Jun 23;16(6):e62975. doi:https://dx.doi.org/10.7759/cureus.62975$56$YR$$M$Y$$$20240828$$HP$US$US
242086711$24208671$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008210$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240814$$MD$US$US
242086731$24208673$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007571$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240814$$CN$US$US
242086743$24208674$3$F$$20240912$20240814$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202408007458$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240917$$CN$US$US
242086751$24208675$1$I$20240401$20240807$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006200$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242086761$24208676$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007552$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240814$$CN$US$US
242086771$24208677$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007262$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240814$$CN$US$US
242086781$24208678$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007441$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240814$$CN$US$US
242086791$24208679$1$I$20240729$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007782$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240814$$CN$US$US
242086801$24208680$1$I$20240201$20240810$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007734$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240814$$CN$US$US
242086812$24208681$2$F$$20240820$20240814$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408006209$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240826$$CN$US$US
242086821$24208682$1$I$20240404$20240805$20240814$20240814$EXP$$BR-SANDOZ INC.-SDZ2024BR072330$SANDOZ$$88$YR$$F$Y$53$KG$20240814$$CN$BR$BR
242086832$24208683$2$F$$20240812$20240814$20240819$PER$$US-AMGEN-USASP2024160986$AMGEN$$$$$$Y$$$20240819$$PH$US$US
242086841$24208684$1$I$20240101$20240808$20240814$20240814$PER$$US-AMGEN-USASP2024158886$AMGEN$$61$YR$A$F$Y$$$20240814$$HP$US$US
242086852$24208685$2$F$$20240814$20240814$20240821$EXP$$US-ABBVIE-5878214$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242086863$24208686$3$F$20240101$20240826$20240814$20240829$EXP$$DE-ABBVIE-5879055$ABBVIE$$74$YR$$M$Y$$$20240829$$CN$DE$DE
242086871$24208687$1$I$$20240812$20240814$20240814$EXP$$US-ABBVIE-5879129$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242086881$24208688$1$I$20240701$20240807$20240814$20240814$EXP$$CA-ABBVIE-5879140$ABBVIE$$83$YR$$F$Y$$$20240814$$CN$CA$CA
242086891$24208689$1$I$20190101$20240808$20240814$20240814$EXP$$GB-ORGANON-O2408GBR000873$ORGANON$$$$$F$Y$$$20240814$$MD$GB$GB
242086901$24208690$1$I$20240701$20240812$20240814$20240814$EXP$$US-ABBVIE-5878021$ABBVIE$$69$YR$$F$Y$$$20240814$$CN$US$US
242086911$24208691$1$I$20240101$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128112$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240814$$HP$US$US
242086921$24208692$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127713$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240814$$HP$US$US
242086931$24208693$1$I$20240810$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160422$AMGEN$$63$YR$A$F$Y$$$20240814$$CN$US$US
242086941$24208694$1$I$$20240809$20240814$20240814$EXP$$FR-AMGEN-FRASP2024159583$AMGEN$$$$$$Y$$$20240814$$PH$FR$FR
242086951$24208695$1$I$$20240806$20240814$20240814$EXP$$JP-009507513-2408JPN000775J$MERCK$$8$DEC$$M$Y$$$20240814$$MD$JP$JP
242086961$24208696$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191860$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242086971$24208697$1$I$20240101$20240725$20240814$20240814$EXP$$GB-CELLTRION INC.-2024GB019473$CELLTRION$$$$$$Y$$$20240814$$MD$GB$GB
242086981$24208698$1$I$20240807$20240808$20240814$20240814$EXP$$US-VANTIVE-2024VAN018935$Vantive US Healthcare$$68$YR$$F$Y$$$20240814$$HP$US$US
242086991$24208699$1$I$$20240810$20240814$20240814$EXP$GB-MHRA-MED-202408100658253420-HDTFK$GB-862174955-ML2024-04462$Unknown Manufacturer$$$$$M$Y$$$20240814$$CN$GB$GB
242087001$24208700$1$I$$20240806$20240814$20240814$EXP$$CN-862174955-ML2024-04452$Unknown Manufacturer$Zhang T, Ye L, Gao H, Dong J, Wang C. Clinical and pathological features of drug- induced liver injury with different types of bile duct injury: An analysis of four cases. J-Clin-Hepatol. 2023;39(7): 1665-1672.$47$YR$A$M$Y$$$20240814$$HP$CN$CN
242087011$24208701$1$I$$20240806$20240814$20240814$EXP$$US-862174955-ML2024-04423$MICRO LABS$Khan S, Reggio C, Shoukat U, Lalwani A, Yousaf Z. Avoiding Premature Brain Death Declaration in Patients With Suspected Baclofen Overdose. American Journal of Respiratory and Critical Care Medicine. 2024;(209):A7027$58$YR$A$M$Y$$$20240814$$HP$US$US
242087021$24208702$1$I$20240430$20240806$20240814$20240814$30DAY$$US-GSK-US2024098139$GLAXOSMITHKLINE$$37$YR$$F$Y$$$20240814$$CN$US$US
242087031$24208703$1$I$$20240806$20240814$20240814$EXP$$JP-862174955-ML2024-04451$MICRO LABS$Kobayashi T, Saito S, Takada M, Sakaguchi K, Takahashi K, Tanaka K, et al. Massive Intoxication with 70 Tablets of Apixaban: A Case Report. Case Reports in Acute Medicine. 2023 Sep 12;6(1): 13-18. doi:10.1159/000533520.$49$YR$A$F$Y$$$20240814$$HP$JP$JP
242087041$24208704$1$I$$20240805$20240814$20240814$EXP$$GB-HBP-2024GB031066$HELSINN HEALTHCARE$$$$$F$Y$$$20240814$$HP$GB$GB
242087062$24208706$2$F$$20240819$20240814$20240830$EXP$$US-ALVOGEN-2024095286$ALVOGEN$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024 Jul 23; doi:https://dx.doi.org/10.3233/NPM-230165$1$DY$$M$Y$$$20240830$$MD$US$US
242087071$24208707$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164992$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242087081$24208708$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126930$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240814$$CN$US$US
242087091$24208709$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040253$AUROBINDO$Poirier CM, Carter AA, Kwan Y, Koo J, Westlund JM, Alkass F, et al. Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy PostePercutaneous Coronary Intervention. CJCOpen. 2023;5 (11):846-858$74$YR$$F$Y$$$20240814$$HP$CA$CA
242087101$24208710$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240830512$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$US$US
242087111$24208711$1$I$20200124$20240807$20240814$20240814$EXP$$US-CHIESI-2024CHF04975$CHIESI$$6$YR$$M$Y$28$KG$20240814$$CN$US$US
242087121$24208712$1$I$$20240812$20240814$20240814$EXP$$US-ABBVIE-5879128$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242087132$24208713$2$F$$20240912$20240814$20240919$30DAY$$DE-UCBSA-2024039544$UCB$$$$$$Y$$$20240919$$PH$DE$DE
242087141$24208714$1$I$$20240808$20240814$20240814$EXP$$US-BAYER-2024A115023$BAYER$$$$$$Y$$$20240814$$CN$US$US
242087151$24208715$1$I$$20240813$20240814$20240814$EXP$$US-ABBVIE-5879425$ABBVIE$$$$$F$Y$$$20240814$$HP$US$US
242087171$24208717$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191936$Haleon PLC$$$$$F$Y$$$20240814$$CN$US$US
242087181$24208718$1$I$20240802$20240808$20240814$20240814$EXP$$SE-MALLINCKRODT-MNK202405092$MALLINCKRODT$$$$$F$Y$44$KG$20240814$$HP$SE$SE
242087191$24208719$1$I$$20240806$20240814$20240814$EXP$$US-NOVITIUMPHARMA-2024USNVP01555$NOVITIUM PHARMA$Saurav Das.Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety.Current Oncology.31-OCT-2023;30(11):9627-9633$33$YR$A$M$Y$$$20240814$$HP$US$US
242087201$24208720$1$I$$20240807$20240814$20240814$EXP$$GB-CELLTRION INC.-2024GB019099$CELLTRION$$$$$$Y$$$20240814$$CN$GB$GB
242087211$24208721$1$I$20240726$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408051140567160-HBMFC$GB-AMAROX PHARMA-AMR2024GB02606$HETERO$$33$YR$$M$Y$$$20240814$$PH$GB$GB
242087221$24208722$1$I$20240604$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039741$AUROBINDO$$17$YR$$M$Y$$$20240814$$PH$FR$FR
242087241$24208724$1$I$20240417$20240813$20240814$20240814$EXP$FR-AFSSAPS-BS2024000500$FR-ORGANON-O2408FRA000979$ORGANON$$80$YR$$F$Y$$$20240814$$MD$FR$FR
242087251$24208725$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55744$$FDA-CTU$$64$YR$$M$N$$$20240813$N$$US$
242087301$24208730$1$I$$20240808$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127475$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$65.77$KG$20240814$$CN$US$US
242087312$24208731$2$F$20240807$20240813$20240814$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128436$BRISTOL MYERS SQUIBB$$97$YR$E$F$Y$$$20240816$$CN$US$US
242087321$24208732$1$I$20240811$20240812$20240814$20240814$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-128128$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240814$$CN$PR$PR
242087331$24208733$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127339$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240814$$HP$US$US
242087341$24208734$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040194$AUROBINDO$$69$YR$$F$Y$60$KG$20240814$$MD$CA$CA
242087361$24208736$1$I$$20240807$20240814$20240814$EXP$$JP-SA-2024SA238980$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240814$$CN$JP$JP
242087381$24208738$1$I$$20240813$20240814$20240814$30DAY$$US-SANDOZ INC.-SDZ2024US072511$SANDOZ$$$$$F$Y$$$20240814$$HP$US$US
242087401$24208740$1$I$20240721$20240807$20240814$20240814$EXP$$RO-ABBVIE-5879372$ABBVIE$$85$YR$$M$Y$$$20240814$$CN$RO$RO
242087411$24208741$1$I$$20240813$20240814$20240814$PER$$US-BAYER-2024A116792$BAYER$$75$YR$E$F$Y$$$20240814$$CN$US$US
242087431$24208743$1$I$20240707$20240807$20240814$20240814$EXP$$FR-AstraZeneca-2024A179305$ASTRAZENECA$$67$YR$$F$Y$104$KG$20240814$$MD$FR$
242087441$24208744$1$I$$20240805$20240814$20240814$EXP$$JP-ROCHE-10000053330$ROCHE$Wakisaka S, Suzuki R, Fusimi A, Uemura Y, Suzuki Y, Kato M et al.. 23 Diffuse large B-cell lymphoma with gastrointestinal perforation 12 weeks after initiation of chemotherapy. The 21st Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology. 2024;29$77$YR$E$F$Y$$$20240814$$MD$JP$JP
242087451$24208745$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179480$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242087461$24208746$1$I$20230901$20240807$20240814$20240814$EXP$$US-SA-2024SA238902$SANOFI AVENTIS$$$$T$M$Y$$$20240814$$MD$US$US
242087471$24208747$1$I$20240808$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024159262$AMGEN$$62$YR$A$F$Y$$$20240814$$CN$US$US
242087482$24208748$2$F$$20240821$20240814$20240823$PER$$US-AMGEN-USASP2024161070$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242087491$24208749$1$I$$20240809$20240814$20240814$EXP$$US-AMGEN-USASP2024159278$AMGEN$$$$A$F$Y$$$20240814$$CN$US$US
242087511$24208751$1$I$20240101$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024158948$AMGEN$$$$$M$Y$$$20240814$$HP$US$US
242087522$24208752$2$F$$20240829$20240814$20240909$PER$$US-BAYER-2024A116798$BAYER$$66$YR$E$F$Y$$$20240909$$CN$US$US
242087531$24208753$1$I$$20240809$20240814$20240814$EXP$$US-TAKEDA-2024TUS080798$TAKEDA$$$$$$Y$$$20240814$$CN$US$US
242087541$24208754$1$I$$20240813$20240814$20240814$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045593$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$56$KG$20240814$$PH$CA$CA
242087551$24208755$1$I$$20240805$20240814$20240814$EXP$$US-RDY-LIT/USA/24/0011752$DR REDDYS$Shahin AB, Greene A, Reeder CB, Costello CM, Pittelkow MR, DiCaudo DJ. Paraneoplastic morphea with prominent mucin deposition. JAAD Case Reports. 2023 Sep 26;41: 110-112. doi:10.1016/j.jdcr.2023.09.015.$80$YR$E$M$Y$$$20240814$$HP$US$US
242087561$24208756$1$I$20240701$20240731$20240814$20240814$EXP$$IN-CIPLA LTD.-2024IN08441$CIPLA$$$$$$Y$$$20240814$$CN$IN$IN
242087571$24208757$1$I$$20240805$20240814$20240814$30DAY$$US-GSK-US2024097541$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
242087583$24208758$3$F$$20240911$20240814$20240918$EXP$$US-TAKEDA-2024TUS043788$TAKEDA$$$$$F$Y$$$20240918$$CN$US$US
242087591$24208759$1$I$20240710$20240812$20240814$20240814$PER$$US-BAYER-2024A116124$BAYER$$77$YR$E$M$Y$$$20240814$$CN$US$US
242087603$24208760$3$F$20240731$20240819$20240814$20240824$EXP$$NVSC2024GB162960$NOVARTIS$$$$$F$Y$$$20240824$$CN$GB$GB
242087621$24208762$1$I$$20240125$20240814$20240814$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00296$AMNEAL$$$$$$Y$$$20240814$$CN$US$US
242087631$24208763$1$I$20240701$20240812$20240814$20240814$PER$$US-JNJFOC-20240830035$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242087641$24208764$1$I$$20240808$20240814$20240814$EXP$$US-TAKEDA-2024TUS080096$TAKEDA$$$$$M$Y$$$20240814$$MD$US$US
242087651$24208765$1$I$$20230814$20240814$20240814$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02930$AMNEAL$$$$$F$Y$$$20240814$$CN$US$US
242087661$24208766$1$I$20230701$20240509$20240814$20240814$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01673$AMNEAL$$$$$$Y$$$20240814$$CN$US$US
242087671$24208767$1$I$$20231130$20240814$20240814$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04195$AMNEAL$$$$$M$Y$$$20240814$$CN$US$US
242087681$24208768$1$I$20240809$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007573$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240814$$CN$US$US
242087691$24208769$1$I$$20240810$20240814$20240814$PER$$US-BAYER-2024A115701$BAYER$$$$$$Y$$$20240814$$CN$US$US
242087721$24208772$1$I$20240809$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160425$AMGEN$$78$YR$E$M$Y$$$20240814$$CN$US$US
242087731$24208773$1$I$20180601$20240802$20240814$20240814$EXP$$UG-MYLANLABS-2024M1073734$MYLAN$Lubega G, Lutaakome J, Kibirige M, Opoka D, Atukunda I, Ruzagira E. Vitamin B12 deficiency presenting as progressive blindness in a 33-year-old HIV-positive female patient on Efavirenz-based regimen: case report. Pan-Afr-Med-J 2024; 47 (0): 164.$30$YR$$F$Y$$$20240814$$HP$UG$UG
242087751$24208775$1$I$$20240802$20240814$20240814$EXP$$US-MYLANLABS-2024M1073760$MYLAN$Garofalo V, Walgamage M, Cuello LN, Wester K, Robinson S, Gemayel CY. Anaplasmosis: from multi-system mayhem to ventricular tachycardia in a heartbeat. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 4506 (plus Poster).$78$YR$$M$Y$$$20240814$$HP$US$US
242087761$24208776$1$I$20240630$20240805$20240814$20240814$EXP$$US-GSK-US2024097500$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240814$$CN$US$US
242087772$24208777$2$F$$20240820$20240814$20240829$30DAY$$US-GSK-US2024097582$GLAXOSMITHKLINE$$$$$M$Y$$$20240829$$CN$US$US
242087791$24208779$1$I$$20240808$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126530$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240814$$CN$US$US
242087801$24208780$1$I$20230101$20240731$20240814$20240814$EXP$$US-ACORDA-ACO_177731_2024$ACORDA$$52$YR$$F$Y$$$20240814$$MD$US$US
242087812$24208781$2$F$20240625$20240828$20240814$20240904$EXP$IT-MINISAL02-997766$IT-009507513-2408ITA003926$MERCK$$67$YR$$M$Y$80$KG$20240904$$MD$IT$IT
242087822$24208782$2$F$$20240924$20240814$20240930$EXP$$US-TAKEDA-2024TUS073373$TAKEDA$$$$$F$Y$$$20240930$$MD$US$US
242087831$24208783$1$I$$20240807$20240814$20240814$PER$$US-BAYER-2024A114194$BAYER$$$$$$Y$$$20240814$$CN$US$US
242087881$24208788$1$I$20240813$20240813$20240813$20240813$DIR$714103$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242087891$24208789$1$I$20240812$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55676$$FDA-CTU$$65$YR$$M$N$$$20240813$Y$PH$US$
242087901$24208790$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55637$$FDA-CTU$$74$YR$$M$N$$$20240813$N$$US$
242087991$24208799$1$I$20240501$20240806$20240814$20240814$EXP$$NVSC2024BR164508$NOVARTIS$$$$$F$Y$64$KG$20240814$$CN$BR$BR
242088002$24208800$2$F$20240811$20240924$20240814$20240928$PER$$US-JNJFOC-20240830283$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240928$$CN$US$US
242088011$24208801$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191844$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242088023$24208802$3$F$$20240916$20240814$20240918$PER$$US-AMGEN-USASP2024160525$AMGEN$$$$$F$Y$$$20240917$$CN$US$US
242088031$24208803$1$I$$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024159554$AMGEN$$$$$$Y$$$20240814$$MD$US$US
242088042$24208804$2$F$$20240819$20240814$20240828$EXP$PL-URPL-1-1720-2020$PL-TEVA-VS-3230721$TEVA$$21$YR$$M$Y$75$KG$20240828$$MD$PL$PL
242088051$24208805$1$I$20240101$20240807$20240814$20240814$EXP$$US-ABBVIE-5872025$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242088062$24208806$2$F$20220307$20240819$20240814$20240826$EXP$$PL-AMGEN-POLSP2024158220$AMGEN$Omyla-staszewska J.. A case of a 63-year-old female patient with initially inoperable advanced sigmoid and rectosigmoid junction cancer with metastases to lymph nodes and liver. Colon cancer- Case report. 2024;1-3$63$YR$A$F$Y$$$20240826$$MD$PL$PL
242088072$24208807$2$F$20240802$20240807$20240814$20240814$EXP$GB-MHRA-MED-202408031331012830-YMSRD$GB-TEVA-VS-3230625$TEVA$$39$YR$$F$Y$$$20240814$$CN$GB$GB
242088081$24208808$1$I$$20240808$20240814$20240814$PER$$US-BAYER-2024A114761$BAYER$$$$$$Y$$$20240814$$CN$US$US
242088091$24208809$1$I$20240503$20240805$20240814$20240814$EXP$FR-AFSSAPS-LL2024001445$FR-TEVA-VS-3230600$TEVA$$70$YR$$F$Y$$$20240814$$PH$FR$FR
242088101$24208810$1$I$$20240806$20240814$20240814$EXP$$US-NOVITIUMPHARMA-2024USNVP01552$NOVITIUM PHARMA$M Abdelsalam.High dose dexamethasone for edema associated with brain tumor leading to acute sigmoid diverticular perforation.The American Journal of the Medical Sciences.22-FEB-2024;367(1):S41$65$YR$A$F$Y$$$20240814$$HP$US$US
242088111$24208811$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040188$AUROBINDO$$71$YR$$F$Y$77$KG$20240814$$PH$CA$CA
242088121$24208812$1$I$$20240803$20240814$20240814$EXP$$IN-ROCHE-10000048649$ROCHE$$$$$$Y$$$20240814$$MD$IN$IN
242088141$24208814$1$I$$20240813$20240814$20240814$EXP$$US-TAKEDA-2024TUS081416$TAKEDA$$$$$F$Y$$$20240814$$CN$US$US
242088151$24208815$1$I$$20240809$20240814$20240814$PER$$US-BAYER-2024A115283$BAYER$$$$$$Y$$$20240814$$CN$US$US
242088161$24208816$1$I$20240804$20240809$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127134$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240814$$CN$US$US
242088171$24208817$1$I$20220801$20240807$20240814$20240814$30DAY$$US-GSK-US2024098433$GLAXOSMITHKLINE$$61$YR$$M$Y$52.16$KG$20240814$$CN$US$US
242088181$24208818$1$I$$20240805$20240814$20240814$EXP$$US-MSNLABS-2024MSNLIT01770$MSN LABORATORIES$Rafeq R, Salzman M..Use of Concentrated Insulin in the Management of Calcium Channel Blocker Overdose: A Case Report.Journal of Pharmacy Practice.2023;36(6):1519-1522$$$$$Y$$$20240814$$PH$US$US
242088191$24208819$1$I$20240325$20240801$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-038684$AUROBINDO$$47$YR$$$Y$$$20240814$$PH$GB$GB
242088201$24208820$1$I$$20240808$20240814$20240814$PER$$US-BAYER-2024A115602$BAYER$$$$$F$Y$$$20240814$$CN$US$US
242088211$24208821$1$I$$20240806$20240814$20240814$EXP$$JP-AstraZeneca-2024A180262$ASTRAZENECA$$$$$F$Y$$$20240814$$MD$JP$
242088221$24208822$1$I$20190730$20240808$20240814$20240814$EXP$$CA-TAKEDA-2024TUS080235$TAKEDA$$71$YR$$F$Y$$$20240814$$MD$CA$CA
242088231$24208823$1$I$20240813$20240813$20240814$20240814$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045600$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$$$20240814$$CN$US$US
242088241$24208824$1$I$$20240801$20240814$20240814$PER$$US-JNJFOC-20240804520$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240814$$CN$US$US
242088252$24208825$2$F$20240808$20240812$20240814$20240819$PER$$US-JNJFOC-20240829926$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$US$US
242088261$24208826$1$I$$20240805$20240814$20240814$PER$$US-BAYER-2024A113184$BAYER$$$$$$Y$$$20240814$$CN$US$US
242088272$24208827$2$F$20220324$20240815$20240814$20240827$EXP$$PT-GILEAD-2024-0683844$GILEAD$$70$YR$E$M$Y$$$20240827$$MD$PT$PT
242088281$24208828$1$I$$20240812$20240814$20240814$EXP$GB-MHRA-MED-202408121431509000-KYFPC$GB-TEVA-VS-3232805$TEVA$$51$YR$$M$Y$$$20240814$$CN$GB$GB
242088291$24208829$1$I$$20240724$20240814$20240814$PER$$US-BAYER-2024A116049$BAYER$$$$$$Y$$$20240814$$CN$US$US
242088302$24208830$2$F$20240810$20240815$20240814$20240820$PER$$US-AMGEN-USASP2024161148$AMGEN$$74$YR$E$F$Y$$$20240820$$CN$US$US
242088312$24208831$2$F$20240806$20240924$20240814$20240927$PER$$US-AMGEN-USASP2024156628$AMGEN$$55$YR$A$F$Y$84.1$KG$20240927$$PH$US$US
242088322$24208832$2$F$$20240822$20240814$20240903$EXP$$JP-INSMED, INC.-2024-03168-JP$INSMED$$81$YR$$$Y$$$20240903$$MD$JP$JP
242088331$24208833$1$I$$20240806$20240814$20240814$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01570$NOVITIUM PHARMA$Haimin Sun.Picalm::MLLT10 can Identify a New Subgroup of Acute Leukemias of Ambiguous Lineage with Unique Extramedullary Disease and Treatment Response.Blood.02-NOV-2023;142:6078-6080$28$YR$A$F$Y$$$20240814$$HP$CN$CN
242088341$24208834$1$I$20240101$20240809$20240814$20240814$EXP$$CO-TAKEDA-2024TUS081340$TAKEDA$$$$$F$Y$53$KG$20240814$$CN$CO$CO
242088351$24208835$1$I$$20240805$20240814$20240814$EXP$$JP-ROCHE-10000053411$ROCHE$Tamamushi M, Nakagawa S, Konishi N, Yara S, Moriyama Y, Takagi R. A case of hepatocellular carcinoma treated solely with durvalumab after drug-free period following administration of atezolizumab and bevacizumab.. The 30th Japan Association of Systemic Therapy for HCC. 2024;131.$7$DEC$E$M$Y$$$20240814$$MD$JP$JP
242088361$24208836$1$I$$20240807$20240814$20240814$EXP$$US-MSNLABS-2024MSNLIT01781$MSN LABORATORIES$Bally K, Trusty R, Naher K.A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone.Cureus.2024;16(6):e62695$$$$$Y$$$20240814$$MD$US$US
242088371$24208837$1$I$$20240808$20240814$20240814$EXP$$FR-IPCA LABORATORIES LIMITED-IPC-2024-FR-002020$IPCA$Antoine Baudriller, Chadi Abbara, Marie Briet et al.. Deaths related to pharmacobezoars: A report on two cases. Toxicologie Analytique + Clinique. xxxx;xxx (xxxx):1-9$$$$$Y$$$20240814$$HP$FR$FR
242088382$24208838$2$F$20230501$20240919$20240814$20240926$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-239881$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240926$$CN$US$US
242088391$24208839$1$I$20240807$20240809$20240814$20240814$EXP$$NVSC2024NL163640$NOVARTIS$$49$YR$$F$Y$$$20240814$$HP$NL$NL
242088401$24208840$1$I$$20240807$20240814$20240814$PER$$US-ROCHE-10000053365$ROCHE$$$$$M$Y$$$20240814$$CN$US$US
242088411$24208841$1$I$$20240809$20240814$20240814$EXP$$NVSC2024US164018$NOVARTIS$Galani J, Gupta T, Waheed N, Sennhauser S, Abdou M. Cytokine Release Syndrome Mediated Myocarditis: A rare complication of chimeric antigen receptor T-cell therapy.. HFSA. 2023;255$59$YR$$M$Y$$$20240814$$HP$US$US
242088421$24208842$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240829818$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242088431$24208843$1$I$$20240807$20240814$20240814$EXP$$NVSC2024MA162846$NOVARTIS$$$$$F$Y$$$20240814$$CN$MA$MA
242088441$24208844$1$I$20220101$20240812$20240814$20240814$EXP$$DE-UCBSA-2024040764$UCB$$34$YR$$F$Y$110$KG$20240814$$MD$DE$DE
242088452$24208845$2$F$20220101$20240812$20240814$20240822$EXP$DE-EMBRYOTOX-202303640$DE-UCBSA-2024040591$UCB$$1$DY$$M$Y$2.49$KG$20240822$$MD$DE$DE
242088461$24208846$1$I$$20240813$20240813$20240813$DIR$714148$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242088472$24208847$2$F$$20240809$20240814$20240814$PER$$US-ROCHE-10000055232$ROCHE$$$$$$Y$$$20240814$$MD$US$US
242088502$24208850$2$F$20210920$20240815$20240814$20240819$EXP$PT-INFARMED-M202210-882$PT-GILEAD-2024-0683893$GILEAD$$77$YR$E$F$Y$$$20240819$$MD$PT$PT
242088511$24208851$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039567$AUROBINDO$$86$YR$$F$Y$$$20240814$$HP$CA$CA
242088531$24208853$1$I$$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128513$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240814$$CN$US$US
242088542$24208854$2$F$20210205$20240816$20240814$20240827$EXP$PT-INFARMED-M202210-433$PT-GILEAD-2024-0684019$GILEAD$$88$YR$E$F$Y$$$20240827$$MD$PT$PT
242088561$24208856$1$I$$20240808$20240814$20240814$EXP$$CA-TAKEDA-2024TUS080361$TAKEDA$$$$$M$Y$$$20240814$$CN$CA$CA
242088581$24208858$1$I$$20240725$20240814$20240814$EXP$$NVSC2024DE164314$NOVARTIS$$$$$$Y$$$20240814$$MD$DE$DE
242088591$24208859$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039659$AUROBINDO$$21$YR$$F$Y$$$20240814$$HP$CA$CA
242088601$24208860$1$I$20240514$20240806$20240814$20240814$EXP$FR-AFSSAPS-AVLY2024000117$FR-TEVA-VS-3231588$TEVA$$23$YR$$F$Y$$$20240814$$MD$FR$FR
242088611$24208861$1$I$20240422$20240805$20240814$20240814$EXP$FR-AFSSAPS-AVMA2024000337$FR-TEVA-VS-3230367$TEVA$$53$YR$$M$Y$$$20240814$$MD$FR$FR
242088621$24208862$1$I$$20240802$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408002216$ELI LILLY AND CO$$87$YR$E$M$Y$$$20240814$$CN$US$US
242088631$24208863$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007647$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242088641$24208864$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007585$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240814$$CN$US$US
242088651$24208865$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007626$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240814$$CN$US$US
242088661$24208866$1$I$20240812$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007579$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240814$$CN$US$US
242088671$24208867$1$I$$20240805$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408005042$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240814$$CN$US$US
242088681$24208868$1$I$20240806$20240806$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408004075$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240814$$CN$US$US
242088691$24208869$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007660$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240814$$CN$US$US
242088702$24208870$2$F$20240701$20240820$20240814$20240826$EXP$$NVSC2024AR056705$NOVARTIS$$52$YR$$F$Y$$$20240826$$CN$AR$AR
242088712$24208871$2$F$$20240815$20240814$20240826$EXP$$GB-BAYER-2024A115708$BAYER$Kubba F; Aliyeva-Derraz P; Gradassi AT. An unusual case of drug-induced annular granulomatous vasculitis in a patient with rheumatoid arthritis and type 2 diabetes mellitus. British Journal of Dermatology (2024) 192 Supplement 1 (i117-i118), 104th Annua. 2024;192:(i117-i118)$61$YR$A$F$Y$$$20240826$$HP$GB$GB
242088721$24208872$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007607$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240814$$CN$US$US
242088741$24208874$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007670$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240814$$CN$US$US
242088751$24208875$1$I$$20240805$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006792$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240814$$CN$US$US
242088761$24208876$1$I$20240530$20240807$20240814$20240814$EXP$ES-AEMPS-1554643$ES-ROCHE-10000051192$ROCHE$$52$YR$A$F$Y$$$20240814$$PH$ES$ES
242088771$24208877$1$I$20240726$20240730$20240814$20240814$PER$$US-TEVA-VS-3228563$TEVA$$45$YR$$F$Y$$$20240814$$CN$US$US
242088781$24208878$1$I$$20240808$20240814$20240814$EXP$$GB-JNJFOC-20240827637$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240814$$CN$GB$GB
242088791$24208879$1$I$$20240813$20240814$20240814$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045589$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$66$KG$20240814$$HP$CA$CA
242088801$24208880$1$I$$20240806$20240814$20240814$EXP$$IN-STERISCIENCE B.V.-2024-ST-001187$Steriscience PTE$Majhi DN, Shetty RA, Nimonkar RA, Pardal MPS.. Clinicoepidemiological Profile of a Fatal Case of Scrub Typhus: Our Experience.. Int-J-Pharmac-Clin-Res. 2024;16 (6):1116-1119$37$YR$$F$Y$$$20240814$$HP$IN$IN
242088811$24208881$1$I$$20240806$20240814$20240814$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP010142$STRIDES$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.. Am-J-Reprod-Immunol. 2024;92 (1)$35$YR$$F$Y$$$20240814$$HP$FR$FR
242088821$24208882$1$I$$20240805$20240814$20240814$EXP$$US-STERISCIENCE B.V.-2024-ST-001177$Steriscience PTE$Eshak N, Ehikhueme G, Ramesh M, Pixley J.. Granulomatous Polyangiitis Refractory to Induction With Rituximab in 3 Patients.. J-Investig-Med-High-Impact-Case-Rep. 2024;12$66$YR$$F$Y$$$20240814$$MD$US$US
242088831$24208883$1$I$20240615$20240804$20240814$20240814$EXP$GB-MHRA-MED-202408042148217470-WLNZK$GB-TEVA-VS-3230148$TEVA$$39$YR$$F$Y$$$20240814$$CN$GB$GB
242088841$24208884$1$I$20240812$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55714$$FDA-CTU$$65$YR$$M$N$$$20240813$N$HP$US$
242088851$24208885$1$I$20240401$20240813$20240813$20240813$DIR$714082$$FDA-CTU$$39$YR$$M$N$84.6$KG$20240813$N$CN$US$
242088872$24208887$2$F$20240101$20240916$20240814$20240923$PER$$US-ROCHE-10000052426$ROCHE$$20$YR$A$F$Y$68.95$KG$20240923$$CN$US$US
242088881$24208888$1$I$$20240808$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126175$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240814$$HP$US$US
242088891$24208889$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127828$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240814$$CN$US$US
242088901$24208890$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128200$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240814$$HP$US$US
242088912$24208891$2$F$20240401$20240826$20240814$20240830$EXP$$US-ANIPHARMA-2024-US-040680$ANI$$65$YR$$F$Y$69.85$KG$20240830$$HP$US$US
242088921$24208892$1$I$$20240806$20240814$20240814$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP010143$STRIDES$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al.. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.. Am-J-Reprod-Immunol. 2024;92 (1)$36$YR$$F$Y$$$20240814$$HP$FR$FR
242088931$24208893$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127832$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240814$$CN$US$US
242088942$24208894$2$F$$20240808$20240814$20240816$PER$$US-ABBVIE-5871325$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242088951$24208895$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55640$$FDA-CTU$$32$YR$$F$N$$$20240813$N$$US$
242088961$24208896$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040226$AUROBINDO$$74$YR$$F$Y$$$20240814$$HP$CA$CA
242088971$24208897$1$I$$20240805$20240814$20240814$EXP$$US-MYLANLABS-2024M1074102$MYLAN$Khattar G, Makram M, Rabah H, Hong C, Khan S, Mourad O, et al. Catastrophic Convergence: Refractory Septic Shock and Multisystem Failure in a Case of Hidradenitis Suppurativa Complicated by Fournier^s Gangrene and Bilateral Pulmonary Embolism. Am-J-Respir-Crit-Care-Med 2024; 209 A1614.$53$YR$$F$Y$$$20240814$$HP$US$US
242088982$24208898$2$F$$20240904$20240814$20240913$30DAY$$US-GSK-US2024098184$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$CN$US$US
242088991$24208899$1$I$$20240805$20240814$20240814$EXP$$US-MYLANLABS-2024M1074222$MYLAN$Pansare R, Khurram D, Rawal M. Severe Vitamin D Deficiency and Hypocalcemia during Pregnancy Masquerading as Thyroid Storm. J-Endocr-Soc 2022; 6 (Suppl.) A218.$22$YR$$F$Y$$$20240814$$HP$US$US
242089001$24208900$1$I$$20240805$20240814$20240814$EXP$$US-GSK-US2024GSK098274$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
242089021$24208902$1$I$$20240805$20240814$20240814$EXP$$US-MYLANLABS-2024M1073989$MYLAN$Mullis CE, Heldman M, Bahr NC, Minamoto GY, Puius YA, Malinis M. Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient. Transpl-Infect-Dis 2024; 26 (3):.$64$YR$$M$Y$$$20240814$$HP$US$US
242089032$24208903$2$F$$20240830$20240814$20240904$EXP$$CA-GSK-CA2024099621$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$HP$CA$CA
242089042$24208904$2$F$20240101$20240809$20240814$20240816$30DAY$$DE-UCBSA-2024040875$UCB$$86$YR$$F$Y$$$20240816$$CN$DE$DE
242089051$24208905$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179400$ASTRAZENECA$$$$$F$Y$59$KG$20240814$$CN$US$
242089061$24208906$1$I$20230317$20240806$20240814$20240814$EXP$$RU-AstraZeneca-2024A181297$ASTRAZENECA$$74$YR$$M$Y$99$KG$20240814$$MD$RU$
242089071$24208907$1$I$$20240805$20240814$20240814$EXP$$US-MYLANLABS-2024M1074107$MYLAN$Patel R, Elghawy O, Gibbs A, Gupta S, Kaur V. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer-Rep 2024; 7 (7): e2110.$84$YR$$M$Y$$$20240814$$HP$US$US
242089081$24208908$1$I$$20240805$20240814$20240814$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010155$STRIDES$Morisaki Y, Takatani T, Kotsugi M, Yamazaki S, Yokoyama S, Nakase K, et al.. Intraoperative monitoring of trigeminal neuralgia: a technical note.. Acta-Neurochir-Wien. 2024;166 (1):1-5$8$DEC$$F$Y$$$20240814$$HP$JP$JP
242089091$24208909$1$I$20160101$20240806$20240814$20240814$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010099$STRIDES$Bai G, Bai Y, Guan H, Ren H, Li H, Wang Y.. A case report of lymphoproliferative disease in brain following therapies with mycophenolate Mofetil and Fingolimod and literature review.. J-Neuroimmunol. 2024;394$32$YR$$M$Y$$$20240814$$HP$CN$CN
242089101$24208910$1$I$$20240806$20240814$20240814$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010119$STRIDES$Sircy A, Ibeh B, Boutros N, Bolyard J.. OTITIS MEDIA TO MENINGITIS: A RARE GROUP A STREPTOCOCCUS MENINGITIS CASE.. Crit-Care-Med. 2024;52 (Suppl.):S705$43$YR$$M$Y$$$20240814$$HP$US$US
242089112$24208911$2$F$20240730$20240905$20240814$20240909$EXP$$FR-PFIZER INC-202400230073$PFIZER$$10$YR$$M$Y$25$KG$20240909$$MD$FR$FR
242089131$24208913$1$I$$20240805$20240814$20240814$EXP$$JP-STERISCIENCE B.V.-2024-ST-001180$Steriscience PTE$Yamamoto H, Kuroda H, Hiramoto N, Hasuike T, Doi A, Nishioka H.. Successful maintenance treatment of disseminated nocardiosis with cerebral abscess in a severely immunocompromised patient allergic to trimethoprim-sulfamethoxazole using moxifloxacin and high-dose minocycline: A case report.. J-Infect-Chemother. 2024$60$YR$$M$Y$$$20240814$$HP$JP$JP
242089153$24208915$3$F$20240101$20240921$20240814$20240923$30DAY$$US-PFIZER INC-202400232553$PFIZER$$25$YR$$F$Y$$$20240923$$PH$US$US
242089161$24208916$1$I$20240812$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160467$AMGEN$$81$YR$E$F$Y$$$20240814$$CN$US$US
242089172$24208917$2$F$20240806$20240904$20240814$20240906$30DAY$$GB-PFIZER INC-202400232091$PFIZER$$33$YR$$M$Y$114.29$KG$20240906$$CN$GB$GB
242089185$24208918$5$F$20240101$20240924$20240814$20240927$30DAY$$US-PFIZER INC-PV202400103454$PFIZER$$68$YR$$M$Y$117.91$KG$20240927$$CN$US$US
242089194$24208919$4$F$20240101$20240919$20240814$20240924$30DAY$$US-PFIZER INC-202400230667$PFIZER$$5$YR$$F$Y$$$20240924$$CN$US$US
242089201$24208920$1$I$$20240805$20240814$20240814$EXP$$ZA-ROCHE-10000050461$ROCHE$$$$A$M$Y$$$20240814$$MD$ZA$ZA
242089213$24208921$3$F$20220501$20240928$20240814$20240930$EXP$$CA-PFIZER INC-202200746473$PFIZER$$65$YR$$F$Y$$$20240930$$MD$CA$CA
242089221$24208922$1$I$20240723$20240726$20240814$20240814$EXP$$US-ROCHE-10000055513$ROCHE$$62$YR$A$F$Y$$$20240814$$CN$US$US
242089231$24208923$1$I$20240810$20240813$20240814$20240814$PER$$US-ROCHE-10000056528$ROCHE$$$$E$M$Y$$$20240814$$CN$US$US
242089241$24208924$1$I$$20240806$20240814$20240814$EXP$$JP-ROCHE-10000055739$ROCHE$$85$YR$E$M$Y$54.3$KG$20240814$$PH$JP$JP
242089251$24208925$1$I$$20240801$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-038650$AUROBINDO$$59$YR$$F$Y$$$20240814$$HP$GB$GB
242089261$24208926$1$I$$20240805$20240814$20240814$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010079$STRIDES$Hua L, Yu-Rong Z, Xiao-Fei L, Si-Min L, Bo Z, Chun-Hua Y, et al.. Application of tofacitinib in treatment of seven patients with anti-MDA5 autoantibody-positive dermatomyositis-associated with interstitial lung disease and literature review. [Chinese].. Med-J-Chinese-Peopl-Liberat-Army. 2023;48 (1):91-96$62$YR$$M$Y$$$20240814$$HP$CN$CN
242089271$24208927$1$I$20200721$20240807$20240814$20240814$EXP$PL-URPL-1-1923-2020$PL-TEVA-VS-3231684$TEVA$$48$YR$$F$Y$80$KG$20240814$$MD$PL$PL
242089283$24208928$3$F$20240806$20240917$20240814$20240920$30DAY$$US-PFIZER INC-202400232626$PFIZER$$13$YR$$F$Y$33.11$KG$20240920$$CN$US$US
242089291$24208929$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040224$AUROBINDO$Poirier CM, Carter AA, Kwan Y, Koo J, Westlund JM, Alkass F, et al.. Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy PostePercutaneous Coronary Intervention.. CJC Open. 2023;5(11):846-858$85$YR$$F$Y$$$20240814$$HP$CA$CA
242089301$24208930$1$I$$20240805$20240814$20240814$EXP$$GR-STRIDES ARCOLAB LIMITED-2024SP010028$STRIDES$Petrikkos L, Kourti M, Stathi A, Antoniadi K, Ampatzidou M, Stefanaki K, et al.. Successful Treatment of Disseminated Fusariosis in a 15-Month-Old Boy With Refractory Acute Lymphoblastic Leukemia Using High-Dose Voriconazole.. Pediatr-Infect-Dis-J. 2024;0 (0):1-5.$15$MON$$M$Y$$$20240814$$HP$GR$GR
242089311$24208931$1$I$$20240807$20240814$20240814$EXP$$FR-MYLANLABS-2024M1075114$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$79$YR$$M$Y$$$20240814$$HP$FR$FR
242089321$24208932$1$I$$20240807$20240814$20240814$EXP$$US-MYLANLABS-2024M1074347$MYLAN$Cheng J, Harney S, Toner K, Kube P, Gong S, Ozdemirli M, et al. Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment. Pediatr-Blood-Cancer 2024; 71 (8): 1-4.$14$YR$$M$Y$$$20240814$$HP$US$US
242089331$24208933$1$I$$20240806$20240814$20240814$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010110$STRIDES$Li Q, Liu M, Liu Y, Shi F, Yuan S, Di G, et al.. Lethal Immune-Related Pneumonitis after Durvalumab Therapy for Small Cell Lung Cancer: A First Case in China.. Case-Rep-Oncol. 2024;17 (1):673-680$68$YR$$M$Y$$$20240814$$HP$CN$CN
242089341$24208934$1$I$$20240805$20240814$20240814$EXP$$US-MYLANLABS-2024M1073988$MYLAN$Lee J, Casey E, Otigbah C, Tompsett MK, Pittathankal A, Sirkova A, et al. Hyperparathyroidism Causing life Threatening Hypercalcaemia in Pregnancy. J-Endocr-Soc 2022; 6 (Suppl. 1) A166-A167.$31$YR$$F$Y$$$20240814$$HP$US$US
242089351$24208935$1$I$$20240807$20240814$20240814$EXP$$FR-MYLANLABS-2024M1075116$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$81$YR$$M$Y$$$20240814$$HP$FR$FR
242089361$24208936$1$I$$20240807$20240814$20240814$EXP$$AU-MYLANLABS-2024M1074358$MYLAN$Barbaro D, Clarke N, Gunawardane D, Teo K, Horvath N, Stokes M. Cardiac Amyloidosis Secondary to Light-Chain Deposition: The Effect of Daratumumab on Clinical Heart Failure Progression in an Elderly Male. Heart-Lung-Circ 2024; 33 (Suppl. 4) S249.$82$YR$$M$Y$$$20240814$$HP$AU$AU
242089371$24208937$1$I$$20240807$20240814$20240814$EXP$$AU-MYLANLABS-2024M1074938$MYLAN$Buckling H, Barlow T, Zielinski R, Karve S. Lorlatinib Induced Severe Hyperlipidaemia: A Case Report. Heart-Lung-Circ 2024; 33 (Suppl. 4) S302.$34$YR$$M$Y$$$20240814$$HP$AU$AU
242089381$24208938$1$I$$20240807$20240814$20240814$EXP$$IE-MYLANLABS-2024M1074691$MYLAN$Tudor RM, Ali EM, Khan SU, McDermott J. Klinefelter syndrome presenting as metastatic bilateral breast cancer: missed diagnostic opportunities. BMJ-Case-Rep 2023; 16.$60$YR$$M$Y$$$20240814$$MD$IE$IE
242089391$24208939$1$I$$20240807$20240814$20240814$EXP$$FR-MYLANLABS-2024M1075101$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$60$YR$$M$Y$$$20240814$$HP$FR$FR
242089402$24208940$2$F$20240728$20240809$20240814$20240815$PER$$US-ROCHE-10000054108$ROCHE$$25$YR$A$F$Y$$$20240815$$CN$US$US
242089411$24208941$1$I$$20240805$20240814$20240814$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010038$STRIDES$Iwasaki Y, Seguchi O, Ikura M, Arisato T, Hada T, Mochizuki H, et al.. BK polyomavirus nephropathy after heart transplantation: A case report.. J-Cardiol-Cases. 2024$56$YR$$M$Y$$$20240814$$MD$JP$JP
242089421$24208942$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040190$AUROBINDO$$80$YR$$F$Y$92$KG$20240814$$HP$CA$CA
242089431$24208943$1$I$20240601$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039507$AUROBINDO$$25$YR$$$Y$$$20240814$$CN$FR$FR
242089441$24208944$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040191$AUROBINDO$$82$YR$$F$Y$$$20240814$$CN$CA$CA
242089451$24208945$1$I$$20240806$20240814$20240814$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01554$NOVITIUM PHARMA$Huiying Zhu.Three cases of late-onset post CAR-T therapy isolated CNS relapse in R/R large B-cell lymphoma.European Journal of Haematology.18-SEP-2023;112(2):310-313$64$YR$A$M$Y$$$20240814$$HP$CN$CN
242089461$24208946$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039625$AUROBINDO$$75$YR$$F$Y$$$20240814$$PH$CA$CA
242089491$24208949$1$I$$20231004$20240814$20240814$EXP$$CA-TEVA-2023-CA-2933900$TEVA$$44$YR$$F$Y$97$KG$20240814$$MD$CA$CA
242089511$24208951$1$I$20240725$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128163$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240814$$CN$US$US
242089521$24208952$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010030$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$49$YR$$M$Y$$$20240814$$HP$NL$NL
242089531$24208953$1$I$$20240813$20240814$20240814$PER$$US-GILEAD-2024-0684112$GILEAD$$$$$M$Y$$$20240814$$CN$US$US
242089541$24208954$1$I$$20240806$20240814$20240814$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP010111$STRIDES$Neto M, Reis A, Santos F, Brigas D, Marques S, Serra S, et al.. A MISFORTUNE.. Eur-J-Case-Rep-Intern-Med. 2023;10 (Suppl. 1):328$45$YR$$F$Y$$$20240814$$HP$PT$PT
242089561$24208956$1$I$$20240805$20240814$20240814$EXP$$US-GSK-US2024097522$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
242089571$24208957$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040185$AUROBINDO$$75$YR$$M$Y$43$KG$20240814$$HP$CA$CA
242089591$24208959$1$I$20240218$20240807$20240814$20240814$PER$$US-ALXN-202408USA000443US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242089601$24208960$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010031$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$25$YR$$M$Y$$$20240814$$HP$NL$NL
242089611$24208961$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010032$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$24$YR$$M$Y$$$20240814$$HP$NL$NL
242089621$24208962$1$I$20200511$20240809$20240814$20240814$EXP$$CO-UCBSA-2024040997$UCB$$53$YR$$F$Y$$$20240814$$CN$CO$CO
242089631$24208963$1$I$$20240806$20240814$20240814$EXP$$CA-STRIDES ARCOLAB LIMITED-2024SP010113$STRIDES$Reyes NGD, Bendahan N, Swinkin E, Lang AE, Bassett AS.. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome.. Neurol-Sci. 2024;0 (0)$49$YR$$F$Y$$$20240814$$HP$CA$CA
242089641$24208964$1$I$$20240802$20240814$20240814$PER$$US-SA-2024SA233945$SANOFI AVENTIS$$$$A$F$Y$112.03$KG$20240814$$MD$US$US
242089652$24208965$2$F$20240101$20240828$20240814$20240918$PER$$US-SA-2024SA233626$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240918$$MD$US$US
242089673$24208967$3$F$$20240918$20240814$20240918$30DAY$$US-PFIZER INC-202400233272$PFIZER$$12$YR$$M$Y$$$20240918$$CN$US$US
242089681$24208968$1$I$$20240722$20240814$20240814$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003933$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242089691$24208969$1$I$$20240813$20240814$20240814$PER$$US-ROCHE-10000056598$ROCHE$$$$$F$Y$$$20240814$$MD$US$US
242089701$24208970$1$I$20240701$20240813$20240814$20240814$EXP$$US-ROCHE-10000056603$ROCHE$$44$YR$A$F$Y$$$20240814$$CN$US$US
242089711$24208971$1$I$$20240710$20240814$20240814$PER$$US-CHATTEMPRD-2024OHG024075$CHATTEM$Siddique AS, Thakur KS, Barlow LC, Gallagher ML. Ring Rash in an Infant: Unmasking Neonatal Lupus. Consultant. 2024 64:6 e2. doi:10.1093/rheumatology/key141.$3$MON$I$M$Y$$$20240814$$HP$US$US
242089721$24208972$1$I$20240325$20240806$20240814$20240814$EXP$ES-AEMPS-1555094$ES-TEVA-VS-3230789$TEVA$$64$YR$$F$Y$$$20240814$$MD$ES$ES
242089731$24208973$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010022$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$47$YR$$M$Y$$$20240814$$HP$NL$NL
242089741$24208974$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010039$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$24$YR$$M$Y$$$20240814$$HP$NL$NL
242089751$24208975$1$I$20240722$20240805$20240814$20240814$PER$$US-SA-2024SA235016$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240814$$MD$US$US
242089761$24208976$1$I$20231001$20240809$20240814$20240814$EXP$$JP-INSMED-2023-04094-JPAA$INSMED$$78$YR$$F$Y$34$KG$20240814$$CN$JP$JP
242089771$24208977$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA237742$SANOFI AVENTIS$$62$YR$A$M$Y$136$KG$20240814$$MD$US$US
242089781$24208978$1$I$20210101$20240805$20240814$20240814$PER$$US-SA-2024SA236214$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240814$$MD$US$US
242089791$24208979$1$I$20240501$20240806$20240814$20240814$PER$$US-SA-2024SA237515$SANOFI AVENTIS$$63$YR$A$M$Y$146$KG$20240814$$MD$US$US
242089801$24208980$1$I$20240805$20240806$20240814$20240814$PER$$US-SA-2024SA237724$SANOFI AVENTIS$$19$YR$A$M$Y$88.45$KG$20240814$$MD$US$US
242089811$24208981$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA235830$SANOFI AVENTIS$$56$YR$A$F$Y$60.78$KG$20240814$$MD$US$US
242089821$24208982$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA237659$SANOFI AVENTIS$$$$E$M$Y$$$20240814$$MD$US$US
242089841$24208984$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA236596$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240814$$MD$US$US
242089851$24208985$1$I$$20240801$20240814$20240814$EXP$$US-AUROBINDO-AUR-APL-2024-039501$AUROBINDO$$$$E$F$Y$$$20240814$$MD$US$US
242089861$24208986$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA236376$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240814$$MD$US$US
242089881$24208988$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA237647$SANOFI AVENTIS$$42$YR$A$F$Y$67.13$KG$20240814$$MD$US$US
242089891$24208989$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA238473$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240814$$MD$US$US
242089901$24208990$1$I$20240813$20240813$20240813$20240813$DIR$714090$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242089911$24208991$1$I$20240101$20240805$20240814$20240814$PER$$US-SA-2024SA235924$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240814$$MD$US$US
242089921$24208992$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA239133$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240814$$MD$US$US
242089931$24208993$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA235614$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240814$$CN$US$US
242089941$24208994$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA235484$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240814$$MD$US$US
242089952$24208995$2$F$20240101$20240829$20240814$20240909$PER$$US-SA-2024SA237038$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240909$$MD$US$US
242089961$24208996$1$I$20240601$20240807$20240814$20240814$PER$$US-SA-2024SA237482$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240814$$MD$US$US
242089971$24208997$1$I$20240724$20240807$20240814$20240814$PER$$US-SA-2024SA237661$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240814$$MD$US$US
242089981$24208998$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA237865$SANOFI AVENTIS$$$$A$F$Y$97.06$KG$20240814$$MD$US$US
242089991$24208999$1$I$20240801$20240807$20240814$20240814$PER$$US-SA-2024SA238310$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240814$$CN$US$US
242090001$24209000$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA238092$SANOFI AVENTIS$$57$YR$A$F$Y$124.73$KG$20240814$$MD$US$US
242090021$24209002$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA237725$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240814$$MD$US$US
242090032$24209003$2$F$$20240814$20240814$20240828$PER$$US-SA-2024SA237489$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240828$$MD$US$US
242090041$24209004$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA238141$SANOFI AVENTIS$$21$YR$A$M$Y$61$KG$20240814$$MD$US$US
242090051$24209005$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA237631$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240814$$MD$US$US
242090061$24209006$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA238713$SANOFI AVENTIS$$$$A$M$Y$102.06$KG$20240814$$MD$US$US
242090071$24209007$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA237471$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240814$$MD$US$US
242090081$24209008$1$I$20240101$20240730$20240814$20240814$EXP$$JP-AMGEN-JPNSP2024135370$AMGEN$$81$YR$E$F$Y$$$20240814$$MD$JP$JP
242090093$24209009$3$F$$20240909$20240814$20240920$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS004067$TERSERA THERAPEUTICS$$$$$$Y$$$20240920$$MD$CN$CN
242090101$24209010$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA235807$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242090113$24209011$3$F$20240701$20240822$20240814$20240918$PER$$US-SA-2024SA236835$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240918$$MD$US$US
242090121$24209012$1$I$$20240730$20240814$20240814$EXP$$JP-LEADINGPHARMA-JP-2024LEALIT00344$LEADING PHARMA$SH Taniguchi.FOLFIRI Chemotherapy for Patients With Metastatic Urachal Carcinoma.Anticancer Research.JAN-2023;43 (No. 12):5699-5704$$$A$$Y$$$20240814$$HP$JP$JP
242090131$24209013$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010041$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$45$YR$$M$Y$$$20240814$$HP$NL$NL
242090141$24209014$1$I$20240701$20240806$20240814$20240814$PER$$US-SA-2024SA238281$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240814$$MD$US$US
242090151$24209015$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238438$SANOFI AVENTIS$$$$T$F$Y$$$20240814$$MD$US$US
242090161$24209016$1$I$20240601$20240805$20240814$20240814$PER$$US-SA-2024SA235301$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240814$$MD$US$US
242090171$24209017$1$I$20240101$20240805$20240814$20240814$PER$$US-SA-2024SA234984$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240814$$MD$US$US
242090181$24209018$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA235597$SANOFI AVENTIS$$$$A$F$Y$104$KG$20240814$$CN$US$US
242090191$24209019$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA235686$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240814$$MD$US$US
242090201$24209020$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA238094$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240814$$MD$US$US
242090211$24209021$1$I$20240730$20240805$20240814$20240814$PER$$US-SA-2024SA234874$SANOFI AVENTIS$$18$YR$A$F$Y$74.8$KG$20240814$$MD$US$US
242090221$24209022$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA239379$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240814$$MD$US$US
242090231$24209023$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA239420$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
242090241$24209024$1$I$20240101$20240805$20240814$20240814$PER$$US-SA-2024SA236759$SANOFI AVENTIS$$11$YR$C$F$Y$54$KG$20240814$$MD$US$US
242090251$24209025$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA236890$SANOFI AVENTIS$$38$YR$A$F$Y$107.5$KG$20240814$$MD$US$US
242090271$24209027$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236834$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
242090281$24209028$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040009$AUROBINDO$$84$YR$$M$Y$65$KG$20240814$$PH$CA$CA
242090291$24209029$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA237715$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240814$$MD$US$US
242090301$24209030$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA237691$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240814$$MD$US$US
242090311$24209031$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA239103$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
242090321$24209032$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA234591$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240814$$MD$US$US
242090501$24209050$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236066$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240814$$MD$US$US
242090511$24209051$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA236400$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240814$$CN$US$US
242090523$24209052$3$F$$20240916$20240814$20240923$PER$$US-SA-2024SA237328$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240923$$MD$US$US
242090531$24209053$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238307$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240814$$MD$US$US
242090541$24209054$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA238057$SANOFI AVENTIS$$8$YR$C$F$Y$31$KG$20240814$$MD$US$US
242090551$24209055$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238819$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240814$$CN$US$US
242090561$24209056$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA238142$SANOFI AVENTIS$$$$E$F$Y$73.48$KG$20240814$$MD$US$US
242090571$24209057$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA237144$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240814$$MD$US$US
242090581$24209058$1$I$20231201$20240806$20240814$20240814$PER$$US-SA-2024SA236848$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240814$$MD$US$US
242090591$24209059$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA236543$SANOFI AVENTIS$$$$A$F$Y$139$KG$20240814$$MD$US$US
242090601$24209060$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA234458$SANOFI AVENTIS$$$$T$M$Y$$$20240814$$MD$US$US
242090611$24209061$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA236789$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240814$$MD$US$US
242090621$24209062$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238717$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240814$$MD$US$US
242090632$24209063$2$F$$20240807$20240814$20240816$PER$$US-SA-2024SA207737$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$MD$US$US
242090642$24209064$2$F$20240101$20240813$20240814$20240826$PER$$US-SA-2024SA238667$SANOFI AVENTIS$$61$YR$A$M$Y$68.03$KG$20240826$$MD$US$US
242090651$24209065$1$I$$20240813$20240813$20240813$DIR$714023$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242090661$24209066$1$I$$20240806$20240814$20240814$EXP$$NL-NOVITIUMPHARMA-2024NLNVP01553$NOVITIUM PHARMA$Tom Dormans.LATE TUBERCULOSIS REACTIVATION AFTER SEVERE COVID-19.European Journal of Case Reports in Internal Medicine.03-APR-2024;11(5):1-6$$$$F$Y$$$20240814$$HP$NL$NL
242090671$24209067$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA236438$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240814$$HP$US$US
242090681$24209068$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA237829$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240814$$MD$US$US
242090691$24209069$1$I$20240601$20240806$20240814$20240814$PER$$US-SA-2024SA238719$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240814$$MD$US$US
242090701$24209070$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010023$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$40$YR$$M$Y$$$20240814$$HP$NL$NL
242090711$24209071$1$I$$20240806$20240814$20240814$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010045$STRIDES$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al.. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.. ESMO-Open. 2024;9 (7):1-8$38$YR$$M$Y$$$20240814$$HP$NL$NL
242090721$24209072$1$I$20240802$20240809$20240814$20240814$EXP$$CO-UCBSA-2024040905$UCB$$13$YR$$M$Y$$$20240814$$CN$CO$CO
242090731$24209073$1$I$20240601$20240806$20240814$20240814$PER$$US-SA-2024SA236694$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240814$$MD$US$US
242090741$24209074$1$I$$20240813$20240813$20240813$DIR$714066$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242090751$24209075$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236919$SANOFI AVENTIS$$$$A$M$Y$77.11$KG$20240814$$MD$US$US
242090761$24209076$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA235533$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240814$$MD$US$US
242090771$24209077$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236995$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240814$$CN$US$US
242090781$24209078$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA080262$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240814$$MD$US$US
242090791$24209079$1$I$20240701$20240807$20240814$20240814$PER$$US-SA-2024SA238248$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240814$$MD$US$US
242090802$24209080$2$F$20240801$20240807$20240814$20240819$PER$$US-SA-2024SA236397$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240820$$MD$US$US
242090811$24209081$1$I$20240625$20240806$20240814$20240814$PER$$US-SA-2024SA239451$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240814$$MD$US$US
242090821$24209082$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA235553$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240814$$MD$US$US
242090831$24209083$1$I$20240701$20240805$20240814$20240814$PER$$US-SA-2024SA236874$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240814$$CN$US$US
242090841$24209084$1$I$20240722$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55690$$FDA-CTU$$37$YR$$F$N$81.65$KG$20240813$N$PH$US$
242090851$24209085$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55638$$FDA-CTU$$77$YR$$F$N$$$20240813$N$$US$
242090861$24209086$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA237065$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240814$$MD$US$US
242090871$24209087$1$I$20240701$20240806$20240814$20240814$PER$$US-SA-2024SA238241$SANOFI AVENTIS$$62$YR$A$M$Y$111.13$KG$20240814$$MD$US$US
242090891$24209089$1$I$20240517$20240813$20240813$20240813$DIR$714159$$FDA-CTU$$36$YR$$F$N$81$KG$20240813$N$$US$
242090901$24209090$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA239382$SANOFI AVENTIS$$$$A$M$Y$86.182$KG$20240814$$MD$US$US
242090911$24209091$1$I$20231201$20240807$20240814$20240814$PER$$US-SA-2024SA239606$SANOFI AVENTIS$$38$YR$A$F$Y$58$KG$20240814$$MD$US$US
242090921$24209092$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA085562$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240814$$MD$US$US
242090931$24209093$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA237757$SANOFI AVENTIS$$$$A$F$Y$115$KG$20240814$$MD$US$US
242090941$24209094$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236847$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240814$$MD$US$US
242090951$24209095$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238831$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240814$$MD$US$US
242090961$24209096$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236538$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240814$$MD$US$US
242090971$24209097$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238221$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240814$$MD$US$US
242090981$24209098$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA238524$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240814$$MD$US$US
242090991$24209099$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA234536$SANOFI AVENTIS$$$$C$F$Y$12.247$KG$20240814$$MD$US$US
242091001$24209100$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA235977$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240814$$MD$US$US
242091011$24209101$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238245$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240814$$MD$US$US
242091023$24209102$3$F$20230101$20240916$20240814$20240923$PER$$US-SA-2024SA237161$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240923$$MD$US$US
242091031$24209103$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA236366$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240814$$MD$US$US
242091041$24209104$1$I$20240701$20240806$20240814$20240814$PER$$US-SA-2024SA237416$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240814$$MD$US$US
242091051$24209105$1$I$20170820$20240805$20240814$20240814$PER$$US-SA-2024SA235249$SANOFI AVENTIS$$51$YR$A$M$Y$81.6$KG$20240814$$MD$US$US
242091061$24209106$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA239044$SANOFI AVENTIS$$$$A$F$Y$88.45$KG$20240814$$MD$US$US
242091071$24209107$1$I$20240621$20240801$20240814$20240814$EXP$$FR-AUROBINDO-AUR-APL-2024-039441$AUROBINDO$$26$YR$$M$Y$$$20240814$$MD$FR$FR
242091081$24209108$1$I$20240101$20240805$20240814$20240814$PER$$US-SA-2024SA235032$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240814$$MD$US$US
242091092$24209109$2$F$20240701$20240809$20240814$20240820$PER$$US-SA-2024SA237167$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240820$$CN$US$US
242091101$24209110$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA238398$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240814$$MD$US$US
242091112$24209111$2$F$$20240814$20240814$20240828$PER$$US-SA-2024SA237165$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240828$$MD$US$US
242091121$24209112$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA237063$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240814$$CN$US$US
242091131$24209113$1$I$20180101$20240808$20240814$20240814$PER$$US-SA-2024SA239029$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240814$$CN$US$US
242091141$24209114$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA236676$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240814$$MD$US$US
242091151$24209115$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA235969$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240814$$MD$US$US
242091161$24209116$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA238952$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240814$$MD$US$US
242091171$24209117$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191910$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242091181$24209118$1$I$20240808$20240809$20240814$20240814$PER$$US-SA-2024SA239333$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240814$$CN$US$US
242091191$24209119$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA239556$SANOFI AVENTIS$$$$C$M$Y$$$20240814$$MD$US$US
242091201$24209120$1$I$20240809$20240809$20240814$20240814$PER$$US-SA-2024SA239825$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240814$$MD$US$US
242091211$24209121$1$I$20240101$20240808$20240814$20240814$PER$$US-SA-2024SA240374$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240814$$MD$US$US
242091221$24209122$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA237997$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240814$$HP$US$US
242091232$24209123$2$F$20240808$20240809$20240814$20240820$PER$$US-SA-2024SA240647$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240820$$HP$US$US
242091241$24209124$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA237655$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$CN$US$US
242091251$24209125$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA239573$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240814$$CN$US$US
242091261$24209126$1$I$20240802$20240808$20240814$20240814$PER$$US-SA-2024SA238708$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240814$$CN$US$US
242091271$24209127$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA238215$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240814$$MD$US$US
242091281$24209128$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA239878$SANOFI AVENTIS$$$$A$M$Y$90$KG$20240814$$MD$US$US
242091291$24209129$1$I$20240701$20240809$20240814$20240814$PER$$US-SA-2024SA239476$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240814$$MD$US$US
242091301$24209130$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA239912$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240814$$MD$US$US
242091311$24209131$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA238227$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$HP$US$US
242091321$24209132$1$I$20240101$20240808$20240814$20240814$PER$$US-SA-2024SA240517$SANOFI AVENTIS$$$$A$F$Y$70$KG$20240814$$MD$US$US
242091332$24209133$2$F$20240601$20240917$20240814$20240925$PER$$US-SA-2024SA239612$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240925$$MD$US$US
242091341$24209134$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA239915$SANOFI AVENTIS$$$$E$M$Y$88.9$KG$20240814$$MD$US$US
242091351$24209135$1$I$20220101$20240809$20240814$20240814$EXP$$US-BIOGEN-2024BI01277909$BIOGEN$$$$$F$Y$$$20240814$$CN$US$US
242091361$24209136$1$I$20240101$20240808$20240814$20240814$PER$$US-SA-2024SA239363$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240814$$CN$US$US
242091371$24209137$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA240140$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240814$$MD$US$US
242091381$24209138$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA239637$SANOFI AVENTIS$$$$A$M$Y$78.4$KG$20240814$$MD$US$US
242091391$24209139$1$I$20240101$20240808$20240814$20240814$PER$$US-SA-2024SA238154$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240814$$CN$US$US
242091403$24209140$3$F$20240101$20240827$20240814$20240909$PER$$US-SA-2024SA239851$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240909$$MD$US$US
242091411$24209141$1$I$20240701$20240808$20240814$20240814$PER$$US-SA-2024SA240501$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240814$$MD$US$US
242091421$24209142$1$I$20240801$20240808$20240814$20240814$PER$$US-SA-2024SA239489$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240814$$MD$US$US
242091431$24209143$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA237274$SANOFI AVENTIS$$$$$F$Y$$$20240814$$HP$US$US
242091451$24209145$1$I$20240101$20240809$20240814$20240814$PER$$US-SA-2024SA239569$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240814$$CN$US$US
242091461$24209146$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA240619$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
242091471$24209147$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA238131$SANOFI AVENTIS$$$$$M$Y$$$20240814$$MD$US$US
242091481$24209148$1$I$$20240812$20240814$20240814$EXP$$NVSC2024US163608$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
242091491$24209149$1$I$$20240812$20240814$20240814$PER$$US-TAKEDA-2024TUS081051$TAKEDA$$$$$$Y$$$20240814$$CN$US$US
242091502$24209150$2$F$$20240921$20240814$20240924$PER$$US-TAKEDA-2024TUS080206$TAKEDA$$$$$M$Y$72$KG$20240924$$HP$US$US
242091511$24209151$1$I$$20240805$20240814$20240814$30DAY$$US-GSK-US2024097591$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
242091521$24209152$1$I$$20240808$20240814$20240814$EXP$$CA-GSK-CA2024099197$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$HP$CA$CA
242091531$24209153$1$I$20240531$20240808$20240814$20240814$EXP$$JP-PFIZER INC-202400191861$PFIZER$$77$YR$$F$Y$$$20240814$$CN$JP$JP
242091552$24209155$2$F$20240506$20240813$20240814$20240815$EXP$DE-CADRBFARM-2024329376$DE-PFIZER INC-202400220410$PFIZER$$88$YR$$M$Y$68$KG$20240815$$MD$DE$DE
242091571$24209157$1$I$20240813$20240813$20240813$20240813$DIR$714130$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242091581$24209158$1$I$20240808$20240808$20240814$20240814$EXP$$US-PFIZER INC-202400233403$PFIZER$$64$YR$$M$Y$$$20240814$$HP$US$US
242091591$24209159$1$I$$20240809$20240814$20240814$EXP$$CA-PFIZER INC-202400233807$PFIZER$$$$$$Y$$$20240814$$HP$CA$CA
242091601$24209160$1$I$$20240806$20240814$20240814$EXP$$FR-PFIZER INC-202400236169$PFIZER$$83$YR$$M$Y$$$20240814$$MD$FR$FR
242091622$24209162$2$F$$20240902$20240814$20240905$EXP$$JP-PFIZER INC-PV202400103006$PFIZER$$$$$$Y$$$20240905$$PH$JP$JP
242091631$24209163$1$I$20240808$20240808$20240814$20240814$EXP$$CA-PFIZER INC-202400233728$PFIZER$$78$YR$$M$Y$$$20240814$$MD$CA$CA
242091641$24209164$1$I$20240722$20240808$20240814$20240814$EXP$$CN-PFIZER INC-PV202400103641$PFIZER$$57$YR$$F$Y$51$KG$20240814$$HP$CN$CN
242091651$24209165$1$I$$20240813$20240813$20240813$DIR$714112$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242091661$24209166$1$I$$20240808$20240814$20240814$EXP$$CA-PFIZER INC-202400234739$PFIZER$$72$YR$$F$Y$57$KG$20240814$$CN$CA$CA
242091671$24209167$1$I$$20240808$20240814$20240814$EXP$$JP-PFIZER INC-PV202400103809$PFIZER$$$$$$Y$$$20240814$$MD$JP$JP
242091701$24209170$1$I$$20240807$20240814$20240814$EXP$$US-PFIZER INC-202400233280$PFIZER$$57$YR$$F$Y$$$20240814$$HP$US$US
242091711$24209171$1$I$$20240808$20240814$20240814$EXP$$CA-PFIZER INC-202400233783$PFIZER$$83$YR$$F$Y$$$20240814$$HP$CA$CA
242091731$24209173$1$I$$20240812$20240814$20240814$EXP$$CA-PFIZER INC-202400235754$PFIZER$$$$N$F$Y$$$20240814$$HP$CA$CA
242091741$24209174$1$I$20240612$20240808$20240814$20240814$EXP$FR-AFSSAPS-GR2024000978$FR-PFIZER INC-202400232687$PFIZER$$65$YR$$F$Y$114$KG$20240814$$MD$FR$FR
242091751$24209175$1$I$$20240730$20240814$20240814$EXP$$TR-LEADINGPHARMA-TR-2024LEALIT00342$LEADING PHARMA$Cakan F.Intraoperative Takotsubo Cardiomyopathy: A Case Report.Journal of Perianesthesia Nursing.MAR-2024$18$YR$T$F$Y$50$KG$20240814$$HP$TR$TR
242091761$24209176$1$I$20240807$20240813$20240813$20240813$DIR$714123$$FDA-CTU$$51$YR$$F$N$88.2$KG$20240813$N$CN$US$
242091771$24209177$1$I$20240317$20240805$20240814$20240814$EXP$$JP-RIGEL-20240800037$RIGEL PHARMACEUTICALS$$80$YR$$F$Y$38.3$KG$20240814$$MD$JP$JP
242091782$24209178$2$F$20240805$20240822$20240814$20240827$EXP$$CA-MYLANLABS-2024M1075422$MYLAN$$60$YR$$F$Y$$$20240827$$PH$CA$CA
242091791$24209179$1$I$$20240801$20240814$20240814$PER$$US-IDORSIA-008340-2024-US$IDORSIA PHARMACEUTICALS$$$$$$Y$$$20240814$$MD$US$US
242091801$24209180$1$I$20240101$20240809$20240814$20240814$EXP$$BR-JNJFOC-20240829186$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240814$$HP$BR$BR
242091811$24209181$1$I$$20240807$20240814$20240814$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01587$NOVITIUM PHARMA$Rui Hu.Management of immunocompromised renal transplant patients infected with coronavirus disease 2019.Zhonghua Wei Zhong Bing Ji Jiu Yi Xue.MAY-2022;34(5):492-496$49$YR$A$M$Y$$$20240814$$HP$CN$CN
242091822$24209182$2$F$20240310$20240813$20240814$20240822$EXP$FR-AFSSAPS-AN2024000995$FR-TEVA-VS-3231188$TEVA$$69$YR$$M$Y$50$KG$20240822$$MD$FR$FR
242091831$24209183$1$I$$20240809$20240814$20240814$PER$$US-TAKEDA-2024TUS080861$TAKEDA$$$$$$Y$$$20240814$$CN$US$US
242091851$24209185$1$I$20240101$20240812$20240814$20240814$EXP$$GB-ABBVIE-5877747$ABBVIE$$$$$$Y$$$20240814$$HP$GB$GB
242091863$24209186$3$F$20240801$20240825$20240814$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024667$UNITED THERAPEUTICS$$65$YR$$F$Y$58.005$KG$20240904$$$US$US
242091871$24209187$1$I$20240105$20240813$20240814$20240814$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045672$BOEHRINGER INGELHEIM$$58$YR$A$M$Y$130$KG$20240814$$MD$RU$RU
242091881$24209188$1$I$$20240729$20240814$20240814$PER$$US-TEVA-VS-3228214$TEVA$$49$YR$$F$Y$$$20240814$$CN$US$US
242091891$24209189$1$I$$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024159634$AMGEN$$$$$F$Y$$$20240814$$MD$US$US
242091901$24209190$1$I$$20240730$20240814$20240814$EXP$$JP-LEADINGPHARMA-JP-2024LEALIT00339$LEADING PHARMA$Taniguchi SH.Chemotherapy for Patients With Metastatic Urachal Carcinoma.Anticancer Research.JAN-2023;43(12):5699-5704$$$A$$Y$$$20240814$$HP$JP$JP
242091911$24209191$1$I$20240813$20240813$20240813$20240813$DIR$714135$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242091921$24209192$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55639$$FDA-CTU$$78$YR$$F$N$90.72$KG$20240813$N$HP$US$
242091951$24209195$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128201$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240814$$CN$US$US
242091961$24209196$1$I$20240807$20240808$20240814$20240814$PER$$US-AMGEN-USASP2024158122$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242091972$24209197$2$F$20240811$20240813$20240814$20240818$PER$$US-AMGEN-USASP2024160477$AMGEN$$82$YR$E$F$Y$$$20240818$$CN$US$US
242091981$24209198$1$I$$20240808$20240814$20240814$EXP$$NL-AMGEN-NLDSL2024138949$AMGEN$$70$YR$E$F$Y$$$20240814$$HP$NL$NL
242091991$24209199$1$I$$20240811$20240814$20240814$EXP$$IN-BIOGEN-2024BI01277916$BIOGEN$$23$YR$$F$Y$$$20240814$$MD$IN$IN
242092001$24209200$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55651$$FDA-CTU$$38$YR$$F$N$$$20240813$N$$US$
242092011$24209201$1$I$$20240808$20240814$20240814$PER$$US-BIOGEN-2013BI044466$BIOGEN$$$$$F$Y$$$20240814$$CN$US$US
242092021$24209202$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A178521$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242092031$24209203$1$I$$20240806$20240814$20240814$EXP$$JP-AstraZeneca-2024A179677$ASTRAZENECA$$81$YR$$M$Y$$$20240814$$MD$JP$
242092041$24209204$1$I$$20240813$20240813$20240813$DIR$714099$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242092051$24209205$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55735$$FDA-CTU$$51$YR$$F$N$$$20240813$N$$US$
242092061$24209206$1$I$$20240808$20240814$20240814$30DAY$$CA-PFIZER INC-202400233078$PFIZER$$33$YR$$F$Y$$$20240814$$PH$CA$CA
242092092$24209209$2$F$20240719$20240917$20240814$20240918$30DAY$EE-SAM-2222407241$EE-PFIZER INC-202400232610$PFIZER$$53$YR$$M$Y$$$20240918$$MD$EE$EE
242092102$24209210$2$F$$20240913$20240814$20240913$30DAY$$US-PFIZER INC-202400233408$PFIZER$$9$YR$$F$Y$$$20240913$$CN$US$US
242092121$24209212$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55671$$FDA-CTU$$11$YR$$M$N$$$20240813$N$$US$
242092141$24209214$1$I$$20240806$20240814$20240814$EXP$$RU-AstraZeneca-2024A180924$ASTRAZENECA$$62$YR$$M$Y$115$KG$20240814$$MD$RU$
242092151$24209215$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A178828$ASTRAZENECA$$$$$$Y$$$20240814$$CN$US$
242092161$24209216$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A180137$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242092171$24209217$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179247$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242092181$24209218$1$I$$20240805$20240814$20240814$30DAY$$US-GSK-US2024097605$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
242092192$24209219$2$F$$20240904$20240814$20240910$EXP$$PL-SA-2024SA238422$SANOFI AVENTIS$Adamska BN, Grabarczyk P, Dzieciatkowski T, Windyga J, Ejduk A, Tomaszewska A et al.. Early post-transplantation lymphoproliferative disorder with central nervous system involvement and EBV infection in a patient receiving allogeneic haematopoietic stem cells transplantation.. Hematology. 2014;5(1):81-8$32$YR$A$M$Y$$$20240910$$HP$PL$PL
242092201$24209220$1$I$$20240809$20240814$20240814$EXP$$IT-AstraZeneca-2024A182426$ASTRAZENECA$$$$E$M$Y$$$20240814$$MD$IT$
242092221$24209222$1$I$$20240806$20240814$20240814$EXP$$ZA-AstraZeneca-2024A179953$ASTRAZENECA$$80$YR$$F$Y$$$20240814$$CN$ZA$
242092232$24209223$2$F$$20240812$20240814$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408006242$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240816$$HP$US$US
242092241$24209224$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007594$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242092251$24209225$1$I$20240811$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007255$ELI LILLY AND CO$$30$YR$A$M$Y$$$20240814$$CN$US$US
242092261$24209226$1$I$20240801$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006725$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240814$$CN$US$US
242092271$24209227$1$I$20240805$20240805$20240814$20240814$EXP$$US-RIGEL-20240800027$RIGEL PHARMACEUTICALS$$42$YR$$F$Y$$$20240814$$CN$US$US
242092281$24209228$1$I$$20240730$20240814$20240814$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00633$GLAND PHARMA$$68$YR$E$M$Y$$$20240814$$HP$CN$CN
242092291$24209229$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA238024$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240814$$MD$US$US
242092301$24209230$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA237801$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242092311$24209231$1$I$20240803$20240809$20240814$20240814$PER$$US-SA-2024SA240984$SANOFI AVENTIS$$45$YR$A$F$Y$54.7$KG$20240814$$MD$US$US
242092321$24209232$1$I$20240701$20240808$20240814$20240814$PER$$US-SA-2024SA239922$SANOFI AVENTIS$$14$YR$T$F$Y$42.22$KG$20240814$$MD$US$US
242092331$24209233$1$I$20230101$20240805$20240814$20240814$PER$$US-SA-2024SA235563$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240814$$MD$US$US
242092341$24209234$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA240053$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$CN$US$US
242092352$24209235$2$F$20240508$20240820$20240814$20240830$PER$$US-SA-2024SA239350$SANOFI AVENTIS$$$$C$M$Y$$$20240830$$MD$US$US
242092361$24209236$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA236845$SANOFI AVENTIS$$$$A$F$Y$104$KG$20240814$$MD$US$US
242092371$24209237$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA237657$SANOFI AVENTIS$$50$YR$A$F$Y$98.8$KG$20240814$$MD$US$US
242092381$24209238$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA239042$SANOFI AVENTIS$$58$YR$A$F$Y$96.16$KG$20240814$$MD$US$US
242092391$24209239$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA239459$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240814$$MD$US$US
242092401$24209240$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA239900$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240814$$CN$US$US
242092411$24209241$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191858$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242092422$24209242$2$F$$20240820$20240814$20240829$EXP$$US-TEVA-VS-3230718$TEVA$Mathias P, Epstein E. Iatrogenic Cushing^s Syndrome following Epidural Steroid Injections in an HIV-Infected Patient on Treatment with Genvoya. J-Endocr-Soc 2019; 3 (Suppl. 1).; Mathias P, Epstein E. Iatrogenic Cushing^s Syndrome following Epidural Steroid Injections in an HIV-Infected Patient on Treatment with Genvoya. J-Endocr-Soc 2019; 3 (Suppl. 1).$76$YR$$F$Y$$$20240829$$MD$US$US
242092441$24209244$1$I$$20240807$20240814$20240814$EXP$$US-NOVITIUMPHARMA-2024USNVP01585$NOVITIUM PHARMA$Rose Mary Attieh.Disseminated Monkeypox Infection in a Kidney Transplant Recipient: A Case Report.Transplantation Proceedings.27-APR-2023;55(3):667-671$44$YR$A$M$Y$$$20240814$$HP$US$US
242092451$24209245$1$I$$20240807$20240814$20240814$EXP$$US-NOVITIUMPHARMA-2024USNVP01573$NOVITIUM PHARMA$Schott C.Disseminated Nocardiosis in a Sarcoidosis Patient Off Pneumocystis Pneumonia Prophylaxis.American Journal of Respiratory and Critical Care Medicine.19-MAY-2024;NA:1-3$81$YR$E$M$Y$$$20240814$$HP$US$US
242092471$24209247$1$I$$20240807$20240814$20240814$EXP$$BR-SANDOZ INC.-NVSC2020BR042728$SANDOZ$$$$E$F$Y$105$KG$20240814$$CN$BR$BR
242092485$24209248$5$F$$20240905$20240814$20240906$EXP$$PT-SANDOZ INC.-SDZ2024PT072115$SANDOZ$$70$YR$$F$Y$$$20240906$$HP$PT$PT
242092491$24209249$1$I$$20240812$20240814$20240814$EXP$$CA-PFIZER INC-202400234969$PFIZER$$$$$M$Y$67$KG$20240814$$HP$CA$CA
242092501$24209250$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55670$$FDA-CTU$$53$YR$$F$N$$$20240813$N$$US$
242092511$24209251$1$I$20210921$20240809$20240814$20240814$EXP$$IN-PFIZER INC-2021168594$PFIZER$$69$YR$$F$Y$77.6$KG$20240814$$CN$IN$IN
242092531$24209253$1$I$$20240812$20240814$20240814$EXP$$CA-PFIZER INC-202400234952$PFIZER$$77$YR$$M$Y$83$KG$20240814$$HP$CA$CA
242092541$24209254$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55677$$FDA-CTU$$41$YR$$F$N$$$20240813$N$$US$
242092551$24209255$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55663$$FDA-CTU$$68$YR$$F$N$81.65$KG$20240813$N$$US$
242092561$24209256$1$I$$20240812$20240814$20240814$EXP$$CA-PFIZER INC-202400235164$PFIZER$$72$YR$$M$Y$$$20240814$$HP$CA$CA
242092571$24209257$1$I$$20240809$20240814$20240814$EXP$$GB-PFIZER INC-202400233739$PFIZER$$66$YR$$F$Y$100$KG$20240814$$HP$GB$GB
242092592$24209259$2$F$$20240816$20240814$20240816$30DAY$$US-PFIZER INC-PV202400104558$PFIZER$$$$$F$Y$$$20240816$$CN$US$US
242092611$24209261$1$I$20240707$20240809$20240814$20240814$EXP$$CN-PFIZER INC-PV202400104276$PFIZER$$93$YR$$M$Y$$$20240814$$HP$CN$CN
242092621$24209262$1$I$20240803$20240809$20240814$20240814$EXP$GB-MHRA-MED-202408071620241670-WLJRM$GB-PFIZER INC-202400233654$PFIZER$$50$YR$$F$Y$$$20240814$$HP$GB$GB
242092631$24209263$1$I$20240805$20240809$20240814$20240814$EXP$$CN-PFIZER INC-PV202400104316$PFIZER$$55$YR$$F$Y$45$KG$20240814$$HP$CN$CN
242092642$24209264$2$F$20240101$20240821$20240814$20240826$EXP$$CA-PFIZER INC-202400235029$PFIZER$$68$YR$$M$Y$$$20240826$$HP$CA$CA
242092651$24209265$1$I$20240717$20240809$20240814$20240814$EXP$$CN-PFIZER INC-PV202400104199$PFIZER$$62$YR$$F$Y$65$KG$20240814$$HP$CN$CN
242092661$24209266$1$I$20240801$20240809$20240814$20240814$EXP$$US-PFIZER INC-202400233794$PFIZER$$$$$M$Y$$$20240814$$HP$US$US
242092671$24209267$1$I$$20240808$20240814$20240814$EXP$$US-TAKEDA-2024TUS079417$TAKEDA$$$$E$F$Y$82.4$KG$20240814$$MD$US$US
242092681$24209268$1$I$$20240808$20240814$20240814$EXP$$DE-JNJFOC-20240834996$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$DE$DE
242092691$24209269$1$I$20240601$20240808$20240814$20240814$PER$$US-JNJFOC-20240824295$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242092701$24209270$1$I$$20240730$20240814$20240814$EXP$$US-GLANDPHARMA-US-2024GLNLIT00606$GLAND PHARMA$K. Lapiano.Nelarabine Neurotoxicity Induced Respiratory Failure. American Journal of Respiratory and Critical Care Medicine.American Journal of Respiratory and Critical Care Medicine.JAN-2024;209:A5696$30$YR$A$F$Y$$$20240814$$HP$US$US
242092711$24209271$1$I$$20240812$20240814$20240814$PER$$US-TAKEDA-2024TUS081342$TAKEDA$$$$$$Y$$$20240814$$CN$US$US
242092725$24209272$5$F$20240101$20240910$20240814$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-013103$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240914$$$US$US
242092731$24209273$1$I$$20240813$20240814$20240814$30DAY$$US-SANDOZ INC.-SDZ2024US072510$SANDOZ$$77$YR$$F$Y$$$20240814$$HP$US$US
242092741$24209274$1$I$$20240809$20240814$20240814$EXP$ES-EMA-DD-20181114-abdul_j-093549$ES-SANDOZ INC.-PHHY2018ES109845$SANDOZ$$58$YR$$F$Y$$$20240814$$MD$ES$ES
242092751$24209275$1$I$$20240806$20240814$20240814$EXP$$TR-MYLANLABS-2024M1074000$MYLAN$Zeytun B, Guney A, Toprak Z, Esman BS, Demirtas E, Kehaya S. Moyamoya Disease with Syphilis: A Case Report. Erciyes-Med-J 2024; 46 (2): 202-205.$37$YR$$F$Y$$$20240814$$HP$TR$TR
242092761$24209276$1$I$$20240806$20240814$20240814$EXP$$IT-MYLANLABS-2024M1074765$MYLAN$Scala M, Chiera M, Bortolotti B, Rodriguez-Jimenez R, Menchetti M. Aggressive behaviour and diabetes: A clinical case of atypical metabolic improvement during clozapine treatment. J-Intellect-Disabil 2024; 1-8.$$$A$M$Y$$$20240814$$HP$IT$IT
242092771$24209277$1$I$$20240806$20240814$20240814$EXP$$SE-MYLANLABS-2024M1074724$MYLAN$Zilg B, Alkass K, Berg S, Druid H. Interpretation of postmortem vitreous concentrations of sodium and chloride. Forensic-Sci-Int 2016; 263 107-113.$47$YR$$M$Y$$$20240814$$HP$SE$SE
242092782$24209278$2$F$$20240806$20240814$20240821$EXP$$CA-MYLANLABS-2024M1074680$MYLAN$Reyes NGD, Bendahan N, Swinkin E, Lang AE, Bassett AS. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurol-Sci 2024; 0 (0):.$53$YR$$F$Y$$$20240821$$HP$CA$CA
242092791$24209279$1$I$$20240806$20240814$20240814$EXP$$US-MYLANLABS-2024M1074404$MYLAN$Adams L, Darabad RR. Case Report on Chronic Shoulder Pain and Response to Peripheral Nerve Stimulation Twenty-Four Months After Placement. Pain-Med-Case-Rep 2024; 8 (4): 151-155.$82$YR$$F$Y$$$20240814$$MD$US$US
242092801$24209280$1$I$$20240807$20240814$20240814$EXP$$SG-ROCHE-10000052448$ROCHE$$58$YR$A$F$Y$$$20240814$$CN$SG$SG
242092811$24209281$1$I$$20240802$20240814$20240814$EXP$$US-INSMED, INC.-2024-02143-US$INSMED$$$$$M$Y$$$20240814$$CN$US$US
242092821$24209282$1$I$$20240809$20240814$20240814$EXP$$US-BEH-2024177106$CSL BEHRING$$68$YR$E$M$Y$$$20240814$$PH$US$US
242092831$24209283$1$I$20240809$20240813$20240814$20240814$30DAY$$US-SANDOZ INC.-SDZ2024US072621$SANDOZ$$72$YR$$M$Y$$$20240814$$HP$US$US
242092841$24209284$1$I$$20240730$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462047$RANBAXY$Gu J, Qian J, Cao X. Composite diffuse large B-cell lymphoma and peripheral T-cell lymphoma: a case report with two-year follow-up and literature review. Front Oncol. 2024;Mar;14 (0):1272209(1-7)$75$YR$$M$Y$$$20240814$$HP$CN$CN
242092851$24209285$1$I$$20240730$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461928$RANBAXY$Weiling L, Jihao Z, Yun C, Lixin W, Guoqiang L, Bingbing W, et al. Geritinib in the targeted therapy of acute myeloid leukemia with FLT3 mutation: report of 5 cases and review of literature. J  Leuk Lymphoma. 2022;Nov 31(11):1-6$16$YR$$M$Y$$$20240814$$HP$CN$CN
242092861$24209286$1$I$$20240730$20240814$20240814$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462036$RANBAXY$SHIROKOV VA, POTATURKO AV, TEREKHOV NL, MOROZOV AA. Fixed combination of orphenadrine and diclofenac in the treatment of acute spondylogenic pain syndromes. Russian Journal of Pain. 2021;19 (1):19-24$$$A$$Y$$$20240814$$HP$RU$RU
242092871$24209287$1$I$$20240730$20240814$20240814$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460167$RANBAXY$Shalaeva D. D, Pereverzeva K. G, Fomina O. A, Yakushin S. S. BRASH-syndrome: ? clinical case. Rational Pharmacotherapy in Cardiology.. 2024;20(3)$85$YR$$F$Y$$$20240814$$HP$RU$RU
242092881$24209288$1$I$$20240730$20240814$20240814$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462001$RANBAXY$Pannunzio A, Palumbo IM. Differential diagnosis of syncope and anemia in a newly discovered systemic transthyretin amyloidosis. Pol Arch Med Wewn. 2022;132(Suppl):20$87$YR$$M$Y$$$20240814$$HP$IT$IT
242092891$24209289$1$I$$20240730$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459121$RANBAXY$Inoue F, Okazaki Y, Ichiba T, Chiba T, Namera A. Giant T waves and QT interval prolongation associated with guanfacine toxicity. Clin Toxicol (Phila). 2024;62(4):269-271$17$YR$$F$Y$$$20240814$$HP$JP$JP
242092901$24209290$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461955$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$40$YR$$M$Y$$$20240814$$HP$DK$DK
242092911$24209291$1$I$$20240730$20240814$20240814$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461949$RANBAXY$Zio ID, Cisternino R. Rare case of thrombocytopenia secondary to taking febuxostat. Italian Journal of Medicine. 2024;18 (2):1724 (1-3)$63$YR$$M$Y$$$20240814$$HP$IT$IT
242092922$24209292$2$F$$20240806$20240814$20240821$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462077$RANBAXY$Isgandarov K. A case of atrial flutter following marijuana abuse and its management. E J Cardiovasc Med. 2020;8 (Suppl.) (1):441-442/ 654-655$28$YR$$M$Y$$$20240821$$HP$TR$TR
242092931$24209293$1$I$$20240730$20240814$20240814$EXP$$AR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460203$RANBAXY$Espindola M, Rojas NG, Vaisentein G, Da Prat G, Cesarini M, Etcheverry JL, et al.. Suicide attempt in a dopamine agonist withdrawal syndrome in Parkinson^s disease. Parkinson Relat Dis. 2024;121 (0):111 (P_340) 106106$43$YR$$M$Y$$$20240814$$HP$AR$AR
242092941$24209294$1$I$$20240730$20240814$20240814$EXP$$ID-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462101$RANBAXY$Firsty NN, Hermansyah D. Neoadjuvant pembrolizumab for triple-negative breast vcancer in 26-year-old woman: A South East Asian perspective. Ann Oncol. 2023;34 (Suppl.):S1459/P45-1$26$YR$$F$Y$$$20240814$$HP$ID$ID
242092951$24209295$1$I$$20240730$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461945$RANBAXY$Liang J, Xu X, Chen Z, Yu J, Tang Y. Combined Use of Emapalumab With Ruxolitinib and Dexamethasone as an Effective Treatment for Epstein-Barr Virus?associated Hemophagocytic Lymphohistiocytosis Complicated With Multiorgan Damage and Severe Infection. J Pediatr Hematol Oncol. 2024;Jul 46(5):e360-e362$8$YR$$F$Y$$$20240814$$MD$CN$CN
242092961$24209296$1$I$$20240730$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461948$RANBAXY$Qu W-F, Ding Z-BQu X-D, Tang Z, Zhu ,Qu X-D, Tang Z, Zhu G-Q, Fu X-T, et al. Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study. BJS Open. 2022;6 (5):1-8$$$A$$Y$$$20240814$$HP$CN$CN
242092971$24209297$1$I$$20240730$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462016$RANBAXY$Ling L, Wei Z, Linghui L. Clinical analysis of Omalizumab in treatment of 28 children with allergic diseases. Chin J Appl Clin Pediatr. 2021;Jun; 36(12):926-930$8$YR$$M$Y$$$20240814$$HP$CN$CN
242092982$24209298$2$F$$20240820$20240814$20240904$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462090$RANBAXY$Bing W, Xiaoyan S, Jinfeng L, Yuan Z. Severe hepatic injury caused by Xuesaitong for injection. ADRJ. 2020;Feb; 22(2):115-117$71$YR$$M$Y$$$20240904$$HP$CN$CN
242092991$24209299$1$I$$20240730$20240814$20240814$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462042$RANBAXY$Corica D, Bottari A, Aversa T, Caudo D,Galletta K, Micalizzi MF, et al. An unusual epididymal localization of Testicular Adrenal Rest Tumor in an adolescent with congenital adrenal hyperplasia. Endocrine. 2019;66(3):695-698$15$YR$$M$Y$$$20240814$$HP$IT$IT
242093001$24209300$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024161197$AMGEN$$$$$$Y$$$20240814$$CN$US$US
242093011$24209301$1$I$$20240807$20240814$20240814$EXP$$US-AMGEN-USASP2024158492$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242093022$24209302$2$F$$20240813$20240814$20240826$PER$$US-AMGEN-USASP2024161292$AMGEN$$$$$F$Y$$$20240825$$CN$US$US
242093031$24209303$1$I$$20240808$20240814$20240814$PER$$US-AMGEN-USASP2024159472$AMGEN$$$$$M$Y$$$20240814$$CN$US$US
242093042$24209304$2$F$20240101$20240910$20240814$20240913$EXP$$US-AMGEN-USASL2024160237$AMGEN$$37$YR$A$F$Y$$$20240913$$MD$US$US
242093051$24209305$1$I$$20240807$20240814$20240814$EXP$CA-MMM-AYUGP3F8$CA-GSK-CA2023107928$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$CA$CA
242093071$24209307$1$I$$20240812$20240814$20240814$EXP$$CA-PFIZER INC-202400234841$PFIZER$$52$YR$$F$Y$$$20240814$$PH$CA$CA
242093081$24209308$1$I$20240806$20240812$20240814$20240814$EXP$GB-MHRA-MED-202408071721281860-WBQZJ$GB-PFIZER INC-202400234655$PFIZER$$44$YR$$F$Y$$$20240814$$HP$GB$GB
242093091$24209309$1$I$$20240812$20240814$20240814$EXP$$DO-PFIZER INC-202400235760$PFIZER$$53$YR$$M$Y$$$20240814$$CN$DO$DO
242093101$24209310$1$I$$20240811$20240814$20240814$EXP$$US-PFIZER INC-202400234282$PFIZER$$$$$M$Y$$$20240814$$CN$US$US
242093111$24209311$1$I$$20240812$20240814$20240814$EXP$$DO-PFIZER INC-202400235765$PFIZER$$78$YR$$M$Y$$$20240814$$CN$DO$DO
242093121$24209312$1$I$$20240812$20240814$20240814$EXP$$DO-PFIZER INC-202400234902$PFIZER$$49$YR$$M$Y$$$20240814$$CN$DO$DO
242093131$24209313$1$I$20240807$20240812$20240814$20240814$EXP$GB-MHRA-MED-202408121525422230-KCFNG$GB-PFIZER INC-202400234842$PFIZER$$76$YR$$M$Y$$$20240814$$HP$GB$GB
242093142$24209314$2$F$20230711$20240909$20240814$20240910$EXP$$ES-PFIZER INC-202400234221$PFIZER$$50$YR$$M$Y$68.2$KG$20240910$$HP$ES$ES
242093151$24209315$1$I$20240726$20240811$20240814$20240814$EXP$$CN-PFIZER INC-PV202400104304$PFIZER$$13$YR$$F$Y$32$KG$20240814$$HP$CN$CN
242093161$24209316$1$I$$20240809$20240814$20240814$EXP$$CA-PFIZER INC-202400234768$PFIZER$$15$YR$$M$Y$$$20240814$$HP$CA$CA
242093171$24209317$1$I$20240101$20240812$20240814$20240814$EXP$$GB-PFIZER INC-PV202400105229$PFIZER$$61$YR$$F$Y$$$20240814$$CN$GB$GB
242093192$24209319$2$F$$20240812$20240814$20240815$EXP$$US-PFIZER INC-202400235045$PFIZER$$20$YR$$M$Y$$$20240815$$CN$US$US
242093201$24209320$1$I$20240501$20240812$20240814$20240814$EXP$IT-MINISAL02-998293$IT-PFIZER INC-202400234371$PFIZER$$40$YR$$F$Y$49$KG$20240814$$MD$IT$IT
242093211$24209321$1$I$$20240812$20240814$20240814$EXP$$US-PFIZER INC-202400235549$PFIZER$$62$YR$$F$Y$63.5$KG$20240814$$CN$US$US
242093221$24209322$1$I$20230518$20240811$20240814$20240814$EXP$$US-PFIZER INC-PV202400104990$PFIZER$$32$YR$$$Y$92.986$KG$20240814$$CN$US$US
242093251$24209325$1$I$20230306$20240809$20240814$20240814$EXP$$CN-PFIZER INC-PV202400104200$PFIZER$$34$YR$$M$Y$73$KG$20240814$$HP$CN$CN
242093261$24209326$1$I$20231017$20240812$20240814$20240814$EXP$$CA-PFIZER INC-PV202300163072$PFIZER$$78$YR$$F$Y$62.5$KG$20240814$$MD$CA$CA
242093271$24209327$1$I$20240220$20240812$20240814$20240814$EXP$FR-AFSSAPS-TO2024001493$FR-PFIZER INC-202400234550$PFIZER$$57$YR$$F$Y$51.2$KG$20240814$$PH$FR$FR
242093281$24209328$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55650$$FDA-CTU$$69$YR$$F$N$$$20240813$N$HP$US$
242093291$24209329$1$I$20240808$20240812$20240814$20240814$EXP$$GB-PFIZER INC-202400234826$PFIZER$$38$YR$$F$Y$$$20240814$$HP$GB$GB
242093301$24209330$1$I$20160101$20240807$20240814$20240814$EXP$$CA-MYLANLABS-2017017975$MYLAN$$$$$F$Y$$$20240814$$CN$CA$CA
242093311$24209331$1$I$$20240812$20240814$20240814$PER$$US-DSJP-DSU-2024-140406$DAIICHI$$$$$F$Y$$$20240814$$CN$US$US
242093321$24209332$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55674$$FDA-CTU$$70$YR$$F$N$$$20240813$N$$US$
242093331$24209333$1$I$$20240813$20240813$20240813$DIR$714015$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242093341$24209334$1$I$$20240730$20240814$20240814$EXP$$US-GLANDPHARMA-US-2024GLNLIT00616$GLAND PHARMA$Michael.gwiazdowski.A Unique Case Presentation of Takotsubo Cardiomyopathy After Cardiac Arrest and Resuscitation Without CPR.American Journal of Respiratory and Critical Care Medicine.MAY-2023;207:A1787$81$YR$E$F$Y$$$20240814$$HP$US$US
242093351$24209335$1$I$20240513$20240808$20240814$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-024871$UNITED THERAPEUTICS$$$$$$Y$$$20240814$$$US$US
242093381$24209338$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55738$$FDA-CTU$$51$YR$$F$N$$$20240813$N$$US$
242093401$24209340$1$I$20240101$20240802$20240814$20240814$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15761$IPSEN$$39$YR$A$F$Y$$$20240814$$HP$US$US
242093411$24209341$1$I$$20240807$20240814$20240814$PER$$US-UNITED THERAPEUTICS-UNT-2024-024662$UNITED THERAPEUTICS$$$$$F$Y$$$20240814$$$US$US
242093422$24209342$2$F$20240731$20240814$20240814$20240829$EXP$$US-Accord-440909$ACCORD$$33$YR$A$M$Y$$$20240829$$HP$US$US
242093431$24209343$1$I$20240704$20240802$20240814$20240814$EXP$CN-HENLIUS-24CN016276$CN-Accord-441278$ACCORD$$62$YR$A$F$Y$59$KG$20240814$$MD$CN$CN
242093441$24209344$1$I$20160101$20240804$20240814$20240814$EXP$GB-MHRA-MED-202408041539579870-DVNKG$GB-Accord-440276$ACCORD$$57$YR$A$F$Y$52$KG$20240814$$CN$GB$GB
242093451$24209345$1$I$20240428$20240803$20240814$20240814$EXP$SK-SUKLSK-20240378$SK-Accord-440235$ACCORD$$16$YR$T$F$Y$$$20240814$$CN$SK$SK
242093461$24209346$1$I$20240810$20240813$20240813$20240813$DIR$714177$$FDA-CTU$$22$YR$$M$N$$$20240813$N$CN$US$
242093481$24209348$1$I$20240812$20240813$20240813$20240813$DIR$714180$$FDA-CTU$$22$YR$$F$N$83.25$KG$20240813$N$CN$US$
242093491$24209349$1$I$$20240803$20240814$20240814$EXP$AU-TGA-811911$AU-Accord-439651$ACCORD$$$$$F$Y$$$20240814$$HP$AU$AU
242093501$24209350$1$I$$20240802$20240814$20240814$EXP$AU-TGA-812550$AU-Accord-439637$ACCORD$$59$YR$A$M$Y$$$20240814$$HP$AU$AU
242093511$24209351$1$I$$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408052011145980-PSRNC$GB-Accord-440398$ACCORD$$30$YR$A$F$Y$57$KG$20240814$$CN$GB$GB
242093521$24209352$1$I$20240701$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160423$AMGEN$$77$YR$E$F$Y$$$20240814$$CN$US$US
242093532$24209353$2$F$20240101$20240812$20240814$20240818$PER$$US-AMGEN-USASP2024160056$AMGEN$$68$YR$E$M$Y$$$20240818$$CN$US$US
242093542$24209354$2$F$$20240827$20240814$20240902$EXP$$JP-AMGEN-JPNSP2024157181$AMGEN$$$$$$Y$$$20240902$$MD$JP$JP
242093551$24209355$1$I$20240813$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55673$$FDA-CTU$$51$YR$$F$N$$$20240813$Y$HP$US$
242093561$24209356$1$I$20240101$20240807$20240814$20240814$EXP$$US-AMGEN-USASP2024157730$AMGEN$$72$YR$E$F$Y$$$20240814$$CN$US$US
242093571$24209357$1$I$$20240812$20240814$20240814$PER$$US-HALEON-2191740$Haleon PLC$$86$YR$$F$Y$$$20240814$$HP$US$US
242093581$24209358$1$I$20240707$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127200$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$78.93$KG$20240814$$PH$US$US
242093591$24209359$1$I$$20240806$20240814$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125439$BRISTOL MYERS SQUIBB$Seki Y, Umeda Y, Taneda T, Umeda M, Kuroha T, Nagai M, et al. A case of Listeria meningoencephalitis successfully diagnosed by mass spectrometry. Medical Journal of Nagaoka Red Cross Hospital .2023; 36(1): 41-4$80$YR$E$M$Y$$$20240814$$MD$JP$JP
242093612$24209361$2$F$$20240913$20240814$20240916$EXP$$US-TAKEDA-2024TUS081360$TAKEDA$$$$$M$Y$$$20240916$$CN$US$US
242093621$24209362$1$I$20180620$20240812$20240814$20240814$EXP$$US-TAKEDA-US201826137$TAKEDA$$61$YR$$F$Y$$$20240814$$CN$US$US
242093631$24209363$1$I$$20240812$20240814$20240814$EXP$$US-TAKEDA-2024TUS075692$TAKEDA$$$$$F$Y$$$20240814$$CN$US$US
242093641$24209364$1$I$$20240809$20240814$20240814$EXP$$ES-AMGEN-ESPSP2024158979$AMGEN$Martinez-selles M.; Valero-masa M. J.; Ortiz-bautista C. D. et al.. Optimization of Hypercholesterolemia Treatment after Heart Transplant: The Role of PCSK9 Inhibitors. Current Pharmaceutical Design. 2024;30:1-4$$$$M$Y$$$20240814$$HP$ES$ES
242093651$24209365$1$I$20240629$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408050942328210-TYRHD$GB-Accord-440376$ACCORD$$53$YR$A$F$Y$$$20240814$$MD$GB$GB
242093661$24209366$1$I$20240801$20240802$20240814$20240814$EXP$$US-Accord-440366$ACCORD$$65$YR$$F$Y$$$20240814$$HP$US$US
242093671$24209367$1$I$$20240803$20240814$20240814$EXP$GB-MHRA-MED-202408031111078320-RZWSQ$GB-Accord-440270$ACCORD$$26$YR$A$F$Y$$$20240814$$CN$GB$GB
242093681$24209368$1$I$$20240802$20240814$20240814$EXP$AU-TGA-812188$AU-Accord-439398$ACCORD$$67$YR$E$F$Y$$$20240814$$HP$AU$AU
242093691$24209369$1$I$$20240802$20240814$20240814$EXP$$US-Accord-440458$ACCORD$$28$YR$A$M$Y$$$20240814$$HP$US$US
242093701$24209370$1$I$$20240804$20240814$20240814$EXP$$AU-Accord-440649$ACCORD$Li A, Farnan L, Mulhall C, Shyamali N. Metastatic Small Cell Carcinoma of the Bladder Complicated by Paraneoplastic Acute Thrombocytopenia. Cureus. 2024 Jun 29;16(6):e63480. doi: 10.7759/cureus.63480.$76$YR$E$M$Y$$$20240814$$MD$AU$AU
242093711$24209371$1$I$20240628$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408051635370580-RMKZV$GB-Accord-440413$ACCORD$$68$YR$E$F$Y$62$KG$20240814$$MD$GB$GB
242093721$24209372$1$I$20240604$20240804$20240814$20240814$EXP$GB-MHRA-WEBRADR-202408041109247600-DCMKP$GB-Accord-440291$ACCORD$$85$YR$E$F$Y$76$KG$20240814$$CN$GB$GB
242093731$24209373$1$I$20240723$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408050824183720-LWDBJ$GB-Accord-440431$ACCORD$$84$YR$E$M$Y$$$20240814$$PH$GB$GB
242093741$24209374$1$I$$20240803$20240814$20240814$EXP$CA-MHPD-E2B_07150273$CA-Accord-440524$ACCORD$$$$$M$Y$$$20240814$$MD$CA$CA
242093751$24209375$1$I$20240731$20240802$20240814$20240814$EXP$$US-Accord-440361$ACCORD$$71$YR$E$F$Y$$$20240814$$HP$US$US
242093761$24209376$1$I$$20240803$20240814$20240814$EXP$CA-MHPD-E2B_07155775$CA-Accord-440540$ACCORD$$59$YR$A$F$Y$$$20240814$$HP$CA$CA
242093771$24209377$1$I$$20240804$20240814$20240814$EXP$$AU-Accord-441075$ACCORD$Li A, Farnan L, Mulhall C, Shyamali N. Metastatic Small Cell Carcinoma of the Bladder Complicated by Paraneoplastic Acute Thrombocytopenia. Cureus. 2024 Jun 29;16(6):e63480. doi: 10.7759/cureus.63480.$76$YR$E$M$Y$$$20240814$$MD$AU$AU
242093781$24209378$1$I$$20240802$20240814$20240814$EXP$AU-TGA-804412$AU-Accord-439489$ACCORD$$$$$F$Y$$$20240814$$HP$AU$AU
242093791$24209379$1$I$$20240804$20240814$20240814$EXP$$KR-Accord-440640$ACCORD$Yang J, Kim Y, Park WY, Jin K, Han S, Kim BH et al. Unilateral testicular tuberculosis in a kidney transplant recipient: a case report. Clin Transplant Res. 2024 Aug 1.$36$YR$A$M$Y$55$KG$20240814$$HP$KR$KR
242093811$24209381$1$I$$20240802$20240814$20240814$EXP$AU-TGA-808324$AU-Accord-439833$ACCORD$$74$YR$E$M$Y$$$20240814$$HP$AU$AU
242093821$24209382$1$I$20170427$20240731$20240814$20240814$EXP$GB-MHRA-ADR 24290030$GB-Accord-097326$ACCORD$$68$YR$E$F$Y$61$KG$20240814$$MD$GB$GB
242093841$24209384$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA237508$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240814$$MD$US$US
242093851$24209385$1$I$$20240730$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462218$RANBAXY$Jia D, Zhang F, Li H, Shen Y, Jin Z, Shi FD, et al. Responsiveness to Tocilizumab in Anti-Acetylcholine Receptor-Positive Generalized Myasthenia Gravis. Aging  Dis. 2024;Apr; 15(2):824-830$77$YR$$M$Y$$$20240814$$HP$CN$CN
242093861$24209386$1$I$$20240730$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462227$RANBAXY$Jia D, Zhang F, Li H, Shen Y, Jin Z, Shi FD, et al. Responsiveness to Tocilizumab in Anti-Acetylcholine Receptor-Positive Generalized Myasthenia Gravis. Aging Dis. 2024;Apr; 15(2):824-830$38$YR$$F$Y$$$20240814$$HP$CN$CN
242093871$24209387$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462195$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$34$YR$$M$Y$$$20240814$$HP$DK$DK
242093881$24209388$1$I$$20240730$20240814$20240814$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462216$RANBAXY$Moszczynska E, Baszynska-Wilk M, Tutka A, Bogusz-Wojcik A, Dasiewicz P, Gryniewicz-Kwiatkowska O, et al. Precocious puberty and other endocrine disorders during mitotane treatment for paediatric adrenocortical carcinoma -case series and literature review. Pediatr Endocrinol Diabetes Metab. 2024;30 (1):14-28$$$C$F$Y$11.2$KG$20240814$$HP$PL$PL
242093891$24209389$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462208$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$54$YR$$F$Y$$$20240814$$HP$DK$DK
242093901$24209390$1$I$$20240730$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462124$RANBAXY$Sada I, Harada Y, Hiyama T, Mizukami M, Kan T, Kawai M, et al. Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma. Melanoma Res. 2023;33 (6):539-546$57$YR$$M$Y$$$20240814$$HP$JP$JP
242093911$24209391$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462436$RANBAXY$Heidari F, Jiwa N, Chang A. A rare case of shewanella algae bacteremia. Am-JRespir-Crit-Care-Med. 2024;209 (0)$87$YR$$M$Y$$$20240814$$HP$US$US
242093921$24209392$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462213$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$26$YR$$M$Y$$$20240814$$HP$DK$DK
242093931$24209393$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462214$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$32$YR$$F$Y$$$20240814$$HP$DK$DK
242093941$24209394$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462194$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$24$YR$$M$Y$$$20240814$$HP$DK$DK
242093951$24209395$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462205$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$24$YR$$M$Y$$$20240814$$HP$DK$DK
242093961$24209396$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462200$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$35$YR$$M$Y$$$20240814$$HP$DK$DK
242093971$24209397$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462183$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$38$YR$$M$Y$$$20240814$$HP$DK$DK
242093981$24209398$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462430$RANBAXY$Cabanilla MG, Shald EA, Hlavacek NL, Bernauer ML, Sosa NR.. Breaking the mold: Insights into the clinical management and outcomes of rhinocerebral mucormycosis in adults. DCases. 2024;37 (0)$$$A$$Y$$$20240814$$HP$US$US
242093991$24209399$1$I$$20240730$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462429$RANBAXY$Katsuma S, Ariyoshi K, Nio A, Taguchi K, Sonoda K. A case report and literature review: A 19-year-old with endometrial carcinoma treated with medroxyprogesterone acetate. Importance of the medical interview and  endometrial examination. Clin Case Rep. 2024;12:e9205$19$YR$$F$Y$58.1$KG$20240814$$HP$JP$JP
242094001$24209400$1$I$$20240730$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462190$RANBAXY$Farouji A, Battah A, Hellou R, Ahmad A, Farouji l. Unique Presentation of Asymptomatic Bacteriuria, Vertebral Osteomyelitis, and Iliopsoas Abscess Due to Klebsiella pneumonia in a 73-Year-Old Man with Type 2 Diabetes Mellitus on Empagliflozin. Am J Case Rep. 2024;25 (0):e943874$73$YR$$M$Y$$$20240814$$HP$US$US
242094012$24209401$2$F$$20240806$20240814$20240821$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462113$RANBAXY$Oli A, Bhatia A. A. Unusual clinical features and histopathological findings in a case of Pseudoendophthalmitis in neovascular glaucoma. Rom J Ophthalmol. 2024;Apr-Jun;68 (2):182-186$54$YR$$M$Y$$$20240821$$MD$IN$IN
242094021$24209402$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462212$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$51$YR$$M$Y$$$20240814$$HP$DK$DK
242094031$24209403$1$I$$20240730$20240814$20240814$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462215$RANBAXY$Castelli M, Betelli M, Valenti A, Merelli B, Loglio A, Vigano M et al. A CASE OF POLYSEROSITIS, CHYLOUS ASCITES AND HEPATITIS INDUCED BY IMMUNE CHECKPOINT INHIBITORS. Eur J Case Rep Intern Med. 2024;11 (7):1-4$39$YR$$M$Y$$$20240814$$HP$IT$IT
242094041$24209404$1$I$$20240730$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462471$RANBAXY$Zhu H, Zhuang Z, Wang W, Zhao D, Zhang W, Zhou D, et al. Three cases of late-onset post CAR-T therapy isolated CNS relapse in R/R large B-cell lymphoma. Eur J Haematol. 2024;112:310-313$62$YR$$F$Y$$$20240814$$HP$CN$CN
242094051$24209405$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462206$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$55$YR$$M$Y$$$20240814$$HP$DK$DK
242094061$24209406$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462180$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$50$YR$$F$Y$$$20240814$$HP$DK$DK
242094071$24209407$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462175$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$52$YR$$F$Y$$$20240814$$HP$DK$DK
242094081$24209408$1$I$$20240730$20240814$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462348$RANBAXY$$60$YR$$F$Y$$$20240814$$MD$GB$GB
242094091$24209409$1$I$$20240731$20240814$20240814$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458324$RANBAXY$Komargodski R, Wittenberg A, Bahat H, Rachmiel M. Acute kidney and liver injury associated with low-dose liraglutide in an obese adolescent patient. Pediatrics. 2024;154 (1):e2023063719.$17$YR$$M$Y$$$20240814$$HP$IL$IL
242094101$24209410$1$I$$20240731$20240814$20240814$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462465$RANBAXY$Farina A, Villagran-Garcia M, Benaiteau M, Lamblin F, Fourier A, Honnorat J, et al. Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors. Neurol Neuroimmunol Neuroinflamm. 2024;11 (5):e200287$52$YR$$M$Y$$$20240814$$MD$FR$FR
242094111$24209411$1$I$$20240731$20240814$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462323$RANBAXY$$19$YR$$F$Y$63$KG$20240814$$CN$GB$GB
242094121$24209412$1$I$$20240730$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462131$RANBAXY$Sada I, Harada Y, Hiyama T, Mizukami M, Kan T, Kawai M, et al. Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma. Melanoma Res. 2023;33 (6):539-546$45$YR$$F$Y$$$20240814$$HP$JP$JP
242094131$24209413$1$I$$20240730$20240814$20240814$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462477$RANBAXY$Dormans T, Zandijk E, Stals F. Late Tuberculosis Reactivation After Severe Covid-19. Eur J Case Rep Intern Med. 2024;11 (5):no pagination$7$DEC$$F$Y$$$20240814$$HP$NL$NL
242094141$24209414$1$I$$20240730$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462223$RANBAXY$Jia D, Zhang F, Li H, Shen Y, Jin Z, Shi FD, et al. Responsiveness to Tocilizumab in Anti-Acetylcholine Receptor-Positive Generalized Myasthenia Gravis. Aging Dis. 2024;Apr; 15(2):824-830$43$YR$$F$Y$$$20240814$$HP$CN$CN
242094151$24209415$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462448$RANBAXY$Nigro SC, Nolan R, Boemio N. Probable Tamsulosin-Induced Hyperglycemia: A Case Study. Clin-Diabet. 2022;40 (1):113-115$68$YR$$M$Y$$$20240814$$HP$US$US
242094161$24209416$1$I$$20240731$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462467$RANBAXY$Deng J, Chen H, Yang Y, Ji H, Liu H. Liposomal mitoxantrone-based multidrug chemotherapy as a bridge to allogeneic hematopoietic stem cell transplantation in relapsed/ refractory acute lymphoblastic leukemia (ALL) after immunotherapy failure: a case report. Front Med. 2024;May;11:1-4$60$YR$$F$Y$$$20240814$$HP$CN$CN
242094171$24209417$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462209$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$25$YR$$F$Y$$$20240814$$HP$DK$DK
242094181$24209418$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462201$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$41$YR$$M$Y$$$20240814$$HP$DK$DK
242094191$24209419$1$I$$20240731$20240814$20240814$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462271$RANBAXY$Serdechnaya AY, Sukmanova IA. CLINICAL CASE OF A 29 WEEKS PREGNANT PATIENT WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. Complex Issues of Cardiovascular Diseases. 2023;12 (2):183-188$37$YR$$F$Y$$$20240814$$HP$RU$RU
242094201$24209420$1$I$$20240730$20240814$20240814$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462290$RANBAXY$Yang J, McCarthy J, Shah SS, Ng E, Shen J, Libianto R, et al. Challenges in Diagnosing and Managing the Spectrum of Primary Aldosteronism. J Endocr Soc. 2024;8 (7):bvae109(1-11)$45$YR$$M$Y$$$20240814$$HP$AU$AU
242094211$24209421$1$I$20210201$20240731$20240814$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462404$RANBAXY$Escola CL, Flores A, Haider W, Zagurova M, Qandil N, Alonso JR, et al.. Unexpected effect of anti-PD-1 immune checkpoint inhibitor on a 61-year-old female with stage III non-small cell lung cancer on progression to chemo-radiotherapy. Clin-Med-London. 2024;24$61$YR$$F$Y$$$20240814$$HP$GB$GB
242094221$24209422$1$I$$20240731$20240814$20240814$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462393$RANBAXY$Unal S, Yuksek T. A case of concomitant hidradenitis suppurativa and psoriasis successfully treated with guselkumab in a patient with Down syndrome. Turk Arch Dermatol Venereol. 2024;58 (2):48-51$29$YR$$M$Y$$$20240814$$HP$TR$TR
242094231$24209423$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462204$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$38$YR$$M$Y$$$20240814$$HP$DK$DK
242094241$24209424$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462449$RANBAXY$Khattar G, Makram M, Rabah H, Hong C, Khan S, Mourad O, et al.. Catastrophic Convergence: Refractory Septic Shock and Multisystem Failure in a Case of Hidradenitis Suppurativa Complicated by Fournier^s Gangrene and Bilateral Pulmonary Embolism. Am J Respir Crit Care Med. 2024;209 (0):No pagination$53$YR$$F$Y$$$20240814$$HP$US$US
242094252$24209425$2$F$$20240808$20240814$20240823$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462382$RANBAXY$$$$$F$Y$$$20240823$$MD$GB$GB
242094261$24209426$1$I$$20240730$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459120$RANBAXY$Inoue F, Okazaki Y, Ichiba T, Chiba T, Namera A. Giant T waves and QT interval prolongation associated with guanfacine toxicity. Clin Toxicol (Phila). 2024;62 (4):269-271$21$YR$$F$Y$$$20240814$$HP$JP$JP
242094271$24209427$1$I$$20240731$20240814$20240814$EXP$$PE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460475$RANBAXY$Quiroz-A J, Durand-V M, Gamarra-O E, Zavaleta-A S, Zavaleta-A A, Rodr?guez-R J, et al.. Diagnostic role of tomography in addison^s disease due to adrenal tuberculosis: A case report. Endocr Metab Immune Disord Drug Targets. 2024;Jul 23$37$YR$$F$Y$$$20240814$$HP$PE$PE
242094281$24209428$1$I$$20240731$20240814$20240814$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462479$RANBAXY$Karafyllis I, Nuoffer J-M, Michelis J-P, Chilver-Stainer L. Untreated Classic Galactosemia: A Rare Cause of Adult-Onset Progressive Cerebellar Ataxia -A Case Report. Case Rep Neurol. 2024;16(1):55-62$39$YR$$F$Y$$$20240814$$HP$CH$CH
242094291$24209429$1$I$20240801$20240813$20240813$20240813$DIR$714039$$FDA-CTU$$$$$F$N$$$20240813$N$CN$US$
242094301$24209430$1$I$$20240731$20240814$20240814$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462383$RANBAXY$De Torres MV, Naranjo-Velasco V, Moreno IS. DERMATOMYOSITIS, WHAT TO LOOK FOR AND UNTIL WHEN?. Eur J Case Rep Intern Med. 2023;10 (Suppl.):564-565$60$YR$$F$Y$$$20240814$$HP$ES$ES
242094312$24209431$2$F$$20240808$20240814$20240823$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462385$RANBAXY$$$$$F$Y$$$20240823$$MD$GB$GB
242094321$24209432$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462452$RANBAXY$Attieh RM, Brumble L, Elwasila SM, Wadei HM. Disseminated Monkeypox Infection in a Kidney Transplant Recipient: ACase Report. Transplant-Proc. 2023;55 (3):667-671$44$YR$$M$Y$$$20240814$$HP$US$US
242094331$24209433$1$I$$20240731$20240814$20240814$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462365$RANBAXY$Aleksandrova N, De Rop J, Camu F, Hubloue I, Devue K. A diagnostic dilemma: distinguishing a sulfasalazine induced DRESS hypersensitivity syndrome from a CD30 + lymphoma in a young patient. Int J Emerg Med. 2024;17 (1):1-7$26$YR$$M$Y$$$20240814$$HP$BE$BE
242094341$24209434$1$I$20240704$20240813$20240813$20240813$DIR$714127$$FDA-CTU$$65$YR$$M$N$121.5$KG$20240813$N$CN$US$
242094351$24209435$1$I$20240813$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55678$$FDA-CTU$$60$YR$$F$N$$$20240813$Y$PH$US$
242094361$24209436$1$I$20240813$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55666$$FDA-CTU$$73$YR$$M$N$$$20240813$Y$HP$US$
242094371$24209437$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462456$RANBAXY$El Labban M, Oluic S, Guleid H, Hassan M, Diab R, Rida MA. Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination. Eur J Case Rep Intern Med. 2024;11 (7):1-3$72$YR$$M$Y$$$20240814$$HP$US$US
242094381$24209438$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462202$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$40$YR$$F$Y$$$20240814$$HP$DK$DK
242094391$24209439$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462427$RANBAXY$Cabanilla MG, Shald EA, Hlavacek NL, Bernauer ML, Sosa NR.. Breaking the mold: Insights into the clinical management and outcomes of rhinocerebral mucormycosis in adults. IDCases. 2024;37 (0)$$$A$$Y$$$20240814$$HP$US$US
242094411$24209441$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462185$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$25$YR$$M$Y$$$20240814$$HP$DK$DK
242094421$24209442$1$I$20240813$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55656$$FDA-CTU$$69$YR$$F$N$$$20240813$Y$PH$US$
242094431$24209443$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462428$RANBAXY$Cabanilla MG, Shald EA, Hlavacek NL, Bernauer ML, Sosa NR.. Breaking the mold: Insights into the clinical management and outcomes of rhinocerebral mucormycosis in adults. IDCases. 2024;37 (0)$$$A$$Y$$$20240814$$HP$US$US
242094441$24209444$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462459$RANBAXY$Mansour M, Mohamed A, Zalt M. A very rare case of an immunocompetent patient with concomitant M avium complex, M. abscessus, and M. shimoidei lung infection. Am J Respir Crit Care Med. 2024;209 (0):A6295$58$YR$$F$Y$$$20240814$$HP$US$US
242094451$24209445$1$I$$20240730$20240814$20240814$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462246$RANBAXY$Seltzer J, Schneir A. Case Files from the University of California San Diego Medical Toxicology Fellowship: Neonatal Flecainide Toxicity from an Accidental Dosing Error. J Med Toxicol. 2024;20(3):314-323$22$DY$$M$Y$3.65$KG$20240814$$HP$CA$CA
242094461$24209446$1$I$$20240731$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462551$RANBAXY$Kasahara S, Kanda S, Takahashi M, Fujioka M, Morita T, Matsudaira K, et al.. Case Report Guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder. Frontiers in Pediatrics. 2023;11:no pagination$15$YR$$F$Y$42.9$KG$20240814$$HP$JP$JP
242094471$24209447$1$I$$20240731$20240814$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462505$RANBAXY$$32$YR$$F$Y$$$20240814$$MD$GB$GB
242094481$24209448$1$I$$20240731$20240814$20240814$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462411$RANBAXY$Rodella L, Pegorin D, Rosati R, Raffo M, Vizzardi E, Metra M. Intramyocardial abscess and endoventricular thrombosis: a complex case. Int J case Cardiovasc Imaging. 2024;40:1597-1603$57$YR$$M$Y$$$20240814$$HP$IT$IT
242094492$24209449$2$F$$20240809$20240814$20240821$EXP$$JP-Accord-440937$ACCORD$Omiya A, Nitta S, Kandori S, Takahashi R, Chihara I, Shiga M, et al. Combination Chemotherapy With TS-1 and Cisplatin for Urinary Adenocarcinoma: A Retrospective Case Series. Clin Genitourin Cancer. 2024 Jul 3;22(5):102149.$$$$$Y$$$20240821$$HP$JP$JP
242094501$24209450$1$I$20240802$20240803$20240814$20240814$EXP$$US-Accord-440569$ACCORD$$72$YR$E$M$Y$$$20240814$$PH$US$US
242094511$24209451$1$I$20240515$20240802$20240814$20240814$EXP$$US-Accord-440587$ACCORD$$57$YR$A$F$Y$$$20240814$$HP$US$US
242094521$24209452$1$I$$20240802$20240814$20240814$EXP$AU-TGA-809569$AU-Accord-439878$ACCORD$$$$$$Y$$$20240814$$HP$AU$AU
242094531$24209453$1$I$$20240803$20240814$20240814$EXP$CA-MHPD-001086645$CA-Accord-440530$ACCORD$$40$YR$A$F$Y$230$KG$20240814$$CN$CA$CA
242094541$24209454$1$I$20240730$20240802$20240814$20240814$EXP$$US-Accord-440367$ACCORD$$49$YR$A$M$Y$$$20240814$$HP$US$US
242094551$24209455$1$I$$20240804$20240814$20240814$EXP$$FR-Accord-440492$ACCORD$Fidan I, Delamotte E, Colombier M, Agossa K. Non-surgical Treatment of Severe Drug-Influenced Gingival Enlargement: A Report of Two Cases. Cureus. 2024;16(6):e63214.$58$YR$A$M$Y$$$20240814$$MD$FR$FR
242094561$24209456$1$I$$20240804$20240814$20240814$EXP$$TW-Accord-440910$ACCORD$Su CS, Kao CL. Stevens-Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report. Journal of medical case reports. 2024;18(1):344.$82$YR$E$F$Y$$$20240814$$PH$TW$TW
242094572$24209457$2$F$20240701$20240807$20240814$20240919$EXP$$US-Accord-440437$ACCORD$$73$YR$E$F$Y$$$20240919$$HP$US$US
242094581$24209458$1$I$$20240802$20240814$20240814$EXP$AU-TGA-806926$AU-Accord-439831$ACCORD$$73$YR$E$M$Y$$$20240814$$HP$AU$AU
242094591$24209459$1$I$$20240812$20240814$20240814$EXP$$CA-PFIZER INC-202400234961$PFIZER$$53$YR$$F$Y$59$KG$20240814$$HP$CA$CA
242094601$24209460$1$I$20240712$20240805$20240814$20240814$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006416$AURINIA PHARMACEUTICALS$$36$YR$$F$Y$$$20240814$$MD$US$US
242094611$24209461$1$I$20240101$20240805$20240814$20240814$EXP$$US-UNITED THERAPEUTICS-UNT-2024-002412$UNITED THERAPEUTICS$$$$$F$Y$78.005$KG$20240814$$$US$US
242094621$24209462$1$I$$20240808$20240814$20240814$PER$$US-JNJFOC-20240827669$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240814$$HP$US$US
242094631$24209463$1$I$$20240805$20240814$20240814$EXP$$US-RDY-LIT/USA/24/0011749$DR REDDYS$Petras JK, Elrod MG, Ty MC, Dawson P, O^Laughlin K, Gee JE, et al. Locally Acquired Melioidosis Linked to Environment - Mississippi, 2020-2023. New England Journal of Medicine. 2023 Dec 21;389: 2355-2362. doi:10.1056/NEJMoa2306448.$62$YR$A$M$Y$$$20240814$$HP$US$US
242094643$24209464$3$F$20240807$20240816$20240814$20240827$EXP$$US-SA-2024SA236234$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240827$$HP$US$US
242094651$24209465$1$I$$20240730$20240814$20240814$EXP$$US-GLANDPHARMA-US-2024GLNLIT00612$GLAND PHARMA$Shane W. Quo.SIGNIFICANT ESOPHAGEAL AND INTESTIINAL ULCERATIONS IN THE SETTING OF RECENT CHEMOTHERAPY FOR PANCREATIC ADENOCARCINOMA.Gastroenterology.MAY-2023;164 (No. 6):S-1209-S-1210$72$YR$E$M$Y$$$20240814$$HP$US$US
242094661$24209466$1$I$20231117$20240805$20240814$20240814$EXP$$US-CHIESI-2024CHF04961$CHIESI$$11$YR$$M$Y$$$20240814$$MD$US$US
242094671$24209467$1$I$$20240807$20240814$20240814$EXP$$BR-NOVITIUMPHARMA-2024BRNVP01574$NOVITIUM PHARMA$Gabriele da Silva.NEFROPATIA POR POLIOMAVIRUS BK EM ENXERTO RENAL.The Brazilian Journal of Infectious Diseases.OCT-2023;27(1):1-5$51$YR$A$M$Y$$$20240814$$HP$BR$BR
242094681$24209468$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232253$TEVA$$76$YR$$M$Y$80$KG$20240814$$HP$CA$CA
242094691$24209469$1$I$$20240807$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045010$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240814$$CN$US$US
242094702$24209470$2$F$$20240802$20240814$20240816$EXP$$US-BAYER-2024A112787$BAYER$$62$YR$A$M$Y$$$20240816$$CN$US$US
242094721$24209472$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462189$RANBAXY$Maloney N, Novoa R, Yeh JE. Chronic ulcer in a patient with essential thrombocythemia taking hydroxyurea. Dermatol Online J. 2024;May-Jun;30 (3):1-3$82$YR$$F$Y$$$20240814$$MD$US$US
242094731$24209473$1$I$$20240730$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462114$RANBAXY$Qin Y, Lu S, Chen J, Peng J, Yang J. Case report: A rare case of anti-PD-1 sintilimab-induced agranulocytosis/severe neutropenia in non-small cell lung cancer and literature review. Front Oncol. 2024;14:1415748$68$YR$$M$Y$$$20240814$$HP$CN$CN
242094741$24209474$1$I$20240703$20240808$20240814$20240814$EXP$CH-SM-2024-14939$CH-MYLANLABS-2024M1075015$MYLAN$$76$YR$$F$Y$93$KG$20240814$$HP$CH$CH
242094751$24209475$1$I$20240101$20240808$20240814$20240814$EXP$$US-MYLANLABS-2024M1074540$MYLAN$$$$$F$Y$$$20240814$$CN$US$US
242094761$24209476$1$I$$20240808$20240814$20240814$EXP$$CZ-MYLANLABS-2024M1075260$MYLAN$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study. Neoplasma. 2017;64(5):762-9$58$YR$$F$Y$$$20240814$$HP$CZ$CZ
242094771$24209477$1$I$20230101$20240808$20240814$20240814$EXP$FR-AFSSAPS-RS2024000776$FR-MYLANLABS-2024M1074546$MYLAN$$70$YR$$F$Y$71$KG$20240814$$MD$FR$FR
242094781$24209478$1$I$$20240731$20240814$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462369$RANBAXY$$86$YR$$M$Y$$$20240814$$PH$GB$GB
242094791$24209479$1$I$20240701$20240731$20240814$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462145$RANBAXY$$69$YR$E$F$Y$$$20240814$$CN$GB$GB
242094801$24209480$1$I$$20240730$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462130$RANBAXY$Sada I, Harada Y, Hiyama T, Mizukami M, Kan T, Kawai M, et al. Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma. Melanoma Res. 2023;33 (6):539-546$39$YR$$M$Y$$$20240814$$HP$JP$JP
242094811$24209481$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462207$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$54$YR$$M$Y$$$20240814$$HP$DK$DK
242094821$24209482$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462540$RANBAXY$Joffe D, Rohan TZ, Mandel J, Suriano J, Banner L, Valiga A, et al. The development of 2 clonally and histologically distinct subtypes of extranodal B-cell lymphomas in the brain and skin in 1 individual. JAAD Case Rep. 2024;49 (0):51-54$61$YR$$M$Y$$$20240814$$HP$US$US
242094831$24209483$1$I$$20240730$20240814$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462253$RANBAXY$$37$YR$$F$Y$75$KG$20240814$$MD$GB$GB
242094841$24209484$1$I$$20240730$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462234$RANBAXY$Azuma N, Natsuaki M, Hashimoto N, Abe T, Ueda S, Ohno Y, et al. Efficacy of anifrolumab in long-term intractable alopecia due to discoid lupus erythematosus. Mod Rheumatol Case Rep. 2024;8 (2):267?271$27$YR$$F$Y$$$20240814$$HP$JP$JP
242094851$24209485$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462451$RANBAXY$Zick JL, Wichser L. Idiopathic catatonic syndrome in a young male with no prior psychiatric history: a case report. Journal of Medical Case Reports. 2023;17 (1):199$20$YR$$M$Y$$$20240814$$HP$US$US
242094861$24209486$1$I$$20240730$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462217$RANBAXY$Jia D, Zhang F, Li H, Shen Y, Jin Z, Shi FD, et al. Responsiveness to Tocilizumab in Anti-Acetylcholine Receptor-Positive Generalized Myasthenia Gravis. Aging  Dis. 2024;Apr; 15(2):824-830$61$YR$$M$Y$$$20240814$$HP$CN$CN
242094871$24209487$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462198$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$30$YR$$M$Y$$$20240814$$HP$DK$DK
242094881$24209488$1$I$$20240730$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462135$RANBAXY$Sada I, Harada Y, Hiyama T, Mizukami M, Kan T, Kawai M, et al. Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma. Melanoma Res. 2023;33 (6):539-546$79$YR$$F$Y$$$20240814$$HP$JP$JP
242094891$24209489$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461089$RANBAXY$$$$E$F$Y$$$20240814$$HP$US$US
242094901$24209490$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462196$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$45$YR$$M$Y$$$20240814$$HP$DK$DK
242094911$24209491$1$I$$20240731$20240814$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462149$RANBAXY$$$$$F$Y$$$20240814$$CN$GB$GB
242094921$24209492$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462211$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$51$YR$$M$Y$$$20240814$$HP$DK$DK
242094931$24209493$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462210$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$34$YR$$M$Y$$$20240814$$HP$DK$DK
242094941$24209494$1$I$$20240730$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459020$RANBAXY$Inoue F, Okazaki Y, Ichiba T, Chiba T, Namera A. Giant T waves and QT interval prolongation associated with guanfacine toxicity. Clin Toxicol (Phila). 2024;62 (4):269-271$51$YR$$M$Y$$$20240814$$HP$JP$JP
242094951$24209495$1$I$$20240731$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462493$RANBAXY$Wang Y-D, Yuan S, Wen C, Ji Z, Xiang B, Wang B, et al. Immune checkpoint inhibitor-related chronic pneumonitis: a case report and literature review. Immunotherapy. 2023;Jul;15(14):1117-1123$54$YR$$M$Y$$$20240814$$HP$CN$CN
242094961$24209496$1$I$$20240730$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462338$RANBAXY$Chalker C, Yilmaz B, Trone K, Parecki G, Chen A, Lim JY, et al. Use of PSMAPET/CTtodetectprostate cancer metastatic to a preexisting thyroid nodule. NPJ Precis Oncol. 2024;8 (1):1-6$70$YR$$M$Y$$$20240814$$HP$US$US
242094971$24209497$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462203$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$25$YR$$M$Y$$$20240814$$HP$DK$DK
242094981$24209498$1$I$20240726$20240730$20240814$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462255$RANBAXY$$29$YR$$F$Y$78$KG$20240814$$MD$GB$GB
242094991$24209499$1$I$$20240730$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462129$RANBAXY$Miyake M, Shimizu T, Oda Y, Tachibana A, Ohmori C, Itami Y, et al. Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study. Jpn J Clin Oncol. 2023;53(3):253-262$79$YR$$M$Y$$$20240814$$HP$JP$JP
242095001$24209500$1$I$$20240730$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462174$RANBAXY$Zhang X, Aoun B. A DEADLY FORM OF DELIRIUM. Eur j Case Rep Intern Med. 2019;6 (Suppl.):373/34$62$YR$$F$Y$$$20240814$$HP$US$US
242095011$24209501$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462177$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$53$YR$$M$Y$$$20240814$$HP$DK$DK
242095021$24209502$1$I$$20240730$20240814$20240814$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462186$RANBAXY$Steentoft A, Linnet K. Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. Forensic Sci Int. 2009;184:74-79$32$YR$$M$Y$$$20240814$$HP$DK$DK
242095031$24209503$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024161215$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242095041$24209504$1$I$$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024161760$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242095061$24209506$1$I$$20240808$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006454$ELI LILLY AND CO$$$$$M$Y$$$20240814$$CN$US$US
242095072$24209507$2$F$$20240819$20240814$20240823$EXP$$JP-GILEAD-2024-0683869$GILEAD$$82$YR$E$F$Y$$$20240823$$PH$JP$JP
242095081$24209508$1$I$$20240813$20240814$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA072394$SANDOZ$$62$YR$$M$Y$$$20240814$$HP$CA$CA
242095091$24209509$1$I$$20240808$20240814$20240814$EXP$$LB-UCBSA-2024040218$UCB$Jomaa N, Nasreddine W, Hmeimess G, Beaini S, Beydoun A, Hotait M, et al. Risk of recurrence in patients with an unprovoked tonic?clonic seizure and generalized epileptiform discharges on EEG. Epilepsia. 2023;64:2153-61$$$$$Y$$$20240814$$HP$LB$LB
242095101$24209510$1$I$20240725$20240808$20240814$20240814$EXP$$US-EXELIXIS-CABO-24080375$EXELIXIS$$62$YR$$F$Y$$$20240814$$PH$US$US
242095111$24209511$1$I$$20240806$20240814$20240814$PER$$US-ALXN-202408USA000395US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242095131$24209513$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA238673$SANOFI AVENTIS$$66$YR$E$F$Y$58.967$KG$20240814$$MD$US$US
242095151$24209515$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127760$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240814$$HP$US$US
242095161$24209516$1$I$20240709$20240807$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126362$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240814$$CN$US$US
242095171$24209517$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA234167$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240814$$MD$US$US
242095181$24209518$1$I$20240203$20240806$20240814$20240814$EXP$FR-AFSSAPS-PV2024000698$FR-TEVA-VS-3230860$TEVA$$12$YR$$F$Y$48$KG$20240814$$MD$FR$FR
242095191$24209519$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA238459$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240814$$MD$US$US
242095223$24209522$3$F$20240601$20240821$20240814$20240829$EXP$$US-BIOGEN-2024BI01278029$BIOGEN$$76$YR$$F$Y$$$20240828$$CN$US$US
242095231$24209523$1$I$20240101$20240807$20240814$20240814$EXP$$US-AMGEN-USASP2024157884$AMGEN$$$$$M$Y$$$20240814$$PH$US$US
242095241$24209524$1$I$$20240726$20240814$20240814$PER$$US-AMGEN-USASP2024157408$AMGEN$$67$YR$E$F$Y$49.433$KG$20240814$$CN$US$US
242095251$24209525$1$I$$20240813$20240813$20240813$DIR$714024$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242095261$24209526$1$I$$20240730$20240814$20240814$EXP$$US-GLANDPHARMA-US-2024GLNLIT00598$GLAND PHARMA$IJ Robertson.Case of metastatic clear cell odontogenic carcinoma with response to chemoimmunotherapy.BMJ Case Reports.APR-2024;17 No.4:1-4$8$DEC$E$F$Y$$$20240814$$HP$US$US
242095271$24209527$1$I$$20240808$20240814$20240814$EXP$$US-AstraZeneca-2024A181592$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242095282$24209528$2$F$20240101$20240813$20240814$20240827$EXP$$US-UCBSA-2024033803$UCB$$$$$F$Y$87$KG$20240827$$HP$US$US
242095291$24209529$1$I$$20240802$20240814$20240814$EXP$$GB-AstraZeneca-2024A184409$ASTRAZENECA$$52$YR$$M$Y$$$20240814$$CN$DE$
242095301$24209530$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A178958$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242095311$24209531$1$I$$20240806$20240814$20240814$EXP$$LB-MYLANLABS-2024M1074841$MYLAN$Nasrallah OG, Fawaz MW, Mahdi JH, Armache AK, El Sayegh N, Nasr RW. Peno-scrotal metastasis of colorectal adenocarcinoma: A case report and review of the literature. Int-J-Surg-Case-Rep 2024; 122.$68$YR$$M$Y$$$20240814$$HP$LB$LB
242095321$24209532$1$I$$20240806$20240814$20240814$EXP$$GB-MYLANLABS-2024M1074826$MYLAN$Santarsieri A, Bennett R, Hopkins D, Lewis KL, Gyansah CN, Cooke L, et al. R-DA-EPOCH Treatment Is Highly Effective Therapy for Primary Mediastinal Large B-Cell Lymphoma: A Real-World Multi-Centre Retrospective Evaluation. Blood 2022; 140 (Suppl. 1) 9551-9553.$$$A$$Y$$$20240814$$HP$GB$GB
242095332$24209533$2$F$$20240819$20240814$20240823$EXP$$US-MYLANLABS-2024M1074731$MYLAN$Lee IJ, Pulido JS, Regillo CD, Leys M. Multiple organ dysfunction syndrome and disseminated intravascular coagulation causing extensive multiple amalric triangular choroidal infarctions. Retin-Cases-Brief-Rep 2024; 18 (2): 251-254.$49$YR$$F$Y$$$20240823$$MD$US$US
242095341$24209534$1$I$$20240806$20240814$20240814$EXP$$GR-MYLANLABS-2024M1074400$MYLAN$Tzikopoulou M, Sanos C, Margaritis D, Tsekou Y, Papathanasiou E, Anagnostopoulou V, et al. Escherichia coli lower limb cellulitis after bacteremia with underlying solid organ malignancy: a case report. Eur-J-Case-Rep-Intern-Med 2023; 10 (Suppl.) 349-350 abstr. 753.$72$YR$$F$Y$$$20240814$$HP$GR$GR
242095351$24209535$1$I$$20240806$20240814$20240814$EXP$$US-MYLANLABS-2024M1074352$MYLAN$Marmol S, Beltre N, Margolesky J. Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT): A Preventable Cerebellar Disorder. Cerebellum 2024; 23 (4): 1733-1735.$60$YR$$M$Y$$$20240814$$HP$US$US
242095361$24209536$1$I$$20240806$20240814$20240814$EXP$$US-MYLANLABS-2024M1074770$MYLAN$Murphy M, Jones K, Ruebner RL, Raabe E. Acute Onset of Abdominal Pain in a 3-year-old Boy with Acute Lymphoblastic Leukemia. Pediatr-Rev 2023; 44 (Suppl. 1) S106-S109.$3$YR$$M$Y$$$20240814$$MD$US$US
242095371$24209537$1$I$$20240806$20240814$20240814$EXP$$CN-MYLANLABS-2024M1074939$MYLAN$Liu C, Ma C, Hao Y. Fondaparinux Results in Similar Pregnancy Outcomes with Lower Adverse Reaction Rates Compared to Low Molecular Weight Heparin in Chinese Recurrent Miscarriage Women.. The Tohoku Journal of Experimental Medicine.. 2024;262(2):125-131$$$$F$Y$$$20240814$$HP$CN$CN
242095381$24209538$1$I$$20240806$20240814$20240814$PER$$US-ABBVIE-5872249$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242095391$24209539$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232386$TEVA$$$$$F$Y$$$20240814$$MD$CA$CA
242095401$24209540$1$I$20240628$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408051635370580-RMKZV$GB-TEVA-VS-3230339$TEVA$$68$YR$$F$Y$62$KG$20240814$$MD$GB$GB
242095414$24209541$4$F$20240803$20240904$20240814$20240907$PER$$US-AMGEN-USASP2024161497$AMGEN$$73$YR$E$F$Y$$$20240907$$CN$US$US
242095422$24209542$2$F$20240601$20240909$20240814$20240911$EXP$$CA-TAKEDA-2024TUS040912$TAKEDA$$42$YR$$F$Y$$$20240911$$CN$CA$CA
242095431$24209543$1$I$$20240809$20240814$20240814$EXP$$CA-TAKEDA-2024TUS080496$TAKEDA$$$$$F$Y$$$20240814$$MD$CA$CA
242095441$24209544$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232352$TEVA$$$$$F$Y$$$20240814$$MD$CA$CA
242095451$24209545$1$I$20240723$20240723$20240814$20240814$PER$$US-CSL-2024-007261$CSL Plasma$$29$YR$$M$Y$$$20240814$$HP$US$US
242095461$24209546$1$I$$20240808$20240814$20240814$PER$$US-JNJFOC-20240821476$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$MD$US$US
242095471$24209547$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232110$TEVA$$18$YR$$F$Y$53$KG$20240814$$PH$CA$CA
242095481$24209548$1$I$$20240813$20240814$20240814$PER$$NVSC2024US165063$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242095491$24209549$1$I$$20240812$20240814$20240814$EXP$$NVSC2024US164303$NOVARTIS$$28$YR$$F$Y$$$20240814$$CN$US$US
242095501$24209550$1$I$$20240811$20240814$20240814$EXP$$PL-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00422$VELOXIS PHARMACEUTICALS$Maciej S, Hanna A-B, Letachowicz K, Dorota K, Miroslaw B, Oktawia M, et al.. Severe Bullous Erysipelas/Cellulitis, atypically caused by Escherichia coli, in kidney transplant recipient - case report and review of literature.. Transplant-Proc. 2024;56 (4):976-980$57$YR$$F$Y$$$20240814$$HP$PL$PL
242095511$24209551$1$I$$20240805$20240814$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127847$BRISTOL MYERS SQUIBB$Sato I, et al. A case of carcinomatous pericarditis during the course of treatment of acute myeloid leukemia that transferred from secondary myelofibrosis. The 21st Kanto Koshinetsu Regional Meeting of the Japanese Society of Hematology.$56$YR$A$M$Y$$$20240814$$HP$JP$JP
242095522$24209552$2$F$$20240819$20240814$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128286$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240822$$HP$US$US
242095531$24209553$1$I$$20240806$20240814$20240814$EXP$$US-MYLANLABS-2024M1074857$MYLAN$Jodeh W, Sparks PJ, Higgins JM, Tom A, Anilovich N, Moit H, et al. Parathyroid hormone-related peptide induced hypercalcemia of pregnancy due to mammary hyperplasia. JBMR-Plus 2024; 8 (8):.$39$YR$$F$Y$$$20240814$$MD$US$US
242095541$24209554$1$I$$20240730$20240814$20240814$PER$$US-TEVA-VS-3229753$TEVA$$47$YR$$M$Y$$$20240814$$CN$US$US
242095551$24209555$1$I$$20240730$20240814$20240814$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00595$GLAND PHARMA$$63$YR$A$M$Y$$$20240814$$MD$JP$JP
242095561$24209556$1$I$$20240806$20240814$20240814$EXP$$DE-TAKEDA-2024TUS079075$TAKEDA$$50$YR$$M$Y$$$20240814$$CN$DE$DE
242095571$24209557$1$I$$20240807$20240814$20240814$EXP$$TR-NOVITIUMPHARMA-2024TRNVP01580$NOVITIUM PHARMA$Ahmet Murt.Chronic Myeloid Leukemia in Renal Transplantation Patients in the Era of Tyrosine Kinase Inhibitors: A Case Report and Review of the Literature.Nephron.04-APR-2024;NA:563-568$63$YR$A$F$Y$$$20240814$$HP$TR$TR
242095581$24209558$1$I$$20240812$20240814$20240814$EXP$$IN-PFIZER INC-PV202400105223$PFIZER$Behera, J.. A Study On Prevalence, Severity Scoring and Causality Assessment of Adverse Drug Reactions in Pediatric Patients. European Journal of Cardiovascular Medicine. 2023;13 (4):720-732$11$YR$$F$Y$$$20240814$$HP$IN$IN
242095592$24209559$2$F$$20240815$20240814$20240819$EXP$$DE-PFIZER INC-202400233698$PFIZER$F. Knorr. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica. 2023;108:1442-1446$15$YR$$M$Y$$$20240819$$MD$DE$DE
242095601$24209560$1$I$$20240805$20240814$20240814$EXP$$DE-PFIZER INC-202400233695$PFIZER$F. Knorr. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica. 2023;108:1442-1446$4$YR$$F$Y$$$20240814$$MD$DE$DE
242095611$24209561$1$I$$20240805$20240814$20240814$EXP$$DE-PFIZER INC-202400233694$PFIZER$F. Knorr. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica. 2023;108:1442-1446$10$YR$$F$Y$$$20240814$$MD$DE$DE
242095621$24209562$1$I$20240728$20240812$20240814$20240814$EXP$$CN-PFIZER INC-PV202400104900$PFIZER$$22$YR$$M$Y$52$KG$20240814$$HP$CN$CN
242095632$24209563$2$F$$20240812$20240814$20240820$EXP$$US-PFIZER INC-PV202400105014$PFIZER$El-Ghoubaira, J.. Retrospective study of ivosidenib for patients with recurrent IDH mutant gliomas. Journal of Clinical Oncology. 2024;42(16 Suppl):2040-2040$$$A$$Y$$$20240820$$HP$US$US
242095641$24209564$1$I$20240810$20240813$20240813$20240813$DIR$714147$$FDA-CTU$$$$$UNK$N$$$20240813$Y$$US$
242095651$24209565$1$I$$20240805$20240814$20240814$EXP$$DE-PFIZER INC-202400233696$PFIZER$F. Knorr. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica. 2023;108:1442-1446$11$YR$$M$Y$$$20240814$$MD$DE$DE
242095661$24209566$1$I$$20240805$20240814$20240814$EXP$$DE-PFIZER INC-202400233691$PFIZER$F. Knorr. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica. 2023;108:1442-1446$7$YR$$M$Y$$$20240814$$MD$DE$DE
242095671$24209567$1$I$$20240813$20240814$20240814$EXP$$CN-PFIZER INC-PV202400105167$PFIZER$$$$A$F$Y$$$20240814$$CN$CN$CN
242095681$24209568$1$I$20240709$20240813$20240814$20240814$EXP$IT-MINISAL02-998702$IT-PFIZER INC-202400235548$PFIZER$$66$YR$$M$Y$85$KG$20240814$$MD$IT$IT
242095691$24209569$1$I$20240101$20240805$20240814$20240814$EXP$$BR-BAYER-2024A113520$BAYER$$39$YR$A$F$Y$$$20240814$$CN$BR$BR
242095701$24209570$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232370$TEVA$$55$YR$$M$Y$$$20240814$$CN$CA$CA
242095721$24209572$1$I$$20240806$20240814$20240814$30DAY$$US-VEROBIOTECH-2024USVEROSPO00177$VERO BIOTECH$$$$N$M$Y$$$20240814$$HP$US$US
242095731$24209573$1$I$20170427$20240731$20240814$20240814$EXP$$GB-TEVA-VS-3228588$TEVA$$68$YR$$F$Y$54$KG$20240814$$MD$GB$GB
242095741$24209574$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128704$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240814$$CN$US$US
242095751$24209575$1$I$$20240716$20240814$20240814$30DAY$$US-VEROBIOTECH-2024USVEROSPO00179$VERO BIOTECH$$$$$$Y$$$20240814$$HP$US$US
242095761$24209576$1$I$$20240802$20240814$20240814$EXP$$NL-MYLANLABS-2024M1073856$MYLAN$Hutten EM, Roeloffzen WW, Lambeck AJ, van den Born-Bondt T, Oude Elberink HN, van de VenAAJ. Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization. J-Investig-Allergol-Clin-Immunol 2024; 34 (3): 214-216.$52$YR$$F$Y$$$20240814$$HP$NL$NL
242095772$24209577$2$F$$20240813$20240814$20240820$EXP$$US-GILEAD-2024-0682682$GILEAD$$$$A$F$Y$$$20240820$$PH$US$US
242095781$24209578$1$I$20240809$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160109$AMGEN$$32$YR$A$M$Y$$$20240814$$CN$US$US
242095791$24209579$1$I$$20240808$20240814$20240814$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099268$VIIV$$$$$$Y$$$20240814$$PH$US$US
242095801$24209580$1$I$$20240813$20240814$20240814$PER$$NVSC2024US165059$NOVARTIS$$$$$$Y$$$20240814$$MD$US$US
242095822$24209582$2$F$$20240913$20240814$20240913$30DAY$$US-PFIZER INC-202400232372$PFIZER$$13$YR$$M$Y$$$20240913$$CN$US$US
242095834$24209583$4$F$20240801$20240919$20240814$20240923$30DAY$$US-PFIZER INC-202400232438$PFIZER$$15$YR$$M$Y$$$20240923$$CN$US$US
242095841$24209584$1$I$$20240805$20240814$20240814$30DAY$$US-PFIZER INC-202400230622$PFIZER$$14$YR$$M$Y$$$20240814$$CN$US$US
242095852$24209585$2$F$$20240913$20240814$20240913$30DAY$$US-PFIZER INC-202400231532$PFIZER$$10$YR$$F$Y$$$20240913$$CN$US$US
242095861$24209586$1$I$$20240802$20240814$20240814$30DAY$$US-PFIZER INC-PV202400101463$PFIZER$$56$YR$$F$Y$$$20240814$$PH$US$US
242095872$24209587$2$F$$20240919$20240814$20240919$30DAY$$GB-PFIZER INC-202400230286$PFIZER$$$$$$Y$$$20240919$$CN$GB$GB
242095884$24209588$4$F$$20240921$20240814$20240923$30DAY$$US-PFIZER INC-202400232451$PFIZER$$14$YR$$M$Y$$$20240923$$CN$US$US
242095891$24209589$1$I$20240806$20240806$20240814$20240814$PER$$US-ABBVIE-5870766$ABBVIE$$29$YR$$F$Y$$$20240814$$CN$US$US
242095902$24209590$2$F$20240701$20240813$20240814$20240820$PER$$US-AMGEN-USASP2024161219$AMGEN$$21$YR$A$M$Y$$$20240819$$HP$US$US
242095911$24209591$1$I$$20240809$20240814$20240814$EXP$$IT-AMGEN-ITASP2024159316$AMGEN$Sacca F.; Pane C.; Stefano V. D. et al.. A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients. Journal of Neurology. 2024;1-11$$$A$$Y$$$20240814$$HP$IT$IT
242095921$24209592$1$I$$20240813$20240814$20240814$PER$$US-AMGEN-USASP2024161263$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242095931$24209593$1$I$$20240718$20240814$20240814$30DAY$$US-VEROBIOTECH-2024USVEROSPO00180$VERO BIOTECH$$$$$$Y$$$20240814$$HP$US$US
242095951$24209595$1$I$20240101$20240808$20240814$20240814$EXP$$US-ABBVIE-5873947$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242095961$24209596$1$I$$20240806$20240814$20240814$EXP$$BR-TAKEDA-2024TUS080088$TAKEDA$$$$$$Y$$$20240814$$CN$BR$BR
242095971$24209597$1$I$$20240722$20240814$20240814$PER$$US-AMGEN-USASP2024159214$AMGEN$$$$$$Y$$$20240814$$CN$US$US
242095982$24209598$2$F$$20240816$20240814$20240823$EXP$$DE-JNJFOC-20240832156$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240823$$MD$DE$DE
242095991$24209599$1$I$$20240812$20240814$20240814$EXP$$US-JNJFOC-20240830211$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242096002$24209600$2$F$20240803$20240827$20240814$20240830$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004436$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240830$$CN$US$US
242096011$24209601$1$I$$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127923$BRISTOL MYERS SQUIBB$$102$YR$E$F$Y$$$20240814$$CN$US$US
242096021$24209602$1$I$$20240730$20240814$20240814$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00596$GLAND PHARMA$$88$YR$E$M$Y$$$20240814$$MD$JP$JP
242096032$24209603$2$F$20231201$20240821$20240814$20240826$EXP$$NVSC2024GT052507$NOVARTIS$$45$YR$$F$Y$54.422$KG$20240826$$CN$GT$GT
242096041$24209604$1$I$20240805$20240809$20240814$20240814$EXP$$CN-TAKEDA-2024TUS080389$TAKEDA$$49$YR$$F$Y$55$KG$20240814$$HP$CN$CN
242096051$24209605$1$I$$20240808$20240814$20240814$EXP$$AZ-UCBSA-2024040332$UCB$Shahla M, Aytan M.. Clinical characteristics, seizure control, and delivery outcomes in pregnant women with focal and generalized epilepsies. Seizure: European Journal of Epilepsy. 2024;117:67-74$$$I$$Y$$$20240814$$HP$AZ$AZ
242096061$24209606$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007334$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240814$$CN$US$US
242096072$24209607$2$F$20240804$20240806$20240814$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408004426$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240816$$CN$US$US
242096081$24209608$1$I$$20240801$20240814$20240814$EXP$$PL-AUROBINDO-AUR-APL-2024-039323$AUROBINDO$Marta Molska, Marta Ziembicka, Micha? D. Siwek. 16 years old girl with  infective endocarditis. Forum Medycyny Rodzinnej (FORUM FAMILY MEDICINE). 2024;18:95-101$16$YR$$F$Y$$$20240814$$HP$PL$PL
242096091$24209609$1$I$$20240806$20240814$20240814$EXP$$GR-MYLANLABS-2024M1074213$MYLAN$Romiou A, Zacharakis D, Zografou A, Panagiotou L, Paraskevi Panoilia M, Sason R, et al. A case of tissierella praeacuta bacteremia secondary to surgical repair of clavicle fracture. Eur-J-Case-Rep-Intern-Med 2023; 10 (Suppl. 1) 339 abstr. 728.$38$YR$$F$Y$$$20240814$$HP$GR$GR
242096101$24209610$1$I$$20240802$20240814$20240814$EXP$AU-TGA-807805$AU-Accord-439860$ACCORD$$$$$M$Y$$$20240814$$HP$AU$AU
242096111$24209611$1$I$$20240804$20240814$20240814$EXP$$US-Accord-440622$ACCORD$Manuel SL, Sapone J, Lin F. Tacrolimus-Induced Recurrent Acute Coronary Syndrome Due to an Unknown Mechanism. Cureus. 2024 Jun 27;16(6):e63266.$74$YR$E$F$Y$$$20240814$$HP$US$US
242096121$24209612$1$I$20240614$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408051235400280-NKCHF$GB-Accord-440406$ACCORD$$56$YR$A$F$Y$$$20240814$$PH$GB$GB
242096131$24209613$1$I$$20240803$20240814$20240814$EXP$CA-MHPD-E2B_07127691$CA-Accord-440535$ACCORD$$80$YR$E$F$Y$$$20240814$$MD$CA$CA
242096141$24209614$1$I$20220101$20240804$20240814$20240814$EXP$$CN-Accord-440645$ACCORD$Zhang HW, Yu HB. Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case. Front Oncol. 2024 Jul 15;14:1428370. doi: 10.3389/fonc.2024.1428370.$51$YR$A$F$Y$$$20240814$$HP$CN$CN
242096151$24209615$1$I$$20240803$20240814$20240814$EXP$GB-MHRA-MED-202408031106086060-QNTZV$GB-Accord-440254$ACCORD$$26$YR$A$F$Y$$$20240814$$CN$GB$GB
242096161$24209616$1$I$20240724$20240802$20240814$20240814$EXP$$US-Accord-440767$ACCORD$$34$YR$A$M$Y$$$20240814$$HP$US$US
242096171$24209617$1$I$20240802$20240803$20240814$20240814$EXP$$US-Accord-440627$ACCORD$$31$YR$A$F$Y$$$20240814$$PH$US$US
242096181$24209618$1$I$20240726$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408051140567160-HBMFC$GB-Accord-440400$ACCORD$$33$YR$A$M$Y$$$20240814$$PH$GB$GB
242096192$24209619$2$F$20240725$20240814$20240814$20240827$EXP$$US-Accord-440365$ACCORD$$59$YR$A$M$Y$$$20240824$$HP$US$US
242096201$24209620$1$I$20240101$20240621$20240814$20240814$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000086$UROGEN PHARMA$$$$$$Y$$$20240814$$CN$US$US
242096211$24209621$1$I$$20240808$20240814$20240814$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004441$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240814$$CN$US$US
242096221$24209622$1$I$$20240807$20240814$20240814$EXP$$MX-NOVITIUMPHARMA-2024MXNVP01588$NOVITIUM PHARMA$Alfredo Fonseca-Chavez.WCN24-2640 HISTOLOGICAL TRANSITION IN LUPUS PODOCYTOPATHY: REPORT OF TWO CASES.Kidney International Reports.APR-2024;9 (4):S197$32$YR$A$M$Y$$$20240814$$HP$MX$MX
242096231$24209623$1$I$$20240730$20240814$20240814$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00599$GLAND PHARMA$Y Kita.Fanconi syndrome with karyomegalic interstitial nephritis after ifosfamide treatment for osteosarcoma: a case report.CEN Case Reports .JAN-2024$18$YR$A$M$Y$$$20240814$$HP$JP$JP
242096241$24209624$1$I$$20240809$20240814$20240814$EXP$$NVSC2024US163308$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
242096252$24209625$2$F$$20240827$20240814$20240909$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-24595$SAMSUNG BIOEPIS$$72$YR$E$F$Y$$$20240909$$CN$CA$CA
242096261$24209626$1$I$$20240807$20240814$20240814$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24360$SAMSUNG BIOEPIS$$62$YR$A$F$Y$$$20240814$$CN$GB$GB
242096271$24209627$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462703$RANBAXY$Singh A, Chidharla A, Jain N, Debnath N, Dawoodi I, Kukreja G. IgD Multiple Myeloma, Does It Still Have a Poor Prognosis?.. Blood. 2022;140 (Suppl.):12520/652$63$YR$$F$Y$$$20240814$$HP$US$US
242096281$24209628$1$I$$20240731$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462564$RANBAXY$Kakeshita K, Imamura T, Noguchi A, Murai S, Fujioka H, Yamazaki H, et al. Nephrotic syndrome induced by aortic regurgitation with Takayasu arteritis: an autopsy case with long-term clinical followup. CEN Case Rep. 2024;13 (3):154-160$55$YR$$F$Y$51.8$KG$20240814$$HP$JP$JP
242096291$24209629$1$I$$20240730$20240814$20240814$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462562$RANBAXY$Yang J, McCarthy J, Shah SS, Ng E, Shen J, Libianto R. Challenges in Diagnosing and Managing the Spectrum of Primary Aldosteronism. J Endocr Soc. 2024;8(7):no pagination$56$YR$$F$Y$$$20240814$$HP$AU$AU
242096301$24209630$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461906$RANBAXY$Pinchman E, Moore A, Barrett L, Pianka JP, Bhullar R. Buprenorphine Microinduction to Mitigate Withdrawal Symptoms During Abrupt Discontinuation of Intrathecal Fentanyl: A Case Report. Pain Med Case Rep. 2024;8 (1):13-15$56$YR$$F$Y$$$20240814$$HP$US$US
242096311$24209631$1$I$$20240730$20240814$20240814$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462565$RANBAXY$Yang J, McCarthy J, Shah SS, Ng E, Shen J, Libianto R. Challenges in Diagnosing and Managing the Spectrum of Primary Aldosteronism. J Endocr Soc. 2024;8(7):no pagination$77$YR$$M$Y$$$20240814$$HP$AU$AU
242096321$24209632$1$I$$20240730$20240814$20240814$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462555$RANBAXY$Yang J, McCarthy J, Shah SS, Ng E, Shen J, Libianto R. Challenges in Diagnosing and Managing the Spectrum of Primary Aldosteronism. J Endocr Soc. 2024;8(7):no pagination$48$YR$$M$Y$$$20240814$$HP$AU$AU
242096331$24209633$1$I$$20240731$20240814$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462623$RANBAXY$$$$$M$Y$$$20240814$$CN$GB$GB
242096341$24209634$1$I$$20240806$20240814$20240814$EXP$NL-LRB-00993530$NL-TEVA-VS-3231385$TEVA$$58$YR$$F$Y$77$KG$20240814$$PH$NL$NL
242096351$24209635$1$I$20231101$20240808$20240814$20240814$EXP$FR-AFSSAPS-NC2024000957$FR-EXELIXIS-CABO-24080475$EXELIXIS$$52$YR$$M$Y$70$KG$20240814$$MD$FR$FR
242096372$24209637$2$F$$20240830$20240814$20240830$PER$$US-ALXN-202408USA000626US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242096381$24209638$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039653$AUROBINDO$$73$YR$$F$Y$$$20240814$$PH$CA$CA
242096391$24209639$1$I$$20240731$20240814$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462691$RANBAXY$Cimen SS, Yucel E, Suleyman A. Hypersensitivity to Ibuprofen: Real-Life Experience in Children With History of Suspected Immediate Reactions. Int Arch Allergy Immunol. 2023;184(1):33-42$$$C$$Y$$$20240814$$HP$GB$GB
242096401$24209640$1$I$$20240731$20240814$20240814$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462682$RANBAXY$Mhiri M, Dhia RB, Dridi F, Gouta N, Frih-Ayed M. Immune Reconstitution Inflammatory Syndrome After Fingolimod Cessation. Mult Scler Relat Dis. 2023;80(0):60$51$YR$$F$Y$$$20240814$$HP$TN$TN
242096411$24209641$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462661$RANBAXY$Stark AI, Ricaurte-Fajardo JS, Shuaibi SN, Manasrah M, Velez J, Lukitsch I. Phospholipase A2 receptor-positive membranous nephropathyafter the use of tiopronin in a patient with cystinuria. A case report and review of the literature. Am J Med Sci. 2024;367 (Suppl.):S312 (521)$45$YR$$F$Y$$$20240814$$HP$US$US
242096422$24209642$2$F$$20240802$20240814$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462688$RANBAXY$Proute M, Haynes T, Fishberg R, Ohonba N. Rethinking Prevention: Need for earlier intervention in Familial Hypercholesteremia despite Statin and PCSK9 Inhibitor Therapy. J Clin Lipidol. 2024;18(Suppl.) (4):e543;210$47$YR$$M$Y$$$20240816$$MD$US$US
242096431$24209643$1$I$$20240731$20240814$20240814$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459552$RANBAXY$Cimen SS, Yucel E, Suleyman A. Hypersensitivity to Ibuprofen: Real-Life Experience in Children With History of Suspected Immediate Reactions. Int Arch Allergy Immunol. 2023;184(1):33-42$$$C$$Y$$$20240814$$HP$GB$GB
242096441$24209644$1$I$$20240731$20240814$20240814$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463005$RANBAXY$Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports. J Pediatr Hematol Oncol. 2024;Aug; 46 (6):e439-e442$13$YR$$M$Y$$$20240814$$MD$IT$IT
242096451$24209645$1$I$$20240731$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462668$RANBAXY$Xiong W, Yang Z, Chen Y. Sintilimab induced severe erosive hemorrhagic gastritis and pyloric obstruction: a case report and literature review. Immunotherapy. 2024;16 (8):513-519$29$YR$$M$Y$$$20240814$$HP$CN$CN
242096461$24209646$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55662$$FDA-CTU$$58$YR$$F$N$$$20240813$N$$US$
242096471$24209647$1$I$$20240731$20240814$20240814$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462685$RANBAXY$Koizumi S, Doi R, Aitake U, Lei X, Izumi T, Mori T, et al. Unfavorable efficacy of pembrolizumab for advanced extramammary Paget^s disease with high tumor mutation burden after failure of taxane-based regimens. J Dermatol. 2024;51(6):e203-e204$74$YR$$M$Y$$$20240814$$HP$JP$JP
242096481$24209648$1$I$$20240731$20240814$20240814$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462855$RANBAXY$Wang H, Wang Z, Wang Z, Li X, Li Y, Yan N, et al. Decitabine induces IRF7-mediated immune responses in p53-mutated triple-negative breast cancer: a clinical and translational study. Front Med. 2024;18(2):357-374$$$$F$Y$$$20240814$$HP$CN$CN
242096491$24209649$1$I$$20240731$20240814$20240814$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462580$RANBAXY$Rogers KA, Zhao Q, Bhat SA, Byrd JC, Grantier C, Grever MR, et al. Extended Follow-up of a Phase 2 Study of Early Intervention with Lenalidomide in Patients with High Risk Chronic Lymphocytic Leukemia. Blood. 2023;Nov;142 (Suppl):3272 (642)$$$$M$Y$$$20240814$$MD$US$US
242096501$24209650$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55727$$FDA-CTU$$77$YR$$F$N$$$20240813$N$$US$
242096511$24209651$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55643$$FDA-CTU$$12$YR$$F$N$$$20240813$N$$US$
242096522$24209652$2$F$$20240802$20240814$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462690$RANBAXY$Proute M, Haynes T, Fishberg R, Ohonba N. Rethinking Prevention: Need for earlier intervention in Familial Hypercholesteremia despite Statin and PCSK9 Inhibitor Therapy. J Clin Lipidol. 2024;18(Suppl.) (4):e543;210$49$YR$$M$Y$$$20240816$$MD$US$US
242096532$24209653$2$F$$20240826$20240814$20240902$EXP$NL-LRB-00993461$NL-TEVA-VS-3231842$TEVA$$69$YR$$F$Y$44$KG$20240902$$MD$NL$NL
242096541$24209654$1$I$20240730$20240812$20240814$20240814$EXP$$CN-TAKEDA-2024TUS081171$TAKEDA$$56$YR$$F$Y$62$KG$20240814$$HP$CN$CN
242096552$24209655$2$F$$20240920$20240814$20240927$EXP$$JP-AMGEN-JPNSP2024157851$AMGEN$$$$$M$Y$$$20240927$$PH$JP$JP
242096561$24209656$1$I$20240101$20240808$20240814$20240814$EXP$$JP-OTSUKA-2024_019647$OTSUKA$$84$YR$$F$Y$$$20240814$$MD$JP$JP
242096571$24209657$1$I$$20240813$20240814$20240814$PER$$US-TAKEDA-2024TUS081374$TAKEDA$$$$$$Y$$$20240814$$CN$US$US
242096601$24209660$1$I$20240810$20240810$20240814$20240814$EXP$GB-MHRA-MED-202408101450059480-VLMWT$GB-MYLANLABS-2024M1074745$MYLAN$$59$YR$$M$Y$$$20240814$$CN$GB$GB
242096611$24209661$1$I$20230801$20240813$20240814$20240814$EXP$$DE-ROCHE-3502078$ROCHE$$27$YR$A$F$Y$61$KG$20240814$$MD$DE$DE
242096621$24209662$1$I$$20240801$20240814$20240814$EXP$$IE-ROCHE-10000047999$ROCHE$$$$$$Y$$$20240814$$MD$IE$IE
242096631$24209663$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039648$AUROBINDO$$31$YR$$F$Y$60$KG$20240814$$HP$CA$CA
242096641$24209664$1$I$$20240808$20240814$20240814$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004442$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240814$$CN$US$US
242096651$24209665$1$I$$20240807$20240814$20240814$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01590$NOVITIUM PHARMA$Kenta Hayashino.Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified.Journal of Clinical and Experimental Hematopathology.28-MAR-2024;64(1):52-58$52$YR$A$M$Y$$$20240814$$HP$JP$JP
242096671$24209667$1$I$20240101$20240812$20240814$20240814$EXP$$CA-UCBSA-2024001114$UCB$$19$YR$$F$Y$$$20240814$$CN$CA$CA
242096681$24209668$1$I$$20240730$20240814$20240814$EXP$$KR-GLANDPHARMA-KR-2024GLNLIT00597$GLAND PHARMA$JH Yi.Real-world outcome of patients with extensively pretreated multiple myeloma who were treated with selinexor and dexamethasone: a Korean multicenter retrospective analysis.Annals of Hematology.JUL-2024;103 (No. 7):2365-2372$$$$$Y$$$20240814$$HP$KR$KR
242096691$24209669$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-040189$AUROBINDO$$68$YR$$F$Y$68$KG$20240814$$PH$CA$CA
242096701$24209670$1$I$20240715$20240807$20240814$20240814$EXP$$CN-009507513-2408CHN003399$MERCK$$76$YR$$M$Y$75$KG$20240814$$HP$CN$CN
242096711$24209671$1$I$20240701$20240805$20240814$20240814$EXP$$ZA-INDIVIOR EUROPE LIMITED-INDV-146234-2024$RECKITT BENCKISER$$$$$$Y$$$20240814$$CN$ZA$ZA
242096721$24209672$1$I$20240706$20240803$20240814$20240814$EXP$$CN-ROCHE-10000049130$ROCHE$$60$YR$A$M$Y$$$20240814$$CN$CN$CN
242096742$24209674$2$F$20240808$20240815$20240814$20240821$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004445$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240821$$CN$US$US
242096751$24209675$1$I$20191016$20240809$20240814$20240814$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024954$UNITED THERAPEUTICS$$84$YR$$F$Y$72.562$KG$20240814$$$US$US
242096761$24209676$1$I$20230912$20240812$20240814$20240814$EXP$$FR-GILEAD-2024-0684005$GILEAD$$1$DY$N$F$Y$$$20240814$$MD$FR$FR
242096772$24209677$2$F$$20240823$20240814$20240830$EXP$$JP-EMD Serono-2024042704$EMD SERONO INC$$85$YR$E$F$Y$42$KG$20240829$$MD$JP$JP
242096781$24209678$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191875$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242096791$24209679$1$I$$20240730$20240814$20240814$EXP$$KR-GLANDPHARMA-KR-2024GLNLIT00621$GLAND PHARMA$JH Yi.Real-world outcome of patients with extensively pretreated multiple myeloma who were treated with selinexor and dexamethasone: a Korean multicenter retrospective analysis.Annals of Hematology.JUL-2024;103(7):2365-2372$$$$$Y$$$20240814$$HP$KR$KR
242096801$24209680$1$I$$20240806$20240814$20240814$EXP$$US-BAYER-2024A113508$BAYER$$52$YR$A$F$Y$$$20240814$$MD$US$US
242096812$24209681$2$F$$20240920$20240814$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-040220$AUROBINDO$Poirier CM, Carter AA, Kwan Y, Koo J, Westlund JM, Alkass F, et al.. Experiences of patients with  atrial fibrillation with combination antithrombotic therapy post-percutaneous coronary  intervention. CJC Open. 2023;5:846-58$86$YR$$M$Y$$$20240928$$HP$CA$CA
242096821$24209682$1$I$$20240812$20240814$20240814$EXP$$US-GILEAD-2024-0678313$GILEAD$$$$E$F$Y$$$20240814$$CN$US$US
242096832$24209683$2$F$$20240906$20240814$20240906$PER$$US-ALXN-202408USA000528US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242096841$24209684$1$I$20240627$20240803$20240814$20240814$EXP$$US-Accord-440571$ACCORD$$32$YR$A$M$Y$$$20240814$$HP$US$US
242096851$24209685$1$I$$20240805$20240814$20240814$30DAY$$US-GSK-US2024098152$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
242096861$24209686$1$I$$20240802$20240814$20240814$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024100172$VIIV$$$$T$$Y$$$20240814$$MD$US$US
242096871$24209687$1$I$20240801$20240809$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126916$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$62.14$KG$20240814$$HP$US$US
242096882$24209688$2$F$20240806$20240903$20240814$20240904$EXP$$JP-009507513-2408JPN000794J$MERCK$$75$YR$$M$Y$$$20240904$$MD$JP$JP
242096892$24209689$2$F$$20240913$20240814$20240913$30DAY$$US-PFIZER INC-202400233482$PFIZER$$10$YR$$M$Y$$$20240913$$CN$US$US
242096911$24209691$1$I$$20240730$20240814$20240814$EXP$$US-GLANDPHARMA-US-2024GLNLIT00607$GLAND PHARMA$Kyle T O Meara.Acute hypoxic respiratory failure due to Lenalidomide induced interstitial  pneumonitis in a patient with multiple myeloma.BMC Pulmonary Medicine.04-JUL-2024;24(321):1-5$80$YR$E$M$Y$$$20240814$$HP$US$US
242096931$24209693$1$I$20240812$20240813$20240814$20240814$EXP$$CN-GILEAD-2024-0683960$GILEAD$$61$YR$A$F$Y$60$KG$20240814$$HP$CN$CN
242096941$24209694$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191951$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242096952$24209695$2$F$20240813$20240814$20240814$20240819$PER$$US-AMGEN-USASP2024161141$AMGEN$$69$YR$E$F$Y$$$20240819$$CN$US$US
242096961$24209696$1$I$$20240808$20240814$20240814$EXP$$TW-AMGEN-TWNSP2024159241$AMGEN$Tsuang F.; Huang A.; Yang C. et al.. Spinal metastases from non-small cell lung cancer: Is surgical extent enough by following suggestions of the Tomita and Tokuhashi scores?. Asian Journal of Surgery. 2024;47 (8):3448-3456$$$$$Y$$$20240814$$HP$TW$TW
242096971$24209697$1$I$20240801$20240813$20240814$20240814$PER$$US-BAUSCH-BL-2024-012305$BAUSCH AND LOMB$$$$$F$Y$$$20240814$$CN$US$US
242096981$24209698$1$I$20240804$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55668$$FDA-CTU$$76$YR$$M$N$$$20240813$Y$PH$US$
242096991$24209699$1$I$$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55741$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242097001$24209700$1$I$20240101$20240808$20240814$20240814$EXP$$JP-SA-2024SA236531$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240814$$MD$JP$JP
242097011$24209701$1$I$$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55653$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242097021$24209702$1$I$$20240809$20240814$20240814$EXP$$KR-SA-2024SA239949$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$CN$KR$KR
242097031$24209703$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55648$$FDA-CTU$$61$YR$$M$N$101.6$KG$20240813$N$$US$
242097043$24209704$3$F$20240101$20240905$20240814$20240906$EXP$$US-SA-2024SA239899$SANOFI AVENTIS$$90$YR$E$M$Y$$$20240906$$MD$US$US
242097061$24209706$1$I$$20240812$20240814$20240814$PER$$US-BAUSCH-BL-2024-012249$BAUSCH AND LOMB$$$$$M$Y$$$20240814$$CN$US$US
242097081$24209708$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA240840$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240814$$MD$US$US
242097091$24209709$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA239696$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$CN$US$US
242097101$24209710$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA235377$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240814$$HP$US$US
242097111$24209711$1$I$20240101$20240808$20240814$20240814$PER$$US-SA-2024SA239435$SANOFI AVENTIS$$$$$F$Y$$$20240814$$CN$US$US
242097121$24209712$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA239731$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$CN$US$US
242097141$24209714$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA239022$SANOFI AVENTIS$$49$YR$A$F$Y$122.47$KG$20240814$$MD$US$US
242097151$24209715$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA239456$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240814$$MD$US$US
242097161$24209716$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA239442$SANOFI AVENTIS$$59$YR$A$F$Y$99.79$KG$20240814$$MD$US$US
242097171$24209717$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA240819$SANOFI AVENTIS$$61$YR$A$M$Y$77.11$KG$20240814$$MD$US$US
242097181$24209718$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA240845$SANOFI AVENTIS$$$$C$F$Y$$$20240814$$MD$US$US
242097191$24209719$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA237721$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240814$$MD$US$US
242097201$24209720$1$I$20240101$20240808$20240814$20240814$PER$$US-SA-2024SA117221$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240814$$MD$US$US
242097211$24209721$1$I$20240801$20240808$20240814$20240814$PER$$US-SA-2024SA239879$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240814$$MD$US$US
242097221$24209722$1$I$$20240731$20240814$20240814$PER$$US-SA-2024SA147045$SANOFI AVENTIS$$$$T$M$Y$$$20240814$$MD$US$US
242097231$24209723$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA238639$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$CN$US$US
242097243$24209724$3$F$20240101$20240828$20240814$20240904$EXP$$PR-KARYOPHARM-2024KPT001415$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240904$$CN$PR$PR
242097252$24209725$2$F$20240720$20240827$20240814$20240911$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-461564$RANBAXY$$70$YR$$M$Y$$$20240911$$MD$NO$NO
242097261$24209726$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179926$ASTRAZENECA$$$$$F$Y$77.1$KG$20240814$$CN$US$
242097271$24209727$1$I$$20240730$20240814$20240814$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00622$GLAND PHARMA$Liang J.Combined Use of Emapalumab With Ruxolitinib and Dexamethasone as an Effective Treatment for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Complicated With Multiorgan Damage and Severe Infection. Journal of Pediatric Hematology/Oncology.JUL-2024;46(5):e360-e362$8$YR$C$F$Y$$$20240814$$HP$CN$CN
242097281$24209728$1$I$20240812$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007667$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240814$$CN$US$US
242097291$24209729$1$I$$20240813$20240814$20240814$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045591$BOEHRINGER INGELHEIM$$38$YR$A$F$Y$$$20240814$$PH$CA$CA
242097301$24209730$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007341$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240814$$CN$US$US
242097311$24209731$1$I$20240812$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007354$ELI LILLY AND CO$$$$$M$Y$$$20240814$$CN$US$US
242097321$24209732$1$I$20240812$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007628$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240814$$CN$US$US
242097332$24209733$2$F$20240801$20240827$20240814$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408007826$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240902$$CN$US$US
242097341$24209734$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55686$$FDA-CTU$$61$YR$$F$N$$$20240813$N$$US$
242097351$24209735$1$I$$20240813$20240813$20240813$DIR$714020$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242097381$24209738$1$I$20240727$20240812$20240814$20240814$EXP$FR-AFSSAPS-RS2024000793$FR-PFIZER INC-202400234430$PFIZER$$19$YR$$M$Y$54$KG$20240814$$MD$FR$FR
242097391$24209739$1$I$20240806$20240813$20240814$20240814$EXP$GB-MHRA-MED-202408131347092120-CKMTR$GB-PFIZER INC-202400235672$PFIZER$$68$YR$$F$Y$$$20240814$$HP$GB$GB
242097401$24209740$1$I$20240321$20240812$20240814$20240814$EXP$IT-MINISAL02-998284$IT-PFIZER INC-202400234204$PFIZER$$75$YR$$F$Y$65$KG$20240814$$PH$IT$IT
242097411$24209741$1$I$20240215$20240812$20240814$20240814$EXP$FR-AFSSAPS-RE2024000781$FR-PFIZER INC-202400234448$PFIZER$$54$YR$$F$Y$67$KG$20240814$$MD$FR$FR
242097421$24209742$1$I$20240727$20240812$20240814$20240814$EXP$$US-PFIZER INC-PV202400104837$PFIZER$$83$YR$$M$Y$$$20240814$$HP$US$US
242097431$24209743$1$I$20240727$20240812$20240814$20240814$EXP$$CN-PFIZER INC-PV202400104877$PFIZER$$60$YR$$F$Y$57$KG$20240814$$HP$CN$CN
242097451$24209745$1$I$$20240813$20240814$20240814$EXP$$US-PFIZER INC-202400236031$PFIZER$$59$YR$$M$Y$$$20240814$$CN$US$US
242097462$24209746$2$F$$20240920$20240814$20240924$30DAY$$US-PFIZER INC-202400233314$PFIZER$$15$YR$$M$Y$68.04$KG$20240924$$CN$US$US
242097471$24209747$1$I$$20240812$20240814$20240814$EXP$$DO-PFIZER INC-202400235768$PFIZER$$78$YR$$M$Y$$$20240814$$CN$DO$DO
242097492$24209749$2$F$20240201$20240905$20240814$20240909$EXP$$CA-PFIZER INC-PV202400105361$PFIZER$$65$YR$$F$Y$$$20240909$$HP$CA$CA
242097501$24209750$1$I$$20240812$20240814$20240814$EXP$$US-PFIZER INC-PV202400105150$PFIZER$$65$YR$$F$Y$$$20240814$$HP$US$US
242097511$24209751$1$I$20240808$20240813$20240814$20240814$EXP$$CN-PFIZER INC-PV202400105454$PFIZER$$20$YR$$F$Y$83$KG$20240814$$HP$CN$CN
242097522$24209752$2$F$20240101$20240923$20240814$20240925$EXP$$DE-PFIZER INC-202400234459$PFIZER$$74$YR$$M$Y$86$KG$20240925$$PH$DE$CH
242097541$24209754$1$I$20240724$20240812$20240814$20240814$EXP$ES-AEMPS-1559081$ES-PFIZER INC-202400234347$PFIZER$$4$YR$$F$Y$$$20240814$$PH$ES$ES
242097551$24209755$1$I$$20240805$20240814$20240814$PER$$US-TEVA-VS-3231287$TEVA$$69$YR$$F$Y$$$20240814$$HP$US$US
242097561$24209756$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191925$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242097571$24209757$1$I$20210909$20240801$20240814$20240814$EXP$$GB-PFIZER INC-202400233460$PFIZER$Benjamin, A.. Disseminated Mycobacterium abscessus with bone and central nervous system (CNS) involvement - a case report and review of the literature. Clinical Infection in Practice. 2024;23:10.1016/j.clinpr.2024.100372$64$YR$$M$Y$$$20240814$$MD$GB$GB
242097611$24209761$1$I$20240701$20240806$20240814$20240814$PER$$US-SA-2024SA237474$SANOFI AVENTIS$$9$YR$C$M$Y$24.94$KG$20240814$$MD$US$US
242097621$24209762$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA236560$SANOFI AVENTIS$$$$A$F$Y$49.89$KG$20240814$$MD$US$US
242097631$24209763$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA237092$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240814$$CN$US$US
242097642$24209764$2$F$20240101$20240807$20240814$20240819$PER$$US-SA-2024SA239800$SANOFI AVENTIS$$$$A$M$Y$107.95$KG$20240819$$CN$US$US
242097651$24209765$1$I$20240805$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55682$$FDA-CTU$$45$YR$$F$N$59$KG$20240813$N$$US$
242097661$24209766$1$I$20240803$20240806$20240814$20240814$PER$$US-AMGEN-USASP2024161385$AMGEN$$81$YR$E$F$Y$$$20240814$$CN$US$US
242097671$24209767$1$I$20240813$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55657$$FDA-CTU$$86$YR$$F$N$$$20240813$Y$PH$US$
242097691$24209769$1$I$20240813$20240813$20240813$20240813$DIR$714158$$FDA-CTU$$37$YR$$F$N$122.85$KG$20240813$N$CN$US$
242097701$24209770$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164546$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
242097711$24209771$1$I$$20240805$20240814$20240814$EXP$$JP-ROCHE-10000053278$ROCHE$Tokuyama H. O-4 A case in which muscle haemorrhage was caused by drug-induced hypofibrinogenaemia after administration of tocilizumab. The 8th Annual Local Meeting of Kyushu Branch, the Japanese Society of Intensive. 2024;41$73$YR$E$M$Y$$$20240814$$MD$JP$JP
242097721$24209772$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55654$$FDA-CTU$$80$YR$$F$N$$$20240813$N$$US$
242097731$24209773$1$I$20240101$20240813$20240814$20240814$EXP$FR-AFSSAPS-BR2024000672$FR-ORGANON-O2408FRA000971$ORGANON$$82$YR$$F$Y$61$KG$20240814$$MD$FR$FR
242097741$24209774$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039639$AUROBINDO$$50$YR$$F$Y$$$20240814$$HP$CA$CA
242097752$24209775$2$F$$20240813$20240814$20240819$EXP$$IE-MYLANLABS-2019M1108143$MYLAN$Grady CO, Awdeh F, Gilhooley E, MacMahon J, Salim A, Connolly M et al.. Vulval Crohn disease: a therapeutic challenge. British Association of Dermatologists. 2019;181 (Suppl S1):49$$$$F$Y$$$20240819$$HP$IE$IE
242097762$24209776$2$F$$20240815$20240814$20240820$PER$$US-PFIZER INC-202400233882$PFIZER$$67$YR$$F$Y$$$20240820$$CN$US$US
242097771$24209777$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-202400233812$PFIZER$$80$YR$$F$Y$$$20240814$$CN$US$US
242097781$24209778$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-PV202300164639$PFIZER$$79$YR$$F$Y$$$20240814$$CN$US$US
242097793$24209779$3$F$$20240913$20240814$20240918$30DAY$$US-PFIZER INC-202400232493$PFIZER$$6$YR$$F$Y$$$20240918$$CN$US$US
242097802$24209780$2$F$$20240913$20240814$20240913$PER$$US-PFIZER INC-PV202300075969$PFIZER$$65$YR$$F$Y$$$20240913$$CN$US$US
242097812$24209781$2$F$20240521$20240916$20240814$20240923$PER$$NVSC2024US160499$NOVARTIS$$65$YR$$F$Y$69$KG$20240923$$HP$US$US
242097822$24209782$2$F$$20240903$20240814$20240912$EXP$$US-Calliditas-2024CAL01114$CALLIDITAS THERAPEUTICS$$64$YR$A$M$Y$$$20240912$$CN$US$US
242097831$24209783$1$I$20240614$20240801$20240814$20240814$PER$$US-Calliditas-2024CAL01143$CALLIDITAS THERAPEUTICS$$35$YR$A$M$Y$104.2$KG$20240814$$CN$US$US
242097841$24209784$1$I$20240101$20240804$20240814$20240814$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15942$IPSEN$$$$$F$Y$$$20240814$$MD$US$US
242097851$24209785$1$I$20221201$20240809$20240814$20240814$EXP$$US-ABBVIE-5859808$ABBVIE$$62$YR$$F$Y$64.863$KG$20240814$$CN$US$US
242097861$24209786$1$I$20240806$20240814$20240814$20240814$EXP$CZ-CZSUKL-24002303$CZ-ROCHE-10000057101$ROCHE$$46$YR$A$F$Y$59$KG$20240814$$MD$CZ$CZ
242097871$24209787$1$I$20240812$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160195$AMGEN$$60$YR$A$F$Y$$$20240814$$CN$US$US
242097881$24209788$1$I$20231101$20240813$20240814$20240814$EXP$$US-UCBSA-2024033979$UCB$$77$YR$$F$Y$$$20240814$$CN$US$US
242097891$24209789$1$I$$20240802$20240814$20240814$EXP$$US-FARMAPROD-202408-2834$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240814$$CN$US$US
242097901$24209790$1$I$20240716$20240716$20240814$20240814$PER$$US-JNJFOC-20240833655$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$HP$US$US
242097921$24209792$1$I$$20240811$20240814$20240814$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-128058$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240814$$HP$TW$TW
242097932$24209793$2$F$$20240909$20240814$20240912$EXP$$CA-SANDOZ INC.-NVSC2019CA037047$SANDOZ$$$$$M$Y$$$20240912$$CN$CA$CA
242097941$24209794$1$I$20240802$20240806$20240814$20240814$EXP$$US-ROCHE-10000050575$ROCHE$$71$YR$E$F$Y$$$20240814$$MD$US$US
242097951$24209795$1$I$$20240810$20240814$20240814$PER$$US-AMGEN-USASP2024159738$AMGEN$$$$A$F$Y$$$20240814$$CN$US$US
242097964$24209796$4$F$20240805$20240826$20240814$20240904$30DAY$$US-ALKERMES INC.-ALK-2024-002056$ALKERMES$$38$YR$$M$Y$104.31$KG$20240904$$HP$US$US
242097971$24209797$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-202400233806$PFIZER$$50$YR$$F$Y$$$20240814$$CN$US$US
242097993$24209799$3$F$$20240912$20240814$20240917$PER$$US-PFIZER INC-PV202400104460$PFIZER$$54$YR$$M$Y$$$20240917$$HP$US$US
242098001$24209800$1$I$$20240808$20240814$20240814$PER$$US-PFIZER INC-202400234022$PFIZER$$65$YR$$F$Y$$$20240814$$HP$US$US
242098011$24209801$1$I$$20240808$20240814$20240814$PER$$US-PFIZER INC-202400236158$PFIZER$$45$YR$$F$Y$$$20240814$$HP$US$US
242098021$24209802$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-202400234146$PFIZER$$39$YR$$M$Y$$$20240814$$HP$US$US
242098032$24209803$2$F$20240722$20240924$20240814$20240927$EXP$$JP-PFIZER INC-PV202400104862$PFIZER$$60$YR$$F$Y$50$KG$20240927$$MD$JP$JP
242098041$24209804$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-202400235082$PFIZER$$61$YR$$F$Y$$$20240814$$HP$US$US
242098051$24209805$1$I$20240707$20240813$20240813$20240813$DIR$714096$$FDA-CTU$$31$YR$$M$N$90$KG$20240813$N$CN$US$
242098062$24209806$2$F$$20240905$20240814$20240909$PER$$US-PFIZER INC-202400233908$PFIZER$$40$YR$$F$Y$$$20240909$$HP$US$US
242098073$24209807$3$F$20231208$20240909$20240814$20240912$EXP$$US-PFIZER INC-202400233834$PFIZER$$77$YR$$F$Y$88.435$KG$20240912$$CN$US$US
242098081$24209808$1$I$$20240808$20240814$20240814$EXP$$CN-PFIZER INC-PV202400103977$PFIZER$Kou, X.. A 48-year-old man with fever, nauseous, vomiting, and dizzy A CARE case report. Medicine. 2024;103(31):e39015$48$YR$$M$Y$$$20240814$$MD$CN$CN
242098091$24209809$1$I$20210101$20240809$20240814$20240814$PER$$US-PFIZER INC-202400235071$PFIZER$$64$YR$$F$Y$$$20240814$$HP$US$US
242098101$24209810$1$I$$20240813$20240814$20240814$EXP$$US-PFIZER INC-202400235989$PFIZER$$$$$F$Y$$$20240814$$CN$US$US
242098112$24209811$2$F$20240701$20240826$20240814$20240829$PER$$US-PFIZER INC-PV202400105274$PFIZER$$45$YR$$F$Y$63.492$KG$20240829$$HP$US$US
242098122$24209812$2$F$$20240905$20240814$20240910$PER$$US-PFIZER INC-202400234045$PFIZER$$69$YR$$M$Y$$$20240910$$CN$US$US
242098131$24209813$1$I$20240101$20240808$20240814$20240814$PER$$US-PFIZER INC-202400234141$PFIZER$$57$YR$$F$Y$$$20240814$$HP$US$US
242098142$24209814$2$F$20150101$20240812$20240814$20240821$EXP$$CN-PFIZER INC-202400233558$PFIZER$Yu, G.. Possible role of a malfunctioning immune system in discordant lymphoma with peripheral T-cell lymphoma secondary to classical Hodgkin lymphoma: A case report.. Oncology Letters. 2024;28(4):10.3892/ol.2024.14583$73$YR$$M$Y$$$20240821$$MD$CN$CN
242098162$24209816$2$F$$20240814$20240814$20240816$PER$$US-HALEON-2191520$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242098172$24209817$2$F$20240709$20240821$20240814$20240827$EXP$$PT-MYLANLABS-2024M1074197$MYLAN$$32$YR$$F$Y$$$20240827$$HP$PT$PT
242098181$24209818$1$I$20240429$20240808$20240814$20240814$EXP$FR-AFSSAPS-AM2024000634$FR-MYLANLABS-2024M1074315$MYLAN$$43$YR$$F$Y$72$KG$20240814$$MD$FR$FR
242098191$24209819$1$I$20240727$20240808$20240814$20240814$EXP$IT-MINISAL02-997704$IT-MYLANLABS-2024M1074295$MYLAN$$12$YR$$M$Y$44$KG$20240814$$MD$IT$IT
242098201$24209820$1$I$20240730$20240808$20240814$20240814$EXP$$GB-MYLANLABS-2024M1074243$MYLAN$$$$$M$Y$$$20240814$$CN$GB$GB
242098222$24209822$2$F$$20240813$20240814$20240819$EXP$$GR-MYLANLABS-2024M1074335$MYLAN$Magaliou S.. Acute renal failure and severe metabolic acidosis induced by metformin and tenofovir. Conference proceedings. 50th Annual Panhellenic Medical Congress. 2024;(301):233-234$74$YR$$M$Y$$$20240819$$MD$GR$GR
242098231$24209823$1$I$20240101$20240808$20240814$20240814$EXP$$US-SA-2024SA238988$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240814$$CN$US$US
242098245$24209824$5$F$20211001$20240925$20240814$20240930$EXP$$PT-JNJFOC-20240813712$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240930$$HP$PT$PT
242098251$24209825$1$I$20240101$20240809$20240814$20240814$EXP$$AU-SA-2024SA240544$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240814$$CN$AU$AU
242098261$24209826$1$I$$20240809$20240814$20240814$PER$$US-ALXN-202408USA000598US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242098271$24209827$1$I$20240809$20240812$20240814$20240814$EXP$$CN-TAKEDA-2024TUS081209$TAKEDA$$72$YR$$M$Y$55$KG$20240814$$HP$CN$CN
242098281$24209828$1$I$$20240801$20240814$20240814$EXP$$BR-AUROBINDO-AUR-APL-2024-040545$AUROBINDO$$$$$$Y$$$20240814$$HP$BR$BR
242098291$24209829$1$I$$20240805$20240814$20240814$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00851$CATALYST PHARMA$$$$$F$Y$$$20240814$$CN$US$US
242098301$24209830$1$I$$20240802$20240814$20240814$EXP$$US-AstraZeneca-2024A177602$ASTRAZENECA$$$$$F$Y$$$20240814$$MD$US$
242098311$24209831$1$I$$20240801$20240814$20240814$EXP$$US-MYLANLABS-2024M1073479$MYLAN$Tseng AM, Heur M, Chiu GB. Sustained descemetocele management with Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) treatment. Am-J-Ophthalmol-Case-Rep 2024; 36 (0):.$56$YR$$M$Y$$$20240814$$HP$US$US
242098321$24209832$1$I$$20240812$20240814$20240814$EXP$$NVSC2024KR164840$NOVARTIS$$$$$F$Y$$$20240814$$MD$KR$KR
242098341$24209834$1$I$$20240808$20240814$20240814$EXP$$US-GSK-US2024099767$GLAXOSMITHKLINE$$$$E$F$Y$$$20240814$$MD$US$US
242098351$24209835$1$I$$20240812$20240814$20240814$PER$$US-BEH-2024177168$CSL BEHRING$$34$YR$A$M$Y$$$20240814$$CN$US$US
242098361$24209836$1$I$20240804$20240805$20240814$20240814$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00852$CATALYST PHARMA$$28$YR$$M$Y$$$20240814$$CN$US$US
242098371$24209837$1$I$20230907$20240807$20240814$20240814$EXP$$NVSC2024IN164981$NOVARTIS$$53$YR$$M$Y$$$20240814$$CN$IN$IN
242098381$24209838$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128526$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240814$$CN$US$US
242098401$24209840$1$I$$20240813$20240814$20240814$PER$$NVSC2024US165115$NOVARTIS$$$$$M$Y$$$20240814$$HP$US$US
242098421$24209842$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007803$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240814$$CN$US$US
242098431$24209843$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007598$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240814$$CN$US$US
242098442$24209844$2$F$$20240815$20240814$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408002071$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240902$$CN$US$US
242098451$24209845$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007374$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240814$$CN$US$US
242098461$24209846$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007263$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242098472$24209847$2$F$20240628$20240823$20240814$20240903$EXP$$DE-JAZZ PHARMACEUTICALS-2024-DE-010816$JAZZ$$$$$$Y$$$20240903$$MD$DE$DE
242098481$24209848$1$I$$20240807$20240814$20240814$EXP$$FR-MYLANLABS-2024M1075199$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$67$YR$$M$Y$$$20240814$$HP$FR$FR
242098491$24209849$1$I$$20240802$20240814$20240814$EXP$$US-MYLANLABS-2024M1073093$MYLAN$Pak WLW, Brumwell NA, Kabel CC, Gutgarts V, Jaffer Sathick I, Mailankody S, et al. Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 Cases. Kidney-Med 2024; 6 (8):.$50$YR$$F$Y$$$20240814$$MD$US$US
242098501$24209850$1$I$20240301$20240808$20240814$20240814$EXP$FR-AFSSAPS-TO2024001445$FR-MYLANLABS-2024M1074073$MYLAN$$98$YR$$F$Y$58.6$KG$20240814$$PH$FR$FR
242098511$24209851$1$I$$20240807$20240814$20240814$EXP$$AU-MYLANLABS-2024M1075096$MYLAN$Adamson A, Michael A, Patel S, Brown M. First case of Drug-Induced Pulmonary Arterial Hypertension: Teriflunomide. Heart-Lung-Circ 2024; 33 (Suppl.) S353.$45$YR$$F$Y$$$20240814$$HP$AU$AU
242098522$24209852$2$F$20230501$20240905$20240814$20240916$EXP$GB-MHRA-31414759$GB-TORRENT-00037550$TORRENT$$$$$F$Y$$$20240916$$CN$GB$GB
242098532$24209853$2$F$$20240821$20240814$20240827$EXP$$IN-TORRENT-00003633$TORRENT$$31$YR$A$M$Y$$$20240827$$CN$IN$IN
242098542$24209854$2$F$$20240829$20240814$20240829$PER$$US-ALXN-202408USA000465US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242098551$24209855$1$I$$20240811$20240814$20240814$EXP$GB-MHRA-MED-202408112206023550-QKDCN$GB-TORRENT-00037568$TORRENT$$2$YR$C$M$Y$$$20240814$$CN$GB$GB
242098561$24209856$1$I$20240729$20240804$20240814$20240814$EXP$GB-MHRA-MED-202408042011333650-DLCHB$GB-Atnahs Limited-ATNAHS20240802270$Atnahs Healthcare$$33$YR$A$F$Y$54$KG$20240814$$CN$GB$GB
242098571$24209857$1$I$20240422$20240806$20240814$20240814$EXP$FR-AFSSAPS-AVMA2024000339$FR-TEVA-VS-3231170$TEVA$$30$YR$$M$Y$$$20240814$$MD$FR$FR
242098581$24209858$1$I$$20230811$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006629$AEGERION$$$$$M$Y$58.957$KG$20240814$$CN$US$US
242098591$24209859$1$I$$20230801$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006617$AEGERION$$$$$F$Y$57.596$KG$20240814$$CN$US$US
242098601$24209860$1$I$$20240813$20240813$20240813$DIR$714098$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242098611$24209861$1$I$$20240119$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006630$AEGERION$$$$$M$Y$89.796$KG$20240814$$CN$US$US
242098621$24209862$1$I$20240307$20240813$20240813$20240813$DIR$714038$$FDA-CTU$$41$YR$$M$N$89.1$KG$20240813$N$CN$US$
242098631$24209863$1$I$$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55732$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242098651$24209865$1$I$$20240805$20240814$20240814$EXP$$US-MYLANLABS-2024M1074711$MYLAN$Srivastava A, Artiles MEJ, Elbanna M, Abu Sheikha M, Parikh V, Feitell S. Cardiogenic Shock: An Unusual Presentation Of Hydralazine-induced Anca-associated Vasculitis. J-Card-Fail 2024; 30 (1): 149-150.$68$YR$$F$Y$$$20240814$$HP$US$US
242098661$24209866$1$I$20240726$20240812$20240814$20240814$EXP$DE-DCGMA-24203746$DE-TORRENT-00027148$TORRENT$$66$YR$E$F$Y$$$20240814$$MD$DE$DE
242098671$24209867$1$I$$20240806$20240814$20240814$EXP$FR-AFSSAPS-MA2024001260$FR-TEVA-VS-3230976$TEVA$$73$YR$$F$Y$$$20240814$$MD$FR$FR
242098681$24209868$1$I$20230301$20240812$20240814$20240814$EXP$DE-CADRBFARM-2024329756$DE-TORRENT-00027147$TORRENT$$28$YR$A$M$Y$86$KG$20240814$$CN$DE$DE
242098691$24209869$1$I$20180101$20240804$20240814$20240814$EXP$$JO-CARNEGIE-000016$Carnegie Pharmaceuticals$$58$YR$A$F$Y$$$20240806$$MD$JO$JO
242098721$24209872$1$I$$20240813$20240813$20240813$DIR$714085$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242098742$24209874$2$F$$20240807$20240814$20240829$EXP$$BR-AMGEN-BRASP2024157379$AMGEN$$71$YR$E$F$Y$$$20240828$$CN$BR$BR
242098751$24209875$1$I$$20230905$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006655$AEGERION$$$$$F$Y$112.47$KG$20240814$$CN$US$US
242098761$24209876$1$I$$20240804$20240814$20240814$EXP$$TW-CARNEGIE-000017$Carnegie Pharmaceuticals$$82$YR$E$F$Y$$$20240806$$PH$TW$TW
242098771$24209877$1$I$$20240804$20240814$20240814$EXP$$TW-VKT-000581$VKT PHARMA PRIVATE LIMITED$$82$YR$E$F$Y$$$20240807$$PH$TW$TW
242098781$24209878$1$I$$20231114$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006769$AEGERION$$$$$F$Y$21.769$KG$20240814$$CN$US$US
242098791$24209879$1$I$$20231009$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006708$AEGERION$$$$$F$Y$51.519$KG$20240814$$CN$US$US
242098801$24209880$1$I$$20240320$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006790$AEGERION$$$$$F$Y$$$20240814$$CN$US$US
242098811$24209881$1$I$$20240118$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006673$AEGERION$$$$$F$Y$37.1$KG$20240814$$CN$US$US
242098821$24209882$1$I$20230101$20240126$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006763$AEGERION$$$$$F$Y$63.492$KG$20240814$$CN$US$US
242098831$24209883$1$I$$20231218$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006816$AEGERION$$$$$M$Y$94.331$KG$20240814$$CN$US$US
242098841$24209884$1$I$$20240806$20240814$20240814$EXP$$CA-TEVA-VS-3231106$TEVA$$53$YR$$M$Y$$$20240814$$HP$CA$CA
242098861$24209886$1$I$$20240812$20240814$20240814$EXP$$US-KYOWAKIRIN-2024KK019118$KYOWA$$$$$$Y$$$20240814$$HP$US$US
242098871$24209887$1$I$$20240110$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006860$AEGERION$$$$$F$Y$81.633$KG$20240814$$CN$US$US
242098881$24209888$1$I$$20240611$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006828$AEGERION$$$$$F$Y$58.05$KG$20240814$$CN$US$US
242098892$24209889$2$F$$20240828$20240814$20240829$PER$$NVSC2024US165023$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242098901$24209890$1$I$20240701$20240808$20240814$20240814$EXP$$NVSC2024AE162459$NOVARTIS$$71$YR$$M$Y$68$KG$20240814$$CN$AE$AE
242098911$24209891$1$I$$20240112$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006842$AEGERION$$$$$M$Y$103.4$KG$20240814$$CN$US$US
242098921$24209892$1$I$$20240509$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006881$AEGERION$$$$$F$Y$$$20240814$$CN$US$US
242098931$24209893$1$I$$20240401$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006979$AEGERION$$$$$F$Y$100.23$KG$20240814$$CN$US$US
242098941$24209894$1$I$$20240111$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006863$AEGERION$$$$$M$Y$67.574$KG$20240814$$CN$US$US
242098951$24209895$1$I$$20240122$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006883$AEGERION$$$$$M$Y$77.098$KG$20240814$$CN$US$US
242098961$24209896$1$I$$20240126$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006888$AEGERION$$$$$F$Y$40.363$KG$20240814$$CN$US$US
242098971$24209897$1$I$$20240607$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006945$AEGERION$$$$$M$Y$$$20240814$$CN$US$US
242098981$24209898$1$I$$20240318$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006929$AEGERION$$$$$M$Y$102.04$KG$20240814$$CN$US$US
242098991$24209899$1$I$20240406$20240411$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR007068$AEGERION$$67$YR$$F$Y$$$20240814$$CN$US$US
242099001$24209900$1$I$$20240801$20240814$20240814$EXP$$CA-AUROBINDO-AUR-APL-2024-039985$AUROBINDO$$86$YR$$M$Y$$$20240814$$PH$CA$CA
242099011$24209901$1$I$$20240318$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR006995$AEGERION$$$$$F$Y$74.83$KG$20240814$$CN$US$US
242099021$24209902$1$I$20240724$20240730$20240814$20240814$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0895$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240813$$MD$US$US
242099032$24209903$2$F$$20240821$20240814$20240826$EXP$$JP-ROCHE-10000054600$ROCHE$Yamato M, Kinoshita M, Miyazawa S, Seki M, Mizuno T, Sonoyama T. Ensitrelvir in patients with SARS-CoV-2: A retrospective chart review. Journal of Infection and Chemotherapy. 2024-Sep;30 (9):946-50. doi:10.1016/j.jiac.2024.02.015.$62$YR$A$F$Y$$$20240826$$HP$JP$JP
242099041$24209904$1$I$$20240809$20240814$20240814$PER$$US-ROCHE-10000054523$ROCHE$$$$E$F$Y$51.25$KG$20240814$$CN$US$US
242099061$24209906$1$I$$20240808$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126310$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240814$$CN$US$US
242099071$24209907$1$I$20240625$20240625$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR007233$AEGERION$$71$YR$$F$Y$$$20240814$$CN$US$US
242099081$24209908$1$I$$20240723$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR007232$AEGERION$$$$$F$Y$$$20240814$$CN$US$US
242099091$24209909$1$I$$20240409$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR007048$AEGERION$$$$$M$Y$61.224$KG$20240814$$CN$US$US
242099101$24209910$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55664$$FDA-CTU$$27$YR$$M$N$$$20240813$N$$US$
242099111$24209911$1$I$$20240730$20240814$20240814$EXP$$IT-GLANDPHARMA-IT-2024GLNLIT00613$GLAND PHARMA$Muggeo P.Combining Brentuximab Vedotin With Dexamethasone, High dose Cytarabine and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma Two Case Reports.Journal of Pediatric Hematology/Oncology.JUN-2024;1-4$15$YR$T$M$Y$$$20240814$$HP$IT$IT
242099121$24209912$1$I$$20240520$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR007166$AEGERION$$$$$F$Y$93.787$KG$20240814$$MD$US$US
242099132$24209913$2$F$20230309$20240903$20240814$20240909$EXP$$CA-TAKEDA-2024TUS046946$TAKEDA$$60$YR$$F$Y$$$20240909$$CN$CA$CA
242099141$24209914$1$I$20240720$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55660$$FDA-CTU$$29$YR$$M$N$$$20240812$N$PH$US$
242099151$24209915$1$I$$20240807$20240814$20240814$EXP$PT-TEVA-VS-3222199$PT-ROCHE-10000053374$ROCHE$Carrilho M, Nobre MB, Santos MC, Silva RC, Martins JR. CO-0062 - (4147) - MYOCARDITIS A CMV .Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts [CNMI]. 2024 May; 162.$72$YR$E$F$Y$$$20240814$$MD$PT$PT
242099161$24209916$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55655$$FDA-CTU$$55$YR$$F$N$$$20240813$N$$US$
242099171$24209917$1$I$$20240730$20240814$20240814$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR007315$AEGERION$$$$$F$Y$83.9$KG$20240814$$CN$US$US
242099182$24209918$2$F$20220701$20240821$20240814$20240823$EXP$$IR-PFIZER INC-202400233668$PFIZER$Nikbin, V.. Failure of ceftazidime/avibactam experimental therapy in the treatment of Klebsiella pneumoniae ST11 co-producing NDM-1 and OXA-48 carbapenemases infection.. European Journal of Clinical Microbiology and Infectious Diseases. 2024;10.1007/s10096-024-04911-x$91$YR$$M$Y$$$20240823$$HP$IR$IR
242099191$24209919$1$I$20240101$20240805$20240814$20240814$EXP$$US-ALKERMES INC.-ALK-2024-002066$ALKERMES$$$$$M$Y$$$20240814$$CN$US$US
242099201$24209920$1$I$20240805$20240805$20240814$20240814$EXP$$US-ALKERMES INC.-ALK-2024-002054$ALKERMES$$38$YR$$M$Y$$$20240814$$HP$US$US
242099211$24209921$1$I$$20240813$20240814$20240814$EXP$$GR-SANDOZ INC.-PHHY2019GR103028$SANDOZ$$82$YR$$M$Y$$$20240814$$MD$GR$GR
242099222$24209922$2$F$20240810$20240814$20240814$20240816$PER$$US-ROCHE-10000056207$ROCHE$$77$YR$E$F$Y$$$20240816$$CN$US$US
242099231$24209923$1$I$$20240802$20240814$20240814$EXP$$IT-CISBIO-2024000508$CURIUM PHARMACEUTICALS$Warmann SW, Lieber J, Schaefer JF, Ebinger M, Urla C, Kirschner HJ, Tsiflikas I, Schmidt A, Fuchs J. Thoracoscopic Resection of Lung Nodules following CT-Guided Labeling in Children and Adolescents with Solid Tumors. Children (Basel). 2023 Mar 12;10(3):542. doi: 10.3390/children10030542.$$$A$$Y$$$20240814$$MD$IT$IT
242099262$24209926$2$F$20240101$20240909$20240814$20240913$EXP$$US-AMGEN-USASL2024160084$AMGEN$$62$YR$A$M$Y$$$20240912$$MD$US$US
242099301$24209930$1$I$20240808$20240808$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126450$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240814$$CN$US$US
242099311$24209931$1$I$$20240809$20240814$20240814$PER$$US-BIOGEN-2024BI01277834$BIOGEN$$$$$F$Y$$$20240814$$CN$US$US
242099321$24209932$1$I$$20240805$20240814$20240814$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007336$AEGERION$$$$$F$Y$$$20240814$$CN$US$US
242099331$24209933$1$I$$20240813$20240814$20240814$PER$$US-TAKEDA-2024TUS081349$TAKEDA$$62$YR$$F$Y$$$20240814$$PH$US$US
242099341$24209934$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024161179$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242099351$24209935$1$I$20240801$20240805$20240814$20240814$EXP$$ES-TEVA-VS-3231463$TEVA$$62$YR$$F$Y$$$20240814$$CN$ES$ES
242099361$24209936$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191955$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242099381$24209938$1$I$20240813$20240813$20240813$20240813$DIR$714051$$FDA-CTU$$6$YR$$F$N$18$KG$20240813$N$$US$
242099391$24209939$1$I$$20240812$20240813$20240813$DIR$FDA-CDER-CTU-2024-55667$$FDA-CTU$$$$$M$N$$$20240812$N$HP$US$
242099401$24209940$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55685$$FDA-CTU$$67$YR$$F$N$220$LBS$20240813$N$$US$
242099411$24209941$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55665$$FDA-CTU$$41$YR$$F$N$$$20240813$N$$US$
242099421$24209942$1$I$20240812$20240813$20240813$20240813$DIR$714045$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242099431$24209943$1$I$$20240813$20240813$20240813$DIR$714084$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242099441$24209944$1$I$$20240806$20240814$20240814$PER$$US-BAYER-2024A113903$BAYER$$$$A$F$Y$$$20240814$$CN$US$US
242099451$24209945$1$I$$20240812$20240814$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA072234$SANDOZ$$85$YR$$F$Y$$$20240814$$CN$CA$CA
242099461$24209946$1$I$20240720$20240807$20240814$20240814$EXP$$PK-ROCHE-10000051818$ROCHE$$64$YR$A$F$Y$$$20240814$$CN$PK$PK
242099471$24209947$1$I$$20240807$20240814$20240814$EXP$$GB-GILEAD-2024-0683670$GILEAD$$$$$M$Y$$$20240814$$HP$GB$GB
242099481$24209948$1$I$20240520$20240521$20240814$20240814$PER$$US-GE HEALTHCARE-2024CSU005526$GE HEALTHCARE$$46$YR$$M$Y$104.31$KG$20240814$$HP$US$US
242099491$24209949$1$I$20240807$20240807$20240814$20240814$EXP$$AU-GE HEALTHCARE-2024CSU009030$GE HEALTHCARE$$74$YR$$M$Y$90$KG$20240814$$HP$AU$AU
242099511$24209951$1$I$20230721$20240812$20240814$20240814$EXP$$KR-009507513-2408KOR003446$MERCK$$48$YR$$F$Y$$$20240814$$HP$KR$KR
242099521$24209952$1$I$$20240812$20240814$20240814$EXP$$GB-SANDOZ INC.-SDZ2024GB072474$SANDOZ$$$$$F$Y$$$20240814$$CN$GB$GB
242099541$24209954$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55661$$FDA-CTU$$12$YR$$F$N$$$20240813$N$$US$
242099562$24209956$2$F$$20240829$20240814$20240829$PER$$US-ALXN-202408USA000592US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242099571$24209957$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55658$$FDA-CTU$$56$YR$$F$N$$$20240813$N$$US$
242099581$24209958$1$I$20240813$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55711$$FDA-CTU$$56$YR$$M$N$$$20240813$N$CN$US$
242099591$24209959$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55646$$FDA-CTU$$62$YR$$F$N$$$20240813$N$$US$
242099601$24209960$1$I$$20240805$20240814$20240814$EXP$$JP-ROCHE-10000053289$ROCHE$Futamura S, Kunimasa K, Tamiya M, Inoe T, Kawamura T, Miyazaki A et al.. 123 A case of irAE colitis leading to colectomy total in the course. Joint Congress of the 132nd Kinki Branch Meeting of the Japanese Society for Tub. 2024;83$76$YR$E$M$Y$$$20240814$$MD$JP$JP
242099621$24209962$1$I$20240811$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55649$$FDA-CTU$$66$YR$$F$N$$$20240813$N$CN$US$
242099631$24209963$1$I$$20240801$20240814$20240814$EXP$$CN-Hisun Pharmaceuticals-2160383$HISUN PHARMACEUTICALS$$81$YR$$F$Y$64$KG$20240814$$$CN$CN
242099641$24209964$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160388$GUARDIAN PHARMACEUTICALS$Full text$13$YR$$$Y$$$20240814$$$TR$TR
242099651$24209965$1$I$$20240806$20240814$20240814$EXP$$CA-TEVA-VS-3231128$TEVA$$73$YR$$F$Y$$$20240814$$CN$CA$CA
242099661$24209966$1$I$20240801$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024159023$AMGEN$$77$YR$E$M$Y$$$20240814$$CN$US$US
242099671$24209967$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160397$GUARDIAN PHARMACEUTICALS$Full text$14$YR$$$Y$$$20240814$$$TR$TR
242099681$24209968$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160400$GUARDIAN PHARMACEUTICALS$Full text$13$YR$$$Y$$$20240814$$$TR$TR
242099691$24209969$1$I$20240719$20240806$20240814$20240814$EXP$$CN-SA-2024SA237153$SANOFI AVENTIS$$68$YR$E$M$Y$60$KG$20240814$$HP$CN$CN
242099701$24209970$1$I$$20240731$20240814$20240814$EXP$$US-Fagron Sterile Services-2160371$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$$$$$Y$$$20240814$$PH$US$US
242099711$24209971$1$I$$20240807$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125859$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240814$$CN$US$US
242099721$24209972$1$I$20240101$20240809$20240814$20240814$PER$$US-SA-2024SA240076$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240814$$MD$US$US
242099731$24209973$1$I$20240806$20240807$20240814$20240814$PER$$US-SA-2024SA237022$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240814$$CN$US$US
242099741$24209974$1$I$20240731$20240731$20240814$20240814$PER$$US-SA-2024SA240475$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240814$$MD$US$US
242099751$24209975$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA239837$SANOFI AVENTIS$$$$$$Y$$$20240814$$MD$US$US
242099761$24209976$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA239741$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
242099771$24209977$1$I$20240701$20240807$20240814$20240814$PER$$US-SA-2024SA239124$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240814$$MD$US$US
242099781$24209978$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160391$GUARDIAN PHARMACEUTICALS$Full text$13$YR$$$Y$$$20240814$$$TR$TR
242099791$24209979$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160389$GUARDIAN PHARMACEUTICALS$Full text$17$YR$$$Y$$$20240814$$$TR$TR
242099802$24209980$2$F$20240320$20240828$20240814$20240903$EXP$$JP-OTSUKA-2024_021837$OTSUKA$$56$YR$$F$Y$$$20240903$$MD$JP$JP
242099811$24209981$1$I$$20240607$20240814$20240814$EXP$$US-AstraZeneca-2024A133980$ASTRAZENECA$$$$$F$Y$47$KG$20240814$$CN$US$
242099821$24209982$1$I$$20240806$20240814$20240814$EXP$$JP-AstraZeneca-2024A179739$ASTRAZENECA$$$$$$Y$$$20240814$$MD$JP$
242099832$24209983$2$F$$20240910$20240814$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA072257$SANDOZ$$48$YR$$M$Y$$$20240912$$HP$CA$CA
242099841$24209984$1$I$$20240813$20240814$20240814$EXP$$FR-SANDOZ INC.-SDZ2024FR072265$SANDOZ$$52$YR$$M$Y$$$20240814$$HP$FR$FR
242099851$24209985$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164564$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
242099862$24209986$2$F$$20240913$20240814$20240918$EXP$$NVSC2024BR162942$NOVARTIS$$$$$M$Y$$$20240918$$CN$BR$BR
242099871$24209987$1$I$$20240807$20240814$20240814$EXP$$GB-RDY-LIT/GBR/24/0011830$DR REDDYS$Oldham J, Goldsmith P. Azacitidine-induced neutrophilic dermatosis. British Journal of Dermatology. 191(1): doi:10.1093/bjd/ljae090.329.$66$YR$E$F$Y$$$20240814$$HP$GB$GB
242099881$24209988$1$I$20240812$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160985$AMGEN$$66$YR$E$F$Y$$$20240814$$CN$US$US
242099892$24209989$2$F$20240101$20240913$20240814$20240926$PER$$US-SA-2024SA237837$SANOFI AVENTIS$$55$YR$A$M$Y$117$KG$20240926$$MD$US$US
242099901$24209990$1$I$20240807$20240808$20240814$20240814$PER$$US-SA-2024SA239841$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240814$$MD$US$US
242099911$24209991$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55652$$FDA-CTU$$$$$M$N$$$20240813$N$HP$US$
242099921$24209992$1$I$$20240813$20240813$20240813$DIR$714027$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242099931$24209993$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55669$$FDA-CTU$$66$YR$$F$N$$$20240813$N$$US$
242099941$24209994$1$I$20240813$20240813$20240813$20240813$DIR$714072$$FDA-CTU$$75$YR$$F$N$$$20240813$N$HP$US$
242099961$24209996$1$I$$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128638$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240814$$CN$US$US
242099971$24209997$1$I$20240812$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128253$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$69.4$KG$20240814$$CN$US$US
242099981$24209998$1$I$20240813$20240813$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128574$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240814$$HP$US$US
242099991$24209999$1$I$$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128039$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240814$$MD$US$US
242100001$24210000$1$I$$20240812$20240814$20240814$EXP$$IT-SANDOZ INC.-PHHY2019IT193133$SANDOZ$$72$YR$$M$Y$$$20240814$$MD$IT$IT
242100011$24210001$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160395$GUARDIAN PHARMACEUTICALS$Full text$8$YR$$$Y$$$20240814$$$TR$TR
242100021$24210002$1$I$20240604$20240809$20240814$20240814$EXP$$CN-HALEON-2191421$Haleon PLC$$37$YR$$M$Y$$$20240814$$HP$CN$CN
242100031$24210003$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160401$GUARDIAN PHARMACEUTICALS$Full text$5$YR$$$Y$$$20240814$$$TR$TR
242100041$24210004$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160393$GUARDIAN PHARMACEUTICALS$Full text$8$YR$$$Y$$$20240814$$$TR$TR
242100051$24210005$1$I$$20240806$20240814$20240814$EXP$$CA-CELLTRION INC.-2023CA022915$CELLTRION$$$$$$Y$$$20240814$$CN$CA$CA
242100061$24210006$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160398$GUARDIAN PHARMACEUTICALS$Full text$9$YR$$$Y$$$20240814$$$TR$TR
242100101$24210010$1$I$20240812$20240813$20240813$20240813$DIR$714064$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242100111$24210011$1$I$$20240808$20240814$20240814$EXP$$PK-PFIZER INC-PV202400104532$PFIZER$Javed, Z.. Non-granulomatous meningoencephalitis with Balamuthia mandrillaris mimicking a tumor: First confirmed case from Pakistan. Surgical Neurology International. 2024;15:10.25259/SNI_181_2024$33$YR$$F$Y$$$20240814$$HP$PK$PK
242100121$24210012$1$I$$20240809$20240814$20240814$30DAY$$US-PFIZER INC-PV202400044117$PFIZER$$$$$$Y$$$20240814$$HP$US$US
242100132$24210013$2$F$20230101$20240813$20240814$20240820$EXP$$GR-PFIZER INC-202400235032$PFIZER$Angelousi, A.. Transformation of a Benign Adrenocortical Adenoma to a Metastatic Adrenocortical Carcinoma Is Rare But It Happens. JCEM case reports. 2024;2(8):luae131$64$YR$$M$Y$$$20240820$$MD$GR$GR
242100142$24210014$2$F$$20240813$20240814$20240819$EXP$$IN-PFIZER INC-202400235337$PFIZER$Gupta, D.. Rare complications of heart transplant: Autopsy findings. Indian Journal of Pathology and Microbiology. 2024;67(3):624-627$33$YR$$M$Y$$$20240819$$MD$IN$IN
242100151$24210015$1$I$20230101$20240402$20240814$20240814$EXP$$NVSC2023CO006071$NOVARTIS$$42$YR$$F$Y$$$20240814$$CN$CO$CO
242100161$24210016$1$I$20240707$20240730$20240814$20240814$EXP$$CN-Hisun Pharmaceuticals-2160382$HISUN PHARMACEUTICALS$$7$YR$$M$Y$26$KG$20240814$$$CN$CN
242100171$24210017$1$I$20240717$20240801$20240814$20240814$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160384$JIANGSU HANSOH PHARMACEUTICAL$$60$YR$$F$Y$$$20240814$$MD$CN$CN
242100181$24210018$1$I$20240412$20240809$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US064429$SANDOZ$$$$$F$Y$$$20240814$$CN$US$US
242100191$24210019$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160390$GUARDIAN PHARMACEUTICALS$Full text$12$YR$$$Y$$$20240814$$$TR$TR
242100201$24210020$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160396$GUARDIAN PHARMACEUTICALS$Full text$16$YR$$$Y$$$20240814$$$TR$TR
242100211$24210021$1$I$$20240801$20240814$20240814$EXP$$GB-AUROBINDO-AUR-APL-2024-038696$AUROBINDO$$75$YR$$M$Y$$$20240814$$CN$GB$GB
242100221$24210022$1$I$$20240801$20240814$20240814$PER$$US-P+L Developments of Newyork Corporation-2160414$PL DEVELOPMENTS$$$$$M$Y$$$20240814$$$US$US
242100231$24210023$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160387$GUARDIAN PHARMACEUTICALS$Full text$9$YR$$$Y$$$20240814$$$TR$TR
242100251$24210025$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160403$GUARDIAN PHARMACEUTICALS$Full text$10$YR$$$Y$$$20240814$$$TR$TR
242100261$24210026$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191876$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242100271$24210027$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160386$GUARDIAN PHARMACEUTICALS$Full text$13$YR$$$Y$$$20240814$$$TR$TR
242100281$24210028$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160412$APTAPHARMA$Full text$16$YR$$$Y$$$20240814$$$TR$TR
242100291$24210029$1$I$$20240801$20240814$20240814$EXP$$US-Fagron Sterile Services-2160372$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$$$$$Y$$$20240814$$PH$US$US
242100301$24210030$1$I$$20240802$20240814$20240814$EXP$$US-Appco Pharma LLC-2160409$APPCO PHARMA$$35$YR$$F$Y$63$KG$20240814$$$US$US
242100311$24210031$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160402$GUARDIAN PHARMACEUTICALS$Full text$16$YR$$$Y$$$20240814$$$TR$TR
242100321$24210032$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160416$APTAPHARMA$Full text$14$YR$$$Y$$$20240814$$$TR$TR
242100331$24210033$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160410$APTAPHARMA$Full text$8$YR$$$Y$$$20240814$$$TR$TR
242100341$24210034$1$I$$20240802$20240814$20240814$EXP$$US-Appco Pharma LLC-2160406$APPCO PHARMA$$12$MON$$M$Y$$$20240814$$$US$US
242100351$24210035$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160399$GUARDIAN PHARMACEUTICALS$Full text$14$YR$$$Y$$$20240814$$$TR$TR
242100361$24210036$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160418$APTAPHARMA$Full text$9$YR$$$Y$$$20240814$$$TR$TR
242100371$24210037$1$I$20240101$20240808$20240814$20240814$EXP$$US-CHIESI-2024CHF05070$CHIESI$$$$$F$Y$68$KG$20240814$$CN$US$US
242100381$24210038$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160408$APTAPHARMA$Full text$81$YR$$M$Y$$$20240814$$$TR$TR
242100391$24210039$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160421$APTAPHARMA$Full text$17$YR$$$Y$$$20240814$$$TR$TR
242100401$24210040$1$I$$20240730$20240814$20240814$EXP$$TR-Guardian Drug Company-2160394$GUARDIAN PHARMACEUTICALS$Full text$14$YR$$$Y$$$20240814$$$TR$TR
242100411$24210041$1$I$$20240730$20240814$20240814$EXP$$AU-AptaPharma Inc.-2160407$APTAPHARMA$Abstract$$$$M$Y$$$20240814$$$AU$AU
242100421$24210042$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160425$APTAPHARMA$Full text$13$YR$$$Y$$$20240814$$$TR$TR
242100432$24210043$2$F$20240530$20240820$20240814$20240823$EXP$IT-BAXTER-2024BAX021665$IT-ROCHE-10000048874$ROCHE$$57$YR$A$F$Y$70$KG$20240823$$HP$IT$IT
242100451$24210045$1$I$$20240809$20240814$20240814$EXP$$US-TAKEDA-2024TUS042886$TAKEDA$$$$$F$Y$$$20240814$$CN$US$US
242100461$24210046$1$I$20240101$20240715$20240814$20240814$PER$$US-Guardian Drug Company-2160431$GUARDIAN PHARMACEUTICALS$$$$$F$Y$$$20240814$$$US$US
242100471$24210047$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160422$APTAPHARMA$Full text$13$YR$$$Y$$$20240814$$$TR$TR
242100481$24210048$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160413$APTAPHARMA$Full text$14$YR$$$Y$$$20240814$$$TR$TR
242100491$24210049$1$I$20240813$20240813$20240813$20240813$DIR$714079$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242100501$24210050$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160415$APTAPHARMA$Full text$9$YR$$$Y$$$20240814$$$TR$TR
242100511$24210051$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160424$APTAPHARMA$Full text$14$YR$$$Y$$$20240814$$$TR$TR
242100521$24210052$1$I$$20240730$20240814$20240814$EXP$$QA-Guardian Drug Company-2160404$GUARDIAN PHARMACEUTICALS$Source document (FTA).$41$YR$$M$Y$$$20240814$$$QA$QA
242100531$24210053$1$I$$20240801$20240814$20240814$EXP$$US-B.Braun Medical Inc.-2160433$B BRAUN$Literature Article$45$YR$$M$Y$$$20240814$$$US$US
242100541$24210054$1$I$20240813$20240813$20240813$20240813$DIR$714102$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242100551$24210055$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160417$APTAPHARMA$Full text$13$YR$$$Y$$$20240814$$$TR$TR
242100561$24210056$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160420$APTAPHARMA$Full text$13$YR$$$Y$$$20240814$$$TR$TR
242100571$24210057$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160411$APTAPHARMA$Full text$10$YR$$$Y$$$20240814$$$TR$TR
242100581$24210058$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160426$APTAPHARMA$Full text$5$YR$$$Y$$$20240814$$$TR$TR
242100591$24210059$1$I$$20240807$20240814$20240814$EXP$$CA-The Proactiv LLC-2160429$PROACTIV$$$$$F$Y$$$20240814$$$CA$CA
242100601$24210060$1$I$$20240730$20240814$20240814$EXP$$GR-AptaPharma Inc.-2160434$APTAPHARMA$Full text$76$YR$$F$Y$$$20240814$$$GR$GR
242100611$24210061$1$I$$20240801$20240814$20240814$EXP$$US-B.Braun Medical Inc.-2160432$B BRAUN$Literature Article$68$YR$$M$Y$$$20240814$$$US$US
242100621$24210062$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160419$APTAPHARMA$Full text$12$YR$$$Y$$$20240814$$$TR$TR
242100631$24210063$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160423$APTAPHARMA$Full text$8$YR$$$Y$$$20240814$$$TR$TR
242100641$24210064$1$I$$20240730$20240814$20240814$EXP$$QA-AptaPharma Inc.-2160435$APTAPHARMA$Full text$41$YR$$M$Y$$$20240814$$$QA$QA
242100651$24210065$1$I$20240101$20240715$20240814$20240814$PER$$US-Guardian Drug Company-2160428$GUARDIAN PHARMACEUTICALS$$$$$M$Y$$$20240814$$$US$US
242100661$24210066$1$I$$20240730$20240814$20240814$EXP$$MX-Karo Pharma-2159947$Karo Pharma$$10$YR$$M$Y$$$20240814$$$MX$MX
242100671$24210067$1$I$$20240730$20240814$20240814$EXP$$US-WES Pharma Inc-2160439$WES PHARMA$Full text$19$YR$$M$Y$$$20240814$$$US$US
242100681$24210068$1$I$$20240730$20240814$20240814$EXP$$TR-AptaPharma Inc.-2160427$APTAPHARMA$Full text$16$YR$$$Y$$$20240814$$$TR$TR
242100691$24210069$1$I$$20240730$20240814$20240814$PER$$US-Karo Pharma-2160186$Karo Pharma$$37$YR$$F$Y$$$20240814$$$US$US
242100701$24210070$1$I$$20240730$20240814$20240814$EXP$$GR-Guardian Drug Company-2160441$GUARDIAN PHARMACEUTICALS$Full text$76$YR$$F$Y$$$20240814$$$GR$GR
242100711$24210071$1$I$$20240813$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US072377$SANDOZ$$$$$$Y$$$20240814$$CN$US$US
242100721$24210072$1$I$20240124$20240807$20240814$20240814$EXP$$CA-OTSUKA-2024_002269$OTSUKA$$43$YR$$F$Y$$$20240814$$MD$CA$CA
242100731$24210073$1$I$20240807$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128475$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240814$$PH$US$US
242100751$24210075$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA240881$SANOFI AVENTIS$$$$A$M$Y$73.923$KG$20240814$$MD$US$US
242100761$24210076$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA152912$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240814$$MD$US$US
242100771$24210077$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA238716$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$MD$US$US
242100781$24210078$1$I$$20240808$20240814$20240814$PER$$US-ROCHE-10000053711$ROCHE$$63$YR$A$F$Y$$$20240814$$MD$US$US
242100791$24210079$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA237700$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240814$$HP$US$US
242100801$24210080$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236567$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240814$$MD$US$US
242100811$24210081$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA239170$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240814$$MD$US$US
242100821$24210082$1$I$$20240809$20240814$20240814$EXP$$US-GILEAD-2024-0683793$GILEAD$$31$YR$A$F$Y$63.9$KG$20240814$$PH$US$US
242100832$24210083$2$F$$20240812$20240814$20240816$PER$$US-BIOGEN-2024BI01277983$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
242100841$24210084$1$I$20230701$20240806$20240814$20240814$EXP$$RO-AstraZeneca-2024A182387$ASTRAZENECA$$59$YR$$F$Y$$$20240814$$CN$RO$
242100852$24210085$2$F$$20240821$20240814$20240829$EXP$$ES-AstraZeneca-2024A179919$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$ES$
242100861$24210086$1$I$$20240812$20240814$20240814$EXP$$CA-SANDOZ INC.-NVSC2022CA250900$SANDOZ$$61$YR$$M$Y$$$20240814$$HP$CA$CA
242100881$24210088$1$I$$20240813$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008292$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240814$$CN$US$US
242100891$24210089$1$I$20240810$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007386$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240814$$CN$US$US
242100901$24210090$1$I$20240812$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007409$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240814$$CN$US$US
242100912$24210091$2$F$$20240814$20240814$20240816$EXP$$US-KYOWAKIRIN-2024KK019177$KYOWA$$$$$$Y$$$20240816$$HP$US$US
242100921$24210092$1$I$$20230301$20240814$20240814$EXP$$CA-DSJP-DSJ-2023-109353$DAIICHI$$$$$F$Y$$$20240814$$MD$CA$CA
242100931$24210093$1$I$20240703$20240808$20240814$20240814$EXP$$NVSC2024IN163615$NOVARTIS$$64$YR$$F$Y$$$20240814$$CN$IN$IN
242100941$24210094$1$I$$20240812$20240814$20240814$EXP$$IT-GILEAD-2024-0683907$GILEAD$Cuomo G., Menozzi M., Albertini M., Todisco V., Gozzi L., Martini E etal. EVALUATING TOLERANCE AND SAFETY PROFILES OF PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV: INSIGHTS FROM RENAL AND HEPATIC FUNCTION MONITORING. Italian Conference on AIDS and Antiviral Research. 2024;100(1):A250-A251. doi:10.1136/sextrans-ICAR-2024.241$$$A$$Y$$$20240814$$HP$IT$IT
242100951$24210095$1$I$$20240812$20240814$20240814$EXP$$US-ABBVIE-5877811$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242100961$24210096$1$I$20231010$20240813$20240813$20240813$DIR$714025$$FDA-CTU$$66$YR$$F$N$49.5$KG$20240813$N$CN$US$
242100971$24210097$1$I$$20240717$20240814$20240814$PER$$US-009507513-2407USA011098$MERCK$Khardori N, Ripley K,Talt I, Pine C, Ingemi A, Tin H, et al.. A Case-Based Review of LVAD Infection by MABC. Infectious Diseases in Clinical Practice. 2024;32 (4)$55$YR$$M$Y$$$20240814$$MD$US$US
242100981$24210098$1$I$$20240806$20240814$20240814$PER$$US-ABBVIE-5870265$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242100991$24210099$1$I$20240813$20240813$20240813$20240813$DIR$714134$$FDA-CTU$$46$YR$$F$N$60.75$KG$20240813$N$CN$US$
242101001$24210100$1$I$$20240813$20240813$20240813$DIR$714091$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242101021$24210102$1$I$20240701$20240807$20240814$20240814$PER$$US-SA-2024SA093559$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240814$$MD$US$US
242101032$24210103$2$F$20240807$20240913$20240814$20240923$PER$$US-SA-2024SA240510$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240923$$MD$US$US
242101041$24210104$1$I$$20240730$20240814$20240814$EXP$$DK-Chemistry + Health FZ LLC-2160444$Chemistry + Health FZ$Full text$76$YR$$F$Y$$$20240814$$$DK$DK
242101051$24210105$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA240636$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240814$$MD$US$US
242101061$24210106$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA238933$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240814$$MD$US$US
242101073$24210107$3$F$20240731$20240913$20240814$20240920$30DAY$$PA-PFIZER INC-PV202400101072$PFIZER$$11$YR$$M$Y$$$20240920$$HP$PA$PA
242101082$24210108$2$F$$20240914$20240814$20240916$30DAY$$US-PFIZER INC-202400229941$PFIZER$$14$YR$$M$Y$$$20240916$$CN$US$US
242101091$24210109$1$I$$20240808$20240814$20240814$EXP$$US-PFIZER INC-202400233774$PFIZER$Li, Xin.. A Case of Disseminated Mycobacterium Haemophilum in a Kidney Transplant Recipient Presenting With Subcutaneous Nodules. Wisconsin Medical Journal. 2024;123(3):233-237$63$YR$$M$Y$$$20240814$$MD$US$US
242101101$24210110$1$I$20230101$20240807$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US072375$SANDOZ$$$$$F$Y$73.02$KG$20240814$$CN$US$US
242101111$24210111$1$I$$20240806$20240814$20240814$EXP$$GR-TEVA-VS-3231094$TEVA$$$$$F$Y$$$20240814$$MD$GR$GR
242101131$24210113$1$I$20240218$20240807$20240814$20240814$EXP$$AR-GSK-AR2024AMR098565$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$AR$AR
242101141$24210114$1$I$20240805$20240808$20240814$20240814$EXP$$AU-Eisai-EC-2024-171642$EISAI$$52$YR$A$F$Y$$$20240814$$HP$AU$AU
242101152$24210115$2$F$$20240904$20240814$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127516$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240906$$CN$US$US
242101161$24210116$1$I$20240810$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160405$AMGEN$$66$YR$E$F$Y$$$20240814$$PH$US$US
242101171$24210117$1$I$$20240805$20240814$20240814$PER$$US-BAYER-2024A113150$BAYER$$$$$F$Y$$$20240814$$CN$US$US
242101181$24210118$1$I$20240614$20240813$20240813$20240813$DIR$714167$$FDA-CTU$$20$YR$$F$N$76.4$KG$20240813$N$HP$US$
242101191$24210119$1$I$20240813$20240813$20240813$20240813$DIR$714050$$FDA-CTU$$66$YR$$F$N$73.35$KG$20240813$Y$PH$US$
242101201$24210120$1$I$20240813$20240813$20240813$20240813$DIR$714071$$FDA-CTU$$44$YR$$F$N$$$20240813$N$HP$US$
242101211$24210121$1$I$$20240813$20240813$20240813$DIR$714093$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242101231$24210123$1$I$20240813$20240813$20240813$20240813$DIR$714132$$FDA-CTU$$44$YR$$F$N$111.6$KG$20240813$N$HP$US$
242101241$24210124$1$I$20240611$20240813$20240813$20240813$DIR$714161$$FDA-CTU$$16$YR$$M$N$63.3$KG$20240813$N$HP$US$
242101261$24210126$1$I$20240812$20240813$20240813$20240813$DIR$714057$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242101271$24210127$1$I$$20240801$20240814$20240814$EXP$$US-B.Braun Medical Inc.-2160445$B BRAUN$Literature Article$53$YR$$M$Y$$$20240814$$$US$US
242101281$24210128$1$I$20240101$20240813$20240814$20240814$EXP$$US-UCBSA-2024003501$UCB$$$$$M$Y$$$20240814$$CN$US$US
242101291$24210129$1$I$$20240808$20240814$20240814$EXP$$US-BAYER-2024A032137$BAYER$$52$YR$A$F$Y$92.971$KG$20240814$$CN$US$US
242101301$24210130$1$I$$20240809$20240814$20240814$EXP$$JP-009507513-2408JPN001379J$MERCK$$80$YR$$M$Y$$$20240814$$HP$JP$JP
242101311$24210131$1$I$$20240808$20240814$20240814$PER$$US-JNJFOC-20240822564$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242101321$24210132$1$I$20240802$20240805$20240814$20240814$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024074$UNITED THERAPEUTICS$$69$YR$$F$Y$47.166$KG$20240814$$$US$US
242101331$24210133$1$I$$20240809$20240814$20240814$PER$$US-JNJFOC-20240825115$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$PH$US$US
242101341$24210134$1$I$$20240806$20240814$20240814$EXP$$CA-JNJFOC-20240823985$JOHNSON AND JOHNSON$$29$YR$A$F$Y$57$KG$20240814$$HP$CA$CA
242101351$24210135$1$I$$20240806$20240814$20240814$PER$$US-BAYER-2024A114034$BAYER$$$$$F$Y$$$20240814$$CN$US$US
242101361$24210136$1$I$$20240812$20240814$20240814$EXP$$CA-ADIENNEP-2024AD000640$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240812$$HP$CA$
242101371$24210137$1$I$$20240812$20240814$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA072321$SANDOZ$$61$YR$$M$Y$$$20240814$$HP$CA$CA
242101382$24210138$2$F$20240811$20240814$20240814$20240914$PER$$US-AMGEN-USASP2024161253$AMGEN$$62$YR$A$M$Y$$$20240913$$CN$US$US
242101391$24210139$1$I$$20240810$20240814$20240814$PER$$US-ROCHE-10000054209$ROCHE$$58$YR$A$F$Y$$$20240814$$CN$US$US
242101401$24210140$1$I$20240722$20240813$20240813$20240813$DIR$714152$$FDA-CTU$$81$YR$$M$N$$$20240813$Y$HP$US$
242101422$24210142$2$F$$20240904$20240814$20240912$30DAY$$US-GSK-US2024AMR098812$GLAXOSMITHKLINE$$$$$M$Y$$$20240912$$CN$US$US
242101431$24210143$1$I$$20240809$20240814$20240814$EXP$$US-TAKEDA-2024TUS040762$TAKEDA$$$$$F$Y$$$20240814$$CN$US$US
242101441$24210144$1$I$20240812$20240813$20240813$20240813$DIR$714048$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242101451$24210145$1$I$$20240731$20240814$20240814$EXP$$OM-Innogenix, LLC-2160446$INNOGENIX$Full text$73$YR$$F$Y$$$20240814$$MD$OM$OM
242101461$24210146$1$I$$20240809$20240814$20240814$PER$$US-BEH-2024177086$CSL BEHRING$$57$YR$A$M$Y$$$20240814$$HP$US$US
242101471$24210147$1$I$$20240813$20240814$20240814$PER$$US-ROCHE-10000055981$ROCHE$$$$$$Y$$$20240814$$MD$US$US
242101481$24210148$1$I$20240101$20240729$20240814$20240814$PER$$US-TEVA-VS-3228542$TEVA$$75$YR$$M$Y$$$20240814$$CN$US$US
242101501$24210150$1$I$$20240809$20240814$20240814$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019355$VALIDUS$$$$$$Y$$$20240814$$MD$US$US
242101521$24210152$1$I$20220719$20220719$20240814$20240814$EXP$$CA-DSJP-DSJ-2022-127033$DAIICHI$$46$YR$$F$Y$64$KG$20240814$$HP$CA$CA
242101541$24210154$1$I$$20240730$20240814$20240814$EXP$$IT-GLANDPHARMA-IT-2024GLNLIT00619$GLAND PHARMA$Muggeo P.Combining Brentuximab Vedotin With Dexamethasone, High dose Cytarabine and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma Two Case Reports.Journal of Pediatric Hematology/Oncology.JUN-2024;1-4$13$YR$T$M$Y$$$20240814$$HP$IT$IT
242101562$24210156$2$F$20240724$20240913$20240814$20240916$EXP$$GB-ARGENX-2024-ARGX-GB006581$ARGENX BVBA$$$$$$Y$$$20240916$$MD$GB$GB
242101571$24210157$1$I$20240101$20240808$20240814$20240814$EXP$$PE-REGENERON PHARMACEUTICALS, INC.-2024-099359$REGENERON$$74$YR$$F$Y$$$20240814$$HP$PE$PE
242101581$24210158$1$I$$20240807$20240814$20240814$PER$$US-EMD Serono-2024043007$EMD SERONO INC$$$$$M$Y$$$20240814$$CN$US$US
242101591$24210159$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA237636$SANOFI AVENTIS$$59$YR$A$F$Y$70.3$KG$20240814$$MD$US$US
242101601$24210160$1$I$20240801$20240809$20240814$20240814$PER$$US-SA-2024SA239486$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240814$$MD$US$US
242101611$24210161$1$I$20240802$20240809$20240814$20240814$PER$$US-BAYER-2024A115537$BAYER$$$$$F$Y$$$20240814$$HP$US$US
242101631$24210163$1$I$20240101$20240801$20240814$20240814$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019347$VALIDUS$$$$$$Y$$$20240814$$CN$US$US
242101641$24210164$1$I$20240101$20240809$20240814$20240814$EXP$$US-009507513-2408USA003499$MERCK$$68$YR$$F$Y$$$20240814$$CN$US$US
242101651$24210165$1$I$$20240717$20240814$20240814$PER$$US-009507513-2408USA004585$MERCK$Khardori N, Ripley K,Talt I, Pine C, Ingemi A, Tin H, et al.. A Case-Based Review of LVAD Infection by MABC. Infectious Diseases in Clinical Practice. 2024;32 (4)$55$YR$$M$Y$$$20240814$$MD$US$US
242101661$24210166$1$I$20240710$20240808$20240814$20240814$EXP$FR-AFSSAPS-LL2024001533$FR-SA-2024SA238419$SANOFI AVENTIS$$74$YR$E$M$Y$90$KG$20240814$$PH$FR$FR
242101672$24210167$2$F$20240201$20240905$20240814$20240911$PER$$US-BAYER-2024A115143$BAYER$$28$YR$A$F$Y$$$20240911$$HP$US$US
242101681$24210168$1$I$$20240806$20240814$20240814$PER$$US-ABBVIE-5871704$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242101691$24210169$1$I$20231027$20240423$20240814$20240814$EXP$$EG-JNJFOC-20240830516$JOHNSON AND JOHNSON$$22$YR$A$F$Y$80$KG$20240814$$CN$EG$EG
242101702$24210170$2$F$20190226$20240808$20240814$20240822$EXP$$CN-SA-2024SA239870$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240822$$HP$CN$CN
242101711$24210171$1$I$20240725$20240807$20240814$20240814$PER$$US-SA-2024SA239054$SANOFI AVENTIS$$6$YR$C$F$Y$32.88$KG$20240814$$MD$US$US
242101721$24210172$1$I$$20240808$20240814$20240814$EXP$$US-SA-2024SA239557$SANOFI AVENTIS$$$$A$$Y$$$20240814$$CN$US$US
242101731$24210173$1$I$$20240719$20240814$20240814$PER$$US-009507513-2407USA012119$MERCK$$$$$F$Y$74.83$KG$20240814$$CN$US$US
242101741$24210174$1$I$$20240809$20240814$20240814$PER$$US-BAYER-2024A115842$BAYER$$$$$F$Y$$$20240814$$CN$US$US
242101751$24210175$1$I$$20240806$20240814$20240814$PER$$US-BAYER-2024A114078$BAYER$$22$YR$A$F$Y$61.68$KG$20240814$$CN$US$US
242101761$24210176$1$I$20220131$20240812$20240814$20240814$EXP$PT-INFARMED-M202210-1038$PT-GILEAD-2024-0683856$GILEAD$$93$YR$E$F$Y$$$20240814$$MD$PT$PT
242101772$24210177$2$F$20240830$20240903$20240814$20240904$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036695$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240904$$CN$US$US
242101791$24210179$1$I$$20240809$20240814$20240814$EXP$$JP-Eisai-EC-2024-171802$EISAI$Kani, N, et al.. Cytokine release syndrome caused by immune checkpoint inhinitors: a report of three cases. The 111th Annual Meeting of the Japanese Urological Association. 2024; 68(03).$$$$$Y$$$20240814$$MD$JP$JP
242101801$24210180$1$I$20240627$20240805$20240814$20240814$EXP$BE-FAMHP-DHH-N2024-122438$BE-TEVA-VS-3231138$TEVA$$24$YR$$F$Y$64.5$KG$20240814$$PH$BE$BE
242101811$24210181$1$I$$20240813$20240814$20240814$EXP$$US-GILEAD-2024-0684151$GILEAD$$39$YR$A$M$Y$$$20240814$$CN$US$US
242101822$24210182$2$F$20230101$20240827$20240814$20240829$EXP$$US-UCBSA-2024041014$UCB$$$$$F$Y$$$20240829$$CN$US$US
242101832$24210183$2$F$20240830$20240830$20240814$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128074$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240906$$CN$US$US
242101841$24210184$1$I$$20240813$20240814$20240814$PER$$NVSC2024US165144$NOVARTIS$$$$$$Y$$$20240814$$MD$US$US
242101851$24210185$1$I$20240801$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127872$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240814$$CN$US$US
242101861$24210186$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128559$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240814$$CN$US$US
242101873$24210187$3$F$20240808$20240829$20240814$20240903$EXP$$US-BAYER-2024A115847$BAYER$$44$YR$A$F$Y$$$20240903$$HP$US$US
242101881$24210188$1$I$20240801$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128147$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240814$$CN$US$US
242101891$24210189$1$I$20240201$20240807$20240814$20240814$EXP$$AR-SANDOZ INC.-SDZ2024AR072567$SANDOZ$$39$YR$$F$Y$$$20240814$$CN$AR$AR
242101901$24210190$1$I$$20240804$20240814$20240814$EXP$$US-JNJFOC-20240827565$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240814$$MD$US$US
242101911$24210191$1$I$20210923$20240807$20240814$20240814$EXP$$GB-JNJFOC-20240140261$JOHNSON AND JOHNSON$$$$$M$Y$90$KG$20240814$$HP$GB$GB
242101921$24210192$1$I$$20240807$20240814$20240814$EXP$$RS-ROCHE-10000052102$ROCHE$Jovanka I, Borivoj S, Marina D, Velimir T, Ivana U, Aleksandar S.. Cladribine in the treatment of hairy cell leukemia - a single-centre ten-year experience. Med Pregl. 2024;77:19-24. doi:10.2298/MPNS2402019I.$$$$$Y$$$20240814$$MD$RS$RS
242101931$24210193$1$I$20240812$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007415$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240814$$CN$US$US
242101941$24210194$1$I$20240701$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007714$ELI LILLY AND CO$$62$YR$A$$Y$$$20240814$$CN$US$US
242101951$24210195$1$I$20240811$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008109$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240814$$CN$US$US
242101961$24210196$1$I$20220901$20240731$20240814$20240814$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07735$LUPIN$Shah N, Dib EG, Joseph N, Fontana RJ. Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits?. Clinical Liver Disease. 2024;23:e0125:1-5$76$YR$$F$Y$$$20240814$$HP$US$US
242101971$24210197$1$I$20240301$20240809$20240814$20240814$PER$$US-BAYER-2024A116095$BAYER$$61$YR$A$F$Y$$$20240814$$MD$US$US
242101981$24210198$1$I$20230601$20240805$20240814$20240814$EXP$$PL-TAKEDA-2024TUS079926$TAKEDA$$$$$$Y$$$20240814$$CN$PL$PL
242101991$24210199$1$I$$20240730$20240814$20240814$EXP$$JP-EAGLE PHARMACEUTICALS, INC.-JP-2024EAG000189$EAGLE$Yamabe C et al. A case of repeated COVID-19 during follow-up after chemotherapy for follicular lymphoma. The Journal of Tohoku Branch of the Japanese Society of Internal Medicine. 2024;36(1):31$$$E$M$Y$$$20240814$$MD$JP$JP
242102001$24210200$1$I$20240808$20240808$20240814$20240814$EXP$$CA-TAKEDA-2024TUS075500$TAKEDA$$52$YR$$M$Y$$$20240814$$CN$CA$CA
242102011$24210201$1$I$$20240812$20240814$20240814$PER$$US-BAYER-2024A116105$BAYER$$37$YR$A$F$Y$$$20240814$$HP$US$US
242102021$24210202$1$I$20240720$20240806$20240814$20240814$EXP$FR-AFSSAPS-SE2024000600$FR-TEVA-VS-3230817$TEVA$$59$YR$$F$Y$76.2$KG$20240814$$MD$FR$FR
242102032$24210203$2$F$20240101$20240910$20240814$20240924$EXP$$US-UCBSA-2024040865$UCB$$$$$M$Y$$$20240924$$CN$US$US
242102041$24210204$1$I$$20240805$20240814$20240814$EXP$$US-MYLANLABS-2024M1074111$MYLAN$Eshak N, Ehikhueme G, Ramesh M, Pixley J. Granulomatous Polyangiitis Refractory to Induction With Rituximab in 3 Patients. J-Investig-Med-High-Impact-Case-Rep 2024; 12.$66$YR$$F$Y$$$20240814$$MD$US$US
242102081$24210208$1$I$$20240813$20240813$20240813$DIR$714110$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242102091$24210209$1$I$20240701$20240813$20240813$20240813$DIR$714089$$FDA-CTU$$46$YR$$UNK$N$$$20240813$N$HP$US$
242102101$24210210$1$I$$20240813$20240813$20240813$DIR$714074$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242102111$24210211$1$I$20240622$20240813$20240813$20240813$DIR$714169$$FDA-CTU$$14$YR$$F$N$74.3$KG$20240813$N$HP$US$
242102121$24210212$1$I$20240812$20240813$20240813$20240813$DIR$714017$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242102131$24210213$1$I$20240803$20240813$20240813$20240813$DIR$714119$$FDA-CTU$$77$YR$$M$N$76.5$KG$20240813$N$CN$US$
242102141$24210214$1$I$$20240808$20240814$20240814$EXP$$CA-TAKEDA-2024TUS068353$TAKEDA$$$$$F$Y$$$20240814$$CN$CA$CA
242102151$24210215$1$I$20240101$20240813$20240814$20240814$EXP$$CZ-TAKEDA-2024TUS081341$TAKEDA$$78$YR$$M$Y$$$20240814$$HP$CZ$CZ
242102171$24210217$1$I$$20240812$20240814$20240814$EXP$$US-TAKEDA-2024TUS081439$TAKEDA$$$$$$Y$$$20240814$$CN$US$US
242102181$24210218$1$I$$20240812$20240814$20240814$PER$$NVSC2024US164511$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
242102191$24210219$1$I$$20240426$20240814$20240814$EXP$$US-ChurchDwight-2024-CDW-01310$CHURCH + DWIGHT$$$$$$Y$$$20240813$$CN$US$US
242102204$24210220$4$F$$20240813$20240814$20240917$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-126773$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$48$KG$20240917$$MD$DE$DE
242102211$24210221$1$I$$20240806$20240814$20240814$EXP$$ZA-AstraZeneca-2024A179174$ASTRAZENECA$$75$YR$$M$Y$$$20240814$$CN$ZA$
242102221$24210222$1$I$20240624$20240812$20240814$20240814$EXP$$FR-AstraZeneca-2024A184374$ASTRAZENECA$$77$YR$$M$Y$64$KG$20240814$$MD$FR$
242102231$24210223$1$I$$20220812$20240814$20240814$EXP$$US-AstraZeneca-2022A240480$ASTRAZENECA$$$$$M$Y$$$20240814$$MD$US$
242102241$24210224$1$I$20240601$20240806$20240814$20240814$EXP$$JP-AstraZeneca-2024A179764$ASTRAZENECA$$$$E$M$Y$$$20240814$$PH$JP$
242102251$24210225$1$I$20240726$20240807$20240814$20240814$EXP$$CH-AstraZeneca-2024A184382$ASTRAZENECA$$16$YR$$F$Y$109$KG$20240814$$MD$CH$
242102261$24210226$1$I$$20240125$20240814$20240814$EXP$$GB-SANDOZ INC.-SDZ2024GB008294$SANDOZ$$45$YR$$F$Y$$$20240814$$HP$GB$GB
242102272$24210227$2$F$20220820$20240816$20240814$20240826$EXP$$BR-BIOCON-BCN-2022-000933$BIOCON$$$$$$Y$$$20240826$$PH$BR$BR
242102281$24210228$1$I$20240601$20240808$20240814$20240814$PER$$US-AMGEN-USASP2024159358$AMGEN$$$$A$$Y$$$20240814$$HP$US$US
242102291$24210229$1$I$20240812$20240813$20240814$20240814$PER$$US-AMGEN-USASP2024161090$AMGEN$$18$YR$A$F$Y$$$20240814$$CN$US$US
242102301$24210230$1$I$$20240808$20240814$20240814$EXP$$DE-AMGEN-DEUSP2024159859$AMGEN$Kafa K.; Hoell J. I. et al.. Transplant-associated thrombotic microangiopathy in pediatrics- incidence, risk factors, therapeutic options, and outcome based on data from a single center. Frontiers in Oncology. 2024;14:1-11$$$$$Y$$$20240814$$HP$DE$DE
242102311$24210231$1$I$20240802$20240805$20240814$20240814$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01205$AIMMUNE$$$$$$Y$$$20240814$$CN$US$US
242102321$24210232$1$I$$20240809$20240814$20240814$PER$$US-TAKEDA-2024TUS080905$TAKEDA$$17$YR$$F$Y$$$20240814$$CN$US$US
242102331$24210233$1$I$20240807$20240813$20240814$20240814$PER$$US-BAYER-2024A116698$BAYER$$22$YR$A$F$Y$$$20240814$$MD$US$US
242102341$24210234$1$I$20240809$20240811$20240814$20240814$PER$$US-PFIZER INC-202400233964$PFIZER$$74$YR$$$Y$$$20240814$$CN$US$US
242102361$24210236$1$I$$20240807$20240814$20240814$EXP$$NVSC2024RU162390$NOVARTIS$Zhuravleva JA, Fedorova LV, Lepik EE, Gusak AA, Popova MO, Lepik KV et al.. A clinical case of successful treatment of CD30-negative angioimmunoblastic T-cell lymphoma using brentuximab vedotin and lenalidomide followed by allogeneic hematopoietic stem cell transplantation. CELLULAR THERAPY AND TRANSPLANTATION. 2024;13 (2):41-6$55$YR$$F$Y$$$20240814$$HP$RU$RU
242102371$24210237$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-202400234428$PFIZER$$70$YR$$M$Y$$$20240814$$CN$US$US
242102381$24210238$1$I$20240806$20240811$20240814$20240814$PER$$US-PFIZER INC-202400234104$PFIZER$$71$YR$$F$Y$$$20240814$$MD$US$US
242102391$24210239$1$I$20240808$20240809$20240814$20240814$PER$$US-PFIZER INC-202400234125$PFIZER$$69$YR$$F$Y$$$20240814$$CN$US$US
242102401$24210240$1$I$20240809$20240812$20240814$20240814$PER$$KR-PFIZER INC-PV202400104966$PFIZER$$$$$F$Y$$$20240814$$CN$KR$KR
242102411$24210241$1$I$20240812$20240813$20240813$20240813$DIR$714062$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242102422$24210242$2$F$20240809$20240828$20240814$20240904$PER$$US-PFIZER INC-202400234365$PFIZER$$57$YR$$F$Y$102.04$KG$20240904$$CN$US$US
242102441$24210244$1$I$20240812$20240812$20240814$20240814$PER$$US-PFIZER INC-202400235390$PFIZER$$$$$$Y$$$20240814$$CN$US$US
242102452$24210245$2$F$$20240814$20240814$20240820$EXP$$US-PFIZER INC-202400234400$PFIZER$Bragg, K.. Testosterone Therapy as an Isolated Risk Factor for Venous Thrombosis: A Case Report. Cureus. 2024;16(7):10.7759/cureus.63611.$3$DEC$$M$Y$$$20240820$$MD$US$US
242102461$24210246$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400235283$PFIZER$$56$YR$$M$Y$$$20240814$$CN$US$US
242102472$24210247$2$F$20240525$20240828$20240814$20240830$PER$$US-PFIZER INC-202400235845$PFIZER$$66$YR$$F$Y$53.515$KG$20240830$$CN$US$US
242102481$24210248$1$I$20240810$20240810$20240814$20240814$PER$$US-PFIZER INC-202400234482$PFIZER$$71$YR$$F$Y$$$20240814$$CN$US$US
242102491$24210249$1$I$20240701$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234157$PFIZER$$85$YR$$F$Y$$$20240814$$HP$US$US
242102501$24210250$1$I$20240811$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234941$PFIZER$$64$YR$$F$Y$$$20240814$$HP$US$US
242102511$24210251$1$I$20240801$20240813$20240814$20240814$PER$$US-PFIZER INC-202400235856$PFIZER$$79$YR$$F$Y$$$20240814$$CN$US$US
242102521$24210252$1$I$20240810$20240813$20240814$20240814$PER$$US-PFIZER INC-202400235863$PFIZER$$75$YR$$F$Y$$$20240814$$CN$US$US
242102532$24210253$2$F$$20240812$20240814$20240819$EXP$$PHHY2018NL072301$NOVARTIS$Van Veen KE. Immunosuppressants Bacterial meningitis: 6 case reports.. REACTIONS WEEKLY. 2017;1671:227$72$YR$$$Y$$$20240819$$HP$NL$NL
242102543$24210254$3$F$20240809$20240908$20240814$20240911$PER$$US-PFIZER INC-202400234340$PFIZER$$33$YR$$F$Y$69.388$KG$20240911$$CN$US$US
242102552$24210255$2$F$20240701$20240818$20240814$20240820$PER$$US-PFIZER INC-202400234971$PFIZER$$82$YR$$F$Y$62.6$KG$20240820$$CN$US$US
242102561$24210256$1$I$20240810$20240811$20240814$20240814$PER$$US-PFIZER INC-202400234095$PFIZER$$41$YR$$M$Y$$$20240814$$CN$US$US
242102572$24210257$2$F$$20240821$20240814$20240821$PER$$US-PFIZER INC-202400234921$PFIZER$$85$YR$$F$Y$$$20240821$$CN$US$US
242102581$24210258$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234898$PFIZER$$$$$F$Y$$$20240814$$CN$US$US
242102592$24210259$2$F$$20240813$20240814$20240816$PER$$US-PFIZER INC-202400235546$PFIZER$$77$YR$$M$Y$$$20240816$$CN$US$US
242102602$24210260$2$F$$20240814$20240814$20240820$EXP$$JP-PFIZER INC-202400235037$PFIZER$Shiroshita, K.. Autopsy case of cardiac mantle cell lymphoma presenting with recurrent pulmonary tumor embolism after chemotherapy. Journal of clinical and experimental hematopathology. 2024;10.3960/jslrt.24024$78$YR$$M$Y$$$20240820$$MD$JP$JP
242102611$24210261$1$I$$20240813$20240814$20240814$PER$$US-PFIZER INC-PV202400105434$PFIZER$$$$$F$Y$$$20240814$$CN$US$US
242102622$24210262$2$F$20240731$20240826$20240814$20240828$PER$$US-PFIZER INC-202400234563$PFIZER$$67$YR$$F$Y$51.701$KG$20240828$$HP$US$US
242102631$24210263$1$I$20240729$20240810$20240814$20240814$PER$$US-PFIZER INC-202400234398$PFIZER$$44$YR$$M$Y$$$20240814$$CN$US$US
242102641$24210264$1$I$20240812$20240813$20240814$20240814$PER$$KR-PFIZER INC-202400235063$PFIZER$$$$$M$Y$$$20240814$$CN$KR$KR
242102651$24210265$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400235477$PFIZER$$56$YR$$F$Y$$$20240814$$CN$US$US
242102661$24210266$1$I$20240810$20240813$20240814$20240814$PER$$US-PFIZER INC-202400235644$PFIZER$$42$YR$$F$Y$$$20240814$$HP$US$US
242102671$24210267$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-202400234109$PFIZER$$46$YR$$F$Y$$$20240814$$CN$US$US
242102681$24210268$1$I$20240801$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234810$PFIZER$$77$YR$$F$Y$$$20240814$$CN$US$US
242102691$24210269$1$I$20240802$20240809$20240814$20240814$PER$$US-PFIZER INC-202400234123$PFIZER$$$$E$M$Y$$$20240814$$PH$US$US
242102701$24210270$1$I$20240807$20240810$20240814$20240814$PER$$US-PFIZER INC-202400234306$PFIZER$$49$YR$$F$Y$$$20240814$$CN$US$US
242102713$24210271$3$F$20240103$20240911$20240814$20240913$PER$$US-PFIZER INC-202400234074$PFIZER$$46$YR$$F$Y$$$20240913$$CN$US$US
242102722$24210272$2$F$$20240820$20240814$20240822$PER$$US-PFIZER INC-PV202400105403$PFIZER$$$$A$F$Y$$$20240822$$CN$US$US
242102731$24210273$1$I$$20240810$20240814$20240814$PER$$US-PFIZER INC-202400234349$PFIZER$$$$$$Y$$$20240814$$CN$US$US
242102741$24210274$1$I$20240809$20240811$20240814$20240814$PER$$US-PFIZER INC-202400234100$PFIZER$$60$YR$$F$Y$$$20240814$$CN$US$US
242102751$24210275$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234973$PFIZER$$$$$$Y$$$20240814$$MD$US$US
242102761$24210276$1$I$20240301$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234913$PFIZER$$76$YR$$F$Y$$$20240814$$CN$US$US
242102771$24210277$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234953$PFIZER$$85$YR$$F$Y$$$20240814$$CN$US$US
242102783$24210278$3$F$$20240923$20240814$20240926$EXP$$US-PFIZER INC-202400234399$PFIZER$Kendric, K.. Successful administration of extended-release buprenorphine in the emergency department. American Journal of Emergency Medicine. 2024;84:189.e1-189.e3$38$YR$$M$Y$$$20240926$$MD$US$US
242102791$24210279$1$I$$20240808$20240814$20240814$EXP$$US-PFIZER INC-202400233766$PFIZER$Li, X.. A Case of Disseminated Mycobacterium Haemophilum in a Kidney Transplant Recipient Presenting With Subcutaneous Nodules. Wisconsin Medical Journal. 2024;123(3):233-237$63$YR$$M$Y$$$20240814$$MD$US$US
242102801$24210280$1$I$$20240811$20240814$20240814$PER$$US-PFIZER INC-PV202400104782$PFIZER$$27$YR$$F$Y$$$20240814$$CN$US$US
242102811$24210281$1$I$20240812$20240812$20240814$20240814$PER$$US-PFIZER INC-202400235106$PFIZER$$71$YR$$F$Y$$$20240814$$CN$US$US
242102821$24210282$1$I$20240811$20240811$20240814$20240814$PER$$US-PFIZER INC-202400234461$PFIZER$$74$YR$$F$Y$$$20240814$$CN$US$US
242102831$24210283$1$I$20240812$20240813$20240814$20240814$PER$$US-PFIZER INC-202400236213$PFIZER$$66$YR$$F$Y$$$20240814$$CN$US$US
242102842$24210284$2$F$$20240816$20240814$20240821$PER$$US-PFIZER INC-202400236166$PFIZER$$$$$$Y$$$20240821$$CN$US$US
242102851$24210285$1$I$20240805$20240812$20240814$20240814$PER$$US-PFIZER INC-202400235369$PFIZER$$35$YR$$M$Y$$$20240814$$CN$US$US
242102861$24210286$1$I$20240810$20240812$20240814$20240814$PER$$US-PFIZER INC-202400235953$PFIZER$$61$YR$$M$Y$$$20240814$$CN$US$US
242102871$24210287$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-PV202400104853$PFIZER$$$$$F$Y$$$20240814$$CN$US$US
242102881$24210288$1$I$20240808$20240811$20240814$20240814$PER$$US-PFIZER INC-202400234267$PFIZER$$73$YR$$F$Y$$$20240814$$CN$US$US
242102891$24210289$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234910$PFIZER$$73$YR$$F$Y$$$20240814$$CN$US$US
242102901$24210290$1$I$20240802$20240811$20240814$20240814$PER$$US-PFIZER INC-202400234562$PFIZER$$45$YR$$$Y$$$20240814$$CN$US$US
242102911$24210291$1$I$20240809$20240811$20240814$20240814$PER$$US-PFIZER INC-202400234488$PFIZER$$66$YR$$F$Y$$$20240814$$MD$US$US
242102921$24210292$1$I$20240813$20240813$20240814$20240814$PER$$US-PFIZER INC-202400235805$PFIZER$$68$YR$$F$Y$$$20240814$$CN$US$US
242102932$24210293$2$F$20240809$20240918$20240814$20240919$PER$$US-PFIZER INC-202400234516$PFIZER$$66$YR$$M$Y$99.773$KG$20240919$$CN$US$US
242102941$24210294$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400236076$PFIZER$$82$YR$$$Y$$$20240814$$MD$US$US
242102951$24210295$1$I$20240808$20240811$20240814$20240814$PER$$US-PFIZER INC-202400234502$PFIZER$$51$YR$$F$Y$$$20240814$$CN$US$US
242102962$24210296$2$F$20240811$20240906$20240814$20240910$PER$$US-PFIZER INC-202400235638$PFIZER$$42$YR$$F$Y$52.608$KG$20240910$$CN$US$US
242102971$24210297$1$I$20240812$20240813$20240814$20240814$PER$$US-PFIZER INC-202400235755$PFIZER$$77$YR$$F$Y$$$20240814$$CN$US$US
242102981$24210298$1$I$20240101$20240709$20240814$20240814$PER$US-I3 Pharmaceuticals, LLC.-I3P202407-000025$US-I3 Pharmaceuticals, LLC.-I3P202407-000025$i3 Pharmaceuticals$$$$$$Y$$$20240814$$CN$US$
242102991$24210299$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400236265$PFIZER$$52$YR$$M$Y$$$20240814$$CN$US$US
242103001$24210300$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234912$PFIZER$$75$YR$$F$Y$$$20240814$$CN$US$US
242103012$24210301$2$F$$20240925$20240814$20240926$PER$$US-PFIZER INC-202400236128$PFIZER$$64$YR$$F$Y$$$20240926$$CN$US$US
242103021$24210302$1$I$20240801$20240813$20240814$20240814$PER$$US-PFIZER INC-202400235869$PFIZER$$75$YR$$M$Y$$$20240814$$CN$US$US
242103031$24210303$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-PV202400100982$PFIZER$$67$YR$$M$Y$$$20240814$$CN$US$US
242103041$24210304$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA238127$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240814$$MD$US$US
242103051$24210305$1$I$20240807$20240813$20240814$20240814$PER$$US-BAYER-2024A116760$BAYER$$20$YR$A$F$Y$$$20240814$$MD$US$US
242103071$24210307$1$I$$20240807$20240814$20240814$EXP$$CA-GSK-CA2022177661$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$HP$CA$CA
242103081$24210308$1$I$$20240802$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07888$LUPIN$$$$$M$Y$$$20240814$$MD$US$US
242103091$24210309$1$I$20220312$20240806$20240814$20240814$EXP$PL-URPL-DML-MLP.4401.1.757.2022$PL-TEVA-VS-3231217$TEVA$$64$YR$$F$Y$$$20240814$$PH$PL$PL
242103101$24210310$1$I$20240101$20240806$20240814$20240814$EXP$$JP-AMGEN-JPNSP2024157040$AMGEN$$85$YR$E$F$Y$$$20240814$$CN$JP$JP
242103112$24210311$2$F$$20240819$20240814$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US072582$SANDOZ$$$$$M$Y$$$20240820$$HP$US$US
242103121$24210312$1$I$$20240808$20240814$20240814$EXP$$US-AMGEN-USASP2024159788$AMGEN$Huggett A. L.; Sulaiman Z. I.; Schwade M. et al.. Paws and Pathogens: A Multidisciplinary Approach Through Bartonella henselae Endocarditis and Hepatosplenic T-Cell Lymphoma. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-6$23$YR$A$M$Y$$$20240814$$HP$US$US
242103133$24210313$3$F$20240722$20240909$20240814$20240916$EXP$$JP-TAKEDA-2024TUS081351$TAKEDA$$8$DEC$$M$Y$$$20240916$$MD$JP$JP
242103141$24210314$1$I$20240812$20240812$20240814$20240814$PER$$US-BAYER-2024A115923$BAYER$$31$YR$A$F$Y$$$20240814$$MD$US$US
242103151$24210315$1$I$20240722$20240802$20240814$20240814$PER$$US-IGSA-BIG0030191$GRIFOLS$$85$YR$$M$Y$$$20240814$$CN$US$US
242103161$24210316$1$I$$20240807$20240814$20240814$EXP$$IL-JNJFOC-20240768626$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$MD$IL$IL
242103171$24210317$1$I$20240618$20240801$20240814$20240814$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000770$PAREXEL$$$$$$Y$$$20240814$$HP$CN$CN
242103183$24210318$3$F$$20240830$20240814$20240904$EXP$$DE-ORGANON-O2407DEU001915$ORGANON$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology.. 2024;48(5):299-313$41$YR$$M$Y$$$20240904$$HP$DE$DE
242103201$24210320$1$I$$20240813$20240814$20240814$PER$$US-TAKEDA-2024TUS081488$TAKEDA$$$$$$Y$$$20240814$$CN$US$US
242103211$24210321$1$I$20240101$20240812$20240814$20240814$PER$$US-BAYER-2024A116113$BAYER$$27$YR$A$F$Y$$$20240814$$HP$US$US
242103221$24210322$1$I$20240709$20240808$20240814$20240814$EXP$FR-AFSSAPS-LL2024001534$FR-SA-2024SA236707$SANOFI AVENTIS$$59$YR$A$F$Y$92.4$KG$20240814$$PH$FR$FR
242103231$24210323$1$I$20240809$20240809$20240814$20240814$EXP$$US-SA-2024SA241345$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240814$$CN$US$US
242103241$24210324$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA238986$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240814$$MD$US$US
242103251$24210325$1$I$20240101$20240808$20240814$20240814$PER$$US-SA-2024SA239255$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240814$$MD$US$US
242103261$24210326$1$I$20240808$20240808$20240814$20240814$PER$$US-SA-2024SA237834$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240814$$CN$US$US
242103271$24210327$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA238684$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240814$$CN$US$US
242103281$24210328$1$I$$20240812$20240814$20240814$PER$$US-BAYER-2024A116136$BAYER$$25$YR$A$F$Y$$$20240814$$MD$US$US
242103291$24210329$1$I$$20240808$20240814$20240814$PER$$US-AstraZeneca-2024A182662$ASTRAZENECA$$$$$$Y$$$20240814$$HP$US$
242103301$24210330$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA238213$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240814$$MD$US$US
242103312$24210331$2$F$20240324$20240826$20240814$20240831$EXP$$JP-AstraZeneca-2024A179003$ASTRAZENECA$$64$YR$$M$Y$63$KG$20240831$$MD$JP$
242103321$24210332$1$I$20240603$20240806$20240814$20240814$EXP$$FR-AstraZeneca-2024A178042$ASTRAZENECA$$63$YR$$M$Y$83.6$KG$20240814$$MD$FR$
242103331$24210333$1$I$$20240730$20240814$20240814$EXP$$US-GLANDPHARMA-US-2024GLNLIT00608$GLAND PHARMA$Alexandra Dennee.Sinus Arrest Related to Dexmedetomidine Infusion in an Infant; a Case Report and Review of Current Literature.Journal of Pharmacy Practice.2024;37(4):1026-1031$11$MON$I$F$Y$$$20240814$$MD$US$US
242103341$24210334$1$I$$20240801$20240814$20240814$PER$$US-Calliditas-2024CAL01221$CALLIDITAS THERAPEUTICS$$24$YR$A$M$Y$75.7$KG$20240814$$CN$US$US
242103351$24210335$1$I$$20240808$20240814$20240814$EXP$$US-AMGEN-USASP2024161085$AMGEN$Herrera A. F.; Zain J.; Savage K.J. et. al. Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study. Lancet Haematology. 2024;1-11$$$$$Y$$$20240814$$MD$US$US
242103361$24210336$1$I$20240802$20240812$20240814$20240814$EXP$ES-AEMPS-1560620$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-127943$BRISTOL MYERS SQUIBB$$2$YR$C$F$Y$$$20240814$$MD$ES$ES
242103383$24210338$3$F$$20240903$20240814$20240903$PER$$US-ALXN-202408USA000490US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242103391$24210339$1$I$20231201$20240809$20240814$20240814$EXP$$US-ABBVIE-5876249$ABBVIE$$$$$$Y$$$20240814$$MD$US$US
242103403$24210340$3$F$20240724$20240904$20240814$20240916$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000021$IOVANCE BIOTHERAPEUTICS$$37$YR$$M$Y$70.9$KG$20240913$$CN$US$US
242103412$24210341$2$F$$20240827$20240814$20240828$PER$$NVSC2024US165120$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242103421$24210342$1$I$$20240730$20240814$20240814$EXP$$US-GLANDPHARMA-US-2024GLNLIT00604$GLAND PHARMA$TM Kuczmarski.Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma.British Journal of Haematology.JAN-2024;205 No.1:100-108$58$YR$A$M$Y$$$20240814$$HP$US$US
242103431$24210343$1$I$20240801$20240804$20240814$20240814$EXP$GB-MHRA-MED-202408042313224140-QBWYD$GB-FERRINGPH-2024FE04374$FERRING$$$$$$Y$$$20240814$$CN$GB$GB
242103441$24210344$1$I$$20240813$20240814$20240814$PER$$US-ROCHE-10000056104$ROCHE$$$$$$Y$$$20240814$$CN$US$US
242103451$24210345$1$I$$20240812$20240814$20240814$PER$$US-ROCHE-10000055939$ROCHE$$82$YR$E$M$Y$$$20240814$$CN$US$US
242103461$24210346$1$I$$20240812$20240814$20240814$PER$$US-ROCHE-10000055328$ROCHE$$$$E$M$Y$$$20240814$$CN$US$US
242103473$24210347$3$F$20240731$20240820$20240814$20240824$PER$$US-AMGEN-USASP2024161196$AMGEN$$78$YR$E$F$Y$$$20240824$$CN$US$US
242103481$24210348$1$I$$20240802$20240814$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002225$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240814$$CN$US$US
242103491$24210349$1$I$$20240802$20240814$20240814$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408001750$ELI LILLY AND CO$$32$YR$A$M$Y$$$20240814$$CN$DE$DE
242103501$24210350$1$I$20240113$20240805$20240814$20240814$EXP$FR-AFSSAPS-NY2024000913$FR-ELI_LILLY_AND_COMPANY-FR202408002650$ELI LILLY AND CO$$85$YR$E$M$Y$82.8$KG$20240814$$CN$FR$FR
242103511$24210351$1$I$20230101$20240805$20240814$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004578$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240814$$CN$US$US
242103521$24210352$1$I$$20240808$20240814$20240814$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202408005013$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240814$$CN$AU$AU
242103531$24210353$1$I$20240609$20240803$20240814$20240814$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408002402$ELI LILLY AND CO$$41$YR$A$F$Y$82$KG$20240814$$CN$CN$CN
242103541$24210354$1$I$20240719$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408051412310250-TSHMQ$GB-ELI_LILLY_AND_COMPANY-GB202408003627$ELI LILLY AND CO$$$$$M$Y$$$20240814$$CN$GB$GB
242103551$24210355$1$I$20240706$20240806$20240814$20240814$EXP$HR-HALMED-300086301$HR-ELI_LILLY_AND_COMPANY-HR202408008569$ELI LILLY AND CO$$66$YR$E$M$Y$85$KG$20240814$$CN$DE$HR
242103561$24210356$1$I$20240227$20240809$20240814$20240814$EXP$FR-AFSSAPS-NT2024001038$FR-ELI_LILLY_AND_COMPANY-FR202408006182$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240814$$CN$FR$FR
242103571$24210357$1$I$$20240802$20240814$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002689$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240814$$CN$US$US
242103581$24210358$1$I$$20240802$20240814$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001912$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240814$$CN$US$US
242103591$24210359$1$I$$20240808$20240814$20240814$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408005609$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240814$$PH$JP$JP
242103601$24210360$1$I$20230201$20240809$20240814$20240814$EXP$$AT-ELI_LILLY_AND_COMPANY-AT202309016925$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240814$$CN$AT$AT
242103611$24210361$1$I$$20240801$20240814$20240814$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202408003642$ELI LILLY AND CO$$$$A$F$Y$$$20240814$$CN$IN$IN
242103621$24210362$1$I$$20240805$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408002754$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242103632$24210363$2$F$20240809$20240814$20240814$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408006552$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240821$$HP$US$US
242103641$24210364$1$I$$20240804$20240814$20240814$EXP$$US-JNJFOC-20240816581$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$HP$US$US
242103651$24210365$1$I$$20240807$20240814$20240814$EXP$$NVSC2024BR164605$NOVARTIS$$$$$F$Y$$$20240814$$CN$BR$BR
242103661$24210366$1$I$20240201$20240807$20240814$20240814$EXP$$NVSC2024AR162762$NOVARTIS$$39$YR$$F$Y$$$20240814$$CN$AR$AR
242103671$24210367$1$I$$20240722$20240814$20240814$PER$$US-BIOVITRUM-2024-US-010868$BIOVITRUM$$77$YR$$M$Y$$$20240814$$CN$US$US
242103682$24210368$2$F$20240805$20240903$20240814$20240913$30DAY$$US-GSK-US2024097578$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240913$$CN$US$US
242103691$24210369$1$I$20240801$20240811$20240814$20240814$EXP$$AU-GSK-AU2024100190$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$AU$AU
242103704$24210370$4$F$$20240819$20240814$20240827$EXP$$NVSC2024PL163188$NOVARTIS$Zajac-Spychala O, Pieczonka A, Janura-Szymanska J, Jonczyk-Potoczna K, Wachowiak J.. Multiple reactivations of viral infections followed by cerebral toxoplasmosis after allogeneic hematopoietic stem cell transplantation in an adolescent with Ph(+) acute lymphoblastic leukemia: A case report.. TRANSPLANTATION PROCEEDINGS. 2021;53(4):1355-9$17$YR$$F$Y$$$20240827$$HP$PL$PL
242103711$24210371$1$I$$20240711$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07219$LUPIN$$$$$$Y$$$20240814$$PH$US$US
242103721$24210372$1$I$$20240627$20240814$20240814$PER$$US-LUNDBECK-DKLU4000992$LUNDBECK$$$$$$Y$$$20240814$$CN$US$US
242103731$24210373$1$I$$20240730$20240814$20240814$EXP$$IN-GLANDPHARMA-IN-2024GLNLIT00617$GLAND PHARMA$Kompalli Rohit Kumar.Topical 5-Fluorouracil as Primary Treatment for Ocular Surface Squamous Neoplasia: A Case Series Evaluation..Research Journal of Medical Sciences.JAN-2024;18 (No.5):574-578$$$$$Y$$$20240814$$HP$IN$IN
242103761$24210376$1$I$$20240812$20240814$20240814$PER$$US-ABBVIE-5877893$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242103771$24210377$1$I$20230901$20240806$20240814$20240814$EXP$FR-AFSSAPS-LY2023001576$FR-TEVA-VS-3230728$TEVA$$$$A$F$Y$$$20240814$$MD$FR$FR
242103781$24210378$1$I$$20240627$20240814$20240814$PER$$US-LUNDBECK-DKLU4000984$LUNDBECK$$$$$$Y$$$20240814$$CN$US$US
242103792$24210379$2$F$$20240803$20240814$20240911$EXP$$CA-BEH-2024176997$CSL BEHRING$$$$E$M$Y$68$KG$20240911$$CN$CA$CA
242103801$24210380$1$I$$20240813$20240814$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA072508$SANDOZ$$$$$F$Y$$$20240814$$MD$CA$CA
242103811$24210381$1$I$20240401$20240802$20240814$20240814$PER$$US-IGSA-BIG0030165$GRIFOLS$$66$YR$$F$Y$$$20240814$$CN$US$US
242103822$24210382$2$F$$20240905$20240814$20240915$EXP$$US-UCBSA-2024039258$UCB$$$$$F$Y$$$20240915$$HP$US$US
242103831$24210383$1$I$$20240730$20240814$20240814$EXP$$US-GLANDPHARMA-US-2024GLNLIT00624$GLAND PHARMA$DP Weigle.Uncommon and Unfavorable: Heparin-Induced Hyperkalemia.Journal of Cardiothoracic and Vascular Anesthesia.JAN-2024;1-4$56$YR$A$M$Y$$$20240814$$HP$US$US
242103841$24210384$1$I$20240723$20240809$20240814$20240814$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000784$PAREXEL$$$$$$Y$$$20240814$$HP$CN$CN
242103851$24210385$1$I$$20240808$20240814$20240814$PER$$US-ROCHE-10000054032$ROCHE$Gupta N, Mahajan D. Tofacitinib as alternative to TNF blockers in refractory anterior uveitis - an observational study.. Annals of the Rheumatic Diseases. 2024-Jun;83:2040. doi:10.1136/annrheumdis-2024-eular.304.$$$$$Y$$$20240814$$HP$US$US
242103861$24210386$1$I$$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408051435516630-MQRCD$GB-TEVA-VS-3230360$TEVA$$$$$M$Y$$$20240814$$PH$GB$GB
242103872$24210387$2$F$20240730$20240829$20240814$20240906$EXP$$JP-ROCHE-10000053212$ROCHE$$84$YR$E$M$Y$$$20240906$$MD$JP$JP
242103882$24210388$2$F$20240505$20240903$20240814$20240903$PER$$US-ALXN-202408USA000578US$ALEXION PHARMACEUTICALS$$93$YR$$M$Y$$$20240903$$CN$US$US
242103891$24210389$1$I$20240613$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408051426392060-BSVCJ$GB-TEVA-VS-3230335$TEVA$$71$YR$$F$Y$77$KG$20240814$$CN$GB$GB
242103901$24210390$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126909$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240814$$CN$US$US
242103911$24210391$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128270$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240814$$CN$US$US
242103921$24210392$1$I$$20240730$20240814$20240814$EXP$$TR-GLANDPHARMA-TR-2024GLNLIT00626$GLAND PHARMA$F Cakan.Intraoperative Takotsubo Cardiomyopathy: A  Case Report.Journal of Perianesthesia Nursing.MAR-2024$18$YR$T$F$Y$50$KG$20240814$$HP$TR$TR
242103931$24210393$1$I$20240701$20240725$20240814$20240814$PER$$CA-TOLMAR, INC.-24CA051331$TOLMAR$$85$YR$$M$Y$$$20240813$$CN$CA$CA
242103941$24210394$1$I$$20240724$20240814$20240814$PER$$CA-TOLMAR, INC.-24CA051350$TOLMAR$$$$$M$Y$$$20240813$$CN$CA$CA
242103951$24210395$1$I$$20240725$20240814$20240814$PER$$CA-TOLMAR, INC.-24CA051330$TOLMAR$$$$$M$Y$$$20240813$$CN$CA$CA
242103971$24210397$1$I$$20240726$20240814$20240814$PER$$CA-TOLMAR, INC.-24CA051359$TOLMAR$$$$$M$Y$$$20240813$$CN$CA$CA
242103981$24210398$1$I$$20240726$20240814$20240814$PER$$CA-TOLMAR, INC.-24CA051371$TOLMAR$$$$$M$Y$$$20240813$$CN$CA$CA
242103991$24210399$1$I$20240726$20240726$20240814$20240814$PER$$CA-TOLMAR, INC.-24CA051382$TOLMAR$$64$YR$$M$Y$$$20240813$$CN$CA$CA
242104001$24210400$1$I$$20240725$20240814$20240814$PER$$CA-TOLMAR, INC.-24CA051403$TOLMAR$$$$$M$Y$$$20240813$$CN$CA$CA
242104011$24210401$1$I$20240726$20240726$20240814$20240814$PER$$CA-TOLMAR, INC.-24CA051414$TOLMAR$$82$YR$$M$Y$$$20240813$$CN$CA$CA
242104021$24210402$1$I$20240719$20240726$20240814$20240814$PER$$CO-TOLMAR, INC.-24CO049852$TOLMAR$$74$YR$$M$Y$$$20240813$$CN$CO$CO
242104031$24210403$1$I$$20240725$20240814$20240814$PER$$CO-TOLMAR, INC.-24CO051384$TOLMAR$$$$$M$Y$$$20240813$$CN$CO$CO
242104041$24210404$1$I$20240301$20240726$20240814$20240814$PER$$CO-TOLMAR, INC.-24CO051336$TOLMAR$$89$YR$$M$Y$$$20240813$$CN$CO$CO
242104051$24210405$1$I$20240601$20240726$20240814$20240814$PER$DK-DKMA-30735082$DK-TOLMAR, INC.-24DK051310$TOLMAR$$86$YR$$M$Y$80$KG$20240813$$MD$DK$DK
242104061$24210406$1$I$20240701$20240725$20240814$20240814$PER$$CO-TOLMAR, INC.-24CO051412$TOLMAR$$76$YR$$M$Y$$$20240813$$CN$CO$CO
242104071$24210407$1$I$20160601$20240808$20240814$20240814$EXP$$AT-009507513-2406AUT003451$MERCK$$$$$M$Y$$$20240814$$MD$AT$AT
242104081$24210408$1$I$$20240812$20240814$20240814$PER$$US-009507513-2408USA004168$MERCK$$$$$M$Y$$$20240814$$CN$US$US
242104091$24210409$1$I$$20240715$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07267$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242104101$24210410$1$I$20240707$20240805$20240814$20240814$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000773$PAREXEL$$$$$$Y$$$20240814$$HP$CN$CN
242104132$24210413$2$F$$20240805$20240814$20240820$EXP$$US-PFIZER INC-PV202400104662$PFIZER$$77$YR$$$Y$$$20240820$$CN$US$US
242104141$24210414$1$I$20240724$20240809$20240814$20240814$EXP$$CN-PFIZER INC-PV202400104237$PFIZER$$43$YR$$F$Y$$$20240814$$HP$CN$CN
242104152$24210415$2$F$20230101$20240912$20240814$20240916$EXP$$US-PFIZER INC-202400234474$PFIZER$$52$YR$$F$Y$107.05$KG$20240916$$CN$US$US
242104161$24210416$1$I$$20240730$20240814$20240814$EXP$$PT-GLANDPHARMA-PT-2024GLNLIT00611$GLAND PHARMA$M. Alzamora.Different kinds of embolization in advanced carcinomas: A review of literature, visual comparison and possible complications.Virchows Archiv.SEP-2023;483:S218-S219$$$$$Y$$$20240814$$HP$PT$PT
242104172$24210417$2$F$20240718$20240808$20240814$20240819$EXP$$ES-ACRAF SpA-2024-034817$SK LIFE SCIENCE$$$$$$Y$$$20240819$$MD$ES$ES
242104183$24210418$3$F$$20240830$20240814$20240906$EXP$$GB-TAKEDA-2022TUS056785$TAKEDA$$$$A$F$Y$$$20240906$$HP$GB$GB
242104191$24210419$1$I$20240101$20240809$20240814$20240814$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-126838$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240814$$CN$PR$PR
242104201$24210420$1$I$$20240801$20240814$20240814$EXP$$DE-Unichem Pharmaceuticals (USA) Inc-UCM202408-001015$UNICHEM$$66$YR$E$F$Y$$$20240814$$HP$DE$
242104211$24210421$1$I$20240803$20240806$20240814$20240814$EXP$$US-RECORDATI RARE DISEASE INC.-2024006105$RECORDATI$$$$$$Y$$$20240814$$CN$US$US
242104222$24210422$2$F$20240812$20240821$20240814$20240828$PER$$US-BAYER-2024A116405$BAYER$$$$$F$Y$$$20240828$$CN$US$US
242104241$24210424$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160965$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242104252$24210425$2$F$$20240826$20240814$20240902$EXP$$BR-JNJFOC-20240833026$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20240902$$CN$BR$BR
242104261$24210426$1$I$20240726$20240809$20240814$20240814$PER$$US-BAYER-2024A115536$BAYER$$19$YR$A$F$Y$$$20240814$$MD$US$US
242104271$24210427$1$I$$20240730$20240814$20240814$EXP$$US-GLANDPHARMA-US-2024GLNLIT00603$GLAND PHARMA$Andrew Murphy.AN UNCOMMON CUASE OF COMPLETE HEART BLOCK IN A PATIENT WITH A HISTORY OF SEIZURES.Journal of the American College of Cardiology .02-APR-2024;83 (No. 13):2881$64$YR$A$M$Y$$$20240814$$HP$US$US
242104282$24210428$2$F$$20240919$20240814$20240919$30DAY$$CO-PFIZER INC-PV202400104724$PFIZER$$11$YR$$M$Y$$$20240919$$CN$CO$CO
242104303$24210430$3$F$20230101$20240823$20240814$20240828$30DAY$$US-PFIZER INC-PV202300026673$PFIZER$$48$YR$$F$Y$86.168$KG$20240828$$MD$US$US
242104321$24210432$1$I$$20240809$20240814$20240814$30DAY$$US-PFIZER INC-PV202400044270$PFIZER$$$$$$Y$$$20240814$$CN$US$US
242104331$24210433$1$I$20210901$20240812$20240814$20240814$EXP$FR-AFSSAPS-RS2024000795$FR-PFIZER INC-202400234441$PFIZER$$74$YR$$F$Y$70$KG$20240814$$PH$FR$FR
242104341$24210434$1$I$$20240808$20240814$20240814$30DAY$$IE-PFIZER INC-PV202400103503$PFIZER$$52$YR$$M$Y$$$20240814$$CN$IE$IE
242104351$24210435$1$I$20240716$20240809$20240814$20240814$EXP$$CN-PFIZER INC-PV202400104274$PFIZER$$14$YR$$M$Y$105$KG$20240814$$HP$CN$CN
242104361$24210436$1$I$20240613$20240808$20240814$20240814$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012235$JAZZ$$57$YR$$F$Y$$$20240814$$HP$US$US
242104371$24210437$1$I$$20240802$20240814$20240814$EXP$$IT-RDY-LIT/ITA/24/0011806$DR REDDYS$Diral E, Furnari G, Bruno A, Greco R, Clerici D, Marktel S, et al. Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience. Frontiers in Oncology. 2024;14: doi:10.3389/fonc.2024.1391743.$$$$$Y$$$20240814$$HP$IT$IT
242104381$24210438$1$I$$20240808$20240814$20240814$EXP$$NVSC2024AU163524$NOVARTIS$$74$YR$$F$Y$$$20240814$$MD$AU$AU
242104391$24210439$1$I$$20240802$20240814$20240814$EXP$$IT-RDY-LIT/ITA/24/0011807$DR REDDYS$Diral E, Furnari G, Bruno A, Greco R, Clerici D, Marktel S, et al. Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience. Frontiers in Oncology. 2024;14: doi:10.3389/fonc.2024.1391743.$$$$$Y$$$20240814$$HP$IT$IT
242104402$24210440$2$F$$20240830$20240814$20240830$PER$$US-ALXN-202408USA000579US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242104411$24210441$1$I$20220825$20240809$20240814$20240814$PER$$US-BAYER-2024A115663$BAYER$$23$YR$A$F$Y$$$20240814$$CN$US$US
242104421$24210442$1$I$20240524$20240806$20240814$20240814$EXP$$US-ZENPEP LLC-2024AIMT01210$AIMMUNE$$$$$$Y$$$20240814$$HP$US$US
242104431$24210443$1$I$$20240809$20240814$20240814$EXP$$US-SA-2024SA240101$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240814$$CN$US$US
242104441$24210444$1$I$20220701$20240729$20240814$20240814$PER$$US-009507513-2407USA015765$MERCK$$$$$F$Y$$$20240814$$CN$US$US
242104451$24210445$1$I$$20240805$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124471$BRISTOL MYERS SQUIBB$Miller AC, Temiz LA, Adjei S, Duran MA, Sassmannshausen J, Dominguez A, et al. Treatment of bullous pemphigoid with dupilumab: a case series of 30 patients. Journal of Drugs in Dermatology. 2024 Jun 01;23(6):e144-8. doi:10.36849/JDD.8258e.$82$YR$E$F$Y$$$20240814$$MD$US$US
242104461$24210446$1$I$20240524$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128291$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240814$$CN$US$US
242104471$24210447$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55777$$FDA-CTU$$15$YR$$$N$$$20240813$N$CN$US$
242104481$24210448$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA137394$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240814$$MD$US$US
242104491$24210449$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA240728$SANOFI AVENTIS$$16$YR$T$M$Y$108.8$KG$20240814$$MD$US$US
242104501$24210450$1$I$20240718$20240809$20240814$20240814$PER$$US-BAYER-2024A116264$BAYER$$38$YR$A$F$Y$$$20240814$$HP$US$US
242104511$24210451$1$I$$20231009$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2023US043456$SANDOZ$$$$$M$Y$111.13$KG$20240814$$HP$US$US
242104521$24210452$1$I$$20240805$20240814$20240814$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000083$PAREXEL$$$$$$Y$$$20240814$$HP$US$US
242104541$24210454$1$I$$20240730$20240814$20240814$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00605$GLAND PHARMA$$40$YR$A$F$Y$$$20240814$$HP$JP$JP
242104551$24210455$1$I$20240530$20240812$20240814$20240814$EXP$$FR-PFIZER INC-202400201365$PFIZER$$67$YR$$F$Y$52$KG$20240814$$PH$FR$FR
242104561$24210456$1$I$20240812$20240813$20240814$20240814$EXP$$US-PFIZER INC-202400236116$PFIZER$$78$YR$$M$Y$$$20240814$$CN$US$US
242104571$24210457$1$I$$20240812$20240814$20240814$EXP$$DO-PFIZER INC-202400235770$PFIZER$$56$YR$$M$Y$$$20240814$$CN$DO$DO
242104581$24210458$1$I$20201215$20240813$20240814$20240814$EXP$$US-PFIZER INC-PV202400105401$PFIZER$$100$YR$$F$Y$$$20240814$$PH$US$US
242104591$24210459$1$I$$20240813$20240814$20240814$EXP$$CN-PFIZER INC-PV202400105158$PFIZER$$$$A$M$Y$$$20240814$$CN$CN$CN
242104611$24210461$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007631$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240814$$CN$US$US
242104621$24210462$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007623$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240814$$PH$US$US
242104631$24210463$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007745$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240814$$CN$US$US
242104641$24210464$1$I$20230823$20240807$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202308015254$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240814$$CN$US$US
242104651$24210465$1$I$20240804$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007366$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242104661$24210466$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007347$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240814$$CN$US$US
242104671$24210467$1$I$$20240808$20240814$20240814$EXP$$TR-ABBVIE-5879348$ABBVIE$Akcan OM, Genceli M, Ustunta  T, Akkus A, Pekcan S, Dogan M. Therapeutic insights: Use of ceftazidime avibactam in pediatric patients. Pediatrics International. 2024;66(1):e15787.$39$MON$$M$Y$$$20240814$$HP$TR$TR
242104681$24210468$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007640$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240814$$CN$US$US
242104691$24210469$1$I$20240101$20240812$20240814$20240814$PER$$US-DSJP-DSU-2024-140533$DAIICHI$$$$$F$Y$$$20240814$$MD$US$US
242104701$24210470$1$I$20240805$20240806$20240814$20240814$PER$$US-BAYER-2024A114192$BAYER$$23$YR$A$F$Y$$$20240814$$MD$US$US
242104711$24210471$1$I$$20240807$20240814$20240814$EXP$$IT-GSK-IT2024GSK100943$GLAXOSMITHKLINE$Riccio F, Annunziata M, Brancaccio M, Marchesano ML, Milone A, Parlati C et al. Efficacy and safety of belimumab in systemic lupus erythematosus: monocentre study. Annals of the Rheumatic Diseases. 2024;83 (Suppl 1):1882-1883$$$$$Y$$$20240814$$HP$IT$IT
242104721$24210472$1$I$20231110$20240812$20240814$20240814$EXP$$KR-MYLANLABS-2024M1074892$MYLAN$$71$YR$$M$Y$86.85$KG$20240814$$HP$KR$KR
242104732$24210473$2$F$20240809$20240828$20240814$20240903$EXP$$GB-MYLANLABS-2024M1075218$MYLAN$$$$$F$Y$$$20240903$$CN$GB$GB
242104741$24210474$1$I$$20240811$20240814$20240814$EXP$GB-MHRA-MED-202408112206023550-QKDCN$GB-MYLANLABS-2024M1074720$MYLAN$$2$YR$$M$Y$$$20240814$$CN$GB$GB
242104751$24210475$1$I$20230101$20240811$20240814$20240814$EXP$GB-MHRA-MED-202408110922541590-VBDRL$GB-MYLANLABS-2024M1074710$MYLAN$$64$YR$$M$Y$$$20240814$$CN$GB$GB
242104761$24210476$1$I$$20240809$20240814$20240814$PER$$NVSC2024US164977$NOVARTIS$$41$YR$$M$Y$$$20240814$$CN$US$US
242104772$24210477$2$F$20240705$20240923$20240814$20240927$EXP$PT-INFARMED-T202407-142$PT-ORGANON-O2408PRT000935$ORGANON$$72$YR$$F$Y$38.6$KG$20240927$$PH$PT$PT
242104781$24210478$1$I$$20240730$20240814$20240814$EXP$$US-GLANDPHARMA-US-2024GLNLIT00618$GLAND PHARMA$Lawrence Kwon.Portable Percussive Massage Device-Related Rectus Sheath Hematoma and Obstructive Uropathy: A Case Report.Biomedicine Hub.27-MAY-2024;9 (No. 1):89-93$$$A$M$Y$$$20240814$$HP$US$US
242104792$24210479$2$F$20240804$20240912$20240814$20240921$EXP$$JP-ROCHE-10000056788$ROCHE$$59$YR$A$M$Y$$$20240921$$MD$JP$JP
242104801$24210480$1$I$20240101$20240809$20240814$20240814$EXP$$US-ABBVIE-5876961$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242104811$24210481$1$I$20240101$20240730$20240814$20240814$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01261$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240814$$CN$US$US
242104821$24210482$1$I$20240812$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55881$$FDA-CTU$$63$YR$$F$N$$$20240813$N$CN$US$
242104832$24210483$2$F$20240806$20240816$20240814$20240822$EXP$$US-VERTEX PHARMACEUTICALS-2024-012952$VERTEX$$21$YR$$F$Y$$$20240822$$HP$US$US
242104841$24210484$1$I$$20240812$20240814$20240814$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013106$VERTEX$$$$A$F$Y$$$20240814$$CN$GB$GB
242104861$24210486$1$I$20231201$20240809$20240814$20240814$EXP$FR-AFSSAPS-LL2024001542$FR-VERTEX PHARMACEUTICALS-2024-013030$VERTEX$$64$YR$$F$Y$57$KG$20240814$$MD$FR$FR
242104891$24210489$1$I$$20240809$20240814$20240814$PER$$US-VERTEX PHARMACEUTICALS-2024-013142$VERTEX$$$$$$Y$$$20240814$$CN$US$US
242104901$24210490$1$I$20240628$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55876$$FDA-CTU$$34$YR$$F$N$81.65$KG$20240813$Y$$US$
242104911$24210491$1$I$20240807$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024159493$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242104921$24210492$1$I$20231009$20240809$20240814$20240814$EXP$$FR-AMGEN-FRASP2024158939$AMGEN$$74$YR$E$F$Y$62$KG$20240814$$MD$FR$FR
242104931$24210493$1$I$$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024161599$AMGEN$$$$$$Y$$$20240814$$CN$US$US
242104941$24210494$1$I$20240628$20240812$20240814$20240814$EXP$FR-AFSSAPS-ST2024001241$FR-ROCHE-10000055136$ROCHE$$73$YR$E$F$Y$70$KG$20240814$$MD$FR$FR
242104951$24210495$1$I$$20240812$20240814$20240814$EXP$$US-LUNDBECK-DKLU4002839$LUNDBECK$$$$$$Y$$$20240814$$HP$US$US
242104961$24210496$1$I$$20240730$20240814$20240814$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00614$GLAND PHARMA$Y Zhao.Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis.Zhonghua Er Ke Za Zhi.JAN-2024;62:60-65$$$$$Y$$$20240814$$HP$CN$CN
242104971$24210497$1$I$$20240808$20240814$20240814$PER$$US-FreseniusKabi-FK202412320$FRESENIUS KABI$$$$A$$Y$$$20240814$$HP$US$US
242104981$24210498$1$I$$20240807$20240814$20240814$PER$$US-FreseniusKabi-FK202412298$FRESENIUS KABI$$71$YR$E$F$Y$52.1$KG$20240814$$CN$US$US
242105001$24210500$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA234439$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240814$$CN$US$US
242105011$24210501$1$I$20240701$20240802$20240814$20240814$PER$$US-SA-2024SA233627$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240814$$MD$US$US
242105021$24210502$1$I$$20231016$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2023US047738$SANDOZ$$$$$M$Y$72.57$KG$20240814$$MD$US$US
242105031$24210503$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128639$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240814$$CN$US$US
242105041$24210504$1$I$20240811$20240813$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128666$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240814$$CN$US$US
242105051$24210505$1$I$20240803$20240806$20240814$20240814$EXP$$US-LUNDBECK-DKLU4002734$LUNDBECK$$$$$$Y$$$20240814$$CN$US$US
242105061$24210506$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55675$$FDA-CTU$$2$YR$$F$N$$$20240813$N$$US$
242105071$24210507$1$I$20240605$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55878$$FDA-CTU$$53$YR$$F$N$108.86$KG$20240813$N$CN$US$
242105091$24210509$1$I$20240310$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55771$$FDA-CTU$$70$YR$$M$N$63.5$KG$20240814$N$CN$US$
242105101$24210510$1$I$$20240812$20240814$20240814$PER$$US-GILEAD-2024-0684042$GILEAD$$$$$F$Y$$$20240814$$MD$US$US
242105123$24210512$3$F$20240809$20240814$20240814$20240819$PER$$US-PFIZER INC-PV202400096066$PFIZER$$73$YR$$F$Y$87.54$KG$20240819$$CN$US$US
242105133$24210513$3$F$20240101$20240906$20240814$20240920$EXP$$CA-UCBSA-2024040756$UCB$$$$$F$Y$$$20240920$$CN$CA$CA
242105141$24210514$1$I$$20240805$20240814$20240814$EXP$$GB-TEVA-VS-3230222$TEVA$$56$YR$$M$Y$125$KG$20240814$$HP$GB$GB
242105151$24210515$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234880$PFIZER$$$$A$M$Y$$$20240814$$MD$US$US
242105161$24210516$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400235055$PFIZER$$90$YR$$F$Y$$$20240814$$CN$US$US
242105171$24210517$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-202400234631$PFIZER$$49$YR$$M$Y$$$20240814$$MD$US$US
242105181$24210518$1$I$20240808$20240811$20240814$20240814$PER$$US-PFIZER INC-202400234240$PFIZER$$55$YR$$F$Y$$$20240814$$CN$US$US
242105201$24210520$1$I$20240101$20240809$20240814$20240814$PER$$US-PFIZER INC-PV202400105261$PFIZER$$57$YR$$F$Y$$$20240814$$HP$US$US
242105212$24210521$2$F$$20240913$20240814$20240913$PER$$US-PFIZER INC-202400232454$PFIZER$$16$YR$$M$Y$$$20240913$$CN$US$US
242105221$24210522$1$I$20240801$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234767$PFIZER$$$$A$F$Y$$$20240814$$PH$US$US
242105232$24210523$2$F$$20240815$20240814$20240820$PER$$US-PFIZER INC-202400234014$PFIZER$$94$YR$$F$Y$$$20240820$$MD$US$US
242105241$24210524$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234903$PFIZER$$82$YR$$F$Y$$$20240814$$CN$US$US
242105261$24210526$1$I$20240807$20240808$20240814$20240814$PER$$US-PFIZER INC-202400233047$PFIZER$$$$$F$Y$$$20240814$$CN$US$US
242105271$24210527$1$I$20240801$20240812$20240814$20240814$PER$$US-PFIZER INC-202400235235$PFIZER$$$$A$F$Y$$$20240814$$PH$US$US
242105281$24210528$1$I$20240812$20240813$20240814$20240814$PER$$US-PFIZER INC-202400235996$PFIZER$$55$YR$$F$Y$$$20240814$$CN$US$US
242105292$24210529$2$F$$20240815$20240814$20240819$PER$$US-PFIZER INC-202400235973$PFIZER$$$$$M$Y$$$20240819$$MD$US$US
242105301$24210530$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400234828$PFIZER$$86$YR$$M$Y$$$20240814$$MD$US$US
242105311$24210531$1$I$20240101$20240809$20240814$20240814$PER$$US-PFIZER INC-PV202400105420$PFIZER$$67$YR$$F$Y$$$20240814$$MD$US$US
242105321$24210532$1$I$$20240731$20240814$20240814$EXP$$FI-JNJFOC-20240828746$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240814$$HP$FI$FI
242105331$24210533$1$I$20240629$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408050942328210-TYRHD$GB-TEVA-VS-3230277$TEVA$$53$YR$$F$Y$$$20240814$$MD$GB$GB
242105341$24210534$1$I$20231001$20240809$20240814$20240814$EXP$$MX-ABBVIE-5879222$ABBVIE$$$$A$F$Y$$$20240814$$CN$MX$MX
242105361$24210536$1$I$20240801$20240813$20240814$20240814$EXP$$AU-MYLANLABS-2024M1075575$MYLAN$$48$YR$$M$Y$$$20240814$$HP$AU$AU
242105371$24210537$1$I$20240727$20240807$20240814$20240814$EXP$$US-Rigel Pharmaceuticals, Inc.-20240800036$RIGEL PHARMACEUTICALS$$35$YR$$M$Y$$$20240814$$CN$US$US
242105381$24210538$1$I$$20240810$20240814$20240814$PER$$US-HALEON-2191463$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242105391$24210539$1$I$20240805$20240813$20240814$20240814$PER$$US-ROCHE-10000056510$ROCHE$$32$YR$A$M$Y$$$20240814$$CN$US$US
242105401$24210540$1$I$$20240730$20240814$20240814$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00615$GLAND PHARMA$Y Zhao.Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis.Zhonghua Er Ke Za Zhi.JAN-2024;62:60-65$$$$$Y$$$20240814$$HP$CN$CN
242105411$24210541$1$I$$20240812$20240814$20240814$PER$$US-ROCHE-10000055855$ROCHE$$$$A$M$Y$$$20240814$$CN$US$US
242105421$24210542$1$I$$20240813$20240814$20240814$PER$$US-ROCHE-10000057010$ROCHE$$$$A$M$Y$$$20240814$$CN$US$US
242105431$24210543$1$I$$20240813$20240814$20240814$PER$$US-HALEON-2191963$Haleon PLC$$$$$$Y$$$20240814$$CN$US$US
242105441$24210544$1$I$20240719$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408051412310250-TSHMQ$GB-TEVA-VS-3230297$TEVA$$$$$M$Y$$$20240814$$MD$GB$GB
242105451$24210545$1$I$20231221$20240808$20240814$20240814$EXP$$US-CHIESI-2024CHF05071$CHIESI$$22$YR$$F$Y$49$KG$20240814$$CN$US$US
242105461$24210546$1$I$$20240812$20240814$20240814$EXP$$US-TAKEDA-2024TUS080712$TAKEDA$$$$$F$Y$$$20240814$$MD$US$US
242105474$24210547$4$F$20201022$20240920$20240814$20240923$EXP$$US-GILEAD-2024-0684165$GILEAD$$52$YR$A$F$Y$$$20240923$$LW$US$US
242105481$24210548$1$I$$20240807$20240814$20240814$EXP$$FR-MYLANLABS-2024M1075109$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$79$YR$$F$Y$$$20240814$$HP$FR$FR
242105491$24210549$1$I$$20221024$20240814$20240814$EXP$$US-AstraZeneca-2022A355412$ASTRAZENECA$$$$$$Y$$$20240814$$CN$US$
242105501$24210550$1$I$$20221125$20240814$20240814$EXP$$US-AstraZeneca-2022A343306$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242105511$24210551$1$I$20240810$20240812$20240814$20240814$PER$$US-JNJFOC-20240829507$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240814$$CN$US$US
242105521$24210552$1$I$20240513$20240730$20240814$20240814$EXP$IS-IMA-8755$IS-PHARMAAND GMBH-2024PHR00454$pharmaAND$$32$YR$$F$Y$67$KG$20240814$$CN$IS$IS
242105531$24210553$1$I$$20240812$20240814$20240814$EXP$$FR-SANDOZ INC.-NVSC2020FR272415$SANDOZ$$51$YR$$F$Y$$$20240814$$MD$FR$FR
242105541$24210554$1$I$$20240807$20240814$20240814$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07129$VIFOR$$$$E$F$Y$$$20240814$$HP$ZA$ZA
242105551$24210555$1$I$20240101$20240806$20240814$20240814$EXP$$FR-SA-2024SA239546$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240814$$MD$FR$FR
242105561$24210556$1$I$20240101$20240807$20240814$20240814$PER$$US-ABBVIE-5871916$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242105571$24210557$1$I$20240503$20240809$20240814$20240814$EXP$$US-JNJFOC-20240520130$JOHNSON AND JOHNSON$$47$YR$A$F$Y$103.6$KG$20240814$$HP$US$US
242105582$24210558$2$F$$20240927$20240814$20240927$PER$$NVSC2024US165178$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
242105592$24210559$2$F$$20240903$20240814$20240906$PER$$US-AMGEN-USASP2024161387$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242105601$24210560$1$I$20240811$20240813$20240814$20240814$PER$$US-AMGEN-USASP2024161194$AMGEN$$66$YR$E$F$Y$$$20240814$$CN$US$US
242105611$24210561$1$I$20240801$20240805$20240814$20240814$30DAY$$US-GSK-US2024097583$GLAXOSMITHKLINE$$81$YR$$F$Y$$$20240814$$CN$US$US
242105622$24210562$2$F$20240101$20240909$20240814$20240923$PER$$US-SA-2024SA240610$SANOFI AVENTIS$$11$YR$C$M$Y$40.4$KG$20240923$$MD$US$US
242105631$24210563$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA240150$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240814$$MD$US$US
242105641$24210564$1$I$$20240809$20240814$20240814$EXP$$IT-AMGEN-ITASP2024159298$AMGEN$Sacca F.; Pane C.; Stefano V.D. et al.. A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients. Journal of Neurology. 2024;1-11$$$$$Y$$$20240814$$HP$IT$IT
242105651$24210565$1$I$$20240806$20240814$20240814$EXP$GB-MHRA-MED-202408061252209360-BSZDV$GB-BAYER-2024A113553$BAYER$$$$$F$Y$$$20240814$$CN$GB$GB
242105661$24210566$1$I$$20240805$20240814$20240814$EXP$$TH-FreseniusKabi-FK202412370$FRESENIUS KABI$Wangapakul T, Riley Moguel AE, Kayssi AR. Necrotizing Parasagittal Meningioma in Patient with Systemic Lupus Erythematosus after Treatments with Methotrexate and Hydroxychloroquine. Journal of Neurological Surgery Reports. 2024 Mar 28;85(1): 25-28. doi:https://doi.org/ 10.1055/a-2277-4296.$29$YR$A$F$Y$$$20240814$$MD$TH$TH
242105671$24210567$1$I$20240101$20240805$20240814$20240814$EXP$$CN-Eisai-EC-2024-171655$EISAI$$69$YR$E$M$Y$60$KG$20240814$$MD$CN$CN
242105692$24210569$2$F$20240801$20240823$20240814$20240905$PER$$US-Calliditas-2024CAL01465$CALLIDITAS THERAPEUTICS$$41$YR$A$M$Y$78.3$KG$20240905$$CN$US$US
242105701$24210570$1$I$20240325$20240812$20240814$20240814$EXP$FR-AFSSAPS-LY2024000961$FR-GSK-FR2024100492$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$FR$FR
242105711$24210571$1$I$$20240812$20240814$20240814$EXP$$CA-TAKEDA-2024TUS081204$TAKEDA$$$$$F$Y$$$20240814$$CN$CA$CA
242105721$24210572$1$I$20220306$20240812$20240814$20240814$EXP$$US-TAKEDA-2022TUS015301$TAKEDA$$69$YR$$M$Y$$$20240814$$MD$US$US
242105731$24210573$1$I$20240503$20240812$20240814$20240814$EXP$$CA-ABBVIE-5877986$ABBVIE$$70$YR$$M$Y$$$20240814$$CN$CA$CA
242105742$24210574$2$F$$20240809$20240814$20240822$EXP$$US-AMGEN-USASP2024159670$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242105762$24210576$2$F$$20240822$20240814$20240827$EXP$$IN-PFIZER INC-202200405037$PFIZER$$45$YR$$M$Y$$$20240827$$CN$IN$IN
242105771$24210577$1$I$$20240813$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008407$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240814$$CN$US$US
242105781$24210578$1$I$20240811$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007357$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240814$$CN$US$US
242105791$24210579$1$I$$20240813$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008279$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240814$$CN$US$US
242105801$24210580$1$I$20240812$20240813$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008516$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240814$$CN$US$US
242105811$24210581$1$I$$20240812$20240814$20240814$PER$$US-BIOGEN-2024BI01278041$BIOGEN$$$$$F$Y$$$20240814$$CN$US$US
242105821$24210582$1$I$20240101$20240812$20240814$20240814$PER$$US-BIOGEN-2024BI01269816$BIOGEN$$$$$F$Y$$$20240814$$CN$US$US
242105831$24210583$1$I$20240804$20240805$20240814$20240814$EXP$$CN-TAKEDA-2024TUS079730$TAKEDA$$54$YR$$F$Y$74$KG$20240814$$HP$CN$CN
242105841$24210584$1$I$$20240812$20240814$20240814$EXP$$CA-TAKEDA-2024TUS081334$TAKEDA$$$$$M$Y$$$20240814$$CN$CA$CA
242105851$24210585$1$I$20240802$20240809$20240814$20240814$EXP$$IE-ABBVIE-5877111$ABBVIE$$59$YR$$F$Y$$$20240814$$CN$IE$IE
242105861$24210586$1$I$20240701$20240808$20240814$20240814$PER$$US-SA-2024SA239308$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240814$$MD$US$US
242105871$24210587$1$I$20240804$20240806$20240814$20240814$PER$$US-SA-2024SA230790$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240814$$MD$US$US
242105881$24210588$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA240048$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240814$$MD$US$US
242105891$24210589$1$I$$20240809$20240814$20240814$EXP$$US-SA-2024SA240422$SANOFI AVENTIS$$$$A$$Y$$$20240814$$MD$US$US
242105901$24210590$1$I$20240101$20240730$20240814$20240814$PER$$US-COSETTE-CP2024US000200$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240814$$HP$US$US
242105911$24210591$1$I$$20240812$20240814$20240814$EXP$$US-JNJFOC-20240832926$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$MD$US$US
242105921$24210592$1$I$20240101$20240805$20240814$20240814$PER$$US-JNJFOC-20240810853$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$HP$US$US
242105931$24210593$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128394$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$94.8$KG$20240814$$HP$US$US
242105941$24210594$1$I$20240810$20240813$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128466$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240814$$CN$US$US
242105951$24210595$1$I$20240710$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55773$$FDA-CTU$$85$YR$$F$N$57.15$KG$20240814$$CN$US$
242105962$24210596$2$F$20201104$20240916$20240814$20240924$EXP$$FR-EMD Serono-2023467096$EMD SERONO INC$$54$YR$A$F$Y$$$20240924$$MD$FR$FR
242105972$24210597$2$F$$20240822$20240814$20240827$EXP$$US-AMGEN-USASP2024159546$AMGEN$Specks U.; Falde S.D.; Lal A. et al.. Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Diffuse Alveolar Hemorrhage With Avacopan. ARC open Rheumatology. 2024;1-10$$$$M$Y$$$20240827$$MD$US$US
242105991$24210599$1$I$20180620$20240806$20240814$20240814$EXP$FR-AFSSAPS-PC2024000603$FR-TEVA-VS-3230831$TEVA$$93$YR$$F$Y$44$KG$20240814$$PH$FR$FR
242106001$24210600$1$I$$20240808$20240814$20240814$PER$$US-ALXN-202408USA000509US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242106011$24210601$1$I$20240104$20240802$20240814$20240814$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000769$PAREXEL$$$$$$Y$$$20240814$$HP$CN$CN
242106021$24210602$1$I$20240512$20240802$20240814$20240814$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000774$PAREXEL$$$$$$Y$$$20240814$$HP$CN$CN
242106032$24210603$2$F$$20240814$20240814$20240820$PER$$US-JNJFOC-20240834859$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242106041$24210604$1$I$20240805$20240813$20240814$20240814$EXP$$CN-JNJFOC-20240835387$JOHNSON AND JOHNSON$$67$YR$E$M$Y$75$KG$20240814$$HP$CN$CN
242106051$24210605$1$I$20240101$20240807$20240814$20240814$EXP$$CN-SA-2024SA218511$SANOFI AVENTIS$$$$A$$Y$$$20240814$$CN$CN$CN
242106062$24210606$2$F$20240802$20240910$20240814$20240917$30DAY$$US-AMGEN-USASP2024157290$AMGEN$$76$YR$E$M$Y$68.3$KG$20240917$$HP$US$US
242106071$24210607$1$I$20221101$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024159273$AMGEN$Krause P.J.; Vannier E.; Rogers R. et al.. Tafenoquine for Relapsing Babesiosis: A Case Series. Clinical Infectious Diseases. 2024;79 (1):130-137$52$YR$A$M$Y$$$20240814$$HP$US$US
242106082$24210608$2$F$20240810$20240912$20240814$20240913$PER$$US-AMGEN-USASP2024161389$AMGEN$$67$YR$E$F$Y$$$20240913$$CN$US$US
242106091$24210609$1$I$$20240803$20240814$20240814$EXP$GB-MHRA-MED-202408031106086060-QNTZV$GB-LUPIN PHARMACEUTICALS INC.-2024-07816$LUPIN$$26$YR$$F$Y$$$20240814$$CN$GB$GB
242106101$24210610$1$I$20240804$20240805$20240814$20240814$PER$$US-ROCHE-10000051819$ROCHE$$$$$F$Y$$$20240814$$CN$US$US
242106111$24210611$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128732$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240814$$CN$US$US
242106121$24210612$1$I$$20240808$20240814$20240814$EXP$$IN-SA-2024SA236370$SANOFI AVENTIS$Bandyopadhyay D.. Exfoliative Dermatitis Induced by Leflunomide Therapy.. The Journal of Dermatology. 2003;30:845-6$52$YR$A$M$Y$$$20240814$$MD$IN$IN
242106131$24210613$1$I$$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128433$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240814$$CN$US$US
242106141$24210614$1$I$20240704$20240809$20240814$20240814$EXP$CH-SM-2024-14704$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-126939$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$50.3$KG$20240814$$PH$CH$CH
242106151$24210615$1$I$$20240805$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124442$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$52.62$KG$20240814$$CN$US$US
242106161$24210616$1$I$$20240813$20240814$20240814$PER$$US-TAKEDA-2024TUS081219$TAKEDA$$$$$F$Y$$$20240814$$CN$US$US
242106171$24210617$1$I$$20231207$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2023US070664$SANDOZ$$$$$M$Y$$$20240814$$HP$US$US
242106181$24210618$1$I$$20240812$20240814$20240814$PER$$US-ROCHE-1924292$ROCHE$Osorio C, Caceres J, Curcio C and Silverberg M. A case of acute fibrinous and organizing pneumonia. Chest 2016;150: 4 (1):808A-.$53$YR$A$F$Y$$$20240814$$HP$US$US
242106193$24210619$3$F$20230901$20240819$20240814$20240826$EXP$FR-AFSSAPS-DJ2024000895$FR-OTSUKA-2024_021995$OTSUKA$$16$YR$$M$Y$$$20240826$$PH$FR$FR
242106201$24210620$1$I$20240803$20240809$20240814$20240814$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000785$PAREXEL$$$$$$Y$$$20240814$$HP$CN$CN
242106211$24210621$1$I$20240730$20240806$20240814$20240814$EXP$$ZA-AstraZeneca-2024A179643$ASTRAZENECA$$48$YR$$M$Y$$$20240814$$CN$ZA$
242106221$24210622$1$I$20240805$20240806$20240814$20240814$EXP$$ZA-AstraZeneca-2024A179646$ASTRAZENECA$$68$YR$$F$Y$$$20240814$$CN$ZA$
242106232$24210623$2$F$20240401$20240822$20240814$20240903$EXP$$AU-BAYER-2024A113287$BAYER$$10$YR$C$$Y$$$20240903$$MD$AU$AU
242106241$24210624$1$I$20240415$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A182501$ASTRAZENECA$$26508$DY$$F$Y$$$20240814$$CN$US$
242106264$24210626$4$F$20231115$20240911$20240814$20240916$EXP$$US-GILEAD-2024-0684162$GILEAD$$59$YR$A$F$Y$$$20240916$$LW$US$US
242106271$24210627$1$I$20240726$20240808$20240813$20240813$DIR$FDA-CDER-CTU-2024-55775$$FDA-CTU$$$$$F$N$$$20240808$N$CN$US$
242106282$24210628$2$F$20240809$20240916$20240814$20240923$PER$$US-ROCHE-10000055497$ROCHE$$69$YR$E$M$Y$107.95$KG$20240923$$CN$US$US
242106291$24210629$1$I$$20240808$20240814$20240814$PER$$US-AstraZeneca-2024A181230$ASTRAZENECA$$$$C$$Y$$$20240814$$HP$US$
242106302$24210630$2$F$$20240808$20240814$20240814$PER$$US-AMGEN-USASP2024159624$AMGEN$Specks U.; Falde S.D.; Lal A. et al.. Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Diffuse Alveolar Hemorrhage With Avacopan. ARC open Rheumatology. 2024;1-10$$$$$Y$$$20240814$$MD$US$US
242106311$24210631$1$I$20240403$20240806$20240814$20240814$EXP$ES-AEMPS-1554511$ES-TEVA-VS-3231366$TEVA$$64$YR$$M$Y$$$20240814$$MD$ES$ES
242106321$24210632$1$I$$20240813$20240814$20240814$PER$$US-ROCHE-10000056681$ROCHE$$$$E$F$Y$$$20240814$$CN$US$US
242106331$24210633$1$I$$20240805$20240814$20240814$EXP$$US-TEVA-VS-3231036$TEVA$$$$$$Y$$$20240814$$CN$US$US
242106341$24210634$1$I$$20240812$20240814$20240814$EXP$$CA-GILEAD-2024-0679099$GILEAD$$$$A$M$Y$$$20240814$$MD$CA$CA
242106351$24210635$1$I$$20240731$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122773$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240814$$CN$US$US
242106361$24210636$1$I$20240530$20240809$20240814$20240814$EXP$FR-AFSSAPS-NC2024000976$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-127105$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240814$$MD$FR$FR
242106373$24210637$3$F$$20240910$20240814$20240920$30DAY$$CA-JNJFOC-20240830978$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$HP$CA$CA
242106381$24210638$1$I$20240718$20240812$20240814$20240814$EXP$FR-AFSSAPS-GR2024000999$FR-GSK-FR2024100486$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$PH$FR$FR
242106391$24210639$1$I$20240806$20240806$20240814$20240814$30DAY$$US-GSK-US2024098117$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240814$$CN$US$US
242106401$24210640$1$I$$20240812$20240814$20240814$30DAY$$US-SANDOZ INC.-SDZ2024US072193$SANDOZ$$$$$F$Y$$$20240814$$CN$US$US
242106411$24210641$1$I$20240614$20240809$20240814$20240814$EXP$$BR-TAKEDA-2024TUS081293$TAKEDA$$40$YR$$F$Y$$$20240814$$CN$BR$BR
242106431$24210643$1$I$$20240730$20240814$20240814$EXP$$DK-GLANDPHARMA-DK-2024GLNLIT00620$GLAND PHARMA$Carina Lundby.Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects..British Journal of Clinical Pharmacology .JAN-2024;90 No. 7:1741-1744$76$YR$E$F$Y$$$20240814$$HP$DK$DK
242106441$24210644$1$I$$20240808$20240814$20240814$EXP$$ES-OTSUKA-2024_022110$OTSUKA$$53$YR$$M$Y$$$20240814$$CN$ES$ES
242106451$24210645$1$I$$20240716$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07342$LUPIN$$$$$$Y$$$20240814$$MD$US$US
242106462$24210646$2$F$20240806$20240913$20240814$20240917$EXP$$NVSC2024ZA161411$NOVARTIS$$62$YR$$F$Y$$$20240918$$HP$ZA$ZA
242106471$24210647$1$I$20240802$20240813$20240814$20240814$EXP$$JP-BAYER-2024A112094$BAYER$$66$YR$E$$Y$$$20240814$$PH$JP$JP
242106481$24210648$1$I$20240708$20240804$20240814$20240814$EXP$GB-MHRA-MED-202408041150455740-QWCZK$GB-TEVA-VS-3230122$TEVA$$76$YR$$F$Y$88$KG$20240814$$MD$GB$GB
242106491$24210649$1$I$$20240810$20240814$20240814$EXP$$US-AMGEN-USASP2024159673$AMGEN$Lipsky P. E.; Salmon J.; Wallace D. J. et al.. Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo -controlled trial. Lupus Science + Medicine. 2024;11(2):1-10$$$$$Y$$$20240814$$MD$US$US
242106501$24210650$1$I$20240701$20240805$20240814$20240814$EXP$$US-TG THERAPEUTICS INC.-TGT003873$TG THERAPEUTICS$$$$$$Y$$$20240814$$CN$US$US
242106511$24210651$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240831262$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242106522$24210652$2$F$$20240909$20240814$20240919$30DAY$$RO-JNJFOC-20240830224$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$RO$RO
242106532$24210653$2$F$$20240816$20240814$20240831$PER$$US-GRANULES-US-2024GRASPO00319$GRANULES INDIA$$$$$$Y$345$KG$20240831$$CN$US$US
242106561$24210656$1$I$20240601$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55776$$FDA-CTU$$85$YR$$F$N$57.15$KG$20240814$N$CN$US$
242106571$24210657$1$I$20240201$20240804$20240813$20240813$DIR$FDA-CDER-CTU-2024-55778$$FDA-CTU$$73$YR$$M$N$90.72$KG$20240804$N$CN$US$
242106591$24210659$1$I$$20240809$20240814$20240814$PER$$US-HALEON-2191514$Haleon PLC$$$$$M$Y$$$20240814$$CN$US$US
242106601$24210660$1$I$20200801$20240813$20240814$20240814$EXP$$HR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045384$BOEHRINGER INGELHEIM$Aljinovic J, Soso D, Lovric Kojundzic S, Martinovic Kaliterna D, Marinovic I. First description of a female patient with advanced ankylosing spondylitis and polymyalgia rheumatica ? A case report. Reumatizam. 2023;2(70): 76-84.$63$YR$A$F$Y$$$20240814$$MD$HR$HR
242106612$24210661$2$F$$20240819$20240814$20240820$EXP$$US-GILEAD-2024-0683745$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$70$YR$E$$Y$$$20240820$$MD$US$US
242106621$24210662$1$I$$20240506$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US048936$SANDOZ$$76$YR$$M$Y$$$20240814$$CN$US$US
242106631$24210663$1$I$20240601$20240812$20240814$20240814$EXP$ES-AEMPS-1557577$ES-FreseniusKabi-FK202412384$FRESENIUS KABI$$$$$M$Y$$$20240814$$HP$ES$ES
242106641$24210664$1$I$$20240812$20240814$20240814$EXP$$DE-FreseniusKabi-FK202412414$FRESENIUS KABI$$28$YR$A$F$Y$108$KG$20240814$$CN$DE$DE
242106661$24210666$1$I$20240706$20240806$20240814$20240814$PER$$JP-Eisai-EC-2024-171696$EISAI$$$$E$M$Y$$$20240814$$MD$JP$JP
242106671$24210667$1$I$20240718$20240807$20240814$20240814$PER$$CN-Eisai-EC-2024-171724$EISAI$$67$YR$E$M$Y$54$KG$20240814$$HP$CN$CN
242106681$24210668$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128505$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240814$$CN$US$US
242106691$24210669$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128111$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240814$$CN$US$US
242106701$24210670$1$I$$20240624$20240814$20240814$PER$$US-LUNDBECK-DKLU4001475$LUNDBECK$$$$$$Y$$$20240814$$CN$US$US
242106711$24210671$1$I$$20240807$20240814$20240814$EXP$$CA-GSK-CA2023019737$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$CA$CA
242106721$24210672$1$I$$20240807$20240814$20240814$EXP$$JP-BAYER-2024A085675$BAYER$$76$YR$E$M$Y$$$20240814$$MD$JP$JP
242106731$24210673$1$I$$20240809$20240814$20240814$EXP$$MY-GSK-MY2024APC100142$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$MD$MY$MY
242106741$24210674$1$I$20240730$20240730$20240814$20240814$PER$$US-GRANULES-US-2024GRASPO00344$GRANULES INDIA$$52$YR$A$F$Y$$$20240814$$CN$US$US
242106751$24210675$1$I$$20240715$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07211$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242106761$24210676$1$I$$20240813$20240813$20240813$DIR$714069$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242106771$24210677$1$I$20240401$20240711$20240813$20240813$DIR$FDA-CDER-CTU-2024-55779$$FDA-CTU$$38$YR$$F$N$61.23$KG$20240711$N$CN$US$
242106781$24210678$1$I$$20240731$20240814$20240814$EXP$$US-HLS-202400663$HLS THERAPEUTICS$$68$YR$E$F$Y$$$20240814$$HP$US$US
242106791$24210679$1$I$20230101$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007725$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240814$$CN$US$US
242106801$24210680$1$I$$20240806$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007595$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240814$$CN$US$US
242106811$24210681$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007609$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240814$$CN$US$US
242106821$24210682$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007540$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240814$$CN$US$US
242106831$24210683$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007689$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240814$$CN$US$US
242106841$24210684$1$I$$20240805$20240814$20240814$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-15748$IPSEN$$61$YR$A$M$Y$$$20240814$$CN$US$US
242106851$24210685$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240831614$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242106861$24210686$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126813$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240814$$CN$US$US
242106871$24210687$1$I$$20240805$20240814$20240814$EXP$$US-GSK-US2024097597$GLAXOSMITHKLINE$$$$$M$Y$$$20240814$$CN$US$US
242106881$24210688$1$I$$20240807$20240814$20240814$EXP$$CA-GSK-CA2024098571$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$CA$CA
242106891$24210689$1$I$$20240812$20240814$20240814$EXP$$US-GILEAD-2024-0683903$GILEAD$$$$A$M$Y$$$20240814$$PH$US$US
242106901$24210690$1$I$$20240730$20240814$20240814$PER$$US-LEADINGPHARMA-US-2024LEASPO00355$LEADING PHARMA$$$$$$Y$$$20240814$$CN$US$US
242106911$24210691$1$I$20240808$20240808$20240814$20240814$EXP$$US-TAKEDA-2024TUS080228$TAKEDA$$33$YR$$F$Y$$$20240814$$CN$US$US
242106921$24210692$1$I$$20240731$20240814$20240814$EXP$IT-MINISAL02-994828$IT-Axellia-005300$XELLIA PHARMACEUTICALS$$72$YR$E$F$Y$$$20240814$$MD$IT$IT
242106931$24210693$1$I$$20240718$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07360$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242106941$24210694$1$I$$20240813$20240814$20240814$PER$$US-ABBVIE-5879635$ABBVIE$$$$$$Y$$$20240814$$MD$US$US
242106951$24210695$1$I$$20240808$20240814$20240814$PER$$US-ALXN-202408USA000510US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242106961$24210696$1$I$$20240808$20240814$20240814$EXP$$CZ-MYLANLABS-2024M1075266$MYLAN$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E et al. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study.. Neoplasma. 2017;64(5):762-9$50$YR$$M$Y$$$20240814$$HP$CZ$CZ
242106971$24210697$1$I$$20240716$20240814$20240814$PER$$US-ALXN-202407USA001112US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240814$$CN$US$US
242106981$24210698$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179927$ASTRAZENECA$$$$$F$Y$97.5$KG$20240814$$CN$US$
242106991$24210699$1$I$$20240729$20240814$20240814$PER$$US-AstraZeneca-2024A172687$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242107001$24210700$1$I$$20240808$20240814$20240814$EXP$$DE-MYLANLABS-2024M1074750$MYLAN$Bingert R, Kolbe V, Boy D, Buttner A. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. [German]. Rechtsmedizin 2023; 33 (5): 396-402.$17$YR$$M$Y$$$20240814$$HP$DE$DE
242107011$24210701$1$I$20240101$20240808$20240814$20240814$EXP$SE-SEMPA-2024-005866$SE-MYLANLABS-2024M1074542$MYLAN$$$$$M$Y$$$20240814$$CN$SE$SE
242107021$24210702$1$I$20240806$20240809$20240814$20240814$EXP$$US-AMGEN-USASP2024159225$AMGEN$$95$YR$E$F$Y$$$20240814$$CN$US$US
242107032$24210703$2$F$20240808$20240808$20240814$20240814$EXP$$US-AMGEN-USASP2024158576$AMGEN$$77$YR$E$F$Y$$$20240814$$HP$US$US
242107041$24210704$1$I$$20240730$20240814$20240814$PER$$US-LEADINGPHARMA-US-2024LEASPO00350$LEADING PHARMA$$$$$$Y$$$20240814$$CN$US$US
242107051$24210705$1$I$20240731$20240809$20240814$20240814$EXP$$CN-BAYER-2024A115798$BAYER$$53$YR$A$M$Y$88$KG$20240814$$HP$CN$CN
242107062$24210706$2$F$$20240909$20240814$20240918$30DAY$$US-JNJFOC-20240828872$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
242107071$24210707$1$I$$20240805$20240814$20240814$EXP$$CA-BAXTER-2024BAX022825$BAXTER$$71$YR$$M$Y$$$20240814$$HP$CA$CA
242107081$24210708$1$I$20240801$20240805$20240814$20240814$EXP$CN-NMPACDR-3704011509867202400697$CN-BAXTER-2024BAX022862$BAXTER$$47$YR$$F$Y$61$KG$20240814$$MD$CN$CN
242107091$24210709$1$I$20240614$20240807$20240814$20240814$EXP$GB-MHRA-MED-202408051235400280-NKCHF$GB-BAXTER-2024BAX022900$BAXTER$$56$YR$$F$Y$$$20240814$$PH$GB$GB
242107101$24210710$1$I$20240709$20240805$20240814$20240814$EXP$CN-NMPACDR-4301011002666202400434$CN-BAXTER-2024BAX022865$BAXTER$$50$YR$$F$Y$50$KG$20240814$$MD$CN$CN
242107112$24210711$2$F$20240626$20240822$20240814$20240906$30DAY$$US-BAXTER-2024BAX022537$BAXTER$$$$$$Y$$$20240906$$CN$US$US
242107121$24210712$1$I$20240729$20240805$20240814$20240814$EXP$CN-NMPACDR-5303011523952202400241$CN-BAXTER-2024BAX022878$BAXTER$$67$YR$$F$Y$$$20240814$$MD$CN$CN
242107131$24210713$1$I$$20240805$20240814$20240814$EXP$$GB-BAXTER-2024BAX022839$BAXTER$$61$YR$$F$Y$84$KG$20240814$$PH$GB$GB
242107141$24210714$1$I$20240807$20240807$20240814$20240814$EXP$$US-SA-2024SA240817$SANOFI AVENTIS$$80$YR$E$F$Y$76.65$KG$20240814$$MD$US$US
242107151$24210715$1$I$20240801$20240805$20240814$20240814$EXP$CN-NMPACDR-3402011513123202400394$CN-BAXTER-2024BAX022859$BAXTER$$40$YR$$F$Y$50$KG$20240814$$MD$CN$CN
242107161$24210716$1$I$$20240805$20240814$20240814$EXP$$CA-BAXTER-2024BAX022823$BAXTER$$71$YR$$M$Y$$$20240814$$HP$CA$CA
242107171$24210717$1$I$$20240805$20240814$20240814$EXP$$US-BAXTER-2024BAX022847$BAXTER$$57$YR$$F$Y$$$20240814$$HP$US$US
242107181$24210718$1$I$20240104$20240812$20240814$20240814$EXP$FR-AFSSAPS-MA2024001171$FR-FreseniusKabi-FK202412446$FRESENIUS KABI$$52$YR$A$F$Y$58$KG$20240814$$PH$FR$FR
242107191$24210719$1$I$20240727$20240812$20240814$20240814$EXP$FR-AFSSAPS-BR2024000636$FR-FreseniusKabi-FK202412443$FRESENIUS KABI$$68$YR$E$M$Y$66$KG$20240814$$MD$FR$FR
242107201$24210720$1$I$20230706$20240812$20240814$20240814$EXP$FR-AFSSAPS-TO2024001479$FR-FreseniusKabi-FK202412440$FRESENIUS KABI$$80$YR$E$M$Y$$$20240814$$PH$FR$FR
242107211$24210721$1$I$20240707$20240812$20240814$20240814$EXP$FR-AFSSAPS-GR2024000978$FR-FreseniusKabi-FK202412447$FRESENIUS KABI$$65$YR$E$F$Y$114$KG$20240814$$MD$FR$FR
242107221$24210722$1$I$$20240731$20240814$20240814$EXP$$NZ-GRANULES-NZ-2024GRALIT00320$GRANULES INDIA$Hyun Kyoung Lee.Lamotrigine-induced generalised pustular psoriasis.New Zealand Medical Journal.01-DEC-2023;136:99-101$23$YR$A$F$Y$$$20240814$$HP$NZ$NZ
242107231$24210723$1$I$$20240809$20240814$20240814$PER$$IQ-REGENERON PHARMACEUTICALS, INC.-2024-111083$REGENERON$$49$YR$$M$Y$$$20240814$$CN$IQ$IQ
242107241$24210724$1$I$$20240808$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126309$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240814$$HP$US$US
242107261$24210726$1$I$$20240813$20240813$20240813$DIR$FDA-CDER-CTU-2024-55780$$FDA-CTU$$64$YR$$F$N$57.15$KG$20240814$N$CN$US$
242107271$24210727$1$I$20240607$20240813$20240813$20240813$DIR$714160$$FDA-CTU$$15$YR$$F$N$60.8$KG$20240813$N$HP$US$
242107281$24210728$1$I$20230707$20240404$20240813$20240813$DIR$FDA-CDER-CTU-2024-55765$$FDA-CTU$$65$YR$$F$N$49.9$KG$20240404$$CN$US$
242107311$24210731$1$I$20230707$20240403$20240813$20240813$DIR$FDA-CDER-CTU-2024-55767$$FDA-CTU$$65$YR$$F$N$49.9$KG$20240403$N$CN$US$
242107321$24210732$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA090221$SANOFI AVENTIS$$$$C$F$Y$$$20240814$$MD$US$US
242107332$24210733$2$F$20240612$20240807$20240814$20240821$PER$$US-SA-2024SA236701$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240821$$MD$US$US
242107341$24210734$1$I$20240530$20240813$20240813$20240813$DIR$714031$$FDA-CTU$$61$YR$$F$N$84.6$KG$20240813$Y$CN$US$
242107351$24210735$1$I$$20240403$20240813$20240813$DIR$FDA-CDER-CTU-2024-55768$$FDA-CTU$$65$YR$$F$N$49.9$KG$20240403$N$CN$US$
242107361$24210736$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA237108$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240814$$MD$US$US
242107371$24210737$1$I$$20231127$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2023US066809$SANDOZ$$57$YR$$F$Y$$$20240814$$MD$US$US
242107381$24210738$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA240499$SANOFI AVENTIS$$$$A$F$Y$$$20240814$$MD$US$US
242107391$24210739$1$I$20240101$20240805$20240814$20240814$PER$$US-SA-2024SA232824$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240814$$MD$US$US
242107401$24210740$1$I$20240101$20240809$20240814$20240814$PER$$US-SA-2024SA240162$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240814$$MD$US$US
242107411$24210741$1$I$$20240730$20240814$20240814$PER$$US-LEADINGPHARMA-US-2024LEASPO00356$LEADING PHARMA$$$$$$Y$$$20240814$$CN$US$US
242107423$24210742$3$F$20240721$20240927$20240814$20240930$EXP$FR-AFSSAPS-GR2024001005$FR-SANDOZ INC.-SDZ2024FR072029$SANDOZ$$23$YR$$F$Y$57$KG$20240930$$PH$FR$FR
242107431$24210743$1$I$20201226$20240805$20240814$20240814$EXP$FR-AFSSAPS-PV2024000673$FR-NORDICGR-057113$NORDIC PHARMA$$15$DY$$M$Y$0.8$KG$20240814$$MD$FR$FR
242107441$24210744$1$I$$20240809$20240814$20240814$EXP$$NVSC2024BE164408$NOVARTIS$$62$YR$$F$Y$$$20240814$$MD$BE$BE
242107451$24210745$1$I$$20240813$20240814$20240814$EXP$$US-KYOWAKIRIN-2024KK019194$KYOWA$$$$$$Y$$$20240814$$HP$US$US
242107461$24210746$1$I$20240723$20240809$20240814$20240814$EXP$$US-BAYER-2024A116267$BAYER$$40$YR$A$M$Y$77.098$KG$20240814$$CN$US$US
242107472$24210747$2$F$20240801$20240821$20240814$20240828$EXP$$IN-VANTIVE-2024VAN018969$Vantive US Healthcare$$51$YR$$M$Y$$$20240828$$CN$IN$IN
242107481$24210748$1$I$$20240801$20240814$20240814$EXP$$IN-PERRIGO-24IN007398$PERRIGO$$28$YR$$M$Y$$$20240814$$MD$IN$IN
242107491$24210749$1$I$$20240811$20240814$20240814$EXP$$US-JNJFOC-20240827474$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$US$US
242107503$24210750$3$F$$20240906$20240814$20240920$30DAY$$CA-JNJFOC-20240827066$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240920$$HP$CA$CA
242107511$24210751$1$I$$20240801$20240814$20240814$EXP$$IN-PERRIGO-24IN007396$PERRIGO$$38$YR$$M$Y$$$20240814$$MD$IN$IN
242107521$24210752$1$I$$20240801$20240814$20240814$EXP$$IN-PERRIGO-24IN007399$PERRIGO$$17$YR$$F$Y$$$20240814$$MD$IN$IN
242107541$24210754$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160972$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242107552$24210755$2$F$$20240816$20240814$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127601$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240822$$MD$JP$JP
242107561$24210756$1$I$$20240725$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07559$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242107571$24210757$1$I$20240806$20240806$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125038$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$74.84$KG$20240814$$HP$US$US
242107581$24210758$1$I$$20240730$20240814$20240814$PER$$US-LEADINGPHARMA-US-2024LEASPO00351$LEADING PHARMA$$$$$$Y$$$20240814$$CN$US$US
242107592$24210759$2$F$$20240819$20240814$20240820$PER$$US-ABBVIE-5876545$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242107601$24210760$1$I$$20240731$20240814$20240814$EXP$$GB-PHARMAAND GMBH-2024PHR00464$pharmaAND$$$$$$Y$$$20240814$$HP$GB$GB
242107613$24210761$3$F$$20240830$20240814$20240904$PER$$US-ALXN-202408USA000517US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
242107621$24210762$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00325$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$10$YR$C$$Y$$$20240814$$HP$TR$TR
242107631$24210763$1$I$$20240813$20240814$20240814$EXP$$PT-WT-2024-EME-099921$Waylis$$$$E$$Y$$$20240814$$HP$PT$PT
242107641$24210764$1$I$$20240809$20240814$20240814$EXP$$US-JNJFOC-20240832000$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$MD$US$US
242107651$24210765$1$I$20240101$20240808$20240814$20240814$EXP$$US-SA-2024SA240112$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240814$$CN$US$US
242107661$24210766$1$I$$20240808$20240814$20240814$EXP$$US-TAKEDA-2021TUS006570$TAKEDA$$$$$F$Y$$$20240814$$HP$US$US
242107671$24210767$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00329$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$$$$$Y$$$20240814$$HP$TR$TR
242107681$24210768$1$I$$20240805$20240814$20240814$EXP$$IT-RDY-LIT/ITA/24/0011768$DR REDDYS$Benevolo G, Bertuglia G, Bringhen S, Maletta F, Bruno B. An atypical presentation of visceral leishmaniasis mimicking multiple myeloma relapse. American Journal of Hematology. 2024 Jan;99(1): 137-141. doi:10.1002/ajh.27147.$79$YR$E$M$Y$$$20240814$$HP$IT$IT
242107691$24210769$1$I$$20240715$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07266$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242107701$24210770$1$I$20230706$20240805$20240814$20240814$EXP$FR-AFSSAPS-TO2024001479$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110875$ZYDUS PHARM$$$$$$Y$$$20240814$$PH$FR$FR
242107711$24210771$1$I$$20240731$20240814$20240814$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-110760$ZYDUS PHARM$GaUr U, Gadkari C, PUndkar A. Hypokalaemic Periodic Paralysis in a Patient with Rheumatoid Arthritis: A Case Report. J-Clin-Diagnostic-Res. 2024;18(7):OD01-OD03$$$$$Y$$$20240814$$MD$IN$IN
242107722$24210772$2$F$$20240909$20240814$20240910$EXP$$CA-BAUSCH-BL-2024-012265$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240910$$CN$CA$CA
242107731$24210773$1$I$20231227$20240805$20240814$20240814$EXP$FR-AFSSAPS-NY2024000890$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110925$ZYDUS PHARM$$$$$$Y$$$20240814$$MD$FR$FR
242107741$24210774$1$I$20230625$20240805$20240814$20240814$EXP$FR-AFSSAPS-PV2024000593$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110959$ZYDUS PHARM$$$$$$Y$$$20240814$$MD$FR$FR
242107751$24210775$1$I$$20240807$20240814$20240814$EXP$$US-FreseniusKabi-FK202412419$FRESENIUS KABI$Rios IP, Nguyen CH, Misra SS, Ryan MS, Nair SS, Khamash HA. Foscarnet-induced nephropathy in a kidney transplant recipient.. Kidney International. 2024 Jul;106(1): 156. doi:https://dx.doi.org/10.1016/j.kint.2024.02.017.$53$YR$A$M$Y$$$20240814$$HP$US$US
242107761$24210776$1$I$20240807$20240808$20240814$20240814$PER$$JP-Eisai-EC-2024-171783$EISAI$$$$$$Y$$$20240814$$MD$JP$JP
242107771$24210777$1$I$20240701$20240809$20240814$20240814$PER$$JP-Eisai-EC-2024-171929$EISAI$$$$E$M$Y$$$20240814$$MD$JP$JP
242107782$24210778$2$F$$20240822$20240814$20240826$EXP$$JP-BAYER-2024A116374$BAYER$$29$YR$A$F$Y$$$20240826$$PH$JP$JP
242107791$24210779$1$I$20240611$20240806$20240814$20240814$EXP$$RU-AstraZeneca-2024A181113$ASTRAZENECA$$73$YR$$F$Y$72$KG$20240814$$MD$RU$
242107801$24210780$1$I$20230101$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179053$ASTRAZENECA$$77$YR$$F$Y$$$20240814$$CN$US$
242107811$24210781$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007759$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240814$$CN$US$US
242107821$24210782$1$I$$20240806$20240814$20240814$EXP$$JP-AstraZeneca-2024A059358$ASTRAZENECA$$50$YR$$F$Y$$$20240814$$MD$JP$
242107831$24210783$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007610$ELI LILLY AND CO$$58$YR$A$F$Y$90.703$KG$20240814$$CN$US$US
242107841$24210784$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007757$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240814$$CN$US$US
242107863$24210786$3$F$$20240906$20240814$20240916$EXP$$JP-ROCHE-10000053221$ROCHE$Sekiguchi Y, Tsutsumi H, Gomyo A, Kudo M, Iizaki Y, Maseki N. Usage experience of pola-R-mini-CHP therapy (R-mini-CHP in combination with polatuzumab vedotin) in patients aged 80 or older with diffuse large B-cell lymphoma (DLBCL): 18 case reports from single facility [Abstract number: P-32]. The Journal of the Japanese Society for Lymphoreticular Tissue Research / The 64. 2024;64:102.$$$E$$Y$$$20240916$$MD$JP$JP
242107871$24210787$1$I$20220622$20240403$20240813$20240813$DIR$FDA-CDER-CTU-2024-55769$$FDA-CTU$$65$YR$$F$N$49.9$KG$20240403$Y$CN$US$
242107891$24210789$1$I$20240809$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55752$$FDA-CTU$$64$YR$$M$N$59.4$KG$20240813$N$$US$
242107901$24210790$1$I$20240812$20240813$20240813$20240813$DIR$714021$$FDA-CTU$$82$YR$$F$N$$$20240813$N$PH$US$
242107911$24210791$1$I$20240809$20240813$20240813$20240813$DIR$714018$$FDA-CTU$$76$YR$$M$N$$$20240813$N$PH$US$
242107921$24210792$1$I$20240809$20240813$20240813$20240813$DIR$714019$$FDA-CTU$$69$YR$$F$N$$$20240813$N$PH$US$
242107931$24210793$1$I$20240809$20240812$20240814$20240814$DIR$FDA-CDER-CTU-2024-55749$$FDA-CTU$$64$YR$$M$N$59.4$KG$20240812$N$$US$
242107941$24210794$1$I$20240730$20240806$20240814$20240814$DIR$FDA-CDER-CTU-2024-55691$$FDA-CTU$$$$$F$N$83.1$KG$20240806$N$$US$
242107951$24210795$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55919$$FDA-CTU$$70$YR$$M$N$$$20240814$N$$US$
242107961$24210796$1$I$$20240806$20240814$20240814$EXP$$US-UCBSA-2024039748$UCB$$$$$F$Y$$$20240814$$HP$US$US
242107971$24210797$1$I$$20240812$20240814$20240814$EXP$$CA-PURDUE-USA-2024-0311356$PURDUE$$60$YR$$F$Y$$$20240814$$PH$CA$CA
242107981$24210798$1$I$$20240812$20240814$20240814$EXP$$GB-PURDUE-USA-2024-0311355$PURDUE$$$$$F$Y$$$20240814$$CN$GB$GB
242107991$24210799$1$I$$20240810$20240814$20240814$EXP$$US-PURDUE PHARMA-USA-2024-0311307$PURDUE$$$$$M$Y$$$20240814$$CN$US$US
242108001$24210800$1$I$$20240806$20240814$20240814$EXP$$EC-PURDUE-USA-2024-0311352$PURDUE$$79$YR$$F$Y$$$20240814$$HP$EC$EC
242108012$24210801$2$F$$20240808$20240814$20240820$PER$$US-SA-2024SA237323$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240820$$MD$US$US
242108021$24210802$1$I$20240101$20240809$20240814$20240814$EXP$$UY-ABBVIE-5852362$ABBVIE$$$$$F$Y$$$20240814$$CN$UY$UY
242108031$24210803$1$I$$20240801$20240814$20240814$PER$$US-SA-2024SA240469$SANOFI AVENTIS$$$$T$M$Y$$$20240814$$MD$US$US
242108041$24210804$1$I$20240726$20240806$20240814$20240814$PER$$US-SA-2024SA237666$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240814$$MD$US$US
242108051$24210805$1$I$20240101$20240805$20240814$20240814$PER$$US-SA-2024SA236602$SANOFI AVENTIS$$48$YR$A$F$Y$99$KG$20240814$$MD$US$US
242108061$24210806$1$I$$20240719$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07359$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242108071$24210807$1$I$20240701$20240731$20240814$20240814$PER$$US-GRANULES-US-2024GRASPO00341$GRANULES INDIA$$30$YR$A$F$Y$208$KG$20240814$$CN$US$US
242108081$24210808$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684064$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$64$YR$A$$Y$$$20240814$$MD$US$US
242108091$24210809$1$I$20240723$20240809$20240814$20240814$EXP$$IT-ABBVIE-5877118$ABBVIE$$76$YR$$F$Y$$$20240814$$MD$IT$IT
242108101$24210810$1$I$20240725$20240813$20240814$20240814$PER$$US-AMGEN-USASP2024161444$AMGEN$$65$YR$E$F$Y$$$20240814$$CN$US$US
242108111$24210811$1$I$$20240809$20240814$20240814$EXP$$US-AMGEN-USASP2024159850$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242108121$24210812$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126839$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240814$$CN$US$US
242108131$24210813$1$I$20230109$20240813$20240813$20240813$DIR$714026$$FDA-CTU$$61$YR$$F$N$103.5$KG$20240813$N$CN$US$
242108141$24210814$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55891$$FDA-CTU$$66$YR$$F$N$68.04$KG$20240814$N$HP$US$
242108161$24210816$1$I$20240101$20240809$20240814$20240814$EXP$$US-ABBVIE-5875375$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242108171$24210817$1$I$20240814$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55893$$FDA-CTU$$47$YR$$F$N$$$20240814$N$$US$
242108181$24210818$1$I$20240813$20240813$20240813$20240813$DIR$714043$$FDA-CTU$$75$YR$$F$N$$$20240813$N$$US$
242108191$24210819$1$I$20240810$20240813$20240813$20240813$DIR$714011$$FDA-CTU$$62$YR$$M$N$$$20240813$N$PH$US$
242108201$24210820$1$I$20240701$20240808$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127721$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240814$$CN$US$US
242108211$24210821$1$I$20240101$20240810$20240814$20240814$EXP$$US-ABBVIE-5876342$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242108221$24210822$1$I$20240725$20240805$20240814$20240814$EXP$DE-BFARM-24005445$DE-ORGANON-O2408DEU001016$ORGANON$$35$YR$$F$Y$$$20240814$$MD$DE$DE
242108231$24210823$1$I$20240812$20240813$20240813$20240813$DIR$714044$$FDA-CTU$$31$YR$$M$N$$$20240813$N$CN$US$
242108243$24210824$3$F$20240101$20240829$20240814$20240905$PER$$US-BIOGEN-2024BI01267891$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
242108251$24210825$1$I$$20240809$20240814$20240814$PER$$US-BIOGEN-2024BI01278261$BIOGEN$$$$$F$Y$$$20240814$$CN$US$US
242108261$24210826$1$I$$20240807$20240814$20240814$EXP$$GB-TAKEDA-2024TUS080292$TAKEDA$$$$$M$Y$$$20240814$$CN$GB$GB
242108271$24210827$1$I$$20240807$20240814$20240814$EXP$$GB-TAKEDA-2024TUS080545$TAKEDA$$$$$M$Y$$$20240814$$CN$GB$GB
242108281$24210828$1$I$$20240730$20240814$20240814$EXP$$IR-DEXPHARM-2024-2762$DEXCEL$Pouya?E . Roozbeh?N . Nahid?S . Seyedeh Maryam?M . Delaram J.?G . Hamidreza?S.  Kounis syndrome type   induced by an intramuscular injection on a diclofenac: A literature review based on a case report. Department of Cardiology, Modarres Hospital Shahid Beheshti University of Medical Sciences Tehran Iran. Clinical case reports, (2024 Jul) Vol. 12, No. 7, pp. e9198.  Electronic Publication Date: 21 Jul 2024 Journal code: 101620385. ISSN: 2050-090$51$YR$A$M$Y$$$20240814$$HP$IR$IR
242108291$24210829$1$I$$20240710$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07029$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242108301$24210830$1$I$20240101$20240805$20240814$20240814$PER$$US-SA-2024SA238229$SANOFI AVENTIS$$17$YR$T$F$Y$77$KG$20240814$$MD$US$US
242108311$24210831$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA110564$SANOFI AVENTIS$$2$YR$C$M$Y$36.4$KG$20240814$$MD$US$US
242108321$24210832$1$I$20240701$20240806$20240814$20240814$PER$$US-SA-2024SA234506$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240814$$MD$US$US
242108331$24210833$1$I$$20240811$20240814$20240814$EXP$$US-ABBVIE-5877088$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242108341$24210834$1$I$$20240806$20240814$20240814$PER$$US-ABBVIE-5871318$ABBVIE$$$$$M$Y$$$20240814$$HP$US$US
242108351$24210835$1$I$$20240810$20240814$20240814$PER$$US-BAYER-2024A115421$BAYER$$$$$$Y$$$20240814$$CN$US$US
242108361$24210836$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00338$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$$$$$Y$$$20240814$$HP$TR$TR
242108371$24210837$1$I$20230801$20240812$20240814$20240814$EXP$$PL-FreseniusKabi-FK202412379$FRESENIUS KABI$$35$YR$A$F$Y$$$20240814$$MD$PL$PL
242108381$24210838$1$I$$20240808$20240814$20240814$PER$$US-FreseniusKabi-FK202412321$FRESENIUS KABI$$$$A$$Y$$$20240814$$HP$US$US
242108391$24210839$1$I$20240628$20240715$20240814$20240814$PER$$US-JNJFOC-20240834554$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240814$$CN$US$US
242108401$24210840$1$I$20240730$20240812$20240814$20240814$EXP$FR-AFSSAPS-RS2024000795$FR-FreseniusKabi-FK202412460$FRESENIUS KABI$$74$YR$E$F$Y$70$KG$20240814$$PH$FR$FR
242108411$24210841$1$I$20210501$20240806$20240814$20240814$EXP$FR-AFSSAPS-DJ2024000870$FR-TEVA-VS-3230917$TEVA$$43$YR$$M$Y$95.5$KG$20240814$$MD$FR$FR
242108421$24210842$1$I$20240712$20240805$20240814$20240814$EXP$$JP-Eisai-EC-2024-171963$EISAI$$$$E$F$Y$$$20240814$$MD$JP$JP
242108441$24210844$1$I$20240629$20240812$20240814$20240814$EXP$$TW-JNJFOC-20240828533$JOHNSON AND JOHNSON$$69$YR$E$F$Y$50$KG$20240814$$CN$TW$TW
242108451$24210845$1$I$20240813$20240813$20240814$20240814$PER$$US-JNJFOC-20240833724$JOHNSON AND JOHNSON$$66$YR$E$$Y$$$20240814$$CN$US$US
242108461$24210846$1$I$$20240805$20240814$20240814$PER$$DE-Eisai-EC-2024-171614$EISAI$$$$$F$Y$$$20240814$$MD$DE$DE
242108471$24210847$1$I$20240101$20240812$20240814$20240814$EXP$$US-ABBVIE-5878993$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242108481$24210848$1$I$$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127348$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240814$$MD$US$US
242108491$24210849$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128123$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240814$$CN$US$US
242108501$24210850$1$I$20240101$20240810$20240814$20240814$EXP$$AU-ABBVIE-5879370$ABBVIE$$$$$M$Y$$$20240814$$CN$AU$AU
242108511$24210851$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684066$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$58$YR$A$$Y$$$20240814$$MD$US$US
242108521$24210852$1$I$$20240813$20240813$20240813$DIR$714068$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242108531$24210853$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55790$$FDA-CTU$$83$YR$$F$N$$$20240814$N$$US$
242108541$24210854$1$I$$20240813$20240813$20240813$DIR$714070$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242108551$24210855$1$I$$20240813$20240813$20240813$DIR$714073$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242108571$24210857$1$I$$20240813$20240813$20240813$DIR$714080$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242108581$24210858$1$I$20240812$20240813$20240813$20240813$DIR$714053$$FDA-CTU$$10$YR$$F$N$$$20240813$N$CN$US$
242108591$24210859$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55794$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242108601$24210860$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55914$$FDA-CTU$$25$YR$$F$N$$$20240814$N$$US$
242108611$24210861$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55781$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242108621$24210862$1$I$$20240813$20240813$20240813$DIR$714081$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242108641$24210864$1$I$20240809$20240813$20240813$20240813$DIR$714012$$FDA-CTU$$59$YR$$M$N$$$20240813$N$PH$US$
242108651$24210865$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55915$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242108661$24210866$1$I$$20240813$20240813$20240813$DIR$714086$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242108681$24210868$1$I$20240212$20240719$20240814$20240814$DIR$FDA-CDER-CTU-2024-55692$$FDA-CTU$$$$$M$N$125.5$KG$20240719$N$$US$
242108691$24210869$1$I$20240809$20240813$20240813$20240813$DIR$714016$$FDA-CTU$$75$YR$$M$N$$$20240813$N$PH$US$
242108701$24210870$1$I$$20240813$20240813$20240813$DIR$714078$$FDA-CTU$$73$YR$$F$N$103.5$KG$20240813$N$CN$US$
242108711$24210871$1$I$$20240813$20240813$20240813$DIR$714094$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242108721$24210872$1$I$$20240813$20240813$20240813$DIR$714100$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242108731$24210873$1$I$$20240813$20240813$20240813$DIR$714092$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242108741$24210874$1$I$20240803$20240813$20240813$20240813$DIR$714033$$FDA-CTU$$44$YR$$F$N$66.6$KG$20240813$Y$CN$US$
242108751$24210875$1$I$20240328$20240808$20240814$20240814$EXP$$GB-TAKEDA-2024TUS034366$TAKEDA$$61$YR$$F$Y$$$20240814$$CN$GB$GB
242108761$24210876$1$I$20230801$20240810$20240814$20240814$EXP$$PL-BAUSCH-BL-2024-012159$BAUSCH AND LOMB$$35$YR$$F$Y$$$20240814$$MD$PL$PL
242108771$24210877$1$I$$20240806$20240814$20240814$EXP$$CN-BAUSCH-BL-2024-012000$BAUSCH AND LOMB$Su C, Kao C. Stevens-Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report. Journal of medical case reports. 2024 JUL 28;18(344):1-5. doi:10.1186/s13256-024-04629-6$82$YR$$F$Y$$$20240814$$HP$CN$CN
242108781$24210878$1$I$20230101$20240812$20240814$20240814$EXP$$US-ABBVIE-5878584$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242108792$24210879$2$F$20230601$20240819$20240814$20240822$EXP$$US-AMGEN-USASP2024156913$AMGEN$$72$YR$E$F$Y$$$20240822$$HP$US$US
242108802$24210880$2$F$$20240815$20240814$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07038$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242108811$24210881$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684100$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$66$YR$E$$Y$$$20240814$$MD$US$US
242108821$24210882$1$I$$20240731$20240814$20240814$EXP$$QA-GRANULES-QA-2024GRALIT00345$GRANULES INDIA$Abdulqadir J. Nashwan.Ibuprofen-Induced Toxic Epidermal Necrolysis:  A Case Report.International Journal of Dermatology and Venereology.JUN-2024;7:108-110$41$YR$A$M$Y$$$20240814$$HP$QA$QA
242108831$24210883$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00331$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$16$YR$T$$Y$$$20240814$$HP$TR$TR
242108852$24210885$2$F$20240101$20240812$20240814$20240816$EXP$$CA-ABBVIE-5875884$ABBVIE$$49$YR$$M$Y$$$20240816$$CN$CA$CA
242108861$24210886$1$I$$20240813$20240814$20240814$EXP$$NVSC2024US164484$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
242108872$24210887$2$F$$20240827$20240814$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA072368$SANDOZ$$$$$F$Y$$$20240830$$MD$CA$CA
242108882$24210888$2$F$20240710$20240827$20240814$20240903$EXP$$NVSC2024CA163472$NOVARTIS$$71$YR$$F$Y$60$KG$20240903$$MD$CA$CA
242108892$24210889$2$F$$20240906$20240814$20240910$EXP$$JP-BAYER-2024A116808$BAYER$$4$DEC$A$F$Y$$$20240910$$MD$JP$JP
242108901$24210890$1$I$$20240617$20240814$20240814$PER$$US-ROCHE-10000009363$ROCHE$$$$$F$Y$$$20240814$$HP$US$US
242108911$24210891$1$I$$20240812$20240814$20240814$EXP$$US-ABBVIE-5840588$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242108921$24210892$1$I$$20240813$20240813$20240813$DIR$714097$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242108931$24210893$1$I$20240730$20240813$20240813$20240813$DIR$714106$$FDA-CTU$$56$YR$$F$N$58.5$KG$20240813$N$CN$US$
242108942$24210894$2$F$20170101$20240813$20240814$20240822$EXP$$US-TAKEDA-2024TUS079832$TAKEDA$$64$YR$$M$Y$$$20240822$$MD$US$US
242108951$24210895$1$I$20240807$20240812$20240814$20240814$EXP$$SA-ABBVIE-5879365$ABBVIE$$60$YR$$F$Y$$$20240814$$CN$SA$SA
242108961$24210896$1$I$$20240813$20240813$20240813$DIR$714104$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242108971$24210897$1$I$$20240813$20240814$20240814$PER$$US-AMGEN-USASP2024161388$AMGEN$$$$A$F$Y$$$20240814$$CN$US$US
242108981$24210898$1$I$$20240813$20240813$20240813$DIR$714111$$FDA-CTU$$$$$UNK$N$$$20240813$N$CN$US$
242108991$24210899$1$I$20240802$20240813$20240813$20240813$DIR$714029$$FDA-CTU$$$$$F$N$$$20240813$N$CN$US$
242109002$24210900$2$F$20240808$20240927$20240814$20240930$PER$$US-AMGEN-USASP2024159432$AMGEN$$72$YR$E$F$Y$$$20240928$$CN$US$US
242109011$24210901$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684101$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$64$YR$A$$Y$$$20240814$$MD$US$US
242109021$24210902$1$I$$20240807$20240814$20240814$PER$$US-ABBVIE-5871898$ABBVIE$$31$YR$$F$Y$$$20240814$$HP$US$US
242109031$24210903$1$I$$20240808$20240814$20240814$EXP$$US-INCYTE CORPORATION-2024IN008354$INCYTE$$$$$$Y$$$20240814$$CN$US$US
242109041$24210904$1$I$$20240813$20240813$20240813$DIR$714035$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242109051$24210905$1$I$20240716$20240813$20240813$20240813$DIR$714115$$FDA-CTU$$33$YR$$F$N$67.3$KG$20240813$N$HP$QW$
242109061$24210906$1$I$20231101$20240809$20240814$20240814$EXP$$KR-MYLANLABS-2024M1053174$MYLAN$$47$YR$$F$Y$$$20240814$$MD$KR$KR
242109071$24210907$1$I$$20240809$20240814$20240814$EXP$$AR-MYLANLABS-2024M1075098$MYLAN$$$$$M$Y$$$20240814$$MD$AR$AR
242109081$24210908$1$I$$20240808$20240814$20240814$EXP$$CZ-MYLANLABS-2024M1074341$MYLAN$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al... Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study.. Neoplasma. 2017;64(5):762-9$28$YR$$M$Y$$$20240814$$HP$CZ$CZ
242109091$24210909$1$I$20230812$20240812$20240814$20240814$EXP$$GB-MYLANLABS-2024M1074910$MYLAN$$62$YR$$M$Y$$$20240814$$CN$GB$GB
242109101$24210910$1$I$$20240808$20240814$20240814$EXP$$DE-MYLANLABS-2024M1074395$MYLAN$$60$YR$$F$Y$$$20240814$$CN$DE$DE
242109111$24210911$1$I$20240712$20240808$20240814$20240814$EXP$FR-AFSSAPS-AVCN2024000595$FR-MYLANLABS-2024M1074447$MYLAN$$34$YR$$M$Y$$$20240814$$MD$FR$FR
242109121$24210912$1$I$$20240808$20240814$20240814$EXP$$CZ-MYLANLABS-2024M1074312$MYLAN$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al.. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study. Neoplasma. 2017;64(5):762-9$34$YR$$F$Y$$$20240814$$HP$CZ$CZ
242109132$24210913$2$F$$20240808$20240814$20240820$EXP$$CZ-MYLANLABS-2024M1074393$MYLAN$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al.. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study. Neoplasma. 2017;64(5):762-9$46$YR$$M$Y$$$20240820$$HP$CZ$CZ
242109141$24210914$1$I$$20240808$20240814$20240814$EXP$$IT-MYLANLABS-2024M1074350$MYLAN$$9$YR$$M$Y$$$20240814$$HP$IT$IT
242109151$24210915$1$I$20240306$20240807$20240814$20240814$PER$$US-BAYER-2024A114563$BAYER$$$$$$Y$$$20240814$$HP$US$US
242109161$24210916$1$I$$20240711$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07089$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242109172$24210917$2$F$$20240813$20240814$20240819$EXP$$PT-MYLANLABS-2024M1074326$MYLAN$$$$$F$Y$$$20240819$$MD$PT$PT
242109181$24210918$1$I$$20240717$20240814$20240814$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091182$GLENMARK$$$$$$Y$$$20240814$$PH$US$US
242109191$24210919$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684102$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$61$YR$A$$Y$$$20240814$$MD$US$US
242109201$24210920$1$I$$20240812$20240814$20240814$PER$$US-SA-2024SA240918$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240814$$CN$US$US
242109211$24210921$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA240732$SANOFI AVENTIS$$$$C$F$Y$39$KG$20240814$$MD$US$US
242109221$24210922$1$I$$20240807$20240814$20240814$EXP$PL-URPL-1-3870-2020$PL-TEVA-VS-3231498$TEVA$$54$YR$$F$Y$70$KG$20240814$$MD$PL$PL
242109231$24210923$1$I$20231221$20240801$20240814$20240814$PER$$US-BAYER-2024A116614$BAYER$$32$YR$A$F$Y$$$20240814$$CN$US$US
242109241$24210924$1$I$20240201$20240809$20240814$20240814$EXP$$CA-JNJFOC-20240825783$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240814$$HP$CA$CA
242109251$24210925$1$I$20240501$20240806$20240814$20240814$PER$$JP-Eisai-EC-2024-171697$EISAI$$$$E$M$Y$$$20240814$$MD$JP$JP
242109261$24210926$1$I$20240708$20240813$20240814$20240814$EXP$$US-BAYER-2024A116701$BAYER$$70$YR$E$M$Y$$$20240814$$HP$US$US
242109271$24210927$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127905$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240814$$CN$US$US
242109281$24210928$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684103$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$65$YR$E$$Y$$$20240814$$MD$US$US
242109291$24210929$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00339$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$14$YR$T$$Y$$$20240814$$HP$TR$TR
242109301$24210930$1$I$20240805$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408050806323860-MLQNV$GB-TEVA-VS-3230150$TEVA$$63$YR$$M$Y$80$KG$20240814$$MD$GB$GB
242109321$24210932$1$I$20231024$20240223$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US009396$SANDOZ$$69$YR$$M$Y$$$20240814$$CN$US$US
242109332$24210933$2$F$$20240806$20240814$20240820$EXP$$JP-ALXN-202408JPN000243JP$ALEXION PHARMACEUTICALS$$4$MON$$M$Y$$$20240820$$CN$JP$JP
242109341$24210934$1$I$$20240731$20240814$20240814$EXP$$US-GRANULES-US-2024GRALIT00322$GRANULES INDIA$Aleksan Khachatryan.Recurrent perimyocarditis associated with long-term Methylphenidate use .Journal of the American College of Cardiology.02-APR-2024;83:3543$19$YR$A$M$Y$$$20240814$$HP$US$US
242109352$24210935$2$F$20230101$20240819$20240814$20240821$EXP$$PL-SANDOZ INC.-SDZ2024PL072327$SANDOZ$$56$YR$$M$Y$$$20240821$$MD$PL$PL
242109362$24210936$2$F$$20240815$20240814$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07090$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242109381$24210938$1$I$20240811$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007901$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240814$$CN$US$US
242109391$24210939$1$I$$20240807$20240814$20240814$EXP$$CA-GSK-CA2023139760$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$CA$CA
242109403$24210940$3$F$$20240919$20240814$20240919$30DAY$$US-PFIZER INC-202400228623$PFIZER$$14$YR$$F$Y$$$20240919$$CN$US$US
242109413$24210941$3$F$$20240919$20240814$20240923$30DAY$$US-PFIZER INC-202400234515$PFIZER$$10$YR$$F$Y$24.49$KG$20240923$$CN$US$US
242109421$24210942$1$I$$20240809$20240814$20240814$EXP$$US-SA-2024SA239180$SANOFI AVENTIS$$$$$M$Y$$$20240814$$HP$US$US
242109431$24210943$1$I$$20240813$20240814$20240814$PER$$US-AMGEN-USASP2024161377$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242109442$24210944$2$F$$20240905$20240814$20240910$EXP$$US-INCYTE CORPORATION-2024IN008389$INCYTE$$$$$$Y$$$20240910$$CN$US$US
242109451$24210945$1$I$$20240812$20240814$20240814$PER$$US-BIOGEN-2024BI01258251$BIOGEN$$$$$F$Y$$$20240814$$CN$US$US
242109462$24210946$2$F$20240301$20240826$20240814$20240828$EXP$$NVSC2024GB164528$NOVARTIS$$52$YR$$F$Y$$$20240828$$MD$GB$GB
242109471$24210947$1$I$$20240805$20240814$20240814$EXP$GB-MHRA-MED-202408050904453420-ZJPYC$GB-TEVA-VS-3230178$TEVA$$$$$M$Y$$$20240814$$HP$GB$GB
242109491$24210949$1$I$20231116$20240808$20240814$20240814$EXP$IE-HPRA-2024-114578$IE-SA-2024SA236095$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240814$$CN$IE$IE
242109501$24210950$1$I$$20240731$20240814$20240814$EXP$$US-GRANULES-US-2024GRALIT00340$GRANULES INDIA$Jacob Applegarth.Calcium Channel Blocker Overdose and ECMO: A Unique Presentation of Harlequin Syndrome.ASAIO Journal.MAY-2024;70:151$18$YR$T$F$Y$$$20240814$$HP$US$US
242109511$24210951$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00327$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$9$YR$C$$Y$$$20240814$$HP$TR$TR
242109523$24210952$3$F$20210721$20240906$20240814$20240913$EXP$$CA-TAKEDA-2024TUS081413$TAKEDA$$76$YR$$F$Y$$$20240913$$HP$CA$CA
242109531$24210953$1$I$20240731$20240813$20240814$20240814$EXP$$CN-BAYER-2024A116801$BAYER$$37$YR$A$F$Y$80$KG$20240814$$HP$CN$CN
242109541$24210954$1$I$$20240711$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07138$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242109551$24210955$1$I$$20240731$20240814$20240814$EXP$$OM-Eywa Pharma Inc.-2160454$EYWA PHARMA$Source document (Abstract).$73$YR$$F$Y$$$20240814$$MD$OM$OM
242109561$24210956$1$I$$20240807$20240814$20240814$EXP$$FR-JNJFOC-20240819664$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$PH$FR$FR
242109571$24210957$1$I$$20240807$20240814$20240814$EXP$$IT-JNJFOC-20240833903$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$HP$IT$IT
242109581$24210958$1$I$$20240813$20240814$20240814$PER$$US-JNJFOC-20240833083$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$MD$US$US
242109591$24210959$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684104$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$65$YR$E$$Y$$$20240814$$MD$US$US
242109602$24210960$2$F$20231201$20240815$20240814$20240819$EXP$$US-ABBVIE-5878994$ABBVIE$$77$YR$$F$Y$45$KG$20240819$$CN$US$US
242109611$24210961$1$I$$20240801$20240814$20240814$EXP$$TN-Creekwood Pharmaceuticals LLC-2160455$CREEKWOOD PHARMACEUTICALS$Abstract$68$YR$$M$Y$$$20240814$$$TN$TN
242109621$24210962$1$I$$20240805$20240814$20240814$EXP$$CN-AMNEAL PHARMACEUTICALS-2024-AMRX-02953$AMNEAL$Qian Y-f, Chen H-p, Ren G-f. Acute therapy-related myelodysplastic syndromes following capecitabine and oxaliplatin therapy in gastric malignant tumor: A case report. Medicine. 2024;103(30)$60$YR$$M$Y$$$20240814$$HP$CN$CN
242109631$24210963$1$I$$20240809$20240809$20240809$DIR$FDA-CDER-CTU-2024-55043$$FDA-CTU$$70$YR$$F$N$$$20240809$N$$US$
242109641$24210964$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55937$$FDA-CTU$$75$YR$$F$N$73.48$KG$20240814$N$$US$
242109651$24210965$1$I$$20240807$20240814$20240814$30DAY$$US-GSK-US2024AMR099406$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
242109661$24210966$1$I$20240416$20240807$20240814$20240814$EXP$$US-GSK-US2024AMR099351$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$US$US
242109671$24210967$1$I$20240101$20240807$20240814$20240814$EXP$$CL-GSK-CL2024AMR098993$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$CL$CL
242109681$24210968$1$I$$20240809$20240814$20240814$PER$$US-BIOGEN-2024BI01277782$BIOGEN$$$$$F$Y$$$20240814$$CN$US$US
242109692$24210969$2$F$20210801$20240813$20240814$20240912$EXP$HR-HALMEDAPP-202408030956270730-TZVLK$HR-ORGANON-O2408HRV000982$ORGANON$$31$YR$$M$Y$76$KG$20240912$$CN$HR$HR
242109701$24210970$1$I$20221030$20240813$20240814$20240814$EXP$DE-CADRBFARM-2023319808$DE-ORGANON-O2306DEU002613$ORGANON$$34$YR$$F$Y$53$KG$20240814$$CN$DE$DE
242109711$24210971$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA236368$SANOFI AVENTIS$$$$E$M$Y$83$KG$20240814$$MD$US$US
242109721$24210972$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00332$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$14$YR$T$$Y$$$20240814$$HP$TR$TR
242109731$24210973$1$I$20240809$20240813$20240814$20240814$EXP$$CN-BAYER-2024A116804$BAYER$$55$YR$A$F$Y$$$20240814$$HP$CN$CN
242109741$24210974$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684105$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$51$YR$A$$Y$$$20240814$$MD$US$US
242109761$24210976$1$I$$20221111$20240814$20240814$EXP$$US-AstraZeneca-2022A375066$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242109771$24210977$1$I$$20221013$20240814$20240814$EXP$$US-AstraZeneca-2022A348217$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242109781$24210978$1$I$$20230605$20240814$20240814$EXP$$US-AstraZeneca-2023A092186$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242109791$24210979$1$I$$20240731$20240814$20240814$EXP$$US-NOVOPROD-1268746$NOVO NORDISK$$$$$M$Y$$$20240814$$CN$US$US
242109801$24210980$1$I$$20240810$20240814$20240814$PER$$US-ABBVIE-5877077$ABBVIE$$$$$$Y$$$20240814$$CN$US$US
242109811$24210981$1$I$$20240731$20240814$20240814$EXP$$US-NOVOPROD-1266343$NOVO NORDISK$$$$$M$Y$$$20240814$$CN$US$US
242109821$24210982$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684106$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$64$YR$A$$Y$$$20240814$$MD$US$US
242109831$24210983$1$I$$20240731$20240814$20240814$EXP$$US-GRANULES-US-2024GRALIT00321$GRANULES INDIA$Stephanie Golob.Bupropion Overdose Requiring Veno-Arterial Extracorporeal Membrane Oxygenation.Circulation.06-NOV-2023;148$32$YR$A$$Y$$$20240814$$HP$US$US
242109841$24210984$1$I$20240422$20240806$20240814$20240814$EXP$FR-AFSSAPS-NY2024000876$FR-TEVA-VS-3230954$TEVA$$52$YR$$F$Y$61$KG$20240814$$PH$FR$FR
242109851$24210985$1$I$$20240711$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07159$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242109861$24210986$1$I$20240801$20240812$20240814$20240814$PER$$US-JNJFOC-20240831165$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240814$$CN$US$US
242109871$24210987$1$I$20231001$20240808$20240814$20240814$EXP$$CA-GSK-CA2023144220$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$CA$CA
242109881$24210988$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232117$TEVA$$47$YR$$F$Y$$$20240814$$HP$CA$CA
242109891$24210989$1$I$$20240530$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US054385$SANDOZ$$$$$F$Y$$$20240814$$MD$US$US
242109901$24210990$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232256$TEVA$$55$YR$$M$Y$76$KG$20240814$$HP$CA$CA
242109911$24210991$1$I$$20240731$20240814$20240814$EXP$$US-GRANULES-US-2024GRASPO00343$GRANULES INDIA$$$$$F$Y$$$20240814$$CN$US$US
242109921$24210992$1$I$20230101$20240808$20240814$20240814$EXP$$CA-GSK-CA2023129520$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$HP$CA$CA
242109931$24210993$1$I$$20240810$20240814$20240814$PER$$US-SA-2024SA239830$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240814$$CN$US$US
242109941$24210994$1$I$20240814$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55946$$FDA-CTU$$64$YR$$F$N$$$20240814$N$PH$US$
242109951$24210995$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684107$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$64$YR$A$$Y$$$20240814$$MD$US$US
242109961$24210996$1$I$20240728$20240813$20240813$20240813$DIR$714116$$FDA-CTU$$66$YR$$F$N$$$20240813$N$$US$
242109971$24210997$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684108$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$73$YR$E$$Y$$$20240814$$MD$US$US
242109981$24210998$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55905$$FDA-CTU$$58$YR$$F$N$94.35$KG$20240814$N$$US$
242109991$24210999$1$I$$20240802$20240814$20240814$PER$$US-INCYTE CORPORATION-2024IN008262$INCYTE$$$$$$Y$$$20240814$$MD$US$US
242110001$24211000$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00336$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$13$YR$T$$Y$$$20240814$$HP$TR$TR
242110011$24211001$1$I$$20240808$20240814$20240814$EXP$$NVSC2024AU025905$NOVARTIS$$$$$F$Y$$$20240814$$HP$AU$AU
242110021$24211002$1$I$$20240810$20240814$20240814$PER$$US-JNJFOC-20240827702$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242110031$24211003$1$I$$20230412$20240814$20240814$EXP$$NL-BIOVITRUM-2023-NL-009450$BIOVITRUM$$$$I$M$Y$5.5$KG$20240814$$HP$NL$NL
242110041$24211004$1$I$$20240621$20240814$20240814$PER$$US-LUNDBECK-DKLU4001071$LUNDBECK$$$$$$Y$$$20240814$$HP$US$US
242110051$24211005$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55927$$FDA-CTU$$58$YR$$F$N$$$20240814$N$$US$
242110061$24211006$1$I$$20240712$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07161$LUPIN$$$$$$Y$$$20240814$$PH$US$US
242110075$24211007$5$F$20240730$20240920$20240814$20240930$PER$$US-ROCHE-10000049988$ROCHE$$22$YR$A$F$Y$$$20240930$$CN$US$US
242110081$24211008$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00324$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$66$MON$C$$Y$$$20240814$$HP$TR$TR
242110091$24211009$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55906$$FDA-CTU$$76$YR$$M$N$144.7$KG$20240814$N$$US$
242110101$24211010$1$I$20240404$20240806$20240814$20240814$EXP$$RU-AstraZeneca-2024A180947$ASTRAZENECA$$75$YR$$F$Y$80$KG$20240814$$MD$RU$
242110112$24211011$2$F$$20240809$20240814$20240815$EXP$$DE-AstraZeneca-2024A181898$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$DE$
242110121$24211012$1$I$20231101$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A180504$ASTRAZENECA$$735$MON$$M$Y$$$20240814$$CN$US$
242110131$24211013$1$I$$20220915$20240814$20240814$EXP$$US-AstraZeneca-2022A324003$ASTRAZENECA$$50$YR$$F$Y$43.1$KG$20240814$$CN$US$
242110141$24211014$1$I$$20240625$20240814$20240814$PER$$US-LUNDBECK-DKLU4001050$LUNDBECK$$$$$$Y$$$20240814$$HP$US$US
242110161$24211016$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55904$$FDA-CTU$$17$YR$$F$N$77.11$KG$20240814$N$$US$
242110201$24211020$1$I$20240805$20240805$20240814$20240814$DIR$FDA-CDER-CTU-2024-55755$$FDA-CTU$$33$YR$$M$N$69.1$KG$20240805$N$$US$
242110211$24211021$1$I$20240810$20240813$20240813$20240813$DIR$714037$$FDA-CTU$$61$YR$$F$N$71.55$KG$20240813$Y$CN$US$
242110221$24211022$1$I$20240722$20240813$20240813$20240813$DIR$714117$$FDA-CTU$$37$YR$$F$N$114.75$KG$20240813$N$CN$US$
242110231$24211023$1$I$20240805$20240813$20240813$20240813$DIR$714125$$FDA-CTU$$74$YR$$M$N$69.1$KG$20240813$N$PH$US$
242110241$24211024$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55855$$FDA-CTU$$73$YR$$M$N$$$20240814$N$HP$US$
242110251$24211025$1$I$$20240813$20240813$20240813$DIR$714128$$FDA-CTU$$82$YR$$M$N$$$20240813$N$$US$
242110261$24211026$1$I$20240627$20240813$20240813$20240813$DIR$714126$$FDA-CTU$$64$YR$$F$N$90$KG$20240813$N$$US$
242110271$24211027$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55925$$FDA-CTU$$56$YR$$F$N$134.26$KG$20240814$N$$US$
242110281$24211028$1$I$$20240813$20240813$20240813$DIR$714133$$FDA-CTU$$$$$UNK$N$$$20240813$$CN$US$
242110291$24211029$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55923$$FDA-CTU$$55$YR$$M$N$$$20240814$N$$US$
242110301$24211030$1$I$20240813$20240813$20240813$20240813$DIR$714142$$FDA-CTU$$49$YR$$UNK$N$$$20240813$N$$US$
242110311$24211031$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55924$$FDA-CTU$$67$YR$$F$N$83.01$KG$20240814$N$$US$
242110321$24211032$1$I$20230101$20240812$20240814$20240814$EXP$$PL-FreseniusKabi-FK202412378$FRESENIUS KABI$$76$YR$E$M$Y$91$KG$20240814$$MD$PL$PL
242110331$24211033$1$I$$20240808$20240814$20240814$PER$$US-JNJFOC-20240827881$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242110341$24211034$1$I$$20240809$20240814$20240814$PER$$US-JNJFOC-20240824973$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242110351$24211035$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00330$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$16$YR$T$$Y$$$20240814$$HP$TR$TR
242110372$24211037$2$F$$20240911$20240814$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07861$LUPIN$$$$$$Y$$$20240921$$CN$US$US
242110381$24211038$1$I$$20240809$20240814$20240814$EXP$$CA-OTSUKA-2024_022225$OTSUKA$$27$YR$$F$Y$56.69$KG$20240814$$HP$CA$CA
242110391$24211039$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408006517$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240814$$CN$US$US
242110401$24211040$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007906$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240814$$CN$US$US
242110411$24211041$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007776$ELI LILLY AND CO$$25$YR$A$$Y$$$20240814$$CN$US$US
242110421$24211042$1$I$20240804$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007332$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240814$$CN$US$US
242110431$24211043$1$I$$20240802$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408002384$ELI LILLY AND CO$$$$$$Y$$$20240814$$CN$US$US
242110441$24211044$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684109$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$55$YR$A$$Y$$$20240814$$MD$US$US
242110451$24211045$1$I$$20240807$20240814$20240814$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16022$IPSEN$$$$$F$Y$$$20240814$$HP$US$US
242110463$24211046$3$F$20240710$20240911$20240814$20240911$EXP$$US-ALXN-202408USA000520US$ALEXION PHARMACEUTICALS$$70$YR$$M$Y$118.2$KG$20240911$$PH$US$US
242110471$24211047$1$I$20240813$20240813$20240813$20240813$DIR$714143$$FDA-CTU$$62$YR$$F$N$$$20240813$N$$US$
242110482$24211048$2$F$$20240906$20240814$20240906$PER$$US-ALXN-202407USA002298US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242110491$24211049$1$I$$20240808$20240814$20240814$EXP$$US-ZENPEP LLC-2024AIMT01221$AIMMUNE$$$$$$Y$$$20240814$$CN$US$US
242110501$24211050$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55918$$FDA-CTU$$65$YR$$F$N$$$20240814$N$$US$
242110511$24211051$1$I$$20240718$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07420$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242110521$24211052$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00334$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$14$YR$T$$Y$$$20240814$$HP$TR$TR
242110532$24211053$2$F$$20240801$20240814$20240826$EXP$$US-SMPA-2024SPA000642$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242110541$24211054$1$I$$20240813$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128463$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240814$$CN$US$US
242110552$24211055$2$F$20230101$20240828$20240814$20240829$EXP$$NVSC2024US164283$NOVARTIS$$60$YR$$M$Y$$$20240829$$CN$US$US
242110561$24211056$1$I$$20240809$20240814$20240814$EXP$$NVSC2024MX164518$NOVARTIS$$33$YR$$F$Y$$$20240814$$MD$MX$MX
242110572$24211057$2$F$20240523$20240920$20240814$20240926$EXP$$US-OTSUKA-2024_016344$OTSUKA$$$$$F$Y$$$20240926$$MD$US$US
242110581$24211058$1$I$$20240806$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125763$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$55.34$KG$20240814$$PH$US$US
242110591$24211059$1$I$20240601$20240809$20240814$20240814$PER$$NVSC2024US162676$NOVARTIS$$38$YR$$M$Y$$$20240814$$CN$US$US
242110601$24211060$1$I$20240101$20240729$20240814$20240814$PER$$US-JNJFOC-20240780210$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$US$US
242110611$24211061$1$I$$20240403$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US036921$SANDOZ$$$$$$Y$$$20240814$$CN$US$US
242110621$24211062$1$I$20240501$20240812$20240814$20240814$EXP$$CA-SANDOZ INC.-NVSC2022CA238125$SANDOZ$$78$YR$$M$Y$$$20240814$$CN$CA$CA
242110632$24211063$2$F$$20240827$20240814$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024078692$VIIV$$$$$$Y$$$20240905$$HP$US$US
242110641$24211064$1$I$$20240806$20240814$20240814$EXP$$RU-AstraZeneca-2024A180104$ASTRAZENECA$$66$YR$$F$Y$71$KG$20240814$$MD$RU$
242110651$24211065$1$I$$20240806$20240814$20240814$EXP$$GB-AstraZeneca-2024A180066$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$GB$
242110661$24211066$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A180313$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242110673$24211067$3$F$$20240826$20240814$20240903$EXP$$CA-AstraZeneca-2024A175059$ASTRAZENECA$$$$$F$Y$$$20240903$$HP$CA$
242110681$24211068$1$I$$20240806$20240814$20240814$EXP$$RU-AstraZeneca-2024A182296$ASTRAZENECA$$60$YR$$F$Y$117$KG$20240814$$MD$RU$
242110691$24211069$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00323$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$13$YR$C$$Y$$$20240814$$HP$TR$TR
242110701$24211070$1$I$$20230807$20240814$20240814$EXP$$US-AstraZeneca-2023A180477$ASTRAZENECA$$$$$F$Y$65.3$KG$20240814$$CN$US$
242110711$24211071$1$I$$20240806$20240814$20240814$EXP$$GB-AstraZeneca-2024A178455$ASTRAZENECA$$$$$M$Y$$$20240814$$MD$GB$
242110721$24211072$1$I$$20240806$20240814$20240814$EXP$$ZA-AstraZeneca-2024A178600$ASTRAZENECA$$65$YR$$F$Y$$$20240814$$CN$ZA$
242110731$24211073$1$I$20240711$20240806$20240814$20240814$EXP$$CA-AstraZeneca-2024A171401$ASTRAZENECA$$12469$DY$$F$Y$$$20240814$$HP$CA$
242110741$24211074$1$I$$20240813$20240814$20240814$30DAY$$US-SANDOZ INC.-SDZ2024US072519$SANDOZ$$28$YR$$M$Y$$$20240814$$CN$US$US
242110751$24211075$1$I$$20240717$20240814$20240814$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07246$LUPIN$$$$$$Y$$$20240814$$CN$US$US
242110761$24211076$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684129$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$39$YR$A$$Y$$$20240814$$MD$US$US
242110771$24211077$1$I$$20240807$20240814$20240814$PER$$US-RDY-SPO/USA/24/0011703$DR REDDYS$$34$YR$A$F$Y$$$20240814$$MD$US$US
242110782$24211078$2$F$$20240826$20240814$20240903$PER$$US-BAYER-2024A116398$BAYER$$$$$F$Y$$$20240903$$CN$US$US
242110791$24211079$1$I$20240129$20240805$20240814$20240814$EXP$$CN-ROCHE-10000049746$ROCHE$$68$YR$E$F$Y$$$20240814$$MD$CN$CN
242110811$24211081$1$I$$20240812$20240814$20240814$PER$$US-FreseniusKabi-FK202412406$FRESENIUS KABI$$$$$F$Y$$$20240814$$HP$US$US
242110831$24211083$1$I$$20240806$20240814$20240814$EXP$$CN-BAUSCH-BL-2024-012063$BAUSCH AND LOMB$Qiuqiu Z, Linyu Y, Xinxiao L, Xue W, Xiaosi J, Junshi Z, Xingli Z. Human immunodeficiency virus complicated with acute lymphoblastic leukemia: A case report and review of the literature. Clinical Medicine of China. 2024 JUL;40 (4):298-301. doi:10.3760/cma.j.cn101721-20230902-00056$73$YR$$M$Y$$$20240814$$HP$CN$CN
242110841$24211084$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55902$$FDA-CTU$$86$YR$$M$N$$$20240814$N$$US$
242110851$24211085$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55931$$FDA-CTU$$54$YR$$M$N$$$20240814$N$$US$
242110861$24211086$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55887$$FDA-CTU$$76$YR$$F$N$58.51$KG$20240814$N$$US$
242110871$24211087$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55939$$FDA-CTU$$50$YR$$F$N$108.86$KG$20240814$N$$US$
242110881$24211088$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55942$$FDA-CTU$$40$YR$$M$N$81.65$KG$20240814$N$$US$
242110891$24211089$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55930$$FDA-CTU$$80$YR$$F$N$$$20240814$N$$US$
242110901$24211090$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55892$$FDA-CTU$$30$YR$$F$N$$$20240814$N$$US$
242110911$24211091$1$I$$20240806$20240814$20240814$PER$$US-BAYER-2024A114557$BAYER$$28$YR$A$F$Y$110$KG$20240814$$CN$US$US
242110921$24211092$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684131$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$64$YR$A$$Y$$$20240814$$MD$US$US
242110931$24211093$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684130$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$68$YR$E$$Y$$$20240814$$MD$US$US
242110941$24211094$1$I$20240101$20240808$20240814$20240814$EXP$$CA-BAUSCH-BL-2024-012186$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240814$$CN$CA$CA
242110952$24211095$2$F$$20240826$20240814$20240829$EXP$$PT-BAUSCH-BL-2024-011999$BAUSCH AND LOMB$Miranda T, Herculano M, Torres J, Coelho F, Rebelo M. From Bronchodilation to Lactic Acidosis: A Case Report on Salbutamol^s Adverse Effect. Cureus. 2024 JUN 26;16(6):1-4. doi:10.7759/cureus.63213.$23$YR$$F$Y$$$20240829$$HP$PT$PT
242110962$24211096$2$F$20240701$20240809$20240814$20240820$EXP$$US-BAUSCH-BL-2024-012138$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240820$$CN$US$US
242110971$24211097$1$I$$20240808$20240814$20240814$PER$$US-ABBVIE-5875343$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242110991$24211099$1$I$20240808$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160092$AMGEN$$55$YR$A$F$Y$$$20240814$$PH$US$US
242111001$24211100$1$I$$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024160133$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242111011$24211101$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684132$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$49$YR$A$$Y$$$20240814$$MD$US$US
242111021$24211102$1$I$$20240807$20240814$20240814$EXP$$TW-VIIV HEALTHCARE LIMITED-TW2024APC098995$VIIV$$$$$$Y$$$20240814$$MD$TW$TW
242111031$24211103$1$I$20230101$20240809$20240814$20240814$EXP$$PH-OTSUKA-2024_022262$OTSUKA$$$$$F$Y$$$20240814$$CN$PH$PH
242111041$24211104$1$I$$20240812$20240814$20240814$EXP$$CA-BAUSCH-BL-2024-012289$BAUSCH AND LOMB$$77$YR$$M$Y$86$KG$20240814$$PH$CA$CA
242111051$24211105$1$I$$20240522$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US053190$SANDOZ$$$$$F$Y$$$20240814$$CN$US$US
242111061$24211106$1$I$$20240625$20240814$20240814$PER$$US-LUNDBECK-DKLU4001053$LUNDBECK$$$$$$Y$$$20240814$$HP$US$US
242111072$24211107$2$F$$20240830$20240814$20240830$PER$$US-ALXN-202408USA000595US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$HP$US$US
242111081$24211108$1$I$20240814$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55928$$FDA-CTU$$60$YR$$F$N$$$20240814$Y$HP$US$
242111091$24211109$1$I$$20230823$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2023US026666$SANDOZ$$$$$F$Y$$$20240814$$HP$US$US
242111101$24211110$1$I$$20240813$20240814$20240814$PER$$NVSC2024US165203$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242111111$24211111$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55813$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242111121$24211112$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55895$$FDA-CTU$$86$YR$$F$N$$$20240814$N$$US$
242111141$24211114$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684133$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$66$YR$E$$Y$$$20240814$$MD$US$US
242111151$24211115$1$I$$20240809$20240814$20240814$EXP$$CA-OTSUKA-2024_004911$OTSUKA$$$$$F$Y$$$20240814$$MD$CA$CA
242111161$24211116$1$I$$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024159328$AMGEN$$$$$$Y$$$20240814$$HP$US$US
242111171$24211117$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128742$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240814$$CN$US$US
242111181$24211118$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55912$$FDA-CTU$$76$YR$$M$N$$$20240814$N$$US$
242111191$24211119$1$I$20240801$20240802$20240814$20240814$DIR$FDA-CDER-CTU-2024-55792$$FDA-CTU$$59$YR$$F$N$$$20240802$Y$HP$US$
242111201$24211120$1$I$20240722$20240809$20240814$20240814$DIR$FDA-CDER-CTU-2024-55951$$FDA-CTU$$78$YR$$F$N$$$20240809$Y$HP$US$
242111211$24211121$1$I$20240628$20240808$20240814$20240814$EXP$CH-SM-2024-15075$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-127008$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240814$$PH$CH$CH
242111221$24211122$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127359$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240814$$CN$US$US
242111231$24211123$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126794$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240814$$CN$US$US
242111241$24211124$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684134$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$61$YR$A$$Y$$$20240814$$MD$US$US
242111261$24211126$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55785$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242111271$24211127$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55952$$FDA-CTU$$50$YR$$M$N$$$20240814$N$$US$
242111281$24211128$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00326$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$8$YR$C$$Y$$$20240814$$HP$TR$TR
242111291$24211129$1$I$$20240614$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US058178$SANDOZ$$57$YR$$M$Y$$$20240814$$MD$US$US
242111301$24211130$1$I$$20240726$20240814$20240814$PER$$NVSC2024US164908$NOVARTIS$$$$$$Y$$$20240814$$CN$US$US
242111311$24211131$1$I$$20240812$20240814$20240814$EXP$$NVSC2024US164293$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
242111322$24211132$2$F$$20240813$20240814$20240819$EXP$$TR-PFIZER INC-202400235044$PFIZER$Uz, B.. Single low-dose methotrexate-induced fatal pancytopenia: case report and review of the literature. Biomedical journal of scientific and technical research. 2019;15(5):10.26717/BJSTR.2019.15.002763$63$YR$$F$Y$$$20240819$$HP$TR$TR
242111341$24211134$1$I$20240808$20240809$20240814$20240814$PER$$US-SA-2024SA240163$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240814$$MD$US$US
242111351$24211135$1$I$20240628$20240808$20240814$20240814$EXP$$US-SA-2024SA240892$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240814$$MD$US$US
242111361$24211136$1$I$20240705$20240731$20240814$20240814$PER$$US-EPICPHARMA-US-2024EPCSPO00966$EPIC PHARM$$36$YR$A$F$Y$$$20240814$$CN$US$US
242111371$24211137$1$I$20240721$20240806$20240814$20240814$PER$$US-AMGEN-USASP2024157364$AMGEN$$63$YR$A$F$Y$$$20240814$$HP$US$US
242111382$24211138$2$F$20240701$20240813$20240814$20240913$PER$$US-Eisai-EC-2024-170940$EISAI$$75$YR$E$M$Y$$$20240913$$CN$US$US
242111391$24211139$1$I$$20240807$20240814$20240814$PER$$CN-Eisai-EC-2024-171736$EISAI$Zhang H, Yu H. Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case.. FRONTIERS IN ONCOLOGY. 2024 Jul 15;(14: 142837): doi:10.3389/fonc.2024.1428370.$51$YR$A$F$Y$$$20240814$$MD$CN$CN
242111401$24211140$1$I$$20240730$20240814$20240814$PER$$US-JNJFOC-20240783740$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$CN$US$US
242111411$24211141$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00328$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$$$T$$Y$$$20240814$$HP$TR$TR
242111421$24211142$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684135$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$57$YR$A$$Y$$$20240814$$MD$US$US
242111431$24211143$1$I$20240808$20240808$20240814$20240814$EXP$$MX-BAYER-2024A117251$BAYER$$43$YR$A$F$Y$$$20240814$$CN$MX$MX
242111442$24211144$2$F$$20240916$20240814$20240918$EXP$$AU-AstraZeneca-2024A179613$ASTRAZENECA$$$$$M$Y$$$20240918$$PH$AU$
242111451$24211145$1$I$20240519$20240808$20240814$20240814$EXP$FR-AFSSAPS-SE2024000622$FR-MYLANLABS-2024M1074162$MYLAN$$64$YR$$F$Y$60$KG$20240814$$HP$FR$FR
242111462$24211146$2$F$$20240816$20240814$20240822$EXP$$BG-MYLANLABS-2024M1074203$MYLAN$V. Petrusheva, M. Samardzhieva, I. Simova, N. Chilingirova, T. Vekov. Cardiotoxicity in patient with breast cancer treated with HER-2 targeted therapy-A case report.. Cardiovascular Diseases. 2024;2:14-23$54$YR$$F$Y$$$20240822$$HP$BG$BG
242111471$24211147$1$I$20240314$20240812$20240814$20240814$EXP$$DE-SANDOZ INC.-SDZ2024DE072003$SANDOZ$$64$YR$$F$Y$$$20240814$$MD$DE$DE
242111481$24211148$1$I$$20240808$20240814$20240814$EXP$$CZ-MYLANLABS-2024M1074202$MYLAN$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al.. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study. Neoplasma. 2017;64(5):762-9$53$YR$$F$Y$$$20240814$$HP$CZ$CZ
242111491$24211149$1$I$20240727$20240808$20240814$20240814$EXP$SE-SEMPA-2024-005868$SE-MYLANLABS-2024M1074291$MYLAN$$38$YR$$F$Y$$$20240814$$MD$SE$SE
242111501$24211150$1$I$20240208$20240808$20240814$20240814$EXP$FR-AFSSAPS-TO2024001330$FR-MYLANLABS-2024M1074075$MYLAN$$87$YR$$F$Y$56.4$KG$20240814$$PH$FR$FR
242111511$24211151$1$I$20240229$20240808$20240814$20240814$EXP$FR-AFSSAPS-TO2024001483$FR-MYLANLABS-2024M1074297$MYLAN$$81$YR$$M$Y$58.7$KG$20240814$$PH$FR$FR
242111521$24211152$1$I$$20240808$20240814$20240814$EXP$FR-AFSSAPS-AVNT2024000598$FR-MYLANLABS-2024M1074346$MYLAN$$22$YR$$M$Y$$$20240814$$MD$FR$FR
242111531$24211153$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A178939$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242111541$24211154$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007819$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240814$$CN$US$US
242111551$24211155$1$I$20240808$20240808$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408005931$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240814$$CN$US$US
242111561$24211156$1$I$20240226$20240806$20240814$20240814$EXP$$GB-AstraZeneca-2024A178354$ASTRAZENECA$$50$YR$$M$Y$100$KG$20240814$$MD$GB$
242111571$24211157$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179266$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242111581$24211158$1$I$20221114$20221116$20240814$20240814$EXP$$ZA-AstraZeneca-2022A380774$ASTRAZENECA$$24362$DY$$M$Y$$$20240814$$CN$ZA$
242111591$24211159$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A178818$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242111602$24211160$2$F$$20240731$20240814$20240916$PER$$US-EPICPHARMA-US-2024EPCSPO00969$EPIC PHARM$$39$YR$A$F$Y$$$20240916$$CN$US$US
242111611$24211161$1$I$$20240813$20240814$20240814$EXP$$US-AstraZeneca-2024A184371$ASTRAZENECA$$$$$M$Y$$$20240814$$HP$US$
242111622$24211162$2$F$$20240902$20240814$20240910$EXP$$US-AstraZeneca-2024A179248$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
242111632$24211163$2$F$20240116$20240828$20240814$20240904$EXP$$US-GSK-US2024098543$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$HP$US$US
242111641$24211164$1$I$20240627$20240812$20240814$20240814$EXP$$US-AstraZeneca-2024A183502$ASTRAZENECA$$$$$M$Y$$$20240814$$CN$US$
242111651$24211165$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A179331$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242111671$24211167$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55917$$FDA-CTU$$10$YR$$M$N$$$20240814$N$$US$
242111681$24211168$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55932$$FDA-CTU$$60$YR$$F$N$$$20240814$N$$US$
242111691$24211169$1$I$$20240806$20240814$20240814$EXP$$CA-AstraZeneca-2024A179878$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$CA$
242111701$24211170$1$I$$20240806$20240814$20240814$EXP$$US-AstraZeneca-2024A178770$ASTRAZENECA$$$$$F$Y$$$20240814$$CN$US$
242111711$24211171$1$I$$20240806$20240814$20240814$EXP$$ZA-AstraZeneca-2024A179932$ASTRAZENECA$$26298$DY$$M$Y$$$20240814$$CN$ZA$
242111721$24211172$1$I$$20240813$20240814$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA072583$SANDOZ$$66$YR$$M$Y$$$20240814$$HP$CA$CA
242111731$24211173$1$I$$20240808$20240814$20240814$EXP$$US-AstraZeneca-2024A181008$ASTRAZENECA$$$$$F$Y$76.2$KG$20240814$$HP$US$
242111741$24211174$1$I$20230209$20230328$20240814$20240814$EXP$$US-AstraZeneca-2023A041946$ASTRAZENECA$$21371$DY$$F$Y$$$20240814$$CN$US$
242111751$24211175$1$I$$20240807$20240814$20240814$EXP$$US-AstraZeneca-2024A182030$ASTRAZENECA$$$$$$Y$$$20240814$$CN$US$
242111761$24211176$1$I$20240808$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A182191$ASTRAZENECA$$15340$DY$$F$Y$62.8$KG$20240814$$CN$US$
242111771$24211177$1$I$$20240806$20240814$20240814$EXP$$RU-AstraZeneca-2024A180925$ASTRAZENECA$$77$YR$$M$Y$80$KG$20240814$$HP$RU$
242111781$24211178$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684136$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$70$YR$E$$Y$$$20240814$$MD$US$US
242111792$24211179$2$F$20240725$20240823$20240814$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118598$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240830$$CN$US$US
242111801$24211180$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00333$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$9$YR$C$$Y$$$20240814$$HP$TR$TR
242111811$24211181$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127762$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240814$$CN$US$US
242111821$24211182$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126967$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240814$$CN$US$US
242111832$24211183$2$F$20231128$20240808$20240814$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-176709$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240815$$MD$JP$JP
242111841$24211184$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684137$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$71$YR$E$$Y$$$20240814$$MD$US$US
242111852$24211185$2$F$20240101$20240814$20240814$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128346$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$80.5$KG$20240816$$PH$US$US
242111861$24211186$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASL2024160545$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242111871$24211187$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00335$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$12$YR$T$$Y$$$20240814$$HP$TR$TR
242111882$24211188$2$F$$20240822$20240814$20240831$EXP$$DE-TEVA-VS-3230904$TEVA$$80$YR$$F$Y$$$20240831$$CN$DE$DE
242111891$24211189$1$I$$20240813$20240814$20240814$PER$$NVSC2024US165192$NOVARTIS$$$$$$Y$$$20240814$$HP$US$US
242111901$24211190$1$I$20240809$20240809$20240814$20240814$EXP$$US-ABBVIE-5876087$ABBVIE$$74$YR$$F$Y$$$20240814$$CN$US$US
242111911$24211191$1$I$$20240812$20240814$20240814$EXP$$US-ABBVIE-5877586$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242111921$24211192$1$I$$20240808$20240814$20240814$EXP$$ES-MYLANLABS-2024M1074663$MYLAN$Rom?n P?rez FJ, Puntero1 LV,  P?rez Guerra EM. An uncommon cause of disorientation in diabetic patients. Journal of the madrid society of family and community medicine. 2024;2$87$YR$$F$Y$$$20240814$$MD$ES$ES
242111931$24211193$1$I$20240531$20240808$20240814$20240814$EXP$FR-AFSSAPS-NY2024000899$FR-MYLANLABS-2024M1074470$MYLAN$$53$YR$$M$Y$66$KG$20240814$$MD$FR$FR
242111941$24211194$1$I$$20240808$20240814$20240814$EXP$$FR-MYLANLABS-2024M1074414$MYLAN$$90$YR$$F$Y$$$20240814$$MD$FR$FR
242111951$24211195$1$I$20240701$20240806$20240814$20240814$PER$$US-SA-2024SA237913$SANOFI AVENTIS$$64$YR$A$M$Y$79$KG$20240814$$MD$US$US
242111971$24211197$1$I$$20240807$20240814$20240814$EXP$$US-SA-2024SA240525$SANOFI AVENTIS$$$$A$F$Y$90.7$KG$20240814$$MD$US$US
242111981$24211198$1$I$20240806$20240806$20240814$20240814$EXP$$US-TEVA-VS-3231966$TEVA$$62$YR$$M$Y$$$20240814$$HP$US$US
242111991$24211199$1$I$$20240731$20240814$20240814$EXP$$TR-GRANULES-TR-2024GRALIT00337$GRANULES INDIA$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.25-OCT-2022;184:33-42$13$YR$T$$Y$$$20240814$$HP$TR$TR
242112001$24211200$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684138$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$69$YR$E$$Y$$$20240814$$MD$US$US
242112011$24211201$1$I$20240812$20240812$20240814$20240814$EXP$$GB-MYLANLABS-2024M1075093$MYLAN$$$$$M$Y$$$20240814$$CN$GB$GB
242112021$24211202$1$I$20240601$20240808$20240814$20240814$EXP$$KR-TAKEDA-2024TUS079853$TAKEDA$$$$A$F$Y$$$20240814$$CN$KR$KR
242112032$24211203$2$F$$20240826$20240814$20240903$EXP$$US-TEVA-VS-3230941$TEVA$Lee K, Hussain K, Balasubramanian S, Salazar JP, Karagodin I, Levisay JP, et al. A ^VEIN^ ATTEMPT AT ANGIOPLASTY. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 4092.; Lee K, Hussain K, Balasubramanian S, Salazar JP, Karagodin I, Levisay JP, et al. A ^VEIN^ ATTEMPT AT ANGIOPLASTY. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 4092.$59$YR$$M$Y$$$20240903$$HP$US$US
242112041$24211204$1$I$$20240802$20240814$20240814$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00394$ACELLA$T. C. D. S. Yahathugoda, Nirmitha Lalindi, Ruben Janaka. et.al.. LEDoxy-SL: A Placebo-Controlled, Double-Blind, Randomized, 24-Month Trial of Six Weeks of Daily Doxycycline Plus Hygiene-Based Essential Care for Reducing Progression of Filarial Lymphedema in Sri Lanka. Am. J. Trop. Med. Hyg.,. 2024;00(00):1-14$53$YR$$F$Y$$$20240814$$HP$US$US
242112051$24211205$1$I$20240801$20240807$20240814$20240814$EXP$$US-GSK-US2024098610$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$PH$US$US
242112064$24211206$4$F$20180313$20240911$20240814$20240912$PER$$US-GILEAD-2024-0684170$GILEAD$$70$YR$E$F$Y$$$20240912$$LW$US$US
242112071$24211207$1$I$20230101$20240806$20240814$20240814$EXP$$US-ABBVIE-5870201$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242112081$24211208$1$I$20240501$20240812$20240814$20240814$EXP$FR-AFSSAPS-GR2024001001$FR-VIIV HEALTHCARE LIMITED-FR2024100487$VIIV$$$$$$Y$$$20240814$$MD$FR$FR
242112091$24211209$1$I$20240201$20240808$20240814$20240814$EXP$$US-GSK-US2024099219$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$US$US
242112101$24211210$1$I$20230602$20240808$20240814$20240814$EXP$$US-GSK-US2024099156$GLAXOSMITHKLINE$$$$$$Y$$$20240814$$CN$US$US
242112111$24211211$1$I$20240101$20240805$20240814$20240814$PER$$US-SA-2024SA234373$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240814$$CN$US$US
242112121$24211212$1$I$$20240802$20240814$20240814$EXP$$US-OSMOTICA PHARMACEUTICALS-2024ALO00395$Alora Pharma$Lee LJ, Bungart B, Wainger B. et.al.. Transient Acute Diplopia as a Rare Side Effect of Hydromorphone: A Case Report. A A Pract.. 2024;18(4):e01780$42$YR$$M$Y$$$20240814$$MD$US$US
242112131$24211213$1$I$20240701$20240806$20240814$20240814$PER$$US-SA-2024SA237779$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240814$$MD$US$US
242112141$24211214$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA237788$SANOFI AVENTIS$$$$C$F$Y$14$KG$20240814$$MD$US$US
242112151$24211215$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA240177$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240814$$MD$US$US
242112161$24211216$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA236010$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240814$$MD$US$US
242112171$24211217$1$I$$20240805$20240814$20240814$EXP$$CA-MYLANLABS-2024M1074621$MYLAN$$40$YR$$F$Y$96$KG$20240814$$HP$CA$CA
242112181$24211218$1$I$$20240813$20240814$20240814$EXP$GB-MHRA-MED-202408131517554900-TYRCG$GB-VIIV HEALTHCARE LIMITED-GB2024100681$VIIV$$$$$$Y$$$20240814$$MD$GB$GB
242112191$24211219$1$I$$20240809$20240814$20240814$EXP$$JP-009507513-2408JPN001372J$MERCK$$70$YR$$M$Y$$$20240814$$HP$JP$JP
242112201$24211220$1$I$20230402$20240813$20240814$20240814$EXP$$US-MYLANLABS-2024M1075720$MYLAN$$$$$M$Y$$$20240814$$CN$US$US
242112211$24211221$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55903$$FDA-CTU$$36$YR$$F$N$113.4$KG$20240814$N$$US$
242112221$24211222$1$I$$20240807$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127491$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240814$$CN$US$US
242112231$24211223$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128845$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240814$$MD$US$US
242112241$24211224$1$I$$20240813$20240814$20240814$EXP$$NVSC2024US156864$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
242112261$24211226$1$I$$20240814$20240814$20240814$EXP$GB-MHRA-MED-202408132355006700-HTPZV$GB-ORGANON-O2408GBR001033$ORGANON$$22$YR$$$Y$$$20240814$$CN$GB$GB
242112271$24211227$1$I$20230706$20240808$20240814$20240814$EXP$FR-AFSSAPS-TO2024001479$FR-MYLANLABS-2024M1074405$MYLAN$$80$YR$$M$Y$$$20240814$$PH$FR$FR
242112282$24211228$2$F$$20240827$20240814$20240903$EXP$$RO-MYLANLABS-2024M1074236$MYLAN$Blaga, L... Risk factors for neonatal cholestasis in small gestational age infants: case report and literature review.. The newborn research + reviews. 2024;2(1):21-26$$$N$M$Y$$$20240903$$HP$RO$RO
242112291$24211229$1$I$20240718$20240808$20240814$20240814$EXP$FR-AFSSAPS-PV2024000711$FR-MYLANLABS-2024M1074391$MYLAN$$67$YR$$F$Y$61$KG$20240814$$MD$FR$FR
242112302$24211230$2$F$$20240813$20240814$20240815$PER$$US-PFIZER INC-202400236058$PFIZER$$75$YR$$M$Y$$$20240815$$MD$US$US
242112311$24211231$1$I$20240801$20240812$20240814$20240814$PER$$US-PFIZER INC-202400235237$PFIZER$$$$A$F$Y$$$20240814$$PH$US$US
242112321$24211232$1$I$$20240813$20240814$20240814$PER$$US-PFIZER INC-202400235897$PFIZER$$73$YR$$F$Y$$$20240814$$CN$US$US
242112331$24211233$1$I$$20240813$20240814$20240814$PER$$US-PFIZER INC-202400236043$PFIZER$$66$YR$$F$Y$$$20240814$$CN$US$US
242112341$24211234$1$I$$20240813$20240814$20240814$PER$$US-PFIZER INC-202400236042$PFIZER$$72$YR$$M$Y$$$20240814$$CN$US$US
242112351$24211235$1$I$$20240813$20240814$20240814$PER$$US-PFIZER INC-202400235839$PFIZER$$75$YR$$F$Y$$$20240814$$CN$US$US
242112361$24211236$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-PV202400081762$PFIZER$$51$YR$$M$Y$$$20240814$$HP$US$US
242112371$24211237$1$I$$20240813$20240814$20240814$PER$$US-PFIZER INC-202400236072$PFIZER$$80$YR$$F$Y$$$20240814$$CN$US$US
242112381$24211238$1$I$$20240813$20240814$20240814$PER$$US-PFIZER INC-202400235828$PFIZER$$85$YR$$F$Y$$$20240814$$CN$US$US
242112391$24211239$1$I$$20240813$20240814$20240814$PER$$US-PFIZER INC-202400236313$PFIZER$$49$YR$$$Y$$$20240814$$MD$US$US
242112401$24211240$1$I$$20240813$20240814$20240814$PER$$US-PFIZER INC-202400235836$PFIZER$$73$YR$$F$Y$$$20240814$$CN$US$US
242112412$24211241$2$F$$20240815$20240814$20240819$PER$$US-PFIZER INC-202400236374$PFIZER$$41$YR$$M$Y$$$20240819$$MD$US$US
242112421$24211242$1$I$20240801$20240812$20240814$20240814$PER$$US-PFIZER INC-202400235236$PFIZER$$$$A$F$Y$$$20240814$$PH$US$US
242112431$24211243$1$I$20240813$20240813$20240814$20240814$PER$$US-PFIZER INC-202400236099$PFIZER$$39$YR$$$Y$$$20240814$$CN$US$US
242112441$24211244$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55817$$FDA-CTU$$52$YR$$F$N$$$20240814$N$$US$
242112451$24211245$1$I$$20240813$20240814$20240814$PER$$US-PFIZER INC-PV202400105149$PFIZER$$67$YR$$F$Y$$$20240814$$CN$US$US
242112461$24211246$1$I$$20240813$20240814$20240814$PER$$US-PFIZER INC-202400233895$PFIZER$$18$YR$$F$Y$$$20240814$$CN$US$US
242112471$24211247$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55812$$FDA-CTU$$49$YR$$M$N$$$20240814$N$$US$
242112481$24211248$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55913$$FDA-CTU$$75$YR$$F$N$68.04$KG$20240814$N$$US$
242112493$24211249$3$F$20240701$20240918$20240814$20240920$PER$$US-PFIZER INC-PV202400105680$PFIZER$$76$YR$$F$Y$$$20240920$$HP$US$US
242112501$24211250$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400235450$PFIZER$$72$YR$$M$Y$$$20240814$$CN$US$US
242112511$24211251$1$I$$20240813$20240814$20240814$PER$$US-PFIZER INC-202400236046$PFIZER$$82$YR$$M$Y$$$20240814$$CN$US$US
242112522$24211252$2$F$20231108$20240924$20240814$20240928$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-16123$IPSEN$$5$YR$C$M$Y$15$KG$20240928$$HP$CA$CA
242112532$24211253$2$F$$20240903$20240814$20240910$EXP$$US-GSK-US2024098487$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
242112541$24211254$1$I$20240217$20240806$20240814$20240814$EXP$FR-AFSSAPS-NY2024000872$FR-TEVA-VS-3230928$TEVA$$26$YR$$F$Y$61.9$KG$20240814$$MD$FR$FR
242112552$24211255$2$F$$20240801$20240814$20240918$PER$$US-AstraZeneca-2024A172854$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
242112561$24211256$1$I$$20240806$20240814$20240814$EXP$$JP-AstraZeneca-2024A117414$ASTRAZENECA$Mukozu T, et al.. OS1-1 Experience using durvalumab plus tremelimumab at out department.. The 30th Japan Association of Systemic Therapy for HCC 2024;82-.$$$A$$Y$$$20240814$$MD$JP$
242112571$24211257$1$I$20200301$20240807$20240814$20240814$EXP$$DE-AstraZeneca-2024A184566$ASTRAZENECA$$41$YR$$F$Y$90$KG$20240814$$MD$DE$
242112581$24211258$1$I$$20240814$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045780$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240814$$CN$US$US
242112591$24211259$1$I$$20240808$20240814$20240814$EXP$$IT-MYLANLABS-2024M1074180$MYLAN$$72$YR$$F$Y$$$20240814$$MD$IT$IT
242112601$24211260$1$I$$20240808$20240814$20240814$EXP$FR-AFSSAPS-RS2024000774$FR-MYLANLABS-2024M1074329$MYLAN$$72$YR$$M$Y$$$20240814$$MD$FR$FR
242112611$24211261$1$I$20240725$20240808$20240814$20240814$EXP$$GB-Eisai-EC-2024-171757$EISAI$$$$$M$Y$$$20240814$$MD$GB$GB
242112621$24211262$1$I$20240524$20240808$20240814$20240814$EXP$FR-AFSSAPS-AN2024001012$FR-MYLANLABS-2024M1074046$MYLAN$$69$YR$$F$Y$53$KG$20240814$$MD$FR$FR
242112631$24211263$1$I$$20240810$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126953$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$154.67$KG$20240814$$CN$US$US
242112641$24211264$1$I$$20240807$20240814$20240814$EXP$$US-JNJFOC-20240821769$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240814$$HP$US$US
242112651$24211265$1$I$$20240805$20240814$20240814$EXP$$US-TEVA-VS-3230942$TEVA$Zhang X, Aoun B. A DEADLY FORM OF DELIRIUM. Eur-J-Case-Rep-Intern-Med 2019; 6 (Suppl.) 373 abstr. #34.$62$YR$$F$Y$$$20240814$$HP$US$US
242112661$24211266$1$I$$20240806$20240814$20240814$EXP$$IT-JNJFOC-20240816731$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$HP$IT$IT
242112682$24211268$2$F$20240620$20240807$20240814$20240819$EXP$$NVSC2024IN030969$NOVARTIS$$50$YR$$M$Y$$$20240819$$CN$IN$IN
242112691$24211269$1$I$20240720$20240808$20240814$20240814$EXP$ES-AEMPS-1556854$ES-MYLANLABS-2024M1074253$MYLAN$$99$YR$$F$Y$47.7$KG$20240814$$MD$ES$ES
242112701$24211270$1$I$$20240807$20240814$20240814$PER$$US-ABBVIE-5872379$ABBVIE$$$$$$Y$$$20240814$$HP$US$US
242112711$24211271$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA236148$SANOFI AVENTIS$$29$YR$A$M$Y$99.79$KG$20240814$$MD$US$US
242112731$24211273$1$I$20240801$20240809$20240814$20240814$EXP$$US-SA-2024SA240092$SANOFI AVENTIS$$84$YR$E$F$Y$74.84$KG$20240814$$MD$US$US
242112741$24211274$1$I$20240719$20240805$20240814$20240814$PER$$US-SA-2024SA237675$SANOFI AVENTIS$$46$YR$A$F$Y$102$KG$20240814$$MD$US$US
242112751$24211275$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236271$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240814$$MD$US$US
242112762$24211276$2$F$$20240812$20240814$20240821$PER$$US-SA-2024SA235968$SANOFI AVENTIS$$30$YR$A$F$Y$111.13$KG$20240821$$MD$US$US
242112771$24211277$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA240766$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240814$$CN$US$US
242112782$24211278$2$F$20240730$20240827$20240814$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-128277$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240902$$MD$JP$JP
242112791$24211279$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127602$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240814$$HP$US$US
242112801$24211280$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55947$$FDA-CTU$$54$YR$$F$N$$$20240814$N$$US$
242112821$24211282$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55948$$FDA-CTU$$71$YR$$F$N$$$20240814$N$$US$
242112831$24211283$1$I$20240812$20240813$20240813$20240813$DIR$714137$$FDA-CTU$$64$YR$$F$N$76.5$KG$20240813$Y$HP$US$
242112841$24211284$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55950$$FDA-CTU$$61$YR$$F$N$88$KG$20240814$N$$US$
242112861$24211286$1$I$$20240813$20240813$20240813$DIR$714154$$FDA-CTU$$$$$F$N$56.25$KG$20240813$N$CN$US$
242112871$24211287$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55862$$FDA-CTU$$$$$M$N$$$20240813$N$HP$US$
242112881$24211288$1$I$20240731$20240813$20240813$20240813$DIR$714118$$FDA-CTU$$67$YR$$M$N$104$KG$20240813$Y$PH$US$
242112891$24211289$1$I$$20240618$20240814$20240814$PER$$US-GILEAD-2024-0678021$GILEAD$$79$YR$E$F$Y$$$20240814$$HP$US$US
242112901$24211290$1$I$$20240808$20240814$20240814$PER$$NVSC2024US164543$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
242112911$24211291$1$I$$20240808$20240814$20240814$EXP$$FR-MYLANLABS-2024M1074560$MYLAN$Liu W., He Q., He Y.. Analysis of clinical characteristics of tramadol induced hypoglycaemia. Chin J Clin Pharmacol Ther. 2024;29(7):819-825$33$YR$$M$Y$$$20240814$$HP$FR$FR
242112921$24211292$1$I$20240805$20240809$20240814$20240814$PER$$US-AMGEN-USASP2024159526$AMGEN$$73$YR$E$F$Y$63.2$KG$20240814$$PH$US$US
242112931$24211293$1$I$$20240807$20240814$20240814$PER$$US-JNJFOC-20240824663$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242112941$24211294$1$I$$20240716$20240814$20240814$EXP$$MX-JAZZ PHARMACEUTICALS-2024-MX-012525$JAZZ$$71$YR$$M$Y$$$20240814$$MD$MX$MX
242112951$24211295$1$I$20240101$20240812$20240814$20240814$PER$$US-SA-2024SA241289$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240814$$CN$US$US
242112961$24211296$1$I$20240729$20240812$20240814$20240814$EXP$$CN-JNJFOC-20240832571$JOHNSON AND JOHNSON$$76$YR$E$F$Y$55$KG$20240814$$HP$CN$CN
242112981$24211298$1$I$$20240806$20240814$20240814$EXP$$GB-BAXTER-2024BAX022835$BAXTER$$54$YR$$F$Y$$$20240814$$CN$GB$GB
242113001$24211300$1$I$20240729$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55825$$FDA-CTU$$76$YR$$F$N$$$20240814$N$$US$
242113011$24211301$1$I$20240613$20240813$20240813$20240813$DIR$714164$$FDA-CTU$$8$MON$$F$N$8.37$KG$20240813$N$HP$US$
242113021$24211302$1$I$20240629$20240813$20240814$20240814$EXP$SE-SEMPA-2024-006008$SE-ORGANON-O2408SWE000985$ORGANON$$57$YR$$M$Y$$$20240814$$MD$SE$SE
242113032$24211303$2$F$20240701$20240821$20240814$20240830$EXP$$US-BAYER-2024A112436$BAYER$$74$YR$E$M$Y$$$20240830$$CN$US$US
242113045$24211304$5$F$20240806$20240920$20240814$20240927$EXP$$US-TAKEDA-2024TUS079241$TAKEDA$$80$YR$$F$Y$$$20240927$$HP$US$US
242113051$24211305$1$I$20240812$20240813$20240813$20240813$DIR$714150$$FDA-CTU$$52$YR$$M$N$$$20240813$Y$HP$US$
242113061$24211306$1$I$20240716$20240813$20240813$20240813$DIR$714170$$FDA-CTU$$37$YR$$F$N$72$KG$20240813$N$CN$US$
242113071$24211307$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55921$$FDA-CTU$$65$YR$$F$N$$$20240814$N$$US$
242113081$24211308$1$I$$20240813$20240814$20240814$PER$$NVSC2024US165082$NOVARTIS$$$$$M$Y$$$20240814$$CN$US$US
242113092$24211309$2$F$$20240910$20240814$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA072577$SANDOZ$$44$YR$$M$Y$$$20240912$$CN$CA$CA
242113101$24211310$1$I$$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127517$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240814$$CN$US$US
242113111$24211311$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128618$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240814$$HP$US$US
242113121$24211312$1$I$$20240808$20240814$20240814$PER$$US-AMGEN-USASL2024158916$AMGEN$$$$$F$Y$$$20240814$$HP$US$US
242113131$24211313$1$I$$20240813$20240814$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA002723$SANDOZ$$76$YR$$M$Y$66$KG$20240814$$HP$CA$CA
242113141$24211314$1$I$20240812$20240814$20240814$20240814$PER$$US-PFIZER INC-202400236543$PFIZER$$49$YR$$F$Y$$$20240814$$CN$US$US
242113151$24211315$1$I$$20240809$20240814$20240814$EXP$$US-AstraZeneca-2024A182403$ASTRAZENECA$$$$$$Y$$$20240814$$CN$US$
242113161$24211316$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-PV202400105303$PFIZER$$60$YR$$M$Y$$$20240814$$HP$US$US
242113171$24211317$1$I$20240807$20240810$20240814$20240814$PER$$US-PFIZER INC-202400234359$PFIZER$$61$YR$$F$Y$$$20240814$$CN$US$US
242113183$24211318$3$F$$20240826$20240814$20240826$PER$$US-PFIZER INC-PV202400105262$PFIZER$$86$YR$$M$Y$71.94$KG$20240826$$MD$US$US
242113191$24211319$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400235838$PFIZER$$38$YR$$F$Y$$$20240814$$HP$US$US
242113201$24211320$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-PV202400104671$PFIZER$$59$YR$$$Y$$$20240814$$CN$US$US
242113211$24211321$1$I$20240101$20240809$20240814$20240814$PER$$US-PFIZER INC-202400233875$PFIZER$$69$YR$$M$Y$83.91$KG$20240814$$CN$US$US
242113221$24211322$1$I$20240327$20240807$20240814$20240814$EXP$IT-MINISAL02-997984$IT-PFIZER INC-202400231950$PFIZER$$75$YR$$M$Y$$$20240814$$MD$IT$IT
242113231$24211323$1$I$20240811$20240814$20240814$20240814$PER$$US-PFIZER INC-202400236538$PFIZER$$68$YR$$F$Y$$$20240814$$CN$US$US
242113241$24211324$1$I$$20240813$20240814$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA072624$SANDOZ$$27$YR$$$Y$60$KG$20240814$$CN$CA$CA
242113251$24211325$1$I$$20240812$20240814$20240814$EXP$$NL-AstraZeneca-2024A183978$ASTRAZENECA$$64$YR$$F$Y$64$KG$20240814$$MD$NL$
242113261$24211326$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238126$SANOFI AVENTIS$$$$$M$Y$$$20240814$$HP$US$US
242113271$24211327$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236528$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240814$$MD$US$US
242113281$24211328$1$I$20240701$20240806$20240814$20240814$PER$$US-SA-2024SA236807$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240814$$MD$US$US
242113291$24211329$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA236440$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240814$$MD$US$US
242113301$24211330$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA238096$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240814$$MD$US$US
242113311$24211331$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238069$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240814$$MD$US$US
242113321$24211332$1$I$20240801$20240807$20240814$20240814$PER$$US-SA-2024SA238078$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240814$$MD$US$US
242113331$24211333$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA238115$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240814$$MD$US$US
242113341$24211334$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236609$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240814$$CN$US$US
242113352$24211335$2$F$20240704$20240827$20240814$20240903$PER$$US-MYLANLABS-2024M1073367$MYLAN$$52$YR$$$Y$$$20240903$$CN$US$US
242113361$24211336$1$I$$20240809$20240814$20240814$EXP$$CA-SANDOZ INC.-SDZ2024CA051828$SANDOZ$$$$$F$Y$$$20240814$$MD$CA$CA
242113371$24211337$1$I$$20240809$20240814$20240814$PER$$US-PFIZER INC-202400234602$PFIZER$$49$YR$$M$Y$$$20240814$$CN$US$US
242113381$24211338$1$I$$20240805$20240814$20240814$EXP$$CA-ABBVIE-5856083$ABBVIE$$$$A$F$Y$$$20240814$$HP$CA$CA
242113391$24211339$1$I$20231205$20240813$20240813$20240813$DIR$714155$$FDA-CTU$$70$YR$$F$N$46.1$KG$20240813$Y$MD$US$
242113411$24211341$1$I$20240806$20240806$20240814$20240814$PER$$US-ABBVIE-5870394$ABBVIE$$80$YR$$M$Y$$$20240814$$CN$US$US
242113421$24211342$1$I$$20240731$20240814$20240814$DIR$FDA-CDER-CTU-2024-55787$$FDA-CTU$$79$YR$$F$N$$$20240731$N$HP$US$
242113441$24211344$1$I$$20240812$20240814$20240814$DIR$FDA-CDER-CTU-2024-55793$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242113452$24211345$2$F$20240701$20240806$20240814$20240905$EXP$$US-BAYER-2024A106861$BAYER$$84$YR$E$F$Y$40.816$KG$20240905$$PH$US$US
242113471$24211347$1$I$20240420$20240813$20240813$20240813$DIR$714120$$FDA-CTU$$63$YR$$F$N$$$20240813$N$CN$US$
242113491$24211349$1$I$20240806$20240806$20240814$20240814$PER$$US-ABBVIE-5871903$ABBVIE$$25$YR$$F$Y$$$20240814$$CN$US$US
242113521$24211352$1$I$$20240805$20240814$20240814$EXP$$PT-FreseniusKabi-FK202412196$FRESENIUS KABI$$79$YR$E$F$Y$$$20240814$$MD$PT$PT
242113531$24211353$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55916$$FDA-CTU$$37$YR$$M$N$$$20240814$N$$US$
242113542$24211354$2$F$20240201$20240816$20240814$20240821$EXP$GB-MHRA-MED-202406070946480090-WQGRV$GB-DSJP-DSE-2024-125907$DAIICHI$$58$YR$$F$Y$65$KG$20240821$$MD$GB$GB
242113551$24211355$1$I$20240620$20240813$20240813$20240813$DIR$714144$$FDA-CTU$$55$YR$$F$N$$$20240813$N$CN$US$
242113561$24211356$1$I$20240301$20240813$20240814$20240814$PER$$US-AMGEN-USASP2024161674$AMGEN$$$$$$Y$$$20240814$$HP$US$US
242113571$24211357$1$I$20230525$20240813$20240814$20240814$EXP$GB-MHRA-MED-202408131613021310-HTCRB$GB-ABBVIE-5879467$ABBVIE$$77$YR$$M$Y$$$20240814$$PH$GB$GB
242113581$24211358$1$I$$20240805$20240814$20240814$EXP$$PT-FreseniusKabi-FK202412197$FRESENIUS KABI$$70$YR$E$F$Y$$$20240814$$MD$PT$PT
242113592$24211359$2$F$$20240910$20240814$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128901$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240912$$CN$US$US
242113601$24211360$1$I$$20240806$20240814$20240814$EXP$$ET-BRISTOL-MYERS SQUIBB COMPANY-2024-124454$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240814$$MD$ET$ET
242113622$24211362$2$F$$20240909$20240814$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127062$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240912$$CN$US$US
242113631$24211363$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA241558$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240814$$CN$US$US
242113641$24211364$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA240143$SANOFI AVENTIS$$$$$$Y$$$20240814$$HP$US$US
242113651$24211365$1$I$$20240807$20240814$20240814$EXP$$US-BAYER-2024A114309$BAYER$$73$YR$E$M$Y$$$20240814$$CN$US$US
242113662$24211366$2$F$$20240814$20240814$20240820$EXP$$US-SANDOZ INC.-SDZ2024US072655$SANDOZ$$$$$$Y$$$20240820$$CN$US$US
242113671$24211367$1$I$20240101$20240809$20240814$20240814$EXP$$US-ABBVIE-5877010$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242113681$24211368$1$I$20240720$20240812$20240814$20240814$EXP$FR-AFSSAPS-SE2024000643$FR-PFIZER INC-202400234540$PFIZER$$54$YR$$F$Y$$$20240814$$MD$FR$FR
242113692$24211369$2$F$20240701$20240816$20240814$20240820$EXP$$CN-PFIZER INC-202400234409$PFIZER$$65$YR$$M$Y$$$20240820$$MD$CN$CN
242113711$24211371$1$I$$20240812$20240814$20240814$EXP$$CA-PFIZER INC-202400234818$PFIZER$$76$YR$$M$Y$$$20240814$$HP$CA$CA
242113721$24211372$1$I$20240716$20240809$20240814$20240814$EXP$$CN-PFIZER INC-PV202400104216$PFIZER$$70$YR$$F$Y$67.5$KG$20240814$$HP$CN$CN
242113731$24211373$1$I$$20240812$20240814$20240814$EXP$$US-PFIZER INC-PV202400104975$PFIZER$$60$YR$$M$Y$$$20240814$$CN$US$US
242113741$24211374$1$I$$20240808$20240814$20240814$EXP$$CA-PFIZER INC-202400234799$PFIZER$$56$YR$$F$Y$59$KG$20240814$$HP$CA$CA
242113751$24211375$1$I$$20240802$20240814$20240814$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408002444$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$CN$CN
242113761$24211376$1$I$20240722$20240801$20240814$20240814$EXP$GB-MHRA-MED-202408010825397670-RFSKW$GB-ELI_LILLY_AND_COMPANY-GB202408000773$ELI LILLY AND CO$$62$YR$A$M$Y$123$KG$20240814$$CN$GB$GB
242113771$24211377$1$I$20240714$20240807$20240814$20240814$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408005282$ELI LILLY AND CO$$58$YR$A$F$Y$143$KG$20240814$$MD$DE$DE
242113781$24211378$1$I$$20240804$20240814$20240814$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202408002469$ELI LILLY AND CO$$$$$F$Y$$$20240814$$MD$SA$SA
242113791$24211379$1$I$$20240802$20240814$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003372$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240814$$CN$US$US
242113802$24211380$2$F$$20240819$20240814$20240826$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408002504$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240826$$CN$BR$BR
242113811$24211381$1$I$$20240801$20240814$20240814$EXP$GB-MHRA-MED-202408011151460980-RKQFB$GB-ELI_LILLY_AND_COMPANY-GB202408000761$ELI LILLY AND CO$$$$$$Y$124$KG$20240814$$CN$GB$GB
242113821$24211382$1$I$20240728$20240805$20240814$20240814$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408002480$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$DE$DE
242113831$24211383$1$I$$20240807$20240814$20240814$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202408005296$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240814$$CN$CA$CA
242113841$24211384$1$I$$20240802$20240814$20240814$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202408001558$ELI LILLY AND CO$$$$$M$Y$$$20240814$$CN$IT$IT
242113851$24211385$1$I$$20240807$20240814$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202404017659$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240814$$CN$US$US
242113861$24211386$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007005$ELI LILLY AND CO$$$$$M$Y$$$20240814$$CN$US$US
242113871$24211387$1$I$$20240802$20240814$20240814$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408005291$ELI LILLY AND CO$$$$$M$Y$$$20240814$$CN$BR$BR
242113881$24211388$1$I$$20240802$20240814$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003013$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240814$$CN$US$US
242113892$24211389$2$F$20240715$20240816$20240814$20240819$EXP$ES-AEMPS-1557416$ES-GILEAD-2024-0684016$GILEAD$$63$YR$A$F$Y$$$20240819$$PH$ES$ES
242113901$24211390$1$I$$20240812$20240814$20240814$PER$$US-ABBVIE-5877651$ABBVIE$$40$YR$$M$Y$$$20240814$$HP$US$US
242113911$24211391$1$I$20240805$20240806$20240814$20240814$PER$$US-ABBVIE-5871923$ABBVIE$$$$$$Y$$$20240814$$CN$US$US
242113922$24211392$2$F$$20240809$20240814$20240821$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006695$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240821$$CN$US$US
242113932$24211393$2$F$20240727$20240828$20240814$20240903$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US002554$PAREXEL$$$$$$Y$$$20240902$$HP$US$US
242113941$24211394$1$I$$20240712$20240814$20240814$EXP$$US-LEX-000395$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240814$$HP$US$US
242113951$24211395$1$I$$20240809$20240814$20240814$PER$$US-MYLANLABS-2024M1075047$MYLAN$$$$$M$Y$$$20240814$$HP$US$US
242113961$24211396$1$I$$20240813$20240814$20240814$PER$$NVSC2024US164878$NOVARTIS$$$$$F$Y$170$KG$20240814$$CN$US$US
242113971$24211397$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA240173$SANOFI AVENTIS$$$$A$M$Y$$$20240814$$CN$US$US
242113981$24211398$1$I$20240101$20240805$20240814$20240814$PER$$US-SA-2024SA237235$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240814$$MD$US$US
242113991$24211399$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA238084$SANOFI AVENTIS$$14$YR$T$F$Y$15.4$KG$20240814$$MD$US$US
242114001$24211400$1$I$$20240808$20240814$20240814$EXP$$CA-AMGEN-CANSL2024158458$AMGEN$$32$YR$A$M$Y$$$20240814$$CN$CA$CA
242114012$24211401$2$F$20240701$20240827$20240814$20240902$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-14161$IPSEN$$75$YR$E$F$Y$$$20240902$$MD$US$US
242114021$24211402$1$I$$20240812$20240814$20240814$PER$$US-AstraZeneca-2024A184536$ASTRAZENECA$$$$$$Y$$$20240814$$CN$US$
242114031$24211403$1$I$20240723$20240806$20240814$20240814$EXP$$CO-AstraZeneca-2024A180293$ASTRAZENECA$$21327$DY$$M$Y$76$KG$20240814$$CN$CO$
242114041$24211404$1$I$20240708$20240812$20240814$20240814$EXP$$CN-PFIZER INC-PV202400104944$PFIZER$$53$YR$$M$Y$59$KG$20240814$$HP$CN$CN
242114061$24211406$1$I$$20240809$20240814$20240814$EXP$$JP-PFIZER INC-202400233502$PFIZER$$$$$$Y$$$20240814$$PH$JP$JP
242114081$24211408$1$I$$20240731$20240814$20240814$EXP$$US-TEVA-VS-3229877$TEVA$$43$YR$$M$Y$$$20240814$$CN$US$US
242114091$24211409$1$I$20240731$20240813$20240813$20240813$DIR$714113$$FDA-CTU$$61$YR$$M$N$109.35$KG$20240813$Y$CN$US$
242114111$24211411$1$I$$20240812$20240814$20240814$EXP$$CA-PFIZER INC-PV202400105268$PFIZER$$59$YR$$F$Y$$$20240814$$MD$CA$CA
242114161$24211416$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55922$$FDA-CTU$$60$YR$$F$N$$$20240814$N$$US$
242114171$24211417$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55860$$FDA-CTU$$48$YR$$M$N$90.26$KG$20240814$N$$US$
242114181$24211418$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55929$$FDA-CTU$$59$YR$$F$N$133.36$KG$20240814$N$$US$
242114191$24211419$1$I$20240701$20240809$20240814$20240814$EXP$$US-SA-2024SA240024$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240814$$MD$US$US
242114201$24211420$1$I$20240712$20240807$20240814$20240814$PER$$GB-Eisai-EC-2024-171645$EISAI$$77$YR$E$F$Y$63$KG$20240814$$MD$GB$GB
242114211$24211421$1$I$$20240805$20240814$20240814$PER$$IT-Eisai-EC-2024-171740$EISAI$Rizzo S, Peretto G, Bosi C, Pomaranzi C, Cigliola A, Tateo V, et al. Myocarditis Following Pembrolizumab Plus Axitinib, and Belzutifan Plus Lenvatinib for Renal Cell Carcinoma: A Case Report. Cardiovascular Toxicology. 2024 Jul 31;doi:10.1007/s12012-024-09906-w.$52$YR$A$F$Y$$$20240814$$MD$IT$IT
242114222$24211422$2$F$20180507$20240808$20240814$20240925$EXP$$CN-SA-2024SA239967$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240925$$HP$CN$CN
242114231$24211423$1$I$20240709$20240812$20240814$20240814$EXP$$US-ABBVIE-5877828$ABBVIE$$59$YR$$M$Y$$$20240814$$CN$US$US
242114242$24211424$2$F$$20240912$20240814$20240918$30DAY$$US-MYLANLABS-2024M1074509$MYLAN$$$$$F$Y$$$20240918$$PH$US$US
242114251$24211425$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126929$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240814$$CN$US$US
242114261$24211426$1$I$20240808$20240808$20240814$20240814$PER$$US-SA-2024SA240395$SANOFI AVENTIS$$54$YR$A$M$Y$103$KG$20240814$$MD$US$US
242114272$24211427$2$F$20240901$20240910$20240814$20240917$PER$$US-SA-2024SA234610$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$MD$US$US
242114291$24211429$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA239370$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240814$$HP$US$US
242114301$24211430$1$I$20240101$20240805$20240814$20240814$PER$$US-SA-2024SA236004$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240814$$MD$US$US
242114311$24211431$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55814$$FDA-CTU$$56$YR$$F$N$$$20240814$N$$US$
242114321$24211432$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55821$$FDA-CTU$$57$YR$$M$N$$$20240814$N$$US$
242114331$24211433$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55828$$FDA-CTU$$68$YR$$F$N$$$20240814$N$$US$
242114341$24211434$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55848$$FDA-CTU$$49$YR$$F$N$$$20240814$N$$US$
242114351$24211435$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55861$$FDA-CTU$$58$YR$$F$N$$$20240814$N$$US$
242114361$24211436$1$I$20240101$20240812$20240814$20240814$EXP$$SE-ABBVIE-5879007$ABBVIE$$$$$F$Y$$$20240814$$HP$SE$SE
242114372$24211437$2$F$$20240926$20240814$20240926$PER$$NVSC2024US165008$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
242114382$24211438$2$F$20240810$20240925$20240814$20240928$PER$$US-JNJFOC-20240828987$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240928$$PH$US$US
242114391$24211439$1$I$$20240808$20240814$20240814$PER$$US-JNJFOC-20240823661$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242114401$24211440$1$I$20240601$20240808$20240814$20240814$EXP$$IT-MYLANLABS-2024M1074043$MYLAN$$78$YR$$F$Y$$$20240814$$CN$IT$IT
242114411$24211441$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA238032$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240814$$CN$US$US
242114421$24211442$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA236804$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240814$$MD$US$US
242114431$24211443$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA238016$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240814$$MD$US$US
242114441$24211444$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA237843$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240814$$MD$US$US
242114462$24211446$2$F$20240801$20240810$20240814$20240819$PER$$US-SA-2024SA236454$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240819$$MD$US$US
242114471$24211447$1$I$$20240813$20240814$20240814$PER$$US-ABBVIE-5879618$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242114481$24211448$1$I$20240101$20240812$20240814$20240814$EXP$$US-ABBVIE-5877898$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242114501$24211450$1$I$$20240812$20240814$20240814$PER$$US-ABBVIE-5879578$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242114512$24211451$2$F$20240101$20240329$20240814$20240925$PER$$US-TEVA-VS-3228942$TEVA$$63$YR$$F$Y$$$20240925$$PH$US$US
242114521$24211452$1$I$20191012$20240808$20240814$20240814$EXP$$CN-SA-2024SA239979$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240814$$HP$CN$CN
242114531$24211453$1$I$20240724$20240802$20240814$20240814$EXP$$US-Accord-440357$ACCORD$$23$YR$A$M$Y$$$20240814$$HP$US$US
242114541$24211454$1$I$$20240804$20240814$20240814$EXP$$CN-Accord-440588$ACCORD$Zhang N, Chen X, Ye T, Ge H, Zhai X, Wu J, et al. Successful Treatment of Generalized Facial Verrucae Vulgaris with a Combination of Curettage and Photodynamic Therapy in an Adolescent: A Case Report. Clin Cosmet Investig Dermatol. 2024 Jul 22;17:1695-1699. doi: 10.2147/CCID.S470435.$17$YR$T$M$Y$$$20240814$$HP$CN$CN
242114551$24211455$1$I$$20240804$20240814$20240814$EXP$$JP-Accord-440798$ACCORD$Sasaki M, Shimura T, Nishie H, Kuroyanagi K, Kanno T, Fukusada S, et al. BRAF K601E-mutated metastatic colorectal cancer in response to combination therapy with encorafenib, binimetinib, and cetuximab: A case report. World J Gastrointest Oncol. 2024 Jul 15;16(7):3357-3363. doi: 10.4251/wjgo.v16.i7.3357.$59$YR$A$F$Y$$$20240814$$HP$JP$JP
242114561$24211456$1$I$$20240804$20240814$20240814$EXP$$JP-Accord-440634$ACCORD$Funo T, Hashimoto D, Yamaki S, Matsumura K, Miyazaki H, Matsui Y, et al. Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based chemotherapy followed by olaparib. Surg Case Rep. 2024 Jul 30;10(1):179.$47$YR$A$M$Y$$$20240814$$HP$JP$JP
242114571$24211457$1$I$20231116$20240808$20240814$20240814$EXP$IE-HPRA-2024-114578$IE-MYLANLABS-2024M1074290$MYLAN$$67$YR$$M$Y$$$20240814$$CN$IE$IE
242114581$24211458$1$I$$20240808$20240814$20240814$EXP$FR-AFSSAPS-PV2024000722$FR-MYLANLABS-2024M1074401$MYLAN$$$$N$M$Y$0.32$KG$20240814$$MD$FR$FR
242114592$24211459$2$F$20220101$20240829$20240814$20240903$EXP$IT-MINISAL02-997859$IT-MYLANLABS-2024M1074054$MYLAN$$30$YR$$M$Y$65$KG$20240903$$CN$IT$IT
242114601$24211460$1$I$$20240812$20240814$20240814$EXP$$CA-FreseniusKabi-FK202412375$FRESENIUS KABI$$71$YR$E$F$Y$$$20240814$$MD$CA$CA
242114611$24211461$1$I$$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128534$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240814$$CN$US$US
242114621$24211462$1$I$$20240807$20240814$20240814$EXP$$ZA-AstraZeneca-2024A180111$ASTRAZENECA$$76$YR$$F$Y$$$20240814$$CN$ZA$
242114632$24211463$2$F$$20240826$20240814$20240903$EXP$$US-TEVA-VS-3230944$TEVA$Kaur K, Othman AR, Dalbah RMR, Erpenwar S, Hoskere GV. Candida Empyema in a Patient With Adenocarcinoma of Gastroesophageal Junction. Am-J-Respir-Crit-Care-Med 2023; 207 1.; Kaur K, Othman AR, Dalbah RMR, Erpenwar S, Hoskere GV. Candida Empyema in a Patient With Adenocarcinoma of Gastroesophageal Junction. Am-J-Respir-Crit-Care-Med 2023; 207 1.$81$YR$$M$Y$$$20240903$$HP$US$US
242114641$24211464$1$I$20240501$20240715$20240814$20240814$PER$$US-009507513-2407USA009790$MERCK$$$$$M$Y$$$20240814$$CN$US$US
242114651$24211465$1$I$20230401$20240812$20240814$20240814$EXP$FR-AFSSAPS-LM2024000440$FR-PFIZER INC-202400234432$PFIZER$$76$YR$$F$Y$39.5$KG$20240814$$MD$FR$FR
242114661$24211466$1$I$$20240808$20240814$20240814$EXP$$DE-MYLANLABS-2024M1074331$MYLAN$$$$$F$Y$$$20240814$$CN$DE$DE
242114701$24211470$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55818$$FDA-CTU$$57$YR$$F$N$$$20240814$N$$US$
242114711$24211471$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55888$$FDA-CTU$$40$YR$$M$N$78.02$KG$20240814$N$$US$
242114721$24211472$1$I$20240812$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55890$$FDA-CTU$$74$YR$$M$N$$$20240814$N$PH$US$
242114731$24211473$1$I$20240708$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55815$$FDA-CTU$$57$YR$$F$N$65.77$KG$20240814$Y$$US$
242114741$24211474$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55911$$FDA-CTU$$62$YR$$F$N$$$20240814$N$$US$
242114761$24211476$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55949$$FDA-CTU$$70$YR$$F$N$$$20240814$N$$US$
242114771$24211477$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55858$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242114782$24211478$2$F$$20240814$20240814$20240820$PER$$US-AMGEN-USASP2024161731$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242114792$24211479$2$F$20240708$20240920$20240814$20240926$EXP$$US-ABBVIE-5877984$ABBVIE$$76$YR$$F$Y$$$20240926$$CN$US$US
242114801$24211480$1$I$$20240726$20240814$20240814$PER$$US-TEVA-VS-3228174$TEVA$$59$YR$$F$Y$$$20240814$$HP$US$US
242114811$24211481$1$I$20240801$20240812$20240814$20240814$EXP$$US-ABBVIE-5877999$ABBVIE$$49$YR$$M$Y$$$20240814$$CN$US$US
242114822$24211482$2$F$$20240814$20240814$20240816$PER$$NVSC2024US165248$NOVARTIS$$$$$F$Y$$$20240816$$HP$US$US
242114832$24211483$2$F$20240811$20240827$20240814$20240831$EXP$$PT-ABBVIE-5879005$ABBVIE$$53$YR$$F$Y$$$20240831$$CN$PT$PT
242114842$24211484$2$F$$20240826$20240814$20240903$EXP$$US-TEVA-VS-3230903$TEVA$Abu Zahra M, Al-Dhmour H, Patel N, Weingarten-Arams J, Gorstein S, Michael Ushay H, et al. Is It Children^s Interstitial Lung Disease (chILD)?. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Abu Zahra M, Al-Dhmour H, Patel N, Weingarten-Arams J, Gorstein S, Michael Ushay H, et al. Is It Children^s Interstitial Lung Disease (chILD)?. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$$$I$M$Y$$$20240903$$HP$US$US
242114852$24211485$2$F$$20240919$20240814$20240927$EXP$$US-TEVA-VS-3230752$TEVA$$$$$F$Y$$$20240927$$CN$US$US
242114862$24211486$2$F$20240629$20240819$20240814$20240826$EXP$FR-AFSSAPS-SE2024000634$FR-GILEAD-2024-0683831$GILEAD$$56$YR$A$F$Y$84$KG$20240826$$HP$FR$FR
242114872$24211487$2$F$20240901$20240903$20240814$20240924$EXP$$US-SA-2024SA241233$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240924$$MD$US$US
242114881$24211488$1$I$20240731$20240813$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128616$BRISTOL MYERS SQUIBB$$103$YR$E$M$Y$$$20240814$$CN$US$US
242114891$24211489$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128776$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240814$$HP$US$US
242114901$24211490$1$I$20240719$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128730$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240814$$CN$US$US
242114911$24211491$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55816$$FDA-CTU$$35$YR$$F$N$$$20240814$N$$US$
242114921$24211492$1$I$$20240812$20240814$20240814$EXP$$US-MYLANLABS-2024M1075729$MYLAN$$$$$M$Y$$$20240814$$CN$US$US
242114931$24211493$1$I$20240802$20240812$20240814$20240814$EXP$GB-MHRA-MED-202408121237418250-VBJCR$GB-MYLANLABS-2024M1075131$MYLAN$$50$YR$$F$Y$54$KG$20240814$$CN$GB$GB
242114941$24211494$1$I$$20240731$20240814$20240814$EXP$$US-HLS-202400658$HLS THERAPEUTICS$$$$A$F$Y$$$20240814$$HP$US$US
242114951$24211495$1$I$$20240812$20240814$20240814$EXP$$CA-PFIZER INC-202400235722$PFIZER$$71$YR$$F$Y$$$20240814$$HP$CA$CA
242114961$24211496$1$I$20221201$20240812$20240814$20240814$EXP$$AT-PFIZER INC-202400234440$PFIZER$$$$T$M$Y$$$20240814$$MD$AT$AT
242114971$24211497$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236273$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240814$$MD$US$US
242114981$24211498$1$I$20240801$20240806$20240814$20240814$PER$$US-SA-2024SA235908$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240814$$MD$US$US
242114991$24211499$1$I$20240101$20240805$20240814$20240814$PER$$US-SA-2024SA235344$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240814$$CN$US$US
242115001$24211500$1$I$20240701$20240806$20240814$20240814$PER$$US-SA-2024SA236282$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240814$$MD$US$US
242115011$24211501$1$I$20240322$20240808$20240814$20240814$EXP$FR-AFSSAPS-NY2024000894$FR-MYLANLABS-2024M1074662$MYLAN$$78$YR$$M$Y$$$20240814$$MD$FR$FR
242115021$24211502$1$I$20201203$20240808$20240814$20240814$EXP$$CA-TAKEDA-2024TUS080204$TAKEDA$$53$YR$$F$Y$$$20240814$$MD$CA$CA
242115051$24211505$1$I$$20240807$20240814$20240814$EXP$$BR-AMGEN-BRASP2024159368$AMGEN$Breviglieri C.; Ginani V.C.; Gouveia R.V. et al.. BLINATUMOMAB + DONOR LEUKOCYTE INFUSIONS (DLI) CAN BE USED TO PREVENT THE RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT). JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 2024;5 (SUPPL_1):82-83$$$$$Y$$$20240814$$HP$BR$BR
242115061$24211506$1$I$20240813$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128916$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240814$$CN$US$US
242115071$24211507$1$I$20240806$20240806$20240814$20240814$PER$$US-ABBVIE-5871824$ABBVIE$$76$YR$$M$Y$$$20240814$$CN$US$US
242115082$24211508$2$F$20230418$20240913$20240814$20240923$EXP$FR-AFSSAPS-NC2024000942$FR-TAKEDA-2024TUS080070$TAKEDA$$38$YR$$F$Y$$$20240923$$HP$FR$FR
242115091$24211509$1$I$$20240813$20240814$20240814$EXP$$PL-BEIGENE-BGN-2024-012703$BEIGENE$$$$$$Y$$$20240814$$MD$PL$PL
242115101$24211510$1$I$$20240806$20240814$20240814$EXP$$CN-TAKEDA-2024TUS079377$TAKEDA$$$$$M$Y$$$20240814$$CN$CN$CN
242115111$24211511$1$I$20240724$20240807$20240814$20240814$EXP$$CN-SA-2024SA241223$SANOFI AVENTIS$$89$YR$E$M$Y$75$KG$20240814$$HP$CN$CN
242115122$24211512$2$F$20240801$20240812$20240814$20240816$PER$$US-AMGEN-USASP2024159495$AMGEN$$81$YR$E$F$Y$$$20240816$$CN$US$US
242115132$24211513$2$F$$20240814$20240814$20240819$EXP$$US-SANDOZ INC.-NVSC2020US234780$SANDOZ$$$$$F$Y$87.08$KG$20240819$$CN$US$US
242115141$24211514$1$I$$20240807$20240814$20240814$PER$$US-ABBVIE-5873803$ABBVIE$$$$$$Y$$$20240814$$CN$US$US
242115151$24211515$1$I$20240709$20240805$20240814$20240814$EXP$CN-91110000556821568D-2024DRL001443$CN-RDY-SPO/CHN/24/0011572$DR REDDYS$$37$YR$A$M$Y$$$20240814$$HP$CN$CN
242115161$24211516$1$I$20240720$20240809$20240814$20240814$EXP$$CN-DSJP-DSJ-2024-140292$DAIICHI$$71$YR$$M$Y$58$KG$20240814$$HP$CN$CN
242115171$24211517$1$I$20240729$20240808$20240814$20240814$EXP$$CN-DSJP-DSJ-2024-140123$DAIICHI$$56$YR$$F$Y$60$KG$20240814$$HP$CN$CN
242115181$24211518$1$I$$20240808$20240814$20240814$EXP$$JP-DSJP-DSJ-2024-140128$DAIICHI$$7$DEC$$M$Y$$$20240814$$MD$JP$JP
242115192$24211519$2$F$20240807$20240902$20240814$20240906$EXP$$JP-DSJP-DSJ-2024-140198$DAIICHI$$87$YR$$F$Y$$$20240906$$PH$JP$JP
242115201$24211520$1$I$$20240430$20240814$20240814$PER$$US-MYLANLABS-2024M1039868$MYLAN$$$$$$Y$$$20240814$$CN$US$US
242115211$24211521$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128773$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240814$$CN$US$US
242115222$24211522$2$F$$20240920$20240814$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126443$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240926$$HP$US$US
242115231$24211523$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128521$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240814$$CN$US$US
242115251$24211525$1$I$20240401$20240805$20240814$20240814$PER$$US-GE HEALTHCARE-2024CSU009005$GE HEALTHCARE$$84$YR$$F$Y$$$20240814$$CN$US$US
242115261$24211526$1$I$20240101$20240805$20240814$20240814$PER$$US-GE HEALTHCARE-2024CSU009004$GE HEALTHCARE$$$$$F$Y$$$20240814$$CN$US$US
242115271$24211527$1$I$20240101$20240805$20240814$20240814$PER$$US-GE HEALTHCARE-2024CSU009003$GE HEALTHCARE$$$$$F$Y$$$20240814$$CN$US$US
242115281$24211528$1$I$20240501$20240812$20240814$20240814$EXP$$US-ABBVIE-5878029$ABBVIE$$42$YR$$F$Y$$$20240814$$CN$US$US
242115291$24211529$1$I$$20240813$20240814$20240814$EXP$$PL-BEIGENE-BGN-2024-012707$BEIGENE$$$$$$Y$$$20240814$$MD$PL$PL
242115302$24211530$2$F$20240101$20240813$20240814$20240816$EXP$$US-PFIZER INC-202400236066$PFIZER$$52$YR$$F$Y$$$20240816$$MD$US$US
242115322$24211532$2$F$20240501$20240820$20240814$20240821$EXP$$FI-PFIZER INC-202400236438$PFIZER$$24$YR$$F$Y$$$20240821$$MD$FI$FI
242115331$24211533$1$I$20231215$20240812$20240814$20240814$EXP$$DE-ABBVIE-5879456$ABBVIE$$64$YR$$F$Y$$$20240814$$CN$DE$DE
242115341$24211534$1$I$$20240811$20240814$20240814$EXP$$MA-JNJFOC-20240830144$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$HP$MA$MA
242115351$24211535$1$I$$20240808$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408005766$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240814$$CN$US$US
242115361$24211536$1$I$$20240813$20240814$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008544$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240814$$HP$US$US
242115371$24211537$1$I$$20240808$20240814$20240814$EXP$NL-LRB-00995991$NL-ELI_LILLY_AND_COMPANY-NL202408005351$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240814$$CN$NL$NL
242115381$24211538$1$I$$20240802$20240814$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001732$ELI LILLY AND CO$$$$$M$Y$$$20240814$$CN$US$US
242115391$24211539$1$I$$20240801$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408001344$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240814$$CN$US$US
242115401$24211540$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA237692$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240814$$MD$US$US
242115411$24211541$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236908$SANOFI AVENTIS$$$$A$F$Y$61.2$KG$20240814$$MD$US$US
242115421$24211542$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA240682$SANOFI AVENTIS$$$$C$M$Y$$$20240814$$MD$US$US
242115431$24211543$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA236582$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240814$$MD$US$US
242115441$24211544$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236915$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240814$$MD$US$US
242115451$24211545$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238140$SANOFI AVENTIS$$$$T$M$Y$$$20240814$$MD$US$US
242115462$24211546$2$F$20240701$20240814$20240814$20240828$PER$$US-SA-2024SA236866$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240828$$MD$US$US
242115471$24211547$1$I$$20240809$20240814$20240814$EXP$$NVSC2024US162807$NOVARTIS$$$$$F$Y$$$20240814$$CN$US$US
242115481$24211548$1$I$$20240802$20240814$20240814$EXP$$TH-BAYER-2024A112682$BAYER$$35$YR$A$M$Y$$$20240814$$MD$TH$TH
242115491$24211549$1$I$20240507$20240808$20240814$20240814$EXP$$IT-MYLANLABS-2024M1074179$MYLAN$$93$YR$$M$Y$$$20240814$$MD$IT$IT
242115501$24211550$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA236830$SANOFI AVENTIS$$$$A$M$Y$80.73$KG$20240814$$MD$US$US
242115511$24211551$1$I$20240613$20240808$20240814$20240814$EXP$FR-AFSSAPS-DJ2024000878$FR-MYLANLABS-2024M1074444$MYLAN$$50$YR$$F$Y$$$20240814$$MD$FR$FR
242115523$24211552$3$F$20240629$20240924$20240814$20240925$EXP$$FR-SANDOZ INC.-SDZ2024FR072250$SANDOZ$$53$YR$$M$Y$100$KG$20240925$$CN$FR$FR
242115541$24211554$1$I$$20240813$20240814$20240814$PER$$US-ABBVIE-5879693$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242115551$24211555$1$I$$20240805$20240814$20240814$PER$$US-SA-2024SA236869$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240814$$MD$US$US
242115562$24211556$2$F$20240101$20240827$20240814$20240910$PER$$US-SA-2024SA237580$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240910$$MD$US$US
242115571$24211557$1$I$$20240805$20240814$20240814$PER$$US-SA-2023SA184291$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240814$$MD$US$US
242115581$24211558$1$I$$20240730$20240814$20240814$EXP$$EU-IMP-2024000577$Harrow Health$$$$$$Y$$$20240814$$CN$EU$EU
242115591$24211559$1$I$20231020$20240805$20240814$20240814$EXP$$AU-009507513-2408AUS002510$MERCK$$64$YR$$F$Y$$$20240814$$MD$AU$AU
242115601$24211560$1$I$$20240809$20240814$20240814$EXP$$NVSC2024IT111626$NOVARTIS$$60$YR$$F$Y$$$20240814$$CN$IT$IT
242115611$24211561$1$I$20240101$20240812$20240814$20240814$EXP$$US-ABBVIE-5878737$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242115621$24211562$1$I$20240625$20240809$20240814$20240814$EXP$$TH-BAYER-2024A115725$BAYER$$64$YR$A$M$Y$$$20240814$$CN$TH$TH
242115631$24211563$1$I$$20240805$20240814$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125876$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240814$$MD$JP$JP
242115642$24211564$2$F$$20231207$20240814$20240927$PER$$US-VIVUS LLC-2023V1001309$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
242115652$24211565$2$F$$20240812$20240814$20240820$PER$$NVSC2024US164091$NOVARTIS$$$$$M$Y$$$20240820$$CN$US$US
242115661$24211566$1$I$20240404$20240808$20240814$20240814$EXP$FR-AFSSAPS-AN2024001003$FR-MYLANLABS-2024M1074084$MYLAN$$60$YR$$M$Y$$$20240814$$PH$FR$FR
242115683$24211568$3$F$20240811$20240919$20240814$20240927$PER$$US-JNJFOC-20240828874$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
242115691$24211569$1$I$20230301$20240810$20240814$20240814$EXP$$US-ABBVIE-5877526$ABBVIE$$54$YR$$F$Y$$$20240814$$CN$US$US
242115701$24211570$1$I$20240805$20240812$20240814$20240814$EXP$$AR-ABBVIE-5877645$ABBVIE$$29$YR$$M$Y$$$20240814$$CN$AR$AR
242115711$24211571$1$I$20201201$20240809$20240814$20240814$EXP$$US-INCYTE CORPORATION-2024IN008395$INCYTE$$$$$$Y$$$20240814$$PH$US$US
242115721$24211572$1$I$$20240807$20240814$20240814$PER$$US-ABBVIE-5872157$ABBVIE$$$$$$Y$$$20240814$$CN$US$US
242115731$24211573$1$I$20240101$20240812$20240814$20240814$EXP$$PT-MEN-2024-107839$MENARINI$Neves AD, Viegas JF, Vilas AP, Pinheiro D. PO-0428 - (2130) - Treat hypertension but not hypotension? Congresses of the Portuguese Society of Internal Medicine: 30th National Congress. 2024;30: 78$87$YR$$F$Y$$$20240814$$HP$PT$PT
242115741$24211574$1$I$$20240808$20240814$20240814$EXP$$CA-TAKEDA-2024TUS080205$TAKEDA$$$$$F$Y$$$20240814$$MD$CA$CA
242115751$24211575$1$I$20230625$20240808$20240814$20240814$EXP$FR-AFSSAPS-PV2024000593$FR-MYLANLABS-2024M1074318$MYLAN$$1$DY$$M$Y$0.28$KG$20240814$$MD$FR$FR
242115771$24211577$1$I$$20240515$20240814$20240814$PER$$US-INCYTE CORPORATION-2024IN005199$INCYTE$$$$$$Y$$$20240814$$CN$US$US
242115781$24211578$1$I$$20240809$20240814$20240814$EXP$$US-INCYTE CORPORATION-2024IN008402$INCYTE$$$$$$Y$$$20240814$$CN$US$US
242115791$24211579$1$I$20240716$20240716$20240814$20240814$PER$$US-SMPA-2024MYSCI0700696$SUNOVION$$$$$$Y$$$20240814$$MD$US$US
242115801$24211580$1$I$$20240715$20240814$20240814$PER$$US-SMPA-2024MYSCI0600615$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242115811$24211581$1$I$$20240718$20240814$20240814$PER$$US-SMPA-2024MYSCI0700775$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242115821$24211582$1$I$20240121$20240716$20240814$20240814$PER$$US-SMPA-2024MYSCI0200809$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242115832$24211583$2$F$20240701$20240820$20240814$20240913$PER$$US-SMPA-2024SPA000829$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
242115841$24211584$1$I$$20240716$20240814$20240814$PER$$US-SMPA-2024MYSCI0700680$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242115851$24211585$1$I$$20240717$20240814$20240814$PER$$US-SMPA-2024MYSCI0700720$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242115862$24211586$2$F$$20240829$20240814$20240917$PER$$US-SMPA-2024MYSCI0700719$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
242115871$24211587$1$I$20231024$20240715$20240814$20240814$PER$$US-SMPA-2024MYSCI0600714$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242115881$24211588$1$I$$20240716$20240814$20240814$PER$$US-SMPA-2024MYSCI0700664$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242115891$24211589$1$I$$20240716$20240814$20240814$PER$$US-SMPA-2024MYSCI0700651$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242115901$24211590$1$I$$20240718$20240814$20240814$PER$$US-SMPA-2024MYSCI0700791$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242115912$24211591$2$F$$20240813$20240814$20240909$PER$$US-SMPA-2024MYSCI0700657$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242115921$24211592$1$I$$20240729$20240814$20240814$PER$$US-SMPA-2024SPA000382$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242115931$24211593$1$I$20240809$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127850$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240814$$CN$US$US
242115941$24211594$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127941$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240814$$HP$US$US
242115951$24211595$1$I$$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127861$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240814$$CN$US$US
242115961$24211596$1$I$$20240809$20240814$20240814$EXP$$US-KYOWAKIRIN-2024KK019070$KYOWA$$$$$$Y$$$20240814$$MD$US$US
242115971$24211597$1$I$$20240805$20240814$20240814$PER$$US-SMPA-2024SPA000910$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242115981$24211598$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126894$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240814$$CN$US$US
242115991$24211599$1$I$20231101$20240809$20240814$20240814$EXP$$US-INCYTE CORPORATION-2024IN008410$INCYTE$$$$$$Y$$$20240814$$CN$US$US
242116001$24211600$1$I$20240716$20240730$20240814$20240814$EXP$$EG-IMP-2024000594$Harrow Health$$18$YR$A$$Y$$$20240814$$MD$EG$EG
242116011$24211601$1$I$$20240806$20240814$20240814$EXP$$CA-TEVA-VS-3232037$TEVA$$81$YR$$M$Y$$$20240814$$CN$CA$CA
242116021$24211602$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008434$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240814$$CN$US$US
242116033$24211603$3$F$20240803$20240823$20240814$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408005412$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240828$$CN$US$US
242116041$24211604$1$I$20240726$20240805$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408002979$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240814$$CN$US$US
242116051$24211605$1$I$$20240812$20240814$20240814$EXP$$US-INCYTE CORPORATION-2024IN008436$INCYTE$$$$$$Y$$$20240814$$HP$US$US
242116061$24211606$1$I$20240810$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160989$AMGEN$$64$YR$A$F$Y$$$20240814$$CN$US$US
242116071$24211607$1$I$$20240802$20240814$20240814$PER$$US-INCYTE CORPORATION-2024IN008138$INCYTE$$$$$$Y$$$20240814$$CN$US$US
242116082$24211608$2$F$$20240812$20240814$20240819$EXP$$PL-MYLANLABS-2024M1074328$MYLAN$Oszer A, Ko?odrubiec J, Pawlik B, Marschollek P, ?wilichowska N, Jakubowska J, et al.. CD19-CAR T-cell therapy with sorafenib in post-HSCT relapse of mixed phenotype acute leukaemia (MPAL) with phenotypic myeloid to lymphoid lineage switch - A case report and review of the literature. British journal of haematology. 2024;1-5$10$YR$$F$Y$$$20240819$$HP$PL$PL
242116091$24211609$1$I$$20240808$20240814$20240814$EXP$$DK-MYLANLABS-2024M1074232$MYLAN$Liu W., He Q., He Y. Analysis of clinical characteristics of tramadol induced hypoglycaemia. Chin J Clin Pharmacol Ther. 2024;29(7):819-825$21$YR$$F$Y$$$20240814$$HP$DK$DK
242116101$24211610$1$I$20240101$20240801$20240814$20240814$EXP$$US-SMPA-2024SPA000600$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242116111$24211611$1$I$$20240808$20240814$20240814$EXP$$CZ-MYLANLABS-2024M1075252$MYLAN$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E et al... Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study.. Neoplasma. 2017;64(5):762-9$52$YR$$F$Y$$$20240814$$HP$CZ$CZ
242116121$24211612$1$I$20240721$20240802$20240814$20240814$EXP$$US-SMPA-2024SPA000693$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242116131$24211613$1$I$$20240801$20240814$20240814$EXP$$US-SMPA-2024SPA000454$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242116151$24211615$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128682$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240814$$CN$US$US
242116161$24211616$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128570$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240814$$CN$US$US
242116181$24211618$1$I$$20240808$20240814$20240814$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012480$JAZZ$$$$$M$Y$73.107$KG$20240814$$MD$US$US
242116191$24211619$1$I$20160218$20240802$20240814$20240814$PER$$US-INCYTE CORPORATION-2024IN008147$INCYTE$$$$$$Y$$$20240814$$CN$US$US
242116202$24211620$2$F$$20240830$20240814$20240909$EXP$$US-SMPA-2024MYSCI0700182$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242116213$24211621$3$F$20240813$20240820$20240814$20240823$PER$$NVSC2024US165135$NOVARTIS$$67$YR$$F$Y$$$20240823$$CN$US$US
242116221$24211622$1$I$20240723$20240808$20240814$20240814$EXP$IT-MINISAL02-997793$IT-MYLANLABS-2024M1074267$MYLAN$$84$YR$$M$Y$$$20240814$$PH$IT$IT
242116231$24211623$1$I$20200501$20240812$20240814$20240814$EXP$$US-INCYTE CORPORATION-2024IN008401$INCYTE$$$$$$Y$$$20240814$$CN$US$US
242116241$24211624$1$I$20240630$20240808$20240814$20240814$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012232$JAZZ$$0$YR$$F$Y$6.803$KG$20240814$$CN$US$US
242116251$24211625$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128199$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240814$$CN$US$US
242116261$24211626$1$I$20240801$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127855$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$71.67$KG$20240814$$CN$US$US
242116271$24211627$1$I$$20240806$20240814$20240814$EXP$$US-MYLANLABS-2024M1074803$MYLAN$Nelson N, Masih D, Sabri A, Monika F, Mirza M. Isolated Myeloid Sarcoma Masquerading as Scattered Abscesses in a Septic Patient: A Case Report and Literature Review. Case-Rep-Oncol 2024; 17 (1): 39-48.$76$YR$$F$Y$$$20240814$$HP$US$US
242116281$24211628$1$I$$20240715$20240814$20240814$PER$$US-SMPA-2024MYSCI0700031$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242116291$24211629$1$I$$20240715$20240814$20240814$PER$$US-SMPA-2024MYSCI0601009$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242116301$24211630$1$I$20240101$20240812$20240814$20240814$EXP$$US-INCYTE CORPORATION-2024IN008441$INCYTE$$$$$$Y$$$20240814$$CN$US$US
242116311$24211631$1$I$$20240812$20240814$20240814$EXP$$US-INCYTE CORPORATION-2024IN008443$INCYTE$$$$$$Y$$$20240814$$CN$US$US
242116321$24211632$1$I$$20240719$20240814$20240814$PER$$US-009507513-2407USA012809$MERCK$$$$$M$Y$$$20240814$$CN$US$US
242116331$24211633$1$I$$20240716$20240814$20240814$PER$$US-009507513-2407USA010859$MERCK$Kuczmarski TM, Lynch RC.. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma. British Journal of Haematology. 2024;205(1):100-8$18$YR$$F$Y$$$20240814$$HP$US$US
242116342$24211634$2$F$20240807$20240820$20240814$20240826$PER$$US-009507513-2408USA003735$MERCK$$$$$F$Y$$$20240826$$MD$US$US
242116352$24211635$2$F$$20240807$20240814$20240924$PER$$US-GILEAD-2024-0683366$GILEAD$$62$YR$A$M$Y$$$20240924$$CN$US$US
242116371$24211637$1$I$$20240801$20240814$20240814$PER$$US-JNJFOC-20240805041$JOHNSON AND JOHNSON$$$$$M$Y$$$20240814$$CN$US$US
242116381$24211638$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240829171$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240814$$CN$US$US
242116391$24211639$1$I$$20240813$20240814$20240814$PER$$US-AMGEN-USASP2024161620$AMGEN$$$$$$Y$$$20240814$$HP$US$US
242116403$24211640$3$F$20240722$20240826$20240814$20240830$EXP$$US-GILEAD-2024-0683875$GILEAD$$62$YR$A$F$Y$80.9$KG$20240830$$MD$US$US
242116413$24211641$3$F$20240701$20240913$20240814$20240914$PER$$US-AMGEN-USASP2024160406$AMGEN$$65$YR$E$F$Y$$$20240914$$CN$US$US
242116421$24211642$1$I$20240101$20240807$20240814$20240814$PER$$US-ABBVIE-5873439$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242116431$24211643$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240831762$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242116441$24211644$1$I$20240801$20240807$20240814$20240814$PER$$US-SA-2024SA236783$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240814$$MD$US$US
242116451$24211645$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA237104$SANOFI AVENTIS$$57$YR$A$F$Y$75.2$KG$20240814$$MD$US$US
242116461$24211646$1$I$20240129$20240812$20240814$20240814$EXP$ES-AEMPS-1557690$ES-009507513-2408ESP004125$MERCK$$84$YR$$M$Y$$$20240814$$MD$ES$ES
242116471$24211647$1$I$20240803$20240809$20240814$20240814$EXP$$CA-APOTEX-2024AP009209$APOTEX$$78$YR$E$F$Y$$$20240814$$PH$CA$CA
242116481$24211648$1$I$20230226$20240808$20240814$20240814$EXP$FR-AFSSAPS-TO2024001482$FR-MYLANLABS-2024M1074302$MYLAN$$80$YR$$M$Y$63$KG$20240814$$PH$FR$FR
242116491$24211649$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128807$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240814$$CN$US$US
242116502$24211650$2$F$20240802$20240824$20240814$20240902$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-126570$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240902$$HP$TW$TW
242116511$24211651$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128460$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$83.91$KG$20240814$$CN$US$US
242116521$24211652$1$I$$20240807$20240814$20240814$PER$$US-ABBVIE-5872223$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242116531$24211653$1$I$20240528$20240813$20240814$20240814$EXP$ES-AEMPS-1557418$ES-GILEAD-2024-0684014$GILEAD$$70$YR$E$M$Y$$$20240814$$PH$ES$ES
242116541$24211654$1$I$$20240807$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US072666$SANDOZ$$$$$$Y$$$20240814$$PH$US$US
242116551$24211655$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684128$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$34$YR$A$$Y$$$20240814$$MD$US$US
242116561$24211656$1$I$20240809$20240813$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008232$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240814$$CN$US$US
242116571$24211657$1$I$$20240731$20240814$20240814$EXP$$CA-HLS-202401916$HLS THERAPEUTICS$$$$A$M$Y$$$20240814$$PH$CA$CA
242116581$24211658$1$I$$20240813$20240814$20240814$PER$$US-ABBVIE-5879844$ABBVIE$$$$$$Y$$$20240814$$HP$US$US
242116592$24211659$2$F$20240701$20240821$20240814$20240827$EXP$$CH-AMERICAN REGENT INC-2024003085$AMERICAN REGENT$$4$DEC$$F$Y$59$KG$20240827$$CN$CH$CH
242116601$24211660$1$I$20240702$20240805$20240814$20240814$EXP$$CO-ABBVIE-5879551$ABBVIE$$75$YR$$F$Y$63$KG$20240814$$HP$CO$CO
242116611$24211661$1$I$$20231108$20240814$20240814$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241091$IRONSHORE PHARMA$$$$$$Y$$$20240814$$MD$US$US
242116621$24211662$1$I$$20231108$20240814$20240814$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241093$IRONSHORE PHARMA$$$$$$Y$$$20240814$$MD$US$US
242116631$24211663$1$I$$20231108$20240814$20240814$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241092$IRONSHORE PHARMA$$$$$$Y$$$20240814$$MD$US$US
242116641$24211664$1$I$$20231108$20240814$20240814$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20241094$IRONSHORE PHARMA$$$$$$Y$$$20240814$$MD$US$US
242116651$24211665$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240833711$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242116661$24211666$1$I$20240101$20240808$20240814$20240814$EXP$FR-AFSSAPS-BR2024000638$FR-MYLANLABS-2024M1074394$MYLAN$$53$YR$$F$Y$$$20240814$$MD$FR$FR
242116672$24211667$2$F$$20240910$20240814$20240913$PER$$US-Taiho Oncology Inc-2024-007769$TAIHO ONCOLOGY INC$$68$YR$E$F$Y$$$20240913$$HP$US$US
242116681$24211668$1$I$20240101$20240806$20240814$20240814$PER$$US-SA-2024SA237684$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240814$$MD$US$US
242116691$24211669$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA239347$SANOFI AVENTIS$$$$E$M$Y$104.32$KG$20240814$$MD$US$US
242116701$24211670$1$I$$20240807$20240814$20240814$PER$$US-SA-2024SA238294$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240814$$CN$US$US
242116711$24211671$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA235190$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240814$$MD$US$US
242116721$24211672$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA239097$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240814$$MD$US$US
242116731$24211673$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA235273$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240814$$MD$US$US
242116741$24211674$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA240633$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240814$$MD$US$US
242116751$24211675$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA235224$SANOFI AVENTIS$$$$E$F$Y$$$20240814$$MD$US$US
242116761$24211676$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA235308$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240814$$MD$US$US
242116771$24211677$1$I$20220725$20240808$20240814$20240814$EXP$$FR-TAKEDA-2024TUS080792$TAKEDA$$1$DY$$F$Y$2.6$KG$20240814$$HP$FR$FR
242116781$24211678$1$I$$20240807$20240814$20240814$PER$$US-ABBVIE-5871701$ABBVIE$$$$$$Y$88.904$KG$20240814$$PH$US$US
242116791$24211679$1$I$$20240812$20240814$20240814$PER$$US-ABBVIE-5878258$ABBVIE$$$$$$Y$$$20240814$$HP$US$US
242116802$24211680$2$F$$20240830$20240814$20240902$EXP$$IT-SANDOZ INC.-SDZ2024IT072011$SANDOZ$$33$YR$$$Y$$$20240902$$MD$IT$IT
242116812$24211681$2$F$20240730$20240817$20240814$20240903$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002207$CORCEPT$$$$$$Y$$$20240902$$HP$US$US
242116821$24211682$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128568$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240814$$HP$US$US
242116831$24211683$1$I$$20240808$20240814$20240814$EXP$$US-BAYER-2024A114839$BAYER$$67$YR$E$M$Y$$$20240814$$CN$US$US
242116841$24211684$1$I$$20240807$20240814$20240814$PER$$US-JNJFOC-20240834273$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$HP$US$US
242116851$24211685$1$I$$20240807$20240814$20240814$PER$$US-JNJFOC-20240834870$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240814$$HP$US$US
242116862$24211686$2$F$20240805$20240903$20240814$20240912$EXP$$IL-Taiho Oncology Inc-2024-007824$TAIHO ONCOLOGY INC$$31$YR$A$M$Y$$$20240912$$CN$IL$IL
242116871$24211687$1$I$$20240806$20240814$20240814$PER$$US-ABBVIE-5872074$ABBVIE$$$$$$Y$$$20240814$$MD$US$US
242116881$24211688$1$I$$20240807$20240814$20240814$EXP$$BR-BIOMARINAP-BR-2024-159765$BIOMARIN$$$$$$Y$$$20240814$$CN$BR$BR
242116891$24211689$1$I$20240812$20240814$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045806$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240814$$CN$US$US
242116902$24211690$2$F$$20240808$20240814$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126158$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240905$$MD$US$US
242116911$24211691$1$I$$20240805$20240814$20240814$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-124874$BRISTOL MYERS SQUIBB$Vrablova L, Klamova H, Skoumalova I, Navratilova J, Janska R, Grohmann J, et al. Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression. Hematology, Transfusion and Cell Therapy. 2024 Jul 22;1-11.doi:10.1016/j.htct.2024.03.010.$37$YR$A$M$Y$$$20240814$$HP$CZ$CZ
242116921$24211692$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128652$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240814$$HP$US$US
242116931$24211693$1$I$20240812$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007908$ELI LILLY AND CO$$$$$$Y$$$20240814$$CN$US$US
242116942$24211694$2$F$20240812$20240826$20240814$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408007727$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240829$$CN$US$US
242116951$24211695$1$I$$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008062$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240814$$CN$US$US
242116961$24211696$1$I$20240809$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007671$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240814$$CN$US$US
242116971$24211697$1$I$$20240805$20240814$20240814$PER$$US-GILEAD-2024-0684201$GILEAD$$63$YR$A$F$Y$$$20240814$$CN$US$US
242116981$24211698$1$I$$20240809$20240814$20240814$EXP$$CA-PFIZER INC-202400233795$PFIZER$$8$YR$$M$Y$28$KG$20240814$$HP$CA$CA
242116992$24211699$2$F$$20240905$20240814$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408008617$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240909$$CN$US$US
242117001$24211700$1$I$$20240812$20240814$20240814$PER$$US-GILEAD-2024-0684202$GILEAD$$29$YR$A$M$Y$$$20240814$$CN$US$US
242117011$24211701$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232173$TEVA$$17$YR$$M$Y$$$20240814$$HP$CA$CA
242117021$24211702$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232209$TEVA$$68$YR$$M$Y$64$KG$20240814$$HP$CA$CA
242117031$24211703$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232207$TEVA$$61$YR$$M$Y$86$KG$20240814$$HP$CA$CA
242117041$24211704$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232381$TEVA$$62$YR$$M$Y$$$20240814$$CN$CA$CA
242117051$24211705$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232213$TEVA$$7$YR$$M$Y$18$KG$20240814$$HP$CA$CA
242117061$24211706$1$I$$20240814$20240814$20240814$EXP$$IT-GILEAD-2024-0684205$GILEAD$$$$E$M$Y$$$20240814$$HP$IT$IT
242117071$24211707$1$I$$20240812$20240814$20240814$EXP$$US-GILEAD-2024-0684211$GILEAD$$71$YR$E$M$Y$$$20240814$$CN$US$US
242117091$24211709$1$I$$20240812$20240814$20240814$PER$$US-ABBVIE-5879360$ABBVIE$$$$$$Y$$$20240814$$CN$US$US
242117101$24211710$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684065$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$54$YR$A$$Y$$$20240814$$MD$US$US
242117113$24211711$3$F$$20240904$20240814$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125809$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240912$$CN$US$US
242117121$24211712$1$I$20240716$20240809$20240814$20240814$PER$$US-ALXN-202408USA000621US$ALEXION PHARMACEUTICALS$$37$YR$$M$Y$$$20240814$$CN$US$US
242117133$24211713$3$F$20230101$20240822$20240814$20240828$EXP$$CA-BAUSCH-BL-2023-015862$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240828$$CN$CA$CA
242117142$24211714$2$F$20130101$20240826$20240814$20240828$EXP$$US-BAUSCH-BL-2024-012080$BAUSCH AND LOMB$$$$$F$Y$$$20240828$$CN$US$US
242117151$24211715$1$I$20240709$20240807$20240814$20240814$EXP$IE-HPRA-2024-114533$IE-TEVA-VS-3231539$TEVA$$15$YR$$F$Y$43.6$KG$20240814$$HP$IE$IE
242117161$24211716$1$I$$20240805$20240814$20240814$EXP$$US-GSK-US2024097555$GLAXOSMITHKLINE$$$$$F$Y$$$20240814$$CN$US$US
242117171$24211717$1$I$20240713$20240807$20240814$20240814$PER$$US-BIOMARINAP-US-2024-159711$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
242117181$24211718$1$I$$20240812$20240814$20240814$PER$$US-ABBVIE-5878963$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242117192$24211719$2$F$20221224$20240814$20240814$20240815$EXP$$US-PURDUE PHARMA-USA-2024-0311332$PURDUE$$22$YR$$M$Y$$$20240815$$CN$US$US
242117201$24211720$1$I$20240731$20240808$20240814$20240814$EXP$$GB-PURDUE-USA-2024-0311354$PURDUE$$34$YR$$F$Y$$$20240814$$MD$GB$GB
242117212$24211721$2$F$$20240813$20240814$20240821$EXP$$GE-PURDUE-USA-2024-0311358$PURDUE$Davis P, Evans D. Emergency Department Buprenorphine and Naloxone Prescribing Disparities Among Racial and Ethnic Minorities Presenting With an Opioid Overdose. Advanced emergency nursing journal. 2024;46(3):187-94$50$YR$$M$Y$$$20240821$$HP$GE$GE
242117221$24211722$1$I$$20240806$20240814$20240814$EXP$$US-PURDUE-USA-2024-0311345$PURDUE$Alamir M, Brauer P, Charles P, Mandato J, Bales R.. Abnormally Large Submandibular Salivary Gland Sialolithiasis. Consultant. 2024;64:7$31$YR$$F$Y$$$20240814$$HP$US$US
242117231$24211723$1$I$20240805$20240810$20240810$20240810$DIR$713749$$FDA-CTU$$72$YR$$F$N$78.75$KG$20240810$Y$CN$US$
242117241$24211724$1$I$$20240814$20240814$20240814$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045810$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240814$$CN$US$US
242117251$24211725$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232149$TEVA$$73$YR$$F$Y$$$20240814$$MD$CA$CA
242117261$24211726$1$I$$20240807$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128170$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$75$KG$20240814$$CN$US$US
242117271$24211727$1$I$20240401$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128710$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240814$$CN$US$US
242117281$24211728$1$I$$20240723$20240814$20240814$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-117887$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$65.32$KG$20240814$$CN$PR$PR
242117291$24211729$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232378$TEVA$$69$YR$$F$Y$75$KG$20240814$$HP$CA$CA
242117301$24211730$1$I$$20240809$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408007981$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240814$$CN$US$US
242117311$24211731$1$I$20240811$20240813$20240814$20240814$PER$$US-PURDUE-USA-2024-0311335$PURDUE$$57$YR$$F$Y$$$20240814$$CN$US$US
242117321$24211732$1$I$$20240813$20240814$20240814$PER$$US-PURDUE PHARMA-USA-2024-0311333$PURDUE$$$$$F$Y$$$20240814$$CN$US$US
242117331$24211733$1$I$$20240807$20240814$20240814$EXP$$CA-TEVA-VS-3232120$TEVA$$8$YR$$F$Y$$$20240814$$HP$CA$CA
242117341$24211734$1$I$20240701$20240806$20240814$20240814$PER$$US-SA-2024SA236926$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240814$$MD$US$US
242117371$24211737$1$I$20240101$20240807$20240814$20240814$PER$$US-SA-2024SA238721$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240814$$CN$US$US
242117381$24211738$1$I$20240607$20240807$20240814$20240814$EXP$SE-SEMPA-2024-005812$SE-TEVA-VS-3231686$TEVA$$60$YR$$M$Y$$$20240814$$MD$SE$SE
242117391$24211739$1$I$$20240812$20240814$20240814$PER$$US-PFIZER INC-202400236057$PFIZER$$53$YR$$F$Y$$$20240814$$HP$US$US
242117411$24211741$1$I$20240801$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128130$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240814$$CN$US$US
242117422$24211742$2$F$20240718$20240812$20240814$20240827$PER$$US-IMP-2024000587$Harrow Health$$74$YR$E$F$Y$58.9$KG$20240827$$CN$US$US
242117431$24211743$1$I$20230801$20240809$20240814$20240814$EXP$$US-OTSUKA-2024_022126$OTSUKA$$50$YR$$F$Y$74.84$KG$20240814$$CN$US$US
242117441$24211744$1$I$20240531$20240805$20240814$20240814$PER$$US-IGSA-BIG0029720$GRIFOLS$$46$YR$$F$Y$71.655$KG$20240814$$CN$US$US
242117461$24211746$1$I$$20240812$20240814$20240814$PER$$US-BAUSCH-BL-2024-012302$BAUSCH AND LOMB$$17$YR$$F$Y$$$20240814$$HP$US$US
242117472$24211747$2$F$$20240909$20240814$20240911$EXP$$CA-BAUSCH-BL-2024-012269$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240911$$CN$CA$CA
242117492$24211749$2$F$20240807$20240917$20240814$20240920$EXP$$NVSC2024ZA163255$NOVARTIS$$57$YR$$F$Y$$$20240920$$MD$ZA$ZA
242117501$24211750$1$I$20240101$20240807$20240814$20240814$EXP$$DE-BAUSCH-BL-2024-012337$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240814$$HP$DE$DE
242117511$24211751$1$I$20240729$20240806$20240814$20240814$EXP$$CN-AstraZeneca-2024A180616$ASTRAZENECA$$21645$DY$$F$Y$50$KG$20240814$$MD$CN$
242117531$24211753$1$I$$20240806$20240814$20240814$EXP$$US-SANDOZ INC.-SDZ2024US072627$SANDOZ$$$$$$Y$$$20240814$$HP$US$US
242117541$24211754$1$I$20210608$20240812$20240814$20240814$EXP$$CA-SANDOZ INC.-NVSC2021CA139631$SANDOZ$$68$YR$$F$Y$$$20240814$$CN$CA$CA
242117551$24211755$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127558$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$55.79$KG$20240814$$CN$US$US
242117561$24211756$1$I$20240701$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127768$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240814$$HP$US$US
242117571$24211757$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127476$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240814$$CN$US$US
242117581$24211758$1$I$20240808$20240808$20240814$20240814$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-126962$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240814$$MD$CO$CO
242117591$24211759$1$I$20240101$20240808$20240814$20240814$PER$$US-BAUSCH-BL-2024-012149$BAUSCH AND LOMB$$$$$F$Y$$$20240814$$CN$US$US
242117601$24211760$1$I$20200122$20240812$20240814$20240814$EXP$$IT-BAUSCH-BL-2024-012260$BAUSCH AND LOMB$$61$YR$$M$Y$85$KG$20240814$$MD$IT$IT
242117611$24211761$1$I$$20240814$20240814$20240814$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045813$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240814$$CN$US$US
242117621$24211762$1$I$$20240814$20240814$20240814$EXP$$US-ANIPHARMA-2024-US-043098$ANI$Martino J, Elfessi Z, Szaflarska K, et al.Take it easy! Serotonin syndrome precipitated by the rapid titration of sertraline and trazodone in the setting of risperidone use..Journal of Pharmacy Practice.2024;.$25$YR$$M$Y$$$20240814$$MD$US$US
242117631$24211763$1$I$20240101$20240806$20240814$20240814$PER$$US-BIOMARINAP-US-2024-159699$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
242117641$24211764$1$I$20240802$20240807$20240814$20240814$PER$$US-BIOGEN-2024BI01277521$BIOGEN$$$$$$Y$$$20240814$$CN$US$US
242117652$24211765$2$F$$20240829$20240814$20240829$PER$$US-ALXN-202408USA000555US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242117661$24211766$1$I$20240121$20240807$20240814$20240814$PER$$US-JNJFOC-20240835573$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240814$$HP$US$US
242117671$24211767$1$I$$20240813$20240814$20240814$EXP$$US-BAUSCH-BL-2024-012316$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240814$$CN$US$US
242117681$24211768$1$I$20140319$20240808$20240814$20240814$EXP$$GB-PFIZER INC-2014MPI00282$PFIZER$$64$YR$$M$Y$89$KG$20240814$$PH$GB$GB
242117692$24211769$2$F$20240101$20240807$20240814$20240816$EXP$$JP-Eisai-EC-2024-171804$EISAI$$71$YR$E$F$Y$$$20240816$$HP$JP$JP
242117702$24211770$2$F$$20240905$20240814$20240909$PER$$NVSC2024US165221$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
242117711$24211771$1$I$$20240813$20240814$20240814$PER$$US-LUNDBECK-DKLU4002893$LUNDBECK$$$$$$Y$$$20240814$$HP$US$US
242117732$24211773$2$F$$20240826$20240814$20240909$PER$$US-SA-2024SA238697$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240909$$MD$US$US
242117741$24211774$1$I$20240710$20240809$20240814$20240814$EXP$GB-MHRA-MIDB-aea73cb5-b1d6-48dd-822a-8a1a84b2a87d$GB-SA-2024SA239682$SANOFI AVENTIS$$68$YR$E$$Y$$$20240814$$HP$GB$GB
242117752$24211775$2$F$$20240807$20240814$20240829$EXP$$US-BAUSCHBL-2024BNL010102$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240829$$CN$US$US
242117761$24211776$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127482$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240814$$CN$US$US
242117771$24211777$1$I$$20240808$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126518$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240814$$CN$US$US
242117781$24211778$1$I$20240624$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127529$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240814$$HP$US$US
242117791$24211779$1$I$$20240807$20240814$20240814$EXP$$JP-LUNDBECK-DKLU4002912$LUNDBECK$$$$$$Y$$$20240814$$PH$JP$JP
242117802$24211780$2$F$20220701$20240808$20240814$20240819$EXP$$NVSC2022GB031247$NOVARTIS$$36$YR$$F$Y$$$20240819$$CN$GB$GB
242117811$24211781$1$I$20240416$20240809$20240814$20240814$EXP$FR-AFSSAPS-PA2024001277$FR-009507513-2408FRA003594$MERCK$$79$YR$$F$Y$75$KG$20240814$$PH$FR$FR
242117821$24211782$1$I$20240201$20240625$20240814$20240814$PER$$US-LUNDBECK-DKLU4001055$LUNDBECK$$$$$$Y$$$20240814$$CN$US$US
242117832$24211783$2$F$$20240829$20240814$20240829$PER$$US-ALXN-202408USA000655US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242117851$24211785$1$I$$20240725$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045830$BOEHRINGER INGELHEIM$$60$YR$A$M$Y$$$20240814$$CN$US$US
242117861$24211786$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127627$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240814$$HP$US$US
242117871$24211787$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127642$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240814$$HP$US$US
242117881$24211788$1$I$20240101$20240808$20240814$20240814$PER$$US-SA-2024SA198150$SANOFI AVENTIS$$62$YR$A$M$Y$113$KG$20240814$$MD$US$US
242117891$24211789$1$I$$20240806$20240814$20240814$EXP$$ZA-AstraZeneca-2024A179673$ASTRAZENECA$$78$YR$$F$Y$$$20240814$$CN$ZA$
242117901$24211790$1$I$20240609$20240805$20240814$20240814$EXP$FR-AFSSAPS-NT2024000972$FR-009507513-2408FRA001598$MERCK$$13$YR$$F$Y$$$20240814$$MD$FR$FR
242117911$24211791$1$I$$20240812$20240814$20240814$PER$$US-ROCHE-10000056663$ROCHE$$34$YR$A$F$Y$$$20240814$$MD$US$US
242117922$24211792$2$F$$20240820$20240814$20240828$EXP$$US-TRAVERE-2024TVT00798$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240828$$CN$US$US
242117932$24211793$2$F$$20240815$20240814$20240821$EXP$$US-GILEAD-2024-0684090$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240821$$MD$US$US
242117941$24211794$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127630$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240814$$HP$US$US
242117952$24211795$2$F$$20240822$20240814$20240830$EXP$$DE-TEVA-VS-3231526$TEVA$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure 2023; 107 107-113.$$$N$$Y$$$20240830$$MD$DE$DE
242117961$24211796$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126944$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240814$$HP$US$US
242117971$24211797$1$I$20240709$20240805$20240814$20240814$EXP$FR-AFSSAPS-BX2024001540$FR-009507513-2408FRA001567$MERCK$$84$YR$$M$Y$49.2$KG$20240814$$MD$FR$FR
242117982$24211798$2$F$20240810$20240813$20240814$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408008046$ELI LILLY AND CO$$$$$M$Y$$$20240820$$CN$US$US
242117991$24211799$1$I$20240812$20240812$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008287$ELI LILLY AND CO$$$$$M$Y$$$20240814$$CN$US$US
242118001$24211800$1$I$20240718$20240805$20240814$20240814$EXP$$CN-009507513-2408CHN002723$MERCK$$41$YR$$F$Y$59$KG$20240814$$HP$CN$CN
242118012$24211801$2$F$20240501$20240730$20240814$20240815$PER$$US-009507513-2407USA015841$MERCK$$63$YR$$F$Y$$$20240815$$CN$US$US
242118025$24211802$5$F$20240404$20240906$20240814$20240913$EXP$$NL-009507513-2407NLD000656$MERCK$$55$YR$$F$Y$52.1$KG$20240913$$MD$NL$NL
242118033$24211803$3$F$20240725$20240904$20240814$20240912$PER$$US-Millicent Holdings Ltd.-MILL20241077$MILLICENT HOLDINGS$$83$YR$E$F$Y$$$20240912$$CN$US$US
242118041$24211804$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684091$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$$$Y$$$20240814$$MD$US$US
242118051$24211805$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684092$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$$$Y$$$20240814$$MD$US$US
242118061$24211806$1$I$$20240806$20240814$20240814$PER$$US-SA-2024SA237014$SANOFI AVENTIS$$$$$F$Y$$$20240814$$CN$US$US
242118071$24211807$1$I$20240701$20240808$20240814$20240814$PER$$US-SA-2024SA238820$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240814$$MD$US$US
242118081$24211808$1$I$$20240730$20240814$20240814$PER$$US-INSUD PHARMA-2407US06092$INSUD PHARMA$$$$$$Y$$$20240814$$CN$US$US
242118091$24211809$1$I$20230712$20240812$20240814$20240814$EXP$$KR-009507513-2408KOR003448$MERCK$$$$$F$Y$$$20240814$$HP$KR$KR
242118101$24211810$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684093$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$$$Y$$$20240814$$MD$US$US
242118111$24211811$1$I$$20240809$20240814$20240814$PER$$US-ALXN-202408USA000648US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240814$$CN$US$US
242118122$24211812$2$F$$20240830$20240814$20240830$PER$$US-ALXN-202408USA000402US$ALEXION PHARMACEUTICALS$$$$E$F$Y$$$20240830$$MD$US$US
242118131$24211813$1$I$$20240808$20240814$20240814$EXP$$US-GILEAD-2024-0684094$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$$$Y$$$20240814$$MD$US$US
242118141$24211814$1$I$$20240805$20240814$20240814$EXP$$PK-INSUD PHARMA-2408PK06358$INSUD PHARMA$Hanif S, Isani Majeed A, Faryal R. M2 Genotype of Varicella zoster virus associated with Severe Herpes zoster in Pakistan. Pak J Med Sci. 2024;40(6):1303-1305$$$$$Y$$$20240814$$HP$PK$PK
242118161$24211816$1$I$$20240809$20240814$20240814$EXP$$JP-009507513-2408JPN001380J$MERCK$$67$YR$$M$Y$$$20240814$$HP$JP$JP
242118171$24211817$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127797$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240814$$CN$US$US
242118181$24211818$1$I$$20240811$20240814$20240814$EXP$$NL-SA-2024SA241376$SANOFI AVENTIS$$$$$F$Y$$$20240814$$CN$NL$NL
242118192$24211819$2$F$20210716$20240815$20240814$20240827$EXP$PT-INFARMED-M202210-794$PT-GILEAD-2024-0683906$GILEAD$$80$YR$E$M$Y$$$20240827$$MD$PT$PT
242118201$24211820$1$I$20240808$20240814$20240814$20240814$PER$$NVSC2024US165246$NOVARTIS$$85$YR$$F$Y$49$KG$20240814$$CN$US$US
242118211$24211821$1$I$$20240812$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127354$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240814$$CN$US$US
242118221$24211822$1$I$$20240802$20240814$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002189$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240814$$CN$US$US
242118241$24211824$1$I$$20240802$20240814$20240814$EXP$GB-MHRA-MED-202408021134309580-SJCKN$GB-ELI_LILLY_AND_COMPANY-GB202408002633$ELI LILLY AND CO$$$$$M$Y$$$20240814$$CN$GB$GB
242118251$24211825$1$I$$20240802$20240814$20240814$EXP$GB-MHRA-MED-202408020700155250-ZKQMR$GB-ELI_LILLY_AND_COMPANY-GB202408002631$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$GB$GB
242118262$24211826$2$F$20050101$20240805$20240814$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003613$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240816$$CN$US$US
242118271$24211827$1$I$20240720$20240802$20240814$20240814$EXP$GB-MHRA-MED-202407312013458520-BFQVC$GB-ELI_LILLY_AND_COMPANY-GB202408002475$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240814$$CN$GB$GB
242118281$24211828$1$I$$20240802$20240814$20240814$EXP$GB-MHRA-MED-202408021629238100-KFNLH$GB-ELI_LILLY_AND_COMPANY-GB202408002639$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$GB$GB
242118302$24211830$2$F$20240807$20240910$20240814$20240918$PER$$US-SA-2024SA238003$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240918$$MD$US$US
242118311$24211831$1$I$$20240805$20240814$20240814$EXP$$JP-ROCHE-10000053218$ROCHE$Saito Y, Yamamoto I, Kawabe M, Oki Y, Hayashi A, Kanzaki G et al.. BK virus nephropathy complicated by repeated urinary tract infections: a case report. The 27th Conference on Renal Allograft Pathology. 2024$75$YR$E$M$Y$$$20240814$$MD$JP$JP
242118323$24211832$3$F$$20240826$20240814$20240905$EXP$$DE-TEVA-VS-3231527$TEVA$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure 2023; 107 107-113.; Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure 2023; 107 107-113.$$$N$$Y$$$20240905$$MD$DE$DE
242118341$24211834$1$I$$20240812$20240814$20240814$PER$$US-JNJFOC-20240832501$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240814$$HP$US$US
242118351$24211835$1$I$20240710$20240812$20240814$20240814$EXP$FR-AFSSAPS-LL2024001554$FR-GILEAD-2024-0683861$GILEAD$$62$YR$A$F$Y$94$KG$20240814$$MD$FR$FR
242118362$24211836$2$F$$20240807$20240814$20240905$EXP$$US-BEH-2024176947$CSL BEHRING$$$$A$F$Y$$$20240905$$CN$US$US
242118371$24211837$1$I$$20240813$20240814$20240814$PER$$US-JNJFOC-20240833096$JOHNSON AND JOHNSON$$$$$F$Y$$$20240814$$HP$US$US
242118381$24211838$1$I$20230201$20240730$20240814$20240814$EXP$$FI-Millicent Holdings Ltd.-MILL20241076$MILLICENT HOLDINGS$$68$YR$E$F$Y$$$20240814$$CN$FI$FI
242118391$24211839$1$I$$20240806$20240814$20240814$EXP$$US-MAYNE PHARMA-2024MYN000344$MAYNE$$$$$$Y$$$20240814$$CN$US$US
242118401$24211840$1$I$$20240808$20240814$20240814$EXP$$US-Taiho Oncology Inc-2023-010523$TAIHO ONCOLOGY INC$$64$YR$A$F$Y$$$20240814$$CN$US$US
242118411$24211841$1$I$$20240802$20240814$20240814$PER$$US-JNJFOC-20240809332$JOHNSON AND JOHNSON$$$$$$Y$$$20240814$$CN$US$US
242118421$24211842$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA238651$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240815$$PH$US$US
242118431$24211843$1$I$20240718$20240809$20240814$20240814$EXP$FR-AFSSAPS-PB2024000862$FR-009507513-2408FRA003628$MERCK$$59$YR$$F$Y$$$20240814$$MD$FR$FR
242118441$24211844$1$I$20240101$20240805$20240814$20240814$PER$$US-009507513-2408USA001789$MERCK$$$$$F$Y$$$20240814$$PH$US$US
242118451$24211845$1$I$$20240808$20240814$20240814$PER$$US-BIOGEN-2024BI01277730$BIOGEN$$$$$$Y$$$20240814$$CN$US$US
242118462$24211846$2$F$$20240826$20240814$20240904$EXP$$DE-TEVA-VS-3231755$TEVA$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S, et al. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. Br-J-Cancer 2023; 128 (6): 1134-1147; Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S, et al. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. Br-J-Cancer 2023; 128 (6): 1134-1147.$$$$$Y$$$20240904$$HP$DE$DE
242118471$24211847$1$I$$20240813$20240814$20240814$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045782$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240814$$MD$BR$BR
242118482$24211848$2$F$20240809$20240810$20240814$20240815$EXP$$CA-AstraZeneca-2024A183349$ASTRAZENECA$$25474$DY$$F$Y$$$20240815$$CN$CA$
242118491$24211849$1$I$$20240812$20240814$20240814$PER$$US-009507513-2408USA004293$MERCK$$64$YR$$M$Y$$$20240814$$MD$US$US
242118501$24211850$1$I$$20240805$20240814$20240814$EXP$$JP-ROCHE-10000053415$ROCHE$Tanaka G, Kono S, Sakaue Y, Mitani K, Oshima S, Hara T et al.. 11 A case of VZV meningoencephalitis which developed after extremely high-risk living donor renal transplant and followed a rapid course. The 139th Sanin Regional Meeting of the Japanese Urological Association. 2024$7$DEC$E$F$Y$$$20240814$$MD$JP$JP
242118522$24211852$2$F$$20240926$20240814$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127302$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$52.62$KG$20240928$$CN$US$US
242118531$24211853$1$I$$20240807$20240814$20240814$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-126437$BRISTOL MYERS SQUIBB$Weinbergerova B, Mayer J, Kabut T, Sperr WR, Stevkova J, Jonasova A, et al. Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis. British Journal of Haematology. 2024 Jul 23;1-5. doi:10.1111/bjh.19670.$65$YR$E$$Y$$$20240814$$HP$CZ$CZ
242118542$24211854$2$F$20240801$20240821$20240814$20240829$PER$$US-BIOGEN-2024BI01277873$BIOGEN$$71$YR$$M$Y$$$20240829$$CN$US$US
242118551$24211855$1$I$20240721$20240808$20240814$20240814$PER$$US-AstraZeneca-2024A180657$ASTRAZENECA$$10$YR$$M$Y$$$20240814$$HP$US$
242118561$24211856$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127114$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240814$$CN$US$US
242118572$24211857$2$F$20240731$20240812$20240814$20240815$PER$$US-JNJFOC-20240809363$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240816$$CN$US$US
242118581$24211858$1$I$$20240802$20240814$20240814$PER$$US-009507513-2408USA001126$MERCK$$$$$F$Y$$$20240814$$HP$US$US
242118591$24211859$1$I$20240101$20240812$20240814$20240814$EXP$$US-ABBVIE-5878625$ABBVIE$$$$$F$Y$$$20240814$$HP$US$US
242118601$24211860$1$I$$20240806$20240814$20240814$PER$$US-Millicent Holdings Ltd.-MILL20241084$MILLICENT HOLDINGS$$68$YR$E$F$Y$$$20240814$$CN$US$US
242118612$24211861$2$F$$20240825$20240814$20240827$EXP$$NVSC2024IL164179$NOVARTIS$$51$YR$$F$Y$$$20240827$$HP$IL$IL
242118621$24211862$1$I$$20240809$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126898$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240814$$HP$US$US
242118632$24211863$2$F$$20240812$20240814$20240820$PER$$US-SA-2024SA237079$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240820$$CN$US$US
242118642$24211864$2$F$20240301$20240819$20240814$20240822$EXP$$DE-APELLIS-2024-APL-0000712$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240822$$PH$DE$DE
242118651$24211865$1$I$20230301$20240809$20240814$20240814$PER$$US-SA-2024SA241317$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240815$$MD$US$US
242118661$24211866$1$I$20240801$20240808$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126120$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240814$$HP$US$US
242118672$24211867$2$F$20240101$20240827$20240814$20240904$EXP$$US-ALXN-202408USA000719US$ALEXION PHARMACEUTICALS$$46$YR$$F$Y$$$20240904$$CN$US$US
242118681$24211868$1$I$$20240807$20240814$20240814$EXP$$NVSC2024CA161836$NOVARTIS$$$$A$F$Y$$$20240815$$MD$CA$CA
242118691$24211869$1$I$$20240801$20240814$20240814$EXP$$US-ETHYPHARM-2024002138$ETHYPHARM$Kumar P, Kaliamurthy S, Thomas J. Initiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments. Pediatrics. 2024;154(2):e2024066226. DOI:10.1542/peds.2024-066226.$$$$$Y$$$20240814$$MD$US$
242118701$24211870$1$I$$20240716$20240814$20240814$PER$$US-009507513-2407USA011352$MERCK$Kuczmarski TM, Lynch RC.. Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma. British Journal of Haematology. 2024;205(1):100-8$58$YR$$M$Y$$$20240814$$HP$US$US
242118721$24211872$1$I$20240801$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128801$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$104.33$KG$20240814$$CN$US$US
242118731$24211873$1$I$$20240730$20240814$20240814$PER$$US-APELLIS-2024-APL-0000591$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240814$$HP$US$US
242118741$24211874$1$I$20090101$20240808$20240814$20240814$EXP$AT-BASGAGES-2024-005683$AT-ROCHE-10000052805$ROCHE$$$$A$F$Y$$$20240814$$PH$AT$AT
242118751$24211875$1$I$20240727$20240808$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126611$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240814$$PH$US$US
242118761$24211876$1$I$$20240809$20240814$20240814$PER$$US-ALXN-202408USA000637US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240814$$HP$US$US
242118772$24211877$2$F$20240801$20240815$20240814$20240821$EXP$$US-SA-2024SA240348$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240821$$CN$US$US
242118781$24211878$1$I$$20240808$20240814$20240814$EXP$$CA-ROCHE-10000052073$ROCHE$Unknown ,  Unknown. Unknown.$51$YR$A$F$Y$$$20240814$$MD$CA$CA
242118791$24211879$1$I$$20240731$20240814$20240814$EXP$$US-HLS-202400674$HLS THERAPEUTICS$$54$YR$A$F$Y$$$20240814$$HP$US$US
242118811$24211881$1$I$$20240801$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202401008928$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240814$$CN$US$US
242118821$24211882$1$I$20240729$20240814$20240814$20240814$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045854$BOEHRINGER INGELHEIM$$60$YR$A$M$Y$$$20240815$$MD$US$US
242118831$24211883$1$I$20240812$20240813$20240814$20240814$PER$$US-AMGEN-USASP2024161025$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242118841$24211884$1$I$$20240812$20240814$20240814$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045721$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240815$$CN$US$US
242118852$24211885$2$F$20240327$20240919$20240814$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124030$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240927$$HP$US$US
242118862$24211886$2$F$$20240826$20240814$20240903$EXP$$US-TEVA-VS-3231276$TEVA$Fenner EG, Simpson CE. An adult patient with pulmonary arterial hypertension, a NOTCH3 mutation, and leflunomide exposure. Pulm-Circ 2024; 14 (3):.; Fenner EG, Simpson CE. An adult patient with pulmonary arterial hypertension, a NOTCH3 mutation, and leflunomide exposure. Pulm-Circ 2024; 14 (3):.; Fenner EG, Simpson CE. An adult patient with pulmonary arterial hypertension, a NOTCH3 mutation, and leflunomide exposure. Pulm-Circ 2024; 14 (3):.$39$YR$$F$Y$$$20240903$$HP$US$US
242118872$24211887$2$F$20240610$20240904$20240814$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125027$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240906$$HP$US$US
242118881$24211888$1$I$20240814$20240814$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045858$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240815$$CN$US$US
242118901$24211890$1$I$20240814$20240814$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045860$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240815$$CN$US$US
242118911$24211891$1$I$20240806$20240807$20240814$20240814$PER$$US-ABBVIE-5872464$ABBVIE$$45$YR$$$Y$$$20240814$$CN$US$US
242118923$24211892$3$F$20240101$20240911$20240814$20240913$PER$$US-AMGEN-USASP2024161455$AMGEN$$37$YR$A$M$Y$$$20240913$$HP$US$US
242118931$24211893$1$I$20240805$20240812$20240814$20240814$EXP$$CN-ABBVIE-5877928$ABBVIE$$49$YR$$F$Y$53$KG$20240814$$MD$CN$CN
242118941$24211894$1$I$20240807$20240809$20240814$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001614$BLUEPRINT MEDICINES$$37$YR$A$F$Y$$$20240815$$CN$US$US
242118951$24211895$1$I$$20240808$20240814$20240814$PER$$US-ABBVIE-5877137$ABBVIE$$$$$$Y$$$20240814$$MD$US$US
242118962$24211896$2$F$$20240822$20240814$20240829$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001605$BLUEPRINT MEDICINES$$$$$F$Y$$$20240829$$CN$US$US
242118971$24211897$1$I$$20240805$20240814$20240814$EXP$$DE-TEVA-VS-3231791$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$13$YR$$F$Y$$$20240814$$HP$DE$DE
242118981$24211898$1$I$$20240812$20240814$20240814$EXP$$US-ABBVIE-5877743$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242118991$24211899$1$I$20240801$20240813$20240814$20240814$EXP$$US-ABBVIE-5880180$ABBVIE$$60$YR$$M$Y$$$20240814$$CN$US$US
242119011$24211901$1$I$$20240811$20240814$20240814$EXP$$EU-BAUSCHBL-2024BNL031416$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240815$$MD$EU$EU
242119021$24211902$1$I$20240101$20240812$20240814$20240814$EXP$$US-ABBVIE-5878539$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242119031$24211903$1$I$20240803$20240812$20240814$20240814$EXP$$AU-ABBVIE-5879363$ABBVIE$$78$YR$$M$Y$$$20240814$$CN$AU$AU
242119041$24211904$1$I$20211001$20240810$20240814$20240814$EXP$$EU-BAUSCHBL-2024BNL031392$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240815$$MD$EU$EU
242119051$24211905$1$I$20240626$20240811$20240814$20240814$EXP$$EU-BAUSCHBL-2024BNL031415$BAUSCH AND LOMB$$72$YR$$M$Y$100$KG$20240815$$MD$EU$EU
242119061$24211906$1$I$$20240812$20240814$20240814$EXP$$US-ABBVIE-5878936$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242119071$24211907$1$I$$20240808$20240814$20240814$PER$$US-BIOMARINAP-US-2024-159714$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
242119081$24211908$1$I$$20240808$20240814$20240814$PER$$US-BIOMARINAP-US-2024-159741$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
242119093$24211909$3$F$20240520$20240903$20240814$20240906$EXP$$US-ABBVIE-5877227$ABBVIE$$74$YR$$M$Y$79.378$KG$20240906$$CN$US$US
242119101$24211910$1$I$$20240807$20240814$20240814$PER$$US-BIOMARINAP-US-2024-159719$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
242119111$24211911$1$I$20240807$20240808$20240814$20240814$PER$$US-BIOMARINAP-US-2024-159752$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
242119121$24211912$1$I$$20240810$20240814$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001617$BLUEPRINT MEDICINES$$$$$M$Y$$$20240815$$CN$US$US
242119131$24211913$1$I$$20240805$20240814$20240814$EXP$$CL-TEVA-VS-3231234$TEVA$Avila E, Roessler BE. [MALA: Lactic acidosis associated with the use of metformin, review of clinical cases]. [Review] [Spanish]. Rev-Med-Chil 2023; 151 (5): 618-627.$81$YR$$F$Y$$$20240814$$HP$CL$CL
242119141$24211914$1$I$$20240805$20240814$20240814$EXP$$CL-TEVA-VS-3231233$TEVA$Avila E, Roessler BE. [MALA: Lactic acidosis associated with the use of metformin, review of clinical cases]. [Review] [Spanish]. Rev-Med-Chil 2023; 151 (5): 618-627.$64$YR$$F$Y$$$20240814$$HP$CL$CL
242119151$24211915$1$I$20240805$20240812$20240814$20240814$PER$$US-BIOMARINAP-US-2024-159811$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
242119161$24211916$1$I$20240809$20240811$20240814$20240814$PER$$US-BIOMARINAP-US-2024-159793$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
242119171$24211917$1$I$$20240811$20240814$20240814$PER$$US-BIOMARINAP-US-2024-159789$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
242119181$24211918$1$I$$20240812$20240814$20240814$PER$$US-BIOMARINAP-US-2024-159813$BIOMARIN$$$$$$Y$$$20240814$$CN$US$US
242119191$24211919$1$I$20240501$20240808$20240814$20240814$EXP$$EU-BAUSCHBL-2024BNL031321$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240815$$CN$EU$EU
242119202$24211920$2$F$20240423$20240826$20240814$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124064$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240906$$HP$US$US
242119221$24211922$1$I$$20240812$20240814$20240814$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001621$BLUEPRINT MEDICINES$$$$$F$Y$$$20240815$$CN$US$US
242119231$24211923$1$I$20240808$20240808$20240814$20240814$EXP$$US-BIOGEN-2024BI01277705$BIOGEN$$55$YR$$M$Y$$$20240814$$HP$US$US
242119242$24211924$2$F$20190401$20240813$20240814$20240820$EXP$$AU-BIOGEN-2024BI01277552$BIOGEN$$39$YR$$F$Y$$$20240820$$MD$AU$AU
242119251$24211925$1$I$$20240812$20240814$20240814$PER$$US-ABBVIE-5879704$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242119261$24211926$1$I$20210101$20240814$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045867$BOEHRINGER INGELHEIM$$7$DEC$$M$Y$$$20240815$$MD$US$US
242119271$24211927$1$I$$20240807$20240814$20240814$PER$$US-ABBVIE-5873156$ABBVIE$$39$YR$$F$Y$$$20240814$$MD$US$US
242119281$24211928$1$I$20240701$20240802$20240814$20240814$PER$$US-AMGEN-USASP2024155489$AMGEN$$$$A$F$Y$$$20240814$$HP$US$US
242119291$24211929$1$I$20240809$20240809$20240814$20240814$EXP$$JP-TAKEDA-2024TJP011961$TAKEDA$$$$$F$Y$$$20240814$$MD$JP$JP
242119302$24211930$2$F$$20240920$20240814$20240927$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001583$BLUEPRINT MEDICINES$$$$$F$Y$$$20240927$$CN$US$US
242119311$24211931$1$I$$20240813$20240814$20240814$PER$$US-AMGEN-USASP2024161406$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242119322$24211932$2$F$20240811$20240828$20240814$20240830$PER$$US-AMGEN-USASP2024159985$AMGEN$$73$YR$E$M$Y$$$20240829$$CN$US$US
242119332$24211933$2$F$20240719$20240819$20240814$20240826$EXP$$IT-BIOGEN-2024BI01277603$BIOGEN$$36$YR$$F$Y$$$20240826$$MD$IT$IT
242119352$24211935$2$F$$20240812$20240814$20240819$EXP$GB-MHRA-MED-202408061015534350-DFWSH$GB-BIOGEN-2024BI01277789$BIOGEN$$63$YR$$M$Y$$$20240819$$MD$GB$GB
242119361$24211936$1$I$$20240809$20240814$20240814$EXP$$US-PFIZER INC-202400233857$PFIZER$$$$$F$Y$$$20240814$$CN$US$US
242119381$24211938$1$I$20230101$20240812$20240814$20240814$EXP$$ZA-PFIZER INC-PV202400104712$PFIZER$$65$YR$$F$Y$$$20240814$$MD$ZA$ZA
242119391$24211939$1$I$20240802$20240812$20240814$20240814$EXP$ES-AEMPS-1557938$ES-PFIZER INC-202400234300$PFIZER$$71$YR$$M$Y$$$20240814$$MD$ES$ES
242119401$24211940$1$I$20240813$20240813$20240814$20240814$EXP$GB-MHRA-MED-202408131855428120-BJSZW$GB-PFIZER INC-202400235808$PFIZER$$36$YR$$M$Y$$$20240814$$HP$GB$GB
242119411$24211941$1$I$20240801$20240812$20240814$20240814$EXP$$CN-PFIZER INC-PV202400104881$PFIZER$$72$YR$$M$Y$55$KG$20240814$$HP$CN$CN
242119421$24211942$1$I$$20240808$20240814$20240814$PER$$FR-Blueprint Medicines Corporation-SP-FR-2024-001592$BLUEPRINT MEDICINES$$$$$$Y$$$20240815$$PH$FR$FR
242119433$24211943$3$F$20240606$20240918$20240814$20240923$EXP$$JP-TAKEDA-2024TJP011956$TAKEDA$$70$YR$$M$Y$70.1$KG$20240923$$MD$JP$JP
242119441$24211944$1$I$$20240806$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128889$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$68.49$KG$20240815$$CN$US$US
242119451$24211945$1$I$$20240809$20240814$20240814$EXP$$JP-TAKEDA-2024TJP011910$TAKEDA$$5$DEC$$M$Y$$$20240814$$MD$JP$JP
242119461$24211946$1$I$$20240807$20240814$20240814$EXP$$US-JNJFOC-20240817415$JOHNSON AND JOHNSON$$$$$F$Y$$$20240815$$HP$US$US
242119471$24211947$1$I$$20240805$20240814$20240814$EXP$$US-SMPA-2024SPA000940$SUNOVION$$$$$$Y$$$20240814$$CN$US$US
242119481$24211948$1$I$$20240808$20240814$20240814$EXP$$CA-ABBVIE-5879127$ABBVIE$$49$YR$$F$Y$$$20240814$$CN$CA$CA
242119491$24211949$1$I$20220101$20240808$20240814$20240814$EXP$$US-ABBVIE-5874454$ABBVIE$$$$$F$Y$62.142$KG$20240814$$CN$US$US
242119502$24211950$2$F$20240809$20240828$20240814$20240901$PER$$US-AMGEN-USASP2024159963$AMGEN$$85$YR$E$F$Y$$$20240901$$CN$US$US
242119511$24211951$1$I$$20240812$20240814$20240814$PER$$US-ABBVIE-5879326$ABBVIE$$$$$$Y$$$20240814$$CN$US$US
242119521$24211952$1$I$20240801$20240812$20240814$20240814$EXP$$BE-ABBVIE-5878462$ABBVIE$$$$E$F$Y$$$20240814$$HP$BE$BE
242119531$24211953$1$I$20240802$20240807$20240814$20240814$EXP$$CN-BEIGENE-BGN-2024-012353$BEIGENE$$$$$$Y$$$20240814$$HP$CN$CN
242119541$24211954$1$I$$20240813$20240814$20240814$PER$$NVSC2024US165154$NOVARTIS$$86$YR$$F$Y$$$20240815$$HP$US$US
242119551$24211955$1$I$$20240809$20240814$20240814$PER$$US-BIOGEN-2024BI01277900$BIOGEN$$$$$$Y$$$20240814$$CN$US$US
242119561$24211956$1$I$$20240809$20240814$20240814$PER$$US-SA-2024SA239921$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240815$$MD$US$US
242119572$24211957$2$F$$20240827$20240814$20240902$PER$$US-AMGEN-USASP2024161744$AMGEN$Topilow N.J.; Penteado R.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024;1-6$$$$$Y$$$20240902$$MD$US$US
242119581$24211958$1$I$20240726$20240807$20240814$20240814$EXP$$CN-BEIGENE-BGN-2024-012354$BEIGENE$$$$$$Y$$$20240814$$HP$CN$CN
242119592$24211959$2$F$$20240826$20240814$20240828$EXP$$US-AVEO PHARMACEUTICALS, INC.-2024-AVEO-US000609$PAREXEL$$$$$$Y$$$20240828$$CN$US$US
242119601$24211960$1$I$20240101$20240807$20240814$20240814$EXP$$US-ABBVIE-5879877$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242119622$24211962$2$F$20240809$20240817$20240814$20240826$30DAY$$US-AMGEN-USASP2024159517$AMGEN$$73$YR$E$F$Y$92.1$KG$20240826$$PH$US$US
242119631$24211963$1$I$20240101$20240808$20240814$20240814$EXP$$US-ABBVIE-5813168$ABBVIE$$$$$M$Y$58.06$KG$20240814$$CN$US$US
242119641$24211964$1$I$20210101$20240809$20240814$20240814$EXP$$US-ABBVIE-5875635$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242119651$24211965$1$I$20210101$20240809$20240814$20240814$EXP$$US-ABBVIE-5878987$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242119671$24211967$1$I$20240101$20240809$20240814$20240814$EXP$$US-ABBVIE-5875145$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242119681$24211968$1$I$20240101$20240812$20240814$20240814$EXP$$US-ABBVIE-5878479$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242119691$24211969$1$I$$20240814$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045869$BOEHRINGER INGELHEIM$$$$$$Y$$$20240815$$MD$US$US
242119702$24211970$2$F$$20240903$20240814$20240910$EXP$$US-ABBVIE-5878618$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
242119711$24211971$1$I$$20240808$20240814$20240814$PER$$US-SA-2024SA237816$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240815$$MD$US$US
242119721$24211972$1$I$$20240814$20240814$20240814$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045872$BOEHRINGER INGELHEIM$$$$$$Y$$$20240815$$MD$US$US
242119732$24211973$2$F$$20240821$20240814$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128135$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240824$$PH$US$US
242119741$24211974$1$I$20210801$20240805$20240814$20240814$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127826$BRISTOL MYERS SQUIBB$Otani K,et al. A case of progressive multifocal leukoencephalopathy developed under small dose steroid administration after HLA-matched unrelated bone marrow transplantation. The 21st Kanto Koshinetsu Regional Meeting of the Japanese Society of Hematology.$61$YR$A$M$Y$$$20240815$$HP$JP$JP
242119751$24211975$1$I$$20240813$20240814$20240814$PER$$US-ELI_LILLY_AND_COMPANY-US202408008438$ELI LILLY AND CO$$$$$F$Y$$$20240814$$CN$US$US
242119761$24211976$1$I$$20240812$20240814$20240814$PER$$US-ABBVIE-5877567$ABBVIE$$26$YR$$F$Y$$$20240814$$HP$US$US
242119771$24211977$1$I$$20240806$20240814$20240814$PER$$US-EMD Serono-2024043062$EMD SERONO INC$$$$$M$Y$$$20240815$$CN$US$US
242119781$24211978$1$I$$20240807$20240814$20240814$EXP$$JP-ROCHE-3531147$ROCHE$$75$YR$E$F$Y$$$20240815$$MD$JP$JP
242119791$24211979$1$I$$20240814$20240814$20240814$PER$$NVSC2024US165316$NOVARTIS$$73$YR$$F$Y$$$20240815$$HP$US$US
242119801$24211980$1$I$20240708$20240807$20240814$20240814$EXP$$CA-ABBVIE-5835256$ABBVIE$$82$YR$$M$Y$$$20240814$$PH$CA$CA
242119811$24211981$1$I$20240101$20240812$20240814$20240814$EXP$$US-ABBVIE-5878629$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242119821$24211982$1$I$$20240813$20240814$20240814$EXP$$US-ABBVIE-5879625$ABBVIE$$$$$F$Y$$$20240814$$CN$US$US
242119832$24211983$2$F$20240101$20240812$20240814$20240816$EXP$$CO-ABBVIE-5879424$ABBVIE$$$$$M$Y$52$KG$20240816$$CN$CO$CO
242119841$24211984$1$I$$20240809$20240814$20240814$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-111099$REGENERON$$$$$M$Y$$$20240815$$MD$CA$CA
242119851$24211985$1$I$20240709$20240812$20240814$20240814$EXP$$CA-ABBVIE-5879445$ABBVIE$$70$YR$$F$Y$$$20240814$$CN$CA$CA
242119861$24211986$1$I$20240101$20240813$20240814$20240814$EXP$$CA-ABBVIE-5880523$ABBVIE$$74$YR$$M$Y$$$20240814$$CN$CA$CA
242119871$24211987$1$I$$20240813$20240814$20240814$PER$$NVSC2024US165318$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
242119881$24211988$1$I$$20240814$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128904$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$60.78$KG$20240815$$HP$US$US
242119891$24211989$1$I$20240509$20240808$20240814$20240814$EXP$$US-ABBVIE-5855920$ABBVIE$$29$YR$$F$Y$61$KG$20240814$$CN$US$US
242119901$24211990$1$I$$20240807$20240814$20240814$EXP$$US-ABBVIE-5879484$ABBVIE$$$$$M$Y$$$20240814$$CN$US$US
242119911$24211991$1$I$$20240808$20240814$20240814$PER$$US-ALXN-202408USA000572US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240815$$CN$US$US
242119923$24211992$3$F$20230101$20240904$20240814$20240911$EXP$$US-ABBVIE-5857137$ABBVIE$$$$$F$Y$85.275$KG$20240911$$CN$US$US
242119934$24211993$4$F$$20240905$20240814$20240909$PER$$US-ALXN-202408USA000503US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242119941$24211994$1$I$20240306$20240731$20240814$20240814$EXP$$US-HLS-202400667$HLS THERAPEUTICS$$49$YR$A$F$Y$$$20240814$$HP$US$US
242119951$24211995$1$I$20240802$20240812$20240814$20240814$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128865$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240815$$CN$US$US
242119961$24211996$1$I$$20240802$20240814$20240814$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408007026$ELI LILLY AND CO$$$$E$M$Y$$$20240814$$CN$DE$BR
242119971$24211997$1$I$20231101$20240812$20240814$20240814$EXP$$US-ELI_LILLY_AND_COMPANY-US202405007889$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240814$$CN$US$US
242119981$24211998$1$I$$20240813$20240814$20240814$PER$$NVSC2024US165319$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
242120011$24212001$1$I$$20240807$20240814$20240814$EXP$$ES-ABBVIE-5878109$ABBVIE$Somoza-Fernandez B, Escudero-Vilaplana V, Collado-Borrell R, Perez-Ramirez S, Villanueva-Bueno C, Montero-Anton M del P, et al. Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient. J Oncol Pharm Pract. 2024;10781552241264530.$60$YR$$M$Y$$$20240814$$HP$ES$ES
242120021$24212002$1$I$$20240716$20240814$20240814$PER$$US-009507513-2407USA016048$MERCK$La Rosa C, Park Y, Yang D, Zhou Q, Kaltcheva T, Karras N, et al. Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antivirals. Haematologic. 2024;109 (7):2303-08$3$YR$$M$Y$$$20240814$$HP$US$US
242120031$24212003$1$I$$20240808$20240814$20240814$EXP$$US-ROCHE-10000052862$ROCHE$$$$$$Y$$$20240815$$CN$US$US
242120041$24212004$1$I$$20240813$20240814$20240814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128673$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$80.29$KG$20240815$$HP$US$US
242120051$24212005$1$I$20240312$20240520$20240814$20240814$EXP$$CL-ABBVIE-5879385$ABBVIE$$60$YR$$F$Y$$$20240814$$CN$CL$CL
242120061$24212006$1$I$$20240812$20240814$20240814$PER$$US-AMGEN-USASP2024160291$AMGEN$Guttman-yassky E.; David E.; Shokrian N. et al.. Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study. Archives of Dermatological research. 2024;316 (7):1-11$$$$$Y$$$20240814$$HP$US$US
242120071$24212007$1$I$20201001$20240813$20240814$20240814$EXP$$JP-TAKEDA-2023TJP016990$TAKEDA$$27$YR$$M$Y$$$20240814$$MD$JP$JP
242120081$24212008$1$I$$20240716$20240814$20240814$PER$$US-009507513-2407USA016045$MERCK$La Rosa C, Park Y, Yang D, Zhou Q, Kaltcheva T, Karras N, et al. Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antivirals. Haematologic. 2024;109 (7):2303-08$21$YR$$M$Y$$$20240814$$HP$US$US
242120091$24212009$1$I$$20240716$20240814$20240814$PER$$US-009507513-2407USA016043$MERCK$La Rosa C, Park Y, Yang D, Zhou Q, Kaltcheva T, Karras N, et al. Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antivirals. Haematologic. 2024;109 (7):2303-08$18$YR$$F$Y$$$20240814$$HP$US$US
242120101$24212010$1$I$$20240716$20240814$20240814$PER$$US-009507513-2407USA016049$MERCK$La Rosa C, Park Y, Yang D, Zhou Q, Kaltcheva T, Karras N, et al. Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antivirals. Haematologic. 2024;109 (7):2303-08$9$YR$$F$Y$$$20240814$$HP$US$US
242120111$24212011$1$I$$20240716$20240814$20240814$PER$$US-009507513-2407USA016046$MERCK$La Rosa C, Park Y, Yang D, Zhou Q, Kaltcheva T, Karras N, et al. Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antivirals. Haematologic. 2024;109 (7):2303-08$8$YR$$F$Y$$$20240814$$HP$US$US
242120121$24212012$1$I$$20240716$20240814$20240814$PER$$US-009507513-2407USA011281$MERCK$La Rosa C, Park Y, Yang D, Zhou Q, Kaltcheva T, Karras N, et al. Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antivirals. Haematologic. 2024;109 (7):2303-08$19$YR$$M$Y$$$20240814$$HP$US$US
242120131$24212013$1$I$$20240716$20240814$20240814$PER$$US-009507513-2407USA016047$MERCK$La Rosa C, Park Y, Yang D, Zhou Q, Kaltcheva T, Karras N, et al. Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antivirals. Haematologic. 2024;109 (7):2303-08$13$YR$$F$Y$$$20240814$$HP$US$US
242120152$24212015$2$F$20210311$20240902$20240814$20240903$EXP$$JP-TAKEDA-2024TJP011955$TAKEDA$$25$YR$$M$Y$$$20240903$$MD$JP$JP
242120161$24212016$1$I$$20240812$20240814$20240814$EXP$$BR-Bion-013672$BIONPHARMA$$36$YR$A$M$Y$$$20240814$$HP$BR$
242120171$24212017$1$I$20240729$20240807$20240814$20240814$EXP$$CN-BEIGENE-BGN-2024-012371$BEIGENE$$$$$$Y$$$20240814$$HP$CN$CN
242120181$24212018$1$I$$20240808$20240814$20240814$EXP$$US-Bion-013659$BIONPHARMA$$24$YR$A$M$Y$$$20240814$$HP$US$US
242120191$24212019$1$I$20230127$20240813$20240814$20240814$EXP$$JP-TAKEDA-2024TJP011965$TAKEDA$$37$YR$$F$Y$$$20240814$$MD$JP$JP
242120202$24212020$2$F$20240101$20240916$20240815$20240923$PER$$US-ABBVIE-5871905$ABBVIE$$$$$F$Y$70$KG$20240923$$HP$US$US
242120211$24212021$1$I$$20240807$20240815$20240815$PER$$US-ABBVIE-5871864$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242120221$24212022$1$I$$20240808$20240815$20240815$EXP$$US-ABBVIE-5873985$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242120231$24212023$1$I$$20240808$20240815$20240815$EXP$$US-AMGEN-USASP2024159897$AMGEN$Jones A. A.; Martin J. S.; Giangiacomo A. L. et al.. Secondary glaucoma after bevacizumab injection in Type-I retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024;36:1-4$$$$M$Y$$$20240814$$HP$US$US
242120241$24212024$1$I$20210507$20240809$20240815$20240815$EXP$RU-RZN-2478500$RU-BIOGEN-2024BI01278074$BIOGEN$$47$YR$$F$Y$50$KG$20240815$$MD$RU$RU
242120251$24212025$1$I$20240101$20240807$20240815$20240815$PER$$US-ABBVIE-5871895$ABBVIE$$$$$M$Y$75$KG$20240815$$CN$US$US
242120261$24212026$1$I$20240806$20240807$20240815$20240815$PER$$US-SA-2024SA237754$SANOFI AVENTIS$$12$YR$T$M$Y$54.38$KG$20240815$$MD$US$US
242120271$24212027$1$I$20240801$20240812$20240815$20240815$EXP$$DE-BIOGEN-2024BI01277920$BIOGEN$$52$YR$$F$Y$$$20240815$$CN$DE$DE
242120281$24212028$1$I$$20240716$20240815$20240815$PER$$US-009507513-2407USA016044$MERCK$La Rosa C, Park Y, Yang D, Zhou Q, Kaltcheva T, Karras N, et al. Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antivirals. Haematologic. 2024;109 (7):2303-08$12$YR$$F$Y$$$20240815$$HP$US$US
242120291$24212029$1$I$20240803$20240812$20240815$20240815$EXP$$CA-ROCHE-10000056383$ROCHE$$78$YR$E$F$Y$58$KG$20240815$$HP$CA$CA
242120301$24212030$1$I$$20240809$20240815$20240815$PER$$US-ROCHE-10000054189$ROCHE$$$$E$M$Y$$$20240815$$HP$US$US
242120312$24212031$2$F$20200101$20240916$20240815$20240918$EXP$$ES-AUROBINDO-AUR-APL-2024-040399$AUROBINDO$$75$YR$$F$Y$$$20240918$$PH$ES$ES
242120321$24212032$1$I$20240201$20240805$20240815$20240815$EXP$CH-SM-2024-14080$CH-JNJFOC-20240809455$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240815$$HP$CH$CH
242120332$24212033$2$F$$20240814$20240815$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125978$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$79$KG$20240818$$HP$US$US
242120341$24212034$1$I$$20240814$20240815$20240815$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045859$BOEHRINGER INGELHEIM$$$$$$Y$$$20240815$$CN$US$US
242120352$24212035$2$F$$20240829$20240815$20240829$PER$$US-ALXN-202408USA000493US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242120361$24212036$1$I$$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A179683$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242120371$24212037$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160352$AMGEN$Guttman-yassky E.; David E.; Shokrian N. et al.. Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study. Archives of Dermatological research. 2024;316 (7):1-11$$$$$Y$$$20240814$$HP$US$US
242120381$24212038$1$I$$20240810$20240815$20240815$PER$$US-ABBVIE-5877036$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242120391$24212039$1$I$20230125$20230818$20240815$20240815$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240637$IRONSHORE PHARMA$$16$YR$T$F$Y$$$20240815$$MD$US$US
242120401$24212040$1$I$20191113$20230908$20240815$20240815$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240585$IRONSHORE PHARMA$$7$YR$C$M$Y$30.418$KG$20240815$$MD$US$US
242120411$24212041$1$I$$20230808$20240815$20240815$PER$$US-Ironshore Pharmaceuticals Inc.-IRON20240671$IRONSHORE PHARMA$$$$$M$Y$$$20240815$$MD$US$US
242120421$24212042$1$I$20240725$20240807$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012373$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242120431$24212043$1$I$20240101$20240808$20240815$20240815$EXP$$US-ABBVIE-5875118$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242120441$24212044$1$I$20230101$20240807$20240815$20240815$EXP$DE-DCGMA-24203744$DE-RDY-SPO/DEU/24/0011618$DR REDDYS$$77$YR$E$M$Y$76$KG$20240814$$MD$DE$DE
242120451$24212045$1$I$$20240731$20240815$20240815$EXP$$US-HLS-202400673$HLS THERAPEUTICS$$$$A$$Y$$$20240815$$HP$US$US
242120461$24212046$1$I$20240101$20240806$20240815$20240815$EXP$$US-JNJFOC-20240815210$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240815$$CN$US$US
242120471$24212047$1$I$$20240808$20240815$20240815$EXP$$US-SA-2024SA240086$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240815$$MD$US$US
242120482$24212048$2$F$$20240827$20240815$20240902$PER$$US-AMGEN-USASP2024161721$AMGEN$Topilow N.J.; Penteado R.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024;1-6$$$$$Y$$$20240902$$MD$US$US
242120491$24212049$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA235964$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240815$$HP$US$US
242120501$24212050$1$I$20240701$20240813$20240815$20240815$EXP$$US-ROCHE-10000056563$ROCHE$$$$$M$Y$$$20240815$$CN$US$US
242120511$24212051$1$I$20240101$20240806$20240815$20240815$PER$$US-SA-2024SA236698$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240815$$CN$US$US
242120521$24212052$1$I$$20240809$20240815$20240815$PER$$US-ABBVIE-5877525$ABBVIE$$$$$$Y$$$20240815$$CN$US$US
242120531$24212053$1$I$$20240808$20240815$20240815$PER$$US-ABBVIE-5875832$ABBVIE$$$$$M$Y$$$20240815$$HP$US$US
242120541$24212054$1$I$20240731$20240807$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012374$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242120551$24212055$1$I$$20240806$20240815$20240815$PER$$US-ABBVIE-5870348$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242120561$24212056$1$I$20240101$20240812$20240815$20240815$EXP$$US-BIOGEN-2024BI01278064$BIOGEN$$$$$F$Y$$$20240815$$CN$US$US
242120572$24212057$2$F$$20240906$20240815$20240912$EXP$$US-BIOGEN-2024BI01278069$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
242120581$24212058$1$I$20240101$20240814$20240815$20240815$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045865$BOEHRINGER INGELHEIM$$6$DEC$A$M$Y$$$20240815$$HP$US$US
242120591$24212059$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128536$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240815$$HP$US$US
242120601$24212060$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128569$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240815$$HP$US$US
242120611$24212061$1$I$20240626$20240813$20240815$20240815$EXP$$US-ABBVIE-5879386$ABBVIE$$60$YR$$M$Y$$$20240815$$CN$US$US
242120621$24212062$1$I$20240701$20240812$20240815$20240815$EXP$$US-ABBVIE-5878648$ABBVIE$$22$YR$$F$Y$$$20240815$$CN$US$US
242120632$24212063$2$F$$20240903$20240815$20240912$EXP$$CA-CELLTRION INC.-2024CA019380$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
242120641$24212064$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128339$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240814$$CN$US$US
242120652$24212065$2$F$20240101$20240808$20240815$20240820$PER$$US-SA-2024SA238240$SANOFI AVENTIS$$28$YR$A$F$Y$72.9$KG$20240820$$MD$US$US
242120661$24212066$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA239458$SANOFI AVENTIS$$$$A$F$Y$74$KG$20240815$$MD$US$US
242120671$24212067$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA240551$SANOFI AVENTIS$$$$A$M$Y$106$KG$20240815$$MD$US$US
242120681$24212068$1$I$20240101$20240812$20240815$20240815$EXP$$ZA-ABBVIE-5879440$ABBVIE$$27$YR$$F$Y$$$20240815$$CN$ZA$ZA
242120691$24212069$1$I$$20240812$20240815$20240815$PER$$US-ROCHE-10000055885$ROCHE$$25$YR$A$F$Y$$$20240815$$HP$US$US
242120702$24212070$2$F$$20240808$20240815$20240819$EXP$$IT-AUROBINDO-AUR-APL-2024-039821$AUROBINDO$Sanga V, Bertoli E, Crimi F, Barbiero G, Battistel M, Seccia TM, et al.. Pickering Syndrome: An Overlooked Renovascular Cause of Recurrent Heart Failure.. J-Am-Heart-Assoc. 2023;12:19$75$YR$$M$Y$$$20240819$$HP$IT$IT
242120711$24212071$1$I$$20240617$20240815$20240815$EXP$$US-AstraZeneca-2024A142108$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242120721$24212072$1$I$$20240807$20240815$20240815$EXP$$ZA-AstraZeneca-2024A180205$ASTRAZENECA$$23376$DY$$F$Y$$$20240815$$CN$ZA$
242120731$24212073$1$I$$20240802$20240815$20240815$EXP$$GB-AUROBINDO-AUR-APL-2024-039194$AUROBINDO$$$$$F$Y$$$20240815$$HP$GB$GB
242120741$24212074$1$I$20220101$20240808$20240815$20240815$EXP$$US-ABBVIE-5861003$ABBVIE$$$$$F$Y$81$KG$20240815$$CN$PR$PR
242120751$24212075$1$I$$20240801$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040232$AUROBINDO$$54$YR$$M$Y$97$KG$20240815$$HP$CA$CA
242120761$24212076$1$I$20240412$20240807$20240815$20240815$EXP$$US-TAKEDA-2024TUS044596$TAKEDA$$77$YR$$F$Y$$$20240815$$MD$US$US
242120771$24212077$1$I$$20240808$20240815$20240815$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099111$VIIV$$$$$M$Y$$$20240815$$HP$US$US
242120781$24212078$1$I$$20240801$20240815$20240815$PER$$US-TEVA-VS-3229410$TEVA$$$$A$F$Y$$$20240815$$CN$US$US
242120792$24212079$2$F$$20240903$20240815$20240908$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125355$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240909$$HP$US$US
242120801$24212080$1$I$$20240802$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040382$AUROBINDO$$63$YR$$F$Y$$$20240815$$HP$CA$CA
242120812$24212081$2$F$$20240826$20240815$20240904$EXP$$IE-TEVA-VS-3231156$TEVA$Crotty TJ, Sexton GP, Kavanagh F, Kinsella J, Lennon P, Timon CV, et al. Fatal cerebritis and ventriculitis secondary to tracheoesophageal prosthesis. J-Surg-Case-Rep 2024; 2024 (4):.; Crotty TJ, Sexton GP, Kavanagh F, Kinsella J, Lennon P, Timon CV, et al. Fatal cerebritis and ventriculitis secondary to tracheoesophageal prosthesis. J-Surg-Case-Rep 2024; 2024 (4):.$70$YR$$M$Y$$$20240904$$HP$IE$IE
242120821$24212082$1$I$20240801$20240808$20240815$20240815$PER$$US-SA-2024SA238646$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240815$$MD$US$US
242120831$24212083$1$I$$20240809$20240815$20240815$PER$$US-ABBVIE-5876862$ABBVIE$$$$$$Y$$$20240815$$MD$US$US
242120841$24212084$1$I$$20240812$20240815$20240815$EXP$$US-ABBVIE-5878966$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242120851$24212085$1$I$$20240810$20240815$20240815$PER$$US-AMGEN-USASP2024159669$AMGEN$Bove R.; Karalius M.; Mohan S. et al.. Pearls + Oy-sters: Optic Neuritis as First Demyelinating Event During Pregnancy in 2 Young Hispanic Women: MS vs MOGAD. American Academy of Neurology. 2024;103 (4):1-6$20$YR$A$F$Y$$$20240814$$MD$US$US
242120861$24212086$1$I$20240716$20240813$20240815$20240815$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045619$BOEHRINGER INGELHEIM$$57$YR$A$M$Y$$$20240814$$HP$SG$SG
242120871$24212087$1$I$20240606$20240722$20240815$20240815$EXP$$GB-CELLTRION INC.-2024GB019550$CELLTRION$$$$$$Y$$$20240815$$CN$GB$GB
242120881$24212088$1$I$20230101$20240808$20240815$20240815$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041137$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$53$KG$20240815$$CN$DE$DE
242120891$24212089$1$I$$20240809$20240815$20240815$EXP$$US-ABBVIE-5875403$ABBVIE$$$$$M$Y$$$20240815$$HP$US$US
242120901$24212090$1$I$$20240809$20240815$20240815$PER$$US-AMGEN-USASP2024159049$AMGEN$$$$$F$Y$$$20240814$$HP$US$US
242120911$24212091$1$I$20240607$20240725$20240815$20240815$EXP$$US-NEBO-665278$PHARMACOSMOS$$50$YR$$F$Y$$$20240815$$HP$US$US
242120922$24212092$2$F$20240726$20240809$20240815$20240816$PER$$US-ALXN-202408USA000515US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242120931$24212093$1$I$20240812$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161564$AMGEN$$56$YR$A$F$Y$$$20240814$$CN$US$US
242120941$24212094$1$I$$20240813$20240815$20240815$EXP$$US-ABBVIE-5880415$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242120951$24212095$1$I$$20240813$20240815$20240815$PER$$US-ROCHE-10000056561$ROCHE$$50$YR$A$F$Y$180$KG$20240815$$MD$US$US
242120962$24212096$2$F$20240801$20240819$20240815$20240820$EXP$$US-JNJFOC-20240819349$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240821$$CN$US$US
242120972$24212097$2$F$$20240830$20240815$20240830$PER$$US-ALXN-202408USA000704US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242120981$24212098$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160799$AMGEN$$$$$$Y$$$20240814$$MD$US$US
242120991$24212099$1$I$20240101$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160769$AMGEN$$55$YR$A$F$Y$$$20240814$$HP$US$US
242121012$24212101$2$F$20240301$20240808$20240815$20240827$EXP$$GB-AMGEN-GBRSP2024161474$AMGEN$$78$YR$E$F$Y$63$KG$20240827$$MD$GB$GB
242121021$24212102$1$I$20240728$20240808$20240815$20240815$EXP$ES-AEMPS-1556392$ES-SA-2024SA238405$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240815$$MD$ES$ES
242121032$24212103$2$F$20240101$20240917$20240815$20240926$PER$$US-SA-2024SA239503$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240926$$MD$US$US
242121041$24212104$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA238691$SANOFI AVENTIS$$15$YR$T$M$Y$119.7$KG$20240815$$HP$US$US
242121051$24212105$1$I$20240101$20240808$20240815$20240815$PER$$US-SA-2024SA238837$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240815$$MD$US$US
242121062$24212106$2$F$20240811$20240814$20240815$20240817$PER$$US-AMGEN-USASP2024161287$AMGEN$$70$YR$E$M$Y$$$20240816$$CN$US$US
242121071$24212107$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA238946$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240815$$MD$US$US
242121081$24212108$1$I$20240101$20240807$20240815$20240815$PER$$US-SA-2024SA240734$SANOFI AVENTIS$$50$YR$A$F$Y$58.05$KG$20240815$$MD$US$US
242121091$24212109$1$I$$20240812$20240815$20240815$PER$$US-ROCHE-10000056721$ROCHE$$$$$$Y$$$20240815$$MD$US$US
242121101$24212110$1$I$$20230720$20240815$20240815$EXP$$US-AstraZeneca-2023A166941$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242121111$24212111$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128623$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240815$$CN$US$US
242121121$24212112$1$I$$20240805$20240815$20240815$30DAY$$US-GSK-US2024097575$GLAXOSMITHKLINE$$$$$M$Y$$$20240815$$CN$US$US
242121131$24212113$1$I$$20240814$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128893$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240815$$CN$US$US
242121141$24212114$1$I$20240811$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160987$AMGEN$$73$YR$E$F$Y$$$20240814$$CN$US$US
242121151$24212115$1$I$20240812$20240812$20240815$20240815$PER$$US-AMGEN-USASL2024160969$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242121161$24212116$1$I$20240712$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160591$AMGEN$$$$$$Y$$$20240814$$PH$US$US
242121173$24212117$3$F$20240101$20240827$20240815$20240830$PER$$US-AMGEN-USASP2024160644$AMGEN$$78$YR$E$F$Y$$$20240829$$CN$US$US
242121181$24212118$1$I$20240101$20240805$20240815$20240815$PER$$US-AMGEN-USASP2024155671$AMGEN$$$$$$Y$$$20240814$$HP$US$US
242121201$24212120$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA239144$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240815$$MD$US$US
242121211$24212121$1$I$$20240814$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128969$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240815$$CN$US$US
242121221$24212122$1$I$$20240814$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128902$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$42.18$KG$20240815$$CN$US$US
242121252$24212125$2$F$$20240830$20240815$20240830$PER$$US-ALXN-202408USA000720US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242121261$24212126$1$I$$20230713$20240815$20240815$EXP$$US-AstraZeneca-2023A161957$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242121271$24212127$1$I$$20240813$20240815$20240815$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-128850$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240815$$CN$PR$PR
242121281$24212128$1$I$$20230621$20240815$20240815$EXP$$US-AstraZeneca-2023A143964$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
242121291$24212129$1$I$20240801$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160552$AMGEN$$41$YR$$M$Y$$$20240814$$CN$US$US
242121301$24212130$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008529$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240815$$CN$US$US
242121311$24212131$1$I$20240612$20240807$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012368$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242121321$24212132$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024161186$AMGEN$$$$$$Y$$$20240814$$MD$US$US
242121331$24212133$1$I$$20240802$20240815$20240815$EXP$$GB-UCBSA-2024039100$UCB$$$$$F$Y$$$20240815$$CN$GB$GB
242121341$24212134$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007811$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240815$$CN$US$US
242121351$24212135$1$I$$20240812$20240815$20240815$PER$$US-ABBVIE-5878403$ABBVIE$$$$$$Y$$$20240815$$CN$US$US
242121361$24212136$1$I$20231101$20240808$20240815$20240815$EXP$ES-AEMPS-1556067$ES-CHEPLA-2024010373$CHEPLAPHARM$$49$YR$$M$Y$72$KG$20240814$$HP$COUNTRY NOT SPECIFIED$ES
242121371$24212137$1$I$$20240806$20240815$20240815$EXP$$JP-CHEPLA-2024010477$CHEPLAPHARM$$73$YR$$F$Y$$$20240814$$PH$COUNTRY NOT SPECIFIED$JP
242121381$24212138$1$I$$20240801$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040207$AUROBINDO$Caylie M. Poirier, Aleesa A. Carter,Yvonne Kwan, Jessica Koo,Jill M. Westlund, Fadi Alkass,Kori Leblanc.. Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post-Percutaneous Coronary Intervention. CJC Open. 2023$78$YR$$M$Y$$$20240815$$HP$CA$CA
242121391$24212139$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA240736$SANOFI AVENTIS$$$$A$M$Y$81.64$KG$20240815$$MD$US$US
242121401$24212140$1$I$20240803$20240808$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012438$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242121411$24212141$1$I$20240725$20240808$20240815$20240815$EXP$ES-AEMPS-1555256$ES-CHEPLA-2024010452$CHEPLAPHARM$$80$YR$$F$Y$35$KG$20240814$$MD$COUNTRY NOT SPECIFIED$ES
242121421$24212142$1$I$$20240807$20240815$20240815$EXP$$BR-CHEPLA-2021003536$CHEPLAPHARM$$65$YR$$F$Y$$$20240814$$MD$COUNTRY NOT SPECIFIED$BR
242121431$24212143$1$I$$20240802$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040076$AUROBINDO$$54$YR$$F$Y$72.57$KG$20240815$$CN$CA$CA
242121441$24212144$1$I$20240101$20240806$20240815$20240815$PER$$US-ABBVIE-5880110$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242121451$24212145$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3232480$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$16$YR$$M$Y$$$20240815$$HP$DE$DE
242121463$24212146$3$F$$20240828$20240815$20240828$EXP$$US-ALXN-202408USA000524US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242121471$24212147$1$I$$20240809$20240815$20240815$PER$$US-AMGEN-USASP2024159772$AMGEN$$$$$F$Y$$$20240814$$CN$US$US
242121491$24212149$1$I$$20240802$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040080$AUROBINDO$$33$YR$$M$Y$$$20240815$$HP$CA$CA
242121501$24212150$1$I$20240722$20240813$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012661$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242121511$24212151$1$I$20240807$20240807$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012370$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242121521$24212152$1$I$20240802$20240808$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012439$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242121532$24212153$2$F$$20240821$20240815$20240828$EXP$$GB-CELLTRION INC.-2024GB019164$CELLTRION$$$$$$Y$$$20240828$$CN$GB$GB
242121541$24212154$1$I$20240801$20240808$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012448$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242121551$24212155$1$I$$20240809$20240815$20240815$PER$$US-AMGEN-USASP2024158895$AMGEN$$$$$M$Y$$$20240814$$CN$US$US
242121561$24212156$1$I$20240811$20240813$20240815$20240815$EXP$$US-AstraZeneca-2024A184372$ASTRAZENECA$$29687$DY$$M$Y$$$20240815$$CN$US$
242121582$24212158$2$F$20230330$20240816$20240815$20240819$EXP$DE-STADA-01276369$DE-ROCHE-10000056711$ROCHE$$65$YR$E$F$Y$67$KG$20240819$$MD$DE$DE
242121591$24212159$1$I$20220601$20220615$20240815$20240815$EXP$$US-AstraZeneca-2022A224711$ASTRAZENECA$$715$MON$$F$Y$$$20240815$$CN$US$
242121601$24212160$1$I$20221111$20231016$20240815$20240815$EXP$$IT-AstraZeneca-2023A234272$ASTRAZENECA$$59$YR$$M$Y$$$20240815$$MD$IT$
242121611$24212161$1$I$20240715$20240808$20240815$20240815$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044943$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240815$$CN$US$US
242121621$24212162$1$I$20240811$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160323$AMGEN$$$$$M$Y$$$20240814$$CN$US$US
242121631$24212163$1$I$$20240809$20240815$20240815$PER$$US-AMGEN-USASP2024159447$AMGEN$$65$YR$E$F$Y$$$20240814$$PH$US$US
242121641$24212164$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127223$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240815$$HP$US$US
242121651$24212165$1$I$$20240814$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128880$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240815$$CN$US$US
242121661$24212166$1$I$20240701$20240725$20240815$20240815$EXP$$MY-ALXN-202407ASI002299MY$ALEXION PHARMACEUTICALS$$65$YR$$M$Y$48$KG$20240815$$MD$MY$MY
242121671$24212167$1$I$$20240808$20240815$20240815$EXP$$NZ-JNJFOC-20240823953$JOHNSON AND JOHNSON$$$$$M$Y$$$20240815$$MD$NZ$NZ
242121692$24212169$2$F$$20240826$20240815$20240903$EXP$$US-TEVA-VS-3230878$TEVA$Abdelsalam M, Sleem M, Islam A. High dose dexamethasone for edema associated with brain tumor leading to acute sigmoid diverticular perforation. Am-J-Med-Sci 2024; 367 (Suppl.) S41.; Abdelsalam M, Sleem M, Islam A. High dose dexamethasone for edema associated with brain tumor leading to acute sigmoid diverticular perforation. Am-J-Med-Sci 2024; 367 (Suppl.) S41.$65$YR$$F$Y$$$20240903$$HP$US$US
242121702$24212170$2$F$20240803$20240828$20240815$20240830$PER$$US-AMGEN-USASP2024161249$AMGEN$$63$YR$A$F$Y$$$20240830$$CN$US$US
242121712$24212171$2$F$20240811$20240830$20240815$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045912$BOEHRINGER INGELHEIM$$57$YR$A$F$Y$$$20240904$$CN$US$US
242121721$24212172$1$I$$20240814$20240815$20240815$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045898$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240815$$CN$US$US
242121731$24212173$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128656$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240815$$CN$US$US
242121741$24212174$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128649$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240815$$CN$US$US
242121751$24212175$1$I$20240812$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024161304$AMGEN$$52$YR$A$M$Y$$$20240814$$CN$US$US
242121761$24212176$1$I$$20240812$20240815$20240815$EXP$$BE-ABBVIE-5878986$ABBVIE$$37$YR$$M$Y$$$20240815$$MD$BE$BE
242121772$24212177$2$F$$20240807$20240815$20240816$EXP$$US-ABBVIE-5392564$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242121781$24212178$1$I$$20240806$20240815$20240815$PER$$US-GILEAD-2024-0683281$GILEAD$$56$YR$A$M$Y$$$20240814$$PH$US$US
242121792$24212179$2$F$20240701$20240729$20240815$20240823$EXP$$CH-BEH-2024177134$CSL BEHRING$$66$YR$E$M$Y$$$20240823$$PH$CH$CH
242121801$24212180$1$I$$20240802$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040091$AUROBINDO$$54$YR$$F$Y$72.57$KG$20240815$$CN$CA$CA
242121811$24212181$1$I$20240705$20240812$20240815$20240815$PER$$US-ALXN-202408USA000726US$ALEXION PHARMACEUTICALS$$72$YR$$M$Y$$$20240815$$CN$US$US
242121821$24212182$1$I$20240714$20240807$20240815$20240815$EXP$$CN-AstraZeneca-2024A181117$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$CN$
242121831$24212183$1$I$$20240802$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040060$AUROBINDO$$89$YR$$F$Y$$$20240815$$PH$CA$CA
242121841$24212184$1$I$20240701$20240812$20240815$20240815$PER$$US-ABBVIE-5877895$ABBVIE$$47$YR$$F$Y$$$20240815$$HP$US$US
242121851$24212185$1$I$$20240813$20240815$20240815$EXP$$JP-ABBVIE-5880370$ABBVIE$$$$$$Y$$$20240815$$MD$JP$JP
242121861$24212186$1$I$$20220701$20240815$20240815$EXP$$US-AstraZeneca-2022A205291$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242121871$24212187$1$I$$20231106$20240815$20240815$EXP$$US-AstraZeneca-2023A253408$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
242121881$24212188$1$I$$20230516$20240815$20240815$EXP$$GB-AstraZeneca-2023A113823$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$GB$
242121891$24212189$1$I$$20240719$20240815$20240815$PER$$US-AstraZeneca-2024A165947$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
242121901$24212190$1$I$$20240807$20240815$20240815$EXP$$US-ROCHE-10000051820$ROCHE$$75$YR$E$F$Y$89.81$KG$20240815$$CN$US$US
242121912$24212191$2$F$20240722$20240820$20240815$20240827$EXP$$JP-009507513-2408JPN001122J$MERCK$$48$YR$$F$Y$$$20240827$$MD$JP$JP
242121921$24212192$1$I$20240726$20240805$20240815$20240815$EXP$GB-MHRA-MED-202408051140567160-HBMFC$GB-GLENMARK PHARMACEUTICALS-2024GMK093139$GLENMARK$$$$$$Y$$$20240815$$PH$GB$GB
242121932$24212193$2$F$20240811$20240814$20240815$20240817$PER$$US-AMGEN-USASP2024161405$AMGEN$$80$YR$E$F$Y$$$20240817$$CN$US$US
242121943$24212194$3$F$20240101$20240814$20240815$20240821$PER$$US-SA-2024SA240737$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240821$$MD$US$US
242121951$24212195$1$I$$20240802$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040038$AUROBINDO$$83$YR$$F$Y$$$20240815$$HP$CA$CA
242121962$24212196$2$F$20240101$20240813$20240815$20240817$PER$$US-AMGEN-USASP2024160436$AMGEN$$70$YR$E$F$Y$$$20240817$$PH$US$US
242121971$24212197$1$I$$20240805$20240815$20240815$EXP$$JP-ROCHE-10000053240$ROCHE$Kubo T, Watanabe O, Yamamoto H, Kaji D, Taya Y, Nishida A. A case in which ruxolitinib was markedly effective against fluid retention that occurred early after cord blood transplant. [Abstract number: 47]. The 21st Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology. 2024;41.$72$YR$E$F$Y$$$20240815$$MD$JP$JP
242121981$24212198$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3232481$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$9$YR$$M$Y$$$20240815$$HP$DE$DE
242121991$24212199$1$I$20240807$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007880$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240815$$CN$US$US
242122001$24212200$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008236$ELI LILLY AND CO$$$$$F$Y$$$20240815$$CN$US$US
242122015$24212201$5$F$20240101$20240903$20240815$20240911$EXP$$CA-CELLTRION INC.-2024CA002604$CELLTRION$$$$$$Y$$$20240911$$MD$CA$CA
242122022$24212202$2$F$$20240820$20240815$20240829$EXP$$US-TEVA-VS-3230877$TEVA$Virupakshaiah A, Moseley CE, Elicegui S, Gerwitz LM, Spencer CM, George E, et al. Life-Threatening MOG Antibody-Associated Hemorrhagic ADEM With Elevated CSF IL-6. Neurol-Neuroimmunol-Neuroinflamm 2024; 11 (4):.; Virupakshaiah A, Moseley CE, Elicegui S, Gerwitz LM, Spencer CM, George E, et al. Life-Threatening MOG Antibody-Associated Hemorrhagic ADEM With Elevated CSF IL-6. Neurol-Neuroimmunol-Neuroinflamm 2024; 11 (4):.; Virupakshaiah A, Moseley CE, Elicegui S, Gerwitz LM, Spencer CM, George...$35$YR$$M$Y$$$20240829$$MD$US$US
242122033$24212203$3$F$20090101$20240916$20240815$20240919$EXP$$US-ABBVIE-5875656$ABBVIE$$49$YR$$F$Y$46.266$KG$20240919$$CN$US$US
242122042$24212204$2$F$$20240830$20240815$20240830$PER$$US-ALXN-202408USA000697US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242122062$24212206$2$F$$20240814$20240815$20240823$PER$$US-ABBVIE-5878016$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242122071$24212207$1$I$$20240813$20240815$20240815$PER$$US-ROCHE-10000056581$ROCHE$$$$$$Y$$$20240815$$CN$US$US
242122081$24212208$1$I$20240630$20240812$20240815$20240815$EXP$GR-GREOF-202400864$GR-ABBVIE-5877230$ABBVIE$$51$YR$$F$Y$97$KG$20240815$$MD$GR$GR
242122091$24212209$1$I$20240803$20240809$20240815$20240815$EXP$$US-ABBVIE-5875887$ABBVIE$$53$YR$$F$Y$$$20240815$$CN$US$US
242122101$24212210$1$I$20240629$20240812$20240815$20240815$EXP$$US-AstraZeneca-2024A183317$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242122111$24212211$1$I$$20240812$20240815$20240815$EXP$$US-AstraZeneca-2024A183704$ASTRAZENECA$$$$$$Y$$$20240815$$HP$US$
242122121$24212212$1$I$$20240805$20240815$20240815$EXP$$US-GSK-US2024097501$GLAXOSMITHKLINE$$$$$F$Y$$$20240815$$CN$US$US
242122131$24212213$1$I$$20240802$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040053$AUROBINDO$$54$YR$$F$Y$$$20240815$$CN$CA$CA
242122141$24212214$1$I$$20230531$20240815$20240815$EXP$$US-AstraZeneca-2023A127138$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242122151$24212215$1$I$$20230515$20240815$20240815$EXP$$BR-AstraZeneca-2023A113833$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$BR$
242122161$24212216$1$I$$20220824$20240815$20240815$EXP$$AU-AstraZeneca-2022A297962$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$AU$
242122171$24212217$1$I$$20240810$20240815$20240815$EXP$$CZ-ABBVIE-5878499$ABBVIE$$$$$M$Y$$$20240815$$CN$CZ$CZ
242122181$24212218$1$I$$20230418$20240815$20240815$EXP$$US-AstraZeneca-2023A091123$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242122191$24212219$1$I$$20230518$20240815$20240815$EXP$$US-AstraZeneca-2023A116205$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242122201$24212220$1$I$$20230808$20240815$20240815$EXP$$US-AstraZeneca-2023A165136$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242122211$24212221$1$I$$20240812$20240815$20240815$EXP$$US-ABBVIE-5878339$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242122221$24212222$1$I$20240812$20240813$20240815$20240815$PER$$US-GILEAD-2024-0684171$GILEAD$$58$YR$A$M$Y$$$20240814$$CN$US$US
242122231$24212223$1$I$20240811$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161813$AMGEN$$41$YR$A$F$Y$$$20240814$$CN$US$US
242122241$24212224$1$I$$20240802$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040084$AUROBINDO$$78$YR$$M$Y$77$KG$20240815$$PH$CA$CA
242122251$24212225$1$I$$20240807$20240815$20240815$EXP$$DE-AMGEN-DEUNI2024160108$AMGEN$Satirer, O.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD Open. 2024;10(3):e004381$1$YR$I$M$Y$$$20240814$$MD$DE$DE
242122261$24212226$1$I$20240810$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160505$AMGEN$$82$YR$E$M$Y$$$20240814$$CN$US$US
242122271$24212227$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128631$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240815$$CN$US$US
242122281$24212228$1$I$$20240814$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128982$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$87.09$KG$20240815$$CN$US$US
242122291$24212229$1$I$$20240805$20240815$20240815$PER$$US-JNJFOC-20240812633$JOHNSON AND JOHNSON$$$$$M$Y$$$20240815$$CN$US$US
242122303$24212230$3$F$$20240829$20240815$20240905$EXP$$JP-AMGEN-JPNSP2024160692$AMGEN$$8$DEC$E$F$Y$$$20240905$$MD$JP$JP
242122311$24212231$1$I$$20240814$20240815$20240815$PER$$NVSC2024US165362$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
242122321$24212232$1$I$20240614$20240809$20240815$20240815$EXP$$JP-ABBVIE-5804809$ABBVIE$$50$YR$$M$Y$$$20240815$$HP$JP$JP
242122331$24212233$1$I$20240723$20240808$20240815$20240815$EXP$$JP-009507513-2407JPN004402J$MERCK$$86$YR$$F$Y$$$20240815$$PH$JP$JP
242122351$24212235$1$I$20240101$20240808$20240815$20240815$PER$$US-SA-2024SA240380$SANOFI AVENTIS$$73$YR$E$F$Y$122$KG$20240815$$MD$US$US
242122361$24212236$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA240128$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240815$$CN$US$US
242122371$24212237$1$I$$20240808$20240815$20240815$EXP$$US-GSK-US2024AMR100139$GLAXOSMITHKLINE$$$$$F$Y$$$20240815$$CN$US$US
242122381$24212238$1$I$20240801$20240812$20240815$20240815$EXP$$AU-GSK-AU2024100411$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$MD$AU$AU
242122391$24212239$1$I$$20240802$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040066$AUROBINDO$$80$YR$$F$Y$108$KG$20240815$$PH$CA$CA
242122401$24212240$1$I$$20240527$20240815$20240815$EXP$$PT-AUROBINDO-AUR-APL-2024-026792$AUROBINDO$Suleac M, Silva J, Mendes E, Naranjo S, Djassi, M, Lavadinho I. Acute heart failure at young age in a transplant patient as a complication of covid-19, what now?. European Journal of Case Reports in Internal Medicine. 2023;10(1):62$20$YR$$F$Y$$$20240815$$HP$PT$PT
242122411$24212241$1$I$20240701$20240812$20240815$20240815$EXP$$ES-ABBVIE-5879449$ABBVIE$$86$YR$$M$Y$$$20240815$$CN$ES$ES
242122421$24212242$1$I$$20240808$20240815$20240815$EXP$$CL-AstraZeneca-2024A185297$ASTRAZENECA$$$$A$F$Y$$$20240815$$MD$CL$
242122431$24212243$1$I$$20220802$20240815$20240815$EXP$$US-AstraZeneca-2022A276624$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242122441$24212244$1$I$$20231122$20240815$20240815$EXP$$US-AstraZeneca-2023A266438$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242122451$24212245$1$I$$20220908$20240815$20240815$EXP$$US-AstraZeneca-2022A313727$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242122461$24212246$1$I$$20220427$20240815$20240815$EXP$$US-AstraZeneca-2022A166316$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242122471$24212247$1$I$$20230502$20240815$20240815$EXP$$US-AstraZeneca-2023A104172$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
242122481$24212248$1$I$20240707$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008309$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240815$$CN$US$US
242122491$24212249$1$I$$20240806$20240815$20240815$EXP$$JO-HIKMA PHARMACEUTICALS-JO-H14001-24-07578$HIKMA$Jadallah RK, Al Sharie AH, Alzghoul SM, Al-Karaki JW, Bani Amer MS, Rawashdeh TH, et al.. Jadallah RK, Al Sharie AH, Alzghoul SM, Al-Karaki JW, Bani Amer MS, Rawashdeh TH, Alshari O. Palbociclib and fulvestrant combined regimen induced prolonged bone metastasis control of stage IV hr+/her2- breast cancer: A case report. Radiology Case Reports. 2024;19(9):4049-4054$58$YR$$F$Y$$$20240815$$MD$JO$JO
242122501$24212250$1$I$20240607$20240807$20240815$20240815$EXP$$CN-AstraZeneca-2024A181640$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$CN$
242122512$24212251$2$F$$20240826$20240815$20240904$EXP$$DE-TEVA-VS-3231804$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience wi...$4$YR$$M$Y$$$20240904$$HP$DE$DE
242122521$24212252$1$I$20240726$20240809$20240815$20240815$EXP$$CN-ABBVIE-5879285$ABBVIE$$64$YR$$F$Y$$$20240815$$HP$CN$CN
242122532$24212253$2$F$$20240813$20240815$20240815$EXP$$US-ROCHE-10000056437$ROCHE$$$$$$Y$$$20240815$$CN$US$US
242122542$24212254$2$F$20240807$20240913$20240815$20240918$EXP$$US-ABBVIE-5879516$ABBVIE$$62$YR$$F$Y$77$KG$20240918$$CN$US$US
242122561$24212256$1$I$20240101$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160932$AMGEN$$58$YR$A$M$Y$$$20240814$$CN$US$US
242122571$24212257$1$I$20231122$20240812$20240815$20240815$EXP$ES-AEMPS-1555131$ES-AMGEN-ESPSP2024160096$AMGEN$$45$YR$A$F$Y$$$20240814$$MD$ES$ES
242122582$24212258$2$F$$20240820$20240815$20240829$EXP$$US-INTERCEPT-PM2024001545$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242122592$24212259$2$F$20240601$20240906$20240815$20240916$EXP$$GR-CELLTRION INC.-2024GR019302$CELLTRION$$$$$$Y$$$20240916$$CN$GR$GR
242122601$24212260$1$I$$20240805$20240815$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125920$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240815$$MD$JP$JP
242122611$24212261$1$I$$20240812$20240815$20240815$EXP$$CA-ABBVIE-5879006$ABBVIE$$$$A$F$Y$$$20240815$$CN$CA$CA
242122621$24212262$1$I$20240701$20240812$20240815$20240815$EXP$$IT-ABBVIE-5879455$ABBVIE$$74$YR$$M$Y$$$20240815$$CN$IT$IT
242122631$24212263$1$I$$20240806$20240815$20240815$PER$$US-ABBVIE-5870565$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242122641$24212264$1$I$$20240813$20240815$20240815$EXP$$IT-ABBVIE-5880522$ABBVIE$$71$YR$$M$Y$$$20240815$$CN$IT$IT
242122651$24212265$1$I$20240101$20240812$20240815$20240815$EXP$$CA-ABBVIE-5878145$ABBVIE$$46$YR$$F$Y$$$20240815$$CN$CA$CA
242122661$24212266$1$I$20240601$20240809$20240815$20240815$EXP$$US-JNJFOC-20240828512$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240815$$PH$US$US
242122671$24212267$1$I$20240404$20240802$20240815$20240815$EXP$$FR-AUROBINDO-AUR-APL-2024-039571$AUROBINDO$$60$YR$$M$Y$$$20240815$$PH$FR$FR
242122681$24212268$1$I$20240429$20240805$20240815$20240815$EXP$FR-AFSSAPS-AM2024000634$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110899$ZYDUS PHARM$$$$$$Y$$$20240814$$MD$FR$FR
242122691$24212269$1$I$20240627$20240805$20240815$20240815$EXP$ES-AEMPS-1557574$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-110867$ZYDUS PHARM$$$$$$Y$$$20240814$$MD$ES$ES
242122701$24212270$1$I$20160315$20240805$20240815$20240815$EXP$FR-AFSSAPS-PP2024000859$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110926$ZYDUS PHARM$$$$$$Y$$$20240814$$MD$FR$FR
242122711$24212271$1$I$20240601$20240805$20240815$20240815$EXP$FR-AFSSAPS-RS2024000767$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110928$ZYDUS PHARM$$$$$$Y$$$20240814$$CN$FR$FR
242122721$24212272$1$I$20221201$20240805$20240815$20240815$EXP$FR-AFSSAPS-PC2024000636$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110915$ZYDUS PHARM$$$$$$Y$$$20240814$$CN$FR$FR
242122731$24212273$1$I$20240229$20240805$20240815$20240815$EXP$FR-AFSSAPS-TO2024001483$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110943$ZYDUS PHARM$$$$$$Y$$$20240814$$PH$FR$FR
242122741$24212274$1$I$20240309$20240805$20240815$20240815$EXP$FR-AFSSAPS-AVMA2024000343$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110937$ZYDUS PHARM$$$$$$Y$$$20240814$$PH$FR$FR
242122751$24212275$1$I$$20240805$20240815$20240815$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110896$ZYDUS PHARM$Puthumana RM, Mintz J, Perez M, Gaddipati S, Gorman D.. Too much of a good thing: A case of beta blocker and warfarin toxicity.. Am-J-Respir-Crit-Care-Med. 2024;209:A5692$$$$$Y$$$20240814$$HP$US$US
242122761$24212276$1$I$20240401$20240812$20240815$20240815$PER$$US-ALXN-202408USA000682US$ALEXION PHARMACEUTICALS$$72$YR$$F$Y$$$20240815$$CN$US$US
242122771$24212277$1$I$20240812$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128622$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240815$$CN$US$US
242122781$24212278$1$I$20240711$20240802$20240815$20240815$EXP$$IT-AUROBINDO-AUR-APL-2024-039546$AUROBINDO$$68$YR$$F$Y$$$20240815$$MD$IT$IT
242122791$24212279$1$I$$20240801$20240815$20240815$PER$$US-TEVA-VS-3229391$TEVA$$72$YR$$F$Y$$$20240815$$PH$US$US
242122801$24212280$1$I$$20240812$20240815$20240815$PER$$US-ABBVIE-5878456$ABBVIE$$$$$$Y$$$20240815$$CN$US$US
242122811$24212281$1$I$20240605$20240806$20240815$20240815$EXP$$PK-ROCHE-10000049986$ROCHE$$44$YR$A$M$Y$55$KG$20240815$$CN$PK$PK
242122821$24212282$1$I$20240601$20240814$20240815$20240815$EXP$ES-AEMPS-1555763$ES-ROCHE-10000057416$ROCHE$$43$YR$A$M$Y$84$KG$20240815$$PH$ES$ES
242122831$24212283$1$I$$20240808$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408006381$ELI LILLY AND CO$$$$$$Y$$$20240815$$CN$US$US
242122841$24212284$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008952$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240815$$CN$US$US
242122851$24212285$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007187$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240815$$CN$US$US
242122861$24212286$1$I$20240701$20240808$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008126$ELI LILLY AND CO$$$$$F$Y$$$20240815$$CN$US$US
242122871$24212287$1$I$20240401$20240808$20240815$20240815$EXP$$JP-AMGEN-JPNSP2024158597$AMGEN$$$$$$Y$$$20240815$$PH$JP$JP
242122882$24212288$2$F$20240812$20240821$20240815$20240824$PER$$US-AMGEN-USASP2024161556$AMGEN$$43$YR$A$F$Y$$$20240824$$MD$US$US
242122891$24212289$1$I$20240805$20240809$20240815$20240815$EXP$$CN-ABBVIE-5874282$ABBVIE$$66$YR$$M$Y$67$KG$20240815$$MD$CN$CN
242122901$24212290$1$I$$20240808$20240815$20240815$PER$$US-AstraZeneca-2024A181908$ASTRAZENECA$$$$$$Y$$$20240815$$MD$US$
242122911$24212291$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231809$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$10$YR$$M$Y$$$20240815$$HP$DE$DE
242122921$24212292$1$I$20240805$20240806$20240815$20240815$PER$$US-RDY-SPO/USA/24/0011673$DR REDDYS$$15$YR$T$F$Y$$$20240815$$PH$US$US
242122932$24212293$2$F$20240809$20240830$20240815$20240830$PER$$US-ALXN-202408USA000732US$ALEXION PHARMACEUTICALS$$41$YR$$M$Y$$$20240830$$CN$US$US
242122941$24212294$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA240122$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240815$$CN$US$US
242122952$24212295$2$F$$20240813$20240815$20240821$EXP$$AR-GSK-AR2024AMR099691$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$AR$AR
242122961$24212296$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA238876$SANOFI AVENTIS$$$$A$M$Y$$$20240815$$MD$US$US
242122971$24212297$1$I$20221001$20230612$20240815$20240815$EXP$$US-AstraZeneca-2023A138196$ASTRAZENECA$$802$MON$$F$Y$$$20240815$$CN$US$
242122981$24212298$1$I$20240723$20240813$20240815$20240815$EXP$$CN-ROCHE-10000056453$ROCHE$$63$YR$A$M$Y$58.5$KG$20240815$$HP$CN$CN
242122991$24212299$1$I$20240515$20240814$20240815$20240815$EXP$FR-AFSSAPS-NT2024001019$FR-ROCHE-10000057310$ROCHE$$45$YR$A$M$Y$73$KG$20240815$$MD$FR$FR
242123001$24212300$1$I$$20240805$20240815$20240815$PER$$US-ROCHE-10000050909$ROCHE$Jones A, Martin J, Giangiacomo A, Costakos D. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024-Dec;36:1-4. doi:10.1016/j.ajoc.2024.102131.$$$I$M$Y$$$20240815$$HP$US$US
242123012$24212301$2$F$$20240902$20240815$20240911$EXP$$JP-ROCHE-10000054577$ROCHE$Saburi M, Nishikawa T, Miyazaki Y. A retrospective study of VenR therapy for CLL/SLL.. The Journal of the Japanese Society for Lymphoreticular Tissue Research. 2024-May-30;64 (95):$$$$$Y$$$20240911$$HP$JP$JP
242123021$24212302$1$I$20240527$20240813$20240815$20240815$EXP$$GB-ABBVIE-5879548$ABBVIE$$55$YR$$F$Y$96$KG$20240815$$HP$GB$GB
242123031$24212303$1$I$$20240814$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128879$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240815$$CN$US$US
242123041$24212304$1$I$20240601$20240807$20240815$20240815$EXP$$US-UCBSA-2024037017$UCB$$58$YR$$F$Y$$$20240815$$CN$US$US
242123051$24212305$1$I$$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008392$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240815$$CN$US$US
242123061$24212306$1$I$20240701$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408006557$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240815$$CN$US$US
242123071$24212307$1$I$$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008402$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240815$$CN$US$US
242123081$24212308$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231835$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$12$YR$$M$Y$$$20240815$$HP$DE$DE
242123091$24212309$1$I$20240101$20240807$20240815$20240815$PER$$US-SA-2024SA239465$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240815$$MD$US$US
242123101$24212310$1$I$20240101$20240808$20240815$20240815$PER$$US-SA-2024SA240523$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240815$$MD$US$US
242123111$24212311$1$I$20240622$20240813$20240815$20240815$EXP$$CN-ROCHE-10000056406$ROCHE$$51$YR$A$M$Y$$$20240815$$HP$CN$CN
242123121$24212312$1$I$$20240808$20240815$20240815$30DAY$$US-GSK-US2024099276$GLAXOSMITHKLINE$$$$A$F$Y$$$20240815$$CN$US$US
242123131$24212313$1$I$$20240802$20240815$20240815$EXP$$GB-CELLTRION INC.-2024GB019557$CELLTRION$$$$$$Y$$$20240815$$MD$GB$GB
242123142$24212314$2$F$20240808$20240820$20240815$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128744$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240829$$CN$US$US
242123151$24212315$1$I$$20240812$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127838$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240815$$CN$US$US
242123161$24212316$1$I$$20240808$20240815$20240815$EXP$$EG-UCBSA-2024040262$UCB$Rafik A, El-Din NS, El Khayat NM, Nada M, Abushady EM. Effect of anti-epileptic drugs usage on thyroid profile in Egyptian epileptic children. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2024;60(1):3:1-18$$$C$$Y$$$20240815$$HP$EG$EG
242123171$24212317$1$I$$20240726$20240815$20240815$EXP$$GB-CELLTRION INC.-2024GB019496$CELLTRION$$$$$$Y$$$20240815$$CN$GB$GB
242123181$24212318$1$I$20230101$20240809$20240815$20240815$EXP$$US-BIOGEN-2024BI01277896$BIOGEN$$$$$M$Y$$$20240815$$CN$US$US
242123192$24212319$2$F$$20240820$20240815$20240829$EXP$$US-TEVA-VS-3230836$TEVA$Chumsky J, Kahn PJ, Carroll WL, Pierce KA, Hillier K. Lupus anti-coagulant hypoprothrombinemia syndrome across different ages: a case report and review of the literature. Clin-Rheumatol 2023; 42 (8): 2231-2236.; Chumsky J, Kahn PJ, Carroll WL, Pierce KA, Hillier K. Lupus anti-coagulant hypoprothrombinemia syndrome across different ages: a case report and review of the literature. Clin-Rheumatol 2023; 42 (8): 2231-2236.; Chumsky J, Kahn PJ, Carroll WL, Pierce KA, Hillier K. Lupus anti-coagulan...$$$$F$Y$$$20240829$$HP$US$US
242123201$24212320$1$I$20240601$20240812$20240815$20240815$EXP$$BR-BIOGEN-2024BI01278173$BIOGEN$$$$A$F$Y$$$20240815$$HP$BR$BR
242123211$24212321$1$I$20240701$20240813$20240815$20240815$EXP$$CR-ROCHE-10000056322$ROCHE$$76$YR$E$M$Y$$$20240815$$MD$CR$CR
242123221$24212322$1$I$$20240806$20240815$20240815$EXP$$US-VIIV HEALTHCARE LIMITED-US2024098099$VIIV$$$$$M$Y$$$20240815$$CN$US$US
242123231$24212323$1$I$20211219$20240809$20240815$20240815$EXP$$JP-009507513-2407JPN004697J$MERCK$$76$YR$$M$Y$52$KG$20240815$$MD$JP$JP
242123241$24212324$1$I$20240806$20240806$20240815$20240815$PER$$US-RDY-SPO/USA/24/0011677$DR REDDYS$$34$YR$A$F$Y$$$20240815$$CN$US$US
242123251$24212325$1$I$$20240806$20240815$20240815$PER$$US-RDY-SPO/USA/24/0011679$DR REDDYS$$$$$F$Y$$$20240815$$MD$US$US
242123261$24212326$1$I$20240601$20240813$20240815$20240815$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-128543$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240815$$CN$PR$PR
242123271$24212327$1$I$$20240809$20240815$20240815$EXP$$US-ABBVIE-5879388$ABBVIE$$$$$$Y$$$20240815$$MD$US$US
242123281$24212328$1$I$20240406$20240813$20240815$20240815$EXP$$IN-ROCHE-10000057204$ROCHE$$69$YR$E$M$Y$$$20240815$$CN$IN$IN
242123291$24212329$1$I$20240425$20240805$20240815$20240815$EXP$$CN-ROCHE-10000049679$ROCHE$$72$YR$E$F$Y$$$20240815$$CN$CN$CN
242123301$24212330$1$I$20240716$20240808$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012433$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242123312$24212331$2$F$20240101$20240910$20240815$20240914$PER$$US-ROCHE-10000049844$ROCHE$$$$C$M$Y$$$20240914$$CN$US$US
242123321$24212332$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008170$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240815$$CN$US$US
242123331$24212333$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202405018413$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240815$$CN$US$US
242123341$24212334$1$I$20240807$20240807$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408005400$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240815$$CN$US$US
242123351$24212335$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160498$AMGEN$$$$$F$Y$$$20240815$$CN$US$US
242123362$24212336$2$F$$20240821$20240815$20240822$PER$$NVSC2024US165350$NOVARTIS$$$$$$Y$$$20240822$$MD$US$US
242123371$24212337$1$I$$20240809$20240815$20240815$EXP$$GB-CELLTRION INC.-2024GB019447$CELLTRION$$$$$$Y$$$20240815$$CN$GB$GB
242123381$24212338$1$I$20240810$20240810$20240815$20240815$PER$$US-SA-2024SA240641$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240815$$MD$US$US
242123391$24212339$1$I$20240101$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024161324$AMGEN$$57$YR$A$F$Y$$$20240815$$CN$US$US
242123401$24212340$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160949$AMGEN$$$$$$Y$$$20240815$$MD$US$US
242123412$24212341$2$F$$20240827$20240815$20240904$EXP$$JP-AMGEN-JPNSP2024161191$AMGEN$$$$$$Y$$$20240904$$PH$JP$JP
242123421$24212342$1$I$20240718$20240809$20240815$20240815$EXP$$DE-ABBVIE-5877101$ABBVIE$$56$YR$$F$Y$$$20240815$$CN$DE$DE
242123451$24212345$1$I$20240604$20240804$20240815$20240815$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK093121$GLENMARK$$$$$$Y$$$20240815$$CN$GB$GB
242123461$24212346$1$I$20240701$20240731$20240815$20240815$PER$$US-TEVA-VS-3228865$TEVA$$30$YR$$M$Y$81.65$KG$20240815$$CN$US$US
242123471$24212347$1$I$$20240805$20240815$20240815$PER$$US-BAUSCHBL-2024BNL031208$BAUSCH AND LOMB$$$$$F$Y$$$20240815$$CN$US$US
242123481$24212348$1$I$$20240814$20240815$20240815$EXP$$IN-ROCHE-10000056847$ROCHE$$74$YR$E$M$Y$$$20240815$$CN$IN$IN
242123491$24212349$1$I$20240308$20240808$20240815$20240815$EXP$FR-AFSSAPS-NT2024000990$FR-CHEPLA-2024010437$CHEPLAPHARM$$69$YR$$M$Y$73$KG$20240815$$MD$COUNTRY NOT SPECIFIED$FR
242123501$24212350$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128410$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$66.22$KG$20240815$$HP$US$US
242123511$24212351$1$I$20240624$20240813$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128793$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240815$$CN$US$US
242123521$24212352$1$I$20240812$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160762$AMGEN$$$$$$Y$$$20240815$$HP$US$US
242123531$24212353$1$I$$20240814$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128954$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$80.29$KG$20240815$$CN$US$US
242123541$24212354$1$I$20240701$20240806$20240815$20240815$PER$$US-SA-2024SA238027$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240815$$MD$US$US
242123551$24212355$1$I$$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A182763$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242123561$24212356$1$I$$20240806$20240815$20240815$PER$$US-SA-2024SA239455$SANOFI AVENTIS$$$$T$F$Y$$$20240815$$MD$US$US
242123571$24212357$1$I$$20240806$20240815$20240815$30DAY$$DE-SA-2024SA235526$SANOFI AVENTIS$$$$A$$Y$$$20240815$$HP$DE$DE
242123581$24212358$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA238208$SANOFI AVENTIS$$$$A$F$Y$$$20240815$$MD$US$US
242123591$24212359$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA240124$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240815$$CN$US$US
242123601$24212360$1$I$20191101$20240807$20240815$20240815$EXP$$US-CHEPLA-3000026613$CHEPLAPHARM$$59$YR$$F$Y$79.379$KG$20240815$$CN$COUNTRY NOT SPECIFIED$US
242123611$24212361$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160403$AMGEN$$$$$$Y$$$20240815$$CN$US$US
242123631$24212363$1$I$$20240812$20240815$20240815$PER$$US-ROCHE-10000055664$ROCHE$$68$YR$E$M$Y$$$20240815$$CN$US$US
242123641$24212364$1$I$$20240808$20240815$20240815$30DAY$$US-GSK-US2024099249$GLAXOSMITHKLINE$$$$A$M$Y$$$20240815$$CN$US$US
242123652$24212365$2$F$20240101$20240814$20240815$20240827$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US000042$PAREXEL$$$$$$Y$$$20240827$$CN$US$US
242123661$24212366$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160338$AMGEN$$$$$M$Y$$$20240815$$CN$US$US
242123671$24212367$1$I$$20240807$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125441$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240815$$HP$US$US
242123681$24212368$1$I$$20240813$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128702$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240815$$CN$US$US
242123692$24212369$2$F$$20240910$20240815$20240914$EXP$$US-GILEAD-2024-0683921$GILEAD$$74$YR$E$F$Y$$$20240914$$CN$US$US
242123701$24212370$1$I$$20240813$20240815$20240815$PER$$US-ROCHE-10000056910$ROCHE$$$$E$M$Y$$$20240815$$CN$US$US
242123711$24212371$1$I$20240801$20240807$20240815$20240815$PER$$US-ABBVIE-5872182$ABBVIE$$50$YR$$F$Y$$$20240815$$CN$US$US
242123721$24212372$1$I$20240301$20240807$20240815$20240815$EXP$$BR-ROCHE-10000052642$ROCHE$$67$YR$E$M$Y$$$20240815$$MD$BR$BR
242123731$24212373$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008533$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240815$$CN$US$US
242123741$24212374$1$I$20240101$20240810$20240815$20240815$EXP$$CA-ABBVIE-5877561$ABBVIE$$50$YR$$F$Y$$$20240815$$CN$CA$CA
242123752$24212375$2$F$$20240813$20240815$20240821$PER$$US-AMGEN-USASP2024161774$AMGEN$$$$$F$Y$$$20240821$$HP$US$US
242123761$24212376$1$I$20240722$20240808$20240815$20240815$PER$$US-SA-2024SA240167$SANOFI AVENTIS$$35$YR$A$M$Y$70.3$KG$20240815$$MD$US$US
242123772$24212377$2$F$$20240910$20240815$20240919$PER$$US-SA-2024SA240626$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240919$$MD$US$US
242123781$24212378$1$I$$20240812$20240815$20240815$EXP$$US-ABBVIE-5877964$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242123791$24212379$1$I$20240101$20240813$20240815$20240815$EXP$$US-ABBVIE-5880442$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242123801$24212380$1$I$$20240812$20240815$20240815$EXP$$US-ABBVIE-5878708$ABBVIE$$$$$F$Y$$$20240815$$HP$US$US
242123812$24212381$2$F$20210617$20240912$20240815$20240917$EXP$$CA-JNJFOC-20240319524$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240917$$CN$CA$CA
242123821$24212382$1$I$20240807$20240813$20240815$20240815$EXP$$CN-ROCHE-10000056400$ROCHE$$26$YR$A$F$Y$$$20240815$$HP$CN$CN
242123843$24212384$3$F$20240801$20240911$20240815$20240914$PER$$US-AMGEN-USASP2024160929$AMGEN$$44$YR$A$F$Y$$$20240914$$PH$US$US
242123851$24212385$1$I$$20240806$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125443$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240815$$HP$US$US
242123871$24212387$1$I$20220301$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129033$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$75.75$KG$20240815$$PH$US$US
242123881$24212388$1$I$20231213$20240529$20240815$20240815$EXP$$US-009507513-2408USA005081$MERCK$$56$YR$$M$Y$$$20240815$$HP$US$US
242123891$24212389$1$I$20240101$20240812$20240815$20240815$EXP$$US-ABBVIE-5878791$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242123901$24212390$1$I$20240501$20240808$20240815$20240815$PER$$US-SA-2024SA239604$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240815$$MD$US$US
242123911$24212391$1$I$20240701$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A180874$ASTRAZENECA$$21087$DY$$F$Y$56.7$KG$20240815$$CN$US$
242123921$24212392$1$I$$20240812$20240815$20240815$PER$$US-ABBVIE-5877795$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242123931$24212393$1$I$$20240813$20240815$20240815$PER$$US-GILEAD-2024-0684159$GILEAD$$$$$$Y$$$20240815$$LW$US$US
242123941$24212394$1$I$20240809$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161364$AMGEN$$68$YR$E$F$Y$$$20240815$$CN$US$US
242123952$24212395$2$F$$20240812$20240815$20240815$EXP$$US-ROCHE-10000055832$ROCHE$$$$A$M$Y$$$20240815$$CN$US$US
242123964$24212396$4$F$20240223$20240913$20240815$20240920$EXP$$GB-EXELIXIS-XL18424074673$EXELIXIS$$$$$$Y$$$20240920$$MD$GB$GB
242123971$24212397$1$I$$20240805$20240815$20240815$EXP$$US-PBT-009631$PANACEA BIOTEC$Dykes K, Tzachanis D, Koura D. A Difficult Case of Calcineurin Inhibitor Neurotoxicity Post-Haploidentical HCT With a Successful Novel Solution: Cytotoxic T-Lymphocyte-Associated Protein 4-Immunoglobulin Blockade for GVHD Prophylaxis. Cell Transplant. 2024 Jan-Dec;33:9636897241265249. doi: 10.1177/09636897241265249.$24$YR$A$M$Y$$$20240814$$HP$US$US
242123981$24212398$1$I$20240731$20240812$20240815$20240815$EXP$$CN-ROCHE-10000055538$ROCHE$$48$YR$A$F$Y$$$20240815$$HP$CN$CN
242123991$24212399$1$I$$20240813$20240815$20240815$PER$$NVSC2024US165382$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
242124001$24212400$1$I$$20240809$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127039$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$60.7$KG$20240815$$HP$US$US
242124011$24212401$1$I$$20240808$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126568$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240815$$HP$US$US
242124021$24212402$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128541$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240815$$CN$US$US
242124031$24212403$1$I$20240531$20240806$20240815$20240815$PER$$US-SA-2024SA238233$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240815$$MD$US$US
242124041$24212404$1$I$20240101$20240807$20240815$20240815$EXP$$CA-CELLTRION INC.-2024CA002339$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
242124051$24212405$1$I$20240101$20240807$20240815$20240815$PER$$US-SA-2024SA238685$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240815$$CN$US$US
242124061$24212406$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008199$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240815$$CN$US$US
242124071$24212407$1$I$20240725$20240814$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009165$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240815$$CN$US$US
242124081$24212408$1$I$$20240806$20240815$20240815$EXP$GB-MHRA-MED-202408061515580660-ZSMPB$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-07597$HIKMA$$89$YR$$F$Y$$$20240815$$PH$GB$GB
242124091$24212409$1$I$$20240808$20240815$20240815$EXP$$US-GSK-US2024099179$GLAXOSMITHKLINE$$$$$F$Y$$$20240815$$CN$US$US
242124101$24212410$1$I$20240730$20240807$20240815$20240815$EXP$$PE-UCBSA-2024040358$UCB$$54$YR$$M$Y$$$20240815$$CN$PE$PE
242124111$24212411$1$I$20240724$20240812$20240815$20240815$EXP$$CN-ROCHE-10000055650$ROCHE$$51$YR$A$F$Y$61$KG$20240815$$HP$CN$CN
242124121$24212412$1$I$20240714$20240808$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012437$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242124142$24212414$2$F$20231101$20240828$20240815$20240903$EXP$$JP-009507513-2407JPN002401J$MERCK$$64$YR$$M$Y$41$KG$20240903$$MD$JP$JP
242124151$24212415$1$I$20240810$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160034$AMGEN$$10$YR$C$M$Y$45.9$KG$20240815$$PH$US$US
242124161$24212416$1$I$20240701$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A180914$ASTRAZENECA$$760$MON$$F$Y$225.8$KG$20240815$$CN$US$
242124171$24212417$1$I$$20240813$20240815$20240815$EXP$$US-ABBVIE-5880360$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242124181$24212418$1$I$$20240809$20240815$20240815$PER$$US-ABBVIE-5878894$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242124192$24212419$2$F$20190321$20240902$20240815$20240913$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07337$HIKMA$$$$$$Y$$$20240913$$HP$US$US
242124201$24212420$1$I$20240802$20240812$20240815$20240815$EXP$$CN-ROCHE-10000055373$ROCHE$$84$YR$E$F$Y$46.5$KG$20240815$$HP$CN$CN
242124213$24212421$3$F$20240815$20240820$20240815$20240827$PER$$US-SA-2024SA239552$SANOFI AVENTIS$$72$YR$E$M$Y$105$KG$20240827$$CN$US$US
242124221$24212422$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3232486$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$15$YR$$M$Y$$$20240815$$HP$DE$DE
242124231$24212423$1$I$20240726$20240809$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126889$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240815$$PH$US$US
242124241$24212424$1$I$20240101$20240807$20240815$20240815$PER$$US-SA-2024SA239023$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240815$$MD$US$US
242124252$24212425$2$F$20240101$20240919$20240815$20240928$EXP$$CA-CELLTRION INC.-2024CA005155$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
242124261$24212426$1$I$$20240810$20240815$20240815$EXP$$US-AMGEN-USASP2024159679$AMGEN$$$$$$Y$$$20240815$$LW$US$US
242124271$24212427$1$I$$20240802$20240815$20240815$EXP$$JP-AMGEN-JPNSP2024159087$AMGEN$Fujisawa Y, Horita S, Wakabayashi K.. Efficacy of sutimlimab for cold agglutinin disease in a patient on chronic hemodialysis. CEN Case Reports. 2024$73$YR$E$M$Y$$$20240815$$MD$JP$JP
242124281$24212428$1$I$$20240723$20240815$20240815$EXP$$GB-CELLTRION INC.-2024GB019534$CELLTRION$$$$$$Y$$$20240815$$PH$GB$GB
242124291$24212429$1$I$$20240808$20240815$20240815$EXP$$US-CHEPLA-2024010355$CHEPLAPHARM$$$$$M$Y$$$20240815$$CN$COUNTRY NOT SPECIFIED$US
242124302$24212430$2$F$20240701$20240905$20240815$20240915$EXP$$JP-ROCHE-10000055705$ROCHE$$62$YR$A$M$Y$$$20240915$$PH$JP$JP
242124311$24212431$1$I$20240811$20240813$20240815$20240815$EXP$$US-ABBVIE-5879560$ABBVIE$$56$YR$$M$Y$$$20240815$$PH$US$US
242124321$24212432$1$I$$20240807$20240815$20240815$EXP$IT-CELLTRION INC.-2024IT016289$IT-ROCHE-10000052513$ROCHE$Musone D, Nicosia V, D^Alessandro R, Andrietti M, Steri PF, Ruosi C et. al. Therapeutic plasmapheresis in idiopathic membranous nephropathy anti-PLA2R-related: A case series. J Clin Apher. 2024;39(3):e22134. doi:doi: 10.1002/jca.22134.$69$YR$E$M$Y$$$20240815$$HP$IT$IT
242124332$24212433$2$F$20240101$20240910$20240815$20240913$EXP$$US-ABBVIE-5877870$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
242124341$24212434$1$I$20240101$20240813$20240815$20240815$EXP$$US-ABBVIE-5847222$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242124351$24212435$1$I$20240101$20240812$20240815$20240815$EXP$$US-ABBVIE-5878836$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242124361$24212436$1$I$20240802$20240812$20240815$20240815$EXP$$US-ABBVIE-5878704$ABBVIE$$58$YR$$F$Y$$$20240815$$CN$US$US
242124372$24212437$2$F$20240801$20240814$20240815$20240822$PER$$US-ALXN-202408USA000368US$ALEXION PHARMACEUTICALS$$47$YR$$F$Y$$$20240822$$CN$US$US
242124381$24212438$1$I$20240405$20240808$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126244$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240815$$CN$US$US
242124391$24212439$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231786$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$12$YR$$F$Y$$$20240815$$HP$DE$DE
242124401$24212440$1$I$$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A180337$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242124411$24212441$1$I$$20220411$20240815$20240815$EXP$$US-AstraZeneca-2022A148806$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242124421$24212442$1$I$$20221115$20240815$20240815$EXP$$US-AstraZeneca-2022A379157$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242124432$24212443$2$F$$20240814$20240815$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408008708$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240818$$HP$US$US
242124441$24212444$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008267$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240815$$CN$US$US
242124451$24212445$1$I$20230101$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408005800$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240815$$CN$US$US
242124461$24212446$1$I$20240601$20240814$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009023$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240815$$CN$US$US
242124471$24212447$1$I$$20240805$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408003707$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240815$$CN$US$US
242124481$24212448$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008202$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240815$$CN$US$US
242124491$24212449$1$I$20240620$20240807$20240815$20240815$PER$$US-ABBVIE-5872742$ABBVIE$$29$YR$$F$Y$96.6$KG$20240815$$MD$US$US
242124501$24212450$1$I$20240808$20240809$20240815$20240815$EXP$$CA-CELLTRION INC.-2024CA019420$CELLTRION$$$$$$Y$$$20240815$$MD$CA$CA
242124512$24212451$2$F$20240101$20240913$20240815$20240918$EXP$$US-ABBVIE-5879293$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
242124522$24212452$2$F$20230901$20240924$20240815$20240930$EXP$$US-ABBVIE-5878642$ABBVIE$$53$YR$$M$Y$61$KG$20240930$$CN$US$US
242124532$24212453$2$F$$20240910$20240815$20240917$EXP$$US-ABBVIE-5880405$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
242124543$24212454$3$F$20230301$20240917$20240815$20240922$EXP$$JP-009507513-2408JPN001394J$MERCK$$2$DEC$$M$Y$$$20240922$$MD$JP$JP
242124551$24212455$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA049170$SANOFI AVENTIS$$$$E$M$Y$$$20240815$$MD$US$US
242124561$24212456$1$I$$20240809$20240815$20240815$EXP$$ES-AMGEN-ESPSP2024159013$AMGEN$Martinez-selles M.; Valero-masa M. J.; Ortiz-bautista C. D. et al.. Optimization of Hypercholesterolemia Treatment after Heart Transplant: The Role of PCSK9 Inhibitors. Current Pharmaceutical Design. 2024;30:1-4$$$$M$Y$$$20240815$$HP$ES$ES
242124571$24212457$1$I$20230701$20240802$20240815$20240815$EXP$$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-07533$HIKMA$$61$YR$$F$Y$84$KG$20240815$$PH$GB$GB
242124581$24212458$1$I$20240809$20240810$20240815$20240815$EXP$$CN-ROCHE-10000054491$ROCHE$$50$YR$A$M$Y$$$20240815$$MD$CN$CN
242124591$24212459$1$I$20240805$20240812$20240815$20240815$EXP$$US-ABBVIE-5879022$ABBVIE$$79$YR$$F$Y$$$20240815$$CN$US$US
242124601$24212460$1$I$20240801$20240813$20240815$20240815$EXP$$AU-ABBVIE-5880367$ABBVIE$$84$YR$$F$Y$$$20240815$$CN$AU$AU
242124611$24212461$1$I$$20240806$20240815$20240815$PER$$US-SA-2024SA238133$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240815$$MD$US$US
242124621$24212462$1$I$$20240719$20240815$20240815$EXP$$GB-CELLTRION INC.-2024GB019477$CELLTRION$$$$$$Y$$$20240815$$HP$GB$GB
242124632$24212463$2$F$$20240917$20240815$20240926$EXP$$JP-SA-2024SA235775$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240926$$HP$JP$JP
242124641$24212464$1$I$$20240807$20240815$20240815$PER$$US-ALXN-202408USA000486US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240815$$CN$US$US
242124651$24212465$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128906$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240815$$HP$US$US
242124671$24212467$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231601$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$13$YR$$M$Y$$$20240815$$HP$DE$DE
242124681$24212468$1$I$$20240809$20240815$20240815$EXP$$GB-JNJFOC-20240834459$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240815$$CN$GB$GB
242124692$24212469$2$F$$20240731$20240815$20240815$EXP$$CA-HLS-202401928$HLS THERAPEUTICS$$$$A$M$Y$$$20240815$$PH$CA$CA
242124701$24212470$1$I$20240101$20240808$20240815$20240815$EXP$$CA-CELLTRION INC.-2024CA019469$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
242124711$24212471$1$I$$20240808$20240815$20240815$EXP$$US-IMMUNOCORE, LTD-2024-IMC-002944$IMMUNOCORE$$$$A$$Y$$$20240815$$MD$US$US
242124722$24212472$2$F$20240618$20240809$20240815$20240822$EXP$$ES-HIKMA PHARMACEUTICALS-ES-H14001-24-07379$HIKMA$$79$YR$$M$Y$78$KG$20240822$$MD$ES$ES
242124731$24212473$1$I$$20240808$20240815$20240815$EXP$$US-RDY-LIT/USA/24/0011761$DR REDDYS$Monge J, Razavi M, Bao L, Patel SS. Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. American Journal of Hematology. 2023 Feb;99: 327-328. doi:10.1002/ajh.26930.$78$YR$E$M$Y$$$20240815$$HP$US$US
242124741$24212474$1$I$20240701$20240805$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408004917$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240815$$CN$US$US
242124751$24212475$1$I$$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161475$AMGEN$$$$$F$Y$$$20240815$$CN$US$US
242124761$24212476$1$I$20240410$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160526$AMGEN$$$$$F$Y$$$20240815$$HP$US$US
242124771$24212477$1$I$$20240805$20240815$20240815$EXP$$GB-CELLTRION INC.-2024GB019511$CELLTRION$$$$$$Y$$$20240815$$MD$GB$GB
242124782$24212478$2$F$20240601$20240821$20240815$20240826$EXP$JP-MMM-MPZWUCNB$JP-GSK-JP2024072396$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$JP$JP
242124791$24212479$1$I$$20240808$20240815$20240815$PER$$US-ROCHE-10000055873$ROCHE$$$$$$Y$$$20240815$$CN$US$US
242124801$24212480$1$I$$20240802$20240815$20240815$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07529$HIKMA$Vincent MN, Jaggers J, Fiske C, Phillips EJ, Stollings JL.. Vincent MN, Jaggers J, Fiske C, Phillips EJ, Stollings JL. Amikacin symmetrical drug-related intertriginous and flexural exanthema on the basis of neomycin cross-reactivity managed with desensitization and treating through.. Annals of Allergy, Asthma and Immunology. 2024;/:1-2$70$YR$$F$Y$$$20240815$$PH$US$US
242124811$24212481$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA239580$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240815$$MD$US$US
242124821$24212482$1$I$$20240812$20240815$20240815$PER$$US-ROCHE-10000055800$ROCHE$$$$A$M$Y$$$20240815$$MD$US$US
242124831$24212483$1$I$20230101$20240812$20240815$20240815$EXP$$CL-ABBVIE-5879558$ABBVIE$$$$$F$Y$$$20240815$$CN$CL$CL
242124842$24212484$2$F$20240601$20240911$20240815$20240917$EXP$$US-ABBVIE-5879305$ABBVIE$$66$YR$$M$Y$65.317$KG$20240917$$CN$US$US
242124851$24212485$1$I$20240812$20240813$20240815$20240815$EXP$$US-ABBVIE-5879533$ABBVIE$$40$YR$$M$Y$$$20240815$$CN$US$US
242124872$24212487$2$F$20240101$20240912$20240815$20240920$EXP$$CA-CELLTRION INC.-2024CA008299$CELLTRION$$$$$$Y$$$20240920$$MD$CA$CA
242124881$24212488$1$I$20240101$20240813$20240815$20240815$EXP$$US-ABBVIE-5880256$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242124891$24212489$1$I$20240101$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161574$AMGEN$$63$YR$A$F$Y$$$20240815$$CN$US$US
242124901$24212490$1$I$$20230612$20240815$20240815$EXP$$US-AstraZeneca-2023A137760$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242124911$24212491$1$I$$20240810$20240815$20240815$EXP$$US-AstraZeneca-2024A183308$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242124921$24212492$1$I$$20230715$20240815$20240815$EXP$$US-AstraZeneca-2023A163855$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242124931$24212493$1$I$20221208$20221213$20240815$20240815$EXP$$TW-AstraZeneca-2022A406245$ASTRAZENECA$$62$YR$$F$Y$$$20240815$$CN$TW$
242124941$24212494$1$I$$20231103$20240815$20240815$EXP$$US-AstraZeneca-2023A215484$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242124961$24212496$1$I$$20240812$20240815$20240815$EXP$$US-MTPC-MTDA2024-0017078$MITSUBISHI TANABE PHARMA$$$$E$M$Y$$$20240815$$CN$US$US
242124971$24212497$1$I$$20240813$20240815$20240815$EXP$$NVSC2024CA165176$NOVARTIS$$33$YR$$M$Y$$$20240815$$CN$CA$CA
242124981$24212498$1$I$$20240807$20240815$20240815$EXP$$CN-MTPC-MTPC2024-0016831$MITSUBISHI TANABE PHARMA$Xia, X L; Li, C G; Zheng, H; Guo, X X; Luo, K H; Sun, F; Zhang, M B; Tong, F; Sun, L Y. Application Research of Combined Therapy with Edaravone and Nimodipine in Endovascular Treatment for Aneurysmal Subarachnoid Hemorrhage.. Indian J.Pharm.Sci.. 2024;86:131-5$$$A$$Y$$$20240815$$MD$CN$CN
242124992$24212499$2$F$20240806$20240904$20240815$20240911$EXP$$JP-MTPC-MTPC2024-0015744$MITSUBISHI TANABE PHARMA$$9$DEC$$F$Y$$$20240911$$PH$JP$JP
242125001$24212500$1$I$20240201$20240814$20240815$20240815$EXP$$BR-GILEAD-2024-0684223$GILEAD$$$$$F$Y$$$20240815$$MD$BR$BR
242125011$24212501$1$I$20240804$20240813$20240815$20240815$EXP$$PK-ROCHE-10000056174$ROCHE$$64$YR$A$F$Y$$$20240815$$CN$PK$PK
242125021$24212502$1$I$$20240805$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR101503$VIIV$$$$$$Y$$$20240815$$HP$US$US
242125031$24212503$1$I$20240628$20240809$20240815$20240815$EXP$$US-ABBVIE-5867611$ABBVIE$$55$YR$$M$Y$$$20240815$$CN$US$US
242125041$24212504$1$I$$20240813$20240815$20240815$EXP$$CN-TAKEDA-2024TUS081383$TAKEDA$$$$$F$Y$$$20240815$$CN$CN$CN
242125052$24212505$2$F$$20240815$20240815$20240818$EXP$$CA-ROCHE-10000057752$ROCHE$$$$A$F$Y$$$20240818$$CN$CA$CA
242125061$24212506$1$I$20240118$20240808$20240815$20240815$EXP$$JP-ROCHE-10000056766$ROCHE$$75$YR$E$M$Y$75$KG$20240815$$MD$JP$JP
242125071$24212507$1$I$$20240809$20240815$20240815$EXP$$US-AstraZeneca-2024A182535$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242125081$24212508$1$I$$20230105$20240815$20240815$EXP$$TW-AstraZeneca-2023A004597$ASTRAZENECA$$57$YR$$M$Y$$$20240815$$CN$TW$
242125091$24212509$1$I$$20240802$20240815$20240815$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07554$HIKMA$$91$YR$$F$Y$$$20240815$$HP$CA$CA
242125111$24212511$1$I$$20240808$20240815$20240815$PER$$US-AMGEN-USASP2024159413$AMGEN$$$$$$Y$$$20240815$$CN$US$US
242125121$24212512$1$I$$20240808$20240815$20240815$EXP$US-drreddys-USA/USA/19/0116734$US-RDY-USA/USA/19/0116734$DR REDDYS$Lum EL, Datta N, Beaird O, Zuckerman J, Bunnapradist S, Schaenman J. Cutaneous Fungal Masses From Prior Environmental Injury Following Kidney Transplant: A Case Report. Transplantation Proceedings. 2019;51(9):3087-3091. DOI:10.1016/j.transproceed.2019.07.011$63$YR$A$M$Y$$$20240815$$MD$US$US
242125132$24212513$2$F$20240801$20240826$20240815$20240902$EXP$$JP-GSK-JP2024JPN099024$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$PH$JP$JP
242125141$24212514$1$I$20240101$20240806$20240815$20240815$PER$$US-SA-2024SA237696$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240815$$MD$US$US
242125151$24212515$1$I$20240514$20240802$20240815$20240815$EXP$$GB-CELLTRION INC.-2024GB019556$CELLTRION$$$$$$Y$$$20240815$$MD$GB$GB
242125161$24212516$1$I$$20240814$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128878$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240815$$HP$US$US
242125172$24212517$2$F$$20240912$20240815$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128781$BRISTOL MYERS SQUIBB$$15$YR$T$F$Y$$$20240913$$HP$US$US
242125181$24212518$1$I$$20240808$20240815$20240815$EXP$$JP-EXELIXIS-CABO-24080119$EXELIXIS$$$$$$Y$$$20240815$$MD$JP$JP
242125191$24212519$1$I$$20240802$20240815$20240815$EXP$$GB-AUROBINDO-AUR-APL-2024-039228$AUROBINDO$$85$YR$$$Y$$$20240815$$PH$GB$GB
242125201$24212520$1$I$20240101$20240811$20240815$20240815$EXP$$US-ABBVIE-5878489$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242125211$24212521$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008253$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240815$$CN$US$US
242125221$24212522$1$I$$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408006693$ELI LILLY AND CO$$$$$F$Y$$$20240815$$CN$US$US
242125231$24212523$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007736$ELI LILLY AND CO$$$$$F$Y$$$20240815$$CN$US$US
242125242$24212524$2$F$$20240814$20240815$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408006736$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$US$US
242125251$24212525$1$I$20240101$20240809$20240815$20240815$PER$$US-ABBVIE-5879453$ABBVIE$$$$$$Y$$$20240815$$CN$US$US
242125272$24212527$2$F$$20240820$20240815$20240821$PER$$NVSC2024US165414$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242125281$24212528$1$I$20240710$20240802$20240815$20240815$EXP$$GB-AUROBINDO-AUR-APL-2024-039248$AUROBINDO$$48$YR$$M$Y$127$KG$20240815$$CN$GB$GB
242125291$24212529$1$I$20240802$20240812$20240815$20240815$PER$$US-ABBVIE-5880590$ABBVIE$$21$YR$$F$Y$$$20240815$$MD$US$US
242125301$24212530$1$I$$20240722$20240815$20240815$PER$$US-ALK-ABELLO A/S-2024AA002979$ALK-ABELLO$$$$$$Y$$$20240815$$CN$US$US
242125311$24212531$1$I$20240101$20240807$20240815$20240815$PER$$US-SA-2024SA239305$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240815$$MD$US$US
242125324$24212532$4$F$20200602$20240906$20240815$20240911$PER$$US-GILEAD-2024-0684153$GILEAD$$39$YR$A$M$Y$$$20240911$$LW$US$US
242125331$24212533$1$I$$20240813$20240815$20240815$PER$$NVSC2024US165190$NOVARTIS$$$$$$Y$$$20240815$$CN$US$US
242125341$24212534$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA240502$SANOFI AVENTIS$$60$YR$A$M$Y$72$KG$20240815$$MD$US$US
242125351$24212535$1$I$$20240807$20240815$20240815$EXP$GB-MHRA-MED-202408071533046970-QKSWJ$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-07602$HIKMA$$$$$F$Y$85$KG$20240815$$PH$GB$GB
242125361$24212536$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129189$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240815$$CN$US$US
242125371$24212537$1$I$20240624$20240806$20240815$20240815$EXP$$GB-CELLTRION INC.-2024GB019518$CELLTRION$$$$$$Y$$$20240815$$CN$GB$GB
242125381$24212538$1$I$20240724$20240808$20240815$20240815$PER$$US-SA-2024SA237681$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240815$$HP$US$US
242125391$24212539$1$I$$20240812$20240815$20240815$EXP$$US-ROCHE-10000056236$ROCHE$$$$$F$Y$$$20240815$$CN$US$US
242125401$24212540$1$I$20240511$20240718$20240815$20240815$EXP$$GB-CELLTRION INC.-2024GB019478$CELLTRION$$$$$$Y$$$20240815$$MD$GB$GB
242125412$24212541$2$F$$20240826$20240815$20240903$EXP$$US-TEVA-VS-3230902$TEVA$Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant BK Virus Nephropathy. Exp-Clin-Transplant 2024; 22 (5): 392-395.; Sharma R, Gonzalez M, Chaudhary V, Villanueva D, Newman C, Danforth J, et al. Collapsing Glomerulopathy Leading To Rapidly Progressive Allograft Failure From Cytomegalovirus and SARS-CoV-2 Infection With Concomitant...$68$YR$$F$Y$$$20240903$$HP$US$US
242125421$24212542$1$I$$20240812$20240815$20240815$EXP$$CA-ROCHE-10000056146$ROCHE$$81$YR$E$F$Y$$$20240815$$HP$CA$CA
242125431$24212543$1$I$$20240801$20240815$20240815$EXP$$US-INSMED, INC.-2024-02176-US$INSMED$$$$$F$Y$$$20240815$$CN$US$US
242125442$24212544$2$F$20220101$20240809$20240815$20240821$EXP$$US-ABBVIE-5875209$ABBVIE$$$$$F$Y$56.699$KG$20240821$$CN$US$US
242125451$24212545$1$I$20240101$20240809$20240815$20240815$EXP$$US-ABBVIE-5875789$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242125461$24212546$1$I$20240802$20240802$20240815$20240815$EXP$$GB-AUROBINDO-AUR-APL-2024-039250$AUROBINDO$$51$YR$$F$Y$89$KG$20240815$$MD$GB$GB
242125472$24212547$2$F$20240101$20240813$20240815$20240820$EXP$$US-ABBVIE-5878250$ABBVIE$$$$$F$Y$63$KG$20240820$$CN$US$US
242125481$24212548$1$I$20240628$20240813$20240815$20240815$EXP$FR-AFSSAPS-LY2024001134$FR-ROCHE-10000056523$ROCHE$$40$YR$A$F$Y$135$KG$20240815$$PH$FR$FR
242125491$24212549$1$I$20240101$20240808$20240815$20240815$EXP$$JP-ABBVIE-5879561$ABBVIE$$$$$$Y$$$20240815$$MD$JP$JP
242125501$24212550$1$I$$20240813$20240815$20240815$EXP$$US-ROCHE-10000057574$ROCHE$$21$YR$A$F$Y$$$20240815$$MD$US$US
242125512$24212551$2$F$$20240812$20240815$20240821$PER$$US-AMGEN-USASP2024160653$AMGEN$$$$$M$Y$$$20240820$$HP$US$US
242125521$24212552$1$I$$20240813$20240815$20240815$PER$$US-ROCHE-10000056989$ROCHE$$62$YR$A$M$Y$$$20240815$$HP$US$US
242125532$24212553$2$F$$20240821$20240815$20240917$PER$$US-TRAVERE-2024TVT00679$TRAVERE THERAPEUTICS$$57$YR$A$F$Y$$$20240917$$CN$US$US
242125541$24212554$1$I$20240801$20240809$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128760$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240815$$HP$US$US
242125553$24212555$3$F$20240809$20240917$20240815$20240923$PER$$US-AMGEN-USASP2024159794$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
242125561$24212556$1$I$$20230901$20240815$20240815$EXP$$US-AstraZeneca-2023A201441$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242125571$24212557$1$I$$20220927$20240815$20240815$EXP$$US-AstraZeneca-2022A332674$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242125581$24212558$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008275$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240815$$CN$US$US
242125592$24212559$2$F$$20240909$20240815$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202408008293$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
242125601$24212560$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008627$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240815$$CN$US$US
242125611$24212561$1$I$$20240617$20240815$20240815$EXP$$NZ-ROCHE-10000025482$ROCHE$$$$$$Y$$$20240815$$MD$NZ$NZ
242125621$24212562$1$I$$20240812$20240815$20240815$EXP$$ZA-ROCHE-10000055308$ROCHE$$$$E$F$Y$$$20240815$$MD$ZA$ZA
242125641$24212564$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA239136$SANOFI AVENTIS$$$$A$F$Y$52.6$KG$20240815$$MD$US$US
242125651$24212565$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA239932$SANOFI AVENTIS$$$$T$F$Y$$$20240815$$MD$US$US
242125661$24212566$1$I$$20240812$20240815$20240815$EXP$$US-ABBVIE-5878263$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242125671$24212567$1$I$20240401$20240813$20240815$20240815$EXP$$US-ABBVIE-5871091$ABBVIE$$78$YR$$M$Y$92.986$KG$20240815$$CN$US$US
242125681$24212568$1$I$20240101$20240730$20240815$20240815$PER$$US-TEVA-VS-3228501$TEVA$$67$YR$$F$Y$$$20240815$$CN$US$US
242125692$24212569$2$F$20240801$20240812$20240815$20240822$EXP$$US-INSMED, INC.-2024-03165-US$INSMED$$68$YR$$F$Y$$$20240822$$CN$US$US
242125702$24212570$2$F$$20240823$20240815$20240826$PER$$NVSC2024US165419$NOVARTIS$$$$$$Y$$$20240826$$HP$US$US
242125711$24212571$1$I$$20240805$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR101578$VIIV$$$$$$Y$$$20240815$$HP$US$US
242125721$24212572$1$I$20240701$20240806$20240815$20240815$PER$$US-SA-2024SA238135$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240815$$MD$US$US
242125731$24212573$1$I$20240101$20240807$20240815$20240815$PER$$US-SA-2024SA240504$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240815$$MD$US$US
242125741$24212574$1$I$$20240805$20240815$20240815$EXP$$US-RDY-LIT/USA/24/0011713$DR REDDYS$Hernandez K, Ahmed T, Liu D, Seiter K, Steinberg A. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. Blood. 2023;142: 7349-7350. doi:10.1182/blood-2023-178225.$28$YR$A$M$Y$$$20240815$$HP$US$US
242125752$24212575$2$F$$20240813$20240815$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128719$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240820$$CN$US$US
242125761$24212576$1$I$$20240802$20240815$20240815$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07411$HIKMA$$63$YR$$M$Y$$$20240815$$HP$CA$CA
242125771$24212577$1$I$$20240813$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128767$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$71.21$KG$20240815$$CN$US$US
242125781$24212578$1$I$20240717$20240807$20240815$20240815$EXP$$KR-CELLTRION INC.-2024KR016964$CELLTRION$$$$$$Y$$$20240815$$HP$KR$KR
242125791$24212579$1$I$$20240801$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040221$AUROBINDO$$86$WK$$M$Y$$$20240815$$HP$CA$CA
242125801$24212580$1$I$$20240801$20240815$20240815$EXP$$PT-AUROBINDO-AUR-APL-2024-039372$AUROBINDO$Carvalhinha C, Henriques C, Barreto F, Fernandes R, Loja JT, Freitas JM, et al... PO-0487 - (4622) - Uma manifesta??o  comum, uma  entidade rara (PO-0487 - (4622) - A common manifestation, a rare entity). Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI (Congresses of. 2024;847$61$YR$$F$Y$$$20240815$$MD$PT$PT
242125811$24212581$1$I$$20240809$20240815$20240815$PER$$US-MTPC-MTDA2024-0016945$MITSUBISHI TANABE PHARMA$$$$E$M$Y$$$20240815$$CN$US$US
242125822$24212582$2$F$$20240913$20240815$20240918$PER$$US-MTPC-MTDA2024-0017081$MITSUBISHI TANABE PHARMA$$$$A$M$Y$$$20240918$$CN$US$US
242125831$24212583$1$I$$20240807$20240815$20240815$PER$$US-MTPC-MTDA2024-0016811$MITSUBISHI TANABE PHARMA$$$$E$M$Y$$$20240815$$CN$US$US
242125841$24212584$1$I$$20240808$20240815$20240815$PER$$US-MTPC-MTDA2024-0016932$MITSUBISHI TANABE PHARMA$$$$A$$Y$$$20240815$$HP$US$US
242125851$24212585$1$I$20240806$20240808$20240815$20240815$PER$$US-BIOGEN-2024BI01277465$BIOGEN$$58$YR$$M$Y$$$20240815$$CN$US$US
242125861$24212586$1$I$$20240809$20240815$20240815$EXP$$US-AMGEN-USASL2024159113$AMGEN$$$$A$F$Y$$$20240815$$CN$US$US
242125871$24212587$1$I$20240723$20240809$20240815$20240815$EXP$$CN-AMGEN-CHNSP2024159131$AMGEN$$69$YR$E$F$Y$$$20240815$$HP$CN$CN
242125881$24212588$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160853$AMGEN$$$$$$Y$$$20240815$$HP$US$US
242125891$24212589$1$I$20240524$20240722$20240815$20240815$EXP$$GB-CELLTRION INC.-2024GB019552$CELLTRION$$$$$$Y$$$20240815$$CN$GB$GB
242125901$24212590$1$I$$20240802$20240815$20240815$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07555$HIKMA$$17$DY$$M$Y$$$20240815$$HP$CA$CA
242125911$24212591$1$I$20240807$20240813$20240815$20240815$EXP$$NVSC2024US165247$NOVARTIS$$87$YR$$F$Y$$$20240815$$HP$US$US
242125922$24212592$2$F$$20240905$20240815$20240905$PER$$US-ALXN-202408USA000485US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$MD$US$US
242125931$24212593$1$I$$20240808$20240815$20240815$EXP$$US-BIOGEN-2024BI01277877$BIOGEN$$$$$M$Y$$$20240815$$PH$US$US
242125941$24212594$1$I$$20240813$20240815$20240815$EXP$$US-BIOGEN-2024BI01277922$BIOGEN$$$$$F$Y$$$20240815$$HP$US$US
242125951$24212595$1$I$$20240806$20240815$20240815$EXP$$ZA-AstraZeneca-2024A182081$ASTRAZENECA$$56$YR$$F$Y$$$20240815$$CN$ZA$
242125961$24212596$1$I$20240101$20240807$20240815$20240815$EXP$$HN-BIOGEN-2024BI01254461$BIOGEN$$$$$F$Y$43.54$KG$20240815$$CN$HN$HN
242125971$24212597$1$I$20240208$20240806$20240815$20240815$EXP$$FR-AstraZeneca-2024A178160$ASTRAZENECA$$66$YR$$M$Y$71$KG$20240815$$MD$FR$
242125981$24212598$1$I$20240701$20240806$20240815$20240815$EXP$$US-AstraZeneca-2024A182025$ASTRAZENECA$$692$MON$$F$Y$$$20240815$$HP$US$
242125991$24212599$1$I$$20221017$20240815$20240815$EXP$$US-AstraZeneca-2022A349595$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242126001$24212600$1$I$$20240814$20240815$20240815$PER$$US-ROCHE-10000058005$ROCHE$$28$YR$A$F$Y$$$20240815$$HP$US$US
242126012$24212601$2$F$$20240821$20240815$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-039424$AUROBINDO$Jachiet M, Samson M, Cottin V, Kahn J-E, Le Guenno G, Bonniaud P, et al.. Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients. Arthritis + Rheumatology. 2016;68(9):2274-82$53$YR$$M$Y$$$20240903$$MD$FR$FR
242126021$24212602$1$I$$20240627$20240815$20240815$PER$$US-TRAVERE-2024TVT00656$TRAVERE THERAPEUTICS$$$$$M$Y$60.78$KG$20240815$$CN$US$US
242126031$24212603$1$I$$20240628$20240815$20240815$PER$$US-TRAVERE-2024TVT00661$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$CN$US$US
242126041$24212604$1$I$$20240627$20240815$20240815$PER$$US-TRAVERE-2024TVT00659$TRAVERE THERAPEUTICS$$54$YR$A$M$Y$$$20240815$$CN$US$US
242126051$24212605$1$I$20240620$20240627$20240815$20240815$PER$$DE-TRAVERE-2024TVT00741$TRAVERE THERAPEUTICS$$50$YR$A$F$Y$61$KG$20240815$$HP$DE$DE
242126061$24212606$1$I$20240727$20240813$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128676$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240815$$CN$US$US
242126071$24212607$1$I$$20240808$20240815$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-128344$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240815$$HP$JP$JP
242126091$24212609$1$I$20240607$20240812$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128720$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240815$$CN$US$US
242126101$24212610$1$I$20231215$20240809$20240815$20240815$EXP$ES-AEMPS-1555674$ES-ROCHE-10000053152$ROCHE$$53$YR$A$M$Y$$$20240815$$MD$ES$ES
242126111$24212611$1$I$20240811$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007405$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240815$$CN$US$US
242126121$24212612$1$I$20240812$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007539$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240815$$CN$US$US
242126131$24212613$1$I$$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408006665$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240815$$CN$US$US
242126141$24212614$1$I$20240601$20240808$20240815$20240815$EXP$$JP-009507513-2408JPN000956J$MERCK$$74$YR$$M$Y$$$20240815$$MD$JP$JP
242126151$24212615$1$I$20240808$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008311$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240815$$CN$US$US
242126161$24212616$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160643$AMGEN$$$$$$Y$$$20240815$$CN$US$US
242126172$24212617$2$F$$20240903$20240815$20240905$EXP$$JP-GILEAD-2024-0683593$GILEAD$$$$E$F$Y$53$KG$20240905$$PH$JP$JP
242126181$24212618$1$I$20240711$20240801$20240815$20240815$EXP$$FR-AUROBINDO-AUR-APL-2024-038789$AUROBINDO$$22$YR$$M$Y$195$KG$20240815$$PH$FR$FR
242126191$24212619$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06324$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126201$24212620$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06323$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126211$24212621$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06322$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126221$24212622$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06325$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126232$24212623$2$F$$20240819$20240815$20240821$EXP$$US-ABBVIE-5880152$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242126241$24212624$1$I$$20240731$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06326$HIKMA$$$$$M$Y$$$20240815$$HP$US$US
242126271$24212627$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06327$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126281$24212628$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06328$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126291$24212629$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06329$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126301$24212630$1$I$20240806$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161814$AMGEN$$69$YR$E$F$Y$$$20240815$$CN$US$US
242126311$24212631$1$I$$20240814$20240815$20240815$PER$$US-ROCHE-10000057923$ROCHE$$15$YR$T$M$Y$$$20240815$$CN$US$US
242126321$24212632$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06331$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126331$24212633$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06330$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126341$24212634$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06332$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126351$24212635$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06333$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126361$24212636$1$I$$20240805$20240815$20240815$EXP$$US-RDY-LIT/USA/24/0011714$DR REDDYS$Hernandez K, Ahmed T, Liu D, Seiter K, Steinberg A. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. Blood. 2023;142: 7349-7350. doi:10.1182/blood-2023-178225.$37$YR$A$M$Y$$$20240815$$HP$US$US
242126371$24212637$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06334$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126381$24212638$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06335$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126391$24212639$1$I$$20240718$20240815$20240815$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06336$HIKMA$$$$$$Y$$$20240815$$HP$US$US
242126401$24212640$1$I$$20240628$20240815$20240815$PER$$US-TRAVERE-2024TVT00662$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240815$$MD$US$US
242126411$24212641$1$I$$20240804$20240815$20240815$EXP$$US-JNJFOC-20240827802$JOHNSON AND JOHNSON$$$$$$Y$$$20240815$$HP$US$US
242126431$24212643$1$I$$20240628$20240815$20240815$PER$$US-TRAVERE-2024TVT00663$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$MD$US$US
242126441$24212644$1$I$$20240628$20240815$20240815$PER$$US-TRAVERE-2024TVT00664$TRAVERE THERAPEUTICS$$42$YR$A$M$Y$$$20240815$$CN$US$US
242126451$24212645$1$I$20240622$20240628$20240815$20240815$EXP$$AT-TRAVERE-2024TVT00743$TRAVERE THERAPEUTICS$$30$YR$A$F$Y$74$KG$20240815$$MD$AT$AT
242126461$24212646$1$I$20240605$20240628$20240815$20240815$PER$$US-TRAVERE-2024TVT00665$TRAVERE THERAPEUTICS$$58$YR$A$F$Y$$$20240815$$CN$US$US
242126471$24212647$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128636$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240815$$HP$US$US
242126481$24212648$1$I$20240802$20240805$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124542$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240815$$PH$US$US
242126492$24212649$2$F$$20240819$20240815$20240820$EXP$$NVSC2024CA165179$NOVARTIS$$6$YR$$M$Y$$$20240820$$HP$CA$CA
242126501$24212650$1$I$$20240812$20240815$20240815$EXP$$US-ROCHE-10000055971$ROCHE$$74$YR$E$F$Y$$$20240815$$CN$US$US
242126512$24212651$2$F$20220101$20240918$20240815$20240926$EXP$$CA-UCBSA-2022051832$UCB$$$$$F$Y$$$20240926$$CN$CA$CA
242126521$24212652$1$I$$20240807$20240815$20240815$EXP$$CA-AstraZeneca-2024A181417$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$CA$
242126531$24212653$1$I$$20240809$20240815$20240815$EXP$$US-AstraZeneca-2024A182398$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242126541$24212654$1$I$20230601$20240812$20240815$20240815$EXP$$US-AstraZeneca-2024A183360$ASTRAZENECA$$1041$MON$$F$Y$$$20240815$$CN$US$
242126551$24212655$1$I$20220901$20221018$20240815$20240815$EXP$$CA-AstraZeneca-2022A347452$ASTRAZENECA$$55$YR$$F$Y$$$20240815$$CN$CA$
242126561$24212656$1$I$$20240808$20240815$20240815$PER$$US-AstraZeneca-2024A181180$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
242126571$24212657$1$I$$20240813$20240815$20240815$PER$$US-ABBVIE-5879713$ABBVIE$$$$$$Y$$$20240815$$CN$US$US
242126583$24212658$3$F$$20240911$20240815$20240917$EXP$$NL-ABBVIE-5865483$ABBVIE$$$$E$F$Y$$$20240917$$CN$NL$NL
242126591$24212659$1$I$$20240812$20240815$20240815$EXP$$ZA-ABBVIE-5879454$ABBVIE$$61$YR$$F$Y$$$20240815$$CN$ZA$ZA
242126601$24212660$1$I$20240101$20240813$20240815$20240815$EXP$$US-ABBVIE-5839624$ABBVIE$$$$$F$Y$99$KG$20240815$$CN$US$US
242126612$24212661$2$F$$20240917$20240815$20240923$EXP$$JP-GSK-JP2024JPN099035$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$PH$JP$JP
242126621$24212662$1$I$$20240802$20240815$20240815$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07413$HIKMA$$$$$$Y$$$20240815$$HP$CA$CA
242126631$24212663$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024161147$AMGEN$$$$$$Y$$$20240815$$HP$US$US
242126641$24212664$1$I$$20240812$20240815$20240815$EXP$$RO-TAKEDA-2024TUS074172$TAKEDA$$37$YR$$F$Y$$$20240815$$HP$RO$RO
242126651$24212665$1$I$$20240813$20240815$20240815$EXP$$ZA-ABBVIE-5880985$ABBVIE$$42$YR$$M$Y$$$20240815$$CN$ZA$ZA
242126661$24212666$1$I$$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161920$AMGEN$$$$$F$Y$$$20240815$$HP$US$US
242126672$24212667$2$F$$20240820$20240815$20240824$PER$$US-AMGEN-USASP2024160732$AMGEN$$61$YR$A$F$Y$$$20240824$$CN$US$US
242126702$24212670$2$F$20240603$20240828$20240815$20240906$EXP$$PT-AUROBINDO-AUR-APL-2024-039047$AUROBINDO$$23$YR$$F$Y$65$KG$20240906$$CN$PT$PT
242126712$24212671$2$F$$20240823$20240815$20240828$30DAY$$DE-UCBSA-2024041208$UCB$$$$A$M$Y$$$20240828$$PH$DE$DE
242126721$24212672$1$I$20240730$20240814$20240815$20240815$EXP$FR-AFSSAPS-LL2024001585$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-128753$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$79$KG$20240815$$MD$FR$FR
242126731$24212673$1$I$$20240806$20240815$20240815$PER$$US-SA-2023SA112693$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240815$$MD$US$US
242126741$24212674$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231579$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$2$YR$$F$Y$$$20240815$$HP$DE$DE
242126751$24212675$1$I$20240101$20240813$20240815$20240815$EXP$$US-UCBSA-2024035849$UCB$$$$$F$Y$$$20240815$$CN$US$US
242126761$24212676$1$I$20240812$20240813$20240815$20240815$EXP$$CA-TAKEDA-2024TUS081637$TAKEDA$$78$YR$$F$Y$$$20240815$$CN$CA$CA
242126771$24212677$1$I$$20240805$20240815$20240815$PER$$US-ROCHE-10000050910$ROCHE$Jones A, Martin J, Giangiacomo A, Costakos D. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024-Dec;36:1-4. doi:10.1016/j.ajoc.2024.102131.$$$I$F$Y$$$20240815$$HP$US$US
242126781$24212678$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008312$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240815$$CN$US$US
242126791$24212679$1$I$$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408006645$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240815$$CN$US$US
242126801$24212680$1$I$20240701$20240813$20240815$20240815$EXP$$US-ROCHE-10000056448$ROCHE$$70$YR$E$M$Y$$$20240815$$CN$US$US
242126811$24212681$1$I$$20240808$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408005962$ELI LILLY AND CO$$63$YR$A$$Y$$$20240815$$LW$US$US
242126821$24212682$1$I$$20240814$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009327$ELI LILLY AND CO$$23$YR$A$M$Y$$$20240815$$CN$US$US
242126831$24212683$1$I$$20240809$20240815$20240815$EXP$$US-ABBVIE-5875891$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242126841$24212684$1$I$20240811$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008102$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240815$$CN$US$US
242126851$24212685$1$I$20210214$20240802$20240815$20240815$EXP$$FR-AUROBINDO-AUR-APL-2024-039624$AUROBINDO$$$$N$M$Y$2.82$KG$20240815$$MD$FR$FR
242126861$24212686$1$I$20240807$20240808$20240815$20240815$EXP$$US-VANTIVE-2024VAN018939$Vantive US Healthcare$$29$YR$$M$Y$$$20240815$$HP$US$US
242126871$24212687$1$I$$20240813$20240815$20240815$EXP$$CN-VANTIVE-2024VAN019038$Vantive US Healthcare$$$$$F$Y$$$20240815$$CN$CN$CN
242126881$24212688$1$I$$20240809$20240815$20240815$EXP$$CN-VANTIVE-2024VAN018961$Vantive US Healthcare$$$$$F$Y$$$20240815$$CN$CN$CN
242126891$24212689$1$I$$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161250$AMGEN$$$$$$Y$2$KG$20240815$$HP$US$US
242126901$24212690$1$I$$20240802$20240815$20240815$EXP$$IT-AUROBINDO-AUR-APL-2024-039788$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol. 2024;113 (1):90-98$17$YR$$F$Y$$$20240815$$HP$IT$IT
242126911$24212691$1$I$$20240809$20240815$20240815$EXP$$US-ABBVIE-5876000$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242126921$24212692$1$I$$20240805$20240815$20240815$PER$$JP-NEBO-666393$PHARMACOSMOS$$$$$F$Y$$$20240815$$PH$JP$JP
242126931$24212693$1$I$20221025$20240813$20240815$20240815$EXP$$US-UCBSA-2024040998$UCB$$60$YR$$F$Y$$$20240815$$HP$US$US
242126941$24212694$1$I$$20240807$20240815$20240815$EXP$$ZA-AstraZeneca-2024A180126$ASTRAZENECA$$28124$DY$$M$Y$$$20240815$$CN$ZA$
242126951$24212695$1$I$$20240807$20240815$20240815$EXP$$GB-AstraZeneca-2024A182409$ASTRAZENECA$$$$$M$Y$$$20240815$$MD$GB$
242126961$24212696$1$I$$20221129$20240815$20240815$EXP$$US-AstraZeneca-2022A394864$ASTRAZENECA$$$$$M$Y$106.6$KG$20240815$$CN$US$
242126971$24212697$1$I$20240622$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A180762$ASTRAZENECA$$21109$DY$$F$Y$$$20240815$$CN$US$
242126981$24212698$1$I$20210115$20240808$20240815$20240815$EXP$$CA-TAKEDA-2024TUS080217$TAKEDA$$85$YR$$F$Y$$$20240815$$CN$CA$CA
242126991$24212699$1$I$20240813$20240813$20240815$20240815$EXP$$AU-ROCHE-10000041407$ROCHE$$52$YR$A$F$Y$$$20240815$$HP$AU$AU
242127001$24212700$1$I$$20240802$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040361$AUROBINDO$Kordy F., Nashid N., Khan S., Read S., Macdougall G, Louch D, Arneson C. Bitnun A... Video directly observed therapy to improve adherence of human immunodeficiency virus infected adolescents to combination antiretroviral therapy: a proof-of-concept study. AIDS Care Psychological and Socio-medical Aspects of AIDS/HIV. 2023;35 (3):417???424$18$YR$$M$Y$$$20240815$$HP$CA$CA
242127011$24212701$1$I$20230101$20240808$20240815$20240815$EXP$$CA-ABBVIE-5805465$ABBVIE$$$$A$M$Y$$$20240815$$CN$CA$CA
242127021$24212702$1$I$$20240811$20240815$20240815$PER$$US-AMGEN-USASP2024160994$AMGEN$$$$A$F$Y$$$20240815$$HP$US$US
242127031$24212703$1$I$$20240813$20240815$20240815$EXP$$FR-TAKEDA-2024TUS080833$TAKEDA$$101$YR$$F$Y$$$20240815$$HP$FR$FR
242127041$24212704$1$I$$20240805$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR101011$VIIV$$$$$$Y$$$20240815$$HP$US$US
242127051$24212705$1$I$20240101$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128007$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240815$$CN$US$US
242127061$24212706$1$I$20240730$20240814$20240815$20240815$EXP$ES-AEMPS-1560664$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-128528$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$59.3$KG$20240815$$MD$ES$ES
242127072$24212707$2$F$$20240829$20240815$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127246$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240902$$CN$US$US
242127081$24212708$1$I$20240806$20240812$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128117$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240815$$CN$US$US
242127091$24212709$1$I$20230701$20240802$20240815$20240815$EXP$$GB-AUROBINDO-AUR-APL-2024-039186$AUROBINDO$$61$YR$$F$Y$84$KG$20240815$$PH$GB$GB
242127101$24212710$1$I$$20240807$20240815$20240815$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-24404$SAMSUNG BIOEPIS$Ernest-Suarez K, Seow C. LIVE ROTAVIRUS VACCINATION APPEARS LOW-RISK IN INFANTS BORN TO MOTHERS WITH INFLAMMATORY BOWEL DISEASE ON BIOLOGICS. Clinical Gastroenterology and Hepatology. doi:https://doi.org/10.1016/j.cgh.2024.07.007$$$I$$Y$$$20240815$$MD$CA$CA
242127111$24212711$1$I$$20240812$20240815$20240815$EXP$$CA-ROCHE-10000055825$ROCHE$$$$$M$Y$$$20240815$$CN$CA$CA
242127121$24212712$1$I$20240214$20240807$20240815$20240815$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-24470$SAMSUNG BIOEPIS$$32$YR$A$F$Y$96$KG$20240815$$CN$CA$CA
242127132$24212713$2$F$$20240822$20240815$20240830$EXP$$DE-TEVA-VS-3231533$TEVA$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure 2023; 107 107-113.$$$A$F$Y$$$20240830$$MD$DE$DE
242127152$24212715$2$F$$20240820$20240815$20240830$EXP$$US-TEVA-VS-3230634$TEVA$Martino J, Elfessi Z, Szaflarska K, Suh M, Antonishina K. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use. J-Pharm-Pract 2024; 0 (0):; Martino J, Elfessi Z, Szaflarska K, Suh M, Antonishina K. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use. J-Pharm-Pract 2024; 0 (0):.; Martino J, Elfessi Z, Szaflarska K, Suh M, Antonishina K. Ta...$23$YR$$M$Y$$$20240830$$MD$US$US
242127161$24212716$1$I$20240101$20240807$20240815$20240815$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-24659$SAMSUNG BIOEPIS$$52$YR$A$M$Y$$$20240815$$CN$CA$CA
242127171$24212717$1$I$20240522$20240810$20240815$20240815$EXP$$CA-JNJFOC-20240827971$JOHNSON AND JOHNSON$$13$YR$$F$Y$$$20240815$$HP$CA$CA
242127181$24212718$1$I$20240716$20240809$20240815$20240815$EXP$FR-AFSSAPS-PB2024000858$FR-TAKEDA-2024TUS079940$TAKEDA$$78$YR$$F$Y$$$20240815$$HP$FR$FR
242127191$24212719$1$I$$20240806$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR101020$VIIV$$$$$$Y$$$20240815$$HP$US$US
242127201$24212720$1$I$$20240808$20240815$20240815$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24573$SAMSUNG BIOEPIS$$59$YR$A$F$Y$$$20240815$$CN$GB$GB
242127211$24212721$1$I$$20240809$20240815$20240815$EXP$$DE-TAKEDA-2024TUS080783$TAKEDA$$5$YR$$M$Y$$$20240815$$CN$DE$DE
242127222$24212722$2$F$$20240828$20240815$20240903$EXP$$BR-TAKEDA-2024TUS080683$TAKEDA$$$$$F$Y$$$20240903$$MD$BR$BR
242127231$24212723$1$I$$20240802$20240815$20240815$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07466$HIKMA$$$$$F$Y$$$20240815$$CN$US$US
242127241$24212724$1$I$$20240812$20240815$20240815$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045915$BOEHRINGER INGELHEIM$$$$$$Y$$$20240815$$CN$US$US
242127252$24212725$2$F$$20240819$20240815$20240820$EXP$$NVSC2024CA164962$NOVARTIS$$10$YR$$F$Y$$$20240820$$HP$CA$CA
242127262$24212726$2$F$$20240822$20240815$20240830$EXP$$DE-TEVA-VS-3231529$TEVA$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure 2023; 107 107-113.$$$N$$Y$$$20240830$$MD$DE$DE
242127273$24212727$3$F$20240722$20240823$20240815$20240827$EXP$$US-ROCHE-10000056309$ROCHE$$54$YR$A$F$Y$86.18$KG$20240827$$MD$US$US
242127291$24212729$1$I$20240805$20240808$20240815$20240815$EXP$$RU-TAKEDA-2024TUS081329$TAKEDA$$9$YR$$F$Y$$$20240815$$CN$RU$RU
242127301$24212730$1$I$$20240813$20240815$20240815$PER$$US-ABBVIE-5880443$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242127311$24212731$1$I$20240101$20240809$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127987$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$48.53$KG$20240815$$PH$US$US
242127321$24212732$1$I$20240810$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160506$AMGEN$$74$YR$E$F$Y$$$20240815$$CN$US$US
242127332$24212733$2$F$20240723$20240823$20240815$20240829$30DAY$$US-AMGEN-USASP2024158463$AMGEN$$79$YR$E$M$Y$74$KG$20240829$$PH$US$US
242127341$24212734$1$I$$20240802$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040364$AUROBINDO$$63$YR$$M$Y$$$20240815$$HP$CA$CA
242127351$24212735$1$I$$20240425$20240815$20240815$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05820$HIKMA$Khandait H, Musleh G, Abruzzo A, Noori MA, Joshi MB.. Khandait H, Musleh G, Abruzzo A, Noori MA, Joshi MB. Idiosyncratic Amiodarone-Induced Torsades de Pointes: A Case Report.. SN Comprehensive Clinical Medicine. 2024;6(1):40$70$YR$$F$Y$$$20240815$$MD$US$US
242127362$24212736$2$F$$20240912$20240815$20240919$EXP$$US-ROCHE-10000053902$ROCHE$$50$YR$A$M$Y$65.77$KG$20240919$$CN$US$US
242127372$24212737$2$F$$20240807$20240815$20240821$EXP$$AU-TAKEDA-2024TUS080031$TAKEDA$$4$DEC$$M$Y$$$20240821$$HP$AU$AU
242127392$24212739$2$F$$20240906$20240815$20240910$PER$$US-ALXN-202408USA000722US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
242127401$24212740$1$I$$20240813$20240815$20240815$PER$$US-ALXN-202408USA000723US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240815$$CN$US$US
242127411$24212741$1$I$20231101$20240807$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408005883$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240815$$CN$US$US
242127421$24212742$1$I$$20230320$20240815$20240815$EXP$$US-AstraZeneca-2023A069121$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242127431$24212743$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008196$ELI LILLY AND CO$$$$$$Y$$$20240815$$HP$US$US
242127441$24212744$1$I$$20221010$20240815$20240815$EXP$$US-AstraZeneca-2022A343214$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242127451$24212745$1$I$20190301$20240812$20240815$20240815$EXP$PL-URPL-1-2283-2019$PL-BIOGEN-2024BI01277902$BIOGEN$$34$YR$$F$Y$67$KG$20240815$$MD$PL$PL
242127461$24212746$1$I$$20220518$20240815$20240815$EXP$$US-AstraZeneca-2022A191469$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242127471$24212747$1$I$20240101$20240813$20240815$20240815$EXP$$US-ABBVIE-5880385$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242127481$24212748$1$I$$20240806$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR101544$VIIV$$$$$$Y$$$20240815$$HP$US$US
242127491$24212749$1$I$20220110$20240802$20240815$20240815$EXP$$FR-AUROBINDO-AUR-APL-2024-039535$AUROBINDO$$32$YR$$F$Y$57$KG$20240815$$PH$FR$FR
242127501$24212750$1$I$$20240812$20240815$20240815$EXP$$US-ABBVIE-5845052$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242127511$24212751$1$I$20240101$20240813$20240815$20240815$EXP$$US-ABBVIE-5880334$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242127522$24212752$2$F$20210101$20240820$20240815$20240829$EXP$$US-ABBVIE-5876670$ABBVIE$$$$$M$Y$64$KG$20240829$$CN$US$US
242127531$24212753$1$I$$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161526$AMGEN$$$$A$F$Y$$$20240815$$MD$US$US
242127541$24212754$1$I$20231001$20240808$20240815$20240815$EXP$$US-AMGEN-USASP2024158547$AMGEN$$57$YR$A$F$Y$$$20240815$$CN$US$US
242127552$24212755$2$F$20240101$20240919$20240815$20240926$EXP$$JP-AMGEN-JPNSP2024156991$AMGEN$$$$$F$Y$$$20240926$$PH$JP$JP
242127564$24212756$4$F$$20240917$20240815$20240921$PER$$US-ROCHE-10000050395$ROCHE$$$$E$M$Y$$$20240921$$MD$US$US
242127571$24212757$1$I$$20240805$20240815$20240815$PER$$US-RDY-SPO/USA/24/0011683$DR REDDYS$$29$YR$A$F$Y$$$20240815$$MD$US$US
242127581$24212758$1$I$$20240807$20240815$20240815$EXP$GB-MLMSERVICE-20240801-PI147356-00191-1$GB-RDY-SPO/GBR/24/0011693$DR REDDYS$Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP. A case of human T-lymphotropic virus-1-associated lichenoid dermatitis. Clinical and Experimental Dermatology. 2024;49(8):916-18. DOI:10.1093/ced/llae076.$61$YR$A$F$Y$$$20240815$$MD$GB$GB
242127592$24212759$2$F$20240101$20240813$20240815$20240816$EXP$GB-MHRA-MED-202408131616197890-GLDQC$GB-ABBVIE-5879521$ABBVIE$$$$$F$Y$$$20240816$$HP$GB$GB
242127601$24212760$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128196$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$99.79$KG$20240815$$CN$US$US
242127621$24212762$1$I$20230901$20240807$20240815$20240815$EXP$$US-ABBVIE-5860191$ABBVIE$$80$YR$$M$Y$90.718$KG$20240815$$CN$US$US
242127642$24212764$2$F$20240801$20240903$20240815$20240909$EXP$$JP-AMGEN-JPNSP2024157791$AMGEN$$$$E$$Y$$$20240909$$PH$JP$JP
242127652$24212765$2$F$$20240814$20240815$20240820$PER$$US-AMGEN-USASP2024161808$AMGEN$$$$$F$Y$$$20240819$$HP$US$US
242127661$24212766$1$I$20240813$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161290$AMGEN$$85$YR$E$F$Y$$$20240815$$CN$US$US
242127671$24212767$1$I$$20240808$20240815$20240815$EXP$$US-ROCHE-10000053417$ROCHE$$61$YR$A$F$Y$$$20240815$$CN$US$US
242127681$24212768$1$I$20230101$20240812$20240815$20240815$EXP$$CA-UCBSA-2024041047$UCB$$$$$F$Y$74.83$KG$20240815$$CN$CA$CA
242127691$24212769$1$I$20240101$20240812$20240815$20240815$EXP$$CA-UCBSA-2024007666$UCB$$$$$M$Y$$$20240815$$CN$CA$CA
242127701$24212770$1$I$$20240503$20240815$20240815$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06493$HIKMA$Rivera D, Muniz-Sarriera AB, Marcial J, Torres H, Colon-Rodriguez E, Crespo MJ.. Rivera D, Muniz-Sarriera AB, Marcial J, Torres H, Colon-Rodriguez E, Crespo MJ. Acute respiratory failure secondary to low-dose opioid administration in a patient with obstructive sleep apnea and obesity hypoventilation syndrome after undergoing trans-sphenoidal tumor resection. Cureus. 202;16(3):e56973$$$$$Y$$$20240815$$MD$US$US
242127721$24212772$1$I$20240113$20240811$20240815$20240815$EXP$GB-MHRA-MED-202408112028056130-RHYPQ$GB-TAKEDA-2024TUS081833$TAKEDA$$40$YR$$F$Y$$$20240815$$HP$GB$GB
242127731$24212773$1$I$$20240801$20240815$20240815$EXP$$CA-AUROBINDO-AUR-APL-2024-040217$AUROBINDO$Piran S, Alhomsi N, Warkentin TE.. Recurrent severe thrombocytopenia in critical illness  complicated by hemolysis. American Journal of Hematology. 2023;98(9):1490-6$60$YR$$M$Y$$$20240815$$HP$CA$CA
242127741$24212774$1$I$$20240806$20240815$20240815$EXP$$US-TAKEDA-2024TUS081506$TAKEDA$$$$E$M$Y$68.2$KG$20240815$$MD$US$US
242127751$24212775$1$I$$20240805$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR101513$VIIV$$$$$$Y$$$20240815$$HP$US$US
242127771$24212777$1$I$$20240814$20240815$20240815$PER$$NVSC2024US165317$NOVARTIS$$$$$M$Y$$$20240815$$HP$US$US
242127781$24212778$1$I$$20240808$20240815$20240815$EXP$$IN-ROCHE-3339454$ROCHE$$74$YR$E$F$Y$$$20240815$$CN$IN$IN
242127792$24212779$2$F$20240708$20240906$20240815$20240917$EXP$$US-ROCHE-10000054188$ROCHE$$55$YR$A$F$Y$70$KG$20240917$$CN$US$US
242127801$24212780$1$I$$20240802$20240815$20240815$EXP$$US-AUROBINDO-AUR-APL-2024-038904$AUROBINDO$Xia YU, Blecher NA, Custer PL, Sieck EG. Optimizing topical drop efficacy with proper eyelid positioning. American Journal of Ophthalmology Case Reports. 2024;36:102111$71$YR$$M$Y$$$20240815$$MD$US$US
242127811$24212781$1$I$$20240805$20240815$20240815$EXP$$US-TAKEDA-2024TUS018254$TAKEDA$$$$$F$Y$$$20240815$$CN$US$US
242127821$24212782$1$I$$20240813$20240815$20240815$PER$$NVSC2024US165142$NOVARTIS$$$$$F$Y$$$20240815$$CN$US$US
242127831$24212783$1$I$$20240812$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128551$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240815$$CN$US$US
242127841$24212784$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128921$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240815$$CN$US$US
242127851$24212785$1$I$$20240808$20240815$20240815$EXP$$CA-GSK-CA2023076064$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$HP$CA$CA
242127862$24212786$2$F$$20240918$20240815$20240919$PER$$NVSC2024US165426$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
242127872$24212787$2$F$20240805$20240808$20240815$20240829$EXP$$IN-ROCHE-RCA5090711$ROCHE$$42$YR$A$M$Y$$$20240829$$MD$IN$IN
242127881$24212788$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008315$ELI LILLY AND CO$$$$$$Y$$$20240815$$HP$US$US
242127891$24212789$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008319$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240815$$CN$US$US
242127901$24212790$1$I$20240601$20240810$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007572$ELI LILLY AND CO$$$$A$F$Y$$$20240815$$CN$US$US
242127911$24212791$1$I$20240501$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008313$ELI LILLY AND CO$$58$YR$A$$Y$$$20240815$$CN$US$US
242127921$24212792$1$I$$20240810$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007544$ELI LILLY AND CO$$$$$F$Y$$$20240815$$CN$US$US
242127931$24212793$1$I$$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161644$AMGEN$$$$$$Y$$$20240815$$PH$US$US
242127941$24212794$1$I$20240813$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161567$AMGEN$$70$YR$E$F$Y$$$20240815$$CN$US$US
242127951$24212795$1$I$$20240802$20240815$20240815$EXP$$GB-UCBSA-2024039129$UCB$$$$$F$Y$$$20240815$$CN$GB$GB
242127971$24212797$1$I$20220101$20240808$20240815$20240815$EXP$$NL-AMGEN-NLDSP2024159469$AMGEN$$74$YR$E$F$Y$$$20240815$$CN$NL$NL
242127981$24212798$1$I$20240113$20240802$20240815$20240815$EXP$$FR-AUROBINDO-AUR-APL-2024-039542$AUROBINDO$$80$YR$$$Y$78.3$KG$20240815$$PH$FR$FR
242127992$24212799$2$F$20240809$20240827$20240815$20240830$EXP$$US-TAKEDA-2024TUS081056$TAKEDA$$46$YR$$M$Y$$$20240830$$HP$US$US
242128001$24212800$1$I$$20240812$20240815$20240815$EXP$$CN-TAKEDA-2024TUS081019$TAKEDA$$$$$M$Y$$$20240815$$CN$CN$CN
242128011$24212801$1$I$20180601$20240808$20240815$20240815$EXP$$CN-SA-2024SA240446$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240815$$HP$CN$CN
242128021$24212802$1$I$20240812$20240812$20240815$20240815$PER$$US-ROCHE-10000055357$ROCHE$$$$A$F$Y$$$20240815$$PH$US$US
242128031$24212803$1$I$$20240808$20240815$20240815$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099209$VIIV$$$$$M$Y$$$20240815$$HP$US$US
242128041$24212804$1$I$$20240805$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR101543$VIIV$$$$$$Y$$$20240815$$HP$US$US
242128081$24212808$1$I$20240806$20240807$20240815$20240815$EXP$CN-91110000556821568D-2024DRL001463$CN-RDY-SPO/CHN/24/0011728$DR REDDYS$$34$YR$A$M$Y$80$KG$20240815$$HP$CN$CN
242128091$24212809$1$I$20240810$20240814$20240815$20240815$PER$$NVSC2024US165295$NOVARTIS$$$$$M$Y$$$20240815$$HP$US$US
242128111$24212811$1$I$$20220913$20240815$20240815$EXP$$US-AstraZeneca-2022A318753$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242128121$24212812$1$I$$20220330$20240815$20240815$EXP$$US-AstraZeneca-2022A133753$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242128131$24212813$1$I$$20220816$20240815$20240815$EXP$$US-AstraZeneca-2022A289648$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242128151$24212815$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128472$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240815$$PH$US$US
242128161$24212816$1$I$$20240813$20240815$20240815$PER$$US-ROCHE-10000057121$ROCHE$$38$YR$A$F$Y$$$20240815$$MD$US$US
242128171$24212817$1$I$20240805$20240805$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024097609$VIIV$$$$$M$Y$$$20240815$$HP$US$US
242128181$24212818$1$I$$20240808$20240815$20240815$EXP$$BR-TAKEDA-2024TUS005225$TAKEDA$$$$$M$Y$$$20240815$$CN$BR$BR
242128191$24212819$1$I$$20240812$20240815$20240815$PER$$US-ROCHE-10000055792$ROCHE$$44$YR$A$M$Y$$$20240815$$CN$US$US
242128201$24212820$1$I$20240101$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161439$AMGEN$$66$YR$E$F$Y$$$20240815$$HP$US$US
242128211$24212821$1$I$20221001$20240812$20240815$20240815$EXP$$US-ROCHE-10000055472$ROCHE$$34$YR$A$F$Y$$$20240815$$CN$US$US
242128221$24212822$1$I$$20240812$20240815$20240815$PER$$US-ABBVIE-5878687$ABBVIE$$$$$$Y$$$20240815$$CN$US$US
242128231$24212823$1$I$20240101$20240807$20240815$20240815$EXP$$CA-CELLTRION INC.-2024CA019390$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
242128241$24212824$1$I$$20240812$20240815$20240815$EXP$$NVSC2024US164643$NOVARTIS$$$$$$Y$$$20240815$$CN$US$US
242128253$24212825$3$F$$20240912$20240815$20240919$EXP$$US-ROCHE-10000053650$ROCHE$$56$YR$A$F$Y$72.12$KG$20240919$$MD$US$US
242128263$24212826$3$F$20240101$20240903$20240815$20240923$EXP$$US-AMGEN-USASL2024145402$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
242128272$24212827$2$F$20240805$20240823$20240815$20240829$PER$$US-AMGEN-USASP2024159337$AMGEN$$$$$$Y$$$20240829$$HP$US$US
242128281$24212828$1$I$$20240812$20240815$20240815$PER$$US-ROCHE-10000054993$ROCHE$$$$$$Y$$$20240815$$CN$US$US
242128291$24212829$1$I$$20240812$20240815$20240815$EXP$$AR-TAKEDA-2024TUS081203$TAKEDA$$$$$M$Y$$$20240815$$CN$AR$AR
242128301$24212830$1$I$$20240812$20240815$20240815$EXP$$US-TAKEDA-2022TUS032319$TAKEDA$$$$$F$Y$$$20240815$$CN$US$US
242128311$24212831$1$I$20220301$20240808$20240815$20240815$EXP$$BR-TAKEDA-2022TUS066363$TAKEDA$$63$YR$$F$Y$$$20240815$$MD$BR$BR
242128321$24212832$1$I$20240101$20240813$20240815$20240815$EXP$$PL-ORGANON-O2408POL001086$ORGANON$$$$$F$Y$$$20240815$$MD$PL$PL
242128332$24212833$2$F$$20240808$20240815$20240815$EXP$$US-ROCHE-10000054359$ROCHE$$$$$$Y$$$20240815$$MD$US$US
242128341$24212834$1$I$20240101$20240812$20240815$20240815$EXP$$CH-ABBVIE-5878443$ABBVIE$$$$$M$Y$$$20240815$$HP$CH$CH
242128432$24212843$2$F$$20240906$20240815$20240912$EXP$$US-ABBVIE-5880018$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
242128441$24212844$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA240575$SANOFI AVENTIS$$$$E$M$Y$77.5$KG$20240815$$MD$US$US
242128451$24212845$1$I$20240101$20240813$20240815$20240815$EXP$$US-ABBVIE-5879579$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242128461$24212846$1$I$$20240808$20240815$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127737$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240815$$MD$JP$JP
242128471$24212847$1$I$$20240807$20240815$20240815$EXP$$FR-AstraZeneca-2024A181853$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$FR$
242128481$24212848$1$I$$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A181013$ASTRAZENECA$$$$$F$Y$58.5$KG$20240815$$CN$US$
242128491$24212849$1$I$$20220822$20240815$20240815$EXP$$US-AstraZeneca-2022A294889$ASTRAZENECA$$$$$$Y$$$20240815$$PH$US$
242128501$24212850$1$I$$20220920$20240815$20240815$EXP$$ZA-AstraZeneca-2022A324596$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$ZA$
242128511$24212851$1$I$20230221$20240807$20240815$20240815$EXP$$JP-AstraZeneca-2023A064734$ASTRAZENECA$$17$YR$$F$Y$53.2$KG$20240815$$MD$JP$
242128531$24212853$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008221$ELI LILLY AND CO$$69$YR$E$$Y$$$20240815$$CN$US$US
242128542$24212854$2$F$20240401$20240820$20240815$20240823$EXP$$CN-ROCHE-10000055195$ROCHE$$65$YR$E$M$Y$$$20240823$$MD$CN$CN
242128551$24212855$1$I$$20240802$20240815$20240815$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07444$HIKMA$$42$YR$$M$Y$77$KG$20240814$$PH$CA$CA
242128562$24212856$2$F$$20240814$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009311$ELI LILLY AND CO$$$$$F$Y$$$20240815$$CN$CA$CA
242128572$24212857$2$F$20240710$20240826$20240815$20240828$EXP$$CL-UCBSA-2024040899$UCB$$54$YR$$M$Y$$$20240828$$CN$CL$CL
242128581$24212858$1$I$$20240802$20240815$20240815$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07464$HIKMA$$$$A$F$Y$$$20240815$$MD$US$US
242128591$24212859$1$I$$20240805$20240815$20240815$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07671$HIKMA$Sheth S, Matthia E, Naik D.. Sheth S, Matthia E, Naik D. Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer. Journal of Clinical Lipidology.. Journal of Clinical Lipidology. 2024;18(4):e555-6$57$YR$$F$Y$$$20240815$$HP$US$US
242128601$24212860$1$I$$20240814$20240815$20240815$PER$$NVSC2024US165349$NOVARTIS$$$$$M$Y$$$20240815$$CN$US$US
242128611$24212861$1$I$$20240802$20240815$20240815$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07558$HIKMA$$55$YR$$M$Y$$$20240815$$HP$CA$CA
242128621$24212862$1$I$20190119$20240808$20240815$20240815$EXP$$CO-UCBSA-2024041189$UCB$$80$YR$$F$Y$$$20240815$$CN$CO$CO
242128631$24212863$1$I$$20240812$20240815$20240815$EXP$$CO-UCBSA-2024041171$UCB$$$$$M$Y$$$20240815$$CN$CO$CO
242128641$24212864$1$I$$20240802$20240815$20240815$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07565$HIKMA$$41$YR$$M$Y$$$20240815$$CN$CA$CA
242128651$24212865$1$I$$20240802$20240815$20240815$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07566$HIKMA$$$$$$Y$$$20240815$$MD$CA$CA
242128671$24212867$1$I$$20240805$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR101545$VIIV$$$$$$Y$$$20240815$$HP$US$US
242128681$24212868$1$I$20240728$20240814$20240815$20240815$EXP$$CN-ROCHE-10000057874$ROCHE$$60$YR$A$F$Y$38$KG$20240815$$HP$CN$CN
242128691$24212869$1$I$$20240808$20240815$20240815$PER$$US-AstraZeneca-2024A180989$ASTRAZENECA$$$$$$Y$$$20240815$$HP$US$
242128701$24212870$1$I$$20240731$20240815$20240815$PER$$US-AstraZeneca-2024A174666$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242128711$24212871$1$I$$20220908$20240815$20240815$EXP$$US-AstraZeneca-2022A313706$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242128721$24212872$1$I$20230210$20230328$20240815$20240815$EXP$$US-AstraZeneca-2023A037438$ASTRAZENECA$$20678$DY$$F$Y$$$20240815$$CN$US$
242128733$24212873$3$F$20240808$20240909$20240815$20240918$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004956$SAREPTA THERAPEUTICS$$15$YR$$M$Y$52.154$KG$20240918$$HP$US$US
242128741$24212874$1$I$$20240807$20240815$20240815$PER$$US-ABBVIE-5872566$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242128751$24212875$1$I$$20211124$20240815$20240815$EXP$$CA-AstraZeneca-2020SF19287$ASTRAZENECA$$$$A$F$Y$$$20240815$$MD$CA$
242128761$24212876$1$I$20240809$20240813$20240815$20240815$EXP$$US-ABBVIE-5880241$ABBVIE$$65$YR$$F$Y$$$20240815$$CN$US$US
242128771$24212877$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160615$AMGEN$$$$$F$Y$$$20240815$$CN$US$US
242128781$24212878$1$I$20240708$20240809$20240815$20240815$EXP$$US-TAKEDA-2024TUS080959$TAKEDA$$63$YR$$F$Y$$$20240815$$CN$US$US
242128791$24212879$1$I$$20240805$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR101577$VIIV$$$$$$Y$$$20240815$$HP$US$US
242128861$24212886$1$I$20240722$20240814$20240815$20240815$EXP$$GB-MYLANLABS-2024M1076003$MYLAN$$$$$M$Y$$$20240815$$HP$GB$GB
242128881$24212888$1$I$20240807$20240812$20240815$20240815$EXP$GB-MHRA-MED-202408121525422230-KCFNG$GB-MYLANLABS-2024M1075178$MYLAN$$76$YR$$M$Y$$$20240815$$HP$GB$GB
242128901$24212890$1$I$20240813$20240813$20240815$20240815$PER$$NVSC2024US165286$NOVARTIS$$66$YR$$F$Y$73.93$KG$20240815$$PH$US$US
242128911$24212891$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024161687$AMGEN$$$$$F$Y$$$20240815$$MD$US$US
242128921$24212892$1$I$$20240814$20240815$20240815$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045953$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240815$$CN$US$US
242128931$24212893$1$I$20240802$20240814$20240815$20240815$EXP$$CN-ROCHE-10000057925$ROCHE$$38$YR$A$F$Y$$$20240815$$HP$CN$CN
242128941$24212894$1$I$20240715$20240812$20240815$20240815$EXP$FR-AFSSAPS-PC2024000629$FR-CHEPLA-2024010456$CHEPLAPHARM$$28$YR$$F$Y$40$KG$20240815$$MD$COUNTRY NOT SPECIFIED$FR
242128951$24212895$1$I$$20240809$20240815$20240815$PER$$JP-CHEPLA-2024009669$CHEPLAPHARM$Shiraiwa T, Katayama H, Iwasaki Y, Kimura S, Satake Y, Sato T, et al. A case of testicular tumor and respiratory failure caused by choriocarcinoma syndrome managed through modified chemotherapy and extracorporeal membrane oxygenation. IJU case reports. 2024;7(4):285-8. DOI: 10.1002/iju5.12725.$35$YR$$M$Y$$$20240815$$MD$COUNTRY NOT SPECIFIED$JP
242128971$24212897$1$I$$20240813$20240815$20240815$PER$$US-ABBVIE-5880620$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242128981$24212898$1$I$$20240808$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127217$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240815$$CN$US$US
242128991$24212899$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128866$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240815$$CN$US$US
242129001$24212900$1$I$20240801$20240807$20240815$20240815$PER$$US-SA-2024SA240595$SANOFI AVENTIS$$$$E$F$Y$68.9$KG$20240815$$MD$US$US
242129011$24212901$1$I$$20240808$20240815$20240815$EXP$$IN-ROCHE-10000053495$ROCHE$$67$YR$E$M$Y$$$20240815$$CN$IN$IN
242129022$24212902$2$F$20240131$20240813$20240815$20240824$EXP$$CH-JAZZ PHARMACEUTICALS-2024-CH-012512$JAZZ$$64$YR$$M$Y$$$20240824$$MD$CH$CH
242129061$24212906$1$I$20240810$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007394$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240815$$CN$US$US
242129071$24212907$1$I$20240801$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007809$ELI LILLY AND CO$$82$YR$E$$Y$$$20240815$$CN$US$US
242129083$24212908$3$F$20240811$20240828$20240815$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408007633$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240830$$CN$US$US
242129091$24212909$1$I$20240730$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008027$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240815$$CN$US$US
242129101$24212910$1$I$$20240805$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408003109$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240815$$CN$US$US
242129112$24212911$2$F$20240601$20240815$20240815$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408007649$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240819$$CN$US$US
242129121$24212912$1$I$20240501$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007613$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240815$$CN$US$US
242129131$24212913$1$I$20240401$20240807$20240815$20240815$EXP$$DE-AstraZeneca-2024A183299$ASTRAZENECA$$765$MON$$F$Y$58.2$KG$20240815$$MD$DE$
242129141$24212914$1$I$$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408006650$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240815$$CN$US$US
242129151$24212915$1$I$20240320$20240812$20240815$20240815$EXP$$US-AstraZeneca-2024A183161$ASTRAZENECA$$23782$DY$$M$Y$$$20240815$$CN$US$
242129161$24212916$1$I$$20240814$20240815$20240815$PER$$US-BAYER-2024A117645$BAYER$$$$$$Y$$$20240815$$CN$US$US
242129171$24212917$1$I$$20220809$20240815$20240815$EXP$$US-AstraZeneca-2022A237363$ASTRAZENECA$$$$$$Y$$$20240815$$MD$US$
242129201$24212920$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231821$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$4$YR$$M$Y$$$20240815$$HP$DE$DE
242129211$24212921$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231822$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$4$YR$$M$Y$$$20240815$$HP$DE$DE
242129221$24212922$1$I$20240101$20240801$20240815$20240815$EXP$$US-CIPLA (EU) LIMITED-2024US08456$CIPLA$$$$$$Y$$$20240815$$CN$US$US
242129231$24212923$1$I$$20240814$20240815$20240815$PER$$US-BAYER-2024A117306$BAYER$$$$$$Y$$$20240815$$CN$US$US
242129241$24212924$1$I$$20240813$20240815$20240815$EXP$$US-ABBVIE-5880221$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242129251$24212925$1$I$20240801$20240809$20240815$20240815$EXP$GB-MHRA-MED-202408070811079670-GSTDQ$GB-SA-2024SA238832$SANOFI AVENTIS$$68$YR$E$$Y$90$KG$20240815$$CN$GB$GB
242129261$24212926$1$I$$20240805$20240815$20240815$EXP$$US-MYLANLABS-2024M1074714$MYLAN$Mess SA, Stephanos KN. Temperance With Tranexamic Acid: Increased Risk of Venous Thromboembolism in Abdominoplasty. Aesth-Surg-J-Open-Forum 2024; 6.$52$YR$$F$Y$$$20240815$$MD$US$US
242129271$24212927$1$I$$20240806$20240815$20240815$EXP$$US-MYLANLABS-2024M1074410$MYLAN$Latif R, Aloqaily M, Rabadi A, Arshad K, Kurian AI, Obeidat I, et al. Apixaban-Induced Hemopericardium in a Post-TAVR Patient: A Case Report Highlighting Diagnostic and Management Challenges. Am-J-Case-Rep 2024; 25.$66$YR$$M$Y$$$20240815$$HP$US$US
242129281$24212928$1$I$$20240805$20240815$20240815$EXP$$JP-VIATRISJAPAN-2024M1075472AA$MYLAN$Morisaki Y, Takatani T, Kotsugi M, Yamazaki S, Yokoyama S, Nakase K, et al. Intraoperative monitoring of trigeminal neuralgia: a technical note. Acta-Neurochir-Wien 2024; 166 (1): 1-5.. 2024;166 (1):1-5$8$DEC$$F$Y$$$20240815$$HP$JP$JP
242129291$24212929$1$I$20240718$20240801$20240815$20240815$EXP$$FR-CIPLA LTD.-2024FR08458$CIPLA$$$$$$Y$$$20240815$$MD$FR$FR
242129301$24212930$1$I$$20240814$20240815$20240815$PER$$US-BAYER-2024A117411$BAYER$$81$YR$E$F$Y$$$20240815$$CN$US$US
242129321$24212932$1$I$$20240805$20240815$20240815$EXP$$JP-MYE-2024M1074185AA$MYLAN$Yamamoto H, Kuroda H, Hiramoto N, Hasuike T, Doi A, Nishioka H. Successful maintenance treatment of disseminated nocardiosis with cerebral abscess in a severely immunocompromised patient allergic to trimethoprim-sulfamethoxazole using moxifloxacin and high-dose minocycline: A case report. J-Infect-Chemother 2024;.. 2024$60$YR$$M$Y$$$20240815$$HP$JP$JP
242129331$24212933$1$I$$20240802$20240815$20240815$EXP$$FR-CIPLA LTD.-2024FR08482$CIPLA$Delbet J, Hogan J, Parmentier C, Ulinski T and Dossier C. Successful global anti-B-cell strategy with Daratumumab in a patient with post-transplant nephrotic syndrome recurrence unresponsive to immunoadsorption and Obinutuzumab. Pediatric transplantation. 2023;E14544$$$$$Y$$$20240815$$HP$FR$FR
242129341$24212934$1$I$$20240814$20240815$20240815$PER$$US-BAYER-2024A117415$BAYER$$$$$$Y$$$20240815$$CN$US$US
242129351$24212935$1$I$$20240815$20240815$20240815$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045963$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240815$$MD$DE$DE
242129361$24212936$1$I$20240101$20240814$20240815$20240815$PER$$US-AMGEN-USASP2024162217$AMGEN$$$$$M$Y$$$20240815$$CN$US$US
242129371$24212937$1$I$$20240808$20240815$20240815$EXP$$JP-AMGEN-JPNSP2024157803$AMGEN$$$$$$Y$$$20240815$$PH$JP$JP
242129381$24212938$1$I$20240101$20240806$20240815$20240815$PER$$US-SA-2024SA237016$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240815$$MD$US$US
242129391$24212939$1$I$$20240802$20240815$20240815$EXP$$US-CIPLA LTD.-2024US08571$CIPLA$$$$$$Y$$$20240815$$HP$US$US
242129404$24212940$4$F$$20240903$20240815$20240904$EXP$$NL-BAYER-2024A116990$BAYER$$21$YR$A$F$Y$$$20240904$$CN$NL$NL
242129411$24212941$1$I$20240812$20240812$20240815$20240815$PER$$US-ABBVIE-5877848$ABBVIE$$26$YR$$F$Y$$$20240815$$HP$US$US
242129421$24212942$1$I$$20240813$20240815$20240815$PER$$US-BAYER-2024A117230$BAYER$$$$$$Y$$$20240815$$CN$US$US
242129431$24212943$1$I$$20240809$20240815$20240815$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-111271$REGENERON$$$$$M$Y$$$20240815$$CN$CA$CA
242129441$24212944$1$I$$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161859$AMGEN$$$$$$Y$$$20240815$$PH$US$US
242129461$24212946$1$I$$20240812$20240815$20240815$PER$$US-BAYER-2024A116126$BAYER$$$$$F$Y$$$20240815$$CN$US$US
242129471$24212947$1$I$$20240812$20240815$20240815$PER$$US-ABBVIE-5877877$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242129481$24212948$1$I$$20240808$20240815$20240815$EXP$$US-TAKEDA-2024TUS080174$TAKEDA$$$$$M$Y$$$20240815$$HP$US$US
242129501$24212950$1$I$$20240812$20240815$20240815$PER$$US-BAYER-2024A116234$BAYER$$$$$$Y$$$20240815$$CN$US$US
242129532$24212953$2$F$$20240912$20240815$20240917$EXP$$IN-ROCHE-10000027719$ROCHE$$64$YR$A$F$Y$$$20240917$$MD$IN$IN
242129542$24212954$2$F$20230711$20240828$20240815$20240830$EXP$$GB-MYLANLABS-2024M1076011$MYLAN$$66$YR$$M$Y$$$20240830$$CN$GB$GB
242129551$24212955$1$I$$20240807$20240815$20240815$EXP$$ES-PERRIGO-24ES007440$PERRIGO$$45$YR$$M$Y$$$20240815$$MD$ES$ES
242129561$24212956$1$I$$20240812$20240815$20240815$PER$$US-ABBVIE-5877818$ABBVIE$$$$$$Y$$$20240815$$HP$US$US
242129571$24212957$1$I$20240730$20240814$20240815$20240815$EXP$$CA-ROCHE-10000057687$ROCHE$$42$YR$A$F$Y$$$20240815$$CN$CA$CA
242129581$24212958$1$I$20240501$20240812$20240815$20240815$EXP$$RU-JNJFOC-20240707509$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240815$$MD$RU$RU
242129591$24212959$1$I$20240701$20240807$20240815$20240815$EXP$$US-JNJFOC-20240821113$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240815$$MD$US$US
242129601$24212960$1$I$$20240811$20240815$20240815$PER$$US-BAYER-2024A115832$BAYER$$$$$$Y$$$20240815$$CN$US$US
242129611$24212961$1$I$$20240811$20240815$20240815$PER$$US-BAYER-2024A115917$BAYER$$$$$$Y$$$20240815$$CN$US$US
242129621$24212962$1$I$$20240806$20240815$20240815$PER$$US-BAYER-2024A114189$BAYER$$$$$$Y$$$20240815$$CN$US$US
242129631$24212963$1$I$$20240812$20240815$20240815$EXP$$US-AstraZeneca-2024A183285$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242129641$24212964$1$I$$20240812$20240815$20240815$EXP$$US-AstraZeneca-2024A183475$ASTRAZENECA$$$$$M$Y$$$20240815$$MD$US$
242129651$24212965$1$I$$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A183624$ASTRAZENECA$$$$$M$Y$$$20240815$$MD$US$
242129661$24212966$1$I$20240808$20240812$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128848$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240815$$CN$US$US
242129671$24212967$1$I$$20240806$20240815$20240815$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07576$HIKMA$$62$YR$$F$Y$$$20240814$$CN$US$US
242129681$24212968$1$I$$20240807$20240815$20240815$PER$$US-MYLANLABS-2024M1073726$MYLAN$$$$$F$Y$$$20240815$$CN$US$US
242129691$24212969$1$I$20240630$20240807$20240815$20240815$EXP$FR-AFSSAPS-DJ2024000874$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07626$HIKMA$$68$YR$$F$Y$$$20240815$$MD$FR$FR
242129712$24212971$2$F$$20240816$20240815$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009366$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240820$$CN$US$US
242129721$24212972$1$I$20240725$20240805$20240815$20240815$EXP$$US-BAYER-2024A113153$BAYER$$39$YR$A$F$Y$$$20240815$$CN$US$US
242129731$24212973$1$I$20240805$20240808$20240815$20240815$PER$$US-ALXN-202408USA000631US$ALEXION PHARMACEUTICALS$$8$YR$$M$Y$$$20240815$$CN$US$US
242129741$24212974$1$I$20240701$20240805$20240815$20240815$EXP$$US-UCBSA-2024039463$UCB$$32$YR$$F$Y$$$20240815$$HP$US$US
242129751$24212975$1$I$20240101$20240806$20240815$20240815$PER$$US-SA-2024SA237037$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240815$$MD$US$US
242129761$24212976$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA239722$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240815$$CN$US$US
242129771$24212977$1$I$$20240812$20240815$20240815$PER$$US-ROCHE-10000056638$ROCHE$$$$$M$Y$$$20240815$$MD$US$US
242129781$24212978$1$I$20240801$20240813$20240815$20240815$PER$$US-DSJP-DSU-2024-140532$DAIICHI$$7$DEC$$F$Y$$$20240815$$MD$US$US
242129791$24212979$1$I$20240711$20240808$20240815$20240815$EXP$$IN-ROCHE-10000053425$ROCHE$$62$YR$A$M$Y$$$20240815$$CN$IN$IN
242129801$24212980$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55988$$FDA-CTU$$$$$M$N$$$20240813$N$HP$US$
242129811$24212981$1$I$20240807$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55971$$FDA-CTU$$15$YR$$M$N$$$20240814$N$PH$US$
242129831$24212983$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55964$$FDA-CTU$$79$YR$$$N$$$20240814$N$$US$
242129841$24212984$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55982$$FDA-CTU$$34$YR$$F$N$$$20240814$N$$US$
242129871$24212987$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55968$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242129881$24212988$1$I$20240101$20240805$20240815$20240815$EXP$$US-ANIPHARMA-2024-US-036527$ANI$$63$YR$$F$Y$68.04$KG$20240815$$HP$US$US
242129891$24212989$1$I$$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161971$AMGEN$$$$$$Y$$$20240815$$PH$US$US
242129901$24212990$1$I$20240309$20240806$20240815$20240815$EXP$$CO-AMGEN-COLSL2024159308$AMGEN$$93$YR$E$M$Y$$$20240815$$CN$CO$CO
242129912$24212991$2$F$$20240822$20240815$20240826$30DAY$$DE-UCBSA-2024039311$UCB$$$$$F$Y$$$20240826$$CN$DE$DE
242129931$24212993$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128643$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240815$$CN$US$US
242129941$24212994$1$I$20240101$20240808$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128670$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240815$$CN$US$US
242129951$24212995$1$I$$20240813$20240815$20240815$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-128419$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240815$$MD$TR$TR
242129961$24212996$1$I$$20240807$20240815$20240815$PER$$US-ABBVIE-5872980$ABBVIE$$42$YR$$M$Y$$$20240815$$MD$US$US
242129971$24212997$1$I$$20240807$20240815$20240815$PER$$US-ROCHE-10000052083$ROCHE$$$$$F$Y$113$KG$20240815$$CN$US$US
242129991$24212999$1$I$20240712$20240813$20240815$20240815$EXP$GB-MHRA-MED-202408131223353980-LRHPG$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045673$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$112$KG$20240815$$HP$GB$GB
242130001$24213000$1$I$20230101$20240808$20240815$20240815$EXP$FR-AFSSAPS-AVBX2024000436$FR-MYLANLABS-2024M1074063$MYLAN$$44$YR$$M$Y$$$20240815$$MD$FR$FR
242130011$24213001$1$I$$20240808$20240815$20240815$EXP$BE-FAMHP-DHH-N2024-122459$BE-MYLANLABS-2024M1074248$MYLAN$$40$YR$$M$Y$$$20240815$$PH$BE$BE
242130021$24213002$1$I$$20240808$20240815$20240815$EXP$$CZ-MYLANLABS-2024M1075270$MYLAN$Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, et al. Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study.. Neoplasma. 2017;64(5):762-9$25$YR$$M$Y$$$20240815$$HP$CZ$CZ
242130032$24213003$2$F$$20240812$20240815$20240819$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045186$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240819$$CN$US$BR
242130041$24213004$1$I$$20240812$20240815$20240815$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045510$BOEHRINGER INGELHEIM$$58$YR$A$M$Y$64$KG$20240814$$HP$CO$CO
242130051$24213005$1$I$$20240806$20240815$20240815$EXP$$US-EMD Serono-2024042780$EMD SERONO INC$$$$A$F$Y$$$20240814$$CN$US$US
242130062$24213006$2$F$$20240830$20240815$20240907$EXP$$JP-AMGEN-JPNSP2024158063$AMGEN$$$$E$F$Y$$$20240907$$MD$JP$JP
242130071$24213007$1$I$$20240808$20240815$20240815$EXP$$DE-MYLANLABS-2024M1074317$MYLAN$$$$$M$Y$$$20240815$$CN$DE$DE
242130091$24213009$1$I$$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161495$AMGEN$$$$$F$Y$$$20240815$$PH$US$US
242130101$24213010$1$I$20240721$20240812$20240815$20240815$EXP$$US-AstraZeneca-2024A183160$ASTRAZENECA$$26351$DY$$F$Y$$$20240815$$CN$US$
242130111$24213011$1$I$$20230629$20240815$20240815$EXP$$US-AstraZeneca-2023A150276$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242130121$24213012$1$I$$20240807$20240815$20240815$EXP$$GB-PERRIGO-24GB007515$PERRIGO$Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP. A case of human T-lymphotropic virus-1-associated lichenoid dermatitis. Clinical and Experimental Dermatology. 2024;49(8):916-18. DOI:10.1093/ced/llae076.$61$YR$$F$Y$$$20240815$$MD$GB$GB
242130131$24213013$1$I$$20240812$20240815$20240815$PER$$US-ROCHE-10000055389$ROCHE$$25$YR$A$F$Y$$$20240815$$CN$US$US
242130142$24213014$2$F$20230101$20240808$20240815$20240822$EXP$$US-ROCHE-10000053072$ROCHE$$48$YR$A$M$Y$64.86$KG$20240822$$CN$US$US
242130151$24213015$1$I$20240801$20240809$20240815$20240815$EXP$$JP-ROCHE-10000057902$ROCHE$$8$DEC$E$$Y$$$20240815$$MD$JP$JP
242130161$24213016$1$I$$20220606$20240815$20240815$EXP$$US-AstraZeneca-2022A210938$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242130171$24213017$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA239718$SANOFI AVENTIS$$$$A$F$Y$$$20240815$$CN$US$US
242130181$24213018$1$I$20220307$20220425$20240815$20240815$EXP$$CA-AstraZeneca-2022A107230$ASTRAZENECA$$27498$DY$$M$Y$$$20240815$$MD$CA$
242130201$24213020$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA240483$SANOFI AVENTIS$$$$A$F$Y$$$20240815$$MD$US$US
242130212$24213021$2$F$20240723$20240814$20240815$20240820$PER$$US-IDORSIA-008361-2024-US$IDORSIA PHARMACEUTICALS$$21$YR$$F$Y$$$20240820$$HP$US$US
242130221$24213022$1$I$$20240731$20240815$20240815$EXP$$US-Fagron Sterile Services-2160482$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$34$YR$$F$Y$77.1$KG$20240815$$PH$US$US
242130231$24213023$1$I$20240806$20240807$20240815$20240815$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160493$JIANGSU HENGRUI MEDICINE$$71$YR$$F$Y$71$KG$20240815$$MD$CN$CN
242130241$24213024$1$I$$20240801$20240815$20240815$EXP$$FR-B.Braun Medical Inc.-2160479$B BRAUN$Literature Article$44$YR$$M$Y$$$20240815$$$FR$FR
242130251$24213025$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231806$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$14$YR$$M$Y$$$20240815$$HP$DE$DE
242130261$24213026$1$I$$20240812$20240815$20240815$EXP$$US-ROCHE-10000056647$ROCHE$$48$YR$A$F$Y$$$20240815$$PH$US$US
242130272$24213027$2$F$20240606$20240815$20240815$20240829$EXP$$DE-CLINUVEL INC-2160495$CLINUVEL$$$$$F$Y$50$KG$20240829$$MD$DE$DE
242130281$24213028$1$I$$20240801$20240815$20240815$EXP$$GR-B.Braun Medical Inc.-2160485$B BRAUN$Literature Article$84$YR$$M$Y$$$20240815$$$GR$GR
242130291$24213029$1$I$$20240807$20240815$20240815$PER$$US-ABBVIE-5872384$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242130311$24213031$1$I$$20240731$20240815$20240815$EXP$$US-Fagron Sterile Services-2160481$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$56$YR$$M$Y$93.9$KG$20240815$$PH$US$US
242130321$24213032$1$I$$20240731$20240815$20240815$EXP$$US-Fagron Sterile Services-2160477$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$31$YR$$M$Y$89.9$KG$20240815$$PH$US$US
242130331$24213033$1$I$$20240801$20240815$20240815$EXP$$TH-B.Braun Medical Inc.-2160483$B BRAUN$Literature Article$73$YR$$M$Y$$$20240815$$$TH$TH
242130341$24213034$1$I$$20240808$20240815$20240815$EXP$$BR-TAKEDA-2024TUS080931$TAKEDA$$$$$F$Y$$$20240815$$CN$BR$BR
242130351$24213035$1$I$20240731$20240809$20240815$20240815$EXP$$GB-AMERICAN REGENT INC-2024003090$AMERICAN REGENT$$45$YR$$F$Y$$$20240815$$HP$GB$GB
242130362$24213036$2$F$$20240820$20240815$20240822$PER$$NVSC2024US165425$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242130371$24213037$1$I$20240710$20240806$20240815$20240815$EXP$SE-SEMPA-2024-005598$SE-TEVA-VS-3230404$TEVA$$54$YR$$F$Y$58$KG$20240815$$MD$SE$SE
242130381$24213038$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231808$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$4$YR$$M$Y$$$20240815$$HP$DE$DE
242130391$24213039$1$I$$20240731$20240815$20240815$EXP$$US-Breckenridge Pharmaceutical, Inc.-2160486$BRECKENRIDGE$Literature article$66$YR$$M$Y$$$20240815$$$IN$US
242130401$24213040$1$I$$20240805$20240815$20240815$EXP$$IT-TAKEDA-2024TUS081047$TAKEDA$$$$$$Y$$$20240815$$MD$IT$IT
242130411$24213041$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55998$$FDA-CTU$$59$YR$$F$N$$$20240814$N$$US$
242130421$24213042$1$I$20240801$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55978$$FDA-CTU$$59$YR$$F$N$$$20240814$N$$US$
242130431$24213043$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55999$$FDA-CTU$$80$YR$$F$N$$$20240814$N$$US$
242130441$24213044$1$I$20240129$20240229$20240814$20240814$DIR$FDA-CDER-CTU-2024-55980$$FDA-CTU$$76$YR$$M$N$$$20240229$N$$US$
242130451$24213045$1$I$20240328$20240516$20240814$20240814$DIR$FDA-CDER-CTU-2024-55981$$FDA-CTU$$76$YR$$F$N$$$20240516$N$$US$
242130461$24213046$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55991$$FDA-CTU$$53$YR$$M$N$$$20240814$N$$US$
242130481$24213048$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55984$$FDA-CTU$$64$YR$$F$N$$$20240814$N$$US$
242130501$24213050$1$I$20240207$20240806$20240815$20240815$EXP$FR-AFSSAPS-RE2024000769$FR-TEVA-VS-3230737$TEVA$$53$YR$$F$Y$59$KG$20240815$$MD$FR$FR
242130511$24213051$1$I$20240101$20240805$20240815$20240815$EXP$$US-UCBSA-2024039502$UCB$$$$$M$Y$$$20240815$$CN$US$US
242130521$24213052$1$I$20240605$20240812$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128062$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240815$$HP$US$US
242130531$24213053$1$I$$20240813$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128474$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$54.43$KG$20240815$$CN$US$US
242130541$24213054$1$I$20170101$20240807$20240815$20240815$EXP$$AT-AMGEN-AUTSP2024158901$AMGEN$Thomas.S.. Therapeutic success in the relapse of multiple myeloma. SPECTRUM ONCOLOGY. 2024;p-99$66$YR$E$F$Y$$$20240815$$MD$AT$AT
242130552$24213055$2$F$20240801$20240812$20240815$20240820$EXP$$CN-JNJFOC-20240829113$JOHNSON AND JOHNSON$$41$YR$A$F$Y$56$KG$20240820$$MD$CN$CN
242130562$24213056$2$F$$20240903$20240815$20240917$EXP$$US-INSMED, INC.-2024-03170-US$INSMED$$$$$F$Y$$$20240917$$CN$US$US
242130572$24213057$2$F$$20240821$20240815$20240823$PER$$US-AMGEN-USASP2024161815$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242130581$24213058$1$I$20240813$20240814$20240815$20240815$PER$$US-AMGEN-USASP2024162033$AMGEN$$55$YR$A$F$Y$$$20240815$$HP$US$US
242130591$24213059$1$I$$20240807$20240815$20240815$EXP$$US-BAYER-2024A114605$BAYER$$75$YR$E$F$Y$$$20240815$$HP$US$US
242130601$24213060$1$I$$20240805$20240815$20240815$EXP$$DE-PFIZER INC-202400233594$PFIZER$F. Knorr. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma. Haematologica. 2023;108:1442-1446$17$YR$$M$Y$$$20240815$$MD$DE$DE
242130622$24213062$2$F$$20240813$20240815$20240820$EXP$$AU-PFIZER INC-202400235207$PFIZER$Li, A.. Metastatic Small Cell Carcinoma of the Bladder Complicated by Paraneoplastic Acute Thrombocytopenia. Cureus. 2024;16(6):10.7759/cureus.63480$76$YR$$M$Y$$$20240820$$MD$AU$AU
242130631$24213063$1$I$20240813$20240814$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009180$ELI LILLY AND CO$$81$YR$E$$Y$$$20240815$$CN$US$US
242130641$24213064$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007398$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240815$$CN$US$US
242130651$24213065$1$I$20240811$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007629$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240815$$CN$US$US
242130661$24213066$1$I$$20240805$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202407019440$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240815$$CN$US$US
242130671$24213067$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008240$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240815$$CN$US$US
242130681$24213068$1$I$$20240807$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009245$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240815$$CN$US$US
242130691$24213069$1$I$20240805$20240805$20240815$20240815$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000043$PAREXEL$$$$$$Y$$$20240815$$CN$US$US
242130712$24213071$2$F$$20240821$20240815$20240822$PER$$NVSC2024US165460$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242130721$24213072$1$I$20240101$20240802$20240815$20240815$PER$$US-009507513-2408USA001188$MERCK$$39$YR$$M$Y$$$20240815$$CN$US$US
242130731$24213073$1$I$20240627$20240809$20240815$20240815$EXP$ES-AEMPS-1542479$ES-LUNDBECK-DKLU4002732$LUNDBECK$$$$$$Y$$$20240815$$MD$ES$ES
242130741$24213074$1$I$20240101$20240812$20240815$20240815$EXP$$DZ-AMGEN-DZASP2024160187$AMGEN$$56$YR$A$F$Y$$$20240815$$MD$DZ$DZ
242130751$24213075$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231793$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$5$YR$$F$Y$$$20240815$$HP$DE$DE
242130771$24213077$1$I$20240721$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A179797$ASTRAZENECA$$3374$DY$$F$Y$$$20240815$$CN$US$
242130781$24213078$1$I$$20220902$20240815$20240815$EXP$$US-AstraZeneca-2022A308552$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242130791$24213079$1$I$$20220921$20240815$20240815$EXP$$US-AstraZeneca-2022A327866$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
242130801$24213080$1$I$$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A179679$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
242130811$24213081$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3232485$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$18$YR$$M$Y$$$20240815$$HP$DE$DE
242130822$24213082$2$F$20190101$20240902$20240815$20240910$EXP$$MX-ROCHE-10000054857$ROCHE$$25$YR$A$F$Y$54$KG$20240910$$CN$MX$MX
242130831$24213083$1$I$$20240808$20240815$20240815$EXP$$BR-TAKEDA-2024TUS081269$TAKEDA$$$$$M$Y$$$20240815$$CN$BR$BR
242130841$24213084$1$I$$20240812$20240815$20240815$EXP$$US-ORGANON-O2408USA000905$ORGANON$$17$YR$$M$Y$$$20240815$$CN$US$US
242130851$24213085$1$I$20240101$20240807$20240815$20240815$EXP$$US-ABBVIE-5875849$ABBVIE$$$$$M$Y$$$20240815$$MD$US$US
242130861$24213086$1$I$20240731$20240806$20240815$20240815$PER$$US-SA-2024SA237090$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240815$$MD$US$US
242130881$24213088$1$I$$20240809$20240815$20240815$EXP$$US-LUNDBECK-DKLU4002843$LUNDBECK$$$$$$Y$$$20240815$$HP$US$US
242130891$24213089$1$I$$20240806$20240815$20240815$PER$$US-SA-2024SA237091$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240815$$MD$US$US
242130901$24213090$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231840$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$16$YR$$F$Y$$$20240815$$HP$DE$DE
242130911$24213091$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55985$$FDA-CTU$$$$$F$N$$$20240814$N$HP$US$
242130931$24213093$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55970$$FDA-CTU$$33$YR$$F$N$$$20240814$N$$US$
242130942$24213094$2$F$$20240826$20240815$20240904$EXP$$GB-TEVA-VS-3231951$TEVA$Joshi H, Earle K. SARS-CoV-2 Trigger in Severe Insulin Resistance With Acute Haemolytic Crisis in Diabetes and Glucose-6- phosphate Dehydrogenase Deficiency. J-Endocr-Soc 2021; 5 (Suppl. 1) A397-A398.; Joshi H, Earle K. SARS-CoV-2 Trigger in Severe Insulin Resistance With Acute Haemolytic Crisis in Diabetes and Glucose-6- phosphate Dehydrogenase Deficiency. J-Endocr-Soc 2021; 5 (Suppl. 1) A397-A398.$64$YR$$M$Y$$$20240904$$MD$GB$GB
242130951$24213095$1$I$$20240806$20240815$20240815$EXP$$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-07622$HIKMA$Freitas JG, Ribeiro T, Moreira C, Moreira I, Mariz JM.. Freitas JG, Ribeiro T, Moreira C, Moreira I, Mariz JM. When ^Myeloma^ is not a Myeloma: a case report of malignant bone lymphoma.. Porto Biomedical Journal.. 2024;e261.:9(4)$$$$$Y$$$20240815$$MD$PT$PT
242130963$24213096$3$F$$20240814$20240815$20240820$PER$$NVSC2024US165346$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242130971$24213097$1$I$$20240812$20240815$20240815$EXP$$SA-TAKEDA-2024TUS081220$TAKEDA$$$$$F$Y$$$20240815$$MD$SA$SA
242130982$24213098$2$F$$20240822$20240815$20240830$EXP$$DE-TEVA-VS-3231532$TEVA$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure 2023; 107 107-113.$$$A$F$Y$$$20240830$$MD$DE$DE
242130992$24213099$2$F$20220401$20240816$20240815$20240827$EXP$PT-AUROBINDO-AUR-APL-2024-037265$PT-ROCHE-10000053551$ROCHE$Henriques C, Melo J, Vasconcelos S, Ramos R, Costa M. PO-0552-(4842)-Respiratory infections: when appearances are deceiving. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. 2024;905.$60$YR$A$F$Y$$$20240827$$HP$PT$PT
242131001$24213100$1$I$$20240813$20240815$20240815$EXP$$US-ABBVIE-5881004$ABBVIE$$$$$$Y$$$20240815$$CN$US$US
242131012$24213101$2$F$20240601$20240816$20240815$20240820$EXP$$CA-LUNDBECK-DKLU4001862$LUNDBECK$$$$$$Y$$$20240820$$CN$CA$CA
242131031$24213103$1$I$20230817$20240806$20240815$20240815$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07540$HIKMA$$$$$$Y$$$20240815$$CN$US$US
242131041$24213104$1$I$$20240813$20240815$20240815$EXP$$NVSC2024US165173$NOVARTIS$$$$$F$Y$$$20240815$$CN$US$US
242131051$24213105$1$I$$20240812$20240815$20240815$EXP$$CA-TAKEDA-2022TUS011415$TAKEDA$$$$$M$Y$$$20240815$$CN$CA$CA
242131061$24213106$1$I$$20240809$20240815$20240815$EXP$$QA-AMGEN-QATSP2024159285$AMGEN$Taha, R.Y. Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11; 14): a case report and literature review. Frontiers in Oncology. 2024;14:1-6$52$YR$A$M$Y$$$20240815$$HP$QA$QA
242131071$24213107$1$I$20240703$20240731$20240815$20240815$EXP$$JP-ROCHE-10000057088$ROCHE$$58$YR$A$M$Y$$$20240815$$MD$JP$JP
242131081$24213108$1$I$$20240812$20240815$20240815$30DAY$$US-GSK-US2024100364$GLAXOSMITHKLINE$$$$$F$Y$$$20240815$$CN$US$US
242131091$24213109$1$I$20240625$20240808$20240815$20240815$EXP$$US-GSK-US2024099634$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$CN$US$US
242131111$24213111$1$I$$20240809$20240815$20240815$EXP$$US-LUNDBECK-DKLU4002842$LUNDBECK$$$$$$Y$$$20240815$$HP$US$US
242131121$24213112$1$I$20240716$20240806$20240815$20240815$EXP$CN-NMPACDR-3206821020589202400156$CN-BAXTER-2024BAX022923$BAXTER$$69$YR$$M$Y$72$KG$20240815$$MD$CN$CN
242131131$24213113$1$I$20240719$20240806$20240815$20240815$EXP$CN-NMPACDR-3412221002221202400191$CN-BAXTER-2024BAX022926$BAXTER$$55$YR$$F$Y$83$KG$20240815$$MD$CN$CN
242131141$24213114$1$I$20240418$20240805$20240815$20240815$EXP$FR-AFSSAPS-LY2024000623$FR-BAXTER-2024BAX022764$BAXTER$$54$YR$$M$Y$64$KG$20240815$$PH$FR$FR
242131151$24213115$1$I$20240803$20240805$20240815$20240815$EXP$CN-NMPACDR-3704011509867202400696$CN-BAXTER-2024BAX022866$BAXTER$$69$YR$$F$Y$70$KG$20240815$$MD$CN$CN
242131161$24213116$1$I$20240730$20240805$20240815$20240815$EXP$CN-NMPACDR-3307811059962202400180$CN-BAXTER-2024BAX022857$BAXTER$$67$YR$$M$Y$52.5$KG$20240815$$MD$CN$CN
242131171$24213117$1$I$$20240807$20240815$20240815$EXP$$CA-BAXTER-2024BAX022892$BAXTER$$$$$F$Y$$$20240815$$HP$CA$CA
242131185$24213118$5$F$20240515$20240916$20240815$20240923$EXP$$DE-BAXTER-2024BAX019597$BAXTER$$70$YR$$F$Y$$$20240923$$HP$DE$DE
242131191$24213119$1$I$$20240807$20240815$20240815$EXP$$CA-BAXTER-2024BAX022891$BAXTER$$9$YR$$F$Y$$$20240815$$HP$CA$CA
242131202$24213120$2$F$20240723$20240820$20240815$20240912$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000477$BECTON DICKINSON$$$$$$Y$$$20240912$$CN$GB$GB
242131211$24213121$1$I$20240101$20240731$20240815$20240815$PER$$US-Eisai-EC-2024-171651$EISAI$$$$$F$Y$$$20240815$$MD$US$US
242131222$24213122$2$F$20240723$20240820$20240815$20240912$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000478$BECTON DICKINSON$$$$$$Y$$$20240912$$CN$GB$GB
242131231$24213123$1$I$20240711$20240808$20240815$20240815$PER$$JP-Eisai-EC-2024-171787$EISAI$Yokoyama Yoshihito. Observational study to assess treatment patterns and clinical outcome in advance and/or recurrent endometrial cancer after adjuvant chemotherapy (PEACH).$$$$F$Y$$$20240815$$MD$JP$JP
242131241$24213124$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231825$TEVA$Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.; Wehming M, Krebs-Schmitt D, Briem-Richter A, Hegen B, Brinkert F, Fischer L, et al. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients. Children-(Basel) 2023; 10 (2):.$5$YR$$M$Y$$$20240815$$HP$DE$DE
242131251$24213125$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128605$BRISTOL MYERS SQUIBB$Tirado S-R, Bass DI, Feroze A, Johnston B, Bi WL, Du R. Ruptured traumatic pseudoaneurysm of the middle cerebral artery following minor trauma treated with an MCA-MCA bypass: a case report. Surgical Neurology International. 2024 Jul 19;15(247):1-4. doi:10.25259/SNI_373_2024.$76$YR$E$M$Y$$$20240815$$HP$US$US
242131261$24213126$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128575$BRISTOL MYERS SQUIBB$Yassin S, Athota S, Khan A, Patel V, Williams J, Dwivedi S. Metastatic non-small-cell lung cancer presenting as renal failure from IgA nephropathy. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-5. doi:10.1177/23247096241262515.$58$YR$A$M$Y$$$20240815$$MD$US$US
242131282$24213128$2$F$$20240802$20240815$20240817$EXP$$GB-Nova Laboratories Limited-2160496$NOVA LABORATORIES$$$$$$Y$$$20240817$$$GB$GB
242131292$24213129$2$F$20240723$20240820$20240815$20240912$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000480$BECTON DICKINSON$$$$$$Y$$$20240912$$CN$GB$GB
242131301$24213130$1$I$$20240809$20240815$20240815$30DAY$$US-GSK-US2024100344$GLAXOSMITHKLINE$$$$$F$Y$$$20240815$$CN$US$US
242131312$24213131$2$F$20190501$20240913$20240815$20240917$EXP$$JP-BAYER-2024A116993$BAYER$$39$YR$A$F$Y$$$20240917$$HP$JP$JP
242131331$24213133$1$I$20240811$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55875$$FDA-CTU$$70$YR$$M$N$83.91$KG$20240814$Y$CN$US$
242131341$24213134$1$I$20240726$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55877$$FDA-CTU$$51$YR$$F$N$81.65$KG$20240814$Y$MD$US$
242131351$24213135$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55977$$FDA-CTU$$11$YR$$M$N$29.94$KG$20240814$N$$US$
242131361$24213136$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56008$$FDA-CTU$$60$YR$$F$N$$$20240814$N$$US$
242131371$24213137$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56000$$FDA-CTU$$64$YR$$F$N$$$20240814$N$$US$
242131381$24213138$1$I$20240806$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008575$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240815$$CN$US$US
242131391$24213139$1$I$$20240809$20240815$20240815$EXP$$US-LUNDBECK-DKLU4002841$LUNDBECK$$$$$$Y$$$20240815$$HP$US$US
242131402$24213140$2$F$20240723$20240820$20240815$20240912$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000479$BECTON DICKINSON$$$$$$Y$$$20240912$$CN$GB$GB
242131412$24213141$2$F$20240723$20240820$20240815$20240912$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000481$BECTON DICKINSON$$$$$$Y$$$20240912$$CN$GB$GB
242131421$24213142$1$I$$20220719$20240815$20240815$EXP$$US-AstraZeneca-2022A262926$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242131433$24213143$3$F$$20240913$20240815$20240918$EXP$$JP-AstraZeneca-2024A183687$ASTRAZENECA$$85$YR$$F$Y$$$20240918$$MD$JP$
242131441$24213144$1$I$$20221213$20240815$20240815$EXP$$US-AstraZeneca-2022A407952$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242131451$24213145$1$I$$20230616$20240815$20240815$EXP$$US-AstraZeneca-2023A141494$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242131461$24213146$1$I$20240806$20240812$20240815$20240815$EXP$$PL-AstraZeneca-2024A185531$ASTRAZENECA$$76$YR$$F$Y$$$20240815$$MD$PL$
242131472$24213147$2$F$20240625$20240911$20240815$20240927$30DAY$$US-BECTON DICKINSON-US-BD-24-000482$BECTON DICKINSON$$$$$$Y$$$20240927$$CN$US$US
242131481$24213148$1$I$$20240813$20240815$20240815$EXP$$US-ABBVIE-5880623$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242131492$24213149$2$F$$20240814$20240815$20240815$PER$$NVSC2024US165415$NOVARTIS$$$$$$Y$$$20240815$$PH$US$US
242131501$24213150$1$I$20240701$20240812$20240815$20240815$30DAY$$US-GSK-US2024100294$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240815$$CN$US$US
242131511$24213151$1$I$20240208$20240809$20240815$20240815$EXP$$CA-TAKEDA-2023TUS117679$TAKEDA$$40$YR$$F$Y$$$20240815$$CN$CA$CA
242131531$24213153$1$I$20240720$20240808$20240815$20240815$EXP$$CN-PFIZER INC-PV202400103646$PFIZER$$57$YR$$F$Y$55$KG$20240815$$HP$CN$CN
242131541$24213154$1$I$$20240808$20240815$20240815$EXP$$CA-PFIZER INC-202400233735$PFIZER$$53$YR$$F$Y$$$20240815$$PH$CA$CA
242131551$24213155$1$I$$20240813$20240815$20240815$PER$$US-PFIZER INC-202400236121$PFIZER$$$$$M$Y$$$20240815$$CN$US$US
242131561$24213156$1$I$20240725$20240809$20240815$20240815$EXP$$CN-PFIZER INC-PV202400104218$PFIZER$$44$YR$$F$Y$$$20240815$$HP$CN$CN
242131581$24213158$1$I$20240704$20240805$20240815$20240815$EXP$FR-AFSSAPS-NY2024000863$FR-PFIZER INC-202400235451$PFIZER$$41$YR$$F$Y$$$20240815$$PH$FR$FR
242131592$24213159$2$F$$20240813$20240815$20240815$PER$$US-PFIZER INC-PV202400105118$PFIZER$$75$YR$$F$Y$$$20240815$$HP$US$US
242131601$24213160$1$I$20240808$20240809$20240815$20240815$EXP$$US-PFIZER INC-202400234589$PFIZER$$21$YR$$F$Y$$$20240815$$PH$US$US
242131611$24213161$1$I$$20240808$20240815$20240815$EXP$$CA-PFIZER INC-202400233838$PFIZER$$48$YR$$F$Y$77$KG$20240815$$HP$CA$CA
242131621$24213162$1$I$$20240808$20240815$20240815$EXP$$CA-PFIZER INC-202400234725$PFIZER$$66$YR$$M$Y$70$KG$20240815$$CN$CA$CA
242131632$24213163$2$F$20240719$20240814$20240815$20240822$EXP$$US-ALIMERA SCIENCES INC.-US-A16013-24-000494$ALIMERA$$65$YR$$M$Y$$$20240822$$MD$US$US
242131642$24213164$2$F$$20240812$20240815$20240829$EXP$$US-GILEAD-2024-0684081$GILEAD$$77$YR$E$M$Y$$$20240829$$CN$US$US
242131651$24213165$1$I$$20240809$20240815$20240815$PER$$US-AMGEN-USASP2024161231$AMGEN$$$$$$Y$$$20240815$$PH$US$US
242131671$24213167$1$I$20240814$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56009$$FDA-CTU$$66$YR$$F$N$$$20240814$Y$PH$US$
242131681$24213168$1$I$$20240802$20240815$20240815$EXP$$ES-B.Braun Medical Inc.-2160497$B BRAUN$$80$YR$$M$Y$74$KG$20240815$$$ES$ES
242131691$24213169$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA239693$SANOFI AVENTIS$$$$A$M$Y$97.52$KG$20240815$$MD$US$US
242131711$24213171$1$I$$20240809$20240815$20240815$EXP$$CA-TAKEDA-2024TUS000517$TAKEDA$$$$$F$Y$$$20240815$$CN$CA$CA
242131731$24213173$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA239971$SANOFI AVENTIS$$$$$M$Y$$$20240815$$CN$US$US
242131741$24213174$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA240465$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240815$$CN$US$US
242131751$24213175$1$I$$20240802$20240815$20240815$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-07567$HIKMA$$$$$$Y$$$20240815$$CN$CA$CA
242131763$24213176$3$F$$20240927$20240815$20240927$PER$$NVSC2024US165359$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
242131771$24213177$1$I$$20240731$20240815$20240815$EXP$$AT-Breckenridge Pharmaceutical, Inc.-2160498$BRECKENRIDGE$Literature Article$83$YR$$F$Y$$$20240815$$$IN$AT
242131781$24213178$1$I$$20240802$20240815$20240815$EXP$$US-UCBSA-2024039600$UCB$$$$$F$Y$$$20240815$$HP$US$US
242131791$24213179$1$I$$20240807$20240815$20240815$EXP$$CA-ROCHE-10000051536$ROCHE$$68$YR$E$M$Y$$$20240815$$HP$CA$CA
242131801$24213180$1$I$$20240813$20240815$20240815$PER$$US-ABBVIE-5881156$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242131811$24213181$1$I$20200620$20240812$20240815$20240815$EXP$$FR-ANIPHARMA-2024-FR-000137$ANI$$95$YR$$F$Y$$$20240815$$PH$FR$FR
242131821$24213182$1$I$$20240805$20240815$20240815$EXP$$US-GSK-US2024AMR098336$GLAXOSMITHKLINE$$$$$M$Y$$$20240815$$CN$US$US
242131831$24213183$1$I$20240705$20240812$20240815$20240815$EXP$$CO-UCBSA-2024041185$UCB$$76$YR$$F$Y$$$20240815$$CN$CO$CO
242131861$24213186$1$I$20240804$20240814$20240814$20240814$DIR$714183$$FDA-CTU$$17$YR$$F$N$48$KG$20240814$N$PH$US$
242131871$24213187$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55976$$FDA-CTU$$84$YR$$M$N$$$20240814$N$$US$
242131881$24213188$1$I$20240814$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56010$$FDA-CTU$$69$YR$$M$N$$$20240814$Y$PH$US$
242131891$24213189$1$I$20240814$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56001$$FDA-CTU$$65$YR$$F$N$$$20240814$Y$PH$US$
242131901$24213190$1$I$20240806$20240814$20240814$20240814$DIR$714184$$FDA-CTU$$48$YR$$F$N$58.5$KG$20240814$N$CN$US$
242131911$24213191$1$I$20240623$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56005$$FDA-CTU$$49$YR$$M$N$$$20240814$N$CN$US$
242131921$24213192$1$I$$20240814$20240814$20240814$DIR$714192$$FDA-CTU$$$$$M$N$$$20240814$N$$US$
242131931$24213193$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55986$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242131971$24213197$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55993$$FDA-CTU$$$$$M$N$$$20240813$N$HP$US$
242131981$24213198$1$I$20240605$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55973$$FDA-CTU$$61$YR$$F$N$$$20240813$N$HP$US$
242131991$24213199$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55972$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242132001$24213200$1$I$$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55966$$FDA-CTU$$$$$M$N$$$20240813$N$HP$US$
242132011$24213201$1$I$$20240814$20240814$20240814$DIR$714193$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242132021$24213202$1$I$20240810$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55975$$FDA-CTU$$65$YR$$F$N$$$20240813$N$HP$US$
242132031$24213203$1$I$20240807$20240814$20240814$20240814$DIR$714186$$FDA-CTU$$44$YR$$F$N$81$KG$20240814$N$PH$US$
242132041$24213204$1$I$$20240814$20240814$20240814$DIR$714205$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242132051$24213205$1$I$$20240814$20240814$20240814$DIR$714194$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242132061$24213206$1$I$20240801$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56004$$FDA-CTU$$56$YR$$M$N$$$20240814$Y$PH$US$
242132071$24213207$1$I$$20240814$20240814$20240814$DIR$714207$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242132091$24213209$1$I$$20240814$20240815$20240815$PER$$US-AMGEN-USASP2024161941$AMGEN$$$$$F$Y$$$20240815$$CN$US$US
242132101$24213210$1$I$$20240811$20240815$20240815$PER$$US-TAKEDA-2024TUS080855$TAKEDA$$$$$F$Y$$$20240815$$CN$US$US
242132112$24213211$2$F$20240710$20240813$20240815$20240821$EXP$$CA-ABBVIE-5879494$ABBVIE$$74$YR$$F$Y$59$KG$20240821$$CN$CA$CA
242132121$24213212$1$I$$20240812$20240815$20240815$PER$$US-TAKEDA-2024TUS080734$TAKEDA$$$$$M$Y$$$20240815$$MD$US$US
242132131$24213213$1$I$$20240806$20240815$20240815$PER$$US-ABBVIE-5870961$ABBVIE$$$$A$$Y$$$20240815$$MD$US$US
242132142$24213214$2$F$$20240812$20240815$20240820$30DAY$$US-GSK-US2024100246$GLAXOSMITHKLINE$$$$$F$Y$$$20240820$$CN$US$US
242132152$24213215$2$F$$20240816$20240815$20240826$EXP$$US-GSK-US2024097594$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
242132161$24213216$1$I$$20240802$20240815$20240815$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07568$HIKMA$$$$$$Y$$$20240815$$CN$CA$CA
242132171$24213217$1$I$$20240813$20240815$20240815$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045524$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240815$$MD$CA$CA
242132182$24213218$2$F$$20240822$20240815$20240830$EXP$$DE-TEVA-VS-3231534$TEVA$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure 2023; 107 107-113.$$$A$F$Y$$$20240830$$MD$DE$DE
242132191$24213219$1$I$20240529$20240809$20240815$20240815$EXP$$US-ABBVIE-5877711$ABBVIE$$60$YR$$F$Y$$$20240815$$CN$US$US
242132201$24213220$1$I$$20240808$20240815$20240815$PER$$JP-Eisai-EC-2024-171798$EISAI$Kohei Hikino et.al.. Results of pembrolizumab/lenvatinib combination therapy at our hospital. Japanese Journal of Gynecological Oncology. 2024; 42(3): 403-.$73$YR$E$F$Y$$$20240815$$MD$JP$JP
242132212$24213221$2$F$20240702$20240812$20240815$20240821$EXP$ES-AEMPS-1559045$ES-Eisai-EC-2024-171846$EISAI$$81$YR$E$M$Y$$$20240821$$MD$ES$ES
242132231$24213223$1$I$20240809$20240808$20240815$20240815$EXP$$CA-CELLTRION INC.-2024CA019524$CELLTRION$$$$$$Y$$$20240815$$HP$CA$CA
242132241$24213224$1$I$20240701$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128144$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240815$$CN$US$US
242132251$24213225$1$I$$20240813$20240815$20240815$PER$$US-ROCHE-10000057573$ROCHE$$37$YR$A$F$Y$$$20240815$$MD$US$US
242132262$24213226$2$F$$20240812$20240815$20240822$EXP$DE-EMA-DD-20240806-7482677-114853$NVSC2024DE165070$NOVARTIS$Driouk L, Schmitt R, Peters A, Heine S, Girschick HJ, Strahm B et al.. Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature. MOLECULAR AND CELLULAR PEDIATRICS. 2021;8(1):5$11$YR$$F$Y$$$20240822$$HP$DE$DE
242132271$24213227$1$I$$20240802$20240815$20240815$EXP$$US-ELI_LILLY_AND_COMPANY-US202408001719$ELI LILLY AND CO$Srikakolapu S.,Sahni D.R.,Madigan L.M..Unique hypersensitivity syndrome secondary to selpercatinib..JAAD Case Reports 2024;50:138-140.DOI:https://doi.org/10.1016/j.jdcr.2024.06.008$75$YR$E$M$Y$$$20240815$$MD$US$US
242132281$24213228$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007299$ELI LILLY AND CO$$$$$M$Y$$$20240815$$CN$US$US
242132291$24213229$1$I$20240701$20240808$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408006682$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240815$$CN$US$US
242132301$24213230$1$I$$20240814$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009189$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240815$$CN$US$US
242132311$24213231$1$I$$20240812$20240815$20240815$EXP$$CN-PFIZER INC-PV202400104602$PFIZER$$$$E$F$Y$$$20240815$$CN$CN$CN
242132322$24213232$2$F$20230428$20240916$20240815$20240918$EXP$$CA-PFIZER INC-202300144929$PFIZER$$86$YR$$M$Y$54.8$KG$20240918$$MD$CA$CA
242132331$24213233$1$I$20240427$20240812$20240815$20240815$EXP$FR-AFSSAPS-BS2024000485$FR-PFIZER INC-202400234521$PFIZER$$7$YR$$F$Y$26$KG$20240815$$MD$FR$FR
242132341$24213234$1$I$20240401$20240812$20240815$20240815$EXP$FR-AFSSAPS-SE2024000342$FR-PFIZER INC-202400095212$PFIZER$$40$YR$$F$Y$56$KG$20240815$$MD$FR$FR
242132352$24213235$2$F$20240715$20240906$20240815$20240909$EXP$FR-AFSSAPS-CF2024000417$FR-PFIZER INC-202400234264$PFIZER$$64$YR$$M$Y$57$KG$20240909$$PH$FR$FR
242132361$24213236$1$I$20240806$20240812$20240815$20240815$EXP$AT-BASGAGES-2024-006055$AT-PFIZER INC-202400234275$PFIZER$$65$YR$$M$Y$49$KG$20240815$$PH$AT$AT
242132381$24213238$1$I$$20240814$20240815$20240815$EXP$$DE-GILEAD-2024-0684177$GILEAD$$$$$F$Y$$$20240815$$MD$DE$DE
242132392$24213239$2$F$20230927$20240808$20240815$20240828$30DAY$$US-GSK-US2024099166$GLAXOSMITHKLINE$$61$YR$$F$Y$50.8$KG$20240828$$MD$US$US
242132401$24213240$1$I$$20240806$20240815$20240815$PER$$US-SA-2024SA237101$SANOFI AVENTIS$$$$A$M$Y$86.182$KG$20240815$$MD$US$US
242132411$24213241$1$I$20240801$20240813$20240815$20240815$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-128862$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240815$$MD$DE$DE
242132421$24213242$1$I$20240601$20240802$20240815$20240815$EXP$$US-UCBSA-2024039871$UCB$$59$YR$$F$Y$124.17$KG$20240815$$HP$US$US
242132431$24213243$1$I$20240101$20240812$20240815$20240815$EXP$$DE-ABBVIE-5876672$ABBVIE$$56$YR$$M$Y$99$KG$20240815$$MD$DE$DE
242132441$24213244$1$I$20180527$20240806$20240815$20240815$EXP$FR-AFSSAPS-PC2024000602$FR-TEVA-VS-3230811$TEVA$$93$YR$$F$Y$44$KG$20240815$$PH$FR$FR
242132451$24213245$1$I$$20240806$20240815$20240815$EXP$$BE-TEVA-VS-3231102$TEVA$$$$$M$Y$$$20240815$$MD$BE$BE
242132461$24213246$1$I$$20240802$20240815$20240815$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07569$HIKMA$$$$$$Y$$$20240815$$CN$CA$CA
242132471$24213247$1$I$$20240814$20240814$20240814$DIR$714208$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242132481$24213248$1$I$$20240814$20240814$20240814$DIR$714216$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242132501$24213250$1$I$20240727$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56007$$FDA-CTU$$77$YR$$F$N$$$20240814$Y$HP$US$
242132511$24213251$1$I$20230901$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55994$$FDA-CTU$$75$YR$$F$N$59.6$KG$20240814$N$PH$US$
242132521$24213252$1$I$$20240814$20240814$20240814$DIR$714217$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242132551$24213255$1$I$20240801$20240814$20240814$20240814$DIR$714197$$FDA-CTU$$9$YR$$F$N$47.1$KG$20240814$N$HP$US$
242132561$24213256$1$I$$20240814$20240814$20240814$DIR$714220$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242132581$24213258$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55963$$FDA-CTU$$55$YR$$M$N$$$20240814$N$$US$
242132591$24213259$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55983$$FDA-CTU$$65$YR$$M$N$162$LBS$20240814$N$$US$
242132612$24213261$2$F$20240301$20240807$20240815$20240828$30DAY$$US-GSK-US2024098576$GLAXOSMITHKLINE$$66$YR$$F$Y$73$KG$20240828$$MD$US$US
242132621$24213262$1$I$$20240813$20240815$20240815$EXP$$CO-PFIZER INC-PV202400105882$PFIZER$$86$YR$$M$Y$$$20240815$$CN$CO$CO
242132631$24213263$1$I$20220416$20240812$20240815$20240815$EXP$$IT-PFIZER INC-202400234380$PFIZER$$76$YR$$M$Y$66$KG$20240815$$HP$IT$IT
242132642$24213264$2$F$$20240816$20240815$20240821$EXP$$US-PFIZER INC-202400234955$PFIZER$$74$YR$$F$Y$$$20240821$$CN$US$US
242132651$24213265$1$I$$20240812$20240815$20240815$EXP$$US-PFIZER INC-2000029117US$PFIZER$$$$$F$Y$$$20240815$$CN$US$US
242132661$24213266$1$I$20240731$20240812$20240815$20240815$EXP$FR-AFSSAPS-BX2024001618$FR-PFIZER INC-202400234511$PFIZER$$17$MON$$F$Y$9.6$KG$20240815$$HP$FR$FR
242132672$24213267$2$F$$20240815$20240815$20240819$EXP$$US-PFIZER INC-202400236353$PFIZER$$41$YR$$M$Y$$$20240819$$MD$US$US
242132681$24213268$1$I$20240101$20240812$20240815$20240815$EXP$$CA-PFIZER INC-202400236061$PFIZER$$65$YR$$F$Y$$$20240815$$HP$CA$CA
242132691$24213269$1$I$20230101$20240813$20240815$20240815$EXP$$US-PFIZER INC-PV202400105847$PFIZER$$$$E$F$Y$$$20240815$$HP$US$US
242132701$24213270$1$I$20240601$20240812$20240815$20240815$EXP$ES-AEMPS-1555763$ES-PFIZER INC-202400234301$PFIZER$$43$YR$$M$Y$84$KG$20240815$$PH$ES$ES
242132711$24213271$1$I$20240101$20240812$20240815$20240815$EXP$$CA-PFIZER INC-202400236710$PFIZER$$41$YR$$F$Y$$$20240815$$MD$CA$CA
242132721$24213272$1$I$20240201$20240812$20240815$20240815$EXP$$US-PFIZER INC-202400235978$PFIZER$$69$YR$$M$Y$$$20240815$$HP$US$US
242132732$24213273$2$F$20240601$20240818$20240815$20240821$EXP$ES-AEMPS-1559076$ES-PFIZER INC-202400234327$PFIZER$$5$DY$$F$Y$$$20240821$$MD$ES$ES
242132741$24213274$1$I$20240316$20240812$20240815$20240815$EXP$ES-AEMPS-1557692$ES-PFIZER INC-202400234308$PFIZER$$38$YR$$F$Y$65$KG$20240815$$MD$ES$ES
242132751$24213275$1$I$20240812$20240812$20240815$20240815$EXP$$US-PFIZER INC-202400236175$PFIZER$$86$YR$$F$Y$$$20240815$$HP$US$US
242132761$24213276$1$I$$20240812$20240815$20240815$EXP$$CA-PFIZER INC-202400236638$PFIZER$$41$YR$$F$Y$$$20240815$$MD$CA$CA
242132771$24213277$1$I$20240603$20240812$20240815$20240815$EXP$FR-AFSSAPS-BX2024001560$FR-PFIZER INC-202400234555$PFIZER$$68$YR$$M$Y$$$20240815$$PH$FR$FR
242132781$24213278$1$I$20240301$20240806$20240815$20240815$30DAY$$US-GSK-US2024098111$GLAXOSMITHKLINE$$$$$F$Y$$$20240815$$CN$US$US
242132792$24213279$2$F$20210902$20240904$20240815$20240906$EXP$$CA-PFIZER INC-202100976144$PFIZER$$64$YR$$M$Y$75$KG$20240906$$MD$CA$CA
242132801$24213280$1$I$20240101$20240809$20240815$20240815$PER$$US-SA-2024SA240365$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240815$$MD$US$US
242132811$24213281$1$I$$20240814$20240814$20240814$DIR$714222$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242132821$24213282$1$I$20240701$20240808$20240815$20240815$PER$$US-SA-2024SA240746$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240815$$MD$US$US
242132831$24213283$1$I$20240804$20240812$20240815$20240815$EXP$$US-PFIZER INC-202400234938$PFIZER$$64$YR$$F$Y$$$20240815$$PH$US$US
242132841$24213284$1$I$20240401$20240813$20240815$20240815$EXP$$US-ABBVIE-5880212$ABBVIE$$91$YR$$F$Y$$$20240815$$CN$US$US
242132851$24213285$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129330$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240815$$CN$US$US
242132861$24213286$1$I$$20240809$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127163$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240815$$CN$US$US
242132871$24213287$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55969$$FDA-CTU$$33$YR$$M$N$$$20240814$N$$US$
242132881$24213288$1$I$$20240807$20240815$20240815$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004949$SAREPTA THERAPEUTICS$$$$$M$Y$72.57$KG$20240815$$HP$US$US
242132891$24213289$1$I$20230410$20240814$20240814$20240814$DIR$714189$$FDA-CTU$$18$YR$$M$N$74.7$KG$20240814$N$PH$US$
242132901$24213290$1$I$20240813$20240814$20240814$20240814$DIR$714223$$FDA-CTU$$69$YR$$F$N$58.5$KG$20240814$N$CN$US$
242132911$24213291$1$I$$20230301$20240815$20240815$EXP$$US-AstraZeneca-2023A051957$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
242132921$24213292$1$I$$20230602$20240815$20240815$EXP$$US-AstraZeneca-2023A129648$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242132931$24213293$1$I$$20230610$20240815$20240815$EXP$$GB-AstraZeneca-2023A135480$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$GB$
242132941$24213294$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55996$$FDA-CTU$$22$YR$$F$N$$$20240814$N$$US$
242132951$24213295$1$I$$20240814$20240814$20240814$DIR$714235$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242132961$24213296$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55967$$FDA-CTU$$74$YR$$F$N$$$20240814$N$$US$
242132971$24213297$1$I$$20240814$20240814$20240814$DIR$714227$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242132981$24213298$1$I$$20240810$20240815$20240815$EXP$$US-AstraZeneca-2024A182793$ASTRAZENECA$$$$A$F$Y$$$20240815$$MD$US$
242132991$24213299$1$I$20240810$20240813$20240815$20240815$EXP$$ZA-AstraZeneca-2024A184870$ASTRAZENECA$$78$YR$$F$Y$$$20240815$$CN$ZA$
242133001$24213300$1$I$20240811$20240814$20240815$20240815$EXP$$IN-PFIZER INC-PV202400106038$PFIZER$$66$YR$$M$Y$$$20240815$$CN$IN$IN
242133011$24213301$1$I$$20240813$20240815$20240815$EXP$$CN-PFIZER INC-PV202400105407$PFIZER$$$$A$M$Y$$$20240815$$CN$CN$CN
242133021$24213302$1$I$20240717$20240814$20240815$20240815$EXP$$US-PFIZER INC-202400236922$PFIZER$$76$YR$$M$Y$$$20240815$$CN$US$US
242133032$24213303$2$F$20240724$20240815$20240815$20240816$EXP$$US-PFIZER INC-PV202400105978$PFIZER$$87$YR$$M$Y$$$20240816$$CN$US$US
242133051$24213305$1$I$20240501$20240814$20240815$20240815$EXP$$CL-PFIZER INC-PV202400105951$PFIZER$$69$YR$$F$Y$$$20240815$$CN$CL$CL
242133061$24213306$1$I$$20240813$20240815$20240815$EXP$$US-PFIZER INC-202400235801$PFIZER$$$$E$M$Y$$$20240815$$PH$US$US
242133071$24213307$1$I$20240323$20240813$20240815$20240815$EXP$ES-AEMPS-1534338$ES-PFIZER INC-202400235296$PFIZER$$$$A$F$Y$$$20240815$$PH$ES$ES
242133082$24213308$2$F$20190918$20240826$20240815$20240830$EXP$$PL-MYLANLABS-2024M1073889$MYLAN$$62$YR$$M$Y$98$KG$20240830$$MD$PL$PL
242133091$24213309$1$I$$20240812$20240815$20240815$EXP$$CA-MEDUNIK-2024CA000318$DUCHESNAY$$$$$$Y$$$20240815$$HP$CA$CA
242133101$24213310$1$I$$20240809$20240815$20240815$30DAY$$US-GSK-US2024099763$GLAXOSMITHKLINE$$$$$F$Y$$$20240815$$HP$US$US
242133111$24213311$1$I$20240301$20240809$20240815$20240815$30DAY$$US-GSK-US2024099711$GLAXOSMITHKLINE$$$$$F$Y$$$20240815$$CN$US$US
242133121$24213312$1$I$$20240814$20240815$20240815$PER$$US-AMGEN-USASP2024162183$AMGEN$$$$$$Y$$$20240815$$CN$US$US
242133132$24213313$2$F$$20240807$20240815$20240919$EXP$$NVSC2024JP164803$NOVARTIS$Iwawaki A, Hida Y, Nakano R, Matsuura M.. A case of porokeratosis occurring during immunosuppressant therapy for nephrotic syndrome. WEST JAPAN DERMATOLOGY. 2024;86(1):95$60$YR$$M$Y$$$20240919$$HP$JP$JP
242133151$24213315$1$I$$20240814$20240815$20240815$PER$$US-AMGEN-USASP2024162129$AMGEN$$$$A$F$Y$$$20240815$$CN$US$US
242133161$24213316$1$I$$20240814$20240815$20240815$EXP$$US-GILEAD-2024-0684285$GILEAD$$$$A$F$Y$$$20240815$$CN$US$US
242133171$24213317$1$I$20211217$20240806$20240815$20240815$EXP$$FR-SERVIER-S24010019$SERVIER$$$$$$Y$$$20240815$$MD$FR$FR
242133182$24213318$2$F$$20240915$20240815$20240916$30DAY$$US-PFIZER INC-202400230925$PFIZER$$12$YR$$M$Y$$$20240916$$CN$US$US
242133192$24213319$2$F$20230101$20240905$20240815$20240909$EXP$FR-AFSSAPS-TO2024001524$FR-PFIZER INC-202400234228$PFIZER$$2$YR$$F$Y$12$KG$20240909$$MD$FR$FR
242133211$24213321$1$I$$20240814$20240815$20240815$PER$$NVSC2024US165471$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
242133231$24213323$1$I$$20240814$20240814$20240814$DIR$714230$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242133251$24213325$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56006$$FDA-CTU$$67$YR$$M$N$$$20240814$N$CN$US$
242133261$24213326$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55987$$FDA-CTU$$59$YR$$F$N$$$20240814$N$$US$
242133271$24213327$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56011$$FDA-CTU$$51$YR$$F$N$$$20240814$N$$US$
242133281$24213328$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55961$$FDA-CTU$$65$YR$$M$N$$$20240814$N$$US$
242133291$24213329$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55962$$FDA-CTU$$65$YR$$M$N$$$20240814$N$$US$
242133301$24213330$1$I$$20240802$20240815$20240815$EXP$$ES-B.Braun Medical Inc.-2160499$B BRAUN$$53$YR$$M$Y$$$20240815$$$ES$ES
242133311$24213331$1$I$$20240709$20240815$20240815$PER$$US-Eisai-EC-2024-169822$EISAI$$$$$$Y$$$20240815$$MD$US$US
242133321$24213332$1$I$$20240812$20240815$20240815$EXP$$US-ABBVIE-5878497$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242133331$24213333$1$I$20240224$20240807$20240815$20240815$EXP$$CN-009507513-2408CHN003620$MERCK$$64$YR$$M$Y$40$KG$20240815$$HP$CN$CN
242133341$24213334$1$I$$20240808$20240815$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-128341$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240815$$PH$JP$JP
242133351$24213335$1$I$$20240806$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128881$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240815$$PH$US$US
242133361$24213336$1$I$$20240813$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128859$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240815$$CN$US$US
242133371$24213337$1$I$20230407$20240812$20240815$20240815$EXP$$KR-MYLANLABS-2024M1075027$MYLAN$$37$YR$$F$Y$58$KG$20240815$$HP$KR$KR
242133383$24213338$3$F$$20240904$20240815$20240906$30DAY$$US-PFIZER INC-PV202400100210$PFIZER$$4$YR$$F$Y$$$20240906$$HP$US$US
242133393$24213339$3$F$$20240914$20240815$20240916$30DAY$$US-PFIZER INC-202400204705$PFIZER$$12$YR$$M$Y$51.3$KG$20240916$$CN$US$US
242133402$24213340$2$F$$20240820$20240815$20240822$30DAY$$US-PFIZER INC-PV202400072252$PFIZER$$$$$$Y$$$20240822$$HP$US$US
242133411$24213341$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-55974$$FDA-CTU$$70$YR$$F$N$$$20240814$N$$US$
242133423$24213342$3$F$$20240920$20240815$20240920$30DAY$$US-PFIZER INC-202400234956$PFIZER$$$$$F$Y$$$20240920$$PH$US$US
242133431$24213343$1$I$20240810$20240813$20240814$20240814$DIR$FDA-CDER-CTU-2024-55965$$FDA-CTU$$65$YR$$F$N$$$20240813$N$$US$
242133452$24213345$2$F$$20240820$20240815$20240820$30DAY$$US-PFIZER INC-202400227727$PFIZER$$10$YR$$F$Y$$$20240820$$CN$US$US
242133461$24213346$1$I$20240805$20240814$20240814$20240814$DIR$714233$$FDA-CTU$$64$YR$$M$N$$$20240814$$CN$US$
242133471$24213347$1$I$$20240814$20240814$20240814$DIR$714236$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242133481$24213348$1$I$20240803$20240814$20240814$20240814$DIR$714237$$FDA-CTU$$81$YR$$F$N$40$KG$20240814$N$$US$
242133491$24213349$1$I$$20240812$20240815$20240815$EXP$$CA-PFIZER INC-202400234967$PFIZER$$75$YR$$F$Y$$$20240815$$HP$CA$CA
242133501$24213350$1$I$$20240808$20240815$20240815$30DAY$$JP-PFIZER INC-PV202400103788$PFIZER$$$$C$M$Y$$$20240815$$CN$JP$JP
242133511$24213351$1$I$$20240812$20240815$20240815$EXP$$GB-PFIZER INC-PV202400104728$PFIZER$$1$YR$$F$Y$$$20240815$$CN$GB$GB
242133522$24213352$2$F$$20240814$20240815$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009265$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240819$$CN$US$US
242133531$24213353$1$I$20240806$20240807$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408005060$ELI LILLY AND CO$$46$YR$A$$Y$$$20240815$$CN$US$US
242133541$24213354$1$I$$20240814$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009192$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240815$$CN$US$US
242133551$24213355$1$I$$20240807$20240815$20240815$30DAY$$US-PFIZER INC-202400232381$PFIZER$$9$YR$$M$Y$$$20240815$$CN$US$US
242133561$24213356$1$I$20240401$20240807$20240815$20240815$EXP$$US-GSK-US2024098541$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$CN$US$US
242133571$24213357$1$I$$20240804$20240815$20240815$PER$$US-MYLANLABS-2024M1073250$MYLAN$$$$$$Y$$$20240815$$CN$US$US
242133604$24213360$4$F$20240808$20240920$20240815$20240925$30DAY$$US-PFIZER INC-202400233972$PFIZER$$16$YR$$M$Y$90.703$KG$20240925$$MD$US$US
242133621$24213362$1$I$$20240812$20240815$20240815$EXP$$CA-PFIZER INC-202400234963$PFIZER$$79$YR$$M$Y$$$20240815$$PH$CA$CA
242133632$24213363$2$F$$20240915$20240815$20240916$30DAY$$US-PFIZER INC-202400230721$PFIZER$$24$YR$$M$Y$$$20240916$$CN$US$US
242133641$24213364$1$I$$20240808$20240815$20240815$PER$$US-MYLANLABS-2024M1075024$MYLAN$$$$$M$Y$$$20240815$$MD$US$US
242133653$24213365$3$F$$20240920$20240815$20240926$30DAY$$US-PFIZER INC-202400231724$PFIZER$$10$YR$$F$Y$$$20240926$$CN$US$US
242133661$24213366$1$I$20240715$20240809$20240815$20240815$EXP$$CO-AstraZeneca-2024A184630$ASTRAZENECA$$25593$DY$$F$Y$58$KG$20240815$$CN$CO$
242133671$24213367$1$I$$20220531$20240815$20240815$EXP$$US-AstraZeneca-2022A206458$ASTRAZENECA$$$$$$Y$48.5$KG$20240815$$CN$US$
242133681$24213368$1$I$$20230216$20240815$20240815$EXP$$IN-AstraZeneca-2023A042099$ASTRAZENECA$$71$YR$$M$Y$$$20240815$$CN$IN$
242133691$24213369$1$I$$20240807$20240815$20240815$EXP$$VN-AstraZeneca-2024A183927$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$VN$
242133701$24213370$1$I$20240704$20240807$20240815$20240815$EXP$$CN-AstraZeneca-2024A182900$ASTRAZENECA$$66$YR$$M$Y$$$20240815$$MD$CN$
242133711$24213371$1$I$$20240802$20240815$20240815$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07764$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240815$$HP$US$US
242133721$24213372$1$I$$20230921$20240815$20240815$EXP$$US-AstraZeneca-2023A216308$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242133731$24213373$1$I$$20220823$20240815$20240815$EXP$$US-AstraZeneca-2022A296296$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
242133741$24213374$1$I$20240602$20240807$20240815$20240815$EXP$$ES-AstraZeneca-2024A185724$ASTRAZENECA$$52$YR$$M$Y$$$20240815$$MD$ES$
242133751$24213375$1$I$$20240813$20240815$20240815$EXP$$US-ABBVIE-5880431$ABBVIE$$$$$F$Y$$$20240815$$HP$US$US
242133761$24213376$1$I$$20220809$20240815$20240815$EXP$$US-AstraZeneca-2022A283259$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242133771$24213377$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129236$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240815$$CN$US$US
242133781$24213378$1$I$20240808$20240813$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128734$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240815$$CN$US$US
242133791$24213379$1$I$20240731$20240814$20240814$20240814$DIR$714240$$FDA-CTU$$64$YR$$F$N$56.8$KG$20240814$N$MD$US$
242133801$24213380$1$I$$20240814$20240814$20240814$DIR$714201$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242133811$24213381$1$I$$20240814$20240814$20240814$DIR$714244$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242133821$24213382$1$I$$20240814$20240814$20240814$DIR$714249$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242133831$24213383$1$I$20240326$20240814$20240814$20240814$DIR$714245$$FDA-CTU$$34$YR$$F$N$123.75$KG$20240814$N$CN$US$
242133851$24213385$1$I$20240813$20240814$20240814$20240814$DIR$714232$$FDA-CTU$$73$YR$$M$N$76.6$KG$20240814$N$PH$US$
242133861$24213386$1$I$20240814$20240814$20240814$20240814$DIR$714247$$FDA-CTU$$89$YR$$F$N$$$20240814$N$$US$
242133871$24213387$1$I$20240201$20240806$20240815$20240815$PER$$US-ROCHE-10000050410$ROCHE$$74$YR$E$F$Y$68.95$KG$20240815$$CN$US$US
242133881$24213388$1$I$$20240814$20240814$20240814$DIR$714251$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242133892$24213389$2$F$$20240812$20240815$20240819$EXP$$US-PFIZER INC-202400236017$PFIZER$Green, K.. The Emergence of Bromazolam in Jefferson County AL. A Case Series. Journal of analytical toxicology. 2024;10.1093/jat/bkae067$20$YR$$M$Y$$$20240819$$MD$US$US
242133921$24213392$1$I$$20240814$20240814$20240814$DIR$714253$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242133941$24213394$1$I$20231102$20231113$20240815$20240815$DIR$FDA-CDER-CTU-2024-55989$$FDA-CTU$$$$$F$N$57.2$KG$20231113$N$$US$
242133961$24213396$1$I$$20240814$20240814$20240814$DIR$714203$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242133972$24213397$2$F$$20240812$20240815$20240819$EXP$$US-PFIZER INC-202400236018$PFIZER$Green, K.. The Emergence of Bromazolam in Jefferson County AL. A Case Series. Journal of analytical toxicology. 2024;10.1093/jat/bkae067$34$YR$$F$Y$$$20240819$$MD$US$US
242133982$24213398$2$F$$20240812$20240815$20240819$EXP$$US-PFIZER INC-202400236016$PFIZER$Green, K.. The Emergence of Bromazolam in Jefferson County AL. A Case Series. Journal of analytical toxicology. 2024;10.1093/jat/bkae067$20$YR$$M$Y$$$20240819$$MD$US$US
242133992$24213399$2$F$$20240812$20240815$20240819$EXP$$US-PFIZER INC-202400236007$PFIZER$Green, K.. The Emergence of Bromazolam in Jefferson County AL. A Case Series. Journal of analytical toxicology. 2024;10.1093/jat/bkae067$25$YR$$M$Y$$$20240819$$MD$US$US
242134012$24213401$2$F$$20240923$20240815$20240924$30DAY$$AR-PFIZER INC-202400233763$PFIZER$$11$YR$$F$Y$$$20240924$$CN$AR$AR
242134023$24213402$3$F$20240719$20240822$20240815$20240828$PER$$US-AMGEN-USASP2024155550$AMGEN$$64$YR$A$M$Y$90.72$KG$20240828$$PH$US$US
242134031$24213403$1$I$20240701$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160072$AMGEN$$80$YR$E$M$Y$$$20240815$$CN$US$US
242134041$24213404$1$I$$20240808$20240815$20240815$PER$$US-ABBVIE-5875881$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242134051$24213405$1$I$$20240813$20240815$20240815$EXP$$US-ABBVIE-5880586$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242134061$24213406$1$I$20240401$20240806$20240815$20240815$EXP$$US-Sprout Pharmaceuticals, Inc.-2024SP000239$SPROUT PHARMACEUTICALS$$46$YR$A$F$Y$$$20240813$$CN$US$US
242134072$24213407$2$F$20240101$20240917$20240815$20240923$EXP$$US-ABBVIE-5879148$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
242134091$24213409$1$I$20240710$20240808$20240815$20240815$EXP$$PK-ROCHE-10000052453$ROCHE$$59$YR$A$M$Y$$$20240815$$CN$PK$PK
242134101$24213410$1$I$$20240812$20240815$20240815$EXP$$US-ABBVIE-5878619$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242134111$24213411$1$I$$20240813$20240815$20240815$PER$$US-009507513-2408USA004713$MERCK$$$$$F$Y$$$20240815$$HP$US$US
242134121$24213412$1$I$20240101$20240813$20240815$20240815$PER$$US-009507513-2408USA004693$MERCK$$$$$F$Y$$$20240815$$HP$US$US
242134133$24213413$3$F$20231001$20240917$20240815$20240925$EXP$$AT-SERVIER-S24008119$SERVIER$$$$$$Y$$$20240925$$MD$AT$AT
242134162$24213416$2$F$$20240918$20240815$20240923$30DAY$$KR-PFIZER INC-202400235688$PFIZER$$9$YR$$$Y$$$20240923$$CN$KR$KR
242134181$24213418$1$I$$20240814$20240814$20240814$DIR$714204$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242134191$24213419$1$I$20240812$20240814$20240815$20240815$DIR$FDA-CDER-CTU-2024-55990$$FDA-CTU$$71$YR$$M$N$141$KG$20240814$N$$US$
242134201$24213420$1$I$$20240805$20240815$20240815$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000163$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240815$$HP$US$US
242134212$24213421$2$F$$20240910$20240815$20240917$30DAY$$US-GSK-US2024100369$GLAXOSMITHKLINE$$$$$M$Y$$$20240917$$CN$US$US
242134221$24213422$1$I$20240719$20240807$20240815$20240815$EXP$$US-RIGEL-20240800039$RIGEL PHARMACEUTICALS$$82$YR$$M$Y$95.254$KG$20240815$$CN$US$US
242134231$24213423$1$I$20240101$20240812$20240815$20240815$EXP$$US-ABBVIE-5878549$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242134241$24213424$1$I$20240806$20240813$20240815$20240815$EXP$$CA-ABBVIE-5880909$ABBVIE$$80$YR$$M$Y$$$20240815$$CN$CA$CA
242134251$24213425$1$I$20240521$20240813$20240815$20240815$EXP$FR-AFSSAPS-RN2024000873$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-128143$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$83$KG$20240815$$MD$FR$FR
242134261$24213426$1$I$20240731$20240812$20240815$20240815$EXP$$US-OTSUKA-2024_015885$OTSUKA$$69$YR$$M$Y$72.57$KG$20240815$$CN$US$US
242134272$24213427$2$F$20240810$20240819$20240815$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408007620$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240823$$CN$US$US
242134292$24213429$2$F$$20240809$20240815$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408007351$ELI LILLY AND CO$$$$$F$Y$$$20240904$$CN$US$US
242134301$24213430$1$I$$20240807$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125627$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240815$$PH$US$US
242134333$24213433$3$F$$20240905$20240815$20240905$PER$$US-ALXN-202408USA000470US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242134341$24213434$1$I$$20240812$20240815$20240815$EXP$$CA-PFIZER INC-202400235750$PFIZER$$33$YR$$F$Y$63$KG$20240815$$HP$CA$CA
242134352$24213435$2$F$$20240828$20240815$20240829$EXP$$GB-PFIZER INC-PV202400105157$PFIZER$Wilson, H.. Clearance of Hepatitis C Virus following Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma: Case Report. Case Reports in Gastroenterology. 2024;18(1):347-351$42$YR$$M$Y$$$20240829$$HP$GB$GB
242134362$24213436$2$F$$20240919$20240815$20240919$30DAY$$CO-PFIZER INC-202400233045$PFIZER$$5$YR$$F$Y$$$20240919$$MD$CO$CO
242134381$24213438$1$I$$20240812$20240815$20240815$EXP$$US-PFIZER INC-202300429725$PFIZER$$102$YR$$F$Y$$$20240815$$HP$US$US
242134391$24213439$1$I$$20240813$20240815$20240815$EXP$$BR-PFIZER INC-PV202400105852$PFIZER$$$$$$Y$$$20240815$$MD$BR$BR
242134401$24213440$1$I$$20240812$20240815$20240815$EXP$$US-PFIZER INC-PV202400105410$PFIZER$Lynch, D.. QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: A case report and review of the literature. Cardiology Journal. 2012;19(4):434-438$49$YR$$M$Y$$$20240815$$HP$US$US
242134411$24213441$1$I$$20240806$20240815$20240815$DIR$FDA-CDER-CTU-2024-55992$$FDA-CTU$$$$$F$N$81$KG$20240806$N$$US$
242134421$24213442$1$I$$20240812$20240815$20240815$EXP$$JP-PFIZER INC-202400235457$PFIZER$Shimizu, A.. Active flare of IgA nephropathy during long-term therapy with anti-tumor necrosis factor-alpha antibody drugs for Crohn^s disease: three case reports and literature review. CEN Case Reports. 2024;13(4):249-257$3$DEC$$M$Y$62.5$KG$20240815$$HP$JP$JP
242134431$24213443$1$I$$20240812$20240815$20240815$EXP$$CA-PFIZER INC-202400235743$PFIZER$$11$YR$$F$Y$$$20240815$$HP$CA$CA
242134443$24213444$3$F$$20240830$20240815$20240904$EXP$$JP-PFIZER INC-PV202400105130$PFIZER$Shimizu, A.. Active flare of IgA nephropathy during long-term therapy with anti-tumor necrosis factor-alpha antibody drugs for Crohn^s disease: three case reports and literature review. CEN Case Reports. 2024;13(4):249-257$5$DEC$$M$Y$65$KG$20240904$$HP$JP$JP
242134452$24213445$2$F$$20240815$20240815$20240819$EXP$$JP-PFIZER INC-202400236294$PFIZER$Onishi, Y.. Emphysematous osteomyelitis of the lumbar spine and sacrum after liver transplantation: A case report.. Cureus. 2024;16(7):10.7759/cureus.63748$62$YR$$M$Y$$$20240819$$MD$JP$JP
242134461$24213446$1$I$20240808$20240814$20240815$20240815$DIR$FDA-CDER-CTU-2024-55995$$FDA-CTU$$20$YR$$M$N$71$KG$20240814$N$$US$
242134471$24213447$1$I$20240801$20240807$20240815$20240815$EXP$$PE-AstraZeneca-2024A182800$ASTRAZENECA$$16679$DY$$F$Y$$$20240815$$CN$PE$
242134481$24213448$1$I$20240812$20240812$20240815$20240815$EXP$$PL-AstraZeneca-2024A185804$ASTRAZENECA$$$$$M$Y$$$20240815$$HP$PL$
242134491$24213449$1$I$$20240812$20240815$20240815$EXP$$CA-PFIZER INC-202400235758$PFIZER$$89$YR$$F$Y$72$KG$20240815$$HP$CA$CA
242134501$24213450$1$I$20240201$20240802$20240815$20240815$EXP$$TW-UCBSA-2024039633$UCB$$67$YR$$F$Y$$$20240815$$MD$TW$TW
242134511$24213451$1$I$20230601$20240812$20240815$20240815$EXP$ES-AEMPS-1461792$ES-ABBVIE-5876291$ABBVIE$$52$YR$$M$Y$90$KG$20240815$$MD$ES$ES
242134521$24213452$1$I$$20240812$20240815$20240815$EXP$$US-ABBVIE-5880575$ABBVIE$$$$$$Y$$$20240815$$HP$US$US
242134531$24213453$1$I$$20240813$20240815$20240815$EXP$$US-BAYER-2024A116828$BAYER$$73$YR$E$F$Y$$$20240815$$HP$US$US
242134551$24213455$1$I$$20240808$20240815$20240815$EXP$$CN-ROCHE-10000053061$ROCHE$Wang M, Honglin L, Lihual Y, Weiron Y. Analysis of efficacy and prognostic factors of R-CHOP in treatment of elderly patients with diffuse large B-cell lymphoma. Geriatrics + Health Care. 2024;30 (3):P655-P667.$$$$$Y$$$20240815$$HP$CN$CN
242134562$24213456$2$F$$20240821$20240815$20240826$EXP$$BR-AKCEA THERAPEUTICS, INC.-2024IS006117$AKCEA THERAPEUTICS$$$$$$Y$$$20240826$$CN$BR$BR
242134571$24213457$1$I$$20240814$20240815$20240815$PER$$US-GILEAD-2024-0684226$GILEAD$$$$$M$Y$$$20240815$$HP$US$US
242134582$24213458$2$F$$20240826$20240815$20240903$EXP$$US-TEVA-VS-3231828$TEVA$Gorbonos A, Kamat A, Williams B, Rodriguez G, Bahtiyar G. Pheochromocytoma in a Pregnant Woman with VHL leading to First Trimester Fetal Demise. J-Endocr-Soc 2022; 6 (Suppl. 1) A93.; Gorbonos A, Kamat A, Williams B, Rodriguez G, Bahtiyar G. Pheochromocytoma in a Pregnant Woman with VHL leading to First Trimester Fetal Demise. J-Endocr-Soc 2022; 6 (Suppl. 1) A93.$39$YR$$F$Y$$$20240903$$HP$US$US
242134601$24213460$1$I$20240727$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56012$$FDA-CTU$$63$YR$$F$N$51.4$KG$20240815$N$$US$
242134611$24213461$1$I$20240731$20240802$20240815$20240815$DIR$FDA-CDER-CTU-2024-55997$$FDA-CTU$$83$YR$$M$N$51.5$KG$20240802$N$$US$
242134621$24213462$1$I$20240725$20240806$20240815$20240815$DIR$FDA-CDER-CTU-2024-56013$$FDA-CTU$$71$YR$$F$N$72.7$KG$20240806$N$$US$
242134641$24213464$1$I$$20240727$20240815$20240815$30DAY$$US-Kaleo, Inc.-2024KL000027$KALEO$$12$YR$T$M$Y$$$20240813$$CN$US$US
242134651$24213465$1$I$20240422$20240814$20240815$20240815$DIR$FDA-CDER-CTU-2024-56015$$FDA-CTU$$68$YR$$F$N$59.6$KG$20240814$N$$US$
242134661$24213466$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA241850$SANOFI AVENTIS$$$$A$F$Y$70.3$KG$20240815$$MD$US$US
242134671$24213467$1$I$20240718$20240808$20240815$20240815$DIR$FDA-CDER-CTU-2024-56014$$FDA-CTU$$74$YR$$M$N$97.5$KG$20240808$N$$US$
242134682$24213468$2$F$20240501$20240910$20240815$20240925$EXP$$IN-CIPLA LTD.-2024IN08517$CIPLA$$$$$$Y$$$20240925$$CN$IN$IN
242134692$24213469$2$F$20240724$20240909$20240815$20240917$EXP$$AR-AKCEA THERAPEUTICS, INC.-2024IS006244$AKCEA THERAPEUTICS$$$$$$Y$$$20240913$$CN$AR$AR
242134701$24213470$1$I$$20240804$20240815$20240815$EXP$$US-NOVOPROD-1267306$NOVO NORDISK$$42$YR$$$Y$$$20240815$$CN$US$US
242134711$24213471$1$I$$20240804$20240815$20240815$EXP$$US-NOVOPROD-1267347$NOVO NORDISK$$45$YR$$$Y$$$20240815$$CN$US$US
242134722$24213472$2$F$$20240827$20240815$20240909$EXP$$SK-NOVOPROD-1266643$NOVO NORDISK$Ingrid Draveck? et al.,. Transplantation of the islets of Langerhans present and future. proL?ka?e.cz. 2024;13(2):79-89$43$YR$$F$Y$$$20240909$$MD$SK$SK
242134732$24213473$2$F$$20240912$20240815$20240926$EXP$$AU-CIPLA LTD.-2024AU08613$CIPLA$Kaul R, Soosapilla K, Nguyen C, Fathieh S, Premawardhana U, Kadappu K. Takotsubo^s cardiomyopathy post-commencement of oral Azacitidine for NPM1+ AML. Heart Lung and Circulation. 2024;33(4):S288 to S289$$$$$Y$$$20240926$$HP$AU$AU
242134751$24213475$1$I$$20240804$20240815$20240815$EXP$$US-NOVOPROD-1267655$NOVO NORDISK$$67$YR$$$Y$$$20240815$$CN$US$US
242134783$24213478$3$F$$20231016$20240815$20240927$PER$$US-VIVUS LLC-2023V1001148$VIVUS$$60$YR$A$F$Y$$$20240912$$CN$US$US
242134791$24213479$1$I$$20240808$20240815$20240815$PER$$US-ABBVIE-5874163$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242134801$24213480$1$I$20240101$20240808$20240815$20240815$EXP$$US-SA-2024SA238780$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240815$$MD$US$US
242134811$24213481$1$I$20231024$20240807$20240815$20240815$PER$$US-ABBVIE-5872391$ABBVIE$$$$$F$Y$$$20240815$$HP$US$US
242134821$24213482$1$I$20240622$20240812$20240815$20240815$EXP$$ZA-AstraZeneca-2024A184375$ASTRAZENECA$$79$YR$$M$Y$$$20240815$$CN$ZA$
242134831$24213483$1$I$20240727$20240805$20240815$20240815$PER$$US-RDY-SPO/USA/24/0011716$DR REDDYS$$76$YR$E$M$Y$86$KG$20240815$$MD$US$US
242134841$24213484$1$I$$20240812$20240815$20240815$EXP$$US-AstraZeneca-2024A183446$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242134851$24213485$1$I$$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161817$AMGEN$$$$$$Y$$$20240815$$CN$US$US
242134861$24213486$1$I$20240101$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024161014$AMGEN$$48$YR$A$M$Y$$$20240815$$CN$US$US
242134872$24213487$2$F$20240810$20240813$20240815$20240819$EXP$$US-BAYER-2024A117363$BAYER$$55$YR$A$M$Y$69.388$KG$20240819$$HP$US$US
242134964$24213496$4$F$$20240928$20240815$20240930$30DAY$$US-PFIZER INC-202400234566$PFIZER$$13$YR$$F$Y$$$20240930$$CN$US$US
242134971$24213497$1$I$$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008420$ELI LILLY AND CO$$$$A$M$Y$$$20240815$$CN$US$US
242134991$24213499$1$I$$20240812$20240815$20240815$EXP$$IT-GILEAD-2024-0684003$GILEAD$Cicetti D., Vitale S., Appolloni L., Pensalfine G., Traficante M., Caprara R etal. THE USE OF PRE-EXPOSURE PROPHYLAXIS (PREP) IN THE CONTROL OF HIV INFECTION AND OTHER SEXUALLY TRANSMITTED DISEASES (STDS). DESCRIPTIVE-OBSERVATIONAL ANALYSIS IN AN ITALIAN POLYCLINIC. Sexually Transmitted Infections. Conference. 2024;100(1):A221. doi:unk$$$A$$Y$$$20240815$$HP$IT$IT
242135011$24213501$1$I$20240101$20240805$20240815$20240815$EXP$$CO-Merz Pharmaceuticals GmbH-2024080000105$MERZ$$37$YR$$F$Y$$$20240815$$MD$CO$CO
242135021$24213502$1$I$20240520$20240808$20240815$20240815$EXP$$US-AMX-008126$AMYLYX PHARMACEUTICALS$$73$YR$$F$Y$$$20240815$$HP$US$US
242135031$24213503$1$I$$20240808$20240815$20240815$EXP$$US-GILEAD-2024-0684095$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$$$Y$$$20240815$$MD$US$US
242135041$24213504$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56080$$FDA-CTU$$74$YR$$F$N$$$20240815$N$$US$
242135061$24213506$1$I$20240801$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56092$$FDA-CTU$$71$YR$$F$N$$$20240815$N$$US$
242135071$24213507$1$I$$20240813$20240815$20240815$PER$$NVSC2024US165309$NOVARTIS$$$$$$Y$$$20240815$$CN$US$US
242135081$24213508$1$I$$20240808$20240815$20240815$EXP$$US-GILEAD-2024-0684097$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$$$Y$$$20240815$$MD$US$US
242135091$24213509$1$I$$20240808$20240815$20240815$EXP$$US-GILEAD-2024-0684096$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$$$Y$$$20240815$$MD$US$US
242135101$24213510$1$I$20240723$20240809$20240815$20240815$EXP$$PE-AMGEN-PERSL2024152533$AMGEN$$52$YR$A$M$Y$$$20240815$$CN$PE$PE
242135111$24213511$1$I$20240701$20240812$20240815$20240815$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045899$BOEHRINGER INGELHEIM$$82$YR$E$M$Y$$$20240815$$CN$US$US
242135121$24213512$1$I$20240513$20240812$20240815$20240815$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004501$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240815$$MD$FR$FR
242135131$24213513$1$I$20240101$20240813$20240815$20240815$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-128788$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240815$$PH$FR$FR
242135141$24213514$1$I$20240725$20240801$20240815$20240815$EXP$$CN-ROCHE-10000048453$ROCHE$$79$YR$E$M$Y$55$KG$20240815$$HP$CN$CN
242135151$24213515$1$I$20240722$20240806$20240815$20240815$EXP$$US-AMGEN-USASP2024156659$AMGEN$$75$YR$E$F$Y$$$20240815$$CN$US$US
242135161$24213516$1$I$20240601$20240808$20240815$20240815$EXP$CH-SM-2024-14857$CH-009507513-2408CHE003315$MERCK$$39$YR$$F$Y$69$KG$20240815$$MD$CH$CH
242135171$24213517$1$I$$20240814$20240815$20240815$EXP$$US-PFIZER INC-202400236971$PFIZER$$65$YR$$F$Y$$$20240815$$CN$US$US
242135181$24213518$1$I$$20240809$20240815$20240815$EXP$$JP-PFIZER INC-202400233499$PFIZER$$9$DEC$$M$Y$$$20240815$$MD$JP$JP
242135192$24213519$2$F$20240517$20240816$20240815$20240820$EXP$$CN-PFIZER INC-PV202400104252$PFIZER$$47$YR$$F$Y$50$KG$20240820$$HP$CN$CN
242135202$24213520$2$F$$20240816$20240815$20240821$EXP$$US-PFIZER INC-202400236377$PFIZER$$47$YR$$F$Y$$$20240821$$MD$US$US
242135212$24213521$2$F$$20240812$20240815$20240819$EXP$$US-PFIZER INC-202400236019$PFIZER$Green, K.. The Emergence of Bromazolam in Jefferson County AL. A Case Series. Journal of analytical toxicology. 2024;10.1093/jat/bkae067$27$YR$$M$Y$$$20240819$$MD$US$US
242135231$24213523$1$I$$20240812$20240815$20240815$EXP$$US-GSK-US2024100179$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$CN$US$US
242135241$24213524$1$I$$20240813$20240815$20240815$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004513$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240815$$HP$US$US
242135251$24213525$1$I$20240731$20240809$20240815$20240815$EXP$$BR-TAKEDA-BR201940646$TAKEDA$$34$YR$$F$Y$73$KG$20240815$$MD$BR$BR
242135261$24213526$1$I$$20240810$20240815$20240815$EXP$$IN-AstraZeneca-2024A183346$ASTRAZENECA$$69$YR$$M$Y$90$KG$20240815$$CN$IN$
242135271$24213527$1$I$$20240712$20240815$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07144$LUPIN$$$$$$Y$$$20240815$$CN$US$US
242135281$24213528$1$I$$20230119$20240815$20240815$EXP$$US-AstraZeneca-2023A016577$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242135291$24213529$1$I$$20240814$20240815$20240815$EXP$$US-BAYER-2024A117341$BAYER$$50$YR$A$F$Y$$$20240815$$HP$US$US
242135302$24213530$2$F$$20240816$20240815$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07194$LUPIN$$$$$$Y$$$20240904$$PH$US$US
242135311$24213531$1$I$20240406$20240809$20240815$20240815$EXP$FR-AFSSAPS-AVLL2024000194$FR-MYLANLABS-2024M1074324$MYLAN$$35$YR$$F$Y$$$20240815$$MD$FR$FR
242135321$24213532$1$I$$20240805$20240815$20240815$EXP$FR-AFSSAPS-PV2024000722$FR-RDY-SPO/FRA/24/0011487$DR REDDYS$$$$N$M$Y$0.32$KG$20240815$$MD$FR$FR
242135331$24213533$1$I$$20240809$20240815$20240815$EXP$SE-SEMPA-2024-005890$SE-MYLANLABS-2024M1074508$MYLAN$$46$YR$$M$Y$$$20240815$$MD$SE$SE
242135341$24213534$1$I$20240419$20240809$20240815$20240815$EXP$FR-AFSSAPS-AVLL2024000192$FR-MYLANLABS-2024M1074322$MYLAN$$27$YR$$F$Y$$$20240815$$CN$FR$FR
242135361$24213536$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56121$$FDA-CTU$$66$YR$$F$N$92.08$KG$20240815$N$$US$
242135371$24213537$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA240600$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240815$$HP$US$US
242135381$24213538$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA237053$SANOFI AVENTIS$$$$T$M$Y$$$20240815$$MD$US$US
242135391$24213539$1$I$20240401$20240809$20240815$20240815$PER$$US-SA-2024SA240134$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240815$$CN$US$US
242135401$24213540$1$I$$20240806$20240815$20240815$EXP$$US-AMGEN-USASP2024156929$AMGEN$$70$YR$E$F$Y$$$20240815$$HP$US$US
242135422$24213542$2$F$$20240820$20240815$20240830$EXP$NL-LRB-00993609$NL-TEVA-VS-3230724$TEVA$$46$YR$$F$Y$90$KG$20240830$$CN$NL$NL
242135431$24213543$1$I$$20240712$20240815$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07296$LUPIN$$$$$$Y$$$20240815$$CN$US$US
242135442$24213544$2$F$20240809$20240819$20240815$20240824$EXP$$US-AMGEN-USASP2024159228$AMGEN$$61$YR$A$F$Y$$$20240823$$CN$US$US
242135463$24213546$3$F$$20240828$20240815$20240903$EXP$$US-PFIZER INC-202400236020$PFIZER$Green, K.. The Emergence of Bromazolam in Jefferson County AL. A Case Series. Journal of analytical toxicology. 2024;10.1093/jat/bkae067$41$YR$$F$Y$$$20240903$$MD$US$US
242135471$24213547$1$I$$20240809$20240815$20240815$EXP$$IT-PFIZER INC-202400233600$PFIZER$Frigerio, M.. Case report: long-term outcome of a heart transplant recipient switched to everolimus after an acute myocardial infarction. Transplantation. 2006;Oct 27;82:19-23$56$YR$$M$Y$$$20240815$$MD$IT$IT
242135482$24213548$2$F$20240810$20240905$20240815$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408008304$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240909$$CN$US$US
242135491$24213549$1$I$$20240811$20240815$20240815$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007992$ELI LILLY AND CO$Ter-Zakarian A.,Donovan L.N.,Nasraty F..Frequency of dose reductions of abemaciclib in metastatic and early-stage hormone positive, HER2 negative breast cancer..Journal of Clinical Oncology. Conference:Annual Meeting of the American Society 2024;42(16):e13099.$$$A$$Y$$$20240815$$HP$US$US
242135501$24213550$1$I$$20240814$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009487$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240815$$CN$US$US
242135513$24213551$3$F$20240807$20240914$20240815$20240925$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408005916$ELI LILLY AND CO$$38$YR$A$F$Y$85.5$KG$20240925$$CN$CN$CN
242135521$24213552$1$I$$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408006607$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240815$$CN$US$US
242135531$24213553$1$I$$20240813$20240815$20240815$EXP$$CA-HLS-202402037$HLS THERAPEUTICS$$76$YR$E$F$Y$$$20240815$$HP$CA$CA
242135541$24213554$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA237736$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240815$$HP$US$US
242135551$24213555$1$I$$20240813$20240815$20240815$EXP$$DE-ABBVIE-5880961$ABBVIE$$$$$F$Y$$$20240815$$MD$DE$DE
242135562$24213556$2$F$20240101$20240812$20240815$20240816$EXP$$PE-009507513-2408PER004727$MERCK$$$$A$M$Y$$$20240816$$HP$PE$PE
242135571$24213557$1$I$20240701$20240814$20240815$20240815$PER$$US-AMGEN-USASP2024162260$AMGEN$$38$YR$A$F$Y$$$20240815$$PH$US$US
242135582$24213558$2$F$$20240812$20240815$20240820$EXP$$CA-PFIZER INC-202400236089$PFIZER$Nguyen, D.. A 16 year-retrospective study of refractory meningiomas: Prognostic factors and systemic treatments.. Journal of Clinical Oncology. 2024;42(16 Suppl):2085$$$E$$Y$$$20240820$$HP$CA$CA
242135591$24213559$1$I$$20240711$20240815$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07068$LUPIN$$$$$$Y$$$20240815$$CN$US$US
242135601$24213560$1$I$$20240812$20240815$20240815$EXP$$CA-PFIZER INC-202400230709$PFIZER$$92$YR$$M$Y$49$KG$20240815$$HP$CA$CA
242135611$24213561$1$I$$20230308$20240815$20240815$EXP$$US-AstraZeneca-2023A057553$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242135621$24213562$1$I$$20230206$20240815$20240815$EXP$$US-AstraZeneca-2023A033205$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242135631$24213563$1$I$$20240814$20240815$20240815$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045974$BOEHRINGER INGELHEIM$$$$$$Y$$$20240815$$CN$US$US
242135651$24213565$1$I$$20240802$20240815$20240815$EXP$$BE-B.Braun Medical Inc.-2160504$B BRAUN$$$$$M$Y$90$KG$20240815$$$BE$BE
242135661$24213566$1$I$20240805$20240814$20240815$20240815$DIR$FDA-CDER-CTU-2024-56115$$FDA-CTU$$34$YR$$F$N$$$20240814$N$$US$
242135671$24213567$1$I$$20240814$20240815$20240815$DIR$FDA-CDER-CTU-2024-56122$$FDA-CTU$$66$YR$$M$N$$$20240814$N$HP$US$
242135681$24213568$1$I$$20240812$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127849$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240815$$HP$US$US
242135691$24213569$1$I$20240715$20240805$20240815$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116695$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240815$$PH$JP$JP
242135701$24213570$1$I$$20240809$20240815$20240815$EXP$$US-TAKEDA-2024TUS081558$TAKEDA$$$$$F$Y$$$20240815$$MD$US$US
242135711$24213571$1$I$$20240713$20240815$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07197$LUPIN$$$$$$Y$$$20240815$$CN$US$US
242135721$24213572$1$I$$20240801$20240815$20240815$PER$$US-MYLANLABS-2024M1072366$MYLAN$$$$$F$Y$$$20240815$$CN$US$US
242135731$24213573$1$I$20240404$20240808$20240815$20240815$EXP$FR-AFSSAPS-AN2024001003$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07694$HIKMA$$60$YR$$M$Y$$$20240815$$PH$FR$FR
242135742$24213574$2$F$20240702$20240815$20240815$20240820$PER$$US-MYLANLABS-2024M1073617$MYLAN$$67$YR$$F$Y$92.99$KG$20240820$$CN$US$US
242135752$24213575$2$F$$20240815$20240815$20240822$EXP$$GB-TAKEDA-2024TUS077468$TAKEDA$$$$$F$Y$$$20240822$$CN$GB$GB
242135762$24213576$2$F$$20240829$20240815$20240830$PER$$NVSC2024US165493$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
242135771$24213577$1$I$20240720$20240806$20240815$20240815$EXP$FR-AFSSAPS-RS2024000749$FR-TEVA-VS-3230889$TEVA$$68$YR$$F$Y$45$KG$20240815$$MD$FR$FR
242135781$24213578$1$I$$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161516$AMGEN$$$$$$Y$$$20240815$$PH$US$US
242135791$24213579$1$I$20230101$20240814$20240815$20240815$EXP$$CN-BAYER-2024A117647$BAYER$$65$YR$E$M$Y$44.6$KG$20240815$$HP$CN$CN
242135811$24213581$1$I$20240815$20240815$20240815$20240815$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045999$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240815$$CN$US$US
242135822$24213582$2$F$20240527$20240902$20240815$20240905$EXP$FR-AFSSAPS-TO2024001499$FR-FreseniusKabi-FK202412444$FRESENIUS KABI$$72$YR$E$F$Y$61$KG$20240905$$HP$FR$FR
242135831$24213583$1$I$20220701$20240805$20240815$20240815$PER$$JP-Eisai-EC-2022-119668$EISAI$Kato M, Komatsu R, Kinugawa M. A case of drug-induced myocarditis caused by combination chemotherapy with pembrolizumab and lenvatinib.. The 134th Meeting of Kinki Regional Off of the Jpn Circulation Soc (program/abstract).. 2022;63-63.$59$YR$A$F$Y$$$20240815$$MD$JP$JP
242135841$24213584$1$I$$20240813$20240815$20240815$EXP$$PT-ORGANON-O2408PRT001005$ORGANON$Teixeira CM, Amaro AM, Dias A, Brito A, Duarte A.. Drug-induced injury secondary to terbinafine.. Italian Medical Journal - Archive for Medical Sciences.. 2024;183:364-6$92$YR$$M$Y$$$20240815$$HP$PT$PT
242135851$24213585$1$I$20240809$20240809$20240815$20240815$PER$$US-ROCHE-10000054874$ROCHE$$80$YR$E$F$Y$$$20240815$$MD$US$US
242135861$24213586$1$I$20240808$20240809$20240815$20240815$EXP$$US-Eisai-EC-2024-171990$EISAI$$77$YR$E$M$Y$80.7$KG$20240815$$CN$US$US
242135881$24213588$1$I$20240724$20240813$20240815$20240815$EXP$$US-TAKEDA-2024TUS081535$TAKEDA$$1$YR$$M$Y$$$20240815$$CN$US$US
242135891$24213589$1$I$$20240805$20240815$20240815$EXP$$US-TEVA-VS-3231013$TEVA$Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. Blood 2023; 142 (Suppl. 1) 5898.$$$A$$Y$$$20240815$$MD$US$US
242135901$24213590$1$I$20240728$20240814$20240814$20240814$DIR$714209$$FDA-CTU$$77$YR$$M$N$60$KG$20240814$N$PH$US$
242135912$24213591$2$F$$20240826$20240815$20240903$EXP$$US-TEVA-VS-3231016$TEVA$Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. Blood 2023; 142 (Suppl. 1) 5898.; Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. Blood 2023; 142 (Suppl. 1...$$$A$$Y$$$20240903$$MD$US$US
242135923$24213592$3$F$20240101$20240917$20240815$20240920$EXP$$US-ABBVIE-5798717$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
242135931$24213593$1$I$$20220415$20240815$20240815$EXP$$US-AstraZeneca-2022A154990$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242135941$24213594$1$I$$20240814$20240815$20240815$PER$$US-BAYER-2024A113178$BAYER$$55$YR$A$F$Y$$$20240815$$CN$US$US
242135951$24213595$1$I$$20240804$20240815$20240815$EXP$$US-UCBSA-2024039495$UCB$$$$$F$Y$$$20240815$$HP$US$US
242135961$24213596$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA239300$SANOFI AVENTIS$$$$E$F$Y$$$20240815$$MD$US$US
242135971$24213597$1$I$20220503$20240814$20240814$20240814$DIR$714252$$FDA-CTU$$54$YR$$F$N$90$KG$20240814$N$CN$US$
242135981$24213598$1$I$20230111$20240808$20240815$20240815$EXP$CH-SM-2023-10659$CH-BRISTOL-MYERS SQUIBB COMPANY-2023-017999$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240815$$MD$CH$CH
242135991$24213599$1$I$20240729$20240809$20240815$20240815$EXP$IT-MINISAL02-997756$IT-MYLANLABS-2024M1074547$MYLAN$$33$YR$$F$Y$$$20240815$$MD$IT$IT
242136001$24213600$1$I$$20240812$20240815$20240815$EXP$$GB-MYLANLABS-2024M1075613$MYLAN$$$$$M$Y$$$20240815$$CN$GB$GB
242136011$24213601$1$I$20240524$20240809$20240815$20240815$EXP$FR-AFSSAPS-NT2024001017$FR-MYLANLABS-2024M1074597$MYLAN$$78$YR$$F$Y$52$KG$20240815$$MD$FR$FR
242136022$24213602$2$F$20230101$20240815$20240815$20240821$EXP$$BR-MYLANLABS-2024M1075046$MYLAN$$$$$$Y$$$20240821$$CN$BR$BR
242136031$24213603$1$I$20240811$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024161343$AMGEN$$62$YR$A$F$Y$$$20240815$$CN$US$US
242136041$24213604$1$I$20231216$20240812$20240815$20240815$EXP$FR-AFSSAPS-BX2024001630$FR-PFIZER INC-202400234193$PFIZER$$80$YR$$F$Y$$$20240815$$PH$FR$FR
242136051$24213605$1$I$20240801$20240815$20240815$20240815$EXP$$TW-PFIZER INC-PV202400106271$PFIZER$$69$YR$$F$Y$$$20240815$$HP$TW$TW
242136061$24213606$1$I$$20240813$20240815$20240815$EXP$$CA-PFIZER INC-PV202400105911$PFIZER$Nianiaris, N.. Retinal and choroidal embolization following soft tissue maxillary injection of corticosteroids. Canadian Journal of Ophthalmology. 1995;30 (6):321-323$37$YR$$F$Y$$$20240815$$MD$CA$CA
242136071$24213607$1$I$$20240722$20240815$20240815$EXP$$US-ABBVIE-5814567$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242136081$24213608$1$I$$20240806$20240815$20240815$EXP$$US-RDY-SPO/USA/24/0011682$DR REDDYS$$59$YR$A$F$Y$$$20240815$$CN$US$US
242136092$24213609$2$F$20240723$20240823$20240815$20240826$PER$$US-BAYER-2024A114198$BAYER$$27$YR$A$F$Y$$$20240826$$HP$US$US
242136101$24213610$1$I$$20240807$20240815$20240815$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000165$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240815$$CN$US$US
242136111$24213611$1$I$20220101$20240806$20240815$20240815$EXP$$US-ROCHE-10000010889$ROCHE$$65$YR$E$F$Y$83.91$KG$20240815$$CN$US$US
242136121$24213612$1$I$$20240814$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129192$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240815$$CN$US$US
242136142$24213614$2$F$20240101$20240830$20240815$20240912$EXP$$US-UCBSA-2024039350$UCB$$$$$F$Y$98.9$KG$20240912$$PH$US$US
242136151$24213615$1$I$20240729$20240812$20240815$20240815$PER$$US-ROCHE-10000056716$ROCHE$$35$YR$A$M$Y$$$20240815$$CN$US$US
242136161$24213616$1$I$$20240812$20240815$20240815$PER$$US-ROCHE-10000055917$ROCHE$$23$YR$A$M$Y$$$20240815$$CN$US$US
242136173$24213617$3$F$$20240819$20240815$20240821$EXP$$CL-ROCHE-10000048035$ROCHE$$$$$M$Y$$$20240821$$MD$CL$CL
242136182$24213618$2$F$$20240821$20240815$20240823$PER$$DE-PFIZER INC-202400233091$PFIZER$$$$$F$Y$$$20240823$$MD$DE$DE
242136191$24213619$1$I$$20240807$20240815$20240815$PER$$US-MYLANLABS-2024M1074164$MYLAN$$$$$F$Y$$$20240815$$CN$US$US
242136201$24213620$1$I$$20240812$20240815$20240815$PER$$US-ROCHE-10000056142$ROCHE$$$$A$F$Y$$$20240815$$CN$US$US
242136211$24213621$1$I$$20240808$20240815$20240815$EXP$$IT-Waylis Therapeutics LLC-ATNAHS20240802304$Waylis$$33$YR$A$F$Y$90$KG$20240815$$MD$IT$IT
242136221$24213622$1$I$$20240812$20240815$20240815$EXP$$US-ABBVIE-5878187$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242136231$24213623$1$I$$20240812$20240815$20240815$PER$$US-ROCHE-10000055246$ROCHE$$$$$$Y$$$20240815$$MD$US$US
242136241$24213624$1$I$20240610$20240814$20240814$20240814$DIR$714242$$FDA-CTU$$63$YR$$F$N$71.91$KG$20240814$Y$MD$US$
242136271$24213627$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56123$$FDA-CTU$$50$YR$$F$N$68.95$KG$20240815$N$$US$
242136281$24213628$1$I$20240808$20240814$20240814$20240814$DIR$714258$$FDA-CTU$$45$YR$$F$N$67.5$KG$20240814$N$HP$US$
242136291$24213629$1$I$$20240809$20240815$20240815$DIR$FDA-CDER-CTU-2024-56124$$FDA-CTU$$$$$M$N$$$20240809$N$HP$US$
242136301$24213630$1$I$20240814$20240814$20240814$20240814$DIR$714260$$FDA-CTU$$62$YR$$F$N$$$20240814$N$$US$
242136311$24213631$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-VS-3231756$TEVA$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S, et al. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. Br-J-Cancer 2023; 128 (6): 1134-1147.$$$$F$Y$$$20240815$$HP$DE$DE
242136321$24213632$1$I$20240513$20240807$20240815$20240815$EXP$FR-AFSSAPS-NC2024000833$FR-TEVA-VS-3231921$TEVA$$61$YR$$F$Y$$$20240815$$MD$FR$FR
242136341$24213634$1$I$$20240813$20240815$20240815$PER$$US-ROCHE-3576173$ROCHE$$65$YR$E$F$Y$$$20240815$$CN$US$US
242136351$24213635$1$I$$20240809$20240815$20240815$EXP$GB-MHRA-MED-202408091442060030-DQZMP$GB-RDY-SPO/GBR/24/0011775$DR REDDYS$$$$$M$Y$$$20240815$$CN$GB$GB
242136361$24213636$1$I$20240729$20240807$20240815$20240815$PER$$US-BAYER-2024A114029$BAYER$$15$YR$T$F$Y$$$20240815$$HP$US$US
242136372$24213637$2$F$20240801$20240828$20240815$20240910$PER$$US-Calliditas-2024CAL01474$CALLIDITAS THERAPEUTICS$$35$YR$A$M$Y$70.8$KG$20240910$$CN$US$US
242136381$24213638$1$I$20240730$20240808$20240815$20240815$PER$$US-BAYER-2024A114715$BAYER$$45$YR$A$F$Y$$$20240815$$CN$US$US
242136401$24213640$1$I$$20240807$20240815$20240815$EXP$$US-MYLANLABS-2024M1075157$MYLAN$Nandan A, Higgins A, Lee R. Startled to Death: A Case of Polymorphic Ventricular Tachycardia in Congenital Long QT Syndrome. US-Cardiol 2024; 18 (Suppl.) 30-31.$57$YR$$M$Y$$$20240815$$HP$US$US
242136411$24213641$1$I$$20240814$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009288$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240815$$CN$US$US
242136421$24213642$1$I$20240701$20240808$20240815$20240815$EXP$FR-AFSSAPS-AVLY2024000130$FR-Waylis Therapeutics LLC-ATNAHS20240802307$Waylis$$22$YR$A$F$Y$$$20240814$$MD$FR$FR
242136431$24213643$1$I$20240805$20240808$20240815$20240815$PER$$US-BAYER-2024A114913$BAYER$$33$YR$A$F$Y$$$20240815$$MD$US$US
242136441$24213644$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA240000$SANOFI AVENTIS$$$$E$F$Y$$$20240815$$MD$US$US
242136451$24213645$1$I$$20240809$20240815$20240815$EXP$$IN-ROCHE-3410517$ROCHE$$59$YR$A$M$Y$$$20240815$$MD$IN$IN
242136501$24213650$1$I$20240625$20240814$20240814$20240814$DIR$714261$$FDA-CTU$$67$YR$$F$N$63$KG$20240814$N$CN$US$
242136511$24213651$1$I$$20240808$20240815$20240815$PER$$US-BAYER-2024A115043$BAYER$$$$$F$Y$$$20240815$$HP$US$US
242136521$24213652$1$I$$20240812$20240815$20240815$EXP$$US-TAKEDA-2024TUS052666$TAKEDA$$$$$M$Y$$$20240815$$CN$US$US
242136533$24213653$3$F$20240805$20240828$20240815$20240903$30DAY$$US-AMGEN-USASP2024158408$AMGEN$$52$YR$A$F$Y$124$KG$20240903$$PH$US$US
242136541$24213654$1$I$$20240724$20240815$20240815$PER$$AU-TOLMAR, INC.-24AU051249$TOLMAR$$$$$M$Y$$$20240814$$CN$AU$AU
242136551$24213655$1$I$20230529$20240808$20240815$20240815$EXP$FR-AFSSAPS-AM2024000649$FR-Waylis Therapeutics LLC-ATNAHS20240802310$Waylis$$50$YR$A$M$Y$122$KG$20240815$$MD$FR$FR
242136561$24213656$1$I$$20240725$20240815$20240815$PER$$AU-TOLMAR, INC.-24AU051277$TOLMAR$$$$$M$Y$$$20240814$$CN$AU$AU
242136571$24213657$1$I$$20240724$20240815$20240815$PER$$AU-TOLMAR, INC.-24AU051265$TOLMAR$$$$$M$Y$$$20240814$$CN$AU$AU
242136581$24213658$1$I$$20240724$20240815$20240815$PER$$AU-TOLMAR, INC.-24AU051343$TOLMAR$$$$$M$Y$$$20240814$$CN$AU$AU
242136591$24213659$1$I$$20240724$20240815$20240815$PER$$AU-TOLMAR, INC.-24AU051345$TOLMAR$$$$$M$Y$$$20240814$$CN$AU$AU
242136601$24213660$1$I$$20240725$20240815$20240815$PER$$AU-TOLMAR, INC.-24AU051304$TOLMAR$$$$$M$Y$$$20240814$$CN$AU$AU
242136611$24213661$1$I$20220101$20240725$20240815$20240815$PER$$BR-TOLMAR, INC.-24BR051380$TOLMAR$$$$$F$Y$$$20240814$$CN$BR$BR
242136621$24213662$1$I$$20240725$20240815$20240815$PER$$AU-TOLMAR, INC.-24AU051396$TOLMAR$$$$$M$Y$$$20240814$$CN$AU$AU
242136631$24213663$1$I$$20240808$20240815$20240815$EXP$$JP-ABBVIE-5879712$ABBVIE$Uchida N. Haematopoietic cell transplant; latest topics. Fukuoka BMT Study Group.$$$$$Y$$$20240815$$MD$JP$JP
242136641$24213664$1$I$$20240809$20240815$20240815$EXP$GB-MHRA-MED-202408091852555040-WQTBF$GB-RDY-SPO/GBR/24/0011772$DR REDDYS$$$$$M$Y$$$20240815$$CN$GB$GB
242136653$24213665$3$F$$20240813$20240815$20240819$EXP$$BR-GENMAB-2024-02960$GENMAB$$25$YR$$F$Y$$$20240819$$MD$BR$BR
242136661$24213666$1$I$$20240813$20240815$20240815$PER$$CA-HLS-202402035$HLS THERAPEUTICS$$$$$F$Y$$$20240815$$HP$CA$CA
242136671$24213667$1$I$$20240627$20240815$20240815$PER$$US-LUNDBECK-DKLU4000978$LUNDBECK$$$$$$Y$$$20240815$$CN$US$US
242136682$24213668$2$F$$20240813$20240815$20240906$EXP$$US-AstraZeneca-2024A184363$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242136691$24213669$1$I$20240220$20240808$20240815$20240815$EXP$FR-AFSSAPS-NT2024001005$FR-Waylis Therapeutics LLC-ATNAHS20240802306$Waylis$$42$YR$A$F$Y$$$20240815$$PH$FR$FR
242136701$24213670$1$I$20230607$20240807$20240815$20240815$EXP$FR-AFSSAPS-CF2024000396$FR-MYLANLABS-2024M1074221$MYLAN$$28$YR$$F$Y$50$KG$20240815$$PH$FR$FR
242136712$24213671$2$F$$20240812$20240815$20240815$EXP$$US-ROCHE-10000057315$ROCHE$$$$$F$Y$$$20240815$$HP$US$US
242136723$24213672$3$F$20240801$20240916$20240815$20240927$EXP$$US-ROCHE-10000056546$ROCHE$$30$YR$A$F$Y$$$20240927$$CN$US$US
242136731$24213673$1$I$$20240808$20240815$20240815$EXP$$CA-GSK-CA2022AMR184328$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$MD$CA$CA
242136741$24213674$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-202400234901$PFIZER$$85$YR$$F$Y$$$20240815$$CN$US$US
242136751$24213675$1$I$$20240814$20240815$20240815$PER$$US-PFIZER INC-202400236944$PFIZER$$46$YR$$F$Y$$$20240815$$CN$US$US
242136761$24213676$1$I$20240801$20240812$20240815$20240815$PER$$US-PFIZER INC-PV202400105055$PFIZER$$46$YR$$M$Y$$$20240815$$HP$US$US
242136772$24213677$2$F$$20240818$20240815$20240822$PER$$US-PFIZER INC-202400234170$PFIZER$$90$YR$$$Y$$$20240822$$CN$US$US
242136782$24213678$2$F$20240101$20240812$20240815$20240816$PER$$US-PFIZER INC-202400078255$PFIZER$$70$YR$$F$Y$$$20240816$$CN$US$US
242136791$24213679$1$I$$20240809$20240815$20240815$PER$$US-PFIZER INC-202400234626$PFIZER$$18$YR$$F$Y$$$20240815$$MD$US$US
242136801$24213680$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-202400234876$PFIZER$$$$C$$Y$$$20240815$$PH$US$US
242136811$24213681$1$I$$20240813$20240815$20240815$PER$$US-PFIZER INC-PV202300129362$PFIZER$$54$YR$$F$Y$$$20240815$$HP$US$US
242136822$24213682$2$F$20240811$20240906$20240815$20240910$PER$$US-PFIZER INC-PV202400105961$PFIZER$$42$YR$$F$Y$52.608$KG$20240910$$CN$US$US
242136832$24213683$2$F$20240101$20240816$20240815$20240819$PER$$US-PFIZER INC-PV202400105672$PFIZER$$7$DEC$$F$Y$$$20240819$$HP$US$US
242136841$24213684$1$I$20240704$20240809$20240815$20240815$PER$$US-PFIZER INC-202400094289$PFIZER$$67$YR$$M$Y$$$20240815$$HP$US$US
242136851$24213685$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-PV202400105051$PFIZER$$92$YR$$$Y$$$20240815$$CN$US$US
242136861$24213686$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-202400235543$PFIZER$$81$YR$$$Y$$$20240815$$CN$US$US
242136871$24213687$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-202400235343$PFIZER$$72$YR$$F$Y$$$20240815$$HP$US$US
242136882$24213688$2$F$$20240813$20240815$20240816$PER$$US-PFIZER INC-202400235006$PFIZER$$62$YR$$F$Y$$$20240816$$HP$US$US
242136891$24213689$1$I$20240813$20240813$20240815$20240815$PER$$US-PFIZER INC-202400236154$PFIZER$$66$YR$$F$Y$$$20240815$$CN$US$US
242136902$24213690$2$F$$20240910$20240815$20240912$PER$$US-PFIZER INC-202400236110$PFIZER$$16$YR$$F$Y$$$20240912$$MD$US$US
242136912$24213691$2$F$20190201$20240904$20240815$20240909$PER$$US-PFIZER INC-202400236296$PFIZER$$40$YR$$F$Y$$$20240909$$CN$US$US
242136921$24213692$1$I$20240810$20240813$20240815$20240815$PER$$US-PFIZER INC-202400236120$PFIZER$$25$YR$$M$Y$$$20240815$$CN$US$US
242136931$24213693$1$I$$20240813$20240815$20240815$PER$$US-PFIZER INC-PV202400105807$PFIZER$$66$YR$$M$Y$$$20240815$$CN$US$US
242136941$24213694$1$I$20240803$20240814$20240814$20240814$DIR$714266$$FDA-CTU$$36$YR$$F$N$67.5$KG$20240814$N$CN$US$
242136951$24213695$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-202400234980$PFIZER$$$$$M$Y$$$20240815$$CN$US$US
242136962$24213696$2$F$20240812$20240828$20240815$20240904$PER$$US-PFIZER INC-202400234856$PFIZER$$73$YR$$F$Y$72.562$KG$20240904$$CN$US$US
242136971$24213697$1$I$20240810$20240812$20240815$20240815$PER$$US-PFIZER INC-202400234848$PFIZER$$76$YR$$F$Y$87.54$KG$20240815$$CN$US$US
242136981$24213698$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56125$$FDA-CTU$$69$YR$$M$N$$$20240815$N$$US$
242136991$24213699$1$I$20240813$20240813$20240815$20240815$PER$$US-PFIZER INC-202400236530$PFIZER$$$$A$M$Y$$$20240815$$MD$US$US
242137011$24213701$1$I$20240809$20240812$20240815$20240815$PER$$US-PFIZER INC-202400235064$PFIZER$$61$YR$$F$Y$$$20240815$$CN$US$US
242137021$24213702$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-202400234957$PFIZER$$40$YR$$F$Y$$$20240815$$CN$US$US
242137031$24213703$1$I$$20240809$20240815$20240815$PER$$US-PFIZER INC-202400234627$PFIZER$$19$YR$$F$Y$$$20240815$$MD$US$US
242137041$24213704$1$I$20240801$20240809$20240815$20240815$PER$$US-PFIZER INC-202400234122$PFIZER$$$$A$F$Y$$$20240815$$PH$US$US
242137051$24213705$1$I$20240801$20240811$20240815$20240815$PER$$US-PFIZER INC-202400234568$PFIZER$$55$YR$$M$Y$$$20240815$$PH$US$US
242137063$24213706$3$F$$20240827$20240815$20240830$PER$$US-PFIZER INC-202400214444$PFIZER$$53$YR$$F$Y$$$20240830$$CN$US$US
242137072$24213707$2$F$20240804$20240903$20240815$20240904$PER$$US-PFIZER INC-202400236205$PFIZER$$56$YR$$F$Y$79.819$KG$20240904$$HP$US$US
242137082$24213708$2$F$20240812$20240814$20240815$20240816$PER$$US-PFIZER INC-202400235104$PFIZER$$60$YR$$F$Y$$$20240816$$CN$US$US
242137093$24213709$3$F$20240807$20240919$20240815$20240924$PER$$US-PFIZER INC-PV202400105737$PFIZER$$33$YR$$F$Y$$$20240924$$CN$US$US
242137101$24213710$1$I$20230801$20240811$20240815$20240815$PER$$US-PFIZER INC-202400234167$PFIZER$$70$YR$$F$Y$$$20240815$$MD$US$US
242137111$24213711$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-202400234061$PFIZER$$53$YR$$F$Y$$$20240815$$CN$US$US
242137122$24213712$2$F$20240101$20240913$20240815$20240918$PER$$US-PFIZER INC-202400236065$PFIZER$$64$YR$$F$Y$$$20240918$$HP$US$US
242137131$24213713$1$I$20240813$20240813$20240815$20240815$PER$$US-PFIZER INC-202400236081$PFIZER$$65$YR$$F$Y$$$20240815$$MD$US$US
242137141$24213714$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-202400234868$PFIZER$$$$$F$Y$$$20240815$$CN$US$US
242137152$24213715$2$F$$20240821$20240815$20240826$PER$$US-PFIZER INC-202400236930$PFIZER$$26$YR$$F$Y$$$20240826$$MD$US$US
242137161$24213716$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-PV202400105369$PFIZER$$57$YR$$F$Y$$$20240815$$HP$US$US
242137171$24213717$1$I$$20240813$20240815$20240815$PER$$US-PFIZER INC-202400236253$PFIZER$$56$YR$$F$Y$$$20240815$$MD$US$US
242137182$24213718$2$F$20240716$20240822$20240815$20240827$PER$$US-PFIZER INC-PV202400095837$PFIZER$$70$YR$$F$Y$$$20240827$$MD$US$US
242137191$24213719$1$I$$20240814$20240815$20240815$PER$$US-PFIZER INC-202400236546$PFIZER$$$$$M$Y$$$20240815$$CN$US$US
242137202$24213720$2$F$$20240813$20240815$20240820$PER$$PR-PFIZER INC-202400235831$PFIZER$$71$YR$$M$Y$$$20240820$$PH$PR$PR
242137211$24213721$1$I$$20240813$20240815$20240815$PER$$US-PFIZER INC-202400236370$PFIZER$$$$$F$Y$$$20240815$$CN$US$US
242137221$24213722$1$I$20240801$20240813$20240815$20240815$PER$$US-PFIZER INC-202400235963$PFIZER$$40$YR$$M$Y$$$20240815$$MD$US$US
242137232$24213723$2$F$20240901$20240911$20240815$20240913$PER$$US-PFIZER INC-PV202400105720$PFIZER$$43$YR$$F$Y$$$20240913$$HP$US$US
242137241$24213724$1$I$20240808$20240811$20240815$20240815$PER$$US-PFIZER INC-202400234429$PFIZER$$45$YR$$F$Y$$$20240815$$CN$US$US
242137251$24213725$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-202400235575$PFIZER$$82$YR$$F$Y$71.67$KG$20240815$$CN$US$US
242137261$24213726$1$I$20240101$20240813$20240815$20240815$PER$$US-PFIZER INC-PV202400105589$PFIZER$$62$YR$$$Y$$$20240815$$CN$US$US
242137272$24213727$2$F$20240810$20240829$20240815$20240904$PER$$US-PFIZER INC-202400234824$PFIZER$$70$YR$$M$Y$68.027$KG$20240904$$CN$US$US
242137282$24213728$2$F$$20240816$20240815$20240819$PER$$US-PFIZER INC-202400236519$PFIZER$$32$YR$$M$Y$$$20240819$$CN$US$US
242137292$24213729$2$F$20240812$20240903$20240815$20240905$PER$$US-PFIZER INC-202400235075$PFIZER$$67$YR$$F$Y$59.41$KG$20240905$$CN$US$US
242137301$24213730$1$I$$20240813$20240815$20240815$PER$$US-PFIZER INC-PV202400105576$PFIZER$$$$$F$Y$$$20240815$$CN$US$US
242137311$24213731$1$I$20240810$20240811$20240815$20240815$PER$$US-PFIZER INC-202400234561$PFIZER$$61$YR$$F$Y$$$20240815$$CN$US$US
242137321$24213732$1$I$$20240813$20240815$20240815$PER$$US-PFIZER INC-202400236032$PFIZER$$70$YR$$F$Y$$$20240815$$CN$US$US
242137331$24213733$1$I$$20240626$20240815$20240815$PER$$US-LUNDBECK-DKLU4001046$LUNDBECK$$$$$$Y$$$20240815$$CN$US$US
242137341$24213734$1$I$$20240809$20240815$20240815$PER$$US-MYLANLABS-2024M1075048$MYLAN$$$$$F$Y$$$20240815$$CN$US$US
242137351$24213735$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-PV202400105889$PFIZER$$54$YR$$F$Y$$$20240815$$HP$US$US
242137361$24213736$1$I$$20240809$20240815$20240815$PER$$US-PFIZER INC-202400233861$PFIZER$$$$$F$Y$$$20240815$$MD$US$US
242137372$24213737$2$F$$20240813$20240815$20240816$PER$$US-PFIZER INC-202400235708$PFIZER$$55$YR$$M$Y$80.74$KG$20240816$$CN$US$US
242137381$24213738$1$I$$20240812$20240815$20240815$PER$$US-PFIZER INC-PV202400105965$PFIZER$$$$$$Y$$$20240815$$CN$US$US
242137391$24213739$1$I$20240811$20240813$20240815$20240815$PER$$US-PFIZER INC-202400236135$PFIZER$$70$YR$$F$Y$$$20240815$$CN$US$US
242137401$24213740$1$I$$20240813$20240815$20240815$PER$$US-PFIZER INC-202400235715$PFIZER$$$$$M$Y$$$20240815$$MD$US$US
242137411$24213741$1$I$$20240814$20240815$20240815$PER$$US-PFIZER INC-PV202400105797$PFIZER$$67$YR$$M$Y$$$20240815$$CN$US$US
242137421$24213742$1$I$$20240808$20240815$20240815$EXP$$US-GILEAD-2024-0684057$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240815$$MD$US$US
242137431$24213743$1$I$$20240813$20240815$20240815$PER$$US-PFIZER INC-PV202400105771$PFIZER$$70$YR$$F$Y$$$20240815$$HP$US$US
242137441$24213744$1$I$20240101$20240813$20240815$20240815$PER$$US-PFIZER INC-PV202400105709$PFIZER$$66$YR$$F$Y$$$20240815$$HP$US$US
242137452$24213745$2$F$20240730$20240918$20240815$20240923$EXP$$US-PFIZER INC-202400234288$PFIZER$$76$YR$$F$Y$75.75$KG$20240923$$CN$US$US
242137461$24213746$1$I$$20240809$20240815$20240815$PER$$US-PFIZER INC-PV202400104473$PFIZER$$69$YR$$F$Y$55.34$KG$20240815$$CN$US$US
242137472$24213747$2$F$$20240923$20240815$20240926$EXP$$US-009507513-2408USA003866$MERCK$$$$$F$Y$$$20240926$$PH$US$US
242137481$24213748$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA239638$SANOFI AVENTIS$$$$E$M$Y$$$20240815$$MD$US$US
242137491$24213749$1$I$20220101$20240806$20240815$20240815$EXP$$US-ROCHE-3339488$ROCHE$$69$YR$E$F$Y$74.84$KG$20240815$$MD$US$US
242137501$24213750$1$I$20240101$20240809$20240815$20240815$PER$$US-BAYER-2024A115538$BAYER$$35$YR$A$F$Y$$$20240815$$MD$US$US
242137511$24213751$1$I$$20240812$20240815$20240815$EXP$$GB-AMGEN-GBRSP2024160452$AMGEN$$$$$M$Y$$$20240815$$CN$GB$GB
242137521$24213752$1$I$20240810$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160341$AMGEN$$42$YR$A$F$Y$$$20240815$$CN$US$US
242137531$24213753$1$I$$20240812$20240815$20240815$PER$$US-BAYER-2024A116119$BAYER$$46$YR$A$F$Y$$$20240815$$MD$US$US
242137541$24213754$1$I$$20240814$20240814$20240814$DIR$714270$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242137551$24213755$1$I$$20240814$20240814$20240814$DIR$714271$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242137561$24213756$1$I$20240809$20240813$20240815$20240815$PER$$US-BAYER-2024A117139$BAYER$$45$YR$A$F$Y$$$20240815$$HP$US$US
242137573$24213757$3$F$20180501$20240910$20240815$20240919$EXP$$CA-TAKEDA-2018TUS021263$TAKEDA$$74$YR$$M$Y$$$20240919$$MD$CA$CA
242137581$24213758$1$I$$20240807$20240815$20240815$EXP$$CA-TOLMAR, INC.-24CA051709$TOLMAR$$$$$M$Y$$$20240815$$PH$CA$CA
242137591$24213759$1$I$$20240807$20240815$20240815$EXP$$CA-TOLMAR, INC.-24CA051741$TOLMAR$$$$$M$Y$$$20240815$$CN$CA$CA
242137601$24213760$1$I$$20240801$20240815$20240815$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07749$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240815$$MD$US$US
242137611$24213761$1$I$$20240809$20240815$20240815$EXP$$NVSC2024DE164148$NOVARTIS$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S, et al.. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. BRITISH JOURNAL OF CANCER. 2023;128 (6):1134-47$$$$F$Y$$$20240815$$HP$DE$DE
242137631$24213763$1$I$$20240812$20240815$20240815$EXP$$GB-GILEAD-2024-0683758$GILEAD$$62$YR$A$M$Y$$$20240815$$HP$GB$GB
242137641$24213764$1$I$20240701$20240803$20240815$20240815$EXP$GB-MHRA-MED-202408031910212490-NWHSF$GB-ELI_LILLY_AND_COMPANY-GB202408003524$ELI LILLY AND CO$$$$$F$Y$57$KG$20240815$$CN$GB$GB
242137652$24213765$2$F$$20240806$20240815$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004723$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240819$$HP$US$US
242137672$24213767$2$F$20240802$20240815$20240815$20240819$PER$$US-AMGEN-USASP2024162481$AMGEN$$84$YR$E$F$Y$$$20240819$$CN$US$US
242137682$24213768$2$F$$20240828$20240815$20240902$EXP$$CA-TAKEDA-2024TUS080731$TAKEDA$$$$$M$Y$$$20240902$$MD$CA$CA
242137711$24213771$1$I$20240812$20240813$20240815$20240815$EXP$$KR-PFIZER INC-PV202400105647$PFIZER$$$$$M$Y$$$20240815$$CN$KR$KR
242137722$24213772$2$F$20220101$20240911$20240815$20240913$EXP$$CZ-PFIZER INC-202400237104$PFIZER$$71$YR$$F$Y$$$20240913$$MD$CZ$CZ
242137731$24213773$1$I$20240805$20240806$20240815$20240815$EXP$$PK-ROCHE-10000049994$ROCHE$$68$YR$E$M$Y$$$20240815$$HP$PK$PK
242137742$24213774$2$F$$20240815$20240815$20240822$EXP$$JP-GENMAB-2024-02907$GENMAB$$8$DEC$$M$Y$$$20240822$$MD$JP$JP
242137752$24213775$2$F$$20240905$20240815$20240913$EXP$$CA-TAKEDA-2024TUS069127$TAKEDA$$$$$F$Y$$$20240913$$CN$CA$CA
242137761$24213776$1$I$20230304$20240808$20240815$20240815$EXP$$NVSC2023GB064458$NOVARTIS$$49$YR$$F$Y$$$20240815$$CN$GB$GB
242137771$24213777$1$I$$20240808$20240815$20240815$EXP$$US-AstraZeneca-2024A181318$ASTRAZENECA$$57$YR$$M$Y$$$20240815$$CN$US$
242137781$24213778$1$I$20240224$20240814$20240814$20240814$DIR$714273$$FDA-CTU$$41$YR$$F$N$58.5$KG$20240814$Y$CN$US$
242137791$24213779$1$I$20240808$20240814$20240814$20240814$DIR$714272$$FDA-CTU$$82$YR$$F$N$$$20240814$N$$US$
242137831$24213783$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128629$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240815$$PH$US$US
242137851$24213785$1$I$$20240806$20240815$20240815$EXP$$PK-ROCHE-10000050901$ROCHE$$74$YR$E$M$Y$$$20240815$$CN$PK$PK
242137861$24213786$1$I$$20240814$20240815$20240815$EXP$$DE-ALXN-202408EEA000807DE$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240815$$MD$DE$DE
242137881$24213788$1$I$20240101$20240812$20240815$20240815$EXP$$US-009507513-2408USA004704$MERCK$$$$$M$Y$$$20240815$$HP$US$US
242137911$24213791$1$I$$20240809$20240815$20240815$EXP$NL-LRB-00994645$NL-MYLANLABS-2024M1074798$MYLAN$$24$YR$$F$Y$55$KG$20240815$$CN$NL$NL
242137921$24213792$1$I$20240726$20240808$20240815$20240815$EXP$$AU-TAKEDA-2024TUS081402$TAKEDA$$56$YR$$F$Y$92$KG$20240815$$MD$AU$AU
242137931$24213793$1$I$$20240808$20240815$20240815$EXP$$US-GILEAD-2024-0684058$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240815$$MD$US$US
242137942$24213794$2$F$$20240828$20240815$20240830$30DAY$$CO-PFIZER INC-202400231947$PFIZER$$6$YR$$F$Y$$$20240830$$CN$CO$CO
242137951$24213795$1$I$$20240808$20240815$20240815$EXP$$US-GILEAD-2024-0684060$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240815$$MD$US$US
242137961$24213796$1$I$$20240812$20240815$20240815$EXP$GB-MHRA-MED-202408122231098460-GFWCY$GB-PFIZER INC-202400234982$PFIZER$$36$YR$$F$Y$$$20240815$$CN$GB$GB
242137971$24213797$1$I$$20240808$20240815$20240815$EXP$$US-GILEAD-2024-0684059$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240815$$MD$US$US
242137981$24213798$1$I$20240724$20240809$20240815$20240815$EXP$$CN-Eisai-EC-2024-171850$EISAI$$46$YR$A$M$Y$$$20240815$$HP$CN$CN
242137992$24213799$2$F$$20240822$20240815$20240827$EXP$$JP-Eisai-EC-2024-171930$EISAI$$$$$$Y$$$20240827$$MD$JP$JP
242138001$24213800$1$I$20240802$20240814$20240815$20240815$PER$$US-AMGEN-USASP2024162170$AMGEN$$$$$M$Y$$$20240815$$CN$US$US
242138021$24213802$1$I$$20240725$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202407016843$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240815$$CN$US$US
242138031$24213803$1$I$20240220$20240814$20240815$20240815$EXP$FR-AFSSAPS-NT2024001005$FR-BAYER-2024A117086$BAYER$$42$YR$A$F$Y$$$20240815$$PH$FR$FR
242138041$24213804$1$I$$20240807$20240815$20240815$EXP$$DE-ALXN-202408EEA000369DE$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240815$$CN$DE$DE
242138071$24213807$1$I$20240808$20240814$20240814$20240814$DIR$714275$$FDA-CTU$$77$YR$$M$N$75.6$KG$20240814$N$CN$US$
242138081$24213808$1$I$$20240814$20240814$20240814$DIR$714276$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242138091$24213809$1$I$20240129$20240814$20240814$20240814$DIR$714263$$FDA-CTU$$59$YR$$F$N$79.2$KG$20240814$N$CN$US$
242138101$24213810$1$I$$20240808$20240815$20240815$EXP$$US-GILEAD-2024-0684062$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240815$$MD$US$US
242138121$24213812$1$I$20240101$20240807$20240815$20240815$EXP$$FR-AstraZeneca-2024A179151$ASTRAZENECA$$79$YR$$M$Y$96$KG$20240815$$MD$FR$
242138131$24213813$1$I$20240730$20240807$20240815$20240815$EXP$$GB-AstraZeneca-2024A178010$ASTRAZENECA$$58$YR$$M$Y$$$20240815$$MD$GB$
242138141$24213814$1$I$$20211015$20240815$20240815$EXP$$US-AstraZeneca-2021A776421$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242138152$24213815$2$F$$20240927$20240815$20240930$PER$$NVSC2024US165481$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
242138161$24213816$1$I$$20240812$20240815$20240815$PER$$US-BAYER-2024A117012$BAYER$$$$$F$Y$$$20240815$$CN$US$US
242138171$24213817$1$I$20221201$20240806$20240815$20240815$EXP$$JP-AKEBIA EUROPE LIMITED-JP-AKEB-23-000196$AKEBIA THERAPEUTICS$$$$$$Y$$$20240815$$MD$JP$JP
242138182$24213818$2$F$$20240802$20240815$20240821$PER$$US-Calliditas-2024CAL01475$CALLIDITAS THERAPEUTICS$$49$YR$A$F$Y$57.1$KG$20240821$$CN$US$US
242138191$24213819$1$I$$20240808$20240815$20240815$EXP$$US-APELLIS-2024-APL-0000578$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240815$$HP$US$US
242138201$24213820$1$I$20221130$20240807$20240815$20240815$EXP$IE-HPRA-2024-114389$IE-TEVA-VS-3231829$TEVA$$5$YR$$F$Y$$$20240815$$CN$IE$IE
242138213$24213821$3$F$20240101$20240912$20240815$20240923$EXP$$JP-TAKEDA-2024TUS070014$TAKEDA$$67$YR$$F$Y$$$20240923$$PH$JP$JP
242138221$24213822$1$I$$20240808$20240815$20240815$EXP$$US-GILEAD-2024-0684061$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240815$$MD$US$US
242138231$24213823$1$I$20240503$20240807$20240815$20240815$EXP$$FR-ZAMBON SWITZERLAND LTD.-2024-ZAM-FR000045$PAREXEL$$$$$$Y$$$20240815$$MD$FR$FR
242138241$24213824$1$I$20240809$20240814$20240814$20240814$DIR$714277$$FDA-CTU$$85$YR$$M$N$67.5$KG$20240814$N$$US$
242138251$24213825$1$I$$20240514$20240815$20240815$EXP$$NVSC2024US030655$NOVARTIS$$$$$M$Y$$$20240815$$HP$US$US
242138261$24213826$1$I$20240101$20240809$20240815$20240815$PER$$US-SA-2024SA239753$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240815$$MD$US$US
242138271$24213827$1$I$20240729$20240813$20240815$20240815$PER$$US-BAYER-2024A116728$BAYER$$32$YR$A$F$Y$$$20240815$$CN$US$US
242138281$24213828$1$I$20240814$20240814$20240814$20240814$DIR$714281$$FDA-CTU$$70$YR$$UNK$N$$$20240814$N$$US$
242138291$24213829$1$I$$20240814$20240814$20240814$DIR$714284$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242138301$24213830$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128577$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240815$$CN$US$US
242138321$24213832$1$I$$20240814$20240814$20240814$DIR$714287$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242138341$24213834$1$I$$20240814$20240814$20240814$DIR$714288$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242138351$24213835$1$I$20240801$20240809$20240815$20240815$EXP$$JP-009507513-2408JPN000561J$MERCK$$37$YR$$F$Y$$$20240815$$MD$JP$JP
242138362$24213836$2$F$$20240819$20240815$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128525$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240821$$CN$US$US
242138371$24213837$1$I$$20240807$20240815$20240815$EXP$$US-BAXTER-2024BAX022901$BAXTER$$$$$F$Y$$$20240815$$CN$US$US
242138381$24213838$1$I$$20240805$20240815$20240815$EXP$$GB-BAXTER-2024BAX022836$BAXTER$$$$$F$Y$$$20240815$$HP$GB$GB
242138391$24213839$1$I$20240205$20240805$20240815$20240815$EXP$CN-NMPACDR-3301051039509202400025$CN-BAXTER-2024BAX022867$BAXTER$$78$YR$$M$Y$50$KG$20240815$$MD$CN$CN
242138403$24213840$3$F$20240101$20240916$20240815$20240925$PER$$US-KARYOPHARM-2024KPT001419$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240925$$CN$US$US
242138411$24213841$1$I$20221012$20240805$20240815$20240815$EXP$$US-BAXTER-2024BAX022752$BAXTER$$65$YR$$M$Y$82.81$KG$20240815$$HP$US$US
242138421$24213842$1$I$$20240807$20240815$20240815$EXP$$AU-TAKEDA-2024TUS079438$TAKEDA$$$$I$M$Y$$$20240815$$HP$AU$AU
242138441$24213844$1$I$20240804$20240814$20240814$20240814$DIR$714282$$FDA-CTU$$$$$F$N$$$20240814$N$PH$US$
242138461$24213846$1$I$$20240814$20240814$20240814$DIR$714289$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242138471$24213847$1$I$$20240814$20240814$20240814$DIR$714293$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242138491$24213849$1$I$$20240814$20240814$20240814$DIR$714291$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242138501$24213850$1$I$20240711$20240814$20240814$20240814$DIR$714256$$FDA-CTU$$77$YR$$M$N$109$KG$20240814$N$PH$US$
242138531$24213853$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA239436$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240815$$HP$US$US
242138541$24213854$1$I$20240401$20240808$20240815$20240815$EXP$CH-SM-2024-14846$CH-009507513-2408CHE003082$MERCK$$48$YR$$F$Y$74$KG$20240815$$MD$CH$CH
242138551$24213855$1$I$$20240815$20240815$20240815$PER$$US-BAYER-2024A117799$BAYER$$$$$$Y$$$20240815$$CN$US$US
242138561$24213856$1$I$$20240731$20240815$20240815$EXP$$SG-JOURNEY MEDICAL CORPORATION-2024JNY00179$JOURNEY MEDICAL CORPORATION$Wong C.J, Lua A.C.Y, Tay Y-K, Tan S.H, Rajaratnam R. Drug reaction with eosinophilia and systemic symptoms secondary to minocycline complicated by posterior reversible encephalopathy syndrome. JAAD Case Rep. 2024;51:1-3$71$YR$$F$Y$$$20240815$$HP$SG$SG
242138571$24213857$1$I$20240101$20240514$20240815$20240815$EXP$$US-COOPERSURGICAL, INC.-2024CPS001466$COOPERSURGICAL$$$$$F$Y$52.608$KG$20240815$$CN$US$US
242138581$24213858$1$I$20230401$20240731$20240815$20240815$EXP$$US-COOPERSURGICAL, INC.-2024CPS001911$COOPERSURGICAL$$37$YR$$F$Y$116.55$KG$20240815$$CN$US$US
242138591$24213859$1$I$20231115$20240731$20240815$20240815$EXP$$US-COOPERSURGICAL, INC.-2024CPS002374$COOPERSURGICAL$$$$$F$Y$$$20240815$$LW$US$US
242138601$24213860$1$I$20240811$20240811$20240815$20240815$EXP$$CA-TAKEDA-2024TUS081484$TAKEDA$$63$YR$$M$Y$$$20240815$$CN$CA$CA
242138611$24213861$1$I$$20240808$20240815$20240815$EXP$$US-GILEAD-2024-0684063$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240815$$MD$US$US
242138622$24213862$2$F$$20240731$20240815$20240826$EXP$$US-PHARMAAND GMBH-2024PHR00329$pharmaAND$$$$$F$Y$$$20240826$$CN$US$US
242138631$24213863$1$I$$20240812$20240815$20240815$EXP$$US-Taiho Oncology Inc-2024-005035$TAIHO ONCOLOGY INC$$82$YR$E$F$Y$$$20240815$$CN$US$US
242138641$24213864$1$I$$20240807$20240815$20240815$EXP$$DE-SENTISSAG-2024SAGLIT-00017$Sentiss Pharma$$12$WK$I$M$Y$$$20240812$$HP$DE$DE
242138661$24213866$1$I$20240805$20240814$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129072$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$92.08$KG$20240815$$CN$US$US
242138671$24213867$1$I$20240229$20240807$20240815$20240815$EXP$$FR-AstraZeneca-2024A179150$ASTRAZENECA$$81$YR$$M$Y$58.7$KG$20240815$$MD$FR$
242138681$24213868$1$I$$20240814$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128911$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240815$$CN$US$US
242138691$24213869$1$I$$20240815$20240815$20240815$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046007$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240815$$CN$US$US
242138701$24213870$1$I$20240101$20240802$20240815$20240815$EXP$$US-UCBSA-2024039371$UCB$$$$$F$Y$72.109$KG$20240815$$HP$US$US
242138711$24213871$1$I$$20240805$20240815$20240815$EXP$$PT-TEVA-VS-3231311$TEVA$Varela O, Malheiro B, Castro AP, Carvalho JA, Costa E. PLASMA CYTE LEUKEMIA - CLINICAL CASE .Revista Medicina Laboratorial. 2024; (5): 141-145.$71$YR$$F$Y$$$20240815$$MD$PT$PT
242138722$24213872$2$F$$20240822$20240815$20240829$EXP$AT-002147023-NVSC2024AT159468$AT-ROCHE-10000057867$ROCHE$$$$E$F$Y$$$20240829$$MD$AT$AT
242138731$24213873$1$I$$20240814$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009285$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240815$$CN$US$US
242138742$24213874$2$F$$20240812$20240815$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408005404$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240820$$CN$US$US
242138751$24213875$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202407011333$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240815$$HP$US$US
242138762$24213876$2$F$20240701$20240814$20240815$20240829$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0744$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240829$$HP$US$US
242138771$24213877$1$I$$20240802$20240815$20240815$EXP$$US-UCBSA-2024039322$UCB$$$$$$Y$$$20240815$$CN$US$US
242138801$24213880$1$I$$20240812$20240815$20240815$EXP$$CA-BAUSCH-BL-2024-012282$BAUSCH AND LOMB$$$$$F$Y$$$20240815$$MD$CA$CA
242138821$24213882$1$I$20240813$20240814$20240814$20240814$DIR$714294$$FDA-CTU$$82$YR$$F$N$$$20240814$N$HP$US$
242138831$24213883$1$I$$20240814$20240814$20240814$DIR$714297$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242138841$24213884$1$I$20240811$20240814$20240814$20240814$DIR$714278$$FDA-CTU$$75$YR$$F$N$51.75$KG$20240814$N$CN$US$
242138861$24213886$1$I$$20240814$20240814$20240814$DIR$714304$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242138871$24213887$1$I$20240225$20240814$20240814$20240814$DIR$714225$$FDA-CTU$$31$YR$$F$N$45$KG$20240814$N$CN$US$
242138881$24213888$1$I$$20240814$20240814$20240814$DIR$714298$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242138891$24213889$1$I$20240812$20240814$20240814$20240814$DIR$714239$$FDA-CTU$$75$YR$$F$N$84.15$KG$20240814$N$CN$US$
242138901$24213890$1$I$$20240806$20240815$20240815$PER$$US-BAUSCH-BL-2024-012072$BAUSCH AND LOMB$$$$$F$Y$$$20240815$$MD$US$US
242138911$24213891$1$I$20240814$20240814$20240814$20240814$DIR$714307$$FDA-CTU$$74$YR$$F$N$$$20240814$N$$US$
242138921$24213892$1$I$$20240812$20240815$20240815$EXP$$US-MYLANLABS-2024M1075458$MYLAN$$$$$M$Y$$$20240815$$CN$US$US
242138931$24213893$1$I$$20240812$20240815$20240815$EXP$$CA-BAUSCH-BL-2024-012284$BAUSCH AND LOMB$$35$YR$$F$Y$$$20240815$$HP$CA$CA
242138941$24213894$1$I$20240101$20240807$20240815$20240815$PER$$US-SA-2024SA236787$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240815$$MD$US$US
242138951$24213895$1$I$$20240806$20240815$20240815$PER$$US-SA-2024SA236822$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240815$$MD$US$US
242138961$24213896$1$I$$20240806$20240815$20240815$PER$$US-SA-2024SA236823$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240815$$CN$US$US
242138981$24213898$1$I$20100325$20240809$20240815$20240815$EXP$$US-BAUSCH-BL-2024-012300$BAUSCH AND LOMB$$52$YR$$F$Y$69.2$KG$20240815$$MD$US$US
242138991$24213899$1$I$20240814$20240814$20240814$20240814$DIR$714306$$FDA-CTU$$24$YR$$M$N$159.3$KG$20240814$Y$HP$US$
242139011$24213901$1$I$$20240807$20240815$20240815$PER$$US-ABBVIE-5872655$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242139021$24213902$1$I$20240501$20240812$20240815$20240815$EXP$$DE-BAUSCH-BL-2024-012259$BAUSCH AND LOMB$$56$YR$$M$Y$99$KG$20240815$$MD$DE$DE
242139041$24213904$1$I$$20240815$20240815$20240815$EXP$$ZA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045992$BOEHRINGER INGELHEIM$$$$$$Y$$$20240815$$CN$ZA$ZA
242139051$24213905$1$I$20211001$20240812$20240815$20240815$EXP$$DE-TAKEDA-2024TUS080958$TAKEDA$$62$YR$$M$Y$$$20240815$$HP$DE$DE
242139062$24213906$2$F$$20240815$20240815$20240904$EXP$$CA-AstraZeneca-2024A179860$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$CA$
242139081$24213908$1$I$20200407$20240731$20240815$20240815$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2020000002$IOVANCE BIOTHERAPEUTICS$$73$YR$$F$Y$95.24$KG$20240809$$MD$US$US
242139101$24213910$1$I$$20240807$20240815$20240815$EXP$NL-LRB-00990247$NL-TEVA-VS-3231824$TEVA$$44$YR$$M$Y$86$KG$20240815$$CN$NL$NL
242139111$24213911$1$I$$20240808$20240815$20240815$PER$$US-009507513-2408USA003253$MERCK$Juarez-Vignon JJ, Pophali P, Chornenkyy Y, Peters ML. Cancer of Unknown Primary: When Imaging, Pathology, and Molecular Biology Do Not Match.. Case Reports in Oncology. 2024;17(1):695-704$$$E$M$Y$$$20240815$$HP$US$US
242139131$24213913$1$I$20240216$20240807$20240815$20240815$EXP$$CA-TAKEDA-2024TUS027041$TAKEDA$$96$YR$$F$Y$$$20240815$$CN$CA$CA
242139141$24213914$1$I$20240810$20240814$20240814$20240814$DIR$714355$$FDA-CTU$$$$$F$N$$$20240814$N$CN$US$
242139171$24213917$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56143$$FDA-CTU$$62$YR$$F$N$101.6$KG$20240815$N$$US$
242139191$24213919$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56144$$FDA-CTU$$50$YR$$F$N$$$20240815$N$HP$US$
242139201$24213920$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56145$$FDA-CTU$$15$YR$$F$N$129.27$KG$20240815$N$$US$
242139211$24213921$1$I$20240527$20240814$20240814$20240814$DIR$714313$$FDA-CTU$$85$YR$$F$N$$$20240814$Y$CN$US$
242139221$24213922$1$I$$20240814$20240814$20240814$DIR$714312$$FDA-CTU$$$$$UNK$N$$$20240814$N$CN$US$
242139231$24213923$1$I$$20240809$20240815$20240815$PER$$US-MYLANLABS-2024M1075051$MYLAN$$$$$F$Y$$$20240815$$CN$US$US
242139241$24213924$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA236971$SANOFI AVENTIS$$$$E$M$Y$$$20240815$$CN$US$US
242139261$24213926$1$I$20240704$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56178$$FDA-CTU$$89$YR$$F$N$$$20240815$N$PH$US$
242139271$24213927$1$I$$20240809$20240815$20240815$EXP$$GB-TAKEDA-GB201802361$TAKEDA$$$$$F$Y$$$20240815$$CN$GB$GB
242139281$24213928$1$I$$20240814$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129376$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240815$$CN$US$US
242139291$24213929$1$I$20231219$20240814$20240815$20240815$EXP$FR-AFSSAPS-NY2024000928$FR-ROCHE-10000057196$ROCHE$$55$YR$A$M$Y$84.3$KG$20240815$$MD$FR$FR
242139301$24213930$1$I$$20240806$20240815$20240815$PER$$US-ABBVIE-5872407$ABBVIE$$$$$M$Y$$$20240815$$MD$US$US
242139321$24213932$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56193$$FDA-CTU$$61$YR$$F$N$195$LBS$20240815$N$$US$
242139331$24213933$1$I$$20240802$20240815$20240815$EXP$$US-UCBSA-2024039332$UCB$$$$$$Y$$$20240815$$CN$US$US
242139341$24213934$1$I$$20240807$20240815$20240815$EXP$$BE-AstraZeneca-2024A182144$ASTRAZENECA$$$$$$Y$$$20240815$$MD$BE$
242139352$24213935$2$F$20240101$20240814$20240815$20240828$PER$$US-SA-2024SA239377$SANOFI AVENTIS$$76$YR$E$F$Y$63.5$KG$20240828$$MD$US$US
242139361$24213936$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA239051$SANOFI AVENTIS$$$$A$M$Y$90.71$KG$20240815$$MD$US$US
242139371$24213937$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA239107$SANOFI AVENTIS$$$$A$F$Y$$$20240815$$MD$US$US
242139381$24213938$1$I$$20240807$20240815$20240815$EXP$$ZA-AstraZeneca-2024A179708$ASTRAZENECA$$17532$DY$$F$Y$$$20240815$$CN$ZA$
242139391$24213939$1$I$$20240807$20240815$20240815$EXP$$BR-AstraZeneca-2024A183752$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$BR$
242139411$24213941$1$I$$20230420$20240815$20240815$EXP$$US-AstraZeneca-2023A095031$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242139421$24213942$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128265$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240815$$CN$US$US
242139431$24213943$1$I$$20240814$20240815$20240815$DIR$FDA-CDER-CTU-2024-56196$$FDA-CTU$$$$$F$N$$$20240814$N$HP$US$
242139441$24213944$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56155$$FDA-CTU$$52$YR$$F$N$92.53$KG$20240815$N$$US$
242139451$24213945$1$I$$20240814$20240814$20240814$DIR$714290$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242139461$24213946$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56146$$FDA-CTU$$56$YR$$F$N$$$20240815$N$$US$
242139481$24213948$1$I$20240723$20240814$20240814$20240814$DIR$714331$$FDA-CTU$$16$YR$$F$N$49.5$KG$20240814$N$PH$US$
242139491$24213949$1$I$$20240814$20240814$20240814$DIR$714301$$FDA-CTU$$$$$UNK$N$$$20240814$$CN$US$
242139501$24213950$1$I$20240810$20240814$20240814$20240814$DIR$714326$$FDA-CTU$$47$YR$$M$N$117$KG$20240814$N$CN$US$
242139511$24213951$1$I$20240730$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56200$$FDA-CTU$$76$YR$$F$N$$$20240815$N$PH$US$
242139521$24213952$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56194$$FDA-CTU$$41$YR$$F$N$$$20240815$N$$US$
242139531$24213953$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56156$$FDA-CTU$$70$YR$$F$N$$$20240815$N$$US$
242139541$24213954$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56198$$FDA-CTU$$46$YR$$F$N$242$LBS$20240815$N$$US$
242139552$24213955$2$F$20240719$20240809$20240815$20240820$EXP$$CA-MYLANLABS-2024M1076097$MYLAN$$83$YR$$F$Y$$$20240820$$HP$CA$CA
242139562$24213956$2$F$$20240829$20240815$20240829$EXP$$US-ALXN-202408USA000553US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242139571$24213957$1$I$$20240522$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000216$Tarsus Pharmaceuticals$$$$$$Y$$$20240815$$MD$US$US
242139581$24213958$1$I$$20240522$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000213$Tarsus Pharmaceuticals$$$$$$Y$$$20240815$$MD$US$US
242139591$24213959$1$I$$20240522$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000214$Tarsus Pharmaceuticals$$$$$$Y$$$20240815$$MD$US$US
242139601$24213960$1$I$$20240814$20240815$20240815$EXP$$US-GILEAD-2024-0684244$GILEAD$$72$YR$E$F$Y$$$20240815$$MD$US$US
242139611$24213961$1$I$20200601$20240815$20240815$20240815$EXP$$NL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045972$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$$$20240815$$MD$NL$NL
242139631$24213963$1$I$20240626$20240703$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000300$Tarsus Pharmaceuticals$$76$YR$$F$Y$$$20240815$$PH$US$US
242139641$24213964$1$I$$20240628$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000294$Tarsus Pharmaceuticals$$$$$$Y$$$20240815$$MD$US$US
242139651$24213965$1$I$$20240628$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000296$Tarsus Pharmaceuticals$$$$$M$Y$$$20240815$$CN$US$US
242139661$24213966$1$I$$20240627$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000292$Tarsus Pharmaceuticals$$$$$$Y$$$20240815$$MD$US$US
242139671$24213967$1$I$$20240627$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000293$Tarsus Pharmaceuticals$$$$$M$Y$79.36$KG$20240815$$PH$US$US
242139681$24213968$1$I$$20240701$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000299$Tarsus Pharmaceuticals$$$$$F$Y$$$20240815$$CN$US$US
242139691$24213969$1$I$$20240701$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000297$Tarsus Pharmaceuticals$$52$YR$$F$Y$$$20240815$$PH$US$US
242139701$24213970$1$I$$20240708$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000302$Tarsus Pharmaceuticals$$76$YR$$F$Y$$$20240815$$PH$US$US
242139711$24213971$1$I$20240704$20240704$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000301$Tarsus Pharmaceuticals$$68$YR$$F$Y$72.56$KG$20240815$$CN$US$US
242139721$24213972$1$I$$20240628$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000295$Tarsus Pharmaceuticals$$15$YR$$F$Y$$$20240815$$PH$US$US
242139731$24213973$1$I$$20240709$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000304$Tarsus Pharmaceuticals$$60$YR$$F$Y$$$20240815$$MD$US$US
242139741$24213974$1$I$$20240814$20240815$20240815$EXP$$US-GILEAD-2024-0684242$GILEAD$$73$YR$E$F$Y$$$20240815$$MD$US$US
242139751$24213975$1$I$20240325$20240710$20240815$20240815$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000298$Tarsus Pharmaceuticals$$78$YR$$F$Y$$$20240815$$PH$US$US
242139762$24213976$2$F$20240802$20240814$20240815$20240821$EXP$$CA-TAKEDA-2024TUS078726$TAKEDA$$69$YR$$F$Y$$$20240821$$CN$CA$CA
242139771$24213977$1$I$20240501$20240805$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR098224$VIIV$$48$YR$$F$Y$91$KG$20240815$$CN$US$US
242139781$24213978$1$I$$20240813$20240815$20240815$PER$$US-MYLANLABS-2024M1075741$MYLAN$$$$$F$Y$$$20240815$$CN$US$US
242139791$24213979$1$I$$20240802$20240815$20240815$EXP$$US-RDY-LIT/USA/24/0011526$DR REDDYS$Pak W, Brumwell NA, Kabel CC, Gutgarts V, Jaffer Sathick I, Mailankody S, et al. Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 Cases. Kidney Medicine. 2024;6(8): doi:10.1016/j.xkme.2024.100856.$$$$M$Y$$$20240815$$HP$US$US
242139801$24213980$1$I$20240101$20240806$20240815$20240815$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000120$PAREXEL$$$$$$Y$$$20240815$$HP$US$US
242139811$24213981$1$I$$20240802$20240815$20240815$EXP$$US-RDY-LIT/USA/24/0011525$DR REDDYS$Pak W, Brumwell NA, Kabel CC, Gutgarts V, Jaffer Sathick I, Mailankody S, et al. Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 Cases. Kidney Medicine. 2024;6(8): doi:10.1016/j.xkme.2024.100856.$$$$F$Y$$$20240815$$MD$US$US
242139841$24213984$1$I$$20240808$20240815$20240815$EXP$$US-KERYX BIOPHARMACEUTICALS INC.-US-AKEB-24-001203$AKEBIA THERAPEUTICS$$$$$M$Y$$$20240815$$HP$US$US
242139891$24213989$1$I$$20240805$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124949$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240815$$CN$US$US
242139902$24213990$2$F$20240801$20240809$20240815$20240823$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1074$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240823$$CN$US$US
242139911$24213991$1$I$$20240706$20240815$20240815$PER$$US-Millicent Holdings Ltd.-MILL20241078$MILLICENT HOLDINGS$$$$$F$Y$$$20240815$$CN$US$US
242139921$24213992$1$I$20240713$20240807$20240815$20240815$EXP$FR-AFSSAPS-TO2024001459$FR-TEVA-VS-3231744$TEVA$$60$YR$$M$Y$85$KG$20240815$$HP$FR$FR
242139931$24213993$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56203$$FDA-CTU$$67$YR$$M$N$$$20240815$N$$US$
242139941$24213994$1$I$20240711$20240814$20240814$20240814$DIR$714334$$FDA-CTU$$78$YR$$F$N$$$20240814$N$HP$US$
242139951$24213995$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56149$$FDA-CTU$$54$YR$$F$N$244$LBS$20240815$N$$US$
242139961$24213996$1$I$20240616$20240814$20240814$20240814$DIR$714336$$FDA-CTU$$48$YR$$M$N$96.1$KG$20240814$N$HP$US$
242139971$24213997$1$I$20240622$20240814$20240814$20240814$DIR$714337$$FDA-CTU$$67$YR$$M$N$68.9$KG$20240814$N$$US$
242139981$24213998$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56197$$FDA-CTU$$63$YR$$F$N$320$LBS$20240815$N$$US$
242139991$24213999$1$I$20240627$20240814$20240814$20240814$DIR$714339$$FDA-CTU$$52$YR$$M$N$88.5$KG$20240814$N$$US$
242140021$24214002$1$I$20240801$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007227$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240815$$CN$US$US
242140031$24214003$1$I$$20230707$20240815$20240815$EXP$$US-AstraZeneca-2023A156991$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242140041$24214004$1$I$20240601$20240807$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408005443$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240815$$CN$US$US
242140061$24214006$1$I$20191001$20220216$20240815$20240815$EXP$$HN-AstraZeneca-2022A079774$ASTRAZENECA$$29752$DY$$F$Y$$$20240815$$CN$HN$
242140071$24214007$1$I$$20230411$20240815$20240815$EXP$$US-AstraZeneca-2023A007927$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242140081$24214008$1$I$20240717$20240807$20240815$20240815$PER$$US-SA-2024SA236017$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240815$$MD$US$US
242140091$24214009$1$I$20220507$20220612$20240815$20240815$EXP$$US-AstraZeneca-2022A218833$ASTRAZENECA$$73$YR$$F$Y$60$KG$20240815$$CN$US$
242140101$24214010$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA236245$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240815$$CN$US$US
242140111$24214011$1$I$$20221207$20240815$20240815$EXP$$US-AstraZeneca-2022A401077$ASTRAZENECA$$$$$$Y$$$20240815$$MD$US$
242140121$24214012$1$I$$20230109$20240815$20240815$EXP$$US-AstraZeneca-2022A375125$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242140131$24214013$1$I$$20230316$20240815$20240815$EXP$$US-AstraZeneca-2023A064412$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242140141$24214014$1$I$20221101$20230111$20240815$20240815$EXP$$CA-AstraZeneca-2023A008931$ASTRAZENECA$$25324$DY$$M$Y$$$20240815$$HP$CA$
242140151$24214015$1$I$20230704$20240807$20240815$20240815$EXP$$US-BIOGEN-2023BI01239373$BIOGEN$$24$YR$$F$Y$74.3$KG$20240815$$CN$US$US
242140161$24214016$1$I$$20240730$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121151$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240815$$CN$US$US
242140172$24214017$2$F$20230717$20240825$20240815$20240903$EXP$$AE-ROCHE-10000051564$ROCHE$$48$YR$A$M$Y$$$20240903$$CN$AE$AE
242140181$24214018$1$I$20240808$20240814$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128894$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$74.84$KG$20240815$$CN$US$US
242140191$24214019$1$I$$20240807$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR098857$VIIV$$58$YR$$F$Y$$$20240815$$HP$US$US
242140201$24214020$1$I$$20240813$20240815$20240815$PER$$CA-HLS-202402031$HLS THERAPEUTICS$$$$$M$Y$$$20240815$$HP$CA$CA
242140224$24214022$4$F$20231011$20240917$20240815$20240920$30DAY$$AR-PFIZER INC-202400233069$PFIZER$$12$YR$$M$Y$$$20240920$$HP$AR$AR
242140231$24214023$1$I$20240726$20240813$20240815$20240815$EXP$$US-PFIZER INC-202400236146$PFIZER$$83$YR$$F$Y$$$20240815$$CN$US$US
242140241$24214024$1$I$20240814$20240814$20240814$20240814$DIR$714305$$FDA-CTU$$59$YR$$F$N$92.25$KG$20240814$N$$US$
242140251$24214025$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56205$$FDA-CTU$$55$YR$$F$N$280$LBS$20240815$N$$US$
242140261$24214026$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56160$$FDA-CTU$$75$YR$$F$N$$$20240815$N$$US$
242140271$24214027$1$I$20240615$20240806$20240815$20240815$DIR$FDA-CDER-CTU-2024-56210$$FDA-CTU$$31$YR$$F$N$$$20240806$N$HP$US$
242140281$24214028$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56211$$FDA-CTU$$48$YR$$M$N$53.07$KG$20240815$N$$US$
242140291$24214029$1$I$$20240806$20240815$20240815$DIR$FDA-CDER-CTU-2024-56153$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
242140301$24214030$1$I$20240801$20240806$20240815$20240815$DIR$FDA-CDER-CTU-2024-56195$$FDA-CTU$$78$YR$$F$N$$$20240806$N$HP$US$
242140311$24214031$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56213$$FDA-CTU$$83$YR$$M$N$$$20240815$N$$US$
242140321$24214032$1$I$20240814$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56208$$FDA-CTU$$61$YR$$M$N$$$20240815$Y$PH$US$
242140341$24214034$1$I$20240701$20240806$20240815$20240815$PER$$US-SA-2024SA238374$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240815$$MD$US$US
242140351$24214035$1$I$20240808$20240808$20240815$20240815$PER$$US-SA-2024SA239507$SANOFI AVENTIS$$15$YR$T$F$Y$86.18$KG$20240815$$MD$US$US
242140362$24214036$2$F$20240808$20240911$20240815$20240917$PER$$US-SA-2024SA237712$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240918$$CN$US$US
242140371$24214037$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA238305$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240815$$MD$US$US
242140381$24214038$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA239564$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240815$$CN$US$US
242140393$24214039$3$F$20240617$20240912$20240815$20240919$EXP$$DE-BAXTER-2024BAX020333$BAXTER$$76$YR$$F$Y$$$20240919$$HP$DE$DE
242140401$24214040$1$I$$20240809$20240815$20240815$EXP$$MX-ROCHE-10000056345$ROCHE$$$$A$M$Y$82$KG$20240815$$CN$MX$MX
242140412$24214041$2$F$$20240822$20240815$20240903$EXP$$JP-AMGEN-JPNSP2024161006$AMGEN$$$$A$$Y$$$20240902$$PH$JP$JP
242140421$24214042$1$I$$20240814$20240815$20240815$PER$$NVSC2024US165524$NOVARTIS$$$$$M$Y$$$20240815$$MD$US$US
242140431$24214043$1$I$$20240730$20240815$20240815$PER$$US-TPU-TPU-2024-00419$TEIKOKU$$$$$F$Y$$$20240815$$CN$US$US
242140441$24214044$1$I$20230101$20240808$20240815$20240815$PER$$US-SA-2024SA238784$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240815$$CN$US$US
242140451$24214045$1$I$20220802$20240805$20240815$20240815$EXP$$KR-BAXTER-2024BAX022745$BAXTER$$51$YR$$M$Y$48.2$KG$20240815$$MD$KR$KR
242140461$24214046$1$I$20240729$20240731$20240815$20240815$PER$$US-TPU-TPU-2024-00420$TEIKOKU$$78$YR$E$F$Y$$$20240815$$CN$US$US
242140472$24214047$2$F$20240707$20240905$20240815$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127774$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240913$$MD$JP$JP
242140481$24214048$1$I$20240806$20240809$20240815$20240815$EXP$$JP-009507513-2408JPN001113J$MERCK$$101$YR$$F$Y$$$20240815$$PH$JP$JP
242140491$24214049$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127928$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240815$$CN$US$US
242140501$24214050$1$I$$20240812$20240815$20240815$PER$$US-JNJFOC-20240831101$JOHNSON AND JOHNSON$$$$$F$Y$$$20240815$$CN$US$US
242140511$24214051$1$I$20240718$20240809$20240815$20240815$EXP$$CN-PFIZER INC-PV202400104235$PFIZER$$53$YR$$F$Y$$$20240815$$HP$CN$CN
242140521$24214052$1$I$$20240812$20240815$20240815$EXP$$US-PFIZER INC-202400235061$PFIZER$$72$YR$$M$Y$67.59$KG$20240815$$CN$US$US
242140532$24214053$2$F$20240609$20240819$20240815$20240821$EXP$FR-AFSSAPS-BS2024000490$FR-PFIZER INC-202400236997$PFIZER$$46$YR$$F$Y$70$KG$20240821$$MD$FR$FR
242140541$24214054$1$I$20240810$20240814$20240815$20240815$EXP$GB-MHRA-MED-202408140853190720-DBCTY$GB-PFIZER INC-202400236385$PFIZER$$$$$M$Y$95$KG$20240815$$CN$GB$GB
242140551$24214055$1$I$$20240814$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009153$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240815$$CN$US$US
242140561$24214056$1$I$$20240813$20240815$20240815$PER$$CA-HLS-202402030$HLS THERAPEUTICS$$$$$M$Y$$$20240815$$HP$CA$CA
242140572$24214057$2$F$$20240805$20240815$20240904$EXP$$PL-REGENERON PHARMACEUTICALS, INC.-2024-108763$REGENERON$Zukowska P, Ciepiela K, Kudrymska A, Kielbowski K, Becht R. Successful Treatment of Cutaneous Squamous Cell Cancer with Cemiplimab-A Report of Two Cases Demonstrating the Management of Pseudoprogression and Adverse Events. J. Clin. Med. 2024;13(14):4236$80$YR$$F$Y$$$20240904$$HP$PL$PL
242140581$24214058$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56166$$FDA-CTU$$89$YR$$F$N$$$20240815$N$$US$
242140591$24214059$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56214$$FDA-CTU$$44$YR$$F$N$$$20240815$N$$US$
242140601$24214060$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56215$$FDA-CTU$$69$YR$$F$N$133$LBS$20240815$N$$US$
242140611$24214061$1$I$$20240806$20240815$20240815$DIR$FDA-CDER-CTU-2024-56216$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
242140621$24214062$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56219$$FDA-CTU$$40$YR$$F$N$$$20240815$N$$US$
242140631$24214063$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56148$$FDA-CTU$$56$YR$$F$N$$$20240815$N$$US$
242140641$24214064$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56209$$FDA-CTU$$57$YR$$F$N$75.75$KG$20240815$N$$US$
242140651$24214065$1$I$20240721$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56221$$FDA-CTU$$53$YR$$F$N$$$20240815$N$HP$US$
242140661$24214066$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56147$$FDA-CTU$$86$YR$$F$N$92.53$KG$20240815$N$$US$
242140691$24214069$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56201$$FDA-CTU$$82$YR$$F$N$70.31$KG$20240815$N$$US$
242140701$24214070$1$I$$20240814$20240815$20240815$PER$$NVSC2024US165485$NOVARTIS$$$$$$Y$$$20240815$$MD$US$US
242140711$24214071$1$I$20240524$20240812$20240815$20240815$EXP$$US-INCYTE CORPORATION-2024IN008440$INCYTE$$$$$$Y$$$20240815$$CN$US$US
242140721$24214072$1$I$$20240814$20240815$20240815$EXP$$US-PAIPHARMA-2024-US-043843$PHARMACEUTICAL ASSOC$Martino J, Elfessi Z, Szaflarska K, et al.Take it easy! Serotonin syndrome precipitated by the rapid titration of sertraline and trazodone in the setting of risperidone use..Journal of Pharmacy Practice.2024;.$25$YR$$M$Y$$$20240815$$MD$US$US
242140731$24214073$1$I$$20240806$20240815$20240815$DIR$FDA-CDER-CTU-2024-56202$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
242140741$24214074$1$I$$20240814$20240815$20240815$PER$$NVSC2024US165541$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
242140751$24214075$1$I$$20240813$20240815$20240815$EXP$$US-TAKEDA-2024TUS081939$TAKEDA$$$$$F$Y$$$20240815$$CN$US$US
242140761$24214076$1$I$20240814$20240814$20240814$20240814$DIR$714316$$FDA-CTU$$15$YR$$F$N$$$20240814$N$PH$US$
242140771$24214077$1$I$20230322$20230404$20240815$20240815$EXP$$US-AstraZeneca-2023A079746$ASTRAZENECA$$24165$DY$$F$Y$$$20240815$$CN$US$
242140781$24214078$1$I$20220520$20220523$20240815$20240815$EXP$$US-AstraZeneca-2022A197658$ASTRAZENECA$$23316$DY$$F$Y$$$20240815$$CN$US$
242140791$24214079$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56223$$FDA-CTU$$37$YR$$F$N$125.65$KG$20240815$N$$US$
242140811$24214081$1$I$$20230710$20240815$20240815$EXP$$US-AstraZeneca-2023A158667$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242140821$24214082$1$I$$20220624$20240815$20240815$EXP$$US-AstraZeneca-2022A235358$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
242140831$24214083$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56154$$FDA-CTU$$68$YR$$F$N$68.04$KG$20240815$N$$US$
242140841$24214084$1$I$20220801$20230224$20240815$20240815$EXP$$US-AstraZeneca-2023A007462$ASTRAZENECA$$625$MON$$F$Y$$$20240815$$CN$US$
242140851$24214085$1$I$20221121$20221123$20240815$20240815$EXP$$CO-AstraZeneca-2022A389386$ASTRAZENECA$$21138$DY$$M$Y$79$KG$20240815$$CN$CO$
242140861$24214086$1$I$$20230620$20240815$20240815$EXP$$US-AstraZeneca-2023A143293$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242140871$24214087$1$I$$20221108$20240815$20240815$EXP$$US-AstraZeneca-2022A328843$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242140881$24214088$1$I$$20220407$20240815$20240815$EXP$$US-AstraZeneca-2022A144051$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242140891$24214089$1$I$$20240809$20240815$20240815$EXP$$US-AstraZeneca-2024A182231$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242140901$24214090$1$I$20240726$20240812$20240815$20240815$EXP$$US-AstraZeneca-2024A183314$ASTRAZENECA$$33128$DY$$M$Y$$$20240815$$CN$US$
242140911$24214091$1$I$$20240809$20240815$20240815$EXP$$US-ROCHE-10000056032$ROCHE$$$$$$Y$$$20240815$$MD$US$US
242140921$24214092$1$I$$20240805$20240815$20240815$EXP$$PT-TEVA-VS-3231420$TEVA$Alto? LS, Santos C, Castro AP. INVASIVE CANDIDA PARAPSILOSIS MULTIDRUG-RESISTANT DISEASE .Revista Medicina Laboratorial. 2024; (5): 105-106.$46$YR$$M$Y$$$20240815$$MD$PT$PT
242140931$24214093$1$I$$20230921$20240815$20240815$EXP$$US-AstraZeneca-2023A217445$ASTRAZENECA$$$$$M$Y$79.4$KG$20240815$$CN$US$
242140942$24214094$2$F$$20240820$20240815$20240830$EXP$$US-TEVA-VS-3230629$TEVA$Abedrabo S, Rodriguez TE, Klein LM, Bitran J. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood 2023; 142 (Suppl. 1).; Abedrabo S, Rodriguez TE, Klein LM, Bitran J. Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin^s Lymphoma Treated with Autologous Stem Cell Transplantation. Blood 2023; 142 (Suppl. 1).$$$$$Y$$$20240830$$MD$US$US
242140953$24214095$3$F$20240717$20240829$20240815$20240903$PER$$US-AMGEN-USASP2024158473$AMGEN$$59$YR$A$F$Y$41.6$KG$20240903$$PH$US$US
242140961$24214096$1$I$20240806$20240814$20240814$20240814$DIR$714335$$FDA-CTU$$70$YR$$M$N$119.25$KG$20240814$N$HP$US$
242140971$24214097$1$I$20240811$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56151$$FDA-CTU$$53$YR$$F$N$$$20240815$N$HP$US$
242140981$24214098$1$I$$20240806$20240815$20240815$DIR$FDA-CDER-CTU-2024-56152$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
242140991$24214099$1$I$20240726$20240814$20240814$20240814$DIR$714348$$FDA-CTU$$76$YR$$M$N$$$20240814$N$HP$US$
242141001$24214100$1$I$20240804$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56187$$FDA-CTU$$80$YR$$M$N$$$20240815$N$CN$US$
242141021$24214102$1$I$20240814$20240814$20240814$20240814$DIR$714347$$FDA-CTU$$24$YR$$F$N$$$20240814$N$PH$US$
242141031$24214103$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56212$$FDA-CTU$$83$YR$$M$N$$$20240815$N$$US$
242141041$24214104$1$I$20240619$20240719$20240815$20240815$DIR$FDA-CDER-CTU-2024-56207$$FDA-CTU$$47$YR$$M$N$$$20240719$N$$US$
242141051$24214105$1$I$$20240814$20240815$20240815$PER$$NVSC2024US165534$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
242141071$24214107$1$I$$20240808$20240815$20240815$EXP$$US-AMGEN-USASP2024159608$AMGEN$Specks U.; Falde S.D.; Lal A. et al.. Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Diffuse Alveolar Hemorrhage With Avacopan. ARC open Rheumatology. 2024;1-10$$$$M$Y$$$20240815$$MD$US$US
242141081$24214108$1$I$$20240808$20240815$20240815$EXP$$US-AMGEN-USASP2024159622$AMGEN$Specks U.; Falde S.D.; Lal A. et al.. Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Diffuse Alveolar Hemorrhage With Avacopan. ARC open Rheumatology. 2024;1-10$$$$$Y$$$20240815$$MD$US$US
242141091$24214109$1$I$20240724$20240813$20240815$20240815$EXP$IT-MINISAL02-998181$IT-ROCHE-10000056977$ROCHE$$72$YR$E$M$Y$$$20240815$$PH$IT$IT
242141102$24214110$2$F$20240101$20240813$20240815$20240820$EXP$$US-KARYOPHARM-2024KPT001406$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240820$$CN$US$US
242141111$24214111$1$I$$20240808$20240815$20240815$EXP$$US-AMGEN-USASP2024159630$AMGEN$Specks U.; Falde S.D.; Lal A. et al.. Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Diffuse Alveolar Hemorrhage With Avacopan. ARC open Rheumatology. 2024;1-10$$$$$Y$$$20240815$$MD$US$US
242141121$24214112$1$I$$20240814$20240815$20240815$EXP$$IT-ACERUSPHRM-2024-IT-000003$ACERUS PHARMACEUTICALS$Di Lisa FS, Villa A, Filomeno L, Arcuri T, Chiofalo B, Sanguineti G, Pizzuti L, Krasniqi E, Barba M, Sergi D, Lombardo F, Romanelli F, Botti C, Zoccali G, Ciliberto G, Vici P.Breast and cervical cancer in transgender men: literature review and a case report.Therapeutic Advances in Medical Oncology.2024;161-13.$61$YR$A$$Y$$$20240815$$HP$IT$IT
242141132$24214113$2$F$$20240830$20240815$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408006620$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240902$$CN$US$US
242141141$24214114$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008462$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240815$$CN$US$US
242141151$24214115$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008038$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240815$$CN$US$US
242141162$24214116$2$F$20240803$20240813$20240815$20240820$EXP$$US-VERTEX PHARMACEUTICALS-2024-013117$VERTEX$$66$YR$$F$Y$$$20240820$$CN$US$US
242141172$24214117$2$F$20240723$20240905$20240815$20240915$EXP$$FR-DENTSPLY-2024SCDP000233$DENTSPLY$$44$YR$$F$Y$72$KG$20240915$$PH$FR$FR
242141182$24214118$2$F$$20240815$20240815$20240816$PER$$NVSC2024US165498$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242141201$24214120$1$I$20220513$20240808$20240815$20240815$PER$$JP-Eisai-EC-2022-115071$EISAI$Hikino K. Results of pembrolizumab/lenvatinib combination therapy at our hospital.. Japanese Journal of Gynecologic Oncology.. 2024;(42(3)): 403-403.$66$YR$E$F$Y$$$20240815$$MD$JP$JP
242141211$24214121$1$I$$20240808$20240815$20240815$PER$$US-AMGEN-USASP2024159698$AMGEN$Sharf K.; Chahin N.; Do T. et al.. Benefits of Early vs Late Initiation of IVIG in the Treatment of Anti-HMGCR Immune-Mediated Necrotizing Myopathy. Arthritis Care + Research. 2024$$$$$Y$$$20240815$$MD$US$US
242141221$24214122$1$I$$20240811$20240815$20240815$EXP$$US-AMGEN-USASP2024159793$AMGEN$Diorio C.; Hernandez-miyares L.; Espinoza D.A. et al.. Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents. Blood. 2024;1-32$14$YR$T$M$Y$$$20240815$$MD$US$US
242141231$24214123$1$I$20240101$20240806$20240815$20240815$EXP$$MX-AMGEN-MEXSP2024158495$AMGEN$$$$$F$Y$$$20240815$$MD$MX$MX
242141241$24214124$1$I$20240101$20240802$20240815$20240815$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-001851$SK LIFE SCIENCE$$$$$$Y$$$20240815$$HP$CA$CA
242141251$24214125$1$I$$20240808$20240815$20240815$PER$$US-AMGEN-USASP2024159710$AMGEN$Theodory B.; Harrison S.; Bhatt V. V. et al.. Cephalic and ocular manifestations of EBV-associated plasmablastic lymphoma: Clinical and radiological response to bortezomib, EPOCH, and intrathecal methotrexate. Radiology Case Reports. 2024;19 (10):4273-4279$38$YR$A$M$Y$$$20240815$$MD$US$US
242141262$24214126$2$F$20240206$20240827$20240815$20240909$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-000408$SK LIFE SCIENCE$$$$$$Y$$$20240909$$HP$CA$CA
242141271$24214127$1$I$$20240802$20240815$20240815$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001827$SK LIFE SCIENCE$$$$$$Y$$$20240815$$CN$US$US
242141281$24214128$1$I$$20240806$20240815$20240815$EXP$PL-URPL-DML-MLP.4401.1.164.2024$PL-TEVA-VS-3230802$TEVA$$77$YR$$F$Y$67$KG$20240815$$PH$PL$PL
242141291$24214129$1$I$20240101$20240801$20240815$20240815$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-001860$SK LIFE SCIENCE$$$$$$Y$$$20240815$$HP$CA$CA
242141311$24214131$1$I$20240724$20240812$20240815$20240815$DIR$FDA-CDER-CTU-2024-56231$$FDA-CTU$$72$YR$$F$N$68.04$KG$20240812$N$CN$US$
242141321$24214132$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56232$$FDA-CTU$$83$YR$$M$N$$$20240815$N$$US$
242141331$24214133$1$I$20240701$20240814$20240814$20240814$DIR$714329$$FDA-CTU$$65$YR$$F$N$119.25$KG$20240814$N$CN$US$
242141341$24214134$1$I$20240316$20240814$20240814$20240814$DIR$714333$$FDA-CTU$$72$YR$$M$N$87.75$KG$20240814$N$CN$US$
242141362$24214136$2$F$$20240816$20240815$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07147$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242141371$24214137$1$I$$20240813$20240815$20240815$PER$$US-ABBVIE-5881399$ABBVIE$$$$$$Y$$$20240815$$HP$US$US
242141382$24214138$2$F$$20240805$20240815$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07196$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242141391$24214139$1$I$20240731$20240807$20240815$20240815$EXP$$GB-AstraZeneca-2024A181039$ASTRAZENECA$$39$YR$$F$Y$$$20240815$$MD$GB$
242141401$24214140$1$I$$20240419$20240815$20240815$PER$$US-AstraZeneca-2024A095195$ASTRAZENECA$$$$$$Y$$$20240815$$CN$US$
242141411$24214141$1$I$$20240424$20240815$20240815$PER$$US-AstraZeneca-2024A099148$ASTRAZENECA$$$$$F$Y$$$20240815$$PH$US$
242141421$24214142$1$I$$20240515$20240815$20240815$PER$$US-AstraZeneca-2024A114638$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141431$24214143$1$I$$20240515$20240815$20240815$PER$$US-AstraZeneca-2024A114849$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141441$24214144$1$I$$20240515$20240815$20240815$PER$$US-AstraZeneca-2024A114866$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141451$24214145$1$I$$20240515$20240815$20240815$PER$$US-AstraZeneca-2024A115076$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141461$24214146$1$I$$20240514$20240815$20240815$PER$$US-AstraZeneca-2024A115138$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141471$24214147$1$I$$20240515$20240815$20240815$PER$$US-AstraZeneca-2024A115475$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141481$24214148$1$I$20240419$20240514$20240815$20240815$PER$$US-AstraZeneca-2024A117029$ASTRAZENECA$$22356$DY$$F$Y$60.6$KG$20240815$$HP$US$
242141491$24214149$1$I$20240429$20240514$20240815$20240815$PER$$US-AstraZeneca-2024A117051$ASTRAZENECA$$22366$DY$$F$Y$60.6$KG$20240815$$HP$US$
242141501$24214150$1$I$$20240523$20240815$20240815$PER$$US-AstraZeneca-2024A121464$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141511$24214151$1$I$$20240528$20240815$20240815$PER$$US-AstraZeneca-2024A124901$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141521$24214152$1$I$20240101$20240531$20240815$20240815$PER$$US-AstraZeneca-2024A128028$ASTRAZENECA$$671$MON$$F$Y$$$20240815$$CN$US$
242141531$24214153$1$I$$20240531$20240815$20240815$PER$$US-AstraZeneca-2024A128774$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141541$24214154$1$I$$20240603$20240815$20240815$PER$$US-AstraZeneca-2024A130476$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141551$24214155$1$I$$20240618$20240815$20240815$PER$$US-AstraZeneca-2024A131963$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141561$24214156$1$I$$20240606$20240815$20240815$PER$$US-AstraZeneca-2024A132409$ASTRAZENECA$$$$$$Y$$$20240815$$HP$US$
242141571$24214157$1$I$$20240605$20240815$20240815$PER$$US-AstraZeneca-2024A132791$ASTRAZENECA$$$$$F$Y$$$20240815$$PH$US$
242141581$24214158$1$I$$20240607$20240815$20240815$PER$$US-AstraZeneca-2024A134468$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141591$24214159$1$I$$20240612$20240815$20240815$PER$$US-AstraZeneca-2024A138575$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141601$24214160$1$I$$20240618$20240815$20240815$PER$$US-AstraZeneca-2024A142280$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141611$24214161$1$I$$20240620$20240815$20240815$PER$$US-AstraZeneca-2024A143737$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242141621$24214162$1$I$$20240808$20240815$20240815$EXP$$US-AMERICAN REGENT INC-2024003083$AMERICAN REGENT$$$$$F$Y$$$20240815$$CN$US$US
242141631$24214163$1$I$$20240619$20240815$20240815$PER$$US-AstraZeneca-2024A144837$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141651$24214165$1$I$$20240625$20240815$20240815$PER$$US-AstraZeneca-2024A147380$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141661$24214166$1$I$$20240815$20240815$20240815$PER$$NVSC2024US165521$NOVARTIS$$$$$$Y$$$20240815$$HP$US$US
242141671$24214167$1$I$$20240626$20240815$20240815$PER$$US-AstraZeneca-2024A149432$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141684$24214168$4$F$$20240827$20240815$20240828$EXP$$NVSC2024CA165275$NOVARTIS$$33$YR$$M$Y$$$20240828$$CN$CA$CA
242141691$24214169$1$I$20240708$20240813$20240815$20240815$EXP$$US-PFIZER INC-202400236961$PFIZER$$60$YR$$F$Y$$$20240815$$HP$US$US
242141701$24214170$1$I$$20240628$20240815$20240815$PER$$US-AstraZeneca-2024A150182$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141711$24214171$1$I$$20240531$20240815$20240815$PER$$US-AstraZeneca-2024A153642$ASTRAZENECA$$$$$$Y$$$20240815$$MD$US$
242141721$24214172$1$I$$20240716$20240815$20240815$PER$$US-AstraZeneca-2024A162960$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141732$24214173$2$F$$20240820$20240815$20240829$EXP$$US-TEVA-VS-3230800$TEVA$Daccache A, Albright J, Malmberg M, Braun J, Lemley K. Intracranial Hypertension as an Initial Sign of Adrenal Insufficiency Secondary to Inhaled Corticosteroids in a Child With Asthma. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.; Daccache A, Albright J, Malmberg M, Braun J, Lemley K. Intracranial Hypertension as an Initial Sign of Adrenal Insufficiency Secondary to Inhaled Corticosteroids in a Child With Asthma. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.$7$YR$$F$Y$$$20240829$$HP$US$US
242141741$24214174$1$I$$20240718$20240815$20240815$PER$$US-AstraZeneca-2024A164761$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141751$24214175$1$I$$20240722$20240815$20240815$PER$$US-AstraZeneca-2024A167154$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141761$24214176$1$I$$20240723$20240815$20240815$PER$$US-AstraZeneca-2024A168286$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141771$24214177$1$I$$20240723$20240815$20240815$PER$$US-AstraZeneca-2024A168458$ASTRAZENECA$$$$$F$Y$$$20240815$$PH$US$
242141782$24214178$2$F$$20240808$20240815$20240902$PER$$US-AstraZeneca-2024A169429$ASTRAZENECA$$$$$F$Y$$$20240902$$PH$US$
242141791$24214179$1$I$$20240722$20240815$20240815$PER$$US-AstraZeneca-2024A169771$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141801$24214180$1$I$$20240725$20240815$20240815$PER$$US-AstraZeneca-2024A170532$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141811$24214181$1$I$$20240805$20240815$20240815$EXP$$AU-VIIV HEALTHCARE LIMITED-AU2024APC100964$VIIV$$$$$$Y$$$20240815$$MD$AU$AU
242141822$24214182$2$F$$20240802$20240815$20240830$PER$$US-AstraZeneca-2024A170729$ASTRAZENECA$$$$$F$Y$95.1$KG$20240830$$MD$US$
242141831$24214183$1$I$$20240726$20240815$20240815$PER$$US-AstraZeneca-2024A171564$ASTRAZENECA$$$$$F$Y$$$20240815$$PH$US$
242141841$24214184$1$I$$20240725$20240815$20240815$PER$$US-AstraZeneca-2024A171975$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141851$24214185$1$I$$20240730$20240815$20240815$PER$$US-AstraZeneca-2024A173716$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242141861$24214186$1$I$$20240723$20240815$20240815$PER$$US-AstraZeneca-2024A174094$ASTRAZENECA$$$$$F$Y$$$20240815$$PH$US$
242141871$24214187$1$I$$20240723$20240815$20240815$PER$$US-AstraZeneca-2024A174097$ASTRAZENECA$$$$$F$Y$$$20240815$$PH$US$
242141881$24214188$1$I$$20240730$20240815$20240815$PER$$US-AstraZeneca-2024A174764$ASTRAZENECA$$$$$F$Y$$$20240815$$PH$US$
242141891$24214189$1$I$$20240801$20240815$20240815$PER$$US-AstraZeneca-2024A175877$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242141901$24214190$1$I$$20240802$20240815$20240815$PER$$US-AstraZeneca-2024A176873$ASTRAZENECA$$$$$$Y$$$20240815$$HP$US$
242141911$24214191$1$I$$20240801$20240815$20240815$PER$$US-AstraZeneca-2024A176995$ASTRAZENECA$$80$YR$$F$Y$$$20240815$$PH$US$
242141921$24214192$1$I$$20240809$20240815$20240815$EXP$$US-AstraZeneca-2024A182276$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242141932$24214193$2$F$$20240807$20240815$20240913$EXP$$RU-AstraZeneca-2024A182249$ASTRAZENECA$$$$$$Y$$$20240913$$CN$RU$
242141941$24214194$1$I$$20240807$20240815$20240815$EXP$$IN-AstraZeneca-2024A182053$ASTRAZENECA$$66$YR$$F$Y$$$20240815$$CN$IN$
242141951$24214195$1$I$20230816$20240808$20240815$20240815$EXP$$CA-ABBVIE-5875198$ABBVIE$$69$YR$$M$Y$$$20240815$$CN$CA$CA
242141962$24214196$2$F$$20240816$20240815$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07198$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242141971$24214197$1$I$$20240814$20240814$20240814$DIR$714357$$FDA-CTU$$55$YR$$F$N$$$20240814$N$CN$US$
242141981$24214198$1$I$20240811$20240814$20240814$20240814$DIR$714349$$FDA-CTU$$69$YR$$F$N$60.75$KG$20240814$N$CN$US$
242141991$24214199$1$I$$20240703$20240815$20240815$PER$$US-TRAVERE-2024TVT00676$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240815$$CN$US$US
242142001$24214200$1$I$$20221003$20240815$20240815$EXP$$US-AstraZeneca-2022A338125$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242142011$24214201$1$I$20240519$20240814$20240814$20240814$DIR$714341$$FDA-CTU$$60$YR$$F$N$66.15$KG$20240814$N$CN$US$
242142021$24214202$1$I$20240813$20240814$20240814$20240814$DIR$714350$$FDA-CTU$$62$YR$$F$N$115.65$KG$20240814$N$CN$US$
242142032$24214203$2$F$$20240829$20240815$20240905$EXP$$JP-Eisai-EC-2024-171913$EISAI$$80$YR$E$F$Y$$$20240905$$PH$JP$JP
242142041$24214204$1$I$20240801$20240812$20240815$20240815$EXP$$BR-BIOMARINAP-BR-2024-159835$BIOMARIN$$$$$$Y$$$20240815$$CN$BR$BR
242142051$24214205$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160332$AMGEN$Guttman-yassky E.; David E.; Shokrian N. et al.. Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study. Archives of Dermatological research. 2024;316 (7):1-11$$$$$Y$$$20240815$$HP$US$US
242142071$24214207$1$I$$20240809$20240815$20240815$EXP$$US-BAYER-2024A116037$BAYER$$75$YR$E$M$Y$$$20240815$$CN$US$US
242142081$24214208$1$I$$20240809$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128625$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240815$$HP$US$US
242142092$24214209$2$F$20210222$20240902$20240815$20240905$EXP$$FR-AMGEN-FRANI2024150592$AMGEN$$45$YR$A$F$Y$85$KG$20240905$$MD$FR$FR
242142101$24214210$1$I$20240726$20240809$20240815$20240815$EXP$$CA-TAKEDA-2024TUS080872$TAKEDA$$57$YR$$M$Y$$$20240815$$CN$CA$CA
242142111$24214211$1$I$$20220426$20240815$20240815$EXP$$US-AstraZeneca-2022A111079$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242142121$24214212$1$I$$20230524$20240815$20240815$EXP$$US-AstraZeneca-2023A121823$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242142131$24214213$1$I$$20240814$20240815$20240815$PER$$US-AstraZeneca-2024A185861$ASTRAZENECA$$$$$F$Y$$$20240815$$HP$US$
242142141$24214214$1$I$20240701$20240806$20240815$20240815$EXP$NL-LRB-00994331$NL-Vifor (International) Inc.-VIT-2024-07074$VIFOR$$75$YR$$F$Y$101$KG$20240815$$HP$NL$NL
242142151$24214215$1$I$$20230831$20240815$20240815$EXP$$US-AstraZeneca-2023A200363$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242142161$24214216$1$I$20221002$20221017$20240815$20240815$EXP$$DO-AstraZeneca-2022A350255$ASTRAZENECA$$33768$DY$$F$Y$$$20240815$$CN$DO$
242142171$24214217$1$I$$20240807$20240815$20240815$EXP$$JP-AstraZeneca-2024A180388$ASTRAZENECA$$50$YR$$M$Y$$$20240815$$MD$JP$
242142191$24214219$1$I$$20240814$20240815$20240815$PER$$US-AstraZeneca-2024A185666$ASTRAZENECA$$$$$F$Y$$$20240815$$CN$US$
242142202$24214220$2$F$$20240911$20240815$20240917$EXP$$AU-AstraZeneca-2024A169121$ASTRAZENECA$$$$$M$Y$91$KG$20240918$$MD$AU$
242142213$24214221$3$F$20240707$20240903$20240815$20240909$PER$$US-AstraZeneca-2024A156928$ASTRAZENECA$$29523$DY$$F$Y$$$20240909$$CN$US$
242142221$24214222$1$I$20240813$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008457$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240815$$CN$US$US
242142231$24214223$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007500$ELI LILLY AND CO$$$$$M$Y$$$20240815$$CN$US$US
242142242$24214224$2$F$$20240826$20240815$20240903$EXP$$US-TEVA-VS-3230943$TEVA$Khan S, Reggio C, Shoukat U, Lalwani A, Yousaf Z. Avoiding Premature Brain Death Declaration in Patients With Suspected Baclofen Overdose. Am-J-Respir-Crit-Care-Med 2024; 209.; Khan S, Reggio C, Shoukat U, Lalwani A, Yousaf Z. Avoiding Premature Brain Death Declaration in Patients With Suspected Baclofen Overdose. Am-J-Respir-Crit-Care-Med 2024; 209.$58$YR$$M$Y$$$20240903$$HP$US$US
242142251$24214225$1$I$20240701$20240802$20240815$20240815$EXP$EU-AFSSAPS-AVBX2024000428$EU-ETHYPHARM-2024002099$ETHYPHARM$$$$$$Y$$$20240814$$MD$EU$EU
242142262$24214226$2$F$$20240826$20240815$20240903$EXP$$US-TEVA-VS-3230898$TEVA$Puthumana RM, Mintz J, Perez M, Gaddipati S, Gorman D. Too Much of a Good Thing: A Case of Beta Blocker and Warfarin Toxicity. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A5692.; Puthumana RM, Mintz J, Perez M, Gaddipati S, Gorman D. Too Much of a Good Thing: A Case of Beta Blocker and Warfarin Toxicity. Am-J-Respir-Crit-Care-Med 2024; 209 (0): abstr. A5692.$38$YR$$M$Y$$$20240903$$HP$US$US
242142271$24214227$1$I$20240723$20240808$20240815$20240815$EXP$$CN-AMERICAN REGENT INC-2024003081$AMERICAN REGENT$$44$YR$$F$Y$45$KG$20240815$$HP$CN$CN
242142291$24214229$1$I$20240716$20240813$20240815$20240815$EXP$$US-ABBVIE-5880071$ABBVIE$$53$YR$$F$Y$$$20240815$$CN$US$US
242142301$24214230$1$I$$20240814$20240815$20240815$PER$$NVSC2024US165464$NOVARTIS$$66$YR$$F$Y$$$20240815$$HP$US$US
242142311$24214231$1$I$$20240813$20240815$20240815$PER$$US-MYLANLABS-2024M1075946$MYLAN$$$$$F$Y$$$20240815$$MD$US$US
242142331$24214233$1$I$$20240713$20240815$20240815$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07195$LUPIN$$$$$$Y$$$20240815$$CN$US$US
242142341$24214234$1$I$20240802$20240808$20240815$20240815$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000701$DECIPHERA PHARMACEUTICALS$$80$YR$E$M$Y$$$20240815$$CN$US$US
242142351$24214235$1$I$20240101$20240813$20240815$20240815$EXP$$TR-ABBVIE-5880386$ABBVIE$$$$$F$Y$$$20240815$$CN$TR$TR
242142361$24214236$1$I$20240803$20240813$20240815$20240815$EXP$$FR-ABBVIE-5880526$ABBVIE$$71$YR$$M$Y$$$20240815$$HP$FR$FR
242142371$24214237$1$I$$20240806$20240815$20240815$DIR$FDA-CDER-CTU-2024-56241$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
242142381$24214238$1$I$20240810$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56245$$FDA-CTU$$19$YR$$M$N$$$20240815$N$HP$US$
242142391$24214239$1$I$$20240723$20240815$20240815$PER$$US-JNJFOC-20240764062$JOHNSON AND JOHNSON$$$$$F$Y$$$20240815$$CN$US$US
242142401$24214240$1$I$20240628$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56246$$FDA-CTU$$78$YR$$F$N$$$20240815$N$$US$
242142423$24214242$3$F$20240801$20240820$20240815$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046032$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240826$$CN$US$US
242142431$24214243$1$I$$20240814$20240815$20240815$EXP$$SA-BIOMARINAP-SA-2024-159851$BIOMARIN$$$$$$Y$$$20240815$$HP$SA$SA
242142441$24214244$1$I$20240505$20240807$20240815$20240815$EXP$DE-DCGMA-24203737$DE-RDY-SPO/DEU/24/0011619$DR REDDYS$$35$YR$A$F$Y$69$KG$20240815$$MD$DE$DE
242142461$24214246$1$I$20240426$20240805$20240815$20240815$EXP$$US-009507513-2408USA005048$MERCK$$48$YR$$F$Y$80.7$KG$20240815$$PH$US$US
242142471$24214247$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA240514$SANOFI AVENTIS$$8$YR$C$F$Y$34$KG$20240815$$MD$US$US
242142481$24214248$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128608$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240815$$CN$US$US
242142491$24214249$1$I$20240801$20240806$20240815$20240815$PER$$US-AMGEN-USASP2024160241$AMGEN$$$$$F$Y$$$20240815$$CN$US$US
242142501$24214250$1$I$$20240807$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR098818$VIIV$$24$YR$$M$Y$$$20240815$$HP$US$US
242142512$24214251$2$F$20240809$20240817$20240815$20240823$EXP$$AU-GE HEALTHCARE-2024CSU009231$GE HEALTHCARE$$40$YR$$M$Y$$$20240823$$HP$AU$AU
242142521$24214252$1$I$20240503$20240522$20240815$20240815$PER$$US-GE HEALTHCARE-2024CSU005566$GE HEALTHCARE$$22$YR$$M$Y$60.771$KG$20240815$$HP$US$US
242142531$24214253$1$I$20240510$20240808$20240815$20240815$DIR$FDA-CDER-CTU-2024-56248$$FDA-CTU$$88$YR$$F$N$$$20240808$N$HP$US$
242142561$24214256$1$I$20240811$20240814$20240814$20240814$DIR$714353$$FDA-CTU$$33$YR$$M$N$89.1$KG$20240814$N$$US$
242142581$24214258$1$I$20220901$20240807$20240815$20240815$EXP$$RO-BRISTOL-MYERS SQUIBB COMPANY-2024-126895$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240815$$MD$RO$RO
242142591$24214259$1$I$20240716$20240814$20240815$20240815$EXP$FR-AFSSAPS-PC2024000650$FR-ROCHE-10000057393$ROCHE$$33$YR$A$F$Y$$$20240815$$PH$FR$FR
242142602$24214260$2$F$20231116$20240910$20240815$20240916$30DAY$$US-AMGEN-USASP2024158154$AMGEN$$53$YR$A$F$Y$$$20240916$$HP$US$US
242142611$24214261$1$I$$20240812$20240815$20240815$EXP$$BR-JNJFOC-20240832699$JOHNSON AND JOHNSON$$67$YR$E$F$Y$58$KG$20240815$$CN$BR$BR
242142642$24214264$2$F$20240418$20240820$20240815$20240828$EXP$$CA-TOLMAR, INC.-24CA051332$TOLMAR$$80$YR$$M$Y$$$20240828$$MD$CA$CA
242142651$24214265$1$I$$20240811$20240815$20240815$PER$$US-009507513-2408USA004081$MERCK$$$$$$Y$$$20240815$$CN$US$US
242142661$24214266$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128255$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240815$$CN$US$US
242142672$24214267$2$F$$20240826$20240815$20240903$EXP$$IN-AstraZeneca-2024A182037$ASTRAZENECA$$$$A$F$Y$$$20240903$$HP$IN$
242142681$24214268$1$I$20230201$20240807$20240815$20240815$EXP$FR-AFSSAPS-RN2023000299$FR-RDY-SPO/FRA/23/0170354$DR REDDYS$$55$YR$A$M$Y$$$20240815$$MD$FR$FR
242142691$24214269$1$I$$20240813$20240815$20240815$EXP$$AU-ABBVIE-5880934$ABBVIE$$$$$M$Y$$$20240815$$HP$AU$AU
242142701$24214270$1$I$20240618$20240808$20240815$20240815$EXP$FR-AFSSAPS-AN2024001089$FR-RDY-SPO/FRA/24/0011694$DR REDDYS$$69$YR$E$F$Y$87$KG$20240815$$PH$FR$FR
242142711$24214271$1$I$20240430$20240814$20240814$20240814$DIR$714359$$FDA-CTU$$28$YR$$M$N$94.5$KG$20240814$Y$CN$US$
242142721$24214272$1$I$$20221027$20240815$20240815$EXP$$US-AstraZeneca-2022A360711$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242142731$24214273$1$I$$20220819$20240815$20240815$EXP$$US-AstraZeneca-2022A292430$ASTRAZENECA$$$$$M$Y$$$20240815$$CN$US$
242142741$24214274$1$I$$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A180676$ASTRAZENECA$$$$$F$Y$$$20240815$$MD$US$
242142751$24214275$1$I$$20240605$20240815$20240815$EXP$$CN-AstraZeneca-2024A185700$ASTRAZENECA$$$$A$F$Y$$$20240815$$MD$CN$
242142762$24214276$2$F$$20240812$20240815$20240819$EXP$$CA-JNJFOC-20240831714$JOHNSON AND JOHNSON$$16$YR$T$M$Y$64$KG$20240819$$HP$CA$CA
242142772$24214277$2$F$20240809$20240913$20240815$20240921$PER$$US-AMGEN-USASP2024160868$AMGEN$$$$A$$Y$$$20240920$$HP$US$US
242142781$24214278$1$I$$20240807$20240815$20240815$EXP$$NVSJ2024JP009587$NOVARTIS$Aizaki T, Shibata Y, Okamoto D, Watanabe T, Kato T, Yamaguchi K et al.. A Case of Idiopathic Multicentric Castleman^s Disease Not Otherwise Specified with Difficulty in Diagnosis and Treatment. THE 252TH TOKAI REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2024;235$54$YR$$F$Y$$$20240815$$HP$JP$JP
242142791$24214279$1$I$$20240321$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202406000746$ELI LILLY AND CO$$$$$$Y$$$20240815$$CN$US$US
242142802$24214280$2$F$$20240919$20240815$20240925$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-15882$IPSEN$$$$E$F$Y$$$20240925$$CN$GB$GB
242142821$24214282$1$I$20240801$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56161$$FDA-CTU$$1$DY$$F$N$3.6$KG$20240814$N$$US$
242142831$24214283$1$I$20240608$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56168$$FDA-CTU$$1$DY$$F$N$3.54$KG$20240814$N$$US$
242142871$24214287$1$I$20240729$20240814$20240815$20240815$EXP$$IE-ROCHE-10000057576$ROCHE$$$$$M$Y$$$20240815$$HP$IE$IE
242142881$24214288$1$I$20230718$20240812$20240815$20240815$EXP$FR-AFSSAPS-PB2024000851$FR-BAYER-2024A115733$BAYER$$46$YR$A$F$Y$59$KG$20240815$$CN$FR$FR
242142911$24214291$1$I$$20240808$20240815$20240815$EXP$$US-BIOGEN-2024BI01277719$BIOGEN$$$$$M$Y$$$20240815$$HP$US$US
242142932$24214293$2$F$$20240820$20240815$20240830$EXP$$US-TEVA-VS-3230839$TEVA$Lam L, Bansal V, Chai T, Driver LC. Recurrent Pain From Chemotherapy-Induced Peripheral Neuropathy After COVID-19 Infection - A Case Report. Pain-Med-Case-Rep 2023; 7 (8): 357-359.; Lam L, Bansal V, Chai T, Driver LC. Recurrent Pain From Chemotherapy-Induced Peripheral Neuropathy After COVID-19 Infection - A Case Report. Pain-Med-Case-Rep 2023; 7 (8): 357-359.$59$YR$$M$Y$$$20240830$$HP$US$US
242142941$24214294$1$I$$20240806$20240815$20240815$EXP$$US-INSUD PHARMA-2408US06433$INSUD PHARMA$Nelson N, Masih D, Sabri A, Monika F, Mirza M. Isolated Myeloid Sarcoma Masquerading as Scattered Abscesses in a Septic Patient: A Case Report and Literature Review. Case Rep Oncol. 2024;17:39-48$$$$$Y$$$20240815$$HP$US$US
242142951$24214295$1$I$$20240805$20240815$20240815$EXP$$CA-AstraZeneca-2024A176808$ASTRAZENECA$$$$$M$Y$$$20240815$$PH$CA$
242142961$24214296$1$I$20240607$20240807$20240815$20240815$EXP$$FR-AstraZeneca-2024A186342$ASTRAZENECA$$54$YR$$F$Y$$$20240815$$MD$FR$
242142982$24214298$2$F$$20240826$20240815$20240904$EXP$$SE-TEVA-VS-3233056$TEVA$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J-Allergy-Clin-Immunol-Pract 2024; 12 (7): 1850-1862.; Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J-Allergy-Clin-Immunol-Pract 2024; 12 (7): 1850-1862.; Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Lar...$57$YR$$$Y$$$20240904$$MD$SE$SE
242142991$24214299$1$I$20240810$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56084$$FDA-CTU$$84$YR$$F$N$72.9$KG$20240814$N$PH$US$
242143001$24214300$1$I$20240814$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56158$$FDA-CTU$$84$YR$$F$N$$$20240814$N$HP$US$
242143011$24214301$1$I$$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56182$$FDA-CTU$$53$YR$$F$N$$$20240814$N$PH$US$
242143021$24214302$1$I$20240813$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56169$$FDA-CTU$$85$YR$$M$N$$$20240814$N$$US$
242143032$24214303$2$F$$20240819$20240815$20240820$EXP$$NVSC2024FR165218$NOVARTIS$$64$YR$$F$Y$$$20240820$$MD$FR$FR
242143041$24214304$1$I$20240724$20240814$20240814$20240814$DIR$FDA-CDER-CTU-2024-56174$$FDA-CTU$$60$YR$$F$N$42.4$KG$20240814$N$MD$US$
242143061$24214306$1$I$$20240805$20240815$20240815$PER$$US-RDY-SPO/USA/24/0011596$DR REDDYS$$30$YR$A$F$Y$$$20240815$$MD$US$US
242143071$24214307$1$I$$20240805$20240815$20240815$PER$$US-RDY-SPO/USA/24/0011604$DR REDDYS$$17$YR$T$$Y$$$20240815$$HP$US$US
242143081$24214308$1$I$$20240805$20240815$20240815$PER$$US-RDY-SPO/USA/24/0011588$DR REDDYS$$34$YR$A$F$Y$$$20240815$$MD$US$US
242143091$24214309$1$I$$20240805$20240815$20240815$PER$$US-RDY-SPO/USA/24/0011585$DR REDDYS$$26$YR$A$F$Y$$$20240815$$MD$US$US
242143101$24214310$1$I$$20240805$20240815$20240815$PER$$US-INSUD PHARMA-2408US06275$INSUD PHARMA$$$$$$Y$$$20240815$$CN$US$US
242143111$24214311$1$I$$20240807$20240815$20240815$EXP$$JP-AMGEN-JPNSP2024161565$AMGEN$Hiroshi Nishi, Masaomi Nangaku, Tadashi Sofue, Takeo Kagimura, Ichiei Narita. Blood NT Pro-BNP Level and Cardiorenal Outcome in Patients with Anemia in Chronic Kidney Disease. Division of Nephrology and Endocrinology$$$$$Y$$$20240815$$MD$JP$JP
242143121$24214312$1$I$20240621$20240814$20240815$20240815$EXP$$JP-AMERICAN REGENT INC-2024002866$AMERICAN REGENT$$77$YR$$F$Y$$$20240815$$MD$JP$JP
242143131$24214313$1$I$$20240812$20240815$20240815$EXP$$US-GILEAD-2024-0683917$GILEAD$$$$$M$Y$$$20240815$$HP$US$US
242143142$24214314$2$F$20240807$20240823$20240815$20240827$EXP$$US-KARYOPHARM-2024KPT001414$KARYOPHARM THERAPEUTICS$$53$YR$$M$Y$93$KG$20240827$$MD$US$US
242143152$24214315$2$F$20240813$20240816$20240815$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012612$JAZZ$$27$YR$$M$Y$$$20240822$$CN$US$US
242143161$24214316$1$I$$20240813$20240815$20240815$PER$$US-JNJFOC-20240833088$JOHNSON AND JOHNSON$$$$$$Y$$$20240815$$CN$US$US
242143171$24214317$1$I$$20240807$20240815$20240815$EXP$$FR-MYLANLABS-2024M1075118$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$78$YR$$M$Y$$$20240815$$HP$FR$FR
242143181$24214318$1$I$$20240807$20240815$20240815$EXP$$US-MYLANLABS-2024M1074777$MYLAN$Lehmann GC, Thomas J, Schuschke E, Menon D. Complete heart block in a child with repaired congenital heart disease and active COVID-19 infection. Prog-Pediatr-Cardiol 2023; 71.$15$MON$$F$Y$$$20240815$$HP$US$US
242143191$24214319$1$I$$20240805$20240815$20240815$EXP$$SE-TEVA-VS-3233070$TEVA$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J-Allergy-Clin-Immunol-Pract 2024; 12 (7): 1850-1862.; Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J-Allergy-Clin-Immunol-Pract 2024; 12 (7): 1850-1862.$38$YR$$$Y$$$20240815$$MD$SE$SE
242143201$24214320$1$I$20240701$20240804$20240815$20240815$PER$$US-INSUD PHARMA-2408US06253$INSUD PHARMA$$$$$$Y$$$20240815$$CN$US$US
242143211$24214321$1$I$20240101$20240805$20240815$20240815$PER$$US-INSUD PHARMA-2408US06257$INSUD PHARMA$$$$$$Y$$$20240815$$CN$US$US
242143222$24214322$2$F$$20240826$20240815$20240904$EXP$$US-TEVA-VS-3230961$TEVA$Kaur S, Isaac S, Westerman J. Life threatening hematologic emergency from low dose methrotrexate. South-Med-J 2023; 116 641-642.; Kaur S, Isaac S, Westerman J. Life threatening hematologic emergency from low dose methrotrexate. South-Med-J 2023; 116 641-642.$63$YR$$F$Y$$$20240904$$MD$US$US
242143231$24214323$1$I$$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A182982$ASTRAZENECA$Fritz, K; Malani, R. Radiation necrosis after concomitant EGFR-TKI and radiation: A case series and consideration for future patients. Central Nervous System Metastases Conference (CNS) - Society for Neuro Oncology (SNO) and American Society of Clinical Oncology (ASCO) 2024;$63$YR$$M$Y$$$20240815$$HP$US$
242143241$24214324$1$I$$20240807$20240815$20240815$EXP$$US-AstraZeneca-2024A182977$ASTRAZENECA$Fritz, K; Malani, R. Radiation necrosis after concomitant EGFR-TKI and radiation: A case series and consideration for future patients. Central Nervous System Metastases Conference (CNS) - Society for Neuro Oncology (SNO) and American Society of Clinical Oncology (ASCO) 2024;$79$YR$$F$Y$$$20240815$$HP$US$
242143251$24214325$1$I$20240601$20240807$20240815$20240815$PER$$US-SA-2024SA236851$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240815$$MD$US$US
242143261$24214326$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA237020$SANOFI AVENTIS$$$$A$F$Y$$$20240815$$HP$US$US
242143271$24214327$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA236856$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240815$$MD$US$US
242143281$24214328$1$I$20240701$20240807$20240815$20240815$PER$$US-SA-2024SA236934$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240815$$MD$US$US
242143291$24214329$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA237583$SANOFI AVENTIS$$$$$F$Y$$$20240815$$CN$US$US
242143321$24214332$1$I$$20240808$20240815$20240815$PER$$US-MYLANLABS-2024M1074638$MYLAN$$$$$M$Y$$$20240815$$CN$US$US
242143331$24214333$1$I$20191001$20240812$20240815$20240815$EXP$$US-PFIZER INC-PV202400105560$PFIZER$Avra, T.. Off-Label Use of Lamotrigine and Naltrexone in the Treatment of Ketamine Use Disorder: A Case Report. Journal of Addiction Medicine. 2024;00:10.1097/ADM.0000000000001359$28$YR$$M$Y$$$20240815$$HP$US$US
242143351$24214335$1$I$20240701$20240814$20240815$20240815$EXP$$GB-PFIZER INC-PV202400105924$PFIZER$$36$YR$$M$Y$$$20240815$$CN$GB$GB
242143371$24214337$1$I$$20240813$20240815$20240815$EXP$$CN-PFIZER INC-202400236367$PFIZER$Zhao, C.. Diffuse lymphoma involvement of the spinal cord showed on [{sup}18{/sup}F]FDG PET/MRI.. Nuclear Medicine Review. 2024;27:24-27$61$YR$$F$Y$$$20240815$$HP$CN$CN
242143381$24214338$1$I$20240627$20240807$20240815$20240815$EXP$$US-FERRINGPH-2024FE04442$FERRING$$$$$$Y$$$20240815$$HP$US$US
242143393$24214339$3$F$20240101$20240916$20240815$20240919$EXP$$CA-FERRINGPH-2024FE04080$FERRING$$$$$$Y$$$20240919$$HP$CA$CA
242143401$24214340$1$I$20240101$20240807$20240815$20240815$EXP$$JP-FERRINGPH-2024FE04487$FERRING$$$$$$Y$$$20240815$$PH$JP$JP
242143411$24214341$1$I$20240707$20240805$20240815$20240815$EXP$FR-AFSSAPS-AN2024001039$FR-FERRINGPH-2024FE04379$FERRING$$$$$$Y$$$20240815$$MD$FR$FR
242143421$24214342$1$I$20240612$20240808$20240815$20240815$EXP$FR-AFSSAPS-PB2024000844$FR-FERRINGPH-2024FE04444$FERRING$$$$$$Y$$$20240815$$MD$FR$FR
242143432$24214343$2$F$$20240819$20240815$20240821$EXP$$DE-FERRINGPH-2024FE04378$FERRING$$$$$$Y$$$20240821$$MD$DE$DE
242143441$24214344$1$I$20240719$20240726$20240815$20240815$PER$$US-INCYTE CORPORATION-2024IN008121$INCYTE$$$$$$Y$$$20240815$$CN$US$US
242143453$24214345$3$F$20240810$20240919$20240815$20240919$30DAY$$AR-PFIZER INC-202400234738$PFIZER$$8$YR$$F$Y$$$20240919$$CN$AR$AR
242143461$24214346$1$I$20240530$20240806$20240815$20240815$EXP$$US-ZENPEP LLC-2024AIMT01213$AIMMUNE$$$$$$Y$$$20240815$$CN$US$US
242143471$24214347$1$I$$20240711$20240815$20240815$PER$$US-Eisai-EC-2024-170089$EISAI$$$$$M$Y$$$20240815$$HP$US$US
242143484$24214348$4$F$20240708$20240905$20240815$20240913$EXP$$US-BEH-2024175449$CSL BEHRING$$89$YR$E$M$Y$99.77$KG$20240913$$CN$US$US
242143491$24214349$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA237068$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240815$$MD$US$US
242143501$24214350$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA237024$SANOFI AVENTIS$$$$$M$Y$$$20240815$$MD$US$US
242143531$24214353$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408005670$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240815$$CN$US$US
242143541$24214354$1$I$$20240321$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202406000753$ELI LILLY AND CO$$$$$$Y$$$20240815$$CN$US$US
242143551$24214355$1$I$20240811$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007582$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240815$$CN$US$US
242143562$24214356$2$F$20240814$20240815$20240815$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009374$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240816$$CN$US$US
242143571$24214357$1$I$20240101$20240806$20240815$20240815$PER$$US-SA-2024SA238913$SANOFI AVENTIS$$49$YR$A$M$Y$80.73$KG$20240815$$MD$US$US
242143581$24214358$1$I$20211001$20240807$20240815$20240815$EXP$$RU-INCYTE CORPORATION-2024IN008527$INCYTE$Kozhokar PV, Paina OV, Gurgenidze NN, Goloshapov OV, Shvetcov AN, Zavarukhin VI et al.. Successful skin alloplasty and allogeneic finger phalanx transplantation from haploidentical donor in all patient with severe chronic gvhd. CELLULAR THERAPY AND TRANSPLANTATION (CTT). 2024;13(2):47-57$$$$$Y$$$20240815$$HP$RU$RU
242143591$24214359$1$I$20240201$20240807$20240815$20240815$PER$$US-SA-2024SA239046$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240815$$MD$US$US
242143601$24214360$1$I$20240801$20240806$20240815$20240815$PER$$US-SA-2024SA238733$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240815$$MD$US$US
242143612$24214361$2$F$$20240807$20240815$20240827$PER$$US-SA-2024SA237301$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240827$$MD$US$US
242143631$24214363$1$I$20240101$20240813$20240815$20240815$PER$$US-PFIZER INC-PV202400105657$PFIZER$$72$YR$$M$Y$$$20240815$$HP$US$US
242143641$24214364$1$I$$20240809$20240815$20240815$PER$$US-PFIZER INC-202400234608$PFIZER$$8$YR$$M$Y$$$20240815$$HP$US$US
242143651$24214365$1$I$20240809$20240811$20240815$20240815$PER$$US-PFIZER INC-202400234552$PFIZER$$72$YR$$M$Y$$$20240815$$CN$US$US
242143671$24214367$1$I$20240813$20240813$20240815$20240815$PER$$US-PFIZER INC-202400235773$PFIZER$$62$YR$$F$Y$$$20240815$$HP$US$US
242143681$24214368$1$I$$20240719$20240815$20240815$PER$$US-INCYTE CORPORATION-2024IN007912$INCYTE$Satta T, Papadopoulos EB, Gyurkocza B, Susman P, Singh A, Calafiore M, et al.. Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd. BLOOD.. 2023;142 (Suppl.1):7019-21$$$$$Y$$$20240815$$HP$US$US
242143692$24214369$2$F$$20240829$20240815$20240906$EXP$$NVSC2016IT008109$NOVARTIS$Cerri S, Sgalla G, Richeldi L, Luppi F. Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: A case report.. JOURNAL OF MEDICAL CASE REPORTS. 2016;10(1):127$75$YR$$M$Y$$$20240906$$HP$IT$IT
242143701$24214370$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA239567$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240815$$CN$US$US
242143711$24214371$1$I$20240701$20240807$20240815$20240815$PER$$US-SA-2024SA239374$SANOFI AVENTIS$$$$A$F$Y$$$20240815$$MD$US$US
242143721$24214372$1$I$$20240808$20240815$20240815$PER$$US-SA-2024SA239513$SANOFI AVENTIS$$$$T$M$Y$$$20240815$$HP$US$US
242143731$24214373$1$I$20240709$20240709$20240815$20240815$PER$$US-Eisai-EC-2024-167957$EISAI$$86$YR$E$F$Y$$$20240815$$CN$US$US
242143741$24214374$1$I$$20240805$20240815$20240815$EXP$$SE-TEVA-VS-3233020$TEVA$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J-Allergy-Clin-Immunol-Pract 2024; 12 (7): 1850-1862.; Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J-Allergy-Clin-Immunol-Pract 2024; 12 (7): 1850-1862.$39$YR$$$Y$$$20240815$$MD$SE$SE
242143761$24214376$1$I$$20240805$20240815$20240815$EXP$$SE-TEVA-VS-3233036$TEVA$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J-Allergy-Clin-Immunol-Pract 2024; 12 (7): 1850-1862.; Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J-Allergy-Clin-Immunol-Pract 2024; 12 (7): 1850-1862.$61$YR$$$Y$$$20240815$$MD$SE$SE
242143771$24214377$1$I$$20240805$20240815$20240815$EXP$$CL-TEVA-VS-3232477$TEVA$Avila E, Roessler BE. [MALA: Lactic acidosis associated with the use of metformin, review of clinical cases]. [Review] [Spanish]. Rev-Med-Chil 2023; 151 (5): 618-627.$61$YR$$F$Y$$$20240815$$HP$CL$CL
242143782$24214378$2$F$20240610$20240919$20240815$20240919$30DAY$$CL-PFIZER INC-202400236446$PFIZER$$$$$$Y$$$20240919$$CN$CL$CL
242143791$24214379$1$I$$20240814$20240815$20240815$EXP$$IN-BAYER-2024A117437$BAYER$$75$YR$E$M$Y$$$20240815$$MD$IN$IN
242143801$24214380$1$I$$20240805$20240815$20240815$EXP$$US-TEVA-VS-3231014$TEVA$Das S, Ailawadhi S, Sher T, Roy V, Fernandez A, Parrondo RD. Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety. Curr-Oncol 2023; 30 9627-9633.; Das S, Ailawadhi S, Sher T, Roy V, Fernandez A, Parrondo RD. Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multip...$33$YR$$M$Y$$$20240815$$HP$US$US
242143821$24214382$1$I$20240801$20240808$20240815$20240815$PER$$US-SA-2024SA239618$SANOFI AVENTIS$$23$YR$A$M$Y$86$KG$20240815$$MD$US$US
242143831$24214383$1$I$20240101$20240806$20240815$20240815$PER$$US-SA-2024SA237103$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240815$$MD$US$US
242143841$24214384$1$I$$20240807$20240815$20240815$EXP$$IT-VIIV HEALTHCARE LIMITED-IT2024GSK099835$VIIV$Gaudiano R, Trizzino M, Romanin B, Piccione M, Arena D, De Luca E et al. Durability and effectiveness of dual versus triple INSTI-based antiretroviral therapy in a real-WORLD cohort in Palermo. Sexually Transmitted Infections. 2024;100 (Suppl 1):A169$$$$$Y$$$20240815$$HP$IT$IT
242143851$24214385$1$I$$20240805$20240815$20240815$EXP$$IT-VIIV HEALTHCARE LIMITED-IT2024GSK099062$VIIV$$$$$$Y$$$20240815$$HP$IT$IT
242143861$24214386$1$I$$20240807$20240815$20240815$EXP$$IT-GSK-IT2024GSK099835$GLAXOSMITHKLINE$Gaudiano R, Trizzino M, Romanin B, Piccione M, Arena D, De Luca E et al. Durability and effectiveness of dual versus triple INSTI-based antiretroviral therapy in a real-WORLD cohort in Palermo. Sexually Transmitted Infections. 2024;100 (Suppl 1):A169$$$$$Y$$$20240815$$HP$IT$IT
242143871$24214387$1$I$$20240808$20240815$20240815$EXP$$FR-GSK-FR2024GSK100697$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$MD$FR$FR
242143881$24214388$1$I$$20240805$20240815$20240815$EXP$$IT-GSK-IT2024GSK099062$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$HP$IT$IT
242143891$24214389$1$I$20240706$20240812$20240815$20240815$EXP$$US-TAKEDA-2024TUS071978$TAKEDA$$44$YR$$M$Y$$$20240815$$CN$US$US
242143901$24214390$1$I$20240101$20240805$20240815$20240815$EXP$$US-RADIUS HEALTH INC.-2024US006030$RADIUS PHARM$$$$$F$Y$$$20240815$$CN$US$US
242143911$24214391$1$I$$20240805$20240815$20240815$EXP$$ES-TEVA-VS-3231214$TEVA$Molto-Balado P, Reverte-Gil R. Aripiprazole: Beware of pathological gambling addiction. Psiq-Biol 2024; 31 (1):.$32$YR$$M$Y$$$20240815$$MD$ES$ES
242143921$24214392$1$I$$20240809$20240815$20240815$EXP$$DE-VIIV HEALTHCARE LIMITED-DE2024GSK100205$VIIV$Webendoerfer M, Konik M, Zettler M, Wienker J, Rawitzer J, Esser S, et al. Hypercalcemia as a rare manifestation of immune reconstitution inflammatory syndrome (IRIS) in a person living with human immunodeficiency virus (HIV) with disseminated nontuberculous mycobacteriosis. Infection. 2024;52(4):1627-1631$$$$$Y$$$20240815$$HP$DE$DE
242143931$24214393$1$I$$20240806$20240815$20240815$EXP$$US-GSK-US2024GSK100169$GLAXOSMITHKLINE$Goel AR, Sylvester C, Avidan OR, Gilvaz VJ. Psoriasis and psoriatic arthritis following use of dostarlimab for endometrial cancer. BMJ case reports. 2024;17(8)$$$$$Y$$$20240815$$MD$US$US
242143941$24214394$1$I$$20240809$20240815$20240815$EXP$$CA-GSK-CA2024AMR099898$GLAXOSMITHKLINE$$$$$$Y$$$20240815$$HP$CA$CA
242143952$24214395$2$F$$20240826$20240815$20240903$EXP$$US-TEVA-VS-3230929$TEVA$Sood N, Kushnir M, Jayavelu B. ACUTE RENAL THROMBOTIC MICROANGIOPATHY CAUSED BY ELTROMBOPAG AND ROMIPLOSTIM IN A PATIENT WITH MYELODYSPLASTIC SYNDROMES (MDS) AND UNDERLYING ANTIPHOSPHOLIPID SYNDROME. Eur-J-Case-Rep-Intern-Med 2024; 11 (7):.; Sood N, Kushnir M, Jayavelu B. ACUTE RENAL THROMBOTIC MICROANGIOPATHY CAUSED BY ELTROMBOPAG AND ROMIPLOSTIM IN A PATIENT WITH MYELODYSPLASTIC SYNDROMES (MDS) AND UNDERLYING ANTIPHOSPHOLIPID SYNDROME. Eur-J-Case-Rep-Intern-Med 2024; 11 (7):.$80$YR$$M$Y$$$20240903$$HP$US$US
242143961$24214396$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128826$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240815$$HP$US$US
242143972$24214397$2$F$$20240826$20240815$20240903$EXP$$US-TEVA-VS-3231283$TEVA$Omiwade O, Prevallet A. Gastrointestinal Bleeding and Hemorrhagic Shock in a Patient Diagnosed with Disseminated Histoplasmosis. ACG-Case-Rep-J 2024; 11 (7): e01402.; Omiwade O, Prevallet A. Gastrointestinal Bleeding and Hemorrhagic Shock in a Patient Diagnosed with Disseminated Histoplasmosis. ACG-Case-Rep-J 2024; 11 (7): e01402.$63$YR$$M$Y$$$20240903$$MD$US$US
242143992$24214399$2$F$$20240826$20240815$20240904$EXP$$IT-TEVA-VS-3231950$TEVA$Fiori L, Tagi VM, Montanari C, Gambino M, Carlevatti V, Zizzo C, et al. Desensitization of olipudase alfa-induced anaphylaxis in a child with chronic neurovisceral acid sphingomyelinase deficiency. Mol-Genet-Metab-Rep 2024; 40.; Fiori L, Tagi VM, Montanari C, Gambino M, Carlevatti V, Zizzo C, et al. Desensitization of olipudase alfa-induced anaphylaxis in a child with chronic neurovisceral acid sphingomyelinase deficiency. Mol-Genet-Metab-Rep 2024; 40.; Fiori L, Tagi VM, Montanari C, Gambino ...$2$YR$$M$Y$$$20240904$$HP$IT$IT
242144003$24214400$3$F$20240801$20240822$20240815$20240826$PER$$US-AMGEN-USASP2024161618$AMGEN$$68$YR$E$F$Y$$$20240826$$CN$US$US
242144011$24214401$1$I$$20240805$20240815$20240815$EXP$$FR-TEVA-VS-3231830$TEVA$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2023; 35 (1): 54-59.$$$$M$Y$$$20240815$$HP$FR$FR
242144021$24214402$1$I$20240501$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007646$ELI LILLY AND CO$$$$$$Y$$$20240815$$CN$US$US
242144031$24214403$1$I$$20240807$20240815$20240815$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024098590$VIIV$$$$$M$Y$$$20240815$$CN$US$US
242144043$24214404$3$F$20240809$20240812$20240815$20240822$PER$$US-TRAVERE-2024TVT00742$TRAVERE THERAPEUTICS$$47$YR$A$M$Y$$$20240822$$CN$US$US
242144051$24214405$1$I$$20240805$20240815$20240815$EXP$$FR-TEVA-VS-3231853$TEVA$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2023; 35 (1): 54-59.$44$YR$$F$Y$$$20240815$$HP$FR$FR
242144081$24214408$1$I$$20240725$20240815$20240815$PER$$US-TRAVERE-2024TVT00746$TRAVERE THERAPEUTICS$$59$YR$A$M$Y$$$20240815$$CN$US$US
242144091$24214409$1$I$$20240725$20240815$20240815$PER$$US-TRAVERE-2024TVT00738$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240815$$CN$US$US
242144102$24214410$2$F$20240703$20240817$20240815$20240823$EXP$$MM-GE HEALTHCARE-2024CSU009130$GE HEALTHCARE$$32$YR$$F$Y$$$20240823$$HP$MM$MM
242144111$24214411$1$I$20240711$20240806$20240815$20240815$EXP$$US-GE HEALTHCARE-2024CSU009028$GE HEALTHCARE$$34$YR$$F$Y$57$KG$20240815$$HP$US$US
242144122$24214412$2$F$20170101$20240821$20240815$20240826$EXP$$CA-TAKEDA-2017TUS012722$TAKEDA$$$$$F$Y$$$20240826$$CN$CA$CA
242144131$24214413$1$I$$20240805$20240815$20240815$EXP$$BR-TAKEDA-2024TUS081498$TAKEDA$$$$$F$Y$$$20240815$$MD$BR$BR
242144141$24214414$1$I$$20240808$20240815$20240815$EXP$$US-TAKEDA-2024TUS079824$TAKEDA$$$$$F$Y$59.592$KG$20240815$$MD$US$US
242144152$24214415$2$F$$20240805$20240815$20240820$EXP$$CN-TAKEDA-2024TUS081212$TAKEDA$$69$YR$$F$Y$$$20240820$$HP$CN$CN
242144161$24214416$1$I$20240101$20240803$20240815$20240815$PER$$US-INSUD PHARMA-2408US06252$INSUD PHARMA$$$$$$Y$$$20240815$$CN$US$US
242144172$24214417$2$F$$20240822$20240815$20240830$EXP$$DE-TEVA-VS-3231530$TEVA$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure 2023; 107 107-113.$4$DY$$$Y$$$20240830$$MD$DE$DE
242144181$24214418$1$I$$20240805$20240815$20240815$EXP$$DE-TEVA-2019-DE-1118963$TEVA$Hoeltzenbein M, Slimi S, Fietz A-K, Onken M, Dathe K, Schaefer C. #33 Lacosamide use during pregnancy - An evaluation of the German embryotox database. Reprod-Toxicol 2019; 88 143-144.; Hoeltzenbein M, Slimi S, Fietz A-K, Onken M, Dathe K, Schaefer C. #33 Lacosamide use during pregnancy - An evaluation of the German embryotox database. Reprod-Toxicol 2019;88:143-144 abstr. 33.$$$$$Y$$$20240815$$HP$DE$DE
242144191$24214419$1$I$$20240813$20240815$20240815$EXP$$US-DSJP-DSU-2024-140646$DAIICHI$$$$$F$Y$$$20240815$$HP$US$US
242144201$24214420$1$I$$20240813$20240815$20240815$EXP$$US-AMGEN-USASP2024161299$AMGEN$$75$YR$E$M$Y$$$20240815$$HP$US$US
242144222$24214422$2$F$$20240820$20240815$20240822$EXP$$US-TAKEDA-2024TUS005500$TAKEDA$$$$$F$Y$$$20240822$$CN$US$US
242144232$24214423$2$F$$20240826$20240815$20240903$EXP$$US-TEVA-VS-3231495$TEVA$Das S, Ailawadhi S, Sher T, Roy V, Fernandez A, Parrondo RD. Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety. Curr-Oncol 2023; 30 9627-9633.; Das S, Ailawadhi S, Sher T, Roy V, Fernandez A, Parrondo RD. Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multip...$62$YR$$F$Y$$$20240903$$HP$US$US
242144242$24214424$2$F$$20240829$20240815$20240906$EXP$$NVSC2020AT360013$NOVARTIS$Haninger-Vacariu N, Aigner C, Kain R, Prohaszka Z, Gaggl M, Bohmig GA et al. Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy. KIDNEY MEDICINE. 2020;2:2:213-7$3$DEC$$F$Y$$$20240906$$HP$AT$AT
242144252$24214425$2$F$20240101$20240830$20240815$20240916$PER$$US-BIOMARINAP-US-2024-159779$BIOMARIN$$$$$$Y$$$20240916$$CN$US$US
242144261$24214426$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA236907$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240815$$MD$US$US
242144271$24214427$1$I$$20240726$20240815$20240815$PER$$US-TRAVERE-2024TVT00744$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$CN$US$US
242144282$24214428$2$F$$20240826$20240815$20240917$PER$$US-TRAVERE-2024TVT00748$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
242144292$24214429$2$F$20240726$20240814$20240815$20240822$PER$$US-TRAVERE-2024TVT00745$TRAVERE THERAPEUTICS$$76$YR$E$M$Y$$$20240822$$CN$US$US
242144301$24214430$1$I$20240701$20240712$20240815$20240815$PER$$US-Eisai-EC-2024-170124$EISAI$$75$YR$E$F$Y$$$20240815$$HP$US$US
242144322$24214432$2$F$20240808$20240808$20240815$20240820$PER$$US-SA-2024SA237830$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240820$$HP$US$US
242144332$24214433$2$F$$20240820$20240815$20240829$EXP$$US-TEVA-VS-3230826$TEVA$Rafeq R, Salzman M. Use of Concentrated Insulin in the Management of Calcium Channel Blocker Overdose: A Case Report. J-Pharm-Pract 2023; 36 (6): 1519-1522.; Rafeq R, Salzman M. Use of Concentrated Insulin in the Management of Calcium Channel Blocker Overdose: A Case Report. J-Pharm-Pract 2023; 36 (6): 1519-1522.$73$YR$$F$Y$69.9$KG$20240829$$PH$US$US
242144342$24214434$2$F$$20240910$20240815$20240919$EXP$$US-BIOGEN-2024BI01277703$BIOGEN$$$$$M$Y$$$20240919$$CN$US$US
242144353$24214435$3$F$20231201$20240829$20240815$20240830$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046002$BOEHRINGER INGELHEIM$$66$YR$E$F$Y$76$KG$20240830$$HP$CO$CO
242144363$24214436$3$F$20240909$20240911$20240815$20240924$EXP$$US-CHIESI-2024CHF05068$CHIESI$$21$YR$$F$Y$$$20240924$$CN$US$US
242144374$24214437$4$F$20240811$20240911$20240815$20240912$PER$$US-AMGEN-USASP2024161558$AMGEN$$72$YR$E$F$Y$$$20240912$$CN$US$US
242144381$24214438$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004915$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$58.5$KG$20240815$$HP$US$US
242144391$24214439$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004914$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$80$KG$20240815$$HP$US$US
242144401$24214440$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA002443$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$74$KG$20240815$$HP$US$US
242144411$24214441$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004919$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$61.5$KG$20240815$$HP$US$US
242144422$24214442$2$F$$20240812$20240815$20240822$EXP$$CA-TAKEDA-2024TUS081491$TAKEDA$$37$YR$$M$Y$90$KG$20240822$$HP$CA$CA
242144433$24214443$3$F$$20240826$20240815$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07153$LUPIN$$$$$$Y$$$20240913$$CN$US$US
242144441$24214444$1$I$$20240812$20240815$20240815$PER$$US-GILEAD-2024-0683989$GILEAD$$6$DEC$A$M$Y$$$20240815$$HP$US$US
242144451$24214445$1$I$$20240731$20240815$20240815$EXP$$CA-HLS-202401919$HLS THERAPEUTICS$$$$A$F$Y$$$20240815$$MD$CA$CA
242144461$24214446$1$I$$20240813$20240815$20240815$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045818$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240815$$MD$CA$CA
242144471$24214447$1$I$$20240809$20240815$20240815$EXP$$US-PFIZER INC-202400234303$PFIZER$$60$YR$$M$Y$$$20240815$$MD$US$US
242144481$24214448$1$I$$20240628$20240815$20240815$PER$$US-LUNDBECK-DKLU4001044$LUNDBECK$$$$$$Y$$$20240815$$HP$US$US
242144491$24214449$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004931$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$57.6$KG$20240815$$HP$US$US
242144501$24214450$1$I$$20240728$20240815$20240815$PER$$US-009507513-2407USA015328$MERCK$$$$$M$Y$$$20240815$$CN$US$US
242144511$24214451$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004930$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$91.1$KG$20240815$$HP$US$US
242144521$24214452$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004920$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$71$KG$20240815$$HP$US$US
242144531$24214453$1$I$$20240627$20240815$20240815$PER$$US-LUNDBECK-DKLU4001171$LUNDBECK$$$$$$Y$$$20240815$$HP$US$US
242144541$24214454$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004932$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$177$KG$20240815$$HP$US$US
242144551$24214455$1$I$$20240805$20240815$20240815$EXP$$US-RADIUS HEALTH INC.-2024US006060$RADIUS PHARM$$$$$F$Y$$$20240815$$CN$US$US
242144561$24214456$1$I$$20240805$20240815$20240815$EXP$$NVSC2024CN163167$NOVARTIS$Pan M, Sun X, Bao Y. A case of Bao YanZhong treated mucometra during pregnancy. CHINESE JOURNAL OF RURAL MEDICINE AND PHARMACY. 2024;31:26-7$31$YR$$F$Y$$$20240815$$HP$CN$CN
242144571$24214457$1$I$20230101$20240812$20240815$20240815$EXP$$US-PFIZER INC-202400236030$PFIZER$Avra, T.. Off-Label Use of Lamotrigine and Naltrexone in the Treatment of Ketamine Use Disorder: A Case Report. Journal of Addiction Medicine. 2024;00(00):10.1097/ADM.0000000000001359$32$YR$$M$Y$$$20240815$$HP$US$US
242144581$24214458$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004933$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$82$KG$20240815$$HP$US$US
242144591$24214459$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004935$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$56.7$KG$20240815$$HP$US$US
242144601$24214460$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004934$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$73$KG$20240815$$HP$US$US
242144611$24214461$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004937$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$90.7$KG$20240815$$HP$US$US
242144621$24214462$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004946$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$81.6$KG$20240815$$HP$US$US
242144631$24214463$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004936$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$90.7$KG$20240815$$HP$US$US
242144651$24214465$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA238834$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240815$$MD$US$US
242144662$24214466$2$F$20240121$20240917$20240815$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129402$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240919$$CN$US$US
242144671$24214467$1$I$$20240805$20240815$20240815$EXP$$ES-TEVA-VS-3232262$TEVA$$76$YR$$F$Y$$$20240815$$MD$ES$ES
242144681$24214468$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127607$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$105.69$KG$20240815$$CN$US$US
242144691$24214469$1$I$$20240628$20240815$20240815$PER$$US-LUNDBECK-DKLU4001043$LUNDBECK$$$$$$Y$$$20240815$$CN$US$US
242144701$24214470$1$I$20240702$20240801$20240815$20240815$EXP$$GB-Ascend Therapeutics US, LLC-2160515$ASCEND$$$$$F$Y$$$20240815$$$GB$GB
242144712$24214471$2$F$$20240816$20240815$20240820$EXP$$JP-PFIZER INC-202400235412$PFIZER$Mandai, S.. Takayasu arteritis manifesting as acute kidney injury and congestion due to renal artery stenosis and myocarditis: a case report 2024;ytae347. European heart journal. Case reports. 2024;8(8):ytae347$18$YR$$F$Y$$$20240820$$MD$JP$JP
242144741$24214474$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004941$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$72$KG$20240815$$HP$US$US
242144751$24214475$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004952$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$63.5$KG$20240815$$HP$US$US
242144761$24214476$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004938$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$63.3$KG$20240815$$HP$US$US
242144771$24214477$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004944$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$81.6$KG$20240815$$HP$US$US
242144781$24214478$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004947$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$99.8$KG$20240815$$HP$US$US
242144791$24214479$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004940$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$103$KG$20240815$$HP$US$US
242144801$24214480$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004948$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$111$KG$20240815$$HP$US$US
242144811$24214481$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004949$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$62.6$KG$20240815$$HP$US$US
242144821$24214482$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004945$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$91.4$KG$20240815$$HP$US$US
242144831$24214483$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004950$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$156$KG$20240815$$HP$US$US
242144841$24214484$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004939$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$F$Y$40.3$KG$20240815$$HP$US$US
242144851$24214485$1$I$$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408006711$ELI LILLY AND CO$$$$$F$Y$$$20240815$$CN$US$US
242144861$24214486$1$I$$20240807$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408005035$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240815$$CN$US$US
242144871$24214487$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008321$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240815$$CN$US$US
242144881$24214488$1$I$$20240815$20240815$20240815$PER$$US-PURDUE PHARMA-USA-2024-0311363$PURDUE$$$$$F$Y$$$20240815$$HP$US$US
242144891$24214489$1$I$$20240814$20240815$20240815$PER$$US-PURDUE PHARMA-USA-2024-0311359$PURDUE$$$$$M$Y$$$20240815$$CN$US$US
242144902$24214490$2$F$$20240814$20240815$20240819$PER$$US-PURDUE PHARMA-USA-2024-0311360$PURDUE$$24$YR$$$Y$$$20240819$$CN$US$US
242144911$24214491$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004951$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$106$KG$20240815$$HP$US$US
242144921$24214492$1$I$20240701$20240807$20240815$20240815$PER$$US-SA-2024SA238825$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240815$$MD$US$US
242144932$24214493$2$F$$20240806$20240815$20240918$PER$$US-LUNDBECK-DKLU4002706$LUNDBECK$$$$$$Y$$$20240918$$CN$US$US
242144941$24214494$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004954$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$73.5$KG$20240815$$HP$US$US
242144951$24214495$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004953$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$66.9$KG$20240815$$HP$US$US
242144961$24214496$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004955$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$54.4$KG$20240815$$HP$US$US
242144971$24214497$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004956$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$62.2$KG$20240815$$HP$US$US
242144981$24214498$1$I$$20240805$20240815$20240815$PER$$US-009507513-2408USA004957$MERCK$Olney K.B, Pai A.P, Thomas K.K, Burgess D.R, Olney W.J, Bruning R.A, et al.. Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy. 2024;00:1-8$$$$M$Y$104$KG$20240815$$HP$US$US
242144991$24214499$1$I$20220101$20240813$20240815$20240815$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045671$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240815$$CN$US$US
242145002$24214500$2$F$20240812$20240813$20240815$20240820$PER$$US-AMGEN-USASP2024161537$AMGEN$$52$YR$A$F$Y$$$20240820$$CN$US$US
242145012$24214501$2$F$$20240903$20240815$20240913$30DAY$$US-GSK-US2024097584$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
242145021$24214502$1$I$$20240627$20240815$20240815$PER$$US-LUNDBECK-DKLU4000986$LUNDBECK$$$$$$Y$$$20240815$$HP$US$US
242145031$24214503$1$I$20240730$20240805$20240815$20240815$EXP$$US-RADIUS HEALTH INC.-2024US005973$RADIUS PHARM$$70$YR$$M$Y$$$20240815$$CN$US$US
242145041$24214504$1$I$$20240809$20240815$20240815$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202408006843$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240815$$MD$CA$CA
242145051$24214505$1$I$$20240812$20240815$20240815$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202408007590$ELI LILLY AND CO$$$$$F$Y$$$20240815$$MD$SA$SA
242145061$24214506$1$I$20240503$20240806$20240815$20240815$EXP$FR-AFSSAPS-PO2024000847$FR-ELI_LILLY_AND_COMPANY-FR202408003631$ELI LILLY AND CO$$83$YR$E$F$Y$79.1$KG$20240815$$CN$FR$FR
242145072$24214507$2$F$20240728$20240809$20240815$20240826$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408006715$ELI LILLY AND CO$$70$YR$E$M$Y$51$KG$20240826$$CN$CN$CN
242145082$24214508$2$F$20231110$20240812$20240815$20240819$EXP$$AU-009507513-2408AUS004837$MERCK$$61$YR$$M$Y$$$20240819$$HP$AU$AU
242145092$24214509$2$F$$20240812$20240815$20240816$EXP$$AU-009507513-2408AUS004841$MERCK$$77$YR$$F$Y$$$20240816$$MD$AU$AU
242145101$24214510$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA240036$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240815$$MD$US$US
242145111$24214511$1$I$$20240814$20240815$20240815$PER$$US-ROCHE-10000057967$ROCHE$$20$YR$A$M$Y$$$20240815$$HP$US$US
242145122$24214512$2$F$20240723$20240919$20240815$20240920$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044893$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$90.9$KG$20240921$$HP$AU$AU
242145131$24214513$1$I$$20240814$20240815$20240815$EXP$$AU-WAYLIS-2024-AU-000331$Waylis$$$$$M$Y$$$20240815$$CN$AU$AU
242145141$24214514$1$I$$20240809$20240815$20240815$PER$$US-ALXN-202408USA000721US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240815$$CN$US$US
242145151$24214515$1$I$20240701$20240813$20240815$20240815$PER$$US-PFIZER INC-202400236924$PFIZER$$59$YR$$F$Y$$$20240815$$HP$US$US
242145161$24214516$1$I$$20240809$20240815$20240815$EXP$$AU-INCYTE CORPORATION-2024IN008521$INCYTE$$$$$$Y$$$20240815$$MD$AU$AU
242145171$24214517$1$I$20220801$20240811$20240815$20240815$EXP$$GB-INCYTE CORPORATION-2024IN008479$INCYTE$$$$$$Y$$$20240815$$MD$GB$GB
242145181$24214518$1$I$$20240813$20240815$20240815$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009014$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240815$$CN$US$US
242145191$24214519$1$I$$20240808$20240815$20240815$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202408005878$ELI LILLY AND CO$$$$$F$Y$$$20240815$$CN$SA$SA
242145201$24214520$1$I$$20240813$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008644$ELI LILLY AND CO$$89$YR$E$F$Y$$$20240815$$CN$US$US
242145211$24214521$1$I$20240727$20240808$20240815$20240815$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408009233$ELI LILLY AND CO$$52$YR$A$M$Y$72$KG$20240815$$CN$DE$CN
242145221$24214522$1$I$$20240802$20240815$20240815$EXP$GB-MHRA-MED-202408011525194950-TYKVJ$GB-ELI_LILLY_AND_COMPANY-GB202408002618$ELI LILLY AND CO$$$$$F$Y$$$20240815$$CN$GB$GB
242145231$24214523$1$I$$20240809$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408008015$ELI LILLY AND CO$$$$$$Y$$$20240815$$CN$US$US
242145242$24214524$2$F$$20240820$20240815$20240828$EXP$$US-TEVA-VS-3230751$TEVA$George MN, Seervai RNH, Chon SY. Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series. JAAD-Case-Rep 2024; 47 72-79.; George MN, Seervai RNH, Chon SY. Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series. JAAD-Case-Rep 2024; 47 72-79.; George MN, Seervai RNH, Chon SY. Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series. JAAD-Case-Rep 2024; 47 72-79.$62$YR$$F$Y$$$20240828$$HP$US$US
242145251$24214525$1$I$$20240805$20240815$20240815$EXP$$US-TEVA-VS-3230756$TEVA$George MN, Seervai RNH, Chon SY. Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series. JAAD-Case-Rep 2024; 47 72-79.; George MN, Seervai RNH, Chon SY. Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series. JAAD-Case-Rep 2024; 47 72-79.$73$YR$$F$Y$$$20240815$$HP$US$US
242145262$24214526$2$F$$20240826$20240815$20240903$EXP$$US-TEVA-VS-3231285$TEVA$Stewart MA, Rives TA, Blanton K, Baldwin L. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecol-Oncol-Rep 2024; 54.; Stewart MA, Rives TA, Blanton K, Baldwin L. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecol-Oncol-Rep 2024; 54.; Stewart MA, Rives TA, Blanton K, Baldwin L. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecol-Oncol-Rep 2024; 54.$33$YR$$F$Y$$$20240903$$HP$US$US
242145271$24214527$1$I$$20240805$20240815$20240815$EXP$$HU-TEVA-VS-3231634$TEVA$B?rczi Gy, Papp R, D?vid DA, F?l?p G?, Kulyassa PM, Kulcs?r F, Skoda R, Straub ?, Becker D. Sudden cardiac death of a patient who has basically low risk profile. Does psychiatric treatment modify risk? Cardiologia Hungarica Supplementum. 2024/3: 309.$18$YR$$M$Y$$$20240815$$MD$HU$HU
242145281$24214528$1$I$$20240809$20240815$20240815$PER$$US-ALXN-202408USA000653US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240815$$HP$US$US
242145292$24214529$2$F$$20240830$20240815$20240830$PER$$US-ALXN-202408USA000658US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242145301$24214530$1$I$$20240805$20240815$20240815$EXP$$US-RADIUS HEALTH INC.-2024US006032$RADIUS PHARM$$$$$F$Y$$$20240815$$CN$US$US
242145312$24214531$2$F$$20240826$20240815$20240904$EXP$$IT-TEVA-VS-3231176$TEVA$Di Zio I, Cisternino R. A rare case of thrombocytopenia secondary to taking febuxostat. Italian-J-Med 2024; 18 (2):.; Di Zio I, Cisternino R. A rare case of thrombocytopenia secondary to taking febuxostat. Italian-J-Med 2024; 18 (2):.$63$YR$$M$Y$$$20240904$$HP$IT$IT
242145322$24214532$2$F$$20240826$20240815$20240903$EXP$$FR-TEVA-VS-3231408$TEVA$Armange L, Lacroix A, Petitgas P, Arvieux C, Piau-Couapel C, Poubeau P, et al. The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review. Eur-J-Clin-Microbiol-Infect-Dis 2023; 42 (4): 413-422.; Armange L, Lacroix A, Petitgas P, Arvieux C, Piau-Couapel C, Poubeau P, et al. The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstituti...$33$YR$$F$Y$$$20240903$$HP$FR$FR
242145331$24214533$1$I$20240401$20240809$20240815$20240815$EXP$$US-SA-2024SA238663$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240815$$CN$US$US
242145341$24214534$1$I$20220227$20231102$20240815$20240815$EXP$$KR-009507513-2408KOR004922$MERCK$$41$YR$$F$Y$57$KG$20240815$$MD$KR$KR
242145351$24214535$1$I$$20240802$20240815$20240815$PER$$US-BIOMARINAP-US-2022-159787$BIOMARIN$$$$$$Y$$$20240815$$HP$US$US
242145361$24214536$1$I$$20240809$20240815$20240815$PER$$US-ALXN-202408USA000640US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240815$$CN$US$US
242145371$24214537$1$I$$20240729$20240815$20240815$PER$$US-TRAVERE-2024TVT00749$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$CN$US$US
242145393$24214539$3$F$20240729$20240903$20240815$20240930$PER$$US-TRAVERE-2024TVT00752$TRAVERE THERAPEUTICS$$73$YR$E$F$Y$$$20240930$$CN$US$US
242145401$24214540$1$I$$20240729$20240815$20240815$PER$$US-TRAVERE-2024TVT00753$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$CN$US$US
242145411$24214541$1$I$20240724$20240729$20240815$20240815$PER$$US-TRAVERE-2024TVT00750$TRAVERE THERAPEUTICS$$50$YR$A$F$Y$$$20240815$$CN$US$US
242145421$24214542$1$I$20240724$20240730$20240815$20240815$PER$$US-TRAVERE-2024TVT00754$TRAVERE THERAPEUTICS$$53$YR$A$F$Y$$$20240815$$CN$US$US
242145431$24214543$1$I$$20240803$20240815$20240815$EXP$$US-SMPA-2024SPA000938$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242145451$24214545$1$I$20240701$20240801$20240815$20240815$EXP$$US-SMPA-2024SPA000818$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242145461$24214546$1$I$$20240802$20240815$20240815$EXP$$US-SMPA-2024SPA000957$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242145471$24214547$1$I$$20240802$20240815$20240815$EXP$$US-SMPA-2024SPA000878$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242145481$24214548$1$I$20240724$20240801$20240815$20240815$EXP$$US-SMPA-2024SPA000704$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242145492$24214549$2$F$$20240827$20240815$20240909$EXP$$US-SMPA-2024SPA000734$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242145501$24214550$1$I$20240701$20240802$20240815$20240815$EXP$$US-SMPA-2024SPA000889$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242145512$24214551$2$F$$20240814$20240815$20240827$EXP$$US-SMPA-2024SPA000875$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242145522$24214552$2$F$$20240830$20240815$20240910$EXP$$US-SMPA-2024SPA000921$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
242145531$24214553$1$I$$20240802$20240815$20240815$EXP$$US-SMPA-2024SPA000775$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242145541$24214554$1$I$20240719$20240801$20240815$20240815$EXP$$US-SMPA-2024SPA000749$SUNOVION$$$$$$Y$$$20240815$$MD$US$US
242145551$24214555$1$I$$20240802$20240815$20240815$EXP$$US-SMPA-2024SPA000843$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242145561$24214556$1$I$$20240802$20240815$20240815$EXP$$US-SMPA-2024SPA000781$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242145571$24214557$1$I$$20240801$20240815$20240815$EXP$$US-SMPA-2024SPA000757$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242145581$24214558$1$I$$20240802$20240815$20240815$EXP$$US-SMPA-2024SPA000813$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242145591$24214559$1$I$$20240801$20240815$20240815$EXP$$US-SMPA-2024SPA000788$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242145601$24214560$1$I$20240808$20240810$20240815$20240815$EXP$GB-MHRA-MED-202408101140377780-CNRDJ$GB-ELI_LILLY_AND_COMPANY-GB202408007921$ELI LILLY AND CO$$77$YR$E$$Y$$$20240815$$CN$GB$GB
242145611$24214561$1$I$$20240808$20240815$20240815$EXP$GB-MHRA-MED-202408081024226200-DCNJY$GB-ELI_LILLY_AND_COMPANY-GB202408006123$ELI LILLY AND CO$$53$YR$A$$Y$63$KG$20240815$$CN$GB$GB
242145621$24214562$1$I$$20240804$20240815$20240815$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002803$ELI LILLY AND CO$$49$YR$A$$Y$$$20240815$$LW$US$US
242145631$24214563$1$I$20231001$20240806$20240815$20240815$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408005285$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240815$$CN$DE$DE
242145641$24214564$1$I$20240809$20240809$20240815$20240815$EXP$GB-MHRA-MED-202408091932537410-RLWMY$GB-ELI_LILLY_AND_COMPANY-GB202408006908$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240815$$CN$GB$GB
242145651$24214565$1$I$$20240806$20240815$20240815$PER$$US-JNJFOC-20240816458$JOHNSON AND JOHNSON$$$$$$Y$$$20240815$$CN$US$US
242145661$24214566$1$I$$20240731$20240815$20240815$PER$$US-TRAVERE-2024TVT00764$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$CN$US$US
242145671$24214567$1$I$$20240805$20240815$20240815$EXP$$FR-TEVA-VS-3231409$TEVA$Armange L, Lacroix A, Petitgas P, Arvieux C, Piau-Couapel C, Poubeau P, et al. The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review. Eur-J-Clin-Microbiol-Infect-Dis 2023; 42 (4): 413-422.; Armange L, Lacroix A, Petitgas P, Arvieux C, Piau-Couapel C, Poubeau P, et al. The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstituti...$26$YR$$F$Y$$$20240815$$HP$FR$FR
242145681$24214568$1$I$$20240730$20240815$20240815$PER$$US-TRAVERE-2024TVT00755$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240815$$CN$US$US
242145691$24214569$1$I$$20240730$20240815$20240815$PER$$US-TRAVERE-2024TVT00756$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240815$$MD$US$US
242145701$24214570$1$I$$20240731$20240815$20240815$PER$$US-TRAVERE-2024TVT00758$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240815$$MD$US$US
242145712$24214571$2$F$$20240820$20240815$20240829$EXP$$BE-TEVA-VS-3231778$TEVA$Meganck S, Raevens S, Ferdinande K, Verhelst X, Hoorens A, Degroote H, et al. Recurrent rejections after liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient. Acta-Clin-Belg 2024; 0 (0):.; Meganck S, Raevens S, Ferdinande K, Verhelst X, Hoorens A, Degroote H, et al. Recurrent rejections after liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient. Acta-Clin-Belg 2024; 0 (0):.$32$YR$$F$Y$$$20240829$$$BE$BE
242145721$24214572$1$I$$20240812$20240815$20240815$EXP$$US-OTSUKA-2024_022417$OTSUKA$$$$$M$Y$$$20240815$$HP$US$US
242145732$24214573$2$F$$20240820$20240815$20240830$EXP$$US-TEVA-VS-3230635$TEVA$Gupta NY, Al Diffalha S, Russ KB. An Unusual Case of Colitis in a Bone Marrow Transplant Patient. Gastroenterology 2024; 167 (3): e1-e4.; Gupta NY, Al Diffalha S, Russ KB. An Unusual Case of Colitis in a Bone Marrow Transplant Patient. Gastroenterology 2024; 167 (3): e1-e4.; Gupta NY, Al Diffalha S, Russ KB. An Unusual Case of Colitis in a Bone Marrow Transplant Patient. Gastroenterology 2024; 167 (3): e1-e4.$65$YR$$M$Y$$$20240830$$HP$US$US
242145742$24214574$2$F$$20240820$20240815$20240829$EXP$$US-TEVA-VS-3230650$TEVA$Wolf AB, Corboy JR. Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. Neurol-Clin-Pract 2024; 14 (5):.; Wolf AB, Corboy JR. Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. Neurol-Clin-Pract 2024; 14 (5):.$36$YR$$F$Y$$$20240829$$MD$US$US
242145752$24214575$2$F$$20240820$20240815$20240829$EXP$$JP-TEVA-VS-3230395$TEVA$Itoh T, Kawasaki T, Kaiho T, Shikano K, Naito A, Abe M, et al. Long-Term Nintedanib Treatment for Interstitial Pneumonia Associated With Hermansky-Pudlak Syndrome Followed by Lung Transplantation. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pagination.; Itoh T, Kawasaki T, Kaiho T, Shikano K, Naito A, Abe M, et al. Long-Term Nintedanib Treatment for Interstitial Pneumonia Associated With Hermansky-Pudlak Syndrome Followed by Lung Transplantation. Am-J-Respir-Crit-Care-Med 2024; 209 (0): no pa...$44$YR$$F$Y$$$20240829$$HP$JP$JP
242145761$24214576$1$I$$20240813$20240815$20240815$EXP$$US-PFIZER INC-202400236993$PFIZER$$53$YR$$F$Y$$$20240815$$MD$US$US
242145771$24214577$1$I$$20240809$20240815$20240815$EXP$$US-PFIZER INC-202400234016$PFIZER$$5$YR$$M$Y$$$20240815$$CN$US$US
242145782$24214578$2$F$20090101$20240820$20240815$20240828$EXP$$US-TEVA-VS-3230633$TEVA$Bederman A, Hristidis VC, Carley J, Duncan C. (060) Between Scylla and Charybdis: A Second Episode of Antiviral Induced Mania. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S30-S31 abstr. 060.; Bederman A, Hristidis VC, Carley J, Duncan C. (060) Between Scylla and Charybdis: A Second Episode of Antiviral Induced Mania. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S30-S31 abstr. 060.$48$YR$$M$Y$$$20240828$$HP$US$US
242145792$24214579$2$F$$20240820$20240815$20240830$EXP$$US-TEVA-VS-3230636$TEVA$Shacker M, Braat JP, Arjuna A. Acute Hepatitis After Lung Transplant in a Recipient from Hep C Donor: The Chicken or the Egg Phenomenon?. J-Heart-Lung-Transplant 2024; 43 (Suppl.) (4): S480 abstr. 1029; Shacker M, Braat JP, Arjuna A. Acute Hepatitis After Lung Transplant in a Recipient from Hep C Donor: The Chicken or the Egg Phenomenon?. J-Heart-Lung-Transplant 2024; 43 (Suppl.) (4): S480 abstr. 1029.$70$YR$$F$Y$$$20240830$$HP$US$US
242145802$24214580$2$F$$20240820$20240815$20240829$EXP$$US-TEVA-VS-3230651$TEVA$Wilcox L, Van Dril E. Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous glucagon-like peptide-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine case report. J-Am-Pharmacists-Assoc 2024; 1-15.; Wilcox L, Van Dril E. Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous glucagon-like peptide-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine case report. J-Am-Pharmacists-Assoc 2024; ...$$$A$F$Y$$$20240829$$PH$US$US
242145811$24214581$1$I$20240720$20240807$20240815$20240815$EXP$FR-AFSSAPS-LY2024001178$FR-TEVA-VS-3231742$TEVA$$22$YR$$M$Y$67$KG$20240815$$PH$FR$FR
242145832$24214583$2$F$$20240820$20240815$20240828$EXP$$US-TEVA-VS-3230713$TEVA$Bayless SL, Walker NV, Scott MM, Leo RJ. Clozapine-Related Cecal Volvulus. Prim-Care-Companion-CNS-Disord 2024; 26 (4):; Bayless SL, Walker NV, Scott MM, Leo RJ. Clozapine-Related Cecal Volvulus. Prim-Care-Companion-CNS-Disord 2024; 26 (4):.; Bayless SL, Walker NV, Scott MM, Leo RJ. Clozapine-Related Cecal Volvulus. Prim-Care-Companion-CNS-Disord 2024; 26 (4):.$58$YR$$F$Y$$$20240828$$MD$US$US
242145851$24214585$1$I$20240523$20240809$20240815$20240815$EXP$$JP-009507513-2408JPN001104J$MERCK$$6$DEC$$M$Y$$$20240815$$MD$JP$JP
242145861$24214586$1$I$20230710$20230712$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300192$RVL PHARMACEUTICALS$$37$YR$A$F$Y$$$20240815$$HP$US$US
242145871$24214587$1$I$20230301$20230712$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300193$RVL PHARMACEUTICALS$$80$YR$E$F$Y$$$20240815$$$US$US
242145881$24214588$1$I$20230520$20230713$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300196$RVL PHARMACEUTICALS$$58$YR$A$F$Y$$$20240815$$$US$US
242145891$24214589$1$I$20230715$20230717$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300197$RVL PHARMACEUTICALS$$19$YR$A$F$Y$$$20240815$$CN$US$US
242145901$24214590$1$I$20230710$20230712$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300198$RVL PHARMACEUTICALS$$40$YR$A$F$Y$$$20240815$$HP$US$US
242145911$24214591$1$I$20230710$20230712$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300199$RVL PHARMACEUTICALS$$55$YR$A$F$Y$$$20240815$$HP$US$US
242145921$24214592$1$I$20230710$20230712$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300200$RVL PHARMACEUTICALS$$23$YR$A$F$Y$$$20240815$$HP$US$US
242145931$24214593$1$I$20230601$20230708$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300191$RVL PHARMACEUTICALS$$54$YR$A$F$Y$$$20240815$$$US$US
242145941$24214594$1$I$20230710$20230712$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300201$RVL PHARMACEUTICALS$$29$YR$A$F$Y$$$20240815$$HP$US$US
242145951$24214595$1$I$20230201$20230719$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300202$RVL PHARMACEUTICALS$$84$YR$E$F$Y$$$20240815$$$US$US
242145961$24214596$1$I$20230701$20230719$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300203$RVL PHARMACEUTICALS$$44$YR$A$F$Y$$$20240815$$HP$US$US
242145971$24214597$1$I$20230716$20230720$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300204$RVL PHARMACEUTICALS$$74$YR$E$F$Y$$$20240815$$$US$US
242145981$24214598$1$I$20230717$20230721$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300205$RVL PHARMACEUTICALS$$67$YR$E$F$Y$$$20240815$$$US$US
242145991$24214599$1$I$20230701$20230721$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300206$RVL PHARMACEUTICALS$$66$YR$E$F$Y$$$20240815$$$US$US
242146001$24214600$1$I$20230701$20230721$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300207$RVL PHARMACEUTICALS$$34$YR$A$F$Y$$$20240815$$$US$US
242146011$24214601$1$I$20220801$20230724$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300209$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146021$24214602$1$I$20230101$20230724$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300210$RVL PHARMACEUTICALS$$64$YR$A$F$Y$$$20240815$$$US$US
242146031$24214603$1$I$20230601$20230722$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300211$RVL PHARMACEUTICALS$$40$YR$A$F$Y$$$20240815$$$US$US
242146041$24214604$1$I$20230724$20230725$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300212$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146051$24214605$1$I$20230101$20230724$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300213$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146061$24214606$1$I$20230101$20230726$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300214$RVL PHARMACEUTICALS$$101$YR$E$M$Y$$$20240815$$CN$US$US
242146071$24214607$1$I$20230724$20230726$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300215$RVL PHARMACEUTICALS$$61$YR$A$F$Y$$$20240815$$$US$US
242146081$24214608$1$I$20230501$20230727$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300216$RVL PHARMACEUTICALS$$19$YR$A$M$Y$$$20240815$$$US$US
242146091$24214609$1$I$20230101$20230727$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300217$RVL PHARMACEUTICALS$$66$YR$E$F$Y$$$20240815$$$US$US
242146101$24214610$1$I$20230723$20230731$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300218$RVL PHARMACEUTICALS$$46$YR$A$F$Y$$$20240815$$$US$US
242146111$24214611$1$I$20230601$20230801$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300219$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146121$24214612$1$I$20230802$20230803$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300220$RVL PHARMACEUTICALS$$40$YR$A$F$Y$$$20240815$$$US$US
242146131$24214613$1$I$20230805$20230807$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300221$RVL PHARMACEUTICALS$$78$YR$E$F$Y$$$20240815$$$US$US
242146141$24214614$1$I$20230601$20230807$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300222$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146151$24214615$1$I$20230804$20230808$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300223$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146161$24214616$1$I$20230706$20230809$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300224$RVL PHARMACEUTICALS$$74$YR$E$F$Y$$$20240815$$$US$US
242146171$24214617$1$I$20230810$20230815$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300226$RVL PHARMACEUTICALS$$59$YR$A$F$Y$$$20240815$$$US$US
242146181$24214618$1$I$20230812$20230816$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300227$RVL PHARMACEUTICALS$$41$YR$A$F$Y$$$20240815$$$US$US
242146191$24214619$1$I$20230817$20230817$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300228$RVL PHARMACEUTICALS$$69$YR$E$F$Y$$$20240815$$$US$US
242146201$24214620$1$I$20230101$20230817$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300229$RVL PHARMACEUTICALS$$46$YR$A$F$Y$$$20240815$$$US$US
242146211$24214621$1$I$20230817$20230819$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300230$RVL PHARMACEUTICALS$$74$YR$E$F$Y$$$20240815$$$US$US
242146221$24214622$1$I$20230822$20230824$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300231$RVL PHARMACEUTICALS$$46$YR$A$F$Y$$$20240815$$HP$US$US
242146231$24214623$1$I$20230801$20230824$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300232$RVL PHARMACEUTICALS$$58$YR$A$F$Y$$$20240815$$HP$US$US
242146241$24214624$1$I$20230805$20230824$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300233$RVL PHARMACEUTICALS$$52$YR$A$F$Y$$$20240815$$$US$US
242146251$24214625$1$I$20230101$20230825$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300234$RVL PHARMACEUTICALS$$67$YR$E$F$Y$$$20240815$$$US$US
242146261$24214626$1$I$20230810$20230831$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300236$RVL PHARMACEUTICALS$$47$YR$A$F$Y$$$20240815$$$US$US
242146271$24214627$1$I$20230831$20230901$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300237$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146281$24214628$1$I$20230801$20230901$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300238$RVL PHARMACEUTICALS$$85$YR$E$F$Y$$$20240815$$CN$US$US
242146291$24214629$1$I$20220807$20230906$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300239$RVL PHARMACEUTICALS$$74$YR$E$F$Y$$$20240815$$$US$US
242146301$24214630$1$I$20230101$20230906$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300240$RVL PHARMACEUTICALS$$$$A$$Y$$$20240815$$$US$US
242146311$24214631$1$I$20230906$20230907$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300241$RVL PHARMACEUTICALS$$53$YR$A$F$Y$$$20240815$$MD$US$US
242146321$24214632$1$I$20230101$20230907$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300242$RVL PHARMACEUTICALS$$39$YR$A$$Y$$$20240815$$$US$US
242146331$24214633$1$I$20230101$20230831$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300243$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146341$24214634$1$I$20230801$20230912$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300244$RVL PHARMACEUTICALS$$45$YR$A$F$Y$$$20240815$$$US$US
242146351$24214635$1$I$20230910$20230915$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300245$RVL PHARMACEUTICALS$$72$YR$E$F$Y$$$20240815$$$US$US
242146361$24214636$1$I$20230914$20230916$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300246$RVL PHARMACEUTICALS$$64$YR$A$F$Y$$$20240815$$$US$US
242146371$24214637$1$I$20221101$20230921$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300247$RVL PHARMACEUTICALS$$79$YR$E$F$Y$$$20240815$$$US$
242146381$24214638$1$I$20220201$20230925$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300249$RVL PHARMACEUTICALS$$56$YR$A$F$Y$$$20240815$$$US$US
242146391$24214639$1$I$20230926$20230926$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300250$RVL PHARMACEUTICALS$$70$YR$E$F$Y$$$20240815$$$US$US
242146401$24214640$1$I$20230925$20230927$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300251$RVL PHARMACEUTICALS$$72$YR$E$F$Y$$$20240815$$$US$US
242146411$24214641$1$I$20210401$20230927$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300252$RVL PHARMACEUTICALS$$56$YR$A$F$Y$$$20240815$$MD$US$US
242146421$24214642$1$I$20230101$20230927$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300253$RVL PHARMACEUTICALS$$54$YR$A$F$Y$$$20240815$$$US$US
242146431$24214643$1$I$20230601$20230928$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300254$RVL PHARMACEUTICALS$$80$YR$E$F$Y$$$20240815$$$US$US
242146441$24214644$1$I$20230927$20230929$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300255$RVL PHARMACEUTICALS$$44$YR$A$F$Y$$$20240815$$$US$US
242146451$24214645$1$I$20231004$20231005$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300256$RVL PHARMACEUTICALS$$22$YR$A$F$Y$$$20240815$$CN$US$US
242146461$24214646$1$I$20230901$20231005$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300257$RVL PHARMACEUTICALS$$73$YR$E$F$Y$$$20240815$$$US$US
242146471$24214647$1$I$20230901$20231005$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300258$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146481$24214648$1$I$20230901$20231006$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300259$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146491$24214649$1$I$20230901$20231006$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300260$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$HP$US$US
242146501$24214650$1$I$20230801$20231006$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300261$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$HP$US$US
242146511$24214651$1$I$20230901$20231005$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300262$RVL PHARMACEUTICALS$$81$YR$E$M$Y$$$20240815$$HP$US$US
242146521$24214652$1$I$20230101$20231006$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300263$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146531$24214653$1$I$20230101$20231009$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300264$RVL PHARMACEUTICALS$$$$A$M$Y$$$20240815$$MD$US$US
242146541$24214654$1$I$20230928$20231018$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300265$RVL PHARMACEUTICALS$$71$YR$E$F$Y$$$20240815$$HP$US$US
242146551$24214655$1$I$20230801$20231019$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300266$RVL PHARMACEUTICALS$$$$A$M$Y$$$20240815$$$US$US
242146561$24214656$1$I$20230901$20231020$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300267$RVL PHARMACEUTICALS$$$$A$M$Y$$$20240815$$$US$US
242146571$24214657$1$I$20230902$20231016$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300268$RVL PHARMACEUTICALS$$46$YR$A$F$Y$$$20240815$$HP$US$US
242146581$24214658$1$I$20231001$20231020$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300269$RVL PHARMACEUTICALS$$65$YR$E$F$Y$$$20240815$$$US$US
242146591$24214659$1$I$20231001$20231023$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300270$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146601$24214660$1$I$20231001$20231024$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300271$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$HP$US$US
242146611$24214661$1$I$20230901$20230923$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300292$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146621$24214662$1$I$20230729$20230729$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300293$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146631$24214663$1$I$20231001$20231027$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300300$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$CN$US$US
242146641$24214664$1$I$20231001$20231031$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300301$RVL PHARMACEUTICALS$$52$YR$A$F$Y$$$20240815$$CN$US$US
242146651$24214665$1$I$20231014$20231029$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300302$RVL PHARMACEUTICALS$$37$YR$A$F$Y$$$20240815$$CN$US$US
242146661$24214666$1$I$20230101$20231101$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300303$RVL PHARMACEUTICALS$$54$YR$A$F$Y$$$20240815$$HP$US$US
242146671$24214667$1$I$20230901$20230924$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300304$RVL PHARMACEUTICALS$$$$A$$Y$$$20240815$$HP$US$US
242146681$24214668$1$I$20230801$20230819$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300306$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$CN$US$US
242146691$24214669$1$I$20231101$20231106$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300310$RVL PHARMACEUTICALS$$62$YR$A$F$Y$$$20240815$$$US$US
242146701$24214670$1$I$20231001$20231106$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300311$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$HP$US$US
242146711$24214671$1$I$20231001$20231107$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300312$RVL PHARMACEUTICALS$$90$YR$E$F$Y$$$20240815$$$US$US
242146721$24214672$1$I$20231101$20231107$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300313$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146731$24214673$1$I$20231001$20231109$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300315$RVL PHARMACEUTICALS$$73$YR$E$M$Y$$$20240815$$$US$US
242146741$24214674$1$I$20231109$20231110$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300317$RVL PHARMACEUTICALS$$62$YR$A$F$Y$$$20240815$$$US$US
242146751$24214675$1$I$20231111$20231115$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300318$RVL PHARMACEUTICALS$$72$YR$E$F$Y$$$20240815$$$US$US
242146761$24214676$1$I$20231005$20231115$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300319$RVL PHARMACEUTICALS$$41$YR$A$F$Y$$$20240815$$$US$US
242146771$24214677$1$I$20231111$20231115$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300320$RVL PHARMACEUTICALS$$52$YR$A$F$Y$$$20240815$$$US$US
242146781$24214678$1$I$20230101$20231116$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300321$RVL PHARMACEUTICALS$$$$A$$Y$$$20240815$$$US$US
242146791$24214679$1$I$20230101$20231116$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300322$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$HP$US$US
242146801$24214680$1$I$20230101$20231119$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300323$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146811$24214681$1$I$20230701$20231120$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300324$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146821$24214682$1$I$20231101$20231120$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300325$RVL PHARMACEUTICALS$$58$YR$A$F$Y$$$20240815$$$US$US
242146831$24214683$1$I$20231118$20231120$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300326$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146841$24214684$1$I$20230101$20231121$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300327$RVL PHARMACEUTICALS$$68$YR$E$M$Y$$$20240815$$$US$US
242146851$24214685$1$I$20231101$20231120$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300328$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146861$24214686$1$I$20230101$20231122$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300329$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146871$24214687$1$I$20230101$20231126$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300330$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146881$24214688$1$I$20230101$20231123$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300331$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146891$24214689$1$I$20210101$20231127$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300332$RVL PHARMACEUTICALS$$71$YR$E$M$Y$$$20240815$$$US$US
242146901$24214690$1$I$20231025$20231128$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300333$RVL PHARMACEUTICALS$$31$YR$A$F$Y$$$20240815$$HP$US$US
242146911$24214691$1$I$20231119$20231130$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300334$RVL PHARMACEUTICALS$$51$YR$A$F$Y$$$20240815$$$US$US
242146921$24214692$1$I$20230101$20231129$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300335$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146931$24214693$1$I$20230921$20231130$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300336$RVL PHARMACEUTICALS$$63$YR$A$F$Y$$$20240815$$$US$US
242146941$24214694$1$I$20231130$20231204$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300337$RVL PHARMACEUTICALS$$52$YR$A$F$Y$$$20240815$$$US$US
242146951$24214695$1$I$20230101$20231202$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300338$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242146961$24214696$1$I$20230101$20231204$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300339$RVL PHARMACEUTICALS$$33$YR$A$F$Y$$$20240815$$HP$US$US
242146971$24214697$1$I$20231205$20231207$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300340$RVL PHARMACEUTICALS$$$$A$$Y$$$20240815$$$US$US
242146981$24214698$1$I$20231208$20231208$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300341$RVL PHARMACEUTICALS$$74$YR$E$F$Y$$$20240815$$$US$US
242146991$24214699$1$I$20230101$20231208$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300342$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147001$24214700$1$I$20230101$20231208$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300343$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147011$24214701$1$I$20230101$20231213$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300344$RVL PHARMACEUTICALS$$73$YR$E$F$Y$$$20240815$$$US$US
242147021$24214702$1$I$20230501$20231217$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300345$RVL PHARMACEUTICALS$$52$YR$A$F$Y$$$20240815$$$US$US
242147031$24214703$1$I$20231101$20231220$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300346$RVL PHARMACEUTICALS$$80$YR$E$F$Y$$$20240815$$$US$US
242147041$24214704$1$I$20231220$20231220$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300347$RVL PHARMACEUTICALS$$58$YR$A$F$Y$$$20240815$$HP$US$US
242147051$24214705$1$I$20231220$20231220$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300348$RVL PHARMACEUTICALS$$26$YR$A$F$Y$$$20240815$$HP$US$US
242147061$24214706$1$I$20231220$20231221$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300349$RVL PHARMACEUTICALS$$26$YR$A$F$Y$$$20240815$$$US$US
242147071$24214707$1$I$20230101$20231226$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300350$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147081$24214708$1$I$20231226$20231227$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202300351$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147091$24214709$1$I$20230101$20231229$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400001$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147101$24214710$1$I$20230101$20240102$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400002$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147111$24214711$1$I$20230901$20240104$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400003$RVL PHARMACEUTICALS$$57$YR$A$F$Y$$$20240815$$$US$US
242147121$24214712$1$I$20231101$20240105$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400004$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147131$24214713$1$I$20231211$20240102$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400005$RVL PHARMACEUTICALS$$47$YR$A$F$Y$$$20240815$$$US$US
242147141$24214714$1$I$20231219$20240109$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400006$RVL PHARMACEUTICALS$$72$YR$E$F$Y$$$20240815$$$US$US
242147151$24214715$1$I$20231218$20240109$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400007$RVL PHARMACEUTICALS$$66$YR$E$F$Y$$$20240815$$$US$US
242147161$24214716$1$I$20231116$20240109$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400009$RVL PHARMACEUTICALS$$51$YR$A$F$Y$$$20240815$$$US$US
242147171$24214717$1$I$20230101$20240111$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400010$RVL PHARMACEUTICALS$$44$YR$A$F$Y$$$20240815$$$US$US
242147181$24214718$1$I$20240104$20240111$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400011$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147191$24214719$1$I$20230101$20240113$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400012$RVL PHARMACEUTICALS$$$$A$M$Y$$$20240815$$$US$US
242147201$24214720$1$I$20231201$20240106$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400013$RVL PHARMACEUTICALS$$69$YR$E$F$Y$$$20240815$$$US$US
242147211$24214721$1$I$20230101$20240116$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400014$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147221$24214722$1$I$20231001$20240119$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400015$RVL PHARMACEUTICALS$$71$YR$E$F$Y$$$20240815$$$US$US
242147231$24214723$1$I$20240101$20240122$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400016$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147241$24214724$1$I$20231201$20240123$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400017$RVL PHARMACEUTICALS$$67$YR$E$F$Y$$$20240815$$$US$US
242147251$24214725$1$I$20230101$20240111$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400018$RVL PHARMACEUTICALS$$$$A$M$Y$$$20240815$$$US$US
242147261$24214726$1$I$20230101$20240123$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400019$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147271$24214727$1$I$20240101$20240126$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400021$RVL PHARMACEUTICALS$$62$YR$A$F$Y$$$20240815$$$US$US
242147281$24214728$1$I$20240130$20240130$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400022$RVL PHARMACEUTICALS$$77$YR$E$F$Y$$$20240815$$$US$US
242147291$24214729$1$I$20240201$20240201$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400023$RVL PHARMACEUTICALS$$57$YR$A$F$Y$$$20240815$$$US$US
242147301$24214730$1$I$20240201$20240202$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400024$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$MD$US$US
242147311$24214731$1$I$20230901$20240202$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400025$RVL PHARMACEUTICALS$$83$YR$E$F$Y$$$20240815$$$US$US
242147321$24214732$1$I$20210101$20240202$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400026$RVL PHARMACEUTICALS$$67$YR$E$M$Y$$$20240815$$$US$US
242147331$24214733$1$I$20240101$20240124$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400028$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147341$24214734$1$I$20230101$20240203$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400029$RVL PHARMACEUTICALS$$59$YR$A$F$Y$$$20240815$$$US$US
242147351$24214735$1$I$20231201$20240205$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400030$RVL PHARMACEUTICALS$$64$YR$A$F$Y$$$20240815$$$US$US
242147361$24214736$1$I$20231201$20240206$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400031$RVL PHARMACEUTICALS$$78$YR$E$F$Y$$$20240815$$$US$US
242147371$24214737$1$I$20230501$20240208$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400032$RVL PHARMACEUTICALS$$89$YR$E$M$Y$$$20240815$$$US$US
242147381$24214738$1$I$20230801$20240209$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400033$RVL PHARMACEUTICALS$$84$YR$E$F$Y$$$20240815$$$US$US
242147391$24214739$1$I$20231001$20240208$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400034$RVL PHARMACEUTICALS$$71$YR$E$F$Y$$$20240815$$$US$US
242147401$24214740$1$I$20240209$20240213$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400035$RVL PHARMACEUTICALS$$35$YR$A$M$Y$$$20240815$$$US$US
242147411$24214741$1$I$20240213$20240214$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400036$RVL PHARMACEUTICALS$$78$YR$E$F$Y$$$20240815$$$US$US
242147421$24214742$1$I$20240214$20240215$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400037$RVL PHARMACEUTICALS$$$$A$M$Y$$$20240815$$CN$US$US
242147431$24214743$1$I$20230101$20240216$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400038$RVL PHARMACEUTICALS$$50$YR$A$F$Y$$$20240815$$$US$US
242147441$24214744$1$I$20240101$20240216$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400039$RVL PHARMACEUTICALS$$59$YR$A$F$Y$$$20240815$$$US$US
242147461$24214746$1$I$20240214$20240216$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400041$RVL PHARMACEUTICALS$$31$YR$A$F$Y$$$20240815$$$US$US
242147471$24214747$1$I$20230101$20240216$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400042$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147481$24214748$1$I$20240101$20240218$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400043$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147491$24214749$1$I$20240125$20240219$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400044$RVL PHARMACEUTICALS$$57$YR$A$F$Y$$$20240815$$$US$US
242147501$24214750$1$I$20240221$20240221$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400045$RVL PHARMACEUTICALS$$78$YR$E$F$Y$$$20240815$$$US$US
242147511$24214751$1$I$20240221$20240221$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400047$RVL PHARMACEUTICALS$$62$YR$A$F$Y$$$20240815$$$US$US
242147521$24214752$1$I$20231201$20240223$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400049$RVL PHARMACEUTICALS$$30$YR$A$F$Y$$$20240815$$$US$US
242147531$24214753$1$I$20230101$20240226$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400050$RVL PHARMACEUTICALS$$67$YR$E$F$Y$$$20240815$$$US$
242147541$24214754$1$I$20240211$20240227$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400051$RVL PHARMACEUTICALS$$62$YR$A$F$Y$$$20240815$$$US$US
242147551$24214755$1$I$20240201$20240226$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400052$RVL PHARMACEUTICALS$$64$YR$A$F$Y$$$20240815$$$US$US
242147561$24214756$1$I$20230101$20240225$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400053$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147571$24214757$1$I$20240101$20240304$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400055$RVL PHARMACEUTICALS$$45$YR$A$F$Y$$$20240815$$HP$US$US
242147581$24214758$1$I$20240101$20240304$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400056$RVL PHARMACEUTICALS$$54$YR$A$F$Y$$$20240815$$HP$US$US
242147591$24214759$1$I$20240130$20240302$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400057$RVL PHARMACEUTICALS$$40$YR$A$$Y$$$20240815$$$US$US
242147601$24214760$1$I$20200101$20240307$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400059$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147611$24214761$1$I$20240305$20240308$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400060$RVL PHARMACEUTICALS$$61$YR$A$F$Y$$$20240815$$$US$US
242147621$24214762$1$I$20240305$20240308$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400061$RVL PHARMACEUTICALS$$61$YR$A$F$Y$$$20240815$$MD$US$US
242147631$24214763$1$I$20240308$20240309$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400062$RVL PHARMACEUTICALS$$66$YR$E$$Y$$$20240815$$$US$US
242147641$24214764$1$I$20240101$20240311$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400063$RVL PHARMACEUTICALS$$$$A$$Y$$$20240815$$$US$US
242147651$24214765$1$I$20230101$20240312$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400064$RVL PHARMACEUTICALS$$54$YR$A$F$Y$61.29$KG$20240815$$$US$US
242147661$24214766$1$I$20240101$20240314$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400065$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$
242147671$24214767$1$I$20240314$20240315$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400066$RVL PHARMACEUTICALS$$78$YR$E$F$Y$$$20240815$$$US$US
242147681$24214768$1$I$20240301$20240318$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400067$RVL PHARMACEUTICALS$$66$YR$E$F$Y$$$20240815$$$US$US
242147691$24214769$1$I$20240101$20240320$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400068$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147701$24214770$1$I$20240321$20240322$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400069$RVL PHARMACEUTICALS$$71$YR$E$F$Y$$$20240815$$$US$US
242147711$24214771$1$I$20220101$20240325$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400070$RVL PHARMACEUTICALS$$52$YR$A$F$Y$$$20240815$$$US$US
242147721$24214772$1$I$20240301$20240328$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400071$RVL PHARMACEUTICALS$$41$YR$A$F$Y$86.26$KG$20240815$$$US$US
242147731$24214773$1$I$20240101$20240325$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400072$RVL PHARMACEUTICALS$$52$YR$A$F$Y$$$20240815$$$US$US
242147741$24214774$1$I$20240301$20240329$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400073$RVL PHARMACEUTICALS$$35$YR$A$F$Y$$$20240815$$$US$US
242147751$24214775$1$I$20240301$20240401$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400074$RVL PHARMACEUTICALS$$55$YR$A$F$Y$$$20240815$$$US$US
242147761$24214776$1$I$20240101$20240401$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400075$RVL PHARMACEUTICALS$$61$YR$A$F$Y$$$20240815$$$US$US
242147771$24214777$1$I$20240101$20240329$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400076$RVL PHARMACEUTICALS$$$$A$$Y$$$20240815$$$US$US
242147781$24214778$1$I$20240301$20240401$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400077$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147791$24214779$1$I$20240229$20240403$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400078$RVL PHARMACEUTICALS$$32$YR$A$F$Y$$$20240815$$HP$US$US
242147801$24214780$1$I$20240404$20240404$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400079$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147811$24214781$1$I$20240331$20240404$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400080$RVL PHARMACEUTICALS$$44$YR$A$F$Y$$$20240815$$$US$US
242147821$24214782$1$I$20240101$20240407$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400081$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147831$24214783$1$I$20240301$20240408$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400082$RVL PHARMACEUTICALS$$32$YR$A$M$Y$$$20240815$$$US$US
242147841$24214784$1$I$20240101$20240406$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400083$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147851$24214785$1$I$20240301$20240409$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400084$RVL PHARMACEUTICALS$$75$YR$E$F$Y$$$20240815$$$US$US
242147861$24214786$1$I$20240407$20240410$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400085$RVL PHARMACEUTICALS$$75$YR$E$$Y$$$20240815$$$US$US
242147871$24214787$1$I$20240101$20240410$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400087$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147881$24214788$1$I$20240301$20240412$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400088$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242147891$24214789$1$I$20240101$20240412$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400089$RVL PHARMACEUTICALS$$60$YR$A$F$Y$$$20240815$$CN$US$US
242147901$24214790$1$I$20240101$20240418$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400090$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$CN$US$US
242147911$24214791$1$I$20210101$20240422$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400091$RVL PHARMACEUTICALS$$76$YR$E$F$Y$$$20240815$$$US$US
242147921$24214792$1$I$20240301$20240423$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400092$RVL PHARMACEUTICALS$$46$YR$A$F$Y$$$20240815$$$US$US
242147931$24214793$1$I$20240419$20240422$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400093$RVL PHARMACEUTICALS$$63$YR$A$F$Y$$$20240815$$$US$US
242147941$24214794$1$I$20240410$20240424$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400094$RVL PHARMACEUTICALS$$66$YR$E$F$Y$$$20240815$$$US$US
242147951$24214795$1$I$20230901$20240425$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400096$RVL PHARMACEUTICALS$$62$YR$A$F$Y$$$20240815$$$US$US
242147961$24214796$1$I$20240409$20240425$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400097$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$MD$US$US
242147971$24214797$1$I$20240425$20240429$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400098$RVL PHARMACEUTICALS$$51$YR$A$F$Y$$$20240815$$$US$US
242147981$24214798$1$I$20231101$20240429$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400099$RVL PHARMACEUTICALS$$59$YR$A$F$Y$$$20240815$$$US$US
242147991$24214799$1$I$20240401$20240502$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400100$RVL PHARMACEUTICALS$$80$YR$E$F$Y$$$20240815$$$US$US
242148001$24214800$1$I$20240401$20240507$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400101$RVL PHARMACEUTICALS$$84$YR$E$F$Y$$$20240815$$$US$US
242148011$24214801$1$I$20240401$20240509$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400102$RVL PHARMACEUTICALS$$70$YR$E$F$Y$$$20240815$$$US$US
242148021$24214802$1$I$20240401$20240513$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400103$RVL PHARMACEUTICALS$$48$YR$A$F$Y$$$20240815$$$US$US
242148031$24214803$1$I$20240101$20240513$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400104$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242148041$24214804$1$I$20240513$20240514$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400105$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242148051$24214805$1$I$20240501$20240515$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400106$RVL PHARMACEUTICALS$$76$YR$E$F$Y$$$20240815$$$US$
242148061$24214806$1$I$20240515$20240516$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400107$RVL PHARMACEUTICALS$$42$YR$A$F$Y$$$20240815$$CN$US$US
242148071$24214807$1$I$20240101$20240516$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400108$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$CN$US$
242148081$24214808$1$I$20240101$20240516$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400109$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$CN$US$US
242148091$24214809$1$I$20240516$20240516$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400110$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242148101$24214810$1$I$20240101$20240518$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400111$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242148111$24214811$1$I$20240101$20240520$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400112$RVL PHARMACEUTICALS$$69$YR$E$F$Y$$$20240815$$$US$US
242148121$24214812$1$I$20240516$20240520$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400113$RVL PHARMACEUTICALS$$59$YR$A$F$Y$79.45$KG$20240815$$$US$US
242148131$24214813$1$I$20240301$20240520$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400114$RVL PHARMACEUTICALS$$75$YR$E$M$Y$$$20240815$$$US$US
242148141$24214814$1$I$20240430$20240520$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400115$RVL PHARMACEUTICALS$$75$YR$E$$Y$$$20240815$$CN$US$US
242148151$24214815$1$I$20231107$20240520$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400116$RVL PHARMACEUTICALS$$50$YR$A$F$Y$$$20240815$$$US$US
242148161$24214816$1$I$20240301$20240521$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400117$RVL PHARMACEUTICALS$$82$YR$E$M$Y$$$20240815$$$US$US
242148171$24214817$1$I$20240501$20240522$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400118$RVL PHARMACEUTICALS$$46$YR$A$F$Y$$$20240815$$$US$US
242148181$24214818$1$I$20240501$20240522$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400119$RVL PHARMACEUTICALS$$52$YR$A$F$Y$$$20240815$$$US$US
242148191$24214819$1$I$20240501$20240522$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400120$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$HP$US$US
242148201$24214820$1$I$20240501$20240528$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400122$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242148211$24214821$1$I$20240101$20240528$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400123$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242148221$24214822$1$I$20240510$20240529$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400124$RVL PHARMACEUTICALS$$82$YR$E$F$Y$71.732$KG$20240815$$$US$US
242148231$24214823$1$I$20240422$20240530$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400125$RVL PHARMACEUTICALS$$15$YR$T$M$Y$$$20240815$$CN$US$US
242148241$24214824$1$I$20240501$20240530$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400126$RVL PHARMACEUTICALS$$61$YR$A$F$Y$$$20240815$$$US$US
242148251$24214825$1$I$20240501$20240605$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400127$RVL PHARMACEUTICALS$$79$YR$E$F$Y$$$20240815$$$US$US
242148261$24214826$1$I$20240501$20240606$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400128$RVL PHARMACEUTICALS$$80$YR$E$F$Y$$$20240815$$$US$US
242148271$24214827$1$I$20240401$20240606$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400129$RVL PHARMACEUTICALS$$40$YR$A$M$Y$$$20240815$$$US$US
242148281$24214828$1$I$20230401$20240607$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400130$RVL PHARMACEUTICALS$$72$YR$E$$Y$$$20240815$$$US$US
242148291$24214829$1$I$20240301$20240607$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400131$RVL PHARMACEUTICALS$$35$YR$A$F$Y$$$20240815$$$US$US
242148301$24214830$1$I$20210401$20240607$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400132$RVL PHARMACEUTICALS$$75$YR$E$F$Y$$$20240815$$$US$US
242148311$24214831$1$I$20240101$20240610$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400133$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242148321$24214832$1$I$20240601$20240610$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400134$RVL PHARMACEUTICALS$$77$YR$E$F$Y$$$20240815$$$US$US
242148331$24214833$1$I$20240101$20240606$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400135$RVL PHARMACEUTICALS$$$$A$$Y$$$20240815$$$US$US
242148341$24214834$1$I$20240601$20240610$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400136$RVL PHARMACEUTICALS$$68$YR$E$F$Y$$$20240815$$$US$US
242148351$24214835$1$I$20240605$20240610$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400137$RVL PHARMACEUTICALS$$41$YR$A$F$Y$$$20240815$$$US$US
242148361$24214836$1$I$20240606$20240612$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400138$RVL PHARMACEUTICALS$$69$YR$E$F$Y$$$20240815$$MD$US$US
242148371$24214837$1$I$20240101$20240613$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400139$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$HP$US$US
242148381$24214838$1$I$20240101$20240613$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400140$RVL PHARMACEUTICALS$$$$A$$Y$$$20240815$$HP$US$US
242148391$24214839$1$I$20240501$20240617$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400141$RVL PHARMACEUTICALS$$66$YR$E$F$Y$$$20240815$$$US$US
242148401$24214840$1$I$20221101$20240617$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400142$RVL PHARMACEUTICALS$$71$YR$E$F$Y$$$20240815$$$US$US
242148411$24214841$1$I$20240101$20240619$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400143$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242148421$24214842$1$I$20240601$20240626$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400145$RVL PHARMACEUTICALS$$47$YR$A$F$Y$$$20240815$$$US$US
242148431$24214843$1$I$20240629$20240701$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400147$RVL PHARMACEUTICALS$$83$YR$E$F$Y$$$20240815$$$US$US
242148441$24214844$1$I$20240101$20240701$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400148$RVL PHARMACEUTICALS$$$$A$M$Y$$$20240815$$$US$US
242148451$24214845$1$I$20240608$20240701$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400149$RVL PHARMACEUTICALS$$75$YR$E$F$Y$84.898$KG$20240815$$$US$US
242148461$24214846$1$I$20240101$20240701$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400150$RVL PHARMACEUTICALS$$66$YR$E$F$Y$$$20240815$$HP$US$US
242148471$24214847$1$I$20240513$20240701$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400151$RVL PHARMACEUTICALS$$33$YR$A$F$Y$$$20240815$$CN$US$US
242148481$24214848$1$I$20240505$20240701$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400152$RVL PHARMACEUTICALS$$39$YR$A$F$Y$$$20240815$$CN$US$US
242148491$24214849$1$I$20240701$20240702$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400153$RVL PHARMACEUTICALS$$$$A$F$Y$$$20240815$$$US$US
242148501$24214850$1$I$20240612$20240703$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400154$RVL PHARMACEUTICALS$$71$YR$E$F$Y$$$20240815$$MD$US$US
242148511$24214851$1$I$20240704$20240705$20240815$20240815$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400155$RVL PHARMACEUTICALS$$77$YR$E$F$Y$$$20240815$$$US$US
242148521$24214852$1$I$20240804$20240806$20240815$20240815$PER$$US-TAKEDA-2024TUS078960$TAKEDA$$61$YR$$F$Y$84$KG$20240815$$HP$US$US
242148531$24214853$1$I$$20240811$20240815$20240815$EXP$$US-WAYLIS-2024-US-043126$Waylis$Puthumana RM, Mintz J, Perez M, Gaddipati S, Gormon D..Too Much of a Good Thing: A Case of Beta Blocker and Warfarin Toxicity.AMERICAN JOUNRAL OF RESPIRATORY CRITICAL CARE MEDICINE.2024;209(A5692):.$38$YR$$M$Y$$$20240815$$CN$US$US
242148541$24214854$1$I$$20240805$20240815$20240815$EXP$$FR-TEVA-VS-3233192$TEVA$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Lorinee La Grandmaison G, et al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxic-Analyt-Clinique 2022; 34 (Suppl.) (3): S109.$53$YR$$F$Y$$$20240815$$HP$FR$FR
242148552$24214855$2$F$$20240826$20240815$20240904$EXP$$IT-TEVA-VS-3233188$TEVA$Conversano E, Debiec H, Colucci M, Emma F, Ronco P, Vivarelli M A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance. Pediatric Nephrology. 2024 Jan, 39: 305-308.; Conversano E, Debiec H, Colucci M, Emma F, Ronco P, Vivarelli M. A CHILD WITH SEMAPHORIN 3B-ASSOCIATED MEMBRANOUS NEPHROPATHY EFFECTIVELLY TREARED WITH OBINUTUZUMAB. Pediatr-Nephrol 2023; 38 (Suppl. 2) S123-S124 abstr. Su-3MP 147.$9$YR$$M$Y$$$20240904$$HP$IT$IT
242148562$24214856$2$F$$20240826$20240815$20240904$EXP$$SG-TEVA-VS-3231945$TEVA$Au Eong DTM, Chiew RLJ, Au Eong KG. Delayed-Onset Hypnopompic Visual Hallucinations 20 Years After Initiation of Propranolol Therapy for Systemic Hypertension: A Case Report. Am-J-Case-Rep 2024; 25 e944342.; Au Eong DTM, Chiew RLJ, Au Eong KG. Delayed-Onset Hypnopompic Visual Hallucinations 20 Years After Initiation of Propranolol Therapy for Systemic Hypertension: A Case Report. Am-J-Case-Rep 2024; 25 e944342.$88$YR$$F$Y$$$20240904$$HP$SG$SG
242148581$24214858$1$I$20230801$20240805$20240815$20240815$EXP$$HU-TEVA-VS-3231661$TEVA$?rvai F, Vargyas L, Farkas ?, Gecse K, Nagy L. Unusual case of flecainide intoxication of a patient with pacemaker. Cardiologia Hungarica Supplementum. 2024/3: 339.$72$YR$$M$Y$$$20240815$$MD$HU$HU
242148591$24214859$1$I$20231102$20240815$20240815$20240815$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-271765$BOEHRINGER INGELHEIM$$69$YR$E$F$Y$$$20240815$$CN$US$US
242148601$24214860$1$I$20130101$20240807$20240815$20240815$EXP$FR-AFSSAPS-AVCN2024000586$FR-TEVA-VS-3231731$TEVA$$18$YR$$F$Y$$$20240815$$MD$FR$FR
242148611$24214861$1$I$20240412$20240807$20240815$20240815$EXP$FR-AFSSAPS-RS2024000746$FR-TEVA-VS-3231728$TEVA$$68$YR$$F$Y$$$20240815$$PH$FR$FR
242148622$24214862$2$F$$20240826$20240815$20240903$EXP$$FR-TEVA-VS-3232031$TEVA$Naim G, Malissin I, Megarbane B. Cerebral microbleeds in the poisoned patient: An observational magnetic resonance imaging study. Basic-Clin-Pharmacol-Toxicol 2023; 133 770-777.; Naim G, Malissin I, Megarbane B. Cerebral microbleeds in the poisoned patient: An observational magnetic resonance imaging study. Basic-Clin-Pharmacol-Toxicol 2023; 133 770-777.; Naim G, Malissin I, Megarbane B. Cerebral microbleeds in the poisoned patient: An observational magnetic resonance imaging study. Basic-Cli...$40$YR$$M$Y$$$20240903$$HP$FR$FR
242148631$24214863$1$I$20240714$20240808$20240815$20240815$EXP$$AR-TAKEDA-2024TUS081560$TAKEDA$$39$YR$$F$Y$$$20240815$$CN$AR$AR
242148641$24214864$1$I$$20240805$20240815$20240815$EXP$$FR-TEVA-VS-3232033$TEVA$Naim G, Malissin I, Megarbane B. Cerebral microbleeds in the poisoned patient: An observational magnetic resonance imaging study. Basic-Clin-Pharmacol-Toxicol 2023; 133 770-777.; Naim G, Malissin I, Megarbane B. Cerebral microbleeds in the poisoned patient: An observational magnetic resonance imaging study. Basic-Clin-Pharmacol-Toxicol 2023; 133 770-777.$72$YR$$F$Y$$$20240815$$HP$FR$FR
242148652$24214865$2$F$$20240826$20240815$20240904$EXP$$DK-TEVA-VS-3231949$TEVA$Nielsen MKK, Johansen SS, Linnet K. Evaluation of poly-drug use in methadone-related fatalities using segmental hair analysis. Forensic-Sci-Int 2015; 248 134-139.; Nielsen MKK, Johansen SS, Linnet K. Evaluation of poly-drug use in methadone-related fatalities using segmental hair analysis. Forensic-Sci-Int 2015; 248 134-139.$$$$$Y$$$20240904$$HP$DK$DK
242148661$24214866$1$I$$20240805$20240815$20240815$EXP$$IN-TEVA-VS-3231631$TEVA$Development of Neutropenia in an Infant with Harlequin Ichthyosis on Acitretin Therapy: A Clinical Quandary; Shah SR, Vyas HR, Vaghasia AT, Brahmbhatt VU, Shah BJ. Development of Neutropenia in an Infant with Harlequin Ichthyosis on Acitretin Therapy: A Clinical Quandary. Skinmed. 2024;22(2):152-156.$45$DY$$M$Y$2.2$KG$20240815$$MD$IN$IN
242148671$24214867$1$I$20240301$20240814$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408009339$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240815$$PH$US$US
242148681$24214868$1$I$$20240722$20240815$20240815$PER$$US-SMPA-2024MYSCI0700897$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242148691$24214869$1$I$$20240722$20240815$20240815$PER$$US-SMPA-2024MYSCI0700904$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242148701$24214870$1$I$$20240717$20240815$20240815$PER$$US-SMPA-2024MYSCI0700735$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242148711$24214871$1$I$20240702$20240717$20240815$20240815$PER$$US-SMPA-2024MYSCI0700736$SUNOVION$$$$$$Y$$$20240815$$HP$US$US
242148721$24214872$1$I$$20240731$20240815$20240815$PER$$US-SMPA-2024SPA000666$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242148731$24214873$1$I$$20240722$20240815$20240815$PER$$US-SMPA-2024MYSCI0500214$SUNOVION$$$$$$Y$$$20240815$$CN$US$US
242148741$24214874$1$I$$20240808$20240815$20240815$30DAY$$AU-SA-2024SA236785$SANOFI AVENTIS$$$$A$$Y$$$20240815$$PH$AU$AU
242148751$24214875$1$I$20240301$20240808$20240815$20240815$EXP$FR-AFSSAPS-NY2024000895$FR-SA-2024SA236703$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240815$$MD$FR$FR
242148761$24214876$1$I$20240709$20240807$20240815$20240815$EXP$FR-AFSSAPS-AM2024000618$FR-TEVA-VS-3231724$TEVA$$90$YR$$F$Y$52$KG$20240815$$PH$FR$FR
242148781$24214878$1$I$$20240805$20240815$20240815$EXP$$PT-TEVA-VS-3231660$TEVA$Santos H, Antunes A, Gomes S, Andrade A, Malheiros M, Prazeres S. A interfer?ncia da trazodona nos resultados de metanefrinas totais urin?rias - a prop?sito de um caso de paraganglioma. Revista Medicina Laboratorial. 2024; (5): 62-63.$68$YR$$F$Y$$$20240815$$MD$PT$PT
242148801$24214880$1$I$$20240815$20240815$20240815$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046036$BOEHRINGER INGELHEIM$$$$$$Y$$$20240815$$CN$US$US
242148811$24214881$1$I$$20240801$20240815$20240815$EXP$$US-HLS-202400697$HLS THERAPEUTICS$$51$YR$A$F$Y$$$20240815$$MD$US$US
242148821$24214882$1$I$$20240812$20240815$20240815$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045361$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240815$$CN$US$US
242148831$24214883$1$I$$20240801$20240815$20240815$EXP$$US-HLS-202400696$HLS THERAPEUTICS$$$$A$$Y$$$20240815$$$COUNTRY NOT SPECIFIED$US
242148841$24214884$1$I$$20240805$20240815$20240815$EXP$$PT-TEVA-VS-3231417$TEVA$Branco CG, Reis MF, Vilas AP. OCTREOTIDE IN COLONIC PSEUDOOBSTRUCTION IN PARKINSON^S DISEASE. Eur-J-Case-Rep-Intern-Med 2021; 8 (Suppl. 1) 160.$77$YR$$M$Y$$$20240815$$HP$PT$PT
242148852$24214885$2$F$$20240911$20240815$20240919$EXP$$GR-TEVA-VS-3231711$TEVA$$$$$F$Y$$$20240919$$MD$GR$GR
242148862$24214886$2$F$$20240805$20240815$20240827$EXP$$JP-009507513-2408JPN000599J$MERCK$Endo Y, Shigeji J, Inokuchi G, Yasui R. 7) A case of rhinosinusitis suspected to be an immune-related adverse event. Journal of Otolaryngology of Japan Hyogo region, The 202nd Hyogo Regional Meetin. 2024;(145):31$55$YR$$M$Y$$$20240827$$MD$JP$JP
242148871$24214887$1$I$20240522$20240808$20240815$20240815$EXP$$GB-009507513-2408GBR003634$MERCK$$68$YR$$F$Y$85$KG$20240815$$MD$GB$GB
242148881$24214888$1$I$20240731$20240814$20240815$20240815$EXP$$US-GILEAD-2024-0684236$GILEAD$$$$A$F$Y$$$20240815$$MD$US$US
242148891$24214889$1$I$20240709$20240805$20240815$20240815$EXP$$CO-APELLIS-2024-APL-0000679$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240812$$HP$CO$CO
242148902$24214890$2$F$$20240829$20240815$20240906$EXP$$PT-TEVA-VS-3231946$TEVA$Reis C, Dias F, Grijo C, Ribeiro A, Almeida J. PSEUDOMEMBRANOUS COLITIS FOLLOWING HELICOBACTER PILORY ERADICATION WITH THE BISMUTH-BASED QUADRUPLE THERAPY. Eur-J-Case-Rep-Intern-Med 2023; 10 (Suppl. 1) 237 abstr. 493.; Reis C, Dias F, Grijo C, Ribeiro A, Almeida J. PSEUDOMEMBRANOUS COLITIS FOLLOWING HELICOBACTER PILORY ERADICATION WITH THE BISMUTH-BASED QUADRUPLE THERAPY. Eur-J-Case-Rep-Intern-Med 2023; 10 (Suppl. 1) 237 abstr. 493.$84$YR$$F$Y$$$20240906$$HP$PT$PT
242148911$24214891$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128456$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$98.43$KG$20240815$$CN$US$US
242148921$24214892$1$I$20240701$20240802$20240815$20240815$PER$$US-JNJFOC-20240809655$JOHNSON AND JOHNSON$$$$$F$Y$$$20240815$$CN$US$US
242148931$24214893$1$I$20240602$20240807$20240815$20240815$EXP$ES-AEMPS-1555664$ES-TEVA-VS-3231696$TEVA$$52$YR$$M$Y$$$20240815$$MD$ES$ES
242148941$24214894$1$I$$20240813$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128174$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240815$$HP$US$US
242148971$24214897$1$I$20240801$20240801$20240815$20240815$EXP$$CA-HLS-202401932$HLS THERAPEUTICS$$41$YR$A$M$Y$$$20240815$$PH$CA$CA
242148981$24214898$1$I$$20240812$20240815$20240815$PER$$US-BIOMARINAP-US-2024-159709$BIOMARIN$$$$$$Y$$$20240815$$CN$US$US
242148991$24214899$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128786$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240815$$PH$US$US
242149011$24214901$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127746$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240815$$CN$US$US
242149021$24214902$1$I$20200317$20240807$20240815$20240815$EXP$PL-URPL-1-1283-2020$PL-TEVA-VS-3231690$TEVA$$50$YR$$F$Y$$$20240815$$MD$PL$PL
242149041$24214904$1$I$$20240801$20240815$20240815$EXP$$US-HLS-202400693$HLS THERAPEUTICS$$$$E$$Y$$$20240815$$PH$US$US
242149061$24214906$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127915$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240815$$HP$US$US
242149071$24214907$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127588$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240815$$HP$US$US
242149081$24214908$1$I$$20240801$20240815$20240815$EXP$$US-HLS-202400687$HLS THERAPEUTICS$$$$A$M$Y$$$20240815$$MD$US$US
242149091$24214909$1$I$20240629$20240807$20240815$20240815$EXP$FR-AFSSAPS-AVCF2024000495$FR-TEVA-VS-3231658$TEVA$$23$YR$$F$Y$$$20240815$$HP$FR$FR
242149102$24214910$2$F$$20240827$20240815$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-126088$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$PH$JP$JP
242149121$24214912$1$I$20240101$20240815$20240815$20240815$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046048$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240815$$CN$US$US
242149131$24214913$1$I$$20240807$20240815$20240815$PER$$US-APELLIS-2024-APL-0000646$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240815$$CN$US$US
242149142$24214914$2$F$20240726$20240905$20240815$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126615$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240909$$PH$US$US
242149152$24214915$2$F$20240101$20240823$20240815$20240829$EXP$$US-BIOGEN-2024BI01277899$BIOGEN$$$$$M$Y$$$20240829$$CN$US$US
242149161$24214916$1$I$$20240812$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128327$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240815$$CN$US$US
242149181$24214918$1$I$20240101$20240809$20240815$20240815$EXP$$CO-BIOGEN-2024BI01255528$BIOGEN$$60$YR$$F$Y$75$KG$20240815$$CN$CO$CO
242149192$24214919$2$F$$20240909$20240815$20240917$EXP$$US-BIOGEN-2024BI01278072$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
242149201$24214920$1$I$20240805$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161491$AMGEN$$$$$$Y$$$20240815$$PH$US$US
242149211$24214921$1$I$20200725$20240807$20240815$20240815$EXP$PL-URPL-1-1716-2020$PL-TEVA-VS-3231866$TEVA$$39$YR$$F$Y$95$KG$20240815$$MD$PL$PL
242149221$24214922$1$I$$20240808$20240815$20240815$EXP$$US-BIOGEN-2024BI01277727$BIOGEN$$$$$F$Y$$$20240815$$HP$US$US
242149231$24214923$1$I$20240718$20240806$20240815$20240815$EXP$$US-BIOGEN-2024BI01277702$BIOGEN$$38$YR$$F$Y$$$20240815$$CN$US$US
242149241$24214924$1$I$$20240812$20240815$20240815$EXP$$US-BIOGEN-2024BI01264313$BIOGEN$$$$$F$Y$$$20240815$$HP$US$US
242149253$24214925$3$F$20240328$20240909$20240815$20240916$EXP$$US-BIOGEN-2024BI01258384$BIOGEN$$68$YR$$F$Y$$$20240916$$CN$US$US
242149261$24214926$1$I$$20240809$20240815$20240815$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127707$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240815$$CN$US$US
242149271$24214927$1$I$$20240812$20240815$20240815$EXP$$BR-BIOGEN-2024BI01278329$BIOGEN$$$$$F$Y$72$KG$20240815$$CN$BR$BR
242149282$24214928$2$F$20240101$20240830$20240815$20240904$PER$$US-AMGEN-USASP2024161481$AMGEN$$51$YR$A$F$Y$$$20240904$$CN$US$US
242149294$24214929$4$F$20240812$20240909$20240815$20240910$PER$$US-AMGEN-USASP2024161111$AMGEN$$76$YR$E$F$Y$$$20240910$$CN$US$US
242149301$24214930$1$I$20240802$20240813$20240815$20240815$PER$$US-AMGEN-USASP2024161054$AMGEN$$76$YR$E$F$Y$$$20240815$$CN$US$US
242149311$24214931$1$I$$20240809$20240815$20240815$PER$$US-SA-2024SA239421$SANOFI AVENTIS$$$$$M$Y$$$20240816$$CN$US$US
242149321$24214932$1$I$$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160719$AMGEN$$$$$M$Y$$$20240815$$MD$US$US
242149332$24214933$2$F$$20240809$20240815$20240821$PER$$US-BIOGEN-2024BI01277894$BIOGEN$$$$$F$Y$$$20240821$$MD$US$US
242149341$24214934$1$I$$20240806$20240815$20240815$EXP$$US-Bion-013669$BIONPHARMA$$$$E$F$Y$$$20240814$$CN$US$US
242149352$24214935$2$F$20240807$20240819$20240815$20240828$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001593$BLUEPRINT MEDICINES$$71$YR$E$M$Y$$$20240828$$CN$US$US
242149361$24214936$1$I$20240418$20240808$20240815$20240815$EXP$$SE-Blueprint Medicines Corporation-SO-SE-2024-001595$BLUEPRINT MEDICINES$$$$$$Y$$$20240816$$CN$GB$GB
242149371$24214937$1$I$$20240814$20240815$20240815$PER$$NVSC2024US165459$NOVARTIS$$$$$M$Y$$$20240816$$HP$US$US
242149381$24214938$1$I$20240802$20240806$20240815$20240815$EXP$$CN-JNJFOC-20240816444$JOHNSON AND JOHNSON$$75$YR$E$F$Y$64$KG$20240816$$HP$CN$CN
242149391$24214939$1$I$$20240809$20240815$20240815$EXP$PL-EMA-20170303-sroyp-160733281$PL-SANDOZ INC.-SDZ2024PL071676$SANDOZ$$32$YR$$M$Y$$$20240815$$HP$PL$PL
242149401$24214940$1$I$20240611$20240813$20240815$20240815$EXP$IT-MINISAL02-998854$IT-ORGANON-O2408ITA000984$ORGANON$$68$YR$$F$Y$$$20240815$$MD$IT$IT
242149411$24214941$1$I$$20240809$20240815$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-129000$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240816$$PH$JP$JP
242149422$24214942$2$F$20240701$20240814$20240815$20240820$EXP$$NVSJ2024JP009585$NOVARTIS$$53$YR$$F$Y$$$20240820$$MD$JP$JP
242149431$24214943$1$I$$20240812$20240815$20240815$PER$$US-BIOMARINAP-US-2024-159816$BIOMARIN$$$$$$Y$$$20240815$$CN$US$US
242149442$24214944$2$F$20221214$20240909$20240815$20240917$EXP$$BR-SANDOZ INC.-SDZ2024BR072307$SANDOZ$$45$YR$$F$Y$64$KG$20240917$$CN$BR$BR
242149451$24214945$1$I$20240809$20240812$20240815$20240815$EXP$$IN-JNJFOC-20240833493$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240816$$MD$IN$IN
242149461$24214946$1$I$$20240814$20240815$20240815$PER$$NVSC2024US165502$NOVARTIS$$$$$$Y$$$20240816$$MD$US$US
242149474$24214947$4$F$20240301$20240809$20240815$20240823$EXP$$JP-AMGEN-JPNSP2024161706$AMGEN$$$$$F$Y$$$20240823$$CN$JP$JP
242149492$24214949$2$F$$20240917$20240815$20240923$30DAY$$JP-JNJFOC-20240834183$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$JP$JP
242149501$24214950$1$I$20240701$20240806$20240815$20240815$PER$$US-SA-2024SA237098$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240816$$MD$US$US
242149511$24214951$1$I$20240508$20240812$20240815$20240815$EXP$$US-JNJFOC-20240831990$JOHNSON AND JOHNSON$$60$YR$A$$Y$$$20240816$$HP$US$US
242149521$24214952$1$I$20240701$20240807$20240815$20240815$EXP$$US-ABBVIE-5695508$ABBVIE$$50$YR$$F$Y$$$20240815$$CN$US$US
242149532$24214953$2$F$20230409$20240818$20240815$20240819$EXP$$NVSJ2023JP006176$NOVARTIS$$$$A$M$Y$57$KG$20240820$$CN$JP$JP
242149542$24214954$2$F$20110705$20240812$20240815$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408008744$ELI LILLY AND CO$$70$YR$E$F$Y$47.4$KG$20240821$$CN$US$US
242149551$24214955$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007338$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240815$$CN$US$US
242149561$24214956$1$I$$20240809$20240815$20240815$EXP$$IT-SANDOZ INC.-NVSC2019IT055544$SANDOZ$$10$YR$$M$Y$$$20240815$$MD$IT$IT
242149571$24214957$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007362$ELI LILLY AND CO$$$$$$Y$$$20240815$$CN$US$US
242149581$24214958$1$I$20240101$20240806$20240815$20240815$EXP$$US-ABBVIE-5873441$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242149591$24214959$1$I$20240724$20240812$20240815$20240815$EXP$FR-AFSSAPS-CF2024000411$FR-SANDOZ INC.-SDZ2024FR072107$SANDOZ$$96$YR$$F$Y$87$KG$20240815$$PH$FR$FR
242149603$24214960$3$F$$20240913$20240815$20240918$EXP$$NVSJ2024JP009616$NOVARTIS$$95$YR$$F$Y$$$20240919$$MD$JP$JP
242149611$24214961$1$I$$20240807$20240815$20240815$PER$$US-SA-2024SA239501$SANOFI AVENTIS$$83$YR$E$M$Y$88.45$KG$20240816$$MD$US$US
242149622$24214962$2$F$20240801$20240814$20240815$20240816$EXP$$US-ABBVIE-5878662$ABBVIE$$64$YR$$M$Y$$$20240816$$CN$US$US
242149632$24214963$2$F$$20240822$20240815$20240828$EXP$$BR-ALXN-202408SAM000550BR$ALEXION PHARMACEUTICALS$$55$YR$$F$Y$$$20240828$$MD$BR$BR
242149641$24214964$1$I$$20240809$20240815$20240815$EXP$DE-BFARM-24005459$DE-ESPERIONTHERAPEUTICS-2024DEU01270$ESPERION THERAPEUTICS$$$$$$Y$$$20240816$$MD$DE$DE
242149651$24214965$1$I$20240101$20240806$20240815$20240815$PER$$US-SA-2024SA238070$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240816$$MD$US$US
242149663$24214966$3$F$$20240920$20240815$20240925$EXP$$NVSJ2024JP009657$NOVARTIS$$$$$$Y$$$20240926$$MD$JP$JP
242149671$24214967$1$I$$20240812$20240815$20240815$EXP$$US-ABBVIE-5878743$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242149681$24214968$1$I$20240814$20240814$20240815$20240815$PER$$US-ORGANON-O2408USA001142$ORGANON$$30$YR$$F$Y$81$KG$20240815$$MD$US$US
242149691$24214969$1$I$20240731$20240814$20240815$20240815$EXP$$US-ABBVIE-5881355$ABBVIE$$86$YR$$F$Y$$$20240815$$CN$US$US
242149701$24214970$1$I$$20240813$20240815$20240815$EXP$$US-ABBVIE-5880757$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242149713$24214971$3$F$$20240830$20240815$20240905$EXP$$DE-ORGANON-O2407DEU002339$ORGANON$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs.  Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in  forensic routine cases.. Journal of Analytical Toxicology.. 2024;48 (5):299-313$37$YR$$M$Y$$$20240905$$HP$DE$DE
242149723$24214972$3$F$20240101$20240823$20240815$20240826$PER$$US-AMGEN-USASP2024162331$AMGEN$$64$YR$A$F$Y$$$20240825$$CN$US$US
242149731$24214973$1$I$$20240809$20240815$20240815$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001616$BLUEPRINT MEDICINES$$$$$M$Y$$$20240816$$CN$US$US
242149741$24214974$1$I$$20240809$20240815$20240815$PER$$US-JNJFOC-20240827709$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$CN$US$US
242149752$24214975$2$F$$20240903$20240815$20240903$PER$$US-ALXN-202408USA000537US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242149761$24214976$1$I$$20240806$20240815$20240815$PER$$US-ABBVIE-5874081$ABBVIE$$$$$$Y$$$20240815$$CN$US$US
242149771$24214977$1$I$20240101$20240810$20240815$20240815$PER$$US-ABBVIE-5877869$ABBVIE$$$$$$Y$$$20240815$$CN$US$US
242149781$24214978$1$I$$20240812$20240815$20240815$PER$$US-JNJFOC-20240830801$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240816$$CN$US$US
242149792$24214979$2$F$20240701$20240815$20240815$20240816$PER$$US-AMGEN-USASP2024162291$AMGEN$$40$YR$A$F$Y$$$20240816$$CN$US$US
242149801$24214980$1$I$$20240809$20240815$20240815$EXP$$NVSJ2024JP008965$NOVARTIS$$64$YR$$M$Y$$$20240816$$PH$JP$JP
242149811$24214981$1$I$$20240812$20240815$20240815$PER$$US-JNJFOC-20240834203$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$CN$US$US
242149821$24214982$1$I$$20240811$20240815$20240815$EXP$$CA-JNJFOC-20240834399$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240816$$HP$CA$CA
242149831$24214983$1$I$$20240812$20240815$20240815$EXP$$US-JNJFOC-20240834238$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
242149841$24214984$1$I$20240701$20240812$20240815$20240815$EXP$$NVSC2024CN165432$NOVARTIS$$66$YR$$M$Y$74$KG$20240816$$HP$CN$CN
242149852$24214985$2$F$20240101$20240819$20240815$20240823$EXP$$JP-JNJFOC-20240837682$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240823$$PH$JP$JP
242149861$24214986$1$I$$20240719$20240815$20240815$EXP$$IN-JNJFOC-20240737948$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240816$$HP$IN$IN
242149872$24214987$2$F$20240416$20240903$20240815$20240906$EXP$$DE-ABBVIE-5870563$ABBVIE$$69$YR$$M$Y$72$KG$20240906$$MD$DE$DE
242149881$24214988$1$I$20240501$20240806$20240815$20240815$EXP$$ES-Blueprint Medicines Corporation-SP-ES-2024-001586$BLUEPRINT MEDICINES$$76$YR$E$F$Y$$$20240816$$CN$ES$ES
242149891$24214989$1$I$20050101$20240808$20240815$20240815$EXP$$AU-ABBVIE-5878514$ABBVIE$$$$$F$Y$$$20240815$$HP$AU$AU
242149901$24214990$1$I$$20240807$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129356$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240816$$CN$US$US
242149912$24214991$2$F$20240807$20240809$20240815$20240823$PER$$US-ROCHE-10000052707$ROCHE$$58$YR$A$F$Y$83.91$KG$20240823$$CN$US$US
242149921$24214992$1$I$20220311$20240810$20240815$20240815$EXP$$PK-AMGEN-PAKSP2019176396$AMGEN$$21$YR$A$F$Y$68$KG$20240815$$CN$PK$PK
242149932$24214993$2$F$$20240819$20240815$20240821$PER$$NVSC2024US165420$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242149942$24214994$2$F$20240809$20240904$20240815$20240908$EXP$$NVSJ2024JP009652$NOVARTIS$$$$A$M$Y$$$20240909$$MD$JP$JP
242149952$24214995$2$F$20240722$20240819$20240815$20240821$EXP$$US-ABBVIE-5880283$ABBVIE$$78$YR$$F$Y$$$20240821$$CN$US$US
242149961$24214996$1$I$$20240809$20240815$20240815$EXP$$DE-ABBVIE-5877533$ABBVIE$$$$E$M$Y$$$20240815$$CN$DE$DE
242149971$24214997$1$I$$20240812$20240815$20240815$EXP$$US-JNJFOC-20240829762$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
242149981$24214998$1$I$$20240814$20240815$20240815$PER$$US-ROCHE-10000057817$ROCHE$$7$YR$C$M$Y$$$20240816$$MD$US$US
242149991$24214999$1$I$20200421$20240813$20240815$20240815$EXP$$US-ABBVIE-5862454$ABBVIE$$52$YR$$M$Y$108.86$KG$20240815$$CN$US$US
242150001$24215000$1$I$$20240812$20240815$20240815$EXP$$IN-ROCHE-10000038886$ROCHE$$76$YR$E$M$Y$55$KG$20240816$$MD$IN$IN
242150011$24215001$1$I$$20240814$20240815$20240815$EXP$GB-MHRA-MED-202408140755121390-FBGNK$GB-ORGANON-O2408GBR001114$ORGANON$$40$YR$$F$Y$$$20240815$$CN$GB$GB
242150022$24215002$2$F$20230101$20240826$20240815$20240830$EXP$$US-ABBVIE-5863033$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242150031$24215003$1$I$20240601$20240814$20240815$20240815$EXP$FR-AFSSAPS-RS2024000806$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-128684$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240816$$MD$FR$FR
242150041$24215004$1$I$20240726$20240809$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012519$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242150052$24215005$2$F$20240101$20240903$20240815$20240910$EXP$$US-ABBVIE-5878927$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
242150061$24215006$1$I$20240605$20240814$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012740$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242150071$24215007$1$I$20240101$20240813$20240815$20240815$EXP$$US-ABBVIE-5880016$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242150081$24215008$1$I$$20240813$20240815$20240815$EXP$$US-ABBVIE-5880382$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242150091$24215009$1$I$$20240813$20240815$20240815$PER$$NVSC2024US165555$NOVARTIS$$$$$$Y$$$20240816$$MD$US$US
242150101$24215010$1$I$20240101$20240808$20240815$20240815$EXP$$US-ABBVIE-5874757$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242150112$24215011$2$F$$20240830$20240815$20240905$EXP$$JP-AMGEN-JPNSP2024162178$AMGEN$$98$YR$E$M$Y$$$20240905$$MD$JP$JP
242150121$24215012$1$I$$20240806$20240815$20240815$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124710$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240816$$PH$US$US
242150131$24215013$1$I$$20240812$20240815$20240815$EXP$$US-ABBVIE-5880104$ABBVIE$$$$$M$Y$$$20240815$$CN$US$US
242150141$24215014$1$I$20240801$20240813$20240815$20240815$EXP$$US-ABBVIE-5880045$ABBVIE$$44$YR$$F$Y$$$20240815$$CN$US$US
242150151$24215015$1$I$$20240812$20240815$20240815$PER$$US-ELI_LILLY_AND_COMPANY-US202408007461$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240815$$CN$US$US
242150161$24215016$1$I$$20240813$20240815$20240815$EXP$$US-TAKEDA-2020TUS007391$TAKEDA$$$$$F$Y$87.98$KG$20240815$$CN$US$US
242150171$24215017$1$I$20240101$20240813$20240815$20240815$EXP$$US-ABBVIE-5880705$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242150185$24215018$5$F$20240613$20240912$20240815$20240926$EXP$$DE-ABBVIE-5813058$ABBVIE$$72$YR$$M$Y$71$KG$20240926$$HP$DE$DE
242150191$24215019$1$I$20240801$20240813$20240815$20240815$EXP$$US-ABBVIE-5880181$ABBVIE$$78$YR$$F$Y$$$20240815$$CN$US$US
242150202$24215020$2$F$$20240813$20240815$20240819$PER$$US-AMGEN-USASP2024161707$AMGEN$$$$$$Y$$$20240818$$PH$US$US
242150211$24215021$1$I$20240812$20240814$20240815$20240815$EXP$$US-ABBVIE-5881349$ABBVIE$$63$YR$$M$Y$$$20240815$$CN$US$US
242150221$24215022$1$I$$20240813$20240815$20240815$EXP$$US-ABBVIE-5880136$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242150232$24215023$2$F$20230307$20240910$20240815$20240918$EXP$$US-ABBVIE-5880187$ABBVIE$$52$YR$$F$Y$81$KG$20240918$$CN$US$US
242150241$24215024$1$I$$20240808$20240815$20240815$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127736$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240816$$MD$JP$JP
242150251$24215025$1$I$20240728$20240808$20240815$20240815$EXP$$IL-AMGEN-ISRSL2024152604$AMGEN$$90$YR$E$M$Y$$$20240815$$CN$IL$IL
242150261$24215026$1$I$20240805$20240809$20240815$20240815$PER$$US-JNJFOC-20240825050$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$CN$US$US
242150271$24215027$1$I$$20240813$20240815$20240815$EXP$$US-AstraZeneca-2024A185481$ASTRAZENECA$$$$$$Y$$$20240816$$MD$US$
242150281$24215028$1$I$$20240813$20240815$20240815$EXP$$US-SANDOZ INC.-SDZ2024US060914$SANDOZ$$$$$$Y$$$20240815$$CN$US$US
242150291$24215029$1$I$$20240813$20240815$20240815$30DAY$$US-SANDOZ INC.-SDZ2024US072564$SANDOZ$$$$$F$Y$$$20240815$$CN$US$US
242150301$24215030$1$I$20240730$20240812$20240815$20240815$EXP$$CA-ABBVIE-5877995$ABBVIE$$67$YR$$F$Y$$$20240815$$CN$CA$CA
242150311$24215031$1$I$$20240812$20240815$20240815$EXP$$US-AstraZeneca-2024A183799$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242150322$24215032$2$F$20240811$20240812$20240815$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408007619$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240820$$PH$US$US
242150331$24215033$1$I$20240501$20240724$20240815$20240815$PER$$US-BEIGENE-BGN-2024-011638$BEIGENE$$$$$$Y$$$20240815$$CN$US$US
242150342$24215034$2$F$20230101$20240819$20240815$20240823$EXP$$US-ABBVIE-5879511$ABBVIE$$$$$F$Y$63$KG$20240823$$CN$US$US
242150352$24215035$2$F$20240101$20240813$20240815$20240828$PER$$US-Encube-001176$ENCUBE ETHICALS$$$$$M$Y$$$20240827$$CN$US$
242150362$24215036$2$F$$20240807$20240815$20240816$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010064$STRIDES$Madhwapathi V, Tso S.. Once in a blue moon?.. Br-J-Dermatol. 2024;192 (Suppl.):i121 abstr. BG07$$$$$Y$$$20240816$$HP$GB$GB
242150372$24215037$2$F$20240601$20240823$20240815$20240830$EXP$$CA-ABBVIE-5881128$ABBVIE$$62$YR$$M$Y$$$20240830$$CN$CA$CA
242150381$24215038$1$I$$20240813$20240815$20240815$EXP$$GB-ABBVIE-5881087$ABBVIE$$$$A$M$Y$$$20240815$$CN$GB$GB
242150391$24215039$1$I$$20240813$20240815$20240815$EXP$$US-ABBVIE-5880486$ABBVIE$$$$$F$Y$$$20240815$$CN$US$US
242150401$24215040$1$I$20240703$20240809$20240815$20240815$EXP$$CN-BEIGENE-BGN-2024-012535$BEIGENE$$$$$$Y$$$20240815$$HP$CN$CN
242150414$24215041$4$F$20240410$20240908$20240815$20240911$PER$$US-AMGEN-USASP2024160326$AMGEN$$46$YR$A$F$Y$$$20240911$$HP$US$US
242150421$24215042$1$I$20240724$20240813$20240815$20240815$EXP$$US-AMGEN-USASP2024161251$AMGEN$$96$YR$E$F$Y$$$20240815$$HP$US$US
242150432$24215043$2$F$20240701$20240829$20240815$20240905$EXP$$NL-ABBVIE-5880992$ABBVIE$$$$E$M$Y$$$20240905$$HP$NL$NL
242150442$24215044$2$F$20240701$20240815$20240815$20240821$EXP$$US-ABBVIE-5878304$ABBVIE$$65$YR$$F$Y$34.472$KG$20240821$$CN$US$US
242150451$24215045$1$I$$20240808$20240815$20240815$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010136$STRIDES$Kerkemeyer K, Vyas A, Walker S, Rickaby W.. A fatal case of disseminated cutaneous Mycobacterium chelonae infection in an immunocompromised patient.. Br-J-Dermatol. 2024;192(Suppl.):i147$$$$$Y$$$20240816$$HP$GB$GB
242150461$24215046$1$I$20240811$20240812$20240815$20240815$PER$$US-AMGEN-USASP2024160412$AMGEN$$61$YR$A$F$Y$$$20240815$$CN$US$US
242150471$24215047$1$I$$20240809$20240816$20240816$EXP$$AE-AstraZeneca-2024A182503$ASTRAZENECA$$$$$$Y$$$20240816$$MD$AE$
242150482$24215048$2$F$$20240906$20240816$20240912$30DAY$$CA-JNJFOC-20240831148$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$CA$CA
242150492$24215049$2$F$20240401$20240924$20240816$20240926$EXP$$US-PFIZER INC-202400234822$PFIZER$$79$YR$$F$Y$53.515$KG$20240926$$CN$US$US
242150501$24215050$1$I$$20240811$20240816$20240816$EXP$$CA-PFIZER INC-202400234981$PFIZER$$56$YR$$M$Y$$$20240815$$MD$CA$CA
242150521$24215052$1$I$$20240809$20240816$20240816$EXP$$CA-PFIZER INC-202400235779$PFIZER$$77$YR$$M$Y$$$20240815$$HP$CA$CA
242150551$24215055$1$I$$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160757$AMGEN$$$$$$Y$$$20240815$$PH$US$US
242150564$24215056$4$F$20230101$20240909$20240816$20240923$EXP$$BR-PFIZER INC-PV202400105224$PFIZER$$45$YR$$F$Y$$$20240923$$HP$BR$BR
242150571$24215057$1$I$$20240813$20240816$20240816$EXP$$US-AMGEN-USASP2024161494$AMGEN$$$$$F$Y$$$20240815$$CN$US$US
242150581$24215058$1$I$$20240605$20240816$20240816$EXP$$US-ADVANZ PHARMA-202406004773$ADVANZ PHARMA$$$$$$Y$$$20240816$$CN$US$US
242150591$24215059$1$I$$20240814$20240816$20240816$PER$$US-HALEON-2192044$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242150601$24215060$1$I$$20240813$20240816$20240816$EXP$$ZA-ABBVIE-5881009$ABBVIE$$61$YR$$F$Y$$$20240816$$CN$ZA$ZA
242150611$24215061$1$I$$20240812$20240816$20240816$EXP$$CA-ABBVIE-5881070$ABBVIE$$73$YR$$F$Y$$$20240816$$CN$CA$CA
242150621$24215062$1$I$20240812$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127890$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240816$$PH$US$US
242150631$24215063$1$I$20240812$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184373$ASTRAZENECA$$26349$DY$$M$Y$$$20240816$$CN$US$
242150641$24215064$1$I$20240807$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184477$ASTRAZENECA$$$$$$Y$$$20240816$$HP$US$
242150651$24215065$1$I$20171215$20240808$20240816$20240816$EXP$$JP-ABBVIE-19P-087-3209041-00$ABBVIE$$71$YR$$M$Y$58.4$KG$20240816$$MD$JP$JP
242150671$24215067$1$I$20240709$20240806$20240816$20240816$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000283$EMCURE$$$$$$Y$$$20240816$$CN$US$US
242150682$24215068$2$F$$20240814$20240816$20240819$PER$$US-AMGEN-USASP2024162380$AMGEN$$$$A$F$Y$$$20240819$$HP$US$US
242150691$24215069$1$I$20240501$20240809$20240816$20240816$EXP$$MX-JNJFOC-20240836078$JOHNSON AND JOHNSON$$68$YR$E$M$Y$54$KG$20240816$$CN$MX$MX
242150702$24215070$2$F$20240714$20240822$20240816$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003879$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240913$$CN$US$US
242150711$24215071$1$I$$20240813$20240816$20240816$PER$$US-HALEON-2191898$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242150721$24215072$1$I$$20240809$20240816$20240816$EXP$$US-ABBVIE-5878764$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242150732$24215073$2$F$$20240819$20240816$20240826$EXP$$JP-CHATTEMPRD-2024OHG026708$CHATTEM$Yoshikawa Y, Tamura Y. A Case of Acquired Fanconi Syndrome with Acute Kidney Injury Following Ingestion of Red Yeast Rice-Related Supplements. The 697th Kanto Regional Meeting of the Japanese Society of Internal Medicine. 2024;$43$YR$A$M$Y$$$20240826$$MD$JP$JP
242150742$24215074$2$F$20240713$20240826$20240816$20240902$EXP$$IN-CHATTEMPRD-2024OHG026906$CHATTEM$$6$YR$C$M$Y$21.7$KG$20240902$$PH$IN$IN
242150751$24215075$1$I$$20240812$20240816$20240816$EXP$$US-ABBVIE-5878782$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242150761$24215076$1$I$$20240813$20240816$20240816$EXP$$US-ABBVIE-5879755$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242150771$24215077$1$I$20240801$20240813$20240816$20240816$EXP$$US-ABBVIE-5880253$ABBVIE$$85$YR$$M$Y$$$20240816$$CN$US$US
242150782$24215078$2$F$$20240808$20240816$20240903$EXP$$VN-AstraZeneca-2024A183003$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$VN$
242150791$24215079$1$I$$20240808$20240816$20240816$EXP$$JP-AstraZeneca-2024A180781$ASTRAZENECA$$$$$$Y$$$20240816$$MD$JP$
242150801$24215080$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165642$NOVARTIS$$$$$$Y$$$20240816$$MD$US$US
242150811$24215081$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003882$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242150821$24215082$1$I$$20240619$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007491$STRIDES$Seibert KE, Bailey MJ, Pruitt DL, Dejesus MS, Toste PA, Hammond TC.. Spontaneous Tension Hemopneumothorax After Weight Training.. Am-J-Respir-Crit-Care-Med. 2024;209$$$$$Y$$$20240816$$HP$US$US
242150832$24215083$2$F$$20240820$20240816$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003881$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
242150841$24215084$1$I$20240612$20240703$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006957$STRIDES$$29$YR$$M$Y$68.027$KG$20240816$$CN$US$US
242150851$24215085$1$I$20221201$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161431$AMGEN$$$$$$Y$$$20240815$$CN$US$US
242150872$24215087$2$F$20210101$20240909$20240816$20240919$EXP$$CN-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000193-2024$QILU PHARMACEUTICAL$Qian YF Chen HP Ren GF.Acute therapy-related myelodysplastic syndromes following capecitabine and oxaliplatin therapy in gastric malignant tumor A case report.Medicine (Baltimore).26-JUL-2024;103(30):1-4$60$YR$A$M$Y$$$20240919$$HP$CN$CN
242150881$24215088$1$I$20240430$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003873$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240816$$CN$US$US
242150891$24215089$1$I$$20240813$20240816$20240816$EXP$$CA-ABBVIE-5881101$ABBVIE$$$$A$F$Y$$$20240816$$MD$CA$CA
242150912$24215091$2$F$$20240827$20240816$20240902$PER$$US-AMGEN-USASP2024161757$AMGEN$Topilow N.J.; Penteado R.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024;1-6$$$$$Y$$$20240902$$MD$US$US
242150921$24215092$1$I$20240101$20240812$20240816$20240816$EXP$$US-ABBVIE-5818028$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242150931$24215093$1$I$$20240815$20240816$20240816$PER$$NVSC2024US165705$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242150952$24215095$2$F$20240701$20240819$20240816$20240826$EXP$$US-ABBVIE-5879948$ABBVIE$$74$YR$$F$Y$88.451$KG$20240826$$CN$US$US
242150961$24215096$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A180912$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242150972$24215097$2$F$$20240905$20240816$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003885$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242150981$24215098$1$I$20240808$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007286$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240816$$CN$US$US
242150991$24215099$1$I$$20240807$20240816$20240816$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000287$EMCURE$LeSaint KT, Kendric KJ, Logan AA.. Successful administration of extended-release buprenorphine in the emergency department. American Journal of Emergency Medicine. 2024;S0735-6757(24):00368-1$38$YR$$M$Y$$$20240816$$MD$US$US
242151001$24215100$1$I$$20240813$20240816$20240816$PER$$US-ABBVIE-5880713$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242151011$24215101$1$I$20240101$20240809$20240816$20240816$EXP$$US-ABBVIE-5875806$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242151021$24215102$1$I$20240101$20240813$20240816$20240816$EXP$$US-ABBVIE-5879585$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242151031$24215103$1$I$$20240807$20240816$20240816$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000286$EMCURE$Kim M, Graham C, Stevens RW, Shah A.. A Rare Case of Bacterial Meningitis Caused by Hematogenous Spread of Vancomycin-Resistant Enterococcus faecium in an Immunocompromised Patient. Case Rep Infect Dis.. 2024;2193650$72$YR$$M$Y$$$20240816$$HP$US$US
242151041$24215104$1$I$20240101$20240813$20240816$20240816$EXP$$US-ABBVIE-5880135$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242151052$24215105$2$F$20240401$20240822$20240816$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003126$ACADIA PHARMACEUTICALS$$19$YR$$F$Y$42.993$KG$20240913$$CN$US$US
242151062$24215106$2$F$20240808$20240816$20240816$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003890$ACADIA PHARMACEUTICALS$$96$YR$$M$Y$$$20240830$$CN$US$US
242151071$24215107$1$I$$20240813$20240816$20240816$EXP$$US-ABBVIE-5880023$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242151081$24215108$1$I$$20240812$20240816$20240816$EXP$$US-ABBVIE-5878377$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242151091$24215109$1$I$20240101$20240812$20240816$20240816$EXP$$US-ABBVIE-5878169$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242151102$24215110$2$F$20240813$20240814$20240816$20240816$EXP$$US-ABBVIE-5881884$ABBVIE$$89$YR$$F$Y$$$20240816$$CN$US$US
242151111$24215111$1$I$20230909$20240809$20240816$20240816$EXP$$FR-JAZZ PHARMACEUTICALS-2023-FR-019499$JAZZ$$$$$$Y$$$20240815$$MD$FR$FR
242151121$24215112$1$I$$20240715$20240816$20240816$EXP$$NG-ROCHE-10000030298$ROCHE$$$$A$$Y$$$20240816$$CN$NG$NG
242151131$24215113$1$I$$20240808$20240816$20240816$30DAY$$US-GSK-US2024099151$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242151141$24215114$1$I$$20240805$20240816$20240816$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-125120$BRISTOL MYERS SQUIBB$Joseph S, Wang A, Leow K, Rao A, Khaw J, Sathinathan D, et al. Myocarditis and complete heart block: a rare complication of immune checkpoint inhibitor therapy-a case report. Heart Lung and Circulation. 2024 Aug 01;33(Supplement 4):S302-3.doi:10.1016/j.hlc.2024.06.385.$76$YR$E$M$Y$$$20240816$$HP$AU$AU
242151151$24215115$1$I$$20240814$20240816$20240816$EXP$$US-ABBVIE-5881976$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242151161$24215116$1$I$$20240801$20240816$20240816$EXP$$CA-AUROBINDO-AUR-APL-2024-039959$AUROBINDO$$40$YR$$F$Y$$$20240816$$CN$CA$CA
242151173$24215117$3$F$$20240905$20240816$20240918$PER$$NVSC2024US165418$NOVARTIS$$35$YR$$F$Y$53.968$KG$20240918$$CN$US$US
242151181$24215118$1$I$20220213$20240806$20240816$20240816$EXP$$DE-EMD Serono-2024042822$EMD SERONO INC$$58$YR$A$M$Y$71$KG$20240816$$CN$DE$DE
242151193$24215119$3$F$$20240826$20240816$20240830$EXP$$JP-ABBVIE-5878257$ABBVIE$$57$YR$$F$Y$$$20240829$$MD$JP$JP
242151202$24215120$2$F$20240101$20240912$20240816$20240920$EXP$$CN-ARGENX-2024-ARGX-CN006205$ARGENX BVBA$$$$$$Y$$$20240920$$CN$CN$CN
242151211$24215121$1$I$$20240809$20240816$20240816$PER$$US-ABBVIE-5876617$ABBVIE$$$$$$Y$$$20240816$$HP$US$US
242151221$24215122$1$I$$20240808$20240816$20240816$EXP$$US-AMGEN-USASP2024159275$AMGEN$$$$$$Y$$$20240815$$PH$US$US
242151232$24215123$2$F$20240706$20240802$20240816$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039219$AUROBINDO$$22$YR$$F$Y$37$KG$20240817$$PH$GB$GB
242151241$24215124$1$I$20240801$20240815$20240816$20240816$PER$$NVSC2024US165722$NOVARTIS$$67$YR$$F$Y$$$20240816$$PH$US$US
242151252$24215125$2$F$$20240903$20240816$20240904$PER$$NVSC2024US165386$NOVARTIS$$$$$M$Y$$$20240904$$CN$US$US
242151262$24215126$2$F$$20240917$20240816$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202408004764$ELI LILLY AND CO$$$$E$F$Y$64.853$KG$20240927$$CN$US$US
242151271$24215127$1$I$$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408004995$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240816$$CN$US$US
242151281$24215128$1$I$$20240806$20240816$20240816$EXP$$JP-AMGEN-JPNSP2024162120$AMGEN$$$$$$Y$$$20240815$$HP$JP$JP
242151292$24215129$2$F$$20240816$20240816$20240822$PER$$US-HALEON-2192114$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242151301$24215130$1$I$20240328$20240806$20240816$20240816$EXP$$GB-ROCHE-10000050274$ROCHE$$73$YR$E$F$Y$$$20240816$$MD$GB$GB
242151311$24215131$1$I$20240731$20240731$20240816$20240816$PER$$US-TEVA-VS-3228755$TEVA$$$$$M$Y$$$20240816$$CN$US$US
242151321$24215132$1$I$20230725$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408061858097280-HTJRZ$GB-TEVA-VS-3231338$TEVA$$30$YR$$F$Y$$$20240816$$MD$GB$GB
242151331$24215133$1$I$$20240809$20240816$20240816$EXP$$FR-HALEON-2191792$Haleon PLC$$64$YR$$F$Y$$$20240814$$MD$FR$FR
242151342$24215134$2$F$$20240822$20240816$20240825$PER$$US-HALEON-2192072$Haleon PLC$$$$A$F$Y$$$20240825$$CN$US$US
242151351$24215135$1$I$$20240814$20240816$20240816$PER$$US-HALEON-2192111$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242151361$24215136$1$I$$20240808$20240816$20240816$PER$$US-AMGEN-USASP2024158725$AMGEN$$$$$$Y$$$20240815$$PH$US$US
242151371$24215137$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165686$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
242151381$24215138$1$I$$20240809$20240816$20240816$EXP$$JP-CHEPLA-2024010563$CHEPLAPHARM$$62$YR$$F$Y$$$20240815$$PH$COUNTRY NOT SPECIFIED$JP
242151391$24215139$1$I$$20240808$20240816$20240816$EXP$$US-CHEPLA-2024010427$CHEPLAPHARM$$$$$M$Y$$$20240815$$CN$COUNTRY NOT SPECIFIED$US
242151401$24215140$1$I$20230123$20240808$20240816$20240816$EXP$CH-SM-2023-10791$CH-CHEPLA-2023001765$CHEPLAPHARM$$65$YR$E$M$Y$$$20240815$$MD$COUNTRY NOT SPECIFIED$CH
242151411$24215141$1$I$$20240814$20240816$20240816$PER$$US-HALEON-2192051$Haleon PLC$$$$$F$Y$$$20240816$$CN$US$US
242151422$24215142$2$F$$20240802$20240816$20240817$EXP$$CA-AUROBINDO-AUR-APL-2024-040078$AUROBINDO$$57$YR$$F$Y$91$KG$20240817$$HP$CA$CA
242151432$24215143$2$F$20230101$20240814$20240816$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-024789$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240820$$$US$US
242151441$24215144$1$I$$20240813$20240816$20240816$PER$$US-ROCHE-10000057532$ROCHE$$81$YR$E$M$Y$$$20240816$$HP$US$US
242151451$24215145$1$I$$20240809$20240816$20240816$EXP$$ES-AMGEN-ESPSP2024159803$AMGEN$Navas-lopez V.; Pujol-muncunill G.; Ledder O. et al.. STEP-CD study: ustekinumab use in paediatric Crohn^s disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN. European Journal of Pediatrics. 2024;183 (8):3253-3262$$$$$Y$$$20240815$$HP$ES$ES
242151461$24215146$1$I$20240806$20240808$20240816$20240816$30DAY$$IT-SANDOZ INC.-SDZ2024IT072669$SANDOZ$$75$YR$$M$Y$78$KG$20240816$$CN$IT$IT
242151481$24215148$1$I$$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A185234$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242151491$24215149$1$I$$20230725$20240816$20240816$EXP$$US-AstraZeneca-2023A135885$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242151502$24215150$2$F$20230816$20240802$20240816$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-039599$AUROBINDO$$33$YR$$F$Y$90$KG$20240817$$HP$FR$FR
242151511$24215151$1$I$$20240812$20240816$20240816$EXP$$IN-BRISTOL-MYERS SQUIBB COMPANY-2024-129352$BRISTOL MYERS SQUIBB$$$$$M$Y$64$KG$20240816$$MD$IN$IN
242151521$24215152$1$I$20190315$20240808$20240816$20240816$EXP$$CA-TAKEDA-2024TUS080333$TAKEDA$$31$YR$$F$Y$$$20240816$$MD$CA$CA
242151532$24215153$2$F$20060101$20240813$20240816$20240819$PER$$NVSC2024US164653$NOVARTIS$$30$YR$$F$Y$$$20240819$$CN$US$US
242151542$24215154$2$F$$20240809$20240816$20240821$EXP$$JP-VALIDUS PHARMACEUTICALS LLC-JP-VDP-2024-019354$VALIDUS$Sodemoto K, Kita S. A case of Lichen planus Pemphigoides in which drug eruption lichen planus-like preceded. Rinsho Derma (Tokyo). 2024;66:1109-12$$$$$Y$$$20240821$$MD$JP$JP
242151552$24215155$2$F$$20240802$20240816$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-039589$AUROBINDO$Liu W, He Q, He Y.. Analysis of clinical characteristics of tramadol induced hypoglycaemia.. Chin J Clin Pharmacol Ther.. 2024;29(7):819-825$33$YR$$M$Y$$$20240817$$HP$FR$FR
242151561$24215156$1$I$$20240805$20240816$20240816$EXP$$US-NOVOPROD-1266661$NOVO NORDISK$$$$$F$Y$$$20240816$$MD$US$US
242151571$24215157$1$I$20240508$20240805$20240816$20240816$EXP$$AR-NOVOPROD-1266783$NOVO NORDISK$$$$$F$Y$$$20240816$$CN$AR$AR
242151581$24215158$1$I$$20240725$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119000$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240816$$CN$US$US
242151591$24215159$1$I$$20240813$20240816$20240816$EXP$$CA-TAKEDA-2024TUS081886$TAKEDA$$$$$F$Y$$$20240816$$MD$CA$CA
242151602$24215160$2$F$20230905$20240829$20240816$20240909$EXP$$JP-NOVOPROD-1113489$NOVO NORDISK$H.Suenaga et al. A non-diabetic patient took an excessive amount of oral semaglutide. The 252nd Tokai Regional Meeting of the Japanese Society of Internal Medicine. 2024;P5$29$YR$$F$Y$51$KG$20240909$$MD$JP$JP
242151611$24215161$1$I$$20240805$20240816$20240816$EXP$$US-NOVOPROD-1267433$NOVO NORDISK$$50$YR$$$Y$$$20240816$$CN$US$US
242151623$24215162$3$F$20240804$20240913$20240816$20240924$EXP$$MX-NOVOPROD-1266438$NOVO NORDISK$$68$YR$$M$Y$75$KG$20240924$$CN$MX$MX
242151641$24215164$1$I$$20240805$20240816$20240816$EXP$$US-NOVOPROD-1267357$NOVO NORDISK$$$$$M$Y$$$20240816$$CN$US$US
242151651$24215165$1$I$$20240805$20240816$20240816$EXP$$US-NOVOPROD-1266880$NOVO NORDISK$Santiago F. Galeano Lovera. Semaglutide-Induced Hepatotoxicity: A Rare Case of Drug Induced Liver Injury. The American Journal of GASTROENTEROLOGY. 2023;118$67$YR$$F$Y$$$20240816$$MD$US$US
242151661$24215166$1$I$$20240805$20240816$20240816$EXP$$KR-NOVOPROD-1267494$NOVO NORDISK$Hong Jun Kim. Severe acquired hemophilia A associated with COVID-19 vaccination: A case report and literature review. Medicine. 2024$56$YR$$M$Y$$$20240816$$HP$KR$KR
242151671$24215167$1$I$$20240805$20240816$20240816$EXP$$US-NOVOPROD-1267228$NOVO NORDISK$$$$$$Y$$$20240816$$CN$US$US
242151681$24215168$1$I$20240804$20240805$20240816$20240816$EXP$$AR-NOVOPROD-1266657$NOVO NORDISK$$$$$F$Y$$$20240816$$CN$AR$AR
242151691$24215169$1$I$$20240805$20240816$20240816$EXP$$NL-NOVOPROD-1267395$NOVO NORDISK$$$$$F$Y$$$20240816$$PH$NL$NL
242151711$24215171$1$I$20240101$20240805$20240816$20240816$EXP$$CO-NOVOPROD-1267107$NOVO NORDISK$$53$YR$$F$Y$103$KG$20240816$$CN$CO$CO
242151721$24215172$1$I$20240618$20240805$20240816$20240816$EXP$$US-NOVOPROD-1266143$NOVO NORDISK$$71$YR$$M$Y$$$20240816$$CN$US$US
242151731$24215173$1$I$$20240805$20240816$20240816$EXP$$GB-NOVOPROD-1265095$NOVO NORDISK$$48$YR$$F$Y$89$KG$20240816$$PH$GB$GB
242151741$24215174$1$I$20230101$20240805$20240816$20240816$EXP$$CO-NOVOPROD-1266562$NOVO NORDISK$$45$YR$$F$Y$98$KG$20240816$$CN$CO$CO
242151751$24215175$1$I$$20240805$20240816$20240816$EXP$GB-MHRA-MED-202408051221595250-HJBND$GB-NOVOPROD-1265181$NOVO NORDISK$$$$$F$Y$$$20240816$$HP$GB$GB
242151762$24215176$2$F$$20240822$20240816$20240902$EXP$$SK-NOVOPROD-1266439$NOVO NORDISK$$45$YR$$M$Y$150$KG$20240902$$CN$SK$SK
242151771$24215177$1$I$$20240805$20240816$20240816$EXP$$US-NOVOPROD-1267538$NOVO NORDISK$$$$$F$Y$$$20240816$$CN$US$US
242151792$24215179$2$F$20230401$20240820$20240816$20240830$EXP$$CN-NOVOPROD-1266144$NOVO NORDISK$$48$YR$$F$Y$60$KG$20240830$$CN$CN$CN
242151802$24215180$2$F$$20240917$20240816$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202408004829$ELI LILLY AND CO$$$$E$F$Y$$$20240927$$CN$US$US
242151812$24215181$2$F$$20240815$20240816$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408007588$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240819$$CN$US$US
242151821$24215182$1$I$$20240806$20240816$20240816$EXP$$US-SANDOZ INC.-SDZ2024US072352$SANDOZ$$$$$$Y$$$20240816$$HP$US$US
242151831$24215183$1$I$20240601$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008052$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240816$$CN$US$US
242151841$24215184$1$I$20230801$20240804$20240816$20240816$EXP$$GB-IHL-000600$INVENTIA HEALTHCARE$$26$YR$A$F$Y$$$20240807$$HP$GB$GB
242151852$24215185$2$F$20240101$20240814$20240816$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-024841$UNITED THERAPEUTICS$$$$$F$Y$70.295$KG$20240822$$$US$US
242151861$24215186$1$I$20190101$20240804$20240816$20240816$EXP$$UA-IHL-000598$INVENTIA HEALTHCARE$$27$YR$A$F$Y$$$20240806$$HP$UA$UA
242151871$24215187$1$I$$20240813$20240816$20240816$PER$$US-ABBVIE-5880988$ABBVIE$$38$YR$$F$Y$$$20240816$$HP$US$US
242151881$24215188$1$I$$20240813$20240816$20240816$PER$$US-ABBVIE-5882159$ABBVIE$$$$$M$Y$$$20240816$$HP$US$US
242151891$24215189$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165713$NOVARTIS$$$$$M$Y$$$20240816$$CN$US$US
242151901$24215190$1$I$20240723$20240802$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-039059$AUROBINDO$$87$YR$$F$Y$80$KG$20240816$$MD$FR$FR
242151911$24215191$1$I$$20240814$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072708$SANDOZ$$$$$$Y$$$20240816$$HP$CA$CA
242151921$24215192$1$I$$20240812$20240816$20240816$EXP$$US-VIIV HEALTHCARE LIMITED-US2024100263$VIIV$$$$$M$Y$$$20240816$$CN$US$US
242151931$24215193$1$I$$20240813$20240816$20240816$EXP$$CA-TAKEDA-2024TUS081718$TAKEDA$$$$$F$Y$$$20240816$$CN$CA$CA
242151942$24215194$2$F$$20240816$20240816$20240819$PER$$NVSC2024US165763$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242151952$24215195$2$F$20240904$20240904$20240816$20240906$EXP$$CA-TAKEDA-2024TUS081885$TAKEDA$$23$YR$$M$Y$$$20240906$$CN$CA$CA
242151961$24215196$1$I$$20240815$20240816$20240816$PER$$NVSC2024US165756$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242151971$24215197$1$I$20240713$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A185547$ASTRAZENECA$$$$$$Y$$$20240816$$MD$US$
242151981$24215198$1$I$$20231125$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2023SP018019$STRIDES$Agoubi LL, Khot SP, Failor RA, Zern NK.. Pheochromocytoma-induced Subarachnoid and Intracerebral Hemorrhage.. J-Endocr-Soc. 2023;7(1):1-4.$63$YR$$F$Y$$$20240816$$MD$US$US
242151991$24215199$1$I$$20240403$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004213$STRIDES$Agrawal A, Kandah F, Mahowald M.. ACUTE PANCREATITIS SECONDARY TO LISINOPRIL USE.. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):3179$55$YR$$F$Y$$$20240816$$HP$US$US
242152001$24215200$1$I$$20231019$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016149$STRIDES$GRIES J, HELLINGS A, PIMENTEL E, LONG JL.. REFRACTORY HYPOTENSION FROM TOXIC INGESTION OF ACE-INHIBITOR AND DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKER TREATED WITH ANGIOTENSIN II.. Chest. 2023;164(Suppl.)(4):A2146-A2147 (plus poster)$54$YR$$F$Y$$$20240816$$HP$US$US
242152011$24215201$1$I$$20240229$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2023SP012753$STRIDES$Ravichander B, Sangha L, Guzman A, Ibarra M, Mishagina I.. The role of fresh frozen plasma in treatment refractory angioedema secondary to angiotensin converting enzyme inhibitor.. J-Gen-Intern-Med. 2023;38(2):S550-S551$50$YR$$F$Y$$$20240816$$HP$US$US
242152022$24215202$2$F$$20240827$20240816$20240903$EXP$$CA-JNJFOC-20240834224$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240903$$CN$CA$CA
242152031$24215203$1$I$$20240729$20240816$20240816$EXP$$US-SINTETICA US LLC-US-SIN-2024-00010$Sintetica$Martin RD, Scanlon M, McCabe K.. Lidocaine-Associated CNS Toxicity at Therapeutic Dosage: A Case Report and Literature Review.. Cureus.. 2024;16(6):e62231.$47$YR$$M$Y$133.9$KG$20240808$$MD$US$US
242152041$24215204$1$I$$20240802$20240816$20240816$EXP$$CA-AUROBINDO-AUR-APL-2024-040442$AUROBINDO$$84$YR$$M$Y$$$20240816$$HP$CA$CA
242152052$24215205$2$F$20240101$20240820$20240816$20240823$PER$$US-AMGEN-USASP2024159903$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242152061$24215206$1$I$20240301$20240807$20240816$20240816$EXP$FR-AFSSAPS-BX2024001576$FR-EMD Serono-2024042655$EMD SERONO INC$$53$YR$A$F$Y$$$20240816$$MD$FR$FR
242152071$24215207$1$I$20240325$20240529$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006413$STRIDES$$57$YR$$F$Y$169.62$KG$20240816$$MD$US$US
242152081$24215208$1$I$20240617$20240813$20240816$20240816$EXP$ES-AEMPS-1560621$ES-ORGANON-O2408ESP000991$ORGANON$$78$YR$$M$Y$$$20240816$$MD$ES$ES
242152091$24215209$1$I$20240201$20240802$20240816$20240816$EXP$$US-BEH-2024176798$CSL BEHRING$$44$YR$A$F$Y$$$20240816$$HP$US$US
242152102$24215210$2$F$20240803$20240819$20240816$20240823$EXP$$IT-ABBVIE-5879996$ABBVIE$$83$YR$$F$Y$$$20240823$$HP$IT$IT
242152111$24215211$1$I$$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003929$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242152131$24215213$1$I$$20240814$20240816$20240816$EXP$$BR-ROCHE-10000058588$ROCHE$$$$$M$Y$$$20240816$$CN$BR$BR
242152141$24215214$1$I$20240728$20240811$20240816$20240816$EXP$$SA-SANDOZ INC.-SDZ2024SA072305$SANDOZ$$8$YR$$M$Y$$$20240816$$CN$SA$SA
242152151$24215215$1$I$$20240812$20240816$20240816$PER$$US-ROCHE-10000055891$ROCHE$$$$$$Y$$$20240816$$HP$US$US
242152161$24215216$1$I$$20240812$20240816$20240816$PER$$US-ROCHE-10000056371$ROCHE$$$$E$F$Y$$$20240816$$CN$US$US
242152171$24215217$1$I$$20240812$20240816$20240816$PER$$US-ROCHE-10000055413$ROCHE$$70$YR$E$F$Y$$$20240816$$CN$US$US
242152181$24215218$1$I$$20240813$20240816$20240816$PER$$NVSC2024US165188$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
242152191$24215219$1$I$$20240807$20240816$20240816$EXP$$TW-JNJFOC-20240818793$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240816$$CN$TW$TW
242152201$24215220$1$I$$20240812$20240816$20240816$EXP$$US-AMGEN-USASP2024161272$AMGEN$$$$A$M$Y$$$20240815$$CN$US$US
242152211$24215221$1$I$20240709$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024161265$AMGEN$$$$$$Y$$$20240815$$HP$US$US
242152221$24215222$1$I$$20240813$20240816$20240816$PER$$US-ROCHE-10000057663$ROCHE$$52$YR$A$F$Y$$$20240816$$CN$US$US
242152231$24215223$1$I$$20240812$20240816$20240816$EXP$$US-ABBVIE-5878623$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242152251$24215225$1$I$20240101$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160013$AMGEN$$$$$F$Y$$$20240815$$CN$US$US
242152261$24215226$1$I$20240801$20240813$20240816$20240816$EXP$$US-ABBVIE-5880231$ABBVIE$$62$YR$$M$Y$$$20240816$$CN$US$US
242152271$24215227$1$I$$20240814$20240816$20240816$EXP$$GB-JNJFOC-20240836870$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$GB$GB
242152281$24215228$1$I$$20240813$20240816$20240816$PER$$US-JNJFOC-20240832412$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$US$US
242152291$24215229$1$I$20240805$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024810$UNITED THERAPEUTICS$$$$$$Y$$$20240816$$$US$US
242152301$24215230$1$I$$20240724$20240816$20240816$PER$$US-AstraZeneca-2024A168961$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242152311$24215231$1$I$$20240807$20240816$20240816$EXP$$SA-STRIDES ARCOLAB LIMITED-2024SP010029$STRIDES$Mirza A, Alsufyani K, Khojah A.. 75 Fatal CMV infection in a 2-month-old Infant with STAT1 Loss of Function Mutation.. Clin-Immunol. 2024;262 (Suppl.)$2$MON$$F$Y$$$20240816$$HP$SA$SA
242152321$24215232$1$I$$20240812$20240816$20240816$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001619$BLUEPRINT MEDICINES$$$$$F$Y$$$20240816$$CN$US$US
242152334$24215233$4$F$$20240926$20240816$20240930$PER$$NVSC2024US165360$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
242152341$24215234$1$I$20240805$20240806$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005063$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$US$US
242152351$24215235$1$I$20240101$20240805$20240816$20240816$EXP$$CA-AMGEN-CANNI2024162100$AMGEN$$$$$M$Y$$$20240815$$HP$CA$CA
242152361$24215236$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007175$ELI LILLY AND CO$$39$YR$A$$Y$$$20240816$$LW$US$US
242152371$24215237$1$I$$20240804$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408002911$ELI LILLY AND CO$$56$YR$A$$Y$$$20240816$$LW$US$US
242152381$24215238$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008343$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240816$$CN$US$US
242152391$24215239$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008338$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242152402$24215240$2$F$20240702$20240821$20240816$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008156$ELI LILLY AND CO$$9$YR$C$M$Y$40.8$KG$20240826$$CN$US$US
242152411$24215241$1$I$$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408006515$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240816$$CN$US$US
242152421$24215242$1$I$20240730$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008341$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242152431$24215243$1$I$$20240807$20240816$20240816$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010227$STRIDES$Gold A, Yesudian PD.. Lung toxicity with Methotrexate: fact or fiction?. Br-J-Dermatol. 2024;192 (Suppl.):i153$$$$$Y$$$20240816$$HP$GB$GB
242152441$24215244$1$I$20230316$20240808$20240816$20240816$EXP$$BR-NOVITIUMPHARMA-2024BRNVP01597$NOVITIUM PHARMA$Roxana Flores Mamani.Severe esophagitis induced by antituberculosis drugs: a case report.Revista do Instituto de Medicina Tropical de Sao Paulo.05-JAN-2024;66:1-4$56$YR$A$F$Y$49$KG$20240816$$HP$BR$BR
242152452$24215245$2$F$$20230706$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2023SP011340$STRIDES$Gerhartz B, Damodharan S, Capitini C.. THE USE OF MILRINONE TO SUPPORT A PEDIATRIC PATIENT WITH HR-AML AND HEART FAILURE THROUGH HSCT.. Pediatr-Blood-Cancer. 2023;70(Suppl.3):No pagination$12$YR$$F$Y$$$20240816$$HP$US$US
242152462$24215246$2$F$$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024807$UNITED THERAPEUTICS$$$$$M$Y$$$20240816$$$US$US
242152471$24215247$1$I$$20240807$20240816$20240816$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010200$STRIDES$Teoh YP, Gold A, Yesudian PD.. Fats and figures: how abnormal lipids unravel the truth.. Br-J-Dermatol. 2024;191 (Suppl. 1):i127-i128 abstr. PA12.$22$YR$$M$Y$$$20240816$$HP$GB$GB
242152481$24215248$1$I$20240101$20240807$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024796$UNITED THERAPEUTICS$$$$$F$Y$46.712$KG$20240816$$$US$US
242152492$24215249$2$F$20240813$20240814$20240816$20240821$PER$$US-AMGEN-USASP2024161631$AMGEN$$64$YR$A$M$Y$$$20240821$$CN$US$US
242152502$24215250$2$F$$20240827$20240816$20240829$EXP$$PL-SANDOZ INC.-NVSC2020PL009716$SANDOZ$$34$YR$$F$Y$$$20240829$$MD$PL$PL
242152511$24215251$1$I$$20240807$20240816$20240816$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP010201$STRIDES$Cuomo G, Menozzi M, Albertini M, Todisco V, Gozzi L, Martini E, et al.. EVALUATING TOLERANCE AND SAFETY PROFILES OF PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV: INSIGHTS FROM RENAL AND HEPATIC FUNCTION MONITORING.. Sex-Transmit-Infect. 2024;100 (Suppl. 1):A250-A251 abstr. P-178.$$$A$$Y$$$20240816$$HP$IT$IT
242152522$24215252$2$F$$20240110$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000540$STRIDES$Adly H, O^Donnell BM, Kirschner LS. Parotid Carcinoma Ex Pleomorphic Adenoma Can Produce Ectopic ACTH Too.. J-Endocr-Soc. 2020;4 (Suppl. 1):A400 abstr. SAT-213.$41$YR$$M$Y$$$20240816$$MD$US$US
242152531$24215253$1$I$20210324$20240802$20240816$20240816$EXP$$FR-SERVIER-S24009827$SERVIER$$$$$$Y$$$20240816$$MD$FR$FR
242152541$24215254$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128352$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240816$$MD$US$US
242152552$24215255$2$F$20240801$20240904$20240816$20240905$PER$$US-AMGEN-USASP2024160018$AMGEN$$43$YR$A$F$Y$$$20240905$$CN$US$US
242152561$24215256$1$I$$20240807$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010208$STRIDES$Zayat N, Arora A, O^Brien J, Bal J, Sugarman R, Rivera L, et al.. Pregnancy-Associated Onset of Adult-Onset Still^s Disease.. AJP-Rep. 2024;14 (2):E145-E155.$29$YR$$F$Y$$$20240816$$MD$US$US
242152571$24215257$1$I$$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003936$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$HP$US$US
242152581$24215258$1$I$$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003939$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242152601$24215260$1$I$$20240805$20240816$20240816$EXP$$US-NOVOPROD-1267666$NOVO NORDISK$$61$YR$$$Y$$$20240816$$CN$US$US
242152611$24215261$1$I$$20240805$20240816$20240816$EXP$$US-NOVOPROD-1267665$NOVO NORDISK$$55$YR$$$Y$$$20240816$$CN$US$US
242152621$24215262$1$I$$20240812$20240816$20240816$PER$$US-CHATTEMPRD-2024OHG027181$CHATTEM$$$$$M$Y$$$20240816$$CN$US$US
242152631$24215263$1$I$$20240812$20240816$20240816$PER$$US-CHATTEMPRD-2024OHG027240$CHATTEM$$$$$F$Y$$$20240816$$CN$US$US
242152641$24215264$1$I$$20240802$20240816$20240816$EXP$$GR-AZURITY PHARMACEUTICALS, INC.-AZR202408-000259$AZURITY PHARMACEUTICALS$Vasilopoulou A, Spaho M, Theotokis P, Grekou A, Meditskou S, Manthou ME.. Fatal misdiagnosis of progressive disseminated histoplasmosis. Med. Mycol. Case Rep. 2024;45:1-4$$$A$M$Y$$$20240813$$HP$GR$GR
242152651$24215265$1$I$20240723$20240724$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003940$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240816$$CN$US$US
242152661$24215266$1$I$$20240807$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010209$STRIDES$Zayat N, Arora A, O^Brien J, Bal J, Sugarman R, Rivera L, et al.. Pregnancy-Associated Onset of Adult-Onset Still^s Disease.. AJP-Rep. 2024;14 (2):E145-E155$$$$$Y$$$20240816$$MD$US$US
242152671$24215267$1$I$$20240807$20240816$20240816$EXP$$US-NOVOPROD-1268932$NOVO NORDISK$$55$YR$$$Y$$$20240816$$CN$US$US
242152681$24215268$1$I$$20240805$20240816$20240816$EXP$$US-NOVOPROD-1268119$NOVO NORDISK$$$$$F$Y$$$20240816$$MD$US$US
242152691$24215269$1$I$$20240814$20240816$20240816$PER$$US-HALEON-2192062$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242152701$24215270$1$I$$20240805$20240816$20240816$EXP$$TR-NOVOPROD-1268286$NOVO NORDISK$$$$$M$Y$$$20240816$$CN$TR$TR
242152711$24215271$1$I$$20240805$20240816$20240816$EXP$$US-NOVOPROD-1268171$NOVO NORDISK$$$$$$Y$$$20240816$$CN$US$US
242152722$24215272$2$F$$20240826$20240816$20240905$EXP$$US-NOVOPROD-1267707$NOVO NORDISK$$$$$M$Y$$$20240905$$CN$US$US
242152731$24215273$1$I$$20240805$20240816$20240816$EXP$$US-NOVOPROD-1268214$NOVO NORDISK$$59$YR$$$Y$$$20240816$$CN$US$US
242152741$24215274$1$I$20240802$20240806$20240816$20240816$EXP$$US-NOVOPROD-1266138$NOVO NORDISK$$79$YR$$M$Y$$$20240816$$CN$US$US
242152751$24215275$1$I$20240701$20240806$20240816$20240816$EXP$$US-NOVOPROD-1266194$NOVO NORDISK$$75$YR$$F$Y$$$20240816$$CN$US$US
242152761$24215276$1$I$$20240805$20240816$20240816$EXP$$JP-NOVOPROD-1268923$NOVO NORDISK$Reisuke Saeki, et al.. Euglycaemic diabetic ketoacidosis occurred extremely early after introduction of SGLT2 inhibitor. The 252nd Tokai Regional Meeting of the Japanese Society of Internal Medicine. 2024;1$50$YR$$F$Y$57.7$KG$20240816$$MD$JP$JP
242152771$24215277$1$I$$20240805$20240816$20240816$EXP$$TR-NOVOPROD-1268947$NOVO NORDISK$$$$$M$Y$$$20240816$$CN$TR$TR
242152781$24215278$1$I$$20240805$20240816$20240816$EXP$$US-NOVOPROD-1267951$NOVO NORDISK$$49$YR$$$Y$$$20240816$$CN$US$US
242152791$24215279$1$I$$20240806$20240816$20240816$EXP$$US-NOVOPROD-1268894$NOVO NORDISK$$50$YR$$$Y$$$20240816$$CN$US$US
242152802$24215280$2$F$20240122$20240826$20240816$20240909$EXP$$JP-NOVOPROD-1268877$NOVO NORDISK$R. Shimode et al.. A patient with hypoglycaemic encephalopathy who had a wide range of abnormal signals in MRI. The 252nd Tokai Regional Meeting of the Japanese Society of Internal Medicine. 2024;36$78$YR$$F$Y$$$20240909$$MD$JP$JP
242152811$24215281$1$I$$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003942$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242152823$24215282$3$F$$20240910$20240816$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003941$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
242152831$24215283$1$I$20240501$20240813$20240816$20240816$EXP$SE-SEMPA-2024-005998$SE-SANDOZ INC.-SDZ2024SE072459$SANDOZ$$67$YR$$F$Y$$$20240816$$MD$SE$SE
242152841$24215284$1$I$$20240806$20240816$20240816$30DAY$$US-GSK-US2024098042$GLAXOSMITHKLINE$$$$$M$Y$$$20240816$$CN$US$US
242152851$24215285$1$I$$20240813$20240816$20240816$EXP$$US-JNJFOC-20240836042$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$HP$US$US
242152861$24215286$1$I$$20240813$20240816$20240816$EXP$$GB-JNJFOC-20240836526$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$HP$GB$GB
242152871$24215287$1$I$$20240807$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010210$STRIDES$Shah P, Rao P.. Tacrolimus-Induced Pericardial Effusion.. South-Med-J. 2023;116 (1):68-69 (plus Poster).$75$YR$$M$Y$$$20240816$$HP$US$US
242152881$24215288$1$I$20240702$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A183851$ASTRAZENECA$$29828$DY$$F$Y$$$20240816$$MD$US$
242152891$24215289$1$I$20240601$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003944$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240816$$CN$US$US
242152901$24215290$1$I$20240712$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408061930558780-YCLPJ$GB-TEVA-VS-3231039$TEVA$$72$YR$$F$Y$76$KG$20240816$$CN$GB$GB
242152911$24215291$1$I$$20240214$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002135$STRIDES$Kundu S, Mehra I, Stevasarova A, Mozafarian M, Adyanthaya S, Chahal K.. GLP-1 Analogue induced AKI.. South-Med-J. 2022;115:530-531$57$YR$$F$Y$$$20240816$$MD$US$US
242152921$24215292$1$I$$20231130$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2023SP018287$STRIDES$Gunaratne NC, Deplewski D.. Unique Considerations For Workup And Management Of An 11 Year Old Male With Concern For A Neuroendocrine Tumor.. J-Endocr-Soc. 2023;7 (Suppl. 1):A804 abstr. FRI601$11$YR$$M$Y$$$20240816$$MD$US$US
242152931$24215293$1$I$$20240807$20240816$20240816$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP010207$STRIDES$Abbott M, Valenti G, Gizzi A, Agrenzano S, Ficalora A, Mancuso A, et al.. HBV REACTIVATION AFTER IMMUNOSUPPRESSIVE THERAPY: AN OPEN QUESTION.. Sex-Transmit-Infect. 2024;100 (Suppl. 1):A271 abstr. P-213$71$YR$$M$Y$$$20240816$$HP$IT$IT
242152941$24215294$1$I$$20240809$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128263$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240816$$HP$US$US
242152951$24215295$1$I$$20240112$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000575$STRIDES$Patel K, Singh V, Bissonette A.. A Combination of Beta-Blockade and Calcium Channel Blockade Leading to Bradycardia, Renal Failure, Atrioventricular Blockade, Shock, and Hyperkalemia (BRASH) Syndrome: A Case Report.. Cureus. 2023;15(6):e40176$56$YR$$F$Y$$$20240816$$HP$US$US
242152961$24215296$1$I$$20240813$20240816$20240816$EXP$$US-JNJFOC-20240833856$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240816$$CN$US$US
242152971$24215297$1$I$20240814$20240814$20240816$20240816$PER$$NVSC2024US165699$NOVARTIS$$60$YR$$F$Y$113.38$KG$20240816$$CN$US$US
242152983$24215298$3$F$$20240917$20240816$20240925$EXP$$CA-JNJFOC-20240834314$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240925$$HP$CA$CA
242152994$24215299$4$F$20240625$20240828$20240816$20240910$PER$$US-AMGEN-USASP2024154506$AMGEN$$47$YR$A$F$Y$$$20240909$$HP$US$US
242153003$24215300$3$F$$20240815$20240816$20240820$PER$$NVSC2024US165487$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242153012$24215301$2$F$$20240816$20240816$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003943$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
242153022$24215302$2$F$$20240820$20240816$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003945$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
242153032$24215303$2$F$20240813$20240904$20240816$20240907$PER$$US-AMGEN-USASP2024161957$AMGEN$$57$YR$A$F$Y$$$20240907$$CN$US$US
242153042$24215304$2$F$$20240917$20240816$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202408004893$ELI LILLY AND CO$$$$E$F$Y$64.853$KG$20240927$$CN$US$US
242153051$24215305$1$I$$20240809$20240816$20240816$EXP$$US-GSK-US2024AMR099497$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$US$US
242153061$24215306$1$I$$20240808$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010139$STRIDES$Arce PS, Murad K.. hyroid Storm In Heart Failure: A Case Report.. J-Card-Fail. 2024;30 (1):178$36$YR$$M$Y$$$20240816$$HP$US$US
242153071$24215307$1$I$$20240808$20240816$20240816$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP010056$STRIDES$Lorenz G, Schaaf C, Moog P, Bachmann Q, Popp F, Rech J, et al.. Brain oedema due to disseminated intravascular coagulation in a patient with adult-onset Still^s disease-associated hemophagocytic lymphohistiocytosis - a case report.. Rheumatology. 2023;62 (6):E188-E190$21$YR$$F$Y$$$20240816$$HP$DE$DE
242153081$24215308$1$I$20240813$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161956$AMGEN$$$$$M$Y$$$20240815$$CN$US$US
242153091$24215309$1$I$$20240802$20240816$20240816$EXP$$FR-MACLEODS PHARMA-MAC2024048754$MACLEODS$Baudriller A, Abbara C, Briet M, Jousset N, Malbranque S, Zabet D, et al..Deaths related to pharmacobezoars: A report on two cases..Toxicologie Analytique et Clinique.2024$$$$$Y$$$20240814$$MD$FR$FR
242153101$24215310$1$I$20240809$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160437$AMGEN$$$$$$Y$$$20240815$$HP$US$US
242153111$24215311$1$I$20231220$20240802$20240816$20240816$EXP$GB-MHRA-MED-202408011848076220-KWQZD$GB-MACLEODS PHARMA-MAC2024048757$MACLEODS$$26$YR$A$F$Y$$$20240814$$CN$GB$GB
242153122$24215312$2$F$$20240820$20240816$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003947$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
242153131$24215313$1$I$20240723$20240803$20240816$20240816$EXP$IT-MINISAL02-997793$IT-MACLEODS PHARMA-MAC2024048761$MACLEODS$$$$$$Y$$$20240814$$PH$IT$IT
242153141$24215314$1$I$$20240808$20240816$20240816$EXP$$US-NOVITIUMPHARMA-2024USNVP01593$NOVITIUM PHARMA$Homiack Damek R.Successful Electroconvulsive Therapy in a Patient with Catatonia and Maternal Duplication 15q11-13 Syndrome.The Journal of ECT.16-MAY-2024;NA:1-4$24$YR$A$M$Y$$$20240816$$HP$US$US
242153152$24215315$2$F$$20240802$20240816$20240816$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462970$RANBAXY$Peng T-R, Wu T-W, Chen H-F, Kao W-Y, Chan C-H. Gemcitabine-Associated Hyperammonemia in a Patient With Cholangiocarcinoma. Am J Ther. 2024;Jul/Aug;31 (4):e439-e440$57$YR$$F$Y$$$20240816$$MD$TW$TW
242153161$24215316$1$I$20240701$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-022528$UNITED THERAPEUTICS$$34$YR$$F$Y$$$20240816$$$US$US
242153172$24215317$2$F$$20240820$20240816$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125233$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240827$$PH$JP$JP
242153182$24215318$2$F$$20240812$20240816$20240823$EXP$$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP001172$JUBILANT - No Location Specified$Inoue F, Okazaki Y, Huh K, Ichiba T, Chiba T, Namera A. Pharmacobezoar Associated Prolonged Clinical Course in a Patient with Immediate Release Quetiapine Overdose. J Med Toxicol.. 2024$57$YR$$F$Y$$$20240823$$HP$JP$JP
242153191$24215319$1$I$$20240805$20240816$20240816$EXP$GB-MYLANLABS-2024M1070672$GB-JUBILANT PHARMA LTD-2024GB001142$JUBILANT$$$$A$F$Y$$$20240816$$PH$GB$GB
242153201$24215320$1$I$20240731$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408041319027800-FRMSV$GB-JUBILANT PHARMA LTD-2024GB001133$JUBILANT$$39$YR$$F$Y$$$20240816$$CN$GB$GB
242153211$24215321$1$I$20240803$20240806$20240816$20240816$30DAY$$US-GSK-US2024098183$GLAXOSMITHKLINE$$83$YR$$M$Y$$$20240816$$CN$US$US
242153223$24215322$3$F$20240802$20240821$20240816$20240901$PER$$US-MTPC-MTDA2024-0017088$Unknown Manufacturer$$69$YR$$M$Y$$$20240901$$CN$US$US
242153241$24215324$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161154$AMGEN$$$$$M$Y$$$20240815$$PH$US$US
242153251$24215325$1$I$20240201$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160518$AMGEN$$57$YR$A$M$Y$$$20240815$$CN$US$US
242153261$24215326$1$I$20240101$20240805$20240816$20240816$EXP$$US-UCBSA-2024039612$UCB$$$$$F$Y$69.388$KG$20240816$$HP$US$US
242153271$24215327$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165437$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
242153281$24215328$1$I$20240719$20240813$20240816$20240816$EXP$$US-JNJFOC-20240758710$JOHNSON AND JOHNSON$$75$YR$E$F$Y$59.1$KG$20240816$$HP$US$US
242153291$24215329$1$I$20240805$20240808$20240816$20240816$EXP$$CO-BIOVITRUM-2024-CO-010941$BIOVITRUM$$52$DY$$M$Y$4$KG$20240816$$CN$CO$CO
242153301$24215330$1$I$20230901$20240812$20240816$20240816$EXP$$US-BIOGEN-2024BI01277919$BIOGEN$$64$YR$$F$Y$$$20240816$$CN$US$US
242153311$24215331$1$I$20240628$20240809$20240816$20240816$EXP$CH-SM-2024-14509$CH-ROCHE-10000054837$ROCHE$$62$YR$A$F$Y$104$KG$20240816$$HP$CH$CH
242153321$24215332$1$I$$20240812$20240816$20240816$EXP$$FR-SANDOZ INC.-SDZ2024FR072492$SANDOZ$Na?m G, Malissin I, M?garbane B. Cerebral microbleeds in the poisoned patient: An observationalmagnetic resonance imaging study.. Basic Clin Pharmacol Toxicol. 2023;133(6):770-777$72$YR$$F$Y$$$20240816$$MD$FR$FR
242153332$24215333$2$F$$20240916$20240816$20240925$EXP$$DE-Encube-001279$ENCUBE ETHICALS$McAllister RK, Hanson JB. Lidocaine toxicity in infant circumcision and the role of lipid emulsion. Forensic Sci Med Pathol. 2024 Sep 14. doi: 10.1007/s12024-024-00894-5. Epub ahead of print. PMID: 39276169.$12$WK$I$M$Y$$$20240924$$MD$DE$
242153341$24215334$1$I$$20240806$20240816$20240816$EXP$$GB-UCBSA-2024040471$UCB$$$$$$Y$$$20240816$$MD$GB$GB
242153351$24215335$1$I$$20240812$20240816$20240816$EXP$$US-JNJFOC-20240834386$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$HP$US$US
242153362$24215336$2$F$20240101$20240807$20240816$20240821$EXP$$PR-ABBVIE-5873465$ABBVIE$$$$$F$Y$65$KG$20240821$$CN$PR$PR
242153371$24215337$1$I$$20240814$20240816$20240816$PER$$US-HALEON-2192033$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242153381$24215338$1$I$20240330$20240805$20240816$20240816$EXP$$IT-AUROBINDO-AUR-APL-2024-040262$AUROBINDO$$84$YR$$M$Y$$$20240816$$PH$IT$IT
242153391$24215339$1$I$20240806$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128316$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240816$$CN$US$US
242153401$24215340$1$I$$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129374$BRISTOL MYERS SQUIBB$$97$YR$E$F$Y$$$20240816$$CN$US$US
242153421$24215342$1$I$$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128726$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$105.69$KG$20240816$$HP$US$US
242153431$24215343$1$I$$20240809$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126822$BRISTOL MYERS SQUIBB$$30$YR$A$M$Y$$$20240816$$CN$US$US
242153441$24215344$1$I$$20240808$20240816$20240816$EXP$$US-EMD Serono-2024043236$EMD SERONO INC$$$$A$M$Y$$$20240816$$CN$US$US
242153451$24215345$1$I$20240805$20240806$20240816$20240816$30DAY$$US-GSK-US2024098608$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240816$$CN$US$US
242153461$24215346$1$I$20240814$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162538$AMGEN$$59$YR$A$M$Y$$$20240815$$CN$US$US
242153471$24215347$1$I$20240731$20240809$20240816$20240816$EXP$$CN-BEIGENE-BGN-2024-012517$BEIGENE$$$$$$Y$$$20240816$$HP$CN$CN
242153481$24215348$1$I$$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024161190$AMGEN$$$$$$Y$$$20240815$$CN$US$US
242153491$24215349$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009485$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240816$$CN$US$US
242153501$24215350$1$I$20240810$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008449$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240816$$CN$US$US
242153512$24215351$2$F$$20240813$20240816$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202408008383$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240912$$CN$US$US
242153521$24215352$1$I$20240605$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408006774$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240816$$CN$US$US
242153531$24215353$1$I$$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007141$ELI LILLY AND CO$$46$YR$A$$Y$$$20240816$$LW$US$US
242153541$24215354$1$I$$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005590$ELI LILLY AND CO$$47$YR$A$$Y$$$20240816$$LW$US$US
242153551$24215355$1$I$20240101$20240810$20240816$20240816$PER$$US-AMGEN-USASP2024159934$AMGEN$$74$YR$E$F$Y$$$20240815$$CN$US$US
242153561$24215356$1$I$20240806$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161213$AMGEN$$$$$F$Y$$$20240815$$CN$US$US
242153573$24215357$3$F$$20240927$20240816$20240930$PER$$NVSC2024US165560$NOVARTIS$$$$$$Y$$$20240930$$MD$US$US
242153581$24215358$1$I$$20240813$20240816$20240816$EXP$$US-ABBVIE-5880437$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242153591$24215359$1$I$20240801$20240813$20240816$20240816$EXP$$CA-ABBVIE-5880374$ABBVIE$$44$YR$$F$Y$$$20240816$$HP$CA$CA
242153602$24215360$2$F$$20240806$20240816$20240820$30DAY$$US-GSK-US2024098065$GLAXOSMITHKLINE$$$$$M$Y$$$20240820$$CN$US$US
242153611$24215361$1$I$20240701$20240813$20240816$20240816$EXP$$US-ABBVIE-5880549$ABBVIE$$69$YR$$F$Y$$$20240816$$CN$US$US
242153621$24215362$1$I$$20240807$20240816$20240816$EXP$$US-Jiangsu Hengrui Medicine Co., Ltd.-2160524$JIANGSU HENGRUI MEDICINE$Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based chemotherapy followed by olaparib$47$YR$$M$Y$$$20240816$$MD$JP$US
242153632$24215363$2$F$20240811$20240816$20240816$20240820$PER$$US-AMGEN-USASP2024159993$AMGEN$$72$YR$E$F$Y$$$20240819$$MD$US$US
242153641$24215364$1$I$$20240809$20240816$20240816$PER$$US-JNJFOC-20240827715$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
242153651$24215365$1$I$20240201$20240813$20240816$20240816$EXP$$US-ABBVIE-5683736$ABBVIE$$57$YR$$M$Y$$$20240816$$CN$US$US
242153661$24215366$1$I$20240806$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160415$AMGEN$$71$YR$E$F$Y$$$20240815$$CN$US$US
242153671$24215367$1$I$$20240806$20240816$20240816$EXP$TW-MLMSERVICE-20240801-PI147082-00246-3$TW-JUBILANT CADISTA PHARMACEUTICALS-2024TW001154$JUBILANT$Huang CC.. Case report: Rare variants in the MTRR gene, 66GG and 524TT cause hyperhomocysteinemia and folic acid deficiency linked to schizophrenia.. Frontiers in Psychiatry. 2024;15:1353308$39$YR$$M$Y$112.8$KG$20240816$$MD$TW$TW
242153681$24215368$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003844$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242153691$24215369$1$I$$20240812$20240816$20240816$EXP$IT-EMA-DD-20240806-7482655-081717$IT-SANDOZ INC.-SDZ2024IT071962$SANDOZ$$51$MON$$M$Y$$$20240816$$MD$IT$IT
242153702$24215370$2$F$20240801$20240819$20240816$20240912$EXP$$US-HETERO-HET2024US02655$HETERO$$55$YR$$F$Y$65.7$KG$20240828$$CN$US$US
242153721$24215372$1$I$20240809$20240809$20240816$20240816$PER$$US-BIOGEN-2024BI01278081$BIOGEN$$5$YR$$M$Y$$$20240816$$CN$US$US
242153731$24215373$1$I$20240723$20240808$20240816$20240816$EXP$$DE-EMD Serono-2024042917$EMD SERONO INC$$76$YR$E$F$Y$82$KG$20240816$$MD$DE$DE
242153741$24215374$1$I$20230101$20240711$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008535$STRIDES$$70$YR$$F$Y$67.12$KG$20240816$$CN$US$US
242153751$24215375$1$I$$20240711$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008735$STRIDES$Mahmoud A, Amir A, Bangash H, Ayaz S.. Pasteurella Multocida-induced Empyema in an Immunocompromised Patient - A Case Report.. Am-J-Respir-Crit-Care-Med. 2024;209(0)$70$YR$$M$Y$$$20240816$$HP$US$US
242153761$24215376$1$I$$20240808$20240816$20240816$30DAY$$US-GSK-US2024099274$GLAXOSMITHKLINE$$$$$M$Y$$$20240816$$CN$US$US
242153771$24215377$1$I$20240702$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003853$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240816$$CN$US$US
242153781$24215378$1$I$20240628$20240723$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003849$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240816$$CN$US$US
242153801$24215380$1$I$20240701$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003861$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240816$$CN$US$US
242153811$24215381$1$I$$20240623$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005765$STRIDES$$$$$M$Y$$$20240816$$PH$US$US
242153821$24215382$1$I$20240718$20240723$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003846$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240816$$CN$US$US
242153832$24215383$2$F$20240719$20240827$20240816$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003845$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240906$$CN$US$US
242153841$24215384$1$I$20240712$20240723$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003859$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240816$$CN$US$US
242153851$24215385$1$I$20240101$20240808$20240816$20240816$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-254292$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240816$$CN$CA$CA
242153862$24215386$2$F$$20240903$20240816$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003864$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242153872$24215387$2$F$$20240813$20240816$20240820$PER$$US-AMGEN-USASP2024162717$AMGEN$$$$$$Y$$$20240819$$CN$US$US
242153882$24215388$2$F$$20240815$20240816$20240824$EXP$$US-AstraZeneca-2024A186278$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242153891$24215389$1$I$$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129262$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240816$$CN$US$US
242153901$24215390$1$I$$20240807$20240816$20240816$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160525$JIANGSU HENGRUI MEDICINE$Literature title: Acute therapy-related myelodysplastic syndromes following capecitabine and oxaliplatin therapy in gastric malignant tumor A case report. ?Literature publication journal: Medicine 2024; : 1-4.?Literature authors: Yi-fan Qian, MM, Hang-ping Chen, MM, Guo-fei Ren, MM.$60$YR$$M$Y$$$20240816$$PH$CN$CN
242153911$24215391$1$I$$20240813$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072542$SANDOZ$$39$YR$$F$Y$$$20240816$$CN$CA$CA
242153921$24215392$1$I$$20240723$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003867$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242153932$24215393$2$F$20240720$20240904$20240816$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003870$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240916$$CN$US$US
242153941$24215394$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008227$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240816$$CN$US$US
242153951$24215395$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008346$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240816$$CN$US$US
242153961$24215396$1$I$$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005801$ELI LILLY AND CO$$51$YR$A$$Y$$$20240816$$LW$US$US
242153971$24215397$1$I$20240805$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007744$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240816$$CN$US$US
242153981$24215398$1$I$20240705$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003868$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240816$$CN$US$US
242153991$24215399$1$I$20240303$20240808$20240816$20240816$EXP$$US-ORG100016242-2024000523$PACIRA$$98$YR$E$F$Y$$$20240816$$HP$US$US
242154002$24215400$2$F$$20240913$20240816$20240917$EXP$$JP-UCBSA-2024039856$UCB$Maiko I. A case of Mycobacterium intracellulare infection in right forearm. The Nishinihon Journal of Dermatology. 2024;86(1):89$63$YR$$M$Y$$$20240917$$MD$JP$JP
242154011$24215401$1$I$20240719$20240724$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003899$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240816$$CN$US$US
242154022$24215402$2$F$$20240814$20240816$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003900$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242154031$24215403$1$I$20240601$20240723$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003874$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240816$$HP$US$US
242154051$24215405$1$I$$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003913$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242154063$24215406$3$F$20240501$20240903$20240816$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003871$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240913$$CN$US$US
242154071$24215407$1$I$$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003905$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$HP$US$US
242154081$24215408$1$I$20240701$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003906$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240816$$CN$US$US
242154091$24215409$1$I$$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003909$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242154101$24215410$1$I$$20240805$20240816$20240816$EXP$$FR-Merck Healthcare KGaA-2024008126$MERCK KGAA$$$$$$Y$$$20240814$$CN$FR$FR
242154112$24215411$2$F$$20240820$20240816$20240912$EXP$$US-HETERO-HET2024US02700$HETERO$$$$$$Y$$$20240829$$HP$US$US
242154121$24215412$1$I$$20240729$20240816$20240816$PER$$US-TEVA-VS-3229261$TEVA$$$$$$Y$$$20240816$$CN$US$US
242154132$24215413$2$F$20240101$20240814$20240816$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-024772$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240820$$$US$US
242154141$24215414$1$I$20240329$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024881$UNITED THERAPEUTICS$$$$$$Y$$$20240816$$$US$US
242154151$24215415$1$I$20240719$20240724$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003918$ACADIA PHARMACEUTICALS$$93$YR$$M$Y$$$20240816$$CN$US$US
242154161$24215416$1$I$20240401$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024875$UNITED THERAPEUTICS$$$$$$Y$$$20240816$$$US$US
242154171$24215417$1$I$20231201$20240813$20240816$20240816$EXP$$CA-UCBSA-2023037565$UCB$$33$YR$$F$Y$$$20240816$$MD$CA$CA
242154181$24215418$1$I$$20240724$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003919$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242154191$24215419$1$I$$20240812$20240816$20240816$PER$$US-LEO Pharma-372730$LEO PHARM$$$$$F$Y$$$20240816$$CN$US$US
242154202$24215420$2$F$$20240724$20240816$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-118794$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240906$$PH$US$US
242154211$24215421$1$I$$20240808$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126634$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240816$$HP$US$US
242154221$24215422$1$I$$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003928$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242154231$24215423$1$I$$20240807$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128171$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$75$KG$20240816$$CN$US$US
242154241$24215424$1$I$$20240813$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072359$SANDOZ$$56$YR$$F$Y$$$20240816$$HP$CA$CA
242154252$24215425$2$F$$20240823$20240816$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003924$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
242154261$24215426$1$I$20240717$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003925$ACADIA PHARMACEUTICALS$$86$YR$$F$Y$$$20240816$$CN$US$US
242154272$24215427$2$F$20240801$20240814$20240816$20240820$PER$$NVSC2024US165677$NOVARTIS$$37$YR$$F$Y$$$20240820$$CN$US$US
242154281$24215428$1$I$$20240805$20240816$20240816$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010034$STRIDES$Jin S, Shen Z, Li J, Liu X, Zhu Q, Li F, et al.. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy.. J-Clin-Pathol. 2024;77 (7):471-477$7$DEC$$M$Y$$$20240816$$MD$CN$CN
242154293$24215429$3$F$20240101$20240909$20240816$20240913$PER$$US-UNITED THERAPEUTICS-UNT-2024-024923$UNITED THERAPEUTICS$$$$$M$Y$60.317$KG$20240913$$$US$US
242154301$24215430$1$I$20240813$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161772$AMGEN$$79$YR$E$F$Y$$$20240815$$CN$US$US
242154311$24215431$1$I$20230301$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160553$AMGEN$$56$YR$A$F$Y$$$20240815$$CN$US$US
242154321$24215432$1$I$$20240806$20240816$20240816$EXP$$GR-STRIDES ARCOLAB LIMITED-2024SP010063$STRIDES$Sarri G, Geladari E, Petropoulos K, Adamopoulou E, Kanari M, Balampinis C, et al.. DOUBLE COVERAGE WITH DAPTOMYCIN AND CEFTAROLINE LED TO ERADICATION OF MRSA BACTEREMIA.. Eur-J-Case-Rep-Intern-Med. 2023;10 (Suppl. 1):341 abstr. 733$67$YR$$M$Y$$$20240816$$HP$GR$GR
242154331$24215433$1$I$$20240812$20240816$20240816$PER$$US-LEO Pharma-372736$LEO PHARM$$57$YR$$F$Y$$$20240816$$CN$US$US
242154341$24215434$1$I$$20240813$20240816$20240816$PER$$US-TAKEDA-2024TUS076593$TAKEDA$$$$$$Y$$$20240816$$HP$US$US
242154351$24215435$1$I$$20240806$20240816$20240816$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001111$ALEMBIC$Deka A, Joseph E, harma N, Berhanu T, Kaplan J.. Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature. Journal of Psychiatric Practice. 2024;30 (3):234-241$$$$$Y$$$20240814$$MD$US$US
242154362$24215436$2$F$20210205$20240917$20240816$20240918$EXP$$JP-TAKEDA-2024TJP011958$TAKEDA$$67$YR$$F$Y$$$20240918$$MD$JP$JP
242154371$24215437$1$I$$20240806$20240816$20240816$EXP$$SE-STRIDES ARCOLAB LIMITED-2024SP010105$STRIDES$Zilg B, Alkass K, Berg S, Druid H.. Interpretation of postmortem vitreous concentrations of sodium and chloride.. Forensic-Sci-Int. 2016;263:107-113$22$YR$$F$Y$$$20240816$$HP$SE$SE
242154382$24215438$2$F$20240401$20240806$20240816$20240817$EXP$$US-JNJFOC-20240815925$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240817$$HP$US$US
242154391$24215439$1$I$$20240813$20240816$20240816$PER$$US-JNJFOC-20240832453$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
242154401$24215440$1$I$20240808$20240809$20240816$20240816$EXP$$NVSC2024US162667$NOVARTIS$$85$YR$$F$Y$$$20240816$$CN$US$US
242154411$24215441$1$I$$20240806$20240816$20240816$EXP$$US-ALEMBIC-2024SCAL001112$ALEMBIC$Deka A, Joseph E, harma N, Berhanu T, Kaplan J. Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature. Journal of Psychiatric Practice. 2024;30:3:234-241$$$$$Y$$$20240814$$MD$US$US
242154421$24215442$1$I$$20240806$20240816$20240816$EXP$$US-ALEMBIC-2024SCAL001113$ALEMBIC$Deka A, Joseph E, harma N, Berhanu T, Kaplan J.. Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature. Journal of Psychiatric Practice. 2024;30 (3):234-241$$$$$Y$$$20240814$$MD$US$US
242154431$24215443$1$I$$20240806$20240816$20240816$EXP$$CH-STRIDES ARCOLAB LIMITED-2024SP010037$STRIDES$Dalmau I Ribas M, Mendez Rubio M, von Gunten A. Increased sexual function after intake of clomethiazole.. BMJ-Case-Rep. 2024;17 (7)$9$DEC$$F$Y$$$20240816$$MD$CH$CH
242154441$24215444$1$I$$20240806$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010098$STRIDES$Lee IJ, Pulido JS, Regillo CD, Leys M.. MULTIPLE ORGAN DYSFUNCTION SYNDROME and DISSEMINATED INTRAVASCULAR COAGULATION CAUSING EXTENSIVE MULTIPLE AMALRIC TRIANGULAR CHOROIDAL INFARCTIONS.. Retin-Cases-Brief-Rep. 2024;18 (2):251-254$49$YR$$F$Y$$$20240816$$MD$US$US
242154451$24215445$1$I$20220101$20240813$20240816$20240816$EXP$GB-MHRA-31453274$GB-SANDOZ INC.-SDZ2024GB072501$SANDOZ$$46$YR$$M$Y$120$KG$20240816$$CN$GB$GB
242154461$24215446$1$I$$20240806$20240816$20240816$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP010223$STRIDES$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al.. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.. Am-J-Reprod-Immunol. 2024;92 (1)$33$YR$$F$Y$$$20240816$$HP$FR$FR
242154481$24215448$1$I$20240101$20240809$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024644$UNITED THERAPEUTICS$$$$$M$Y$75.737$KG$20240816$$$US$US
242154491$24215449$1$I$20240722$20240812$20240816$20240816$EXP$$US-BIOVITRUM-2024-US-010899$BIOVITRUM$$68$YR$$M$Y$$$20240816$$CN$US$US
242154502$24215450$2$F$$20240819$20240816$20240820$PER$$US-JNJFOC-20240833927$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$HP$US$US
242154511$24215451$1$I$20100201$20240807$20240816$20240816$PER$$US-JNJFOC-20240823571$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20240816$$HP$US$US
242154522$24215452$2$F$20240101$20240816$20240816$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-024063$UNITED THERAPEUTICS$$$$$M$Y$62.585$KG$20240821$$$US$US
242154531$24215453$1$I$$20240806$20240816$20240816$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP010216$STRIDES$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al.. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.. Am-J-Reprod-Immunol. 2024;92 (1)$37$YR$$F$Y$$$20240816$$HP$FR$FR
242154541$24215454$1$I$$20240806$20240816$20240816$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP010224$STRIDES$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al.. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.. Am-J-Reprod-Immunol. 2024;92 (1)$34$YR$$F$Y$$$20240816$$HP$FR$FR
242154551$24215455$1$I$$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128225$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$68.49$KG$20240816$$CN$US$US
242154561$24215456$1$I$$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129202$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240816$$CN$US$US
242154571$24215457$1$I$$20240809$20240816$20240816$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-024891$UNITED THERAPEUTICS$$$$$F$Y$7$KG$20240816$$$CA$CA
242154581$24215458$1$I$$20240807$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010055$STRIDES$Cheng J, Harney S, Toner K, Kube P, Gong S, Ozdemirli M, et al.. Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment.. Pediatr-Blood-Cancer. 2024;71 (8):1-4$9$YR$$M$Y$$$20240816$$HP$US$US
242154591$24215459$1$I$20240812$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160367$AMGEN$$72$YR$E$M$Y$$$20240816$$CN$US$US
242154601$24215460$1$I$$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005709$ELI LILLY AND CO$$$$$$Y$$$20240816$$HP$US$US
242154611$24215461$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008389$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240816$$CN$US$US
242154621$24215462$1$I$20240812$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008487$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240816$$CN$US$US
242154631$24215463$1$I$$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005583$ELI LILLY AND CO$$47$YR$A$$Y$$$20240816$$LW$US$US
242154641$24215464$1$I$$20240807$20240816$20240816$EXP$$IE-STRIDES ARCOLAB LIMITED-2024SP010154$STRIDES$Tudor RM, Ali EM, Khan SU, McDermott J.. Klinefelter syndrome presenting as metastatic bilateral breast cancer: missed diagnostic opportunities.. BMJ-Case-Rep. 2023;16$60$YR$$M$Y$$$20240816$$MD$IE$IE
242154653$24215465$3$F$20230101$20240822$20240816$20240830$EXP$$CA-CELLTRION INC.-2023CA014381$CELLTRION$$$$$$Y$$$20240830$$CN$CA$CA
242154661$24215466$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008458$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240816$$CN$US$US
242154671$24215467$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008424$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240816$$CN$US$US
242154681$24215468$1$I$$20240804$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408003210$ELI LILLY AND CO$$50$YR$A$$Y$$$20240816$$LW$US$US
242154691$24215469$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008440$ELI LILLY AND CO$$24$YR$A$M$Y$$$20240816$$CN$US$US
242154701$24215470$1$I$$20240807$20240816$20240816$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010158$STRIDES$Nonaka K, Kawase K, Takagi K, Takatsu Y, Maniwa K, Takao C, et al.. Development of Fournier^s gangrene after chemotherapy for the recurrence of testicular cancer despite the absence of anorectal lesions:A case report.. Medicine. 2024;103 (30):e38688$54$YR$$M$Y$$$20240816$$MD$JP$JP
242154711$24215471$1$I$$20240807$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010085$STRIDES$Alshawa L, Leahy B, Rueckert J, Maskey A, Anstead M, Keshavamurthy S, et al.. Hemophagocytic Lymphohistiocytosis: A Rare Diagnosis in the Immediate Aftermath of Lung Transplantation.. J-Heart-Lung-Transplant. 2024;43 (Suppl.) (4):S484-S485 abstr. 1040.$63$YR$$M$Y$$$20240816$$HP$US$US
242154724$24215472$4$F$20240101$20240917$20240816$20240926$EXP$$CA-CELLTRION INC.-2024CA012621$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
242154731$24215473$1$I$20240301$20240803$20240816$20240816$EXP$$ES-ABBVIE-5877556$ABBVIE$$27$YR$$F$Y$$$20240816$$CN$ES$ES
242154741$24215474$1$I$$20240806$20240816$20240816$EXP$$US-APOTEX-2024AP009165$APOTEX$Sircy A, Ibeh B, Boutros N, Bolyard J.. Otitis Media To Meningitis: A Rare Group A Streptococcus Meningitis Case. Critical Care Medicine. 2024;52 (1):S705-S707$43$YR$$M$Y$$$20240816$$HP$US$US
242154751$24215475$1$I$$20240808$20240816$20240816$PER$$US-ROCHE-10000053193$ROCHE$$$$$F$Y$$$20240816$$HP$US$US
242154761$24215476$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003866$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242154773$24215477$3$F$20240807$20240905$20240816$20240912$PER$$US-AMGEN-USASP2024159795$AMGEN$$74$YR$E$M$Y$77$KG$20240912$$PH$US$US
242154791$24215479$1$I$20240403$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040022$AUROBINDO$$81$YR$$F$Y$50$KG$20240816$$MD$FR$FR
242154801$24215480$1$I$$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129123$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240816$$CN$US$US
242154811$24215481$1$I$$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129400$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240816$$CN$US$US
242154832$24215483$2$F$$20240912$20240816$20240916$PER$$US-HALEON-2192102$Haleon PLC$$$$$$Y$$$20240916$$CN$US$US
242154841$24215484$1$I$20240701$20240729$20240816$20240816$PER$$US-TEVA-VS-3227536$TEVA$$64$YR$$F$Y$$$20240816$$CN$US$US
242154852$24215485$2$F$20240703$20240831$20240816$20240903$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037974$BOEHRINGER INGELHEIM$$91$YR$E$M$Y$$$20240903$$PH$IT$IT
242154861$24215486$1$I$20240101$20240809$20240816$20240816$EXP$$JP-ROCHE-10000058222$ROCHE$$$$A$M$Y$$$20240816$$MD$JP$JP
242154871$24215487$1$I$$20240812$20240816$20240816$EXP$$CA-AMGEN-CANSP2024161934$AMGEN$$$$$F$Y$$$20240816$$CN$CA$CA
242154882$24215488$2$F$20240101$20240814$20240816$20240822$PER$$US-AMGEN-USASP2024162346$AMGEN$$50$YR$A$M$Y$$$20240822$$HP$US$US
242154891$24215489$1$I$$20240809$20240816$20240816$EXP$$AU-JUBILANT CADISTA PHARMACEUTICALS-2024AU001167$JUBILANT$$$$A$$Y$$$20240816$$HP$AU$AU
242154901$24215490$1$I$20240101$20240806$20240816$20240816$EXP$SE-SEMPA-2024-005906$SE-JUBILANT CADISTA PHARMACEUTICALS-2024SE001145$JUBILANT$$30$YR$$F$Y$$$20240816$$MD$SE$SE
242154921$24215492$1$I$$20240815$20240816$20240816$PER$$NVSC2024US165877$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242154931$24215493$1$I$$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024476$UNITED THERAPEUTICS$$$$$F$Y$$$20240816$$MD$US$US
242154941$24215494$1$I$20220701$20240806$20240816$20240816$EXP$$CN-009507513-2408CHN004343$MERCK$Wen X, Zhu L, Tao L, Yu X. Nursing care of chronic wounds caused by extravasation of chemotherapeutic drugs through abdominal wall intravenous infusion port.. Chinese Journal of Rural Medicine and Pharmacy. 2024;31 (14):68-70$55$YR$$F$Y$$$20240816$$HP$CN$CN
242154952$24215495$2$F$$20240816$20240816$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003914$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
242154961$24215496$1$I$$20240809$20240816$20240816$EXP$$BR-AstraZeneca-2024A185792$ASTRAZENECA$$52$YR$$F$Y$$$20240816$$CN$BR$
242154971$24215497$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003892$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242154981$24215498$1$I$$20240807$20240816$20240816$PER$$US-AstraZeneca-2024A179922$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242154991$24215499$1$I$$20240809$20240816$20240816$EXP$$US-AstraZeneca-2024A182278$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242155001$24215500$1$I$20240101$20240729$20240816$20240816$PER$$US-TEVA-VS-3228359$TEVA$$$$$F$Y$$$20240816$$CN$US$US
242155022$24215502$2$F$20240101$20240905$20240816$20240909$PER$$US-AMGEN-USASP2024160401$AMGEN$$73$YR$E$F$Y$$$20240909$$CN$US$US
242155032$24215503$2$F$20240101$20240815$20240816$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-025158$UNITED THERAPEUTICS$$$$$M$Y$65.76$KG$20240820$$$US$US
242155041$24215504$1$I$20240806$20240806$20240816$20240816$PER$$US-CHATTEMPRD-2024OHG026850$CHATTEM$$$$$F$Y$$$20240816$$CN$US$US
242155052$24215505$2$F$20130101$20240815$20240816$20240822$PER$$US-JNJFOC-20240833962$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240823$$LW$US$US
242155061$24215506$1$I$20240813$20240814$20240816$20240816$PER$$US-ABBVIE-5881713$ABBVIE$$35$YR$$F$Y$$$20240816$$MD$US$US
242155071$24215507$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127410$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240816$$CN$US$US
242155081$24215508$1$I$20240730$20240812$20240816$20240816$EXP$$CN-SANDOZ INC.-SDZ2024CN072243$SANDOZ$$70$YR$$F$Y$52$KG$20240816$$HP$CN$CN
242155091$24215509$1$I$20230625$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040138$AUROBINDO$$1$DY$$M$Y$0.28$KG$20240816$$MD$FR$FR
242155101$24215510$1$I$20240813$20240814$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009281$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240816$$CN$US$US
242155111$24215511$1$I$$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005602$ELI LILLY AND CO$$70$YR$E$$Y$$$20240816$$LW$US$US
242155121$24215512$1$I$$20230922$20240816$20240816$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409847$RANBAXY$$$$$F$Y$$$20240816$$CN$US$US
242155131$24215513$1$I$$20240515$20240816$20240816$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447026$RANBAXY$$$$$M$Y$$$20240816$$CN$US$US
242155141$24215514$1$I$$20231018$20240816$20240816$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415246$RANBAXY$$$$$$Y$$$20240816$$CN$US$US
242155151$24215515$1$I$$20231103$20240816$20240816$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417928$RANBAXY$$$$$M$Y$$$20240816$$CN$US$US
242155161$24215516$1$I$$20230918$20240816$20240816$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409218$RANBAXY$$$$$F$Y$$$20240816$$CN$US$US
242155174$24215517$4$F$$20240814$20240816$20240827$EXP$$GB-TEVA-VS-3230864$TEVA$$$$E$F$Y$$$20240827$$CN$GB$GB
242155181$24215518$1$I$$20240312$20240816$20240816$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436681$RANBAXY$$$$E$F$Y$$$20240816$$CN$US$US
242155191$24215519$1$I$$20230911$20240816$20240816$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408429$RANBAXY$$$$$F$Y$$$20240816$$CN$US$US
242155202$24215520$2$F$$20240815$20240816$20240821$PER$$US-HALEON-2192073$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242155211$24215521$1$I$20240721$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003915$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240816$$CN$US$US
242155231$24215523$1$I$$20240805$20240816$20240816$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-22493$SAMSUNG BIOEPIS$$79$YR$E$F$Y$$$20240814$$CN$GB$GB
242155241$24215524$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127577$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240816$$MD$US$US
242155251$24215525$1$I$$20240803$20240816$20240816$EXP$$NL-AUROBINDO-AUR-APL-2024-039933$AUROBINDO$$24$YR$$F$Y$55$KG$20240816$$CN$NL$NL
242155261$24215526$1$I$$20240806$20240816$20240816$EXP$$JP-EMD Serono-2024042595$EMD SERONO INC$$78$YR$E$F$Y$$$20240816$$PH$JP$JP
242155272$24215527$2$F$20240729$20240826$20240816$20240905$EXP$$IT-AUROBINDO-AUR-APL-2024-039737$AUROBINDO$$33$YR$$F$Y$$$20240905$$MD$IT$IT
242155281$24215528$1$I$20211222$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-039684$AUROBINDO$$51$YR$$M$Y$64$KG$20240816$$MD$FR$FR
242155301$24215530$1$I$$20240810$20240816$20240816$EXP$$US-AstraZeneca-2024A183377$ASTRAZENECA$$$$$$Y$$$20240816$$CN$US$
242155313$24215531$3$F$20190919$20240910$20240816$20240912$EXP$$CO-UCBSA-2024041341$UCB$$48$YR$$F$Y$165$KG$20240912$$CN$CO$CO
242155321$24215532$1$I$$20240813$20240816$20240816$EXP$$ZA-AstraZeneca-2024A184790$ASTRAZENECA$$77$YR$$M$Y$$$20240816$$CN$ZA$
242155331$24215533$1$I$$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A185327$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242155341$24215534$1$I$$20240809$20240816$20240816$EXP$$GB-AstraZeneca-2024A183313$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$GB$
242155351$24215535$1$I$$20240808$20240816$20240816$EXP$$US-AMGEN-USASP2024159925$AMGEN$Jones A.A.; Martin J.S.; Giangiacomo A.L. et al.. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024;36:1-4$$$I$F$Y$$$20240816$$HP$US$US
242155371$24215537$1$I$20240522$20240813$20240816$20240816$EXP$$US-BIOGEN-2024BI01278355$BIOGEN$$6$YR$$$Y$$$20240816$$MD$US$US
242155381$24215538$1$I$20240701$20240812$20240816$20240816$EXP$$IN-BIOGEN-2024BI01278363$BIOGEN$$68$YR$$F$Y$$$20240816$$CN$IN$IN
242155392$24215539$2$F$$20240821$20240816$20240828$EXP$US-DRL-USA-LIT/USA/24/0011707$US-RDY-LIT/USA/24/0011707$DR REDDYS$Patel R, Elghawy O, Gibbs A, Gupta S, Kaur V. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer Reports. 2024;7(7): e2110. doi:10.1002/cnr2.2110.$84$YR$E$M$Y$$$20240828$$HP$US$US
242155401$24215540$1$I$$20240805$20240816$20240816$EXP$$US-RDY-LIT/USA/24/0011710$DR REDDYS$Lee J, Casey E, Tompsett K, Otigbah C, Pittathankal A, Sirkova A, et al. Hyperparathyroidism Causing life Threatening Hypercalcaemia in Pregnancy. Journal of the Endocrine Society. 2022;6: A166-A167. doi:10.1210/jendso/bvac150.342.$31$YR$A$F$Y$$$20240816$$MD$US$US
242155411$24215541$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127788$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240816$$CN$US$US
242155421$24215542$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003895$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242155431$24215543$1$I$20230301$20240803$20240816$20240816$EXP$$IT-AUROBINDO-AUR-APL-2024-038637$AUROBINDO$Ferri, R.; Taraschi, G.; Vecchiet, J.; Falasca, K.; Ucciferri, C.. ARE NEW LIPID LOWERING AGENTS A GOOD OPTION FOR ACHIEVE LIPID GOAL IN HIV SUBJECTS?. 16th Italian Conference on AIDS and Antiviral Research (ICAR) - Italian Society of Infectious and Tropical Diseases (SIMIT).. Abstract of Congress$62$YR$$M$Y$$$20240816$$HP$IT$IT
242155441$24215544$1$I$$20240815$20240816$20240816$PER$$NVSC2024US165818$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242155464$24215546$4$F$$20240816$20240816$20240829$EXP$$DE-AUROBINDO-AUR-APL-2024-039913$AUROBINDO$Jansen N, Wulff L, Conty M, Schabitz W-R, Klingebiel R. CHANTER syndrome in the context of pain medication: a case report. BMC Neurology. 2024;24(1):249$62$YR$$M$Y$$$20240829$$HP$DE$DE
242155471$24215547$1$I$$20240812$20240816$20240816$EXP$$CA-ADIENNEP-2024AD000646$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240812$$HP$CA$
242155481$24215548$1$I$$20240723$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003917$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$HP$US$US
242155492$24215549$2$F$20240401$20240822$20240816$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003946$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240913$$CN$US$US
242155501$24215550$1$I$$20240807$20240816$20240816$PER$$US-ABBVIE-5873284$ABBVIE$$$$$$Y$$$20240816$$CN$US$US
242155512$24215551$2$F$$20240924$20240816$20240926$EXP$$PL-JNJFOC-20240819836$JOHNSON AND JOHNSON$Korzeniowska K. Anaphylactic shock in a 7-year-old patient treated with cefaclor  case report and literature review.. FARMACJA WSPOLCZESNA. 2024;2:135-139.$7$YR$C$F$Y$18$KG$20240926$$HP$PL$PL
242155521$24215552$1$I$20240801$20240806$20240816$20240816$30DAY$$US-GSK-US2024098172$GLAXOSMITHKLINE$$64$YR$$M$Y$$$20240816$$CN$US$US
242155531$24215553$1$I$20231023$20240808$20240816$20240816$EXP$$CA-CELLTRION INC.-2023CA007205$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
242155542$24215554$2$F$$20240830$20240816$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003932$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
242155551$24215555$1$I$20240724$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003957$ACADIA PHARMACEUTICALS$$16$YR$$F$Y$$$20240816$$CN$US$US
242155561$24215556$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003963$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242155572$24215557$2$F$20240816$20240821$20240816$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003956$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240913$$CN$US$US
242155581$24215558$1$I$$20240815$20240816$20240816$PER$$NVSC2024US165879$NOVARTIS$$$$$F$Y$$$20240816$$HP$US$US
242155591$24215559$1$I$$20240812$20240816$20240816$EXP$$CA-ADIENNEP-2024AD000644$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240812$$HP$CA$
242155602$24215560$2$F$20240701$20240814$20240816$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003965$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240906$$CN$US$US
242155611$24215561$1$I$20240711$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003964$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240816$$CN$US$US
242155622$24215562$2$F$$20240904$20240816$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003969$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242155631$24215563$1$I$20240722$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003896$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240816$$CN$US$US
242155641$24215564$1$I$20230522$20240812$20240816$20240816$EXP$$NL-HALEON-2191889$Haleon PLC$$9$YR$$M$Y$$$20240816$$MD$NL$NL
242155652$24215565$2$F$$20240828$20240816$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003968$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
242155662$24215566$2$F$$20240906$20240816$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003972$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242155672$24215567$2$F$20240621$20240917$20240816$20240923$EXP$$BR-AMGEN-BRASP2024155186$AMGEN$$89$YR$E$F$Y$$$20240922$$CN$BR$BR
242155681$24215568$1$I$20240723$20240723$20240816$20240816$EXP$$GB-CELLTRION INC.-2024GB019488$CELLTRION$$$$$$Y$$$20240816$$PH$GB$GB
242155691$24215569$1$I$20240628$20240812$20240816$20240816$EXP$ES-AEMPS-1554676$ES-BIOGEN-2024BI01278305$BIOGEN$$51$YR$$F$Y$49$KG$20240816$$CN$ES$ES
242155701$24215570$1$I$20240802$20240812$20240816$20240816$EXP$$MX-BIOGEN-2024BI01278183$BIOGEN$$33$YR$$F$Y$$$20240816$$CN$MX$MX
242155711$24215571$1$I$20240706$20240808$20240816$20240816$EXP$$CN-JNJFOC-20240827775$JOHNSON AND JOHNSON$$38$YR$A$F$Y$55$KG$20240816$$HP$CN$CN
242155721$24215572$1$I$20240727$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040033$AUROBINDO$$68$YR$$M$Y$66$KG$20240816$$MD$FR$FR
242155731$24215573$1$I$$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129360$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240816$$CN$US$US
242155741$24215574$1$I$20240101$20240723$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003921$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240816$$CN$US$US
242155751$24215575$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003980$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242155762$24215576$2$F$$20240819$20240816$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003973$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
242155771$24215577$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003981$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242155781$24215578$1$I$20240701$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003975$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240816$$CN$US$US
242155791$24215579$1$I$$20240809$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-025076$UNITED THERAPEUTICS$$$$$M$Y$71.202$KG$20240816$$$US$US
242155801$24215580$1$I$$20240809$20240816$20240816$PER$$US-ABBVIE-5877551$ABBVIE$$$$$$Y$$$20240816$$CN$US$US
242155811$24215581$1$I$$20240808$20240816$20240816$PER$$US-EMD Serono-2024043218$EMD SERONO INC$$53$YR$A$M$Y$86$KG$20240816$$CN$US$US
242155822$24215582$2$F$20240801$20240826$20240816$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-025048$UNITED THERAPEUTICS$$64$YR$$F$Y$76.644$KG$20240829$$$US$US
242155831$24215583$1$I$$20240812$20240816$20240816$EXP$$CA-SANDOZ INC.-NVSC2021CA075598$SANDOZ$$11$YR$$M$Y$$$20240816$$CN$CA$CA
242155841$24215584$1$I$$20240811$20240816$20240816$EXP$$US-SANDOZ INC.-SDZ2024US072348$SANDOZ$$$$$$Y$$$20240816$$CN$US$US
242155851$24215585$1$I$$20240809$20240816$20240816$EXP$$US-SANDOZ INC.-SDZ2024US071892$SANDOZ$$33$YR$$F$Y$$$20240816$$CN$US$US
242155862$24215586$2$F$20240623$20240816$20240816$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003982$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240910$$CN$US$US
242155871$24215587$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008398$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$US$US
242155882$24215588$2$F$$20240815$20240816$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009290$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240817$$CN$US$US
242155891$24215589$1$I$$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007160$ELI LILLY AND CO$$51$YR$A$$Y$$$20240816$$LW$US$US
242155901$24215590$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008460$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$US$US
242155911$24215591$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008403$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$US$US
242155921$24215592$1$I$$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005821$ELI LILLY AND CO$$68$YR$E$$Y$$$20240816$$LW$US$US
242155932$24215593$2$F$$20240814$20240816$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408008396$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240823$$PH$US$US
242155941$24215594$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007758$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240816$$CN$US$US
242155951$24215595$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008422$ELI LILLY AND CO$$61$YR$A$$Y$$$20240816$$CN$US$US
242155961$24215596$1$I$20240601$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005655$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240816$$CN$US$US
242155971$24215597$1$I$20240802$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008391$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240816$$CN$US$US
242155981$24215598$1$I$$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408061607072160-KTSDZ$GB-TEVA-VS-3230681$TEVA$$$$$M$Y$$$20240816$$CN$GB$GB
242155991$24215599$1$I$$20240806$20240816$20240816$30DAY$$US-GSK-US2024AMR098341$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242156001$24215600$1$I$$20240723$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003923$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242156011$24215601$1$I$20240201$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-039289$AUROBINDO$$77$YR$$M$Y$53.6$KG$20240816$$MD$FR$FR
242156031$24215603$1$I$$20240809$20240816$20240816$EXP$$AU-AMGEN-AUSSP2024161311$AMGEN$He W.; Jape D.; Nanayakkara S. et al.. Adherence to Statin Therapy Post Percutaneous Coronary Intervention Amongst Patients Presenting With Recurrent Acute Coronary Syndrome. Heart, Lung and Circulation. 2024;33:p.S506$$$$$Y$$$20240816$$HP$AU$AU
242156041$24215604$1$I$$20240808$20240816$20240816$PER$$US-BAUSCHBL-2024BNL031636$BAUSCH AND LOMB$$83$YR$$F$Y$$$20240816$$HP$US$US
242156051$24215605$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003926$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242156061$24215606$1$I$$20240805$20240816$20240816$PER$$US-BAUSCHBL-2024BNL031189$BAUSCH AND LOMB$$$$$F$Y$$$20240816$$CN$US$US
242156071$24215607$1$I$$20240809$20240816$20240816$EXP$$GB-JNJFOC-20240827891$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$GB$GB
242156082$24215608$2$F$$20240827$20240816$20240902$PER$$US-AMGEN-USASP2024161801$AMGEN$Topilow N.J.; Penteado R.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024;1-6$$$$$Y$$$20240902$$MD$US$US
242156091$24215609$1$I$20240326$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160091$AMGEN$$$$$F$Y$$$20240816$$CN$US$US
242156102$24215610$2$F$$20240827$20240816$20240902$PER$$US-AMGEN-USASP2024161732$AMGEN$Topilow N.J.; Penteado R.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024;1-6$$$$$Y$$$20240902$$MD$US$US
242156112$24215611$2$F$$20240827$20240816$20240902$PER$$US-AMGEN-USASP2024161626$AMGEN$Topilow N.J.; Penteado R.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024;1-6$$$$$Y$$$20240902$$MD$US$US
242156121$24215612$1$I$$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128368$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$90.26$KG$20240816$$HP$US$US
242156131$24215613$1$I$$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129232$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240816$$CN$US$US
242156141$24215614$1$I$20240723$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129023$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240816$$HP$US$US
242156153$24215615$3$F$20240626$20240912$20240816$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003002$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240923$$CN$US$US
242156161$24215616$1$I$$20240808$20240816$20240816$EXP$$US-GSK-US2024099124$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$MD$US$US
242156171$24215617$1$I$20240730$20240808$20240816$20240816$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099261$VIIV$$35$YR$$M$Y$$$20240816$$MD$US$US
242156181$24215618$1$I$20240806$20240807$20240816$20240816$EXP$$JP-SA-2024SA238859$SANOFI AVENTIS$$59$YR$A$F$Y$64$KG$20240816$$HP$JP$JP
242156191$24215619$1$I$$20240814$20240816$20240816$EXP$$CA-TAKEDA-2024TUS081932$TAKEDA$$32$YR$$F$Y$$$20240816$$HP$CA$CA
242156201$24215620$1$I$20240710$20240813$20240816$20240816$EXP$$CA-TAKEDA-2024TUS082066$TAKEDA$$73$YR$$F$Y$$$20240816$$CN$CA$CA
242156211$24215621$1$I$$20240807$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR099046$VIIV$$37$YR$$M$Y$$$20240816$$HP$US$US
242156221$24215622$1$I$20240201$20240814$20240816$20240816$EXP$$US-009507513-2408USA005074$MERCK$$81$YR$$F$Y$$$20240816$$MD$US$US
242156232$24215623$2$F$$20240826$20240816$20240903$EXP$$JP-UCBSA-2024039884$UCB$Hosokawa K, Oi K, Hitomi T, Mitsueda T, Nakagawa T, Ikeda A.. A case of Alice in Wonderland syndrome after Epstein-Barr virus (EBC) encephalitis: a mimicry of focal epileptic seizure/A case of an adult patient, presented with Alice in Wonderland syndrome intermittently after Epstein-Barr virus encephalitis and required a differential diagnosis from epileptic seizure. Clinical Neurology. 2024;64(2):99-104$30$YR$$M$Y$$$20240903$$MD$JP$JP
242156241$24215624$1$I$$20240813$20240816$20240816$EXP$$NVSC2024US165311$NOVARTIS$$65$YR$$F$Y$68.04$KG$20240816$$CN$US$US
242156251$24215625$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165263$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
242156272$24215627$2$F$$20240827$20240816$20240902$EXP$$US-AMGEN-USASP2024161946$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024$$$$$Y$$$20240902$$MD$US$US
242156281$24215628$1$I$$20240808$20240816$20240816$EXP$$CH-AMGEN-CHESP2024159643$AMGEN$Mark M.;  Mora  A R.;  Winder  T et al. Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study. Bone Reports. 2024;22:1-6$$$$$Y$$$20240816$$HP$CH$CH
242156292$24215629$2$F$$20240827$20240816$20240902$EXP$$US-AMGEN-USASP2024161998$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024$$$$$Y$$$20240902$$MD$US$US
242156302$24215630$2$F$20240812$20240824$20240816$20240827$PER$$US-AMGEN-USASP2024161436$AMGEN$$63$YR$A$M$Y$$$20240827$$CN$US$US
242156311$24215631$1$I$20240701$20240808$20240816$20240816$EXP$$US-AMGEN-USASP2024158440$AMGEN$$6$YR$C$F$Y$$$20240816$$CN$US$US
242156321$24215632$1$I$20240721$20240803$20240816$20240816$EXP$$IT-AUROBINDO-AUR-APL-2024-040074$AUROBINDO$$17$YR$$F$Y$$$20240816$$MD$IT$IT
242156331$24215633$1$I$20240807$20240814$20240816$20240816$EXP$$US-AstraZeneca-2024A185671$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242156341$24215634$1$I$20240608$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A183404$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242156351$24215635$1$I$$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A183934$ASTRAZENECA$Bulleit C, Rho J, Fleisch SB, Radhakrishnan NS. Treating Malignant Catatonia With Liquid Amantadine: A Case Report and Literature Review. Journal of Psychiatric Practice 2024;30(4):308-10.$51$YR$$F$Y$$$20240816$$MD$US$
242156361$24215636$1$I$20240101$20240808$20240816$20240816$EXP$$DE-AMGEN-DEUSP2024161623$AMGEN$$$$A$F$Y$$$20240816$$MD$DE$DE
242156371$24215637$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003898$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242156381$24215638$1$I$20240807$20240807$20240816$20240816$30DAY$$US-GSK-US2024098540$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240816$$CN$US$US
242156391$24215639$1$I$$20240806$20240816$20240816$30DAY$$US-GSK-US2024098124$GLAXOSMITHKLINE$$$$$M$Y$$$20240816$$CN$US$US
242156402$24215640$2$F$$20240827$20240816$20240902$EXP$$US-AMGEN-USASP2024162016$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024$$$$$Y$$$20240902$$MD$US$US
242156412$24215641$2$F$$20240829$20240816$20240903$EXP$$BH-AMGEN-BHRSP2024159615$AMGEN$Surmeli Z G.. Cisplatin-induced bone marrow failure in an adult patient with Fanconi anemia. Journal of oncology pharmacy practice. 2024;1-4$38$YR$A$F$Y$$$20240903$$HP$BH$BH
242156421$24215642$1$I$$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129085$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240816$$CN$US$US
242156431$24215643$1$I$$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129150$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240816$$CN$US$US
242156441$24215644$1$I$20240201$20240810$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126956$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240816$$PH$US$US
242156451$24215645$1$I$$20240805$20240816$20240816$EXP$GB-MHRA-MIDB-adad5717-5c83-4933-8a18-530839a11a37$GB-UCBSA-2024039185$UCB$$23$YR$$$Y$$$20240816$$PH$GB$GB
242156461$24215646$1$I$20230101$20240809$20240816$20240816$EXP$$CA-UCBSA-2024040993$UCB$$$$$$Y$$$20240816$$CN$CA$CA
242156472$24215647$2$F$20240701$20240812$20240816$20240821$EXP$$NVSC2024IE164003$NOVARTIS$$$$$F$Y$$$20240821$$HP$IE$IE
242156481$24215648$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003901$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$HP$US$US
242156491$24215649$1$I$20240301$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003930$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240816$$CN$US$US
242156501$24215650$1$I$$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005782$ELI LILLY AND CO$$65$YR$E$$Y$$$20240816$$LW$US$US
242156511$24215651$1$I$$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005210$ELI LILLY AND CO$$66$YR$E$$Y$$$20240816$$LW$US$US
242156521$24215652$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008399$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240816$$CN$US$US
242156531$24215653$1$I$20240812$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008336$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240816$$CN$US$US
242156541$24215654$1$I$$20240814$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009492$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240816$$CN$US$US
242156551$24215655$1$I$20231201$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008351$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240816$$CN$US$US
242156561$24215656$1$I$20240101$20240814$20240816$20240816$EXP$$US-UCBSA-2024041244$UCB$$$$$F$Y$$$20240816$$CN$US$US
242156571$24215657$1$I$20240601$20240812$20240816$20240816$EXP$$AR-TAKEDA-2024TUS081211$TAKEDA$$69$YR$$F$Y$$$20240816$$CN$AR$AR
242156581$24215658$1$I$20240808$20240808$20240816$20240816$30DAY$$US-GSK-US2024099270$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242156591$24215659$1$I$20221212$20240815$20240816$20240816$EXP$$US-UCBSA-2023000705$UCB$$47$YR$$F$Y$$$20240816$$HP$US$US
242156601$24215660$1$I$20240707$20240812$20240816$20240816$EXP$ES-AEMPS-1557507$ES-UCBSA-2024040590$UCB$$68$YR$$F$Y$$$20240816$$PH$ES$ES
242156611$24215661$1$I$$20240812$20240816$20240816$EXP$$CA-ADIENNEP-2024AD000642$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240812$$HP$CA$
242156621$24215662$1$I$$20240812$20240816$20240816$EXP$$CA-ADIENNEP-2024AD000643$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240812$$HP$CA$
242156631$24215663$1$I$$20240812$20240816$20240816$EXP$$US-JNJFOC-20240834431$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$CN$US$US
242156641$24215664$1$I$$20240808$20240816$20240816$PER$$US-ABBVIE-5873712$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242156651$24215665$1$I$20240801$20240813$20240816$20240816$EXP$$US-AMGEN-USASP2024161266$AMGEN$$12$YR$T$M$Y$$$20240816$$PH$US$US
242156662$24215666$2$F$$20240826$20240816$20240901$EXP$$JP-AMGEN-JPNSP2024162497$AMGEN$$8$DEC$E$$Y$$$20240901$$CN$JP$JP
242156671$24215667$1$I$20231101$20240808$20240816$20240816$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-004109$JAZZ$$33$YR$$F$Y$$$20240816$$CN$US$US
242156681$24215668$1$I$$20240812$20240816$20240816$EXP$$CA-ADIENNEP-2024AD000645$ADIENNE PHARMA + BIOTECH$$$$$$Y$$$20240812$$HP$CA$
242156691$24215669$1$I$20240419$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040149$AUROBINDO$$27$YR$$F$Y$$$20240816$$CN$FR$FR
242156702$24215670$2$F$$20240823$20240816$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003902$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$HP$US$US
242156711$24215671$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003934$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242156721$24215672$1$I$20240701$20240816$20240816$20240816$EXP$SE-SEMPA-2024-006009$SE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046169$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240816$$MD$SE$SE
242156731$24215673$1$I$$20240805$20240816$20240816$EXP$$US-RDY-LIT/USA/24/0011711$DR REDDYS$Lee J, Casey E, Otigbah C, Tompsett K, Pittathankal A, Sirkova A, et al. Hyperparathyroidism Causing life Threatening Hypercalcaemia in Pregnancy. Journal of the Endocrine Society. 2022;6: A166-A167. doi:10.1210/jendso/bvac150.342.$$$I$M$Y$$$20240816$$MD$US$US
242156741$24215674$1$I$20240718$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040140$AUROBINDO$$28$YR$$F$Y$40$KG$20240816$$MD$FR$FR
242156751$24215675$1$I$$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129078$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240816$$CN$US$US
242156761$24215676$1$I$$20240815$20240816$20240816$PER$$NVSC2024US165938$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242156771$24215677$1$I$$20240809$20240816$20240816$EXP$$CY-AMGEN-CYPSP2024159766$AMGEN$$89$YR$E$M$Y$$$20240816$$CN$CY$CY
242156781$24215678$1$I$$20240801$20240816$20240816$EXP$$RU-MELINTA THERAPEUTICS, LLC-RU-MLNT-24-00390$RIBON THERAPEUTICS$$$$$$Y$$$20240816$$CN$RU$RU
242156791$24215679$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003904$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$HP$US$US
242156821$24215682$1$I$$20240808$20240816$20240816$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012283$JAZZ$$$$$F$Y$$$20240816$$CN$US$US
242156831$24215683$1$I$20240731$20240809$20240816$20240816$EXP$$CN-BEIGENE-BGN-2024-012518$BEIGENE$$$$$$Y$$$20240816$$HP$CN$CN
242156841$24215684$1$I$$20240812$20240816$20240816$EXP$$US-AMGEN-USASP2024160353$AMGEN$Miller A.C.; Temiz L.A.; Adjei S. et al.. Treatment of Bullous Pemphigoid With Dupilumab: A Case Series of 30 Patients. Journal of Drugs in Dermatology : JDD. 2024;23 (6):e144-e148$$$$$Y$$$20240816$$MD$US$US
242156851$24215685$1$I$$20240812$20240816$20240816$PER$$US-BIOGEN-2024BI01277977$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
242156861$24215686$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129241$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240816$$CN$US$US
242156872$24215687$2$F$$20240803$20240816$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039319$AUROBINDO$$26$YR$$F$Y$$$20240817$$CN$GB$GB
242156882$24215688$2$F$$20240904$20240816$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003907$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
242156901$24215690$1$I$20240301$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040144$AUROBINDO$$69$YR$$F$Y$63$KG$20240816$$MD$FR$FR
242156911$24215691$1$I$20240711$20240808$20240816$20240816$EXP$IT-MINISAL02-996377$IT-TEVA-VS-3232430$TEVA$$65$YR$$F$Y$$$20240816$$MD$IT$IT
242156921$24215692$1$I$20240529$20240809$20240816$20240816$EXP$$CN-BEIGENE-BGN-2024-012520$BEIGENE$$$$$$Y$$$20240816$$HP$CN$CN
242156931$24215693$1$I$$20240809$20240816$20240816$EXP$$US-HALEON-2191407$Haleon PLC$$$$$$Y$$$20240813$$CN$US$US
242156941$24215694$1$I$$20240809$20240816$20240816$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012338$JAZZ$$$$$M$Y$$$20240816$$CN$US$US
242156952$24215695$2$F$$20240808$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126427$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240817$$CN$US$US
242156971$24215697$1$I$$20240725$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003984$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242156981$24215698$1$I$$20240813$20240816$20240816$EXP$$NVSJ2024JP009693$NOVARTIS$$$$$$Y$$$20240816$$MD$JP$JP
242156991$24215699$1$I$$20240809$20240816$20240816$EXP$$CA-ABBVIE-5876028$ABBVIE$$$$E$F$Y$$$20240816$$CN$CA$CA
242157001$24215700$1$I$$20240812$20240816$20240816$EXP$$US-AMGEN-USASP2024160272$AMGEN$Miller A.C.; Temiz L.A.; Adjei S. et al.. Treatment of Bullous Pemphigoid With Dupilumab: A Case Series of 30 Patients. Journal of Drugs in Dermatology : JDD. 2024;23 (6):e144-e148$74$YR$E$F$Y$$$20240816$$MD$US$US
242157021$24215702$1$I$$20240813$20240816$20240816$EXP$$JP-VANTIVE-2024VAN019019$Vantive US Healthcare$$$$$F$Y$$$20240816$$MD$JP$JP
242157032$24215703$2$F$$20240903$20240816$20240903$PER$$US-ALXN-202408USA000519US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
242157042$24215704$2$F$20240604$20240809$20240816$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408005863$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240822$$CN$US$US
242157051$24215705$1$I$$20240805$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408003917$ELI LILLY AND CO$$30$YR$A$$Y$$$20240816$$LW$US$US
242157061$24215706$1$I$$20240812$20240816$20240816$EXP$$CA-ABBVIE-5879776$ABBVIE$$$$A$F$Y$$$20240816$$CN$CA$CA
242157071$24215707$1$I$20190706$20240812$20240816$20240816$EXP$$CO-UCBSA-2024041296$UCB$$65$YR$$M$Y$$$20240816$$CN$CO$CO
242157082$24215708$2$F$20240809$20240815$20240816$20240816$PER$$NVSC2024US165527$NOVARTIS$$53$YR$$M$Y$$$20240816$$CN$US$US
242157091$24215709$1$I$$20240807$20240816$20240816$EXP$GB-MHRA-MED-202408071416135850-QGJMR$GB-TEVA-VS-3230815$TEVA$$$$$M$Y$$$20240816$$PH$GB$GB
242157101$24215710$1$I$$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160346$AMGEN$Miller A.C.; Temiz L.A.; Adjei S. et al.. Treatment of Bullous Pemphigoid With Dupilumab: A Case Series of 30 Patients. Journal of Drugs in Dermatology : JDD. 2024;23 (6):e144-e148$79$YR$E$F$Y$$$20240816$$MD$US$US
242157111$24215711$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003986$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242157121$24215712$1$I$20240714$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003908$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240816$$CN$US$US
242157131$24215713$1$I$20240530$20240809$20240816$20240816$EXP$$CN-BEIGENE-BGN-2024-012521$BEIGENE$$$$$$Y$$$20240816$$HP$CN$CN
242157141$24215714$1$I$20240527$20240812$20240816$20240816$EXP$$CO-UCBSA-2024038672$UCB$$89$YR$$M$Y$$$20240816$$CN$CO$CO
242157152$24215715$2$F$$20240812$20240816$20240820$PER$$US-BIOGEN-2024BI01278167$BIOGEN$$$$$F$Y$$$20240820$$CN$US$US
242157161$24215716$1$I$20240101$20240809$20240816$20240816$PER$$US-BIOGEN-2024BI01257646$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
242157172$24215717$2$F$20210601$20240903$20240816$20240912$EXP$$US-ROCHE-10000053405$ROCHE$$67$YR$E$F$Y$63.5$KG$20240912$$CN$US$US
242157181$24215718$1$I$$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160304$AMGEN$Miller A.C.; Temiz L.A.; Adjei S. et al.. Treatment of Bullous Pemphigoid With Dupilumab: A Case Series of 30 Patients. Journal of Drugs in Dermatology : JDD. 2024;23 (6):e144-e148$62$YR$A$M$Y$$$20240816$$MD$US$US
242157191$24215719$1$I$$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160335$AMGEN$Miller A.C.; Temiz L.A.; Adjei S. et al.. Treatment of Bullous Pemphigoid With Dupilumab: A Case Series of 30 Patients. Journal of Drugs in Dermatology : JDD. 2024;23 (6):e144-e148$77$YR$E$F$Y$$$20240816$$MD$US$US
242157211$24215721$1$I$$20240809$20240816$20240816$PER$$US-AMGEN-USASP2024158918$AMGEN$$$$$F$Y$$$20240816$$CN$US$US
242157221$24215722$1$I$$20240813$20240816$20240816$EXP$$US-TAKEDA-2024TUS081643$TAKEDA$$$$$F$Y$59$KG$20240816$$MD$US$US
242157231$24215723$1$I$20240810$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129159$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240816$$CN$US$US
242157251$24215725$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003988$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242157261$24215726$1$I$$20240813$20240816$20240816$EXP$$US-ABBVIE-5879650$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242157272$24215727$2$F$20240805$20240805$20240816$20240827$EXP$$NZ-BEH-2024176956$CSL BEHRING$$44$YR$A$M$Y$93$KG$20240827$$HP$NZ$NZ
242157283$24215728$3$F$$20240815$20240816$20240824$EXP$$BR-CELLTRION INC.-2024BR019435$CELLTRION$$$$$$Y$$$20240824$$CN$BR$BR
242157291$24215729$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003910$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242157312$24215731$2$F$20240805$20240816$20240816$20240819$EXP$$NVSC2024GN165565$NOVARTIS$$22$YR$$F$Y$56$KG$20240819$$MD$GN$GN
242157321$24215732$1$I$$20240725$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003987$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242157331$24215733$1$I$$20240812$20240816$20240816$EXP$$DE-SANDOZ INC.-SDZ2024DE072360$SANDOZ$$$$$F$Y$$$20240816$$HP$DE$DE
242157341$24215734$1$I$$20240812$20240816$20240816$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001632$BLUEPRINT MEDICINES$$$$$$Y$$$20240816$$MD$US$US
242157351$24215735$1$I$20240703$20240809$20240816$20240816$EXP$$CN-BEIGENE-BGN-2024-012534$BEIGENE$$$$$$Y$$$20240816$$HP$CN$CN
242157371$24215737$1$I$20240801$20240812$20240816$20240816$PER$$US-BIOGEN-2024BI01277974$BIOGEN$$57$YR$$F$Y$$$20240816$$CN$US$US
242157382$24215738$2$F$$20240918$20240816$20240920$PER$$US-JNJFOC-20240828226$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$HP$US$US
242157391$24215739$1$I$$20240815$20240816$20240816$PER$$US-ROCHE-10000058691$ROCHE$$59$YR$A$F$Y$$$20240816$$HP$US$US
242157411$24215741$1$I$$20240809$20240816$20240816$EXP$$BR-TAKEDA-2023TUS062786$TAKEDA$$$$$M$Y$$$20240816$$CN$BR$BR
242157421$24215742$1$I$$20240812$20240816$20240816$EXP$$IN-AMGEN-INDSP2024160350$AMGEN$Hiwarkar P.; Khan S.; Krishnan V. P. et al.. Disease-burden-adapted immunotherapy protocol for primary refractory or high-risk relapsed pediatric acute lymphoblastic leukemia. HemaSphere. 2024;8 (8):1-5$5$YR$C$$Y$$$20240816$$MD$IN$IN
242157431$24215743$1$I$20240723$20240813$20240816$20240816$EXP$$JP-GENMAB-2024-02947$GENMAB$$69$YR$$$Y$$$20240816$$MD$JP$JP
242157441$24215744$1$I$20240801$20240810$20240816$20240816$PER$$US-009507513-2408USA003871$MERCK$$55$YR$$F$Y$97.5$KG$20240816$$HP$US$US
242157451$24215745$1$I$$20240809$20240816$20240816$PER$$US-BIOGEN-2024BI01278062$BIOGEN$$$$$M$Y$$$20240816$$HP$US$US
242157464$24215746$4$F$$20240821$20240816$20240829$PER$$US-BIOGEN-2024BI01278144$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
242157471$24215747$1$I$$20240814$20240816$20240816$EXP$$US-TAKEDA-2023TUS078858$TAKEDA$$$$$F$Y$$$20240816$$CN$US$US
242157483$24215748$3$F$$20240906$20240816$20240914$EXP$$JP-ROCHE-10000053298$ROCHE$Sekiguchi Y, Tsutsumi H, Gomyo A, Kudo M, Iizaki Y, Maseki N. Usage experience of pola-R-mini-CHP therapy (R-mini-CHP in combination with polatuzumab vedotin) in patients aged 80 or older with diffuse large B-cell lymphoma (DLBCL): 18 case reports from single facility [Abstract number: P-32]. The Journal of the Japanese Society for Lymphoreticular Tissue Research / The 64.. 2024;(64):102.$$$E$$Y$$$20240914$$MD$JP$JP
242157491$24215749$1$I$$20240809$20240816$20240816$EXP$$FR-SANDOZ INC.-SDZ2024FR071791$SANDOZ$$$$$F$Y$$$20240816$$PH$FR$FR
242157501$24215750$1$I$20240730$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024815$UNITED THERAPEUTICS$$$$$$Y$$$20240816$$$US$US
242157511$24215751$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161810$AMGEN$$$$$$Y$$$20240816$$CN$US$US
242157521$24215752$1$I$$20240809$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-025042$UNITED THERAPEUTICS$$$$$M$Y$68.027$KG$20240816$$$US$US
242157541$24215754$1$I$$20240807$20240816$20240816$PER$$US-BIOGEN-2024BI01278327$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
242157552$24215755$2$F$20240814$20240827$20240816$20240829$EXP$$US-ORGANON-O2408USA001185$ORGANON$$50$YR$$F$Y$$$20240828$$MD$US$US
242157561$24215756$1$I$20240101$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129416$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240816$$HP$US$US
242157571$24215757$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128630$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240816$$CN$US$US
242157591$24215759$1$I$$20240813$20240816$20240816$PER$$US-BIOGEN-2024BI01277584$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
242157601$24215760$1$I$$20240812$20240816$20240816$EXP$$DE-JNJFOC-20240832254$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$MD$DE$DE
242157612$24215761$2$F$20240531$20240910$20240816$20240912$EXP$$ES-TAKEDA-2024TUS081845$TAKEDA$$4$YR$$M$Y$$$20240912$$HP$ES$ES
242157621$24215762$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165614$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
242157631$24215763$1$I$20240713$20240812$20240816$20240816$EXP$$NVSC2024EG162902$NOVARTIS$$23$YR$$F$Y$61$KG$20240816$$CN$EG$EG
242157641$24215764$1$I$$20240812$20240816$20240816$EXP$$NVSC2024ZA164164$NOVARTIS$$59$YR$$F$Y$$$20240816$$HP$ZA$ZA
242157651$24215765$1$I$$20240804$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408003084$ELI LILLY AND CO$$62$YR$A$$Y$$$20240816$$LW$US$US
242157661$24215766$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007513$ELI LILLY AND CO$$41$YR$A$$Y$$$20240816$$LW$US$US
242157671$24215767$1$I$20240201$20240814$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009006$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240816$$CN$US$US
242157681$24215768$1$I$$20240814$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008984$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240816$$CN$US$US
242157691$24215769$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008601$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242157703$24215770$3$F$20240101$20240821$20240816$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-024607$UNITED THERAPEUTICS$$$$$M$Y$90.249$KG$20240824$$$US$US
242157711$24215771$1$I$$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408004851$ELI LILLY AND CO$$50$YR$A$$Y$$$20240816$$LW$US$US
242157721$24215772$1$I$$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408004840$ELI LILLY AND CO$$52$YR$A$$Y$$$20240816$$LW$US$US
242157731$24215773$1$I$20240701$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008423$ELI LILLY AND CO$$73$YR$E$$Y$$$20240816$$CN$US$US
242157741$24215774$1$I$$20240804$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408003320$ELI LILLY AND CO$$66$YR$E$$Y$$$20240816$$LW$US$US
242157751$24215775$1$I$$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007396$ELI LILLY AND CO$$72$YR$E$$Y$$$20240816$$LW$US$US
242157761$24215776$1$I$$20240806$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005253$ELI LILLY AND CO$$58$YR$A$$Y$$$20240816$$LW$US$US
242157771$24215777$1$I$20240805$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008326$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242157781$24215778$1$I$20240806$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008353$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240816$$CN$US$US
242157791$24215779$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008728$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240816$$CN$US$US
242157801$24215780$1$I$20240813$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008350$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240816$$CN$US$US
242157811$24215781$1$I$$20230517$20240816$20240816$EXP$$US-AstraZeneca-2023A115789$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242157821$24215782$1$I$20240805$20240812$20240816$20240816$EXP$$GB-AstraZeneca-2024A183064$ASTRAZENECA$$34$YR$$F$Y$53$KG$20240816$$MD$GB$
242157831$24215783$1$I$20230916$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A183166$ASTRAZENECA$$31020$DY$$$Y$$$20240816$$MD$US$
242157841$24215784$1$I$$20220630$20240816$20240816$EXP$$US-AstraZeneca-2022A241034$ASTRAZENECA$$$$A$F$Y$$$20240816$$CN$US$
242157851$24215785$1$I$20221223$20230202$20240816$20240816$EXP$$CA-AstraZeneca-2023A003208$ASTRAZENECA$$17886$DY$$F$Y$$$20240816$$CN$CA$
242157871$24215787$1$I$$20230314$20240816$20240816$EXP$$US-AstraZeneca-2023A063690$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242157881$24215788$1$I$$20240812$20240816$20240816$EXP$$CA-JNJFOC-20240433017$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240816$$HP$CA$CA
242157891$24215789$1$I$20240806$20240809$20240816$20240816$EXP$$CA-CELLTRION INC.-2024CA019433$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
242157901$24215790$1$I$$20240801$20240816$20240816$EXP$$US-Long Grove-000070$Long Grove Pharmaceuticals$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$$$$M$Y$$$20240816$$MD$US$US
242157911$24215791$1$I$$20240813$20240816$20240816$PER$$NVSC2024US165213$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
242157921$24215792$1$I$20240807$20240812$20240816$20240816$EXP$$CN-AMGEN-CHNSP2024159811$AMGEN$$68$YR$E$M$Y$60$KG$20240816$$CN$CN$CN
242157932$24215793$2$F$20240101$20240904$20240816$20240912$EXP$$JP-AMGEN-JPNSP2024162167$AMGEN$$$$$$Y$$$20240912$$PH$JP$JP
242157941$24215794$1$I$$20240806$20240816$20240816$30DAY$$US-GSK-US2024AMR098793$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$US$US
242157951$24215795$1$I$$20240812$20240816$20240816$PER$$US-BIOGEN-2024BI01278066$BIOGEN$$$$$M$Y$$$20240816$$CN$US$US
242157961$24215796$1$I$$20240813$20240816$20240816$30DAY$$DE-ABBVIE-5535716$ABBVIE$$$$$$Y$$$20240816$$HP$DE$DE
242157971$24215797$1$I$$20240802$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124118$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240816$$CN$US$US
242157983$24215798$3$F$20240809$20240905$20240816$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024700$UNITED THERAPEUTICS$$65$YR$$F$Y$107.94$KG$20240914$$$US$US
242157992$24215799$2$F$20240101$20240907$20240816$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-024833$UNITED THERAPEUTICS$$$$$F$Y$68.934$KG$20240917$$$US$US
242158001$24215800$1$I$20240101$20240814$20240816$20240816$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046173$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240816$$CN$US$US
242158021$24215802$1$I$$20240812$20240816$20240816$PER$$US-ROCHE-10000056182$ROCHE$$$$A$$Y$$$20240816$$CN$US$US
242158032$24215803$2$F$20240727$20240823$20240816$20240902$EXP$$GB-TEVA-VS-3231239$TEVA$$34$YR$$M$Y$$$20240902$$MD$GB$GB
242158041$24215804$1$I$20240806$20240806$20240816$20240816$EXP$$GB-TEVA-VS-3230615$TEVA$$85$YR$$F$Y$74$KG$20240816$$MD$GB$GB
242158051$24215805$1$I$$20230802$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2023SP012757$STRIDES$Busey L, Makepeace J.. Lisinopril induced uvular angioedema.. J-Gen-Intern-Med. 2022;38 (Suppl 2):S488-S489.$75$YR$$M$Y$$$20240816$$HP$US$US
242158061$24215806$1$I$$20230821$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2023SP013585$STRIDES$Ling E, Rus N.. NON-CUTANEOUS MELANOMA: AN ELUSIVE DISGUISE.. J-Gen-Intern-Med.. 2023;38(2):S504-S505.$63$YR$$M$Y$$$20240816$$HP$US$US
242158071$24215807$1$I$20240718$20240808$20240816$20240816$EXP$IT-MINISAL02-996954$IT-TEVA-VS-3232418$TEVA$$65$YR$$F$Y$60$KG$20240816$$MD$IT$IT
242158081$24215808$1$I$$20240123$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP001095$STRIDES$Ingley M, Quebedeaux P, Schmidbauer K, Amghaiab IA, Chan J.. Hyperglycemia Dilemma: Concomitant Type 1 Diabetes Mellitus and Cushing^s disease. J-Endocr-Soc. 2022;6(1):A624-A625 abstr. PMON315.$11$YR$$M$Y$$$20240816$$MD$US$US
242158091$24215809$1$I$$20240422$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005015$STRIDES$Laudon S, Duncanson L, Sandercock K, Morales-Ortiz M, Ramos A, Pishko S.. The complexities of care in a teenager with neuropsychiatric lupus.. Am-J-Med-Sci. 2024;367 (Suppl.):S265.$16$YR$$F$Y$$$20240816$$HP$US$US
242158101$24215810$1$I$$20240814$20240816$20240816$PER$$US-HALEON-2192070$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242158111$24215811$1$I$$20240507$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005454$STRIDES$Flinn C, Massaro I.. Isolated Laryngeal Angioedema in a Patient with Long-term ACE Inhibitor Use: A Case Report.. Clinical Practice and Cases in Emergency Medicine. 2024;8(1):18-21$82$YR$$F$Y$$$20240816$$HP$US$US
242158122$24215812$2$F$20240601$20240903$20240816$20240903$PER$$US-ALXN-202408USA000547US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$PH$US$US
242158132$24215813$2$F$$20240903$20240816$20240909$EXP$$CA-SANDOZ INC.-NVSC2022CA178740$SANDOZ$$$$$F$Y$$$20240909$$CN$CA$CA
242158142$24215814$2$F$$20240903$20240816$20240903$PER$$US-ALXN-202408USA000543US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
242158161$24215816$1$I$$20240814$20240816$20240816$PER$$US-HALEON-2192093$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242158171$24215817$1$I$$20240813$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072584$SANDOZ$$79$YR$$M$Y$$$20240816$$CN$CA$CA
242158191$24215819$1$I$$20240802$20240816$20240816$EXP$$US-HLS-202400703$HLS THERAPEUTICS$$$$A$M$Y$$$20240816$$HP$US$US
242158201$24215820$1$I$$20240810$20240816$20240816$PER$$US-ROCHE-10000056090$ROCHE$$$$$M$Y$$$20240816$$CN$US$US
242158213$24215821$3$F$20240101$20240910$20240816$20240917$EXP$$CA-CELLTRION INC.-2024CA014668$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
242158222$24215822$2$F$20240101$20240831$20240816$20240905$EXP$$CA-ABBVIE-5879761$ABBVIE$$38$YR$$M$Y$$$20240905$$CN$CA$CA
242158231$24215823$1$I$$20240814$20240816$20240816$EXP$$JP-GSK-JP2024JPN101470$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$JP$JP
242158241$24215824$1$I$$20240814$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072687$SANDOZ$$58$YR$$F$Y$78$KG$20240816$$PH$CA$CA
242158253$24215825$3$F$20240802$20240912$20240816$20240921$EXP$$GB-CELLTRION INC.-2024GB013073$CELLTRION$$$$$$Y$$$20240921$$CN$GB$GB
242158261$24215826$1$I$$20240807$20240816$20240816$EXP$$US-ABBVIE-5882685$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242158272$24215827$2$F$20240703$20240913$20240816$20240919$PER$$US-ABBVIE-5872970$ABBVIE$$45$YR$$F$Y$70$KG$20240919$$HP$US$US
242158281$24215828$1$I$$20240814$20240816$20240816$PER$$US-HALEON-2192157$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242158291$24215829$1$I$$20240813$20240816$20240816$EXP$$US-ABBVIE-5880098$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242158301$24215830$1$I$$20240812$20240816$20240816$PER$$US-CHATTEMPRD-2024OHG027275$CHATTEM$$6$YR$C$M$Y$$$20240816$$CN$US$US
242158313$24215831$3$F$$20240919$20240816$20240920$EXP$$US-JNJFOC-20240828756$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
242158321$24215832$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161865$AMGEN$$$$$$Y$$$20240816$$PH$US$US
242158331$24215833$1$I$$20240803$20240816$20240816$EXP$$NL-AUROBINDO-AUR-APL-2024-039903$AUROBINDO$$63$YR$$M$Y$92$KG$20240816$$MD$NL$NL
242158341$24215834$1$I$$20240804$20240816$20240816$EXP$$US-CBL-002751$CONCORD BIOTECH$Manuel SL, Sapone J, Lin F. Tacrolimus-Induced Recurrent Acute Coronary Syndrome Due to an Unknown Mechanism. Cureus. 2024 Jun 27;16(6):e63266. doi: 10.7759/cureus.63266.$74$YR$E$F$Y$$$20240816$$HP$US$US
242158352$24215835$2$F$$20240917$20240816$20240921$PER$$US-ROCHE-10000055714$ROCHE$$$$E$M$Y$$$20240921$$CN$US$US
242158361$24215836$1$I$$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408004736$ELI LILLY AND CO$$58$YR$A$$Y$$$20240816$$LW$US$US
242158381$24215838$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008325$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240816$$CN$US$US
242158391$24215839$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008348$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240816$$CN$US$US
242158412$24215841$2$F$20240520$20240913$20240816$20240921$EXP$$IN-ROCHE-10000057709$ROCHE$$75$YR$E$M$Y$$$20240921$$CN$IN$IN
242158421$24215842$1$I$20240808$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008349$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240816$$CN$US$US
242158431$24215843$1$I$$20240813$20240816$20240816$PER$$US-ABBVIE-5881314$ABBVIE$$$$A$F$Y$$$20240816$$MD$US$US
242158451$24215845$1$I$$20240815$20240816$20240816$PER$$NVSC2024US166008$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242158471$24215847$1$I$20240812$20240812$20240816$20240816$PER$$US-BIOGEN-2024BI01278008$BIOGEN$$53$YR$$F$Y$$$20240816$$CN$US$US
242158483$24215848$3$F$$20240830$20240816$20240902$EXP$$HU-JNJFOC-20240837477$JOHNSON AND JOHNSON$Sudden cardiac death of a patient who has basically low profile. Does psychiatric treatment modify risk?. Cardiologia Hungarica.$18$YR$A$M$Y$$$20240903$$HP$HU$HU
242158501$24215850$1$I$$20240814$20240816$20240816$PER$$US-HALEON-2192026$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242158511$24215851$1$I$20240101$20240812$20240816$20240816$EXP$$US-ABBVIE-5878170$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242158521$24215852$1$I$20230706$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040061$AUROBINDO$$80$YR$$M$Y$$$20240816$$PH$FR$FR
242158531$24215853$1$I$$20240808$20240816$20240816$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP010117$STRIDES$Bingert R, Kolbe V, Boy D, Buttner A.. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. [German].. Rechtsmedizin. 2023;33 (5):396-402$14$YR$$F$Y$$$20240816$$HP$DE$DE
242158541$24215854$1$I$$20240812$20240816$20240816$EXP$$US-ABBVIE-5877770$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242158551$24215855$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165492$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
242158561$24215856$1$I$$20240808$20240816$20240816$EXP$$US-ABBVIE-5818854$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242158571$24215857$1$I$20101112$20240621$20240816$20240816$EXP$$NZ-ROCHE-10000044475$ROCHE$$45$YR$A$M$Y$52$KG$20240816$$HP$NZ$NZ
242158581$24215858$1$I$$20240813$20240816$20240816$EXP$$US-AMGEN-USASP2024161691$AMGEN$$$$$$Y$$$20240816$$PH$US$US
242158591$24215859$1$I$20230101$20240814$20240816$20240816$EXP$$US-CIPLA (EU) LIMITED-2024US08359$CIPLA$$$$$$Y$$$20240816$$CN$US$US
242158601$24215860$1$I$20240506$20240807$20240816$20240816$PER$$US-ROCHE-3562697$ROCHE$$39$YR$A$F$Y$$$20240816$$CN$US$US
242158612$24215861$2$F$20190130$20240826$20240816$20240829$EXP$DE-002147023-PHHY2019DE121451$DE-RDY-CLI/GER/23/0183359$DR REDDYS$$68$YR$E$F$Y$88.8$KG$20240829$$MD$DE$DE
242158621$24215862$1$I$20240723$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003935$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240816$$CN$US$US
242158631$24215863$1$I$20240714$20240813$20240816$20240816$EXP$$KR-AstraZeneca-2024A186078$ASTRAZENECA$$20455$DY$$M$Y$$$20240816$$CN$KR$
242158641$24215864$1$I$$20230929$20240816$20240816$EXP$$US-AstraZeneca-2023A186605$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242158651$24215865$1$I$20240809$20240809$20240816$20240816$EXP$$US-AstraZeneca-2024A181778$ASTRAZENECA$$76$YR$$M$Y$64$KG$20240816$$HP$US$
242158661$24215866$1$I$$20240805$20240816$20240816$EXP$GB-MHRA-TPP17742326C576475YC1722345779072$GB-Accord-440405$ACCORD$$56$YR$A$M$Y$125$KG$20240816$$HP$GB$GB
242158671$24215867$1$I$$20240809$20240816$20240816$EXP$$US-AstraZeneca-2024A182404$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242158681$24215868$1$I$$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129327$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240816$$CN$US$US
242158692$24215869$2$F$$20240913$20240816$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129554$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$67.13$KG$20240916$$CN$US$US
242158701$24215870$1$I$$20240808$20240816$20240816$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP010118$STRIDES$Bingert R, Kolbe V, Boy D, Buttner A.. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. [German].. Rechtsmedizin. 2023;33 (5):396-402$17$YR$$F$Y$$$20240816$$HP$DE$DE
242158712$24215871$2$F$$20240809$20240816$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-128454$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240821$$MD$JP$JP
242158721$24215872$1$I$20240729$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129050$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240816$$CN$US$US
242158731$24215873$1$I$20240101$20240801$20240816$20240816$PER$$US-EPICPHARMA-US-2024EPCSPO00970$EPIC PHARM$$72$YR$E$F$Y$140$KG$20240816$$CN$US$US
242158741$24215874$1$I$20240223$20240803$20240816$20240816$EXP$$SK-AUROBINDO-AUR-APL-2024-039310$AUROBINDO$$75$YR$$F$Y$$$20240816$$MD$SK$SK
242158751$24215875$1$I$20240705$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040023$AUROBINDO$$76$YR$$F$Y$$$20240816$$HP$FR$FR
242158761$24215876$1$I$20240630$20240812$20240816$20240816$EXP$$CO-UCBSA-2024041289$UCB$$76$YR$$F$Y$$$20240816$$CN$CO$CO
242158771$24215877$1$I$$20240808$20240816$20240816$PER$$US-JNJFOC-20240821521$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$PH$US$US
242158791$24215879$1$I$$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162581$AMGEN$$$$$$Y$$$20240816$$HP$US$US
242158801$24215880$1$I$$20240808$20240816$20240816$EXP$US-MLMSERVICE-20240320-4895904-1$US-STRIDES ARCOLAB LIMITED-2024SP010090$STRIDES$Suffian H, Le T, Pandya A.. COMPLICATIONS POST-CHEMOTHERAPY IN A CHILD WITH T-CELL LEUKEMIA AND ATAXIA TELANGIECTASIA.. Ann-Allergy-Asthma-Immunol. 2023;131(Suppl.1)(5):S156 abstr. M261$4$YR$$M$Y$$$20240816$$HP$US$US
242158821$24215882$1$I$$20240809$20240816$20240816$PER$$US-ROCHE-10000054379$ROCHE$$71$YR$E$M$Y$$$20240816$$CN$US$US
242158831$24215883$1$I$$20240814$20240816$20240816$PER$$US-TAKEDA-2024TUS081945$TAKEDA$$$$$F$Y$$$20240816$$CN$US$US
242158861$24215886$1$I$$20240807$20240816$20240816$PER$$US-TAKEDA-2024TUS079140$TAKEDA$$$$$$Y$$$20240816$$CN$US$US
242158871$24215887$1$I$$20240801$20240816$20240816$PER$$US-EPICPHARMA-US-2024EPCSPO00967$EPIC PHARM$$57$YR$A$M$Y$92.98$KG$20240816$$CN$US$US
242158883$24215888$3$F$20240701$20240910$20240816$20240912$PER$$US-BIOGEN-2024BI01247488$BIOGEN$$54$YR$$F$Y$$$20240912$$CN$US$US
242158891$24215889$1$I$$20240812$20240816$20240816$PER$$US-BIOGEN-2024BI01278019$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
242158903$24215890$3$F$20240701$20240906$20240816$20240920$30DAY$$US-JNJFOC-20240831536$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240920$$CN$US$US
242158911$24215891$1$I$$20240803$20240816$20240816$EXP$$DE-AUROBINDO-AUR-APL-2024-039999$AUROBINDO$$$$$M$Y$$$20240816$$CN$DE$DE
242158921$24215892$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003911$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242158931$24215893$1$I$20240401$20240803$20240816$20240816$EXP$$IT-AUROBINDO-AUR-APL-2024-040087$AUROBINDO$$69$YR$$M$Y$$$20240816$$PH$IT$IT
242158941$24215894$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165412$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
242158951$24215895$1$I$$20240803$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039312$AUROBINDO$$26$YR$$F$Y$$$20240816$$CN$GB$GB
242158962$24215896$2$F$$20240830$20240816$20240830$PER$$US-ALXN-202408USA000591US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240830$$HP$US$US
242158971$24215897$1$I$$20240722$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004283$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242158981$24215898$1$I$$20230705$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202307-000031$OREXO$$$$$F$Y$$$20240816$$CN$US$
242158991$24215899$1$I$$20230703$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202307-000030$OREXO$$$$$M$Y$$$20240816$$$US$
242159001$24215900$1$I$$20230703$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202307-000029$OREXO$$46$YR$$F$Y$$$20240816$$CN$US$
242159011$24215901$1$I$20240719$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040154$AUROBINDO$$65$YR$$M$Y$86.6$KG$20240816$$PH$FR$FR
242159021$24215902$1$I$$20230711$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202307-000033$OREXO$$$$$M$Y$$$20240816$$CN$US$
242159031$24215903$1$I$$20230710$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202307-000032$OREXO$$$$$M$Y$$$20240816$$CN$US$
242159041$24215904$1$I$$20230801$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202308-000034$OREXO$$$$$F$Y$$$20240816$$CN$US$
242159051$24215905$1$I$$20230811$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202308-000035$OREXO$$$$$F$Y$$$20240816$$CN$US$
242159061$24215906$1$I$20230717$20230904$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202309-000036$OREXO$$39$YR$A$M$Y$113$KG$20240816$$MD$US$
242159071$24215907$1$I$20230905$20230905$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202309-000037$OREXO$$$$$M$Y$$$20240816$$$US$
242159081$24215908$1$I$$20240809$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010213$STRIDES$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al.. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children.. ASAIO-J. 2024;70 (7):e92-e96$14$YR$$F$Y$$$20240816$$HP$US$US
242159091$24215909$1$I$$20230907$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202309-000038$OREXO$$$$$F$Y$$$20240816$$CN$US$
242159101$24215910$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129480$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240816$$HP$US$US
242159111$24215911$1$I$20240731$20240808$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127075$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$66.68$KG$20240816$$HP$US$US
242159121$24215912$1$I$$20231026$20240816$20240816$EXP$$US-Orexo US, Inc.-ORE202310-000040$OREXO$$$$$F$Y$$$20240816$$MD$US$
242159131$24215913$1$I$$20231002$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202310-000039$OREXO$$$$$M$Y$68.03$KG$20240816$$CN$US$
242159141$24215914$1$I$$20231030$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202311-000042$OREXO$$$$$M$Y$$$20240816$$CN$US$
242159151$24215915$1$I$20231001$20231026$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202310-000041$OREXO$$64$YR$A$F$Y$72.12$KG$20240816$$CN$US$
242159161$24215916$1$I$$20240727$20240816$20240816$PER$$US-UniquePharma-US-2024UPLSPO00026$UNIQUE PHARMACEUTICALS$$37$YR$A$$Y$160$KG$20240816$$CN$US$US
242159171$24215917$1$I$$20231108$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202311-000043$OREXO$$$$$M$Y$$$20240816$$CN$US$
242159181$24215918$1$I$$20231115$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202311-000045$OREXO$$$$$$Y$$$20240816$$CN$US$
242159191$24215919$1$I$$20231116$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202311-000046$OREXO$$$$$$Y$$$20240816$$HP$US$
242159201$24215920$1$I$20231102$20231227$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202311-000048$OREXO$$49$YR$A$F$Y$49.89$KG$20240816$$MD$US$
242159211$24215921$1$I$20230101$20231121$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202311-000049$OREXO$$$$$M$Y$$$20240816$$CN$US$
242159221$24215922$1$I$$20231128$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202311-000050$OREXO$$$$$M$Y$$$20240816$$CN$US$
242159231$24215923$1$I$$20240809$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010214$STRIDES$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al.. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children.. ASAIO-J. 2024;70 (7):e92-e96$15$YR$$F$Y$$$20240816$$HP$US$US
242159241$24215924$1$I$20240101$20240808$20240816$20240816$EXP$$US-GILEAD-2024-0674428$GILEAD$$84$YR$E$F$Y$$$20240816$$CN$US$US
242159261$24215926$1$I$20230101$20231208$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202312-000051$OREXO$$$$$F$Y$$$20240816$$CN$US$
242159271$24215927$1$I$$20231211$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202312-000052$OREXO$$$$$$Y$$$20240816$$CN$US$
242159281$24215928$1$I$20231205$20231212$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202312-000053$OREXO$$39$YR$A$M$Y$104$KG$20240816$$CN$US$
242159292$24215929$2$F$20240807$20240823$20240816$20240903$EXP$$JP-CHEPLA-2024010503$CHEPLAPHARM$$9$DEC$$F$Y$$$20240903$$PH$COUNTRY NOT SPECIFIED$JP
242159301$24215930$1$I$$20240102$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202401-000001$OREXO$$$$$F$Y$$$20240816$$CN$US$
242159311$24215931$1$I$$20231227$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202312-000054$OREXO$$$$$M$Y$$$20240816$$CN$US$
242159321$24215932$1$I$20240720$20240803$20240816$20240816$EXP$$ES-AUROBINDO-AUR-APL-2024-039721$AUROBINDO$$99$YR$$F$Y$47.7$KG$20240816$$MD$ES$ES
242159331$24215933$1$I$$20240105$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202401-000002$OREXO$$$$$F$Y$$$20240816$$CN$US$
242159341$24215934$1$I$$20240119$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202401-000003$OREXO$$$$$F$Y$$$20240816$$CN$US$
242159351$24215935$1$I$$20240122$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202401-000004$OREXO$$$$$$Y$$$20240816$$MD$US$
242159361$24215936$1$I$$20240202$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202402-000005$OREXO$$$$$F$Y$88.4$KG$20240816$$CN$US$
242159371$24215937$1$I$$20240202$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202402-000006$OREXO$$$$$$Y$$$20240816$$MD$US$
242159381$24215938$1$I$$20240212$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202402-000009$OREXO$$$$$F$Y$$$20240816$$CN$US$
242159392$24215939$2$F$20220101$20240806$20240816$20240819$EXP$$CZ-ROCHE-3577748$ROCHE$Matlova K, Sakarova B L. Two Cases of Rare Bisphosphonates Treatment Side Effects : Atypical Femoral Fracture and Inflammatory Eye Reaction. JBMR Plus. 2023;7 (Supp 3):$72$YR$E$F$Y$$$20240819$$HP$CZ$CZ
242159401$24215940$1$I$$20240809$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010218$STRIDES$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al.. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children.. ASAIO-J. 2024;70 (7):e92-e96.$12$YR$$F$Y$$$20240816$$HP$US$US
242159411$24215941$1$I$$20240326$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202403-000016$OREXO$$$$$F$Y$$$20240816$$MD$US$
242159421$24215942$1$I$$20240401$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202404-000018$OREXO$$$$$F$Y$63.5$KG$20240816$$CN$US$
242159431$24215943$1$I$$20240424$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202404-000019$OREXO$$$$$F$Y$$$20240816$$CN$US$
242159441$24215944$1$I$$20240426$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202404-000020$OREXO$$$$$M$Y$$$20240816$$CN$US$
242159451$24215945$1$I$$20240506$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202405-000022$OREXO$$$$$F$Y$$$20240816$$CN$US$
242159461$24215946$1$I$$20240509$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202405-000023$OREXO$$$$$$Y$$$20240816$$CN$US$
242159471$24215947$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008331$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240816$$CN$US$US
242159483$24215948$3$F$$20240923$20240816$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202408008274$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240925$$CN$US$US
242159491$24215949$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007144$ELI LILLY AND CO$$60$YR$A$$Y$$$20240816$$LW$US$US
242159501$24215950$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009250$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242159511$24215951$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008316$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240816$$CN$US$US
242159521$24215952$1$I$20240101$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008553$ELI LILLY AND CO$$$$$F$Y$$$20240816$$MD$US$US
242159531$24215953$1$I$20240812$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008645$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240816$$CN$US$US
242159541$24215954$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009302$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240816$$CN$US$US
242159551$24215955$1$I$$20240516$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202405-000024$OREXO$$$$$M$Y$$$20240816$$CN$US$
242159561$24215956$1$I$20240601$20240624$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202406-000027$OREXO$$32$YR$A$M$Y$58.96$KG$20240816$$CN$US$
242159571$24215957$1$I$20240626$20240626$20240816$20240816$PER$$US-Orexo US, Inc.-ORE202406-000030$OREXO$$75$YR$E$M$Y$62.59$KG$20240816$$CN$US$
242159581$24215958$1$I$20220101$20240814$20240816$20240816$EXP$$US-GILEAD-2024-0684316$GILEAD$$70$YR$E$M$Y$$$20240816$$CN$US$US
242159591$24215959$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165421$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
242159601$24215960$1$I$$20240812$20240816$20240816$EXP$$US-JNJFOC-20240830598$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$CN$US$US
242159611$24215961$1$I$$20240723$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003912$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242159623$24215962$3$F$$20240930$20240816$20240930$PER$$NVSC2024US165859$NOVARTIS$$33$YR$$M$Y$$$20240930$$CN$US$US
242159632$24215963$2$F$20240528$20240815$20240816$20240821$EXP$$US-ABBVIE-5878195$ABBVIE$$78$YR$$F$Y$58$KG$20240821$$CN$US$US
242159641$24215964$1$I$$20240815$20240816$20240816$PER$$US-ROCHE-10000058756$ROCHE$$$$A$M$Y$$$20240816$$MD$US$US
242159651$24215965$1$I$$20240625$20240816$20240816$EXP$$CN-ROCHE-10000057099$ROCHE$$64$YR$A$M$Y$$$20240816$$MD$CN$CN
242159661$24215966$1$I$$20240812$20240816$20240816$EXP$$US-ABBVIE-5878559$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242159671$24215967$1$I$20230101$20240812$20240816$20240816$EXP$$DE-862174955-ML2024-04465$MICRO LABS$$77$YR$E$M$Y$76$KG$20240816$$MD$DE$DE
242159681$24215968$1$I$20240809$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160290$AMGEN$$69$YR$E$F$Y$$$20240816$$CN$US$US
242159691$24215969$1$I$$20240806$20240816$20240816$EXP$$CZ-CHEPLA-2024010588$CHEPLAPHARM$Nov?kov? M, Kotolov? H, Ustohal L. Zku?enost s pod?n?m klozapinu a dlouhodobe pusob?c?ho paliperidonu palmit?tu v kombinaci u pacienta s paranoidn? schizofreni? a ab?zem marihuany. Cesk? a slovensk? psychiatrie, 2024/3.$45$YR$$M$Y$$$20240816$$HP$COUNTRY NOT SPECIFIED$CZ
242159701$24215970$1$I$$20240809$20240816$20240816$EXP$$GB-862174955-ML2024-04456$MICRO LABS$$35$YR$A$F$Y$73$KG$20240816$$PH$GB$GB
242159721$24215972$1$I$$20240805$20240816$20240816$EXP$$US-862174955-ML2024-04439$MICRO LABS$Wagle L, Regmi DR, Regmi R, Poudel S, Pant HN. Metformin Toxicity Leading to Severe Refractory Hyperkalemia and Metabolic Acidosis: A Case Report. Cureus. 2024;16(6):e63130. DOI: 10.7759/cureus.63130.$74$YR$E$M$Y$$$20240816$$MD$US$US
242159731$24215973$1$I$20240731$20240807$20240816$20240816$EXP$$GB-862174955-ML2024-04419$MICRO LABS$$74$YR$E$F$Y$103$KG$20240816$$HP$GB$GB
242159741$24215974$1$I$20240810$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127914$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240816$$CN$US$US
242159752$24215975$2$F$$20240906$20240816$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129162$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240909$$HP$US$US
242159762$24215976$2$F$20240810$20240813$20240816$20240821$EXP$$US-CHATTEMPRD-2024OHG026900$CHATTEM$$$$E$F$Y$$$20240821$$CN$US$US
242159771$24215977$1$I$$20240806$20240816$20240816$EXP$GB-MHRA-31415142$GB-TEVA-VS-3231124$TEVA$$$$$F$Y$$$20240816$$CN$GB$GB
242159781$24215978$1$I$$20240803$20240816$20240816$EXP$$IT-AUROBINDO-AUR-APL-2024-039850$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al.. Surgical treatment of invasive fungal infection in pediatric oncology.. Eur-J-Haematol. 2024;113 (1):90-98.$10$YR$$F$Y$$$20240816$$HP$IT$IT
242159791$24215979$1$I$$20240806$20240816$20240816$EXP$$BR-JNJFOC-20240821429$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240816$$MD$BR$BR
242159801$24215980$1$I$$20240801$20240816$20240816$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07852$LUPIN$Abbasi F, Garcia SN, Dean J. Disseminated cryptococcosis in an HIV negative patient on hemodialysis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A1684$67$YR$$M$Y$$$20240816$$HP$US$US
242159812$24215981$2$F$20240807$20240912$20240816$20240919$PER$$US-ROCHE-10000053969$ROCHE$$73$YR$E$F$Y$79.37$KG$20240919$$CN$US$US
242159821$24215982$1$I$$20240814$20240816$20240816$EXP$$TW-GILEAD-2024-0684180$GILEAD$$50$YR$A$M$Y$$$20240816$$MD$TW$TW
242159831$24215983$1$I$20221201$20221216$20240816$20240816$EXP$$US-AstraZeneca-2022A410670$ASTRAZENECA$$777$MON$$F$Y$$$20240816$$CN$US$
242159851$24215985$1$I$20240714$20240804$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039389$AUROBINDO$$71$YR$$M$Y$83$KG$20240816$$CN$GB$GB
242159861$24215986$1$I$$20230324$20240816$20240816$EXP$$US-AstraZeneca-2023A033662$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242159871$24215987$1$I$$20240808$20240816$20240816$EXP$$ZA-AstraZeneca-2024A183401$ASTRAZENECA$$73$YR$$F$Y$$$20240816$$CN$ZA$
242159881$24215988$1$I$$20230807$20240816$20240816$EXP$$US-AstraZeneca-2023A180449$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242159891$24215989$1$I$$20230809$20240816$20240816$EXP$$US-AstraZeneca-2023A184671$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242159901$24215990$1$I$$20230412$20240816$20240816$EXP$$ZA-AstraZeneca-2023A061872$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$ZA$
242159912$24215991$2$F$$20240820$20240816$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003971$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
242159922$24215992$2$F$$20240927$20240816$20240927$PER$$NVSC2024US166051$NOVARTIS$$$$$M$Y$$$20240927$$HP$US$US
242159931$24215993$1$I$20240604$20240804$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039368$AUROBINDO$$85$YR$$F$Y$76$KG$20240816$$CN$GB$GB
242159941$24215994$1$I$20220222$20240803$20240816$20240816$EXP$$DE-AUROBINDO-AUR-APL-2024-040007$AUROBINDO$$51$YR$$F$Y$72$KG$20240816$$MD$DE$DE
242159951$24215995$1$I$$20240808$20240816$20240816$PER$$US-ROCHE-10000053114$ROCHE$$$$$$Y$$$20240816$$CN$US$US
242159961$24215996$1$I$20240101$20240807$20240816$20240816$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024740$UNITED THERAPEUTICS$$$$$M$Y$70.295$KG$20240816$$$US$US
242159971$24215997$1$I$$20240810$20240816$20240816$PER$$US-ROCHE-10000054899$ROCHE$$56$YR$A$F$Y$$$20240816$$CN$US$US
242159981$24215998$1$I$20240810$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024162411$AMGEN$$72$YR$E$F$Y$$$20240816$$CN$US$US
242159991$24215999$1$I$20240729$20240804$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039374$AUROBINDO$$33$YR$$F$Y$54$KG$20240816$$CN$GB$GB
242160001$24216000$1$I$$20240807$20240816$20240816$EXP$$US-APOTEX-2024AP009192$APOTEX$Goyal A, Jakula RS, Hans K, Kolbeck MC, Yarrarapu SN, Bhyan P, et al. Accidental Minoxidil Ingestion Causing Refractory Shock, Pulmonary Edema, and Significant EKG Changes. US Cardiology Review. 2024;18 (Suppl):23-24$51$YR$$M$Y$$$20240816$$HP$US$US
242160041$24216004$1$I$20240812$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129094$BRISTOL MYERS SQUIBB$$31$YR$A$F$Y$$$20240816$$HP$US$US
242160051$24216005$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128562$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240816$$HP$US$US
242160062$24216006$2$F$20240801$20240816$20240816$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129464$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240822$$PH$US$US
242160071$24216007$1$I$20240101$20240807$20240816$20240816$PER$$US-ABBVIE-5873433$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242160081$24216008$1$I$$20240806$20240816$20240816$EXP$$CA-TOLMAR, INC.-24CA051646$TOLMAR$$$$$M$Y$$$20240814$$CN$CA$CA
242160091$24216009$1$I$$20240806$20240816$20240816$EXP$$CA-TOLMAR, INC.-24CA051702$TOLMAR$$$$$M$Y$$$20240814$$CN$CA$CA
242160101$24216010$1$I$$20240806$20240816$20240816$EXP$$CA-TOLMAR, INC.-24CA051647$TOLMAR$$$$$M$Y$$$20240814$$CN$CA$CA
242160111$24216011$1$I$$20240812$20240816$20240816$EXP$$US-GILEAD-2024-0683953$GILEAD$$$$E$F$Y$$$20240816$$HP$US$US
242160121$24216012$1$I$$20240501$20240816$20240816$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06344$HIKMA$Seidler N, Terlep O, Ramanujam V.. Seidler N, Terlep O, Ramanujam V. Peripheral nerve blocks for through-knee amputation in a patient on extracorporeal membrane oxygenation. BMJ Case Reports. 2024;17(3):e259987$5$DEC$$F$Y$$$20240816$$MD$US$US
242160131$24216013$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007170$ELI LILLY AND CO$$42$YR$A$$Y$$$20240816$$LW$US$US
242160141$24216014$1$I$20240813$20240814$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009077$ELI LILLY AND CO$$29$YR$A$M$Y$$$20240816$$PH$US$US
242160151$24216015$1$I$20240813$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009306$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242160161$24216016$1$I$20240802$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009308$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240816$$CN$US$US
242160171$24216017$1$I$$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408004976$ELI LILLY AND CO$$52$YR$A$$Y$$$20240816$$LW$US$US
242160181$24216018$1$I$$20240814$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008951$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240816$$CN$US$US
242160191$24216019$1$I$20240501$20240814$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008953$ELI LILLY AND CO$$$$A$F$Y$$$20240816$$MD$US$US
242160202$24216020$2$F$20240731$20240919$20240816$20240927$EXP$$AU-BEH-2024176775$CSL BEHRING$$66$YR$E$F$Y$88$KG$20240927$$HP$AU$AU
242160211$24216021$1$I$20240802$20240815$20240816$20240816$EXP$$CN-ROCHE-10000058650$ROCHE$$75$YR$E$F$Y$60.1$KG$20240816$$HP$CN$CN
242160221$24216022$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165787$NOVARTIS$$$$$M$Y$$$20240816$$CN$US$US
242160231$24216023$1$I$20240811$20240813$20240816$20240816$PER$$NVSC2024US164504$NOVARTIS$$54$YR$$M$Y$$$20240816$$CN$US$US
242160241$24216024$1$I$20240726$20240815$20240816$20240816$EXP$IT-MINISAL02-998904$IT-GILEAD-2024-0684394$GILEAD$$80$YR$E$M$Y$$$20240816$$MD$IT$IT
242160252$24216025$2$F$$20240827$20240816$20240902$EXP$$US-AMGEN-USASP2024161932$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024$$$$$Y$$$20240902$$MD$US$US
242160261$24216026$1$I$20240811$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160361$AMGEN$$72$YR$E$M$Y$$$20240816$$CN$US$US
242160271$24216027$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161862$AMGEN$$$$$$Y$$$20240816$$PH$US$US
242160281$24216028$1$I$20220101$20240812$20240816$20240816$EXP$$GB-AMGEN-GBRSP2024160695$AMGEN$$$$$F$Y$$$20240816$$CN$GB$GB
242160301$24216030$1$I$20240101$20240813$20240816$20240816$EXP$$US-ABBVIE-5818627$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242160312$24216031$2$F$20240601$20240826$20240816$20240908$EXP$$CA-UCBSA-2024028386$UCB$$64$YR$$M$Y$$$20240909$$CN$CA$CA
242160322$24216032$2$F$20240101$20240820$20240816$20240826$EXP$$NL-RECORDATI RARE DISEASE INC.-2024006107$RECORDATI$$$$$$Y$$$20240826$$CN$NL$NL
242160331$24216033$1$I$20240701$20240809$20240816$20240816$EXP$$JP-AMGEN-JPNSP2024161734$AMGEN$$8$DEC$E$F$Y$$$20240816$$MD$JP$JP
242160341$24216034$1$I$$20240812$20240816$20240816$EXP$$US-AMGEN-USASP2024160327$AMGEN$$57$YR$A$F$Y$$$20240816$$CN$US$US
242160351$24216035$1$I$$20240725$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009349$STRIDES$$92$YR$$F$Y$$$20240816$$PH$US$US
242160361$24216036$1$I$$20240603$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006575$STRIDES$$61$YR$$M$Y$$$20240816$$CN$US$US
242160371$24216037$1$I$$20240619$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007565$STRIDES$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients.. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster)$$$$$Y$$$20240816$$HP$US$US
242160381$24216038$1$I$$20240725$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP009558$STRIDES$Patel G, Khan DA.. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria.. J-Allergy-Clin-Immunol-Pract. 2024;12 (6):1663-1665$49$YR$$F$Y$$$20240816$$MD$US$US
242160391$24216039$1$I$$20240812$20240816$20240816$EXP$$US-JNJFOC-20240832836$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240816$$MD$US$US
242160401$24216040$1$I$$20240803$20240816$20240816$EXP$$IT-AUROBINDO-AUR-APL-2024-039927$AUROBINDO$$75$YR$$M$Y$74$KG$20240816$$MD$IT$IT
242160411$24216041$1$I$$20240812$20240816$20240816$EXP$NL-LRB-00995812$NL-BIOCON-BCN-2024-000162$BIOCON$$64$YR$A$F$Y$64$KG$20240816$$CN$NL$NL
242160421$24216042$1$I$$20240805$20240816$20240816$EXP$$US-RDY-LIT/USA/24/0011754$DR REDDYS$Wagner CB, Julian K, Bryan B, Steinbach MN, Shewan S, Maxwell L, et al. Carfilzomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (KDCEP) for the Treatment of Relapsed/Refractory Aggressive Plasma Cell Dyscrasias. Blood. 2023 Nov 28;142: 6623. doi:10.1182/blood-2023-174123.$$$$$Y$$$20240816$$HP$US$US
242160431$24216043$1$I$$20240805$20240816$20240816$EXP$$US-RDY-LIT/USA/24/0011764$DR REDDYS$Wagner CB, Julian K, Bryan B, Steinbach MN, Shewan S, Maxwell L, et al. Carfilzomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (KDCEP) for the Treatment of Relapsed/Refractory Aggressive Plasma Cell Dyscrasias. Blood. 2023 Nov 28;142: 6623. doi:10.1182/blood-2023-174123.$$$$$Y$$$20240816$$HP$US$US
242160441$24216044$1$I$$20240813$20240816$20240816$PER$$US-ABBVIE-5881342$ABBVIE$$$$$F$Y$$$20240816$$HP$US$US
242160451$24216045$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129065$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240816$$HP$US$US
242160461$24216046$1$I$20240809$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129279$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240816$$CN$US$US
242160471$24216047$1$I$$20240730$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121518$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$70.31$KG$20240816$$CN$US$US
242160481$24216048$1$I$$20240814$20240816$20240816$EXP$JP-MLMSERVICE-20240528-PI079734-00059-1$JP-SANDOZ INC.-SDZ2024JP072692$SANDOZ$$61$YR$$M$Y$$$20240816$$MD$JP$JP
242160491$24216049$1$I$$20240807$20240816$20240816$EXP$$JP-JNJFOC-20240829991$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240816$$MD$JP$JP
242160501$24216050$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A181088$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242160511$24216051$1$I$$20220628$20240816$20240816$EXP$$TW-AstraZeneca-2022A238902$ASTRAZENECA$$71$YR$$M$Y$$$20240816$$CN$TW$
242160521$24216052$1$I$$20230621$20240816$20240816$EXP$$US-AstraZeneca-2023A143817$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242160531$24216053$1$I$$20221011$20240816$20240816$EXP$$US-AstraZeneca-2022A345761$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242160541$24216054$1$I$$20240812$20240816$20240816$PER$$NVSC2024US164491$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
242160551$24216055$1$I$20240801$20240808$20240816$20240816$EXP$$US-VANTIVE-2024VAN018934$Vantive US Healthcare$$78$YR$$M$Y$$$20240816$$HP$US$US
242160561$24216056$1$I$$20240731$20240816$20240816$PER$$US-AstraZeneca-2024A177687$ASTRAZENECA$$$$$F$Y$$$20240816$$HP$US$
242160571$24216057$1$I$$20240814$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072699$SANDOZ$$30$YR$$F$Y$55$KG$20240816$$PH$CA$CA
242160591$24216059$1$I$20240401$20240805$20240816$20240816$EXP$$US-TAKEDA-2024TUS074613$TAKEDA$$44$YR$$M$Y$$$20240816$$CN$US$US
242160601$24216060$1$I$$20240805$20240816$20240816$EXP$$US-UCBSA-2024039233$UCB$$$$$F$Y$57$KG$20240816$$MD$US$US
242160611$24216061$1$I$$20240815$20240816$20240816$EXP$$PL-GILEAD-2024-0684335$GILEAD$$$$A$F$Y$$$20240816$$MD$PL$PL
242160621$24216062$1$I$20230912$20240813$20240816$20240816$EXP$FR-AFSSAPS-PO2024000878$FR-JNJFOC-20240839117$JOHNSON AND JOHNSON$$1$DY$N$F$Y$$$20240816$$MD$FR$FR
242160631$24216063$1$I$$20240812$20240816$20240816$EXP$$US-AMGEN-USASL2024160144$AMGEN$$73$YR$E$F$Y$$$20240816$$CN$US$US
242160641$24216064$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161867$AMGEN$$$$$$Y$$$20240816$$CN$US$US
242160651$24216065$1$I$20240705$20240810$20240816$20240816$EXP$$AR-EMD Serono-2024043372$EMD SERONO INC$$52$YR$A$M$Y$$$20240816$$CN$AR$AR
242160661$24216066$1$I$$20240811$20240816$20240816$EXP$$CA-AMGEN-CANSP2024159854$AMGEN$Taqi K.; Lee J.; Hurton S. et al.. Long-Tenn Outcomes following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin. Current Oncology. 2024;31 (7):3657-3668$$$$$Y$$$20240816$$HP$CA$CA
242160671$24216067$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192223$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242160681$24216068$1$I$$20240813$20240816$20240816$PER$$US-ROCHE-10000057061$ROCHE$$70$YR$E$F$Y$$$20240816$$CN$US$US
242160691$24216069$1$I$$20240815$20240816$20240816$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046140$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$$$20240816$$MD$DE$DE
242160701$24216070$1$I$20240101$20240809$20240816$20240816$EXP$$US-UCBSA-2024040283$UCB$$$$$F$Y$$$20240816$$CN$US$US
242160711$24216071$1$I$20240801$20240807$20240816$20240816$EXP$$US-RECORDATI-2024006192$RECORDATI$$$$$$Y$$$20240816$$CN$US$US
242160721$24216072$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129163$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$75.3$KG$20240816$$CN$US$US
242160731$24216073$1$I$$20240806$20240816$20240816$30DAY$$US-GSK-US2024AMR098342$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242160741$24216074$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129120$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240816$$CN$US$US
242160751$24216075$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128700$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240816$$CN$US$US
242160762$24216076$2$F$$20240814$20240816$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129285$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240821$$CN$US$US
242160772$24216077$2$F$$20240829$20240816$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-129458$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$PH$JP$JP
242160781$24216078$1$I$$20240715$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07254$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242160791$24216079$1$I$20240101$20240813$20240816$20240816$EXP$$US-ORGANON-O2408USA001045$ORGANON$$18$YR$$F$Y$$$20240816$$HP$US$US
242160801$24216080$1$I$20240723$20240804$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039387$AUROBINDO$$75$YR$$F$Y$78$KG$20240816$$CN$GB$GB
242160812$24216081$2$F$20240720$20240830$20240816$20240903$EXP$$AT-TAKEDA-2024TUS081708$TAKEDA$$$$E$F$Y$$$20240903$$CN$AT$AT
242160821$24216082$1$I$20240709$20240812$20240816$20240816$EXP$$GB-SANDOZ INC.-SDZ2024GB072121$SANDOZ$$57$YR$$M$Y$81$KG$20240816$$CN$GB$GB
242160831$24216083$1$I$$20240813$20240816$20240816$PER$$US-JNJFOC-20240836135$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$HP$US$US
242160851$24216085$1$I$$20240808$20240816$20240816$PER$$US-ABBVIE-5881470$ABBVIE$$$$$$Y$$$20240816$$MD$US$US
242160861$24216086$1$I$$20240804$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408003065$ELI LILLY AND CO$$40$YR$A$$Y$$$20240816$$LW$US$US
242160871$24216087$1$I$$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005019$ELI LILLY AND CO$$47$YR$A$$Y$$$20240816$$LW$US$US
242160881$24216088$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008610$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240816$$CN$US$US
242160891$24216089$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007183$ELI LILLY AND CO$$52$YR$A$$Y$$$20240816$$CN$US$US
242160901$24216090$1$I$$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007178$ELI LILLY AND CO$$51$YR$A$$Y$$$20240816$$LW$US$US
242160911$24216091$1$I$20240813$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009362$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242160921$24216092$1$I$20240811$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008595$ELI LILLY AND CO$$56$YR$A$$Y$$$20240816$$CN$US$US
242160941$24216094$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008467$ELI LILLY AND CO$$44$YR$A$$Y$$$20240816$$CN$US$US
242160951$24216095$1$I$20240615$20240804$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039378$AUROBINDO$$39$YR$$F$Y$$$20240816$$CN$GB$GB
242160961$24216096$1$I$$20240715$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07255$LUPIN$$$$$$Y$$$20240816$$PH$US$US
242160971$24216097$1$I$$20240809$20240816$20240816$PER$$US-ALXN-202408USA000725US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242160991$24216099$1$I$20240726$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160344$AMGEN$$$$$$Y$$$20240816$$CN$US$US
242161001$24216100$1$I$$20240813$20240816$20240816$EXP$$CA-UCBSA-2024041243$UCB$$$$$F$Y$$$20240816$$CN$CA$CA
242161011$24216101$1$I$$20240812$20240816$20240816$PER$$US-ROCHE-10000056582$ROCHE$Bhullar P, Motaparthi K, Zieman D, Johnson C, Gurnani P, Sokumbi O. Toxic epidermal necrolysis-like cutaneous toxicity following chimeric antigen receptor T-cell therapy in recurrent large B-cell lymphoma. J Cutan Pathol.. 2024-Jul-09;1-6. doi:10.1111/cup.14687.$69$YR$E$M$Y$$$20240816$$MD$US$US
242161041$24216104$1$I$20240731$20240805$20240816$20240816$PER$$US-IGSA-BIG0030179$GRIFOLS$$76$YR$$M$Y$$$20240816$$CN$US$US
242161051$24216105$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A181469$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242161061$24216106$1$I$$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040082$AUROBINDO$$22$YR$$M$Y$$$20240816$$MD$FR$FR
242161072$24216107$2$F$$20240827$20240816$20240902$EXP$$DE-AstraZeneca-2024A181102$ASTRAZENECA$$77$YR$$M$Y$$$20240902$$CN$DE$
242161081$24216108$1$I$$20240802$20240816$20240816$EXP$$CA-AUROBINDO-AUR-APL-2024-040387$AUROBINDO$Waldner RC, Doulla M, Atallah J, Rathwell S, Grimbly C.. Leuprolide Acetate and ?Tc Interval in Gender-Diverse Youth.. Transgender Health.. 2023;8 (1):84-88$17$YR$$M$Y$$$20240816$$HP$CA$CA
242161091$24216109$1$I$$20240811$20240816$20240816$PER$$US-AMGEN-USASP2024161659$AMGEN$Huang Y.; Yoh K.; Szamreta E. A. et al.. Patterns of pembrolizumab use for recurrent cervical cancer. Journal of Clinical Oncology. 2024;42 (16):1-5$$$$$Y$$$20240816$$HP$US$US
242161101$24216110$1$I$$20240811$20240816$20240816$PER$$US-AMGEN-USASP2024159959$AMGEN$Zisa D.; Zhang-sun J.; Christos P. J. et al.. Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares. Lupus. 2024;33 (9):938-947$55$YR$A$F$Y$$$20240816$$HP$US$US
242161111$24216111$1$I$20240813$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162471$AMGEN$$23$YR$A$F$Y$$$20240816$$CN$US$US
242161121$24216112$1$I$20190101$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160384$AMGEN$$66$YR$E$F$Y$$$20240816$$CN$US$US
242161131$24216113$1$I$$20240811$20240816$20240816$PER$$US-AMGEN-USASP2024160003$AMGEN$Smith J.M.; Jester D.A.. Profound improvement in vision and electroretinogram after intensive steroid treatment in unexplained visual loss after silicone oil removal. American Journal of Ophthalmology Case Reports. 2024;36:1-6$63$YR$A$M$Y$85$KG$20240816$$HP$US$US
242161141$24216114$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129191$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240816$$HP$US$US
242161151$24216115$1$I$$20240715$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07298$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242161162$24216116$2$F$$20240814$20240816$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129219$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240819$$PH$US$US
242161171$24216117$1$I$$20240813$20240816$20240816$EXP$$CA-TAKEDA-2024TUS081913$TAKEDA$$$$$M$Y$$$20240816$$CN$CA$CA
242161181$24216118$1$I$20240813$20240813$20240816$20240816$PER$$US-HALEON-2191850$Haleon PLC$$29$YR$$M$Y$$$20240816$$CN$US$US
242161191$24216119$1$I$20240808$20240812$20240816$20240816$PER$$US-ROCHE-10000056698$ROCHE$$$$$$Y$$$20240816$$PH$US$US
242161201$24216120$1$I$20240704$20240724$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003951$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240816$$CN$US$US
242161212$24216121$2$F$20230508$20240919$20240816$20240927$EXP$$JP-ROCHE-10000023210$ROCHE$$78$YR$E$M$Y$52$KG$20240927$$MD$JP$JP
242161231$24216123$1$I$$20240809$20240816$20240816$PER$$US-AMGEN-USASP2024159902$AMGEN$$$$$$Y$$$20240816$$CN$US$US
242161241$24216124$1$I$20240611$20240809$20240816$20240816$EXP$$CH-AMGEN-CHESP2024158771$AMGEN$$87$YR$E$M$Y$$$20240816$$MD$CH$CH
242161251$24216125$1$I$$20240803$20240816$20240816$EXP$$IT-AUROBINDO-AUR-APL-2024-039847$AUROBINDO$Federica F, Elisa Z, Maria Grazia P, Calogero V, Patrizia DI, Maria Caterina P, et al. Surgical treatment of invasive fungal infection in pediatric oncology. Eur-J-Haematol. 2024;113 (1):90-98$4$YR$$F$Y$$$20240816$$HP$IT$IT
242161261$24216126$1$I$$20240815$20240816$20240816$PER$$US-ROCHE-10000058824$ROCHE$$75$YR$E$M$Y$$$20240816$$CN$US$US
242161271$24216127$1$I$20231101$20240814$20240816$20240816$EXP$DK-DKMA-30729643$DK-AMGEN-DNKSP2024162009$AMGEN$$43$YR$A$M$Y$$$20240816$$MD$DK$DK
242161282$24216128$2$F$20240810$20240819$20240816$20240823$EXP$$US-AMGEN-USASP2024162182$AMGEN$$62$YR$A$F$Y$$$20240823$$MD$US$US
242161291$24216129$1$I$$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040134$AUROBINDO$$29$YR$$F$Y$$$20240816$$MD$FR$FR
242161301$24216130$1$I$20240709$20240812$20240816$20240816$EXP$$NVSC2024CN165457$NOVARTIS$$8$YR$$M$Y$28$KG$20240816$$HP$CN$CN
242161311$24216131$1$I$$20240715$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07301$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242161331$24216133$1$I$20240801$20240806$20240816$20240816$PER$$US-TRIS PHARMA, INC.-24US011591$TRIS PHARM$$$$$$Y$$$20240816$$CN$US$US
242161341$24216134$1$I$$20240808$20240816$20240816$PER$$US-TRIS PHARMA, INC.-24US011589$TRIS PHARM$$$$$$Y$$$20240816$$HP$US$US
242161351$24216135$1$I$$20240808$20240816$20240816$PER$$US-TRIS PHARMA, INC.-24US011590$TRIS PHARM$$$$$$Y$$$20240816$$HP$US$US
242161362$24216136$2$F$20210101$20240816$20240816$20240824$EXP$$US-ABBVIE-5447922$ABBVIE$$$$$M$Y$127.01$KG$20240824$$CN$US$US
242161371$24216137$1$I$$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003953$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242161381$24216138$1$I$$20240723$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009412$STRIDES$Anwar A, Chahine Z, Piecoro D, Kesler M, Qasrawi A.. Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia. Hum-Pathol-Rep. 2023;33:300713$51$YR$$F$Y$$$20240816$$HP$US$US
242161391$24216139$1$I$20240701$20240809$20240816$20240816$EXP$$US-NEBO-665706$PHARMACOSMOS$$$$E$M$Y$$$20240816$$PH$US$US
242161402$24216140$2$F$20240807$20240909$20240816$20240913$PER$$US-ROCHE-10000056686$ROCHE$$25$YR$A$M$Y$100.7$KG$20240913$$MD$US$US
242161411$24216141$1$I$$20240527$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006466$STRIDES$Hicks ED, Agada NO, Yates TR, Kelly MS, Tam JS, Ferdman RM, et al.. Case Report: Nontuberculous mycobacterial infections in children with complete DiGeorge anomaly. Front-Immunol. 2023;14:1078976$$$N$$Y$$$20240816$$HP$US$US
242161421$24216142$1$I$$20240523$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006274$STRIDES$Obagi S, Obagi Z, Thiede R.. Stevens-Johnson syndrome/toxic epidermal necrolysis associated with natural thyroid medication.. Dermatol-Online-J. 2024;30(1)$52$YR$$F$Y$$$20240816$$MD$US$US
242161431$24216143$1$I$$20240717$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009137$STRIDES$Wilson P, Rosenstengle C, Spak C.. Underrecognized cause diarrhea in solid organ transplant: a report of astroviridae enteritis in liver transplant.. Transpl-Infect-Dis. 2024;26 (2)$72$YR$$M$Y$$$20240816$$MD$US$US
242161441$24216144$1$I$$20240814$20240816$20240816$PER$$US-GILEAD-2024-0684253$GILEAD$$$$$F$Y$$$20240816$$MD$US$US
242161451$24216145$1$I$$20240812$20240816$20240816$PER$$US-ROCHE-10000055242$ROCHE$$72$YR$E$M$Y$$$20240816$$CN$US$US
242161462$24216146$2$F$$20240822$20240816$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003958$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
242161471$24216147$1$I$$20240812$20240816$20240816$PER$$US-ABBVIE-5881263$ABBVIE$$$$$$Y$$$20240816$$MD$US$US
242161493$24216149$3$F$$20240910$20240816$20240913$PER$$US-ROCHE-10000051636$ROCHE$$81$YR$E$F$Y$63.04$KG$20240913$$CN$US$US
242161502$24216150$2$F$$20240807$20240816$20240821$EXP$$CA-TAKEDA-2024TUS076999$TAKEDA$$$$$F$Y$$$20240821$$CN$CA$CA
242161521$24216152$1$I$$20240715$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07302$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242161531$24216153$1$I$20240809$20240813$20240816$20240816$PER$$US-ROCHE-10000056602$ROCHE$$$$$$Y$$$20240816$$PH$US$US
242161541$24216154$1$I$20240625$20240808$20240816$20240816$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07148$VIFOR$$68$YR$$F$Y$$$20240816$$CN$ZA$ZA
242161551$24216155$1$I$20240706$20240808$20240816$20240816$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07150$VIFOR$$82$YR$$F$Y$$$20240816$$MD$ZA$ZA
242161561$24216156$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161875$AMGEN$$$$$$Y$$$20240816$$PH$US$US
242161571$24216157$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161155$AMGEN$$$$$F$Y$$$20240816$$CN$US$US
242161582$24216158$2$F$20240812$20240814$20240816$20240819$PER$$US-AMGEN-USASP2024160374$AMGEN$$60$YR$A$F$Y$$$20240818$$CN$US$US
242161591$24216159$1$I$20240411$20240724$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112232$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240816$$CN$US$US
242161612$24216161$2$F$20240101$20240905$20240816$20240912$EXP$$AU-RECORDATI RARE DISEASE INC.-2024006125$RECORDATI$$$$$$Y$$$20240912$$HP$AU$AU
242161622$24216162$2$F$20240805$20240827$20240816$20240904$30DAY$$US-GSK-US2024098168$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240904$$CN$US$US
242161632$24216163$2$F$$20240918$20240816$20240930$PER$$US-GSK-US2024GSK100230$GLAXOSMITHKLINE$$$$$$Y$$$20240928$$MD$US$US
242161641$24216164$1$I$20190419$20240814$20240816$20240816$EXP$$US-GSK-US2019GSK177552$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$US$US
242161651$24216165$1$I$20240701$20240807$20240816$20240816$30DAY$$US-GSK-US2024098606$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240816$$CN$US$US
242161661$24216166$1$I$$20240806$20240816$20240816$30DAY$$US-GSK-US2024AMR098711$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$US$US
242161671$24216167$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008727$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240816$$CN$US$US
242161681$24216168$1$I$$20240808$20240816$20240816$30DAY$$US-GSK-US2024AMR099827$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242161691$24216169$1$I$20240616$20240807$20240816$20240816$PER$$US-MSNLABS-2024MSNSPO01757$MSN LABORATORIES$$$$$$Y$$$20240816$$CN$US$US
242161701$24216170$1$I$$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408006327$ELI LILLY AND CO$$45$YR$A$$Y$$$20240816$$LW$US$US
242161711$24216171$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007197$ELI LILLY AND CO$$65$YR$E$$Y$$$20240816$$LW$US$US
242161722$24216172$2$F$$20240814$20240816$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408008357$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240820$$CN$US$US
242161731$24216173$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008560$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240816$$CN$US$US
242161742$24216174$2$F$$20240812$20240816$20240820$EXP$$US-SA-2024SA240435$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$CN$US$US
242161752$24216175$2$F$$20240520$20240816$20240820$EXP$FR-AFSSAPS-AVGR2024000100$FR-SA-2024SA152030$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240820$$PH$FR$FR
242161762$24216176$2$F$20240822$20240822$20240816$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408008804$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240827$$CN$US$US
242161781$24216178$1$I$$20240715$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07305$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242161791$24216179$1$I$$20240806$20240816$20240816$EXP$$JP-ROCHE-10000055764$ROCHE$$6$DEC$A$M$Y$$$20240816$$MD$JP$JP
242161801$24216180$1$I$20240101$20240806$20240816$20240816$EXP$$CA-TEVA-VS-3230880$TEVA$$66$YR$$F$Y$94$KG$20240816$$HP$CA$CA
242161811$24216181$1$I$$20240808$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126204$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240816$$CN$US$US
242161821$24216182$1$I$$20240806$20240816$20240816$EXP$$GB-TEVA-VS-3231624$TEVA$$40$YR$$F$Y$$$20240816$$CN$GB$GB
242161832$24216183$2$F$20240801$20240814$20240816$20240902$EXP$$BE-GILEAD-2024-0683680$GILEAD$$35$YR$A$F$Y$$$20240902$$MD$BE$BE
242161841$24216184$1$I$$20240812$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128136$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240816$$CN$US$US
242161851$24216185$1$I$$20240807$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126866$BRISTOL MYERS SQUIBB$$16$YR$T$M$Y$$$20240816$$MD$US$US
242161861$24216186$1$I$20240601$20240802$20240816$20240816$EXP$$US-UCBSA-2024039280$UCB$$59$YR$$F$Y$124.17$KG$20240816$$HP$US$US
242161871$24216187$1$I$20240101$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127981$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$137$KG$20240816$$PH$US$US
242161883$24216188$3$F$20190301$20240828$20240816$20240918$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-126472$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240918$$MD$DE$DE
242161891$24216189$1$I$$20240805$20240816$20240816$EXP$$US-Emmaus Medical, Inc.-EMM202408-000392$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240816$$CN$US$
242161901$24216190$1$I$20240721$20240724$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003979$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240816$$CN$US$US
242161911$24216191$1$I$20240711$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128716$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$54.88$KG$20240816$$CN$US$US
242161921$24216192$1$I$$20240807$20240816$20240816$PER$$US-JNJFOC-20240820856$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
242161932$24216193$2$F$20240801$20240911$20240816$20240919$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001631$BLUEPRINT MEDICINES$$50$YR$A$F$Y$$$20240919$$CN$US$US
242161941$24216194$1$I$20240601$20240803$20240816$20240816$EXP$$ES-AUROBINDO-AUR-APL-2024-039726$AUROBINDO$$72$YR$$F$Y$$$20240816$$MD$ES$ES
242161964$24216196$4$F$20240806$20240909$20240816$20240917$PER$$US-AMGEN-USASP2024157687$AMGEN$$71$YR$E$F$Y$$$20240916$$HP$US$US
242161971$24216197$1$I$20240101$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160051$AMGEN$$46$YR$A$F$Y$$$20240816$$CN$US$US
242161982$24216198$2$F$20240601$20240820$20240816$20240829$PER$$US-ABBVIE-5872113$ABBVIE$$60$YR$$F$Y$99.79$KG$20240829$$CN$US$US
242161991$24216199$1$I$20240301$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040015$AUROBINDO$$98$YR$$F$Y$58.6$KG$20240816$$PH$FR$FR
242162001$24216200$1$I$20240814$20240814$20240816$20240816$PER$$US-ABBVIE-5881172$ABBVIE$$$$$F$Y$$$20240816$$MD$US$US
242162021$24216202$1$I$20240216$20240812$20240816$20240816$EXP$$FR-AstraZeneca-2024A182557$ASTRAZENECA$$75$YR$$M$Y$$$20240816$$MD$FR$
242162031$24216203$1$I$20240701$20240812$20240816$20240816$EXP$$FR-AstraZeneca-2024A182668$ASTRAZENECA$$93$YR$$F$Y$$$20240816$$MD$FR$
242162042$24216204$2$F$20240101$20240822$20240816$20240830$EXP$$JP-AstraZeneca-2024A183223$ASTRAZENECA$$51$YR$$M$Y$$$20240830$$MD$JP$
242162052$24216205$2$F$$20240806$20240816$20240911$EXP$$US-AstraZeneca-2024A179815$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
242162061$24216206$1$I$$20240805$20240816$20240816$PER$$US-TAKEDA-2024TUS078487$TAKEDA$$$$E$M$Y$$$20240816$$MD$US$US
242162071$24216207$1$I$20240623$20240814$20240816$20240816$EXP$$US-AstraZeneca-2024A186172$ASTRAZENECA$$28010$DY$$$Y$$$20240816$$CN$US$
242162081$24216208$1$I$$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A183685$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242162101$24216210$1$I$$20240809$20240816$20240816$EXP$$US-AstraZeneca-2024A185900$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242162111$24216211$1$I$20220704$20240807$20240816$20240816$EXP$FR-AFSSAPS-ST2024001208$FR-TEVA-VS-3231654$TEVA$$85$YR$$M$Y$$$20240816$$MD$FR$FR
242162121$24216212$1$I$$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A183726$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242162143$24216214$3$F$$20240823$20240816$20240828$PER$$IQ-REGENERON PHARMACEUTICALS, INC.-2024-112023$REGENERON$$56$YR$$M$Y$$$20240828$$CN$IQ$IQ
242162151$24216215$1$I$20240718$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040027$AUROBINDO$$67$YR$$F$Y$61$KG$20240816$$MD$FR$FR
242162161$24216216$1$I$20240301$20240814$20240816$20240816$EXP$$US-ABBVIE-5881984$ABBVIE$$76$YR$$M$Y$$$20240816$$MD$US$US
242162171$24216217$1$I$$20240808$20240816$20240816$EXP$$JP-AMGEN-JPNSP2024113238$AMGEN$$$$E$F$Y$$$20240816$$MD$JP$JP
242162183$24216218$3$F$20240719$20240905$20240816$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128484$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240911$$CN$US$US
242162191$24216219$1$I$$20240806$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010138$STRIDES$Nelson N, Masih D, Sabri A, Monika F, Mirza M.. Isolated Myeloid Sarcoma Masquerading as Scattered Abscesses in a Septic Patient: A Case Report and Literature Review.. Case-Rep-Oncol. 2024;17 (1):39-48$$$$$Y$$$20240816$$HP$US$US
242162202$24216220$2$F$20230101$20240918$20240816$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003961$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
242162211$24216221$1$I$20240229$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040058$AUROBINDO$$81$YR$$M$Y$58.7$KG$20240816$$PH$FR$FR
242162222$24216222$2$F$20240601$20240820$20240816$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126455$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240829$$CN$US$US
242162232$24216223$2$F$20240709$20240909$20240816$20240918$30DAY$$US-GSK-US2024098160$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240918$$CN$US$US
242162241$24216224$1$I$20240101$20240807$20240816$20240816$30DAY$$US-GSK-US2024099147$GLAXOSMITHKLINE$$33$YR$$M$Y$$$20240816$$HP$US$US
242162251$24216225$1$I$$20240814$20240816$20240816$PER$$US-TAKEDA-2024TUS081967$TAKEDA$$$$$M$Y$$$20240816$$CN$US$US
242162261$24216226$1$I$$20240803$20240816$20240816$EXP$$ES-AUROBINDO-AUR-APL-2024-039862$AUROBINDO$Rom?n P?rez FJ, Puntero1 LV,  P?rez Guerra EM.. AN UNCOMMON CAUSE OF DISORIENTATION IN  DIABETIC PATIENTS.. JOURNAL OF THE MADRID SOCIETY OF FAMILY AND COMMUNITY MEDICINE. 2024;2$87$YR$$F$Y$$$20240816$$MD$ES$ES
242162271$24216227$1$I$$20240812$20240816$20240816$EXP$$NVSC2024US163852$NOVARTIS$$75$YR$$M$Y$79.38$KG$20240816$$CN$US$US
242162291$24216229$1$I$20231116$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040077$AUROBINDO$$62$YR$$M$Y$85.5$KG$20240816$$MD$FR$FR
242162301$24216230$1$I$20240510$20240808$20240816$20240816$EXP$$US-AMX-008127$AMYLYX PHARMACEUTICALS$$65$YR$$F$Y$$$20240816$$HP$US$US
242162311$24216231$1$I$20240722$20240722$20240816$20240816$PER$$TR-TOLMAR, INC.-24TR051254$TOLMAR$$70$YR$$M$Y$$$20240816$$MD$TR$TR
242162321$24216232$1$I$$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-039923$AUROBINDO$$90$YR$$F$Y$$$20240816$$MD$FR$FR
242162331$24216233$1$I$20240712$20240803$20240816$20240816$EXP$$IT-AUROBINDO-AUR-APL-2024-040263$AUROBINDO$$89$YR$$F$Y$45$KG$20240816$$MD$IT$IT
242162346$24216234$6$F$20240516$20240925$20240816$20240930$EXP$$CH-ROCHE-10000012517$ROCHE$$$$E$F$Y$$$20240930$$MD$CH$CH
242162351$24216235$1$I$20240723$20240803$20240816$20240816$EXP$$IT-AUROBINDO-AUR-APL-2024-039736$AUROBINDO$$84$YR$$M$Y$$$20240816$$PH$IT$IT
242162362$24216236$2$F$20190101$20240813$20240816$20240819$EXP$$US-ROCHE-10000056618$ROCHE$$37$YR$A$F$Y$72.57$KG$20240819$$CN$US$US
242162371$24216237$1$I$20240628$20240724$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003962$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240816$$CN$US$US
242162381$24216238$1$I$$20240815$20240816$20240816$PER$$US-TAKEDA-2024TUS082155$TAKEDA$$$$$$Y$$$20240816$$CN$US$US
242162391$24216239$1$I$20240802$20240809$20240816$20240816$EXP$ES-AEMPS-1557938$ES-BIOCON BIOLOGICS LIMITED-BBL2024005897$BIOCON$$$$$$Y$$$20240816$$MD$ES$ES
242162401$24216240$1$I$$20240805$20240816$20240816$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010122$STRIDES$Srivastava A, Artiles MEJ, Elbanna M, Abu Sheikha M, Parikh V, Feitell S.. Cardiogenic Shock: An Unusual Presentation Of Hydralazine-induced Anca-associated Vasculitis.. J-Card-Fail. 2024;30 (1):149-150$68$YR$$F$Y$$$20240816$$HP$US$US
242162411$24216241$1$I$$20240807$20240816$20240816$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010179$STRIDES$Dobashi N, Sada K-E, Kanemori G, Okada T, Tarutani Y, Yamamoto M, et al.. Pulmonary alveolar proteinosis during treatment of immune-mediated necrotizing myopathy.. Int-J-Rheum-Diseases. 2024;27 (2)$71$YR$$F$Y$$$20240816$$HP$JP$JP
242162423$24216242$3$F$$20240903$20240816$20240911$EXP$$US-ROCHE-10000057773$ROCHE$$80$YR$E$M$Y$143.34$KG$20240911$$CN$US$US
242162432$24216243$2$F$20240101$20240823$20240816$20240827$PER$$US-AMGEN-USASP2024161069$AMGEN$$48$YR$A$M$Y$$$20240827$$CN$US$US
242162441$24216244$1$I$$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160854$AMGEN$$$$$$Y$$$20240816$$PH$US$US
242162451$24216245$1$I$20240813$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161187$AMGEN$$85$YR$E$F$Y$$$20240816$$CN$US$US
242162461$24216246$1$I$$20240808$20240816$20240816$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010245$STRIDES$Thomas LH, Lau D, Dave K.. Evaluating the process of initiating elexacaftor/tezacaftor/ivacaftor in lung transplant recipients and its effects on immunosuppression medication.. J-Cystic-Fibrosis. 2024;23 (Suppl. 1):S104 abstr. P160$$$$$Y$$$20240816$$HP$GB$GB
242162471$24216247$1$I$20240724$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408060826128380-YSHNW$GB-TEVA-VS-3230534$TEVA$$37$YR$$F$Y$$$20240816$$HP$GB$GB
242162481$24216248$1$I$$20240809$20240816$20240816$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010203$STRIDES$Kawashima S, Kinoshita H, Kawashima W, Nakajima Y.. Electroencephalogram inability to detect intraoperative awakening in a patient with remimazolam tolerance.. Minerv-Anestesiol. 2023;89 (5):482-483$57$YR$$M$Y$$$20240816$$HP$JP$JP
242162491$24216249$1$I$20240801$20240815$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009923$ELI LILLY AND CO$$31$YR$A$M$Y$$$20240816$$CN$US$US
242162501$24216250$1$I$20240601$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008615$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240816$$CN$US$US
242162511$24216251$1$I$$20240806$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408004227$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240816$$CN$US$US
242162521$24216252$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008328$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$US$US
242162531$24216253$1$I$20240810$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008517$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240816$$CN$US$US
242162541$24216254$1$I$$20240806$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408003899$ELI LILLY AND CO$$43$YR$A$$Y$$$20240816$$LW$US$US
242162551$24216255$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008629$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240816$$CN$US$US
242162561$24216256$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008528$ELI LILLY AND CO$$49$YR$A$$Y$$$20240816$$CN$US$US
242162571$24216257$1$I$$20240804$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408002924$ELI LILLY AND CO$$62$YR$A$$Y$$$20240816$$CN$US$US
242162581$24216258$1$I$$20240813$20240816$20240816$EXP$$MX-JNJFOC-20240837371$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240816$$MD$MX$MX
242162592$24216259$2$F$$20240813$20240816$20240819$EXP$$CA-JNJFOC-20240838660$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240819$$HP$CA$CA
242162602$24216260$2$F$20240801$20240828$20240816$20240905$PER$$US-JNJFOC-20240829804$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240906$$CN$US$US
242162611$24216261$1$I$$20240807$20240816$20240816$EXP$$GB-TEVA-VS-3231103$TEVA$$42$YR$$F$Y$$$20240816$$MD$GB$GB
242162621$24216262$1$I$20230226$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040014$AUROBINDO$$80$YR$$M$Y$63$KG$20240816$$PH$FR$FR
242162631$24216263$1$I$$20240809$20240816$20240816$EXP$$MX-AMGEN-MEXSP2024159450$AMGEN$$$$$F$Y$$$20240816$$CN$MX$MX
242162642$24216264$2$F$20240707$20240827$20240816$20240904$PER$$US-AMGEN-USASP2024161428$AMGEN$$$$$$Y$$$20240904$$HP$US$US
242162652$24216265$2$F$20240815$20240816$20240816$20240820$PER$$US-AMGEN-USASP2024162977$AMGEN$$54$YR$A$M$Y$$$20240820$$CN$US$US
242162662$24216266$2$F$$20240813$20240816$20240821$EXP$$US-AMGEN-USASP2024161060$AMGEN$$68$YR$E$F$Y$$$20240821$$CN$US$US
242162671$24216267$1$I$20240701$20240724$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003960$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240816$$HP$US$US
242162681$24216268$1$I$20240601$20240807$20240816$20240816$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07571$HIKMA$$$$$M$Y$102$KG$20240816$$CN$US$US
242162691$24216269$1$I$20240101$20240806$20240816$20240816$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00593$MIRUM PHARMACEUTICALS$$$$$M$Y$20$KG$20240816$$CN$US$US
242162701$24216270$1$I$$20240806$20240816$20240816$EXP$$GB-TEVA-VS-3230444$TEVA$$67$YR$$F$Y$88$KG$20240816$$MD$GB$GB
242162711$24216271$1$I$$20240801$20240816$20240816$EXP$$US-Long Grove-000071$Long Grove Pharmaceuticals$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$$$$F$Y$$$20240816$$MD$US$US
242162721$24216272$1$I$20220801$20240806$20240816$20240816$30DAY$$US-GSK-US2024098083$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240816$$CN$US$US
242162731$24216273$1$I$$20240806$20240816$20240816$30DAY$$US-GSK-US2024098150$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242162741$24216274$1$I$$20240806$20240816$20240816$EXP$$US-GSK-US2024AMR098987$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242162751$24216275$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A183523$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242162761$24216276$1$I$$20240808$20240816$20240816$PER$$US-AstraZeneca-2024A182465$ASTRAZENECA$$$$$$Y$$$20240816$$MD$US$
242162771$24216277$1$I$20240720$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A180849$ASTRAZENECA$$$$$$Y$$$20240816$$CN$US$
242162781$24216278$1$I$$20240809$20240816$20240816$EXP$$US-AstraZeneca-2024A182759$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242162791$24216279$1$I$$20240805$20240816$20240816$EXP$$KR-JUBILANT CADISTA PHARMACEUTICALS-2024KR001168$JUBILANT$Jeong S, Kim Y, Choe S, Kang H, Kim HM, Kang JS. A fatal case of desvenlafaxine and paroxetine poisoning. J Pharm Biomed Anal.. 2024;245:116148$41$YR$$F$Y$$$20240816$$HP$KR$KR
242162801$24216280$1$I$20240601$20240808$20240816$20240816$EXP$$BE-AstraZeneca-2024A182158$ASTRAZENECA$$61$YR$$F$Y$$$20240816$$MD$BE$
242162811$24216281$1$I$$20240814$20240816$20240816$EXP$$US-AstraZeneca-2024A185818$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242162832$24216283$2$F$$20240919$20240816$20240930$PER$$US-JNJFOC-20240822566$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
242162843$24216284$3$F$20230101$20240917$20240816$20240920$EXP$$US-AMGEN-USASP2024161725$AMGEN$$21$YR$A$F$Y$$$20240920$$MD$US$US
242162864$24216286$4$F$20240729$20240820$20240816$20240829$EXP$$BR-CELLTRION INC.-2024BR019350$CELLTRION$$$$$$Y$$$20240829$$CN$BR$BR
242162873$24216287$3$F$20240101$20240920$20240816$20240930$EXP$$CA-CELLTRION INC.-2024CA009812$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
242162881$24216288$1$I$20230526$20240813$20240816$20240816$EXP$$GB-ABBVIE-5879448$ABBVIE$$66$YR$$F$Y$75$KG$20240816$$HP$GB$GB
242162891$24216289$1$I$20240301$20240814$20240816$20240816$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046200$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240816$$HP$US$US
242162901$24216290$1$I$$20240724$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003966$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$HP$US$US
242162911$24216291$1$I$$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040132$AUROBINDO$$1$DY$$M$Y$0.79$KG$20240816$$HP$FR$FR
242162922$24216292$2$F$20240806$20240829$20240816$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024836$UNITED THERAPEUTICS$$47$YR$$F$Y$144.22$KG$20240906$$$US$US
242162931$24216293$1$I$$20240801$20240816$20240816$EXP$$CN-Reliance-000412$RELIANCE GENEMEDIX$Zhang L, Liu M, Xie L, Tian X. Cardiac Arrest Due to Capecitabine Toxicosis Treated With ECMO and CRRT: A Case Report. Crit Care Nurse. 2024 Aug 1;44(4):57-62.$58$YR$A$M$Y$$$20240816$$MD$CN$CN
242162941$24216294$1$I$$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129401$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240816$$CN$US$US
242162952$24216295$2$F$20240301$20240903$20240816$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-129136$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240910$$MD$JP$JP
242162962$24216296$2$F$20240726$20240830$20240816$20240905$EXP$$JP-ABBVIE-5881316$ABBVIE$$74$YR$$M$Y$57.7$KG$20240905$$MD$JP$JP
242162981$24216298$1$I$20240512$20240805$20240816$20240816$EXP$$ES-AUROBINDO-AUR-APL-2024-040169$AUROBINDO$$66$YR$$M$Y$$$20240816$$HP$ES$ES
242162991$24216299$1$I$20210101$20240801$20240816$20240816$EXP$$CN-Reliance-000413$RELIANCE GENEMEDIX$Qian YF, Chen HP, Ren GF. Acute therapy-related myelodysplastic syndromes following capecitabine and oxaliplatin therapy in gastric malignant tumor: A case report. Medicine (Baltimore). 2024 Jul 26;103(30):e39049.$60$YR$A$M$Y$$$20240816$$HP$CN$CN
242163011$24216301$1$I$20240805$20240807$20240816$20240816$EXP$$US-GSK-US2024098465$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240816$$CN$US$US
242163021$24216302$1$I$$20240724$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003967$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242163031$24216303$1$I$20240801$20240808$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024099285$VIIV$$$$$$Y$$$20240816$$HP$US$US
242163042$24216304$2$F$20240801$20240905$20240816$20240909$EXP$$BG-ABBVIE-5879612$ABBVIE$$55$YR$$M$Y$$$20240909$$CN$BG$BG
242163051$24216305$1$I$$20240805$20240816$20240816$EXP$$KR-009507513-2408KOR002821$MERCK$$$$$F$Y$$$20240816$$PH$KR$KR
242163061$24216306$1$I$$20240812$20240816$20240816$PER$$US-JNJFOC-20240832227$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$HP$US$US
242163072$24216307$2$F$$20240906$20240816$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003978$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242163081$24216308$1$I$20240727$20240809$20240816$20240816$EXP$$DE-ABBVIE-5880301$ABBVIE$$69$YR$$M$Y$$$20240816$$MD$DE$DE
242163092$24216309$2$F$20240101$20240903$20240816$20240911$EXP$$US-INSMED, INC.-2024-00867-US$INSMED$$$$$M$Y$$$20240911$$CN$US$US
242163101$24216310$1$I$20240602$20240805$20240816$20240816$EXP$$ES-AUROBINDO-AUR-APL-2024-040168$AUROBINDO$$77$YR$$M$Y$$$20240816$$MD$ES$ES
242163111$24216311$1$I$$20240809$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127091$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$48.53$KG$20240816$$CN$US$US
242163121$24216312$1$I$$20240813$20240816$20240816$EXP$$CN-AMGEN-CHNSP2024161358$AMGEN$Qian H.; Zhang Y.; Chen J. et al.. Long-Term Remission in T3151+ Relapsed Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia with Blinatumomab and Allogeneic Stem Cell Transplantation: Two Case Studies. The American journal of case reports. 2024;25:1-5$48$YR$A$F$Y$$$20240816$$HP$CN$CN
242163132$24216313$2$F$20220101$20240904$20240816$20240912$EXP$$US-ROCHE-10000050826$ROCHE$$47$YR$A$M$Y$149.68$KG$20240912$$CN$US$US
242163141$24216314$1$I$$20240812$20240816$20240816$EXP$$IN-AMGEN-INDSP2024160337$AMGEN$Hiwarkar P.; Khan S.; Krishnan V. P. et al.. Disease-burden-adapted immunotherapy protocol for primary refractory or high-risk relapsed pediatric acute lymphoblastic leukemia. HemaSphere. 2024;8 (8):1-5$15$YR$T$$Y$$$20240816$$MD$IN$IN
242163152$24216315$2$F$$20240925$20240816$20240930$EXP$$US-AMGEN-USASP2024161975$AMGEN$$$$$M$Y$126.98$KG$20240930$$HP$US$US
242163161$24216316$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192271$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242163173$24216317$3$F$20240808$20240823$20240816$20240902$EXP$$CA-ROCHE-10000055034$ROCHE$$54$YR$A$F$Y$$$20240902$$PH$CA$CA
242163182$24216318$2$F$20240813$20240813$20240816$20240816$EXP$$AU-TAKEDA-2024TUS081887$TAKEDA$$76$YR$$M$Y$$$20240816$$CN$AU$AU
242163191$24216319$1$I$20240619$20240724$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003970$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240816$$CN$US$US
242163201$24216320$1$I$20240101$20240812$20240816$20240816$EXP$$US-009507513-2408USA004502$MERCK$$$$$M$Y$$$20240816$$MD$US$US
242163211$24216321$1$I$20240801$20240815$20240816$20240816$EXP$$CN-ROCHE-10000058823$ROCHE$$78$YR$E$F$Y$57$KG$20240816$$HP$CN$CN
242163222$24216322$2$F$$20240812$20240816$20240816$EXP$$US-AMGEN-USASP2024161373$AMGEN$$$$A$$Y$$$20240816$$PH$US$US
242163231$24216323$1$I$$20240712$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07199$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242163241$24216324$1$I$$20240814$20240816$20240816$EXP$$BG-ABBVIE-5882206$ABBVIE$$67$YR$$$Y$$$20240816$$HP$BG$BG
242163271$24216327$1$I$20240710$20240808$20240816$20240816$EXP$FR-AFSSAPS-AN2024000981$FR-TEVA-VS-3232464$TEVA$$17$YR$$F$Y$$$20240816$$PH$FR$FR
242163281$24216328$1$I$$20240815$20240816$20240816$PER$$NVSC2024US166153$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242163292$24216329$2$F$$20240820$20240816$20240824$EXP$$NVSC2024ZA165106$NOVARTIS$$56$YR$$F$Y$$$20240824$$HP$ZA$ZA
242163301$24216330$1$I$20240810$20240814$20240816$20240816$EXP$$CN-ROCHE-10000057681$ROCHE$$61$YR$A$F$Y$54$KG$20240816$$HP$CN$CN
242163311$24216331$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008504$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240816$$CN$US$US
242163321$24216332$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008344$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240816$$CN$US$US
242163331$24216333$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008798$ELI LILLY AND CO$$$$$M$Y$$$20240816$$CN$US$US
242163341$24216334$1$I$$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005589$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240816$$CN$US$US
242163351$24216335$1$I$$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408061032103830-KCFHY$GB-ADVANZ PHARMA-202408006641$ADVANZ PHARMA$$$$$$Y$$$20240816$$PH$GB$GB
242163361$24216336$1$I$$20240812$20240816$20240816$EXP$$IN-ROCHE-10000027756$ROCHE$$77$YR$E$M$Y$55.6$KG$20240816$$MD$IN$IN
242163371$24216337$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192234$Haleon PLC$$77$YR$$M$Y$$$20240816$$CN$US$US
242163391$24216339$1$I$$20240805$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039485$AUROBINDO$$34$YR$$M$Y$$$20240816$$CN$GB$GB
242163401$24216340$1$I$$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128872$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240816$$HP$US$US
242163411$24216341$1$I$$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003977$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242163422$24216342$2$F$20240101$20240828$20240816$20240906$EXP$$CA-CELLTRION INC.-2024CA010948$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
242163431$24216343$1$I$$20240813$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072555$SANDOZ$$25$YR$$F$Y$$$20240816$$HP$CA$CA
242163441$24216344$1$I$$20240716$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07292$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242163451$24216345$1$I$$20240802$20240816$20240816$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0315$GRAVITI PHARMACEUTICALS$Kramkowski J, Rath S. .Efficacious retrial of electroconvulsive therapy for major depressive disorder after a prolonged seizure in an older adult..BMJ-Case-Rep.2023;16 (5):e247633$7$DEC$$F$Y$$$20240816$$MD$US$US
242163481$24216348$1$I$$20240806$20240816$20240816$30DAY$$US-GSK-US2024098182$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242163491$24216349$1$I$20220101$20240815$20240816$20240816$EXP$$GB-JNJFOC-20240838670$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240816$$MD$GB$GB
242163501$24216350$1$I$$20240815$20240816$20240816$EXP$$US-GILEAD-2024-0684349$GILEAD$$$$A$F$Y$$$20240816$$HP$US$US
242163511$24216351$1$I$$20240805$20240816$20240816$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15690$IPSEN$$38$YR$A$M$Y$$$20240816$$MD$US$US
242163521$24216352$1$I$20240805$20240812$20240816$20240816$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-16132$IPSEN$$34$YR$A$F$Y$$$20240816$$CN$GB$GB
242163531$24216353$1$I$$20240802$20240816$20240816$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0316$GRAVITI PHARMACEUTICALS$Kruttiventi S, Olcott J, Doubledee B.Ditch the Itch Propofol in the Management of Cholestatic Pruritus.Clin-Pediatr-Phila.2024;63(4):580 to 583$17$YR$T$F$Y$$$20240816$$MD$US$US
242163541$24216354$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004008$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242163552$24216355$2$F$$20240903$20240816$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127864$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240905$$HP$US$US
242163561$24216356$1$I$20240111$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129396$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240816$$CN$US$US
242163571$24216357$1$I$$20240802$20240816$20240816$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0317$GRAVITI PHARMACEUTICALS$Nwankwo A, Koyyalagunta D, Huh B, D^Souza RS, Javed S..A comprehensive review of the typical and atypical side effects of gabapentin. .Pain Practice.01-JUL-2024;00:1-8$28$YR$A$M$Y$$$20240816$$MD$US$US
242163581$24216358$1$I$$20240717$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07244$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242163591$24216359$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A181014$ASTRAZENECA$$$$$$Y$$$20240816$$CN$US$
242163601$24216360$1$I$$20240806$20240816$20240816$EXP$$US-GSK-US2024AMR099416$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242163611$24216361$1$I$20220721$20220920$20240816$20240816$EXP$$US-AstraZeneca-2022A280113$ASTRAZENECA$$27196$DY$$M$Y$$$20240816$$CN$US$
242163621$24216362$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004010$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242163631$24216363$1$I$20240713$20240813$20240816$20240816$EXP$$UY-ABBVIE-5881072$ABBVIE$$64$YR$$F$Y$$$20240816$$CN$UY$UY
242163641$24216364$1$I$$20240809$20240816$20240816$EXP$GR-PFIZER INC-PV202400096191$GR-ROCHE-10000053172$ROCHE$Argyropoulou M, Flouda S, Pelekanou E. Rituximab-Induced Serum Sickness (RISS): Case Presentation. 4th Pathology Clinic of Attikon University Hospital, 50th Annual Panhellenic Medical Conference. 2024;258.$51$YR$A$F$Y$$$20240816$$MD$GR$GR
242163651$24216365$1$I$20240805$20240805$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039487$AUROBINDO$$63$YR$$M$Y$80$KG$20240816$$MD$GB$GB
242163671$24216367$1$I$20240304$20240809$20240816$20240816$EXP$$FR-ABBVIE-5791711$ABBVIE$$56$YR$$M$Y$80$KG$20240816$$MD$FR$FR
242163681$24216368$1$I$20240711$20240724$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003983$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240816$$CN$US$US
242163691$24216369$1$I$20141101$20240812$20240816$20240816$PER$$US-JNJFOC-20240831426$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240816$$HP$US$US
242163701$24216370$1$I$20240808$20240809$20240816$20240816$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-111949$REGENERON$$$$$F$Y$$$20240816$$CN$CA$CA
242163712$24216371$2$F$$20240810$20240816$20240820$EXP$$TN-ROCHE-10000049693$ROCHE$Bahrini K, Ben Cheikh Larbi H, Ben Azaiez M, Stambouli N, Zakraoui M, Boughariou S, et al. Efficacy and Safety of Tocilizumab Treatment in Tunisian Critically Ill COVID-19 Patients. Journal of Immunology Research. 2024-Jan;2024:1-10. doi:10.1155/2024/2585821.$$$$$Y$$$20240820$$HP$TN$TN
242163732$24216373$2$F$20240731$20240820$20240816$20240823$EXP$$NVSC2024US164949$NOVARTIS$$80$YR$$M$Y$$$20240824$$CN$US$US
242163741$24216374$1$I$20240630$20240803$20240816$20240816$EXP$$EG-MYLANLABS-2024M1074737$MYLAN$$24$YR$$M$Y$120$KG$20240816$$MD$EG$EG
242163751$24216375$1$I$$20240805$20240816$20240816$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000064$PAREXEL$$$$$$Y$$$20240816$$CN$US$US
242163761$24216376$1$I$20240101$20240814$20240816$20240816$EXP$$US-009507513-2408USA004990$MERCK$$$$$F$Y$$$20240816$$CN$US$US
242163771$24216377$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161877$AMGEN$$$$$$Y$$$20240816$$PH$US$US
242163782$24216378$2$F$$20240816$20240816$20240819$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045940$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240819$$MD$DE$DE
242163791$24216379$1$I$$20240717$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07322$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242163801$24216380$1$I$20240805$20240807$20240816$20240816$PER$$US-ABBVIE-5873341$ABBVIE$$19$YR$$F$Y$$$20240816$$CN$US$US
242163811$24216381$1$I$20240709$20240812$20240816$20240816$EXP$$GB-AMGEN-GBRSP2024160697$AMGEN$$57$YR$A$M$Y$81$KG$20240816$$CN$GB$GB
242163821$24216382$1$I$20221012$20240806$20240816$20240816$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-07537$HIKMA$$$$$$Y$$$20240816$$HP$US$US
242163851$24216385$1$I$20240715$20240809$20240816$20240816$EXP$FR-AFSSAPS-CF2024000417$FR-RDY-SPO/FRA/24/0011739$DR REDDYS$$64$YR$A$M$Y$57$KG$20240816$$PH$FR$FR
242163861$24216386$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192132$Haleon PLC$$$$$M$Y$$$20240816$$CN$US$US
242163871$24216387$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004012$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242163881$24216388$1$I$$20240809$20240816$20240816$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-024894$UNITED THERAPEUTICS$$6$YR$$M$Y$22$KG$20240816$$$CA$CA
242163896$24216389$6$F$20240801$20240918$20240816$20240926$EXP$$CN-RDY-CLI/CHN/24/0011652$DR REDDYS$$6$MON$I$M$Y$6.9$KG$20240926$$MD$CN$CN
242163903$24216390$3$F$$20240822$20240816$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07373$LUPIN$$$$$$Y$$$20240911$$CN$US$US
242163913$24216391$3$F$$20240823$20240816$20240827$EXP$$NVSC2024CN165455$NOVARTIS$$32$YR$$F$Y$$$20240827$$CN$CN$CN
242163921$24216392$1$I$20230101$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008499$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240816$$CN$US$US
242163931$24216393$1$I$$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408006290$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240816$$CN$US$US
242163942$24216394$2$F$$20240821$20240816$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004013$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
242163952$24216395$2$F$$20240826$20240816$20240830$EXP$$JP-JNJFOC-20240834059$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240830$$MD$JP$JP
242163961$24216396$1$I$20240726$20240805$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039760$AUROBINDO$$33$YR$$M$Y$$$20240816$$PH$GB$GB
242163971$24216397$1$I$20240409$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040021$AUROBINDO$$15$YR$$F$Y$55.8$KG$20240816$$MD$FR$FR
242163981$24216398$1$I$$20240805$20240816$20240816$EXP$$US-SLATERUN-2024SRLIT00140$SLATE RUN$Abdelal Q, et al.Azith and the Myth.American Journal of Respiratory and Critical Care Medicine.may-2024;209:A2032-A2032$73$YR$E$F$Y$$$20240816$$HP$US$US
242163991$24216399$1$I$$20240805$20240816$20240816$EXP$$US-SLATERUN-2024SRLIT00139$SLATE RUN$Abdelal Q, et al.Azith and the Myth.American Journal of Respiratory and Critical Care Medicine.may-2024;209:A2032-A2032$73$YR$E$F$Y$$$20240816$$HP$US$US
242164001$24216400$1$I$$20240801$20240816$20240816$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462604$RANBAXY$Kaur M, Patra S, Khera S. Dermal steroid deposits due to intralesional triamcinolone. Indian J Dermatol Venereol Leprol. 2024;Jul-Aug; 90 (4):540-541$26$YR$$M$Y$$$20240816$$HP$IN$IN
242164011$24216401$1$I$$20240801$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420366$RANBAXY$joshi H, Earle K. SARS-CoV-2 Trigger in Severe Insulin Resistance With Acute Haemolytic Crisis in Diabetes and Glucose-6-phosphate Dehydrogenase Deficiency. J Endocrine Soc. 2021;5(Suppl 1):A397-A398$64$YR$$M$Y$75$KG$20240816$$MD$GB$GB
242164031$24216403$1$I$$20240801$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461356$RANBAXY$Gaur D, Michalopulos MG, Drake KA, Gattineni J. Acetaminophen induced high anion gap metabolic acidosis a potentially under-recognized consequence from a common medication. Pediatr Nephrol. 2024$12$YR$$F$Y$$$20240816$$HP$US$US
242164041$24216404$1$I$$20240801$20240816$20240816$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462597$RANBAXY$Pigni S, Cristofolini G, Jaafar S, Maida G, Grossrubatscher E, Dalino P, et al. Late-onset Schmidt?s Syndrome Presenting with Severe Hyponatremia: A Case Report. Endocr Metab Immune Disord Drug Targets. 2024;15 jul, 0 (0):1-3$73$YR$$F$Y$$$20240816$$HP$IT$IT
242164052$24216405$2$F$$20240808$20240816$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462660$RANBAXY$Shimomura M, Okura Y, Takahashi Y, Kobayashi I. Successful treatment of erythema nodosum with salazosulfapyridine in a 9-year-old patient with chronic non-bacterial osteomyelitis. Mod Rheumatol Case Rep. 2024;8(2):394-397$9$YR$$F$Y$$$20240823$$HP$JP$JP
242164061$24216406$1$I$$20240801$20240816$20240816$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462633$RANBAXY$Spangemacher M, Hart XM, Saalfrank E, Grunder G, Reinwald J, Sartorius A. Elevation of Alpha-1 Acid Glycoprotein During Acute Infection Increases Clozapine Levels Without Signs of Intoxication. J Clin Psychopharmacol. 2024;Jan/Feb; 44 (1):60-63$58$YR$$M$Y$$$20240816$$MD$DE$DE
242164071$24216407$1$I$$20240801$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462757$RANBAXY$$77$YR$$F$Y$$$20240816$$HP$GB$GB
242164081$24216408$1$I$$20240801$20240816$20240816$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462644$RANBAXY$Conversano E, Debiec H, Colucci M, Emma F, Ronco P, Vivarelli M. A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance. Pediatr Nephrol. 2024;39:305-308$2$YR$$M$Y$$$20240816$$HP$IT$IT
242164091$24216409$1$I$$20240801$20240816$20240816$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462631$RANBAXY$Trapanese V, Maruca F, Natale MR, Giofre F, Cosentino F, Sergi S, et al. Sodium-glucose co-transporter-2 inhibitor-associated non-diabetic ketoacidosis: a case report. Italian J Med. 2024;18(2):1716$26$YR$$M$Y$142$KG$20240816$$HP$IT$IT
242164101$24216410$1$I$$20240801$20240816$20240816$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462594$RANBAXY$Rosa e Silva MG, Coutinho JVSC, Guimara TF, de Ara?jo Filho JA. RARE CASE OF PULMONARY INFECTION BY MYCOBACTERIUM NEBRASKENSE IN CENTRAL-WEST BRAZIL. braz j infect dis. 2023;27(S1):102812; 418-419$70$YR$$F$Y$$$20240816$$HP$BR$BR
242164111$24216411$1$I$$20240801$20240816$20240816$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462626$RANBAXY$Joseph JT, Jammigumpula A, Jaise J, Naik P, Purohith AN, Shenoy S, et al. Long?term repetitive transcranial magnetic stimulation for treatment?resistant depression: Report of two cases. Indian J Psychiatry. 2024;66:679-681$56$YR$$M$Y$$$20240816$$HP$IN$IN
242164121$24216412$1$I$$20240813$20240816$20240816$PER$$US-ABBVIE-5881817$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242164131$24216413$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129439$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240816$$HP$US$US
242164141$24216414$1$I$20240719$20240805$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039490$AUROBINDO$$$$$M$Y$$$20240816$$MD$GB$GB
242164151$24216415$1$I$$20240809$20240816$20240816$EXP$$US-AstraZeneca-2024A182447$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242164162$24216416$2$F$$20240813$20240816$20240823$EXP$$CN-Ipsen Biopharmaceuticals, Inc.-2024-16143$IPSEN$$67$YR$E$F$Y$$$20240823$$MD$CN$CN
242164171$24216417$1$I$20240807$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A185019$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242164181$24216418$1$I$20231120$20240808$20240816$20240816$EXP$$ES-AstraZeneca-2024A185460$ASTRAZENECA$$45$DY$$M$Y$9.3$KG$20240816$$MD$ES$
242164191$24216419$1$I$20240731$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184933$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242164201$24216420$1$I$20240730$20240808$20240816$20240816$EXP$$CN-AstraZeneca-2024A181762$ASTRAZENECA$$19591$DY$$M$Y$54$KG$20240816$$MD$CN$
242164211$24216421$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A181351$ASTRAZENECA$$$$$M$Y$$$20240816$$HP$US$
242164221$24216422$1$I$$20240814$20240816$20240816$PER$$US-ROCHE-10000057134$ROCHE$$$$A$F$Y$$$20240816$$CN$US$US
242164232$24216423$2$F$20240101$20240812$20240816$20240820$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023910$UNITED THERAPEUTICS$$$$$F$Y$69.388$KG$20240820$$$US$US
242164241$24216424$1$I$20240601$20240807$20240816$20240816$EXP$$US-GSK-US2024GSK099914$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240816$$HP$US$US
242164251$24216425$1$I$$20240803$20240816$20240816$EXP$$PT-AUROBINDO-AUR-APL-2023-041564$AUROBINDO$Lopes DF, Simoes FO, Andrade J, Sousa RM, Iglesias F, Gon?alves I et.al. Micobacteriose disseminada por Mycobacterium celatum: Um caso de persist?ncia diagn?stica (Mycobacteriosis disseminated by Mycobacterium celatum: A case of diagnostic persistence). Congressos da Sociedade Portuguesa de Medicina Interna: 29.? Congresso Nacional. 2023;819-819$60$YR$$F$Y$$$20240816$$HP$PT$PT
242164261$24216426$1$I$$20240813$20240816$20240816$PER$$US-ABBVIE-5881406$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242164271$24216427$1$I$$20240810$20240816$20240816$EXP$$US-GSK-US2024101251$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$PH$US$US
242164282$24216428$2$F$$20240904$20240816$20240914$30DAY$$US-GSK-US2024099257$GLAXOSMITHKLINE$$$$$M$Y$$$20240914$$CN$US$US
242164293$24216429$3$F$$20240911$20240816$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004014$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
242164301$24216430$1$I$20240801$20240812$20240816$20240816$EXP$ES-AEMPS-1559706$ES-RDY-SPO/ESP/24/0011797$DR REDDYS$$79$YR$E$M$Y$$$20240816$$MD$ES$ES
242164311$24216431$1$I$20221024$20240813$20240816$20240816$EXP$$FR-AstraZeneca-2024A184266$ASTRAZENECA$$74$YR$$F$Y$82$KG$20240816$$MD$FR$
242164321$24216432$1$I$$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184497$ASTRAZENECA$$$$$M$Y$$$20240816$$MD$US$
242164331$24216433$1$I$20220702$20240813$20240816$20240816$EXP$$FR-AstraZeneca-2024A184238$ASTRAZENECA$$71$YR$$M$Y$90$KG$20240816$$MD$FR$
242164341$24216434$1$I$$20240815$20240816$20240816$EXP$$TH-ROCHE-10000058220$ROCHE$$64$YR$A$F$Y$$$20240816$$MD$TH$TH
242164351$24216435$1$I$$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184594$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242164361$24216436$1$I$20240201$20240808$20240816$20240816$EXP$$MX-AstraZeneca-2024A182339$ASTRAZENECA$$3961$WK$$M$Y$60$KG$20240816$$CN$MX$
242164371$24216437$1$I$$20240809$20240816$20240816$EXP$DE-Gedeon Richter Plc.-2023_GR_002926$DE-RDY-SPO/DEU/24/0011747$DR REDDYS$$32$YR$A$F$Y$75$KG$20240816$$MD$DE$DE
242164381$24216438$1$I$$20240801$20240816$20240816$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462694$RANBAXY$Magira E. Time of Herpes Simplex-1 Virus Detection Among Critical-ill With COVID-19 Pneumonia Patients. Am J Respir Crit Care Med. 2023;207:A3442$$$A$$Y$$$20240816$$HP$GR$GR
242164391$24216439$1$I$$20240801$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462718$RANBAXY$Raghunandan S, Pauly M, Blum WG, Qayed M, Dhodapkar MV, Elkhalifa M, et al. BCMA CAR- T induces complete and durable remission in refractory plasmablastic lymphoma. J Immunother Cancer. 2023;11 (5):e006684$$$T$$Y$$$20240816$$MD$US$US
242164401$24216440$1$I$$20240801$20240816$20240816$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462926$RANBAXY$Tsaktanis T, Stritzelberger J, To VTD, Uhl M, Schwab S, Heuss D, et al.. Case report: Cerebrospinal fluid neutrophilic pleocytosis upon intrathecal triamcinolone injection. Front Neurol. 2024;15 (0):1372266 (1-5)$76$YR$$F$Y$$$20240816$$HP$DE$DE
242164411$24216441$1$I$$20240802$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463055$RANBAXY$Sreekumar S, Rubin R. A Case of Pulmonary Mucormycosis Leading to Non-hepatic Hyperammonemia. Am J Respir Crit Care Med. 2024;209:A3563$31$YR$$F$Y$$$20240816$$HP$US$US
242164421$24216442$1$I$$20240801$20240816$20240816$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462726$RANBAXY$Jarolimova J, Kazmir M. Severe autoimmune thyreotoxicosis complicated by febrile neutropenia as a result of thyreostatic therapy. Int Med. 2023;69(2):E19-E22$53$YR$$F$Y$$$20240816$$MD$CZ$CZ
242164431$24216443$1$I$$20240802$20240816$20240816$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462592$RANBAXY$Romano A, Gasparro R, Campana MD, Pinchera B, Di Crescenzo RM, Del Guercio D, et al. COVID-19 as a critical risk factor for osteonecrosis of the jaw: diagnostic challenge and surgical treatment. Curr Probl Surg. 2024;61 (9):no pagination$74$YR$$M$Y$$$20240816$$MD$IT$IT
242164441$24216444$1$I$20231128$20240802$20240816$20240816$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462697$RANBAXY$$60$YR$$F$Y$84$KG$20240816$$MD$FR$FR
242164451$24216445$1$I$20240728$20240802$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462657$RANBAXY$$76$YR$$M$Y$$$20240816$$CN$GB$GB
242164461$24216446$1$I$$20240802$20240816$20240816$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461060$RANBAXY$Ancilla LC, Sundaram B, Pathak N, Raj A. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. J Nephropharmacol. 2024;13 (2):1-5$58$YR$$M$Y$$$20240816$$HP$IN$IN
242164471$24216447$1$I$20200502$20240802$20240816$20240816$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462614$RANBAXY$$18$YR$$F$Y$$$20240816$$MD$PL$PL
242164481$24216448$1$I$$20240803$20240816$20240816$EXP$$IT-AUROBINDO-AUR-APL-2024-039929$AUROBINDO$Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G, et al. Stevens-Johnson syndrome associated with drugs and vaccines in children: a case-control study.. Plos One.. 2013;JUL 16;8:7:1-8$108$MON$$F$Y$$$20240816$$HP$IT$IT
242164491$24216449$1$I$20240404$20240802$20240816$20240816$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462696$RANBAXY$$35$YR$$F$Y$51$KG$20240816$$MD$FR$FR
242164501$24216450$1$I$$20240802$20240816$20240816$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462664$RANBAXY$$$$E$F$Y$60$KG$20240816$$MD$DE$DE
242164511$24216451$1$I$$20240801$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462372$RANBAXY$$38$YR$$M$Y$$$20240816$$PH$GB$GB
242164521$24216452$1$I$$20240802$20240816$20240816$EXP$$ID-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463084$RANBAXY$Bagus BI, Bagus MI, Ayu SI, Hanis S, Widyanti S, Kristanto YY et al. Long Term Quality of Life (QoL) Assesment of Complicated Ulcerative Colitis Undergoing Total Colectomy and J-Pouch Ileo Rectal Reconstruction. KDDW. 2023;-:108/EP03-001$65$YR$$F$Y$$$20240816$$HP$ID$ID
242164531$24216453$1$I$$20240802$20240816$20240816$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462994$RANBAXY$Morita S, Monden N, Aoi J, Aibara S, Tahara H, Teramoto N. Primary malignant glomus tumors of the thyroid gland: A case report. Acta Oto-Laryngologica Case Rep. 2024;9:1:114-119$80$YR$$M$Y$$$20240816$$HP$JP$JP
242164541$24216454$1$I$$20240802$20240816$20240816$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462741$RANBAXY$O Brien S, Griffin B, Dorman AM. Interesting Biopsy of a Patient with AKI on a Background of Systemic Mastocytosis. J Am Soc Nephrol. 2023;34:110, TH-PO077$72$YR$$F$Y$$$20240816$$HP$IE$IE
242164551$24216455$1$I$$20240802$20240816$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463200$RANBAXY$Hua Y, Ou X. A Case Report of Severe Accidental Acute Ammonia Exposure. J Burn Care Res. 2024;Jan-Feb;45(1):250-252$54$YR$$M$Y$$$20240816$$MD$CN$CN
242164561$24216456$1$I$$20240803$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462832$RANBAXY$$$$$F$Y$$$20240816$$HP$GB$GB
242164571$24216457$1$I$20240424$20240802$20240816$20240816$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462421$RANBAXY$$81$YR$$F$Y$67$KG$20240816$$MD$FR$FR
242164581$24216458$1$I$$20240801$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462710$RANBAXY$$59$YR$$F$Y$$$20240816$$HP$GB$GB
242164591$24216459$1$I$20240802$20240802$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462761$RANBAXY$$62$YR$$M$Y$65$KG$20240816$$CN$GB$GB
242164601$24216460$1$I$$20240802$20240816$20240816$EXP$$ID-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463077$RANBAXY$Bagus BI, Bagus MI, Ayu SI, Hanis S, Widyanti S, Kristanto YY et al. Long Term Quality of Life (QoL) Assesment of Complicated Ulcerative Colitis Undergoing Total Colectomy and J-Pouch Ileo Rectal Reconstruction. KDDW. 2023;-:108/EP03-001$32$YR$$M$Y$$$20240816$$HP$ID$ID
242164611$24216461$1$I$$20240803$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462826$RANBAXY$$26$YR$$F$Y$$$20240816$$CN$GB$GB
242164621$24216462$1$I$20240514$20240802$20240816$20240816$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462669$RANBAXY$$81$YR$$F$Y$50$KG$20240816$$PH$FR$FR
242164631$24216463$1$I$$20240802$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463018$RANBAXY$Pak WLW, Brumwell NA, Kabel CC, Gutgarts V, Jaffer Sathick I, Mailankody S, et al. Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 Cases. Kidney Med. 2024;6 (8):100856 (1-5)$70$YR$$M$Y$$$20240816$$HP$US$US
242164641$24216464$1$I$20170415$20240802$20240816$20240816$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461278$RANBAXY$Xu Y, Qian H, Qian W, Dong L, Liu W, Zhu Y et al. Successful rescue of disseminated Nocardia infection with multiple abscesses in a patient with membranous nephropathy after cardiopulmonary resuscitation: A three-year follow-up. J Biomed Res. 2024;38 (2):189-194$43$YR$$F$Y$$$20240816$$HP$CN$CN
242164651$24216465$1$I$$20240801$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462687$RANBAXY$Khan S, Reggio C, Shoukat U, Lalwani A, Yousaf Z. Avoiding. Avoiding Premature Brain Death Declaration in Patients With Suspected Baclofen Overdose. Am J Respir Crit Care Med. 2024;209:A7027$58$YR$$M$Y$$$20240816$$HP$US$US
242164661$24216466$1$I$20220601$20240802$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462610$RANBAXY$$63$YR$$M$Y$65$KG$20240816$$MD$GB$GB
242164671$24216467$1$I$20231122$20240802$20240816$20240816$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462624$RANBAXY$$62$YR$$F$Y$$$20240816$$MD$FR$FR
242164681$24216468$1$I$20240320$20240802$20240816$20240816$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462392$RANBAXY$$19$YR$$$Y$52$KG$20240816$$PH$FR$FR
242164691$24216469$1$I$$20240802$20240816$20240816$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461000$RANBAXY$Uvais NA, Moideen S. Polypharmacy-Associated Tardive Dystonia Responding to Clozapine Optimization. Am J Ther. 2024;Jul/Aug;31 (4):e444-e445$36$YR$$F$Y$$$20240816$$MD$IN$IN
242164701$24216470$1$I$20240325$20240801$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462378$RANBAXY$$47$YR$$$Y$$$20240816$$PH$GB$GB
242164711$24216471$1$I$20240423$20240802$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462681$RANBAXY$$72$YR$$F$Y$53$KG$20240816$$CN$GB$GB
242164721$24216472$1$I$20240215$20240802$20240816$20240816$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462450$RANBAXY$$61$YR$$F$Y$$$20240816$$PH$FR$FR
242164731$24216473$1$I$$20240716$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07331$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242164742$24216474$2$F$$20240829$20240816$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462971$RANBAXY$Estabrooks KL, DeSilva K, Survela L, Stevenson WS. Haemophagocytic lymphohistiocytosis due to leishmaniasis following anti-tumour necrosis factor-alpha therapy. Br J Haematol. 2023;203:497-498$56$YR$$M$Y$$$20240913$$HP$AU$AU
242164751$24216475$1$I$$20240802$20240816$20240816$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463037$RANBAXY$Arslan A, Ozkaya OG, Aytemiz F, Altay H, Ozcan EE, Kucukaksu DS, et al. Oral amiodarone and propranolol in maintenance therapy of postimplantation tachycardia An observational study. Medicine. 2024;103(28):e38839;1-8$60$YR$$M$Y$$$20240816$$MD$TR$TR
242164762$24216476$2$F$20230902$20240821$20240816$20240905$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-423828$RANBAXY$$73$YR$E$M$Y$59$KG$20240905$$MD$CN$CN
242164791$24216479$1$I$20240702$20240801$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462619$RANBAXY$$71$YR$$M$Y$71$KG$20240816$$MD$GB$GB
242164801$24216480$1$I$$20240802$20240816$20240816$EXP$$ID-SUNPHARMA-2024R1-460843AA$RANBAXY$Rohmah SN, Puspitasari M, Wardhani Y, Ananda NR, Khotijah AA. Diagnostic and therapeutic challenges of tuberculosis in kidney transplant recipients; a case series study. J Nephropharmacol. 2024;13 (2):e11679$29$YR$$M$Y$$$20240816$$HP$ID$ID
242164811$24216481$1$I$$20240802$20240816$20240816$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461059$RANBAXY$Ancilla LC, Sundaram B, Pathak N, Raj A. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. J Nephropharmacol. 2024;13 (2):1-5$55$YR$$M$Y$$$20240816$$HP$IN$IN
242164821$24216482$1$I$20180101$20240802$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462522$RANBAXY$$12$YR$$F$Y$$$20240816$$CN$GB$GB
242164831$24216483$1$I$$20240801$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462725$RANBAXY$Hung E, Face C, Yu DH. Is Osimertinib the New Medical ICU Miracle Drug? The Role of Osimertinib in Critical Illness for Patients With Metastatic EGFR Mutated Lung Cancer. Am J Respir Crit Care Med. 2024;209 (0):A6566$33$YR$$F$Y$$$20240816$$HP$US$US
242164841$24216484$1$I$$20240802$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463069$RANBAXY$Wang J, Elghawy O, Kurpiel B, Kaur v. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors. Clin J Gastroenterol. 2023;16:807-814$75$YR$$F$Y$$$20240816$$HP$US$US
242164851$24216485$1$I$20200212$20240802$20240816$20240816$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462608$RANBAXY$$31$YR$$M$Y$93$KG$20240816$$MD$PL$PL
242164861$24216486$1$I$$20240802$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463000$RANBAXY$Cherabuddi MR, Schloop M, Shakaroun D, Abu Sayf A. Pulmonary Tumor Thrombotic Microangiopathy Leading to the Discovery of Underlying Gastric Adenocarcinoma. Am J Respir Crit Care Med. 2024;209 (0):no pagination$45$YR$$M$Y$$$20240816$$HP$US$US
242164881$24216488$1$I$$20240802$20240816$20240816$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463041$RANBAXY$Arslan A, Ozkaya OG, Aytemiz F, Altay H, Ozcan EE, Kucukaksu DS, et al. Oral amiodarone and propranolol in maintenance therapy of postimplantation tachycardia An observational study. Medicine. 2024;103(28):e38839;1-8$52$YR$$F$Y$$$20240816$$MD$TR$TR
242164891$24216489$1$I$20240201$20240802$20240816$20240816$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462700$RANBAXY$$62$YR$$M$Y$89$KG$20240816$$MD$FR$FR
242164901$24216490$1$I$$20240802$20240816$20240816$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462896$RANBAXY$Boylu ME, Kirpinar I. Myelinolysis cases presenting with manic attack after rapid correction of hyponatremia: Two cases. Bipolar Disord. 2024;26:401-404$48$YR$$M$Y$$$20240816$$HP$TR$TR
242164911$24216491$1$I$$20240801$20240816$20240816$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462132$RANBAXY$Sokolewicz EM, Dzwilewski K, Omieczynska N, Zawadzka M, Mazurkiewicz-Beldzinska M. Drug resistant epilepsy as the consequence of inadequate control of type 1 diabetes. Pediatr Endocrinol. 2024;30 (1):42-44$11$YR$$M$Y$$$20240816$$HP$PL$PL
242164931$24216493$1$I$20231101$20240802$20240816$20240816$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462418$RANBAXY$$75$YR$$M$Y$$$20240816$$MD$SE$SE
242164941$24216494$1$I$$20240802$20240816$20240816$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462873$RANBAXY$Vajgel G, Xavier LS, Alves IR, Santos TO, Oliveira CB, Machado AN, et al. Thrombotic Microangiopathy Associated with Exostosin-1-Associated Membranous Nephropathy: Case Report. J Am Soc Nephrol. 2023;34:278-279; TH-PO672$15$YR$$F$Y$$$20240816$$HP$BR$BR
242164951$24216495$1$I$$20240801$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462792$RANBAXY$Wang AW, Steed K,  Mundi PS, Greenberg  P, Saul SR. Hunt for  Hypercalcemia. J Endocr Soc. 2022;Nov-Dec6(supl.):A163-A164/bvac150.336/ODP093$71$YR$$M$Y$$$20240816$$MD$US$US
242164961$24216496$1$I$20240217$20240802$20240816$20240816$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462416$RANBAXY$$92$YR$$M$Y$60$KG$20240816$$HP$SE$SE
242164971$24216497$1$I$$20240802$20240816$20240816$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462876$RANBAXY$Chauhan A, Agrawal M, Yadav P, Chauhan VS. Rapid cycling in late-onset bipolar affective disorder predominantly mania. Med J Armed Forces India. 2024;0 (0):1-3$70$YR$$F$Y$$$20240816$$MD$IN$IN
242164981$24216498$1$I$$20240801$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462724$RANBAXY$Qadir N, Rulka K, Shirazi I, Durgun A, Trehan M. A Day on the Beach, a Risk for Vibrio Vulnificus Septicemia. Am J Respir Crit Care Med. 2024;209(0):no pagination$61$YR$$M$Y$$$20240816$$HP$US$US
242164991$24216499$1$I$20240710$20240803$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462524$RANBAXY$$44$YR$$$Y$$$20240816$$PH$GB$GB
242165001$24216500$1$I$$20240802$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463007$RANBAXY$Tidwell J, Thakkar B, Nguyen MTT, Parker S, Schoenfeld A. Primary Hepatic Neuroendocrine Carcinoma: A Rare Entity. ACG Case Rep J. 2024;11 (7):e01411 (1-4)$65$YR$$M$Y$$$20240816$$HP$US$US
242165011$24216501$1$I$$20240802$20240816$20240816$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462649$RANBAXY$$29$YR$$M$Y$$$20240816$$MD$FR$FR
242165021$24216502$1$I$20240710$20240802$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462753$RANBAXY$$48$YR$$M$Y$127$KG$20240816$$CN$GB$GB
242165032$24216503$2$F$20231001$20240821$20240816$20240905$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-418405$RANBAXY$$41$YR$A$M$Y$97$KG$20240905$$MD$CN$CN
242165051$24216505$1$I$20210827$20240813$20240816$20240816$EXP$$CA-AMGEN-CANSP2024160984$AMGEN$$59$YR$A$M$Y$$$20240816$$CN$CA$CA
242165061$24216506$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024162579$AMGEN$$$$$F$Y$$$20240816$$HP$US$US
242165071$24216507$1$I$$20240801$20240816$20240816$EXP$$US-Long Grove-000067$Long Grove Pharmaceuticals$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. J Neonatal Perinatal Med. 2024 Jul 23.$$$$M$Y$$$20240816$$MD$US$US
242165081$24216508$1$I$$20240813$20240816$20240816$PER$$US-HALEON-2191943$Haleon PLC$$78$YR$$F$Y$$$20240816$$CN$US$US
242165091$24216509$1$I$20240101$20240812$20240816$20240816$EXP$$CA-ABBVIE-5879160$ABBVIE$$$$A$M$Y$$$20240816$$MD$CA$CA
242165101$24216510$1$I$20240611$20240725$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004016$ACADIA PHARMACEUTICALS$$64$YR$$M$Y$$$20240816$$CN$US$US
242165113$24216511$3$F$20240806$20240910$20240816$20240918$30DAY$$CA-JNJFOC-20240835433$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240919$$PH$CA$CA
242165121$24216512$1$I$20240803$20240808$20240816$20240816$PER$$US-009507513-2408USA003498$MERCK$$52$YR$$F$Y$$$20240816$$CN$US$US
242165151$24216515$1$I$20230913$20240802$20240816$20240816$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462563$RANBAXY$$64$YR$$F$Y$$$20240816$$MD$FR$FR
242165161$24216516$1$I$$20240802$20240816$20240816$EXP$$ET-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462859$RANBAXY$Solela G, Aschenek A, Dawit M, Wondafrash G.. Coronavirus disease 2019 and malaria coinfection in a middle-aged Ethiopian woman presenting with acute febrile illness and bilateral pleural effusion: a case report.. J Med Case Rep. 2023;17:no pagination$57$YR$$F$Y$$$20240816$$HP$ET$ET
242165171$24216517$1$I$20240401$20240802$20240816$20240816$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462409$RANBAXY$$85$YR$$F$Y$$$20240816$$MD$SE$SE
242165181$24216518$1$I$$20240802$20240816$20240816$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462620$RANBAXY$Nagao S, Yabuuchi Y, Tanaka K, Morihisa Y, Kobayashi T, Akiyama S, et al. Multiple Gastric Neuroendocrine Tumors Associated with Long-term Use of a Proton Pump Inhibitor and a Potassiumcompetitive Acid Blocker. Intern Med. 2024;63 (14):2001-2010$52$YR$$M$Y$$$20240816$$HP$JP$JP
242165191$24216519$1$I$$20240802$20240816$20240816$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463023$RANBAXY$Stabel C, Woei-A-Jin FJSH, Tousseyn T, Garmyn M. Sulfasalazine-Induced Epstein?Barr Virus-Positive Mucocutaneous Ulcer. Case Rep Hematol. 2024;2024 (0):1-4$68$YR$$M$Y$$$20240816$$HP$BE$BE
242165211$24216521$1$I$$20240802$20240816$20240816$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463159$RANBAXY$Agarwal A, Saha SC, Kaur A, Naganur S. Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum. BMJ Case Rep. 2023;16(12):1-5(e255808)$$$N$M$Y$2.578$KG$20240816$$HP$IN$IN
242165221$24216522$1$I$20220131$20240802$20240816$20240816$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462400$RANBAXY$$62$YR$$F$Y$80$KG$20240816$$MD$DE$DE
242165231$24216523$1$I$$20240802$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463016$RANBAXY$Pak WLW, Brumwell NA, Kabel CC, Gutgarts V, Jaffer Sathick I, Mailankody S, et al. Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 Cases. Kidney Med. 2024;6 (8):100856(1-5)$50$YR$$F$Y$$$20240816$$MD$US$US
242165241$24216524$1$I$$20240801$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462346$RANBAXY$$59$YR$$F$Y$$$20240816$$HP$GB$GB
242165251$24216525$1$I$20240305$20240802$20240816$20240816$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462387$RANBAXY$$62$YR$$F$Y$77$KG$20240816$$MD$RO$RO
242165261$24216526$1$I$20231201$20240802$20240816$20240816$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462397$RANBAXY$$68$YR$$M$Y$99$KG$20240816$$MD$FR$FR
242165271$24216527$1$I$$20240802$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462998$RANBAXY$Garofalo V, Walgamage M, Cuello LN, Wester K, Robinson S, Gemayel CY. ANAPLASMOSIS: FROM MULTI-SYSTEM MAYHEM TO VENTRICULAR TACHYCARDIA IN A HEARTBEAT. J Am Coll Cardiol. 2024;83 (Suppl.)(13):4506$78$YR$$M$Y$$$20240816$$HP$US$US
242165281$24216528$1$I$$20240802$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462996$RANBAXY$Lindsay A, Niccum DE. An Underestimated Toxin: The Case of Intentional Benzonatate Overdose Resulting in Seizure and Cardiac Arrest. Am J Respir Crit Care Med. 2024;209:A7034$41$YR$$F$Y$$$20240816$$HP$US$US
242165291$24216529$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129293$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240816$$HP$US$US
242165301$24216530$1$I$$20240812$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128271$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240816$$CN$US$US
242165311$24216531$1$I$$20240806$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125748$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240816$$HP$US$US
242165322$24216532$2$F$20240802$20240815$20240816$20240820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-129113$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$66.2$KG$20240820$$MD$JP$JP
242165331$24216533$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128812$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$76.2$KG$20240816$$HP$US$US
242165341$24216534$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129298$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240816$$HP$US$US
242165351$24216535$1$I$20240806$20240806$20240816$20240816$PER$$US-ABBVIE-5872251$ABBVIE$$37$YR$$F$Y$$$20240816$$CN$US$US
242165361$24216536$1$I$20240710$20240808$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126896$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$105$KG$20240816$$PH$US$US
242165371$24216537$1$I$20240528$20240808$20240816$20240816$EXP$ES-AEMPS-1556067$ES-TEVA-VS-3232440$TEVA$$49$YR$$M$Y$72$KG$20240816$$HP$ES$ES
242165391$24216539$1$I$$20240719$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07358$LUPIN$$$$$$Y$$$20240816$$PH$US$US
242165403$24216540$3$F$20200916$20240809$20240816$20240821$EXP$$IT-AUROBINDO-AUR-APL-2022-050802$AUROBINDO$$65$YR$$F$Y$$$20240821$$MD$IT$IT
242165411$24216541$1$I$$20240807$20240816$20240816$30DAY$$US-GSK-US2024098495$GLAXOSMITHKLINE$$$$$M$Y$$$20240816$$CN$US$US
242165423$24216542$3$F$$20240909$20240816$20240918$30DAY$$US-GSK-US2024098459$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
242165431$24216543$1$I$$20240812$20240816$20240816$EXP$$AU-ABBVIE-5880581$ABBVIE$James F, Goh MS, Vogrin S, Ng I, Douglas AP, Holmes NE, et al. The Australasian Registry for Severe Cutaneous Adverse Reactions (Aus-scar) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions. World Allergy Organization Journal. 2024;17(8):1-38.$$$$$Y$$$20240816$$HP$AU$AU
242165442$24216544$2$F$20240429$20240803$20240816$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-040120$AUROBINDO$$43$YR$$F$Y$72$KG$20240817$$MD$FR$FR
242165451$24216545$1$I$$20240809$20240816$20240816$EXP$$US-GSK-US2024099731$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$US$US
242165461$24216546$1$I$20240101$20240808$20240816$20240816$EXP$$US-UCBSA-2024024346$UCB$$$$$F$Y$$$20240816$$CN$US$US
242165471$24216547$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004018$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242165481$24216548$1$I$20240715$20240726$20240816$20240816$EXP$$AU-BEH-2024176469$CSL BEHRING$$55$YR$A$F$Y$$$20240816$$CN$AU$AU
242165491$24216549$1$I$$20240809$20240816$20240816$PER$$US-EMD Serono-2024043532$EMD SERONO INC$$69$YR$E$F$Y$$$20240816$$CN$US$US
242165501$24216550$1$I$$20240514$20240816$20240816$PER$$US-BAYER-2024A117563$BAYER$$40$YR$A$F$Y$$$20240816$$CN$US$US
242165511$24216551$1$I$20220809$20240808$20240816$20240816$EXP$$CA-ROCHE-3161001$ROCHE$$16$YR$T$F$Y$57$KG$20240816$$CN$CA$CA
242165521$24216552$1$I$$20240814$20240816$20240816$EXP$$GB-MYLANLABS-2024M1075925$MYLAN$$80$YR$$$Y$$$20240816$$PH$GB$GB
242165531$24216553$1$I$$20240806$20240816$20240816$EXP$$IN-MYLANLABS-2024M1074689$MYLAN$Krishna S, Vijayaraghavan A, Philip DSJ, Sundaram S, Sukumaran S. Intrathecal methotrexate induced subacute combined degeneration of spinal cord like presentation in a patient with acute lymphocytic leukaemia. Acta-Neurol-Belg 2024; 124 (2): 679-681.$17$YR$$M$Y$$$20240816$$HP$IN$IN
242165541$24216554$1$I$$20240805$20240816$20240816$EXP$$US-MYLANLABS-2024M1074210$MYLAN$Harmouch W, Zhang JR, Peterson JM, Uran DP, Buja LM, Zhao B, et al. A challenging case of eosinophilic myocarditis leading to heart failure and transplantation. Cardiovasc-Pathol 2024; 72.$4$DEC$$M$Y$$$20240816$$HP$US$US
242165551$24216555$1$I$20221101$20240805$20240816$20240816$EXP$$GB-MYLANLABS-2024M1074839$MYLAN$Premraj S, Lane S, Camilleri B. IgA crescentic glomerulonephritis in psoriatic arthritis - disease or treatment related?. Clin-Med-London 2024; 24 (Suppl.) 42-43.$$$A$F$Y$$$20240816$$HP$GB$GB
242165561$24216556$1$I$$20240806$20240816$20240816$EXP$$US-MYLANLABS-2024M1074349$MYLAN$Welch L, Maldonado L, Banadera F, Trapane P, Hasan R, Benson M, et al. Severe Hyperparathyroidism in a Newborn: Response to Cinacalcet. J-Endocr-Soc 2022; 6 (Suppl. 1) A233 abstr. PSAT178.$39$WK$$F$Y$2.38$KG$20240816$$MD$US$US
242165571$24216557$1$I$$20240805$20240816$20240816$EXP$$US-MYLANLABS-2024M1074818$MYLAN$Shaikh Y, Jamal I, Gumireddy S, Idriss S, Piya S, Jabiev A, et al. #1705929 Treatment refractory hyperthyroidism in an elderly patient and pre-operative management with therapeutic plasma exchange. Endocr-Pract 2024; 30 (Suppl.) (5): S157-S158 abstr. #1705929.$94$YR$$F$Y$$$20240816$$MD$US$US
242165581$24216558$1$I$$20240813$20240816$20240816$EXP$GB-MHRA-MED-202407311408079480-RQVLB$GB-MYLANLABS-2024M1071747$MYLAN$$52$YR$$M$Y$$$20240816$$MD$GB$GB
242165591$24216559$1$I$$20240725$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004017$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242165601$24216560$1$I$$20240806$20240816$20240816$EXP$$US-MYLANLABS-2024M1074726$MYLAN$Mossner J, Saleh NB, Shahin MN, Rosenow JM, Raskin JS. Occipital nerve stimulation in pediatric patients with refractory occipital neuralgia. Childs-Nerv-Syst 2024; 40 (8): 2465-2470.$17$YR$$F$Y$$$20240816$$HP$US$US
242165611$24216561$1$I$20240103$20240803$20240816$20240816$EXP$$FR-AUROBINDO-AUR-APL-2024-040101$AUROBINDO$$59$YR$$F$Y$$$20240816$$PH$FR$FR
242165621$24216562$1$I$20220101$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160899$AMGEN$$65$YR$E$M$Y$$$20240816$$CN$US$US
242165632$24216563$2$F$20240812$20240822$20240816$20240827$PER$$US-AMGEN-USASP2024161100$AMGEN$$77$YR$E$F$Y$$$20240827$$CN$US$US
242165641$24216564$1$I$$20240806$20240816$20240816$30DAY$$US-GSK-US2024098125$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242165651$24216565$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008485$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240816$$CN$US$US
242165661$24216566$1$I$20240810$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007717$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240816$$CN$US$US
242165671$24216567$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008465$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240816$$CN$US$US
242165681$24216568$1$I$20240501$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008532$ELI LILLY AND CO$$26$YR$A$M$Y$$$20240816$$CN$US$US
242165691$24216569$1$I$20240813$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008534$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240816$$CN$US$US
242165701$24216570$1$I$$20240815$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009793$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240816$$CN$US$US
242165711$24216571$1$I$$20240815$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009835$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240816$$CN$US$US
242165721$24216572$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008492$ELI LILLY AND CO$$$$$M$Y$$$20240816$$CN$US$US
242165731$24216573$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007622$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240816$$CN$US$US
242165741$24216574$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008408$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240816$$CN$US$US
242165751$24216575$1$I$20240810$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007658$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240816$$CN$US$US
242165761$24216576$1$I$$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408006610$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240816$$CN$US$US
242165771$24216577$1$I$$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408006580$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240816$$CN$US$US
242165782$24216578$2$F$$20240906$20240816$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202308006178$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240910$$CN$US$US
242165791$24216579$1$I$$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005607$ELI LILLY AND CO$$41$YR$A$$Y$$$20240816$$LW$US$US
242165801$24216580$1$I$$20240811$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008121$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242165812$24216581$2$F$$20240906$20240816$20240909$EXP$$US-ROCHE-10000058743$ROCHE$$41$YR$A$F$Y$$$20240909$$CN$US$US
242165821$24216582$1$I$20240501$20240806$20240816$20240816$EXP$$FR-TEVA-VS-3230538$TEVA$$57$YR$$M$Y$$$20240816$$MD$FR$FR
242165833$24216583$3$F$$20240815$20240816$20240820$PER$$NVSC2024US165528$NOVARTIS$$$$$M$Y$$$20240820$$CN$US$US
242165841$24216584$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165594$NOVARTIS$$$$$M$Y$$$20240816$$CN$US$US
242165855$24216585$5$F$20240724$20240905$20240816$20240916$30DAY$$JO-JNJFOC-20240774886$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240916$$HP$JO$JO
242165861$24216586$1$I$$20240809$20240816$20240816$EXP$$US-AstraZeneca-2024A182951$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242165871$24216587$1$I$20240805$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184393$ASTRAZENECA$$25607$DY$$M$Y$$$20240816$$HP$US$
242165881$24216588$1$I$$20230413$20240816$20240816$EXP$$US-AstraZeneca-2023A088223$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242165891$24216589$1$I$20240724$20240808$20240816$20240816$EXP$$KZ-AstraZeneca-2024A183429$ASTRAZENECA$$$$T$M$Y$43$KG$20240816$$MD$KZ$
242165902$24216590$2$F$20231231$20240816$20240816$20240821$EXP$$BE-AstraZeneca-2024A180315$ASTRAZENECA$$85$YR$$M$Y$$$20240821$$MD$BE$
242165911$24216591$1$I$20230801$20230817$20240816$20240816$EXP$$US-AstraZeneca-2023A190041$ASTRAZENECA$$59$YR$$F$Y$$$20240816$$CN$US$
242165921$24216592$1$I$$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A185008$ASTRAZENECA$$$$$$Y$$$20240816$$CN$US$
242165931$24216593$1$I$20240731$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184875$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242165942$24216594$2$F$20240101$20240822$20240816$20240830$EXP$$US-ABBVIE-5880636$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242165951$24216595$1$I$20220630$20220726$20240816$20240816$EXP$$US-AstraZeneca-2022A269321$ASTRAZENECA$$18662$DY$$F$Y$100.4$KG$20240816$$HP$US$
242165971$24216597$1$I$20240723$20240802$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123539$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240816$$PH$US$US
242165981$24216598$1$I$20240701$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129112$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240816$$HP$US$US
242165991$24216599$1$I$$20240812$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128634$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240816$$HP$US$US
242166001$24216600$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129292$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240816$$HP$US$US
242166011$24216601$1$I$$20240808$20240816$20240816$EXP$$US-ABBVIE-5874377$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242166031$24216603$1$I$$20240814$20240816$20240816$PER$$US-HALEON-2192221$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242166044$24216604$4$F$20230416$20240814$20240816$20240905$EXP$$IE-BEH-2023157974$CSL BEHRING$$67$YR$E$F$Y$$$20240905$$CN$IE$IE
242166051$24216605$1$I$20230412$20240808$20240816$20240816$EXP$$US-AMX-008130$AMYLYX PHARMACEUTICALS$$66$YR$$M$Y$105$KG$20240816$$HP$US$US
242166062$24216606$2$F$20231201$20240912$20240816$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004019$ACADIA PHARMACEUTICALS$$92$YR$$F$Y$$$20240923$$CN$US$US
242166071$24216607$1$I$20240723$20240803$20240816$20240816$EXP$$DE-AUROBINDO-AUR-APL-2024-039992$AUROBINDO$$76$YR$$F$Y$82$KG$20240816$$MD$DE$DE
242166091$24216609$1$I$$20240808$20240816$20240816$EXP$NL-LRB-00993569$NL-TEVA-VS-3232457$TEVA$$77$YR$$F$Y$79$KG$20240816$$CN$NL$NL
242166101$24216610$1$I$$20240811$20240816$20240816$EXP$GB-MHRA-MED-202408112206023550-QKDCN$GB-RDY-SPO/GBR/24/0011796$DR REDDYS$$2$YR$C$M$Y$$$20240816$$CN$GB$GB
242166111$24216611$1$I$$20240813$20240816$20240816$PER$$US-ABBVIE-5881752$ABBVIE$$$$$M$Y$$$20240816$$MD$US$US
242166121$24216612$1$I$20240101$20240813$20240816$20240816$EXP$$US-ABBVIE-5865010$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242166131$24216613$1$I$20240622$20240813$20240816$20240816$PER$$US-ROCHE-10000056658$ROCHE$$56$YR$A$F$Y$62.59$KG$20240816$$CN$US$US
242166141$24216614$1$I$20240721$20240809$20240816$20240816$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US000167$PAREXEL$$$$$$Y$$$20240816$$CN$US$US
242166151$24216615$1$I$$20240807$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125477$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$95.71$KG$20240816$$CN$US$US
242166161$24216616$1$I$$20240816$20240816$20240816$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-102184$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240816$$CN$CA$CA
242166201$24216620$1$I$$20240813$20240816$20240816$EXP$$AR-ROCHE-10000057172$ROCHE$$$$$F$Y$$$20240816$$MD$AR$AR
242166213$24216621$3$F$20240101$20240823$20240816$20240828$EXP$$US-ABBVIE-5875637$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242166221$24216622$1$I$$20240807$20240816$20240816$EXP$$JP-ARDELYX-2024ARDX004662$ARDELYX$$8$DEC$$F$Y$$$20240816$$MD$JP$JP
242166231$24216623$1$I$$20240808$20240816$20240816$EXP$$DE-EMD Serono-2024042999$EMD SERONO INC$$$$$F$Y$$$20240816$$MD$DE$DE
242166241$24216624$1$I$$20240805$20240816$20240816$EXP$$US-ARDELYX-2024ARDX005985$ARDELYX$$$$$M$Y$$$20240816$$HP$US$US
242166251$24216625$1$I$20240801$20240806$20240816$20240816$EXP$$US-ARDELYX-2024ARDX006019$ARDELYX$$66$YR$$M$Y$$$20240816$$CN$US$US
242166262$24216626$2$F$20231001$20240807$20240816$20240820$30DAY$$US-GSK-US2024098546$GLAXOSMITHKLINE$$54$YR$$F$Y$$$20240820$$CN$US$US
242166271$24216627$1$I$20240722$20240807$20240816$20240816$EXP$$US-ARDELYX-2024ARDX006058$ARDELYX$$67$YR$$F$Y$$$20240816$$CN$US$US
242166281$24216628$1$I$$20240807$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR099398$VIIV$$$$$M$Y$$$20240816$$CN$US$US
242166292$24216629$2$F$$20240827$20240816$20240905$EXP$$JP-ARDELYX-2024ARDX006145$ARDELYX$$6$DEC$$F$Y$$$20240904$$PH$JP$JP
242166302$24216630$2$F$20240101$20240814$20240816$20240821$PER$$US-AMGEN-USASP2024162687$AMGEN$$34$YR$A$M$Y$$$20240821$$HP$US$US
242166311$24216631$1$I$$20240724$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003938$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$HP$US$US
242166322$24216632$2$F$20240420$20240823$20240816$20240826$EXP$$NVSC2024AE165544$NOVARTIS$$80$YR$$M$Y$54.2$KG$20240826$$MD$AE$AE
242166331$24216633$1$I$20240810$20240813$20240816$20240816$PER$$US-JNJFOC-20240833553$JOHNSON AND JOHNSON$$34$YR$A$$Y$$$20240816$$PH$US$US
242166341$24216634$1$I$20210101$20240802$20240816$20240816$EXP$$GB-CIPLA LTD.-2024GB08518$CIPLA$$$$$$Y$$$20240816$$CN$GB$GB
242166351$24216635$1$I$20240813$20240814$20240816$20240816$PER$$US-ALXN-202408USA000861US$ALEXION PHARMACEUTICALS$$56$YR$$F$Y$$$20240816$$HP$US$US
242166361$24216636$1$I$20240409$20240806$20240816$20240816$EXP$FR-AFSSAPS-NT2024000977$FR-STRIDES ARCOLAB LIMITED-2024SP009891$STRIDES$$15$YR$$F$Y$55.8$KG$20240816$$MD$FR$FR
242166371$24216637$1$I$20240101$20240812$20240816$20240816$EXP$$US-009507513-2408USA005133$MERCK$$74$YR$$M$Y$$$20240816$$CN$US$US
242166381$24216638$1$I$20240813$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162468$AMGEN$$81$YR$E$M$Y$$$20240816$$CN$US$US
242166391$24216639$1$I$20240801$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162679$AMGEN$$57$YR$A$F$Y$$$20240816$$HP$US$US
242166401$24216640$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161931$AMGEN$$$$$$Y$$$20240816$$HP$US$US
242166411$24216641$1$I$$20240805$20240816$20240816$EXP$$SG-ROCHE-10000051244$ROCHE$$71$YR$E$F$Y$$$20240816$$CN$SG$SG
242166421$24216642$1$I$$20240806$20240816$20240816$EXP$$BR-STERISCIENCE B.V.-2024-ST-001182$Steriscience PTE$Farias LABG, de Araujo RMO, Maia KM, de Azevedo MQ, Cavalcante KF, de Sousa LLF, et al.. CASO DE RAIVA HUMANA APOS MORDEDURA POR SAGUI (CALLITHRIX JACCHUS) EM PACIENTE COM COVID-19: EVOLUCAO CLINICA, CUIDADOS INTENSIVOS E CONTEXTO EPIDEMIOLOGICO. Brazil-J-Infect-Dis. 2023;27 (Suppl. 1)$36$YR$$M$Y$$$20240816$$HP$BR$BR
242166431$24216643$1$I$$20240806$20240816$20240816$EXP$$KR-STERISCIENCE B.V.-2024-ST-001194$Steriscience PTE$Lee H-G, Kwon S, Goto H, Fujimoto M, Kainuma M, Cho K-H.. Successful treatment of restless legs syndrome accompanied by headaches for 30 years with herbal prescriptions containing Paeoniae Radix: A case report. Explore-NY. 2024;20 (6):1-4$70$YR$$F$Y$$$20240816$$HP$KR$KR
242166441$24216644$1$I$$20240806$20240816$20240816$EXP$$GR-STERISCIENCE B.V.-2024-ST-001195$Steriscience PTE$Sarri G, Geladari E, Petropoulos K, Adamopoulou E, Kanari M, Balampinis C, et al.. DOUBLE COVERAGE WITH DAPTOMYCIN AND CEFTAROLINE LED TO ERADICATION OF MRSA BACTEREMIA.. Eur-J-Case-Rep-Intern-Med. 2023;10 (Suppl. 1):341 abstr. 733.$67$YR$$M$Y$$$20240816$$HP$GR$GR
242166451$24216645$1$I$$20240805$20240816$20240816$EXP$GB-MLMSERVICE-20240729-PI145355-00263-1$GB-STERISCIENCE B.V.-2024-ST-001205$Steriscience PTE$Townsend K, Leck C, Billahalli T, Barachina E, Watts TJ. Maculopapular rash with multiple drug hypersensitivity to cotrimoxazole, amikacin, piperacillin/tazobactam, and meropenem in a patient with hairy cell leukemia. Allergologie select. 2024;8:265-9$54$YR$$F$Y$$$20240816$$MD$GB$GB
242166461$24216646$1$I$$20240806$20240816$20240816$EXP$$PT-STERISCIENCE B.V.-2024-ST-001191$Steriscience PTE$Neto M, Reis A, Santos F, Brigas D, Marques S, Serra S, et al.. A MISFORTUNE.. Eur-J-Case-Rep-Intern-Med. 2023;10 (Suppl. 1):328$45$YR$$F$Y$$$20240816$$HP$PT$PT
242166471$24216647$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004038$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240816$$HP$US$US
242166481$24216648$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129061$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240816$$CN$US$US
242166491$24216649$1$I$20240731$20240806$20240816$20240816$EXP$GB-MHRA-MED-202407311046435960-GSYJP$GB-TEVA-VS-3230618$TEVA$$39$YR$$F$Y$$$20240816$$CN$GB$GB
242166502$24216650$2$F$20240801$20240912$20240816$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024844$UNITED THERAPEUTICS$$42$YR$$F$Y$51.701$KG$20240919$$$US$US
242166511$24216651$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A180868$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242166521$24216652$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A185178$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242166531$24216653$1$I$$20240809$20240816$20240816$EXP$$US-AstraZeneca-2024A182307$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242166542$24216654$2$F$20240723$20240816$20240816$20240821$EXP$$US-VANTIVE-2024VAN018907$Vantive US Healthcare$$74$YR$$F$Y$$$20240821$$CN$US$US
242166551$24216655$1$I$20210202$20240813$20240816$20240816$EXP$$US-ABBVIE-5880608$ABBVIE$$58$YR$$F$Y$$$20240816$$CN$US$US
242166561$24216656$1$I$20220329$20220620$20240816$20240816$EXP$$US-AstraZeneca-2022A228091$ASTRAZENECA$$21578$DY$$F$Y$$$20240816$$CN$US$
242166571$24216657$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56307$$FDA-CTU$$91$YR$$M$N$$$20240815$N$$US$
242166581$24216658$1$I$$20240802$20240816$20240816$EXP$$US-QUAGEN-2024QUALIT00238$QUAGEN PHARMACEUTICALS$TM Curtis.18-Month-Old with Lethargy and Accelerated Idioventricular Rhythm in Prehospital Setting: A Case Report.Prehospital Emergency Care: Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors .JAN-2024;1-4$18$MON$I$M$Y$$$20240816$$HP$US$US
242166591$24216659$1$I$$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A184741$ASTRAZENECA$$$$$F$Y$$$20240816$$MD$US$
242166602$24216660$2$F$$20240828$20240816$20240905$EXP$GR-MLMSERVICE-20240801-PI150213-00059-1$GR-STRIDES ARCOLAB LIMITED-2024SP010164$STRIDES$Vasilopoulou A, Spaho M, Theotokis P, Grekou A, Meditskou S, Manthou ME.. Fatal misdiagnosis of progressive disseminated histoplasmosis.. Medical Mycology Case Reports. 2024;45:1-4$$$A$M$Y$$$20240905$$MD$GR$GR
242166611$24216661$1$I$20120101$20240806$20240816$20240816$EXP$$US-AUROBINDO-AUR-APL-2014-00889$AUROBINDO$Mowry James B.. 2012 Annual Report of the American Association of Poison Control Centers? National Poison Data System (NPDS): 30th Annual Report. Clinical Toxicology. 2013;51:949 - 1229$37$YR$$M$Y$$$20240816$$PH$US$US
242166621$24216662$1$I$$20240803$20240816$20240816$EXP$$PT-AUROBINDO-AUR-APL-2024-039329$AUROBINDO$Imunoterapia aplicada ao mieloma m?ltiplo.. Hematologia e Oncologia.. 2024;12(46):13-16$$$A$F$Y$$$20240816$$HP$PT$PT
242166631$24216663$1$I$$20240807$20240816$20240816$30DAY$$US-GSK-US2024098618$GLAXOSMITHKLINE$$$$A$M$Y$$$20240816$$CN$US$US
242166641$24216664$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008949$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240816$$CN$US$US
242166651$24216665$1$I$$20240809$20240816$20240816$EXP$$IN-ROCHE-10000037953$ROCHE$$70$YR$E$M$Y$$$20240816$$CN$IN$IN
242166661$24216666$1$I$20220901$20240807$20240816$20240816$EXP$$US-MSNLABS-2024MSNLIT01782$MSN LABORATORIES$Shah N, Dib EG, Joseph N, Fontana RJ..Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits?.Clinical Liver Disease.2024;23(1):e0125$$$$$Y$$$20240816$$MD$US$US
242166681$24216668$1$I$$20240806$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024098628$VIIV$$$$$$Y$$$20240816$$CN$US$US
242166691$24216669$1$I$20240805$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005898$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240816$$CN$US$US
242166701$24216670$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007602$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240816$$CN$US$US
242166711$24216671$1$I$$20240725$20240816$20240816$PER$$US-JNJFOC-20240772301$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
242166722$24216672$2$F$$20240827$20240816$20240902$EXP$$US-AMGEN-USASP2024161836$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024$$$$$Y$$$20240902$$MD$US$US
242166731$24216673$1$I$20240812$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161595$AMGEN$$74$YR$E$F$Y$$$20240816$$CN$US$US
242166741$24216674$1$I$$20240812$20240816$20240816$EXP$$AR-AMGEN-ARGSP2024162011$AMGEN$$55$YR$A$M$Y$$$20240816$$CN$AR$AR
242166752$24216675$2$F$$20240827$20240816$20240902$EXP$$US-AMGEN-USASP2024161886$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024$$$$$Y$$$20240902$$MD$US$US
242166772$24216677$2$F$$20240827$20240816$20240902$EXP$$US-AMGEN-USASP2024161984$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024$$$$$Y$$$20240901$$MD$US$US
242166781$24216678$1$I$20240810$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161445$AMGEN$$76$YR$E$F$Y$$$20240816$$HP$US$US
242166802$24216680$2$F$$20240827$20240816$20240902$EXP$$US-AMGEN-USASP2024161854$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024$$$$$Y$$$20240901$$MD$US$US
242166812$24216681$2$F$$20240827$20240816$20240902$EXP$$US-AMGEN-USASP2024161905$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024$$$$$Y$$$20240902$$MD$US$US
242166822$24216682$2$F$$20240827$20240816$20240902$EXP$$US-AMGEN-USASP2024161864$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024$$$$$Y$$$20240901$$MD$US$US
242166831$24216683$1$I$20240729$20240806$20240816$20240816$EXP$CN-NMPACDR-3707011010485202401009$CN-BAXTER-2024BAX022930$BAXTER$$62$YR$$M$Y$80$KG$20240816$$MD$CN$CN
242166841$24216684$1$I$$20240806$20240816$20240816$EXP$$GB-BAXTER-2024BAX022840$BAXTER$$$$$F$Y$$$20240816$$HP$GB$GB
242166851$24216685$1$I$$20240807$20240816$20240816$EXP$GB-MHRA-MIDB-c048a809-b0e5-474c-807b-76b0c88619b8$GB-BAXTER-2024BAX022902$BAXTER$$68$YR$$F$Y$$$20240816$$PH$GB$GB
242166861$24216686$1$I$$20240806$20240816$20240816$EXP$$CA-BAXTER-2024BAX022884$BAXTER$$$$$F$Y$65$KG$20240816$$CN$CA$CA
242166872$24216687$2$F$20240805$20240814$20240816$20240826$EXP$$US-MACLEODS PHARMA-MAC2024048765$MACLEODS$$$$$$Y$$$20240826$$CN$US$US
242166881$24216688$1$I$$20240722$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07380$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242166891$24216689$1$I$$20240805$20240816$20240816$EXP$$KR-MACLEODS PHARMA-MAC2024048780$MACLEODS$Kim TM, Jo SJ..Short-term Safety of Dimethyl Fumarate for Psoriasis in Korea.Annals of Dermatology.2024;36(4):252-254$$$$$Y$$$20240816$$HP$KR$KR
242166901$24216690$1$I$20240805$20240805$20240816$20240816$EXP$GB-MHRA-MED-202408050806323860-MLQNV$GB-MACLEODS PHARMA-MAC2024048792$MACLEODS$$63$YR$A$M$Y$80$KG$20240816$$MD$GB$GB
242166911$24216691$1$I$20240726$20240805$20240816$20240816$EXP$GB-MHRA-MED-202408051140567160-HBMFC$GB-MACLEODS PHARMA-MAC2024048794$MACLEODS$$$$$$Y$$$20240816$$PH$GB$GB
242166922$24216692$2$F$$20240904$20240816$20240916$EXP$$US-MACLEODS PHARMA-MAC2024048776$MACLEODS$Surineni K, Armstrong A, Wallace S, Schrader N.The Emergence of Mania After Initiating Escitalopram for Anxiety Disorder.Cureus.2024;16(6):e63441$$$$$Y$$$20240916$$MD$US$US
242166931$24216693$1$I$20120101$20240806$20240816$20240816$EXP$$US-AUROBINDO-AUR-APL-2014-00894$AUROBINDO$Mowry James B, Spyker DA, Cantilena LR, Bailey JE, Ford M. 2012 Annual Report of the American Association of Poison Control Centers? National Poison Data System (NPDS): 30th Annual Report. Clinical Toxicology. 2013;51:949 - 1229$40$YR$$M$Y$$$20240816$$PH$US$US
242166941$24216694$1$I$20240629$20240805$20240816$20240816$EXP$GB-MHRA-MED-202408050942328210-TYRHD$GB-MACLEODS PHARMA-MAC2024048793$MACLEODS$$$$$$Y$$$20240816$$MD$GB$GB
242166952$24216695$2$F$20240808$20240909$20240816$20240915$PER$$US-ROCHE-10000054528$ROCHE$$$$$F$Y$$$20240915$$PH$US$US
242166961$24216696$1$I$20240806$20240809$20240816$20240816$EXP$$IN-ROCHE-10000054771$ROCHE$$36$YR$A$M$Y$$$20240816$$CN$IN$IN
242166973$24216697$3$F$20240812$20240823$20240816$20240827$PER$$US-AMGEN-USASP2024162888$AMGEN$$10$YR$C$F$Y$$$20240827$$CN$US$US
242166981$24216698$1$I$$20240812$20240816$20240816$EXP$$US-AMGEN-USASP2024161303$AMGEN$Cornell L.; Buglioni A.; Jenkins S. et al.. Clinicopathologic Features of IgG4-Related Kidney Disease. Kidney international reports. 2024;9 (8):2462-2473$$$$$Y$$$20240816$$HP$US$US
242166991$24216699$1$I$$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162545$AMGEN$$$$$F$Y$$$20240816$$CN$US$US
242167002$24216700$2$F$$20240827$20240816$20240902$EXP$$US-AMGEN-USASP2024161921$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien. 2024$$$$$Y$$$20240902$$MD$US$US
242167012$24216701$2$F$$20240908$20240816$20240916$EXP$$US-AMGEN-USASP2024161044$AMGEN$Herrera A. F.; Zain J.; Savage K.J. et. al. Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study. Lancet Haematology. 2024;1-11$$$$$Y$$$20240916$$MD$US$US
242167021$24216702$1$I$$20240811$20240816$20240816$EXP$$US-AMGEN-USASP2024159983$AMGEN$Zisa D.; Zhang-sun J.; Christos Christos P.J. et.al.. Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares. Lupus. 2024;33 (9):938-947$24$YR$A$M$Y$$$20240816$$HP$US$US
242167031$24216703$1$I$$20240807$20240816$20240816$30DAY$$US-GSK-US2024AMR098811$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242167041$24216704$1$I$$20240805$20240816$20240816$EXP$$US-MALLINCKRODT-MNK202405004$MALLINCKRODT$$$$$M$Y$$$20240816$$PH$US$US
242167051$24216705$1$I$$20240802$20240816$20240816$EXP$$TR-QUAGEN-2024QUALIT00240$QUAGEN PHARMACEUTICALS$F Cakan.Intraoperative Takotsubo Cardiomyopathy: A Case Report.Journal of Perianesthesia Nursing.MAR-2024$18$YR$T$F$Y$50$KG$20240816$$HP$TR$TR
242167061$24216706$1$I$$20231122$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017866$STRIDES$Abideen ZU, Janga C, Memon RA, Ucciferro PM. A Case of Mineralocorticoid Induced Hypertension Secondary to Cushing^s Syndrome. J-Endocr-Soc. 2022;6 (Suppl.):A568$78$YR$$F$Y$$$20240816$$MD$US$US
242167071$24216707$1$I$$20240111$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000673$STRIDES$Ferri-Guerra J, Sacco SB, Manzano AJ.. Posterior Reversible Leukoencephalopathy Syndrome Associated With Cushing^s Syndrome.. J-Endocr-Soc. 2022;6 (Suppl. 1):A110$57$YR$$F$Y$$$20240816$$MD$US$US
242167081$24216708$1$I$$20240812$20240816$20240816$EXP$$NVSC2024CA165251$NOVARTIS$$85$YR$$F$Y$$$20240816$$CN$CA$CA
242167101$24216710$1$I$$20231011$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015842$STRIDES$ORIAKHI M, JEFFRIES J, PRANDECKI A, AMSRALA G, CHIMELSKI EA, KIOKA M.. ACUTE ACQUIRED MACROGLOSSIA OF KIDNEY TRANSPLANTED PATIENT.. Chest.. 2023;164(4):A2055-A2056.$45$YR$$M$Y$$$20240816$$HP$US$US
242167111$24216711$1$I$$20240507$20240816$20240816$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005465$STRIDES$Pirzada S, Raza B, Mankani AA, Naveed B.. A Case of Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Small Bowel Angioedema.. Cureus. 2023;15(10):e47739$58$YR$$F$Y$$$20240816$$HP$US$US
242167122$24216712$2$F$$20240814$20240816$20240816$EXP$$US-ROCHE-10000058398$ROCHE$$$$$F$Y$$$20240816$$HP$US$US
242167131$24216713$1$I$$20240809$20240816$20240816$EXP$$US-MYLANLABS-2024M1075254$MYLAN$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J 2024; 70 (7): e92-e96.$12$YR$$F$Y$$$20240816$$HP$US$US
242167143$24216714$3$F$$20240829$20240816$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012241$JAZZ$$$$$F$Y$$$20240902$$HP$US$US
242167151$24216715$1$I$$20240801$20240816$20240816$PER$$US-RDY-SPO/USA/24/0011470$DR REDDYS$$24$YR$A$$Y$$$20240816$$MD$US$US
242167171$24216717$1$I$20190101$20240805$20240816$20240816$EXP$$CA-BAYER-2024A112603$BAYER$$28$YR$A$F$Y$$$20240816$$CN$CA$CA
242167181$24216718$1$I$$20240812$20240816$20240816$EXP$DE-Gedeon Richter Plc.-2023_GR_002926$DE-TORRENT-00027165$TORRENT$$32$YR$A$F$Y$75$KG$20240816$$MD$DE$DE
242167191$24216719$1$I$20230919$20240813$20240816$20240816$EXP$DE-CADRBFARM-2024328857$DE-TORRENT-00026937$TORRENT$$32$YR$A$F$Y$64$KG$20240816$$CN$DE$DE
242167201$24216720$1$I$$20240812$20240816$20240816$EXP$DE-EMA-20141104-shavetasoodp-133905501$DE-TORRENT-00027168$TORRENT$$69$YR$E$M$Y$$$20240816$$MD$DE$DE
242167211$24216721$1$I$20240801$20240809$20240816$20240816$EXP$GB-MHRA-MED-202408070811079670-GSTDQ$GB-TORRENT-00037570$TORRENT$$68$YR$E$$Y$90$KG$20240816$$CN$GB$GB
242167221$24216722$1$I$20240710$20240809$20240816$20240816$EXP$GB-MHRA-MIDB-aea73cb5-b1d6-48dd-822a-8a1a84b2a87d$GB-TORRENT-00037562$TORRENT$$68$YR$E$$Y$$$20240816$$HP$GB$GB
242167231$24216723$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56296$$FDA-CTU$$79$YR$$M$N$$$20240815$N$$US$
242167241$24216724$1$I$$20240808$20240816$20240816$EXP$$US-TORRENT-00013712$TORRENT$$71$YR$E$M$Y$$$20240816$$MD$US$US
242167251$24216725$1$I$$20240808$20240816$20240816$EXP$$US-TORRENT-00013713$TORRENT$$$$$F$Y$$$20240816$$CN$US$US
242167261$24216726$1$I$$20240806$20240816$20240816$EXP$$US-TORRENT-00013711$TORRENT$$$$A$F$Y$$$20240816$$HP$US$US
242167281$24216728$1$I$$20240805$20240816$20240816$PER$$US-JNJFOC-20240812446$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$US$US
242167291$24216729$1$I$$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162573$AMGEN$$$$A$F$Y$$$20240816$$HP$US$US
242167301$24216730$1$I$20240101$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129355$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240816$$CN$US$US
242167311$24216731$1$I$$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129530$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240816$$PH$US$US
242167322$24216732$2$F$20240710$20240912$20240816$20240916$EXP$IT-MINISAL02-999132$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-129204$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240916$$MD$IT$IT
242167331$24216733$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129444$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240816$$CN$US$US
242167341$24216734$1$I$$20240717$20240816$20240816$PER$$US-009507513-2407USA011405$MERCK$Abers MS, Vo P, Allg?uer M, Manion M, Butman JA, Bishop RJ, et al.. A multidisciplinary approach to mucormycosis. Journal of Infection. 2024;89(2)$8$YR$$F$Y$$$20240816$$HP$US$US
242167351$24216735$1$I$$20240805$20240816$20240816$EXP$$CN-MSNLABS-2024MSNLIT01807$MSN LABORATORIES$Zhang L, Liu M, Xie L, Tian X.Cardiac Arrest Due to Capecitabine Toxicosis Treated With ECMO and CRRT: A Case Report.Critical Care Nurse.AUG-2024;44 (4):57-62$$$$$Y$$$20240816$$MD$CN$CN
242167361$24216736$1$I$$20240812$20240816$20240816$EXP$$CA-Orion Corporation ORION PHARMA-24_00031283$ORION$$59$YR$A$F$Y$$$20240816$$MD$CA$
242167371$24216737$1$I$20240529$20240815$20240816$20240816$PER$$NVSC2024US166220$NOVARTIS$$91$YR$$M$Y$75.3$KG$20240816$$HP$US$US
242167381$24216738$1$I$20230101$20240805$20240816$20240816$EXP$NL-LRB-00994229$NL-BAYER-2024A112612$BAYER$$25$YR$A$F$Y$53$KG$20240816$$CN$NL$NL
242167391$24216739$1$I$20221027$20240814$20240816$20240816$EXP$$US-UCBSA-2024041168$UCB$$53$YR$$F$Y$$$20240816$$HP$US$US
242167401$24216740$1$I$20240414$20240805$20240816$20240816$EXP$$SG-ROCHE-10000050566$ROCHE$$70$YR$E$F$Y$$$20240816$$CN$SG$SG
242167411$24216741$1$I$$20240809$20240816$20240816$EXP$$US-MYLANLABS-2024M1075256$MYLAN$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J 2024; 70 (7): e92-e96.$14$YR$$F$Y$$$20240816$$HP$US$US
242167421$24216742$1$I$20240101$20240813$20240816$20240816$EXP$$US-ORGANON-O2408USA001046$ORGANON$$87$YR$$M$Y$$$20240816$$MD$US$US
242167431$24216743$1$I$$20240802$20240816$20240816$EXP$$US-QUAGEN-2024QUALIT00239$QUAGEN PHARMACEUTICALS$Aleksan Khachatryan.Recurrent perimyocarditis associated with long-term Methylphenidate use..Journal of the American College of Cardiology.02-APR-2024;83:3543$19$YR$A$M$Y$$$20240816$$HP$US$US
242167442$24216744$2$F$20240426$20240918$20240816$20240923$EXP$$US-ABBVIE-5878411$ABBVIE$$75$YR$$F$Y$102.05$KG$20240923$$CN$US$US
242167451$24216745$1$I$20240101$20240806$20240816$20240816$EXP$$US-TEVA-VS-3156027$TEVA$$76$YR$$M$Y$$$20240816$$CN$US$US
242167461$24216746$1$I$20240611$20240806$20240816$20240816$EXP$$CA-TEVA-VS-3231486$TEVA$$65$YR$$M$Y$100$KG$20240816$$HP$CA$CA
242167471$24216747$1$I$$20240812$20240816$20240816$EXP$$CA-Orion Corporation ORION PHARMA-24_00031272$ORION$$11$YR$C$F$Y$$$20240816$$HP$CA$
242167482$24216748$2$F$$20240910$20240816$20240923$30DAY$$TW-JNJFOC-20240833601$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$TW$TW
242167492$24216749$2$F$20240622$20240815$20240816$20240822$EXP$$US-ROCHE-10000058218$ROCHE$$54$YR$A$F$Y$$$20240822$$CN$US$US
242167501$24216750$1$I$$20240807$20240816$20240816$EXP$$CA-TEVA-VS-3232201$TEVA$$71$YR$$M$Y$103$KG$20240816$$HP$CA$CA
242167512$24216751$2$F$20240701$20240827$20240816$20240904$EXP$$US-Calliditas-2024CAL01528$CALLIDITAS THERAPEUTICS$$44$YR$A$F$Y$87$KG$20240904$$CN$US$US
242167523$24216752$3$F$$20240821$20240816$20240830$EXP$$PT-AUROBINDO-AUR-APL-2024-040264$AUROBINDO$Pereira P, Ling T, Loureiro A,  Pereira A, Guerreiro R, Fa?sca Silva MJ. LEUCEMIA MIELOMONOC?TICA JUVENIL COM MONOSSOMIA DO CROMOSSOMA 7 - RELATO DE CASO CL?NICO. MEDICINA LABORATORIAL. 132-133$13$MON$$F$Y$$$20240830$$MD$PT$PT
242167533$24216753$3$F$20230101$20240806$20240816$20240906$EXP$$US-BEH-2024177010$CSL BEHRING$$$$A$F$Y$$$20240906$$CN$US$US
242167541$24216754$1$I$$20240808$20240816$20240816$PER$$US-ROCHE-10000052655$ROCHE$Lynch E, Citta A, Alford C, Ligon J, Dalal M, Castillo P, et al. Avatrombopag for severe refractory thrombocytopenia in a pediatric patient with ALL following allogeneic hematopoietic stem cell transplantation: A case report. Leukemia Research Reports. 2024-Jan;22:1-3. doi:10.1016/j.lrr.2024.100472.$14$YR$T$M$Y$$$20240816$$HP$US$US
242167551$24216755$1$I$$20240813$20240816$20240816$EXP$$CN-AstraZeneca-2024A185530$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$CN$
242167562$24216756$2$F$$20240814$20240816$20240821$EXP$$CA-AstraZeneca-2024A146046$ASTRAZENECA$$$$A$M$Y$$$20240821$$MD$CA$
242167572$24216757$2$F$20240701$20240905$20240816$20240908$EXP$$US-GILEAD-2024-0684328$GILEAD$$61$YR$A$F$Y$$$20240908$$CN$US$US
242167581$24216758$1$I$$20240808$20240816$20240816$EXP$$ZA-AstraZeneca-2024A183478$ASTRAZENECA$$67$YR$$F$Y$$$20240816$$CN$ZA$
242167591$24216759$1$I$$20240806$20240816$20240816$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07538$HIKMA$$$$$$Y$$$20240816$$HP$US$US
242167601$24216760$1$I$$20240807$20240816$20240816$30DAY$$US-GSK-US2024098625$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242167611$24216761$1$I$$20240807$20240816$20240816$EXP$$CA-TEVA-VS-3232391$TEVA$$16$YR$$F$Y$110$KG$20240816$$CN$CA$CA
242167631$24216763$1$I$20240508$20240807$20240816$20240816$EXP$FR-AFSSAPS-AN2024000998$FR-TEVA-VS-3231647$TEVA$$64$YR$$M$Y$77$KG$20240816$$MD$FR$FR
242167641$24216764$1$I$20240101$20240807$20240816$20240816$EXP$FR-AFSSAPS-AN2024000960$FR-ROCHE-10000051131$ROCHE$$66$YR$E$M$Y$$$20240816$$MD$FR$FR
242167651$24216765$1$I$$20240807$20240816$20240816$EXP$$JP-MYE-2024M1075508AA$MYLAN$Maruyama T, Kondo S, Nomura H. Case series of bradycardia, renal failure, atrioventricular nodal blockers, shock and hyperkalemia syndrome in patients with dementia. Geriatr-Gerontol-Int 2024; 24 (7): 737-738.. 2024;24 (7):737-738$97$YR$$F$Y$$$20240816$$HP$JP$JP
242167663$24216766$3$F$20240814$20240909$20240816$20240910$PER$$US-AMGEN-USASP2024162307$AMGEN$$63$YR$A$F$Y$$$20240910$$CN$US$US
242167671$24216767$1$I$$20240806$20240816$20240816$EXP$$US-RDY-LIT/USA/24/0011753$DR REDDYS$Narula S, Snodgrass C. Botulinum Treatment Induced Dropped Head Syndrome in a Patient With Chronic Migraines and Multiple Sclerosis. Pain Medicine Case Reports. 2024 May;8(4): 157-160.$$$$F$Y$$$20240816$$MD$US$US
242167682$24216768$2$F$20230920$20240904$20240816$20240914$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-024242$UNITED THERAPEUTICS$Koga Y, et al.. A case of systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) successfully treated with immunosuppression treatment$69$YR$$F$Y$$$20240914$$MD$JP$JP
242167691$24216769$1$I$$20240806$20240816$20240816$EXP$$JP-MYLANLABS-2024M1075483$MYLAN$Otsuka M, Tojo N, Yanagisawa S, Hayashi A. Gas Tamponade Improved Cilio-Choroidal Effusion Induced by an Ab Interno Trabeculotomy with a Microhook: Two Cases. Int-Med-Case-Rep-J 2024; 17 479-486.. 2024;17:479-486$52$YR$$M$Y$$$20240816$$HP$JP$JP
242167702$24216770$2$F$20240605$20240824$20240816$20240902$EXP$$JP-ROCHE-10000053488$ROCHE$Kawaguchi T, Ozaki N, Shimoyama T. A case of cytomegalovirus retinitis that developed during chimeric antigen receptor T-cell therapy. [Abstract number: GE-07-01]. OIIA (Ocular Infection, Inflammation and Allergy) 2024 in Sapporo / The 57th Mee.. 2024;100.$55$YR$A$M$Y$$$20240902$$MD$JP$JP
242167711$24216771$1$I$20230721$20240812$20240816$20240816$EXP$$KR-MYLANLABS-2024M1075533$MYLAN$$$$A$F$Y$66$KG$20240816$$HP$KR$KR
242167721$24216772$1$I$$20240806$20240816$20240816$EXP$$JP-MYLANLABS-2024M1075498$MYLAN$Yoshino R, Nakatsubo M, Ujiie N, Kitada M. Breast cancer with biomarker reversal during the course of treatment: a case report. J-Surg-Case-Rep 2024; 2024 (6):.. 2024;6$37$YR$$F$Y$$$20240816$$HP$JP$JP
242167731$24216773$1$I$$20240806$20240816$20240816$EXP$$AU-MYLANLABS-2024M1074848$MYLAN$Bosi I, Wong W-K, Mohammad S, Britton P, Hsu P. Unusual Manifestations of APECED. J-Clin-Immunol 2024; 44.$5$YR$$M$Y$$$20240816$$HP$AU$AU
242167741$24216774$1$I$20240611$20240806$20240816$20240816$EXP$FR-AFSSAPS-BR2024000630$FR-MYLANLABS-2024M1073532$MYLAN$$76$YR$$M$Y$59$KG$20240816$$MD$FR$FR
242167751$24216775$1$I$$20240806$20240816$20240816$EXP$$US-MYLANLABS-2024M1074769$MYLAN$Sircy A, Ibeh B, Boutros N, Bolyard J. Otitis media to meningitis: A rare group a streptococcus meningitis case. Crit-Care-Med 2024; 52 (Suppl.) S705.$43$YR$$M$Y$$$20240816$$HP$US$US
242167761$24216776$1$I$20221205$20240812$20240816$20240816$EXP$$KR-MYLANLABS-2024M1075825$MYLAN$$$$A$M$Y$$$20240816$$PH$KR$KR
242167771$24216777$1$I$20240812$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161553$AMGEN$$$$$$Y$$$20240816$$HP$US$US
242167781$24216778$1$I$$20240806$20240816$20240816$EXP$$US-MYLANLABS-2024M1074742$MYLAN$Navari Y, Chinnappan J, Dawood T, Marcus H. When rhythm correction turns risky: rare right-sided haemorrhagic pleural effusion post maze procedure. Eur-J-Case-Rep-Intern-Med 2024; 11 (7): 1-3.$54$YR$$F$Y$$$20240816$$HP$US$US
242167801$24216780$1$I$20240723$20240808$20240816$20240816$EXP$GB-MHRA-MED-202408071606547360-YTDNH$GB-MSNLABS-2024MSNSPO01787$MSN LABORATORIES$$$$$$Y$$$20240816$$PH$GB$GB
242167811$24216781$1$I$$20240806$20240816$20240816$EXP$$SD-EMD Serono-2024042667$EMD SERONO INC$Taha M, Azhary A, Hajhamed NM, Sir Alkhatim WA, Bakheit AM, Ahmed AE. A case report of metformin-associated lactic acidosis. Clinical case reports. 2024 Aug 01;12(8): 1-5. doi:10.1002/ccr3.9255.$73$YR$E$F$Y$$$20240816$$MD$SD$SD
242167821$24216782$1$I$$20240802$20240816$20240816$EXP$$US-QUAGEN-2024QUALIT00241$QUAGEN PHARMACEUTICALS$EJ Patel.Invasive Fungal Sinusitis in an Immunocompetent Patient After Sinus Surgery for Chronic Rhinosinusitis with Nasal Polyps and a Mycetoma.Laryngoscope.APR-2024$38$YR$A$F$Y$$$20240816$$HP$US$US
242167831$24216783$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007384$ELI LILLY AND CO$$60$YR$A$$Y$$$20240816$$CN$US$US
242167843$24216784$3$F$20240101$20240821$20240816$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408008543$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240828$$CN$US$US
242167851$24216785$1$I$$20240806$20240816$20240816$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408005868$ELI LILLY AND CO$Yasuda C, et al..The 30th Pulmonary Embolism Study Group General Session 2: O2-5 A case of autologous subcutaneous dalteparin in the treatment of cancer-related thrombosis.heart 2024;56 (7):738-741.$55$YR$A$F$Y$$$20240816$$MD$JP$JP
242167871$24216787$1$I$$20240809$20240816$20240816$PER$$NVSC2024US162816$NOVARTIS$$68$YR$$F$Y$$$20240816$$CN$US$US
242167881$24216788$1$I$$20240808$20240816$20240816$30DAY$$US-GSK-US2024099263$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242167901$24216790$1$I$20240101$20240805$20240816$20240816$EXP$ES-AEMPS-1557359$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-110888$ZYDUS PHARM$$$$$$Y$$$20240816$$MD$ES$ES
242167911$24216791$1$I$$20240802$20240816$20240816$EXP$$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110863$ZYDUS PHARM$Naim G, Malissin I, Megarbane B.. Cerebral microbleeds in the poisoned patient: An observational magnetic resonance imaging study.. Basic-Clin-Pharmacol-Toxicol. 2023;133:770-777$$$$$Y$$$20240816$$HP$FR$FR
242167921$24216792$1$I$20240310$20240805$20240816$20240816$EXP$FR-AFSSAPS-AN2024000995$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110874$ZYDUS PHARM$$$$$$Y$$$20240816$$MD$FR$FR
242167931$24216793$1$I$20210214$20240805$20240816$20240816$EXP$FR-AFSSAPS-NC2024000931$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110916$ZYDUS PHARM$$$$$$Y$$$20240816$$MD$FR$FR
242167941$24216794$1$I$20240510$20240805$20240816$20240816$EXP$FR-AFSSAPS-NT2024000965$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110877$ZYDUS PHARM$$$$$$Y$$$20240816$$PH$FR$FR
242167951$24216795$1$I$$20240805$20240816$20240816$EXP$$CN-TEYRO-2024-TY-000429$Teyro Labs$Zhang J, He W, Zhang Z, Dong H, Deng X, Wen Q, et al.Skin metastasis from ovarian cancer with somatic BRCA1 mutation: A case report and literature review..Oncol Lett.2024;28:348$49$YR$A$F$Y$$$20240816$$HP$CN$CN
242167961$24216796$1$I$20240409$20240805$20240816$20240816$EXP$FR-AFSSAPS-NT2024000977$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110948$ZYDUS PHARM$$$$$$Y$$$20240816$$MD$FR$FR
242167971$24216797$1$I$$20240802$20240816$20240816$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-110849$ZYDUS PHARM$Mevada D, Chabhadiya P, Singh A.. Acetaminophen-induced toxic epidermal necrolysis in pediatric patients - A case series.. Int-J-Pharm-Pharmaceut-Sci. 2024;16(7):50-53$$$$$Y$$$20240816$$HP$IN$IN
242167981$24216798$1$I$20230226$20240805$20240816$20240816$EXP$FR-AFSSAPS-TO2024001482$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110944$ZYDUS PHARM$$$$$$Y$$$20240816$$PH$FR$FR
242167991$24216799$1$I$$20240802$20240816$20240816$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110850$ZYDUS PHARM$Cohen P, Kudchadkar S, Schultz B, Schuette J.. REPEATED HEMODIALYSIS AFTER EXTENDEDRELEASE ACETAMINOPHEN INGESTION.. Crit-Care-Med. 2024;52 (Suppl.)(1):S301$$$$$Y$$$20240816$$HP$US$US
242168001$24216800$1$I$20240611$20240805$20240816$20240816$EXP$FR-AFSSAPS-PV2024000567$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110957$ZYDUS PHARM$$$$$$Y$$$20240816$$MD$FR$FR
242168011$24216801$1$I$$20240807$20240816$20240816$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111052$ZYDUS PHARM$Omiwade O, Prevallet A.. Gastrointestinal Bleeding and Hemorrhagic Shock in a Patient Diagnosed with Disseminated Histoplasmosis.. ACG-Case-Rep-J. 2024;11(7):e01402.$$$$$Y$$$20240816$$MD$US$US
242168021$24216802$1$I$20240719$20240805$20240816$20240816$EXP$FR-AFSSAPS-PA2024001425$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-110905$ZYDUS PHARM$$$$$$Y$$$20240816$$MD$FR$FR
242168031$24216803$1$I$20240808$20240812$20240816$20240816$PER$$US-ROCHE-10000055384$ROCHE$$$$$$Y$$$20240816$$PH$US$US
242168051$24216805$1$I$$20240805$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039795$AUROBINDO$$$$$M$Y$$$20240816$$HP$GB$GB
242168061$24216806$1$I$20240801$20240807$20240816$20240816$EXP$$JP-009507513-2408JPN000901J$MERCK$$$$$F$Y$$$20240816$$MD$JP$JP
242168072$24216807$2$F$$20240906$20240816$20240918$PER$$US-ROCHE-10000056511$ROCHE$$$$E$F$Y$$$20240918$$CN$US$US
242168101$24216810$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004023$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242168111$24216811$1$I$$20240806$20240816$20240816$30DAY$$US-GSK-US2024098179$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242168121$24216812$1$I$20240614$20240805$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039805$AUROBINDO$$56$YR$$F$Y$$$20240816$$PH$GB$GB
242168131$24216813$1$I$20240712$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184739$ASTRAZENECA$$27519$DY$$F$Y$$$20240816$$CN$US$
242168141$24216814$1$I$20240313$20240813$20240816$20240816$EXP$$KR-AstraZeneca-2024A185519$ASTRAZENECA$$54$YR$$F$Y$$$20240816$$CN$KR$
242168151$24216815$1$I$$20240814$20240816$20240816$PER$$US-BAYER-2024A117795$BAYER$$43$YR$A$M$Y$$$20240816$$CN$US$US
242168161$24216816$1$I$20240729$20240806$20240816$20240816$EXP$$GB-AstraZeneca-2024A186789$ASTRAZENECA$$39$YR$$F$Y$$$20240816$$MD$GB$
242168172$24216817$2$F$$20240917$20240816$20240918$PER$$US-ALXN-A202200881$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
242168181$24216818$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A182572$ASTRAZENECA$$$$$$Y$$$20240816$$CN$US$
242168192$24216819$2$F$20240101$20240911$20240816$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-024911$UNITED THERAPEUTICS$$$$$F$Y$43.084$KG$20240919$$$US$US
242168201$24216820$1$I$$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024780$UNITED THERAPEUTICS$$$$$M$Y$105.22$KG$20240816$$$US$US
242168211$24216821$1$I$$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024867$UNITED THERAPEUTICS$$$$$F$Y$57.596$KG$20240816$$$US$US
242168221$24216822$1$I$20231101$20240807$20240816$20240816$EXP$$JP-009507513-2408JPN000915J$MERCK$$77$YR$$M$Y$$$20240816$$MD$JP$JP
242168231$24216823$1$I$20240813$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56350$$FDA-CTU$$88$YR$$F$N$$$20240815$Y$PH$US$
242168241$24216824$1$I$$20240807$20240816$20240816$EXP$$JP-VIATRISJAPAN-2024M1075501AA$MYLAN$Maruyama T, Kondo S, Nomura H. Case series of bradycardia, renal failure, atrioventricular nodal blockers, shock and hyperkalemia syndrome in patients with dementia. Geriatr-Gerontol-Int 2024; 24 (7): 737-738.. 2024;24 (7):737-738$94$YR$$M$Y$$$20240816$$HP$JP$JP
242168252$24216825$2$F$20230101$20240814$20240816$20240821$PER$$US-AMGEN-USASP2024162353$AMGEN$$49$YR$A$M$Y$$$20240820$$CN$US$US
242168261$24216826$1$I$$20240807$20240816$20240816$EXP$$TR-MYLANLABS-2024M1075783$MYLAN$Tombak Y, Karaahmet OZ, Unlu Akyuz E. Intramuscular botulinum toxin-A in complex regional pain syndrome resistant to standard treatment: a case report. Wien-Klin-Wochenschr 2024; 136 (13-14): 419-422.$53$YR$$F$Y$$$20240816$$HP$TR$TR
242168271$24216827$1$I$20230101$20240815$20240816$20240816$PER$$US-AMGEN-USASP2024162961$AMGEN$$73$YR$E$F$Y$$$20240816$$CN$US$US
242168281$24216828$1$I$$20240812$20240816$20240816$EXP$$US-AMGEN-USASP2024160726$AMGEN$$$$$F$Y$$$20240816$$HP$US$US
242168291$24216829$1$I$$20240802$20240816$20240816$PER$$US-RDY-SPO/USA/24/0011522$DR REDDYS$$$$$F$Y$$$20240816$$CN$US$US
242168301$24216830$1$I$$20240815$20240816$20240816$PER$$NVSC2024US166242$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
242168311$24216831$1$I$$20240807$20240816$20240816$EXP$$CA-RDY-CLI/CAN/23/0160936$DR REDDYS$$67$YR$E$F$Y$$$20240816$$HP$CA$CA
242168321$24216832$1$I$$20240813$20240816$20240816$PER$$NVSC2024US164821$NOVARTIS$$$$$M$Y$$$20240816$$CN$US$US
242168341$24216834$1$I$$20240804$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462819$RANBAXY$Dutcher D, Hicks S, Hoppe M, Whitten S, Falk K.. Combined robotic and hysteroscopic repair of isthmocele containing retained products of conception. J-Minim-Invasive-Gynecol. 2023;30:S99$31$YR$$F$Y$$$20240816$$HP$US$US
242168351$24216835$1$I$$20240802$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463070$RANBAXY$Wang J, Elghawy O, Kurpiel B, Kaur V. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors. Clin J Gastroenterol. 2023;16:807-814$70$YR$$M$Y$$$20240816$$HP$US$US
242168361$24216836$1$I$$20240802$20240816$20240816$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460674$RANBAXY$Murphy D, Waldron D, Kennedy G, Molony J. Central anticholinergic syndrome from hyoscine hydrobromide in an unresponsive patient. BMJ Support Palliat Care. 2022;0:1-4$7$DEC$$F$Y$$$20240816$$HP$IE$IE
242168371$24216837$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56287$$FDA-CTU$$93$YR$$F$N$$$20240815$N$$US$
242168381$24216838$1$I$20240101$20240803$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462858$RANBAXY$$61$YR$$F$Y$84$KG$20240816$$PH$GB$GB
242168391$24216839$1$I$20240615$20240804$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462922$RANBAXY$$39$YR$$F$Y$$$20240816$$CN$GB$GB
242168401$24216840$1$I$20240723$20240804$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462733$RANBAXY$$75$YR$$F$Y$78$KG$20240816$$CN$GB$GB
242168411$24216841$1$I$$20240802$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461970$RANBAXY$Bayless SL, Walker NV, Scott MM, Leo RJ. Clozapine-Related Cecal Volvulus. Prim Care Companion CNS Disord. 2024;26 (4):24cr03729$58$YR$$F$Y$$$20240816$$MD$US$US
242168421$24216842$1$I$$20240814$20240816$20240816$PER$$US-ROCHE-10000057858$ROCHE$$$$$$Y$$$20240816$$PH$US$US
242168431$24216843$1$I$$20240814$20240816$20240816$PER$$US-ROCHE-10000058308$ROCHE$$32$YR$A$F$Y$$$20240816$$CN$US$US
242168441$24216844$1$I$$20240806$20240816$20240816$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US000104$PAREXEL$$$$$$Y$$$20240816$$CN$US$US
242168461$24216846$1$I$20240730$20240808$20240816$20240816$PER$$US-MSNLABS-2024MSNSPO01769$MSN LABORATORIES$$$$$$Y$$$20240816$$CN$US$US
242168471$24216847$1$I$20231101$20240815$20240816$20240816$PER$$US-BAYER-2024A118004$BAYER$$82$YR$E$F$Y$$$20240816$$CN$US$US
242168481$24216848$1$I$20240501$20240807$20240816$20240816$EXP$$CA-NEBO-666207$PHARMACOSMOS$$$$E$F$Y$$$20240816$$HP$CA$CA
242168491$24216849$1$I$20240101$20240812$20240816$20240816$PER$$US-BIOGEN-2024BI01277999$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
242168521$24216852$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56369$$FDA-CTU$$50$YR$$F$N$$$20240815$N$$US$
242168531$24216853$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56325$$FDA-CTU$$8$MON$$M$N$$$20240815$N$$US$
242168541$24216854$1$I$$20240807$20240816$20240816$EXP$$CA-BAYER-2024A114963$BAYER$$70$YR$E$F$Y$$$20240816$$CN$CA$CA
242168551$24216855$1$I$20240101$20240813$20240816$20240816$EXP$$ZA-ABBVIE-5879470$ABBVIE$$80$YR$$F$Y$$$20240816$$MD$ZA$ZA
242168562$24216856$2$F$$20240805$20240816$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039416$AUROBINDO$$$$$F$Y$$$20240817$$MD$GB$GB
242168571$24216857$1$I$20220101$20240807$20240816$20240816$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS004114$TERSERA THERAPEUTICS$$$$$$Y$$$20240816$$CN$AU$AU
242168581$24216858$1$I$20240728$20240806$20240816$20240816$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS004103$TERSERA THERAPEUTICS$$$$$$Y$$$20240816$$MD$CN$CN
242168601$24216860$1$I$$20240807$20240816$20240816$EXP$$US-GSK-US2024098615$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242168611$24216861$1$I$20240307$20240809$20240816$20240816$EXP$$CA-ROCHE-3464095$ROCHE$$72$YR$E$M$Y$$$20240816$$CN$CA$CA
242168621$24216862$1$I$20240722$20240725$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004031$ACADIA PHARMACEUTICALS$$68$YR$$F$Y$$$20240816$$CN$US$US
242168631$24216863$1$I$20240723$20240805$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039419$AUROBINDO$$61$YR$$F$Y$62$KG$20240816$$PH$GB$GB
242168641$24216864$1$I$$20240807$20240816$20240816$EXP$$CA-TEVA-VS-3232384$TEVA$$44$YR$$F$Y$$$20240816$$HP$CA$CA
242168651$24216865$1$I$$20240806$20240816$20240816$EXP$$CA-TEVA-VS-3232145$TEVA$$63$YR$$F$Y$$$20240816$$PH$CA$CA
242168661$24216866$1$I$20240101$20240808$20240816$20240816$EXP$$CA-CELLTRION INC.-2024CA019567$CELLTRION$$$$$$Y$$$20240816$$HP$CA$CA
242168671$24216867$1$I$20240701$20240812$20240816$20240816$EXP$$CO-UCBSA-2024040900$UCB$$44$YR$$M$Y$$$20240816$$CN$CO$CO
242168681$24216868$1$I$20240101$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128727$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240816$$CN$US$US
242168692$24216869$2$F$$20240819$20240816$20240820$PER$$US-BAYER-2024A116523$BAYER$$$$$F$Y$$$20240820$$CN$US$US
242168701$24216870$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56327$$FDA-CTU$$23$YR$$M$N$$$20240815$N$$US$
242168711$24216871$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56318$$FDA-CTU$$40$YR$$F$N$$$20240815$N$$US$
242168722$24216872$2$F$$20240906$20240816$20240920$PER$$US-USAntibiotics-000330$USAntibiotics$$$$$F$Y$$$20240919$$MD$US$
242168731$24216873$1$I$$20240718$20240816$20240816$PER$$US-USAntibiotics-000327$USAntibiotics$$$$A$F$Y$$$20240812$$HP$US$
242168741$24216874$1$I$$20240808$20240816$20240816$EXP$$GB-JNJFOC-20240827622$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240816$$HP$GB$GB
242168761$24216876$1$I$20240805$20240814$20240815$20240815$DIR$FDA-CDER-CTU-2024-56304$$FDA-CTU$$37$YR$$M$N$$$20240814$N$HP$US$
242168772$24216877$2$F$$20240815$20240816$20240823$PER$$US-BIOGEN-2024BI01278128$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
242168781$24216878$1$I$$20240808$20240816$20240816$PER$$US-ABBVIE-5874141$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242168791$24216879$1$I$$20240813$20240816$20240816$PER$$US-BIOGEN-2024BI01278130$BIOGEN$$$$$M$Y$$$20240816$$CN$US$US
242168801$24216880$1$I$$20240725$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004036$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242168822$24216882$2$F$20240808$20240809$20240816$20240911$EXP$GB-MHRA-MED-202408090916168170-JNLSH$GB-BEH-2024177148$CSL BEHRING$$65$YR$E$M$Y$$$20240911$$HP$GB$GB
242168832$24216883$2$F$$20240905$20240816$20240916$EXP$$AU-ABBVIE-5877115$ABBVIE$$$$$F$Y$$$20240916$$HP$AU$AU
242168841$24216884$1$I$$20240814$20240816$20240816$EXP$$TR-ROCHE-10000058096$ROCHE$$$$$$Y$$$20240816$$MD$TR$TR
242168851$24216885$1$I$$20240815$20240816$20240816$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046145$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240816$$CN$US$US
242168861$24216886$1$I$20231201$20240808$20240816$20240816$EXP$$CA-GSK-CA2024009423$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$HP$CA$CA
242168871$24216887$1$I$20240218$20240317$20240816$20240816$EXP$$KW-ULTRAGENYX PHARMACEUTICAL INC.-KW-UGX-24-00367$ULTRAGENYX PHARMACEUTICAL$$9$YR$$M$Y$25$KG$20240816$$MD$KW$KW
242168881$24216888$1$I$20240814$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162355$AMGEN$$79$YR$E$F$Y$$$20240816$$CN$US$US
242168891$24216889$1$I$20240815$20240815$20240816$20240816$PER$$US-AMGEN-USASP2024162925$AMGEN$$41$YR$A$F$Y$$$20240816$$HP$US$US
242168902$24216890$2$F$20210501$20240821$20240816$20240826$EXP$$NVSJ2024JP009610$NOVARTIS$$$$A$F$Y$$$20240826$$MD$JP$JP
242168911$24216891$1$I$$20240815$20240816$20240816$PER$$NVSC2024US166268$NOVARTIS$$63$YR$$M$Y$$$20240816$$MD$US$US
242168921$24216892$1$I$20240501$20240809$20240816$20240816$EXP$$GB-JNJFOC-20240834473$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240816$$CN$GB$GB
242168932$24216893$2$F$$20240917$20240816$20240926$30DAY$$TR-JNJFOC-20240833571$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$TR$TR
242168942$24216894$2$F$20220506$20240912$20240816$20240918$EXP$$NVSJ2024JP009563$NOVARTIS$Minamitani Y, Iwamoto Y, Ishido H, Masutani S. A Fatal Case of Congenital Hypertrophic Cardiomyopathy due to PRKAG2 Syndrome with Refractory Fluid Condition in the Abdominal Cavity. The 60th Annual Meeting of Japanese Society of Pediatric Cariology and Cardiac S. 2024;II-P01-6-02$0$YR$$F$Y$2.5$KG$20240918$$HP$JP$JP
242168961$24216896$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129222$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240816$$HP$US$US
242168971$24216897$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127739$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240816$$CN$US$US
242168981$24216898$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004035$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242168991$24216899$1$I$20221230$20240814$20240816$20240816$EXP$$US-UCBSA-2023014926$UCB$$66$YR$$F$Y$$$20240816$$HP$US$US
242169001$24216900$1$I$$20240812$20240816$20240816$PER$$US-BIOGEN-2024BI01278037$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
242169011$24216901$1$I$$20240807$20240816$20240816$EXP$$US-MYLANLABS-2024M1074811$MYLAN$Martin CE, Kuhn AK, Leopold KN, Creo AL, Schoettler PJ, Allen-Rhoades WA. Exogenous steroid replacement in a pediatric patient with adrenocortical carcinoma receiving mitotane. Pediatr-Blood-Cancer 2024; 71 (8):.$16$YR$$F$Y$$$20240816$$HP$US$US
242169021$24216902$1$I$$20240807$20240816$20240816$EXP$$FR-MYLANLABS-2024M1075107$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$80$YR$$F$Y$$$20240816$$HP$FR$FR
242169031$24216903$1$I$$20240807$20240816$20240816$EXP$$GB-MYLANLABS-2024M1074946$MYLAN$Damani N, Gold A, Krishnakumar S, Yesudian PD. Erythroderma: uncovering the culprit. Br-J-Dermatol 2024; 192 (Suppl. 1) i162-i163 abstr. GD04.$$$A$M$Y$$$20240816$$HP$GB$GB
242169041$24216904$1$I$$20240807$20240816$20240816$EXP$$JP-MYE-2024M1075502AA$MYLAN$Dobashi N, Sada K-E, Kanemori G, Okada T, Tarutani Y, Yamamoto M, et al. Pulmonary alveolar proteinosis during treatment of immune-mediated necrotizing myopathy. Int-J-Rheum-Diseases 2024; 27 (2):.. 2024;27 (2)$71$YR$$F$Y$$$20240816$$HP$JP$JP
242169051$24216905$1$I$20240722$20240725$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004037$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240816$$CN$US$US
242169061$24216906$1$I$$20240812$20240816$20240816$EXP$$IQ-AstraZeneca-2024A183600$ASTRAZENECA$$$$$M$Y$$$20240816$$MD$IQ$
242169071$24216907$1$I$$20240807$20240816$20240816$EXP$$IT-MYLANLABS-2024M1075227$MYLAN$Abbott M, Valenti G, Gizzi A, Agrenzano S, Ficalora A, Mancuso A, et al. HBV reactivation after immunosuppressive therapy: An open question. Sex-Transmit-Infect 2024; 100 (Suppl. 1) A271 abstr. P-213.$71$YR$$M$Y$$$20240816$$HP$IT$IT
242169082$24216908$2$F$$20240816$20240816$20240829$EXP$$FR-AUROBINDO-AUR-APL-2024-039464$AUROBINDO$Beigneux Y, Louapre C, Bihan K, Roux T, de Paz R, Lubetzki C, et al. Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab. Mult-Scler-J. 2024;30(1):131-133$38$YR$$F$Y$$$20240829$$HP$FR$FR
242169091$24216909$1$I$20240804$20240804$20240815$20240815$DIR$FDA-CDER-CTU-2024-56292$$FDA-CTU$$78$YR$$M$N$$$20240804$N$HP$US$
242169101$24216910$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009570$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242169111$24216911$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56317$$FDA-CTU$$75$YR$$M$N$$$20240815$N$$US$
242169121$24216912$1$I$20240813$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56375$$FDA-CTU$$54$YR$$F$N$$$20240815$Y$$US$
242169132$24216913$2$F$20240802$20240814$20240816$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408006430$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240820$$CN$US$US
242169142$24216914$2$F$20240808$20240819$20240816$20240821$PER$$US-AMGEN-USASP2024162398$AMGEN$$61$YR$A$$Y$$$20240821$$PH$US$US
242169152$24216915$2$F$$20240816$20240816$20240828$EXP$$DE-AUROBINDO-AUR-APL-2024-039773$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 2023;107:107-113$$$A$F$Y$$$20240828$$HP$DE$DE
242169161$24216916$1$I$$20240814$20240816$20240816$EXP$$NVSC2024US165533$NOVARTIS$$$$$M$Y$$$20240816$$HP$US$US
242169171$24216917$1$I$$20240814$20240816$20240816$EXP$$NVSC2024AU165549$NOVARTIS$$$$$$Y$$$20240816$$MD$AU$AU
242169181$24216918$1$I$$20240808$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR099415$VIIV$$$$$M$Y$$$20240816$$MD$US$US
242169192$24216919$2$F$20240101$20240817$20240816$20240820$EXP$$NVSC2024SG165490$NOVARTIS$$$$$F$Y$$$20240820$$MD$SG$SG
242169202$24216920$2$F$$20240820$20240816$20240903$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07715$HIKMA$Akhdar G, Akpan I, Myles A, Atencah SE. Akhdar G, Akpan I, Myles A, Atencah SE. Single Low-Dose Methotrexate and Vitamin B12 Deficiency-Induced Pancytopenia Causing Fatality: A Case Report.. Cureus. 2024;16(6):e63528$71$YR$$M$Y$$$20240903$$MD$US$US
242169211$24216921$1$I$20240101$20240814$20240816$20240816$EXP$$US-ABBVIE-5881938$ABBVIE$$$$$M$Y$136$KG$20240816$$MD$US$US
242169221$24216922$1$I$$20240813$20240816$20240816$PER$$US-ROCHE-10000057876$ROCHE$$$$A$F$Y$$$20240816$$HP$US$US
242169231$24216923$1$I$$20240805$20240816$20240816$EXP$$US-B.Braun Medical Inc.-2160530$B BRAUN$Literature Article$14$YR$$F$Y$68$KG$20240816$$$US$US
242169241$24216924$1$I$20071226$20240813$20240816$20240816$EXP$$KR-JNJFOC-20240832119$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$HP$KR$KR
242169251$24216925$1$I$$20240812$20240816$20240816$PER$$US-ROCHE-10000055581$ROCHE$$8$YR$C$M$Y$$$20240816$$CN$US$US
242169281$24216928$1$I$$20230627$20240816$20240816$PER$$US-SA-2023MK000070$SANOFI AVENTIS$$$$A$F$Y$$$20240812$$CN$US$US
242169291$24216929$1$I$$20230717$20240816$20240816$PER$$US-SA-2023MK000072$SANOFI AVENTIS$$$$$F$Y$$$20240812$$CN$US$US
242169301$24216930$1$I$$20230721$20240816$20240816$PER$$US-SA-2023MK000073$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240812$$CN$US$US
242169311$24216931$1$I$20230807$20230807$20240816$20240816$PER$$US-SA-2023MK000076$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240812$$CN$US$US
242169321$24216932$1$I$$20230808$20240816$20240816$PER$$US-SA-2023MK000077$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240812$$CN$US$US
242169331$24216933$1$I$$20230811$20240816$20240816$PER$$US-SA-2023MK000078$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240812$$CN$US$US
242169341$24216934$1$I$$20230830$20240816$20240816$PER$$US-SA-2023MK000082$SANOFI AVENTIS$$$$$$Y$$$20240812$$HP$US$US
242169351$24216935$1$I$20230915$20230918$20240816$20240816$PER$$US-SA-2023MK000089$SANOFI AVENTIS$$$$$M$Y$$$20240812$$PH$US$US
242169361$24216936$1$I$$20230921$20240816$20240816$PER$$US-SA-2023MK000091$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240812$$MD$US$US
242169371$24216937$1$I$$20230731$20240816$20240816$PER$$US-SA-2023MK000074$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240812$$CN$US$US
242169381$24216938$1$I$20230814$20230814$20240816$20240816$PER$$US-SA-2023MK000079$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240812$$CN$US$US
242169391$24216939$1$I$$20230908$20240816$20240816$PER$$US-SA-2023MK000085$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240812$$CN$US$US
242169401$24216940$1$I$$20230915$20240816$20240816$PER$$US-SA-2023MK000088$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240812$$CN$US$US
242169411$24216941$1$I$$20230919$20240816$20240816$PER$$US-SA-2023MK000090$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240812$$CN$US$US
242169421$24216942$1$I$20230921$20230928$20240816$20240816$PER$$US-SA-2023MK000092$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240812$$CN$US$US
242169431$24216943$1$I$20231009$20231010$20240816$20240816$PER$$US-SA-2023MK000093$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240812$$CN$US$US
242169441$24216944$1$I$20230901$20231012$20240816$20240816$PER$$US-SA-2023MK000095$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240812$$CN$US$US
242169452$24216945$2$F$20240801$20240815$20240816$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-039898$AUROBINDO$$69$YR$$M$Y$85$KG$20240828$$MD$GB$GB
242169461$24216946$1$I$$20240805$20240816$20240816$EXP$$DE-AUROBINDO-AUR-APL-2024-039772$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 2023;107:107-113$$$$$Y$$$20240816$$HP$DE$DE
242169471$24216947$1$I$$20240814$20240816$20240816$EXP$$NVSC2024US165725$NOVARTIS$$$$$M$Y$$$20240816$$HP$US$US
242169482$24216948$2$F$$20240905$20240816$20240912$30DAY$$US-GSK-US2024AMR098301$GLAXOSMITHKLINE$$$$$F$Y$$$20240912$$CN$US$US
242169491$24216949$1$I$$20240806$20240816$20240816$EXP$$US-GSK-US2024AMR098789$GLAXOSMITHKLINE$$$$$F$Y$64.399$KG$20240816$$CN$US$US
242169503$24216950$3$F$$20240813$20240816$20240819$PER$$US-ROCHE-10000054197$ROCHE$$80$YR$E$F$Y$$$20240819$$CN$US$US
242169521$24216952$1$I$$20240808$20240816$20240816$EXP$$GB-MSNLABS-2024MSNSPO01785$MSN LABORATORIES$$$$$$Y$$$20240816$$CN$GB$GB
242169531$24216953$1$I$$20240802$20240816$20240816$PER$$US-RDY-SPO/USA/24/0011684$DR REDDYS$$16$YR$T$$Y$$$20240816$$MD$US$US
242169542$24216954$2$F$$20240823$20240816$20240902$EXP$$US-GSK-US2024098174$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$HP$US$US
242169561$24216956$1$I$20240731$20240802$20240816$20240816$PER$$US-RDY-SPO/USA/24/0011593$DR REDDYS$$91$YR$E$F$Y$$$20240816$$CN$US$US
242169571$24216957$1$I$$20240802$20240816$20240816$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461012$RANBAXY$Kakeshita K, Imamura T, Onoda H, Kinugawa K. Impact of Goreisan upon aquaporin-2-incorporated aquaresis system in patients with congestive heart failure. CEN Case Rep. 2023;12 (1):73-77$85$YR$$M$Y$74.5$KG$20240816$$HP$JP$JP
242169581$24216958$1$I$20240515$20240802$20240816$20240816$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462701$RANBAXY$$42$YR$$M$Y$110$KG$20240816$$MD$FR$FR
242169591$24216959$1$I$$20240802$20240816$20240816$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463052$RANBAXY$Tang CJ, Balu R, Thomas CA, King CS, Shlobin OA, Aryal S, et al. Spinal Cord Infarction Associated With VA-ECMO Support. Am J Respir Crit Care Med. 2024;May 22;209 (0):A7037;D23$46$YR$$F$Y$$$20240816$$HP$US$US
242169601$24216960$1$I$$20240811$20240816$20240816$EXP$$CN-JNJFOC-20240832477$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$MD$CN$CN
242169611$24216961$1$I$$20240802$20240816$20240816$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463019$RANBAXY$Nho D, Kim W-B, Park C, Lee R, Lee D-G, Cho S-Y.. Disseminated Saprochaete capitata infection in a hematologic malignancy patient. Infect Chemotherap. 2023;55(Suppl.):S383$65$YR$$F$Y$$$20240816$$HP$KR$KR
242169621$24216962$1$I$$20240808$20240816$20240816$EXP$$GB-MYLANLABS-2024M1075351$MYLAN$Zwain A, Crawford A, Belgi A, Morgan C, August S. Severe pyoderma gangrenosum in a child and the response to adalimumab. Br-J-Dermatol 2024; 192 (Suppl.) i134.$7$YR$$M$Y$$$20240816$$HP$GB$GB
242169631$24216963$1$I$$20240808$20240816$20240816$EXP$$US-MYLANLABS-2024M1075623$MYLAN$Friedman R, Joshi S. Prophylactic TXA for a patient with late-onset HAE-PLG. Ann-Allergy-Asthma-Immunol 2023; 131 (Suppl.) (5): S125 abstr. M121.$66$YR$$M$Y$$$20240816$$HP$US$US
242169641$24216964$1$I$$20240806$20240816$20240816$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000118$PAREXEL$$$$$$Y$$$20240816$$HP$US$US
242169651$24216965$1$I$$20240808$20240816$20240816$EXP$$AU-MYLANLABS-2024M1075367$MYLAN$Satchithanandha A, Sethi A, Nanayakkara B. Isolated pulmonary anti-glomerular basement disease in Central Western New South Wales. Intern-Med-J 2024; 54 (6): 1040-1041.$72$YR$$M$Y$$$20240816$$HP$AU$AU
242169661$24216966$1$I$$20240808$20240816$20240816$EXP$$IR-MYLANLABS-2024M1075836$MYLAN$Sasani E, Khodavaisy S, Salehi M, Bagheri-Josheghani S, Abdorahimi M, Manshadi SAD, et al. Concomitant tuberculosis and aspergillosis in patients with COVID-19: a case report. Iranian-J-Microbiol 2024; 16 (3): 428-433.$51$YR$$F$Y$$$20240816$$MD$IR$IR
242169671$24216967$1$I$$20240802$20240816$20240816$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-444444$RANBAXY$Wollweber B, Keck ME, Schmidt U. Improvement of nonsuicidal self-injury following treatment with antipsychotics possessing strong D1 antagonistic activity: evidence from a report of three cases. Ther Adv Psychopharmacol. 2015;5(4):208-213$37$YR$$F$Y$$$20240816$$MD$DE$DE
242169681$24216968$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56319$$FDA-CTU$$57$YR$$F$N$117.93$KG$20240815$N$$US$
242169691$24216969$1$I$20240812$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56297$$FDA-CTU$$73$YR$$M$N$$$20240815$N$$US$
242169741$24216974$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56301$$FDA-CTU$$37$YR$$M$N$$$20240815$N$$US$
242169751$24216975$1$I$$20240815$20240815$20240815$DIR$714375$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242169771$24216977$1$I$$20240815$20240815$20240815$DIR$714444$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242169781$24216978$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56314$$FDA-CTU$$59$YR$$F$N$87.09$KG$20240815$N$$US$
242169791$24216979$1$I$$20240808$20240816$20240816$EXP$$US-AMGEN-USASP2024161335$AMGEN$Brown T. J.; Gimotty P. A.; Mamtani R. et al.. Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab. JCO Clinical Cancer lnformatics. 2024;8:1-9$$$$$Y$$$20240816$$HP$US$US
242169801$24216980$1$I$$20240815$20240815$20240815$DIR$714402$$FDA-CTU$$$$$M$N$$$20240815$Y$HP$US$
242169811$24216981$1$I$$20240815$20240816$20240816$EXP$$US-GILEAD-2024-0684388$GILEAD$$$$$M$Y$$$20240816$$MD$US$US
242169821$24216982$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56300$$FDA-CTU$$61$YR$$F$N$64.41$KG$20240815$N$$US$
242169832$24216983$2$F$$20240816$20240816$20240826$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004538$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240826$$HP$FR$FR
242169842$24216984$2$F$20240809$20240819$20240816$20240830$EXP$$CH-ROCHE-10000056157$ROCHE$$56$YR$A$F$Y$$$20240830$$CN$CH$CH
242169851$24216985$1$I$$20240809$20240816$20240816$EXP$$US-MYLANLABS-2024M1075183$MYLAN$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J 2024; 70 (7): e92-e96.$15$YR$$F$Y$$$20240816$$HP$US$US
242169861$24216986$1$I$20240621$20240725$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002245$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240816$$CN$US$US
242169871$24216987$1$I$19920101$20240812$20240816$20240816$EXP$GB-MHRA-MED-202405131339048220-TYRGZ$GB-TEVA-VS-3232283$TEVA$$$$A$F$Y$102$KG$20240816$$CN$GB$GB
242169892$24216989$2$F$$20240827$20240816$20240902$EXP$$US-AMGEN-USASP2024161844$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024$$$$$Y$$$20240902$$HP$US$US
242169911$24216991$1$I$$20240804$20240816$20240816$EXP$$CN-Accord-440642$ACCORD$Zhu Z, Li X, Yuan X, Chen X, Lin T, Guo X, et.al. Efficacy and safety of stem cell mobilization with etoposide +cytarabine plus G-CSF in poor mobilizers with relapsed or refractory lymphoma. Front Immunol. 2024 Jul 18;15:1439253.$$$$$Y$$$20240816$$HP$CN$CN
242169922$24216992$2$F$20240805$20240807$20240816$20240819$EXP$GB-MHRA-MED-202408051535024400-VQSNR$GB-Accord-440741$ACCORD$$39$YR$A$F$Y$$$20240819$$CN$GB$GB
242169941$24216994$1$I$20240701$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56308$$FDA-CTU$$40$YR$$F$N$$$20240815$N$HP$US$
242169951$24216995$1$I$$20240812$20240816$20240816$EXP$$US-JNJFOC-20240830248$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
242169961$24216996$1$I$$20240815$20240815$20240815$DIR$714423$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242169971$24216997$1$I$$20240803$20240816$20240816$EXP$$NL-AUROBINDO-AUR-APL-2019-080811$AUROBINDO$Rhodius- Meester HFM, Kuper IMJA, Otten HMMB, Hamburger HL.. An unusual presentation of a varicella zoster virus encephalitis in a patient treated for metastatic prostate cancer. Journal of the American Geriatrics Society.. 2010;58 (12):2437-2438$84$YR$$M$Y$$$20240816$$MD$NL$NL
242169992$24216999$2$F$$20240908$20240816$20240918$EXP$$US-UCBSA-2024039497$UCB$$$$$F$Y$$$20240918$$HP$US$US
242170001$24217000$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56286$$FDA-CTU$$60$YR$$M$N$$$20240815$N$$US$
242170011$24217001$1$I$20240814$20240815$20240815$20240815$DIR$714462$$FDA-CTU$$71$YR$$M$N$$$20240815$N$$US$
242170021$24217002$1$I$$20240804$20240816$20240816$EXP$$KR-Accord-441241$ACCORD$Kim TM, Jo SJ. Short-term Safety of Dimethyl Fumarate for Psoriasis in Korea. Ann Dermatol. 2024 Aug;36(4):252-254. doi: 10.5021/ad.23.054.$50$YR$A$F$Y$$$20240816$$MD$KR$KR
242170031$24217003$1$I$$20240807$20240816$20240816$EXP$GB-MHRA-MED-202408071416135850-QGJMR$GB-Accord-440865$ACCORD$$$$$M$Y$$$20240816$$PH$GB$GB
242170042$24217004$2$F$20240802$20240807$20240816$20240819$EXP$GB-MHRA-MED-202408031331012830-YMSRD$GB-Accord-440745$ACCORD$$39$YR$A$F$Y$$$20240819$$CN$GB$GB
242170051$24217005$1$I$20240805$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56388$$FDA-CTU$$72$YR$$M$N$86.64$KG$20240815$N$HP$US$
242170061$24217006$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004039$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242170071$24217007$1$I$$20240812$20240816$20240816$PER$$US-PFIZER INC-PV202400104994$PFIZER$$48$YR$$F$Y$$$20240816$$MD$US$US
242170081$24217008$1$I$$20240812$20240816$20240816$PER$$US-PFIZER INC-202400235038$PFIZER$$12$YR$$M$Y$$$20240816$$CN$US$US
242170101$24217010$1$I$20240808$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56303$$FDA-CTU$$49$YR$$F$N$$$20240815$N$$US$
242170112$24217011$2$F$$20240814$20240816$20240816$PER$$US-PFIZER INC-PV202400106154$PFIZER$$$$$F$Y$$$20240816$$CN$US$US
242170121$24217012$1$I$$20240815$20240816$20240816$PER$$US-BAYER-2024A118008$BAYER$$81$YR$E$M$Y$$$20240816$$CN$US$US
242170131$24217013$1$I$20240723$20240809$20240816$20240816$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-07722$HIKMA$$63$YR$$F$Y$$$20240816$$MD$IT$IT
242170141$24217014$1$I$$20240806$20240816$20240816$EXP$$US-KOANAAP-SML-US-2024-00843$SHILPA MEDICARE$Stewart MA, Rives TA, Blanton K, Baldwin L. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecologic Oncology Reports. 2024;doi:10.1016/j.gore.2024.101452.$33$YR$A$F$Y$$$20240816$$MD$US$US
242170151$24217015$1$I$$20240815$20240816$20240816$PER$$NVSC2024US166050$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242170161$24217016$1$I$$20240808$20240816$20240816$EXP$US-MLMSERVICE-20240801-PI148778-00106-1$US-RDY-SPO/USA/24/0011740$DR REDDYS$Sachdeva N, Sun LW, Young J, Chen A. Early to late explantation of Hydrus microstent MIGS device: A case series. American Journal of Ophthalmology Case Reports. 2024;36:102105. DOI: 10.1016/j.ajoc.2024.102105.$71$YR$E$M$Y$$$20240816$$MD$US$US
242170171$24217017$1$I$20240712$20240809$20240816$20240816$EXP$$CN-009507513-2408CHN004366$MERCK$$72$YR$$M$Y$62$KG$20240816$$HP$CN$CN
242170181$24217018$1$I$$20240813$20240816$20240816$PER$$US-BAYER-2024A117227$BAYER$$$$$$Y$$$20240816$$CN$US$US
242170191$24217019$1$I$$20240809$20240816$20240816$EXP$$JP-BAYER-2024A103455$BAYER$$$$$F$Y$$$20240816$$HP$JP$JP
242170201$24217020$1$I$$20240808$20240816$20240816$PER$$US-ALXN-202408USA000552US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240816$$HP$US$US
242170212$24217021$2$F$20240801$20240926$20240816$20240930$PER$$US-JNJFOC-20240840852$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240930$$CN$US$US
242170221$24217022$1$I$20240711$20240809$20240816$20240816$EXP$$CO-GSK-CO2024AMR101070$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$CO$CO
242170231$24217023$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161639$AMGEN$$47$YR$A$M$Y$$$20240816$$HP$US$US
242170241$24217024$1$I$20240719$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160618$AMGEN$$$$$$Y$$$20240816$$PH$US$US
242170252$24217025$2$F$$20240827$20240816$20240902$PER$$US-AMGEN-USASP2024161576$AMGEN$Topilow N.J.; Penteado R.C..; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian Journal of Ophthalmology / Journal Canadien d^Ophtalmologie. 2024$$$$$Y$$$20240902$$MD$US$US
242170261$24217026$1$I$$20240813$20240816$20240816$EXP$$US-MYLANLABS-2024M1075965$MYLAN$$$$$$Y$$$20240816$$CN$US$US
242170271$24217027$1$I$20240712$20240725$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004040$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240816$$CN$US$US
242170281$24217028$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008598$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240816$$CN$US$US
242170291$24217029$1$I$20230725$20240813$20240816$20240816$PER$$US-ORGANON-O2408USA001047$ORGANON$$21$YR$$F$Y$50.794$KG$20240816$$CN$US$US
242170301$24217030$1$I$20231223$20240815$20240816$20240816$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-140730$DAIICHI$$97$YR$$F$Y$41$KG$20240816$$HP$JP$JP
242170311$24217031$1$I$20191201$20240809$20240816$20240816$EXP$$US-JAZZ-2019-US-017852$JAZZ$$33$YR$$M$Y$$$20240816$$CN$US$US
242170321$24217032$1$I$20240212$20240813$20240816$20240816$EXP$FR-AFSSAPS-BX2024001648$FR-ORGANON-O2408FRA000960$ORGANON$$63$YR$$M$Y$$$20240816$$MD$FR$FR
242170331$24217033$1$I$$20240703$20240816$20240816$30DAY$$US-VEROBIOTECH-2024USVEROSPO00181$VERO BIOTECH$$$$$$Y$$$20240816$$HP$US$US
242170341$24217034$1$I$$20240812$20240816$20240816$PER$$US-ROCHE-10000057248$ROCHE$$37$YR$A$F$Y$$$20240816$$CN$US$US
242170361$24217036$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161933$AMGEN$$$$$$Y$$$20240816$$HP$US$US
242170372$24217037$2$F$20240812$20240815$20240816$20240821$PER$$US-AMGEN-USASP2024162375$AMGEN$$73$YR$E$M$Y$$$20240821$$PH$US$US
242170381$24217038$1$I$$20240809$20240816$20240816$EXP$$US-ABBVIE-5876125$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242170391$24217039$1$I$20240811$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160826$AMGEN$$62$YR$A$F$Y$$$20240816$$CN$US$US
242170401$24217040$1$I$$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128888$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$55.34$KG$20240816$$HP$US$US
242170411$24217041$1$I$20240814$20240815$20240816$20240816$PER$$US-HALEON-2192214$Haleon PLC$$22$YR$$F$Y$$$20240816$$CN$US$US
242170421$24217042$1$I$$20240808$20240816$20240816$EXP$$US-AMGEN-USASP2024159628$AMGEN$Chang J. C.; Zhang E.; Capponi D. et al.. Real-world application of the pediatric Glucocorticoid Toxicity Index in childhood-onset lupus. Seminars in Arthritis and Rheumatism. 2024;68:1-8$$$$$Y$$$20240816$$HP$US$US
242170431$24217043$1$I$$20240717$20240816$20240816$30DAY$$US-VEROBIOTECH-2024USVEROSPO00182$VERO BIOTECH$$$$I$$Y$$$20240816$$HP$US$US
242170441$24217044$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56379$$FDA-CTU$$57$YR$$F$N$$$20240815$N$$US$
242170451$24217045$1$I$$20240815$20240815$20240815$DIR$714425$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242170461$24217046$1$I$20240806$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56344$$FDA-CTU$$56$YR$$F$N$51$KG$20240815$N$PH$US$
242170481$24217048$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56288$$FDA-CTU$$77$YR$$M$N$$$20240815$N$$US$
242170491$24217049$1$I$$20240815$20240815$20240815$DIR$714516$$FDA-CTU$$64$YR$$M$N$74.25$KG$20240815$N$CN$US$
242170501$24217050$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56347$$FDA-CTU$$79$YR$$M$N$$$20240815$N$$US$
242170511$24217051$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56316$$FDA-CTU$$3$YR$$F$N$$$20240815$N$$US$
242170521$24217052$1$I$20240815$20240815$20240815$20240815$DIR$714422$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242170531$24217053$1$I$$20240808$20240816$20240816$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24567$SAMSUNG BIOEPIS$$61$YR$A$M$Y$$$20240816$$CN$GB$GB
242170541$24217054$1$I$$20240815$20240815$20240815$DIR$714390$$FDA-CTU$$$$$UNK$N$$$20240815$$CN$US$
242170551$24217055$1$I$20240702$20240814$20240815$20240815$DIR$FDA-CDER-CTU-2024-56293$$FDA-CTU$$58$YR$$M$N$$$20240814$N$HP$US$
242170561$24217056$1$I$$20240815$20240815$20240815$DIR$714376$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242170572$24217057$2$F$$20240828$20240816$20240904$EXP$$JP-DSJP-DSJ-2024-140490$DAIICHI$$80$YR$$F$Y$$$20240904$$PH$JP$JP
242170581$24217058$1$I$20240729$20240805$20240816$20240816$EXP$$US-Accord-440632$ACCORD$$34$YR$A$F$Y$$$20240816$$HP$US$US
242170591$24217059$1$I$$20240808$20240816$20240816$EXP$$US-APOTEX-2024AP009216$APOTEX$Monge J, Razavi M, Bao L, Patel SS.. Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. American Journal of Hematology. 2024;99(2):327-328$78$YR$$M$Y$$$20240816$$HP$US$US
242170611$24217061$1$I$20240814$20240815$20240815$20240815$DIR$714382$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242170622$24217062$2$F$20240725$20240822$20240816$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004041$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240913$$CN$US$US
242170631$24217063$1$I$$20240815$20240815$20240815$DIR$714403$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242170641$24217064$1$I$20240801$20240805$20240816$20240816$EXP$$US-Accord-440639$ACCORD$$27$YR$A$F$Y$$$20240816$$HP$US$US
242170651$24217065$1$I$$20240804$20240816$20240816$EXP$$CN-Accord-440737$ACCORD$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024 Jul 15;14:1374149.$$$$$Y$$$20240816$$HP$CN$CN
242170661$24217066$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56402$$FDA-CTU$$56$YR$$M$N$$$20240815$N$$US$
242170671$24217067$1$I$20240814$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56395$$FDA-CTU$$13$YR$$M$N$$$20240815$N$$US$
242170681$24217068$1$I$$20240805$20240816$20240816$EXP$$US-Accord-440633$ACCORD$$66$YR$E$F$Y$$$20240816$$HP$US$US
242170691$24217069$1$I$$20240804$20240816$20240816$EXP$$US-Accord-440782$ACCORD$Spiegel DR, Jahelka C, Shelton M, Strohm S, Duraiswami D, Kaplan Z. A Case and Differential Diagnosis of Catatonia in a Patient With Hypothyroidism Due to Levothyroxine Nonadherence. Prim Care Companion CNS Disord. 2024 Aug 1;26(4):23cr03700.$72$YR$E$F$Y$$$20240816$$HP$US$US
242170711$24217071$1$I$20240815$20240815$20240815$20240815$DIR$714556$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242170722$24217072$2$F$$20240820$20240816$20240831$EXP$$BH-Accord-440636$ACCORD$Surmeli ZG, Ibrahim RH, Alkhalfan N, Mahmood Z. Cisplatin-induced bone marrow failure in an adult patient with Fanconi anemia. Journal of oncology pharmacy practice: Official publication of the International Society of Oncology Pharmacy Practitioners. 2024:1-4.$38$YR$A$F$Y$$$20240831$$MD$BH$BH
242170731$24217073$1$I$20240802$20240805$20240816$20240816$EXP$$US-Accord-440568$ACCORD$$57$YR$A$F$Y$$$20240816$$HP$US$US
242170741$24217074$1$I$$20240805$20240816$20240816$EXP$$DE-AUROBINDO-AUR-APL-2024-039777$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 2023;107:107-113$$$N$$Y$$$20240816$$HP$DE$DE
242170751$24217075$1$I$20240501$20240807$20240816$20240816$EXP$$SG-ROCHE-10000052601$ROCHE$$55$YR$A$F$Y$$$20240816$$CN$SG$SG
242170761$24217076$1$I$$20240815$20240816$20240816$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046097$BOEHRINGER INGELHEIM$$91$YR$E$F$Y$$$20240816$$PH$JP$JP
242170771$24217077$1$I$$20240813$20240816$20240816$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-111816$REGENERON$$$$$$Y$$$20240816$$CN$US$US
242170781$24217078$1$I$$20240813$20240816$20240816$EXP$$NVSC2024US165313$NOVARTIS$$$$$M$Y$$$20240816$$HP$US$US
242170801$24217080$1$I$20240101$20240808$20240816$20240816$EXP$$ES-AMGEN-ESPSP2024158029$AMGEN$$$$E$F$Y$$$20240816$$CN$ES$ES
242170811$24217081$1$I$20240729$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160417$AMGEN$$59$YR$A$F$Y$$$20240816$$CN$US$US
242170821$24217082$1$I$$20240811$20240816$20240816$EXP$$SA-AMGEN-SAUSP2024161310$AMGEN$Motabi I.. Phase 2 Study of 5 Days Azacytidine Priming Prior to Fludarabine, Cytarabine and G-CSF Combination for Patients with Relapsed or Refractory AML. Blood. 2018;132:1-3$$$$$Y$$$20240816$$MD$SA$SA
242170832$24217083$2$F$20240801$20240906$20240816$20240906$PER$$US-ALXN-202408USA000639US$ALEXION PHARMACEUTICALS$$75$YR$$M$Y$$$20240906$$CN$US$US
242170841$24217084$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129534$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240816$$PH$US$US
242170851$24217085$1$I$$20240718$20240816$20240816$30DAY$$US-VEROBIOTECH-2024USVEROSPO00184$VERO BIOTECH$$$$$$Y$$$20240816$$HP$US$US
242170862$24217086$2$F$$20240910$20240816$20240916$30DAY$$CN-JNJFOC-20240833551$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$CN$CN
242170881$24217088$1$I$$20240813$20240816$20240816$PER$$US-BAYER-2024A117253$BAYER$$$$$$Y$$$20240816$$CN$US$US
242170892$24217089$2$F$20240808$20240822$20240816$20240822$EXP$$CA-BAYER-2024A114822$BAYER$$53$YR$A$F$Y$$$20240822$$MD$CA$CA
242170901$24217090$1$I$20240513$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024817$UNITED THERAPEUTICS$$$$$$Y$$$20240816$$$US$US
242170911$24217091$1$I$$20240804$20240816$20240816$PER$$US-AstraZeneca-2024A179547$ASTRAZENECA$$$$$$Y$$$20240816$$CN$US$
242170921$24217092$1$I$$20230309$20240816$20240816$EXP$$US-AstraZeneca-2023A058875$ASTRAZENECA$$$$$$Y$$$20240816$$CN$US$
242170931$24217093$1$I$$20221215$20240816$20240816$EXP$$US-AstraZeneca-2022A410549$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242170941$24217094$1$I$20240326$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024876$UNITED THERAPEUTICS$$$$$$Y$$$20240816$$$US$US
242170961$24217096$1$I$$20240717$20240816$20240816$EXP$$NVSC2024US164877$NOVARTIS$$$$$$Y$$$20240816$$LW$US$US
242170971$24217097$1$I$$20240813$20240816$20240816$EXP$$NVSC2024CA165674$NOVARTIS$$$$$$Y$$$20240816$$MD$CA$CA
242170981$24217098$1$I$$20240812$20240816$20240816$EXP$$US-ROCHE-10000055886$ROCHE$$60$YR$A$F$Y$$$20240816$$HP$US$US
242170991$24217099$1$I$$20240809$20240816$20240816$EXP$$US-ABBVIE-5878610$ABBVIE$$$$$$Y$$$20240816$$HP$US$US
242171001$24217100$1$I$20240807$20240808$20240816$20240816$PER$$US-BAYER-2024A114680$BAYER$$$$$$Y$$$20240816$$CN$US$US
242171013$24217101$3$F$20240803$20240910$20240816$20240918$PER$$US-ROCHE-10000049510$ROCHE$$45$YR$A$F$Y$95.25$KG$20240918$$CN$US$US
242171032$24217103$2$F$$20240923$20240816$20240925$PER$$US-HALEON-2192028$Haleon PLC$$$$$M$Y$$$20240925$$CN$US$US
242171045$24217104$5$F$$20240830$20240816$20240902$PER$$US-HALEON-2191967$Haleon PLC$$83$YR$$$Y$$$20240902$$CN$US$US
242171051$24217105$1$I$$20240806$20240816$20240816$EXP$$CA-LUNDBECK-DKLU4002927$LUNDBECK$$$$$$Y$$$20240816$$HP$CA$CA
242171062$24217106$2$F$$20240819$20240816$20240821$30DAY$$DE-UCBSA-2024040668$UCB$$$$$F$Y$$$20240821$$PH$DE$DE
242171071$24217107$1$I$$20240812$20240816$20240816$EXP$$AL-MYLANLABS-2024M1075835$MYLAN$Puca E, Puca E, Vrekaj K, Puca D. Severe hypoglycemia induced by Tigecycline in a diabetic and hemodialysis patient. J-Infect-Develop-Countr 2024; 18 (7): 1157-1160.$54$YR$$F$Y$$$20240816$$HP$AL$AL
242171081$24217108$1$I$20240101$20240808$20240816$20240816$PER$$US-ABBVIE-5873767$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242171091$24217109$1$I$20240601$20240815$20240816$20240816$EXP$$PT-GILEAD-2024-0683876$GILEAD$$$$$F$Y$$$20240816$$MD$PT$PT
242171101$24217110$1$I$$20240808$20240816$20240816$PER$$US-BAYER-2024A114849$BAYER$$67$YR$E$F$Y$$$20240816$$CN$US$US
242171112$24217111$2$F$$20240905$20240816$20240911$30DAY$$PL-JNJFOC-20240826276$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$PL$PL
242171121$24217112$1$I$20221027$20240812$20240816$20240816$EXP$$KR-MYLANLABS-2024M1074959$MYLAN$$$$A$F$Y$$$20240816$$MD$KR$KR
242171131$24217113$1$I$20240718$20240809$20240816$20240816$EXP$$US-BAYER-2024A116467$BAYER$$78$YR$E$F$Y$$$20240816$$PH$US$US
242171143$24217114$3$F$$20240913$20240816$20240923$EXP$$FI-CLINIGEN-FI-CLI-2024-010400$CLINIGEN$$$$$$Y$$$20240923$$PH$FI$FI
242171152$24217115$2$F$20240101$20240923$20240816$20240926$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-111720$REGENERON$$$$$M$Y$$$20240926$$HP$US$US
242171161$24217116$1$I$20240725$20240725$20240816$20240816$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004043$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240816$$CN$US$US
242171172$24217117$2$F$$20240819$20240816$20240820$EXP$$NVSC2024CA164912$NOVARTIS$$44$YR$$F$Y$97$KG$20240821$$MD$CA$CA
242171191$24217119$1$I$20240809$20240809$20240816$20240816$PER$$US-BAYER-2024A115732$BAYER$$$$$$Y$$$20240816$$CN$US$US
242171201$24217120$1$I$20240713$20240719$20240816$20240816$EXP$$NVSC2024CN150963$NOVARTIS$$40$YR$$M$Y$55$KG$20240816$$HP$CN$CN
242171231$24217123$1$I$20240806$20240815$20240815$20240815$DIR$714468$$FDA-CTU$$31$YR$$F$N$77.4$KG$20240815$N$CN$US$
242171241$24217124$1$I$20240814$20240815$20240815$20240815$DIR$714383$$FDA-CTU$$59$YR$$M$N$$$20240815$N$PH$US$
242171251$24217125$1$I$20240810$20240814$20240815$20240815$DIR$FDA-CDER-CTU-2024-56309$$FDA-CTU$$60$YR$$F$N$$$20240814$N$HP$US$
242171261$24217126$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56302$$FDA-CTU$$81$YR$$F$N$75.3$KG$20240815$N$$US$
242171281$24217128$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56298$$FDA-CTU$$59$YR$$F$N$$$20240815$N$$US$
242171291$24217129$1$I$20240801$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56291$$FDA-CTU$$78$YR$$M$N$$$20240815$Y$PH$US$
242171301$24217130$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56382$$FDA-CTU$$50$YR$$F$N$$$20240815$N$$US$
242171311$24217131$1$I$$20240815$20240815$20240815$DIR$714440$$FDA-CTU$$$$$UNK$N$$$20240815$$CN$US$
242171321$24217132$1$I$20240812$20240815$20240815$20240815$DIR$714487$$FDA-CTU$$60$YR$$F$N$70.65$KG$20240815$N$HP$US$
242171341$24217134$1$I$20240812$20240815$20240815$20240815$DIR$714504$$FDA-CTU$$63$YR$$M$N$142.2$KG$20240815$N$PH$US$
242171351$24217135$1$I$$20240815$20240815$20240815$DIR$714429$$FDA-CTU$$$$$UNK$N$$$20240815$$CN$US$
242171361$24217136$1$I$$20240812$20240816$20240816$EXP$$GB-SANDOZ INC.-NVSC2021GB052115$SANDOZ$$$$$F$Y$$$20240816$$CN$GB$GB
242171372$24217137$2$F$20230521$20240815$20240816$20240821$EXP$FR-AFSSAPS-LM2024000450$FR-GSK-FR2024101567$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$FR$FR
242171381$24217138$1$I$20240417$20240807$20240816$20240816$EXP$FR-AFSSAPS-RS2024000742$FR-TEVA-VS-3231792$TEVA$$56$YR$$F$Y$$$20240816$$PH$FR$FR
242171392$24217139$2$F$$20240826$20240816$20240828$EXP$$US-ALXN-202408USA000643US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242171401$24217140$1$I$$20240809$20240816$20240816$EXP$$IL-AMGEN-ISRSP2024160318$AMGEN$$$$$$Y$$$20240816$$MD$IL$IL
242171411$24217141$1$I$$20240725$20240816$20240816$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004044$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242171421$24217142$1$I$$20240813$20240816$20240816$EXP$$US-BAYER-2024A117248$BAYER$$$$$F$Y$$$20240816$$CN$US$US
242171431$24217143$1$I$$20240812$20240816$20240816$EXP$$CA-JNJFOC-20240840394$JOHNSON AND JOHNSON$$83$YR$E$F$Y$66$KG$20240816$$HP$CA$CA
242171441$24217144$1$I$$20240813$20240816$20240816$EXP$$DE-SANDOZ INC.-SDZ2024DE072452$SANDOZ$$39$YR$$F$Y$$$20240816$$HP$DE$DE
242171451$24217145$1$I$$20240808$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126391$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240816$$HP$US$US
242171461$24217146$1$I$20240101$20240723$20240816$20240816$PER$$US-009507513-2407USA013512$MERCK$$73$YR$$M$Y$$$20240816$$CN$US$US
242171473$24217147$3$F$20240701$20240913$20240816$20240920$EXP$$JP-009507513-2408JPN001082J$MERCK$$8$DEC$$M$Y$$$20240920$$MD$JP$JP
242171481$24217148$1$I$$20240805$20240816$20240816$EXP$$IT-B.Braun Medical Inc.-2160532$B BRAUN$Literature Article$38$YR$$F$Y$$$20240816$$$IT$IT
242171491$24217149$1$I$20240101$20240813$20240816$20240816$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013166$VERTEX$$$$$F$Y$$$20240816$$CN$GB$GB
242171501$24217150$1$I$20240624$20240807$20240816$20240816$EXP$FR-AFSSAPS-ST2024001243$FR-TEVA-VS-3231816$TEVA$$62$YR$$F$Y$54$KG$20240816$$PH$FR$FR
242171511$24217151$1$I$$20240809$20240816$20240816$PER$$US-VERTEX PHARMACEUTICALS-2024-013055$VERTEX$$$$$$Y$$$20240816$$CN$US$US
242171521$24217152$1$I$$20240812$20240816$20240816$EXP$$US-VERTEX PHARMACEUTICALS-2024-013150$VERTEX$$$$$F$Y$$$20240816$$CN$US$US
242171531$24217153$1$I$$20240812$20240816$20240816$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013115$VERTEX$$$$$M$Y$$$20240816$$CN$GB$GB
242171541$24217154$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008540$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240816$$CN$US$US
242171551$24217155$1$I$$20240805$20240816$20240816$EXP$$BE-AUROBINDO-AUR-APL-2024-040043$AUROBINDO$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J-Allergy-Clin-Immunol-Pract. 2024;12(7):1850-1862$66$YR$$M$Y$$$20240816$$MD$BE$BE
242171561$24217156$1$I$$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007059$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242171571$24217157$1$I$20240801$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005530$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242171582$24217158$2$F$$20240917$20240816$20240919$30DAY$$CO-PFIZER INC-202400232121$PFIZER$$$$$$Y$$$20240919$$CN$CO$CO
242171593$24217159$3$F$$20240921$20240816$20240923$30DAY$$US-PFIZER INC-202400236004$PFIZER$$11$YR$$M$Y$$$20240923$$CN$US$US
242171601$24217160$1$I$$20240806$20240816$20240816$EXP$$US-KOANAAP-SML-US-2024-00841$SHILPA MEDICARE$Wang J, Elghawy O, Kurpiel B, Kaur V. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors. Clinical Journal of Gastroenterology. 2023 Aug 31;16: 807-814. doi:10.1007/s12328-023-01853-3.$75$YR$E$F$Y$$$20240816$$MD$US$US
242171611$24217161$1$I$$20240806$20240816$20240816$PER$$US-MYLANLABS-2024M1074061$MYLAN$$$$$F$Y$$$20240816$$CN$US$US
242171621$24217162$1$I$$20240813$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA042832$SANDOZ$$47$YR$$F$Y$$$20240816$$HP$CA$CA
242171641$24217164$1$I$20240101$20240808$20240816$20240816$PER$$US-ABBVIE-5874051$ABBVIE$$$$$$Y$$$20240816$$CN$US$US
242171651$24217165$1$I$$20240805$20240816$20240816$EXP$$GB-AUROBINDO-AUR-APL-2024-039524$AUROBINDO$Hyde K, Rashed K. A case of embolic stroke and failed treatment with anticoagulation with papillary fibroelastoma. Clinical Medicine. 2024;24 (Suppl 44):6336073$38$YR$$F$Y$$$20240816$$HP$GB$GB
242171661$24217166$1$I$20041101$20240802$20240816$20240816$EXP$$BR-EMD Serono-2024043420$EMD SERONO INC$$44$YR$A$M$Y$$$20240816$$CN$BR$BR
242171671$24217167$1$I$$20240813$20240816$20240816$EXP$$US-GSK-US2024100789$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$US$US
242171681$24217168$1$I$20240714$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184384$ASTRAZENECA$$25178$DY$$F$Y$$$20240816$$HP$US$
242171691$24217169$1$I$$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A184716$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242171702$24217170$2$F$20240801$20240820$20240816$20240828$EXP$$JP-RADIUS HEALTH, INC.-2024JP006041$RADIUS PHARM$$8$DEC$$F$Y$$$20240828$$PH$JP$JP
242171711$24217171$1$I$20240801$20240812$20240816$20240816$EXP$$US-ABBVIE-5878902$ABBVIE$$72$YR$$F$Y$$$20240816$$CN$US$US
242171721$24217172$1$I$20240813$20240813$20240816$20240816$EXP$$US-KARYOPHARM-2024KPT001434$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240816$$CN$US$US
242171731$24217173$1$I$$20240805$20240816$20240816$EXP$$DE-MEITHEAL-2024MPLIT00242$MEITHEAL PHARMACEUTICALS$Pottharst A, et al.Specialized Palliative Care in a 54 y/o pat with RAS G12Cmutated NSCLC in need of high-flow oxygen at dischargement: An ethical and logistic dilemma.Oncology Research and Treatment.03-Oct-2023;46 (5):332$54$YR$A$$Y$$$20240816$$HP$DE$DE
242171741$24217174$1$I$$20240723$20240816$20240816$PER$$US-HALEON-2191944$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242171751$24217175$1$I$20240322$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-024879$UNITED THERAPEUTICS$$$$$$Y$$$20240816$$$US$US
242171761$24217176$1$I$20240809$20240809$20240816$20240816$EXP$$AU-MYLANLABS-2024M1046662$MYLAN$$20$YR$$M$Y$$$20240816$$HP$AU$AU
242171771$24217177$1$I$20240726$20240809$20240816$20240816$EXP$$TR-MYLANLABS-2024M1075066$MYLAN$$54$YR$$M$Y$82$KG$20240816$$CN$TR$TR
242171781$24217178$1$I$$20240808$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-007539$UNITED THERAPEUTICS$$$$$F$Y$10.884$KG$20240816$$$US$US
242171791$24217179$1$I$$20240814$20240816$20240816$PER$$US-BAUSCH-BL-2024-012364$BAUSCH AND LOMB$$74$YR$$F$Y$$$20240816$$HP$US$US
242171801$24217180$1$I$$20240808$20240816$20240816$PER$$US-ABBVIE-5874244$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242171811$24217181$1$I$$20240809$20240816$20240816$EXP$$US-MYLANLABS-2024M1074955$MYLAN$Dietrich DK, Laidlaw E, Hammoud DA, Pau AK, Smith BR. Dramatic improvement of MRI abnormalities of HIV encephalopathy after suppressive antiretroviral therapy. AIDS 2023; 37 (8): 1339-1340.$59$YR$$M$Y$$$20240816$$MD$US$US
242171821$24217182$1$I$20240808$20240809$20240816$20240816$EXP$$GB-MYLANLABS-2024M1075084$MYLAN$$$$$M$Y$$$20240816$$CN$GB$GB
242171831$24217183$1$I$$20240808$20240816$20240816$EXP$$FR-MYLANLABS-2024M1075579$MYLAN$Pattou M, Neuzillet Y, Lebret T, Yonneau L, Madec FX. [Penile necrosis, a specific complication of prostatic artery embolization]. [French]. Prog-Urol 2023; 33 407-411.$75$YR$$M$Y$$$20240816$$HP$FR$FR
242171842$24217184$2$F$$20240914$20240816$20240917$PER$$US-AMGEN-USASP2024162663$AMGEN$$54$YR$A$F$Y$$$20240917$$HP$US$US
242171851$24217185$1$I$$20230918$20240816$20240816$EXP$$ZA-AstraZeneca-2023A213523$ASTRAZENECA$$26$YR$$M$Y$$$20240816$$CN$ZA$
242171861$24217186$1$I$$20240806$20240816$20240816$EXP$$US-MYLANLABS-2024M1074751$MYLAN$Bass AR, Sama ML. Inflammatory arthritis complicating mogamulizumab treatment of Sezary syndrome. Rheumatology 2024; 63 (3): E113-E114.$54$YR$$F$Y$$$20240816$$HP$US$US
242171871$24217187$1$I$$20240719$20240816$20240816$PER$$US-AstraZeneca-2024A165209$ASTRAZENECA$$$$$$Y$$$20240816$$CN$US$
242171881$24217188$1$I$$20240718$20240816$20240816$PER$$US-AstraZeneca-2024A164252$ASTRAZENECA$$$$$$Y$$$20240816$$MD$US$
242171891$24217189$1$I$$20221205$20240816$20240816$EXP$$US-AstraZeneca-2022A402264$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242171901$24217190$1$I$$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184442$ASTRAZENECA$$$$$F$Y$$$20240816$$MD$US$
242171911$24217191$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192243$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242171921$24217192$1$I$$20240812$20240816$20240816$EXP$$IT-GILEAD-2024-0684187$GILEAD$Cicetti D., Vitale S., Appolloni L., Pensalfine G., Traficante M., Caprara R etal. THE USE OF PRE-EXPOSURE PROPHYLAXIS (PREP) IN THE CONTROL OF HIV INFECTION AND OTHER SEXUALLY TRANSMITTED DISEASES (STDS). DESCRIPTIVE-OBSERVATIONAL ANALYSIS IN AN ITALIAN POLYCLINIC. Italian Conference on AIDS and Antiviral Research. 2024;100(1):A221. doi:10.1136/sextrans-ICAR-2024.204$$$A$$Y$$$20240816$$HP$IT$IT
242171931$24217193$1$I$20240721$20240809$20240816$20240816$EXP$$CN-AstraZeneca-2024A185499$ASTRAZENECA$$16$YR$$F$Y$37$KG$20240816$$MD$CN$
242171942$24217194$2$F$$20240814$20240816$20240821$EXP$$CN-009507513-2408CHN004999$MERCK$$74$YR$$M$Y$$$20240821$$MD$CN$CN
242171951$24217195$1$I$20240701$20240806$20240816$20240816$PER$$US-INCYTE CORPORATION-2024IN008285$INCYTE$$$$$$Y$$$20240816$$CN$US$US
242171961$24217196$1$I$$20240807$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024098506$VIIV$$$$$$Y$$$20240816$$HP$US$US
242171971$24217197$1$I$$20240807$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024098605$VIIV$$$$$M$Y$$$20240816$$CN$US$US
242171981$24217198$1$I$$20240814$20240816$20240816$EXP$$FR-BAUSCH-BL-2024-012399$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240816$$MD$FR$FR
242172001$24217200$1$I$20240615$20240809$20240816$20240816$EXP$$CH-AMGEN-CHESP2024158839$AMGEN$$64$YR$A$F$Y$50$KG$20240816$$MD$CH$CH
242172011$24217201$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192292$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242172021$24217202$1$I$20240805$20240813$20240816$20240816$EXP$GB-MHRA-MED-202408100842521440-PTBJR$GB-SANDOZ INC.-SDZ2024GB072504$SANDOZ$$72$YR$$F$Y$63$KG$20240816$$CN$GB$GB
242172031$24217203$1$I$$20240803$20240816$20240816$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462825$RANBAXY$$26$YR$$F$Y$$$20240816$$CN$GB$GB
242172051$24217205$1$I$20240810$20240815$20240815$20240815$DIR$714540$$FDA-CTU$$33$YR$$F$N$62.1$KG$20240815$N$CN$US$
242172061$24217206$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56295$$FDA-CTU$$90$YR$$F$N$$$20240815$N$$US$
242172081$24217208$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56285$$FDA-CTU$$84$YR$$F$N$$$20240815$N$$US$
242172091$24217209$1$I$$20240815$20240815$20240815$DIR$714396$$FDA-CTU$$$$$UNK$N$$$20240815$$CN$US$
242172101$24217210$1$I$$20240815$20240815$20240815$DIR$714411$$FDA-CTU$$34$YR$$M$N$76.23$KG$20240815$N$HP$US$
242172111$24217211$1$I$$20240815$20240815$20240815$DIR$714553$$FDA-CTU$$78$YR$$M$N$66.15$KG$20240815$N$CN$US$
242172121$24217212$1$I$$20240815$20240815$20240815$DIR$714434$$FDA-CTU$$$$$UNK$N$$$20240815$$CN$US$
242172131$24217213$1$I$20240815$20240815$20240815$20240815$DIR$714420$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242172141$24217214$1$I$20240613$20240815$20240815$20240815$DIR$714526$$FDA-CTU$$73$YR$$F$N$113$KG$20240815$N$CN$US$
242172151$24217215$1$I$20240815$20240815$20240815$20240815$DIR$714481$$FDA-CTU$$59$YR$$M$N$117$KG$20240815$N$PH$US$
242172161$24217216$1$I$20240815$20240815$20240815$20240815$DIR$714480$$FDA-CTU$$59$YR$$M$N$117$KG$20240815$N$PH$US$
242172171$24217217$1$I$$20240815$20240815$20240815$DIR$714421$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242172191$24217219$1$I$$20240805$20240816$20240816$EXP$$US-AUROBINDO-AUR-APL-2024-039647$AUROBINDO$Hung E, Face C, Yu DH.. Is Osimertinib the New Medical ICU Miracle Drug? The Role of Osimertinib in Critical Illness for Patients With Metastatic EGFR Mutated Lung Cancer. Am-J-RespirCrit-Care-Med. 2024;209:A6566$33$YR$$F$Y$$$20240816$$HP$US$US
242172201$24217220$1$I$20221226$20240729$20240816$20240816$30DAY$$EG-SANDOZ INC.-SDZ2023EG030260$SANDOZ$$13$YR$$F$Y$40$KG$20240816$$CN$EG$EG
242172212$24217221$2$F$$20240923$20240816$20240926$EXP$$NZ-MYLANLABS-2024M1075132$MYLAN$$$$$M$Y$$$20240926$$CN$NZ$NZ
242172221$24217222$1$I$20240101$20240813$20240816$20240816$PER$$US-JNJFOC-20240834426$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
242172231$24217223$1$I$$20240808$20240816$20240816$PER$$US-JNJFOC-20240838366$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$MD$US$US
242172242$24217224$2$F$$20240906$20240816$20240911$EXP$$JP-GILEAD-2024-0684237$GILEAD$$8$DEC$E$M$Y$$$20240911$$PH$JP$JP
242172251$24217225$1$I$20240528$20240805$20240816$20240816$EXP$$ES-AUROBINDO-AUR-APL-2024-040165$AUROBINDO$$87$YR$$F$Y$82$KG$20240816$$HP$ES$ES
242172261$24217226$1$I$20240813$20240815$20240815$20240815$DIR$714479$$FDA-CTU$$87$YR$$M$N$$$20240815$N$PH$US$
242172271$24217227$1$I$$20240731$20240816$20240816$PER$$US-TEVA-VS-3229602$TEVA$$50$YR$$F$Y$$$20240816$$CN$US$US
242172282$24217228$2$F$20240806$20240820$20240816$20240829$EXP$$JP-RADIUS HEALTH, INC.-2024JP005948$RADIUS PHARM$$62$YR$$F$Y$$$20240828$$PH$JP$JP
242172291$24217229$1$I$20240304$20240815$20240815$20240815$DIR$714525$$FDA-CTU$$78$YR$$M$N$$$20240815$Y$PH$US$
242172301$24217230$1$I$$20240815$20240815$20240815$DIR$714388$$FDA-CTU$$$$$UNK$N$$$20240815$$CN$US$
242172311$24217231$1$I$$20240802$20240816$20240816$PER$$US-GLANDPHARMA-US-2024GLNSPO00602$GLAND PHARMA$$$$$$Y$$$20240816$$CN$US$US
242172321$24217232$1$I$$20240814$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072714$SANDOZ$$80$YR$$F$Y$$$20240816$$PH$CA$CA
242172331$24217233$1$I$20240815$20240815$20240815$20240815$DIR$714445$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242172351$24217235$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192233$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242172362$24217236$2$F$$20240912$20240816$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004045$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
242172371$24217237$1$I$$20240815$20240816$20240816$EXP$$NVSC2024CN166151$NOVARTIS$$72$YR$$M$Y$$$20240816$$CN$CN$CN
242172381$24217238$1$I$$20240814$20240816$20240816$EXP$$US-GILEAD-2024-0684352$GILEAD$$$$$F$Y$$$20240816$$MD$US$US
242172391$24217239$1$I$$20240809$20240816$20240816$EXP$$IN-ROCHE-10000054931$ROCHE$$58$YR$A$F$Y$36.6$KG$20240816$$CN$IN$IN
242172401$24217240$1$I$20240507$20240807$20240816$20240816$EXP$IT-MINISAL02-985775$IT-SAMSUNG BIOEPIS-SB-2024-24083$SAMSUNG BIOEPIS$$62$YR$A$F$Y$68$KG$20240816$$HP$IT$IT
242172411$24217241$1$I$20240215$20240807$20240816$20240816$EXP$ES-AEMPS-1523020$ES-SAMSUNG BIOEPIS-SB-2024-24087$SAMSUNG BIOEPIS$$28$YR$A$M$Y$$$20240816$$PH$ES$ES
242172421$24217242$1$I$20240602$20240812$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127938$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240816$$CN$US$US
242172431$24217243$1$I$$20240813$20240816$20240816$EXP$$US-GILEAD-2024-0684156$GILEAD$$$$$M$Y$$$20240816$$CN$US$US
242172441$24217244$1$I$$20240813$20240816$20240816$PER$$US-BIOGEN-2024BI01278126$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
242172451$24217245$1$I$$20240806$20240816$20240816$PER$$US-INCYTE CORPORATION-2024IN008256$INCYTE$$$$$$Y$$$20240816$$CN$US$US
242172471$24217247$1$I$$20240807$20240816$20240816$PER$$US-JNJFOC-20240831681$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
242172491$24217249$1$I$$20240814$20240816$20240816$EXP$$US-GILEAD-2024-0684384$GILEAD$$$$A$M$Y$$$20240816$$CN$US$US
242172501$24217250$1$I$$20240806$20240816$20240816$PER$$US-INCYTE CORPORATION-2024IN008250$INCYTE$$$$$$Y$$$20240816$$CN$US$US
242172512$24217251$2$F$$20240822$20240816$20240902$EXP$$PL-AUROBINDO-AUR-APL-2024-038107$AUROBINDO$Korzeniowska K.. Anaphylactic shock in a 7-year-old patient treated with cefaclor ? case report and literature review.. FARMACJA WSP??CZESNA.. 2024;(2):135-139$7$YR$$F$Y$18$KG$20240902$$MD$PL$PL
242172521$24217252$1$I$20240131$20240806$20240816$20240816$PER$$US-INCYTE CORPORATION-2024IN008248$INCYTE$$$$$$Y$$$20240816$$CN$US$US
242172532$24217253$2$F$$20240902$20240816$20240911$EXP$$JP-AMGEN-JPNSP2024161642$AMGEN$$$$$$Y$$$20240910$$PH$JP$JP
242172541$24217254$1$I$$20240807$20240816$20240816$EXP$PL-URPL-1-1858-2020$PL-TEVA-VS-3231671$TEVA$$45$YR$$F$Y$75$KG$20240816$$MD$PL$PL
242172551$24217255$1$I$20190619$20240805$20240816$20240816$EXP$$JP-AMGEN-JPNCT2024104206$AMGEN$Saitou Y, Miyate H, Sugai Y, Nakasato H, Miyasawa M. P-1-14 Case series study of medication-related osteonecrosis of the jaw (MRONJ) in the elderly with over 90 years old. The 2nd Annual Meeting of the Young Oral Surgeons Exchange Meeting. 2024;88$90$YR$E$F$Y$$$20240816$$MD$JP$JP
242172561$24217256$1$I$$20240814$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072720$SANDOZ$$33$YR$$F$Y$$$20240816$$HP$CA$CA
242172571$24217257$1$I$20240812$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024161590$AMGEN$$58$YR$A$F$Y$$$20240816$$CN$US$US
242172582$24217258$2$F$20240506$20240911$20240816$20240917$EXP$GB-MHRA-MED-202408072019074410-NTCRP$GB-RDY-SPO/GBR/24/0011777$DR REDDYS$$68$YR$E$F$Y$51$KG$20240917$$MD$GB$GB
242172591$24217259$1$I$$20240620$20240816$20240816$PER$$US-LUNDBECK-DKLU4000787$LUNDBECK$$$$$$Y$$$20240816$$MD$US$US
242172601$24217260$1$I$20240222$20240223$20240816$20240816$PER$$US-RVL_Pharmaceuticals-USA-POI1255202400048$RVL PHARMACEUTICALS$$63$YR$A$F$Y$$$20240816$$$US$US
242172611$24217261$1$I$$20240805$20240816$20240816$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110834$ZYDUS PHARM$Khan S, Reggio C, Shoukat U, Lalwani A, Yousaf Z.. Avoiding Premature Brain Death Declaration in Patients With Suspected Baclofen Overdose.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240816$$HP$US$US
242172621$24217262$1$I$$20240805$20240816$20240816$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110902$ZYDUS PHARM$Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al.. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes.. Blood. 2023;142 (Suppl. 1):5898.$$$$$Y$$$20240816$$MD$US$US
242172631$24217263$1$I$$20240715$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07218$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242172651$24217265$1$I$20240719$20240722$20240816$20240816$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000662$PAREXEL$$$$$$Y$$$20240816$$HP$US$US
242172661$24217266$1$I$$20240806$20240816$20240816$PER$$US-INCYTE CORPORATION-2024IN008247$INCYTE$$$$$$Y$$$20240816$$CN$US$US
242172671$24217267$1$I$$20240807$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR098939$VIIV$$26$YR$$M$Y$$$20240816$$HP$US$US
242172681$24217268$1$I$$20240807$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR099857$VIIV$$47$YR$$M$Y$$$20240816$$HP$US$US
242172691$24217269$1$I$$20240808$20240816$20240816$EXP$$US-GSK-US2024AMR099407$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$HP$US$US
242172701$24217270$1$I$20220101$20240805$20240816$20240816$PER$$US-INCYTE CORPORATION-2024IN008226$INCYTE$$$$$$Y$$$20240816$$CN$US$US
242172712$24217271$2$F$20240814$20240823$20240816$20240827$PER$$US-AMGEN-USASP2024162395$AMGEN$$68$YR$E$M$Y$$$20240827$$MD$US$US
242172731$24217273$1$I$20240815$20240815$20240815$20240815$DIR$714414$$FDA-CTU$$40$YR$$F$N$$$20240815$N$PH$US$
242172741$24217274$1$I$20240628$20240807$20240816$20240816$EXP$GB-MHRA-MED-202408071325151110-FKRTY$GB-TEVA-VS-3231253$TEVA$$69$YR$$M$Y$$$20240816$$MD$GB$GB
242172751$24217275$1$I$$20240808$20240816$20240816$EXP$$RO-BIOCON BIOLOGICS LIMITED-BBL2024005878$BIOCON$Radu CD, Gogirla C, Coverca E, Istratescu D, Meianu C, Lucuta R et al.. Vedolizumab - The key to clinical remission for refractory pouchitis.. J Gastrointestin Liver Dis.. 2024;33 (2):68$$$$$Y$$$20240816$$HP$RO$RO
242172761$24217276$1$I$20220314$20240528$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-2022M1028066$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242172771$24217277$1$I$$20240618$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-2022M1094991$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242172782$24217278$2$F$20240101$20240916$20240816$20240924$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00839$CATALYST PHARMA$$$$$M$Y$27.211$KG$20240924$$CN$US$US
242172791$24217279$1$I$20240101$20240807$20240816$20240816$EXP$FR-AFSSAPS-TS2024000872$FR-TEVA-VS-3231736$TEVA$$71$YR$$M$Y$98$KG$20240816$$MD$FR$FR
242172831$24217283$1$I$20240725$20240812$20240816$20240816$EXP$$GT-AstraZeneca-2024A185694$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$GT$
242172841$24217284$1$I$20230101$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A185031$ASTRAZENECA$$83$YR$$F$Y$$$20240816$$CN$US$
242172851$24217285$1$I$$20240808$20240816$20240816$EXP$$CA-AstraZeneca-2024A181510$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$CA$
242172861$24217286$1$I$20240205$20240805$20240816$20240816$PER$$US-INCYTE CORPORATION-2024IN008225$INCYTE$$$$$$Y$$$20240816$$HP$US$US
242172871$24217287$1$I$20240610$20240810$20240816$20240816$EXP$$MX-AstraZeneca-2024A184783$ASTRAZENECA$$22447$DY$$F$Y$75$KG$20240816$$CN$MX$
242172881$24217288$1$I$$20240809$20240816$20240816$EXP$$IN-AstraZeneca-2024A183459$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$IN$
242172892$24217289$2$F$20240101$20240912$20240816$20240917$EXP$$CA-JNJFOC-20240601577$JOHNSON AND JOHNSON$$22$YR$A$F$Y$62$KG$20240917$$CN$CA$CA
242172911$24217291$1$I$20240628$20240813$20240816$20240816$EXP$$CN-AstraZeneca-2024A185834$ASTRAZENECA$$80$YR$$F$Y$50$KG$20240816$$MD$CN$
242172921$24217292$1$I$$20240812$20240816$20240816$EXP$$GB-AstraZeneca-2024A184811$ASTRAZENECA$$$$$F$Y$$$20240816$$HP$GB$
242172931$24217293$1$I$$20240809$20240816$20240816$PER$$US-EMD Serono-2024043297$EMD SERONO INC$$64$YR$A$F$Y$$$20240816$$CN$US$US
242172941$24217294$1$I$20240513$20240528$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003409$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242172951$24217295$1$I$$20240814$20240816$20240816$EXP$$AU-GILEAD-2024-0684261$GILEAD$$65$YR$E$M$Y$$$20240816$$MD$AU$AU
242172961$24217296$1$I$$20240701$20240816$20240816$PER$$US-LUNDBECK-DKLU4001182$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
242172971$24217297$1$I$$20240812$20240816$20240816$EXP$$US-ABBVIE-5879200$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242172982$24217298$2$F$$20240906$20240816$20240912$EXP$$JP-EMD Serono-2024043138$EMD SERONO INC$$77$YR$E$M$Y$50$KG$20240912$$MD$JP$JP
242172991$24217299$1$I$$20240815$20240816$20240816$EXP$$US-GILEAD-2024-0684404$GILEAD$$$$A$$Y$$$20240816$$MD$US$US
242173001$24217300$1$I$20240329$20240801$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024096987$VIIV$$26$YR$$M$Y$$$20240816$$HP$US$US
242173021$24217302$1$I$20240720$20240721$20240816$20240816$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000663$PAREXEL$$$$$$Y$$$20240816$$CN$US$US
242173031$24217303$1$I$$20240815$20240815$20240815$DIR$714521$$FDA-CTU$$$$$M$N$60.75$KG$20240815$Y$CN$US$
242173041$24217304$1$I$20240718$20240815$20240815$20240815$DIR$714495$$FDA-CTU$$62$YR$$M$N$$$20240815$N$$US$
242173051$24217305$1$I$$20240809$20240816$20240816$EXP$$US-MYLANLABS-2024M1076307$MYLAN$Ali ST, VanderWeele DJ. Prolonged Response to Osimertinib in EGFR-Mutated Metastatic Urothelial Carcinoma, a Case Report. Curr-Oncol 2024; 31 (7): 4015-4021.$48$YR$$F$Y$$$20240816$$HP$US$US
242173061$24217306$1$I$$20240808$20240816$20240816$EXP$$AU-MYLANLABS-2024M1075552$MYLAN$Weetman J, Hayes O. New Diagnosis of Congenital Heart Disease in a 54-Year-Old Male After Presenting With Spontaneous Atrial Flutter With 1:1 AV Conduction: A Case Report. Heart-Lung-Circ 2024; 33 (Suppl.) S498.$54$YR$$M$Y$$$20240816$$HP$AU$AU
242173071$24217307$1$I$$20240809$20240816$20240816$EXP$$US-MYLANLABS-2024M1075832$MYLAN$Bedi R, Das D, Ahmad A, Atallah I, Smart SC, Verma D, et al. Mechanical support as a rescue bridge to tavr in a patient with cardiogenic shock (cs) due to severe as and ar. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3856.$71$YR$$F$Y$$$20240816$$HP$US$US
242173081$24217308$1$I$20240815$20240815$20240815$20240815$DIR$714452$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242173091$24217309$1$I$$20240805$20240816$20240816$EXP$$DE-MYLANLABS-2024M1074831$MYLAN$Bienenstein E, Jakob A, Dalla PR, Fischer M, Haas N. Acute Yew-Intoxication (Taxus baccata): Lessons to Be Learned for Pediatric Cardiologists. Thorac-Cardiovasc-Surg 2024; 72 (Suppl.).$16$YR$$M$Y$$$20240816$$HP$DE$DE
242173101$24217310$1$I$$20240809$20240816$20240816$EXP$$US-MYLANLABS-2024M1075833$MYLAN$Wang KL, Crum OM, Swanson AA, Johnson EF. Cutaneous metastasis of uterine carcinosarcoma mimicking drug eruption. JAAD-Case-Rep 2024; 47 44-46.$71$YR$$F$Y$$$20240816$$MD$US$US
242173121$24217312$1$I$$20240812$20240816$20240816$PER$$US-BAYER-2024A116271$BAYER$$19$YR$A$F$Y$$$20240816$$MD$US$US
242173132$24217313$2$F$20121206$20240826$20240816$20240827$EXP$$DE-SANDOZ INC.-PHHY2014DE051254$SANDOZ$$34$YR$$M$Y$$$20240827$$MD$DE$DE
242173141$24217314$1$I$$20240808$20240816$20240816$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000167$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240816$$CN$US$US
242173151$24217315$1$I$20230501$20240814$20240816$20240816$EXP$$US-ROCHE-3345031$ROCHE$$60$YR$A$F$Y$$$20240816$$MD$US$US
242173161$24217316$1$I$20221201$20240808$20240816$20240816$EXP$SE-SEMPA-2024-005870$SE-TEVA-VS-3231979$TEVA$$$$$F$Y$$$20240816$$CN$SE$SE
242173181$24217318$1$I$20240723$20240814$20240816$20240816$PER$$US-ABBVIE-5881703$ABBVIE$$39$YR$$F$Y$$$20240816$$HP$US$US
242173193$24217319$3$F$$20240821$20240816$20240826$PER$$JP-Eisai-EC-2024-171799$EISAI$$74$YR$E$F$Y$$$20240826$$MD$JP$JP
242173212$24217321$2$F$20240101$20240823$20240816$20240903$EXP$$PE-BAYER-2024A113944$BAYER$$46$YR$A$F$Y$$$20240903$$CN$PE$PE
242173221$24217322$1$I$20240615$20240809$20240816$20240816$EXP$ES-AEMPS-1557576$ES-009507513-2408ESP003495$MERCK$$$$E$F$Y$$$20240816$$PH$ES$ES
242173231$24217323$1$I$$20240807$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR098946$VIIV$$48$YR$$F$Y$$$20240816$$HP$US$US
242173241$24217324$1$I$20240719$20240808$20240816$20240816$EXP$ES-AEMPS-1556169$ES-TEVA-VS-3232438$TEVA$$50$YR$$F$Y$$$20240816$$PH$ES$ES
242173251$24217325$1$I$20240101$20240812$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128066$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240816$$CN$US$US
242173261$24217326$1$I$20240101$20240809$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-086078$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240816$$CN$US$US
242173271$24217327$1$I$$20240629$20240816$20240816$PER$$US-LUNDBECK-DKLU4001064$LUNDBECK$$$$$$Y$$$20240816$$HP$US$US
242173283$24217328$3$F$$20240923$20240816$20240926$EXP$$CA-SANDOZ INC.-SDZ2024CA072202$SANDOZ$$40$YR$$F$Y$$$20240926$$HP$CA$CA
242173291$24217329$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56289$$FDA-CTU$$77$YR$$F$N$$$20240815$N$$US$
242173301$24217330$1$I$$20240814$20240815$20240815$DIR$FDA-CDER-CTU-2024-56311$$FDA-CTU$$$$$M$N$$$20240814$N$HP$US$
242173311$24217331$1$I$20240815$20240815$20240815$20240815$DIR$714441$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242173321$24217332$1$I$$20240815$20240815$20240815$DIR$714527$$FDA-CTU$$$$$F$N$84.6$KG$20240815$N$HP$US$
242173351$24217335$1$I$20230901$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56290$$FDA-CTU$$76$YR$$M$N$104$KG$20240815$N$PH$US$
242173361$24217336$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56326$$FDA-CTU$$63$YR$$F$N$$$20240815$N$$US$
242173371$24217337$1$I$20240810$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56306$$FDA-CTU$$21$YR$$M$N$$$20240815$N$$US$
242173381$24217338$1$I$20240810$20240814$20240815$20240815$DIR$FDA-CDER-CTU-2024-56310$$FDA-CTU$$60$YR$$F$N$$$20240814$N$HP$US$
242173392$24217339$2$F$20240101$20240812$20240816$20240822$PER$$US-AMGEN-USASP2024160654$AMGEN$$59$YR$A$F$Y$$$20240822$$CN$US$US
242173401$24217340$1$I$20240806$20240812$20240816$20240816$EXP$$US-BAYER-2024A116852$BAYER$$38$YR$A$F$Y$$$20240816$$MD$US$US
242173411$24217341$1$I$20240615$20240807$20240816$20240816$30DAY$$US-GSK-US2024098537$GLAXOSMITHKLINE$$92$YR$$F$Y$$$20240816$$CN$US$US
242173421$24217342$1$I$$20240807$20240816$20240816$30DAY$$US-GSK-US2024AMR098979$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$US$US
242173433$24217343$3$F$$20240829$20240816$20240907$EXP$$CA-CELLTRION INC.-2023CA024375$CELLTRION$$$$$$Y$$$20240907$$CN$CA$CA
242173441$24217344$1$I$$20240701$20240816$20240816$PER$$US-LUNDBECK-DKLU4001183$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
242173452$24217345$2$F$$20240814$20240816$20240816$PER$$US-GILEAD-2024-0684292$GILEAD$$49$YR$A$F$Y$$$20240816$$MD$US$US
242173461$24217346$1$I$20240716$20240807$20240816$20240816$EXP$$CN-009507513-2408CHN003548$MERCK$$61$YR$$M$Y$80$KG$20240816$$HP$CN$CN
242173481$24217348$1$I$20240719$20240722$20240816$20240816$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000664$PAREXEL$$$$$$Y$$$20240816$$PH$US$US
242173491$24217349$1$I$$20240806$20240816$20240816$EXP$$US-TEVA-VS-3232340$TEVA$$21$YR$$$Y$$$20240816$$CN$US$US
242173501$24217350$1$I$20240617$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024162593$AMGEN$$75$YR$E$$Y$$$20240816$$CN$US$US
242173511$24217351$1$I$20240809$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024161861$AMGEN$$67$YR$E$M$Y$$$20240816$$CN$US$US
242173521$24217352$1$I$$20240813$20240816$20240816$EXP$$US-AMGEN-USASP2024161538$AMGEN$Cherian S.; Modelevsky L.; Reiner A. S. et al.. Treatment of methotrexate-refractory primary central nervous system lymphoma (PCNSL) at Memorial Sloan Kettering Cancer Center. Leukemia + Lymphoma. 2024;65 (8):1194-1197$$$$$Y$$$20240816$$HP$US$US
242173531$24217353$1$I$$20240701$20240816$20240816$PER$$US-LUNDBECK-DKLU4001310$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
242173541$24217354$1$I$$20240715$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07209$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242173552$24217355$2$F$$20240904$20240816$20240912$30DAY$$CA-JNJFOC-20240819790$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$PH$CA$CA
242173561$24217356$1$I$20240101$20240812$20240816$20240816$EXP$$BY-BAYER-2024A116927$BAYER$$43$YR$A$F$Y$$$20240816$$MD$BY$BY
242173571$24217357$1$I$$20240812$20240816$20240816$EXP$GB-MHRA-MED-202408121616211700-JCZFP$GB-PFIZER INC-202400234861$PFIZER$$44$YR$$F$Y$$$20240816$$PH$GB$GB
242173601$24217360$1$I$$20240815$20240816$20240816$PER$$US-GILEAD-2024-0684386$GILEAD$$$$E$M$Y$$$20240816$$PH$US$US
242173612$24217361$2$F$$20240816$20240816$20240821$PER$$US-AMGEN-USASP2024162399$AMGEN$$$$$M$Y$$$20240821$$CN$US$US
242173621$24217362$1$I$20240714$20240807$20240816$20240816$EXP$FR-AFSSAPS-BS2024000474$FR-TEVA-VS-3231723$TEVA$$21$YR$$M$Y$$$20240816$$MD$FR$FR
242173635$24217363$5$F$$20240922$20240816$20240923$30DAY$$US-PFIZER INC-PV202400105007$PFIZER$$$$$F$Y$$$20240923$$CN$US$US
242173642$24217364$2$F$20240423$20240821$20240816$20240826$30DAY$$US-PFIZER INC-PV202400072413$PFIZER$$$$$$Y$$$20240826$$HP$US$US
242173651$24217365$1$I$$20240806$20240816$20240816$EXP$$US-ROCHE-10000050831$ROCHE$$68$YR$E$M$Y$$$20240816$$CN$US$US
242173661$24217366$1$I$20220207$20240813$20240816$20240816$EXP$FR-AFSSAPS-AN20220706$FR-SANDOZ INC.-NVSC2022FR059232$SANDOZ$$78$YR$$F$Y$58$KG$20240816$$PH$FR$FR
242173671$24217367$1$I$$20240807$20240816$20240816$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07608$HIKMA$$$$$F$Y$$$20240816$$CN$US$US
242173681$24217368$1$I$$20240802$20240816$20240816$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67082$HIKMA$Guntaka S, Barron C, Baer T, Cohen L, Regelmann M. Dexamethasone swish and spit, a cause of iatrogenic adrenal insufficiency. Hormone Research in Paediatrics. 2023;96:13-14$14$YR$$M$Y$$$20240816$$MD$US$US
242173701$24217370$1$I$20240803$20240805$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408003249$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240816$$CN$US$US
242173711$24217371$1$I$20240625$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56324$$FDA-CTU$$57$YR$$M$N$$$20240815$Y$HP$US$
242173721$24217372$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56299$$FDA-CTU$$60$YR$$F$N$$$20240815$N$$US$
242173731$24217373$1$I$$20240808$20240816$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-JPN-20210103933$BRISTOL MYERS SQUIBB$Tanaka S, Asakawa R, Komuta K, Tanizaki S, Kanai T, Kuroyama M, et al. A case of simultaneous occurrence of hepatitis and pancreatitis during the combination immunochemotherapy for non-small cell lung carcinoma. Respiratory Medicine Case Reports. 2020;31:1-4. doi:10.1016/j.rmcr.2020.101266.$65$YR$E$M$Y$$$20240816$$MD$JP$JP
242173741$24217374$1$I$$20240815$20240816$20240816$EXP$GB-MHRA-TPP21929512C6827883YC1723650273416$GB-SANDOZ INC.-SDZ2024GB073019$SANDOZ$$81$YR$$F$Y$65$KG$20240816$$PH$GB$GB
242173751$24217375$1$I$20240501$20240809$20240816$20240816$EXP$FR-AFSSAPS-AVGR2024000142$FR-Waylis Therapeutics LLC-ATNAHS20240802317$Waylis$$14$YR$T$M$Y$$$20240815$$MD$FR$FR
242173761$24217376$1$I$20240716$20240815$20240816$20240816$EXP$$CN-ROCHE-10000058646$ROCHE$$73$YR$E$M$Y$60.5$KG$20240816$$HP$CN$CN
242173771$24217377$1$I$$20240811$20240816$20240816$EXP$$US-AMGEN-USASP2024162319$AMGEN$Iyer S P.; Jagadeesh D.; Domingo-domenech E. et al.. Frontline brentuximab vedotin and CHP (A+CHP) in patients (pts) with peripheral T-cell lymphoma with less than 10% CD30 expression- Results from the phase 2 SGN35-032 study. Journal of Clinical Oncology. 2024;42 (16):7069$$$$$Y$$$20240816$$HP$US$US
242173781$24217378$1$I$20240101$20240808$20240816$20240816$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000166$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240816$$CN$US$US
242173791$24217379$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192298$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242173801$24217380$1$I$$20240701$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004912$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242173811$24217381$1$I$$20240705$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003657$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242173821$24217382$1$I$$20240521$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003662$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242173831$24217383$1$I$$20240624$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004698$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242173841$24217384$1$I$$20240713$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004702$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242173851$24217385$1$I$$20240624$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004712$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242173861$24217386$1$I$$20240701$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004810$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242173871$24217387$1$I$$20240626$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004850$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242173881$24217388$1$I$$20240705$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004906$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242173891$24217389$1$I$20240628$20240628$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004871$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242173901$24217390$1$I$20240401$20240809$20240816$20240816$EXP$$US-GSK-US2024099721$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$US$US
242173921$24217392$1$I$20240611$20240625$20240816$20240816$EXP$$CA-CELLTRION INC.-2022CA022776$CELLTRION$$$$$$Y$$$20240816$$MD$CA$CA
242173931$24217393$1$I$20240606$20240815$20240816$20240816$EXP$$US-ROCHE-10000059010$ROCHE$$44$YR$A$F$Y$$$20240816$$CN$US$US
242173941$24217394$1$I$$20240815$20240816$20240816$PER$$US-ROCHE-10000059260$ROCHE$$$$$F$Y$$$20240816$$CN$US$US
242173951$24217395$1$I$20240717$20240722$20240816$20240816$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000665$PAREXEL$$$$$$Y$$$20240816$$PH$US$US
242173962$24217396$2$F$$20240820$20240816$20240823$EXP$US-MLMSERVICE-20240603-PI086146-00275-1$US-SANDOZ INC.-SDZ2024US072788$SANDOZ$$18$YR$$M$Y$65.5$KG$20240823$$MD$US$US
242173971$24217397$1$I$$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2022-045097$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240816$$CN$US$US
242173981$24217398$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129368$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240816$$HP$US$US
242173991$24217399$1$I$$20240814$20240816$20240816$EXP$$ZA-ROCHE-10000058498$ROCHE$$$$E$F$Y$$$20240816$$MD$ZA$ZA
242174002$24217400$2$F$20240809$20240830$20240816$20240830$PER$$US-ALXN-202408USA000676US$ALEXION PHARMACEUTICALS$$48$YR$$F$Y$$$20240830$$CN$US$US
242174011$24217401$1$I$$20240811$20240816$20240816$EXP$$US-AMGEN-USASP2024162330$AMGEN$Iyer S P.; Jagadeesh D.; Domingo-domenech E. et al.. Frontline brentuximab vedotin and CHP (A+CHP) in patients (pts) with peripheral Tcell lymphoma with less than 10% CD30 expression- Results from the phase 2 SGN35-032 study. Journal of Clinical Oncology. 2024;42 (16):7069$$$$$Y$$$20240816$$HP$US$US
242174021$24217402$1$I$20240814$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162067$AMGEN$$65$YR$E$F$Y$$$20240816$$CN$US$US
242174041$24217404$1$I$20240101$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161479$AMGEN$$75$YR$E$F$Y$$$20240816$$HP$US$US
242174051$24217405$1$I$$20240802$20240816$20240816$PER$$US-JNJFOC-20240809619$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$US$US
242174061$24217406$1$I$$20240811$20240816$20240816$EXP$$US-AMGEN-USASP2024162528$AMGEN$Dalia T.; Goyal A.; Jakulla R. S. et al.. Myasthenia Crisis Complicated with Takotsubo Cardiomyopathy. US Cardiology Review. 2024;18 (SUPPL1):7-8$77$YR$E$F$Y$$$20240816$$HP$US$US
242174081$24217408$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56363$$FDA-CTU$$82$YR$$M$N$$$20240815$N$$US$
242174091$24217409$1$I$20240813$20240815$20240815$20240815$DIR$714531$$FDA-CTU$$55$YR$$M$N$132.75$KG$20240815$N$CN$US$
242174101$24217410$1$I$$20240815$20240815$20240815$DIR$714488$$FDA-CTU$$$$$UNK$N$$$20240815$$CN$US$
242174111$24217411$1$I$20240812$20240815$20240815$20240815$DIR$714509$$FDA-CTU$$48$YR$$F$N$$$20240815$Y$PH$US$
242174121$24217412$1$I$20240815$20240815$20240815$20240815$DIR$714551$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242174131$24217413$1$I$$20240731$20240816$20240816$PER$$US-TEVA-VS-3228871$TEVA$$54$YR$$M$Y$$$20240816$$PH$US$US
242174143$24217414$3$F$20200714$20240923$20240816$20240925$EXP$$US-PFIZER INC-2020000965$PFIZER$$69$YR$$F$Y$56.25$KG$20240925$$CN$US$US
242174151$24217415$1$I$20240101$20240813$20240816$20240816$EXP$$KR-PFIZER INC-PV202400106016$PFIZER$$8$YR$$F$Y$$$20240816$$HP$KR$KR
242174161$24217416$1$I$20240805$20240809$20240815$20240815$DIR$FDA-CDER-CTU-2024-56294$$FDA-CTU$$32$YR$$F$N$$$20240809$N$HP$US$
242174171$24217417$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56320$$FDA-CTU$$63$YR$$F$N$$$20240815$N$$US$
242174191$24217419$1$I$20240801$20240806$20240816$20240816$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-00862$CATALYST PHARMA$$60$YR$$M$Y$$$20240816$$CN$US$US
242174201$24217420$1$I$20240801$20240806$20240816$20240816$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-00861$CATALYST PHARMA$$36$YR$$M$Y$$$20240816$$CN$US$US
242174211$24217421$1$I$20240608$20240813$20240816$20240816$EXP$$US-BAYER-2024A116871$BAYER$$25$YR$A$M$Y$$$20240816$$CN$US$US
242174231$24217423$1$I$$20240730$20240816$20240816$EXP$$US-SANDOZ INC.-SDZ2024US072804$SANDOZ$$$$$M$Y$$$20240816$$MD$US$US
242174241$24217424$1$I$$20240813$20240816$20240816$EXP$$NVSC2024US165128$NOVARTIS$$44$YR$$F$Y$$$20240816$$HP$US$US
242174251$24217425$1$I$$20240813$20240816$20240816$PER$$US-BAYER-2024A117577$BAYER$$34$YR$A$F$Y$$$20240816$$MD$US$US
242174262$24217426$2$F$$20240823$20240816$20240901$30DAY$$US-GSK-US2024AMR098310$GLAXOSMITHKLINE$$$$$M$Y$$$20240901$$CN$US$US
242174271$24217427$1$I$20240712$20240723$20240816$20240816$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000680$PAREXEL$$$$$$Y$$$20240816$$HP$US$US
242174281$24217428$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129220$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240816$$CN$US$US
242174292$24217429$2$F$20210727$20240918$20240816$20240928$EXP$$GB-CELLTRION INC.-2024GB019471$CELLTRION$$$$$$Y$$$20240928$$MD$GB$GB
242174301$24217430$1$I$20231214$20240815$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129907$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240816$$CN$US$US
242174311$24217431$1$I$$20240811$20240816$20240816$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-127879$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240816$$MD$IL$IL
242174322$24217432$2$F$20240715$20240821$20240816$20240826$PER$$US-BAYER-2024A117630$BAYER$$32$YR$A$F$Y$$$20240826$$MD$US$US
242174331$24217433$1$I$20240718$20240815$20240816$20240816$EXP$$CA-BEIGENE-BGN-2024-012763$BEIGENE$$$$$$Y$$$20240816$$PH$CA$CA
242174341$24217434$1$I$$20240807$20240816$20240816$EXP$$JP-BAYER-2024A085676$BAYER$$74$YR$E$M$Y$$$20240816$$MD$JP$JP
242174351$24217435$1$I$$20240811$20240816$20240816$EXP$$US-AMGEN-USASP2024159977$AMGEN$Zisa D.; Zhang-sun J.; Christos P. J. et al.. Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares. Lupus. 2024;33 (9):938-947$19$YR$A$F$Y$$$20240816$$HP$US$US
242174361$24217436$1$I$$20240802$20240816$20240816$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07434$HIKMA$$64$YR$$F$Y$$$20240816$$HP$CA$CA
242174371$24217437$1$I$$20240814$20240816$20240816$PER$$US-ROCHE-10000057156$ROCHE$$74$YR$E$F$Y$$$20240816$$MD$US$US
242174381$24217438$1$I$$20240813$20240816$20240816$EXP$$ES-Bion-013684$BIONPHARMA$$59$YR$A$F$Y$$$20240816$$HP$ES$ES
242174391$24217439$1$I$$20240813$20240816$20240816$EXP$$IT-Bion-013683$BIONPHARMA$$$$A$M$Y$$$20240816$$HP$IT$IT
242174401$24217440$1$I$20240521$20240815$20240816$20240816$EXP$$JP-DSJP-DSJ-2024-137805AA$DAIICHI$$58$YR$$F$Y$36.3$KG$20240816$$MD$JP$JP
242174421$24217442$1$I$20240726$20240731$20240816$20240816$PER$$US-TEVA-VS-3228894$TEVA$$62$YR$$F$Y$$$20240816$$CN$US$US
242174431$24217443$1$I$20220220$20240813$20240816$20240816$EXP$$FR-AstraZeneca-2024A184226$ASTRAZENECA$$59$YR$$M$Y$93$KG$20240816$$MD$FR$
242174441$24217444$1$I$$20240812$20240816$20240816$EXP$$JP-Bion-013674$BIONPHARMA$$9$YR$C$F$Y$$$20240816$$HP$JP$JP
242174451$24217445$1$I$$20240812$20240816$20240816$EXP$$US-Bion-013673$BIONPHARMA$$41$YR$A$F$Y$$$20240816$$HP$US$US
242174462$24217446$2$F$20240701$20240820$20240816$20240827$EXP$$AR-SANDOZ INC.-SDZ2024AR072767$SANDOZ$$52$YR$$F$Y$$$20240827$$CN$AR$AR
242174471$24217447$1$I$$20240814$20240816$20240816$PER$$US-ROCHE-10000057926$ROCHE$$77$YR$E$F$Y$$$20240816$$CN$US$US
242174481$24217448$1$I$$20240812$20240816$20240816$EXP$$US-Bion-013675$BIONPHARMA$$35$YR$A$F$Y$$$20240816$$HP$US$US
242174491$24217449$1$I$$20240813$20240816$20240816$EXP$GB-MHRA-MIDB-0575d771-8d4d-4fc3-9015-01765a334cc3$GB-MYLANLABS-2024M1075779$MYLAN$$66$YR$$F$Y$$$20240816$$PH$GB$GB
242174502$24217450$2$F$20240813$20240914$20240816$20240918$EXP$$AR-MYLANLABS-2024M1076212$MYLAN$$54$YR$$F$Y$$$20240918$$CN$AR$AR
242174511$24217451$1$I$$20240809$20240816$20240816$EXP$$US-Bion-013678$BIONPHARMA$$$$$F$Y$$$20240816$$CN$US$US
242174522$24217452$2$F$$20240905$20240816$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004113$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242174532$24217453$2$F$$20240819$20240816$20240823$PER$$US-ALXN-202408USA000533US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
242174551$24217455$1$I$$20240803$20240816$20240816$EXP$GB-MHRA-MED-202408031111078320-RZWSQ$GB-LUPIN PHARMACEUTICALS INC.-2024-07817$LUPIN$$26$YR$$F$Y$$$20240816$$CN$GB$GB
242174561$24217456$1$I$$20240809$20240816$20240816$EXP$$RU-ADVANZ PHARMA-202407006754$ADVANZ PHARMA$$$$$$Y$$$20240816$$HP$RU$RU
242174571$24217457$1$I$$20240815$20240816$20240816$EXP$$US-GILEAD-2024-0684406$GILEAD$$$$A$M$Y$$$20240816$$MD$US$US
242174611$24217461$1$I$20240809$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56313$$FDA-CTU$$64$YR$$M$N$59.4$KG$20240815$N$$US$
242174631$24217463$1$I$20240802$20240809$20240816$20240816$DIR$FDA-CDER-CTU-2024-56315$$FDA-CTU$$$$$M$N$84.5$KG$20240809$N$$US$
242174641$24217464$1$I$20240814$20240815$20240815$20240815$DIR$714500$$FDA-CTU$$72$YR$$F$N$94.5$KG$20240815$N$CN$US$
242174652$24217465$2$F$$20240917$20240816$20240923$EXP$$IN-VANTIVE-2024VAN018991$Vantive US Healthcare$$83$YR$$M$Y$$$20240923$$CN$IN$IN
242174661$24217466$1$I$$20240807$20240816$20240816$EXP$$US-SA-2024SA239071$SANOFI AVENTIS$$58$YR$A$F$Y$50.8$KG$20240816$$CN$US$US
242174673$24217467$3$F$$20240820$20240816$20240827$EXP$JP-MLMSERVICE-20240805-PI151933-00103-1$JP-SA-2024SA240745$SANOFI AVENTIS$$73$YR$E$F$Y$57$KG$20240827$$MD$JP$JP
242174681$24217468$1$I$20240101$20240808$20240816$20240816$EXP$$US-SA-2024SA241202$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240816$$MD$US$MX
242174691$24217469$1$I$20240101$20240808$20240816$20240816$EXP$$IL-SA-2024SA240118$SANOFI AVENTIS$$$$E$F$Y$$$20240816$$CN$IL$IL
242174721$24217472$1$I$20240101$20240809$20240816$20240816$EXP$FR-AFSSAPS-GR2024000973$FR-SA-2024SA238421$SANOFI AVENTIS$$21$YR$A$M$Y$64$KG$20240816$$PH$FR$FR
242174731$24217473$1$I$20240719$20240808$20240816$20240816$EXP$$CN-SA-2024SA241637$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240816$$HP$CN$CN
242174751$24217475$1$I$20240804$20240809$20240816$20240816$EXP$$CN-SA-2024SA241198$SANOFI AVENTIS$$69$YR$E$M$Y$75$KG$20240816$$HP$CN$CN
242174761$24217476$1$I$20240812$20240813$20240816$20240816$EXP$$AU-SA-2024SA242068$SANOFI AVENTIS$$$$$F$Y$$$20240816$$CN$AU$AU
242174771$24217477$1$I$$20240808$20240816$20240816$EXP$$US-SA-2024SA240876$SANOFI AVENTIS$$$$T$F$Y$33$KG$20240816$$MD$US$US
242174781$24217478$1$I$20240801$20240810$20240816$20240816$EXP$$CN-SA-2024SA242216$SANOFI AVENTIS$$73$YR$E$F$Y$36$KG$20240816$$HP$CN$CN
242174801$24217480$1$I$20240718$20240807$20240816$20240816$EXP$$CN-SA-2024SA240873$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240816$$HP$CN$CN
242174833$24217483$3$F$20240812$20240909$20240816$20240918$EXP$$US-GSK-US2024099176$GLAXOSMITHKLINE$$81$YR$$F$Y$$$20240918$$HP$US$US
242174841$24217484$1$I$$20240807$20240816$20240816$EXP$$IE-AMGEN-IRLSP2024159986$AMGEN$Grechin, C.. Tumour necrosis factor-alpha-induced lupus panniculitis: one case report and literature review. British Journal of Dermatology. 2024;192(Suppleme 1):i17$62$YR$A$F$Y$$$20240816$$HP$IE$IE
242174851$24217485$1$I$$20240806$20240816$20240816$EXP$$US-APOTEX-2024AP009162$APOTEX$Lee IJ, Pulido JS, Regillo CD, Leys M. MULTIPLE ORGAN DYSFUNCTION SYNDROME AND DISSEMINATED INTRAVASCULAR COAGULATION CAUSING EXTENSIVE MULTIPLE AMALRIC TRIANGULAR CHOROIDAL INFARCTIONS. RETINAL CASES + BRIEF REPORTS. 2024;18 (2):251-254$49$YR$$F$Y$$$20240816$$MD$US$US
242174861$24217486$1$I$$20240808$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126176$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240816$$CN$US$US
242174871$24217487$1$I$$20240812$20240816$20240816$PER$$US-MYLANLABS-2024M1075292$MYLAN$$$$$F$Y$172$KG$20240816$$CN$US$US
242174881$24217488$1$I$$20240808$20240816$20240816$PER$$US-MYLANLABS-2024M1075052$MYLAN$$$$$$Y$$$20240816$$CN$US$US
242174891$24217489$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127787$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240816$$CN$US$US
242174901$24217490$1$I$$20240802$20240816$20240816$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07845$LUPIN$Elsayed M. An interesting case of drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis with pulmonary and renal involvement. American Journal of Respiratory and Critical Care Medicine. 2024;209:A5780 ((plus poster)$75$YR$$M$Y$$$20240816$$HP$US$US
242174912$24217491$2$F$20240809$20240828$20240816$20240902$EXP$$NVSC2024AT164420$NOVARTIS$$35$YR$$F$Y$$$20240902$$MD$AT$AT
242174921$24217492$1$I$20240801$20240812$20240816$20240816$PER$$US-BAYER-2024A112610$BAYER$$34$YR$A$F$Y$$$20240816$$HP$US$US
242174931$24217493$1$I$20240809$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408006589$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240816$$CN$US$US
242174941$24217494$1$I$$20240812$20240816$20240816$PER$$US-BAYER-2024A116101$BAYER$$24$YR$A$F$Y$$$20240816$$CN$US$US
242174951$24217495$1$I$20240701$20240807$20240816$20240816$EXP$$RO-AMGEN-ROUSP2024158390$AMGEN$$64$YR$A$F$Y$$$20240816$$PH$RO$RO
242174961$24217496$1$I$$20240812$20240816$20240816$EXP$$CA-JNJFOC-20240838603$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240816$$HP$CA$CA
242174971$24217497$1$I$20240101$20240805$20240816$20240816$EXP$SE-SEMPA-2024-005806$SE-GLENMARK PHARMACEUTICALS-2024GMK093168$GLENMARK$$$$$$Y$$$20240816$$HP$SE$SE
242174982$24217498$2$F$20240731$20240924$20240816$20240927$PER$$US-AMGEN-USASP2024160131$AMGEN$$56$YR$A$F$Y$71.882$KG$20240927$$PH$US$US
242174991$24217499$1$I$$20240811$20240816$20240816$EXP$$US-AMGEN-USASP2024159800$AMGEN$Diorio C.; Hernandez-miyares L.; Espinoza D. A. et al.. Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents. Blood. 2024;1-32$7$YR$C$M$Y$$$20240816$$MD$US$US
242175001$24217500$1$I$$20240807$20240816$20240816$EXP$$IN-ROCHE-3347489$ROCHE$$65$YR$E$M$Y$75.3$KG$20240816$$MD$IN$IN
242175011$24217501$1$I$$20240812$20240816$20240816$PER$$US-BAYER-2024A116476$BAYER$$42$YR$A$F$Y$$$20240816$$CN$US$US
242175021$24217502$1$I$$20240802$20240816$20240816$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07436$HIKMA$$64$YR$$M$Y$$$20240816$$HP$CA$CA
242175034$24217503$4$F$$20240917$20240816$20240918$PER$$US-ALXN-202408USA000377US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
242175041$24217504$1$I$$20240815$20240815$20240815$DIR$714483$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242175051$24217505$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56460$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242175061$24217506$1$I$$20240808$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125982$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240816$$HP$US$US
242175071$24217507$1$I$$20240812$20240816$20240816$PER$$US-BAYER-2024A116503$BAYER$$$$$F$Y$$$20240816$$CN$US$US
242175081$24217508$1$I$$20240806$20240816$20240816$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-00865$CATALYST PHARMA$$$$$M$Y$$$20240816$$CN$US$US
242175091$24217509$1$I$20240806$20240807$20240816$20240816$PER$$US-ABBVIE-5873810$ABBVIE$$53$YR$$M$Y$$$20240816$$CN$US$US
242175101$24217510$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024162418$AMGEN$$$$$$Y$$$20240816$$CN$US$US
242175112$24217511$2$F$20240801$20240820$20240816$20240826$PER$$US-AMGEN-USASP2024162480$AMGEN$$75$YR$E$F$Y$$$20240825$$MD$US$US
242175121$24217512$1$I$20230917$20240812$20240816$20240816$EXP$FR-AFSSAPS-PP2024000887$FR-PFIZER INC-202400234541$PFIZER$$23$YR$$F$Y$60$KG$20240816$$PH$FR$FR
242175131$24217513$1$I$$20240814$20240816$20240816$EXP$$CA-PFIZER INC-202400236716$PFIZER$$39$YR$$M$Y$$$20240816$$CN$CA$CA
242175141$24217514$1$I$$20240807$20240816$20240816$EXP$$CA-TEVA-VS-3232250$TEVA$$72$YR$$M$Y$79$KG$20240816$$HP$CA$CA
242175151$24217515$1$I$20240807$20240813$20240816$20240816$EXP$GB-MHRA-MED-202408081158340560-CGTMZ$GB-PFIZER INC-202400235473$PFIZER$$57$YR$$M$Y$$$20240816$$HP$GB$GB
242175162$24217516$2$F$$20240821$20240816$20240823$EXP$$GB-PFIZER INC-202400237163$PFIZER$$$$$M$Y$$$20240823$$HP$GB$GB
242175171$24217517$1$I$20200929$20240807$20240816$20240816$EXP$$US-PFIZER INC-PV202300022139$PFIZER$$77$YR$$F$Y$63.22$KG$20240816$$HP$US$US
242175181$24217518$1$I$20240101$20240813$20240816$20240816$EXP$GB-MHRA-MED-202408131405064460-JNKSH$GB-PFIZER INC-202400235689$PFIZER$$42$YR$$F$Y$$$20240816$$PH$GB$GB
242175191$24217519$1$I$20050101$20240813$20240816$20240816$EXP$$US-PFIZER INC-202400235844$PFIZER$$40$YR$$M$Y$$$20240816$$CN$US$US
242175202$24217520$2$F$20240101$20240910$20240816$20240912$EXP$$CA-PFIZER INC-202400237023$PFIZER$$9$YR$$F$Y$$$20240912$$HP$CA$CA
242175221$24217522$1$I$20220416$20240812$20240816$20240816$EXP$$IT-PFIZER INC-202400234378$PFIZER$$76$YR$$M$Y$66$KG$20240816$$HP$IT$IT
242175231$24217523$1$I$20230501$20240813$20240816$20240816$EXP$$CA-PFIZER INC-202300206848$PFIZER$$60$YR$$F$Y$$$20240816$$HP$CA$CA
242175241$24217524$1$I$20240727$20240814$20240816$20240816$EXP$$CN-PFIZER INC-PV202400106073$PFIZER$$20$YR$$F$Y$$$20240816$$HP$CN$CN
242175251$24217525$1$I$$20240814$20240816$20240816$EXP$$US-PFIZER INC-202400237285$PFIZER$$67$YR$$F$Y$$$20240816$$CN$US$US
242175261$24217526$1$I$20230401$20240812$20240816$20240816$EXP$$AT-PFIZER INC-202400234442$PFIZER$$70$YR$$F$Y$60$KG$20240816$$MD$AT$AT
242175271$24217527$1$I$$20240814$20240816$20240816$EXP$$GB-PFIZER INC-202400236895$PFIZER$$68$YR$$F$Y$$$20240816$$CN$GB$GB
242175281$24217528$1$I$$20240814$20240816$20240816$EXP$$US-PFIZER INC-PV202400106450$PFIZER$$83$YR$$F$Y$$$20240816$$HP$US$US
242175291$24217529$1$I$20240711$20240814$20240816$20240816$EXP$ES-AEMPS-1560026$ES-PFIZER INC-202400236379$PFIZER$$58$YR$$F$Y$$$20240816$$HP$ES$ES
242175301$24217530$1$I$20240809$20240812$20240816$20240816$EXP$GB-MHRA-MED-202408121620151650-FLGZT$GB-PFIZER INC-202400234860$PFIZER$$49$YR$$F$Y$$$20240816$$HP$GB$GB
242175311$24217531$1$I$$20240812$20240816$20240816$EXP$$CA-PFIZER INC-202400235764$PFIZER$$31$YR$$F$Y$71$KG$20240816$$MD$CA$CA
242175321$24217532$1$I$$20240814$20240816$20240816$EXP$$US-PFIZER INC-202400237507$PFIZER$$64$YR$$M$Y$$$20240816$$HP$US$US
242175331$24217533$1$I$20240801$20240815$20240816$20240816$EXP$$US-PFIZER INC-202400237634$PFIZER$$$$$F$Y$$$20240816$$CN$US$US
242175341$24217534$1$I$20240514$20240813$20240816$20240816$EXP$$CN-PFIZER INC-PV202400105528$PFIZER$$61$YR$$M$Y$65.9$KG$20240816$$HP$CN$CN
242175351$24217535$1$I$$20240814$20240816$20240816$EXP$$US-PFIZER INC-202400237298$PFIZER$$$$$$Y$$$20240816$$CN$US$US
242175361$24217536$1$I$20240803$20240815$20240816$20240816$EXP$$CN-PFIZER INC-PV202400106749$PFIZER$$29$YR$$F$Y$78$KG$20240816$$HP$CN$CN
242175371$24217537$1$I$$20240812$20240816$20240816$EXP$$IE-UCBSA-2024040746$UCB$Grechin C, Doheny J, Pilson K, Howard D, Roche M. Tumour necrosis factor-?-induced lupus panniculitis: one case report and literature review. British Journal of Dermatology. 2024;192 (1):i17$62$YR$$F$Y$$$20240816$$HP$IE$IE
242175381$24217538$1$I$20240801$20240812$20240816$20240816$EXP$$CN-PFIZER INC-PV202400104866$PFIZER$$48$YR$$F$Y$48$KG$20240816$$HP$CN$CN
242175392$24217539$2$F$20200101$20240821$20240816$20240826$EXP$$HN-PFIZER INC-202400237167$PFIZER$$79$YR$$F$Y$73.48$KG$20240826$$CN$HN$HN
242175401$24217540$1$I$20220101$20240813$20240816$20240816$EXP$ES-AEMPS-1464564$ES-PFIZER INC-202400235298$PFIZER$$$$A$F$Y$68$KG$20240816$$CN$ES$ES
242175431$24217543$1$I$$20240813$20240816$20240816$EXP$$AR-PFIZER INC-202400236472$PFIZER$$65$YR$$M$Y$$$20240816$$CN$AR$AR
242175441$24217544$1$I$20240701$20240812$20240816$20240816$EXP$FR-AFSSAPS-RN2024000868$FR-PFIZER INC-202400234449$PFIZER$$76$YR$$M$Y$$$20240816$$MD$FR$FR
242175451$24217545$1$I$20240814$20240815$20240816$20240816$EXP$$AU-PFIZER INC-202400237233$PFIZER$$83$YR$$M$Y$$$20240816$$HP$AU$AU
242175462$24217546$2$F$$20240822$20240816$20240823$EXP$$GB-PFIZER INC-202400235780$PFIZER$$85$YR$$M$Y$183.4$KG$20240823$$HP$GB$GB
242175471$24217547$1$I$20240809$20240813$20240816$20240816$EXP$$CN-PFIZER INC-PV202400105450$PFIZER$$47$YR$$F$Y$53.5$KG$20240816$$HP$CN$CN
242175481$24217548$1$I$20240304$20240813$20240816$20240816$EXP$PT-INFARMED-T202408-43$PT-PFIZER INC-202400235288$PFIZER$$55$YR$$M$Y$63$KG$20240816$$PH$PT$PT
242175491$24217549$1$I$20240712$20240814$20240816$20240816$EXP$$US-PFIZER INC-202400237451$PFIZER$$80$YR$$F$Y$$$20240816$$CN$US$US
242175511$24217551$1$I$20240801$20240815$20240816$20240816$EXP$$US-PFIZER INC-202400237496$PFIZER$$72$YR$$F$Y$$$20240816$$CN$US$US
242175521$24217552$1$I$20240719$20240812$20240816$20240816$EXP$FR-AFSSAPS-RE2024000778$FR-PFIZER INC-202400234206$PFIZER$$39$YR$$M$Y$$$20240816$$MD$FR$FR
242175532$24217553$2$F$20230605$20240917$20240816$20240917$EXP$$PL-PFIZER INC-202400235362$PFIZER$$40$YR$$M$Y$68$KG$20240917$$MD$PL$PL
242175543$24217554$3$F$20240618$20240826$20240816$20240903$EXP$FR-AFSSAPS-AN2024001089$FR-PFIZER INC-202400234202$PFIZER$$69$YR$$F$Y$87$KG$20240903$$PH$FR$FR
242175551$24217555$1$I$20240601$20240813$20240816$20240816$EXP$$DE-PFIZER INC-PV202400105875$PFIZER$$$$$$Y$$$20240816$$MD$DE$DE
242175561$24217556$1$I$$20240812$20240816$20240816$EXP$$US-PFIZER INC-202400234887$PFIZER$$65$YR$$$Y$$$20240816$$MD$US$US
242175571$24217557$1$I$$20240808$20240816$20240816$EXP$$US-GSK-US2024099264$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242175581$24217558$1$I$20240517$20240805$20240816$20240816$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000783$PAREXEL$$$$$$Y$$$20240816$$HP$CN$CN
242175591$24217559$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128566$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$60.3$KG$20240816$$PH$US$US
242175611$24217561$1$I$20240731$20240813$20240816$20240816$EXP$$DE-ABBVIE-5882203$ABBVIE$$82$YR$$F$Y$$$20240816$$CN$DE$DE
242175621$24217562$1$I$$20240813$20240816$20240816$EXP$$US-AMGEN-USASP2024161003$AMGEN$$$$$M$Y$$$20240816$$HP$US$US
242175631$24217563$1$I$$20240815$20240816$20240816$PER$$US-AMGEN-USASP2024162965$AMGEN$$$$$$Y$$$20240816$$CN$US$US
242175641$24217564$1$I$$20240812$20240816$20240816$EXP$$GB-AMGEN-GBRSP2024160364$AMGEN$$$$$M$Y$$$20240816$$CN$GB$GB
242175651$24217565$1$I$$20240814$20240816$20240816$EXP$$BR-ROCHE-10000002977$ROCHE$$29$YR$A$M$Y$$$20240816$$MD$BR$BR
242175661$24217566$1$I$20240722$20240813$20240816$20240816$EXP$FR-AFSSAPS-NT2024001040$FR-ABBVIE-5878041$ABBVIE$$31$YR$$M$Y$65$KG$20240816$$MD$FR$FR
242175671$24217567$1$I$$20240809$20240816$20240816$PER$$US-ALXN-202408USA000615US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240816$$HP$US$US
242175691$24217569$1$I$$20240806$20240816$20240816$EXP$$SG-ROCHE-10000051191$ROCHE$$62$YR$A$F$Y$$$20240816$$CN$SG$SG
242175701$24217570$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129012$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240816$$HP$US$US
242175711$24217571$1$I$20240731$20240814$20240816$20240816$EXP$FR-AFSSAPS-MP2024001293$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-128870$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$85$KG$20240816$$MD$FR$FR
242175731$24217573$1$I$20240801$20240814$20240816$20240816$PER$$US-ABBVIE-5881651$ABBVIE$$$$$F$Y$$$20240816$$MD$US$US
242175741$24217574$1$I$$20240812$20240816$20240816$EXP$$GB-SANDOZ INC.-SDZ2024GB002763$SANDOZ$$$$$M$Y$$$20240816$$CN$GB$GB
242175751$24217575$1$I$20240813$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161174$AMGEN$$$$$$Y$$$20240816$$HP$US$US
242175762$24217576$2$F$$20240821$20240816$20240823$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006421$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242175771$24217577$1$I$$20240815$20240815$20240815$DIR$714501$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242175782$24217578$2$F$$20240821$20240816$20240823$EXP$$JP-BAYER-2024A117422$BAYER$$$$$F$Y$$$20240823$$MD$JP$JP
242175791$24217579$1$I$$20240811$20240816$20240816$EXP$$US-AMGEN-USASP2024162334$AMGEN$Iyer S P.; Jagadeesh D.; Domingo-domenech E. et al.. Frontline brentuximab vedotin and CHP (A+CHP) in patients (pts) with peripheral Tcell lymphoma with less than 10% CD30 expression- Results from the phase 2 SGN35-032 study. Journal of Clinical Oncology. 2024;42 (16):7069$$$$$Y$$$20240816$$HP$US$US
242175801$24217580$1$I$$20240815$20240815$20240815$DIR$714419$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242175811$24217581$1$I$$20240813$20240816$20240816$EXP$$US-GILEAD-2024-0684160$GILEAD$$69$YR$E$M$Y$$$20240816$$CN$US$US
242175821$24217582$1$I$20231017$20240815$20240815$20240815$DIR$714562$$FDA-CTU$$34$YR$$F$N$58.5$KG$20240815$N$CN$US$
242175843$24217584$3$F$20230501$20240905$20240816$20240914$EXP$$GB-TEVA-VS-3231908$TEVA$$$$$F$Y$$$20240914$$CN$GB$GB
242175851$24217585$1$I$$20240812$20240816$20240816$EXP$$US-AGIOS-2408US03857$AGIOS PHARMACEUTICALS$$$$$M$Y$$$20240816$$HP$US$US
242175861$24217586$1$I$$20240806$20240816$20240816$PER$$US-Eisai-EC-2024-172118$EISAI$$$$A$F$Y$$$20240816$$MD$US$US
242175871$24217587$1$I$$20240808$20240816$20240816$30DAY$$US-GSK-US2024099189$GLAXOSMITHKLINE$$$$$M$Y$$$20240816$$CN$US$US
242175881$24217588$1$I$$20240815$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129640$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$50.35$KG$20240816$$CN$US$US
242175891$24217589$1$I$20160101$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129174$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240816$$CN$US$US
242175901$24217590$1$I$$20240802$20240816$20240816$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-07545$HIKMA$$62$YR$$F$Y$$$20240816$$HP$CA$CA
242175911$24217591$1$I$20240619$20240814$20240816$20240816$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-129604$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240816$$HP$CA$CA
242175921$24217592$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129819$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240816$$CN$US$US
242175931$24217593$1$I$20240811$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129781$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240816$$CN$US$US
242175941$24217594$1$I$20230301$20240811$20240816$20240816$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-128439$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240816$$MD$IL$IL
242175951$24217595$1$I$$20240808$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128754$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240816$$CN$US$US
242175961$24217596$1$I$$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128480$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240816$$CN$US$US
242175971$24217597$1$I$$20240813$20240816$20240816$EXP$$CA-Orion Corporation ORION PHARMA-24_00031275$ORION$$71$YR$E$F$Y$$$20240816$$HP$CA$
242175981$24217598$1$I$20240813$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024162455$AMGEN$$83$YR$E$M$Y$$$20240816$$PH$US$US
242175991$24217599$1$I$$20240717$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07215$LUPIN$$$$$$Y$$$20240816$$CN$US$US
242176001$24217600$1$I$20240808$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A185117$ASTRAZENECA$$31359$DY$$M$Y$$$20240816$$CN$US$
242176011$24217601$1$I$$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A185230$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242176021$24217602$1$I$$20240811$20240816$20240816$PER$$US-BIOGEN-2024BI01278035$BIOGEN$$$$$M$Y$$$20240816$$CN$US$US
242176031$24217603$1$I$$20240806$20240816$20240816$EXP$$GB-TEVA-VS-3230543$TEVA$$64$YR$$M$Y$79$KG$20240816$$HP$GB$GB
242176041$24217604$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A184707$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242176051$24217605$1$I$$20240809$20240816$20240816$PER$$US-ABBVIE-5876372$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242176061$24217606$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008833$ELI LILLY AND CO$$$$A$F$Y$$$20240816$$CN$US$US
242176081$24217608$1$I$$20240808$20240816$20240816$EXP$$ZA-AstraZeneca-2024A182222$ASTRAZENECA$$75$YR$$M$Y$$$20240816$$CN$ZA$
242176091$24217609$1$I$20240721$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A183798$ASTRAZENECA$$24470$DY$$$Y$$$20240816$$MD$US$
242176101$24217610$1$I$$20240805$20240816$20240816$EXP$$IT-MYLANLABS-2024M1074771$MYLAN$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ-Genom-Precis-Med 2024; 17 (2): E004353.$1$YR$$M$Y$$$20240816$$MD$IT$IT
242176111$24217611$1$I$$20240809$20240816$20240816$EXP$$TR-MYLANLABS-2024M1075905$MYLAN$Gunay M, Uzlu D, Akyol N. Outcomes of Gonioscopy-Assisted Transluminal Trabeculotomy as a Primary Surgical Treatment for Glaucoma Secondary to Juvenile Idiopathic Arthritis-Associated Uveitis. Ocular-Immunol-Inflamm 2023; 31 (10): 2060-2064.$7$YR$$M$Y$$$20240816$$MD$TR$TR
242176121$24217612$1$I$20221124$20240815$20240815$20240815$DIR$714544$$FDA-CTU$$52$YR$$F$N$88.65$KG$20240815$N$CN$US$
242176132$24217613$2$F$$20240809$20240816$20240822$EXP$$US-MYLANLABS-2024M1075158$MYLAN$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J 2024; 70 (7): e92-e96.$17$YR$$M$Y$$$20240822$$HP$US$US
242176141$24217614$1$I$20240723$20240815$20240815$20240815$DIR$714474$$FDA-CTU$$52$YR$$M$N$90.5$KG$20240815$Y$$US$
242176151$24217615$1$I$20240804$20240815$20240815$20240815$DIR$714393$$FDA-CTU$$53$YR$$F$N$67.05$KG$20240815$N$CN$US$
242176161$24217616$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56462$$FDA-CTU$$73$YR$$F$N$$$20240816$N$HP$US$
242176171$24217617$1$I$20240717$20240815$20240815$20240815$DIR$714385$$FDA-CTU$$10$YR$$M$N$33.75$KG$20240815$N$CN$US$
242176181$24217618$1$I$$20240802$20240816$20240816$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07882$LUPIN$Garofalo V, Walgamage M, Cuello LN, Wester K, Robinson S, Gemayel CY. Anaplasmosis: From multi-system mayhem to ventricular tachycardia in a heartbeat. Journal of the American College of  Cardiology. 2024;83(13):4506$78$YR$$M$Y$$$20240816$$HP$US$US
242176191$24217619$1$I$20240717$20240814$20240816$20240816$EXP$RU-RZN-2503244$RU-BAYER-2024A117788$BAYER$$63$YR$A$F$Y$70$KG$20240816$$HP$RU$RU
242176201$24217620$1$I$20240801$20240815$20240815$20240815$DIR$714518$$FDA-CTU$$86$YR$$F$N$$$20240815$Y$PH$US$
242176211$24217621$1$I$20240727$20240807$20240816$20240816$EXP$GB-MHRA-MED-202408071511276660-SMVKG$GB-TEVA-VS-3231275$TEVA$$61$YR$$F$Y$62$KG$20240816$$CN$GB$GB
242176222$24217622$2$F$20240701$20240812$20240816$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202407019087$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240820$$HP$US$US
242176231$24217623$1$I$20240601$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005679$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$US$US
242176244$24217624$4$F$20240808$20240830$20240816$20240902$EXP$$HU-BIOVITRUM-2024-HU-010907$BIOVITRUM$$4$MON$$M$Y$4.3$KG$20240902$$MD$HU$HU
242176251$24217625$1$I$$20240814$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072746$SANDOZ$$70$YR$$F$Y$$$20240816$$HP$CA$CA
242176262$24217626$2$F$20170101$20240905$20240816$20240918$EXP$$FR-UCBSA-2023044569$UCB$$$$$M$Y$52$KG$20240918$$CN$FR$FR
242176273$24217627$3$F$$20240912$20240816$20240917$30DAY$$US-MYLANLABS-2024M1074411$MYLAN$$$$$M$Y$$$20240917$$PH$US$US
242176281$24217628$1$I$20240729$20240729$20240816$20240816$PER$$TR-TOLMAR, INC.-24TR051400$TOLMAR$$63$YR$$M$Y$$$20240816$$MD$TR$TR
242176291$24217629$1$I$$20240702$20240816$20240816$PER$$AU-TOLMAR, INC.-24AU050779$TOLMAR$$$$$M$Y$$$20240816$$MD$AU$AU
242176302$24217630$2$F$20240711$20240826$20240816$20240913$PER$$US-TOLMAR, INC.-24US051035$TOLMAR$$91$YR$$M$Y$$$20240913$$HP$US$US
242176312$24217631$2$F$20240715$20240828$20240816$20240917$PER$$US-TOLMAR, INC.-24US051109$TOLMAR$$76$YR$$M$Y$$$20240917$$HP$US$US
242176321$24217632$1$I$$20240725$20240816$20240816$PER$$US-TOLMAR, INC.-24US051308$TOLMAR$$$$$M$Y$44.458$KG$20240816$$MD$US$US
242176331$24217633$1$I$20240722$20240725$20240816$20240816$PER$$US-TOLMAR, INC.-24US051292$TOLMAR$$86$YR$$M$Y$$$20240816$$HP$US$US
242176342$24217634$2$F$20240724$20240903$20240816$20240925$PER$$US-TOLMAR, INC.-24US051311$TOLMAR$$74$YR$$M$Y$$$20240925$$HP$US$US
242176351$24217635$1$I$20240725$20240725$20240816$20240816$PER$$US-TOLMAR, INC.-24US051372$TOLMAR$$36$YR$$F$Y$$$20240816$$HP$US$US
242176361$24217636$1$I$20240725$20240725$20240816$20240816$PER$$US-TOLMAR, INC.-24US051346$TOLMAR$$81$YR$$M$Y$$$20240816$$PH$US$US
242176371$24217637$1$I$$20240726$20240816$20240816$PER$$US-TOLMAR, INC.-24US051379$TOLMAR$$$$$M$Y$$$20240816$$PH$US$US
242176384$24217638$4$F$20240718$20240917$20240816$20240923$EXP$$NVSC2024US164404$NOVARTIS$$66$YR$$M$Y$127$KG$20240923$$HP$US$US
242176394$24217639$4$F$$20240927$20240816$20240930$PER$$US-AMGEN-USASP2024162494$AMGEN$$$$$F$Y$$$20240928$$PH$US$US
242176404$24217640$4$F$20240730$20240909$20240816$20240917$PER$$US-KARYOPHARM-2024KPT001425$KARYOPHARM THERAPEUTICS$$71$YR$$M$Y$61$KG$20240917$$MD$US$US
242176411$24217641$1$I$$20240807$20240816$20240816$EXP$$CA-APOTEX-2024AP009189$APOTEX$Vigano M, Kubal S, Lu Y, Habib S, Samarani S, Costiniuk C. T, et al. Impact of Cannabidiol and Exercise on Clinical Outcomes and Gut Microbiota for Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors: A Case Report. Pharmaceuticals. 2024;17(7):834 (1-11)$52$YR$$F$Y$$$20240816$$HP$CA$CA
242176421$24217642$1$I$$20240813$20240816$20240816$EXP$$IT-BIOVITRUM-2024-IT-010908$BIOVITRUM$$65$YR$$$Y$$$20240816$$MD$IT$IT
242176431$24217643$1$I$20240101$20240812$20240816$20240816$EXP$$NVSC2024DE165341$NOVARTIS$$44$YR$$M$Y$$$20240816$$MD$DE$DE
242176441$24217644$1$I$20240811$20240814$20240816$20240816$EXP$$CN-BAYER-2024A118047$BAYER$$60$YR$A$M$Y$53$KG$20240816$$HP$CN$CN
242176461$24217646$1$I$$20240813$20240816$20240816$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-16148$IPSEN$$$$$M$Y$$$20240816$$CN$GB$GB
242176471$24217647$1$I$$20240521$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003716$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176481$24217648$1$I$$20240604$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003780$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242176491$24217649$1$I$$20240530$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003883$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176501$24217650$1$I$$20240526$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003886$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176511$24217651$1$I$$20240528$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003892$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176521$24217652$1$I$$20240529$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003911$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242176531$24217653$1$I$$20240529$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003932$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176541$24217654$1$I$20240523$20240523$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003767$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176551$24217655$1$I$$20240605$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003772$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242176561$24217656$1$I$$20240529$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003935$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176571$24217657$1$I$$20240606$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003948$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176581$24217658$1$I$$20240529$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003956$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176591$24217659$1$I$$20240614$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003979$BIOCON$$$$$$Y$$$20240816$$HP$US$US
242176601$24217660$1$I$$20240529$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004016$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176611$24217661$1$I$$20240531$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004025$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176621$24217662$1$I$$20240531$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004049$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176632$24217663$2$F$20240801$20240924$20240816$20240926$PER$$US-BAYER-2024A117593$BAYER$$46$YR$A$F$Y$$$20240926$$CN$US$US
242176641$24217664$1$I$$20240530$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003832$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242176661$24217666$1$I$20220101$20240726$20240816$20240816$PER$$US-TEVA-VS-3229592$TEVA$$$$$F$Y$$$20240816$$HP$US$US
242176671$24217667$1$I$20240530$20240618$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003966$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176681$24217668$1$I$20240701$20240804$20240816$20240816$PER$$US-INSUD PHARMA-2408US06255$INSUD PHARMA$$$$$$Y$$$20240816$$CN$US$US
242176691$24217669$1$I$20240401$20240418$20240816$20240816$PER$$US-SA-2024MK000030$SANOFI AVENTIS$$$$$M$Y$$$20240812$$CN$US$US
242176701$24217670$1$I$20240501$20240502$20240816$20240816$PER$$US-SA-2024MK000031$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240812$$CN$US$US
242176711$24217671$1$I$20240506$20240506$20240816$20240816$PER$$US-SA-2024MK000032$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240812$$CN$US$US
242176721$24217672$1$I$20240515$20240515$20240816$20240816$PER$$US-SA-2024MK000033$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240812$$MD$US$US
242176731$24217673$1$I$20240515$20240515$20240816$20240816$PER$$US-SA-2024MK000034$SANOFI AVENTIS$$$$$F$Y$$$20240812$$CN$US$US
242176741$24217674$1$I$$20240520$20240816$20240816$PER$$US-SA-2024MK000036$SANOFI AVENTIS$$$$E$F$Y$$$20240812$$CN$US$US
242176751$24217675$1$I$20240523$20240523$20240816$20240816$PER$$US-SA-2024MK000037$SANOFI AVENTIS$$$$A$$Y$$$20240812$$CN$US$US
242176761$24217676$1$I$$20240812$20240816$20240816$EXP$$CA-JNJFOC-20240836434$JOHNSON AND JOHNSON$$80$YR$E$M$Y$76$KG$20240816$$HP$CA$CA
242176771$24217677$1$I$20240524$20240524$20240816$20240816$PER$$US-SA-2024MK000038$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240812$$CN$US$US
242176781$24217678$1$I$20240607$20240607$20240816$20240816$PER$$US-SA-2024MK000039$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240812$$CN$US$US
242176791$24217679$1$I$20240605$20240610$20240816$20240816$PER$$US-SA-2024MK000040$SANOFI AVENTIS$$$$$M$Y$$$20240812$$CN$US$US
242176801$24217680$1$I$20240615$20240617$20240816$20240816$PER$$US-SA-2024MK000042$SANOFI AVENTIS$$$$$F$Y$$$20240812$$CN$US$US
242176811$24217681$1$I$20240614$20240617$20240816$20240816$PER$$US-SA-2024MK000043$SANOFI AVENTIS$$61$YR$A$$Y$$$20240812$$CN$US$US
242176821$24217682$1$I$20240620$20240620$20240816$20240816$PER$$US-SA-2024MK000044$SANOFI AVENTIS$$$$$F$Y$$$20240812$$CN$US$US
242176831$24217683$1$I$20230830$20240624$20240816$20240816$PER$$US-SA-2024MK000045$SANOFI AVENTIS$$$$$F$Y$$$20240812$$CN$US$US
242176841$24217684$1$I$$20240802$20240816$20240816$EXP$$US-Mundipharma Research Limited-2160534$MUNDIPHARMA EDO$$$$$F$Y$$$20240816$$MD$US$US
242176851$24217685$1$I$$20240809$20240816$20240816$PER$$US-MYLANLABS-2024M1075300$MYLAN$$$$$F$Y$$$20240816$$CN$US$US
242176861$24217686$1$I$$20240812$20240816$20240816$EXP$NL-LRB-00995906$NL-LABORATORIOS LICONSA S.A.-2408NL06367$INSUD PHARMA$$72$YR$$M$Y$6$KG$20240816$$MD$NL$NL
242176881$24217688$1$I$20240815$20240815$20240815$20240815$DIR$714446$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242176891$24217689$1$I$20240411$20240411$20240816$20240816$PER$$US-SA-2024MK000028$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240812$$CN$US$US
242176901$24217690$1$I$20240801$20240815$20240815$20240815$DIR$714513$$FDA-CTU$$83$YR$$M$N$$$20240815$Y$PH$US$
242176911$24217691$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56471$$FDA-CTU$$50$YR$$F$N$$$20240816$N$$US$
242176931$24217693$1$I$20240815$20240815$20240815$20240815$DIR$714465$$FDA-CTU$$69$YR$$F$N$60.75$KG$20240815$N$HP$US$
242176941$24217694$1$I$$20240522$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003709$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242176981$24217698$1$I$20240727$20240806$20240816$20240816$EXP$CN-NMPACDR-3205831023857202400848$CN-BAXTER-2024BAX022927$BAXTER$$66$YR$$F$Y$54.6$KG$20240816$$MD$CN$CN
242176991$24217699$1$I$$20240807$20240816$20240816$EXP$$CA-BAXTER-2024BAX022952$BAXTER$$3$YR$$M$Y$$$20240816$$HP$CA$CA
242177004$24217700$4$F$$20240904$20240816$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129529$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240911$$HP$US$US
242177011$24217701$1$I$$20240603$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004081$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242177021$24217702$1$I$$20240807$20240816$20240816$EXP$$CA-BAXTER-2024BAX022893$BAXTER$$67$YR$$F$Y$$$20240816$$MD$CA$CA
242177041$24217704$1$I$20230501$20240814$20240816$20240816$EXP$CA-MMM-QK3TZ60O$CA-GSK-CA2023103495$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$CA$CA
242177052$24217705$2$F$$20240906$20240816$20240911$EXP$$NVSJ2024JP009101$NOVARTIS$$$$E$M$Y$$$20240912$$MD$JP$JP
242177061$24217706$1$I$$20240812$20240816$20240816$EXP$$JP-SANDOZ INC.-SDZ2024JP072989$SANDOZ$Tatsumura M, Kato M, Takahashi K, Funayama T. A Case of Significant Coagulopathy Due to Vitamin K Deficiency Caused by the Administration of Cefazolin and Rifampicin and Hyponutrition After a Postoperative Infection of the Lumbar Spine. Open Access Case Report. 2024$70$YR$$M$Y$60$KG$20240816$$MD$JP$JP
242177071$24217707$1$I$$20240808$20240816$20240816$30DAY$$US-GSK-US2024099254$GLAXOSMITHKLINE$$$$$M$Y$$$20240816$$CN$US$US
242177081$24217708$1$I$$20240619$20240816$20240816$PER$$US-Mundipharma Research Limited-2160535$MUNDIPHARMA EDO$$$$$M$Y$$$20240816$$MD$US$US
242177091$24217709$1$I$20240722$20240809$20240816$20240816$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07660$HIKMA$$19$YR$$M$Y$$$20240816$$MD$US$US
242177102$24217710$2$F$$20240920$20240816$20240926$EXP$$GB-MYLANLABS-2024M1075190$MYLAN$$$$$M$Y$$$20240926$$PH$GB$GB
242177111$24217711$1$I$20240115$20240812$20240816$20240816$EXP$$DE-MYLANLABS-2024M1074908$MYLAN$$79$YR$$M$Y$94$KG$20240816$$MD$DE$DE
242177121$24217712$1$I$$20240816$20240816$20240816$EXP$$GB-Karo Pharma-2160536$Karo Pharma$$$$$F$Y$$$20240816$$$GB$GB
242177133$24217713$3$F$20240101$20240912$20240816$20240920$EXP$$US-INTERCEPT-PM2024001596$INTERCEPT PHARMACEUTICALS$$$$$F$Y$52.608$KG$20240920$$CN$US$US
242177141$24217714$1$I$20190326$20240808$20240816$20240816$EXP$$CN-SA-2024SA241444$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240816$$HP$CN$CN
242177152$24217715$2$F$20240301$20240821$20240816$20240902$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001596$BLUEPRINT MEDICINES$$61$YR$A$F$Y$$$20240829$$MD$US$US
242177163$24217716$3$F$20240808$20240918$20240816$20240925$PER$$US-ROCHE-10000053692$ROCHE$$60$YR$A$F$Y$63.5$KG$20240925$$CN$US$US
242177171$24217717$1$I$20240223$20240808$20240816$20240816$EXP$$US-Kindeva Drug Delivery L.P.-2160537$KINDEVA DRUG DELIVERY$$54$YR$$F$Y$$$20240816$$$US$US
242177181$24217718$1$I$20240814$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024163297$AMGEN$$70$YR$E$F$Y$$$20240816$$MD$US$US
242177191$24217719$1$I$20240620$20240815$20240816$20240816$EXP$FR-AFSSAPS-NC2024000975$FR-BAYER-2024A117758$BAYER$$64$YR$A$F$Y$58$KG$20240816$$MD$FR$FR
242177202$24217720$2$F$20240101$20240905$20240816$20240926$EXP$$US-SA-2024SA240476$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240926$$CN$US$US
242177211$24217721$1$I$20240726$20240809$20240816$20240816$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000787$PAREXEL$$$$$$Y$$$20240816$$HP$CN$CN
242177221$24217722$1$I$20240706$20240805$20240816$20240816$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000788$PAREXEL$$$$$$Y$$$20240816$$HP$CN$CN
242177232$24217723$2$F$$20240823$20240816$20240830$EXP$$CA-GSK-CA2024101841$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$CA$CA
242177241$24217724$1$I$$20240805$20240816$20240816$PER$$US-ROCHE-10000049895$ROCHE$$$$$$Y$$$20240816$$CN$US$US
242177251$24217725$1$I$20240516$20240813$20240816$20240816$EXP$GB-MHRA-MED-202408131405064460-JNKSH$GB-Orion Corporation ORION PHARMA-24_00031267$ORION$$42$YR$A$F$Y$$$20240816$$PH$GB$
242177261$24217726$1$I$$20240629$20240816$20240816$PER$$US-TEVA-VS-3222663$TEVA$$$$$$Y$$$20240816$$CN$US$US
242177271$24217727$1$I$20180509$20240808$20240816$20240816$EXP$$CN-SA-2024SA238487$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240816$$HP$CN$CN
242177283$24217728$3$F$$20240913$20240816$20240915$PER$$US-ALXN-202408USA000638US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
242177291$24217729$1$I$20200604$20240807$20240816$20240816$EXP$PL-URPL-1-1551-2020$PL-TEVA-VS-3231439$TEVA$$56$YR$$M$Y$$$20240816$$MD$PL$PL
242177301$24217730$1$I$20230320$20240812$20240816$20240816$EXP$ES-AEMPS-1557516$ES-VERTEX PHARMACEUTICALS-2024-013083$VERTEX$$12$YR$$F$Y$$$20240816$$MD$ES$ES
242177321$24217732$1$I$$20240812$20240816$20240816$EXP$$US-JNJFOC-20240835781$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240816$$HP$US$US
242177331$24217733$1$I$$20240808$20240816$20240816$EXP$$US-JNJFOC-20240835928$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$PH$US$US
242177341$24217734$1$I$$20240815$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129680$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240816$$CN$US$US
242177351$24217735$1$I$$20240814$20240816$20240816$EXP$$US-SANDOZ INC.-SDZ2024US073022$SANDOZ$$$$$F$Y$$$20240816$$CN$US$US
242177361$24217736$1$I$20240101$20240803$20240816$20240816$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1056$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240815$$HP$US$US
242177371$24217737$1$I$20230101$20240815$20240816$20240816$EXP$$CN-BAYER-2024A118085$BAYER$$40$YR$A$F$Y$62$KG$20240816$$HP$CN$CN
242177411$24217741$1$I$20240517$20240807$20240816$20240816$EXP$SE-SEMPA-2024-005760$SE-TEVA-VS-3231698$TEVA$$7$DY$$M$Y$3$KG$20240816$$CN$SE$SE
242177422$24217742$2$F$$20240829$20240816$20240903$EXP$PL-EMA-20130614-AUTODUP-355587$PL-SA-2024SA241205$SANOFI AVENTIS$Jeleniewicz R, Majdan M, Targonska-Stepniak B, Wielosz E.. Selected problems of biologic therapy in rheumatoid arthritis patients-inefficacy of several biologic therapies. Case reports.. Reumatologia. 2013;51(1):89-92$35$YR$A$F$Y$$$20240903$$MD$PL$PL
242177432$24217743$2$F$$20240819$20240816$20240821$EXP$$FR-SA-2024SA240180$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240821$$HP$FR$FR
242177441$24217744$1$I$20240801$20240815$20240816$20240816$EXP$$US-UCBSA-2024030336$UCB$$44$YR$$M$Y$$$20240816$$CN$US$US
242177451$24217745$1$I$20240101$20240812$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA071606$SANDOZ$$$$$M$Y$$$20240816$$MD$CA$CA
242177461$24217746$1$I$20231101$20240812$20240816$20240816$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16114$IPSEN$$58$YR$A$F$Y$$$20240816$$CN$US$US
242177471$24217747$1$I$$20240801$20240816$20240816$EXP$$US-PHARMAAND GMBH-2024PHR00456$pharmaAND$$$$$F$Y$$$20240816$$CN$US$US
242177481$24217748$1$I$20240731$20240807$20240816$20240816$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00690$PARATEK PHARMACEUTICALS$$53$YR$$M$Y$$$20240816$$HP$CN$CN
242177491$24217749$1$I$$20240802$20240816$20240816$EXP$$CA-MEDEXUS PHARMA, INC.-2024MED00335$MEDEXUS PHARMA$Neder JA, O^Donnell DE, Berton DC. The role of the pulmonary function laboratory to assist in disease management: connective tissue diseases. J Bras Pneumol. 2024;50(3):e20240093$22$YR$$F$Y$$$20240816$$MD$CA$CA
242177502$24217750$2$F$$20240902$20240816$20240916$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00692$Phathom Pharmaceuticals$$81$YR$$F$Y$$$20240916$$MD$JP$JP
242177511$24217751$1$I$$20240801$20240816$20240816$EXP$$US-OSMOTICA PHARMACEUTICALS-2024ALO00389$Alora Pharma$Ketigian LA, Kidambi SS. Postoperative Catatonia After Fentanyl, Hydromorphone, and Ketamine Administration in a Patient Taking Sertraline: A Case Report. A A Pract.. 2023;17(7):e01695$81$YR$$F$Y$$$20240816$$MD$US$US
242177521$24217752$1$I$20240101$20240815$20240816$20240816$EXP$$CN-BAYER-2024A118173$BAYER$$$$$F$Y$52.5$KG$20240816$$CN$CN$CN
242177531$24217753$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130070$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240816$$HP$US$US
242177541$24217754$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128596$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240816$$CN$US$US
242177551$24217755$1$I$$20240814$20240816$20240816$EXP$$US-OTSUKA-2024_022540$OTSUKA$$$$$F$Y$$$20240816$$CN$US$US
242177561$24217756$1$I$20240802$20240807$20240816$20240816$EXP$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000084$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240816$$CN$US$US
242177571$24217757$1$I$20240301$20240807$20240816$20240816$PER$$US-Eisai-EC-2024-172090$EISAI$$51$YR$A$F$Y$98.19$KG$20240816$$CN$US$US
242177581$24217758$1$I$20240801$20240809$20240816$20240816$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000789$PAREXEL$$$$$$Y$$$20240816$$HP$CN$CN
242177591$24217759$1$I$$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184619$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242177601$24217760$1$I$$20240808$20240816$20240816$EXP$$US-GSK-US2024099282$GLAXOSMITHKLINE$$34$YR$$F$Y$$$20240816$$MD$US$US
242177611$24217761$1$I$20240810$20240815$20240816$20240816$EXP$$CN-BAYER-2024A118192$BAYER$$52$YR$A$M$Y$54.1$KG$20240816$$HP$CN$CN
242177621$24217762$1$I$$20240805$20240816$20240816$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093201$GLENMARK$Motaparthi K, Rechdan M, Svoboda S, Mojica R, Chung M, Saikaly SK.. Acute vesiculobullous eruption in lupus patient on trimethoprim-sulfamethoxazole.. JAAD Case Reports.. 2024;50:126-8$$$$$Y$$$20240816$$MD$US$US
242177631$24217763$1$I$$20240813$20240816$20240816$PER$$US-Kindeva Drug Delivery L.P.-2160538$KINDEVA DRUG DELIVERY$$42$YR$$F$Y$$$20240816$$$US$US
242177641$24217764$1$I$20240723$20240806$20240816$20240816$EXP$$DE-JNJFOC-20240775209$JOHNSON AND JOHNSON$$29$YR$A$M$Y$85$KG$20240816$$HP$DE$DE
242177651$24217765$1$I$20240612$20240805$20240816$20240816$PER$$US-INCYTE CORPORATION-2024IN008224$INCYTE$$$$$$Y$$$20240816$$CN$US$US
242177661$24217766$1$I$$20240807$20240816$20240816$EXP$$US-SSPHARMA-2024USSSP00072$SS PHARMA$$35$YR$A$F$Y$67.1$KG$20240816$$HP$US$US
242177671$24217767$1$I$20230101$20240813$20240816$20240816$EXP$$CA-UCBSA-2024022789$UCB$$$$$F$Y$$$20240816$$CN$CA$CA
242177681$24217768$1$I$20240501$20240812$20240816$20240816$EXP$$US-INDIVIOR US-INDV-156013-2024$RECKITT BENCKISER$$$$$$Y$$$20240816$$MD$US$US
242177691$24217769$1$I$$20240805$20240816$20240816$PER$$US-INCYTE CORPORATION-2024IN008202$INCYTE$$$$$$Y$$$20240816$$CN$US$US
242177701$24217770$1$I$20240807$20240808$20240816$20240816$PER$$US-ABBVIE-5874639$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242177711$24217771$1$I$$20240809$20240816$20240816$EXP$$US-ALXN-202408USA000728US$ALEXION PHARMACEUTICALS$$$$$M$Y$88.435$KG$20240816$$CN$US$US
242177723$24217772$3$F$$20240917$20240816$20240917$30DAY$$US-PFIZER INC-202400231535$PFIZER$$10$YR$$F$Y$$$20240917$$CN$US$US
242177732$24217773$2$F$$20240918$20240816$20240918$30DAY$$US-PFIZER INC-202400231480$PFIZER$$14$YR$$F$Y$$$20240918$$CN$US$US
242177752$24217775$2$F$$20240918$20240816$20240918$30DAY$$US-PFIZER INC-202400231712$PFIZER$$10$YR$$F$Y$$$20240918$$CN$US$US
242177771$24217777$1$I$20240713$20240713$20240816$20240816$EXP$$GB-TEVA-VS-3228632$TEVA$$25$YR$$M$Y$75$KG$20240816$$PH$GB$GB
242177781$24217778$1$I$20240815$20240815$20240815$20240815$DIR$714426$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242177801$24217780$1$I$$20240808$20240816$20240816$EXP$$DE-MYLANLABS-2024M1074408$MYLAN$$$$$F$Y$$$20240816$$CN$DE$DE
242177814$24217781$4$F$$20240919$20240816$20240924$30DAY$$US-PFIZER INC-202400234114$PFIZER$$6$YR$$M$Y$16.78$KG$20240924$$MD$US$US
242177823$24217782$3$F$20230811$20240904$20240816$20240906$30DAY$$US-PFIZER INC-PV202400044423$PFIZER$$$$$$Y$$$20240906$$HP$US$US
242177831$24217783$1$I$$20240809$20240816$20240816$EXP$$NVSC2024US165259$NOVARTIS$$$$$$Y$$$20240816$$MD$US$US
242177841$24217784$1$I$20240718$20240718$20240816$20240816$PER$$US-009507513-2407USA011739$MERCK$$$$$M$Y$$$20240816$$HP$US$US
242177851$24217785$1$I$$20240807$20240816$20240816$PER$$US-009507513-2408USA002799$MERCK$Babici Denis, Mohamed Ali A., Mattner Olivia, Canosa Jessica, Gan Willy, Patel Pooja. Candida dubliniensis meningitis in an immunocompetent patient: A case report and review of the literature. eNeurologicalSci. 2024;36:1-4$22$YR$$F$Y$$$20240816$$HP$US$US
242177862$24217786$2$F$$20240826$20240816$20240903$EXP$$US-INCYTE CORPORATION-2024IN008200$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242177876$24217787$6$F$20231028$20240911$20240816$20240917$EXP$$BR-SANDOZ INC.-SDZ2023BR068984$SANDOZ$$49$YR$$F$Y$$$20240917$$CN$BR$BR
242177881$24217788$1$I$20240628$20240807$20240816$20240816$EXP$FR-AFSSAPS-ST2024001242$FR-TEVA-VS-3231820$TEVA$$73$YR$$F$Y$80$KG$20240816$$PH$FR$FR
242177891$24217789$1$I$20240317$20240808$20240816$20240816$PER$$RU-Eisai-EC-2024-171979$EISAI$$55$YR$A$M$Y$65$KG$20240816$$MD$RU$RU
242177901$24217790$1$I$$20240805$20240816$20240816$PER$$US-INCYTE CORPORATION-2024IN008199$INCYTE$$$$$$Y$$$20240816$$CN$US$US
242177911$24217791$1$I$20240801$20240802$20240816$20240816$EXP$$CN-EAGLE PHARMACEUTICALS, INC.-CN-2024EAG000198$EAGLE$$72$YR$$M$Y$70.03$KG$20240816$$HP$CN$CN
242177923$24217792$3$F$20240518$20240919$20240816$20240927$EXP$$TW-PHARMAESSENTIA CORPORATION-TW-2024-PEC-003974$PHARMAESSENTIA$$52$YR$$M$Y$$$20240927$$CN$TW$TW
242177931$24217793$1$I$20240409$20240813$20240816$20240816$PER$$US-BIOGEN-2024BI01264001$BIOGEN$$36$YR$$F$Y$$$20240816$$CN$US$US
242177942$24217794$2$F$20240627$20240812$20240816$20240826$EXP$ES-AEMPS-1557574$ES-MYLANLABS-2024M1074859$MYLAN$$48$YR$$F$Y$$$20240826$$MD$ES$ES
242177951$24217795$1$I$$20240815$20240816$20240816$PER$$NVSC2024US165618$NOVARTIS$$70$YR$$M$Y$$$20240816$$CN$US$US
242177962$24217796$2$F$$20240918$20240816$20240918$30DAY$$US-PFIZER INC-202400232498$PFIZER$$15$YR$$M$Y$$$20240918$$CN$US$US
242177981$24217798$1$I$20240101$20240813$20240816$20240816$EXP$$CA-PFIZER INC-202400237473$PFIZER$$79$YR$$F$Y$$$20240816$$HP$CA$CA
242177991$24217799$1$I$20240624$20240815$20240815$20240815$DIR$714530$$FDA-CTU$$77$YR$$F$N$49.5$KG$20240815$N$CN$US$
242178001$24217800$1$I$20240216$20240815$20240815$20240815$DIR$714364$$FDA-CTU$$69$YR$$F$N$56.7$KG$20240815$N$CN$US$
242178011$24217801$1$I$$20240815$20240815$20240815$DIR$714432$$FDA-CTU$$$$$UNK$N$$$20240815$$CN$US$
242178021$24217802$1$I$$20240815$20240815$20240815$DIR$714431$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242178031$24217803$1$I$$20240815$20240815$20240815$DIR$714380$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242178071$24217807$1$I$$20240814$20240816$20240816$EXP$$IN-PFIZER INC-PV202400107114$PFIZER$$46$YR$$F$Y$$$20240816$$CN$IN$IN
242178081$24217808$1$I$20240617$20240813$20240816$20240816$EXP$$US-PFIZER INC-PV202400105419$PFIZER$$$$$F$Y$$$20240816$$CN$US$US
242178091$24217809$1$I$$20240808$20240816$20240816$EXP$$JP-PFIZER INC-202400235278$PFIZER$$$$$$Y$$$20240816$$PH$JP$JP
242178101$24217810$1$I$20240710$20240809$20240816$20240816$EXP$$GB-AstraZeneca-2024A181491$ASTRAZENECA$$68$YR$$$Y$$$20240816$$MD$GB$
242178111$24217811$1$I$20240801$20240805$20240816$20240816$PER$$US-INCYTE CORPORATION-2024IN008198$INCYTE$$$$$$Y$$$20240816$$CN$US$US
242178122$24217812$2$F$$20240915$20240816$20240916$30DAY$$US-PFIZER INC-202400231763$PFIZER$$14$YR$$M$Y$$$20240916$$CN$US$US
242178132$24217813$2$F$$20240805$20240816$20240820$30DAY$$US-PFIZER INC-202400230943$PFIZER$$10$YR$$F$Y$$$20240820$$CN$US$US
242178153$24217815$3$F$$20240917$20240816$20240920$30DAY$$US-PFIZER INC-202400231665$PFIZER$$16$YR$$M$Y$70.31$KG$20240920$$CN$US$US
242178162$24217816$2$F$$20240919$20240816$20240923$30DAY$$US-PFIZER INC-202400230939$PFIZER$$9$YR$$M$Y$22.68$KG$20240923$$CN$US$US
242178171$24217817$1$I$20240810$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A184153$ASTRAZENECA$$29686$DY$$M$Y$$$20240816$$CN$US$
242178181$24217818$1$I$$20240808$20240816$20240816$EXP$$VN-AstraZeneca-2024A183070$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$VN$
242178191$24217819$1$I$20240321$20240805$20240816$20240816$EXP$FR-AFSSAPS-NT2024000990$FR-GLENMARK PHARMACEUTICALS-2024GMK093234$GLENMARK$$$$$$Y$$$20240816$$MD$FR$FR
242178201$24217820$1$I$$20240813$20240816$20240816$EXP$$US-JNJFOC-20240833340$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$HP$US$US
242178211$24217821$1$I$$20240813$20240816$20240816$PER$$US-JNJFOC-20240834532$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
242178221$24217822$1$I$$20240809$20240816$20240816$EXP$$US-AstraZeneca-2024A181953$ASTRAZENECA$$$$$F$Y$$$20240816$$MD$US$
242178231$24217823$1$I$20240329$20240812$20240816$20240816$EXP$FR-AFSSAPS-TO2024001395$FR-MYLANLABS-2024M1074836$MYLAN$$50$YR$$F$Y$$$20240816$$MD$FR$FR
242178241$24217824$1$I$20240726$20240812$20240816$20240816$EXP$FR-AFSSAPS-RN2024000864$FR-MYLANLABS-2024M1074869$MYLAN$$77$YR$$M$Y$$$20240816$$PH$FR$FR
242178251$24217825$1$I$$20240812$20240816$20240816$EXP$$CA-JNJFOC-20240839248$JOHNSON AND JOHNSON$$61$YR$A$M$Y$120$KG$20240816$$HP$CA$CA
242178266$24217826$6$F$20240726$20240826$20240816$20240830$EXP$$US-AMGEN-USASP2024159252$AMGEN$$$$E$F$Y$$$20240830$$PH$US$US
242178281$24217828$1$I$$20240812$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128717$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240816$$CN$US$US
242178291$24217829$1$I$$20240812$20240816$20240816$PER$$US-BAYER-2024A116357$BAYER$$$$$F$Y$$$20240816$$HP$US$US
242178301$24217830$1$I$20240720$20240724$20240816$20240816$PER$$US-009507513-2407USA014082$MERCK$$29$YR$$F$Y$$$20240816$$MD$US$US
242178321$24217832$1$I$20240601$20240814$20240816$20240816$EXP$CH-SM-2024-14689$CH-GSK-CH2024101085$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$CH$CH
242178331$24217833$1$I$20240711$20240809$20240816$20240816$PER$$US-AstraZeneca-2024A182062$ASTRAZENECA$$44$YR$$M$Y$97.4$KG$20240816$$MD$US$
242178341$24217834$1$I$$20240808$20240816$20240816$EXP$$ZA-AstraZeneca-2024A182233$ASTRAZENECA$$69$YR$$F$Y$$$20240816$$CN$ZA$
242178352$24217835$2$F$20240801$20240828$20240816$20240829$EXP$$US-UCBSA-2024041429$UCB$$35$YR$$M$Y$$$20240829$$CN$US$US
242178362$24217836$2$F$$20240812$20240816$20240818$PER$$US-JNJFOC-20240830147$JOHNSON AND JOHNSON$$$$$F$Y$$$20240818$$HP$US$US
242178371$24217837$1$I$$20240805$20240816$20240816$EXP$$AU-JNJFOC-20240839714$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240816$$MD$AU$AU
242178381$24217838$1$I$$20240807$20240816$20240816$EXP$GB-MHRA-30702762$GB-TEVA-VS-3230959$TEVA$$78$YR$$F$Y$57$KG$20240816$$CN$GB$GB
242178392$24217839$2$F$20240602$20240911$20240816$20240925$EXP$$CA-AMGEN-CANNI2024163054$AMGEN$$59$YR$A$F$Y$$$20240924$$CN$CA$CA
242178401$24217840$1$I$$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162553$AMGEN$$$$$F$Y$$$20240816$$CN$US$US
242178411$24217841$1$I$20240805$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128819$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240816$$CN$US$US
242178421$24217842$1$I$$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129542$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240816$$HP$US$US
242178431$24217843$1$I$20240611$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129362$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240816$$CN$US$US
242178461$24217846$1$I$20240725$20240815$20240815$20240815$DIR$714507$$FDA-CTU$$78$YR$$F$N$70.11$KG$20240815$N$HP$US$
242178471$24217847$1$I$20240815$20240815$20240815$20240815$DIR$714557$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242178501$24217850$1$I$20240802$20240806$20240816$20240816$EXP$$US-TEVA-VS-3231050$TEVA$$57$YR$$M$Y$68.04$KG$20240816$$HP$US$US
242178511$24217851$1$I$$20240809$20240816$20240816$EXP$$HK-GSK-HK2024APC099885$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$HK$HK
242178521$24217852$1$I$20240810$20240815$20240815$20240815$DIR$714471$$FDA-CTU$$17$YR$$M$N$$$20240815$Y$HP$US$
242178533$24217853$3$F$$20240927$20240816$20240927$PER$$NVSC2024US166213$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
242178541$24217854$1$I$$20240812$20240816$20240816$PER$$US-BIOGEN-2024BI01278059$BIOGEN$$$$$F$Y$$$20240816$$CN$US$US
242178551$24217855$1$I$20240806$20240807$20240816$20240816$30DAY$$US-GSK-US2024098498$GLAXOSMITHKLINE$$59$YR$$M$Y$$$20240816$$CN$US$US
242178562$24217856$2$F$$20240808$20240816$20240821$EXP$$US-GSK-US2024AMR099850$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240821$$CN$US$US
242178585$24217858$5$F$20240101$20240923$20240816$20240925$30DAY$$US-PFIZER INC-202400233169$PFIZER$$11$YR$$F$Y$34.02$KG$20240925$$CN$US$US
242178602$24217860$2$F$$20240920$20240816$20240924$30DAY$$US-PFIZER INC-202400234663$PFIZER$$8$YR$$M$Y$$$20240924$$CN$US$US
242178612$24217861$2$F$$20240915$20240816$20240916$30DAY$$US-PFIZER INC-202400231613$PFIZER$$12$YR$$F$Y$$$20240916$$CN$US$US
242178632$24217863$2$F$$20240918$20240816$20240918$30DAY$$US-PFIZER INC-202400234304$PFIZER$$12$YR$$F$Y$$$20240918$$CN$US$US
242178642$24217864$2$F$$20240915$20240816$20240916$30DAY$$US-PFIZER INC-202400235493$PFIZER$$16$YR$$M$Y$$$20240916$$CN$US$US
242178651$24217865$1$I$20240101$20240806$20240816$20240816$EXP$$US-PADAGIS-2024PAD01299$PADAGIS$$$$$$Y$$$20240816$$CN$US$US
242178661$24217866$1$I$$20240807$20240816$20240816$EXP$$FR-MYLANLABS-2024M1075104$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$79$YR$$M$Y$$$20240816$$HP$FR$FR
242178681$24217868$1$I$$20240809$20240816$20240816$PER$$US-JNJFOC-20240824838$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$CN$US$US
242178691$24217869$1$I$$20240807$20240816$20240816$EXP$$US-TEVA-VS-3232176$TEVA$$$$$F$Y$$$20240816$$CN$US$US
242178702$24217870$2$F$20240201$20240809$20240816$20240902$EXP$$FR-ORGANON-O2407FRA002601$ORGANON$$80$YR$$F$Y$$$20240902$$CN$FR$FR
242178711$24217871$1$I$$20240809$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126651$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240816$$HP$US$US
242178721$24217872$1$I$$20240805$20240816$20240816$EXP$$US-ROCHE-10000003568$ROCHE$Selvaratnam V,  Malaysia: Long-term real-world experience in clinical outcomes of reduced dose emicizumab in Haemophilila A with inhibitor [Abstract: PB0239]. International Society on Thrombosis and Haemostasis (ISTH) Congress. 2024;$$$$$Y$$$20240816$$HP$US$US
242178731$24217873$1$I$$20240812$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072337$SANDOZ$$80$YR$$M$Y$89$KG$20240816$$HP$CA$CA
242178744$24217874$4$F$20240801$20240919$20240816$20240926$EXP$$DE-CHIESI-2024CHF05073$CHIESI$$$$N$F$Y$1$KG$20240926$$MD$DE$DE
242178751$24217875$1$I$20240503$20240809$20240816$20240816$EXP$$DE-BAYER-2024A067554$BAYER$$57$YR$A$F$Y$$$20240816$$HP$DE$DE
242178761$24217876$1$I$20240625$20240807$20240816$20240816$EXP$FR-AFSSAPS-NT2024000968$FR-TEVA-VS-3231872$TEVA$$83$YR$$F$Y$$$20240816$$MD$FR$FR
242178771$24217877$1$I$$20240805$20240816$20240816$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK093264$GLENMARK$$$$$$Y$$$20240816$$CN$CA$CA
242178782$24217878$2$F$$20240813$20240816$20240819$PER$$US-JNJFOC-20240831908$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$HP$US$US
242178791$24217879$1$I$$20240812$20240816$20240816$EXP$$US-ABBVIE-5878974$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242178801$24217880$1$I$$20240813$20240816$20240816$EXP$$US-GSK-US2024100770$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$US$US
242178811$24217881$1$I$$20240809$20240816$20240816$PER$$US-FreseniusKabi-FK202412402$FRESENIUS KABI$$$$E$F$Y$$$20240816$$MD$US$US
242178821$24217882$1$I$$20240813$20240816$20240816$PER$$US-FreseniusKabi-FK202412471$FRESENIUS KABI$$$$$F$Y$$$20240816$$CN$US$US
242178831$24217883$1$I$20211207$20240812$20240816$20240816$EXP$DE-002147023-NVSC2021DE284220$DE-RDY-SPO/DEU/24/0011779$DR REDDYS$$$$E$F$Y$88$KG$20240816$$HP$DE$DE
242178851$24217885$1$I$20240701$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129278$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240816$$CN$US$US
242178861$24217886$1$I$20240726$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129193$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240816$$CN$US$US
242178871$24217887$1$I$$20240813$20240816$20240816$EXP$$KR-BAYER-2024A117269$BAYER$$$$$F$Y$$$20240816$$HP$KR$KR
242178881$24217888$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192305$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242178891$24217889$1$I$$20240814$20240816$20240816$PER$$NVSC2024US166069$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
242178901$24217890$1$I$20240708$20240807$20240816$20240816$EXP$$JP-EMD Serono-2024038720$EMD SERONO INC$$71$YR$E$M$Y$78$KG$20240816$$MD$JP$JP
242178911$24217891$1$I$$20240809$20240816$20240816$EXP$$US-AstraZeneca-2024A182257$ASTRAZENECA$$59$YR$$M$Y$$$20240816$$HP$US$
242178921$24217892$1$I$$20240815$20240816$20240816$EXP$$US-AstraZeneca-2024A150581$ASTRAZENECA$Stanek K., Hussain M. T., Spaulding A. C., Borkar S., Shaikh M. E.. Improving Patient Safety Through Proper Ordering and Administration of Andexanet Alfa. Mayo Clinic Proceedings: Innovations, Quality + Outcomes 2024;8(4):407-414.$85$YR$$F$Y$$$20240816$$MD$US$
242178931$24217893$1$I$20240807$20240815$20240815$20240815$DIR$714497$$FDA-CTU$$40$YR$$M$N$58.5$KG$20240815$N$$US$
242178941$24217894$1$I$20240814$20240815$20240815$20240815$DIR$714536$$FDA-CTU$$50$YR$$F$N$$$20240815$N$HP$US$
242178961$24217896$1$I$20240801$20240806$20240816$20240816$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408004435$ELI LILLY AND CO$$35$YR$A$F$Y$78$KG$20240816$$CN$CN$CN
242178971$24217897$1$I$$20240812$20240816$20240816$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202408007536$ELI LILLY AND CO$$$$$F$Y$$$20240816$$MD$SA$SA
242178981$24217898$1$I$$20240809$20240816$20240816$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408007532$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240816$$CN$JP$JP
242178991$24217899$1$I$$20240810$20240816$20240816$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408002131$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240816$$CN$JP$JP
242179002$24217900$2$F$$20240819$20240816$20240820$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408001064$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240820$$CN$JP$JP
242179012$24217901$2$F$20240601$20240918$20240816$20240930$EXP$FR-AFSSAPS-LY2024001198$FR-ELI_LILLY_AND_COMPANY-FR202408006119$ELI LILLY AND CO$$40$YR$A$F$Y$44$KG$20240930$$CN$FR$FR
242179021$24217902$1$I$$20240806$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004242$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240816$$HP$US$US
242179032$24217903$2$F$20240601$20240814$20240816$20240819$EXP$$US-GSK-US2024101394$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$PH$US$US
242179041$24217904$1$I$$20240809$20240816$20240816$EXP$$BR-GSK-BR2024AMR100795$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$BR$BR
242179051$24217905$1$I$$20240814$20240816$20240816$EXP$NL-LRB-00996021$NL-GSK-NL2024101289$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$NL$NL
242179071$24217907$1$I$$20240812$20240816$20240816$EXP$$NVSC2024CN165145$NOVARTIS$He S, Wang L, Sun Y, Du H, Yu X. Case Report: Successful immune checkpoint inhibitor-based rechallenge in a patient with advanced renal clear cell cancer. FRONTIERS IN IMMUNOLOGY. 2023;14:1-5$34$YR$$F$Y$$$20240816$$HP$CN$CN
242179081$24217908$1$I$$20240815$20240816$20240816$EXP$$NVSC2024GB165523$NOVARTIS$$$$E$M$Y$$$20240816$$HP$GB$GB
242179091$24217909$1$I$$20240808$20240816$20240816$EXP$$PL-FreseniusKabi-FK202412509$FRESENIUS KABI$Litwin M, Skoczynski K, Koziej J, Szyma?ska S, Obrycki L, Grenda R. Adalimumab as a cause of kidney injury in patients with Crohn?s  disease. Pediatric Nephrology. 2024 Aug;39(8): 2359-2361.$15$YR$T$M$Y$$$20240816$$HP$PL$PL
242179112$24217911$2$F$20240411$20240813$20240816$20240821$EXP$$US-GUERBET / LLC-US-20240121$GUERBET$$28$YR$A$F$Y$61$KG$20240821$$HP$US$US
242179122$24217912$2$F$20240715$20240812$20240816$20240824$EXP$$US-UCBSA-2024039468$UCB$$33$YR$$F$Y$$$20240824$$HP$US$US
242179131$24217913$1$I$$20240808$20240816$20240816$EXP$$PL-FreseniusKabi-FK202412510$FRESENIUS KABI$Litwin M, Skoczynski K, Koziej J, Szymanska S, Obrycki L, Grenda R. Adalimumab as a cause of kidney injury in patients with Crohn?s  disease. Pediatric Nephrology. 2024 Aug;39(8): 2359-2361. doi:https://doi.org/10.1007/s00467-024-06338-0.$15$YR$T$M$Y$$$20240816$$HP$PL$PL
242179151$24217915$1$I$20240815$20240815$20240815$20240815$DIR$714554$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242179161$24217916$1$I$20240815$20240815$20240815$20240815$DIR$714533$$FDA-CTU$$23$YR$$F$N$98.55$KG$20240815$N$CN$US$
242179171$24217917$1$I$20240212$20240816$20240816$20240816$EXP$FR-AFSSAPS-BX2024001648$NVSC2024FR166054$NOVARTIS$$63$YR$$M$Y$$$20240816$$MD$FR$FR
242179181$24217918$1$I$20240601$20240809$20240816$20240816$EXP$$JP-009507513-2408JPN001367J$MERCK$$17$YR$$F$Y$$$20240816$$MD$JP$JP
242179191$24217919$1$I$$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162584$AMGEN$$$$A$F$Y$$$20240816$$MD$US$US
242179201$24217920$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192278$Haleon PLC$$$$$F$Y$$$20240816$$CN$US$US
242179212$24217921$2$F$$20240828$20240816$20240904$EXP$$EG-SANDOZ INC.-SDZ2024EG033166$SANDOZ$$$$$M$Y$$$20240904$$CN$EG$EG
242179221$24217922$1$I$20240101$20240808$20240816$20240816$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-012795$JAZZ$$60$YR$$$Y$$$20240816$$MD$JP$JP
242179231$24217923$1$I$20240708$20240815$20240816$20240816$EXP$$US-INCYTE CORPORATION-2024IN008561$INCYTE$$$$$$Y$$$20240816$$HP$US$US
242179261$24217926$1$I$20220101$20240809$20240816$20240816$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-109267$REGENERON$$$$$M$Y$$$20240816$$CN$US$US
242179281$24217928$1$I$$20240805$20240816$20240816$EXP$$MY-AUROBINDO-AUR-APL-2024-039879$AUROBINDO$Nee TS, Shuan CT, Karunakan R, Nurliyana W, Sulaiman H. A synergy test to assess the activity of the Ceftazidime-Avibactam and Aztreonam combination: An experience from a single centre in Malaysia. Open-Forum-Infect-Dis. 2023;10 (Suppl. 1):S1242$69$YR$$M$Y$$$20240816$$MD$MY$MY
242179291$24217929$1$I$20240202$20240815$20240816$20240816$EXP$$US-INCYTE CORPORATION-2024IN008560$INCYTE$$$$$$Y$$$20240816$$MD$US$US
242179301$24217930$1$I$20240306$20240812$20240816$20240816$EXP$$GB-BAYER-2024A116394$BAYER$$72$YR$E$M$Y$65$KG$20240816$$CN$GB$GB
242179321$24217932$1$I$$20240815$20240815$20240815$DIR$714433$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242179331$24217933$1$I$20240616$20240815$20240815$20240815$DIR$714363$$FDA-CTU$$41$YR$$F$N$74.25$KG$20240815$N$CN$US$
242179341$24217934$1$I$$20240718$20240816$20240816$30DAY$$US-VEROBIOTECH-2024USVEROSPO00183$VERO BIOTECH$$62$YR$A$F$Y$$$20240816$$HP$US$US
242179351$24217935$1$I$$20240805$20240816$20240816$EXP$$CN-JNJFOC-20240816897$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$MD$CN$CN
242179371$24217937$1$I$$20240806$20240816$20240816$EXP$$KR-JNJFOC-20240823192$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240816$$MD$KR$KR
242179381$24217938$1$I$$20240813$20240816$20240816$EXP$$CA-JNJFOC-20240834875$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240816$$HP$CA$CA
242179401$24217940$1$I$20240604$20240805$20240816$20240816$EXP$FR-AFSSAPS-PB2024000864$FR-BEH-2024176838$CSL BEHRING$$39$YR$A$F$Y$39$KG$20240816$$MD$FR$FR
242179411$24217941$1$I$20240807$20240815$20240815$20240815$DIR$714436$$FDA-CTU$$37$YR$$F$N$58.5$KG$20240815$N$CN$US$
242179431$24217943$1$I$20240808$20240812$20240816$20240816$30DAY$$GR-PFIZER INC-PV202400105241$PFIZER$$14$YR$$F$Y$46$KG$20240816$$CN$GR$GR
242179453$24217945$3$F$20240812$20240919$20240816$20240924$30DAY$$GR-PFIZER INC-PV202400105246$PFIZER$$5$YR$$$Y$16$KG$20240924$$CN$GR$GR
242179462$24217946$2$F$$20240918$20240816$20240918$30DAY$$US-PFIZER INC-202400231871$PFIZER$$10$YR$$F$Y$$$20240918$$CN$US$US
242179472$24217947$2$F$$20240917$20240816$20240919$30DAY$$CO-PFIZER INC-PV202400104697$PFIZER$$19$YR$$M$Y$$$20240919$$CN$CO$CO
242179481$24217948$1$I$20240713$20240812$20240816$20240816$EXP$FR-AFSSAPS-PC2024000651$FR-FreseniusKabi-FK202412463$FRESENIUS KABI$$62$YR$A$F$Y$$$20240816$$PH$FR$FR
242179491$24217949$1$I$20240719$20240812$20240816$20240816$EXP$FR-AFSSAPS-RE2024000778$FR-FreseniusKabi-FK202412462$FRESENIUS KABI$$39$YR$A$M$Y$$$20240816$$MD$FR$FR
242179501$24217950$1$I$$20240813$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072391$SANDOZ$$62$YR$$M$Y$$$20240816$$CN$CA$CA
242179513$24217951$3$F$20240808$20240920$20240816$20240920$30DAY$$US-PFIZER INC-202400234044$PFIZER$$14$YR$$M$Y$49.887$KG$20240920$$CN$US$US
242179521$24217952$1$I$20240601$20240812$20240816$20240816$EXP$$IL-SA-2024SA242180$SANOFI AVENTIS$$$$$M$Y$$$20240816$$MD$IL$IL
242179531$24217953$1$I$20240719$20240806$20240816$20240816$EXP$GB-MHRA-31414252$GB-TEVA-VS-3230749$TEVA$$73$YR$$F$Y$77$KG$20240816$$CN$GB$GB
242179541$24217954$1$I$20240201$20240813$20240816$20240816$EXP$FR-AFSSAPS-RN2024000866$FR-SA-2024SA239959$SANOFI AVENTIS$$28$YR$A$F$Y$78$KG$20240816$$MD$FR$FR
242179551$24217955$1$I$20240714$20240813$20240816$20240816$EXP$PL-URPL-DML-MLP.4401.1.168.2024$PL-SA-2024SA242352$SANOFI AVENTIS$$71$YR$E$M$Y$70$KG$20240816$$PH$PL$PL
242179561$24217956$1$I$$20240807$20240816$20240816$EXP$$US-SSPHARMA-2024USSSP00073$SS PHARMA$$$$$M$Y$$$20240816$$HP$US$US
242179571$24217957$1$I$$20240814$20240816$20240816$EXP$$US-SANDOZ INC.-SDZ2024US072665$SANDOZ$$52$YR$$F$Y$$$20240816$$MD$US$US
242179581$24217958$1$I$20220101$20240813$20240816$20240816$PER$$US-ABBVIE-5879587$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242179601$24217960$1$I$$20240812$20240816$20240816$EXP$$CA-PFIZER INC-202400230973$PFIZER$$92$YR$$M$Y$49$KG$20240816$$HP$CA$CA
242179621$24217962$1$I$20240812$20240814$20240816$20240816$EXP$$CN-GILEAD-2024-0684179$GILEAD$$77$YR$E$F$Y$$$20240816$$HP$CN$CN
242179631$24217963$1$I$$20240701$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003154$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179641$24217964$1$I$$20240501$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003186$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179651$24217965$1$I$$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408061728378870-SHCJK$GB-TEVA-VS-3230627$TEVA$$$$$M$Y$$$20240816$$CN$GB$GB
242179661$24217966$1$I$$20240502$20240816$20240816$EXP$$ES-HIKMA PHARMACEUTICALS USA INC.-ES-H14001-24-06540$HIKMA$Chen Weng Z, Tapia Salinas B, Noguera Tomas J, Del Castillo Pardo De Vera JL, De La Morena Molina JD.. Chen Weng Z, Tapia Salinas B, Noguera Tomas J, Del Castillo Pardo De Vera JL, De La Morena Molina JD. Anesthetic Management of a Patient with Madelung^s Disease Presenting with a Giant Cervical Lipoma: A Case Report.. A and A Practice. 2024;18(4):E01779.$60$YR$$M$Y$73$KG$20240816$$MD$ES$ES
242179671$24217967$1$I$$20240506$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003220$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179681$24217968$1$I$$20240506$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003229$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179691$24217969$1$I$$20240507$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003257$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179701$24217970$1$I$20240101$20240809$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-019692$UNITED THERAPEUTICS$$$$$M$Y$74.376$KG$20240816$$$US$US
242179711$24217971$1$I$$20240509$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003193$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179721$24217972$1$I$$20240508$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003279$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179731$24217973$1$I$$20240531$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003089$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179741$24217974$1$I$$20240501$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003109$BIOCON$$$$$F$Y$81$KG$20240816$$PH$US$US
242179751$24217975$1$I$$20240502$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003120$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242179761$24217976$1$I$$20240430$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003170$BIOCON$$$$$$Y$$$20240816$$HP$US$US
242179771$24217977$1$I$20210401$20240812$20240816$20240816$EXP$$US-CHIESI-2024CHF05150$CHIESI$$20$YR$$F$Y$42.6$KG$20240816$$CN$US$US
242179791$24217979$1$I$$20240503$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003202$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179801$24217980$1$I$$20240429$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003078$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179811$24217981$1$I$20240101$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162296$AMGEN$$$$$M$Y$$$20240816$$CN$US$US
242179822$24217982$2$F$20230101$20240815$20240816$20240822$EXP$$FI-009507513-2408FIN003460$MERCK$$80$YR$$F$Y$$$20240822$$CN$FI$FI
242179831$24217983$1$I$20240501$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408060800543350-PGSRB$GB-TEVA-VS-3230547$TEVA$$59$YR$$M$Y$124$KG$20240816$$MD$GB$GB
242179841$24217984$1$I$$20240809$20240816$20240816$PER$$US-UNITED THERAPEUTICS-UNT-2024-017590$UNITED THERAPEUTICS$$$$$F$Y$45.805$KG$20240816$$$US$US
242179851$24217985$1$I$$20240531$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003328$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242179861$24217986$1$I$20240716$20240805$20240816$20240816$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000792$PAREXEL$$$$$$Y$$$20240816$$HP$CN$CN
242179871$24217987$1$I$$20240813$20240816$20240816$EXP$$NVSC2024US164890$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
242179881$24217988$1$I$20220101$20240813$20240816$20240816$EXP$$NVSC2024BR165897$NOVARTIS$$$$$M$Y$66$KG$20240816$$CN$BR$BR
242179891$24217989$1$I$$20240501$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003114$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179901$24217990$1$I$$20240509$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003375$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179911$24217991$1$I$$20240711$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003403$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179921$24217992$1$I$$20240513$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003411$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179931$24217993$1$I$$20240510$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003432$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242179941$24217994$1$I$$20240603$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003446$BIOCON$$$$$$Y$$$20240816$$MD$US$US
242179951$24217995$1$I$$20240510$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003356$BIOCON$$$$$$Y$$$20240816$$HP$US$US
242179961$24217996$1$I$$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408061037128880-WGHZD$GB-TEVA-VS-3230448$TEVA$$64$YR$$M$Y$$$20240816$$HP$GB$GB
242179981$24217998$1$I$20240803$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408061343109220-MDRSN$GB-TEVA-VS-3231143$TEVA$$82$YR$$F$Y$$$20240816$$HP$GB$GB
242179995$24217999$5$F$20240808$20240919$20240816$20240926$EXP$$DE-CHIESI-2024CHF05069$CHIESI$$0$YR$$F$Y$1$KG$20240926$$MD$DE$DE
242180001$24218000$1$I$$20240812$20240816$20240816$EXP$$US-MAYNE PHARMA-2024MYN000350$MAYNE$$$$$$Y$$$20240816$$CN$US$US
242180011$24218001$1$I$20240701$20240814$20240816$20240816$EXP$ES-AEMPS-1560624$ES-PFIZER INC-202400236216$PFIZER$$54$YR$$F$Y$$$20240816$$MD$ES$ES
242180021$24218002$1$I$20230101$20240812$20240816$20240816$EXP$$US-PFIZER INC-PV202300100839$PFIZER$$62$YR$$M$Y$$$20240816$$CN$US$US
242180032$24218003$2$F$20231218$20240911$20240816$20240913$EXP$$DE-PFIZER INC-PV202400106418$PFIZER$$73$YR$$F$Y$$$20240913$$MD$DE$DE
242180041$24218004$1$I$20240101$20240813$20240816$20240816$EXP$$US-PFIZER INC-202400209113$PFIZER$$77$YR$$F$Y$$$20240816$$HP$US$US
242180052$24218005$2$F$$20240821$20240816$20240823$EXP$$US-PFIZER INC-PV202400105754$PFIZER$Abedrabo, S.. Relapse Hodgkin lymphoma autologous stem cell transplant long term follow up. Journal of Clinical Oncology. 2024;42(16 Supple):e19031$$$A$$Y$$$20240823$$HP$US$US
242180061$24218006$1$I$20240527$20240813$20240816$20240816$EXP$$CN-PFIZER INC-PV202400105508$PFIZER$$27$YR$$F$Y$$$20240816$$HP$CN$CN
242180081$24218008$1$I$20240613$20240812$20240816$20240816$EXP$$US-PFIZER INC-202400224727$PFIZER$$55$YR$$F$Y$$$20240816$$HP$US$US
242180091$24218009$1$I$$20240814$20240816$20240816$EXP$$JP-PFIZER INC-PV202400106472$PFIZER$Shindo, Y.. Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer.. Cancers. 2024;16(14):10.3390/cancers16142522$67$YR$$M$Y$$$20240816$$HP$JP$JP
242180102$24218010$2$F$20240520$20240924$20240816$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-021386$JAZZ$$34$YR$$F$Y$$$20240926$$MD$US$US
242180111$24218011$1$I$$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408061515580660-ZSMPB$GB-TEVA-VS-3230772$TEVA$$89$YR$$F$Y$$$20240816$$PH$GB$GB
242180121$24218012$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130043$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240816$$CN$US$US
242180131$24218013$1$I$$20240812$20240816$20240816$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-127326$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240816$$HP$TW$TW
242180142$24218014$2$F$$20240813$20240816$20240821$EXP$$BR-DSJP-DSE-2024-140527$DAIICHI$$67$YR$$F$Y$$$20240821$$MD$BR$BR
242180151$24218015$1$I$20211020$20240806$20240816$20240816$EXP$$JP-AKEBIA THERAPEUTICS, INC.-AKE-2022-000340$AKEBIA THERAPEUTICS$$$$$$Y$$$20240816$$MD$JP$JP
242180161$24218016$1$I$20240317$20240806$20240816$20240816$EXP$$GB-TEVA-VS-3230562$TEVA$$78$YR$$M$Y$85$KG$20240816$$MD$GB$GB
242180172$24218017$2$F$$20240816$20240816$20240822$PER$$US-BIOGEN-2024BI01278335$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242180191$24218019$1$I$20240810$20240810$20240816$20240816$EXP$$JP-PFIZER INC-PV202400104854$PFIZER$$$$C$$Y$$$20240816$$CN$JP$JP
242180202$24218020$2$F$$20240919$20240816$20240923$30DAY$$KR-PFIZER INC-202400237400$PFIZER$$13$YR$$$Y$$$20240923$$CN$KR$KR
242180211$24218021$1$I$20240520$20240813$20240816$20240816$EXP$CH-SM-2024-14215$CH-PFIZER INC-202400235692$PFIZER$$48$YR$$M$Y$73$KG$20240816$$PH$CH$CH
242180221$24218022$1$I$$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408061032103830-KCFHY$GB-TEVA-VS-3230539$TEVA$$37$YR$$F$Y$$$20240816$$PH$GB$GB
242180231$24218023$1$I$$20240808$20240816$20240816$EXP$$ZA-AstraZeneca-2024A181133$ASTRAZENECA$$23010$DY$$M$Y$$$20240816$$CN$ZA$
242180241$24218024$1$I$$20240812$20240816$20240816$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-110668$REGENERON$$$$$M$Y$$$20240816$$CN$US$US
242180261$24218026$1$I$20230101$20240814$20240816$20240816$EXP$$US-BAUSCH-BL-2023-011745$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240816$$CN$US$US
242180271$24218027$1$I$$20240805$20240816$20240816$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15824$IPSEN$$$$$F$Y$$$20240816$$CN$US$US
242180282$24218028$2$F$20240628$20240820$20240816$20240829$EXP$$IT-BIOGEN-2024BI01277098$BIOGEN$$69$YR$$F$Y$$$20240829$$MD$IT$IT
242180291$24218029$1$I$$20240806$20240816$20240816$EXP$GB-MHRA-MED-202408061410485740-TCFWQ$GB-TEVA-VS-3230663$TEVA$$42$YR$$F$Y$64$KG$20240816$$MD$GB$GB
242180304$24218030$4$F$20240801$20240913$20240816$20240919$EXP$$US-Calliditas-2024CAL01556$CALLIDITAS THERAPEUTICS$$61$YR$A$F$Y$93.4$KG$20240919$$CN$US$US
242180312$24218031$2$F$20240724$20240826$20240816$20240829$EXP$$US-ROCHE-10000058359$ROCHE$$78$YR$E$F$Y$$$20240829$$CN$US$US
242180321$24218032$1$I$$20240814$20240816$20240816$EXP$$CA-BAUSCH-BL-2024-012384$BAUSCH AND LOMB$$40$YR$$F$Y$73$KG$20240816$$MD$CA$CA
242180331$24218033$1$I$$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56455$$FDA-CTU$$$$$M$N$$$20240815$N$$US$
242180342$24218034$2$F$20240712$20240806$20240816$20240823$EXP$$CN-BEH-2024177026$CSL BEHRING$$87$YR$E$M$Y$60$KG$20240823$$CN$CN$CN
242180351$24218035$1$I$$20240816$20240816$20240816$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046262$BOEHRINGER INGELHEIM$$$$$$Y$$$20240816$$CN$US$US
242180361$24218036$1$I$20240201$20240812$20240816$20240816$EXP$$ES-AUROBINDO-AUR-APL-2024-040736$AUROBINDO$$82$YR$$F$Y$$$20240816$$MD$ES$ES
242180371$24218037$1$I$$20240809$20240816$20240816$PER$$US-RDY-SPO/USA/24/0011836$DR REDDYS$$22$YR$A$F$Y$$$20240816$$MD$US$US
242180391$24218039$1$I$20240709$20240722$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116765$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$69.4$KG$20240816$$CN$US$US
242180401$24218040$1$I$$20240812$20240816$20240816$EXP$$US-JNJFOC-20240835682$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240816$$HP$US$US
242180411$24218041$1$I$$20240812$20240816$20240816$EXP$$NVSC2024ZA164495$NOVARTIS$$66$YR$$M$Y$$$20240816$$HP$ZA$ZA
242180421$24218042$1$I$$20240815$20240816$20240816$EXP$$NVSC2024US165815$NOVARTIS$$$$$F$Y$$$20240816$$HP$US$US
242180431$24218043$1$I$$20240809$20240816$20240816$PER$$US-ROCHE-10000053940$ROCHE$$$$$M$Y$$$20240816$$HP$US$US
242180441$24218044$1$I$$20240807$20240816$20240816$30DAY$$US-GSK-US2024AMR100182$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$US$US
242180451$24218045$1$I$$20240812$20240816$20240816$PER$$US-ROCHE-10000055765$ROCHE$$$$A$M$Y$$$20240816$$CN$US$US
242180471$24218047$1$I$$20240808$20240816$20240816$PER$$US-ABBVIE-5875053$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242180481$24218048$1$I$$20240808$20240816$20240816$EXP$$CA-GSK-CA2023143086$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$CA$CA
242180491$24218049$1$I$20240806$20240813$20240816$20240816$PER$$US-ROCHE-10000058303$ROCHE$$25$YR$A$M$Y$$$20240816$$CN$US$US
242180502$24218050$2$F$20240401$20240822$20240816$20240827$EXP$$US-SPRINGWORKS THERAPEUTICS-SW-001678$SPRINGWORKS THERAPEUTIC$$45$YR$$F$Y$$$20240827$$CN$US$US
242180521$24218052$1$I$$20240812$20240816$20240816$EXP$$FR-MYLANLABS-2024M1074827$MYLAN$$$$$$Y$$$20240816$$MD$FR$FR
242180531$24218053$1$I$$20240815$20240816$20240816$PER$$NVSC2024US166488$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242180542$24218054$2$F$$20240813$20240816$20240820$EXP$$AU-PFIZER INC-202400235057$PFIZER$Li, A.. Metastatic Small Cell Carcinoma of the Bladder Complicated by Paraneoplastic Acute Thrombocytopenia. Cureus. 2024;16(6):10.7759/cureus.63480$76$YR$$M$Y$$$20240820$$MD$AU$AU
242180561$24218056$1$I$20240717$20240814$20240816$20240816$PER$$US-ROCHE-10000057494$ROCHE$$19$YR$A$M$Y$84.37$KG$20240816$$CN$US$US
242180572$24218057$2$F$$20240912$20240816$20240913$PER$$US-ROCHE-10000057628$ROCHE$$$$C$M$Y$19.96$KG$20240913$$CN$US$US
242180582$24218058$2$F$$20240909$20240816$20240910$PER$$US-ROCHE-10000057435$ROCHE$$$$I$M$Y$$$20240910$$CN$US$US
242180592$24218059$2$F$20240729$20240820$20240816$20240903$EXP$$US-NAPO PHARMACEUTICALS-2024US002546$PAREXEL$$$$$$Y$$$20240903$$CN$US$US
242180604$24218060$4$F$20240808$20240910$20240816$20240924$EXP$$AU-GUERBET / LLC-AU-20240048$GUERBET$$63$YR$A$M$Y$80$KG$20240924$$HP$AU$AU
242180611$24218061$1$I$$20240813$20240816$20240816$PER$$US-HALEON-2191953$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242180621$24218062$1$I$$20240814$20240816$20240816$PER$$US-ROCHE-10000058433$ROCHE$$$$A$M$Y$$$20240816$$CN$US$US
242180631$24218063$1$I$$20240814$20240816$20240816$PER$$US-ROCHE-10000057839$ROCHE$$57$YR$A$F$Y$$$20240816$$CN$US$US
242180641$24218064$1$I$20231201$20240807$20240816$20240816$EXP$$AR-GSK-AR2024AMR098989$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$AR$AR
242180651$24218065$1$I$20240701$20240814$20240816$20240816$PER$$US-Eisai-EC-2024-170085$EISAI$$64$YR$A$M$Y$$$20240816$$CN$US$US
242180661$24218066$1$I$20240101$20240809$20240816$20240816$EXP$$US-Eisai-EC-2024-170483$EISAI$$65$YR$E$$Y$$$20240816$$CN$US$US
242180671$24218067$1$I$$20240814$20240816$20240816$PER$$US-ROCHE-10000058401$ROCHE$$$$T$M$Y$$$20240816$$CN$US$US
242180681$24218068$1$I$20240724$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56438$$FDA-CTU$$$$$M$N$67.5$KG$20240815$N$MD$US$
242180691$24218069$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56529$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242180711$24218071$1$I$$20240815$20240816$20240816$PER$$NVSC2024US166496$NOVARTIS$$$$$M$Y$$$20240816$$HP$US$US
242180722$24218072$2$F$20240723$20240919$20240816$20240926$EXP$IT-MINISAL02-999016$NVSC2024IT166066$NOVARTIS$$21$YR$$F$Y$50$KG$20240926$$MD$IT$IT
242180731$24218073$1$I$$20240812$20240816$20240816$EXP$$US-SANDOZ INC.-SDZ2024US072616$SANDOZ$$$$$$Y$$$20240816$$HP$US$US
242180741$24218074$1$I$$20240402$20240816$20240816$EXP$$US-Hello Bello Consumer Wellness-2160543$COSMETIC MANUFACTURER$$38$YR$$F$Y$$$20240816$$$US$US
242180751$24218075$1$I$$20240815$20240816$20240816$PER$$US-ROCHE-10000058469$ROCHE$$$$C$M$Y$$$20240816$$CN$US$US
242180761$24218076$1$I$$20240805$20240816$20240816$EXP$$US-B.Braun Medical Inc.-2160541$B BRAUN$Literature Article$86$YR$$F$Y$$$20240816$$$US$US
242180781$24218078$1$I$$20240814$20240816$20240816$PER$$US-ROCHE-10000057837$ROCHE$$9$YR$C$M$Y$$$20240816$$CN$US$US
242180801$24218080$1$I$20240815$20240815$20240815$20240815$DIR$FDA-CDER-CTU-2024-56442$$FDA-CTU$$69$YR$$M$N$78$KG$20240815$N$CN$US$
242180811$24218081$1$I$$20240809$20240816$20240816$EXP$$CA-GSK-CA2024099689$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$CA$CA
242180821$24218082$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56530$$FDA-CTU$$$$$M$N$$$20240815$N$HP$US$
242180831$24218083$1$I$20240630$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129948$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240816$$CN$US$US
242180841$24218084$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56505$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242180851$24218085$1$I$20240811$20240811$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128258$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240816$$CN$US$US
242180862$24218086$2$F$$20240809$20240816$20240820$EXP$$AU-JNJFOC-20240834112$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$HP$AU$AU
242180871$24218087$1$I$20240804$20240815$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129943$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240816$$HP$US$US
242180882$24218088$2$F$20240801$20240821$20240816$20240830$EXP$$GB-KARYOPHARM-2024KPT001441$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240830$$HP$GB$GB
242180892$24218089$2$F$20240801$20240828$20240816$20240906$EXP$$MX-BIOVITRUM-2024-MX-010945$BIOVITRUM$$18$MON$$M$Y$9.8$KG$20240906$$CN$MX$MX
242180901$24218090$1$I$20240618$20240807$20240816$20240816$EXP$FR-AFSSAPS-NC2024000834$FR-TEVA-VS-3231734$TEVA$$85$YR$$M$Y$$$20240816$$MD$FR$FR
242180911$24218091$1$I$$20240812$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2023CA016857$SANDOZ$$$$$M$Y$$$20240816$$CN$CA$CA
242180921$24218092$1$I$20240107$20240807$20240816$20240816$EXP$FR-AFSSAPS-TO2024001399$FR-TEVA-VS-3231656$TEVA$$66$YR$$M$Y$$$20240816$$PH$FR$FR
242180931$24218093$1$I$$20240809$20240816$20240816$EXP$US-MLMSERVICE-20240802-PI151713-00312-1$US-RDY-SPO/USA/24/0011785$DR REDDYS$Bragg K, Miller H, Buckshaw R, Simon LV, King C. Testosterone Therapy as an Isolated Risk Factor for Venous Thrombosis: A Case Report. Cureus. 2024;16(7):e63611. DOI: 10.7759/cureus.63611.$3$DEC$A$M$Y$$$20240816$$MD$US$US
242180941$24218094$1$I$20240720$20240809$20240816$20240816$EXP$ES-AEMPS-1558327$ES-RDY-SPO/ESP/24/0011746$DR REDDYS$$64$YR$A$F$Y$54$KG$20240816$$MD$ES$ES
242180953$24218095$3$F$20240101$20240827$20240816$20240830$EXP$$US-AVEO PHARMACEUTICALS, INC.-2024-AVEO-US000575$PAREXEL$$$$$$Y$$$20240830$$CN$US$US
242180961$24218096$1$I$$20240812$20240816$20240816$EXP$GB-MHRA-MED-202408121431509000-KYFPC$GB-RDY-SPO/GBR/24/0011840$DR REDDYS$$51$YR$A$M$Y$$$20240816$$CN$GB$GB
242180971$24218097$1$I$$20240813$20240816$20240816$EXP$$JP-JNJFOC-20240841206$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240816$$MD$JP$JP
242180981$24218098$1$I$$20240808$20240816$20240816$EXP$$JP-AstraZeneca-2024A143877$ASTRAZENECA$$75$YR$$F$Y$$$20240816$$MD$JP$
242180991$24218099$1$I$$20240808$20240816$20240816$EXP$$VN-AstraZeneca-2024A183021$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$VN$
242181001$24218100$1$I$$20240809$20240816$20240816$EXP$$CA-AstraZeneca-2024A185215$ASTRAZENECA$$26$YR$$F$Y$$$20240816$$HP$CA$
242181012$24218101$2$F$20240801$20240812$20240816$20240913$EXP$$US-AstraZeneca-2024A183800$ASTRAZENECA$$987$MON$$M$Y$$$20240913$$CN$US$
242181021$24218102$1$I$20231201$20240807$20240816$20240816$EXP$FR-AFSSAPS-TS2024000867$FR-TEVA-VS-3231807$TEVA$$61$YR$$M$Y$110$KG$20240816$$MD$FR$FR
242181041$24218104$1$I$20240527$20240808$20240816$20240816$EXP$$CH-AstraZeneca-2024A185884$ASTRAZENECA$$48$YR$$M$Y$$$20240816$$MD$CH$
242181051$24218105$1$I$20240804$20240808$20240816$20240816$EXP$$PE-AstraZeneca-2024A182188$ASTRAZENECA$$20256$DY$$M$Y$$$20240816$$CN$PE$
242181061$24218106$1$I$$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A183427$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242181071$24218107$1$I$$20240813$20240816$20240816$EXP$$AU-MYLANLABS-2024M1075329$MYLAN$$$$$F$Y$$$20240816$$HP$AU$AU
242181081$24218108$1$I$$20240806$20240816$20240816$EXP$$PL-TEVA-VS-3231667$TEVA$Soboci ska M. High-grade adenocarcinoma of the prostate in a 32-year-old patient. PROGRESS IN HEALTH SCIENCES. 2024;(1):56-59$32$YR$$M$Y$$$20240816$$HP$PL$PL
242181091$24218109$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192238$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242181101$24218110$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56509$$FDA-CTU$$$$$M$N$$$20240815$N$HP$US$
242181121$24218112$1$I$20240801$20240807$20240816$20240816$DIR$FDA-CDER-CTU-2024-56518$$FDA-CTU$$48$YR$$F$N$$$20240807$N$HP$US$
242181131$24218113$1$I$20240701$20240809$20240816$20240816$DIR$FDA-CDER-CTU-2024-56510$$FDA-CTU$$49$YR$$M$N$$$20240809$N$HP$US$
242181142$24218114$2$F$20240729$20240903$20240816$20240906$EXP$$US-ABBVIE-5878002$ABBVIE$$52$YR$$M$Y$$$20240906$$CN$US$US
242181152$24218115$2$F$$20240829$20240816$20240829$EXP$$CA-BAYER-2024A117045$BAYER$$$$$F$Y$$$20240829$$HP$CA$CA
242181161$24218116$1$I$$20240814$20240816$20240816$EXP$$RU-BIOVITRUM-2024-RU-010942$BIOVITRUM$$$$E$F$Y$$$20240816$$MD$RU$RU
242181171$24218117$1$I$20240805$20240807$20240816$20240816$EXP$$CN-BIOVITRUM-2024-CN-010754$BIOVITRUM$$55$YR$$F$Y$86$KG$20240816$$MD$CN$CN
242181183$24218118$3$F$20240101$20240828$20240816$20240831$EXP$$US-ABBVIE-5877993$ABBVIE$$75$YR$$M$Y$90.718$KG$20240831$$CN$US$US
242181191$24218119$1$I$20240601$20240813$20240816$20240816$EXP$$US-ABBVIE-5880611$ABBVIE$$42$YR$$F$Y$$$20240816$$CN$US$US
242181201$24218120$1$I$$20240809$20240816$20240816$PER$$US-ABBVIE-5876525$ABBVIE$$$$$$Y$$$20240816$$HP$US$US
242181211$24218121$1$I$$20240815$20240816$20240816$EXP$$US-INCYTE CORPORATION-2024IN008559$INCYTE$$$$$$Y$$$20240816$$CN$US$US
242181232$24218123$2$F$20240807$20240917$20240816$20240918$30DAY$$FI-PFIZER INC-202400232740$PFIZER$$$$$$Y$$$20240918$$PH$FI$FI
242181251$24218125$1$I$$20240807$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR099051$VIIV$$$$$M$Y$$$20240816$$CN$US$US
242181261$24218126$1$I$$20240814$20240816$20240816$EXP$$BR-GSK-BR2024AMR094675$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$BR$BR
242181271$24218127$1$I$20240625$20240808$20240816$20240816$EXP$$JP-GUERBET / LLC-JP-20240087$GUERBET$$4$DEC$A$F$Y$$$20240816$$MD$JP$JP
242181282$24218128$2$F$20230101$20240813$20240816$20240822$PER$$US-PFIZER INC-202400236932$PFIZER$$82$YR$$F$Y$$$20240822$$HP$US$US
242181292$24218129$2$F$$20240814$20240816$20240819$PER$$US-PFIZER INC-202400236616$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
242181301$24218130$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400237545$PFIZER$$56$YR$$M$Y$$$20240816$$CN$US$US
242181311$24218131$1$I$20240404$20240814$20240816$20240816$EXP$$US-PFIZER INC-202400236980$PFIZER$$61$YR$$F$Y$$$20240816$$CN$US$US
242181321$24218132$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-PV202400106040$PFIZER$$48$YR$$F$Y$$$20240816$$HP$US$US
242181332$24218133$2$F$$20240814$20240816$20240819$PER$$US-PFIZER INC-202400236495$PFIZER$$$$$F$Y$46.72$KG$20240819$$CN$US$US
242181351$24218135$1$I$$20240815$20240816$20240816$EXP$$US-INCYTE CORPORATION-2024IN008558$INCYTE$$$$$$Y$$$20240816$$HP$US$US
242181361$24218136$1$I$$20240815$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129934$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240816$$HP$US$US
242181371$24218137$1$I$20240806$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129306$BRISTOL MYERS SQUIBB$$98$YR$E$M$Y$$$20240816$$CN$US$US
242181382$24218138$2$F$20240101$20240905$20240816$20240913$EXP$$BR-SA-2024SA234312$SANOFI AVENTIS$$$$$F$Y$$$20240913$$LW$BR$BR
242181391$24218139$1$I$$20240814$20240816$20240816$EXP$$US-JNJFOC-20240836403$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
242181401$24218140$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236992$PFIZER$$27$YR$$F$Y$$$20240816$$MD$US$US
242181411$24218141$1$I$$20240813$20240816$20240816$PER$$US-PFIZER INC-202400236979$PFIZER$$52$YR$$F$Y$$$20240816$$HP$US$US
242181421$24218142$1$I$$20240812$20240816$20240816$PER$$US-PFIZER INC-202400236289$PFIZER$$65$YR$$F$Y$$$20240816$$HP$US$US
242181431$24218143$1$I$$20240812$20240816$20240816$PER$$US-PFIZER INC-PV202400105883$PFIZER$$$$$F$Y$$$20240816$$CN$US$US
242181442$24218144$2$F$$20240818$20240816$20240822$PER$$US-PFIZER INC-202400235348$PFIZER$$13$YR$$M$Y$$$20240822$$CN$US$US
242181451$24218145$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236987$PFIZER$$$$E$F$Y$$$20240816$$CN$US$US
242181461$24218146$1$I$20240801$20240813$20240816$20240816$PER$$US-PFIZER INC-202400235814$PFIZER$$81$YR$$F$Y$$$20240816$$CN$US$US
242181471$24218147$1$I$$20240813$20240816$20240816$PER$$US-PFIZER INC-PV202400089883$PFIZER$$76$YR$$M$Y$86.6$KG$20240816$$MD$US$US
242181491$24218149$1$I$20240401$20240814$20240816$20240816$PER$$US-PFIZER INC-202400237472$PFIZER$$63$YR$$F$Y$$$20240816$$CN$US$US
242181501$24218150$1$I$20240401$20240813$20240816$20240816$PER$$US-PFIZER INC-202400237191$PFIZER$$45$YR$$F$Y$$$20240816$$HP$US$US
242181511$24218151$1$I$20240813$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236972$PFIZER$$65$YR$$$Y$69.85$KG$20240816$$CN$US$US
242181522$24218152$2$F$$20240818$20240816$20240822$PER$$US-PFIZER INC-202400236679$PFIZER$$65$YR$$F$Y$$$20240822$$MD$US$US
242181533$24218153$3$F$$20240924$20240816$20240927$PER$$US-PFIZER INC-202400237061$PFIZER$$86$YR$$F$Y$$$20240927$$CN$US$US
242181542$24218154$2$F$$20240910$20240816$20240913$PER$$US-PFIZER INC-202400237450$PFIZER$$75$YR$$F$Y$$$20240913$$CN$US$US
242181551$24218155$1$I$$20240813$20240816$20240816$PER$$US-PFIZER INC-202400236641$PFIZER$$17$YR$$$Y$$$20240816$$CN$US$US
242181561$24218156$1$I$$20240813$20240816$20240816$PER$$US-PFIZER INC-PV202400106195$PFIZER$$58$YR$$F$Y$$$20240816$$CN$US$US
242181571$24218157$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236561$PFIZER$$$$$$Y$$$20240816$$MD$US$US
242181582$24218158$2$F$19900415$20240826$20240816$20240829$PER$$US-PFIZER INC-PV202400045780$PFIZER$$28$YR$$M$Y$68.04$KG$20240829$$CN$US$US
242181592$24218159$2$F$20240801$20240820$20240816$20240822$PER$$KR-PFIZER INC-202400237719$PFIZER$$$$E$$Y$$$20240822$$PH$KR$KR
242181602$24218160$2$F$20240811$20240903$20240816$20240904$PER$$US-PFIZER INC-202400236978$PFIZER$$69$YR$$F$Y$59.864$KG$20240904$$CN$US$US
242181611$24218161$1$I$20240701$20240809$20240816$20240816$PER$$US-PFIZER INC-202400236587$PFIZER$$71$YR$$F$Y$$$20240816$$HP$US$US
242181621$24218162$1$I$20240806$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236251$PFIZER$$64$YR$$F$Y$$$20240816$$HP$US$US
242181631$24218163$1$I$20240814$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236914$PFIZER$$45$YR$$M$Y$$$20240816$$CN$US$US
242181641$24218164$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400237062$PFIZER$$32$YR$$F$Y$$$20240816$$MD$US$US
242181654$24218165$4$F$$20240904$20240816$20240905$PER$$US-PFIZER INC-PV202400106288$PFIZER$$72$YR$$F$Y$$$20240905$$CN$US$US
242181661$24218166$1$I$$20240813$20240816$20240816$PER$$US-PFIZER INC-PV202400106169$PFIZER$$77$YR$$M$Y$71.202$KG$20240816$$MD$US$US
242181671$24218167$1$I$20240601$20240814$20240816$20240816$PER$$US-PFIZER INC-PV202400091169$PFIZER$$49$YR$$F$Y$$$20240816$$HP$US$US
242181681$24218168$1$I$20240813$20240813$20240816$20240816$PER$$US-PFIZER INC-202400235894$PFIZER$$63$YR$$F$Y$32.43$KG$20240816$$PH$US$US
242181691$24218169$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236889$PFIZER$$$$$F$Y$$$20240816$$PH$US$US
242181701$24218170$1$I$$20240812$20240816$20240816$PER$$US-PFIZER INC-PV202400105945$PFIZER$$57$YR$$F$Y$$$20240816$$CN$US$US
242181711$24218171$1$I$$20240815$20240816$20240816$PER$$US-PFIZER INC-202400237514$PFIZER$$$$A$M$Y$$$20240816$$MD$US$US
242181721$24218172$1$I$20240801$20240813$20240816$20240816$PER$$US-PFIZER INC-202400236071$PFIZER$$$$$$Y$$$20240816$$CN$US$US
242181731$24218173$1$I$$20240812$20240816$20240816$PER$$US-PFIZER INC-202400235471$PFIZER$$53$YR$$F$Y$$$20240816$$HP$US$US
242181741$24218174$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236995$PFIZER$$62$YR$$M$Y$$$20240816$$MD$US$US
242181751$24218175$1$I$$20240813$20240816$20240816$PER$$US-PFIZER INC-PV202400105959$PFIZER$$89$YR$$M$Y$$$20240816$$CN$US$US
242181761$24218176$1$I$$20240813$20240816$20240816$PER$$US-PFIZER INC-202400237002$PFIZER$$66$YR$$F$Y$$$20240816$$MD$US$US
242181772$24218177$2$F$$20240815$20240816$20240820$PER$$US-PFIZER INC-PV202400106478$PFIZER$$76$YR$$F$Y$$$20240820$$HP$US$US
242181781$24218178$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400231254$PFIZER$$33$YR$$F$Y$$$20240816$$CN$US$US
242181791$24218179$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236661$PFIZER$$$$$M$Y$$$20240816$$MD$US$US
242181801$24218180$1$I$20230801$20240814$20240816$20240816$PER$$US-PFIZER INC-202400237024$PFIZER$$76$YR$$F$Y$$$20240816$$HP$US$US
242181811$24218181$1$I$20240811$20240814$20240816$20240816$PER$$US-PFIZER INC-202400237211$PFIZER$$72$YR$$M$Y$$$20240816$$CN$US$US
242181821$24218182$1$I$20240813$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236982$PFIZER$$76$YR$$M$Y$$$20240816$$CN$US$US
242181831$24218183$1$I$$20240815$20240816$20240816$PER$$US-PFIZER INC-202400237532$PFIZER$$$$A$M$Y$$$20240816$$MD$US$US
242181841$24218184$1$I$20240812$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236705$PFIZER$$68$YR$$F$Y$$$20240816$$CN$US$US
242181851$24218185$1$I$$20240812$20240816$20240816$PER$$US-PFIZER INC-202101732751$PFIZER$$69$YR$$M$Y$$$20240816$$CN$US$US
242181861$24218186$1$I$$20240815$20240816$20240816$PER$$US-PFIZER INC-202400237550$PFIZER$$$$A$F$Y$$$20240816$$HP$US$US
242181871$24218187$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400201181$PFIZER$$69$YR$$F$Y$$$20240816$$CN$US$US
242181882$24218188$2$F$$20240814$20240816$20240819$PER$$US-PFIZER INC-202400236586$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
242181891$24218189$1$I$$20240813$20240816$20240816$PER$$US-PFIZER INC-202400236106$PFIZER$$66$YR$$M$Y$$$20240816$$MD$US$US
242181901$24218190$1$I$20240808$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236934$PFIZER$$71$YR$$F$Y$$$20240816$$CN$US$US
242181911$24218191$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400237636$PFIZER$$64$YR$$F$Y$$$20240816$$HP$US$US
242181922$24218192$2$F$20240101$20240814$20240816$20240821$PER$$US-PFIZER INC-202400236733$PFIZER$$68$YR$$F$Y$$$20240821$$CN$US$US
242181941$24218194$1$I$$20240813$20240816$20240816$PER$$US-PFIZER INC-PV202400106251$PFIZER$$57$YR$$F$Y$$$20240816$$CN$US$US
242181951$24218195$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400237623$PFIZER$$$$$F$Y$$$20240816$$MD$US$US
242181962$24218196$2$F$20240730$20240903$20240816$20240905$PER$$US-PFIZER INC-202400236168$PFIZER$$58$YR$$M$Y$87.528$KG$20240905$$MD$US$US
242181971$24218197$1$I$$20240812$20240816$20240816$PER$$US-PFIZER INC-PV202300197550$PFIZER$$65$YR$$F$Y$68.04$KG$20240816$$CN$US$US
242181981$24218198$1$I$20240707$20240813$20240816$20240816$PER$$US-PFIZER INC-202400236287$PFIZER$$68$YR$$F$Y$76.2$KG$20240816$$CN$US$US
242181991$24218199$1$I$20240716$20240813$20240816$20240816$PER$$US-PFIZER INC-202400236015$PFIZER$$88$YR$$F$Y$$$20240816$$HP$US$US
242182001$24218200$1$I$$20240812$20240816$20240816$PER$$US-PFIZER INC-202400235497$PFIZER$$67$YR$$F$Y$$$20240816$$CN$US$US
242182011$24218201$1$I$$20240812$20240816$20240816$PER$$US-PFIZER INC-202400236056$PFIZER$$70$YR$$F$Y$$$20240816$$PH$US$US
242182021$24218202$1$I$20240807$20240812$20240816$20240816$PER$$US-PFIZER INC-202400236000$PFIZER$$88$YR$$F$Y$$$20240816$$HP$US$US
242182031$24218203$1$I$$20240813$20240816$20240816$PER$$US-PFIZER INC-202400235867$PFIZER$$$$$$Y$$$20240816$$PH$US$US
242182042$24218204$2$F$$20240910$20240816$20240911$PER$$US-PFIZER INC-202400237014$PFIZER$$58$YR$$F$Y$49.887$KG$20240911$$CN$US$US
242182051$24218205$1$I$$20240812$20240816$20240816$PER$$US-PFIZER INC-PV202400105069$PFIZER$$37$YR$$M$Y$$$20240816$$CN$US$US
242182062$24218206$2$F$$20240906$20240816$20240910$PER$$US-PFIZER INC-PV202400105811$PFIZER$$$$$M$Y$$$20240910$$CN$US$US
242182082$24218208$2$F$$20240814$20240816$20240819$PER$$US-PFIZER INC-PV202400106257$PFIZER$$$$$$Y$$$20240819$$CN$US$US
242182093$24218209$3$F$20240801$20240823$20240816$20240828$PER$$US-PFIZER INC-202400237740$PFIZER$$62$YR$$M$Y$104.31$KG$20240828$$CN$US$US
242182112$24218211$2$F$20240801$20240815$20240816$20240821$PER$$US-PFIZER INC-202400236674$PFIZER$$47$YR$$M$Y$$$20240821$$CN$US$US
242182121$24218212$1$I$20240813$20240814$20240816$20240816$PER$$US-PFIZER INC-202400237255$PFIZER$$36$YR$$F$Y$$$20240816$$CN$US$US
242182131$24218213$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400237196$PFIZER$$50$YR$$$Y$$$20240816$$MD$US$US
242182142$24218214$2$F$20240813$20240814$20240816$20240819$PER$$US-PFIZER INC-202400236536$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
242182153$24218215$3$F$$20240909$20240816$20240911$PER$$US-PFIZER INC-PV202400102697$PFIZER$$61$YR$$F$Y$$$20240911$$HP$US$US
242182161$24218216$1$I$20240807$20240813$20240816$20240816$PER$$US-PFIZER INC-202400236991$PFIZER$$50$YR$$F$Y$$$20240816$$HP$US$US
242182171$24218217$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236981$PFIZER$$44$YR$$F$Y$$$20240816$$CN$US$US
242182182$24218218$2$F$$20240906$20240816$20240910$PER$$US-PFIZER INC-PV202400106189$PFIZER$$13$YR$$F$Y$$$20240910$$HP$US$US
242182191$24218219$1$I$$20240813$20240816$20240816$PER$$US-PFIZER INC-PV202400105688$PFIZER$$50$YR$$$Y$$$20240816$$CN$US$US
242182201$24218220$1$I$$20240815$20240816$20240816$PER$$JP-PFIZER INC-202400236913$PFIZER$$$$$$Y$$$20240816$$PH$JP$JP
242182212$24218221$2$F$20240731$20240827$20240816$20240912$EXP$$US-SA-2024SA242665$SANOFI AVENTIS$$57$YR$A$M$Y$124$KG$20240912$$MD$US$US
242182221$24218222$1$I$$20240807$20240816$20240816$PER$$US-INCYTE CORPORATION-2024IN008276$INCYTE$$$$$$Y$$$20240816$$CN$US$US
242182231$24218223$1$I$$20240810$20240816$20240816$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006450$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242182242$24218224$2$F$$20240909$20240816$20240913$PER$$US-009507513-2408USA001199$MERCK$$$$$F$Y$59.9$KG$20240913$$HP$US$US
242182252$24218225$2$F$$20240903$20240816$20240910$EXP$$CA-GSK-CA2022AMR105037$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$HP$CA$CA
242182261$24218226$1$I$$20240812$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2024CA072095$SANDOZ$$43$YR$$F$Y$96$KG$20240816$$HP$CA$CA
242182271$24218227$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56491$$FDA-CTU$$50$YR$$F$N$$$20240816$N$$US$
242182281$24218228$1$I$20240814$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56545$$FDA-CTU$$63$YR$$F$N$$$20240816$N$PH$US$
242182291$24218229$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56544$$FDA-CTU$$62$YR$$F$N$$$20240816$N$$US$
242182311$24218231$1$I$$20240807$20240816$20240816$EXP$$US-MYLANLABS-2024M1075143$MYLAN$Kelly L, Ahmed E. When Buprenorphine is Not Enough: A Case of Transitioning Off of Buprenorphine in Cancer Pain and Opioid Use Disorder. J-Pain-Symptom-Manage 2024; 67 (5): e757-e758.$55$YR$$M$Y$$$20240816$$MD$US$US
242182322$24218232$2$F$20240101$20240829$20240816$20240903$EXP$$US-ORGANON-O2408USA001234$ORGANON$$$$$F$Y$65.7$KG$20240903$$HP$US$US
242182332$24218233$2$F$$20240819$20240816$20240903$EXP$$US-GENERICUS, INC.-2024GNR00007$GENERICUS$$$$$M$Y$40.122$KG$20240903$$CN$US$US
242182341$24218234$1$I$$20240809$20240816$20240816$EXP$$US-SA-2024SA242719$SANOFI AVENTIS$$$$A$F$Y$77.11$KG$20240816$$MD$US$US
242182351$24218235$1$I$$20240809$20240816$20240816$EXP$$US-SA-2024SA241849$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$HP$US$US
242182371$24218237$1$I$$20240814$20240816$20240816$PER$$US-BIOVITRUM-2024-US-010918$BIOVITRUM$$42$YR$$F$Y$$$20240816$$CN$US$US
242182381$24218238$1$I$$20240813$20240816$20240816$EXP$$US-JNJFOC-20240836035$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$CN$US$US
242182392$24218239$2$F$$20240826$20240816$20240916$EXP$$US-SA-2024SA138676$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
242182401$24218240$1$I$$20240815$20240816$20240816$EXP$GB-MHRA-MED-202408150536153340-FDRHY$GB-TEVA-VS-3233545$TEVA$$$$$F$Y$$$20240816$$CN$GB$GB
242182411$24218241$1$I$$20240812$20240816$20240816$PER$$US-Taiho Oncology Inc-2024-007808$TAIHO ONCOLOGY INC$$$$$F$Y$$$20240816$$HP$US$US
242182422$24218242$2$F$$20240814$20240816$20240829$EXP$$TW-ALXN-202408ASI000815TW$ALEXION PHARMACEUTICALS$$41$YR$$M$Y$$$20240829$$MD$TW$TW
242182431$24218243$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56522$$FDA-CTU$$74$YR$$F$N$$$20240816$N$$US$
242182451$24218245$1$I$20201101$20240812$20240816$20240816$EXP$GB-MHRA-MED-202408121641507570-NDJLF$GB-RDY-SPO/GBR/24/0011837$DR REDDYS$$22$YR$A$F$Y$67$KG$20240816$$CN$GB$GB
242182461$24218246$1$I$20231201$20240809$20240816$20240816$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003803$CURRAX PHARMACEUTICALS$$46$YR$$F$Y$$$20240816$$CN$CA$CA
242182482$24218248$2$F$20240808$20240917$20240816$20240924$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003804$CURRAX PHARMACEUTICALS$$$$$$Y$$$20240924$$CN$CA$CA
242182492$24218249$2$F$20240801$20240822$20240816$20240902$EXP$$JP-GUERBET / LLC-JP-20240120$GUERBET$$$$A$F$Y$$$20240902$$HP$JP$JP
242182501$24218250$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56535$$FDA-CTU$$71$YR$$F$N$271$LBS$20240816$N$$US$
242182511$24218251$1$I$20240712$20240809$20240816$20240816$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003473$CURRAX PHARMACEUTICALS$$70$YR$$F$Y$$$20240816$$CN$CA$CA
242182531$24218253$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127549$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240816$$HP$US$US
242182541$24218254$1$I$20240101$20240814$20240816$20240816$EXP$$US-UCBSA-2024041212$UCB$$$$$F$Y$$$20240816$$MD$US$US
242182551$24218255$1$I$$20240809$20240816$20240816$EXP$$US-ARGENX-2024-ARGX-US006487$ARGENX BVBA$$$$$$Y$$$20240816$$HP$US$US
242182561$24218256$1$I$20240601$20240813$20240816$20240816$EXP$$US-MYLANLABS-2024M1065963$MYLAN$$57$YR$$F$Y$99.79$KG$20240816$$CN$US$US
242182571$24218257$1$I$20240201$20240814$20240816$20240816$EXP$ES-AEMPS-1559963$NVSC2024ES164847$NOVARTIS$$63$YR$$F$Y$95$KG$20240816$$PH$ES$ES
242182581$24218258$1$I$20230705$20240807$20240816$20240816$EXP$$BR-JNJFOC-20240826768$JOHNSON AND JOHNSON$$74$YR$E$M$Y$61$KG$20240816$$MD$BR$BR
242182591$24218259$1$I$20240101$20240807$20240816$20240816$EXP$$US-JNJFOC-20240818691$JOHNSON AND JOHNSON$$89$YR$E$M$Y$$$20240816$$CN$US$US
242182601$24218260$1$I$$20240813$20240816$20240816$EXP$$US-ABBVIE-5880035$ABBVIE$$$$$F$Y$$$20240816$$HP$US$US
242182611$24218261$1$I$$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162728$AMGEN$$$$$$Y$$$20240816$$PH$US$US
242182631$24218263$1$I$20240101$20240806$20240816$20240816$EXP$$AT-TEVA-VS-3219034$TEVA$$41$YR$$F$Y$$$20240816$$MD$AT$AT
242182641$24218264$1$I$20240101$20240813$20240816$20240816$EXP$$US-ABBVIE-5879953$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242182651$24218265$1$I$$20240813$20240816$20240816$EXP$$CA-ABBVIE-5880716$ABBVIE$$$$A$F$Y$$$20240816$$CN$CA$CA
242182662$24218266$2$F$20240101$20240924$20240816$20240927$EXP$$DE-ABBVIE-5881064$ABBVIE$$59$YR$$M$Y$$$20240927$$CN$DE$DE
242182671$24218267$1$I$$20240731$20240816$20240816$PER$$US-BAYER-2024A112590$BAYER$$$$A$F$Y$$$20240816$$CN$US$US
242182681$24218268$1$I$$20240806$20240816$20240816$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-23-001304$AKEBIA THERAPEUTICS$Imai, Enyu. The Comparison between Vadadustat and Daprodustat Regarding Dose, Cost, and Safety of Treatment for Renal Anemia in Non-dialysis Patients with Chronic Kidney Diseases.. Internal medicine (Tokyo, Japan). 2024;63:13:1855-1861$83$YR$$M$Y$$$20240816$$MD$JP$JP
242182691$24218269$1$I$$20240812$20240816$20240816$PER$$US-JNJFOC-20240835273$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$HP$US$US
242182701$24218270$1$I$$20240813$20240816$20240816$EXP$$KR-JNJFOC-20240838158$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240816$$CN$KR$KR
242182711$24218271$1$I$$20240802$20240816$20240816$DIR$FDA-CDER-CTU-2024-56542$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
242182721$24218272$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56521$$FDA-CTU$$21$YR$$F$N$$$20240816$N$$US$
242182731$24218273$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56541$$FDA-CTU$$64$YR$$M$N$308$LBS$20240816$N$$US$
242182741$24218274$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56526$$FDA-CTU$$66$YR$$F$N$238$LBS$20240816$N$$US$
242182751$24218275$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56524$$FDA-CTU$$60$YR$$F$N$210$LBS$20240816$N$$US$
242182761$24218276$1$I$$20240807$20240816$20240816$EXP$$US-MALLINCKRODT-MNK202405049$MALLINCKRODT$$65$YR$E$F$Y$230$KG$20240816$$HP$US$US
242182771$24218277$1$I$$20240807$20240816$20240816$EXP$$US-MALLINCKRODT-MNK202405059$MALLINCKRODT$$$$$F$Y$$$20240816$$CN$US$US
242182802$24218280$2$F$$20240819$20240816$20240821$EXP$$CA-PFIZER INC-202400234974$PFIZER$$75$YR$$F$Y$$$20240821$$HP$CA$CA
242182812$24218281$2$F$$20240819$20240816$20240826$EXP$$AU-GSK-AU2024100189$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$AU$AU
242182821$24218282$1$I$$20240806$20240816$20240816$EXP$$CA-TEVA-VS-3232041$TEVA$$67$YR$$F$Y$$$20240816$$MD$CA$CA
242182831$24218283$1$I$20240530$20240807$20240816$20240816$PER$$US-BAYER-2024A114562$BAYER$$$$$$Y$$$20240816$$HP$US$US
242182842$24218284$2$F$$20240916$20240816$20240918$EXP$$NVSC2024US166308$NOVARTIS$$$$$F$Y$50.8$KG$20240919$$HP$US$US
242182851$24218285$1$I$$20240815$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129816$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240816$$HP$US$US
242182871$24218287$1$I$20240401$20240813$20240816$20240816$EXP$$US-ABBVIE-5879759$ABBVIE$$66$YR$$F$Y$$$20240816$$CN$US$US
242182881$24218288$1$I$$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129372$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240816$$CN$US$US
242182891$24218289$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A180841$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242182901$24218290$1$I$$20240808$20240816$20240816$EXP$$ZA-AstraZeneca-2024A182299$ASTRAZENECA$$13514$DY$$F$Y$$$20240816$$CN$ZA$
242182911$24218291$1$I$$20240705$20240816$20240816$PER$$US-AMGEN-USASP2024162063$AMGEN$$$$$$Y$$$20240816$$CN$US$US
242182921$24218292$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A182562$ASTRAZENECA$$$$$F$Y$68.9$KG$20240816$$CN$US$
242182931$24218293$1$I$$20240719$20240816$20240816$PER$$US-AstraZeneca-2024A165578$ASTRAZENECA$$$$$$Y$$$20240816$$CN$US$
242182941$24218294$1$I$20240729$20240813$20240816$20240816$EXP$$CN-AstraZeneca-2024A186775$ASTRAZENECA$$29588$DY$$M$Y$69$KG$20240816$$MD$CN$
242182951$24218295$1$I$$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A185501$ASTRAZENECA$$$$$M$Y$$$20240816$$MD$US$
242182961$24218296$1$I$$20240809$20240816$20240816$EXP$$US-AstraZeneca-2024A182671$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242182971$24218297$1$I$$20240808$20240816$20240816$EXP$$ZA-AstraZeneca-2024A182141$ASTRAZENECA$$66$YR$$F$Y$$$20240816$$CN$ZA$
242182981$24218298$1$I$20240601$20240808$20240816$20240816$EXP$$EG-AstraZeneca-2024A133959$ASTRAZENECA$$23175$DY$$F$Y$$$20240816$$CN$EG$
242182991$24218299$1$I$$20240809$20240816$20240816$EXP$$AU-AstraZeneca-2024A182711$ASTRAZENECA$Dhaliwal N, Roberts D.. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. Clinical Toxicology 2024;62(3):168-173.$$$$$Y$$$20240816$$HP$AU$
242183001$24218300$1$I$20240501$20240812$20240816$20240816$EXP$$DE-ABBVIE-5880669$ABBVIE$$58$YR$$F$Y$$$20240816$$CN$DE$DE
242183011$24218301$1$I$$20240812$20240816$20240816$EXP$$CA-AstraZeneca-2024A185774$ASTRAZENECA$$14$YR$$M$Y$41$KG$20240816$$MD$CA$
242183021$24218302$1$I$$20240806$20240816$20240816$EXP$$JP-AKEBIA THERAPEUTICS, INC.-JP-AKEB-23-001380$AKEBIA THERAPEUTICS$Imai Enyu. The Comparison between Vadadustat and Daprodustat Regarding Dose, Cost, and Safety of Treatment for Renal Anemia in Non-dialysis Patients with Chronic Kidney Diseases.. Internal medicine (Tokyo, Japan). 2024;63:13:1855-1861$72$YR$$F$Y$$$20240816$$MD$JP$JP
242183031$24218303$1$I$20240101$20240813$20240816$20240816$EXP$$US-JNJFOC-20240833822$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240816$$HP$US$US
242183041$24218304$1$I$$20240809$20240816$20240816$PER$$US-VERTEX PHARMACEUTICALS-2024-013037$VERTEX$$$$$$Y$$$20240816$$CN$US$US
242183052$24218305$2$F$$20240821$20240816$20240823$EXP$$NVSC2024US165182$NOVARTIS$$$$$M$Y$$$20240823$$HP$US$US
242183061$24218306$1$I$$20240805$20240816$20240816$EXP$$US-BAYER-2024A115291$BAYER$$64$YR$A$F$Y$$$20240816$$CN$US$US
242183071$24218307$1$I$20200502$20240807$20240816$20240816$EXP$PL-URPL-1-1643-2020$PL-TEVA-VS-3231445$TEVA$$18$YR$$F$Y$$$20240816$$MD$PL$PL
242183081$24218308$1$I$$20240719$20240816$20240816$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07448$LUPIN$$$$$$Y$$$20240816$$MD$US$US
242183091$24218309$1$I$20240101$20240813$20240816$20240816$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140638$DAIICHI$$$$$F$Y$$$20240816$$CN$US$US
242183102$24218310$2$F$20231201$20240919$20240816$20240925$EXP$$US-ABBVIE-5881439$ABBVIE$$78$YR$$F$Y$$$20240925$$CN$US$US
242183111$24218311$1$I$20240814$20240814$20240816$20240816$EXP$$CH-ABBVIE-5881118$ABBVIE$$78$YR$$M$Y$$$20240816$$CN$CH$CH
242183121$24218312$1$I$$20240807$20240816$20240816$EXP$$PT-GUERBET / LLC-PT-20240016$GUERBET$Bullous Drug Eruption. 2024;doi:doi/10.1093/ced/llae294/7728278.$63$YR$A$F$Y$$$20240816$$MD$PT$PT
242183132$24218313$2$F$20240710$20240816$20240816$20240821$EXP$$US-KYOWAKIRIN-2024KK019278$KYOWA$$$$$$Y$$$20240821$$HP$US$US
242183141$24218314$1$I$20231012$20240809$20240816$20240816$EXP$$US-OTSUKA-2024_022238$OTSUKA$$59$YR$$M$Y$$$20240816$$HP$US$US
242183151$24218315$1$I$20240702$20240814$20240816$20240816$EXP$$CO-ABBVIE-5882368$ABBVIE$$83$YR$$F$Y$$$20240816$$CN$CO$CO
242183161$24218316$1$I$$20240815$20240816$20240816$EXP$$US-JNJFOC-20240840284$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$HP$US$US
242183171$24218317$1$I$$20240813$20240816$20240816$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140688$DAIICHI$$$$$F$Y$$$20240816$$HP$US$US
242183181$24218318$1$I$20140701$20240801$20240816$20240816$EXP$$DE-SANDOZ INC.-PHHY2018DE104426$SANDOZ$$47$YR$$M$Y$74$KG$20240816$$MD$DE$DE
242183192$24218319$2$F$20240530$20240821$20240816$20240828$EXP$IT-MINISAL02-999073$NVSC2024IT166126$NOVARTIS$$49$YR$$F$Y$70$KG$20240828$$MD$IT$IT
242183201$24218320$1$I$20221223$20240809$20240816$20240816$EXP$$CA-GSK-CA2023002346$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$CA$CA
242183211$24218321$1$I$20240805$20240807$20240816$20240816$PER$$US-ABBVIE-5873780$ABBVIE$$47$YR$$F$Y$$$20240816$$CN$US$US
242183232$24218323$2$F$20240101$20240816$20240816$20240823$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-012624$JAZZ$$70$YR$$$Y$$$20240823$$PH$JP$JP
242183241$24218324$1$I$20200101$20240809$20240816$20240816$EXP$$US-ABBVIE-5875345$ABBVIE$$19$YR$$M$Y$$$20240816$$CN$US$US
242183251$24218325$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192219$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242183262$24218326$2$F$20240101$20240903$20240816$20240906$EXP$$US-ABBVIE-5878106$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242183273$24218327$3$F$20240101$20240821$20240816$20240828$PER$$US-ABBVIE-5878985$ABBVIE$$$$$F$Y$54.431$KG$20240828$$CN$US$US
242183281$24218328$1$I$20240101$20240813$20240816$20240816$EXP$$US-ABBVIE-5879526$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242183291$24218329$1$I$$20240814$20240816$20240816$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-129939$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240816$$MD$GB$GB
242183311$24218331$1$I$$20240805$20240816$20240816$EXP$$US-JNJFOC-20240810854$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$CN$US$US
242183321$24218332$1$I$$20240813$20240816$20240816$EXP$$US-ABBVIE-5880209$ABBVIE$$$$$F$Y$$$20240816$$HP$US$US
242183334$24218333$4$F$20240803$20240919$20240816$20240926$EXP$$DE-CHIESI-2024CHF05094$CHIESI$$0$YR$$M$Y$1.05$KG$20240926$$MD$DE$DE
242183341$24218334$1$I$20231117$20240805$20240816$20240816$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000793$PAREXEL$$$$$$Y$$$20240816$$HP$CN$CN
242183351$24218335$1$I$$20240812$20240816$20240816$EXP$$NVSC2024TW165340$NOVARTIS$$$$$$Y$$$20240816$$MD$TW$TW
242183361$24218336$1$I$$20240805$20240816$20240816$PER$$US-SMPA-2024SPA000973$SUNOVION$$$$$$Y$$$20240816$$CN$US$US
242183371$24218337$1$I$$20240718$20240816$20240816$PER$$US-SMPA-2024MYSCI0700766$SUNOVION$$$$$$Y$$$20240816$$CN$US$US
242183381$24218338$1$I$$20240729$20240816$20240816$PER$$US-SMPA-2024SPA001079$SUNOVION$$$$$$Y$$$20240816$$CN$US$US
242183404$24218340$4$F$$20240917$20240816$20240930$EXP$$US-SMPA-2024MYSCI0700777$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242183411$24218341$1$I$$20240801$20240816$20240816$PER$$US-SMPA-2024SPA000717$SUNOVION$$$$$$Y$$$20240816$$CN$US$US
242183421$24218342$1$I$$20240801$20240816$20240816$PER$$US-SMPA-2024SPA000720$SUNOVION$$$$$$Y$$$20240816$$CN$US$US
242183431$24218343$1$I$$20240718$20240816$20240816$PER$$US-SMPA-2024MYSCI0700787$SUNOVION$$$$$$Y$$$20240816$$CN$US$US
242183442$24218344$2$F$$20240828$20240816$20240915$PER$$US-SMPA-2024MYSCI0601277$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
242183451$24218345$1$I$$20240718$20240816$20240816$PER$$US-SMPA-2024MYSCI0700795$SUNOVION$$$$$$Y$$$20240816$$CN$US$US
242183461$24218346$1$I$20240730$20240809$20240816$20240816$EXP$$NVSC2024CN164064$NOVARTIS$$7$YR$$M$Y$15$KG$20240816$$HP$CN$CN
242183471$24218347$1$I$$20240808$20240816$20240816$EXP$$NVSC2024US164278$NOVARTIS$Stewart-Bates B, Hall G, Mousallem T, Stallings A, Sleasman J.. Transient loss of peripheral b cells in a patient with congenital athymia and omenn?s syndrome. ANN ALLERGY ASTHMA IMMUNOL. 2023;131:S160$14$MON$$M$Y$$$20240816$$HP$US$US
242183481$24218348$1$I$$20240813$20240816$20240816$EXP$$GB-ABBVIE-5881943$ABBVIE$$$$A$M$Y$$$20240816$$CN$GB$GB
242183493$24218349$3$F$20201201$20240714$20240816$20240911$EXP$$DE-009507513-2407DEU010949$MERCK$$72$YR$$F$Y$$$20240911$$CN$DE$DE
242183501$24218350$1$I$20211201$20240813$20240816$20240816$EXP$DK-DKMA-WBS-0097442$DK-SANDOZ INC.-NVSC2022DK099744$SANDOZ$$81$YR$$F$Y$$$20240816$$HP$DK$DK
242183511$24218351$1$I$20240724$20240809$20240816$20240816$EXP$$CN-OTSUKA-2024_022252$OTSUKA$$35$YR$$M$Y$$$20240816$$HP$CN$CN
242183521$24218352$1$I$20220101$20240810$20240816$20240816$EXP$$US-BAYER-2024A116501$BAYER$$$$$$Y$$$20240816$$CN$US$US
242183542$24218354$2$F$20240701$20240912$20240816$20240919$EXP$FR-AFSSAPS-MP2024001211$FR-TEVA-VS-3231814$TEVA$$66$YR$$M$Y$71$KG$20240919$$HP$FR$FR
242183551$24218355$1$I$20240801$20240809$20240816$20240816$EXP$GB-MHRA-MED-202408070811079670-GSTDQ$GB-RDY-SPO/GBR/24/0011776$DR REDDYS$$68$YR$E$$Y$90$KG$20240816$$CN$GB$GB
242183561$24218356$1$I$20240814$20240814$20240816$20240816$PER$$US-GILEAD-2024-0684277$GILEAD$$$$$F$Y$$$20240816$$HP$US$US
242183571$24218357$1$I$20240801$20240815$20240816$20240816$PER$$US-DSJP-DSU-2024-140715$DAIICHI$$$$$F$Y$$$20240816$$MD$US$US
242183581$24218358$1$I$$20240815$20240816$20240816$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140716$DAIICHI$$$$$F$Y$$$20240816$$MD$US$US
242183591$24218359$1$I$20240630$20240807$20240816$20240816$EXP$PT-INFARMED-T202407-555$PT-TEVA-VS-3231487$TEVA$$80$YR$$M$Y$$$20240816$$PH$PT$PT
242183601$24218360$1$I$20240701$20240814$20240816$20240816$EXP$$US-ABBVIE-5881285$ABBVIE$$54$YR$$F$Y$$$20240816$$CN$US$US
242183611$24218361$1$I$20240527$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129323$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240816$$CN$US$US
242183622$24218362$2$F$20240120$20240923$20240816$20240930$EXP$$NVSC2024BE165691$NOVARTIS$$50$YR$$F$Y$$$20240930$$MD$BE$BE
242183631$24218363$1$I$$20240809$20240816$20240816$EXP$$CA-AstraZeneca-2024A183508$ASTRAZENECA$$76$YR$$F$Y$$$20240816$$MD$CA$
242183641$24218364$1$I$20230115$20240815$20240815$20240815$DIR$714482$$FDA-CTU$$69$YR$$F$N$115.2$KG$20240815$N$CN$US$
242183651$24218365$1$I$20240601$20240808$20240816$20240816$EXP$$CH-AstraZeneca-2024A186811$ASTRAZENECA$$39$YR$$F$Y$69$KG$20240816$$MD$CH$
242183662$24218366$2$F$$20240812$20240816$20240824$EXP$$NL-AstraZeneca-2024A185766$ASTRAZENECA$$$$$$Y$$$20240823$$CN$NL$
242183671$24218367$1$I$$20221006$20240816$20240816$EXP$$US-AstraZeneca-2022A341212$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242183681$24218368$1$I$20240701$20240803$20240816$20240816$EXP$$CZ-RIGEL-20240800052$RIGEL PHARMACEUTICALS$$19$YR$$F$Y$$$20240816$$MD$CZ$CZ
242183691$24218369$1$I$$20220628$20240816$20240816$EXP$$US-AstraZeneca-2022A239995$ASTRAZENECA$$$$$$Y$$$20240816$$MD$US$
242183701$24218370$1$I$20230217$20240806$20240816$20240816$EXP$$JP-AstraZeneca-2023A054154$ASTRAZENECA$$14$YR$$F$Y$51$KG$20240816$$MD$JP$
242183711$24218371$1$I$20240101$20240808$20240816$20240816$EXP$$US-RIGEL-20240800050$RIGEL PHARMACEUTICALS$$$$$F$Y$129.27$KG$20240816$$CN$US$US
242183721$24218372$1$I$$20240809$20240816$20240816$EXP$$AU-AstraZeneca-2024A181359$ASTRAZENECA$Dhaliwal N, Roberts D.. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study.. Clinical Toxicology 2024;62(3):1-6.$$$$$Y$$$20240816$$HP$AU$
242183731$24218373$1$I$$20230117$20240816$20240816$EXP$$US-AstraZeneca-2023A015515$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242183741$24218374$1$I$20240718$20240808$20240816$20240816$EXP$FR-AFSSAPS-PV2024000711$FR-Rigel Pharmaceuticals, Inc.-20240800058$RIGEL PHARMACEUTICALS$$67$YR$$F$Y$61$KG$20240816$$MD$FR$FR
242183751$24218375$1$I$$20220520$20240816$20240816$EXP$$US-AstraZeneca-2022A142514$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242183762$24218376$2$F$20240808$20240815$20240816$20240822$PER$$US-HALEON-2192226$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242183771$24218377$1$I$20220129$20240813$20240816$20240816$EXP$$FR-AstraZeneca-2024A184262$ASTRAZENECA$$82$YR$$M$Y$93$KG$20240816$$MD$FR$
242183791$24218379$1$I$$20240812$20240816$20240816$EXP$$US-JNJFOC-20240829416$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$HP$US$US
242183801$24218380$1$I$$20230121$20240816$20240816$EXP$$IN-AstraZeneca-2023A019984$ASTRAZENECA$$63$YR$$$Y$$$20240816$$CN$IN$
242183814$24218381$4$F$20240101$20240826$20240816$20240903$EXP$$CA-AstraZeneca-2024A173194$ASTRAZENECA$$48$YR$$F$Y$$$20240903$$CN$CA$
242183822$24218382$2$F$20240810$20240904$20240816$20240906$EXP$$IT-ALXN-202408EEA000816IT$ALEXION PHARMACEUTICALS$$47$YR$$F$Y$64$KG$20240906$$MD$IT$IT
242183832$24218383$2$F$20231220$20240830$20240816$20240906$EXP$$FR-AstraZeneca-2024A180329$ASTRAZENECA$$84$YR$$F$Y$48$KG$20240906$$MD$FR$
242183841$24218384$1$I$$20230316$20240816$20240816$EXP$$US-AstraZeneca-2023A064914$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242183851$24218385$1$I$$20230202$20240816$20240816$EXP$$US-AstraZeneca-2023A029415$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242183861$24218386$1$I$$20230707$20240816$20240816$EXP$$US-AstraZeneca-2023A157492$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242183871$24218387$1$I$$20230808$20240816$20240816$EXP$$US-AstraZeneca-2023A181798$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242183881$24218388$1$I$$20240808$20240816$20240816$EXP$$ZA-AstraZeneca-2024A182214$ASTRAZENECA$$82$YR$$M$Y$$$20240816$$CN$ZA$
242183891$24218389$1$I$20220117$20240813$20240816$20240816$EXP$$FR-AstraZeneca-2024A184230$ASTRAZENECA$$85$YR$$M$Y$$$20240816$$MD$FR$
242183901$24218390$1$I$20240801$20240813$20240816$20240816$PER$$US-BAUSCH-BL-2024-012326$BAUSCH AND LOMB$$$$$F$Y$$$20240816$$CN$US$US
242183911$24218391$1$I$$20240814$20240816$20240816$PER$$US-ABBVIE-5882048$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242183921$24218392$1$I$$20240812$20240816$20240816$EXP$$CA-BAUSCH-BL-2024-012252$BAUSCH AND LOMB$$57$YR$$F$Y$$$20240816$$HP$CA$CA
242183931$24218393$1$I$20240101$20240813$20240816$20240816$EXP$$US-ABBVIE-5880444$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242183941$24218394$1$I$20240501$20240814$20240816$20240816$EXP$SE-SEMPA-2024-005998$SE-GSK-SE2024101207$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$SE$SE
242183951$24218395$1$I$$20240809$20240816$20240816$EXP$$CN-BAUSCH-BL-2024-012152$BAUSCH AND LOMB$Wang W, Zhai W, Zhang Y, Tao L, Li Y, Jiang T, Zhang J. Splenic abscess secondary to COVID-19 acute infection: A case report and literature review. Medicine. 2024;103(31):1-4. doi:10.1097/MD.0000000000039194.$71$YR$$F$Y$$$20240816$$HP$CN$CN
242183961$24218396$1$I$$20240813$20240816$20240816$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02993$AMNEAL$$$$$F$Y$$$20240816$$CN$US$US
242183971$24218397$1$I$20240813$20240813$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128650$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240816$$CN$US$US
242183981$24218398$1$I$$20240810$20240816$20240816$EXP$$IT-BAUSCH-BL-2024-012164$BAUSCH AND LOMB$Celardo G, Scaffei E, Buchignani B, Donatelli G, Costagli M, Cristofani P, Canapicchi R, Pasquariello R, Tosetti M, Battini R, Biagi L. Exploring chemoradiotherapy-induced leukoencephalopathy with 7T imaging and quantitative susceptibility mapping. Frontiers in Neurology. 2024 FEB 14;15:1-6. doi:10.3389/fneur.2024.1362704$9$YR$$M$Y$$$20240816$$HP$IT$IT
242183991$24218399$1$I$20240810$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161702$AMGEN$$27$YR$A$F$Y$$$20240816$$PH$US$US
242184001$24218400$1$I$$20240815$20240816$20240816$PER$$US-HALEON-2192294$Haleon PLC$$53$YR$$F$Y$$$20240816$$CN$US$US
242184011$24218401$1$I$$20240813$20240816$20240816$PER$$US-JNJFOC-20240833592$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$US$US
242184021$24218402$1$I$$20240815$20240816$20240816$EXP$$US-BAUSCH-BL-2024-008014$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240816$$CN$US$US
242184031$24218403$1$I$20240812$20240814$20240816$20240816$PER$$US-BAUSCH-BL-2024-012408$BAUSCH AND LOMB$$$$$F$Y$$$20240816$$CN$US$US
242184051$24218405$1$I$20240101$20240813$20240816$20240816$EXP$$CA-BAUSCH-BL-2024-010800$BAUSCH AND LOMB$$49$YR$$F$Y$$$20240816$$CN$CA$CA
242184061$24218406$1$I$$20240814$20240816$20240816$EXP$$CA-BAUSCH-BL-2024-012386$BAUSCH AND LOMB$$$$$F$Y$$$20240816$$MD$CA$CA
242184071$24218407$1$I$$20240718$20240816$20240816$PER$$US-LEX-000401$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242184082$24218408$2$F$20240812$20240920$20240816$20240925$PER$$US-BIOVITRUM-2024-US-010896$BIOVITRUM$$74$YR$$M$Y$$$20240925$$CN$US$US
242184091$24218409$1$I$$20240814$20240816$20240816$PER$$US-BIOVITRUM-2024-US-010919$BIOVITRUM$$81$YR$$F$Y$$$20240816$$CN$US$US
242184101$24218410$1$I$$20240815$20240816$20240816$PER$$NVSC2024US166515$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242184111$24218411$1$I$20240801$20240812$20240816$20240816$EXP$$NVSC2024CN164942$NOVARTIS$$78$YR$$M$Y$50$KG$20240816$$HP$CN$CN
242184121$24218412$1$I$20230101$20240806$20240816$20240816$EXP$$CO-Merz Pharmaceuticals GmbH-2024080000095$MERZ$Claudia GONZALEZ. High-Resolution Ultrasound for Complications of Botulinum Toxin Use: A Case Series and Literature Review.. Cureus. 2024;16(6):doi:10.7759/cureus.63232$61$YR$$F$Y$$$20240816$$HP$CO$CO
242184133$24218413$3$F$$20240805$20240816$20240930$EXP$$MX-BEH-2024177059$CSL BEHRING$$$$$$Y$$$20240930$$CN$MX$MX
242184141$24218414$1$I$$20240806$20240816$20240816$EXP$$CO-MRZWEB-2024080000139$MERZ$Claudia GONZALEZ. High-Resolution Ultrasound for Complications of Botulinum Toxin Use: A Case Series and Literature Review.. Cureus. 2024;16(6):doi:10.7759/cureus.63232$45$YR$$F$Y$$$20240816$$HP$CO$CO
242184161$24218416$1$I$20240101$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129404$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240816$$CN$US$US
242184172$24218417$2$F$20240101$20240819$20240816$20240824$EXP$$US-ABBVIE-5878910$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242184181$24218418$1$I$$20240813$20240816$20240816$EXP$$DE-JNJFOC-20240732561$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240816$$HP$DE$DE
242184191$24218419$1$I$$20240808$20240816$20240816$EXP$$BR-JNJFOC-20240824988$JOHNSON AND JOHNSON$$40$YR$A$F$Y$73$KG$20240816$$CN$BR$BR
242184202$24218420$2$F$$20240821$20240816$20240826$EXP$$IT-JNJFOC-20240839088$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240826$$HP$IT$IT
242184211$24218421$1$I$20240722$20240809$20240816$20240816$EXP$$ES-AstraZeneca-2024A181248$ASTRAZENECA$$76$YR$$M$Y$$$20240816$$MD$ES$
242184221$24218422$1$I$20240301$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A183180$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242184231$24218423$1$I$20240128$20240808$20240816$20240816$EXP$$NVSC2024US037161$NOVARTIS$$17$YR$$F$Y$56.9$KG$20240816$$MD$US$US
242184241$24218424$1$I$20220901$20240812$20240816$20240816$EXP$FR-AFSSAPS-LM2024000437$FR-MYLANLABS-2024M1074801$MYLAN$$63$YR$$F$Y$66.5$KG$20240816$$PH$FR$FR
242184251$24218425$1$I$$20240812$20240816$20240816$EXP$$ZA-AstraZeneca-2024A184456$ASTRAZENECA$$76$YR$$M$Y$$$20240816$$CN$ZA$
242184261$24218426$1$I$$20240806$20240816$20240816$EXP$FR-AFSSAPS-PV2024000722$FR-BAXTER-2024BAX022854$BAXTER$$$$N$M$Y$0.32$KG$20240816$$MD$FR$FR
242184271$24218427$1$I$$20240815$20240816$20240816$EXP$$US-TAKEDA-2024TUS030369$TAKEDA$$$$$M$Y$$$20240816$$CN$US$US
242184281$24218428$1$I$20240630$20240814$20240816$20240816$EXP$$US-TAKEDA-2024TUS082164$TAKEDA$$25$YR$$F$Y$$$20240816$$CN$US$US
242184291$24218429$1$I$$20240813$20240816$20240816$EXP$$CA-TAKEDA-2024TUS081919$TAKEDA$$$$$M$Y$$$20240816$$CN$CA$CA
242184302$24218430$2$F$20230428$20240813$20240816$20240823$EXP$$IE-BAXTER-2023BAX020607$BAXTER$$63$YR$$M$Y$109$KG$20240823$$CN$IE$IE
242184314$24218431$4$F$20240722$20240911$20240816$20240912$EXP$$ES-TAKEDA-2024TUS081890$TAKEDA$$6$YR$$F$Y$$$20240912$$HP$ES$ES
242184321$24218432$1$I$$20240805$20240816$20240816$PER$$US-TAKEDA-2024TUS078764$TAKEDA$$$$$$Y$$$20240816$$HP$US$US
242184331$24218433$1$I$$20240813$20240816$20240816$EXP$$CA-TAKEDA-2024TUS081904$TAKEDA$$$$$F$Y$$$20240816$$MD$CA$CA
242184341$24218434$1$I$$20240814$20240816$20240816$PER$$US-TAKEDA-2024TUS082257$TAKEDA$$$$$$Y$$$20240816$$CN$US$US
242184351$24218435$1$I$$20240814$20240816$20240816$PER$$US-TAKEDA-2024TUS081946$TAKEDA$$$$$F$Y$$$20240816$$HP$US$US
242184361$24218436$1$I$20230607$20240807$20240816$20240816$EXP$$GB-BAXTER-2024BAX022963$BAXTER$$76$YR$$M$Y$103$KG$20240816$$HP$GB$GB
242184371$24218437$1$I$20240724$20240812$20240816$20240816$EXP$$CA-TAKEDA-2023TUS076889$TAKEDA$$72$YR$$M$Y$$$20240816$$CN$CA$CA
242184391$24218439$1$I$$20240808$20240816$20240816$EXP$$CH-TAKEDA-2024TUS082166$TAKEDA$$$$$$Y$$$20240816$$MD$CH$CH
242184413$24218441$3$F$20240516$20240919$20240816$20240927$EXP$$CA-TAKEDA-2024TUS050037$TAKEDA$$47$YR$$F$Y$$$20240927$$CN$CA$CA
242184422$24218442$2$F$20240813$20240905$20240816$20240917$PER$$US-TAKEDA-2024TUS081941$TAKEDA$$74$YR$$M$Y$94.35$KG$20240917$$HP$US$US
242184431$24218443$1$I$20240701$20240809$20240816$20240816$EXP$$CH-TAKEDA-2024TUS080751$TAKEDA$$59$YR$$M$Y$$$20240816$$CN$CH$CH
242184442$24218444$2$F$20240829$20240829$20240816$20240903$EXP$$CA-TAKEDA-2024TUS080168$TAKEDA$$29$YR$$F$Y$$$20240903$$CN$CA$CA
242184451$24218445$1$I$$20240812$20240816$20240816$EXP$$US-TAKEDA-2024TUS081516$TAKEDA$$$$A$F$Y$50.1$KG$20240816$$MD$US$US
242184462$24218446$2$F$$20240823$20240816$20240828$EXP$$NL-TAKEDA-2024TUS081318$TAKEDA$$$$$M$Y$$$20240828$$CN$NL$NL
242184473$24218447$3$F$20240801$20240919$20240816$20240928$EXP$$MX-TAKEDA-2024TUS082127$TAKEDA$$71$YR$$F$Y$$$20240928$$MD$MX$MX
242184481$24218448$1$I$20240601$20240807$20240816$20240816$30DAY$$US-GSK-US2024098451$GLAXOSMITHKLINE$$82$YR$$F$Y$74.84$KG$20240816$$CN$US$US
242184492$24218449$2$F$20240717$20240814$20240816$20240930$PER$$US-LUNDBECK-DKLU4001932$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
242184501$24218450$1$I$$20240812$20240816$20240816$EXP$$IE-TAKEDA-2023TUS019555$TAKEDA$$$$$F$Y$$$20240816$$MD$IE$IE
242184511$24218451$1$I$$20240813$20240816$20240816$EXP$$CA-TAKEDA-2024TUS081898$TAKEDA$$$$$F$Y$$$20240816$$CN$CA$CA
242184522$24218452$2$F$20201103$20240925$20240816$20240930$EXP$$CA-TAKEDA-2022TUS043392$TAKEDA$$53$YR$$F$Y$$$20240930$$CN$CA$CA
242184531$24218453$1$I$20231226$20240808$20240816$20240816$EXP$$US-TAKEDA-2024TUS001475$TAKEDA$$57$YR$$M$Y$$$20240816$$CN$US$US
242184562$24218456$2$F$20240510$20240910$20240816$20240912$EXP$$ES-TAKEDA-2024TUS081835$TAKEDA$$11$YR$$F$Y$$$20240912$$HP$ES$ES
242184571$24218457$1$I$20240704$20240814$20240816$20240816$PER$$US-GILEAD-2024-0684272$GILEAD$$56$YR$A$M$Y$$$20240816$$PH$US$US
242184581$24218458$1$I$$20240806$20240816$20240816$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI08119$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240816$$MD$JP$JP
242184591$24218459$1$I$$20240801$20240816$20240816$EXP$$US-HLS-202400695$HLS THERAPEUTICS$$$$A$$Y$$$20240816$$MD$US$US
242184601$24218460$1$I$20240509$20240718$20240816$20240816$EXP$CH-SM-2024-14861$CH-JNJFOC-20240820307$JOHNSON AND JOHNSON$$62$YR$A$M$Y$73$KG$20240816$$PH$CH$CH
242184611$24218461$1$I$20240101$20240813$20240816$20240816$EXP$$CA-ABBVIE-5881105$ABBVIE$$$$A$F$Y$$$20240816$$CN$CA$CA
242184622$24218462$2$F$20240101$20240822$20240816$20240828$EXP$$US-ABBVIE-5881633$ABBVIE$$$$$F$Y$87$KG$20240828$$CN$US$US
242184632$24218463$2$F$$20240819$20240816$20240826$EXP$$CA-SANDOZ INC.-SDZ2023CA048917$SANDOZ$$57$YR$$F$Y$$$20240826$$CN$CA$CA
242184642$24218464$2$F$20240811$20240813$20240816$20240822$EXP$$US-KYOWAKIRIN-2024KK019230$KYOWA$$$$$$Y$$$20240822$$HP$US$US
242184651$24218465$1$I$$20240813$20240816$20240816$EXP$$CA-PFIZER INC-202400236539$PFIZER$$14$YR$$M$Y$$$20240816$$HP$CA$CA
242184662$24218466$2$F$20240522$20240807$20240816$20240821$EXP$$IT-VANTIVE-2024VAN018960$Vantive US Healthcare$$77$YR$$F$Y$57.4$KG$20240821$$MD$IT$IT
242184671$24218467$1$I$$20240807$20240816$20240816$EXP$$US-GSK-US2024098598$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$MD$US$US
242184701$24218470$1$I$$20230809$20240816$20240816$EXP$$NVSC2023US280970$NOVARTIS$$$$$$Y$$$20240816$$CN$US$US
242184711$24218471$1$I$20190901$20240813$20240816$20240816$EXP$UY-19K-168-2962154-00$UY-ABBVIE-19K-168-2962154-00$ABBVIE$$49$YR$$F$Y$$$20240816$$CN$UY$UY
242184721$24218472$1$I$20240802$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127814$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$65.18$KG$20240816$$HP$US$US
242184731$24218473$1$I$$20240806$20240816$20240816$EXP$$US-GSK-US2024AMR099421$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$US$US
242184741$24218474$1$I$20240806$20240806$20240816$20240816$EXP$$BE-ABBVIE-5878340$ABBVIE$$36$YR$$M$Y$$$20240816$$CN$BE$BE
242184751$24218475$1$I$$20240813$20240816$20240816$EXP$$US-ABBVIE-5880081$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242184771$24218477$1$I$20240725$20240807$20240816$20240816$EXP$ES-AEMPS-1555769$ES-TEVA-VS-3231746$TEVA$$70$YR$$F$Y$$$20240816$$PH$ES$ES
242184781$24218478$1$I$$20240726$20240816$20240816$PER$$US-ABBVIE-5879760$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242184792$24218479$2$F$$20240823$20240816$20240902$30DAY$$US-GSK-US2024AMR098969$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$CN$US$US
242184803$24218480$3$F$20240806$20240918$20240816$20240927$EXP$$JP-LANTHEUS-LMI-2024-01006$LANTHEUS MEDICAL IMAGING$$77$YR$$M$Y$66.4$KG$20240927$$HP$JP$JP
242184811$24218481$1$I$20220606$20240807$20240816$20240816$EXP$$JP-AKEBIA THERAPEUTICS, INC.-JP-AKEB-22-021478$AKEBIA THERAPEUTICS$$$$$$Y$$$20240816$$MD$JP$JP
242184822$24218482$2$F$$20240814$20240816$20240819$EXP$$NVSC2024US166002$NOVARTIS$$$$$M$Y$$$20240819$$HP$US$US
242184831$24218483$1$I$$20240812$20240816$20240816$EXP$$US-JNJFOC-20240832891$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240816$$HP$US$US
242184851$24218485$1$I$$20240814$20240816$20240816$EXP$$US-TAKEDA-2016BLT006716$TAKEDA$$$$$F$Y$$$20240816$$CN$US$US
242184861$24218486$1$I$$20240806$20240816$20240816$EXP$$CA-TEVA-VS-3232013$TEVA$$$$$$Y$$$20240816$$PH$CA$CA
242184872$24218487$2$F$20240806$20240812$20240816$20240823$EXP$$CN-SANDOZ INC.-SDZ2024CN072512$SANDOZ$$88$YR$$M$Y$50$KG$20240823$$MD$CN$CN
242184891$24218489$1$I$20240803$20240815$20240815$20240815$DIR$714361$$FDA-CTU$$64$YR$$M$N$80.8$KG$20240815$N$PH$US$
242184901$24218490$1$I$$20240813$20240816$20240816$EXP$$US-VER-202400265$VERITY PHARMACEUTICALS$$86$YR$E$M$Y$$$20240816$$CN$US$US
242184921$24218492$1$I$20240721$20240807$20240816$20240816$EXP$$CN-SA-2024SA239008$SANOFI AVENTIS$$3$YR$C$M$Y$15.5$KG$20240816$$HP$CN$CN
242184931$24218493$1$I$$20240813$20240816$20240816$PER$$US-ABBVIE-5881165$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242184941$24218494$1$I$$20240719$20240816$20240816$PER$$US-LEX-000402$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242184951$24218495$1$I$$20240603$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004086$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242184961$24218496$1$I$$20240603$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004091$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242184971$24218497$1$I$$20240604$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004118$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242184981$24218498$1$I$20240604$20240604$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004135$BIOCON$$$$$$Y$$$20240816$$HP$US$US
242184991$24218499$1$I$$20240610$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004143$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185001$24218500$1$I$20240606$20240606$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004185$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185011$24218501$1$I$$20240607$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004242$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185021$24218502$1$I$$20240618$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004283$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185031$24218503$1$I$20240611$20240611$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004336$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185041$24218504$1$I$$20240612$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004383$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242185051$24218505$1$I$20240604$20240604$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004122$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185061$24218506$1$I$$20240610$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004148$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185071$24218507$1$I$$20240614$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004331$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185081$24218508$1$I$$20240626$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004426$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242185091$24218509$1$I$$20240620$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004500$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185101$24218510$1$I$$20240618$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004532$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185111$24218511$1$I$$20240804$20240816$20240816$EXP$$US-SMPA-2024SPA000797$SUNOVION$$$$$$Y$$$20240816$$CN$US$US
242185132$24218513$2$F$20240701$20240904$20240816$20240911$EXP$$US-SMPA-2024MYSCI0400719$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
242185141$24218514$1$I$20240606$20240606$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004221$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185151$24218515$1$I$$20240617$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004433$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185161$24218516$1$I$$20240617$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004480$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185171$24218517$1$I$$20240710$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004494$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185181$24218518$1$I$20230101$20240813$20240816$20240816$EXP$$NVSC2024US165257$NOVARTIS$$$$$M$Y$$$20240816$$PH$US$US
242185192$24218519$2$F$20240802$20240830$20240816$20240909$EXP$$US-SA-2024SA239960$SANOFI AVENTIS$$67$YR$E$F$Y$72.3$KG$20240909$$MD$US$US
242185213$24218521$3$F$$20240915$20240816$20240918$PER$$US-AMGEN-USASP2024162891$AMGEN$$53$YR$A$F$Y$$$20240918$$MD$US$US
242185221$24218522$1$I$20240629$20240723$20240816$20240816$EXP$$US-VANTIVE-2024VAN019086$Vantive US Healthcare$$$$$M$Y$$$20240816$$CN$US$US
242185231$24218523$1$I$20240812$20240812$20240816$20240816$EXP$$US-JNJFOC-20240836019$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240816$$CN$US$US
242185241$24218524$1$I$$20240626$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004852$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185251$24218525$1$I$20240625$20240722$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004759$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185261$24218526$1$I$$20240711$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004872$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242185271$24218527$1$I$$20240701$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004908$BIOCON$$$$$$Y$$$20240816$$HP$US$US
242185281$24218528$1$I$$20240708$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004960$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185291$24218529$1$I$$20240710$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004997$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185301$24218530$1$I$$20240703$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005003$BIOCON$$$$$$Y$$$20240816$$HP$US$US
242185311$24218531$1$I$20240705$20240705$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005045$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185321$24218532$1$I$20240620$20240715$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004626$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242185331$24218533$1$I$20240513$20240718$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004630$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185341$24218534$1$I$$20240620$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004640$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185351$24218535$1$I$$20240620$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004645$BIOCON$$$$$$Y$$$20240816$$HP$US$US
242185361$24218536$1$I$$20240624$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004670$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185371$24218537$1$I$$20240621$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004682$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185381$24218538$1$I$$20240624$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004699$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185391$24218539$1$I$$20240701$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004703$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185401$24218540$1$I$$20240618$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004538$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185411$24218541$1$I$$20240705$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004914$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185421$24218542$1$I$20240807$20240812$20240816$20240816$EXP$$US-SA-2024SA242178$SANOFI AVENTIS$$85$YR$E$F$Y$40$KG$20240816$$MD$US$US
242185431$24218543$1$I$20240328$20240813$20240816$20240816$EXP$FR-AFSSAPS-TO2024001533$FR-SA-2024SA242416$SANOFI AVENTIS$$84$YR$E$M$Y$70$KG$20240816$$MD$FR$FR
242185441$24218544$1$I$$20240807$20240816$20240816$30DAY$$US-GSK-US2024AMR099855$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242185451$24218545$1$I$20240801$20240813$20240816$20240816$EXP$$US-ABBVIE-5880168$ABBVIE$$73$YR$$F$Y$$$20240816$$CN$US$US
242185461$24218546$1$I$$20240711$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005185$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185471$24218547$1$I$$20240704$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005057$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185481$24218548$1$I$$20240718$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005075$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185491$24218549$1$I$20240710$20240710$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005172$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185501$24218550$1$I$20240711$20240723$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005195$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185511$24218551$1$I$$20240709$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005112$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185521$24218552$1$I$20240805$20240813$20240816$20240816$EXP$$US-ABBVIE-5880006$ABBVIE$$57$YR$$F$Y$$$20240816$$CN$US$US
242185531$24218553$1$I$$20240710$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005146$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185541$24218554$1$I$$20240708$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005098$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242185551$24218555$1$I$$20240813$20240816$20240816$EXP$$US-TAKEDA-2023TUS049126$TAKEDA$$$$$M$Y$118$KG$20240816$$CN$US$US
242185561$24218556$1$I$$20240813$20240816$20240816$EXP$$US-PURDUE-USA-2024-0311384$PURDUE$Enstrom C., Gast S., Church L., Heflin M.K., Moore C., Cook C., Walsh D., Gage A., Bock A.. Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine /Dextroamphetamine-associated Cardiomyopathy. US Cardiology Review. 2024;18(Supple) 1:01$29$YR$$M$Y$$$20240816$$HP$US$US
242185571$24218557$1$I$$20240813$20240816$20240816$EXP$$US-PURDUE-USA-2024-0311370$PURDUE$Enstrom C., Gast S., Church L., Heflin M.K., Moore C., Cook C., Walsh D., Gage A., Bock A.. Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine /Dextroamphetamine-associated Cardiomyopathy. US Cardiology Review. 2024;18(Suppl 1):01$25$YR$$M$Y$$$20240816$$HP$US$US
242185581$24218558$1$I$20240702$20240813$20240816$20240816$EXP$$NVSC2024FR154889$NOVARTIS$$72$YR$$F$Y$81.5$KG$20240816$$MD$FR$FR
242185591$24218559$1$I$$20240815$20240816$20240816$EXP$$US-BAYER-2024A117851$BAYER$$83$YR$E$M$Y$$$20240816$$CN$US$US
242185601$24218560$1$I$$20240814$20240816$20240816$EXP$$US-PURDUE PHARMA-USA-2024-0311366$PURDUE$$$$$F$Y$$$20240816$$CN$US$US
242185611$24218561$1$I$20230101$20240816$20240816$20240816$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046154$BOEHRINGER INGELHEIM$$$$$M$Y$136.2$KG$20240816$$MD$DE$DE
242185621$24218562$1$I$$20240813$20240816$20240816$EXP$$CA-JNJFOC-20240834090$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$HP$CA$CA
242185631$24218563$1$I$20240724$20240808$20240816$20240816$EXP$$CN-009507513-2408CHN003921$MERCK$$83$YR$$F$Y$50$KG$20240816$$HP$CN$CN
242185641$24218564$1$I$20240809$20240812$20240816$20240816$EXP$$CN-DSJP-DSJ-2024-140429$DAIICHI$$69$YR$$M$Y$61$KG$20240816$$HP$CN$CN
242185653$24218565$3$F$20240809$20240902$20240816$20240906$EXP$$AT-DSJP-DSE-2024-140394$DAIICHI$$84$YR$$F$Y$$$20240906$$CN$AT$AT
242185661$24218566$1$I$20210308$20240807$20240816$20240816$EXP$$FR-TEVA-VS-3231537$TEVA$$$$$F$Y$$$20240816$$HP$FR$FR
242185671$24218567$1$I$$20240813$20240816$20240816$EXP$$US-BAYER-2024A102193$BAYER$$58$YR$A$M$Y$$$20240816$$CN$US$US
242185681$24218568$1$I$20240814$20240815$20240816$20240816$PER$$US-BAYER-2024A118383$BAYER$$33$YR$A$F$Y$$$20240816$$HP$US$US
242185691$24218569$1$I$$20240425$20240816$20240816$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-06403$HIKMA$Maciej K, Sarvarinder G, Kevin K, Karan O, Robert L.. Maciej K, Sarvarinder G, Kevin K, Karan O, Robert L. Hepatic veno-occlusive disease complicated with extreme hyperammonaemia (920 ?mol/L) treated with defibrotide, lactulose, rifampin and haemodialysis.. BMJ Case Reports. 2024;17:e258876.:1 pg$3$DEC$$M$Y$$$20240816$$MD$US$US
242185701$24218570$1$I$20240601$20240812$20240816$20240816$EXP$$US-009507513-2408USA005316$MERCK$$59$YR$$M$Y$$$20240816$$CN$US$US
242185711$24218571$1$I$20240811$20240813$20240816$20240816$EXP$$DE-BIOMARINAP-DE-2024-159797$BIOMARIN$$$$$$Y$$$20240816$$MD$DE$DE
242185721$24218572$1$I$20240301$20240813$20240816$20240816$EXP$FR-AFSSAPS-GR2024000989$FR-ABBVIE-5882147$ABBVIE$$40$YR$$F$Y$$$20240816$$PH$FR$FR
242185731$24218573$1$I$20200101$20240807$20240816$20240816$EXP$FR-AFSSAPS-AVCF2024000486$FR-TEVA-VS-3231859$TEVA$$31$YR$$M$Y$$$20240816$$MD$FR$FR
242185742$24218574$2$F$$20240819$20240816$20240828$PER$$US-ABBVIE-5875856$ABBVIE$$$$$F$Y$$$20240828$$PH$US$US
242185761$24218576$1$I$20240812$20240815$20240815$20240815$DIR$714362$$FDA-CTU$$43$YR$$F$N$90.7$KG$20240815$N$PH$US$
242185771$24218577$1$I$20240812$20240815$20240815$20240815$DIR$714416$$FDA-CTU$$55$YR$$F$N$88.25$KG$20240815$N$PH$US$
242185781$24218578$1$I$$20240815$20240815$20240815$DIR$714418$$FDA-CTU$$$$$F$N$90.9$KG$20240815$N$MD$US$
242185791$24218579$1$I$$20240815$20240815$20240815$DIR$714427$$FDA-CTU$$$$$UNK$N$$$20240815$$CN$US$
242185801$24218580$1$I$20240815$20240815$20240815$20240815$DIR$714448$$FDA-CTU$$37$YR$$M$N$$$20240815$N$HP$US$
242185821$24218582$1$I$$20240815$20240815$20240815$DIR$714379$$FDA-CTU$$$$$F$N$68.5$KG$20240815$N$HP$US$
242185831$24218583$1$I$20240813$20240815$20240815$20240815$DIR$714377$$FDA-CTU$$60$YR$$M$N$$$20240815$N$HP$US$
242185841$24218584$1$I$20240809$20240809$20240816$20240816$EXP$$US-AMGEN-USASP2024159025$AMGEN$$39$YR$A$M$Y$$$20240816$$HP$US$US
242185861$24218586$1$I$20230329$20240810$20240816$20240816$EXP$$NVSC2024MY163395$NOVARTIS$$58$YR$$F$Y$$$20240816$$MD$MY$MY
242185871$24218587$1$I$$20240814$20240816$20240816$EXP$$US-KYOWAKIRIN-2024KK019266$KYOWA$$$$$$Y$$$20240816$$HP$US$US
242185881$24218588$1$I$20240718$20240812$20240816$20240816$EXP$$CN-OTSUKA-2024_022330$OTSUKA$$94$YR$$F$Y$55$KG$20240816$$HP$CN$CN
242185891$24218589$1$I$20240809$20240812$20240816$20240816$EXP$$CA-OTSUKA-2024_022356$OTSUKA$$58$YR$$M$Y$$$20240816$$PH$CA$CA
242185902$24218590$2$F$20240801$20240822$20240816$20240828$EXP$$US-BAYER-2024A116238$BAYER$$61$YR$A$F$Y$$$20240828$$CN$US$US
242185911$24218591$1$I$20240601$20240729$20240816$20240816$PER$$US-TEVA-VS-3229141$TEVA$$26$YR$$F$Y$$$20240816$$CN$US$US
242185922$24218592$2$F$20240502$20240818$20240816$20240821$PER$$US-AMGEN-USASP2024162868$AMGEN$$44$YR$A$M$Y$$$20240820$$CN$US$US
242185931$24218593$1$I$20240813$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162177$AMGEN$$74$YR$E$F$Y$$$20240816$$CN$US$US
242185941$24218594$1$I$$20240813$20240816$20240816$EXP$$NVSC2024AU165352$NOVARTIS$$$$$F$Y$$$20240816$$MD$AU$AU
242185951$24218595$1$I$20240719$20240812$20240816$20240816$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019359$VALIDUS$$$$$$Y$$$20240816$$MD$US$US
242185961$24218596$1$I$20240723$20240808$20240816$20240816$EXP$$IT-VALIDUS PHARMACEUTICALS LLC-IT-VDP-2024-019358$VALIDUS$$$$$$Y$$$20240816$$PH$IT$IT
242185971$24218597$1$I$$20240701$20240816$20240816$PER$$US-LUNDBECK-DKLU4001181$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
242185981$24218598$1$I$20240703$20240806$20240816$20240816$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-07551$HIKMA$$73$YR$$F$Y$$$20240816$$MD$IT$IT
242186002$24218600$2$F$$20240814$20240816$20240820$EXP$$JP-PFIZER INC-202400235991$PFIZER$Imataki, O.. Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus. International Journal of Hematology. 2024;120(1):1-2$58$YR$$M$Y$$$20240820$$MD$JP$JP
242186022$24218602$2$F$$20240816$20240816$20240820$EXP$$CA-PFIZER INC-202400235876$PFIZER$$69$YR$$F$Y$$$20240820$$HP$CA$CA
242186031$24218603$1$I$20240220$20240812$20240816$20240816$EXP$FR-AFSSAPS-TS2024000891$FR-PFIZER INC-202400234443$PFIZER$$72$YR$$M$Y$64$KG$20240816$$MD$FR$FR
242186041$24218604$1$I$$20240809$20240816$20240816$EXP$$KR-PFIZER INC-202400233574$PFIZER$Kim, S.. Acute Ischemic Stroke in a Patient with Metastatic Gastric Cancer after Ramucirumab Chemotherapy. Journal of The Korean Neurological Association. 2024;42(3):251-254$51$YR$$F$Y$$$20240816$$MD$KR$KR
242186052$24218605$2$F$20240304$20240919$20240816$20240919$EXP$$IT-PFIZER INC-202400235418$PFIZER$$72$YR$$M$Y$75$KG$20240919$$MD$IT$IT
242186061$24218606$1$I$20230611$20240814$20240816$20240816$EXP$IT-MINISAL02-998771$IT-PFIZER INC-202400236223$PFIZER$$50$YR$$M$Y$64$KG$20240816$$MD$IT$IT
242186071$24218607$1$I$20231101$20240812$20240816$20240816$EXP$GB-MHRA-MED-202311070917016100-LCNRS$GB-VIIV HEALTHCARE LIMITED-GB2023154838$VIIV$$$$$$Y$$$20240816$$HP$GB$GB
242186081$24218608$1$I$20240101$20240814$20240816$20240816$EXP$ES-AEMPS-1559627$ES-GSK-ES2024101348$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$MD$ES$ES
242186091$24218609$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A180981$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242186101$24218610$1$I$$20240813$20240816$20240816$EXP$$AT-AstraZeneca-2024A184512$ASTRAZENECA$$$$$M$Y$$$20240816$$MD$AT$
242186121$24218612$1$I$$20240813$20240816$20240816$PER$$US-MYLANLABS-2024M1076133$MYLAN$$$$$F$Y$$$20240816$$MD$US$US
242186131$24218613$1$I$20200412$20240807$20240816$20240816$EXP$PL-URPL-1-2217-2020$PL-TEVA-VS-3231638$TEVA$$31$YR$$M$Y$93$KG$20240816$$MD$PL$PL
242186142$24218614$2$F$$20240809$20240816$20240822$EXP$$US-AstraZeneca-2024A185261$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242186153$24218615$3$F$20240730$20240909$20240816$20240920$EXP$$US-ABBVIE-5879414$ABBVIE$$60$YR$$M$Y$88$KG$20240920$$CN$US$US
242186161$24218616$1$I$20240625$20240815$20240815$20240815$DIR$714451$$FDA-CTU$$61$YR$$F$N$76.5$KG$20240815$N$CN$US$
242186171$24218617$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56572$$FDA-CTU$$73$YR$$F$N$$$20240816$N$$US$
242186181$24218618$1$I$20140101$20240801$20240816$20240816$EXP$$DE-SANDOZ INC.-PHHY2018DE104863$SANDOZ$$25$YR$$F$Y$$$20240816$$MD$DE$DE
242186191$24218619$1$I$20240813$20240813$20240816$20240816$EXP$$US-BIOMARINAP-US-2024-159860$BIOMARIN$$$$$$Y$$$20240816$$CN$US$US
242186201$24218620$1$I$$20240815$20240815$20240815$DIR$714437$$FDA-CTU$$$$$UNK$N$$$20240815$$CN$US$
242186211$24218621$1$I$20240719$20240807$20240816$20240816$EXP$FR-AFSSAPS-SE2024000612$FR-TEVA-VS-3231629$TEVA$$54$YR$$F$Y$$$20240816$$MD$FR$FR
242186231$24218623$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56555$$FDA-CTU$$49$YR$$F$N$$$20240816$N$$US$
242186241$24218624$1$I$$20240815$20240815$20240815$DIR$714472$$FDA-CTU$$$$$M$N$$$20240815$Y$HP$US$
242186251$24218625$1$I$20240624$20240815$20240815$20240815$DIR$714374$$FDA-CTU$$44$YR$$F$N$44.3$KG$20240815$N$HP$US$
242186261$24218626$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56571$$FDA-CTU$$78$YR$$M$N$$$20240816$N$PH$US$
242186271$24218627$1$I$$20240815$20240815$20240815$DIR$714486$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242186281$24218628$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56554$$FDA-CTU$$74$YR$$M$N$$$20240816$N$$US$
242186291$24218629$1$I$$20240815$20240815$20240815$DIR$714499$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242186301$24218630$1$I$$20240815$20240815$20240815$DIR$714498$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242186311$24218631$1$I$20240813$20240815$20240815$20240815$DIR$714478$$FDA-CTU$$19$YR$$F$N$77$KG$20240815$N$PH$US$
242186321$24218632$1$I$20240727$20240815$20240815$20240815$DIR$714475$$FDA-CTU$$40$YR$$F$N$86.4$KG$20240815$N$CN$US$
242186331$24218633$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56558$$FDA-CTU$$29$YR$$F$N$69.85$KG$20240816$N$$US$
242186361$24218636$1$I$20231001$20240808$20240816$20240816$EXP$$US-OTSUKA-2023_028099$OTSUKA$$71$YR$$M$Y$$$20240816$$HP$US$US
242186371$24218637$1$I$$20240808$20240816$20240816$EXP$$US-TAKEDA-2024TUS080237$TAKEDA$Alizadeh M, Zisman E, Wong U. Hidradenocarcinoma in a Crohn^s Patient on Ustekinumab. SAGE Open Medical Case Reports. 2024;12:1-3$36$YR$$F$Y$$$20240816$$MD$US$US
242186391$24218639$1$I$$20240806$20240816$20240816$PER$$US-ABBVIE-5870083$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242186401$24218640$1$I$20230101$20240814$20240816$20240816$EXP$$US-ABBVIE-5774725$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242186411$24218641$1$I$20230901$20240814$20240816$20240816$EXP$$US-ABBVIE-5881315$ABBVIE$$62$YR$$M$Y$$$20240816$$CN$US$US
242186421$24218642$1$I$20240704$20240807$20240816$20240816$EXP$FR-AFSSAPS-NY2024000863$FR-TEVA-VS-3231810$TEVA$$41$YR$$F$Y$$$20240816$$PH$FR$FR
242186431$24218643$1$I$$20240816$20240816$20240816$PER$$NVSC2024US166541$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242186441$24218644$1$I$$20240815$20240816$20240816$PER$$US-ABBVIE-5882804$ABBVIE$$$$$F$Y$$$20240816$$HP$US$US
242186451$24218645$1$I$$20240814$20240816$20240816$EXP$$US-ABBVIE-5881249$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242186461$24218646$1$I$20240101$20240802$20240816$20240816$PER$$US-SA-2024SA241071$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240816$$MD$US$US
242186471$24218647$1$I$20240731$20240731$20240816$20240816$PER$$US-SA-2024SA242139$SANOFI AVENTIS$$$$$F$Y$$$20240816$$CN$US$US
242186481$24218648$1$I$$20240808$20240816$20240816$EXP$$US-GSK-US2024GSK102163$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242186491$24218649$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA236930$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240816$$MD$US$US
242186501$24218650$1$I$20240125$20240711$20240816$20240816$EXP$$US-ABBVIE-5882014$ABBVIE$$76$YR$$M$Y$89$KG$20240816$$HP$US$US
242186511$24218651$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA235692$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240816$$HP$US$US
242186521$24218652$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238797$SANOFI AVENTIS$$$$A$M$Y$85.72$KG$20240816$$MD$US$US
242186531$24218653$1$I$20240729$20240807$20240816$20240816$PER$$US-SA-2024SA237773$SANOFI AVENTIS$$15$YR$T$M$Y$102.96$KG$20240816$$MD$US$US
242186541$24218654$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA237442$SANOFI AVENTIS$$10$MON$I$M$Y$$$20240816$$MD$US$US
242186551$24218655$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA237895$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240816$$MD$US$US
242186561$24218656$1$I$$20240807$20240816$20240816$PER$$US-SA-2023SA268344$SANOFI AVENTIS$$$$A$F$Y$95.2$KG$20240816$$MD$US$US
242186571$24218657$1$I$20240801$20240807$20240816$20240816$PER$$US-SA-2024SA239277$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240816$$MD$US$US
242186591$24218659$1$I$20240701$20240806$20240816$20240816$PER$$US-SA-2024SA238924$SANOFI AVENTIS$$67$YR$E$F$Y$65.997$KG$20240816$$MD$US$US
242186601$24218660$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA237832$SANOFI AVENTIS$$$$C$$Y$$$20240816$$MD$US$US
242186611$24218661$1$I$20240101$20240805$20240816$20240816$PER$$US-SA-2024SA238292$SANOFI AVENTIS$$51$YR$A$F$Y$105$KG$20240816$$MD$US$US
242186621$24218662$1$I$20240101$20240806$20240816$20240816$PER$$US-SA-2024SA239070$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240816$$MD$US$US
242186631$24218663$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA238916$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240816$$MD$US$US
242186641$24218664$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA238868$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240816$$MD$US$US
242186651$24218665$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA239303$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242186661$24218666$1$I$20240703$20240807$20240816$20240816$PER$$US-SA-2024SA240384$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240816$$MD$US$US
242186671$24218667$1$I$20240701$20240806$20240816$20240816$PER$$US-SA-2024SA237682$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240816$$MD$US$US
242186681$24218668$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239453$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240816$$MD$US$US
242186691$24218669$1$I$$20240814$20240816$20240816$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-129705$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240816$$MD$GB$GB
242186701$24218670$1$I$$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162259$AMGEN$$$$A$F$Y$$$20240816$$CN$US$US
242186711$24218671$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238858$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242186721$24218672$1$I$$20240807$20240816$20240816$EXP$NL-LRB-00993499$NL-TEVA-VS-3231895$TEVA$$62$YR$$F$Y$101$KG$20240816$$CN$NL$NL
242186731$24218673$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA237670$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240816$$MD$US$US
242186741$24218674$1$I$20240601$20240807$20240816$20240816$PER$$US-SA-2024SA237973$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240816$$MD$US$US
242186751$24218675$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239758$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240816$$MD$US$US
242186761$24218676$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA207898$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240816$$MD$US$US
242186771$24218677$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA240820$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240816$$MD$US$US
242186782$24218678$2$F$20240101$20240916$20240816$20240923$PER$$US-SA-2024SA239143$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240923$$MD$US$US
242186791$24218679$1$I$20240101$20240806$20240816$20240816$PER$$US-SA-2024SA237105$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240816$$MD$US$US
242186801$24218680$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239438$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242186811$24218681$1$I$20240701$20240807$20240816$20240816$PER$$US-SA-2024SA237106$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240816$$MD$US$US
242186821$24218682$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239441$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240816$$MD$US$US
242186831$24218683$1$I$20240724$20240807$20240816$20240816$PER$$US-SA-2024SA237771$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240816$$CN$US$US
242186841$24218684$1$I$$20240806$20240816$20240816$PER$$US-SA-2024SA238234$SANOFI AVENTIS$$$$A$M$Y$117.9$KG$20240816$$MD$US$US
242186851$24218685$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA237798$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240816$$MD$US$US
242186861$24218686$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA236496$SANOFI AVENTIS$$8$YR$C$M$Y$32.1$KG$20240816$$HP$US$US
242186871$24218687$1$I$$20240806$20240816$20240816$PER$$US-SA-2024SA237606$SANOFI AVENTIS$$46$YR$A$M$Y$102$KG$20240816$$MD$US$US
242186881$24218688$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA240727$SANOFI AVENTIS$$$$A$M$Y$87.9$KG$20240816$$MD$US$US
242186891$24218689$1$I$$20240806$20240816$20240816$PER$$US-SA-2024SA236003$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240816$$MD$US$US
242186901$24218690$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239231$SANOFI AVENTIS$$62$YR$A$M$Y$65.3$KG$20240816$$MD$US$US
242186911$24218691$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA236011$SANOFI AVENTIS$$$$A$F$Y$54.4$KG$20240816$$MD$US$US
242186921$24218692$1$I$20240801$20240807$20240816$20240816$PER$$US-SA-2024SA240651$SANOFI AVENTIS$$33$YR$A$F$Y$68$KG$20240816$$MD$US$US
242186931$24218693$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA236043$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242186941$24218694$1$I$$20240806$20240816$20240816$PER$$US-SA-2024SA235298$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240816$$MD$US$US
242186951$24218695$1$I$20240805$20240806$20240816$20240816$PER$$US-SA-2024SA239410$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240816$$MD$US$US
242186961$24218696$1$I$20240718$20240806$20240816$20240816$EXP$$CN-TEVA-VS-3231484$TEVA$$54$YR$$M$Y$$$20240816$$HP$CN$CN
242186971$24218697$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA240604$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242186981$24218698$1$I$20240101$20240806$20240816$20240816$PER$$US-SA-2024SA238110$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240816$$MD$US$US
242186991$24218699$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA237776$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240816$$MD$US$US
242187011$24218701$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA237519$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240816$$MD$US$US
242187021$24218702$1$I$20220101$20240807$20240816$20240816$PER$$US-SA-2024SA240480$SANOFI AVENTIS$$$$E$M$Y$$$20240816$$HP$US$US
242187031$24218703$1$I$20240501$20240807$20240816$20240816$PER$$US-SA-2024SA239728$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240816$$MD$US$US
242187042$24218704$2$F$$20240806$20240816$20240927$PER$$US-SA-2024SA235802$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240927$$MD$US$US
242187051$24218705$1$I$20240701$20240806$20240816$20240816$PER$$US-SA-2024SA237718$SANOFI AVENTIS$$$$A$F$Y$120$KG$20240816$$MD$US$US
242187061$24218706$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA239721$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240816$$MD$US$US
242187071$24218707$1$I$20240501$20240807$20240816$20240816$PER$$US-SA-2024SA240611$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240816$$MD$US$US
242187081$24218708$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239470$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$MD$US$US
242187091$24218709$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA236691$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240816$$PH$US$US
242187101$24218710$1$I$$20231016$20240816$20240816$EXP$$EG-JNJFOC-20240831050$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240816$$CN$EG$EG
242187111$24218711$1$I$20240701$20240807$20240816$20240816$PER$$US-SA-2022SA037262$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240816$$MD$US$US
242187122$24218712$2$F$$20240905$20240816$20240930$PER$$US-SA-2024SA238938$SANOFI AVENTIS$$59$YR$A$F$Y$86.63$KG$20240930$$MD$US$US
242187141$24218714$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239148$SANOFI AVENTIS$$$$E$F$Y$$$20240816$$MD$US$US
242187151$24218715$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56556$$FDA-CTU$$$$$M$N$$$20240816$N$HP$US$
242187171$24218717$1$I$19850101$20240807$20240816$20240816$EXP$FR-AFSSAPS-TO2024001451$FR-TEVA-VS-3231852$TEVA$$30$YR$$F$Y$$$20240816$$MD$FR$FR
242187181$24218718$1$I$20240615$20240815$20240816$20240816$EXP$$CN-AstraZeneca-2024A155835$ASTRAZENECA$$813$MON$$M$Y$$$20240816$$MD$CN$
242187191$24218719$1$I$$20240729$20240816$20240816$PER$$US-AstraZeneca-2024A172360$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242187201$24218720$1$I$$20240808$20240816$20240816$EXP$$US-AstraZeneca-2024A184732$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242187211$24218721$1$I$$20240813$20240816$20240816$EXP$$CN-AstraZeneca-2024A186356$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$CN$
242187221$24218722$1$I$$20240805$20240816$20240816$DIR$FDA-CDER-CTU-2024-56565$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
242187231$24218723$1$I$$20240719$20240816$20240816$PER$$US-ALXN-202407USA001411US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242187241$24218724$1$I$20240719$20240815$20240815$20240815$DIR$714477$$FDA-CTU$$36$YR$$F$N$58.5$KG$20240815$N$CN$US$
242187251$24218725$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56537$$FDA-CTU$$48$YR$$F$N$$$20240816$N$$US$
242187261$24218726$1$I$$20240809$20240816$20240816$EXP$$CA-AstraZeneca-2024A184712$ASTRAZENECA$$48$YR$$F$Y$$$20240816$$MD$CA$
242187271$24218727$1$I$20221024$20240813$20240816$20240816$EXP$$FR-AstraZeneca-2024A184220$ASTRAZENECA$$74$YR$$M$Y$82$KG$20240816$$MD$FR$
242187281$24218728$1$I$20240705$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184887$ASTRAZENECA$$24185$DY$$M$Y$$$20240816$$CN$US$
242187291$24218729$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA237047$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240816$$CN$US$US
242187301$24218730$1$I$20240801$20240815$20240815$20240815$DIR$714512$$FDA-CTU$$83$YR$$F$N$$$20240815$Y$$US$
242187311$24218731$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56536$$FDA-CTU$$24$YR$$F$N$$$20240816$N$$US$
242187321$24218732$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56547$$FDA-CTU$$56$YR$$F$N$$$20240816$N$$US$
242187331$24218733$1$I$20240726$20240815$20240815$20240815$DIR$714534$$FDA-CTU$$36$YR$$F$N$56.25$KG$20240815$N$CN$US$
242187341$24218734$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA240154$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$MD$US$US
242187351$24218735$1$I$20240801$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184689$ASTRAZENECA$$86$YR$$F$Y$$$20240816$$HP$US$
242187361$24218736$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA237109$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240816$$MD$US$US
242187371$24218737$1$I$20240320$20240808$20240816$20240816$EXP$$GB-AstraZeneca-2024A180599$ASTRAZENECA$$77$YR$$M$Y$97$KG$20240816$$MD$GB$
242187381$24218738$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA240471$SANOFI AVENTIS$$$$A$F$Y$102.5$KG$20240816$$MD$US$US
242187391$24218739$1$I$20240101$20240806$20240816$20240816$PER$$US-SA-2024SA237687$SANOFI AVENTIS$$54$YR$A$M$Y$108$KG$20240816$$MD$US$US
242187401$24218740$1$I$20240814$20240815$20240815$20240815$DIR$714386$$FDA-CTU$$79$YR$$M$N$63.9$KG$20240815$N$PH$US$
242187421$24218742$1$I$20240815$20240815$20240815$20240815$DIR$714394$$FDA-CTU$$$$$UNK$N$$$20240815$N$CN$US$
242187431$24218743$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA238904$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242187442$24218744$2$F$20240101$20240819$20240816$20240830$PER$$US-SA-2024SA241322$SANOFI AVENTIS$$66$YR$E$M$Y$89$KG$20240830$$MD$US$US
242187451$24218745$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238201$SANOFI AVENTIS$$$$E$F$Y$$$20240816$$MD$US$US
242187461$24218746$1$I$$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184499$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242187472$24218747$2$F$$20240819$20240816$20240901$PER$$US-AstraZeneca-2024A186039$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
242187481$24218748$1$I$$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A184419$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242187492$24218749$2$F$$20240927$20240816$20240927$PER$$NVSC2024US166302$NOVARTIS$$$$$$Y$$$20240927$$MD$US$US
242187501$24218750$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238856$SANOFI AVENTIS$$$$$F$Y$$$20240816$$CN$US$US
242187511$24218751$1$I$20240701$20240807$20240816$20240816$PER$$US-SA-2024SA237744$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240816$$MD$US$US
242187521$24218752$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA239361$SANOFI AVENTIS$$58$YR$A$M$Y$86$KG$20240816$$MD$US$US
242187531$24218753$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2023SA319626$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240816$$MD$US$US
242187541$24218754$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA238103$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240816$$HP$US$US
242187551$24218755$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238808$SANOFI AVENTIS$$$$A$M$Y$71$KG$20240816$$MD$US$US
242187561$24218756$1$I$20240806$20240807$20240816$20240816$PER$$US-SA-2024SA240497$SANOFI AVENTIS$$38$YR$A$F$Y$59.42$KG$20240816$$MD$US$US
242187571$24218757$1$I$20240805$20240807$20240816$20240816$PER$$US-SA-2024SA237477$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240816$$CN$US$US
242187581$24218758$1$I$20240101$20240806$20240816$20240816$PER$$US-SA-2024SA236475$SANOFI AVENTIS$$48$YR$A$M$Y$81.646$KG$20240816$$MD$US$US
242187591$24218759$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239686$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$MD$US$US
242187601$24218760$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238304$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240816$$MD$US$US
242187612$24218761$2$F$$20240906$20240816$20240920$PER$$US-SA-2024SA237977$SANOFI AVENTIS$$6$YR$C$M$Y$18.1$KG$20240920$$MD$US$US
242187621$24218762$1$I$20240806$20240807$20240816$20240816$PER$$US-SA-2024SA237513$SANOFI AVENTIS$$$$T$M$Y$$$20240816$$MD$US$US
242187641$24218764$1$I$20240806$20240807$20240816$20240816$PER$$US-SA-2024SA236641$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240816$$CN$US$US
242187651$24218765$1$I$20230701$20240807$20240816$20240816$PER$$US-SA-2024SA239759$SANOFI AVENTIS$$17$YR$T$M$Y$71.6$KG$20240816$$MD$US$US
242187662$24218766$2$F$20240101$20240813$20240816$20240821$PER$$US-SA-2024SA223409$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240821$$CN$US$US
242187671$24218767$1$I$$20240806$20240816$20240816$PER$$US-SA-2024SA242425$SANOFI AVENTIS$$$$A$F$Y$74.38$KG$20240816$$MD$US$US
242187681$24218768$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA240291$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240816$$MD$US$US
242187691$24218769$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238218$SANOFI AVENTIS$$$$E$F$Y$$$20240816$$MD$US$US
242187701$24218770$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA237756$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240816$$MD$US$US
242187711$24218771$1$I$20191024$20240807$20240816$20240816$PER$$US-SA-2024SA239542$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240816$$CN$US$US
242187721$24218772$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA236800$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240816$$HP$US$US
242187731$24218773$1$I$$20240813$20240816$20240816$EXP$$AU-ABBVIE-5787907$ABBVIE$$$$$M$Y$$$20240816$$MD$AU$AU
242187741$24218774$1$I$20240101$20240814$20240816$20240816$EXP$$US-ABBVIE-5882057$ABBVIE$$$$$$Y$$$20240816$$CN$US$US
242187751$24218775$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238882$SANOFI AVENTIS$$$$A$F$Y$49.4$KG$20240816$$MD$US$US
242187761$24218776$1$I$20240101$20240806$20240816$20240816$PER$$US-SA-2024SA239497$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240816$$MD$US$US
242187771$24218777$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238912$SANOFI AVENTIS$$$$C$F$Y$17.69$KG$20240816$$MD$US$US
242187781$24218778$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA239086$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240816$$MD$US$US
242187791$24218779$1$I$$20240806$20240816$20240816$PER$$US-SA-2024SA237789$SANOFI AVENTIS$$$$C$F$Y$$$20240816$$MD$US$US
242187801$24218780$1$I$20240101$20240806$20240816$20240816$PER$$US-SA-2024SA237099$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240816$$MD$US$US
242187811$24218781$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA240580$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240816$$HP$US$US
242187821$24218782$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239139$SANOFI AVENTIS$$$$A$F$Y$95$KG$20240816$$MD$US$US
242187831$24218783$1$I$20240101$20240806$20240816$20240816$PER$$US-SA-2024SA238435$SANOFI AVENTIS$$$$I$M$Y$7.71$KG$20240816$$MD$US$US
242187841$24218784$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238909$SANOFI AVENTIS$$$$T$F$Y$45.3$KG$20240816$$MD$US$US
242187851$24218785$1$I$20240601$20240807$20240816$20240816$PER$$US-SA-2024SA238219$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240816$$MD$US$US
242187861$24218786$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA239272$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240816$$MD$US$US
242187881$24218788$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238941$SANOFI AVENTIS$$$$A$M$Y$146.41$KG$20240816$$MD$US$US
242187901$24218790$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA238966$SANOFI AVENTIS$$10$YR$C$F$Y$49.887$KG$20240816$$CN$US$US
242187911$24218791$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA239083$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240816$$MD$US$US
242187921$24218792$1$I$20240101$20240806$20240816$20240816$PER$$US-SA-2024SA239364$SANOFI AVENTIS$$73$YR$E$F$Y$68.04$KG$20240816$$MD$US$US
242187931$24218793$1$I$$20240810$20240816$20240816$PER$$US-BAYER-2024A115492$BAYER$$$$$$Y$$$20240816$$CN$US$US
242187941$24218794$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239448$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240816$$MD$US$US
242187951$24218795$1$I$20170101$20240807$20240816$20240816$PER$$US-SA-2024SA240570$SANOFI AVENTIS$$35$YR$A$M$Y$131$KG$20240816$$MD$US$US
242187961$24218796$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239423$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$HP$US$US
242187971$24218797$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239440$SANOFI AVENTIS$$$$T$M$Y$$$20240816$$MD$US$US
242187992$24218799$2$F$20240101$20240904$20240816$20240927$PER$$US-SA-2024SA240506$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240927$$MD$US$US
242188001$24218800$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239027$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242188011$24218801$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA237208$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240816$$MD$US$US
242188021$24218802$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA137309$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240816$$MD$US$US
242188031$24218803$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239117$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240816$$CN$US$US
242188041$24218804$1$I$$20240806$20240816$20240816$PER$$US-SA-2024SA236889$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$CN$US$US
242188051$24218805$1$I$20230101$20240807$20240816$20240816$PER$$US-SA-2024SA236768$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240816$$MD$US$US
242188061$24218806$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA237120$SANOFI AVENTIS$$15$YR$T$M$Y$46.75$KG$20240816$$MD$US$US
242188071$24218807$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA240634$SANOFI AVENTIS$$58$YR$A$M$Y$74.8$KG$20240816$$MD$US$US
242188081$24218808$1$I$20240814$20240815$20240815$20240815$DIR$714535$$FDA-CTU$$71$YR$$F$N$$$20240815$N$$US$
242188091$24218809$1$I$20240501$20240815$20240815$20240815$DIR$714546$$FDA-CTU$$70$YR$$M$N$78.75$KG$20240815$N$CN$US$
242188101$24218810$1$I$$20240801$20240816$20240816$EXP$$US-HLS-202400692$HLS THERAPEUTICS$$$$A$M$Y$$$20240816$$PH$US$US
242188111$24218811$1$I$$20240808$20240816$20240816$DIR$FDA-CDER-CTU-2024-56551$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
242188131$24218813$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56480$$FDA-CTU$$$$$M$N$$$20240816$N$HP$US$
242188151$24218815$1$I$20240806$20240808$20240816$20240816$PER$$US-SA-2024SA240496$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240816$$MD$US$US
242188161$24218816$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA239568$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240816$$MD$US$US
242188171$24218817$1$I$20240815$20240815$20240815$20240815$DIR$714547$$FDA-CTU$$24$YR$$F$N$90$KG$20240815$N$CN$US$
242188181$24218818$1$I$20190101$20240808$20240816$20240816$PER$$US-SA-2024SA239505$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240816$$MD$US$US
242188191$24218819$1$I$20240812$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56563$$FDA-CTU$$100$YR$$F$N$$$20240816$N$HP$US$
242188201$24218820$1$I$20240726$20240815$20240815$20240815$DIR$714412$$FDA-CTU$$18$YR$$F$N$$$20240815$N$PH$US$
242188211$24218821$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA239260$SANOFI AVENTIS$$$$A$F$Y$78$KG$20240816$$MD$US$US
242188221$24218822$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239896$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240816$$MD$US$US
242188231$24218823$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA240513$SANOFI AVENTIS$$$$E$M$Y$$$20240816$$MD$US$US
242188241$24218824$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA240836$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240816$$MD$US$US
242188251$24218825$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239483$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240816$$MD$US$US
242188261$24218826$1$I$20240801$20240808$20240816$20240816$PER$$US-SA-2024SA239263$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240816$$HP$US$US
242188271$24218827$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239512$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242188291$24218829$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA239653$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240816$$CN$US$US
242188301$24218830$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA241226$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$CN$US$US
242188311$24218831$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA239801$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242188321$24218832$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240125$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240816$$MD$US$US
242188331$24218833$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA240508$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$CN$US$US
242188341$24218834$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA240839$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$MD$US$US
242188361$24218836$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA237195$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240816$$CN$US$US
242188371$24218837$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA237249$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240816$$MD$US$US
242188382$24218838$2$F$$20240828$20240816$20240919$PER$$US-SA-2024SA241186$SANOFI AVENTIS$$$$A$F$Y$86$KG$20240919$$MD$US$US
242188391$24218839$1$I$20240701$20240809$20240816$20240816$PER$$US-SA-2024SA241678$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240816$$MD$US$US
242188401$24218840$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA239725$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240816$$MD$US$US
242188411$24218841$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA241555$SANOFI AVENTIS$$$$E$M$Y$96.16$KG$20240816$$MD$US$US
242188421$24218842$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239160$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240816$$CN$US$US
242188431$24218843$1$I$$20240808$20240816$20240816$PER$$US-SA-2023SA339964$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240816$$MD$US$US
242188441$24218844$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA239675$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240816$$MD$US$US
242188451$24218845$1$I$20240101$20240809$20240816$20240816$PER$$US-SA-2024SA241378$SANOFI AVENTIS$$44$YR$A$F$Y$161$KG$20240816$$MD$US$US
242188461$24218846$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA239585$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242188471$24218847$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA238803$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240816$$MD$US$US
242188481$24218848$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA238860$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240816$$MD$US$US
242188501$24218850$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA239319$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240816$$MD$US$US
242188511$24218851$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA241087$SANOFI AVENTIS$$$$E$F$Y$55$KG$20240816$$MD$US$US
242188521$24218852$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA241663$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242188531$24218853$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA238937$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240816$$MD$US$US
242188541$24218854$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA238891$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240816$$CN$US$US
242188551$24218855$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA240494$SANOFI AVENTIS$$$$C$F$Y$$$20240816$$CN$US$US
242188561$24218856$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA239234$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240816$$MD$US$US
242188571$24218857$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA238920$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240816$$MD$US$US
242188581$24218858$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA240860$SANOFI AVENTIS$$$$T$F$Y$97$KG$20240816$$MD$US$US
242188591$24218859$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240137$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240816$$CN$US$US
242188611$24218861$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA239642$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240816$$MD$US$US
242188621$24218862$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA241734$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240816$$MD$US$US
242188631$24218863$1$I$$20240815$20240816$20240816$PER$$NVSC2024US166537$NOVARTIS$$$$$$Y$$$20240816$$HP$US$US
242188641$24218864$1$I$$20240815$20240815$20240815$DIR$714559$$FDA-CTU$$$$$F$N$97.2$KG$20240815$Y$CN$US$
242188661$24218866$1$I$$20240813$20240816$20240816$DIR$FDA-CDER-CTU-2024-56511$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242188681$24218868$1$I$20240815$20240815$20240815$20240815$DIR$714560$$FDA-CTU$$20$YR$$F$N$63$KG$20240815$N$CN$US$
242188691$24218869$1$I$$20240807$20240816$20240816$DIR$FDA-CDER-CTU-2024-56508$$FDA-CTU$$$$$M$N$$$20240807$N$HP$US$
242188701$24218870$1$I$20240809$20240813$20240816$20240816$DIR$FDA-CDER-CTU-2024-56562$$FDA-CTU$$68$YR$$F$N$$$20240813$N$HP$US$
242188711$24218871$1$I$20240801$20240812$20240816$20240816$DIR$FDA-CDER-CTU-2024-56504$$FDA-CTU$$37$YR$$M$N$$$20240812$N$HP$US$
242188721$24218872$1$I$20240729$20240808$20240816$20240816$DIR$FDA-CDER-CTU-2024-56514$$FDA-CTU$$90$YR$$M$N$$$20240808$N$HP$US$
242188731$24218873$1$I$20240808$20240815$20240815$20240815$DIR$714435$$FDA-CTU$$61$YR$$M$N$122.4$KG$20240815$N$CN$US$
242188741$24218874$1$I$20240728$20240806$20240816$20240816$DIR$FDA-CDER-CTU-2024-56500$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
242188754$24218875$4$F$20240519$20240904$20240816$20240911$EXP$$US-SA-2024SA239291$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240911$$MD$US$US
242188761$24218876$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239510$SANOFI AVENTIS$$$$E$F$Y$$$20240816$$MD$US$US
242188771$24218877$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA134167$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242188781$24218878$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA238707$SANOFI AVENTIS$$$$$F$Y$$$20240816$$CN$US$US
242188791$24218879$1$I$20240701$20240808$20240816$20240816$PER$$US-SA-2024SA239469$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240816$$MD$US$US
242188801$24218880$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239806$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240816$$MD$US$US
242188812$24218881$2$F$20240101$20240816$20240816$20240830$PER$$US-SA-2024SA240528$SANOFI AVENTIS$$$$A$F$Y$$$20240830$$CN$US$US
242188821$24218882$1$I$20231201$20240808$20240816$20240816$PER$$US-SA-2024SA241681$SANOFI AVENTIS$$$$A$F$Y$81.6$KG$20240816$$MD$US$US
242188831$24218883$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239264$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242188841$24218884$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA240607$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240816$$MD$US$US
242188851$24218885$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA240474$SANOFI AVENTIS$$$$A$M$Y$98.883$KG$20240816$$MD$US$US
242188861$24218886$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239548$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240816$$HP$US$US
242188871$24218887$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA239798$SANOFI AVENTIS$$$$C$M$Y$15.14$KG$20240816$$MD$US$US
242188881$24218888$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA240716$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240816$$MD$US$US
242188891$24218889$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA240136$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240816$$MD$US$US
242188901$24218890$1$I$20240801$20240808$20240816$20240816$PER$$US-SA-2024SA239168$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240816$$CN$US$US
242188911$24218891$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239620$SANOFI AVENTIS$$$$A$M$Y$95.25$KG$20240816$$MD$US$US
242188921$24218892$1$I$20240501$20240808$20240816$20240816$PER$$US-SA-2024SA240597$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240816$$CN$US$US
242188931$24218893$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA108102$SANOFI AVENTIS$$$$A$M$Y$86.1$KG$20240816$$MD$US$US
242188941$24218894$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239384$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240816$$MD$US$US
242188951$24218895$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239150$SANOFI AVENTIS$$$$C$F$Y$42.63$KG$20240816$$MD$US$US
242188961$24218896$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239506$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240816$$MD$US$US
242188971$24218897$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56520$$FDA-CTU$$$$$M$N$$$20240816$N$HP$US$
242188981$24218898$1$I$20240805$20240814$20240816$20240816$DIR$FDA-CDER-CTU-2024-56560$$FDA-CTU$$70$YR$$M$N$$$20240814$N$HP$US$
242188991$24218899$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA240087$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240816$$MD$US$US
242189002$24218900$2$F$20240809$20240911$20240816$20240913$PER$$US-BAYER-2024A115908$BAYER$$70$YR$E$F$Y$$$20240913$$HP$US$US
242189011$24218901$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56516$$FDA-CTU$$$$$M$N$$$20240815$N$HP$US$
242189021$24218902$1$I$20240802$20240809$20240816$20240816$PER$$US-SA-2024SA240012$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240816$$MD$US$US
242189041$24218904$1$I$20240101$20240809$20240816$20240816$PER$$US-SA-2024SA239950$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240816$$MD$US$US
242189051$24218905$1$I$20240712$20240812$20240816$20240816$EXP$$US-TAKEDA-2024TUS081101$TAKEDA$$70$YR$$M$Y$76.644$KG$20240816$$MD$US$US
242189061$24218906$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240312$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240816$$CN$US$US
242189071$24218907$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA241023$SANOFI AVENTIS$$$$E$M$Y$$$20240816$$MD$US$US
242189081$24218908$1$I$20240701$20240809$20240816$20240816$PER$$US-SA-2024SA239578$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240816$$MD$US$US
242189091$24218909$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240419$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240816$$MD$US$US
242189101$24218910$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA239810$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240816$$CN$US$US
242189111$24218911$1$I$20240803$20240809$20240816$20240816$PER$$US-SA-2024SA207353$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240816$$MD$US$US
242189121$24218912$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240487$SANOFI AVENTIS$$$$C$M$Y$$$20240816$$CN$US$US
242189131$24218913$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA241464$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$CN$US$US
242189141$24218914$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240484$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240816$$MD$US$US
242189152$24218915$2$F$$20240812$20240816$20240821$PER$$US-SA-2024SA241040$SANOFI AVENTIS$$66$YR$E$F$Y$81.647$KG$20240821$$HP$US$US
242189161$24218916$1$I$20240101$20240809$20240816$20240816$PER$$US-SA-2024SA241453$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240816$$MD$US$US
242189171$24218917$1$I$20180101$20240809$20240816$20240816$PER$$US-SA-2024SA240309$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240816$$HP$US$US
242189181$24218918$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240779$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240816$$CN$US$US
242189192$24218919$2$F$$20240906$20240816$20240919$PER$$US-SA-2024SA239934$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240919$$MD$US$US
242189201$24218920$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240436$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240816$$MD$US$US
242189211$24218921$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA239591$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240816$$CN$US$US
242189221$24218922$1$I$20160101$20240809$20240816$20240816$PER$$US-SA-2024SA239852$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240816$$CN$US$US
242189231$24218923$1$I$20240806$20240809$20240816$20240816$PER$$US-SA-2024SA241204$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240816$$MD$US$US
242189241$24218924$1$I$20240301$20240809$20240816$20240816$PER$$US-SA-2024SA240424$SANOFI AVENTIS$$57$YR$A$F$Y$64.86$KG$20240816$$MD$US$US
242189251$24218925$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240105$SANOFI AVENTIS$$$$A$$Y$$$20240816$$CN$US$US
242189261$24218926$1$I$20240101$20240809$20240816$20240816$PER$$US-SA-2024SA239563$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240816$$CN$US$US
242189271$24218927$1$I$20240101$20240809$20240816$20240816$PER$$US-SA-2024SA240767$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$CN$US$US
242189281$24218928$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240470$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$MD$US$US
242189291$24218929$1$I$20240701$20240809$20240816$20240816$PER$$US-SA-2024SA239641$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240816$$MD$US$US
242189301$24218930$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA241456$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242189311$24218931$1$I$20240101$20240809$20240816$20240816$PER$$US-SA-2024SA241744$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240816$$MD$US$US
242189323$24218932$3$F$$20240911$20240816$20240926$PER$$US-SA-2024SA241200$SANOFI AVENTIS$$16$YR$T$F$Y$80.55$KG$20240926$$MD$US$US
242189341$24218934$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA241095$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240816$$MD$US$US
242189351$24218935$1$I$20231001$20240809$20240816$20240816$PER$$US-SA-2024SA240017$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240816$$MD$US$US
242189361$24218936$1$I$20240801$20240809$20240816$20240816$PER$$US-SA-2024SA242078$SANOFI AVENTIS$$48$YR$A$F$Y$78.9$KG$20240816$$MD$US$US
242189371$24218937$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240010$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240816$$MD$US$US
242189381$24218938$1$I$20240101$20240809$20240816$20240816$PER$$US-SA-2024SA239886$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$MD$US$US
242189391$24218939$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA242541$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240816$$CN$US$US
242189401$24218940$1$I$20240724$20240809$20240816$20240816$PER$$US-SA-2024SA240368$SANOFI AVENTIS$$54$YR$A$F$Y$56.97$KG$20240816$$MD$US$US
242189412$24218941$2$F$20220101$20240809$20240816$20240821$PER$$US-SA-2024SA239280$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240821$$MD$US$US
242189422$24218942$2$F$20240714$20240814$20240816$20240824$EXP$FR-AFSSAPS-BR2024000629$FR-TEVA-VS-3231862$TEVA$$53$YR$$M$Y$70$KG$20240824$$MD$FR$FR
242189432$24218943$2$F$20240730$20240821$20240816$20240827$PER$$US-BAYER-2024A116338$BAYER$$47$YR$A$F$Y$81.179$KG$20240827$$MD$US$US
242189441$24218944$1$I$20240101$20240809$20240816$20240816$PER$$US-SA-2024SA239864$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240816$$MD$US$US
242189451$24218945$1$I$20240801$20240809$20240816$20240816$PER$$US-SA-2021SA419736$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240816$$MD$US$US
242189461$24218946$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA239929$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240816$$CN$US$US
242189471$24218947$1$I$20240101$20240809$20240816$20240816$PER$$US-SA-2024SA241855$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240816$$MD$US$US
242189481$24218948$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA239775$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240816$$MD$US$US
242189491$24218949$1$I$20240701$20240809$20240816$20240816$PER$$US-SA-2023SA289883$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240816$$MD$US$US
242189501$24218950$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA005872$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240816$$MD$US$US
242189511$24218951$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA239964$SANOFI AVENTIS$$$$$M$Y$$$20240816$$CN$US$US
242189521$24218952$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA239626$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240816$$MD$US$US
242189531$24218953$1$I$$20240810$20240816$20240816$PER$$US-SA-2024SA241475$SANOFI AVENTIS$$$$T$M$Y$$$20240816$$MD$US$US
242189542$24218954$2$F$20240809$20240812$20240816$20240821$PER$$US-SA-2024SA241282$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240821$$MD$US$US
242189551$24218955$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA241765$SANOFI AVENTIS$$$$A$F$Y$129$KG$20240816$$MD$US$US
242189561$24218956$1$I$20240101$20240812$20240816$20240816$PER$$US-SA-2024SA241900$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240816$$MD$US$US
242189571$24218957$1$I$$20240811$20240816$20240816$PER$$US-SA-2024SA241776$SANOFI AVENTIS$$$$A$M$Y$$$20240816$$MD$US$US
242189581$24218958$1$I$$20240811$20240816$20240816$PER$$US-SA-2024SA241925$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242189591$24218959$1$I$$20240810$20240816$20240816$PER$$US-SA-2024SA239822$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240816$$CN$US$US
242189601$24218960$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240070$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240816$$MD$US$US
242189611$24218961$1$I$20240701$20240810$20240816$20240816$PER$$US-SA-2024SA241958$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240816$$MD$US$US
242189622$24218962$2$F$20240701$20240814$20240816$20240828$PER$$US-SA-2024SA240983$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240828$$CN$US$US
242189631$24218963$1$I$20240801$20240812$20240816$20240816$PER$$US-SA-2024SA241296$SANOFI AVENTIS$$$$E$M$Y$$$20240816$$MD$US$US
242189641$24218964$1$I$20240101$20240812$20240816$20240816$PER$$US-SA-2024SA242260$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240816$$MD$US$US
242189651$24218965$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA241300$SANOFI AVENTIS$$$$$F$Y$$$20240816$$CN$US$US
242189671$24218967$1$I$20240101$20240810$20240816$20240816$PER$$US-SA-2024SA184426$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240816$$MD$US$US
242189681$24218968$1$I$20240601$20240810$20240816$20240816$PER$$US-SA-2024SA241822$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240816$$MD$US$US
242189691$24218969$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA241795$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240816$$CN$US$US
242189701$24218970$1$I$20210101$20240809$20240816$20240816$PER$$US-SA-2024SA240141$SANOFI AVENTIS$$$$$M$Y$$$20240816$$CN$US$US
242189711$24218971$1$I$20240701$20240812$20240816$20240816$PER$$US-SA-2024SA241957$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240816$$MD$US$US
242189723$24218972$3$F$$20240830$20240816$20240904$PER$$US-SA-2024SA239812$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240904$$CN$US$US
242189731$24218973$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA241597$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240816$$MD$US$US
242189741$24218974$1$I$20240601$20240812$20240816$20240816$PER$$US-SA-2024SA242393$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240816$$MD$US$US
242189752$24218975$2$F$$20240812$20240816$20240821$PER$$US-SA-2024SA240804$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240821$$MD$US$US
242189761$24218976$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA242553$SANOFI AVENTIS$$$$A$F$Y$62$KG$20240816$$MD$US$US
242189771$24218977$1$I$20240101$20240812$20240816$20240816$PER$$US-SA-2024SA241766$SANOFI AVENTIS$$$$T$F$Y$$$20240816$$MD$US$US
242189781$24218978$1$I$20240201$20240812$20240816$20240816$PER$$US-SA-2024SA241947$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240816$$MD$US$US
242189791$24218979$1$I$20240812$20240812$20240816$20240816$PER$$US-SA-2024SA240396$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240816$$MD$US$US
242189801$24218980$1$I$20240101$20240812$20240816$20240816$PER$$US-SA-2024SA240961$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240816$$MD$US$US
242189811$24218981$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA241303$SANOFI AVENTIS$$$$$F$Y$$$20240816$$CN$US$US
242189824$24218982$4$F$20240801$20240911$20240816$20240917$PER$$US-SA-2024SA241452$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240918$$CN$US$US
242189831$24218983$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA241346$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240816$$MD$US$US
242189842$24218984$2$F$20240101$20240814$20240816$20240826$PER$$US-SA-2024SA241439$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240826$$CN$US$US
242189851$24218985$1$I$20240101$20240812$20240816$20240816$PER$$US-SA-2024SA240835$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242189861$24218986$1$I$20240811$20240812$20240816$20240816$PER$$US-SA-2024SA242327$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240816$$MD$US$US
242189871$24218987$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA241847$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242189881$24218988$1$I$20230101$20240812$20240816$20240816$PER$$US-SA-2024SA241599$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240816$$CN$US$US
242189891$24218989$1$I$20230101$20240812$20240816$20240816$PER$$US-SA-2024SA242263$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240816$$CN$US$US
242189901$24218990$1$I$20240812$20240812$20240816$20240816$PER$$US-SA-2024SA240657$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240816$$CN$US$US
242189911$24218991$1$I$20240101$20240812$20240816$20240816$PER$$US-SA-2024SA242254$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240816$$CN$US$US
242189921$24218992$1$I$$20240812$20240816$20240816$DIR$FDA-CDER-CTU-2024-56570$$FDA-CTU$$$$$M$N$$$20240812$N$HP$US$
242189931$24218993$1$I$$20240814$20240816$20240816$DIR$FDA-CDER-CTU-2024-56567$$FDA-CTU$$$$$M$N$$$20240814$N$HP$US$
242189941$24218994$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA240981$SANOFI AVENTIS$$$$A$F$Y$$$20240816$$MD$US$US
242189952$24218995$2$F$20240810$20240813$20240816$20240820$PER$$US-SA-2024SA240833$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240820$$MD$US$US
242189961$24218996$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA241549$SANOFI AVENTIS$$90$YR$E$F$Y$$$20240816$$CN$US$US
242189971$24218997$1$I$20240201$20240812$20240816$20240816$PER$$US-SA-2024SA240559$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240816$$CN$US$US
242189981$24218998$1$I$20240724$20240807$20240816$20240816$EXP$IT-MINISAL02-997198$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-07633$HIKMA$$68$YR$$F$Y$71$KG$20240816$$MD$IT$IT
242189991$24218999$1$I$20240701$20240808$20240816$20240816$DIR$FDA-CDER-CTU-2024-56492$$FDA-CTU$$86$YR$$M$N$$$20240808$N$HP$US$
242190001$24219000$1$I$$20240814$20240816$20240816$DIR$FDA-CDER-CTU-2024-56507$$FDA-CTU$$$$$F$N$$$20240814$N$HP$US$
242190011$24219001$1$I$$20240814$20240816$20240816$EXP$$CA-ABBVIE-5881735$ABBVIE$$$$E$M$Y$$$20240816$$HP$CA$CA
242190022$24219002$2$F$20230101$20240828$20240816$20240904$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-041921$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240904$$CN$BR$BR
242190032$24219003$2$F$$20240806$20240816$20240910$EXP$$GB-BEH-2024177067$CSL BEHRING$$$$E$M$Y$$$20240910$$HP$GB$GB
242190041$24219004$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56523$$FDA-CTU$$$$$M$N$$$20240815$N$HP$US$
242190051$24219005$1$I$$20240809$20240816$20240816$EXP$$NVSC2024JO165168$NOVARTIS$Jadallah RK, Al Sharie AH, Alzghoul SM, Al-Karaki JM, Amer MSB, Rawashdeh TH et al.. Palbociclib and Fulvestrant Combined Regimen Induced Prolonged Bone Metastasis Control of Stage IV HR+/HER2- Breast Cancer: A Case Report. RADIOLOGY CASE REPORTS. 2024;19(9):4049-54$58$YR$$F$Y$$$20240816$$HP$JO$JO
242190061$24219006$1$I$20240813$20240816$20240816$20240816$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046252$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240816$$HP$US$US
242190071$24219007$1$I$$20240809$20240816$20240816$EXP$$US-SA-2024SA241688$SANOFI AVENTIS$$$$$F$Y$$$20240816$$CN$US$US
242190081$24219008$1$I$$20240729$20240816$20240816$PER$$US-009507513-2407USA015485$MERCK$$$$$M$Y$$$20240816$$CN$US$US
242190091$24219009$1$I$20240707$20240814$20240816$20240816$EXP$$CA-JNJFOC-20240839366$JOHNSON AND JOHNSON$$20$YR$A$F$Y$68$KG$20240816$$HP$CA$CA
242190101$24219010$1$I$20240507$20240812$20240816$20240816$EXP$$US-OTSUKA-2024_014611$OTSUKA$$$$$F$Y$$$20240816$$CN$US$US
242190121$24219012$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA239803$SANOFI AVENTIS$$$$C$M$Y$$$20240816$$MD$US$US
242190132$24219013$2$F$$20240812$20240816$20240821$PER$$US-SA-2024SA239478$SANOFI AVENTIS$$$$E$F$Y$69.39$KG$20240821$$MD$US$US
242190141$24219014$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA240825$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240816$$MD$US$US
242190151$24219015$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA238908$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240816$$MD$US$US
242190161$24219016$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56548$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242190171$24219017$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56540$$FDA-CTU$$82$YR$$F$N$$$20240816$N$$US$
242190181$24219018$1$I$20230201$20240808$20240816$20240816$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012265$JAZZ$$44$YR$$F$Y$$$20240816$$CN$US$US
242190191$24219019$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA239329$SANOFI AVENTIS$$21$YR$A$M$Y$83.9$KG$20240816$$HP$US$US
242190201$24219020$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA237011$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240816$$HP$US$US
242190211$24219021$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA237042$SANOFI AVENTIS$$$$$F$Y$$$20240816$$HP$US$US
242190221$24219022$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA237556$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240816$$MD$US$US
242190231$24219023$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239153$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240816$$MD$US$US
242190241$24219024$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA238888$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240816$$CN$US$US
242190251$24219025$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA240623$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240816$$MD$US$US
242190261$24219026$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA240818$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240816$$MD$US$US
242190271$24219027$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA237812$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240816$$CN$US$US
242190281$24219028$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238108$SANOFI AVENTIS$$$$C$M$Y$17$KG$20240816$$MD$US$US
242190293$24219029$3$F$$20240828$20240816$20240830$PER$$US-SA-2024SA236997$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240830$$CN$US$US
242190301$24219030$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA237821$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240816$$MD$US$US
242190311$24219031$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239709$SANOFI AVENTIS$$$$A$F$Y$67$KG$20240816$$MD$US$US
242190321$24219032$1$I$20220301$20240807$20240816$20240816$PER$$US-SA-2024SA238896$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240816$$MD$US$US
242190331$24219033$1$I$20230922$20240812$20240816$20240816$PER$$US-SA-2024SA242165$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240816$$MD$US$US
242190341$24219034$1$I$20240101$20240812$20240816$20240816$PER$$US-SA-2024SA242864$SANOFI AVENTIS$$64$YR$A$M$Y$85.27$KG$20240816$$MD$US$US
242190351$24219035$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA242163$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240816$$MD$US$US
242190361$24219036$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA239973$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240816$$MD$US$US
242190371$24219037$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240247$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240816$$MD$US$US
242190381$24219038$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240621$SANOFI AVENTIS$$$$A$F$Y$63.503$KG$20240816$$MD$US$US
242190391$24219039$1$I$20240101$20240809$20240816$20240816$PER$$US-SA-2024SA241607$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240816$$MD$US$US
242190401$24219040$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240585$SANOFI AVENTIS$$$$E$F$Y$81.19$KG$20240816$$MD$US$US
242190411$24219041$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240622$SANOFI AVENTIS$$$$A$M$Y$117$KG$20240816$$MD$US$US
242190421$24219042$1$I$20220905$20240815$20240816$20240816$EXP$ES-AEMPS-1560145$ES-GILEAD-2024-0684393$GILEAD$$69$YR$E$F$Y$$$20240816$$PH$ES$ES
242190432$24219043$2$F$20240721$20240814$20240816$20240824$PER$$US-ABBVIE-5882222$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242190441$24219044$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239226$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240816$$MD$US$US
242190451$24219045$1$I$$20240812$20240816$20240816$EXP$$US-AstraZeneca-2024A183378$ASTRAZENECA$$$$$M$Y$$$20240816$$CN$US$
242190461$24219046$1$I$$20240813$20240816$20240816$EXP$$US-AstraZeneca-2024A185432$ASTRAZENECA$$$$$M$Y$$$20240816$$HP$US$
242190471$24219047$1$I$$20240806$20240816$20240816$EXP$$AU-TEVA-VS-3233569$TEVA$$$$$F$Y$$$20240816$$CN$AU$AU
242190481$24219048$1$I$$20240802$20240816$20240816$PER$$US-MYLANLABS-2024M1072995$MYLAN$$$$$M$Y$$$20240816$$CN$US$US
242190491$24219049$1$I$$20240809$20240816$20240816$EXP$$US-MYLANLABS-2024M1075045$MYLAN$$$$$F$Y$$$20240816$$CN$US$US
242190501$24219050$1$I$20240101$20240809$20240816$20240816$EXP$$US-JNJFOC-20240827694$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$HP$US$US
242190511$24219051$1$I$20240310$20240807$20240816$20240816$EXP$FR-AFSSAPS-AN2024000995$FR-TEVA-VS-3231738$TEVA$$69$YR$$M$Y$50$KG$20240816$$MD$FR$FR
242190521$24219052$1$I$$20240807$20240816$20240816$EXP$$IT-009507513-2408ITA003422$MERCK$$$$E$M$Y$$$20240816$$MD$IT$IT
242190531$24219053$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161951$AMGEN$$$$$$Y$$$20240816$$CN$US$US
242190541$24219054$1$I$$20240812$20240816$20240816$PER$$US-ABBVIE-5877683$ABBVIE$$$$$$Y$$$20240816$$CN$US$US
242190551$24219055$1$I$$20240815$20240816$20240816$EXP$$NVSC2024US166011$NOVARTIS$$$$$F$Y$$$20240816$$CN$US$US
242190561$24219056$1$I$$20240809$20240816$20240816$EXP$$US-MYLANLABS-2024M1075450$MYLAN$$$$$F$Y$$$20240816$$CN$US$US
242190571$24219057$1$I$20230911$20240812$20240816$20240816$EXP$$CA-ABBVIE-5879377$ABBVIE$$43$YR$$M$Y$$$20240816$$CN$CA$CA
242190582$24219058$2$F$$20240815$20240816$20240827$EXP$$CN-BEH-2024177104$CSL BEHRING$$61$YR$A$F$Y$60$KG$20240827$$HP$CN$CN
242190591$24219059$1$I$20240201$20240805$20240816$20240816$EXP$$US-GSK-US2024101354$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240816$$CN$US$US
242190601$24219060$1$I$20240101$20240701$20240816$20240816$PER$$US-LUNDBECK-DKLU4001311$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
242190611$24219061$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA240752$SANOFI AVENTIS$$$$A$M$Y$99.79$KG$20240816$$MD$US$US
242190621$24219062$1$I$20240101$20240812$20240816$20240816$PER$$US-SA-2024SA242131$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240816$$CN$US$US
242190631$24219063$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239894$SANOFI AVENTIS$$$$C$F$Y$$$20240816$$MD$US$US
242190641$24219064$1$I$20240814$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024162179$AMGEN$$74$YR$E$M$Y$$$20240816$$CN$US$US
242190652$24219065$2$F$$20240902$20240816$20240905$EXP$$CA-ABBVIE-5874012$ABBVIE$$$$A$M$Y$$$20240905$$CN$CA$CA
242190661$24219066$1$I$$20240814$20240816$20240816$EXP$$US-ABBVIE-5882395$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242190671$24219067$1$I$$20240801$20240816$20240816$EXP$$CA-HLS-202401930$HLS THERAPEUTICS$$$$A$F$Y$$$20240816$$PH$CA$CA
242190682$24219068$2$F$$20240815$20240816$20240826$EXP$$TW-BEH-2024177181$CSL BEHRING$$23$YR$A$M$Y$$$20240826$$HP$TW$TW
242190701$24219070$1$I$20240101$20240715$20240816$20240816$PER$$US-Eisai-EC-2024-170192$EISAI$$$$$F$Y$$$20240816$$MD$US$US
242190711$24219071$1$I$$20240712$20240816$20240816$PER$$US-Eisai-EC-2024-169214$EISAI$$60$YR$A$M$Y$$$20240816$$MD$US$US
242190721$24219072$1$I$$20240805$20240816$20240816$DIR$FDA-CDER-CTU-2024-56519$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
242190741$24219074$1$I$$20240814$20240816$20240816$EXP$$NVSC2024IN166395$NOVARTIS$$$$$M$Y$$$20240816$$CN$IN$IN
242190761$24219076$1$I$$20240812$20240816$20240816$EXP$$US-ABBVIE-5880678$ABBVIE$Doukas S, Martinez B, Rosenthal M, Vageli D. Controlled ovarian stimulation therapy as a potential risk for the development and progression of renal cell carcinomas: A case report and literature review. Mol Clin Oncol. 2021;15(1):140.$35$YR$$F$Y$$$20240816$$MD$US$US
242190771$24219077$1$I$$20240812$20240816$20240816$PER$$US-BAYER-2024A117133$BAYER$$$$$F$Y$$$20240816$$HP$US$US
242190781$24219078$1$I$20240726$20240813$20240816$20240816$EXP$$US-OTSUKA-2024_022381$OTSUKA$$$$$M$Y$$$20240816$$CN$US$US
242190791$24219079$1$I$20240701$20240812$20240816$20240816$EXP$$CA-OTSUKA-2024_022371$OTSUKA$$63$YR$$F$Y$$$20240816$$CN$CA$CA
242190801$24219080$1$I$20240701$20240808$20240816$20240816$EXP$SE-SEMPA-2024-005842$SE-TEVA-VS-3232308$TEVA$$34$YR$$F$Y$$$20240816$$MD$SE$SE
242190811$24219081$1$I$20240801$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56483$$FDA-CTU$$72$YR$$F$N$$$20240815$N$HP$US$
242190821$24219082$1$I$$20240814$20240816$20240816$EXP$$US-ABBVIE-5882172$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242190831$24219083$1$I$$20240813$20240816$20240816$EXP$$FR-ABBVIE-5882207$ABBVIE$$80$YR$$M$Y$$$20240816$$CN$FR$FR
242190841$24219084$1$I$$20240723$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005223$BIOCON$$$$$$Y$$$20240816$$PH$US$US
242190851$24219085$1$I$$20240726$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005230$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242190861$24219086$1$I$$20240715$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005252$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242190871$24219087$1$I$$20240715$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005265$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242190881$24219088$1$I$$20240716$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005314$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242190891$24219089$1$I$$20240725$20240816$20240816$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005333$BIOCON$$$$$$Y$$$20240816$$CN$US$US
242190901$24219090$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA242496$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240816$$CN$US$US
242190911$24219091$1$I$20240101$20240812$20240816$20240816$PER$$US-SA-2024SA242270$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240816$$MD$US$US
242190921$24219092$1$I$$20240806$20240816$20240816$EXP$$US-RADIUS HEALTH INC.-2024US006135$RADIUS PHARM$$$$$F$Y$$$20240816$$CN$US$US
242190931$24219093$1$I$$20240805$20240816$20240816$EXP$$PT-MYLANLABS-2024M1067555$MYLAN$Bonito IG, Carvalho IP, Coimbra A, Pona AP, Fernandes M, Ferreira J. Thrombotic risk in cancer patients - about a clinical case. Congresses of the Portuguese Society of Internal Medicine. 2024;972$76$YR$$F$Y$$$20240816$$MD$PT$PT
242190941$24219094$1$I$$20240806$20240816$20240816$PER$$US-ABBVIE-5874663$ABBVIE$$$$$$Y$$$20240816$$MD$US$US
242190951$24219095$1$I$20240707$20240812$20240816$20240816$EXP$FR-AFSSAPS-GR2024000978$FR-MYLANLABS-2024M1074864$MYLAN$$65$YR$$F$Y$114$KG$20240816$$MD$FR$FR
242190961$24219096$1$I$$20240813$20240816$20240816$EXP$$NVSC2024US165293$NOVARTIS$$66$YR$$F$Y$71.2$KG$20240816$$CN$US$US
242190981$24219098$1$I$$20240809$20240816$20240816$PER$$US-BAUSCHBL-2024BNL031499$BAUSCH AND LOMB$$$$$M$Y$$$20240816$$MD$US$US
242191001$24219100$1$I$20240713$20240715$20240816$20240816$PER$$US-Eisai-EC-2024-170231$EISAI$$67$YR$E$F$Y$$$20240816$$CN$US$US
242191011$24219101$1$I$20240101$20240715$20240816$20240816$PER$$US-Eisai-EC-2024-170210$EISAI$$$$$F$Y$$$20240816$$HP$US$US
242191031$24219103$1$I$20240101$20240807$20240816$20240816$PER$$US-BAUSCHBL-2024BNL031331$BAUSCH AND LOMB$$$$$F$Y$$$20240816$$CN$US$US
242191041$24219104$1$I$20240808$20240808$20240816$20240816$PER$$US-BAUSCHBL-2024BNL031454$BAUSCH AND LOMB$$$$$F$Y$$$20240816$$CN$US$US
242191051$24219105$1$I$$20240808$20240816$20240816$EXP$$US-ALXN-202408USA000513US$ALEXION PHARMACEUTICALS$$15$YR$$F$Y$$$20240816$$MD$US$US
242191061$24219106$1$I$20240811$20240812$20240816$20240816$PER$$US-AMGEN-USASP2024160368$AMGEN$$68$YR$E$F$Y$$$20240816$$PH$US$US
242191071$24219107$1$I$20240101$20240813$20240816$20240816$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140654$DAIICHI$$$$$F$Y$$$20240816$$MD$US$US
242191081$24219108$1$I$$20240813$20240816$20240816$EXP$$AU-JAZZ PHARMACEUTICALS-2024-AU-012590$JAZZ$$$$$M$Y$$$20240816$$PH$AU$AU
242191091$24219109$1$I$20230406$20240813$20240816$20240816$EXP$GB-MHRA-MED-202408100732140300-CKYFG$GB-MYLANLABS-2024M1076012$MYLAN$$60$YR$$F$Y$$$20240816$$CN$GB$GB
242191101$24219110$1$I$$20240809$20240816$20240816$EXP$$FR-DSJP-DSE-2024-140503$DAIICHI$$$$A$F$Y$79$KG$20240816$$MD$FR$FR
242191111$24219111$1$I$$20240806$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR098798$VIIV$$$$$M$Y$$$20240816$$CN$US$US
242191121$24219112$1$I$$20240806$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024098145$VIIV$$$$$M$Y$$$20240816$$CN$US$US
242191131$24219113$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56486$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242191142$24219114$2$F$$20240917$20240816$20240919$PER$$NVSC2024US166351$NOVARTIS$$$$$M$Y$73$KG$20240919$$CN$US$US
242191151$24219115$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA240977$SANOFI AVENTIS$$$$E$F$Y$$$20240816$$CN$US$US
242191161$24219116$1$I$$20240814$20240816$20240816$DIR$FDA-CDER-CTU-2024-56496$$FDA-CTU$$$$$F$N$$$20240814$N$HP$US$
242191171$24219117$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56495$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242191181$24219118$1$I$20240807$20240814$20240816$20240816$EXP$$GB-MYLANLABS-2024M1076031$MYLAN$$67$YR$$F$Y$68$KG$20240816$$MD$GB$GB
242191192$24219119$2$F$20240805$20240904$20240816$20240911$EXP$$US-BAYER-2024A114116$BAYER$$60$YR$A$M$Y$123.81$KG$20240911$$CN$US$US
242191201$24219120$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56549$$FDA-CTU$$67$YR$$F$N$$$20240816$N$$US$
242191211$24219121$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56513$$FDA-CTU$$90$YR$$F$N$$$20240816$N$$US$
242191231$24219123$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56538$$FDA-CTU$$67$YR$$M$N$$$20240816$N$$US$
242191242$24219124$2$F$$20240820$20240816$20240902$PER$$US-EMD Serono-2024043066$EMD SERONO INC$$$$$M$Y$$$20240902$$CN$US$US
242191251$24219125$1$I$$20240808$20240816$20240816$EXP$$US-JNJFOC-20240820854$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$CN$US$US
242191261$24219126$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56532$$FDA-CTU$$40$YR$$M$N$$$20240816$N$$US$
242191271$24219127$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56559$$FDA-CTU$$57$YR$$F$N$75.75$KG$20240816$N$$US$
242191281$24219128$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56517$$FDA-CTU$$85$YR$$F$N$51.71$KG$20240816$N$$US$
242191292$24219129$2$F$20240801$20240821$20240816$20240826$EXP$$NL-Ipsen Biopharmaceuticals, Inc.-2024-16156$IPSEN$$78$YR$E$F$Y$$$20240826$$CN$NL$NL
242191301$24219130$1$I$20240617$20240812$20240816$20240816$EXP$ES-AEMPS-1558386$ES-FreseniusKabi-FK202412388$FRESENIUS KABI$$50$YR$A$M$Y$84$KG$20240816$$MD$ES$ES
242191311$24219131$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56569$$FDA-CTU$$38$YR$$M$N$92.99$KG$20240816$N$$US$
242191321$24219132$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56477$$FDA-CTU$$76$YR$$F$N$$$20240816$N$$US$
242191331$24219133$1$I$20240815$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56534$$FDA-CTU$$76$YR$$F$N$$$20240816$N$$US$
242191353$24219135$3$F$20240807$20240820$20240816$20240916$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-15924$IPSEN$$58$YR$A$M$Y$87.08$KG$20240916$$CN$US$US
242191361$24219136$1$I$20240618$20240812$20240816$20240816$EXP$FR-AFSSAPS-AN2024001089$FR-FreseniusKabi-FK202412457$FRESENIUS KABI$$69$YR$E$F$Y$87$KG$20240816$$PH$FR$FR
242191371$24219137$1$I$20240617$20240812$20240816$20240816$EXP$FR-AFSSAPS-TO2024001173$FR-FreseniusKabi-FK202412505$FRESENIUS KABI$$70$YR$E$M$Y$61$KG$20240816$$MD$FR$FR
242191381$24219138$1$I$20220101$20240808$20240816$20240816$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-08775$IPSEN$$58$YR$A$F$Y$$$20240816$$MD$CA$CA
242191391$24219139$1$I$20240513$20240812$20240816$20240816$EXP$FR-AFSSAPS-BR2024000642$FR-MYLANLABS-2024M1074876$MYLAN$$85$YR$$F$Y$72$KG$20240816$$MD$FR$FR
242191401$24219140$1$I$20240813$20240813$20240816$20240816$EXP$GB-MHRA-MED-202408131855428120-BJSZW$GB-MYLANLABS-2024M1075593$MYLAN$$36$YR$$M$Y$$$20240816$$HP$GB$GB
242191411$24219141$1$I$20240215$20240812$20240816$20240816$EXP$FR-AFSSAPS-CF2024000407$FR-MYLANLABS-2024M1074862$MYLAN$$58$YR$$F$Y$89$KG$20240816$$HP$FR$FR
242191421$24219142$1$I$$20240806$20240816$20240816$EXP$$US-GSK-US2024GSK102354$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$MD$US$US
242191431$24219143$1$I$$20240806$20240816$20240816$30DAY$$US-GSK-US2024AMR098428$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242191441$24219144$1$I$20240418$20240716$20240816$20240816$PER$$US-Eisai-EC-2024-170260$EISAI$$57$YR$A$M$Y$$$20240816$$MD$US$US
242191451$24219145$1$I$20240719$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129288$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240816$$CN$US$US
242191461$24219146$1$I$$20240809$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128875$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240816$$CN$US$US
242191471$24219147$1$I$$20240807$20240816$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-129869$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240816$$MD$JP$JP
242191481$24219148$1$I$20240805$20240807$20240816$20240816$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-125744$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240816$$HP$FR$FR
242191491$24219149$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127962$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240816$$CN$US$US
242191501$24219150$1$I$20230117$20240813$20240816$20240816$EXP$DE-PEI-CADR2023317260$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-128172$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$56$KG$20240816$$CN$DE$DE
242191521$24219152$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA242495$SANOFI AVENTIS$$$$C$M$Y$$$20240816$$MD$US$US
242191531$24219153$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239669$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240816$$MD$US$US
242191541$24219154$1$I$20240801$20240814$20240816$20240816$PER$$US-AMGEN-USASP2024161953$AMGEN$$$$$$Y$$$20240816$$CN$US$US
242191551$24219155$1$I$$20240808$20240816$20240816$PER$$US-ALXN-202408USA000551US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240816$$CN$US$US
242191561$24219156$1$I$$20240805$20240816$20240816$EXP$$FR-INSMED, INC.-2024-03198-FR$INSMED$$70$YR$$M$Y$$$20240816$$HP$FR$FR
242191572$24219157$2$F$20240219$20240925$20240816$20240927$EXP$$NVSC2024US056978$NOVARTIS$$38$YR$$F$Y$$$20240927$$CN$US$US
242191591$24219159$1$I$$20240805$20240816$20240816$EXP$$US-BRAEBURN-US-BRA-24-000735$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240816$$CN$US$US
242191601$24219160$1$I$$20240806$20240816$20240816$30DAY$$US-GSK-US2024AMR099331$GLAXOSMITHKLINE$$$$$F$Y$51.247$KG$20240816$$CN$US$US
242191611$24219161$1$I$$20240807$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024099155$VIIV$$$$$F$Y$$$20240816$$CN$US$US
242191622$24219162$2$F$20240606$20240819$20240816$20240821$EXP$$US-GSK-US2024101443$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$PH$US$US
242191631$24219163$1$I$20240604$20240808$20240816$20240816$EXP$FR-AFSSAPS-AVPO2024000149$FR-TEVA-VS-3232336$TEVA$$17$YR$$M$Y$$$20240816$$PH$FR$FR
242191641$24219164$1$I$20240707$20240807$20240816$20240816$EXP$FR-AFSSAPS-AN2024000947$FR-TEVA-VS-3231267$TEVA$$71$YR$$M$Y$73$KG$20240816$$MD$FR$FR
242191651$24219165$1$I$20240714$20240807$20240816$20240816$EXP$FR-AFSSAPS-AN2024000977$FR-TEVA-VS-3231737$TEVA$$69$YR$$M$Y$150$KG$20240816$$MD$FR$FR
242191662$24219166$2$F$$20240828$20240816$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130126$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240829$$MD$US$US
242191671$24219167$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130211$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240816$$CN$US$US
242191681$24219168$1$I$$20240815$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129795$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240816$$CN$US$US
242191691$24219169$1$I$$20240809$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126883$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240816$$CN$US$US
242191701$24219170$1$I$20240803$20240815$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129860$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240816$$CN$US$US
242191711$24219171$1$I$20240815$20240815$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129995$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240816$$PH$US$US
242191721$24219172$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129265$BRISTOL MYERS SQUIBB$$40$YR$A$M$Y$74.39$KG$20240816$$CN$US$US
242191731$24219173$1$I$$20240812$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127649$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240816$$CN$US$US
242191741$24219174$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130197$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240816$$CN$US$US
242191751$24219175$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129216$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$63.96$KG$20240816$$CN$US$US
242191761$24219176$1$I$$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129138$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240816$$CN$US$US
242191771$24219177$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130193$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240816$$CN$US$US
242191782$24219178$2$F$$20240829$20240816$20240903$PER$$US-TAKEDA-2024TUS080913$TAKEDA$$$$$$Y$$$20240903$$CN$US$US
242191791$24219179$1$I$$20240814$20240816$20240816$EXP$GB-MHRA-MED-202408141826266670-DMGBN$GB-MYLANLABS-2024M1076229$MYLAN$$$$$F$Y$$$20240816$$CN$GB$GB
242191803$24219180$3$F$$20240815$20240816$20240930$PER$$US-LUNDBECK-DKLU4001912$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
242191811$24219181$1$I$$20240814$20240816$20240816$EXP$$GB-MYLANLABS-2024M1075977$MYLAN$$71$YR$$F$Y$50$KG$20240816$$MD$GB$GB
242191821$24219182$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA239047$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240816$$MD$US$US
242191831$24219183$1$I$20240101$20240813$20240816$20240816$EXP$$US-ABBVIE-5879733$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242191841$24219184$1$I$20240605$20240807$20240816$20240816$EXP$ES-AEMPS-1555666$ES-TEVA-VS-3231747$TEVA$$86$YR$$M$Y$$$20240816$$MD$ES$ES
242191851$24219185$1$I$20240726$20240807$20240816$20240816$DIR$FDA-CDER-CTU-2024-56566$$FDA-CTU$$47$YR$$F$N$$$20240807$N$HP$US$
242191861$24219186$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56494$$FDA-CTU$$71$YR$$M$N$$$20240816$N$$US$
242191871$24219187$1$I$20240701$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56546$$FDA-CTU$$43$YR$$M$N$$$20240816$N$HP$US$
242191881$24219188$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56503$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242191891$24219189$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56528$$FDA-CTU$$75$YR$$M$N$107.05$KG$20240816$N$$US$
242191901$24219190$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56525$$FDA-CTU$$45$YR$$M$N$$$20240816$N$$US$
242191911$24219191$1$I$$20240702$20240816$20240816$PER$$US-LUNDBECK-DKLU4001298$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
242191921$24219192$1$I$20240101$20240814$20240816$20240816$EXP$$US-ABBVIE-5882067$ABBVIE$$$$$F$Y$$$20240816$$MD$US$US
242191932$24219193$2$F$$20240813$20240816$20240821$PER$$US-AMGEN-USASP2024161840$AMGEN$$$$$M$Y$$$20240821$$HP$US$US
242191941$24219194$1$I$$20240814$20240816$20240816$EXP$$US-GILEAD-2024-0684443$GILEAD$$61$YR$A$M$Y$$$20240816$$CN$US$US
242191952$24219195$2$F$$20240809$20240816$20240820$EXP$$GB-TAKEDA-2024TUS081831$TAKEDA$$$$$$Y$$$20240820$$CN$GB$GB
242191961$24219196$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130214$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240816$$CN$US$US
242191972$24219197$2$F$$20240819$20240816$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-119702$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240827$$CN$US$US
242191981$24219198$1$I$$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129237$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240816$$CN$US$US
242191991$24219199$1$I$20240813$20240814$20240816$20240816$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129286$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240816$$CN$US$US
242192001$24219200$1$I$$20240812$20240816$20240816$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-128565$BRISTOL MYERS SQUIBB$Lin K-Y, Chang A, Lin C-J, Chung Y-C, Hsu W-C. Myasthenia gravis and myositis overlap syndrome caused by immune check point inhibitor: a case report. International Journal of Gerontology. 2024 Jul 01;18(3):194-6. doi:10.6890/IJGE.202407_18(3).0011.$62$YR$A$M$Y$$$20240816$$HP$TW$TW
242192013$24219201$3$F$$20240910$20240816$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128841$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240913$$PH$US$US
242192022$24219202$2$F$20230101$20240815$20240816$20240826$PER$$US-ABBVIE-5881236$ABBVIE$$$$A$M$Y$$$20240826$$HP$US$US
242192031$24219203$1$I$$20240814$20240816$20240816$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-130044$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240816$$CN$PR$PR
242192041$24219204$1$I$$20240813$20240816$20240816$EXP$NL-LRB-00995888$NL-FreseniusKabi-FK202412427$FRESENIUS KABI$$74$YR$E$M$Y$93.2$KG$20240816$$MD$NL$NL
242192051$24219205$1$I$$20240813$20240816$20240816$EXP$NL-LRB-00995858$NL-FreseniusKabi-FK202412429$FRESENIUS KABI$$27$YR$A$F$Y$69.5$KG$20240816$$HP$NL$NL
242192062$24219206$2$F$20240608$20240819$20240816$20240823$EXP$$US-GSK-US2024101432$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$PH$US$US
242192071$24219207$1$I$20240808$20240808$20240816$20240816$PER$$US-SA-2024SA238175$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240816$$MD$US$US
242192081$24219208$1$I$20240801$20240807$20240816$20240816$PER$$US-SA-2024SA240673$SANOFI AVENTIS$$$$E$F$Y$86.168$KG$20240816$$MD$US$US
242192091$24219209$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA242368$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240816$$MD$US$US
242192101$24219210$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56533$$FDA-CTU$$62$YR$$F$N$$$20240816$N$$US$
242192111$24219211$1$I$20240601$20240812$20240816$20240816$PER$$US-SA-2024SA242133$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240816$$MD$US$US
242192121$24219212$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240568$SANOFI AVENTIS$$$$$$Y$$$20240816$$HP$US$US
242192131$24219213$1$I$$20240805$20240816$20240816$DIR$FDA-CDER-CTU-2024-56553$$FDA-CTU$$$$$M$N$$$20240805$N$HP$US$
242192141$24219214$1$I$$20240814$20240816$20240816$DIR$FDA-CDER-CTU-2024-56531$$FDA-CTU$$$$$F$N$$$20240814$N$HP$US$
242192151$24219215$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56552$$FDA-CTU$$42$YR$$M$N$$$20240816$N$$US$
242192173$24219217$3$F$20240731$20240816$20240816$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122860$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$72.12$KG$20240823$$CN$US$US
242192181$24219218$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56539$$FDA-CTU$$$$$M$N$$$20240815$N$$US$
242192191$24219219$1$I$20240808$20240808$20240816$20240816$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099245$VIIV$$49$YR$$$Y$$$20240816$$CN$US$US
242192201$24219220$1$I$$20240809$20240816$20240816$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024099676$VIIV$$$$$M$Y$$$20240816$$MD$US$US
242192211$24219221$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA242217$SANOFI AVENTIS$$$$C$F$Y$$$20240816$$MD$US$US
242192221$24219222$1$I$20240728$20240809$20240816$20240816$PER$$US-SA-2024SA239983$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240816$$MD$US$US
242192231$24219223$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA239632$SANOFI AVENTIS$$$$E$F$Y$$$20240816$$CN$US$US
242192241$24219224$1$I$20240101$20240810$20240816$20240816$PER$$US-SA-2024SA241827$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240816$$MD$US$US
242192251$24219225$1$I$20240724$20240725$20240816$20240816$EXP$$US-Crown Laboratories, Inc.-2160549$CROWN LABORATORIES$$$$$F$Y$$$20240816$$$US$US
242192261$24219226$1$I$$20240812$20240816$20240816$EXP$$NVSC2024GB164558$NOVARTIS$$$$A$F$Y$$$20240816$$CN$GB$GB
242192271$24219227$1$I$$20240809$20240816$20240816$EXP$$US-AstraZeneca-2024A184307$ASTRAZENECA$$$$$F$Y$$$20240816$$CN$US$
242192282$24219228$2$F$20240729$20240909$20240816$20240911$PER$$US-PFIZER INC-202400236614$PFIZER$$85$YR$$F$Y$$$20240911$$HP$US$US
242192291$24219229$1$I$$20240814$20240816$20240816$PER$$US-PFIZER INC-PV202400106358$PFIZER$$$$$F$Y$$$20240816$$HP$US$US
242192303$24219230$3$F$$20240920$20240816$20240924$PER$$US-PFIZER INC-PV202300137983$PFIZER$$52$YR$$F$Y$$$20240924$$MD$US$US
242192313$24219231$3$F$$20240827$20240816$20240830$PER$$US-PFIZER INC-PV202400106193$PFIZER$$62$YR$$F$Y$$$20240830$$HP$US$US
242192322$24219232$2$F$20240101$20240820$20240816$20240821$PER$$US-PFIZER INC-202400237666$PFIZER$$60$YR$$M$Y$$$20240821$$HP$US$US
242192331$24219233$1$I$20240101$20240812$20240816$20240816$PER$$US-PFIZER INC-202400089749$PFIZER$$58$YR$$M$Y$$$20240816$$CN$US$US
242192341$24219234$1$I$20240101$20240814$20240816$20240816$PER$$US-ABBVIE-5882747$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242192361$24219236$1$I$20240624$20240724$20240816$20240816$30DAY$$US-JNJFOC-20240832572$JOHNSON AND JOHNSON$$69$YR$E$$Y$$$20240816$$CN$US$US
242192381$24219238$1$I$20240329$20240812$20240816$20240816$EXP$FR-AFSSAPS-AM2024000333$FR-FreseniusKabi-FK202412502$FRESENIUS KABI$$29$YR$A$F$Y$102$KG$20240816$$MD$FR$FR
242192391$24219239$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128941$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$86.18$KG$20240816$$CN$US$US
242192412$24219241$2$F$20240806$20240814$20240816$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129843$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$70.9$KG$20240822$$HP$US$US
242192421$24219242$1$I$20240101$20240808$20240816$20240816$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-095528$BRISTOL MYERS SQUIBB$$7$DEC$E$$Y$$$20240816$$MD$JP$JP
242192431$24219243$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128933$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240816$$CN$US$US
242192451$24219245$1$I$20220101$20240805$20240816$20240816$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-126775$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$55$KG$20240816$$MD$DE$DE
242192461$24219246$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA240540$SANOFI AVENTIS$$54$YR$A$M$Y$99.79$KG$20240816$$MD$US$US
242192471$24219247$1$I$20240101$20240806$20240816$20240816$EXP$$GB-TEVA-VS-3231436$TEVA$$59$YR$$F$Y$$$20240816$$CN$GB$GB
242192481$24219248$1$I$20240726$20240807$20240816$20240816$DIR$FDA-CDER-CTU-2024-56568$$FDA-CTU$$47$YR$$F$N$$$20240807$N$$US$
242192491$24219249$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56543$$FDA-CTU$$73$YR$$F$N$$$20240816$N$$US$
242192501$24219250$1$I$20240301$20240814$20240816$20240816$EXP$FR-AFSSAPS-MP2024001122$FR-TAKEDA-2024TUS082325$TAKEDA$$75$YR$$M$Y$$$20240816$$HP$FR$FR
242192511$24219251$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56501$$FDA-CTU$$69$YR$$F$N$$$20240816$N$$US$
242192542$24219254$2$F$20240601$20240815$20240816$20240823$EXP$$US-LEX-000425$LEXICON PHARMACEUTICALS$$73$YR$$M$Y$$$20240823$$CN$US$US
242192552$24219255$2$F$20240809$20240909$20240816$20240913$EXP$$US-LEX-000433$LEXICON PHARMACEUTICALS$$80$YR$$M$Y$59.874$KG$20240913$$MD$US$US
242192561$24219256$1$I$20240101$20240813$20240816$20240816$EXP$$US-ABBVIE-5880007$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242192571$24219257$1$I$20240816$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56502$$FDA-CTU$$53$YR$$M$N$101.38$KG$20240816$Y$HP$US$
242192581$24219258$1$I$$20240806$20240816$20240816$PER$$US-JNJFOC-20240816670$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240816$$CN$US$US
242192591$24219259$1$I$20240101$20240812$20240816$20240816$EXP$$US-ABBVIE-5878973$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242192601$24219260$1$I$$20240813$20240816$20240816$EXP$$US-ABBVIE-5865786$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242192611$24219261$1$I$20240812$20240813$20240816$20240816$EXP$$DE-ABBVIE-5881883$ABBVIE$$86$YR$$M$Y$$$20240816$$CN$DE$DE
242192621$24219262$1$I$$20240809$20240816$20240816$EXP$$US-ALKERMES INC.-ALK-2024-002109$ALKERMES$$$$$M$Y$$$20240816$$HP$US$US
242192631$24219263$1$I$20240801$20240806$20240816$20240816$EXP$$US-ALKERMES INC.-ALK-2024-002067$ALKERMES$$44$YR$$M$Y$99.773$KG$20240816$$CN$US$US
242192641$24219264$1$I$$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128333$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$59.96$KG$20240816$$CN$US$US
242192651$24219265$1$I$$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128691$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240816$$HP$US$US
242192671$24219267$1$I$20240301$20240807$20240816$20240816$EXP$FR-AFSSAPS-TS2024000869$FR-TEVA-VS-3231811$TEVA$$41$YR$$F$Y$88$KG$20240816$$MD$FR$FR
242192682$24219268$2$F$$20240819$20240816$20240913$PER$$US-SMPA-2024MYSCI0700832$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
242192691$24219269$1$I$20240708$20240814$20240816$20240816$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004551$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240816$$MD$US$US
242192711$24219271$1$I$20231218$20240814$20240816$20240816$EXP$$CA-PFIZER INC-202400091003$PFIZER$$49$YR$$F$Y$$$20240816$$HP$CA$CA
242192733$24219273$3$F$20240914$20240918$20240816$20240919$EXP$$US-PFIZER INC-PV202400083191$PFIZER$$77$YR$$F$Y$$$20240919$$CN$US$US
242192742$24219274$2$F$$20240909$20240816$20240911$EXP$$US-PFIZER INC-202400237754$PFIZER$$$$$F$Y$$$20240911$$CN$US$US
242192751$24219275$1$I$20240812$20240813$20240816$20240816$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-16264$IPSEN$$75$YR$E$F$Y$$$20240816$$CN$US$US
242192761$24219276$1$I$$20240815$20240816$20240816$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046179$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240816$$CN$US$US
242192791$24219279$1$I$$20240807$20240816$20240816$PER$$US-ABBVIE-5873757$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242192801$24219280$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008393$ELI LILLY AND CO$$$$$$Y$$$20240816$$PH$US$US
242192811$24219281$1$I$20240809$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408006636$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240816$$CN$US$US
242192821$24219282$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008654$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240816$$CN$US$US
242192831$24219283$1$I$$20240806$20240816$20240816$EXP$$GB-MYLANLABS-2024M1074719$MYLAN$Erblich T, Manisty C, Gribben J. Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated Risk. Case-Rep-Hematol 2024; 2024 1-6.$87$YR$$M$Y$$$20240816$$HP$GB$GB
242192841$24219284$1$I$$20240809$20240816$20240816$EXP$$US-MYLANLABS-2024M1075445$MYLAN$$$$$F$Y$$$20240816$$CN$US$US
242192851$24219285$1$I$$20240815$20240816$20240816$EXP$$US-SANDOZ INC.-SDZ2024US073141$SANDOZ$$$$$F$Y$$$20240816$$CN$US$US
242192871$24219287$1$I$$20240813$20240816$20240816$EXP$$CA-SANDOZ INC.-SDZ2023CA046073$SANDOZ$$$$$M$Y$$$20240816$$MD$CA$CA
242192881$24219288$1$I$$20240813$20240816$20240816$EXP$$NVSC2024GB164526$NOVARTIS$$47$YR$$F$Y$$$20240816$$CN$GB$GB
242192891$24219289$1$I$20240322$20240815$20240816$20240816$EXP$SE-SEMPA-2024-006078$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-129392$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240816$$MD$SE$SE
242192901$24219290$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129627$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240816$$CN$US$US
242192911$24219291$1$I$$20240814$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129974$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240816$$CN$US$US
242192922$24219292$2$F$$20240910$20240816$20240910$EXP$$US-ALXN-202408USA000652US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
242192931$24219293$1$I$20240523$20240808$20240816$20240816$EXP$$JP-ALXN-202407JPN000275JP$ALEXION PHARMACEUTICALS$$9$DEC$$F$Y$$$20240816$$MD$JP$JP
242192952$24219295$2$F$20240813$20240826$20240816$20240827$EXP$$US-BAYER-2024A117897$BAYER$$83$YR$E$M$Y$$$20240827$$HP$US$US
242192961$24219296$1$I$$20240814$20240816$20240816$EXP$$US-ABBVIE-5881725$ABBVIE$$$$$M$Y$$$20240816$$MD$US$US
242192972$24219297$2$F$20240801$20240917$20240816$20240925$EXP$$CA-HLS-202401965$HLS THERAPEUTICS$$66$YR$E$F$Y$$$20240925$$CN$CA$CA
242192981$24219298$1$I$$20240813$20240816$20240816$EXP$$NVSC2024GB164499$NOVARTIS$$$$$F$Y$$$20240816$$CN$GB$GB
242192991$24219299$1$I$$20240814$20240816$20240816$EXP$$CA-ABBVIE-5882022$ABBVIE$$$$E$M$Y$$$20240816$$CN$CA$CA
242193001$24219300$1$I$20240221$20240807$20240816$20240816$EXP$FR-AFSSAPS-NC2024000919$FR-TEVA-VS-3231813$TEVA$$48$YR$$F$Y$97$KG$20240816$$MD$FR$FR
242193011$24219301$1$I$20240521$20240807$20240816$20240816$EXP$FR-AFSSAPS-NC2024000916$FR-TEVA-VS-3231812$TEVA$$68$YR$$F$Y$$$20240816$$MD$FR$FR
242193021$24219302$1$I$20220331$20240809$20240816$20240816$EXP$$FR-009507513-2408FRA003770$MERCK$$64$YR$$M$Y$78$KG$20240816$$MD$FR$FR
242193031$24219303$1$I$20240624$20240807$20240816$20240816$EXP$FR-AFSSAPS-AM2024000616$FR-TEVA-VS-3231749$TEVA$$90$YR$$F$Y$52$KG$20240816$$PH$FR$FR
242193041$24219304$1$I$20240801$20240807$20240816$20240816$EXP$$FR-ABBVIE-5875221$ABBVIE$$63$YR$$F$Y$$$20240816$$CN$FR$FR
242193051$24219305$1$I$$20240805$20240816$20240816$EXP$$US-VIVUS LLC-2022V1000673$VIVUS$$$$A$F$Y$$$20240816$$HP$US$US
242193062$24219306$2$F$$20240812$20240816$20240820$EXP$$CA-AstraZeneca-2024A184274$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$CA$
242193073$24219307$3$F$20240801$20240820$20240816$20240822$EXP$$GR-ABBVIE-5881086$ABBVIE$$78$YR$$F$Y$$$20240822$$CN$GR$GR
242193083$24219308$3$F$20231108$20240812$20240816$20240926$PER$$US-TEVA-VS-3233834$TEVA$$$$$F$Y$$$20240926$$CN$US$US
242193091$24219309$1$I$20240809$20240812$20240816$20240816$EXP$$AU-MYLANLABS-2024M1074723$MYLAN$$77$YR$$F$Y$$$20240816$$HP$AU$AU
242193101$24219310$1$I$20240802$20240808$20240816$20240816$PER$$US-ALXN-202408USA000635US$ALEXION PHARMACEUTICALS$$55$YR$$F$Y$108.84$KG$20240816$$CN$US$US
242193112$24219311$2$F$20240901$20240905$20240816$20240917$EXP$$US-BAYER-2024A105937$BAYER$$61$YR$A$M$Y$$$20240917$$CN$US$US
242193121$24219312$1$I$$20240702$20240816$20240816$PER$$US-LUNDBECK-DKLU4001301$LUNDBECK$$$$$$Y$$$20240816$$HP$US$US
242193131$24219313$1$I$20240628$20240702$20240816$20240816$PER$$US-LUNDBECK-DKLU4001297$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
242193141$24219314$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165461$NOVARTIS$$57$YR$$M$Y$$$20240816$$MD$US$US
242193151$24219315$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008404$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240816$$CN$US$US
242193161$24219316$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008411$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240816$$CN$US$US
242193171$24219317$1$I$$20240702$20240816$20240816$PER$$US-LUNDBECK-DKLU4001180$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
242193181$24219318$1$I$20240703$20240718$20240816$20240816$PER$$US-009507513-2407USA011827$MERCK$$$$$$Y$$$20240816$$PH$US$US
242193191$24219319$1$I$$20240812$20240816$20240816$EXP$$CA-PURDUE-USA-2024-0311380$PURDUE$$53$YR$$M$Y$$$20240816$$CN$CA$CA
242193201$24219320$1$I$$20240814$20240816$20240816$EXP$$US-KYOWAKIRIN-2024KK019243$KYOWA$$$$$$Y$$$20240816$$HP$US$US
242193211$24219321$1$I$20240712$20240813$20240816$20240816$EXP$$GB-PURDUE-USA-2024-0311385$PURDUE$$63$YR$$F$Y$67$KG$20240816$$MD$GB$GB
242193221$24219322$1$I$20220701$20240815$20240816$20240816$EXP$$US-PURDUE PHARMA-USA-2024-0311364$PURDUE$$$$$M$Y$$$20240816$$CN$US$US
242193231$24219323$1$I$$20240802$20240816$20240816$EXP$$US-HLS-202400710$HLS THERAPEUTICS$$$$A$F$Y$$$20240816$$PH$US$US
242193241$24219324$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA242230$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240816$$MD$US$US
242193251$24219325$1$I$$20240812$20240816$20240816$PER$$US-SA-2024SA242231$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240816$$MD$US$US
242193262$24219326$2$F$20240101$20240814$20240816$20240828$PER$$US-SA-2024SA242356$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240828$$MD$US$US
242193271$24219327$1$I$$20240813$20240816$20240816$EXP$$CA-PURDUE-USA-2024-0311388$PURDUE$$51$YR$$F$Y$77$KG$20240816$$HP$CA$CA
242193281$24219328$1$I$$20240812$20240816$20240816$EXP$$CA-PURDUE-USA-2024-0311372$PURDUE$$85$YR$$F$Y$$$20240816$$CN$CA$CA
242193291$24219329$1$I$20240727$20240808$20240816$20240816$EXP$IT-MINISAL02-997200$IT-TEVA-VS-3232000$TEVA$$25$YR$$M$Y$64$KG$20240816$$CN$IT$IT
242193301$24219330$1$I$$20240814$20240816$20240816$PER$$US-ABBVIE-5882518$ABBVIE$$$$$$Y$$$20240816$$CN$US$US
242193321$24219332$1$I$$20240815$20240816$20240816$EXP$$US-KYOWAKIRIN-2024KK019291$KYOWA$$$$$$Y$$$20240816$$PH$US$US
242193331$24219333$1$I$$20240815$20240816$20240816$PER$$US-PURDUE PHARMA-USA-2024-0311368$PURDUE$$32$YR$$M$Y$$$20240816$$CN$US$US
242193341$24219334$1$I$$20240702$20240816$20240816$PER$$US-LUNDBECK-DKLU4001308$LUNDBECK$$$$$$Y$$$20240816$$HP$US$US
242193351$24219335$1$I$$20240815$20240816$20240816$PER$$US-PURDUE PHARMA-USA-2024-0311379$PURDUE$$52$YR$$M$Y$$$20240816$$CN$US$US
242193361$24219336$1$I$$20240815$20240816$20240816$PER$$US-PURDUE PHARMA-USA-2024-0311367$PURDUE$$39$YR$$M$Y$$$20240816$$CN$US$US
242193371$24219337$1$I$$20240813$20240816$20240816$EXP$$NVSC2024AT159468$NOVARTIS$$$$E$F$Y$$$20240816$$MD$AT$AT
242193381$24219338$1$I$20240801$20240815$20240816$20240816$EXP$$US-BAYER-2024A105502$BAYER$$90$YR$E$M$Y$$$20240816$$CN$US$US
242193391$24219339$1$I$$20240812$20240816$20240816$PER$$US-JNJFOC-20240830054$JOHNSON AND JOHNSON$$$$$M$Y$$$20240816$$CN$US$US
242193401$24219340$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA238300$SANOFI AVENTIS$$$$I$M$Y$$$20240816$$MD$US$US
242193412$24219341$2$F$$20240905$20240816$20240910$PER$$US-PFIZER INC-PV202400105428$PFIZER$$65$YR$$F$Y$$$20240910$$HP$US$US
242193422$24219342$2$F$$20240814$20240816$20240819$PER$$US-PFIZER INC-202400236573$PFIZER$$$$$M$Y$$$20240819$$CN$US$US
242193431$24219343$1$I$20240813$20240814$20240816$20240816$PER$$US-PFIZER INC-202400236917$PFIZER$$68$YR$$F$Y$$$20240816$$CN$US$US
242193442$24219344$2$F$$20240823$20240816$20240827$PER$$US-PFIZER INC-PV202400106566$PFIZER$$$$$M$Y$$$20240827$$CN$US$US
242193452$24219345$2$F$20240801$20240903$20240816$20240903$PER$$US-ALXN-202408USA000531US$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240903$$CN$US$US
242193471$24219347$1$I$20240507$20240813$20240816$20240816$EXP$$US-ABBVIE-5780351$ABBVIE$$51$YR$$F$Y$$$20240816$$CN$US$US
242193481$24219348$1$I$20240812$20240813$20240816$20240816$EXP$$US-ABBVIE-5880441$ABBVIE$$61$YR$$F$Y$$$20240816$$CN$US$US
242193491$24219349$1$I$$20240813$20240816$20240816$EXP$$US-ABBVIE-5880463$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242193501$24219350$1$I$$20240807$20240816$20240816$PER$$US-JNJFOC-20240841319$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240816$$HP$US$US
242193511$24219351$1$I$$20240807$20240816$20240816$PER$$US-JNJFOC-20240839471$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240816$$HP$US$US
242193521$24219352$1$I$20240501$20240805$20240816$20240816$PER$$US-JNJFOC-20240839241$JOHNSON AND JOHNSON$$$$$F$Y$$$20240816$$CN$US$US
242193541$24219354$1$I$$20240807$20240816$20240816$PER$$US-JNJFOC-20240839240$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240816$$HP$US$US
242193551$24219355$1$I$$20240807$20240816$20240816$PER$$US-JNJFOC-20240839529$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240816$$CN$US$US
242193561$24219356$1$I$20240729$20240813$20240816$20240816$PER$$CN-Eisai-EC-2024-172027$EISAI$$45$YR$A$F$Y$50$KG$20240816$$HP$CN$CN
242193571$24219357$1$I$$20240814$20240816$20240816$EXP$$NVSC2024US165647$NOVARTIS$$$$$M$Y$$$20240816$$CN$US$US
242193581$24219358$1$I$20240808$20240809$20240816$20240816$PER$$US-ALXN-202408USA000668US$ALEXION PHARMACEUTICALS$$55$YR$$M$Y$$$20240816$$PH$US$US
242193593$24219359$3$F$20240701$20240905$20240816$20240910$PER$$US-ALXN-202408USA000564US$ALEXION PHARMACEUTICALS$$66$YR$$M$Y$128.35$KG$20240910$$CN$US$US
242193614$24219361$4$F$20240101$20240905$20240816$20240911$EXP$$US-ABBVIE-5881916$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
242193622$24219362$2$F$20240813$20240816$20240816$20240821$EXP$$FR-ABBVIE-5881918$ABBVIE$$77$YR$$F$Y$$$20240821$$HP$FR$FR
242193631$24219363$1$I$$20240722$20240816$20240816$EXP$$NVSC2024CN152748$NOVARTIS$Liu W, Li FE, Su P, Xu XM. Efficacy of zhenwu decoction combined with modified buxinqi prescription in treatment of patients with chronic heart failure of heart and kidney yang deficiency and its effects on oxidative stress and vascular endothelial functions. WORLD JOURNAL OF INTEGRATED TRADITIONAL AND WESTERN MEDICINE. 2024;19(6)$$$$$Y$$$20240816$$HP$CN$CN
242193641$24219364$1$I$$20240813$20240816$20240816$EXP$$US-PFIZER INC-PV202400105710$PFIZER$$$$$$Y$$$20240816$$CN$US$US
242193652$24219365$2$F$$20240607$20240816$20240910$EXP$$US-PFIZER INC-PV202400100858$PFIZER$$79$YR$$F$Y$$$20240910$$CN$US$US
242193662$24219366$2$F$$20240905$20240816$20240909$EXP$$US-OTSUKA-2024_022541$OTSUKA$$$$$M$Y$$$20240909$$HP$US$US
242193671$24219367$1$I$20240320$20240814$20240816$20240816$EXP$$US-OTSUKA-2024_022531$OTSUKA$$53$YR$$$Y$$$20240816$$CN$US$US
242193681$24219368$1$I$$20240809$20240816$20240816$EXP$$GB-TAKEDA-2024TUS080779$TAKEDA$$$$$M$Y$$$20240816$$CN$GB$GB
242193691$24219369$1$I$20240502$20240523$20240816$20240816$PER$$US-GE HEALTHCARE-2024CSU005573$GE HEALTHCARE$$56$YR$$M$Y$$$20240816$$HP$US$US
242193701$24219370$1$I$20240510$20240523$20240816$20240816$PER$$US-GE HEALTHCARE-2024CSU005571$GE HEALTHCARE$$68$YR$$M$Y$70.3$KG$20240816$$HP$US$US
242193711$24219371$1$I$20240521$20240523$20240816$20240816$PER$$US-GE HEALTHCARE-2024CSU005539$GE HEALTHCARE$$78$YR$$F$Y$61$KG$20240816$$HP$US$US
242193731$24219373$1$I$20240729$20240814$20240816$20240816$EXP$$DE-ABBVIE-5835001$ABBVIE$$80$YR$$F$Y$$$20240816$$CN$DE$DE
242193741$24219374$1$I$$20240809$20240816$20240816$EXP$$FR-AstraZeneca-2024A186681$ASTRAZENECA$$$$N$M$Y$0.8$KG$20240816$$MD$FR$
242193751$24219375$1$I$20240522$20240523$20240816$20240816$PER$$US-GE HEALTHCARE-2024CSU005572$GE HEALTHCARE$$79$YR$$M$Y$70$KG$20240816$$HP$US$US
242193761$24219376$1$I$$20240814$20240816$20240816$EXP$$US-OTSUKA-2024_022517$OTSUKA$$$$$F$Y$$$20240816$$HP$US$US
242193771$24219377$1$I$20240813$20240814$20240816$20240816$EXP$$NVSC2024DE165558$NOVARTIS$$$$A$F$Y$$$20240816$$CN$DE$DE
242193781$24219378$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008470$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$US$US
242193791$24219379$1$I$20240813$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009343$ELI LILLY AND CO$$$$A$F$Y$$$20240816$$CN$US$US
242193801$24219380$1$I$20240813$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009349$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240816$$CN$US$US
242193811$24219381$1$I$20240813$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008365$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240816$$CN$US$US
242193831$24219383$1$I$20200101$20240809$20240816$20240816$EXP$$US-ABBVIE-5864983$ABBVIE$$$$$M$Y$104.32$KG$20240816$$CN$US$US
242193851$24219385$1$I$$20240813$20240816$20240816$EXP$$US-ABBVIE-5881026$ABBVIE$$$$$F$Y$$$20240816$$CN$US$US
242193861$24219386$1$I$$20240813$20240816$20240816$EXP$$US-TAKEDA-2024TUS081298$TAKEDA$$$$$M$Y$$$20240816$$CN$US$US
242193871$24219387$1$I$20240723$20240813$20240816$20240816$EXP$$NL-ABBVIE-5842288$ABBVIE$$$$E$M$Y$$$20240816$$CN$NL$NL
242193882$24219388$2$F$$20240812$20240816$20240826$PER$$US-SA-2024SA240257$SANOFI AVENTIS$$$$A$F$Y$61$KG$20240826$$MD$US$US
242193891$24219389$1$I$$20240814$20240816$20240816$PER$$NVSC2024US165842$NOVARTIS$$$$A$F$Y$$$20240816$$HP$US$US
242193901$24219390$1$I$20210101$20240809$20240816$20240816$EXP$$US-ABBVIE-5876104$ABBVIE$$$$$M$Y$$$20240816$$CN$US$US
242193911$24219391$1$I$20220101$20240517$20240816$20240816$EXP$$CL-ABBVIE-5658559$ABBVIE$$$$$F$Y$$$20240816$$CN$CL$CL
242193921$24219392$1$I$20240801$20240808$20240816$20240816$EXP$$US-ABBVIE-5874734$ABBVIE$$24$YR$$F$Y$$$20240816$$CN$US$US
242193931$24219393$1$I$20240101$20240814$20240816$20240816$EXP$$US-Eisai-EC-2024-172136$EISAI$$69$YR$E$M$Y$$$20240816$$CN$US$US
242193941$24219394$1$I$$20240813$20240816$20240816$PER$$US-JNJFOC-20240833795$JOHNSON AND JOHNSON$$$$$$Y$$$20240816$$HP$US$US
242193951$24219395$1$I$$20240807$20240816$20240816$PER$$US-SA-2024SA238878$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240816$$MD$US$US
242193963$24219396$3$F$20240806$20240913$20240816$20240919$EXP$$KR-ABBVIE-5881010$ABBVIE$$57$YR$$M$Y$55$KG$20240919$$MD$KR$KR
242193971$24219397$1$I$20240101$20240815$20240816$20240816$EXP$$US-PFIZER INC-PV202400106821$PFIZER$$72$YR$$M$Y$$$20240816$$HP$US$US
242193981$24219398$1$I$$20240815$20240816$20240816$EXP$$US-009507513-2408USA005737$MERCK$$$$$M$Y$$$20240816$$CN$US$US
242193991$24219399$1$I$20240729$20240814$20240816$20240816$EXP$$CA-ABBVIE-5882002$ABBVIE$$74$YR$$M$Y$$$20240816$$CN$CA$CA
242194001$24219400$1$I$20240501$20240809$20240816$20240816$EXP$$US-ABBVIE-5879476$ABBVIE$$23$YR$$M$Y$$$20240816$$CN$US$US
242194012$24219401$2$F$20240729$20240823$20240816$20240825$EXP$$ES-ABBVIE-5882199$ABBVIE$$76$YR$$F$Y$$$20240825$$CN$ES$ES
242194022$24219402$2$F$20240731$20240821$20240816$20240826$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004601$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
242194031$24219403$1$I$$20240807$20240816$20240816$PER$$US-LUNDBECK-DKLU4002862$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
242194041$24219404$1$I$$20240810$20240816$20240816$PER$$US-SA-2024SA239956$SANOFI AVENTIS$$$$$F$Y$$$20240816$$MD$US$US
242194051$24219405$1$I$20230101$20240808$20240816$20240816$PER$$US-SA-2024SA238953$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240816$$CN$US$US
242194061$24219406$1$I$$20240809$20240816$20240816$EXP$$US-PERRIGO-24US007585$PERRIGO$$$$A$$Y$$$20240816$$CN$US$US
242194072$24219407$2$F$20240728$20240823$20240816$20240830$EXP$$US-ABBVIE-5878871$ABBVIE$$48$YR$$M$Y$$$20240828$$CN$US$US
242194081$24219408$1$I$20240614$20240814$20240816$20240816$EXP$$CA-ABBVIE-5813391$ABBVIE$$77$YR$$F$Y$$$20240816$$CN$CA$CA
242194092$24219409$2$F$20240719$20240815$20240816$20240822$EXP$$US-KYOWAKIRIN-2024KK019277$KYOWA$$$$$$Y$$$20240822$$HP$US$US
242194101$24219410$1$I$$20240801$20240816$20240816$PER$$US-LUNDBECK-DKLU4002670$LUNDBECK$$$$$$Y$$$20240816$$CN$US$US
242194111$24219411$1$I$20240220$20240813$20240816$20240816$EXP$FR-AFSSAPS-TO2024001493$FR-LUNDBECK-DKLU4003029$LUNDBECK$$$$$$Y$$$20240816$$PH$FR$FR
242194122$24219412$2$F$$20240910$20240816$20240917$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202408004667$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240917$$CN$CA$CA
242194131$24219413$1$I$20240101$20240807$20240816$20240816$PER$$US-SA-2024SA238854$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240816$$MD$US$US
242194141$24219414$1$I$20240801$20240806$20240816$20240816$PER$$US-MYLANLABS-2024M1074050$MYLAN$$86$YR$$F$Y$$$20240816$$CN$US$US
242194152$24219415$2$F$$20240812$20240816$20240823$EXP$$GB-FOUNDATIONCONSUMERHC-2024-UK-000158$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240823$$CN$GB$GB
242194161$24219416$1$I$$20240814$20240816$20240816$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046156$BOEHRINGER INGELHEIM$$$$$$Y$$$20240816$$HP$US$US
242194171$24219417$1$I$20230101$20240812$20240816$20240816$PER$$US-009507513-2408USA004833$MERCK$$$$$F$Y$$$20240816$$MD$US$US
242194181$24219418$1$I$20240701$20240801$20240816$20240816$PER$$US-MYLANLABS-2024M1072646$MYLAN$$70$YR$$F$Y$$$20240816$$CN$US$US
242194191$24219419$1$I$$20240813$20240816$20240816$EXP$$KR-AstraZeneca-2024A185699$ASTRAZENECA$$69$YR$$F$Y$$$20240816$$CN$KR$
242194201$24219420$1$I$20240521$20240805$20240816$20240816$EXP$FR-AFSSAPS-NC2024000916$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07542$HIKMA$$68$YR$$F$Y$$$20240816$$MD$FR$FR
242194211$24219421$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007168$ELI LILLY AND CO$$58$YR$A$$Y$$$20240816$$LW$US$US
242194221$24219422$1$I$$20240813$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408008468$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240816$$CN$US$US
242194231$24219423$1$I$$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408006412$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240816$$CN$US$US
242194241$24219424$1$I$$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007193$ELI LILLY AND CO$$39$YR$A$$Y$$$20240816$$LW$US$US
242194251$24219425$1$I$$20240809$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007203$ELI LILLY AND CO$$59$YR$A$$Y$$$20240816$$LW$US$US
242194261$24219426$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007812$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240816$$CN$US$US
242194271$24219427$1$I$$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408006569$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$US$US
242194281$24219428$1$I$20240812$20240814$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408009347$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240816$$CN$US$US
242194291$24219429$1$I$20240723$20240805$20240816$20240816$EXP$$US-HLS-202400723$HLS THERAPEUTICS$$54$YR$A$F$Y$$$20240816$$HP$US$US
242194301$24219430$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239177$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240816$$MD$US$US
242194311$24219431$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA239609$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240816$$MD$US$US
242194322$24219432$2$F$20240501$20240828$20240816$20240903$PER$$US-AMGEN-USASP2024154470$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242194332$24219433$2$F$20240702$20240917$20240816$20240918$EXP$FR-AFSSAPS-AN2024001067$FR-ALXN-202407GLO002294FR$ALEXION PHARMACEUTICALS$$53$YR$$M$Y$$$20240918$$PH$FR$FR
242194342$24219434$2$F$20240704$20240809$20240816$20240821$EXP$$JP-ALXN-202407JPN001011JP$ALEXION PHARMACEUTICALS$$51$YR$$M$Y$$$20240821$$MD$JP$JP
242194352$24219435$2$F$20240809$20240821$20240816$20240829$PER$$US-AMGEN-USASP2024159513$AMGEN$$51$YR$A$F$Y$77.551$KG$20240828$$PH$US$US
242194362$24219436$2$F$20240723$20240826$20240816$20240902$30DAY$$US-AMGEN-USASP2024159498$AMGEN$$82$YR$E$M$Y$74.7$KG$20240902$$HP$US$US
242194371$24219437$1$I$20240808$20240809$20240816$20240816$30DAY$$US-AMGEN-USASP2024159494$AMGEN$$$$$$Y$$$20240816$$PH$US$US
242194381$24219438$1$I$20230707$20240808$20240816$20240816$EXP$IT-MINISAL02-996936$IT-TEVA-VS-3232437$TEVA$$52$YR$$M$Y$$$20240816$$MD$IT$IT
242194391$24219439$1$I$20221106$20240808$20240816$20240816$EXP$ES-AEMPS-1551210$ES-TEVA-VS-3233006$TEVA$$48$YR$$F$Y$$$20240816$$MD$ES$ES
242194401$24219440$1$I$$20240815$20240816$20240816$EXP$$MA-VISTAPHARM-2024-MA-000011$VISTAPHARM$Mourabiti H, Esayh G, Hoummani H, et al.Paraparesis secondary to metformin: A rare condition to be aware of, with characteristic MRI images..Toxicologie Analytique et Clinique.2024;.$63$YR$$F$Y$$$20240816$$HP$MA$MA
242194411$24219441$1$I$20240709$20240815$20240816$20240816$PER$$US-GILEAD-2024-0684309$GILEAD$$75$YR$E$F$Y$$$20240816$$HP$US$US
242194422$24219442$2$F$$20240819$20240816$20240821$EXP$PT-TEVA-VS-3222019$PT-ROCHE-10000053066$ROCHE$Lopes T, Antes J, Melo B, Goncalves F. Organizing pneumonia due to human Metapneumovirus in a lung transplant recipient [Abstract number: CO-0237-(4707)]. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts [CNM]. 2024-May;331.$25$YR$A$M$Y$$$20240821$$MD$PT$PT
242194431$24219443$1$I$20240101$20240812$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127820$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240816$$CN$US$US
242194441$24219444$1$I$20240720$20240722$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000269$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194451$24219445$1$I$20240723$20240724$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000277$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194461$24219446$1$I$20240701$20240726$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000287$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194471$24219447$1$I$20240101$20240802$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000208$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194481$24219448$1$I$$20240725$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000281$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194491$24219449$1$I$$20240726$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000288$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194501$24219450$1$I$20240101$20240729$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000295$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194511$24219451$1$I$20240725$20240726$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000291$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194521$24219452$1$I$$20240731$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000303$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194531$24219453$1$I$$20240729$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000297$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194542$24219454$2$F$20240501$20240904$20240816$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000298$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
242194551$24219455$1$I$20240101$20240730$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000299$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194561$24219456$1$I$$20240801$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000306$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194571$24219457$1$I$20240101$20240802$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000309$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194581$24219458$1$I$20240101$20240806$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000095$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194591$24219459$1$I$20240724$20240724$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000276$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194611$24219461$1$I$$20240730$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000300$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194631$24219463$1$I$$20240731$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2023-THE-TES-000400$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194642$24219464$2$F$20240722$20240819$20240816$20240826$EXP$IT-MINISAL02-998905$IT-GILEAD-2024-0684392$GILEAD$$68$YR$E$M$Y$$$20240826$$MD$IT$IT
242194651$24219465$1$I$20240101$20240802$20240816$20240816$PER$$US-009507513-2408USA001190$MERCK$$39$YR$$M$Y$$$20240816$$MD$US$US
242194661$24219466$1$I$$20240730$20240816$20240816$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000302$Unknown Manufacturer$$$$$$Y$$$20240816$$CN$US$US
242194671$24219467$1$I$$20240815$20240816$20240816$EXP$$CA-GILEAD-2024-0684414$GILEAD$$$$E$M$Y$$$20240816$$HP$CA$CA
242194681$24219468$1$I$20240725$20240807$20240816$20240816$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202405011247$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240816$$CN$GB$GB
242194691$24219469$1$I$$20240808$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005882$ELI LILLY AND CO$$40$YR$A$$Y$$$20240816$$LW$US$US
242194701$24219470$1$I$$20240321$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202406000768$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242194711$24219471$1$I$$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408005441$ELI LILLY AND CO$$25$YR$A$$Y$$$20240816$$LW$US$US
242194722$24219472$2$F$$20240915$20240816$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129765$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$66.68$KG$20240916$$CN$US$US
242194731$24219473$1$I$$20240815$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129780$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$78.47$KG$20240816$$CN$US$US
242194751$24219475$1$I$20240730$20240809$20240816$20240816$PER$$US-SA-2024SA239747$SANOFI AVENTIS$$$$E$F$Y$$$20240817$$CN$US$US
242194761$24219476$1$I$20240305$20240807$20240816$20240816$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004047$JAZZ$$25$YR$$F$Y$$$20240816$$CN$US$US
242194772$24219477$2$F$20240720$20240902$20240816$20240905$EXP$$SA-GILEAD-2024-0684492$GILEAD$$57$YR$A$M$Y$79.4$KG$20240905$$MD$SA$SA
242194782$24219478$2$F$$20240905$20240816$20240910$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-140717$DAIICHI$$$$$F$Y$$$20240910$$CN$US$US
242194791$24219479$1$I$20240601$20240717$20240816$20240816$PER$$US-009507513-2407USA011249$MERCK$$72$YR$$F$Y$$$20240816$$HP$US$US
242194802$24219480$2$F$$20240826$20240816$20240830$EXP$$US-ZENPEP LLC-2024AIMT01235$AIMMUNE$$$$$$Y$$$20240830$$HP$US$US
242194811$24219481$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239038$SANOFI AVENTIS$$$$$M$Y$$$20240817$$HP$US$US
242194821$24219482$1$I$20240101$20240808$20240816$20240816$PER$$US-SA-2024SA239619$SANOFI AVENTIS$$27$YR$A$F$Y$53$KG$20240817$$MD$US$US
242194832$24219483$2$F$20240101$20240911$20240816$20240926$PER$$US-SA-2024SA240186$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240926$$MD$US$US
242194841$24219484$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA238879$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240817$$MD$US$US
242194861$24219486$1$I$$20240802$20240816$20240816$EXP$$US-HLS-202400712$HLS THERAPEUTICS$$$$A$F$Y$$$20240816$$HP$US$US
242194871$24219487$1$I$$20240802$20240816$20240816$EXP$$US-HLS-202400713$HLS THERAPEUTICS$$$$A$F$Y$$$20240816$$HP$US$US
242194882$24219488$2$F$$20240808$20240816$20240906$EXP$$ID-AstraZeneca-2024A183627$ASTRAZENECA$$$$A$M$Y$$$20240906$$MD$ID$
242194891$24219489$1$I$$20240812$20240816$20240816$EXP$$US-GILEAD-2024-0684200$GILEAD$$66$YR$E$F$Y$$$20240816$$CN$US$US
242194901$24219490$1$I$$20240806$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408004356$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240816$$CN$US$US
242194911$24219491$1$I$20240704$20240805$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408003820$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240816$$CN$US$US
242194922$24219492$2$F$20240815$20240816$20240816$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009884$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240817$$CN$US$US
242194933$24219493$3$F$$20240917$20240816$20240918$PER$$US-GILEAD-2024-0684220$GILEAD$$64$YR$A$M$Y$$$20240918$$CN$US$US
242194941$24219494$1$I$$20240802$20240816$20240816$EXP$$US-HLS-202400711$HLS THERAPEUTICS$$$$E$F$Y$$$20240816$$HP$US$US
242194951$24219495$1$I$$20240814$20240816$20240816$EXP$$US-GILEAD-2024-0684235$GILEAD$$53$YR$A$M$Y$$$20240816$$CN$US$US
242194961$24219496$1$I$20240801$20240813$20240816$20240816$PER$$US-GILEAD-2024-0684269$GILEAD$$$$$M$Y$$$20240816$$HP$US$US
242194971$24219497$1$I$20240101$20240806$20240816$20240816$PER$$US-SA-2024SA237888$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240817$$MD$US$US
242194981$24219498$1$I$$20240802$20240816$20240816$EXP$$US-HLS-202400709$HLS THERAPEUTICS$$$$T$M$Y$$$20240816$$CN$US$US
242194991$24219499$1$I$$20240804$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003309$ELI LILLY AND CO$$68$YR$E$$Y$$$20240816$$LW$US$US
242195001$24219500$1$I$20240601$20240805$20240816$20240816$EXP$ES-AEMPS-1557575$ES-ELI_LILLY_AND_COMPANY-ES202408003472$ELI LILLY AND CO$$$$E$M$Y$$$20240816$$CN$ES$ES
242195011$24219501$1$I$$20240805$20240816$20240816$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408003487$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240816$$MD$GB$GB
242195021$24219502$1$I$20240804$20240804$20240816$20240816$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202408009682$ELI LILLY AND CO$$$$$$Y$$$20240816$$PH$CA$CA
242195031$24219503$1$I$$20240805$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003997$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$US$US
242195041$24219504$1$I$20240730$20240805$20240816$20240816$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408003616$ELI LILLY AND CO$$47$YR$A$F$Y$79$KG$20240816$$CN$GB$GB
242195051$24219505$1$I$$20240804$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003159$ELI LILLY AND CO$$66$YR$E$$Y$$$20240816$$LW$US$US
242195061$24219506$1$I$$20240805$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003772$ELI LILLY AND CO$$57$YR$A$$Y$$$20240816$$LW$US$US
242195071$24219507$1$I$$20240804$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003151$ELI LILLY AND CO$$61$YR$A$$Y$$$20240816$$LW$US$US
242195081$24219508$1$I$20240812$20240814$20240816$20240816$EXP$$US-AstraZeneca-2024A186558$ASTRAZENECA$$$$$F$Y$$$20240816$$HP$US$
242195092$24219509$2$F$20240102$20240821$20240816$20240903$PER$$US-009507513-2408USA005307$MERCK$$$$$F$Y$$$20240903$$MD$US$US
242195101$24219510$1$I$$20240802$20240816$20240816$EXP$$US-HLS-202400708$HLS THERAPEUTICS$$$$E$$Y$$$20240816$$PH$US$US
242195111$24219511$1$I$$20240809$20240816$20240816$PER$$US-APELLIS-2024-APL-0000695$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240816$$CN$US$US
242195121$24219512$1$I$$20240802$20240816$20240816$EXP$$US-HLS-202400705$HLS THERAPEUTICS$$$$A$$Y$$$20240816$$HP$US$US
242195131$24219513$1$I$20240527$20240802$20240816$20240816$EXP$$CA-HLS-202401949$HLS THERAPEUTICS$$76$YR$E$M$Y$$$20240816$$PH$CA$CA
242195141$24219514$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA239809$SANOFI AVENTIS$$$$A$F$Y$86$KG$20240817$$MD$US$US
242195151$24219515$1$I$20240708$20240807$20240816$20240816$EXP$FR-AFSSAPS-MP2024001246$FR-009507513-2408FRA002502$MERCK$$74$YR$$M$Y$$$20240816$$HP$FR$FR
242195161$24219516$1$I$20240806$20240812$20240816$20240816$EXP$ES-AEMPS-1558862$ES-FreseniusKabi-FK202412389$FRESENIUS KABI$$68$YR$E$F$Y$50$KG$20240816$$PH$ES$ES
242195171$24219517$1$I$$20240805$20240816$20240816$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07851$NEUROCRINE BIOSCIENCES$$72$YR$$M$Y$$$20240816$$HP$US$US
242195181$24219518$1$I$20240808$20240809$20240816$20240816$PER$$US-APELLIS-2024-APL-0000696$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240816$$CN$US$US
242195191$24219519$1$I$$20240805$20240816$20240816$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07843$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240816$$CN$US$US
242195201$24219520$1$I$$20240816$20240816$20240816$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046295$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240816$$CN$US$US
242195211$24219521$1$I$$20240805$20240816$20240816$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07855$NEUROCRINE BIOSCIENCES$$63$YR$$M$Y$$$20240816$$CN$US$US
242195222$24219522$2$F$$20240903$20240816$20240903$PER$$US-ALXN-202408USA000661US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242195231$24219523$1$I$20211103$20211130$20240816$20240816$PER$$US-McGuff Pharmaceuticals, Inc.-2160554$MCGUFF$$66$YR$$M$Y$$$20240816$$$US$US
242195241$24219524$1$I$$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128996$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240816$$CN$US$US
242195251$24219525$1$I$20240101$20240809$20240816$20240816$PER$$US-SA-2024SA240910$SANOFI AVENTIS$$62$YR$A$F$Y$68$KG$20240817$$CN$US$US
242195261$24219526$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240387$SANOFI AVENTIS$$$$A$F$Y$$$20240817$$MD$US$US
242195271$24219527$1$I$$20240813$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129314$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240817$$CN$US$US
242195283$24219528$3$F$20240812$20240911$20240816$20240920$EXP$$AU-BEH-2024177163$CSL BEHRING$$56$YR$A$F$Y$70$KG$20240920$$MD$AU$AU
242195291$24219529$1$I$$20240803$20240816$20240816$PER$$US-009507513-2408USA001693$MERCK$$$$$M$Y$$$20240816$$HP$US$US
242195321$24219532$1$I$$20240806$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003906$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240816$$CN$US$US
242195331$24219533$1$I$$20240805$20240816$20240816$EXP$GB-MHRA-MED-202408051819476570-GYMJC$GB-ELI_LILLY_AND_COMPANY-GB202408003618$ELI LILLY AND CO$$36$YR$A$F$Y$95$KG$20240816$$CN$GB$GB
242195341$24219534$1$I$20240805$20240806$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003988$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240816$$CN$US$US
242195351$24219535$1$I$20240718$20240805$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002659$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240816$$PH$US$US
242195361$24219536$1$I$$20240807$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408004521$ELI LILLY AND CO$$$$$M$Y$$$20240816$$CN$US$US
242195371$24219537$1$I$$20240805$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003873$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242195381$24219538$1$I$20240729$20240806$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004333$ELI LILLY AND CO$$41$YR$A$$Y$$$20240816$$CN$US$US
242195391$24219539$1$I$$20240806$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003791$ELI LILLY AND CO$$49$YR$A$$Y$$$20240816$$LW$US$US
242195402$24219540$2$F$$20240806$20240816$20240922$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004924$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240922$$CN$US$US
242195411$24219541$1$I$20240101$20240719$20240816$20240816$PER$$US-009507513-2407USA012167$MERCK$$70$YR$$M$Y$$$20240816$$CN$US$US
242195421$24219542$1$I$20240701$20240806$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004424$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240816$$CN$US$US
242195431$24219543$1$I$$20240806$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003903$ELI LILLY AND CO$$41$YR$A$$Y$$$20240816$$LW$US$US
242195441$24219544$1$I$20231101$20240806$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005018$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240816$$CN$US$US
242195451$24219545$1$I$$20240802$20240816$20240816$EXP$$US-SMPA-2024SPA000763$SUNOVION$$$$$$Y$$$20240816$$CN$US$US
242195462$24219546$2$F$$20240920$20240816$20240921$EXP$$SE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046192$BOEHRINGER INGELHEIM$$50$YR$A$M$Y$88$KG$20240921$$MD$SE$SE
242195471$24219547$1$I$$20240801$20240816$20240816$EXP$$US-SMPA-2024SPA000675$SUNOVION$$$$$$Y$$$20240816$$CN$US$US
242195482$24219548$2$F$20240806$20240813$20240816$20240827$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408006953$ELI LILLY AND CO$$$$$M$Y$$$20240827$$CN$GB$GB
242195492$24219549$2$F$20240803$20240827$20240816$20240903$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408007105$ELI LILLY AND CO$$$$$M$Y$$$20240903$$CN$JP$JP
242195501$24219550$1$I$$20240808$20240816$20240816$EXP$GB-MHRA-MED-202408081106480830-DBCFR$GB-ELI_LILLY_AND_COMPANY-GB202408006167$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$GB$GB
242195511$24219551$1$I$$20240808$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006572$ELI LILLY AND CO$$62$YR$A$$Y$$$20240816$$LW$US$US
242195521$24219552$1$I$$20240809$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007148$ELI LILLY AND CO$$45$YR$A$$Y$$$20240816$$LW$US$US
242195531$24219553$1$I$20230113$20240807$20240816$20240816$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408005283$ELI LILLY AND CO$$61$YR$A$F$Y$78$KG$20240816$$CN$DE$DE
242195541$24219554$1$I$$20240808$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005814$ELI LILLY AND CO$$53$YR$A$$Y$$$20240816$$LW$US$US
242195551$24219555$1$I$$20240809$20240816$20240816$EXP$GB-MHRA-MED-202408091002531440-LPHQS$GB-ELI_LILLY_AND_COMPANY-GB202408006985$ELI LILLY AND CO$$$$$F$Y$$$20240816$$CN$GB$GB
242195561$24219556$1$I$$20240808$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005876$ELI LILLY AND CO$$54$YR$A$$Y$$$20240816$$LW$US$US
242195571$24219557$1$I$$20240809$20240816$20240816$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408006142$ELI LILLY AND CO$$$$$M$Y$$$20240816$$CN$GB$GB
242195581$24219558$1$I$$20240808$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005598$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240816$$CN$US$US
242195591$24219559$1$I$$20240712$20240816$20240816$EXP$$US-BIOMARINAP-US-2024-159932$BIOMARIN$$$$$$Y$$$20240816$$CN$US$US
242195601$24219560$1$I$$20240805$20240816$20240816$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07859$NEUROCRINE BIOSCIENCES$$6$DEC$$M$Y$$$20240817$$HP$US$US
242195611$24219561$1$I$$20240809$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006385$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240816$$HP$US$US
242195621$24219562$1$I$$20240806$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007192$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240816$$CN$US$US
242195631$24219563$1$I$$20240805$20240816$20240816$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07864$NEUROCRINE BIOSCIENCES$$52$YR$$F$Y$$$20240817$$HP$US$US
242195641$24219564$1$I$$20240809$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006586$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240816$$CN$US$US
242195651$24219565$1$I$$20240809$20240816$20240816$EXP$GB-MHRA-MED-202408091130350400-SJMFY$GB-ELI_LILLY_AND_COMPANY-GB202408007029$ELI LILLY AND CO$$$$$M$Y$$$20240816$$CN$GB$GB
242195661$24219566$1$I$$20240812$20240816$20240816$EXP$GB-MHRA-MED-202408121244091290-BMTQL$GB-ELI_LILLY_AND_COMPANY-GB202408008025$ELI LILLY AND CO$$54$YR$A$$Y$$$20240816$$CN$GB$GB
242195671$24219567$1$I$20240813$20240813$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008307$ELI LILLY AND CO$$$$$$Y$$$20240816$$MD$US$US
242195681$24219568$1$I$20240803$20240804$20240816$20240816$EXP$GB-MHRA-MED-202408041610257030-DVLQS$GB-ELI_LILLY_AND_COMPANY-GB202408003498$ELI LILLY AND CO$$53$YR$A$F$Y$95$KG$20240816$$CN$GB$GB
242195691$24219569$1$I$$20240812$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007489$ELI LILLY AND CO$$53$YR$A$$Y$$$20240816$$LW$US$US
242195701$24219570$1$I$$20240812$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007370$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240816$$CN$US$US
242195711$24219571$1$I$20240802$20240809$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006740$ELI LILLY AND CO$$$$A$F$Y$$$20240816$$CN$US$US
242195721$24219572$1$I$$20240812$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007477$ELI LILLY AND CO$$29$YR$A$$Y$$$20240816$$LW$US$US
242195731$24219573$1$I$$20240809$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006720$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240816$$CN$US$US
242195741$24219574$1$I$20240801$20240812$20240816$20240816$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007515$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240816$$CN$US$US
242195751$24219575$1$I$$20240321$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202406000773$ELI LILLY AND CO$$$$$$Y$$$20240816$$CN$US$US
242195761$24219576$1$I$$20240807$20240816$20240816$PER$$US-009507513-2408USA002537$MERCK$$70$YR$$M$Y$$$20240816$$HP$US$US
242195771$24219577$1$I$20240710$20240710$20240816$20240816$PER$$US-Eisai-EC-2024-170384$EISAI$$75$YR$E$F$Y$$$20240817$$CN$US$US
242195781$24219578$1$I$20240422$20240809$20240816$20240816$PER$$US-Eisai-EC-2024-170099$EISAI$$78$YR$E$F$Y$$$20240817$$HP$US$US
242195791$24219579$1$I$20230101$20240809$20240816$20240816$EXP$$SD-BAUSCH-BL-2024-012154$BAUSCH AND LOMB$Taha M, Azhary A, Hajhamed N, Alkhatim W, Bakheit A, Ahmed A. A case report of metformin-associated lactic acidosis. Clinical case reports. 2024;12:1-5. doi:10.1002/ccr3.9255$73$YR$$F$Y$$$20240817$$HP$SD$SD
242195801$24219580$1$I$20230101$20240809$20240816$20240816$EXP$$GB-BAUSCH-BL-2024-012153$BAUSCH AND LOMB$Alharmoodi K, Kathirgamachelvam J, Nafri D. Prolonged Discontinuation Syndrome of Venlafaxine: A Case Study of Severe Gastrointestinal Manifestations.. Cureus. 2024 JAN 07;16(7):1-3. doi:10.7759/cureus.63560$26$YR$$F$Y$$$20240817$$HP$GB$GB
242195811$24219581$1$I$$20240815$20240816$20240816$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130094$BRISTOL MYERS SQUIBB$$23$YR$A$M$Y$$$20240817$$HP$US$US
242195821$24219582$1$I$$20240808$20240816$20240816$PER$$US-SA-2024SA121931$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240817$$MD$US$US
242195831$24219583$1$I$$20240812$20240816$20240816$PER$$US-ELI_LILLY_AND_COMPANY-US202408007967$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240816$$CN$US$US
242195841$24219584$1$I$20240813$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024161513$AMGEN$$65$YR$E$M$Y$$$20240816$$CN$US$US
242195861$24219586$1$I$$20240809$20240816$20240816$PER$$US-SA-2024SA240781$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240817$$MD$US$US
242195871$24219587$1$I$$20240813$20240816$20240816$EXP$$ZA-ROCHE-10000055916$ROCHE$$$$E$F$Y$$$20240817$$MD$ZA$ZA
242195882$24219588$2$F$$20240923$20240816$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129118$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240924$$HP$US$US
242195891$24219589$1$I$$20240815$20240816$20240816$PER$$US-AMGEN-USASP2024163661$AMGEN$$$$$$Y$$$20240816$$HP$US$US
242195901$24219590$1$I$$20240808$20240816$20240816$PER$$US-ROCHE-10000053954$ROCHE$$$$A$F$Y$$$20240817$$CN$US$US
242195911$24219591$1$I$20230502$20240812$20240816$20240816$EXP$$KR-009507513-2408KOR003454$MERCK$$$$A$M$Y$$$20240816$$HP$KR$KR
242195921$24219592$1$I$20240101$20240812$20240816$20240816$PER$$US-SA-2023SA249536$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240817$$MD$US$US
242195931$24219593$1$I$$20240807$20240816$20240816$EXP$$US-GSK-US2024098467$GLAXOSMITHKLINE$$$$$F$Y$$$20240816$$CN$US$US
242195941$24219594$1$I$$20240807$20240816$20240816$30DAY$$US-GSK-US2024098612$GLAXOSMITHKLINE$$$$A$F$Y$$$20240816$$CN$US$US
242195951$24219595$1$I$$20240813$20240816$20240816$PER$$US-AMGEN-USASP2024147451$AMGEN$$$$$F$Y$$$20240816$$CN$US$US
242195962$24219596$2$F$$20240823$20240816$20240829$EXP$$IT-ROCHE-10000054797$ROCHE$Castelli M, Betelli M, Valenti A, Merelli B, Loglio A, Vigano M, et al. A Case of Polyserositis, Chylous Ascites and Hepatitis Induced by Immune Checkpoint Inhibitors. Eur J Case Rep Intern Med. 2024-May-31;11 (7):004237. doi:10.12890/2024_004237.$39$YR$A$M$Y$$$20240829$$HP$IT$IT
242195971$24219597$1$I$$20240809$20240816$20240816$EXP$$JP-ROCHE-10000058805$ROCHE$$$$E$$Y$$$20240817$$MD$JP$JP
242195982$24219598$2$F$20240813$20240826$20240816$20240828$PER$$US-AMGEN-USASP2024161391$AMGEN$$91$YR$E$F$Y$$$20240827$$CN$US$US
242195992$24219599$2$F$$20240819$20240816$20240821$EXP$SE-BIOVITRUM-2024-SE-010613$SE-ROCHE-10000058390$ROCHE$$$$C$F$Y$$$20240822$$MD$SE$SE
242196001$24219600$1$I$$20240807$20240816$20240816$30DAY$$US-GSK-US2024AMR099856$GLAXOSMITHKLINE$$$$$$Y$$$20240816$$CN$US$US
242196012$24219601$2$F$$20240821$20240816$20240826$PER$$US-AMGEN-USASP2024161435$AMGEN$$$$$F$Y$$$20240826$$HP$US$US
242196021$24219602$1$I$20240101$20240809$20240816$20240816$PER$$US-SA-2024SA242339$SANOFI AVENTIS$$6$YR$C$F$Y$24.2$KG$20240817$$MD$US$US
242196031$24219603$1$I$$20240809$20240816$20240816$EXP$$JP-ROCHE-10000058729$ROCHE$$$$E$$Y$$$20240817$$MD$JP$JP
242196041$24219604$1$I$20240607$20240815$20240816$20240816$EXP$$PK-ROCHE-10000058271$ROCHE$$36$YR$A$M$Y$$$20240817$$CN$PK$PK
242196052$24219605$2$F$$20240904$20240816$20240913$30DAY$$US-GSK-US2024098643$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
242196062$24219606$2$F$20240711$20240902$20240816$20240903$EXP$$PK-ROCHE-10000058562$ROCHE$$75$YR$E$M$Y$68$KG$20240903$$CN$PK$PK
242196072$24219607$2$F$20240101$20240815$20240817$20240822$PER$$US-AMGEN-USASP2024162674$AMGEN$$31$YR$A$F$Y$$$20240822$$HP$US$US
242196081$24219608$1$I$20240101$20240812$20240817$20240817$EXP$$UY-GENMAB-2024-02862AA$GENMAB$$$$$M$Y$$$20240817$$MD$UY$UY
242196091$24219609$1$I$20240814$20240815$20240817$20240817$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046275$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240817$$HP$CO$CO
242196101$24219610$1$I$20240812$20240813$20240817$20240817$EXP$$PK-ROCHE-10000055748$ROCHE$$31$YR$A$F$Y$$$20240817$$CN$PK$PK
242196112$24219611$2$F$$20240814$20240816$20240820$EXP$$LB-ROCHE-10000057108$ROCHE$$$$A$M$Y$$$20240820$$MD$LB$LB
242196121$24219612$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA241579$SANOFI AVENTIS$$$$$F$Y$$$20240817$$MD$US$US
242196141$24219614$1$I$$20240809$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408007702$ELI LILLY AND CO$$69$YR$E$$Y$$$20240817$$LW$US$US
242196151$24219615$1$I$20240622$20240805$20240817$20240817$EXP$FR-AFSSAPS-TS2024000884$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-124738$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$60$KG$20240817$$MD$FR$FR
242196161$24219616$1$I$20240701$20240815$20240817$20240817$PER$$US-AMGEN-USASP2024163449$AMGEN$$29$YR$A$F$Y$$$20240816$$CN$US$US
242196171$24219617$1$I$20171101$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024162388$AMGEN$$24$YR$A$F$Y$$$20240816$$CN$US$US
242196181$24219618$1$I$20240101$20240802$20240817$20240817$PER$$US-GRANULES-US-2024GRASPO00346$GRANULES INDIA$$$$$F$Y$$$20240817$$CN$US$US
242196191$24219619$1$I$$20240802$20240817$20240817$PER$$US-GRANULES-US-2024GRASPO00347$GRANULES INDIA$$$$$F$Y$$$20240817$$CN$US$US
242196211$24219621$1$I$$20240809$20240817$20240817$PER$$US-SA-2024SA242272$SANOFI AVENTIS$$$$A$F$Y$$$20240817$$MD$US$US
242196221$24219622$1$I$$20240815$20240817$20240817$EXP$$ZA-ROCHE-10000058885$ROCHE$$$$A$M$Y$$$20240817$$MD$ZA$ZA
242196231$24219623$1$I$$20240809$20240817$20240817$EXP$$CA-GSK-CA2024AMR100438$GLAXOSMITHKLINE$$$$$$Y$$$20240817$$CN$CA$CA
242196241$24219624$1$I$$20240811$20240817$20240817$EXP$$NVSC2023IN280215$NOVARTIS$$$$$F$Y$$$20240817$$CN$IN$IN
242196252$24219625$2$F$20240815$20240816$20240817$20240821$PER$$US-AMGEN-USASP2024163352$AMGEN$$67$YR$E$F$Y$$$20240821$$CN$US$US
242196264$24219626$4$F$20240527$20240822$20240817$20240830$EXP$$US-ROCHE-10000058124$ROCHE$$$$$F$Y$$$20240831$$CN$US$US
242196273$24219627$3$F$20240812$20240911$20240817$20240914$EXP$$US-ROCHE-10000057904$ROCHE$$81$YR$E$F$Y$$$20240914$$MD$US$US
242196281$24219628$1$I$$20240808$20240817$20240817$PER$$US-SA-2023SA309844$SANOFI AVENTIS$$$$E$M$Y$$$20240817$$MD$US$US
242196291$24219629$1$I$20240807$20240807$20240817$20240817$30DAY$$US-GSK-US2024098644$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240817$$CN$US$US
242196301$24219630$1$I$$20240804$20240817$20240817$PER$$US-COSETTE-CP2024US000208$COSETTE PHARMACEUTICALS$$$$A$F$Y$$$20240817$$CN$US$US
242196311$24219631$1$I$$20240804$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039357$AUROBINDO$$102$YR$$F$Y$$$20240817$$CN$GB$GB
242196321$24219632$1$I$20240801$20240813$20240817$20240817$PER$$US-AMGEN-USASP2024161425$AMGEN$$80$YR$E$F$Y$$$20240816$$CN$US$US
242196331$24219633$1$I$$20240813$20240817$20240817$PER$$US-SA-2024SA241862$SANOFI AVENTIS$$$$E$M$Y$$$20240817$$MD$US$US
242196341$24219634$1$I$20240803$20240809$20240817$20240817$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408006672$ELI LILLY AND CO$$79$YR$E$F$Y$60$KG$20240817$$CN$CN$CN
242196352$24219635$2$F$$20240816$20240817$20240822$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202408009142$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240822$$CN$KR$KR
242196361$24219636$1$I$20240501$20240805$20240817$20240817$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003054$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240817$$CN$US$US
242196371$24219637$1$I$$20240809$20240817$20240817$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408006900$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240817$$CN$BR$BR
242196382$24219638$2$F$$20240905$20240817$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005531$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240917$$CN$US$US
242196391$24219639$1$I$$20240807$20240817$20240817$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005182$ELI LILLY AND CO$$19$YR$A$M$Y$$$20240817$$CN$US$US
242196402$24219640$2$F$$20240911$20240817$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003638$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240923$$CN$US$US
242196412$24219641$2$F$20240201$20240814$20240817$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009042$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240826$$CN$US$US
242196422$24219642$2$F$20240729$20240909$20240817$20240919$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009203$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240919$$MD$US$US
242196431$24219643$1$I$20240703$20240807$20240817$20240817$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005884$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240817$$CN$US$US
242196441$24219644$1$I$$20240808$20240817$20240817$PER$$US-HETERO-HET2024US02675$HETERO$$$$$F$Y$63.039$KG$20240817$$CN$US$US
242196452$24219645$2$F$$20240816$20240817$20240824$PER$$US-AMGEN-USASP2024162778$AMGEN$$$$$F$Y$$$20240824$$PH$US$US
242196461$24219646$1$I$20240808$20240813$20240817$20240817$PER$$US-AMGEN-USASP2024161831$AMGEN$$64$YR$A$F$Y$$$20240816$$PH$US$US
242196471$24219647$1$I$20240101$20240808$20240817$20240817$PER$$US-SA-2024SA175857$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240817$$MD$US$US
242196481$24219648$1$I$$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024162539$AMGEN$$$$$F$Y$$$20240816$$CN$US$US
242196491$24219649$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009320$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240817$$CN$US$US
242196501$24219650$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009102$ELI LILLY AND CO$$$$$F$Y$$$20240817$$CN$US$US
242196517$24219651$7$F$20240101$20240909$20240817$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023737$UNITED THERAPEUTICS$$$$$F$Y$72.109$KG$20240919$$$US$US
242196521$24219652$1$I$$20240809$20240817$20240817$PER$$US-SA-2024SA241839$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240817$$MD$US$US
242196531$24219653$1$I$20240810$20240813$20240817$20240817$PER$$US-AMGEN-USASP2024161560$AMGEN$$$$$$Y$$$20240816$$PH$US$US
242196541$24219654$1$I$20170401$20240813$20240817$20240817$EXP$ES-EMA-DD-20200327-sandevhp-162450$ES-SANDOZ INC.-SDZ2024ES072393$SANDOZ$$45$YR$$M$Y$$$20240817$$HP$ES$ES
242196551$24219655$1$I$$20240806$20240817$20240817$EXP$001088091$CA-USP-004892$USPHARMA$$71$YR$E$M$Y$$$20240817$$HP$CA$CA
242196561$24219656$1$I$$20240813$20240817$20240817$PER$$US-SA-2024SA241868$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240817$$MD$US$US
242196572$24219657$2$F$20240101$20240909$20240817$20240918$PER$$US-SA-2024SA239771$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240918$$MD$US$US
242196583$24219658$3$F$20230101$20240823$20240817$20240830$EXP$$NVSC2023AR245902$NOVARTIS$$$$$F$Y$$$20240830$$CN$AR$AR
242196592$24219659$2$F$$20240821$20240817$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07190$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242196601$24219660$1$I$20240613$20240807$20240817$20240817$EXP$$JP-ROCHE-10000056790$ROCHE$$7$DEC$E$F$Y$$$20240817$$PH$JP$JP
242196611$24219661$1$I$$20240717$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07338$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242196621$24219662$1$I$20240806$20240807$20240817$20240817$EXP$$JP-ROCHE-10000056815$ROCHE$$$$$M$Y$$$20240817$$MD$JP$JP
242196631$24219663$1$I$$20240809$20240817$20240817$EXP$$JP-ROCHE-10000058289$ROCHE$$6$DEC$A$$Y$$$20240817$$MD$JP$JP
242196641$24219664$1$I$$20240807$20240817$20240817$EXP$$JP-ROCHE-10000055542$ROCHE$$$$E$$Y$$$20240817$$MD$JP$JP
242196651$24219665$1$I$$20240815$20240817$20240817$EXP$$DE-SANDOZ INC.-SDZ2024DE072920$SANDOZ$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$67$YR$$M$Y$$$20240817$$HP$DE$DE
242196661$24219666$1$I$$20240715$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07299$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242196671$24219667$1$I$$20240813$20240817$20240817$PER$$US-SA-2024SA242114$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240817$$MD$US$US
242196681$24219668$1$I$$20240717$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07243$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242196692$24219669$2$F$20240813$20240913$20240817$20240916$PER$$US-AMGEN-USASP2024162173$AMGEN$$65$YR$E$F$Y$$$20240915$$CN$US$US
242196701$24219670$1$I$$20240813$20240817$20240817$EXP$$AU-CELLTRION INC.-2024AU019554$CELLTRION$$$$$$Y$$$20240817$$HP$AU$AU
242196711$24219671$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009176$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240817$$CN$US$US
242196721$24219672$1$I$20240814$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009247$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240817$$CN$US$US
242196731$24219673$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009103$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240817$$CN$US$US
242196741$24219674$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009106$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240817$$CN$US$US
242196751$24219675$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009316$ELI LILLY AND CO$$$$$F$Y$$$20240817$$CN$US$US
242196761$24219676$1$I$$20240718$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07259$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242196772$24219677$2$F$20240101$20240911$20240817$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018282$UNITED THERAPEUTICS$$$$$F$Y$$$20240919$$$US$US
242196781$24219678$1$I$$20240809$20240817$20240817$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-024887$UNITED THERAPEUTICS$$22$MON$$F$Y$$$20240817$$$CA$CA
242196791$24219679$1$I$$20240717$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07344$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242196801$24219680$1$I$20240101$20240806$20240817$20240817$EXP$$CN-ROCHE-10000050877$ROCHE$$51$YR$A$F$Y$$$20240817$$CN$CN$CN
242196811$24219681$1$I$$20240718$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07362$LUPIN$$$$$$Y$$$20240817$$PH$US$US
242196821$24219682$1$I$20240701$20240806$20240817$20240817$PER$$US-SA-2024SA238486$SANOFI AVENTIS$$$$C$M$Y$$$20240817$$MD$US$US
242196831$24219683$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009219$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240817$$CN$US$US
242196841$24219684$1$I$$20240806$20240817$20240817$EXP$E2B_07176606$CA-USP-004889$USPHARMA$$61$YR$A$F$Y$$$20240817$$HP$CA$CA
242196851$24219685$1$I$$20240718$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07349$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242196862$24219686$2$F$20211004$20240909$20240817$20240917$EXP$$CA-CELLTRION INC.-2021CA016862$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
242196871$24219687$1$I$$20240722$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07469$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242196891$24219689$1$I$$20240809$20240817$20240817$PER$$US-ROCHE-RCA5177996$ROCHE$$$$A$F$Y$$$20240817$$CN$US$US
242196901$24219690$1$I$$20240812$20240817$20240817$PER$$US-AstraZeneca-2024A183954$ASTRAZENECA$$$$$M$Y$$$20240817$$MD$US$
242196911$24219691$1$I$20240101$20240812$20240817$20240817$PER$$US-SA-2024SA241142$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240817$$MD$US$US
242196921$24219692$1$I$$20240807$20240817$20240817$EXP$$US-TEVA-VS-3231144$TEVA$$$$$$Y$$$20240817$$CN$US$US
242196931$24219693$1$I$$20240807$20240817$20240817$EXP$GB-MHRA-MED-202408072348525630-ZFNMG$GB-TEVA-VS-3231446$TEVA$$$$$M$Y$$$20240817$$CN$GB$GB
242196941$24219694$1$I$20240809$20240812$20240817$20240817$PER$$US-SA-2024SA242298$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240817$$MD$US$US
242196951$24219695$1$I$20240722$20240722$20240817$20240817$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012760$JAZZ$$11$YR$$M$Y$$$20240816$$CN$US$US
242196961$24219696$1$I$$20240805$20240817$20240817$EXP$$BE-AUROBINDO-AUR-APL-2024-040044$AUROBINDO$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J-Allergy-Clin-Immunol-Pract. 2024;12(7):1850-1862$31$YR$$M$Y$$$20240817$$MD$BE$BE
242196971$24219697$1$I$20240802$20240813$20240817$20240817$PER$$US-SA-2024SA242243$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240817$$MD$US$US
242196981$24219698$1$I$20240724$20240809$20240817$20240817$PER$$US-SA-2024SA242170$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240817$$MD$US$US
242196991$24219699$1$I$$20240813$20240817$20240817$PER$$US-SA-2024SA242713$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240817$$MD$US$US
242197001$24219700$1$I$20240101$20240812$20240817$20240817$PER$$US-SA-2024SA242297$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240817$$MD$US$US
242197012$24219701$2$F$$20240816$20240817$20240828$EXP$$DE-AUROBINDO-AUR-APL-2024-039775$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 2023;107:107-113$$$N$$Y$$$20240828$$HP$DE$DE
242197021$24219702$1$I$$20240812$20240817$20240817$PER$$US-AstraZeneca-2024A183908$ASTRAZENECA$$$$$F$Y$$$20240817$$CN$US$
242197031$24219703$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009156$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240817$$CN$US$US
242197041$24219704$1$I$20240301$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009111$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240817$$CN$US$US
242197051$24219705$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009133$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240817$$CN$US$US
242197061$24219706$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009125$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240817$$CN$US$US
242197071$24219707$1$I$$20240816$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408010600$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240817$$CN$US$US
242197081$24219708$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009292$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240817$$CN$US$US
242197091$24219709$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009313$ELI LILLY AND CO$$62$YR$A$$Y$$$20240817$$CN$US$US
242197101$24219710$1$I$20240814$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009283$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240817$$CN$US$US
242197111$24219711$1$I$20240813$20240813$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009610$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240817$$CN$US$US
242197121$24219712$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009078$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240817$$CN$US$US
242197131$24219713$1$I$20240810$20240812$20240817$20240817$PER$$US-AMGEN-USASP2024163408$AMGEN$$$$$M$Y$$$20240816$$CN$US$US
242197151$24219715$1$I$$20240811$20240817$20240817$EXP$$AU-GSK-AU2024100209$GLAXOSMITHKLINE$$$$$$Y$$$20240817$$CN$AU$AU
242197162$24219716$2$F$$20240823$20240817$20240905$EXP$$US-AUROBINDO-AUR-APL-2024-039961$AUROBINDO$Gupta S, Gowda N, Shin D, Gogineni K, Bower D, Greer M. PP01.127 A rare case of pulmonary enteric adenocarcinoma in a 26-year-old female non-smoker. Journal of Thoracic Oncology. 2024;19 (Suppl.) (7):e55-e56 abstr. PP01.127$26$YR$$F$Y$$$20240905$$MD$US$US
242197171$24219717$1$I$20240612$20240805$20240817$20240817$EXP$$IT-AUROBINDO-AUR-APL-2024-040315$AUROBINDO$$1$MON$$F$Y$$$20240817$$HP$IT$IT
242197181$24219718$1$I$$20240805$20240817$20240817$EXP$$US-AUROBINDO-AUR-APL-2024-039614$AUROBINDO$Singh S, Lee M, Nguyen A, Silberstein DJ.. A Case of Rhino-Orbital-Cerebral Mucormycosis Leading to Multifocal Embolic Stroke, Mycotic Aneurysm, Interventricular, and Subarachnoid Hemorrhage. Am-J-Respir-Crit-Care-Med. 2024;209:A5637$52$YR$$F$Y$$$20240817$$HP$US$US
242197192$24219719$2$F$20240101$20240916$20240817$20240919$EXP$$US-AMGEN-USASL2024161210$AMGEN$$63$YR$A$F$Y$$$20240919$$HP$US$US
242197212$24219721$2$F$20240801$20240819$20240817$20240902$EXP$$JP-UCBSA-2024039858$UCB$$14$YR$$M$Y$$$20240902$$MD$JP$JP
242197231$24219723$1$I$20240810$20240813$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008718$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240817$$CN$US$US
242197241$24219724$1$I$$20240802$20240817$20240817$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07850$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242197251$24219725$1$I$$20240805$20240817$20240817$EXP$$BE-AUROBINDO-AUR-APL-2024-040050$AUROBINDO$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts.. J-Allergy-Clin-Immunol-Pract. 2024;12(7):1850- 1862$29$YR$$M$Y$$$20240817$$MD$BE$BE
242197261$24219726$1$I$$20240813$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009587$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240817$$CN$US$US
242197271$24219727$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009144$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240817$$CN$US$US
242197281$24219728$1$I$20240811$20240813$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008586$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240817$$PH$US$US
242197291$24219729$1$I$$20240816$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408010596$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240817$$CN$US$US
242197301$24219730$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009137$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240817$$CN$US$US
242197321$24219732$1$I$20240101$20240806$20240817$20240817$PER$$US-SA-2024SA238392$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240817$$MD$US$US
242197332$24219733$2$F$$20240816$20240817$20240829$PER$$US-SA-2024SA238581$SANOFI AVENTIS$$95$YR$E$M$Y$$$20240829$$MD$US$US
242197341$24219734$1$I$20240810$20240812$20240817$20240817$PER$$US-AMGEN-USASP2024160328$AMGEN$$82$YR$E$F$Y$$$20240817$$CN$US$US
242197351$24219735$1$I$$20240813$20240817$20240817$PER$$US-AMGEN-USASP2024161469$AMGEN$$$$$M$Y$$$20240817$$CN$US$US
242197361$24219736$1$I$$20240809$20240817$20240817$PER$$US-SA-2024SA239777$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240817$$MD$US$US
242197371$24219737$1$I$$20240809$20240817$20240817$PER$$US-SA-2024SA241927$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240817$$MD$US$US
242197382$24219738$2$F$$20240806$20240817$20240821$EXP$$JP-UCBSA-2023025155$UCB$$68$YR$$M$Y$$$20240821$$PH$JP$JP
242197391$24219739$1$I$$20240809$20240817$20240817$PER$$US-SA-2024SA241785$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240817$$MD$US$US
242197421$24219742$1$I$$20240809$20240817$20240817$EXP$$US-JNJFOC-20240829532$JOHNSON AND JOHNSON$$$$$$Y$$$20240817$$HP$US$US
242197431$24219743$1$I$20240812$20240813$20240817$20240817$PER$$US-AMGEN-USASP2024161498$AMGEN$$68$YR$E$F$Y$$$20240817$$CN$US$US
242197441$24219744$1$I$$20240807$20240817$20240817$EXP$$CN-JNJFOC-20240842568$JOHNSON AND JOHNSON$$$$$$Y$$$20240817$$MD$CN$CN
242197452$24219745$2$F$20240720$20240809$20240817$20240820$EXP$$DE-AUROBINDO-AUR-APL-2024-040267$AUROBINDO$$73$YR$$M$Y$91$KG$20240820$$MD$DE$DE
242197463$24219746$3$F$20240710$20240829$20240817$20240909$EXP$$DE-AUROBINDO-AUR-APL-2024-040252$AUROBINDO$$59$YR$$F$Y$$$20240909$$MD$DE$DE
242197471$24219747$1$I$20240814$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009146$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240817$$CN$US$US
242197481$24219748$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009154$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240817$$CN$US$US
242197491$24219749$1$I$20240805$20240813$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008548$ELI LILLY AND CO$$49$YR$A$$Y$$$20240817$$PH$US$US
242197501$24219750$1$I$20240801$20240808$20240817$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025023$UNITED THERAPEUTICS$$$$$$Y$$$20240817$$$US$US
242197511$24219751$1$I$$20240805$20240817$20240817$EXP$$US-AUROBINDO-AUR-APL-2024-039526$AUROBINDO$Adimora I, Zhang B, Idowu M. Recurrent Strokes in a Woman with a History of Thrombotic Thrombocytopenic Purpura. Case-Rep-Med. 2023$53$YR$$F$Y$$$20240817$$HP$US$US
242197522$24219752$2$F$20240711$20240816$20240817$20240829$EXP$$IT-AUROBINDO-AUR-APL-2024-039748$AUROBINDO$$79$YR$$M$Y$$$20240829$$MD$IT$IT
242197531$24219753$1$I$$20240805$20240817$20240817$EXP$$BE-AUROBINDO-AUR-APL-2024-040048$AUROBINDO$Beyens M, Sabato V, Ebo DG, Zaghmout T, Gulen T. Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts. J-Allergy-Clin-Immunol-Pract. 2024;12(7):1850- 1862$54$YR$$M$Y$$$20240817$$MD$BE$BE
242197541$24219754$1$I$$20240810$20240817$20240817$PER$$US-AstraZeneca-2024A183595$ASTRAZENECA$$$$$$Y$$$20240817$$CN$US$
242197552$24219755$2$F$$20240902$20240817$20240910$EXP$$JP-AMGEN-JPNSP2024158654$AMGEN$$$$$$Y$$$20240909$$MD$JP$JP
242197562$24219756$2$F$20240801$20240820$20240817$20240902$PER$$US-SA-2024SA242303$SANOFI AVENTIS$$77$YR$E$M$Y$82.5$KG$20240902$$CN$US$US
242197581$24219758$1$I$$20240805$20240817$20240817$EXP$$US-AUROBINDO-AUR-APL-2024-039519$AUROBINDO$Bandali T, Kim Y, Khodadoust M, Rieger K, Fernandez-Pol S, Saleem A, et al. Polatuzumab vedotin-piiq for treatment of primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCLLT) in older adults. J-Invest-Dermatol. 2024;144 (Suppl.)(8):S49$83$YR$$F$Y$$$20240817$$HP$US$US
242197591$24219759$1$I$$20240805$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039410$AUROBINDO$Abdolrasouli A, Borman AM, Johnson EM, Hay RJ, Arias M.. Terbinafine-resistant Trichophyton indotineae causing extensive dermatophytosis in a returning traveller, London, UK. Clinical and experimental dermatology. 2024;49(6):635-637$26$YR$$M$Y$$$20240817$$HP$GB$GB
242197601$24219760$1$I$20240101$20240813$20240817$20240817$PER$$US-AMGEN-USASP2024161754$AMGEN$$63$YR$A$F$Y$$$20240817$$CN$US$US
242197621$24219762$1$I$20240101$20240805$20240817$20240817$EXP$$ES-AUROBINDO-AUR-APL-2024-040160$AUROBINDO$$67$YR$$M$Y$80$KG$20240817$$MD$ES$ES
242197631$24219763$1$I$$20231128$20240817$20240817$EXP$$EG-JNJFOC-20240831182$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240817$$CN$EG$EG
242197642$24219764$2$F$20240807$20240814$20240817$20240822$PER$$US-AMGEN-USASP2024162446$AMGEN$$64$YR$A$F$Y$$$20240822$$CN$US$US
242197651$24219765$1$I$20240814$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009155$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240817$$CN$US$US
242197663$24219766$3$F$20240101$20240828$20240817$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021551$UNITED THERAPEUTICS$$$$$F$Y$102.04$KG$20240906$$$US$US
242197671$24219767$1$I$20240624$20240805$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039758$AUROBINDO$$79$YR$$F$Y$$$20240817$$MD$GB$GB
242197681$24219768$1$I$20240101$20240806$20240817$20240817$EXP$$GB-UCBSA-2024038249$UCB$$$$A$F$Y$$$20240817$$CN$GB$GB
242197691$24219769$1$I$$20240802$20240817$20240817$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-07872$LUPIN$Sahoo J, Kamalanathan S, Vivekanandan M,  Swaminathan RP. Acalculous pyelonephritis and cholecystitis occurring simultaneously in a diabetic patient on sitagliptin therapy. Journal of Pharmacology and Pharmacotherapeutics. 2015;6(3):172-174$58$YR$$F$Y$$$20240817$$HP$IN$IN
242197701$24219770$1$I$20220301$20230605$20240817$20240817$EXP$$CA-CELLTRION INC.-2021CA019586$CELLTRION$$$$$$Y$$$20240817$$MD$CA$CA
242197713$24219771$3$F$20240101$20240905$20240817$20240919$PER$$US-SA-2024SA242318$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240919$$CN$US$US
242197721$24219772$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA242618$SANOFI AVENTIS$$$$T$M$Y$$$20240817$$MD$US$US
242197732$24219773$2$F$20240808$20240827$20240817$20240917$PER$$US-SA-2024SA239989$SANOFI AVENTIS$$90$YR$E$M$Y$83.7$KG$20240918$$PH$US$US
242197741$24219774$1$I$$20240809$20240817$20240817$EXP$$US-AstraZeneca-2024A183568$ASTRAZENECA$$$$$F$Y$$$20240817$$CN$US$
242197751$24219775$1$I$20240729$20240808$20240817$20240817$EXP$$GB-AstraZeneca-2024A185491$ASTRAZENECA$$39$YR$$F$Y$$$20240817$$MD$GB$
242197761$24219776$1$I$20240701$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-040351$AUROBINDO$$78$YR$$F$Y$$$20240817$$PH$FR$FR
242197771$24219777$1$I$20240701$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-040352$AUROBINDO$$58$YR$$M$Y$115$KG$20240817$$MD$FR$FR
242197781$24219778$1$I$$20240806$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039859$AUROBINDO$$64$YR$$M$Y$$$20240817$$HP$GB$GB
242197791$24219779$1$I$$20240806$20240817$20240817$EXP$$US-UCBSA-2024039654$UCB$$$$$M$Y$$$20240817$$HP$US$US
242197801$24219780$1$I$20240705$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-039955$AUROBINDO$$77$YR$$M$Y$$$20240817$$PH$FR$FR
242197811$24219781$1$I$20240807$20240808$20240817$20240817$EXP$$CA-SA-2024SA239850$SANOFI AVENTIS$$67$YR$E$M$Y$113$KG$20240817$$MD$CA$CA
242197821$24219782$1$I$20240101$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024162180$AMGEN$$$$$F$Y$$$20240817$$CN$US$US
242197841$24219784$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009359$ELI LILLY AND CO$$$$$M$Y$$$20240817$$CN$US$US
242197851$24219785$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009069$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240817$$CN$US$US
242197861$24219786$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009282$ELI LILLY AND CO$$$$$F$Y$$$20240817$$CN$US$US
242197871$24219787$1$I$$20240805$20240817$20240817$EXP$$DE-AUROBINDO-AUR-APL-2024-039774$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 2023;107:107-113$$$N$$Y$$$20240817$$HP$DE$DE
242197881$24219788$1$I$$20240806$20240817$20240817$PER$$US-JNJFOC-20240816112$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240817$$CN$US$US
242197891$24219789$1$I$20240807$20240808$20240817$20240817$PER$$US-SA-2024SA239093$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240817$$MD$US$US
242197901$24219790$1$I$20240701$20240806$20240817$20240817$EXP$$JP-UCBSA-2024039888$UCB$$9$DEC$$F$Y$$$20240817$$MD$JP$JP
242197911$24219791$1$I$$20240806$20240817$20240817$PER$$US-JNJFOC-20240816999$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240817$$CN$US$US
242197921$24219792$1$I$20231101$20240812$20240817$20240817$PER$$US-SA-2024SA241529$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240817$$MD$US$US
242197931$24219793$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA242137$SANOFI AVENTIS$$$$E$F$Y$$$20240817$$CN$US$US
242197941$24219794$1$I$20240628$20240805$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039802$AUROBINDO$$68$YR$$F$Y$62$KG$20240817$$MD$GB$GB
242197952$24219795$2$F$$20240823$20240817$20240829$EXP$$JP-SA-2024SA241733$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240829$$MD$JP$JP
242197961$24219796$1$I$20240807$20240807$20240817$20240817$30DAY$$US-GSK-US2024098636$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240817$$CN$US$US
242197971$24219797$1$I$$20240806$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-040005$AUROBINDO$$43$YR$$F$Y$68$KG$20240817$$MD$GB$GB
242197981$24219798$1$I$20240629$20240805$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039783$AUROBINDO$$53$YR$$F$Y$$$20240817$$MD$GB$GB
242198001$24219800$1$I$20240101$20240808$20240817$20240817$PER$$US-SA-2024SA239285$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240817$$MD$US$US
242198011$24219801$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA241490$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240817$$MD$US$US
242198021$24219802$1$I$20240802$20240805$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039792$AUROBINDO$$37$YR$$F$Y$69$KG$20240817$$CN$GB$GB
242198031$24219803$1$I$20240615$20240805$20240817$20240817$EXP$$ES-AUROBINDO-AUR-APL-2024-040171$AUROBINDO$$$$E$F$Y$$$20240817$$PH$ES$ES
242198041$24219804$1$I$20240101$20240808$20240817$20240817$PER$$US-SA-2024SA241535$SANOFI AVENTIS$$$$A$F$Y$$$20240817$$MD$US$US
242198052$24219805$2$F$20240801$20240819$20240817$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025447$UNITED THERAPEUTICS$$74$YR$$F$Y$63.039$KG$20240829$$$US$US
242198061$24219806$1$I$20240416$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-040400$AUROBINDO$$79$YR$$F$Y$75$KG$20240817$$PH$FR$FR
242198073$24219807$3$F$$20240829$20240817$20240909$EXP$$ES-AUROBINDO-AUR-APL-2022-031028$AUROBINDO$Adrian CG, Ivan QCE,? Richard B, Idoia MM, Cristina AP, Manuel SIJ et al.. Mogamulizumab en el tratamiento de micosis fungoide avanzada y sindrome de sezary: A proposito de cuatro casos. (Mogamulizumab in the treatment of advanced mycosis fungoides and Sezary syndrome: report of four cases.. LXIII Congreso Nacional de la SEHH - XXXVII Congreso Nacional de la SETH Pamplon. 2021;373-374$73$YR$$M$Y$$$20240909$$HP$ES$ES
242198081$24219808$1$I$20240813$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009275$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240817$$CN$US$US
242198091$24219809$1$I$20240809$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009148$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240817$$CN$US$US
242198101$24219810$1$I$20240809$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009429$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240817$$CN$US$US
242198111$24219811$1$I$20240811$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009130$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240817$$CN$US$US
242198121$24219812$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009261$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240817$$CN$US$US
242198131$24219813$1$I$$20240813$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008478$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240817$$CN$US$US
242198141$24219814$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009279$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240817$$CN$US$US
242198151$24219815$1$I$20240813$20240813$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009550$ELI LILLY AND CO$$$$$$Y$$$20240817$$CN$US$US
242198161$24219816$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009318$ELI LILLY AND CO$$$$A$F$Y$$$20240817$$CN$US$US
242198171$24219817$1$I$20240812$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009384$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240817$$CN$US$US
242198181$24219818$1$I$20240813$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009067$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240817$$CN$US$US
242198191$24219819$1$I$$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024163137$AMGEN$$$$$$Y$$$20240817$$PH$US$US
242198201$24219820$1$I$$20240808$20240817$20240817$PER$$US-SA-2024SA239359$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240817$$MD$US$US
242198211$24219821$1$I$$20240807$20240817$20240817$PER$$US-JNJFOC-20240820031$JOHNSON AND JOHNSON$$$$$$Y$$$20240817$$CN$US$US
242198221$24219822$1$I$20240215$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-040307$AUROBINDO$$58$YR$$F$Y$89$KG$20240817$$MD$FR$FR
242198231$24219823$1$I$$20240806$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039865$AUROBINDO$$$$$M$Y$$$20240817$$CN$GB$GB
242198241$24219824$1$I$$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024163138$AMGEN$$$$$$Y$$$20240817$$PH$US$US
242198251$24219825$1$I$$20240806$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039987$AUROBINDO$$$$$F$Y$$$20240817$$CN$GB$GB
242198261$24219826$1$I$$20240809$20240817$20240817$EXP$GB-MHRA-MED-202408091442060030-DQZMP$GB-AMAROX PHARMA-AMR2024GB02677$HETERO$$$$$M$Y$$$20240817$$CN$GB$GB
242198271$24219827$1$I$20240731$20240806$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039962$AUROBINDO$$39$YR$$F$Y$$$20240817$$CN$GB$GB
242198281$24219828$1$I$20240812$20240813$20240817$20240817$PER$$US-AMGEN-USASP2024161835$AMGEN$$73$YR$E$M$Y$$$20240817$$CN$US$US
242198291$24219829$1$I$20240101$20240808$20240817$20240817$PER$$US-SA-2024SA239380$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240817$$MD$US$US
242198301$24219830$1$I$20240101$20240808$20240817$20240817$PER$$US-SA-2024SA239623$SANOFI AVENTIS$$$$A$F$Y$$$20240817$$MD$US$US
242198311$24219831$1$I$20240101$20240812$20240817$20240817$PER$$US-SA-2024SA241641$SANOFI AVENTIS$$13$YR$T$F$Y$88.4$KG$20240817$$MD$US$US
242198321$24219832$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA242141$SANOFI AVENTIS$$$$$F$Y$$$20240817$$CN$US$US
242198332$24219833$2$F$20240101$20240821$20240817$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022590$UNITED THERAPEUTICS$$$$$M$Y$$$20240829$$$US$US
242198341$24219834$1$I$$20240808$20240817$20240817$30DAY$$US-GSK-US2024099287$GLAXOSMITHKLINE$$$$$F$Y$$$20240817$$CN$US$US
242198361$24219836$1$I$20240723$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-040350$AUROBINDO$$61$YR$$F$Y$65$KG$20240817$$PH$FR$FR
242198371$24219837$1$I$20240813$20240813$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008342$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240817$$CN$US$US
242198381$24219838$1$I$$20240815$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009997$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240817$$CN$US$US
242198391$24219839$1$I$20240801$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009244$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240817$$CN$US$US
242198401$24219840$1$I$20240801$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009506$ELI LILLY AND CO$$$$$$Y$$$20240817$$CN$US$US
242198411$24219841$1$I$$20240813$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008484$ELI LILLY AND CO$$57$YR$A$$Y$$$20240817$$CN$US$US
242198421$24219842$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009260$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240817$$CN$US$US
242198431$24219843$1$I$$20240813$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008807$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240817$$HP$US$US
242198441$24219844$1$I$$20240812$20240817$20240817$EXP$$IT-SA-2024SA241701$SANOFI AVENTIS$Zangari P, Giancotta C, Pacillo L, Colantoni N, Leone F, Amodio D et al.. Use of dupilumab for atopic dermatitis in pediatric and young adult patients with inborn errors of immunity. Pediatr Allergy Immunol.. 2024;35:1-6$23$YR$A$F$Y$$$20240817$$HP$IT$IT
242198451$24219845$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA242275$SANOFI AVENTIS$$$$A$M$Y$$$20240817$$MD$US$US
242198461$24219846$1$I$$20240808$20240817$20240817$PER$$US-SA-2024SA238643$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240817$$CN$US$US
242198471$24219847$1$I$20210801$20240808$20240817$20240817$PER$$US-SA-2024SA239490$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240817$$MD$US$US
242198491$24219849$1$I$20240701$20240808$20240817$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024824$UNITED THERAPEUTICS$$$$$$Y$$$20240817$$$US$US
242198501$24219850$1$I$20240717$20240808$20240817$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022541$UNITED THERAPEUTICS$$70$YR$$F$Y$57.596$KG$20240817$$$US$US
242198511$24219851$1$I$20240601$20240815$20240817$20240817$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046240$BOEHRINGER INGELHEIM$$88$YR$E$$Y$$$20240817$$CN$US$US
242198521$24219852$1$I$20240731$20240815$20240817$20240817$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046286$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240817$$HP$CO$CO
242198531$24219853$1$I$$20240805$20240817$20240817$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0312$GRAVITI PHARMACEUTICALS$Khan S, Reggio C, Shoukat U, Lalwani A, Yousaf Z.Avoiding Premature Brain Death Declaration in Patients With Suspected Baclofen Overdose.Am-J-Respir-Crit-Care-Med.2024;209:A7027$58$YR$A$M$Y$$$20240817$$HP$US$US
242198541$24219854$1$I$20240101$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-040354$AUROBINDO$$28$YR$$M$Y$$$20240817$$MD$FR$FR
242198552$24219855$2$F$20240530$20240903$20240817$20240913$EXP$$US-UCBSA-2024028450$UCB$$7$YR$$F$Y$24.49$KG$20240913$$CN$US$US
242198561$24219856$1$I$$20240809$20240817$20240817$EXP$$US-GSK-US2024099639$GLAXOSMITHKLINE$$$$$M$Y$$$20240817$$MD$US$US
242198581$24219858$1$I$20240101$20240807$20240817$20240817$EXP$$RU-AMGEN-RUSSP2024156535$AMGEN$$75$YR$E$F$Y$$$20240817$$CN$RU$RU
242198601$24219860$1$I$$20240805$20240817$20240817$EXP$$KR-PBT-009633$PANACEA BIOTEC$Yang J, Kim Y, Park WY, Jin K, Han S, Kim BH, et al. Unilateral testicular tuberculosis in a kidney transplant recipient: a case report. Clin Transplat Res. 2024 Aug 1. doi: 10.4285/ctr.24.0023.$36$YR$A$M$Y$$$20240817$$HP$KR$KR
242198612$24219861$2$F$$20240806$20240817$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-039972$AUROBINDO$$$$$M$Y$$$20240820$$CN$GB$GB
242198621$24219862$1$I$20240626$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-039953$AUROBINDO$$72$YR$$F$Y$46.2$KG$20240817$$MD$FR$FR
242198631$24219863$1$I$$20240805$20240817$20240817$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0311$GRAVITI PHARMACEUTICALS$Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D.Rhabdomyolysis Risk: The Dangers of Tribulus Terrestris, an Over-the-Counter Supplement.Am-J-Case-Rep.2024;25: e943492:e943492$71$YR$E$M$Y$$$20240817$$HP$US$US
242198641$24219864$1$I$$20240809$20240817$20240817$EXP$$US-AMGEN-USASP2024159862$AMGEN$$$$$M$Y$$$20240817$$MD$US$US
242198651$24219865$1$I$$20240809$20240817$20240817$30DAY$$US-GSK-US2024099692$GLAXOSMITHKLINE$$$$$F$Y$$$20240817$$CN$US$US
242198661$24219866$1$I$$20240809$20240817$20240817$EXP$$US-GSK-US2024099713$GLAXOSMITHKLINE$$$$$M$Y$$$20240817$$MD$US$US
242198671$24219867$1$I$20240101$20240806$20240817$20240817$PER$$US-SA-2024SA237505$SANOFI AVENTIS$$$$A$M$Y$$$20240817$$MD$US$US
242198681$24219868$1$I$20240808$20240812$20240817$20240817$PER$$US-SA-2024SA242306$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240817$$MD$US$US
242198691$24219869$1$I$20240101$20240806$20240817$20240817$PER$$US-SA-2024SA238066$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240817$$MD$US$US
242198701$24219870$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA241858$SANOFI AVENTIS$$$$A$F$Y$$$20240817$$MD$US$US
242198712$24219871$2$F$$20240806$20240817$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-039890$AUROBINDO$$$$$M$Y$$$20240820$$CN$GB$GB
242198721$24219872$1$I$$20240806$20240817$20240817$EXP$$US-ROCHE-10000050570$ROCHE$$62$YR$A$F$Y$$$20240817$$CN$US$US
242198731$24219873$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009018$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240817$$CN$US$US
242198741$24219874$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008969$ELI LILLY AND CO$$17$YR$T$$Y$$$20240817$$CN$US$US
242198751$24219875$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009805$ELI LILLY AND CO$$$$$F$Y$$$20240817$$CN$US$US
242198761$24219876$1$I$20240806$20240815$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009739$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240817$$CN$US$US
242198771$24219877$1$I$20220101$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009252$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240817$$CN$US$US
242198781$24219878$1$I$$20240813$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008720$ELI LILLY AND CO$$$$$$Y$$$20240817$$CN$US$US
242198791$24219879$1$I$20240503$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-039956$AUROBINDO$$83$YR$$F$Y$79.1$KG$20240817$$MD$FR$FR
242198801$24219880$1$I$20220831$20240404$20240817$20240817$EXP$$CA-CELLTRION INC.-2021CA019574$CELLTRION$$$$$$Y$$$20240817$$MD$CA$CA
242198811$24219881$1$I$20240801$20240806$20240817$20240817$PER$$US-SA-2024SA236786$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240817$$MD$US$US
242198821$24219882$1$I$$20240814$20240817$20240817$PER$$US-ROCHE-10000055811$ROCHE$$$$$M$Y$$$20240817$$CN$US$US
242198831$24219883$1$I$20240601$20240813$20240817$20240817$PER$$US-AMGEN-USASP2024161458$AMGEN$$79$YR$E$F$Y$$$20240817$$HP$US$US
242198844$24219884$4$F$$20240909$20240817$20240920$EXP$$IT-AUROBINDO-AUR-APL-2024-040208$AUROBINDO$Pagni G, Pardini F. Utilizzo di lurasidone in un paziente affetto da schizofrenia con disturbo ossessivocompulsivo e ludopatia: efficacia e tollerabilit?. IJOP [Internet]. 2024;10(1 (Suppl. 3)$35$YR$$M$Y$$$20240920$$MD$IT$IT
242198851$24219885$1$I$$20240810$20240817$20240817$EXP$$NVSC2024US162751$NOVARTIS$$$$$M$Y$$$20240817$$MD$US$US
242198861$24219886$1$I$$20240808$20240817$20240817$PER$$US-SA-2024SA240757$SANOFI AVENTIS$$$$A$M$Y$95.25$KG$20240817$$MD$US$US
242198871$24219887$1$I$$20240810$20240817$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-024971$UNITED THERAPEUTICS$$$$$F$Y$86.621$KG$20240817$$$US$US
242198881$24219888$1$I$$20240810$20240817$20240817$EXP$GB-MHRA-MED-202408091852555040-WQTBF$GB-AMAROX PHARMA-AMR2024GB02678$HETERO$$$$$M$Y$$$20240817$$CN$GB$GB
242198892$24219889$2$F$$20240807$20240817$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-040665$AUROBINDO$$36$YR$$M$Y$$$20240820$$HP$CA$CA
242198903$24219890$3$F$20240101$20240916$20240817$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-019287$UNITED THERAPEUTICS$$$$$F$Y$66.667$KG$20240924$$$US$US
242198911$24219891$1$I$20240814$20240815$20240817$20240817$PER$$US-AMGEN-USASP2024164160$AMGEN$$69$YR$E$M$Y$$$20240817$$MD$US$US
242198921$24219892$1$I$$20240808$20240817$20240817$PER$$US-SA-2024SA239485$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240817$$MD$US$US
242198931$24219893$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008989$ELI LILLY AND CO$$$$A$F$Y$$$20240817$$CN$US$US
242198941$24219894$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008983$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240817$$CN$US$US
242198951$24219895$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008980$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240817$$CN$US$US
242198961$24219896$1$I$$20240815$20240817$20240817$EXP$$TR-ROCHE-10000058419$ROCHE$Guzelis I, Kucukzeybek B, Uyaroglu M, Gokova M, Sezgin G, Kucukzeybek Y. HER2-positive mucinous cystadenocarcinoma of the breast coexisting with invasive lobular carcinoma: A case report and review of the literature. Diagnostic Cytopathology. 2024-Sep;52 (9):E208-E214. doi:10.1002/dc.25364.$68$YR$E$F$Y$$$20240817$$MD$TR$TR
242198971$24219897$1$I$$20240808$20240817$20240817$30DAY$$US-GSK-US2024099248$GLAXOSMITHKLINE$$$$$F$Y$$$20240817$$CN$US$US
242198981$24219898$1$I$20240113$20240806$20240817$20240817$EXP$$PT-AUROBINDO-AUR-APL-2024-040337$AUROBINDO$$31$YR$$F$Y$$$20240817$$MD$PT$PT
242198992$24219899$2$F$20240101$20240830$20240817$20240904$PER$$US-SA-2024SA239629$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240904$$MD$US$US
242199001$24219900$1$I$$20240809$20240817$20240817$PER$$US-SA-2024SA239782$SANOFI AVENTIS$$$$A$F$Y$$$20240817$$CN$US$US
242199011$24219901$1$I$$20240808$20240817$20240817$PER$$US-SA-2024SA240579$SANOFI AVENTIS$$$$A$F$Y$72.562$KG$20240817$$MD$US$US
242199021$24219902$1$I$20240707$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-039938$AUROBINDO$$65$YR$$F$Y$114$KG$20240817$$MD$FR$FR
242199031$24219903$1$I$$20240816$20240817$20240817$PER$$NVSC2024US166678$NOVARTIS$$$$$$Y$$$20240817$$HP$US$US
242199042$24219904$2$F$20240802$20240913$20240817$20240918$EXP$$US-TAKEDA-2024TUS081050$TAKEDA$$50$YR$$F$Y$$$20240918$$CN$US$US
242199051$24219905$1$I$$20240809$20240817$20240817$PER$$US-SA-2024SA240769$SANOFI AVENTIS$$94$YR$E$$Y$$$20240817$$HP$US$US
242199081$24219908$1$I$$20240720$20240817$20240817$EXP$$AU-CELLTRION INC.-2024AU019225$CELLTRION$$$$$$Y$$$20240817$$MD$AU$AU
242199091$24219909$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009242$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240817$$CN$US$US
242199101$24219910$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008992$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240817$$CN$US$US
242199111$24219911$1$I$20240701$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008998$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240817$$CN$US$US
242199121$24219912$1$I$20240814$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008990$ELI LILLY AND CO$$55$YR$A$$Y$$$20240817$$CN$US$US
242199131$24219913$1$I$$20240815$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009889$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240817$$CN$US$US
242199141$24219914$1$I$20230301$20240807$20240817$20240817$EXP$$DE-AUROBINDO-AUR-APL-2024-040426$AUROBINDO$$28$YR$$M$Y$86$KG$20240817$$CN$DE$DE
242199151$24219915$1$I$20240601$20240807$20240817$20240817$EXP$$ES-AUROBINDO-AUR-APL-2024-040432$AUROBINDO$$88$YR$$F$Y$$$20240817$$MD$ES$ES
242199161$24219916$1$I$$20240816$20240817$20240817$PER$$NVSC2024US166682$NOVARTIS$$$$$$Y$$$20240817$$HP$US$US
242199173$24219917$3$F$$20240910$20240817$20240923$EXP$GB-MHRA-MED-202408051436201010-PNQJC$GB-Axellia-005312$XELLIA PHARMACEUTICALS$$$$$$Y$$$20240923$$PH$GB$GB
242199181$24219918$1$I$20180101$20240807$20240817$20240817$EXP$$US-TEVA-VS-3231593$TEVA$$63$YR$$M$Y$$$20240817$$CN$US$US
242199191$24219919$1$I$20240101$20240808$20240817$20240817$PER$$US-SA-2024SA239797$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240817$$MD$US$US
242199201$24219920$1$I$20240101$20240808$20240817$20240817$PER$$US-SA-2024SA239990$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240817$$MD$US$US
242199211$24219921$1$I$20240701$20240808$20240817$20240817$PER$$US-SA-2024SA239997$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240817$$CN$US$US
242199221$24219922$1$I$20240101$20240805$20240817$20240817$EXP$$US-UCBSA-2024039638$UCB$$66$YR$$F$Y$$$20240817$$HP$US$US
242199231$24219923$1$I$$20240816$20240817$20240817$PER$$NVSC2024US166687$NOVARTIS$$$$$$Y$$$20240817$$HP$US$US
242199241$24219924$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009020$ELI LILLY AND CO$$$$$F$Y$$$20240817$$CN$US$US
242199251$24219925$1$I$$20240816$20240817$20240817$PER$$NVSC2024US166689$NOVARTIS$$$$$$Y$$$20240817$$HP$US$US
242199261$24219926$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009240$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240817$$CN$US$US
242199271$24219927$1$I$$20240816$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408010593$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240817$$CN$US$US
242199291$24219929$1$I$20240101$20240813$20240817$20240817$PER$$US-SA-2024SA242107$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240817$$CN$US$US
242199301$24219930$1$I$20240808$20240808$20240817$20240817$PER$$US-SA-2024SA240113$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240817$$MD$US$US
242199311$24219931$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA241411$SANOFI AVENTIS$$$$E$M$Y$$$20240817$$MD$US$US
242199321$24219932$1$I$$20240813$20240817$20240817$PER$$US-SA-2024SA242109$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240817$$PH$US$US
242199331$24219933$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA240920$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240817$$CN$US$US
242199351$24219935$1$I$$20240809$20240817$20240817$PER$$US-SA-2024SA240187$SANOFI AVENTIS$$$$E$M$Y$$$20240817$$MD$US$US
242199361$24219936$1$I$$20240809$20240817$20240817$PER$$US-SA-2024SA241129$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240817$$CN$US$US
242199373$24219937$3$F$$20240812$20240817$20240926$EXP$$EU-DCGMA-24203737$UNITED THERAPEUTICS$$35$YR$$$Y$69$KG$20240926$$MD$EU$EU
242199381$24219938$1$I$$20240813$20240817$20240817$EXP$$CN-AMGEN-CHNSP2024161383$AMGEN$Qian H.; Huang Z.; Zhang Y. et al.. Long-Term Remission in T315I+ Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Blinatumomab and Allogeneic Stem Cell Transplantation: Two Case Studies. The American Journal of Case Reports. 2024;25:e944956-1-e944956-5$$$A$M$Y$$$20240817$$HP$CN$CN
242199391$24219939$1$I$$20240812$20240817$20240817$EXP$$IN-AMGEN-INDSP2024160354$AMGEN$Hiwarkar P.; Khan S.; Vp K. et al.. Disease-burden-adapted immunotherapy protocol for primary refractory or high-risk relapsed pediatric acute lymphoblastic leukemia. HemaSphere. 2024;8 (8):1-5$17$YR$T$$Y$$$20240817$$MD$IN$IN
242199401$24219940$1$I$20240813$20240813$20240817$20240817$PER$$US-SA-2024SA242699$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240817$$HP$US$US
242199411$24219941$1$I$20240803$20240807$20240817$20240817$EXP$$ES-TEVA-VS-3232344$TEVA$$65$YR$$F$Y$$$20240817$$CN$ES$ES
242199421$24219942$1$I$$20240808$20240817$20240817$EXP$$US-AMGEN-USASP2024159910$AMGEN$Jones A.A.; Martin J.S.; Giangiacomo A.L. et al.. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024;36:1-4$$$I$M$Y$$$20240817$$HP$US$US
242199441$24219944$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009039$ELI LILLY AND CO$$$$$F$Y$$$20240817$$CN$US$US
242199451$24219945$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009025$ELI LILLY AND CO$$$$$F$Y$$$20240817$$CN$US$US
242199461$24219946$1$I$20240501$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009221$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240817$$CN$US$US
242199471$24219947$1$I$20240805$20240815$20240817$20240817$PER$$US-AMGEN-USASP2024163455$AMGEN$$30$YR$A$F$Y$$$20240817$$CN$US$US
242199482$24219948$2$F$20231101$20240919$20240817$20240926$EXP$$AU-TAKEDA-2024TUS080318$TAKEDA$$68$YR$$F$Y$$$20240926$$CN$AU$AU
242199491$24219949$1$I$$20240813$20240817$20240817$PER$$US-SA-2024SA242689$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240817$$CN$US$US
242199501$24219950$1$I$$20240808$20240817$20240817$PER$$US-SA-2024SA240023$SANOFI AVENTIS$$$$A$F$Y$95.2$KG$20240817$$MD$US$US
242199512$24219951$2$F$$20240823$20240817$20240905$EXP$$US-AUROBINDO-AUR-APL-2024-039719$AUROBINDO$Wang J, Elghawy O, Kurpiel B, Kaur V.. Diagnosis and management of gastrointestinal SMARCA4- deficient undifferentiated tumors. Clinical Journal of Gastroenterology. 2023;16:807-814$75$YR$$F$Y$$$20240905$$HP$US$US
242199522$24219952$2$F$20240815$20240819$20240817$20240820$PER$$US-AMGEN-USASP2024163813$AMGEN$$40$YR$A$F$Y$$$20240820$$CN$US$US
242199532$24219953$2$F$$20240816$20240817$20240829$EXP$$PT-AUROBINDO-AUR-APL-2024-040260$AUROBINDO$Ol?mpia Varela, Bruna Malheiro, Ana Paula Castro, Jos? Ant?nio Carvalho, Eliana Costa. LEUCEMIA DE PLASM?CITOS ? CASO CL?NICO (PLASMOCYTE LEUKEMIA ? CLINICAL CASE). Revista Medicina Laboratorial. 2024;(5):141-145$71$YR$$F$Y$$$20240829$$MD$PT$PT
242199541$24219954$1$I$$20240808$20240817$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2024-003399$UNITED THERAPEUTICS$$$$$F$Y$104.31$KG$20240817$$$US$US
242199551$24219955$1$I$$20240805$20240817$20240817$EXP$$US-AUROBINDO-AUR-APL-2024-039621$AUROBINDO$Schwartz M, Gutman JA, Amaya ML, Pollyea DA, McMahon CM, Witkowski M, et al. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes. Blood. 2023;142 (Suppl. 1):5898-5899$$$$$Y$$$20240817$$MD$US$US
242199561$24219956$1$I$$20240813$20240817$20240817$PER$$US-SA-2024SA242694$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240817$$MD$US$US
242199571$24219957$1$I$$20240805$20240817$20240817$EXP$$US-AUROBINDO-AUR-APL-2024-039494$AUROBINDO$Daccache A, Albright J, Malmberg M, Braun J, Lemley K. Intracranial Hypertension as an Initial Sign of Adrenal Insufficiency Secondary to Inhaled Corticosteroids in a Child With Asthma. Am-JRespir-Crit-Care-Med. 2024;209:A6176$7$YR$$F$Y$$$20240817$$HP$US$US
242199584$24219958$4$F$$20240919$20240817$20240928$EXP$$US-TAKEDA-2024TUS076378$TAKEDA$$$$$F$Y$$$20240928$$MD$US$US
242199591$24219959$1$I$$20240808$20240817$20240817$EXP$$US-GSK-US2024099173$GLAXOSMITHKLINE$$$$$M$Y$$$20240817$$CN$US$US
242199601$24219960$1$I$$20240808$20240817$20240817$PER$$US-SA-2024SA240547$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240817$$MD$US$US
242199612$24219961$2$F$$20240912$20240817$20240920$EXP$$US-TAKEDA-2024TUS061636$TAKEDA$$$$$F$Y$58$KG$20240920$$CN$US$US
242199621$24219962$1$I$20240701$20240812$20240817$20240817$EXP$$US-AMGEN-USASP2024160116$AMGEN$$$$$F$Y$$$20240817$$CN$US$US
242199631$24219963$1$I$$20240815$20240817$20240817$PER$$US-ROCHE-10000059202$ROCHE$$$$$F$Y$$$20240817$$HP$US$US
242199641$24219964$1$I$20240814$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009457$ELI LILLY AND CO$$62$YR$A$$Y$$$20240817$$CN$US$US
242199651$24219965$1$I$20240201$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009499$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240817$$CN$US$US
242199662$24219966$2$F$20240701$20240814$20240817$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408009218$ELI LILLY AND CO$$59$YR$A$$Y$$$20240823$$CN$US$US
242199671$24219967$1$I$20240806$20240807$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408005492$ELI LILLY AND CO$$69$YR$E$$Y$$$20240817$$CN$US$US
242199681$24219968$1$I$20240101$20240809$20240817$20240817$EXP$$CA-CELLTRION INC.-2024CA018214$CELLTRION$$$$$$Y$$$20240817$$HP$CA$CA
242199692$24219969$2$F$$20240813$20240817$20240817$EXP$$US-ROCHE-10000057029$ROCHE$$$$A$M$Y$$$20240817$$HP$US$US
242199701$24219970$1$I$20231225$20240815$20240817$20240817$EXP$GB-MHRA-TPP12271851C7216619YC1723634581216$GB-SANDOZ INC.-SDZ2024GB073011$SANDOZ$$79$YR$$F$Y$65$KG$20240817$$MD$GB$GB
242199711$24219971$1$I$20240101$20240808$20240817$20240817$30DAY$$US-GSK-US2024099139$GLAXOSMITHKLINE$$83$YR$$M$Y$$$20240817$$CN$US$US
242199721$24219972$1$I$$20240813$20240817$20240817$EXP$PT-INFARMED-M202210-459$PT-ROCHE-10000056884$ROCHE$$72$YR$E$M$Y$$$20240817$$MD$PT$PT
242199731$24219973$1$I$$20240805$20240817$20240817$EXP$$US-AUROBINDO-AUR-APL-2024-039660$AUROBINDO$On S, Domingo W, Cheung E, Johnston L. Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen with Methotrexate-Based GvHD Prophylaxis. Blood. Transplant-Cell-Ther, The 65th ASH Annual Meeting Abstracts. 2024;30 (Suppl.)(2):S163 abstr. 211. - [abstract]$$$A$$Y$$$20240817$$HP$US$US
242199741$24219974$1$I$20240801$20240808$20240817$20240817$PER$$US-SA-2024SA240061$SANOFI AVENTIS$$28$YR$A$M$Y$85.72$KG$20240817$$MD$US$US
242199752$24219975$2$F$$20240805$20240817$20240820$EXP$$NL-AUROBINDO-AUR-APL-2024-040994$AUROBINDO$Dormans T, Zandijk E, Stals F. LATE TUBERCULOSIS REACTIVATION AFTER SEVERE COVID19. European Journal of Case Reports in Internal Medicine. 2024;11:5$8$DEC$$F$Y$$$20240820$$HP$NL$NL
242199762$24219976$2$F$$20240823$20240817$20240905$EXP$$US-AUROBINDO-AUR-APL-2024-039572$AUROBINDO$Pushparaji B, Sankar PR, Achuthanandan S, Basnet A, Cordeiro N, Epstein DJ, et al. ECMO RESCUE IN FULMINANT MYOCARDITIS: TAMING THE VT STORM.. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):3851$38$YR$$F$Y$$$20240905$$HP$US$US
242199771$24219977$1$I$$20240815$20240817$20240817$EXP$$US-TAKEDA-2024TUS082218$TAKEDA$$$$$F$Y$$$20240817$$CN$US$US
242199782$24219978$2$F$20240501$20240820$20240817$20240825$PER$$US-AMGEN-USASP2024163112$AMGEN$$77$YR$E$F$Y$$$20240825$$CN$US$US
242199791$24219979$1$I$$20240814$20240817$20240817$EXP$$US-TAKEDA-2024TUS082131$TAKEDA$$$$$M$Y$$$20240817$$CN$US$US
242199803$24219980$3$F$$20240823$20240817$20240904$EXP$$US-AUROBINDO-AUR-APL-2024-039725$AUROBINDO$Wang J, Elghawy O, Kurpiel B, Kaur V. Diagnosis and management of gastrointestinal SMARCA4- deficient undifferentiated tumors.. Clinical Journal of Gastroenterology. 2023;16:807-814$75$YR$$F$Y$$$20240904$$HP$US$US
242199812$24219981$2$F$$20240823$20240817$20240905$EXP$$US-AUROBINDO-AUR-APL-2024-039467$AUROBINDO$Wolf AB, Corboy JR. Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. Neurol-Clin-Pract. 2024;14:No. 5$36$YR$$F$Y$$$20240905$$MD$US$US
242199821$24219982$1$I$20220101$20240807$20240817$20240817$EXP$$US-UNITED THERAPEUTICS-UNT-2023-016731$UNITED THERAPEUTICS$$$$$M$Y$90.703$KG$20240817$$$US$US
242199831$24219983$1$I$$20240805$20240817$20240817$EXP$$DE-AUROBINDO-AUR-APL-2024-039554$AUROBINDO$Kyselyova AA, Fiehler J, Bester M. Flow diversion in a giant fusiform m2 aneurysm: very delayed parent vessel occlusion and post-thrombectomy re-in-stent thrombosis. J-NeuroIntervent-Surgery. 2023;15:(Suppl 2): A1?A90$50$YR$$$Y$$$20240817$$HP$DE$DE
242199841$24219984$1$I$$20240722$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07508$LUPIN$$$$$$Y$$$20240817$$MD$US$US
242199852$24219985$2$F$$20240805$20240817$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-036973$AUROBINDO$Stewart MA, Rives TA, Blanton K, Baldwin L.. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecologic Oncology Reports. 2024;54:101452.$33$YR$$F$Y$$$20240820$$MD$US$US
242199863$24219986$3$F$$20240828$20240817$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-039907$AUROBINDO$Pechacek J, Schmitt MM, Ferr? EMN, Webb T, Goldberg J, Lionakis MS et al.,. Successful Treatment of Refractory Cutaneous Protothecosis With MAT2203, an Oral Lipid Nanocrystal Formulation of Amphotericin B. Open Forum Infectious Diseases. 2024;11:1-4$71$YR$$M$Y$$$20240910$$MD$US$US
242199871$24219987$1$I$20240101$20240808$20240817$20240817$PER$$US-SA-2024SA240744$SANOFI AVENTIS$$11$YR$C$F$Y$40.2$KG$20240817$$MD$US$US
242199881$24219988$1$I$20240801$20240808$20240817$20240817$PER$$US-SA-2024SA240754$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240817$$MD$US$US
242199892$24219989$2$F$20240816$20240819$20240817$20240821$PER$$US-AMGEN-USASP2024163873$AMGEN$$60$YR$A$F$Y$$$20240820$$CN$US$US
242199901$24219990$1$I$$20240814$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008976$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240817$$CN$US$US
242199912$24219991$2$F$$20240805$20240817$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-039543$AUROBINDO$Chalker C, Yilmaz B, Trone K, Parecki G, Chen A, Lim JY, et al. Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule. NPJ-precision oncology. 2024;8(1):01-06$70$YR$$M$Y$$$20240820$$HP$US$US
242199932$24219993$2$F$20240203$20240919$20240817$20240926$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240100075$UPSHER SMITH LABORATORIES$$0$YR$$M$Y$9.42$KG$20240926$$CN$US$US
242199942$24219994$2$F$$20240806$20240817$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-040465$AUROBINDO$$83$YR$$M$Y$$$20240820$$MD$CA$CA
242199951$24219995$1$I$$20240723$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07514$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242199961$24219996$1$I$$20240805$20240817$20240817$EXP$$NL-AUROBINDO-AUR-APL-2024-039600$AUROBINDO$Anna M.Aalbers, Paul L. A. van Daele, Virgil A. S. H. Dalm, Peter J. M. Valk, Marc H. G. P. Raaijmakers. Long?term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome. HemaSphere. 2024;8 (8):e129$67$YR$$$Y$$$20240817$$HP$NL$NL
242199971$24219997$1$I$20220510$20240729$20240817$20240817$EXP$$CA-CELLTRION INC.-2021CA019571$CELLTRION$$$$$$Y$$$20240817$$CN$CA$CA
242199981$24219998$1$I$20240101$20240808$20240817$20240817$PER$$US-SA-2024SA240658$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240817$$MD$US$US
242199991$24219999$1$I$20240101$20240808$20240817$20240817$PER$$US-SA-2024SA240709$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240817$$CN$US$US
242200001$24220000$1$I$20240701$20240806$20240817$20240817$EXP$$US-UCBSA-2024039763$UCB$$34$YR$$F$Y$$$20240817$$HP$US$US
242200012$24220001$2$F$$20240805$20240817$20240820$EXP$$DE-AUROBINDO-AUR-APL-2024-039771$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 2023;107:107-113$$$N$$Y$$$20240820$$HP$DE$DE
242200021$24220002$1$I$20240321$20240805$20240817$20240817$EXP$$DE-AUROBINDO-AUR-APL-2024-040241$AUROBINDO$$43$YR$$F$Y$$$20240817$$MD$DE$DE
242200032$24220003$2$F$$20240819$20240817$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07934$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242200042$24220004$2$F$20240605$20240806$20240817$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-039948$AUROBINDO$$23$YR$$F$Y$43.5$KG$20240820$$PH$FR$FR
242200061$24220006$1$I$$20240806$20240817$20240817$EXP$$KR-MACLEODS PHARMA-MAC2024048801$MACLEODS$Moon KM, Jung SY, Han MS, Cho Y, Rah YM, Kim JW..Diffuse alveolar hemorrhage confirmed by  bronchoalveolar lavage in a patient with haemoptysis after sildenafil use for erectile  dysfunction.Korean Journal of Critical Care Medicine.28-FEB-2015;30(1):31-33$$$$$Y$$$20240817$$MD$KR$KR
242200071$24220007$1$I$20240515$20240806$20240817$20240817$EXP$$ZA-MACLEODS PHARMA-MAC2024048751$MACLEODS$$$$$$Y$$$20240817$$CN$ZA$ZA
242200081$24220008$1$I$$20240806$20240817$20240817$EXP$$FR-MACLEODS PHARMA-MAC2024048723$MACLEODS$$$$$$Y$$$20240817$$MD$FR$FR
242200091$24220009$1$I$$20240807$20240817$20240817$EXP$$JP-MACLEODS PHARMA-MAC2024048829$MACLEODS$Shinohara K, Itoi S, Nakamura S, Miyazaki Y, Mutoh Y, Hagiwara S, et al.Micafungin-breakthrough Coniochaeta hoffmannii (Lecythophora hoffmannii) fungemia following cord blood transplant in a patient with acute myeloid leukemia successfully treated with voriconazole.Journal of Infection and Chemotherapy.2024;30(9):934-7$$$$$Y$$$20240817$$MD$JP$JP
242200101$24220010$1$I$$20240807$20240817$20240817$EXP$GB-MHRA-MED-202408070148142890-ZBQNP$GB-MACLEODS PHARMA-MAC2024048822$MACLEODS$$$$$F$Y$$$20240817$$CN$GB$GB
242200112$24220011$2$F$$20240812$20240817$20240823$EXP$$JP-MACLEODS PHARMA-MAC2024048819$MACLEODS$$$$$$Y$$$20240823$$MD$JP$JP
242200121$24220012$1$I$$20240806$20240817$20240817$EXP$$TW-MACLEODS PHARMA-MAC2024048802$MACLEODS$Huang CC..Case report: Rare variants in the MTRR gene, 66GG and 524TT cause hyperhomocysteinemia and folic acid deficiency linked to schizophrenia.Frontiers in Psychiatry.2024;15:1353308$$$$$Y$$$20240817$$MD$TW$TW
242200131$24220013$1$I$$20240807$20240817$20240817$EXP$$GB-MACLEODS PHARMA-MAC2024048830$MACLEODS$Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP..A case of human T-lymphotropic virus-1-associated lichenoid dermatitis.Clinical and Experimental Dermatology.2024;49(8):916-18$$$$$Y$$$20240817$$MD$GB$GB
242200142$24220014$2$F$$20240808$20240817$20240820$EXP$$PT-AUROBINDO-AUR-APL-2024-040775$AUROBINDO$Jose S.F; Jorge L; Arsenio S; Lelita S... INTERACTION BETWEEN STATIN AND SGLT-2 INHIBITOR: A CASE REPORT.. 22nd European Congress of Internal Medicine (ECIM) - European Fe Eur J Intern Me$78$YR$$F$Y$$$20240820$$HP$PT$PT
242200151$24220015$1$I$$20240805$20240817$20240817$EXP$$DE-AUROBINDO-AUR-APL-2024-039778$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 2023;107:107-113$4$DY$$$Y$$$20240817$$HP$DE$DE
242200161$24220016$1$I$20240501$20240809$20240817$20240817$PER$$US-SA-2024SA241821$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240817$$MD$US$US
242200171$24220017$1$I$$20240809$20240817$20240817$PER$$US-SA-2024SA241735$SANOFI AVENTIS$$$$A$F$Y$63.492$KG$20240817$$MD$US$US
242200181$24220018$1$I$$20240808$20240817$20240817$EXP$$US-AMAROX PHARMA-HET2024US02684$HETERO$Sachdeva N, Sun LW, Young J, Chen A. Early to late explantation of Hydrus microstent MIGS  device: A case series. American Journal of Ophthalmology Case Reports. 2024;36$71$YR$$M$Y$$$20240817$$MD$US$US
242200191$24220019$1$I$$20240806$20240817$20240817$EXP$$DE-AUROBINDO-AUR-APL-2024-040288$AUROBINDO$$$$$M$Y$$$20240817$$CN$DE$DE
242200201$24220020$1$I$20220331$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-040385$AUROBINDO$$64$YR$$M$Y$78$KG$20240817$$MD$FR$FR
242200211$24220021$1$I$20240803$20240806$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-040001$AUROBINDO$$82$YR$$F$Y$$$20240817$$HP$GB$GB
242200221$24220022$1$I$$20240806$20240817$20240817$EXP$$IT-AUROBINDO-AUR-APL-2024-040278$AUROBINDO$Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G et al. Stevens-Johnson syndrome associated with drugs and vaccines in children: a case-control study. Plos One. 2013;8(7):1-8$33$MON$$F$Y$$$20240817$$HP$IT$IT
242200233$24220023$3$F$20240704$20240920$20240817$20240928$EXP$$DE-AUROBINDO-AUR-APL-2024-040339$AUROBINDO$$61$YR$$M$Y$64$KG$20240928$$MD$DE$DE
242200241$24220024$1$I$$20240815$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009741$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240817$$CN$US$US
242200251$24220025$1$I$20240808$20240813$20240817$20240817$PER$$US-BAYER-2024A116725$BAYER$$45$YR$A$F$Y$$$20240817$$HP$US$US
242200261$24220026$1$I$20240814$20240814$20240817$20240817$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-025370$UNITED THERAPEUTICS$$74$YR$$F$Y$$$20240817$$MD$JP$JP
242200271$24220027$1$I$20240101$20240808$20240817$20240817$EXP$$CA-TEVA-VS-3233217$TEVA$$36$YR$$F$Y$105$KG$20240817$$HP$CA$CA
242200281$24220028$1$I$20240513$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-040303$AUROBINDO$$85$YR$$F$Y$72$KG$20240817$$MD$FR$FR
242200291$24220029$1$I$20240620$20240812$20240817$20240817$PER$$US-BAYER-2024A116411$BAYER$$32$YR$A$F$Y$$$20240817$$HP$US$US
242200301$24220030$1$I$20240222$20240809$20240817$20240817$EXP$$GB-CELLTRION INC.-2024GB004873$CELLTRION$$$$$$Y$$$20240817$$HP$GB$GB
242200311$24220031$1$I$20240101$20240811$20240817$20240817$PER$$US-SA-2024SA241232$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240817$$MD$US$US
242200322$24220032$2$F$$20240910$20240817$20240918$PER$$US-SA-2024SA241305$SANOFI AVENTIS$$$$C$F$Y$$$20240918$$MD$US$US
242200331$24220033$1$I$20240809$20240812$20240817$20240817$PER$$US-BAYER-2024A116731$BAYER$$27$YR$A$F$Y$$$20240817$$HP$US$US
242200341$24220034$1$I$$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-039957$AUROBINDO$$30$YR$$M$Y$$$20240817$$MD$FR$FR
242200351$24220035$1$I$$20240808$20240817$20240817$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240800077$UPSHER SMITH LABORATORIES$$$$$$Y$$$20240817$$$US$US
242200361$24220036$1$I$$20240806$20240817$20240817$EXP$$CA-AUROBINDO-AUR-APL-2024-040463$AUROBINDO$$68$YR$$M$Y$$$20240817$$HP$CA$CA
242200371$24220037$1$I$20240101$20240815$20240817$20240817$PER$$US-AMGEN-USASP2024163469$AMGEN$$76$YR$E$F$Y$$$20240817$$CN$US$US
242200381$24220038$1$I$20240801$20240813$20240817$20240817$EXP$$US-AMGEN-USASP2024161483$AMGEN$$19$YR$A$M$Y$$$20240817$$CN$US$US
242200391$24220039$1$I$20240124$20240808$20240817$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-024883$UNITED THERAPEUTICS$$$$$$Y$$$20240817$$$US$US
242200401$24220040$1$I$20240122$20240808$20240817$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-024882$UNITED THERAPEUTICS$$$$$$Y$$$20240817$$$US$US
242200411$24220041$1$I$20240101$20240808$20240817$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-024885$UNITED THERAPEUTICS$$$$$$Y$$$20240817$$$US$US
242200421$24220042$1$I$$20240808$20240817$20240817$30DAY$$US-GSK-US2024099266$GLAXOSMITHKLINE$$$$A$M$Y$$$20240817$$CN$US$US
242200431$24220043$1$I$20240806$20240806$20240817$20240817$PER$$US-BAYER-2024A113818$BAYER$$$$$F$Y$$$20240817$$CN$US$US
242200441$24220044$1$I$$20240806$20240817$20240817$PER$$US-BAYER-2024A113893$BAYER$$40$YR$A$F$Y$$$20240817$$HP$US$US
242200451$24220045$1$I$$20240808$20240817$20240817$PER$$US-JNJFOC-20240822410$JOHNSON AND JOHNSON$$$$$$Y$$$20240817$$CN$US$US
242200461$24220046$1$I$20240713$20240806$20240817$20240817$EXP$$FR-AUROBINDO-AUR-APL-2024-039944$AUROBINDO$$15$YR$$F$Y$57$KG$20240817$$MD$FR$FR
242200476$24220047$6$F$20240101$20240910$20240817$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024138$UNITED THERAPEUTICS$$$$$F$Y$78.912$KG$20240920$$$US$US
242200491$24220049$1$I$$20240807$20240817$20240817$EXP$GB-MHRA-MED-202408070148142890-ZBQNP$GB-TEVA-VS-3231256$TEVA$$$$$F$Y$$$20240817$$CN$GB$GB
242200501$24220050$1$I$$20240815$20240817$20240817$PER$$US-AMGEN-USASP2024164285$AMGEN$$$$$$Y$$$20240817$$MD$US$US
242200511$24220051$1$I$$20240815$20240817$20240817$PER$$US-AMGEN-USASP2024163159$AMGEN$$$$$$Y$$$20240817$$MD$US$US
242200521$24220052$1$I$20240731$20240807$20240817$20240817$EXP$$GB-TEVA-VS-3231246$TEVA$$74$YR$$F$Y$103$KG$20240817$$HP$GB$GB
242200531$24220053$1$I$20240811$20240814$20240817$20240817$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129885$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240817$$CN$US$US
242200541$24220054$1$I$$20240807$20240817$20240817$PER$$US-SA-2024SA239444$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240817$$MD$US$US
242200551$24220055$1$I$20240101$20240808$20240817$20240817$PER$$US-SA-2024SA241364$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240817$$MD$US$US
242200561$24220056$1$I$$20240808$20240817$20240817$PER$$US-SA-2024SA240033$SANOFI AVENTIS$$$$$F$Y$$$20240817$$CN$US$US
242200571$24220057$1$I$20240101$20240812$20240817$20240817$PER$$US-SA-2024SA242166$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240817$$MD$US$US
242200581$24220058$1$I$20240801$20240811$20240817$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-025025$UNITED THERAPEUTICS$$67$YR$$F$Y$61.224$KG$20240817$$$US$US
242200592$24220059$2$F$$20240805$20240817$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07378$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242200601$24220060$1$I$$20240717$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07232$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242200611$24220061$1$I$$20240805$20240817$20240817$EXP$$US-AUROBINDO-AUR-APL-2024-039612$AUROBINDO$Mathias P, Epstein E. Iatrogenic Cushing^s Syndrome following Epidural Steroid Injections in an HIV-Infected Patient on Treatment with Genvoya. J-Endocr-Soc. 2019$76$YR$$F$Y$$$20240817$$HP$US$US
242200621$24220062$1$I$$20240808$20240817$20240817$EXP$$US-TEVA-VS-3232022$TEVA$$$$A$F$Y$$$20240817$$HP$US$US
242200632$24220063$2$F$$20240815$20240817$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-025139$UNITED THERAPEUTICS$$$$$F$Y$163.72$KG$20240822$$$US$US
242200642$24220064$2$F$$20240913$20240817$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130038$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240918$$CN$US$US
242200651$24220065$1$I$20240805$20240815$20240817$20240817$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129491$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240817$$PH$US$US
242200661$24220066$1$I$$20240806$20240817$20240817$EXP$$CN-AUROBINDO-AUR-APL-2024-039895$AUROBINDO$Liu J, Zhao L, Zou H, Xue Y. ?????????????????? ??????????????((Analysis on clinical characteristics of rituximab?related progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis). [????????]. Journal of Adverse Drug Reactions. 2022;24(10):534-539$58$YR$$M$Y$$$20240817$$HP$CN$CN
242200671$24220067$1$I$$20240806$20240817$20240817$EXP$$US-AUROBINDO-AUR-APL-2024-034346$AUROBINDO$Lam L, Bansal V, Chai T, Driver LC. Recurrent Pain From Chemotherapy-Induced Peripheral Neuropathy After COVID-19 Infection ? A Case Report.. Pain Medicine Case Reports.. 2023;7(8):357-9$59$YR$$M$Y$$$20240817$$MD$US$US
242200681$24220068$1$I$$20240718$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07257$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242200692$24220069$2$F$$20240830$20240817$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-040428$AUROBINDO$Topp MS, Duell J, Guijarro AMA, Odin M, Nielsen T, Rajeswaran A, et al.. Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma.. Haematologica.. 2020;105(5):e256-e260.$68$YR$$M$Y$$$20240910$$HP$DE$DE
242200701$24220070$1$I$$20240806$20240817$20240817$EXP$$NL-AUROBINDO-AUR-APL-2024-040581$AUROBINDO$Flinterman AE et al.. Spectrum of reactive neutrophilic dermatoses in a patient with meylodysplastic syndrome: treatment with anti-TNF alpha antibodies. Nederlands voor dematolgie en venerolgie. 2009;19:289-292$28$YR$$M$Y$$$20240817$$MD$NL$NL
242200711$24220071$1$I$$20240805$20240817$20240817$EXP$$US-AUROBINDO-AUR-APL-2024-039776$AUROBINDO$Gillespie L, Diaz M, Gorder K, Shaw C, Ahmad S, Hinckley W et al.. The Successful Rotor Wing Transport of 2 Patients Requiring Biventricular Impella Support: A Case Series and Review. Air-Med-J. 2023;42:499-503$81$YR$$F$Y$$$20240817$$HP$US$US
242200721$24220072$1$I$20240101$20240812$20240817$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-025126$UNITED THERAPEUTICS$$$$$F$Y$101.59$KG$20240817$$$US$US
242200731$24220073$1$I$$20240812$20240817$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-011129$UNITED THERAPEUTICS$$$$$M$Y$79.365$KG$20240817$$$US$US
242200741$24220074$1$I$$20240805$20240817$20240817$EXP$$US-AUROBINDO-AUR-APL-2024-039391$AUROBINDO$Sheth S, Matthia E, Naik D. Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer. Journal of Clinical Lipidology. 2024;18(4):e555-6$57$YR$$F$Y$$$20240817$$HP$US$US
242200751$24220075$1$I$$20240808$20240817$20240817$PER$$US-JNJFOC-20240823191$JOHNSON AND JOHNSON$$$$$M$Y$$$20240817$$CN$US$US
242200761$24220076$1$I$$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024162902$AMGEN$$$$$$Y$$$20240817$$PH$US$US
242200771$24220077$1$I$$20240718$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07340$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242200783$24220078$3$F$20240101$20240909$20240817$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-025224$UNITED THERAPEUTICS$$$$$M$Y$63.492$KG$20240914$$$US$US
242200792$24220079$2$F$20240101$20240829$20240817$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-025147$UNITED THERAPEUTICS$$$$$M$Y$$$20240830$$$US$US
242200801$24220080$1$I$$20240813$20240817$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-025248$UNITED THERAPEUTICS$$$$$M$Y$117.91$KG$20240817$$$US$US
242200811$24220081$1$I$$20240814$20240817$20240817$PER$$NVSC2024US165694$NOVARTIS$$$$$M$Y$$$20240817$$CN$US$US
242200821$24220082$1$I$20240802$20240806$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039837$AUROBINDO$$39$YR$$F$Y$$$20240817$$CN$GB$GB
242200831$24220083$1$I$$20240806$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039835$AUROBINDO$$$$$$Y$$$20240817$$CN$GB$GB
242200841$24220084$1$I$$20240807$20240817$20240817$EXP$$CA-AUROBINDO-AUR-APL-2024-040613$AUROBINDO$$54$YR$$F$Y$$$20240817$$HP$CA$CA
242200851$24220085$1$I$$20240718$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07347$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242200861$24220086$1$I$$20240806$20240817$20240817$EXP$$GB-AUROBINDO-AUR-APL-2024-039886$AUROBINDO$$89$YR$$F$Y$$$20240817$$PH$GB$GB
242200872$24220087$2$F$$20240904$20240817$20240913$EXP$$US-HETERO-HET2024US02686$HETERO$$$$$F$Y$50.8$KG$20240913$$CN$US$US
242200881$24220088$1$I$$20240718$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07357$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242200891$24220089$1$I$20240101$20240809$20240817$20240817$PER$$US-SA-2024SA240234$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240817$$MD$US$US
242200901$24220090$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA242176$SANOFI AVENTIS$$67$YR$E$M$Y$68.94$KG$20240817$$MD$US$US
242200912$24220091$2$F$20240806$20240823$20240817$20240902$PER$$US-SA-2024SA242415$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240902$$MD$US$US
242200921$24220092$1$I$20200729$20240807$20240817$20240817$EXP$PL-URPL-1-1717-2020$PL-TEVA-VS-3231677$TEVA$$26$YR$$F$Y$52$KG$20240817$$MD$PL$PL
242200941$24220094$1$I$$20240812$20240817$20240817$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012548$JAZZ$$$$$M$Y$$$20240817$$HP$US$US
242200951$24220095$1$I$$20240807$20240817$20240817$EXP$$US-TEVA-VS-3231569$TEVA$$67$YR$$F$Y$$$20240817$$PH$US$US
242200961$24220096$1$I$$20240718$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07377$LUPIN$$$$$$Y$$$20240817$$MD$US$US
242200971$24220097$1$I$20240401$20240807$20240817$20240817$EXP$FR-AFSSAPS-AVMP2024000219$FR-TEVA-VS-3231578$TEVA$$23$YR$$F$Y$$$20240817$$PH$FR$FR
242200981$24220098$1$I$20240806$20240807$20240817$20240817$30DAY$$US-GSK-US2024098626$GLAXOSMITHKLINE$$65$YR$$M$Y$$$20240817$$CN$US$US
242200991$24220099$1$I$20240101$20240813$20240817$20240817$PER$$US-SA-2024SA242641$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240817$$MD$US$US
242201001$24220100$1$I$20240101$20240808$20240817$20240817$PER$$US-SA-2024SA241441$SANOFI AVENTIS$$7$YR$C$F$Y$37.9$KG$20240817$$MD$US$US
242201011$24220101$1$I$20240201$20240812$20240817$20240817$PER$$US-SA-2024SA242692$SANOFI AVENTIS$$43$YR$A$F$Y$101$KG$20240817$$MD$US$US
242201021$24220102$1$I$$20240719$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07356$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242201031$24220103$1$I$$20240719$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07424$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242201041$24220104$1$I$$20240722$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07383$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242201051$24220105$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA242714$SANOFI AVENTIS$$$$A$F$Y$72.57$KG$20240817$$MD$US$US
242201062$24220106$2$F$20240101$20240827$20240817$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-024957$UNITED THERAPEUTICS$$$$$M$Y$107.03$KG$20240829$$$US$US
242201071$24220107$1$I$$20240813$20240817$20240817$PER$$US-SA-2024SA242503$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240817$$MD$US$US
242201081$24220108$1$I$20240401$20240812$20240817$20240817$EXP$$NVSC2024MX135763$NOVARTIS$$71$YR$$F$Y$30$KG$20240817$$CN$MX$MX
242201091$24220109$1$I$$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024163294$AMGEN$$$$$$Y$$$20240817$$CN$US$US
242201101$24220110$1$I$20240101$20240807$20240817$20240817$PER$$US-SA-2024SA239297$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240817$$MD$US$US
242201121$24220112$1$I$$20240719$20240817$20240817$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07432$LUPIN$$$$$$Y$$$20240817$$CN$US$US
242201131$24220113$1$I$20240513$20240806$20240817$20240817$EXP$GB-MHRA-MED-202405140626359200-LVCRM$GB-Accord-440589$ACCORD$$45$YR$A$F$Y$91$KG$20240817$$CN$GB$GB
242201141$24220114$1$I$20240801$20240805$20240817$20240817$EXP$$US-Accord-440432$ACCORD$$63$YR$A$M$Y$$$20240817$$HP$US$US
242201161$24220116$1$I$20240426$20240807$20240817$20240817$EXP$$US-BAXTER-2024BAX022848$BAXTER$$54$YR$$F$Y$63.4$KG$20240817$$HP$US$US
242201171$24220117$1$I$20240809$20240809$20240817$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-024988$UNITED THERAPEUTICS$$44$YR$$M$Y$126.98$KG$20240817$$$US$US
242201182$24220118$2$F$20240717$20240913$20240817$20240924$EXP$$SG-BAXTER-2024BAX022373$BAXTER$$33$YR$$M$Y$98.95$KG$20240924$$HP$SG$SG
242201192$24220119$2$F$$20240918$20240817$20240924$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140843$DAIICHI$$$$$M$Y$$$20240924$$CN$US$US
242201204$24220120$4$F$20240101$20240903$20240817$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025133$UNITED THERAPEUTICS$$$$$F$Y$113.38$KG$20240906$$$US$US
242201211$24220121$1$I$20240101$20240808$20240817$20240817$PER$$US-UNITED THERAPEUTICS-UNT-2024-025100$UNITED THERAPEUTICS$$$$$F$Y$65.306$KG$20240817$$$US$US
242201231$24220123$1$I$20240101$20240812$20240817$20240817$PER$$US-SA-2024SA242736$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240817$$MD$US$US
242201241$24220124$1$I$20240101$20240812$20240817$20240817$PER$$US-SA-2024SA241874$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240817$$MD$US$US
242201251$24220125$1$I$$20240807$20240817$20240817$30DAY$$US-GSK-US2024098613$GLAXOSMITHKLINE$$$$$F$Y$$$20240817$$CN$US$US
242201261$24220126$1$I$20240730$20240808$20240817$20240817$EXP$GB-MHRA-MED-202408081408065380-VJRNC$GB-TEVA-VS-3231940$TEVA$$42$YR$$F$Y$70$KG$20240817$$CN$GB$GB
242201271$24220127$1$I$20240809$20240809$20240817$20240817$PER$$US-SA-2024SA241786$SANOFI AVENTIS$$62$YR$A$F$Y$66.224$KG$20240817$$MD$US$US
242201281$24220128$1$I$20240401$20240809$20240817$20240817$PER$$US-SA-2024SA242688$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240817$$MD$US$US
242201291$24220129$1$I$20240101$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024163273$AMGEN$$74$YR$E$F$Y$$$20240817$$CN$US$US
242201301$24220130$1$I$20240701$20240809$20240817$20240817$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012396$JAZZ$$47$YR$$F$Y$$$20240817$$MD$US$US
242201311$24220131$1$I$20240801$20240812$20240817$20240817$PER$$US-SA-2024SA242138$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240817$$CN$US$US
242201322$24220132$2$F$20240801$20240814$20240817$20240917$PER$$US-AMGEN-USASP2024160395$AMGEN$$79$YR$E$M$Y$$$20240917$$CN$US$US
242201331$24220133$1$I$20240814$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024163277$AMGEN$$79$YR$E$F$Y$$$20240817$$CN$US$US
242201342$24220134$2$F$20240801$20240812$20240817$20240821$PER$$US-SA-2024SA240509$SANOFI AVENTIS$$42$YR$A$F$Y$79.365$KG$20240821$$MD$US$US
242201351$24220135$1$I$20240701$20240812$20240817$20240817$PER$$US-SA-2024SA242741$SANOFI AVENTIS$$$$A$F$Y$$$20240817$$HP$US$US
242201361$24220136$1$I$$20240807$20240817$20240817$EXP$$CA-BAXTER-2024BAX022888$BAXTER$$8$YR$$F$Y$$$20240817$$HP$CA$CA
242201371$24220137$1$I$20240410$20240812$20240817$20240817$PER$$US-AMGEN-USASP2024160523$AMGEN$$$$$$Y$$$20240817$$HP$US$US
242201381$24220138$1$I$$20240807$20240817$20240817$EXP$$CA-BAXTER-2024BAX022890$BAXTER$$$$$F$Y$$$20240817$$HP$CA$CA
242201391$24220139$1$I$$20240724$20240817$20240817$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003920$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240817$$CN$US$US
242201402$24220140$2$F$20240801$20240815$20240817$20240827$EXP$GB-MHRA-MED-202408061821540410-NBCRV$GB-Accord-440519$ACCORD$$69$YR$E$M$Y$85$KG$20240827$$MD$GB$GB
242201411$24220141$1$I$20240801$20240807$20240817$20240817$EXP$$US-Accord-441335$ACCORD$$51$YR$A$M$Y$$$20240817$$PH$US$US
242201421$24220142$1$I$20240806$20240809$20240817$20240817$EXP$GB-MHRA-MED-202408071620241670-WLJRM$GB-Accord-441171$ACCORD$$50$YR$A$F$Y$$$20240817$$HP$GB$GB
242201432$24220143$2$F$20240206$20240828$20240817$20240904$EXP$$DE-TEVA-VS-3210975$TEVA$$79$YR$$F$Y$57.2$KG$20240904$$MD$DE$DE
242201442$24220144$2$F$$20240820$20240817$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012545$JAZZ$$$$$F$Y$$$20240823$$HP$US$US
242201451$24220145$1$I$20221130$20240807$20240817$20240817$EXP$IE-HPRA-2024-114389$IE-Accord-440772$ACCORD$$5$YR$C$F$Y$$$20240817$$CN$IE$IE
242201462$24220146$2$F$20240814$20240827$20240817$20240829$PER$$US-AMGEN-USASP2024163283$AMGEN$$81$YR$E$F$Y$$$20240828$$CN$US$US
242201471$24220147$1$I$$20240806$20240817$20240817$PER$$US-JNJFOC-20240816686$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240817$$HP$US$US
242201481$24220148$1$I$$20240809$20240817$20240817$PER$$US-SA-2024SA240412$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240817$$MD$US$US
242201491$24220149$1$I$$20240809$20240817$20240817$EXP$$JP-VANTIVE-2024VAN018629$Vantive US Healthcare$$9$DEC$$F$Y$$$20240817$$MD$JP$JP
242201501$24220150$1$I$20240805$20240808$20240817$20240817$EXP$$JP-VANTIVE-2024VAN018844$Vantive US Healthcare$$$$$F$Y$$$20240817$$HP$JP$JP
242201511$24220151$1$I$20240815$20240815$20240817$20240817$PER$$US-AMGEN-USASP2024164568$AMGEN$$$$$$Y$$$20240817$$CN$US$US
242201522$24220152$2$F$20240806$20240807$20240817$20240828$EXP$$US-GSK-US2024098501$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240828$$CN$US$US
242201531$24220153$1$I$$20240808$20240817$20240817$PER$$US-JNJFOC-20240822181$JOHNSON AND JOHNSON$$$$$$Y$$$20240817$$CN$US$US
242201551$24220155$1$I$20240101$20240812$20240817$20240817$EXP$$US-009507513-2408USA004359$MERCK$$$$$F$Y$$$20240817$$CN$US$US
242201561$24220156$1$I$20240101$20240808$20240817$20240817$EXP$$US-TEVA-VS-3232795$TEVA$$55$YR$$F$Y$$$20240817$$CN$US$US
242201571$24220157$1$I$$20240805$20240817$20240817$EXP$FR-GERMAN-SPO/FRA/24/0011510$FR-RDY-SPO/FRA/24/0011510$DR REDDYS$$36$YR$A$F$Y$$$20240817$$MD$FR$FR
242201581$24220158$1$I$$20240811$20240817$20240817$EXP$$IL-AMGEN-ISRSP2024164232$AMGEN$Bauer S.; Saad A.; Greenhouse I. et al.. Phase II study of pembrolizumab and lenvatinib in platinum sensitive recurrent ovarian cancer. Journal of Clinical Oncology. 2024;42 (16):5581$$$$$Y$$$20240817$$HP$IL$IL
242201591$24220159$1$I$$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024163311$AMGEN$$$$$M$Y$$$20240817$$CN$US$US
242201602$24220160$2$F$20240716$20240904$20240817$20240909$30DAY$$US-AMGEN-USASP2024151677$AMGEN$$58$YR$A$M$Y$$$20240909$$HP$US$US
242201611$24220161$1$I$20240101$20240815$20240817$20240817$PER$$US-AMGEN-USASP2024163754$AMGEN$$28$YR$A$M$Y$$$20240817$$HP$US$US
242201621$24220162$1$I$20240101$20240815$20240817$20240817$PER$$US-AMGEN-USASP2024163760$AMGEN$$43$YR$A$M$Y$$$20240817$$HP$US$US
242201631$24220163$1$I$20220609$20240807$20240817$20240817$EXP$$US-BAXTER-2024BAX022905$BAXTER$$51$YR$$F$Y$50.6$KG$20240817$$MD$US$US
242201641$24220164$1$I$$20240806$20240817$20240817$EXP$GB-MHRA-MED-202408061233211950-KGVQH$GB-Accord-440606$ACCORD$$$$$M$Y$$$20240817$$CN$GB$GB
242201651$24220165$1$I$$20240807$20240817$20240817$EXP$$CA-BAXTER-2024BAX022960$BAXTER$$62$WK$$F$Y$$$20240817$$HP$CA$CA
242201661$24220166$1$I$20240727$20240806$20240817$20240817$EXP$GB-MHRA-MED-202408060847240140-BKTQJ$GB-Accord-440586$ACCORD$$45$YR$A$F$Y$82$KG$20240817$$CN$GB$GB
242201671$24220167$1$I$20240501$20240806$20240817$20240817$EXP$GB-MHRA-MED-202408060800543350-PGSRB$GB-Accord-440599$ACCORD$$59$YR$A$M$Y$124$KG$20240817$$MD$GB$GB
242201681$24220168$1$I$20240723$20240805$20240817$20240817$EXP$CN-HENLIUS-24CN016295$CN-Accord-441568$ACCORD$$51$YR$A$F$Y$55$KG$20240817$$MD$CN$CN
242201691$24220169$1$I$20240715$20240807$20240817$20240817$EXP$$US-Accord-441098$ACCORD$$41$YR$A$$Y$$$20240817$$HP$US$US
242201702$24220170$2$F$20240807$20240809$20240817$20240821$EXP$$US-Accord-441187$ACCORD$$61$YR$A$F$Y$$$20240821$$HP$US$US
242201721$24220172$1$I$20240801$20240812$20240817$20240817$PER$$US-AMGEN-USASP2024160581$AMGEN$$79$YR$E$M$Y$$$20240817$$CN$US$US
242201731$24220173$1$I$20240814$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024163345$AMGEN$$53$YR$A$M$Y$$$20240817$$CN$US$US
242201742$24220174$2$F$$20240823$20240817$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07315$LUPIN$$$$$$Y$$$20240913$$CN$US$US
242201751$24220175$1$I$$20240815$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408009832$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240817$$CN$US$US
242201762$24220176$2$F$20240814$20240816$20240817$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010798$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240821$$CN$US$US
242201771$24220177$1$I$$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024161901$AMGEN$$$$$$Y$$$20240817$$CN$US$US
242201781$24220178$1$I$$20240808$20240817$20240817$EXP$$EC-AMGEN-ECUSP2024159681$AMGEN$Chiang-wong H.; Gonzalez-saldana P. et al.. Romiplostim use in immune thrombocytopenia: Experience in Cuenca (Ecuador). Biomedica : revista del Instituto Nacional de Salud. 2024;44 (SUPP_1):198-204$$$$$Y$$$20240817$$HP$EC$EC
242201792$24220179$2$F$$20240821$20240817$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07319$LUPIN$$$$$$Y$$$20240910$$CN$US$US
242201801$24220180$1$I$$20240812$20240817$20240817$EXP$$CN-AMGEN-CHNSP2024163347$AMGEN$Sun H.; Zhu Y.; Li J. et al.. Picalm:MLLT10 can Identify a New Subgroup of Acute Leukemias of Ambiguous Lineage with Unique Extramedullary Disease and Treatment Response. Blood. 2023;142:6078-6078$44$YR$A$M$Y$$$20240817$$HP$CN$CN
242201811$24220181$1$I$20240812$20240812$20240817$20240817$PER$$US-AMGEN-USASP2024160473$AMGEN$$$$$$Y$$$20240817$$HP$US$US
242201821$24220182$1$I$$20240808$20240817$20240817$PER$$US-SA-2024SA238630$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240817$$MD$US$US
242201831$24220183$1$I$$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024163300$AMGEN$$$$$$Y$$$20240817$$PH$US$US
242201842$24220184$2$F$20240801$20240821$20240817$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-024736$UNITED THERAPEUTICS$$69$YR$$F$Y$69.388$KG$20240824$$$US$US
242201881$24220188$1$I$20240101$20240807$20240817$20240817$EXP$$US-Accord-441156$ACCORD$$72$YR$E$M$Y$$$20240817$$MD$US$US
242201891$24220189$1$I$20240802$20240806$20240817$20240817$EXP$$US-Accord-441576$ACCORD$$61$YR$A$M$Y$$$20240817$$HP$US$US
242201902$24220190$2$F$20240806$20240821$20240817$20240902$EXP$$US-Accord-441183$ACCORD$$33$YR$A$F$Y$$$20240902$$MD$US$US
242201911$24220191$1$I$20231205$20240805$20240817$20240817$EXP$$US-Accord-440644$ACCORD$$82$YR$E$F$Y$$$20240817$$HP$US$US
242201922$24220192$2$F$20240806$20240814$20240817$20240824$EXP$$US-Accord-440656$ACCORD$$71$YR$E$M$Y$$$20240824$$MD$US$US
242201932$24220193$2$F$20240701$20240812$20240817$20240822$EXP$GB-MHRA-MED-202408081056022780-PSZCD$GB-TEVA-VS-3231898$TEVA$$$$$M$Y$$$20240822$$PH$GB$GB
242201941$24220194$1$I$$20240806$20240817$20240817$EXP$$DE-Accord-441293$ACCORD$Paulzen M. Kling I. Management of weight gain under psychopharmacotherapy - know and take into account the risk profiles of the substances. DNP -DIE NEUROLOGIE UND PSYCHIATRIE. 2024;25(04):42-51.$55$YR$A$F$Y$147$KG$20240817$$MD$DE$DE
242201951$24220195$1$I$$20240805$20240817$20240817$EXP$$JP-Accord-439172$ACCORD$Marunaka Y, Ohashi T, Kubota T, Nishibeppu K, Konishi H, Shiozaki A, et. al. Dropped head syndrome suspected due to oxaliplatin used in adjuvant chemotherapy for gastric cancer: a case report. Surg Case Rep. 2024 Jul 25;10(1):174.$72$YR$E$M$Y$60.7$KG$20240817$$HP$JP$JP
242201961$24220196$1$I$20240813$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024163603$AMGEN$$$$$$Y$$$20240817$$PH$US$US
242201973$24220197$3$F$20240807$20240821$20240817$20240827$PER$$US-AMGEN-USASP2024161863$AMGEN$$75$YR$E$F$Y$$$20240827$$CN$US$US
242201981$24220198$1$I$20240301$20240809$20240817$20240817$EXP$$JP-AMGEN-JPNSP2024159329$AMGEN$$$$$$Y$$$20240817$$CN$JP$JP
242201991$24220199$1$I$$20240812$20240817$20240817$EXP$$GB-TAKEDA-2024TUS081936$TAKEDA$$$$$F$Y$$$20240817$$CN$GB$GB
242202001$24220200$1$I$20240808$20240808$20240817$20240817$EXP$GB-MHRA-MED-202408081809415130-PCBNJ$GB-TEVA-VS-3231920$TEVA$$$$$$Y$$$20240817$$HP$GB$GB
242202011$24220201$1$I$$20240808$20240817$20240817$EXP$GB-MHRA-MED-202408081058109930-HGRMQ$GB-TEVA-VS-3231586$TEVA$$79$YR$$F$Y$$$20240817$$HP$GB$GB
242202061$24220206$1$I$$20240807$20240817$20240817$30DAY$$US-GSK-US2024AMR098937$GLAXOSMITHKLINE$$$$$F$Y$$$20240817$$CN$US$US
242202071$24220207$1$I$$20240813$20240817$20240817$PER$$US-AMGEN-USASP2024161376$AMGEN$$$$A$F$Y$$$20240817$$CN$US$US
242202081$24220208$1$I$20240723$20240807$20240817$20240817$EXP$GB-MHRA-MED-202408071606547360-YTDNH$GB-TEVA-VS-3231329$TEVA$$$$$M$Y$$$20240817$$PH$GB$GB
242202091$24220209$1$I$$20240807$20240817$20240817$EXP$GB-MHRA-MED-202408071426044480-YFBQK$GB-TEVA-VS-3230822$TEVA$$$$$$Y$$$20240817$$CN$GB$GB
242202101$24220210$1$I$20240715$20240814$20240817$20240817$EXP$$US-AstraZeneca-2024A185657$ASTRAZENECA$$23473$DY$$F$Y$$$20240817$$MD$US$
242202111$24220211$1$I$$20240813$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408008641$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240817$$CN$US$US
242202121$24220212$1$I$$20240815$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408010138$ELI LILLY AND CO$$45$YR$A$$Y$$$20240817$$CN$US$US
242202142$24220214$2$F$20240603$20240923$20240817$20240926$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140847$DAIICHI$$86$YR$$F$Y$68.6$KG$20240927$$MD$US$US
242202161$24220216$1$I$$20240813$20240817$20240817$EXP$$NVSC2024US165127$NOVARTIS$$$$$M$Y$$$20240817$$CN$US$US
242202171$24220217$1$I$20240805$20240814$20240817$20240817$PER$$US-AMGEN-USASP2024162181$AMGEN$$68$YR$E$F$Y$$$20240817$$CN$US$US
242202201$24220220$1$I$20240222$20240814$20240817$20240817$EXP$$US-AstraZeneca-2024A185866$ASTRAZENECA$$26901$DY$$M$Y$$$20240817$$HP$US$
242202211$24220221$1$I$20240815$20240816$20240817$20240817$PER$$US-AMGEN-USASP2024163858$AMGEN$$39$YR$A$$Y$$$20240817$$CN$US$US
242202221$24220222$1$I$$20240815$20240817$20240817$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129809$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$105.69$KG$20240817$$CN$US$US
242202231$24220223$1$I$20240401$20240807$20240817$20240817$30DAY$$US-GSK-US2024098524$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240817$$CN$US$US
242202251$24220225$1$I$$20240815$20240817$20240817$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129803$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240817$$CN$US$US
242202261$24220226$1$I$20240809$20240812$20240817$20240817$EXP$$US-JNJFOC-20240831233$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240817$$MD$US$US
242202271$24220227$1$I$$20240807$20240817$20240817$EXP$$US-GSK-US2024098452$GLAXOSMITHKLINE$$$$$F$Y$$$20240817$$HP$US$US
242202341$24220234$1$I$$20240815$20240817$20240817$PER$$US-JNJFOC-20240839733$JOHNSON AND JOHNSON$$$$$$Y$$$20240817$$PH$US$US
242202351$24220235$1$I$$20240807$20240817$20240817$EXP$$US-TEVA-VS-3232436$TEVA$$74$YR$$F$Y$$$20240817$$CN$US$US
242202361$24220236$1$I$$20240815$20240817$20240817$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129834$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240817$$CN$US$US
242202371$24220237$1$I$$20240813$20240817$20240817$PER$$US-AMGEN-USASP2024161584$AMGEN$$$$$$Y$$$20240817$$CN$US$US
242202411$24220241$1$I$$20240812$20240817$20240817$EXP$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US001040$PAREXEL$Enstrom C., Gast S., Church L., Heflin M.K., Moore C., Cook C., Walsh D., Gage A., Bock A.. Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy. US Cardiology Review. 2024;18:2$25$YR$$M$Y$$$20240817$$MD$US$US
242202421$24220242$1$I$20240621$20240807$20240817$20240817$EXP$CN-NMPACDR-4602001068793202400106$CN-BAXTER-2024BAX022989$BAXTER$$55$YR$$F$Y$62$KG$20240817$$MD$CN$CN
242202451$24220245$1$I$$20240815$20240817$20240817$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129782$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240817$$CN$US$US
242202463$24220246$3$F$20240812$20240924$20240817$20240926$EXP$$NVSC2024US163558$NOVARTIS$$67$YR$$M$Y$$$20240926$$CN$US$US
242202491$24220249$1$I$$20240805$20240817$20240817$EXP$FR-GERMAN-SPO/FRA/24/0011508$FR-RDY-SPO/FRA/24/0011508$DR REDDYS$$37$YR$A$F$Y$$$20240817$$MD$FR$FR
242202501$24220250$1$I$20240810$20240815$20240817$20240817$EXP$$US-AstraZeneca-2024A186732$ASTRAZENECA$$26359$DY$$F$Y$$$20240817$$CN$US$
242202514$24220251$4$F$20230427$20240827$20240817$20240903$EXP$$CA-GSK-CA2023AMR063254$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$HP$CA$CA
242202521$24220252$1$I$20240813$20240813$20240817$20240817$PER$$US-AMGEN-USASP2024161492$AMGEN$$63$YR$A$F$Y$43$KG$20240817$$PH$US$US
242202571$24220257$1$I$$20240805$20240817$20240817$PER$$US-RDY-SPO/USA/24/0011518$DR REDDYS$$$$$F$Y$$$20240817$$CN$US$US
242202581$24220258$1$I$20240810$20240812$20240817$20240817$PER$$US-AMGEN-USASP2024161332$AMGEN$$68$YR$E$F$Y$$$20240817$$HP$US$US
242202591$24220259$1$I$$20240809$20240817$20240817$PER$$US-JNJFOC-20240831639$JOHNSON AND JOHNSON$$8$YR$C$F$Y$$$20240817$$CN$US$US
242202601$24220260$1$I$20240710$20240809$20240817$20240817$EXP$GB-MHRA-MIDB-aea73cb5-b1d6-48dd-822a-8a1a84b2a87d$GB-RDY-SPO/GBR/24/0011790$DR REDDYS$$68$YR$E$$Y$$$20240817$$HP$GB$GB
242202611$24220261$1$I$20200205$20240807$20240817$20240817$EXP$PL-URPL-2-432-2020$PL-TEVA-VS-3231509$TEVA$$27$YR$$F$Y$55$KG$20240817$$CN$PL$PL
242202621$24220262$1$I$20210101$20240808$20240817$20240817$EXP$SE-SEMPA-2024-005863$SE-TEVA-VS-3231972$TEVA$$77$YR$$F$Y$$$20240817$$CN$SE$SE
242202631$24220263$1$I$20240712$20240807$20240817$20240817$EXP$FR-AFSSAPS-LY2024001115$FR-TEVA-VS-3231819$TEVA$$69$YR$$M$Y$73$KG$20240817$$PH$FR$FR
242202641$24220264$1$I$20221130$20240812$20240817$20240817$EXP$ES-AEMPS-1560335$ES-RDY-SPO/ESP/24/0011798$DR REDDYS$$59$YR$A$M$Y$$$20240817$$PH$ES$ES
242202651$24220265$1$I$20240719$20240816$20240817$20240817$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046338$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240817$$HP$US$US
242202661$24220266$1$I$20240602$20240815$20240817$20240817$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046253$BOEHRINGER INGELHEIM$$89$YR$E$M$Y$68.93$KG$20240817$$MD$US$US
242202671$24220267$1$I$20240702$20240807$20240817$20240817$EXP$FR-AFSSAPS-AVCF2024000498$FR-TEVA-VS-3231861$TEVA$$41$YR$$F$Y$$$20240817$$HP$FR$FR
242202681$24220268$1$I$$20240809$20240817$20240817$EXP$$US-AMGEN-USASP2024163542$AMGEN$$$$$$Y$$$20240817$$MD$US$US
242202691$24220269$1$I$$20240808$20240817$20240817$EXP$$NL-AMGEN-FRASP2024161600$AMGEN$$74$YR$E$F$Y$$$20240817$$CN$NL$FR
242202711$24220271$1$I$$20240805$20240817$20240817$EXP$$US-Accord-440610$ACCORD$$$$$F$Y$$$20240817$$HP$US$US
242202721$24220272$1$I$20240805$20240806$20240817$20240817$EXP$$US-Accord-440706$ACCORD$$46$YR$A$F$Y$$$20240817$$HP$US$US
242202731$24220273$1$I$20240806$20240807$20240817$20240817$EXP$CN-HENLIUS-24CN016331$CN-Accord-441890$ACCORD$$71$YR$E$F$Y$71$KG$20240817$$MD$CN$CN
242202741$24220274$1$I$20240805$20240806$20240817$20240817$EXP$$US-Accord-440705$ACCORD$$59$YR$A$F$Y$$$20240817$$HP$US$US
242202751$24220275$1$I$$20240807$20240817$20240817$EXP$CA-MHPD-E2B_07165431$CA-Accord-440617$ACCORD$$30$YR$A$M$Y$$$20240817$$HP$CA$CA
242202761$24220276$1$I$$20240807$20240817$20240817$EXP$CA-MHPD-E2B_07176976$CA-Accord-441080$ACCORD$$76$YR$E$F$Y$$$20240817$$MD$CA$CA
242202771$24220277$1$I$20240718$20240806$20240817$20240817$EXP$$US-Accord-440662$ACCORD$$73$YR$E$F$Y$$$20240817$$HP$US$US
242202781$24220278$1$I$$20240806$20240817$20240817$EXP$GB-MHRA-MED-202408061624494640-SDVLZ$GB-Accord-440595$ACCORD$$54$YR$A$M$Y$$$20240817$$PH$GB$GB
242202791$24220279$1$I$20240803$20240805$20240817$20240817$EXP$$US-Accord-440637$ACCORD$$30$YR$A$M$Y$$$20240817$$HP$US$US
242202801$24220280$1$I$$20240807$20240817$20240817$EXP$CA-MHPD-E2B_07172038$CA-Accord-440831$ACCORD$$76$YR$E$F$Y$$$20240817$$CN$CA$CA
242202811$24220281$1$I$$20240806$20240817$20240817$EXP$GB-CRESCENT PHARMA LIMITED-2024-GB-05637$GB-Accord-430453$ACCORD$$$$T$M$Y$$$20240817$$MD$GB$GB
242202831$24220283$1$I$$20240816$20240817$20240817$PER$$US-ELI_LILLY_AND_COMPANY-US202408010925$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240817$$CN$US$US
242202841$24220284$1$I$$20240808$20240817$20240817$EXP$NL-LRB-00993932$NL-TEVA-VS-3231985$TEVA$$26$YR$$F$Y$59$KG$20240817$$CN$NL$NL
242202851$24220285$1$I$20240613$20240807$20240817$20240817$EXP$CH-SM-2024-14126$CH-TEVA-VS-3230892$TEVA$$67$YR$$M$Y$$$20240817$$PH$CH$CH
242202861$24220286$1$I$20240725$20240808$20240817$20240817$PER$$US-SA-2024SA239294$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240817$$MD$US$US
242202872$24220287$2$F$20240101$20240824$20240817$20240903$EXP$$CA-TEVA-VS-3232727$TEVA$$35$YR$$F$Y$$$20240903$$MD$CA$CA
242202881$24220288$1$I$20240718$20240808$20240817$20240817$EXP$FR-AFSSAPS-LY2024001193$FR-TEVA-VS-3232385$TEVA$$55$YR$$M$Y$$$20240817$$MD$FR$FR
242202891$24220289$1$I$$20240808$20240817$20240817$EXP$$CN-AMGEN-CHNSP2024159717$AMGEN$Bai O. A retrospective study on the efficacy of pegfilgrastim-filgrastim combination regimen in the mobilization for autologous stem cell transplantation in lymphoma patients. The American Journal of the Medical Sciences. 2024;1-30$$$$$Y$$$20240817$$MD$CN$CN
242202901$24220290$1$I$20240626$20240807$20240817$20240817$EXP$FR-AFSSAPS-AN2024001028$FR-TEVA-VS-3231741$TEVA$$64$YR$$M$Y$53.4$KG$20240817$$MD$FR$FR
242202911$24220291$1$I$20240701$20240808$20240817$20240817$PER$$US-SA-2024SA240032$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240817$$MD$US$US
242202921$24220292$1$I$$20240524$20240817$20240817$PER$$US-SA-2024SA242257$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240817$$MD$US$US
242202931$24220293$1$I$20240812$20240812$20240817$20240817$PER$$US-SA-2024SA242281$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240817$$CN$US$US
242202941$24220294$1$I$20240625$20240808$20240817$20240817$EXP$FR-AFSSAPS-AM2024000619$FR-TEVA-VS-3232363$TEVA$$87$YR$$F$Y$68.6$KG$20240817$$PH$FR$FR
242202952$24220295$2$F$$20240813$20240817$20240828$PER$$US-AstraZeneca-2024A185246$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242202962$24220296$2$F$$20240827$20240817$20240905$EXP$$NL-VER-202400051$VERITY PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$NL$NL
242202971$24220297$1$I$20240812$20240812$20240817$20240817$PER$$US-SA-2024SA240521$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240817$$CN$US$US
242202982$24220298$2$F$$20240815$20240817$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129764$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$79.83$KG$20240910$$CN$US$US
242202992$24220299$2$F$$20240822$20240817$20240831$EXP$$ES-TEVA-VS-3232330$TEVA$$$$$F$Y$$$20240831$$MD$ES$ES
242203001$24220300$1$I$20230301$20240808$20240817$20240817$EXP$FR-AFSSAPS-AVMP2024000221$FR-TEVA-VS-3232354$TEVA$$25$YR$$M$Y$$$20240817$$MD$FR$FR
242203011$24220301$1$I$20240725$20240806$20240817$20240817$EXP$$CA-VER-202400373$VERITY PHARMACEUTICALS$$75$YR$E$M$Y$$$20240817$$CN$CA$CA
242203021$24220302$1$I$$20240815$20240817$20240817$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129859$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240817$$HP$US$US
242203031$24220303$1$I$20240601$20240808$20240817$20240817$EXP$FR-AFSSAPS-RS2024000767$FR-TEVA-VS-3232406$TEVA$$25$YR$$$Y$$$20240817$$CN$FR$FR
242203042$24220304$2$F$20240802$20240905$20240817$20240930$PER$$US-SA-2024SA242290$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240930$$HP$US$US
242203051$24220305$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA123144$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240817$$MD$US$US
242203061$24220306$1$I$20240628$20240808$20240817$20240817$EXP$FR-AFSSAPS-AVNY2024000231$FR-TEVA-VS-3232362$TEVA$$29$YR$$F$Y$65$KG$20240817$$MD$FR$FR
242203071$24220307$1$I$20240219$20240808$20240817$20240817$EXP$FR-AFSSAPS-SE2024000592$FR-TEVA-VS-3232359$TEVA$$71$YR$$F$Y$56$KG$20240817$$MD$FR$FR
242203081$24220308$1$I$$20240815$20240817$20240817$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129831$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240817$$HP$US$US
242203091$24220309$1$I$$20240620$20240817$20240817$PER$$US-TRAVERE-2024TVT00628$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240817$$CN$US$US
242203101$24220310$1$I$20240809$20240809$20240817$20240817$PER$$US-SA-2024SA241592$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240817$$PH$US$US
242203111$24220311$1$I$$20240624$20240817$20240817$PER$$US-TRAVERE-2024TVT00636$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240817$$CN$US$US
242203122$24220312$2$F$$20240820$20240817$20240903$EXP$$US-ZENPEP LLC-2024AIMT01090$AIMMUNE$$$$$$Y$$$20240903$$HP$US$US
242203131$24220313$1$I$$20240809$20240817$20240817$PER$$US-JNJFOC-20240827843$JOHNSON AND JOHNSON$$$$$$Y$$$20240817$$CN$US$US
242203142$24220314$2$F$$20240819$20240817$20240821$PER$$US-JNJFOC-20240839304$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$PH$US$US
242203151$24220315$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA242292$SANOFI AVENTIS$$$$A$F$Y$61.2$KG$20240817$$MD$US$US
242203161$24220316$1$I$20240627$20240812$20240817$20240817$PER$$US-SA-2024SA241288$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240817$$MD$US$US
242203171$24220317$1$I$$20240809$20240817$20240817$PER$$US-SA-2024SA240532$SANOFI AVENTIS$$$$A$M$Y$$$20240817$$MD$US$US
242203181$24220318$1$I$$20240812$20240817$20240817$PER$$US-SA-2024SA241789$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240817$$MD$US$US
242203191$24220319$1$I$$20240815$20240817$20240817$PER$$NVSC2024US166917$NOVARTIS$$$$$F$Y$$$20240818$$MD$US$US
242203221$24220322$1$I$$20240814$20240817$20240817$PER$$US-AstraZeneca-2024A185410$ASTRAZENECA$$$$$F$Y$$$20240818$$CN$US$
242203231$24220323$1$I$20240809$20240812$20240817$20240817$PER$$US-SA-2024SA241070$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240818$$CN$US$US
242203271$24220327$1$I$20240805$20240813$20240817$20240817$PER$$US-AMGEN-USASP2024161352$AMGEN$$74$YR$E$F$Y$$$20240817$$CN$US$US
242203282$24220328$2$F$$20240909$20240817$20240917$PER$$US-AstraZeneca-2024A183972$ASTRAZENECA$$66$YR$$M$Y$81.6$KG$20240917$$HP$US$
242203311$24220331$1$I$20240101$20240809$20240817$20240817$PER$$US-SA-2024SA240258$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240818$$MD$US$US
242203321$24220332$1$I$20240802$20240809$20240817$20240817$PER$$US-SA-2024SA242907$SANOFI AVENTIS$$53$YR$A$F$Y$63$KG$20240818$$MD$US$US
242203351$24220335$1$I$$20240812$20240817$20240817$EXP$$US-SA-2024SA239951$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240818$$CN$US$US
242203362$24220336$2$F$20240501$20240830$20240817$20240904$EXP$$NVSC2024CR115897$NOVARTIS$$54$YR$$F$Y$$$20240904$$CN$CR$CR
242203371$24220337$1$I$20240705$20240813$20240818$20240818$EXP$ES-AEMPS-1558103$ES-SA-2024SA241567$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240818$$HP$ES$ES
242203381$24220338$1$I$$20240812$20240818$20240818$EXP$$US-AstraZeneca-2024A183956$ASTRAZENECA$$$$$M$Y$$$20240818$$CN$US$
242203401$24220340$1$I$$20240805$20240818$20240818$EXP$$US-AUROBINDO-AUR-APL-2024-039482$AUROBINDO$Khan S, Reggio C, Shoukat U, Lalwani A, Yousaf Z. Avoiding Premature Brain Death Declaration in Patients With Suspected Baclofen Overdose. Am-J-Respir-Crit-Care-Med. 2024;209:A7027$58$YR$$M$Y$$$20240818$$HP$US$US
242203411$24220341$1$I$$20240806$20240818$20240818$EXP$$NL-AUROBINDO-AUR-APL-2019-076695$AUROBINDO$A.E. Flinterman, L. Timmer-de Mik^ , M.R. Canninga-van Dijk, C.J.G. Sanders. Spectrum of reactive neutrophilic dermatoses with a patient suffering from myelodysplastic syndrome. Ned-Tijd-Dermatol-Venereo. 2009;19(5):279-282$28$YR$$M$Y$$$20240818$$MD$NL$NL
242203421$24220342$1$I$$20240806$20240818$20240818$EXP$$US-AUROBINDO-AUR-APL-2024-039732$AUROBINDO$Kumar R, Sadek A. THE EFFECTS OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST THERAPYON DIURETIC RESISTANT FLUID RETENTION IN A PATIENT WITH PULMONARY HYPERTENSION AND RIGHT HEART FAILURE.. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):2802$59$YR$$M$Y$134.26$KG$20240818$$HP$US$US
242203431$24220343$1$I$$20240806$20240818$20240818$EXP$$PT-AUROBINDO-AUR-APL-2016-11377$AUROBINDO$Gago JP, et al.. Docetaxel : Various toxicities and septic shocks: case report. Reactions weekly. 2016;1617:99$63$YR$$M$Y$$$20240818$$HP$PT$PT
242203441$24220344$1$I$$20240810$20240818$20240818$PER$$US-JNJFOC-20240827913$JOHNSON AND JOHNSON$$$$$$Y$$$20240818$$CN$US$US
242203451$24220345$1$I$$20240808$20240818$20240818$EXP$GB-MHRA-MED-202408071113249260-DSQMT$GB-DEXPHARM-2024-2742$DEXCEL$$73$YR$E$F$Y$50$KG$20240818$$HP$GB$GB
242203461$24220346$1$I$$20240731$20240818$20240818$PER$$US-AstraZeneca-2024A178091$ASTRAZENECA$$$$$F$Y$$$20240818$$CN$US$
242203472$24220347$2$F$$20240807$20240818$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-040125$AUROBINDO$$$$$M$Y$$$20240820$$PH$GB$GB
242203481$24220348$1$I$$20240806$20240818$20240818$30DAY$$US-GSK-US2024098158$GLAXOSMITHKLINE$$$$$M$Y$$$20240818$$CN$US$US
242203492$24220349$2$F$20240703$20240807$20240818$20240820$EXP$$IT-AUROBINDO-AUR-APL-2024-040577$AUROBINDO$$91$YR$$M$Y$$$20240820$$MD$IT$IT
242203501$24220350$1$I$$20240808$20240818$20240818$PER$$US-SA-2024SA238931$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240818$$MD$US$US
242203511$24220351$1$I$20230101$20240812$20240818$20240818$PER$$US-SA-2024SA242624$SANOFI AVENTIS$$$$A$F$Y$79.56$KG$20240818$$MD$US$US
242203521$24220352$1$I$$20240702$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004949$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203531$24220353$1$I$$20240705$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005026$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203541$24220354$1$I$$20240718$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005399$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203551$24220355$1$I$$20240719$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005384$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203561$24220356$1$I$$20240722$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005419$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203571$24220357$1$I$$20240723$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004918$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203581$24220358$1$I$$20240705$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005047$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203591$24220359$1$I$20240708$20240708$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005066$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203601$24220360$1$I$$20240718$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005360$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203611$24220361$1$I$$20240722$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005462$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203621$24220362$1$I$$20240722$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005437$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203631$24220363$1$I$$20240726$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005593$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203641$24220364$1$I$$20240703$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004998$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203651$24220365$1$I$$20240726$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005584$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203661$24220366$1$I$20240718$20240807$20240818$20240818$EXP$$BE-AUROBINDO-AUR-APL-2024-040411$AUROBINDO$$84$YR$$F$Y$67$KG$20240818$$MD$BE$BE
242203671$24220367$1$I$$20240805$20240818$20240818$EXP$$US-AUROBINDO-AUR-APL-2024-039381$AUROBINDO$Thor DC, Patel K, Singh M. Navigation of a New-Onset Pulmonary Embolism in a Patient Receiving Female-to-Male Gender-Affirming Care: A Case Report. Cureus. 2024;16(6):e63101$21$YR$$F$Y$$$20240818$$MD$US$US
242203681$24220368$1$I$$20240725$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005558$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203691$24220369$1$I$$20240705$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005051$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203701$24220370$1$I$$20240805$20240818$20240818$EXP$$US-AUROBINDO-AUR-APL-2024-039616$AUROBINDO$Omiwade O, Prevallet A. Gastrointestinal Bleeding and Hemorrhagic Shock in a Patient Diagnosed with Disseminated Histoplasmosis. ACG-Case-Rep-J. 2024;11(7):e01402$63$YR$$M$Y$$$20240818$$MD$US$US
242203711$24220371$1$I$$20240724$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004995$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242203721$24220372$1$I$20211225$20240806$20240818$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-039644$AUROBINDO$$59$YR$$F$Y$85$KG$20240818$$PH$FR$FR
242203731$24220373$1$I$$20240812$20240818$20240818$PER$$US-SA-2024SA242964$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240818$$MD$US$US
242203741$24220374$1$I$$20240807$20240818$20240818$EXP$$CA-AUROBINDO-AUR-APL-2024-040615$AUROBINDO$$$$$M$Y$$$20240818$$HP$CA$CA
242203753$24220375$3$F$20240101$20240906$20240818$20240917$EXP$$JP-JNJFOC-20240707497$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240917$$CN$JP$JP
242203761$24220376$1$I$$20240806$20240818$20240818$EXP$$US-AUROBINDO-AUR-APL-2024-039707$AUROBINDO$Zhang X, Aoun B. A DEADLYFORM OF DELIRIUM. Eur-J-Case-Rep-Intern-Med. 2019;6 (Suppl.):373$62$YR$$F$Y$$$20240818$$HP$US$US
242203771$24220377$1$I$20240605$20240807$20240818$20240818$EXP$$SE-AUROBINDO-AUR-APL-2024-040599$AUROBINDO$$82$YR$$M$Y$$$20240818$$MD$SE$SE
242203781$24220378$1$I$20240531$20240806$20240818$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-039946$AUROBINDO$$48$YR$$M$Y$85$KG$20240818$$PH$FR$FR
242203791$24220379$1$I$$20240807$20240818$20240818$EXP$$GB-AUROBINDO-AUR-APL-2024-037495$AUROBINDO$$41$YR$$M$Y$$$20240818$$PH$GB$GB
242203801$24220380$1$I$20240501$20240806$20240818$20240818$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-125434$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240818$$MD$DE$DE
242203811$24220381$1$I$$20240807$20240818$20240818$EXP$$CA-AUROBINDO-AUR-APL-2021-031433$AUROBINDO$$50$YR$$F$Y$$$20240818$$HP$CA$CA
242203821$24220382$1$I$$20240807$20240818$20240818$EXP$$CA-AUROBINDO-AUR-APL-2024-040546$AUROBINDO$$36$YR$$M$Y$$$20240818$$CN$CA$CA
242203831$24220383$1$I$$20240807$20240818$20240818$EXP$$CA-AUROBINDO-AUR-APL-2024-040616$AUROBINDO$$$$$M$Y$$$20240818$$HP$CA$CA
242203843$24220384$3$F$20240416$20240903$20240818$20240912$EXP$$DE-AUROBINDO-AUR-APL-2024-040540$AUROBINDO$$69$YR$$M$Y$72$KG$20240912$$MD$DE$DE
242203851$24220385$1$I$$20240807$20240818$20240818$EXP$$CA-AUROBINDO-AUR-APL-2024-040556$AUROBINDO$$$$$M$Y$$$20240818$$MD$CA$CA
242203861$24220386$1$I$$20240812$20240818$20240818$PER$$US-SA-2024SA242828$SANOFI AVENTIS$$$$A$M$Y$$$20240818$$MD$US$US
242203871$24220387$1$I$$20240807$20240818$20240818$EXP$$GB-AUROBINDO-AUR-APL-2024-040111$AUROBINDO$$$$$$Y$$$20240818$$CN$GB$GB
242203881$24220388$1$I$20240619$20240807$20240818$20240818$EXP$$GB-AUROBINDO-AUR-APL-2024-033217$AUROBINDO$$$$$F$Y$$$20240818$$CN$GB$GB
242203891$24220389$1$I$$20240808$20240818$20240818$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012322$JAZZ$$$$$F$Y$$$20240817$$CN$US$US
242203902$24220390$2$F$20240711$20240814$20240818$20240827$EXP$$DE-AUROBINDO-AUR-APL-2024-040008$AUROBINDO$$$$A$F$Y$122$KG$20240827$$MD$DE$DE
242203911$24220391$1$I$20240101$20240812$20240818$20240818$PER$$US-SA-2024SA242820$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240818$$MD$US$US
242203921$24220392$1$I$$20240812$20240818$20240818$PER$$US-SA-2024SA240913$SANOFI AVENTIS$$$$A$F$Y$$$20240818$$CN$US$US
242203932$24220393$2$F$20240101$20240814$20240818$20240822$30DAY$$US-GSK-US2024099663$GLAXOSMITHKLINE$$64$YR$$M$Y$$$20240822$$CN$US$US
242203941$24220394$1$I$20240215$20240807$20240818$20240818$EXP$$DE-AUROBINDO-AUR-APL-2024-040533$AUROBINDO$$$$A$F$Y$$$20240818$$HP$DE$DE
242203951$24220395$1$I$$20240806$20240818$20240818$EXP$$PT-DEXPHARM-2024-2763$DEXCEL$Gaspar CF, Greenfield H, Carneiro L. DONEPEZIL AS A CAUSE OF CARDIOGENIC? SYNCOPE - ELDERLY HEAVEN OR HELL? European Journal? of Case Reports in Internal Medicine. 2019;6(1):116?7. doi:10.12890/2019_v6sup1.$80$YR$E$F$Y$$$20240818$$HP$PT$PT
242203963$24220396$3$F$$20240906$20240818$20240918$EXP$$DE-AUROBINDO-AUR-APL-2024-040683$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz A, Stegherr R, Onken M, Beyersmann J, et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure:. European Journal of Epilepsy. 2023;107:107-113$$$N$F$Y$$$20240918$$MD$DE$DE
242203971$24220397$1$I$20240323$20240808$20240818$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-040575$AUROBINDO$$38$YR$$M$Y$97$KG$20240818$$PH$FR$FR
242203981$24220398$1$I$20230101$20240807$20240818$20240818$EXP$$DE-AUROBINDO-AUR-APL-2024-040418$AUROBINDO$$77$YR$$M$Y$76$KG$20240818$$MD$DE$DE
242203991$24220399$1$I$20240216$20240808$20240818$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-040468$AUROBINDO$$74$YR$$M$Y$$$20240818$$PH$FR$FR
242204011$24220401$1$I$$20240812$20240818$20240818$EXP$$US-AstraZeneca-2024A183893$ASTRAZENECA$$$$$F$Y$$$20240818$$HP$US$
242204021$24220402$1$I$20240102$20240808$20240818$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-040471$AUROBINDO$$89$YR$$M$Y$$$20240818$$PH$FR$FR
242204032$24220403$2$F$$20240823$20240818$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-039587$AUROBINDO$Armange L, Lacroix A, Petitgas P, Arvieux C, Piau-Couapel C, Tattevin P et al.. The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review. European Journal of Clinical Microbiology + Infectious Diseases. 2023;42 (4):413-422$33$YR$$F$Y$$$20240903$$HP$FR$FR
242204041$24220404$1$I$$20240812$20240818$20240818$EXP$$US-AstraZeneca-2024A183616$ASTRAZENECA$$$$$F$Y$$$20240818$$CN$US$
242204051$24220405$1$I$$20240805$20240818$20240818$EXP$$US-AUROBINDO-AUR-APL-2024-039502$AUROBINDO$Mayhew JA, Christenson JC, Alali M. Recurrent Serratia marcescens osteomyelitis eight years after a contaminated open fracture: a case report and review of the literature. Transl-Pediatr. 2024;13(2):350-358$16$YR$$M$Y$$$20240818$$HP$US$US
242204062$24220406$2$F$$20240809$20240818$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-040494$AUROBINDO$$$$$M$Y$$$20240820$$CN$GB$GB
242204071$24220407$1$I$20240601$20240812$20240818$20240818$EXP$$NVSC2024CR137443$NOVARTIS$$34$YR$$M$Y$$$20240818$$CN$CR$CR
242204081$24220408$1$I$$20240810$20240818$20240818$EXP$$GB-AUROBINDO-AUR-APL-2024-040511$AUROBINDO$$$$$M$Y$$$20240818$$CN$GB$GB
242204091$24220409$1$I$20240101$20240813$20240818$20240818$PER$$US-ABBVIE-5880293$ABBVIE$$$$$F$Y$$$20240818$$HP$US$US
242204101$24220410$1$I$$20240808$20240818$20240818$PER$$US-SA-2024SA238767$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240818$$MD$US$US
242204111$24220411$1$I$$20240808$20240818$20240818$PER$$US-SA-2024SA238870$SANOFI AVENTIS$$9$MON$I$F$Y$$$20240818$$MD$US$US
242204132$24220413$2$F$20211210$20240808$20240818$20240820$EXP$$NL-AUROBINDO-AUR-APL-2022-030998$AUROBINDO$$70$YR$$M$Y$86.2$KG$20240820$$MD$NL$NL
242204143$24220414$3$F$$20240805$20240818$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-039518$AUROBINDO$Bandali T, Kim Y, Khodadoust M, Rieger K, Fernandez-Pol S, Saleem A, et al.. Polatuzumab vedotin-piiq for treatment of primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCL-LT) in older adults. J-Invest-Dermatol. 2024;144 (Suppl.)(8):S49$92$YR$$M$Y$$$20240828$$HP$US$US
242204151$24220415$1$I$$20240807$20240818$20240818$EXP$$CA-AUROBINDO-AUR-APL-2024-040663$AUROBINDO$$36$YR$$M$Y$$$20240818$$HP$CA$CA
242204161$24220416$1$I$$20240813$20240818$20240818$30DAY$$AT-ABBVIE-5883514$ABBVIE$$$$$$Y$$$20240818$$CN$AT$US
242204171$24220417$1$I$20230701$20240815$20240818$20240818$EXP$$CA-ABBVIE-5883030$ABBVIE$$60$YR$$F$Y$$$20240818$$CN$CA$CA
242204181$24220418$1$I$$20240529$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003912$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204191$24220419$1$I$$20240624$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004710$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204201$24220420$1$I$$20240628$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004919$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204211$24220421$1$I$$20240701$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004958$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204221$24220422$1$I$$20240703$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004996$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204231$24220423$1$I$$20240703$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004999$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204241$24220424$1$I$$20240705$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005049$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204251$24220425$1$I$$20240705$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005053$BIOCON$$$$$$Y$$$20240818$$PH$US$US
242204261$24220426$1$I$$20240815$20240818$20240818$EXP$$US-AstraZeneca-2024A186872$ASTRAZENECA$$$$$F$Y$$$20240818$$CN$US$
242204271$24220427$1$I$$20240814$20240818$20240818$EXP$$US-AstraZeneca-2024A186165$ASTRAZENECA$$$$$$Y$$$20240818$$CN$US$
242204281$24220428$1$I$$20240708$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005104$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204291$24220429$1$I$$20240710$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005145$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204301$24220430$1$I$$20240711$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005188$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204311$24220431$1$I$$20240711$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005194$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204321$24220432$1$I$$20240711$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005183$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204331$24220433$1$I$$20240712$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005205$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204341$24220434$1$I$$20240713$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005263$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204351$24220435$1$I$$20240715$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005253$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204361$24220436$1$I$$20240708$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005106$BIOCON$$$$$$Y$$$20240818$$PH$US$US
242204371$24220437$1$I$$20240708$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005073$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204381$24220438$1$I$$20240708$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005081$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204391$24220439$1$I$$20240711$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005182$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204401$24220440$1$I$$20240711$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005197$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204411$24220441$1$I$$20240712$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005224$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204421$24220442$1$I$$20240715$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005246$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204431$24220443$1$I$$20240705$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005043$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204441$24220444$1$I$$20240709$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004959$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204451$24220445$1$I$$20240708$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004236$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204461$24220446$1$I$$20240710$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005149$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204471$24220447$1$I$$20240812$20240818$20240818$PER$$US-SA-2024SA242835$SANOFI AVENTIS$$$$T$M$Y$51$KG$20240818$$MD$US$US
242204481$24220448$1$I$$20240719$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005385$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204491$24220449$1$I$$20240719$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005387$BIOCON$$$$$$Y$$$20240818$$HP$US$US
242204501$24220450$1$I$$20240724$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005496$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204511$24220451$1$I$20240720$20240722$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005412$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204521$24220452$1$I$$20240722$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005427$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204531$24220453$1$I$$20240723$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005455$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204541$24220454$1$I$$20240716$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005283$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204551$24220455$1$I$$20240716$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005304$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204561$24220456$1$I$$20240717$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005316$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204571$24220457$1$I$$20240719$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005383$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204581$24220458$1$I$$20240722$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005411$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204591$24220459$1$I$$20240722$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005422$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204601$24220460$1$I$$20240722$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005446$BIOCON$$$$$$Y$$$20240818$$HP$US$US
242204611$24220461$1$I$$20240723$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005454$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204621$24220462$1$I$$20240724$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005492$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204631$24220463$1$I$$20240725$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005154$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204641$24220464$1$I$$20240725$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005345$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204651$24220465$1$I$$20240726$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005596$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204661$24220466$1$I$20240726$20240726$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005583$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204671$24220467$1$I$$20240717$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005318$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204681$24220468$1$I$$20240724$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005497$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204691$24220469$1$I$$20240725$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005578$BIOCON$$$$$$Y$$$20240818$$PH$US$US
242204701$24220470$1$I$$20240725$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005563$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204711$24220471$1$I$$20240725$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005560$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204721$24220472$1$I$$20240726$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005588$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204731$24220473$1$I$$20240726$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005590$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204741$24220474$1$I$$20240730$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005363$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204751$24220475$1$I$20240501$20240809$20240818$20240818$EXP$$US-GSK-US2024099662$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240818$$CN$US$US
242204761$24220476$1$I$20240708$20240719$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005078$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204771$24220477$1$I$$20240729$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005490$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204781$24220478$1$I$$20240719$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005117$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204791$24220479$1$I$$20240723$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005452$BIOCON$$$$$$Y$$$20240818$$CN$US$US
242204801$24220480$1$I$$20240715$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005240$BIOCON$$$$$$Y$$$20240818$$HP$US$US
242204811$24220481$1$I$$20240723$20240818$20240818$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005209$BIOCON$$$$$$Y$$$20240818$$PH$US$US
242204821$24220482$1$I$$20240807$20240818$20240818$EXP$GB-MHRA-MED-202405131339048220-TYRGZ$GB-DEXPHARM-2024-2721$DEXCEL$$$$$F$Y$102$KG$20240818$$HP$GB$GB
242204841$24220484$1$I$20240321$20240812$20240818$20240818$EXP$ES-AEMPS-1559574$ES-RDY-SPO/ESP/24/0011780$DR REDDYS$$74$YR$E$M$Y$$$20240818$$MD$ES$ES
242204851$24220485$1$I$$20240805$20240818$20240818$EXP$$US-AUROBINDO-AUR-APL-2024-039362$AUROBINDO$Wagle L, Regmi DR, Regmi R, Poudel S, Pant HN.. Metformin Toxicity Leading to Severe Refractory Hyperkalemia and Metabolic Acidosis: A Case Report. Cureus. 2024;16(6):e63130$74$YR$$M$Y$$$20240818$$MD$US$US
242204861$24220486$1$I$$20240813$20240818$20240818$EXP$$US-AstraZeneca-2024A185543$ASTRAZENECA$$$$$M$Y$$$20240818$$CN$US$
242204871$24220487$1$I$20240601$20240809$20240818$20240818$30DAY$$US-GSK-US2024099632$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240818$$CN$US$US
242204881$24220488$1$I$$20240812$20240818$20240818$PER$$US-SA-2024SA241706$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240818$$MD$US$US
242204891$24220489$1$I$$20240808$20240818$20240818$PER$$US-SA-2024SA238928$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240818$$CN$US$US
242204902$24220490$2$F$20240601$20240904$20240818$20240917$PER$$US-SA-2024SA239232$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240918$$MD$US$US
242204912$24220491$2$F$$20240805$20240818$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-039917$AUROBINDO$Jodeh W, Sparks PJ, Higgins JM, Tom A, Anilovich N, Moit H, et al. Parathyroid hormone-related peptide induced hypercalcemia of pregnancy due to mammary hyperplasia. JBMR-Plus. 2024;8:1 to 5$39$YR$$F$Y$$$20240820$$MD$US$US
242204921$24220492$1$I$20240325$20240808$20240818$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-040693$AUROBINDO$$$YR$$M$Y$$$20240818$$CN$FR$FR
242204931$24220493$1$I$20240101$20240813$20240818$20240818$PER$$US-ABBVIE-5879797$ABBVIE$$$$$F$Y$$$20240818$$HP$US$US
242204941$24220494$1$I$$20240806$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408004660$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240818$$CN$US$US
242204951$24220495$1$I$20240621$20240808$20240818$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-040606$AUROBINDO$$18$YR$$F$Y$$$20240818$$PH$FR$FR
242204961$24220496$1$I$20240531$20240806$20240818$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-040383$AUROBINDO$$79$YR$$M$Y$64$KG$20240818$$MD$FR$FR
242204971$24220497$1$I$$20240815$20240818$20240818$PER$$US-JNJFOC-20240840341$JOHNSON AND JOHNSON$$$$$$Y$$$20240818$$HP$US$US
242204981$24220498$1$I$$20240807$20240818$20240818$EXP$$CA-AUROBINDO-AUR-APL-2024-040572$AUROBINDO$$$$$M$Y$$$20240818$$HP$CA$CA
242204991$24220499$1$I$20240101$20240812$20240818$20240818$PER$$US-SA-2024SA242728$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240818$$MD$US$US
242205002$24220500$2$F$$20240807$20240818$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-040153$AUROBINDO$$$$$F$Y$$$20240820$$CN$GB$GB
242205011$24220501$1$I$20240723$20240807$20240818$20240818$EXP$$GB-AUROBINDO-AUR-APL-2024-040097$AUROBINDO$$$$$M$Y$$$20240818$$PH$GB$GB
242205022$24220502$2$F$20230901$20240807$20240818$20240820$EXP$$ES-AUROBINDO-AUR-APL-2024-040520$AUROBINDO$$66$YR$$M$Y$$$20240820$$MD$ES$ES
242205031$24220503$1$I$$20240807$20240818$20240818$EXP$$CA-AUROBINDO-AUR-APL-2024-040567$AUROBINDO$$$$$M$Y$$$20240818$$HP$CA$CA
242205041$24220504$1$I$$20240807$20240818$20240818$EXP$$NL-AUROBINDO-AUR-APL-2024-040591$AUROBINDO$$72$YR$$M$Y$6$KG$20240818$$MD$NL$NL
242205051$24220505$1$I$20240606$20240807$20240818$20240818$EXP$$ES-AUROBINDO-AUR-APL-2024-040430$AUROBINDO$$81$YR$$M$Y$$$20240818$$MD$ES$ES
242205061$24220506$1$I$$20240813$20240818$20240818$PER$$US-SA-2024SA242837$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240818$$HP$US$US
242205071$24220507$1$I$20240726$20240807$20240818$20240818$EXP$$DE-AUROBINDO-AUR-APL-2024-040413$AUROBINDO$$66$YR$$F$Y$$$20240818$$MD$DE$DE
242205081$24220508$1$I$$20240807$20240818$20240818$EXP$$IT-AUROBINDO-AUR-APL-2020-063637$AUROBINDO$Tovo P, Garazzino S, Saglio F, Scolfaro C, Bustamante J, Badolato R. et al.. Successful Hematopoietic Stem Cell Transplantation in a Patient with Complete IFN-? Receptor 2 Deficiency: a Case Report and Literature Review.. Journal of Clinical Immunology.. 2020;40:1191-1195$4$YR$$M$Y$$$20240818$$MD$IT$IT
242205091$24220509$1$I$$20240808$20240818$20240818$EXP$$CA-AUROBINDO-AUR-APL-2024-040727$AUROBINDO$$76$YR$$M$Y$$$20240818$$CN$CA$CA
242205101$24220510$1$I$20230501$20240808$20240818$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-040697$AUROBINDO$$57$YR$$F$Y$100$KG$20240818$$MD$FR$FR
242205111$24220511$1$I$20240327$20240808$20240818$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-040740$AUROBINDO$$32$YR$$F$Y$$$20240818$$MD$FR$FR
242205131$24220513$1$I$20240603$20240808$20240818$20240818$EXP$$FR-AUROBINDO-AUR-APL-2024-040439$AUROBINDO$$68$YR$$M$Y$$$20240818$$PH$FR$FR
242205141$24220514$1$I$$20240808$20240818$20240818$EXP$$PL-AUROBINDO-AUR-APL-2020-004572$AUROBINDO$W?udarczyk LA, Kolkosz M, Szczeklik W.. Perioperative care of a patient with inflammatory rheumatic disease.. MEDYCYNA PRAKTYCZNA. 2019;11:121-9$34$YR$$F$Y$$$20240818$$MD$PL$PL
242205151$24220515$1$I$20240802$20240808$20240818$20240818$PER$$US-SA-2024SA240719$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240818$$MD$US$US
242205161$24220516$1$I$$20240812$20240818$20240818$PER$$US-SA-2024SA241143$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240818$$MD$US$US
242205171$24220517$1$I$$20240808$20240818$20240818$EXP$$IT-AUROBINDO-AUR-APL-2024-040730$AUROBINDO$$33$YR$$F$Y$90$KG$20240818$$MD$IT$IT
242205181$24220518$1$I$20190101$20240808$20240818$20240818$EXP$$US-SANDOZ INC.-SDZ2024US073164$SANDOZ$$$$$F$Y$$$20240818$$CN$US$US
242205191$24220519$1$I$$20240809$20240818$20240818$EXP$$GB-AUROBINDO-AUR-APL-2024-040443$AUROBINDO$$$$$M$Y$$$20240818$$CN$GB$GB
242205201$24220520$1$I$20240810$20240810$20240818$20240818$EXP$$GB-AUROBINDO-AUR-APL-2024-040513$AUROBINDO$$47$YR$$F$Y$$$20240818$$PH$GB$GB
242205221$24220522$1$I$$20240805$20240818$20240818$EXP$$US-AUROBINDO-AUR-APL-2024-039608$AUROBINDO$Geiger AJ, Yasar DG, Sitwala KV. HLH and TET2 Mutation Presenting after First Cycle of CLL Treatment. Clin-Med-Res. 2023;21:155-158$75$YR$$M$Y$$$20240818$$MD$US$US
242205231$24220523$1$I$$20240805$20240818$20240818$EXP$$US-AUROBINDO-AUR-APL-2024-040903$AUROBINDO$$60$YR$$$Y$$$20240818$$CN$US$US
242205241$24220524$1$I$20240101$20240809$20240818$20240818$PER$$US-SA-2024SA241756$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240818$$MD$US$US
242205251$24220525$1$I$$20240807$20240818$20240818$PER$$US-SA-2024SA242239$SANOFI AVENTIS$$$$$$Y$$$20240818$$MD$US$US
242205261$24220526$1$I$20240401$20240806$20240818$20240818$EXP$$DE-AUROBINDO-AUR-APL-2024-039641$AUROBINDO$$64$YR$$F$Y$66$KG$20240818$$PH$DE$DE
242205271$24220527$1$I$$20240806$20240818$20240818$EXP$$GB-AUROBINDO-AUR-APL-2024-039831$AUROBINDO$$68$YR$$F$Y$$$20240818$$PH$GB$GB
242205281$24220528$1$I$$20240814$20240818$20240818$PER$$US-JNJFOC-20240836083$JOHNSON AND JOHNSON$$$$$$Y$$$20240818$$HP$US$US
242205291$24220529$1$I$$20240805$20240818$20240818$EXP$$IT-AUROBINDO-AUR-APL-2024-039547$AUROBINDO$Tuccori M, Di Paolo M, Maiese A, Scatena A, Bonaso M, Marcacci I, et al. Fat overload syndrome following intravenous lipid emulsion administration as antidote in suspected anesthetic intoxication: insights from a clinical and forensic case experience. Clin-Ter. 2024;175(4):211-215$30$YR$$F$Y$50$KG$20240818$$MD$IT$IT
242205301$24220530$1$I$$20240813$20240818$20240818$EXP$$JP-JNJFOC-20240841288$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240818$$MD$JP$JP
242205311$24220531$1$I$$20240719$20240818$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07426$LUPIN$$$$$$Y$$$20240818$$CN$US$US
242205321$24220532$1$I$$20240805$20240818$20240818$EXP$$US-AUROBINDO-AUR-APL-2024-039594$AUROBINDO$Das S, Ailawadhi S, Sher T, Roy V, Fernandez A, Parrondo RD. Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety. Curr-Oncol. 2023;30:9627- 9633$33$YR$$M$Y$$$20240818$$HP$US$US
242205332$24220533$2$F$20240104$20240919$20240818$20240927$EXP$IT-MINISAL02-997245$IT-TEVA-VS-3232305$TEVA$$51$YR$$F$Y$68$KG$20240927$$PH$IT$IT
242205342$24220534$2$F$20240301$20240820$20240818$20240826$EXP$$NVSC2024US165692$NOVARTIS$$69$YR$$F$Y$$$20240826$$CN$US$US
242205351$24220535$1$I$$20240813$20240818$20240818$PER$$US-JNJFOC-20240833478$JOHNSON AND JOHNSON$$$$$$Y$$$20240818$$PH$US$US
242205361$24220536$1$I$$20240728$20240818$20240818$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07751$LUPIN$$$$$$Y$$$20240818$$CN$US$US
242205371$24220537$1$I$$20240805$20240818$20240818$EXP$$US-AUROBINDO-AUR-APL-2024-039591$AUROBINDO$Das S, Ailawadhi S, Sher T, Roy V, Fernandez A, Parrondo RD.. Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety. Current Oncology. 2023;30:9627-9633$62$YR$$F$Y$$$20240818$$HP$US$US
242205381$24220538$1$I$20190201$20240808$20240818$20240818$EXP$IT-MINISAL02-997140$IT-TEVA-VS-3232114$TEVA$$33$YR$$F$Y$$$20240818$$MD$IT$IT
242205391$24220539$1$I$20240101$20240808$20240818$20240818$EXP$FR-AFSSAPS-ST2024001238$FR-TEVA-VS-3232592$TEVA$$85$YR$$F$Y$$$20240818$$MD$FR$FR
242205401$24220540$1$I$20240309$20240808$20240818$20240818$EXP$FR-AFSSAPS-AVMA2024000343$FR-TEVA-VS-3232343$TEVA$$39$YR$$F$Y$140$KG$20240818$$PH$FR$FR
242205411$24220541$1$I$20231227$20240808$20240818$20240818$EXP$FR-AFSSAPS-NY2024000890$FR-TEVA-VS-3232419$TEVA$$95$YR$$M$Y$70.4$KG$20240818$$MD$FR$FR
242205421$24220542$1$I$20240807$20240808$20240818$20240818$EXP$$US-JNJFOC-20240827777$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240818$$HP$US$US
242205432$24220543$2$F$20240209$20240821$20240818$20240830$EXP$FR-AFSSAPS-TO2024001468$FR-TEVA-VS-3232427$TEVA$$69$YR$$M$Y$106$KG$20240830$$PH$FR$FR
242205441$24220544$1$I$20240607$20240808$20240818$20240818$EXP$IT-MINISAL02-996896$IT-TEVA-VS-3232435$TEVA$$43$YR$$F$Y$$$20240818$$PH$IT$IT
242205451$24220545$1$I$20140101$20240808$20240818$20240818$EXP$FR-AFSSAPS-RS2024000775$FR-TEVA-VS-3232445$TEVA$$77$YR$$F$Y$38$KG$20240818$$MD$FR$FR
242205461$24220546$1$I$20200501$20240808$20240818$20240818$EXP$IT-MINISAL02-997150$IT-TEVA-VS-3232451$TEVA$$34$YR$$F$Y$$$20240818$$MD$IT$IT
242205471$24220547$1$I$20240719$20240808$20240818$20240818$EXP$FR-AFSSAPS-PA2024001425$FR-TEVA-VS-3232398$TEVA$$83$YR$$F$Y$56.9$KG$20240818$$MD$FR$FR
242205481$24220548$1$I$20240101$20240812$20240818$20240818$PER$$US-SA-2024SA189659$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240818$$MD$US$US
242205491$24220549$1$I$$20240108$20240818$20240818$EXP$$EG-JNJFOC-20240830409$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240818$$CN$EG$EG
242205501$24220550$1$I$20190501$20240807$20240818$20240818$EXP$$DE-RDY-LIT/DEU/24/0011831$DR REDDYS$Mispelbaum R, Hattenhauer T, Bauernfeind F, Lau J, Brossart P, Heine A. Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden. Frontiers in Oncology. 2024;14: doi:10.3389/fonc.2024.1406616.$68$YR$E$F$Y$$$20240818$$HP$DE$DE
242205511$24220551$1$I$20240801$20240813$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408008812$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240818$$CN$US$US
242205521$24220552$1$I$$20240808$20240818$20240818$EXP$$US-GSK-US2024099211$GLAXOSMITHKLINE$$$$$F$Y$$$20240818$$CN$US$US
242205531$24220553$1$I$$20240813$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408008370$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240818$$CN$US$US
242205541$24220554$1$I$$20230817$20240818$20240818$EXP$$EG-JNJFOC-20240828899$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240818$$CN$EG$EG
242205551$24220555$1$I$20240809$20240809$20240818$20240818$PER$$US-RDY-SPO/USA/24/0011759$DR REDDYS$$68$YR$E$M$Y$$$20240818$$CN$US$US
242205561$24220556$1$I$$20240805$20240818$20240818$EXP$$US-RDY-LIT/USA/24/0011708$DR REDDYS$Mullis CE, Heldman M, Bahr NC, Minamoto GY, Puius YA, Malinis M. Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient. Transplant Infectious Disease. 26(3): doi:10.1111/tid.14271.$64$YR$A$M$Y$$$20240818$$HP$US$US
242205571$24220557$1$I$20240808$20240809$20240818$20240818$PER$$US-SA-2024SA239836$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240818$$MD$US$US
242205581$24220558$1$I$$20240805$20240818$20240818$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07914$LUPIN$Patel R, Elghawy O, Gibbs A, Gupta S, Kaur V. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer Reports. 2024;7:1-6$84$YR$$M$Y$$$20240818$$HP$US$US
242205591$24220559$1$I$$20240809$20240818$20240818$PER$US-MLMSERVICE-20240802-PI151713-00312-2$US-RDY-SPO/USA/24/0011784$DR REDDYS$Bragg K, Miller H, Buckshaw R, Simon LV, King C. Testosterone Therapy as an Isolated Risk Factor for Venous Thrombosis: A Case Report. Cureus. 2024;16(7):e63611. DOI: 10.7759/cureus.63611.$$$E$M$Y$$$20240818$$MD$US$US
242205601$24220560$1$I$$20240813$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408008401$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240818$$CN$US$US
242205611$24220561$1$I$$20240805$20240818$20240818$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-07998$LUPIN$Sethi J, Subramani V, Kumar R, Patil S, Sharma A. Drug-resistant monoarticular wrist joint tuberculosis in renal transplant recipient with literature review. Indian Journal of Transplantation. 2023;17:371-374$69$YR$$M$Y$$$20240818$$MD$IN$IN
242205621$24220562$1$I$$20240813$20240818$20240818$EXP$$NVSC2024GB165778$NOVARTIS$$$$A$F$Y$$$20240818$$CN$GB$GB
242205641$24220564$1$I$20240801$20240813$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408008472$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240818$$CN$US$US
242205651$24220565$1$I$20240301$20240813$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408008476$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240818$$CN$US$US
242205661$24220566$1$I$20240101$20240812$20240818$20240818$PER$$US-JNJFOC-20240831458$JOHNSON AND JOHNSON$$$$$F$Y$$$20240818$$CN$US$US
242205683$24220568$3$F$20240814$20240814$20240818$20240830$PER$$US-AMGEN-USASP2024162596$AMGEN$$54$YR$A$F$Y$$$20240830$$CN$US$US
242205691$24220569$1$I$20240707$20240808$20240818$20240818$EXP$FR-AFSSAPS-CF2024000394$FR-TEVA-VS-3232350$TEVA$$15$YR$$F$Y$57$KG$20240818$$PH$FR$FR
242205701$24220570$1$I$20240717$20240808$20240818$20240818$EXP$FR-AFSSAPS-CF2024000395$FR-TEVA-VS-3232394$TEVA$$81$YR$$F$Y$49$KG$20240818$$PH$FR$FR
242205711$24220571$1$I$$20240812$20240818$20240818$PER$$US-SA-2024SA240973$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240818$$CN$US$US
242205722$24220572$2$F$$20240815$20240818$20240903$PER$$US-AstraZeneca-2024A186738$ASTRAZENECA$$$$$M$Y$$$20240903$$HP$US$
242205732$24220573$2$F$20240701$20240808$20240818$20240819$EXP$CH-SM-2024-15154$CH-TEVA-VS-3231568$TEVA$$60$YR$$M$Y$70.5$KG$20240819$$MD$CH$CH
242205741$24220574$1$I$20240630$20240808$20240818$20240818$EXP$FR-AFSSAPS-DJ2024000874$FR-TEVA-VS-3232379$TEVA$$68$YR$$F$Y$$$20240818$$MD$FR$FR
242205761$24220576$1$I$20240621$20240808$20240818$20240818$EXP$FR-AFSSAPS-RN2024000846$FR-TEVA-VS-3232377$TEVA$$26$YR$$M$Y$$$20240818$$MD$FR$FR
242205771$24220577$1$I$20230707$20240808$20240818$20240818$EXP$FR-AFSSAPS-CF2024000396$FR-TEVA-VS-3232355$TEVA$$28$YR$$F$Y$50$KG$20240818$$PH$FR$FR
242205781$24220578$1$I$$20240813$20240818$20240818$EXP$$NL-JNJFOC-20240838551$JOHNSON AND JOHNSON$$$$$F$Y$$$20240818$$CN$NL$NL
242205791$24220579$1$I$$20240808$20240818$20240818$PER$$US-SA-2024SA239257$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240818$$MD$US$US
242205801$24220580$1$I$$20240808$20240818$20240818$PER$$US-SA-2024SA239243$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240818$$MD$US$US
242205811$24220581$1$I$$20240809$20240818$20240818$PER$$US-SA-2024SA241751$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240818$$MD$US$US
242205821$24220582$1$I$20240801$20240809$20240818$20240818$PER$$US-SA-2024SA240503$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240818$$MD$US$US
242205831$24220583$1$I$$20240806$20240818$20240818$EXP$$US-SAMSUNG BIOEPIS-SB-2024-24304$SAMSUNG BIOEPIS$$79$YR$E$M$Y$$$20240818$$CN$US$US
242205841$24220584$1$I$20231201$20240807$20240818$20240818$EXP$ES-AEMPS-1523611$ES-SAMSUNG BIOEPIS-SB-2024-24116$SAMSUNG BIOEPIS$$47$YR$A$M$Y$$$20240818$$MD$ES$ES
242205861$24220586$1$I$20201101$20240807$20240818$20240818$EXP$FR-AFSSAPS-PP2024000522$FR-SAMSUNG BIOEPIS-SB-2024-24082$SAMSUNG BIOEPIS$$38$YR$A$M$Y$$$20240818$$MD$FR$FR
242205871$24220587$1$I$$20240809$20240818$20240818$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24749$SAMSUNG BIOEPIS$$92$YR$E$F$Y$$$20240818$$CN$GB$GB
242205881$24220588$1$I$$20240813$20240818$20240818$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045832$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240818$$MD$CA$CA
242205891$24220589$1$I$$20240809$20240818$20240818$PER$US-MLMSERVICE-20240802-PI149624-00123-1$US-RDY-SPO/USA/24/0011783$DR REDDYS$Ra OH, Tan JC, Zhao CW, Burns SL. Transient recurrence of chemotherapy-induced peripheral neuropathy in the immediate postoperative period following gynaecological surgery under general anaesthesia. Anaesthesia Reports. 2024;12(2):e12315. DOI:10.1002/anr3.12315.$57$YR$A$F$Y$$$20240818$$MD$US$US
242205901$24220590$1$I$$20240809$20240818$20240818$EXP$$IL-AMGEN-ISRSP2024160513$AMGEN$$$$$$Y$$$20240818$$MD$IL$IL
242205911$24220591$1$I$20240301$20240812$20240818$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127993$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240818$$PH$US$US
242205921$24220592$1$I$$20240806$20240818$20240818$EXP$$US-RDY-LIT/USA/24/0011755$DR REDDYS$Nelson N, Masih D, Sabri A, Monika F, Mirza M. Isolated Myeloid Sarcoma Masquerading as Scattered Abscesses in a Septic Patient: A Case Report and Literature Review. Case Reports in Oncology. 2024 Jan 05;(17): 39-48.$76$YR$E$F$Y$$$20240818$$HP$US$US
242205931$24220593$1$I$$20240809$20240818$20240818$EXP$$IL-AMGEN-ISRNI2024161712$AMGEN$$$$$M$Y$$$20240818$$MD$IL$IL
242205941$24220594$1$I$$20240811$20240818$20240818$EXP$$ES-AMGEN-ESPSP2024162562$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242205951$24220595$1$I$$20240809$20240818$20240818$EXP$$US-RDY-SPO/USA/24/0011787$DR REDDYS$$15$YR$T$F$Y$$$20240818$$MD$US$US
242205961$24220596$1$I$20210101$20240812$20240818$20240818$EXP$$US-AMGEN-USASP2024160083$AMGEN$$59$YR$A$F$Y$$$20240818$$CN$US$US
242205971$24220597$1$I$$20240812$20240818$20240818$PER$$US-SA-2024SA242745$SANOFI AVENTIS$$$$A$F$Y$$$20240818$$MD$US$US
242205981$24220598$1$I$$20240811$20240818$20240818$EXP$$ES-AMGEN-ESPSP2024162592$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242205991$24220599$1$I$$20240811$20240818$20240818$EXP$$ES-AMGEN-ESPSP2024162583$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242206001$24220600$1$I$$20240812$20240818$20240818$EXP$$IE-BRISTOL-MYERS SQUIBB COMPANY-2024-128068$BRISTOL MYERS SQUIBB$Carroll E, Leahy M, Dhonncha EN. Scar: more than just a mark on the skin. British Journal of Dermatology. 2024 Jul 01;192(Suppl 1):i146-7.$34$YR$A$F$Y$$$20240818$$HP$IE$IE
242206011$24220601$1$I$$20240811$20240818$20240818$EXP$$ES-AMGEN-ESPSP2024162570$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242206021$24220602$1$I$$20240811$20240818$20240818$EXP$$ES-AMGEN-ESPSP2024162819$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242206031$24220603$1$I$$20240811$20240818$20240818$EXP$$ES-AMGEN-ESPSP2024162689$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242206041$24220604$1$I$$20240811$20240818$20240818$EXP$$ES-AMGEN-ESPSP2024162594$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242206051$24220605$1$I$$20240807$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408005678$ELI LILLY AND CO$$$$$$Y$$$20240818$$HP$US$US
242206061$24220606$1$I$$20240812$20240818$20240818$PER$$US-ROCHE-10000058669$ROCHE$Foster R, Ong S. Subretinal surprise: Subretinal tractional bands in diabetic tractional retinal detachment. American Journal of Ophthalmology Case Reports. 2024;36:1-2. doi:10.1016/j.ajoc.2024.102104.$46$YR$A$F$Y$$$20240818$$MD$US$US
242206071$24220607$1$I$$20230705$20240818$20240818$EXP$$US-AstraZeneca-2023A154658$ASTRAZENECA$$$$$M$Y$$$20240818$$CN$US$
242206081$24220608$1$I$$20230912$20240818$20240818$EXP$$US-AstraZeneca-2023A180712$ASTRAZENECA$$$$$F$Y$36.3$KG$20240818$$HP$US$
242206091$24220609$1$I$$20230202$20240818$20240818$EXP$$US-AstraZeneca-2023A030431$ASTRAZENECA$$$$$F$Y$$$20240818$$CN$US$
242206101$24220610$1$I$20220201$20220614$20240818$20240818$EXP$$US-AstraZeneca-2022A163818$ASTRAZENECA$$74$YR$$F$Y$74.4$KG$20240818$$CN$US$
242206111$24220611$1$I$$20230824$20240818$20240818$EXP$$US-AstraZeneca-2023A194705$ASTRAZENECA$$$$$F$Y$$$20240818$$CN$US$
242206131$24220613$1$I$$20230511$20240818$20240818$EXP$$US-AstraZeneca-2023A110595$ASTRAZENECA$$$$$$Y$132$KG$20240818$$HP$US$
242206141$24220614$1$I$$20240812$20240818$20240818$PER$$US-AstraZeneca-2024A183339$ASTRAZENECA$$$$$F$Y$$$20240818$$CN$US$
242206151$24220615$1$I$$20230615$20240818$20240818$EXP$$US-AstraZeneca-2023A139509$ASTRAZENECA$$$$$F$Y$$$20240818$$CN$US$
242206161$24220616$1$I$$20220829$20240818$20240818$EXP$$GB-AstraZeneca-2022A294075$ASTRAZENECA$$$$$$Y$$$20240818$$MD$GB$
242206171$24220617$1$I$$20240805$20240818$20240818$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK093057$GLENMARK$$$$$$Y$$$20240818$$HP$CA$CA
242206181$24220618$1$I$$20240805$20240818$20240818$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK093066$GLENMARK$$$$$$Y$$$20240818$$HP$CA$CA
242206192$24220619$2$F$$20240821$20240818$20240826$EXP$$US-JNJFOC-20240836058$JOHNSON AND JOHNSON$$45$YR$A$F$Y$86.26$KG$20240826$$HP$US$US
242206201$24220620$1$I$$20240805$20240818$20240818$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093105$GLENMARK$Wagle L, Regmi DR, Regmi R, Poudel S, Pant HN.. Metformin Toxicity Leading to Severe Refractory Hyperkalemia and Metabolic Acidosis: A Case Report.. Cureus.. 2024;16 (6):e63130$$$$$Y$$$20240818$$MD$US$US
242206212$24220621$2$F$20240530$20240918$20240818$20240920$EXP$$NVSC2024CA116709$NOVARTIS$$33$YR$$F$Y$$$20240920$$CN$CA$CA
242206221$24220622$1$I$20240601$20240807$20240818$20240818$EXP$FR-AFSSAPS-BX2024001536$FR-Accord-440718$ACCORD$$31$YR$A$F$Y$50$KG$20240818$$MD$FR$FR
242206231$24220623$1$I$20240619$20240807$20240818$20240818$EXP$GB-MHRA-MED-202407030823125260-LZMNC$GB-Accord-434196$ACCORD$$$$$F$Y$$$20240818$$CN$GB$GB
242206241$24220624$1$I$20240306$20240807$20240818$20240818$EXP$SE-SEMPA-2024-005754$SE-Accord-440891$ACCORD$$19$YR$A$M$Y$$$20240818$$MD$SE$SE
242206251$24220625$1$I$$20240806$20240818$20240818$EXP$$PT-Accord-440483$ACCORD$Freitas JG, Ribeiro T, Moreira C, Moreira I, Mariz JM. When Myeloma is not a Myeloma: a case report of malignant bone lymphoma. Porto Biomedical Journal. 2024;9(4):e261.$63$YR$A$F$Y$$$20240818$$MD$PT$PT
242206262$24220626$2$F$$20240923$20240818$20240930$PER$$US-JNJFOC-20240833016$JOHNSON AND JOHNSON$$$$$$Y$$$20240929$$MD$US$US
242206271$24220627$1$I$20240702$20240808$20240818$20240818$EXP$FR-AFSSAPS-CF2024000392$FR-TEVA-VS-3232345$TEVA$$15$YR$$F$Y$59$KG$20240818$$PH$FR$FR
242206281$24220628$1$I$20240101$20240808$20240818$20240818$EXP$SE-SEMPA-2024-005806$SE-TEVA-VS-3232365$TEVA$$48$YR$$F$Y$$$20240818$$HP$SE$SE
242206291$24220629$1$I$$20240813$20240818$20240818$EXP$$NVSC2024GB165679$NOVARTIS$$$$$F$Y$$$20240818$$CN$GB$GB
242206301$24220630$1$I$$20240815$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408010273$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240818$$CN$US$US
242206311$24220631$1$I$20160315$20240808$20240818$20240818$EXP$FR-AFSSAPS-PP2024000859$FR-TEVA-VS-3232415$TEVA$$82$YR$$F$Y$$$20240818$$MD$FR$FR
242206321$24220632$1$I$$20240813$20240818$20240818$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046130$BOEHRINGER INGELHEIM$$$$$$Y$$$20240818$$HP$US$US
242206331$24220633$1$I$20240607$20240808$20240818$20240818$EXP$FR-AFSSAPS-LY2024000956$FR-TEVA-VS-3232420$TEVA$$66$YR$$F$Y$47.6$KG$20240818$$PH$FR$FR
242206341$24220634$1$I$20240709$20240808$20240818$20240818$EXP$IT-MINISAL02-996900$IT-TEVA-VS-3232434$TEVA$$6$YR$$M$Y$25$KG$20240818$$PH$IT$IT
242206351$24220635$1$I$20240710$20240808$20240818$20240818$EXP$IT-MINISAL02-996325$IT-TEVA-VS-3232411$TEVA$$52$YR$$M$Y$$$20240818$$MD$IT$IT
242206361$24220636$1$I$20240201$20240812$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408008933$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240818$$CN$US$US
242206371$24220637$1$I$20240701$20240808$20240818$20240818$EXP$FR-AFSSAPS-MA2024001288$FR-TEVA-VS-3232390$TEVA$$45$YR$$M$Y$$$20240818$$MD$FR$FR
242206381$24220638$1$I$20240723$20240808$20240818$20240818$EXP$FR-AFSSAPS-LY2024001194$FR-TEVA-VS-3232424$TEVA$$27$YR$$M$Y$$$20240818$$MD$FR$FR
242206391$24220639$1$I$20240711$20240808$20240818$20240818$EXP$FR-AFSSAPS-CF2024000397$FR-TEVA-VS-3232399$TEVA$$29$YR$$F$Y$53.7$KG$20240818$$PH$FR$FR
242206401$24220640$1$I$20240519$20240808$20240818$20240818$EXP$FR-AFSSAPS-CF2024000379$FR-TEVA-VS-3232387$TEVA$$70$YR$$M$Y$75.5$KG$20240818$$MD$FR$FR
242206411$24220641$1$I$$20240812$20240818$20240818$PER$$US-RDY-SPO/USA/24/0011786$DR REDDYS$$70$YR$E$F$Y$$$20240818$$CN$US$US
242206421$24220642$1$I$$20240814$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408009072$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240818$$CN$US$US
242206431$24220643$1$I$$20240814$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408009066$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240818$$CN$US$US
242206441$24220644$1$I$$20240814$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408009050$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240818$$CN$US$US
242206451$24220645$1$I$20240814$20240815$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408009861$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240818$$CN$US$US
242206461$24220646$1$I$$20240805$20240818$20240818$EXP$$AU-CIPLA LTD.-2024AU08737$CIPLA$$$$$$Y$$$20240818$$PH$AU$AU
242206471$24220647$1$I$$20240809$20240818$20240818$EXP$US-drreddys-USA/USA/15/0054682$US-RDY-USA/USA/15/0054682$DR REDDYS$Shaigany S, Dabela E, Husain S, Grossman ME. Herpetic zoster folliculitis in the immunocompromised host. JAAD Case Reports. 2015;1(1):38-40.$78$YR$E$M$Y$$$20240818$$MD$US$US
242206481$24220648$1$I$$20240807$20240818$20240818$PER$US-MLMSERVICE-20240805-PI149432-00306-4$US-RDY-SPO/USA/24/0011695$DR REDDYS$Dykes K, Tzachanis D, Koura D. A Difficult Case of Calcineurin Inhibitor Neurotoxicity Post-Haploidentical HCT With a Successful Novel Solution: Cytotoxic T-Lymphocyte-Associated Protein 4-Immunoglobulin Blockade for GVHD Prophylaxis. Cell transplantation. 2024;33:1-7. DOI: 10.1177/09636897241265249.$24$YR$A$M$Y$$$20240818$$MD$US$US
242206491$24220649$1$I$$20240808$20240818$20240818$PER$US-MLMSERVICE-20240801-PI150595-00073-1$US-RDY-SPO/USA/24/0011742$DR REDDYS$Braun HM, Taylor JL, Axelrath S. Buprenorphine/naloxone - one formulation that doesn^t fit all: a case report. Harm Reduction Journal. 2024;21(1):143. DOI: 10.1186/s12954-024-01054-2.$5$DEC$A$F$Y$$$20240818$$MD$US$US
242206501$24220650$1$I$$20240809$20240818$20240818$EXP$$US-RDY-LIT/USA/24/0011925$DR REDDYS$Wang KL, Crum OM, Swanson AA, Johnson EF. Cutaneous metastasis of uterine carcinosarcoma mimicking drug eruption. JAAD Case Reports. 2024 May;47: 44-46. doi:10.1016/j.jdcr.2024.03.006.$71$YR$E$F$Y$$$20240818$$HP$US$US
242206511$24220651$1$I$$20240812$20240818$20240818$EXP$$US-RDY-LIT/USA/24/0011926$DR REDDYS$Shaker N, Amadi CC, Welliver M, Otterson GA, Liebner DA, Shilo K. A Case of Mediastinal Carcinosarcoma With Beta-HCG Production and KRAS Mutation. International Journal of Surgical Pathology. 2023;31(8): 1598-1604. doi:10.1177/10668969231166297.$44$YR$A$F$Y$$$20240818$$MD$US$US
242206521$24220652$1$I$$20240805$20240818$20240818$EXP$$AU-CIPLA (EU) LIMITED-2024AU08740$CIPLA$Kamsani SH, Middeldorp ME, Chiang G, Stefil M, Evans S, Nguyen MT et al.. Safety of outpatient commencement of Sotalol. Heart rhythm O2. 2024;5:6:341 to 350$$$$$Y$$$20240818$$MD$AU$AU
242206531$24220653$1$I$$20240806$20240818$20240818$PER$$US-RDY-LIT/USA/24/0011770$DR REDDYS$Adams L, Darabad RR. Case Report on Chronic Shoulder Pain and Response to Peripheral Nerve Stimulation Twenty-Four Months After Placement. Pain Medicine Case Reports. 2024 May;8(4): 151-155.$82$YR$E$F$Y$$$20240818$$MD$US$US
242206541$24220654$1$I$$20240805$20240818$20240818$EXP$$AU-CIPLA LTD.-2024AU08744$CIPLA$McClatchy J, Yap T, Nirenberg A, Scardamaglia L.. Fixed drug eruptions-the common and novel culprits since 2000.. J-Dtsch-Dermatol-Ges.. 2022;20 (10):1289-1302$$$$$Y$$$20240818$$HP$AU$AU
242206551$24220655$1$I$$20240805$20240818$20240818$EXP$$AU-CIPLA LTD.-2024AU08747$CIPLA$Dhaliwal N, Roberts DM.. Clinical outcomes associated with Orphenadrine deliberate self-poisoning: A retrospective poisons centre study.. Clinical Toxicology.. 2024;62 (3):168 to 173$$$$$Y$$$20240818$$HP$AU$AU
242206561$24220656$1$I$20230502$20240805$20240818$20240818$EXP$$AU-CIPLA LTD.-2024AU08734$CIPLA$$$$$$Y$$$20240818$$HP$AU$AU
242206571$24220657$1$I$20180801$20240805$20240818$20240818$EXP$$AU-CIPLA LTD.-2024AU08735$CIPLA$$$$$$Y$$$20240818$$HP$AU$AU
242206581$24220658$1$I$20240813$20240814$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408009080$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240818$$CN$US$US
242206591$24220659$1$I$$20240805$20240818$20240818$EXP$$AU-CIPLA LTD.-2024AU08732$CIPLA$$$$$$Y$$$20240818$$CN$AU$AU
242206602$24220660$2$F$$20240819$20240818$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009231$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240821$$PH$US$US
242206611$24220661$1$I$20240101$20240808$20240818$20240818$PER$$US-SA-2024SA240726$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240818$$CN$US$US
242206621$24220662$1$I$$20240809$20240818$20240818$EXP$US-drreddys-USA/USA/18/0099334$US-RDY-USA/USA/18/0099334$DR REDDYS$Velez MG, Suero-Abreu G, Duma N, Gutierrez M, Singh TP. Immune-related myocarditis and conduction abnormalities secondary to combination immunotherapy treatment with ipilimumab/nivolumab in a patient with merkel cell carcinoma. Journal of the American College of Cardiology. 2018;71(11): doi:10.1016/S0735-1097(18)33158-9.$69$YR$E$F$Y$$$20240818$$HP$US$US
242206631$24220663$1$I$20240101$20240807$20240818$20240818$PER$$US-JNJFOC-20240822966$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240818$$CN$US$US
242206641$24220664$1$I$$20240808$20240818$20240818$EXP$$IN-RDY-LIT/IND/24/0011913$DR REDDYS$Trivedi M, Mehta RD, Ghiya BC, Soni P. Impact of Chemotherapy-Induced Nail Changes on Quality of Life: A Cross-Sectional Study from a Tertiary Care Centre. Indian Journal of Dermatology. 2024;69(3): 205-211. doi:10.4103/ijd.ijd_723_22.$$$$$Y$$$20240818$$HP$IN$IN
242206652$24220665$2$F$20240101$20240813$20240818$20240826$EXP$$US-CIPLA LTD.-2024US08657$CIPLA$$$$$$Y$$$20240826$$CN$US$US
242206661$24220666$1$I$$20240805$20240818$20240818$EXP$$US-CIPLA LTD.-2024US08131$CIPLA$Thor DC, Patel K, Singh M.. Navigation of a new-onset pulmonary embolism in a patient receiving female-to-male gender-affirming care: A case report.. Cureus. 2024;16 (6): e63101$$$$$Y$$$20240818$$MD$US$US
242206671$24220667$1$I$20240720$20240805$20240818$20240818$EXP$$FR-CIPLA LTD.-2024FR08609$CIPLA$$$$$$Y$$$20240818$$CN$FR$FR
242206683$24220668$3$F$20240101$20240918$20240818$20240926$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000713$DECIPHERA PHARMACEUTICALS$$45$YR$A$M$Y$$$20240926$$CN$US$US
242206691$24220669$1$I$20240808$20240808$20240818$20240818$30DAY$$US-GSK-US2024099271$GLAXOSMITHKLINE$$79$YR$$M$Y$$$20240818$$CN$US$US
242206701$24220670$1$I$20141001$20240813$20240818$20240818$EXP$$ES-ABBVIE-1801552US$ABBVIE$Ruiz De Morales, J. Successful treatment of common variable immunodeficiency-associated inflammatory bowel disease with Ustekinumab. Journal of Crohn^s and Colitis. 2017; 11(9):1154-1155.; Ruiz De Morales, J., Munoz, F. and Hernando, M.. Successful treatment of common variable immunodeficiency-associated inflammatory bowel disease with Ustekinumab. Journal of Crohns and Colitis. 2017;11(9):1154-1155; Ruiz de Morales JG, Munoz F, Hernando M. Successful treatment of common variable immunodefici...$60$YR$$M$Y$$$20240818$$MD$ES$ES
242206711$24220671$1$I$$20240808$20240818$20240818$30DAY$$US-GSK-US2024AMR099989$GLAXOSMITHKLINE$$$$$M$Y$$$20240818$$CN$US$US
242206721$24220672$1$I$$20240816$20240818$20240818$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046348$BOEHRINGER INGELHEIM$$$$$$Y$$$20240818$$CN$US$US
242206731$24220673$1$I$$20240815$20240818$20240818$EXP$$TR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045964$BOEHRINGER INGELHEIM$Ekimci Deniz F, Onur B, S?kmen N. Unilateral Painless Vision Loss Detected Incidentally During the Driver^s Health Examination at the Family Medicine Polyclinic: Case Report. A?r? Med J. 2024;(2(2)): 77-79.$48$YR$A$M$Y$$$20240818$$MD$TR$TR
242206741$24220674$1$I$20240301$20240815$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408010959$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240818$$CN$US$US
242206752$24220675$2$F$20240809$20240821$20240818$20240823$PER$$US-AMGEN-USASP2024160938$AMGEN$$65$YR$E$F$Y$$$20240823$$CN$US$US
242206761$24220676$1$I$20240812$20240814$20240818$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129465$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240818$$HP$US$US
242206771$24220677$1$I$$20240814$20240818$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129493$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240818$$HP$US$US
242206781$24220678$1$I$$20240812$20240818$20240818$PER$$US-SA-2024SA242384$SANOFI AVENTIS$$$$$$Y$$$20240818$$HP$US$US
242206792$24220679$2$F$$20240808$20240818$20240821$EXP$$JP-Eisai-EC-2024-171925$EISAI$$60$YR$A$F$Y$$$20240821$$PH$JP$JP
242206801$24220680$1$I$20240805$20240809$20240818$20240818$PER$$GB-Eisai-EC-2024-172204$EISAI$$37$YR$A$F$Y$55.6$KG$20240818$$PH$GB$GB
242206811$24220681$1$I$$20240812$20240818$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129284$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240818$$HP$US$US
242206831$24220683$1$I$20240501$20240813$20240818$20240818$EXP$FR-AFSSAPS-TS2024000891$FR-SA-2024SA241114$SANOFI AVENTIS$$72$YR$E$M$Y$64$KG$20240818$$MD$FR$FR
242206911$24220691$1$I$$20240815$20240818$20240818$EXP$$US-AstraZeneca-2024A187253$ASTRAZENECA$$$$$F$Y$$$20240818$$HP$US$
242206951$24220695$1$I$20240807$20240809$20240818$20240818$PER$$US-BIOGEN-2024BI01277911$BIOGEN$$20$YR$$F$Y$$$20240818$$CN$US$US
242207031$24220703$1$I$20240101$20240807$20240818$20240818$PER$$US-SA-2024SA236340$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240819$$MD$US$US
242207161$24220716$1$I$$20240806$20240818$20240818$EXP$$US-SMPA-2024SPA000959$SUNOVION$$$$$$Y$$$20240818$$CN$US$US
242207191$24220719$1$I$$20240805$20240818$20240818$EXP$$US-SMPA-2024SPA000877$SUNOVION$$$$$$Y$$$20240818$$CN$US$US
242207202$24220720$2$F$$20240805$20240818$20240822$EXP$$US-SMPA-2024SPA000860$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242207211$24220721$1$I$$20240805$20240818$20240818$EXP$$US-SMPA-2024SPA000892$SUNOVION$$$$$$Y$$$20240818$$CN$US$US
242207221$24220722$1$I$$20240805$20240818$20240818$EXP$$US-SMPA-2024SPA000828$SUNOVION$$$$$$Y$$$20240818$$CN$US$US
242207251$24220725$1$I$$20240813$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408009693$ELI LILLY AND CO$$$$A$M$Y$117.91$KG$20240818$$CN$US$US
242207321$24220732$1$I$20240814$20240814$20240818$20240818$PER$$US-AMGEN-USASP2024162550$AMGEN$$70$YR$E$F$Y$$$20240818$$CN$US$US
242207331$24220733$1$I$20240801$20240814$20240818$20240818$EXP$$JP-SAKK-2024SA240980AA$SANOFI AVENTIS$$$$$$Y$$$20240819$$PH$JP$JP
242207341$24220734$1$I$$20240816$20240818$20240818$EXP$$AU-SANDOZ INC.-SDZ2024AU073218$SANDOZ$$$$$$Y$$$20240818$$HP$AU$AU
242207351$24220735$1$I$$20240813$20240818$20240818$EXP$$CA-BIOGEN-2024BI01278353$BIOGEN$$81$YR$$M$Y$$$20240818$$PH$CA$CA
242207362$24220736$2$F$20240530$20240821$20240818$20240824$EXP$PT-INFARMED-V202408-268$PT-JNJFOC-20240842488$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240824$$PH$PT$PT
242207371$24220737$1$I$$20240813$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408008656$ELI LILLY AND CO$$25$YR$A$M$Y$$$20240818$$CN$US$US
242207382$24220738$2$F$20240813$20240918$20240818$20240922$EXP$$JP-JNJFOC-20240841222$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240923$$MD$JP$JP
242207391$24220739$1$I$$20240814$20240818$20240818$PER$$US-AMGEN-USASP2024162493$AMGEN$$$$$M$Y$$$20240818$$CN$US$US
242207401$24220740$1$I$20240811$20240813$20240818$20240818$EXP$$HU-ABBVIE-5883261$ABBVIE$$57$YR$$M$Y$$$20240818$$MD$HU$HU
242207412$24220741$2$F$20240801$20240924$20240818$20240930$EXP$$JP-BEH-2024177008$CSL BEHRING$$55$YR$A$M$Y$68.2$KG$20240930$$PH$JP$JP
242207422$24220742$2$F$20240815$20240820$20240818$20240826$PER$$US-AMGEN-USASP2024163876$AMGEN$$71$YR$E$F$Y$$$20240825$$CN$US$US
242207431$24220743$1$I$20240808$20240808$20240818$20240818$EXP$$PR-ABBVIE-5874297$ABBVIE$$62$YR$$M$Y$$$20240818$$CN$PR$PR
242207442$24220744$2$F$20240813$20240820$20240818$20240823$PER$$US-ABBVIE-5882069$ABBVIE$$23$YR$$F$Y$$$20240823$$MD$US$US
242207452$24220745$2$F$$20240822$20240818$20240825$EXP$$GB-JNJFOC-20240841889$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240826$$HP$GB$GB
242207461$24220746$1$I$$20240809$20240818$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130180$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240819$$HP$US$US
242207472$24220747$2$F$$20240820$20240818$20240829$EXP$$US-BAUSCHBL-2024BNL031563$BAUSCH AND LOMB$$$$$M$Y$$$20240829$$CN$US$US
242207481$24220748$1$I$20240813$20240814$20240818$20240818$PER$$US-AMGEN-USASP2024162526$AMGEN$$$$$$Y$$$20240818$$PH$US$US
242207491$24220749$1$I$$20240812$20240818$20240818$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127729$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240819$$CN$US$US
242207501$24220750$1$I$20240101$20240814$20240818$20240818$EXP$DK-DKMA-30737457$DK-JNJFOC-20240843047$JOHNSON AND JOHNSON$$56$YR$A$M$Y$83$KG$20240819$$MD$DK$DK
242207531$24220753$1$I$20240808$20240808$20240818$20240818$PER$$US-BAUSCHBL-2024BNL031409$BAUSCH AND LOMB$$$$$F$Y$$$20240819$$CN$US$US
242207541$24220754$1$I$$20240813$20240818$20240818$EXP$$DE-JNJFOC-20240843326$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$CN$DE$DE
242207551$24220755$1$I$20170401$20240813$20240818$20240818$EXP$$ES-SANDOZ INC.-PHHY2019ES065684$SANDOZ$$45$YR$$M$Y$$$20240818$$MD$ES$ES
242207561$24220756$1$I$20240701$20240802$20240818$20240818$PER$$US-BAUSCHBL-2024BNL031190$BAUSCH AND LOMB$$83$YR$$F$Y$$$20240819$$CN$US$US
242207571$24220757$1$I$20240421$20240816$20240818$20240818$EXP$FR-AFSSAPS-LY2024001091$FR-JNJFOC-20240845493$JOHNSON AND JOHNSON$$83$YR$E$M$Y$60$KG$20240819$$HP$FR$FR
242207581$24220758$1$I$20240701$20240807$20240818$20240818$PER$$US-BAUSCHBL-2024BNL031439$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240819$$CN$US$US
242207591$24220759$1$I$20240713$20240810$20240818$20240818$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160573$JIANGSU HENGRUI MEDICINE$$62$YR$$F$Y$70$KG$20240818$$MD$CN$CN
242207601$24220760$1$I$$20240812$20240818$20240818$PER$$US-JNJFOC-20240828524$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240819$$HP$US$US
242207611$24220761$1$I$$20240809$20240818$20240818$EXP$$AR-AMGEN-ARGSP2024152068$AMGEN$$67$YR$E$F$Y$$$20240818$$CN$AR$AR
242207621$24220762$1$I$20240701$20240812$20240818$20240818$EXP$$US-ABBVIE-5863647$ABBVIE$$65$YR$$F$Y$82.1$KG$20240818$$CN$US$US
242207632$24220763$2$F$20240803$20240821$20240818$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126911$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240823$$HP$US$US
242207641$24220764$1$I$$20240814$20240818$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130080$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240819$$CN$US$US
242207661$24220766$1$I$20240813$20240814$20240818$20240818$PER$$US-JNJFOC-20240837333$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20240819$$HP$US$US
242207673$24220767$3$F$20240807$20240916$20240818$20240926$PER$$US-JNJFOC-20240818658$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240926$$CN$US$US
242207681$24220768$1$I$$20240813$20240818$20240818$EXP$NO-NOMAADVRE-PASRAPP-2024-Vakxz6$NO-JNJFOC-20240844014$JOHNSON AND JOHNSON$$25$YR$A$M$Y$78$KG$20240819$$CN$NO$NO
242207691$24220769$1$I$$20240814$20240818$20240818$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130120$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240819$$CN$US$US
242207701$24220770$1$I$20240101$20240813$20240818$20240818$EXP$$US-ABBVIE-5880487$ABBVIE$$$$$F$Y$$$20240818$$CN$US$US
242207711$24220771$1$I$$20240814$20240818$20240818$EXP$$US-ABBVIE-5881824$ABBVIE$$$$$F$Y$$$20240818$$CN$US$US
242207721$24220772$1$I$20240101$20240814$20240818$20240818$EXP$$US-ABBVIE-5881969$ABBVIE$$$$$F$Y$$$20240818$$CN$US$US
242207731$24220773$1$I$$20240807$20240818$20240818$EXP$$IT-OrBion Pharmaceuticals Private Limited-2160574$ORBION PHARMACEUTICALS$Fiori L, Tagi VM, Montanari C, Gambino M, Carlevatti V, Zizzo C, D^Auria E, Dilillo D, Verduci E, Zuccotti G. Desensitization of olipudase alfa-induced anaphylaxis in a child with chronic neurovisceral acid sphingomyelinase deficiency. Mol Genet Metab Rep. 2024 Jul 17;40:101120. doi: 10.1016/j.ymgmr.2024.101120.$15$MON$$$Y$$$20240818$$MD$IT$IT
242207741$24220774$1$I$20240801$20240813$20240818$20240818$EXP$$BR-ABBVIE-5880935$ABBVIE$$79$YR$$M$Y$80$KG$20240818$$CN$BR$BR
242207751$24220775$1$I$20240812$20240813$20240818$20240818$PER$$US-SA-2024SA242373$SANOFI AVENTIS$$$$$$Y$$$20240819$$MD$US$US
242207761$24220776$1$I$$20240809$20240818$20240818$PER$$US-SA-2024SA063453$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240819$$MD$US$US
242207774$24220777$4$F$$20240911$20240818$20240921$EXP$$US-ABBVIE-5881983$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
242207781$24220778$1$I$20240101$20240815$20240818$20240818$EXP$$CA-ABBVIE-5722440$ABBVIE$$$$E$M$Y$$$20240818$$HP$CA$CA
242207791$24220779$1$I$$20240807$20240818$20240818$EXP$$US-OrBion Pharmaceuticals Private Limited-2160575$ORBION PHARMACEUTICALS$Acuff KN, Villatoro GA, Baxter SL. Acute Bilateral Periorbital Edema in a Psychiatric Patient. JAMA Ophthalmol. 2024 Aug 1. doi: 10.1001/jamaophthalmol.2024.2815.$$$$$Y$$$20240818$$MD$US$US
242207813$24220781$3$F$$20240829$20240818$20240903$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046374$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240903$$CN$US$US
242207821$24220782$1$I$$20240815$20240818$20240818$EXP$$US-ABBVIE-5883429$ABBVIE$$$$$M$Y$$$20240818$$CN$US$US
242207831$24220783$1$I$20240727$20240809$20240818$20240818$EXP$$US-GSK-US2024AMR101541$GLAXOSMITHKLINE$$32$YR$$F$Y$124$KG$20240818$$CN$US$US
242207841$24220784$1$I$$20240807$20240818$20240818$EXP$$DE-OrBion Pharmaceuticals Private Limited-2160576$ORBION PHARMACEUTICALS$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 2023 Apr; 107:107-113. doi: 10.1016/j.seizure.2023.02.015.$$$$$Y$$$20240818$$MD$DE$DE
242207851$24220785$1$I$$20240807$20240818$20240818$EXP$$DE-OrBion Pharmaceuticals Private Limited-2160577$ORBION PHARMACEUTICALS$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 2023 Apr;107:107-113. doi: 10.1016/j.seizure.2023.02.015.$4$DY$$$Y$$$20240818$$MD$DE$DE
242207861$24220786$1$I$20240212$20240815$20240818$20240818$EXP$$CN-JNJFOC-20240842326$JOHNSON AND JOHNSON$$87$YR$E$F$Y$50$KG$20240819$$HP$CN$CN
242207871$24220787$1$I$$20240811$20240818$20240818$PER$$US-JNJFOC-20240830813$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$US$US
242207881$24220788$1$I$$20240805$20240818$20240818$PER$$US-BAUSCHBL-2024BNL031201$BAUSCH AND LOMB$$$$$M$Y$$$20240819$$CN$US$US
242207891$24220789$1$I$$20240806$20240818$20240818$PER$$US-BAUSCHBL-2024BNL031272$BAUSCH AND LOMB$$$$$F$Y$$$20240819$$CN$US$US
242207902$24220790$2$F$20240701$20240830$20240818$20240909$PER$$US-BAUSCHBL-2024BNL031354$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240910$$CN$US$US
242207912$24220791$2$F$$20240830$20240818$20240909$PER$$US-BAUSCHBL-2024BNL031313$BAUSCH AND LOMB$$$$$F$Y$$$20240910$$CN$US$US
242207921$24220792$1$I$$20240807$20240818$20240818$PER$$US-BAUSCHBL-2024BNL031368$BAUSCH AND LOMB$$$$$F$Y$$$20240819$$CN$US$US
242207931$24220793$1$I$$20240807$20240818$20240818$EXP$$DE-OrBion Pharmaceuticals Private Limited-2160578$ORBION PHARMACEUTICALS$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 2023 Apr;107:107-113. doi: 10.1016/j.seizure.2023.02.015.$4$DY$$$Y$$$20240818$$MD$DE$DE
242207941$24220794$1$I$$20240806$20240818$20240818$PER$$US-BAUSCHBL-2024BNL031257$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240819$$CN$US$US
242207951$24220795$1$I$$20240808$20240818$20240818$PER$$US-BAUSCHBL-2024BNL031355$BAUSCH AND LOMB$$$$$M$Y$$$20240819$$CN$US$US
242207961$24220796$1$I$$20240807$20240818$20240818$EXP$$LB-OrBion Pharmaceuticals Private Limited-2160579$ORBION PHARMACEUTICALS$Salem J, Fares F, El-Haddad R, Fares M, El Helou G. Legionella lymphadenitis in immunocompetent adult: Case report. ID Cases 2024 Jul 2; 37:e02023. doi: 10.1016/j.idcr.2024.e02023.$53$YR$$F$Y$$$20240818$$MD$LB$LB
242207971$24220797$1$I$20240201$20240619$20240818$20240818$PER$$US-ABBVIE-5882225$ABBVIE$$84$YR$$F$Y$$$20240818$$CN$US$US
242207981$24220798$1$I$20240101$20240812$20240818$20240818$EXP$$US-ABBVIE-5878079$ABBVIE$$$$$F$Y$$$20240818$$CN$US$US
242207991$24220799$1$I$20240501$20240808$20240818$20240818$PER$$US-BAUSCHBL-2024BNL031511$BAUSCH AND LOMB$$61$YR$$M$Y$83.91$KG$20240819$$CN$US$US
242208001$24220800$1$I$$20240807$20240818$20240818$PER$$US-BAUSCHBL-2024BNL031467$BAUSCH AND LOMB$$$$$F$Y$$$20240819$$CN$US$US
242208011$24220801$1$I$$20240813$20240818$20240818$PER$$US-SA-2024SA241779$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240819$$MD$US$US
242208021$24220802$1$I$20240101$20240808$20240818$20240818$PER$$US-ABBVIE-5874211$ABBVIE$$$$$$Y$$$20240818$$CN$US$US
242208031$24220803$1$I$$20240812$20240818$20240818$PER$$US-AstraZeneca-2024A183719$ASTRAZENECA$$$$$$Y$$$20240819$$MD$US$
242208041$24220804$1$I$$20240809$20240818$20240818$EXP$$US-JNJFOC-20240825494$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
242208051$24220805$1$I$20240803$20240815$20240818$20240818$EXP$$CN-BEIGENE-BGN-2024-012801$BEIGENE$$$$$$Y$$$20240818$$HP$CN$CN
242208061$24220806$1$I$20240201$20240814$20240818$20240818$EXP$$BR-ABBVIE-5882528$ABBVIE$$30$YR$$M$Y$78$KG$20240818$$CN$BR$BR
242208071$24220807$1$I$$20231031$20240818$20240818$EXP$$EG-JNJFOC-20240828266$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240819$$CN$EG$EG
242208081$24220808$1$I$$20240815$20240818$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130226$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240819$$CN$US$US
242208091$24220809$1$I$20240101$20240813$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408008493$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240818$$CN$US$US
242208102$24220810$2$F$20240722$20240823$20240818$20240830$EXP$$BE-JNJFOC-20240826494$JOHNSON AND JOHNSON$$71$YR$E$M$Y$57$KG$20240830$$MD$BE$BE
242208111$24220811$1$I$20240112$20240812$20240818$20240818$EXP$FR-AFSSAPS-NT2024001025$FR-AMGEN-FRASP2024162884$AMGEN$$16$YR$T$F$Y$46$KG$20240818$$MD$FR$FR
242208121$24220812$1$I$20240809$20240814$20240818$20240818$EXP$$GB-AMGEN-GBRSP2024162956$AMGEN$$77$YR$E$F$Y$$$20240818$$CN$GB$GB
242208131$24220813$1$I$$20240812$20240818$20240818$EXP$$US-JNJFOC-20240835266$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$MD$US$US
242208151$24220815$1$I$20240801$20240810$20240818$20240818$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127093$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240819$$PH$US$US
242208161$24220816$1$I$$20240809$20240818$20240818$30DAY$$US-GSK-US2023160019$GLAXOSMITHKLINE$$$$$F$Y$$$20240818$$CN$US$US
242208171$24220817$1$I$20240201$20240815$20240818$20240818$EXP$FR-AFSSAPS-BR2024000668$FR-JNJFOC-20240845085$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240819$$PH$FR$FR
242208181$24220818$1$I$20240101$20240814$20240818$20240818$EXP$$US-ABBVIE-5882382$ABBVIE$$$$$M$Y$$$20240818$$CN$US$US
242208191$24220819$1$I$$20240814$20240818$20240818$PER$$US-ABBVIE-5881507$ABBVIE$$$$$F$Y$$$20240818$$CN$US$US
242208201$24220820$1$I$$20240814$20240818$20240818$EXP$$US-ABBVIE-5882515$ABBVIE$$$$$M$Y$$$20240818$$CN$US$US
242208211$24220821$1$I$20240101$20240813$20240818$20240818$EXP$$CA-ABBVIE-5881164$ABBVIE$$47$YR$$F$Y$$$20240818$$CN$CA$CA
242208221$24220822$1$I$20240727$20240813$20240818$20240818$PER$$US-AMGEN-USASP2024161471$AMGEN$$77$YR$E$F$Y$$$20240818$$CN$US$US
242208231$24220823$1$I$$20240808$20240818$20240818$PER$$US-SA-2024SA239882$SANOFI AVENTIS$$$$A$F$Y$$$20240819$$MD$US$US
242208241$24220824$1$I$$20240814$20240818$20240818$EXP$$ZA-AstraZeneca-2024A185738$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$ZA$
242208251$24220825$1$I$$20240814$20240818$20240818$EXP$$ZA-AstraZeneca-2024A185786$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$ZA$
242208262$24220826$2$F$20240701$20240909$20240818$20240918$EXP$PT-INFARMED-F202408-59$PT-ROCHE-10000056156$ROCHE$$49$YR$A$F$Y$68$KG$20240918$$PH$PT$PT
242208271$24220827$1$I$$20240809$20240818$20240818$PER$$US-HALEON-2191516$Haleon PLC$$$$$F$Y$$$20240818$$CN$US$US
242208281$24220828$1$I$20240813$20240813$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408009427$ELI LILLY AND CO$$$$$$Y$$$20240818$$CN$US$US
242208292$24220829$2$F$$20240827$20240818$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408010035$ELI LILLY AND CO$$$$$$Y$$$20240830$$CN$US$US
242208301$24220830$1$I$$20240815$20240818$20240818$EXP$$NVSC2024US166552$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242208321$24220832$1$I$$20240815$20240818$20240818$PER$$US-ELI_LILLY_AND_COMPANY-US202408010993$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240818$$CN$US$US
242208331$24220833$1$I$$20240812$20240818$20240818$EXP$$EG-ROCHE-10000055786$ROCHE$Nassar Y, Mokhtar A, Elhadidy A, Abdelfattah M, Mostafa F, Rady A, et al. Tocilizumab Therapy in Critically Ill Patients with Coronavirus Disease-2019 Pneumonia  A Propensity Score Adjusted Analysis. Open Access Macedonian Journal of Medical Sciences. 2023-Jan;11 (B):480-488. doi:10.3889/oamjms.2023.10987.$$$$$Y$$$20240819$$HP$EG$EG
242208341$24220834$1$I$$20240812$20240818$20240818$EXP$$CA-ROCHE-10000056152$ROCHE$$46$YR$A$F$Y$132$KG$20240819$$HP$CA$CA
242208351$24220835$1$I$20240701$20240812$20240818$20240818$EXP$FR-AFSSAPS-LM2024000427$FR-ROCHE-10000055627$ROCHE$$74$YR$E$M$Y$$$20240819$$MD$FR$FR
242208362$24220836$2$F$$20240903$20240818$20240903$PER$$US-ALXN-202408USA000748US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242208381$24220838$1$I$$20240814$20240818$20240818$EXP$$GB-AMGEN-GBRSP2024162955$AMGEN$$89$YR$E$F$Y$$$20240818$$CN$GB$GB
242208391$24220839$1$I$$20240618$20240818$20240818$EXP$$GB-TEVA-VS-3222414$TEVA$$51$YR$$F$Y$$$20240818$$CN$GB$GB
242208401$24220840$1$I$$20240812$20240818$20240818$EXP$$US-ROCHE-10000055924$ROCHE$$84$YR$E$F$Y$$$20240819$$CN$US$US
242208411$24220841$1$I$$20240812$20240818$20240818$PER$$US-ROCHE-10000056482$ROCHE$$$$A$F$Y$83.01$KG$20240819$$CN$US$US
242208421$24220842$1$I$$20240813$20240818$20240818$PER$$US-SA-2024SA242271$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240819$$PH$US$US
242208431$24220843$1$I$20240501$20240809$20240818$20240818$PER$$US-SA-2024SA241395$SANOFI AVENTIS$$11$YR$C$M$Y$31$KG$20240819$$MD$US$US
242208441$24220844$1$I$20240811$20240815$20240818$20240818$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130123$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240819$$CN$US$US
242208452$24220845$2$F$20240712$20240812$20240818$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127799$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$76.66$KG$20240827$$PH$US$US
242208461$24220846$1$I$20240801$20240815$20240818$20240818$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046246$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240819$$CN$US$US
242208471$24220847$1$I$$20240813$20240818$20240818$EXP$$US-ROCHE-10000056797$ROCHE$$83$YR$E$F$Y$$$20240819$$CN$US$US
242208481$24220848$1$I$20231001$20240813$20240818$20240818$EXP$FR-AFSSAPS-PA2024001313$FR-ROCHE-10000056544$ROCHE$$74$YR$E$F$Y$63$KG$20240819$$PH$FR$FR
242208491$24220849$1$I$20240814$20240814$20240818$20240818$PER$$US-009507513-2408USA004970$MERCK$$$$$$Y$$$20240818$$CN$US$US
242208501$24220850$1$I$$20240814$20240818$20240818$PER$$US-ROCHE-10000057908$ROCHE$$$$E$F$Y$$$20240819$$CN$US$US
242208514$24220851$4$F$20240701$20240814$20240818$20240823$PER$$US-ROCHE-10000056210$ROCHE$$75$YR$E$F$Y$62.6$KG$20240823$$HP$US$US
242208521$24220852$1$I$$20240814$20240818$20240818$PER$$US-ROCHE-10000057920$ROCHE$$$$A$F$Y$$$20240819$$CN$US$US
242208542$24220854$2$F$$20240918$20240818$20240921$PER$$US-ROCHE-10000054424$ROCHE$$73$YR$E$F$Y$$$20240921$$CN$US$US
242208552$24220855$2$F$$20240919$20240818$20240923$PER$$US-ROCHE-10000058548$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
242208562$24220856$2$F$$20240918$20240818$20240921$EXP$$US-ABBVIE-5855756$ABBVIE$$$$$F$Y$79.379$KG$20240921$$CN$US$US
242208572$24220857$2$F$$20240906$20240818$20240906$PER$$US-ALXN-202408USA000680US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242208581$24220858$1$I$$20240812$20240818$20240818$PER$$US-ALXN-202408USA000730US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
242208591$24220859$1$I$$20240813$20240818$20240818$PER$$US-ROCHE-10000057105$ROCHE$$$$$$Y$$$20240819$$MD$US$US
242208601$24220860$1$I$$20240814$20240818$20240818$EXP$$US-ABBVIE-5881847$ABBVIE$$$$$M$Y$$$20240818$$CN$US$US
242208611$24220861$1$I$20240807$20240813$20240819$20240819$EXP$$US-ABBVIE-5880772$ABBVIE$$65$YR$$F$Y$$$20240819$$CN$US$US
242208621$24220862$1$I$$20240812$20240819$20240819$EXP$$VN-AstraZeneca-2024A185594$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$VN$
242208631$24220863$1$I$$20240815$20240819$20240819$PER$$US-AstraZeneca-2024A186863$ASTRAZENECA$$$$A$F$Y$$$20240819$$MD$US$
242208643$24220864$3$F$20240101$20240824$20240819$20240831$EXP$$JP-GENMAB-2024-00768AA$GENMAB$$60$YR$$F$Y$$$20240831$$MD$JP$JP
242208661$24220866$1$I$$20240813$20240819$20240819$EXP$$US-ABBVIE-5880579$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242208671$24220867$1$I$20230101$20240813$20240819$20240819$EXP$$US-ABBVIE-5334062$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242208681$24220868$1$I$20240101$20240812$20240819$20240819$EXP$$US-JNJFOC-20240836934$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240819$$HP$US$US
242208691$24220869$1$I$$20240812$20240819$20240819$EXP$$CA-JNJFOC-20240832702$JOHNSON AND JOHNSON$$6$YR$C$M$Y$36$KG$20240819$$PH$CA$CA
242208703$24220870$3$F$20240801$20240830$20240819$20240903$EXP$$US-ABBVIE-5882059$ABBVIE$$62$YR$$F$Y$$$20240903$$CN$US$US
242208711$24220871$1$I$$20240814$20240819$20240819$PER$$US-ROCHE-10000057909$ROCHE$$60$YR$A$F$Y$$$20240819$$CN$US$US
242208721$24220872$1$I$20240801$20240814$20240819$20240819$EXP$$US-ABBVIE-5882421$ABBVIE$$73$YR$$M$Y$$$20240819$$CN$US$US
242208731$24220873$1$I$$20240814$20240819$20240819$EXP$$US-ABBVIE-5881663$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242208741$24220874$1$I$20240601$20240814$20240819$20240819$EXP$$US-ABBVIE-5881376$ABBVIE$$65$YR$$F$Y$$$20240819$$CN$US$US
242208751$24220875$1$I$20240601$20240812$20240819$20240819$EXP$$CN-ABBVIE-5878152$ABBVIE$$59$YR$$F$Y$45$KG$20240819$$MD$CN$CN
242208762$24220876$2$F$20240802$20240805$20240819$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-125413$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240819$$CN$JP$JP
242208781$24220878$1$I$20240101$20240814$20240819$20240819$EXP$$RO-ABBVIE-5883023$ABBVIE$$77$YR$$M$Y$$$20240819$$CN$RO$RO
242208791$24220879$1$I$$20240812$20240819$20240819$PER$$US-ALXN-202408USA000685US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
242208803$24220880$3$F$20240101$20240828$20240819$20240904$EXP$$CH-ABBVIE-5859890$ABBVIE$$$$$F$Y$$$20240904$$HP$CH$CH
242208811$24220881$1$I$20240510$20240812$20240819$20240819$EXP$$CO-JNJFOC-20240832650$JOHNSON AND JOHNSON$$27$YR$A$M$Y$86$KG$20240819$$HP$CO$CO
242208823$24220882$3$F$20240801$20240822$20240819$20240828$EXP$$BR-GENMAB-2024-02977$GENMAB$$$$$M$Y$$$20240828$$MD$BR$BR
242208831$24220883$1$I$$20240812$20240819$20240819$EXP$$US-ABBVIE-5787929$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242208841$24220884$1$I$20240811$20240812$20240819$20240819$PER$$US-AMGEN-USASP2024161461$AMGEN$$65$YR$E$M$Y$$$20240818$$HP$US$US
242208851$24220885$1$I$$20240813$20240819$20240819$EXP$$US-ABBVIE-5881016$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242208862$24220886$2$F$$20240913$20240819$20240923$PER$$US-SA-2024SA242331$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240923$$MD$US$US
242208871$24220887$1$I$$20240813$20240819$20240819$PER$$US-SA-2024SA242319$SANOFI AVENTIS$$$$$F$Y$$$20240819$$HP$US$US
242208881$24220888$1$I$$20240813$20240819$20240819$PER$$US-SA-2024SA242309$SANOFI AVENTIS$$$$$$Y$$$20240819$$HP$US$US
242208891$24220889$1$I$20240101$20240809$20240819$20240819$EXP$SE-SEMPA-2024-005902$SE-TAKEDA-2024TUS079970$TAKEDA$$28$YR$$F$Y$77$KG$20240819$$HP$SE$SE
242208901$24220890$1$I$20231124$20240814$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162731$AMGEN$$53$YR$A$M$Y$$$20240818$$PH$ES$ES
242208911$24220891$1$I$$20240808$20240819$20240819$PER$$US-ABBVIE-5874961$ABBVIE$$$$$$Y$$$20240819$$CN$US$US
242208921$24220892$1$I$20240101$20240813$20240819$20240819$EXP$$US-ABBVIE-5880178$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242208931$24220893$1$I$20220902$20221202$20240819$20240819$EXP$$US-AstraZeneca-2022A397775$ASTRAZENECA$$29171$DY$$M$Y$$$20240819$$CN$US$
242208941$24220894$1$I$$20230606$20240819$20240819$EXP$$US-AstraZeneca-2023A132496$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242208951$24220895$1$I$$20240725$20240819$20240819$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003992$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242208961$24220896$1$I$$20240725$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003991$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242208971$24220897$1$I$$20220429$20240819$20240819$EXP$$US-AstraZeneca-2022A150836$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242208981$24220898$1$I$20240802$20240813$20240819$20240819$PER$$US-SA-2024SA242353$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240819$$MD$US$US
242208991$24220899$1$I$$20240813$20240819$20240819$PER$$US-SA-2024SA242332$SANOFI AVENTIS$$$$$$Y$$$20240819$$HP$US$US
242209001$24220900$1$I$$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024161976$AMGEN$$$$$F$Y$$$20240818$$CN$US$US
242209011$24220901$1$I$20240201$20240813$20240819$20240819$PER$$US-SA-2024SA242355$SANOFI AVENTIS$$$$A$F$Y$$$20240819$$MD$US$US
242209021$24220902$1$I$20230301$20240805$20240819$20240819$EXP$$JP-AMGEN-JPNCT2024104223$AMGEN$Saitou Y, Miyate H, Sugai Y, Nakasato H, Miyasawa M. P-1-14 Case series study of medication-related osteonecrosis of the jaw (MRONJ) in the elderly with over 90 years old. The 2nd Annual Meeting of the Young Oral Surgeons Exchange Meeting. 2024;88$91$YR$E$F$Y$$$20240818$$MD$JP$JP
242209031$24220903$1$I$$20240725$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003994$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
242209041$24220904$1$I$$20240813$20240819$20240819$EXP$$US-AMGEN-USASL2024161594$AMGEN$$$$$F$Y$$$20240818$$CN$US$US
242209052$24220905$2$F$20240101$20240816$20240819$20240823$EXP$$US-ABBVIE-5880797$ABBVIE$$70$YR$$M$Y$96$KG$20240823$$CN$US$US
242209061$24220906$1$I$$20240812$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127667$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$79.38$KG$20240819$$MD$US$US
242209071$24220907$1$I$$20240705$20240819$20240819$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008420$STRIDES$Kassels A, Edwards L, Kraus CN.. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series. JAAD-Case-Rep. 2023;40:14-18$$$$F$Y$$$20240819$$MD$US$US
242209081$24220908$1$I$$20230202$20240819$20240819$EXP$$US-AstraZeneca-2023A029312$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242209091$24220909$1$I$20240701$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A186011$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242209101$24220910$1$I$$20240801$20240819$20240819$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009913$STRIDES$Fakhraie S, Chovatiya R.. Janus Kinase Inhibition in the Treatment of Prurigo Nodularis.. Dermatitis. 2023;35 (3):299-300$5$DEC$$F$Y$$$20240819$$MD$US$US
242209111$24220911$1$I$$20240705$20240819$20240819$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008407$STRIDES$Sancillo R, Wickham J, DeMasters D.. A CASE OF RITUXIMAB RESCUE THERAPY IN CLASS V LUPUS NEPHRITIS WITH SEVERE HEMATOLOGICAL MANIFESTATIONS.. Am-J-Kidney-Dis. 2023;81 (Suppl.1)(4):S42-S43 abstr. 145.$2$DEC$$F$Y$$$20240819$$HP$US$US
242209121$24220912$1$I$$20230117$20240819$20240819$EXP$$US-AstraZeneca-2022A400517$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242209131$24220913$1$I$$20240725$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003997$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240819$$HP$US$US
242209151$24220915$1$I$$20240811$20240819$20240819$EXP$$AU-AstraZeneca-2024A186124$ASTRAZENECA$$$$$F$Y$$$20240819$$MD$AU$
242209161$24220916$1$I$$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A186049$ASTRAZENECA$$$$$F$Y$$$20240819$$MD$US$
242209171$24220917$1$I$$20230627$20240819$20240819$EXP$$US-AstraZeneca-2023A110396$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242209181$24220918$1$I$20240101$20240814$20240819$20240819$EXP$$US-ABBVIE-5882050$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242209191$24220919$1$I$$20240725$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003998$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242209204$24220920$4$F$$20240822$20240819$20240828$EXP$$US-ABBVIE-5882158$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242209211$24220921$1$I$$20240725$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003999$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242209221$24220922$1$I$$20240725$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004000$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
242209231$24220923$1$I$20240813$20240813$20240819$20240819$EXP$$FR-ABBVIE-5882275$ABBVIE$$60$YR$$M$Y$$$20240819$$MD$FR$FR
242209241$24220924$1$I$20240813$20240815$20240819$20240819$PER$$US-AMGEN-USASP2024163483$AMGEN$$21$YR$A$F$Y$$$20240818$$CN$US$US
242209251$24220925$1$I$$20240814$20240819$20240819$EXP$$US-ABBVIE-5881882$ABBVIE$$$$$F$Y$$$20240819$$HP$US$US
242209261$24220926$1$I$20230801$20240813$20240819$20240819$EXP$$US-ABBVIE-5880359$ABBVIE$$57$YR$$F$Y$$$20240819$$CN$US$US
242209282$24220928$2$F$20240730$20240813$20240819$20240821$30DAY$$US-GSK-US2024099658$GLAXOSMITHKLINE$$68$YR$$M$Y$$$20240821$$CN$US$US
242209303$24220930$3$F$$20240906$20240819$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004001$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242209312$24220931$2$F$20240801$20240902$20240819$20240909$EXP$$JP-SA-2024SA242062$SANOFI AVENTIS$$$$$F$Y$$$20240909$$MD$JP$JP
242209321$24220932$1$I$$20240725$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003134$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
242209331$24220933$1$I$$20240807$20240819$20240819$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP010236$STRIDES$Dasgupta S.. Letrozole-resistant PCOS: prevalence, further options and course of fertility treatment.. Hum-Reprod. 2024;39 (Suppl.):i104-i105 abstr. O-189.$$$A$F$Y$$$20240819$$HP$IN$IN
242209341$24220934$1$I$20070101$20240813$20240819$20240819$EXP$FR-EMA-DD-20240808-7483181-123026$FR-SANDOZ INC.-SDZ2024FR072353$SANDOZ$$46$YR$$M$Y$$$20240819$$HP$FR$FR
242209352$24220935$2$F$$20240813$20240819$20240822$EXP$$ES-AMGEN-ESPSP2024162870$AMGEN$Rodriguez-Cuadrado, F.. Multirefractory bullous pemphigoid, psoriasis and psoriatic arthritis successfully treated with guselkumab. Anais Brasileiros de Dermatologia. 2024;99(5):783-785$48$YR$A$M$Y$$$20240822$$MD$ES$ES
242209371$24220937$1$I$$20240808$20240819$20240819$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP010252$STRIDES$Teodosio Chicharo A, Lopes AR, Barreira S, Pinto L, Cruz-Machado AR, Capela S.. BIOSIMILARS IN BLOOM: MATERNAL AND PERINATAL OUTCOMES IN PREGNANT WOMEN WITH RHEUMATIC DISEASES TREATED WITH BIOSIMILAR TNF INHIBITORS.. Ann-Rheum-Dis. 2024;83 (Suppl.):2121-2122$29$YR$$F$Y$$$20240819$$HP$PT$PT
242209381$24220938$1$I$$20240808$20240819$20240819$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010246$STRIDES$Thomas LH, Lau D, Dave K.. Evaluating the process of initiating elexacaftor/tezacaftor/ivacaftor in lung transplant recipients and its effects on immunosuppression medication.. J-Cystic-Fibrosis. 2024;23 (Suppl. 1):S104 abstr. P160$$$$$Y$$$20240819$$HP$GB$GB
242209391$24220939$1$I$$20240808$20240819$20240819$EXP$$IL-STRIDES ARCOLAB LIMITED-2024SP010238$STRIDES$Shaklai S, Marcus-Perlman Y, Klein A, Stern N, Greenman Y.. De-Novo Graves Ophthalmopathy After Total Thyroidectomy With Exacerbation Following Rifampicin Therapy for Latent Tuberculosis: A Call for Attention to Disease Modifying Interventions.. J-Endocr-Soc. 2020;4 (Suppl. 1):A1125 abstr. SUN-LB87.$46$YR$$F$Y$$$20240819$$MD$IL$IL
242209401$24220940$1$I$$20240731$20240819$20240819$PER$$US-SERVIER-S24009900$SERVIER$$$$$$Y$$$20240819$$MD$US$US
242209411$24220941$1$I$20240722$20240812$20240819$20240819$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001630$BLUEPRINT MEDICINES$$26$YR$A$F$Y$$$20240819$$CN$US$US
242209422$24220942$2$F$20220101$20240820$20240819$20240822$EXP$$US-ABBVIE-5881978$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242209431$24220943$1$I$$20240808$20240819$20240819$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010268$STRIDES$Thomas LH, Lau D, Dave K.. Evaluating the process of initiating elexacaftor/tezacaftor/ivacaftor in lung transplant recipients and its effects on immunosuppression medication.. J-Cystic-Fibrosis. 2024;23 (Suppl. 1):S104 abstr. P160$$$$$Y$$$20240819$$HP$GB$GB
242209451$24220945$1$I$$20230806$20240819$20240819$EXP$$EG-JNJFOC-20240828479$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240819$$CN$EG$EG
242209462$24220946$2$F$$20240903$20240819$20240903$PER$$US-ALXN-202408USA000746US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242209471$24220947$1$I$20240815$20240816$20240819$20240819$EXP$GB-MHRA-MED-202408161703410070-KGNCW$GB-JNJFOC-20240843243$JOHNSON AND JOHNSON$$23$YR$A$M$Y$56$KG$20240819$$MD$GB$GB
242209491$24220949$1$I$$20240808$20240819$20240819$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010269$STRIDES$Thomas LH, Lau D, Dave K.. Evaluating the process of initiating elexacaftor/tezacaftor/ivacaftor in lung transplant recipients and its effects on immunosuppression medication.. J-Cystic-Fibrosis. 2024;23 (Suppl. 1):S104 abstr. P160$$$$$Y$$$20240819$$HP$GB$GB
242209511$24220951$1$I$$20230815$20240819$20240819$EXP$$US-AstraZeneca-2023A186915$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242209521$24220952$1$I$20240624$20240805$20240819$20240819$EXP$$FR-IBSA PHARMA INC.-2024IBS000372$IBSA INSTITUT BIOCHIMIQUE$$71$YR$$F$Y$94$KG$20240816$$MD$FR$FR
242209531$24220953$1$I$$20240813$20240819$20240819$EXP$$CA-ABBVIE-5882219$ABBVIE$$$$$M$Y$$$20240819$$HP$CA$CA
242209541$24220954$1$I$$20240814$20240819$20240819$EXP$$US-ABBVIE-5881891$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242209552$24220955$2$F$20240720$20240909$20240819$20240910$PER$$US-GILEAD-2024-0684286$GILEAD$$28$YR$A$M$Y$$$20240910$$HP$US$US
242209561$24220956$1$I$20240801$20240815$20240819$20240819$PER$$US-GRUNENTHAL-2024-124170$AVERITAS$$81$YR$$F$Y$$$20240816$$CN$US$US
242209572$24220957$2$F$$20240902$20240819$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-128999$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240910$$MD$JP$JP
242209581$24220958$1$I$20240101$20240813$20240819$20240819$EXP$$DE-ABBVIE-5882335$ABBVIE$$$$$M$Y$$$20240819$$CN$DE$DE
242209591$24220959$1$I$$20240809$20240819$20240819$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010219$STRIDES$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al.. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children.. ASAIO-J. 2024;70 (7):e92-e96.$$$$$Y$$$20240819$$HP$US$US
242209601$24220960$1$I$20240701$20240812$20240819$20240819$EXP$$FR-GSK-FR2024100328$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$PH$FR$FR
242209611$24220961$1$I$20240101$20240815$20240819$20240819$EXP$$US-ABBVIE-5882788$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242209621$24220962$1$I$$20240810$20240819$20240819$PER$$US-ROCHE-10000055517$ROCHE$$$$$M$Y$$$20240819$$CN$US$US
242209631$24220963$1$I$$20240809$20240819$20240819$EXP$$IL-AMGEN-ISRSP2024160510$AMGEN$$$$$F$Y$$$20240818$$MD$IL$IL
242209641$24220964$1$I$$20240809$20240819$20240819$EXP$$GB-ROCHE-10000055128$ROCHE$$$$E$M$Y$$$20240819$$CN$GB$GB
242209651$24220965$1$I$$20240813$20240819$20240819$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001639$BLUEPRINT MEDICINES$$$$$F$Y$$$20240819$$CN$US$US
242209661$24220966$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000059070$ROCHE$$$$$M$Y$$$20240819$$CN$US$US
242209671$24220967$1$I$20240401$20240815$20240819$20240819$EXP$FR-AFSSAPS-TS2024000909$FR-JNJFOC-20240844998$JOHNSON AND JOHNSON$$41$YR$A$M$Y$66$KG$20240819$$MD$FR$FR
242209681$24220968$1$I$20240810$20240813$20240819$20240819$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001638$BLUEPRINT MEDICINES$$71$YR$E$M$Y$$$20240819$$CN$US$US
242209691$24220969$1$I$20240726$20240806$20240819$20240819$EXP$$CN-Hisun Pharmaceuticals-2160580$HISUN PHARMACEUTICALS$$63$YR$$M$Y$55$KG$20240819$$$CN$CN
242209701$24220970$1$I$$20240812$20240819$20240819$EXP$$CN-AMGEN-CHNSP2024163330$AMGEN$Sun H.; Zhu Y.; Li J. et al.. Picalm:MLLT10 can Identify a New Subgroup of Acute Leukemias of Ambiguous Lineage with Unique Extramedullary Disease and Treatment Response. Blood. 2023;142:6078-6078$28$YR$A$F$Y$$$20240818$$HP$CN$CN
242209711$24220971$1$I$$20221213$20240819$20240819$EXP$$US-AstraZeneca-2022A406392$ASTRAZENECA$$$$$F$Y$54$KG$20240819$$CN$US$
242209721$24220972$1$I$20220802$20221215$20240819$20240819$EXP$$AU-AstraZeneca-2022A374937$ASTRAZENECA$$1965$WK$$M$Y$113$KG$20240819$$MD$AU$
242209731$24220973$1$I$20230501$20230601$20240819$20240819$EXP$$US-AstraZeneca-2023A127479$ASTRAZENECA$$787$MON$$M$Y$$$20240819$$CN$US$
242209751$24220975$1$I$$20240808$20240819$20240819$PER$$US-JNJFOC-20240831617$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$US$US
242209761$24220976$1$I$20240813$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024161652$AMGEN$$72$YR$E$M$Y$$$20240818$$CN$US$US
242209771$24220977$1$I$$20240809$20240819$20240819$30DAY$$US-GSK-US2024099741$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
242209781$24220978$1$I$$20240812$20240819$20240819$EXP$$CA-TAKEDA-2024TUS081762$TAKEDA$$72$YR$$F$Y$73$KG$20240819$$HP$CA$CA
242209792$24220979$2$F$20030101$20240819$20240819$20240827$EXP$IT-002147023-PHBS2006IT17134$IT-SA-2024SA239773$SANOFI AVENTIS$Frigerio M, Cipriani M, Roubina E, Orrego P, Vitali E.. Case report: long-term outcome of a heart transplant recipient switched to everolimus after an acute myocardial infarction.. Transplantation.. 2006;82:19-23$56$YR$A$M$Y$$$20240827$$MD$IT$IT
242209801$24220980$1$I$$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024161192$AMGEN$$$$$M$Y$$$20240818$$HP$US$US
242209811$24220981$1$I$$20240814$20240819$20240819$PER$$US-ROCHE-10000058072$ROCHE$$$$A$M$Y$$$20240819$$CN$US$US
242209821$24220982$1$I$20240701$20240813$20240819$20240819$PER$$US-SA-2024SA242364$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240819$$MD$US$US
242209831$24220983$1$I$20240217$20240813$20240819$20240819$EXP$FR-AFSSAPS-NY2024000872$FR-HALEON-2191891$Haleon PLC$$26$YR$$F$Y$61.9$KG$20240816$$MD$FR$FR
242209841$24220984$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162665$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242209851$24220985$1$I$20240806$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024162174$AMGEN$$63$YR$A$F$Y$$$20240818$$CN$US$US
242209861$24220986$1$I$$20240814$20240819$20240819$PER$$NVSC2024US167094$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242209871$24220987$1$I$$20240815$20240819$20240819$EXP$$US-AstraZeneca-2024A186644$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242209881$24220988$1$I$20240101$20240813$20240819$20240819$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046129$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$$$20240819$$CN$US$US
242209891$24220989$1$I$$20240806$20240819$20240819$EXP$$US-ENDO USA, INC.-2024-003156$ENDO$$$$$$Y$$$20240819$$CN$US$US
242209901$24220990$1$I$20240101$20240814$20240819$20240819$EXP$$US-ABBVIE-5882005$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242209911$24220991$1$I$$20240807$20240819$20240819$EXP$$US-Oxford Pharmaceuticals, LLC-2160581$OXFORD PHARMACEUTICALS$Source document$86$YR$$M$Y$$$20240819$$MD$US$US
242209921$24220992$1$I$$20240813$20240819$20240819$PER$$US-JNJFOC-20240833524$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$PH$US$US
242209931$24220993$1$I$$20240723$20240819$20240819$PER$$AU-TOLMAR, INC.-24AU051289$TOLMAR$$$$$M$Y$$$20240814$$CN$AU$AU
242209941$24220994$1$I$$20240723$20240819$20240819$PER$$BR-TOLMAR, INC.-24BR051293$TOLMAR$$$$$F$Y$$$20240814$$CN$BR$BR
242209952$24220995$2$F$20240701$20240904$20240819$20240906$EXP$$KZ-TAKEDA-2024TUS082207$TAKEDA$$$$E$M$Y$60$KG$20240906$$CN$KZ$KZ
242209961$24220996$1$I$$20240808$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US073173$SANDOZ$$$$$$Y$$$20240819$$PH$US$US
242209971$24220997$1$I$20240101$20240813$20240819$20240819$PER$$US-ABBVIE-5883527$ABBVIE$$$$$$Y$$$20240819$$CN$US$US
242209981$24220998$1$I$20220101$20240109$20240819$20240819$PER$$US-ENDO PHARMACEUTICALS INC-2024-000260$ENDO$$$$$F$Y$$$20240819$$HP$US$US
242209991$24220999$1$I$20210601$20230809$20240819$20240819$PER$$US-ENDO USA, INC.-2023-004638$ENDO$$43$YR$$F$Y$52.154$KG$20240819$$CN$US$US
242210001$24221000$1$I$20211101$20231211$20240819$20240819$PER$$US-ENDO PHARMACEUTICALS INC-2023-006148$ENDO$$$$$F$Y$$$20240819$$HP$US$US
242210011$24221001$1$I$20221014$20230905$20240819$20240819$PER$$US-ENDO USA, INC.-2023-004634$ENDO$$41$YR$$F$Y$$$20240819$$LW$US$US
242210021$24221002$1$I$20211201$20231218$20240819$20240819$PER$$US-ENDO USA, INC.-2023-004348$ENDO$$57$YR$$F$Y$$$20240819$$MD$US$US
242210041$24221004$1$I$$20240809$20240819$20240819$30DAY$$US-GSK-US2024099745$GLAXOSMITHKLINE$$$$$M$Y$$$20240819$$CN$US$US
242210052$24221005$2$F$$20240809$20240819$20240828$EXP$$US-GSK-US2024099704$GLAXOSMITHKLINE$$$$$M$Y$$$20240828$$CN$US$US
242210061$24221006$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162673$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242210071$24221007$1$I$20210101$20230926$20240819$20240819$PER$$US-ENDO PHARMACEUTICALS INC-2023-005187$ENDO$$$$$F$Y$$$20240819$$CN$US$US
242210081$24221008$1$I$20220801$20230711$20240819$20240819$PER$$US-ENDO PHARMACEUTICALS INC-2023-004296$ENDO$$42$YR$$F$Y$$$20240819$$HP$US$US
242210091$24221009$1$I$$20240807$20240819$20240819$PER$$US-HALEON-2192064$Haleon PLC$$$$$F$Y$$$20240819$$CN$US$CA
242210101$24221010$1$I$$20240814$20240819$20240819$EXP$$US-AMGEN-USASP2024162379$AMGEN$$$$$F$Y$$$20240818$$HP$US$US
242210111$24221011$1$I$20240802$20240813$20240819$20240819$EXP$FR-AFSSAPS-ST2024001294$FR-ORGANON-O2408FRA000962$ORGANON$$72$YR$$M$Y$65$KG$20240819$$CN$FR$FR
242210121$24221012$1$I$20240101$20240814$20240819$20240819$EXP$$US-ABBVIE-5816399$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242210131$24221013$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162759$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242210141$24221014$1$I$20240201$20240419$20240819$20240819$PER$$US-AUROBINDO-AUR-APL-2024-017874$AUROBINDO$$78$YR$$F$Y$65.7$KG$20240819$$CN$US$US
242210151$24221015$1$I$$20231108$20240819$20240819$PER$$US-AUROBINDO-AUR-APL-2023-066700$AUROBINDO$$66$YR$$F$Y$$$20240819$$CN$US$US
242210161$24221016$1$I$20240801$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130010$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240819$$HP$US$US
242210171$24221017$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162762$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242210181$24221018$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162818$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242210192$24221019$2$F$20220101$20240819$20240819$20240823$EXP$$US-ABBVIE-5881949$ABBVIE$$$$$F$Y$68$KG$20240823$$CN$US$US
242210201$24221020$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162829$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240818$$HP$ES$ES
242210211$24221021$1$I$20240730$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024161103$AMGEN$$$$$F$Y$$$20240818$$CN$US$US
242210221$24221022$1$I$20240101$20240809$20240819$20240819$PER$$US-SA-2024SA239748$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240819$$MD$US$US
242210231$24221023$1$I$20240703$20240723$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003916$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240819$$CN$US$US
242210241$24221024$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167103$NOVARTIS$$$$$$Y$$$20240819$$CN$US$US
242210251$24221025$1$I$20240805$20240813$20240819$20240819$EXP$$US-HALEON-2191933$Haleon PLC$$43$YR$$F$Y$$$20240816$$CN$US$US
242210261$24221026$1$I$$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A185559$ASTRAZENECA$$$$$M$Y$$$20240819$$MD$US$
242210271$24221027$1$I$20240807$20240816$20240819$20240819$EXP$$CN-ROCHE-10000059025$ROCHE$$55$YR$A$F$Y$56$KG$20240819$$HP$CN$CN
242210281$24221028$1$I$$20240812$20240819$20240819$PER$$CZ-Blueprint Medicines Corporation-SP-CZ-2024-001634$BLUEPRINT MEDICINES$$$$$M$Y$$$20240819$$MD$CZ$CZ
242210291$24221029$1$I$20240808$20240815$20240819$20240819$EXP$$US-ABBVIE-5883086$ABBVIE$$84$YR$$F$Y$$$20240819$$CN$US$US
242210303$24221030$3$F$$20240821$20240819$20240827$PER$$US-AMGEN-USASP2024164212$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242210311$24221031$1$I$$20240818$20240819$20240819$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046354$BOEHRINGER INGELHEIM$$$$$$Y$$$20240819$$CN$US$US
242210331$24221033$1$I$$20240812$20240819$20240819$PER$$US-JNJFOC-20240829522$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
242210341$24221034$1$I$$20240809$20240819$20240819$30DAY$$US-JNJFOC-20240843990$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$US$US
242210351$24221035$1$I$$20240814$20240819$20240819$EXP$$US-TAKEDA-2024TUS071494$TAKEDA$$$$$M$Y$$$20240819$$CN$US$US
242210365$24221036$5$F$20240801$20240905$20240819$20240912$EXP$$ES-ABBVIE-5882559$ABBVIE$$75$YR$$F$Y$$$20240912$$HP$ES$ES
242210372$24221037$2$F$20240101$20240828$20240819$20240918$PER$$CA-TOLMAR, INC.-24CA050793$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
242210381$24221038$1$I$20240601$20240725$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA050862$TOLMAR$$70$YR$$M$Y$$$20240819$$CN$CA$CA
242210391$24221039$1$I$20240512$20240725$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051076$TOLMAR$$82$YR$$M$Y$$$20240819$$CN$CA$CA
242210401$24221040$1$I$$20240724$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051258$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
242210411$24221041$1$I$$20240724$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051089$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
242210421$24221042$1$I$$20240724$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051259$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
242210431$24221043$1$I$20240209$20240725$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051298$TOLMAR$$74$YR$$M$Y$$$20240819$$CN$CA$CA
242210442$24221044$2$F$20240716$20240903$20240819$20240926$PER$$CA-TOLMAR, INC.-24CA051219$TOLMAR$$75$YR$$M$Y$$$20240926$$HP$CA$CA
242210451$24221045$1$I$20240601$20240813$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051297$TOLMAR$$87$YR$$M$Y$$$20240819$$CN$CA$CA
242210461$24221046$1$I$$20240726$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051318$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
242210471$24221047$1$I$$20240724$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051315$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
242210481$24221048$1$I$20240725$20240725$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051301$TOLMAR$$81$YR$$M$Y$$$20240819$$CN$COUNTRY NOT SPECIFIED$CA
242210491$24221049$1$I$$20240809$20240819$20240819$EXP$$PE-BIOVITRUM-2024-PE-010989$BIOVITRUM$$$$I$M$Y$$$20240819$$CN$PE$PE
242210501$24221050$1$I$$20240814$20240819$20240819$EXP$$US-HALEON-2192099$Haleon PLC$$$$$$Y$$$20240816$$CN$US$US
242210512$24221051$2$F$$20240814$20240819$20240823$EXP$$NVSC2024US165643$NOVARTIS$$$$$$Y$$$20240823$$CN$US$US
242210522$24221052$2$F$$20240906$20240819$20240906$PER$$US-ALXN-202408USA000735US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242210541$24221054$1$I$20240711$20240729$20240819$20240819$PER$$US-NOVITIUMPHARMA-2024USNVP01527$NOVITIUM PHARMA$$18$MON$I$M$Y$13$KG$20240819$$PH$US$US
242210561$24221056$1$I$$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A186080$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242210571$24221057$1$I$$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A185750$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242210581$24221058$1$I$$20230913$20240819$20240819$EXP$$CA-AstraZeneca-2023A211935$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$CA$
242210591$24221059$1$I$$20240815$20240819$20240819$EXP$$US-AstraZeneca-2024A186845$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242210601$24221060$1$I$$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A185581$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242210611$24221061$1$I$20220117$20220330$20240819$20240819$EXP$$US-AstraZeneca-2022A133901$ASTRAZENECA$$24903$DY$$F$Y$113.4$KG$20240819$$CN$US$
242210621$24221062$1$I$$20240814$20240819$20240819$EXP$$CN-HALEON-2192084$Haleon PLC$Chin J of Clinical Rational Drug Use, Vol. 17 No. 22 Aug 10, 2024.?Qin Qinghua, Deng Qing?Analysis of a case report on gastrointestinal bleeding caused by warfarin combined with diclofenac sodium after mechanical valve replacement ? DOI 10.15887/j.cnki.13-1389/r.2024.22.046; Qinghua Q, Qing D. Analysis of a case report on gastrointestinal bleeding caused by warfarin combined with diclofenac sodium after mechanical valve replacement. Clinically M. 2024;17(22):157-159+166. DOI: 10.15887/j.cnki....$70$YR$$M$Y$53$KG$20240816$$HP$CN$CN
242210631$24221063$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010999$ELI LILLY AND CO$$$$$$Y$$$20240819$$CN$US$US
242210641$24221064$1$I$20240801$20240812$20240819$20240819$EXP$$US-ABBVIE-5878581$ABBVIE$$20$YR$$F$Y$$$20240819$$CN$US$US
242210651$24221065$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162444$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240818$$HP$US$US
242210661$24221066$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162462$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240818$$HP$US$US
242210673$24221067$3$F$$20240916$20240819$20240925$EXP$$GB-AMGEN-GBRSP2024162943$AMGEN$$83$YR$E$F$Y$$$20240924$$CN$GB$GB
242210681$24221068$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162448$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240818$$HP$US$US
242210691$24221069$1$I$20240801$20240808$20240819$20240819$PER$$US-SA-2024SA238118$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240819$$MD$US$US
242210701$24221070$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162461$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240818$$HP$US$US
242210711$24221071$1$I$20240808$20240808$20240819$20240819$PER$$US-SA-2024SA239360$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240819$$MD$US$US
242210721$24221072$1$I$20240809$20240809$20240819$20240819$PER$$US-SA-2024SA239082$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240819$$MD$US$US
242210731$24221073$1$I$20240101$20240814$20240819$20240819$PER$$CH-Blueprint Medicines Corporation-SP-CH-2024-001641$BLUEPRINT MEDICINES$$$$$$Y$$$20240819$$MD$CH$CH
242210741$24221074$1$I$20240810$20240814$20240819$20240819$EXP$$US-ABBVIE-5882155$ABBVIE$$59$YR$$F$Y$$$20240819$$CN$US$US
242210751$24221075$1$I$$20240816$20240819$20240819$EXP$$AU-SANDOZ INC.-SDZ2024AU073200$SANDOZ$$$$$$Y$$$20240819$$HP$AU$AU
242210761$24221076$1$I$20240807$20240812$20240819$20240819$PER$$US-ABBVIE-5881702$ABBVIE$$38$YR$$F$Y$$$20240819$$MD$US$US
242210771$24221077$1$I$$20240812$20240819$20240819$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001627$BLUEPRINT MEDICINES$$$$$F$Y$$$20240819$$CN$US$US
242210781$24221078$1$I$$20240809$20240819$20240819$30DAY$$US-GSK-US2024099769$GLAXOSMITHKLINE$$$$$M$Y$$$20240819$$CN$US$US
242210791$24221079$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162467$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240818$$HP$US$US
242210801$24221080$1$I$20240701$20240806$20240819$20240819$EXP$$JP-AMGEN-JPNSP2024163614$AMGEN$$66$YR$E$M$Y$$$20240818$$MD$JP$JP
242210812$24221081$2$F$$20240715$20240819$20240918$EXP$$CA-HALEON-2191332$Haleon PLC$$44$YR$$F$Y$$$20240918$$HP$CA$CA
242210821$24221082$1$I$$20240813$20240819$20240819$EXP$$US-TAKEDA-2022TUS081300$TAKEDA$$$$$F$Y$$$20240819$$CN$US$US
242210831$24221083$1$I$$20240812$20240819$20240819$PER$$US-AMGEN-USASP2024162507$AMGEN$Faleck D.; Magahis P.T.; Corso T. et al.. Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors. Journal for Immunotherapy of Cancer. 2024;12 (7):1-10$$$$$Y$$$20240818$$MD$US$US
242210841$24221084$1$I$$20240813$20240819$20240819$EXP$$US-TAKEDA-2024TUS056575$TAKEDA$$$$$F$Y$$$20240819$$CN$US$US
242210851$24221085$1$I$$20240814$20240819$20240819$PER$$US-ABBVIE-5883498$ABBVIE$$$$$$Y$$$20240819$$CN$US$US
242210861$24221086$1$I$20240701$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129257$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240819$$PH$US$US
242210871$24221087$1$I$$20240810$20240819$20240819$PER$$US-ROCHE-10000055243$ROCHE$$$$$F$Y$$$20240819$$MD$US$US
242210881$24221088$1$I$$20240815$20240819$20240819$PER$$NVSC2024US166924$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242210891$24221089$1$I$20240812$20240812$20240819$20240819$PER$$US-ROCHE-10000055436$ROCHE$$$$$$Y$$$20240819$$PH$US$US
242210901$24221090$1$I$20240809$20240812$20240819$20240819$PER$$US-ROCHE-10000055490$ROCHE$$$$$$Y$$$20240819$$PH$US$US
242210913$24221091$3$F$20240731$20240820$20240819$20240829$PER$$US-ROCHE-10000055874$ROCHE$$11$YR$C$M$Y$40$KG$20240829$$CN$US$US
242210921$24221092$1$I$20240811$20240816$20240819$20240819$EXP$$CN-ROCHE-10000059043$ROCHE$$66$YR$E$M$Y$80$KG$20240819$$HP$CN$CN
242210934$24221093$4$F$$20240918$20240819$20240921$PER$$US-ROCHE-10000057915$ROCHE$$62$YR$A$F$Y$$$20240921$$CN$US$US
242210941$24221094$1$I$20240801$20240812$20240819$20240819$PER$$US-ROCHE-10000055820$ROCHE$$29$YR$A$M$Y$63.5$KG$20240819$$CN$US$US
242210951$24221095$1$I$20240330$20240808$20240819$20240819$EXP$IT-MINISAL02-997959$IT-BAXTER-2024BAX022918$BAXTER$$84$YR$$M$Y$$$20240819$$PH$IT$IT
242210962$24221096$2$F$$20240903$20240819$20240904$EXP$$DE-AMGEN-DEUSP2024159840$AMGEN$$$$$F$Y$$$20240904$$MD$DE$DE
242210972$24221097$2$F$$20240904$20240819$20240911$30DAY$$US-GSK-US2024099750$GLAXOSMITHKLINE$$$$$M$Y$$$20240911$$CN$US$US
242210981$24221098$1$I$20240720$20240808$20240819$20240819$EXP$CN-NMPACDR-5301001032953202400718$CN-BAXTER-2024BAX023053$BAXTER$$88$YR$$F$Y$$$20240819$$MD$CN$CN
242210992$24221099$2$F$$20240819$20240819$20240827$EXP$$CA-BAXTER-2024BAX023010$BAXTER$$73$YR$$F$Y$$$20240827$$MD$CA$CA
242211001$24221100$1$I$20240521$20240808$20240819$20240819$EXP$CN-NMPACDR-3301051028618202400173$CN-BAXTER-2024BAX023066$BAXTER$$1$YR$$F$Y$10$KG$20240819$$MD$CN$CN
242211011$24221101$1$I$20240801$20240808$20240819$20240819$EXP$CN-NMPACDR-3310211059335202400184$CN-BAXTER-2024BAX023065$BAXTER$$57$YR$$F$Y$54$KG$20240819$$MD$CN$CN
242211021$24221102$1$I$$20240808$20240819$20240819$EXP$$CA-BAXTER-2024BAX023013$BAXTER$$52$YR$$M$Y$$$20240819$$MD$CA$CA
242211031$24221103$1$I$$20240808$20240819$20240819$EXP$$US-BAXTER-2024BAX023103$BAXTER$$60$YR$$F$Y$$$20240819$$HP$US$US
242211041$24221104$1$I$$20240808$20240819$20240819$EXP$$CA-BAXTER-2024BAX023011$BAXTER$$62$YR$$F$Y$$$20240819$$MD$CA$CA
242211061$24221106$1$I$$20230214$20240819$20240819$EXP$$EG-JNJFOC-20240828192$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240819$$CN$EG$EG
242211071$24221107$1$I$$20240814$20240819$20240819$30DAY$$US-SANDOZ INC.-SDZ2024US072849$SANDOZ$$$$$F$Y$$$20240819$$CN$US$US
242211081$24221108$1$I$20240707$20240812$20240819$20240819$EXP$$CN-ABBVIE-5878788$ABBVIE$$33$YR$$F$Y$$$20240819$$MD$CN$CN
242211091$24221109$1$I$20080101$20240812$20240819$20240819$PER$$US-JNJFOC-20240833986$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240819$$LW$US$US
242211101$24221110$1$I$$20240814$20240819$20240819$EXP$$JP-JNJFOC-20240846157$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$PH$JP$JP
242211111$24221111$1$I$20240812$20240812$20240819$20240819$EXP$$US-JNJFOC-20240830911$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240819$$CN$US$US
242211121$24221112$1$I$$20240812$20240819$20240819$PER$$US-JNJFOC-20240828835$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$US$US
242211141$24221114$1$I$20240805$20240813$20240819$20240819$30DAY$$US-GSK-US2024100680$GLAXOSMITHKLINE$$25$YR$$F$Y$$$20240819$$CN$US$US
242211151$24221115$1$I$$20240812$20240819$20240819$30DAY$$US-GSK-US2024AMR100995$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
242211161$24221116$1$I$$20240807$20240819$20240819$EXP$$PT-COLLEGIUM PHARMACEUTICAL, INC.-20240800600$COLLEGIUM PHARMACEUTICAL$maria guilherme m, jos? diogo m, patr?cia s, maria in?s r, ana patr?cia c, joana urbano.. serotoninergic syndrome: the  purpose of a clinical case.. emergency, intermediate care and critically ill patients. clinical case.. 481$79$YR$$F$Y$$$20240818$$HP$PT$PT
242211171$24221117$1$I$20221031$20240805$20240819$20240819$EXP$AU-TGA-0000804528$AU-COLLEGIUM PHARMACEUTICAL, INC.-20240800595$COLLEGIUM PHARMACEUTICAL$$26$YR$$M$Y$$$20240818$$CN$AU$AU
242211181$24221118$1$I$$20240814$20240819$20240819$PER$$US-ROCHE-10000057736$ROCHE$$1$YR$I$M$Y$$$20240819$$CN$US$US
242211191$24221119$1$I$$20240814$20240819$20240819$PER$$US-ROCHE-10000058911$ROCHE$$$$A$F$Y$$$20240819$$CN$US$US
242211201$24221120$1$I$20240522$20240815$20240819$20240819$EXP$$US-UCBSA-2024028686$UCB$$64$YR$$M$Y$$$20240819$$CN$US$US
242211211$24221121$1$I$$20240814$20240819$20240819$PER$$US-ROCHE-10000057782$ROCHE$$44$YR$A$F$Y$$$20240819$$HP$US$US
242211221$24221122$1$I$20240715$20240815$20240819$20240819$PER$$US-AMGEN-USASP2024163465$AMGEN$$35$YR$A$F$Y$$$20240818$$CN$US$US
242211231$24221123$1$I$$20240807$20240819$20240819$EXP$$CA-AUROBINDO-AUR-APL-2024-040712$AUROBINDO$$65$YR$$F$Y$$$20240819$$HP$CA$CA
242211241$24221124$1$I$$20240814$20240819$20240819$PER$$US-ROCHE-10000057723$ROCHE$$$$$$Y$67$KG$20240819$$HP$US$US
242211251$24221125$1$I$20240614$20240814$20240819$20240819$PER$$US-ROCHE-10000058060$ROCHE$$82$YR$E$M$Y$$$20240819$$CN$US$US
242211263$24221126$3$F$$20240814$20240819$20240822$PER$$US-ROCHE-10000058302$ROCHE$$$$$$Y$$$20240822$$MD$US$US
242211272$24221127$2$F$20240814$20240904$20240819$20240906$PER$$US-ROCHE-10000057879$ROCHE$$52$YR$A$M$Y$83.91$KG$20240906$$CN$US$US
242211281$24221128$1$I$$20240815$20240819$20240819$PER$$US-ABBVIE-5882629$ABBVIE$$$$$$Y$$$20240819$$CN$US$US
242211291$24221129$1$I$$20231002$20240819$20240819$EXP$$GB-AstraZeneca-2023A224284$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$GB$
242211301$24221130$1$I$20240729$20240809$20240819$20240819$EXP$$US-TAKEDA-2024TUS011906$TAKEDA$$45$YR$$F$Y$$$20240819$$CN$US$US
242211311$24221131$1$I$$20240815$20240819$20240819$EXP$$US-AstraZeneca-2024A186626$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242211321$24221132$1$I$$20220804$20240819$20240819$EXP$$US-AstraZeneca-2022A278831$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242211331$24221133$1$I$$20220425$20240819$20240819$EXP$$US-AstraZeneca-2022A164600$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242211342$24221134$2$F$20240620$20240913$20240819$20240923$PER$$US-ROCHE-10000059241$ROCHE$$43$YR$A$F$Y$$$20240923$$CN$US$US
242211351$24221135$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000059123$ROCHE$$$$$$Y$$$20240819$$CN$US$US
242211361$24221136$1$I$20240401$20240729$20240819$20240819$EXP$$CH-UCBSA-2024040841$UCB$$$$A$F$Y$$$20240819$$MD$CH$CH
242211371$24221137$1$I$$20240814$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130165$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240819$$CN$US$US
242211382$24221138$2$F$20240101$20240724$20240819$20240821$PER$$US-JNJFOC-20240768669$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
242211401$24221140$1$I$20210222$20240807$20240819$20240819$EXP$$DE-AUROBINDO-AUR-APL-2024-040019$AUROBINDO$$$$E$F$Y$49.5$KG$20240819$$MD$DE$DE
242211411$24221141$1$I$$20240807$20240819$20240819$EXP$$CA-AUROBINDO-AUR-APL-2024-040610$AUROBINDO$$43$YR$$M$Y$$$20240819$$CN$CA$CA
242211421$24221142$1$I$20240624$20240813$20240819$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA073040$SANDOZ$$77$YR$$M$Y$$$20240819$$MD$CA$CA
242211431$24221143$1$I$20240701$20240815$20240819$20240819$PER$$US-ROCHE-10000058834$ROCHE$$51$YR$A$F$Y$$$20240819$$CN$US$US
242211451$24221145$1$I$$20240807$20240819$20240819$EXP$$IT-AUROBINDO-AUR-APL-2024-040031$AUROBINDO$$14$YR$$F$Y$$$20240819$$PH$IT$IT
242211461$24221146$1$I$$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A186413$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242211471$24221147$1$I$$20220401$20240819$20240819$EXP$$CA-AstraZeneca-2022A089050$ASTRAZENECA$$$$$F$Y$$$20240819$$MD$CA$
242211481$24221148$1$I$$20240815$20240819$20240819$EXP$$US-AstraZeneca-2024A186669$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242211491$24221149$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000058940$ROCHE$$$$$$Y$$$20240819$$CN$US$US
242211501$24221150$1$I$$20220909$20240819$20240819$EXP$$US-AstraZeneca-2022A313601$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242211511$24221151$1$I$$20240816$20240819$20240819$PER$$US-HALEON-2192414$Haleon PLC$$$$$$Y$$$20240819$$CN$US$US
242211521$24221152$1$I$20240401$20240815$20240819$20240819$EXP$IT-MINISAL02-998533$IT-ROCHE-10000058201$ROCHE$$40$YR$A$F$Y$$$20240819$$HP$IT$IT
242211541$24221154$1$I$20240723$20240814$20240819$20240819$PER$$US-ABBVIE-5881648$ABBVIE$$31$YR$$F$Y$$$20240819$$MD$US$US
242211551$24221155$1$I$$20240807$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408007084$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240819$$CN$US$US
242211563$24221156$3$F$20240101$20240819$20240819$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408006489$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240821$$CN$US$US
242211571$24221157$1$I$20240813$20240814$20240819$20240819$EXP$$CN-JNJFOC-20240840501$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$MD$CN$CN
242211581$24221158$1$I$20200601$20201014$20240819$20240819$EXP$$JP-TAKEDA-2020TJP013296$TAKEDA$$47$YR$$M$Y$$$20240819$$MD$JP$JP
242211591$24221159$1$I$$20240808$20240819$20240819$EXP$$CH-JNJFOC-20240775662$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$PH$CH$CH
242211602$24221160$2$F$20240809$20240904$20240819$20240913$30DAY$$US-GSK-US2024099774$GLAXOSMITHKLINE$$61$YR$$M$Y$$$20240913$$CN$US$US
242211621$24221162$1$I$$20230713$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401587$RANBAXY$$$$$$Y$$$20240819$$CN$US$US
242211631$24221163$1$I$20221018$20240812$20240819$20240819$EXP$$US-TAKEDA-US202031596$TAKEDA$$72$YR$$M$Y$$$20240819$$HP$US$US
242211641$24221164$1$I$$20230807$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404666$RANBAXY$$$$$F$Y$$$20240819$$MD$US$US
242211651$24221165$1$I$$20230815$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406254$RANBAXY$$$$$$Y$$$20240819$$MD$US$US
242211661$24221166$1$I$$20230922$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410116$RANBAXY$$$$$$Y$$$20240819$$CN$US$US
242211671$24221167$1$I$$20231012$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415228$RANBAXY$$$$A$F$Y$70$KG$20240819$$CN$US$US
242211681$24221168$1$I$$20230719$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402481$RANBAXY$$$$$$Y$$$20240819$$HP$US$US
242211691$24221169$1$I$$20230828$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406561$RANBAXY$$$$$$Y$$$20240819$$CN$US$US
242211701$24221170$1$I$$20230809$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405581$RANBAXY$$$$$F$Y$$$20240819$$HP$US$US
242211711$24221171$1$I$$20231002$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-412156$RANBAXY$$$$E$M$Y$$$20240819$$CN$US$US
242211721$24221172$1$I$$20240408$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442047$RANBAXY$$$$A$F$Y$$$20240819$$HP$US$US
242211731$24221173$1$I$$20230922$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410331$RANBAXY$$$$E$F$Y$$$20240819$$CN$US$US
242211741$24221174$1$I$$20240603$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450787$RANBAXY$$80$YR$$F$Y$$$20240819$$MD$US$US
242211751$24221175$1$I$$20230905$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407634$RANBAXY$$$$A$M$Y$$$20240819$$HP$US$US
242211761$24221176$1$I$$20230725$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-403780$RANBAXY$$72$YR$$F$Y$$$20240819$$HP$US$US
242211771$24221177$1$I$$20240314$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438276$RANBAXY$$$$A$F$Y$$$20240819$$CN$US$US
242211781$24221178$1$I$$20231204$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424257$RANBAXY$$$$$$Y$$$20240819$$HP$US$US
242211791$24221179$1$I$$20231208$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425164$RANBAXY$$$$A$F$Y$$$20240819$$CN$US$US
242211801$24221180$1$I$$20230828$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407773$RANBAXY$$$$$$Y$$$20240819$$MD$US$US
242211811$24221181$1$I$$20240604$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438282$RANBAXY$$$$A$F$Y$$$20240819$$HP$US$US
242211821$24221182$1$I$20240215$20240226$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-435500$RANBAXY$$62$YR$A$M$Y$$$20240819$$CN$US$US
242211831$24221183$1$I$$20230718$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402312$RANBAXY$$$$$$Y$$$20240819$$CN$US$US
242211841$24221184$1$I$$20240419$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-443503$RANBAXY$$$$A$M$Y$$$20240819$$CN$US$US
242211851$24221185$1$I$$20230821$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407046$RANBAXY$$$$$$Y$$$20240819$$CN$US$US
242211861$24221186$1$I$$20231204$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424255$RANBAXY$$$$$$Y$$$20240819$$HP$US$US
242211871$24221187$1$I$$20240403$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441428$RANBAXY$$$$C$M$Y$$$20240819$$HP$US$US
242211881$24221188$1$I$$20231025$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415251$RANBAXY$$$$$M$Y$98.87$KG$20240819$$CN$US$US
242211891$24221189$1$I$$20230712$20240819$20240819$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-401456$RANBAXY$$$$$$Y$$$20240819$$HP$US$US
242211901$24221190$1$I$$20240815$20240819$20240819$EXP$$NVSC2024US166477$NOVARTIS$$$$$$Y$$$20240819$$CN$US$US
242211911$24221191$1$I$$20230131$20240819$20240819$EXP$$US-AstraZeneca-2023A026634$ASTRAZENECA$$$$$M$Y$$$20240819$$HP$US$
242211921$24221192$1$I$$20240801$20240819$20240819$PER$$US-AstraZeneca-2024A175629$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242211931$24221193$1$I$$20221128$20240819$20240819$EXP$$US-AstraZeneca-2022A393326$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242211941$24221194$1$I$$20230911$20240819$20240819$EXP$$CA-AstraZeneca-2023A212331$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$CA$
242211951$24221195$1$I$$20240806$20240819$20240819$EXP$GB-MHRA-MIDB-1c98115a-ff43-4269-b76d-632e3460b7d9$GB-DEXPHARM-2024-2700$DEXCEL$$90$YR$E$F$Y$$$20240819$$HP$GB$GB
242211962$24221196$2$F$20230504$20240902$20240819$20240910$EXP$FR-AFSSAPS-PO2024000870$FR-JNJFOC-20240845416$JOHNSON AND JOHNSON$$1$DY$N$M$Y$3.415$KG$20240911$$HP$FR$FR
242211971$24221197$1$I$20230606$20240814$20240819$20240819$EXP$DK-DKMA-30737269$DK-JNJFOC-20240842740$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240819$$HP$DK$DK
242211981$24221198$1$I$20240101$20240809$20240819$20240819$PER$$US-SA-2024SA240969$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240819$$CN$US$US
242211991$24221199$1$I$20230101$20240815$20240819$20240819$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046242$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240819$$CN$US$US
242212001$24221200$1$I$20240809$20240809$20240819$20240819$PER$$US-SA-2024SA240139$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240819$$CN$US$US
242212011$24221201$1$I$$20240808$20240819$20240819$PER$$US-SA-2024SA239138$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240819$$CN$US$US
242212021$24221202$1$I$$20240812$20240819$20240819$PER$$US-SA-2024SA241866$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240819$$MD$US$US
242212031$24221203$1$I$20240717$20240809$20240819$20240819$PER$$US-SA-2024SA241487$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240819$$MD$US$US
242212041$24221204$1$I$20240201$20240813$20240819$20240819$EXP$$CO-ABBVIE-5881092$ABBVIE$$43$YR$$F$Y$60$KG$20240819$$CN$CO$CO
242212052$24221205$2$F$20240811$20240814$20240819$20240825$PER$$US-AMGEN-USASP2024163420$AMGEN$$35$YR$A$M$Y$$$20240825$$CN$US$US
242212071$24221207$1$I$20240808$20240813$20240819$20240819$PER$$US-ABBVIE-5883737$ABBVIE$$44$YR$$F$Y$$$20240819$$HP$US$US
242212081$24221208$1$I$20220101$20240810$20240819$20240819$PER$$US-JNJFOC-20240828294$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
242212092$24221209$2$F$20240715$20240902$20240819$20240912$EXP$FR-AFSSAPS-AN2024001090$FR-JNJFOC-20240845386$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240912$$CN$FR$FR
242212101$24221210$1$I$$20240812$20240819$20240819$PER$$US-ALXN-202408USA000750US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242212111$24221211$1$I$$20240812$20240819$20240819$EXP$GR-EMA-20170314-dkevhprod-103605666$GR-SA-2024SA239734$SANOFI AVENTIS$Koufos, et al.. Extended tuberculosis with pulmonary and extrapulmonary localisation caused by Mycobacterium Avium in a patient with rheumatoid arthritis and dermatomyositis.. Pneumon, Supplementa; Book of Abstracts. 2011;24:46$45$YR$A$M$Y$$$20240819$$MD$GR$GR
242212121$24221212$1$I$$20240809$20240819$20240819$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024099681$VIIV$$$$$M$Y$$$20240819$$MD$US$US
242212131$24221213$1$I$20240601$20240805$20240819$20240819$EXP$$US-UCBSA-2024040908$UCB$$58$YR$$F$Y$$$20240819$$HP$US$US
242212141$24221214$1$I$$20240814$20240819$20240819$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001647$BLUEPRINT MEDICINES$$$$$M$Y$$$20240819$$CN$US$US
242212161$24221216$1$I$$20240809$20240819$20240819$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024099679$VIIV$$$$$M$Y$$$20240819$$MD$US$US
242212171$24221217$1$I$$20240813$20240819$20240819$EXP$$CA-ABBVIE-5880419$ABBVIE$$$$A$F$Y$$$20240819$$CN$CA$CA
242212181$24221218$1$I$$20240814$20240819$20240819$EXP$$GB-ABBVIE-5882223$ABBVIE$$$$E$F$Y$$$20240819$$CN$GB$GB
242212191$24221219$1$I$20240701$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129364$BRISTOL MYERS SQUIBB$$58$YR$A$$Y$$$20240819$$CN$US$US
242212201$24221220$1$I$$20240814$20240819$20240819$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-130079$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240819$$CN$GB$GB
242212211$24221221$1$I$$20240812$20240819$20240819$EXP$$BR-CELLTRION INC.-2024BR019603$CELLTRION$Rozza-de-Menezes RE., Lopes DN., de Oliveira NP., de Campos Augusto KC., Milagres A. Miguez, AN., et al.. Co-occurrence of oral pemphigus vulgaris and herpes simplex virus infection in a young patient with Crohn^s disease: report of a rare case of oral lesions during anti-TFN alpha and immunomodulator therapy. International Journal of Colorectal Disease. 2024;39 (1):125$$$$$Y$$$20240819$$HP$BR$BR
242212221$24221222$1$I$$20230428$20240819$20240819$EXP$$US-AstraZeneca-2023A094294$ASTRAZENECA$$$$$F$Y$$$20240819$$MD$US$
242212231$24221223$1$I$$20230417$20240819$20240819$EXP$$US-AstraZeneca-2023A052759$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242212241$24221224$1$I$$20240731$20240819$20240819$PER$$US-TEVA-VS-3229119$TEVA$$63$YR$$F$Y$$$20240819$$PH$US$US
242212251$24221225$1$I$$20221228$20240819$20240819$EXP$$IN-AstraZeneca-2022A421054$ASTRAZENECA$$57$YR$$M$Y$$$20240819$$CN$IN$
242212262$24221226$2$F$$20240827$20240819$20240902$EXP$$US-AMGEN-USASP2024160377$AMGEN$$5$YR$C$F$Y$$$20240902$$CN$US$US
242212271$24221227$1$I$$20221005$20240819$20240819$EXP$$US-AstraZeneca-2022A339606$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242212281$24221228$1$I$$20230810$20240819$20240819$EXP$$CA-AstraZeneca-2023A088930$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$CA$
242212291$24221229$1$I$20240808$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009925$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240819$$CN$US$US
242212302$24221230$2$F$$20240906$20240819$20240909$EXP$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448170$GR-VIIV HEALTHCARE LIMITED-GR2024101680$VIIV$$$$$$Y$$$20240909$$HP$GR$GR
242212312$24221231$2$F$$20240906$20240819$20240909$EXP$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448170$GR-GSK-GR2024101680$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$HP$GR$GR
242212321$24221232$1$I$20240101$20240805$20240819$20240819$PER$$US-009507513-2408USA002755$MERCK$$72$YR$$M$Y$81.08$KG$20240819$$CN$US$US
242212342$24221234$2$F$20231001$20240814$20240819$20240827$EXP$$FR-AUROBINDO-AUR-APL-2024-040598$AUROBINDO$$84$YR$$F$Y$$$20240827$$MD$FR$FR
242212351$24221235$1$I$$20240812$20240819$20240819$EXP$TW-MLMSERVICE-20201112-2577092-1$TW-RDY-SPO/TWN/24/0011862$DR REDDYS$Chien SC, Chien SC, Hu TY. Rapid-onset acute respiratory distress syndrome after mastectomy in a breast cancer patient: A case report and review of literature. Medicine. 2020;99(43):e22795. DOI: 10.1097/MD.0000000000022795.$53$YR$A$F$Y$$$20240819$$MD$TW$TW
242212361$24221236$1$I$$20240808$20240819$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-040696$AUROBINDO$$86$YR$$M$Y$$$20240819$$MD$FR$FR
242212372$24221237$2$F$20240822$20240823$20240819$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004029$ACADIA PHARMACEUTICALS$$5$YR$$F$Y$$$20240916$$CN$US$US
242212381$24221238$1$I$$20240726$20240819$20240819$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004028$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
242212391$24221239$1$I$20240504$20240808$20240819$20240819$EXP$$JP-ROCHE-10000058286$ROCHE$$16$YR$T$M$Y$$$20240819$$MD$JP$JP
242212402$24221240$2$F$20240101$20240910$20240819$20240928$EXP$$US-SA-2024SA240353$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240928$$MD$US$US
242212411$24221241$1$I$20220101$20240813$20240819$20240819$EXP$$GB-CELLTRION INC.-2024GB019594$CELLTRION$$$$$$Y$$$20240819$$CN$GB$GB
242212421$24221242$1$I$$20240726$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004030$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242212431$24221243$1$I$$20240726$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004032$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242212441$24221244$1$I$20240807$20240809$20240819$20240819$EXP$$JP-AMGEN-JPNSP2024160430$AMGEN$$$$E$M$Y$$$20240818$$PH$JP$JP
242212451$24221245$1$I$20240101$20240726$20240819$20240819$PER$$US-009507513-2407USA014567$MERCK$$75$YR$$F$Y$$$20240819$$CN$US$US
242212462$24221246$2$F$$20240821$20240819$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004034$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
242212471$24221247$1$I$$20240815$20240819$20240819$PER$$US-AMGEN-USASP2024163202$AMGEN$$$$$F$Y$$$20240818$$CN$US$US
242212481$24221248$1$I$$20220816$20240819$20240819$EXP$$US-AstraZeneca-2022A289663$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242212491$24221249$1$I$20230501$20240811$20240819$20240819$EXP$GB-MHRA-TPP58493008C11413433YC1723193117207$GB-DEXPHARM-2024-2807$DEXCEL$$76$YR$E$F$Y$64$KG$20240819$$HP$GB$GB
242212501$24221250$1$I$20240813$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024162381$AMGEN$$61$YR$A$F$Y$$$20240819$$CN$US$US
242212511$24221251$1$I$$20240808$20240819$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-128284$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240819$$CN$JP$JP
242212521$24221252$1$I$20240731$20240807$20240819$20240819$EXP$$GB-AUROBINDO-AUR-APL-2024-040059$AUROBINDO$$74$YR$$F$Y$103$KG$20240819$$HP$GB$GB
242212531$24221253$1$I$20240701$20240809$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126560$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240819$$HP$US$US
242212552$24221255$2$F$20240727$20240823$20240819$20240903$EXP$$GB-AUROBINDO-AUR-APL-2024-040034$AUROBINDO$$34$YR$$M$Y$$$20240903$$MD$GB$GB
242212561$24221256$1$I$$20240708$20240819$20240819$EXP$$ES-NORMON-2023001181$NORMON$Fedirchyk-Tymchuk O, Corral-Tuesta C, Duran-Barata D, Torras de Caralt E, Ortega-Garcia P, Cabanes-Martinez L., N?206 - Myasthenic crisis triggered by levofloxacin: A case report. Clinical Neurophysiology. 2023;150:e138. DOI: 10.1016/j.clinph.2023.03.200$76$YR$$M$Y$$$20240819$$MD$ES$
242212571$24221257$1$I$$20240806$20240819$20240819$EXP$$US-BELUSA-2024BELLIT0091$BIOLOGICAL E.$Sinclair De Frias J, Olivero L, Fleissner Z, Burns J.Intraoperative vascular air embolism and intracardiac thrombosis complicating liver transplantation: a case report.Journal of Medical Case Reports.2024;18(59):1-4$$$$$Y$$$20240819$$HP$US$US
242212581$24221258$1$I$$20240809$20240819$20240819$EXP$$US-APOTEX-2024AP009345$APOTEX$Sorabella RA, Gray WH, Dabal RJ, Padilla LA, Hock K, Clark MG, et al.. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024;70 (7):e92-e96$17$YR$$M$Y$85$KG$20240819$$HP$US$US
242212591$24221259$1$I$$20240815$20240819$20240819$PER$$NVSC2024US166922$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242212601$24221260$1$I$20240801$20240807$20240819$20240819$EXP$$GB-AUROBINDO-AUR-APL-2024-040113$AUROBINDO$$64$YR$$F$Y$$$20240819$$PH$GB$GB
242212612$24221261$2$F$$20240822$20240819$20240827$EXP$$AT-AMGEN-AUTSP2024161414$AMGEN$$$$E$F$Y$$$20240827$$MD$AT$AT
242212621$24221262$1$I$$20240805$20240819$20240819$EXP$$TR-NOVOPROD-1268838$NOVO NORDISK$$$$$F$Y$$$20240819$$CN$TR$TR
242212631$24221263$1$I$20210101$20240805$20240819$20240819$EXP$$TR-NOVOPROD-1269643$NOVO NORDISK$$$$$M$Y$$$20240819$$CN$TR$TR
242212642$24221264$2$F$20240625$20240826$20240819$20240904$EXP$$US-NOVOPROD-1267279$NOVO NORDISK$$$$$F$Y$$$20240904$$CN$US$US
242212661$24221266$1$I$20170101$20240805$20240819$20240819$EXP$$US-NOVOPROD-1267697$NOVO NORDISK$$65$YR$$M$Y$$$20240819$$CN$US$US
242212671$24221267$1$I$$20240806$20240819$20240819$EXP$$JP-NOVOPROD-1266435$NOVO NORDISK$$85$YR$$M$Y$$$20240819$$PH$JP$JP
242212682$24221268$2$F$$20240814$20240819$20240826$EXP$$EG-NOVOPROD-1266456$NOVO NORDISK$$$$$M$Y$70$KG$20240826$$CN$EG$EG
242212691$24221269$1$I$20240101$20240806$20240819$20240819$EXP$$SK-NOVOPROD-1265689$NOVO NORDISK$Ingrid Draveck? et al.. Transplantation of the islets of Langerhans ? present and future, First experience with islet of Langerhans transplantation in Slovakia. Forum Diab. 2024;13(2):79-89$38$YR$$F$Y$$$20240819$$MD$SK$SK
242212701$24221270$1$I$$20240815$20240819$20240819$EXP$$BR-JNJFOC-20240846094$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$BR$BR
242212711$24221271$1$I$$20240805$20240819$20240819$EXP$$US-NOVOPROD-1266938$NOVO NORDISK$Jessie M. Nelson et al.. Pancreatic panniculitis mimicking bilateral cellulitis: a case report. Clinical and Experimental Dermatology. 2024;49(8):910-912$43$YR$$M$Y$$$20240819$$HP$US$US
242212723$24221272$3$F$$20240827$20240819$20240909$EXP$$GR-ROCHE-10000055536$ROCHE$Lani E. HIGH-DOSE INTRAVENTRICULAR THROMBOLYSIS IN SPONTANEOUS INTRAVENTRICULAR HEMORRHAGE: A PILOT STUDY. 37th annual congress of the Hellenic neurosurgical society joint meeting with the Bulgarian society of neurosurgery and 17th annual neurosurgery nurses meeting, 13-16 June 2024, Corfu Holiday Palace, Corfu, Greece.$55$YR$A$M$Y$$$20240909$$MD$GR$GR
242212731$24221273$1$I$$20240812$20240819$20240819$PER$$US-ALXN-202408USA000686US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
242212741$24221274$1$I$20240717$20240726$20240819$20240819$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004060$ACADIA PHARMACEUTICALS$$59$YR$$F$Y$$$20240819$$CN$US$US
242212751$24221275$1$I$20231001$20240806$20240819$20240819$EXP$$US-NOVOPROD-1266243$NOVO NORDISK$$42$YR$$F$Y$$$20240819$$CN$US$US
242212761$24221276$1$I$$20240806$20240819$20240819$EXP$$US-NOVOPROD-1268195$NOVO NORDISK$$79$YR$$$Y$$$20240819$$CN$US$US
242212771$24221277$1$I$$20240813$20240819$20240819$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14653$DE-GSK-DE2024087037$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$HP$DE$DE
242212791$24221279$1$I$$20240806$20240819$20240819$EXP$$US-NOVOPROD-1268577$NOVO NORDISK$$53$YR$$$Y$$$20240819$$CN$US$US
242212801$24221280$1$I$20220101$20240806$20240819$20240819$EXP$$EG-NOVOPROD-1266525$NOVO NORDISK$$840$MON$$F$Y$83$KG$20240819$$CN$EG$EG
242212811$24221281$1$I$$20240806$20240819$20240819$EXP$$US-NOVOPROD-1267924$NOVO NORDISK$$$$$F$Y$$$20240819$$CN$US$US
242212821$24221282$1$I$$20240806$20240819$20240819$EXP$$US-NOVOPROD-1268101$NOVO NORDISK$$68$YR$$$Y$$$20240819$$CN$US$US
242212831$24221283$1$I$$20240806$20240819$20240819$EXP$$US-NOVOPROD-1268112$NOVO NORDISK$$$$$F$Y$$$20240819$$CN$US$US
242212841$24221284$1$I$$20240806$20240819$20240819$EXP$$FR-NOVOPROD-1266440$NOVO NORDISK$$54$YR$$M$Y$$$20240819$$PH$FR$FR
242212852$24221285$2$F$20220101$20240814$20240819$20240826$EXP$$IL-NOVOPROD-1267201$NOVO NORDISK$$59$YR$$F$Y$$$20240826$$MD$IL$IL
242212861$24221286$1$I$$20240806$20240819$20240819$EXP$$US-NOVOPROD-1268464$NOVO NORDISK$$$$$F$Y$$$20240819$$CN$US$US
242212871$24221287$1$I$20240701$20240806$20240819$20240819$EXP$DK-DKMA-30737201$DK-NOVOPROD-1268310$NOVO NORDISK$$55$YR$$M$Y$115$KG$20240819$$MD$DK$DK
242212881$24221288$1$I$20240201$20240806$20240819$20240819$EXP$$US-NOVOPROD-1268346$NOVO NORDISK$$$$$F$Y$$$20240819$$CN$US$US
242212891$24221289$1$I$$20240806$20240819$20240819$EXP$$US-NOVOPROD-1268338$NOVO NORDISK$$$$$F$Y$$$20240819$$CN$US$US
242212902$24221290$2$F$20230403$20240812$20240819$20240822$EXP$SE-SEMPA-2024-005898$SE-NOVOPROD-1268331$NOVO NORDISK$$61$YR$$F$Y$63$KG$20240822$$MD$SE$SE
242212911$24221291$1$I$20240509$20240806$20240819$20240819$EXP$$US-NOVOPROD-1266481$NOVO NORDISK$$67$YR$$M$Y$$$20240819$$CN$US$US
242212922$24221292$2$F$20240701$20240813$20240819$20240823$EXP$DK-DKMA-30735177$DK-NOVOPROD-1268312$NOVO NORDISK$$56$YR$$M$Y$103$KG$20240823$$MD$DK$DK
242212931$24221293$1$I$20230101$20240806$20240819$20240819$EXP$$EE-NOVOPROD-1266432$NOVO NORDISK$$44$YR$$M$Y$$$20240819$$HP$EE$EE
242212941$24221294$1$I$20240721$20240806$20240819$20240819$EXP$CN-NMPA-3301831047620202400087$CN-NOVOPROD-1266726$NOVO NORDISK$$68$YR$$F$Y$51$KG$20240819$$HP$CN$CN
242212951$24221295$1$I$20240101$20240806$20240819$20240819$EXP$DK-DKMA-30736522$DK-NOVOPROD-1268315$NOVO NORDISK$$68$YR$$M$Y$92$KG$20240819$$MD$DK$DK
242212961$24221296$1$I$20240401$20240806$20240819$20240819$EXP$$US-NOVOPROD-1268269$NOVO NORDISK$$74$YR$$F$Y$$$20240819$$CN$US$US
242212972$24221297$2$F$20231001$20240821$20240819$20240902$EXP$$BE-NOVOPROD-1266833$NOVO NORDISK$$56$YR$$M$Y$121$KG$20240902$$MD$BE$BE
242212991$24221299$1$I$20180101$20240806$20240819$20240819$EXP$$TR-NOVOPROD-1268844$NOVO NORDISK$$$$$F$Y$$$20240819$$CN$TR$TR
242213001$24221300$1$I$$20240806$20240819$20240819$EXP$$US-NOVOPROD-1268084$NOVO NORDISK$$$$$$Y$$$20240819$$CN$US$US
242213011$24221301$1$I$20220101$20240806$20240819$20240819$EXP$$US-NOVOPROD-1268224$NOVO NORDISK$$39$YR$$M$Y$$$20240819$$CN$US$US
242213021$24221302$1$I$20240207$20240806$20240819$20240819$EXP$DK-DKMA-30729518$DK-NOVOPROD-1268320$NOVO NORDISK$$61$YR$$F$Y$$$20240819$$MD$DK$DK
242213031$24221303$1$I$$20240806$20240819$20240819$EXP$$TR-NOVOPROD-1268884$NOVO NORDISK$$$$$M$Y$$$20240819$$CN$TR$TR
242213041$24221304$1$I$20240625$20240726$20240819$20240819$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004068$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240819$$CN$US$US
242213052$24221305$2$F$20240701$20240904$20240819$20240917$EXP$$US-UCBSA-2024041272$UCB$$61$YR$$M$Y$$$20240917$$CN$US$US
242213063$24221306$3$F$$20240828$20240819$20240904$PER$$US-BAUSCH-BL-2024-012244$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240904$$CN$US$US
242213071$24221307$1$I$20240701$20240808$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126006$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240819$$HP$US$US
242213081$24221308$1$I$$20220908$20240819$20240819$EXP$$US-AstraZeneca-2022A313798$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242213091$24221309$1$I$$20240808$20240819$20240819$EXP$$PL-Orion Corporation ORION PHARMA-24_00031229$ORION$Habraszka D, Gaweda S. Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia with accompanying hereditary hemorrhagic telangiectasia. Acta Haematologica Polonica. 2024;55(2):123-5.$42$YR$A$F$Y$$$20240819$$MD$PL$
242213101$24221310$1$I$$20230925$20240819$20240819$EXP$$HN-AstraZeneca-2023A219631$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$HN$
242213111$24221311$1$I$$20211228$20240819$20240819$EXP$$CA-AstraZeneca-2021A910673$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$CA$
242213121$24221312$1$I$$20240807$20240819$20240819$EXP$$CA-NOVOPROD-1267100$NOVO NORDISK$$72$YR$$F$Y$$$20240819$$HP$CA$CA
242213131$24221313$1$I$20240711$20240807$20240819$20240819$EXP$GB-MHRA-MED-202408061346011960-BSQTJ$GB-NOVOPROD-1267479$NOVO NORDISK$$46$YR$$F$Y$98$KG$20240819$$CN$GB$GB
242213141$24221314$1$I$$20240807$20240819$20240819$EXP$$CN-NOVOPROD-1267416$NOVO NORDISK$$$$$F$Y$$$20240819$$CN$CN$CN
242213151$24221315$1$I$20240101$20240807$20240819$20240819$EXP$$CN-NOVOPROD-1267229$NOVO NORDISK$$64$YR$$F$Y$$$20240819$$CN$CN$CN
242213162$24221316$2$F$20240805$20240816$20240819$20240827$EXP$$CN-NOVOPROD-1267034$NOVO NORDISK$$$$$F$Y$$$20240827$$CN$CN$CN
242213171$24221317$1$I$20240101$20240807$20240819$20240819$EXP$$US-NOVOPROD-1268725$NOVO NORDISK$$81$YR$$M$Y$$$20240819$$CN$US$US
242213181$24221318$1$I$$20240807$20240819$20240819$EXP$$CA-NOVOPROD-1267788$NOVO NORDISK$$$$$F$Y$$$20240819$$CN$CA$CA
242213191$24221319$1$I$$20240807$20240819$20240819$EXP$$US-NOVOPROD-1266838$NOVO NORDISK$$$$A$F$Y$$$20240819$$HP$US$US
242213201$24221320$1$I$$20240807$20240819$20240819$EXP$$CH-NOVOPROD-1267866$NOVO NORDISK$$$$$M$Y$$$20240819$$MD$CH$CH
242213211$24221321$1$I$$20240807$20240819$20240819$EXP$$DE-NOVOPROD-1268370$NOVO NORDISK$$37$YR$$F$Y$$$20240819$$CN$DE$DE
242213221$24221322$1$I$$20240807$20240819$20240819$EXP$$US-NOVOPROD-1268412$NOVO NORDISK$$42$YR$$$Y$$$20240819$$CN$US$US
242213231$24221323$1$I$$20240807$20240819$20240819$EXP$$CA-NOVOPROD-1267603$NOVO NORDISK$$$$$M$Y$$$20240819$$PH$CA$CA
242213241$24221324$1$I$20240601$20240807$20240819$20240819$EXP$$US-NOVOPROD-1268396$NOVO NORDISK$$52$YR$$F$Y$$$20240819$$CN$US$US
242213251$24221325$1$I$$20240807$20240819$20240819$EXP$$JP-NOVOPROD-1267027$NOVO NORDISK$$60$YR$$M$Y$$$20240819$$PH$JP$JP
242213271$24221327$1$I$$20240807$20240819$20240819$EXP$$US-NOVOPROD-1268823$NOVO NORDISK$$$$$M$Y$$$20240819$$CN$US$US
242213281$24221328$1$I$$20240807$20240819$20240819$EXP$$US-NOVOPROD-1268938$NOVO NORDISK$$57$YR$$$Y$$$20240819$$CN$US$US
242213301$24221330$1$I$20240201$20240807$20240819$20240819$EXP$$NL-NOVOPROD-1267217$NOVO NORDISK$$$$E$F$Y$$$20240819$$HP$NL$NL
242213311$24221331$1$I$$20240807$20240819$20240819$EXP$$US-NOVOPROD-1268442$NOVO NORDISK$$$$$M$Y$$$20240819$$CN$US$US
242213321$24221332$1$I$$20240806$20240819$20240819$EXP$$CA-NOVOPROD-1269674$NOVO NORDISK$$$$A$M$Y$$$20240819$$CN$CA$CA
242213331$24221333$1$I$$20240814$20240819$20240819$EXP$$US-JNJFOC-20240836064$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$US$US
242213341$24221334$1$I$$20240807$20240819$20240819$EXP$GB-MHRA-EMIS-1444-cccb10b0-493d-46c2-96e4-e397899df535$GB-NOVOPROD-1267483$NOVO NORDISK$$66$YR$$F$Y$87$KG$20240819$$PH$GB$GB
242213351$24221335$1$I$20240101$20240806$20240819$20240819$EXP$$US-NOVOPROD-1268170$NOVO NORDISK$$66$YR$$M$Y$103.86$KG$20240819$$CN$US$US
242213361$24221336$1$I$$20240814$20240819$20240819$EXP$$GB-JNJFOC-20240841344$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$HP$GB$GB
242213371$24221337$1$I$$20240816$20240819$20240819$EXP$$FR-SANDOZ INC.-SDZ2024FR073072$SANDOZ$$75$YR$$F$Y$$$20240819$$HP$FR$FR
242213381$24221338$1$I$20240314$20240807$20240819$20240819$EXP$$DE-AUROBINDO-AUR-APL-2024-040415$AUROBINDO$$64$YR$$F$Y$$$20240819$$MD$DE$DE
242213391$24221339$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000059602$ROCHE$$39$YR$A$F$Y$$$20240819$$CN$US$US
242213401$24221340$1$I$$20240813$20240819$20240819$30DAY$$US-GSK-US2024100842$GLAXOSMITHKLINE$$$$$M$Y$$$20240819$$CN$US$US
242213411$24221341$1$I$$20240815$20240819$20240819$PER$$US-ABBVIE-5883921$ABBVIE$$$$$$Y$$$20240819$$HP$US$US
242213421$24221342$1$I$$20240808$20240819$20240819$EXP$$US-NOVOPROD-1269472$NOVO NORDISK$$50$YR$$M$Y$$$20240819$$HP$US$US
242213431$24221343$1$I$$20240808$20240819$20240819$EXP$$US-NOVOPROD-1269466$NOVO NORDISK$$45$YR$$F$Y$$$20240819$$CN$US$US
242213441$24221344$1$I$$20240807$20240819$20240819$EXP$$TR-NOVOPROD-1269664$NOVO NORDISK$$$$$M$Y$73$KG$20240819$$CN$TR$TR
242213451$24221345$1$I$$20240808$20240819$20240819$EXP$$US-NOVOPROD-1269485$NOVO NORDISK$$41$YR$$$Y$$$20240819$$CN$US$US
242213461$24221346$1$I$$20240808$20240819$20240819$EXP$$US-NOVOPROD-1268822$NOVO NORDISK$$$$$F$Y$$$20240819$$CN$US$US
242213471$24221347$1$I$$20240808$20240819$20240819$EXP$$US-NOVOPROD-1269486$NOVO NORDISK$$62$YR$$$Y$$$20240819$$CN$US$US
242213481$24221348$1$I$$20240807$20240819$20240819$EXP$$US-NOVOPROD-1269094$NOVO NORDISK$$51$YR$$$Y$$$20240819$$CN$US$US
242213491$24221349$1$I$$20240808$20240819$20240819$EXP$$US-NOVOPROD-1269451$NOVO NORDISK$$29$YR$$$Y$$$20240819$$CN$US$US
242213501$24221350$1$I$$20240808$20240819$20240819$EXP$$US-NOVOPROD-1269476$NOVO NORDISK$$53$YR$$F$Y$$$20240819$$CN$US$US
242213511$24221351$1$I$$20240809$20240819$20240819$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001615$BLUEPRINT MEDICINES$$$$$F$Y$$$20240819$$CN$US$US
242213524$24221352$4$F$$20240917$20240819$20240924$PER$$NVSC2024US167176$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
242213531$24221353$1$I$$20240809$20240819$20240819$30DAY$$NO-SANDOZ INC.-SDZ2024NO072711$SANDOZ$$$$$$Y$$$20240819$$CN$NO$NO
242213541$24221354$1$I$20230914$20240805$20240819$20240819$EXP$$NL-AZURITY PHARMACEUTICALS, INC.-AZR202310-000004$AZURITY PHARMACEUTICALS$$75$YR$$M$Y$75$KG$20240819$$MD$NL$NL
242213551$24221355$1$I$20240505$20240807$20240819$20240819$EXP$$GB-AUROBINDO-AUR-APL-2024-033781$AUROBINDO$$15$YR$$F$Y$$$20240819$$MD$GB$GB
242213561$24221356$1$I$20221215$20240808$20240819$20240819$EXP$$GB-AUROBINDO-AUR-APL-2024-040265$AUROBINDO$$38$YR$$F$Y$$$20240819$$CN$GB$GB
242213572$24221357$2$F$20240601$20240822$20240819$20240826$EXP$$CN-GSK-CN2024APC101000$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$CN$CN
242213581$24221358$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009971$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240819$$CN$US$US
242213592$24221359$2$F$20240814$20240819$20240819$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009332$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240821$$CN$US$US
242213601$24221360$1$I$20240815$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010915$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240819$$CN$US$US
242213611$24221361$1$I$$20240812$20240819$20240819$PER$$US-ROCHE-10000056219$ROCHE$$69$YR$E$F$Y$$$20240819$$CN$US$US
242213621$24221362$1$I$$20240815$20240819$20240819$EXP$$DE-SANDOZ INC.-SDZ2024DE072941$SANDOZ$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$80$YR$$M$Y$$$20240819$$HP$DE$DE
242213631$24221363$1$I$$20240815$20240819$20240819$PER$$US-ABBVIE-5882625$ABBVIE$$$$$F$Y$$$20240819$$HP$US$US
242213642$24221364$2$F$$20240813$20240819$20240826$EXP$$DE-AUROBINDO-AUR-APL-2024-040424$AUROBINDO$Lancia M, Gambelunghe A, Gili A, Bacci M, Aroni K, Gambelunghe C.. Pregabalin Abuse in Combination With Other Drugs: Monitoring Among Methadone Patients. Frontiers in Psychiatry. 2020;10:1022$44$YR$$F$Y$$$20240826$$HP$DE$DE
242213651$24221365$1$I$$20240809$20240819$20240819$30DAY$$US-GSK-US2024AMR100428$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$PH$US$US
242213661$24221366$1$I$$20240812$20240819$20240819$EXP$$IT-ROCHE-10000057032$ROCHE$Zappulo E, Ametrano L, Barbato S, Fusco L, Severino A, Pane F, et al. Clinical Features And Impact on Mortality of COVID-19 Epidemics in Patients with Non-Hodgkin Lymphoma: Long-Term Results from a Tertiary center in Italy. [Abstract no. OC59]. Sexually Transmitted Infections. 2024-Jun;100 (SUPP: 1):A56-7. doi:10.1136/sextrans-ICAR-2024.53.$$$$$Y$$$20240819$$HP$IT$IT
242213671$24221367$1$I$$20240805$20240819$20240819$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK093263$GLENMARK$$$$$$Y$$$20240819$$HP$CA$CA
242213682$24221368$2$F$20230101$20240828$20240819$20240830$EXP$US-MLMSERVICE-20240530-PI081249-00095-2$US-SANDOZ INC.-SDZ2024US072779$SANDOZ$$52$YR$$F$Y$$$20240830$$MD$US$US
242213691$24221369$1$I$$20230628$20240819$20240819$EXP$$US-AstraZeneca-2023A149336$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242213701$24221370$1$I$20230630$20230717$20240819$20240819$EXP$$IT-AstraZeneca-2023A162366$ASTRAZENECA$$43$YR$$M$Y$$$20240819$$MD$IT$
242213711$24221371$1$I$$20220214$20240819$20240819$EXP$$US-AstraZeneca-2022A072699$ASTRAZENECA$$$$$M$Y$66.7$KG$20240819$$CN$US$
242213721$24221372$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162597$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242213732$24221373$2$F$20240518$20240815$20240819$20240821$EXP$$NVSC2024GB107081$NOVARTIS$$35$YR$$F$Y$$$20240821$$HP$GB$GB
242213741$24221374$1$I$$20240809$20240819$20240819$EXP$$US-JNJFOC-20240825359$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240819$$CN$US$US
242213751$24221375$1$I$$20240726$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004072$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242213761$24221376$1$I$20240718$20240808$20240819$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-040823$AUROBINDO$$20$YR$$M$Y$70$KG$20240819$$PH$FR$FR
242213771$24221377$1$I$$20240813$20240819$20240819$PER$$US-ALXN-202408USA000759US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242213781$24221378$1$I$$20240811$20240819$20240819$PER$$US-AMGEN-USASP2024162447$AMGEN$Ogdie A. DRUG SURVIVAL OF FIRST-LINE TNF AND APREMILAST AND DESCRIPTION OF SECONDLINE THERAPY AMONG PSORIATIC ARTHRITIS (PSA) PATIENTS IN THE COREVITAS PSA/ SPONDYLOARTHRITIS (SPA) REGISTRY. Annals of the Rheumatic Diseases. 2024;83:703-704$$$$$Y$$$20240819$$HP$US$US
242213791$24221379$1$I$$20240803$20240819$20240819$PER$$US-EPICPHARMA-US-2024EPCSPO01016$EPIC PHARM$$$$$F$Y$200$KG$20240819$$CN$US$US
242213801$24221380$1$I$$20240807$20240819$20240819$PER$$US-JNJFOC-20240821208$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$MD$US$US
242213811$24221381$1$I$20240730$20240809$20240819$20240819$EXP$$CN-SANDOZ INC.-SDZ2024CN073263$SANDOZ$$7$YR$$M$Y$15$KG$20240819$$HP$CN$CN
242213821$24221382$1$I$$20240726$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004073$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242213831$24221383$1$I$20240212$20240808$20240819$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-040609$AUROBINDO$$79$YR$$F$Y$52$KG$20240819$$PH$FR$FR
242213841$24221384$1$I$$20240812$20240819$20240819$EXP$$CN-ROCHE-10000055695$ROCHE$Xia Y, Cai Q, Zhang P, Tian X, Fang X. Orelabrutinib, rituximab, temozolomide and high-dose methotrexate (RMOT) in newly diagnosed primary central nervous system lymphoma (PCNSL): A retrospective analysis on efficacy and safety. [Abstract number: e19041]. Journal of Clinical Oncology. 2024-Jun;42 (16):$$$$$Y$$$20240819$$HP$CN$CN
242213851$24221385$1$I$$20240809$20240819$20240819$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24826$SAMSUNG BIOEPIS$$57$YR$A$F$Y$$$20240819$$CN$GB$GB
242213861$24221386$1$I$20240529$20240812$20240819$20240819$EXP$$SG-ROCHE-10000054939$ROCHE$$56$YR$A$M$Y$$$20240819$$HP$SG$SG
242213871$24221387$1$I$20240712$20240808$20240819$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-040596$AUROBINDO$$77$YR$$M$Y$$$20240819$$PH$FR$FR
242213881$24221388$1$I$20200301$20240807$20240819$20240819$EXP$$DE-AUROBINDO-AUR-APL-2024-040552$AUROBINDO$$41$YR$$F$Y$90$KG$20240819$$CN$DE$DE
242213892$24221389$2$F$$20240821$20240819$20240828$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001611$BLUEPRINT MEDICINES$$$$$F$Y$$$20240828$$CN$US$US
242213901$24221390$1$I$$20240813$20240819$20240819$PER$$US-JNJFOC-20240840895$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240819$$MD$US$US
242213911$24221391$1$I$20240704$20240814$20240819$20240819$EXP$IT-MINISAL02-998849$IT-JNJFOC-20240842964$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240819$$MD$IT$IT
242213922$24221392$2$F$20240801$20240816$20240819$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004083$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240910$$CN$US$US
242213931$24221393$1$I$$20240814$20240819$20240819$30DAY$$US-GSK-US2024101431$GLAXOSMITHKLINE$$$$A$M$Y$$$20240819$$CN$US$US
242213941$24221394$1$I$$20240809$20240819$20240819$30DAY$$US-GSK-US2024099785$GLAXOSMITHKLINE$$$$$M$Y$$$20240819$$CN$US$US
242213951$24221395$1$I$20240401$20240808$20240819$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-040587$AUROBINDO$$24$YR$$F$Y$$$20240819$$MD$FR$FR
242213965$24221396$5$F$20240802$20240924$20240819$20240930$EXP$$CA-TAKEDA-2024TUS078633$TAKEDA$$19$YR$$F$Y$104$KG$20240930$$MD$CA$CA
242213971$24221397$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129601$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240819$$HP$US$US
242213981$24221398$1$I$20240524$20240807$20240819$20240819$EXP$$JP-ROCHE-10000017017$ROCHE$$79$YR$E$M$Y$$$20240819$$MD$JP$JP
242213991$24221399$1$I$20240201$20240727$20240819$20240819$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004054$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240819$$CN$US$US
242214001$24221400$1$I$$20240812$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US072662$SANDOZ$$$$$$Y$$$20240819$$CN$US$US
242214012$24221401$2$F$20230522$20240902$20240819$20240903$EXP$$NL-ORGANON-O2408NLD000980$ORGANON$$9$YR$$M$Y$$$20240903$$CN$NL$NL
242214022$24221402$2$F$$20240903$20240819$20240903$PER$$US-ALXN-202408USA000764US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242214031$24221403$1$I$$20230221$20240819$20240819$EXP$$US-AstraZeneca-2023A044252$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242214041$24221404$1$I$$20220628$20240819$20240819$EXP$$US-AstraZeneca-2022A240020$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242214051$24221405$1$I$$20220523$20240819$20240819$EXP$$US-AstraZeneca-2022A198853$ASTRAZENECA$$$$$F$Y$36.6$KG$20240819$$CN$US$
242214061$24221406$1$I$$20240812$20240819$20240819$PER$$US-ALXN-202408USA000794US$ALEXION PHARMACEUTICALS$$$$$F$Y$114.29$KG$20240819$$CN$US$US
242214081$24221408$1$I$20231226$20240812$20240819$20240819$EXP$FR-AFSSAPS-NY2024000936$FR-PFIZER INC-202400234263$PFIZER$$57$YR$$M$Y$76$KG$20240819$$PH$FR$FR
242214091$24221409$1$I$20240614$20240813$20240819$20240819$EXP$$IT-PFIZER INC-202400235372$PFIZER$$43$YR$$F$Y$$$20240819$$MD$IT$IT
242214102$24221410$2$F$20240529$20240826$20240819$20240903$EXP$$CN-PFIZER INC-202400191178$PFIZER$$35$YR$$M$Y$92$KG$20240903$$MD$CN$CN
242214111$24221411$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009860$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240819$$CN$US$US
242214121$24221412$1$I$$20240808$20240819$20240819$EXP$$CN-ROCHE-10000052947$ROCHE$Pan C, Ge L, Zhang H, Sang K, Zhou J, Yi T, et al. Case report: A promising neoadjuvant treatment option for individuals with locally advanced HER2-positive breast cancer involves the use of Pyrotinib Maleate in combination with Trastuzumab and Pertuzumab. Heliyon. 2024-Jul-11;10 (14):e34511. doi:10.1016/j.heliyon.2024.e34511.$64$YR$A$F$Y$$$20240819$$HP$CN$CN
242214141$24221414$1$I$$20240808$20240819$20240819$EXP$$CA-AUROBINDO-AUR-APL-2024-040704$AUROBINDO$$15$YR$$F$Y$51$KG$20240819$$MD$CA$CA
242214152$24221415$2$F$20240101$20240904$20240819$20240912$EXP$$CA-CELLTRION INC.-2024CA019762$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
242214171$24221417$1$I$20240715$20240813$20240819$20240819$EXP$$CA-JNJFOC-20240836294$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240819$$HP$CA$CA
242214181$24221418$1$I$20230201$20240731$20240819$20240819$PER$$US-TEVA-VS-3228973$TEVA$$31$YR$$F$Y$$$20240819$$CN$US$US
242214191$24221419$1$I$20240101$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130033$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240819$$CN$US$US
242214202$24221420$2$F$$20240829$20240819$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-129203$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240905$$PH$JP$JP
242214221$24221422$1$I$20240701$20240807$20240819$20240819$EXP$$JP-ROCHE-10000055562$ROCHE$$$$E$M$Y$$$20240819$$MD$JP$JP
242214231$24221423$1$I$20181201$20240812$20240819$20240819$EXP$$US-CHEPLA-2022008427$CHEPLAPHARM$$58$YR$A$F$Y$$$20240819$$CN$COUNTRY NOT SPECIFIED$US
242214241$24221424$1$I$20240723$20240812$20240819$20240819$EXP$FR-AFSSAPS-LY2024001216$FR-CHEPLA-2024010567$CHEPLAPHARM$$61$YR$$F$Y$65$KG$20240819$$PH$COUNTRY NOT SPECIFIED$FR
242214261$24221426$1$I$20240725$20240819$20240819$20240819$EXP$FR-AFSSAPS-TO2024001578$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046418$BOEHRINGER INGELHEIM$$89$YR$E$M$Y$74$KG$20240819$$HP$FR$FR
242214271$24221427$1$I$20230330$20240809$20240819$20240819$EXP$$DE-SANDOZ INC.-SDZ2024DE072132$SANDOZ$$65$YR$$F$Y$67$KG$20240819$$HP$DE$DE
242214281$24221428$1$I$$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024161450$AMGEN$$66$YR$E$F$Y$$$20240819$$CN$US$US
242214291$24221429$1$I$$20240813$20240819$20240819$PER$$US-ALXN-202408USA000777US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
242214301$24221430$1$I$$20240813$20240819$20240819$PER$$US-ALXN-202408USA000811US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242214312$24221431$2$F$20240605$20240815$20240819$20240822$PER$$US-ABBVIE-5882607$ABBVIE$$12$YR$$$Y$44$KG$20240822$$HP$US$US
242214321$24221432$1$I$$20240815$20240819$20240819$PER$$US-AMGEN-USASP2024163544$AMGEN$$$$$$Y$$$20240819$$PH$US$US
242214331$24221433$1$I$$20240809$20240819$20240819$EXP$$US-TEVA-VS-3233736$TEVA$$67$YR$$M$Y$$$20240819$$HP$US$US
242214341$24221434$1$I$$20240808$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127340$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240819$$PH$US$US
242214351$24221435$1$I$20240101$20240813$20240819$20240819$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-129970$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240819$$PH$FR$FR
242214361$24221436$1$I$$20240812$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127911$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240819$$CN$US$US
242214371$24221437$1$I$20231101$20240808$20240819$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-040703$AUROBINDO$$62$YR$$F$Y$$$20240819$$HP$FR$FR
242214381$24221438$1$I$$20240809$20240819$20240819$EXP$$US-RECORDATI-2024006219$RECORDATI$$$$$$Y$$$20240819$$HP$US$US
242214391$24221439$1$I$$20240806$20240819$20240819$EXP$$DE-VANTIVE-2024VAN018694$Vantive US Healthcare$$$$$M$Y$73$KG$20240819$$MD$DE$DE
242214402$24221440$2$F$20231201$20240820$20240819$20240823$EXP$$EG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-001692$BOEHRINGER INGELHEIM$$56$YR$A$F$Y$71$KG$20240823$$CN$EG$EG
242214411$24221441$1$I$20240815$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010913$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240819$$CN$US$US
242214421$24221442$1$I$20240816$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010970$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240819$$CN$US$US
242214431$24221443$1$I$20240727$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010278$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240819$$CN$US$US
242214441$24221444$1$I$20240814$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024163577$AMGEN$$84$YR$E$F$Y$$$20240819$$CN$US$US
242214452$24221445$2$F$$20240827$20240819$20240902$PER$$US-AMGEN-USASP2024161654$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian journal ofOphthalmology/Journal Canadien d^Ophtalmologie. 2024;1-6$$$$$Y$$$20240902$$MD$US$US
242214462$24221446$2$F$20240810$20240814$20240819$20240823$PER$$US-AMGEN-USASP2024162709$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242214472$24221447$2$F$20240813$20240904$20240819$20240904$PER$$US-ALXN-202408USA000780US$ALEXION PHARMACEUTICALS$$17$YR$$F$Y$$$20240904$$CN$US$US
242214482$24221448$2$F$$20240916$20240819$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001640$BLUEPRINT MEDICINES$$$$$F$Y$$$20240920$$MD$US$US
242214491$24221449$1$I$$20240812$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127991$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240819$$HP$US$US
242214501$24221450$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130130$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240819$$CN$US$US
242214511$24221451$1$I$$20240805$20240819$20240819$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK093265$GLENMARK$$$$$$Y$$$20240819$$HP$CA$CA
242214521$24221452$1$I$$20240814$20240819$20240819$EXP$$JP-GSK-JP2024JPN101467$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$CN$JP$JP
242214531$24221453$1$I$$20240812$20240819$20240819$EXP$$US-SA-2024SA242200$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240819$$CN$US$US
242214541$24221454$1$I$20240629$20240812$20240819$20240819$EXP$CH-SM-2024-14873$CH-SA-2024SA242636$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240819$$MD$CH$CH
242214551$24221455$1$I$20240701$20240722$20240819$20240819$PER$$FR-TOLMAR, INC.-24FR051197$TOLMAR$$78$YR$$M$Y$$$20240819$$PH$FR$FR
242214561$24221456$1$I$$20230606$20240819$20240819$EXP$$US-AstraZeneca-2023A133057$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242214572$24221457$2$F$$20240821$20240819$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA072544$SANDOZ$$60$YR$$F$Y$$$20240823$$MD$CA$CA
242214581$24221458$1$I$20240101$20240722$20240819$20240819$PER$$NL-TOLMAR, INC.-24NL051196$TOLMAR$$$$$M$Y$$$20240819$$CN$NL$NL
242214591$24221459$1$I$20210101$20240722$20240819$20240819$PER$$PA-TOLMAR, INC.-24PA051215$TOLMAR$$$$$M$Y$$$20240819$$CN$PA$PA
242214601$24221460$1$I$$20221005$20240819$20240819$EXP$$TW-AstraZeneca-2022A339768$ASTRAZENECA$$79$YR$$M$Y$$$20240819$$HP$TW$
242214611$24221461$1$I$20240722$20240722$20240819$20240819$PER$$TR-TOLMAR, INC.-24TR051199$TOLMAR$$$$$$Y$$$20240819$$HP$TR$TR
242214621$24221462$1$I$$20230504$20240819$20240819$EXP$$US-AstraZeneca-2023A105478$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242214631$24221463$1$I$$20221220$20240819$20240819$EXP$$US-AstraZeneca-2022A414833$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242214641$24221464$1$I$$20230324$20240819$20240819$EXP$$US-AstraZeneca-2023A071162$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242214651$24221465$1$I$$20221012$20240819$20240819$EXP$$US-AstraZeneca-2022A345639$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242214661$24221466$1$I$$20220801$20240819$20240819$EXP$$CA-AstraZeneca-2022A273809$ASTRAZENECA$$51$YR$$F$Y$$$20240819$$MD$CA$
242214671$24221467$1$I$20230101$20240809$20240819$20240819$EXP$$BR-NOVOPROD-1267848$NOVO NORDISK$$531$MON$$F$Y$$$20240819$$CN$BR$BR
242214681$24221468$1$I$$20240808$20240819$20240819$EXP$$US-NOVOPROD-1269490$NOVO NORDISK$$63$YR$$$Y$$$20240819$$CN$US$US
242214691$24221469$1$I$$20240808$20240819$20240819$EXP$$US-NOVOPROD-1269488$NOVO NORDISK$$67$YR$$$Y$$$20240819$$CN$US$US
242214701$24221470$1$I$$20240808$20240819$20240819$EXP$$US-NOVOPROD-1269491$NOVO NORDISK$$71$YR$$$Y$$$20240819$$CN$US$US
242214711$24221471$1$I$$20240812$20240819$20240819$PER$$US-ROCHE-10000056676$ROCHE$$$$$$Y$$$20240819$$CN$US$US
242214721$24221472$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129515$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240819$$CN$US$US
242214731$24221473$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129338$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240819$$CN$US$US
242214741$24221474$1$I$$20240810$20240819$20240819$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-128458$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240819$$MD$IL$IL
242214751$24221475$1$I$$20240812$20240819$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012553$JAZZ$$$$$M$Y$$$20240819$$CN$US$US
242214761$24221476$1$I$$20240809$20240819$20240819$EXP$$AT-TEVA-VS-3233291$TEVA$$70$YR$$F$Y$$$20240819$$MD$AT$AT
242214771$24221477$1$I$20240101$20240813$20240819$20240819$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046126$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$$$20240819$$CN$US$US
242214781$24221478$1$I$$20240809$20240819$20240819$EXP$$IN-TAKEDA-2024TUS082312$TAKEDA$$$$$$Y$$$20240819$$HP$IN$IN
242214791$24221479$1$I$$20240812$20240819$20240819$EXP$$BR-JNJFOC-20240837176$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$MD$BR$BR
242214801$24221480$1$I$20240513$20240808$20240819$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-040737$AUROBINDO$$30$YR$$F$Y$$$20240819$$PH$FR$FR
242214811$24221481$1$I$20240101$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024163062$AMGEN$$$$$F$Y$$$20240819$$HP$US$US
242214822$24221482$2$F$$20240904$20240819$20240904$PER$$US-ALXN-202408USA000678US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240904$$CN$US$US
242214831$24221483$1$I$$20240805$20240819$20240819$EXP$$US-EPICPHARMA-US-2024EPCLIT00971$EPIC PHARM$EJ Patel.Invasive Fungal Sinusitis in an Immunocompetent Patient After Sinus Surgery for Chronic Rhinosinusitis with Nasal Polyps and a Mycetoma.Laryngoscope.APR-2024$38$YR$A$F$Y$$$20240819$$HP$US$US
242214841$24221484$1$I$20240101$20240808$20240819$20240819$EXP$ES-AEMPS-1556067$ES-ROCHE-10000057082$ROCHE$$49$YR$A$M$Y$72$KG$20240819$$HP$ES$ES
242214851$24221485$1$I$$20220801$20240819$20240819$EXP$$US-AstraZeneca-2022A277182$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242214861$24221486$1$I$$20221227$20240819$20240819$EXP$$US-AstraZeneca-2022A419434$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242214871$24221487$1$I$$20221208$20240819$20240819$EXP$$IN-AstraZeneca-2022A405362$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$IN$
242214881$24221488$1$I$$20220426$20240819$20240819$EXP$$US-AstraZeneca-2022A114169$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242214891$24221489$1$I$$20240811$20240819$20240819$EXP$$US-JNJFOC-20240828380$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
242214901$24221490$1$I$$20230718$20240819$20240819$EXP$$US-AstraZeneca-2023A128678$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242214911$24221491$1$I$$20220928$20240819$20240819$EXP$$US-AstraZeneca-2022A333609$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242214921$24221492$1$I$$20230428$20240819$20240819$EXP$$US-AstraZeneca-2023A100601$ASTRAZENECA$$$$C$F$Y$17.5$KG$20240819$$CN$US$
242214931$24221493$1$I$$20221031$20240819$20240819$EXP$$US-AstraZeneca-2022A364709$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242214941$24221494$1$I$$20230524$20240819$20240819$EXP$$US-AstraZeneca-2023A120515$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242214951$24221495$1$I$20220903$20221223$20240819$20240819$EXP$$US-AstraZeneca-2022A416485$ASTRAZENECA$$27640$DY$$F$Y$$$20240819$$CN$US$
242214961$24221496$1$I$$20221214$20240819$20240819$EXP$$US-AstraZeneca-2022A408056$ASTRAZENECA$$$$$F$Y$67$KG$20240819$$HP$US$
242214971$24221497$1$I$$20240815$20240819$20240819$PER$$US-BIOVITRUM-2024-US-010969$BIOVITRUM$$72$YR$$M$Y$$$20240819$$CN$US$US
242214981$24221498$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130382$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240819$$CN$US$US
242214991$24221499$1$I$20240110$20240207$20240819$20240819$EXP$ES-AEMPS-1477875$ES-NORMON-2024000465$NORMON$$80$YR$E$F$Y$$$20240819$$HP$ES$
242215001$24221500$1$I$$20240805$20240819$20240819$EXP$$PT-EPICPHARMA-PT-2024EPCLIT01001$EPIC PHARM$M Alzamora.Different kinds of embolization in advanced carcinomas: A review of literature, visual comparison and possible complications.Virchows Archiv.SEP-2023;483 (Suppl.):S218-S219$$$$M$Y$$$20240819$$HP$PT$PT
242215011$24221501$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010782$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240819$$CN$US$US
242215021$24221502$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010531$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240819$$CN$US$US
242215031$24221503$1$I$$20240813$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408008505$ELI LILLY AND CO$$$$$$Y$$$20240819$$CN$US$US
242215041$24221504$1$I$$20240809$20240819$20240819$EXP$$GB-AUROBINDO-AUR-APL-2024-040449$AUROBINDO$$$$$M$Y$$$20240819$$CN$GB$GB
242215052$24221505$2$F$20240101$20240822$20240819$20240827$PER$$US-AMGEN-USASP2024163844$AMGEN$$46$YR$A$M$Y$$$20240826$$MD$US$US
242215061$24221506$1$I$$20240815$20240819$20240819$PER$$US-AMGEN-USASP2024163527$AMGEN$$$$$$Y$$$20240819$$PH$US$US
242215071$24221507$1$I$20240809$20240812$20240819$20240819$EXP$$IN-JNJFOC-20240834758$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240819$$MD$IN$IN
242215082$24221508$2$F$20180101$20240921$20240819$20240925$EXP$$CA-TAKEDA-2018TUS021956$TAKEDA$$$$$F$Y$48$KG$20240925$$CN$CA$CA
242215092$24221509$2$F$20240101$20240821$20240819$20240826$EXP$$US-AMGEN-USASP2024160089$AMGEN$$82$YR$E$M$Y$$$20240826$$CN$US$US
242215102$24221510$2$F$20240124$20240816$20240819$20240823$EXP$CH-SM-2024-14179$CH-Blueprint Medicines Corporation-SP-CH-2024-001610$BLUEPRINT MEDICINES$$71$YR$E$M$Y$$$20240824$$MD$CH$CH
242215111$24221511$1$I$$20240813$20240819$20240819$EXP$$US-TAKEDA-2024TUS023486$TAKEDA$$$$$M$Y$$$20240819$$CN$US$US
242215121$24221512$1$I$$20240718$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07350$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242215131$24221513$1$I$$20230628$20240819$20240819$EXP$$US-AstraZeneca-2023A149423$ASTRAZENECA$$$$$M$Y$$$20240819$$MD$US$
242215141$24221514$1$I$$20221214$20240819$20240819$EXP$$US-AstraZeneca-2022A407969$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242215151$24221515$1$I$$20240812$20240819$20240819$PER$$US-ALXN-202408USA000755US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
242215161$24221516$1$I$$20230718$20240819$20240819$EXP$$AU-AstraZeneca-2023A098876$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$AU$
242215171$24221517$1$I$$20230830$20240819$20240819$EXP$$US-AstraZeneca-2023A200401$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242215181$24221518$1$I$$20221123$20240819$20240819$EXP$$US-AstraZeneca-2022A388393$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242215191$24221519$1$I$20220902$20230619$20240819$20240819$EXP$$US-AstraZeneca-2023A142220$ASTRAZENECA$$25079$DY$$F$Y$$$20240819$$CN$US$
242215201$24221520$1$I$20220304$20220517$20240819$20240819$EXP$$US-AstraZeneca-2022A137102$ASTRAZENECA$$32142$DY$$M$Y$$$20240819$$CN$US$
242215211$24221521$1$I$$20240813$20240819$20240819$EXP$$US-EMD Serono-2024043787$EMD SERONO INC$$56$YR$A$F$Y$$$20240819$$HP$US$US
242215221$24221522$1$I$$20240814$20240819$20240819$EXP$$US-ABBVIE-5882153$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242215231$24221523$1$I$20240605$20240813$20240819$20240819$EXP$$CO-UCBSA-2024041534$UCB$$76$YR$$M$Y$$$20240819$$CN$CO$CO
242215241$24221524$1$I$$20240805$20240819$20240819$EXP$$US-EPICPHARMA-US-2024EPCLIT00973$EPIC PHARM$Shane W. Quo.Significant Esophageal and Intestiinal Ulcerations in the Setting of Recent Chemotherapy for Pancreatic Adenocarcinoma .Gastroenterology.MAY-2023;164:S-1209-S-1210$72$YR$E$M$Y$$$20240819$$HP$US$US
242215251$24221525$1$I$20231201$20240809$20240819$20240819$EXP$$BR-TAKEDA-2023TUS054233$TAKEDA$$49$YR$$F$Y$$$20240819$$CN$BR$BR
242215261$24221526$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130095$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$58.06$KG$20240819$$HP$US$US
242215271$24221527$1$I$20210508$20220217$20240819$20240819$EXP$$CA-CELLTRION INC.-2021CA019569$CELLTRION$$$$$$Y$$$20240819$$CN$CA$CA
242215281$24221528$1$I$$20240809$20240819$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012332$JAZZ$$$$$F$Y$28$KG$20240819$$CN$US$US
242215291$24221529$1$I$$20240815$20240819$20240819$EXP$$DE-SANDOZ INC.-SDZ2024DE072930$SANDOZ$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$79$YR$$M$Y$$$20240819$$HP$DE$DE
242215301$24221530$1$I$$20240717$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07245$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242215311$24221531$1$I$20200221$20240812$20240819$20240819$EXP$$CA-CELLTRION INC.-2019CA028736$CELLTRION$$$$$$Y$$$20240819$$MD$CA$CA
242215321$24221532$1$I$$20240809$20240819$20240819$30DAY$$US-GSK-US2024099777$GLAXOSMITHKLINE$$$$$M$Y$$$20240819$$PH$US$US
242215331$24221533$1$I$20240101$20240813$20240819$20240819$EXP$$AT-ABBVIE-5880687$ABBVIE$$31$YR$$M$Y$$$20240819$$CN$AT$AT
242215341$24221534$1$I$$20240807$20240819$20240819$EXP$$GB-AUROBINDO-AUR-APL-2024-040075$AUROBINDO$$$$$M$Y$$$20240819$$CN$GB$GB
242215351$24221535$1$I$20240101$20240814$20240819$20240819$EXP$$US-ABBVIE-5882031$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242215361$24221536$1$I$$20240815$20240819$20240819$EXP$$DE-SANDOZ INC.-SDZ2024DE072937$SANDOZ$Groth O, Roider G, Graw M. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$80$YR$$F$Y$$$20240819$$HP$DE$DE
242215371$24221537$1$I$20231024$20240813$20240819$20240819$EXP$$CA-JNJFOC-20231061310$JOHNSON AND JOHNSON$$25$YR$A$F$Y$101$KG$20240819$$HP$CA$CA
242215381$24221538$1$I$$20240814$20240819$20240819$EXP$$CA-TAKEDA-2021TUS018417$TAKEDA$$$$$F$Y$$$20240819$$CN$CA$CA
242215391$24221539$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129526$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240819$$CN$US$US
242215401$24221540$1$I$20240729$20240810$20240819$20240819$EXP$$CN-BEIGENE-BGN-2024-012528$BEIGENE$$$$$$Y$$$20240819$$HP$CN$CN
242215412$24221541$2$F$$20240829$20240819$20240902$EXP$$JP-GSK-JP2024JPN100931$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$PH$JP$JP
242215421$24221542$1$I$$20221215$20240819$20240819$EXP$$US-AstraZeneca-2022A409223$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242215432$24221543$2$F$20240731$20240823$20240819$20240828$EXP$$US-GILEAD-2024-0684476$GILEAD$$33$YR$A$F$Y$$$20240828$$CN$US$US
242215441$24221544$1$I$$20230418$20240819$20240819$EXP$$US-AstraZeneca-2023A055717$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242215451$24221545$1$I$$20230901$20240819$20240819$EXP$$US-AstraZeneca-2023A199956$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242215461$24221546$1$I$20221114$20221116$20240819$20240819$EXP$$US-AstraZeneca-2022A381921$ASTRAZENECA$$24898$DY$$F$Y$$$20240819$$CN$US$
242215471$24221547$1$I$$20230317$20240819$20240819$EXP$$US-AstraZeneca-2023A065192$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242215481$24221548$1$I$$20230421$20240819$20240819$EXP$$US-AstraZeneca-2023A092241$ASTRAZENECA$$3563$WK$$M$Y$$$20240819$$CN$US$
242215491$24221549$1$I$$20230217$20240819$20240819$EXP$$US-AstraZeneca-2023A042188$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242215501$24221550$1$I$$20220831$20240819$20240819$EXP$$US-AstraZeneca-2022A304555$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242215512$24221551$2$F$20230101$20240828$20240819$20240903$EXP$$CA-ORGANON-O2408CAN001261$ORGANON$$$$$F$Y$84.59$KG$20240903$$MD$CA$CA
242215521$24221552$1$I$20240810$20240813$20240819$20240819$EXP$GB-MHRA-MED-202408131359032980-FBRDC$GB-GE HEALTHCARE-2024CSU009296$GE HEALTHCARE$$63$YR$$F$Y$$$20240819$$HP$GB$GB
242215531$24221553$1$I$20240815$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010133$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240819$$CN$US$US
242215541$24221554$1$I$$20240723$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07497$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242215551$24221555$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010091$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240819$$CN$US$US
242215561$24221556$1$I$20240701$20240808$20240819$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-040719$AUROBINDO$$22$YR$$F$Y$$$20240819$$MD$FR$FR
242215571$24221557$1$I$20240722$20240808$20240819$20240819$EXP$$ES-AUROBINDO-AUR-APL-2024-040792$AUROBINDO$$72$YR$$M$Y$$$20240819$$MD$ES$ES
242215582$24221558$2$F$$20240815$20240819$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07498$LUPIN$$$$$$Y$$$20240828$$HP$US$US
242215591$24221559$1$I$$20240806$20240819$20240819$EXP$$CA-TAKEDA-2024TUS004015$TAKEDA$$$$$F$Y$$$20240819$$MD$CA$CA
242215604$24221560$4$F$$20240913$20240819$20240923$PER$$US-ROCHE-10000051731$ROCHE$$$$A$F$Y$63.5$KG$20240923$$CN$US$US
242215611$24221561$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129167$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240819$$CN$US$US
242215622$24221562$2$F$20230923$20240819$20240819$20240824$EXP$$US-ABBVIE-5880336$ABBVIE$$75$YR$$M$Y$$$20240824$$CN$US$US
242215633$24221563$3$F$20240801$20240823$20240819$20240829$PER$$US-AMGEN-USASP2024154451$AMGEN$$$$$$Y$$$20240829$$CN$US$US
242215641$24221564$1$I$20240814$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024162523$AMGEN$$38$YR$A$F$Y$$$20240819$$CN$US$US
242215661$24221566$1$I$20231216$20240814$20240819$20240819$EXP$$CA-UCBSA-2024002834$UCB$$72$YR$$F$Y$$$20240819$$CN$CA$CA
242215671$24221567$1$I$20240701$20240716$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07327$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242215681$24221568$1$I$$20240814$20240819$20240819$EXP$$US-ABBVIE-5882169$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242215691$24221569$1$I$$20240724$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07495$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242215701$24221570$1$I$20240701$20240812$20240819$20240819$EXP$$CO-ABBVIE-5881790$ABBVIE$$79$YR$$M$Y$$$20240819$$CN$CO$CO
242215711$24221571$1$I$$20240807$20240819$20240819$EXP$$DE-AMGEN-DEUNI2024160115$AMGEN$Satirer, O.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD Open. 2024;10(3):e004381$2$YR$C$F$Y$$$20240819$$MD$DE$DE
242215723$24221572$3$F$20230509$20240909$20240819$20240924$EXP$$JP-AMGEN-JPNNI2023191906$AMGEN$Fujita T, Tazawa A, Okita A, Sekino K, Nagawa D, Kinjo I. Initial evaluation of a protocol for the combination of avacopan and early taper of prednisolone in the remission induction in microscopic polyangiitis. Journal of Japanese Society of Nephrology. 2024;66(4):634.$50$YR$A$F$Y$70.9$KG$20240923$$MD$JP$JP
242215732$24221573$2$F$$20240828$20240819$20240902$EXP$$JP-JNJFOC-20240846071$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$PH$JP$JP
242215741$24221574$1$I$$20240812$20240819$20240819$EXP$$DE-EMD Serono-2024043430$EMD SERONO INC$$$$$F$Y$$$20240819$$CN$DE$DE
242215751$24221575$1$I$$20240812$20240819$20240819$EXP$$IE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045079$BOEHRINGER INGELHEIM$Martin WP. Case Report: Diabetic ketoacidosis after coadministration of empagliflozin and probenecid. Wellcome open research. 2024;8: 268. doi:https://dx.doi.org/10.12688/wellcomeopenres.19148.2.$54$YR$A$F$Y$$$20240819$$HP$IE$IE
242215762$24221576$2$F$$20240822$20240819$20240827$EXP$$JP-GILEAD-2024-0684284$GILEAD$$84$YR$E$M$Y$$$20240827$$PH$JP$JP
242215771$24221577$1$I$$20220926$20240819$20240819$EXP$$US-AstraZeneca-2022A332057$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242215781$24221578$1$I$$20240815$20240819$20240819$EXP$$DE-SANDOZ INC.-SDZ2024DE072950$SANDOZ$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$84$YR$$F$Y$$$20240819$$HP$DE$DE
242215791$24221579$1$I$20240617$20240814$20240819$20240819$EXP$$GB-ABBVIE-5882258$ABBVIE$$59$YR$$F$Y$$$20240819$$CN$GB$GB
242215801$24221580$1$I$$20221220$20240819$20240819$EXP$$US-AstraZeneca-2022A415777$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242215811$24221581$1$I$$20230412$20240819$20240819$EXP$$CA-AstraZeneca-2023A087697$ASTRAZENECA$$$$$F$Y$$$20240819$$HP$CA$
242215821$24221582$1$I$$20230801$20240819$20240819$EXP$$US-AstraZeneca-2023A169505$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242215831$24221583$1$I$$20230419$20240819$20240819$EXP$$US-AstraZeneca-2023A092415$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242215841$24221584$1$I$20240801$20240812$20240819$20240819$EXP$$PT-EMD Serono-2024043459$EMD SERONO INC$$26$YR$A$F$Y$$$20240819$$CN$PT$PT
242215851$24221585$1$I$20230127$20240808$20240819$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-040720$AUROBINDO$$69$YR$$F$Y$73$KG$20240819$$MD$FR$FR
242215861$24221586$1$I$20240812$20240812$20240819$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012465$JAZZ$$18$YR$$F$Y$$$20240819$$HP$US$US
242215871$24221587$1$I$20220901$20240816$20240819$20240819$EXP$ES-AEMPS-1450032$ES-JNJFOC-20240846382$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240819$$MD$ES$ES
242215882$24221588$2$F$20221101$20240826$20240819$20240905$EXP$BG-EMA-DD-20240808-7482663-174416$BG-BIOCON BIOLOGICS LIMITED-BBL2024005895$BIOCON$Petrusheva, V.. Cardiotoxicity in patient with breast cancer treated with HER-2 targeted therapy - a case report.. Cardiovascular diseases.. 2024;2:14-23$$$$$Y$$$20240905$$HP$BG$BG
242215891$24221589$1$I$20240701$20240812$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129988$BRISTOL MYERS SQUIBB$$37$YR$A$M$Y$$$20240819$$HP$US$US
242215902$24221590$2$F$$20240925$20240819$20240927$EXP$$NVSC2024US150869$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
242215913$24221591$3$F$20201009$20240920$20240819$20240927$EXP$$CA-TAKEDA-2024TUS060195$TAKEDA$$31$YR$$F$Y$$$20240927$$CN$CA$CA
242215921$24221592$1$I$20240815$20240815$20240819$20240819$PER$$US-AMGEN-USASP2024163492$AMGEN$$74$YR$E$F$Y$$$20240819$$CN$US$US
242215932$24221593$2$F$$20240827$20240819$20240830$EXP$$CA-TAKEDA-2024TUS073995$TAKEDA$$$$$F$Y$$$20240830$$CN$CA$CA
242215943$24221594$3$F$$20240911$20240819$20240917$EXP$$US-ABBVIE-5638184$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
242215951$24221595$1$I$$20240808$20240819$20240819$EXP$$DE-AUROBINDO-AUR-APL-2024-040256$AUROBINDO$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S, et al.. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre.. Br-J-Cancer. 2023;128 (6):1134-1147$$$$F$Y$$$20240819$$HP$DE$DE
242215961$24221596$1$I$$20240814$20240819$20240819$EXP$$CA-SANDOZ INC.-NVSC2022CA001706$SANDOZ$$$$$F$Y$$$20240819$$CN$CA$CA
242215973$24221597$3$F$20210213$20240819$20240819$20240910$EXP$PT-INFARMED-M202210-435$PT-GILEAD-2024-0683902$GILEAD$$64$YR$A$M$Y$$$20240910$$MD$PT$PT
242215983$24221598$3$F$$20240827$20240819$20240903$EXP$$US-ABBVIE-5882032$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242215991$24221599$1$I$20230101$20240812$20240819$20240819$EXP$$US-SA-2024SA024324$SANOFI AVENTIS$$32$YR$A$M$Y$99.7$KG$20240819$$MD$US$US
242216001$24221600$1$I$$20240815$20240819$20240819$EXP$$US-ABBVIE-5882965$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242216011$24221601$1$I$$20240805$20240819$20240819$EXP$$US-EPICPHARMA-US-2024EPCLIT01005$EPIC PHARM$A. Carranza Morales.A Painful Case of Asthma.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$43$YR$A$F$Y$$$20240819$$HP$US$US
242216021$24221602$1$I$20240801$20240812$20240819$20240819$EXP$ES-AEMPS-1557224$ES-ESPERIONTHERAPEUTICS-2024ESP01287$ESPERION THERAPEUTICS$$$$$$Y$$$20240819$$MD$ES$ES
242216031$24221603$1$I$$20240813$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US073041$SANDOZ$$$$$F$Y$$$20240819$$MD$US$US
242216042$24221604$2$F$20240408$20240919$20240819$20240927$EXP$$JP-ROCHE-10000057769$ROCHE$$72$YR$E$F$Y$51.7$KG$20240927$$MD$JP$JP
242216051$24221605$1$I$$20240731$20240819$20240819$PER$$US-TEVA-VS-3228902$TEVA$$73$YR$$F$Y$$$20240819$$CN$US$US
242216061$24221606$1$I$20230330$20240805$20240819$20240819$EXP$$JP-AMGEN-JPNNI2023214295$AMGEN$$63$YR$A$F$Y$37.3$KG$20240819$$MD$JP$JP
242216071$24221607$1$I$$20240808$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126347$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240819$$CN$US$US
242216081$24221608$1$I$20240701$20240808$20240819$20240819$EXP$GB-MHRA-MED-202407151637427260-YNFTP$GB-LEO Pharma-372032$LEO PHARM$$$$$F$Y$$$20240819$$HP$GB$GB
242216091$24221609$1$I$$20240812$20240819$20240819$EXP$$AT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045653$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240819$$MD$AT$AT
242216101$24221610$1$I$$20230501$20240819$20240819$EXP$$US-AstraZeneca-2023A101723$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242216111$24221611$1$I$20160101$20240811$20240819$20240819$EXP$$NZ-AMGEN-NZLSP2024161561$AMGEN$Simpson, D.. Fixed Dose Carfilzomib Triplets in Lenalidomide Refractory Myeloma. Blood. 2018;132 (1):3306$$$$$Y$$$20240819$$MD$NZ$NZ
242216121$24221612$1$I$$20240806$20240819$20240819$EXP$$US-ENDO USA, INC.-2024-003164$ENDO$$$$$M$Y$$$20240819$$CN$US$US
242216131$24221613$1$I$20230901$20231205$20240819$20240819$EXP$$US-AstraZeneca-2023A233966$ASTRAZENECA$$942$MON$$F$Y$$$20240819$$CN$US$
242216141$24221614$1$I$$20240812$20240819$20240819$EXP$$CA-APOTEX-2024AP008667$APOTEX$$76$YR$$F$Y$$$20240819$$HP$CA$CA
242216151$24221615$1$I$$20240806$20240819$20240819$EXP$$US-SINTETICA US LLC-US-SIN-2024-00011$Sintetica$Bansal V, D^Souza G, Aladade E, et al.. Postdural Puncture Headaches in Pediatric Patients: A Review of Options When Repeated Epidural Blood Patches Do Not Work. Cureus. 2024;16(6):e62833$14$YR$$F$Y$68$KG$20240814$$MD$US$US
242216161$24221616$1$I$$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A186562$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242216171$24221617$1$I$$20230505$20240819$20240819$EXP$$AR-AstraZeneca-2023A106860$ASTRAZENECA$$76$YR$$F$Y$$$20240819$$CN$AR$
242216181$24221618$1$I$$20240814$20240819$20240819$PER$$US-ROCHE-10000059787$ROCHE$$29$YR$A$M$Y$$$20240819$$CN$US$US
242216191$24221619$1$I$$20230125$20240819$20240819$EXP$$US-AstraZeneca-2023A022266$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242216201$24221620$1$I$$20220916$20240819$20240819$EXP$$US-AstraZeneca-2022A320387$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242216211$24221621$1$I$$20240814$20240819$20240819$PER$$US-ABBVIE-5881670$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242216221$24221622$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129547$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240819$$CN$US$US
242216233$24221623$3$F$$20240829$20240819$20240902$EXP$$AU-JNJFOC-20240831132$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240902$$HP$AU$AU
242216242$24221624$2$F$$20240911$20240819$20240924$EXP$$US-ABBVIE-5883690$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
242216251$24221625$1$I$$20240812$20240819$20240819$PER$$US-JNJFOC-20240831934$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$MD$US$US
242216262$24221626$2$F$20240814$20240819$20240819$20240822$PER$$US-JNJFOC-20240840865$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$HP$US$US
242216272$24221627$2$F$$20240907$20240819$20240911$EXP$$CA-TAKEDA-2024TUS081391$TAKEDA$$$$$M$Y$$$20240911$$CN$CA$CA
242216283$24221628$3$F$20240503$20240913$20240819$20240918$EXP$$FR-AMGEN-FRANI2024123352$AMGEN$$69$YR$E$F$Y$55.2$KG$20240918$$HP$FR$FR
242216292$24221629$2$F$20240101$20240830$20240819$20240904$PER$$US-ROCHE-10000058156$ROCHE$$75$YR$E$F$Y$63.96$KG$20240904$$CN$US$US
242216301$24221630$1$I$20240101$20240813$20240819$20240819$EXP$$CA-ABBVIE-5880246$ABBVIE$$$$A$M$Y$$$20240819$$CN$CA$CA
242216313$24221631$3$F$20240101$20240819$20240819$20240827$EXP$$US-ABBVIE-5879913$ABBVIE$$$$$F$Y$64$KG$20240827$$CN$US$US
242216321$24221632$1$I$20240811$20240814$20240819$20240819$EXP$$US-ABBVIE-5881286$ABBVIE$$42$YR$$M$Y$$$20240819$$CN$US$US
242216331$24221633$1$I$$20240111$20240819$20240819$PER$$US-AUROBINDO-AUR-APL-2024-002363$AUROBINDO$$$$$M$Y$$$20240819$$CN$US$US
242216341$24221634$1$I$$20240812$20240819$20240819$EXP$$US-ABBVIE-5878744$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242216351$24221635$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000058930$ROCHE$$$$E$M$Y$$$20240819$$CN$US$US
242216361$24221636$1$I$20240701$20240812$20240819$20240819$EXP$$US-RECORDATI-2024006252$RECORDATI$$$$$$Y$$$20240819$$CN$US$US
242216371$24221637$1$I$$20230809$20240819$20240819$PER$$US-AUROBINDO-AUR-APL-2023-050380$AUROBINDO$$$$$F$Y$$$20240819$$MD$US$US
242216381$24221638$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000058783$ROCHE$$35$YR$A$F$Y$$$20240819$$PH$US$US
242216391$24221639$1$I$$20230905$20240819$20240819$PER$$US-AUROBINDO-AUR-APL-2023-053270$AUROBINDO$$62$YR$$F$Y$81.6$KG$20240819$$CN$US$US
242216403$24221640$3$F$20130824$20240826$20240819$20240828$EXP$$DE-SANDOZ INC.-GXKR2013DE002867$SANDOZ$$46$YR$$M$Y$$$20240828$$MD$DE$DE
242216411$24221641$1$I$20240725$20240808$20240819$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-040726$AUROBINDO$$32$YR$$M$Y$$$20240819$$PH$FR$FR
242216421$24221642$1$I$20240101$20240814$20240819$20240819$EXP$$GB-ABBVIE-5881104$ABBVIE$$58$YR$$M$Y$$$20240819$$CN$GB$GB
242216431$24221643$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010618$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240819$$CN$US$US
242216442$24221644$2$F$$20240827$20240819$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-040723$AUROBINDO$$20$YR$$F$Y$55$KG$20240905$$HP$CA$CA
242216451$24221645$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010532$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240819$$CN$US$US
242216461$24221646$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408011074$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$US$US
242216471$24221647$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010585$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240819$$CN$US$US
242216481$24221648$1$I$$20240808$20240819$20240819$EXP$$CN-ROCHE-10000052987$ROCHE$Shi Y, Zhang X, Bai Z, Zhang S, Sun Y, Qiao G. Study on autoimmune hemolytic anemia after umbilical cord blood transplant in patients with mucopolysaccharidosis. Journal of China Pediatric Blood and Cancer. 2024-Jun;29 (3):200-3. doi:10.3969/j.issn.1673-5323.2024.03.009.$$$$M$Y$$$20240819$$HP$CN$CN
242216491$24221649$1$I$20240108$20240808$20240819$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-040476$AUROBINDO$$64$YR$$M$Y$62$KG$20240819$$PH$FR$FR
242216502$24221650$2$F$20240703$20240822$20240819$20240827$EXP$$KW-UCBSA-2024041497$UCB$$0$YR$$M$Y$1.85$KG$20240827$$HP$KW$KW
242216513$24221651$3$F$$20240903$20240819$20240903$PER$$US-ALXN-202408USA000771US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242216521$24221652$1$I$$20240814$20240819$20240819$EXP$$US-JNJFOC-20240837249$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
242216533$24221653$3$F$20240301$20240905$20240819$20240915$EXP$$FR-AUROBINDO-AUR-APL-2024-039593$AUROBINDO$Fidan I, Delamotte E, Colombier M, Agossa K.. Non-surgical Treatment of Severe Drug-Influenced Gingival Enlargement: A Report of Two Cases. Cureus. 2024;16(6):1-7$58$YR$$M$Y$$$20240915$$MD$FR$FR
242216541$24221654$1$I$20240101$20240808$20240819$20240819$PER$$US-BAUSCHBL-2024BNL031448$BAUSCH AND LOMB$$$$$M$Y$$$20240819$$CN$US$US
242216551$24221655$1$I$$20240815$20240819$20240819$EXP$$US-GILEAD-2024-0669557$GILEAD$$$$A$F$Y$$$20240819$$CN$US$US
242216561$24221656$1$I$$20240808$20240819$20240819$EXP$$GB-AUROBINDO-AUR-APL-2024-040295$AUROBINDO$$58$YR$$M$Y$$$20240819$$PH$GB$GB
242216571$24221657$1$I$20240611$20240814$20240819$20240819$EXP$$US-ABBVIE-5881779$ABBVIE$$22$YR$$M$Y$$$20240819$$CN$US$US
242216581$24221658$1$I$20240720$20240808$20240819$20240819$EXP$$GB-AUROBINDO-AUR-APL-2024-040300$AUROBINDO$$67$YR$$$Y$$$20240819$$CN$GB$GB
242216591$24221659$1$I$$20230609$20240819$20240819$EXP$$TW-AstraZeneca-2023A134833$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$TW$
242216601$24221660$1$I$20240501$20240812$20240819$20240819$EXP$$EU-BAUSCHBL-2024BNL031453$BAUSCH AND LOMB$$56$YR$$M$Y$99$KG$20240819$$MD$EU$EU
242216613$24221661$3$F$$20240918$20240819$20240920$PER$$NVSC2024US167264$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
242216624$24221662$4$F$20240808$20240904$20240819$20240909$EXP$$CA-TAKEDA-2024TUS080794$TAKEDA$$45$YR$$F$Y$$$20240909$$CN$CA$CA
242216631$24221663$1$I$20240101$20240814$20240819$20240819$EXP$$CA-UCBSA-2024041359$UCB$$$$$F$Y$$$20240819$$CN$CA$CA
242216641$24221664$1$I$20180702$20240813$20240819$20240819$EXP$$DE-SANDOZ INC.-NVSC2020DE081374$SANDOZ$$35$YR$$F$Y$$$20240819$$MD$DE$DE
242216651$24221665$1$I$$20240814$20240819$20240819$EXP$$GB-JNJFOC-20240841845$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$HP$GB$GB
242216661$24221666$1$I$$20240812$20240819$20240819$EXP$$US-TAKEDA-2024TUS080892$TAKEDA$Kettani M.E., Shah K., Farooq H., Li K., Badar T.. Chronic myeloid leukemia with involvement of membranous labyrinth. Leukemia Research Reports. 2024;22 (100471):1-4$39$YR$$M$Y$$$20240819$$MD$US$US
242216671$24221667$1$I$20190101$20240813$20240819$20240819$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045677$BOEHRINGER INGELHEIM$$38$YR$A$F$Y$$$20240819$$CN$US$US
242216681$24221668$1$I$$20240805$20240819$20240819$EXP$$AR-EPICPHARMA-AR-2024EPCLIT00992$EPIC PHARM$Espindola M.Suicide attempt in a dopamine agonist withdrawal syndrome in Parkinson^s disease.Parkinsonism and Related Disorders .APR-2024;121$43$YR$A$M$Y$$$20240819$$HP$AR$AR
242216692$24221669$2$F$20240711$20240903$20240819$20240904$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-112568$REGENERON$$81$YR$$M$Y$$$20240904$$MD$JP$JP
242216701$24221670$1$I$20240813$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024162420$AMGEN$$51$YR$A$F$Y$$$20240819$$CN$US$US
242216711$24221671$1$I$$20240808$20240819$20240819$EXP$$TR-ROCHE-10000057116$ROCHE$Tekgoz L, Colak S, Cimen Gunes E, Cinar M, Yilmaz S. Mycophenolate mofetil versus azathioprine in patients with connective tissue disease related interstitial lung disease (Abstract number: AB0386). Annals of the Rheumatic Diseases. 2024-Jun;83:1439. doi:10.1136/annrheumdis-2024-eular.4269.$$$$$Y$$$20240819$$HP$TR$TR
242216721$24221672$1$I$$20240805$20240819$20240819$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK093310$GLENMARK$$$$$$Y$$$20240819$$HP$CA$CA
242216731$24221673$1$I$$20240809$20240819$20240819$PER$$US-BAUSCHBL-2024BNL031459$BAUSCH AND LOMB$$$$$F$Y$$$20240819$$CN$US$US
242216741$24221674$1$I$$20240717$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07241$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242216751$24221675$1$I$$20240812$20240819$20240819$EXP$$PT-ROCHE-10000057987$ROCHE$Brito-Santana L, Medinas R, Neves A, Gago J. Steroid-induced psychosis: a spectrum of neuropsychiatric glucocorticoid side effects. BMJ Case Reports. 2024-Jul-22;17 (7):1-5. doi:10.1136/bcr-2023-259134.$$$A$M$Y$$$20240819$$MD$PT$PT
242216761$24221676$1$I$$20240605$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003196$BIOCON$$$$$$Y$$$20240819$$HP$US$US
242216771$24221677$1$I$$20240521$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003191$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242216781$24221678$1$I$$20240501$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003115$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242216791$24221679$1$I$$20240502$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003171$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242216801$24221680$1$I$$20240503$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003208$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242216811$24221681$1$I$$20240503$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003194$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242216821$24221682$1$I$20240506$20240506$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003231$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242216831$24221683$1$I$$20240513$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003224$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242216841$24221684$1$I$$20240430$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003133$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242216851$24221685$1$I$$20240523$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003155$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242216861$24221686$1$I$$20240503$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003197$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242216871$24221687$1$I$20240412$20240808$20240819$20240819$EXP$$FR-AUROBINDO-AUR-APL-2024-040687$AUROBINDO$$79$YR$$F$Y$$$20240819$$PH$FR$FR
242216881$24221688$1$I$20240710$20240809$20240819$20240819$EXP$$GB-AUROBINDO-AUR-APL-2024-040359$AUROBINDO$$80$YR$$F$Y$$$20240819$$MD$GB$GB
242216892$24221689$2$F$$20240809$20240819$20240821$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002120$Alvotech$$69$YR$$F$Y$$$20240821$$CN$CA$CA
242216901$24221690$1$I$$20240805$20240819$20240819$EXP$$GB-EPICPHARMA-GB-2024EPCLIT00993$EPIC PHARM$N P Rossi .Toxic leukoencephalopathy versus delayed post-hypoxic leukoencephalopathy after oral morphine sulphate overdose..BMJ Case Reports.JAN-2023;16$5$DEC$A$M$Y$$$20240819$$HP$GB$GB
242216911$24221691$1$I$$20240808$20240819$20240819$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002119$Alvotech$$80$YR$$F$Y$$$20240819$$MD$CA$CA
242216921$24221692$1$I$$20240814$20240819$20240819$PER$$US-HALEON-2192080$Haleon PLC$$$$$$Y$$$20240819$$CN$US$US
242216933$24221693$3$F$$20240918$20240819$20240924$EXP$$US-TAKEDA-2024TUS081064$TAKEDA$$$$$$Y$$$20240924$$PH$US$US
242216941$24221694$1$I$$20240717$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07321$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242216951$24221695$1$I$$20240814$20240819$20240819$EXP$$US-GILEAD-2024-0684356$GILEAD$$$$A$F$Y$$$20240819$$CN$US$US
242216961$24221696$1$I$$20240808$20240819$20240819$EXP$$CA-ROCHE-10000052019$ROCHE$$23$MON$I$F$Y$$$20240819$$HP$CA$CA
242216971$24221697$1$I$20240703$20240809$20240819$20240819$EXP$$CN-TAKEDA-2024TUS082209$TAKEDA$$75$YR$$M$Y$71$KG$20240819$$HP$CN$CN
242216981$24221698$1$I$20230101$20240814$20240819$20240819$PER$$US-ABBVIE-5883642$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242216991$24221699$1$I$20230811$20240813$20240819$20240819$EXP$FR-AFSSAPS-PO2023000997$FR-RDY-SPO/FRA/24/0011858$DR REDDYS$$76$YR$E$F$Y$50$KG$20240819$$PH$FR$FR
242217001$24221700$1$I$$20240816$20240819$20240819$EXP$$NVSC2024US166991$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242217024$24221702$4$F$$20240905$20240819$20240910$30DAY$$US-AMGEN-USASP2024162423$AMGEN$$$$$$Y$$$20240909$$CN$US$US
242217031$24221703$1$I$$20240815$20240819$20240819$EXP$$CA-TAKEDA-2024TUS082365$TAKEDA$$80$YR$$F$Y$$$20240819$$HP$CA$CA
242217041$24221704$1$I$$20240807$20240819$20240819$PER$$US-JNJFOC-20240817519$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
242217051$24221705$1$I$$20240816$20240819$20240819$EXP$$CN-AstraZeneca-2024A187709$ASTRAZENECA$$66$YR$$M$Y$$$20240819$$CN$CN$
242217061$24221706$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010749$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$US$US
242217071$24221707$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408011072$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240819$$CN$US$US
242217081$24221708$1$I$20240815$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010331$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240819$$CN$US$US
242217091$24221709$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010658$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240819$$CN$US$US
242217111$24221711$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010714$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240819$$CN$US$US
242217131$24221713$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009901$ELI LILLY AND CO$$$$$M$Y$$$20240819$$CN$US$US
242217141$24221714$1$I$20240727$20240807$20240819$20240819$PER$$US-FARMAPROD-202407-2746$DOMPE FARMACEUTICI$$87$YR$E$F$Y$$$20240819$$CN$US$US
242217151$24221715$1$I$$20240808$20240819$20240819$EXP$$CA-ROCHE-10000051812$ROCHE$Unknown ,  Unknown. Unknown.$33$YR$A$F$Y$$$20240819$$MD$CA$CA
242217161$24221716$1$I$$20240815$20240819$20240819$EXP$$US-JNJFOC-20240840207$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$US$US
242217171$24221717$1$I$$20240815$20240819$20240819$PER$$US-JNJFOC-20240845258$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$CN$US$US
242217181$24221718$1$I$$20240807$20240819$20240819$PER$$US-TAKEDA-2024TUS079157$TAKEDA$$48$YR$$F$Y$$$20240819$$MD$US$US
242217193$24221719$3$F$20240805$20240923$20240819$20240924$PER$$US-AMGEN-USASP2024164673$AMGEN$$74$YR$E$M$Y$$$20240924$$CN$US$US
242217211$24221721$1$I$$20240814$20240819$20240819$PER$$US-AMGEN-AUSSP2024161512$AMGEN$$$$$$Y$$$20240819$$CN$US$US
242217221$24221722$1$I$20240801$20240808$20240819$20240819$EXP$$DE-JNJFOC-20240822770$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$CN$DE$DE
242217231$24221723$1$I$$20240731$20240819$20240819$PER$$US-TEVA-VS-3229756$TEVA$$$$$F$Y$$$20240819$$CN$US$US
242217241$24221724$1$I$$20240809$20240819$20240819$PER$$US-ABBVIE-5876943$ABBVIE$$$$$$Y$$$20240819$$CN$US$US
242217251$24221725$1$I$$20240813$20240819$20240819$EXP$$CA-ABBVIE-5881371$ABBVIE$$$$A$F$Y$$$20240819$$CN$CA$CA
242217261$24221726$1$I$20240301$20240813$20240819$20240819$EXP$FR-AFSSAPS-RN2024000865$FR-ORGANON-O2408FRA000967$ORGANON$$37$YR$$F$Y$$$20240819$$PH$FR$FR
242217271$24221727$1$I$20240608$20240814$20240819$20240819$EXP$$US-ABBVIE-5881540$ABBVIE$$72$YR$$M$Y$$$20240819$$CN$US$US
242217281$24221728$1$I$$20240813$20240819$20240819$EXP$$US-TAKEDA-2024TUS036906$TAKEDA$$$$$M$Y$$$20240819$$MD$US$US
242217292$24221729$2$F$20240101$20240823$20240819$20240828$PER$$US-AMGEN-USASP2024164076$AMGEN$$69$YR$E$F$Y$$$20240827$$CN$US$US
242217301$24221730$1$I$20240807$20240814$20240819$20240819$EXP$$US-ABBVIE-5882185$ABBVIE$$75$YR$$M$Y$$$20240819$$CN$US$US
242217311$24221731$1$I$20240729$20240809$20240819$20240819$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099730$VIIV$$29$YR$$F$Y$$$20240819$$CN$US$US
242217321$24221732$1$I$20240328$20240807$20240819$20240819$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024098630$VIIV$$27$YR$$M$Y$$$20240819$$CN$US$US
242217331$24221733$1$I$20230101$20240812$20240819$20240819$EXP$$HU-009507513-2408HUN005320$MERCK$Porpaczy A, Lenard L, Gojak I, Szukits S, Kajtarne EP, Komocsi A, et al.. A case of cardiac complications of the immune checkpoint inhibitor-therapy with a severe course. Cardiologia Hungarica. 2024;54 (3):222-6$50$YR$$M$Y$$$20240819$$MD$HU$HU
242217341$24221734$1$I$20240101$20240812$20240819$20240819$EXP$$US-SA-2024SA163651$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240819$$MD$US$US
242217351$24221735$1$I$20240814$20240814$20240819$20240819$EXP$$US-ABBVIE-5881957$ABBVIE$$67$YR$$M$Y$$$20240819$$CN$US$US
242217362$24221736$2$F$$20240813$20240819$20240823$EXP$$US-TAKEDA-2024TUS082070$TAKEDA$$$$$F$Y$63$KG$20240823$$CN$US$US
242217371$24221737$1$I$$20240808$20240819$20240819$EXP$$CH-TAKEDA-2024TUS082604$TAKEDA$$$$$M$Y$$$20240819$$MD$CH$CH
242217381$24221738$1$I$20240101$20240814$20240819$20240819$EXP$$US-ABBVIE-5881434$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242217391$24221739$1$I$20231101$20240813$20240819$20240819$PER$$US-ALXN-202408USA000765US$ALEXION PHARMACEUTICALS$$63$YR$$F$Y$$$20240819$$CN$US$US
242217411$24221741$1$I$20240730$20240813$20240819$20240819$EXP$$NVSC2024CN166236$NOVARTIS$$75$YR$$F$Y$59$KG$20240819$$HP$CN$CN
242217421$24221742$1$I$$20240814$20240819$20240819$EXP$$CA-ABBVIE-5881704$ABBVIE$$$$E$F$Y$$$20240819$$CN$CA$CA
242217433$24221743$3$F$20240101$20240827$20240819$20240828$PER$$US-ABBVIE-5881834$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242217442$24221744$2$F$20240301$20240904$20240819$20240913$EXP$$US-ABBVIE-5882862$ABBVIE$$76$YR$$M$Y$$$20240913$$CN$US$US
242217452$24221745$2$F$20210809$20240828$20240819$20240902$EXP$$CO-TAKEDA-CO202031915$TAKEDA$$53$YR$$F$Y$56$KG$20240902$$HP$CO$CO
242217461$24221746$1$I$20240717$20240812$20240819$20240819$EXP$$CA-JNJFOC-20240474712$JOHNSON AND JOHNSON$$42$YR$A$F$Y$55.2$KG$20240819$$HP$CA$CA
242217471$24221747$1$I$$20240815$20240819$20240819$EXP$$RU-JNJFOC-20240842224$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240819$$MD$RU$RU
242217482$24221748$2$F$20190809$20240820$20240819$20240826$EXP$$CA-TAKEDA-2022TUS033471$TAKEDA$$39$YR$$F$Y$$$20240826$$CN$CA$CA
242217491$24221749$1$I$$20240816$20240819$20240819$EXP$$TR-ABBVIE-5883687$ABBVIE$$$$$F$Y$$$20240819$$CN$TR$TR
242217501$24221750$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010686$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240819$$CN$US$US
242217511$24221751$1$I$20240816$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010657$ELI LILLY AND CO$$$$$M$Y$$$20240819$$CN$US$US
242217521$24221752$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010826$ELI LILLY AND CO$$$$$$Y$$$20240819$$HP$US$US
242217531$24221753$1$I$$20240807$20240819$20240819$EXP$$GB-ROCHE-10000051437$ROCHE$$$$$F$Y$$$20240819$$HP$GB$GB
242217542$24221754$2$F$$20240815$20240819$20240820$EXP$$BR-ABBVIE-5882278$ABBVIE$$$$$F$Y$$$20240820$$MD$BR$BR
242217551$24221755$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167259$NOVARTIS$$77$YR$$F$Y$$$20240819$$MD$US$US
242217561$24221756$1$I$20240731$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010672$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240819$$CN$US$US
242217571$24221757$1$I$20230101$20240813$20240819$20240819$EXP$NO-NOMAADVRE-PASRAPP-2024-Vzb3nk$NO-TAKEDA-2024TUS080918$TAKEDA$$48$YR$$F$Y$70$KG$20240819$$HP$NO$NO
242217581$24221758$1$I$$20240812$20240819$20240819$EXP$$CN-ROCHE-10000054399$ROCHE$$57$YR$A$F$Y$$$20240819$$MD$CN$CN
242217591$24221759$1$I$20240801$20240814$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408007077$ELI LILLY AND CO$$46$YR$A$F$Y$70.295$KG$20240819$$CN$US$US
242217601$24221760$1$I$$20240814$20240819$20240819$PER$$US-ABBVIE-5881664$ABBVIE$$$$$$Y$$$20240819$$CN$US$US
242217612$24221761$2$F$20240101$20240828$20240819$20240901$EXP$$CA-ORGANON-O2408CAN001095$ORGANON$$$$$F$Y$84.59$KG$20240901$$MD$CA$CA
242217621$24221762$1$I$$20240611$20240819$20240819$EXP$$TH-009507513-2408THA005872$MERCK$$75$YR$$M$Y$$$20240819$$MD$TH$TH
242217631$24221763$1$I$20240530$20240813$20240819$20240819$EXP$$US-TAKEDA-2024TUS065640$TAKEDA$$61$YR$$F$Y$68$KG$20240819$$MD$US$US
242217642$24221764$2$F$20140728$20240918$20240819$20240926$EXP$$US-RECORDATI-2024006239$RECORDATI$$$$$$Y$$$20240926$$CN$US$US
242217651$24221765$1$I$$20240812$20240819$20240819$EXP$$NVSC2024BR166146$NOVARTIS$$$$$F$Y$$$20240819$$CN$BR$BR
242217661$24221766$1$I$$20240806$20240819$20240819$EXP$$US-BELUSA-2024BELLIT0090$BIOLOGICAL E.$Benes L, Nelson N, Sloane MF.Lemierre^s Syndrome Complicated by Tension Hemothorax in the Setting of the Concomitant Use of Intrapleural Fibrinolytics and Systemic Anticoagulation.American Journal of Respiratory and Critical Care Medicine.2023;207:A5017$$$$$Y$$$20240819$$HP$US$US
242217671$24221767$1$I$$20240809$20240819$20240819$EXP$$US-TAKEDA-2021TUS031852$TAKEDA$$$$$F$Y$81$KG$20240819$$CN$US$US
242217681$24221768$1$I$20231201$20240816$20240819$20240819$EXP$FR-AFSSAPS-PB2024000886$FR-SA-2024SA243022$SANOFI AVENTIS$$50$YR$A$F$Y$56$KG$20240819$$PH$FR$FR
242217693$24221769$3$F$20240803$20240904$20240819$20240910$EXP$$US-TAKEDA-2024TUS082415$TAKEDA$$61$YR$$F$Y$$$20240910$$MD$US$US
242217711$24221771$1$I$$20240806$20240819$20240819$EXP$$DE-Merck Healthcare KGaA-2024041827$MERCK KGAA$$$$A$F$Y$$$20240814$$CN$DE$DE
242217721$24221772$1$I$20240201$20240807$20240819$20240819$PER$$US-GILEAD-2024-0683780$GILEAD$$$$A$M$Y$$$20240819$$HP$US$US
242217731$24221773$1$I$20171021$20240813$20240819$20240819$EXP$$CA-TAKEDA-2017TUS022417$TAKEDA$$29$YR$$F$Y$$$20240819$$CN$CA$CA
242217741$24221774$1$I$20181012$20240815$20240819$20240819$EXP$GB-MHRA-MED-202408151324348930-QWLHN$GB-SANDOZ INC.-SDZ2024GB073009$SANDOZ$$53$YR$$F$Y$83$KG$20240819$$CN$GB$GB
242217751$24221775$1$I$20220913$20220921$20240819$20240819$EXP$$US-AstraZeneca-2022A329699$ASTRAZENECA$$23165$DY$$M$Y$$$20240819$$CN$US$
242217761$24221776$1$I$$20230327$20240819$20240819$EXP$$US-AstraZeneca-2023A072466$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242217772$24221777$2$F$$20240821$20240819$20240827$EXP$IT-UCBSA-2024040634$IT-UCBSA-2024040634$UCB$$4$YR$$M$Y$$$20240827$$MD$IT$IT
242217781$24221778$1$I$$20220908$20240819$20240819$EXP$$US-AstraZeneca-2022A315386$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242217791$24221779$1$I$$20240812$20240819$20240819$EXP$US-MLMSERVICE-20160916-0426795-1$US-CHEPLA-2024010527$CHEPLAPHARM$Shaigany S, Dabela E, Husain S, Grossman ME. Herpetic zoster folliculitis in the immunocompromised host. JAAD Case Reports. 2015;1(1):38-40. http://dx.doi.org/10.1016/j.jdcr.2014.11.003.$78$YR$$M$Y$$$20240819$$HP$COUNTRY NOT SPECIFIED$US
242217802$24221780$2$F$$20240821$20240819$20240829$EXP$$US-CHEPLA-2024010546$CHEPLAPHARM$$$$A$M$Y$97.5$KG$20240829$$CN$COUNTRY NOT SPECIFIED$US
242217821$24221782$1$I$$20240815$20240819$20240819$EXP$$US-GILEAD-2024-0684431$GILEAD$$69$YR$E$F$Y$$$20240819$$CN$US$US
242217831$24221783$1$I$$20240808$20240819$20240819$PER$$US-TAKEDA-2024TUS080048$TAKEDA$$70$YR$$F$Y$$$20240819$$CN$US$US
242217841$24221784$1$I$$20240814$20240819$20240819$EXP$$IL-UCBSA-2024023275$UCB$$10$YR$$F$Y$$$20240819$$CN$IL$IL
242217851$24221785$1$I$$20240809$20240819$20240819$EXP$$NVSC2024US165630$NOVARTIS$$$$$$Y$$$20240819$$CN$US$US
242217861$24221786$1$I$$20240811$20240819$20240819$EXP$$US-ASPIRO-ASP2024US02704$ASPIRO PHARMA$Jha V, Jha SK, Aryal B, Dhungel S, Jha S, Brock M.. A Report of a Rare Case of Kounis Syndrome in a Patient With HIV/AIDS and Mpox. Cureus. 2024;16(7):e63957$45$YR$$M$Y$$$20240819$$HP$US$US
242217872$24221787$2$F$20230101$20240828$20240819$20240903$EXP$$CA-ORGANON-O2408CAN001260$ORGANON$$$$$F$Y$84.59$KG$20240903$$MD$CA$CA
242217881$24221788$1$I$$20240813$20240819$20240819$EXP$$CA-TAKEDA-2024TUS081931$TAKEDA$$$$$F$Y$$$20240819$$CN$CA$CA
242217891$24221789$1$I$20240807$20240812$20240819$20240819$EXP$$KR-CELLTRION INC.-2024KR019564$CELLTRION$$$$$$Y$$$20240819$$CN$KR$KR
242217902$24221790$2$F$$20240814$20240819$20240821$EXP$$US-JNJFOC-20240842168$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240821$$HP$US$US
242217911$24221791$1$I$$20240814$20240819$20240819$EXP$$CA-TAKEDA-2024TUS082144$TAKEDA$$$$$M$Y$$$20240819$$CN$CA$CA
242217921$24221792$1$I$$20240812$20240819$20240819$EXP$$US-GILEAD-2024-0684017$GILEAD$$$$N$$Y$$$20240819$$HP$US$US
242217931$24221793$1$I$$20220708$20240819$20240819$EXP$$US-AstraZeneca-2022A252538$ASTRAZENECA$$$$$$Y$55.3$KG$20240819$$CN$US$
242217941$24221794$1$I$$20240729$20240819$20240819$PER$$US-AstraZeneca-2024A172285$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242217952$24221795$2$F$$20240916$20240819$20240918$EXP$$GB-AstraZeneca-2024A184711$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$GB$
242217962$24221796$2$F$$20240724$20240819$20240904$EXP$$US-AstraZeneca-2024A187538$ASTRAZENECA$$$$$$Y$$$20240904$$MD$US$
242217971$24221797$1$I$$20220816$20240819$20240819$EXP$$US-AstraZeneca-2022A246383$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242217981$24221798$1$I$20221102$20221104$20240819$20240819$EXP$$CA-AstraZeneca-2022A368910$ASTRAZENECA$$22687$DY$$F$Y$$$20240819$$CN$CA$
242217991$24221799$1$I$20240301$20240814$20240819$20240819$EXP$$CA-AstraZeneca-2024A185710$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$CA$
242218001$24221800$1$I$$20240812$20240819$20240819$EXP$$US-AstraZeneca-2024A184000$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242218011$24221801$1$I$$20221220$20240819$20240819$EXP$$US-AstraZeneca-2022A413348$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242218021$24221802$1$I$$20230327$20240819$20240819$EXP$$US-AstraZeneca-2023A034965$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242218042$24221804$2$F$$20240903$20240819$20240904$EXP$$CA-TAKEDA-2024TUS060747$TAKEDA$$$$$M$Y$$$20240904$$MD$CA$CA
242218052$24221805$2$F$$20240906$20240819$20240914$EXP$$PL-TAKEDA-2024TUS082318$TAKEDA$$44$YR$$M$Y$$$20240914$$CN$PL$PL
242218061$24221806$1$I$$20240814$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US072800$SANDOZ$$74$YR$$F$Y$$$20240819$$MD$US$US
242218081$24221808$1$I$$20240812$20240819$20240819$EXP$$IN-ROCHE-10000056418$ROCHE$Das P, Gupta K, Raj G, Tandon V, Awasthi N, Parashar Y. Unusual presentation in a case of diffuse large B-cell lymphoma. Radiology Case Reports. 2024;19 (10):4440-4. doi:10.1016/j.radcr.2024.06.074.$70$YR$E$F$Y$$$20240819$$MD$IN$IN
242218091$24221809$1$I$$20240814$20240819$20240819$EXP$$US-GILEAD-2024-0681844$GILEAD$$$$E$F$Y$$$20240819$$CN$US$US
242218101$24221810$1$I$20231110$20240808$20240819$20240819$EXP$$CA-TAKEDA-2024TUS080299$TAKEDA$$47$YR$$M$Y$$$20240819$$HP$CA$CA
242218111$24221811$1$I$20240815$20240815$20240819$20240819$EXP$$CA-TAKEDA-2024TUS082766$TAKEDA$$78$YR$$M$Y$$$20240819$$CN$CA$CA
242218122$24221812$2$F$$20240813$20240819$20240824$PER$$US-ABBVIE-5882933$ABBVIE$$$$$$Y$$$20240824$$HP$US$US
242218131$24221813$1$I$$20240804$20240819$20240819$EXP$$AU-TEVA-VS-3230151$TEVA$$$$$M$Y$$$20240819$$MD$AU$AU
242218141$24221814$1$I$$20240809$20240819$20240819$30DAY$$US-GSK-US2024099748$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
242218151$24221815$1$I$$20240812$20240819$20240819$EXP$$HK-ROCHE-10000054576$ROCHE$$$$$$Y$$$20240819$$MD$HK$HK
242218162$24221816$2$F$$20240914$20240819$20240920$EXP$$CN-BEIGENE-BGN-2024-012629$BEIGENE$$$$$$Y$$$20240920$$MD$CN$CN
242218171$24221817$1$I$$20240809$20240819$20240819$EXP$$BR-TAKEDA-2024TUS081520$TAKEDA$$44$YR$$M$Y$64.5$KG$20240819$$CN$BR$BR
242218181$24221818$1$I$$20240805$20240819$20240819$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07619$HIKMA$Thor DC, Patel K, Singh M.. Thor DC, Patel K, Singh M. Navigation of a New-Onset Pulmonary Embolism in a Patient Receiving Female-to-Male Gender-Affirming Care: A Case Report. Cureus. 2024;16(6):1-5$21$YR$$F$Y$$$20240819$$MD$US$US
242218191$24221819$1$I$$20240814$20240819$20240819$PER$$US-TAKEDA-2024TUS082138$TAKEDA$$$$$F$Y$57$KG$20240819$$MD$US$US
242218202$24221820$2$F$20240501$20240816$20240819$20240826$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00839$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
242218211$24221821$1$I$20240723$20240812$20240819$20240819$EXP$$PK-ROCHE-10000055262$ROCHE$$44$YR$A$M$Y$$$20240819$$CN$PK$PK
242218221$24221822$1$I$$20240815$20240819$20240819$EXP$$DE-SANDOZ INC.-SDZ2024DE072908$SANDOZ$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$59$YR$$F$Y$$$20240819$$HP$DE$DE
242218231$24221823$1$I$$20240809$20240819$20240819$EXP$$US-TEVA-VS-3232299$TEVA$$$$$F$Y$$$20240819$$CN$US$US
242218241$24221824$1$I$$20240815$20240819$20240819$PER$$US-TAKEDA-2024TUS082167$TAKEDA$$$$$$Y$$$20240819$$HP$US$US
242218252$24221825$2$F$$20240812$20240819$20240823$EXP$$IT-AUROBINDO-AUR-APL-2024-038416$AUROBINDO$Di Zio I, Cisternino R. A rare case of thrombocytopenia secondary to taking febuxostat. Italian Journal of Medicine. 2024;18No. 2:1724$63$YR$$M$Y$$$20240823$$MD$IT$IT
242218262$24221826$2$F$20240501$20240830$20240819$20240904$EXP$$AR-JNJFOC-20240836812$JOHNSON AND JOHNSON$$69$YR$E$F$Y$64$KG$20240904$$CN$AR$AR
242218271$24221827$1$I$20240815$20240815$20240819$20240819$EXP$$NVSC2024US166265$NOVARTIS$$$$$$Y$$$20240819$$MD$US$US
242218282$24221828$2$F$$20240821$20240819$20240827$EXP$$US-GILEAD-2024-0684231$GILEAD$$$$A$F$Y$$$20240827$$CN$US$US
242218291$24221829$1$I$$20240811$20240819$20240819$EXP$$AU-INFO-20240248$INFORLIFE$See AYS, Lau AZ, Thiruvengadam S. Pyroglutamic acidosis in the setting of Staphylococcus aureus bacteremia treated with flucloxacillin-An uncommon cause of high anion gap metabolic acidosis. Clin Case Rep. 2024 Aug 7;12(8):e9243. doi: 10.1002/ccr3.9243. PMID: 39114848; PMCID: PMC11305870.$64$YR$A$M$Y$$$20240813$$HP$AU$
242218301$24221830$1$I$$20230309$20240819$20240819$EXP$$US-AstraZeneca-2023A060434$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242218311$24221831$1$I$$20240811$20240819$20240819$EXP$$US-AstraZeneca-2024A186971$ASTRAZENECA$$$$$M$Y$$$20240819$$MD$US$
242218321$24221832$1$I$$20240811$20240819$20240819$EXP$$US-AMAROX PHARMA-HET2024US02705$HETERO$Toubasi AA, Allon S, Bagnato F.. Disseminated histoplasmosis mimicking post-vaccination side effects in an immunocompromised person with multiple sclerosis. Multiple Sclerosis Journal-Experimental, Translational and Clinical. 2024;1-4$58$YR$$M$Y$$$20240819$$HP$US$US
242218341$24221834$1$I$$20240812$20240819$20240819$EXP$$ZA-AstraZeneca-2024A183870$ASTRAZENECA$$86$YR$$F$Y$$$20240819$$CN$ZA$
242218351$24221835$1$I$20240719$20240815$20240819$20240819$EXP$$US-AstraZeneca-2024A186821$ASTRAZENECA$$$$$M$Y$$$20240819$$MD$US$
242218361$24221836$1$I$$20240812$20240819$20240819$EXP$$US-AstraZeneca-2024A183667$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242218371$24221837$1$I$20240530$20240812$20240819$20240819$EXP$ES-AEMPS-1557221$ES-ROCHE-10000055069$ROCHE$$66$YR$E$F$Y$65$KG$20240819$$PH$ES$ES
242218381$24221838$1$I$$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A185642$ASTRAZENECA$$$$$F$Y$$$20240819$$HP$US$
242218391$24221839$1$I$$20210922$20240819$20240819$EXP$$AU-AstraZeneca-2021A652785$ASTRAZENECA$$$$$F$Y$$$20240819$$HP$AU$
242218401$24221840$1$I$$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A185526$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242218411$24221841$1$I$20230101$20240809$20240819$20240819$EXP$FR-AFSSAPS-RS2024000776$FR-TEVA-VS-3232995$TEVA$$70$YR$$F$Y$71$KG$20240819$$MD$FR$FR
242218421$24221842$1$I$$20240726$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004081$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
242218431$24221843$1$I$$20240812$20240819$20240819$EXP$$CA-009507513-2408USA004405$MERCK$$$$$F$Y$$$20240819$$CN$CA$CA
242218441$24221844$1$I$20240724$20240814$20240819$20240819$EXP$$CA-JNJFOC-20240841361$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240819$$HP$CA$CA
242218451$24221845$1$I$$20240808$20240819$20240819$30DAY$$US-JNJFOC-20240842454$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$US$US
242218461$24221846$1$I$20240725$20240808$20240819$20240819$EXP$$GB-MSNLABS-2024MSNSPO01784$MSN LABORATORIES$$$$$$Y$$$20240819$$HP$GB$GB
242218471$24221847$1$I$20240730$20240815$20240819$20240819$EXP$IT-MINISAL02-998445$IT-ROCHE-10000058188$ROCHE$$52$YR$A$F$Y$$$20240819$$MD$IT$IT
242218481$24221848$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167314$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242218491$24221849$1$I$$20240816$20240819$20240819$PER$$US-HALEON-2192464$Haleon PLC$$$$$F$Y$$$20240819$$CN$US$US
242218501$24221850$1$I$$20240815$20240819$20240819$PER$$US-TAKEDA-2024TUS082381$TAKEDA$$$$$M$Y$$$20240819$$CN$US$US
242218512$24221851$2$F$20240808$20240919$20240819$20240924$EXP$$US-AMGEN-USASL2024161581$AMGEN$$51$YR$A$F$Y$$$20240923$$MD$US$US
242218521$24221852$1$I$20240101$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024162416$AMGEN$$$$$M$Y$$$20240819$$HP$US$US
242218531$24221853$1$I$$20240806$20240819$20240819$EXP$$US-FARMAPROD-202408-2860$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240819$$CN$US$US
242218541$24221854$1$I$20240624$20240805$20240819$20240819$EXP$$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07547$HIKMA$$$$$$Y$$$20240819$$PH$FR$FR
242218551$24221855$1$I$20240801$20240814$20240819$20240819$EXP$$AR-JNJFOC-20240839708$JOHNSON AND JOHNSON$$80$YR$E$F$Y$70$KG$20240819$$CN$AR$AR
242218561$24221856$1$I$$20240813$20240819$20240819$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001646$BLUEPRINT MEDICINES$$$$$F$Y$$$20240819$$CN$US$US
242218571$24221857$1$I$$20240726$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004142$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
242218581$24221858$1$I$20240101$20240815$20240819$20240819$EXP$$CA-UCBSA-2024041607$UCB$$$$$M$Y$$$20240819$$MD$CA$CA
242218591$24221859$1$I$20240520$20240814$20240819$20240819$EXP$$CO-UCBSA-2024027080$UCB$$36$YR$$M$Y$60$KG$20240819$$CN$CO$CO
242218601$24221860$1$I$$20240815$20240819$20240819$PER$$US-TAKEDA-2024TUS082425$TAKEDA$$$$$F$Y$$$20240819$$MD$US$US
242218612$24221861$2$F$$20240826$20240819$20240903$EXP$$JP-009507513-2408JPN001726J$MERCK$$$$$F$Y$$$20240903$$MD$JP$JP
242218621$24221862$1$I$20230718$20240812$20240819$20240819$EXP$$IT-EMD Serono-2024043769$EMD SERONO INC$$80$YR$E$F$Y$$$20240819$$MD$IT$IT
242218631$24221863$1$I$$20240815$20240819$20240819$EXP$$US-AstraZeneca-2024A186729$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242218641$24221864$1$I$20240622$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A185533$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242218651$24221865$1$I$$20230629$20240819$20240819$EXP$$US-AstraZeneca-2023A152203$ASTRAZENECA$$$$$F$Y$$$20240819$$HP$US$
242218661$24221866$1$I$$20220714$20240819$20240819$EXP$$US-AstraZeneca-2022A257256$ASTRAZENECA$$69$YR$$F$Y$$$20240819$$MD$US$
242218681$24221868$1$I$$20240813$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408008453$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240819$$CN$US$US
242218691$24221869$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010289$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240819$$CN$US$US
242218701$24221870$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010702$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240819$$CN$US$US
242218711$24221871$1$I$$20240726$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004058$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242218721$24221872$1$I$$20240812$20240819$20240819$EXP$$US-ASPIRO-ASP2024US02722$ASPIRO PHARMA$Nandan A, Higgins A, Lee R. Startled to Death: A Case of Polymorphic Ventricular Tachycardia in Congenital Long QT Syndrome. US Cardiology Review. 2024;18(1):63$57$YR$$M$Y$$$20240819$$MD$US$US
242218731$24221873$1$I$20240520$20240809$20240819$20240819$EXP$PT-INFARMED-F202405-900$PT-TEVA-VS-3232599$TEVA$$83$YR$$M$Y$92$KG$20240819$$MD$PT$PT
242218741$24221874$1$I$$20240813$20240819$20240819$PER$$US-ALXN-202408USA000770US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240819$$CN$US$US
242218751$24221875$1$I$$20240813$20240819$20240819$EXP$$DE-SANDOZ INC.-SDZ2024DE072397$SANDOZ$$48$YR$$F$Y$$$20240819$$HP$DE$DE
242218761$24221876$1$I$$20240727$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004064$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242218771$24221877$1$I$$20240814$20240819$20240819$PER$$US-TAKEDA-2024TUS082214$TAKEDA$$$$$$Y$$$20240819$$CN$US$US
242218781$24221878$1$I$20240113$20240809$20240819$20240819$EXP$ES-AEMPS-1555828$ES-TEVA-VS-3232990$TEVA$$56$YR$$M$Y$72.1$KG$20240819$$MD$ES$ES
242218791$24221879$1$I$$20240813$20240819$20240819$EXP$$IT-SANDOZ INC.-SDZ2024IT072334$SANDOZ$$41$YR$$M$Y$$$20240819$$MD$IT$IT
242218801$24221880$1$I$20240630$20240708$20240819$20240819$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01009$TARO$$$$$$Y$$$20240819$$CN$US$US
242218811$24221881$1$I$20230622$20240814$20240819$20240819$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045907$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$$$20240819$$HP$US$US
242218831$24221883$1$I$$20240812$20240819$20240819$PER$$NVSC2024US164622$NOVARTIS$$$$$$Y$$$20240819$$CN$US$US
242218841$24221884$1$I$20240628$20240805$20240819$20240819$EXP$$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07546$HIKMA$$73$YR$$F$Y$80$KG$20240819$$PH$FR$FR
242218851$24221885$1$I$$20240814$20240819$20240819$EXP$$US-ABBVIE-5882962$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242218861$24221886$1$I$20240605$20240814$20240819$20240819$EXP$$US-ABBVIE-5881895$ABBVIE$$65$YR$$F$Y$$$20240819$$CN$US$US
242218871$24221887$1$I$$20240814$20240819$20240819$EXP$$US-TAKEDA-2019TUS071654$TAKEDA$$$$$F$Y$$$20240819$$CN$US$US
242218881$24221888$1$I$20240806$20240816$20240819$20240819$EXP$$CN-ROCHE-10000059064$ROCHE$$34$YR$A$M$Y$71$KG$20240819$$HP$CN$CN
242218891$24221889$1$I$$20240805$20240819$20240819$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK093314$GLENMARK$$$$$$Y$$$20240819$$HP$CA$CA
242218901$24221890$1$I$$20240716$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07343$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242218911$24221891$1$I$$20240808$20240819$20240819$EXP$GB-002147023-NVSC2022GB181391$GB-KOANAAP-SML-GB-2022-01022$Unknown Manufacturer$$$$E$F$Y$$$20240819$$CN$GB$GB
242218921$24221892$1$I$20211210$20240808$20240819$20240819$EXP$$NL-KOANAAP-SML-NL-2022-00895$Unknown Manufacturer$$70$YR$E$M$Y$86.2$KG$20240819$$MD$NL$NL
242218931$24221893$1$I$20240805$20240805$20240819$20240819$EXP$$DE-ALVOGEN-2024095317$ALVOGEN$$80$YR$$F$Y$$$20240819$$PH$DE$DE
242218941$24221894$1$I$$20240812$20240819$20240819$EXP$$CA-GSK-CA2024099184$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$HP$CA$CA
242218952$24221895$2$F$$20240812$20240819$20240821$EXP$$CN-SA-2024SA240748$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240821$$HP$CN$CN
242218961$24221896$1$I$$20240717$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07210$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242218971$24221897$1$I$20240103$20240805$20240819$20240819$EXP$PT-INFARMED-J202407-1051$PT-SERVIER-S24009833$SERVIER$$$$$$Y$$$20240819$$PH$PT$PT
242218981$24221898$1$I$$20240815$20240819$20240819$PER$$US-ABBVIE-5883203$ABBVIE$$$$$$Y$$$20240819$$HP$US$US
242218991$24221899$1$I$$20240507$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003258$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242219001$24221900$1$I$$20240618$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003281$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242219011$24221901$1$I$$20240509$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003336$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242219021$24221902$1$I$$20240510$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003359$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242219031$24221903$1$I$$20240621$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003614$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242219041$24221904$1$I$$20240514$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003443$BIOCON$$63$YR$$M$Y$72$KG$20240819$$CN$US$US
242219051$24221905$1$I$$20240530$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003405$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242219061$24221906$1$I$$20240513$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003412$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242219071$24221907$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167313$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242219082$24221908$2$F$$20240826$20240819$20240830$EXP$$US-AstraZeneca-2024A186636$ASTRAZENECA$$$$$F$Y$$$20240830$$HP$US$
242219091$24221909$1$I$$20240604$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003504$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242219101$24221910$1$I$20230117$20230510$20240819$20240819$EXP$$CA-AstraZeneca-2023A111370$ASTRAZENECA$$22562$DY$$F$Y$$$20240819$$CN$CA$
242219113$24221911$3$F$$20240826$20240819$20240903$EXP$$GB-VANTIVE-2024VAN018956$Vantive US Healthcare$$$$$F$Y$$$20240903$$CN$GB$GB
242219122$24221912$2$F$$20240923$20240819$20240926$EXP$$IN-VANTIVE-2024VAN019074$Vantive US Healthcare$$27$YR$$F$Y$$$20240926$$CN$IN$IN
242219131$24221913$1$I$20240806$20240814$20240819$20240819$EXP$$VN-VANTIVE-2024VAN019062$Vantive US Healthcare$$$$E$F$Y$$$20240819$$CN$VN$VN
242219141$24221914$1$I$20230101$20240724$20240819$20240819$PER$$US-JNJFOC-20240768604$JOHNSON AND JOHNSON$$7$DEC$$F$Y$$$20240819$$CN$US$US
242219151$24221915$1$I$20200101$20240815$20240819$20240819$EXP$IT-MINISAL02-998487$IT-JNJFOC-20240846122$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240819$$MD$IT$IT
242219161$24221916$1$I$20240319$20240812$20240819$20240819$EXP$AT-BASGAGES-2024-005957$AT-009507513-2408AUT004477$MERCK$$61$YR$$F$Y$80$KG$20240819$$MD$AT$AT
242219171$24221917$1$I$$20240812$20240819$20240819$EXP$$US-SA-2024SA241133$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240819$$MD$US$US
242219191$24221919$1$I$20240801$20240812$20240819$20240819$EXP$$US-SA-2024SA242453$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240819$$MD$US$US
242219201$24221920$1$I$$20240718$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07271$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242219211$24221921$1$I$20240809$20240812$20240819$20240819$EXP$$CA-TAKEDA-2024TUS081337$TAKEDA$$75$YR$$M$Y$$$20240819$$CN$CA$CA
242219231$24221923$1$I$20200720$20240814$20240819$20240819$EXP$$US-TAKEDA-US202014879$TAKEDA$$56$YR$$F$Y$$$20240819$$HP$US$US
242219241$24221924$1$I$$20240809$20240819$20240819$30DAY$$US-GSK-US2024AMR099997$GLAXOSMITHKLINE$$$$$M$Y$$$20240819$$CN$US$US
242219251$24221925$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009870$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240819$$CN$US$US
242219261$24221926$1$I$$20240812$20240819$20240819$EXP$$CA-JNJFOC-20240838807$JOHNSON AND JOHNSON$$77$YR$E$M$Y$94$KG$20240819$$MD$CA$CA
242219271$24221927$1$I$20240731$20240812$20240819$20240819$PER$$US-JNJFOC-20240832202$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240819$$CN$US$US
242219281$24221928$1$I$20240801$20240813$20240819$20240819$EXP$$US-SA-2024SA242151$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240819$$MD$US$US
242219301$24221930$1$I$20240813$20240813$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408008334$ELI LILLY AND CO$$51$YR$A$$Y$$$20240819$$CN$US$US
242219312$24221931$2$F$$20240820$20240819$20240827$EXP$$CN-SA-2024SA242070$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240827$$MD$CN$CN
242219322$24221932$2$F$$20240813$20240819$20240821$EXP$$AR-SA-2024SA243033$SANOFI AVENTIS$$$$$F$Y$$$20240821$$CN$AR$AR
242219331$24221933$1$I$$20240813$20240819$20240819$EXP$$CA-TAKEDA-2023TUS114991$TAKEDA$$$$$M$Y$$$20240819$$CN$CA$CA
242219351$24221935$1$I$$20240718$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07346$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242219361$24221936$1$I$20240212$20240815$20240819$20240819$EXP$$US-UCBSA-2024007303$UCB$$51$YR$$M$Y$$$20240819$$CN$US$US
242219371$24221937$1$I$$20240810$20240819$20240819$PER$$US-TAKEDA-2024TUS080886$TAKEDA$$$$$$Y$$$20240819$$MD$US$US
242219381$24221938$1$I$$20240809$20240819$20240819$EXP$$CA-TEVA-VS-3232667$TEVA$$41$YR$$F$Y$$$20240819$$CN$CA$CA
242219391$24221939$1$I$20240806$20240816$20240819$20240819$EXP$$RU-SANDOZ INC.-SDZ2024RU073327$SANDOZ$$$$$M$Y$144$KG$20240819$$HP$RU$RU
242219401$24221940$1$I$$20240805$20240819$20240819$EXP$$ZA-CIPLA LTD.-2024ZA08705$CIPLA$Bishop MD, Frenkel LM, Korutaro V, Boyce CL, Beck IA, Styrchak SM et al.. Characterizing HIV drug resistance in cases of vertical transmission in the VesTed randomized antiretroviral treatment trial. J Acquir Immune Defic Syndr. 2024;96 (4):385 to 392$$$$$Y$$$20240819$$HP$ZA$ZA
242219411$24221941$1$I$$20240717$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07293$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242219421$24221942$1$I$$20240809$20240819$20240819$EXP$$CA-TEVA-VS-3232637$TEVA$$84$YR$$F$Y$$$20240819$$MD$CA$CA
242219431$24221943$1$I$$20240809$20240819$20240819$EXP$NL-LRB-00993803$NL-TEVA-VS-3232861$TEVA$$84$YR$$M$Y$81$KG$20240819$$CN$NL$NL
242219441$24221944$1$I$$20240812$20240819$20240819$EXP$$CA-AUROBINDO-AUR-APL-2024-041132$AUROBINDO$$$$$F$Y$$$20240819$$HP$CA$CA
242219451$24221945$1$I$20240621$20240815$20240819$20240819$EXP$$US-UCBSA-2024041391$UCB$$37$YR$$M$Y$$$20240819$$CN$US$US
242219461$24221946$1$I$$20240813$20240819$20240819$PER$$US-TAKEDA-2024TUS082229$TAKEDA$$$$$F$Y$$$20240819$$CN$US$US
242219471$24221947$1$I$$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A186331$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242219481$24221948$1$I$$20230105$20240819$20240819$EXP$$CA-AstraZeneca-2023A123208$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$CA$
242219491$24221949$1$I$$20220809$20240819$20240819$EXP$$US-AstraZeneca-2022A237321$ASTRAZENECA$$$$$$Y$$$20240819$$MD$US$
242219501$24221950$1$I$$20230310$20240819$20240819$EXP$$US-AstraZeneca-2023A060360$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242219511$24221951$1$I$$20220803$20240819$20240819$EXP$$US-AstraZeneca-2022A276491$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242219521$24221952$1$I$$20240717$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07345$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242219531$24221953$1$I$$20240814$20240819$20240819$PER$$US-ROCHE-10000058318$ROCHE$$$$$$Y$$$20240819$$MD$US$US
242219541$24221954$1$I$20240814$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024163510$AMGEN$$69$YR$E$M$Y$$$20240819$$CN$US$US
242219551$24221955$1$I$20240811$20240812$20240819$20240819$PER$$US-AMGEN-USASP2024160267$AMGEN$$62$YR$A$F$Y$$$20240819$$CN$US$US
242219561$24221956$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167342$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242219571$24221957$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024159976$AMGEN$Yuen C A.;  Baob S.; Konga X. T. et al.. A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient. Biomarkers in Medicine. 2024;18 (9):433-441$75$YR$E$F$Y$$$20240819$$HP$US$US
242219582$24221958$2$F$$20240826$20240819$20240828$PER$$US-AMGEN-USASP2024163456$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242219591$24221959$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162647$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242219601$24221960$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162656$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242219611$24221961$1$I$$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024162580$AMGEN$$$$$F$Y$$$20240819$$PH$US$US
242219621$24221962$1$I$20240216$20240815$20240819$20240819$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-112069$REGENERON$$$$$F$Y$$$20240819$$CN$US$US
242219641$24221964$1$I$$20240816$20240819$20240819$PER$$US-HALEON-2192466$Haleon PLC$$$$$$Y$$$20240819$$CN$US$US
242219651$24221965$1$I$$20240719$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07379$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242219661$24221966$1$I$$20240614$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-2022M1050262$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242219671$24221967$1$I$$20240806$20240819$20240819$PER$$US-P+L Developments of Newyork Corporation-2160584$PL DEVELOPMENTS$$$$$F$Y$$$20240819$$$US$US
242219681$24221968$1$I$$20240813$20240819$20240819$EXP$$CN-RDY-LIT/CHN/24/0011986$DR REDDYS$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turkish Journal of Hematology. 2023;40: 284-285. doi:10.4274/tjh.galenos.2023.2023.0263.$61$YR$A$F$Y$$$20240819$$HP$CN$CN
242219691$24221969$1$I$20230601$20240819$20240819$20240819$EXP$FR-AFSSAPS-PA2024001449$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046419$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$88$KG$20240819$$CN$FR$FR
242219701$24221970$1$I$20220101$20240812$20240819$20240819$EXP$DE-ROCHE-3316504$DE-RDY-SPO/DEU/24/0010371$DR REDDYS$$51$YR$A$M$Y$$$20240819$$MD$DE$DE
242219711$24221971$1$I$$20240807$20240819$20240819$EXP$$US-JNJFOC-20240822528$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$CN$US$US
242219721$24221972$1$I$$20240812$20240819$20240819$EXP$$CA-JNJFOC-20240842236$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240819$$CN$CA$CA
242219731$24221973$1$I$20200925$20240812$20240819$20240819$EXP$$CA-CELLTRION INC.-2020CA035298$CELLTRION$$$$$$Y$$$20240819$$HP$CA$CA
242219743$24221974$3$F$$20240905$20240819$20240911$PER$$US-ROCHE-10000055649$ROCHE$$$$$M$Y$$$20240911$$CN$US$US
242219751$24221975$1$I$$20240813$20240819$20240819$EXP$$MX-ROCHE-10000050129$ROCHE$$$$$F$Y$$$20240819$$MD$MX$MX
242219761$24221976$1$I$$20240722$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07462$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242219772$24221977$2$F$20240401$20240826$20240819$20240902$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045092$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$53$KG$20240902$$CN$BR$BR
242219791$24221979$1$I$20240809$20240814$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130023$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$134.6$KG$20240819$$PH$US$US
242219801$24221980$1$I$$20240808$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125896$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240819$$CN$US$US
242219811$24221981$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129565$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240819$$CN$US$US
242219821$24221982$1$I$20240812$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130202$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240819$$CN$US$US
242219831$24221983$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129595$BRISTOL MYERS SQUIBB$$57$YR$A$$Y$$$20240819$$HP$US$US
242219841$24221984$1$I$$20240812$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127467$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$53.98$KG$20240819$$CN$US$US
242219851$24221985$1$I$20240801$20240814$20240819$20240819$EXP$$US-ABBVIE-5882897$ABBVIE$$58$YR$$F$Y$$$20240819$$CN$US$US
242219861$24221986$1$I$$20240809$20240819$20240819$EXP$$IL-AMGEN-ISRSP2024160288$AMGEN$$$$$M$Y$$$20240819$$MD$IL$IL
242219871$24221987$1$I$$20240807$20240819$20240819$EXP$$GB-UCBSA-2024039787$UCB$$$$$M$Y$$$20240819$$CN$GB$GB
242219881$24221988$1$I$$20240814$20240819$20240819$EXP$$US-ABBVIE-5883444$ABBVIE$$$$$F$Y$$$20240819$$HP$US$US
242219891$24221989$1$I$20240710$20240809$20240819$20240819$EXP$SE-SEMPA-2024-005876$SE-TEVA-VS-3232958$TEVA$$73$YR$$M$Y$$$20240819$$HP$SE$SE
242219901$24221990$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010065$ELI LILLY AND CO$$$$$$Y$$$20240819$$CN$US$US
242219911$24221991$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010764$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240819$$CN$US$US
242219921$24221992$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010803$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240819$$CN$US$US
242219932$24221993$2$F$$20240816$20240819$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010028$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240821$$CN$US$US
242219942$24221994$2$F$$20240904$20240819$20240917$PER$GB-MHRA-MED-202408071312534650-VCMZP$GB-IGSA-BIG0030206$GRIFOLS$$$$$F$Y$$$20240917$$CN$GB$GB
242219961$24221996$1$I$20210101$20240805$20240819$20240819$EXP$$SE-GLENMARK PHARMACEUTICALS-2024GMK093236$GLENMARK$$$$$$Y$$$20240819$$CN$SE$SE
242219971$24221997$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162763$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242219981$24221998$1$I$20240720$20240808$20240819$20240819$EXP$$US-ABBVIE-5874851$ABBVIE$$67$YR$$F$Y$$$20240819$$CN$US$US
242219991$24221999$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162764$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220001$24222000$1$I$20240514$20240813$20240819$20240819$EXP$FR-AFSSAPS-DJ2024000914$FR-AMGEN-FRASP2024161331$AMGEN$$59$YR$A$M$Y$50$KG$20240819$$MD$FR$FR
242220011$24222001$1$I$20231229$20240806$20240819$20240819$EXP$$US-UCBSA-2024006619$UCB$$44$YR$$F$Y$$$20240819$$CN$US$US
242220031$24222003$1$I$20240802$20240814$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024161486$AMGEN$$71$YR$E$M$Y$$$20240819$$MD$ES$ES
242220041$24222004$1$I$20240719$20240809$20240819$20240819$EXP$FR-AFSSAPS-LY2024001196$FR-TEVA-VS-3232666$TEVA$$91$YR$$F$Y$$$20240819$$MD$FR$FR
242220053$24222005$3$F$$20240830$20240819$20240909$EXP$$ES-AUROBINDO-AUR-APL-2024-023194$AUROBINDO$$53$YR$$F$Y$$$20240909$$HP$ES$ES
242220061$24222006$1$I$$20240722$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07372$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242220071$24222007$1$I$$20221122$20240819$20240819$EXP$$RU-AstraZeneca-2022A390247$ASTRAZENECA$$$$$$Y$$$20240819$$MD$RU$
242220081$24222008$1$I$$20221025$20240819$20240819$EXP$$US-AstraZeneca-2022A315697$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242220091$24222009$1$I$$20240809$20240819$20240819$30DAY$$US-GSK-US2024099780$GLAXOSMITHKLINE$$$$$M$Y$$$20240819$$CN$US$US
242220101$24222010$1$I$$20230515$20240819$20240819$EXP$$US-AstraZeneca-2023A113341$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242220111$24222011$1$I$20221201$20221202$20240819$20240819$EXP$$US-AstraZeneca-2022A397248$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242220121$24222012$1$I$20220301$20220311$20240819$20240819$EXP$$US-AstraZeneca-2022A112189$ASTRAZENECA$$1138$MON$$M$Y$$$20240819$$CN$US$
242220131$24222013$1$I$20240714$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A185599$ASTRAZENECA$$26217$DY$$F$Y$$$20240819$$CN$US$
242220141$24222014$1$I$$20221101$20240819$20240819$EXP$$US-AstraZeneca-2022A364148$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242220151$24222015$1$I$$20231016$20240819$20240819$EXP$$CA-AstraZeneca-2023A237050$ASTRAZENECA$$$$$M$Y$$$20240819$$HP$CA$
242220161$24222016$1$I$$20240809$20240819$20240819$EXP$$GB-JNJFOC-20240824315$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$GB$GB
242220171$24222017$1$I$$20240810$20240819$20240819$EXP$$GB-JNJFOC-20240830750$JOHNSON AND JOHNSON$$$$A$$Y$$$20240819$$CN$GB$GB
242220183$24222018$3$F$$20240823$20240819$20240903$EXP$$GB-MYLANLABS-2024M1076583$MYLAN$$$$$M$Y$$$20240903$$HP$GB$GB
242220191$24222019$1$I$$20240814$20240819$20240819$EXP$$CA-MYLANLABS-2024M1075999$MYLAN$$$$$M$Y$$$20240819$$PH$CA$CA
242220201$24222020$1$I$$20240814$20240819$20240819$EXP$$AU-MYLANLABS-2024M1076172$MYLAN$$$$$F$Y$$$20240819$$HP$AU$AU
242220211$24222021$1$I$$20240816$20240819$20240819$EXP$$CA-MYLANLABS-2024M1076593$MYLAN$$$$$F$Y$$$20240819$$HP$CA$CA
242220231$24222023$1$I$20240716$20240814$20240819$20240819$EXP$FR-AFSSAPS-PC2024000650$FR-MYLANLABS-2024M1075719$MYLAN$$33$YR$$F$Y$$$20240819$$PH$FR$FR
242220241$24222024$1$I$20240323$20240814$20240819$20240819$EXP$FR-AFSSAPS-BR2024000650$FR-MYLANLABS-2024M1075717$MYLAN$$38$YR$$M$Y$97$KG$20240819$$PH$FR$FR
242220251$24222025$1$I$20130101$20240814$20240819$20240819$EXP$$GR-MYLANLABS-2024M1075713$MYLAN$Theodoridis M, Dimitrakopoulos C, Papantoniou E, Bounta T, Kantartzi K, Panagoutsos S... Application of peritoneal dialysis in a patient with Seckel syndrome: a rare case report. Ellin Nephrol. 2024;36(1):56-64$23$YR$$M$Y$14.5$KG$20240819$$HP$GR$GR
242220261$24222026$1$I$20231225$20240815$20240819$20240819$EXP$$GB-MYLANLABS-2024M1076396$MYLAN$$79$YR$$F$Y$65$KG$20240819$$MD$GB$GB
242220271$24222027$1$I$20240708$20240814$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US073124$SANDOZ$$57$YR$$F$Y$65.91$KG$20240819$$CN$US$US
242220281$24222028$1$I$20240812$20240814$20240819$20240819$EXP$$NVSC2024CN166018$NOVARTIS$$76$YR$$F$Y$52$KG$20240819$$HP$CN$CN
242220291$24222029$1$I$$20240812$20240819$20240819$EXP$$US-ROCHE-10000060000$ROCHE$Tun A, Patel R, St-Pierre F, Ouchveridze E, Niu A, Thordardottir T, et al. Anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study. American Journal of Hematology. 2024;99 (9):1712-20. doi:10.1002/ajh.27381.$80$YR$E$M$Y$$$20240819$$HP$US$US
242220301$24222030$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162823$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220311$24222031$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162767$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220321$24222032$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162812$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220331$24222033$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162824$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220341$24222034$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162821$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220351$24222035$1$I$$20240813$20240819$20240819$EXP$$CA-SANDOZ INC.-NVSC2021CA037003$SANDOZ$$65$YR$$F$Y$69$KG$20240819$$HP$CA$CA
242220361$24222036$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162820$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220373$24222037$3$F$20240601$20240903$20240819$20240904$PER$$US-ALXN-202408USA000842US$ALEXION PHARMACEUTICALS$$47$YR$$F$Y$$$20240904$$CN$US$US
242220381$24222038$1$I$20240101$20240807$20240819$20240819$EXP$$JP-ROCHE-10000056459$ROCHE$$75$YR$E$M$Y$55$KG$20240819$$PH$JP$JP
242220392$24222039$2$F$$20240826$20240819$20240827$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046399$BOEHRINGER INGELHEIM$$27$YR$A$F$Y$$$20240827$$CN$CN$CN
242220411$24222041$1$I$$20240807$20240819$20240819$EXP$$US-AUROBINDO-AUR-APL-2024-039782$AUROBINDO$Surineni K, Armstrong A, Wallace S, Schrader N.. The Emergence of Mania After Initiating Escitalopram for Anxiety Disorder. Cureus. 2024;16(6):e63441$22$YR$$F$Y$$$20240819$$MD$US$US
242220421$24222042$1$I$$20240816$20240819$20240819$PER$$US-JNJFOC-20240843947$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$HP$US$US
242220432$24222043$2$F$20140101$20240823$20240819$20240903$EXP$$NL-AUROBINDO-AUR-APL-2024-039901$AUROBINDO$Hoppe B.P.C, de Jongh. E, Griffioen-Keijzer. A, Zijlstra-Baalbergen. J.M, IJzerman. E.P.F, Baboe. F.. Human metapneumovirus in haematopoietic stem cell transplantation recipients: a case series and review of the diagnostic and therapeutic approach.. The Netherlands Journal of medicine. 2016;74(8):336-341$67$YR$$F$Y$$$20240903$$HP$NL$NL
242220441$24222044$1$I$$20240815$20240819$20240819$EXP$$IN-ROCHE-10000058069$ROCHE$Negi S, Ranjan P. Veno occlusive disease (sinusoidal obstruction syndrome) - case series (abstract number: 359). Journal of Clinical and Experimental Hepatology. 2024-Jan;14:S2. doi:10.1016/j.jceh.2024.101998.$36$YR$A$M$Y$$$20240819$$HP$IN$IN
242220451$24222045$1$I$$20240703$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001099$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220461$24222046$1$I$$20240429$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003087$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220471$24222047$1$I$$20240430$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003119$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220481$24222048$1$I$$20240502$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003153$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220491$24222049$1$I$$20240501$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003169$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220501$24222050$1$I$20240429$20240430$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003077$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220511$24222051$1$I$$20240501$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003108$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220521$24222052$1$I$$20240722$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07434$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242220531$24222053$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162830$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220541$24222054$1$I$20240401$20240809$20240819$20240819$EXP$$JP-EMD Serono-2024043852$EMD SERONO INC$$57$YR$A$M$Y$$$20240819$$MD$JP$JP
242220551$24222055$1$I$$20240501$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003113$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220561$24222056$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024163322$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220571$24222057$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162832$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220581$24222058$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024163329$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220591$24222059$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024163317$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220601$24222060$1$I$$20240814$20240819$20240819$EXP$$EG-AMGEN-EGYSP2024164383$AMGEN$$29$YR$A$F$Y$$$20240819$$CN$EG$EG
242220612$24222061$2$F$20240807$20240808$20240819$20240821$EXP$$US-JNJFOC-20240822177$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240821$$CN$US$US
242220621$24222062$1$I$20240503$20240514$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003192$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220631$24222063$1$I$$20240510$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003195$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220641$24222064$1$I$20240503$20240520$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003199$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220651$24222065$1$I$$20240529$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003215$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220661$24222066$1$I$$20240502$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003184$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220671$24222067$1$I$20240808$20240816$20240819$20240819$EXP$$CN-ROCHE-10000059838$ROCHE$$52$YR$A$F$Y$50$KG$20240819$$HP$CN$CN
242220681$24222068$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129686$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240819$$MD$US$US
242220691$24222069$1$I$$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024163016$AMGEN$$$$$$Y$$$20240819$$HP$US$US
242220701$24222070$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024163335$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242220711$24222071$1$I$20240601$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024161136$AMGEN$$80$YR$E$F$Y$$$20240819$$CN$US$US
242220722$24222072$2$F$$20240814$20240819$20240823$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02914$AMNEAL$$$$$M$Y$$$20240823$$CN$US$US
242220731$24222073$1$I$20240625$20240809$20240819$20240819$EXP$PT-INFARMED-R202407-751$PT-TEVA-VS-3232946$TEVA$$72$YR$$M$Y$$$20240819$$MD$PT$PT
242220751$24222075$1$I$$20230802$20240819$20240819$PER$$US-STRIDES ARCOLAB LIMITED-2023SP012842$STRIDES$Michelle L, Post RJ, Kuan EC, Nageotte MP.. Spontaneous skull base cerebrospinal fluid leak during pregnancy: a case report and review of the literature.. BMC-Pregnancy-Childbirth. 2023;23 (1)$31$YR$$F$Y$$$20240819$$HP$US$US
242220762$24222076$2$F$20240515$20240816$20240819$20240821$EXP$$US-SANDOZ INC.-SDZ2024US073053$SANDOZ$$12$YR$$M$Y$$$20240821$$HP$US$US
242220772$24222077$2$F$$20240820$20240819$20240823$EXP$$NVSC2024US010281$NOVARTIS$$$$$M$Y$$$20240823$$HP$US$US
242220781$24222078$1$I$$20230907$20240819$20240819$EXP$$US-AstraZeneca-2023A204800$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242220791$24222079$1$I$20240710$20240815$20240819$20240819$EXP$$NVSC2024CN166211$NOVARTIS$$31$YR$$M$Y$70$KG$20240819$$HP$CN$CN
242220803$24222080$3$F$20240731$20240905$20240819$20240913$PER$$US-AstraZeneca-2024A174361$ASTRAZENECA$$25549$DY$$F$Y$$$20240913$$MD$US$
242220811$24222081$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010854$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240819$$CN$US$US
242220821$24222082$1$I$$20240807$20240819$20240819$EXP$$JP-ROCHE-10000056806$ROCHE$$87$YR$E$F$Y$$$20240819$$MD$JP$JP
242220851$24222085$1$I$$20240814$20240819$20240819$PER$$US-ROCHE-10000058020$ROCHE$$29$YR$A$M$Y$$$20240819$$MD$US$US
242220861$24222086$1$I$20240301$20240812$20240819$20240819$EXP$$US-TAKEDA-2024TUS080859$TAKEDA$$72$YR$$F$Y$$$20240819$$CN$US$US
242220871$24222087$1$I$$20240806$20240819$20240819$EXP$$US-BELUSA-2024BELLIT0092$BIOLOGICAL E.$Teeri S, Hussien M, Garg VP.PREOPERATIVE USE OF DISOPYRAMIDE IN A PATIENT WITH SUSPECTED HYPERTROPHIC CARDIOMYOPATHY AND SEVERE LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION.Journal of the American College of Cardiology.2024;83 (13):3209$$$$$Y$$$20240819$$HP$US$US
242220881$24222088$1$I$$20240813$20240819$20240819$EXP$$NVSC2024CA166352$NOVARTIS$$$$$F$Y$$$20240819$$HP$CA$CA
242220901$24222090$1$I$$20240513$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003407$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220911$24222091$1$I$$20240507$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003296$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220921$24222092$1$I$$20240517$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003615$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220931$24222093$1$I$$20240521$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003665$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220941$24222094$1$I$$20240522$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003741$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220951$24222095$1$I$$20240523$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003769$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220961$24222096$1$I$$20240528$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003824$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242220971$24222097$1$I$$20240513$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003389$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220981$24222098$1$I$$20240523$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003444$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242220991$24222099$1$I$$20240506$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003228$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242221001$24222100$1$I$$20240515$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003534$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221011$24222101$1$I$$20240521$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003660$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242221021$24222102$1$I$$20240531$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003711$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221031$24222103$1$I$$20240523$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003774$BIOCON$$$$$$Y$$$20240819$$HP$US$US
242221041$24222104$1$I$$20240510$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003361$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221051$24222105$1$I$$20240511$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003415$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242221061$24222106$1$I$$20240508$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003278$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221071$24222107$1$I$$20240516$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003255$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221081$24222108$1$I$$20240531$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003337$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221091$24222109$1$I$$20240816$20240819$20240819$EXP$$NVSC2024DE166920$NOVARTIS$$$$E$F$Y$$$20240819$$CN$DE$DE
242221101$24222110$1$I$20240614$20240806$20240819$20240819$30DAY$$US-ALIMERA SCIENCES INC.-US-A16013-24-000442$ALIMERA$$63$YR$$$Y$$$20240819$$MD$US$US
242221111$24222111$1$I$$20240730$20240819$20240819$PER$$US-ALIMERA SCIENCES INC.-US-A16013-24-000493$ALIMERA$$$$$$Y$$$20240819$$MD$US$US
242221121$24222112$1$I$$20240718$20240819$20240819$PER$$US-ALIMERA SCIENCES INC.-US-A16013-24-000479$ALIMERA$$$$$$Y$$$20240819$$MD$US$US
242221132$24222113$2$F$20240701$20240815$20240819$20240826$PER$$US-AMGEN-USASP2024162421$AMGEN$$58$YR$A$F$Y$$$20240826$$CN$US$US
242221141$24222114$1$I$20240801$20240813$20240819$20240819$EXP$$GB-AMGEN-GBRSL2024162360$AMGEN$$82$YR$E$F$Y$$$20240819$$CN$GB$GB
242221151$24222115$1$I$$20240526$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003888$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221161$24222116$1$I$$20240529$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003913$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221171$24222117$1$I$$20240529$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003833$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221181$24222118$1$I$$20240605$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003893$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221191$24222119$1$I$$20240529$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003933$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221201$24222120$1$I$$20240528$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003884$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221211$24222121$1$I$$20240806$20240819$20240819$EXP$$US-BELUSA-2024BELLIT0093$BIOLOGICAL E.$Usman S, Ashraf A, Badar F, Iftikhar A.Evidence Based Management of Right Heart Failure in Intensive Care Unit: A Case Report.American Journal of Respiratory and Critical Care Medicine.2023;207:A1785$$$$$Y$$$20240819$$HP$US$US
242221222$24222122$2$F$20240510$20240904$20240819$20240913$EXP$ES-AEMPS-1555777$ES-TEVA-VS-3232766$TEVA$$83$YR$$M$Y$$$20240913$$MD$ES$ES
242221232$24222123$2$F$$20240816$20240819$20240820$EXP$$US-ROCHE-10000057797$ROCHE$$75$YR$E$F$Y$$$20240820$$HP$US$US
242221241$24222124$1$I$20240730$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129502$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240819$$CN$US$US
242221251$24222125$1$I$$20240807$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125974$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240819$$HP$US$US
242221261$24222126$1$I$$20240807$20240819$20240819$EXP$$PT-ASPEN-GLO2024PT005476$ASPEN$Imunoterapia aplicada ao mieloma multiplo.. Hematologia e Oncologia. 2024;12(46):13-16$$$$$Y$$$20240819$$HP$PT$PT
242221271$24222127$1$I$$20240813$20240819$20240819$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045667$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240819$$CN$US$US
242221281$24222128$1$I$20240806$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129106$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240819$$PH$US$US
242221291$24222129$1$I$$20240723$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07490$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242221301$24222130$1$I$$20240805$20240819$20240819$EXP$$JP-AMGEN-JPNSP2024162109$AMGEN$$$$$$Y$$$20240819$$MD$JP$JP
242221312$24222131$2$F$20240814$20240917$20240819$20240918$PER$$US-AMGEN-USASP2024163362$AMGEN$$74$YR$E$F$Y$$$20240917$$CN$US$US
242221321$24222132$1$I$20240201$20240815$20240819$20240819$EXP$$US-TAKEDA-2024TUS028933$TAKEDA$$72$YR$$F$Y$$$20240819$$CN$US$US
242221342$24222134$2$F$20240716$20240926$20240819$20240928$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012412$JAZZ$$18$YR$$F$Y$$$20240928$$CN$US$US
242221351$24222135$1$I$20240603$20240805$20240819$20240819$EXP$$AU-CIPLA LTD.-2024AU08717$CIPLA$$$$$$Y$$$20240819$$HP$AU$AU
242221361$24222136$1$I$20240719$20240805$20240819$20240819$EXP$$GB-CIPLA (EU) LIMITED-2024GB08622$CIPLA$$$$$$Y$$$20240819$$MD$GB$GB
242221371$24222137$1$I$20220101$20240812$20240819$20240819$EXP$$US-GILEAD-2024-0683950$GILEAD$$37$YR$A$M$Y$$$20240819$$CN$US$US
242221381$24222138$1$I$20240701$20240812$20240819$20240819$EXP$$US-SA-2024SA241321$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240819$$MD$US$US
242221391$24222139$1$I$$20240812$20240819$20240819$EXP$$US-SA-2024SA241299$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240819$$MD$US$US
242221401$24222140$1$I$$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024161884$AMGEN$$$$$F$Y$$$20240819$$CN$US$US
242221462$24222146$2$F$20240701$20240904$20240819$20240912$EXP$$US-SA-2024SA241508$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240912$$MD$US$US
242221471$24222147$1$I$$20240807$20240819$20240819$EXP$$FR-MYLANLABS-2024M1075117$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$83$YR$$F$Y$$$20240819$$HP$FR$FR
242221481$24222148$1$I$$20240806$20240819$20240819$EXP$$US-MYLANLABS-2024M1074808$MYLAN$Mossner J, Saleh NB, Shahin MN, Rosenow JM, Raskin JS. Occipital nerve stimulation in pediatric patients with refractory occipital neuralgia. Childs-Nerv-Syst 2024; 40 (8): 2465-2470.$15$YR$$F$Y$$$20240819$$HP$US$US
242221491$24222149$1$I$$20240807$20240819$20240819$EXP$$FR-MYLANLABS-2024M1075103$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$65$YR$$F$Y$$$20240819$$HP$FR$FR
242221501$24222150$1$I$$20240806$20240819$20240819$EXP$$US-MYLANLABS-2024M1074849$MYLAN$Mossner J, Saleh NB, Shahin MN, Rosenow JM, Raskin JS. Occipital nerve stimulation in pediatric patients with refractory occipital neuralgia. Childs-Nerv-Syst 2024; 40 (8): 2465-2470.$15$YR$$M$Y$$$20240819$$HP$US$US
242221511$24222151$1$I$$20240807$20240819$20240819$EXP$$FR-MYLANLABS-2024M1075121$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$69$YR$$F$Y$$$20240819$$HP$FR$FR
242221521$24222152$1$I$$20240806$20240819$20240819$EXP$$FR-MYLANLABS-2024M1074782$MYLAN$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies. Am-J-Reprod-Immunol 2024; 92 (1).$35$YR$$F$Y$$$20240819$$HP$FR$FR
242221531$24222153$1$I$$20240807$20240819$20240819$EXP$$FR-MYLANLABS-2024M1075112$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$76$YR$$F$Y$$$20240819$$HP$FR$FR
242221541$24222154$1$I$$20240807$20240819$20240819$EXP$$GB-MYLANLABS-2024M1075235$MYLAN$Ntatsaki E, Aboul Hossn T, Khaddage B, Vassiliou V, Vayalambrone D. Hydroxychloroquine monitoring- retinal toxicity rates and service challenges. Ann-Rheum-Dis 2024; 83 (Suppl.) 2022.$$$E$$Y$$$20240819$$HP$GB$GB
242221551$24222155$1$I$$20240807$20240819$20240819$EXP$$FR-MYLANLABS-2024M1075120$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$79$YR$$F$Y$$$20240819$$HP$FR$FR
242221561$24222156$1$I$$20240807$20240819$20240819$EXP$$FR-MYLANLABS-2024M1075085$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$74$YR$$M$Y$$$20240819$$HP$FR$FR
242221571$24222157$1$I$$20240807$20240819$20240819$EXP$$FR-MYLANLABS-2024M1075111$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$67$YR$$M$Y$$$20240819$$HP$FR$FR
242221581$24222158$1$I$$20240807$20240819$20240819$EXP$$FR-MYLANLABS-2024M1075086$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$77$YR$$F$Y$$$20240819$$HP$FR$FR
242221591$24222159$1$I$$20240806$20240819$20240819$EXP$$FR-MYLANLABS-2024M1074880$MYLAN$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies. Am-J-Reprod-Immunol 2024; 92 (1):.$36$YR$$F$Y$$$20240819$$HP$FR$FR
242221602$24222160$2$F$$20240823$20240819$20240826$PER$$NVSC2024US167402$NOVARTIS$$$$$F$Y$$$20240826$$HP$US$US
242221621$24222162$1$I$20231001$20240812$20240819$20240819$EXP$$NVSC2024US164199$NOVARTIS$$73$YR$$M$Y$$$20240819$$CN$US$US
242221641$24222164$1$I$$20240529$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003937$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221651$24222165$1$I$$20240529$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003957$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221661$24222166$1$I$$20240530$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003985$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221671$24222167$1$I$20240501$20240607$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004027$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221681$24222168$1$I$$20240529$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003949$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221691$24222169$1$I$$20240531$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004021$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221701$24222170$1$I$$20240603$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004074$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221711$24222171$1$I$$20240809$20240819$20240819$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP010014$STRIDES$Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G et al.. Stevens-Johnson syndrome associated with drugs and vaccines in children: a case-control study.. Plos One.. 2013;8(7):1-8$33$MON$$F$Y$$$20240819$$HP$IT$IT
242221721$24222172$1$I$$20240808$20240819$20240819$PER$$US-ABBVIE-5876181$ABBVIE$$$$$M$Y$$$20240819$$MD$US$US
242221732$24222173$2$F$20240807$20240917$20240819$20240927$EXP$$JP-ROCHE-10000058442$ROCHE$$7$DEC$E$M$Y$$$20240927$$MD$JP$JP
242221743$24222174$3$F$20240801$20240917$20240819$20240919$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044189$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240919$$MD$JP$JP
242221751$24222175$1$I$$20240530$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003968$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242221762$24222176$2$F$$20240917$20240819$20240925$30DAY$$CA-JNJFOC-20240842033$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$CA$CA
242221781$24222178$1$I$20240813$20240813$20240819$20240819$EXP$$US-AMGEN-USASP2024161294$AMGEN$$67$YR$E$F$Y$$$20240819$$PH$US$US
242221791$24222179$1$I$$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024162003$AMGEN$$$$$F$Y$$$20240819$$CN$US$US
242221801$24222180$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00974$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$14$YR$T$$Y$$$20240819$$HP$TR$TR
242221811$24222181$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010955$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240819$$CN$US$US
242221821$24222182$1$I$$20240814$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009135$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$US$US
242221831$24222183$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010590$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240819$$CN$US$US
242221841$24222184$1$I$$20240814$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009380$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240819$$CN$US$US
242221851$24222185$1$I$$20240809$20240819$20240819$EXP$$US-TEVA-VS-3233183$TEVA$$$$$F$Y$$$20240819$$CN$US$US
242221862$24222186$2$F$20240802$20240923$20240819$20240930$PER$$US-ROCHE-10000060047$ROCHE$$51$YR$A$F$Y$89.81$KG$20240930$$CN$US$US
242221881$24222188$1$I$20240816$20240816$20240819$20240819$PER$$US-AMGEN-USASP2024164377$AMGEN$$$$$$Y$$$20240819$$PH$US$US
242221901$24222190$1$I$$20240812$20240819$20240819$EXP$IE-EMA-DD-20190717-kumarsingh_a-094101$IE-SANDOZ INC.-SDZ2024IE071875$SANDOZ$$$$$F$Y$$$20240819$$HP$IE$IE
242221911$24222191$1$I$20230822$20240812$20240819$20240819$EXP$$CN-TAKEDA-2024TUS081577$TAKEDA$$65$YR$$M$Y$$$20240819$$HP$CN$CN
242221922$24222192$2$F$20240101$20240910$20240819$20240924$EXP$$US-UCBSA-2024041151$UCB$$$$$F$Y$$$20240924$$CN$US$US
242221931$24222193$1$I$$20240813$20240819$20240819$EXP$$GB-MYLANLABS-2024M1075751$MYLAN$$$$$M$Y$$$20240819$$CN$GB$GB
242221941$24222194$1$I$$20240807$20240819$20240819$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02907$AMNEAL$$$$$$Y$$$20240819$$CN$US$US
242221951$24222195$1$I$$20240813$20240819$20240819$EXP$$GB-MYLANLABS-2024M1076023$MYLAN$$$$$M$Y$$$20240819$$PH$GB$GB
242221961$24222196$1$I$$20240813$20240819$20240819$EXP$$GB-MYLANLABS-2024M1075877$MYLAN$$$$$F$Y$$$20240819$$CN$GB$GB
242221971$24222197$1$I$$20240807$20240819$20240819$EXP$$FR-MYLANLABS-2024M1074686$MYLAN$Padovani P, Benbrik N, Baruteau A-E. Late aortic obstruction due to ductal vasoconstriction on pulmonic end after transcatheter patent ductus arteriosus closure in an extremely low-birth-weight infant. Cardiol-Young 2023; 33 (10): 2113-2115.$$$I$M$Y$$$20240819$$HP$FR$FR
242221981$24222198$1$I$$20240814$20240819$20240819$EXP$$CA-ABBVIE-5882394$ABBVIE$$$$A$F$Y$$$20240819$$CN$CA$CA
242221993$24222199$3$F$$20240911$20240819$20240913$EXP$$US-AMGEN-USASP2024161193$AMGEN$$$$$M$Y$$$20240913$$CN$US$US
242222002$24222200$2$F$20240703$20240822$20240819$20240827$EXP$$KW-UCBSA-2024034050$UCB$$26$YR$$F$Y$$$20240827$$HP$KW$KW
242222011$24222201$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00975$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$13$YR$T$$Y$$$20240819$$HP$TR$TR
242222021$24222202$1$I$20240729$20240812$20240819$20240819$EXP$$PK-ROCHE-10000055019$ROCHE$$47$YR$A$M$Y$$$20240819$$CN$PK$PK
242222031$24222203$1$I$$20240806$20240819$20240819$EXP$$GB-CIPLA LTD.-2024GB08652$CIPLA$$$$$$Y$$$20240819$$CN$GB$GB
242222041$24222204$1$I$$20240806$20240819$20240819$EXP$$PT-AUROBINDO-AUR-APL-2024-039601$AUROBINDO$Freitas JG, Ribeiro T, Moreira C, Moreira I, Mariz JM.. When ^Myeloma^ is not a Myeloma: a case report of malignant bone lymphoma.. Porto Biomedical Journal. 2024;9(4):e261$63$YR$$F$Y$$$20240819$$MD$PT$PT
242222051$24222205$1$I$$20240606$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004189$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222061$24222206$1$I$$20240610$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004277$BIOCON$$$$$$Y$$$20240819$$HP$US$US
242222071$24222207$1$I$$20240612$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004333$BIOCON$$$$$$Y$$$20240819$$HP$US$US
242222081$24222208$1$I$$20240611$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004370$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222091$24222209$1$I$$20240711$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004384$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222101$24222210$1$I$$20240613$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004435$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222111$24222211$1$I$$20240621$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004481$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222121$24222212$1$I$$20240627$20240819$20240819$PER$$UN-BIOCON BIOLOGICS LIMITED-BBL2024004825$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222131$24222213$1$I$$20240614$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004087$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222141$24222214$1$I$$20240531$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004097$BIOCON$$$$$$Y$$$20240819$$HP$US$US
242222151$24222215$1$I$$20240618$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004429$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242222161$24222216$1$I$$20240617$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004496$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222171$24222217$1$I$$20240604$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004120$BIOCON$$$$$$Y$$$20240819$$HP$US$US
242222181$24222218$1$I$$20240610$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004133$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222191$24222219$1$I$$20240604$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004140$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222201$24222220$1$I$$20240606$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004224$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242222211$24222221$1$I$$20240630$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004293$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222221$24222222$1$I$$20240808$20240819$20240819$EXP$$SE-P+L Developments of Newyork Corporation-2160588$PL DEVELOPMENTS$Initial$54$YR$$$Y$$$20240819$$MD$SE$SE
242222231$24222223$1$I$$20240605$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004145$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222241$24222224$1$I$$20240605$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004165$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222251$24222225$1$I$$20240812$20240819$20240819$EXP$$CA-TAKEDA-2024TUS081546$TAKEDA$$32$YR$$F$Y$60$KG$20240819$$HP$CA$CA
242222291$24222229$1$I$$20240813$20240819$20240819$PER$$US-JNJFOC-20240833336$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
242222301$24222230$1$I$$20240817$20240819$20240819$PER$$US-BAYER-2024A118520$BAYER$$$$$$Y$$$20240819$$CN$US$US
242222311$24222231$1$I$20231030$20231102$20240819$20240819$EXP$$US-AstraZeneca-2023A251906$ASTRAZENECA$$20908$DY$$F$Y$64.9$KG$20240819$$CN$US$
242222321$24222232$1$I$20240304$20240809$20240819$20240819$EXP$ES-AEMPS-1556659$ES-TEVA-VS-3232991$TEVA$$54$YR$$F$Y$61$KG$20240819$$HP$ES$ES
242222331$24222233$1$I$20010101$20240812$20240819$20240819$EXP$$PHBS2002FR07760$NOVARTIS$Lelievre JD, Sacre K, Adle-Biassette H, Molinier-Frenkel V, Gaulard P, Papo T. Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression. J Am Acad Dermatol. 2005;52(2):24-7$53$YR$$M$Y$$$20240819$$HP$FR$FR
242222341$24222234$1$I$20240801$20240815$20240819$20240819$EXP$$NVSC2024US166303$NOVARTIS$$51$YR$$F$Y$$$20240819$$HP$US$US
242222351$24222235$1$I$$20240809$20240819$20240819$EXP$$NVSC2024CN164068$NOVARTIS$Tang Y, Hu D-D, Yang L-P, Wang J-L, Yang Y-Y, Zhu H-J et al.. Efficacy and Safety of Long-Term Use of Octreotide Acetate Microspheres in Acromegaly Patients. CHIN PHARM J. 2022;57(12):1033-39$$$$$Y$$$20240819$$HP$CN$CN
242222361$24222236$1$I$$20240617$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004503$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242222371$24222237$1$I$$20240812$20240819$20240819$EXP$ES-EMA-DD-20240807-7482655-080043$NVSC2024ES165378$NOVARTIS$Redondo Benito A, Curran A, Villar Gomez A, Trallero Araguas E, Fernandez Codina A, Pinal Fernandez I. Opportunistic infections in patients with idiopathic inflammatory myopathies. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2018;21:487-96$43$YR$$F$Y$$$20240819$$HP$ES$ES
242222391$24222239$1$I$20240223$20240808$20240819$20240819$EXP$GB-MHRA-MED-202408081620388910-WFVHJ$GB-UCBSA-2024040013$UCB$$32$YR$$F$Y$82$KG$20240819$$PH$GB$GB
242222401$24222240$1$I$20240701$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129821$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240819$$HP$US$US
242222411$24222241$1$I$20230101$20240808$20240819$20240819$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02929$AMNEAL$$$$$F$Y$68.027$KG$20240819$$CN$US$US
242222421$24222242$1$I$20230801$20240814$20240819$20240819$EXP$$AT-ABBVIE-5881321$ABBVIE$$34$YR$$F$Y$$$20240819$$CN$AT$AT
242222431$24222243$1$I$20240809$20240814$20240819$20240819$PER$$US-BAYER-2024A117352$BAYER$$41$YR$A$F$Y$$$20240819$$CN$US$US
242222451$24222245$1$I$$20240809$20240819$20240819$EXP$$FR-TEVA-VS-3233228$TEVA$$$$$M$Y$$$20240819$$CN$FR$FR
242222461$24222246$1$I$$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024164209$AMGEN$$$$$$Y$$$20240819$$HP$US$US
242222471$24222247$1$I$$20240809$20240819$20240819$EXP$$US-BEH-2024177088$CSL BEHRING$$46$YR$A$M$Y$69.85$KG$20240819$$CN$US$US
242222481$24222248$1$I$20240813$20240814$20240819$20240819$PER$$US-BAYER-2024A117498$BAYER$$25$YR$A$F$Y$$$20240819$$MD$US$US
242222492$24222249$2$F$20230101$20240822$20240819$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-006626$JAZZ$$$$$F$Y$$$20240826$$MD$US$US
242222501$24222250$1$I$20230101$20240722$20240819$20240819$PER$$US-009507513-2407USA013021$MERCK$$$$$M$Y$$$20240819$$CN$US$US
242222511$24222251$1$I$20240221$20240807$20240819$20240819$EXP$FR-AFSSAPS-NC2024000919$FR-Accord-440719$ACCORD$$48$YR$A$F$Y$97$KG$20240819$$MD$FR$FR
242222521$24222252$1$I$$20240807$20240819$20240819$EXP$$IN-Accord-440813$ACCORD$Varghese G, Sarawat D, Jamwal A, Patel SS, Tejan N, Sahu C. Case Series: Microbacterium aurum Bacteremia in Immunosuppressed Patients-An Emerging Threat. American Journal of Tropical Medicine and Hygiene. 2024;111(1):132-5.$40$YR$A$F$Y$$$20240819$$MD$IN$IN
242222531$24222253$1$I$20240624$20240807$20240819$20240819$EXP$FR-AFSSAPS-ST2024001243$FR-Accord-440716$ACCORD$$62$YR$A$F$Y$54$KG$20240819$$PH$FR$FR
242222541$24222254$1$I$20240624$20240807$20240819$20240819$EXP$FR-AFSSAPS-AM2024000616$FR-Accord-440791$ACCORD$$90$YR$E$F$Y$52$KG$20240819$$PH$FR$FR
242222551$24222255$1$I$$20240807$20240819$20240819$EXP$CA-MHPD-E2B_07185479$CA-Accord-440916$ACCORD$$29$YR$A$F$Y$$$20240819$$MD$CA$CA
242222561$24222256$1$I$$20240807$20240819$20240819$EXP$GB-MHRA-TPP14301011C6194694YC1722877729664$GB-Accord-440855$ACCORD$$23$YR$A$F$Y$65$KG$20240819$$PH$GB$GB
242222571$24222257$1$I$20240601$20240814$20240819$20240819$PER$$US-BAYER-2024A117553$BAYER$$18$YR$A$F$Y$$$20240819$$HP$US$US
242222581$24222258$1$I$20180620$20240807$20240819$20240819$EXP$FR-AFSSAPS-PC2024000603$FR-Accord-440732$ACCORD$$93$YR$E$F$Y$44$KG$20240819$$PH$FR$FR
242222592$24222259$2$F$$20240919$20240819$20240920$PER$$NVSC2024US167414$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
242222602$24222260$2$F$$20240815$20240819$20240824$EXP$$IT-AMGEN-ITASP2024161430$AMGEN$Cerchione C.. Pegfilgrastim Versus Filgrastim in the Management of Therapy-Related Neutropenia in Relapsed and Refractory Multiple Myeloma in Treatment with Pomalidomide-Dexamethasone. Blood. 2018;132 (1):5905$$$$$Y$$$20240824$$MD$IT$IT
242222611$24222261$1$I$$20240808$20240819$20240819$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010280$STRIDES$Parmeshwar N, Song S, Alcon A, Kim EA.. The Incidence of Breast Cancer After Gender-Affirming Mastectomy in Transmen. [Review].. Ann-Plast-Surg. 2022;88 (4):S332-S336$49$YR$$$Y$$$20240819$$MD$US$US
242222622$24222262$2$F$20240808$20240823$20240819$20240828$EXP$$US-AMGEN-USASP2024158937$AMGEN$$77$YR$E$F$Y$$$20240828$$HP$US$US
242222631$24222263$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162453$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240819$$HP$US$US
242222641$24222264$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162472$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240819$$HP$US$US
242222651$24222265$1$I$20240813$20240814$20240819$20240819$PER$$US-BAYER-2024A117574$BAYER$$$$$F$Y$$$20240819$$CN$US$US
242222661$24222266$1$I$$20240808$20240819$20240819$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010281$STRIDES$Parmeshwar N, Song S, Alcon A, Kim EA.. The Incidence of Breast Cancer After Gender-Affirming Mastectomy in Transmen. [Review].. Ann-Plast-Surg. 2022;88 (4):S332-S336$54$YR$$$Y$$$20240819$$MD$US$US
242222671$24222267$1$I$20240808$20240814$20240819$20240819$PER$$US-BAYER-2024A117580$BAYER$$33$YR$A$F$Y$$$20240819$$HP$US$US
242222681$24222268$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162440$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240819$$HP$US$US
242222701$24222270$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000058894$ROCHE$$$$$F$Y$$$20240819$$CN$US$US
242222711$24222271$1$I$$20240816$20240819$20240819$PER$$US-JNJFOC-20240843927$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$HP$US$US
242222722$24222272$2$F$$20240919$20240819$20240927$30DAY$$AU-JNJFOC-20240841940$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$AU$AU
242222732$24222273$2$F$20240701$20240903$20240819$20240911$PER$$US-JNJFOC-20240833802$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240911$$HP$US$US
242222741$24222274$1$I$$20240812$20240819$20240819$PER$$US-TAKEDA-2024TUS081039$TAKEDA$$62$YR$$F$Y$91$KG$20240819$$MD$US$US
242222793$24222279$3$F$20240801$20240918$20240819$20240924$EXP$$US-ROCHE-10000059663$ROCHE$$56$YR$A$F$Y$$$20240924$$CN$US$US
242222801$24222280$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000059426$ROCHE$$$$A$F$Y$$$20240819$$CN$US$US
242222811$24222281$1$I$20240814$20240815$20240819$20240819$PER$$US-ROCHE-10000059282$ROCHE$$59$YR$A$F$Y$$$20240819$$CN$US$US
242222821$24222282$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129158$BRISTOL MYERS SQUIBB$$13$YR$T$F$Y$$$20240819$$HP$US$US
242222831$24222283$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129548$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240819$$CN$US$US
242222841$24222284$1$I$20240701$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130216$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240819$$HP$US$US
242222851$24222285$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130132$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$93.44$KG$20240819$$CN$US$US
242222861$24222286$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128645$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240819$$CN$US$US
242222871$24222287$1$I$20240101$20240809$20240819$20240819$EXP$SE-SEMPA-2024-005866$SE-TEVA-VS-3232961$TEVA$$$$$M$Y$$$20240819$$CN$SE$SE
242222881$24222288$1$I$$20240814$20240819$20240819$PER$$US-BAYER-2024A117597$BAYER$$25$YR$A$F$Y$$$20240819$$CN$US$US
242222891$24222289$1$I$$20240807$20240819$20240819$EXP$$TH-ROCHE-10000053568$ROCHE$$39$YR$A$M$Y$$$20240819$$MD$TH$TH
242222903$24222290$3$F$20240808$20240909$20240819$20240911$EXP$$GB-MYLANLABS-2024M1075108$MYLAN$$67$YR$$M$Y$$$20240911$$PH$GB$GB
242222911$24222291$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009907$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240819$$CN$US$US
242222921$24222292$1$I$$20240815$20240819$20240819$PER$$NVSC2024US167082$NOVARTIS$$$$$$Y$$$20240819$$CN$US$US
242222931$24222293$1$I$20240801$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010650$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240819$$CN$US$US
242222942$24222294$2$F$$20240827$20240819$20240829$EXP$$NVSC2024IR164041$NOVARTIS$$$$$$Y$$$20240829$$CN$IR$IR
242222951$24222295$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162487$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42(16):1-5$$$$$Y$$$20240819$$HP$US$US
242222961$24222296$1$I$20230601$20240809$20240819$20240819$EXP$RO-NMA-2024-SP0493$RO-TEVA-VS-3232950$TEVA$$47$YR$$F$Y$$$20240819$$MD$RO$RO
242222971$24222297$1$I$$20240723$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07491$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242222991$24222299$1$I$$20240814$20240819$20240819$PER$$US-BAYER-2024A117598$BAYER$$36$YR$A$F$Y$$$20240819$$MD$US$US
242223001$24222300$1$I$20240724$20240809$20240819$20240819$EXP$$CN-JNJFOC-20240829173$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240819$$HP$CN$CN
242223012$24222301$2$F$$20240916$20240819$20240924$30DAY$$CN-JNJFOC-20240837843$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$CN$CN
242223021$24222302$1$I$$20240805$20240819$20240819$EXP$$TR-EPICPHARMA-TR-2024EPCLIT01006$EPIC PHARM$F Cakan.Intraoperative Takotsubo Cardiomyopathy: A Case Report.Journal of Perianesthesia Nursing.MAR-2024$18$YR$T$F$Y$50$KG$20240819$$HP$TR$TR
242223031$24222303$1$I$$20240808$20240819$20240819$EXP$$SE-P+L Developments of Newyork Corporation-2160589$PL DEVELOPMENTS$Initial$42$YR$$$Y$$$20240819$$MD$SE$SE
242223041$24222304$1$I$20240101$20240805$20240819$20240819$EXP$$US-INSMED, INC.-2024-03192-US$INSMED$$$$$F$Y$$$20240819$$CN$US$US
242223051$24222305$1$I$$20240814$20240819$20240819$PER$$US-ROCHE-10000059796$ROCHE$$$$E$F$Y$$$20240819$$CN$US$US
242223061$24222306$1$I$$20240814$20240819$20240819$PER$$US-ROCHE-10000058573$ROCHE$$$$E$F$Y$$$20240819$$MD$US$US
242223071$24222307$1$I$$20240813$20240819$20240819$PER$$US-ROCHE-10000058373$ROCHE$$12$YR$T$M$Y$$$20240819$$CN$US$US
242223091$24222309$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162511$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240819$$HP$US$US
242223101$24222310$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162510$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240819$$HP$US$US
242223111$24222311$1$I$$20240809$20240819$20240819$EXP$$AT-MYLANLABS-2024M1076225$MYLAN$Gelbenegger G, Buchtele N, Schoergenhofer C, Grafeneder J, Schwameis M, Schellongowski P, et al. Disseminated Intravascular Coagulation in Anaphylaxis. [Review]. Semin-Thromb-Hemost 2024; 50 (4): 569-579.$$$$F$Y$$$20240819$$MD$AT$AT
242223121$24222312$1$I$$20240814$20240819$20240819$EXP$$NVSC2024CA165561$NOVARTIS$$$$$$Y$$$20240819$$MD$CA$CA
242223131$24222313$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162587$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242223142$24222314$2$F$$20240811$20240819$20240903$EXP$$ES-AMGEN-ESPSP2024162595$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240903$$HP$ES$ES
242223151$24222315$1$I$$20240811$20240819$20240819$EXP$$FR-AMGEN-FRASP2024162224$AMGEN$Vidal V.. A Single Center Experience of Cladribine, Cytarabine, Filgrastim and Mitoxantrone (CLAG-M regimen) in High-Risk or Relapsed/Refractory, Acute Myelold Leukemia (AML). Blood. 2018;132$$$$$Y$$$20240819$$HP$FR$FR
242223161$24222316$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162566$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242223171$24222317$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162501$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240819$$HP$US$US
242223181$24222318$1$I$$20240811$20240819$20240819$EXP$$FR-AMGEN-FRASP2024162205$AMGEN$Vidal V.. A Single Center Experience of Cladribine, Cytarabine, Filgrastim and Mitoxantrone (CLAG-M regimen) in High-Risk or Relapsed/Refractory, Acute Myelold Leukemia (AML). Blood. 2018;132$$$$$Y$$$20240819$$HP$FR$FR
242223191$24222319$1$I$$20240811$20240819$20240819$EXP$$FR-AMGEN-FRASP2024162198$AMGEN$Vidal V.. A Single Center Experience of Cladribine, Cytarabine, Filgrastim and Mitoxantrone (CLAG-M regimen) in High-Risk or Relapsed/Refractory, Acute Myelold Leukemia (AML). Blood. 2018;132$$$$$Y$$$20240819$$HP$FR$FR
242223201$24222320$1$I$$20240811$20240819$20240819$EXP$$US-AMGEN-USASP2024162508$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240819$$HP$US$US
242223211$24222321$1$I$$20230222$20240819$20240819$EXP$$US-AstraZeneca-2023A006181$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242223221$24222322$1$I$$20220927$20240819$20240819$EXP$$US-AstraZeneca-2022A285018$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242223231$24222323$1$I$$20230314$20240819$20240819$EXP$$US-AstraZeneca-2023A062309$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242223241$24222324$1$I$$20240815$20240819$20240819$EXP$$CN-AstraZeneca-2024A187563$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$CN$
242223251$24222325$1$I$20240101$20240813$20240819$20240819$EXP$$CA-Orion Corporation ORION PHARMA-24_00031276$ORION$$41$YR$A$F$Y$$$20240819$$MD$CA$
242223271$24222327$1$I$20240808$20240808$20240819$20240819$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02942$AMNEAL$$$$$F$Y$$$20240819$$HP$US$US
242223281$24222328$1$I$$20240814$20240819$20240819$PER$$US-BAYER-2024A117778$BAYER$$90$YR$E$M$Y$$$20240819$$CN$US$US
242223293$24222329$3$F$20240101$20240919$20240819$20240926$EXP$$US-BAYER-2024A116286$BAYER$$74$YR$E$F$Y$55.329$KG$20240926$$CN$US$US
242223301$24222330$1$I$$20240812$20240819$20240819$EXP$$GB-JNJFOC-20240837730$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240819$$CN$GB$GB
242223312$24222331$2$F$$20240909$20240819$20240911$PER$$US-ROCHE-10000059472$ROCHE$$$$A$M$Y$79.3$KG$20240911$$CN$US$US
242223321$24222332$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000058895$ROCHE$$$$$F$Y$$$20240819$$CN$US$US
242223331$24222333$1$I$$20240805$20240819$20240819$EXP$$FR-EPICPHARMA-FR-2024EPCLIT01004$EPIC PHARM$Lescarbotte F.Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases.Annales de Chirurgie Plastique et Esthetique.JAN-2024;69:27-33$65$YR$A$F$Y$$$20240819$$HP$FR$FR
242223341$24222334$1$I$20240101$20240813$20240819$20240819$EXP$$AU-ROCHE-10000057174$ROCHE$$65$YR$E$F$Y$$$20240819$$CN$AU$AU
242223351$24222335$1$I$20240811$20240814$20240819$20240819$PER$$US-BAYER-2024A117781$BAYER$$$$$F$Y$$$20240819$$CN$US$US
242223361$24222336$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129955$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$70.76$KG$20240819$$CN$US$US
242223381$24222338$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129858$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$98.43$KG$20240819$$CN$US$US
242223391$24222339$1$I$$20240815$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130055$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240819$$CN$US$US
242223401$24222340$1$I$20240509$20240819$20240819$20240819$EXP$ES-AEMPS-1561636$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046450$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240819$$MD$ES$ES
242223412$24222341$2$F$$20240910$20240819$20240917$30DAY$$US-GSK-US2024100348$GLAXOSMITHKLINE$$$$$F$Y$$$20240917$$CN$US$US
242223421$24222342$1$I$$20240807$20240819$20240819$EXP$$US-AUROBINDO-AUR-APL-2024-039965$AUROBINDO$Ables C, Jaramillo C, Wood EL, Stern S, Alashari M, Book L, et al.. Subacute liver injury in two young infants following gene replacement therapy for spinal muscular atrophy. Mol-Ther-Methods-Clin-De. 2024;32(3):1-8$$$I$F$Y$$$20240819$$HP$US$US
242223431$24222343$1$I$$20240814$20240819$20240819$EXP$$AU-ABBVIE-5882044$ABBVIE$$$$$M$Y$$$20240819$$MD$AU$AU
242223441$24222344$1$I$$20240806$20240819$20240819$EXP$$US-AUROBINDO-AUR-APL-2024-039734$AUROBINDO$Gupta NY, Al Diffalha S, Russ KB. An Unusual Case of Colitis in a Bone Marrow Transplant Patient. Gastroenterology. 2024;167(3):e1-e4$65$YR$$M$Y$$$20240819$$MD$US$US
242223471$24222347$1$I$$20240815$20240819$20240819$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046417$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240819$$HP$US$US
242223483$24222348$3$F$20240813$20240919$20240819$20240919$30DAY$$US-PFIZER INC-202400236670$PFIZER$$10$YR$$M$Y$$$20240919$$CN$US$US
242223501$24222350$1$I$$20240805$20240819$20240819$EXP$$FR-EPICPHARMA-FR-2024EPCLIT01007$EPIC PHARM$Lescarbotte F.Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases.Annales de Chirurgie Plastique et Esthetique.JAN-2024;69:27-33$55$YR$A$F$Y$$$20240819$$HP$FR$FR
242223522$24222352$2$F$$20240920$20240819$20240920$30DAY$$US-PFIZER INC-202400236088$PFIZER$$7$YR$$M$Y$$$20240920$$CN$US$US
242223532$24222353$2$F$20240808$20240814$20240819$20240822$30DAY$$US-PFIZER INC-202400235965$PFIZER$$13$YR$$M$Y$$$20240822$$CN$US$US
242223572$24222357$2$F$$20240920$20240819$20240920$30DAY$$US-PFIZER INC-202400231540$PFIZER$$10$YR$$F$Y$$$20240920$$CN$US$US
242223583$24222358$3$F$$20240925$20240819$20240925$30DAY$$US-PFIZER INC-PV202400072455$PFIZER$$11$YR$$M$Y$$$20240925$$MD$US$US
242223592$24222359$2$F$$20240919$20240819$20240919$30DAY$$US-PFIZER INC-202400049173$PFIZER$$8$YR$$F$Y$$$20240919$$CN$US$US
242223615$24222361$5$F$20240101$20240922$20240819$20240923$30DAY$$US-PFIZER INC-202400235197$PFIZER$$8$YR$$F$Y$23.59$KG$20240923$$MD$US$US
242223621$24222362$1$I$$20240807$20240819$20240819$30DAY$$US-PFIZER INC-202400238638$PFIZER$$$$$$Y$$$20240819$$HP$US$US
242223633$24222363$3$F$20240701$20240920$20240819$20240920$30DAY$$US-PFIZER INC-202400232423$PFIZER$$13$YR$$F$Y$29.478$KG$20240920$$CN$US$US
242223643$24222364$3$F$$20240923$20240819$20240925$30DAY$$US-PFIZER INC-202400233449$PFIZER$$65$YR$$M$Y$$$20240925$$CN$US$US
242223651$24222365$1$I$$20240806$20240819$20240819$30DAY$$US-PFIZER INC-202400231787$PFIZER$$15$YR$$M$Y$$$20240819$$CN$US$US
242223663$24222366$3$F$20240809$20240919$20240819$20240919$30DAY$$US-PFIZER INC-202400235433$PFIZER$$13$YR$$F$Y$89.81$KG$20240919$$CN$US$US
242223673$24222367$3$F$$20240923$20240819$20240925$30DAY$$US-PFIZER INC-202400233393$PFIZER$$12$YR$$M$Y$40.816$KG$20240925$$CN$US$US
242223691$24222369$1$I$20240810$20240812$20240819$20240819$30DAY$$GR-PFIZER INC-PV202400105196$PFIZER$$11$YR$$F$Y$36$KG$20240819$$CN$GR$GR
242223702$24222370$2$F$$20240918$20240819$20240918$30DAY$$US-PFIZER INC-202400231465$PFIZER$$93$YR$$F$Y$$$20240918$$CN$US$US
242223711$24222371$1$I$20240701$20240723$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07492$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242223722$24222372$2$F$$20240821$20240819$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-040063$AUROBINDO$Otiniano A, Tassin C, Serris A, Guennouni N, Lanternier F, Servais A, et al. Emphysematous pyelonephritis in a diabetic patient. J-Nephrol. 2023;362621-2624$56$YR$$M$Y$$$20240903$$HP$FR$FR
242223733$24222373$3$F$$20240905$20240819$20240909$30DAY$$US-PFIZER INC-PV202400044396$PFIZER$$$$$$Y$$$20240909$$CN$US$US
242223743$24222374$3$F$20230101$20240920$20240819$20240920$30DAY$$US-PFIZER INC-202400234089$PFIZER$$12$YR$$M$Y$$$20240920$$CN$US$US
242223751$24222375$1$I$20240808$20240813$20240819$20240819$EXP$$NVSC2024CN166023$NOVARTIS$$68$YR$$F$Y$$$20240819$$HP$CN$CN
242223761$24222376$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162601$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242223772$24222377$2$F$$20240827$20240819$20240902$PER$$US-AMGEN-USASP2024161669$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian journal ofOphthalmology/Journal Canadien d^Ophtalmologie. 2024;1-6$$$$$Y$$$20240901$$MD$US$US
242223782$24222378$2$F$$20240827$20240819$20240902$PER$$US-AMGEN-USASP2024161698$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian journal ofOphthalmology/Journal Canadien d^Ophtalmologie. 2024;1-6$$$$$Y$$$20240902$$MD$US$US
242223791$24222379$1$I$$20240811$20240819$20240819$EXP$$FR-AMGEN-FRASP2024162199$AMGEN$Vidal V.. A Single Center Experience of Cladribine, Cytarabine, Filgrastim and Mitoxantrone (CLAG-M regimen) in High-Risk or Relapsed/Refractory, Acute Myelold Leukemia (AML). Blood. 2018;132$$$$$Y$$$20240819$$HP$FR$FR
242223802$24222380$2$F$$20240827$20240819$20240902$PER$$US-AMGEN-USASP2024161662$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian journal ofOphthalmology/Journal Canadien d^Ophtalmologie. 2024;1-6$$$$$Y$$$20240902$$MD$US$US
242223812$24222381$2$F$$20240827$20240819$20240902$PER$$US-AMGEN-USASP2024161681$AMGEN$Topilow N.J.; Penteado R.C.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian journal ofOphthalmology/Journal Canadien d^Ophtalmologie. 2024;1-6$$$$$Y$$$20240902$$HP$US$US
242223821$24222382$1$I$$20240811$20240819$20240819$EXP$$FR-AMGEN-FRASP2024162189$AMGEN$Vidal V.. A Single Center Experience of Cladribine, Cytarabine, Filgrastim and Mitoxantrone (CLAG-M regimen) in High-Risk or Relapsed/Refractory, Acute Myelold Leukemia (AML). Blood. 2018;132$$$$$Y$$$20240819$$HP$FR$FR
242223831$24222383$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162615$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242223841$24222384$1$I$$20240811$20240819$20240819$EXP$$FR-AMGEN-FRASP2024162197$AMGEN$Vidal V.. A Single Center Experience of Cladribine, Cytarabine, Filgrastim and Mitoxantrone (CLAG-M regimen) in High-Risk or Relapsed/Refractory, Acute Myelold Leukemia (AML). Blood. 2018;132$$$$$Y$$$20240819$$HP$FR$FR
242223852$24222385$2$F$$20240830$20240819$20240909$30DAY$$US-GSK-US2024029123$GLAXOSMITHKLINE$$$$$M$Y$$$20240909$$CN$US$US
242223861$24222386$1$I$$20240808$20240819$20240819$EXP$$US-GSK-US2024099625$GLAXOSMITHKLINE$$$$$M$Y$$$20240819$$PH$US$US
242223871$24222387$1$I$20240815$20240815$20240819$20240819$PER$$US-GILEAD-2024-0684436$GILEAD$$88$YR$E$F$Y$$$20240819$$CN$US$US
242223882$24222388$2$F$$20240820$20240819$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-040417$AUROBINDO$$24$YR$$M$Y$$$20240829$$PH$US$US
242223901$24222390$1$I$$20240718$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-116452$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240819$$HP$US$US
242223911$24222391$1$I$20240726$20240809$20240819$20240819$30DAY$$US-GSK-US2024020611$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240819$$HP$US$US
242223921$24222392$1$I$$20240807$20240819$20240819$EXP$$US-AUROBINDO-AUR-APL-2024-040089$AUROBINDO$Nguyen A, Norman M, O^reilly E, Robinson CL, Fonseca A, Madabhushi S, et al. Case Series: Spinal Cord Stimulator Therapy Alleviates Neuropathic Pain in Patients with Failed Back Surgery Syndrome in the Setting of Spinal Cord Injury. Pain-Med-Case-Rep. 2023;7(7):337-340$50$YR$$M$Y$$$20240819$$HP$US$US
242223931$24222393$1$I$20240626$20240815$20240819$20240819$PER$$US-BAYER-2024A117849$BAYER$$$$$F$Y$$$20240819$$HP$US$US
242223941$24222394$1$I$$20240809$20240819$20240819$EXP$$AU-SANDOZ INC.-SDZ2024AU071693$SANDOZ$$$$$F$Y$$$20240819$$CN$AU$AU
242223951$24222395$1$I$$20240805$20240819$20240819$EXP$$FR-EPICPHARMA-FR-2024EPCLIT01008$EPIC PHARM$Lescarbotte F.Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases.Annales de Chirurgie Plastique et Esthetique.JAN-2024;69:27-33$76$YR$E$F$Y$$$20240819$$HP$FR$FR
242223961$24222396$1$I$$20240813$20240819$20240819$EXP$$US-ABBVIE-5880413$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242223981$24222398$1$I$$20240813$20240819$20240819$EXP$$US-ABBVIE-5880701$ABBVIE$$$$$F$Y$$$20240819$$HP$US$US
242223991$24222399$1$I$20240815$20240815$20240819$20240819$PER$$US-BAYER-2024A117926$BAYER$$41$YR$A$F$Y$$$20240819$$MD$US$US
242224001$24222400$1$I$20240424$20240813$20240819$20240819$EXP$$US-PFIZER INC-PV202400105689$PFIZER$$57$YR$$M$Y$127$KG$20240819$$HP$US$US
242224011$24222401$1$I$$20240813$20240819$20240819$EXP$$US-PFIZER INC-202400236950$PFIZER$$72$YR$$M$Y$$$20240819$$HP$US$US
242224031$24222403$1$I$20211001$20240812$20240819$20240819$EXP$$BR-PFIZER INC-PV202400105131$PFIZER$de Medeiros Dutra, R.. Risks and benefits of anti-TNF therapy for ulcerative colitis in a patient with autoimmune hepatitis-related cirrhosis. Medicine. 2024;103(31):10.1097/MD.0000000000039095$28$YR$$F$Y$$$20240819$$MD$BR$BR
242224042$24222404$2$F$$20240815$20240819$20240821$EXP$$TW-PFIZER INC-PV202400105869$PFIZER$Yao, C.. Repetitive transcranial magnetic stimulation (rTMS) treatment in ketamine use disorder: A case report. Asian Journal of Psychiatry. 2022;67:10.1016/j.ajp.2021.102912$34$YR$$M$Y$$$20240821$$HP$TW$TW
242224072$24222407$2$F$$20240813$20240819$20240820$EXP$$BR-PFIZER INC-PV202400104826$PFIZER$Lopes, D.. Co-occurrence of oral pemphigus vulgaris and herpes simplex virus infection in a young patient with Crohn^s disease: report of a rare case of oral lesions during anti-TFN alpha and immunomodulator therapy. International Journal of Colorectal Disease. 2024;39(1):10.1007/s00384-024-04673-0$18$YR$$F$Y$$$20240820$$HP$BR$BR
242224081$24222408$1$I$20211001$20240812$20240819$20240819$EXP$$BR-PFIZER INC-202400235947$PFIZER$de Medeiros Dutra, R.. Risks and benefits of anti-TNF therapy for ulcerative colitis in a patient with autoimmune hepatitis-related cirrhosis. Medicine. 2024;103(31):10.1097/MD.0000000000039095$28$YR$$F$Y$$$20240819$$MD$BR$BR
242224102$24222410$2$F$$20240905$20240819$20240918$EXP$$US-AUROBINDO-AUR-APL-2024-040093$AUROBINDO$Noor F, Ali M, Khan H, Cluzet V. A RARE CASE OF POLYURIA SECONDARYTO VASOPRESSIN WITHDRAWAL IN A CRITICALLYILL PATIENT. Critical-Care-Medicine. 2024;52 (Suppl.)(1):S725$67$YR$$M$Y$$$20240918$$HP$US$US
242224111$24222411$1$I$$20240813$20240819$20240819$PER$$US-ROCHE-10000056547$ROCHE$$$$$$Y$$$20240819$$CN$US$US
242224121$24222412$1$I$$20240724$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07494$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242224131$24222413$1$I$$20240808$20240819$20240819$EXP$$SE-P+L Developments of Newyork Corporation-2160590$PL DEVELOPMENTS$Initial$26$YR$$$Y$$$20240819$$MD$SE$SE
242224141$24222414$1$I$$20240815$20240819$20240819$EXP$$CA-ROCHE-10000059644$ROCHE$$$$A$F$Y$$$20240819$$CN$CA$CA
242224151$24222415$1$I$20030101$20240807$20240819$20240819$EXP$$IT-AUROBINDO-AUR-APL-2024-040498$AUROBINDO$Frigerio M,Cipriani M,Roubina E,Orrego P,Vitali E.. Case report: long-term outcome of a heart transplant recipient switched to everolimus after an acute myocardial infarction. Transplantation. 2006;27;82:19-23$56$YR$$M$Y$$$20240819$$MD$IT$IT
242224161$24222416$1$I$$20240809$20240819$20240819$EXP$$US-GSK-US2024AMR100181$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
242224171$24222417$1$I$$20240812$20240819$20240819$EXP$$US-GSK-US2024100330$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$CN$US$US
242224181$24222418$1$I$$20240805$20240819$20240819$EXP$$MA-EPICPHARMA-MA-2024EPCLIT00972$EPIC PHARM$H Mourabiti.Paraparesis secondary to metformin: A rare condition to be aware of, with characteristic MRI images..Toxicologie Analytique et Clinique.JUL-2024;1-6$$$$$Y$$$20240819$$HP$MA$MA
242224191$24222419$1$I$20240814$20240815$20240819$20240819$PER$$US-BAYER-2024A117927$BAYER$$22$YR$A$F$Y$$$20240819$$CN$US$US
242224201$24222420$1$I$$20240807$20240819$20240819$EXP$$US-AUROBINDO-AUR-APL-2024-039967$AUROBINDO$Ables C, Jaramillo C, Wood EL, Stern S, Alashari M, Book L, et al.. Subacute liver injury in two young infants following gene replacement therapy for spinal muscular atrophy. Mol-Ther-Methods-Clin-Dev. 2024;32(3):1-8$$$I$F$Y$$$20240819$$HP$US$US
242224211$24222421$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130018$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240819$$CN$US$US
242224221$24222422$1$I$20240811$20240813$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130067$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240819$$CN$US$US
242224231$24222423$1$I$$20240812$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127485$BRISTOL MYERS SQUIBB$$23$YR$A$F$Y$$$20240819$$HP$US$US
242224241$24222424$1$I$20240726$20240808$20240819$20240819$EXP$$CN-ROCHE-10000053606$ROCHE$$61$YR$A$F$Y$77.5$KG$20240819$$HP$CN$CN
242224251$24222425$1$I$$20240815$20240819$20240819$PER$$US-BAYER-2024A118246$BAYER$$44$YR$A$F$Y$$$20240819$$HP$US$US
242224261$24222426$1$I$$20220920$20240819$20240819$EXP$$US-AstraZeneca-2022A324971$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242224271$24222427$1$I$$20221109$20240819$20240819$EXP$$US-AstraZeneca-2022A372526$ASTRAZENECA$$$$$F$Y$71.2$KG$20240819$$CN$US$
242224281$24222428$1$I$$20230109$20240819$20240819$EXP$$US-AstraZeneca-2023A005923$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242224291$24222429$1$I$20240815$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010656$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240819$$CN$US$US
242224301$24222430$1$I$20240815$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010671$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240819$$CN$US$US
242224311$24222431$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010788$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240819$$CN$US$US
242224321$24222432$1$I$20240501$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010143$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$US$US
242224331$24222433$1$I$$20240807$20240819$20240819$EXP$$US-AUROBINDO-AUR-APL-2024-039949$AUROBINDO$Aisha S, Brumwell NA, Kabel CC, Gutgarts V, Jaffer Sathick I, Mailankody S, et al.. Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 Cases. Kidney-Med. 2024;6:No. 8$50$YR$$F$Y$$$20240819$$MD$US$US
242224341$24222434$1$I$$20240809$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US072009$SANDOZ$$$$$F$Y$$$20240819$$CN$US$US
242224351$24222435$1$I$$20240813$20240819$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA072599$SANDOZ$$57$YR$$M$Y$104$KG$20240819$$PH$CA$CA
242224361$24222436$1$I$$20240816$20240819$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA073319$SANDOZ$$31$YR$$F$Y$$$20240819$$HP$CA$CA
242224371$24222437$1$I$20240809$20240809$20240819$20240819$30DAY$$US-GSK-US2024099744$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240819$$CN$US$US
242224381$24222438$1$I$$20240805$20240819$20240819$EXP$$IN-EPICPHARMA-IN-2024EPCLIT00994$EPIC PHARM$Bala Sundaram.Twin neurological enigmas radiological and medical  insight into a dual encounter with metformin induced encephalopathy..Journal of Nephropharmacology.29-JUN-2024;13(2):1-5$55$YR$A$M$Y$$$20240819$$HP$IN$IN
242224391$24222439$1$I$$20240815$20240819$20240819$PER$$US-HALEON-2192328$Haleon PLC$$$$$$Y$$$20240819$$CN$US$US
242224401$24222440$1$I$20240101$20240813$20240819$20240819$EXP$$PL-GILEAD-2024-0684110$GILEAD$$37$YR$A$M$Y$$$20240819$$MD$PL$PL
242224411$24222441$1$I$$20240811$20240819$20240819$EXP$$FR-AMGEN-FRASP2024162185$AMGEN$Vidal V.. A Single Center Experience of Cladribine, Cytarabine, Filgrastim and Mitoxantrone (CLAG-M regimen) in High-Risk or Relapsed/Refractory, Acute Myelold Leukemia (AML). Blood. 2018;132$$$$$Y$$$20240819$$HP$FR$FR
242224421$24222442$1$I$20240521$20240816$20240819$20240819$EXP$$PK-ROCHE-10000059540$ROCHE$$49$YR$A$F$Y$$$20240819$$CN$PK$PK
242224431$24222443$1$I$$20240816$20240819$20240819$PER$$US-ROCHE-10000059701$ROCHE$$57$YR$A$F$Y$$$20240819$$MD$US$US
242224441$24222444$1$I$20240808$20240808$20240819$20240819$PER$$US-BRACCO-2024US04969$BRACCO$$63$YR$$F$Y$$$20240819$$CN$US$US
242224451$24222445$1$I$$20240805$20240819$20240819$EXP$$IN-EPICPHARMA-IN-2024EPCLIT01000$EPIC PHARM$Bala Sundaram.Twin neurological enigmas radiological and medical  insight into a dual encounter with metformin induced encephalopathy..Journal of Nephropharmacology.29-JUN-2024;13(2):1-5$58$YR$A$M$Y$$$20240819$$HP$IN$IN
242224462$24222446$2$F$20240801$20240819$20240819$20240902$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07929$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242224471$24222447$1$I$20240101$20240814$20240819$20240819$EXP$$US-AMGEN-USASP2024162132$AMGEN$$25$YR$A$F$Y$$$20240819$$HP$US$US
242224481$24222448$1$I$20230101$20240804$20240819$20240819$EXP$$GB-CPL-004527$CADILA$Alharmoodi K, Kathirgamachelvam J, Nafri D. Prolonged Discontinuation Syndrome of Venlafaxine: A Case Study of Severe Gastrointestinal Manifestations. Cureus. 2024 Jul 1;16(7):e63560.$26$YR$A$F$Y$$$20240819$$HP$GB$GB
242224491$24222449$1$I$$20240813$20240819$20240819$EXP$$CN-RDY-LIT/CHN/24/0011985$DR REDDYS$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turkish Journal of Hematology. 2023;40: 284-285. doi:10.4274/tjh.galenos.2023.2023.0263.$68$YR$E$M$Y$$$20240819$$HP$CN$CN
242224501$24222450$1$I$20240701$20240813$20240819$20240819$PER$$US-ALXN-202408USA000863US$ALEXION PHARMACEUTICALS$$43$YR$$F$Y$$$20240819$$HP$US$US
242224511$24222451$1$I$$20240814$20240819$20240819$EXP$$US-TAKEDA-2024TUS048191$TAKEDA$$$$$M$Y$$$20240819$$CN$US$US
242224521$24222452$1$I$$20240816$20240819$20240819$PER$$US-BAYER-2024A118502$BAYER$$50$YR$A$F$Y$$$20240819$$MD$US$US
242224531$24222453$1$I$$20240812$20240819$20240819$EXP$$CO-GSK-CO2024AMR101069$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$CN$CO$CO
242224541$24222454$1$I$20240401$20240812$20240819$20240819$EXP$$US-GSK-US2024100394$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$CN$US$US
242224551$24222455$1$I$20240722$20240809$20240819$20240819$EXP$IT-MINISAL02-997514$IT-TEVA-VS-3232324$TEVA$$43$YR$$F$Y$$$20240819$$MD$IT$IT
242224561$24222456$1$I$20240719$20240723$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051082$TOLMAR$$67$YR$$M$Y$$$20240819$$CN$CA$CA
242224571$24222457$1$I$$20240723$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051239$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
242224581$24222458$1$I$$20240723$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051078$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
242224591$24222459$1$I$20240723$20240723$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051316$TOLMAR$$83$YR$$M$Y$$$20240819$$CN$CA$CA
242224601$24222460$1$I$20240709$20240723$20240819$20240819$PER$$FR-TOLMAR, INC.-24FR050927$TOLMAR$$69$YR$$M$Y$$$20240819$$HP$FR$FR
242224611$24222461$1$I$20240701$20240723$20240819$20240819$PER$$FR-TOLMAR, INC.-24FR050728$TOLMAR$$76$YR$$M$Y$$$20240819$$PH$FR$FR
242224621$24222462$1$I$20240409$20240723$20240819$20240819$PER$$FR-TOLMAR, INC.-24FR051256$TOLMAR$$$$$F$Y$$$20240819$$PH$FR$FR
242224631$24222463$1$I$$20240816$20240819$20240819$PER$$US-BAYER-2024A118633$BAYER$$$$$$Y$$$20240819$$CN$US$US
242224641$24222464$1$I$$20240807$20240819$20240819$EXP$$SG-ROCHE-10000052504$ROCHE$$54$YR$A$F$Y$$$20240819$$CN$SG$SG
242224651$24222465$1$I$20240707$20240806$20240819$20240819$PER$$US-BEH-2024176878$CSL BEHRING$$75$YR$E$F$Y$$$20240819$$CN$US$US
242224661$24222466$1$I$$20240807$20240819$20240819$EXP$$US-MYLANLABS-2024M1075240$MYLAN$Pattock A, Elison D, McCabe JM. Tricuspid transcatheter edge-to-edge repair in patient with carcinoid heart disease and torrential tricuspid regurgitation. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3773 abstr.  1381-047.$43$YR$$F$Y$$$20240819$$HP$US$US
242224671$24222467$1$I$$20240805$20240819$20240819$EXP$$BG-EPICPHARMA-BG-2024EPCLIT00998$EPIC PHARM$N Grigorov.Metformin intoxication - three clinical cases with lethal outcomes. Recommendations to the general practitioner.General Medicine.JAN-2023;25:45-48$70$YR$E$F$Y$$$20240819$$HP$BG$BG
242224691$24222469$1$I$$20240809$20240819$20240819$EXP$$AU-MYLANLABS-2024M1076220$MYLAN$Backhouse B, Scully T, Rajakariar K, Jin D, Chandrasekhar J, Freeman M. Coronary Artery Vasospasm in Patients With Eosinophilia. JACC-Case-Rep 2023; 19 1-7.$67$YR$$M$Y$$$20240819$$MD$AU$AU
242224701$24222470$1$I$$20240808$20240819$20240819$EXP$$US-MYLANLABS-2024M1075622$MYLAN$Paz Rios LH, Salazar Adum JP, Barriga Guzman RC, Levisay JP, Ricciardi MJ. A Case of Valve-in-Valve-in-Valve for Severe Aortic Regurgitation: Is Lifetime Management Upon Us?. Cardiovasc-Revasc-Med 2023; 53 (Suppl.) S180-S183.$76$YR$$M$Y$$$20240819$$HP$US$US
242224711$24222471$1$I$$20240808$20240819$20240819$EXP$$US-MYLANLABS-2024M1074814$MYLAN$Arce PS, Murad K. Thyroid Storm In Heart Failure: A Case Report. J-Card-Fail 2024; 30 (1): 178.$36$YR$$M$Y$$$20240819$$HP$US$US
242224721$24222472$1$I$$20240809$20240819$20240819$EXP$$JP-MYLANLABS-2024M1075984$MYLAN$Mimura Y, Komatsu K, Yasushi Y, Seki M, Nakajima S, Uchida H, et al. A case of painful legs and moving toes syndrome mimicking somatic symptom disorder. Psychogeriatrics 2024; 24 (4): 1023-1029.. 2024;24 (4):1023-1029$8$DEC$$F$Y$$$20240819$$MD$JP$JP
242224731$24222473$1$I$$20240805$20240819$20240819$EXP$$US-PFIZER INC-202400237562$PFIZER$$28$YR$$M$Y$$$20240819$$CN$US$US
242224742$24222474$2$F$20240704$20240820$20240819$20240826$EXP$$JP-PFIZER INC-202400235489$PFIZER$$7$DEC$$M$Y$$$20240826$$MD$JP$JP
242224753$24222475$3$F$$20240821$20240819$20240828$EXP$$IN-PFIZER INC-PV202400105863$PFIZER$Routh, D.. A case report on primary hepatic diffuse large B cell lymphoma (DLBCL) and unique complication of it^s management. Journal of Clinical and Experimental Hepatology. 2024;14(Suppl 1):10.1016/j.jceh.2024.102190$57$YR$$F$Y$$$20240828$$HP$IN$IN
242224761$24222476$1$I$$20240813$20240819$20240819$EXP$$US-PFIZER INC-PV202400105895$PFIZER$Bajwa, S.. Venetoclax combined with hypomethylating agents for favorable risk acute myeloidleukemia: A single center experience. Journal of Clinical Oncology. 2024;42(16 Suppl)$$$A$$Y$$$20240819$$HP$US$US
242224772$24222477$2$F$$20240821$20240819$20240826$EXP$$MT-PFIZER INC-PV202400105743$PFIZER$Gauci, L.. Interstitial lung disease secondary to oxaliplatin-raltitrexed based chemotherapy.. Malta Medical Journal. 2024;36(3):73-77$72$YR$$M$Y$72$KG$20240826$$MD$MT$MT
242224782$24222478$2$F$$20240816$20240819$20240819$PER$$US-ROCHE-10000060158$ROCHE$$$$A$F$Y$$$20240819$$CN$US$US
242224791$24222479$1$I$$20240809$20240819$20240819$PER$$US-BAUSCHBL-2024BNL031533$BAUSCH AND LOMB$$$$$F$Y$$$20240819$$CN$US$US
242224801$24222480$1$I$$20240809$20240819$20240819$EXP$$CA-TEVA-VS-3232714$TEVA$$6$YR$$M$Y$21$KG$20240819$$HP$CA$CA
242224811$24222481$1$I$$20240809$20240819$20240819$EXP$$CA-TEVA-VS-3232673$TEVA$$56$YR$$F$Y$69$KG$20240819$$MD$CA$CA
242224821$24222482$1$I$$20240813$20240819$20240819$PER$$US-BAYER-2024A116742$BAYER$$42$YR$A$F$Y$$$20240819$$MD$US$US
242224831$24222483$1$I$$20240522$20240819$20240819$PER$$US-GE HEALTHCARE-2024CSU005520$GE HEALTHCARE$$49$YR$$F$Y$$$20240819$$HP$US$US
242224841$24222484$1$I$$20240812$20240819$20240819$EXP$$CA-BAYER-2024A116590$BAYER$$90$YR$E$M$Y$64$KG$20240819$$HP$CA$CA
242224851$24222485$1$I$$20240808$20240819$20240819$30DAY$$US-GSK-US2024099277$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
242224861$24222486$1$I$20180801$20240813$20240819$20240819$PER$$US-BAYER-2024A116748$BAYER$$22$YR$A$F$Y$$$20240819$$MD$US$US
242224891$24222489$1$I$20230101$20240812$20240819$20240819$EXP$$US-SA-2024SA242589$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240819$$MD$US$US
242224903$24222490$3$F$20240101$20240909$20240819$20240918$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00201$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
242224911$24222491$1$I$$20240730$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123818$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240819$$CN$US$US
242224922$24222492$2$F$$20240822$20240819$20240826$EXP$$US-ROCHE-10000059974$ROCHE$$$$$$Y$$$20240826$$MD$US$US
242224933$24222493$3$F$20240809$20240812$20240819$20240904$EXP$$CN-SA-2024SA240091$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240904$$CN$CN$CN
242224941$24222494$1$I$20240731$20240813$20240819$20240819$EXP$$US-ABBVIE-5882115$ABBVIE$$33$YR$$M$Y$$$20240819$$CN$US$US
242224952$24222495$2$F$20240729$20240805$20240819$20240903$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099790$VIIV$$65$YR$$M$Y$$$20240903$$PH$US$US
242224961$24222496$1$I$$20220628$20240819$20240819$EXP$$US-AstraZeneca-2022A240144$ASTRAZENECA$$$$$$Y$$$20240819$$MD$US$
242224971$24222497$1$I$$20240813$20240819$20240819$EXP$$JP-AstraZeneca-2024A185946$ASTRAZENECA$$$$$F$Y$$$20240819$$MD$JP$
242224981$24222498$1$I$20230505$20230720$20240819$20240819$EXP$$US-AstraZeneca-2023A143935$ASTRAZENECA$$27092$DY$$M$Y$$$20240819$$CN$US$
242224991$24222499$1$I$$20230712$20240819$20240819$EXP$$US-AstraZeneca-2023A160285$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242225001$24222500$1$I$20240720$20240809$20240819$20240819$EXP$IT-MINISAL02-998556$IT-BIOCON BIOLOGICS LIMITED-BBL2024005896$BIOCON$$$$$$Y$$$20240819$$MD$IT$IT
242225011$24222501$1$I$$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024164656$AMGEN$$$$$F$Y$$$20240819$$CN$US$US
242225021$24222502$1$I$20240712$20240809$20240819$20240819$EXP$FR-AFSSAPS-AVCN2024000595$FR-TEVA-VS-3232820$TEVA$$34$YR$$M$Y$$$20240819$$MD$FR$FR
242225031$24222503$1$I$20220301$20240812$20240819$20240819$EXP$$US-AMGEN-USASP2024160062$AMGEN$$90$YR$E$F$Y$$$20240819$$CN$US$US
242225042$24222504$2$F$20240812$20240813$20240819$20240823$30DAY$$US-GSK-US2024100267$GLAXOSMITHKLINE$$41$YR$$F$Y$$$20240823$$CN$US$US
242225052$24222505$2$F$$20240917$20240819$20240918$EXP$$US-TAKEDA-2024TUS064957$TAKEDA$$$$$F$Y$$$20240918$$HP$US$US
242225061$24222506$1$I$20240603$20240812$20240819$20240819$EXP$ES-AEMPS-1559623$ES-FreseniusKabi-FK202412385$FRESENIUS KABI$$$$E$F$Y$$$20240819$$MD$ES$ES
242225071$24222507$1$I$$20240805$20240819$20240819$EXP$$BG-EPICPHARMA-BG-2024EPCLIT00999$EPIC PHARM$N Grigorov.Metformin intoxication - three clinical cases with lethal outcomes. Recommendations to the general practitioner.General Medicine.JAN-2023;25:45-48$53$YR$A$F$Y$$$20240819$$HP$BG$BG
242225081$24222508$1$I$$20240815$20240819$20240819$EXP$$NVSC2024US166237$NOVARTIS$$$$$$Y$$$20240819$$MD$US$US
242225091$24222509$1$I$$20240813$20240819$20240819$EXP$$NVSC2024AU166569$NOVARTIS$$$$$F$Y$$$20240819$$MD$AU$AU
242225101$24222510$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130671$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240819$$CN$US$US
242225111$24222511$1$I$$20240809$20240819$20240819$PER$$US-JNJFOC-20240827707$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$US$US
242225121$24222512$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129682$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$55.79$KG$20240819$$CN$US$US
242225132$24222513$2$F$$20240821$20240819$20240829$30DAY$$BR-JNJFOC-20240837789$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$PH$BR$BR
242225141$24222514$1$I$$20240805$20240819$20240819$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07913$LUPIN$Khattar G, Makram M, Rabah H, Hong C, Khan S, Mourad O, et al. Catastrophic convergence: refractory septic shock and multisystem failure in a case of hidradenitis suppurativa complicated by Fournier^s gangrene and bilateral pulmonary embolism. American Journal of Respiratory and Critical Care Medicine. 2024;209$53$YR$$F$Y$$$20240819$$HP$US$US
242225151$24222515$1$I$$20240806$20240819$20240819$EXP$$US-STERISCIENCE B.V.-2024-ST-001200$Steriscience PTE$Sircy A, Ibeh B, Boutros N, Bolyard J. OTITIS MEDIA TO MENINGITIS: A RARE GROUP A STREPTOCOCCUS MENINGITIS CASE.. Crit-Care-Med. 2024;52 (Suppl.):S705$43$YR$$M$Y$$$20240819$$HP$US$US
242225162$24222516$2$F$20240222$20240829$20240819$20240902$EXP$$DE-TAKEDA-2024TUS080781$TAKEDA$$63$YR$$M$Y$$$20240902$$HP$DE$DE
242225172$24222517$2$F$20240416$20240905$20240819$20240911$EXP$$EU-BAUSCHBL-2024BNL031369$BAUSCH AND LOMB$$69$YR$$M$Y$72$KG$20240912$$MD$EU$EU
242225181$24222518$1$I$20240718$20240812$20240819$20240819$EXP$$US-BAYER-2024A117024$BAYER$$39$YR$A$F$Y$$$20240819$$CN$US$US
242225201$24222520$1$I$20240816$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010687$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240819$$CN$US$US
242225211$24222521$1$I$$20240813$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408008820$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240819$$CN$US$US
242225221$24222522$1$I$20240806$20240813$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408008322$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240819$$CN$US$US
242225231$24222523$1$I$20240810$20240814$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010290$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240819$$CN$US$US
242225241$24222524$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408011156$ELI LILLY AND CO$$70$YR$E$$Y$$$20240819$$CN$US$US
242225252$24222525$2$F$$20240819$20240819$20240822$EXP$$NVSC2024CA166282$NOVARTIS$$90$MON$$M$Y$$$20240822$$HP$CA$CA
242225261$24222526$1$I$$20240812$20240819$20240819$EXP$$BR-AMGEN-BRASP2024160432$AMGEN$$32$YR$A$F$Y$$$20240819$$MD$BR$BR
242225271$24222527$1$I$20240701$20240814$20240819$20240819$EXP$$US-AMGEN-USASP2024163701$AMGEN$$$$T$M$Y$$$20240819$$HP$US$US
242225281$24222528$1$I$$20240805$20240819$20240819$EXP$$BG-EPICPHARMA-BG-2024EPCLIT01003$EPIC PHARM$N Grigorov.Metformin intoxication - three clinical cases with lethal outcomes. Recommendations to the general practitioner.General Medicine.JAN-2023;25:45-48$85$YR$E$M$Y$$$20240819$$HP$BG$BG
242225291$24222529$1$I$20200101$20240812$20240819$20240819$EXP$RO-MLMSERVICE-20240729-PI144859-00152-1$RO-CHEPLA-2024010526$CHEPLAPHARM$Georgescu D, Lighezan DF, Lascu A, Buzas R, Faur A, Ionita I, et al. Hepatic Veno-Occlusive Disease and Colorectal Cancer: Expect the Unexpected?. Life. 2024;14(7):845. doi: 10.3390/life14070845.$65$YR$$F$Y$$$20240819$$MD$COUNTRY NOT SPECIFIED$RO
242225301$24222530$1$I$$20240809$20240819$20240819$EXP$$LV-MYLANLABS-2024M1076214$MYLAN$Renemane L, Rancans E. Case report: Treatment-resistant schizophrenia with auto-aggressive compulsive behavior-Successful management with cariprazine. Front-Psychiatry 2023; 14.$23$YR$$M$Y$$$20240819$$HP$LV$LV
242225311$24222531$1$I$20240806$20240807$20240819$20240819$PER$$US-INCYTE CORPORATION-2024IN008417$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242225321$24222532$1$I$20230427$20240809$20240819$20240819$EXP$FR-AFSSAPS-CF2024000243$FR-TEVA-VS-3232812$TEVA$$73$YR$$M$Y$$$20240819$$MD$FR$FR
242225371$24222537$1$I$$20240531$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003644$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242225381$24222538$1$I$$20240627$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003661$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242225391$24222539$1$I$$20240521$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003666$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225401$24222540$1$I$$20240522$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003713$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225411$24222541$1$I$$20240624$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004535$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242225421$24222542$1$I$$20240620$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004624$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225431$24222543$1$I$$20240625$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004628$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225441$24222544$1$I$$20240709$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004631$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225451$24222545$1$I$$20240712$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004700$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242225461$24222546$1$I$$20240802$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004641$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225471$24222547$1$I$20240620$20240627$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004674$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225481$24222548$1$I$$20240624$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004697$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225491$24222549$1$I$$20240624$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004707$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225501$24222550$1$I$$20240626$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004808$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225511$24222551$1$I$$20240627$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004866$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225521$24222552$1$I$$20240701$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004911$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225532$24222553$2$F$20240101$20240821$20240819$20240826$PER$$US-BAYER-2024A116753$BAYER$$22$YR$A$F$Y$78.5$KG$20240826$$MD$US$US
242225541$24222554$1$I$$20240726$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004882$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225551$24222555$1$I$$20240620$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004651$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225561$24222556$1$I$20240627$20240627$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004827$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225581$24222558$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167437$NOVARTIS$$$$$F$Y$$$20240819$$HP$US$US
242225591$24222559$1$I$$20240816$20240819$20240819$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046372$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240819$$CN$US$US
242225601$24222560$1$I$$20240813$20240819$20240819$EXP$$CN-RDY-LIT/CHN/24/0011994$DR REDDYS$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turkish Journal of Hematology. 2023;40: 284-285. doi:10.4274/tjh.galenos.2023.2023.0263.$69$YR$E$F$Y$$$20240819$$HP$CN$CN
242225611$24222561$1$I$20240630$20240705$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004916$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242225622$24222562$2$F$20240702$20240809$20240819$20240827$EXP$GB-MHRA-MED-202408051443326070-VTRLG$GB-BEH-2024177149$CSL BEHRING$$67$YR$E$M$Y$$$20240827$$HP$GB$GB
242225631$24222563$1$I$20240520$20240813$20240819$20240819$EXP$IT-MINISAL02-988045$IT-BAYER-2024A116540$BAYER$$65$YR$E$M$Y$51$KG$20240819$$MD$IT$IT
242225641$24222564$1$I$20240701$20240812$20240819$20240819$EXP$$CA-GSK-CA2024100279$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$CN$CA$CA
242225651$24222565$1$I$20240617$20240814$20240819$20240819$PER$$CN-Eisai-EC-2024-172110$EISAI$$67$YR$E$F$Y$50$KG$20240819$$HP$CN$CN
242225661$24222566$1$I$$20240125$20240819$20240819$EXP$$GB-TEVA-VS-3219656$TEVA$$63$YR$$M$Y$$$20240819$$CN$GB$GB
242225672$24222567$2$F$$20240816$20240819$20240824$EXP$$CA-TAKEDA-2024TUS082234$TAKEDA$$$$$M$Y$$$20240824$$CN$CA$CA
242225681$24222568$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130217$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240819$$CN$US$US
242225691$24222569$1$I$20240101$20240808$20240819$20240819$EXP$$AU-JNJFOC-20240830612$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240819$$MD$AU$AU
242225701$24222570$1$I$20240401$20240814$20240819$20240819$EXP$$CA-JNJFOC-20240838992$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240819$$HP$CA$CA
242225711$24222571$1$I$20240101$20240814$20240819$20240819$PER$$US-JNJFOC-20240819898$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$US$US
242225721$24222572$1$I$$20240726$20240819$20240819$PER$$US-009507513-2407USA015211$MERCK$$$$$F$Y$$$20240819$$CN$US$US
242225731$24222573$1$I$$20240812$20240819$20240819$EXP$$US-009507513-2408USA005031$MERCK$$59$YR$$M$Y$$$20240819$$CN$US$US
242225741$24222574$1$I$$20240522$20240819$20240819$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000215$Tarsus Pharmaceuticals$$$$$$Y$$$20240819$$MD$US$US
242225751$24222575$1$I$20240401$20240426$20240819$20240819$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000177$Tarsus Pharmaceuticals$$$$$F$Y$$$20240819$$MD$US$US
242225761$24222576$1$I$20240801$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56584$$FDA-CTU$$80$YR$$M$N$$$20240816$N$PH$US$
242225771$24222577$1$I$$20240523$20240819$20240819$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000218$Tarsus Pharmaceuticals$$76$YR$$F$Y$$$20240819$$PH$US$US
242225781$24222578$1$I$$20240613$20240819$20240819$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000269$Tarsus Pharmaceuticals$$$$$$Y$$$20240819$$CN$US$US
242225791$24222579$1$I$20240522$20240531$20240819$20240819$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000235$Tarsus Pharmaceuticals$$$$$$Y$$$20240819$$CN$US$US
242225801$24222580$1$I$$20240606$20240819$20240819$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000245$Tarsus Pharmaceuticals$$68$YR$$F$Y$$$20240819$$PH$US$US
242225811$24222581$1$I$$20240708$20240819$20240819$PER$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000303$Tarsus Pharmaceuticals$$$$$M$Y$$$20240819$$CN$US$US
242225821$24222582$1$I$20180101$20240808$20240819$20240819$EXP$$CH-BIOGEN-2024BI01277928$BIOGEN$$$$$$Y$$$20240819$$MD$CH$CH
242225831$24222583$1$I$$20230621$20240819$20240819$EXP$$US-AstraZeneca-2023A145256$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242225841$24222584$1$I$$20221004$20240819$20240819$EXP$$US-AstraZeneca-2022A338849$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242225851$24222585$1$I$$20230328$20240819$20240819$EXP$$US-AstraZeneca-2023A074858$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242225861$24222586$1$I$20230503$20230620$20240819$20240819$EXP$$US-AstraZeneca-2023A106583$ASTRAZENECA$$16617$DY$$F$Y$$$20240819$$HP$US$
242225871$24222587$1$I$$20240812$20240819$20240819$PER$$US-BEH-2024177166$CSL BEHRING$$$$$$Y$$$20240819$$CN$US$US
242225881$24222588$1$I$$20240320$20240816$20240816$DIR$FDA-CDER-CTU-2024-56598$$FDA-CTU$$$$$M$N$$$20240320$N$HP$US$
242225891$24222589$1$I$20221024$20240809$20240819$20240819$EXP$$CN-AMGEN-CHNSP2024161107$AMGEN$Qu Z. Micro-transplantation in an elderly patient with very high risk MDS:A case report and literature review. Leukemia Research Reports. 2024;22:1-2$74$YR$E$F$Y$$$20240819$$HP$CN$CN
242225901$24222590$1$I$20240101$20240805$20240819$20240819$EXP$$US-ROCHE-10000050765$ROCHE$$90$YR$E$F$Y$$$20240819$$MD$US$US
242225911$24222591$1$I$$20240809$20240819$20240819$30DAY$$US-GSK-US2024099772$GLAXOSMITHKLINE$$$$$M$Y$$$20240819$$CN$US$US
242225921$24222592$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56636$$FDA-CTU$$74$YR$$M$N$$$20240816$N$$US$
242225932$24222593$2$F$$20240904$20240819$20240912$30DAY$$US-GSK-US2024AMR099825$GLAXOSMITHKLINE$$$$$M$Y$$$20240912$$CN$US$US
242225941$24222594$1$I$20210601$20240812$20240819$20240819$EXP$$US-GSK-US2021139744$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$MD$US$US
242225951$24222595$1$I$$20240812$20240819$20240819$EXP$$NVSC2024PL014456$NOVARTIS$Stepien B, Gajdecki J, Brzezinska O, Makowska J, Opinc-Rosiak A.. Calcinosis cutis in the course of systemic sclerosis overlapped by anti-MDA5 positive dermatomyositis: a case report.. ALERGIA ASTMA IMMUNOLOGIA. 2023;28(4):124-28$57$YR$$F$Y$$$20240819$$HP$PL$PL
242225961$24222596$1$I$$20240809$20240819$20240819$EXP$$NVSC2024CN163955$NOVARTIS$Tang Y, Hu DD, Yang LP, Wang JL, Yang YY, Zhu HJ et al.. Efficacy and safety of long-term use of octreotide acetate microspheres in acromegaly patient.. CHIN PHARM J. 2022;57 (12):1033-9$$$$$Y$$$20240819$$HP$CN$CN
242225972$24222597$2$F$$20240812$20240819$20240826$EXP$$NVSC2024DE165332$NOVARTIS$Scheiter A, Hierl F, Luke F, Keil F, Heudobler D, Einhell S et al.. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. BRITISH JOURNAL OF CANCER. 2023;128 (6):1134-47$$$$F$Y$$$20240826$$HP$DE$DE
242225981$24222598$1$I$20240807$20240814$20240819$20240819$EXP$$NVSC2024CN166228$NOVARTIS$$73$YR$$M$Y$80$KG$20240819$$HP$CN$CN
242225991$24222599$1$I$$20240809$20240816$20240816$DIR$FDA-CDER-CTU-2024-56619$$FDA-CTU$$$$$F$N$$$20240809$N$HP$US$
242226001$24222600$1$I$$20240809$20240819$20240819$EXP$$IN-MYLANLABS-2024M1076241$MYLAN$Kaur J, Singh A, Shah M, Chandrani P, Chougule A, Shetty O, et al. Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy. Cancer-Res-Stat-Treat 2023; 6 (2): 288-295.$77$YR$$M$Y$$$20240819$$MD$IN$IN
242226011$24222601$1$I$$20240809$20240819$20240819$EXP$$IN-MYLANLABS-2024M1076235$MYLAN$Mohod V, Gautam S, Prasad PSD, Rajshree. Anaesthesia Considerations of a Paediatric Patient with Recurrent Bronchopneumonia in a post-MDR Tb Seqeule: A Case Report. Eur-J-Cardiovasc-Med 2023; 13 (4): 526-530.$10$YR$$M$Y$$$20240819$$HP$IN$IN
242226031$24222603$1$I$$20240814$20240816$20240816$DIR$FDA-CDER-CTU-2024-56628$$FDA-CTU$$$$$F$N$$$20240814$N$HP$US$
242226041$24222604$1$I$$20240813$20240819$20240819$EXP$$NVSC2024IT165277$NOVARTIS$$$$A$F$Y$$$20240819$$MD$IT$IT
242226051$24222605$1$I$$20240812$20240816$20240816$DIR$FDA-CDER-CTU-2024-56576$$FDA-CTU$$$$$M$N$$$20240812$N$HP$US$
242226061$24222606$1$I$$20240807$20240816$20240816$DIR$FDA-CDER-CTU-2024-56587$$FDA-CTU$$$$$M$N$$$20240807$N$HP$US$
242226071$24222607$1$I$20240816$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56601$$FDA-CTU$$65$YR$$M$N$$$20240816$Y$HP$US$
242226081$24222608$1$I$20240815$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56607$$FDA-CTU$$61$YR$$M$N$$$20240816$Y$HP$US$
242226091$24222609$1$I$$20240814$20240816$20240816$DIR$FDA-CDER-CTU-2024-56708$$FDA-CTU$$$$$M$N$$$20240814$N$HP$US$
242226101$24222610$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56594$$FDA-CTU$$57$YR$$F$N$$$20240816$N$$US$
242226111$24222611$1$I$20240102$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56694$$FDA-CTU$$64$YR$$F$N$$$20240816$N$$US$
242226121$24222612$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56616$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242226131$24222613$1$I$$20240814$20240816$20240816$DIR$FDA-CDER-CTU-2024-56705$$FDA-CTU$$$$$F$N$$$20240814$N$HP$US$
242226141$24222614$1$I$$20240816$20240816$20240816$DIR$714693$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242226151$24222615$1$I$$20240816$20240816$20240816$DIR$714641$$FDA-CTU$$$$$M$N$$$20240816$Y$HP$US$
242226161$24222616$1$I$20240815$20240816$20240816$20240816$DIR$714613$$FDA-CTU$$76$YR$$F$N$$$20240816$N$HP$US$
242226171$24222617$1$I$20240515$20240816$20240816$20240816$DIR$714612$$FDA-CTU$$77$YR$$F$N$70.65$KG$20240816$N$CN$US$
242226181$24222618$1$I$$20240816$20240816$20240816$DIR$714614$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242226191$24222619$1$I$$20240816$20240816$20240816$DIR$714616$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242226201$24222620$1$I$$20230227$20240819$20240819$EXP$$CA-INCYTE CORPORATION-2023IN001068$INCYTE$$$$$$Y$$$20240819$$MD$CA$CA
242226211$24222621$1$I$20240501$20240809$20240819$20240819$PER$$US-SA-2024SA240786$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240819$$CN$US$US
242226231$24222623$1$I$$20240805$20240819$20240819$PER$$US-SA-2024SA241668$SANOFI AVENTIS$$$$E$M$Y$$$20240819$$MD$US$US
242226241$24222624$1$I$$20240809$20240819$20240819$PER$$US-SA-2023SA380222$SANOFI AVENTIS$$$$A$F$Y$93.878$KG$20240819$$MD$US$US
242226251$24222625$1$I$$20240808$20240819$20240819$PER$$US-SA-2024SA238579$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240819$$CN$US$US
242226261$24222626$1$I$20240720$20240816$20240816$20240816$DIR$714581$$FDA-CTU$$45$YR$$M$N$90.9$KG$20240816$N$HP$US$
242226271$24222627$1$I$$20240808$20240819$20240819$PER$$US-SA-2024SA240518$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240819$$HP$US$US
242226281$24222628$1$I$20240701$20240808$20240819$20240819$PER$$US-SA-2024SA241519$SANOFI AVENTIS$$60$YR$A$F$Y$72.57$KG$20240819$$MD$US$US
242226291$24222629$1$I$20240816$20240816$20240816$20240816$DIR$714629$$FDA-CTU$$69$YR$$UNK$N$$$20240816$N$$US$
242226301$24222630$1$I$20240731$20240809$20240819$20240819$PER$$US-SA-2024SA240775$SANOFI AVENTIS$$83$YR$E$M$Y$83.91$KG$20240819$$MD$US$US
242226321$24222632$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56617$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242226331$24222633$1$I$20240805$20240809$20240819$20240819$PER$$US-SA-2024SA240901$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240819$$CN$US$US
242226341$24222634$1$I$$20240808$20240819$20240819$PER$$US-SA-2024SA240098$SANOFI AVENTIS$$$$A$F$Y$49.895$KG$20240819$$MD$US$US
242226351$24222635$1$I$20240728$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56583$$FDA-CTU$$60$YR$$M$N$$$20240816$N$HP$US$
242226363$24222636$3$F$20240101$20240913$20240819$20240927$PER$$US-SA-2024SA240795$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240927$$MD$US$US
242226371$24222637$1$I$$20240809$20240819$20240819$PER$$US-SA-2024SA240336$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240819$$CN$US$US
242226381$24222638$1$I$20240101$20240809$20240819$20240819$PER$$US-SA-2024SA240401$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240819$$MD$US$US
242226392$24222639$2$F$$20240909$20240819$20240923$EXP$$CA-UCBSA-2024041193$UCB$$$$$F$Y$$$20240923$$HP$CA$CA
242226411$24222641$1$I$20240809$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56613$$FDA-CTU$$79$YR$$F$N$$$20240816$N$HP$US$
242226421$24222642$1$I$$20240808$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127604$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240819$$CN$US$US
242226431$24222643$1$I$20240805$20240807$20240816$20240816$DIR$FDA-CDER-CTU-2024-56578$$FDA-CTU$$80$YR$$F$N$$$20240807$N$HP$US$
242226441$24222644$1$I$20240801$20240815$20240819$20240819$PER$$US-JNJFOC-20240819331$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$CN$US$US
242226451$24222645$1$I$$20240813$20240819$20240819$PER$$US-SA-2024SA242933$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240819$$CN$US$US
242226461$24222646$1$I$$20240813$20240819$20240819$PER$$US-SA-2024SA243104$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240819$$CN$US$US
242226471$24222647$1$I$$20240812$20240819$20240819$PER$$US-SA-2024SA242687$SANOFI AVENTIS$$$$A$F$Y$81$KG$20240819$$MD$US$US
242226481$24222648$1$I$20240622$20240813$20240819$20240819$PER$$US-SA-2024SA242190$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240819$$MD$US$US
242226491$24222649$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56711$$FDA-CTU$$42$YR$$F$N$144.24$KG$20240816$N$$US$
242226501$24222650$1$I$$20240812$20240819$20240819$PER$$US-SA-2024SA243237$SANOFI AVENTIS$$$$A$F$Y$78.9$KG$20240819$$MD$US$US
242226511$24222651$1$I$$20240810$20240819$20240819$PER$$US-SA-2024SA242898$SANOFI AVENTIS$$$$A$F$Y$$$20240819$$MD$US$US
242226521$24222652$1$I$$20240812$20240819$20240819$PER$$US-SA-2024SA243481$SANOFI AVENTIS$$$$A$F$Y$117$KG$20240819$$MD$US$US
242226531$24222653$1$I$20240101$20240812$20240819$20240819$PER$$US-SA-2024SA192533$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240819$$MD$US$US
242226541$24222654$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56618$$FDA-CTU$$68$YR$$M$N$$$20240816$N$$US$
242226551$24222655$1$I$$20240813$20240819$20240819$PER$$US-SA-2024SA242795$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240819$$MD$US$US
242226561$24222656$1$I$$20240812$20240819$20240819$PER$$US-SA-2024SA243483$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240819$$MD$US$US
242226572$24222657$2$F$20240101$20240816$20240819$20240830$PER$$US-SA-2024SA243113$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240830$$MD$US$US
242226581$24222658$1$I$20240101$20240812$20240819$20240819$PER$$US-SA-2024SA243484$SANOFI AVENTIS$$50$YR$A$F$Y$89.3$KG$20240819$$MD$US$US
242226591$24222659$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56612$$FDA-CTU$$63$YR$$M$N$$$20240816$N$$US$
242226601$24222660$1$I$$20240807$20240819$20240819$EXP$$JP-ROCHE-10000055975$ROCHE$$$$A$F$Y$$$20240819$$MD$JP$JP
242226611$24222661$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56690$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242226621$24222662$1$I$$20240808$20240819$20240819$EXP$$CN-ROCHE-10000054055$ROCHE$Chen Y, Liu C, Wen X, Wang C, He J. Treatment of HER2-Positive Breast Cancer with Brain Metastases Using Anlotinib and Trastuzumab Deruxtecan: A Case Report. International journal of women^s health. 2024;16:1277-1283. doi:10.2147/IJWH.S472628.$37$YR$A$F$Y$$$20240819$$HP$CN$CN
242226631$24222663$1$I$$20240805$20240819$20240819$EXP$$US-EPICPHARMA-US-2024EPCLIT00997$EPIC PHARM$E. Mikhail.Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A3410$72$YR$E$F$Y$$$20240819$$HP$US$US
242226641$24222664$1$I$20230321$20230327$20240816$20240816$DIR$FDA-CDER-CTU-2024-56595$$FDA-CTU$$61$YR$$F$N$70.3$KG$20230327$N$$US$
242226651$24222665$1$I$$20240812$20240819$20240819$EXP$$US-SA-2024SA244197$SANOFI AVENTIS$$$$E$F$Y$77$KG$20240819$$MD$US$US
242226661$24222666$1$I$$20240813$20240819$20240819$EXP$$US-SA-2024SA242152$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240819$$MD$US$US
242226671$24222667$1$I$$20240807$20240819$20240819$PER$$US-JNJFOC-20240822685$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$US$US
242226684$24222668$4$F$20240805$20240909$20240819$20240924$30DAY$$US-JNJFOC-20240829581$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240924$$HP$US$US
242226701$24222670$1$I$$20240812$20240819$20240819$EXP$$US-SA-2024SA244245$SANOFI AVENTIS$$$$A$F$Y$55.7$KG$20240819$$MD$US$US
242226711$24222671$1$I$$20240814$20240819$20240819$EXP$$US-SA-2024SA243992$SANOFI AVENTIS$$$$E$F$Y$69.85$KG$20240819$$MD$US$US
242226731$24222673$1$I$$20240812$20240819$20240819$EXP$$CA-ABBVIE-5879383$ABBVIE$$$$A$F$Y$$$20240819$$CN$CA$CA
242226741$24222674$1$I$$20240808$20240819$20240819$EXP$$US-ROCHE-10000053400$ROCHE$$$$A$F$Y$$$20240819$$CN$US$US
242226751$24222675$1$I$$20240729$20240819$20240819$PER$$US-SA-2024SA242596$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240819$$CN$US$US
242226762$24222676$2$F$20240808$20240916$20240819$20240919$EXP$$US-BAYER-2024A116895$BAYER$$40$YR$A$M$Y$$$20240919$$CN$US$US
242226771$24222677$1$I$$20240810$20240819$20240819$PER$$US-SA-2024SA240463$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240819$$MD$US$US
242226782$24222678$2$F$$20240815$20240819$20240828$PER$$US-SA-2024SA242984$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240828$$CN$US$US
242226791$24222679$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56597$$FDA-CTU$$60$YR$$M$N$$$20240816$N$$US$
242226801$24222680$1$I$20240101$20240816$20240819$20240819$EXP$$US-ORGANON-O2408USA001310$ORGANON$$$$$F$Y$$$20240819$$CN$US$US
242226811$24222681$1$I$$20240810$20240819$20240819$PER$$US-SA-2024SA242128$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240819$$MD$US$US
242226821$24222682$1$I$$20240815$20240819$20240819$PER$$NVSC2024US166119$NOVARTIS$$$$$M$Y$$$20240819$$CN$US$US
242226831$24222683$1$I$$20240816$20240819$20240819$EXP$$NVSC2024US166683$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242226842$24222684$2$F$20240815$20240815$20240819$20240819$PER$$US-GILEAD-2024-0684454$GILEAD$$35$YR$A$M$Y$$$20240819$$PH$US$US
242226851$24222685$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00980$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$10$YR$C$$Y$$$20240819$$HP$TR$TR
242226861$24222686$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56602$$FDA-CTU$$63$YR$$F$N$$$20240816$N$$US$
242226871$24222687$1$I$$20240805$20240819$20240819$EXP$$DE-ROCHE-10000040088$ROCHE$$$$$$Y$$$20240819$$MD$DE$DE
242226892$24222689$2$F$20240807$20240821$20240819$20240824$EXP$$US-ABBVIE-5881402$ABBVIE$$81$YR$$M$Y$$$20240824$$CN$US$US
242226921$24222692$1$I$$20240321$20240816$20240816$DIR$FDA-CDER-CTU-2024-56719$$FDA-CTU$$$$$F$N$$$20240321$N$HP$US$
242226931$24222693$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129361$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240819$$CN$US$US
242226971$24222697$1$I$20240803$20240812$20240816$20240816$DIR$FDA-CDER-CTU-2024-56582$$FDA-CTU$$83$YR$$F$N$$$20240812$N$HP$US$
242226981$24222698$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56609$$FDA-CTU$$67$YR$$M$N$$$20240816$N$$US$
242226991$24222699$1$I$20240802$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56458$$FDA-CTU$$41$YR$$F$N$61.23$KG$20240816$N$CN$US$
242227001$24222700$1$I$20240809$20240816$20240816$20240816$DIR$714679$$FDA-CTU$$74$YR$$F$N$$$20240816$N$PH$US$
242227011$24222701$1$I$$20240808$20240816$20240816$DIR$FDA-CDER-CTU-2024-56671$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
242227021$24222702$1$I$20240805$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56604$$FDA-CTU$$60$YR$$M$N$$$20240816$Y$PH$US$
242227031$24222703$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56614$$FDA-CTU$$76$YR$$F$N$47.17$KG$20240816$N$$US$
242227041$24222704$1$I$$20240816$20240816$20240816$DIR$714676$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242227051$24222705$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56586$$FDA-CTU$$69$YR$$F$N$$$20240816$N$$US$
242227061$24222706$1$I$20240201$20240731$20240816$20240816$DIR$FDA-CDER-CTU-2024-56615$$FDA-CTU$$16$YR$$F$N$$$20240731$N$HP$US$
242227071$24222707$1$I$$20240815$20240819$20240819$EXP$$US-UCBSA-2024038209$UCB$$$$$M$Y$$$20240819$$CN$US$US
242227081$24222708$1$I$20240404$20240809$20240819$20240819$EXP$FR-AFSSAPS-AN2024001003$FR-TEVA-VS-3232661$TEVA$$60$YR$$M$Y$$$20240819$$PH$FR$FR
242227101$24222710$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00981$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$$$C$$Y$$$20240819$$HP$TR$TR
242227111$24222711$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167468$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242227121$24222712$1$I$20240815$20240816$20240816$20240816$DIR$714627$$FDA-CTU$$65$YR$$F$N$$$20240816$N$HP$US$
242227141$24222714$1$I$$20240811$20240819$20240819$EXP$$IL-ROCHE-10000057793$ROCHE$$$$A$F$Y$$$20240819$$MD$IL$IL
242227151$24222715$1$I$$20240814$20240819$20240819$PER$$US-ABBVIE-5884022$ABBVIE$$$$$$Y$$$20240819$$CN$US$US
242227171$24222717$1$I$$20240816$20240816$20240816$DIR$714652$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242227182$24222718$2$F$20240701$20240816$20240819$20240820$PER$$US-AMGEN-USASP2024164030$AMGEN$$49$YR$A$M$Y$$$20240819$$HP$US$US
242227191$24222719$1$I$$20240815$20240819$20240819$EXP$$US-GILEAD-2024-0684420$GILEAD$$$$E$M$Y$$$20240819$$CN$US$US
242227201$24222720$1$I$20240524$20240814$20240819$20240819$EXP$ES-AEMPS-1561035$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-128871$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240819$$MD$ES$ES
242227221$24222722$1$I$20240412$20240809$20240819$20240819$EXP$IT-MINISAL02-997848$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-07720$HIKMA$$70$YR$$F$Y$65$KG$20240819$$MD$IT$IT
242227231$24222723$1$I$$20240816$20240816$20240816$DIR$714662$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242227251$24222725$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00984$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$16$YR$T$$Y$$$20240819$$HP$TR$TR
242227263$24222726$3$F$20240803$20240903$20240819$20240913$PER$$US-BEH-2024171519$CSL BEHRING$$31$YR$A$F$Y$134.69$KG$20240913$$HP$US$US
242227271$24222727$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237414$PFIZER$$$$$F$Y$$$20240819$$MD$US$US
242227281$24222728$1$I$$20240816$20240816$20240816$DIR$714626$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242227291$24222729$1$I$20240101$20240724$20240819$20240819$PER$$US-009507513-2407USA014803$MERCK$$50$YR$$F$Y$$$20240819$$HP$US$US
242227301$24222730$1$I$20240801$20240813$20240819$20240819$PER$$US-PFIZER INC-202400237011$PFIZER$$34$YR$$F$Y$$$20240819$$HP$US$US
242227331$24222733$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-PV202400106453$PFIZER$$32$YR$$F$Y$$$20240819$$CN$US$US
242227361$24222736$1$I$$20240809$20240819$20240819$EXP$$IN-ROCHE-10000054616$ROCHE$$47$YR$A$F$Y$$$20240819$$MD$IN$IN
242227372$24222737$2$F$20240812$20240819$20240819$20240822$PER$$US-AMGEN-USASP2024164140$AMGEN$$76$YR$E$F$Y$$$20240822$$CN$US$US
242227401$24222740$1$I$$20240812$20240819$20240819$PER$$US-PFIZER INC-202400235408$PFIZER$$$$$F$Y$$$20240819$$HP$US$US
242227411$24222741$1$I$20240610$20240814$20240819$20240819$EXP$$RU-BAYER-2024A111572$BAYER$$68$YR$E$F$Y$63$KG$20240819$$MD$RU$RU
242227421$24222742$1$I$$20240717$20240819$20240819$PER$$US-FMCRTG-FMC-2407-000874$FRESENIUS MEDICAL CARE$$72$YR$E$F$Y$$$20240819$$HP$US$US
242227431$24222743$1$I$$20240806$20240819$20240819$EXP$$US-FMCRTG-FMC-2408-000949$FRESENIUS MEDICAL CARE$$58$YR$A$M$Y$$$20240819$$HP$US$US
242227441$24222744$1$I$20240809$20240815$20240819$20240819$EXP$$CN-ROCHE-10000058839$ROCHE$$69$YR$E$F$Y$90$KG$20240819$$HP$CN$CN
242227451$24222745$1$I$20240123$20240702$20240819$20240819$PER$$US-FMCRTG-FMC-2407-000797$FRESENIUS MEDICAL CARE$$64$YR$A$M$Y$100$KG$20240819$$HP$US$US
242227462$24222746$2$F$$20240820$20240819$20240821$PER$$US-ABBVIE-5882926$ABBVIE$$$$$$Y$$$20240821$$HP$US$US
242227481$24222748$1$I$$20240813$20240819$20240819$EXP$$US-ROCHE-10000057074$ROCHE$$49$YR$A$F$Y$102.05$KG$20240819$$MD$US$US
242227492$24222749$2$F$$20240827$20240819$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129183$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240902$$CN$US$US
242227501$24222750$1$I$20240229$20240809$20240819$20240819$EXP$FR-AFSSAPS-RE2024000803$FR-TEVA-VS-3232642$TEVA$$66$YR$$F$Y$109$KG$20240819$$HP$FR$FR
242227511$24222751$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130097$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240819$$HP$US$US
242227522$24222752$2$F$20240701$20240821$20240819$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129980$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240903$$HP$US$US
242227531$24222753$1$I$20240101$20240813$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128725$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240819$$CN$US$US
242227541$24222754$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130076$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$106.59$KG$20240819$$CN$US$US
242227551$24222755$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130466$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240819$$CN$US$US
242227561$24222756$1$I$$20240814$20240819$20240819$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-129950$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240819$$CN$PR$PR
242227571$24222757$1$I$$20240812$20240819$20240819$PER$$US-AstraZeneca-2024A183724$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242227581$24222758$1$I$$20240810$20240819$20240819$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07661$HIKMA$$$$$F$Y$$$20240819$$CN$US$US
242227591$24222759$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00985$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$14$YR$T$$Y$$$20240819$$HP$TR$TR
242227601$24222760$1$I$$20240815$20240819$20240819$PER$$NVSC2024US166498$NOVARTIS$$$$$M$Y$$$20240819$$CN$US$US
242227622$24222762$2$F$$20240820$20240819$20240820$30DAY$$US-PFIZER INC-PV202400105002$PFIZER$$$$$$Y$$$20240820$$CN$US$US
242227631$24222763$1$I$$20240812$20240819$20240819$EXP$$CN-PFIZER INC-202400236460$PFIZER$$60$YR$$M$Y$$$20240819$$CN$CN$CN
242227651$24222765$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009964$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240819$$CN$US$US
242227661$24222766$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010268$ELI LILLY AND CO$$$$$M$Y$$$20240819$$CN$US$US
242227671$24222767$1$I$20240812$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009917$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240819$$CN$US$US
242227681$24222768$1$I$$20240808$20240819$20240819$EXP$$CZ-TOLMAR, INC.-24CZ051431$TOLMAR$$70$YR$$M$Y$$$20240819$$MD$CZ$CZ
242227691$24222769$1$I$20240816$20240816$20240816$20240816$DIR$714675$$FDA-CTU$$53$YR$$F$N$103.5$KG$20240816$N$CN$US$
242227701$24222770$1$I$20230724$20240816$20240816$20240816$DIR$714575$$FDA-CTU$$82$YR$$F$N$70.8$KG$20240816$N$HP$US$
242227722$24222772$2$F$20240801$20240918$20240819$20240918$30DAY$$US-PFIZER INC-202400232393$PFIZER$$6$MON$$F$Y$$$20240918$$CN$US$US
242227741$24222774$1$I$$20240809$20240819$20240819$EXP$$US-GSK-US2024099753$GLAXOSMITHKLINE$$$$$M$Y$$$20240819$$CN$US$US
242227751$24222775$1$I$20240805$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56717$$FDA-CTU$$54$YR$$M$N$122.47$KG$20240816$Y$HP$US$
242227761$24222776$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00976$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$8$YR$C$$Y$$$20240819$$HP$TR$TR
242227771$24222777$1$I$$20240816$20240819$20240819$PER$$US-ROCHE-10000059632$ROCHE$$26$YR$A$F$Y$$$20240819$$CN$US$US
242227781$24222778$1$I$20240816$20240816$20240816$20240816$DIR$714653$$FDA-CTU$$43$YR$$M$N$80.1$KG$20240816$N$HP$US$
242227791$24222779$1$I$$20240816$20240819$20240819$PER$$US-HALEON-2192498$Haleon PLC$$$$$$Y$$$20240819$$CN$US$US
242227801$24222780$1$I$$20240814$20240819$20240819$PER$$NVSC2024US165664$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
242227811$24222781$1$I$$20240812$20240819$20240819$EXP$$PHHY2016IT104986$NOVARTIS$Sbrana F, Loggini B, Galimberti S, Coceani M, Latorre M, Seccia V et al.. Chronic skin lichenification as an unusual presentation of eosinophilic granulomatosis with polyangiitis: case report and literature review. ACTA REUMATOL PORT. 2016;41:158-61$52$YR$$F$Y$92$KG$20240819$$HP$IT$IT
242227821$24222782$1$I$$20240731$20240819$20240819$PER$$US-TEVA-VS-3229796$TEVA$$$$$F$Y$$$20240819$$CN$US$US
242227831$24222783$1$I$$20240812$20240819$20240819$PER$$US-EMD Serono-2024043596$EMD SERONO INC$$$$A$F$Y$$$20240819$$CN$US$US
242227841$24222784$1$I$$20240816$20240819$20240819$EXP$$JP-ABBVIE-5882673$ABBVIE$$40$YR$$F$Y$$$20240819$$MD$JP$JP
242227851$24222785$1$I$$20240530$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003890$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227861$24222786$1$I$$20240729$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003914$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227871$24222787$1$I$$20240529$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003940$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227881$24222788$1$I$20240530$20240530$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003962$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227891$24222789$1$I$$20240529$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003766$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227901$24222790$1$I$$20240606$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003771$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227911$24222791$1$I$$20240523$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003776$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227921$24222792$1$I$$20240530$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003986$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227931$24222793$1$I$$20240531$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004047$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227941$24222794$1$I$$20240606$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004077$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227951$24222795$1$I$$20240524$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003831$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227961$24222796$1$I$$20240529$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003934$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227971$24222797$1$I$$20240710$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003950$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227981$24222798$1$I$$20240530$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003978$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242227991$24222799$1$I$20240531$20240531$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004022$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242228001$24222800$1$I$$20240528$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003885$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242228011$24222801$1$I$$20240620$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004084$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242228021$24222802$1$I$$20240528$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003881$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242228031$24222803$1$I$$20240806$20240819$20240819$30DAY$$GB-PFIZER INC-202400232841$PFIZER$$23$YR$$M$Y$$$20240819$$CN$GB$GB
242228041$24222804$1$I$$20240621$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003909$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242228051$24222805$1$I$$20240809$20240819$20240819$EXP$$CA-TEVA-VS-3232635$TEVA$$34$YR$$F$Y$$$20240819$$HP$CA$CA
242228061$24222806$1$I$$20240812$20240819$20240819$30DAY$$US-PFIZER INC-PV202400105935$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
242228071$24222807$1$I$$20240812$20240819$20240819$EXP$$CN-PFIZER INC-PV202400104534$PFIZER$$60$YR$$M$Y$$$20240819$$CN$CN$CN
242228082$24222808$2$F$$20240917$20240819$20240919$30DAY$$AU-PFIZER INC-202400231690$PFIZER$$57$YR$$F$Y$$$20240919$$PH$AU$AU
242228095$24222809$5$F$20240812$20240924$20240819$20240930$30DAY$$DE-PFIZER INC-202400234702$PFIZER$$40$YR$$F$Y$60$KG$20240930$$PH$DE$DE
242228112$24222811$2$F$$20240910$20240819$20240912$30DAY$$DE-PFIZER INC-202400231922$PFIZER$$$$$$Y$$$20240912$$HP$DE$DE
242228122$24222812$2$F$$20240830$20240819$20240910$EXP$$JP-ROCHE-10000058371$ROCHE$$60$YR$A$F$Y$$$20240910$$PH$JP$JP
242228131$24222813$1$I$$20240604$20240819$20240819$EXP$$IT-TEVA-VS-3220100$TEVA$Ferrante L. Maria e Ivo: due storie, lo stesso sospetto diagnostico. Focus Farmacovigilanza Anno XXVI - n.117$77$YR$$F$Y$$$20240819$$MD$IT$IT
242228141$24222814$1$I$$20240806$20240819$20240819$EXP$$US-ASCENT-2024ASLIT00024$ASCENT$Russe JR, Abdelhamid I, Meier R, Giblen G and Maheshwari A.Overwhelming Cytochrome P450 Isoenzyme Activity Generating Druginduced Liver Injury Resulting In Fulminant Liver Failure.Hepatology.OCT-2023;78:S643-4$41$YR$A$F$Y$$$20240819$$HP$US$US
242228152$24222815$2$F$$20240923$20240819$20240927$30DAY$$AR-PFIZER INC-202400236456$PFIZER$$51$YR$$F$Y$$$20240927$$CN$AR$AR
242228171$24222817$1$I$$20240807$20240819$20240819$30DAY$$US-PFIZER INC-202400237839$PFIZER$$$$$$Y$$$20240819$$CN$US$US
242228181$24222818$1$I$20240815$20240816$20240819$20240819$PER$$US-AMGEN-USASP2024164027$AMGEN$$27$YR$A$F$Y$$$20240819$$CN$US$US
242228191$24222819$1$I$$20240603$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004089$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242228201$24222820$1$I$$20240813$20240819$20240819$PER$$US-BAYER-2024A117222$BAYER$$$$$$Y$$$20240819$$CN$US$US
242228211$24222821$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00979$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$$$T$$Y$$$20240819$$HP$TR$TR
242228221$24222822$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00986$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$9$YR$C$$Y$$$20240819$$HP$TR$TR
242228231$24222823$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129268$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240819$$CN$US$US
242228241$24222824$1$I$$20240807$20240819$20240819$PER$$US-BAYER-2024A115071$BAYER$$$$$$Y$$$20240819$$CN$US$US
242228253$24222825$3$F$20240805$20240906$20240819$20240925$EXP$$TR-JNJFOC-20240823005$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$PH$TR$TR
242228261$24222826$1$I$20240524$20240814$20240819$20240819$PER$$US-BAYER-2024A117839$BAYER$$19$YR$A$F$Y$$$20240819$$CN$US$US
242228272$24222827$2$F$20210602$20240819$20240819$20240829$EXP$$FR-SERVIER-S24009944$SERVIER$$$$$$Y$$$20240829$$MD$FR$FR
242228281$24222828$1$I$$20240812$20240819$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA072187$SANDOZ$$43$YR$$F$Y$97$KG$20240819$$HP$CA$CA
242228291$24222829$1$I$$20240809$20240819$20240819$EXP$FR-HOSPIRA-2994263$FR-ROCHE-10000053174$ROCHE$$68$YR$E$F$Y$$$20240819$$HP$FR$FR
242228301$24222830$1$I$$20240813$20240819$20240819$EXP$$US-Atnahs Limited-ATNAHS20240802360$Atnahs Healthcare$$71$YR$E$F$Y$$$20240819$$MD$US$US
242228311$24222831$1$I$20231204$20240805$20240819$20240819$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-07593$HIKMA$$$$$$Y$$$20240819$$MD$GB$GB
242228322$24222832$2$F$20240501$20240923$20240819$20240924$EXP$$NVSC2024ZA166034$NOVARTIS$$71$YR$$M$Y$$$20240924$$PH$ZA$ZA
242228333$24222833$3$F$$20240925$20240819$20240926$EXP$$GB-MYLANLABS-2024M1075587$MYLAN$$$$$M$Y$$$20240926$$CN$GB$GB
242228342$24222834$2$F$$20240821$20240819$20240826$EXP$$GB-MYLANLABS-2024M1075584$MYLAN$$$$$F$Y$$$20240826$$PH$GB$GB
242228351$24222835$1$I$$20240813$20240819$20240819$EXP$$GB-MYLANLABS-2024M1076294$MYLAN$$$$$M$Y$$$20240819$$PH$GB$GB
242228361$24222836$1$I$20240808$20240813$20240819$20240819$EXP$GB-MHRA-MED-202408130514228020-JZBTF$GB-MYLANLABS-2024M1075335$MYLAN$$$$$$Y$$$20240819$$CN$GB$GB
242228371$24222837$1$I$20240810$20240813$20240819$20240819$EXP$GB-MHRA-MED-202408131719474290-JHNLS$GB-MYLANLABS-2024M1075693$MYLAN$$39$YR$$F$Y$$$20240819$$HP$GB$GB
242228381$24222838$1$I$$20240810$20240819$20240819$PER$$US-BAYER-2024A116305$BAYER$$$$$$Y$$$20240819$$HP$US$US
242228391$24222839$1$I$$20240807$20240819$20240819$PER$$US-INCYTE CORPORATION-2024IN008307$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242228401$24222840$1$I$$20240814$20240819$20240819$PER$$US-ABBVIE-5881414$ABBVIE$$$$$$Y$$$20240819$$CN$US$US
242228411$24222841$1$I$$20240813$20240819$20240819$PER$$US-BAYER-2024A117599$BAYER$$$$$$Y$$$20240819$$CN$US$US
242228421$24222842$1$I$$20240807$20240819$20240819$PER$$US-INCYTE CORPORATION-2024IN008300$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242228431$24222843$1$I$20240701$20240809$20240819$20240819$PER$$US-JNJFOC-20240827788$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$CN$US$US
242228441$24222844$1$I$$20240813$20240819$20240819$EXP$$CL-JNJFOC-20240836789$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240819$$CN$CL$CL
242228451$24222845$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00982$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$9$YR$C$$Y$$$20240819$$HP$TR$TR
242228461$24222846$1$I$$20240813$20240819$20240819$PER$$US-JNJFOC-20240833816$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
242228472$24222847$2$F$$20240906$20240819$20240913$30DAY$$TR-JNJFOC-20240822999$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$MD$TR$TR
242228481$24222848$1$I$$20240807$20240819$20240819$PER$$US-INCYTE CORPORATION-2024IN008297$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242228491$24222849$1$I$20240301$20240809$20240819$20240819$EXP$FR-AFSSAPS-AN2024000999$FR-TEVA-VS-3232877$TEVA$$73$YR$$M$Y$$$20240819$$MD$FR$FR
242228501$24222850$1$I$$20240809$20240819$20240819$EXP$$GB-Atnahs Limited-ATNAHS20240802323$Atnahs Healthcare$$38$YR$A$F$Y$64$KG$20240819$$MD$GB$GB
242228511$24222851$1$I$20240725$20240725$20240819$20240819$PER$$US-CSL-2024-007053$CSL Plasma$$49$YR$$M$Y$$$20240819$$HP$US$US
242228521$24222852$1$I$20230501$20240815$20240819$20240819$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-129577$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240819$$CN$CA$CA
242228531$24222853$1$I$20240801$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024163670$AMGEN$$80$YR$E$F$Y$$$20240819$$CN$US$US
242228541$24222854$1$I$$20240809$20240819$20240819$PER$$US-ABBVIE-5875418$ABBVIE$$$$$F$Y$$$20240819$$HP$US$US
242228551$24222855$1$I$20221101$20240807$20240819$20240819$PER$$US-INCYTE CORPORATION-2024IN008296$INCYTE$$$$$$Y$$$20240819$$HP$US$US
242228561$24222856$1$I$20240801$20240801$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122367$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240819$$CN$US$US
242228571$24222857$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00988$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$14$YR$T$$Y$$$20240819$$HP$TR$TR
242228581$24222858$1$I$$20240819$20240819$20240819$EXP$$MY-PFIZER INC-PV202400107483$PFIZER$$67$YR$$M$Y$$$20240819$$MD$MY$MY
242228601$24222860$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00989$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$12$YR$T$$Y$$$20240819$$HP$TR$TR
242228621$24222862$1$I$$20240815$20240819$20240819$EXP$$CN-PFIZER INC-PV202400106432$PFIZER$$$$E$M$Y$$$20240819$$CN$CN$CN
242228631$24222863$1$I$20240718$20240722$20240819$20240819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003850$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240819$$CN$US$US
242228641$24222864$1$I$20240802$20240813$20240819$20240819$EXP$$CN-PFIZER INC-PV202400105492$PFIZER$$68$YR$$M$Y$$$20240819$$HP$CN$CN
242228651$24222865$1$I$20230501$20240813$20240819$20240819$EXP$$DE-PFIZER INC-PV202400106352$PFIZER$$$$$F$Y$$$20240819$$MD$DE$DE
242228661$24222866$1$I$$20240814$20240819$20240819$EXP$$IN-PFIZER INC-PV202200132483$PFIZER$$62$YR$$M$Y$$$20240819$$CN$IN$IN
242228671$24222867$1$I$20240730$20240814$20240819$20240819$EXP$$CN-PFIZER INC-PV202400106132$PFIZER$$4$YR$$M$Y$14.5$KG$20240819$$HP$CN$CN
242228681$24222868$1$I$20240803$20240813$20240819$20240819$EXP$$CN-PFIZER INC-PV202400105467$PFIZER$$58$YR$$F$Y$65$KG$20240819$$HP$CN$CN
242228692$24222869$2$F$$20240924$20240819$20240927$EXP$$US-PFIZER INC-PV202400031339$PFIZER$$70$YR$$F$Y$$$20240927$$CN$US$US
242228711$24222871$1$I$20230420$20240808$20240819$20240819$EXP$$US-PFIZER INC-202400233218$PFIZER$$$$$M$Y$$$20240819$$CN$US$US
242228721$24222872$1$I$$20240814$20240819$20240819$EXP$$HN-PFIZER INC-202400237647$PFIZER$$$$A$F$Y$$$20240819$$PH$HN$HN
242228731$24222873$1$I$20220101$20240813$20240819$20240819$EXP$GB-MHRA-31453274$GB-PFIZER INC-202400235744$PFIZER$$46$YR$$M$Y$120$KG$20240819$$CN$GB$GB
242228742$24222874$2$F$20231027$20240819$20240819$20240821$EXP$FR-AFSSAPS-RE2024000779$FR-PFIZER INC-202400234436$PFIZER$$62$YR$$F$Y$$$20240821$$HP$FR$FR
242228751$24222875$1$I$$20240815$20240819$20240819$EXP$$CN-PFIZER INC-PV202400106382$PFIZER$$$$A$M$Y$$$20240819$$CN$CN$CN
242228761$24222876$1$I$$20240815$20240819$20240819$EXP$$TW-PFIZER INC-PV202400106837$PFIZER$$$$$$Y$$$20240819$$CN$TW$TW
242228771$24222877$1$I$20240724$20240813$20240819$20240819$EXP$$CN-PFIZER INC-PV202400105460$PFIZER$$55$YR$$M$Y$65$KG$20240819$$HP$CN$CN
242228781$24222878$1$I$$20240814$20240819$20240819$EXP$$IN-PFIZER INC-PV202400106199$PFIZER$$50$YR$$F$Y$$$20240819$$CN$IN$IN
242228791$24222879$1$I$$20240816$20240819$20240819$EXP$$CN-PFIZER INC-PV202400106999$PFIZER$$$$A$M$Y$$$20240819$$CN$CN$CN
242228801$24222880$1$I$20240731$20240809$20240819$20240819$EXP$$CN-PFIZER INC-202400235572$PFIZER$$15$YR$$F$Y$50$KG$20240819$$HP$CN$CN
242228811$24222881$1$I$$20240814$20240819$20240819$EXP$$ID-PFIZER INC-PV202400106047$PFIZER$$47$YR$$F$Y$$$20240819$$CN$ID$ID
242228821$24222882$1$I$20240730$20240809$20240819$20240819$EXP$$CN-PFIZER INC-202400236395$PFIZER$$54$YR$$M$Y$74$KG$20240819$$HP$CN$CN
242228832$24222883$2$F$20240501$20240918$20240819$20240919$EXP$$US-INCYTE CORPORATION-2024IN008295$INCYTE$$$$$$Y$$$20240919$$MD$US$US
242228841$24222884$1$I$$20240812$20240819$20240819$PER$$US-BAYER-2024A116609$BAYER$$$$$$Y$$$20240819$$CN$US$US
242228851$24222885$1$I$$20240527$20240819$20240819$EXP$$US-GUERBET / LLC-US-20240088$GUERBET$Intranodal Lymphangiography and Embolization for Management of Iatrogenic Chylous Ascites after Oncological Surgery. J Vasc Interv Radiol. 2024;35(6): 883-889. doi:https://doi.org/10.1016/j.jvir.2024.02.015.$$$A$$Y$$$20240819$$MD$US$US
242228861$24222886$1$I$20230808$20240816$20240819$20240819$EXP$$US-INCYTE CORPORATION-2024IN008605$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242228871$24222887$1$I$$20240816$20240819$20240819$EXP$$US-INCYTE CORPORATION-2024IN008607$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242228881$24222888$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00987$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$13$YR$T$$Y$$$20240819$$HP$TR$TR
242228892$24222889$2$F$$20240919$20240819$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129790$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$73.03$KG$20240923$$CN$US$US
242228901$24222890$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129596$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$88.9$KG$20240819$$CN$US$US
242228911$24222891$1$I$20240803$20240812$20240819$20240819$EXP$$MX-JNJFOC-20240832548$JOHNSON AND JOHNSON$$60$YR$A$M$Y$85$KG$20240819$$MD$MX$MX
242228931$24222893$1$I$20240422$20240815$20240819$20240819$EXP$$NVSC2024GB087433$NOVARTIS$$$$$F$Y$$$20240819$$CN$GB$GB
242228941$24222894$1$I$20231001$20240816$20240819$20240819$PER$$NVSC2024US167464$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242228951$24222895$1$I$$20240805$20240819$20240819$EXP$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-07159$PT-INCYTE CORPORATION-2024IN008241$INCYTE$Patricio J, Modesto F, Caldeira V, Fernandes I.. PO-0125 - (2930) - Quando o tratamento despoleta a doenca - um caso clinic.. CONGRESSOS DA SOCIEDADE PORTUGUESA DE MEDICINA INTERNA. 2024$$$$$Y$$$20240819$$HP$PT$PT
242228961$24222896$1$I$$20240814$20240819$20240819$EXP$$RU-ROCHE-10000059081$ROCHE$$$$$F$Y$$$20240819$$CN$RU$RU
242228971$24222897$1$I$$20240812$20240819$20240819$EXP$$US-ABBVIE-5878071$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242228981$24222898$1$I$$20240805$20240819$20240819$EXP$$US-SMPA-2024SPA000927$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
242228992$24222899$2$F$$20240819$20240819$20240829$EXP$$US-SMPA-2024SPA000912$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242229001$24222900$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010800$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$US$US
242229011$24222901$1$I$$20240812$20240819$20240819$EXP$$US-TAKEDA-2024TUS009964$TAKEDA$$$$$F$Y$73$KG$20240819$$MD$US$US
242229021$24222902$1$I$$20240816$20240819$20240819$EXP$$FR-SANDOZ INC.-SDZ2024FR073078$SANDOZ$$77$YR$$M$Y$$$20240819$$HP$FR$FR
242229031$24222903$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00977$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$13$YR$T$$Y$$$20240819$$HP$TR$TR
242229041$24222904$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00990$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$$$T$$Y$$$20240819$$HP$TR$TR
242229051$24222905$1$I$$20240805$20240819$20240819$EXP$$US-SMPA-2024SPA000951$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
242229061$24222906$1$I$20240716$20240813$20240819$20240819$EXP$FR-AFSSAPS-GR2024001011$FR-Waylis Therapeutics LLC-ATNAHS20240802338$Waylis$$27$YR$A$F$Y$$$20240819$$PH$FR$FR
242229071$24222907$1$I$$20240805$20240819$20240819$EXP$$US-SMPA-2024SPA000933$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
242229081$24222908$1$I$$20240805$20240819$20240819$EXP$$US-SMPA-2024SPA000944$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
242229091$24222909$1$I$$20240805$20240819$20240819$EXP$$US-SMPA-2024SPA000962$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
242229101$24222910$1$I$20240401$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408091020594970-KFVBM$GB-TEVA-VS-3232180$TEVA$$59$YR$$M$Y$$$20240819$$HP$GB$GB
242229111$24222911$1$I$$20240805$20240819$20240819$EXP$$US-SMPA-2024SPA000967$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
242229121$24222912$1$I$$20240805$20240819$20240819$EXP$$US-SMPA-2024SPA000943$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
242229133$24222913$3$F$20240101$20240912$20240819$20240926$EXP$$US-SMPA-2024SPA000972$SUNOVION$$$$$$Y$$$20240926$$CN$US$US
242229141$24222914$1$I$$20240805$20240819$20240819$EXP$$US-SMPA-2024SPA000909$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
242229151$24222915$1$I$$20240805$20240819$20240819$EXP$$US-SMPA-2024SPA000905$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
242229161$24222916$1$I$20240201$20240813$20240819$20240819$EXP$FR-AFSSAPS-RE2024000808$FR-Waylis Therapeutics LLC-ATNAHS20240802341$Waylis$$45$YR$A$M$Y$59$KG$20240819$$PH$FR$FR
242229171$24222917$1$I$20240703$20240809$20240819$20240819$EXP$$GB-TEVA-VS-3232224$TEVA$$65$YR$$M$Y$90$KG$20240819$$PH$GB$GB
242229181$24222918$1$I$20240412$20240815$20240819$20240819$EXP$$US-GSK-US2024101857$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$CN$US$US
242229191$24222919$1$I$$20240809$20240819$20240819$PER$$US-ABBVIE-5876023$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242229201$24222920$1$I$20240731$20240812$20240819$20240819$EXP$$CN-ROCHE-10000055479$ROCHE$$68$YR$E$F$Y$55$KG$20240819$$HP$CN$CN
242229213$24222921$3$F$20230407$20240918$20240819$20240926$EXP$$DE-SANDOZ INC.-SDZ2023DE000464$SANDOZ$$$$A$F$Y$66$KG$20240926$$MD$DE$DE
242229221$24222922$1$I$$20240808$20240819$20240819$EXP$$JP-ROCHE-10000008626$ROCHE$$80$YR$E$$Y$$$20240819$$MD$JP$JP
242229231$24222923$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56497$$FDA-CTU$$53$YR$$F$N$$$20240816$N$$US$
242229241$24222924$1$I$$20240816$20240816$20240816$DIR$714659$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242229251$24222925$1$I$$20240816$20240816$20240816$DIR$714698$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242229261$24222926$1$I$20120720$20240816$20240816$20240816$DIR$714668$$FDA-CTU$$21$YR$$F$N$103.95$KG$20240816$N$CN$US$
242229271$24222927$1$I$20240706$20240816$20240816$20240816$DIR$714590$$FDA-CTU$$42$YR$$F$N$69.75$KG$20240816$N$CN$US$
242229281$24222928$1$I$$20240816$20240816$20240816$DIR$714694$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242229301$24222930$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56703$$FDA-CTU$$$$$M$N$$$20240815$N$HP$US$
242229311$24222931$1$I$20240816$20240816$20240816$20240816$DIR$714624$$FDA-CTU$$55$YR$$F$N$82.8$KG$20240816$N$CN$US$
242229331$24222933$1$I$20240816$20240816$20240816$20240816$DIR$714712$$FDA-CTU$$81$YR$$M$N$94.95$KG$20240816$N$HP$US$
242229351$24222935$1$I$$20240816$20240816$20240816$DIR$714700$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242229361$24222936$1$I$20240625$20240816$20240816$20240816$DIR$714655$$FDA-CTU$$55$YR$$F$N$74$KG$20240816$Y$HP$US$
242229391$24222939$1$I$20240815$20240816$20240816$20240816$DIR$714631$$FDA-CTU$$69$YR$$F$N$72.45$KG$20240816$N$CN$US$
242229401$24222940$1$I$$20240816$20240816$20240816$DIR$714667$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242229421$24222942$1$I$20240812$20240816$20240816$20240816$DIR$714656$$FDA-CTU$$42$YR$$F$N$61.65$KG$20240816$N$CN$US$
242229431$24222943$1$I$20240801$20240808$20240819$20240819$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-24744$SAMSUNG BIOEPIS$$$$$$Y$$$20240819$$HP$CA$CA
242229451$24222945$1$I$20240815$20240816$20240816$20240816$DIR$714638$$FDA-CTU$$79$YR$$M$N$$$20240816$N$HP$US$
242229461$24222946$1$I$20240810$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56610$$FDA-CTU$$71$YR$$M$N$$$20240816$N$HP$US$
242229482$24222948$2$F$$20240903$20240819$20240916$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-24794$SAMSUNG BIOEPIS$$84$YR$E$F$Y$$$20240916$$CN$CA$CA
242229532$24222953$2$F$20230504$20240912$20240819$20240919$EXP$FR-AFSSAPS-PO2024000870$FR-Waylis Therapeutics LLC-ATNAHS20240802339$Waylis$$1$DY$N$M$Y$3.415$KG$20240919$$HP$FR$FR
242229541$24222954$1$I$$20240527$20240819$20240819$EXP$$US-GUERBET / LLC-US-20240087$GUERBET$Aly A. Intranodal Lymphangiography and Embolization for Management of Iatrogenic Chylous Ascites after Oncological Surgery. J Vasc Interv Radiol. 2024;35(6): 883-889. doi:https://doi.org/10.1016/j.jvir.2024.02.015.$$$A$$Y$$$20240819$$MD$US$US
242229551$24222955$1$I$20240722$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56608$$FDA-CTU$$74$YR$$M$N$$$20240816$Y$HP$US$
242229561$24222956$1$I$20240806$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56603$$FDA-CTU$$69$YR$$M$N$75.02$KG$20240816$N$HP$US$
242229571$24222957$1$I$20240601$20240815$20240819$20240819$PER$$US-ABBVIE-5882558$ABBVIE$$43$YR$$F$Y$59$KG$20240819$$CN$US$US
242229581$24222958$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129482$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240819$$HP$US$US
242229601$24222960$1$I$20240801$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56605$$FDA-CTU$$78$YR$$F$N$$$20240816$N$HP$US$
242229611$24222961$1$I$20220106$20221103$20240819$20240819$EXP$$DE-SANDOZ INC.-NVSC2022DE065925$SANDOZ$$$$A$F$Y$168$KG$20240819$$HP$DE$DE
242229621$24222962$1$I$$20240814$20240819$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA005984$SANDOZ$$41$YR$$F$Y$$$20240819$$CN$CA$CA
242229631$24222963$1$I$$20240813$20240819$20240819$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-129329$BRISTOL MYERS SQUIBB$Santos J, Almeida MJ, Ribeiro P, Albuquerque I, Almeida J. Poliserosite imunomediada secundaria a inibidores do checkpoint imunologico. Congressos Da Sociedade Portuguesa De Medicina Interna: 30.o Congresso Nacional. 2024;30:692.$50$YR$A$M$Y$$$20240819$$MD$PT$PT
242229642$24222964$2$F$$20240910$20240819$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129490$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$MD$US$US
242229651$24222965$1$I$20240816$20240816$20240816$20240816$DIR$714685$$FDA-CTU$$$$$F$N$$$20240816$$CN$US$
242229661$24222966$1$I$20240815$20240816$20240816$20240816$DIR$714578$$FDA-CTU$$$$$UNK$N$$$20240816$N$CN$US$
242229671$24222967$1$I$20240607$20240816$20240816$20240816$DIR$714707$$FDA-CTU$$$$$UNK$N$$$20240816$N$CN$US$
242229681$24222968$1$I$20240216$20240816$20240816$20240816$DIR$714633$$FDA-CTU$$78$YR$$M$N$84.6$KG$20240816$N$CN$US$
242229691$24222969$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129848$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$99.34$KG$20240819$$CN$US$US
242229701$24222970$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129506$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240819$$MD$US$US
242229711$24222971$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56675$$FDA-CTU$$68$YR$$M$N$$$20240816$N$$US$
242229721$24222972$1$I$20240715$20240816$20240816$20240816$DIR$714649$$FDA-CTU$$61$YR$$F$N$107.1$KG$20240816$N$CN$US$
242229741$24222974$1$I$20240812$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56590$$FDA-CTU$$76$YR$$F$N$$$20240816$Y$HP$US$
242229752$24222975$2$F$$20240816$20240819$20240822$PER$$US-AMGEN-USASP2024164206$AMGEN$$$$$M$Y$$$20240822$$HP$US$US
242229762$24222976$2$F$20240813$20240917$20240819$20240919$PER$$US-AMGEN-USASP2024162040$AMGEN$$88$YR$E$F$Y$$$20240919$$CN$US$US
242229771$24222977$1$I$20240216$20240816$20240816$20240816$DIR$714640$$FDA-CTU$$78$YR$$F$N$84.6$KG$20240816$N$CN$US$
242229792$24222979$2$F$20240101$20240828$20240819$20240906$EXP$$US-INSMED, INC.-2024-02496-US$INSMED$$$$$F$Y$$$20240906$$CN$US$US
242229801$24222980$1$I$20230601$20240809$20240819$20240819$EXP$AT-BASGAGES-2024-005677$AT-TEVA-VS-3233003$TEVA$$74$YR$$F$Y$$$20240819$$PH$AT$AT
242229811$24222981$1$I$20240815$20240816$20240816$20240816$DIR$714580$$FDA-CTU$$$$$UNK$N$$$20240816$N$CN$US$
242229821$24222982$1$I$$20240813$20240819$20240819$EXP$$AU-SANDOZ INC.-SDZ2024AU072763$SANDOZ$Montarello NL, Irvine I, Warner V, Hare J, Kaye D, Cloud GC.. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report. BMC Neurology. 2024;24(1):1-6$51$YR$$F$Y$$$20240819$$HP$AU$AU
242229832$24222983$2$F$20240801$20240906$20240819$20240917$EXP$$US-UCBSA-2024039922$UCB$$71$YR$$M$Y$110$KG$20240917$$CN$US$US
242229841$24222984$1$I$20240529$20240816$20240816$20240816$DIR$714673$$FDA-CTU$$$$$M$N$$$20240816$N$$US$
242229851$24222985$1$I$$20240812$20240819$20240819$PER$$US-ABBVIE-5882235$ABBVIE$$$$$$Y$$$20240819$$HP$US$US
242229861$24222986$1$I$$20240813$20240819$20240819$EXP$$NVSC2024IN090496$NOVARTIS$$$$A$F$Y$$$20240819$$CN$IN$IN
242229871$24222987$1$I$$20240813$20240819$20240819$EXP$$US-MYLANLABS-2024M1031852$MYLAN$$$$$M$Y$88.9$KG$20240819$$MD$US$US
242229881$24222988$1$I$20240101$20240810$20240819$20240819$EXP$$US-NEBO-666339$PHARMACOSMOS$$$$A$F$Y$$$20240819$$HP$US$US
242229891$24222989$1$I$20240807$20240814$20240819$20240819$EXP$$US-BAYER-2024A118078$BAYER$$61$YR$A$F$Y$58.05$KG$20240819$$HP$US$US
242229902$24222990$2$F$20210225$20240916$20240819$20240925$EXP$$CA-CELLTRION INC.-2020CA035368$CELLTRION$$$$$$Y$$$20240925$$CN$CA$CA
242229911$24222991$1$I$$20240809$20240819$20240819$30DAY$$US-GSK-US2024099752$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
242229921$24222992$1$I$$20240812$20240819$20240819$30DAY$$US-GSK-US2024100375$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
242229931$24222993$1$I$$20240812$20240819$20240819$PER$$US-EMD Serono-2024043572$EMD SERONO INC$$41$YR$A$F$Y$$$20240819$$MD$US$US
242229942$24222994$2$F$$20240813$20240819$20240819$PER$$US-JNJFOC-20240831001$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240819$$CN$US$US
242229961$24222996$1$I$$20240813$20240819$20240819$EXP$$FR-MYLANLABS-2024M1075782$MYLAN$$$$$F$Y$$$20240819$$CN$FR$FR
242229971$24222997$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00978$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$66$MON$C$$Y$$$20240819$$HP$TR$TR
242229981$24222998$1$I$$20240606$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004183$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242229991$24222999$1$I$20240605$20240605$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004141$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242230001$24223000$1$I$$20240614$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004240$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230011$24223001$1$I$$20240629$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004371$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230021$24223002$1$I$$20240613$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004432$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230031$24223003$1$I$$20240617$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004491$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230041$24223004$1$I$$20240619$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004625$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230051$24223005$1$I$$20240604$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004146$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230061$24223006$1$I$$20240614$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004190$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230071$24223007$1$I$$20240610$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004278$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230081$24223008$1$I$$20240617$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004385$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230091$24223009$1$I$$20240614$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004461$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230101$24223010$1$I$$20240618$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004537$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230111$24223011$1$I$$20240620$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004629$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230121$24223012$1$I$$20240814$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US073341$SANDOZ$$$$$F$Y$$$20240819$$MD$US$US
242230131$24223013$1$I$$20240604$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004134$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230141$24223014$1$I$$20240610$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004302$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230151$24223015$1$I$$20240604$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004115$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230161$24223016$1$I$$20240611$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004334$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230171$24223017$1$I$20240604$20240604$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004121$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230181$24223018$1$I$20240710$20240809$20240819$20240819$EXP$GB-MHRA-MIDB-aea73cb5-b1d6-48dd-822a-8a1a84b2a87d$GB-TEVA-VS-3232107$TEVA$$68$YR$$$Y$$$20240819$$HP$GB$GB
242230191$24223019$1$I$20240710$20240807$20240819$20240819$EXP$$JP-UCBSA-2024040814$UCB$$3$YR$$M$Y$$$20240819$$PH$JP$JP
242230201$24223020$1$I$20240101$20240620$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004635$BIOCON$$$$$$Y$$$20240819$$HP$US$US
242230211$24223021$1$I$20240620$20240619$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004642$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230221$24223022$1$I$$20240621$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004661$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230231$24223023$1$I$$20240712$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004680$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242230251$24223025$1$I$20240221$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56596$$FDA-CTU$$79$YR$$F$N$73.48$KG$20240816$N$$US$
242230261$24223026$1$I$20230601$20240816$20240816$20240816$DIR$714567$$FDA-CTU$$24$YR$$F$N$90$KG$20240816$N$CN$US$
242230281$24223028$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56577$$FDA-CTU$$$$$M$N$$$20240816$N$HP$US$
242230291$24223029$1$I$20090907$20240816$20240816$20240816$DIR$714615$$FDA-CTU$$39$YR$$M$N$90$KG$20240816$Y$CN$US$
242230301$24223030$1$I$20240515$20240816$20240816$20240816$DIR$714570$$FDA-CTU$$37$YR$$F$N$94.95$KG$20240816$N$CN$US$
242230331$24223033$1$I$20240101$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130411$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$71.8$KG$20240819$$PH$US$US
242230341$24223034$1$I$$20240805$20240819$20240819$EXP$$TR-PURACAP-TR-2024EPCLIT00983$PURACAP$Sevgi Sipahi Cimen.Hypersensitivity to Ibuprofen: Real-Life  Experience in Children with History of  Suspected Immediate Reactions.International Archives of Allergy and Immunology.2023;184:33-42$16$YR$T$$Y$$$20240819$$HP$TR$TR
242230352$24223035$2$F$$20240822$20240819$20240830$EXP$$US-ZENPEP LLC-2024AIMT01224$AIMMUNE$$$$$$Y$$$20240830$$HP$US$US
242230361$24223036$1$I$20240813$20240813$20240819$20240819$PER$$US-JNJFOC-20240833197$JOHNSON AND JOHNSON$$70$YR$E$$Y$$$20240819$$PH$US$US
242230371$24223037$1$I$20240715$20240813$20240819$20240819$EXP$GB-MHRA-MED-202408110913447380-GSJPR$GB-MYLANLABS-2024M1075763$MYLAN$$34$YR$$F$Y$65$KG$20240819$$CN$GB$GB
242230382$24223038$2$F$20240703$20240909$20240819$20240912$EXP$IT-MINISAL02-998218$IT-MYLANLABS-2024M1075261$MYLAN$$91$YR$$M$Y$$$20240912$$MD$IT$IT
242230391$24223039$1$I$$20240813$20240819$20240819$EXP$$GB-MYLANLABS-2024M1057718$MYLAN$$$$$M$Y$$$20240819$$HP$GB$GB
242230402$24223040$2$F$20240716$20240819$20240819$20240822$EXP$$GB-MYLANLABS-2024M1075585$MYLAN$$47$YR$$M$Y$101.05$KG$20240822$$MD$GB$GB
242230411$24223041$1$I$20210719$20240813$20240819$20240819$EXP$$GR-MYLANLABS-2024M1075289$MYLAN$$56$YR$$M$Y$$$20240819$$HP$GR$GR
242230421$24223042$1$I$20230101$20240813$20240819$20240819$EXP$$DE-MYLANLABS-2024M1076608$MYLAN$$77$YR$$M$Y$76$KG$20240819$$MD$DE$DE
242230452$24223045$2$F$20240728$20240813$20240819$20240821$EXP$$IN-VANTIVE-2024VAN018989$Vantive US Healthcare$$64$YR$$M$Y$$$20240821$$CN$IN$IN
242230461$24223046$1$I$20240701$20240805$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003052$ELI LILLY AND CO$$$$$M$Y$$$20240819$$CN$US$US
242230471$24223047$1$I$$20240814$20240819$20240819$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408009215$ELI LILLY AND CO$$$$$$Y$$$20240819$$CN$CN$CN
242230481$24223048$1$I$$20240805$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003017$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240819$$CN$US$US
242230491$24223049$1$I$$20240808$20240819$20240819$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408005745$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$DE$DE
242230501$24223050$1$I$20240721$20240808$20240819$20240819$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408005982$ELI LILLY AND CO$$35$YR$A$M$Y$65$KG$20240819$$CN$CN$CN
242230511$24223051$1$I$20240801$20240808$20240819$20240819$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408008919$ELI LILLY AND CO$$$$$$Y$$$20240819$$CN$JP$JP
242230525$24223052$5$F$$20240918$20240819$20240923$EXP$$PT-ELI_LILLY_AND_COMPANY-PT202408008736$ELI LILLY AND CO$$$$E$$Y$$$20240923$$CN$PT$PT
242230531$24223053$1$I$20240731$20240809$20240819$20240819$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408010543$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240819$$CN$DE$CN
242230541$24223054$1$I$$20240814$20240819$20240819$PER$$US-ABBVIE-5882327$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242230551$24223055$1$I$20240805$20240814$20240814$20240814$DIR$714345$$FDA-CTU$$72$YR$$M$N$70$KG$20240814$N$CN$US$
242230561$24223056$1$I$20240606$20240809$20240819$20240819$EXP$IT-MINISAL02-997272$IT-TEVA-VS-3232951$TEVA$$48$YR$$M$Y$85$KG$20240819$$PH$IT$IT
242230581$24223058$1$I$20240808$20240815$20240819$20240819$EXP$$SA-PFIZER INC-202400237314$PFIZER$$71$YR$$M$Y$$$20240819$$CN$SA$SA
242230591$24223059$1$I$$20240815$20240819$20240819$EXP$$CA-PFIZER INC-202400237511$PFIZER$$68$YR$$F$Y$$$20240819$$HP$CA$CA
242230601$24223060$1$I$20190115$20240814$20240819$20240819$EXP$$ZA-PFIZER INC-202400237539$PFIZER$$56$YR$$F$Y$$$20240819$$MD$ZA$ZA
242230613$24223061$3$F$$20240830$20240819$20240904$EXP$$GB-PFIZER INC-202400237303$PFIZER$$21$MON$$M$Y$$$20240904$$MD$GB$GB
242230631$24223063$1$I$20240806$20240815$20240819$20240819$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004574$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
242230641$24223064$1$I$20240101$20240812$20240819$20240819$PER$$US-JNJFOC-20240830072$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240819$$CN$US$US
242230672$24223067$2$F$$20240821$20240819$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA072242$SANDOZ$$62$YR$$M$Y$$$20240823$$HP$CA$CA
242230684$24223068$4$F$20240418$20240826$20240819$20240907$EXP$$NVSC2024AR087152$NOVARTIS$$56$YR$$F$Y$60$KG$20240907$$CN$AR$AR
242230692$24223069$2$F$$20240821$20240819$20240903$EXP$$ES-GLENMARK PHARMACEUTICALS-2024GMK093281$GLENMARK$Somoza-fernandez B, Escudero-Vilaplana V, Collado-Borrell R, Perez-Ram?rez S, Villanueva-Bueno C, Montero-Anton MDP.. Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient.. Journal of oncology pharmacy practice.. 2024;0(0):1-6$$$$$Y$$$20240903$$HP$ES$ES
242230703$24223070$3$F$20240710$20240911$20240819$20240920$EXP$$US-EXELIXIS-CABO-24079371$EXELIXIS$$59$YR$$M$Y$73.887$KG$20240920$$CN$US$US
242230711$24223071$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130087$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240819$$CN$US$US
242230721$24223072$1$I$20240814$20240814$20240819$20240819$EXP$$DE-BAYER-2024A118342$BAYER$$89$YR$E$M$Y$$$20240819$$CN$DE$DE
242230731$24223073$1$I$$20240808$20240819$20240819$PER$$US-ABBVIE-5876722$ABBVIE$$$$A$F$Y$$$20240819$$MD$US$US
242230741$24223074$1$I$$20240811$20240819$20240819$EXP$$US-AstraZeneca-2024A187200$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242230781$24223078$1$I$$20240812$20240819$20240819$EXP$$US-AstraZeneca-2024A184377$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242230791$24223079$1$I$20240808$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A185687$ASTRAZENECA$$31737$DY$$F$Y$$$20240819$$CN$US$
242230801$24223080$1$I$$20240819$20240819$20240819$EXP$$NVSC2024HK167371$NOVARTIS$$$$$$Y$$$20240819$$MD$HK$HK
242230811$24223081$1$I$20171001$20240813$20240819$20240819$EXP$$PL-SANDOZ INC.-PHHY2018PL079008$SANDOZ$$61$YR$$M$Y$$$20240819$$MD$PL$PL
242230841$24223084$1$I$$20240808$20240819$20240819$EXP$$US-VIVUS, Inc.-2024V1001004$VIVUS$$$$A$F$Y$$$20240814$$CN$US$US
242230852$24223085$2$F$20240101$20240906$20240819$20240918$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-00515$IPSEN$$83$YR$E$F$Y$51$KG$20240918$$CN$US$US
242230861$24223086$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128909$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240819$$CN$US$US
242230871$24223087$1$I$$20240805$20240816$20240816$DIR$FDA-CDER-CTU-2024-56620$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
242230901$24223090$1$I$20211207$20240806$20240819$20240819$EXP$$DE-SANDOZ INC.-NVSC2021DE284220$SANDOZ$$$$E$F$Y$88$KG$20240819$$HP$DE$DE
242230912$24223091$2$F$$20240823$20240819$20240826$EXP$$PL-SANDOZ INC.-PHHY2013PL037727$SANDOZ$$35$YR$$F$Y$$$20240826$$MD$PL$PL
242230921$24223092$1$I$$20240814$20240816$20240816$DIR$FDA-CDER-CTU-2024-56621$$FDA-CTU$$$$$F$N$$$20240814$N$HP$US$
242230932$24223093$2$F$$20240919$20240819$20240919$30DAY$$US-PFIZER INC-202400231503$PFIZER$$14$YR$$M$Y$$$20240919$$CN$US$US
242230941$24223094$1$I$$20240814$20240816$20240816$DIR$FDA-CDER-CTU-2024-56631$$FDA-CTU$$$$$F$N$$$20240814$N$$US$
242230951$24223095$1$I$20240719$20240809$20240819$20240819$EXP$FR-AFSSAPS-NT2024000997$FR-TEVA-VS-3232654$TEVA$$71$YR$$M$Y$$$20240819$$MD$FR$FR
242230961$24223096$1$I$$20240813$20240819$20240819$EXP$$CA-ROCHE-10000056253$ROCHE$$$$$F$Y$$$20240819$$HP$CA$CA
242230981$24223098$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56662$$FDA-CTU$$75$YR$$M$N$$$20240816$N$$US$
242230991$24223099$1$I$$20240814$20240819$20240819$EXP$$NVSC2024EC166535$NOVARTIS$$$$$F$Y$$$20240819$$MD$EC$EC
242231012$24223101$2$F$20240101$20240826$20240819$20240909$EXP$$CA-UCBSA-2024041205$UCB$$$$$F$Y$$$20240909$$CN$CA$CA
242231021$24223102$1$I$$20240812$20240819$20240819$EXP$$CA-APOTEX-2024AP009310$APOTEX$$31$YR$$F$Y$71$KG$20240819$$MD$CA$CA
242231031$24223103$1$I$20220701$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128864$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240819$$HP$US$US
242231041$24223104$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128957$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$80.29$KG$20240819$$CN$US$US
242231051$24223105$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56580$$FDA-CTU$$61$YR$$F$N$$$20240816$N$$US$
242231062$24223106$2$F$20240710$20240828$20240819$20240904$EXP$$JP-ROCHE-10000043787$ROCHE$$6$DEC$A$M$Y$61.8$KG$20240904$$PH$JP$JP
242231071$24223107$1$I$20240802$20240808$20240819$20240819$PER$$US-JNJFOC-20240821297$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240819$$CN$US$US
242231081$24223108$1$I$20240729$20240809$20240819$20240819$EXP$FR-AFSSAPS-MA2024001305$FR-TEVA-VS-3232931$TEVA$$71$YR$$F$Y$$$20240819$$PH$FR$FR
242231091$24223109$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167526$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242231101$24223110$1$I$$20240813$20240819$20240819$EXP$$US-BIOGEN-2024BI01278284$BIOGEN$$$$$M$Y$$$20240819$$MD$US$US
242231111$24223111$1$I$20240627$20240815$20240815$20240815$DIR$714519$$FDA-CTU$$43$YR$$M$N$98.1$KG$20240815$N$HP$US$
242231121$24223112$1$I$20240807$20240813$20240819$20240819$EXP$$IL-SA-2024SA243405$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240819$$MD$IL$IL
242231131$24223113$1$I$$20240814$20240819$20240819$EXP$$CN-PFIZER INC-PV202400105734$PFIZER$$$$E$M$Y$$$20240819$$CN$CN$CN
242231141$24223114$1$I$$20240814$20240819$20240819$EXP$$US-PFIZER INC-202400237213$PFIZER$$17$YR$$F$Y$$$20240819$$CN$US$US
242231152$24223115$2$F$20240701$20240918$20240819$20240923$EXP$$US-PFIZER INC-202400237747$PFIZER$$75$YR$$F$Y$$$20240923$$CN$US$US
242231161$24223116$1$I$20240529$20240814$20240819$20240819$EXP$$CN-PFIZER INC-PV202400106163$PFIZER$$45$YR$$F$Y$69$KG$20240819$$HP$CN$CN
242231171$24223117$1$I$20240703$20240814$20240819$20240819$EXP$$US-PFIZER INC-202400237685$PFIZER$$49$YR$$F$Y$$$20240819$$HP$US$US
242231181$24223118$1$I$$20240815$20240819$20240819$EXP$$CA-PFIZER INC-2021723605$PFIZER$$$$$M$Y$$$20240819$$HP$CA$CA
242231191$24223119$1$I$20230901$20240813$20240819$20240819$EXP$$CA-PFIZER INC-202400034032$PFIZER$$70$YR$$F$Y$138$KG$20240819$$HP$CA$CA
242231201$24223120$1$I$20240501$20240814$20240819$20240819$EXP$$IT-PFIZER INC-PV202400107137$PFIZER$$$$$F$Y$$$20240819$$MD$IT$IT
242231211$24223121$1$I$20240805$20240814$20240819$20240819$EXP$$CN-PFIZER INC-PV202400106142$PFIZER$$55$YR$$F$Y$65$KG$20240819$$HP$CN$CN
242231223$24223122$3$F$20140109$20240903$20240819$20240905$EXP$$US-PFIZER INC-202400237732$PFIZER$$60$YR$$M$Y$$$20240905$$CN$US$US
242231231$24223123$1$I$20240618$20240814$20240819$20240819$EXP$$CN-PFIZER INC-PV202400106138$PFIZER$$70$YR$$F$Y$34$KG$20240819$$HP$CN$CN
242231241$24223124$1$I$$20240815$20240819$20240819$EXP$$CA-PFIZER INC-202400237493$PFIZER$$$$$$Y$$$20240819$$HP$CA$CA
242231251$24223125$1$I$$20240815$20240819$20240819$EXP$$US-PFIZER INC-202400237728$PFIZER$$62$YR$$F$Y$$$20240819$$CN$US$US
242231263$24223126$3$F$20240501$20240915$20240819$20240919$EXP$$ZA-PFIZER INC-PV202400105814$PFIZER$$62$YR$$M$Y$92$KG$20240919$$MD$ZA$ZA
242231271$24223127$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56669$$FDA-CTU$$51$YR$$F$N$72.57$KG$20240816$N$$US$
242231281$24223128$1$I$20240731$20240814$20240819$20240819$EXP$$CN-PFIZER INC-PV202400106081$PFIZER$$14$YR$$F$Y$$$20240819$$HP$CN$CN
242231291$24223129$1$I$$20240813$20240819$20240819$EXP$$ZA-PFIZER INC-202400236398$PFIZER$$65$YR$$F$Y$$$20240819$$MD$ZA$ZA
242231301$24223130$1$I$20240101$20240814$20240819$20240819$EXP$$US-PFIZER INC-202400236678$PFIZER$$68$YR$$M$Y$64.86$KG$20240819$$CN$US$US
242231311$24223131$1$I$$20240813$20240819$20240819$EXP$$CA-PFIZER INC-202300435677$PFIZER$$75$YR$$F$Y$$$20240819$$PH$CA$CA
242231323$24223132$3$F$$20240919$20240819$20240923$EXP$$US-PFIZER INC-PV202400085114$PFIZER$$73$YR$$F$Y$$$20240923$$CN$US$US
242231331$24223133$1$I$20240814$20240815$20240819$20240819$EXP$GB-MHRA-MED-202408151413228720-DPJMV$GB-PFIZER INC-202400237384$PFIZER$$45$YR$$F$Y$$$20240819$$HP$GB$GB
242231351$24223135$1$I$20240809$20240815$20240819$20240819$EXP$GB-MHRA-MED-202408151512346970-MTFSV$GB-PFIZER INC-202400237431$PFIZER$$29$YR$$F$Y$65$KG$20240819$$PH$GB$GB
242231361$24223136$1$I$$20240814$20240819$20240819$EXP$$US-PFIZER INC-202400237727$PFIZER$$66$YR$$F$Y$$$20240819$$HP$US$US
242231371$24223137$1$I$20240401$20240815$20240819$20240819$EXP$$US-PFIZER INC-202400237801$PFIZER$$70$YR$$F$Y$$$20240819$$CN$US$US
242231381$24223138$1$I$$20240815$20240819$20240819$EXP$$CA-ROCHE-10000058635$ROCHE$$$$E$F$Y$$$20240819$$HP$CA$CA
242231391$24223139$1$I$20190617$20240715$20240819$20240819$EXP$SE-MPA-2019-005239$SE-SAMSUNG BIOEPIS-SB-2019-38901$SAMSUNG BIOEPIS$$30$YR$A$F$Y$$$20240819$$MD$SE$SE
242231401$24223140$1$I$20240101$20240809$20240819$20240819$PER$$US-SA-2024SA241034$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240819$$MD$US$US
242231411$24223141$1$I$$20240527$20240819$20240819$EXP$$US-GUERBET / LLC-US-20240090$GUERBET$Intranodal lymphangiography and embolization for management of iatrogenic chylous ascites after oncological surgery. J Vasc Interv Radiol 2024 June; 35(6):883-889.$$$A$$Y$$$20240819$$MD$US$US
242231421$24223142$1$I$$20240527$20240819$20240819$EXP$$US-GUERBET / LLC-US-20240089$GUERBET$Intranodal Lymphangiography and Embolization for Management of Iatrogenic Chylous Ascites after Oncological Surgery. J Vasc Interv Radiol 2024 June; 35(6): 883-889.$$$A$$Y$$$20240819$$MD$US$US
242231431$24223143$1$I$20160101$20240813$20240819$20240819$EXP$$US-INCYTE CORPORATION-2024IN008492$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242231441$24223144$1$I$20240729$20240729$20240819$20240819$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-23568$SAMSUNG BIOEPIS$$51$YR$A$M$Y$$$20240819$$HP$CA$CA
242231451$24223145$1$I$$20240812$20240819$20240819$EXP$$GB-MYLANLABS-2024M1075951$MYLAN$$$$$M$Y$$$20240819$$CN$GB$GB
242231462$24223146$2$F$$20240920$20240819$20240925$EXP$$GB-MYLANLABS-2024M1075981$MYLAN$$$$$F$Y$$$20240925$$MD$GB$GB
242231472$24223147$2$F$20240501$20240820$20240819$20240826$EXP$$GB-MYLANLABS-2024M1076001$MYLAN$$$$$M$Y$$$20240826$$PH$GB$GB
242231481$24223148$1$I$20240528$20240812$20240819$20240819$EXP$ES-AEMPS-1557508$ES-MYLANLABS-2024M1075013$MYLAN$$87$YR$$F$Y$82$KG$20240819$$HP$ES$ES
242231491$24223149$1$I$20240703$20240812$20240819$20240819$EXP$FR-AFSSAPS-PA2024001448$FR-MYLANLABS-2024M1074990$MYLAN$$16$YR$$F$Y$$$20240819$$CN$FR$FR
242231501$24223150$1$I$20240705$20240812$20240819$20240819$EXP$FR-AFSSAPS-PB2024000857$FR-MYLANLABS-2024M1074974$MYLAN$$77$YR$$M$Y$$$20240819$$PH$FR$FR
242231511$24223151$1$I$20240201$20240812$20240819$20240819$EXP$FR-AFSSAPS-PO2024000889$FR-MYLANLABS-2024M1075137$MYLAN$$21$YR$$M$Y$$$20240819$$MD$FR$FR
242231521$24223152$1$I$20240723$20240812$20240819$20240819$EXP$FR-AFSSAPS-LM2024000441$FR-MYLANLABS-2024M1074949$MYLAN$$58$YR$$M$Y$115$KG$20240819$$MD$FR$FR
242231531$24223153$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56588$$FDA-CTU$$78$YR$$F$N$$$20240816$N$$US$
242231541$24223154$1$I$20230130$20240812$20240819$20240819$EXP$$KR-MYLANLABS-2024M1076401$MYLAN$$81$YR$$M$Y$$$20240819$$HP$KR$KR
242231551$24223155$1$I$$20240812$20240819$20240819$EXP$$GB-MYLANLABS-2024M1075994$MYLAN$$$$$M$Y$$$20240819$$PH$GB$GB
242231561$24223156$1$I$20231006$20240812$20240819$20240819$EXP$$KR-MYLANLABS-2024M1075903$MYLAN$$$$A$F$Y$$$20240819$$PH$KR$KR
242231571$24223157$1$I$$20240812$20240819$20240819$EXP$$IT-MYLANLABS-2024M1075280$MYLAN$Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G et al.. Stevens-Johnson syndrome associated with drugs and vaccines in children: a case-control study. Plos One.. 2013;8(7):1-8$33$MON$$F$Y$$$20240819$$HP$IT$IT
242231591$24223159$1$I$$20240812$20240819$20240819$EXP$$GB-MYLANLABS-2024M1075993$MYLAN$$$$$F$Y$$$20240819$$PH$GB$GB
242231601$24223160$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129020$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240819$$CN$US$US
242231611$24223161$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130492$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240819$$HP$US$US
242231621$24223162$1$I$$20240815$20240819$20240819$EXP$$GB-ROCHE-10000059594$ROCHE$$$$E$F$Y$$$20240819$$CN$GB$GB
242231631$24223163$1$I$20240618$20240812$20240819$20240819$EXP$$GB-MYLANLABS-2024M1075169$MYLAN$$72$YR$$M$Y$85$KG$20240819$$MD$GB$GB
242231641$24223164$1$I$$20240814$20240819$20240819$EXP$$US-SA-2024SA243853$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240819$$MD$US$US
242231651$24223165$1$I$$20240812$20240819$20240819$EXP$$US-AstraZeneca-2024A184628$ASTRAZENECA$$$$$M$Y$$$20240819$$HP$US$
242231661$24223166$1$I$$20240811$20240819$20240819$EXP$$GB-JNJFOC-20240835120$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240819$$HP$GB$GB
242231671$24223167$1$I$20240101$20240814$20240819$20240819$EXP$$US-JNJFOC-20240842091$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240819$$CN$US$US
242231681$24223168$1$I$20240809$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56589$$FDA-CTU$$84$YR$$M$N$$$20240816$N$HP$US$
242231691$24223169$1$I$20231018$20240814$20240819$20240819$EXP$$IT-AstraZeneca-2024A185237$ASTRAZENECA$$67$YR$$M$Y$95$KG$20240819$$MD$IT$
242231701$24223170$1$I$20240601$20240813$20240819$20240819$PER$$US-BAYER-2024A117587$BAYER$$49$YR$A$F$Y$$$20240819$$MD$US$US
242231731$24223173$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167514$NOVARTIS$$$$$F$Y$$$20240819$$HP$US$US
242231741$24223174$1$I$20240617$20240813$20240819$20240819$EXP$$US-MYLANLABS-2024M1076494$MYLAN$$33$YR$$F$Y$$$20240819$$MD$US$US
242231752$24223175$2$F$$20240922$20240819$20240926$EXP$$GB-MYLANLABS-2024M1072178$MYLAN$$$$$F$Y$$$20240926$$PH$GB$GB
242231761$24223176$1$I$$20240814$20240819$20240819$EXP$$IT-MYLANLABS-2024M1076643$MYLAN$G. Capano. Schizophrenia and drug use: a case report.. Italian Journal of psychiatry.. 2024;10:S-10$20$YR$$M$Y$$$20240819$$MD$IT$IT
242231771$24223177$1$I$$20240814$20240819$20240819$EXP$$PL-MYLANLABS-2024M1075870$MYLAN$Maciej S, Hanna A-B, Letachowicz K, Dorota K, Miroslaw B, Oktawia M, et al.. Severe Bullous Erysipelas/Cellulitis, Atypically Caused by Escherichia coli, in Kidney Transplant Recipient - Case Report and Review of Literature.. Transplant-Proc. 2024;56 (4):976-980$57$YR$$F$Y$$$20240819$$HP$PL$PL
242231781$24223178$1$I$$20240814$20240819$20240819$EXP$$GB-MYLANLABS-2024M1076182$MYLAN$$$$$M$Y$$$20240819$$PH$GB$GB
242231791$24223179$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56592$$FDA-CTU$$63$YR$$M$N$$$20240816$N$$US$
242231801$24223180$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56680$$FDA-CTU$$50$YR$$F$N$73.94$KG$20240816$N$$US$
242231811$24223181$1$I$$20240814$20240819$20240819$EXP$GB-MHRA-MED-202408140755121390-FBGNK$GB-MYLANLABS-2024M1076000$MYLAN$$40$YR$$F$Y$$$20240819$$CN$GB$GB
242231824$24223182$4$F$$20240823$20240819$20240828$EXP$$GB-MYLANLABS-2024M1076024$MYLAN$$$$$M$Y$$$20240828$$PH$GB$GB
242231831$24223183$1$I$20240815$20240816$20240816$20240816$DIR$714568$$FDA-CTU$$24$YR$$M$N$105.75$KG$20240816$N$CN$US$
242231841$24223184$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56593$$FDA-CTU$$16$YR$$F$N$86.18$KG$20240816$N$$US$
242231851$24223185$1$I$20240730$20240814$20240819$20240819$EXP$FR-AFSSAPS-RS2024000795$FR-MYLANLABS-2024M1075728$MYLAN$$74$YR$$F$Y$70$KG$20240819$$PH$FR$FR
242231862$24223186$2$F$$20240912$20240819$20240917$30DAY$$IL-PFIZER INC-PV202400105824$PFIZER$$11$YR$$F$Y$$$20240917$$HP$IL$IL
242231872$24223187$2$F$$20240925$20240819$20240930$30DAY$$DE-PFIZER INC-202400232863$PFIZER$$$$$F$Y$$$20240930$$HP$DE$DE
242231881$24223188$1$I$20240716$20240812$20240819$20240819$EXP$$US-Vifor (International) Inc.-VIT-2024-07250$VIFOR$$42$YR$$F$Y$62.8$KG$20240819$$HP$US$US
242231891$24223189$1$I$20240719$20240812$20240819$20240819$EXP$$US-Vifor (International) Inc.-VIT-2024-07251$VIFOR$$24$YR$$M$Y$82$KG$20240819$$HP$US$US
242231901$24223190$1$I$$20240814$20240819$20240819$EXP$$US-TAKEDA-2024TUS082103$TAKEDA$$$$$M$Y$$$20240819$$MD$US$US
242231911$24223191$1$I$$20240809$20240819$20240819$EXP$$CA-TEVA-VS-3232644$TEVA$$29$YR$$F$Y$55$KG$20240819$$CN$CA$CA
242231921$24223192$1$I$20240805$20240815$20240819$20240819$EXP$$US-BAYER-2024A118552$BAYER$$86$YR$E$M$Y$$$20240819$$HP$US$US
242231931$24223193$1$I$$20240807$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128409$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240819$$CN$US$US
242231953$24223195$3$F$20240809$20240910$20240819$20240917$EXP$$NVSC2024DE166513$NOVARTIS$$$$A$M$Y$86$KG$20240918$$HP$DE$DE
242231961$24223196$1$I$$20240809$20240819$20240819$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024099768$VIIV$$$$$$Y$$$20240819$$HP$US$US
242231971$24223197$1$I$20240801$20240809$20240819$20240819$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16048$IPSEN$$64$YR$A$F$Y$$$20240819$$HP$US$US
242231981$24223198$1$I$20240801$20240811$20240819$20240819$PER$$US-SA-2024SA241067$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240819$$CN$US$US
242231991$24223199$1$I$20240810$20240810$20240819$20240819$EXP$GB-MHRA-MED-202408101738409260-WRPDM$GB-BAXTER-2024BAX023068$BAXTER$$47$YR$$F$Y$$$20240819$$PH$GB$GB
242232001$24223200$1$I$20240701$20240809$20240819$20240819$EXP$CN-NMPACDR-8201011013184202400429$CN-BAXTER-2024BAX023148$BAXTER$$70$YR$$F$Y$56$KG$20240819$$MD$CN$CN
242232012$24223201$2$F$20240527$20240902$20240819$20240912$EXP$FR-AFSSAPS-TO2024001499$FR-BAXTER-2024BAX022975$BAXTER$$72$YR$$F$Y$61$KG$20240912$$HP$FR$FR
242232021$24223202$1$I$20240701$20240809$20240819$20240819$EXP$CH-SM-2024-14541$CH-BAXTER-2024BAX022978$BAXTER$$60$YR$$F$Y$$$20240819$$HP$CH$CH
242232031$24223203$1$I$20190101$20240808$20240819$20240819$EXP$$CH-BIOGEN-2024BI01277930$BIOGEN$$$$$$Y$$$20240819$$MD$CH$CH
242232041$24223204$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000058734$ROCHE$$$$$$Y$$$20240819$$PH$US$US
242232052$24223205$2$F$$20240911$20240819$20240918$PER$$US-RDY-SPO/USA/24/0011599$DR REDDYS$$50$YR$A$F$Y$$$20240918$$MD$US$US
242232061$24223206$1$I$$20240808$20240819$20240819$EXP$$US-RDY-LIT/USA/24/0011712$DR REDDYS$Essink J, Niebur H. DELAYED DIAGNOSIS OF COMMON VARIABLE IMMUNODEFICIENCY AND IMPORTANCE OF MULTI-SPECIALTY COLLABORATION. Annals of Allergy, Asthma and Immunology. 2023 Nov;131(5): S158-S159. doi:10.1016/j.anai.2023.08.486.$17$YR$T$M$Y$$$20240819$$HP$US$US
242232071$24223207$1$I$20240801$20240813$20240819$20240819$EXP$IT-MINISAL02-998460$IT-MYLANLABS-2024M1075179$MYLAN$$44$YR$$F$Y$$$20240819$$MD$IT$IT
242232081$24223208$1$I$$20240814$20240819$20240819$PER$$US-ROCHE-10000060118$ROCHE$$$$$$Y$$$20240819$$HP$US$US
242232091$24223209$1$I$20240101$20240718$20240819$20240819$PER$$US-Eisai-EC-2024-170663$EISAI$$71$YR$E$F$Y$$$20240819$$CN$US$US
242232101$24223210$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130194$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240819$$HP$US$US
242232112$24223211$2$F$$20240905$20240819$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129738$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240909$$CN$US$US
242232121$24223212$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128295$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240819$$HP$US$US
242232131$24223213$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130773$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240819$$CN$US$US
242232141$24223214$1$I$$20240812$20240819$20240819$PER$$US-009507513-2408USA004379$MERCK$$41$YR$$F$Y$$$20240819$$CN$US$US
242232151$24223215$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130090$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240819$$CN$US$US
242232161$24223216$1$I$$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56683$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242232181$24223218$1$I$20240812$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56697$$FDA-CTU$$69$YR$$M$N$$$20240816$N$HP$US$
242232191$24223219$1$I$20240701$20240815$20240816$20240816$DIR$FDA-CDER-CTU-2024-56714$$FDA-CTU$$74$YR$$F$N$$$20240815$N$HP$US$
242232221$24223222$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56721$$FDA-CTU$$$$$F$N$$$20240816$Y$PH$US$
242232231$24223223$1$I$$20240807$20240819$20240819$EXP$$US-UCBSA-2024040037$UCB$$$$$F$Y$$$20240819$$CN$US$US
242232241$24223224$1$I$$20240805$20240819$20240819$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07480$HIKMA$Zouridis S, Oo YH, Syn W-K. Zouridis S, Oo YH, Syn W-K. Role of Sirolimus and Rituximab in the Treatment of Autoimmune Hepatitis. ACG Case Reports Journal. 2024;11(7)$23$YR$$F$Y$$$20240819$$MD$US$US
242232251$24223225$1$I$20240730$20240812$20240819$20240819$EXP$$CA-SA-2024SA228433$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240819$$MD$CA$CA
242232261$24223226$1$I$$20240812$20240819$20240819$EXP$$US-GILEAD-2024-0684032$GILEAD$$$$A$M$Y$$$20240819$$CN$US$US
242232271$24223227$1$I$$20240813$20240819$20240819$EXP$$GB-MYLANLABS-2024M1075966$MYLAN$$$$$M$Y$$$20240819$$CN$GB$GB
242232281$24223228$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000059386$ROCHE$$51$YR$A$F$Y$$$20240819$$MD$US$US
242232301$24223230$1$I$$20240813$20240819$20240819$EXP$$US-SA-2024SA170296$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240819$$MD$US$US
242232311$24223231$1$I$20240701$20240813$20240819$20240819$PER$$US-SA-2024SA242747$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240819$$MD$US$US
242232321$24223232$1$I$20240101$20240813$20240819$20240819$PER$$US-SA-2024SA242726$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240819$$HP$US$US
242232331$24223233$1$I$$20240812$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US072777$SANDOZ$Dao, Kevin T, Ghadiya, Kishan, Inga Jaco, Elias, Sharma, Rupam, Rahimi, Roshun, Sukkar, Marah, Adebayo, Moujin, Bhandohal, Janpreet, Dhillon, Harmanjeet, Joolhar, Fowrooz. A Case of Revelation Due to Pegfilgrastim. 2024$68$YR$$M$Y$$$20240819$$HP$US$US
242232341$24223234$1$I$$20240813$20240819$20240819$PER$$US-SA-2024SA242777$SANOFI AVENTIS$$$$$M$Y$$$20240819$$CN$US$US
242232351$24223235$1$I$$20240806$20240819$20240819$EXP$$US-CIPLA LTD.-2024US08699$CIPLA$Vasireddy R, Bilalaga MM, Iding J, Sankineni A.. Challenges in diagnosis: Primary hepatic lymphoma presenting as a space-occupying liver lesion. ACG CASE REPORTS JOURNAL. 2024;11(7):e01443:1 to 3$$$$$Y$$$20240819$$MD$US$US
242232361$24223236$1$I$20240201$20240808$20240819$20240819$PER$$US-SA-2024SA243354$SANOFI AVENTIS$$55$YR$A$M$Y$113$KG$20240819$$MD$US$US
242232371$24223237$1$I$$20240806$20240819$20240819$EXP$$US-HLS-202400737$HLS THERAPEUTICS$$$$E$F$Y$$$20240819$$MD$US$US
242232381$24223238$1$I$20240811$20240816$20240819$20240819$EXP$$US-GILEAD-2024-0684533$GILEAD$$73$YR$E$F$Y$$$20240819$$CN$US$US
242232391$24223239$1$I$$20240814$20240819$20240819$PER$$US-LEO Pharma-372798$LEO PHARM$$64$YR$$F$Y$$$20240819$$PH$US$US
242232401$24223240$1$I$$20220606$20240819$20240819$EXP$$US-AstraZeneca-2022A215003$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242232411$24223241$1$I$$20220927$20240819$20240819$EXP$$ZA-AstraZeneca-2022A333234$ASTRAZENECA$$50$YR$$F$Y$$$20240819$$CN$ZA$
242232421$24223242$1$I$20240710$20240813$20240819$20240819$EXP$$GB-AstraZeneca-2024A184337$ASTRAZENECA$$42$YR$$F$Y$58$KG$20240819$$MD$GB$
242232431$24223243$1$I$20230504$20230705$20240819$20240819$EXP$$CA-AstraZeneca-2023A124521$ASTRAZENECA$$26796$DY$$M$Y$$$20240819$$HP$CA$
242232441$24223244$1$I$$20230310$20240819$20240819$EXP$$US-AstraZeneca-2023A060910$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242232451$24223245$1$I$20240606$20240809$20240819$20240819$EXP$FR-AFSSAPS-NC2024000941$FR-009507513-2408FRA003602$MERCK$$66$YR$$F$Y$61.4$KG$20240819$$PH$FR$FR
242232461$24223246$1$I$20240701$20240812$20240819$20240819$EXP$$NVSC2024CN165466$NOVARTIS$$49$YR$$M$Y$$$20240819$$HP$CN$CN
242232471$24223247$1$I$$20240814$20240819$20240819$EXP$$NVSC2024IN166904$NOVARTIS$Gupta D, Singh L, Kumar S, Singh K, Mendonca S, Chatterjee T.. Rare complications of heart transplant: Autopsy findings.. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY. 2024;67(3):624-7$33$YR$$M$Y$$$20240819$$HP$IN$IN
242232481$24223248$1$I$$20240808$20240819$20240819$PER$$US-APOTEX-2024AP009336$APOTEX$Garg M, Lam P, Gupta R, Sheikh F, Rodrigo ME.. Benign Presentation Of A Fatal Infection In Heart Transplant Patient. Journal of Cardiac Failure. 2024;30 (1):250$62$YR$$M$Y$$$20240819$$HP$US$US
242232492$24223249$2$F$20240720$20240823$20240819$20240826$EXP$GB-MHRA-MED-202408151632358990-NFQWS$GB-MYLANLABS-2024M1076466$MYLAN$$$$$F$Y$$$20240826$$MD$GB$GB
242232501$24223250$1$I$$20240805$20240819$20240819$EXP$$DE-UCBSA-2024039571$UCB$$$$$F$Y$$$20240819$$PH$DE$DE
242232511$24223251$1$I$20240101$20240809$20240819$20240819$EXP$$GB-TEVA-VS-3233779$TEVA$$54$YR$$F$Y$$$20240819$$CN$GB$GB
242232521$24223252$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130462$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240819$$CN$US$US
242232531$24223253$1$I$$20240814$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129171$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240819$$CN$US$US
242232541$24223254$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130647$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$53.98$KG$20240819$$CN$US$US
242232551$24223255$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130210$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240819$$PH$US$US
242232561$24223256$1$I$20240716$20240815$20240819$20240819$PER$$US-AMGEN-USASP2024163221$AMGEN$$70$YR$E$F$Y$$$20240819$$CN$US$US
242232571$24223257$1$I$20210301$20240814$20240819$20240819$EXP$$CO-UCBSA-2024041614$UCB$$67$YR$$F$Y$$$20240819$$CN$CO$CO
242232581$24223258$1$I$20231207$20240815$20240819$20240819$EXP$GB-MHRA-MED-202408151451326480-SWHGZ$GB-MYLANLABS-2024M1076193$MYLAN$$36$YR$$M$Y$80$KG$20240819$$CN$GB$GB
242232591$24223259$1$I$20240401$20240814$20240819$20240819$EXP$$US-ABBVIE-5881981$ABBVIE$$68$YR$$F$Y$$$20240819$$CN$US$US
242232601$24223260$1$I$$20240813$20240819$20240819$PER$$US-SA-2024SA243056$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240819$$CN$US$US
242232611$24223261$1$I$$20240815$20240819$20240819$EXP$HR-EMA-DD-20240808-7482707-074726$HR-MYLANLABS-2024M1076154$MYLAN$$73$YR$$M$Y$$$20240819$$HP$HR$HR
242232622$24223262$2$F$20230704$20240912$20240819$20240922$EXP$$JP-ROCHE-10000058290$ROCHE$$75$YR$E$M$Y$$$20240922$$MD$JP$JP
242232633$24223263$3$F$$20240821$20240819$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408009975$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240823$$CN$US$US
242232641$24223264$1$I$$20240809$20240819$20240819$EXP$$NVSC2024US162954$NOVARTIS$$$$$$Y$$$20240819$$CN$US$US
242232651$24223265$1$I$$20240816$20240819$20240819$EXP$$AU-SANDOZ INC.-SDZ2024AU073214$SANDOZ$$$$$$Y$$$20240819$$HP$AU$AU
242232661$24223266$1$I$$20240814$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US072986$SANDOZ$$$$$F$Y$$$20240819$$CN$US$US
242232671$24223267$1$I$20220101$20240816$20240816$20240816$DIR$714563$$FDA-CTU$$55$YR$$F$N$67$KG$20240816$N$CN$FR$
242232681$24223268$1$I$20220904$20240816$20240816$20240816$DIR$714625$$FDA-CTU$$31$YR$$M$N$65.25$KG$20240816$N$CN$US$
242232691$24223269$1$I$$20240807$20240819$20240819$PER$$US-ABBVIE-5876061$ABBVIE$$$$$$Y$$$20240819$$MD$US$US
242232701$24223270$1$I$20240815$20240816$20240816$20240816$DIR$714623$$FDA-CTU$$76$YR$$M$N$$$20240816$N$PH$US$
242232711$24223271$1$I$$20240802$20240816$20240816$DIR$FDA-CDER-CTU-2024-56723$$FDA-CTU$$72$YR$$F$N$63.96$KG$20240802$N$CN$US$
242232721$24223272$1$I$20240601$20240815$20240819$20240819$EXP$$FR-MYLANLABS-2024M1055061$MYLAN$$$$E$M$Y$171$KG$20240819$$MD$FR$FR
242232751$24223275$1$I$$20240813$20240819$20240819$EXP$$JP-PFIZER INC-202400237341$PFIZER$Ohba, A.. Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial. Journal of Clinical Oncology. 2024;JCO2302010$$$$$Y$$$20240819$$MD$JP$JP
242232761$24223276$1$I$$20240812$20240819$20240819$EXP$$DE-PFIZER INC-2018SGN00387$PFIZER$Behle, V.. Sezary syndrome with nodal CD30-positive manifestation treated with brentuximab vedotin and extracorporeal photopheresis. Acta Dermato-Venereologica. 2017;97(8):973-975$77$YR$$M$Y$$$20240819$$HP$DE$DE
242232774$24223277$4$F$20240718$20240827$20240819$20240830$EXP$FR-AFSSAPS-SE2024000619$FR-PFIZER INC-202400229881$PFIZER$$51$YR$$F$Y$82$KG$20240830$$MD$FR$FR
242232791$24223279$1$I$$20240813$20240819$20240819$EXP$$JP-PFIZER INC-PV202400106494$PFIZER$Ohba, A.. Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial. Journal of Clinical Oncology. 2024;JCO2302010$$$$$Y$$$20240819$$MD$JP$JP
242232832$24223283$2$F$$20240816$20240819$20240821$EXP$$US-PFIZER INC-202400237698$PFIZER$Dao, K.. A case of revelation due to pegfilgrastim. Cureus. 2024;16(7):10.7759/cureus.63777$68$YR$$M$Y$$$20240821$$MD$US$US
242232841$24223284$1$I$$20240807$20240819$20240819$EXP$CA-MHPD-E2B_07170966$CA-Accord-440612$ACCORD$$27$YR$A$F$Y$$$20240819$$CN$CA$CA
242232851$24223285$1$I$$20230815$20240819$20240819$PER$$US-ANIPHARMA-2023-US-025224$ANI$$$$$F$Y$$$20240819$$HP$US$US
242232861$24223286$1$I$$20230825$20240819$20240819$PER$$US-ANIPHARMA-2023-US-026885$ANI$$$$$UNK$Y$$$20240819$$MD$US$US
242232871$24223287$1$I$20221001$20230907$20240819$20240819$PER$$US-ANIPHARMA-2023-US-028659$ANI$$$$$F$Y$56.7$KG$20240819$$CN$US$US
242232881$24223288$1$I$20231001$20231108$20240819$20240819$PER$$US-ANIPHARMA-2023-US-037671$ANI$$$$$F$Y$$$20240819$$CN$US$US
242232891$24223289$1$I$$20230829$20240819$20240819$PER$$US-ANIPHARMA-2023-US-027163$ANI$$$$$F$Y$$$20240819$$HP$US$US
242232901$24223290$1$I$$20230831$20240819$20240819$PER$$US-ANIPHARMA-2023-US-027573$ANI$$$$$F$Y$$$20240819$$CN$US$US
242232911$24223291$1$I$$20231004$20240819$20240819$PER$$US-ANIPHARMA-2023-US-032485$ANI$$57$YR$$F$Y$$$20240819$$HP$US$US
242232921$24223292$1$I$$20231005$20240819$20240819$PER$$US-ANIPHARMA-2023-US-032635$ANI$$$$$F$Y$$$20240819$$PH$US$US
242232931$24223293$1$I$$20230928$20240819$20240819$PER$$US-ANIPHARMA-2023-US-031641$ANI$$$$$UNK$Y$$$20240819$$CN$US$US
242232941$24223294$1$I$$20231002$20240819$20240819$PER$$US-ANIPHARMA-2023-US-032263$ANI$$66$YR$$F$Y$$$20240819$$CN$US$US
242232951$24223295$1$I$20231107$20231115$20240819$20240819$PER$$US-ANIPHARMA-2023-US-038661$ANI$$$$$F$Y$$$20240819$$CN$US$US
242232961$24223296$1$I$20190901$20231121$20240819$20240819$PER$$US-ANIPHARMA-2023-US-039571$ANI$$72$YR$$F$Y$104.33$KG$20240819$$CN$US$US
242232971$24223297$1$I$20230724$20231214$20240819$20240819$PER$$US-ANIPHARMA-2023-US-042865$ANI$$78$YR$$F$Y$55.34$KG$20240819$$PH$US$US
242232981$24223298$1$I$$20231213$20240819$20240819$PER$$US-ANIPHARMA-2023-US-042996$ANI$$51$YR$$F$Y$$$20240819$$HP$US$US
242232991$24223299$1$I$20231022$20231218$20240819$20240819$PER$$US-ANIPHARMA-2023-US-043539$ANI$$$$$UNK$Y$$$20240819$$HP$US$US
242233001$24223300$1$I$20231208$20231219$20240819$20240819$PER$$US-ANIPHARMA-2023-US-043684$ANI$$$$$UNK$Y$$$20240819$$CN$US$US
242233011$24223301$1$I$20230808$20231219$20240819$20240819$PER$$US-ANIPHARMA-2023-US-043836$ANI$$70$YR$$F$Y$$$20240819$$CN$US$US
242233021$24223302$1$I$$20240103$20240819$20240819$PER$$US-ANIPHARMA-2024-US-000472$ANI$$50$YR$$F$Y$$$20240819$$CN$US$US
242233031$24223303$1$I$$20240125$20240819$20240819$PER$$US-ANIPHARMA-2024-US-005139$ANI$$$$$F$Y$$$20240819$$CN$US$US
242233041$24223304$1$I$$20240206$20240819$20240819$PER$$US-ANIPHARMA-2024-US-007652$ANI$$$$$F$Y$$$20240819$$CN$US$US
242233051$24223305$1$I$$20240320$20240819$20240819$PER$$US-ANIPHARMA-2024-US-017159$ANI$$$$$UNK$Y$$$20240819$$HP$US$US
242233061$24223306$1$I$$20240404$20240819$20240819$PER$$US-ANIPHARMA-2024-US-020154$ANI$$71$YR$$F$Y$77.11$KG$20240819$$HP$US$US
242233071$24223307$1$I$20240504$20240517$20240819$20240819$PER$$US-ANIPHARMA-2024-US-026219$ANI$$56$YR$$F$Y$57.61$KG$20240819$$CN$US$US
242233081$24223308$1$I$$20240514$20240819$20240819$PER$$US-ANIPHARMA-2024-US-028168$ANI$$$$$UNK$Y$$$20240819$$HP$US$US
242233091$24223309$1$I$20240419$20240523$20240819$20240819$PER$$US-ANIPHARMA-2024-US-029764$ANI$$85$YR$$F$Y$59.87$KG$20240819$$CN$US$US
242233101$24223310$1$I$$20240613$20240819$20240819$PER$$US-ANIPHARMA-2024-US-033812$ANI$$$$$F$Y$75.75$KG$20240819$$CN$US$US
242233111$24223311$1$I$$20240614$20240819$20240819$PER$$US-ANIPHARMA-2024-US-033882$ANI$$$$$F$Y$$$20240819$$CN$US$US
242233121$24223312$1$I$20230101$20240618$20240819$20240819$PER$$US-ANIPHARMA-2024-US-034310$ANI$$$$$F$Y$$$20240819$$CN$US$US
242233131$24223313$1$I$$20231017$20240819$20240819$PER$$US-ANIPHARMA-2023-US-034345$ANI$$$$$F$Y$$$20240819$$CN$US$US
242233141$24223314$1$I$$20231025$20240819$20240819$PER$$US-ANIPHARMA-2023-US-035620$ANI$$$$$UNK$Y$$$20240819$$CN$US$US
242233151$24223315$1$I$$20240617$20240819$20240819$PER$$US-ANIPHARMA-2024-US-034419$ANI$$$$$F$Y$59.9$KG$20240819$$CN$US$US
242233161$24223316$1$I$20240612$20240701$20240819$20240819$PER$$US-ANIPHARMA-2024-US-036481$ANI$$$$$UNK$Y$$$20240819$$CN$US$US
242233171$24223317$1$I$$20240702$20240819$20240819$PER$$US-ANIPHARMA-2024-US-036579$ANI$$56$YR$$F$Y$$$20240819$$CN$US$US
242233181$24223318$1$I$$20240702$20240819$20240819$PER$$US-ANIPHARMA-2024-US-036763$ANI$$$$$F$Y$$$20240819$$CN$US$US
242233191$24223319$1$I$20240701$20240708$20240819$20240819$PER$$US-ANIPHARMA-2024-US-038033$ANI$$61$YR$$F$Y$$$20240819$$CN$US$US
242233201$24223320$1$I$$20240724$20240819$20240819$PER$$US-ANIPHARMA-2024-US-040426$ANI$$$$$F$Y$$$20240819$$HP$US$US
242233211$24223321$1$I$$20240816$20240819$20240819$EXP$$US-BAUSCH-BL-2024-012499$BAUSCH AND LOMB$$57$YR$$$Y$$$20240819$$CN$US$US
242233221$24223322$1$I$20180101$20240808$20240819$20240819$EXP$$CH-BIOGEN-2024BI01277924$BIOGEN$$$$$$Y$$$20240819$$MD$CH$CH
242233231$24223323$1$I$20220301$20240423$20240819$20240819$PER$$US-ANIPHARMA-2024-US-023888$ANI$$74$YR$$F$Y$$$20240819$$PH$US$US
242233242$24223324$2$F$20240813$20240829$20240819$20240830$EXP$$MA-PFIZER INC-PV202400106529$PFIZER$$$$$F$Y$$$20240830$$CN$MA$MA
242233252$24223325$2$F$20231101$20240905$20240819$20240906$EXP$$US-PFIZER INC-202400238468$PFIZER$$41$YR$$F$Y$$$20240906$$HP$US$US
242233261$24223326$1$I$$20240723$20240819$20240819$PER$$US-ANIPHARMA-2024-US-040099$ANI$$$$$F$Y$82.1$KG$20240819$$CN$US$US
242233271$24223327$1$I$20220518$20240813$20240819$20240819$EXP$$PL-GILEAD-2024-0683997$GILEAD$$$$A$M$Y$$$20240819$$HP$PL$PL
242233282$24223328$2$F$20240730$20240920$20240819$20240926$EXP$$DE-PFIZER INC-202400236229$PFIZER$$61$YR$$F$Y$58.8$KG$20240926$$MD$DE$DE
242233291$24223329$1$I$20240723$20240806$20240819$20240819$EXP$$IT-BAUSCH-BL-2024-012456$BAUSCH AND LOMB$$84$YR$$M$Y$$$20240819$$PH$IT$IT
242233301$24223330$1$I$20240227$20240321$20240819$20240819$PER$$US-ANIPHARMA-2024-US-017924$ANI$$58$YR$$F$Y$72.6$KG$20240819$$CN$US$US
242233311$24223331$1$I$20240803$20240816$20240819$20240819$EXP$$US-PFIZER INC-202400238535$PFIZER$$32$YR$$F$Y$$$20240819$$CN$US$US
242233321$24223332$1$I$$20230815$20240819$20240819$PER$$US-ANIPHARMA-2023-US-025286$ANI$$80$YR$$F$Y$$$20240819$$PH$US$US
242233331$24223333$1$I$20201108$20240813$20240819$20240819$EXP$$FI-PFIZER INC-202400235366$PFIZER$$60$YR$$F$Y$$$20240819$$MD$FI$FI
242233342$24223334$2$F$20240202$20240827$20240819$20240830$EXP$$CA-PFIZER INC-202300445443$PFIZER$$45$YR$$M$Y$$$20240830$$MD$CA$CA
242233353$24223335$3$F$$20240817$20240819$20240822$EXP$$IN-PFIZER INC-PV202400105899$PFIZER$$30$YR$$M$Y$$$20240822$$CN$IN$IN
242233362$24223336$2$F$20230401$20240829$20240819$20240830$EXP$$MA-PFIZER INC-PV202400106503$PFIZER$$$$$F$Y$$$20240830$$CN$MA$MA
242233371$24223337$1$I$$20240813$20240819$20240819$EXP$$MA-PFIZER INC-PV202400106513$PFIZER$$$$$F$Y$$$20240819$$CN$MA$MA
242233381$24223338$1$I$$20240807$20240819$20240819$EXP$CA-MHPD-E2B_07166820$CA-Accord-440623$ACCORD$$43$YR$A$M$Y$$$20240819$$MD$CA$CA
242233391$24223339$1$I$$20240807$20240819$20240819$EXP$SE-SEMPA-2024-005764$SE-Accord-440842$ACCORD$$50$YR$A$M$Y$150$KG$20240819$$CN$SE$SE
242233401$24223340$1$I$20240723$20240807$20240819$20240819$EXP$GB-MHRA-MED-202408071606547360-YTDNH$GB-Accord-440868$ACCORD$$$$$M$Y$$$20240819$$PH$GB$GB
242233411$24223341$1$I$20230603$20240807$20240819$20240819$EXP$DK-DKMA-30736598$DK-Accord-440728$ACCORD$$35$YR$A$F$Y$75$KG$20240819$$CN$DK$DK
242233421$24223342$1$I$20240731$20240807$20240819$20240819$EXP$GB-MHRA-TPP6939755C9945216YC1722971583338$GB-Accord-440819$ACCORD$$74$YR$E$F$Y$103$KG$20240819$$HP$GB$GB
242233431$24223343$1$I$20240101$20240807$20240819$20240819$EXP$SE-SEMPA-2024-005601$SE-Accord-440739$ACCORD$$70$YR$E$F$Y$$$20240819$$MD$SE$SE
242233441$24223344$1$I$$20240807$20240819$20240819$EXP$GB-MHRA-MED-202408072348525630-ZFNMG$GB-Accord-441161$ACCORD$$$$$M$Y$$$20240819$$CN$GB$GB
242233453$24223345$3$F$20240803$20240912$20240819$20240918$EXP$$IT-BAUSCH-BL-2024-012446$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240918$$MD$IT$IT
242233461$24223346$1$I$20240729$20240816$20240819$20240819$EXP$$CN-BAYER-2024A118847$BAYER$$18$YR$A$F$Y$84$KG$20240819$$HP$CN$CN
242233482$24223348$2$F$20240811$20240819$20240819$20240826$EXP$$AT-Eisai-EC-2024-172266$EISAI$$64$YR$A$M$Y$$$20240826$$MD$AT$AT
242233491$24223349$1$I$20240713$20240817$20240819$20240819$EXP$FR-AFSSAPS-AVLL2024000205$FR-BAUSCH-BL-2024-012485$BAUSCH AND LOMB$$$$A$M$Y$$$20240819$$MD$FR$FR
242233501$24223350$1$I$20240801$20240808$20240819$20240819$EXP$$US-UCBSA-2024040513$UCB$$60$YR$$F$Y$74.83$KG$20240819$$HP$US$US
242233511$24223351$1$I$20240522$20240815$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130669$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240819$$CN$US$US
242233521$24223352$1$I$$20240809$20240819$20240819$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR102763$VIIV$$$$$$Y$$$20240819$$HP$US$US
242233531$24223353$1$I$$20240813$20240819$20240819$EXP$$US-AMERICAN REGENT INC-2024003137$AMERICAN REGENT$Narula S, Snodgrass C. Botulinum treatment induced dropped head syndrome in a patient with chronic migraines and multiple sclerosis. Pain Medicine Case Reports. 2024;8(4):157-160$$$$F$Y$$$20240819$$MD$US$US
242233541$24223354$1$I$20240616$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130579$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240819$$PH$US$US
242233551$24223355$1$I$20240717$20240815$20240819$20240819$EXP$FR-AFSSAPS-GR2024001019$FR-BAUSCH-BL-2024-012448$BAUSCH AND LOMB$$48$YR$$F$Y$$$20240819$$PH$FR$FR
242233561$24223356$1$I$$20240813$20240819$20240819$PER$$US-LEO Pharma-372790$LEO PHARM$$26$YR$$F$Y$$$20240819$$PH$US$US
242233571$24223357$1$I$20240701$20240814$20240819$20240819$EXP$ES-AEMPS-1560624$ES-BAUSCH-BL-2024-012402$BAUSCH AND LOMB$$54$YR$$F$Y$$$20240819$$MD$ES$ES
242233581$24223358$1$I$$20240814$20240819$20240819$EXP$$CA-BAUSCH-BL-2024-012374$BAUSCH AND LOMB$$$$$F$Y$$$20240819$$HP$CA$CA
242233591$24223359$1$I$$20240814$20240819$20240819$EXP$$ZA-AstraZeneca-2024A187390$ASTRAZENECA$$74$YR$$F$Y$$$20240819$$CN$ZA$
242233601$24223360$1$I$$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A185955$ASTRAZENECA$$$$$$Y$$$20240819$$HP$US$
242233611$24223361$1$I$$20220503$20240819$20240819$EXP$$US-AstraZeneca-2022A176779$ASTRAZENECA$$$$$F$Y$$$20240819$$HP$US$
242233621$24223362$1$I$$20240816$20240819$20240819$EXP$$CN-AstraZeneca-2024A188172$ASTRAZENECA$$67$YR$$F$Y$$$20240819$$MD$CN$
242233631$24223363$1$I$$20240731$20240819$20240819$PER$$US-TEVA-VS-3229328$TEVA$$49$YR$$F$Y$$$20240819$$CN$US$US
242233642$24223364$2$F$$20240909$20240819$20240913$EXP$$PT-TAKEDA-2024TUS082913$TAKEDA$$73$YR$$M$Y$$$20240913$$HP$PT$PT
242233651$24223365$1$I$$20240705$20240819$20240819$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06944$LUPIN$$$$$$Y$$$20240819$$CN$US$US
242233661$24223366$1$I$20240807$20240815$20240819$20240819$EXP$$US-KYOWAKIRIN-2024KK019288$KYOWA$$$$$$Y$$$20240819$$HP$US$US
242233671$24223367$1$I$$20240815$20240819$20240819$EXP$$GB-SANDOZ INC.-SDZ2024GB073150$SANDOZ$$10$MON$$M$Y$$$20240819$$MD$GB$GB
242233681$24223368$1$I$$20240809$20240819$20240819$PER$$US-SA-2024SA239663$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240819$$CN$US$US
242233711$24223371$1$I$$20240815$20240819$20240819$EXP$$CA-PFIZER INC-202300077327$PFIZER$$8$YR$$M$Y$$$20240819$$HP$CA$CA
242233731$24223373$1$I$$20240809$20240819$20240819$EXP$$IT-MYLANLABS-2024M1076470$MYLAN$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series. J-Clin-Med 2023; 12 (1):.$37$YR$$M$Y$$$20240819$$HP$IT$IT
242233741$24223374$1$I$20240726$20240806$20240819$20240819$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000225$DENDREON$$$$$$Y$$$20240819$$HP$US$US
242233752$24223375$2$F$$20240829$20240819$20240902$EXP$$MA-PFIZER INC-PV202400106528$PFIZER$$$$$F$Y$$$20240902$$CN$MA$MA
242233761$24223376$1$I$20240719$20240809$20240819$20240819$PER$$US-BAYER-2024A116097$BAYER$$42$YR$A$F$Y$$$20240819$$CN$US$US
242233781$24223378$1$I$20240805$20240814$20240819$20240819$EXP$$NVSC2024CN166244$NOVARTIS$$66$YR$$F$Y$$$20240819$$HP$CN$CN
242233791$24223379$1$I$20240101$20240813$20240819$20240819$PER$$US-BAYER-2024A117349$BAYER$$16$YR$T$F$Y$$$20240819$$MD$US$US
242233801$24223380$1$I$$20240814$20240819$20240819$PER$$US-BAYER-2024A117608$BAYER$$23$YR$A$F$Y$$$20240819$$MD$US$US
242233811$24223381$1$I$20240501$20240812$20240819$20240819$PER$$US-ROCHE-10000055727$ROCHE$$56$YR$A$F$Y$$$20240819$$CN$US$US
242233821$24223382$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130602$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240819$$HP$US$US
242233831$24223383$1$I$20221101$20230329$20240819$20240819$EXP$$US-SANDOZ INC.-NVSC2023US053438$SANDOZ$$33$YR$$F$Y$90.7$KG$20240819$$HP$US$US
242233841$24223384$1$I$$20240812$20240819$20240819$PER$$US-BAYER-2024A116201$BAYER$$34$YR$A$M$Y$$$20240819$$CN$US$US
242233851$24223385$1$I$20240816$20240816$20240819$20240819$PER$$NVSC2024US167398$NOVARTIS$$$$$$Y$$$20240819$$HP$US$US
242233861$24223386$1$I$$20240814$20240819$20240819$PER$$US-BAYER-2024A117653$BAYER$$33$YR$A$F$Y$$$20240819$$MD$US$US
242233871$24223387$1$I$$20240806$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006850$ELI LILLY AND CO$Carll T, Antic T..An abdominal wall mass of exogenous insulin amyloidosis in setting of metastatic sarcoma.J Cutan Pathol 2020;47(4):406?8.DOI:10.1111/cup.13613$72$YR$E$M$Y$$$20240819$$HP$US$US
242233881$24223388$1$I$20240605$20240815$20240819$20240819$EXP$FR-AFSSAPS-DJ2024000913$FR-MYLANLABS-2024M1076039$MYLAN$$77$YR$$M$Y$70$KG$20240819$$MD$FR$FR
242233891$24223389$1$I$$20240815$20240819$20240819$PER$$US-LEO Pharma-372769$LEO PHARM$$56$YR$$F$Y$$$20240819$$PH$US$US
242233901$24223390$1$I$20190101$20240812$20240819$20240819$PER$$US-BAYER-2024A116331$BAYER$$$$$F$Y$$$20240819$$CN$US$US
242233911$24223391$1$I$$20240816$20240819$20240819$EXP$$NVSC2024NL166085$NOVARTIS$$$$$F$Y$$$20240819$$MD$NL$NL
242233931$24223393$1$I$$20240813$20240819$20240819$PER$$US-LEO Pharma-372767$LEO PHARM$$27$YR$$M$Y$$$20240819$$CN$US$US
242233941$24223394$1$I$20240213$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-56737$$FDA-CTU$$82$YR$$F$N$61.23$KG$20240819$N$CN$US$
242233951$24223395$1$I$$20240817$20240817$20240817$DIR$FDA-CDER-CTU-2024-56754$$FDA-CTU$$59$YR$$F$N$$$20240817$N$$US$
242233961$24223396$1$I$$20240812$20240819$20240819$EXP$$DE-MYLANLABS-2024M1074901$MYLAN$$$$$M$Y$$$20240819$$CN$DE$DE
242233971$24223397$1$I$$20240812$20240819$20240819$EXP$$SK-MYLANLABS-2024M1074878$MYLAN$$$$A$M$Y$$$20240819$$MD$SK$SK
242233981$24223398$1$I$20240716$20240812$20240819$20240819$EXP$FR-AFSSAPS-GR2024000979$FR-MYLANLABS-2024M1074868$MYLAN$$77$YR$$F$Y$53$KG$20240819$$PH$FR$FR
242233991$24223399$1$I$$20240812$20240819$20240819$EXP$$FR-MYLANLABS-2024M1074889$MYLAN$$$$A$F$Y$75$KG$20240819$$MD$FR$FR
242234001$24223400$1$I$$20240812$20240819$20240819$EXP$SK-EMA-20171006-pbishtp-122444624$SK-MYLANLABS-2024M1074888$MYLAN$Pecova T, Vorcakova K, Adamicova K. Extremely Severe Form of Psoriasis - Rebus of Therapy (case Report).. Martin BEMER. 2017;5:7-11$46$YR$$M$Y$80$KG$20240819$$MD$SK$SK
242234011$24223401$1$I$20240627$20240812$20240819$20240819$EXP$FR-AFSSAPS-GR2024000971$FR-MYLANLABS-2024M1074870$MYLAN$$80$YR$$F$Y$70$KG$20240819$$PH$FR$FR
242234023$24223402$3$F$20240704$20240926$20240819$20240930$EXP$$DE-MYLANLABS-2024M1074871$MYLAN$$61$YR$$M$Y$64$KG$20240930$$MD$DE$DE
242234031$24223403$1$I$20240709$20240812$20240819$20240819$EXP$FR-AFSSAPS-AVLL2024000195$FR-MYLANLABS-2024M1074823$MYLAN$$28$YR$$M$Y$$$20240819$$MD$FR$FR
242234042$24223404$2$F$20240104$20240812$20240819$20240822$EXP$FR-AFSSAPS-MA2024001171$FR-MYLANLABS-2024M1074796$MYLAN$$52$YR$$F$Y$58$KG$20240822$$PH$FR$FR
242234051$24223405$1$I$20240102$20240812$20240819$20240819$EXP$FR-AFSSAPS-TO2024001515$FR-MYLANLABS-2024M1074945$MYLAN$$89$YR$$M$Y$$$20240819$$PH$FR$FR
242234061$24223406$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000059411$ROCHE$$66$YR$E$F$Y$$$20240819$$CN$US$US
242234072$24223407$2$F$20240716$20240822$20240819$20240823$EXP$$FR-AMERICAN REGENT INC-2024003174$AMERICAN REGENT$$14$YR$$M$Y$45.7$KG$20240823$$PH$FR$FR
242234081$24223408$1$I$$20240815$20240819$20240819$EXP$$US-KYOWAKIRIN-2024KK019286$KYOWA$$$$$$Y$$$20240819$$HP$US$US
242234091$24223409$1$I$$20240809$20240819$20240819$EXP$$MY-OTSUKA-2024_022632$OTSUKA$$$$$$Y$$$20240819$$MD$MY$MY
242234101$24223410$1$I$$20240816$20240819$20240819$PER$$US-ROCHE-10000060125$ROCHE$$28$YR$A$F$Y$$$20240819$$CN$US$US
242234111$24223411$1$I$$20240813$20240819$20240819$PER$$US-ROCHE-10000056463$ROCHE$$$$$$Y$$$20240819$$CN$US$US
242234121$24223412$1$I$$20240814$20240819$20240819$PER$$US-009507513-2408USA005141$MERCK$Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancer. npj Precision Oncology. 2024;8 (152):1-6$34$YR$$F$Y$$$20240819$$HP$US$US
242234141$24223414$1$I$20231101$20240815$20240819$20240819$PER$$US-ROCHE-10000059636$ROCHE$$80$YR$E$M$Y$$$20240819$$CN$US$US
242234151$24223415$1$I$20240723$20240813$20240819$20240819$PER$$US-BAYER-2024A116812$BAYER$$43$YR$A$F$Y$$$20240819$$CN$US$US
242234162$24223416$2$F$20240617$20240904$20240819$20240906$PER$$US-ROCHE-10000059679$ROCHE$$18$YR$A$F$Y$93$KG$20240906$$MD$US$US
242234171$24223417$1$I$$20240809$20240819$20240819$EXP$$CA-OTSUKA-2024_022228$OTSUKA$$45$YR$$F$Y$$$20240819$$HP$CA$CA
242234181$24223418$1$I$$20240702$20240819$20240819$PER$$US-LUNDBECK-DKLU4001173$LUNDBECK$$$$$$Y$$$20240819$$HP$US$US
242234191$24223419$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000059227$ROCHE$$$$E$F$Y$$$20240819$$CN$US$US
242234201$24223420$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129940$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240819$$CN$US$US
242234221$24223422$1$I$20240801$20240812$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127995$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240819$$HP$US$US
242234241$24223424$1$I$$20240809$20240819$20240819$PER$$US-ABBVIE-5875904$ABBVIE$$$$$$Y$$$20240819$$CN$US$US
242234251$24223425$1$I$$20240807$20240819$20240819$EXP$$US-GSK-US2024AMR099829$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
242234261$24223426$1$I$20240806$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408071620241670-WLJRM$GB-TEVA-VS-3232289$TEVA$$50$YR$$F$Y$$$20240819$$HP$GB$GB
242234271$24223427$1$I$20240509$20240813$20240819$20240819$EXP$IT-MINISAL02-998298$IT-SA-2024SA242375$SANOFI AVENTIS$$64$YR$A$M$Y$73$KG$20240819$$MD$IT$IT
242234281$24223428$1$I$$20240812$20240819$20240819$EXP$$CN-SA-2024SA241353$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240819$$MD$CN$CN
242234291$24223429$1$I$20240112$20240806$20240816$20240816$DIR$FDA-CDER-CTU-2024-56733$$FDA-CTU$$83$YR$$F$N$54.43$KG$20240806$N$CN$US$
242234301$24223430$1$I$20240502$20240814$20240819$20240819$EXP$$CA-TAKEDA-2024TUS043769$TAKEDA$$92$YR$$F$Y$$$20240819$$CN$CA$CA
242234311$24223431$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-PV202400106593$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
242234321$24223432$1$I$20240730$20240813$20240819$20240819$EXP$FR-AFSSAPS-RS2024000795$FR-SA-2024SA241124$SANOFI AVENTIS$$74$YR$E$F$Y$70$KG$20240819$$PH$FR$FR
242234331$24223433$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-PV202200113244$PFIZER$$74$YR$$F$Y$$$20240819$$CN$US$US
242234341$24223434$1$I$20240813$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237217$PFIZER$$76$YR$$F$Y$$$20240819$$CN$US$US
242234351$24223435$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-PV202400106314$PFIZER$$$$$F$Y$$$20240819$$HP$US$US
242234361$24223436$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-PV202400106316$PFIZER$$78$YR$$M$Y$$$20240819$$CN$US$US
242234372$24223437$2$F$$20240816$20240819$20240821$PER$$US-PFIZER INC-202400237077$PFIZER$$82$YR$$F$Y$$$20240821$$CN$US$US
242234392$24223439$2$F$$20240916$20240819$20240918$PER$$US-PFIZER INC-202400237726$PFIZER$$36$YR$$M$Y$$$20240918$$HP$US$US
242234412$24223441$2$F$$20240829$20240819$20240830$PER$$US-PFIZER INC-202400237724$PFIZER$$$$$$Y$$$20240830$$MD$US$US
242234421$24223442$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400236731$PFIZER$$$$A$M$Y$$$20240819$$PH$US$US
242234431$24223443$1$I$20240813$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237176$PFIZER$$$$$$Y$$$20240819$$CN$US$US
242234441$24223444$1$I$20240812$20240813$20240819$20240819$PER$$US-PFIZER INC-202400235972$PFIZER$$40$YR$$F$Y$81.65$KG$20240819$$CN$US$US
242234451$24223445$1$I$20240811$20240814$20240819$20240819$PER$$US-PFIZER INC-202400236923$PFIZER$$51$YR$$F$Y$$$20240819$$HP$US$US
242234461$24223446$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237311$PFIZER$$27$YR$$F$Y$74.84$KG$20240819$$CN$US$US
242234471$24223447$1$I$$20240809$20240819$20240819$PER$$US-PFIZER INC-202400233890$PFIZER$$$$$F$Y$$$20240819$$HP$US$US
242234481$24223448$1$I$20240810$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237192$PFIZER$$66$YR$$F$Y$$$20240819$$CN$US$US
242234491$24223449$1$I$20240807$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237446$PFIZER$$49$YR$$M$Y$79.38$KG$20240819$$CN$US$US
242234501$24223450$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237681$PFIZER$$65$YR$$F$Y$$$20240819$$HP$US$US
242234511$24223451$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237059$PFIZER$$38$YR$$F$Y$$$20240819$$HP$US$US
242234521$24223452$1$I$$20240816$20240816$20240816$DIR$714647$$FDA-CTU$$32$YR$$M$N$56.25$KG$20240816$$CN$US$
242234531$24223453$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400236627$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
242234541$24223454$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400236513$PFIZER$$62$YR$$M$Y$$$20240819$$HP$US$US
242234552$24223455$2$F$20240813$20240903$20240819$20240904$PER$$US-PFIZER INC-202400236397$PFIZER$$62$YR$$F$Y$58.957$KG$20240904$$CN$US$US
242234561$24223456$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400236666$PFIZER$$$$A$M$Y$$$20240819$$MD$US$US
242234571$24223457$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400236511$PFIZER$$85$YR$$F$Y$$$20240819$$CN$US$US
242234583$24223458$3$F$20240101$20240823$20240819$20240830$PER$$US-PFIZER INC-PV202400106575$PFIZER$$51$YR$$F$Y$$$20240830$$CN$US$US
242234591$24223459$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237625$PFIZER$$$$A$$Y$$$20240819$$MD$US$US
242234602$24223460$2$F$$20240816$20240819$20240820$PER$$US-PFIZER INC-202400237722$PFIZER$$59$YR$$F$Y$$$20240820$$HP$US$US
242234611$24223461$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400236707$PFIZER$$56$YR$$F$Y$73.48$KG$20240819$$MD$US$US
242234622$24223462$2$F$$20240821$20240819$20240827$PER$$US-PFIZER INC-202400235958$PFIZER$$72$YR$$F$Y$$$20240827$$CN$US$US
242234631$24223463$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237515$PFIZER$$70$YR$$F$Y$$$20240819$$MD$US$US
242234642$24223464$2$F$20240101$20240819$20240819$20240822$PER$$US-PFIZER INC-PV202400045831$PFIZER$$80$YR$$M$Y$$$20240822$$MD$US$US
242234662$24223466$2$F$20240813$20240819$20240819$20240821$PER$$US-PFIZER INC-202400237299$PFIZER$$54$YR$$M$Y$$$20240821$$CN$US$US
242234681$24223468$1$I$$20240813$20240819$20240819$PER$$US-PFIZER INC-PV202400105962$PFIZER$$30$YR$$F$Y$$$20240819$$HP$US$US
242234691$24223469$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237745$PFIZER$$$$$$Y$$$20240819$$MD$US$US
242234701$24223470$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237004$PFIZER$$78$YR$$F$Y$51.71$KG$20240819$$CN$US$US
242234711$24223471$1$I$20240101$20240805$20240819$20240819$EXP$$US-UCBSA-2024040074$UCB$$$$$F$Y$$$20240819$$HP$US$US
242234721$24223472$1$I$20230901$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237635$PFIZER$$54$YR$$F$Y$$$20240819$$HP$US$US
242234731$24223473$1$I$20240401$20240809$20240819$20240819$PER$$US-SA-2024SA239596$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240819$$MD$US$US
242234741$24223474$1$I$$20240806$20240819$20240819$PER$$US-SA-2024SA238671$SANOFI AVENTIS$$$$A$F$Y$$$20240819$$MD$US$US
242234752$24223475$2$F$20240618$20240904$20240819$20240904$PER$$US-ALXN-202408USA000887US$ALEXION PHARMACEUTICALS$$73$YR$$F$Y$$$20240904$$CN$US$US
242234761$24223476$1$I$$20240814$20240819$20240819$EXP$$US-NALPROPION PHARMACEUTICALS INC.-US-2024CUR003805$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242234771$24223477$1$I$20240807$20240807$20240819$20240819$EXP$CN-NMPA-3205081023865202400887$CN-Ipsen Biopharmaceuticals, Inc.-2024-16322$IPSEN$$54$YR$A$F$Y$40$KG$20240819$$HP$CN$CN
242234781$24223478$1$I$$20240813$20240819$20240819$PER$$US-BAYER-2024A117022$BAYER$$40$YR$A$F$Y$$$20240819$$MD$US$US
242234791$24223479$1$I$$20240816$20240819$20240819$EXP$$FR-SANDOZ INC.-SDZ2024FR073073$SANDOZ$$78$YR$$F$Y$$$20240819$$HP$FR$FR
242234801$24223480$1$I$20240101$20240809$20240819$20240819$PER$$US-SA-2024SA239789$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240819$$MD$US$US
242234811$24223481$1$I$$20240808$20240819$20240819$PER$$US-SA-2024SA240713$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240819$$MD$US$US
242234821$24223482$1$I$$20240814$20240819$20240819$EXP$$JP-AMGEN-JPNSP2024162635$AMGEN$$$$$$Y$$$20240819$$MD$JP$JP
242234831$24223483$1$I$20240805$20240805$20240819$20240819$PER$$US-JNJFOC-20240838674$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$HP$US$US
242234841$24223484$1$I$20230901$20240813$20240819$20240819$EXP$$US-VERTEX PHARMACEUTICALS-2023-015657$VERTEX$$17$YR$$M$Y$$$20240819$$MD$US$US
242234851$24223485$1$I$$20240809$20240819$20240819$PER$$US-VERTEX PHARMACEUTICALS-2024-013057$VERTEX$$$$$$Y$$$20240819$$CN$US$US
242234861$24223486$1$I$$20240809$20240819$20240819$PER$$US-VERTEX PHARMACEUTICALS-2024-013080$VERTEX$$32$YR$$F$Y$$$20240819$$CN$US$US
242234871$24223487$1$I$$20240809$20240819$20240819$PER$$US-VERTEX PHARMACEUTICALS-2024-013137$VERTEX$$$$$F$Y$$$20240819$$CN$US$US
242234881$24223488$1$I$$20240809$20240819$20240819$EXP$$US-VERTEX PHARMACEUTICALS-2024-013225$VERTEX$$56$YR$$$Y$$$20240819$$CN$US$US
242234891$24223489$1$I$$20240812$20240819$20240819$PER$$US-VERTEX PHARMACEUTICALS-2024-013136$VERTEX$$68$YR$$$Y$$$20240819$$CN$US$US
242234901$24223490$1$I$$20240809$20240819$20240819$PER$$US-VERTEX PHARMACEUTICALS-2024-013050$VERTEX$$$$$$Y$$$20240819$$CN$US$US
242234911$24223491$1$I$$20240809$20240819$20240819$PER$$US-VERTEX PHARMACEUTICALS-2024-013085$VERTEX$$$$A$F$Y$$$20240819$$CN$US$US
242234923$24223492$3$F$$20240919$20240819$20240925$PER$$US-VERTEX PHARMACEUTICALS-2024-013092$VERTEX$$44$YR$$F$Y$$$20240925$$CN$US$US
242234931$24223493$1$I$$20240809$20240819$20240819$PER$$US-VERTEX PHARMACEUTICALS-2024-013082$VERTEX$$$$C$M$Y$$$20240819$$CN$US$US
242234942$24223494$2$F$$20240912$20240819$20240918$EXP$$IT-VERTEX PHARMACEUTICALS-2024-013159$VERTEX$Traunero A, Galletti A, Ghirardo S, Barbi E, Maschio M.. Lung transplant list withdrawal in a liver transplant patient thanks to elexacaftor-tezacaftor-ivacaftor: a case report. Ital J Pediatr. 2024;50$17$YR$$F$Y$$$20240918$$HP$IT$IT
242234951$24223495$1$I$20240701$20240702$20240819$20240819$PER$$US-LUNDBECK-DKLU4001172$LUNDBECK$$$$$$Y$$$20240819$$CN$US$US
242234961$24223496$1$I$$20240813$20240819$20240819$EXP$$US-GILEAD-2024-0683788$GILEAD$Sumarli A, Choi J, Wong V, Aluzri N, Pineda L, Reynoso E, et al. Cesarean Section in a Group 1 Pulmonary Hypertension Parturient Patient: A Case Report. Cureus. 2024;16(6):e63390. doi:DOI: 10.7759/cureus.63390$31$YR$A$F$Y$$$20240819$$HP$US$US
242234971$24223497$1$I$$20240814$20240819$20240819$EXP$$US-MYLANLABS-2024M1076848$MYLAN$Carr KA, Sokolow AG, O^Connor MG, Austin ED. An Atypical Cause of an Acute Exacerbation of Bronchopulmonary Dysplasia Associated Pulmonary Hypertension. Am-J-Respir-Crit-Care-Med 2023; 207.$4$MON$$F$Y$$$20240819$$HP$US$US
242234993$24223499$3$F$20220127$20240919$20240819$20240927$EXP$$US-AGIOS-2406US03813$AGIOS PHARMACEUTICALS$$56$YR$$$Y$$$20240927$$MD$US$US
242235001$24223500$1$I$$20240812$20240819$20240819$EXP$$US-OTSUKA-2024_019802$OTSUKA$$$$$M$Y$83.46$KG$20240819$$CN$US$US
242235021$24223502$1$I$$20240812$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127871$BRISTOL MYERS SQUIBB$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 06;73(10):1-9. doi:10.1007/s00262-024-03775-6.$75$YR$E$F$Y$$$20240819$$HP$US$US
242235041$24223504$1$I$20230508$20240814$20240819$20240819$EXP$$US-AstraZeneca-2024A186552$ASTRAZENECA$$29337$DY$$$Y$$$20240819$$CN$US$
242235051$24223505$1$I$20240615$20240816$20240816$20240816$DIR$714619$$FDA-CTU$$59$YR$$F$N$67.95$KG$20240816$N$CN$US$
242235061$24223506$1$I$$20240816$20240816$20240816$DIR$714654$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242235071$24223507$1$I$$20240814$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010783$ELI LILLY AND CO$$$$$$Y$$$20240819$$CN$US$US
242235081$24223508$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010736$ELI LILLY AND CO$$$$A$F$Y$$$20240819$$CN$US$US
242235091$24223509$1$I$20240816$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408011120$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240819$$CN$US$US
242235101$24223510$1$I$$20240817$20240817$20240817$DIR$FDA-CDER-CTU-2024-56756$$FDA-CTU$$82$YR$$F$N$$$20240817$N$$US$
242235111$24223511$1$I$$20240812$20240819$20240819$EXP$$US-AstraZeneca-2024A184973$ASTRAZENECA$$68$YR$$F$Y$$$20240819$$CN$US$
242235131$24223513$1$I$20041230$20240816$20240816$20240816$DIR$714658$$FDA-CTU$$50$YR$$F$N$55.35$KG$20240816$N$CN$US$
242235151$24223515$1$I$20240726$20240807$20240819$20240819$EXP$CN-NMPA-3306861056562202400144$CN-Ipsen Biopharmaceuticals, Inc.-2024-16318$IPSEN$$60$YR$A$F$Y$39$KG$20240819$$HP$CN$CN
242235161$24223516$1$I$$20240807$20240819$20240819$PER$$US-ABBVIE-5876060$ABBVIE$$$$$$Y$$$20240819$$MD$US$US
242235181$24223518$1$I$20240801$20240813$20240819$20240819$PER$$US-JNJFOC-20240833828$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240819$$PH$US$US
242235192$24223519$2$F$$20240816$20240819$20240821$EXP$$US-PFIZER INC-202400236226$PFIZER$Dao, K.. A case of revelation due to pegfilgrastim. Cureus. 2024;16(7):10.7759/cureus.63777$68$YR$$M$Y$$$20240821$$MD$US$US
242235211$24223521$1$I$$20240813$20240819$20240819$30DAY$$US-GSK-US2024100823$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
242235221$24223522$1$I$$20240814$20240819$20240819$PER$$US-ABBVIE-5882052$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242235231$24223523$1$I$20240612$20240813$20240819$20240819$EXP$FR-AFSSAPS-RN2024000869$FR-VIIV HEALTHCARE LIMITED-FR2024101115$VIIV$$$$$$Y$$$20240819$$MD$FR$FR
242235241$24223524$1$I$$20240723$20240819$20240819$PER$$US-009507513-2407USA014038$MERCK$Khan S, Yetiskul E, Khattar G, Ghada A, Afif S, Khan MWZ, et al.. Failure of the PD-1 blocking agent pembrolizumab to benefit a patient with renal squamous cell cancer. European Journal of Case Reports in Internal Medicine. 2024;11(7)$80$YR$$F$Y$$$20240819$$HP$US$US
242235251$24223525$1$I$20240715$20240809$20240819$20240819$EXP$$CN-SA-2024SA242193$SANOFI AVENTIS$$26$YR$A$M$Y$76$KG$20240819$$HP$CN$CN
242235262$24223526$2$F$20240726$20240829$20240819$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130059$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$26.83$KG$20240903$$CN$US$US
242235271$24223527$1$I$$20240813$20240819$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-129264$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240819$$MD$JP$JP
242235281$24223528$1$I$$20240514$20240819$20240819$PER$$US-MARIUS PHARMACEUTICALS, LLC-2024US001564$PAREXEL$$$$$$Y$$$20240812$$CN$US$US
242235301$24223530$1$I$$20240809$20240819$20240819$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00700$PARATEK PHARMACEUTICALS$$$$$$Y$$$20240819$$MD$US$US
242235321$24223532$1$I$$20240809$20240819$20240819$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00699$PARATEK PHARMACEUTICALS$$$$$$Y$$$20240819$$MD$US$US
242235331$24223533$1$I$$20240809$20240819$20240819$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00697$PARATEK PHARMACEUTICALS$$$$$$Y$$$20240819$$MD$US$US
242235351$24223535$1$I$20240626$20240816$20240817$20240817$DIR$FDA-CDER-CTU-2024-56757$$FDA-CTU$$72$YR$$M$N$95.6$KG$20240816$N$$US$
242235361$24223536$1$I$$20240816$20240816$20240816$DIR$714684$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242235372$24223537$2$F$$20240820$20240819$20240827$EXP$$CA-GSK-CA2024014845$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$CA$CA
242235381$24223538$1$I$20240801$20240812$20240819$20240819$EXP$$CN-GSK-CN2024APC100515$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$HP$CN$CN
242235392$24223539$2$F$20240729$20240923$20240819$20240925$EXP$$GB-SANDOZ INC.-SDZ2023GB051890$SANDOZ$$7$YR$$M$Y$$$20240925$$CN$GB$GB
242235401$24223540$1$I$$20240801$20240819$20240819$PER$$US-SOMERSET-2024-US-000608$ODIN PHARMACEUTICALS$$$$$UNK$Y$$$20240819$$HP$US$US
242235411$24223541$1$I$20240813$20240816$20240817$20240817$DIR$FDA-CDER-CTU-2024-56760$$FDA-CTU$$$$$M$N$86$KG$20240816$N$$US$
242235421$24223542$1$I$20231215$20240813$20240819$20240819$EXP$FR-AFSSAPS-PO2024000878$FR-VIIV HEALTHCARE LIMITED-FR2024101114$VIIV$$$$$$Y$$$20240819$$MD$FR$FR
242235431$24223543$1$I$$20240816$20240816$20240816$DIR$714664$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242235441$24223544$1$I$$20240816$20240816$20240816$DIR$714672$$FDA-CTU$$$$$M$N$$$20240816$N$$US$
242235451$24223545$1$I$$20240814$20240819$20240819$EXP$$US-LUNDBECK-DKLU4003015$LUNDBECK$$$$$$Y$$$20240819$$HP$US$US
242235491$24223549$1$I$$20240816$20240816$20240816$DIR$714674$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242235501$24223550$1$I$20240730$20240809$20240819$20240819$EXP$$GB-TEVA-VS-3232261$TEVA$$55$YR$$F$Y$81$KG$20240819$$MD$GB$GB
242235511$24223551$1$I$$20240816$20240819$20240819$EXP$AU-TGA-0000816607$AU-SANDOZ INC.-SDZ2024AU073237$SANDOZ$$$$$$Y$$$20240819$$HP$AU$AU
242235521$24223552$1$I$$20240816$20240816$20240816$DIR$714620$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242235531$24223553$1$I$$20240817$20240819$20240819$DIR$FDA-CDER-CTU-2024-56852$$FDA-CTU$$$$$F$N$$$20240817$N$HP$US$
242235541$24223554$1$I$20240816$20240816$20240816$20240816$DIR$714686$$FDA-CTU$$$$$UNK$N$$$20240816$N$CN$US$
242235551$24223555$1$I$$20240817$20240817$20240817$DIR$FDA-CDER-CTU-2024-56749$$FDA-CTU$$43$YR$$F$N$$$20240817$N$$US$
242235561$24223556$1$I$20240812$20240816$20240816$20240816$DIR$714622$$FDA-CTU$$56$YR$$F$N$84.6$KG$20240816$N$CN$US$
242235571$24223557$1$I$20240815$20240816$20240816$20240816$DIR$714628$$FDA-CTU$$57$YR$$M$N$$$20240816$N$$US$
242235581$24223558$1$I$20240814$20240816$20240817$20240817$DIR$FDA-CDER-CTU-2024-56758$$FDA-CTU$$$$$M$N$88.7$KG$20240816$N$$US$
242235591$24223559$1$I$20240219$20240816$20240816$20240816$DIR$714691$$FDA-CTU$$70$YR$$F$N$56.7$KG$20240816$N$CN$US$
242235601$24223560$1$I$20240416$20240816$20240817$20240817$DIR$FDA-CDER-CTU-2024-56764$$FDA-CTU$$27$YR$$F$N$59.9$KG$20240816$N$$US$
242235611$24223561$1$I$$20240816$20240816$20240816$DIR$714687$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242235632$24223563$2$F$$20240807$20240819$20240820$EXP$$AU-INCYTE CORPORATION-2024IN008556$INCYTE$Hamid S, Bennet R, Wong. Ruxolitinib Discontinuation Syndrome - A Rare Cause of Cardiac Tamponade. HEART-LUNG-CIRC. 2024;33 (Suppl. 4):S306$$$$$Y$$$20240821$$HP$AU$AU
242235641$24223564$1$I$20240805$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128627$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$80.74$KG$20240819$$CN$US$US
242235651$24223565$1$I$20240801$20240815$20240819$20240819$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-130449$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240819$$MD$IL$IL
242235661$24223566$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130143$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240819$$CN$US$US
242235671$24223567$1$I$$20240813$20240819$20240819$EXP$$US-BEH-2024177209$CSL BEHRING$$$$A$M$Y$$$20240819$$CN$US$US
242235691$24223569$1$I$20240101$20240808$20240819$20240819$EXP$$US-NORTHSTAR RX LLC-US-2024NSR000011$NORTHSTAR$$54$YR$$M$Y$$$20240819$$CN$US$US
242235701$24223570$1$I$$20240814$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US072796$SANDOZ$$49$YR$$M$Y$$$20240819$$MD$US$US
242235711$24223571$1$I$$20240809$20240819$20240819$PER$$US-MYLANLABS-2024M1075910$MYLAN$$$$$F$Y$73.02$KG$20240819$$CN$US$US
242235732$24223573$2$F$$20240904$20240819$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127926$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$63.62$KG$20240905$$CN$US$US
242235741$24223574$1$I$$20240814$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130128$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240819$$CN$US$US
242235751$24223575$1$I$$20240816$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130663$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240819$$CN$US$US
242235761$24223576$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130782$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240819$$CN$US$US
242235771$24223577$1$I$20240713$20240812$20240819$20240819$EXP$FR-AFSSAPS-NC2024000954$FR-MYLANLABS-2024M1074791$MYLAN$$15$YR$$F$Y$57$KG$20240819$$MD$FR$FR
242235781$24223578$1$I$20240723$20240812$20240819$20240819$EXP$FR-AFSSAPS-LY2024001216$FR-MYLANLABS-2024M1074792$MYLAN$$61$YR$$F$Y$65$KG$20240819$$PH$FR$FR
242235791$24223579$1$I$$20240812$20240819$20240819$EXP$$IT-REGENERON PHARMACEUTICALS, INC.-2024-112106$REGENERON$Mori N, Fidanzi C, Bevilacqua M, Ciccarese G, D^Erme AM, Janowska A.. Cemiplimab-Induced Erythema Multiforme in a Patient with Metastatic Squamous Cell Carcinoma of the Penis. DERMATITIS. 2024$66$YR$$M$Y$$$20240819$$MD$IT$IT
242235801$24223580$1$I$$20240807$20240819$20240819$EXP$$US-MYLANLABS-2024M1075258$MYLAN$Robinson CL, Wahab S, Cai V. Delayed Hypersensitivity Reaction to Iodinated-Contrast Following Lumbar Epidural Steroid Injection: Case Report. Pain-Med-Case-Rep 2023; 7 (1): 11-14.$54$YR$$F$Y$$$20240819$$MD$US$US
242235822$24223582$2$F$20230101$20240806$20240819$20240903$PER$$CO-MRZWEB-2024080000140$MERZ$Claudia GONZALEZ. High-Resolution Ultrasound for Complications of Botulinum Toxin Use: A Case Series and Literature Review.. Cureus. 2024;16(6):doi:10.7759/cureus.63232$$$A$F$Y$$$20240903$$HP$CO$CO
242235842$24223584$2$F$$20240820$20240819$20240823$EXP$$US-PFIZER INC-PV202400106556$PFIZER$Kreitman, R.. Effect of rituximab on remissions without minimal residual disease and immunogenicity in patients with relapsed/refractory hairy cell leukemia receiving moxetumomab pasudotox. Journal of Clinical Oncology. 2024;42(16 Suppl):e19015$$$$$Y$$$20240823$$HP$US$US
242235851$24223585$1$I$20230801$20240812$20240819$20240819$EXP$$CN-PFIZER INC-PV202400105678$PFIZER$Lu, L.. Pathological complete response to neoadjuvant lorlatinib in a patient with stage IIIA ALK-positive non-small cell lung cancer: a case report. Translational Lung Cancer Research. 2024;13(7):1742-1748$35$YR$$M$Y$$$20240819$$HP$CN$CN
242235861$24223586$1$I$$20240816$20240819$20240819$EXP$$NVSC2024IN167459$NOVARTIS$$$$$F$Y$$$20240819$$MD$IN$IN
242235881$24223588$1$I$$20240812$20240819$20240819$EXP$$CA-PURDUE-USA-2024-0311381$PURDUE$$65$YR$$F$Y$34$KG$20240819$$HP$CA$CA
242235892$24223589$2$F$$20240821$20240819$20240821$PER$$US-ALXN-202407USA001582US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
242235901$24223590$1$I$$20240812$20240819$20240819$PER$$US-MYLANLABS-2024M1076385$MYLAN$$73$YR$$F$Y$$$20240819$$CN$US$US
242235911$24223591$1$I$20240811$20240812$20240819$20240819$EXP$$US-BAYER-2024A116811$BAYER$$19$YR$A$F$Y$58.957$KG$20240819$$CN$US$US
242235921$24223592$1$I$$20240815$20240819$20240819$PER$$US-HALEON-2192424$Haleon PLC$$$$$$Y$$$20240819$$CN$US$US
242235931$24223593$1$I$20240812$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024163513$AMGEN$$81$YR$E$F$Y$$$20240819$$CN$US$US
242235942$24223594$2$F$$20240814$20240819$20240822$PER$$US-AMGEN-USASP2024164022$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
242235952$24223595$2$F$$20240812$20240819$20240819$EXP$$US-AMGEN-USASP2024161349$AMGEN$$81$YR$E$F$Y$$$20240819$$PH$US$US
242235961$24223596$1$I$$20240816$20240816$20240816$DIR$714697$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242235981$24223598$1$I$20240422$20240816$20240817$20240817$DIR$FDA-CDER-CTU-2024-56759$$FDA-CTU$$68$YR$$F$N$59.6$KG$20240816$N$$US$
242235991$24223599$1$I$20240814$20240816$20240817$20240817$DIR$FDA-CDER-CTU-2024-56755$$FDA-CTU$$83$YR$$M$N$55.1$KG$20240816$N$$US$
242236001$24223600$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56822$$FDA-CTU$$47$YR$$F$N$83.46$KG$20240819$N$HP$US$
242236011$24223601$1$I$$20240817$20240817$20240817$DIR$FDA-CDER-CTU-2024-56747$$FDA-CTU$$41$YR$$F$N$$$20240817$N$$US$
242236021$24223602$1$I$$20240817$20240817$20240817$DIR$FDA-CDER-CTU-2024-56751$$FDA-CTU$$65$YR$$F$N$$$20240817$N$$US$
242236031$24223603$1$I$20240701$20240812$20240817$20240817$DIR$FDA-CDER-CTU-2024-56763$$FDA-CTU$$$$$F$N$48.6$KG$20240812$N$$US$
242236041$24223604$1$I$$20240817$20240817$20240817$DIR$FDA-CDER-CTU-2024-56750$$FDA-CTU$$9$YR$$F$N$$$20240817$N$$US$
242236051$24223605$1$I$$20240817$20240817$20240817$DIR$FDA-CDER-CTU-2024-56752$$FDA-CTU$$63$YR$$F$N$$$20240817$N$$US$
242236071$24223607$1$I$20240814$20240816$20240816$20240816$DIR$714651$$FDA-CTU$$24$YR$$F$N$$$20240816$N$HP$US$
242236081$24223608$1$I$$20240816$20240816$20240816$DIR$714696$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242236091$24223609$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56833$$FDA-CTU$$50$YR$$F$N$68.04$KG$20240819$N$$US$
242236101$24223610$1$I$$20240817$20240817$20240817$DIR$FDA-CDER-CTU-2024-56748$$FDA-CTU$$81$YR$$M$N$$$20240817$N$$US$
242236131$24223613$1$I$$20240816$20240816$20240816$DIR$714665$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242236142$24223614$2$F$$20240829$20240819$20240903$EXP$$MA-PFIZER INC-PV202400106527$PFIZER$$$$$F$Y$$$20240903$$CN$MA$MA
242236151$24223615$1$I$$20240816$20240818$20240818$DIR$FDA-CDER-CTU-2024-56745$$FDA-CTU$$$$$M$N$$$20240816$N$HP$US$
242236162$24223616$2$F$20240520$20240828$20240819$20240829$EXP$PT-INFARMED-F202405-900$PT-PFIZER INC-202400235323$PFIZER$$83$YR$$M$Y$92$KG$20240829$$MD$PT$PT
242236173$24223617$3$F$20240122$20240830$20240819$20240906$EXP$$AT-PFIZER INC-202400236240$PFIZER$$75$YR$$F$Y$83$KG$20240906$$MD$AT$AT
242236191$24223619$1$I$20240701$20240813$20240819$20240819$EXP$$US-AGIOS-2408US03858$AGIOS PHARMACEUTICALS$$75$YR$$F$Y$$$20240819$$CN$US$US
242236221$24223622$1$I$$20240812$20240819$20240819$PER$$NVSC2024US164550$NOVARTIS$$80$YR$$F$Y$$$20240819$$CN$US$US
242236242$24223624$2$F$$20240813$20240819$20240821$EXP$$US-AstraZeneca-2024A186373$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242236251$24223625$1$I$$20220624$20240819$20240819$EXP$$US-AstraZeneca-2022A237866$ASTRAZENECA$$$$$$Y$$$20240819$$MD$US$
242236271$24223627$1$I$$20240815$20240819$20240819$EXP$$US-GILEAD-2024-0684463$GILEAD$$54$YR$A$M$Y$$$20240819$$CN$US$US
242236282$24223628$2$F$$20240830$20240819$20240902$EXP$HR-EMA-20121115-slalp-155302780$HR-SANDOZ INC.-SDZ2024HR072442$SANDOZ$$31$YR$$F$Y$$$20240902$$MD$HR$HR
242236291$24223629$1$I$20240601$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130613$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240819$$CN$US$US
242236301$24223630$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129525$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$87.09$KG$20240819$$CN$US$US
242236312$24223631$2$F$20240815$20240908$20240819$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129520$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$71.67$KG$20240913$$CN$US$US
242236321$24223632$1$I$$20240814$20240819$20240819$EXP$$US-INCYTE CORPORATION-2024IN008534$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242236341$24223634$1$I$$20240813$20240819$20240819$EXP$$QA-SA-2024SA242565$SANOFI AVENTIS$$10$YR$C$$Y$$$20240819$$MD$QA$QA
242236352$24223635$2$F$$20240821$20240819$20240822$EXP$JP-MLMSERVICE-20240808-PI156795-00249-1$JP-SA-2024SA244161$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240822$$HP$JP$JP
242236361$24223636$1$I$20240808$20240812$20240819$20240819$EXP$$CA-ROCHE-10000055534$ROCHE$$88$YR$E$F$Y$$$20240819$$CN$CA$CA
242236371$24223637$1$I$$20240813$20240819$20240819$EXP$$IN-MYLANLABS-2024M1075819$MYLAN$John AO, Singh A, Bala D, Joel A, Georgy JT, Jesudasan MR, et al. Total Neoadjuvant Therapy (TNT) with Full Dose Concurrent Chemotherapy in Locally Advanced Rectal Adenocarcinoma Including Signet Ring and Mucinous Cancers. J-Gastrointest-Can 2023;.$$$A$$Y$$$20240819$$HP$IN$IN
242236381$24223638$1$I$$20240801$20240819$20240819$PER$$US-JNJFOC-20240842584$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$PH$US$US
242236391$24223639$1$I$$20240807$20240819$20240819$PER$$US-JNJFOC-20240842415$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
242236401$24223640$1$I$$20240807$20240819$20240819$PER$$US-JNJFOC-20240842427$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20240819$$HP$US$US
242236421$24223642$1$I$$20240813$20240819$20240819$EXP$$FR-SANDOZ INC.-SDZ2024FR072813$SANDOZ$Brehon Alice, Lourenco Jeremy, Badaoui Antoine, Amsler Emmanuelle, Lopez Zaragoza Jose Luis, Soria Angele, Barbaud Annick. Doxycycline-induced fixed drug eruption: The new epidemic?. Journal of the European Academy of Dermatology and Venereology$31$YR$$M$Y$$$20240819$$HP$FR$FR
242236432$24223643$2$F$$20240905$20240819$20240906$PER$$US-JAZZ PHARMACEUTICALS-2024-US-012420$JAZZ$$$$$M$Y$$$20240906$$CN$US$US
242236451$24223645$1$I$$20240815$20240819$20240819$EXP$$NVSC2024CN166342$NOVARTIS$$41$YR$$M$Y$$$20240819$$CN$CN$CN
242236461$24223646$1$I$$20240810$20240819$20240819$PER$$US-SA-2024SA241105$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240819$$CN$US$US
242236471$24223647$1$I$20240811$20240812$20240819$20240819$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-112908$REGENERON$$70$YR$$F$Y$$$20240819$$HP$CO$CO
242236481$24223648$1$I$$20240812$20240819$20240819$EXP$$IN-ROCHE-10000038233$ROCHE$$68$YR$E$M$Y$57$KG$20240819$$MD$IN$IN
242236491$24223649$1$I$$20240731$20240819$20240819$DIR$FDA-CDER-CTU-2024-56898$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
242236511$24223651$1$I$20240813$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024161467$AMGEN$$$$$$Y$$$20240819$$CN$US$US
242236521$24223652$1$I$$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024162988$AMGEN$$$$$$Y$$$20240819$$MD$US$US
242236531$24223653$1$I$20240730$20240802$20240818$20240818$DIR$FDA-CDER-CTU-2024-56778$$FDA-CTU$$$$$M$N$18.6$KG$20240802$N$$US$
242236571$24223657$1$I$$20240813$20240819$20240819$EXP$$CA-ABBVIE-5879466$ABBVIE$$$$$$Y$$$20240819$$MD$CA$CA
242236582$24223658$2$F$20221201$20240819$20240819$20240823$EXP$$US-GILEAD-2024-0684425$GILEAD$$37$YR$A$F$Y$$$20240823$$CN$US$US
242236611$24223661$1$I$20240718$20240813$20240818$20240818$DIR$FDA-CDER-CTU-2024-56761$$FDA-CTU$$58$YR$$F$N$$$20240813$N$HP$US$
242236621$24223662$1$I$$20240815$20240818$20240818$DIR$FDA-CDER-CTU-2024-56767$$FDA-CTU$$$$$M$N$$$20240815$N$HP$US$
242236641$24223664$1$I$$20240816$20240818$20240818$DIR$FDA-CDER-CTU-2024-56769$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242236651$24223665$1$I$$20240816$20240818$20240818$DIR$FDA-CDER-CTU-2024-56775$$FDA-CTU$$$$$M$N$$$20240816$N$HP$US$
242236661$24223666$1$I$20240718$20240813$20240818$20240818$DIR$FDA-CDER-CTU-2024-56746$$FDA-CTU$$58$YR$$F$N$$$20240813$N$HP$US$
242236691$24223669$1$I$$20240812$20240819$20240819$EXP$$CA-Covis Pharma GmbH-2024COV01002$COVIS PHARMA$$$$$M$Y$$$20240819$$PH$CA$CA
242236721$24223672$1$I$$20240815$20240819$20240819$EXP$$NVSC2024CN167460$NOVARTIS$$75$YR$$M$Y$$$20240819$$CN$CN$CN
242236731$24223673$1$I$$20220315$20240819$20240819$EXP$$US-AstraZeneca-2022A117386$ASTRAZENECA$$$$$F$Y$66.2$KG$20240819$$CN$US$
242236741$24223674$1$I$20240127$20240816$20240819$20240819$EXP$FR-AFSSAPS-AM2024000654$NVSC2024FR166219$NOVARTIS$$37$YR$$M$Y$84$KG$20240819$$MD$FR$FR
242236751$24223675$1$I$$20220726$20240819$20240819$EXP$$US-AstraZeneca-2022A268386$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242236761$24223676$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167403$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
242236771$24223677$1$I$20240428$20240815$20240819$20240819$EXP$$NVSC2024US091354$NOVARTIS$$45$YR$$M$Y$$$20240819$$CN$US$US
242236781$24223678$1$I$$20240807$20240819$20240819$EXP$$FR-MYLANLABS-2024M1075119$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$64$YR$$F$Y$$$20240819$$HP$FR$FR
242236792$24223679$2$F$20240531$20240912$20240819$20240918$EXP$FR-DEAQVIDAP-20240052$FR-MYLANLABS-2024M1066069$MYLAN$$79$YR$$M$Y$64$KG$20240918$$MD$FR$FR
242236801$24223680$1$I$20230117$20230123$20240819$20240819$EXP$$CO-AstraZeneca-2023A022725$ASTRAZENECA$$20663$DY$$F$Y$65$KG$20240819$$CN$CO$
242236811$24223681$1$I$20240802$20240809$20240819$20240819$PER$$JP-Eisai-EC-2024-171914$EISAI$$$$A$M$Y$$$20240819$$MD$JP$JP
242236822$24223682$2$F$20240101$20240904$20240819$20240917$EXP$$US-UCBSA-2024024147$UCB$$$$$M$Y$$$20240917$$CN$US$US
242236831$24223683$1$I$$20240812$20240819$20240819$PER$$US-AMGEN-USASP2024160532$AMGEN$$69$YR$E$F$Y$$$20240819$$CN$US$US
242236841$24223684$1$I$$20240816$20240819$20240819$EXP$$MX-BRISTOL-MYERS SQUIBB COMPANY-2024-130682$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240819$$MD$MX$MX
242236851$24223685$1$I$20230707$20240814$20240819$20240819$EXP$$DE-SA-2024SA244303$SANOFI AVENTIS$$39$YR$A$M$Y$110$KG$20240819$$MD$DE$DE
242236861$24223686$1$I$$20240807$20240819$20240819$PER$$US-ABBVIE-5875401$ABBVIE$$$$$$Y$$$20240819$$MD$US$US
242236881$24223688$1$I$20240721$20240816$20240819$20240819$EXP$$CN-ROCHE-10000059072$ROCHE$$52$YR$A$F$Y$66$KG$20240819$$HP$CN$CN
242236891$24223689$1$I$20230908$20240814$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009338$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240819$$CN$US$US
242236901$24223690$1$I$$20240812$20240819$20240819$EXP$$IT-JNJFOC-20240836995$JOHNSON AND JOHNSON$$36$YR$A$M$Y$105$KG$20240819$$MD$IT$IT
242236911$24223691$1$I$20240701$20240723$20240819$20240819$PER$$US-TOLMAR, INC.-24US051102$TOLMAR$$89$YR$$M$Y$$$20240819$$PH$US$US
242236921$24223692$1$I$20240723$20240723$20240819$20240819$PER$$US-TOLMAR, INC.-24US051268$TOLMAR$$29$YR$$F$Y$$$20240819$$HP$US$US
242236932$24223693$2$F$20240723$20240905$20240819$20240926$PER$$US-TOLMAR, INC.-24US051281$TOLMAR$$82$YR$$M$Y$$$20240926$$HP$US$US
242236942$24223694$2$F$20240214$20240904$20240819$20240926$PER$$US-TOLMAR, INC.-24US051240$TOLMAR$$71$YR$$M$Y$$$20240926$$HP$US$US
242236951$24223695$1$I$$20240814$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US072834$SANDOZ$$$$$F$Y$$$20240819$$HP$US$US
242236961$24223696$1$I$20231211$20240814$20240819$20240819$EXP$$CO-UCBSA-2024041626$UCB$$62$YR$$F$Y$$$20240819$$CN$CO$CO
242236971$24223697$1$I$$20240813$20240819$20240819$EXP$$US-GILEAD-2024-0684111$GILEAD$$39$YR$A$M$Y$$$20240819$$CN$US$US
242236982$24223698$2$F$20240101$20240827$20240819$20240830$EXP$$US-ABBVIE-5880080$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242236991$24223699$1$I$$20220809$20240819$20240819$EXP$$GB-AstraZeneca-2022A274525$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$GB$
242237001$24223700$1$I$$20230419$20240819$20240819$EXP$$US-AstraZeneca-2023A092402$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242237011$24223701$1$I$$20240812$20240819$20240819$EXP$$US-OTSUKA-2024_022410$OTSUKA$$$$$M$Y$$$20240819$$CN$US$US
242237021$24223702$1$I$$20240814$20240819$20240819$EXP$$US-ABBVIE-5881869$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242237032$24223703$2$F$$20240904$20240819$20240916$EXP$$CL-PFIZER INC-PV202400106578$PFIZER$Vidal, C.. Clinical experience of using brentuximab-vedotin as therapy in relapsed/refractory Hodgkin^s lymphoma at Hospital Guillermo Grant Benavente, Concepcion, Chile. Rev Med Chile. 2023;151:1361-1366$48$YR$$M$Y$$$20240916$$HP$CL$CL
242237041$24223704$1$I$20231108$20240813$20240819$20240819$EXP$$KR-PFIZER INC-202400235122$PFIZER$$76$YR$$M$Y$$$20240819$$PH$KR$KR
242237051$24223705$1$I$$20240813$20240819$20240819$EXP$$US-ABBVIE-5881014$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242237061$24223706$1$I$$20240814$20240819$20240819$EXP$$US-INCYTE CORPORATION-2024IN008531$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242237071$24223707$1$I$$20240813$20240819$20240819$EXP$$NVSC2024US165330$NOVARTIS$$$$A$F$Y$$$20240819$$MD$US$US
242237081$24223708$1$I$20220101$20240729$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-2022M1135280$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242237091$24223709$1$I$20230707$20240726$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1074525$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242237101$24223710$1$I$$20240814$20240819$20240819$EXP$$US-SA-2024SA244009$SANOFI AVENTIS$$$$A$M$Y$57.153$KG$20240819$$HP$US$US
242237111$24223711$1$I$20230101$20240816$20240819$20240819$PER$$US-BAYER-2024A118514$BAYER$$66$YR$E$F$Y$$$20240819$$CN$US$US
242237121$24223712$1$I$$20240806$20240819$20240819$PER$$US-SA-2024SA238111$SANOFI AVENTIS$$$$A$F$Y$97.5$KG$20240819$$MD$US$US
242237131$24223713$1$I$$20240806$20240819$20240819$PER$$US-SA-2024SA240235$SANOFI AVENTIS$$$$E$F$Y$63.9$KG$20240819$$MD$US$US
242237142$24223714$2$F$20181201$20240823$20240819$20240903$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2024-112956$REGENERON$$61$YR$$F$Y$$$20240903$$HP$GB$GB
242237151$24223715$1$I$$20240811$20240819$20240819$EXP$$CO-JNJFOC-20240835123$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$CO$CO
242237171$24223717$1$I$20240806$20240809$20240819$20240819$EXP$$MX-LUNDBECK-DKLU4003037$LUNDBECK$$$$$$Y$$$20240819$$CN$MX$MX
242237181$24223718$1$I$$20240815$20240819$20240819$EXP$$US-GILEAD-2024-0684462$GILEAD$$35$YR$A$F$Y$$$20240819$$CN$US$US
242237201$24223720$1$I$20240803$20240812$20240819$20240819$PER$$US-RDY-SPO/USA/24/0011888$DR REDDYS$$77$YR$E$M$Y$81$KG$20240819$$CN$US$US
242237211$24223721$1$I$$20240813$20240819$20240819$EXP$$MY-DSJP-DSJ-2024-140753$DAIICHI$$$$$M$Y$$$20240819$$CN$MY$MY
242237221$24223722$1$I$20240704$20240809$20240819$20240819$EXP$$GB-TEVA-VS-3232146$TEVA$$55$YR$$M$Y$62$KG$20240819$$MD$GB$GB
242237231$24223723$1$I$$20240811$20240819$20240819$PER$$US-AMGEN-USASP2024159943$AMGEN$Zisa D.; Zhang-sun J.; Christos P. J. et al.. Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares. Lupus. 2024;33 (9):938-947$54$YR$A$F$Y$$$20240819$$HP$US$US
242237241$24223724$1$I$$20240511$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003111$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242237251$24223725$1$I$$20240613$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003575$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242237261$24223726$1$I$$20240529$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003643$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242237271$24223727$1$I$$20240429$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003075$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242237281$24223728$1$I$$20240429$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003085$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242237291$24223729$1$I$$20240429$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003095$BIOCON$$$$$$Y$$$20240819$$PH$US$US
242237311$24223731$1$I$$20240515$20240819$20240819$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003501$BIOCON$$$$$$Y$$$20240819$$CN$US$US
242237321$24223732$1$I$$20240813$20240819$20240819$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-129494$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240819$$PH$FR$FR
242237331$24223733$1$I$$20240818$20240818$20240818$DIR$FDA-CDER-CTU-2024-56771$$FDA-CTU$$71$YR$$F$N$$$20240818$N$$US$
242237341$24223734$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56784$$FDA-CTU$$71$YR$$F$N$$$20240819$N$$US$
242237371$24223737$1$I$20240717$20240816$20240816$20240816$DIR$714681$$FDA-CTU$$82$YR$$F$N$86.4$KG$20240816$N$MD$US$
242237381$24223738$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56783$$FDA-CTU$$61$YR$$F$N$$$20240819$N$$US$
242237391$24223739$1$I$$20240816$20240816$20240816$DIR$714690$$FDA-CTU$$$$$UNK$N$$$20240816$$CN$US$
242237401$24223740$1$I$20240815$20240816$20240816$20240816$DIR$714704$$FDA-CTU$$80$YR$$M$N$$$20240816$Y$HP$US$
242237411$24223741$1$I$20240802$20240814$20240818$20240818$DIR$FDA-CDER-CTU-2024-56765$$FDA-CTU$$76$YR$$M$N$$$20240814$N$HP$US$
242237421$24223742$1$I$20240810$20240816$20240816$20240816$DIR$714598$$FDA-CTU$$9$YR$$F$N$20.25$KG$20240816$N$CN$US$
242237431$24223743$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56926$$FDA-CTU$$18$YR$$F$N$66.22$KG$20240819$N$HP$US$
242237441$24223744$1$I$20210801$20240816$20240816$20240816$DIR$714705$$FDA-CTU$$42$YR$$F$N$122.4$KG$20240816$N$CN$US$
242237451$24223745$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56927$$FDA-CTU$$36$YR$$F$N$$$20240819$N$HP$US$
242237471$24223747$1$I$20220609$20240814$20240819$20240819$EXP$$CO-UCBSA-2024041606$UCB$$64$YR$$M$Y$$$20240819$$CN$CO$CO
242237481$24223748$1$I$$20240812$20240819$20240819$EXP$$US-ABBVIE-5878161$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242237491$24223749$1$I$$20240812$20240819$20240819$EXP$$US-ABBVIE-5878470$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242237501$24223750$1$I$20240724$20240815$20240819$20240819$EXP$$NVSC2024US166389$NOVARTIS$$63$YR$$F$Y$$$20240819$$CN$US$US
242237511$24223751$1$I$20240801$20240816$20240819$20240819$EXP$$KR-PFIZER INC-202400237778$PFIZER$$86$YR$$F$Y$$$20240819$$HP$KR$KR
242237521$24223752$1$I$$20240812$20240819$20240819$EXP$$US-OTSUKA-2024_022471$OTSUKA$$$$$F$Y$$$20240819$$HP$US$US
242237531$24223753$1$I$$20240815$20240819$20240819$EXP$$US-PFIZER INC-202400238320$PFIZER$$54$YR$$M$Y$$$20240819$$CN$US$US
242237541$24223754$1$I$20240701$20240815$20240819$20240819$EXP$$US-PFIZER INC-202400238333$PFIZER$$17$YR$$M$Y$$$20240819$$HP$US$US
242237551$24223755$1$I$20240701$20240815$20240819$20240819$EXP$$TW-PFIZER INC-PV202400106807$PFIZER$$69$YR$$F$Y$$$20240819$$HP$TW$TW
242237572$24223757$2$F$$20240904$20240819$20240913$EXP$$CL-PFIZER INC-202400237721$PFIZER$Vidal, C.. Clinical experience of using brentuximab-vedotin as therapy in relapsed/refractory Hodgkins lymphoma at Hospital Guillermo Grant Benavente, Concepcion, Chile. Rev Med Chile. 2023;151:1361-1366$23$YR$$F$Y$$$20240913$$HP$CL$CL
242237583$24223758$3$F$$20240917$20240819$20240919$EXP$$CL-PFIZER INC-202400237469$PFIZER$Vidal, C.. Clinical experience of using brentuximab-vedotin as therapy in relapsed/refractory Hodgkin^s lymphoma at Hospital Guillermo Grant Benavente, Concepcion, Chile. Rev Med Chile. 2023;151:1361-1366$21$YR$$M$Y$$$20240919$$HP$CL$CL
242237591$24223759$1$I$20240627$20240815$20240819$20240819$EXP$$US-UCBSA-2024033524$UCB$$67$YR$$F$Y$$$20240819$$CN$US$US
242237602$24223760$2$F$20240601$20240823$20240819$20240828$EXP$$CA-PFIZER INC-202400238323$PFIZER$$55$YR$$M$Y$$$20240828$$MD$CA$CA
242237611$24223761$1$I$20191127$20240816$20240819$20240819$EXP$$FR-GILEAD-2024-0684514$GILEAD$$59$YR$A$M$Y$63$KG$20240819$$CN$FR$FR
242237621$24223762$1$I$20240803$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408091007476250-TKNFM$GB-TEVA-VS-3232076$TEVA$$$$$M$Y$$$20240819$$PH$GB$GB
242237631$24223763$1$I$$20240816$20240819$20240819$EXP$$NVSC2024US167197$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
242237641$24223764$1$I$20230601$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408091437098330-KRLCS$GB-TEVA-VS-3232270$TEVA$$90$YR$$M$Y$$$20240819$$PH$GB$GB
242237651$24223765$1$I$$20240809$20240819$20240819$EXP$$GB-TEVA-VS-3232266$TEVA$$38$YR$$F$Y$64$KG$20240819$$MD$GB$GB
242237661$24223766$1$I$$20240813$20240819$20240819$PER$$NVSC2024US164808$NOVARTIS$$$$$$Y$$$20240819$$CN$US$US
242237671$24223767$1$I$$20240812$20240819$20240819$EXP$$US-VIVUS, Inc.-2024V1001008$VIVUS$$$$A$F$Y$$$20240819$$CN$US$US
242237681$24223768$1$I$$20240816$20240819$20240819$30DAY$$US-SANDOZ INC.-SDZ2023US041202$SANDOZ$$$$$F$Y$$$20240819$$CN$US$US
242237691$24223769$1$I$$20240809$20240819$20240819$EXP$$GB-TEVA-VS-3232195$TEVA$$19$YR$$F$Y$43$KG$20240819$$MD$GB$GB
242237702$24223770$2$F$20230608$20240814$20240819$20240906$EXP$FR-AFSSAPS-CF2024000396$FR-SANDOZ INC.-SDZ2024FR073301$SANDOZ$$28$YR$$F$Y$50$KG$20240906$$PH$FR$FR
242237721$24223772$1$I$$20240813$20240819$20240819$EXP$$DE-SANDOZ INC.-SDZ2024DE072531$SANDOZ$$31$YR$$F$Y$$$20240819$$HP$DE$DE
242237741$24223774$1$I$20240807$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408090839441180-RVWKL$GB-TEVA-VS-3231978$TEVA$$31$YR$$M$Y$$$20240819$$HP$GB$GB
242237751$24223775$1$I$20240726$20240813$20240819$20240819$PER$$US-SA-2024SA243277$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240819$$MD$US$US
242237761$24223776$1$I$20240101$20240806$20240819$20240819$PER$$US-SA-2024SA193312$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240819$$MD$US$US
242237771$24223777$1$I$20180718$20240815$20240819$20240819$EXP$$AU-GSK-AU2024APC102078$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$MD$AU$AU
242237781$24223778$1$I$20240407$20240816$20240819$20240819$EXP$$NVSC2024IN167465$NOVARTIS$$47$YR$$M$Y$$$20240819$$MD$IN$IN
242237792$24223779$2$F$$20240816$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129944$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240820$$CN$US$US
242237804$24223780$4$F$20240711$20240917$20240819$20240925$30DAY$$FI-JNJFOC-20240810200$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$FI$FI
242237812$24223781$2$F$20240506$20240911$20240819$20240920$EXP$GB-MHRA-MED-202408072019074410-NTCRP$GB-TEVA-VS-3232288$TEVA$$68$YR$$F$Y$51$KG$20240920$$MD$GB$GB
242237821$24223782$1$I$$20240814$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130102$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240819$$CN$US$US
242237833$24223783$3$F$20240601$20240823$20240819$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128810$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240829$$HP$US$US
242237841$24223784$1$I$20240101$20240815$20240819$20240819$EXP$$DK-BRISTOL-MYERS SQUIBB COMPANY-2024-127103$BRISTOL MYERS SQUIBB$$31$YR$A$M$Y$$$20240819$$MD$DK$DK
242237851$24223785$1$I$20210101$20240805$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123620$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240819$$MD$US$US
242237861$24223786$1$I$20240701$20240808$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126060$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240819$$HP$US$US
242237871$24223787$1$I$$20240513$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000157$ARCUTIS$$$$$$Y$$$20240819$$MD$US$US
242237881$24223788$1$I$$20240530$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000185$ARCUTIS$$$$$$Y$$$20240819$$MD$US$US
242237891$24223789$1$I$$20240612$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000202$ARCUTIS$$$$$$Y$$$20240819$$CN$US$US
242237901$24223790$1$I$$20240620$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000214$ARCUTIS$$$$$M$Y$$$20240819$$MD$US$US
242237911$24223791$1$I$20240601$20240627$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000223$ARCUTIS$$$$$$Y$$$20240819$$CN$US$US
242237921$24223792$1$I$$20240703$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000228$ARCUTIS$$$$$$Y$$$20240819$$CN$US$US
242237931$24223793$1$I$$20240708$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000235$ARCUTIS$$60$YR$$$Y$$$20240819$$CN$US$US
242237941$24223794$1$I$$20240719$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000246$ARCUTIS$$$$$F$Y$$$20240819$$CN$US$US
242237951$24223795$1$I$20240101$20240812$20240819$20240819$PER$$US-BEH-2024177178$CSL BEHRING$$$$$F$Y$$$20240819$$CN$US$US
242237961$24223796$1$I$$20240812$20240819$20240819$PER$$US-BAYER-2024A116607$BAYER$$$$$$Y$$$20240819$$CN$US$US
242237971$24223797$1$I$$20240812$20240819$20240819$PER$$US-AstraZeneca-2024A185104$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242237981$24223798$1$I$20240807$20240812$20240819$20240819$PER$$US-AstraZeneca-2024A183964$ASTRAZENECA$$20189$DY$$F$Y$$$20240819$$CN$US$
242237991$24223799$1$I$$20240812$20240819$20240819$EXP$$US-OTSUKA-2024_022298$OTSUKA$$$$$M$Y$117.93$KG$20240819$$CN$US$US
242238001$24223800$1$I$$20240509$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000150$ARCUTIS$$$$$$Y$$$20240819$$HP$US$US
242238011$24223801$1$I$$20240516$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000161$ARCUTIS$$$$$$Y$$$20240819$$CN$US$US
242238021$24223802$1$I$$20240516$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000167$ARCUTIS$$73$YR$$F$Y$$$20240819$$HP$US$US
242238031$24223803$1$I$$20240604$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000190$ARCUTIS$$$$$$Y$$$20240819$$CN$US$US
242238041$24223804$1$I$$20240606$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000197$ARCUTIS$$$$$$Y$$$20240819$$MD$US$US
242238051$24223805$1$I$$20240618$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000210$ARCUTIS$$$$$M$Y$$$20240819$$MD$US$US
242238061$24223806$1$I$$20240701$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000226$ARCUTIS$$$$$M$Y$$$20240819$$MD$US$US
242238071$24223807$1$I$$20240818$20240818$20240818$DIR$FDA-CDER-CTU-2024-56770$$FDA-CTU$$60$YR$$F$N$$$20240818$N$$US$
242238081$24223808$1$I$$20240816$20240816$20240816$DIR$714711$$FDA-CTU$$47$YR$$F$N$64.8$KG$20240816$N$CN$US$
242238091$24223809$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56793$$FDA-CTU$$63$YR$$F$N$$$20240819$N$$US$
242238101$24223810$1$I$$20240816$20240819$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA073295$SANDOZ$$44$YR$$F$Y$70$KG$20240819$$HP$CA$CA
242238111$24223811$1$I$20240528$20240816$20240816$20240816$DIR$714710$$FDA-CTU$$90$YR$$F$N$52.4$KG$20240816$N$PH$US$
242238131$24223813$1$I$$20240815$20240819$20240819$EXP$SE-BLUEFISH PHARMACEUTICALS AB-2024BF001148$SE-GSK-SE2024101690$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$CN$SE$SE
242238141$24223814$1$I$20240815$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009934$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240819$$CN$US$US
242238151$24223815$1$I$$20240813$20240819$20240819$PER$$US-BAYER-2024A116700$BAYER$$$$$$Y$$$20240819$$CN$US$US
242238162$24223816$2$F$$20240820$20240819$20240828$EXP$$IT-JNJFOC-20240836033$JOHNSON AND JOHNSON$$$$A$$Y$$$20240828$$HP$IT$IT
242238171$24223817$1$I$20240807$20240812$20240819$20240819$EXP$$US-APELLIS-2024-APL-0000713$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
242238191$24223819$1$I$$20240813$20240819$20240819$EXP$FR-AFSSAPS-AVPA2024000665$FR-SA-2024SA241702$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240819$$PH$FR$FR
242238201$24223820$1$I$$20240809$20240819$20240819$EXP$$US-ACORDA-ACO_177756_2024$ACORDA$$$$$F$Y$$$20240819$$CN$US$US
242238211$24223821$1$I$$20240807$20240819$20240819$30DAY$$US-GSK-US2024098637$GLAXOSMITHKLINE$$$$$F$Y$$$20240819$$CN$US$US
242238222$24223822$2$F$20240101$20240823$20240819$20240917$EXP$$US-SA-2024SA243996$SANOFI AVENTIS$$46$YR$A$F$Y$108$KG$20240917$$MD$US$US
242238231$24223823$1$I$$20240813$20240819$20240819$PER$$US-BAYER-2024A116758$BAYER$$67$YR$E$F$Y$$$20240819$$HP$US$US
242238241$24223824$1$I$$20240807$20240819$20240819$PER$$US-RDY-LIT/USA/24/0011829$DR REDDYS$Rios IP, Nguyen CH, Misra SS, Ryan MS, Nair SS, Khamash HA. Foscarnet-induced nephropathy in a kidney transplant recipient. Kidney International. 106(1): 156. doi:10.1016/j.kint.2024.02.017.$53$YR$A$M$Y$$$20240819$$HP$US$US
242238251$24223825$1$I$$20240816$20240819$20240819$EXP$$US-TAKEDA-2024TUS056228$TAKEDA$$$$$F$Y$$$20240819$$CN$US$US
242238261$24223826$1$I$$20240814$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US073182$SANDOZ$$$$$F$Y$$$20240819$$HP$US$US
242238271$24223827$1$I$$20240813$20240819$20240819$EXP$$CN-RDY-LIT/CHN/24/0011991$DR REDDYS$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turkish Journal of Hematology. 2023;40: 284-285. doi:10.4274/tjh.galenos.2023.2023.0263.$72$YR$E$M$Y$$$20240819$$HP$CN$CN
242238281$24223828$1$I$$20240813$20240819$20240819$PER$$US-SA-2024SA242810$SANOFI AVENTIS$$$$A$F$Y$$$20240819$$HP$US$US
242238292$24223829$2$F$$20240815$20240819$20240821$EXP$$JP-FERRINGPH-2024FE04598$FERRING$$$$$$Y$$$20240821$$MD$JP$JP
242238301$24223830$1$I$$20240813$20240819$20240819$EXP$$JP-FERRINGPH-2024FE04599$FERRING$$$$$$Y$$$20240819$$HP$JP$JP
242238311$24223831$1$I$$20240813$20240819$20240819$EXP$$US-TAKEDA-2024TUS081319$TAKEDA$$$$$F$Y$$$20240819$$CN$US$US
242238322$24223832$2$F$20240809$20240910$20240819$20240913$30DAY$$US-AMGEN-USASP2024160509$AMGEN$$50$YR$A$M$Y$105.1$KG$20240913$$PH$US$US
242238331$24223833$1$I$20240807$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024163288$AMGEN$$59$YR$A$F$Y$$$20240819$$CN$US$US
242238342$24223834$2$F$20240813$20240902$20240819$20240906$PER$$US-AMGEN-USASP2024161449$AMGEN$$70$YR$E$F$Y$102$KG$20240906$$HP$US$US
242238361$24223836$1$I$$20240528$20240819$20240819$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000075$ARCUTIS$$66$YR$$F$Y$$$20240819$$CN$US$US
242238371$24223837$1$I$$20240806$20240819$20240819$EXP$$AU-GENERIC HEALTH PTY. LTD.-2024-07958$LUPIN$$$$$$Y$$$20240819$$CN$AU$AU
242238381$24223838$1$I$$20240814$20240819$20240819$PER$$US-HALEON-2192119$Haleon PLC$$73$YR$$M$Y$$$20240819$$CN$US$US
242238391$24223839$1$I$20240717$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56929$$FDA-CTU$$40$YR$$F$N$$$20240819$N$$US$
242238411$24223841$1$I$20240101$20240813$20240819$20240819$EXP$$US-JNJFOC-20240833834$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240819$$HP$US$US
242238421$24223842$1$I$$20240809$20240819$20240819$EXP$$US-ABBVIE-5876908$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242238431$24223843$1$I$20240808$20240815$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130803$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240819$$CN$US$US
242238441$24223844$1$I$20240726$20240813$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128317$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240819$$CN$US$US
242238451$24223845$1$I$$20240816$20240819$20240819$EXP$$NVSC2024IN167457$NOVARTIS$$$$$F$Y$$$20240819$$MD$IN$IN
242238461$24223846$1$I$20230501$20240808$20240819$20240819$EXP$$BR-BAYER-2023A166563$BAYER$$68$YR$E$M$Y$$$20240819$$CN$BR$BR
242238471$24223847$1$I$$20240814$20240819$20240819$EXP$$NZ-AstraZeneca-2024A187461$ASTRAZENECA$$$$A$M$Y$$$20240819$$MD$NZ$
242238481$24223848$1$I$$20240812$20240819$20240819$EXP$$IN-RDY-SPO/IND/24/0011900$DR REDDYS$$$$$$Y$$$20240819$$CN$IN$IN
242238491$24223849$1$I$$20240807$20240819$20240819$EXP$$US-RDY-LIT/USA/24/0011794$DR REDDYS$Cheng J, Harney S, Toner K, Kube P, Gong S, Ozdemirli M, et al. Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment. Pediatric Blood and Cancer. 2024 Aug;71(8): 1-4. doi:10.1002/pbc.31096.$14$YR$T$M$Y$$$20240819$$HP$US$US
242238511$24223851$1$I$20240703$20240814$20240819$20240819$EXP$$CA-JNJFOC-20240755633$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240819$$HP$CA$CA
242238521$24223852$1$I$20230718$20240816$20240819$20240819$EXP$FR-AFSSAPS-SE2024000650$NVSC2024FR166112$NOVARTIS$$23$YR$$F$Y$55$KG$20240819$$MD$FR$FR
242238531$24223853$1$I$20230601$20240809$20240819$20240819$EXP$$US-UCBSA-2024041088$UCB$$0$YR$$F$Y$3.514$KG$20240819$$CN$US$US
242238541$24223854$1$I$20240813$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024163367$AMGEN$$78$YR$E$F$Y$$$20240819$$CN$US$US
242238551$24223855$1$I$$20240816$20240819$20240819$EXP$$US-ABBVIE-5884648$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242238561$24223856$1$I$20240810$20240817$20240817$20240817$DIR$714779$$FDA-CTU$$63$YR$$F$N$119.25$KG$20240817$N$CN$US$
242238571$24223857$1$I$20240113$20240809$20240819$20240819$EXP$FR-AFSSAPS-ST2024001273$FR-TEVA-VS-3232707$TEVA$$80$YR$$$Y$78.3$KG$20240819$$PH$FR$FR
242238581$24223858$1$I$$20240806$20240819$20240819$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202408010538$ELI LILLY AND CO$$$$A$F$Y$$$20240819$$CN$DE$MX
242238591$24223859$1$I$20240801$20240813$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408008899$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240819$$CN$US$US
242238601$24223860$1$I$$20240810$20240819$20240819$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408007718$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240819$$CN$CN$CN
242238611$24223861$1$I$$20240815$20240819$20240819$PER$$US-BAYER-2024A118358$BAYER$$25$YR$A$F$Y$$$20240819$$MD$US$US
242238631$24223863$1$I$20240601$20240816$20240819$20240819$PER$$US-BAYER-2024A118504$BAYER$$24$YR$A$F$Y$$$20240819$$CN$US$US
242238643$24223864$3$F$20240101$20240920$20240819$20240930$EXP$$US-JNJFOC-20240833886$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240930$$HP$US$US
242238651$24223865$1$I$20240728$20240815$20240819$20240819$EXP$$NVSC2024CN167368$NOVARTIS$$51$YR$$M$Y$$$20240819$$HP$CN$CN
242238661$24223866$1$I$$20240819$20240819$20240819$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046501$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240819$$CN$US$US
242238671$24223867$1$I$$20240813$20240819$20240819$EXP$$NVSC2024US165861$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
242238682$24223868$2$F$20240813$20240916$20240819$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130643$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240917$$CN$US$US
242238691$24223869$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130567$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240819$$HP$US$US
242238701$24223870$1$I$20240816$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130838$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240819$$CN$US$US
242238711$24223871$1$I$$20240815$20240819$20240819$EXP$$US-INCYTE CORPORATION-2024IN008574$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242238721$24223872$1$I$$20240813$20240819$20240819$PER$$US-SA-2024SA242771$SANOFI AVENTIS$$$$A$F$Y$$$20240819$$MD$US$US
242238751$24223875$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56935$$FDA-CTU$$74$YR$$F$N$$$20240819$N$HP$US$
242238761$24223876$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56791$$FDA-CTU$$64$YR$$F$N$$$20240819$N$$US$
242238771$24223877$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56932$$FDA-CTU$$45$YR$$F$N$$$20240819$N$$US$
242238781$24223878$1$I$20240815$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56942$$FDA-CTU$$65$YR$$M$N$$$20240819$N$$US$
242238792$24223879$2$F$20240808$20240924$20240819$20240930$EXP$$US-INCYTE CORPORATION-2024IN008567$INCYTE$$$$$$Y$$$20240930$$CN$US$US
242238801$24223880$1$I$$20240812$20240819$20240819$EXP$$US-GSK-US2024AMR101231$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$MD$US$US
242238811$24223881$1$I$$20240807$20240819$20240819$PER$$US-RDY-CLI/USA/24/0011704$DR REDDYS$$25$YR$A$F$Y$56$KG$20240819$$CN$US$US
242238831$24223883$1$I$20240717$20240814$20240819$20240819$EXP$$CA-JNJFOC-20240674029$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240819$$CN$CA$CA
242238853$24223885$3$F$$20240917$20240819$20240924$EXP$$US-GSK-US2024100208$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$US$US
242238861$24223886$1$I$20231123$20240813$20240819$20240819$EXP$$DE-ABBVIE-5881219$ABBVIE$$62$YR$$M$Y$$$20240819$$MD$DE$DE
242238871$24223887$1$I$$20240816$20240819$20240819$DIR$FDA-CDER-CTU-2024-56777$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242238881$24223888$1$I$$20240806$20240819$20240819$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US000123$PAREXEL$$76$YR$$F$Y$$$20240819$$CN$US$US
242238891$24223889$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56811$$FDA-CTU$$77$YR$$M$N$$$20240819$N$$US$
242238901$24223890$1$I$20240812$20240815$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130723$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240819$$CN$US$US
242238911$24223891$1$I$$20240816$20240819$20240819$EXP$$FR-SANDOZ INC.-SDZ2024FR073126$SANDOZ$$80$YR$$F$Y$$$20240819$$HP$FR$FR
242238921$24223892$1$I$$20240814$20240819$20240819$EXP$$US-INCYTE CORPORATION-2024IN008566$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242238931$24223893$1$I$$20240813$20240819$20240819$PER$$US-BAYER-2024A117067$BAYER$$$$$$Y$$$20240819$$PH$US$US
242238943$24223894$3$F$20240401$20240906$20240819$20240913$EXP$PT-INFARMED-T202407-1133$PT-OTSUKA-2024_022250$OTSUKA$$70$YR$$F$Y$$$20240913$$CN$PT$PT
242238951$24223895$1$I$$20240716$20240819$20240819$EXP$$ZA-AstraZeneca-2024A187758$ASTRAZENECA$$83$YR$$F$Y$$$20240819$$CN$ZA$
242238961$24223896$1$I$$20240813$20240819$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA072532$SANDOZ$$76$YR$$M$Y$$$20240819$$PH$CA$CA
242238971$24223897$1$I$$20240811$20240819$20240819$EXP$$US-AstraZeneca-2024A186304$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242238981$24223898$1$I$$20240812$20240819$20240819$EXP$$CA-AstraZeneca-2024A186861$ASTRAZENECA$$80$YR$$M$Y$89$KG$20240819$$MD$CA$
242238991$24223899$1$I$$20240816$20240819$20240819$PER$$US-BAYER-2024A118619$BAYER$$$$$$Y$$$20240819$$CN$US$US
242239001$24223900$1$I$20220815$20240813$20240819$20240819$EXP$$DE-DSJP-DSE-2024-140641$DAIICHI$$56$YR$$F$Y$$$20240819$$CN$DE$DE
242239011$24223901$1$I$20240101$20240808$20240819$20240819$PER$$US-ABBVIE-5876879$ABBVIE$$$$A$F$Y$$$20240819$$MD$US$US
242239021$24223902$1$I$$20240813$20240819$20240819$PER$$NVSC2024US165285$NOVARTIS$$$$$$Y$$$20240819$$CN$US$US
242239032$24223903$2$F$20240101$20240821$20240819$20240829$EXP$$US-JNJFOC-20240835474$JOHNSON AND JOHNSON$$34$YR$A$M$Y$98.518$KG$20240829$$HP$US$US
242239041$24223904$1$I$20240719$20240814$20240819$20240819$EXP$$CO-UCBSA-2024041638$UCB$$30$YR$$M$Y$$$20240819$$CN$CO$CO
242239052$24223905$2$F$20240801$20240819$20240819$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130420$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240820$$CN$US$US
242239061$24223906$1$I$20240805$20240808$20240819$20240819$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-126840$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240819$$CN$PR$PR
242239071$24223907$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129691$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240819$$PH$US$US
242239081$24223908$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129797$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240819$$CN$US$US
242239101$24223910$1$I$$20240811$20240819$20240819$EXP$$GB-JNJFOC-20240835065$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$GB$GB
242239111$24223911$1$I$$20240813$20240819$20240819$PER$$US-JNJFOC-20240834142$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$CN$US$US
242239121$24223912$1$I$$20240812$20240819$20240819$EXP$$US-LUNDBECK-DKLU4003036$LUNDBECK$$$$$$Y$$$20240819$$CN$US$US
242239131$24223913$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56944$$FDA-CTU$$73$YR$$F$N$$$20240819$N$$US$
242239141$24223914$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56792$$FDA-CTU$$53$YR$$F$N$91.17$KG$20240819$N$HP$US$
242239151$24223915$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56795$$FDA-CTU$$63$YR$$F$N$63.5$KG$20240819$N$$US$
242239171$24223917$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56881$$FDA-CTU$$77$YR$$F$N$$$20240819$N$$US$
242239181$24223918$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56931$$FDA-CTU$$69$YR$$F$N$75.3$KG$20240819$N$$US$
242239191$24223919$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56941$$FDA-CTU$$81$YR$$M$N$$$20240819$N$$US$
242239202$24223920$2$F$$20240813$20240819$20240821$PER$$US-JNJFOC-20240833850$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
242239211$24223921$1$I$20240815$20240817$20240817$20240817$DIR$714775$$FDA-CTU$$31$YR$$F$N$54$KG$20240817$N$CN$US$
242239221$24223922$1$I$$20240812$20240819$20240819$EXP$$IN-JNJFOC-20240837469$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240819$$HP$IN$IN
242239231$24223923$1$I$$20240811$20240819$20240819$EXP$$GR-JNJFOC-20240834106$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$GR$GR
242239242$24223924$2$F$$20240814$20240819$20240826$EXP$$JP-KYOWAKIRIN-2024KK018931$KYOWA$$$$$$Y$$$20240826$$HP$JP$JP
242239251$24223925$1$I$20240815$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130558$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240819$$CN$US$US
242239261$24223926$1$I$20230801$20240817$20240817$20240817$DIR$714768$$FDA-CTU$$56$YR$$F$N$92.25$KG$20240817$N$CN$US$
242239271$24223927$1$I$$20240810$20240819$20240819$PER$$US-SA-2024SA240555$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240819$$MD$US$US
242239281$24223928$1$I$20240727$20240805$20240819$20240819$PER$$US-SA-2024SA233382$SANOFI AVENTIS$$73$YR$E$M$Y$78.005$KG$20240819$$MD$US$US
242239292$24223929$2$F$20240813$20240829$20240819$20240902$PER$$US-AMGEN-USASP2024163480$AMGEN$$83$YR$E$F$Y$$$20240902$$CN$US$US
242239301$24223930$1$I$$20240811$20240819$20240819$PER$$US-AMGEN-USASP2024163494$AMGEN$Makhani S.; Azhar W.; Shah E. et al.. Inpatient burden and clinical outcomes of cytokine release syndrome in patients with cancer- A National Inpatient Sample study. Journal of Clinical Oncology. 2024;42 (16):11067$$$$$Y$$$20240819$$HP$US$US
242239321$24223932$1$I$20231001$20240812$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408007701$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240819$$CN$US$US
242239332$24223933$2$F$$20240916$20240819$20240918$EXP$$CA-PFIZER INC-202400238355$PFIZER$$11$YR$$M$Y$$$20240918$$HP$CA$CA
242239342$24223934$2$F$$20240816$20240819$20240821$EXP$$US-PFIZER INC-202400237223$PFIZER$Goyal, A.. Accidental Minoxidil Ingestion Causing Refractory Shock, Pulmonary Edema, and Significant EKG Changes. US Cardiology Review. 2024;18(Suppl 1):39:23-24$51$YR$$M$Y$$$20240821$$MD$US$US
242239351$24223935$1$I$20240521$20240814$20240819$20240819$EXP$$CA-JNJFOC-20240512161$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240819$$HP$CA$CA
242239361$24223936$1$I$$20240812$20240819$20240819$EXP$$CA-JNJFOC-20240835734$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$CN$CA$CA
242239372$24223937$2$F$$20240926$20240819$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128586$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240927$$CN$US$US
242239383$24223938$3$F$$20240918$20240819$20240927$PER$$US-TAKEDA-2024TUS081620$TAKEDA$$$$$$Y$$$20240927$$CN$US$US
242239392$24223939$2$F$20240811$20240819$20240819$20240829$PER$$US-AstraZeneca-2024A186582$ASTRAZENECA$$21560$DY$$F$Y$$$20240829$$CN$US$
242239401$24223940$1$I$$20240814$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US005575$SANDOZ$$$$$F$Y$$$20240819$$CN$US$US
242239411$24223941$1$I$20240619$20240816$20240819$20240819$EXP$ES-AEMPS-1561227$ES-JNJFOC-20240846426$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240819$$MD$ES$ES
242239421$24223942$1$I$$20240813$20240819$20240819$EXP$$CN-RDY-LIT/CHN/24/0011987$DR REDDYS$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turkish Journal of Hematology. 2023;40: 284-285. doi:10.4274/tjh.galenos.2023.2023.0263.$75$YR$E$F$Y$$$20240819$$HP$CN$CN
242239431$24223943$1$I$20240803$20240813$20240819$20240819$EXP$$CN-OTSUKA-2024_022442$OTSUKA$$78$YR$$M$Y$$$20240819$$HP$CN$CN
242239441$24223944$1$I$20240801$20240812$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128615$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240819$$CN$US$US
242239454$24223945$4$F$20240730$20240903$20240819$20240919$EXP$$JP-ABBVIE-5883795$ABBVIE$$43$YR$$F$Y$$$20240919$$MD$JP$JP
242239471$24223947$1$I$20240809$20240817$20240817$20240817$DIR$714716$$FDA-CTU$$40$YR$$F$N$60.75$KG$20240817$N$CN$US$
242239491$24223949$1$I$20230127$20240817$20240817$20240817$DIR$714787$$FDA-CTU$$42$YR$$F$N$130.5$KG$20240817$N$CN$US$
242239501$24223950$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56937$$FDA-CTU$$38$YR$$F$N$160.12$KG$20240819$N$$US$
242239511$24223951$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56948$$FDA-CTU$$21$YR$$F$N$$$20240819$N$$US$
242239521$24223952$1$I$20240815$20240817$20240817$20240817$DIR$714780$$FDA-CTU$$47$YR$$F$N$121.5$KG$20240817$N$CN$US$
242239531$24223953$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56840$$FDA-CTU$$55$YR$$F$N$74.84$KG$20240819$N$$US$
242239541$24223954$1$I$$20240817$20240817$20240817$DIR$714796$$FDA-CTU$$$$$M$N$$$20240817$N$CN$US$
242239551$24223955$1$I$20240401$20240817$20240817$20240817$DIR$714786$$FDA-CTU$$70$YR$$F$N$83.25$KG$20240817$N$CN$US$
242239561$24223956$1$I$20240816$20240817$20240817$20240817$DIR$714763$$FDA-CTU$$61$YR$$F$N$$$20240817$N$CN$US$
242239571$24223957$1$I$20240816$20240817$20240817$20240817$DIR$714736$$FDA-CTU$$28$YR$$F$N$121.5$KG$20240817$N$CN$US$
242239581$24223958$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56894$$FDA-CTU$$64$YR$$M$N$$$20240819$N$$US$
242239601$24223960$1$I$20240815$20240817$20240817$20240817$DIR$714785$$FDA-CTU$$40$YR$$F$N$67.5$KG$20240817$N$CN$US$
242239611$24223961$1$I$20240808$20240817$20240817$20240817$DIR$714784$$FDA-CTU$$62$YR$$F$N$$$20240817$Y$CN$US$
242239621$24223962$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56939$$FDA-CTU$$47$YR$$F$N$96.16$KG$20240819$N$$US$
242239631$24223963$1$I$$20240817$20240817$20240817$DIR$714758$$FDA-CTU$$32$YR$$UNK$N$86.4$KG$20240817$Y$CN$US$
242239651$24223965$1$I$20240101$20240813$20240819$20240819$EXP$$US-ABBVIE-5881022$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242239662$24223966$2$F$$20240827$20240819$20240828$EXP$$IR-SA-2024SA244720$SANOFI AVENTIS$$4$MON$I$F$Y$4.5$KG$20240828$$MD$IR$IR
242239671$24223967$1$I$20240701$20240813$20240819$20240819$PER$$US-SA-2024SA242773$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240819$$MD$US$US
242239681$24223968$1$I$20240801$20240813$20240819$20240819$EXP$$US-SA-2024SA243390$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240819$$MD$US$US
242239691$24223969$1$I$$20240815$20240819$20240819$EXP$$US-PFIZER INC-202400238424$PFIZER$$$$A$M$Y$$$20240819$$MD$US$US
242239701$24223970$1$I$20240808$20240814$20240819$20240819$EXP$$US-SA-2024SA243994$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240819$$MD$US$US
242239711$24223971$1$I$20240101$20240815$20240819$20240819$EXP$$CA-PFIZER INC-202400189795$PFIZER$$19$YR$$M$Y$$$20240819$$HP$CA$CA
242239721$24223972$1$I$$20240816$20240819$20240819$EXP$$HN-PFIZER INC-202400239160$PFIZER$$60$YR$$F$Y$$$20240819$$CN$HN$HN
242239731$24223973$1$I$$20240815$20240819$20240819$EXP$GB-MHRA-MED-202408151341096990-VYTKH$GB-PFIZER INC-202400237372$PFIZER$$60$YR$$F$Y$$$20240819$$HP$GB$GB
242239741$24223974$1$I$20240701$20240814$20240819$20240819$EXP$$US-ABBVIE-5881564$ABBVIE$$73$YR$$M$Y$$$20240819$$CN$US$US
242239751$24223975$1$I$$20240814$20240819$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA072974$SANDOZ$$48$YR$$F$Y$$$20240819$$CN$CA$CA
242239761$24223976$1$I$$20240814$20240819$20240819$PER$$US-ALXN-202408USA000839US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240819$$CN$US$US
242239771$24223977$1$I$$20240812$20240819$20240819$PER$$US-ALXN-202408USA000921US$ALEXION PHARMACEUTICALS$$$$$F$Y$65.76$KG$20240819$$CN$US$US
242239781$24223978$1$I$$20240815$20240819$20240819$EXP$$NVSC2024CN167384$NOVARTIS$$50$YR$$M$Y$$$20240819$$CN$CN$CN
242239791$24223979$1$I$$20240816$20240819$20240819$PER$$US-GILEAD-2024-0684532$GILEAD$$$$$F$Y$$$20240819$$PH$US$US
242239801$24223980$1$I$20240801$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128588$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240819$$CN$US$US
242239811$24223981$1$I$$20240812$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130538$BRISTOL MYERS SQUIBB$Noble CW, Gangaputra SS, Thompson IA, Yuan A, Apolo AB, Lee J-M, et al. Ocular adverse events following use of immune checkpoint inhibitors for metastatic malignancies. Ocular Immunology and Inflammation. 2019 Apr 23;28(6):854-9.doi:10.1080/09273948.2019.1583347.$56$YR$A$M$Y$$$20240819$$HP$US$US
242239821$24223982$1$I$$20240812$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130536$BRISTOL MYERS SQUIBB$Noble CW, Gangaputra SS, Thompson IA, Yuan A, Apolo AB, Lee J-M, et al. Ocular adverse events following use of immune checkpoint inhibitors for metastatic malignancies. Ocular Immunology and Inflammation. 2019 Apr 23;28(6):854-9.doi:10.1080/09273948.2019.1583347.$42$YR$A$F$Y$$$20240819$$HP$US$US
242239831$24223983$1$I$20240725$20240809$20240819$20240819$EXP$$US-BAYER-2024A108916$BAYER$$62$YR$A$M$Y$$$20240819$$CN$US$US
242239841$24223984$1$I$20240101$20240812$20240819$20240819$EXP$$US-ABBVIE-5880204$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242239851$24223985$1$I$20240101$20240813$20240819$20240819$EXP$$US-ABBVIE-5881844$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242239861$24223986$1$I$20240715$20240809$20240819$20240819$EXP$CN-NMPACDR-4201051974489202400791$CN-BAXTER-2024BAX023137$BAXTER$$58$YR$$M$Y$60$KG$20240819$$MD$CN$CN
242239872$24223987$2$F$20240808$20240905$20240819$20240920$EXP$$PL-BAXTER-2024BAX022994$BAXTER$$35$YR$$M$Y$$$20240920$$MD$PL$PL
242239881$24223988$1$I$20240802$20240809$20240819$20240819$EXP$CN-NMPACDR-3310821058829202400096$CN-BAXTER-2024BAX023146$BAXTER$$51$YR$$M$Y$$$20240819$$MD$CN$CN
242239891$24223989$1$I$20240713$20240809$20240819$20240819$EXP$CN-NMPACDR-3307841060712202400026$CN-BAXTER-2024BAX023144$BAXTER$$64$YR$$F$Y$57$KG$20240819$$MD$CN$CN
242239902$24223990$2$F$$20240830$20240819$20240907$EXP$GR-EMA-DD-20240805-7483181-111303$GR-BAXTER-2024BAX023090$BAXTER$$39$YR$$F$Y$$$20240907$$HP$GR$GR
242239911$24223991$1$I$$20240808$20240819$20240819$EXP$$CA-BAXTER-2024BAX023012$BAXTER$$6$MON$$F$Y$$$20240819$$HP$CA$CA
242239921$24223992$1$I$$20240814$20240819$20240819$EXP$$US-ABBVIE-5881958$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242239932$24223993$2$F$$20240820$20240819$20240825$EXP$$US-JNJFOC-20240846332$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$CN$US$US
242239941$24223994$1$I$20240809$20240816$20240819$20240819$EXP$GB-MHRA-MED-202408131351163910-RZLVB$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046491$BOEHRINGER INGELHEIM$$34$YR$A$F$Y$156$KG$20240819$$PH$GB$GB
242239951$24223995$1$I$20240101$20240815$20240819$20240819$PER$$US-AMGEN-USASP2024162931$AMGEN$$$$$F$Y$$$20240819$$HP$US$US
242239961$24223996$1$I$20240101$20240813$20240819$20240819$EXP$$US-ABBVIE-5880651$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242239974$24223997$4$F$20240101$20240906$20240819$20240911$EXP$$ZA-ABBVIE-5882201$ABBVIE$$$$$M$Y$78$KG$20240911$$MD$ZA$ZA
242239981$24223998$1$I$$20240808$20240819$20240819$EXP$$JP-ABBVIE-5780036$ABBVIE$$27$YR$$F$Y$$$20240819$$MD$JP$JP
242239991$24223999$1$I$$20240809$20240819$20240819$PER$$US-AstraZeneca-2024A182869$ASTRAZENECA$$$$$$Y$$$20240819$$CN$US$
242240021$24224002$1$I$$20240322$20240819$20240819$PER$$US-AstraZeneca-2024A187548$ASTRAZENECA$$$$$$Y$$$20240819$$LW$US$
242240031$24224003$1$I$$20240813$20240819$20240819$EXP$$JP-AstraZeneca-2024A184100$ASTRAZENECA$Kakiuchi and Yosuke; Tajima and Yuka. Efficacy and Safety of Combined Immunotherapy for Extensive-Stage Small Cell Lung Cancer in Patients Aged 80 or Older (The efficacy and safety of chemoimmunotherapy for patients with extensive-stage small cell lung cancer aged 80 years and. 64th Annual Meeting of the Japanese Respiratory Society (JRS) [Location: Yokohama; Japan] 2024;$90$YR$$$Y$$$20240819$$HP$JP$
242240041$24224004$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56879$$FDA-CTU$$21$YR$$F$N$54.43$KG$20240819$N$$US$
242240053$24224005$3$F$$20240903$20240819$20240910$EXP$$PT-OTSUKA-2024_021115$OTSUKA$Ferreira BS, Andrade I, Presume M, Damaso F, Ribeiro AM, De Liz FF, et.al.. For the purpose of the differential diagnosis of acute hepatitis. Congresses of the Portuguese Society of Internal Medicine. 2024;30:616$65$YR$$F$Y$$$20240910$$MD$PT$PT
242240071$24224007$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56812$$FDA-CTU$$60$YR$$F$N$56.7$KG$20240819$N$$US$
242240091$24224009$1$I$20240817$20240817$20240817$20240817$DIR$714797$$FDA-CTU$$67$YR$$F$N$135$KG$20240817$N$CN$US$
242240101$24224010$1$I$20240607$20240817$20240817$20240817$DIR$714765$$FDA-CTU$$40$YR$$F$N$61.2$KG$20240817$N$CN$US$
242240111$24224011$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56959$$FDA-CTU$$39$YR$$M$N$$$20240819$N$$US$
242240151$24224015$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56960$$FDA-CTU$$64$YR$$F$N$$$20240819$N$$US$
242240181$24224018$1$I$$20240814$20240819$20240819$PER$$US-ABBVIE-5881835$ABBVIE$$$$$$Y$$$20240819$$HP$US$US
242240191$24224019$1$I$20240815$20240817$20240817$20240817$DIR$714776$$FDA-CTU$$67$YR$$F$N$76.5$KG$20240817$$CN$US$
242240201$24224020$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-202400238048$PFIZER$$65$YR$$F$Y$$$20240819$$CN$US$US
242240211$24224021$1$I$20240813$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237447$PFIZER$$50$YR$$F$Y$$$20240819$$CN$US$US
242240231$24224023$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-202400238369$PFIZER$$59$YR$$F$Y$$$20240819$$HP$US$US
242240241$24224024$1$I$20240811$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56824$$FDA-CTU$$61$YR$$F$N$$$20240819$N$$US$
242240251$24224025$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400106935$PFIZER$$61$YR$$F$Y$$$20240819$$CN$US$US
242240261$24224026$1$I$20240815$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237564$PFIZER$$63$YR$$F$Y$$$20240819$$CN$US$US
242240291$24224029$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56925$$FDA-CTU$$52$YR$$F$N$$$20240819$N$$US$
242240301$24224030$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237812$PFIZER$$$$$$Y$$$20240819$$CN$US$US
242240311$24224031$1$I$$20240816$20240819$20240819$PER$$US-PFIZER INC-202400238437$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
242240321$24224032$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237499$PFIZER$$$$A$F$Y$$$20240819$$MD$US$US
242240331$24224033$1$I$$20240816$20240819$20240819$PER$$US-PFIZER INC-202400238430$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
242240342$24224034$2$F$$20240820$20240819$20240820$30DAY$$DE-PFIZER INC-202400238419$PFIZER$$$$$$Y$$$20240820$$HP$DE$DE
242240351$24224035$1$I$$20240816$20240819$20240819$PER$$US-PFIZER INC-202400238536$PFIZER$$$$$$Y$$$20240819$$CN$US$US
242240361$24224036$1$I$20240814$20240816$20240819$20240819$PER$$JP-PFIZER INC-202400237671$PFIZER$$$$$$Y$$$20240819$$PH$JP$JP
242240371$24224037$1$I$20240101$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400106683$PFIZER$$49$YR$$F$Y$$$20240819$$HP$US$US
242240381$24224038$1$I$20240801$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400106900$PFIZER$$82$YR$$$Y$$$20240819$$CN$US$US
242240391$24224039$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-202400238093$PFIZER$$$$$$Y$$$20240819$$CN$US$US
242240402$24224040$2$F$20240813$20240819$20240819$20240820$PER$$US-PFIZER INC-202400237554$PFIZER$$41$YR$$F$Y$$$20240820$$CN$US$US
242240411$24224041$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400236617$PFIZER$$62$YR$$M$Y$$$20240819$$CN$US$US
242240421$24224042$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400106840$PFIZER$$52$YR$$F$Y$$$20240819$$HP$US$US
242240431$24224043$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237424$PFIZER$$70$YR$$F$Y$69.4$KG$20240819$$CN$US$US
242240441$24224044$1$I$20240814$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237748$PFIZER$$67$YR$$F$Y$$$20240819$$CN$US$US
242240451$24224045$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400106925$PFIZER$$$$A$F$Y$$$20240819$$HP$US$US
242240461$24224046$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-202400238338$PFIZER$$$$A$$Y$$$20240819$$MD$US$US
242240471$24224047$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400106667$PFIZER$$72$YR$$F$Y$$$20240819$$CN$US$US
242240481$24224048$1$I$20240807$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237574$PFIZER$$65$YR$$F$Y$$$20240819$$CN$US$US
242240491$24224049$1$I$20230101$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237988$PFIZER$$72$YR$$M$Y$$$20240819$$CN$US$US
242240501$24224050$1$I$20240101$20240816$20240819$20240819$PER$$US-PFIZER INC-PV202400107253$PFIZER$$8$DEC$$F$Y$$$20240819$$PH$US$US
242240512$24224051$2$F$20240101$20240905$20240819$20240909$PER$$US-PFIZER INC-202400237209$PFIZER$$80$YR$$M$Y$$$20240909$$CN$US$US
242240521$24224052$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400107227$PFIZER$$48$YR$$F$Y$$$20240819$$CN$US$US
242240533$24224053$3$F$20240813$20240913$20240819$20240917$PER$$US-PFIZER INC-202400237642$PFIZER$$55$YR$$F$Y$$$20240917$$HP$US$US
242240542$24224054$2$F$20240815$20240905$20240819$20240906$PER$$US-PFIZER INC-202400237738$PFIZER$$55$YR$$F$Y$62.132$KG$20240906$$CN$US$US
242240551$24224055$1$I$20240813$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237750$PFIZER$$42$YR$$$Y$$$20240819$$CN$US$US
242240562$24224056$2$F$$20240820$20240819$20240826$PER$$US-PFIZER INC-202400237694$PFIZER$$$$$$Y$$$20240826$$CN$US$US
242240571$24224057$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400236888$PFIZER$$$$$F$Y$$$20240819$$PH$US$US
242240581$24224058$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237706$PFIZER$$66$YR$$M$Y$$$20240819$$HP$US$US
242240591$24224059$1$I$$20240816$20240819$20240819$PER$$US-PFIZER INC-202400238606$PFIZER$$73$YR$$F$Y$$$20240819$$CN$US$US
242240601$24224060$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400106923$PFIZER$$$$A$F$Y$$$20240819$$HP$US$US
242240612$24224061$2$F$20240811$20240912$20240819$20240916$PER$$US-PFIZER INC-PV202400107012$PFIZER$$79$YR$$F$Y$$$20240916$$CN$US$US
242240621$24224062$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400107274$PFIZER$$43$YR$$F$Y$$$20240819$$CN$US$US
242240631$24224063$1$I$$20240816$20240819$20240819$PER$$US-PFIZER INC-202400238590$PFIZER$$39$YR$$F$Y$$$20240819$$HP$US$US
242240641$24224064$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-202200317300$PFIZER$$71$YR$$F$Y$$$20240819$$CN$US$US
242240651$24224065$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-PV202400106268$PFIZER$$$$$M$Y$$$20240819$$CN$US$US
242240662$24224066$2$F$20240801$20240919$20240819$20240919$PER$$US-PFIZER INC-202400236673$PFIZER$$72$YR$$M$Y$53.52$KG$20240919$$CN$US$US
242240672$24224067$2$F$$20240819$20240819$20240822$PER$$US-PFIZER INC-202400237770$PFIZER$$57$YR$$F$Y$$$20240822$$CN$US$US
242240682$24224068$2$F$20240813$20240823$20240819$20240827$PER$$US-PFIZER INC-202400238033$PFIZER$$58$YR$$F$Y$$$20240827$$CN$US$US
242240691$24224069$1$I$20240802$20240815$20240819$20240819$PER$$US-PFIZER INC-202400238028$PFIZER$$71$YR$$M$Y$$$20240819$$CN$US$US
242240702$24224070$2$F$$20240926$20240819$20240930$PER$$US-PFIZER INC-202400236571$PFIZER$$39$YR$$F$Y$$$20240930$$CN$US$US
242240711$24224071$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400106984$PFIZER$$47$YR$$F$Y$$$20240819$$CN$US$US
242240721$24224072$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400106674$PFIZER$$79$YR$$F$Y$$$20240819$$CN$US$US
242240731$24224073$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-PV202400106233$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
242240741$24224074$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-202400238464$PFIZER$$27$YR$$M$Y$$$20240819$$HP$US$US
242240751$24224075$1$I$20240813$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237827$PFIZER$$66$YR$$M$Y$$$20240819$$CN$US$US
242240762$24224076$2$F$20240810$20240820$20240819$20240822$PER$$US-PFIZER INC-202400237246$PFIZER$$85$YR$$F$Y$65.77$KG$20240822$$CN$US$US
242240771$24224077$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400107255$PFIZER$$77$YR$$F$Y$$$20240819$$CN$US$US
242240781$24224078$1$I$20240816$20240817$20240819$20240819$PER$$US-PFIZER INC-202400238544$PFIZER$$73$YR$$M$Y$$$20240819$$CN$US$US
242240791$24224079$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-PV202400106901$PFIZER$$86$YR$$F$Y$$$20240819$$HP$US$US
242240801$24224080$1$I$20240814$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237160$PFIZER$$77$YR$$M$Y$$$20240819$$MD$US$US
242240811$24224081$1$I$20240801$20240814$20240819$20240819$PER$$US-PFIZER INC-202400236562$PFIZER$$79$YR$$F$Y$$$20240819$$CN$US$US
242240821$24224082$1$I$20240808$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237578$PFIZER$$30$YR$$F$Y$$$20240819$$HP$US$US
242240832$24224083$2$F$20240805$20240905$20240819$20240909$PER$$US-PFIZER INC-202400237802$PFIZER$$72$YR$$F$Y$81.633$KG$20240909$$CN$US$US
242240851$24224085$1$I$20240811$20240813$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408008861$ELI LILLY AND CO$$$$A$F$Y$$$20240819$$CN$US$US
242240861$24224086$1$I$$20240818$20240818$20240818$DIR$714803$$FDA-CTU$$55$YR$$F$N$65.25$KG$20240818$N$CN$US$
242240871$24224087$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56958$$FDA-CTU$$35$YR$$F$N$$$20240819$N$$US$
242240891$24224089$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56962$$FDA-CTU$$72$YR$$M$N$$$20240819$N$$US$
242240901$24224090$1$I$$20240814$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US073056$SANDOZ$$$$$F$Y$$$20240819$$CN$US$US
242240911$24224091$1$I$20240620$20240813$20240819$20240819$EXP$$US-OTSUKA-2024_022400$OTSUKA$$62$YR$$F$Y$$$20240819$$CN$US$US
242240922$24224092$2$F$20240806$20240822$20240819$20240826$EXP$$US-SANDOZ INC.-SDZ2024US072548$SANDOZ$$57$YR$$F$Y$69.2$KG$20240826$$CN$US$US
242240931$24224093$1$I$20240514$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130878$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240819$$HP$US$US
242240941$24224094$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129249$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240819$$HP$US$US
242240951$24224095$1$I$$20240809$20240819$20240819$EXP$$US-JNJFOC-20240825058$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$CN$US$US
242240961$24224096$1$I$$20240816$20240819$20240819$EXP$AU-TGA-0000816014$AU-SANDOZ INC.-SDZ2024AU073435$SANDOZ$$73$YR$$M$Y$$$20240819$$HP$AU$AU
242240971$24224097$1$I$$20240805$20240819$20240819$EXP$$GB-UCBSA-2024039640$UCB$$$$$F$Y$$$20240819$$CN$GB$GB
242240981$24224098$1$I$20240101$20240814$20240819$20240819$EXP$$US-SA-2024SA244014$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240819$$MD$US$US
242240991$24224099$1$I$$20240723$20240819$20240819$PER$$US-009507513-2407USA013207$MERCK$$$$$F$Y$56.7$KG$20240819$$CN$US$US
242241001$24224100$1$I$$20240809$20240819$20240819$EXP$$US-TEVA-VS-3233064$TEVA$$58$YR$$M$Y$$$20240819$$LW$US$US
242241011$24224101$1$I$$20240807$20240819$20240819$PER$$US-SA-2024SA240722$SANOFI AVENTIS$$$$A$M$Y$131$KG$20240819$$MD$US$US
242241021$24224102$1$I$$20240815$20240819$20240819$PER$$US-Eisai-EC-2024-172259$EISAI$$$$$M$Y$$$20240819$$HP$US$US
242241031$24224103$1$I$$20240815$20240819$20240819$EXP$$US-INCYTE CORPORATION-2024IN008563$INCYTE$$$$$$Y$$$20240819$$PH$US$US
242241042$24224104$2$F$$20240904$20240819$20240913$30DAY$$US-GSK-US2024099770$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
242241051$24224105$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130610$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240819$$CN$US$US
242241061$24224106$1$I$$20240813$20240819$20240819$EXP$$US-BAYER-2024A117366$BAYER$$60$YR$A$M$Y$$$20240819$$CN$US$US
242241081$24224108$1$I$20240628$20240816$20240819$20240819$DIR$FDA-CDER-CTU-2024-56776$$FDA-CTU$$66$YR$$F$N$$$20240816$N$HP$US$
242241091$24224109$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56946$$FDA-CTU$$68$YR$$F$N$77.56$KG$20240819$N$$US$
242241111$24224111$1$I$$20240816$20240819$20240819$DIR$FDA-CDER-CTU-2024-56779$$FDA-CTU$$$$$M$N$$$20240816$N$HP$US$
242241121$24224112$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56870$$FDA-CTU$$93$YR$$M$N$$$20240819$N$$US$
242241141$24224114$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56928$$FDA-CTU$$77$YR$$F$N$$$20240819$N$$US$
242241151$24224115$1$I$20240726$20240818$20240818$20240818$DIR$714817$$FDA-CTU$$76$YR$$F$N$60$KG$20240818$N$CN$US$
242241161$24224116$1$I$$20240815$20240819$20240819$EXP$$US-INCYTE CORPORATION-2024IN008562$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242241171$24224117$1$I$20240701$20240815$20240819$20240819$EXP$$US-TAKEDA-2024TUS076770$TAKEDA$$77$YR$$M$Y$$$20240819$$CN$US$US
242241182$24224118$2$F$$20240826$20240819$20240830$EXP$$US-INCYTE CORPORATION-2024IN008485$INCYTE$$$$$$Y$$$20240830$$MD$US$US
242241201$24224120$1$I$20240809$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408091343505770-CPDHV$GB-TEVA-VS-3232241$TEVA$$61$YR$$F$Y$$$20240819$$PH$GB$GB
242241211$24224121$1$I$20201101$20240812$20240819$20240819$EXP$$US-SA-2024SA240992$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240819$$HP$US$US
242241221$24224122$1$I$20210101$20240812$20240819$20240819$EXP$$US-SA-2024SA239917$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240819$$CN$US$US
242241232$24224123$2$F$20240713$20240906$20240819$20240909$EXP$$JP-PFIZER INC-PV202400094012$PFIZER$$7$DEC$$F$Y$55$KG$20240909$$PH$JP$JP
242241241$24224124$1$I$20230101$20240815$20240819$20240819$PER$$US-BAUSCH-BL-2024-012431$BAUSCH AND LOMB$$$$$M$Y$$$20240819$$CN$US$US
242241251$24224125$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167511$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
242241262$24224126$2$F$20240712$20240823$20240819$20240826$30DAY$$US-SANDOZ INC.-SDZ2024US073548$SANDOZ$$66$YR$$F$Y$$$20240826$$HP$US$US
242241272$24224127$2$F$$20240820$20240819$20240830$EXP$$PL-TEVA-VS-3232589$TEVA$$55$YR$$F$Y$$$20240830$$PH$PL$PL
242241281$24224128$1$I$20240622$20240813$20240819$20240819$EXP$$US-BAUSCH-BL-2023-019055$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240819$$CN$US$US
242241291$24224129$1$I$20240801$20240813$20240819$20240819$PER$$US-BAUSCH-BL-2024-012314$BAUSCH AND LOMB$$87$YR$$F$Y$$$20240819$$CN$US$US
242241302$24224130$2$F$20240613$20240822$20240819$20240827$EXP$$DE-BAUSCH-BL-2024-012510$BAUSCH AND LOMB$$77$YR$$M$Y$65$KG$20240827$$MD$DE$DE
242241311$24224131$1$I$20240101$20240813$20240819$20240819$PER$$US-BAUSCH-BL-2024-003669$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240819$$CN$US$US
242241321$24224132$1$I$$20240814$20240819$20240819$EXP$$CA-OTSUKA-2024_018330$OTSUKA$$$$$M$Y$$$20240819$$CN$CA$CA
242241331$24224133$1$I$$20240809$20240819$20240819$EXP$$JO-MYLANLABS-2024M1076210$MYLAN$Jadallah RK, Al Sharie AH, Alzghoul SM, Al-Karaki JM, Amer MSB, Rawashdeh TH, et al. Palbociclib and Fulvestrant Combined Regimen Induced Prolonged Bone Metastasis Control of Stage IV HR+/HER2- Breast Cancer: A Case Report. Radiol-Case-Rep 2024; 19 (9): 4049-4054.$58$YR$$F$Y$$$20240819$$HP$JO$JO
242241342$24224134$2$F$20240807$20240823$20240819$20240823$EXP$$IT-BAUSCH-BL-2024-012490$BAUSCH AND LOMB$$54$YR$$M$Y$77$KG$20240823$$HP$IT$IT
242241352$24224135$2$F$20240628$20240917$20240819$20240918$EXP$$US-TAKEDA-2024TUS081930$TAKEDA$$19$YR$$M$Y$$$20240918$$HP$US$US
242241361$24224136$1$I$20240730$20240812$20240819$20240819$EXP$$CN-009507513-2408CHN005393$MERCK$$83$YR$$M$Y$60$KG$20240819$$HP$CN$CN
242241371$24224137$1$I$20230101$20240814$20240819$20240819$PER$$US-ABBVIE-5881625$ABBVIE$$$$$F$Y$99.79$KG$20240819$$CN$US$US
242241381$24224138$1$I$$20240815$20240819$20240819$PER$$NVSC2024US167477$NOVARTIS$$$$$$Y$$$20240819$$MD$US$US
242241392$24224139$2$F$20240101$20240907$20240819$20240912$EXP$$CA-BAUSCH-BL-2024-012368$BAUSCH AND LOMB$$69$YR$$M$Y$$$20240912$$CN$CA$CA
242241401$24224140$1$I$20240815$20240816$20240819$20240819$EXP$$US-TAKEDA-2024TUS082765$TAKEDA$$68$YR$$F$Y$$$20240819$$CN$US$US
242241411$24224141$1$I$20240813$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237202$PFIZER$$35$YR$$M$Y$$$20240819$$MD$US$US
242241421$24224142$1$I$20240814$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237015$PFIZER$$54$YR$$F$Y$$$20240819$$CN$US$US
242241431$24224143$1$I$20240815$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237582$PFIZER$$56$YR$$F$Y$$$20240819$$CN$US$US
242241441$24224144$1$I$$20240814$20240819$20240819$PER$$US-PFIZER INC-PV202400106234$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
242241451$24224145$1$I$20240808$20240814$20240819$20240819$PER$$US-PFIZER INC-202400237181$PFIZER$$63$YR$$F$Y$$$20240819$$CN$US$US
242241471$24224147$1$I$$20240813$20240819$20240819$PER$$US-PFIZER INC-PV202400106564$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
242241482$24224148$2$F$20240101$20240919$20240819$20240919$PER$$US-PFIZER INC-202400237147$PFIZER$$58$YR$$M$Y$$$20240919$$CN$US$US
242241491$24224149$1$I$20240815$20240815$20240819$20240819$PER$$US-PFIZER INC-202400237800$PFIZER$$71$YR$$M$Y$$$20240819$$CN$US$US
242241501$24224150$1$I$20240101$20240815$20240819$20240819$EXP$$CA-ORGANON-O2408CAN001306$ORGANON$$19$YR$$F$Y$$$20240819$$PH$CA$CA
242241511$24224151$1$I$20240205$20240814$20240819$20240819$PER$$US-ABBVIE-5881662$ABBVIE$$76$YR$$F$Y$64.863$KG$20240819$$CN$US$US
242241521$24224152$1$I$$20240402$20240819$20240819$PER$$US-TPU-TPU2023-00575$TEIKOKU$$$$$$Y$$$20240819$$CN$US$US
242241531$24224153$1$I$20240701$20240816$20240819$20240819$PER$$NVSC2024US167408$NOVARTIS$$18$YR$$F$Y$$$20240819$$CN$US$US
242241541$24224154$1$I$$20240809$20240819$20240819$PER$US-MLMSERVICE-20240805-PI152046-00150-1$US-RDY-SPO/USA/24/0011788$DR REDDYS$Shah PJ, Blair JE. Voriconazole-Induced Periostitis: A Mimicker of Skeletal Coccidioidomycosis. The American journal of case reports. 2024;25:e944102. DOI: 10.12659/AJCR.944102.$50$YR$A$F$Y$62$KG$20240819$$MD$US$US
242241551$24224155$1$I$$20240812$20240819$20240819$EXP$$CA-TOLMAR, INC.-24CA051809$TOLMAR$$$$$M$Y$$$20240819$$MD$CA$CA
242241561$24224156$1$I$$20240812$20240819$20240819$EXP$$CA-TOLMAR, INC.-24CA051810$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
242241571$24224157$1$I$$20240812$20240819$20240819$EXP$$CA-TOLMAR, INC.-24CA051833$TOLMAR$$$$$M$Y$$$20240819$$CN$CA$CA
242241581$24224158$1$I$20240101$20240813$20240819$20240819$EXP$$GR-BIOMARINAP-GR-2024-159821$BIOMARIN$$$$$$Y$$$20240819$$CN$GR$GR
242241591$24224159$1$I$20240809$20240818$20240818$20240818$DIR$714816$$FDA-CTU$$$$$F$N$40.5$KG$20240818$N$CN$US$
242241601$24224160$1$I$20230701$20240809$20240819$20240819$EXP$FR-AFSSAPS-ST2024001256$FR-TEVA-VS-3232927$TEVA$$21$YR$$F$Y$$$20240819$$MD$FR$FR
242241611$24224161$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56961$$FDA-CTU$$52$YR$$F$N$83.91$KG$20240819$N$$US$
242241621$24224162$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56964$$FDA-CTU$$65$YR$$F$N$79.38$KG$20240819$N$$US$
242241631$24224163$1$I$$20240731$20240819$20240819$DIR$FDA-CDER-CTU-2024-56924$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
242241641$24224164$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128584$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240819$$HP$US$US
242241651$24224165$1$I$$20240814$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129766$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240819$$CN$US$US
242241661$24224166$1$I$$20240813$20240819$20240819$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-121617$BRISTOL MYERS SQUIBB$$102$YR$E$M$Y$$$20240819$$CN$FR$FR
242241671$24224167$1$I$$20240814$20240819$20240819$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-129694$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240819$$CN$PR$PR
242241681$24224168$1$I$$20240812$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130537$BRISTOL MYERS SQUIBB$Noble CW, Gangaputra SS, Thompson IA, Yuan A, Apolo AB, Lee J-M, et al. Ocular adverse events following use of immune checkpoint inhibitors for metastatic malignancies. Ocular Immunology and Inflammation. 2019 Apr 23;28(6):854-9.doi:10.1080/09273948.2019.1583347.$63$YR$A$M$Y$$$20240819$$HP$US$US
242241691$24224169$1$I$$20240814$20240819$20240819$EXP$$NVSC2024GB165559$NOVARTIS$$$$$M$Y$$$20240819$$MD$GB$GB
242241703$24224170$3$F$20240708$20240905$20240819$20240910$EXP$$NVSC2024AR166849$NOVARTIS$$4$YR$$F$Y$18$KG$20240910$$CN$AR$AR
242241711$24224171$1$I$20240803$20240814$20240819$20240819$EXP$$CN-009507513-2408CHN005784$MERCK$$74$YR$$M$Y$63$KG$20240819$$HP$CN$CN
242241731$24224173$1$I$20240811$20240818$20240818$20240818$DIR$714819$$FDA-CTU$$67$YR$$M$N$101.25$KG$20240818$N$CN$US$
242241742$24224174$2$F$20240730$20240916$20240819$20240917$PER$$NVSC2024US167085$NOVARTIS$$76$YR$$M$Y$$$20240918$$CN$US$US
242241751$24224175$1$I$20240811$20240812$20240819$20240819$PER$$US-Xttrium Laboratories, Inc-2160594$XTTRIUM$$$$$M$Y$$$20240819$$$US$US
242241761$24224176$1$I$$20240814$20240819$20240819$EXP$$US-BIOMARINAP-US-2024-159847$BIOMARIN$$$$$$Y$$$20240819$$CN$US$US
242241771$24224177$1$I$20240711$20240812$20240819$20240819$PER$$US-Rare Disease Therapeutics, Inc.-2160596$RARE DISEASE THERAPEUTICS$$29$YR$$M$Y$95.3$KG$20240819$$PH$US$US
242241781$24224178$1$I$20240813$20240813$20240819$20240819$EXP$$US-BIOMARINAP-US-2024-159859$BIOMARIN$$$$$$Y$$$20240819$$CN$US$US
242241791$24224179$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56945$$FDA-CTU$$80$YR$$F$N$$$20240819$N$$US$
242241801$24224180$1$I$20240519$20240805$20240819$20240819$EXP$$US-Kindeva Drug Delivery L.P.-2160539$KINDEVA DRUG DELIVERY$$37$YR$$M$Y$$$20240819$$$US$US
242241811$24224181$1$I$20240812$20240816$20240819$20240819$EXP$$CN-PFIZER INC-PV202400107449$PFIZER$$60$YR$$M$Y$50$KG$20240819$$HP$CN$CN
242241821$24224182$1$I$20240815$20240816$20240819$20240819$PER$$US-AMGEN-USASP2024163874$AMGEN$$$$$F$Y$$$20240819$$CN$US$US
242241831$24224183$1$I$$20240807$20240819$20240819$EXP$$JP-B.Braun Medical Inc.-2160595$B BRAUN$Literature Article$19$YR$$F$Y$$$20240819$$$JP$JP
242241841$24224184$1$I$$20240807$20240819$20240819$EXP$$US-B.Braun Medical Inc.-2160597$B BRAUN$Literature Article$16$YR$$M$Y$$$20240819$$$US$US
242241851$24224185$1$I$$20240809$20240819$20240819$EXP$$US-TEVA-VS-3233151$TEVA$$26$YR$$M$Y$$$20240819$$HP$US$US
242241861$24224186$1$I$20240608$20240819$20240819$20240819$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046508$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240819$$CN$CA$CA
242241872$24224187$2$F$20240814$20240815$20240819$20240824$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025614$UNITED THERAPEUTICS$$52$YR$$F$Y$125.62$KG$20240824$$$US$US
242241881$24224188$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130879$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240819$$CN$US$US
242241891$24224189$1$I$$20240814$20240819$20240819$EXP$$US-OTSUKA-2024_022533$OTSUKA$$$$$M$Y$$$20240819$$CN$US$US
242241921$24224192$1$I$$20240805$20240819$20240819$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK093313$GLENMARK$$$$$$Y$$$20240819$$HP$CA$CA
242241931$24224193$1$I$$20240816$20240819$20240819$DIR$FDA-CDER-CTU-2024-56781$$FDA-CTU$$76$YR$$M$N$$$20240816$N$HP$US$
242241941$24224194$1$I$20240815$20240818$20240818$20240818$DIR$714850$$FDA-CTU$$38$YR$$M$N$108$KG$20240818$N$CN$US$
242241951$24224195$1$I$20240720$20240818$20240819$20240819$DIR$FDA-CDER-CTU-2024-56934$$FDA-CTU$$74$YR$$M$N$$$20240818$N$HP$US$
242241961$24224196$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56930$$FDA-CTU$$91$YR$$M$N$$$20240819$N$$US$
242241971$24224197$1$I$$20240816$20240819$20240819$DIR$FDA-CDER-CTU-2024-56892$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242241981$24224198$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56940$$FDA-CTU$$56$YR$$M$N$$$20240819$N$$US$
242241991$24224199$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56858$$FDA-CTU$$59$YR$$M$N$117.93$KG$20240819$N$$US$
242242031$24224203$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56963$$FDA-CTU$$72$YR$$M$N$$$20240819$N$$US$
242242041$24224204$1$I$$20240816$20240819$20240819$PER$$US-TAKEDA-2024TUS082685$TAKEDA$$$$$M$Y$$$20240819$$CN$US$US
242242051$24224205$1$I$20230101$20240812$20240819$20240819$EXP$$CN-KARYOPHARM-2024KPT001427$KARYOPHARM THERAPEUTICS$Shi-xuan Wang, Fang Wang, Ye-chao Tu, et.al. Rare case of simultaneous occurrence of chronic neutrophil leukemia and T lymphoblastic lymphoma: case report and literature review. Annals of Hematology. 2024$$$$$Y$$$20240819$$MD$CN$CN
242242061$24224206$1$I$20240814$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024163477$AMGEN$$46$YR$A$M$Y$$$20240819$$CN$US$US
242242081$24224208$1$I$20240729$20240809$20240819$20240819$EXP$$CN-AstraZeneca-2024A182345$ASTRAZENECA$$43$YR$$F$Y$$$20240819$$MD$CN$
242242091$24224209$1$I$20240701$20240815$20240819$20240819$EXP$$AE-AstraZeneca-2024A187731$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$AE$
242242101$24224210$1$I$$20240816$20240819$20240819$PER$$US-JNJFOC-20240842391$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$US$US
242242112$24224211$2$F$20190417$20240809$20240819$20240820$EXP$$AU-JNJFOC-20240831293$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240820$$MD$AU$AU
242242121$24224212$1$I$$20240816$20240819$20240819$EXP$$US-BAYER-2024A118972$BAYER$$76$YR$E$M$Y$$$20240819$$MD$US$US
242242131$24224213$1$I$$20240807$20240819$20240819$PER$$US-BAYER-2024A119167$BAYER$$28$YR$A$F$Y$$$20240819$$HP$US$US
242242152$24224215$2$F$20240101$20240911$20240819$20240923$EXP$$CA-SK LIFE SCIENCE, INC.-SKPVG-2024-001440$SK LIFE SCIENCE$$$$$$Y$$$20240923$$HP$CA$CA
242242161$24224216$1$I$$20240811$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127144$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$90.72$KG$20240819$$CN$US$US
242242171$24224217$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128490$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$45.36$KG$20240819$$CN$US$US
242242181$24224218$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129728$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$93.89$KG$20240819$$HP$US$US
242242191$24224219$1$I$$20240812$20240819$20240819$PER$$US-SA-2024SA243191$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240819$$MD$US$US
242242201$24224220$1$I$$20240807$20240819$20240819$PER$$US-BAYER-2024A119166$BAYER$$64$YR$A$F$Y$$$20240819$$HP$US$US
242242211$24224221$1$I$20240809$20240814$20240819$20240819$EXP$$CN-DAIICHI SANKYO, INC.-DSJ-2024-140662$DAIICHI$$54$YR$$M$Y$56.2$KG$20240819$$HP$CN$CN
242242221$24224222$1$I$$20240806$20240819$20240819$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001813$SK LIFE SCIENCE$$$$$$Y$$$20240819$$HP$US$US
242242231$24224223$1$I$20240614$20240809$20240819$20240819$EXP$ES-AEMPS-1556398$ES-TEVA-VS-3232759$TEVA$$46$YR$$M$Y$83.9$KG$20240819$$MD$ES$ES
242242241$24224224$1$I$20240703$20240818$20240818$20240818$DIR$714820$$FDA-CTU$$80$YR$$M$N$83.25$KG$20240818$N$CN$US$
242242251$24224225$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56951$$FDA-CTU$$63$YR$$F$N$$$20240819$N$$US$
242242261$24224226$1$I$$20240815$20240819$20240819$30DAY$$US-SANDOZ INC.-SDZ2024US073359$SANDOZ$$$$$F$Y$$$20240819$$HP$US$US
242242272$24224227$2$F$$20240820$20240819$20240830$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001817$SK LIFE SCIENCE$$$$$$Y$$$20240830$$CN$US$US
242242281$24224228$1$I$20240629$20240816$20240819$20240819$DIR$FDA-CDER-CTU-2024-56788$$FDA-CTU$$59$YR$$M$N$$$20240816$N$HP$US$
242242291$24224229$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56825$$FDA-CTU$$83$YR$$F$N$$$20240819$N$$US$
242242301$24224230$1$I$$20240814$20240819$20240819$PER$$US-ABBVIE-5882829$ABBVIE$$$$A$F$Y$$$20240819$$MD$US$US
242242321$24224232$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56794$$FDA-CTU$$59$YR$$F$N$$$20240819$N$$US$
242242331$24224233$1$I$$20240816$20240819$20240819$DIR$FDA-CDER-CTU-2024-56903$$FDA-CTU$$$$$F$N$$$20240816$N$$US$
242242341$24224234$1$I$20240325$20240818$20240818$20240818$DIR$714856$$FDA-CTU$$46$YR$$F$N$74.25$KG$20240818$N$CN$US$
242242352$24224235$2$F$$20240820$20240819$20240826$EXP$$US-MYLANLABS-2024M1076674$MYLAN$$$$$M$Y$99.79$KG$20240826$$CN$US$US
242242361$24224236$1$I$$20240807$20240819$20240819$EXP$$US-MYLANLABS-2024M1074713$MYLAN$Alshawa L, Leahy B, Rueckert J, Maskey A, Anstead M, Keshavamurthy S, et al. Hemophagocytic Lymphohistiocytosis: A Rare Diagnosis in the Immediate Aftermath of Lung Transplantation. J-Heart-Lung-Transplant 2024; 43 (Suppl.) (4): S484-S485 abstr. 1040.$63$YR$$M$Y$$$20240819$$HP$US$US
242242371$24224237$1$I$20240101$20240809$20240819$20240819$PER$$US-ABBVIE-5876013$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242242381$24224238$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56943$$FDA-CTU$$$$$F$N$$$20240819$N$$US$
242242391$24224239$1$I$20240806$20240818$20240818$20240818$DIR$714843$$FDA-CTU$$82$YR$$F$N$67.5$KG$20240818$Y$CN$US$
242242401$24224240$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56936$$FDA-CTU$$34$YR$$F$N$169$LBS$20240819$N$$US$
242242411$24224241$1$I$20240618$20240809$20240819$20240819$EXP$FR-AFSSAPS-NC2024000948$FR-009507513-2408FRA003911$MERCK$$46$YR$$F$Y$52.5$KG$20240819$$MD$FR$FR
242242422$24224242$2$F$$20240910$20240819$20240920$30DAY$$US-GSK-US2024AMR102076$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
242242431$24224243$1$I$$20240814$20240819$20240819$EXP$$FR-GSK-FR2024GSK101062$GLAXOSMITHKLINE$$$$$$Y$$$20240819$$MD$FR$FR
242242441$24224244$1$I$$20240812$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US072462$SANDOZ$Farooq O, Lin R, Easow B, Chhabra P, Kaur P. A Rare Case of Cephalosporin Anaphylaxis Induced Reverse Takotsubo. Cureus Part of Springer Nature. 2024;16(7):e63987; 1-5$66$YR$$F$Y$$$20240819$$HP$US$US
242242451$24224245$1$I$$20240813$20240819$20240819$EXP$$CA-SANDOZ INC.-SDZ2023CA005803$SANDOZ$$53$YR$$F$Y$53$KG$20240819$$HP$CA$CA
242242473$24224247$3$F$$20240909$20240819$20240912$30DAY$$GB-MYLANLABS-2024M1075972$MYLAN$$$$$$Y$$$20240912$$CN$GB$GB
242242483$24224248$3$F$$20240923$20240819$20240930$30DAY$$US-MYLANLABS-2024M1075949$MYLAN$$$$$M$Y$113.4$KG$20240930$$CN$US$US
242242492$24224249$2$F$$20240814$20240819$20240828$PER$$US-SA-2024SA242317$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240828$$MD$US$US
242242501$24224250$1$I$20240702$20240812$20240819$20240819$PER$$US-SA-2024SA243184$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240819$$MD$US$US
242242511$24224251$1$I$20231128$20240812$20240819$20240819$EXP$$AU-009507513-2408AUS005155$MERCK$$74$YR$$F$Y$81.2$KG$20240819$$MD$AU$AU
242242521$24224252$1$I$20240710$20240806$20240819$20240819$EXP$$US-Fagron Sterile Services-2160607$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$30$YR$$F$Y$91.39$KG$20240819$$PH$US$US
242242542$24224254$2$F$20240808$20240905$20240819$20240920$EXP$$PL-BAXTER-2024BAX022999$BAXTER$$63$YR$$F$Y$$$20240920$$MD$PL$PL
242242551$24224255$1$I$$20240809$20240819$20240819$EXP$$US-BAXTER-2024BAX023041$BAXTER$$$$$F$Y$$$20240819$$CN$US$US
242242561$24224256$1$I$20240803$20240815$20240819$20240819$EXP$$NVSC2024CN167231$NOVARTIS$$70$YR$$F$Y$62$KG$20240819$$HP$CN$CN
242242571$24224257$1$I$$20240807$20240819$20240819$PER$$US-ABBVIE-5876062$ABBVIE$$$$$M$Y$$$20240819$$MD$US$US
242242581$24224258$1$I$$20240814$20240819$20240819$EXP$$US-TAKEDA-2024TUS082273$TAKEDA$$$$$M$Y$$$20240819$$CN$US$US
242242601$24224260$1$I$20230401$20240819$20240819$20240819$EXP$RO-NMA-2024-SP0532$RO-ROCHE-10000060189$ROCHE$$36$YR$A$F$Y$$$20240819$$MD$RO$RO
242242612$24224261$2$F$20240101$20240912$20240819$20240918$EXP$$CA-KARYOPHARM-2024KPT001070$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240918$$CN$CA$CA
242242631$24224263$1$I$20240726$20240818$20240818$20240818$DIR$714851$$FDA-CTU$$26$YR$$F$N$62.55$KG$20240818$Y$CN$US$
242242641$24224264$1$I$20231016$20240818$20240818$20240818$DIR$714863$$FDA-CTU$$79$YR$$F$N$59.4$KG$20240818$N$CN$US$
242242661$24224266$1$I$20240126$20240818$20240818$20240818$DIR$714867$$FDA-CTU$$69$YR$$F$N$60.75$KG$20240818$N$CN$US$
242242671$24224267$1$I$20240714$20240818$20240818$20240818$DIR$714871$$FDA-CTU$$72$YR$$F$N$67.5$KG$20240818$N$CN$US$
242242682$24224268$2$F$20240101$20240917$20240819$20240919$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16091$IPSEN$$56$YR$A$F$Y$56.1$KG$20240919$$CN$US$US
242242691$24224269$1$I$$20240814$20240819$20240819$30DAY$$US-SANDOZ INC.-SDZ2024US073353$SANDOZ$$$$E$F$Y$$$20240819$$CN$US$US
242242701$24224270$1$I$$20240726$20240819$20240819$PER$$US-INCYTE CORPORATION-2024IN008044$INCYTE$$$$$$Y$$$20240819$$HP$US$US
242242711$24224271$1$I$20240807$20240818$20240818$20240818$DIR$714842$$FDA-CTU$$46$YR$$F$N$110.25$KG$20240818$N$CN$US$
242242721$24224272$1$I$20240810$20240818$20240818$20240818$DIR$714872$$FDA-CTU$$9$YR$$F$N$36.9$KG$20240818$N$CN$US$
242242731$24224273$1$I$20240816$20240818$20240818$20240818$DIR$714869$$FDA-CTU$$80$YR$$F$N$46.35$KG$20240818$N$CN$US$
242242741$24224274$1$I$20010101$20240819$20240819$20240819$EXP$DE-EMA-DD-20240813-7482663-073613$DE-SANDOZ INC.-SDZ2024DE073448$SANDOZ$$8$YR$$M$Y$35$KG$20240819$$MD$DE$DE
242242751$24224275$1$I$20231201$20240808$20240819$20240819$PER$$US-ORGANON-O2408USA000853$ORGANON$$$$$F$Y$$$20240819$$CN$US$US
242242761$24224276$1$I$20240813$20240813$20240819$20240819$EXP$$US-MYLANLABS-2024M1076358$MYLAN$$$$E$M$Y$$$20240819$$PH$US$US
242242771$24224277$1$I$20240814$20240818$20240818$20240818$DIR$714874$$FDA-CTU$$52$YR$$F$N$$$20240818$N$CN$US$
242242781$24224278$1$I$20240813$20240818$20240818$20240818$DIR$714844$$FDA-CTU$$43$YR$$M$N$166.5$KG$20240818$N$CN$US$
242242791$24224279$1$I$$20240818$20240818$20240818$DIR$714873$$FDA-CTU$$37$YR$$F$N$76.05$KG$20240818$N$CN$CA$
242242801$24224280$1$I$$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024162997$AMGEN$$$$$$Y$$$20240819$$PH$US$US
242242811$24224281$1$I$$20240809$20240819$20240819$EXP$NL-LRB-00994477$NL-TEVA-VS-3232947$TEVA$$71$YR$$M$Y$82$KG$20240819$$CN$NL$NL
242242831$24224283$1$I$20030101$20240812$20240819$20240819$EXP$$PHBS2006IT17134$NOVARTIS$Frigerio M, Cipriani MG, Roubina E, Orrego PS, Vitali E. Case report: long-term outcome of a heart transplant recipient switched to everolimus after an acute myocardial infarction. TRANSPLANTATION. 2006;82(8S):S19-23$56$YR$$M$Y$$$20240819$$HP$IT$IT
242242841$24224284$1$I$20240519$20240809$20240819$20240819$EXP$FR-AFSSAPS-SE2024000622$FR-TEVA-VS-3232800$TEVA$$64$YR$$F$Y$60$KG$20240819$$HP$FR$FR
242242851$24224285$1$I$$20240814$20240819$20240819$EXP$$CL-SANDOZ INC.-SDZ2024CL062912$SANDOZ$$$$$M$Y$38$KG$20240819$$PH$CL$CL
242242861$24224286$1$I$20230601$20240817$20240819$20240819$EXP$$EG-SANDOZ INC.-SDZ2023EG005886$SANDOZ$$41$YR$$M$Y$102$KG$20240819$$CN$EG$EG
242242871$24224287$1$I$20220401$20240819$20240819$20240819$EXP$RO-NMA-2024-SP0531$RO-ROCHE-10000060143$ROCHE$$26$YR$A$M$Y$$$20240819$$MD$RO$RO
242242882$24224288$2$F$20231214$20240820$20240819$20240827$EXP$FR-AFSSAPS-RE2024000799$FR-TEVA-VS-3232831$TEVA$$72$YR$$F$Y$52.5$KG$20240827$$MD$FR$FR
242242891$24224289$1$I$20240713$20240806$20240819$20240819$EXP$$US-Fagron Sterile Services-2160608$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$33$YR$$F$Y$74$KG$20240819$$PH$US$US
242242901$24224290$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009953$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240819$$CN$US$US
242242911$24224291$1$I$20240713$20240814$20240819$20240819$PER$$US-GILEAD-2024-0684317$GILEAD$$75$YR$E$M$Y$$$20240819$$HP$US$US
242242921$24224292$1$I$20240810$20240813$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408008904$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240819$$CN$US$US
242242933$24224293$3$F$20240813$20240826$20240819$20240903$30DAY$$US-AMGEN-USASP2024161775$AMGEN$$67$YR$E$M$Y$$$20240903$$CN$US$US
242242941$24224294$1$I$$20240812$20240819$20240819$PER$$US-AMGEN-USA-20180305551$AMGEN$$61$YR$A$M$Y$$$20240819$$CN$US$US
242242951$24224295$1$I$20240719$20240806$20240819$20240819$EXP$$US-Fagron Sterile Services-2160609$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$23$YR$$F$Y$102.05$KG$20240819$$PH$US$US
242242961$24224296$1$I$$20240816$20240819$20240819$EXP$$CA-ROCHE-10000060180$ROCHE$$$$A$F$Y$$$20240819$$CN$CA$CA
242242971$24224297$1$I$20240812$20240812$20240819$20240819$PER$$US-ABBVIE-5884314$ABBVIE$$$$$$Y$$$20240819$$MD$US$US
242242981$24224298$1$I$$20240816$20240819$20240819$EXP$$US-GILEAD-2024-0684478$GILEAD$$66$YR$E$F$Y$$$20240819$$MD$US$US
242242991$24224299$1$I$20240711$20240809$20240819$20240819$EXP$IT-MINISAL02-997439$IT-TEVA-VS-3232983$TEVA$$68$YR$$F$Y$$$20240819$$MD$IT$IT
242243001$24224300$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130717$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240819$$CN$US$US
242243011$24224301$1$I$$20240809$20240819$20240819$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099688$VIIV$$$$$M$Y$$$20240819$$HP$US$US
242243022$24224302$2$F$$20240815$20240819$20240821$EXP$IT-EMA-DD-20240808-7482831-083504$IT-MYLANLABS-2024M1076124$MYLAN$Di Renzo B, Montanaro A, Spinelli A, Covella P, De Giorgi A, Flores A et al.. A case of septic shock with oliguric acute renal failure resolved with CVVHF coupled with cytosorb?. Blood Purification.. 2019;47(4):11-12$72$YR$$M$Y$$$20240821$$HP$IT$IT
242243031$24224303$1$I$20230101$20240809$20240819$20240819$EXP$FR-AFSSAPS-PO2024000855$FR-TEVA-VS-3232836$TEVA$$67$YR$$F$Y$$$20240819$$MD$FR$FR
242243051$24224305$1$I$20240101$20240813$20240819$20240819$EXP$$US-009507513-2408USA004814$MERCK$$$$$F$Y$$$20240819$$CN$US$US
242243061$24224306$1$I$20240802$20240817$20240819$20240819$EXP$$NVSC2024CN167493$NOVARTIS$$62$YR$$F$Y$50$KG$20240819$$HP$CN$CN
242243072$24224307$2$F$20240807$20240916$20240819$20240918$PER$$US-JNJFOC-20240832445$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240918$$HP$US$US
242243081$24224308$1$I$20240801$20240815$20240819$20240819$EXP$$JP-ROCHE-10000060147$ROCHE$$$$E$F$Y$$$20240819$$MD$JP$JP
242243091$24224309$1$I$20240719$20240806$20240819$20240819$EXP$$US-Fagron Sterile Services-2160611$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$29$YR$$F$Y$81.3$KG$20240819$$PH$US$US
242243101$24224310$1$I$20240101$20240815$20240819$20240819$EXP$$US-SA-2024SA242977$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240819$$MD$US$US
242243121$24224312$1$I$20240801$20240813$20240819$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA073057$SANDOZ$$80$YR$$F$Y$$$20240819$$CN$CA$CA
242243131$24224313$1$I$20240804$20240809$20240819$20240819$EXP$$US-VIIV HEALTHCARE LIMITED-US2024099705$VIIV$$45$YR$$M$Y$$$20240819$$CN$US$US
242243141$24224314$1$I$$20240816$20240819$20240819$EXP$$NVSC2024US167098$NOVARTIS$$$$$M$Y$$$20240819$$CN$US$US
242243152$24224315$2$F$20240101$20240816$20240819$20240819$EXP$$US-GILEAD-2024-0684536$GILEAD$$$$A$M$Y$$$20240819$$HP$US$US
242243162$24224316$2$F$20240816$20240925$20240819$20240930$PER$$US-AMGEN-USASP2024164288$AMGEN$$59$YR$A$F$Y$$$20240930$$CN$US$US
242243171$24224317$1$I$$20240815$20240819$20240819$EXP$$US-ROCHE-10000058933$ROCHE$$$$A$F$Y$$$20240819$$CN$US$US
242243181$24224318$1$I$20240724$20240806$20240819$20240819$EXP$$US-Fagron Sterile Services-2160612$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$34$YR$$F$Y$101.74$KG$20240819$$PH$US$US
242243191$24224319$1$I$20240701$20240814$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129399$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240819$$CN$US$US
242243201$24224320$1$I$20240721$20240818$20240818$20240818$DIR$714876$$FDA-CTU$$59$YR$$F$N$81$KG$20240818$N$CN$US$
242243211$24224321$1$I$20240607$20240818$20240818$20240818$DIR$714849$$FDA-CTU$$62$YR$$F$N$45$KG$20240818$N$CN$US$
242243221$24224322$1$I$20240817$20240818$20240818$20240818$DIR$714864$$FDA-CTU$$54$YR$$F$N$60.75$KG$20240818$N$CN$US$
242243231$24224323$1$I$20240817$20240818$20240818$20240818$DIR$714861$$FDA-CTU$$44$YR$$F$N$112.95$KG$20240818$N$CN$US$
242243241$24224324$1$I$20240807$20240818$20240818$20240818$DIR$714877$$FDA-CTU$$85$YR$$M$N$67.5$KG$20240818$N$CN$US$
242243251$24224325$1$I$20240804$20240818$20240818$20240818$DIR$714845$$FDA-CTU$$50$YR$$F$N$72.45$KG$20240818$N$CN$US$
242243271$24224327$1$I$20210402$20240818$20240818$20240818$DIR$714878$$FDA-CTU$$29$YR$$F$N$78.75$KG$20240818$Y$CN$US$
242243282$24224328$2$F$$20240816$20240819$20240827$30DAY$$US-JNJFOC-20240768923$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$US$US
242243291$24224329$1$I$$20240815$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130866$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240819$$CN$US$US
242243301$24224330$1$I$$20240813$20240819$20240819$PER$$US-009507513-2408USA004721$MERCK$$$$$M$Y$$$20240819$$CN$US$US
242243311$24224331$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130438$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240819$$CN$US$US
242243321$24224332$1$I$20240730$20240806$20240819$20240819$EXP$$US-Fagron Sterile Services-2160613$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$25$YR$$F$Y$65.46$KG$20240819$$PH$US$US
242243331$24224333$1$I$20201001$20240813$20240819$20240819$EXP$FR-AFSSAPS-PO2024000637$FR-ABBVIE-5795631$ABBVIE$$33$YR$$F$Y$39$KG$20240819$$MD$FR$FR
242243341$24224334$1$I$20240809$20240809$20240819$20240819$EXP$$US-TEVA-VS-3232327$TEVA$$56$YR$$M$Y$$$20240819$$CN$US$US
242243352$24224335$2$F$20240401$20240903$20240819$20240903$EXP$DE-PEI-202400016786$DE-ROCHE-10000057267$ROCHE$$65$YR$E$F$Y$$$20240903$$CN$DE$DE
242243361$24224336$1$I$20240728$20240813$20240819$20240819$EXP$$UA-MYLANLABS-2024M1076768$MYLAN$$42$YR$$F$Y$$$20240819$$HP$UA$UA
242243371$24224337$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130562$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$66.3$KG$20240819$$CN$US$US
242243382$24224338$2$F$20240801$20240819$20240819$20240829$30DAY$$US-GSK-US2024099764$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240829$$CN$US$US
242243393$24224339$3$F$20240101$20240910$20240819$20240917$EXP$$US-SA-2024SA244003$SANOFI AVENTIS$$5$YR$C$M$Y$19.55$KG$20240917$$MD$US$US
242243402$24224340$2$F$$20240829$20240819$20240906$PER$$US-BELCHER PHARMACEUTICALS, LLC-2024US002506$PAREXEL$$$$$$Y$$$20240905$$MD$US$US
242243411$24224341$1$I$$20240814$20240819$20240819$EXP$$US-SA-2024SA244296$SANOFI AVENTIS$$$$A$M$Y$106$KG$20240819$$MD$US$US
242243422$24224342$2$F$$20240726$20240819$20240925$PER$$US-INCYTE CORPORATION-2024IN007890$INCYTE$$$$$$Y$$$20240925$$CN$US$US
242243431$24224343$1$I$20240801$20240808$20240819$20240819$PER$$US-JNJFOC-20240842038$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
242243442$24224344$2$F$20240804$20240925$20240819$20240930$EXP$$US-PFIZER INC-PV202400106632$PFIZER$$25$YR$$M$Y$$$20240930$$HP$US$US
242243451$24224345$1$I$$20240814$20240819$20240819$PER$$NVSC2024US165814$NOVARTIS$$$$$M$Y$$$20240819$$PH$US$US
242243462$24224346$2$F$$20240814$20240819$20240823$PER$$US-ABBVIE-5882958$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242243471$24224347$1$I$$20240725$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120100$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240819$$CN$US$US
242243481$24224348$1$I$$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024163498$AMGEN$$$$$$Y$$$20240819$$PH$US$US
242243491$24224349$1$I$20210214$20240809$20240819$20240819$EXP$FR-AFSSAPS-NC2024000931$FR-TEVA-VS-3232846$TEVA$$0$DY$$M$Y$2.82$KG$20240819$$MD$FR$FR
242243501$24224350$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167592$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
242243511$24224351$1$I$20240809$20240809$20240819$20240819$EXP$$US-PROGENICS PHARMACEUTICALS, INC.-LMI-2024-01013$PROGENICS PHARMACEUTICALS$$75$YR$$M$Y$118$KG$20240819$$CN$US$US
242243521$24224352$1$I$$20240816$20240819$20240819$EXP$$US-JNJFOC-20240846173$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240819$$HP$US$US
242243541$24224354$1$I$$20240813$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009030$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240819$$CN$US$US
242243551$24224355$1$I$$20240813$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009276$ELI LILLY AND CO$$57$YR$A$$Y$$$20240819$$LW$US$US
242243561$24224356$1$I$$20240815$20240819$20240819$EXP$GB-MHRA-MED-202408151519577930-KWPGS$GB-MYLANLABS-2024M1076234$MYLAN$$$$$M$Y$$$20240819$$HP$GB$GB
242243571$24224357$1$I$$20240814$20240819$20240819$EXP$$IN-MYLANLABS-2024M1076774$MYLAN$Gupta D, Singh L, Kumar S, Singh K, Mendonca S, Chatterjee T. Rare complications of heart transplant: Autopsy findings. Indian-J-Pathol-Microbiol 2024; 67 (3): 624-627.$33$YR$$M$Y$$$20240819$$HP$IN$IN
242243581$24224358$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162599$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242243591$24224359$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162586$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242243601$24224360$1$I$20240415$20240814$20240819$20240819$EXP$$NVSC2024TR166510$NOVARTIS$$66$YR$$F$Y$79$KG$20240819$$CN$TR$TR
242243612$24224361$2$F$20240729$20240815$20240819$20240826$EXP$$NVSC2024CN167389$NOVARTIS$$81$YR$$F$Y$55$KG$20240826$$HP$CN$CN
242243621$24224362$1$I$$20240808$20240819$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012879$JAZZ$$$$$M$Y$$$20240819$$CN$US$US
242243631$24224363$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162549$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242243641$24224364$1$I$20240808$20240815$20240819$20240819$EXP$$CN-BAYER-2024A118645$BAYER$$77$YR$E$M$Y$56$KG$20240819$$HP$CN$CN
242243651$24224365$1$I$20240701$20240722$20240819$20240819$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00770$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
242243661$24224366$1$I$$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130405$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$44$KG$20240819$$HP$US$US
242243672$24224367$2$F$20240813$20240904$20240819$20240906$PER$$US-BAYER-2024A118287$BAYER$$22$YR$A$F$Y$$$20240906$$HP$US$US
242243681$24224368$1$I$$20240812$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130539$BRISTOL MYERS SQUIBB$Noble CW, Gangaputra SS, Thompson IA, Yuan A, Apolo AB, Lee J-M, et al. Ocular adverse events following use of immune checkpoint inhibitors for metastatic malignancies. Ocular Immunology and Inflammation. 2019 Apr 23;28(6):854-9.doi:10.1080/09273948.2019.1583347.$62$YR$A$F$Y$$$20240819$$HP$US$US
242243691$24224369$1$I$$20240809$20240819$20240819$EXP$$GB-TEVA-VS-3232357$TEVA$$66$YR$$F$Y$100$KG$20240819$$HP$GB$GB
242243701$24224370$1$I$20240710$20240809$20240819$20240819$EXP$$GB-TEVA-VS-3232291$TEVA$$80$YR$$F$Y$$$20240819$$PH$GB$GB
242243711$24224371$1$I$20240802$20240809$20240819$20240819$EXP$$US-BIOGEN-2024BI01277820$BIOGEN$$21$YR$$M$Y$$$20240819$$CN$US$US
242243732$24224373$2$F$20240813$20240916$20240819$20240919$PER$$US-ROCHE-10000058916$ROCHE$$19$YR$A$M$Y$$$20240919$$CN$US$US
242243741$24224374$1$I$$20240811$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127156$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$99.34$KG$20240819$$CN$US$US
242243751$24224375$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130585$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$59.7$KG$20240819$$PH$US$US
242243761$24224376$1$I$$20240809$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126850$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240819$$CN$US$US
242243782$24224378$2$F$20240617$20240821$20240819$20240827$PER$$JP-Eisai-EC-2024-172348$EISAI$$72$YR$E$M$Y$$$20240827$$MD$JP$JP
242243791$24224379$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162600$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242243801$24224380$1$I$$20240808$20240819$20240819$EXP$$MX-JNJFOC-20240824253$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240819$$CN$MX$MX
242243813$24224381$3$F$20221230$20240910$20240819$20240913$EXP$$US-BAYER-2024A116740$BAYER$$19$YR$A$F$Y$72.562$KG$20240913$$CN$US$US
242243821$24224382$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162604$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242243841$24224384$1$I$$20240726$20240819$20240819$PER$$US-INCYTE CORPORATION-2024IN007880$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242243851$24224385$1$I$$20240725$20240819$20240819$PER$$US-INCYTE CORPORATION-2024IN007833$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242243862$24224386$2$F$$20240806$20240819$20240830$EXP$$RU-BAYER-2024A119127$BAYER$Elena Yu. Antonova, Irina A. Dzhanyan, Ilya V. Savchenko, Ekaterina A. Moroz, Konstantin K.  Laktionov, Ksenia A. Romanova, Roman I. Pimenov, Elena V. Sharapova, Valeriy V. Breder. Experience with the use of nivolumab and ipilimumab in  metastatic fibrolamellar liver carcinoma. MEDICAL COUNCIL. 2024;18(10):162-166$11$YR$C$M$Y$$$20240830$$MD$RU$RU
242243872$24224387$2$F$$20240904$20240819$20240904$PER$$US-ALXN-202408USA000787US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
242243881$24224388$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000059138$ROCHE$$$$$M$Y$$$20240819$$CN$US$US
242243891$24224389$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000059191$ROCHE$$14$YR$T$M$Y$$$20240819$$CN$US$US
242243901$24224390$1$I$$20240724$20240819$20240819$PER$$US-INCYTE CORPORATION-2024IN007831$INCYTE$$$$$$Y$$$20240819$$CN$US$US
242243912$24224391$2$F$20240811$20240821$20240819$20240827$EXP$$GT-BIOMARINAP-GT-2024-159908$BIOMARIN$$$$$$Y$$$20240827$$CN$GT$GT
242243921$24224392$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162667$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242243931$24224393$1$I$$20240805$20240819$20240819$EXP$$TR-NOVOPROD-1269671$NOVO NORDISK$$$$$M$Y$$$20240819$$CN$TR$TR
242243941$24224394$1$I$20240710$20240805$20240819$20240819$EXP$$ES-NOVOPROD-1266831$NOVO NORDISK$$63$YR$$F$Y$84$KG$20240819$$CN$ES$ES
242243951$24224395$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162657$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242243961$24224396$1$I$$20240815$20240819$20240819$PER$$US-ROCHE-10000059199$ROCHE$$$$T$M$Y$$$20240819$$CN$US$US
242243981$24224398$1$I$$20240702$20240819$20240819$PER$$US-LUNDBECK-DKLU4001176$LUNDBECK$$$$$$Y$$$20240819$$HP$US$US
242244011$24224401$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162613$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244021$24224402$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162623$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244031$24224403$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162649$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244041$24224404$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162675$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244051$24224405$1$I$$20240816$20240819$20240819$PER$$US-ROCHE-10000059356$ROCHE$$$$A$M$Y$$$20240819$$CN$US$US
242244061$24224406$1$I$$20240813$20240819$20240819$PER$$US-ROCHE-10000059353$ROCHE$$49$YR$A$$Y$$$20240819$$CN$US$US
242244071$24224407$1$I$$20240813$20240819$20240819$PER$$US-ROCHE-10000059318$ROCHE$$3$MON$I$M$Y$$$20240819$$CN$US$US
242244081$24224408$1$I$$20240702$20240819$20240819$PER$$US-LUNDBECK-DKLU4001177$LUNDBECK$$$$$$Y$$$20240819$$HP$US$US
242244091$24224409$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167308$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
242244101$24224410$1$I$20240101$20240814$20240819$20240819$EXP$$US-SA-2024SA243401$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240819$$MD$US$US
242244111$24224411$1$I$20240810$20240814$20240819$20240819$EXP$$US-SA-2024SA244007$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240819$$CN$US$US
242244122$24224412$2$F$20240701$20240829$20240819$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012478$JAZZ$$45$YR$$F$Y$$$20240902$$CN$US$US
242244131$24224413$1$I$$20230804$20240819$20240819$EXP$$US-AstraZeneca-2023A142277$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242244141$24224414$1$I$20240701$20240702$20240819$20240819$PER$$US-LUNDBECK-DKLU4001281$LUNDBECK$$$$$$Y$$$20240819$$HP$US$US
242244151$24224415$1$I$20240101$20240810$20240819$20240819$PER$$US-SA-2024SA241458$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240819$$MD$US$US
242244161$24224416$1$I$$20240814$20240819$20240819$PER$$US-JNJFOC-20240837168$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
242244171$24224417$1$I$$20240814$20240819$20240819$EXP$$MY-PFIZER INC-PV202400106253$PFIZER$Farooq, H.. Case report of a rare fungal infection Kodamaea ohmeri in COVID-19 patient in North Malaysian hospital. Indian Journal of Pathology and Microbiology. 2024;67(3):654-657$4$DEC$$F$Y$$$20240819$$HP$MY$MY
242244182$24224418$2$F$$20240724$20240819$20240926$PER$$US-INCYTE CORPORATION-2024IN007800$INCYTE$$$$$$Y$$$20240926$$CN$US$US
242244191$24224419$1$I$$20240809$20240819$20240819$PER$$US-ABBVIE-5875860$ABBVIE$$$$$$Y$$$20240819$$CN$US$US
242244201$24224420$1$I$20240805$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130052$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240819$$PH$US$US
242244211$24224421$1$I$$20240724$20240819$20240819$PER$$US-INCYTE CORPORATION-2024IN007798$INCYTE$$$$$$Y$$$20240819$$PH$US$US
242244221$24224422$1$I$20240701$20240809$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127125$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240819$$CN$US$US
242244231$24224423$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162686$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244241$24224424$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162684$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244251$24224425$1$I$$20240814$20240819$20240819$EXP$$US-TAKEDA-2024TUS082176$TAKEDA$$$$$F$Y$$$20240819$$CN$US$US
242244261$24224426$1$I$$20240724$20240819$20240819$PER$$US-INCYTE CORPORATION-2024IN007786$INCYTE$$$$$$Y$$$20240819$$PH$US$US
242244271$24224427$1$I$$20240807$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005586$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$US$US
242244281$24224428$1$I$20240806$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408091741500990-NLHFQ$GB-ELI_LILLY_AND_COMPANY-GB202408006909$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240819$$CN$GB$GB
242244291$24224429$1$I$20240806$20240807$20240819$20240819$EXP$GB-MHRA-MED-202408071023559780-RZTWV$GB-ELI_LILLY_AND_COMPANY-GB202408005225$ELI LILLY AND CO$$30$YR$A$M$Y$102$KG$20240819$$CN$GB$GB
242244301$24224430$1$I$$20240807$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005052$ELI LILLY AND CO$$$$A$F$Y$$$20240819$$CN$US$US
242244311$24224431$1$I$$20240808$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007265$ELI LILLY AND CO$$$$A$F$Y$$$20240819$$CN$US$US
242244321$24224432$1$I$20240806$20240808$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005563$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240819$$CN$US$US
242244331$24224433$1$I$$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408092320426320-DJTVW$GB-ELI_LILLY_AND_COMPANY-GB202408006905$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240819$$CN$GB$GB
242244341$24224434$1$I$20230801$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408091646253760-YMJRK$GB-ELI_LILLY_AND_COMPANY-GB202408006910$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240819$$CN$GB$GB
242244351$24224435$1$I$20240804$20240806$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004422$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240819$$CN$US$US
242244371$24224437$1$I$$20240805$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002781$ELI LILLY AND CO$$$$$$Y$$$20240819$$CN$US$US
242244381$24224438$1$I$$20240805$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003116$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240819$$CN$US$US
242244391$24224439$1$I$$20240805$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003753$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240819$$CN$US$US
242244401$24224440$1$I$20240802$20240807$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004688$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240819$$CN$US$US
242244411$24224441$1$I$20240701$20240807$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004681$ELI LILLY AND CO$$$$$M$Y$$$20240819$$CN$US$US
242244421$24224442$1$I$$20240807$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005305$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240819$$CN$US$US
242244431$24224443$1$I$$20240806$20240819$20240819$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408004371$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$BR$BR
242244441$24224444$1$I$20240724$20240806$20240819$20240819$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408004377$ELI LILLY AND CO$$61$YR$A$M$Y$102$KG$20240819$$CN$GB$GB
242244451$24224445$1$I$$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408091232568630-STDFJ$GB-ELI_LILLY_AND_COMPANY-GB202408006853$ELI LILLY AND CO$$64$YR$A$F$Y$114$KG$20240819$$CN$GB$GB
242244461$24224446$1$I$$20240806$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004349$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240819$$CN$US$US
242244471$24224447$1$I$$20240806$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004785$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240819$$CN$US$US
242244481$24224448$1$I$$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408092054396580-TJMCP$GB-ELI_LILLY_AND_COMPANY-GB202408006906$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240819$$CN$GB$GB
242244491$24224449$1$I$$20240805$20240819$20240819$EXP$GB-MHRA-MED-202408051438098010-VYKSD$GB-ELI_LILLY_AND_COMPANY-GB202408003625$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$GB$GB
242244501$24224450$1$I$20240727$20240805$20240819$20240819$EXP$GB-MHRA-MED-202408051726392890-NLYFG$GB-ELI_LILLY_AND_COMPANY-GB202408003620$ELI LILLY AND CO$$28$YR$A$F$Y$96$KG$20240819$$CN$GB$GB
242244511$24224451$1$I$$20240806$20240819$20240819$EXP$GB-MHRA-MED-202408061247229440-HYCGR$GB-ELI_LILLY_AND_COMPANY-GB202408004496$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240819$$CN$GB$GB
242244521$24224452$1$I$$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408081224250200-CFHNY$GB-ELI_LILLY_AND_COMPANY-GB202408006911$ELI LILLY AND CO$$39$YR$A$F$Y$73$KG$20240819$$CN$GB$GB
242244531$24224453$1$I$20220101$20240807$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004826$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240819$$CN$US$US
242244541$24224454$1$I$20240802$20240807$20240819$20240819$EXP$GB-MHRA-MED-202408071107261100-CLYDN$GB-ELI_LILLY_AND_COMPANY-GB202408005226$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$GB$GB
242244551$24224455$1$I$20240502$20240806$20240819$20240819$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408004369$ELI LILLY AND CO$$65$YR$E$M$Y$111$KG$20240819$$CN$GB$GB
242244561$24224456$1$I$$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408091437137890-FNYJV$GB-ELI_LILLY_AND_COMPANY-GB202408006863$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$GB$GB
242244571$24224457$1$I$20240802$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408082020006800-GVPRW$GB-ELI_LILLY_AND_COMPANY-GB202408006074$ELI LILLY AND CO$$36$YR$A$F$Y$79$KG$20240819$$CN$GB$GB
242244581$24224458$1$I$$20240805$20240819$20240819$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408004975$ELI LILLY AND CO$$71$YR$E$F$Y$52.5$KG$20240819$$CN$CN$CN
242244591$24224459$1$I$20240805$20240807$20240819$20240819$EXP$GB-MHRA-MED-202408072357163760-CPRDJ$GB-ELI_LILLY_AND_COMPANY-GB202408005237$ELI LILLY AND CO$$36$YR$A$F$Y$145$KG$20240819$$CN$GB$GB
242244601$24224460$1$I$$20240808$20240819$20240819$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408005893$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240819$$PH$GB$GB
242244611$24224461$1$I$$20240805$20240819$20240819$EXP$GB-MHRA-MED-202408051551169140-NSQWT$GB-ELI_LILLY_AND_COMPANY-GB202408003621$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240819$$CN$GB$GB
242244621$24224462$1$I$$20240806$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408003615$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$US$US
242244631$24224463$1$I$$20240807$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004828$ELI LILLY AND CO$$$$$M$Y$$$20240819$$CN$US$US
242244641$24224464$1$I$20240806$20240806$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004180$ELI LILLY AND CO$$$$$$Y$$$20240819$$CN$US$US
242244651$24224465$1$I$$20240809$20240819$20240819$EXP$GB-MHRA-MED-202408091136183380-PHZBK$GB-ELI_LILLY_AND_COMPANY-GB202408006825$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$GB$GB
242244672$24224467$2$F$20240710$20240828$20240819$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005269$ELI LILLY AND CO$$40$YR$A$M$Y$104$KG$20240910$$CN$US$US
242244681$24224468$1$I$$20240807$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005173$ELI LILLY AND CO$$88$YR$E$M$Y$$$20240819$$CN$US$US
242244691$24224469$1$I$$20240804$20240819$20240819$EXP$GB-MHRA-MED-202408042037312150-VTMWH$GB-ELI_LILLY_AND_COMPANY-GB202408003500$ELI LILLY AND CO$$33$YR$A$F$Y$96$KG$20240819$$CN$GB$GB
242244701$24224470$1$I$$20240806$20240819$20240819$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408004421$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240819$$CN$GB$GB
242244711$24224471$1$I$$20240807$20240819$20240819$EXP$GB-MHRA-MED-202408070951272060-JBYVL$GB-ELI_LILLY_AND_COMPANY-GB202408005273$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$GB$GB
242244721$24224472$1$I$$20240808$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005618$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$US$US
242244731$24224473$1$I$20240201$20240806$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004443$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240819$$CN$US$US
242244742$24224474$2$F$$20240816$20240819$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005511$ELI LILLY AND CO$$$$A$F$Y$$$20240828$$CN$US$US
242244753$24224475$3$F$$20240909$20240819$20240917$EXP$PT-MYLANLABS-2024M1074209$PT-GSK-PT2024102444$GLAXOSMITHKLINE$Brites, FM. Howell-Jolly Body like Inclusions in Neutrophils and Monocytes. XIII National Congress of Clinical Pathology. 2024;112$$$$$Y$$$20240917$$MD$PT$PT
242244761$24224476$1$I$20240814$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024163518$AMGEN$$61$YR$A$M$Y$$$20240819$$CN$US$US
242244781$24224478$1$I$20230101$20240814$20240819$20240819$EXP$$UY-ABBVIE-5881071$ABBVIE$$$$$F$Y$$$20240819$$CN$UY$UY
242244791$24224479$1$I$20240804$20240812$20240819$20240819$EXP$$CA-OTSUKA-2023_011657$OTSUKA$$32$YR$$M$Y$$$20240819$$CN$CA$CA
242244802$24224480$2$F$$20240822$20240819$20240828$PER$$US-ALXN-202408USA000802US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242244811$24224481$1$I$20240729$20240809$20240819$20240819$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024096965$VIIV$$5$DEC$$M$Y$$$20240819$$HP$US$US
242244821$24224482$1$I$$20240816$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130597$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240819$$CN$US$US
242244831$24224483$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167341$NOVARTIS$$$$$F$Y$$$20240819$$CN$US$US
242244841$24224484$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162716$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244851$24224485$1$I$20240601$20240813$20240819$20240819$PER$$US-JNJFOC-20240833818$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240819$$HP$US$US
242244861$24224486$1$I$20240731$20240814$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129698$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240819$$CN$US$US
242244881$24224488$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162705$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244891$24224489$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162694$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244901$24224490$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162712$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244911$24224491$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162692$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244921$24224492$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162718$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244941$24224494$1$I$20240101$20240808$20240819$20240819$PER$$US-ALKERMES INC.-ALK-2024-002092$ALKERMES$$$$$F$Y$$$20240819$$HP$US$US
242244951$24224495$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162723$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242244961$24224496$1$I$20240801$20240812$20240819$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012515$JAZZ$$70$YR$$F$Y$$$20240819$$CN$US$US
242244972$24224497$2$F$$20240817$20240819$20240820$EXP$$US-PURDUE PHARMA-USA-2024-0311415$PURDUE$$$$$M$Y$$$20240820$$CN$US$US
242244991$24224499$1$I$$20240809$20240819$20240819$EXP$$CA-TEVA-VS-3232596$TEVA$$63$YR$$F$Y$$$20240819$$HP$CA$CA
242245001$24224500$1$I$$20240815$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129897$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240819$$CN$US$US
242245011$24224501$1$I$$20240814$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130203$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240819$$CN$US$US
242245021$24224502$1$I$$20240812$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127950$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240819$$CN$US$US
242245032$24224503$2$F$$20240913$20240819$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130139$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240917$$CN$US$US
242245041$24224504$1$I$$20240811$20240819$20240819$EXP$$ES-AMGEN-ESPSP2024162726$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242245051$24224505$1$I$$20240812$20240819$20240819$EXP$$US-MYLANLABS-2024M1076088$MYLAN$$$$$F$Y$$$20240819$$CN$US$US
242245061$24224506$1$I$$20240814$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US073163$SANDOZ$$$$$F$Y$$$20240819$$PH$US$US
242245072$24224507$2$F$$20240822$20240819$20240829$PER$$US-JNJFOC-20240840241$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$HP$US$US
242245082$24224508$2$F$20240101$20240820$20240819$20240821$EXP$$US-KARYOPHARM-2024KPT001354$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240821$$CN$US$US
242245091$24224509$1$I$$20240815$20240819$20240819$PER$$US-JNJFOC-20240841266$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$HP$US$US
242245101$24224510$1$I$20240812$20240812$20240819$20240819$PER$$US-APELLIS-2024-APL-0000733$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
242245111$24224511$1$I$$20240725$20240819$20240819$PER$$US-009507513-2407USA016021$MERCK$$72$YR$$M$Y$83.9$KG$20240819$$CN$US$US
242245121$24224512$1$I$$20240812$20240819$20240819$EXP$$CA-TAKEDA-2024TUS082982$TAKEDA$$82$YR$$M$Y$$$20240819$$HP$CA$CA
242245141$24224514$1$I$20240805$20240812$20240819$20240819$30DAY$$US-GSK-US2024100350$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240819$$CN$US$US
242245151$24224515$1$I$20230301$20240813$20240819$20240819$EXP$DE-CADRBFARM-2024329756$DE-MYLANLABS-2024M1076618$MYLAN$$28$YR$$M$Y$86$KG$20240819$$CN$DE$DE
242245162$24224516$2$F$$20240902$20240819$20240907$EXP$$US-AMGEN-USASP2024161509$AMGEN$El-amir Z.; Mclane M.J.; Kaminski M.S. et al.. Incidence, characteristics and outcomes in relapsed and refractory CD20+ PTLD: An institutional retrospective cohort study. Journal of Clinical Oncology. 2024;42 (16)$$$$$Y$$$20240907$$HP$US$US
242245171$24224517$1$I$$20240809$20240819$20240819$EXP$$CA-TEVA-VS-3196416$TEVA$$$$$M$Y$$$20240819$$MD$CA$CA
242245181$24224518$1$I$20240701$20240731$20240819$20240819$PER$$US-KARYOPHARM-2024KPT001383$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240819$$CN$US$US
242245191$24224519$1$I$20240731$20240814$20240819$20240819$EXP$$US-PFIZER INC-202201021068$PFIZER$$68$YR$$F$Y$67.59$KG$20240819$$PH$US$US
242245221$24224522$1$I$20240812$20240812$20240819$20240819$PER$$US-APELLIS-2024-APL-0000735$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240819$$CN$US$US
242245231$24224523$1$I$$20240815$20240819$20240819$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-130612$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240819$$HP$RU$RU
242245241$24224524$1$I$$20240809$20240819$20240819$EXP$$CA-TEVA-VS-3232682$TEVA$$73$YR$$F$Y$88$KG$20240819$$HP$CA$CA
242245252$24224525$2$F$$20240811$20240819$20240821$PER$$NVSC2024US164548$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
242245271$24224527$1$I$$20240809$20240819$20240819$EXP$$CA-TEVA-VS-3232640$TEVA$$35$YR$$M$Y$$$20240819$$HP$CA$CA
242245281$24224528$1$I$$20240805$20240819$20240819$EXP$$ES-ABBVIE-5881142$ABBVIE$$30$YR$$F$Y$$$20240819$$CN$ES$ES
242245291$24224529$1$I$$20240819$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408011278$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240819$$CN$US$US
242245301$24224530$1$I$$20240809$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408007064$ELI LILLY AND CO$$56$YR$A$$Y$$$20240819$$CN$US$US
242245311$24224531$1$I$$20240809$20240819$20240819$EXP$$US-MYLANLABS-2024M1074961$MYLAN$Torres-Ruiz TA, Wharry L, Simo KA. Marginal Ulcer Following Completion Pancreatectomy Complicated by Portal Vein Erosion. Am-Surg 2023; 89 (12): 6334-6337.$57$YR$$F$Y$$$20240819$$MD$US$US
242245321$24224532$1$I$$20240814$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009329$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240819$$CN$US$US
242245331$24224533$1$I$$20240814$20240819$20240819$30DAY$$US-SANDOZ INC.-SDZ2024US073131$SANDOZ$$$$$M$Y$$$20240819$$CN$US$US
242245341$24224534$1$I$20240101$20240810$20240819$20240819$PER$$US-SA-2024SA241910$SANOFI AVENTIS$$$$A$F$Y$$$20240819$$MD$US$US
242245351$24224535$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130593$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240819$$CN$US$US
242245361$24224536$1$I$20240807$20240812$20240819$20240819$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-128092$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240819$$CN$PR$PR
242245371$24224537$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129169$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$57.61$KG$20240819$$HP$US$US
242245381$24224538$1$I$20200101$20240812$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128802$BRISTOL MYERS SQUIBB$Soliman A, Hassan R, Codreanu I, Plaxe SC, Dasanu CA. Sjogren^s syndrome due to immune checkpoint inhibitors (ICIs): insights from a single-institution series and systematic review of the literature. Journal of Oncology Pharmacy Practice. 2024 Aug 08;1-8.doi:10.1177/10781552241271753.$79$YR$E$M$Y$$$20240819$$HP$US$US
242245391$24224539$1$I$$20240813$20240819$20240819$EXP$$GR-MYLANLABS-2019M1086536$MYLAN$Thermos G, Andreou A, Georgaki M, Piperi E, Nikitakis NG. Oral potentially malignant disorders in patients with oral cGVHD: A case report and review of the literature.. 4th Panhellenic Congress on Stomatology. 2019;1-2$45$YR$$M$Y$$$20240819$$MD$GR$GR
242245401$24224540$1$I$20240801$20240812$20240819$20240819$PER$$US-SA-2024SA242916$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240819$$MD$US$US
242245411$24224541$1$I$20230606$20240812$20240819$20240819$EXP$$US-ALXN-A202307623$ALEXION PHARMACEUTICALS$$25$YR$$F$Y$$$20240819$$CN$US$US
242245421$24224542$1$I$20231228$20240812$20240819$20240819$EXP$$US-009507513-2408USA004292$MERCK$$67$YR$$F$Y$$$20240819$$MD$US$US
242245431$24224543$1$I$$20240812$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127464$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240819$$HP$US$US
242245441$24224544$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130724$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$90.72$KG$20240819$$CN$US$US
242245451$24224545$1$I$20240301$20240813$20240819$20240819$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-008748$JAZZ$$27$YR$$F$Y$72.562$KG$20240819$$HP$US$US
242245462$24224546$2$F$20240723$20240823$20240819$20240827$EXP$$US-OTSUKA-2024_022555$OTSUKA$$21$YR$$M$Y$$$20240827$$MD$US$US
242245482$24224548$2$F$$20240830$20240819$20240911$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15827$IPSEN$$$$$F$Y$$$20240911$$CN$US$US
242245491$24224549$1$I$20200301$20240813$20240819$20240819$EXP$DE-CADRBFARM-2024329655$DE-MYLANLABS-2024M1075879$MYLAN$$41$YR$$F$Y$90$KG$20240819$$CN$DE$DE
242245501$24224550$1$I$$20240817$20240819$20240819$PER$$NVSC2024US167589$NOVARTIS$$$$$$Y$$$20240819$$CN$US$US
242245512$24224551$2$F$$20240818$20240819$20240820$PER$$NVSC2024US167605$NOVARTIS$$$$$$Y$$$20240820$$CN$US$US
242245522$24224552$2$F$20240702$20240919$20240819$20240924$PER$$US-ALKERMES INC.-ALK-2024-001839$ALKERMES$$63$YR$$M$Y$$$20240924$$PH$US$US
242245542$24224554$2$F$20240801$20240816$20240819$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130718$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240822$$CN$US$US
242245552$24224555$2$F$20240811$20240829$20240819$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129048$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240904$$CN$US$US
242245561$24224556$1$I$20231031$20240813$20240819$20240819$EXP$$FR-MYLANLABS-2024M1075923$MYLAN$$$$E$F$Y$$$20240819$$MD$FR$FR
242245572$24224557$2$F$20220608$20240813$20240819$20240823$EXP$$US-ALXN-A202207033$ALEXION PHARMACEUTICALS$$78$YR$$M$Y$$$20240823$$CN$US$US
242245581$24224558$1$I$20240807$20240816$20240819$20240819$PER$$CN-Eisai-EC-2024-172338$EISAI$$80$YR$E$M$Y$73$KG$20240819$$HP$CN$CN
242245592$24224559$2$F$$20240904$20240819$20240904$PER$$US-ALXN-202408USA000803US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$HP$US$US
242245601$24224560$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128658$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240819$$MD$US$US
242245611$24224561$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130521$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240819$$CN$US$US
242245631$24224563$1$I$20240728$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130293$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240819$$HP$US$US
242245641$24224564$1$I$20240730$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130958$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240819$$MD$US$US
242245651$24224565$1$I$$20240812$20240819$20240819$EXP$$US-SA-2024SA242598$SANOFI AVENTIS$$$$E$F$Y$$$20240819$$MD$US$US
242245671$24224567$1$I$$20240620$20240819$20240819$PER$$US-Stallergenes SAS-2160617$STALLERGENES$$12$YR$$M$Y$$$20240819$$MD$US$US
242245681$24224568$1$I$$20240812$20240819$20240819$PER$$US-JNJFOC-20240830391$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$PH$US$US
242245701$24224570$1$I$20240101$20240806$20240819$20240819$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15755$IPSEN$$$$$F$Y$$$20240819$$HP$US$US
242245711$24224571$1$I$$20240808$20240819$20240819$EXP$$US-INSUD PHARMA-2408US06442$INSUD PHARMA$Parmeshwar N, Song S, Alcon A, Kim EA. The Incidence of Breast Cancer After Gender-Affirming Mastectomy in Transmen. Annals of Plastic Surgery. 2022;88, Suppl 4:S332 - S336$$$$$Y$$$20240819$$MD$US$US
242245721$24224572$1$I$$20240811$20240819$20240819$EXP$$JP-Prasco Laboratories-PRAS20241100$PRASCO$Kikuchi T, Tsukada N, Kunisada K, Matsumoto C, Nomura-Yogo M, Oda Y, Sato K, Takei T, Ogura M, Abe Y. Adverse impact of 1q amplification on outcomes in patients with multiple myeloma treated with daratumumab, carfilzomib and dexamethasone in a real-world setting. Hematological Oncology. 2024;E3306:1-4. doi:10.1002/hon.3306$$$$$Y$$$20240819$$HP$JP$JP
242245731$24224573$1$I$$20240808$20240819$20240819$EXP$$US-INSUD PHARMA-2408US06439$INSUD PHARMA$Parmeshwar N, Song S, Alcon A, Kim EA. The Incidence of Breast Cancer After Gender-Affirming Mastectomy in Transmen. Annals of Plastic Surgery. 2022;88, Supplement:S332 - S336$$$$$Y$$$20240819$$MD$US$US
242245741$24224574$1$I$$20240815$20240819$20240819$PER$$US-TAKEDA-2024TUS082973$TAKEDA$$$$$F$Y$$$20240819$$CN$US$US
242245751$24224575$1$I$20240812$20240816$20240819$20240819$PER$$CN-Eisai-EC-2024-172289$EISAI$$44$YR$A$F$Y$56.5$KG$20240819$$HP$CN$CN
242245761$24224576$1$I$$20240814$20240819$20240819$PER$$JP-Eisai-EC-2024-172200$EISAI$Ito Yosuke. Considerations from treatment experience with pembrolizumab + lenvatinib combination therapy$$$$F$Y$$$20240819$$MD$JP$JP
242245771$24224577$1$I$$20240809$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127405$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$50.8$KG$20240819$$CN$US$US
242245781$24224578$1$I$$20240815$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129678$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240819$$PH$US$US
242245791$24224579$1$I$20240615$20240819$20240819$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-130316$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$45$KG$20240819$$PH$JP$JP
242245801$24224580$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130754$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240819$$CN$US$US
242245811$24224581$1$I$$20240813$20240819$20240819$EXP$$GB-SA-2024SA242659$SANOFI AVENTIS$$31$YR$A$F$Y$84$KG$20240819$$MD$GB$GB
242245823$24224582$3$F$$20240821$20240819$20240912$EXP$$NL-Ipsen Biopharmaceuticals, Inc.-2024-16016$IPSEN$$53$YR$A$F$Y$$$20240912$$HP$NL$NL
242245841$24224584$1$I$20240601$20240818$20240818$20240818$DIR$714855$$FDA-CTU$$$$$M$N$$$20240818$Y$CN$US$
242245851$24224585$1$I$$20240813$20240819$20240819$EXP$$DE-DSJP-DSE-2024-140633$DAIICHI$$$$A$F$Y$$$20240819$$MD$DE$DE
242245861$24224586$1$I$$20240814$20240819$20240819$EXP$$NVSC2024ES166986$NOVARTIS$$$$A$F$Y$$$20240819$$MD$ES$ES
242245871$24224587$1$I$$20240819$20240819$20240819$EXP$$NVSC2024IT167232$NOVARTIS$$65$YR$$$Y$$$20240819$$MD$IT$IT
242245881$24224588$1$I$20240804$20240814$20240819$20240819$EXP$$CN-DSJP-DSJ-2024-140669$DAIICHI$$56$YR$$M$Y$60$KG$20240819$$HP$CN$CN
242245891$24224589$1$I$$20240809$20240819$20240819$PER$$US-ABBVIE-5875177$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242245902$24224590$2$F$$20240821$20240819$20240829$EXP$GB-MHRA-31446417$GB-PERRIGO-24GB007493$PERRIGO$$$$A$$Y$$$20240829$$CN$GB$GB
242245912$24224591$2$F$20240705$20240905$20240819$20240913$EXP$$KR-KOWA-24JP001994$KOWA PHARM$$53$YR$$M$Y$67$KG$20240913$$MD$KR$KR
242245921$24224592$1$I$$20240813$20240819$20240819$EXP$$JP-Eisai-EC-2024-172102$EISAI$Oki Ryosuke. Cases of treatment with PEM+LEN therapy at our hospital. Adverse reaction management seminar; -; .$83$YR$E$F$Y$$$20240819$$MD$JP$JP
242245931$24224593$1$I$20240815$20240819$20240819$20240819$EXP$DE-BFARM-24005759$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-130696$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$83$KG$20240819$$MD$DE$DE
242245941$24224594$1$I$20240806$20240808$20240819$20240819$EXP$GB-MHRA-TPP41842564C11275380YC1722964068210$GB-PERRIGO-24GB007459$PERRIGO$$33$YR$$F$Y$70$KG$20240819$$MD$GB$GB
242245951$24224595$1$I$$20240815$20240819$20240819$EXP$$CA-Eisai-EC-2024-172160$EISAI$$$$$M$Y$$$20240819$$MD$CA$CA
242245962$24224596$2$F$20240815$20240819$20240819$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130966$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240820$$CN$US$US
242245972$24224597$2$F$$20240919$20240819$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130638$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240920$$CN$US$US
242245981$24224598$1$I$$20240805$20240819$20240819$PER$$US-Calliditas-2024CAL01486$CALLIDITAS THERAPEUTICS$$80$YR$E$F$Y$$$20240819$$CN$US$US
242245991$24224599$1$I$20240101$20240814$20240819$20240819$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013245$VERTEX$$$$A$F$Y$$$20240819$$CN$GB$GB
242246001$24224600$1$I$$20240809$20240819$20240819$PER$$US-ABBVIE-5877462$ABBVIE$$$$$$Y$$$20240819$$CN$US$US
242246012$24224601$2$F$20230101$20240809$20240819$20240902$EXP$$JP-009507513-2308JPN000029J$MERCK$Aoki M, Miyamoto T, Fujisawa T, Yanagida Y. EP-0534 A Case of Biliary Stenosis with Mass Forming Pancreatitis Developed after Pre-operative Chemotherapy for Triple-Negative Brest Cancer. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 311$37$YR$$F$Y$$$20240902$$MD$JP$JP
242246021$24224602$1$I$$20240815$20240819$20240819$PER$$US-JNJFOC-20240840437$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$MD$US$US
242246031$24224603$1$I$$20240813$20240819$20240819$PER$$US-JNJFOC-20240832542$JOHNSON AND JOHNSON$$$$$$Y$$$20240819$$PH$US$US
242246041$24224604$1$I$20240711$20240813$20240819$20240819$PER$$US-JNJFOC-20240832278$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240819$$HP$US$US
242246051$24224605$1$I$20240601$20240818$20240818$20240818$DIR$714855$$FDA-CTU$$25$YR$$F$N$51.75$KG$20240818$Y$CN$US$
242246072$24224607$2$F$20240710$20240904$20240819$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124553$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240905$$HP$US$US
242246081$24224608$1$I$$20240813$20240819$20240819$PER$$US-JNJFOC-20240834534$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240819$$CN$US$US
242246091$24224609$1$I$$20240814$20240819$20240819$EXP$$US-OTSUKA-2022_049366$OTSUKA$$$$$F$Y$66.63$KG$20240819$$HP$US$US
242246102$24224610$2$F$20240714$20240814$20240819$20240822$PER$$US-AMGEN-USASP2024162699$AMGEN$$54$YR$A$F$Y$$$20240821$$HP$US$US
242246111$24224611$1$I$20240812$20240813$20240819$20240819$EXP$$CN-009507513-2408CHN005824$MERCK$$46$YR$$F$Y$44$KG$20240819$$HP$CN$CN
242246121$24224612$1$I$$20240815$20240819$20240819$PER$$US-PURDUE PHARMA-USA-2024-0311395$PURDUE$$$$$F$Y$$$20240819$$CN$US$US
242246132$24224613$2$F$$20240817$20240819$20240820$PER$$US-PURDUE PHARMA-USA-2024-0311412$PURDUE$$37$YR$$M$Y$$$20240820$$CN$US$US
242246141$24224614$1$I$20230201$20240815$20240819$20240819$PER$$US-PURDUE-USA-2024-0311401$PURDUE$$$$$F$Y$$$20240819$$CN$US$US
242246151$24224615$1$I$$20240816$20240819$20240819$PER$$US-PURDUE PHARMA-USA-2024-0311392$PURDUE$$46$YR$$M$Y$$$20240819$$CN$US$US
242246161$24224616$1$I$$20240816$20240819$20240819$PER$$US-PURDUE PHARMA-USA-2024-0311421$PURDUE$$40$YR$$M$Y$$$20240819$$CN$US$US
242246171$24224617$1$I$$20240816$20240819$20240819$PER$$US-PURDUE PHARMA-USA-2024-0311424$PURDUE$$42$YR$$M$Y$$$20240819$$CN$US$US
242246181$24224618$1$I$$20240816$20240819$20240819$PER$$US-PURDUE PHARMA-USA-2024-0311404$PURDUE$$40$YR$$M$Y$$$20240819$$CN$US$US
242246191$24224619$1$I$$20240815$20240819$20240819$PER$$US-PURDUE PHARMA-USA-2024-0311402$PURDUE$$$$$F$Y$$$20240819$$CN$US$US
242246201$24224620$1$I$$20240816$20240819$20240819$PER$$US-PURDUE PHARMA-USA-2024-0311405$PURDUE$$$$$M$Y$$$20240819$$CN$US$US
242246211$24224621$1$I$$20240816$20240819$20240819$PER$$US-PURDUE PHARMA-USA-2024-0311423$PURDUE$$60$YR$$F$Y$$$20240819$$CN$US$US
242246221$24224622$1$I$$20240809$20240819$20240819$PER$$US-PFIZER INC-PV202400107580$PFIZER$$$$$F$Y$$$20240819$$CN$US$US
242246231$24224623$1$I$$20240815$20240819$20240819$PER$$US-PFIZER INC-202400238003$PFIZER$$28$YR$$$Y$$$20240819$$CN$US$US
242246251$24224625$1$I$$20240814$20240819$20240819$PER$$US-BAUSCH-BL-2024-012338$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240819$$CN$US$US
242246261$24224626$1$I$20240811$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009620$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240819$$CN$US$US
242246272$24224627$2$F$20240811$20240919$20240819$20240919$30DAY$$US-PFIZER INC-202400235204$PFIZER$$67$YR$$F$Y$$$20240919$$CN$US$US
242246281$24224628$1$I$$20240815$20240819$20240819$EXP$$US-GILEAD-2024-0664190$GILEAD$Spiegel J, Jain M, Nastoupil L, Tamaresis J., Ghobadi A., Lin Y., et al. Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium. Blood. 2023;142 supplement1:1032. doi:https://doi.org/10.1182/blood-2023-179868$$$A$$Y$$$20240819$$HP$US$US
242246291$24224629$1$I$20240101$20240804$20240819$20240819$PER$$US-ALKERMES INC.-ALK-2024-002068$ALKERMES$$$$$F$Y$$$20240819$$CN$US$US
242246301$24224630$1$I$20240101$20240805$20240819$20240819$PER$$US-ALKERMES INC.-ALK-2024-002060$ALKERMES$$$$$F$Y$$$20240819$$CN$US$US
242246313$24224631$3$F$$20240821$20240819$20240902$PER$$US-APELLIS-2024-APL-0000686$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240902$$CN$US$US
242246331$24224633$1$I$$20230821$20240819$20240819$EXP$$US-AstraZeneca-2023A191281$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242246341$24224634$1$I$20230509$20230511$20240819$20240819$EXP$$TW-AstraZeneca-2023A110708$ASTRAZENECA$$57$YR$$M$Y$$$20240819$$CN$TW$
242246351$24224635$1$I$$20230830$20240819$20240819$EXP$$US-AstraZeneca-2023A199741$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242246361$24224636$1$I$$20230718$20240819$20240819$EXP$$US-AstraZeneca-2023A131982$ASTRAZENECA$$$$$F$Y$$$20240819$$CN$US$
242246371$24224637$1$I$$20230621$20240819$20240819$EXP$$US-AstraZeneca-2023A144181$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242246381$24224638$1$I$$20240812$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130540$BRISTOL MYERS SQUIBB$Noble CW, Gangaputra SS, Thompson IA, Yuan A, Apolo AB, Lee J-M, et al. Ocular adverse events following use of immune checkpoint inhibitors for metastatic malignancies. Ocular Immunology and Inflammation. 2019 Apr 23;28(6):854-9.doi:10.1080/09273948.2019.1583347.$30$YR$A$F$Y$$$20240819$$HP$US$US
242246391$24224639$1$I$20230515$20230615$20240819$20240819$EXP$$US-AstraZeneca-2023A139755$ASTRAZENECA$$18736$DY$$F$Y$$$20240819$$CN$US$
242246401$24224640$1$I$$20240805$20240819$20240819$PER$$US-ALKERMES INC.-ALK-2024-002052$ALKERMES$$$$$M$Y$$$20240819$$HP$US$US
242246411$24224641$1$I$$20240815$20240819$20240819$EXP$$JP-009507513-2408JPN005742$MERCK$Oyake T, Maeta T, Takahata T, Tamai Y, Kameoka Y, Takahashi N, et al. Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin^s lymphoma. Journal of clinical and experimental hematopathology. 2024$58$YR$$M$Y$$$20240819$$HP$JP$JP
242246421$24224642$1$I$$20240806$20240819$20240819$PER$$US-ALKERMES INC.-ALK-2024-002057$ALKERMES$$$$$F$Y$$$20240819$$MD$US$US
242246431$24224643$1$I$$20240814$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130390$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240819$$CN$US$US
242246441$24224644$1$I$20240801$20240815$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130777$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240819$$MD$US$US
242246451$24224645$1$I$20240812$20240812$20240819$20240819$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-110652$REGENERON$$61$YR$$F$Y$$$20240819$$MD$US$US
242246462$24224646$2$F$$20240925$20240819$20240927$PER$$NVSC2024US167339$NOVARTIS$$$$$M$Y$94$KG$20240927$$CN$US$US
242246471$24224647$1$I$$20230905$20240819$20240819$EXP$$US-AstraZeneca-2023A169899$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242246481$24224648$1$I$20240501$20240815$20240819$20240819$PER$$US-009507513-2405USA002244$MERCK$$$$$F$Y$44.4$KG$20240819$$CN$US$US
242246491$24224649$1$I$$20230804$20240819$20240819$EXP$$US-AstraZeneca-2023A179362$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242246501$24224650$1$I$$20230815$20240819$20240819$EXP$$US-AstraZeneca-2023A186990$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242246511$24224651$1$I$$20221209$20240819$20240819$EXP$$US-AstraZeneca-2022A356842$ASTRAZENECA$$$$$M$Y$$$20240819$$CN$US$
242246521$24224652$1$I$$20230413$20240819$20240819$EXP$$CA-AstraZeneca-2023A068801$ASTRAZENECA$$$$$M$Y$$$20240819$$MD$CA$
242246531$24224653$1$I$$20240611$20240819$20240819$EXP$$IN-AstraZeneca-2024A135739$ASTRAZENECA$$49$YR$$F$Y$85$KG$20240819$$CN$IN$
242246552$24224655$2$F$$20240822$20240819$20240825$EXP$$CA-SANDOZ INC.-NVSC2023CA094723$SANDOZ$$15$YR$$M$Y$$$20240825$$MD$CA$CA
242246561$24224656$1$I$$20240813$20240819$20240819$EXP$$SK-INCYTE CORPORATION-2024IN008499$INCYTE$$$$$$Y$$$20240819$$MD$SK$SK
242246571$24224657$1$I$20230126$20240809$20240819$20240819$PER$$JP-Eisai-EC-2023-133417$EISAI$$71$YR$E$F$Y$$$20240819$$MD$JP$JP
242246581$24224658$1$I$$20240813$20240819$20240819$EXP$$CA-ABBVIE-5882567$ABBVIE$$43$YR$$F$Y$70$KG$20240819$$HP$CA$CA
242246601$24224660$1$I$$20240726$20240819$20240819$PER$$US-JNJFOC-20240775975$JOHNSON AND JOHNSON$$$$$M$Y$$$20240819$$CN$US$US
242246612$24224661$2$F$20240725$20240830$20240819$20240904$EXP$$JP-Taiho Oncology Inc-2024-007477$TAIHO ONCOLOGY INC$$76$YR$E$M$Y$$$20240904$$MD$JP$JP
242246622$24224662$2$F$$20240903$20240819$20240904$PER$$NVSC2024US167603$NOVARTIS$$$$$M$Y$$$20240904$$HP$US$US
242246632$24224663$2$F$$20240917$20240819$20240919$EXP$$US-Taiho Oncology Inc-2024-007889$TAIHO ONCOLOGY INC$$75$YR$E$F$Y$51.71$KG$20240919$$CN$US$US
242246642$24224664$2$F$$20240918$20240819$20240919$EXP$$NVSC2024LK167469$NOVARTIS$$$$$M$Y$$$20240919$$MD$LK$LK
242246652$24224665$2$F$$20240925$20240819$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129889$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240928$$CN$US$US
242246661$24224666$1$I$20240710$20240815$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130408$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240819$$HP$US$US
242246671$24224667$1$I$20240727$20240813$20240819$20240819$PER$$US-MYLANLABS-2024M1075926$MYLAN$$57$YR$$M$Y$78.46$KG$20240819$$CN$US$US
242246691$24224669$1$I$$20240814$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009650$ELI LILLY AND CO$$$$$$Y$$$20240819$$CN$US$US
242246701$24224670$1$I$$20240809$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408007062$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240819$$CN$US$US
242246711$24224671$1$I$20240814$20240814$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009624$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$US$US
242246721$24224672$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408009649$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240819$$CN$US$US
242246733$24224673$3$F$20240816$20240909$20240819$20240916$EXP$$US-OTSUKA-2024_021771$OTSUKA$$76$YR$$M$Y$112.5$KG$20240916$$CN$US$US
242246741$24224674$1$I$20240117$20240814$20240819$20240819$EXP$$EU-BAUSCHBL-2024BNL028655$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240819$$HP$EU$EU
242246761$24224676$1$I$$20240816$20240819$20240819$PER$$NVSC2024US167648$NOVARTIS$$$$$$Y$$$20240819$$MD$US$US
242246772$24224677$2$F$$20240812$20240819$20240819$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08080$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240819$$PH$US$US
242246781$24224678$1$I$$20240808$20240819$20240819$EXP$$US-GILEAD-2024-0664191$GILEAD$Spiegel J, Jain M, Nastoupil L, Tamaresis J., Ghobadi A., Lin Y., et al. Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium. Blood. 2023;142 supplement1:1032. doi:https://doi.org/10.1182/blood-2023-179868$$$A$$Y$$$20240819$$HP$US$US
242246791$24224679$1$I$$20240814$20240819$20240819$EXP$$US-KYOWAKIRIN-2024KK019285$KYOWA$$$$$$Y$$$20240819$$HP$US$US
242246801$24224680$1$I$$20240813$20240819$20240819$EXP$$JP-009507513-2408JPN001412J$MERCK$$79$YR$$M$Y$$$20240819$$MD$JP$JP
242246823$24224682$3$F$$20240912$20240819$20240912$PER$$US-ALXN-202408USA000745US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
242246832$24224683$2$F$$20240828$20240819$20240910$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI08118$NEUROCRINE BIOSCIENCES$$51$YR$$F$Y$$$20240910$$MD$JP$JP
242246841$24224684$1$I$20240601$20240813$20240819$20240819$EXP$$US-ABBVIE-5881254$ABBVIE$$63$YR$$M$Y$$$20240819$$CN$US$US
242246851$24224685$1$I$$20240815$20240819$20240819$EXP$$US-KYOWAKIRIN-2024KK019295$KYOWA$$$$$$Y$$$20240819$$HP$US$US
242246862$24224686$2$F$20231201$20240906$20240819$20240912$EXP$$CA-ABBVIE-5439443$ABBVIE$$86$YR$$M$Y$$$20240912$$PH$CA$CA
242246871$24224687$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130273$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$76.66$KG$20240819$$CN$US$US
242246881$24224688$1$I$20240731$20240815$20240819$20240819$EXP$$US-KYOWAKIRIN-2024KK019302$KYOWA$$$$$$Y$$$20240819$$HP$US$US
242246892$24224689$2$F$$20240812$20240819$20240830$EXP$$US-ALXN-202408USA000753US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240830$$MD$US$US
242246902$24224690$2$F$$20240826$20240819$20240903$EXP$$JP-009507513-2408JPN001724J$MERCK$$$$$F$Y$$$20240903$$MD$JP$JP
242246911$24224691$1$I$20240123$20240816$20240819$20240819$EXP$FR-AFSSAPS-RE2024000802$FR-GILEAD-2024-0684520$GILEAD$$67$YR$E$F$Y$51$KG$20240819$$HP$FR$FR
242246921$24224692$1$I$$20240816$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130351$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$106.59$KG$20240819$$CN$US$US
242246932$24224693$2$F$$20240820$20240819$20240827$EXP$$AU-Ipsen Biopharmaceuticals, Inc.-2024-14267$IPSEN$$2$YR$C$F$Y$$$20240827$$MD$AU$AU
242246942$24224694$2$F$20240713$20240818$20240819$20240822$EXP$$NVSC2024EG157524$NOVARTIS$$65$YR$$F$Y$73$KG$20240822$$CN$EG$EG
242246951$24224695$1$I$20240219$20240816$20240819$20240819$EXP$$FR-DSJP-DSE-2024-141038$DAIICHI$$$$E$F$Y$67$KG$20240819$$MD$FR$FR
242246981$24224698$1$I$$20240813$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009272$ELI LILLY AND CO$$42$YR$A$$Y$$$20240819$$LW$US$US
242246991$24224699$1$I$$20240814$20240819$20240819$EXP$$US-GILEAD-2024-0684458$GILEAD$$$$A$F$Y$$$20240819$$CN$US$US
242247001$24224700$1$I$$20240812$20240819$20240819$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127443$BRISTOL MYERS SQUIBB$Fukuzawa S, Yamagata K, Uchida F, Endo M, Sakamoto N, Bukawa H. A case of cholangitis as a nivolumab-induced immune-related adverse event in a patient with pulmonary metastasis after surgery for oral cancer. Journal of Maxillofacial and Oral Surgery. 2024 Aug 01;23(4):979-83. doi:10.1007/s12663-023-01976-7.$72$YR$E$M$Y$$$20240819$$HP$JP$JP
242247011$24224701$1$I$20240701$20240808$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005349$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240819$$CN$US$US
242247021$24224702$1$I$$20240813$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008811$ELI LILLY AND CO$$$$A$M$Y$$$20240819$$CN$US$US
242247031$24224703$1$I$$20240813$20240819$20240819$EXP$$US-009507513-2408USA005203$MERCK$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer immunology, immunotherapy. 2024;73 (10):200$71$YR$$F$Y$$$20240819$$HP$US$US
242247063$24224706$3$F$$20240919$20240819$20240923$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046504$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$$$20240923$$MD$US$US
242247071$24224707$1$I$20240101$20240809$20240819$20240819$EXP$$CA-GILEAD-2024-0683770$GILEAD$$$$A$M$Y$$$20240819$$MD$CA$CA
242247081$24224708$1$I$20240804$20240812$20240819$20240819$EXP$GB-MHRA-MED-202408091356522780-VKLFD$GB-ELI_LILLY_AND_COMPANY-GB202408007919$ELI LILLY AND CO$$42$YR$A$F$Y$115$KG$20240819$$CN$GB$GB
242247091$24224709$1$I$$20240812$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007692$ELI LILLY AND CO$$71$YR$E$F$Y$87.528$KG$20240819$$CN$US$US
242247101$24224710$1$I$20240728$20240812$20240819$20240819$EXP$GB-MHRA-MED-202408071330319320-JSMKH$GB-ELI_LILLY_AND_COMPANY-GB202408007915$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240819$$CN$GB$GB
242247111$24224711$1$I$$20240812$20240819$20240819$EXP$GB-MHRA-MED-202408121629308190-CVDQN$GB-ELI_LILLY_AND_COMPANY-GB202408007861$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$GB$GB
242247121$24224712$1$I$20240812$20240812$20240819$20240819$EXP$GB-MHRA-MED-202408121010081830-PMHDS$GB-ELI_LILLY_AND_COMPANY-GB202408007986$ELI LILLY AND CO$$27$YR$A$F$Y$95$KG$20240819$$CN$GB$GB
242247131$24224713$1$I$20240805$20240812$20240819$20240819$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408007910$ELI LILLY AND CO$$73$YR$E$M$Y$131$KG$20240819$$CN$GB$GB
242247141$24224714$1$I$$20240809$20240819$20240819$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202408010166$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240819$$HP$TW$TW
242247151$24224715$1$I$$20240811$20240819$20240819$EXP$GB-MHRA-MED-202408110859269560-NSZQB$GB-ELI_LILLY_AND_COMPANY-GB202408007928$ELI LILLY AND CO$$51$YR$A$F$Y$59$KG$20240819$$CN$GB$GB
242247161$24224716$1$I$20240601$20240811$20240819$20240819$EXP$GB-MHRA-MED-202408111017367090-WLBNH$GB-ELI_LILLY_AND_COMPANY-GB202408007929$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240819$$CN$GB$GB
242247171$24224717$1$I$20230811$20240811$20240819$20240819$EXP$GB-MHRA-MED-202408110654075400-YKDZB$GB-ELI_LILLY_AND_COMPANY-GB202408007924$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$GB$GB
242247181$24224718$1$I$20240629$20240813$20240819$20240819$EXP$GB-MHRA-MED-202408122045475870-LSDZJ$GB-ELI_LILLY_AND_COMPANY-GB202408007864$ELI LILLY AND CO$$34$YR$A$F$Y$79$KG$20240819$$CN$GB$GB
242247191$24224719$1$I$$20240812$20240819$20240819$EXP$GB-MHRA-MED-202408121242041390-VSMKR$GB-ELI_LILLY_AND_COMPANY-GB202408008023$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$GB$GB
242247201$24224720$1$I$20240812$20240812$20240819$20240819$EXP$GB-MHRA-MED-202408121217336020-QVFKL$GB-ELI_LILLY_AND_COMPANY-GB202408008021$ELI LILLY AND CO$$67$YR$E$F$Y$66$KG$20240819$$CN$GB$GB
242247211$24224721$1$I$20240606$20240811$20240819$20240819$EXP$GB-MHRA-MED-202408110747266510-ZNDGF$GB-ELI_LILLY_AND_COMPANY-GB202408007927$ELI LILLY AND CO$$34$YR$A$F$Y$106$KG$20240819$$CN$GB$GB
242247221$24224722$1$I$20240615$20240814$20240819$20240819$EXP$SE-SEMPA-2024-005987$SE-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2408SE06421$INSUD PHARMA$$33$YR$$F$Y$65$KG$20240819$$CN$SE$SE
242247231$24224723$1$I$$20240813$20240819$20240819$EXP$$US-009507513-2408USA006162$MERCK$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer immunology, immunotherapy. 2024;73 (10):200$60$YR$$F$Y$$$20240819$$HP$US$US
242247241$24224724$1$I$$20240813$20240819$20240819$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202408008029$ELI LILLY AND CO$$17$YR$T$M$Y$$$20240819$$CN$CA$CA
242247251$24224725$1$I$$20240816$20240819$20240819$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010755$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240819$$CN$US$US
242247261$24224726$1$I$$20240819$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408011283$ELI LILLY AND CO$$$$$M$Y$$$20240819$$CN$US$US
242247271$24224727$1$I$20240721$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130430$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240819$$HP$US$US
242247281$24224728$1$I$$20240814$20240819$20240819$PER$$US-TAKEDA-2024TUS082150$TAKEDA$$$$$$Y$$$20240819$$CN$US$US
242247291$24224729$1$I$$20240816$20240819$20240819$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046511$BOEHRINGER INGELHEIM$$52$YR$A$M$Y$$$20240819$$CN$US$US
242247301$24224730$1$I$$20240815$20240819$20240819$EXP$$NVSC2024US167010$NOVARTIS$$$$$M$Y$$$20240820$$CN$US$US
242247311$24224731$1$I$20240814$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010572$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$US$US
242247321$24224732$1$I$$20240805$20240819$20240819$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07850$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240819$$MD$US$US
242247331$24224733$1$I$$20240808$20240819$20240819$PER$$US-BIOMARINAP-US-2024-159739$BIOMARIN$$$$$$Y$$$20240819$$CN$US$US
242247341$24224734$1$I$$20240808$20240819$20240819$PER$$US-BIOMARINAP-US-2024-159723$BIOMARIN$$$$$$Y$$$20240819$$CN$US$US
242247351$24224735$1$I$20240808$20240811$20240819$20240819$PER$$US-BIOMARINAP-US-2024-159788$BIOMARIN$$$$$$Y$$$20240819$$CN$US$US
242247362$24224736$2$F$20240101$20240810$20240819$20240828$PER$$US-BIOMARINAP-US-2024-159845$BIOMARIN$$$$$$Y$$$20240828$$MD$US$US
242247371$24224737$1$I$$20240809$20240819$20240819$PER$$US-BIOMARINAP-US-2024-159799$BIOMARIN$$$$$$Y$$$20240819$$CN$US$US
242247381$24224738$1$I$$20240808$20240819$20240819$PER$$US-BIOMARINAP-US-2024-159756$BIOMARIN$$$$$$Y$$$20240819$$CN$US$US
242247391$24224739$1$I$20240101$20240801$20240819$20240819$PER$$US-BIOMARINAP-US-2024-159778$BIOMARIN$$$$$$Y$$$20240819$$CN$US$US
242247401$24224740$1$I$$20240813$20240819$20240819$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01253$AIMMUNE$$$$$$Y$$$20240819$$HP$US$US
242247411$24224741$1$I$$20240813$20240819$20240819$EXP$$US-009507513-2408USA006161$MERCK$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer immunology, immunotherapy. 2024;73 (10):200$55$YR$$F$Y$$$20240819$$HP$US$US
242247422$24224742$2$F$$20240911$20240819$20240917$EXP$$NVSC2024ZA167279$NOVARTIS$$38$YR$$F$Y$$$20240918$$CN$ZA$ZA
242247432$24224743$2$F$20240610$20240823$20240819$20240904$PER$$US-BIOMARINAP-US-2024-159792$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242247441$24224744$1$I$$20240815$20240819$20240819$EXP$$BR-JNJFOC-20240846385$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$BR$BR
242247451$24224745$1$I$$20240812$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128844$BRISTOL MYERS SQUIBB$Noble CW, Gangaputra SS, Thompson IA, Yuan A, Apolo AB, Lee J-M, et al. Ocular adverse events following use of immune checkpoint inhibitors for metastatic malignancies. Ocular Immunology and Inflammation. 2019 Apr 23;28(6):854-9.doi:10.1080/09273948.2019.1583347.$61$YR$A$M$Y$$$20240819$$HP$US$US
242247461$24224746$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010554$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240819$$CN$US$US
242247471$24224747$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010552$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240819$$CN$US$US
242247482$24224748$2$F$20240101$20240909$20240819$20240918$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01248$AIMMUNE$$$$$$Y$$$20240918$$CN$US$US
242247491$24224749$1$I$20240501$20240815$20240819$20240819$EXP$$MX-JNJFOC-20240846478$JOHNSON AND JOHNSON$$91$YR$E$F$Y$80$KG$20240819$$CN$MX$MX
242247501$24224750$1$I$$20240806$20240819$20240819$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07899$NEUROCRINE BIOSCIENCES$$77$YR$$F$Y$$$20240819$$PH$US$US
242247512$24224751$2$F$$20240906$20240819$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130873$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$93.44$KG$20240910$$CN$US$US
242247521$24224752$1$I$20240806$20240807$20240819$20240819$EXP$$ES-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000023$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240819$$MD$ES$ES
242247531$24224753$1$I$$20240804$20240819$20240819$PER$$US-JNJFOC-20240812176$JOHNSON AND JOHNSON$$$$$F$Y$$$20240819$$CN$US$US
242247541$24224754$1$I$$20240812$20240819$20240819$PER$$US-BIOMARINAP-US-2024-159812$BIOMARIN$$$$$$Y$$$20240819$$CN$US$US
242247551$24224755$1$I$$20240815$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408010382$ELI LILLY AND CO$$$$$F$Y$$$20240819$$CN$US$US
242247561$24224756$1$I$$20240814$20240819$20240819$EXP$$US-Bion-013689$BIONPHARMA$$78$YR$E$M$Y$$$20240819$$HP$US$US
242247571$24224757$1$I$$20240814$20240819$20240819$EXP$$US-Bion-013692$BIONPHARMA$$4$YR$C$M$Y$$$20240819$$HP$US$US
242247581$24224758$1$I$$20240812$20240819$20240819$EXP$$US-Bion-013699$BIONPHARMA$$$$$F$Y$$$20240819$$CN$US$US
242247591$24224759$1$I$$20240813$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US073043$SANDOZ$$$$$F$Y$68.18$KG$20240819$$CN$US$US
242247601$24224760$1$I$$20240815$20240819$20240819$EXP$$DE-SANDOZ INC.-SDZ2024DE072903$SANDOZ$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$59$YR$$F$Y$$$20240819$$HP$DE$DE
242247611$24224761$1$I$$20240813$20240819$20240819$EXP$$US-009507513-2408USA006160$MERCK$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer immunology, immunotherapy. 2024;73 (10):200$69$YR$$M$Y$$$20240819$$HP$US$US
242247621$24224762$1$I$$20240813$20240819$20240819$EXP$$US-009507513-2408USA006163$MERCK$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer immunology, immunotherapy. 2024;73 (10):200$61$YR$$F$Y$$$20240819$$HP$US$US
242247631$24224763$1$I$$20240813$20240819$20240819$EXP$$US-JNJFOC-20240833222$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242247641$24224764$1$I$20240811$20240812$20240819$20240819$PER$$US-JNJFOC-20240830836$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
242247651$24224765$1$I$$20240812$20240819$20240819$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-113085$REGENERON$$$$$F$Y$$$20240820$$MD$US$US
242247661$24224766$1$I$$20240813$20240819$20240819$EXP$$US-JNJFOC-20240836087$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$US$US
242247681$24224768$1$I$$20240816$20240819$20240819$PER$$US-JNJFOC-20240843886$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$CN$US$US
242247691$24224769$1$I$20240717$20240806$20240819$20240819$EXP$$DE-ESPERIONTHERAPEUTICS-2024DEU01273$ESPERION THERAPEUTICS$$53$YR$$F$Y$70$KG$20240820$$CN$DE$DE
242247701$24224770$1$I$$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024162055$AMGEN$$$$$M$Y$$$20240819$$CN$US$US
242247711$24224771$1$I$$20240808$20240819$20240819$PER$$US-ABBVIE-5874799$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242247721$24224772$1$I$$20240816$20240819$20240819$EXP$GB-MHRA-MED-202408161230116890-YHVQR$GB-SANDOZ INC.-SDZ2024GB073317$SANDOZ$$$$$M$Y$$$20240819$$HP$GB$GB
242247731$24224773$1$I$$20240812$20240819$20240819$PER$$US-SA-2024SA243176$SANOFI AVENTIS$$$$C$F$Y$$$20240820$$MD$US$US
242247741$24224774$1$I$$20240808$20240819$20240819$PER$$US-BAUSCHBL-2024BNL031438$BAUSCH AND LOMB$$$$$M$Y$$$20240820$$MD$US$US
242247754$24224775$4$F$20240721$20240926$20240819$20240927$EXP$$US-SANDOZ INC.-SDZ2024US072557$SANDOZ$$71$YR$$M$Y$$$20240927$$HP$US$US
242247762$24224776$2$F$$20240815$20240819$20240905$EXP$$DE-JNJFOC-20240847346$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240905$$CN$DE$DE
242247772$24224777$2$F$$20240916$20240819$20240920$30DAY$$AT-JNJFOC-20240842215$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$PH$AT$AT
242247781$24224778$1$I$$20240813$20240819$20240819$EXP$$CA-SANDOZ INC.-SDZ2024CA072566$SANDOZ$$65$YR$$F$Y$34$KG$20240819$$HP$CA$CA
242247791$24224779$1$I$20240708$20240814$20240819$20240819$PER$$NVSC2024US167597$NOVARTIS$$57$YR$$F$Y$65.91$KG$20240820$$CN$US$US
242247812$24224781$2$F$$20240923$20240819$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129468$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$87.09$KG$20240924$$CN$US$US
242247842$24224784$2$F$$20240910$20240819$20240925$30DAY$$CA-JNJFOC-20240841435$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$CA$CA
242247851$24224785$1$I$$20240814$20240819$20240819$EXP$$US-ABBVIE-5883255$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242247862$24224786$2$F$20240628$20240904$20240819$20240904$PER$$US-ALXN-202408USA000840US$ALEXION PHARMACEUTICALS$$71$YR$$F$Y$$$20240904$$CN$US$US
242247871$24224787$1$I$20240814$20240816$20240819$20240819$EXP$$CN-BEIGENE-BGN-2024-012891$BEIGENE$$$$$$Y$$$20240819$$HP$CN$CN
242247881$24224788$1$I$$20240808$20240819$20240819$PER$$US-JNJFOC-20240820880$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$US$US
242247892$24224789$2$F$$20240912$20240819$20240925$30DAY$$CA-JNJFOC-20240841511$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$HP$CA$CA
242247903$24224790$3$F$$20240822$20240819$20240828$EXP$$NVSC2024GB167566$NOVARTIS$$57$YR$$F$Y$$$20240828$$PH$GB$GB
242247911$24224791$1$I$20240501$20240812$20240819$20240819$EXP$$BR-JNJFOC-20240832396$JOHNSON AND JOHNSON$$49$YR$A$M$Y$86$KG$20240820$$CN$BR$BR
242247921$24224792$1$I$20240501$20240809$20240819$20240819$EXP$$BR-JNJFOC-20240829940$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240820$$PH$BR$BR
242247931$24224793$1$I$20240101$20240813$20240819$20240819$PER$$US-AstraZeneca-2024A185440$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242247941$24224794$1$I$$20240814$20240819$20240819$EXP$$EU-BAUSCHBL-2024BNL031751$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240820$$MD$EU$EU
242247951$24224795$1$I$$20240813$20240819$20240819$30DAY$$US-SANDOZ INC.-SDZ2024US072654$SANDOZ$$$$$$Y$$$20240819$$CN$US$US
242247961$24224796$1$I$$20240813$20240819$20240819$EXP$$SG-BEIGENE-BGN-2024-012709$BEIGENE$$$$$$Y$$$20240819$$MD$SG$SG
242247971$24224797$1$I$$20240819$20240819$20240819$PER$$NVSC2024US167695$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242247981$24224798$1$I$$20240804$20240819$20240819$30DAY$$CA-JNJFOC-20240813515$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240820$$HP$CA$CA
242247992$24224799$2$F$$20240910$20240819$20240918$EXP$$JP-JNJFOC-20240846500$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240918$$MD$JP$JP
242248001$24224800$1$I$$20240819$20240819$20240819$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046520$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240820$$CN$US$US
242248012$24224801$2$F$20240101$20240909$20240819$20240916$PER$$US-SA-2024SA241867$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240916$$MD$US$US
242248021$24224802$1$I$$20240812$20240819$20240819$EXP$$US-JNJFOC-20240828684$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
242248032$24224803$2$F$$20240910$20240819$20240918$EXP$$JP-JNJFOC-20240846441$JOHNSON AND JOHNSON$$9$DEC$E$M$Y$$$20240918$$MD$JP$JP
242248041$24224804$1$I$$20240816$20240819$20240819$PER$$US-ELI_LILLY_AND_COMPANY-US202408011346$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240819$$CN$US$US
242248051$24224805$1$I$20230810$20240816$20240819$20240819$EXP$$JP-TAKEDA-2024TJP012016$TAKEDA$$76$YR$$M$Y$70$KG$20240819$$MD$JP$JP
242248061$24224806$1$I$20230828$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024162165$AMGEN$$74$YR$E$F$Y$$$20240819$$CN$US$US
242248071$24224807$1$I$20240101$20240815$20240819$20240819$PER$$US-AMGEN-USASP2024162909$AMGEN$$73$YR$E$M$Y$$$20240819$$HP$US$US
242248081$24224808$1$I$20240801$20240815$20240819$20240819$PER$$US-AMGEN-USASP2024164136$AMGEN$$60$YR$A$M$Y$$$20240819$$CN$US$US
242248091$24224809$1$I$$20240815$20240819$20240819$PER$$US-AMGEN-USASP2024164019$AMGEN$$$$$$Y$$$20240819$$PH$US$US
242248101$24224810$1$I$$20240816$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130542$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240820$$CN$US$US
242248111$24224811$1$I$20240101$20240813$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128654$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240820$$CN$US$US
242248121$24224812$1$I$20240601$20240813$20240819$20240819$PER$$US-JNJFOC-20240833280$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240820$$PH$US$US
242248131$24224813$1$I$20240710$20240813$20240819$20240819$EXP$$GB-JNJFOC-20240836679$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240820$$CN$GB$GB
242248141$24224814$1$I$20240802$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024163777$AMGEN$$65$YR$E$F$Y$$$20240819$$CN$US$US
242248151$24224815$1$I$20240730$20240813$20240819$20240819$PER$$US-ABBVIE-5883742$ABBVIE$$35$YR$$F$Y$$$20240819$$MD$US$US
242248163$24224816$3$F$$20240910$20240819$20240913$EXP$$US-ABBVIE-5880223$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
242248171$24224817$1$I$20240814$20240814$20240819$20240819$PER$$US-ORGANON-O2408USA001182$ORGANON$$$$$F$Y$$$20240819$$CN$US$US
242248181$24224818$1$I$20240101$20240812$20240819$20240819$EXP$$US-ABBVIE-5878849$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242248201$24224820$1$I$$20240813$20240819$20240819$PER$$US-JNJFOC-20240836006$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$HP$US$US
242248221$24224822$1$I$20240410$20240815$20240819$20240819$EXP$$GB-ABBVIE-5882381$ABBVIE$$31$YR$$M$Y$89$KG$20240819$$HP$GB$GB
242248233$24224823$3$F$20240801$20240904$20240819$20240916$EXP$$JP-SMPA-2024SMP012164$SUNOVION$$$$$$Y$$$20240916$$CN$JP$JP
242248241$24224824$1$I$20240803$20240814$20240819$20240819$EXP$$CN-ABBVIE-5883943$ABBVIE$$65$YR$$M$Y$$$20240819$$HP$CN$CN
242248251$24224825$1$I$20240720$20240813$20240819$20240819$EXP$$BR-TAKEDA-2024TUS077224$TAKEDA$$57$YR$$M$Y$$$20240819$$CN$BR$BR
242248281$24224828$1$I$$20240815$20240819$20240819$EXP$$DE-JNJFOC-20240848418$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$PH$DE$DE
242248292$24224829$2$F$$20240906$20240819$20240912$30DAY$$BR-JNJFOC-20240840772$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$PH$BR$BR
242248301$24224830$1$I$$20240813$20240819$20240819$EXP$$US-JNJFOC-20240835674$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240820$$CN$US$US
242248311$24224831$1$I$20240730$20240813$20240819$20240819$PER$$US-JNJFOC-20240834110$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$MD$US$US
242248321$24224832$1$I$$20240819$20240819$20240819$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046554$BOEHRINGER INGELHEIM$$$$$$Y$$$20240820$$CN$US$US
242248332$24224833$2$F$$20240913$20240819$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129863$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240919$$HP$US$US
242248341$24224834$1$I$20150101$20240814$20240819$20240819$PER$$US-JNJFOC-20240838915$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240820$$HP$US$US
242248351$24224835$1$I$20240530$20240816$20240819$20240819$EXP$$US-AstraZeneca-2024A188181$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242248361$24224836$1$I$$20240815$20240819$20240819$EXP$$US-ABBVIE-5659299$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242248372$24224837$2$F$20240808$20240828$20240819$20240904$EXP$$CR-BIOGEN-2024BI01278419$BIOGEN$$47$YR$$F$Y$70$KG$20240904$$CN$CR$CR
242248381$24224838$1$I$20230801$20240812$20240819$20240819$EXP$$US-BIOGEN-2024BI01278023$BIOGEN$$47$YR$$M$Y$$$20240819$$CN$US$US
242248391$24224839$1$I$$20240814$20240819$20240819$EXP$$US-ABBVIE-5882183$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242248401$24224840$1$I$$20240812$20240819$20240819$EXP$$US-ABBVIE-5878090$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242248411$24224841$1$I$20240801$20240812$20240819$20240819$PER$$US-SA-2024SA242817$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240820$$MD$US$US
242248421$24224842$1$I$$20240819$20240819$20240819$EXP$$NVSC2024US167607$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242248432$24224843$2$F$$20240814$20240819$20240822$PER$$US-AMGEN-USASP2024163104$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242248442$24224844$2$F$20240518$20240820$20240819$20240827$EXP$$US-BIOGEN-2024BI01278200$BIOGEN$$65$YR$$F$Y$$$20240827$$MD$US$US
242248451$24224845$1$I$20240719$20240812$20240819$20240819$EXP$FR-AFSSAPS-PB2024000853$FR-BIOGEN-2024BI01277990$BIOGEN$$38$YR$$M$Y$48$KG$20240819$$MD$FR$FR
242248461$24224846$1$I$$20240813$20240819$20240819$EXP$$CA-BIOGEN-2023BI01211251$BIOGEN$$$$$F$Y$$$20240819$$CN$CA$CA
242248471$24224847$1$I$$20240812$20240819$20240819$PER$$US-ABBVIE-5879437$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242248481$24224848$1$I$$20240816$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130795$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240820$$CN$US$US
242248491$24224849$1$I$20230901$20240812$20240819$20240819$EXP$$CA-JNJFOC-20230901282$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240820$$HP$CA$CA
242248501$24224850$1$I$20240101$20240809$20240819$20240819$PER$$US-ABBVIE-5875237$ABBVIE$$$$$M$Y$90.718$KG$20240819$$CN$US$US
242248514$24224851$4$F$20220101$20240904$20240819$20240909$EXP$$US-ABBVIE-5882170$ABBVIE$$$$$F$Y$92.986$KG$20240909$$CN$US$US
242248521$24224852$1$I$$20240809$20240819$20240819$EXP$$US-SANDOZ INC.-SDZ2024US071988$SANDOZ$$19$YR$$$Y$$$20240819$$CN$US$US
242248531$24224853$1$I$$20240815$20240819$20240819$PER$$US-AMGEN-USASP2024164930$AMGEN$$$$$$Y$$$20240819$$MD$US$US
242248541$24224854$1$I$20240814$20240815$20240819$20240819$PER$$US-SA-2024SA242976$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240820$$CN$US$US
242248551$24224855$1$I$$20240812$20240819$20240819$PER$$US-SA-2024SA241390$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240820$$MD$US$US
242248561$24224856$1$I$20240701$20240813$20240819$20240819$EXP$$US-BIOGEN-2024BI01278371$BIOGEN$$38$YR$$F$Y$$$20240819$$CN$US$US
242248571$24224857$1$I$$20240813$20240819$20240819$EXP$$US-ABBVIE-5882232$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242248581$24224858$1$I$20200101$20240813$20240819$20240819$EXP$$JP-ABBVIE-5883981$ABBVIE$$$$$M$Y$57$KG$20240819$$MD$JP$JP
242248591$24224859$1$I$20240801$20240812$20240819$20240819$EXP$IT-MINISAL02-998231$IT-BIOGEN-2024BI01277975$BIOGEN$$39$YR$$F$Y$70$KG$20240819$$MD$IT$IT
242248601$24224860$1$I$$20240813$20240819$20240819$EXP$$US-BIOGEN-2024BI01278230$BIOGEN$$$$$M$Y$$$20240819$$CN$US$US
242248611$24224861$1$I$$20240815$20240819$20240819$EXP$$BG-ABBVIE-5851026$ABBVIE$$79$YR$$F$Y$$$20240819$$CN$BG$BG
242248621$24224862$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130477$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240820$$HP$US$US
242248641$24224864$1$I$20240416$20240815$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130615$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240820$$HP$US$US
242248662$24224866$2$F$$20240920$20240819$20240924$30DAY$$FI-JNJFOC-20240843944$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$PH$FI$FI
242248671$24224867$1$I$$20240813$20240819$20240819$PER$$US-JNJFOC-20240832871$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242248681$24224868$1$I$$20240815$20240819$20240819$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130213$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240820$$CN$US$US
242248691$24224869$1$I$$20240815$20240819$20240819$EXP$$US-GILEAD-2024-0684429$GILEAD$$$$A$M$Y$$$20240819$$CN$US$US
242248701$24224870$1$I$20240805$20240806$20240819$20240819$PER$$US-AstraZeneca-2024A178642$ASTRAZENECA$$28747$DY$$M$Y$$$20240820$$CN$US$
242248711$24224871$1$I$20240101$20240814$20240819$20240819$EXP$$CA-ABBVIE-5873058$ABBVIE$$$$E$M$Y$$$20240819$$CN$CA$CA
242248722$24224872$2$F$20230721$20240912$20240819$20240918$EXP$$JP-009507513-2403JPN003083J$MERCK$$89$YR$$M$Y$$$20240918$$MD$JP$JP
242248731$24224873$1$I$20231105$20240813$20240819$20240819$EXP$$GB-ABBVIE-5881175$ABBVIE$$50$YR$$M$Y$$$20240819$$HP$GB$GB
242248741$24224874$1$I$20240401$20240813$20240819$20240819$EXP$$US-ABBVIE-5881873$ABBVIE$$58$YR$$M$Y$$$20240819$$CN$US$US
242248751$24224875$1$I$20240709$20240812$20240819$20240819$EXP$$GB-CELLTRION INC.-2024GB019723$CELLTRION$$$$$$Y$$$20240820$$CN$GB$GB
242248761$24224876$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130734$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240820$$CN$US$US
242248771$24224877$1$I$$20240819$20240819$20240819$PER$$NVSC2024US167737$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242248781$24224878$1$I$20240615$20240815$20240819$20240819$EXP$$US-ABBVIE-5883539$ABBVIE$$71$YR$$F$Y$$$20240819$$CN$US$US
242248801$24224880$1$I$20240401$20240806$20240819$20240819$EXP$$HU-SMPA-2024SPA000888$SUNOVION$$$$$$Y$$$20240819$$MD$DE$DE
242248811$24224881$1$I$$20240806$20240819$20240819$EXP$$US-SMPA-2024SPA000868$SUNOVION$$$$$$Y$$$20240819$$CN$US$US
242248821$24224882$1$I$$20240819$20240819$20240819$EXP$$GB-JNJFOC-20240846489$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$CN$GB$GB
242248831$24224883$1$I$$20240815$20240819$20240819$EXP$$US-009507513-2408USA005772$MERCK$$$$$M$Y$$$20240819$$HP$US$US
242248841$24224884$1$I$$20240813$20240819$20240819$PER$$US-AMGEN-USASP2024161488$AMGEN$$$$$F$Y$$$20240819$$PH$US$US
242248851$24224885$1$I$20231129$20240811$20240819$20240819$EXP$$JO-EMD Serono-2024011322$EMD SERONO INC$$27$YR$A$F$Y$$$20240820$$CN$JO$JO
242248861$24224886$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128119$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240820$$CN$US$US
242248871$24224887$1$I$$20240816$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130452$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$85.28$KG$20240820$$CN$US$US
242248882$24224888$2$F$20240808$20240809$20240819$20240827$PER$$US-JNJFOC-20240828031$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$HP$US$US
242248891$24224889$1$I$20240814$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024163520$AMGEN$$82$YR$E$F$Y$$$20240819$$CN$US$US
242248901$24224890$1$I$20240711$20240813$20240819$20240819$EXP$BE-FAMHP-DHH-N2024-122471$BE-ABBVIE-5882175$ABBVIE$$36$YR$$M$Y$55$KG$20240819$$CN$BE$BE
242248911$24224891$1$I$20240101$20240814$20240819$20240819$EXP$$US-JNJFOC-20240842177$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240820$$HP$US$US
242248932$24224893$2$F$20240701$20240904$20240819$20240904$PER$$US-ALXN-202408USA000793US$ALEXION PHARMACEUTICALS$$71$YR$$F$Y$$$20240904$$CN$US$US
242248941$24224894$1$I$$20240819$20240819$20240819$PER$$NVSC2024US167745$NOVARTIS$$$$$M$Y$93$KG$20240820$$CN$US$US
242248951$24224895$1$I$$20240814$20240819$20240819$EXP$$US-ABBVIE-5882150$ABBVIE$$$$$F$Y$$$20240819$$CN$US$US
242248961$24224896$1$I$$20240814$20240819$20240819$EXP$$CA-ABBVIE-5882866$ABBVIE$$$$A$M$Y$$$20240819$$CN$CA$CA
242248971$24224897$1$I$$20240722$20240819$20240819$PER$$CA-TOLMAR, INC.-24CA051278$TOLMAR$$$$$M$Y$$$20240814$$CN$CA$CA
242248981$24224898$1$I$20240101$20240722$20240819$20240819$PER$$CO-TOLMAR, INC.-24CO051255$TOLMAR$$69$YR$$M$Y$$$20240814$$CN$CO$CO
242248991$24224899$1$I$$20240718$20240819$20240819$PER$$ES-TOLMAR, INC.-24ES051547$TOLMAR$$$$$$Y$$$20240814$$HP$ES$ES
242249001$24224900$1$I$20240101$20240819$20240819$20240819$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046587$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240820$$CN$US$US
242249011$24224901$1$I$20240801$20240816$20240819$20240819$EXP$$ES-ABBVIE-5883935$ABBVIE$$64$YR$$M$Y$$$20240819$$MD$ES$ES
242249021$24224902$1$I$20200701$20240813$20240819$20240819$PER$$US-JNJFOC-20240834379$JOHNSON AND JOHNSON$$7$DEC$E$F$Y$$$20240820$$CN$US$US
242249032$24224903$2$F$$20240917$20240819$20240926$30DAY$$JP-JNJFOC-20240841833$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$PH$JP$JP
242249041$24224904$1$I$20201201$20240812$20240819$20240819$EXP$$BR-JNJFOC-20240839116$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240820$$MD$BR$BR
242249071$24224907$1$I$$20240814$20240819$20240819$PER$$US-AMGEN-USASP2024162058$AMGEN$$$$$$Y$$$20240819$$CN$US$US
242249081$24224908$1$I$20240730$20240812$20240819$20240819$EXP$$US-ABBVIE-5877555$ABBVIE$$73$YR$$F$Y$$$20240819$$CN$US$US
242249091$24224909$1$I$$20240815$20240819$20240819$EXP$$US-ABBVIE-5884017$ABBVIE$$$$$M$Y$$$20240819$$CN$US$US
242249101$24224910$1$I$20240301$20240812$20240819$20240819$EXP$$US-ABBVIE-5865048$ABBVIE$$54$YR$$F$Y$94$KG$20240819$$CN$US$US
242249111$24224911$1$I$$20240811$20240819$20240819$EXP$$TR-JNJFOC-20240829067$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$TR$TR
242249132$24224913$2$F$$20240818$20240819$20240827$EXP$$PL-JNJFOC-20240846396$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240827$$HP$PL$PL
242249141$24224914$1$I$20240812$20240812$20240819$20240819$EXP$$US-ABBVIE-5878671$ABBVIE$$79$YR$$M$Y$$$20240819$$CN$US$US
242249151$24224915$1$I$20240701$20240812$20240819$20240819$EXP$$US-ABBVIE-5878232$ABBVIE$$71$YR$$M$Y$$$20240819$$CN$US$US
242249162$24224916$2$F$$20240827$20240819$20240901$EXP$$JP-GSK-JP2024JPN100947$GLAXOSMITHKLINE$$$$$$Y$$$20240901$$PH$JP$JP
242249181$24224918$1$I$$20240813$20240819$20240819$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128158$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240820$$CN$US$US
242249201$24224920$1$I$20240701$20240809$20240819$20240819$PER$$US-SA-2024SA241001$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240820$$MD$US$US
242249271$24224927$1$I$$20240813$20240819$20240819$EXP$$BR-ABBVIE-5884254$ABBVIE$$$$$F$Y$$$20240819$$MD$BR$BR
242249281$24224928$1$I$20240801$20240814$20240820$20240820$PER$$US-ABBVIE-5883465$ABBVIE$$$$$$Y$$$20240819$$CN$US$US
242249301$24224930$1$I$20240801$20240812$20240820$20240820$EXP$$US-ABBVIE-5878545$ABBVIE$$60$YR$$F$Y$$$20240820$$CN$US$US
242249311$24224931$1$I$$20240808$20240819$20240819$EXP$$CA-TAKEDA-2023TUS025604$TAKEDA$$$$$M$Y$$$20240819$$CN$CA$CA
242249326$24224932$6$F$20240208$20240910$20240820$20240924$30DAY$$US-AMGEN-USASP2024162234$AMGEN$$40$YR$A$F$Y$97.5$KG$20240924$$PH$US$US
242249331$24224933$1$I$$20240812$20240820$20240820$EXP$$US-AMGEN-USASP2024159954$AMGEN$$$$$M$Y$$$20240819$$CN$US$US
242249343$24224934$3$F$20240101$20240904$20240820$20240906$EXP$$US-ABBVIE-5882171$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242249351$24224935$1$I$$20240816$20240820$20240820$PER$$NVSC2024US167742$NOVARTIS$$$$A$F$Y$$$20240820$$CN$US$US
242249362$24224936$2$F$20240814$20240819$20240820$20240820$PER$$US-AMGEN-USASP2024164343$AMGEN$$78$YR$E$F$Y$$$20240820$$CN$US$US
242249371$24224937$1$I$$20240814$20240820$20240820$EXP$$CA-TAKEDA-CA201924688$TAKEDA$$$$$M$Y$79$KG$20240820$$CN$CA$CA
242249381$24224938$1$I$20240801$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024162960$AMGEN$$$$$F$Y$$$20240819$$CN$US$US
242249392$24224939$2$F$20240101$20240919$20240820$20240926$EXP$$US-ABBVIE-5880229$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
242249401$24224940$1$I$20230101$20240814$20240820$20240820$EXP$$ZA-ABBVIE-5881763$ABBVIE$$53$YR$$F$Y$$$20240820$$HP$ZA$ZA
242249412$24224941$2$F$$20240911$20240820$20240914$EXP$$US-ABBVIE-5882173$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
242249421$24224942$1$I$20230528$20240816$20240820$20240820$EXP$FR-AFSSAPS-PO2024000897$FR-GSK-FR2024102333$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$MD$FR$FR
242249431$24224943$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA240770$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$CN$US$US
242249441$24224944$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA241683$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240820$$MD$US$US
242249451$24224945$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241890$SANOFI AVENTIS$$$$C$F$Y$47.4$KG$20240820$$MD$US$US
242249491$24224949$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5882028$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242249511$24224951$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A186645$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242249521$24224952$1$I$$20240812$20240820$20240820$EXP$$VN-AstraZeneca-2024A185584$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$VN$
242249531$24224953$1$I$20171001$20240812$20240820$20240820$EXP$$PL-VELOXIS PHARMACEUTICALS, INC.-2018-VEL-00326$VELOXIS PHARMACEUTICALS$Pietraszewska K, Januszko Giergielewicz B, Arlukowicz T, Jaroslawski J, Kozak L, Skutecki R et al.. Acute pancreatitis after kidney transplantation-serious complication, therapeutic dilemmas-a case report and literature overview.. Nefrologia I Dializoterapia Polska. 2018;22:2$61$YR$$M$Y$$$20240820$$MD$PL$PL
242249561$24224956$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883962$ABBVIE$$$$A$M$Y$$$20240820$$HP$US$US
242249571$24224957$1$I$20240801$20240816$20240820$20240820$EXP$$US-AstraZeneca-2024A188080$ASTRAZENECA$$31282$DY$$F$Y$$$20240820$$CN$US$
242249581$24224958$1$I$$20240815$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046432$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240820$$MD$US$US
242249591$24224959$1$I$$20240815$20240820$20240820$EXP$$US-AMGEN-USASP2024162863$AMGEN$$$$$F$Y$$$20240819$$CN$US$US
242249602$24224960$2$F$20240813$20240814$20240820$20240822$PER$$US-AMGEN-USASP2024162318$AMGEN$$74$YR$E$M$Y$$$20240822$$PH$US$US
242249612$24224961$2$F$20231101$20240821$20240820$20240828$EXP$$US-ABBVIE-5880942$ABBVIE$$67$YR$$M$Y$86$KG$20240828$$CN$US$US
242249621$24224962$1$I$$20240807$20240820$20240820$EXP$$US-STERISCIENCE B.V.-2024-ST-001196$Steriscience PTE$Alshawa L, Leahy B, Rueckert J, Maskey A, Anstead M, Keshavamurthy S, et al.. Hemophagocytic Lymphohistiocytosis: A Rare Diagnosis in the Immediate Aftermath of Lung Transplantation.. J-Heart-Lung-Transplant. 2024;43 (Suppl.) (4):S484-S485 abstr. 1040$63$YR$$M$Y$$$20240820$$HP$US$US
242249631$24224963$1$I$$20240807$20240820$20240820$EXP$$SA-STERISCIENCE B.V.-2024-ST-001197$Steriscience PTE$Mirza A, Alsufyani K, Khojah A.. 75 Fatal CMV infection in a 2-month-old Infant with STAT1 Loss of Function Mutation.. Clin-Immunol. 2024;262 (Suppl.)$2$MON$$F$Y$$$20240820$$HP$SA$SA
242249641$24224964$1$I$$20240807$20240820$20240820$EXP$$IE-STERISCIENCE B.V.-2024-ST-001210$Steriscience PTE$Carroll E, Leahy M, Dhonncha EN.. SCAR: more than just a mark on the skin.. Br-J-Dermatol. 2024;192 (Suppl. 1):i146-i147 abstr. BI19.$34$YR$$F$Y$$$20240820$$HP$IE$IE
242249651$24224965$1$I$$20240808$20240820$20240820$EXP$$US-STERISCIENCE B.V.-2024-ST-001202$Steriscience PTE$Arce PS, Murad K.. Thyroid Storm In Heart Failure: A Case Report.. J-Card-Fail. 2024;30 (1):178.$36$YR$$M$Y$$$20240820$$HP$US$US
242249661$24224966$1$I$$20240807$20240820$20240820$EXP$$JP-STERISCIENCE B.V.-2024-ST-001212$Steriscience PTE$Shinohara K, Itoi S, Nakamura S, Miyazaki Y, Mutoh Y, Hagiwara S., et al.. Micafungin-breakthrough Coniochaeta hoffmannii (Lecythophora hoffmannii) fungemia following cord blood transplant in a patient with acute myeloid leukemia successfully treated with voriconazole. Journal of Infection and Chemotherapy. 2024;30(9):934-7$48$YR$$F$Y$$$20240820$$MD$JP$JP
242249691$24224969$1$I$20240811$20240816$20240820$20240820$EXP$$BG-ABBVIE-5883966$ABBVIE$$67$YR$$M$Y$$$20240820$$CN$BG$BG
242249703$24224970$3$F$20240801$20240826$20240820$20240827$EXP$$ES-ABBVIE-5883947$ABBVIE$$86$YR$$M$Y$$$20240827$$CN$ES$ES
242249712$24224971$2$F$$20240828$20240820$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012690$JAZZ$$$$$M$Y$91.5$KG$20240830$$HP$US$US
242249721$24224972$1$I$$20240709$20240820$20240820$PER$$US-Umedica-000067$UMEDICA LABS$$$$$$Y$$$20240818$$HP$US$
242249731$24224973$1$I$$20240819$20240820$20240820$PER$$NVSC2024US167800$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242249752$24224975$2$F$$20240906$20240820$20240914$EXP$$IN-ROCHE-10000059769$ROCHE$$86$YR$E$M$Y$$$20240914$$CN$IN$IN
242249761$24224976$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A186862$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242249771$24224977$1$I$20231201$20240816$20240820$20240820$EXP$$US-AstraZeneca-2024A187810$ASTRAZENECA$$29610$DY$$$Y$$$20240820$$HP$US$
242249781$24224978$1$I$$20230630$20240820$20240820$EXP$$CA-AstraZeneca-2023A126461$ASTRAZENECA$$$$$M$Y$$$20240820$$MD$CA$
242249791$24224979$1$I$$20240814$20240820$20240820$EXP$$US-JNJFOC-20240836500$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242249803$24224980$3$F$20240701$20240827$20240820$20240901$EXP$$DE-JNJFOC-20240838584$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240901$$MD$DE$DE
242249822$24224982$2$F$$20240814$20240820$20240822$EXP$IN-MLMSERVICE-20240805-PI152413-00306-1$IN-STRIDES ARCOLAB LIMITED-2024SP010287$STRIDES$Gupta D, Singh L, Kumar S, Singh K, Mendonca S, Chatterjee T. Rare complications of heart transplant: Autopsy findings. Indian Journal of Pathology and Microbiology.. 2024;67(3):624-627$33$YR$$M$Y$$$20240822$$MD$IN$IN
242249831$24224983$1$I$$20240806$20240820$20240820$EXP$$GB-CIPLA LTD.-2024GB08667$CIPLA$$$$$$Y$$$20240820$$CN$GB$GB
242249842$24224984$2$F$20240101$20240909$20240820$20240913$EXP$$CA-ABBVIE-5880939$ABBVIE$$85$YR$$M$Y$93$KG$20240913$$CN$CA$CA
242249851$24224985$1$I$20240601$20240809$20240820$20240820$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000288$EMCURE$$$$$$Y$$$20240820$$CN$US$US
242249861$24224986$1$I$$20240817$20240820$20240820$EXP$$US-ROCHE-10000059980$ROCHE$$74$YR$E$F$Y$$$20240820$$CN$US$US
242249871$24224987$1$I$20240701$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164596$AMGEN$$66$YR$E$F$Y$$$20240819$$HP$US$US
242249881$24224988$1$I$$20240819$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046560$BOEHRINGER INGELHEIM$$$$$$Y$$$20240820$$MD$US$US
242249891$24224989$1$I$$20240813$20240820$20240820$EXP$$SA-CHEPLA-2024010589$CHEPLAPHARM$Mirza A, Alsufyani K, Khojah A. Fatal CMV infection in a 2-month-old Infant with STAT1 Loss of Function Mutation. Clinical Immunology. 2024;262S. doi.org/10.1016/j.clim.2024.110017.$2$MON$$F$Y$$$20240819$$MD$COUNTRY NOT SPECIFIED$SA
242249901$24224990$1$I$20240503$20240814$20240820$20240820$EXP$$US-ABBVIE-5881972$ABBVIE$$64$YR$$F$Y$$$20240820$$CN$US$US
242249911$24224991$1$I$$20240812$20240820$20240820$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP010330$STRIDES$Bozca BC, Alpsoy A, Bilgic A, Bassorgun CI, Unal B, Alpsoy E.. Clinicopathological analysis of patients diagnosed with DRESS.. Turk-Arch-Dermatol-Venereol. 2023;57:101-107$$$$$Y$$$20240820$$HP$TR$TR
242249921$24224992$1$I$$20240816$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US073515$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
242249931$24224993$1$I$20231201$20240815$20240820$20240820$EXP$$US-ABBVIE-5883735$ABBVIE$$79$YR$$M$Y$$$20240820$$CN$US$US
242249941$24224994$1$I$$20240809$20240820$20240820$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP010309$STRIDES$Backhouse B, Scully T, Rajakariar K, Jin D, Chandrasekhar J, Freeman M.. Coronary Artery Vasospasm in Patients With Eosinophilia.. JACC-Case-Rep. 2023;19:1-7$53$YR$$M$Y$$$20240820$$MD$AU$AU
242249951$24224995$1$I$20210101$20240812$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130854$BRISTOL MYERS SQUIBB$Soliman A, Hassan R, Codreanu I, Plaxe SC, Dasanu CA. Sjogren^s syndrome due to immune checkpoint inhibitors (ICIs): insights from a single-institution series and systematic review of the literature. Journal of Oncology Pharmacy Practice. 2024 Aug 08;1-8.doi:10.1177/10781552241271753.$76$YR$E$M$Y$$$20240820$$HP$US$US
242250011$24225001$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883558$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242250021$24225002$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5881982$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242250031$24225003$1$I$$20240813$20240820$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012685$JAZZ$$$$$M$Y$29$KG$20240819$$CN$US$US
242250041$24225004$1$I$20240701$20240808$20240820$20240820$PER$$US-JNJFOC-20240822337$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240820$$CN$US$US
242250051$24225005$1$I$$20240814$20240820$20240820$EXP$$BR-JNJFOC-20240840164$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$MD$BR$BR
242250081$24225008$1$I$20240501$20240815$20240820$20240820$EXP$$US-ABBVIE-5883697$ABBVIE$$61$YR$$M$Y$$$20240820$$CN$US$US
242250092$24225009$2$F$20240801$20240819$20240820$20240825$EXP$$US-ABBVIE-5880459$ABBVIE$$84$YR$$F$Y$$$20240825$$CN$US$US
242250101$24225010$1$I$$20240816$20240820$20240820$EXP$$TR-ABBVIE-5883720$ABBVIE$$$$$M$Y$$$20240820$$CN$TR$TR
242250111$24225011$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5883560$ABBVIE$$$$$F$Y$$$20240820$$HP$US$US
242250121$24225012$1$I$$20240814$20240820$20240820$EXP$GB-MHRA-MED-202408121431509000-KYFPC$GB-STRIDES ARCOLAB LIMITED-2024SP010328$STRIDES$$51$YR$$M$Y$$$20240820$$CN$GB$GB
242250132$24225013$2$F$20240201$20240820$20240820$20240826$EXP$$US-ABBVIE-5883622$ABBVIE$$74$YR$$F$Y$107.5$KG$20240826$$CN$US$US
242250141$24225014$1$I$$20240816$20240820$20240820$EXP$$ZA-ABBVIE-5883699$ABBVIE$$51$YR$$F$Y$$$20240820$$CN$ZA$ZA
242250151$24225015$1$I$$20240813$20240820$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012669$JAZZ$$$$$M$Y$$$20240819$$CN$US$US
242250171$24225017$1$I$20240801$20240808$20240820$20240820$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000291$NOVAST$$$$$$Y$$$20240820$$HP$CN$CN
242250181$24225018$1$I$$20240813$20240820$20240820$EXP$$US-CHATTEMPRD-2024OHG027309$CHATTEM$$$$$F$Y$$$20240820$$LW$US$US
242250191$24225019$1$I$$20240812$20240820$20240820$EXP$$GB-NOVITIUMPHARMA-2024GBNVP01614$NOVITIUM PHARMA$Vidya Madhwapathi.Once in a blue moon?.British Journal of Dermatology.28-JUN-2024;191(1):i121$80$YR$E$F$Y$$$20240820$$HP$GB$GB
242250201$24225020$1$I$20240803$20240806$20240820$20240820$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000290$NOVAST$$$$$$Y$$$20240820$$HP$CN$CN
242250211$24225021$1$I$20240101$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024162449$AMGEN$$20$YR$A$F$Y$$$20240819$$CN$US$US
242250231$24225023$1$I$$20240814$20240820$20240820$EXP$$US-JNJFOC-20240840862$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$HP$US$US
242250241$24225024$1$I$$20240803$20240820$20240820$PER$$NVSC2024US167686$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242250253$24225025$3$F$20240725$20240905$20240820$20240910$PER$$FR-JAZZ PHARMACEUTICALS-2024-FR-012787$JAZZ$$$$$$Y$$$20240910$$MD$FR$FR
242250261$24225026$1$I$20210723$20240814$20240820$20240820$EXP$$DE-ABBVIE-5883953$ABBVIE$$77$YR$$F$Y$$$20240820$$CN$DE$DE
242250271$24225027$1$I$20240717$20240814$20240820$20240820$EXP$$US-AMGEN-USASL2024162034$AMGEN$$36$YR$A$F$Y$$$20240819$$CN$US$US
242250281$24225028$1$I$20240815$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164495$AMGEN$$$$$M$Y$$$20240819$$CN$US$US
242250293$24225029$3$F$$20240904$20240820$20240911$EXP$$US-ABBVIE-5882029$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
242250302$24225030$2$F$$20240821$20240820$20240909$EXP$$NL-ABBVIE-5865602$ABBVIE$$$$E$F$Y$$$20240909$$CN$NL$NL
242250321$24225032$1$I$$20230505$20240820$20240820$EXP$$US-AstraZeneca-2023A106747$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
242250331$24225033$1$I$$20240812$20240820$20240820$EXP$$CA-ABBVIE-5881303$ABBVIE$$$$E$F$Y$$$20240820$$CN$CA$CA
242250341$24225034$1$I$$20240816$20240820$20240820$EXP$$US-AstraZeneca-2024A187726$ASTRAZENECA$$$$$M$Y$$$20240820$$MD$US$
242250351$24225035$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA241312$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240820$$MD$US$US
242250361$24225036$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243140$SANOFI AVENTIS$$$$$M$Y$$$20240820$$HP$US$US
242250371$24225037$1$I$$20220920$20240820$20240820$EXP$$AU-AstraZeneca-2022A326349$ASTRAZENECA$$$$$F$Y$$$20240820$$MD$AU$
242250381$24225038$1$I$$20230320$20240820$20240820$EXP$$US-AstraZeneca-2023A029438$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242250391$24225039$1$I$20221009$20221021$20240820$20240820$EXP$$TW-AstraZeneca-2022A354649$ASTRAZENECA$$67$YR$$F$Y$$$20240820$$CN$TW$
242250401$24225040$1$I$$20240819$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046575$BOEHRINGER INGELHEIM$$56$YR$A$F$Y$$$20240820$$CN$US$US
242250411$24225041$1$I$20220901$20220928$20240820$20240820$EXP$$CO-AstraZeneca-2022A334277$ASTRAZENECA$$22387$DY$$F$Y$$$20240820$$MD$CO$
242250421$24225042$1$I$$20220711$20240820$20240820$EXP$$US-AstraZeneca-2022A252694$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242250431$24225043$1$I$$20221006$20240820$20240820$EXP$$US-AstraZeneca-2022A341059$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242250441$24225044$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5882942$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242250451$24225045$1$I$20240729$20240813$20240820$20240820$EXP$$CO-AstraZeneca-2024A185832$ASTRAZENECA$$22846$DY$$F$Y$$$20240820$$CN$CO$
242250461$24225046$1$I$20230701$20230808$20240820$20240820$EXP$$US-AstraZeneca-2023A182157$ASTRAZENECA$$928$MON$$$Y$$$20240820$$PH$US$
242250471$24225047$1$I$20240731$20240815$20240820$20240820$EXP$$CN-PFIZER INC-PV202400106758$PFIZER$$21$YR$$F$Y$45$KG$20240820$$HP$CN$CN
242250481$24225048$1$I$20230101$20240815$20240820$20240820$EXP$$CA-PFIZER INC-202400238391$PFIZER$$39$YR$$F$Y$$$20240820$$HP$CA$CA
242250492$24225049$2$F$$20240904$20240820$20240906$EXP$$US-PFIZER INC-PV202400106470$PFIZER$$80$YR$$F$Y$$$20240906$$MD$US$US
242250511$24225051$1$I$$20240814$20240820$20240820$EXP$$US-PFIZER INC-202400237678$PFIZER$$63$YR$$F$Y$$$20240820$$HP$US$US
242250521$24225052$1$I$20240701$20240815$20240820$20240820$EXP$$AR-PFIZER INC-202400237413$PFIZER$$51$YR$$F$Y$$$20240820$$CN$AR$AR
242250531$24225053$1$I$20240101$20240816$20240820$20240820$EXP$$CA-PFIZER INC-202400238951$PFIZER$$82$YR$$F$Y$$$20240820$$HP$CA$CA
242250541$24225054$1$I$20240813$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009271$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240820$$CN$US$US
242250551$24225055$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA243155$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240820$$MD$US$US
242250561$24225056$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242991$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240820$$CN$US$US
242250572$24225057$2$F$$20240813$20240820$20240830$EXP$$US-ALXN-202408USA000835US$ALEXION PHARMACEUTICALS$$$$$F$Y$78.884$KG$20240830$$CN$US$US
242250581$24225058$1$I$$20240813$20240820$20240820$PER$$US-AMGEN-USASP2024164657$AMGEN$$$$$F$Y$$$20240819$$HP$US$US
242250591$24225059$1$I$20240101$20240814$20240820$20240820$PER$$US-ABBVIE-5883445$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242250601$24225060$1$I$20240701$20240805$20240820$20240820$EXP$$US-Axsome Therapeutics, Inc.-AXS202408-001156$AXSOME THERAPEUTICS$$61$YR$A$M$Y$$$20240820$$CN$US$
242250621$24225062$1$I$$20240813$20240820$20240820$PER$$US-JNJFOC-20240836091$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$US$US
242250631$24225063$1$I$$20240812$20240820$20240820$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001626$BLUEPRINT MEDICINES$$$$$M$Y$$$20240820$$CN$US$US
242250641$24225064$1$I$20240813$20240813$20240820$20240820$EXP$$US-JNJFOC-20240842176$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240820$$MD$US$US
242250661$24225066$1$I$20231201$20240814$20240820$20240820$EXP$$US-ABBVIE-5882662$ABBVIE$$58$YR$$M$Y$$$20240820$$CN$US$US
242250671$24225067$1$I$20240401$20240815$20240820$20240820$EXP$$US-ABBVIE-5883407$ABBVIE$$79$YR$$M$Y$$$20240820$$CN$US$US
242250681$24225068$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5881929$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242250691$24225069$1$I$20240803$20240814$20240820$20240820$EXP$$US-ABBVIE-5881962$ABBVIE$$47$YR$$F$Y$$$20240820$$CN$US$US
242250702$24225070$2$F$20240806$20240820$20240820$20240823$EXP$$US-ABBVIE-5883566$ABBVIE$$63$YR$$M$Y$85$KG$20240823$$CN$US$US
242250711$24225071$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5883625$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242250721$24225072$1$I$$20240812$20240820$20240820$EXP$$FR-SANDOZ INC.-SDZ2024FR072347$SANDOZ$$39$YR$$M$Y$$$20240820$$HP$FR$FR
242250731$24225073$1$I$$20240815$20240820$20240820$EXP$$CA-ABBVIE-5885252$ABBVIE$$$$$M$Y$$$20240820$$HP$CA$CA
242250741$24225074$1$I$20180101$20240815$20240820$20240820$PER$$US-ABBVIE-5883987$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242250791$24225079$1$I$$20221219$20240820$20240820$EXP$$US-AstraZeneca-2022A412079$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242250801$24225080$1$I$$20220927$20240820$20240820$EXP$$GB-AstraZeneca-2022A323830$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$GB$
242250811$24225081$1$I$$20230810$20240820$20240820$EXP$$US-AstraZeneca-2023A184090$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242250821$24225082$1$I$$20220715$20240820$20240820$EXP$$US-AstraZeneca-2022A207350$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242250831$24225083$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A187141$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242250841$24225084$1$I$$20221031$20240820$20240820$EXP$$US-AstraZeneca-2022A363434$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242250851$24225085$1$I$$20230215$20240820$20240820$EXP$$US-AstraZeneca-2023A040591$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242250871$24225087$1$I$$20221206$20240820$20240820$EXP$$US-AstraZeneca-2022A400164$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242250881$24225088$1$I$$20220824$20240820$20240820$EXP$$US-AstraZeneca-2022A298610$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242250891$24225089$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5883172$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242250901$24225090$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1268919$NOVO NORDISK$$41$YR$$$Y$$$20240820$$CN$US$US
242250921$24225092$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1268861$NOVO NORDISK$$$$A$M$Y$$$20240820$$CN$US$US
242250931$24225093$1$I$$20240806$20240820$20240820$EXP$$US-NOVOPROD-1268796$NOVO NORDISK$$$$$F$Y$$$20240820$$CN$US$US
242250941$24225094$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1268798$NOVO NORDISK$$58$YR$$$Y$$$20240820$$CN$US$US
242250951$24225095$1$I$20240401$20240806$20240820$20240820$EXP$$US-NOVOPROD-1268638$NOVO NORDISK$$75$YR$$F$Y$$$20240820$$CN$US$US
242250961$24225096$1$I$20240101$20240807$20240820$20240820$EXP$$US-NOVOPROD-1266829$NOVO NORDISK$$69$YR$$F$Y$$$20240820$$CN$US$US
242250971$24225097$1$I$20231101$20240807$20240820$20240820$EXP$$US-NOVOPROD-1268459$NOVO NORDISK$$$$$F$Y$$$20240820$$CN$US$US
242250981$24225098$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1268969$NOVO NORDISK$$65$YR$$$Y$$$20240820$$CN$US$US
242250991$24225099$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1268603$NOVO NORDISK$$37$YR$$$Y$$$20240820$$CN$US$US
242251001$24225100$1$I$20240702$20240807$20240820$20240820$EXP$$US-NOVOPROD-1268901$NOVO NORDISK$$62$YR$$$Y$$$20240820$$CN$US$US
242251012$24225101$2$F$20190301$20240823$20240820$20240904$EXP$$TR-NOVOPROD-1270606$NOVO NORDISK$$85$YR$$M$Y$96$KG$20240904$$HP$TR$TR
242251021$24225102$1$I$20240801$20240807$20240820$20240820$EXP$GB-MHRA-MED-202408071205442570-WGCPL$GB-NOVOPROD-1267406$NOVO NORDISK$$56$YR$$M$Y$145$KG$20240820$$CN$GB$GB
242251031$24225103$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1268986$NOVO NORDISK$$57$YR$$$Y$$$20240820$$CN$US$US
242251041$24225104$1$I$$20240809$20240820$20240820$EXP$$HU-BRISTOL-MYERS SQUIBB COMPANY-2024-126565$BRISTOL MYERS SQUIBB$Pinczes LI, Jona ?, Mezei G, Kenyeres A, Vekszler PP, Illes ?, et al. Successful ruxolitinib rechallenge after fedratinib failure in a patient with overt myelofibrosis. Annals of Hematology. 2024 Aug 02;doi:10.1007/s00277-024-05825-6.$69$YR$E$M$Y$$$20240820$$HP$HU$HU
242251051$24225105$1$I$$20240812$20240820$20240820$PER$$US-ROCHE-10000055836$ROCHE$$$$$F$Y$$$20240820$$CN$US$US
242251062$24225106$2$F$$20240918$20240820$20240927$PER$$US-ROCHE-10000058480$ROCHE$$84$YR$E$M$Y$$$20240927$$CN$US$US
242251071$24225107$1$I$$20240814$20240820$20240820$PER$$US-ROCHE-3563921$ROCHE$$$$E$M$Y$$$20240820$$CN$US$US
242251081$24225108$1$I$20240601$20240812$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408007978$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240820$$CN$US$US
242251091$24225109$1$I$$20240806$20240820$20240820$EXP$$IN-DEXPHARM-2024-2770$DEXCEL$Holla, U. P.; Patil, A.  SSA mediated endocardial fibroelastosis treated with dexamethasone  and IVIG. Indian Journal of Rheumatology 2023, V18 (Suppl. 2), PS358-S359 abstr. CAS124.$27$YR$A$F$Y$$$20240820$$HP$IN$IN
242251101$24225110$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1269024$NOVO NORDISK$$$$A$F$Y$$$20240820$$CN$US$US
242251111$24225111$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1269281$NOVO NORDISK$$63$YR$$$Y$$$20240820$$CN$US$US
242251121$24225112$1$I$20240301$20240807$20240820$20240820$EXP$$US-NOVOPROD-1269312$NOVO NORDISK$$72$YR$$F$Y$$$20240820$$CN$US$US
242251131$24225113$1$I$$20240807$20240820$20240820$EXP$$TR-NOVOPROD-1270570$NOVO NORDISK$$$$$M$Y$$$20240820$$CN$TR$TR
242251141$24225114$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1269184$NOVO NORDISK$$55$YR$$$Y$$$20240820$$CN$US$US
242251151$24225115$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1269347$NOVO NORDISK$$54$YR$$M$Y$$$20240820$$CN$US$US
242251161$24225116$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1269069$NOVO NORDISK$$62$YR$$$Y$$$20240820$$CN$US$US
242251171$24225117$1$I$20100101$20240807$20240820$20240820$EXP$$US-NOVOPROD-1269276$NOVO NORDISK$$58$YR$$M$Y$$$20240820$$CN$US$US
242251181$24225118$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1269031$NOVO NORDISK$$51$YR$$$Y$$$20240820$$CN$US$US
242251191$24225119$1$I$$20240807$20240820$20240820$EXP$$US-NOVOPROD-1269009$NOVO NORDISK$$59$YR$$$Y$$$20240820$$CN$US$US
242251201$24225120$1$I$$20240816$20240820$20240820$PER$$US-ROCHE-10000059673$ROCHE$$$$$$Y$$$20240820$$MD$US$US
242251212$24225121$2$F$20240101$20240912$20240820$20240918$EXP$$US-ABBVIE-5882795$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
242251221$24225122$1$I$20240802$20240816$20240820$20240820$EXP$$US-ABBVIE-5884870$ABBVIE$$75$YR$$F$Y$$$20240820$$HP$US$US
242251233$24225123$3$F$20240101$20240820$20240820$20240827$EXP$$ES-ABBVIE-5883933$ABBVIE$$$$$F$Y$52$KG$20240827$$CN$ES$ES
242251241$24225124$1$I$20240701$20240816$20240820$20240820$EXP$$US-ABBVIE-5884541$ABBVIE$$74$YR$$M$Y$$$20240820$$HP$US$US
242251251$24225125$1$I$20240813$20240814$20240820$20240820$PER$$US-ABBVIE-5883390$ABBVIE$$32$YR$$F$Y$$$20240820$$MD$US$US
242251261$24225126$1$I$$20240815$20240820$20240820$PER$$US-ROCHE-10000059672$ROCHE$$44$YR$A$M$Y$$$20240820$$CN$US$US
242251271$24225127$1$I$20240730$20240812$20240820$20240820$PER$$US-ABBVIE-5882750$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242251281$24225128$1$I$20230101$20240813$20240820$20240820$EXP$$US-AMGEN-USASP2024162540$AMGEN$$86$YR$E$M$Y$$$20240819$$CN$US$US
242251306$24225130$6$F$20240101$20240905$20240820$20240912$EXP$$ES-ABBVIE-5881121$ABBVIE$$$$$M$Y$70$KG$20240912$$HP$ES$ES
242251311$24225131$1$I$$20240818$20240820$20240820$PER$$NVSC2024US167811$NOVARTIS$$$$$M$Y$91$KG$20240820$$CN$US$US
242251321$24225132$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA243185$SANOFI AVENTIS$$63$YR$A$F$Y$68$KG$20240820$$MD$US$US
242251331$24225133$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA239889$SANOFI AVENTIS$$$$A$F$Y$66$KG$20240820$$MD$US$US
242251341$24225134$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA243381$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240820$$MD$US$US
242251351$24225135$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA240710$SANOFI AVENTIS$$$$I$F$Y$$$20240820$$MD$US$US
242251361$24225136$1$I$$20240814$20240820$20240820$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001648$BLUEPRINT MEDICINES$$$$$F$Y$$$20240820$$CN$US$US
242251371$24225137$1$I$$20220413$20240820$20240820$EXP$$US-AstraZeneca-2022A152733$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242251381$24225138$1$I$$20230302$20240820$20240820$EXP$$US-AstraZeneca-2023A053161$ASTRAZENECA$$$$$F$Y$81.6$KG$20240820$$CN$US$
242251391$24225139$1$I$$20230215$20240820$20240820$EXP$$US-AstraZeneca-2023A040622$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242251401$24225140$1$I$$20221010$20240820$20240820$EXP$$CA-AstraZeneca-2022A316489$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$CA$
242251411$24225141$1$I$$20230214$20240820$20240820$EXP$$US-AstraZeneca-2023A038969$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
242251421$24225142$1$I$$20240723$20240820$20240820$PER$$NL-TOLMAR, INC.-24NL051247$TOLMAR$$$$$M$Y$$$20240813$$HP$NL$NL
242251431$24225143$1$I$20240401$20240723$20240820$20240820$PER$$NL-TOLMAR, INC.-24NL051246$TOLMAR$$87$YR$$M$Y$$$20240813$$CN$NL$NL
242251442$24225144$2$F$$20240905$20240820$20240926$PER$$NL-TOLMAR, INC.-24NL051270$TOLMAR$$$$$M$Y$$$20240926$$CN$NL$NL
242251451$24225145$1$I$20240620$20240723$20240820$20240820$PER$$NL-TOLMAR, INC.-24NL051290$TOLMAR$$76$YR$$M$Y$$$20240813$$CN$NL$NL
242251461$24225146$1$I$$20240723$20240820$20240820$PER$$SE-TOLMAR, INC.-24SE051276$TOLMAR$$92$YR$$M$Y$$$20240813$$HP$SE$SE
242251471$24225147$1$I$20240723$20240723$20240820$20240820$PER$$TR-TOLMAR, INC.-24TR051279$TOLMAR$$63$YR$$M$Y$$$20240813$$HP$TR$TR
242251481$24225148$1$I$20240709$20240723$20240820$20240820$PER$$NL-TOLMAR, INC.-24NL051294$TOLMAR$$83$YR$$M$Y$$$20240813$$CN$NL$NL
242251491$24225149$1$I$20240221$20240723$20240820$20240820$PER$$NL-TOLMAR, INC.-24NL051291$TOLMAR$$69$YR$$M$Y$$$20240813$$HP$NL$NL
242251501$24225150$1$I$20240709$20240723$20240820$20240820$PER$$TR-TOLMAR, INC.-24TR050967$TOLMAR$$83$YR$$M$Y$$$20240813$$PH$TR$TR
242251511$24225151$1$I$20240723$20240723$20240820$20240820$PER$$TR-TOLMAR, INC.-24TR051285$TOLMAR$$79$YR$$M$Y$$$20240813$$MD$TR$TR
242251521$24225152$1$I$$20240723$20240820$20240820$PER$$TR-TOLMAR, INC.-24TR051288$TOLMAR$$72$YR$$M$Y$$$20240813$$PH$TR$TR
242251532$24225153$2$F$20211101$20240923$20240820$20240926$EXP$$US-AMGEN-USASP2024161532$AMGEN$$65$YR$E$M$Y$$$20240926$$MD$US$US
242251541$24225154$1$I$20240810$20240812$20240820$20240820$PER$$US-SA-2024SA240862$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240820$$MD$US$US
242251551$24225155$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA243457$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240820$$MD$US$US
242251561$24225156$1$I$$20240815$20240820$20240820$PER$$US-ROCHE-10000059635$ROCHE$$70$YR$E$M$Y$$$20240820$$CN$US$US
242251571$24225157$1$I$$20240814$20240820$20240820$EXP$$NVSC2024GB167086$NOVARTIS$$$$$F$Y$$$20240820$$MD$GB$GB
242251582$24225158$2$F$$20240906$20240820$20240909$PER$$US-ALXN-202408USA000860US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242251591$24225159$1$I$20240701$20240812$20240820$20240820$PER$$US-SA-2024SA243034$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240820$$MD$US$US
242251601$24225160$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241727$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240820$$MD$US$US
242251611$24225161$1$I$$20240807$20240820$20240820$EXP$$PT-MACLEODS PHARMA-MAC2015002024$MACLEODS$Santos-Antunes J, Coelho R, Cardoso H, Macedo G..Drug-induced small-bowel mucosal atrophy.Endoscopy.2015;47(1)$$$$$Y$$$20240819$$MD$PT$PT
242251622$24225162$2$F$$20240819$20240820$20240830$EXP$$DE-MACLEODS PHARMA-MAC2024048836$MACLEODS$Dyballa N, Hartel JA, Prangenberg J, Andresen-Streichert H..A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting - clinical, toxicological and forensic aspects.Forensic science, medicine, and pathology.1-AUG-2024$$$$$Y$$$20240830$$HP$DE$DE
242251631$24225163$1$I$20240728$20240808$20240820$20240820$EXP$PT-INFARMED-R202408-146$PT-MACLEODS PHARMA-MAC2024048833$MACLEODS$$$$$$Y$$$20240819$$PH$PT$PT
242251641$24225164$1$I$$20240808$20240820$20240820$EXP$$US-MACLEODS PHARMA-MAC2024048832$MACLEODS$Sachdeva N, Sun LW, Young J, Chen A..Early to late explantation of Hydrus microstent MIGS device: A case series..American Journal of Ophthalmology Case Reports.2024;36:102105$$$$$Y$$$20240819$$MD$US$US
242251651$24225165$1$I$20240801$20240812$20240820$20240820$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160625$JIANGSU HANSOH PHARMACEUTICAL$$75$YR$$F$Y$55.6$KG$20240820$$MD$CN$CN
242251661$24225166$1$I$20230101$20240807$20240820$20240820$EXP$$GB-MACLEODS PHARMA-MAC2024048835$MACLEODS$Alharmoodi K, Kathirgamachelvam J, Nafri D..Prolonged Discontinuation Syndrome of Venlafaxine: A Case Study of Severe Gastrointestinal Manifestations.Cureus.01-JUL-2024;16(7):e63560$$$$$Y$$$20240819$$MD$GB$GB
242251671$24225167$1$I$$20240808$20240820$20240820$EXP$$SE-P+L Developments of Newyork Corporation-2160626$PL DEVELOPMENTS$Initial$66$YR$$$Y$$$20240820$$MD$SE$SE
242251681$24225168$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009598$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240820$$CN$US$US
242251691$24225169$1$I$$20240812$20240820$20240820$EXP$$US-ROCHE-10000059998$ROCHE$Tun A, Patel R, St-Pierre F, Ouchveridze E, Niu A, Thordardottir T, et al. Anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study. American Journal of Hematology. 2024;99 (9):1712-20. doi:10.1002/ajh.27381.$85$YR$E$M$Y$$$20240820$$HP$US$US
242251701$24225170$1$I$20171001$20180105$20240820$20240820$EXP$$JP-TAKEDA-JP201735113$TAKEDA$$8$DEC$$M$Y$$$20240820$$CN$JP$JP
242251711$24225171$1$I$$20240812$20240820$20240820$EXP$$GB-CELLTRION INC.-2024GB019747$CELLTRION$$$$$$Y$$$20240820$$HP$GB$GB
242251721$24225172$1$I$$20240814$20240820$20240820$EXP$$US-AMGEN-USASP2024162021$AMGEN$$$$A$F$Y$$$20240819$$CN$US$US
242251731$24225173$1$I$$20240812$20240820$20240820$EXP$$CA-APOTEX-2024AP009226$APOTEX$$10$YR$$F$Y$$$20240820$$HP$CA$CA
242251741$24225174$1$I$$20240819$20240820$20240820$EXP$$CA-ROCHE-10000060202$ROCHE$$83$YR$E$F$Y$56$KG$20240820$$HP$CA$CA
242251751$24225175$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A187922$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242251761$24225176$1$I$$20240812$20240820$20240820$30DAY$$US-GSK-US2024100254$GLAXOSMITHKLINE$$$$$M$Y$$$20240820$$CN$US$US
242251771$24225177$1$I$$20240816$20240820$20240820$PER$$US-ROCHE-10000060044$ROCHE$$66$YR$E$F$Y$$$20240820$$CN$US$US
242251781$24225178$1$I$$20240816$20240820$20240820$PER$$US-ROCHE-10000059967$ROCHE$$61$YR$A$F$Y$$$20240820$$CN$US$US
242251791$24225179$1$I$$20240812$20240820$20240820$EXP$$ZA-AstraZeneca-2024A183412$ASTRAZENECA$$68$YR$$F$Y$$$20240820$$CN$ZA$
242251801$24225180$1$I$$20240807$20240820$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-040661$AUROBINDO$$$$$F$Y$$$20240820$$HP$CA$CA
242251812$24225181$2$F$$20240830$20240820$20240903$EXP$$US-ALXN-202408USA000865US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242251821$24225182$1$I$20240702$20240805$20240820$20240820$EXP$$US-MACLEODS PHARMA-MAC2024048721$MACLEODS$$$$$$Y$$$20240820$$CN$US$US
242251831$24225183$1$I$$20240814$20240820$20240820$PER$$US-ALXN-202408USA000867US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
242251841$24225184$1$I$20240501$20240808$20240820$20240820$EXP$$US-NOVOPROD-1267556$NOVO NORDISK$$71$YR$$M$Y$$$20240820$$HP$US$US
242251851$24225185$1$I$$20240808$20240820$20240820$EXP$$AU-NOVOPROD-1267814$NOVO NORDISK$$$$A$F$Y$$$20240820$$MD$AU$AU
242251862$24225186$2$F$20231001$20240822$20240820$20240902$EXP$$CN-NOVOPROD-1267819$NOVO NORDISK$$58$YR$$M$Y$48$KG$20240902$$CN$CN$CN
242251871$24225187$1$I$$20240808$20240820$20240820$EXP$GB-MHRA-MED-202408081700127260-CSDQW$GB-NOVOPROD-1267303$NOVO NORDISK$$31$YR$$F$Y$$$20240820$$HP$GB$GB
242251881$24225188$1$I$$20240808$20240820$20240820$EXP$$JP-NOVOPROD-1267614$NOVO NORDISK$$77$YR$$M$Y$67$KG$20240820$$CN$JP$JP
242251891$24225189$1$I$20240620$20240808$20240820$20240820$EXP$GB-MHRA-MED-202408081105145050-CMFTJ$GB-NOVOPROD-1267314$NOVO NORDISK$$73$YR$$M$Y$119$KG$20240820$$HP$GB$GB
242251902$24225190$2$F$$20240913$20240820$20240924$EXP$$AU-NOVOPROD-1267645$NOVO NORDISK$$$$$F$Y$$$20240924$$HP$AU$AU
242251911$24225191$1$I$$20240808$20240820$20240820$EXP$GB-MHRA-MED-202408081241357330-DHWTL$GB-NOVOPROD-1267312$NOVO NORDISK$$$$$F$Y$$$20240820$$PH$GB$GB
242251921$24225192$1$I$$20240807$20240820$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-040086$AUROBINDO$Nguyen A, Norman M, O^reilly E, Robinson CL, Fonseca A, Madabhushi S, et al.. Case Series: Spinal Cord Stimulator Therapy Alleviates Neuropathic Pain in Patients with Failed Back Surgery Syndrome in the Setting of Spinal Cord Injury. Pain-Med-Case-Rep. 2023;7(7):337-340$49$YR$$M$Y$$$20240820$$HP$US$US
242251931$24225193$1$I$20240204$20240808$20240820$20240820$EXP$$CA-NOVOPROD-1267711$NOVO NORDISK$$57$YR$$F$Y$$$20240820$$CN$CA$CA
242251941$24225194$1$I$$20240813$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128132$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$44.45$KG$20240820$$CN$US$US
242251951$24225195$1$I$$20240814$20240820$20240820$30DAY$$IN-ABBVIE-5503105$ABBVIE$$$$$$Y$$$20240820$$MD$IN$IN
242251962$24225196$2$F$$20240805$20240820$20240909$EXP$$MX-BEH-2024177000$CSL BEHRING$$$$$$Y$$$20240909$$CN$MX$MX
242251971$24225197$1$I$$20240807$20240820$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-039995$AUROBINDO$Embry E, Xiong J, Zahid U, Abdelghani L.. Massive Hemoptysis Preceded by Dabigatran in a Patient With Bronchiectasis. Am-J-Respir-Crit-Care-Med. 2024;209:A5835$66$YR$$M$Y$$$20240820$$HP$US$US
242251981$24225198$1$I$20240101$20240814$20240820$20240820$PER$$US-ABBVIE-5882913$ABBVIE$$$$$$Y$$$20240820$$HP$US$US
242251991$24225199$1$I$$20240807$20240820$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-039796$AUROBINDO$Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP. A case of human T-lymphotropic virus-1-associated lichenoid dermatitis. Clinical and Experimental Dermatology. 2024;49(8):916-18$61$YR$$F$Y$$$20240820$$MD$GB$GB
242252001$24225200$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164470$AMGEN$$57$YR$A$F$Y$$$20240819$$MD$US$US
242252011$24225201$1$I$$20240816$20240820$20240820$PER$$NVSC2024US167681$NOVARTIS$$$$$M$Y$81$KG$20240820$$CN$US$US
242252021$24225202$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA239020$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240820$$CN$US$US
242252041$24225204$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241754$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240820$$CN$US$US
242252051$24225205$1$I$20240801$20240814$20240820$20240820$EXP$$CN-ROCHE-10000057898$ROCHE$$68$YR$E$M$Y$60$KG$20240820$$HP$CN$CN
242252061$24225206$1$I$$20240808$20240820$20240820$EXP$$SE-P+L Developments of Newyork Corporation-2160627$PL DEVELOPMENTS$Initial$61$YR$$$Y$$$20240820$$MD$SE$SE
242252071$24225207$1$I$$20240815$20240820$20240820$EXP$$PR-ABBVIE-5882574$ABBVIE$$40$YR$$F$Y$$$20240820$$MD$PR$PR
242252081$24225208$1$I$$20240815$20240820$20240820$EXP$$US-AMGEN-USASP2024163719$AMGEN$$$$$$Y$$$20240819$$CN$US$US
242252091$24225209$1$I$20240811$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024162242$AMGEN$$90$YR$E$M$Y$$$20240819$$CN$US$US
242252103$24225210$3$F$20240721$20240910$20240820$20240923$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000162$PAREXEL$$$$$$Y$$$20240923$$CN$US$US
242252111$24225211$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A187813$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242252122$24225212$2$F$20220919$20240827$20240820$20240904$EXP$$ZA-CELLTRION INC.-2022ZA019029$CELLTRION$$$$$$Y$$$20240904$$MD$ZA$ZA
242252131$24225213$1$I$$20240819$20240820$20240820$PER$$NVSC2024US167850$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242252141$24225214$1$I$$20220912$20240820$20240820$EXP$$US-AstraZeneca-2022A316075$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
242252151$24225215$1$I$20220204$20220518$20240820$20240820$EXP$$AU-AstraZeneca-2022A120675$ASTRAZENECA$$27919$DY$$M$Y$$$20240820$$CN$AU$
242252161$24225216$1$I$$20240625$20240820$20240820$EXP$$CA-ROCHE-10000057058$ROCHE$$30$YR$A$M$Y$$$20240820$$CN$CA$CA
242252171$24225217$1$I$$20240806$20240820$20240820$EXP$$US-CIPLA LTD.-2013US00149$CIPLA$del Carmen MG, Micha J, Small L, Street DG, Londhe A, McGowan T. A phase II clinical trial of pegylated liposomal Doxorubicin and Carboplatin plus Bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer$$$$$Y$$$20240820$$HP$US$US
242252181$24225218$1$I$20240813$20240813$20240820$20240820$EXP$$US-GSK-US2024100752$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240820$$CN$US$US
242252191$24225219$1$I$$20240814$20240820$20240820$PER$$US-AstraZeneca-2024A185661$ASTRAZENECA$$$$$$Y$$$20240820$$PH$US$
242252201$24225220$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A186917$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
242252211$24225221$1$I$$20240816$20240820$20240820$EXP$$IN-ROCHE-10000059966$ROCHE$$67$YR$E$F$Y$$$20240820$$MD$IN$IN
242252222$24225222$2$F$20240812$20240912$20240820$20240916$PER$$US-ROCHE-10000055775$ROCHE$$81$YR$E$M$Y$$$20240916$$CN$US$US
242252231$24225223$1$I$20240801$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009330$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240820$$CN$US$US
242252241$24225224$1$I$20240816$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011082$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242252251$24225225$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009396$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240820$$CN$US$US
242252261$24225226$1$I$$20240806$20240820$20240820$EXP$$US-RDY-LIT/USA/24/0011751$DR REDDYS$Mossner J, Saleh NB, Shahin MN, Rosenow JM, Raskin JS. Occipital nerve stimulation in pediatric patients with refractory occipital neuralgia. Child^s Nervous System. 2024 Aug;40(8): 2465-2470. doi:10.1007/s00381-024-06376-x.$17$YR$T$F$Y$$$20240820$$HP$US$US
242252271$24225227$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009759$ELI LILLY AND CO$$$$$M$Y$$$20240820$$CN$US$US
242252281$24225228$1$I$20220215$20240819$20240820$20240820$EXP$DE-PEI-CADR2023317206$DE-ROCHE-10000059956$ROCHE$$66$YR$E$M$Y$$$20240820$$CN$DE$DE
242252291$24225229$1$I$20240630$20240813$20240820$20240820$EXP$$CN-TAKEDA-2024TUS082322$TAKEDA$$56$YR$$M$Y$56$KG$20240820$$HP$CN$CN
242252301$24225230$1$I$20240815$20240815$20240820$20240820$EXP$$US-JNJFOC-20240840013$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240820$$HP$US$US
242252311$24225231$1$I$$20240728$20240820$20240820$PER$$CA-TOLMAR, INC.-24CA051357$TOLMAR$$$$$M$Y$$$20240820$$CN$CA$CA
242252321$24225232$1$I$$20240727$20240820$20240820$PER$$CA-TOLMAR, INC.-24CA051360$TOLMAR$$$$$M$Y$$$20240820$$CN$CA$CA
242252331$24225233$1$I$$20240727$20240820$20240820$PER$$CA-TOLMAR, INC.-24CA051389$TOLMAR$$$$$M$Y$$$20240820$$CN$CA$CA
242252341$24225234$1$I$20240727$20240727$20240820$20240820$PER$$CA-TOLMAR, INC.-24CA051386$TOLMAR$$79$YR$$M$Y$$$20240820$$CN$CA$CA
242252351$24225235$1$I$20240101$20240727$20240820$20240820$PER$$CA-TOLMAR, INC.-24CA051397$TOLMAR$$$$$M$Y$$$20240820$$CN$CA$CA
242252361$24225236$1$I$20240727$20240727$20240820$20240820$PER$$CA-TOLMAR, INC.-24CA051420$TOLMAR$$87$YR$$M$Y$$$20240820$$CN$CA$CA
242252371$24225237$1$I$$20240727$20240820$20240820$PER$$CA-TOLMAR, INC.-24CA051435$TOLMAR$$$$$M$Y$$$20240820$$CN$CA$CA
242252381$24225238$1$I$$20240727$20240820$20240820$PER$$IT-TOLMAR, INC.-24IT051436$TOLMAR$$83$YR$$M$Y$$$20240820$$CN$IT$IT
242252391$24225239$1$I$$20240819$20240820$20240820$PER$$NVSC2024US167869$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242252401$24225240$1$I$20240711$20240727$20240820$20240820$PER$$TR-TOLMAR, INC.-24TR051282$TOLMAR$$82$YR$$M$Y$$$20240820$$PH$TR$TR
242252411$24225241$1$I$$20240812$20240820$20240820$EXP$$CA-TAKEDA-2024TUS081524$TAKEDA$$64$YR$$F$Y$60$KG$20240820$$HP$CA$CA
242252421$24225242$1$I$$20240815$20240820$20240820$PER$$US-ROCHE-10000059703$ROCHE$$$$E$$Y$$$20240820$$CN$US$US
242252431$24225243$1$I$$20240617$20240820$20240820$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007339$STRIDES$Kanbour S, Balaji A, Maragakis N, Stanley Clarke N, Mathioudakis N.. Concurrent diagnoses of treatment-induced neuropathy of diabetes and restless leg syndrome.. J-Clin-Transl-Endocrinol-Case-Rep. 2023;28:1-4$36$YR$$M$Y$$$20240820$$HP$US$US
242252441$24225244$1$I$20240811$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024163675$AMGEN$$74$YR$E$F$Y$$$20240819$$CN$US$US
242252451$24225245$1$I$20240212$20240814$20240820$20240820$EXP$$CO-UCBSA-2024041649$UCB$$53$YR$$F$Y$$$20240820$$CN$CO$CO
242252461$24225246$1$I$$20240816$20240820$20240820$PER$$US-ROCHE-10000059770$ROCHE$$$$A$F$Y$$$20240820$$CN$US$US
242252482$24225248$2$F$$20240813$20240820$20240822$EXP$JP-MLMSERVICE-20240806-PI151441-00128-1$JP-STRIDES ARCOLAB LIMITED-2024SP010285$STRIDES$Kudo H, Shiroshita K, Shiozawa Y, Fujita S, Sakamoto M, Nakamura N, et al.. Autopsy case of cardiac mantle cell lymphoma presenting with recurrent pulmonary tumor embolism after chemotherapy.. Journal of clinical and experimental hematopathology.. 2024$78$YR$$M$Y$$$20240822$$MD$JP$JP
242252491$24225249$1$I$$20240813$20240820$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-025463$UNITED THERAPEUTICS$$$$$M$Y$83.9$KG$20240820$$$US$US
242252501$24225250$1$I$20240809$20240809$20240820$20240820$PER$$US-JNJFOC-20240827785$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
242252511$24225251$1$I$$20240807$20240820$20240820$EXP$JP-ASTELLAS-2024JP001436$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP001166$JUBILANT$Shinohara K, Itoi S, Nakamura S, Miyazaki Y, Mutoh Y, Hagiwara S, et al. Micafungin-breakthrough Coniochaeta hoffmannii (Lecythophora hoffmannii) fungemia following cord blood transplant in a patient with acute myeloid leukemia successfully treated with voriconazole. Journal of Infection and Chemotherapy. 2024$$$A$F$Y$$$20240820$$MD$JP$JP
242252521$24225252$1$I$20240801$20240816$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130556$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$112.04$KG$20240820$$CN$US$US
242252531$24225253$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130231$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240820$$CN$US$US
242252541$24225254$1$I$$20240819$20240820$20240820$PER$$NVSC2024US167889$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242252551$24225255$1$I$$20240813$20240820$20240820$EXP$$FI-TAKEDA-2024TUS082756$TAKEDA$$72$YR$$M$Y$$$20240820$$CN$FI$FI
242252561$24225256$1$I$20240807$20240812$20240820$20240820$PER$$US-ROCHE-10000057818$ROCHE$$$$$$Y$$$20240820$$CN$US$US
242252571$24225257$1$I$20240719$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024162137$AMGEN$$15$YR$T$F$Y$$$20240819$$PH$US$US
242252582$24225258$2$F$20240810$20240910$20240820$20240923$PER$$US-ROCHE-10000058120$ROCHE$$77$YR$E$F$Y$68.04$KG$20240923$$CN$US$US
242252591$24225259$1$I$$20240815$20240820$20240820$EXP$$CA-JNJFOC-20240845174$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240820$$HP$CA$CA
242252601$24225260$1$I$$20240808$20240820$20240820$EXP$$CL-NOVOPROD-1267965$NOVO NORDISK$$$$A$M$Y$$$20240820$$CN$CL$CL
242252612$24225261$2$F$20231001$20240819$20240820$20240828$EXP$$BR-NOVOPROD-1268281$NOVO NORDISK$$55$YR$$M$Y$$$20240828$$CN$BR$BR
242252621$24225262$1$I$20090101$20240808$20240820$20240820$EXP$$FR-NOVOPROD-1268142$NOVO NORDISK$$72$YR$$M$Y$$$20240820$$CN$FR$FR
242252632$24225263$2$F$20240401$20240814$20240820$20240826$EXP$$US-NOVOPROD-1269468$NOVO NORDISK$$76$YR$$F$Y$$$20240826$$CN$US$US
242252641$24225264$1$I$20240702$20240808$20240820$20240820$EXP$CH-SM-2024-14536$CH-NOVOPROD-1268035$NOVO NORDISK$$56$YR$$F$Y$68.3$KG$20240820$$HP$CH$CH
242252651$24225265$1$I$$20221124$20240820$20240820$EXP$$ZA-AstraZeneca-2022A391918$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$ZA$
242252661$24225266$1$I$$20240808$20240820$20240820$EXP$$US-NOVOPROD-1269040$NOVO NORDISK$$$$$F$Y$$$20240820$$PH$US$US
242252671$24225267$1$I$20240806$20240808$20240820$20240820$EXP$$US-NOVOPROD-1269200$NOVO NORDISK$$48$YR$$F$Y$$$20240820$$CN$US$US
242252681$24225268$1$I$20231101$20240808$20240820$20240820$EXP$FI-FIMEA-202402805$FI-NOVOPROD-1269005$NOVO NORDISK$$62$YR$$F$Y$$$20240820$$HP$FI$FI
242252691$24225269$1$I$20230201$20240808$20240820$20240820$EXP$$CO-NOVOPROD-1268302$NOVO NORDISK$$78$YR$$F$Y$84$KG$20240820$$CN$CO$CO
242252701$24225270$1$I$20240724$20240815$20240820$20240820$EXP$$SG-ABBVIE-5882943$ABBVIE$$24$YR$$F$Y$$$20240820$$HP$SG$SG
242252711$24225271$1$I$20240101$20240808$20240820$20240820$EXP$$US-NOVOPROD-1269215$NOVO NORDISK$$$$A$F$Y$$$20240820$$HP$US$US
242252721$24225272$1$I$20240521$20240808$20240820$20240820$EXP$$US-NOVOPROD-1268424$NOVO NORDISK$$44$YR$$M$Y$$$20240820$$CN$US$US
242252731$24225273$1$I$$20240808$20240820$20240820$EXP$$AU-NOVOPROD-1268304$NOVO NORDISK$$$$A$F$Y$$$20240820$$MD$AU$AU
242252741$24225274$1$I$20240101$20240808$20240820$20240820$EXP$SE-SEMPA-2024-005959$SE-NOVOPROD-1269011$NOVO NORDISK$$37$YR$$F$Y$$$20240820$$CN$SE$SE
242252752$24225275$2$F$20240722$20240822$20240820$20240830$EXP$$CN-NOVOPROD-1268308$NOVO NORDISK$$4$YR$$M$Y$20$KG$20240830$$CN$CN$CN
242252761$24225276$1$I$$20240806$20240820$20240820$EXP$$US-RDY-LIT/USA/24/0011750$DR REDDYS$Mossner J, Saleh NB, Shahin MN, Rosenow JM, Raskin JS. Occipital nerve stimulation in pediatric patients with refractory occipital neuralgia. Child^s Nervous System. 2024 Aug;40(8): 2465-2470. doi:10.1007/s00381-024-06376-x.$15$YR$T$M$Y$$$20240820$$HP$US$US
242252771$24225277$1$I$$20240813$20240820$20240820$EXP$$US-TAKEDA-2024TUS073047$TAKEDA$$$$$F$Y$$$20240820$$CN$US$US
242252782$24225278$2$F$$20240826$20240820$20240828$PER$$US-AMGEN-USASP2024163704$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242252792$24225279$2$F$$20240822$20240820$20240904$EXP$$PT-AUROBINDO-AUR-APL-2024-040239$AUROBINDO$Assis JG, Santos A. Myxedema Coma: Recognition of a Rare Endocrine Emergency. Cureus. 2024;16(8):e66053$82$YR$$F$Y$$$20240904$$MD$PT$PT
242252801$24225280$1$I$$20240806$20240820$20240820$EXP$$US-RDY-LIT/USA/24/0011851$DR REDDYS$Petric UB, Marks D, Dickman M, Rieger KE, Kibbi N. A Severe Case of Pan-Facial Vitamin C Serum-Induced Foreign Body Granulomatous Reaction. Dermatologic Surgery. 2024;50(6): 590-592. doi:10.1097/DSS.0000000000004118.$53$YR$A$F$Y$$$20240820$$HP$US$US
242252811$24225281$1$I$$20240809$20240820$20240820$EXP$$JP-ROCHE-10000058626$ROCHE$$8$DEC$E$M$Y$$$20240820$$MD$JP$JP
242252831$24225283$1$I$$20240812$20240820$20240820$EXP$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US001038$PAREXEL$Enstrom C., Gast S., Church L., Heflin M.K., Moore C., Cook C., Walsh D., Gage A., Bock A. Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy. US Cardiology Review. 2024;18:2$29$YR$$M$Y$$$20240820$$MD$US$US
242252841$24225284$1$I$20240807$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024162987$AMGEN$$20$YR$A$M$Y$$$20240819$$CN$US$US
242252851$24225285$1$I$$20240807$20240820$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-041295$AUROBINDO$$27$YR$$M$Y$$$20240820$$HP$CA$CA
242252871$24225287$1$I$20240814$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010631$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240820$$CN$US$US
242252881$24225288$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009960$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240820$$CN$US$US
242252891$24225289$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010528$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$US$US
242252901$24225290$1$I$20240814$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010025$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$US$US
242252911$24225291$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009820$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240820$$CN$US$US
242252921$24225292$1$I$20240814$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010253$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240820$$CN$US$US
242252931$24225293$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009354$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240820$$CN$US$US
242252941$24225294$1$I$$20240814$20240820$20240820$PER$$US-ABBVIE-5883658$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242252951$24225295$1$I$20240529$20240808$20240820$20240820$EXP$$CA-ROCHE-10000009750$ROCHE$$79$YR$E$F$Y$$$20240820$$CN$CA$CA
242252961$24225296$1$I$20240628$20240814$20240820$20240820$EXP$$CN-HALEON-2192031$Haleon PLC$$26$YR$$F$Y$45$KG$20240819$$HP$CN$CN
242252971$24225297$1$I$$20240723$20240820$20240820$EXP$$CA-002147023-NVSC2022CA304060$Haleon PLC$$44$YR$$F$Y$97$KG$20240819$$HP$CA$CA
242252982$24225298$2$F$$20240911$20240820$20240913$PER$$US-AMGEN-USASP2024162424$AMGEN$$$$$$Y$$$20240912$$MD$US$US
242252991$24225299$1$I$20240101$20240815$20240820$20240820$PER$$US-ABBVIE-5883195$ABBVIE$$$$$F$Y$$$20240820$$HP$US$US
242253001$24225300$1$I$20210101$20240814$20240820$20240820$EXP$$US-ROCHE-10000058075$ROCHE$$51$YR$A$F$Y$54.43$KG$20240820$$CN$US$US
242253011$24225301$1$I$$20240812$20240820$20240820$PER$$US-AMGEN-USASP2024161038$AMGEN$$$$$F$Y$$$20240819$$HP$US$US
242253021$24225302$1$I$20240101$20240813$20240820$20240820$EXP$$US-SA-2024SA242978$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240820$$MD$US$US
242253031$24225303$1$I$20240701$20240726$20240820$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004009$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240820$$CN$US$US
242253042$24225304$2$F$20240101$20240911$20240820$20240916$EXP$$CO-SA-2024SA242890$SANOFI AVENTIS$$59$YR$A$M$Y$75$KG$20240916$$CN$CO$CO
242253051$24225305$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA243408$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240820$$MD$US$US
242253061$24225306$1$I$20240426$20240813$20240820$20240820$PER$$US-TAKEDA-2024TUS081580$TAKEDA$$70$YR$$F$Y$109$KG$20240820$$MD$US$US
242253071$24225307$1$I$$20240810$20240820$20240820$PER$$US-SA-2024SA242289$SANOFI AVENTIS$$$$T$M$Y$$$20240820$$MD$US$US
242253082$24225308$2$F$20240101$20240916$20240820$20240923$PER$$US-SA-2024SA210370$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240923$$MD$US$US
242253091$24225309$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241459$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240820$$MD$US$US
242253101$24225310$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA243226$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240820$$MD$US$US
242253112$24225311$2$F$20240801$20240819$20240820$20240822$EXP$$US-ABBVIE-5880999$ABBVIE$$78$YR$$F$Y$76$KG$20240822$$CN$US$US
242253122$24225312$2$F$$20240826$20240820$20240829$EXP$$FR-ABBVIE-5882025$ABBVIE$$75$YR$$F$Y$$$20240829$$MD$FR$FR
242253131$24225313$1$I$$20240813$20240820$20240820$EXP$$CA-CHEPLA-2024010570$CHEPLAPHARM$Tien MC, Kaplan AJ. Severe Occlusive Retinal Vasculitis in an Immunocompetent Patient with Chronic CMV Anterior Uveitis. Ocular immunology and inflammation. 2024;1-2. doi: 10.1080/09273948.2024.2389460.$32$YR$$F$Y$$$20240820$$HP$COUNTRY NOT SPECIFIED$CA
242253141$24225314$1$I$20240101$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024162434$AMGEN$$37$YR$A$F$Y$$$20240819$$CN$US$US
242253151$24225315$1$I$20230901$20240813$20240820$20240820$EXP$$US-UCBSA-2024041510$UCB$$0$YR$$F$Y$2.806$KG$20240820$$CN$US$US
242253161$24225316$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162645$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240819$$HP$ES$ES
242253181$24225318$1$I$$20240808$20240820$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-024965$UNITED THERAPEUTICS$$$$$$Y$$$20240820$$$US$US
242253191$24225319$1$I$$20240816$20240820$20240820$PER$$US-ROCHE-10000059985$ROCHE$$$$$$Y$$$20240820$$PH$US$US
242253201$24225320$1$I$$20240726$20240820$20240820$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003996$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242253211$24225321$1$I$20220911$20240816$20240820$20240820$EXP$$IT-ROCHE-3195372$ROCHE$$68$YR$E$M$Y$80$KG$20240820$$HP$IT$IT
242253222$24225322$2$F$20240701$20240829$20240820$20240906$EXP$$US-ARGENX-2024-ARGX-US006130$ARGENX BVBA$$$$$$Y$$$20240906$$CN$US$US
242253241$24225324$1$I$$20221130$20240820$20240820$EXP$$US-AstraZeneca-2022A394313$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242253251$24225325$1$I$$20240812$20240820$20240820$EXP$$CA-APOTEX-2024AP009332$APOTEX$$82$YR$$F$Y$$$20240820$$HP$CA$CA
242253261$24225326$1$I$20240707$20240726$20240820$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003990$ACADIA PHARMACEUTICALS$$54$YR$$M$Y$$$20240820$$CN$US$US
242253272$24225327$2$F$$20240821$20240820$20240828$EXP$$AU-RDY-LIT/AUS/24/0011854$DR REDDYS$Bosi I, Wong W, Mohammad S, Britton P, Hsu P. Unusual Manifestations of APECED. Journal of Clinical Immunology. 2024;44: doi:10.1007/s10875-023-01647-9.$5$YR$C$M$Y$$$20240828$$HP$AU$AU
242253281$24225328$1$I$$20240816$20240820$20240820$EXP$$US-JNJFOC-20240844939$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240820$$HP$US$US
242253302$24225330$2$F$$20240902$20240820$20240903$PER$$NVSC2024US167918$NOVARTIS$$$$$$Y$$$20240903$$HP$US$US
242253311$24225331$1$I$$20240816$20240820$20240820$EXP$$NVSC2023US153997$NOVARTIS$$$$$$Y$$$20240820$$CN$US$US
242253321$24225332$1$I$$20240813$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US072630$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
242253331$24225333$1$I$20240101$20240813$20240820$20240820$PER$$US-ROCHE-10000056961$ROCHE$$59$YR$A$M$Y$96.16$KG$20240820$$CN$US$US
242253341$24225334$1$I$20230101$20240816$20240820$20240820$EXP$$DE-ABBVIE-5885034$ABBVIE$$77$YR$$M$Y$$$20240820$$CN$DE$DE
242253351$24225335$1$I$20240815$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010400$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240820$$CN$US$US
242253361$24225336$1$I$20240808$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010060$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240820$$CN$US$US
242253371$24225337$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009764$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240820$$CN$US$US
242253381$24225338$1$I$20240814$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009965$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240820$$CN$US$US
242253391$24225339$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009827$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240820$$CN$US$US
242253401$24225340$1$I$20240801$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009386$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240820$$CN$US$US
242253411$24225341$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009891$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242253421$24225342$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010779$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240820$$CN$US$US
242253431$24225343$1$I$20240815$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010802$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240820$$CN$US$US
242253441$24225344$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883677$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242253451$24225345$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009919$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242253461$24225346$1$I$20240501$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009367$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240820$$CN$US$US
242253471$24225347$1$I$$20240807$20240820$20240820$PER$$US-BEIGENE-BGN-2024-012443$BEIGENE$$$$$$Y$$$20240820$$CN$US$US
242253481$24225348$1$I$$20240814$20240820$20240820$EXP$$DE-SANDOZ INC.-SDZ2024DE072748$SANDOZ$$32$YR$$F$Y$$$20240820$$MD$DE$DE
242253491$24225349$1$I$$20240815$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US073345$SANDOZ$$$$$$Y$$$20240820$$MD$US$US
242253501$24225350$1$I$20240809$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024163753$AMGEN$$71$YR$E$M$Y$$$20240819$$CN$US$US
242253512$24225351$2$F$$20240816$20240820$20240821$PER$$US-ABBVIE-5884477$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242253521$24225352$1$I$20240124$20240808$20240820$20240820$EXP$$US-NOVOPROD-1269357$NOVO NORDISK$$41$YR$$$Y$$$20240820$$CN$US$US
242253531$24225353$1$I$$20240808$20240820$20240820$EXP$$US-NOVOPROD-1269343$NOVO NORDISK$$$$$M$Y$$$20240820$$CN$US$US
242253541$24225354$1$I$$20240808$20240820$20240820$EXP$$US-NOVOPROD-1269443$NOVO NORDISK$$$$$$Y$$$20240820$$CN$US$US
242253551$24225355$1$I$$20240808$20240820$20240820$EXP$$US-NOVOPROD-1269266$NOVO NORDISK$$54$YR$$$Y$$$20240820$$CN$US$US
242253561$24225356$1$I$$20240808$20240820$20240820$EXP$$US-NOVOPROD-1269305$NOVO NORDISK$$$$$M$Y$$$20240820$$CN$US$US
242253572$24225357$2$F$20240725$20240816$20240820$20240828$EXP$$US-NOVOPROD-1269263$NOVO NORDISK$$78$YR$$F$Y$$$20240828$$CN$US$US
242253581$24225358$1$I$$20240814$20240820$20240820$PER$$US-ROCHE-10000057822$ROCHE$$64$YR$A$F$Y$58.51$KG$20240820$$PH$US$US
242253601$24225360$1$I$$20240813$20240820$20240820$EXP$$ES-ARGENX-2024-ARGX-ES006626$ARGENX BVBA$$$$$$Y$$$20240820$$MD$ES$ES
242253611$24225361$1$I$20240527$20240527$20240820$20240820$EXP$$US-VANTIVE-2024VAN019085$Vantive US Healthcare$$$$$M$Y$$$20240820$$CN$US$US
242253621$24225362$1$I$20220101$20240808$20240820$20240820$PER$$US-SA-2024SA239947$SANOFI AVENTIS$$$$C$M$Y$15.8$KG$20240820$$MD$US$US
242253631$24225363$1$I$20240701$20240807$20240820$20240820$EXP$$US-UCBSA-2024039892$UCB$$32$YR$$F$Y$$$20240820$$HP$US$US
242253641$24225364$1$I$$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024164655$AMGEN$$$$$M$Y$$$20240819$$CN$US$US
242253651$24225365$1$I$$20240813$20240820$20240820$EXP$$AU-CELLTRION INC.-2024AU019644$CELLTRION$$$$$$Y$$$20240820$$HP$AU$AU
242253661$24225366$1$I$$20240807$20240820$20240820$EXP$$DE-RDY-LIT/DEU/24/0011826$DR REDDYS$Satirer O, Henes J, Doering M, Lesk T, Pediatric Rheumatology S. PEDIATRIC AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN TREATMENT RESISTANT AUTOIMMUNE DISEASES: A REAL LIFE SINGLECENTER EXPERIENCE. Annals of the Rheumatic Diseases. 83(1): 2037-2038. doi:10.1136/annrheumdis-2024-eular.5113.$$$C$$Y$$$20240820$$HP$DE$DE
242253671$24225367$1$I$$20240815$20240820$20240820$EXP$$DE-SANDOZ INC.-SDZ2024DE072921$SANDOZ$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$72$YR$$F$Y$$$20240820$$HP$DE$DE
242253681$24225368$1$I$$20240726$20240820$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004011$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242253691$24225369$1$I$$20240809$20240820$20240820$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024099779$VIIV$$$$$$Y$$$20240820$$HP$US$US
242253701$24225370$1$I$20240305$20240807$20240820$20240820$EXP$$DE-ABBVIE-5810297$ABBVIE$$35$YR$$M$Y$65$KG$20240820$$MD$DE$DE
242253711$24225371$1$I$$20240819$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA073593$SANDOZ$$82$YR$$M$Y$$$20240820$$PH$CA$CA
242253721$24225372$1$I$$20240812$20240820$20240820$EXP$GB-MHRA-MED-202408121729244000-BKHSR$GB-SA-2024SA242333$SANOFI AVENTIS$$$$$M$Y$$$20240820$$PH$GB$GB
242253731$24225373$1$I$$20240814$20240820$20240820$EXP$$CN-ROCHE-10000057018$ROCHE$Zhao C, Yu L, Li L, Su M. Diffuse lymphoma involvement of the spinal cord showed on 18 FFDG PET/MRI. Nuclear Medicine Review. 2024-Jan;27:24-7. doi:10.5603/nmr.99771.$61$YR$A$F$Y$$$20240820$$HP$CN$CN
242253741$24225374$1$I$$20240726$20240820$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004004$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242253752$24225375$2$F$20240101$20240905$20240820$20240930$PER$$US-SA-2024SA242788$SANOFI AVENTIS$$35$YR$A$F$Y$100$KG$20240930$$MD$US$US
242253761$24225376$1$I$20240801$20240812$20240820$20240820$PER$$US-SA-2024SA242199$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240820$$MD$US$US
242253771$24225377$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA239584$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240820$$CN$US$US
242253781$24225378$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA238984$SANOFI AVENTIS$$$$E$M$Y$$$20240820$$MD$US$US
242253791$24225379$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA241328$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240820$$MD$US$US
242253801$24225380$1$I$$20240813$20240820$20240820$EXP$$GB-SANDOZ INC.-NVSC2023GB038182$SANDOZ$$84$YR$$F$Y$$$20240820$$CN$GB$GB
242253811$24225381$1$I$$20240813$20240820$20240820$EXP$$US-BIOGEN-2024BI01278312$BIOGEN$$$$$F$Y$$$20240820$$CN$US$US
242253821$24225382$1$I$20240813$20240814$20240820$20240820$EXP$$US-BIOGEN-2024BI01278391$BIOGEN$$65$YR$$F$Y$$$20240820$$CN$US$US
242253833$24225383$3$F$20240601$20240829$20240820$20240905$EXP$$US-BIOGEN-2024BI01278330$BIOGEN$$51$YR$$F$Y$$$20240905$$CN$US$US
242253841$24225384$1$I$$20240726$20240820$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004071$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242253851$24225385$1$I$$20240814$20240820$20240820$EXP$$IN-Bion-013695$BIONPHARMA$$9$YR$C$F$Y$$$20240820$$HP$IN$IN
242253861$24225386$1$I$20240314$20240815$20240820$20240820$EXP$$CN-JNJFOC-20240847710$JOHNSON AND JOHNSON$$83$YR$E$F$Y$50$KG$20240820$$HP$CN$CN
242253871$24225387$1$I$$20240815$20240820$20240820$PER$$US-ROCHE-10000059204$ROCHE$$$$A$M$Y$$$20240820$$HP$US$US
242253881$24225388$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243044$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240820$$HP$US$US
242253891$24225389$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA238723$SANOFI AVENTIS$$16$YR$T$$Y$$$20240820$$MD$US$US
242253901$24225390$1$I$20240726$20240812$20240820$20240820$PER$$US-SA-2024SA240848$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240820$$CN$US$US
242253911$24225391$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242858$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240820$$MD$US$US
242253921$24225392$1$I$20230101$20240813$20240820$20240820$EXP$$US-UCBSA-2023053327$UCB$$$$$F$Y$63.492$KG$20240820$$CN$US$US
242253931$24225393$1$I$$20240814$20240820$20240820$EXP$$IR-Bion-013685$BIONPHARMA$$51$YR$A$F$Y$$$20240820$$HP$IR$IR
242253951$24225395$1$I$20240701$20240812$20240820$20240820$PER$$US-SA-2024SA241832$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240820$$MD$US$US
242253961$24225396$1$I$$20240809$20240820$20240820$30DAY$$US-GSK-US2024AMR103034$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$US$US
242253971$24225397$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024162948$AMGEN$$$$$$Y$$$20240819$$CN$US$US
242253981$24225398$1$I$20240801$20240812$20240820$20240820$PER$$US-SA-2024SA242904$SANOFI AVENTIS$$56$YR$A$F$Y$74.84$KG$20240820$$MD$US$US
242253992$24225399$2$F$$20240829$20240820$20240905$EXP$$US-ARGENX-2024-ARGX-US006544$ARGENX BVBA$$$$$$Y$$$20240905$$CN$US$US
242254001$24225400$1$I$$20240814$20240820$20240820$EXP$$US-TAKEDA-2024TUS026005$TAKEDA$$$$$M$Y$$$20240820$$CN$US$US
242254011$24225401$1$I$$20240816$20240820$20240820$EXP$$US-UCBSA-2024041646$UCB$$$$$F$Y$$$20240820$$CN$US$US
242254022$24225402$2$F$$20240814$20240820$20240821$EXP$$JP-ROCHE-10000057796$ROCHE$$6$DEC$A$F$Y$$$20240821$$MD$JP$JP
242254031$24225403$1$I$20230211$20230220$20240820$20240820$EXP$$ZA-BIOVITRUM-2023-ZA-005867$BIOVITRUM$$120$DY$$M$Y$4.3$KG$20240820$$CN$ZA$ZA
242254041$24225404$1$I$20220520$20220802$20240820$20240820$EXP$$CO-BIOVITRUM-2022CO07885$BIOVITRUM$$271$DY$$F$Y$$$20240820$$CN$CO$CO
242254053$24225405$3$F$$20240819$20240820$20240830$EXP$$CA-AUROBINDO-AUR-APL-2024-017370$AUROBINDO$Lafreniere S, Blier P. Remission from severe treatment-resistant depression with moclobemide: A case report. Encephale. 2023;49(6):649-650$65$YR$$F$Y$$$20240830$$HP$CA$CA
242254061$24225406$1$I$$20230308$20240820$20240820$EXP$$US-AstraZeneca-2023A058873$ASTRAZENECA$$$$$F$Y$55.3$KG$20240820$$CN$US$
242254071$24225407$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A184082$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
242254081$24225408$1$I$20240815$20240816$20240820$20240820$EXP$$US-AstraZeneca-2024A188053$ASTRAZENECA$$$$$M$Y$$$20240820$$MD$US$
242254091$24225409$1$I$$20240816$20240820$20240820$EXP$$US-AstraZeneca-2024A187621$ASTRAZENECA$$51$YR$$M$Y$$$20240820$$HP$US$
242254101$24225410$1$I$$20240807$20240820$20240820$PER$$US-AstraZeneca-2024A179786$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242254111$24225411$1$I$20240725$20240812$20240820$20240820$EXP$$FR-AstraZeneca-2024A182612$ASTRAZENECA$$72$YR$$F$Y$$$20240820$$MD$FR$
242254121$24225412$1$I$$20240809$20240820$20240820$EXP$$GB-NOVOPROD-1267744$NOVO NORDISK$$72$YR$$M$Y$83$KG$20240820$$MD$GB$GB
242254132$24225413$2$F$$20240814$20240820$20240826$EXP$$US-NOVOPROD-1269160$NOVO NORDISK$$$$E$M$Y$$$20240826$$CN$US$US
242254141$24225414$1$I$20240809$20240809$20240820$20240820$EXP$GB-MHRA-MED-202408091654596400-ZWRMY$GB-NOVOPROD-1267747$NOVO NORDISK$$50$YR$$F$Y$77$KG$20240820$$MD$GB$GB
242254151$24225415$1$I$20240801$20240809$20240820$20240820$EXP$GB-MHRA-MED-202408090946352120-PGQNS$GB-NOVOPROD-1267749$NOVO NORDISK$$66$YR$$F$Y$$$20240820$$PH$GB$GB
242254161$24225416$1$I$20240804$20240809$20240820$20240820$EXP$CN-NMPA-3601021028606202400446$CN-NOVOPROD-1268784$NOVO NORDISK$$53$YR$$F$Y$46$KG$20240820$$HP$CN$CN
242254173$24225417$3$F$20240803$20240830$20240820$20240910$EXP$$JP-NOVOPROD-1268827$NOVO NORDISK$$70$YR$$F$Y$48.8$KG$20240910$$PH$JP$JP
242254181$24225418$1$I$$20240809$20240820$20240820$EXP$$AT-NOVOPROD-1268836$NOVO NORDISK$$$$$F$Y$$$20240820$$MD$AT$AT
242254191$24225419$1$I$$20240809$20240820$20240820$EXP$$EG-NOVOPROD-1267821$NOVO NORDISK$$$$$M$Y$$$20240820$$CN$EG$EG
242254201$24225420$1$I$$20240809$20240820$20240820$EXP$$CN-NOVOPROD-1268434$NOVO NORDISK$$$$$M$Y$$$20240820$$CN$CN$CN
242254211$24225421$1$I$20240718$20240809$20240820$20240820$EXP$$GB-NOVOPROD-1267745$NOVO NORDISK$$62$YR$$M$Y$106$KG$20240820$$MD$GB$GB
242254221$24225422$1$I$$20240809$20240820$20240820$EXP$$AU-NOVOPROD-1268289$NOVO NORDISK$$$$$M$Y$$$20240820$$MD$AU$AU
242254232$24225423$2$F$$20240827$20240820$20240905$EXP$$JP-TEVA-VS-3233015$TEVA$Iwasaki Y, Seguchi O, Ikura M, Arisato T, Hada T, Mochizuki H, et al. BK polyomavirus nephropathy after heart transplantation: A case report. J-Cardiol-Cases 2024;.; Iwasaki Y, Seguchi O, Ikura M, Arisato T, Hada T, Mochizuki H, et al. BK polyomavirus nephropathy after heart transplantation: A case report. J-Cardiol-Cases 2024;.; Iwasaki Y, Seguchi O, Ikura M, Arisato T, Hada T, Mochizuki H, et al. BK polyomavirus nephropathy after heart transplantation: A case report. J-Cardiol-Cases 2024;.$$$A$M$Y$$$20240905$$MD$JP$JP
242254242$24225424$2$F$20240814$20240829$20240820$20240902$EXP$$JP-TAKEDA-2024TJP012022$TAKEDA$$69$YR$$F$Y$$$20240902$$MD$JP$JP
242254252$24225425$2$F$20240815$20240817$20240820$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010700$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240821$$CN$US$US
242254261$24225426$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010816$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240820$$CN$US$US
242254271$24225427$1$I$20240801$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010953$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240820$$CN$US$US
242254281$24225428$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009589$ELI LILLY AND CO$$62$YR$A$$Y$$$20240820$$CN$US$US
242254291$24225429$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009209$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$US$US
242254301$24225430$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010776$ELI LILLY AND CO$$$$$F$Y$$$20240820$$HP$US$US
242254311$24225431$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010132$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240820$$CN$US$US
242254321$24225432$1$I$20240814$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009803$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242254331$24225433$1$I$20240815$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010805$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240820$$CN$US$US
242254341$24225434$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA241195$SANOFI AVENTIS$$$$E$F$Y$59.87$KG$20240820$$MD$US$US
242254351$24225435$1$I$20240401$20240807$20240820$20240820$PER$$US-SA-2024SA239468$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240820$$MD$US$US
242254361$24225436$1$I$20240815$20240815$20240820$20240820$PER$$US-JNJFOC-20240845420$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
242254373$24225437$3$F$20240813$20240828$20240820$20240902$PER$$US-AMGEN-USASP2024162019$AMGEN$$63$YR$A$M$Y$$$20240902$$CN$US$US
242254382$24225438$2$F$20240701$20240829$20240820$20240903$PER$$US-LEO Pharma-372771$LEO PHARM$$73$YR$$F$Y$$$20240903$$CN$US$US
242254391$24225439$1$I$$20240812$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US072629$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
242254401$24225440$1$I$20240101$20240815$20240820$20240820$EXP$$US-JNJFOC-20240844887$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240820$$HP$US$US
242254411$24225441$1$I$$20240813$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130075$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240820$$MD$US$US
242254421$24225442$1$I$$20240811$20240820$20240820$EXP$$JP-MEDLEY-000022$MEDLEY PHARMACEUTICALS$$88$YR$E$F$Y$33$KG$20240813$$MD$JP$JP
242254432$24225443$2$F$$20240925$20240820$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130199$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240930$$CN$US$US
242254441$24225444$1$I$$20240812$20240820$20240820$PER$$US-CHATTEMPRD-2024OHG027109$CHATTEM$$$$$$Y$$$20240820$$CN$US$US
242254451$24225445$1$I$$20240812$20240820$20240820$PER$$US-LEO Pharma-372772$LEO PHARM$$58$YR$$F$Y$$$20240819$$CN$US$US
242254461$24225446$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883343$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242254472$24225447$2$F$20240814$20240814$20240820$20240822$PER$$US-AMGEN-USASP2024163791$AMGEN$$81$YR$E$M$Y$$$20240822$$CN$US$US
242254491$24225449$1$I$$20240812$20240820$20240820$PER$$US-CHATTEMPRD-2024OHG027166$CHATTEM$$$$$$Y$$$20240820$$CN$US$US
242254501$24225450$1$I$20240806$20240809$20240820$20240820$EXP$$US-NOVOPROD-1269433$NOVO NORDISK$$54$YR$$F$Y$$$20240820$$CN$US$US
242254511$24225451$1$I$$20240809$20240820$20240820$EXP$BE-FAMHP-DHH-N2024-122472$BE-NOVOPROD-1269223$NOVO NORDISK$$$$$F$Y$$$20240820$$CN$BE$BE
242254521$24225452$1$I$$20240809$20240820$20240820$EXP$$US-NOVOPROD-1269253$NOVO NORDISK$$$$A$F$Y$$$20240820$$CN$US$US
242254531$24225453$1$I$20160101$20240809$20240820$20240820$EXP$$US-NOVOPROD-1269479$NOVO NORDISK$$68$YR$$F$Y$$$20240820$$CN$US$US
242254561$24225456$1$I$$20240807$20240820$20240820$PER$$US-CHATTEMPRD-2024OHG026712$CHATTEM$$$$$F$Y$$$20240820$$CN$US$US
242254581$24225458$1$I$$20230727$20240820$20240820$EXP$$CA-AstraZeneca-2023A175021$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$CA$
242254591$24225459$1$I$$20231102$20240820$20240820$EXP$$CA-AstraZeneca-2023A252599$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$CA$
242254601$24225460$1$I$$20240809$20240820$20240820$EXP$$US-NOVOPROD-1269745$NOVO NORDISK$$$$A$M$Y$$$20240820$$CN$US$US
242254641$24225464$1$I$$20230222$20240820$20240820$EXP$$US-AstraZeneca-2023A047658$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242254652$24225465$2$F$$20240903$20240820$20240916$EXP$$US-NOVOPROD-1269995$NOVO NORDISK$$48$YR$$F$Y$$$20240916$$CN$US$US
242254661$24225466$1$I$$20240809$20240820$20240820$EXP$$US-NOVOPROD-1269777$NOVO NORDISK$$$$$M$Y$$$20240820$$MD$US$US
242254671$24225467$1$I$$20240809$20240820$20240820$EXP$$RU-NOVOPROD-1268168$NOVO NORDISK$$$$$F$Y$$$20240820$$PH$RU$RU
242254681$24225468$1$I$$20240813$20240820$20240820$PER$$US-LEO Pharma-372776$LEO PHARM$$74$YR$$F$Y$$$20240819$$CN$US$US
242254691$24225469$1$I$20240401$20240809$20240820$20240820$EXP$$US-NOVOPROD-1269768$NOVO NORDISK$$88$YR$$M$Y$$$20240820$$CN$US$US
242254701$24225470$1$I$$20240815$20240820$20240820$PER$$US-ROCHE-10000059128$ROCHE$$14$YR$T$M$Y$$$20240820$$CN$US$US
242254711$24225471$1$I$$20240813$20240820$20240820$EXP$$CA-APOTEX-2024AP009376$APOTEX$$62$YR$$F$Y$$$20240820$$HP$CA$CA
242254722$24225472$2$F$20240810$20240816$20240820$20240820$PER$$US-JNJFOC-20240839735$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240820$$CN$US$US
242254732$24225473$2$F$$20240904$20240820$20240905$PER$$US-ROCHE-10000060488$ROCHE$$$$A$M$Y$$$20240905$$CN$US$US
242254751$24225475$1$I$20240814$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164382$AMGEN$$58$YR$A$F$Y$$$20240820$$CN$US$US
242254761$24225476$1$I$$20240813$20240820$20240820$PER$$US-ROCHE-10000056782$ROCHE$$13$YR$T$M$Y$65.1$KG$20240820$$HP$US$US
242254771$24225477$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009804$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240820$$CN$US$US
242254782$24225478$2$F$$20240827$20240820$20240905$EXP$$JP-TEVA-VS-3233011$TEVA$Morisaki Y, Takatani T, Kotsugi M, Yamazaki S, Yokoyama S, Nakase K, et al. Intraoperative monitoring of trigeminal neuralgia: a technical note. Acta-Neurochir-Wien 2024; 166 (1): 1-5.; Morisaki Y, Takatani T, Kotsugi M, Yamazaki S, Yokoyama S, Nakase K, et al. Intraoperative monitoring of trigeminal neuralgia: a technical note. Acta-Neurochir-Wien 2024; 166 (1): 1-5.$$$$F$Y$$$20240905$$HP$JP$JP
242254791$24225479$1$I$$20240809$20240820$20240820$PER$$US-CHATTEMPRD-2024OHG027232$CHATTEM$$$$$M$Y$$$20240820$$CN$US$US
242254801$24225480$1$I$20210101$20240813$20240820$20240820$EXP$$GB-Orion Corporation ORION PHARMA-24_00031271$ORION$Illango A, Laws P. A 12-month history of a progressive rash on a background of significant long-term immunosuppression.. British Journal of Dermatology. 2024;191(SUPPLEMENT 1):I153-4.$52$YR$A$$Y$$$20240820$$MD$GB$
242254811$24225481$1$I$$20240222$20240820$20240820$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-03956$ALKEM$$$$$F$Y$$$20240820$$CN$US$US
242254821$24225482$1$I$$20240414$20240820$20240820$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06980$ALKEM$$84$YR$$$Y$$$20240820$$CN$US$US
242254831$24225483$1$I$$20231117$20240820$20240820$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-14751$ALKEM$$$$$$Y$$$20240820$$CN$US$US
242254841$24225484$1$I$$20240608$20240820$20240820$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06987$ALKEM$$$$$$Y$$$20240820$$CN$US$US
242254851$24225485$1$I$$20230808$20240820$20240820$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-09077$ALKEM$$$$$F$Y$$$20240820$$CN$US$US
242254861$24225486$1$I$$20240813$20240820$20240820$EXP$$HU-CELLTRION INC.-2024HU019760$CELLTRION$$$$$$Y$$$20240820$$HP$HU$HU
242254871$24225487$1$I$$20240528$20240820$20240820$EXP$$MU-ALKEM LABORATORIES LIMITED-MU-ALKEM-2024-11416$ALKEM$Suroowan S, Abdallah HH, Mahomoodally MF.. Herb-drug interactions and toxicity: Underscoring potential mechanisms and forecasting clinically relevant interactions induced by common phytoconstituents via data mining and computational approaches. Food and Chemical Toxicology. 2021;156:112432$82$YR$$F$Y$$$20240820$$HP$MU$TR
242254882$24225488$2$F$$20240909$20240820$20240919$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07970$LUPIN$$$$$$Y$$$20240919$$CN$US$US
242254891$24225489$1$I$$20240813$20240820$20240820$PER$$US-ABBVIE-5879522$ABBVIE$$$$E$$Y$$$20240820$$CN$US$US
242254902$24225490$2$F$20240730$20240902$20240820$20240906$EXP$FR-AFSSAPS-DJ2024000923$FR-JNJFOC-20240847305$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20240906$$MD$FR$FR
242254911$24225491$1$I$$20240813$20240820$20240820$EXP$$US-JNJFOC-20240842393$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240820$$HP$US$US
242254921$24225492$1$I$$20240809$20240820$20240820$PER$$US-CHATTEMPRD-2024OHG026966$CHATTEM$$$$$F$Y$$$20240820$$CN$US$US
242254932$24225493$2$F$$20240918$20240820$20240920$PER$$US-HALEON-2192581$Haleon PLC$$$$$$Y$$$20240920$$CN$US$US
242254942$24225494$2$F$$20240822$20240820$20240828$EXP$ES-EMA-2024730-AUTODUP-1722367981805$ES-Accord-441457$ACCORD$$$$$F$Y$$$20240828$$MD$ES$ES
242254951$24225495$1$I$$20240812$20240820$20240820$PER$$US-CHATTEMPRD-2024OHG027231$CHATTEM$$$$$F$Y$$$20240820$$CN$US$US
242254971$24225497$1$I$20230101$20240812$20240820$20240820$EXP$$PE-ROCHE-10000058369$ROCHE$$$$E$M$Y$$$20240820$$MD$PE$PE
242254981$24225498$1$I$$20240814$20240820$20240820$EXP$$US-Taiho Oncology Inc-2024-007863$TAIHO ONCOLOGY INC$$$$A$F$Y$$$20240820$$CN$US$US
242254991$24225499$1$I$$20240813$20240820$20240820$EXP$$CA-APOTEX-2024AP009384$APOTEX$$75$YR$$F$Y$$$20240820$$HP$CA$CA
242255001$24225500$1$I$20240807$20240808$20240820$20240820$EXP$$US-PADAGIS-2024PAD01312$PADAGIS$$$$$$Y$$$20240820$$CN$US$US
242255012$24225501$2$F$$20240909$20240820$20240917$EXP$$CA-APOTEX-2024AP009347$APOTEX$$40$YR$$F$Y$96$KG$20240917$$HP$CA$CA
242255021$24225502$1$I$$20240805$20240820$20240820$EXP$$US-PADAGIS-2024PAD01283$PADAGIS$Desai D, Nohria A, Sicco K L, Shapiro J. The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report. JAAD Case Reports. 2024;50:141-143$$$$$Y$$$20240820$$HP$US$US
242255031$24225503$1$I$$20240809$20240820$20240820$EXP$$US-PADAGIS-2024PAD01323$PADAGIS$$$$$$Y$$$20240820$$CN$US$US
242255041$24225504$1$I$$20240815$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130836$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240820$$CN$US$US
242255051$24225505$1$I$$20240808$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127228$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240820$$MD$US$US
242255062$24225506$2$F$20240706$20240820$20240820$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004015$ACADIA PHARMACEUTICALS$$59$YR$$M$Y$$$20240912$$MD$US$US
242255071$24225507$1$I$$20240815$20240820$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012768$JAZZ$$$$$M$Y$$$20240820$$CN$US$US
242255081$24225508$1$I$$20240812$20240820$20240820$EXP$GB-MHRA-MED-202408121500517630-NJZBD$GB-AMAROX PHARMA-AMR2024GB02698$HETERO$$66$YR$$F$Y$$$20240820$$HP$GB$GB
242255092$24225509$2$F$20240720$20240812$20240820$20240826$EXP$$CN-ROCHE-10000057706$ROCHE$$70$YR$E$F$Y$$$20240826$$HP$CN$CN
242255101$24225510$1$I$$20230808$20240820$20240820$EXP$$US-AstraZeneca-2023A182210$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242255111$24225511$1$I$$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164425$AMGEN$$$$$$Y$$$20240820$$HP$US$US
242255122$24225512$2$F$$20240814$20240820$20240828$PER$$US-SA-2024SA241068$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240828$$CN$US$US
242255131$24225513$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA237386$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240820$$CN$US$US
242255141$24225514$1$I$20240814$20240814$20240820$20240820$PER$$US-SA-2024SA243412$SANOFI AVENTIS$$$$$M$Y$$$20240820$$CN$US$US
242255151$24225515$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240652$SANOFI AVENTIS$$$$$F$Y$$$20240820$$HP$US$US
242255161$24225516$1$I$$20240810$20240820$20240820$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025034$UNITED THERAPEUTICS$$$$$F$Y$77.098$KG$20240820$$$US$US
242255171$24225517$1$I$20240812$20240812$20240820$20240820$EXP$$AT-ROCHE-10000055772$ROCHE$$49$YR$A$M$Y$$$20240820$$HP$AT$AT
242255181$24225518$1$I$$20230418$20240820$20240820$EXP$$US-AstraZeneca-2023A105229$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242255195$24225519$5$F$20240808$20240918$20240820$20240927$30DAY$$US-JNJFOC-20240824237$JOHNSON AND JOHNSON$$58$YR$A$$Y$$$20240927$$HP$US$US
242255202$24225520$2$F$$20240821$20240820$20240826$EXP$$US-JNJFOC-20240844920$JOHNSON AND JOHNSON$$$$A$F$Y$89.892$KG$20240826$$HP$US$US
242255211$24225521$1$I$$20240809$20240820$20240820$EXP$$US-GSK-US2024099667$GLAXOSMITHKLINE$$$$$F$Y$$$20240820$$CN$US$US
242255221$24225522$1$I$20230101$20240815$20240820$20240820$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-164379$BOEHRINGER INGELHEIM$$88$YR$E$M$Y$$$20240820$$CN$US$US
242255231$24225523$1$I$$20240726$20240820$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004021$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
242255242$24225524$2$F$20240703$20240828$20240820$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004046$ACADIA PHARMACEUTICALS$$8$YR$$F$Y$$$20240920$$CN$US$US
242255253$24225525$3$F$$20240911$20240820$20240912$PER$$US-JAZZ PHARMACEUTICALS-2024-US-012759$JAZZ$$$$$M$Y$$$20240912$$HP$US$US
242255261$24225526$1$I$$20240808$20240820$20240820$EXP$$IN-RDY-LIT/IND/24/0011914$DR REDDYS$Trivedi M, Mehta RD, Ghiya BC, Soni P. Impact of Chemotherapy-Induced Nail Changes on Quality of Life: A Cross-Sectional Study from a Tertiary Care Centre. Indian Journal of Dermatology. 2024;69(3): 205-211. doi:10.4103/ijd.ijd_723_22.$$$$$Y$$$20240820$$HP$IN$IN
242255271$24225527$1$I$$20240813$20240820$20240820$EXP$$LK-DEXPHARM-2024-2825$DEXCEL$K. Manojkumar; F. Hiruni; M. Hassan H; V. Neranjana. Proton Pump Inhibitor Induced Hypomagnesemia Causing Seizures: A Rare Adverse Effect of a Commonly Used Medication. Cureus, (2024 Jul) Vol. 16, No. 7, pp. e64044.  Electronic Publication Date: 7 Jul 2024. Journal code: 101596737. ISSN: 2168-8184. L-ISSN: 2168-8184. Report No.: PMC-PMC11303836. ?DOI  http://dx.doi.org/10.7759/cureus.64044$49$YR$A$M$Y$$$20240820$$HP$LK$LK
242255281$24225528$1$I$$20240814$20240820$20240820$EXP$$US-JNJFOC-20240837367$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240820$$CN$US$US
242255291$24225529$1$I$$20240807$20240820$20240820$EXP$$US-RDY-LIT/USA/24/0011709$DR REDDYS$Schlatter MI, Yandamuri SS, O^Connor KC, Nowak RJ, Pham MC, Obaid AH, et al. Remission of severe myasthenia gravis after autologous stem cell transplantation. Annals of Clinical and Translational Neurology. 2023;10(11): 2105-2113. doi:10.1002/acn3.51898.$33$YR$A$F$Y$$$20240820$$HP$US$US
242255301$24225530$1$I$$20240813$20240820$20240820$EXP$$IL-EMD Serono-2024043880$EMD SERONO INC$$31$YR$A$F$Y$$$20240820$$CN$IL$IL
242255311$24225531$1$I$$20240726$20240820$20240820$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004049$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242255321$24225532$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009426$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240820$$CN$US$US
242255331$24225533$1$I$$20240807$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408007805$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242255341$24225534$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010006$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240820$$CN$US$US
242255351$24225535$1$I$20240812$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010413$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240820$$CN$US$US
242255361$24225536$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009847$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240820$$CN$US$US
242255371$24225537$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010919$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240820$$CN$US$US
242255381$24225538$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011138$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240820$$CN$US$US
242255392$24225539$2$F$$20240909$20240820$20240909$EXP$$US-ALXN-202408USA000736US$ALEXION PHARMACEUTICALS$$23$YR$$F$Y$73$KG$20240909$$MD$US$US
242255401$24225540$1$I$20240724$20240806$20240820$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-041637$AUROBINDO$$37$YR$$F$Y$$$20240820$$HP$GB$GB
242255411$24225541$1$I$$20240813$20240820$20240820$EXP$GB-BLUEFISH PHARMACEUTICALS AB-2024BF001568$GB-DEXPHARM-2024-2777$DEXCEL$$$$$M$Y$$$20240819$$HP$GB$GB
242255421$24225542$1$I$$20240814$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA072853$SANDOZ$$8$YR$$M$Y$$$20240820$$HP$CA$CA
242255431$24225543$1$I$20240730$20240812$20240820$20240820$EXP$PT-INFARMED-R202407-1069$PT-TEVA-VS-3233302$TEVA$$58$YR$$M$Y$80$KG$20240820$$MD$PT$PT
242255441$24225544$1$I$$20231115$20240820$20240820$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017458$STRIDES$Lessard KK, Miller JL, Arzeno L. Megestrol Acetate for Bodybuilding Resulting in Abrupt Hypothalamic-Pituitary Dysfunction. J-Endocr-Soc. 2020;4 (Suppl. 1):A740 abstr. SUN-031.$24$YR$$M$Y$$$20240820$$MD$US$US
242255451$24225545$1$I$$20240223$20240820$20240820$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002509$STRIDES$$$$$F$Y$$$20240820$$PH$US$US
242255461$24225546$1$I$$20240815$20240820$20240820$PER$$US-ROCHE-10000059707$ROCHE$$$$A$F$Y$$$20240820$$CN$US$US
242255471$24225547$1$I$20190101$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024163440$AMGEN$$90$YR$E$F$Y$$$20240820$$HP$US$US
242255481$24225548$1$I$20240804$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164372$AMGEN$$65$YR$E$F$Y$$$20240820$$CN$US$US
242255491$24225549$1$I$20240801$20240809$20240820$20240820$PER$$US-JNJFOC-20240827728$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240820$$CN$US$US
242255502$24225550$2$F$$20240830$20240820$20240903$EXP$$JP-JNJFOC-20240849333$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$PH$JP$JP
242255511$24225551$1$I$$20240112$20240820$20240820$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000719$STRIDES$Waqar F, Arif A, Muazzam A, Wadood R, Khakwani AS, Khan UA.. A Curious Case of Psychosis.. J-Endocr-Soc. 2023;7 (Suppl. 1):A108-A109 abstr. FRI202$51$YR$$F$Y$$$20240820$$MD$US$US
242255521$24225552$1$I$$20231227$20240820$20240820$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000035$STRIDES$Cheng JM, Gaillard S, Beavis AL, Rushton T, Fader AN.. Case report: prolonged durable clinical benefit and low toxicity from combination endocrine therapy in a patient with recurrent endometrial carcinoma.. Front-Oncol. 2023;13$7$DEC$$F$Y$$$20240820$$HP$US$US
242255531$24225553$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168001$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242255541$24225554$1$I$20240714$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A186912$ASTRAZENECA$$$$$F$Y$$$20240820$$HP$US$
242255551$24225555$1$I$$20240812$20240820$20240820$EXP$$TR-SANDOZ INC.-SDZ2024TR073619$SANDOZ$Bozca BC, Alpsoy A, Bilgic A, Bassorgun CI, Unal B, Alpsoy E. Clinicopathological analysis of patients diagnosed with dress. TURKDERM-TURK ARCH DERMATOL VENEREOL. 2023;57:101-7$$$$$Y$$$20240820$$HP$TR$TR
242255561$24225556$1$I$20220307$20220623$20240820$20240820$EXP$$US-AstraZeneca-2022A123795$ASTRAZENECA$$30748$DY$$F$Y$$$20240820$$CN$US$
242255571$24225557$1$I$$20221220$20240820$20240820$EXP$$US-AstraZeneca-2022A414127$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242255581$24225558$1$I$$20240819$20240820$20240820$PER$$NVSC2024US167795$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242255592$24225559$2$F$20240718$20240815$20240820$20240828$EXP$$NVSC2024CN167240$NOVARTIS$$54$YR$$M$Y$$$20240828$$HP$CN$CN
242255601$24225560$1$I$20230116$20230811$20240820$20240820$EXP$$US-AstraZeneca-2023A014615$ASTRAZENECA$$29797$DY$$$Y$$$20240820$$CN$US$
242255611$24225561$1$I$$20221128$20240820$20240820$EXP$$BE-AstraZeneca-2022A396334$ASTRAZENECA$$$$$$Y$$$20240820$$MD$BE$
242255623$24225562$3$F$$20240905$20240820$20240909$EXP$$DE-JNJFOC-20240834789$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$DE$DE
242255631$24225563$1$I$$20240814$20240820$20240820$EXP$$PL-TAKEDA-2024TUS081533$TAKEDA$$7$YR$$F$Y$$$20240820$$HP$PL$PL
242255641$24225564$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242707$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240820$$MD$US$US
242255653$24225565$3$F$20220418$20240911$20240820$20240918$EXP$$CA-AMGEN-CANSL2024143309$AMGEN$$41$YR$A$F$Y$$$20240918$$CN$CA$CA
242255663$24225566$3$F$20240101$20240913$20240820$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-025264$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240920$$$US$US
242255671$24225567$1$I$20240813$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024163793$AMGEN$$51$YR$A$F$Y$$$20240820$$CN$US$US
242255681$24225568$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A186904$ASTRAZENECA$$$$$$Y$$$20240820$$HP$US$
242255692$24225569$2$F$20240101$20240919$20240820$20240926$EXP$$US-UCBSA-2024029221$UCB$$$$$M$Y$$$20240926$$CN$US$US
242255701$24225570$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164430$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242255713$24225571$3$F$20240815$20240926$20240820$20240928$PER$$US-AMGEN-USASP2024164408$AMGEN$$87$YR$E$F$Y$$$20240928$$HP$US$US
242255721$24225572$1$I$$20230519$20240820$20240820$EXP$$US-AstraZeneca-2023A118047$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242255731$24225573$1$I$$20240813$20240820$20240820$30DAY$$US-GSK-US2024100771$GLAXOSMITHKLINE$$$$$M$Y$$$20240820$$CN$US$US
242255741$24225574$1$I$$20240812$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US072656$SANDOZ$$$$$$Y$$$20240820$$CN$US$US
242255752$24225575$2$F$20240812$20240912$20240820$20240916$PER$$US-AMGEN-USASP2024162588$AMGEN$$65$YR$E$F$Y$$$20240916$$HP$US$US
242255763$24225576$3$F$$20240917$20240820$20240923$EXP$$US-TAKEDA-2024TUS079687$TAKEDA$$$$$F$Y$$$20240923$$CN$US$US
242255771$24225577$1$I$20240101$20240810$20240820$20240820$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000712$DECIPHERA PHARMACEUTICALS$$58$YR$A$$Y$$$20240820$$CN$US$US
242255791$24225579$1$I$$20240813$20240820$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-024635$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240820$$$US$US
242255801$24225580$1$I$$20240814$20240820$20240820$EXP$$BR-JNJFOC-20240843828$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$BR$BR
242255811$24225581$1$I$20240101$20240812$20240820$20240820$EXP$$AR-JNJFOC-20240832944$JOHNSON AND JOHNSON$$70$YR$E$F$Y$87$KG$20240820$$CN$AR$AR
242255821$24225582$1$I$20240702$20240726$20240820$20240820$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004051$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240820$$HP$US$US
242255832$24225583$2$F$$20240913$20240820$20240917$EXP$$JP-TAKEDA-2024TJP012027$TAKEDA$$39$YR$$M$Y$$$20240917$$MD$JP$JP
242255843$24225584$3$F$20240708$20240909$20240820$20240918$EXP$$GB-EXELIXIS-CABO-24080599$EXELIXIS$$17$YR$$F$Y$49$KG$20240918$$MD$GB$GB
242255853$24225585$3$F$$20240916$20240820$20240926$EXP$$FR-ROCHE-10000058790$ROCHE$Fargeas M, Devouassoux G G. Onset of eosinophilic granulomatosis with polyangiitis (EGPA) after anti-Th2 biotherapy initiation in severe asthma patients: Report of 3 cases.. RESPIR-MED-RES. 2024;85:1-3. doi:10.1016/j.resmer.2023.101070.$63$YR$A$F$Y$$$20240926$$HP$FR$FR
242255861$24225586$1$I$$20240819$20240820$20240820$PER$$NVSC2024US167792$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242255871$24225587$1$I$$20240809$20240820$20240820$EXP$$CA-AUROBINDO-AUR-APL-2023-040323$AUROBINDO$$37$YR$$F$Y$$$20240820$$HP$CA$CA
242255881$24225588$1$I$$20240812$20240820$20240820$EXP$$CA-TOLMAR, INC.-24CA051843$TOLMAR$$$$$M$Y$$$20240820$$CN$CA$CA
242255891$24225589$1$I$$20240726$20240820$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004056$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242255901$24225590$1$I$$20240726$20240820$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004057$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242255913$24225591$3$F$20240802$20240912$20240820$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004024$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$$$20240930$$CN$US$US
242255921$24225592$1$I$$20240809$20240820$20240820$EXP$$IN-ROCHE-10000055009$ROCHE$$76$YR$E$F$Y$$$20240820$$CN$IN$IN
242255931$24225593$1$I$20240801$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130257$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240820$$CN$US$US
242255941$24225594$1$I$20240516$20240813$20240820$20240820$EXP$GB-MHRA-MED-202408131554211170-BSMTN$GB-SA-2024SA242642$SANOFI AVENTIS$$57$YR$A$F$Y$65$KG$20240820$$CN$GB$GB
242255951$24225595$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240936$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240820$$MD$US$US
242255961$24225596$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA243128$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240820$$CN$US$US
242255971$24225597$1$I$20240101$20240813$20240820$20240820$EXP$$US-SA-2024SA243415$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242255982$24225598$2$F$20240101$20240905$20240820$20240918$EXP$$US-UCBSA-2024041672$UCB$$$$$M$Y$$$20240918$$CN$US$US
242255991$24225599$1$I$$20240813$20240820$20240820$EXP$$US-JNJFOC-20240836011$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
242256001$24225600$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011011$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242256021$24225602$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011087$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240820$$CN$US$US
242256031$24225603$1$I$$20220429$20240820$20240820$EXP$$US-AstraZeneca-2022A117475$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242256041$24225604$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A185003$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242256051$24225605$1$I$$20240815$20240820$20240820$PER$$US-BIOGEN-2024BI01278469$BIOGEN$$$$$F$Y$$$20240820$$MD$US$US
242256062$24225606$2$F$20240815$20240815$20240820$20240824$PER$$US-AMGEN-USASP2024164418$AMGEN$$59$YR$A$F$Y$$$20240824$$CN$US$US
242256071$24225607$1$I$20240716$20240726$20240820$20240820$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004059$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240820$$CN$US$US
242256091$24225609$1$I$20231101$20240816$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046639$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240820$$CN$US$US
242256101$24225610$1$I$$20240726$20240820$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004061$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242256111$24225611$1$I$20240726$20240726$20240820$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004025$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240820$$CN$US$US
242256132$24225613$2$F$20240815$20240819$20240820$20240821$PER$$US-AMGEN-USASP2024164603$AMGEN$$48$YR$A$M$Y$$$20240821$$CN$US$US
242256141$24225614$1$I$$20240814$20240820$20240820$EXP$$US-BEH-2024177255$CSL BEHRING$$$$A$M$Y$$$20240820$$MD$US$US
242256152$24225615$2$F$$20240927$20240820$20240930$EXP$$CA-SANDOZ INC.-SDZ2024CA072540$SANDOZ$$65$YR$$F$Y$$$20240930$$HP$CA$CA
242256161$24225616$1$I$$20240819$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046644$BOEHRINGER INGELHEIM$$$$$$Y$$$20240820$$CN$US$US
242256173$24225617$3$F$20240813$20240903$20240820$20240910$EXP$$JP-ABBVIE-5885237$ABBVIE$$75$YR$$F$Y$$$20240910$$PH$JP$JP
242256193$24225619$3$F$$20240904$20240820$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004026$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242256201$24225620$1$I$20231207$20240815$20240820$20240820$EXP$GB-MHRA-MED-202408151451326480-SWHGZ$GB-ABBVIE-5885352$ABBVIE$$36$YR$$M$Y$$$20240820$$CN$GB$GB
242256211$24225621$1$I$$20240809$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127029$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240820$$CN$US$US
242256221$24225622$1$I$$20240814$20240820$20240820$EXP$$JP-Orion Corporation ORION PHARMA-24_00031303$ORION$Yamaguchi T, Aihara A. Exacerbation of delirium and epileptic seizures in an older man with idiopathic Parkinson^s disease due to multiple prescriptions: a case report. Frontiers in Medicine. 2024;11:1415988.$8$DEC$E$M$Y$$$20240820$$MD$JP$
242256232$24225623$2$F$20240808$20240822$20240820$20240827$PER$$US-AMGEN-USASP2024163428$AMGEN$$60$YR$A$F$Y$$$20240827$$CN$US$US
242256241$24225624$1$I$$20240726$20240820$20240820$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004027$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
242256251$24225625$1$I$$20240812$20240820$20240820$EXP$$CA-APOTEX-2024AP009351$APOTEX$$48$YR$$F$Y$$$20240820$$PH$CA$CA
242256261$24225626$1$I$20240711$20240815$20240820$20240820$EXP$$CA-JNJFOC-20240842025$JOHNSON AND JOHNSON$$14$YR$T$F$Y$$$20240820$$HP$CA$CA
242256271$24225627$1$I$20240815$20240815$20240820$20240820$PER$$US-JNJFOC-20240839700$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240820$$CN$US$US
242256281$24225628$1$I$20231214$20240813$20240820$20240820$EXP$$CO-UCBSA-2024041479$UCB$$37$YR$$F$Y$$$20240820$$CN$CO$CO
242256291$24225629$1$I$20240101$20240813$20240820$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-024285$UNITED THERAPEUTICS$$$$$F$Y$$$20240820$$$US$US
242256301$24225630$1$I$$20240816$20240820$20240820$PER$$US-BIOVITRUM-2024-US-011027$BIOVITRUM$$23$YR$$F$Y$$$20240820$$CN$US$US
242256311$24225631$1$I$$20240807$20240820$20240820$EXP$$CA-ROCHE-10000054175$ROCHE$$56$YR$A$F$Y$$$20240820$$CN$CA$CA
242256331$24225633$1$I$$20240807$20240820$20240820$EXP$$GB-TEVA-VS-3231635$TEVA$$59$YR$$M$Y$$$20240820$$HP$GB$GB
242256341$24225634$1$I$$20240722$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07459$LUPIN$$$$$$Y$$$20240820$$CN$US$US
242256351$24225635$1$I$20240803$20240813$20240820$20240820$EXP$$CN-ROCHE-10000059269$ROCHE$$55$YR$A$M$Y$74.1$KG$20240820$$HP$CN$CN
242256361$24225636$1$I$20240717$20240726$20240820$20240820$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004005$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240820$$CN$US$US
242256371$24225637$1$I$$20240813$20240820$20240820$EXP$$AU-CELLTRION INC.-2024AU019643$CELLTRION$$$$$$Y$$$20240820$$HP$AU$AU
242256381$24225638$1$I$$20240726$20240820$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004007$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242256392$24225639$2$F$20240101$20240909$20240820$20240917$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000715$DECIPHERA PHARMACEUTICALS$$88$YR$E$F$Y$$$20240917$$CN$US$US
242256401$24225640$1$I$$20240807$20240820$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-039945$AUROBINDO$Schott C, Massad KM, Held N.. Disseminated Nocardiosis in a Sarcoidosis Patient Off Pneumocystis Pneumonia Prophylaxis. Am-J-Respir-Crit-Care-Med. 2024;209:A2418$81$YR$$M$Y$$$20240820$$HP$US$US
242256411$24225641$1$I$$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024163886$AMGEN$$$$$$Y$$$20240820$$CN$US$US
242256421$24225642$1$I$20230925$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164409$AMGEN$$80$YR$E$F$Y$$$20240820$$HP$US$US
242256432$24225643$2$F$20240801$20240912$20240820$20240917$EXP$$US-ABBVIE-5882671$ABBVIE$$69$YR$$F$Y$$$20240917$$CN$US$US
242256441$24225644$1$I$$20240814$20240820$20240820$30DAY$$IN-ABBVIE-5477440$ABBVIE$$$$$$Y$$$20240820$$MD$IN$IN
242256451$24225645$1$I$20230225$20240815$20240820$20240820$PER$$US-BIOVITRUM-2024-US-011023$BIOVITRUM$$77$YR$$F$Y$$$20240820$$CN$US$US
242256461$24225646$1$I$$20240809$20240820$20240820$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000716$DECIPHERA PHARMACEUTICALS$$66$YR$A$M$Y$$$20240820$$CN$US$US
242256471$24225647$1$I$$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129669$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240820$$CN$US$US
242256481$24225648$1$I$$20240807$20240820$20240820$EXP$$IN-ABBVIE-5883251$ABBVIE$Modi D, Dessureault S, Greene J. Diagnosis and treatment challenges of candida guilliermondii in immunocompromised patients: a case study in a neutropenic aml patient. Chowdhury R, editor. Case Reports in Infectious Diseases. 2024;2024(1):7806235.$30$YR$$F$Y$$$20240820$$HP$IN$IN
242256491$24225649$1$I$20190101$20240805$20240820$20240820$EXP$$US-ENDO USA, INC.-2024-003149$ENDO$$$$$F$Y$$$20240820$$CN$US$US
242256502$24225650$2$F$$20240902$20240820$20240903$PER$$NVSC2024US168021$NOVARTIS$$$$$$Y$$$20240903$$HP$US$US
242256511$24225651$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162813$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242256522$24225652$2$F$$20240827$20240820$20240905$EXP$$PT-TEVA-VS-3233611$TEVA$Neto M, Reis A, Santos F, Brigas D, Marques S, Serra S, et al. A MISFORTUNE. Eur-J-Case-Rep-Intern-Med 2023; 10 (Suppl. 1) 328.; Neto M, Reis A, Santos F, Brigas D, Marques S, Serra S, et al. A MISFORTUNE. Eur-J-Case-Rep-Intern-Med 2023; 10 (Suppl. 1) 328.$45$YR$$F$Y$$$20240905$$HP$PT$PT
242256531$24225653$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010665$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240820$$CN$US$US
242256541$24225654$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010773$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$US$US
242256551$24225655$1$I$$20240815$20240820$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-025538$UNITED THERAPEUTICS$$$$$F$Y$87.982$KG$20240820$$$US$US
242256571$24225657$1$I$20240816$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011061$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240820$$CN$US$US
242256582$24225658$2$F$20240811$20240819$20240820$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408010020$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240823$$CN$US$US
242256591$24225659$1$I$20240813$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009402$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240820$$CN$US$US
242256601$24225660$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010670$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240820$$CN$US$US
242256611$24225661$1$I$$20240813$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009991$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240820$$CN$US$US
242256621$24225662$1$I$20240815$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010626$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242256631$24225663$1$I$20240814$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011031$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240820$$CN$US$US
242256641$24225664$1$I$$20240813$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009437$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240820$$CN$US$US
242256651$24225665$1$I$20240816$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010917$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240820$$CN$US$US
242256661$24225666$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011032$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240820$$MD$US$US
242256671$24225667$1$I$$20240722$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07485$LUPIN$$$$$$Y$$$20240820$$CN$US$US
242256681$24225668$1$I$20240809$20240812$20240820$20240820$EXP$$CO-BIOVITRUM-2024-CO-011041$BIOVITRUM$$97$DY$$F$Y$$$20240820$$CN$CO$CO
242256691$24225669$1$I$20240101$20240812$20240820$20240820$EXP$$PL-BLUEPRINT MEDICINES CORPORATION-2024BUS004468$BLUEPRINT MEDICINES$$$$$$Y$$$20240816$$CN$PL$PL
242256702$24225670$2$F$20240101$20240910$20240820$20240918$EXP$$CA-CELLTRION INC.-2024CA019768$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
242256711$24225671$1$I$20240725$20240726$20240820$20240820$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004052$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240820$$CN$US$US
242256721$24225672$1$I$$20240814$20240820$20240820$EXP$$JP-SANDOZ INC.-SDZ2024JP055025$SANDOZ$$81$YR$$F$Y$$$20240820$$MD$JP$JP
242256731$24225673$1$I$20240803$20240816$20240820$20240820$EXP$$US-UCBSA-2024041855$UCB$$53$YR$$M$Y$$$20240820$$CN$US$US
242256741$24225674$1$I$20231001$20240815$20240820$20240820$EXP$$US-ABBVIE-5882609$ABBVIE$$58$YR$$F$Y$$$20240820$$CN$US$US
242256751$24225675$1$I$20240101$20240815$20240820$20240820$EXP$$CA-UCBSA-2024041601$UCB$$$$$F$Y$$$20240820$$CN$CA$CA
242256761$24225676$1$I$$20240723$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07386$LUPIN$$$$$$Y$$$20240820$$CN$US$US
242256771$24225677$1$I$$20240808$20240820$20240820$EXP$$US-RDY-LIT/USA/24/0011893$DR REDDYS$Stewart-Bates B, Hall G, Mousallem T, Stallings A, Sleasman J. TRANSIENT LOSS OF PERIPHERAL B-CELLS IN A PATIENT WITH CONGENITAL ATHYMIA AND OMENN^S SYNDROME. Annals of Allergy, Asthma and Immunology. 2023;131(5): doi:10.1016/j.anai.2023.08.491.$14$MON$I$M$Y$$$20240820$$HP$US$US
242256781$24225678$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162751$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242256791$24225679$1$I$$20240813$20240820$20240820$PER$$US-BIOGEN-2024BI01278253$BIOGEN$$$$$F$Y$$$20240820$$CN$US$US
242256802$24225680$2$F$$20240815$20240820$20240820$PER$$US-BIOGEN-2024BI01278170$BIOGEN$$$$$F$Y$$$20240820$$CN$US$US
242256811$24225681$1$I$$20240812$20240820$20240820$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024100264$VIIV$$$$$$Y$$$20240820$$MD$US$US
242256821$24225682$1$I$$20240813$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130809$BRISTOL MYERS SQUIBB$$54$YR$A$$Y$$$20240820$$HP$US$US
242256831$24225683$1$I$$20240809$20240820$20240820$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000708$DECIPHERA PHARMACEUTICALS$$50$YR$A$M$Y$$$20240820$$CN$US$US
242256841$24225684$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162828$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242256851$24225685$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163338$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242256861$24225686$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163344$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242256872$24225687$2$F$$20240823$20240820$20240829$PER$$US-AMGEN-USASP2024164687$AMGEN$$$$$F$Y$$$20240829$$CN$US$US
242256881$24225688$1$I$20240101$20240808$20240820$20240820$EXP$$US-ARDELYX-2024ARDX005660$ARDELYX$$$$$F$Y$$$20240820$$PH$US$US
242256891$24225689$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168031$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242256901$24225690$1$I$20240601$20240808$20240820$20240820$EXP$$JP-ARDELYX-2024ARDX006173$ARDELYX$$7$DEC$$M$Y$$$20240820$$MD$JP$JP
242256911$24225691$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883463$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242256921$24225692$1$I$$20240813$20240820$20240820$EXP$$US-UCBSA-2024040896$UCB$$$$$M$Y$120.63$KG$20240820$$MD$US$US
242256931$24225693$1$I$$20240808$20240820$20240820$30DAY$$US-GSK-US2024102705$GLAXOSMITHKLINE$$$$$F$Y$$$20240820$$CN$US$US
242256941$24225694$1$I$20240501$20240814$20240820$20240820$EXP$$CO-JNJFOC-20240842963$JOHNSON AND JOHNSON$$62$YR$A$$Y$$$20240820$$MD$CO$CO
242256951$24225695$1$I$$20240807$20240820$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-039952$AUROBINDO$Sood N, Kushnir M, Jayavelu B.. ACUTE RENAL THROMBOTIC MICROANGIOPATHY CAUSED BYELTROMBOPAG AND ROMIPLOSTIM IN A PATIENT WITH MYELODYSPLASTIC SYNDROMES (MDS) AND UNDERLYING ANTIPHOSPHOLIPID SYNDROME. European-Journal-Case-Reports-Internal-Medicine. 2024;11No. 7$80$YR$$M$Y$$$20240820$$HP$US$US
242256961$24225696$1$I$$20240814$20240820$20240820$EXP$GB-MHRA-MED-202408140755121390-FBGNK$GB-RDY-SPO/GBR/24/0011936$DR REDDYS$$40$YR$A$F$Y$$$20240820$$CN$GB$GB
242256971$24225697$1$I$$20240815$20240820$20240820$EXP$$US-CHEPLA-2024010593$CHEPLAPHARM$$$$A$F$Y$$$20240820$$CN$COUNTRY NOT SPECIFIED$US
242256981$24225698$1$I$20240311$20240815$20240820$20240820$EXP$FR-AFSSAPS-NC2024000952$FR-CHEPLA-2024010600$CHEPLAPHARM$$78$YR$$M$Y$42$KG$20240820$$MD$COUNTRY NOT SPECIFIED$FR
242256991$24225699$1$I$20240606$20240815$20240820$20240820$EXP$$US-EXELIXIS-CABO-24080638$EXELIXIS$$70$YR$$F$Y$$$20240820$$HP$US$US
242257001$24225700$1$I$20231012$20240815$20240820$20240820$EXP$$US-EXELIXIS-CABO-24080639$EXELIXIS$$30$YR$$M$Y$$$20240820$$HP$US$US
242257012$24225701$2$F$$20240807$20240820$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-039958$AUROBINDO$Kuniyoshi J, Huang R, Choi H, Bernas M, Techasatian W, Nishimura Y. Immune Checkpoint Inhibitor-Induced Myocarditis With Concurrent Myasthenia Gravis. Can-J-Cardiol. 2023;39(11):1646-1648$67$YR$$M$Y$$$20240821$$HP$US$US
242257021$24225702$1$I$$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164367$AMGEN$$$$$$Y$$$20240820$$CN$US$US
242257031$24225703$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162756$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242257041$24225704$1$I$20240814$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024163697$AMGEN$$$$$$Y$$$20240820$$CN$US$US
242257051$24225705$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163349$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242257061$24225706$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162753$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242257071$24225707$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163314$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242257081$24225708$1$I$$20240809$20240820$20240820$EXP$$AU-ROCHE-3576865$ROCHE$$26$YR$A$F$Y$$$20240820$$MD$AU$AU
242257091$24225709$1$I$20240501$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129752$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$113.85$KG$20240820$$CN$US$US
242257102$24225710$2$F$20240601$20240816$20240820$20240821$EXP$$US-ROCHE-10000054581$ROCHE$$50$YR$A$F$Y$$$20240821$$CN$US$US
242257111$24225711$1$I$$20240812$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127756$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240820$$CN$US$US
242257121$24225712$1$I$20240814$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024163895$AMGEN$$84$YR$E$$Y$$$20240820$$PH$US$US
242257131$24225713$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163337$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242257142$24225714$2$F$$20240819$20240820$20240821$PER$$US-JNJFOC-20240846698$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242257151$24225715$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011035$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240820$$CN$US$US
242257161$24225716$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010775$ELI LILLY AND CO$$$$$F$Y$$$20240820$$HP$US$US
242257171$24225717$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011077$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242257181$24225718$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009204$ELI LILLY AND CO$$58$YR$A$$Y$$$20240820$$CN$US$US
242257191$24225719$1$I$20240816$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010674$ELI LILLY AND CO$$57$YR$A$$Y$$$20240820$$CN$US$US
242257202$24225720$2$F$20240401$20240821$20240820$20240827$EXP$$US-ABBVIE-5881900$ABBVIE$$69$YR$$M$Y$$$20240827$$CN$US$US
242257212$24225721$2$F$20230404$20240814$20240820$20240828$EXP$$US-GSK-US2024101126$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240828$$HP$US$US
242257222$24225722$2$F$$20240827$20240820$20240905$EXP$$JP-TEVA-VS-3233017$TEVA$Kakuguchi W, Ashikaga Y, Moritani Y, Nakano S, Ogawa N, Yoshitatsu R, et al. Nonspecific inflammatory pseudotumor of the maxillary and temporal fossa: a study of seven cases. Oral-Surg-Oral-Med-Oral-Pathol-Oral-Radiol 2024;.; Kakuguchi W, Ashikaga Y, Moritani Y, Nakano S, Ogawa N, Yoshitatsu R, et al. Nonspecific inflammatory pseudotumor of the maxillary and temporal fossa: a study of seven cases. Oral-Surg-Oral-Med-Oral-Pathol-Oral-Radiol 2024;.$46$YR$$F$Y$$$20240905$$MD$JP$JP
242257231$24225723$1$I$20240701$20240814$20240820$20240820$EXP$$US-ABBVIE-5881980$ABBVIE$$65$YR$$F$Y$$$20240820$$CN$US$US
242257241$24225724$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5882955$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242257261$24225726$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163343$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242257271$24225727$1$I$$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164310$AMGEN$$$$$F$Y$$$20240820$$HP$US$US
242257281$24225728$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162620$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242257291$24225729$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162659$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242257301$24225730$1$I$20240815$20240816$20240820$20240820$EXP$$US-ABBVIE-5884664$ABBVIE$$71$YR$$F$Y$$$20240820$$CN$US$US
242257311$24225731$1$I$20240101$20240813$20240820$20240820$EXP$$US-009507513-2408USA004365$MERCK$$$$$F$Y$$$20240820$$CN$US$US
242257321$24225732$1$I$20240108$20240819$20240820$20240820$EXP$FR-AFSSAPS-DJ2024000921$FR-ABBVIE-5885199$ABBVIE$$25$YR$$M$Y$$$20240820$$MD$FR$FR
242257332$24225733$2$F$20240802$20240816$20240820$20240825$PER$$US-AMGEN-USASP2024163864$AMGEN$$63$YR$A$F$Y$$$20240825$$CN$US$US
242257343$24225734$3$F$$20240821$20240820$20240828$EXP$$CA-AstraZeneca-2024A186310$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$CA$
242257351$24225735$1$I$$20240812$20240820$20240820$EXP$$CA-AstraZeneca-2024A186865$ASTRAZENECA$$67$YR$$M$Y$$$20240820$$MD$CA$
242257361$24225736$1$I$$20240809$20240820$20240820$PER$$US-JNJFOC-20240828436$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$CN$US$US
242257371$24225737$1$I$$20240814$20240820$20240820$EXP$$US-JNJFOC-20240837732$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240820$$CN$US$US
242257384$24225738$4$F$20240808$20240927$20240820$20240930$PER$$US-JNJFOC-20240839856$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240930$$PH$US$US
242257392$24225739$2$F$$20240819$20240820$20240822$PER$$US-JNJFOC-20240846752$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
242257401$24225740$1$I$$20240814$20240820$20240820$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001650$BLUEPRINT MEDICINES$$$$$F$Y$$$20240820$$MD$US$US
242257412$24225741$2$F$20240701$20240819$20240820$20240826$EXP$$CA-BIOGEN-2024BI01278356$BIOGEN$$52$YR$$M$Y$$$20240826$$CN$CA$CA
242257421$24225742$1$I$$20240814$20240820$20240820$EXP$$US-BIOGEN-2024BI01278670$BIOGEN$$$$$F$Y$$$20240820$$CN$US$US
242257431$24225743$1$I$20240718$20240812$20240820$20240820$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07231$VIFOR$$26$YR$$F$Y$$$20240820$$CN$ZA$ZA
242257441$24225744$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130178$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240820$$HP$US$US
242257451$24225745$1$I$20230226$20240809$20240820$20240820$EXP$$US-ABBVIE-5882444$ABBVIE$$80$YR$$M$Y$63$KG$20240820$$HP$US$US
242257462$24225746$2$F$20240701$20240828$20240820$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07361$LUPIN$$$$$$Y$$$20240919$$CN$US$US
242257471$24225747$1$I$$20240816$20240820$20240820$PER$$US-JNJFOC-20240846473$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242257481$24225748$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5881934$ABBVIE$$68$YR$$M$Y$$$20240820$$CN$US$US
242257492$24225749$2$F$$20240916$20240820$20240919$PER$$US-HALEON-2192547$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
242257501$24225750$1$I$$20240814$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US069084$SANDOZ$$$$$M$Y$$$20240820$$HP$US$US
242257511$24225751$1$I$20240811$20240812$20240820$20240820$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-24914$SAMSUNG BIOEPIS$$62$YR$A$F$Y$$$20240820$$CN$CA$CA
242257521$24225752$1$I$$20240815$20240820$20240820$PER$$NVSC2024US167126$NOVARTIS$$$$$$Y$$$20240820$$CN$US$US
242257532$24225753$2$F$$20240923$20240820$20240930$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-24903$SAMSUNG BIOEPIS$$$$A$F$Y$92$KG$20241001$$HP$CA$CA
242257541$24225754$1$I$$20240811$20240820$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-025020$UNITED THERAPEUTICS$$$$$F$Y$83.9$KG$20240820$$$US$US
242257551$24225755$1$I$$20240812$20240820$20240820$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24902$SAMSUNG BIOEPIS$$82$YR$$F$Y$$$20240820$$CN$GB$GB
242257561$24225756$1$I$20230101$20240812$20240820$20240820$EXP$$PR-ABBVIE-5548114$ABBVIE$$$$$F$Y$74$KG$20240820$$CN$PR$PR
242257571$24225757$1$I$$20240813$20240820$20240820$EXP$$IT-SANDOZ INC.-SDZ2024IT072361$SANDOZ$$$$A$M$Y$$$20240820$$HP$IT$IT
242257581$24225758$1$I$$20240731$20240820$20240820$30DAY$$US-GSK-US2024AMR103227$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$US$US
242257592$24225759$2$F$20240810$20240810$20240820$20240912$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24811$SAMSUNG BIOEPIS$$21$YR$A$F$Y$$$20240912$$CN$GB$GB
242257601$24225760$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168092$NOVARTIS$$$$$$Y$$$20240820$$CN$US$US
242257612$24225761$2$F$$20240823$20240820$20240906$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25005$SAMSUNG BIOEPIS$$64$YR$A$M$Y$$$20240906$$MD$CA$CA
242257621$24225762$1$I$$20240816$20240820$20240820$EXP$$CA-AMX-008133$AMYLYX PHARMACEUTICALS$$64$YR$$M$Y$$$20240820$$MD$CA$CA
242257631$24225763$1$I$$20240722$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07466$LUPIN$$$$$$Y$$$20240820$$CN$US$US
242257642$24225764$2$F$$20240827$20240820$20240905$EXP$$JP-TEVA-VS-3233013$TEVA$Sakai Y, Ikawa Y, Takenaka M, Noguchi K, Fujiki T, Ikeda H, et al. Histopathological maturation in juvenile xanthogranuloma: a blueberry muffin infant mimicking aleukemic leukemia cutis. Int-J-Hematol 2024; 119 93-98.; Sakai Y, Ikawa Y, Takenaka M, Noguchi K, Fujiki T, Ikeda H, et al. Histopathological maturation in juvenile xanthogranuloma: a blueberry muffin infant mimicking aleukemic leukemia cutis. Int-J-Hematol 2024; 119 93-98.; Sakai Y, Ikawa Y, Takenaka M, Noguchi K, Fujiki T, Ikeda H,...$2$MON$$F$Y$$$20240905$$HP$JP$JP
242257651$24225765$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129946$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$99.79$KG$20240820$$CN$US$US
242257661$24225766$1$I$$20240815$20240820$20240820$EXP$$CA-JNJFOC-20240844974$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$HP$CA$CA
242257672$24225767$2$F$20240808$20240826$20240820$20240905$EXP$$JP-BAXTER-2024BAX023161$BAXTER$$8$DEC$$F$Y$$$20240905$$PH$JP$JP
242257682$24225768$2$F$20240807$20240826$20240820$20240904$EXP$$JP-BAXTER-2024BAX023102$BAXTER$$7$DEC$$F$Y$$$20240904$$PH$JP$JP
242257702$24225770$2$F$$20240905$20240820$20240911$PER$$US-AstraZeneca-2024A174738$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
242257711$24225771$1$I$$20240813$20240820$20240820$EXP$$GB-ABBVIE-5880704$ABBVIE$$$$A$F$Y$$$20240820$$CN$GB$GB
242257721$24225772$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009800$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240820$$CN$US$US
242257731$24225773$1$I$20230101$20240813$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408008523$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240820$$CN$US$US
242257741$24225774$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011036$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240820$$CN$US$US
242257751$24225775$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011051$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240820$$CN$US$US
242257761$24225776$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010587$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240820$$CN$US$US
242257771$24225777$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010623$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$US$US
242257781$24225778$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009768$ELI LILLY AND CO$$$$A$F$Y$$$20240820$$CN$US$US
242257791$24225779$1$I$20240816$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011513$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240820$$CN$US$US
242257801$24225780$1$I$$20240816$20240820$20240820$PER$$NVSC2024US167556$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242257811$24225781$1$I$20240816$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011055$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240820$$CN$US$US
242257821$24225782$1$I$20240101$20240814$20240820$20240820$EXP$$US-ABBVIE-5881914$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242257851$24225785$1$I$$20240813$20240820$20240820$EXP$$CA-APOTEX-2024AP009385$APOTEX$$5$YR$$F$Y$$$20240820$$HP$CA$CA
242257861$24225786$1$I$$20240816$20240820$20240820$PER$$US-HALEON-2192470$Haleon PLC$$$$$$Y$$$20240820$$CN$US$US
242257871$24225787$1$I$$20240722$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07460$LUPIN$$$$$$Y$$$20240820$$CN$US$US
242257881$24225788$1$I$$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024162002$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242257901$24225790$1$I$20240725$20240809$20240820$20240820$PER$$US-AMGEN-USASP2024159451$AMGEN$$50$YR$A$F$Y$$$20240820$$CN$US$US
242257911$24225791$1$I$$20240808$20240820$20240820$EXP$$CN-ROCHE-10000054047$ROCHE$$55$YR$A$F$Y$$$20240820$$CN$CN$CN
242257922$24225792$2$F$$20240814$20240820$20240827$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-18512$ALKEM$Edison DC, Philip J, Mallhi RS, Basnotra R, Pynadath V, Sane K.. Severe amlodipine toxicity: A medical dilemma managed with therapeutic plasma exchange. Transfus Apher Sci. 2024;63(4):103958$25$YR$$M$Y$$$20240827$$HP$IN$IN
242257932$24225793$2$F$$20240813$20240820$20240825$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-18581$ALKEM$Hayashi M, Aoki A, Asakawa K, Sakagami T, Kikuchi T, Takada T.. Cytokine profiles of amyopathic dermatomyositis with interstitial lung diseases treated with mycophenolate. Respirology Case Reports. 2017;5(4):e00235$59$YR$$M$Y$$$20240825$$HP$JP$JP
242257942$24225794$2$F$$20240813$20240820$20240825$EXP$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-18482$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-18482$ALKEM$Inoue F, Okazaki Y, Huh K, Ichiba T, Chiba T, Namera A.. Pharmacobezoar Associated Prolonged Clinical Course in a Patient with Immediate Release Quetiapine Overdose. Journal of Medical Toxicology. 2024;Unk:Unk$57$YR$$F$Y$$$20240825$$MD$JP$JP
242257952$24225795$2$F$$20240814$20240820$20240827$EXP$TW-MLMSERVICE-20240726-PI144015-00202-1$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-18363$ALKEM$Chung SH, Liu YY, Huang SY, Sung MT, Wu AY.. Secondary hemophagocytic lymphohistiocytosis triggered by Staphylococcus aureus bacteremia: A case report and systemic review. IDCases. 2024;37:e02031$86$YR$$F$Y$$$20240827$$MD$TW$TW
242257962$24225796$2$F$$20240813$20240820$20240825$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-18580$ALKEM$Saito T, Mizobuchi M, Miwa Y, Sugiyama M, Mima Y, Iida A, Kanazawa N, Morikawa T, Hayashi J, Fukuda K, Shikida Y, Suzuki T, Honda H.. Anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease treated with therapeutic plasma exchange: A case series. Journal of Clinical Apheresis. 2021;36:196-205$47$YR$$M$Y$$$20240825$$HP$JP$JP
242257971$24225797$1$I$$20240805$20240820$20240820$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18655$ALKEM$Lenfestey A, Friedmann D, Burke WA.. Metformin-induced pseudoporphyria. Journal of Drugs in Dermatology. 2012;11(11):1272$71$YR$$M$Y$$$20240820$$HP$US$US
242257981$24225798$1$I$$20240722$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07467$LUPIN$$$$$$Y$$$20240820$$CN$US$US
242257991$24225799$1$I$20240701$20240807$20240820$20240820$EXP$$US-UCBSA-2024040184$UCB$$48$YR$$M$Y$$$20240820$$HP$US$US
242258001$24225800$1$I$20220101$20240813$20240820$20240820$EXP$GB-MHRA-31453274$GB-ROCHE-10000056332$ROCHE$$46$YR$A$M$Y$120$KG$20240820$$CN$GB$GB
242258011$24225801$1$I$$20240719$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07449$LUPIN$$$$$$Y$$$20240820$$MD$US$US
242258022$24225802$2$F$20240101$20240923$20240820$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127839$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240926$$HP$US$US
242258031$24225803$1$I$$20240812$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128711$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240820$$MD$US$US
242258041$24225804$1$I$20231203$20240805$20240820$20240820$EXP$$CN-ROCHE-10000060549$ROCHE$$54$YR$A$M$Y$80$KG$20240820$$MD$CN$CN
242258051$24225805$1$I$$20240815$20240820$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012771$JAZZ$$$$$M$Y$$$20240820$$CN$US$US
242258061$24225806$1$I$$20240805$20240820$20240820$EXP$$DE-UCBSA-2024041560$UCB$Wildermann T, Becker F, Jesse S, Baier H, Wagner J. Successful use of Fenfluramine in super-refractory status epilepticus in a patient with tuberous sclerosis complex and Lennox-Gastaut syndrome. Epilepsy and Behavior Reports. 2024;27:1-5$24$YR$$F$Y$$$20240820$$HP$DE$DE
242258071$24225807$1$I$$20240719$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07450$LUPIN$$$$$$Y$$$20240820$$MD$US$US
242258082$24225808$2$F$$20240910$20240820$20240916$EXP$$JP-SA-2024SA236013$SANOFI AVENTIS$$22$DY$N$F$Y$$$20240917$$MD$JP$JP
242258091$24225809$1$I$$20240722$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07431$LUPIN$$$$$$Y$$$20240820$$PH$US$US
242258101$24225810$1$I$20240101$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164558$AMGEN$$63$YR$A$F$Y$40.823$KG$20240820$$CN$US$US
242258111$24225811$1$I$20240816$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164675$AMGEN$$66$YR$E$M$Y$$$20240820$$CN$US$US
242258122$24225812$2$F$20211108$20240912$20240820$20240918$EXP$$CN-AMGEN-CHNSP2024159775$AMGEN$Zhen, Z. A case of acute lung injury in a peripheral blood stem cell donor mobilized with pegylated recombinant human granulocyte colony-stimulating factor. International Journal of Hematology. 2024;120 (2):262-266$50$YR$A$M$Y$$$20240918$$HP$CN$CN
242258131$24225813$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5881299$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242258141$24225814$1$I$$20220826$20240820$20240820$EXP$$US-AstraZeneca-2022A255260$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242258151$24225815$1$I$$20221227$20240820$20240820$EXP$$US-AstraZeneca-2022A379637$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242258161$24225816$1$I$$20240814$20240820$20240820$EXP$$IL-ABBVIE-5882042$ABBVIE$$$$A$M$Y$$$20240820$$MD$IL$IL
242258181$24225818$1$I$20210101$20240812$20240820$20240820$EXP$$US-AMGEN-USASP2024161896$AMGEN$$62$YR$A$F$Y$$$20240820$$CN$US$US
242258201$24225820$1$I$$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164444$AMGEN$$60$YR$A$F$Y$$$20240820$$MD$US$US
242258213$24225821$3$F$20240101$20240828$20240820$20240902$EXP$$ES-ABBVIE-5881913$ABBVIE$$$$$F$Y$$$20240902$$CN$ES$ES
242258221$24225822$1$I$20240814$20240815$20240820$20240820$EXP$$CA-ROCHE-10000059553$ROCHE$$58$YR$A$F$Y$$$20240820$$CN$CA$CA
242258232$24225823$2$F$$20240821$20240820$20240827$EXP$$CN-ROCHE-10000060350$ROCHE$$$$$$Y$$$20240827$$MD$CN$CN
242258241$24225824$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130806$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240820$$HP$US$US
242258251$24225825$1$I$$20240809$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126957$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$54.7$KG$20240820$$CN$US$US
242258261$24225826$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010603$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240820$$CN$US$US
242258272$24225827$2$F$20240814$20240820$20240820$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408009840$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240823$$CN$US$US
242258291$24225829$1$I$20240816$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010720$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240820$$CN$US$US
242258301$24225830$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009752$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240820$$CN$US$US
242258311$24225831$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009956$ELI LILLY AND CO$$$$$$Y$$$20240820$$MD$US$US
242258321$24225832$1$I$20240802$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010679$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240820$$CN$US$US
242258331$24225833$1$I$20240815$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010633$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$US$US
242258341$24225834$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009383$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240820$$CN$US$US
242258351$24225835$1$I$$20240726$20240820$20240820$PER$$US-BEIGENE-BGN-2024-011710$BEIGENE$$$$$$Y$$$20240820$$MD$US$US
242258361$24225836$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010643$ELI LILLY AND CO$$41$YR$A$$Y$$$20240820$$CN$US$US
242258372$24225837$2$F$$20240820$20240820$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408008489$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240823$$CN$US$US
242258383$24225838$3$F$$20240910$20240820$20240916$EXP$$GB-JNJFOC-20240834488$JOHNSON AND JOHNSON$$78$YR$E$M$Y$98.9$KG$20240916$$CN$GB$GB
242258391$24225839$1$I$$20240813$20240820$20240820$PER$$US-BEIGENE-BGN-2024-010722$BEIGENE$$$$$$Y$$$20240820$$HP$US$US
242258401$24225840$1$I$20240730$20240809$20240820$20240820$EXP$$GB-MSNLABS-2024MSNSPO01792$MSN LABORATORIES$$$$$$Y$$$20240820$$MD$GB$GB
242258411$24225841$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5881977$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242258422$24225842$2$F$$20240901$20240820$20240904$EXP$$US-ABBVIE-5883526$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242258431$24225843$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5881800$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242258441$24225844$1$I$20240101$20240814$20240820$20240820$EXP$$US-ABBVIE-5881909$ABBVIE$$53$YR$$M$Y$$$20240820$$CN$US$US
242258451$24225845$1$I$20230528$20231024$20240820$20240820$EXP$$US-GSK-US2023AMR187510$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$HP$US$US
242258461$24225846$1$I$$20240811$20240820$20240820$EXP$$US-JNJFOC-20240831711$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$US$US
242258472$24225847$2$F$20240807$20240827$20240820$20240903$EXP$$US-ABBVIE-5882027$ABBVIE$$84$YR$$M$Y$$$20240903$$CN$US$US
242258481$24225848$1$I$$20240807$20240820$20240820$EXP$$US-RDY-LIT/USA/24/0011819$DR REDDYS$Kane N, Rikard R, McCrory K, Marx AH. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels. Open Forum Infectious Diseases. 2023 Nov 27;10(2): S1108. doi:10.1093/ofid/ofad500.2163.$74$YR$E$M$Y$$$20240820$$PH$US$US
242258492$24225849$2$F$$20240807$20240820$20240820$EXP$$US-RDY-LIT/USA/24/0011822$DR REDDYS$Kane N, Rikard R, McCrory K, Marx AH. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels. Open Forum Infectious Diseases. 2023 Nov 27;10(2): S1108. doi:10.1093/ofid/ofad500.2163.$26$YR$A$F$Y$$$20240820$$PH$US$US
242258502$24225850$2$F$$20240807$20240820$20240820$EXP$$US-RDY-LIT/USA/24/0011825$DR REDDYS$Kane N, Rikard R, McCrory K, Marx AH. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels. Open Forum Infectious Diseases. 10(2): doi:10.1093/ofid/ofad500.2163.$74$YR$E$M$Y$$$20240820$$PH$US$US
242258522$24225852$2$F$20240815$20240822$20240820$20240826$PER$$US-AMGEN-USASP2024163846$AMGEN$$64$YR$A$$Y$$$20240825$$MD$US$US
242258531$24225853$1$I$$20240814$20240820$20240820$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-245349$BOEHRINGER INGELHEIM$$53$YR$A$M$Y$$$20240820$$CN$CA$CA
242258541$24225854$1$I$$20240810$20240820$20240820$EXP$$GB-MSNLABS-2024MSNSPO01794$MSN LABORATORIES$$$$$$Y$$$20240820$$PH$GB$GB
242258552$24225855$2$F$$20240819$20240820$20240824$EXP$$NVSC2024GB166756$NOVARTIS$$$$A$M$Y$$$20240824$$MD$GB$GB
242258561$24225856$1$I$20230701$20240816$20240820$20240820$EXP$$NVSC2024DE167531$NOVARTIS$$$$A$M$Y$$$20240820$$MD$DE$DE
242258571$24225857$1$I$$20221026$20240820$20240820$EXP$$US-AstraZeneca-2022A358292$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242258581$24225858$1$I$$20230609$20240820$20240820$EXP$$US-AstraZeneca-2023A135738$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242258591$24225859$1$I$$20230124$20240820$20240820$EXP$$US-AstraZeneca-2022A406220$ASTRAZENECA$$69$YR$$F$Y$71.2$KG$20240820$$CN$US$
242258601$24225860$1$I$20240718$20240815$20240820$20240820$EXP$$ID-AstraZeneca-2024A188002$ASTRAZENECA$$21705$DY$$M$Y$$$20240820$$CN$ID$
242258611$24225861$1$I$$20230504$20240820$20240820$EXP$$US-AstraZeneca-2023A105319$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242258621$24225862$1$I$20220101$20221228$20240820$20240820$EXP$$CA-AstraZeneca-2022A410350$ASTRAZENECA$$63$YR$$F$Y$$$20240820$$HP$CA$
242258631$24225863$1$I$20220613$20220616$20240820$20240820$EXP$$US-AstraZeneca-2022A224705$ASTRAZENECA$$22330$DY$$F$Y$$$20240820$$CN$US$
242258641$24225864$1$I$$20240812$20240820$20240820$EXP$$ZA-AstraZeneca-2024A184028$ASTRAZENECA$$86$YR$$F$Y$$$20240820$$CN$ZA$
242258651$24225865$1$I$$20240816$20240820$20240820$EXP$$US-GILEAD-2024-0684558$GILEAD$$$$E$M$Y$$$20240820$$CN$US$US
242258662$24225866$2$F$20240815$20240919$20240820$20240921$PER$$US-AMGEN-USASP2024164360$AMGEN$$82$YR$E$M$Y$$$20240921$$CN$US$US
242258671$24225867$1$I$$20240811$20240820$20240820$EXP$$FR-AMGEN-FRASP2024162188$AMGEN$Vidal V.. A Single Center Experience of Cladribine, Cytarabine, Filgrastim and Mitoxantrone (CLAG-M regimen) in High-Risk or Relapsed/Refractory, Acute Myelold Leukemia (AML). Blood. 2018;132$$$$$Y$$$20240820$$HP$FR$FR
242258681$24225868$1$I$20240101$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164125$AMGEN$$65$YR$E$F$Y$$$20240820$$HP$US$US
242258691$24225869$1$I$$20240811$20240820$20240820$EXP$$MX-AMGEN-MEXSP2024163166$AMGEN$Aranda-gutierrez A.; Conde-flores E.; Meraz-brenez A. et al.. The efficacy of atezolizumab plus bevacizumab in the treatment of unresectable hepatocellular carcinoma in cirrhotic and non-cirrhotic patients. Journal of Clinical Oncology. 2024;24 (16):e16214$$$$$Y$$$20240820$$HP$MX$MX
242258711$24225871$1$I$$20240812$20240820$20240820$EXP$$CN-AMGEN-CHNSP2024163346$AMGEN$Sun H.; Zhu Y.; Li J. et al.. Picalm:MLLT10 can Identify a New Subgroup of Acute Leukemias of Ambiguous Lineage with Unique Extramedullary Disease and Treatment Response. Blood. 2023;142:6078-6078$34$YR$A$F$Y$$$20240820$$HP$CN$CN
242258721$24225872$1$I$20240813$20240819$20240820$20240820$EXP$$CZ-GILEAD-2024-0683954$GILEAD$$$$$F$Y$$$20240820$$PH$CZ$CZ
242258731$24225873$1$I$$20240814$20240820$20240820$EXP$$NVSC2024US165957$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242258741$24225874$1$I$$20231122$20240820$20240820$EXP$NL-LRB-00923897$NL-TEVA-VS-3143954$TEVA$$64$YR$$M$Y$78$KG$20240820$$CN$NL$NL
242258751$24225875$1$I$$20240812$20240820$20240820$EXP$$IL-AMGEN-ISRSP2024161637$AMGEN$Naffaa M. E.; Jeries H.; Daood R. et al.. Is interleukin-1 blockade a therapeutic option for patients with palindromic rheumatism?. Clinical Rheumatology. 2024;43 (8):2715-2717$38$YR$A$M$Y$$$20240820$$HP$IL$IL
242258771$24225877$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162737$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242258781$24225878$1$I$$20240816$20240820$20240820$EXP$PL-URPL-1-2547-2020$PL-AMGEN-POLSP2024163789$AMGEN$$16$YR$T$F$Y$55$KG$20240820$$MD$PL$PL
242258791$24225879$1$I$$20240810$20240820$20240820$EXP$GB-MHRA-MED-202408100658253420-HDTFK$GB-MSNLABS-2024MSNSPO01795$MSN LABORATORIES$$$$$$Y$$$20240820$$CN$GB$GB
242258801$24225880$1$I$$20240809$20240820$20240820$PER$$US-ABBVIE-5876402$ABBVIE$$87$YR$$$Y$$$20240820$$CN$US$US
242258811$24225881$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130544$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240820$$CN$US$US
242258822$24225882$2$F$20240814$20240912$20240820$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130429$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$93.89$KG$20240916$$CN$US$US
242258831$24225883$1$I$20231127$20240820$20240820$20240820$PER$$US-PROD-AS2-212756134-RB-080499-2024$RECKITT BENCKISER$$$$$M$Y$$$20240820$$CN$US$US
242258851$24225885$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009502$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240820$$CN$US$US
242258861$24225886$1$I$$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011714$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240820$$CN$US$US
242258871$24225887$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010635$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$US$US
242258881$24225888$1$I$$20240808$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408006388$ELI LILLY AND CO$$69$YR$E$$Y$$$20240820$$LW$US$US
242258891$24225889$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010869$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$US$US
242258901$24225890$1$I$20240319$20240814$20240820$20240820$EXP$$CN-ROCHE-10000008165$ROCHE$$88$YR$E$F$Y$$$20240820$$MD$CN$CN
242258911$24225891$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163410$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242258923$24225892$3$F$20240101$20240912$20240820$20240918$PER$$US-AMGEN-USASP2024164395$AMGEN$$59$YR$A$M$Y$$$20240918$$HP$US$US
242258934$24225893$4$F$20240112$20240911$20240820$20240917$30DAY$$US-AMGEN-USASP2024162231$AMGEN$$68$YR$E$F$Y$80$KG$20240917$$PH$US$US
242258942$24225894$2$F$$20240813$20240820$20240825$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-18577$ALKEM$So H, Wong VT, Lao VW, Pang HT, Yip RM. Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis. Clinical Rheumatology. 2018;37:1983-1989$49$YR$$F$Y$$$20240825$$HP$CN$CN
242258951$24225895$1$I$20240101$20240814$20240820$20240820$EXP$$US-JNJFOC-20240844915$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$CN$US$US
242258964$24225896$4$F$20240501$20240912$20240820$20240926$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006462$AURINIA PHARMACEUTICALS$$$$$$Y$$$20240926$$CN$US$US
242258971$24225897$1$I$$20240813$20240820$20240820$EXP$$CA-APOTEX-2024AP009381$APOTEX$$70$YR$$F$Y$65$KG$20240820$$PH$CA$CA
242258981$24225898$1$I$$20240814$20240820$20240820$EXP$$CA-CHEPLA-2024010551$CHEPLAPHARM$$30$YR$$M$Y$84$KG$20240820$$HP$COUNTRY NOT SPECIFIED$CA
242258991$24225899$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024163108$AMGEN$Li, B.. Comparing Bortezomib-Lenalidomide-Dexamethasone (VRd) with Carfilzomib-Lenalidomide-Dexamethasone (KRd) in the Patients with Newly Diagnosed Multiple Myeloma (NDMM) in Two Observational Studies. Blood. 2018;132 (supp 1):3298$$$$$Y$$$20240820$$MD$US$US
242259001$24225900$1$I$20240101$20240815$20240820$20240820$EXP$$ZA-ABBVIE-5883721$ABBVIE$$32$YR$$F$Y$$$20240820$$CN$ZA$ZA
242259022$24225902$2$F$20240817$20240911$20240820$20240917$PER$$US-RDY-SPO/USA/24/0011846$DR REDDYS$$45$YR$A$M$Y$$$20240917$$MD$US$US
242259031$24225903$1$I$20240730$20240813$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011845$DR REDDYS$$22$YR$A$$Y$$$20240820$$MD$US$US
242259041$24225904$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883334$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242259051$24225905$1$I$20230101$20240810$20240820$20240820$PER$$US-ABBVIE-5877450$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242259061$24225906$1$I$20230127$20240429$20240820$20240820$EXP$PT-INFARMED-F202404-525$PT-NORMON-202400303$NORMON$$55$YR$A$F$Y$67$KG$20240820$$MD$PT$
242259071$24225907$1$I$$20240813$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128222$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$80.29$KG$20240820$$CN$US$US
242259081$24225908$1$I$20240814$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024162922$AMGEN$$$$$M$Y$$$20240820$$CN$US$US
242259091$24225909$1$I$$20240811$20240820$20240820$EXP$$MX-AMGEN-MEXSP2024161709$AMGEN$Gomez-cruz G B.. Outpatient Autotransplants for Persons with Multiple Sclerosis. Blood. 2018;132:731$$$$$Y$$$20240820$$MD$MX$MX
242259102$24225910$2$F$$20240814$20240820$20240823$EXP$$US-ROCHE-10000058109$ROCHE$$$$$$Y$$$20240823$$MD$US$US
242259111$24225911$1$I$20240307$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040469$AUROBINDO$$52$YR$$F$Y$$$20240820$$MD$FR$FR
242259122$24225912$2$F$20240810$20240906$20240820$20240911$30DAY$$US-AMGEN-USASP2024160170$AMGEN$$$$$M$Y$$$20240911$$CN$US$US
242259131$24225913$1$I$$20240813$20240820$20240820$EXP$$JP-AMGEN-JPNSP2024161572$AMGEN$$$$$$Y$$$20240820$$CN$JP$JP
242259141$24225914$1$I$20240815$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163397$AMGEN$$73$YR$E$M$Y$$$20240820$$CN$US$US
242259153$24225915$3$F$20240802$20240917$20240820$20240923$PER$$US-AMGEN-USASP2024161309$AMGEN$$77$YR$E$M$Y$115$KG$20240923$$PH$US$US
242259161$24225916$1$I$$20240815$20240820$20240820$EXP$$CA-TAKEDA-2024TUS082670$TAKEDA$$$$$F$Y$$$20240820$$MD$CA$CA
242259171$24225917$1$I$20240723$20240813$20240820$20240820$PER$$US-Vifor (International) Inc.-VIT-2024-07288$VIFOR$$79$YR$$M$Y$96$KG$20240820$$HP$US$US
242259182$24225918$2$F$20240801$20240913$20240820$20240923$30DAY$$US-AMGEN-USASP2024162146$AMGEN$$77$YR$E$F$Y$77.1$KG$20240923$$PH$US$US
242259191$24225919$1$I$20240713$20240813$20240820$20240820$PER$$US-Vifor (International) Inc.-VIT-2024-07294$VIFOR$$63$YR$$F$Y$65.1$KG$20240820$$HP$US$US
242259201$24225920$1$I$$20240813$20240820$20240820$EXP$$US-TAKEDA-2021TUS052425$TAKEDA$$$$$M$Y$$$20240820$$CN$US$US
242259211$24225921$1$I$20240501$20240815$20240820$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011197$JAZZ$$51$YR$$F$Y$$$20240820$$HP$US$US
242259221$24225922$1$I$$20240814$20240820$20240820$EXP$$DE-JNJFOC-20240849434$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240820$$CN$DE$DE
242259233$24225923$3$F$20240801$20240916$20240820$20240919$EXP$$US-TAKEDA-2024TUS082079$TAKEDA$$73$YR$$F$Y$72.186$KG$20240919$$CN$US$US
242259242$24225924$2$F$$20240822$20240820$20240830$EXP$$US-ABBVIE-5884495$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242259251$24225925$1$I$$20240814$20240820$20240820$EXP$$IN-ROCHE-10000057714$ROCHE$$44$YR$A$F$Y$$$20240820$$CN$IN$IN
242259261$24225926$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130453$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$72.57$KG$20240820$$CN$US$US
242259271$24225927$1$I$$20240812$20240820$20240820$EXP$$CA-CELLTRION INC.-2024CA019901$CELLTRION$$$$$$Y$$$20240820$$MD$CA$CA
242259281$24225928$1$I$$20240814$20240820$20240820$PER$$NVSC2024US168111$NOVARTIS$$$$$$Y$$$20240820$$MD$US$US
242259291$24225929$1$I$$20240813$20240820$20240820$EXP$$GB-AstraZeneca-2024A184810$ASTRAZENECA$$$$$$Y$$$20240820$$PH$GB$
242259301$24225930$1$I$$20240808$20240820$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-040963$AUROBINDO$Gu, Y. A Case of Pick^s Disease Presenting with Corticobasal Syndrome.. J-Neuropathol-Exp-Neurol.. 2021;80(6):598$75$YR$$F$Y$$$20240820$$HP$CA$CA
242259311$24225931$1$I$20240122$20240814$20240820$20240820$EXP$$CA-TAKEDA-2024TUS008179$TAKEDA$$31$YR$$F$Y$$$20240820$$CN$CA$CA
242259321$24225932$1$I$$20240811$20240820$20240820$EXP$$FR-AMGEN-FRASP2024162233$AMGEN$Vidal V.. A Single Center Experience of Cladribine, Cytarabine, Filgrastim and Mitoxantrone (CLAG-M regimen) in High-Risk or Relapsed/Refractory, Acute Myelold Leukemia (AML). Blood. 2018;132$$$$$Y$$$20240820$$HP$FR$FR
242259341$24225934$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010968$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240820$$CN$US$US
242259351$24225935$1$I$$20240813$20240820$20240820$EXP$$DE-TAKEDA-2024TUS081855$TAKEDA$$$$$M$Y$$$20240820$$HP$DE$DE
242259361$24225936$1$I$20240713$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040902$AUROBINDO$$62$YR$$F$Y$$$20240820$$PH$FR$FR
242259371$24225937$1$I$20240811$20240812$20240820$20240820$EXP$$US-TAKEDA-2024TUS079071$TAKEDA$$18$YR$$M$Y$$$20240820$$PH$US$US
242259381$24225938$1$I$20240808$20240812$20240820$20240820$EXP$$CN-JNJFOC-20240834103$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240820$$HP$CN$CN
242259391$24225939$1$I$$20240813$20240820$20240820$PER$$US-BIOGEN-2024BI01278271$BIOGEN$$$$$F$Y$$$20240820$$CN$US$US
242259401$24225940$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130553$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240820$$CN$US$US
242259411$24225941$1$I$20240701$20240813$20240820$20240820$EXP$CA-MMM-Y2T381Q9$CA-GSK-CA2023112622$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$CA$CA
242259421$24225942$1$I$$20240813$20240820$20240820$EXP$$US-AMGEN-USASP2024161720$AMGEN$$$$$$Y$$$20240820$$CN$US$US
242259434$24225943$4$F$20240815$20240912$20240820$20240913$PER$$US-AMGEN-USASP2024164612$AMGEN$$64$YR$A$F$Y$$$20240913$$CN$US$US
242259442$24225944$2$F$$20240814$20240820$20240826$PER$$US-AMGEN-USASP2024164420$AMGEN$$$$$$Y$$$20240826$$MD$US$US
242259451$24225945$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162721$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242259461$24225946$1$I$$20240813$20240820$20240820$EXP$$MX-ROCHE-10000058497$ROCHE$$$$E$M$Y$$$20240820$$CN$MX$MX
242259471$24225947$1$I$20240803$20240809$20240820$20240820$EXP$$CN-ROCHE-10000054410$ROCHE$$59$YR$A$F$Y$63$KG$20240820$$HP$CN$CN
242259481$24225948$1$I$$20240812$20240820$20240820$PER$$US-ROCHE-10000055925$ROCHE$$77$YR$E$F$Y$$$20240820$$MD$US$US
242259492$24225949$2$F$20240905$20240909$20240820$20240910$EXP$$US-TAKEDA-2024TUS082348$TAKEDA$$69$YR$$M$Y$$$20240910$$HP$US$US
242259501$24225950$1$I$$20240814$20240820$20240820$EXP$$CA-TAKEDA-2024TUS077493$TAKEDA$$$$$F$Y$$$20240820$$MD$CA$CA
242259511$24225951$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168158$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242259521$24225952$1$I$$20240816$20240820$20240820$EXP$$FR-SANDOZ INC.-SDZ2024FR073195$SANDOZ$$67$YR$$M$Y$$$20240820$$HP$FR$FR
242259531$24225953$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162715$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242259541$24225954$1$I$$20240812$20240820$20240820$EXP$$US-HETERO-HET2024US02727$HETERO$Kim J, Prasad S, Roshan NS, Hasan BF, Gill G, Gunturu S.. Sleep disruptions and the pathway to psychosis:  An in-depth case and literature review. Clinical Case Reports.. 2024;12(6):1-5$20$YR$$M$Y$$$20240820$$HP$US$US
242259561$24225956$1$I$$20240810$20240820$20240820$PER$$US-GILEAD-2024-0683810$GILEAD$$28$YR$A$M$Y$$$20240820$$HP$US$US
242259571$24225957$1$I$20240701$20240818$20240820$20240820$EXP$$AU-GILEAD-2024-0684567$GILEAD$$$$$M$Y$$$20240820$$PH$AU$AU
242259581$24225958$1$I$$20240814$20240820$20240820$PER$$US-ALXN-202408USA000973US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242259591$24225959$1$I$20240501$20240809$20240820$20240820$EXP$SE-SEMPA-2024-005952$SE-NEBO-666135$PHARMACOSMOS$$40$YR$$F$Y$$$20240820$$MD$SE$SE
242259601$24225960$1$I$$20240807$20240820$20240820$EXP$$US-APOTEX-2024AP009190$APOTEX$Alshawa L.; Leahy B.; Rueckert J.; Maskey A.; Anstead M.; Keshavamurthy S.; Nandavaram S.. Hemophagocytic Lymphohistiocytosis: A Rare Diagnosis in the Immediate Aftermath of Lung Transplantation. Journal of Heart and Lung Transplantation. 2024;43 (4):S484-S488$63$YR$$M$Y$$$20240820$$HP$US$US
242259613$24225961$3$F$$20240912$20240820$20240917$EXP$$US-TAKEDA-2024TUS065367$TAKEDA$$$$$M$Y$84.27$KG$20240917$$HP$US$US
242259621$24225962$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5882953$ABBVIE$$74$YR$$F$Y$$$20240820$$CN$US$US
242259631$24225963$1$I$20240101$20240812$20240820$20240820$EXP$$DE-JNJFOC-20240849485$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240820$$CN$DE$DE
242259641$24225964$1$I$$20240808$20240820$20240820$EXP$$IN-ROCHE-10000052110$ROCHE$Doshi V, Thummar V, Mehta P. A Case Report on Trastuzumab Emtansine (T-DM1) in a Patient With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer and Brain Metastases: Long-Term Treatment and Survival. Cureus. 2024;16 (7):1-6. doi:10.7759/cureus.63589.$53$YR$A$F$Y$$$20240820$$HP$IN$IN
242259651$24225965$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5882921$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242259661$24225966$1$I$$20240808$20240820$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-040829$AUROBINDO$$35$YR$$M$Y$$$20240820$$HP$CA$CA
242259671$24225967$1$I$20240730$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040763$AUROBINDO$$74$YR$$F$Y$70$KG$20240820$$PH$FR$FR
242259682$24225968$2$F$$20240829$20240820$20240904$EXP$$CA-ABBVIE-5883691$ABBVIE$$$$E$M$Y$$$20240904$$CN$CA$CA
242259691$24225969$1$I$$20240813$20240820$20240820$PER$$US-TAKEDA-2024TUS081819$TAKEDA$$$$$F$Y$$$20240820$$CN$US$US
242259702$24225970$2$F$20240801$20240904$20240820$20240909$EXP$$JP-SA-2024SA234859$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240909$$MD$JP$JP
242259711$24225971$1$I$20240601$20240816$20240820$20240820$EXP$$GB-ABBVIE-5883972$ABBVIE$$63$YR$$F$Y$$$20240820$$CN$GB$GB
242259721$24225972$1$I$20240326$20240815$20240820$20240820$EXP$$DE-ABBVIE-5883508$ABBVIE$$29$YR$$F$Y$79$KG$20240820$$MD$DE$DE
242259731$24225973$1$I$20240701$20240813$20240820$20240820$EXP$SE-SEMPA-2024-006006$SE-SANDOZ INC.-SDZ2024SE073486$SANDOZ$$56$YR$$F$Y$$$20240820$$MD$SE$SE
242259741$24225974$1$I$20240816$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164641$AMGEN$$80$YR$E$M$Y$$$20240820$$CN$US$US
242259751$24225975$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162619$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242259761$24225976$1$I$20240814$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024163413$AMGEN$$84$YR$E$M$Y$$$20240820$$CN$US$US
242259771$24225977$1$I$20240815$20240815$20240820$20240820$EXP$$US-ABBVIE-5882936$ABBVIE$$58$YR$$F$Y$$$20240820$$CN$US$US
242259781$24225978$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5883121$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242259792$24225979$2$F$$20240815$20240820$20240823$PER$$US-ABBVIE-5883111$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242259811$24225981$1$I$$20240815$20240820$20240820$PER$$US-TAKEDA-2024TUS082385$TAKEDA$$$$$$Y$$$20240820$$CN$US$US
242259821$24225982$1$I$20240101$20240813$20240820$20240820$EXP$$CA-ABBVIE-5881369$ABBVIE$$54$YR$$F$Y$$$20240820$$CN$CA$CA
242259831$24225983$1$I$20240718$20240815$20240820$20240820$EXP$$CA-JNJFOC-20240845937$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240820$$HP$CA$CA
242259841$24225984$1$I$$20240814$20240820$20240820$PER$$US-JNJFOC-20240840882$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$MD$US$US
242259851$24225985$1$I$$20240815$20240820$20240820$EXP$$CA-ABBVIE-5882847$ABBVIE$$$$E$M$Y$$$20240820$$CN$CA$CA
242259861$24225986$1$I$20240730$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129466$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$48.08$KG$20240820$$PH$US$US
242259871$24225987$1$I$20240101$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130899$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240820$$HP$US$US
242259881$24225988$1$I$$20240808$20240820$20240820$EXP$$HK-SA-2024SA238846$SANOFI AVENTIS$Tam L-S, Li E.K, Wong C-K, Lam CWK, Szeto C-C.. Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus.. Lupus. 2004;13:601-4$$$A$$Y$$$20240820$$MD$HK$HK
242259891$24225989$1$I$20240808$20240812$20240820$20240820$EXP$$US-CELLTRION INC.-2024US019714$CELLTRION$$$$$$Y$$$20240820$$CN$US$US
242259901$24225990$1$I$$20240816$20240820$20240820$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-112386$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242259912$24225991$2$F$$20240826$20240820$20240902$EXP$$JP-009507513-2408JPN001719J$MERCK$$$$$F$Y$$$20240902$$MD$JP$JP
242259921$24225992$1$I$$20240813$20240820$20240820$EXP$$US-TAKEDA-2024TUS082119$TAKEDA$$$$$F$Y$$$20240820$$MD$US$US
242259931$24225993$1$I$20240810$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163656$AMGEN$$74$YR$E$F$Y$$$20240820$$CN$US$US
242259951$24225995$1$I$20240815$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164458$AMGEN$$64$YR$A$F$Y$$$20240820$$CN$US$US
242259961$24225996$1$I$$20240807$20240820$20240820$EXP$$GB-ADVANZ PHARMA-202408006683$ADVANZ PHARMA$$$$$$Y$$$20240820$$MD$GB$GB
242259971$24225997$1$I$20240815$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163165$AMGEN$$72$YR$E$F$Y$$$20240820$$CN$US$US
242259982$24225998$2$F$20240101$20240827$20240820$20240903$EXP$$US-ABBVIE-5883362$ABBVIE$$$$$M$Y$88.45$KG$20240903$$CN$US$US
242259991$24225999$1$I$$20240816$20240820$20240820$PER$$NVSC2024US166921$NOVARTIS$$$$$M$Y$$$20240820$$CN$US$US
242260003$24226000$3$F$$20240819$20240820$20240820$PER$$NVSC2024US168156$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242260022$24226002$2$F$20240801$20240814$20240820$20240822$EXP$$CA-CELLTRION INC.-2024CA019903$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
242260031$24226003$1$I$20240815$20240816$20240820$20240820$EXP$$IT-ABBVIE-5883707$ABBVIE$$73$YR$$M$Y$$$20240820$$CN$IT$IT
242260041$24226004$1$I$$20240731$20240820$20240820$PER$$US-TEVA-VS-3229875$TEVA$$$$$F$Y$$$20240820$$CN$US$US
242260051$24226005$1$I$20240807$20240808$20240820$20240820$PER$$US-ABBVIE-5875161$ABBVIE$$29$YR$$F$Y$$$20240820$$CN$US$US
242260062$24226006$2$F$20240726$20240906$20240820$20240919$EXP$$DE-AUROBINDO-AUR-APL-2024-040676$AUROBINDO$$69$YR$$F$Y$$$20240919$$MD$DE$DE
242260072$24226007$2$F$$20240814$20240820$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-129602$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240822$$MD$JP$JP
242260081$24226008$1$I$$20240813$20240820$20240820$EXP$$JP-AMGEN-JPNSP2024161799$AMGEN$$$$$$Y$$$20240820$$PH$JP$JP
242260091$24226009$1$I$$20240807$20240820$20240820$EXP$$CA-Amarin Pharma, Inc-2024AMR000326$AMARIN$$86$YR$E$M$Y$$$20240818$$CN$CA$CA
242260101$24226010$1$I$$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129083$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240820$$HP$US$US
242260112$24226011$2$F$20240809$20240816$20240820$20240822$EXP$$CA-JNJFOC-20240845900$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240822$$PH$CA$CA
242260121$24226012$1$I$20200101$20240809$20240820$20240820$EXP$$US-Amarin Pharma, Inc-2024AMR000416$AMARIN$$69$YR$E$M$Y$$$20240819$$CN$US$US
242260131$24226013$1$I$20230817$20240227$20240820$20240820$EXP$ES-AEMPS-1485106$ES-NORMON-2024000643$NORMON$$62$YR$A$M$Y$$$20240820$$PH$ES$
242260161$24226016$1$I$20240805$20240816$20240820$20240820$EXP$$US-GILEAD-2024-0684585$GILEAD$$44$YR$A$$Y$$$20240820$$HP$US$US
242260172$24226017$2$F$$20240817$20240820$20240822$PER$$NVSC2024US167650$NOVARTIS$$$$$$Y$$$20240822$$CN$US$US
242260181$24226018$1$I$$20240816$20240820$20240820$EXP$$US-TAKEDA-2024TUS082966$TAKEDA$$$$$M$Y$$$20240820$$CN$US$US
242260191$24226019$1$I$20240728$20240808$20240820$20240820$EXP$$PT-AUROBINDO-AUR-APL-2024-040653$AUROBINDO$$20$YR$$F$Y$$$20240820$$PH$PT$PT
242260201$24226020$1$I$$20240815$20240820$20240820$EXP$$US-SA-2024SA243852$SANOFI AVENTIS$$$$E$F$Y$$$20240820$$MD$US$US
242260212$24226021$2$F$20240101$20240912$20240820$20240918$EXP$$US-ABBVIE-5883212$ABBVIE$$$$$M$Y$70$KG$20240918$$CN$US$US
242260221$24226022$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010784$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240820$$CN$US$US
242260231$24226023$1$I$20240812$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009842$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240820$$CN$US$US
242260241$24226024$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010114$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240820$$CN$US$US
242260251$24226025$1$I$20240711$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040819$AUROBINDO$$60$YR$$M$Y$87$KG$20240820$$PH$FR$FR
242260261$24226026$1$I$$20240808$20240820$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-040961$AUROBINDO$$93$YR$$$Y$$$20240820$$CN$CA$CA
242260291$24226029$1$I$20240814$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009767$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240820$$CN$US$US
242260301$24226030$1$I$$20240815$20240820$20240820$PER$$US-LEO Pharma-372580$LEO PHARM$$32$YR$$M$Y$$$20240820$$PH$US$US
242260312$24226031$2$F$20240101$20240904$20240820$20240912$PER$$US-APOTEX-2024AP009124$APOTEX$$$$$F$Y$$$20240912$$PH$US$US
242260322$24226032$2$F$$20240911$20240820$20240925$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07993$LUPIN$$$$$$Y$$$20240925$$CN$US$US
242260341$24226034$1$I$20240529$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040894$AUROBINDO$$45$YR$$M$Y$85$KG$20240820$$PH$FR$FR
242260382$24226038$2$F$$20240819$20240820$20240826$PER$$NVSC2024US168103$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
242260393$24226039$3$F$20240829$20240829$20240820$20240903$EXP$$CA-TAKEDA-2018TUS027231$TAKEDA$$67$YR$$F$Y$$$20240903$$CN$CA$CA
242260403$24226040$3$F$$20240912$20240820$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012609$JAZZ$$$$$M$Y$$$20240917$$MD$US$US
242260421$24226042$1$I$$20240731$20240820$20240820$PER$$US-TEVA-VS-3229117$TEVA$$60$YR$$F$Y$72.57$KG$20240820$$CN$US$US
242260432$24226043$2$F$$20240829$20240820$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-040905$AUROBINDO$D^Onofrio G, Delrue M-A, Lortie A, Marquis C, Striano P, Jaworski M, et al.. Treatment of Refractory Epilepsy With MEK Inhibitor in Patients With RASopathy.. Pediatr-Neurol. 2023;148:148-151$$$$F$Y$$$20240909$$HP$CA$CA
242260442$24226044$2$F$20220101$20240918$20240820$20240924$EXP$$CA-ABBVIE-5883745$ABBVIE$$$$E$M$Y$$$20240924$$CN$CA$CA
242260452$24226045$2$F$20240712$20240820$20240820$20240826$EXP$$CA-ABBVIE-5883931$ABBVIE$$63$YR$$M$Y$$$20240826$$CN$CA$CA
242260461$24226046$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5884773$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242260472$24226047$2$F$20200801$20240820$20240820$20240826$EXP$$US-ROCHE-2708606$ROCHE$$35$YR$A$F$Y$83.91$KG$20240826$$CN$US$US
242260502$24226050$2$F$$20240826$20240820$20240905$EXP$$JP-TEVA-VS-3233009$TEVA$Yoshizaki C, Yoshida Y, Nohmi S, Go Y, Kusakado R, Kawamura S, et al. EGFR-TKI-induced Factor V deficiency in a patient with advanced non-small cell lung cancer: The first case report. Lung-Cancer 2024; 194 (0): 1-3.; Yoshizaki C, Yoshida Y, Nohmi S, Go Y, Kusakado R, Kawamura S, et al. EGFR-TKI-induced Factor V deficiency in a patient with advanced non-small cell lung cancer: The first case report. Lung-Cancer 2024; 194 (0): 1-3.; Yoshizaki C, Yoshida Y, Nohmi S, Go Y, Kusakado R, Kawamura S...$61$YR$$M$Y$$$20240905$$HP$JP$JP
242260511$24226051$1$I$$20240809$20240820$20240820$EXP$$DE-AUROBINDO-AUR-APL-2024-040952$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology.. 2024;48 (5):299-313$31$YR$$F$Y$$$20240820$$HP$DE$DE
242260521$24226052$1$I$$20230724$20240820$20240820$EXP$$US-AstraZeneca-2023A169709$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242260531$24226053$1$I$$20240813$20240820$20240820$EXP$$US-AMGEN-USASP2024162710$AMGEN$$$$$$Y$$$20240820$$CN$US$US
242260541$24226054$1$I$$20240808$20240820$20240820$PER$$US-AstraZeneca-2024A181092$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242260551$24226055$1$I$$20220726$20240820$20240820$EXP$$US-AstraZeneca-2022A268467$ASTRAZENECA$$$$$$Y$73.5$KG$20240820$$CN$US$
242260561$24226056$1$I$$20230323$20240820$20240820$EXP$$US-AstraZeneca-2023A070234$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242260571$24226057$1$I$$20240815$20240820$20240820$EXP$$CA-AstraZeneca-2024A188929$ASTRAZENECA$$62$YR$$M$Y$$$20240820$$MD$CA$
242260581$24226058$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0684575$GILEAD$$39$YR$A$M$Y$$$20240820$$CN$US$US
242260591$24226059$1$I$20230812$20240812$20240820$20240820$EXP$$GB-862174955-ML2024-04474$MICRO LABS$$62$YR$A$M$Y$$$20240820$$CN$GB$GB
242260601$24226060$1$I$20240730$20240809$20240820$20240820$EXP$$GB-862174955-ML2024-04458$MICRO LABS$$55$YR$A$F$Y$81$KG$20240820$$MD$GB$GB
242260611$24226061$1$I$20240215$20240814$20240820$20240820$EXP$FR-AFSSAPS-RE2024000781$FR-ROCHE-10000057146$ROCHE$$54$YR$A$F$Y$67$KG$20240820$$MD$FR$FR
242260621$24226062$1$I$20240617$20240809$20240820$20240820$EXP$$ES-AUROBINDO-AUR-APL-2024-040669$AUROBINDO$$50$YR$$M$Y$84$KG$20240820$$MD$ES$ES
242260631$24226063$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130238$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240820$$HP$US$US
242260641$24226064$1$I$20240719$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040826$AUROBINDO$$78$YR$$F$Y$52$KG$20240820$$MD$FR$FR
242260651$24226065$1$I$20240502$20240814$20240820$20240820$EXP$$CA-TAKEDA-2024TUS043290$TAKEDA$$26$YR$$M$Y$$$20240820$$MD$CA$CA
242260661$24226066$1$I$$20240814$20240820$20240820$PER$$US-LEO Pharma-372811$LEO PHARM$$47$YR$$F$Y$$$20240820$$PH$US$US
242260673$24226067$3$F$$20240829$20240820$20240905$EXP$$US-ABBVIE-5884233$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242260701$24226070$1$I$$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024164427$AMGEN$$$$$$Y$$$20240820$$MD$US$US
242260712$24226071$2$F$20240813$20240815$20240820$20240826$PER$$US-AMGEN-USASP2024164350$AMGEN$$63$YR$A$F$Y$$$20240826$$CN$US$US
242260721$24226072$1$I$20240814$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024163131$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242260731$24226073$1$I$$20240815$20240820$20240820$EXP$$US-ROCHE-10000005953$ROCHE$$74$YR$E$F$Y$$$20240820$$MD$US$US
242260742$24226074$2$F$$20240904$20240820$20240916$EXP$$GB-UCBSA-2022045780$UCB$$$$$F$Y$$$20240916$$CN$GB$GB
242260751$24226075$1$I$$20240116$20240820$20240820$EXP$$US-Accord-402807$ACCORD$$$$$F$Y$$$20240820$$CN$US$US
242260761$24226076$1$I$$20240613$20240820$20240820$EXP$$US-Accord-429919$ACCORD$$$$$F$Y$$$20240820$$CN$US$US
242260771$24226077$1$I$20240710$20240809$20240820$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-040366$AUROBINDO$$68$YR$$$Y$$$20240820$$HP$GB$GB
242260781$24226078$1$I$$20240731$20240820$20240820$PER$$US-TEVA-VS-3230275$TEVA$$39$YR$$F$Y$$$20240820$$CN$US$US
242260791$24226079$1$I$$20240809$20240820$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-041155$AUROBINDO$$64$YR$$F$Y$$$20240820$$HP$CA$CA
242260801$24226080$1$I$$20240815$20240820$20240820$EXP$$CA-TAKEDA-2024TUS082762$TAKEDA$$$$$F$Y$$$20240820$$MD$CA$CA
242260811$24226081$1$I$$20240816$20240820$20240820$PER$$NVSC2024US167190$NOVARTIS$$$$$M$Y$$$20240820$$HP$US$US
242260821$24226082$1$I$$20240809$20240820$20240820$EXP$$NL-AUROBINDO-AUR-APL-2024-040854$AUROBINDO$$74$YR$$M$Y$93.2$KG$20240820$$MD$NL$NL
242260831$24226083$1$I$$20240807$20240820$20240820$EXP$$IN-Encube-001282$ENCUBE ETHICALS$Izhar FM, Asrar KF, Haque AA. Metronidazole Associated Acute Encephalopathy. Indian J Pediatr. 2024 Jul 29. doi: 10.1007/s12098-024-05208-9.$14$YR$T$F$Y$$$20240814$$MD$IN$
242260841$24226084$1$I$$20240815$20240820$20240820$PER$$US-ABBVIE-5885009$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242260862$24226086$2$F$20220726$20240823$20240820$20240830$EXP$FR-AFSSAPS-MA2024001369$FR-GILEAD-2024-0684654$GILEAD$$82$YR$E$F$Y$$$20240830$$HP$FR$FR
242260871$24226087$1$I$$20240809$20240820$20240820$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07786$HIKMA$Bragg K, Miller H, Buckshaw R, Simon LV, King C.. Bragg K, Miller H, Buckshaw R, Simon LV, King C. Testosterone Therapy as an Isolated Risk Factor for Venous Thrombosis: A Case Report. Cureus. 2024;16(7):e63611:1-5$3$DEC$$M$Y$$$20240820$$MD$US$US
242260881$24226088$1$I$$20221214$20240820$20240820$EXP$$ES-AstraZeneca-2022A406968$ASTRAZENECA$$66$YR$$M$Y$$$20240820$$MD$ES$
242260891$24226089$1$I$20220829$20220902$20240820$20240820$EXP$$CO-AstraZeneca-2022A308964$ASTRAZENECA$$27985$DY$$M$Y$70$KG$20240820$$CN$CO$
242260901$24226090$1$I$$20191031$20240820$20240820$EXP$$CA-AstraZeneca-2019SF55847$ASTRAZENECA$$48$YR$$F$Y$$$20240820$$MD$CA$
242260911$24226091$1$I$$20230821$20240820$20240820$EXP$$US-AstraZeneca-2023A190867$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242260921$24226092$1$I$20240621$20240810$20240820$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-019213$UNITED THERAPEUTICS$$70$YR$$F$Y$$$20240820$$$US$US
242260931$24226093$1$I$20240716$20240813$20240820$20240820$PER$$US-Vifor (International) Inc.-VIT-2024-07295$VIFOR$$78$YR$$M$Y$$$20240820$$HP$US$US
242260941$24226094$1$I$20240815$20240818$20240820$20240820$EXP$$IL-ROCHE-10000060630$ROCHE$$36$YR$A$F$Y$$$20240820$$CN$IL$IL
242260951$24226095$1$I$$20240809$20240820$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-020175$AUROBINDO$Watson P.. Stevens-Johnson syndrome induced by lacosamide:A rare adverse reaction.. Annales de Dermatologie et de Venereologie. 2022$69$YR$$M$Y$$$20240820$$HP$CA$CA
242260961$24226096$1$I$$20240816$20240820$20240820$EXP$$IN-ROCHE-10000059774$ROCHE$$60$YR$A$M$Y$$$20240820$$CN$IN$IN
242260971$24226097$1$I$$20240812$20240820$20240820$PER$$US-TAKEDA-2024TUS081284$TAKEDA$$$$$$Y$$$20240820$$CN$US$US
242260981$24226098$1$I$20240724$20240809$20240820$20240820$EXP$$CN-ROCHE-10000054091$ROCHE$$55$YR$A$F$Y$69.9$KG$20240820$$HP$CN$CN
242260991$24226099$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131128$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240820$$HP$US$US
242261001$24226100$1$I$20240630$20240815$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130736$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240820$$CN$US$US
242261011$24226101$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130344$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240820$$HP$US$US
242261031$24226103$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130656$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$102.06$KG$20240820$$CN$US$US
242261041$24226104$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162646$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261051$24226105$1$I$20240701$20240812$20240820$20240820$30DAY$$US-GSK-US2024100187$GLAXOSMITHKLINE$$60$YR$$M$Y$$$20240820$$CN$US$US
242261062$24226106$2$F$20240101$20240902$20240820$20240903$EXP$$US-UCBSA-2024041637$UCB$$$$$M$Y$$$20240903$$CN$US$US
242261081$24226108$1$I$$20240812$20240820$20240820$EXP$$CA-APOTEX-2024AP009308$APOTEX$$37$YR$$F$Y$$$20240820$$HP$CA$CA
242261091$24226109$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162688$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261101$24226110$1$I$$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024163015$AMGEN$$$$$M$Y$$$20240820$$HP$US$US
242261111$24226111$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162719$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261121$24226112$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162676$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261131$24226113$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162658$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261141$24226114$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162678$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261151$24226115$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162571$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261163$24226116$3$F$20240817$20240826$20240820$20240902$PER$$US-AMGEN-USASP2024165268$AMGEN$$51$YR$A$F$Y$$$20240902$$CN$US$US
242261171$24226117$1$I$20240617$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040828$AUROBINDO$$47$YR$$F$Y$$$20240820$$PH$FR$FR
242261181$24226118$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024161392$AMGEN$Portuguese A. J. Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive Chemomobilization. Transplantation and Cellular Therapy. 2024;30(8):774.e1-774.e12$$$$$Y$$$20240820$$HP$US$US
242261191$24226119$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010147$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242261201$24226120$1$I$$20240812$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011892$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242261211$24226121$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010012$ELI LILLY AND CO$$$$A$F$Y$$$20240820$$CN$US$US
242261221$24226122$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009569$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240820$$CN$US$US
242261231$24226123$1$I$$20240805$20240820$20240820$EXP$$IN-UNIQUE PHARMACEUTICAL LABORATORIES-20240800108$UNIQUE PHARMACEUTICALS$Mehul Tyagi. Fixed Drug Eruptions Due To/Caused by Levocetirizine and Cetirizine: An Uncommon Adverse Cutaneous Drug Reaction to Commonly Used Piperazine Derivatives. Indian Dermatology Online Journal. 2024;15(4):678-680$$$$$Y$$$20240820$$HP$IN$IN
242261241$24226124$1$I$$20240814$20240820$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012694$JAZZ$$$$$F$Y$$$20240820$$CN$US$US
242261251$24226125$1$I$$20240815$20240820$20240820$PER$$NVSC2024US165554$NOVARTIS$$$$$$Y$$$20240820$$CN$US$US
242261261$24226126$1$I$$20240816$20240820$20240820$EXP$$NVSC2024US167585$NOVARTIS$$$$$$Y$$$20240820$$MD$US$US
242261274$24226127$4$F$$20240904$20240820$20240911$EXP$$GB-SANDOZ INC.-SDZ2024GB073017$SANDOZ$$21$MON$$M$Y$$$20240911$$MD$GB$GB
242261281$24226128$1$I$$20240814$20240820$20240820$PER$$US-JNJFOC-20240837716$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$US$US
242261291$24226129$1$I$20220602$20240816$20240820$20240820$EXP$$US-UCBSA-2024024291$UCB$$60$YR$$F$Y$$$20240820$$HP$US$US
242261302$24226130$2$F$$20240829$20240820$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07390$LUPIN$$$$$$Y$$$20240918$$CN$US$US
242261321$24226132$1$I$$20221125$20240820$20240820$EXP$$US-AstraZeneca-2022A344384$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242261331$24226133$1$I$$20230427$20240820$20240820$EXP$$US-AstraZeneca-2023A100152$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242261341$24226134$1$I$$20220912$20240820$20240820$EXP$$US-AstraZeneca-2022A317377$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242261351$24226135$1$I$$20200807$20240820$20240820$EXP$$US-AstraZeneca-2020SF01657$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242261361$24226136$1$I$$20240815$20240820$20240820$EXP$$ZA-AstraZeneca-2024A187857$ASTRAZENECA$$78$YR$$F$Y$$$20240820$$CN$ZA$
242261371$24226137$1$I$$20240816$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA073354$SANDOZ$$44$YR$$M$Y$91$KG$20240820$$HP$CA$CA
242261381$24226138$1$I$$20221220$20240820$20240820$EXP$$US-AstraZeneca-2022A417191$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242261391$24226139$1$I$$20230621$20240820$20240820$EXP$$US-AstraZeneca-2023A143793$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242261401$24226140$1$I$$20230726$20240820$20240820$EXP$$US-AstraZeneca-2023A173462$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242261411$24226141$1$I$20220731$20220830$20240820$20240820$EXP$$ES-AstraZeneca-2022A304906$ASTRAZENECA$$60$YR$$M$Y$$$20240820$$CN$ES$
242261421$24226142$1$I$$20221221$20240820$20240820$EXP$$US-AstraZeneca-2022A415164$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242261431$24226143$1$I$20240519$20240816$20240820$20240820$EXP$$CH-GILEAD-2024-0684493$GILEAD$$60$YR$A$F$Y$$$20240820$$MD$CH$CH
242261441$24226144$1$I$$20240723$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07391$LUPIN$$$$$$Y$$$20240820$$CN$US$US
242261451$24226145$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162652$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261461$24226146$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162668$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261471$24226147$1$I$$20240813$20240820$20240820$EXP$$JP-AMGEN-JPNSP2024161027$AMGEN$$90$YR$E$$Y$$$20240820$$CN$JP$JP
242261481$24226148$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162734$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261491$24226149$1$I$$20240814$20240820$20240820$EXP$$JP-AMGEN-JPNSP2024162515$AMGEN$$$$A$M$Y$$$20240820$$PH$JP$JP
242261502$24226150$2$F$$20240827$20240820$20240904$EXP$$US-TAKEDA-2024TUS082181$TAKEDA$$$$$M$Y$$$20240904$$CN$US$US
242261522$24226152$2$F$$20240819$20240820$20240825$PER$$US-ROCHE-10000060996$ROCHE$$45$YR$A$F$Y$$$20240825$$CN$US$US
242261531$24226153$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162590$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261541$24226154$1$I$$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024162169$AMGEN$$$$A$F$Y$$$20240820$$CN$US$US
242261551$24226155$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162738$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261561$24226156$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162747$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261571$24226157$1$I$$20231111$20240820$20240820$EXP$$US-Accord-379914$ACCORD$$$$$F$Y$$$20240820$$PH$US$US
242261591$24226159$1$I$$20240305$20240820$20240820$EXP$$US-Accord-410828$ACCORD$$65$YR$E$F$Y$63.5$KG$20240820$$CN$US$US
242261601$24226160$1$I$20240813$20240814$20240820$20240820$PER$$US-JNJFOC-20240845568$JOHNSON AND JOHNSON$$74$YR$$F$Y$$$20240820$$CN$US$US
242261611$24226161$1$I$$20240813$20240820$20240820$PER$$US-JNJFOC-20240833487$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$HP$US$US
242261622$24226162$2$F$20240801$20240902$20240820$20240906$EXP$$CO-AMGEN-COLSL2024162445$AMGEN$$80$YR$E$F$Y$$$20240906$$CN$CO$CO
242261631$24226163$1$I$20240801$20240810$20240820$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-025013$UNITED THERAPEUTICS$$37$YR$$F$Y$48.073$KG$20240820$$$US$US
242261662$24226166$2$F$$20240820$20240820$20240826$PER$$US-ROCHE-10000060939$ROCHE$$$$$F$Y$$$20240826$$CN$US$US
242261681$24226168$1$I$$20240806$20240820$20240820$PER$$US-APOTEX-2024AP009166$APOTEX$$$$$$Y$$$20240820$$CN$US$US
242261691$24226169$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163353$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261701$24226170$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5884301$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242261711$24226171$1$I$$20240812$20240820$20240820$EXP$$JP-CELLTRION INC.-2024JP019591$CELLTRION$Yamada K, Ida-Ichikawa M, Fujimoto N, Ishida M, Dohi K. Takotsubo syndrome in a cancer patient treated with a combination of anti-cancer drugs including immune checkpoint inhibitors: a case report. European Heart Journal - Case Reports. 2024;8:ytae355$$$$$Y$$$20240820$$HP$JP$JP
242261721$24226172$1$I$20240731$20240812$20240820$20240820$30DAY$$US-GSK-US2024100324$GLAXOSMITHKLINE$$39$YR$$F$Y$$$20240820$$CN$US$US
242261744$24226174$4$F$20240801$20240925$20240820$20240927$PER$$US-AMGEN-USASP2024165169$AMGEN$$73$YR$E$F$Y$$$20240927$$CN$US$US
242261751$24226175$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163364$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261761$24226176$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163361$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261771$24226177$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163371$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261781$24226178$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163375$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261791$24226179$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163360$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261811$24226181$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163372$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242261821$24226182$1$I$$20240816$20240820$20240820$PER$$US-HALEON-2192549$Haleon PLC$$$$$$Y$$$20240820$$CN$US$US
242261832$24226183$2$F$20240726$20240816$20240820$20240829$EXP$$NVSC2024CN167968$NOVARTIS$$66$YR$$M$Y$55$KG$20240829$$HP$CN$CN
242261841$24226184$1$I$$20240807$20240820$20240820$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001162$ALEMBIC$Marsh J, Logan AT, Bilgili EP, Bowman LJ, Webb AR. Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion. American Journal of Health-System Pharmacy. 2024;81(13):e345-e352$$$$$Y$$$20240820$$PH$US$US
242261851$24226185$1$I$20240101$20240812$20240820$20240820$EXP$$IL-AMGEN-ISRSL2024071019$AMGEN$$42$YR$A$F$Y$$$20240820$$CN$IL$IL
242261861$24226186$1$I$20240809$20240813$20240820$20240820$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024100821$VIIV$$33$YR$$M$Y$$$20240820$$CN$US$US
242261871$24226187$1$I$$20240806$20240820$20240820$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001110$ALEMBIC$Deka A, Joseph E, harma N, Berhanu T, Kaplan J.. Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature. Journal of Psychiatric Practice. 2024;30 (3):234-241$$$$$Y$$$20240820$$MD$US$US
242261882$24226188$2$F$$20240906$20240820$20240909$EXP$$FR-JNJFOC-20240823424$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240909$$MD$FR$FR
242261901$24226190$1$I$$20240808$20240820$20240820$EXP$$US-ROCHE-10000052492$ROCHE$$71$YR$E$F$Y$$$20240820$$CN$US$US
242261911$24226191$1$I$$20240813$20240820$20240820$EXP$$JP-ROCHE-10000058853$ROCHE$$6$DEC$A$M$Y$$$20240820$$MD$JP$JP
242261921$24226192$1$I$$20240819$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA073716$SANDOZ$$$$$M$Y$$$20240820$$MD$CA$CA
242261931$24226193$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5874796$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242261941$24226194$1$I$$20230124$20240820$20240820$EXP$$NL-BIOVITRUM-2023NL01522$BIOVITRUM$$$$I$M$Y$7.6$KG$20240820$$HP$NL$NL
242261951$24226195$1$I$20240101$20240807$20240820$20240820$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000695$DECIPHERA PHARMACEUTICALS$$74$YR$E$F$Y$64.9$KG$20240820$$CN$US$US
242261961$24226196$1$I$20240720$20240809$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040992$AUROBINDO$$54$YR$$F$Y$$$20240820$$MD$FR$FR
242261981$24226198$1$I$20220101$20221031$20240820$20240820$EXP$$BR-BIOVITRUM-2022BR12952$BIOVITRUM$$$$$F$Y$$$20240820$$CN$BR$BR
242261992$24226199$2$F$$20240926$20240820$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-125619$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240927$$CN$US$US
242262001$24226200$1$I$20240813$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130911$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240820$$HP$US$US
242262011$24226201$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163379$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262021$24226202$1$I$$20240812$20240820$20240820$EXP$$CN-AMGEN-CHNSP2024163348$AMGEN$Sun H.; Zhu Y.; Li J. et al.. Picalm:MLLT10 can Identify a New Subgroup of Acute Leukemias of Ambiguous Lineage with Unique Extramedullary Disease and Treatment Response. Blood. 2023;142:6078-6078$50$YR$A$M$Y$$$20240820$$HP$CN$CN
242262031$24226203$1$I$$20240806$20240820$20240820$EXP$$JP-BELUSA-2024BELLIT0095$BIOLOGICAL E.$Kato A, Kitano M, Shimabukuro A, Sato S.Successful Percutaneous Revascularization for Femoral Artery Occlusion After Catheter Intervention: Serial Case Report.SN Comprehensive Clinical Medicine.2024;6 (1):63 (1-4)$$$$$Y$$$20240820$$HP$JP$JP
242262042$24226204$2$F$20240810$20240813$20240820$20240826$PER$$US-JNJFOC-20240834436$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240826$$CN$US$US
242262051$24226205$1$I$$20240819$20240820$20240820$PER$$US-HALEON-2192545$Haleon PLC$$$$$$Y$$$20240820$$CN$US$US
242262062$24226206$2$F$$20240815$20240820$20240822$PER$$NVSC2024US166295$NOVARTIS$$$$$$Y$$$20240822$$CN$US$US
242262071$24226207$1$I$$20240815$20240820$20240820$EXP$$BG-ABBVIE-5884119$ABBVIE$$$$A$M$Y$$$20240820$$CN$BG$BG
242262082$24226208$2$F$$20240815$20240820$20240825$PER$$US-AMGEN-USASP2024162851$AMGEN$$76$YR$E$F$Y$$$20240825$$HP$US$US
242262091$24226209$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162577$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262101$24226210$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162575$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262111$24226211$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164257$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242262121$24226212$1$I$20240421$20240805$20240820$20240820$EXP$FR-AFSSAPS-NT2024000984$FR-GLENMARK PHARMACEUTICALS-2024GMK093233$GLENMARK$$$$$$Y$$$20240820$$MD$FR$FR
242262131$24226213$1$I$$20240205$20240820$20240820$PER$$NVSC2024US030075$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242262141$24226214$1$I$$20240809$20240820$20240820$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000709$DECIPHERA PHARMACEUTICALS$$49$YR$A$F$Y$$$20240820$$CN$US$US
242262151$24226215$1$I$20240101$20240816$20240820$20240820$EXP$$TN-ABBVIE-5884043$ABBVIE$$3$YR$$F$Y$$$20240820$$CN$TN$TN
242262161$24226216$1$I$$20240809$20240820$20240820$EXP$$AT-STRIDES ARCOLAB LIMITED-2024SP010331$STRIDES$Gelbenegger G, Buchtele N, Schoergenhofer C, Grafeneder J, Schwameis M, Schellongowski P, et al.. Disseminated Intravascular Coagulation in Anaphylaxis. [Review].. Semin-Thromb-Hemost. 2024;50 (4):569-579$78$YR$$F$Y$$$20240820$$MD$AT$AT
242262171$24226217$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024162441$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240820$$HP$US$US
242262181$24226218$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162603$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262191$24226219$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162654$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262202$24226220$2$F$$20240811$20240820$20240903$EXP$$ES-AMGEN-ESPSP2024162714$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240903$$HP$ES$ES
242262211$24226221$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162697$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262221$24226222$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024162432$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240820$$HP$US$US
242262231$24226223$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163429$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262241$24226224$1$I$$20240809$20240820$20240820$PER$$US-BAUSCHBL-2024BNL031646$BAUSCH AND LOMB$$$$$F$Y$$$20240820$$MD$US$US
242262251$24226225$1$I$$20240812$20240820$20240820$EXP$$PL-AMGEN-POLSP2024161676$AMGEN$Adamczuk-nurzynska A.. Electrolyte disturbances in an elderly patient with colon cancer. Unknown. 2024;1-3$73$YR$E$M$Y$$$20240820$$MD$PL$PL
242262271$24226227$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024162451$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240820$$HP$US$US
242262281$24226228$1$I$$20230524$20240820$20240820$EXP$$BR-BIOVITRUM-2023-BR-011484$BIOVITRUM$$$$$F$Y$$$20240820$$CN$BR$BR
242262291$24226229$1$I$20220722$20221018$20240820$20240820$EXP$$CO-BIOVITRUM-2022CO12366$BIOVITRUM$$6$WK$$M$Y$6.8$KG$20240820$$CN$CO$CO
242262301$24226230$1$I$$20231115$20240820$20240820$EXP$$US-AstraZeneca-2023A261864$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242262311$24226231$1$I$$20230616$20240820$20240820$EXP$$US-AstraZeneca-2023A103916$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242262331$24226233$1$I$20240506$20240812$20240820$20240820$EXP$$CN-AstraZeneca-2024A185845$ASTRAZENECA$$52$YR$$M$Y$$$20240820$$MD$CN$
242262341$24226234$1$I$20201101$20240814$20240820$20240820$EXP$GB-MHRA-MED-202408121641507570-NDJLF$GB-STRIDES ARCOLAB LIMITED-2024SP010337$STRIDES$$22$YR$$F$Y$67$KG$20240820$$CN$GB$GB
242262351$24226235$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A187441$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242262371$24226237$1$I$$20230816$20240820$20240820$EXP$$US-AstraZeneca-2023A187764$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242262381$24226238$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A186634$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
242262391$24226239$1$I$$20230616$20240820$20240820$EXP$$US-AstraZeneca-2023A099545$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242262401$24226240$1$I$$20240809$20240820$20240820$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP010342$STRIDES$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N.. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series.. J-Clin-Med. 2023;12 (1)$$$$M$Y$$$20240820$$HP$IT$IT
242262411$24226241$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010634$ELI LILLY AND CO$$$$A$M$Y$$$20240820$$CN$US$US
242262421$24226242$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011071$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240820$$CN$US$US
242262432$24226243$2$F$20240814$20240820$20240820$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009536$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240829$$CN$US$US
242262441$24226244$1$I$$20240812$20240820$20240820$EXP$$CA-APOTEX-2024AP009325$APOTEX$$6$YR$$M$Y$$$20240820$$HP$CA$CA
242262451$24226245$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162735$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262461$24226246$1$I$20240101$20240809$20240820$20240820$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000702$DECIPHERA PHARMACEUTICALS$$64$YR$A$M$Y$$$20240820$$CN$US$US
242262471$24226247$1$I$20240811$20240812$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US072575$SANDOZ$$48$YR$$F$Y$$$20240820$$CN$US$US
242262481$24226248$1$I$$20240816$20240820$20240820$EXP$$GB-SANDOZ INC.-SDZ2024GB073574$SANDOZ$$$$$F$Y$$$20240820$$HP$GB$GB
242262491$24226249$1$I$20240801$20240818$20240820$20240820$EXP$$CN-ABBVIE-5884511$ABBVIE$$59$YR$$F$Y$65$KG$20240820$$MD$CN$CN
242262501$24226250$1$I$$20240813$20240820$20240820$PER$$US-ABBVIE-5879461$ABBVIE$$$$$$Y$$$20240820$$HP$US$US
242262512$24226251$2$F$$20240812$20240820$20240906$PER$$US-BEH-2024177089$CSL BEHRING$$51$YR$A$M$Y$$$20240906$$PH$US$US
242262521$24226252$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163417$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262531$24226253$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024162458$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240820$$HP$US$US
242262541$24226254$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162703$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262551$24226255$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163312$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262561$24226256$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162669$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262571$24226257$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024162486$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240820$$HP$US$US
242262581$24226258$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163309$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262591$24226259$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162742$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS- A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262601$24226260$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024162479$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240820$$HP$US$US
242262611$24226261$1$I$$20240812$20240820$20240820$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010393$STRIDES$Braun HM, Taylor JL, Axelrath S.. Buprenorphine/naloxone - one formulation that doesn^t fit all: a case report.. Harm-Reduct-J. 2024;21 (1)$4$DEC$$F$Y$$$20240820$$HP$US$US
242262621$24226262$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162749$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262642$24226264$2$F$$20240821$20240820$20240823$PER$$NVSC2024US166313$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
242262651$24226265$1$I$$20240812$20240820$20240820$30DAY$$US-GSK-US2024100338$GLAXOSMITHKLINE$$$$$F$Y$$$20240820$$CN$US$US
242262661$24226266$1$I$20240101$20240809$20240820$20240820$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000710$DECIPHERA PHARMACEUTICALS$$69$YR$E$M$Y$$$20240820$$CN$US$US
242262671$24226267$1$I$$20240806$20240820$20240820$EXP$$JP-BELUSA-2024BELLIT0096$BIOLOGICAL E.$Kato A, Kitano M, Shimabukuro A, Sato S.Successful Percutaneous Revascularization for Femoral Artery Occlusion After Catheter Intervention: Serial Case Report.SN Comprehensive Clinical Medicine.04-JUN-2024;6(1):1-4$$$$$Y$$$20240820$$HP$JP$JP
242262681$24226268$1$I$$20240731$20240820$20240820$PER$$US-TEVA-VS-3229990$TEVA$$$$$M$Y$$$20240820$$CN$US$US
242262701$24226270$1$I$20240804$20240813$20240820$20240820$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025515$UNITED THERAPEUTICS$$66$YR$$F$Y$63.492$KG$20240820$$$US$US
242262711$24226271$1$I$20240101$20240814$20240820$20240820$PER$$US-ALXN-202408USA000953US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242262721$24226272$1$I$20240817$20240819$20240820$20240820$PER$$US-AMGEN-USASP2024165430$AMGEN$$39$YR$A$F$Y$$$20240820$$CN$US$US
242262731$24226273$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163423$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262742$24226274$2$F$$20240819$20240820$20240824$PER$$US-AMGEN-USASP2024165131$AMGEN$$$$$F$Y$$$20240824$$CN$US$US
242262751$24226275$1$I$20240731$20240812$20240820$20240820$PER$$US-BAUSCHBL-2024BNL031515$BAUSCH AND LOMB$$88$YR$$M$Y$$$20240820$$CN$US$US
242262761$24226276$1$I$20240101$20240812$20240820$20240820$EXP$$US-BAUSCHBL-2024BNL031642$BAUSCH AND LOMB$$$$$F$Y$$$20240820$$CN$US$US
242262771$24226277$1$I$20240101$20240812$20240820$20240820$PER$$US-BAUSCHBL-2024BNL031637$BAUSCH AND LOMB$$$$$F$Y$$$20240820$$CN$US$US
242262781$24226278$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163419$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242262791$24226279$1$I$20240801$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163396$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242262801$24226280$1$I$20240709$20240813$20240820$20240820$PER$$US-Vifor (International) Inc.-VIT-2024-07301$VIFOR$$41$YR$$F$Y$54.5$KG$20240820$$HP$US$US
242262811$24226281$1$I$20240809$20240814$20240820$20240820$EXP$$CN-AMGEN-CHNSP2024161748$AMGEN$$69$YR$E$F$Y$$$20240820$$HP$CN$CN
242262821$24226282$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024162513$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240820$$HP$US$US
242262831$24226283$1$I$$20240811$20240820$20240820$EXP$$FR-AMGEN-FRASP2024161587$AMGEN$Amigues C.; Trojani M. C.; Roux C. et al.. FRACTURE RISK FOLLOWING DENOSUMAB DISCONTINUATION IN THE ONCOLOGIC POPULATION: INCIDENCE AND RISK FACTORS. Annals of the Rheumatic Diseases. 2024;83:1397$$$$$Y$$$20240820$$HP$FR$FR
242262841$24226284$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024162504$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240820$$HP$US$US
242262851$24226285$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024162456$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240820$$HP$US$US
242262861$24226286$1$I$20221221$20240813$20240820$20240820$EXP$$PL-AMGEN-POLSP2024161797$AMGEN$$67$YR$E$F$Y$$$20240820$$MD$PL$PL
242262871$24226287$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129852$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240820$$HP$US$US
242262881$24226288$1$I$20240101$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130867$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240820$$HP$US$US
242262891$24226289$1$I$20240101$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130555$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240820$$CN$US$US
242262902$24226290$2$F$$20240821$20240820$20240830$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-129452$BRISTOL MYERS SQUIBB$Santos JM, Duro JG, Quinteiro I, Gonzaga B, Jancar N, Goncalves F. POSA-170-(4698)- Abdominal hematoma of etiology to be clarified. Congressos da Sociedade Portuguesa de Medicina Interna: 30.o Congresso Nacional. 2024;30:1247.$70$YR$E$M$Y$$$20240830$$MD$PT$PT
242262951$24226295$1$I$20240502$20240806$20240820$20240820$EXP$$RU-MELINTA THERAPEUTICS, LLC-RU-MLNT-24-00392$MELINTA THERAPEUTICS$$$$$$Y$$$20240820$$MD$RU$RU
242262961$24226296$1$I$$20240812$20240820$20240820$EXP$$IT-ROCHE-10000055632$ROCHE$Novi G, Sbragia E, Benedetti L, Schenone A, Uccelli A, Magliozzi R. Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder. Multiple Sclerosis Journal. 2024;1-4. doi:10.1177/13524585241261549.$40$YR$A$F$Y$$$20240820$$HP$IT$IT
242262971$24226297$1$I$20230101$20240809$20240820$20240820$EXP$$US-SA-2024SA242653$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240820$$MD$US$US
242262982$24226298$2$F$20240809$20240820$20240820$20240827$EXP$$US-CHIESI-2024CHF05156$CHIESI$$36$YR$$M$Y$65$KG$20240827$$CN$US$US
242262991$24226299$1$I$$20240814$20240820$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012684$JAZZ$$$$$M$Y$$$20240820$$CN$US$US
242263003$24226300$3$F$20240906$20240924$20240820$20240926$PER$$US-ROCHE-10000060049$ROCHE$$32$YR$A$M$Y$$$20240926$$CN$US$US
242263012$24226301$2$F$$20240819$20240820$20240826$EXP$$US-ABBVIE-5878882$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242263022$24226302$2$F$$20240827$20240820$20240906$EXP$$DE-TEVA-VS-3234241$TEVA$Bienenstein E, Jakob A, Dalla PR, Fischer M, Haas N. Acute Yew-Intoxication (Taxus baccata): Lessons to Be Learned for Pediatric Cardiologists. Thorac-Cardiovasc-Surg 2024; 72 (Suppl.).; Bienenstein E, Jakob A, Dalla PR, Fischer M, Haas N. Acute Yew-Intoxication (Taxus baccata): Lessons to Be Learned for Pediatric Cardiologists. Thorac-Cardiovasc-Surg 2024; 72 (Suppl.).$16$YR$$M$Y$$$20240906$$HP$DE$DE
242263031$24226303$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024162470$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240820$$HP$US$US
242263041$24226304$1$I$$20240715$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-112301$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240820$$HP$US$US
242263061$24226306$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5885222$ABBVIE$$22$YR$$M$Y$$$20240820$$CN$US$US
242263071$24226307$1$I$20230905$20240814$20240820$20240820$EXP$$CO-TAKEDA-2023TUS087622$TAKEDA$$31$YR$$F$Y$68$KG$20240820$$CN$CO$CO
242263083$24226308$3$F$20231116$20240909$20240820$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004003$ACADIA PHARMACEUTICALS$$11$YR$$F$Y$69.7$KG$20240927$$CN$US$US
242263091$24226309$1$I$20220101$20240813$20240820$20240820$EXP$$CN-SA-2024SA242614$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240820$$HP$CN$CN
242263102$24226310$2$F$20240801$20240819$20240820$20240823$EXP$$CA-ABBVIE-5884158$ABBVIE$$65$YR$$F$Y$$$20240823$$CN$CA$CA
242263131$24226313$1$I$20240726$20240809$20240820$20240820$PER$$US-JNJFOC-20240827732$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20240820$$CN$US$US
242263142$24226314$2$F$20181005$20240812$20240820$20240822$EXP$$US-SA-2024SA241025$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240822$$CN$US$US
242263151$24226315$1$I$$20230523$20240820$20240820$EXP$$US-AstraZeneca-2023A120214$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242263161$24226316$1$I$$20240808$20240820$20240820$PER$$US-AstraZeneca-2024A181032$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242263171$24226317$1$I$20240627$20240812$20240820$20240820$EXP$$FR-AstraZeneca-2024A182553$ASTRAZENECA$$63$YR$$F$Y$$$20240820$$MD$FR$
242263191$24226319$1$I$$20230421$20240820$20240820$EXP$$TW-AstraZeneca-2023A094333$ASTRAZENECA$$73$YR$$M$Y$$$20240820$$CN$TW$
242263201$24226320$1$I$$20240812$20240820$20240820$EXP$$CN-AstraZeneca-2024A185675$ASTRAZENECA$$$$$F$Y$$$20240820$$MD$CN$
242263211$24226321$1$I$20220911$20221011$20240820$20240820$EXP$$NL-TERSERA THERAPEUTICS LLC-2022TRS004425$TERSERA THERAPEUTICS$$$$$$Y$$$20240820$$CN$NL$NL
242263221$24226322$1$I$$20240812$20240820$20240820$EXP$$CN-ROCHE-10000054441$ROCHE$$62$YR$A$F$Y$55.6$KG$20240820$$MD$CN$CN
242263231$24226323$1$I$20240815$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164605$AMGEN$$59$YR$A$M$Y$$$20240820$$CN$US$US
242263241$24226324$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024162437$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240820$$HP$US$US
242263253$24226325$3$F$20240811$20240902$20240820$20240909$EXP$$MY-TAKEDA-2024TUS027481$TAKEDA$$72$YR$$M$Y$$$20240909$$CN$MY$MY
242263261$24226326$1$I$$20240809$20240820$20240820$EXP$GB-MHRA-MED-202408081309454270-FZNKD$GB-MSNLABS-2024MSNSPO01789$MSN LABORATORIES$$$$$$Y$$$20240820$$PH$GB$GB
242263271$24226327$1$I$$20240818$20240820$20240820$PER$$NVSC2024US167627$NOVARTIS$$$$$M$Y$$$20240820$$CN$US$US
242263281$24226328$1$I$$20240815$20240820$20240820$EXP$CZ-AVMCP-AVMEDICAL20240723b_Lit$CZ-ROCHE-10000057899$ROCHE$Kufa J, Novotna J, Lukasova M. Raritni granulomatozni procesy. Transfuze a hematologie dnes. 2024;30 (2):122-30.$48$YR$A$M$Y$$$20240820$$MD$CZ$CZ
242263301$24226330$1$I$$20240807$20240820$20240820$PER$$US-JNJFOC-20240838412$JOHNSON AND JOHNSON$$$$A$M$Y$79$KG$20240820$$MD$US$US
242263313$24226331$3$F$20240101$20240906$20240820$20240920$EXP$$US-UCBSA-2024041851$UCB$$$$$F$Y$103.4$KG$20240920$$CN$US$US
242263321$24226332$1$I$$20240819$20240820$20240820$EXP$$DE-SANDOZ INC.-NVSC2020DE305434$SANDOZ$$$$$$Y$$$20240820$$MD$DE$DE
242263331$24226333$1$I$$20240814$20240820$20240820$EXP$$AU-JAZZ PHARMACEUTICALS-2024-AU-012649$JAZZ$$$$$M$Y$$$20240820$$HP$AU$AU
242263341$24226334$1$I$$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011752$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240820$$CN$US$US
242263351$24226335$1$I$$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011638$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240820$$CN$US$US
242263361$24226336$1$I$$20240813$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408008817$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240820$$CN$US$US
242263371$24226337$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009138$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240820$$CN$US$US
242263381$24226338$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011104$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240820$$CN$US$US
242263391$24226339$1$I$20240801$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010328$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240820$$CN$US$US
242263401$24226340$1$I$20240814$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010095$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240820$$CN$US$US
242263411$24226341$1$I$20240808$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009826$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240820$$CN$US$US
242263431$24226343$1$I$$20240814$20240820$20240820$EXP$$NVSC2024US165862$NOVARTIS$$$$$M$Y$$$20240820$$CN$US$US
242263441$24226344$1$I$$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130799$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240820$$CN$US$US
242263451$24226345$1$I$$20240806$20240820$20240820$EXP$$JP-UCBSA-2024039844$UCB$Kozaneyori A, et al.,. A case of pneumocystis pneumonia with low beta-D-glucan at onset. The 252nd Hokuriku regional meeting of The Japanese Society of Internal Medicine. 2024;36$73$YR$$F$Y$$$20240820$$MD$JP$JP
242263461$24226346$1$I$$20240814$20240820$20240820$EXP$$US-BEH-2024177214$CSL BEHRING$$$$E$F$Y$$$20240820$$CN$US$US
242263471$24226347$1$I$$20240814$20240820$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012676$JAZZ$$$$$M$Y$$$20240820$$CN$US$US
242263481$24226348$1$I$20230812$20240812$20240820$20240820$EXP$$GB-MSNLABS-2024MSNSPO01803$MSN LABORATORIES$$$$$$Y$$$20240820$$CN$GB$GB
242263501$24226350$1$I$20240801$20240810$20240820$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-022501$UNITED THERAPEUTICS$$41$YR$$M$Y$58.503$KG$20240820$$$US$US
242263511$24226351$1$I$$20231221$20240820$20240820$EXP$$PT-NORMON-2023002678$NORMON$Matos CRC, Beirao EMDCSP, Neves RS, Assuncao AJ, Marques RM. When the fever will not stop, stop the pills! A case report. Sao Paulo Med J. 2024;142(3):e2022401. DOI: 10.1590/1516-3180.2022.0401.R1.13032023.$39$YR$$F$Y$$$20240820$$MD$PT$
242263521$24226352$1$I$20240807$20240807$20240820$20240820$EXP$$US-UCBSA-2024040538$UCB$$14$YR$$M$Y$29.5$KG$20240820$$MD$US$US
242263531$24226353$1$I$$20240819$20240820$20240820$PER$$NVSC2024US167730$NOVARTIS$$$$$M$Y$$$20240820$$CN$US$US
242263541$24226354$1$I$$20240819$20240820$20240820$EXP$$NVSC2024US167709$NOVARTIS$$$$$$Y$$$20240820$$CN$US$US
242263553$24226355$3$F$20231004$20240911$20240820$20240917$30DAY$$US-AMGEN-USASP2024162244$AMGEN$$65$YR$E$F$Y$49$KG$20240917$$PH$US$US
242263561$24226356$1$I$20240813$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024161989$AMGEN$$68$YR$E$F$Y$$$20240820$$HP$US$US
242263571$24226357$1$I$20240813$20240813$20240820$20240820$EXP$$AR-AMGEN-ARGSP2024162927$AMGEN$$33$YR$A$F$Y$$$20240820$$CN$AR$AR
242263591$24226359$1$I$20240809$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163105$AMGEN$$$$$$Y$$$20240820$$HP$US$US
242263601$24226360$1$I$$20240731$20240820$20240820$PER$$US-TEVA-VS-3230725$TEVA$$36$YR$$F$Y$$$20240820$$CN$US$US
242263612$24226361$2$F$$20240820$20240820$20240823$PER$$US-ALXN-202408USA000868US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242263621$24226362$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130906$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240820$$PH$US$US
242263631$24226363$1$I$20240602$20240814$20240820$20240820$EXP$FR-AFSSAPS-AM2024000659$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-128931$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$75.5$KG$20240820$$MD$FR$FR
242263641$24226364$1$I$$20240805$20240820$20240820$EXP$$QA-PURACAP-QA-2024EPCLIT01018$PURACAP$Abdulqadir J. Nashwan.Ibuprofen-Induced Toxic Epidermal Necrolysis:  A Case Report.International Journal of Dermatology and Venereology.JUN-2024;7:108-110$41$YR$A$M$Y$$$20240820$$HP$QA$QA
242263651$24226365$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130245$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240820$$HP$US$US
242263661$24226366$1$I$20240814$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130416$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240820$$CN$US$US
242263671$24226367$1$I$$20240812$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127758$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$117.48$KG$20240820$$HP$US$US
242263681$24226368$1$I$$20240819$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046697$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240820$$CN$US$US
242263691$24226369$1$I$$20240816$20240820$20240820$EXP$$US-GILEAD-2024-0684500$GILEAD$$$$C$M$Y$$$20240820$$CN$US$US
242263701$24226370$1$I$$20240815$20240820$20240820$EXP$$CA-TAKEDA-2024TUS082453$TAKEDA$$57$YR$$F$Y$$$20240820$$HP$CA$CA
242263711$24226371$1$I$20240809$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A186735$ASTRAZENECA$$33063$DY$$M$Y$$$20240820$$HP$US$
242263721$24226372$1$I$20221016$20240813$20240820$20240820$EXP$$FR-AstraZeneca-2024A184223$ASTRAZENECA$$73$YR$$M$Y$70$KG$20240820$$MD$FR$
242263731$24226373$1$I$$20240816$20240820$20240820$EXP$$US-AstraZeneca-2024A187783$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242263741$24226374$1$I$$20220216$20240820$20240820$EXP$$US-AstraZeneca-2022A031021$ASTRAZENECA$$$$$F$Y$$$20240820$$HP$US$
242263751$24226375$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A186657$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242263761$24226376$1$I$$20240816$20240820$20240820$EXP$$JP-HALEON-2192244$Haleon PLC$$53$YR$$M$Y$$$20240820$$PH$JP$JP
242263771$24226377$1$I$$20240724$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07533$LUPIN$$$$$$Y$$$20240820$$MD$US$US
242263781$24226378$1$I$$20240811$20240820$20240820$EXP$$US-AMAROX PHARMA-HET2024US02707$HETERO$Walterscheid B, Batchinsky M, Tarbox M. Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Preceding Toxic Epidermal Necrolysis Secondary to Sildenafil: A Case Report. Cureus. 2024;16(7):e63922$66$YR$$F$Y$$$20240820$$HP$US$US
242263791$24226379$1$I$$20240808$20240820$20240820$EXP$$CA-ROCHE-10000052521$ROCHE$$$$$F$Y$$$20240820$$HP$CA$CA
242263801$24226380$1$I$20240229$20240812$20240820$20240820$EXP$FR-AFSSAPS-TO2024001483$FR-TEVA-VS-3233253$TEVA$$81$YR$$M$Y$58.7$KG$20240820$$PH$FR$FR
242263811$24226381$1$I$$20240805$20240820$20240820$EXP$$DE-EPICPHARMA-DE-2024EPCLIT01012$EPIC PHARM$N Walle.The last resort-Suicide by taking pentobarbital.Rechtsmedizin.AUG-2023;33 (No.4):301-306$53$YR$A$F$Y$$$20240820$$HP$DE$DE
242263821$24226382$1$I$$20240815$20240820$20240820$EXP$$US-JNJFOC-20240840322$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$HP$US$US
242263831$24226383$1$I$20240101$20240813$20240820$20240820$EXP$$US-JNJFOC-20240833244$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240820$$PH$US$US
242263841$24226384$1$I$20240814$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130395$BRISTOL MYERS SQUIBB$$33$YR$A$M$Y$$$20240820$$MD$US$US
242263852$24226385$2$F$20240504$20240913$20240820$20240923$EXP$$JP-HALEON-2192228$Haleon PLC$$50$YR$$M$Y$78.8$KG$20240921$$PH$JP$JP
242263861$24226386$1$I$$20240806$20240820$20240820$PER$$US-JNJFOC-20240817130$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
242263872$24226387$2$F$$20240827$20240820$20240905$EXP$$US-TEVA-VS-3234234$TEVA$Joffe D, Rohan TZ, Mandel J, Suriano J, Banner L, Valiga A, et al. The development of 2 clonally and histologically distinct subtypes of extranodal B-cell lymphomas in the brain and skin in 1 individual. JAAD-Case-Rep 2024; 49 51-54.; Joffe D, Rohan TZ, Mandel J, Suriano J, Banner L, Valiga A, et al. The development of 2 clonally and histologically distinct subtypes of extranodal B-cell lymphomas in the brain and skin in 1 individual. JAAD-Case-Rep 2024; 49 51-54.; Joffe D, Rohan TZ, Mandel J...$61$YR$$M$Y$$$20240905$$HP$US$US
242263881$24226388$1$I$$20240809$20240820$20240820$EXP$IT-JNJFOC-20240755184$IT-ROCHE-10000054813$ROCHE$Randone P, Sanna E, Gallo C, Gallo E, Mingozzi S, Tarragoni R, Niarchos A, Mella A, Manzione A, Barreca A, Deambrosis I, Giraudi R, Biancone L, Torazza M. Rescue with Obinutuzumab and Daratumumab as Combined B-cell/Plasma Cell Targeting Approach in Severe Post-Transplant FSGS Recurrence. Am J Transplant. 2024;. doi:https://doi.org/10.1016/j.ajt.2024.06.010$$$A$M$Y$$$20240820$$HP$IT$IT
242263891$24226389$1$I$20240524$20240808$20240820$20240820$EXP$$US-AMX-008124$AMYLYX PHARMACEUTICALS$$81$YR$$M$Y$$$20240820$$HP$US$US
242263901$24226390$1$I$$20240819$20240820$20240820$PER$$US-HALEON-2192674$Haleon PLC$$$$$$Y$$$20240820$$CN$US$US
242263911$24226391$1$I$$20240807$20240820$20240820$EXP$$TZ-MYLANLABS-2024M1074953$MYLAN$Mwakyula IH, Makarius E, Maro H, Ngatunga C. Pneumoconiosis among artisanal miners in Chunya district, Mbeya, Tanzania. BMJ-Case-Rep 2024; 17 (6):.$4$DEC$$M$Y$$$20240820$$MD$TZ$TZ
242263922$24226392$2$F$20181101$20240827$20240820$20240827$EXP$$SK-SANDOZ INC.-PHHY2019SK119607$SANDOZ$$39$YR$$F$Y$$$20240827$$MD$SK$SK
242263931$24226393$1$I$20240101$20240814$20240820$20240820$EXP$DE-CADRBFARM-2024329864$DE-RDY-SPO/DEU/24/0011908$DR REDDYS$$55$YR$A$M$Y$78$KG$20240820$$CN$DE$DE
242263941$24226394$1$I$20240701$20240814$20240820$20240820$EXP$$US-AMGEN-USASP2024162136$AMGEN$$70$YR$E$M$Y$$$20240820$$CN$US$US
242263961$24226396$1$I$$20240805$20240820$20240820$EXP$$RO-EPICPHARMA-RO-2024EPCLIT00996$EPIC PHARM$Ovidiu I. Neacsu.Unusual etiology of pulmonary hypertension.Polskie Archiwum Medycyny Wewnetrznej .JAN-2022;132 (Suppl.):19-20$43$YR$A$M$Y$$$20240820$$HP$RO$RO
242263972$24226397$2$F$$20240913$20240820$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025472$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240920$$$US$US
242264011$24226401$1$I$20240101$20240813$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128324$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240820$$HP$US$US
242264021$24226402$1$I$20240801$20240813$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128838$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240820$$CN$US$US
242264031$24226403$1$I$$20231202$20240820$20240820$PER$$US-AUROBINDO-AUR-APL-2023-065595$AUROBINDO$$76$YR$$F$Y$$$20240820$$CN$US$US
242264041$24226404$1$I$$20240812$20240820$20240820$EXP$$DE-TEVA-VS-3234242$TEVA$Bienenstein E, Jakob A, Dalla PR, Fischer M, Haas N. Acute Yew-Intoxication (Taxus baccata): Lessons to Be Learned for Pediatric Cardiologists. Thorac-Cardiovasc-Surg 2024; 72 (Suppl.).$16$YR$$M$Y$$$20240820$$HP$DE$DE
242264053$24226405$3$F$20240624$20240912$20240820$20240913$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046655$BOEHRINGER INGELHEIM$$7$DEC$E$M$Y$86$KG$20240913$$MD$JP$JP
242264061$24226406$1$I$$20240814$20240820$20240820$PER$$US-ABBVIE-5885146$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242264071$24226407$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011015$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240820$$CN$US$US
242264081$24226408$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009894$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240820$$CN$US$US
242264091$24226409$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010617$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240820$$CN$US$US
242264101$24226410$1$I$$20240813$20240820$20240820$EXP$CA-GLAXOSMITHKLINE-CA2019AMR149267$CA-WT-2019-AMR-149267$Waylis$$72$YR$$M$Y$$$20240820$$MD$CA$CA
242264111$24226411$1$I$20231201$20240806$20240820$20240820$EXP$$BR-UCBSA-2024039807$UCB$$61$YR$$F$Y$98$KG$20240820$$CN$BR$BR
242264121$24226412$1$I$20231101$20240816$20240820$20240820$EXP$KR-WT-2024-APC-099796$KR-WT-2024-APC-099796$Waylis$$7$DEC$$F$Y$$$20240820$$CN$KR$KR
242264131$24226413$1$I$$20240812$20240820$20240820$EXP$$KR-JNJFOC-20240831527$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$HP$KR$KR
242264141$24226414$1$I$$20240809$20240820$20240820$EXP$$US-JNJFOC-20240828390$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242264152$24226415$2$F$20240101$20240912$20240820$20240919$EXP$$JP-JNJFOC-20240516541$JOHNSON AND JOHNSON$$83$YR$E$M$Y$50$KG$20240919$$HP$JP$JP
242264162$24226416$2$F$$20240828$20240820$20240905$EXP$$GB-AMGEN-GBRSP2024162900$AMGEN$$91$YR$E$F$Y$182$KG$20240905$$CN$GB$GB
242264171$24226417$1$I$20240208$20240812$20240820$20240820$EXP$FR-AFSSAPS-TO2024001330$FR-TEVA-VS-3233249$TEVA$$87$YR$$F$Y$56.4$KG$20240820$$PH$FR$FR
242264181$24226418$1$I$20210327$20230601$20240820$20240820$EXP$PT-INFARMED-J202305-631$PT-NORMON-2023001549$NORMON$$69$YR$A$F$Y$$$20240820$$MD$PT$
242264191$24226419$1$I$$20240815$20240820$20240820$PER$$US-HALEON-2192429$Haleon PLC$$$$$M$Y$$$20240820$$CN$US$US
242264201$24226420$1$I$$20240113$20240820$20240820$PER$$US-AUROBINDO-AUR-APL-2023-076955$AUROBINDO$$59$YR$$F$Y$$$20240820$$CN$US$US
242264211$24226421$1$I$20240528$20240807$20240820$20240820$EXP$ES-AEMPS-1556067$ES-MYLANLABS-2024M1073811$MYLAN$$49$YR$$M$Y$72$KG$20240820$$HP$ES$ES
242264232$24226423$2$F$$20240816$20240820$20240823$EXP$$ES-ADVANZ PHARMA-202408006787$ADVANZ PHARMA$$$$$$Y$$$20240823$$CN$ES$ES
242264242$24226424$2$F$20240101$20240910$20240820$20240913$EXP$$CA-Orion Corporation ORION PHARMA-24_00031305$ORION$$9$YR$C$F$Y$$$20240913$$HP$CA$
242264251$24226425$1$I$$20240805$20240820$20240820$EXP$$FR-EPICPHARMA-FR-2024EPCLIT01002$EPIC PHARM$F Lescarbotte.Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases..Annales de Chirurgie Plastique et Esthetique.JAN-2024;69:27-33$60$YR$A$F$Y$$$20240820$$HP$FR$FR
242264261$24226426$1$I$20231201$20240809$20240820$20240820$PER$$US-ABBVIE-5876108$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242264271$24226427$1$I$$20240807$20240820$20240820$PER$$US-APOTEX-2024AP009163$APOTEX$$$$$F$Y$$$20240820$$CN$US$US
242264282$24226428$2$F$$20240826$20240820$20240904$EXP$$FR-TEVA-VS-3233410$TEVA$Siblini L, Schott R, Trensz P, Pencreach E, Bender L. Primary resistance to ALK inhibitors in KLC1/ALK-rearranged pleural metastatic lung adenocarcinoma: a case report. Transl-Lung-Cancer-Res 2023; 12 2342-2346.; Siblini L, Schott R, Trensz P, Pencreach E, Bender L. Primary resistance to ALK inhibitors in KLC1/ALK-rearranged pleural metastatic lung adenocarcinoma: a case report. Transl-Lung-Cancer-Res 2023; 12 2342-2346.$34$YR$$M$Y$$$20240904$$HP$FR$FR
242264291$24226429$1$I$20230822$20240122$20240820$20240820$EXP$$US-AstraZeneca-2023A196465$ASTRAZENECA$$26214$DY$$F$Y$$$20240820$$CN$US$
242264301$24226430$1$I$$20220802$20240820$20240820$EXP$$US-AstraZeneca-2022A228133$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242264311$24226431$1$I$$20240816$20240820$20240820$PER$$US-AstraZeneca-2024A187920$ASTRAZENECA$$$$$F$Y$$$20240820$$MD$US$
242264321$24226432$1$I$$20240813$20240820$20240820$EXP$$US-AstraZeneca-2024A185404$ASTRAZENECA$$$$$F$Y$53$KG$20240820$$CN$US$
242264331$24226433$1$I$$20231011$20240820$20240820$EXP$$CA-AstraZeneca-2023A234955$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$CA$
242264342$24226434$2$F$20240804$20240909$20240820$20240912$EXP$$US-JNJFOC-20240811686$JOHNSON AND JOHNSON$$68$YR$E$M$Y$89.5$KG$20240912$$HP$US$US
242264351$24226435$1$I$$20221109$20240820$20240820$EXP$$US-AstraZeneca-2022A371675$ASTRAZENECA$$$$$F$Y$103.9$KG$20240820$$CN$US$
242264361$24226436$1$I$$20230501$20240820$20240820$EXP$$US-AstraZeneca-2023A102109$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242264371$24226437$1$I$$20220919$20240820$20240820$EXP$$US-AstraZeneca-2022A323195$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242264381$24226438$1$I$$20220512$20240820$20240820$EXP$$US-AstraZeneca-2022A185049$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242264391$24226439$1$I$$20221020$20240820$20240820$EXP$$US-AstraZeneca-2022A352456$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242264401$24226440$1$I$20240703$20240813$20240820$20240820$EXP$ES-AEMPS-1558099$ES-ROCHE-10000056155$ROCHE$$72$YR$E$F$Y$$$20240820$$HP$ES$ES
242264411$24226441$1$I$$20240814$20240820$20240820$EXP$$US-ARGENX-2024-ARGX-US006667$ARGENX BVBA$$$$$$Y$$$20240820$$CN$US$US
242264421$24226442$1$I$$20240710$20240820$20240820$PER$$US-CHATTEMPRD-2024OHG024143$CHATTEM$Didomenico L, Garrity LC, Poisson KE, Broomall E. Enteral Ketamine for Status Epilepticus in Children with Epilepsy. Pediatric Neurology. 2024;158: 41-48. doi:10.1016/j.pediatrneurol.2024.05.006.$20$YR$A$M$Y$$$20240820$$HP$US$US
242264431$24226443$1$I$20240701$20240812$20240820$20240820$PER$$US-ABBVIE-5884675$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242264441$24226444$1$I$$20240814$20240820$20240820$EXP$$US-IMMUNOGEN, INC.-US-IMGN-24-00639$IMMUNOGEN$$$$$F$Y$$$20240820$$HP$US$US
242264451$24226445$1$I$20240101$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163316$AMGEN$$78$YR$E$F$Y$$$20240820$$CN$US$US
242264461$24226446$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131183$BRISTOL MYERS SQUIBB$$45$YR$A$$Y$$$20240820$$HP$US$US
242264471$24226447$1$I$$20240814$20240820$20240820$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-129853$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240820$$CN$FR$FR
242264481$24226448$1$I$$20240814$20240820$20240820$PER$$US-TAKEDA-2024TUS081971$TAKEDA$$$$$$Y$$$20240820$$CN$US$US
242264491$24226449$1$I$20240601$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130839$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$70.31$KG$20240820$$CN$US$US
242264501$24226450$1$I$20240801$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164561$AMGEN$$69$YR$E$M$Y$$$20240820$$CN$US$US
242264512$24226451$2$F$20240814$20240829$20240820$20240902$EXP$$JP-WT-2024-05994$Waylis$$4$DEC$$F$Y$$$20240902$$PH$JP$JP
242264551$24226455$1$I$20240802$20240806$20240820$20240820$EXP$GB-MHRA-MED-202408052239374680-WZNGL$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18317$ALKEM$$37$YR$$F$Y$69$KG$20240820$$CN$GB$GB
242264561$24226456$1$I$$20240806$20240820$20240820$EXP$GB-MHRA-MED-202408051005127000-JCLST$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18353$ALKEM$$34$YR$$M$Y$$$20240820$$CN$GB$GB
242264571$24226457$1$I$$20240806$20240820$20240820$EXP$US-MLMSERVICE-20231128-4694600-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18358$ALKEM$Al-Bayati M, Mohammed BU, Dharmarpandi G, Abdelmalek K, Varghese J, Tumula PK. Drug Induced Thrombotic Microangiopathy Secondary to Quetiapine; The Second Reportable Case in Medical Literature. Blood. 2022;140(1):11354-5$27$YR$$M$Y$$$20240820$$MD$US$US
242264581$24226458$1$I$20240629$20240806$20240820$20240820$EXP$GB-MHRA-MED-202408050942328210-TYRHD$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18350$ALKEM$$53$YR$$F$Y$$$20240820$$MD$GB$GB
242264591$24226459$1$I$20160101$20240806$20240820$20240820$EXP$GB-MHRA-MED-202408051535024400-VQSNR$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18340$ALKEM$$39$YR$$F$Y$$$20240820$$CN$GB$GB
242264601$24226460$1$I$20240616$20240806$20240820$20240820$EXP$$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07584$HIKMA$$$$$$Y$$$20240820$$MD$FR$FR
242264611$24226461$1$I$20230928$20240215$20240820$20240820$EXP$$US-Accord-409489$ACCORD$$75$YR$$F$Y$49.44$KG$20240820$$CN$US$US
242264621$24226462$1$I$$20240508$20240820$20240820$EXP$$US-Accord-424525$ACCORD$$$$$M$Y$$$20240820$$CN$US$US
242264631$24226463$1$I$20240625$20240815$20240820$20240820$PER$$US-ABBVIE-5885090$ABBVIE$$53$YR$$M$Y$$$20240820$$HP$US$US
242264641$24226464$1$I$$20240805$20240820$20240820$EXP$$FR-EPICPHARMA-FR-2024EPCLIT01010$EPIC PHARM$Pierre Tattevin.The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review.European Journal of Clinical Microbiology and Infectious Diseases.APR-2023;42:413-422$33$YR$A$F$Y$$$20240820$$MD$FR$FR
242264652$24226465$2$F$$20240903$20240820$20240903$EXP$$CN-JNJFOC-20240776494$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$HP$CN$CN
242264661$24226466$1$I$$20240812$20240820$20240820$PER$$US-ALXN-A202307647$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242264671$24226467$1$I$20240202$20240812$20240820$20240820$EXP$IT-MINISAL02-997839$IT-TEVA-VS-3233179$TEVA$$54$YR$$F$Y$63$KG$20240820$$MD$IT$IT
242264681$24226468$1$I$20230419$20230526$20240820$20240820$EXP$PT-INFARMED-R202305-537$PT-NORMON-2023001179$NORMON$$69$YR$E$F$Y$$$20240820$$PH$PT$
242264691$24226469$1$I$$20220217$20240820$20240820$EXP$$AU-TERSERA THERAPEUTICS LLC-2022TRS005486$TERSERA THERAPEUTICS$$$$$$Y$$$20240820$$CN$AU$AU
242264701$24226470$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168051$NOVARTIS$$$$$F$Y$$$20240820$$HP$US$US
242264712$24226471$2$F$20240815$20240820$20240820$20240823$PER$$US-AMGEN-USASP2024162951$AMGEN$$46$YR$A$F$Y$$$20240823$$CN$US$US
242264721$24226472$1$I$20240815$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164502$AMGEN$$82$YR$E$M$Y$$$20240820$$CN$US$US
242264731$24226473$1$I$20240625$20240807$20240820$20240820$EXP$$GB-CIPLA LTD.-2024GB08686$CIPLA$$$$$$Y$$$20240820$$MD$GB$GB
242264742$24226474$2$F$$20240910$20240820$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130323$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240911$$CN$US$US
242264752$24226475$2$F$$20240816$20240820$20240826$EXP$$US-ROCHE-10000060193$ROCHE$$67$YR$E$F$Y$$$20240826$$MD$US$US
242264761$24226476$1$I$$20240818$20240820$20240820$PER$$US-HALEON-2192642$Haleon PLC$$$$$$Y$$$20240820$$CN$US$US
242264771$24226477$1$I$20180831$20240812$20240820$20240820$EXP$$AU-009507513-1908AUS002472$MERCK$$26$YR$$M$Y$85$KG$20240820$$MD$AU$AU
242264781$24226478$1$I$20230901$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-113383$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242264791$24226479$1$I$20230101$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-113307$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242264801$24226480$1$I$$20240812$20240820$20240820$EXP$$CA-ROCHE-10000059394$ROCHE$$22$YR$A$F$Y$$$20240820$$CN$CA$CA
242264811$24226481$1$I$$20240805$20240820$20240820$EXP$$JP-VISIOX-2024VSX00002$Visiox$??, ??. Appropriate Selection of Outflow Pathway Reconstruction Surgeries in Elderly Patients. Journal of the Eye. 2023;40(10):1289 to 1297$81$YR$$F$Y$$$20240820$$MD$JP$JP
242264821$24226482$1$I$20240801$20240805$20240820$20240820$EXP$$JP-VISIOX-2024VSX00067$Visiox$$53$YR$$M$Y$$$20240820$$MD$JP$JP
242264831$24226483$1$I$$20240813$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128898$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240820$$HP$US$US
242264841$24226484$1$I$20221207$20230529$20240820$20240820$EXP$ES-AEMPS-1369196$ES-NORMON-2023001142$NORMON$$61$YR$A$M$Y$69.8$KG$20240820$$MD$ES$
242264851$24226485$1$I$$20240806$20240820$20240820$EXP$$JP-BELUSA-2024BELLIT0097$BIOLOGICAL E.$Kato A, Kitano M, Shimabukuro A, Sato S.Successful Percutaneous Revascularization for Femoral Artery Occlusion After Catheter Intervention: Serial Case Report.SN Comprehensive Clinical Medicine.04-JUN-2024;6 (1):63 (1-4)$$$$$Y$$$20240820$$HP$JP$JP
242264861$24226486$1$I$$20240812$20240820$20240820$PER$$US-ROCHE-10000055359$ROCHE$$$$$$Y$$$20240820$$PH$US$US
242264881$24226488$1$I$$20240805$20240820$20240820$EXP$$FR-EPICPHARMA-FR-2024EPCLIT01009$EPIC PHARM$Pierre Tattevin.The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review.European Journal of Clinical Microbiology and Infectious Diseases.APR-2023;42:413-422$27$YR$A$M$Y$$$20240820$$MD$FR$FR
242264891$24226489$1$I$20240101$20240808$20240820$20240820$EXP$$US-INSMED, INC.-2024-03024-US$INSMED$$$$$F$Y$$$20240820$$CN$US$US
242264901$24226490$1$I$$20240813$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US072631$SANDOZ$$$$$M$Y$$$20240820$$CN$US$US
242264912$24226491$2$F$20240101$20240816$20240820$20240902$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000700$DECIPHERA PHARMACEUTICALS$$65$YR$A$M$Y$$$20240902$$CN$US$US
242264921$24226492$1$I$$20240816$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US073504$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
242264931$24226493$1$I$$20240815$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US073042$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
242264951$24226495$1$I$$20240816$20240820$20240820$EXP$AU-JNJFOC-20240701326$AU-SANDOZ INC.-SDZ2024AU073168$SANDOZ$$14$YR$$M$Y$$$20240820$$MD$AU$AU
242264961$24226496$1$I$$20240819$20240820$20240820$EXP$$DE-SANDOZ INC.-SDZ2024DE073523$SANDOZ$$$$$$Y$$$20240820$$HP$DE$DE
242264971$24226497$1$I$$20220916$20240820$20240820$EXP$$US-AstraZeneca-2022A321707$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242264981$24226498$1$I$$20230418$20240820$20240820$EXP$$ZA-AstraZeneca-2023A091495$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$ZA$
242264991$24226499$1$I$20220101$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-114155$REGENERON$$$$$M$Y$$$20240820$$HP$US$US
242265001$24226500$1$I$$20231120$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-114156$REGENERON$$$$$$Y$$$20240820$$PH$US$US
242265011$24226501$1$I$20230918$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-114611$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242265021$24226502$1$I$20230101$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-114994$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265031$24226503$1$I$20230919$20231211$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-114996$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242265041$24226504$1$I$$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-114999$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265051$24226505$1$I$$20221116$20240820$20240820$EXP$$US-AstraZeneca-2022A381434$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242265061$24226506$1$I$$20231114$20240820$20240820$EXP$$US-AstraZeneca-2023A260103$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242265071$24226507$1$I$20230106$20230130$20240820$20240820$EXP$$US-AstraZeneca-2023A027339$ASTRAZENECA$$28314$DY$$M$Y$$$20240820$$CN$US$
242265081$24226508$1$I$$20230615$20240820$20240820$EXP$$US-AstraZeneca-2023A139834$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242265091$24226509$1$I$$20220624$20240820$20240820$EXP$$US-AstraZeneca-2022A238850$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242265111$24226511$1$I$$20230613$20240820$20240820$EXP$$US-AstraZeneca-2023A091855$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242265121$24226512$1$I$$20221129$20240820$20240820$EXP$$US-AstraZeneca-2022A350407$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242265131$24226513$1$I$$20240815$20240820$20240820$EXP$GB-MHRA-MED-202408151519577930-KWPGS$GB-VIIV HEALTHCARE LIMITED-GB2024101763$VIIV$$$$$$Y$$$20240820$$HP$GB$GB
242265151$24226515$1$I$$20230203$20240820$20240820$EXP$$FR-AstraZeneca-2023A032074$ASTRAZENECA$$$$E$$Y$$$20240820$$MD$FR$
242265161$24226516$1$I$$20220908$20240820$20240820$EXP$$US-AstraZeneca-2022A313385$ASTRAZENECA$$$$$$Y$$$20240820$$HP$US$
242265171$24226517$1$I$$20240816$20240820$20240820$EXP$$NVSC2024US167272$NOVARTIS$$77$YR$$M$Y$$$20240820$$CN$US$US
242265181$24226518$1$I$20230101$20230915$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-114139$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242265191$24226519$1$I$20230101$20230929$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-114545$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242265201$24226520$1$I$20230917$20240112$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-114610$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242265211$24226521$1$I$$20240809$20240820$20240820$EXP$$IT-ROCHE-10000053231$ROCHE$Lazzari G, Benevento I, Montagna A, Dandrea B, De Marco G, Castaldo G, et al. Breast Cancer Adjuvant Radiotherapy in Up-Front to Chemotherapy: Is There a Worthwhile Benefit? A Preliminary Report. Breast Cancer: Targets and Therapy. 2024;16:359-367. doi:10.2147/BCTT.S471345.$$$$$Y$$$20240820$$HP$IT$IT
242265221$24226522$1$I$20230917$20230929$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115003$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265231$24226523$1$I$20240716$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040891$AUROBINDO$$33$YR$$F$Y$$$20240820$$PH$FR$FR
242265241$24226524$1$I$20230901$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115007$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265251$24226525$1$I$20230914$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115039$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265261$24226526$1$I$20230901$20231109$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115041$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242265271$24226527$1$I$20230915$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115131$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242265281$24226528$1$I$20230101$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115135$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242265291$24226529$1$I$20230920$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115308$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265301$24226530$1$I$20230918$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115251$REGENERON$$$$$M$Y$$$20240820$$MD$US$US
242265311$24226531$1$I$20230901$20240126$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115256$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265321$24226532$1$I$20230901$20230920$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115262$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265332$24226533$2$F$20240805$20240815$20240820$20240823$PER$$US-AMGEN-USASP2024162924$AMGEN$$72$YR$E$M$Y$$$20240823$$CN$US$US
242265341$24226534$1$I$20240814$20240819$20240820$20240820$PER$$US-AMGEN-USASP2024165085$AMGEN$$53$YR$A$M$Y$$$20240820$$CN$US$US
242265352$24226535$2$F$$20240916$20240820$20240919$EXP$$CA-Orion Corporation ORION PHARMA-24_00031319$ORION$$11$YR$C$M$Y$$$20240919$$HP$CA$
242265361$24226536$1$I$20240707$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040866$AUROBINDO$$71$YR$$M$Y$73$KG$20240820$$MD$FR$FR
242265372$24226537$2$F$20240101$20240823$20240820$20240828$EXP$$US-ABBVIE-5881370$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242265384$24226538$4$F$20240601$20240923$20240820$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-041386$AUROBINDO$$64$YR$$F$Y$80$KG$20240927$$MD$FR$FR
242265391$24226539$1$I$$20240815$20240820$20240820$PER$$US-TAKEDA-2024TUS082920$TAKEDA$$$$$$Y$$$20240820$$CN$US$US
242265401$24226540$1$I$$20240805$20240820$20240820$EXP$$FR-EPICPHARMA-FR-2024EPCLIT01011$EPIC PHARM$Pierre Tattevin.The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review.European Journal of Clinical Microbiology and Infectious Diseases.APR-2023;42:413-422$26$YR$A$F$Y$$$20240820$$MD$FR$FR
242265411$24226541$1$I$$20240812$20240820$20240820$EXP$$CA-APOTEX-2024AP009228$APOTEX$$25$YR$$F$Y$$$20240820$$HP$CA$CA
242265431$24226543$1$I$20240812$20240816$20240820$20240820$EXP$$CN-ROCHE-10000059041$ROCHE$$43$YR$A$M$Y$93$KG$20240820$$HP$CN$CN
242265441$24226544$1$I$$20240819$20240820$20240820$PER$$US-HALEON-2192659$Haleon PLC$$$$$$Y$$$20240820$$CN$US$US
242265471$24226547$1$I$$20240814$20240820$20240820$EXP$$TW-REGENERON PHARMACEUTICALS, INC.-2024-108789$REGENERON$$$$$$Y$$$20240820$$CN$TW$TW
242265481$24226548$1$I$$20240809$20240820$20240820$EXP$$FR-AJANTA-2024AJA00141$AJANTA PHARMA$Toutain J, Fares S, Cochereau I, Gargouri MA, Titah C.Severe Vaso-Occlusive and Ocular Decompression Retinopathy Revealing a Sickle Cell Trait in a Patient with Herpetic Uveitis.OCULAR IMMUNOLOGY AND INFLAMMATION.AUG-2024;32(6):1079-1082$24$YR$A$M$Y$$$20240820$$MD$FR$FR
242265491$24226549$1$I$$20240819$20240820$20240820$EXP$AT-NOVPHSZ-PHHY2019AT062785$AT-SANDOZ INC.-PHHY2019AT062785$SANDOZ$$54$YR$$F$Y$$$20240820$$MD$AT$AT
242265501$24226550$1$I$20230921$20231101$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115530$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242265511$24226551$1$I$20230301$20240110$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115533$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265521$24226552$1$I$$20240521$20240820$20240820$PER$$US-AUROBINDO-AUR-APL-2024-026696$AUROBINDO$$$$E$F$Y$$$20240820$$MD$US$US
242265532$24226553$2$F$$20240620$20240820$20240820$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004514$BIOCON$$$$$$Y$$$20240820$$CN$US$US
242265541$24226554$1$I$20240101$20240816$20240820$20240820$EXP$$CA-Orion Corporation ORION PHARMA-24_00030291$ORION$$19$YR$A$M$Y$$$20240820$$MD$CA$
242265551$24226555$1$I$$20230421$20240820$20240820$EXP$$ES-NORMON-2023000853$NORMON$Mir-Ihara P, Morales-Cabeza C, Bellon T, Gonzalez-Munoz M, Ramirez E, Gomez-Traseira C. Drug reaction with eosinophilia and systemic symptoms in children. Allergy: European Journal of Allergy and Clinical Immunology. 2023;78(Supplement 111):684-5. DOI: 10.1111/all.15616.$12$YR$$F$Y$$$20240820$$MD$ES$
242265561$24226556$1$I$20240107$20240806$20240820$20240820$EXP$$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07590$HIKMA$$66$YR$$M$Y$$$20240820$$PH$FR$FR
242265571$24226557$1$I$$20240808$20240820$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-040708$AUROBINDO$$18$YR$$F$Y$$$20240820$$CN$CA$CA
242265581$24226558$1$I$$20240812$20240820$20240820$EXP$$US-MSNLABS-2024MSNLIT01811$MSN LABORATORIES$Cohen NT, Buraniqi E, Smith JD, Vezina LG, Gaillard WD.Ictal Arterial Spin Labeling-Magnetic Resonance Imaging Identifies Seizure Onset Zone in Epilepsia Partialis Continua.Annals of Neurology.2024;95(4):760-761$$$$$Y$$$20240820$$MD$US$US
242265591$24226559$1$I$20240220$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040747$AUROBINDO$$42$YR$$F$Y$$$20240820$$PH$FR$FR
242265603$24226560$3$F$$20240910$20240820$20240912$EXP$$CA-ROCHE-3419548$ROCHE$$$$A$M$Y$$$20240912$$CN$CA$CA
242265612$24226561$2$F$20240803$20240826$20240820$20240829$EXP$$TW-SANDOZ INC.-SDZ2024TW071776$SANDOZ$$86$YR$$F$Y$60$KG$20240829$$CN$TW$TW
242265621$24226562$1$I$20230919$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115620$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265631$24226563$1$I$20230921$20231109$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115636$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265641$24226564$1$I$20230920$20231113$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-116678$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265651$24226565$1$I$$20230912$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117037$REGENERON$$61$YR$$M$Y$$$20240820$$CN$US$US
242265661$24226566$1$I$20230922$20231204$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117256$REGENERON$$82$YR$$F$Y$$$20240820$$PH$US$US
242265671$24226567$1$I$$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117305$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265681$24226568$1$I$20230923$20231109$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117389$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265691$24226569$1$I$20230916$20230921$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-115544$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242265701$24226570$1$I$20230923$20231005$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-116634$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265711$24226571$1$I$20220223$20240812$20240820$20240820$EXP$PL-URPL-DML-MLP.4401.1.752.2022$PL-TEVA-VS-3233114$TEVA$$69$YR$$M$Y$83$KG$20240820$$MD$PL$PL
242265721$24226572$1$I$20230827$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117302$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242265732$24226573$2$F$20240729$20240814$20240820$20240827$EXP$$DE-AUROBINDO-AUR-APL-2024-040270$AUROBINDO$$56$YR$$F$Y$41$KG$20240827$$MD$DE$DE
242265741$24226574$1$I$$20240813$20240820$20240820$EXP$$US-TAKEDA-2024TUS081818$TAKEDA$$69$YR$$F$Y$$$20240820$$CN$US$US
242265751$24226575$1$I$$20240812$20240820$20240820$EXP$$KR-ABBVIE-5881970$ABBVIE$Lee MO, Cho S, Kim C, Koh H. Does drug-induced liver injury still occur after sevoflurane anesthesia? -A case report-. Anesth Pain Med. 2024;19(3):227-32.$69$YR$$M$Y$70$KG$20240820$$MD$KR$KR
242265761$24226576$1$I$$20230421$20240820$20240820$EXP$$ES-NORMON-2023000785$NORMON$Mir-Ihara P, Morales-Cabeza C, Bellon T, Gonzalez-Munoz M, Ramirez E, Gomez-Traseira C. Drug reaction with eosinophilia and systemic symptoms in children. Allergy: European Journal of Allergy and Clinical Immunology. 2023;78(Supplement 111):684-5. DOI: 10.1111/all.15616.$15$YR$$M$Y$$$20240820$$MD$ES$
242265771$24226577$1$I$20230711$20240808$20240820$20240820$EXP$$ES-AUROBINDO-AUR-APL-2024-040668$AUROBINDO$$50$YR$$M$Y$68.2$KG$20240820$$HP$ES$ES
242265781$24226578$1$I$$20240816$20240820$20240820$PER$$US-BIOVITRUM-2024-US-011016$BIOVITRUM$$70$YR$$F$Y$$$20240820$$CN$US$US
242265792$24226579$2$F$$20240819$20240820$20240821$EXP$$NVSC2024CA089345$NOVARTIS$$70$YR$$F$Y$$$20240821$$CN$CA$CA
242265801$24226580$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130311$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240820$$HP$US$US
242265811$24226581$1$I$20240801$20240815$20240820$20240820$PER$$US-ALXN-202408USA000966US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242265841$24226584$1$I$$20240819$20240819$20240819$DIR$714888$$FDA-CTU$$$$$UNK$N$$$20240819$N$CN$US$
242265861$24226586$1$I$20240816$20240819$20240819$20240819$DIR$714897$$FDA-CTU$$$$$UNK$N$$$20240819$N$CN$US$
242265871$24226587$1$I$$20240819$20240819$20240819$DIR$714891$$FDA-CTU$$$$$UNK$N$$$20240819$N$CN$US$
242265881$24226588$1$I$$20240819$20240819$20240819$DIR$714893$$FDA-CTU$$$$$UNK$N$$$20240819$N$CN$US$
242265891$24226589$1$I$20240705$20240819$20240819$20240819$DIR$714900$$FDA-CTU$$75$YR$$F$N$61$KG$20240819$Y$$US$
242265902$24226590$2$F$20240802$20240917$20240820$20240924$30DAY$$US-AMGEN-USASP2024162923$AMGEN$$54$YR$A$F$Y$76.3$KG$20240924$$HP$US$US
242265913$24226591$3$F$20240801$20240826$20240820$20240901$PER$$US-AMGEN-USASP2024158155$AMGEN$$$$$F$Y$$$20240901$$CN$US$US
242265921$24226592$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024162936$AMGEN$$$$$M$Y$$$20240820$$CN$US$US
242265951$24226595$1$I$20230801$20240808$20240820$20240820$EXP$$PL-AUROBINDO-AUR-APL-2024-040855$AUROBINDO$$35$YR$$F$Y$$$20240820$$MD$PL$PL
242265972$24226597$2$F$$20240823$20240820$20240829$EXP$$CA-ROCHE-10000053522$ROCHE$$$$E$F$Y$$$20240829$$CN$CA$CA
242265981$24226598$1$I$$20240806$20240820$20240820$EXP$$ES-BELUSA-2024BELLIT0094$BIOLOGICAL E.$Ontiveros SF, Del Pino GF, Torres ABM, Martinez RMP, Dominguez FLS.SEVERE TREATMENT-REFRACTORY HYPOKALEMIA AFTER HIP FRACTURE SURGERY.European Journal of Case Reports in Internal Medicine.2023;10 (1):210-211$$$$$Y$$$20240820$$HP$ES$ES
242265991$24226599$1$I$$20240816$20240820$20240820$EXP$$GB-SANDOZ INC.-SDZ2024GB073567$SANDOZ$$$$$F$Y$$$20240820$$CN$GB$GB
242266001$24226600$1$I$$20240813$20240820$20240820$EXP$$US-GSK-US2024100808$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$US$US
242266011$24226601$1$I$20240712$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040505$AUROBINDO$$64$YR$$M$Y$92$KG$20240820$$PH$FR$FR
242266021$24226602$1$I$$20240816$20240820$20240820$PER$$NVSC2024US167249$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242266031$24226603$1$I$20240801$20240810$20240820$20240820$EXP$$CN-BAYER-2024A115812$BAYER$$29$YR$A$M$Y$$$20240820$$HP$CN$CN
242266041$24226604$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162740$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242266051$24226605$1$I$$20240807$20240820$20240820$PER$$US-JNJFOC-20240817012$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242266061$24226606$1$I$$20240815$20240820$20240820$EXP$$US-TAKEDA-2024TUS048643$TAKEDA$$$$$F$Y$$$20240820$$CN$US$US
242266071$24226607$1$I$$20240808$20240820$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-040282$AUROBINDO$$24$YR$$F$Y$69$KG$20240820$$MD$GB$GB
242266081$24226608$1$I$$20240805$20240820$20240820$EXP$$US-EPICPHARMA-US-2024EPCLIT00995$EPIC PHARM$Sidra Kalsoom.A Silent Inferior Wall ST Segment Elevation Myocardial Infarction.Arteriosclerosis Thrombosis and Vascular Biology.02-OCT-2023;43(1):1-5$36$YR$A$M$Y$$$20240820$$HP$US$US
242266091$24226609$1$I$$20230418$20240820$20240820$EXP$$PT-NORMON-2023000771$NORMON$Oliveira SR, Monteiro IC, Rodrigues C, Soares MJ. Fever in a Patient with a Central Venous Catheter Colonized by Pandoraea pnomenusa. Acta Medica Portuguesa. 2023;36(2):127-30. DOI: 10.20344/amp.16176.$51$YR$$F$Y$$$20240820$$MD$PT$
242266101$24226610$1$I$20230923$20231204$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117391$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266111$24226611$1$I$20230101$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117398$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266121$24226612$1$I$20230925$20231204$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117836$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242266131$24226613$1$I$20180101$20230926$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117845$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242266141$24226614$1$I$20230101$20231222$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117863$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242266151$24226615$1$I$20230919$20240103$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-118383$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266161$24226616$1$I$20230927$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-118959$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266171$24226617$1$I$20231005$20240112$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-118386$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266181$24226618$1$I$$20240819$20240820$20240820$EXP$$US-UCBSA-2024041872$UCB$$$$$F$Y$$$20240820$$MD$US$US
242266194$24226619$4$F$20240101$20240904$20240820$20240917$EXP$$ES-AUROBINDO-AUR-APL-2024-040528$AUROBINDO$$78$YR$$F$Y$40$KG$20240917$$HP$ES$ES
242266201$24226620$1$I$20240501$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040760$AUROBINDO$$72$YR$$M$Y$64$KG$20240820$$MD$FR$FR
242266211$24226621$1$I$$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117400$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242266221$24226622$1$I$20230901$20230926$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117841$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242266231$24226623$1$I$20230101$20231211$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-118960$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266241$24226624$1$I$20230101$20231002$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-120209$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242266251$24226625$1$I$20230101$20230929$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-120044$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266261$24226626$1$I$20230101$20240229$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-120042$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266271$24226627$1$I$20230929$20231211$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-120043$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266282$24226628$2$F$20240801$20240906$20240820$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202408010691$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240911$$CN$US$US
242266292$24226629$2$F$20240813$20240821$20240820$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408010048$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240825$$CN$US$US
242266301$24226630$1$I$$20240201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-117861$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266311$24226631$1$I$$20240812$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408007344$ELI LILLY AND CO$$89$YR$E$$Y$$$20240820$$CN$US$US
242266321$24226632$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009806$ELI LILLY AND CO$$$$$M$Y$$$20240820$$CN$US$US
242266331$24226633$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010770$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240820$$CN$US$US
242266341$24226634$1$I$$20240812$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408008796$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240820$$HP$US$US
242266351$24226635$1$I$20240815$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010712$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240820$$CN$US$US
242266361$24226636$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009784$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240820$$CN$US$US
242266371$24226637$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010655$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240820$$CN$US$US
242266381$24226638$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009397$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240820$$CN$US$US
242266391$24226639$1$I$20240701$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010082$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240820$$CN$US$US
242266401$24226640$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010879$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$US$US
242266411$24226641$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009722$ELI LILLY AND CO$$41$YR$A$$Y$$$20240820$$CN$US$US
242266421$24226642$1$I$20230101$20231013$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-120246$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266431$24226643$1$I$20230101$20231003$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-120651$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242266441$24226644$1$I$20230101$20231211$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-120749$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242266451$24226645$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5883211$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242266461$24226646$1$I$20230701$20231211$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-120219$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266471$24226647$1$I$20230901$20231211$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-120615$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266482$24226648$2$F$20240806$20240807$20240820$20240905$EXP$$NZ-BEH-2024177046$CSL BEHRING$$45$YR$A$M$Y$120$KG$20240905$$HP$NZ$NZ
242266491$24226649$1$I$20150317$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040287$AUROBINDO$$68$YR$$M$Y$117$KG$20240820$$HP$FR$FR
242266501$24226650$1$I$$20240814$20240820$20240820$EXP$$CA-TAKEDA-2024TUS061946$TAKEDA$$$$$F$Y$$$20240820$$MD$CA$CA
242266512$24226651$2$F$20240701$20240827$20240820$20240831$EXP$$GB-TAKEDA-2024TUS081328$TAKEDA$$63$YR$$M$Y$$$20240831$$CN$GB$GB
242266521$24226652$1$I$20230101$20231005$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-121623$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242266531$24226653$1$I$20231005$20231211$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-122409$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266541$24226654$1$I$20231006$20240112$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-122421$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266551$24226655$1$I$20230101$20231227$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-121177$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266561$24226656$1$I$$20240805$20240820$20240820$EXP$$FR-EPICPHARMA-FR-2024EPCLIT01013$EPIC PHARM$Pierre Tattevin.The use of TNF-alpha antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review.European Journal of Clinical Microbiology and Infectious Diseases.APR-2023;42:413-422$61$YR$A$F$Y$$$20240820$$MD$FR$FR
242266571$24226657$1$I$20230101$20231108$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-121620$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266581$24226658$1$I$$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-121743$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266601$24226660$1$I$20230101$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-122412$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266611$24226661$1$I$20240818$20240819$20240820$20240820$EXP$$US-UCBSA-2024041875$UCB$$47$YR$$M$Y$$$20240820$$CN$US$US
242266631$24226663$1$I$20230529$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040672$AUROBINDO$$50$YR$$M$Y$122$KG$20240820$$MD$FR$FR
242266641$24226664$1$I$20240703$20240816$20240820$20240820$EXP$ES-AEMPS-1561072$ES-JNJFOC-20240846417$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240820$$MD$ES$ES
242266651$24226665$1$I$20240323$20240418$20240820$20240820$EXP$$NVSC2024IN087182$NOVARTIS$$46$YR$$M$Y$$$20240820$$CN$IN$IN
242266661$24226666$1$I$20230216$20230306$20240820$20240820$EXP$PT-INFARMED-V202302-844$PT-NORMON-2023000592$NORMON$$26$YR$A$M$Y$$$20240820$$MD$PT$
242266681$24226668$1$I$$20240812$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130681$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$67.59$KG$20240820$$CN$US$US
242266691$24226669$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129998$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240820$$HP$US$US
242266702$24226670$2$F$20240817$20240819$20240820$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131429$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$95$KG$20240822$$CN$US$US
242266711$24226671$1$I$20240810$20240816$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130767$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240820$$CN$US$US
242266721$24226672$1$I$20231005$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-122441$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266731$24226673$1$I$$20231009$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-122961$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266741$24226674$1$I$$20231009$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-123004$REGENERON$$$$$$Y$$$20240820$$HP$US$US
242266751$24226675$1$I$20230101$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-124349$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266761$24226676$1$I$20230901$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-124282$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266771$24226677$1$I$20230101$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-124430$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266781$24226678$1$I$20230101$20240118$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-124936$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266791$24226679$1$I$$20240813$20240820$20240820$EXP$$US-AMGEN-USASP2024161705$AMGEN$$$$$$Y$$$20240820$$MD$US$US
242266801$24226680$1$I$$20240807$20240820$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-040767$AUROBINDO$$55$YR$$F$Y$$$20240820$$HP$US$US
242266811$24226681$1$I$$20240812$20240820$20240820$EXP$$US-HETERO-HET2024US02746$HETERO$Srivastava A, Artiles ME, Elbanna M, Sheikha MA, Parikh V, Feitell S.. Cardiogenic Shock: An Unusual Presentation Of Hydralazine-induced Anca-associated Vasculitis. Journal of Cardiac Failure.. 2024;30(1):149-50$68$YR$$F$Y$$$20240820$$HP$US$US
242266821$24226682$1$I$20240610$20240815$20240820$20240820$EXP$$PE-EMD Serono-2024044359$EMD SERONO INC$$11$YR$C$F$Y$$$20240820$$CN$PE$PE
242266831$24226683$1$I$20230101$20240229$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-122435$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242266841$24226684$1$I$20240814$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024162102$AMGEN$$57$YR$A$M$Y$$$20240820$$CN$US$US
242266851$24226685$1$I$$20240812$20240820$20240820$EXP$$US-MYLANLABS-2024M1075846$MYLAN$$42$YR$$F$Y$$$20240820$$CN$US$US
242266871$24226687$1$I$$20240815$20240820$20240820$PER$$US-ALXN-202408USA000965US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
242266891$24226689$1$I$20240618$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040689$AUROBINDO$$69$YR$$F$Y$87$KG$20240820$$PH$FR$FR
242266911$24226691$1$I$20240816$20240819$20240819$20240819$DIR$714881$$FDA-CTU$$71$YR$$F$N$111.6$KG$20240819$N$CN$US$
242266931$24226693$1$I$20240815$20240816$20240820$20240820$EXP$$US-UCBSA-2024041625$UCB$$55$YR$$F$Y$$$20240820$$CN$US$US
242266941$24226694$1$I$$20240807$20240820$20240820$EXP$$US-UCBSA-2024040784$UCB$$47$YR$$M$Y$$$20240820$$HP$US$US
242266951$24226695$1$I$$20240812$20240820$20240820$EXP$$DE-AUROBINDO-AUR-APL-2024-041080$AUROBINDO$Lorenz G, Schaaf C, Moog P, Bachmann Q, Popp F, Rech J, et al.. Brain oedema due to disseminated intravascular coagulation in a patient with adult-onset Still^s disease-associated hemophagocytic lymphohistiocytosis - a case report.. Rheumatology. 2023;62(6):E188-E190$23$YR$$F$Y$$$20240820$$HP$DE$DE
242266961$24226696$1$I$$20240808$20240820$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-040798$AUROBINDO$$14$YR$$$Y$$$20240820$$MD$CA$CA
242266971$24226697$1$I$$20240814$20240820$20240820$EXP$$RU-ROCHE-10000033948$ROCHE$Kondrateva N, Dvoryakovskaya T, Kriulina T, Isaeva K, Chomakhidze A, Lomakina O, et al. Safety of long-term use of rituximab in patients with juvenile idiopathic arthritis: results of a cohort retrospective study. Voprosy Prakticheskoi Pediatrii (Clinical Practice in Pediatrics). 2024;19 (2):33-58. doi:10.20953/1817-7646-2024-2-33-58.$$$$$Y$$$20240820$$MD$RU$RU
242266981$24226698$1$I$20240728$20240808$20240820$20240820$EXP$$CN-AUROBINDO-AUR-APL-2024-041420$AUROBINDO$$59$YR$$F$Y$$$20240820$$HP$CN$CN
242266991$24226699$1$I$$20230726$20240820$20240820$EXP$$US-AstraZeneca-2023A171793$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242267001$24226700$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A184423$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242267011$24226701$1$I$$20210301$20240820$20240820$EXP$$CA-AstraZeneca-2020SF31274$ASTRAZENECA$$57$YR$$M$Y$$$20240820$$MD$CA$
242267021$24226702$1$I$20220301$20221021$20240820$20240820$EXP$$US-AstraZeneca-2022A333679$ASTRAZENECA$$857$MON$$F$Y$66.2$KG$20240820$$HP$US$
242267031$24226703$1$I$20220401$20220502$20240820$20240820$EXP$$US-AstraZeneca-2022A171789$ASTRAZENECA$$487$MON$$M$Y$$$20240820$$CN$US$
242267041$24226704$1$I$$20220915$20240820$20240820$EXP$$RU-AstraZeneca-2022A323368$ASTRAZENECA$$$$E$F$Y$$$20240820$$MD$RU$
242267051$24226705$1$I$$20230201$20240820$20240820$EXP$$PT-NORMON-2023000169$NORMON$Gomes R, Carlos P, Faisca AR, Vicente L. Q Fever Spondylodiscitis: A Rare Manifestation of a Challenging Disease. European Journal of Case Reports in Internal Medicine. 2022;9(12). DOI: 10.12890/2022_003703.$72$YR$$M$Y$$$20240820$$MD$PT$
242267061$24226706$1$I$$20240805$20240820$20240820$EXP$$ID-EPICPHARMA-ID-2024EPCLIT01017$EPIC PHARM$Siti Nur Rohmah.Diagnostic and therapeutic challenges of tuberculosis in kidney transplant recipients; a case series study.Journal of Nephropharmacology.JAN-2024;13: No. 2$42$YR$A$M$Y$$$20240820$$HP$ID$ID
242267071$24226707$1$I$$20220224$20240820$20240820$EXP$$TW-AstraZeneca-2022A091119$ASTRAZENECA$$62$YR$$F$Y$$$20240820$$PH$TW$
242267081$24226708$1$I$20220101$20221102$20240820$20240820$EXP$$CA-AstraZeneca-2022A262173$ASTRAZENECA$$58$YR$$M$Y$$$20240820$$HP$CA$
242267101$24226710$1$I$$20230622$20240820$20240820$EXP$$US-AstraZeneca-2023A144885$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242267111$24226711$1$I$$20220421$20240820$20240820$EXP$$US-AstraZeneca-2022A162553$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242267121$24226712$1$I$$20221205$20240820$20240820$EXP$$US-AstraZeneca-2022A267172$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242267131$24226713$1$I$20240805$20240819$20240820$20240820$PER$$US-AMGEN-USASP2024165404$AMGEN$$46$YR$A$F$Y$$$20240820$$CN$US$US
242267141$24226714$1$I$$20240816$20240820$20240820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-131129$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240820$$PH$JP$JP
242267161$24226716$1$I$20240819$20240819$20240819$20240819$DIR$714908$$FDA-CTU$$70$YR$$M$N$$$20240819$N$$US$
242267172$24226717$2$F$$20240904$20240820$20240913$EXP$$DE-AUROBINDO-AUR-APL-2020-014173$AUROBINDO$Blassmann U, Bockler D, Hoppe-Tichy T. The challenge of peripheral occlusive artery disease: Anticoagulants, antibiotics and analgesics pose a high interaction risk. Deutsche Apotheker Zeitung. 2019;159(51):PA33$77$YR$$M$Y$$$20240913$$MD$DE$DE
242267181$24226718$1$I$20231013$20231222$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-125622$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242267191$24226719$1$I$20240723$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130722$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$44.45$KG$20240820$$HP$US$US
242267202$24226720$2$F$$20240816$20240820$20240820$PER$$US-GILEAD-2024-0684512$GILEAD$$$$A$F$Y$$$20240820$$CN$US$US
242267221$24226722$1$I$$20240813$20240820$20240820$EXP$$ZA-ROCHE-10000058918$ROCHE$$65$YR$E$F$Y$$$20240820$$CN$ZA$ZA
242267231$24226723$1$I$20231018$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-128164$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267241$24226724$1$I$20231001$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-125654$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267251$24226725$1$I$20231012$20231222$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-125658$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267261$24226726$1$I$20230901$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-126700$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267271$24226727$1$I$$20231018$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-127300$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267281$24226728$1$I$$20231019$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-128185$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242267291$24226729$1$I$$20231012$20240820$20240820$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2023-128670$REGENERON$$70$YR$$F$Y$$$20240820$$CN$US$US
242267301$24226730$1$I$20230901$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129131$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267311$24226731$1$I$20230701$20231227$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-125624$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267331$24226733$1$I$20230101$20231222$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-126132$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267341$24226734$1$I$$20240816$20240820$20240820$EXP$$FR-TAKEDA-2024TUS083261$TAKEDA$$$$E$F$Y$$$20240820$$MD$FR$FR
242267351$24226735$1$I$20240119$20240813$20240820$20240820$EXP$$ID-TAKEDA-2024TUS010883$TAKEDA$$42$YR$$M$Y$$$20240820$$CN$ID$ID
242267361$24226736$1$I$20211001$20240808$20240820$20240820$EXP$$DE-AUROBINDO-AUR-APL-2024-040637$AUROBINDO$$62$YR$$M$Y$$$20240820$$MD$DE$DE
242267371$24226737$1$I$$20240808$20240820$20240820$EXP$$CA-ROCHE-10000052194$ROCHE$$$$$F$Y$$$20240820$$CN$CA$CA
242267381$24226738$1$I$$20240814$20240820$20240820$PER$$ZA-REGENERON PHARMACEUTICALS, INC.-2024-112590$REGENERON$$$$$F$Y$$$20240820$$MD$ZA$ZA
242267391$24226739$1$I$$20240223$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129148$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267401$24226740$1$I$20231019$20231019$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129156$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267411$24226741$1$I$20230101$20231222$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129159$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267421$24226742$1$I$20231020$20240126$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129521$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242267431$24226743$1$I$20231020$20231222$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129519$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242267441$24226744$1$I$20230101$20240425$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129546$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267451$24226745$1$I$20231006$20231227$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129569$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267461$24226746$1$I$$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129547$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267471$24226747$1$I$20231021$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129579$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267481$24226748$1$I$$20240807$20240820$20240820$EXP$$FR-MYLANLABS-2024M1074923$MYLAN$Bennassi A, Rivin Del Campo E, Theodore C, Huguet F. Breast cancer in a transgender man and hypofractionated radiotherapy: A case report and review of literature. Cancer-Radiother 2024; 28 (3): 272-274.$77$YR$$F$Y$$$20240820$$HP$FR$FR
242267491$24226749$1$I$$20240807$20240820$20240820$EXP$$US-MYLANLABS-2024M1074960$MYLAN$Nance M, Merten J, Grooms A. (022) Catatonia: Where to Look When ECT Fails. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S11-S12 abstr. 022.$65$YR$$F$Y$$$20240820$$HP$US$US
242267501$24226750$1$I$$20240807$20240820$20240820$EXP$$FR-MYLANLABS-2024M1075105$MYLAN$Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, et al. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. [French]. J-Fr-Ophtalmol 2023; 46 (9): 1039-1046.$68$YR$$M$Y$$$20240820$$HP$FR$FR
242267511$24226751$1$I$$20240807$20240820$20240820$EXP$$US-MYLANLABS-2024M1074954$MYLAN$Palatinus JA. Indolent Giant Cell Myocarditis Requiring Prolonged Veno-arterial Extracorporeal Membrane Oxygenation Support as a Bridge to Transplantation. US-Cardiol 2024; 18 (Suppl.) 19-20 abstr. 30.$65$YR$$M$Y$$$20240820$$MD$US$US
242267521$24226752$1$I$$20240807$20240820$20240820$EXP$$US-MYLANLABS-2024M1075245$MYLAN$Gondal MUR, Rovenstine L, Ansari F, Kiyani Z, Nair DPJR, Khan T, et al. Navigating a complex case of mycobacterium xenopi in a patient with blue rubber bleb nevus syndrome. Eur-J-Case-Rep-Intern-Med 2024; 11 (6).$40$YR$$F$Y$$$20240820$$HP$US$US
242267531$24226753$1$I$$20240807$20240820$20240820$EXP$$DE-MYLANLABS-2024M1075123$MYLAN$Paschen S, Becktepe JS, Hobert MA, Zeuner KE, Helmers A-K, Berg D, et al. The Challenge of Choosing the Right Stimulation Target for Dystonic Tremor-A Series of Instructive Cases. Mov-Disord-Clin-Pract 2023; 10 1478-1484.$73$YR$$M$Y$$$20240820$$MD$DE$DE
242267542$24226754$2$F$20231101$20240820$20240820$20240824$EXP$$US-ABBVIE-5883299$ABBVIE$$78$YR$$F$Y$$$20240824$$CN$US$US
242267551$24226755$1$I$$20240807$20240820$20240820$EXP$$US-MYLANLABS-2024M1075279$MYLAN$Kane N, Rikard R, McCrory K, Marx AH. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels. Open-Forum-Infect-Dis 2023; 10 (Suppl. 2) S1108 (plus Poster) abstr. 2546.$74$YR$$M$Y$$$20240820$$PH$US$US
242267561$24226756$1$I$$20240807$20240820$20240820$EXP$$US-MYLANLABS-2024M1075147$MYLAN$Scullin D, Goetz R, Wille K, Rusanov V, Gongora E, Orozco Hernandez E, et al. Acute Graft versus Host Disease in a Lung Transplant Recipient. J-Heart-Lung-Transplant 2024; 43 (Suppl.) (4): S489-S490 abstr. 1051.$64$YR$$M$Y$$$20240820$$HP$US$US
242267571$24226757$1$I$$20240807$20240820$20240820$EXP$$US-MYLANLABS-2024M1074951$MYLAN$Shah P, Rao P. Tacrolimus-Induced Pericardial Effusion. South-Med-J 2023; 116 (1): 68-69 (plus Poster).$75$YR$$M$Y$$$20240820$$HP$US$US
242267581$24226758$1$I$$20240806$20240820$20240820$EXP$$US-MYLANLABS-2024M1074741$MYLAN$Petric UB, Marks D, Dickman M, Rieger KE, Kibbi N. A Severe Case of Pan-Facial Vitamin C Serum-Induced Foreign Body Granulomatous Reaction. Dermatol-Surg 2024; 50 (6): 590-592.$53$YR$$F$Y$$$20240820$$HP$US$US
242267591$24226759$1$I$20240803$20240817$20240820$20240820$EXP$$GB-ABBVIE-5883979$ABBVIE$$34$YR$$M$Y$86$KG$20240820$$CN$GB$GB
242267601$24226760$1$I$20230101$20231023$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129862$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267611$24226761$1$I$$20231024$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129875$REGENERON$$$$$M$Y$$$20240820$$MD$US$US
242267621$24226762$1$I$20231024$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-130374$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267631$24226763$1$I$$20240126$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-130375$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267641$24226764$1$I$20230101$20231025$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-130392$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242267651$24226765$1$I$$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-130868$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242267661$24226766$1$I$20240624$20240815$20240820$20240820$EXP$FR-AFSSAPS-GR2024001012$FR-ABBVIE-5885309$ABBVIE$$76$YR$$F$Y$69$KG$20240820$$PH$FR$FR
242267671$24226767$1$I$20230928$20231222$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129590$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267681$24226768$1$I$20210101$20231024$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129872$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242267691$24226769$1$I$20230101$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-131581$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267701$24226770$1$I$20230101$20231222$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-129884$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242267711$24226771$1$I$20240201$20240808$20240820$20240820$EXP$$FR-AUROBINDO-AUR-APL-2024-040512$AUROBINDO$$80$YR$$M$Y$74$KG$20240820$$MD$FR$FR
242267721$24226772$1$I$20240703$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129967$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240820$$HP$US$US
242267732$24226773$2$F$20240701$20240822$20240820$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128009$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240902$$CN$US$US
242267741$24226774$1$I$20240317$20240806$20240820$20240820$EXP$$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-07595$HIKMA$$78$YR$$M$Y$85$KG$20240820$$MD$GB$GB
242267751$24226775$1$I$20231026$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-131596$REGENERON$$$$$M$Y$$$20240820$$MD$US$US
242267761$24226776$1$I$$20230726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-093543$REGENERON$$$$$$Y$$$20240820$$HP$US$US
242267771$24226777$1$I$20230701$20230929$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-093551$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242267781$24226778$1$I$$20230727$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-093961$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267791$24226779$1$I$$20230929$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-094031$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267801$24226780$1$I$20230101$20230929$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-094037$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267811$24226781$1$I$20240318$20240812$20240820$20240820$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-110674$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242267821$24226782$1$I$20220101$20231005$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-093964$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267831$24226783$1$I$20240730$20240814$20240820$20240820$PER$$US-GILEAD-2024-0682360$GILEAD$$34$YR$A$$Y$72.472$KG$20240820$$HP$US$US
242267841$24226784$1$I$20230101$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-094830$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267851$24226785$1$I$20230701$20230906$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-093016$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242267861$24226786$1$I$20240708$20240812$20240820$20240820$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160633$JIANGSU HENGRUI MEDICINE$$3$YR$$M$Y$32$KG$20240820$$MD$CN$CN
242267871$24226787$1$I$$20240805$20240820$20240820$PER$$US-GRANULES-US-2024GRASPO00348$GRANULES INDIA$$59$YR$A$F$Y$$$20240820$$CN$US$US
242267881$24226788$1$I$20240705$20240815$20240820$20240820$PER$FR-AFSSAPS-PB2024000857$FR-CHEPLA-2024010594$CHEPLAPHARM$$77$YR$$M$Y$$$20240820$$PH$COUNTRY NOT SPECIFIED$FR
242267901$24226790$1$I$$20240806$20240820$20240820$PER$$US-P+L Developments of Newyork Corporation-2160630$PL DEVELOPMENTS$$60$YR$$M$Y$$$20240820$$$US$US
242267911$24226791$1$I$$20240815$20240820$20240820$EXP$$US-SA-2024SA244339$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240820$$MD$US$US
242267921$24226792$1$I$$20240807$20240820$20240820$EXP$$DE-B.Braun Medical Inc.-2160635$B BRAUN$$$$$$Y$$$20240820$$$DE$DE
242267931$24226793$1$I$$20240810$20240820$20240820$EXP$GB-MHRA-MED-202408100658253420-HDTFK$GB-TEVA-VS-3232380$TEVA$$$$$M$Y$$$20240820$$CN$GB$GB
242267951$24226795$1$I$$20240814$20240820$20240820$EXP$$JP-AMGEN-JPNSP2024163147$AMGEN$$$$$$Y$$$20240820$$MD$JP$JP
242267961$24226796$1$I$$20240805$20240820$20240820$EXP$$US-CorePharma LLC-2160634$COREPHARMA$Source document (Abstract)$28$YR$$M$Y$$$20240820$$$US$US
242267971$24226797$1$I$$20240813$20240820$20240820$EXP$$ZA-AstraZeneca-2024A184455$ASTRAZENECA$$25202$DY$$F$Y$$$20240820$$CN$ZA$
242267981$24226798$1$I$$20220520$20240820$20240820$EXP$$US-AstraZeneca-2022A142820$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242267991$24226799$1$I$$20221027$20240820$20240820$EXP$$TW-AstraZeneca-2022A360099$ASTRAZENECA$$57$YR$$F$Y$$$20240820$$CN$TW$
242268001$24226800$1$I$20240701$20240815$20240820$20240820$EXP$$US-ABBVIE-5735225$ABBVIE$$57$YR$$F$Y$$$20240820$$CN$US$US
242268012$24226801$2$F$$20240821$20240820$20240823$EXP$$TW-009507513-2408TWN005952$MERCK$$61$YR$$M$Y$$$20240823$$MD$TW$TW
242268021$24226802$1$I$$20240815$20240820$20240820$EXP$$US-SA-2024SA245228$SANOFI AVENTIS$$$$E$F$Y$39$KG$20240820$$MD$US$US
242268031$24226803$1$I$20220731$20220805$20240820$20240820$EXP$$US-AstraZeneca-2022A280261$ASTRAZENECA$$26981$DY$$F$Y$52.2$KG$20240820$$CN$US$
242268041$24226804$1$I$20230727$20230728$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-094834$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268051$24226805$1$I$20230728$20231005$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-094831$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268061$24226806$1$I$20230728$20231113$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-094843$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268071$24226807$1$I$$20231005$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-095438$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268081$24226808$1$I$$20230731$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-095441$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268091$24226809$1$I$$20230503$20240820$20240820$EXP$$US-AstraZeneca-2023A104105$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242268101$24226810$1$I$$20240809$20240820$20240820$PER$$US-AstraZeneca-2024A182878$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
242268111$24226811$1$I$20230830$20230830$20240820$20240820$EXP$$US-AstraZeneca-2023A200046$ASTRAZENECA$$30575$DY$$M$Y$84.5$KG$20240820$$CN$US$
242268121$24226812$1$I$$20240815$20240820$20240820$PER$$US-ALXN-202408USA000951US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242268131$24226813$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0684522$GILEAD$$64$YR$A$F$Y$$$20240820$$CN$US$US
242268141$24226814$1$I$$20240810$20240820$20240820$EXP$$US-BAXTER-2024BAX023040$BAXTER$$$$$F$Y$$$20240820$$HP$US$US
242268151$24226815$1$I$20240805$20240807$20240820$20240820$EXP$$US-ACORDA-ACO_177743_2024$ACORDA$$82$YR$$F$Y$$$20240820$$CN$US$US
242268161$24226816$1$I$20240725$20240812$20240820$20240820$EXP$$DE-BAXTER-2024BAX023112$BAXTER$$68$YR$$F$Y$$$20240820$$HP$DE$DE
242268191$24226819$1$I$$20240703$20240820$20240820$PER$$US-LUNDBECK-DKLU4001292$LUNDBECK$$$$$$Y$$$20240820$$CN$US$US
242268201$24226820$1$I$20240729$20240813$20240820$20240820$EXP$IT-MINISAL02-998160$IT-TEVA-VS-3233520$TEVA$$71$YR$$M$Y$$$20240820$$MD$IT$IT
242268231$24226823$1$I$20240802$20240816$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130801$BRISTOL MYERS SQUIBB$$103$YR$E$F$Y$$$20240820$$CN$US$US
242268241$24226824$1$I$$20240812$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128079$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240820$$HP$US$US
242268251$24226825$1$I$$20240814$20240820$20240820$EXP$$GB-PERRIGO-24GB007718$PERRIGO$Kubba F, Aliyeva-Derraz P, Gradassi AT. An unusual case of drug-induced annular granulomatous vasculitis in a patient with rheumatoid arthritis and type 2 diabetes mellitus. British Journal of Dermatology. 2024;191(Supplement 1):i117-i8. DOI: 10.1093/bjd/ljae090.246.$7$DEC$$F$Y$$$20240820$$MD$GB$GB
242268263$24226826$3$F$20240815$20240828$20240820$20240830$PER$$US-AMGEN-USASP2024164154$AMGEN$$69$YR$E$$Y$$$20240830$$CN$US$US
242268271$24226827$1$I$$20240805$20240820$20240820$PER$$US-GRANULES-US-2024GRASPO00349$GRANULES INDIA$$$$$F$Y$65.77$KG$20240820$$CN$US$US
242268291$24226829$1$I$$20240812$20240820$20240820$EXP$$CA-APOTEX-2024AP009333$APOTEX$$82$YR$$F$Y$$$20240820$$HP$CA$CA
242268301$24226830$1$I$$20240808$20240820$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-040789$AUROBINDO$Capua M, Amlicke M, Esposito E, Belfer J, Bellis M, Falkowitz D etal. Time of  Observation in Xenobiotic Ingestions in Children Is 6 Hours Too Long?. Pediatric  Emergency Care. 2023;39 (1):e24-e29$$$$$Y$$$20240820$$HP$CA$CA
242268311$24226831$1$I$$20230810$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-095508$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268321$24226832$1$I$20230701$20230728$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-096101$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268331$24226833$1$I$20230101$20231005$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-096573$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268341$24226834$1$I$20230803$20231005$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-097096$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268351$24226835$1$I$20230803$20231013$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-097635$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268361$24226836$1$I$$20231013$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-097721$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268371$24226837$1$I$20230807$20231013$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-098235$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268381$24226838$1$I$20230731$20230803$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-097098$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268391$24226839$1$I$$20240819$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046699$BOEHRINGER INGELHEIM$$$$$$Y$$$20240820$$CN$US$US
242268401$24226840$1$I$20230101$20230802$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-096569$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268411$24226841$1$I$$20240805$20240820$20240820$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110900$ZYDUS PHARM$Schwartz M, Gutman JA, McMahon CM, Amaya ML, Pollyea DA, Witkowski M, et al.. Age-Adapted Chemotherapy for Adults }40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes.. Blood. 2023;142 (Suppl. 1):5898.$$$$$Y$$$20240820$$MD$US$US
242268421$24226842$1$I$$20240816$20240820$20240820$EXP$$CA-ABBVIE-5885062$ABBVIE$$$$A$F$Y$$$20240820$$HP$CA$CA
242268441$24226844$1$I$$20240812$20240820$20240820$EXP$$IL-BAYER-2024A117760$BAYER$$$$$M$Y$$$20240820$$HP$IL$IL
242268451$24226845$1$I$$20240703$20240820$20240820$PER$$US-LUNDBECK-DKLU4001280$LUNDBECK$$$$$$Y$$$20240820$$HP$US$US
242268461$24226846$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010778$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240820$$CN$US$US
242268471$24226847$1$I$20240815$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010614$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240820$$CN$US$US
242268481$24226848$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010813$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240820$$CN$US$US
242268491$24226849$1$I$20230806$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-098246$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268501$24226850$1$I$20230701$20231013$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-098988$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268511$24226851$1$I$20230810$20230810$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-099907$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268521$24226852$1$I$20230727$20231026$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-099920$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268531$24226853$1$I$20230811$20231026$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-100519$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268541$24226854$1$I$20230803$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-098243$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268551$24226855$1$I$20230101$20230831$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-099388$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268561$24226856$1$I$$20240806$20240820$20240820$EXP$$JP-UCBSA-2024013335$UCB$Moriya K, Hara R, Tomooka F, Shimozato N, Nishimura N, Kawaratani H, et al.. Concurrent Ulcerative Colitis in a Pregnant Patient with Rheumatoid Arthritis. Internal Medicine. 2024;63(3):385-91$32$YR$$F$Y$$$20240820$$HP$JP$JP
242268571$24226857$1$I$20230809$20230814$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-101026$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268581$24226858$1$I$$20231013$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-098250$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268601$24226860$1$I$$20240702$20240820$20240820$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092092$GLENMARK$$$$$$Y$$$20240820$$CN$US$US
242268611$24226861$1$I$$20240812$20240820$20240820$EXP$$SD-IPCA LABORATORIES LIMITED-IPC-2024-SD-002044$IPCA$Mohammed Taha, Ayman Azhary, Nooh Mohamed Hajhamed et al.. A case report of metformin-associated lactic acidosis. Clinical Case Reports. 2024;12(e9255):1-5$$$$$Y$$$20240820$$HP$SD$SD
242268621$24226862$1$I$$20230817$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-102181$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268631$24226863$1$I$$20230919$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-102310$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268641$24226864$1$I$20230817$20231027$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-102636$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242268651$24226865$1$I$$20230818$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-102668$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268661$24226866$1$I$$20230810$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-101215$REGENERON$$64$YR$$F$Y$$$20240820$$CN$US$US
242268671$24226867$1$I$20230101$20231026$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-101241$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268681$24226868$1$I$$20231026$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-101244$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268691$24226869$1$I$20230815$20231026$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-101737$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268701$24226870$1$I$$20230918$20240820$20240820$PER$$US-AUROBINDO-AUR-APL-2023-060182$AUROBINDO$$$$$F$Y$$$20240820$$PH$US$US
242268711$24226871$1$I$$20240812$20240820$20240820$EXP$$CA-APOTEX-2024AP009254$APOTEX$$14$YR$$M$Y$$$20240820$$HP$CA$CA
242268721$24226872$1$I$$20231026$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-102121$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242268731$24226873$1$I$$20240102$20240820$20240820$PER$$US-AUROBINDO-AUR-APL-2024-001005$AUROBINDO$$67$YR$$F$Y$60.32$KG$20240820$$CN$US$US
242268741$24226874$1$I$$20231026$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-101731$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268751$24226875$1$I$$20240805$20240820$20240820$PER$$US-GILEAD-2024-0682974$GILEAD$$$$E$M$Y$$$20240820$$MD$US$US
242268761$24226876$1$I$$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-102675$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268771$24226877$1$I$20230810$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-103119$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268781$24226878$1$I$20230801$20231027$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-103121$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268791$24226879$1$I$$20230818$20240820$20240820$PER$$US-AUROBINDO-AUR-APL-2023-055553$AUROBINDO$$76$YR$$F$Y$58$KG$20240820$$CN$US$US
242268801$24226880$1$I$20230818$20240103$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-103271$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268811$24226881$1$I$$20240808$20240820$20240820$EXP$$PT-ASPEN-GLO2024PT005523$ASPEN$Baptista M.. A SESS?O III DA SABATINA DE  HEMATOLOGIA, DA TARDE DO  20 DE ABRIL, FOI DEDICADA O  MIELOMAM?LTIPLO (MM).  SOB MODERA??O DE RUI  BERGANTIM, FOI  APRESENTADO UM CASO  Imunoterapia aplicadaao  mieloma m?ltiplo(SESSION III OF THE HEMATOLOGY SABBATH, ON THE AFTERNOON OF APRIL 20, WAS DEDICATED TO MULTIPLE MYELOM (MM).  UNDER RUI BERGANTIM^S MODERATION, A CASE WAS PRESENTED Immunotherapy applied to multiple myeloma).. 32 SABATINA DE HEMATOLOGIA. (32nd HEMATOLOGY SABATINE)$$$$$Y$$$20240820$$HP$PT$PT
242268821$24226882$1$I$20230101$20231026$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-103278$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268831$24226883$1$I$$20240808$20240820$20240820$PER$$US-AstraZeneca-2024A181872$ASTRAZENECA$$$$$F$Y$$$20240820$$MD$US$
242268841$24226884$1$I$$20221121$20240820$20240820$EXP$$US-AstraZeneca-2022A384846$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
242268851$24226885$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163452$AMGEN$$$$$$Y$$$20240820$$HP$US$US
242268861$24226886$1$I$$20240809$20240820$20240820$EXP$$US-MYLANLABS-2024M1076298$MYLAN$Tomassoni GF, Aasbo J, Lee J, Krummen DE. PO-04-197 forward solution machine learning ecg mapping to guide remote magnetic navigation catheter ablation in a patient with polymorphic ventricular tachycardia. Heart-Rhythm 2024; 21 (Suppl.) (5): S518 abstr. PO-04-197.$65$YR$$M$Y$$$20240820$$HP$US$US
242268871$24226887$1$I$$20240809$20240820$20240820$PER$$US-ABBVIE-5877756$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242268882$24226888$2$F$20240807$20240905$20240820$20240910$EXP$$NVSC2024CA167415$NOVARTIS$$35$YR$$F$Y$$$20240910$$CN$CA$CA
242268891$24226889$1$I$20230101$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-105726$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268901$24226890$1$I$20230808$20231027$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-104313$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268911$24226891$1$I$$20230901$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-104380$REGENERON$$$$$F$Y$$$20240820$$MD$US$US
242268921$24226892$1$I$20230816$20231027$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-103905$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268931$24226893$1$I$$20231027$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-104310$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268941$24226894$1$I$$20240812$20240820$20240820$EXP$$US-GSK-US2024100386$GLAXOSMITHKLINE$$$$$F$Y$$$20240820$$CN$US$US
242268951$24226895$1$I$20230806$20230824$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-105676$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242268961$24226896$1$I$20230823$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-104312$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268971$24226897$1$I$20240501$20240815$20240820$20240820$EXP$$US-JNJFOC-20240844940$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240820$$HP$US$US
242268981$24226898$1$I$20230828$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-106303$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242268991$24226899$1$I$$20240814$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-103872$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269001$24226900$1$I$20240101$20240815$20240820$20240820$PER$$US-ABBVIE-5884883$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242269011$24226901$1$I$20230827$20230828$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-106304$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269021$24226902$1$I$20230101$20230825$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-106306$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269031$24226903$1$I$20230829$20231227$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-106495$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269041$24226904$1$I$$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-105750$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269051$24226905$1$I$20230828$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-106348$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269061$24226906$1$I$$20231120$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-106963$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269071$24226907$1$I$20230101$20230908$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-107072$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269081$24226908$1$I$20230824$20230828$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-106339$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269093$24226909$3$F$20240701$20240910$20240820$20240910$PER$$US-ALXN-202408USA000779US$ALEXION PHARMACEUTICALS$$80$YR$$M$Y$$$20240910$$CN$US$US
242269101$24226910$1$I$20230101$20240417$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-106389$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269111$24226911$1$I$20230801$20230828$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-107001$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269131$24226913$1$I$$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-107278$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269141$24226914$1$I$$20231027$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-107285$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269151$24226915$1$I$20230830$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-107277$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242269161$24226916$1$I$20230801$20231027$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-107663$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269171$24226917$1$I$$20230901$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-108451$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269181$24226918$1$I$20230101$20230901$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-108453$REGENERON$$$$$M$Y$$$20240820$$MD$US$US
242269191$24226919$1$I$20230101$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-108474$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269201$24226920$1$I$20230630$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-108476$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269211$24226921$1$I$20230821$20230901$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-108485$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269221$24226922$1$I$20240710$20240819$20240819$20240819$DIR$714910$$FDA-CTU$$81$YR$$F$N$$$20240819$N$PH$US$
242269231$24226923$1$I$20240818$20240819$20240819$20240819$DIR$714903$$FDA-CTU$$33$YR$$F$N$58.5$KG$20240819$N$$US$
242269241$24226924$1$I$20230614$20230901$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-108472$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269251$24226925$1$I$20181020$20220926$20240820$20240820$EXP$PT-INFARMED-J202209-731$PT-NORMON-2022001276$NORMON$$60$YR$A$F$Y$$$20240820$$MD$PT$
242269261$24226926$1$I$20210504$20240819$20240819$20240819$DIR$714905$$FDA-CTU$$29$YR$$F$N$$$20240819$N$HP$US$
242269271$24226927$1$I$20240801$20240819$20240819$20240819$DIR$714882$$FDA-CTU$$13$YR$$M$N$42.75$KG$20240819$N$CN$US$
242269281$24226928$1$I$20240802$20240819$20240819$20240819$DIR$714909$$FDA-CTU$$63$YR$$F$N$80.55$KG$20240819$N$CN$US$
242269301$24226930$1$I$20240814$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024162032$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242269311$24226931$1$I$$20240813$20240820$20240820$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045387$BOEHRINGER INGELHEIM$Yuen CA, Bao S, Kong X. A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient. Biomarkers in Medicine. 2024;18:9: 433-441. doi:10.1080/17520363.2024.2342231.$75$YR$E$F$Y$$$20240820$$HP$US$US
242269332$24226933$2$F$$20240913$20240820$20240918$30DAY$$US-PFIZER INC-202400235662$PFIZER$$10$YR$$M$Y$$$20240918$$CN$US$US
242269341$24226934$1$I$20240101$20240815$20240820$20240820$EXP$$CA-PFIZER INC-202400224107$PFIZER$$73$YR$$M$Y$$$20240820$$HP$CA$CA
242269354$24226935$4$F$$20240919$20240820$20240924$30DAY$$US-PFIZER INC-PV202400047083$PFIZER$$13$YR$$M$Y$28.8$KG$20240924$$MD$US$US
242269371$24226937$1$I$20240714$20240806$20240820$20240820$EXP$$RO-OCTA-ONORM06524$OCTAPHARMA$$42$YR$A$M$Y$80$KG$20240820$$MD$EU$EU
242269381$24226938$1$I$$20240805$20240820$20240820$EXP$IT-NOVA LABORATORIES LTD-IT-001342$IT-SERVIER-S24009840$SERVIER$$$$$$Y$$$20240820$$HP$IT$IT
242269391$24226939$1$I$20221114$20230103$20240820$20240820$EXP$$NL-TERSERA THERAPEUTICS LLC-2023TRS000033$TERSERA THERAPEUTICS$$$$$$Y$$$20240820$$CN$NL$NL
242269402$24226940$2$F$20240709$20240822$20240820$20240903$EXP$$US-BAYER-2024A115483$BAYER$$34$YR$A$F$Y$$$20240903$$MD$US$US
242269411$24226941$1$I$20230101$20230901$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-108585$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269421$24226942$1$I$20230905$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-109564$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269431$24226943$1$I$20230906$20231109$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-110205$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269441$24226944$1$I$20230906$20231109$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-110213$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269451$24226945$1$I$20230901$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-110240$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269461$24226946$1$I$20230907$20231227$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-110610$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269471$24226947$1$I$20230801$20231120$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-110614$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269481$24226948$1$I$$20230828$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-109252$REGENERON$$64$YR$$F$Y$$$20240820$$CN$US$US
242269491$24226949$1$I$20230101$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-109606$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269501$24226950$1$I$$20231109$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-110251$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269511$24226951$1$I$20230101$20230907$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-110576$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269521$24226952$1$I$$20231120$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-110606$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269531$24226953$1$I$$20231109$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-110189$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269541$24226954$1$I$20230101$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-109723$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269551$24226955$1$I$20220101$20240812$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127422$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240820$$CN$US$US
242269561$24226956$1$I$20230911$20231120$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-111710$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269571$24226957$1$I$20200518$20240820$20240820$20240820$EXP$PL-URPL-1-1572-2020$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046675$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$83$KG$20240820$$MD$PL$PL
242269581$24226958$1$I$20230907$20231107$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-110616$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269591$24226959$1$I$$20230912$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-112367$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242269611$24226961$1$I$$20231109$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-111176$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269621$24226962$1$I$$20231109$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-111182$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242269631$24226963$1$I$20230101$20231120$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-112404$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269641$24226964$1$I$20230903$20231120$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-112392$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242269652$24226965$2$F$$20240816$20240820$20240823$EXP$$NVSC2022PL076182$NOVARTIS$Liszka K, Resztak M, Zalewska P, Kalwak K. Therapeutic drug monitoring of posaconazole for effective prophylaxis of invasive fungal infections in pediatric patients: A pilot study. ACTA HAEMATOLOGICA POLONICA. 2021;52(6):578-83$1$YR$$$Y$8.8$KG$20240823$$HP$PL$PL
242269671$24226967$1$I$$20240812$20240820$20240820$EXP$$CA-APOTEX-2024AP009303$APOTEX$$35$YR$$F$Y$$$20240820$$HP$CA$CA
242269681$24226968$1$I$$20240731$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-101328$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269702$24226970$2$F$$20240821$20240820$20240826$EXP$$NVSC2024AU166578$NOVARTIS$$$$$M$Y$$$20240826$$HP$AU$AU
242269711$24226971$1$I$$20240812$20240820$20240820$EXP$$NVSC2024DE165329$NOVARTIS$Hierl F, Luke F, Keil F, Heudobler D, Einhell S, Klier-Richter M et al.. Critical evaluation of molecular tumour board outcomesfollowing 2 years of clinical practice in a Comprehensive Cancer Centre. BRITISH JOURNAL OF CANCER. 2023;128(6):1134-47$$$$F$Y$$$20240820$$HP$DE$DE
242269721$24226972$1$I$20220101$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-112408$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269731$24226973$1$I$20240810$20240816$20240820$20240820$PER$$US-ROCHE-10000060560$ROCHE$$$$$$Y$$$20240820$$CN$US$US
242269741$24226974$1$I$$20240724$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-102216$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242269751$24226975$1$I$20240612$20240813$20240820$20240820$EXP$$GB-ABBVIE-5881129$ABBVIE$$28$YR$$F$Y$$$20240820$$HP$GB$GB
242269771$24226977$1$I$$20240813$20240820$20240820$EXP$$NVSC2024DE164361$NOVARTIS$Satirer O, Doring M, Lesk T, Benseler S, Kuemmerle-Deschne J, Henes J. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD OPEN. 2024;10$$$$M$Y$$$20240820$$HP$DE$DE
242269801$24226980$1$I$$20240815$20240820$20240820$EXP$$US-PFIZER INC-202400237755$PFIZER$$44$YR$$F$Y$$$20240820$$MD$US$US
242269832$24226983$2$F$$20240919$20240820$20240919$30DAY$$US-PFIZER INC-202400231858$PFIZER$$14$YR$$M$Y$$$20240919$$CN$US$US
242269841$24226984$1$I$$20240815$20240820$20240820$EXP$$CA-PFIZER INC-202400238618$PFIZER$$59$YR$$M$Y$$$20240820$$CN$CA$CA
242269853$24226985$3$F$$20240910$20240820$20240912$30DAY$$GB-PFIZER INC-202400230332$PFIZER$$16$YR$$M$Y$$$20240912$$CN$GB$GB
242269861$24226986$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163023$AMGEN$$56$YR$A$F$Y$$$20240820$$CN$US$US
242269881$24226988$1$I$$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024164164$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242269891$24226989$1$I$$20240814$20240820$20240820$EXP$$US-GSK-US2024101380$GLAXOSMITHKLINE$$3$DEC$$F$Y$$$20240820$$HP$US$US
242269902$24226990$2$F$$20240812$20240820$20240828$30DAY$$US-GSK-US2024100285$GLAXOSMITHKLINE$$$$$M$Y$$$20240828$$CN$US$US
242269911$24226991$1$I$$20240814$20240820$20240820$PER$$US-JNJFOC-20240842388$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
242269921$24226992$1$I$$20240815$20240820$20240820$EXP$$CA-Orion Corporation ORION PHARMA-24_00031324$ORION$$68$YR$E$F$Y$$$20240820$$HP$CA$
242269931$24226993$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129801$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240820$$HP$US$US
242269941$24226994$1$I$$20240815$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130386$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240820$$MD$US$US
242269951$24226995$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129987$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240820$$CN$US$US
242269982$24226998$2$F$$20240904$20240820$20240904$PER$$US-ALXN-202408USA000800US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
242269991$24226999$1$I$20240801$20240819$20240820$20240820$EXP$$US-UCBSA-2024041908$UCB$$71$YR$$F$Y$$$20240820$$CN$US$US
242270001$24227000$1$I$20240807$20240812$20240820$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-040887$AUROBINDO$$76$YR$$M$Y$$$20240820$$HP$GB$GB
242270011$24227001$1$I$20240807$20240809$20240820$20240820$EXP$$CN-JNJFOC-20240835600$JOHNSON AND JOHNSON$$52$YR$A$F$Y$65$KG$20240820$$HP$CN$CN
242270021$24227002$1$I$$20200226$20240820$20240820$EXP$$US-AstraZeneca-2020SE30808$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242270031$24227003$1$I$$20221010$20240820$20240820$EXP$$ES-NORMON-2022001212$NORMON$Macias-Iglesias EM, Campanon-Toro MV, Moreno Rodilla E, de Arriba-Mendez S, Sobrino-Garcia M, Gallardo-Higueras A et al. DRESS Syndrome Induced by a Gadolinium-Based Contrast Agent in a 13-Year-Old Boy. J Investig Allergol Clin Immunol. 2022;32(3):238-40. DOI:10.18176/jiaci.0742$13$YR$$M$Y$$$20240820$$MD$ES$
242270041$24227004$1$I$20230201$20230308$20240820$20240820$EXP$$US-AstraZeneca-2023A057346$ASTRAZENECA$$626$MON$$M$Y$$$20240820$$CN$US$
242270051$24227005$1$I$$20240807$20240820$20240820$PER$$US-AstraZeneca-2024A182248$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
242270061$24227006$1$I$$20240809$20240820$20240820$PER$$US-AstraZeneca-2024A182238$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242270071$24227007$1$I$$20221020$20240820$20240820$EXP$$US-AstraZeneca-2022A352739$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242270081$24227008$1$I$20230913$20240812$20240820$20240820$EXP$$CN-AstraZeneca-2024A186900$ASTRAZENECA$Wang Z, Chu Y et al.. A case of white blood cell increased caused by budesonide suspension for inhalation in a patient with abdominal infection. Clinical Medication Journal 2024;22(7):87-89.$49$YR$$F$Y$82$KG$20240820$$HP$CN$
242270091$24227009$1$I$20220401$20220425$20240820$20240820$EXP$$US-AstraZeneca-2022A164708$ASTRAZENECA$$26099$DY$$M$Y$$$20240820$$CN$US$
242270101$24227010$1$I$$20240808$20240820$20240820$PER$$US-AstraZeneca-2024A181547$ASTRAZENECA$$$$$$Y$$$20240820$$MD$US$
242270111$24227011$1$I$$20221024$20240820$20240820$EXP$$US-AstraZeneca-2022A313095$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242270121$24227012$1$I$20230101$20240813$20240820$20240820$EXP$$CN-009507513-2408CHN005886$MERCK$Song B, Zhao G, Xie M, Dai W, Zhang N.. Acute myocardial infarction-like electrocardiogram caused by left lung malignant tumor with cardiac metastasis: A case report. Journal of Practical Electrocardiology. 2024;33 (4):411-4$50$YR$$M$Y$$$20240820$$MD$CN$CN
242270131$24227013$1$I$20240813$20240814$20240820$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012741$JAZZ$$28$YR$$F$Y$$$20240820$$CN$US$US
242270141$24227014$1$I$$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011739$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242270151$24227015$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010179$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240820$$CN$US$US
242270161$24227016$1$I$$20240814$20240820$20240820$EXP$$US-GSK-US2024101243$GLAXOSMITHKLINE$$$$$F$Y$$$20240820$$CN$US$US
242270171$24227017$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010649$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240820$$CN$US$US
242270182$24227018$2$F$20230721$20240829$20240820$20240905$EXP$$BG-AKCEA THERAPEUTICS, INC.-2023IS001939$AKCEA THERAPEUTICS$$$$$$Y$$$20240905$$CN$BG$BG
242270202$24227020$2$F$$20240919$20240820$20240919$30DAY$$US-PFIZER INC-202400233453$PFIZER$$13$YR$$M$Y$$$20240919$$CN$US$US
242270211$24227021$1$I$$20240813$20240820$20240820$30DAY$$KR-PFIZER INC-202400238560$PFIZER$$$$$$Y$$$20240820$$HP$KR$KR
242270221$24227022$1$I$$20240813$20240820$20240820$30DAY$$KR-PFIZER INC-PV202400105711$PFIZER$$11$YR$$M$Y$$$20240820$$HP$KR$KR
242270233$24227023$3$F$$20240920$20240820$20240920$30DAY$$US-PFIZER INC-202400235222$PFIZER$$3$YR$$M$Y$13.4$KG$20240920$$CN$US$US
242270243$24227024$3$F$$20240922$20240820$20240923$30DAY$$US-PFIZER INC-202400235249$PFIZER$$8$YR$$M$Y$37.5$KG$20240923$$CN$US$US
242270251$24227025$1$I$20240809$20240819$20240819$20240819$DIR$714894$$FDA-CTU$$19$YR$$F$N$49.5$KG$20240819$Y$CN$US$
242270273$24227027$3$F$$20240925$20240820$20240925$30DAY$$US-PFIZER INC-202400235226$PFIZER$$14$YR$$M$Y$$$20240925$$CN$US$US
242270282$24227028$2$F$$20240809$20240820$20240822$30DAY$$US-PFIZER INC-202400234030$PFIZER$$13$YR$$M$Y$$$20240822$$CN$US$US
242270303$24227030$3$F$20240808$20240919$20240820$20240924$30DAY$$US-PFIZER INC-202400234567$PFIZER$$14$YR$$F$Y$$$20240924$$CN$US$US
242270311$24227031$1$I$$20240805$20240820$20240820$EXP$$JP-EPICPHARMA-JP-2024EPCLIT01014$EPIC PHARM$Yuji Takahashi.Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review.Acute Medicine and Surgery.JAN-2024;11:1-5$45$YR$A$F$Y$90$KG$20240820$$HP$JP$JP
242270321$24227032$1$I$20240101$20240812$20240820$20240820$EXP$ES-AEMPS-1557359$ES-TEVA-VS-3233243$TEVA$$67$YR$$M$Y$80$KG$20240820$$MD$ES$ES
242270331$24227033$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883363$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242270342$24227034$2$F$20240701$20240906$20240820$20240912$EXP$$BR-AKCEA THERAPEUTICS, INC.-2024IS006037$AKCEA THERAPEUTICS$$$$$$Y$$$20240911$$CN$BR$BR
242270351$24227035$1$I$20240401$20240812$20240820$20240820$EXP$IT-MINISAL02-997842$IT-TEVA-VS-3233149$TEVA$$69$YR$$M$Y$$$20240820$$PH$IT$IT
242270361$24227036$1$I$$20240806$20240820$20240820$EXP$$JP-EMD Serono-2024043928$EMD SERONO INC$$33$YR$A$M$Y$93$KG$20240820$$MD$JP$JP
242270371$24227037$1$I$20240802$20240814$20240820$20240820$EXP$$CN-EMD Serono-2024044134$EMD SERONO INC$$36$YR$A$F$Y$57$KG$20240820$$HP$CN$CN
242270381$24227038$1$I$$20240815$20240820$20240820$PER$$US-JNJFOC-20240842256$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$MD$US$US
242270392$24227039$2$F$$20240821$20240820$20240906$PER$$US-JNJFOC-20240840170$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$MD$US$US
242270411$24227041$1$I$20240101$20240816$20240820$20240820$EXP$$US-JNJFOC-20240846504$JOHNSON AND JOHNSON$$24$YR$A$F$Y$$$20240820$$HP$US$US
242270421$24227042$1$I$20190329$20240810$20240820$20240820$EXP$$ES-TEVA-VS-3234515$TEVA$$61$YR$$M$Y$68$KG$20240820$$HP$ES$ES
242270431$24227043$1$I$$20240806$20240820$20240820$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06113$HIKMA$$$$$$Y$$$20240820$$CN$US$US
242270451$24227045$1$I$20240716$20240815$20240820$20240820$EXP$$PL-ABBVIE-5884268$ABBVIE$$79$YR$$M$Y$$$20240820$$MD$PL$PL
242270471$24227047$1$I$$20240807$20240820$20240820$EXP$CA-MHPD-E2B_07169187$CA-Accord-441094$ACCORD$$$$$$Y$$$20240820$$HP$CA$CA
242270481$24227048$1$I$20240618$20240807$20240820$20240820$EXP$FR-AFSSAPS-AN2024000972$FR-Accord-440828$ACCORD$$52$YR$A$F$Y$73.5$KG$20240820$$PH$FR$FR
242270491$24227049$1$I$$20240808$20240820$20240820$EXP$$IR-Accord-441507$ACCORD$Sharifi P, Moradi A, Moghadasi AN. Fingolimod-associated Balo^s concentric sclerosis in multiple sclerosis: A case report. Clin Case Rep. 2024;12:e9266.$37$YR$A$F$Y$$$20240820$$HP$IR$IR
242270502$24227050$2$F$20240811$20240819$20240820$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025146$UNITED THERAPEUTICS$$73$YR$$M$Y$69.841$KG$20240823$$$US$US
242270511$24227051$1$I$20210308$20240807$20240820$20240820$EXP$FR-EMA-2024728-AUTODUP-1722195203750$FR-Accord-440715$ACCORD$$$$$F$Y$$$20240820$$HP$FR$FR
242270521$24227052$1$I$20240601$20240807$20240820$20240820$EXP$FR-AFSSAPS-NT2024000953$FR-Accord-440817$ACCORD$$$$A$M$Y$$$20240820$$MD$FR$FR
242270531$24227053$1$I$20240807$20240808$20240820$20240820$EXP$$US-Accord-441200$ACCORD$$27$YR$A$F$Y$$$20240820$$HP$US$US
242270541$24227054$1$I$$20240807$20240820$20240820$EXP$CA-MHPD-E2B_07142131$CA-Accord-441092$ACCORD$$79$YR$E$F$Y$73$KG$20240820$$CN$CA$CA
242270552$24227055$2$F$20240724$20240906$20240820$20240923$30DAY$$CA-BECTON DICKINSON-CA-BD-24-000484$BECTON DICKINSON$$$$$$Y$$$20240923$$CN$CA$CA
242270561$24227056$1$I$$20240815$20240820$20240820$EXP$$NVSC2024GB166932$NOVARTIS$$$$$F$Y$$$20240820$$HP$GB$GB
242270572$24227057$2$F$$20240925$20240820$20240927$30DAY$$US-PFIZER INC-202400237256$PFIZER$$14$YR$$F$Y$35.38$KG$20240927$$CN$US$US
242270583$24227058$3$F$$20240923$20240820$20240926$30DAY$$US-PFIZER INC-202400237030$PFIZER$$14$YR$$M$Y$$$20240926$$MD$US$US
242270603$24227060$3$F$20240101$20240919$20240820$20240919$30DAY$$US-PFIZER INC-PV202400097328$PFIZER$$15$YR$$M$Y$$$20240919$$MD$US$US
242270612$24227061$2$F$$20240919$20240820$20240919$30DAY$$US-PFIZER INC-PV202400059729$PFIZER$$9$YR$$F$Y$$$20240919$$HP$US$US
242270623$24227062$3$F$$20240920$20240820$20240920$30DAY$$US-PFIZER INC-202400236148$PFIZER$$14$YR$$F$Y$43.084$KG$20240920$$CN$US$US
242270643$24227064$3$F$$20240920$20240820$20240924$30DAY$$US-PFIZER INC-202400235308$PFIZER$$10$YR$$M$Y$$$20240924$$CN$US$US
242270652$24227065$2$F$20240702$20240911$20240820$20240912$30DAY$$UY-PFIZER INC-202400237412$PFIZER$$16$YR$$F$Y$$$20240912$$CN$UY$UY
242270661$24227066$1$I$$20240805$20240820$20240820$EXP$$JP-Vista Pharmaceuticals Inc.-2160637$VISTAPHARM$Full text$80$YR$$F$Y$48$KG$20240820$$$JP$JP
242270673$24227067$3$F$$20240926$20240820$20240926$30DAY$$US-PFIZER INC-202400237114$PFIZER$$16$YR$$M$Y$$$20240926$$CN$US$US
242270691$24227069$1$I$20220330$20220408$20240820$20240820$EXP$PT-INFARMED-V202203-1149$PT-NORMON-2022000395$NORMON$$64$YR$A$M$Y$$$20240820$$PH$PT$
242270701$24227070$1$I$$20240813$20240820$20240820$EXP$$US-GSK-US2024100672$GLAXOSMITHKLINE$$$$$M$Y$$$20240820$$CN$US$US
242270711$24227071$1$I$$20240812$20240820$20240820$EXP$$CA-AMERICAN REGENT INC-2024003101$AMERICAN REGENT$$35$YR$$F$Y$$$20240820$$HP$CA$CA
242270721$24227072$1$I$$20240809$20240820$20240820$EXP$$DE-AUROBINDO-AUR-APL-2024-034800$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$54$YR$$M$Y$$$20240820$$HP$DE$DE
242270731$24227073$1$I$$20240811$20240820$20240820$EXP$GB-MHRA-MED-202408112206023550-QKDCN$GB-TEVA-VS-3232469$TEVA$$2$YR$$M$Y$$$20240820$$CN$GB$GB
242270741$24227074$1$I$$20240819$20240819$20240819$DIR$714918$$FDA-CTU$$$$$UNK$N$$$20240819$N$CN$US$
242270751$24227075$1$I$20240701$20240819$20240819$20240819$DIR$714922$$FDA-CTU$$37$YR$$M$N$101.25$KG$20240819$N$CN$US$
242270761$24227076$1$I$20240211$20240819$20240819$20240819$DIR$714923$$FDA-CTU$$70$YR$$M$N$98$KG$20240819$N$$US$
242270781$24227078$1$I$$20240819$20240819$20240819$DIR$714932$$FDA-CTU$$$$$UNK$N$$$20240819$N$CN$US$
242270791$24227079$1$I$20221101$20240819$20240819$20240819$DIR$714907$$FDA-CTU$$51$YR$$F$N$92.25$KG$20240819$N$CN$US$
242270811$24227081$1$I$20240819$20240819$20240819$20240819$DIR$714927$$FDA-CTU$$61$YR$$F$N$$$20240819$Y$$US$
242270831$24227083$1$I$20240815$20240816$20240820$20240820$PER$$US-JNJFOC-20240843197$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240820$$CN$US$US
242270841$24227084$1$I$20240802$20240814$20240820$20240820$EXP$$CN-EMD Serono-2024044241$EMD SERONO INC$$29$YR$A$F$Y$60$KG$20240820$$HP$CN$CN
242270862$24227086$2$F$20240730$20240812$20240820$20240822$EXP$$CA-CELLTRION INC.-2024CA019441$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
242270871$24227087$1$I$20240816$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164478$AMGEN$$73$YR$E$F$Y$$$20240820$$CN$US$US
242270881$24227088$1$I$20240817$20240819$20240820$20240820$PER$$US-AMGEN-USASP2024165288$AMGEN$$41$YR$A$F$Y$$$20240820$$CN$US$US
242270891$24227089$1$I$$20240815$20240820$20240820$EXP$$CA-Orion Corporation ORION PHARMA-24_00031322$ORION$$$$$$Y$$$20240820$$HP$CA$
242270901$24227090$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164363$AMGEN$$$$$$Y$$$20240820$$HP$US$US
242270911$24227091$1$I$20240814$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024163540$AMGEN$$57$YR$A$F$Y$$$20240820$$HP$US$US
242270922$24227092$2$F$$20240902$20240820$20240903$EXP$$CA-BAYER-2024A118600$BAYER$$$$$F$Y$$$20240903$$MD$CA$CA
242270931$24227093$1$I$20240618$20240813$20240820$20240820$EXP$$CN-CHEPLA-2024010642$CHEPLAPHARM$$80$YR$E$F$Y$$$20240820$$HP$COUNTRY NOT SPECIFIED$CN
242270942$24227094$2$F$20231201$20240821$20240820$20240826$EXP$$AU-ABBVIE-5880226$ABBVIE$$29$YR$$F$Y$$$20240826$$PH$AU$AU
242270951$24227095$1$I$20240814$20240814$20240820$20240820$EXP$$DE-BAYER-2024A117754$BAYER$$73$YR$E$F$Y$76$KG$20240820$$MD$DE$DE
242270961$24227096$1$I$$20240816$20240820$20240820$EXP$$US-JNJFOC-20240846595$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240820$$HP$US$US
242270971$24227097$1$I$$20240809$20240820$20240820$EXP$$CA-AUROBINDO-AUR-APL-2024-041153$AUROBINDO$Pehlivan EP, Tabatabai GT, Zerafati GMZJ, Galindo R.. A case of newborn refractory seizures in  kernicterus secondary to G6PD deficiency.. Annals of Neurology.. 2023;94 (31):S76$4$DY$$M$Y$$$20240820$$HP$CA$CA
242270991$24227099$1$I$$20240809$20240820$20240820$EXP$$NVSC2024IN167562$NOVARTIS$$$$$F$Y$$$20240820$$CN$IN$IN
242271001$24227100$1$I$20240815$20240816$20240820$20240820$PER$$US-ABBVIE-5885543$ABBVIE$$29$YR$$F$Y$$$20240820$$HP$US$US
242271011$24227101$1$I$$20240813$20240820$20240820$EXP$$US-GSK-US2024100608$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$US$US
242271022$24227102$2$F$20240816$20240822$20240820$20240824$PER$$US-AMGEN-USASP2024164415$AMGEN$$73$YR$E$M$Y$93.3$KG$20240824$$MD$US$US
242271031$24227103$1$I$$20220819$20240820$20240820$EXP$$US-AstraZeneca-2022A241774$ASTRAZENECA$$$$$$Y$$$20240820$$MD$US$
242271041$24227104$1$I$$20240613$20240820$20240820$EXP$$IN-AstraZeneca-2024A138073$ASTRAZENECA$$17532$DY$$M$Y$$$20240820$$CN$IN$
242271051$24227105$1$I$$20220727$20240820$20240820$EXP$$US-AstraZeneca-2022A269391$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242271061$24227106$1$I$$20230627$20240820$20240820$EXP$$US-AstraZeneca-2023A148616$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242271071$24227107$1$I$$20240812$20240820$20240820$EXP$$CA-AstraZeneca-2024A187984$ASTRAZENECA$$$$$$Y$$$20240820$$MD$CA$
242271084$24227108$4$F$$20240828$20240820$20240830$30DAY$$US-SANDOZ INC.-SDZ2024US047280$SANDOZ$$$$$F$Y$$$20240830$$HP$US$US
242271091$24227109$1$I$$20240804$20240820$20240820$PER$$KR-CBL-002752$CONCORD BIOTECH$Yang J, Kim Y, Park WY, Jin K, Han S, Kim BH, et al. Unilateral testicular tuberculosis in a kidney transplant recipient: a case report. Clin Transplant Res. 2024 Aug 1. doi: 10.4285/ctr.24.0023.$36$YR$A$M$Y$$$20240820$$HP$KR$KR
242271101$24227110$1$I$$20240805$20240820$20240820$EXP$$BR-EPICPHARMA-BR-2024EPCLIT01015$EPIC PHARM$ESG Filho.REACAO ADVERSA A VACINA BCG EM LACTENTE.Brazilian Journal of Infectious Diseases.OCT-2023;27 (Suppl. 1):153-154$1$MON$N$M$Y$$$20240820$$HP$BR$BR
242271111$24227111$1$I$$20240807$20240820$20240820$EXP$CA-MHPD-001089913$CA-Accord-441088$ACCORD$$74$YR$E$F$Y$67$KG$20240820$$HP$CA$CA
242271125$24227112$5$F$20240101$20240828$20240820$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025377$UNITED THERAPEUTICS$$$$$F$Y$65.76$KG$20240906$$$US$US
242271131$24227113$1$I$$20240807$20240820$20240820$EXP$$HU-Accord-437122$ACCORD$Kiraly P. Monomorf epiteliotrop T-sejtes lymphoma miatt gondozott betegunk kortortenete bemutatasa. Hematologia - Transfuzialogia. 2023 JAN; 2022/3:117-121.$41$YR$A$M$Y$$$20240820$$MD$HU$HU
242271141$24227114$1$I$$20240809$20240820$20240820$EXP$$TW-KOWA-24JP002102$KOWA PHARM$$58$YR$$F$Y$$$20240820$$HP$TW$TW
242271151$24227115$1$I$$20240816$20240820$20240820$EXP$$US-BAYER-2024A118768$BAYER$$73$YR$E$F$Y$$$20240820$$CN$US$US
242271161$24227116$1$I$20240813$20240814$20240820$20240820$EXP$$VN-BAYER-2024A118432$BAYER$$51$YR$A$F$Y$$$20240820$$HP$VN$VN
242271171$24227117$1$I$$20240815$20240820$20240820$PER$$US-ABBVIE-5883827$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242271181$24227118$1$I$20240101$20240812$20240820$20240820$PER$$US-ABBVIE-5877855$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242271191$24227119$1$I$20190101$20240808$20240820$20240820$EXP$$US-ADVANZ PHARMA-201910006008$ADVANZ PHARMA$$$$$$Y$$$20240820$$CN$US$US
242271201$24227120$1$I$20211108$20220420$20240820$20240820$EXP$ES-AEMPS-1156870$ES-NORMON-2022000393$NORMON$$78$YR$E$M$Y$$$20240820$$MD$ES$
242271211$24227121$1$I$20240806$20240813$20240820$20240820$EXP$$CN-SA-2024SA244398$SANOFI AVENTIS$$51$YR$A$M$Y$57$KG$20240820$$HP$CN$CN
242271221$24227122$1$I$$20240812$20240820$20240820$EXP$$CA-APOTEX-2024AP009240$APOTEX$$85$YR$$F$Y$$$20240820$$HP$CA$CA
242271231$24227123$1$I$$20240807$20240820$20240820$EXP$$CN-Unichem Pharmaceuticals (USA) Inc-UCM202408-001020$UNICHEM$$73$YR$E$F$Y$$$20240820$$HP$CN$
242271252$24227125$2$F$$20240920$20240820$20240924$EXP$$US-SANDOZ INC.-SDZ2024US073758$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
242271261$24227126$1$I$$20240814$20240820$20240820$EXP$$DO-MYLANLABS-2024M1076531$MYLAN$$$$$F$Y$$$20240820$$CN$DO$DO
242271271$24227127$1$I$$20240806$20240820$20240820$EXP$$TW-Unichem Pharmaceuticals (USA) Inc-UCM202408-000998$UNICHEM$$82$YR$E$F$Y$$$20240820$$HP$TW$
242271282$24227128$2$F$20240906$20240920$20240820$20240925$EXP$$GB-MYLANLABS-2024M1076486$MYLAN$$32$YR$$F$Y$130$KG$20240925$$MD$GB$GB
242271291$24227129$1$I$$20240814$20240820$20240820$EXP$$US-MYLANLABS-2024M1076844$MYLAN$Goyal A, Jakulla RS, Alarfaj M, Tayeb T, Barker S, Bhyan P, et al. Myasthenia Crisis Complicated with Takotsubo Cardiomyopathy. US-Cardiol 2024; 18 (Suppl.) 7-8.$77$YR$$F$Y$$$20240820$$HP$US$US
242271301$24227130$1$I$$20240814$20240820$20240820$EXP$$IR-MYLANLABS-2024M1077012$MYLAN$Bahramy MA, Hashempour Z, Shahriarirad R. Chronic inflammatory demyelinating polyneuropathy following COVID-19 vaccination: a case report and literature review. BMC-Neurol 2024; 24 1-14.$67$YR$$M$Y$$$20240820$$HP$IR$IR
242271311$24227131$1$I$20240715$20240809$20240820$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-040451$AUROBINDO$$$$$F$Y$$$20240820$$PH$GB$GB
242271322$24227132$2$F$20240723$20240826$20240820$20240830$EXP$$CN-ROCHE-10000060425$ROCHE$$58$YR$A$M$Y$61.8$KG$20240830$$MD$CN$CN
242271331$24227133$1$I$$20240819$20240820$20240820$EXP$SE-SEMPA-2024-006095$NVSC2024SE167303$NOVARTIS$$75$YR$$F$Y$$$20240820$$MD$SE$SE
242271341$24227134$1$I$20211101$20240819$20240820$20240820$EXP$ES-AEMPS-1561534$NVSC2024ES167506$NOVARTIS$$21$YR$$F$Y$59$KG$20240820$$HP$ES$ES
242271351$24227135$1$I$20240804$20240819$20240820$20240820$EXP$$BR-GILEAD-2024-0684204$GILEAD$$$$$F$Y$$$20240820$$CN$BR$BR
242271362$24227136$2$F$20240101$20240910$20240820$20240915$EXP$$US-ABBVIE-5880624$ABBVIE$$57$YR$$F$Y$48$KG$20240915$$HP$US$US
242271371$24227137$1$I$$20240806$20240820$20240820$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07962$LUPIN$$$$$$Y$$$20240820$$CN$US$US
242271381$24227138$1$I$$20240807$20240820$20240820$PER$$TW-PBT-009637$PANACEA BIOTEC$Chan WM, Wu TW, Peng TR. Prasugrel-Associated Drug Fever. Am J Ther. 2024 Jul-Aug 01;31(4):e522. doi: 10.1097/MJT.0000000000001739.$81$YR$E$M$Y$$$20240820$$HP$TW$TW
242271391$24227139$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010032$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240820$$PH$US$US
242271401$24227140$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009833$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242271412$24227141$2$F$$20240816$20240820$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011084$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240823$$CN$US$US
242271421$24227142$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010962$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240820$$CN$US$US
242271431$24227143$1$I$20240728$20240812$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012576$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242271451$24227145$1$I$$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024165039$AMGEN$$$$$$Y$$$20240820$$CN$US$US
242271461$24227146$1$I$20240812$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024162947$AMGEN$$82$YR$E$F$Y$$$20240820$$CN$US$US
242271481$24227148$1$I$$20240808$20240820$20240820$EXP$$US-MYLANLABS-2024M1074819$MYLAN$Suffian H, Le T, Pandya A. Complications post-chemotherapy in a child with t-cell leukemia and ataxia telangiectasia. Ann-Allergy-Asthma-Immunol 2023; 131 (Suppl. 1) (5): S156 abstr. M261.$4$YR$$M$Y$$$20240820$$HP$US$US
242271491$24227149$1$I$$20240808$20240820$20240820$EXP$$US-MYLANLABS-2024M1075617$MYLAN$Marco T, Amaraneni A, Shroff P. Refractory hemolytic anemia in setting of digeorge syndrome (partial 22q11.2 deletion). Ann-Allergy-Asthma-Immunol 2023; 131 (Suppl.) (5): S167.$34$YR$$M$Y$$$20240820$$HP$US$US
242271501$24227150$1$I$$20240808$20240820$20240820$EXP$$US-MYLANLABS-2024M1075384$MYLAN$Essink J, Niebur H. DELAYED DIAGNOSIS OF COMMON VARIABLE IMMUNODEFICIENCY AND IMPORTANCE OF MULTI-SPECIALTY COLLABORATION. Ann-Allergy-Asthma-Immunol 2023; 131 (Suppl.) (5): S158-S159.$17$YR$$M$Y$$$20240820$$HP$US$US
242271511$24227151$1$I$$20240808$20240820$20240820$EXP$$US-MYLANLABS-2024M1075661$MYLAN$Shakoor HI, Farsakh D, Shewmake H, Maliakkal N, Hanks A, Funk K, et al. Multiple Viral Infections With Elevated Cell-free DNA After Heart Transplantation. J-Card-Fail 2024; 30 (1) 210 abstr. 218.$60$YR$$M$Y$$$20240820$$HP$US$US
242271521$24227152$1$I$$20240808$20240820$20240820$EXP$$DE-MYLANLABS-2024M1074682$MYLAN$Bingert R, Kolbe V, Boy D, Buttner A. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. [German]. Rechtsmedizin 2023; 33 (5): 396-402.$17$YR$$F$Y$$$20240820$$HP$DE$DE
242271531$24227153$1$I$$20240808$20240820$20240820$EXP$$FR-MYLANLABS-2024M1075344$MYLAN$Baber A, Legendre P, Palmic P, Lupo-Mansuet A, Burroni B, Azoulay C, et al. EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Spleen: Report of an Aggressive Form With Molecular Characterization. Int-J-Surg-Pathol 2020; 32 150-154.$79$YR$$F$Y$$$20240820$$MD$FR$FR
242271541$24227154$1$I$$20240812$20240820$20240820$EXP$$BE-MYLANLABS-2024M1076370$MYLAN$Boogers A, Van Bogaert T, Peeters J, Kilic U, Sunaert S, Vandenberghe W, et al. Aligning Dentato-Rubro-Thalamic Tract and Subthalamic Nucleus Targets in a Patient with Comorbid Essential Tremor and Parkinson^s Disease: Case Report. Stereotac-Funct-Neurosurg 2023; 100 (5-6): 340-345.$70$YR$$M$Y$$$20240820$$HP$BE$BE
242271561$24227156$1$I$$20240808$20240820$20240820$EXP$$IT-MYLANLABS-2024M1075345$MYLAN$Colussi L, Dagri A, Pastore S, Taddio A, Tommasini A. Effect of the janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma. Pediatr-Rheumatol 2023; 21 (Suppl.) abstr. P134.$3$YR$$F$Y$$$20240820$$HP$IT$IT
242271581$24227158$1$I$$20240815$20240820$20240820$PER$$US-ABBVIE-5883706$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242271591$24227159$1$I$$20240808$20240820$20240820$EXP$$US-MYLANLABS-2024M1074816$MYLAN$Monge J, Razavi M, Bao L, Patel SS. Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. Am-J-Hematol 2023; 99 327-328.$78$YR$$M$Y$$$20240820$$HP$US$US
242271611$24227161$1$I$$20240808$20240820$20240820$EXP$$CA-MYLANLABS-2024M1075370$MYLAN$Alawneh I, Amburgey K, Gonorazky H, Gorodetsky C. CAMK4-related Case of Hyperkinetic Movement Disorder. Mov-Disord-Clin-Pract 2023; 10 (4): 707-709.$16$YR$$M$Y$$$20240820$$MD$CA$CA
242271621$24227162$1$I$$20240811$20240820$20240820$EXP$$US-AMGEN-USASP2024162442$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240820$$HP$US$US
242271631$24227163$1$I$$20240808$20240820$20240820$EXP$$US-MYLANLABS-2024M1075620$MYLAN$Difiore E, Pittman J. A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting. Case-Rep-Psychiatry 2024; 2024 (0).$54$YR$$M$Y$$$20240820$$HP$US$US
242271641$24227164$1$I$20240810$20240810$20240820$20240820$EXP$$GB-AUROBINDO-AUR-APL-2024-040506$AUROBINDO$$59$YR$$M$Y$$$20240820$$CN$GB$GB
242271651$24227165$1$I$20240601$20240813$20240820$20240820$EXP$$CA-OTSUKA-2024_017854$OTSUKA$$42$YR$$M$Y$$$20240820$$PH$CA$CA
242271661$24227166$1$I$20240401$20240819$20240820$20240820$EXP$NO-NOMAADVRE-PASRAPP-2024-Vp3b9n$NO-JNJFOC-20240848463$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240820$$CN$NO$NO
242271681$24227168$1$I$$20240806$20240820$20240820$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07996$LUPIN$Lee IJ, Pulido JS, Regillo CD, Leys M. Multiple organ dysfunction syndrome and disseminated intravascular coagulation causing extensive multiple amalric triangular choroidal infarctions. Retinal Cases and Brief Reports. 2024;18 (2):251-254$49$YR$$F$Y$$$20240820$$MD$US$US
242271711$24227171$1$I$$20240816$20240820$20240820$EXP$$US-GILEAD-2024-0684578$GILEAD$$70$YR$E$M$Y$$$20240820$$HP$US$US
242271722$24227172$2$F$$20240826$20240820$20240904$EXP$$JP-TEVA-VS-3233085$TEVA$Sasako T, Suzuki K, Odawara S, Suwanai H, Akuta N, Kubota N, et al. Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report. J-Diabetes-Investig 2024; 15 (6): 782-785.; Sasako T, Suzuki K, Odawara S, Suwanai H, Akuta N, Kubota N, et al. Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report. J-Diabetes-Investig 2024; 15 (6): 782-785.; Sasako T, Suzuki K, Odawara S, Suwanai H, Akuta N, Kubota N, et al. Corticosteroid-triggered acute skel...$28$YR$$F$Y$$$20240904$$HP$JP$JP
242271731$24227173$1$I$20240814$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164341$AMGEN$$62$YR$A$M$Y$$$20240820$$CN$US$US
242271741$24227174$1$I$$20240809$20240820$20240820$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08049$LUPIN$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central extracorporeal membrane oxygenation support following calcium channel blocker overdose in children. American Society for Artificial Internal Organs. 2024;70 (7):e92-e96$12$YR$$F$Y$63$KG$20240820$$HP$US$US
242271751$24227175$1$I$$20240809$20240820$20240820$PER$$US-ABBVIE-5876369$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242271761$24227176$1$I$$20240815$20240820$20240820$EXP$SE-SEMPA-2024-006014$SE-BAYER-2024A117749$BAYER$$33$YR$A$F$Y$$$20240820$$CN$SE$SE
242271771$24227177$1$I$20240101$20240814$20240820$20240820$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004135$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240820$$HP$CA$CA
242271791$24227179$1$I$$20240809$20240820$20240820$EXP$$JP-TERSERA THERAPEUTICS LLC-2024TRS004145$TERSERA THERAPEUTICS$$$$$$Y$$$20240820$$PH$JP$JP
242271801$24227180$1$I$$20240812$20240820$20240820$EXP$$JP-TEVA-VS-3233542$TEVA$Naka M, Inaba A, Miyasaka H, Suzue K, Ishigaki J, Shibuya H, et al. An elderly case of paraneoplastic anti-NMDA receptor encephalitis associated with large cell neuroendocrine carcinoma of the lung. BMC-Pulm-Med 2024; 24 1-6.; Naka M, Inaba A, Miyasaka H, Suzue K, Ishigaki J, Shibuya H, et al. An elderly case of paraneoplastic anti-NMDA receptor encephalitis associated with large cell neuroendocrine carcinoma of the lung. BMC-Pulm-Med 2024; 24 1-6.$78$YR$$M$Y$$$20240820$$HP$JP$JP
242271812$24227181$2$F$20240801$20240819$20240820$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131512$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240821$$HP$US$US
242271821$24227182$1$I$20240726$20240808$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN008374$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242271831$24227183$1$I$$20240816$20240820$20240820$EXP$$US-BAYER-2024A118835$BAYER$Elias M.D.; Brothers J.A.; Hogarty A.N.; Martino J.; O^Byrne M.L.; Patel C.; Stephens P.; Tingo J.; Vetter V.L.; Ravishankar C.; Giglia T.M.. Outcomes Associated with Giant Coronary Artery Aneurysms after Kawasaki Disease: A Single-Center United States Experience. Journal of Pediatrics. 2024;274:114145$$$$M$Y$$$20240820$$HP$US$US
242271842$24227184$2$F$$20240827$20240820$20240905$EXP$$JP-TEVA-VS-3233541$TEVA$Naka M, Inaba A, Miyasaka H, Suzue K, Ishigaki J, Shibuya H, et al. An elderly case of paraneoplastic anti-NMDA receptor encephalitis associated with large cell neuroendocrine carcinoma of the lung. BMC-Pulm-Med 2024; 24 1-6.; Naka M, Inaba A, Miyasaka H, Suzue K, Ishigaki J, Shibuya H, et al. An elderly case of paraneoplastic anti-NMDA receptor encephalitis associated with large cell neuroendocrine carcinoma of the lung. BMC-Pulm-Med 2024; 24 1-6.; Naka M, Inaba A, Miyasaka H, Suzue K, Ishig...$70$YR$$M$Y$$$20240905$$HP$JP$JP
242271851$24227185$1$I$$20240813$20240820$20240820$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004552$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240820$$CN$US$US
242271861$24227186$1$I$$20240808$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN008360$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242271871$24227187$1$I$20240801$20240819$20240820$20240820$EXP$$US-BAYER-2024A119198$BAYER$$71$YR$E$F$Y$$$20240820$$CN$US$US
242271881$24227188$1$I$20240731$20240814$20240820$20240820$EXP$PT-INFARMED-J202408-49$PT-MYLANLABS-2024M1076079$MYLAN$$51$YR$$M$Y$70$KG$20240820$$MD$PT$PT
242271891$24227189$1$I$20240617$20240814$20240820$20240820$EXP$FR-AFSSAPS-PO2024000890$FR-MYLANLABS-2024M1075824$MYLAN$$47$YR$$F$Y$$$20240820$$PH$FR$FR
242271901$24227190$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A187146$ASTRAZENECA$$$$$F$Y$70$KG$20240820$$CN$US$
242271912$24227191$2$F$20240618$20240827$20240820$20240830$EXP$FR-AFSSAPS-AN2024001089$FR-009507513-2408FRA005712$MERCK$$69$YR$$F$Y$87$KG$20240830$$PH$FR$FR
242271921$24227192$1$I$20240804$20240812$20240820$20240820$EXP$$CN-AstraZeneca-2024A185780$ASTRAZENECA$$20692$DY$$M$Y$62$KG$20240820$$MD$CN$
242271931$24227193$1$I$$20240808$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN008357$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242271941$24227194$1$I$$20240808$20240820$20240820$EXP$$US-LEO Pharma-372682$LEO PHARM$$$$$M$Y$$$20240820$$MD$US$US
242271951$24227195$1$I$$20240818$20240820$20240820$PER$$US-BRACCO-2024US05099$BRACCO$Amro, A., Mansoor, K, Amro, M, Studeny, M, El-Hamdani, M. GADOLINIUM CONTRAST INDUCED KOUNIS SYNDROME. JACC. 2019;73, Issue 9 Mar:2413$52$YR$$F$Y$$$20240820$$HP$US$US
242271961$24227196$1$I$$20240808$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN008355$INCYTE$$$$$$Y$$$20240820$$PH$US$US
242271971$24227197$1$I$20240701$20240812$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012579$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242271981$24227198$1$I$20240815$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024162964$AMGEN$$73$YR$E$M$Y$$$20240820$$CN$US$US
242271991$24227199$1$I$20240801$20240814$20240820$20240820$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004553$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240820$$CN$IT$IT
242272001$24227200$1$I$20240808$20240812$20240820$20240820$PER$$US-BAYER-2024A116739$BAYER$$49$YR$A$F$Y$$$20240820$$MD$US$US
242272011$24227201$1$I$$20240808$20240820$20240820$EXP$$US-MYLANLABS-2024M1075635$MYLAN$Stewart-Bates B, Hall G, Mousallem T, Stallings A, Sleasman J. Transient loss of peripheral b-cells in a patient with congenital athymia and omenn^s syndrome. Ann-Allergy-Asthma-Immunol 2023; 131 (Suppl.) (5): S160 abstr. M275.$14$MON$$M$Y$$$20240820$$HP$US$US
242272021$24227202$1$I$20230101$20240809$20240820$20240820$EXP$$CA-UCBSA-2023040659$UCB$$$$$F$Y$$$20240820$$CN$CA$CA
242272031$24227203$1$I$$20240812$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128069$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$78.017$KG$20240820$$PH$US$US
242272041$24227204$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164323$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242272051$24227205$1$I$20240814$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163400$AMGEN$$70$YR$E$F$Y$$$20240820$$CN$US$US
242272061$24227206$1$I$20240301$20240816$20240820$20240820$EXP$$US-TAKEDA-US202022334$TAKEDA$$72$YR$$M$Y$$$20240820$$HP$US$US
242272071$24227207$1$I$$20240817$20240820$20240820$EXP$$CA-TAKEDA-2024TUS083370$TAKEDA$$$$$F$Y$$$20240820$$CN$CA$CA
242272092$24227209$2$F$$20240812$20240820$20240820$EXP$DE-EMA-DD-20240806-7482663-105013$DE-TORRENT-00027158$TORRENT$$14$MON$I$M$Y$$$20240820$$MD$DE$DE
242272102$24227210$2$F$$20240812$20240820$20240820$EXP$GB-MHRA-MED-202408121500517630-NJZBD$GB-TORRENT-00037584$TORRENT$$66$YR$E$F$Y$$$20240820$$HP$GB$GB
242272112$24227211$2$F$20230101$20240809$20240820$20240820$EXP$$GB-TORRENT-00037589$TORRENT$$26$YR$A$F$Y$$$20240820$$MD$GB$GB
242272122$24227212$2$F$20240721$20240808$20240820$20240821$EXP$$US-TORRENT-00013714$TORRENT$$47$YR$A$M$Y$$$20240821$$CN$US$US
242272132$24227213$2$F$$20240813$20240820$20240821$EXP$$US-TORRENT-00013715$TORRENT$$61$YR$A$F$Y$$$20240821$$HP$US$US
242272143$24227214$3$F$$20240828$20240820$20240902$EXP$$US-TORRENT-00013716$TORRENT$$40$YR$A$F$Y$$$20240902$$HP$US$US
242272151$24227215$1$I$$20240808$20240820$20240820$EXP$$NL-ROCHE-10000051849$ROCHE$Morsink L, Hazenberg C, Choi G, Groot M, Biswana A, Bellido M, et al. Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune Suppression. Transplantation and Cellular Therapy. 2024-Aug;30 (8):794-807. doi:10.1016/j.jtct.2024.05.009.$$$$$Y$$$20240820$$MD$NL$NL
242272161$24227216$1$I$$20240812$20240820$20240820$PER$$US-ABBVIE-5879357$ABBVIE$$$$$F$Y$$$20240820$$HP$US$US
242272171$24227217$1$I$$20240812$20240820$20240820$EXP$$GB-MYLANLABS-2024M1076794$MYLAN$Botrugno R, Rajlawat B, Finn D, Yesudian PD. Use of roflumilast in erosive oral inflammatory conditions. Br-J-Dermatol 2024; 191 (Suppl. 1) i62-i63 abstr. P099.$57$YR$$F$Y$$$20240820$$HP$GB$GB
242272181$24227218$1$I$20240628$20240812$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012580$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242272191$24227219$1$I$$20240812$20240820$20240820$EXP$$US-MYLANLABS-2024M1075849$MYLAN$Shaker N, Amadi CC, Welliver M, Otterson GA, Liebner DA, Shilo K. A Case of Mediastinal Carcinosarcoma With Beta-HCG Production and KRAS Mutation. Int-J-Surg-Pathol 2023; 31 (8): 1598-1604.$44$YR$$F$Y$$$20240820$$MD$US$US
242272201$24227220$1$I$$20240812$20240820$20240820$EXP$$AT-MYLANLABS-2024M1076816$MYLAN$Scorza CA, Scorza FA, Finsterer J. Daytime bruxism, tardive orofacial dyskinesia, and dysphagia as side effects to duloxetine use over nine years in an octogenarian. Clinics 2024; 79 1-2.$82$YR$$F$Y$$$20240820$$HP$AT$AT
242272221$24227222$1$I$$20240808$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN008352$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242272241$24227224$1$I$$20240812$20240820$20240820$EXP$$US-MYLANLABS-2024M1076418$MYLAN$Juneja P, Swor D. An Evidence-Based Approach to Diagnosis and Prognosis in a Young Woman with New-Onset Super-Refractory Status Epilepticus: A Case Report. Case-Rep-Neurol 2022; 14 (1): 5-11.$24$YR$$F$Y$$$20240820$$HP$US$US
242272252$24227225$2$F$$20240822$20240820$20240826$EXP$$US-Indivior Limited-INDV-156008-2024$RECKITT BENCKISER$$$$$$Y$$$20240826$$HP$US$US
242272261$24227226$1$I$$20240812$20240820$20240820$PER$$US-UNITED THERAPEUTICS-UNT-2024-025268$UNITED THERAPEUTICS$$$$$F$Y$$$20240820$$$US$US
242272271$24227227$1$I$$20240411$20240820$20240820$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442381$RANBAXY$$$$$F$Y$$$20240820$$CN$US$US
242272281$24227228$1$I$20240701$20240813$20240820$20240820$EXP$$SV-GSK-SV2024AMR101741$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$MD$SV$SV
242272291$24227229$1$I$$20240817$20240820$20240820$EXP$$NVSC2024IL137256$NOVARTIS$$$$$M$Y$$$20240820$$PH$IL$IL
242272301$24227230$1$I$20240801$20240819$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131339$BRISTOL MYERS SQUIBB$$100$YR$E$F$Y$$$20240820$$CN$US$US
242272311$24227231$1$I$20240605$20240819$20240820$20240820$EXP$$NVSC2024IN168090$NOVARTIS$$45$YR$$F$Y$$$20240820$$CN$IN$IN
242272325$24227232$5$F$20240726$20240827$20240820$20240905$EXP$$NVSC2024CN164502$NOVARTIS$$61$YR$$F$Y$63.5$KG$20240905$$MD$CN$CN
242272331$24227233$1$I$$20240815$20240820$20240820$PER$$US-JNJFOC-20240846201$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$MD$US$US
242272341$24227234$1$I$$20240807$20240820$20240820$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024098585$VIIV$$$$$$Y$$$20240820$$MD$US$US
242272351$24227235$1$I$20240802$20240813$20240820$20240820$PER$$US-BAYER-2024A116624$BAYER$$30$YR$A$F$Y$$$20240820$$MD$US$US
242272362$24227236$2$F$20240813$20240917$20240820$20240924$PER$$US-JNJFOC-20240836376$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240924$$PH$US$US
242272371$24227237$1$I$20240807$20240808$20240820$20240820$EXP$$US-Accord-441193$ACCORD$$23$YR$A$M$Y$$$20240820$$HP$US$US
242272401$24227240$1$I$20240521$20240807$20240820$20240820$EXP$FR-AFSSAPS-NC2024000916$FR-Accord-440721$ACCORD$$68$YR$E$F$Y$$$20240820$$MD$FR$FR
242272411$24227241$1$I$20240807$20240808$20240820$20240820$EXP$$US-Accord-441805$ACCORD$$67$YR$E$M$Y$$$20240820$$HP$US$US
242272421$24227242$1$I$20140101$20240808$20240820$20240820$EXP$FR-AFSSAPS-RS2024000775$FR-Accord-441103$ACCORD$$77$YR$E$F$Y$38$KG$20240820$$MD$FR$FR
242272431$24227243$1$I$20240628$20240807$20240820$20240820$EXP$FR-AFSSAPS-ST2024001242$FR-Accord-440806$ACCORD$$73$YR$E$F$Y$80$KG$20240820$$PH$FR$FR
242272441$24227244$1$I$$20240815$20240820$20240820$EXP$$US-TAKEDA-2024TUS082377$TAKEDA$$$$$M$Y$$$20240820$$HP$US$US
242272451$24227245$1$I$$20240812$20240820$20240820$EXP$$CA-APOTEX-2024AP009327$APOTEX$$$$$F$Y$$$20240820$$LW$CA$CA
242272461$24227246$1$I$$20240807$20240820$20240820$EXP$$GB-Accord-440811$ACCORD$Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP. A case of human T-lymphotropic virus-1-associated lichenoid dermatitis. Clinical and Experimental Dermatology. 2024;49(8):916-18. DOI:10.1093/ced/llae076.$61$YR$A$F$Y$$$20240820$$MD$GB$GB
242272472$24227247$2$F$$20240812$20240820$20240822$EXP$$US-TEVA-VS-3233125$TEVA$$$$$M$Y$$$20240822$$CN$US$US
242272481$24227248$1$I$$20240807$20240820$20240820$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07625$HIKMA$Lee M, McCarron J, Balinski A, Bower R. Lee M, McCarron J, Balinski A, Bower R. Intravenous acetaminophen associated with acute liver failure. BMJ case reports. 2022;15(11):e251305$7$DEC$$F$Y$$$20240820$$MD$US$US
242272491$24227249$1$I$20240101$20240815$20240820$20240820$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025530$UNITED THERAPEUTICS$$$$$M$Y$78.458$KG$20240820$$$US$US
242272501$24227250$1$I$$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011864$ELI LILLY AND CO$$86$YR$E$M$Y$$$20240820$$HP$US$US
242272511$24227251$1$I$20240809$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010664$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240820$$CN$US$US
242272521$24227252$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011006$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240820$$CN$US$US
242272531$24227253$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010566$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240820$$CN$US$US
242272541$24227254$1$I$20240809$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010597$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240820$$CN$US$US
242272551$24227255$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010735$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240820$$CN$US$US
242272561$24227256$1$I$$20240813$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408008802$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240820$$CN$US$US
242272571$24227257$1$I$$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011742$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240820$$CN$US$US
242272592$24227259$2$F$$20240819$20240820$20240822$EXP$$US-PFIZER INC-202400237970$PFIZER$Jha, V.. A Report of a Rare Case of Kounis Syndrome in a Patient With HIV/AIDS and Mpox. Cureus. 2024;16(7):10.7759/cureus.63957$45$YR$$M$Y$$$20240822$$MD$US$US
242272601$24227260$1$I$$20240816$20240820$20240820$EXP$$US-PFIZER INC-202400238612$PFIZER$$86$YR$$M$Y$$$20240820$$PH$US$US
242272612$24227261$2$F$$20240816$20240820$20240823$EXP$$RU-PFIZER INC-202400236439$PFIZER$Abdurashidova, R.. Primary cutaneous gamma/delta t-cell lymphoma: a clinical case. Hematology and Transfusiology. 2024;69(2):157-158$54$YR$$F$Y$$$20240823$$MD$RU$RU
242272621$24227262$1$I$$20240816$20240820$20240820$EXP$$GE-PFIZER INC-PV202400107526$PFIZER$Kashibadze, K.. Is Liver Retransplant Possible After Oropharyngeal Squamous Cell Carcinoma Development?. Exp-Clin-Transplant. 2023;21(7):626-629$44$YR$$M$Y$$$20240820$$HP$GE$GE
242272641$24227264$1$I$$20240816$20240820$20240820$EXP$$CA-PFIZER INC-202400238326$PFIZER$$$$$$Y$$$20240820$$HP$CA$CA
242272651$24227265$1$I$$20240816$20240820$20240820$EXP$$US-PFIZER INC-PV202400107590$PFIZER$Wright, M.. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021;25(6):10.1111/petr.14041$23$MON$$F$Y$$$20240820$$HP$US$US
242272662$24227266$2$F$$20240821$20240820$20240827$EXP$$IN-PFIZER INC-PV202400107124$PFIZER$Nimi, G.. Disseminated Protozoa Zopfii Infection in Liver transplant Recipient. Journal of Clinical and Experimental Hepatology. 2024;14(Suppl 1):S86$62$YR$$M$Y$$$20240827$$HP$IN$IN
242272681$24227268$1$I$20230330$20240807$20240820$20240820$EXP$$CN-PFIZER INC-2023SGN04204$PFIZER$$57$YR$$M$Y$50$KG$20240820$$MD$CN$CN
242272703$24227270$3$F$20230901$20240821$20240820$20240829$EXP$$CN-PFIZER INC-PV202400107497$PFIZER$Li, J.. Clinical diagnosis and detection of hemolytic crisis caused by anti-tigecycline antibody. Chinese Journal of Microbiology and Immunology. 2024;44(7):614-619$11$MON$$F$Y$$$20240829$$HP$CN$CN
242272712$24227271$2$F$$20240819$20240820$20240822$EXP$$JP-PFIZER INC-202400237222$PFIZER$Fujimoto, N.. Takotsubo syndrome in a cancer patient treated with a combination of anti-cancer drugs including immune checkpoint inhibitors: a case report.. European heart journal. Case reports. 2024;8(8):ytae355$66$YR$$F$Y$$$20240822$$MD$JP$JP
242272732$24227273$2$F$20210101$20240823$20240820$20240829$EXP$$IT-PFIZER INC-202400235403$PFIZER$Frezzini, S.. PARP Inhibitors in Brain Metastases from Epithelial Ovarian Cancer through a Multimodal Patient Journey: Case Reports and Literature Review. International Journal of Molecular Sciences. 2024;25(14):7887$52$YR$$F$Y$$$20240829$$MD$IT$IT
242272763$24227276$3$F$$20240828$20240820$20240903$EXP$$US-PFIZER INC-202400237976$PFIZER$Perry, R.. SARS-CoV-2-Triggered Hemophagocytic Lymphohistiocytosis with Complications of Posterior Reversible Encephalopathy Syndrome. Case reports in pediatrics. 2024;2024:10.1155/2024/8829060$6$YR$$F$Y$$$20240903$$MD$US$US
242272781$24227278$1$I$$20240809$20240820$20240820$PER$$US-SMPA-2024SPA001227$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272792$24227279$2$F$20240101$20240917$20240820$20240927$PER$$US-SMPA-2024SPA001011$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242272801$24227280$1$I$$20240722$20240820$20240820$PER$$US-SMPA-202402-URV-000206$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272811$24227281$1$I$$20240808$20240820$20240820$PER$$US-SMPA-2024SPA001144$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272821$24227282$1$I$$20240806$20240820$20240820$PER$$US-SMPA-2024SPA001000$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272831$24227283$1$I$$20240722$20240820$20240820$PER$$US-SMPA-2024MYSCI0700888$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272841$24227284$1$I$$20240722$20240820$20240820$PER$$US-SMPA-2024MYSCI0700910$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272851$24227285$1$I$$20240723$20240820$20240820$PER$$US-SMPA-202407-URV-001108$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272863$24227286$3$F$20240701$20240916$20240820$20240930$EXP$$US-SMPA-2024SPA000394$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242272871$24227287$1$I$$20240807$20240820$20240820$PER$$US-SMPA-2024SPA001049$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272881$24227288$1$I$$20240724$20240820$20240820$PER$$US-SMPA-202407-URV-001110$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272901$24227290$1$I$$20240812$20240820$20240820$PER$$US-SMPA-2024SPA001261$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272911$24227291$1$I$$20240801$20240820$20240820$PER$$US-SMPA-2024SPA000699$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272921$24227292$1$I$20240719$20240812$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012583$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242272941$24227294$1$I$20240101$20240806$20240820$20240820$PER$$US-SMPA-2024SPA000983$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272952$24227295$2$F$20240601$20240906$20240820$20240925$PER$$US-SMPA-202407-URV-001098$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242272971$24227297$1$I$$20240808$20240820$20240820$PER$$US-SMPA-2024SPA001118$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272981$24227298$1$I$$20240722$20240820$20240820$PER$$US-SMPA-2024MYSCI0600849$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242272992$24227299$2$F$$20240816$20240820$20240910$PER$$US-SMPA-2024SPA001160$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
242273001$24227300$1$I$$20240722$20240820$20240820$PER$$US-SMPA-2024MYSCI0700932$SUNOVION$$$$$$Y$$$20240820$$MD$US$US
242273011$24227301$1$I$$20240809$20240820$20240820$PER$$US-SMPA-2024SPA001179$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242273021$24227302$1$I$$20240806$20240820$20240820$PER$$US-SMPA-2024SPA001048$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242273031$24227303$1$I$$20240807$20240820$20240820$PER$$US-SMPA-2024SPA001041$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242273041$24227304$1$I$20240816$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-57119$$FDA-CTU$$$$$$N$$$20240816$$CN$US$
242273051$24227305$1$I$$20240730$20240820$20240820$PER$$US-SMPA-2024SPA000500$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242273062$24227306$2$F$$20240903$20240820$20240906$PER$$NVSC2024US166270$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
242273071$24227307$1$I$$20221102$20240820$20240820$EXP$$US-AstraZeneca-2022A364792$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242273081$24227308$1$I$$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-57131$$FDA-CTU$$$$$$N$$$20240816$N$$US$
242273101$24227310$1$I$$20240814$20240820$20240820$EXP$$NVSC2024BR167065$NOVARTIS$$$$$$Y$$$20240820$$MD$BR$BR
242273111$24227311$1$I$20240815$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-57123$$FDA-CTU$$73$YR$$M$N$$$20240816$N$$US$
242273121$24227312$1$I$$20240814$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA072787$SANDOZ$$78$YR$$M$Y$$$20240820$$HP$CA$CA
242273131$24227313$1$I$20240101$20240812$20240820$20240820$PER$$US-BAYER-2024A116591$BAYER$$63$YR$A$F$Y$92.5$KG$20240820$$CN$US$US
242273142$24227314$2$F$20240101$20240909$20240820$20240914$PER$$US-AMGEN-USASP2024164662$AMGEN$$75$YR$E$F$Y$$$20240914$$CN$US$US
242273152$24227315$2$F$20240101$20240816$20240820$20240827$EXP$$US-Indivior Limited-SV-MMM-L1H95CDK$RECKITT BENCKISER$$$$$$Y$$$20240827$$CN$US$US
242273161$24227316$1$I$20240606$20240815$20240820$20240820$EXP$$US-RDY-SPO/USA/23/0181964$DR REDDYS$$43$YR$A$M$Y$$$20240820$$CN$US$US
242273171$24227317$1$I$$20240819$20240820$20240820$EXP$$GB-MYLANLABS-2024M1076997$MYLAN$$$$$M$Y$$$20240820$$CN$GB$GB
242273182$24227318$2$F$$20240816$20240820$20240912$PER$$US-BEH-2024177363$CSL BEHRING$$76$YR$E$M$Y$$$20240912$$CN$US$US
242273191$24227319$1$I$20231116$20240812$20240820$20240820$EXP$FR-AFSSAPS-NY2024000911$FR-TEVA-VS-3233246$TEVA$$62$YR$$M$Y$85.5$KG$20240820$$MD$FR$FR
242273211$24227321$1$I$20240815$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-57125$$FDA-CTU$$28$YR$$F$N$$$20240816$N$HP$US$
242273221$24227322$1$I$20240815$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-57127$$FDA-CTU$$77$YR$$F$N$$$20240816$N$$US$
242273231$24227323$1$I$20240807$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-57122$$FDA-CTU$$52$YR$$F$N$$$20240816$N$PH$US$
242273242$24227324$2$F$20240403$20240911$20240820$20240918$EXP$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000779$PAREXEL$$$$$$Y$$$20240918$$HP$US$US
242273251$24227325$1$I$20240819$20240819$20240820$20240820$PER$$US-AMGEN-USASP2024165132$AMGEN$$69$YR$E$F$Y$$$20240820$$CN$US$US
242273271$24227327$1$I$$20240819$20240820$20240820$PER$$US-ROCHE-10000060813$ROCHE$$$$$$Y$$$20240820$$CN$US$US
242273281$24227328$1$I$20240102$20240819$20240820$20240820$PER$$US-ROCHE-10000060798$ROCHE$$14$YR$T$F$Y$$$20240820$$CN$US$US
242273291$24227329$1$I$$20240809$20240820$20240820$PER$$US-ABBVIE-5876414$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242273312$24227331$2$F$$20240904$20240820$20240905$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046630$BOEHRINGER INGELHEIM$N A, Karibe H, Narisawa A, Endo H. Characteristics and outcome of patients with traumatic brain injury after specific reversal of anticoagulants. Journal of Japan Society of Neurological Emergencies + Critical Care. 2024;36(2): 27-33.$87$YR$E$M$Y$$$20240905$$MD$JP$JP
242273321$24227332$1$I$$20240815$20240820$20240820$EXP$$GB-MYLANLABS-2024M1076313$MYLAN$$$$$F$Y$$$20240820$$PH$GB$GB
242273332$24227333$2$F$$20240822$20240820$20240826$EXP$$HU-MYLANLABS-2024M1076076$MYLAN$Barczi Gy, Papp R, David DA, Fulop GA, Kulyassa PM, Kulcsar F, Skoda R, Straub E, Becker D.. Sudden cardiac death of a patient who has basically low profile. Does psychiatric treatment modify risk?. Cardiologia Hungarica Supplementum. 2024;C 309$18$YR$$M$Y$$$20240826$$HP$HU$HU
242273341$24227334$1$I$20220101$20240815$20240820$20240820$EXP$GB-SYR-69041$GB-MYLANLABS-2024M1076393$MYLAN$Williams H, Thoppuram N, Law KY, Simms J. Post-operative post-cognitive dysfunction: progressive multifocal leukoencephalopathy (PML), an unexpected finding in an elderly patient. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24$87$YR$$F$Y$$$20240820$$MD$GB$GB
242273353$24227335$3$F$20230401$20240904$20240820$20240918$EXP$$US-UCBSA-2024041668$UCB$$39$YR$$F$Y$$$20240918$$CN$US$US
242273361$24227336$1$I$20220101$20240816$20240820$20240820$EXP$$US-UCBSA-2024024973$UCB$$$$$F$Y$$$20240820$$HP$US$US
242273381$24227338$1$I$$20240819$20240820$20240820$PER$$US-ROCHE-10000060782$ROCHE$$$$A$$Y$$$20240820$$CN$US$US
242273391$24227339$1$I$$20240722$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07384$LUPIN$$$$$$Y$$$20240820$$CN$US$US
242273401$24227340$1$I$$20240819$20240820$20240820$EXP$$NVSC2024CN168268$NOVARTIS$$83$YR$$M$Y$$$20240820$$CN$CN$CN
242273411$24227341$1$I$20240807$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-57121$$FDA-CTU$$79$YR$$M$N$80$KG$20240816$Y$HP$US$
242273423$24227342$3$F$20240911$20240923$20240820$20240927$EXP$$NVSC2024US138645$NOVARTIS$$67$YR$$F$Y$$$20240927$$CN$US$US
242273432$24227343$2$F$20220101$20240819$20240820$20240821$EXP$$US-JNJFOC-20240842150$JOHNSON AND JOHNSON$$59$YR$A$F$Y$63.56$KG$20240821$$CN$US$US
242273443$24227344$3$F$20240508$20240822$20240820$20240823$EXP$$CA-UCBSA-2024040741$UCB$$50$YR$$F$Y$$$20240823$$CN$CA$CA
242273451$24227345$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57032$$FDA-CTU$$64$YR$$F$N$280$LBS$20240819$N$$US$
242273461$24227346$1$I$20240808$20240813$20240820$20240820$EXP$$BR-SERVIER DO BRASIL-S24010158$SERVIER$$$$$$Y$$$20240820$$MD$BR$BR
242273472$24227347$2$F$20240305$20240830$20240820$20240903$EXP$GB-MHRA-MED-202408131609536260-DYWZV$GB-MYLANLABS-2024M1076939$MYLAN$$84$YR$$F$Y$44$KG$20240903$$MD$GB$GB
242273481$24227348$1$I$$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-131750$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242273491$24227349$1$I$$20231030$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-132286$REGENERON$$$$$M$Y$$$20240820$$PH$US$US
242273501$24227350$1$I$20231001$20240118$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-133768$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242273511$24227351$1$I$$20240201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-131619$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242273521$24227352$1$I$20230101$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-132973$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242273531$24227353$1$I$20230101$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-131629$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242273541$24227354$1$I$20231019$20231027$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-131633$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242273551$24227355$1$I$20231019$20231101$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-133769$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242273561$24227356$1$I$20231031$20231031$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-133058$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242273571$24227357$1$I$$20230929$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-093024$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242273581$24227358$1$I$$20240816$20240820$20240820$PER$$US-GILEAD-2024-0684582$GILEAD$$$$A$F$Y$$$20240820$$CN$US$US
242273591$24227359$1$I$20240810$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-57137$$FDA-CTU$$63$YR$$M$N$67$KG$20240816$N$MD$US$
242273601$24227360$1$I$$20240813$20240820$20240820$EXP$$NVSC2024DE165424$NOVARTIS$Wielenberg CF, Fostitsch JC, Volz C, Marks R, Michalski K, Wasch R et al.. FDG-PET/CT als effektives Verfahren zur Vorhersage und Bewertung des Ansprechens auf CAR-T-Zell-Therapie bei Patienten mit einem Non-Hodgkin-Lymphom (NHL) [ FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin- Lymphoma (NHL)]. NUKLEARMEDIZIN-NUCLEARMEDICINE. 2024;63:252-8$$$$$Y$$$20240820$$HP$DE$DE
242273611$24227361$1$I$20240814$20240816$20240816$20240816$DIR$FDA-CDER-CTU-2024-57134$$FDA-CTU$$79$YR$$M$N$80$KG$20240816$Y$HP$US$
242273621$24227362$1$I$$20240808$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN008344$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242273632$24227363$2$F$$20240920$20240820$20240920$30DAY$$US-PFIZER INC-202400234120$PFIZER$$6$YR$$M$Y$16.78$KG$20240920$$CN$US$US
242273641$24227364$1$I$$20240814$20240820$20240820$EXP$$CA-SANDOZ INC.-NVSC2021CA119555$SANDOZ$$23$YR$$F$Y$$$20240820$$HP$CA$CA
242273663$24227366$3$F$20240801$20240925$20240820$20240927$30DAY$$US-PFIZER INC-202400236092$PFIZER$$9$YR$$F$Y$24.04$KG$20240927$$MD$US$US
242273671$24227367$1$I$$20240722$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07463$LUPIN$$$$$$Y$$$20240820$$CN$US$US
242273681$24227368$1$I$$20240709$20240820$20240820$PER$$US-FMCRTG-FMC-2407-000826$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240820$$CN$US$US
242273691$24227369$1$I$$20240711$20240820$20240820$PER$$US-FMCRTG-FMC-2407-000814$FRESENIUS MEDICAL CARE$$71$YR$E$F$Y$$$20240820$$HP$US$US
242273701$24227370$1$I$$20240710$20240820$20240820$PER$$US-FMCRTG-FMC-2407-000856$FRESENIUS MEDICAL CARE$$80$YR$E$M$Y$89$KG$20240820$$HP$US$US
242273721$24227372$1$I$20240706$20240710$20240820$20240820$PER$$US-FMCRTG-FMC-2407-000825$FRESENIUS MEDICAL CARE$$82$YR$E$F$Y$52$KG$20240820$$HP$US$US
242273731$24227373$1$I$$20240708$20240820$20240820$PER$$US-FMCRTG-FMC-2407-000845$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240820$$HP$US$US
242273741$24227374$1$I$$20240709$20240820$20240820$PER$$US-FMCRTG-FMC-2407-000854$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240820$$HP$US$US
242273751$24227375$1$I$$20240621$20240820$20240820$PER$$US-FMCRTG-FMC-2406-000759$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240820$$HP$US$US
242273761$24227376$1$I$$20240710$20240820$20240820$PER$$US-FMCRTG-FMC-2407-000855$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240820$$CN$US$US
242273771$24227377$1$I$20240710$20240711$20240820$20240820$PER$$US-FMCRTG-FMC-2407-000841$FRESENIUS MEDICAL CARE$$52$YR$A$M$Y$124$KG$20240820$$HP$US$US
242273781$24227378$1$I$20240710$20240712$20240820$20240820$PER$$US-FMCRTG-FMC-2407-000838$FRESENIUS MEDICAL CARE$$76$YR$E$M$Y$$$20240820$$HP$US$US
242273791$24227379$1$I$$20240708$20240820$20240820$PER$$US-FMCRTG-FMC-2407-000834$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240820$$CN$US$US
242273801$24227380$1$I$$20240710$20240820$20240820$PER$$US-FMCRTG-FMC-2407-000835$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240820$$CN$US$US
242273811$24227381$1$I$20240724$20240814$20240820$20240820$PER$$US-BAYER-2024A117801$BAYER$$59$YR$A$F$Y$$$20240820$$CN$US$US
242273821$24227382$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164299$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242273841$24227384$1$I$20230101$20231102$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134078$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242273851$24227385$1$I$20230101$20231102$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134081$REGENERON$$$$$F$Y$$$20240820$$MD$US$US
242273861$24227386$1$I$20231102$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134067$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242273871$24227387$1$I$20230101$20231102$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134086$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242273881$24227388$1$I$$20240209$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134123$REGENERON$$$$$M$Y$$$20240820$$PH$US$US
242273891$24227389$1$I$20231103$20231227$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134139$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242273901$24227390$1$I$$20240126$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134366$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242273911$24227391$1$I$20230101$20231106$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134378$REGENERON$$$$$F$Y$$$20240820$$MD$US$US
242273921$24227392$1$I$20231102$20240112$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134399$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242273931$24227393$1$I$20230101$20240112$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134878$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242273941$24227394$1$I$20231001$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-135630$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242273951$24227395$1$I$20230101$20231120$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-135652$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242273961$24227396$1$I$20230101$20240201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-135766$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242273971$24227397$1$I$20231001$20240104$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134085$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242273981$24227398$1$I$$20231108$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-135641$REGENERON$$$$$$Y$$$20240820$$HP$US$US
242273991$24227399$1$I$20230901$20231227$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-136417$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274001$24227400$1$I$20231001$20240103$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-137537$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274011$24227401$1$I$20230101$20240112$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-137545$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242274021$24227402$1$I$$20240817$20240820$20240820$EXP$GB-MHRA-MED-202408170702368450-SLYHV$GB-MYLANLABS-2024M1076809$MYLAN$$$$$M$Y$$$20240820$$CN$GB$GB
242274031$24227403$1$I$$20240812$20240820$20240820$EXP$$CA-FreseniusKabi-FK202412424$FRESENIUS KABI$$19$YR$A$F$Y$$$20240820$$HP$CA$CA
242274041$24227404$1$I$20231001$20231103$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134128$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274051$24227405$1$I$20230711$20240812$20240820$20240820$EXP$$ES-FreseniusKabi-FK202412391$FRESENIUS KABI$$50$YR$A$M$Y$$$20240820$$HP$ES$ES
242274061$24227406$1$I$20240601$20240812$20240820$20240820$EXP$$FR-FreseniusKabi-FK202409601$FRESENIUS KABI$$$$E$M$Y$171$KG$20240820$$MD$FR$FR
242274071$24227407$1$I$20240807$20240815$20240820$20240820$EXP$$NVSC2024US167146$NOVARTIS$$74$YR$$M$Y$$$20240820$$HP$US$US
242274081$24227408$1$I$20230101$20231215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-134149$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274091$24227409$1$I$20240709$20240812$20240820$20240820$EXP$GB-MHRA-MED-202408121723240630-QZMCD$GB-FreseniusKabi-FK202412468$FRESENIUS KABI$$57$YR$A$M$Y$81$KG$20240820$$CN$GB$GB
242274101$24227410$1$I$$20240815$20240820$20240820$EXP$$US-LUNDBECK-DKLU4003098$LUNDBECK$$$$$$Y$$$20240820$$HP$US$US
242274111$24227411$1$I$20240801$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130728$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240820$$PH$US$US
242274121$24227412$1$I$20231115$20240112$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-138956$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274131$24227413$1$I$20231114$20231122$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-138984$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274141$24227414$1$I$20231103$20240126$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-141026$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242274151$24227415$1$I$$20231117$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-141038$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274161$24227416$1$I$20221215$20240816$20240820$20240820$EXP$$US-UCBSA-2024041657$UCB$$41$YR$$F$Y$$$20240820$$HP$US$US
242274171$24227417$1$I$$20240807$20240820$20240820$PER$$US-AstraZeneca-2024A183733$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242274181$24227418$1$I$20231101$20240112$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-137564$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242274191$24227419$1$I$20230101$20231116$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-139476$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274201$24227420$1$I$20231014$20240110$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-141019$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242274211$24227421$1$I$20231116$20240126$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-141034$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274221$24227422$1$I$20231122$20231211$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-143037$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242274231$24227423$1$I$20231128$20240205$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-144623$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242274241$24227424$1$I$20231128$20240201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-144645$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274252$24227425$2$F$20240801$20240827$20240820$20240827$EXP$$SE-AMERICAN REGENT INC-2024003195$AMERICAN REGENT$$$$E$F$Y$$$20240827$$CN$SE$SE
242274261$24227426$1$I$20230101$20231117$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-141041$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274271$24227427$1$I$20230501$20231117$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-141042$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242274281$24227428$1$I$20231101$20240118$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-141337$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242274291$24227429$1$I$20231113$20240229$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-144673$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242274301$24227430$1$I$20231118$20240201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-144150$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242274311$24227431$1$I$20240806$20240807$20240820$20240820$PER$$US-SA-2024SA239392$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240820$$MD$US$US
242274321$24227432$1$I$20240807$20240807$20240820$20240820$PER$$US-SA-2024SA239823$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240820$$MD$US$US
242274332$24227433$2$F$20240101$20240812$20240820$20240821$PER$$US-SA-2024SA238726$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240821$$MD$US$US
242274341$24227434$1$I$20240801$20240808$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN008341$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242274352$24227435$2$F$20210101$20240812$20240820$20240821$PER$$US-SA-2024SA240659$SANOFI AVENTIS$$75$YR$E$F$Y$48.98$KG$20240821$$MD$US$US
242274361$24227436$1$I$20231127$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-145003$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274371$24227437$1$I$20230101$20240118$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-144683$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274381$24227438$1$I$$20240223$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-145012$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274391$24227439$1$I$$20240229$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-145015$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242274401$24227440$1$I$20230101$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-146665$REGENERON$$$$$$Y$$$20240820$$CN$US$US
242274411$24227441$1$I$20231203$20240209$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-147100$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274421$24227442$1$I$$20240201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-148289$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274431$24227443$1$I$20231120$20231206$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-148305$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242274441$24227444$1$I$$20240124$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-148329$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274451$24227445$1$I$20231122$20240209$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-148798$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274461$24227446$1$I$20231209$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-151181$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274471$24227447$1$I$20220101$20240112$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-151284$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242274481$24227448$1$I$20230101$20231201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-146578$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242274491$24227449$1$I$20231203$20240508$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-147099$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242274501$24227450$1$I$20231203$20240229$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-147660$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274511$24227451$1$I$20231211$20240112$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-150642$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242274521$24227452$1$I$20231201$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-151207$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242274531$24227453$1$I$20230101$20240223$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-151300$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242274541$24227454$1$I$$20240812$20240820$20240820$EXP$$GB-TEVA-VS-3232964$TEVA$$66$YR$$M$Y$70$KG$20240820$$PH$GB$GB
242274551$24227455$1$I$20240301$20240806$20240820$20240820$PER$$US-SA-2024SA238802$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240820$$MD$US$US
242274561$24227456$1$I$20240101$20240808$20240820$20240820$PER$$US-SA-2024SA240685$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240820$$MD$US$US
242274571$24227457$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA241192$SANOFI AVENTIS$$$$A$F$Y$88.9$KG$20240820$$MD$US$US
242274581$24227458$1$I$20240201$20240806$20240820$20240820$PER$$US-SA-2024SA226172$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240820$$MD$US$US
242274591$24227459$1$I$20240701$20240808$20240820$20240820$PER$$US-SA-2024SA241177$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240820$$MD$US$US
242274601$24227460$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA239061$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242274611$24227461$1$I$20240812$20240812$20240820$20240820$EXP$$GB-TEVA-VS-3232914$TEVA$$49$YR$$M$Y$103$KG$20240820$$MD$GB$GB
242274621$24227462$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA230794$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240820$$CN$US$US
242274631$24227463$1$I$20240101$20240808$20240820$20240820$PER$$US-SA-2024SA185349$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240820$$MD$US$US
242274642$24227464$2$F$20240801$20240812$20240820$20240821$PER$$US-SA-2024SA239218$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240821$$MD$US$US
242274651$24227465$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA240081$SANOFI AVENTIS$$$$C$F$Y$$$20240820$$MD$US$US
242274661$24227466$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA240161$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240820$$MD$US$US
242274671$24227467$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA239962$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240820$$CN$US$US
242274681$24227468$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA237384$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240820$$PH$US$US
242274691$24227469$1$I$$20240817$20240819$20240819$DIR$FDA-CDER-CTU-2024-56985$$FDA-CTU$$$$$M$N$$$20240817$N$HP$US$
242274701$24227470$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA243189$SANOFI AVENTIS$$$$A$F$Y$84.413$KG$20240820$$MD$US$US
242274711$24227471$1$I$20240101$20240808$20240820$20240820$PER$$US-SA-2024SA238894$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240820$$MD$US$US
242274721$24227472$1$I$20240801$20240808$20240820$20240820$PER$$US-SA-2024SA240711$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240820$$CN$US$US
242274731$24227473$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241625$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240820$$CN$US$US
242274741$24227474$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA239480$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242274751$24227475$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA240793$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240820$$MD$US$US
242274762$24227476$2$F$20240801$20240819$20240820$20240828$PER$$US-SA-2024SA241577$SANOFI AVENTIS$$56$YR$A$M$Y$67.13$KG$20240828$$MD$US$US
242274771$24227477$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA241960$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240820$$MD$US$US
242274781$24227478$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA240276$SANOFI AVENTIS$$$$A$M$Y$65$KG$20240820$$MD$US$US
242274791$24227479$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA239970$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240820$$MD$US$US
242274801$24227480$1$I$20240805$20240809$20240820$20240820$PER$$US-SA-2024SA242300$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240820$$MD$US$US
242274811$24227481$1$I$20240101$20240808$20240820$20240820$PER$$US-SA-2024SA240145$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240820$$MD$US$US
242274821$24227482$1$I$20240601$20240809$20240820$20240820$PER$$US-SA-2024SA242285$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240820$$MD$US$US
242274831$24227483$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164077$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242274841$24227484$1$I$$20240819$20240820$20240820$EXP$$US-GILEAD-2024-0684645$GILEAD$$72$YR$E$M$Y$$$20240820$$MD$US$US
242274851$24227485$1$I$20211015$20240809$20240820$20240820$PER$$US-SA-2024SA242992$SANOFI AVENTIS$$63$YR$A$F$Y$113$KG$20240820$$MD$US$US
242274861$24227486$1$I$20231001$20240809$20240820$20240820$PER$$US-SA-2024SA241573$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240820$$MD$US$US
242274874$24227487$4$F$$20240906$20240820$20240915$PER$$US-SA-2024SA243020$SANOFI AVENTIS$$$$$F$Y$$$20240915$$CN$US$US
242274881$24227488$1$I$20240809$20240809$20240820$20240820$PER$$US-SA-2024SA241552$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240820$$MD$US$US
242274891$24227489$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241272$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242274901$24227490$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA239770$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240820$$MD$US$US
242274911$24227491$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241803$SANOFI AVENTIS$$$$A$F$Y$77$KG$20240820$$MD$US$US
242274921$24227492$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240536$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240820$$MD$US$US
242274932$24227493$2$F$$20240821$20240820$20240829$EXP$GB-MHRA-TPP53600481C20568229YC1723034693510$GB-PERRIGO-24GB007458$PERRIGO$$24$YR$$F$Y$69$KG$20240829$$HP$GB$GB
242274942$24227494$2$F$20240801$20240809$20240820$20240826$PER$$US-SA-2024SA241246$SANOFI AVENTIS$$$$$F$Y$$$20240826$$CN$US$US
242274951$24227495$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA241380$SANOFI AVENTIS$$14$YR$T$M$Y$42.086$KG$20240820$$MD$US$US
242274961$24227496$1$I$20230101$20240809$20240820$20240820$PER$$US-SA-2024SA240911$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240820$$MD$US$US
242274971$24227497$1$I$20240101$20240805$20240820$20240820$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1051$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240820$$CN$US$US
242274981$24227498$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240874$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$CN$US$US
242274991$24227499$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240478$SANOFI AVENTIS$$5$YR$C$M$Y$33.4$KG$20240820$$HP$US$US
242275011$24227501$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240615$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240820$$CN$US$US
242275021$24227502$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA239322$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240820$$HP$US$US
242275031$24227503$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241782$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240820$$MD$US$US
242275041$24227504$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241955$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242275051$24227505$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240721$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240820$$MD$US$US
242275062$24227506$2$F$20240807$20240813$20240820$20240827$PER$$US-SA-2024SA240708$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240827$$HP$US$US
242275071$24227507$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240185$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242275082$24227508$2$F$20240801$20240919$20240820$20240930$PER$$US-SA-2024SA241354$SANOFI AVENTIS$$76$YR$E$F$Y$$$20241001$$MD$US$US
242275091$24227509$1$I$$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-151891$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242275101$24227510$1$I$20231215$20240201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-152572$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242275111$24227511$1$I$20231201$20231218$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-153073$REGENERON$$$$$M$Y$$$20240820$$MD$US$US
242275121$24227512$1$I$20231213$20240126$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-153086$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242275131$24227513$1$I$20230101$20240201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-153809$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242275141$24227514$1$I$$20240223$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-153813$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242275151$24227515$1$I$$20240808$20240820$20240820$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24501$SAMSUNG BIOEPIS$$32$YR$A$F$Y$$$20240820$$CN$GB$GB
242275161$24227516$1$I$20240101$20240813$20240820$20240820$EXP$$US-Vifor (International) Inc.-VIT-2024-07286$VIFOR$$62$YR$$M$Y$83.8$KG$20240820$$HP$US$US
242275181$24227518$1$I$20230101$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-152999$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242275191$24227519$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA242851$SANOFI AVENTIS$$50$YR$A$M$Y$107.95$KG$20240820$$MD$US$US
242275201$24227520$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240792$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240820$$HP$US$US
242275211$24227521$1$I$$20231214$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-152610$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242275221$24227522$1$I$20230101$20240223$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-153005$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242275231$24227523$1$I$20231214$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-153812$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242275241$24227524$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241941$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240820$$MD$US$US
242275252$24227525$2$F$20240101$20240822$20240820$20240906$PER$$US-SA-2024SA242732$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240906$$MD$US$US
242275261$24227526$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242497$SANOFI AVENTIS$$$$A$M$Y$102.51$KG$20240820$$MD$US$US
242275271$24227527$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241065$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240820$$MD$US$US
242275281$24227528$1$I$20240701$20240809$20240820$20240820$PER$$US-SA-2024SA240919$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240820$$MD$US$US
242275291$24227529$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA241127$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240820$$MD$US$US
242275301$24227530$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240796$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240820$$MD$US$US
242275311$24227531$1$I$20240101$20240813$20240820$20240820$PER$$US-SA-2024SA242826$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240820$$MD$US$US
242275321$24227532$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241275$SANOFI AVENTIS$$$$A$M$Y$$$20240820$$MD$US$US
242275331$24227533$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241425$SANOFI AVENTIS$$$$E$F$Y$$$20240820$$MD$US$US
242275341$24227534$1$I$$20240815$20240820$20240820$PER$$US-BAYER-2024A117821$BAYER$$$$$$Y$$$20240820$$CN$US$US
242275351$24227535$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241360$SANOFI AVENTIS$$$$T$F$Y$$$20240820$$HP$US$US
242275371$24227537$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA196377$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240820$$MD$US$US
242275381$24227538$1$I$20240601$20240809$20240820$20240820$PER$$US-SA-2024SA242727$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240820$$MD$US$US
242275391$24227539$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA243134$SANOFI AVENTIS$$$$$F$Y$$$20240820$$CN$US$US
242275401$24227540$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242551$SANOFI AVENTIS$$$$A$F$Y$52$KG$20240820$$CN$US$US
242275411$24227541$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242821$SANOFI AVENTIS$$$$A$M$Y$$$20240820$$MD$US$US
242275421$24227542$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242715$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240820$$CN$US$US
242275434$24227543$4$F$$20240906$20240820$20240913$PER$$US-SA-2024SA243043$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240913$$CN$US$US
242275441$24227544$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242324$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240820$$MD$US$US
242275451$24227545$1$I$20240801$20240812$20240820$20240820$PER$$US-SA-2024SA242873$SANOFI AVENTIS$$3$YR$C$M$Y$12.24$KG$20240820$$MD$US$US
242275462$24227546$2$F$$20240904$20240820$20240927$PER$$US-SA-2024SA242721$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240927$$MD$US$US
242275481$24227548$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242910$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240820$$MD$US$US
242275492$24227549$2$F$$20240829$20240820$20240911$PER$$US-SA-2024SA241887$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240911$$MD$US$US
242275501$24227550$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA200340$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240820$$MD$US$US
242275511$24227551$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242720$SANOFI AVENTIS$$$$T$F$Y$40$KG$20240820$$MD$US$US
242275521$24227552$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA241624$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240820$$MD$US$US
242275531$24227553$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA243563$SANOFI AVENTIS$$$$T$F$Y$$$20240820$$MD$US$US
242275541$24227554$1$I$20240101$20240813$20240820$20240820$PER$$US-SA-2024SA244422$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240820$$MD$US$US
242275551$24227555$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA242767$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242275561$24227556$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241645$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240820$$MD$US$US
242275571$24227557$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA243273$SANOFI AVENTIS$$$$A$$Y$$$20240820$$PH$US$US
242275581$24227558$1$I$20240812$20240813$20240820$20240820$PER$$US-SA-2024SA243064$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240820$$CN$US$US
242275591$24227559$1$I$20240809$20240813$20240820$20240820$PER$$US-SA-2024SA243299$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240820$$MD$US$US
242275602$24227560$2$F$$20240826$20240820$20240903$PER$$US-SA-2024SA242439$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240903$$CN$US$US
242275611$24227561$1$I$20231221$20240201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-154395$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242275621$24227562$1$I$20231223$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-156115$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242275631$24227563$1$I$20231222$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-156151$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242275641$24227564$1$I$$20240703$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-156606$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242275651$24227565$1$I$20230101$20231228$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-157161$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242275661$24227566$1$I$20231222$20240223$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-155355$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242275671$24227567$1$I$20231213$20240308$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-157073$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242275681$24227568$1$I$$20240308$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-157074$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242275691$24227569$1$I$20231225$20240627$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-010105$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242275701$24227570$1$I$$20240813$20240820$20240820$PER$$US-JNJFOC-20240843514$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$US$US
242275722$24227572$2$F$$20240812$20240820$20240821$PER$$US-SA-2024SA241870$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240821$$MD$US$US
242275731$24227573$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA243725$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240820$$MD$US$US
242275741$24227574$1$I$20230101$20240111$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-156631$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242275751$24227575$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242789$SANOFI AVENTIS$$$$T$M$Y$74.8$KG$20240820$$MD$US$US
242275761$24227576$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242288$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240820$$CN$US$US
242275772$24227577$2$F$20221201$20240816$20240820$20240826$PER$$US-SA-2024SA243837$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240826$$MD$US$US
242275781$24227578$1$I$20240812$20240813$20240820$20240820$PER$$US-SA-2024SA242280$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240820$$CN$US$US
242275791$24227579$1$I$20240101$20240813$20240820$20240820$PER$$US-SA-2024SA242832$SANOFI AVENTIS$$$$A$M$Y$$$20240820$$MD$US$US
242275801$24227580$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241905$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240820$$MD$US$US
242275811$24227581$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243329$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240820$$MD$US$US
242275821$24227582$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA242761$SANOFI AVENTIS$$43$YR$A$F$Y$56$KG$20240820$$MD$US$US
242275831$24227583$1$I$20230117$20240813$20240820$20240820$PER$$US-SA-2024SA242305$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240820$$MD$US$US
242275841$24227584$1$I$20240601$20240814$20240820$20240820$PER$$US-SA-2024SA244275$SANOFI AVENTIS$$41$YR$A$M$Y$86.18$KG$20240820$$MD$US$US
242275861$24227586$1$I$20240801$20240812$20240820$20240820$PER$$US-SA-2024SA243153$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240820$$MD$US$US
242275871$24227587$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243338$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240820$$MD$US$US
242275881$24227588$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242900$SANOFI AVENTIS$$$$A$M$Y$56.69$KG$20240820$$MD$US$US
242275891$24227589$1$I$20240101$20240813$20240820$20240820$PER$$US-SA-2024SA244620$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240820$$MD$US$US
242275901$24227590$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241473$SANOFI AVENTIS$$$$T$M$Y$68$KG$20240820$$MD$US$US
242275913$24227591$3$F$20240804$20240815$20240820$20240828$PER$$US-SA-2024SA241443$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240828$$MD$US$US
242275921$24227592$1$I$20240501$20240813$20240820$20240820$PER$$US-SA-2024SA242880$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240820$$MD$US$US
242275931$24227593$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA242274$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240820$$MD$US$US
242275941$24227594$1$I$20240601$20240812$20240820$20240820$PER$$US-SA-2024SA242182$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240820$$MD$US$US
242275951$24227595$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA244173$SANOFI AVENTIS$$$$E$F$Y$$$20240820$$MD$US$US
242275961$24227596$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA243070$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240820$$CN$US$US
242275971$24227597$1$I$$20240105$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-013148$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242275981$24227598$1$I$20240103$20240411$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-013373$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242275991$24227599$1$I$$20240308$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-014687$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242276001$24227600$1$I$$20240108$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-014696$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242276011$24227601$1$I$20230101$20240314$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-014730$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242276021$24227602$1$I$20230101$20231229$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-010111$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242276031$24227603$1$I$20231228$20240229$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-010114$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242276041$24227604$1$I$20230101$20240219$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-010944$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242276051$24227605$1$I$20240102$20240308$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-011710$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242276061$24227606$1$I$20240102$20240308$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-011724$REGENERON$$$$$F$Y$$$20240820$$MD$US$US
242276071$24227607$1$I$20230101$20240308$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-011632$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242276081$24227608$1$I$20240101$20240209$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-012320$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242276091$24227609$1$I$20240103$20240314$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-013124$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242276101$24227610$1$I$20230101$20240105$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-013141$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242276111$24227611$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA244627$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240820$$MD$US$US
242276122$24227612$2$F$20240101$20240814$20240820$20240821$PER$$US-SA-2024SA243403$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240821$$MD$US$US
242276131$24227613$1$I$20240701$20240814$20240820$20240820$PER$$US-SA-2024SA243135$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242276141$24227614$1$I$20230101$20240813$20240820$20240820$PER$$US-SA-2024SA243073$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240820$$CN$US$US
242276151$24227615$1$I$20231229$20240308$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-010112$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242276161$24227616$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA243122$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240820$$CN$US$US
242276171$24227617$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241501$SANOFI AVENTIS$$$$A$M$Y$$$20240820$$CN$US$US
242276181$24227618$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242225$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240820$$CN$US$US
242276191$24227619$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241594$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240820$$CN$US$US
242276202$24227620$2$F$20240101$20240815$20240820$20240829$PER$$US-SA-2024SA243490$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240829$$MD$US$US
242276211$24227621$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA241959$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240820$$CN$US$US
242276221$24227622$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA242712$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240820$$MD$US$US
242276231$24227623$1$I$$20240815$20240820$20240820$PER$$US-SA-2024SA244109$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240820$$MD$US$US
242276241$24227624$1$I$20240801$20240812$20240820$20240820$PER$$US-SA-2024SA241864$SANOFI AVENTIS$$$$C$F$Y$$$20240820$$MD$US$US
242276251$24227625$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242287$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240820$$CN$US$US
242276264$24227626$4$F$20240814$20240906$20240820$20240913$PER$$US-SA-2024SA243453$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240913$$MD$US$US
242276271$24227627$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA243772$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240820$$CN$US$US
242276281$24227628$1$I$$20240815$20240820$20240820$PER$$US-SA-2024SA243589$SANOFI AVENTIS$$$$$F$Y$$$20240820$$HP$US$US
242276291$24227629$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA243771$SANOFI AVENTIS$$$$$M$Y$$$20240820$$CN$US$US
242276301$24227630$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA243774$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240820$$CN$US$US
242276311$24227631$1$I$20230801$20240812$20240820$20240820$PER$$US-SA-2024SA242831$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240820$$HP$US$US
242276321$24227632$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241159$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240820$$MD$US$US
242276331$24227633$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242236$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240820$$MD$US$US
242276341$24227634$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241504$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240820$$CN$US$US
242276351$24227635$1$I$20240814$20240815$20240820$20240820$PER$$US-BAYER-2024A117866$BAYER$$87$YR$E$F$Y$$$20240820$$CN$US$US
242276362$24227636$2$F$$20240903$20240820$20240916$PER$$US-SA-2024SA242481$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240916$$MD$US$US
242276371$24227637$1$I$20240701$20240815$20240820$20240820$PER$$US-SA-2024SA244347$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240820$$MD$US$US
242276381$24227638$1$I$20240101$20240724$20240820$20240820$PER$$US-009507513-2407USA014804$MERCK$$78$YR$$F$Y$$$20240820$$MD$US$US
242276391$24227639$1$I$$20240812$20240820$20240820$PER$$US-EMD Serono-2024043524$EMD SERONO INC$$$$A$F$Y$$$20240820$$HP$US$US
242276401$24227640$1$I$$20240816$20240820$20240820$EXP$$NVSC2024US166681$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242276412$24227641$2$F$$20240910$20240820$20240919$EXP$$CH-BIOVITRUM-2024-CH-010763$ADC THERAPEUTICS$$$$A$M$Y$$$20240919$$MD$CH$CH
242276421$24227642$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5882023$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242276431$24227643$1$I$$20240816$20240820$20240820$EXP$$NVSC2024RU167652$NOVARTIS$$$$E$F$Y$$$20240820$$MD$RU$RU
242276441$24227644$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130565$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$86.18$KG$20240820$$CN$US$US
242276451$24227645$1$I$20240816$20240816$20240820$20240820$PER$$US-BAYER-2024A118418$BAYER$$72$YR$E$M$Y$$$20240820$$CN$US$US
242276461$24227646$1$I$20240809$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164453$AMGEN$$63$YR$A$F$Y$$$20240820$$CN$US$US
242276471$24227647$1$I$20230101$20240815$20240820$20240820$EXP$$US-ABBVIE-5878808$ABBVIE$$$$$F$Y$62$KG$20240820$$CN$US$US
242276481$24227648$1$I$$20240816$20240820$20240820$EXP$$US-INCYTE CORPORATION-2024IN008614$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242276501$24227650$1$I$$20240818$20240820$20240820$EXP$GB-MHRA-MED-202408181711299420-LSKGF$GB-SANDOZ INC.-SDZ2024GB073397$SANDOZ$$29$YR$$F$Y$$$20240820$$CN$GB$GB
242276512$24227651$2$F$$20240910$20240820$20240913$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006455$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
242276521$24227652$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024162976$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242276532$24227653$2$F$20240101$20240907$20240820$20240912$EXP$$US-ABBVIE-5883282$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
242276541$24227654$1$I$20240724$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57209$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242276561$24227656$1$I$$20240723$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07388$LUPIN$$$$$$Y$$$20240820$$CN$US$US
242276571$24227657$1$I$20220502$20220602$20240820$20240820$EXP$$CO-BIOVITRUM-2022CO07615$BIOVITRUM$$441$DY$$F$Y$8$KG$20240820$$CN$CO$CO
242276581$24227658$1$I$20240501$20240813$20240820$20240820$EXP$$US-GSK-US2024100824$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$US$US
242276591$24227659$1$I$$20240814$20240820$20240820$PER$$US-BAYER-2024A117556$BAYER$$38$YR$A$F$Y$$$20240820$$HP$US$US
242276601$24227660$1$I$$20240815$20240820$20240820$PER$$US-BAYER-2024A118597$BAYER$$$$$M$Y$$$20240820$$CN$US$US
242276611$24227661$1$I$$20240812$20240820$20240820$EXP$$CN-BBU-2024000183$BIOGEN$Shen J, Shen X, Zhao F, Yao J. Pneumomediastinum and pneumoretroperitoneum after COVID-19: concealed intestinal perforation. BMC Infectious Diseases. 2024 Aug 08;24:1-6. doi:10.1186/s12879-024-09720-3$74$YR$$F$Y$$$20240820$$HP$CN$CN
242276621$24227662$1$I$20220928$20221004$20240820$20240820$EXP$$CO-BIOVITRUM-2022CO11660$BIOVITRUM$$155$DY$$M$Y$6$KG$20240820$$CN$CO$CO
242276631$24227663$1$I$20240702$20240815$20240820$20240820$EXP$$CA-LUNDBECK-DKLU4002442$LUNDBECK$$$$$$Y$$$20240820$$HP$CA$CA
242276641$24227664$1$I$$20240811$20240820$20240820$EXP$$JP-ACS-20240296$ACS DOBFAR$Harada T, Nakanishi T, Kutsuna S, Nakai M. Unexpected Sudden Deaths Following the Co-administration of Ceftriaxone and Lansoprazole: A Case Series. Cureus. 2024 Jul 9;16(7):e64143. doi: 10.7759/cureus.64143. PMID: 39119376; PMCID: PMC11308275.$81$YR$E$M$Y$$$20240813$$MD$JP$
242276651$24227665$1$I$$20240811$20240820$20240820$EXP$$JP-ACS-20240297$ACS DOBFAR$Harada T, Nakanishi T, Kutsuna S, Nakai M. Unexpected Sudden Deaths Following the Co-administration of Ceftriaxone and Lansoprazole: A Case Series. Cureus. 2024 Jul 9;16(7):e64143. doi: 10.7759/cureus.64143. PMID: 39119376; PMCID: PMC11308275.$79$YR$E$M$Y$$$20240813$$MD$JP$
242276661$24227666$1$I$$20240802$20240820$20240820$PER$$US-TEVA-VS-3229735$TEVA$$18$YR$$F$Y$$$20240820$$CN$US$US
242276671$24227667$1$I$$20240813$20240820$20240820$PER$$US-JNJFOC-20240834511$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242276691$24227669$1$I$20220816$20220823$20240820$20240820$EXP$$CO-BIOVITRUM-2022CO10129$BIOVITRUM$$61$DY$$F$Y$2.5$KG$20240820$$CN$CO$CO
242276701$24227670$1$I$20220927$20221004$20240820$20240820$EXP$$CO-BIOVITRUM-2022CO11656$BIOVITRUM$$$$$M$Y$3.5$KG$20240820$$CN$CO$CO
242276711$24227671$1$I$20240101$20240814$20240820$20240820$PER$$US-BAYER-2024A117590$BAYER$$20$YR$A$F$Y$$$20240820$$HP$US$US
242276731$24227673$1$I$20230815$20240816$20240820$20240820$EXP$$GB-MYLANLABS-2023M1086664$MYLAN$$39$YR$$M$Y$$$20240820$$MD$GB$GB
242276742$24227674$2$F$$20240902$20240820$20240905$EXP$HU-EMA-20170405-gdhingrap-150411445$HU-MYLANLABS-2024M1076355$MYLAN$Banhegyi RJ, Vargane TR, Zsilak J, Fulop F, Fulop N and Piko B.. The Role of Palliative Endocrine Therapy in a Premenopausal Status Patient with Breast cancer. LAM. 2015;25(8-9):375-376$38$YR$$F$Y$$$20240905$$MD$HU$HU
242276751$24227675$1$I$20200122$20240816$20240820$20240820$EXP$$IT-MYLANLABS-2024M1076350$MYLAN$$61$YR$$M$Y$85$KG$20240820$$MD$IT$IT
242276761$24227676$1$I$20240807$20240816$20240820$20240820$EXP$$CN-MYLANLABS-2024M1076911$MYLAN$$20$YR$$M$Y$70$KG$20240820$$HP$CN$CN
242276771$24227677$1$I$20221024$20221129$20240820$20240820$EXP$$CO-BIOVITRUM-2022CO12611$BIOVITRUM$$258$DY$$M$Y$7.5$KG$20240820$$CN$CO$CO
242276781$24227678$1$I$$20240814$20240820$20240820$EXP$$FR-MYLANLABS-2024M1075813$MYLAN$Vigue p, cidolit s, hamed hadj hamdi s, ben salah m, amalou r, botramamy a, et al.. Hypoparathyroidism has no age of onset or the history of a robust centenarian.. Rev Geriatr.. 2024;49 (6):349-54$101$YR$$F$Y$$$20240820$$HP$FR$FR
242276791$24227679$1$I$$20240817$20240820$20240820$PER$$US-BAYER-2024A118558$BAYER$$$$$$Y$$$20240820$$CN$US$US
242276801$24227680$1$I$$20240814$20240820$20240820$PER$$US-BAYER-2024A117594$BAYER$$30$YR$A$F$Y$$$20240820$$MD$US$US
242276811$24227681$1$I$$20240814$20240820$20240820$EXP$$US-UCBSA-2024041475$UCB$$$$$F$Y$51.701$KG$20240820$$MD$US$US
242276821$24227682$1$I$20240703$20240815$20240820$20240820$PER$$CN-Eisai-EC-2024-172287$EISAI$$49$YR$A$F$Y$67$KG$20240820$$HP$CN$CN
242276831$24227683$1$I$$20240818$20240820$20240820$PER$$US-BAYER-2024A118568$BAYER$$$$$$Y$$$20240820$$CN$US$US
242276841$24227684$1$I$20240810$20240813$20240820$20240820$EXP$$US-SA-2024SA244563$SANOFI AVENTIS$$67$YR$E$M$Y$131$KG$20240820$$MD$US$US
242276851$24227685$1$I$20240701$20240813$20240820$20240820$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-128137$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$77.11$KG$20240820$$CN$PR$PR
242276861$24227686$1$I$$20240815$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130400$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240820$$CN$US$US
242276871$24227687$1$I$20240401$20240813$20240820$20240820$EXP$$US-SA-2024SA242395$SANOFI AVENTIS$$$$$F$Y$$$20240820$$MD$US$US
242276881$24227688$1$I$$20240814$20240820$20240820$PER$$US-BAYER-2024A117696$BAYER$$44$YR$A$F$Y$$$20240820$$MD$US$US
242276891$24227689$1$I$$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164224$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242276901$24227690$1$I$20240812$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164876$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242276911$24227691$1$I$$20240812$20240820$20240820$EXP$$CA-JNJFOC-20240836922$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$CN$CA$CA
242276921$24227692$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009757$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$US$US
242276931$24227693$1$I$20240819$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57142$$FDA-CTU$$72$YR$$F$N$$$20240819$N$$US$
242276941$24227694$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010565$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240820$$HP$US$US
242276951$24227695$1$I$20240101$20240808$20240820$20240820$EXP$$CN-ROCHE-10000053588$ROCHE$$$$E$F$Y$$$20240820$$CN$CN$CN
242276961$24227696$1$I$20240715$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010912$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240820$$CN$US$US
242276981$24227698$1$I$$20240816$20240820$20240820$PER$$US-BAYER-2024A118501$BAYER$$34$YR$A$F$Y$$$20240820$$HP$US$US
242276991$24227699$1$I$20240717$20240815$20240820$20240820$EXP$$CA-TAKEDA-2024TUS071687$TAKEDA$$20$YR$$F$Y$$$20240820$$CN$CA$CA
242277001$24227700$1$I$$20240811$20240820$20240820$EXP$$AU-AMGEN-AUSSP2024162616$AMGEN$Arthur C.K;. Treatment of Elderly and Unfit AML Patients with Prolonged Administration of Low Dose Cytarabine and Thloguanine Achieves High Complete Remission Rates in an outpatient Setting. Blood. 2018;132 (1):3998$$$E$$Y$$$20240820$$HP$AU$AU
242277011$24227701$1$I$$20240814$20240820$20240820$EXP$$CA-TAKEDA-2024TUS082199$TAKEDA$$$$$M$Y$$$20240820$$CN$CA$CA
242277021$24227702$1$I$20240721$20240818$20240820$20240820$EXP$$EG-SA-2024SA245552$SANOFI AVENTIS$$16$YR$T$M$Y$63$KG$20240820$$HP$EG$EG
242277031$24227703$1$I$$20240816$20240820$20240820$PER$$US-BAYER-2024A118586$BAYER$$18$YR$A$F$Y$$$20240820$$HP$US$US
242277041$24227704$1$I$$20240809$20240820$20240820$EXP$$NZ-BEH-2024177122$CSL BEHRING$$$$A$F$Y$74$KG$20240820$$HP$NZ$NZ
242277051$24227705$1$I$$20240314$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-015454$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277061$24227706$1$I$20240106$20240321$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-016154$REGENERON$$$$$M$Y$$$20240820$$HP$US$US
242277071$24227707$1$I$$20240112$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-016167$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242277081$24227708$1$I$20240112$20240314$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-016179$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277091$24227709$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130598$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240820$$CN$US$US
242277101$24227710$1$I$20240111$20240314$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-015404$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242277111$24227711$1$I$20180101$20240113$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-016545$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242277121$24227712$1$I$$20240418$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-017291$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277131$24227713$1$I$20231101$20240111$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-015401$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277141$24227714$1$I$$20240308$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-015375$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242277151$24227715$1$I$$20240312$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-017332$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242277161$24227716$1$I$20240801$20240816$20240820$20240820$EXP$$PE-UCBSA-2024041678$UCB$$46$YR$$F$Y$$$20240820$$CN$PE$PE
242277172$24227717$2$F$$20240819$20240820$20240822$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-16429$IPSEN$$$$$F$Y$$$20240822$$CN$CA$CA
242277181$24227718$1$I$$20240321$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-017851$REGENERON$$$$$M$Y$$$20240820$$HP$US$US
242277191$24227719$1$I$20231001$20240321$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-017341$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277201$24227720$1$I$$20240314$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-017926$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277211$24227721$1$I$20240118$20240321$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-017975$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242277221$24227722$1$I$20240123$20240328$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-019683$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277231$24227723$1$I$20231201$20240523$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-019699$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277241$24227724$1$I$$20240209$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-017922$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242277251$24227725$1$I$20240122$20240328$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-019785$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277261$24227726$1$I$$20240123$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-019893$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277271$24227727$1$I$20240101$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-019686$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277291$24227729$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57100$$FDA-CTU$$51$YR$$F$N$$$20240819$N$$US$
242277311$24227731$1$I$20240101$20240807$20240820$20240820$PER$$US-SA-2024SA239388$SANOFI AVENTIS$$31$YR$A$M$Y$170$KG$20240820$$MD$US$US
242277321$24227732$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA239030$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240820$$MD$US$US
242277331$24227733$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA241073$SANOFI AVENTIS$$$$A$F$Y$56.689$KG$20240820$$MD$US$US
242277342$24227734$2$F$$20240827$20240820$20240905$EXP$$US-TEVA-VS-3234189$TEVA$El Labban M, Oluic S, Guleid H, Hassan M, Diab R, Rida MA. POLYMYALGIA RHEUMATICA FOLLOWING RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINATION. Eur-J-Case-Rep-Intern-Med 2024; 11 (7):.; El Labban M, Oluic S, Guleid H, Hassan M, Diab R, Rida MA. POLYMYALGIA RHEUMATICA FOLLOWING RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINATION. Eur-J-Case-Rep-Intern-Med 2024; 11 (7):.$72$YR$$M$Y$$$20240905$$HP$US$US
242277361$24227736$1$I$$20240813$20240820$20240820$EXP$$CA-PFIZER INC-202400236554$PFIZER$$39$YR$$M$Y$$$20240820$$HP$CA$CA
242277371$24227737$1$I$20240101$20240813$20240820$20240820$EXP$$CN-PFIZER INC-PV202400104997$PFIZER$$85$YR$$F$Y$$$20240820$$CN$CN$CN
242277382$24227738$2$F$20230101$20240922$20240820$20240923$EXP$$CA-PFIZER INC-202300321005$PFIZER$$37$YR$$M$Y$$$20240923$$HP$CA$CA
242277392$24227739$2$F$20240101$20240926$20240820$20240930$EXP$$DE-PFIZER INC-202400236458$PFIZER$$$$$F$Y$$$20240930$$MD$DE$DE
242277401$24227740$1$I$20240307$20240815$20240820$20240820$PER$$US-BAYER-2024A118680$BAYER$$$$$F$Y$$$20240820$$CN$US$US
242277411$24227741$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57004$$FDA-CTU$$43$YR$$F$N$$$20240819$N$$US$
242277421$24227742$1$I$20240817$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57224$$FDA-CTU$$62$YR$$F$N$$$20240819$N$HP$US$
242277431$24227743$1$I$$20240816$20240820$20240820$PER$$US-BAYER-2024A118777$BAYER$$$$$F$Y$$$20240820$$CN$US$US
242277441$24227744$1$I$20240611$20240809$20240820$20240820$PER$$US-SA-2024SA241749$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240820$$MD$US$US
242277451$24227745$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242744$SANOFI AVENTIS$$$$$M$Y$$$20240820$$MD$US$US
242277461$24227746$1$I$20240713$20240812$20240820$20240820$EXP$FR-AFSSAPS-PC2024000651$FR-PFIZER INC-202400234278$PFIZER$$62$YR$$F$Y$$$20240820$$PH$FR$FR
242277471$24227747$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA238661$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240820$$MD$US$US
242277481$24227748$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA241546$SANOFI AVENTIS$$$$A$F$Y$85.27$KG$20240820$$MD$US$US
242277491$24227749$1$I$20240701$20240809$20240820$20240820$PER$$US-SA-2024SA241583$SANOFI AVENTIS$$$$E$F$Y$$$20240820$$MD$US$US
242277501$24227750$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241062$SANOFI AVENTIS$$$$A$F$Y$106.58$KG$20240820$$MD$US$US
242277511$24227751$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA170958$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240820$$MD$US$US
242277521$24227752$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA242696$SANOFI AVENTIS$$$$E$F$Y$$$20240820$$MD$US$US
242277531$24227753$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA243172$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240820$$MD$US$US
242277541$24227754$1$I$20240101$20240813$20240820$20240820$PER$$US-SA-2024SA242748$SANOFI AVENTIS$$$$E$F$Y$$$20240820$$MD$US$US
242277551$24227755$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243344$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240820$$MD$US$US
242277561$24227756$1$I$20240810$20240813$20240820$20240820$PER$$US-SA-2024SA242737$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240820$$MD$US$US
242277581$24227758$1$I$$20240811$20240820$20240820$EXP$$AU-AMGEN-AUSSP2024162612$AMGEN$Arthur C.K;. Treatment of Elderly and Unfit AML Patients with Prolonged Administration of Low Dose Cytarabine and Thloguanine Achieves High Complete Remission Rates in an outpatient Setting. Blood. 2018;132 (1):3998$$$E$$Y$$$20240820$$HP$AU$AU
242277591$24227759$1$I$$20240201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-020300$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242277601$24227760$1$I$20240101$20240328$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-020349$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277611$24227761$1$I$$20240321$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-020863$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242277621$24227762$1$I$20240123$20240123$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-020895$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277631$24227763$1$I$20230101$20240314$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-023277$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277641$24227764$1$I$20240109$20240124$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-020341$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277652$24227765$2$F$$20240830$20240820$20240923$PER$$US-SA-2024SA243877$SANOFI AVENTIS$$$$E$F$Y$90.26$KG$20240923$$MD$US$US
242277661$24227766$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242786$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240820$$MD$US$US
242277671$24227767$1$I$20240812$20240813$20240820$20240820$PER$$US-SA-2024SA242329$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240820$$CN$US$US
242277681$24227768$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA240960$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240820$$MD$US$US
242277691$24227769$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA244380$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240820$$MD$US$US
242277701$24227770$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242776$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240820$$MD$US$US
242277711$24227771$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242735$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242277721$24227772$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA243700$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240820$$CN$US$US
242277731$24227773$1$I$$20240810$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011802$DR REDDYS$$60$YR$A$$Y$$$20240820$$MD$US$US
242277741$24227774$1$I$$20240812$20240820$20240820$EXP$$US-RDY-SPO/USA/24/0011853$DR REDDYS$$$$$F$Y$$$20240820$$CN$US$US
242277751$24227775$1$I$20221220$20240813$20240820$20240820$PER$$US-SA-2024SA242408$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240820$$MD$US$US
242277761$24227776$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241931$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240820$$MD$US$US
242277771$24227777$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242814$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240820$$MD$US$US
242277781$24227778$1$I$20240801$20240813$20240820$20240820$PER$$US-SA-2024SA242433$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240820$$MD$US$US
242277801$24227780$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242282$SANOFI AVENTIS$$$$$F$Y$$$20240820$$MD$US$US
242277811$24227781$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242326$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240820$$MD$US$US
242277821$24227782$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243624$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240820$$MD$US$US
242277831$24227783$1$I$20240625$20240813$20240820$20240820$PER$$US-SA-2024SA242374$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240820$$MD$US$US
242277841$24227784$1$I$20240801$20240813$20240820$20240820$PER$$US-SA-2024SA242731$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240820$$MD$US$US
242277851$24227785$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242793$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240820$$CN$US$US
242277861$24227786$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241495$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240820$$MD$US$US
242277871$24227787$1$I$$20240815$20240820$20240820$PER$$US-SA-2024SA244383$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240820$$MD$US$US
242277881$24227788$1$I$$20240410$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-023973$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277891$24227789$1$I$$20240318$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-024058$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242277901$24227790$1$I$20240126$20240404$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-024067$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242277911$24227791$1$I$$20240328$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-025187$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242277921$24227792$1$I$20240131$20240607$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-025307$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277931$24227793$1$I$$20240131$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-025468$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242277941$24227794$1$I$$20240201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-026048$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242277951$24227795$1$I$20240101$20240411$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-027230$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242277961$24227796$1$I$$20240502$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-025193$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242277971$24227797$1$I$20230101$20240321$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-025837$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242277981$24227798$1$I$20231101$20240202$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-026606$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242277991$24227799$1$I$$20240202$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-026664$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278001$24227800$1$I$20231221$20240202$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-026614$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278013$24227801$3$F$20240101$20240905$20240820$20240919$EXP$$IN-CIPLA LTD.-2024IN08902$CIPLA$$$$$$Y$$$20240919$$CN$IN$IN
242278031$24227803$1$I$20240805$20240812$20240820$20240820$EXP$$KR-VANTIVE-2024VAN019039$Vantive US Healthcare$$36$YR$$M$Y$$$20240820$$HP$KR$KR
242278041$24227804$1$I$$20240718$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-024738$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278052$24227805$2$F$20240722$20240830$20240820$20240903$PER$$US-BAYER-2024A118957$BAYER$$19$YR$A$F$Y$$$20240903$$HP$US$US
242278062$24227806$2$F$20240801$20240829$20240820$20240909$EXP$$US-SPRINGWORKS THERAPEUTICS-SW-001895$SPRINGWORKS THERAPEUTIC$$43$YR$$F$Y$89.342$KG$20240909$$CN$US$US
242278071$24227807$1$I$$20240131$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-025386$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242278081$24227808$1$I$20240819$20240819$20240820$20240820$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046571$BOEHRINGER INGELHEIM$$$$$$Y$$$20240820$$CN$US$US
242278091$24227809$1$I$$20240812$20240820$20240820$EXP$$JP-TEVA-VS-3233083$TEVA$Kuzume D, Ohturu S, Yosida T, Morimoto Y, Yamasaki M, Hosomi N. A case of a young woman with bilateral medial medullary infarcts caused by varicella-zoster virus vasculopathy without skin rash. Rinsho-Shinkeigaku 2024;.$36$YR$$F$Y$$$20240820$$MD$JP$JP
242278101$24227810$1$I$20240204$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-027334$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278111$24227811$1$I$20230601$20240206$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-027980$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242278121$24227812$1$I$20240206$20240404$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-028109$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278131$24227813$1$I$20231220$20240220$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-028595$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278141$24227814$1$I$$20240201$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-028999$REGENERON$$65$YR$$F$Y$$$20240820$$CN$US$US
242278151$24227815$1$I$20240207$20240502$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-030183$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278161$24227816$1$I$20240205$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-030193$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242278171$24227817$1$I$20231101$20240404$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-030198$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278181$24227818$1$I$20240101$20240502$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-030232$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242278191$24227819$1$I$20240101$20240212$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-030758$REGENERON$$$$$M$Y$$$20240820$$MD$US$US
242278201$24227820$1$I$20240101$20240813$20240820$20240820$EXP$$US-009507513-2408USA004787$MERCK$$53$YR$$F$Y$$$20240820$$HP$US$US
242278211$24227821$1$I$$20240723$20240820$20240820$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07493$LUPIN$$$$$$Y$$$20240820$$CN$US$US
242278221$24227822$1$I$$20240816$20240820$20240820$PER$$US-BAYER-2024A119439$BAYER$$45$YR$A$F$Y$$$20240820$$MD$US$US
242278231$24227823$1$I$20240101$20240801$20240820$20240820$PER$$US-TEVA-VS-3229247$TEVA$$35$YR$$F$Y$$$20240820$$CN$US$US
242278241$24227824$1$I$$20240816$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130940$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240820$$CN$US$US
242278251$24227825$1$I$$20240811$20240820$20240820$EXP$$JP-ACS-20240298$ACS DOBFAR$Harada T, Nakanishi T, Kutsuna S, Nakai M. Unexpected Sudden Deaths Following the Co-administration of Ceftriaxone and Lansoprazole: A Case Series. Cureus. 2024 Jul 9;16(7):e64143. doi: 10.7759/cureus.64143. PMID: 39119376; PMCID: PMC11308275.$88$YR$E$F$Y$$$20240813$$MD$JP$
242278261$24227826$1$I$$20240812$20240820$20240820$PER$$US-BAUSCH-BL-2024-012278$BAUSCH AND LOMB$$$$$M$Y$$$20240820$$CN$US$US
242278271$24227827$1$I$20240811$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129753$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240820$$HP$US$US
242278283$24227828$3$F$20240201$20240912$20240820$20240926$EXP$$US-SMPA-2024SPA000906$SUNOVION$$$$$$Y$$$20240926$$CN$US$US
242278291$24227829$1$I$$20240814$20240820$20240820$EXP$$CA-TAKEDA-2024TUS082433$TAKEDA$$77$YR$$F$Y$$$20240820$$HP$CA$CA
242278301$24227830$1$I$$20240806$20240820$20240820$EXP$$US-SMPA-2024SPA000974$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242278311$24227831$1$I$$20240722$20240820$20240820$EXP$$US-SMPA-2024MYSCI0700934$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242278321$24227832$1$I$$20240731$20240820$20240820$EXP$$US-SMPA-2024SPA000215$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242278331$24227833$1$I$$20240806$20240820$20240820$EXP$$US-SMPA-2024SPA000988$SUNOVION$$$$$$Y$$$20240820$$MD$US$US
242278343$24227834$3$F$$20240923$20240820$20240930$PER$$US-AMGEN-USASP2024162978$AMGEN$$$$$F$Y$$$20240930$$CN$US$US
242278351$24227835$1$I$$20240808$20240820$20240820$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08006$LUPIN$Arce PS, Murad K. Thyroid storm in heart failure: A case report. Journal of Cardiac Failure. 2024;30(1):178$36$YR$$M$Y$$$20240820$$HP$US$US
242278361$24227836$1$I$$20240418$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-030809$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278371$24227837$1$I$$20240327$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-030932$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278381$24227838$1$I$20240817$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024165010$AMGEN$$64$YR$A$F$Y$$$20240820$$CN$US$US
242278391$24227839$1$I$$20240811$20240820$20240820$EXP$$AU-AMGEN-AUSSP2024162628$AMGEN$Arthur C.K. Treatment of Elderly and Unfit AML Patients with Prolonged Administration of Low Dose Cytarabine and Thloguanine Achieves High Complete Remission Rates in an outpatient Setting. Blood. 2018;132 (1):3998$$$E$$Y$$$20240820$$HP$AU$AU
242278401$24227840$1$I$$20240811$20240820$20240820$EXP$$AU-AMGEN-AUSSP2024162626$AMGEN$Arthur C.K. Treatment of Elderly and Unfit AML Patients with Prolonged Administration of Low Dose Cytarabine and Thloguanine Achieves High Complete Remission Rates in an outpatient Setting. Blood. 2018;132 (1):3998$$$E$$Y$$$20240820$$HP$AU$AU
242278411$24227841$1$I$$20240811$20240820$20240820$EXP$$AU-AMGEN-AUSSP2024162622$AMGEN$Arthur C.K. Treatment of Elderly and Unfit AML Patients with Prolonged Administration of Low Dose Cytarabine and Thloguanine Achieves High Complete Remission Rates in an outpatient Setting. Blood. 2018;132 (1):3998$$$E$$Y$$$20240820$$HP$AU$AU
242278421$24227842$1$I$$20240813$20240820$20240820$PER$$US-JNJFOC-20240841599$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$CN$US$US
242278431$24227843$1$I$20220523$20240819$20240820$20240820$EXP$ES-AEMPS-1561582$ES-GILEAD-2024-0684651$GILEAD$$69$YR$E$F$Y$$$20240820$$MD$ES$ES
242278441$24227844$1$I$20240808$20240814$20240820$20240820$EXP$$FR-PFIZER INC-PV202400045281$PFIZER$$32$YR$$F$Y$$$20240820$$PH$FR$FR
242278451$24227845$1$I$20240312$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57159$$FDA-CTU$$27$YR$$M$N$150$LBS$20240819$N$$US$
242278461$24227846$1$I$$20240816$20240819$20240819$DIR$FDA-CDER-CTU-2024-57021$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242278474$24227847$4$F$$20240925$20240820$20240930$30DAY$$US-PFIZER INC-202400238360$PFIZER$$2$YR$$M$Y$$$20240930$$HP$US$US
242278481$24227848$1$I$$20240815$20240820$20240820$EXP$$CN-PFIZER INC-202400237157$PFIZER$$$$T$$Y$$$20240820$$MD$CN$CN
242278491$24227849$1$I$20240701$20240814$20240820$20240820$EXP$$IN-PFIZER INC-PV202400106832$PFIZER$$63$YR$$M$Y$82$KG$20240820$$CN$IN$IN
242278501$24227850$1$I$$20240815$20240820$20240820$EXP$$AR-PFIZER INC-202400238291$PFIZER$$71$YR$$F$Y$$$20240820$$CN$AR$AR
242278511$24227851$1$I$20240804$20240814$20240820$20240820$EXP$$CN-PFIZER INC-PV202400106130$PFIZER$$14$YR$$M$Y$69.7$KG$20240820$$HP$CN$CN
242278521$24227852$1$I$20240809$20240815$20240820$20240820$EXP$$CN-PFIZER INC-PV202400106744$PFIZER$$69$YR$$F$Y$51$KG$20240820$$CN$CN$CN
242278532$24227853$2$F$$20240912$20240820$20240916$30DAY$$CA-PFIZER INC-202400238392$PFIZER$$$$$$Y$$$20240916$$CN$CA$CA
242278541$24227854$1$I$20240724$20240814$20240820$20240820$EXP$$CN-PFIZER INC-PV202400106098$PFIZER$$52$YR$$F$Y$43$KG$20240820$$HP$CN$CN
242278551$24227855$1$I$$20240814$20240820$20240820$EXP$$CA-PFIZER INC-202400237989$PFIZER$$59$YR$$F$Y$76$KG$20240820$$HP$CA$CA
242278561$24227856$1$I$20240101$20240814$20240820$20240820$EXP$$CA-PFIZER INC-202400070518$PFIZER$$61$YR$$F$Y$$$20240820$$MD$CA$CA
242278581$24227858$1$I$20240722$20240814$20240820$20240820$EXP$$CN-PFIZER INC-PV202400106092$PFIZER$$70$YR$$M$Y$65$KG$20240820$$HP$CN$CN
242278591$24227859$1$I$$20240815$20240820$20240820$EXP$$US-PFIZER INC-202400237658$PFIZER$$74$YR$$F$Y$$$20240820$$CN$US$US
242278602$24227860$2$F$20240701$20240827$20240820$20240830$30DAY$$GB-PFIZER INC-PV202400105282$PFIZER$$66$YR$$M$Y$$$20240830$$CN$GB$GB
242278611$24227861$1$I$$20240815$20240820$20240820$EXP$$PK-PFIZER INC-PV202200010332$PFIZER$$63$YR$$M$Y$$$20240820$$CN$PK$PK
242278622$24227862$2$F$$20240920$20240820$20240920$30DAY$$US-PFIZER INC-202400235107$PFIZER$$12$YR$$M$Y$$$20240920$$CN$US$US
242278631$24227863$1$I$20240619$20240815$20240820$20240820$EXP$$CN-PFIZER INC-PV202400106719$PFIZER$$42$YR$$F$Y$52$KG$20240820$$HP$CN$CN
242278641$24227864$1$I$20230726$20240815$20240820$20240820$EXP$$CA-PFIZER INC-202300198918$PFIZER$$43$YR$$F$Y$$$20240820$$HP$CA$CA
242278651$24227865$1$I$20240130$20240425$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-031552$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278661$24227866$1$I$$20240328$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-031559$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278671$24227867$1$I$20240214$20240418$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-032044$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278681$24227868$1$I$$20240411$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-032613$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278691$24227869$1$I$20240131$20240321$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-032733$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278701$24227870$1$I$$20240215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-032739$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242278711$24227871$1$I$$20240215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-032759$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242278721$24227872$1$I$20240216$20240501$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-033352$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242278732$24227873$2$F$20240101$20240911$20240820$20240916$EXP$$US-SA-2024SA243442$SANOFI AVENTIS$$95$YR$E$M$Y$$$20240916$$MD$US$US
242278741$24227874$1$I$$20240411$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-032183$REGENERON$$28$YR$$F$Y$$$20240820$$PH$US$US
242278751$24227875$1$I$$20240418$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-033349$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278761$24227876$1$I$$20240815$20240820$20240820$PER$$US-ROCHE-10000059634$ROCHE$$$$A$F$Y$$$20240820$$CN$US$US
242278771$24227877$1$I$$20240819$20240820$20240820$PER$$US-BAYER-2024A119229$BAYER$$$$$M$Y$$$20240820$$CN$US$US
242278781$24227878$1$I$$20240321$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-033444$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278791$24227879$1$I$$20240215$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-033472$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278801$24227880$1$I$20240217$20240411$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-034182$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278811$24227881$1$I$$20240411$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-034720$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278821$24227882$1$I$20240221$20240410$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-036001$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242278831$24227883$1$I$$20240530$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-036033$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278841$24227884$1$I$$20240815$20240820$20240820$EXP$$US-SA-2024SA245532$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240820$$MD$US$US
242278852$24227885$2$F$20240101$20240904$20240820$20240919$EXP$$US-SA-2024SA244268$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240919$$CN$US$US
242278861$24227886$1$I$$20240816$20240820$20240820$PER$$US-ROCHE-10000059777$ROCHE$$$$E$F$Y$$$20240820$$CN$US$US
242278871$24227887$1$I$$20240819$20240820$20240820$PER$$US-BAYER-2024A119221$BAYER$$52$YR$A$F$Y$$$20240820$$MD$US$US
242278881$24227888$1$I$$20240716$20240820$20240820$PER$$US-MYLANLABS-2024M1076353$MYLAN$$$$$F$Y$$$20240820$$HP$US$US
242278892$24227889$2$F$20240812$20240819$20240820$20240822$PER$$US-AMGEN-USASP2024163711$AMGEN$$84$YR$E$F$Y$$$20240822$$PH$US$US
242278901$24227890$1$I$20240713$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024162792$AMGEN$$60$YR$A$$Y$$$20240820$$CN$US$US
242278911$24227891$1$I$20240222$20240222$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-036040$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242278921$24227892$1$I$20240201$20240523$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-036060$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242278931$24227893$1$I$$20240404$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-036807$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242278941$24227894$1$I$20240227$20240404$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-038129$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278951$24227895$1$I$$20240411$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-038138$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242278961$24227896$1$I$$20240411$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-038141$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242278971$24227897$1$I$20240227$20240418$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-038669$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242278981$24227898$1$I$20240806$20240812$20240820$20240820$EXP$GB-MHRA-MED-202408071721281860-WBQZJ$GB-TEVA-VS-3232508$TEVA$$44$YR$$F$Y$$$20240820$$HP$GB$GB
242278991$24227899$1$I$20240101$20240813$20240820$20240820$PER$$US-SA-2024SA243371$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240820$$MD$US$US
242279001$24227900$1$I$20240201$20240403$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-036208$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279011$24227901$1$I$$20240308$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-037570$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242279021$24227902$1$I$20240227$20240425$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-038130$REGENERON$$$$$M$Y$$$20240820$$HP$US$US
242279031$24227903$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA243037$SANOFI AVENTIS$$$$A$F$Y$77.11$KG$20240820$$MD$US$US
242279041$24227904$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242130$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240820$$MD$US$US
242279051$24227905$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242345$SANOFI AVENTIS$$$$A$M$Y$108.84$KG$20240820$$MD$US$US
242279061$24227906$1$I$$20240811$20240820$20240820$EXP$$AU-AMGEN-AUSSP2024162766$AMGEN$Arthur, C. K.. Treatment of Elderly and Unfit ANIL Patients with Prolonged Administration of Low Dose Cytarabine and Thioguanine Achieves High Complete Remission Rates in an Outpatient Setting. Blood. 2018;132 (Suppl 1)$$$E$$Y$$$20240820$$HP$AU$AU
242279071$24227907$1$I$$20240811$20240820$20240820$EXP$$AU-AMGEN-AUSSP2024162782$AMGEN$Arthur, C. K.. Treatment of Elderly and Unfit ANIL Patients with Prolonged Administration of Low Dose Cytarabine and Thioguanine Achieves High Complete Remission Rates in an Outpatient Setting. Blood. 2018;132 (Suppl 1)$$$E$$Y$$$20240820$$HP$AU$AU
242279081$24227908$1$I$$20240811$20240820$20240820$EXP$$AU-AMGEN-AUSSP2024162774$AMGEN$Arthur, C. K.. Treatment of Elderly and Unfit ANIL Patients with Prolonged Administration of Low Dose Cytarabine and Thioguanine Achieves High Complete Remission Rates in an Outpatient Setting. Blood. 2018;132 (Suppl 1)$$$E$$Y$$$20240820$$HP$AU$AU
242279091$24227909$1$I$$20240819$20240820$20240820$PER$$US-BAYER-2024A119238$BAYER$$$$$F$Y$$$20240820$$CN$US$US
242279101$24227910$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242422$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240820$$MD$US$US
242279111$24227911$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243242$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242279121$24227912$1$I$20240801$20240812$20240820$20240820$PER$$US-SA-2024SA242398$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240820$$MD$US$US
242279131$24227913$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA242442$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240820$$MD$US$US
242279141$24227914$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243282$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240820$$MD$US$US
242279151$24227915$1$I$20240101$20240814$20240820$20240820$PER$$US-SA-2024SA244416$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240820$$MD$US$US
242279161$24227916$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA243745$SANOFI AVENTIS$$$$C$M$Y$11.33$KG$20240820$$MD$US$US
242279171$24227917$1$I$20240802$20240812$20240820$20240820$PER$$US-SA-2024SA243879$SANOFI AVENTIS$$16$YR$T$M$Y$95$KG$20240820$$MD$US$US
242279181$24227918$1$I$$20240811$20240820$20240820$EXP$$AU-AMGEN-AUSSP2024162787$AMGEN$Arthur, C. K.. Treatment of Elderly and Unfit ANIL Patients with Prolonged Administration of Low Dose Cytarabine and Thioguanine Achieves High Complete Remission Rates in an Outpatient Setting. Blood. 2018;132 (Suppl 1)$$$E$$Y$$$20240820$$HP$AU$AU
242279191$24227919$1$I$$20240812$20240820$20240820$EXP$GB-MHRA-MED-202408121500517630-NJZBD$GB-TEVA-VS-3232799$TEVA$$66$YR$$F$Y$$$20240820$$HP$GB$GB
242279201$24227920$1$I$20240227$20240228$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-038670$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242279211$24227921$1$I$$20240502$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-039372$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279221$24227922$1$I$20240219$20240502$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-039446$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242279231$24227923$1$I$20240219$20240530$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-039460$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279241$24227924$1$I$$20240502$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-040765$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279251$24227925$1$I$20240304$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-040798$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279261$24227926$1$I$20240305$20240314$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-041429$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242279271$24227927$1$I$20240306$20240306$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-042029$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279281$24227928$1$I$$20240807$20240820$20240820$EXP$$US-CIPLA LTD.-2024US08831$CIPLA$Yeboah?Korang A, Memon A, Patel N, Portocarrero?Castillo A, Osman A, Kleesattel D, et al.. Impact of prior drug allergies on the risk, clinical features, and outcomes of idiosyncratic drug-induced liver injury in adults. Digestive Diseases and Sciences. 2022;67:5262 to 5271$$$$$Y$$$20240820$$HP$US$US
242279291$24227929$1$I$20240301$20240502$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-040080$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279301$24227930$1$I$$20240814$20240820$20240820$PER$$US-JNJFOC-20240841048$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$CN$US$US
242279311$24227931$1$I$20240717$20240806$20240820$20240820$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000796$PAREXEL$$$$$$Y$$$20240820$$HP$CN$CN
242279321$24227932$1$I$20240101$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-044167$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242279331$24227933$1$I$$20240305$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-044809$REGENERON$$71$YR$$M$Y$$$20240820$$CN$US$US
242279341$24227934$1$I$20240101$20240516$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-044879$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279351$24227935$1$I$$20240516$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-045419$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279361$24227936$1$I$$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-046741$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242279371$24227937$1$I$$20240815$20240820$20240820$EXP$$ID-AstraZeneca-2024A188096$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$ID$
242279381$24227938$1$I$20240301$20240311$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-044927$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242279391$24227939$1$I$$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-045424$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242279401$24227940$1$I$20240201$20240312$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-044871$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279411$24227941$1$I$20240315$20240523$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-046740$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279422$24227942$2$F$$20240826$20240820$20240827$PER$$US-PFIZER INC-PV202400107269$PFIZER$$$$$$Y$$$20240827$$CN$US$US
242279441$24227944$1$I$20240101$20240404$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-043585$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279452$24227945$2$F$$20240920$20240820$20240920$PER$$US-PFIZER INC-PV202400107162$PFIZER$$11$YR$$F$Y$$$20240920$$MD$US$US
242279461$24227946$1$I$$20240815$20240820$20240820$EXP$$GB-MYLANLABS-2024M1076808$MYLAN$$$$$M$Y$$$20240820$$CN$GB$GB
242279471$24227947$1$I$20240301$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-046758$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242279482$24227948$2$F$20240801$20240821$20240820$20240826$EXP$$IQ-MYLANLABS-2024M1076910$MYLAN$$39$YR$$M$Y$130$KG$20240826$$MD$IQ$IQ
242279491$24227949$1$I$20240728$20240807$20240820$20240820$EXP$$ES-CIPLA LTD.-2024ES08677$CIPLA$$$$$$Y$$$20240820$$CN$ES$ES
242279501$24227950$1$I$20240811$20240813$20240820$20240820$EXP$$BR-FreseniusKabi-FK202412525$FRESENIUS KABI$$43$YR$A$M$Y$103$KG$20240820$$PH$BR$BR
242279511$24227951$1$I$20240610$20240816$20240820$20240820$PER$$US-ROCHE-10000059695$ROCHE$$18$YR$A$M$Y$80$KG$20240820$$MD$US$US
242279521$24227952$1$I$$20240814$20240820$20240820$EXP$$AU-GILEAD-2024-0684247$GILEAD$$41$YR$A$M$Y$$$20240820$$MD$AU$AU
242279531$24227953$1$I$$20240813$20240820$20240820$EXP$$FR-SANDOZ INC.-SDZ2024FR072774$SANDOZ$Alice Brehon, J?r?my Lourenco, Antoine Badaoui, Emmanuelle Amsler, Jos? Luis Lopez Zaragoza, Ang?le Soria, Annick Barbaud. Doxycycline-induced fixed drug eruption: The new epidemic?. Journal of The European Academy of Dermatology and Venereology. 2024;1?3$27$YR$$M$Y$$$20240820$$MD$FR$FR
242279541$24227954$1$I$$20240811$20240820$20240820$PER$$US-EMD Serono-2024043768$EMD SERONO INC$$$$A$F$Y$$$20240820$$CN$US$US
242279551$24227955$1$I$$20240815$20240820$20240820$PER$$US-ROCHE-10000059027$ROCHE$$$$$F$Y$$$20240820$$CN$US$US
242279561$24227956$1$I$20100101$20240816$20240820$20240820$EXP$$US-TAKEDA-2024TUS082959$TAKEDA$$35$YR$$F$Y$$$20240820$$CN$US$US
242279572$24227957$2$F$20240805$20240807$20240820$20240902$EXP$GB-MHRA-MED-202408061623363120-LVDJB$GB-BEH-2024176954$CSL BEHRING$$32$YR$A$M$Y$$$20240902$$HP$GB$GB
242279581$24227958$1$I$$20240501$20240820$20240820$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06600$HIKMA$Meyer C, Martin C, Fukui N. Palliating. Meyer C, Martin C, Fukui N. Palliating Undifferentiated Encephalopathy in Creutzfeldt-Jakob Disease vs. Autoimmune Encephalitis. Journal of Pain and Symptom Management. 2024;67(5):744-5$63$YR$$M$Y$$$20240820$$MD$US$US
242279591$24227959$1$I$20240813$20240813$20240820$20240820$EXP$$SA-SA-2024SA243856$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240820$$MD$SA$SA
242279602$24227960$2$F$$20240924$20240820$20240926$EXP$$US-GILEAD-2024-0684490$GILEAD$$$$N$F$Y$2.168$KG$20240926$$HP$US$US
242279611$24227961$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243050$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240820$$CN$US$US
242279621$24227962$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243651$SANOFI AVENTIS$$32$YR$A$$Y$$$20240820$$HP$US$US
242279631$24227963$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA240784$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240820$$MD$US$US
242279641$24227964$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168398$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242279651$24227965$1$I$20240721$20240812$20240820$20240820$EXP$IT-MINISAL02-997917$IT-TEVA-VS-3233314$TEVA$$17$YR$$F$Y$$$20240820$$MD$IT$IT
242279661$24227966$1$I$20240101$20240807$20240820$20240820$EXP$$US-BIOCODEX2-2024000882$BIOCODEX$$7$YR$$F$Y$23.2$KG$20240814$$HP$US$US
242279671$24227967$1$I$20240309$20240814$20240820$20240820$EXP$$BR-SERVIER DO BRASIL-S24010433$SERVIER$$$$$$Y$$$20240820$$MD$BR$BR
242279682$24227968$2$F$$20240813$20240820$20240822$EXP$$GB-009507513-2408GBR005989$MERCK$$$$$F$Y$$$20240822$$HP$GB$GB
242279691$24227969$1$I$$20240806$20240820$20240820$PER$$US-JNJFOC-20240843548$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$CN$US$US
242279701$24227970$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA242169$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240820$$MD$US$US
242279711$24227971$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241385$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240820$$CN$US$US
242279721$24227972$1$I$20240101$20240814$20240820$20240820$PER$$US-SA-2024SA244486$SANOFI AVENTIS$$47$YR$A$M$Y$95.25$KG$20240820$$MD$US$US
242279731$24227973$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA075425$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240820$$CN$US$US
242279741$24227974$1$I$20240804$20240812$20240820$20240820$EXP$$CN-AstraZeneca-2024A185851$ASTRAZENECA$$74$YR$$M$Y$56.5$KG$20240820$$MD$CN$
242279761$24227976$1$I$20240727$20240812$20240820$20240820$EXP$$CN-AstraZeneca-2024A185933$ASTRAZENECA$$16066$DY$$F$Y$$$20240820$$MD$CN$
242279781$24227978$1$I$$20240816$20240820$20240820$PER$$US-ROCHE-10000059897$ROCHE$$$$$$Y$$$20240820$$PH$US$US
242279801$24227980$1$I$$20240816$20240820$20240820$PER$$US-ROCHE-10000060543$ROCHE$$76$YR$E$F$Y$$$20240820$$CN$US$US
242279811$24227981$1$I$20240321$20240812$20240820$20240820$EXP$PT-INFARMED-F202404-483$PT-TEVA-VS-3233344$TEVA$$73$YR$$F$Y$$$20240820$$MD$PT$PT
242279821$24227982$1$I$$20240812$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US072745$SANDOZ$Myeongji Kim, Christopher Graham , Ryan W. Stevens , Aditya Shah. A Rare Case of Bacterial Meningitis Caused by HematogenousSpread of Vancomycin-Resistant Enterococcus faecium in anImmunocompromised Patient. Case Reports in Infectious Diseases. 2024;2024:5$72$YR$$M$Y$$$20240820$$HP$US$US
242279831$24227983$1$I$20240510$20240813$20240820$20240820$EXP$$FR-FreseniusKabi-FK202412038$FRESENIUS KABI$$78$YR$E$$Y$$$20240820$$HP$FR$FR
242279852$24227985$2$F$20240815$20240909$20240820$20240910$PER$$US-AMGEN-USASP2024162950$AMGEN$$72$YR$E$M$Y$$$20240909$$CN$US$US
242279861$24227986$1$I$20240801$20240819$20240820$20240820$PER$$US-ROCHE-10000060850$ROCHE$$36$YR$A$F$Y$80.74$KG$20240820$$CN$US$US
242279871$24227987$1$I$20240423$20240812$20240820$20240820$EXP$$SG-ROCHE-10000054937$ROCHE$$60$YR$A$M$Y$98.5$KG$20240820$$HP$SG$SG
242279891$24227989$1$I$$20240812$20240820$20240820$PER$$US-ABBVIE-5877865$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242279901$24227990$1$I$20240712$20240815$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129551$BRISTOL MYERS SQUIBB$$30$YR$A$M$Y$$$20240820$$CN$US$US
242279912$24227991$2$F$20240803$20240826$20240820$20240829$EXP$$TW-SANDOZ INC.-SDZ2024TW071743$SANDOZ$$87$YR$$M$Y$70.98$KG$20240829$$CN$TW$TW
242279921$24227992$1$I$20240310$20240813$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128809$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$62.14$KG$20240820$$CN$US$US
242279931$24227993$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57057$$FDA-CTU$$78$YR$$M$N$$$20240819$N$$US$
242279941$24227994$1$I$20240812$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57197$$FDA-CTU$$67$YR$$F$N$159$LBS$20240819$N$MD$US$
242279952$24227995$2$F$20231201$20240903$20240820$20240906$EXP$$JP-EXELIXIS-CABO-24080629$EXELIXIS$$75$YR$$F$Y$59$KG$20240906$$MD$JP$JP
242279962$24227996$2$F$20230512$20240827$20240820$20240904$EXP$$AU-EXELIXIS-CABO-23060009$EXELIXIS$$47$YR$$F$Y$78$KG$20240904$$HP$AU$AU
242279971$24227997$1$I$20240717$20240808$20240820$20240820$EXP$FR-AFSSAPS-CF2024000395$FR-SANDOZ INC.-SDZ2024FR073303$SANDOZ$$81$YR$$F$Y$49$KG$20240820$$PH$FR$FR
242279981$24227998$1$I$$20240815$20240820$20240820$EXP$$US-OTSUKA-2024_022651$OTSUKA$$$$$F$Y$68.95$KG$20240820$$HP$US$US
242280021$24228002$1$I$$20240806$20240820$20240820$PER$$US-JNJFOC-20240842204$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242280031$24228003$1$I$$20240812$20240820$20240820$EXP$$UZ-ROCHE-10000055635$ROCHE$Kamishov S, Tillyashaykhov M, Boyko E, Niyozova S, Izrailbekova K, Lipartiya M, et al. Possibilities of long-term atezolizumab immunotherapy in patients with metastatic urothelial cancer. Journal of Clinical Oncology. 2024-Jun;42 (16):e14628.$$$$$Y$$$20240820$$HP$UZ$UZ
242280041$24228004$1$I$$20240501$20240820$20240820$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06399$HIKMA$Lee C, Scheinman MM.. Lee C, Scheinman MM. Wide Complex Tachycardia: Mind Your Medicine! Circulation.. Mind Your Medicine! Circulation. 2024;149(12):963-66$59$YR$$M$Y$$$20240820$$MD$US$US
242280051$24228005$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA244172$SANOFI AVENTIS$$$$$$Y$$$20240820$$MD$US$US
242280061$24228006$1$I$20240301$20240809$20240820$20240820$PER$$US-SA-2024SA241182$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240820$$MD$US$US
242280071$24228007$1$I$20231113$20240816$20240820$20240820$EXP$$CN-BAYER-2024A118736$BAYER$$43$YR$A$F$Y$51.2$KG$20240820$$HP$CN$CN
242280081$24228008$1$I$$20240812$20240820$20240820$EXP$$CN-BAYER-2024A118454$BAYER$Jin S; Shen ZY; Li J; Liu XG; Zhu QF; Li F; Shi YQ; Lin P; Xu XL; Chen XH; Geng XM; Ding XQ; Liu H. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. Journal of Clinical Pathology. 2024;77:471-477$7$DEC$E$F$Y$$$20240820$$MD$CN$CN
242280091$24228009$1$I$20240709$20240810$20240820$20240820$EXP$$CN-009507513-2408CHN004711$MERCK$$61$YR$$M$Y$60$KG$20240820$$HP$CN$CN
242280101$24228010$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883333$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242280111$24228011$1$I$20170101$20240812$20240820$20240820$EXP$$IT-SANDOZ INC.-PHHY2019IT027060$SANDOZ$$25$YR$$F$Y$$$20240820$$MD$IT$IT
242280121$24228012$1$I$$20240814$20240820$20240820$EXP$$US-PERRIGO-24US007717$PERRIGO$Goyal A, Jakula RS, Hans K, Kolbeck MC, Yarrarapu SN, Bhyan P, et al. Accidental Minoxidil Ingestion Causing Refractory Shock, Pulmonary Edema, and Significant EKG Changes. US Cardiology Review. 2024;18(Supplement 1):23-4. DOI:10.15420/usc.2024.18.s1.$51$YR$$M$Y$$$20240820$$MD$US$US
242280131$24228013$1$I$$20240812$20240820$20240820$EXP$$CA-APOTEX-2024AP009341$APOTEX$$76$YR$$M$Y$$$20240820$$PH$CA$CA
242280141$24228014$1$I$$20240819$20240820$20240820$EXP$$US-BAYER-2024A119331$BAYER$$$$$F$Y$$$20240820$$CN$US$US
242280161$24228016$1$I$20210627$20240816$20240820$20240820$EXP$SE-SEMPA-2024-006020$SE-MYLANLABS-2024M1076419$MYLAN$$16$YR$$F$Y$$$20240820$$CN$SE$SE
242280171$24228017$1$I$$20240816$20240820$20240820$PER$$US-ROCHE-10000059573$ROCHE$$$$$$Y$$$20240820$$MD$US$US
242280181$24228018$1$I$$20240813$20240820$20240820$EXP$$US-AMGEN-USASP2024163691$AMGEN$$$$$$Y$$$20240820$$CN$US$US
242280191$24228019$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164132$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242280201$24228020$1$I$$20240813$20240820$20240820$EXP$$CN-GSK-CN2024APC101024$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$MD$CN$CN
242280211$24228021$1$I$20240101$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164198$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242280222$24228022$2$F$20240814$20240830$20240820$20240904$EXP$$US-ABBVIE-5882561$ABBVIE$$$$$F$Y$$$20240904$$MD$US$US
242280231$24228023$1$I$$20240819$20240820$20240820$EXP$$ES-SANDOZ INC.-SDZ2024ES073737$SANDOZ$$50$YR$$M$Y$$$20240820$$MD$ES$ES
242280241$24228024$1$I$$20240812$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA072264$SANDOZ$$63$YR$$M$Y$$$20240820$$HP$CA$CA
242280251$24228025$1$I$20210905$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57174$$FDA-CTU$$41$YR$$F$N$170$LBS$20240819$N$HP$US$
242280261$24228026$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56974$$FDA-CTU$$54$YR$$M$N$1485$LBS$20240819$N$$US$
242280272$24228027$2$F$20240708$20240816$20240820$20240823$EXP$$US-GSK-US2024102524$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$HP$US$US
242280292$24228029$2$F$$20240821$20240820$20240823$EXP$$KR-BAYER-2024A119073$BAYER$$$$$F$Y$$$20240823$$CN$KR$KR
242280311$24228031$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56998$$FDA-CTU$$20$YR$$F$N$$$20240819$N$$US$
242280321$24228032$1$I$20240731$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57161$$FDA-CTU$$40$YR$$F$N$$$20240819$N$HP$US$
242280342$24228034$2$F$$20240827$20240820$20240905$EXP$$US-TEVA-VS-3234190$TEVA$Mccreary DL, Talon A, Young K, Suliman SA. Acute Pulmonary Manifestations and Management of Idiopathic Inflammatory Myopathies. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).; Mccreary DL, Talon A, Young K, Suliman SA. Acute Pulmonary Manifestations and Management of Idiopathic Inflammatory Myopathies. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$44$YR$$M$Y$$$20240905$$HP$US$US
242280351$24228035$1$I$20240810$20240819$20240820$20240820$EXP$SE-SEMPA-2024-006060$SE-FreseniusKabi-FK202412657$FRESENIUS KABI$$76$YR$E$M$Y$$$20240820$$MD$SE$SE
242280361$24228036$1$I$20240430$20240816$20240820$20240820$EXP$IT-MINISAL02-997297$IT-FreseniusKabi-FK202412585$FRESENIUS KABI$$70$YR$E$F$Y$$$20240820$$MD$IT$IT
242280371$24228037$1$I$$20240807$20240820$20240820$PER$$US-RDY-LIT/USA/24/0011823$DR REDDYS$Kane N, Rikard R, McCrory K, Marx AH. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels. Open Forum Infectious Diseases. 2023 Nov 27;10(2): S1108. doi:10.1093/ofid/ofad500.2163.$81$YR$E$M$Y$$$20240820$$HP$US$US
242280381$24228038$1$I$$20240807$20240820$20240820$PER$$US-JNJFOC-20240842591$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240820$$HP$US$US
242280391$24228039$1$I$$20240811$20240820$20240820$EXP$$US-JNJFOC-20240835342$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$HP$US$US
242280401$24228040$1$I$$20240812$20240820$20240820$EXP$$US-FreseniusKabi-FK202412691$FRESENIUS KABI$Dennee A, Fogarty TP, Howard TS, Hunter RB. Sinus Arrest Related to Dexmedetomidine Infusion in an Infant; a Case Report and Review of Current Literature. Journal of Pharmacy Practice. 2023;37(4): 1026-1031. doi:10.1177/08971900231193558.$11$MON$I$F$Y$$$20240820$$MD$US$US
242280411$24228041$1$I$20240701$20240809$20240820$20240820$EXP$$MX-DSJP-DSJ-2024-140815$DAIICHI$$65$YR$$F$Y$36$KG$20240820$$CN$MX$MX
242280421$24228042$1$I$20240813$20240813$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011949$DR REDDYS$$34$YR$A$F$Y$$$20240820$$MD$US$US
242280431$24228043$1$I$$20240813$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011954$DR REDDYS$$33$YR$A$$Y$$$20240820$$MD$US$US
242280441$24228044$1$I$$20240812$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011849$DR REDDYS$$16$YR$T$$Y$$$20240820$$MD$US$US
242280451$24228045$1$I$20240805$20240813$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011955$DR REDDYS$$19$YR$A$F$Y$$$20240820$$CN$US$US
242280462$24228046$2$F$$20240819$20240820$20240821$EXP$$AU-SANDOZ INC.-SDZ2024AU073612$SANDOZ$$$$$M$Y$$$20240821$$HP$AU$AU
242280471$24228047$1$I$$20240806$20240820$20240820$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093196$GLENMARK$Manuel SL, Sapone J, Lin F.. Tacrolimus-induced recurrent acute coronary syndrome due to an unknown mechanism.. Cureus.. 2024;16(6):e63266$$$$$Y$$$20240820$$MD$US$US
242280481$24228048$1$I$$20240814$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130402$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240820$$CN$US$US
242280491$24228049$1$I$$20240806$20240820$20240820$EXP$$US-SMPA-2024SPA001004$SUNOVION$$$$$$Y$$$20240820$$$US$US
242280501$24228050$1$I$20240622$20240806$20240820$20240820$EXP$$US-SMPA-2024SPA000999$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242280511$24228051$1$I$$20240806$20240820$20240820$EXP$$US-SMPA-2024SPA000992$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242280521$24228052$1$I$$20240806$20240820$20240820$EXP$$US-SMPA-2024SPA000996$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242280532$24228053$2$F$20240805$20240830$20240820$20240905$PER$$US-AMGEN-USASP2024164301$AMGEN$$$$$F$Y$$$20240904$$HP$US$US
242280541$24228054$1$I$$20240814$20240820$20240820$PER$$US-ROCHE-10000059238$ROCHE$$41$YR$A$F$Y$$$20240820$$CN$US$US
242280552$24228055$2$F$20240507$20240809$20240820$20240911$EXP$$US-BEH-2024177098$CSL BEHRING$$81$YR$E$F$Y$$$20240911$$CN$US$US
242280561$24228056$1$I$$20240814$20240820$20240820$PER$$US-AstraZeneca-2024A186096$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
242280571$24228057$1$I$20220302$20240813$20240820$20240820$EXP$$JP-ROCHE-10000058979$ROCHE$Aramaki O, Moriguchi M, Nakamura M, Abe H, Mitsuka Y, Yoshida N et al.. MO35-2 Comparing the impact of Atezolizumab Plus Bevacizumab and Lenvatinib for Recurrent Hepatocellular Carcinoma after Resection. The 36th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery. 2024;500$71$YR$E$M$Y$$$20240820$$MD$JP$JP
242280581$24228058$1$I$$20240812$20240820$20240820$EXP$$US-SA-2024SA244392$SANOFI AVENTIS$$$$A$F$Y$86.18$KG$20240820$$MD$US$US
242280591$24228059$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A186646$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242280602$24228060$2$F$$20240819$20240820$20240822$30DAY$$US-SANDOZ INC.-SDZ2024US073771$SANDOZ$$$$$M$Y$$$20240822$$CN$US$US
242280611$24228061$1$I$$20240815$20240820$20240820$PER$$US-BAYER-2024A117934$BAYER$$$$$$Y$$$20240820$$CN$US$US
242280621$24228062$1$I$$20240816$20240820$20240820$EXP$$CA-PFIZER INC-202400239146$PFIZER$$95$YR$$M$Y$$$20240820$$HP$CA$CA
242280631$24228063$1$I$20240129$20240816$20240820$20240820$EXP$FR-AFSSAPS-BR2024000659$FR-PFIZER INC-202400237956$PFIZER$$63$YR$$F$Y$$$20240820$$MD$FR$FR
242280641$24228064$1$I$$20240816$20240820$20240820$EXP$$FR-PFIZER INC-PV202400107664$PFIZER$$65$YR$$F$Y$$$20240820$$MD$FR$FR
242280651$24228065$1$I$$20240816$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US073387$SANDOZ$$$$$M$Y$$$20240820$$MD$US$US
242280671$24228067$1$I$20240812$20240816$20240820$20240820$EXP$$CL-PFIZER INC-PV202400107266$PFIZER$$80$YR$$F$Y$$$20240820$$CN$CL$CL
242280681$24228068$1$I$$20240816$20240820$20240820$EXP$$CA-PFIZER INC-202400238310$PFIZER$$50$YR$$F$Y$81$KG$20240820$$MD$CA$CA
242280691$24228069$1$I$20240701$20240816$20240820$20240820$EXP$CH-SM-2024-15136$CH-PFIZER INC-202400238078$PFIZER$$81$YR$$M$Y$69.3$KG$20240820$$MD$CH$CH
242280701$24228070$1$I$20240601$20240816$20240820$20240820$EXP$FR-AFSSAPS-LY2024001204$FR-PFIZER INC-202400237952$PFIZER$$60$YR$$M$Y$58.8$KG$20240820$$PH$FR$FR
242280711$24228071$1$I$$20240815$20240820$20240820$EXP$$US-PFIZER INC-PV202400107277$PFIZER$$57$YR$$F$Y$$$20240820$$CN$US$US
242280721$24228072$1$I$$20240816$20240820$20240820$EXP$$JP-PFIZER INC-202400237915$PFIZER$$$$$$Y$$$20240820$$PH$JP$JP
242280731$24228073$1$I$20240715$20240816$20240820$20240820$EXP$FR-AFSSAPS-LL2024001565$FR-PFIZER INC-202400237929$PFIZER$$79$YR$$F$Y$60$KG$20240820$$PH$FR$FR
242280741$24228074$1$I$20240815$20240815$20240820$20240820$EXP$$CN-PFIZER INC-PV202400106687$PFIZER$$27$YR$$F$Y$60.8$KG$20240820$$HP$CN$CN
242280753$24228075$3$F$20240301$20240827$20240820$20240902$EXP$$JP-PFIZER INC-PV202400106947$PFIZER$$44$YR$$M$Y$$$20240902$$MD$JP$JP
242280761$24228076$1$I$$20240816$20240820$20240820$EXP$$US-PFIZER INC-202400046864$PFIZER$$67$YR$$F$Y$$$20240820$$MD$US$US
242280771$24228077$1$I$20240815$20240815$20240820$20240820$EXP$GB-MHRA-MED-202408151622008700-FGZLQ$GB-PFIZER INC-202400237432$PFIZER$$81$YR$$M$Y$79$KG$20240820$$HP$GB$GB
242280781$24228078$1$I$20240811$20240816$20240820$20240820$EXP$$CN-PFIZER INC-PV202400107445$PFIZER$$27$YR$$F$Y$65$KG$20240820$$HP$CN$CN
242280791$24228079$1$I$$20240815$20240820$20240820$EXP$$TW-PFIZER INC-PV202400106915$PFIZER$$69$YR$$F$Y$$$20240820$$HP$TW$TW
242280801$24228080$1$I$20240717$20240817$20240820$20240820$EXP$$CN-PFIZER INC-PV202400107460$PFIZER$$25$YR$$F$Y$70$KG$20240820$$HP$CN$CN
242280811$24228081$1$I$$20240815$20240820$20240820$EXP$$CN-PFIZER INC-PV202400106773$PFIZER$$$$A$M$Y$$$20240820$$CN$CN$CN
242280821$24228082$1$I$20240101$20240816$20240820$20240820$EXP$$IN-PFIZER INC-PV202400079506$PFIZER$$49$YR$$F$Y$$$20240820$$CN$IN$IN
242280831$24228083$1$I$20240814$20240816$20240820$20240820$EXP$$CN-PFIZER INC-PV202400107413$PFIZER$$90$YR$$M$Y$70$KG$20240820$$HP$CN$CN
242280841$24228084$1$I$$20240809$20240820$20240820$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408006197$ELI LILLY AND CO$$$$$M$Y$$$20240820$$CN$BR$BR
242280851$24228085$1$I$20240808$20240808$20240820$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006480$ELI LILLY AND CO$$$$A$M$Y$$$20240820$$MD$US$US
242280881$24228088$1$I$20240101$20240808$20240820$20240820$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408006070$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240820$$PH$FR$FR
242280902$24228090$2$F$$20240808$20240820$20240821$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408003490$ELI LILLY AND CO$$$$$F$Y$$$20240821$$CN$BR$BR
242280911$24228091$1$I$$20240815$20240820$20240820$PER$$US-ROCHE-10000059145$ROCHE$$$$A$M$Y$$$20240820$$CN$US$US
242280921$24228092$1$I$20210101$20240813$20240820$20240820$PER$$US-SA-2024SA243469$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240820$$MD$US$US
242280931$24228093$1$I$20240801$20240816$20240820$20240820$EXP$$US-PFIZER INC-202400238262$PFIZER$$72$YR$$M$Y$$$20240820$$MD$US$US
242280941$24228094$1$I$20240817$20240817$20240820$20240820$EXP$GB-MHRA-MED-202408171650572170-NQMDZ$GB-PFIZER INC-202400238493$PFIZER$$37$YR$$F$Y$104$KG$20240820$$CN$GB$GB
242280951$24228095$1$I$$20240819$20240820$20240820$EXP$$US-UCBSA-2024041919$UCB$$$$$F$Y$$$20240820$$CN$US$US
242280961$24228096$1$I$$20240813$20240820$20240820$PER$$US-BAYER-2024A117193$BAYER$$82$YR$E$F$Y$$$20240820$$CN$US$US
242280972$24228097$2$F$$20240808$20240820$20240823$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463169$RANBAXY$Aboznadah W, Bond R. Case Report: Uncontrolled Hyperthyroidism In Pregnancy Associated With Fetal Heart Malformation. Can J Diab. 2023;47 (Suppl.) (7):S128$24$YR$$F$Y$$$20240823$$HP$CA$CA
242280982$24228098$2$F$$20240808$20240820$20240823$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463175$RANBAXY$Aboznadah W, Bond R. CASE REPORT: UNCONTROLLED HYPERTHYROIDISM IN PREGNANCY ASSOCIATED WITH FETAL HEART MALFORMATION. Can J Diab. 2023;47 (Suppl.) (7):S128 (CSEMP003)$$$N$$Y$$$20240823$$HP$CA$CA
242280991$24228099$1$I$$20240805$20240820$20240820$EXP$$RS-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463153$RANBAXY$Jovisevic M, Zelen TB, Prica A. HORMON POSITIVE BREAST CANCER WITH EARLY RELAPSE. Breast. 2023;71(Suppl):S60/PR129$60$YR$$F$Y$$$20240820$$HP$RS$RS
242281001$24228100$1$I$20231120$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463198$RANBAXY$$59$YR$$M$Y$111$KG$20240820$$MD$FR$FR
242281011$24228101$1$I$20240430$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463024$RANBAXY$$33$YR$$F$Y$90$KG$20240820$$MD$FR$FR
242281021$24228102$1$I$$20240805$20240820$20240820$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463269$RANBAXY$Jin S, Shen Z, Li J, Liu X, Zhu Q, Li F, et al. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. J Clin Pathol. 2024;77;0(0):471-477; 1-7$$$$M$Y$$$20240820$$HP$CN$CN
242281031$24228103$1$I$$20240805$20240820$20240820$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463279$RANBAXY$Jin S, Shen Z, Li J, Liu X, Zhu Q, Li F, et al. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. J Clin Pathol. 2024;77;0(0):471-477; 1-7$$$E$M$Y$$$20240820$$HP$CN$CN
242281041$24228104$1$I$$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463165$RANBAXY$$52$YR$$F$Y$$$20240820$$HP$FR$FR
242281051$24228105$1$I$$20240805$20240820$20240820$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463145$RANBAXY$Kim E, Baek Y-H.. A Case of Concomitant Liver and Brain Abscesses Caused by Parvimonas Micra.. Gut Liver. 2017;11 (Suppl.):181-182$65$YR$$F$Y$$$20240820$$HP$KR$KR
242281062$24228106$2$F$$20240913$20240820$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463187$RANBAXY$$70$YR$$F$Y$45$KG$20240927$$MD$FR$FR
242281071$24228107$1$I$20231230$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463180$RANBAXY$$87$YR$$M$Y$$$20240820$$MD$FR$FR
242281081$24228108$1$I$20230922$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463201$RANBAXY$$30$YR$$M$Y$$$20240820$$MD$FR$FR
242281091$24228109$1$I$$20240815$20240820$20240820$PER$$US-BAYER-2024A118234$BAYER$$$$$F$Y$$$20240820$$CN$US$US
242281102$24228110$2$F$$20240812$20240820$20240827$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463186$RANBAXY$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ Genom Precis Med. 2024;Apr;17(2):E004353$12$YR$$F$Y$$$20240827$$MD$IT$IT
242281111$24228111$1$I$$20240819$20240820$20240820$EXP$$DE-SANDOZ INC.-NVSC2020DE305737$SANDOZ$$$$E$$Y$$$20240820$$MD$DE$DE
242281122$24228112$2$F$$20240812$20240820$20240827$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463223$RANBAXY$Sakai Y, Ikawa Y, Takenaka M Noguchi K, Fujiki T, Ikeda H, et al. Histopathological maturation in juvenile xanthogranuloma: a blueberry mu n infant mimicking aleukemic leukemia cutis. Int J Hematol. 2024;119:93-98$1$YR$$F$Y$$$20240827$$HP$JP$JP
242281132$24228113$2$F$20240516$20240821$20240820$20240905$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462785$RANBAXY$$75$YR$$M$Y$$$20240905$$MD$IT$IT
242281141$24228114$1$I$20210614$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462847$RANBAXY$$84$YR$$F$Y$87$KG$20240820$$MD$FR$FR
242281151$24228115$1$I$20230101$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462831$RANBAXY$$38$YR$$M$Y$$$20240820$$MD$FR$FR
242281161$24228116$1$I$$20240805$20240820$20240820$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462823$RANBAXY$Nishiwaki Y, Kusano T, Hiraiwa T, Ozawa T. Fifteen-year survival of a hepatocellular carcinoma extending into the right atrium treated by surgical resection with the heart-first approach under cardiopulmonary bypass: a case report and review of the literature. Clin J Gatroenterol. 2024;17:118-129$67$YR$$M$Y$$$20240820$$HP$JP$JP
242281171$24228117$1$I$20240419$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462810$RANBAXY$$85$YR$$F$Y$78.8$KG$20240820$$PH$FR$FR
242281181$24228118$1$I$20231226$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462814$RANBAXY$$75$YR$$F$Y$46$KG$20240820$$HP$FR$FR
242281191$24228119$1$I$$20240805$20240820$20240820$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-460891$RANBAXY$Taniguchi SH, Komine K, Takenaga N, Yoshida Y, Sasaki K, Kawamura Y, et al.. FOLFIRI Chemotherapy for Patients With Metastatic Urachal Carcinoma.. Anticancer Res. 2023;43 (12):5699-5704$52$YR$$M$Y$$$20240820$$HP$JP$JP
242281202$24228120$2$F$$20240828$20240820$20240912$EXP$$MA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462461$RANBAXY$Tahri N, Bensalem S, Kaddar K, Belharti K, Zizi N, Dikhaye S. Acute exanthematous pustulosis generalized induced by Erlotinib: report of a case. Rev Fr Allergol. 2024;64 (Suppl.):103923$63$YR$$$Y$$$20240912$$HP$MA$MA
242281211$24228121$1$I$20240425$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463202$RANBAXY$$72$YR$$F$Y$60.5$KG$20240820$$PH$FR$FR
242281221$24228122$1$I$20240517$20240805$20240820$20240820$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462863$RANBAXY$$85$YR$$M$Y$80$KG$20240820$$MD$GR$GR
242281231$24228123$1$I$$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462958$RANBAXY$$52$YR$$F$Y$$$20240820$$HP$FR$FR
242281241$24228124$1$I$$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462949$RANBAXY$$52$YR$$F$Y$$$20240820$$HP$FR$FR
242281251$24228125$1$I$$20240805$20240820$20240820$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462547$RANBAXY$$85$YR$$F$Y$$$20240820$$HP$GB$GB
242281261$24228126$1$I$20240507$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462860$RANBAXY$$100$YR$$M$Y$91$KG$20240820$$MD$FR$FR
242281271$24228127$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462904$RANBAXY$Wagner CB, Julian K, Bryan B, Steinbach MN, Shewan S, Maxwell L, et al. Carfilzomib in combination with dexamethasone, cyclophosphamide, etoposide, and cisplatin (KDCEP) for the treatment of relapsed/refractory aggressive plasma Cell dyscrasias. Blood. 2023;142 (Suppl.):6623$47$YR$$M$Y$$$20240820$$HP$US$US
242281281$24228128$1$I$$20240805$20240820$20240820$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462772$RANBAXY$Mohammad AP, Noroozi E, Mesgarha MG, Shayanfar N, Goodarzi A. Interesting Mucocutaneous Manifestations in COVID-19 Infection or Vaccination Confirmed by Histopathology: A Case Series. Case Rep Dermatol. 2024;16 (1):21-34$51$YR$$F$Y$$$20240820$$HP$IR$IR
242281291$24228129$1$I$$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462740$RANBAXY$Siblini L, Schott R, Trensz P, Pencreach E, Bender L. Primary resistance to ALK inhibitors in KLC1 /ALK-rearranged pleural metastatic lung adenocarcinoma: a case report. Transl Lung Cancer Res. 2023;12:2342-2346$34$YR$$M$Y$$$20240820$$HP$FR$FR
242281301$24228130$1$I$$20240805$20240820$20240820$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463096$RANBAXY$Hou CX, Chen Y, Liu SH, Jiang YZ, Huang DP, Chen SN.. Effective treatment with Gilteritinib-based regimens for FLT3-mutant extramedullary relapse in acute promyelocytic leukemia. Hematology. 2023;29:2293496$18$YR$$M$Y$$$20240820$$HP$CN$CN
242281311$24228131$1$I$20240425$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462875$RANBAXY$$47$YR$$M$Y$$$20240820$$HP$FR$FR
242281321$24228132$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462915$RANBAXY$Wagner CB, Julian K, Bryan B, Steinbach MN, Shewan S, Maxwell L, et al. Carfilzomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (KDCEP) for the Treatment of Relapsed/Refractory Aggressive Plasma Cell Dyscrasias. Blood. 2023;142 (Suppl.):6623$69$YR$$M$Y$$$20240820$$HP$US$US
242281331$24228133$1$I$$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463108$RANBAXY$$63$YR$$F$Y$$$20240820$$MD$FR$FR
242281341$24228134$1$I$$20240805$20240820$20240820$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462829$RANBAXY$Grewal TS, Soni D, Nada R, Sharma N, Pannu AK. A young boy with severe pulmonary-renal syndrome: Will you suspect IgA nephropathy. Turk J Emerg Med. 2023;23 (1):52-56$15$YR$$M$Y$$$20240820$$HP$IN$IN
242281351$24228135$1$I$20240404$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463248$RANBAXY$$70$YR$$M$Y$60$KG$20240820$$MD$FR$FR
242281362$24228136$2$F$$20240812$20240820$20240827$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463176$RANBAXY$Altundag I, Cete R, Toksul IH, Korkut S, Sahin A. Bupropion Overdose and Acute Renal Failure. Am J Ther. 2024;31(1):E52-E53$22$YR$$M$Y$$$20240827$$MD$TR$TR
242281371$24228137$1$I$20230615$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462821$RANBAXY$$26$YR$$M$Y$69$KG$20240820$$MD$FR$FR
242281381$24228138$1$I$$20240805$20240820$20240820$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463121$RANBAXY$Takada T, Katoh R, Yamada K, Ojima H.. Two cases of metastatic colorectal cancer with prolonged liver injury following capecitabine combination chemotherapy. BMJCaseRep. 2024;17 (7)$5$DEC$$M$Y$$$20240820$$MD$JP$JP
242281391$24228139$1$I$20240304$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462764$RANBAXY$$57$YR$$M$Y$$$20240820$$MD$FR$FR
242281401$24228140$1$I$20240506$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463082$RANBAXY$$68$YR$$F$Y$67$KG$20240820$$PH$FR$FR
242281411$24228141$1$I$$20240805$20240820$20240820$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463067$RANBAXY$$$$$F$Y$$$20240820$$PH$GB$GB
242281421$24228142$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462888$RANBAXY$Eshak N, Ehikhueme G, Ramesh M, Pixley J. Granulomatous Polyangiitis Refractory to Induction With Rituximab in 3 Patients. J Investig Med High Impact Case Rep. 2023;12:1-5$34$YR$$M$Y$$$20240820$$MD$US$US
242281431$24228143$1$I$20220501$20240805$20240820$20240820$EXP$$CA-SUNPHARMA-2022R1-404911AA$RANBAXY$$21$YR$$F$Y$87.528$KG$20240820$$CN$CA$CA
242281441$24228144$1$I$20231201$20240805$20240820$20240820$EXP$$US-SUNPHARMA-2024R1-433240AA$RANBAXY$$27$YR$$F$Y$104.76$KG$20240820$$CN$US$US
242281451$24228145$1$I$$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462999$RANBAXY$$45$YR$$M$Y$$$20240820$$HP$FR$FR
242281461$24228146$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462882$RANBAXY$Eshak N, Ehikhueme G, Ramesh M, Pixley J. Granulomatous Polyangiitis Refractory to Induction With Rituximab in 3 Patients. J Investig Med High Impact Case Rep. 2023;12:1-5$66$YR$$F$Y$$$20240820$$MD$US$US
242281471$24228147$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462934$RANBAXY$Hernandez K, Ahmed T, Liu D, Seiter K, Steinberg A. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. Blood. 2023;142 (Suppl.):7349$37$YR$$M$Y$$$20240820$$HP$US$US
242281481$24228148$1$I$$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462968$RANBAXY$$$$$F$Y$$$20240820$$HP$FR$FR
242281491$24228149$1$I$20240501$20240805$20240820$20240820$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463235$RANBAXY$$75$YR$$M$Y$$$20240820$$MD$ES$ES
242281501$24228150$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463321$RANBAXY$Patel R, Elghawy O, Gibbs A, Gupta S,Kaur V. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer Rep. 2024;7(7):e2110(1-6)$84$YR$$M$Y$$$20240820$$HP$US$US
242281511$24228151$1$I$$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462944$RANBAXY$$15$YR$$M$Y$$$20240820$$HP$FR$FR
242281521$24228152$1$I$$20240814$20240819$20240819$DIR$FDA-CDER-CTU-2024-56982$$FDA-CTU$$$$$F$N$$$20240814$N$HP$US$
242281531$24228153$1$I$20240315$20240805$20240820$20240820$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462884$RANBAXY$$19$YR$$F$Y$$$20240820$$HP$IT$IT
242281541$24228154$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462932$RANBAXY$Hernandez K, Ahmed T, Liu D, Seiter K, Steinberg A. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. Blood. 2023;142 (Suppl.)nov:7349$28$YR$$M$Y$$$20240820$$HP$US$US
242281551$24228155$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57191$$FDA-CTU$$$$$$N$$$20240819$N$CN$US$
242281561$24228156$1$I$20230601$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462890$RANBAXY$$30$YR$$F$Y$$$20240820$$MD$FR$FR
242281571$24228157$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462916$RANBAXY$Wagner CB, Julian K, Bryan B, Steinbach MN, Shewan S, Maxwell L, et al. Carfilzomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (KDCEP) for the Treatment of Relapsed/Refractory Aggressive Plasma Cell Dyscrasias. Blood. 2023;142 (Suppl.):6623-6625$73$YR$$F$Y$$$20240820$$HP$US$US
242281581$24228158$1$I$20240710$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57171$$FDA-CTU$$18$YR$$M$N$42.7$KG$20240819$N$HP$US$
242281591$24228159$1$I$20140101$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463128$RANBAXY$$29$YR$$M$Y$$$20240820$$MD$FR$FR
242281602$24228160$2$F$$20240808$20240820$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462880$RANBAXY$Srivastava A, Artiles MEJ, Elbanna M, Abu Sheikha M, Parikh V, Feitell S. Cardiogenic Shock: An Unusual Presentation Of Hydralazine-induced Anca-associated Vasculitis. J Card Fail. 2024;Jan; 30(1):149-150/070$68$YR$$F$Y$$$20240823$$HP$US$US
242281612$24228161$2$F$$20240824$20240820$20240906$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463753$RANBAXY$Laajimi R, Mansour K, Chadli Z, Ben Fredj N, Ben Romdhane H, Chaabane A, et al.. Tolerability of Meropenem and Ertapenem in a Patient with Documented Delayed Hypersensitivity Reaction to Imipenem-Cilastatin: A Literature Review.. Dermatitis. 2024;0 (0):no pagination$50$YR$$M$Y$$$20240906$$HP$TN$TN
242281621$24228162$1$I$$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463002$RANBAXY$$$$$F$Y$$$20240820$$HP$FR$FR
242281631$24228163$1$I$20200422$20240805$20240820$20240820$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463229$RANBAXY$$38$YR$$F$Y$$$20240820$$MD$ES$ES
242281641$24228164$1$I$20240401$20240805$20240820$20240820$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462721$RANBAXY$$70$YR$$F$Y$$$20240820$$MD$IT$IT
242281651$24228165$1$I$$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463008$RANBAXY$$68$YR$$M$Y$$$20240820$$HP$FR$FR
242281661$24228166$1$I$$20240805$20240820$20240820$EXP$ES-EMA-DD-20240528-7482691-102859$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462689$RANBAXY$$$$E$$Y$$$20240820$$HP$ES$ES
242281671$24228167$1$I$$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462818$RANBAXY$$59$YR$$F$Y$$$20240820$$HP$FR$FR
242281681$24228168$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462967$RANBAXY$Phang CR, Farooqi A, Sangwan Y. Unmasking the Unusual: Cryptococcal Pericarditis in a Patient with Liver Failure -a Rare Occurrence. Am J Case Rep. 2024;25(0):e943530$47$YR$$M$Y$$$20240820$$HP$US$US
242281691$24228169$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462947$RANBAXY$Shahin AB, Greene A, Reeder CB, Costello CM, Pittelkow MR, DiCaudo DJ. Paraneoplastic morphea with prominent mucin deposition. JAAD Case Rep. 2023;41:110-112$80$YR$$M$Y$$$20240820$$HP$US$US
242281701$24228170$1$I$$20240805$20240820$20240820$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461772$RANBAXY$Golubovskaya DP, Dren^ EV, Iurkina AV, Pecherina TB, Barbarash OL. Clinical case of generalized amyloidosis (ATTR-amyloidosis) with a progressive course of chronic heart failure.Case report. Terapevticheskii Arkhiv. 2024;96(7):695-700$45$YR$$M$Y$66$KG$20240820$$HP$RU$RU
242281711$24228171$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462885$RANBAXY$Eshak N, Ehikhueme G, Ramesh M, Pixley J. Granulomatous Polyangiitis Refractory to Induction With Rituximab in 3 Patients. J Investig Med High Impact Case Rep. 2023;12:1-5$44$YR$$M$Y$$$20240820$$MD$US$US
242281721$24228172$1$I$$20240805$20240820$20240820$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462736$RANBAXY$Mansour K, Chadli Z, Ghachem I, Fredj NB, Romdhane HB, Fadhel NB, et al. Seronegative acute encephalitis following COVID-19 vaccines: a case series of an overlooked diagnosis with literature review. Eur J Clin Pharmacol. 2023;79 (7):975-987$40$YR$$F$Y$$$20240820$$HP$TN$TN
242281731$24228173$1$I$20240726$20240805$20240820$20240820$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462939$RANBAXY$$33$YR$$M$Y$$$20240820$$PH$GB$GB
242281741$24228174$1$I$$20240819$20240820$20240820$EXP$$US-PFIZER INC-202400239448$PFIZER$$86$YR$$M$Y$$$20240820$$CN$US$US
242281751$24228175$1$I$20240516$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463078$RANBAXY$$72$YR$$F$Y$106$KG$20240820$$MD$FR$FR
242281761$24228176$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164236$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242281771$24228177$1$I$$20240815$20240820$20240820$EXP$$NVSC2024US166391$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242281781$24228178$1$I$$20240819$20240820$20240820$EXP$$CN-PFIZER INC-PV202400107636$PFIZER$$$$E$M$Y$$$20240820$$CN$CN$CN
242281791$24228179$1$I$$20240819$20240820$20240820$EXP$$US-PFIZER INC-202400239237$PFIZER$$91$YR$$F$Y$$$20240820$$HP$US$US
242281801$24228180$1$I$20240401$20240819$20240820$20240820$EXP$$CL-PFIZER INC-PV202400107891$PFIZER$$77$YR$$M$Y$$$20240820$$CN$CL$CL
242281812$24228181$2$F$$20240829$20240820$20240902$EXP$$US-PFIZER INC-202400239469$PFIZER$$57$YR$$F$Y$$$20240902$$CN$US$US
242281821$24228182$1$I$$20240819$20240820$20240820$EXP$$CN-PFIZER INC-PV202400107600$PFIZER$$$$E$M$Y$$$20240820$$CN$CN$CN
242281831$24228183$1$I$$20240819$20240820$20240820$EXP$$CN-PFIZER INC-PV202400107703$PFIZER$$$$A$F$Y$$$20240820$$CN$CN$CN
242281842$24228184$2$F$$20240906$20240820$20240910$EXP$$AU-PFIZER INC-PV202400107673$PFIZER$$88$YR$$F$Y$79$KG$20240910$$MD$AU$AU
242281851$24228185$1$I$$20240819$20240820$20240820$EXP$$US-PFIZER INC-202400239431$PFIZER$$$$$M$Y$$$20240820$$CN$US$US
242281862$24228186$2$F$20240730$20240920$20240820$20240925$EXP$$CA-LUNDBECK-DKLU4003111$LUNDBECK$$$$$$Y$$$20240925$$HP$CA$CA
242281871$24228187$1$I$20240805$20240807$20240820$20240820$EXP$GB-MHRA-MED-202408071652157240-TMPGV$HU-SMPA-2024SPA000885$SUNOVION$$$$$$Y$$$20240820$$PH$GB$GB
242281881$24228188$1$I$20240301$20240807$20240820$20240820$EXP$$US-SMPA-2024SPA001031$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242281891$24228189$1$I$20240804$20240807$20240820$20240820$EXP$$US-SMPA-2024SPA001035$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242281901$24228190$1$I$$20240806$20240820$20240820$EXP$$US-SMPA-2024SPA001113$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242281911$24228191$1$I$$20240813$20240820$20240820$EXP$$IN-ROCHE-10000057216$ROCHE$$67$YR$E$M$Y$$$20240820$$CN$IN$IN
242281921$24228192$1$I$$20240819$20240820$20240820$PER$$US-BAYER-2024A119222$BAYER$$23$YR$A$F$Y$$$20240820$$MD$US$US
242281933$24228193$3$F$20240812$20240918$20240820$20240930$EXP$$AR-BIOMARINAP-AR-2023-159898$BIOMARIN$$$$$$Y$$$20240930$$CN$AR$AR
242281942$24228194$2$F$20240101$20240818$20240820$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131562$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$94.44$KG$20240821$$PH$US$US
242281951$24228195$1$I$20240809$20240819$20240820$20240820$EXP$ES-AEMPS-1562221$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-130826$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$66$KG$20240820$$MD$ES$ES
242281961$24228196$1$I$20240814$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163416$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242281971$24228197$1$I$$20240812$20240820$20240820$PER$$US-009507513-2408USA004270$MERCK$$74$YR$$M$Y$$$20240820$$CN$US$US
242281981$24228198$1$I$20240814$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57010$$FDA-CTU$$76$YR$$M$N$90.72$KG$20240820$N$CN$US$
242282001$24228200$1$I$$20240815$20240820$20240820$PER$$US-BAYER-2024A117944$BAYER$$$$$$Y$$$20240820$$CN$US$US
242282012$24228201$2$F$20240101$20240828$20240820$20240904$EXP$$US-BIOGEN-2024BI01277517$BIOGEN$$$$$F$Y$$$20240904$$CN$US$US
242282021$24228202$1$I$$20240808$20240820$20240820$EXP$$US-MYLANLABS-2024M1076985$MYLAN$Sidhu SK, Ciancarelli J, Alviar C, Greco A. A Case of Severe Cardiopulmonary Sarcoidosis and Sub-massive Pulmonary Embolism. US-Cardiol 2024; 18 (Suppl. 1) 25-26.$68$YR$$M$Y$$$20240820$$HP$US$US
242282031$24228203$1$I$20230501$20240814$20240820$20240820$EXP$FR-AFSSAPS-TS2024000890$FR-MYLANLABS-2024M1075815$MYLAN$$57$YR$$F$Y$100$KG$20240820$$MD$FR$FR
242282041$24228204$1$I$$20240805$20240820$20240820$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463132$RANBAXY$Takada T, Katoh R, Yamada K, Ojima H.. Two cases of metastatic colorectal cancer with prolonged liver injury following capecitabine combination chemotherapy. BMJCaseRep. 2024;17 (7)$5$DEC$$M$Y$$$20240820$$MD$JP$JP
242282051$24228205$1$I$$20240805$20240820$20240820$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463071$RANBAXY$Yang Y, Zheng H, Ye H, Lin Y, Liu J, Li R, et al.. Sanji Peiyuan decoction combined with dydrogesterone in the treatment of massive subchorionic hematoma A case report. Medicine. 2023;102(49):E36382(1-3)$23$YR$$F$Y$$$20240820$$HP$CN$CN
242282061$24228206$1$I$$20240805$20240820$20240820$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463270$RANBAXY$Jin S, Shen Z, Li J, Liu X, Zhu Q, Li F, et al. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. J Clin Pathol. 2024;77;0(0):471-477; 1-7$$$$F$Y$$$20240820$$HP$CN$CN
242282071$24228207$1$I$$20240805$20240820$20240820$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462948$RANBAXY$$21$YR$$F$Y$55$KG$20240820$$CN$GB$GB
242282081$24228208$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462917$RANBAXY$Wagner CB, Julian K, Bryan B, Steinbach MN, Shewan S, Maxwell L, et al. Carfilzomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (KDCEP) for the Treatment of Relapsed/Refractory Aggressive Plasma Cell Dyscrasias. blood. 2023;142 (Suppl.):6623-6625$69$YR$$F$Y$$$20240820$$HP$US$US
242282091$24228209$1$I$$20240805$20240820$20240820$EXP$$TH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463112$RANBAXY$Wangapakul T, Riley A. Necrotizing Phenomenon in WHO Grade I Meningioma in an SLE Patient Following Immunosuppressive Treatment. J Neurol Surg B Skull Base. 2024;85(S 01):no pagination$29$YR$$F$Y$$$20240820$$HP$TH$TH
242282101$24228210$1$I$$20240805$20240820$20240820$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462743$RANBAXY$Mansour K, Chadli Z, Ghachem I, Fredj NB, Romdhane HB, Fadhel NB, et al. Seronegative acute encephalitis following COVID-19 vaccines: a case series of an overlooked diagnosis with literature review. Eur J Clin Pharmacol. 2023;79 (7):975-987$35$YR$$F$Y$$$20240820$$HP$TN$TN
242282111$24228211$1$I$20240331$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463246$RANBAXY$$80$YR$$F$Y$48$KG$20240820$$MD$FR$FR
242282121$24228212$1$I$20240519$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462909$RANBAXY$$72$YR$$M$Y$88$KG$20240820$$PH$FR$FR
242282131$24228213$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462900$RANBAXY$Marof BZ, Saado J, Lee K, Groner A, May TP. A case of use dependence effect and toxicity of flecainide due to pacemaker Tracked atrial tachycardia, renal failure, and hyponatremia. J Am Coll Cardiol. 2024;83 (Suppl.) (13:2892$76$YR$$F$Y$$$20240820$$HP$US$US
242282141$24228214$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462940$RANBAXY$Seltzer J, Hardin J, Galust H, Friedman N, Corbett B, Clark RF. Pharmacokinetic analysis of a phenobarbital overdose treated with urinary alkalinization alone. Toxicol Rep. 2024;12 (0):574-577$14$YR$$F$Y$45$KG$20240820$$HP$US$US
242282151$24228215$1$I$$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462945$RANBAXY$$15$YR$$M$Y$$$20240820$$HP$FR$FR
242282161$24228216$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463408$RANBAXY$Lee J, Casey E, Otigbah C, Tompsett MK, Pittathankal A, Sirkova A, et al. Hyperparathyroidism Causing life Threatening Hypercalcaemia in Pregnancy. J Endocr Soc. 2022;Nov-Dec;6 (S1):A166-A167;ODP099$31$YR$$F$Y$$$20240820$$HP$US$US
242282171$24228217$1$I$20240518$20240805$20240820$20240820$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462969$RANBAXY$$17$YR$$M$Y$$$20240820$$PH$IT$IT
242282181$24228218$1$I$20190723$20240805$20240820$20240820$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462817$RANBAXY$$$$$M$Y$$$20240820$$CN$PL$PL
242282191$24228219$1$I$20240510$20240805$20240820$20240820$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462768$RANBAXY$$70$YR$$M$Y$$$20240820$$MD$IT$IT
242282201$24228220$1$I$$20240805$20240820$20240820$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463409$RANBAXY$Lee J, Casey E, Otigbah C, Tompsett MK, Pittathankal A, Sirkova A, et al. Hyperparathyroidism Causing life Threatening Hypercalcaemia in Pregnancy. J Endocr Soc. 2022;6 (Suppl.):A166-A167 (ODP099); bvac150.34$$$I$M$Y$$$20240820$$HP$US$US
242282211$24228221$1$I$$20240805$20240820$20240820$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461608$RANBAXY$Vladimirovich SS. Patient with the eosinophilic phenotype of chronic obstructive pulmonary disease. Clinical case$68$YR$$M$Y$$$20240820$$MD$RU$RU
242282222$24228222$2$F$$20240808$20240820$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462953$RANBAXY$Cheng CP, Chung T, Chelnis JG. Repository Corticotropin Injection (Acthar Gel) Resolving Recurrent Idiopathic Orbital Myositis: A Case Report. J Neurol Surg B Skull Base. 2024;85 (Suppl.):no pagination$64$YR$$M$Y$$$20240823$$HP$US$US
242282231$24228223$1$I$20240814$20240814$20240820$20240820$PER$$US-ABBVIE-5881127$ABBVIE$$$$A$F$Y$$$20240820$$MD$US$US
242282241$24228224$1$I$$20240815$20240820$20240820$EXP$$US-JNJFOC-20240847404$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240820$$MD$US$US
242282251$24228225$1$I$$20240814$20240820$20240820$PER$$US-JNJFOC-20240844763$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$HP$US$US
242282261$24228226$1$I$20240727$20240814$20240820$20240820$EXP$NL-LRB-00995888$NL-SA-2024SA245712$SANOFI AVENTIS$$74$YR$E$M$Y$93.2$KG$20240820$$MD$NL$NL
242282271$24228227$1$I$20240801$20240809$20240820$20240820$PER$$US-SA-2024SA240537$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240820$$MD$US$US
242282281$24228228$1$I$$20240815$20240820$20240820$PER$$US-BAYER-2024A118041$BAYER$$$$$$Y$$$20240820$$CN$US$US
242282291$24228229$1$I$20240602$20240812$20240820$20240820$EXP$ES-AEMPS-1557514$ES-TEVA-VS-3233092$TEVA$$77$YR$$M$Y$$$20240820$$MD$ES$ES
242282301$24228230$1$I$$20231122$20240820$20240820$EXP$$NVSC2023IN252289$NOVARTIS$$$$$M$Y$$$20240820$$CN$IN$IN
242282311$24228231$1$I$20240809$20240815$20240820$20240820$PER$$US-BAYER-2024A118590$BAYER$$50$YR$A$M$Y$$$20240820$$CN$US$US
242282321$24228232$1$I$20240815$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56977$$FDA-CTU$$26$YR$$F$N$63.5$KG$20240819$Y$HP$US$
242282331$24228233$1$I$20240418$20240805$20240820$20240820$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463174$RANBAXY$$54$YR$$F$Y$$$20240820$$CN$FR$FR
242282341$24228234$1$I$$20240813$20240820$20240820$EXP$$FR-SANDOZ INC.-SDZ2024FR072789$SANDOZ$Alice Brehon, J?r?my Lourenco, Antoine Badaoui, Emmanuelle Amsler, Jos? Luis Lopez Zaragoza, Ang?le Soria, Annick Barbaud. Doxycycline-induced fixed drug eruption: The new epidemic?. Journal of The European Academy of Dermatology and Venereology. 2024;1?3$32$YR$$M$Y$$$20240820$$MD$FR$FR
242282351$24228235$1$I$$20240819$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US073749$SANDOZ$$$$$M$Y$$$20240820$$HP$US$US
242282361$24228236$1$I$20240501$20240813$20240820$20240820$EXP$$DE-SANDOZ INC.-SDZ2024DE072457$SANDOZ$$56$YR$$M$Y$99$KG$20240820$$MD$DE$DE
242282371$24228237$1$I$20240101$20240820$20240820$20240820$EXP$$TW-BAYER-2024A119587$BAYER$$$$$M$Y$$$20240820$$HP$TW$TW
242282381$24228238$1$I$20240807$20240813$20240820$20240820$EXP$$US-TAKEDA-2024TUS080418$TAKEDA$$43$YR$$M$Y$68.9$KG$20240820$$CN$US$US
242282391$24228239$1$I$20240812$20240814$20240820$20240820$EXP$$IN-PFIZER INC-PV202400093224$PFIZER$$56$YR$$F$Y$$$20240820$$CN$IN$IN
242282403$24228240$3$F$20240813$20240921$20240820$20240925$EXP$$IN-PFIZER INC-PV202400106402$PFIZER$$68$YR$$F$Y$$$20240925$$CN$IN$IN
242282411$24228241$1$I$20240301$20240816$20240820$20240820$EXP$FR-AFSSAPS-RE2024000824$FR-PFIZER INC-202400237944$PFIZER$$36$YR$$M$Y$92$KG$20240820$$MD$FR$FR
242282421$24228242$1$I$$20240816$20240820$20240820$EXP$AU-TGA-0000815262$AU-SANDOZ INC.-SDZ2024AU073236$SANDOZ$$53$YR$$F$Y$$$20240820$$MD$AU$AU
242282431$24228243$1$I$$20240819$20240820$20240820$EXP$$US-BIOVITRUM-2024-US-011067$BIOVITRUM$$2$MON$$M$Y$$$20240820$$CN$US$US
242282441$24228244$1$I$20240725$20240813$20240820$20240820$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000810$PAREXEL$$$$$$Y$$$20240820$$HP$CN$CN
242282452$24228245$2$F$20240615$20240917$20240820$20240918$EXP$$PL-PFIZER INC-202400238948$PFIZER$$67$YR$$F$Y$$$20240918$$MD$PL$PL
242282461$24228246$1$I$20220101$20240430$20240820$20240820$EXP$$NVSC2024IN094617$NOVARTIS$$$$$M$Y$$$20240820$$CN$IN$IN
242282471$24228247$1$I$$20240812$20240820$20240820$EXP$$CA-ROCHE-10000054760$ROCHE$$50$YR$A$F$Y$$$20240820$$HP$CA$CA
242282481$24228248$1$I$$20240813$20240820$20240820$PER$$US-MYLANLABS-2024M1075950$MYLAN$$$$$F$Y$65.77$KG$20240820$$PH$US$US
242282492$24228249$2$F$$20240912$20240820$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129623$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240916$$CN$US$US
242282501$24228250$1$I$$20240813$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128553$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240820$$CN$US$US
242282511$24228251$1$I$20240101$20240813$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128430$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240820$$CN$US$US
242282522$24228252$2$F$$20240816$20240820$20240820$PER$$US-GILEAD-2024-0684538$GILEAD$$45$YR$A$F$Y$$$20240820$$HP$US$US
242282531$24228253$1$I$20231001$20240813$20240820$20240820$EXP$$US-GSK-US2024100717$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$US$US
242282542$24228254$2$F$20240801$20240830$20240820$20240903$PER$$US-BAYER-2024A119106$BAYER$$78$YR$E$F$Y$$$20240903$$CN$US$US
242282551$24228255$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010007$ELI LILLY AND CO$$$$$M$Y$$$20240820$$CN$US$US
242282561$24228256$1$I$20240701$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010009$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240820$$CN$US$US
242282571$24228257$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010711$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242282581$24228258$1$I$$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011662$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240820$$CN$US$US
242282591$24228259$1$I$$20240807$20240820$20240820$EXP$$US-SMPA-2024SPA001055$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242282612$24228261$2$F$20240809$20240818$20240820$20240829$EXP$$US-SMPA-2024SPA001082$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242282621$24228262$1$I$$20240807$20240820$20240820$EXP$$US-SMPA-2024SPA001085$SUNOVION$$$$$$Y$$$20240820$$CN$US$US
242282631$24228263$1$I$$20240814$20240820$20240820$PER$$US-JNJFOC-20240837203$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$US$US
242282641$24228264$1$I$20240809$20240814$20240820$20240820$EXP$$US-Vifor (International) Inc.-VIT-2024-07315$VIFOR$$33$YR$$F$Y$63$KG$20240820$$HP$US$US
242282651$24228265$1$I$$20240814$20240820$20240820$EXP$$AU-TAKEDA-2024TUS082412$TAKEDA$$29$YR$$M$Y$96$KG$20240820$$HP$AU$AU
242282661$24228266$1$I$20230626$20240808$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN008343$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242282673$24228267$3$F$20200608$20240918$20240820$20240920$EXP$$CA-TAKEDA-2023TUS030153$TAKEDA$$49$YR$$M$Y$$$20240920$$HP$CA$CA
242282681$24228268$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57217$$FDA-CTU$$57$YR$$F$N$$$20240820$N$$US$
242282691$24228269$1$I$20240720$20240813$20240820$20240820$EXP$$US-Vifor (International) Inc.-VIT-2024-07293$VIFOR$$50$YR$$$Y$100.7$KG$20240820$$HP$US$US
242282701$24228270$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168402$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242282711$24228271$1$I$20240812$20240812$20240820$20240820$EXP$$DE-BAXTER-2024BAX023155$BAXTER$$67$YR$$M$Y$$$20240820$$HP$DE$DE
242282721$24228272$1$I$$20240819$20240820$20240820$EXP$NL-LRB-00996839$NVSC2024NL167318$NOVARTIS$$38$YR$$M$Y$80$KG$20240820$$MD$NL$NL
242282731$24228273$1$I$20240807$20240812$20240820$20240820$EXP$GB-MHRA-MED-202408121516162620-BZVQH$GB-TEVA-VS-3233295$TEVA$$62$YR$$F$Y$$$20240820$$HP$GB$GB
242282741$24228274$1$I$20240801$20240810$20240820$20240820$PER$$US-SA-2024SA241268$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240820$$CN$US$US
242282761$24228276$1$I$$20240806$20240820$20240820$PER$$US-SA-2024SA238460$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240820$$MD$US$US
242282781$24228278$1$I$20240701$20240808$20240820$20240820$PER$$US-SA-2024SA240698$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240820$$MD$US$US
242282791$24228279$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA242799$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242282801$24228280$1$I$20230812$20240812$20240820$20240820$EXP$$GB-TEVA-VS-3232491$TEVA$$62$YR$$M$Y$$$20240820$$CN$GB$GB
242282811$24228281$1$I$20240724$20240816$20240820$20240820$EXP$$US-INCYTE CORPORATION-2024IN008613$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242282822$24228282$2$F$$20240821$20240820$20240920$EXP$$US-Vifor (International) Inc.-VIT-2024-06706$VIFOR$$77$YR$$F$Y$92.53$KG$20240920$$CN$US$US
242282831$24228283$1$I$$20240813$20240820$20240820$EXP$$GB-009507513-2408GBR005062$MERCK$Agarwal V, Chamberlain G, Bala L, El Shimy N.. A case of pembrolizumab-induced psoriasiform rash treated with risankizumab. British Journal of Dermatology. 2024;192 (Supple 1):i152-i153$77$YR$$F$Y$$$20240820$$HP$GB$GB
242282842$24228284$2$F$$20240819$20240820$20240820$PER$$US-JNJFOC-20240843404$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240820$$CN$US$US
242282851$24228285$1$I$20240429$20240812$20240820$20240820$EXP$FR-AFSSAPS-AM2024000634$FR-TEVA-VS-3233273$TEVA$$43$YR$$F$Y$72$KG$20240820$$MD$FR$FR
242282871$24228287$1$I$20240805$20240809$20240820$20240820$PER$$US-ABBVIE-5877772$ABBVIE$$80$YR$$F$Y$$$20240820$$CN$US$US
242282881$24228288$1$I$20240101$20240813$20240820$20240820$EXP$$US-ABBVIE-5881920$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242282891$24228289$1$I$$20240812$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA072633$SANDOZ$$$$$F$Y$$$20240820$$MD$CA$CA
242282901$24228290$1$I$20180527$20240807$20240820$20240820$EXP$FR-AFSSAPS-PC2024000602$FR-Accord-441208$ACCORD$$93$YR$E$F$Y$44$KG$20240820$$PH$FR$FR
242282911$24228291$1$I$$20240808$20240820$20240820$EXP$GB-MHRA-WEBRADR-202408081127569880-YNPTZ$GB-Accord-440985$ACCORD$$60$YR$A$F$Y$$$20240820$$HP$GB$GB
242282921$24228292$1$I$20240627$20240819$20240819$20240819$DIR$714934$$FDA-CTU$$48$YR$$M$N$82.4$KG$20240819$N$HP$US$
242282931$24228293$1$I$$20240808$20240820$20240820$EXP$$JP-Accord-441320$ACCORD$Sasaki K, Hirose T, Suetsugu Y, et al. (July 06, 2024) Successful Treatment of Hepatitis B Virus Reactivation With a Combination of Entecavir and Short-Term Administration of Interferon-beta Twice per Day. Cureus 16(7): e63978.$76$YR$E$M$Y$$$20240820$$MD$JP$JP
242282941$24228294$1$I$$20240808$20240820$20240820$EXP$CA-MHPD-E2B_07115407$CA-Accord-441321$ACCORD$$$$A$F$Y$$$20240820$$MD$CA$CA
242282951$24228295$1$I$$20240808$20240820$20240820$EXP$GB-MHRA-MED-202408081140126560-YGFTN$GB-Accord-441133$ACCORD$$58$YR$A$M$Y$$$20240820$$PH$GB$GB
242282961$24228296$1$I$$20240808$20240820$20240820$EXP$GB-MHRA-MED-202408081058109930-HGRMQ$GB-Accord-441114$ACCORD$$79$YR$E$F$Y$$$20240820$$HP$GB$GB
242282971$24228297$1$I$20230401$20240808$20240820$20240820$EXP$$CN-Accord-441392$ACCORD$Sun M, Xu G, Cai L, He S. Misdiagnosis of severe and atypical oxaliplatin-related hypersensitivity reaction following chemotherapy combined with PD-1 inhibitor: A case report and literature review. Oncol Lett. 2024 Jul 23;28(4):452.$67$YR$E$M$Y$$$20240820$$HP$CN$CN
242282981$24228298$1$I$20240626$20240808$20240820$20240820$EXP$FR-AFSSAPS-AN2024001028$FR-Accord-441169$ACCORD$$64$YR$A$M$Y$53.4$KG$20240820$$MD$FR$FR
242282991$24228299$1$I$$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130865$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240820$$HP$US$US
242283001$24228300$1$I$$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129519$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240820$$HP$US$US
242283012$24228301$2$F$20240724$20240905$20240820$20240917$EXP$$JP-Accord-441352$ACCORD$$75$YR$E$F$Y$49.8$KG$20240917$$HP$JP$JP
242283022$24228302$2$F$20240808$20240812$20240820$20240821$EXP$GB-MHRA-MED-202408120752037640-VDNHZ$GB-BIOGEN-2024BI01277915$BIOGEN$$41$YR$$F$Y$$$20240821$$HP$GB$GB
242283031$24228303$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5883012$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242283041$24228304$1$I$20240701$20240815$20240820$20240820$EXP$$JP-PFIZER INC-202400233544$PFIZER$$$$$F$Y$$$20240820$$CN$JP$JP
242283051$24228305$1$I$$20240819$20240820$20240820$EXP$$US-PFIZER INC-202400239665$PFIZER$$65$YR$$F$Y$$$20240820$$CN$US$US
242283062$24228306$2$F$$20240910$20240820$20240911$EXP$$IN-PFIZER INC-PV202400107724$PFIZER$$60$YR$$M$Y$$$20240911$$CN$IN$IN
242283073$24228307$3$F$20170101$20240819$20240820$20240826$EXP$$US-PFIZER INC-202400238554$PFIZER$$53$YR$$M$Y$84.37$KG$20240826$$CN$US$US
242283081$24228308$1$I$$20240816$20240820$20240820$EXP$GB-MHRA-TPP26475717C9906057YC1723715759993$GB-PFIZER INC-202400238144$PFIZER$$54$YR$$M$Y$69$KG$20240820$$MD$GB$GB
242283091$24228309$1$I$20240701$20240723$20240820$20240820$PER$$US-Vifor (International) Inc.-VIT-2024-06632$VIFOR$$70$YR$$F$Y$$$20240820$$CN$US$US
242283101$24228310$1$I$20240801$20240815$20240820$20240820$EXP$$US-ABBVIE-5883220$ABBVIE$$34$YR$$M$Y$$$20240820$$CN$US$US
242283111$24228311$1$I$$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024163850$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242283121$24228312$1$I$$20240810$20240820$20240820$EXP$$US-JNJFOC-20240834480$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242283131$24228313$1$I$20240816$20240816$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US073692$SANDOZ$$65$YR$$F$Y$$$20240820$$CN$US$US
242283141$24228314$1$I$$20240814$20240820$20240820$EXP$$CA-JNJFOC-20240386048$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240820$$HP$CA$CA
242283151$24228315$1$I$20221006$20240816$20240820$20240820$EXP$$GB-MYLANLABS-2024M1072077$MYLAN$$25$YR$$M$Y$111$KG$20240820$$MD$GB$GB
242283161$24228316$1$I$$20240819$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA073770$SANDOZ$$$$$F$Y$$$20240820$$HP$CA$CA
242283171$24228317$1$I$$20240807$20240820$20240820$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08042$LUPIN$Gondal MUR, Rovenstine L, Ansari F, Kiyani Z, Nair DPJR, Khan T, et al.. Navigating a complex case of Mycobacterium xenopi in a patient with blue rubber bleb nevus syndrome. European Journal of Case Reports in Internal Medicine. 2024;11 (6)$40$YR$$F$Y$$$20240820$$HP$US$US
242283181$24228318$1$I$$20240610$20240820$20240820$EXP$$NVSC2023IN246196$NOVARTIS$$$$$M$Y$$$20240820$$CN$IN$IN
242283192$24228319$2$F$20220101$20240819$20240820$20240822$EXP$$US-ABBVIE-5882046$ABBVIE$$$$$M$Y$73.482$KG$20240822$$CN$US$US
242283212$24228321$2$F$20240603$20240920$20240820$20240926$EXP$$US-INCYTE CORPORATION-2024IN008565$INCYTE$$$$$$Y$$$20240926$$HP$US$US
242283221$24228322$1$I$20240101$20240816$20240820$20240820$EXP$$CO-ABBVIE-5885861$ABBVIE$$$$$M$Y$$$20240820$$CN$CO$CO
242283231$24228323$1$I$$20240816$20240820$20240820$EXP$GB-MHRA-MED-202408160957521500-JTDRC$GB-PFIZER INC-202400238081$PFIZER$$28$YR$$F$Y$57$KG$20240820$$CN$GB$GB
242283252$24228325$2$F$$20240827$20240820$20240830$EXP$$DE-TAKEDA-2024TUS081688$TAKEDA$$31$YR$$F$Y$$$20240830$$HP$DE$DE
242283262$24228326$2$F$20240627$20240820$20240820$20240824$EXP$$US-ABBVIE-5882654$ABBVIE$$71$YR$$M$Y$$$20240824$$CN$US$US
242283271$24228327$1$I$20240725$20240812$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011887$DR REDDYS$$71$YR$E$F$Y$$$20240820$$CN$US$US
242283281$24228328$1$I$$20240819$20240819$20240819$DIR$714941$$FDA-CTU$$$$$UNK$N$$$20240819$N$CN$US$
242283291$24228329$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57027$$FDA-CTU$$74$YR$$F$N$83.01$KG$20240819$N$$US$
242283301$24228330$1$I$20240719$20240819$20240819$20240819$DIR$714943$$FDA-CTU$$21$YR$$F$N$43.5$KG$20240819$N$$US$
242283311$24228331$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57054$$FDA-CTU$$59$YR$$F$N$$$20240819$N$$US$
242283331$24228333$1$I$20230501$20240812$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN008442$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242283341$24228334$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57001$$FDA-CTU$$77$YR$$F$N$56.25$KG$20240819$N$$US$
242283351$24228335$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56978$$FDA-CTU$$48$YR$$F$N$$$20240819$N$$US$
242283361$24228336$1$I$20240601$20240808$20240820$20240820$EXP$$US-BIOCODEX2-2024000900$BIOCODEX$$4$YR$$M$Y$19$KG$20240819$$MD$US$US
242283371$24228337$1$I$$20240807$20240820$20240820$EXP$$US-ABBVIE-5872771$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242283381$24228338$1$I$20230912$20240812$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128512$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$60.3$KG$20240820$$HP$US$US
242283391$24228339$1$I$20240803$20240820$20240820$20240820$EXP$$IN-PFIZER INC-PV202400108179$PFIZER$$35$YR$$F$Y$$$20240820$$CN$IN$IN
242283401$24228340$1$I$$20240819$20240820$20240820$EXP$$US-PFIZER INC-PV202400108224$PFIZER$$76$YR$$F$Y$$$20240820$$HP$US$US
242283421$24228342$1$I$20231101$20240815$20240820$20240820$EXP$$CA-PFIZER INC-202300361596$PFIZER$$50$YR$$F$Y$$$20240820$$HP$CA$CA
242283431$24228343$1$I$$20240819$20240820$20240820$EXP$$AR-PFIZER INC-202400239941$PFIZER$$40$YR$$F$Y$$$20240820$$CN$AR$AR
242283442$24228344$2$F$20240503$20240920$20240820$20240920$EXP$ES-AEMPS-1558964$ES-PFIZER INC-202400237996$PFIZER$$82$YR$$M$Y$$$20240920$$MD$ES$ES
242283451$24228345$1$I$20240817$20240819$20240820$20240820$EXP$$CN-PFIZER INC-PV202400107968$PFIZER$$6$YR$$F$Y$18$KG$20240820$$HP$CN$CN
242283471$24228347$1$I$$20240815$20240820$20240820$EXP$$GB-MYLANLABS-2024M1076302$MYLAN$$$$$M$Y$$$20240820$$PH$GB$GB
242283491$24228349$1$I$20240715$20240722$20240820$20240820$PER$$US-LEX-000404$LEXICON PHARMACEUTICALS$$67$YR$$M$Y$$$20240820$$CN$US$US
242283502$24228350$2$F$$20240807$20240820$20240902$PER$$US-JNJFOC-20240820074$JOHNSON AND JOHNSON$$58$YR$A$F$Y$83.9$KG$20240902$$CN$US$US
242283511$24228351$1$I$$20240808$20240820$20240820$EXP$$US-AMX-008125$AMYLYX PHARMACEUTICALS$$$$$M$Y$$$20240820$$HP$US$US
242283521$24228352$1$I$20240102$20240807$20240820$20240820$PER$$US-BAYER-2024A024591$BAYER$$71$YR$E$M$Y$$$20240820$$HP$US$US
242283532$24228353$2$F$$20240917$20240820$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129733$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240918$$CN$US$US
242283541$24228354$1$I$$20240812$20240820$20240820$EXP$$CA-TEVA-VS-3233065$TEVA$$$$$F$Y$$$20240820$$CN$CA$CA
242283552$24228355$2$F$20240717$20240805$20240820$20240820$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000794$PAREXEL$$$$$$Y$$$20240820$$HP$CN$CN
242283561$24228356$1$I$20240801$20240812$20240820$20240820$EXP$$JP-AstraZeneca-2024A185467$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$JP$
242283571$24228357$1$I$20240806$20240816$20240820$20240820$EXP$$CN-PFIZER INC-PV202400107424$PFIZER$$66$YR$$M$Y$82.5$KG$20240820$$HP$CN$CN
242283591$24228359$1$I$20240301$20240315$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-046767$REGENERON$$$$$M$Y$$$20240820$$HP$US$US
242283601$24228360$1$I$20240308$20240315$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-046764$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242283611$24228361$1$I$20240301$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-046779$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242283621$24228362$1$I$20240101$20240319$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-048082$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242283631$24228363$1$I$20240303$20240516$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-048735$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242283642$24228364$2$F$20240717$20240902$20240820$20240909$PER$$US-AMGEN-USASP2024146753$AMGEN$$72$YR$E$F$Y$71.7$KG$20240909$$PH$US$US
242283651$24228365$1$I$$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024163968$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242283671$24228367$1$I$20240101$20240523$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-048087$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242283691$24228369$1$I$$20240813$20240820$20240820$EXP$$US-ABBVIE-5879505$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242283701$24228370$1$I$20240101$20240814$20240820$20240820$EXP$$US-ABBVIE-5881392$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242283711$24228371$1$I$20240229$20240812$20240820$20240820$EXP$$US-ABBVIE-5662216$ABBVIE$$68$YR$$F$Y$$$20240820$$CN$US$US
242283721$24228372$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5882055$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242283731$24228373$1$I$$20240819$20240819$20240819$DIR$714972$$FDA-CTU$$$$$UNK$N$$$20240819$$CN$US$
242283741$24228374$1$I$20240804$20240819$20240819$20240819$DIR$714992$$FDA-CTU$$73$YR$$M$N$$$20240819$Y$$US$
242283761$24228376$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57107$$FDA-CTU$$51$YR$$F$N$$$20240819$N$$US$
242283771$24228377$1$I$$20240819$20240819$20240819$DIR$714959$$FDA-CTU$$31$YR$$M$N$74.25$KG$20240819$N$CN$US$
242283781$24228378$1$I$$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57114$$FDA-CTU$$$$$M$N$$$20240819$N$HP$US$
242283791$24228379$1$I$20240813$20240819$20240819$20240819$DIR$714978$$FDA-CTU$$67$YR$$F$N$60.75$KG$20240819$N$CN$US$
242283801$24228380$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56987$$FDA-CTU$$71$YR$$F$N$$$20240819$N$$US$
242283811$24228381$1$I$20240805$20240819$20240819$20240819$DIR$714935$$FDA-CTU$$76$YR$$M$N$83$KG$20240819$Y$HP$US$
242283821$24228382$1$I$20240819$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57068$$FDA-CTU$$66$YR$$F$N$$$20240819$N$$US$
242283831$24228383$1$I$$20240819$20240819$20240819$DIR$714953$$FDA-CTU$$$$$F$N$$$20240819$Y$HP$US$
242283841$24228384$1$I$$20240811$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128406$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240820$$MD$US$US
242283851$24228385$1$I$20230401$20240813$20240820$20240820$EXP$DE-EMBRYOTOX-202303640$DE-LUNDBECK-DKLU4003125$LUNDBECK$$$$$$Y$$$20240820$$MD$DE$DE
242283861$24228386$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131316$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240820$$CN$US$US
242283871$24228387$1$I$$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129144$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240820$$HP$US$US
242283882$24228388$2$F$$20240820$20240820$20240826$EXP$$BD-SANDOZ INC.-SDZ2024BD073804$SANDOZ$$64$YR$$F$Y$60$KG$20240826$$CN$BD$BD
242283891$24228389$1$I$20240818$20240819$20240820$20240820$PER$$US-AMGEN-USASP2024165831$AMGEN$$69$YR$E$M$Y$$$20240820$$CN$US$US
242283902$24228390$2$F$20240707$20240828$20240820$20240902$PER$$US-AMGEN-USASP2024161440$AMGEN$$$$$F$Y$$$20240902$$HP$US$US
242283911$24228391$1$I$$20240516$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-048739$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242283921$24228392$1$I$20240301$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-048776$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242283931$24228393$1$I$20240320$20240523$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-049328$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242283941$24228394$1$I$20240101$20240322$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-050026$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242283951$24228395$1$I$20240321$20240516$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-050037$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242283961$24228396$1$I$20240301$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-050374$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242283971$24228397$1$I$$20240322$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-050070$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242283981$24228398$1$I$$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-050030$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242283991$24228399$1$I$20240323$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-050395$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284001$24228400$1$I$$20240710$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-053324$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284011$24228401$1$I$20230101$20240530$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-053327$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242284021$24228402$1$I$$20240813$20240820$20240820$EXP$$CN-GSK-CN2024APC101022$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$MD$CN$CN
242284031$24228403$1$I$20231229$20240805$20240820$20240820$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000795$PAREXEL$$$$$$Y$$$20240820$$HP$CN$CN
242284041$24228404$1$I$$20240806$20240820$20240820$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07872$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240820$$MD$US$US
242284051$24228405$1$I$20240328$20240605$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-052159$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242284061$24228406$1$I$20240320$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-048768$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284071$24228407$1$I$20240324$20240523$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-050913$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242284081$24228408$1$I$20230101$20240814$20240820$20240820$EXP$$CA-ABBVIE-5882357$ABBVIE$$40$YR$$M$Y$$$20240820$$CN$CA$CA
242284091$24228409$1$I$20230101$20240626$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-054105$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284101$24228410$1$I$$20240607$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-054189$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242284111$24228411$1$I$20230101$20240530$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-054103$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284131$24228413$1$I$$20240813$20240820$20240820$EXP$$GB-009507513-2408GBR005954$MERCK$$$$$M$Y$$$20240820$$HP$GB$GB
242284141$24228414$1$I$$20240816$20240820$20240820$EXP$$IN-ROCHE-10000047380$ROCHE$$64$YR$A$M$Y$$$20240820$$CN$IN$IN
242284151$24228415$1$I$20240617$20240816$20240820$20240820$EXP$ES-AEMPS-1560621$NVSC2024ES166553$NOVARTIS$$78$YR$$M$Y$$$20240820$$MD$ES$ES
242284161$24228416$1$I$20170401$20240813$20240820$20240820$EXP$$ES-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00426$VELOXIS PHARMACEUTICALS$Ordonez-Fernandez L, Rodriguez-Ferreras A, Carriles C, Martinez-Torron A, Lazaro-Lopez E, Rosado-Maria MC.. Pneumonia in a patient with kidney transplant treated with alirocumab and everolimus.. Farmacia Hospitalaria.. 2019;43 (2):74-76$45$YR$$M$Y$$$20240820$$HP$ES$ES
242284171$24228417$1$I$$20240411$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-055620$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284181$24228418$1$I$20240405$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-056752$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284191$24228419$1$I$20240409$20240531$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-056782$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284201$24228420$1$I$$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-056792$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242284211$24228421$1$I$$20240717$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-054763$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284221$24228422$1$I$$20240620$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-055340$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284231$24228423$1$I$$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-056409$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242284241$24228424$1$I$$20240403$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-054726$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284251$24228425$1$I$$20240711$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-056312$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242284261$24228426$1$I$20240404$20240620$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-055407$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242284271$24228427$1$I$$20240815$20240820$20240820$PER$$US-BIOVITRUM-2024-US-011033$BIOVITRUM$$$$$F$Y$$$20240820$$CN$US$US
242284281$24228428$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131654$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240820$$CN$US$US
242284291$24228429$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131680$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240820$$HP$US$US
242284301$24228430$1$I$$20240816$20240820$20240820$EXP$$US-ABBVIE-5884854$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242284311$24228431$1$I$$20240813$20240820$20240820$EXP$$AU-MYLANLABS-2024M1076827$MYLAN$Litkouhi P, Bhat A, Choong C, Bhindi R. Spontaneous Coronary Artery Dissection in the Distal Portion of a Hyper-Dominant Left Anterior Descending Artery: A Rare Clinical Case. Heart-Lung-Circ 2024; 33 (Suppl. 4) S537-S538.$61$YR$$M$Y$$$20240820$$HP$AU$AU
242284322$24228432$2$F$20240807$20240819$20240820$20240823$EXP$$NZ-MYLANLABS-2024M1073871$MYLAN$$52$YR$$M$Y$$$20240823$$CN$NZ$NZ
242284331$24228433$1$I$20240411$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-057856$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284341$24228434$1$I$$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-058897$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242284351$24228435$1$I$20240411$20240627$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-057853$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242284361$24228436$1$I$20240201$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-057488$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284371$24228437$1$I$20240409$20240620$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-057858$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284381$24228438$1$I$$20240620$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-058887$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284391$24228439$1$I$20240412$20240807$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-058914$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284401$24228440$1$I$20240413$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-059340$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284411$24228441$1$I$20240407$20240418$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-057307$REGENERON$$$$$M$Y$$$20240820$$PH$US$US
242284421$24228442$1$I$$20240816$20240820$20240820$EXP$$GB-OTSUKA-2024_022710$OTSUKA$$$$$F$Y$$$20240820$$HP$GB$GB
242284431$24228443$1$I$$20240819$20240820$20240820$PER$$US-ROCHE-10000061201$ROCHE$$63$YR$A$F$Y$$$20240820$$CN$US$US
242284441$24228444$1$I$$20240814$20240820$20240820$EXP$$US-AUROBINDO-AUR-APL-2024-040997$AUROBINDO$Yu R. Exaggerated Increases in the Serum Cortisol Level in a Woman Following Oral Contraceptive Treatment. AACE Clinical Case Rep. 2024$50$YR$$F$Y$$$20240820$$MD$US$US
242284451$24228445$1$I$20240801$20240807$20240820$20240820$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000798$PAREXEL$$$$$$Y$$$20240820$$HP$CN$CN
242284462$24228446$2$F$20240806$20240816$20240820$20240821$PER$$US-PFIZER INC-PV202400107298$PFIZER$$78$YR$$M$Y$$$20240821$$HP$US$US
242284471$24228447$1$I$20240814$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237895$PFIZER$$29$YR$$F$Y$$$20240820$$CN$US$US
242284481$24228448$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237872$PFIZER$$16$YR$$F$Y$$$20240820$$CN$US$US
242284491$24228449$1$I$$20240816$20240820$20240820$PER$$US-PFIZER INC-202400238565$PFIZER$$$$$F$Y$$$20240820$$CN$US$US
242284511$24228451$1$I$$20240816$20240820$20240820$PER$$US-PFIZER INC-PV202400107608$PFIZER$$19$YR$$F$Y$$$20240820$$HP$US$US
242284521$24228452$1$I$20240413$20240718$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-059339$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284531$24228453$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237852$PFIZER$$41$YR$$M$Y$$$20240820$$CN$US$US
242284541$24228454$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237869$PFIZER$$$$$F$Y$$$20240820$$CN$US$US
242284551$24228455$1$I$20240801$20240816$20240820$20240820$PER$$US-PFIZER INC-202400238499$PFIZER$$$$A$M$Y$$$20240820$$HP$US$US
242284561$24228456$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237997$PFIZER$$85$YR$$F$Y$$$20240820$$HP$US$US
242284571$24228457$1$I$20240809$20240815$20240820$20240820$EXP$$CN-PFIZER INC-PV202400106755$PFIZER$$7$YR$$F$Y$$$20240820$$HP$CN$CN
242284591$24228459$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237039$PFIZER$$72$YR$$F$Y$56.689$KG$20240820$$CN$US$US
242284602$24228460$2$F$$20240909$20240820$20240910$PER$$US-PFIZER INC-202400237746$PFIZER$$53$YR$$F$Y$$$20240910$$CN$US$US
242284611$24228461$1$I$20240812$20240816$20240820$20240820$PER$$US-PFIZER INC-202400238788$PFIZER$$64$YR$$F$Y$$$20240820$$CN$US$US
242284621$24228462$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400238005$PFIZER$$$$$F$Y$$$20240820$$CN$US$US
242284631$24228463$1$I$20240809$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57013$$FDA-CTU$$78$YR$$F$N$$$20240819$Y$HP$US$
242284641$24228464$1$I$20240813$20240814$20240820$20240820$PER$$US-PFIZER INC-202400237137$PFIZER$$27$YR$$F$Y$$$20240820$$HP$US$US
242284651$24228465$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400238459$PFIZER$$85$YR$$F$Y$$$20240820$$HP$US$US
242284661$24228466$1$I$20240819$20240819$20240819$20240819$DIR$714960$$FDA-CTU$$74$YR$$F$N$$$20240819$N$$US$
242284672$24228467$2$F$20240814$20240903$20240820$20240904$PER$$US-PFIZER INC-202400237544$PFIZER$$62$YR$$F$Y$78.458$KG$20240904$$CN$US$US
242284681$24228468$1$I$20240101$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237789$PFIZER$$75$YR$$F$Y$79.38$KG$20240820$$CN$US$US
242284691$24228469$1$I$$20240814$20240820$20240820$PER$$US-PFIZER INC-PV202400106413$PFIZER$$61$YR$$F$Y$$$20240820$$HP$US$US
242284701$24228470$1$I$20240811$20240814$20240820$20240820$PER$$US-PFIZER INC-202400237183$PFIZER$$50$YR$$M$Y$$$20240820$$CN$US$US
242284711$24228471$1$I$$20240819$20240819$20240819$DIR$714906$$FDA-CTU$$$$$UNK$N$$$20240819$$CN$US$
242284731$24228473$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400238746$PFIZER$$69$YR$$F$Y$$$20240820$$HP$US$US
242284742$24228474$2$F$20240101$20240910$20240820$20240912$PER$$US-PFIZER INC-202400235948$PFIZER$$13$YR$$F$Y$91.9$KG$20240912$$HP$US$US
242284751$24228475$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-PV202400107219$PFIZER$$35$YR$$F$Y$$$20240820$$CN$US$US
242284762$24228476$2$F$20240801$20240904$20240820$20240909$PER$$US-PFIZER INC-202400238458$PFIZER$$89$YR$$F$Y$$$20240909$$PH$US$US
242284771$24228477$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237673$PFIZER$$$$$$Y$$$20240820$$CN$US$US
242284781$24228478$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237569$PFIZER$$$$$M$Y$$$20240820$$CN$US$US
242284791$24228479$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400209837$PFIZER$$75$YR$$F$Y$$$20240820$$HP$US$US
242284811$24228481$1$I$20240801$20240814$20240820$20240820$PER$$US-PFIZER INC-202400237648$PFIZER$$21$YR$$F$Y$$$20240820$$HP$US$US
242284821$24228482$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-PV202400024552$PFIZER$$76$YR$$F$Y$70.31$KG$20240820$$CN$US$US
242284851$24228485$1$I$20240425$20240703$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-065362$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242284861$24228486$1$I$$20240620$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-059397$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242284871$24228487$1$I$20240301$20240607$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-059532$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284881$24228488$1$I$$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-059983$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242284891$24228489$1$I$$20240418$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-061144$REGENERON$$$$$$Y$$$20240820$$CN$US$US
242284901$24228490$1$I$$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-059344$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242284911$24228491$1$I$$20240718$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-059435$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284921$24228492$1$I$$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-059977$REGENERON$$$$$M$Y$$$20240820$$MD$US$US
242284931$24228493$1$I$20240416$20240425$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-059980$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284941$24228494$1$I$$20240418$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-061098$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284951$24228495$1$I$20240101$20240417$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-061102$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284961$24228496$1$I$$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-061103$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242284971$24228497$1$I$$20240418$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-061206$REGENERON$$$$$$Y$$$20240820$$CN$US$US
242284981$24228498$1$I$20240419$20240425$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-062272$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242284991$24228499$1$I$20240101$20240523$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-062273$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242285001$24228500$1$I$20240101$20240627$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-062278$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242285011$24228501$1$I$20240101$20240515$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-062282$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242285021$24228502$1$I$20240419$20240425$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-062350$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242285031$24228503$1$I$20240421$20240502$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-062442$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242285041$24228504$1$I$20240313$20240422$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-063018$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242285051$24228505$1$I$20230101$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-063717$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242285061$24228506$1$I$20240417$20240424$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-064163$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242285071$24228507$1$I$20240101$20240424$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-064287$REGENERON$$$$$M$Y$$$20240820$$MD$US$US
242285081$24228508$1$I$20240423$20240627$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-064298$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242285091$24228509$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5882208$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242285101$24228510$1$I$20240801$20240814$20240820$20240820$EXP$$US-ABBVIE-5881921$ABBVIE$$74$YR$$F$Y$$$20240820$$CN$US$US
242285111$24228511$1$I$20240101$20240530$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-062874$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242285121$24228512$1$I$$20240813$20240820$20240820$PER$$US-BAUSCH-BL-2024-012355$BAUSCH AND LOMB$$$$$F$Y$$$20240820$$CN$US$US
242285131$24228513$1$I$$20240422$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-063493$REGENERON$$$$$M$Y$$$20240820$$HP$US$US
242285141$24228514$1$I$20240328$20240619$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-064889$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242285151$24228515$1$I$20190101$20240815$20240820$20240820$EXP$$NVSC2019CA071879$NOVARTIS$$56$YR$$M$Y$$$20240820$$CN$CA$CA
242285161$24228516$1$I$20240426$20240620$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-065363$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242285171$24228517$1$I$$20240815$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130177$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240820$$CN$US$US
242285181$24228518$1$I$$20240815$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130172$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$78.93$KG$20240820$$MD$US$US
242285191$24228519$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130141$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240820$$CN$US$US
242285201$24228520$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131365$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240820$$HP$US$US
242285221$24228522$1$I$20231201$20240812$20240820$20240820$EXP$$NVSC2024US102682$NOVARTIS$$44$YR$$F$Y$$$20240820$$CN$US$US
242285232$24228523$2$F$20240801$20240917$20240820$20240918$PER$$US-Eisai-EC-2024-171965$EISAI$$63$YR$A$M$Y$81.6$KG$20240918$$CN$US$US
242285241$24228524$1$I$$20240620$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-063708$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242285252$24228525$2$F$20240808$20240919$20240820$20240921$PER$$US-ABBVIE-5876994$ABBVIE$$67$YR$$F$Y$93$KG$20240921$$HP$US$US
242285261$24228526$1$I$20240601$20240809$20240820$20240820$EXP$$US-BIOCODEX2-2024000935$BIOCODEX$$15$YR$$M$Y$52.2$KG$20240819$$MD$US$US
242285271$24228527$1$I$$20240812$20240820$20240820$EXP$$CA-TEVA-VS-3233043$TEVA$$57$YR$$F$Y$44$KG$20240820$$CN$CA$CA
242285281$24228528$1$I$$20240812$20240820$20240820$PER$$US-ABBVIE-5878017$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242285291$24228529$1$I$20240814$20240815$20240820$20240820$EXP$$US-OTSUKA-2024_022621$OTSUKA$$26$YR$$M$Y$82.8$KG$20240820$$PH$US$US
242285301$24228530$1$I$20240716$20240724$20240820$20240820$PER$$US-LEX-000406$LEXICON PHARMACEUTICALS$$77$YR$$F$Y$74.8$KG$20240820$$CN$US$US
242285311$24228531$1$I$20240130$20240807$20240820$20240820$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000801$PAREXEL$$$$$$Y$$$20240820$$HP$CN$CN
242285321$24228532$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163531$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242285331$24228533$1$I$20240701$20240808$20240820$20240820$EXP$$FR-AstraZeneca-2024A188666$ASTRAZENECA$$86$YR$$F$Y$$$20240820$$MD$FR$
242285341$24228534$1$I$$20240723$20240820$20240820$PER$$US-AstraZeneca-2024A168441$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242285351$24228535$1$I$$20240816$20240820$20240820$EXP$$US-AstraZeneca-2024A188169$ASTRAZENECA$$$$$M$Y$$$20240820$$HP$US$
242285361$24228536$1$I$$20240814$20240820$20240820$EXP$$MX-JNJFOC-20240842133$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$MX$MX
242285371$24228537$1$I$20240801$20240814$20240820$20240820$EXP$$US-ABBVIE-5882723$ABBVIE$$77$YR$$M$Y$$$20240820$$CN$US$US
242285381$24228538$1$I$20240701$20240814$20240820$20240820$EXP$$DE-ABBVIE-5883327$ABBVIE$$57$YR$$M$Y$$$20240820$$CN$DE$DE
242285391$24228539$1$I$$20240819$20240819$20240819$DIR$714944$$FDA-CTU$$$$$UNK$N$$$20240819$N$CN$US$
242285401$24228540$1$I$20240810$20240819$20240819$20240819$DIR$715004$$FDA-CTU$$41$YR$$F$N$$$20240819$N$CN$US$
242285411$24228541$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5883621$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242285421$24228542$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57249$$FDA-CTU$$31$YR$$M$N$$$20240820$N$$US$
242285431$24228543$1$I$20240310$20240819$20240820$20240820$EXP$GB-MHRA-MED-202408190134368090-SQLMH$GB-MYLANLABS-2024M1076789$MYLAN$$41$YR$$F$Y$127$KG$20240820$$CN$GB$GB
242285441$24228544$1$I$$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129272$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240820$$HP$US$US
242285451$24228545$1$I$$20240816$20240820$20240820$EXP$$US-INCYTE CORPORATION-2024IN006787$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242285461$24228546$1$I$$20240814$20240820$20240820$EXP$$IE-PFIZER INC-202400239638$PFIZER$$$$E$F$Y$$$20240820$$HP$IE$IE
242285471$24228547$1$I$$20240812$20240820$20240820$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07228$VIFOR$$74$YR$$F$Y$$$20240820$$HP$ZA$ZA
242285481$24228548$1$I$$20240814$20240820$20240820$PER$$US-BAYER-2024A117824$BAYER$$$$$F$Y$$$20240820$$HP$US$US
242285492$24228549$2$F$20240101$20240913$20240820$20240918$EXP$$US-ABBVIE-5884852$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
242285502$24228550$2$F$20240101$20240916$20240820$20240919$EXP$$US-ABBVIE-5884436$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
242285512$24228551$2$F$$20240828$20240820$20240829$PER$$US-BAYER-2024A118500$BAYER$$35$YR$A$F$Y$$$20240829$$MD$US$US
242285521$24228552$1$I$20220101$20240815$20240820$20240820$EXP$$US-SA-2024SA244041$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240820$$MD$US$US
242285532$24228553$2$F$$20240827$20240820$20240905$EXP$$TW-TEVA-VS-3233647$TEVA$Leong PY, Shih PC, Huo AP. Is low-dose tumor necrosis factor inhibitor effective and safe in patients with ankylosing spondylitis flare-up after renal transplantation? A case report and literature review. [Review]. Int-J-Rheum-Diseases 2023; 27 e14877.; Leong PY, Shih PC, Huo AP. Is low-dose tumor necrosis factor inhibitor effective and safe in patients with ankylosing spondylitis flare-up after renal transplantation? A case report and literature review. [Review]. Int-J-Rheum-Diseases 2023; 2...$55$YR$$M$Y$$$20240905$$HP$TW$TW
242285541$24228554$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163424$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242285552$24228555$2$F$20240724$20240918$20240820$20240927$PER$$US-ALKERMES INC.-ALK-2024-002084$ALKERMES$$21$YR$$M$Y$$$20240927$$HP$US$US
242285571$24228557$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57246$$FDA-CTU$$74$YR$$F$N$85.73$KG$20240820$N$HP$US$
242285581$24228558$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57252$$FDA-CTU$$69$YR$$F$N$$$20240820$N$$US$
242285591$24228559$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56983$$FDA-CTU$$59$YR$$F$N$$$20240819$N$$US$
242285601$24228560$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56984$$FDA-CTU$$41$YR$$F$N$62.6$KG$20240819$N$$US$
242285611$24228561$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57258$$FDA-CTU$$36$YR$$F$N$$$20240820$N$$US$
242285621$24228562$1$I$20240807$20240808$20240820$20240820$EXP$$US-Accord-441196$ACCORD$$66$YR$E$M$Y$$$20240820$$HP$US$US
242285631$24228563$1$I$20240806$20240808$20240820$20240820$EXP$$US-Accord-441195$ACCORD$$38$YR$A$M$Y$$$20240820$$HP$US$US
242285641$24228564$1$I$$20240807$20240820$20240820$EXP$CA-MHPD-E2B_07116671$CA-Accord-441087$ACCORD$$70$YR$E$M$Y$$$20240820$$HP$CA$CA
242285651$24228565$1$I$20240107$20240808$20240820$20240820$EXP$FR-AFSSAPS-TO2024001399$FR-Accord-441057$ACCORD$$66$YR$E$M$Y$$$20240820$$PH$FR$FR
242285662$24228566$2$F$$20240815$20240820$20240827$EXP$$DK-Accord-441444$ACCORD$Skajaa T, Faerch M, Hasle H. Acute kidney injury in a child treated with cisplatin and amphotericin B. Cancer Chemother Pharmacol. 2024 Aug 7.$17$YR$T$F$Y$$$20240827$$HP$DK$DK
242285671$24228567$1$I$20240701$20240806$20240820$20240820$EXP$FR-AFSSAPS-CN2024000747$FR-Accord-440528$ACCORD$$78$YR$E$F$Y$$$20240820$$PH$FR$FR
242285681$24228568$1$I$$20230922$20240820$20240820$EXP$$US-Accord-382430$ACCORD$$64$YR$A$F$Y$$$20240820$$CN$US$US
242285691$24228569$1$I$20240710$20240807$20240820$20240820$EXP$SE-SEMPA-2024-005598$SE-Accord-440814$ACCORD$$54$YR$A$F$Y$58$KG$20240820$$MD$SE$SE
242285701$24228570$1$I$$20240807$20240820$20240820$EXP$CA-MHPD-001089687$CA-Accord-441086$ACCORD$$67$YR$E$F$Y$48$KG$20240820$$HP$CA$CA
242285711$24228571$1$I$20240630$20240808$20240820$20240820$EXP$FR-AFSSAPS-DJ2024000874$FR-Accord-441127$ACCORD$$68$YR$E$F$Y$$$20240820$$MD$FR$FR
242285721$24228572$1$I$$20240808$20240820$20240820$EXP$$US-Accord-441017$ACCORD$Sachdeva N, Sun LW, Young J, Chen A. Early to late explantation of Hydrus microstent MIGS device: A case series. American Journal of Ophthalmology Case Reports. 2024;36:102105. DOI: 10.1016/j.ajoc.2024.102105.$71$YR$E$M$Y$$$20240820$$MD$US$US
242285732$24228573$2$F$$20240826$20240820$20240906$EXP$$US-Accord-441201$ACCORD$$32$YR$A$M$Y$$$20240906$$PH$US$US
242285741$24228574$1$I$20240727$20240807$20240820$20240820$EXP$CN-HENLIUS-24CN016318$CN-Accord-441897$ACCORD$$48$YR$A$F$Y$81$KG$20240820$$MD$CN$CN
242285751$24228575$1$I$20240607$20240808$20240820$20240820$EXP$FR-AFSSAPS-LY2024000956$FR-Accord-441106$ACCORD$$66$YR$E$F$Y$47.6$KG$20240820$$PH$FR$FR
242285761$24228576$1$I$20240722$20240808$20240820$20240820$EXP$CN-HENLIUS-24CN016336$CN-Accord-442087$ACCORD$$54$YR$A$F$Y$$$20240820$$MD$CN$CN
242285771$24228577$1$I$20240808$20240808$20240820$20240820$EXP$$US-Accord-441204$ACCORD$$78$YR$E$F$Y$$$20240820$$HP$US$US
242285782$24228578$2$F$$20240911$20240820$20240911$PER$$US-ALXN-202408USA000702US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
242285792$24228579$2$F$$20240820$20240820$20240831$EXP$$US-Accord-439937$ACCORD$Akhdar G, Akpan I, Myles A, et al. (June 30, 2024) Single Low-Dose Methotrexate and Vitamin B12 Deficiency-Induced Pancytopenia Causing Fatality: A Case Report. Cureus 16(6): e63528.$71$YR$E$M$Y$$$20240831$$MD$US$US
242285801$24228580$1$I$$20240807$20240820$20240820$EXP$CA-MHPD-E2B_07147320$CA-Accord-441081$ACCORD$$$$$$Y$$$20240820$$HP$CA$CA
242285812$24228581$2$F$$20240905$20240820$20240905$PER$$US-ALXN-202408USA000758US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$MD$US$US
242285821$24228582$1$I$$20240813$20240820$20240820$PER$$US-ABBVIE-5881677$ABBVIE$$$$$$Y$$$20240820$$HP$US$US
242285831$24228583$1$I$20240809$20240809$20240820$20240820$EXP$$JP-009507513-2408JPN001097J$MERCK$$76$YR$$F$Y$$$20240820$$PH$JP$JP
242285841$24228584$1$I$20240101$20240816$20240820$20240820$PER$$US-ABBVIE-5886530$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242285851$24228585$1$I$$20240813$20240820$20240820$PER$$US-BIOGEN-2024BI01278211$BIOGEN$$$$$M$Y$$$20240820$$HP$US$US
242285862$24228586$2$F$20220801$20240814$20240820$20240823$EXP$$SK-MYLANLABS-2024M1075730$MYLAN$Lachvac L.. Complete regression of clear cell renal cell carcinoma after treatment with sunitinib. Klin urol. 2024;20 (2):80-81$58$YR$$M$Y$$$20240823$$MD$SK$SK
242285871$24228587$1$I$20230901$20240814$20240820$20240820$EXP$FR-AFSSAPS-TS2024000888$FR-MYLANLABS-2024M1075852$MYLAN$$70$YR$$M$Y$89$KG$20240820$$CN$FR$FR
242285881$24228588$1$I$$20240814$20240820$20240820$EXP$$NL-MYLANLABS-2024M1076243$MYLAN$$70$YR$$M$Y$86.2$KG$20240820$$MD$NL$NL
242285893$24228589$3$F$20050101$20240913$20240820$20240919$EXP$$DE-MYLANLABS-2024M1076141$MYLAN$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD Open. 2024;10 (3):1-10$2$YR$$M$Y$$$20240919$$HP$DE$DE
242285901$24228590$1$I$$20240814$20240820$20240820$EXP$$IN-MYLANLABS-2024M1076776$MYLAN$Likhitha N, Mohammed KS. Tumor and thrombus: the dual threat of advanced hepatocellular carcinoma. J-Clin-Exp-Hepatol 2024; 14 (Suppl.).$70$YR$$M$Y$$$20240820$$HP$IN$IN
242285911$24228591$1$I$20240807$20240807$20240820$20240820$PER$$US-ALKERMES INC.-ALK-2024-002086$ALKERMES$$$$$M$Y$$$20240820$$HP$US$US
242285921$24228592$1$I$20240101$20240813$20240820$20240820$EXP$$US-SA-2024SA245226$SANOFI AVENTIS$$84$YR$E$F$Y$76.2$KG$20240820$$MD$US$US
242285931$24228593$1$I$$20240703$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-065368$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242285941$24228594$1$I$20240425$20240617$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-065369$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242285951$24228595$1$I$20240408$20240711$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067299$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242285961$24228596$1$I$$20240711$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067300$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242285971$24228597$1$I$$20240703$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067413$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242285981$24228598$1$I$20240101$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067418$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242285991$24228599$1$I$20240504$20240516$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067929$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286001$24228600$1$I$20240101$20240430$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-066865$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286011$24228601$1$I$20230101$20240430$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-066871$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242286021$24228602$1$I$20240101$20240808$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067255$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286031$24228603$1$I$20190101$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067289$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286041$24228604$1$I$20240815$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164234$AMGEN$$65$YR$E$$Y$$$20240820$$CN$US$US
242286051$24228605$1$I$20240501$20240627$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067297$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242286062$24228606$2$F$20240814$20240815$20240820$20240822$PER$$US-AMGEN-USASP2024164188$AMGEN$$76$YR$E$F$Y$$$20240822$$CN$US$US
242286071$24228607$1$I$$20240808$20240820$20240820$PER$$US-ALKERMES INC.-ALK-2024-002105$ALKERMES$$$$T$$Y$$$20240820$$PH$US$US
242286082$24228608$2$F$20240725$20240911$20240820$20240920$PER$$US-ALKERMES INC.-ALK-2024-002089$ALKERMES$$33$YR$$M$Y$51.247$KG$20240920$$HP$US$US
242286091$24228609$1$I$20240801$20240808$20240820$20240820$PER$$US-ALKERMES INC.-ALK-2024-002095$ALKERMES$$56$YR$$M$Y$$$20240820$$HP$US$US
242286101$24228610$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA244693$SANOFI AVENTIS$$$$A$F$Y$61$KG$20240820$$MD$US$US
242286114$24228611$4$F$20240101$20240913$20240820$20240924$PER$$US-SA-2024SA240868$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240924$$HP$US$US
242286131$24228613$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242877$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240820$$MD$US$US
242286141$24228614$1$I$20240801$20240815$20240820$20240820$EXP$$US-SA-2024SA244407$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240820$$MD$US$US
242286153$24228615$3$F$$20240816$20240820$20240829$PER$$US-SA-2024SA243476$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240829$$MD$US$US
242286161$24228616$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA243783$SANOFI AVENTIS$$56$YR$A$M$Y$99.79$KG$20240820$$MD$US$US
242286171$24228617$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA203136$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240820$$MD$US$US
242286181$24228618$1$I$20220513$20240819$20240820$20240820$EXP$$US-TAKEDA-2022TUS033864$TAKEDA$$70$YR$$F$Y$$$20240820$$CN$US$US
242286191$24228619$1$I$$20240812$20240820$20240820$EXP$$US-JNJFOC-20240831340$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242286201$24228620$1$I$$20240815$20240820$20240820$EXP$$US-JNJFOC-20240846185$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
242286211$24228621$1$I$$20240709$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067933$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286221$24228622$1$I$$20240506$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067966$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286231$24228623$1$I$20240101$20240731$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067949$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286241$24228624$1$I$20240101$20240506$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067964$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286251$24228625$1$I$20240101$20240516$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067969$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242286261$24228626$1$I$$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129421$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240820$$HP$US$US
242286271$24228627$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131356$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240820$$HP$US$US
242286281$24228628$1$I$20240806$20240816$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130318$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$75.02$KG$20240820$$PH$US$US
242286291$24228629$1$I$20240701$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131151$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240820$$HP$US$US
242286301$24228630$1$I$20240801$20240812$20240820$20240820$PER$$US-SA-2024SA242867$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240820$$MD$US$US
242286312$24228631$2$F$$20240816$20240820$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408010874$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240827$$CN$US$US
242286322$24228632$2$F$$20240827$20240820$20240905$EXP$$JP-TEVA-VS-3233084$TEVA$Okamoto K, Takeda A, Hatsuta H, Sano T, Takao M, Ohsawa M, et al. An autopsy case of progressive multifocal leukoencephalopathy with massive iron deposition in juxtacortical lesions. Neuropathology 2023; 43 (5): 396-402.; Okamoto K, Takeda A, Hatsuta H, Sano T, Takao M, Ohsawa M, et al. An autopsy case of progressive multifocal leukoencephalopathy with massive iron deposition in juxtacortical lesions. Neuropathology 2023; 43 (5): 396-402.; Okamoto K, Takeda A, Hatsuta H, Sano T, Takao M, Ohsa...$71$YR$$F$Y$$$20240905$$HP$JP$JP
242286331$24228633$1$I$20240101$20240808$20240820$20240820$PER$$US-JNJFOC-20240822394$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240820$$CN$US$US
242286342$24228634$2$F$20240723$20240916$20240820$20240917$EXP$$US-TAKEDA-2024TUS069764$TAKEDA$$45$YR$$F$Y$$$20240917$$MD$US$US
242286351$24228635$1$I$$20240814$20240820$20240820$PER$$US-BIOGEN-2023BI01228172$BIOGEN$$$$$F$Y$$$20240820$$CN$US$US
242286361$24228636$1$I$$20240815$20240820$20240820$EXP$$US-TAKEDA-2024TUS082305$TAKEDA$$$$$F$Y$$$20240820$$CN$US$US
242286371$24228637$1$I$$20240815$20240820$20240820$PER$$US-JNJFOC-20240839045$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
242286381$24228638$1$I$20240709$20240809$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127670$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240820$$CN$US$US
242286391$24228639$1$I$20240101$20240807$20240820$20240820$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00868$CATALYST PHARMA$$$$$M$Y$40.816$KG$20240820$$CN$US$US
242286411$24228641$1$I$20240804$20240819$20240819$20240819$DIR$715017$$FDA-CTU$$38$YR$$F$N$57.6$KG$20240819$N$CN$US$
242286441$24228644$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56972$$FDA-CTU$$72$YR$$M$N$$$20240819$N$$US$
242286451$24228645$1$I$20240814$20240819$20240819$20240819$DIR$714988$$FDA-CTU$$94$YR$$F$N$60.75$KG$20240819$N$CN$US$
242286461$24228646$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57233$$FDA-CTU$$56$YR$$F$N$$$20240820$N$$US$
242286481$24228648$1$I$20240819$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56995$$FDA-CTU$$87$YR$$F$N$$$20240819$N$HP$US$
242286501$24228650$1$I$$20240711$20240820$20240820$PER$$US-BIOGEN-2024BI01278692$BIOGEN$$$$$$Y$$$20240820$$CN$US$US
242286511$24228651$1$I$$20240711$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-067995$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286521$24228652$1$I$20240808$20240808$20240820$20240820$PER$$US-ALKERMES INC.-ALK-2024-002080$ALKERMES$$$$$F$Y$$$20240820$$HP$US$US
242286531$24228653$1$I$$20240808$20240820$20240820$PER$$US-ALKERMES INC.-ALK-2024-002081$ALKERMES$$$$$F$Y$$$20240820$$PH$US$US
242286541$24228654$1$I$20240812$20240812$20240820$20240820$PER$$US-SA-2024SA243750$SANOFI AVENTIS$$66$YR$E$F$Y$88.435$KG$20240820$$MD$US$US
242286551$24228655$1$I$20240801$20240809$20240820$20240820$PER$$US-SA-2024SA240774$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240820$$MD$US$US
242286561$24228656$1$I$$20240819$20240820$20240820$PER$$US-PFIZER INC-PV202400107955$PFIZER$$64$YR$$F$Y$$$20240820$$HP$US$US
242286581$24228658$1$I$20240818$20240819$20240820$20240820$PER$$US-PFIZER INC-202400239405$PFIZER$$56$YR$$F$Y$$$20240820$$CN$US$US
242286591$24228659$1$I$$20240819$20240820$20240820$PER$$US-PFIZER INC-202400239455$PFIZER$$68$YR$$F$Y$$$20240820$$HP$US$US
242286601$24228660$1$I$$20240819$20240820$20240820$PER$$US-PFIZER INC-202400239537$PFIZER$$82$YR$$F$Y$$$20240820$$CN$US$US
242286612$24228661$2$F$20240819$20240906$20240820$20240909$PER$$US-PFIZER INC-202400239407$PFIZER$$67$YR$$M$Y$77.098$KG$20240909$$CN$US$US
242286622$24228662$2$F$20240817$20240906$20240820$20240909$PER$$US-PFIZER INC-202400239409$PFIZER$$70$YR$$F$Y$49.887$KG$20240909$$CN$US$US
242286631$24228663$1$I$20240811$20240819$20240820$20240820$PER$$US-PFIZER INC-202400239419$PFIZER$$72$YR$$F$Y$$$20240820$$MD$US$US
242286641$24228664$1$I$20240812$20240816$20240819$20240819$DIR$FDA-CDER-CTU-2024-57000$$FDA-CTU$$90$YR$$F$N$$$20240816$N$HP$US$
242286651$24228665$1$I$20240817$20240819$20240819$20240819$DIR$714924$$FDA-CTU$$48$YR$$M$N$78.75$KG$20240819$N$CN$US$
242286663$24228666$3$F$$20240823$20240820$20240827$PER$$US-PFIZER INC-PV202400108133$PFIZER$$89$YR$$F$Y$$$20240827$$CN$US$US
242286671$24228667$1$I$$20240819$20240819$20240819$DIR$714965$$FDA-CTU$$$$$UNK$N$$$20240819$$CN$US$
242286681$24228668$1$I$20240809$20240819$20240819$20240819$DIR$714997$$FDA-CTU$$87$YR$$M$N$56.25$KG$20240819$N$CN$US$
242286691$24228669$1$I$$20240819$20240819$20240819$DIR$714945$$FDA-CTU$$89$YR$$F$N$$$20240819$N$PH$US$
242286702$24228670$2$F$$20240819$20240820$20240821$PER$$US-PFIZER INC-202400239613$PFIZER$$71$YR$$F$Y$97.52$KG$20240821$$CN$US$US
242286711$24228671$1$I$$20240819$20240820$20240820$PER$$US-PFIZER INC-202400239525$PFIZER$$57$YR$$F$Y$$$20240820$$HP$US$US
242286721$24228672$1$I$20240814$20240819$20240819$20240819$DIR$714995$$FDA-CTU$$79$YR$$F$N$$$20240819$N$$US$
242286731$24228673$1$I$20240815$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57092$$FDA-CTU$$70$YR$$M$N$$$20240819$Y$HP$US$
242286741$24228674$1$I$20240816$20240819$20240819$20240819$DIR$714940$$FDA-CTU$$66$YR$$M$N$59$KG$20240819$N$PH$US$
242286751$24228675$1$I$20240801$20240819$20240820$20240820$PER$$US-PFIZER INC-PV202400108061$PFIZER$$$$$$Y$$$20240820$$HP$US$US
242286761$24228676$1$I$20240817$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238699$PFIZER$$44$YR$$M$Y$$$20240820$$HP$US$US
242286771$24228677$1$I$20240507$20240507$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-068543$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242286781$24228678$1$I$20240101$20240626$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-069204$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242286791$24228679$1$I$$20240509$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-069706$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286801$24228680$1$I$20240501$20240509$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-069709$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286811$24228681$1$I$20240508$20240509$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-069710$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286821$24228682$1$I$20240405$20240509$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-070783$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286831$24228683$1$I$20240510$20240710$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-070785$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242286841$24228684$1$I$20240401$20240813$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011956$DR REDDYS$$21$YR$A$F$Y$$$20240820$$CN$US$US
242286851$24228685$1$I$20240817$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238696$PFIZER$$62$YR$$F$Y$$$20240820$$CN$US$US
242286861$24228686$1$I$$20240509$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-069729$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242286871$24228687$1$I$20240301$20240510$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-070782$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286881$24228688$1$I$20240101$20240513$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-071427$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242286891$24228689$1$I$$20240813$20240820$20240820$EXP$$FR-SANDOZ INC.-SDZ2024FR072783$SANDOZ$Alice Brehon, J?r?my Lourenco, Antoine Badaoui, Emmanuelle Amsler, Jos? Luis Lopez Zaragoza, Ang?le Soria, Annick Barbaud. Doxycycline-induced fixed drug eruption: The new epidemic?. Journal of The European Academy of Dermatology and Venereology. 2024;1?3$28$YR$$F$Y$$$20240820$$MD$FR$FR
242286901$24228690$1$I$$20240816$20240820$20240820$EXP$$US-JNJFOC-20240842774$JOHNSON AND JOHNSON$$9$DEC$E$M$Y$$$20240820$$MD$US$US
242286911$24228691$1$I$$20240813$20240820$20240820$EXP$$JP-AstraZeneca-2024A187312$ASTRAZENECA$Kakiuchi Y, et al. PP238 Efficacy and safety of combined immunotherapy for advanced small. he 64th Annual Meeting of the Japanese Respiratory Society 2024;$90$YR$$$Y$$$20240820$$MD$JP$
242286921$24228692$1$I$$20240813$20240820$20240820$EXP$$JP-AstraZeneca-2024A187316$ASTRAZENECA$Kakiuchi Y, et al. PP238 Efficacy and safety of combined immunotherapy for advanced small cell lung cancer in patients over 80 years old. The 64th Annual Meeting of the Japanese Respiratory Society 2024;$90$YR$$$Y$$$20240820$$MD$JP$
242286931$24228693$1$I$$20240815$20240820$20240820$PER$$US-JNJFOC-20240839810$JOHNSON AND JOHNSON$$12$YR$T$F$Y$$$20240820$$CN$US$US
242286941$24228694$1$I$$20240812$20240820$20240820$EXP$$GB-TAKEDA-2024TUS082755$TAKEDA$$$$$$Y$$$20240820$$CN$GB$GB
242286951$24228695$1$I$20240101$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024163892$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242286962$24228696$2$F$20240717$20240909$20240820$20240916$30DAY$$US-AMGEN-USASP2024154843$AMGEN$$78$YR$E$F$Y$$$20240916$$HP$US$US
242286971$24228697$1$I$$20240805$20240820$20240820$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00704$Phathom Pharmaceuticals$$$$E$M$Y$$$20240820$$MD$JP$JP
242286991$24228699$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168271$NOVARTIS$$$$$M$Y$$$20240820$$CN$US$US
242287001$24228700$1$I$$20240817$20240820$20240820$EXP$$NVSC2024US167211$NOVARTIS$$$$$$Y$$$20240820$$MD$PR$US
242287012$24228701$2$F$20240723$20240905$20240820$20240915$EXP$$FR-DENTSPLY-2024SCDP000238$DENTSPLY$$73$YR$$F$Y$46$KG$20240915$$PH$FR$FR
242287022$24228702$2$F$$20240820$20240820$20240821$PER$$US-PFIZER INC-202400239265$PFIZER$$$$$F$Y$$$20240821$$CN$US$US
242287032$24228703$2$F$$20240823$20240820$20240828$PER$$US-PFIZER INC-202400239788$PFIZER$$65$YR$$$Y$$$20240828$$MD$US$US
242287051$24228705$1$I$$20240819$20240820$20240820$PER$$US-PFIZER INC-202400239787$PFIZER$$$$$$Y$$$20240820$$MD$US$US
242287062$24228706$2$F$$20240820$20240820$20240821$PER$$US-PFIZER INC-202400239267$PFIZER$$$$$F$Y$$$20240821$$CN$US$US
242287071$24228707$1$I$$20240819$20240820$20240820$PER$$US-PFIZER INC-202400239390$PFIZER$$$$A$$Y$$$20240820$$CN$US$US
242287081$24228708$1$I$20240801$20240819$20240820$20240820$PER$$US-PFIZER INC-PV202400108320$PFIZER$$51$YR$$F$Y$$$20240820$$HP$US$US
242287091$24228709$1$I$$20240819$20240820$20240820$PER$$US-PFIZER INC-202400239530$PFIZER$$63$YR$$F$Y$$$20240820$$CN$US$US
242287101$24228710$1$I$$20240819$20240820$20240820$PER$$US-PFIZER INC-PV202400107939$PFIZER$$$$A$$Y$$$20240820$$CN$US$US
242287112$24228711$2$F$20240725$20240905$20240820$20240915$EXP$$FR-DENTSPLY-2024SCDP000239$DENTSPLY$$52$YR$$F$Y$62$KG$20240915$$PH$FR$FR
242287121$24228712$1$I$$20240816$20240820$20240820$PER$$US-ABBVIE-5885890$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242287131$24228713$1$I$$20240811$20240820$20240820$PER$$US-ABBVIE-5878962$ABBVIE$$62$YR$$F$Y$$$20240820$$CN$US$US
242287141$24228714$1$I$20240101$20240809$20240820$20240820$PER$$US-ALKERMES INC.-ALK-2024-002113$ALKERMES$$$$$M$Y$92.971$KG$20240820$$HP$US$US
242287151$24228715$1$I$20231016$20231016$20240820$20240820$PER$$US-SA-2023MK000096$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240820$$CN$US$US
242287161$24228716$1$I$20231016$20231016$20240820$20240820$PER$$US-SA-2023MK000097$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240820$$CN$US$US
242287171$24228717$1$I$$20231031$20240820$20240820$PER$$US-SA-2023MK000099$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240820$$CN$US$US
242287181$24228718$1$I$$20231110$20240820$20240820$PER$$US-SA-2023MK000102$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240820$$CN$US$US
242287191$24228719$1$I$20231127$20231127$20240820$20240820$PER$$US-SA-2023MK000109$SANOFI AVENTIS$$$$$F$Y$$$20240820$$CN$US$US
242287201$24228720$1$I$20231128$20231128$20240820$20240820$PER$$US-SA-2023MK000110$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240820$$CN$US$US
242287211$24228721$1$I$20231208$20231211$20240820$20240820$PER$$US-SA-2023MK000119$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240820$$CN$US$US
242287221$24228722$1$I$20231212$20231214$20240820$20240820$PER$$US-SA-2023MK000124$SANOFI AVENTIS$$$$$F$Y$$$20240820$$CN$US$US
242287231$24228723$1$I$$20231215$20240820$20240820$PER$$US-SA-2023MK000125$SANOFI AVENTIS$$$$$M$Y$$$20240820$$CN$US$US
242287241$24228724$1$I$20230601$20231228$20240820$20240820$PER$$US-SA-2023MK000129$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240820$$CN$US$US
242287251$24228725$1$I$20231105$20231120$20240820$20240820$PER$$US-SA-2023MK000100$SANOFI AVENTIS$$63$YR$E$F$Y$$$20240820$$CN$US$US
242287261$24228726$1$I$20231220$20231220$20240820$20240820$PER$$US-SA-2023MK000126$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240820$$CN$US$US
242287271$24228727$1$I$20240111$20240111$20240820$20240820$PER$$US-SA-2024MK000005$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240820$$CN$US$US
242287281$24228728$1$I$20240122$20240123$20240820$20240820$PER$$US-SA-2024MK000008$SANOFI AVENTIS$$61$YR$E$M$Y$$$20240820$$CN$US$US
242287291$24228729$1$I$20240206$20240206$20240820$20240820$PER$$US-SA-2024MK000009$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240820$$CN$US$US
242287301$24228730$1$I$20231107$20240207$20240820$20240820$PER$$US-SA-2024MK000012$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240820$$CN$US$US
242287311$24228731$1$I$$20240207$20240820$20240820$PER$$US-SA-2024MK000013$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240820$$CN$US$US
242287321$24228732$1$I$20240209$20240209$20240820$20240820$PER$$US-SA-2024MK000014$SANOFI AVENTIS$$$$$F$Y$$$20240820$$CN$US$US
242287331$24228733$1$I$20240221$20240221$20240820$20240820$PER$$US-SA-2024MK000016$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240820$$CN$US$US
242287341$24228734$1$I$20240315$20240315$20240820$20240820$PER$$US-SA-2024MK000021$SANOFI AVENTIS$$$$$F$Y$$$20240820$$CN$US$US
242287351$24228735$1$I$20231211$20231211$20240820$20240820$PER$$US-SA-2023MK000118$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240820$$CN$US$US
242287361$24228736$1$I$20240201$20240229$20240820$20240820$PER$$US-SA-2024MK000017$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240820$$CN$US$US
242287371$24228737$1$I$20240311$20240313$20240820$20240820$PER$$US-SA-2024MK000020$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240820$$CN$US$US
242287381$24228738$1$I$20240319$20240319$20240820$20240820$PER$$US-SA-2024MK000022$SANOFI AVENTIS$$$$$F$Y$$$20240820$$CN$US$US
242287401$24228740$1$I$20240405$20240405$20240820$20240820$PER$$US-SA-2024MK000027$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240820$$CN$US$US
242287411$24228741$1$I$$20240809$20240820$20240820$EXP$$BR-EXELIXIS-CABO-24080648$EXELIXIS$$$$$$Y$$$20240820$$MD$BR$BR
242287421$24228742$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5884470$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242287431$24228743$1$I$$20240807$20240820$20240820$EXP$$NVSC2023IN279766$NOVARTIS$$$$$M$Y$$$20240820$$CN$IN$IN
242287441$24228744$1$I$20240117$20240118$20240820$20240820$PER$$US-SA-2024MK000007$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240820$$CN$US$US
242287451$24228745$1$I$$20240819$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA073706$SANDOZ$$74$YR$$M$Y$$$20240820$$PH$CA$CA
242287463$24228746$3$F$$20240911$20240820$20240911$PER$$US-ALXN-202408USA000945US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
242287472$24228747$2$F$20240805$20240823$20240820$20240827$PER$$US-JNJFOC-20240838756$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240827$$CN$US$US
242287481$24228748$1$I$$20240809$20240820$20240820$PER$$US-ALKERMES INC.-ALK-2024-002100$ALKERMES$$$$$M$Y$$$20240820$$HP$US$US
242287491$24228749$1$I$20240109$20240809$20240820$20240820$EXP$$NVSC2024DE150628$NOVARTIS$$26$YR$$F$Y$$$20240820$$MD$DE$DE
242287501$24228750$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A185078$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242287521$24228752$1$I$$20240816$20240820$20240820$PER$$US-TAKEDA-2024TUS083301$TAKEDA$$$$$F$Y$$$20240820$$CN$US$US
242287541$24228754$1$I$20240819$20240819$20240819$20240819$DIR$714958$$FDA-CTU$$54$YR$$M$N$148.05$KG$20240819$N$CN$US$
242287551$24228755$1$I$20240819$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57072$$FDA-CTU$$71$YR$$M$N$$$20240819$Y$HP$US$
242287561$24228756$1$I$20240812$20240819$20240819$20240819$DIR$714962$$FDA-CTU$$69$YR$$M$N$80.55$KG$20240819$N$$US$
242287571$24228757$1$I$20240505$20240819$20240819$20240819$DIR$715009$$FDA-CTU$$69$YR$$F$N$58.5$KG$20240819$N$CN$US$
242287581$24228758$1$I$$20240812$20240820$20240820$EXP$$CA-BAXTER-2024BAX023092$BAXTER$$21$YR$$F$Y$$$20240820$$HP$CA$CA
242287591$24228759$1$I$20231211$20240813$20240820$20240820$EXP$$US-APELLIS-APL-2024-003586$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240820$$MD$US$US
242287601$24228760$1$I$20221227$20230109$20240820$20240820$EXP$$KW-BIOVITRUM-2023KW00837$BIOVITRUM$$65$DY$$M$Y$$$20240820$$CN$KW$KW
242287611$24228761$1$I$$20240815$20240820$20240820$PER$$US-ROCHE-10000059217$ROCHE$$14$YR$T$M$Y$$$20240820$$CN$US$US
242287621$24228762$1$I$$20240819$20240820$20240820$PER$$US-HALEON-2192757$Haleon PLC$$$$$$Y$$$20240820$$CN$US$US
242287631$24228763$1$I$20240424$20240813$20240820$20240820$EXP$$NVSC2024CN166202$NOVARTIS$$51$YR$$M$Y$105$KG$20240820$$HP$CN$CN
242287651$24228765$1$I$$20240809$20240820$20240820$EXP$$US-SA-2024SA239969$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240820$$CN$US$US
242287671$24228767$1$I$20240701$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010795$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240820$$CN$US$US
242287681$24228768$1$I$$20240531$20240820$20240820$EXP$$US-BAXTER-2024BAX021678$BAXTER$$$$$M$Y$$$20240820$$HP$US$US
242287692$24228769$2$F$$20240826$20240820$20240902$EXP$$NVSC2024RU167077$NOVARTIS$$49$YR$$F$Y$$$20240902$$MD$RU$RU
242287701$24228770$1$I$$20240819$20240820$20240820$EXP$$CA-ORGANON-O2408CAN001357$ORGANON$$76$YR$$F$Y$$$20240820$$HP$CA$CA
242287711$24228771$1$I$$20240816$20240820$20240820$EXP$$US-SA-2024SA245584$SANOFI AVENTIS$$77$YR$E$M$Y$79.37$KG$20240820$$MD$US$US
242287721$24228772$1$I$$20240815$20240820$20240820$PER$$US-ALXN-202408USA000946US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242287732$24228773$2$F$20190501$20240827$20240820$20240905$EXP$$ES-TEVA-VS-3233441$TEVA$Castellano-Damaso S, Vazquez-Gomez F, Moreno-Carrasco JL, Arce B, Borrego P, Lassaletta A. Continuous response despite reduced dose of trametinib as single agent in an adolescent with a relapsed disseminated pediatric low-grade glioma KIAA1549-BRAF fusion positive: a case report and review of the literature. Front-Oncol 2024; 14.; Castellano-Damaso S, Vazquez-Gomez F, Moreno-Carrasco JL, Arce B, Borrego P, Lassaletta A. Continuous response despite reduced dose of trametinib as single agent in...$13$YR$$M$Y$$$20240905$$HP$ES$ES
242287741$24228774$1$I$20240101$20240815$20240820$20240820$EXP$$US-SA-2024SA245989$SANOFI AVENTIS$$$$A$M$Y$$$20240820$$MD$US$US
242287751$24228775$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240945$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242287761$24228776$1$I$20240621$20240815$20240820$20240820$EXP$$CN-SA-2024SA244330$SANOFI AVENTIS$$78$YR$E$F$Y$55$KG$20240820$$HP$CN$CN
242287771$24228777$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131146$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240820$$HP$US$US
242287781$24228778$1$I$$20240818$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131189$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$82.55$KG$20240820$$CN$US$US
242287801$24228780$1$I$$20240818$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131185$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$87.09$KG$20240820$$CN$US$US
242287811$24228781$1$I$20240727$20240819$20240819$20240819$DIR$714970$$FDA-CTU$$44$YR$$F$N$79$KG$20240819$N$HP$US$
242287821$24228782$1$I$20240817$20240819$20240819$20240819$DIR$715005$$FDA-CTU$$44$YR$$M$N$78.75$KG$20240819$Y$CN$US$
242287831$24228783$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130570$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240820$$CN$US$US
242287841$24228784$1$I$20240101$20240806$20240820$20240820$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-001884$SK LIFE SCIENCE$$$$$$Y$$$20240820$$HP$CA$CA
242287851$24228785$1$I$20240713$20240812$20240820$20240820$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001878$SK LIFE SCIENCE$$$$$$Y$$$20240820$$CN$US$US
242287861$24228786$1$I$20240819$20240819$20240819$20240819$DIR$714991$$FDA-CTU$$67$YR$$F$N$51.3$KG$20240819$N$CN$US$
242287872$24228787$2$F$20240101$20240723$20240820$20240826$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-001488$SK LIFE SCIENCE$$$$$$Y$$$20240826$$HP$CA$CA
242287881$24228788$1$I$20240804$20240819$20240819$20240819$DIR$714946$$FDA-CTU$$66$YR$$F$N$76.7$KG$20240819$N$HP$US$
242287891$24228789$1$I$20240725$20240814$20240820$20240820$EXP$$US-SA-2024SA244302$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240820$$MD$US$US
242287901$24228790$1$I$20240808$20240814$20240820$20240820$EXP$$RU-SA-2024SA245147$SANOFI AVENTIS$$8$YR$C$M$Y$12$KG$20240820$$HP$RU$RU
242287911$24228791$1$I$$20240817$20240820$20240820$EXP$$US-PFIZER INC-202400238980$PFIZER$$$$$M$Y$$$20240820$$CN$US$US
242287921$24228792$1$I$$20240813$20240820$20240820$EXP$$CH-PFIZER INC-202400239404$PFIZER$$$$$M$Y$$$20240820$$MD$CH$CH
242287931$24228793$1$I$20240816$20240817$20240820$20240820$EXP$$US-PFIZER INC-202400238556$PFIZER$$67$YR$$M$Y$$$20240820$$HP$US$US
242287942$24228794$2$F$20210214$20240815$20240820$20240822$EXP$$CA-009507513-2106CAN004303$MERCK$$73$YR$$M$Y$$$20240822$$HP$CA$CA
242287953$24228795$3$F$$20240905$20240820$20240906$EXP$$US-PFIZER INC-202400238466$PFIZER$$69$YR$$F$Y$$$20240906$$HP$US$US
242287963$24228796$3$F$20231226$20240819$20240820$20240828$EXP$$CN-PFIZER INC-2024SGN02666$PFIZER$$41$YR$$F$Y$76$KG$20240828$$MD$CN$CN
242287971$24228797$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A187996$ASTRAZENECA$$$$$F$Y$$$20240820$$HP$US$
242287981$24228798$1$I$$20220531$20240820$20240820$EXP$$US-AstraZeneca-2022A204689$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242287991$24228799$1$I$$20221227$20240820$20240820$EXP$$US-AstraZeneca-2022A418690$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242288001$24228800$1$I$$20220914$20240820$20240820$EXP$$US-AstraZeneca-2022A320309$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242288011$24228801$1$I$20240801$20240816$20240820$20240820$EXP$$CN-GSK-CN2024GSK103588$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$HP$CN$CN
242288021$24228802$1$I$$20221123$20240820$20240820$EXP$$US-AstraZeneca-2022A388540$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242288031$24228803$1$I$20230308$20230309$20240820$20240820$EXP$$CO-AstraZeneca-2023A061294$ASTRAZENECA$$18048$DY$$F$Y$69$KG$20240820$$CN$CO$
242288041$24228804$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164305$AMGEN$$$$$$Y$$$20240820$$CN$US$US
242288052$24228805$2$F$20240801$20240820$20240820$20240822$PER$$US-AMGEN-USASP2024165220$AMGEN$$55$YR$A$F$Y$$$20240822$$CN$US$US
242288065$24228806$5$F$20230101$20240828$20240820$20240902$EXP$$CA-PFIZER INC-202400236114$PFIZER$$74$YR$$F$Y$$$20240902$$CN$CA$CA
242288072$24228807$2$F$$20240903$20240820$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US073633$SANDOZ$$$$$M$Y$$$20240904$$CN$US$US
242288082$24228808$2$F$$20240823$20240820$20240826$PER$$US-TAKEDA-2024TUS082683$TAKEDA$$$$$$Y$$$20240826$$CN$US$US
242288102$24228810$2$F$$20240917$20240820$20240918$EXP$$GB-MYLANLABS-2024M1076989$MYLAN$$$$$M$Y$$$20240918$$PH$GB$GB
242288112$24228811$2$F$$20240823$20240820$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129092$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240902$$MD$US$US
242288121$24228812$1$I$$20240816$20240820$20240820$EXP$AU-ASPEN-AUS2024AU004948$AU-SANDOZ INC.-SDZ2024AU073832$SANDOZ$$$$$$Y$$$20240820$$HP$AU$AU
242288131$24228813$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131728$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240820$$CN$US$US
242288144$24228814$4$F$20240807$20240822$20240820$20240925$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25036$SAMSUNG BIOEPIS$$81$YR$E$F$Y$$$20240925$$CN$CA$CA
242288172$24228817$2$F$20240619$20240823$20240820$20240830$EXP$$DE-BAXTER-2024BAX020442$BAXTER$$66$YR$$M$Y$$$20240830$$HP$DE$DE
242288181$24228818$1$I$$20240812$20240820$20240820$EXP$$IT-SAMSUNG BIOEPIS-SB-2024-25193$SAMSUNG BIOEPIS$AB0654 neutrophil-to-lymphocyte ratio, leukocytic formula reversal and prevalence of large granular t lymphocyte leukemia in an Italian monocentric rheumatoid arthritis cohort. Annals of the Rheumatic Diseases.. 2024;83(1):. doi:10.1136/annrheumdis-2024-eular.4151$$$$$Y$$$20240820$$HP$IT$IT
242288191$24228819$1$I$$20240812$20240820$20240820$EXP$$IT-SAMSUNG BIOEPIS-SB-2024-25190$SAMSUNG BIOEPIS$Amati A, Cincinelli G. NEUTROPHIL-TO-LYMPHOCYTE RATIO, LEUKOCYTIC FORMULA REVERSAL AND PREVALENCE OF LARGE GRANULAR T LYMPHOCYTE LEUKEMIA IN AN ITALIAN MONOCENTRIC RHEUMATOID ARTHRITIS COHORT.. Annals of the Rheumatic Diseases.. 2024;83(SUPPLEMENT 1):. doi:10.1136/annrheumdis-2024-eular.4151$$$$$Y$$$20240820$$HP$IT$IT
242288201$24228820$1$I$$20240812$20240820$20240820$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25032$SAMSUNG BIOEPIS$$61$YR$A$M$Y$$$20240820$$CN$CA$CA
242288211$24228821$1$I$20240815$20240816$20240820$20240820$EXP$GB-MHRA-MED-202408161238414280-FMBWH$GB-MYLANLABS-2024M1076624$MYLAN$$60$YR$$F$Y$$$20240820$$PH$GB$GB
242288221$24228822$1$I$$20240816$20240820$20240820$EXP$NL-LRB-00996070$NL-MYLANLABS-2024M1076409$MYLAN$$65$YR$$F$Y$77$KG$20240820$$PH$NL$NL
242288231$24228823$1$I$20230522$20240816$20240820$20240820$EXP$$IT-MYLANLABS-2024M1076397$MYLAN$$43$YR$$F$Y$$$20240820$$MD$IT$IT
242288241$24228824$1$I$$20240816$20240820$20240820$EXP$NL-LRB-00996238$NL-MYLANLABS-2024M1076561$MYLAN$$28$YR$$M$Y$88$KG$20240820$$CN$NL$NL
242288251$24228825$1$I$$20240816$20240820$20240820$EXP$$IT-MYLANLABS-2024M1076427$MYLAN$Corazelli G, Cuccaro A, Morelli E, Arcamone M, De Chiara A, Paccone A, et al. Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVDDD-DI phase II study. Br J Haematol. 2024;00:1-6$61$YR$$M$Y$$$20240820$$HP$IT$IT
242288261$24228826$1$I$20240722$20240816$20240820$20240820$EXP$$FR-MYLANLABS-2024M1076283$MYLAN$$66$YR$$M$Y$$$20240820$$MD$FR$FR
242288271$24228827$1$I$$20240816$20240820$20240820$EXP$$IT-MYLANLABS-2024M1076331$MYLAN$Corazelli G, Cuccaro A, Morelli E, Arcamone M, De Chiara A, Paccone A, et al.. Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVDDD-DI phase II study. Br J Haematol. 2024;00:1-6$40$YR$$M$Y$$$20240820$$HP$IT$IT
242288282$24228828$2$F$$20240816$20240820$20240930$PER$$US-LUNDBECK-DKLU4001742$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
242288291$24228829$1$I$20240101$20240815$20240820$20240820$EXP$$US-UCBSA-2024041588$UCB$$$$$F$Y$$$20240820$$CN$US$US
242288302$24228830$2$F$20240710$20240816$20240820$20240822$EXP$IT-MINISAL02-998178$IT-GILEAD-2024-0683840$GILEAD$$37$YR$A$F$Y$58$KG$20240822$$MD$IT$IT
242288311$24228831$1$I$$20240809$20240820$20240820$PER$$US-TAKEDA-2024TUS080345$TAKEDA$$$$$F$Y$$$20240820$$CN$US$US
242288321$24228832$1$I$$20240813$20240820$20240820$PER$$US-ALXN-202408USA000785US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
242288331$24228833$1$I$$20240819$20240820$20240820$EXP$$IE-SANDOZ INC.-SDZ2024IE073698$SANDOZ$$62$YR$$F$Y$$$20240820$$HP$IE$IE
242288353$24228835$3$F$$20240813$20240820$20240829$PER$$NVSC2024US167304$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242288361$24228836$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168463$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242288371$24228837$1$I$$20240812$20240820$20240820$EXP$$NVSC2024GB166478$NOVARTIS$Guckian J, Picton S, Muinonen-Martin A, Mitra A, Shanmugam S. PA21 A child with longitudinal melanonychia secondary to subungual naevus showing regression during treatment with a single-agent MEK inhibitor (trametinib). BR-J-DERMATOL. 2024;191 (supp 1):i131-2$3$YR$$M$Y$$$20240820$$HP$GB$GB
242288381$24228838$1$I$20240815$20240819$20240820$20240820$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046565$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240820$$HP$US$US
242288391$24228839$1$I$20240301$20240816$20240820$20240820$EXP$$NVSC2024RU163589$NOVARTIS$$$$A$$Y$$$20240820$$HP$RU$RU
242288401$24228840$1$I$$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129196$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240820$$HP$US$US
242288412$24228841$2$F$$20240823$20240820$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130952$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240828$$HP$US$US
242288421$24228842$1$I$$20240809$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126995$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$92.53$KG$20240820$$HP$US$US
242288431$24228843$1$I$$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130036$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240820$$CN$US$US
242288441$24228844$1$I$$20240814$20240820$20240820$PER$$US-JNJFOC-20240837756$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
242288454$24228845$4$F$20240812$20240917$20240820$20240926$30DAY$$US-JNJFOC-20240832815$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240926$$CN$US$US
242288461$24228846$1$I$$20240812$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN008422$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242288471$24228847$1$I$20181012$20240815$20240820$20240820$EXP$GB-MHRA-MED-202408151324348930-QWLHN$GB-MYLANLABS-2024M1076581$MYLAN$$54$YR$$F$Y$83$KG$20240820$$CN$GB$GB
242288481$24228848$1$I$20240624$20240814$20240820$20240820$EXP$FR-AFSSAPS-TS2024000893$FR-MYLANLABS-2024M1075780$MYLAN$$77$YR$$M$Y$64$KG$20240820$$MD$FR$FR
242288491$24228849$1$I$$20240814$20240820$20240820$EXP$BE-EMA-20160128-siwachevhp-125129404$BE-MYLANLABS-2024M1075851$MYLAN$Stael Rebecca; Smith Vanessa; Wittoek Ruth; Creytens David; Mielants Herman. Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review. Clinical rheumatology. 2015;34(1):189-193$25$YR$$M$Y$$$20240820$$MD$BE$BE
242288501$24228850$1$I$20240722$20240814$20240820$20240820$EXP$$ES-MYLANLABS-2024M1075775$MYLAN$$72$YR$$M$Y$$$20240820$$MD$ES$ES
242288511$24228851$1$I$$20240814$20240820$20240820$EXP$FR-AFSSAPS-TS2024000897$FR-MYLANLABS-2024M1075845$MYLAN$$86$YR$$M$Y$$$20240820$$MD$FR$FR
242288521$24228852$1$I$20240801$20240815$20240820$20240820$EXP$$US-SA-2024SA246062$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240820$$MD$US$US
242288541$24228854$1$I$$20240815$20240820$20240820$EXP$$US-PFIZER INC-202400238460$PFIZER$$58$YR$$F$Y$$$20240820$$HP$US$US
242288551$24228855$1$I$$20240814$20240820$20240820$EXP$$ES-MYLANLABS-2024M1076014$MYLAN$Suarez, S. Tinea ignota, a diagnostic challenge in systemic autoinflammatory diseasesArgentine journal of medicine. Argentine journal of medicine. 2024;12:136-138$56$YR$$F$Y$$$20240820$$MD$ES$ES
242288561$24228856$1$I$20240801$20240812$20240820$20240820$EXP$$US-BAYER-2024A118349$BAYER$$66$YR$E$M$Y$$$20240820$$CN$US$US
242288571$24228857$1$I$20240730$20240814$20240820$20240820$EXP$ES-AEMPS-1560664$ES-RDY-SPO/ESP/24/0011911$DR REDDYS$$88$YR$E$M$Y$59.3$KG$20240820$$MD$ES$ES
242288581$24228858$1$I$$20240808$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011762$DR REDDYS$$15$YR$T$F$Y$$$20240820$$MD$US$US
242288592$24228859$2$F$20240811$20240816$20240820$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006417$JAZZ$$29$YR$$F$Y$$$20240822$$MD$US$US
242288601$24228860$1$I$$20240812$20240820$20240820$EXP$NL-LRB-00994568$NL-TEVA-VS-3233336$TEVA$$63$YR$$M$Y$92$KG$20240820$$MD$NL$NL
242288611$24228861$1$I$20240101$20240815$20240820$20240820$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013270$VERTEX$$$$A$F$Y$$$20240820$$CN$GB$GB
242288621$24228862$1$I$20240101$20240815$20240820$20240820$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013268$VERTEX$$$$E$M$Y$$$20240820$$CN$GB$GB
242288631$24228863$1$I$20240101$20240815$20240820$20240820$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013288$VERTEX$$$$$M$Y$$$20240820$$CN$GB$GB
242288641$24228864$1$I$$20240813$20240820$20240820$PER$$US-VERTEX PHARMACEUTICALS-2024-013223$VERTEX$$$$$$Y$$$20240820$$HP$US$US
242288651$24228865$1$I$20240101$20240812$20240820$20240820$PER$$US-VERTEX PHARMACEUTICALS-2024-013177$VERTEX$$$$$F$Y$$$20240820$$CN$US$US
242288665$24228866$5$F$$20240919$20240820$20240927$PER$$US-VERTEX PHARMACEUTICALS-2024-013291$VERTEX$$26$YR$$M$Y$$$20240927$$CN$US$US
242288671$24228867$1$I$$20240815$20240820$20240820$PER$$US-VERTEX PHARMACEUTICALS-2024-013292$VERTEX$$7$YR$$F$Y$$$20240820$$CN$US$US
242288681$24228868$1$I$20240101$20240815$20240820$20240820$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013271$VERTEX$$$$A$M$Y$$$20240820$$CN$GB$GB
242288691$24228869$1$I$20240801$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024162914$AMGEN$$67$YR$E$F$Y$$$20240820$$CN$US$US
242288701$24228870$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163606$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242288711$24228871$1$I$20240228$20240813$20240820$20240820$EXP$$US-APELLIS-APL-2024-003587$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240820$$MD$US$US
242288721$24228872$1$I$20240717$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130842$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240820$$HP$US$US
242288732$24228873$2$F$20240810$20240905$20240820$20240918$PER$$US-JNJFOC-20240847496$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240918$$CN$US$US
242288741$24228874$1$I$$20240813$20240820$20240820$EXP$$DE-VERTEX PHARMACEUTICALS-2024-013127$VERTEX$$39$YR$$F$Y$49$KG$20240820$$MD$DE$DE
242288752$24228875$2$F$20240806$20240816$20240820$20240830$EXP$$US-FARMAPROD-202407-2541$DOMPE FARMACEUTICI$$90$YR$E$F$Y$$$20240829$$CN$US$US
242288761$24228876$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131137$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240820$$CN$US$US
242288781$24228878$1$I$20240801$20240808$20240820$20240820$PER$$US-SA-2024SA240705$SANOFI AVENTIS$$$$E$F$Y$$$20240820$$MD$US$US
242288791$24228879$1$I$$20240812$20240820$20240820$EXP$$IN-AstraZeneca-2024A184424$ASTRAZENECA$$64$YR$$F$Y$$$20240820$$CN$IN$
242288801$24228880$1$I$$20240815$20240820$20240820$EXP$$US-SA-2024SA243997$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240820$$MD$US$US
242288811$24228881$1$I$$20240809$20240820$20240820$PER$$US-ABBVIE-5885927$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242288821$24228882$1$I$$20221220$20240820$20240820$EXP$$US-AstraZeneca-2022A414125$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242288831$24228883$1$I$$20230310$20240820$20240820$EXP$$US-AstraZeneca-2023A001649$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242288841$24228884$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A186661$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242288852$24228885$2$F$$20240826$20240820$20240905$EXP$$TR-TEVA-VS-3233086$TEVA$Gulmez A. A case report: Secondary cancers due to oncological treatment modalities. J-Cancer-Res-Ther 2023; 19 493-497.; Gulmez A. A case report: Secondary cancers due to oncological treatment modalities. J-Cancer-Res-Ther 2023; 19 493-497.$64$YR$$F$Y$$$20240905$$HP$TR$TR
242288861$24228886$1$I$$20230104$20240820$20240820$EXP$$US-AstraZeneca-2023A003147$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242288871$24228887$1$I$20240701$20240814$20240820$20240820$PER$$US-SA-2024SA244376$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240820$$MD$US$US
242288881$24228888$1$I$20240709$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A183647$ASTRAZENECA$$24279$DY$$M$Y$$$20240820$$CN$US$
242288891$24228889$1$I$20240618$20240814$20240820$20240820$EXP$FR-AFSSAPS-AN2024001089$FR-MYLANLABS-2024M1076122$MYLAN$$69$YR$$F$Y$87$KG$20240820$$PH$FR$FR
242288901$24228890$1$I$$20240813$20240820$20240820$EXP$$GB-009507513-2408GBR004700$MERCK$Weerasuriya S, Seddon D, Salota V.. Asystolic cardiac arrest secondary to sugammadex administration in a young patient. Anaesthesiology Intensive Therapy. 2024;56(2):160-3$26$YR$$F$Y$93$KG$20240820$$MD$GB$GB
242288911$24228891$1$I$20240801$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010567$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240820$$CN$US$US
242288921$24228892$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010952$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240820$$CN$US$US
242288931$24228893$1$I$$20240815$20240820$20240820$EXP$$US-AVEVA-000725$AVEVA$$$$$M$Y$$$20240820$$$US$US
242288942$24228894$2$F$$20240827$20240820$20240905$EXP$$US-TEVA-VS-3234158$TEVA$Garofalo V, Walgamage M, Cuello LN, Wester K, Robinson S, Gemayel CY. ANAPLASMOSIS: FROM MULTI-SYSTEM MAYHEM TO VENTRICULAR TACHYCARDIA IN A HEARTBEAT. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 4506 (plus Poster).; Garofalo V, Walgamage M, Cuello LN, Wester K, Robinson S, Gemayel CY. ANAPLASMOSIS: FROM MULTI-SYSTEM MAYHEM TO VENTRICULAR TACHYCARDIA IN A HEARTBEAT. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 4506 (plus Poster).$78$YR$$M$Y$$$20240905$$HP$US$US
242288962$24228896$2$F$$20240819$20240820$20240823$EXP$$NVSC2024CA167674$NOVARTIS$$60$YR$$F$Y$$$20240823$$HP$CA$CA
242288971$24228897$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130309$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240820$$CN$US$US
242288981$24228898$1$I$20240724$20240806$20240820$20240820$EXP$$US-AMGEN-USASP2024156921$AMGEN$$$$A$M$Y$$$20240820$$MD$US$US
242288991$24228899$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241180$SANOFI AVENTIS$$$$A$F$Y$95.25$KG$20240820$$MD$US$US
242289002$24228900$2$F$20240813$20240815$20240820$20240826$PER$$US-SA-2024SA244237$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240826$$MD$US$US
242289011$24228901$1$I$$20240809$20240820$20240820$PER$$US-ABBVIE-5876428$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242289021$24228902$1$I$20240101$20240815$20240820$20240820$EXP$$CA-PFIZER INC-202400226952$PFIZER$$48$YR$$F$Y$$$20240820$$CN$CA$CA
242289031$24228903$1$I$20240725$20240814$20240820$20240820$EXP$$FR-MYLANLABS-2024M1075831$MYLAN$$32$YR$$M$Y$$$20240820$$PH$FR$FR
242289041$24228904$1$I$$20240814$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US073088$SANDOZ$$$$$$Y$$$20240820$$HP$US$US
242289051$24228905$1$I$20240731$20240812$20240820$20240820$EXP$DE-CADRBFARM-2024329699$DE-TEVA-VS-3233357$TEVA$$37$YR$$F$Y$54$KG$20240820$$CN$DE$DE
242289061$24228906$1$I$20240707$20240814$20240820$20240820$EXP$FR-AFSSAPS-AN2024000947$FR-MYLANLABS-2024M1076132$MYLAN$$71$YR$$M$Y$73$KG$20240820$$MD$FR$FR
242289071$24228907$1$I$20240812$20240816$20240820$20240820$PER$$US-JNJFOC-20240842480$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240820$$CN$US$US
242289081$24228908$1$I$20240723$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56981$$FDA-CTU$$74$YR$$M$N$$$20240819$Y$HP$US$
242289091$24228909$1$I$20240801$20240812$20240820$20240820$EXP$$US-JNJFOC-20240830421$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240820$$CN$US$US
242289101$24228910$1$I$$20240819$20240820$20240820$EXP$GB-MHRA-MED-202408191141120190-NVSHL$GB-SANDOZ INC.-SDZ2024GB073573$SANDOZ$$52$YR$$M$Y$101$KG$20240820$$CN$GB$GB
242289111$24228911$1$I$$20240815$20240820$20240820$EXP$$GR-AMGEN-GRCSP2024162861$AMGEN$$57$YR$A$M$Y$$$20240820$$CN$GR$GR
242289121$24228912$1$I$$20240816$20240820$20240820$EXP$$US-ROCHE-10000059768$ROCHE$$$$E$F$Y$$$20240820$$CN$US$US
242289131$24228913$1$I$20240628$20240703$20240820$20240820$PER$$US-LUNDBECK-DKLU4001286$LUNDBECK$$$$$$Y$$$20240820$$CN$US$US
242289141$24228914$1$I$$20240819$20240820$20240820$EXP$$NVSC2024US167914$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242289151$24228915$1$I$20240701$20240816$20240820$20240820$EXP$$CA-GILEAD-2024-0681565$GILEAD$$58$YR$A$M$Y$$$20240820$$CN$CA$CA
242289161$24228916$1$I$20240517$20240517$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-074660$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289171$24228917$1$I$$20240703$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-075290$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289181$24228918$1$I$20240101$20240607$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-078924$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289191$24228919$1$I$20231001$20240626$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-073504$REGENERON$$$$$F$Y$$$20240820$$MD$US$US
242289202$24228920$2$F$$20240815$20240820$20240820$PER$$US-ALXN-202407USA001378US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$CN$US$US
242289231$24228923$1$I$20240621$20240621$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-088837$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242289241$24228924$1$I$20240624$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-089555$REGENERON$$$$$M$Y$$$20240820$$HP$US$US
242289251$24228925$1$I$20240101$20240703$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-089620$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289261$24228926$1$I$20230101$20240711$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-090068$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242289271$24228927$1$I$20240613$20240719$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-090650$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242289281$24228928$1$I$20240627$20240627$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-090655$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289291$24228929$1$I$20240628$20240711$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-092261$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289301$24228930$1$I$20240530$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-080055$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242289311$24228931$1$I$20240501$20240724$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-080575$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289321$24228932$1$I$$20240603$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-081576$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289331$24228933$1$I$20240627$20240703$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-090728$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242289341$24228934$1$I$20240611$20240620$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-084398$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289351$24228935$1$I$20240529$20240628$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-086161$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289361$24228936$1$I$20240616$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-086478$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289371$24228937$1$I$$20240711$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-092918$REGENERON$$$$$$Y$$$20240820$$PH$US$US
242289381$24228938$1$I$20240101$20240718$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-095087$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289391$24228939$1$I$20240705$20240809$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-095092$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289401$24228940$1$I$20240701$20240718$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-095078$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242289411$24228941$1$I$20240701$20240718$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-095664$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289421$24228942$1$I$20240709$20240718$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-096647$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289431$24228943$1$I$20240609$20240731$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-084463$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289441$24228944$1$I$20240620$20240805$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-088816$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242289451$24228945$1$I$20240709$20240718$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-095768$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289461$24228946$1$I$$20240711$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-093459$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289471$24228947$1$I$20240726$20240812$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127435$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240820$$PH$US$US
242289481$24228948$1$I$20240626$20240628$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-091743$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289492$24228949$2$F$$20240826$20240820$20240904$EXP$$DE-TEVA-VS-3233404$TEVA$Spangemacher M, Hart XM, Saalfrank E, Grunder G, Reinwald J, Sartorius A. Elevation of Alpha-1 Acid Glycoprotein During Acute Infection Increases Clozapine Levels Without Signs of Intoxication. J-Clin-Psychopharmacol 2024; 44 (1): 60-63.; Spangemacher M, Hart XM, Saalfrank E, Grunder G, Reinwald J, Sartorius A. Elevation of Alpha-1 Acid Glycoprotein During Acute Infection Increases Clozapine Levels Without Signs of Intoxication. J-Clin-Psychopharmacol 2024; 44 (1): 60-63.$58$YR$$M$Y$$$20240904$$HP$DE$DE
242289501$24228950$1$I$$20240809$20240820$20240820$EXP$$US-JNJFOC-20240850212$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242289511$24228951$1$I$$20240621$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-088834$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242289521$24228952$1$I$$20240819$20240820$20240820$EXP$$NVSC2024US168026$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242289532$24228953$2$F$20230401$20240821$20240820$20240829$EXP$$NVSC2024EG167412$NOVARTIS$$38$YR$$F$Y$85$KG$20240829$$CN$EG$EG
242289541$24228954$1$I$20240601$20240711$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-092264$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289551$24228955$1$I$$20240718$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-096655$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289561$24228956$1$I$$20240702$20240820$20240820$PER$$US-LUNDBECK-DKLU4001300$LUNDBECK$$$$$$Y$$$20240820$$HP$US$US
242289571$24228957$1$I$20240701$20240815$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-097675$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242289581$24228958$1$I$$20240814$20240820$20240820$EXP$$DE-BAYER-2024A117820$BAYER$$$$$M$Y$$$20240820$$PH$DE$DE
242289592$24228959$2$F$20240801$20240913$20240820$20240918$EXP$$US-SA-2024SA243958$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240918$$MD$US$US
242289601$24228960$1$I$20240101$20240814$20240820$20240820$EXP$$US-ABBVIE-5881744$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242289611$24228961$1$I$$20240815$20240820$20240820$EXP$$GB-AstraZeneca-2024A186772$ASTRAZENECA$$$$$M$Y$$$20240820$$HP$GB$
242289621$24228962$1$I$20211207$20220311$20240820$20240820$EXP$$US-AstraZeneca-2022A113350$ASTRAZENECA$$62$YR$$F$Y$68.9$KG$20240820$$CN$US$
242289631$24228963$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5881963$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242289641$24228964$1$I$20240812$20240817$20240820$20240820$EXP$$IN-AstraZeneca-2024A188911$ASTRAZENECA$$26887$DY$$F$Y$$$20240820$$CN$IN$
242289652$24228965$2$F$$20240819$20240820$20240822$EXP$$US-PFIZER INC-202400237221$PFIZER$Kim, M.. A Rare Case of Bacterial Meningitis Caused by Hematogenous Spread of Vancomycin-Resistant Enterococcus faecium in an Immunocompromised Patient.. Case Reports in Infectious Diseases. 2024;2024:10.1155/2024/2193650.$72$YR$$M$Y$$$20240822$$MD$US$US
242289661$24228966$1$I$$20240815$20240820$20240820$EXP$$CA-AstraZeneca-2024A188796$ASTRAZENECA$$62$YR$$M$Y$$$20240820$$MD$CA$
242289681$24228968$1$I$20230410$20240819$20240819$20240819$DIR$714948$$FDA-CTU$$68$YR$$F$N$67.5$KG$20240819$N$CN$US$
242289711$24228971$1$I$$20221006$20240820$20240820$EXP$$US-AstraZeneca-2022A342282$ASTRAZENECA$$$$$$Y$$$20240820$$CN$US$
242289721$24228972$1$I$$20240819$20240819$20240819$DIR$714973$$FDA-CTU$$$$$UNK$N$$$20240819$$CN$US$
242289731$24228973$1$I$$20240815$20240820$20240820$EXP$$CA-AstraZeneca-2024A188833$ASTRAZENECA$$62$YR$$M$Y$$$20240820$$MD$CA$
242289743$24228974$3$F$$20240920$20240820$20240924$30DAY$$US-PFIZER INC-202400233211$PFIZER$$13$YR$$M$Y$$$20240924$$HP$US$US
242289751$24228975$1$I$$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-098682$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242289761$24228976$1$I$20240101$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-099189$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289771$24228977$1$I$$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-099316$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289781$24228978$1$I$20240722$20240731$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-100859$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289791$24228979$1$I$$20240731$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-100939$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289801$24228980$1$I$20240721$20240731$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-100942$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289811$24228981$1$I$$20240514$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-072328$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242289821$24228982$1$I$20240101$20240514$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-072366$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289831$24228983$1$I$$20240513$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-072416$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242289841$24228984$1$I$20240516$20240711$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-073624$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289851$24228985$1$I$$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-098681$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242289861$24228986$1$I$$20240612$20240820$20240820$PER$$US-TRAVERE-2024TVT00599$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240820$$HP$US$US
242289871$24228987$1$I$$20240815$20240820$20240820$PER$$US-ABBVIE-5885750$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242289881$24228988$1$I$20240401$20240709$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-073505$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242289892$24228989$2$F$$20240905$20240820$20240916$EXP$$CA-AstraZeneca-2024A186926$ASTRAZENECA$$80$YR$$M$Y$89$KG$20240916$$MD$CA$
242289901$24228990$1$I$20240628$20240819$20240820$20240820$PER$$US-JNJFOC-20240732189$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240820$$CN$US$US
242289911$24228991$1$I$20240812$20240812$20240820$20240820$EXP$$GB-TEVA-VS-3232909$TEVA$$64$YR$$F$Y$59$KG$20240820$$MD$GB$GB
242289921$24228992$1$I$$20240809$20240820$20240820$EXP$$US-JNJFOC-20240832329$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240820$$MD$US$US
242289931$24228993$1$I$20240701$20240815$20240820$20240820$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-16368$IPSEN$$69$YR$E$F$Y$$$20240820$$CN$GB$GB
242289951$24228995$1$I$20240801$20240815$20240820$20240820$EXP$$AU-JNJFOC-20240846799$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$MD$AU$AU
242289961$24228996$1$I$20230101$20240814$20240820$20240820$EXP$$US-ABBVIE-5517696$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242289971$24228997$1$I$20240503$20240814$20240820$20240820$EXP$FR-AFSSAPS-AN2024001063$FR-MYLANLABS-2024M1075746$MYLAN$$74$YR$$F$Y$$$20240820$$PH$FR$FR
242289981$24228998$1$I$20240601$20240814$20240820$20240820$EXP$$CA-TAKEDA-2024TUS082430$TAKEDA$$63$YR$$F$Y$$$20240820$$CN$CA$CA
242289991$24228999$1$I$20240807$20240814$20240820$20240820$EXP$$TR-MYLANLABS-2024M1076201$MYLAN$$63$YR$$F$Y$$$20240820$$CN$TR$TR
242290001$24229000$1$I$20130101$20240812$20240820$20240820$EXP$$US-AMGEN-USASP2024162535$AMGEN$$$$A$F$Y$$$20240820$$CN$US$US
242290011$24229001$1$I$$20240813$20240820$20240820$EXP$$BR-TAKEDA-2023TUS011641$TAKEDA$$$$$M$Y$62$KG$20240820$$CN$BR$BR
242290021$24229002$1$I$20240101$20240814$20240820$20240820$EXP$$US-BAYER-2024A119363$BAYER$$81$YR$E$M$Y$$$20240820$$CN$US$US
242290031$24229003$1$I$20240501$20240518$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-074639$REGENERON$$75$YR$$M$Y$$$20240820$$CN$US$US
242290041$24229004$1$I$$20240703$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-075293$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290051$24229005$1$I$20240520$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-075362$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242290061$24229006$1$I$20240522$20240523$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-077227$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242290071$24229007$1$I$$20240627$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-077241$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290081$24229008$1$I$20240501$20240528$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-078896$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290091$24229009$1$I$20240525$20240731$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-078911$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290101$24229010$1$I$20240525$20240724$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-078957$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290111$24229011$1$I$$20240731$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-079451$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290121$24229012$1$I$20240301$20240703$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-079461$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290131$24229013$1$I$20240101$20240621$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-077766$REGENERON$$$$$M$Y$$$20240820$$MD$US$US
242290141$24229014$1$I$$20240731$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-077783$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290151$24229015$1$I$20240401$20240524$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-077785$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242290161$24229016$1$I$20240519$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-075289$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242290171$24229017$1$I$20240520$20240620$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-075309$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290181$24229018$1$I$$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-076084$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290191$24229019$1$I$20240801$20240811$20240820$20240820$EXP$$US-INSUD PHARMA-2408US06400$INSUD PHARMA$$$$$$Y$$$20240820$$CN$US$US
242290201$24229020$1$I$$20240815$20240820$20240820$PER$$US-ABBVIE-5885668$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242290221$24229022$1$I$20240524$20240531$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-080571$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242290231$24229023$1$I$20240725$20240809$20240820$20240820$EXP$$CN-ROCHE-10000054095$ROCHE$$48$YR$A$F$Y$47.5$KG$20240820$$HP$CN$CN
242290241$24229024$1$I$$20240806$20240820$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007937$ELI LILLY AND CO$Sullivan CA, Gedik R, Haddady S..An atypical presentation of insulin amyloidosis: an uncommon but important complication of insulin therapy..AACE Clinical Case Reports 2018;4(1):e80-e83.DOI:10.4158/EP171865.CR$62$YR$A$F$Y$$$20240820$$MD$US$US
242290251$24229025$1$I$$20240802$20240820$20240820$30DAY$$CL-PFIZER INC-202400230435$PFIZER$$$$$$Y$$$20240820$$CN$CL$CL
242290271$24229027$1$I$20240101$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-098038$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290281$24229028$1$I$$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-098666$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242290291$24229029$1$I$20240101$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-098667$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290301$24229030$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA242605$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240820$$MD$US$US
242290312$24229031$2$F$20240701$20240916$20240820$20240916$EXP$$CN-PFIZER INC-PV202400054922$PFIZER$$28$YR$$M$Y$$$20240916$$CN$CN$CN
242290321$24229032$1$I$20240101$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-097997$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290331$24229033$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA242569$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240820$$MD$US$US
242290341$24229034$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241895$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240820$$MD$US$US
242290351$24229035$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242798$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242290361$24229036$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA240946$SANOFI AVENTIS$$$$T$F$Y$61.23$KG$20240820$$MD$US$US
242290371$24229037$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241815$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240820$$MD$US$US
242290381$24229038$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241269$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242290391$24229039$1$I$20240815$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164888$AMGEN$$82$YR$E$F$Y$$$20240820$$CN$US$US
242290401$24229040$1$I$20240811$20240813$20240820$20240820$PER$$US-AMGEN-USASP2024163243$AMGEN$$$$$$Y$$$20240820$$HP$US$US
242290422$24229042$2$F$20240601$20240816$20240820$20240822$EXP$$US-ABBVIE-5885178$ABBVIE$$79$YR$$F$Y$$$20240822$$CN$US$US
242290431$24229043$1$I$20240601$20240610$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-084847$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290441$24229044$1$I$$20240808$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-085455$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290451$24229045$1$I$$20240613$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-085476$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290461$24229046$1$I$20230401$20240617$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-086940$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290471$24229047$1$I$20240501$20240620$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-081029$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242290481$24229048$1$I$20240604$20240605$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-081943$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290491$24229049$1$I$20240101$20240612$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-084878$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242290501$24229050$1$I$$20240614$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-086596$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290511$24229051$1$I$20240101$20240617$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-086935$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290521$24229052$1$I$20240601$20240618$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-086984$REGENERON$$$$$M$Y$$$20240820$$MD$US$US
242290531$24229053$1$I$20240101$20240619$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-087511$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290541$24229054$1$I$20240101$20240621$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-088815$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242290551$24229055$1$I$$20240703$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-080576$REGENERON$$$$$F$Y$$$20240820$$HP$US$US
242290561$24229056$1$I$20240101$20240807$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-089608$REGENERON$$$$$F$Y$$$20240820$$PH$US$US
242290571$24229057$1$I$$20240626$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-090182$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290581$24229058$1$I$20240627$20240627$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-090653$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242290591$24229059$1$I$20240101$20240711$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-092884$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242290602$24229060$2$F$$20240910$20240820$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130284$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$48.99$KG$20240911$$CN$US$US
242290611$24229061$1$I$$20240819$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131458$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240820$$CN$US$US
242290621$24229062$1$I$$20240812$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128679$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240820$$CN$US$US
242290631$24229063$1$I$20240619$20240619$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-087414$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242290641$24229064$1$I$$20240627$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-090747$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290651$24229065$1$I$$20240819$20240820$20240820$EXP$$JP-BAYER-2024A117391$BAYER$$$$$$Y$$$20240820$$PH$JP$JP
242290661$24229066$1$I$20240722$20240819$20240819$20240819$DIR$714963$$FDA-CTU$$80$YR$$F$N$$$20240819$Y$HP$US$
242290671$24229067$1$I$20240816$20240819$20240819$20240819$DIR$714928$$FDA-CTU$$76$YR$$M$N$72$KG$20240819$N$CN$US$
242290681$24229068$1$I$$20240819$20240819$20240819$DIR$714964$$FDA-CTU$$$$$UNK$N$$$20240819$$CN$US$
242290691$24229069$1$I$$20240819$20240819$20240819$DIR$714968$$FDA-CTU$$$$$UNK$N$$$20240819$N$CN$US$
242290701$24229070$1$I$20240802$20240819$20240819$20240819$DIR$715019$$FDA-CTU$$40$YR$$F$N$73.35$KG$20240819$N$CN$US$
242290711$24229071$1$I$20240816$20240819$20240819$20240819$DIR$714996$$FDA-CTU$$74$YR$$F$N$67.5$KG$20240819$N$CN$US$
242290721$24229072$1$I$$20240815$20240820$20240820$EXP$$CA-TAKEDA-2024TUS082461$TAKEDA$$12$YR$$F$Y$$$20240820$$HP$CA$CA
242290731$24229073$1$I$20240814$20240819$20240819$20240819$DIR$714952$$FDA-CTU$$64$YR$$M$N$78.3$KG$20240819$N$$US$
242290741$24229074$1$I$$20240819$20240819$20240819$DIR$714969$$FDA-CTU$$$$$UNK$N$$$20240819$$CN$US$
242290751$24229075$1$I$$20240813$20240820$20240820$EXP$$US-GSK-US2024100846$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$US$US
242290761$24229076$1$I$20240814$20240819$20240819$20240819$DIR$714998$$FDA-CTU$$68$YR$$M$N$82.8$KG$20240819$N$CN$US$
242290771$24229077$1$I$20240613$20240819$20240819$20240819$DIR$715021$$FDA-CTU$$85$YR$$M$N$53.1$KG$20240819$N$PH$US$
242290781$24229078$1$I$20240723$20240814$20240820$20240820$PER$$US-Eisai-EC-2024-172359$EISAI$$74$YR$E$F$Y$81$KG$20240820$$CN$US$US
242290801$24229080$1$I$$20240809$20240820$20240820$EXP$$US-GILEAD-2024-0683920$GILEAD$$$$E$F$Y$$$20240820$$CN$US$US
242290822$24229082$2$F$20240815$20240821$20240820$20240824$EXP$$US-ABBVIE-5885417$ABBVIE$$67$YR$$F$Y$$$20240824$$CN$US$US
242290831$24229083$1$I$20240715$20240715$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-098055$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290841$24229084$1$I$$20240717$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-099315$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290851$24229085$1$I$$20240717$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-099427$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290861$24229086$1$I$$20240702$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-092920$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242290871$24229087$1$I$20240628$20240702$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-092988$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290881$24229088$1$I$20240703$20240703$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-093391$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242290891$24229089$1$I$$20240705$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-094643$REGENERON$$$$$M$Y$$$20240820$$CN$US$US
242290901$24229090$1$I$$20240705$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-095090$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290911$24229091$1$I$$20240711$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-097643$REGENERON$$56$YR$$F$Y$$$20240820$$HP$US$US
242290921$24229092$1$I$20240101$20240726$20240820$20240820$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-098042$REGENERON$$$$$F$Y$$$20240820$$CN$US$US
242290931$24229093$1$I$$20240813$20240820$20240820$EXP$$IN-ROCHE-10000057155$ROCHE$$19$YR$A$M$Y$$$20240820$$CN$IN$IN
242290942$24229094$2$F$$20240924$20240820$20240927$EXP$$NVSC2024US145541$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
242290952$24229095$2$F$$20240814$20240820$20240827$EXP$$US-BEH-2024177298$CSL BEHRING$$54$YR$A$F$Y$$$20240827$$CN$US$US
242290961$24229096$1$I$$20240816$20240820$20240820$PER$$US-JNJFOC-20240842881$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$MD$US$US
242290972$24229097$2$F$20240606$20240906$20240820$20240909$EXP$$CA-PFIZER INC-202400239225$PFIZER$$82$YR$$M$Y$$$20240909$$HP$CA$CA
242290984$24229098$4$F$$20240903$20240820$20240905$30DAY$$US-PFIZER INC-202400235022$PFIZER$$15$YR$$M$Y$$$20240905$$HP$US$US
242290991$24229099$1$I$$20240812$20240820$20240820$EXP$$GB-AstraZeneca-2024A183681$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$GB$
242291001$24229100$1$I$$20240816$20240820$20240820$EXP$$PT-PFIZER INC-202400238278$PFIZER$Reis, Jorge. Bacteriemia por salmonela - quando nao se trata de uma simples gastroenterite. Congresso Nacional de Medicina Interna - Livro de Resumos. 2024;30 (Sup 1):671$54$YR$$F$Y$$$20240820$$HP$PT$PT
242291011$24229101$1$I$20240809$20240812$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012584$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242291021$24229102$1$I$$20240812$20240820$20240820$EXP$$FR-AstraZeneca-2024A186133$ASTRAZENECA$$74$YR$$M$Y$$$20240820$$PH$FR$
242291031$24229103$1$I$$20221205$20240820$20240820$EXP$$US-AstraZeneca-2022A403558$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242291041$24229104$1$I$20220501$20220917$20240820$20240820$EXP$$US-AstraZeneca-2022A323816$ASTRAZENECA$$908$MON$$M$Y$$$20240820$$CN$US$
242291051$24229105$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A183671$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242291061$24229106$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242629$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240820$$MD$US$US
242291072$24229107$2$F$20240101$20240916$20240820$20240925$PER$$US-SA-2024SA242631$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240925$$MD$US$US
242291081$24229108$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A188074$ASTRAZENECA$$70$YR$$M$Y$$$20240820$$HP$US$
242291091$24229109$1$I$$20240812$20240820$20240820$EXP$$CA-AstraZeneca-2024A188854$ASTRAZENECA$$$$$M$Y$$$20240820$$PH$CA$
242291101$24229110$1$I$$20240807$20240820$20240820$PER$$US-AstraZeneca-2024A179697$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242291111$24229111$1$I$$20240816$20240820$20240820$EXP$$US-AstraZeneca-2024A187867$ASTRAZENECA$$$$C$F$Y$25.4$KG$20240820$$CN$US$
242291121$24229112$1$I$$20230315$20240820$20240820$EXP$$US-AstraZeneca-2023A062922$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242291131$24229113$1$I$$20230307$20240820$20240820$EXP$$US-AstraZeneca-2023A056666$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242291141$24229114$1$I$20240422$20240812$20240820$20240820$EXP$IT-MINISAL02-998035$IT-INCYTE CORPORATION-2024IN008314$INCYTE$$$$$$Y$$$20240820$$MD$IT$IT
242291151$24229115$1$I$$20240812$20240820$20240820$EXP$$CA-AstraZeneca-2024A187330$ASTRAZENECA$$65$YR$$F$Y$$$20240820$$MD$CA$
242291161$24229116$1$I$20240126$20240812$20240820$20240820$EXP$$FR-AstraZeneca-2024A060234$ASTRAZENECA$$67$YR$$M$Y$$$20240820$$MD$FR$
242291171$24229117$1$I$20240715$20240815$20240820$20240820$EXP$$AT-GILEAD-2024-0681128$GILEAD$$67$YR$E$M$Y$$$20240820$$MD$AT$AT
242291181$24229118$1$I$20240810$20240812$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012585$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242291201$24229120$1$I$$20240816$20240820$20240820$EXP$$AU-SANDOZ INC.-SDZ2024AU073334$SANDOZ$$17$YR$$$Y$$$20240820$$MD$AU$AU
242291211$24229121$1$I$$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129263$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240820$$HP$US$US
242291221$24229122$1$I$$20240813$20240820$20240820$EXP$$US-AMERICAN REGENT INC-2024003138$AMERICAN REGENT$Nelson N, Masih D, Sabri A, Monika F, Mirza M.. Isolated Myeloid Sarcoma Masquerading as Scattered Abscesses in a Septic Patient: A Case Report and Literature Review.. Case Reports on Oncology. 2024;17(1):39-48$76$YR$$F$Y$$$20240820$$HP$US$US
242291231$24229123$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131361$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$98.88$KG$20240820$$CN$US$US
242291241$24229124$1$I$20240808$20240816$20240820$20240820$EXP$$DE-TAKEDA-2024TUS082907$TAKEDA$$61$YR$$M$Y$$$20240820$$HP$DE$DE
242291271$24229127$1$I$$20240816$20240820$20240820$PER$$US-JNJFOC-20240843912$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242291281$24229128$1$I$20240308$20240814$20240820$20240820$EXP$$JP-009507513-2405JPN000074J$MERCK$$5$DEC$$F$Y$$$20240820$$MD$JP$JP
242291291$24229129$1$I$20240606$20240819$20240819$20240819$DIR$714971$$FDA-CTU$$52$YR$$M$N$85.5$KG$20240819$N$CN$US$
242291301$24229130$1$I$20240416$20240815$20240820$20240820$EXP$$GB-SANDOZ INC.-SDZ2024GB040657$SANDOZ$$40$YR$$F$Y$$$20240820$$CN$GB$GB
242291311$24229131$1$I$20240816$20240816$20240820$20240820$PER$$US-PFIZER INC-202400238997$PFIZER$$61$YR$$M$Y$$$20240820$$CN$US$US
242291331$24229133$1$I$20240819$20240819$20240819$20240819$DIR$714916$$FDA-CTU$$35$YR$$F$N$$$20240819$N$$US$
242291352$24229135$2$F$$20240822$20240820$20240827$PER$$US-PFIZER INC-PV202400107653$PFIZER$$60$YR$$F$Y$$$20240827$$CN$US$US
242291362$24229136$2$F$20240813$20240918$20240820$20240919$PER$$US-PFIZER INC-202400238624$PFIZER$$57$YR$$F$Y$58.957$KG$20240919$$CN$US$US
242291371$24229137$1$I$$20240816$20240820$20240820$PER$$KR-PFIZER INC-PV202400107496$PFIZER$$$$$F$Y$$$20240820$$CN$KR$KR
242291381$24229138$1$I$20240727$20240819$20240819$20240819$DIR$715001$$FDA-CTU$$68$YR$$F$N$63$KG$20240819$N$CN$US$
242291391$24229139$1$I$20240801$20240819$20240819$20240819$DIR$714912$$FDA-CTU$$58$YR$$F$N$$$20240819$N$HP$US$
242291402$24229140$2$F$$20240819$20240820$20240821$PER$$US-PFIZER INC-202400238644$PFIZER$$47$YR$$F$Y$$$20240821$$HP$US$US
242291412$24229141$2$F$20240807$20240913$20240820$20240917$EXP$$IN-PFIZER INC-202400238613$PFIZER$$70$YR$$F$Y$$$20240917$$CN$IN$US
242291431$24229143$1$I$20240809$20240816$20240820$20240820$PER$$US-PFIZER INC-202400238820$PFIZER$$36$YR$$M$Y$$$20240820$$CN$US$US
242291441$24229144$1$I$20240101$20240816$20240820$20240820$PER$$US-PFIZER INC-PV202400107716$PFIZER$$46$YR$$F$Y$$$20240820$$HP$US$US
242291451$24229145$1$I$20240801$20240816$20240820$20240820$PER$$US-PFIZER INC-202400239341$PFIZER$$41$YR$$F$Y$$$20240820$$CN$US$US
242291461$24229146$1$I$20240801$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238542$PFIZER$$77$YR$$F$Y$$$20240820$$CN$US$US
242291471$24229147$1$I$20240815$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238994$PFIZER$$64$YR$$F$Y$$$20240820$$CN$US$US
242291481$24229148$1$I$20240813$20240817$20240820$20240820$PER$$US-PFIZER INC-202400239031$PFIZER$$39$YR$$M$Y$$$20240820$$CN$US$US
242291491$24229149$1$I$20220101$20240816$20240820$20240820$PER$$US-PFIZER INC-202400238654$PFIZER$$67$YR$$F$Y$68.04$KG$20240820$$CN$US$US
242291501$24229150$1$I$20240801$20240816$20240820$20240820$PER$$US-PFIZER INC-PV202400107495$PFIZER$$53$YR$$F$Y$68.027$KG$20240820$$CN$US$US
242291511$24229151$1$I$20240816$20240816$20240820$20240820$PER$$US-PFIZER INC-202400238547$PFIZER$$46$YR$$F$Y$$$20240820$$CN$US$US
242291521$24229152$1$I$20240101$20240816$20240820$20240820$PER$$US-PFIZER INC-PV202400107605$PFIZER$$48$YR$$M$Y$$$20240820$$HP$US$US
242291531$24229153$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237579$PFIZER$$$$$M$Y$$$20240820$$CN$US$US
242291542$24229154$2$F$$20240820$20240820$20240826$PER$$US-PFIZER INC-202400236033$PFIZER$$57$YR$$F$Y$$$20240826$$CN$US$US
242291552$24229155$2$F$20240816$20240923$20240820$20240925$PER$$US-PFIZER INC-202400238978$PFIZER$$62$YR$$F$Y$65.76$KG$20240925$$CN$US$US
242291562$24229156$2$F$$20240823$20240820$20240826$PER$$US-PFIZER INC-202400238619$PFIZER$$72$YR$$F$Y$$$20240826$$CN$US$US
242291571$24229157$1$I$20240601$20240814$20240820$20240820$PER$$US-PFIZER INC-PV202400106609$PFIZER$$53$YR$$F$Y$$$20240820$$HP$US$US
242291581$24229158$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237575$PFIZER$$51$YR$$F$Y$$$20240820$$CN$US$US
242291591$24229159$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237581$PFIZER$$$$$F$Y$$$20240820$$CN$US$US
242291601$24229160$1$I$$20240816$20240820$20240820$PER$$US-PFIZER INC-202400238572$PFIZER$$62$YR$$M$Y$$$20240820$$MD$US$US
242291611$24229161$1$I$20240815$20240816$20240820$20240820$PER$$US-PFIZER INC-202400238271$PFIZER$$60$YR$$F$Y$$$20240820$$CN$US$US
242291621$24229162$1$I$$20240816$20240820$20240820$PER$$US-PFIZER INC-PV202400107658$PFIZER$$82$YR$$F$Y$$$20240820$$HP$US$US
242291631$24229163$1$I$20240801$20240816$20240820$20240820$PER$$US-PFIZER INC-202400238364$PFIZER$$85$YR$$F$Y$$$20240820$$CN$US$US
242291641$24229164$1$I$$20240809$20240820$20240820$PER$$US-ABBVIE-5879367$ABBVIE$$$$$$Y$$$20240820$$MD$US$US
242291651$24229165$1$I$20240814$20240816$20240820$20240820$PER$$US-PFIZER INC-202400238712$PFIZER$$47$YR$$M$Y$$$20240820$$CN$US$US
242291661$24229166$1$I$$20240815$20240820$20240820$EXP$$NVSC2024AR167761$NOVARTIS$$$$$M$Y$$$20240820$$CN$AR$AR
242291682$24229168$2$F$$20240906$20240820$20240913$EXP$$IN-VANTIVE-2024VAN019050$Vantive US Healthcare$$52$YR$$M$Y$$$20240913$$CN$IN$IN
242291691$24229169$1$I$$20240816$20240820$20240820$EXP$$CN-VANTIVE-2024VAN019126$Vantive US Healthcare$$$$$M$Y$$$20240820$$CN$CN$CN
242291701$24229170$1$I$20210407$20240814$20240820$20240820$EXP$$GB-SANDOZ INC.-NVSC2021GB083352$SANDOZ$$7$YR$$M$Y$$$20240820$$CN$GB$GB
242291711$24229171$1$I$20240716$20240813$20240820$20240820$EXP$FR-AFSSAPS-AN2024001132$FR-RDY-SPO/FRA/24/0011852$DR REDDYS$$75$YR$E$M$Y$66$KG$20240820$$MD$FR$FR
242291721$24229172$1$I$20240615$20240819$20240819$20240819$DIR$714956$$FDA-CTU$$56$YR$$F$N$72$KG$20240819$N$CN$US$
242291731$24229173$1$I$20240814$20240819$20240819$20240819$DIR$714980$$FDA-CTU$$65$YR$$F$N$108$KG$20240819$N$CN$US$
242291741$24229174$1$I$20240817$20240819$20240819$20240819$DIR$715006$$FDA-CTU$$80$YR$$F$N$60.75$KG$20240819$N$CN$US$
242291751$24229175$1$I$20240819$20240819$20240819$20240819$DIR$714929$$FDA-CTU$$73$YR$$M$N$$$20240819$N$$US$
242291761$24229176$1$I$20240819$20240819$20240819$20240819$DIR$715008$$FDA-CTU$$33$YR$$F$N$105.75$KG$20240819$N$CN$US$
242291771$24229177$1$I$$20240810$20240820$20240820$30DAY$$US-GSK-US2024AMR100408$GLAXOSMITHKLINE$$$$$F$Y$$$20240820$$CN$US$US
242291781$24229178$1$I$20240731$20240812$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012589$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242291791$24229179$1$I$20240801$20240814$20240820$20240820$PER$$US-JNJFOC-20240841553$JOHNSON AND JOHNSON$$$$$F$Y$$$20240820$$CN$US$US
242291811$24229181$1$I$$20240816$20240820$20240820$EXP$$FR-SANDOZ INC.-SDZ2024FR073116$SANDOZ$$72$YR$$M$Y$$$20240820$$HP$FR$FR
242291821$24229182$1$I$$20240819$20240820$20240820$EXP$$AU-SANDOZ INC.-SDZ2024AU073729$SANDOZ$$7$YR$$F$Y$$$20240820$$CN$AU$AU
242291831$24229183$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241455$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240820$$CN$US$US
242291841$24229184$1$I$20240817$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011708$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240820$$CN$US$US
242291851$24229185$1$I$$20240807$20240820$20240820$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000181$PAREXEL$$69$YR$$F$Y$$$20240820$$CN$US$US
242291861$24229186$1$I$20240801$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238877$PFIZER$$30$YR$$M$Y$$$20240820$$CN$US$US
242291871$24229187$1$I$20240807$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238703$PFIZER$$68$YR$$M$Y$$$20240820$$CN$US$US
242291881$24229188$1$I$$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238787$PFIZER$$$$$$Y$$$20240820$$CN$US$US
242291892$24229189$2$F$20240801$20240906$20240820$20240909$PER$$US-PFIZER INC-202400238563$PFIZER$$51$YR$$F$Y$67.392$KG$20240909$$CN$US$US
242291901$24229190$1$I$20240816$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238629$PFIZER$$65$YR$$F$Y$$$20240820$$CN$US$US
242291911$24229191$1$I$20240817$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238559$PFIZER$$86$YR$$M$Y$$$20240820$$CN$US$US
242291921$24229192$1$I$20240816$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238558$PFIZER$$74$YR$$F$Y$$$20240820$$CN$US$US
242291931$24229193$1$I$20240816$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238935$PFIZER$$49$YR$$F$Y$$$20240820$$CN$US$US
242291941$24229194$1$I$20240815$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238555$PFIZER$$69$YR$$M$Y$$$20240820$$CN$US$US
242291951$24229195$1$I$20240816$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238701$PFIZER$$52$YR$$F$Y$$$20240820$$CN$US$US
242291961$24229196$1$I$20240601$20240819$20240820$20240820$EXP$GB-MHRA-MED-202408121653247800-JHVNP$GB-ORGANON-O2408GBR001368$ORGANON$$70$YR$$M$Y$$$20240820$$PH$GB$GB
242291972$24229197$2$F$20240101$20240923$20240820$20240927$EXP$$US-ABBVIE-5882092$ABBVIE$$$$$M$Y$77$KG$20240927$$CN$US$US
242291981$24229198$1$I$20240401$20240819$20240819$20240819$DIR$714957$$FDA-CTU$$34$YR$$F$N$103.5$KG$20240819$N$CN$US$
242292002$24229200$2$F$$20240819$20240820$20240918$PER$$US-GILEAD-2024-0684678$GILEAD$$$$$M$Y$$$20240918$$MD$US$US
242292011$24229201$1$I$20240818$20240819$20240819$20240819$DIR$714947$$FDA-CTU$$62$YR$$F$N$72$KG$20240819$N$HP$US$
242292021$24229202$1$I$20230811$20240816$20240820$20240820$EXP$FR-AFSSAPS-LM2024000451$FR-GSK-FR2024102218$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$MD$FR$FR
242292032$24229203$2$F$$20240919$20240820$20240926$EXP$$CA-ABBVIE-5884039$ABBVIE$$$$E$F$Y$$$20240926$$CN$CA$CA
242292041$24229204$1$I$$20240812$20240820$20240820$EXP$$CA-TEVA-VS-3233072$TEVA$$$$$F$Y$$$20240820$$HP$CA$CA
242292061$24229206$1$I$20230101$20240816$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131441$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240820$$CN$US$US
242292071$24229207$1$I$20240722$20240816$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130741$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240820$$CN$US$US
242292081$24229208$1$I$20240701$20240813$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128548$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240820$$HP$US$US
242292092$24229209$2$F$20240806$20240828$20240820$20240905$PER$$US-ROCHE-10000055176$ROCHE$$34$YR$A$F$Y$$$20240905$$CN$US$US
242292101$24229210$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5883540$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242292111$24229211$1$I$$20240816$20240820$20240820$EXP$$UY-ABBVIE-5884087$ABBVIE$$$$$F$Y$$$20240820$$CN$UY$UY
242292121$24229212$1$I$$20240816$20240820$20240820$EXP$$US-ABBVIE-5885117$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242292131$24229213$1$I$20240101$20240813$20240820$20240820$EXP$$US-SA-2024SA245481$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240820$$CN$US$US
242292141$24229214$1$I$20240101$20240814$20240820$20240820$EXP$$US-ABBVIE-5863327$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242292151$24229215$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A171329$ASTRAZENECA$$16$YR$$M$Y$$$20240820$$CN$US$
242292161$24229216$1$I$$20240820$20240820$20240820$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046638$BOEHRINGER INGELHEIM$$8$DEC$E$F$Y$$$20240820$$MD$JP$JP
242292171$24229217$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A184758$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242292181$24229218$1$I$$20240812$20240820$20240820$EXP$$GB-AstraZeneca-2024A183017$ASTRAZENECA$$66$YR$$F$Y$$$20240820$$MD$GB$
242292191$24229219$1$I$20240722$20240815$20240820$20240820$EXP$$ID-AstraZeneca-2024A188238$ASTRAZENECA$$25699$DY$$F$Y$$$20240820$$CN$ID$
242292201$24229220$1$I$$20240809$20240820$20240820$PER$$US-ABBVIE-5876706$ABBVIE$$$$A$F$Y$$$20240820$$MD$US$US
242292212$24229221$2$F$$20240828$20240820$20240903$EXP$$GB-MYLANLABS-2024M1076684$MYLAN$$$$$F$Y$$$20240903$$MD$GB$GB
242292221$24229222$1$I$$20240806$20240820$20240820$EXP$$US-NOVOPROD-1269133$NOVO NORDISK$$$$$$Y$$$20240820$$CN$US$US
242292231$24229223$1$I$$20240714$20240820$20240820$EXP$$DK-NOVOPROD-1256836$NOVO NORDISK$$$$$F$Y$83$KG$20240820$$HP$DK$DK
242292241$24229224$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA242509$SANOFI AVENTIS$$56$YR$A$F$Y$84.36$KG$20240820$$MD$US$US
242292251$24229225$1$I$20231120$20240815$20240820$20240820$PER$$US-GILEAD-2024-0684354$GILEAD$$49$YR$A$M$Y$128$KG$20240820$$HP$US$US
242292261$24229226$1$I$20240712$20240816$20240820$20240820$PER$$CN-Eisai-EC-2024-172291$EISAI$$51$YR$A$F$Y$60$KG$20240820$$HP$CN$CN
242292271$24229227$1$I$20240814$20240818$20240820$20240820$PER$$US-PFIZER INC-202400239043$PFIZER$$61$YR$$F$Y$$$20240820$$CN$US$US
242292281$24229228$1$I$$20240820$20240820$20240820$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046734$BOEHRINGER INGELHEIM$$$$$$Y$$$20240820$$CN$US$US
242292291$24229229$1$I$$20240814$20240820$20240820$EXP$$PT-MYLANLABS-2024M1075864$MYLAN$Teixeira L, Fonseca C, Sousa S, Vinagre F, Cordeiro A, Goncalves P, et al.. Safety of Etanercept in the treatment of rheumatic disease patients with Hepatitis C virus infection.. Acta-Reumatol-Port. 2018;43(2):159-160$61$YR$$F$Y$$$20240820$$HP$PT$PT
242292301$24229230$1$I$$20240814$20240820$20240820$EXP$$DE-MYLANLABS-2024M1076107$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$31$YR$$M$Y$$$20240820$$HP$DE$DE
242292312$24229231$2$F$20231214$20240816$20240820$20240824$PER$$US-JAZZ PHARMACEUTICALS-2023-US-025293$JAZZ$$57$YR$$F$Y$$$20240824$$MD$US$US
242292331$24229233$1$I$20240801$20240815$20240820$20240820$EXP$$CA-ABBVIE-5885644$ABBVIE$$53$YR$$F$Y$$$20240820$$CN$CA$CA
242292342$24229234$2$F$$20240830$20240820$20240906$PER$$US-BIOMARINAP-US-2024-159738$BIOMARIN$$$$$$Y$$$20240906$$CN$US$US
242292351$24229235$1$I$20240701$20240812$20240820$20240820$EXP$$US-BIOMARINAP-US-2024-159899$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242292361$24229236$1$I$$20240802$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159846$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242292371$24229237$1$I$$20240812$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159838$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242292381$24229238$1$I$$20240813$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159834$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242292391$24229239$1$I$$20240813$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159828$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242292401$24229240$1$I$20240817$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238743$PFIZER$$65$YR$$F$Y$$$20240820$$CN$US$US
242292411$24229241$1$I$$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238523$PFIZER$$$$A$F$Y$$$20240820$$CN$US$US
242292421$24229242$1$I$20240818$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238757$PFIZER$$72$YR$$F$Y$$$20240820$$CN$US$US
242292431$24229243$1$I$20240814$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238548$PFIZER$$79$YR$$M$Y$$$20240820$$CN$US$US
242292441$24229244$1$I$20240812$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238878$PFIZER$$72$YR$$F$Y$$$20240820$$CN$US$US
242292452$24229245$2$F$20240817$20240821$20240820$20240822$PER$$US-PFIZER INC-202400238759$PFIZER$$$$$$Y$$$20240822$$CN$US$US
242292461$24229246$1$I$20240817$20240817$20240820$20240820$PER$$US-PFIZER INC-202400238561$PFIZER$$53$YR$$F$Y$$$20240820$$CN$US$US
242292471$24229247$1$I$20240817$20240818$20240820$20240820$PER$$US-PFIZER INC-202400239062$PFIZER$$80$YR$$F$Y$$$20240820$$CN$US$US
242292481$24229248$1$I$20240815$20240817$20240820$20240820$PER$$US-PFIZER INC-202400239016$PFIZER$$77$YR$$F$Y$$$20240820$$CN$US$US
242292491$24229249$1$I$$20240816$20240820$20240820$EXP$$US-ABBVIE-5883967$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242292501$24229250$1$I$20240101$20240815$20240820$20240820$EXP$$DE-ABBVIE-5884208$ABBVIE$$63$YR$$F$Y$$$20240820$$CN$DE$DE
242292511$24229251$1$I$$20240819$20240820$20240820$EXP$$CA-ORGANON-O2408CAN001354$ORGANON$$60$YR$$M$Y$$$20240820$$HP$CA$CA
242292521$24229252$1$I$20240123$20240729$20240820$20240820$PER$$US-009507513-2407USA015326$MERCK$$$$$F$Y$97.506$KG$20240820$$CN$US$US
242292531$24229253$1$I$20240101$20240723$20240820$20240820$PER$$US-009507513-2407USA013227$MERCK$$$$$F$Y$$$20240820$$CN$US$US
242292542$24229254$2$F$$20240811$20240820$20240903$EXP$$ES-AMGEN-ESPSP2024163368$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240902$$HP$ES$ES
242292551$24229255$1$I$20240805$20240812$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012599$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242292561$24229256$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024162746$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242292571$24229257$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883198$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242292591$24229259$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163380$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242292601$24229260$1$I$$20240811$20240820$20240820$EXP$$ES-AMGEN-ESPSP2024163381$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242292611$24229261$1$I$20240719$20240812$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012600$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242292621$24229262$1$I$20240805$20240813$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012677$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242292631$24229263$1$I$20240712$20240809$20240820$20240820$EXP$NL-LRB-00994467$NL-SA-2024SA238865$SANOFI AVENTIS$$86$YR$E$F$Y$54$KG$20240820$$MD$NL$NL
242292641$24229264$1$I$20240808$20240814$20240820$20240820$PER$$US-BAUSCH-BL-2024-012352$BAUSCH AND LOMB$$55$YR$$F$Y$$$20240820$$CN$US$US
242292651$24229265$1$I$20240801$20240816$20240820$20240820$PER$$US-BAUSCH-BL-2024-012470$BAUSCH AND LOMB$$78$YR$$F$Y$75.818$KG$20240820$$CN$US$US
242292661$24229266$1$I$$20240819$20240820$20240820$EXP$$US-JNJFOC-20240847303$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$CN$US$US
242292671$24229267$1$I$20230928$20240813$20240820$20240820$EXP$$CL-JNJFOC-20231113610$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240820$$CN$CL$CL
242292681$24229268$1$I$20240101$20240816$20240820$20240820$EXP$$US-ABBVIE-5884905$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242292691$24229269$1$I$20231101$20240812$20240820$20240820$PER$$US-SA-2024SA241965$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240820$$MD$US$US
242292701$24229270$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240951$SANOFI AVENTIS$$$$A$F$Y$63.5$KG$20240820$$MD$US$US
242292711$24229271$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241175$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240820$$MD$US$US
242292721$24229272$1$I$20240722$20240815$20240820$20240820$PER$$US-SA-2024SA244146$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240820$$MD$US$US
242292731$24229273$1$I$20240101$20240811$20240820$20240820$PER$$US-SA-2024SA240964$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240820$$MD$US$US
242292741$24229274$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA243796$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242292751$24229275$1$I$20240801$20240812$20240820$20240820$PER$$US-SA-2024SA242342$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240820$$CN$US$US
242292761$24229276$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA240931$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240820$$CN$US$US
242292773$24229277$3$F$20220101$20240911$20240820$20240916$EXP$$US-ABBVIE-5884617$ABBVIE$$$$$M$Y$71.66$KG$20240916$$CN$US$US
242292781$24229278$1$I$20240201$20240805$20240820$20240820$EXP$CH-SM-2024-14080$CH-UCBSA-2024039579$UCB$$69$YR$$F$Y$$$20240820$$HP$CH$CH
242292791$24229279$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012576$BAUSCH AND LOMB$$69$YR$$M$Y$$$20240820$$CN$CA$CA
242292801$24229280$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012573$BAUSCH AND LOMB$$78$YR$$M$Y$$$20240820$$CN$CA$CA
242292811$24229281$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012585$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240820$$CN$CA$CA
242292821$24229282$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012568$BAUSCH AND LOMB$$53$YR$$F$Y$$$20240820$$HP$CA$CA
242292831$24229283$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012604$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240820$$HP$CA$CA
242292842$24229284$2$F$20240806$20240924$20240820$20240925$EXP$$NVSC2024US168346$NOVARTIS$$72$YR$$M$Y$90.72$KG$20240926$$HP$US$US
242292851$24229285$1$I$20240801$20240815$20240820$20240820$EXP$$US-ABBVIE-5884756$ABBVIE$$64$YR$$F$Y$$$20240820$$CN$US$US
242292861$24229286$1$I$$20240811$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US072676$SANDOZ$$$$$$Y$$$20240820$$CN$US$US
242292871$24229287$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5885548$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242292881$24229288$1$I$20240801$20240812$20240820$20240820$EXP$$CN-AstraZeneca-2024A185779$ASTRAZENECA$$20478$DY$$M$Y$60$KG$20240820$$MD$CN$
242292892$24229289$2$F$20240806$20240822$20240820$20240829$EXP$$NVSC2024US160446$NOVARTIS$$80$YR$$M$Y$80.454$KG$20240829$$CN$US$US
242292902$24229290$2$F$20200101$20240909$20240820$20240909$EXP$$US-ALXN-202408USA000795US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242292911$24229291$1$I$$20240815$20240820$20240820$EXP$$GB-AstraZeneca-2024A186848$ASTRAZENECA$$75$YR$$M$Y$$$20240820$$MD$GB$
242292922$24229292$2$F$$20240830$20240820$20240906$EXP$$FR-AstraZeneca-2024A186143$ASTRAZENECA$$63$YR$$F$Y$$$20240906$$CN$FR$
242292931$24229293$1$I$$20240814$20240820$20240820$PER$$US-AstraZeneca-2024A177995$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242292941$24229294$1$I$20240101$20240815$20240820$20240820$PER$$US-ORGANON-O2408USA001199$ORGANON$$$$$F$Y$$$20240820$$CN$US$US
242292951$24229295$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A183965$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242292961$24229296$1$I$20240726$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A186846$ASTRAZENECA$$25044$DY$$M$Y$$$20240820$$CN$US$
242292971$24229297$1$I$$20230601$20240820$20240820$EXP$$US-AstraZeneca-2023A127871$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242292981$24229298$1$I$20220101$20240817$20240820$20240820$EXP$FR-AFSSAPS-ST2024001313$FR-GE HEALTHCARE-2024CSU009413$GE HEALTHCARE$$72$YR$$F$Y$$$20240820$$HP$FR$FR
242292992$24229299$2$F$$20240820$20240820$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408010806$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240829$$CN$US$US
242293001$24229300$1$I$20240804$20240812$20240820$20240820$EXP$$CN-GE HEALTHCARE-2024CSU009274$GE HEALTHCARE$$56$YR$$F$Y$54$KG$20240820$$HP$CN$CN
242293011$24229301$1$I$$20240816$20240820$20240820$EXP$$CA-GE HEALTHCARE-2024CSU009392$GE HEALTHCARE$$53$YR$$F$Y$$$20240820$$HP$CA$CA
242293025$24229302$5$F$20240805$20240919$20240820$20240925$EXP$$NVSC2024FR167629$NOVARTIS$$$$E$F$Y$66.2$KG$20240925$$MD$FR$FR
242293031$24229303$1$I$$20240812$20240820$20240820$EXP$$US-USAntibiotics-000331$USAntibiotics$$60$YR$A$F$Y$$$20240820$$CN$US$
242293041$24229304$1$I$$20240819$20240820$20240820$PER$$US-ROCHE-10000061098$ROCHE$$66$YR$E$F$Y$$$20240820$$MD$US$US
242293051$24229305$1$I$$20240816$20240820$20240820$EXP$$US-GILEAD-2024-0684609$GILEAD$$$$A$F$Y$$$20240820$$HP$US$US
242293063$24229306$3$F$20240101$20240917$20240820$20240924$EXP$$JP-GENMAB-2024-01210AA$GENMAB$$75$YR$$F$Y$$$20240924$$MD$JP$JP
242293071$24229307$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243707$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240820$$HP$US$US
242293081$24229308$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA242302$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240820$$MD$US$US
242293091$24229309$1$I$20240701$20240801$20240820$20240820$PER$$US-USAntibiotics-000328$USAntibiotics$$66$YR$E$F$Y$65.8$KG$20240819$$CN$US$
242293101$24229310$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA244689$SANOFI AVENTIS$$$$E$F$Y$56.69$KG$20240820$$MD$US$US
242293111$24229311$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA244578$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240820$$MD$US$US
242293121$24229312$1$I$20240809$20240809$20240820$20240820$PER$$US-SA-2024SA241682$SANOFI AVENTIS$$13$YR$T$F$Y$53.97$KG$20240820$$MD$US$US
242293131$24229313$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240005$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240820$$MD$US$US
242293141$24229314$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA242245$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240820$$MD$US$US
242293151$24229315$1$I$$20240806$20240820$20240820$PER$$US-Calliditas-2024CAL01499$CALLIDITAS THERAPEUTICS$$$$E$$Y$$$20240820$$CN$US$US
242293161$24229316$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240789$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240820$$MD$US$US
242293171$24229317$1$I$$20240807$20240820$20240820$PER$$US-RDY-LIT/USA/24/0011815$DR REDDYS$Kane N, Rikard R, McCrory K, Marx AH. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels. Open Forum Infectious Diseases. 2023 Nov 27;10(2): S1108. doi:10.1093/ofid/ofad500.2163.$80$YR$E$F$Y$$$20240820$$PH$US$US
242293181$24229318$1$I$20240701$20240808$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011812$DR REDDYS$$19$YR$A$F$Y$$$20240820$$MD$US$US
242293191$24229319$1$I$$20240815$20240820$20240820$EXP$$JP-009507513-2408JPN001861J$MERCK$$5$DEC$$$Y$$$20240820$$HP$JP$JP
242293201$24229320$1$I$$20240807$20240820$20240820$PER$$US-RDY-LIT/USA/24/0011817$DR REDDYS$Kane N, Rikard R, McCrory K, Marx AH. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels. Open Forum Infectious Diseases. 2023 Nov 27;10(2): S1108. doi:10.1093/ofid/ofad500.2163.$60$YR$A$M$Y$$$20240820$$PH$US$US
242293211$24229321$1$I$$20240820$20240820$20240820$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046745$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240820$$CN$US$US
242293221$24229322$1$I$$20240813$20240820$20240820$EXP$$US-GSK-US2024100760$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$US$US
242293231$24229323$1$I$20240729$20240816$20240820$20240820$EXP$$NVSC2024CN168142$NOVARTIS$$69$YR$$M$Y$$$20240820$$HP$CN$CN
242293241$24229324$1$I$20240501$20240814$20240820$20240820$EXP$FR-AFSSAPS-TS2024000891$FR-MYLANLABS-2024M1075883$MYLAN$$72$YR$$M$Y$64$KG$20240820$$MD$FR$FR
242293252$24229325$2$F$20240101$20240917$20240820$20240926$PER$$US-SA-2024SA238849$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240926$$MD$US$US
242293261$24229326$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243121$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240820$$MD$US$US
242293271$24229327$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA242683$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240820$$CN$US$US
242293282$24229328$2$F$20240808$20240822$20240820$20240905$EXP$$MY-SA-2024SA244551$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240905$$HP$MY$MY
242293291$24229329$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA244609$SANOFI AVENTIS$$$$A$M$Y$$$20240820$$MD$US$US
242293301$24229330$1$I$20240101$20240808$20240820$20240820$PER$$US-SA-2024SA241251$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240820$$MD$US$US
242293311$24229331$1$I$$20240815$20240820$20240820$EXP$$US-SA-2024SA244356$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240820$$MD$US$US
242293321$24229332$1$I$20240619$20240819$20240820$20240820$EXP$$US-GILEAD-2024-0684686$GILEAD$$81$YR$E$M$Y$$$20240820$$CN$US$US
242293331$24229333$1$I$$20240816$20240820$20240820$EXP$$AU-SANDOZ INC.-SDZ2024AU073361$SANDOZ$$45$YR$$F$Y$$$20240820$$MD$AU$AU
242293341$24229334$1$I$20240819$20240819$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US073829$SANDOZ$$1$YR$$$Y$$$20240820$$CN$US$US
242293351$24229335$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168485$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242293362$24229336$2$F$$20240827$20240820$20240905$EXP$$US-TEVA-VS-3234229$TEVA$Singh A, Chidharla A, Jain N, Debnath N, Dawoodi I, Kukreja G. IgD Multiple Myeloma, Does It Still Have a Poor Prognosis?. Blood 2022; 140 (Suppl. 1).; Singh A, Chidharla A, Jain N, Debnath N, Dawoodi I, Kukreja G. IgD Multiple Myeloma, Does It Still Have a Poor Prognosis?. Blood 2022; 140 (Suppl. 1).$63$YR$$F$Y$$$20240905$$HP$US$US
242293371$24229337$1$I$$20240814$20240820$20240820$EXP$$US-MYLANLABS-2024M1076849$MYLAN$Alicea DS, Santana Felipes R, McLellan BN. Management of refractory pruritus in Alagille syndrome with dupilumab treatment: A case report. JAAD-Case-Rep 2024; 51 63-65.$18$YR$$F$Y$$$20240820$$MD$US$US
242293381$24229338$1$I$20240722$20240808$20240820$20240820$EXP$$US-Accord-441361$ACCORD$$23$YR$A$F$Y$$$20240820$$HP$US$US
242293391$24229339$1$I$20240806$20240808$20240820$20240820$EXP$$US-Accord-441205$ACCORD$$44$YR$A$M$Y$$$20240820$$HP$US$US
242293401$24229340$1$I$$20240808$20240820$20240820$EXP$$US-Accord-441312$ACCORD$Sheth K, Lee C, Srinivas N, Hasan Y, Myat K. Hydrochlorothiazide-Induced Exfoliative Rash and Sepsis. Cureus. 2024;16(7):e63655.$86$YR$E$M$Y$$$20240820$$HP$US$US
242293411$24229341$1$I$20240807$20240808$20240820$20240820$EXP$$US-Accord-441207$ACCORD$$39$YR$A$F$Y$$$20240820$$HP$US$US
242293421$24229342$1$I$$20240807$20240820$20240820$EXP$GB-MHRA-30702762$GB-Accord-440832$ACCORD$$78$YR$E$F$Y$57$KG$20240820$$CN$GB$GB
242293431$24229343$1$I$$20240808$20240820$20240820$EXP$GB-MHRA-TPP28720062C8796798YC1722930495748$GB-Accord-441066$ACCORD$$74$YR$E$M$Y$95$KG$20240820$$HP$GB$GB
242293441$24229344$1$I$$20240808$20240820$20240820$EXP$$GR-Accord-441018$ACCORD$Vasilopoulou A, Spaho M, Theotokis P, Grekou A, Meditskou S, Manthou ME. Fatal misdiagnosis of progressive disseminated histoplasmosis. Medical Mycology Case Reports. 2024;45:100662. DOI: 10.1016/j.mmcr.2024.100662.$$$A$M$Y$$$20240820$$MD$GR$GR
242293451$24229345$1$I$20230501$20240808$20240820$20240820$EXP$$CN-Accord-441400$ACCORD$Sun M, Xu G, Cai L, He S. Misdiagnosis of severe and atypical oxaliplatin related hypersensitivity reaction following chemotherapy combined with PD 1 inhibitor: A case report and literature review. ONCOLOGY LETTERS. 2024;28(4):452. DOI:10.3892/ol.2024.14586.$67$YR$E$M$Y$$$20240820$$HP$CN$CN
242293461$24229346$1$I$20240717$20240807$20240820$20240820$EXP$PT-INFARMED-J202407-465$PT-Accord-440905$ACCORD$$67$YR$E$M$Y$$$20240820$$HP$PT$PT
242293471$24229347$1$I$20150915$20240807$20240820$20240820$EXP$$US-Accord-434156$ACCORD$$56$YR$A$F$Y$$$20240820$$LW$US$US
242293481$24229348$1$I$20220301$20240808$20240820$20240820$EXP$$CN-Accord-441491$ACCORD$Chen L, Cao X, Luo X, Jiang T. Refractory pruritus caused by sintilimab and its clinical management: A case report. Heliyon. 2024 Jul 4;10(14):e34107.$55$YR$A$F$Y$$$20240820$$PH$CN$CN
242293491$24229349$1$I$20231227$20240808$20240820$20240820$EXP$FR-AFSSAPS-NY2024000890$FR-Accord-441060$ACCORD$$95$YR$E$M$Y$70.4$KG$20240820$$MD$FR$FR
242293501$24229350$1$I$$20240808$20240820$20240820$EXP$$US-Accord-441016$ACCORD$Vasireddy R, Bilalaga MM, Iding J, Sankineni A. Challenges in Diagnosis: Primary Hepatic Lymphoma Presenting as a Space-Occupying Liver Lesion. ACG Case Reports Journal. 2024;11(7):e01443.. DOI: 10.14309/crj.0000000000001443.$85$YR$E$F$Y$$$20240820$$MD$US$US
242293511$24229351$1$I$20240419$20240807$20240820$20240820$EXP$FR-AFSSAPS-RN2024000845$FR-Accord-440885$ACCORD$$69$YR$E$F$Y$78$KG$20240820$$MD$FR$FR
242293522$24229352$2$F$$20240813$20240820$20240824$EXP$$PT-Accord-441383$ACCORD$Peixoto M, Alves D, Lopes A, Queiroz L, Almeida M. Fluoropyrimidine Toxicities and DPYD Genotyping: A Clinical Case. Cureus. 2024;16(7):e63814.$52$YR$A$F$Y$$$20240824$$HP$PT$PT
242293532$24229353$2$F$20240209$20240822$20240820$20240903$EXP$FR-AFSSAPS-2024067945$FR-Accord-441166$ACCORD$$69$YR$E$M$Y$106$KG$20240903$$PH$FR$FR
242293541$24229354$1$I$$20240816$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130981$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240820$$CN$US$US
242293551$24229355$1$I$$20240816$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131517$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240820$$CN$US$US
242293561$24229356$1$I$20240816$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131600$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$56.7$KG$20240820$$PH$US$US
242293571$24229357$1$I$20221215$20240808$20240820$20240820$EXP$GB-MHRA-MED-202309131553585350-RLQSD$GB-Accord-441139$ACCORD$$38$YR$A$F$Y$$$20240820$$CN$GB$GB
242293581$24229358$1$I$20240719$20240808$20240820$20240820$EXP$FR-AFSSAPS-PA2024001425$FR-Accord-441054$ACCORD$$83$YR$E$F$Y$56.9$KG$20240820$$MD$FR$FR
242293591$24229359$1$I$$20240816$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130915$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240820$$CN$US$US
242293601$24229360$1$I$20240101$20240814$20240820$20240820$EXP$$CA-JNJFOC-20240842300$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240820$$HP$CA$CA
242293611$24229361$1$I$20240220$20240806$20240820$20240820$EXP$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000772$PAREXEL$$$$$$Y$$$20240820$$HP$US$US
242293621$24229362$1$I$$20240816$20240820$20240820$EXP$$IT-MYLANLABS-2024M1076311$MYLAN$Corazelli G, Cuccaro A, Morelli E, Arcamone M, De Chiara A, Paccone A, et al. Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVDDD-DI phase II study.. Br J Haematol. 2024;1-6$54$YR$$F$Y$$$20240820$$HP$IT$IT
242293631$24229363$1$I$20240501$20240812$20240820$20240820$PER$$US-009507513-2408USA004408$MERCK$$55$YR$$F$Y$$$20240820$$MD$US$US
242293641$24229364$1$I$$20240730$20240820$20240820$PER$$US-Eisai-EC-2024-171240$EISAI$$$$E$M$Y$$$20240820$$MD$US$US
242293651$24229365$1$I$$20240809$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011834$DR REDDYS$$20$YR$A$F$Y$$$20240820$$MD$US$US
242293661$24229366$1$I$20240801$20240815$20240820$20240820$EXP$$NVSC2024US167083$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242293671$24229367$1$I$20240101$20240814$20240820$20240820$EXP$$JP-GENMAB-2024-02949$GENMAB$$75$YR$$$Y$$$20240820$$MD$JP$JP
242293681$24229368$1$I$20240522$20240806$20240820$20240820$EXP$$FR-Ipsen Biopharmaceuticals, Inc.-2024-09952$IPSEN$$40$YR$A$F$Y$62$KG$20240820$$MD$FR$FR
242293691$24229369$1$I$$20240815$20240820$20240820$EXP$$US-TAKEDA-2024TUS082952$TAKEDA$$$$$M$Y$$$20240820$$MD$US$US
242293701$24229370$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131198$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$45.36$KG$20240820$$CN$US$US
242293721$24229372$1$I$$20240813$20240820$20240820$PER$$US-ABBVIE-5882438$ABBVIE$$29$YR$$F$Y$$$20240820$$CN$US$US
242293731$24229373$1$I$$20240815$20240820$20240820$PER$$US-JNJFOC-20240845415$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$CN$US$US
242293742$24229374$2$F$20240819$20240819$20240820$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012216$ELI LILLY AND CO$$$$$$Y$$$20240830$$CN$US$US
242293751$24229375$1$I$$20240813$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408008327$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242293761$24229376$1$I$20240717$20240812$20240820$20240820$EXP$IT-MINISAL02-997870$IT-TEVA-VS-3233316$TEVA$$53$YR$$M$Y$75$KG$20240820$$MD$IT$IT
242293771$24229377$1$I$20240815$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011021$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240820$$CN$US$US
242293781$24229378$1$I$$20240816$20240820$20240820$PER$$US-ABBVIE-5886519$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242293791$24229379$1$I$$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024162707$AMGEN$$$$$M$Y$$$20240820$$CN$US$US
242293801$24229380$1$I$20240815$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164155$AMGEN$$81$YR$E$F$Y$$$20240820$$CN$US$US
242293811$24229381$1$I$$20240813$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408008815$ELI LILLY AND CO$$$$$F$Y$$$20240820$$HP$US$US
242293822$24229382$2$F$20230801$20240911$20240820$20240918$PER$$US-Calliditas-2024CAL01507$CALLIDITAS THERAPEUTICS$$28$YR$A$F$Y$112.3$KG$20240918$$CN$US$US
242293831$24229383$1$I$$20240807$20240820$20240820$EXP$$IT-CIPLA LTD.-2024IT08990$CIPLA$Formica G, Somma G, Ducci F, Toti G, Kiros ST, Mencarini J, et al.. Efficacy and safety of switching to co-formulated DOR/TDF/3TC in HIV-1-infected, art experienced adults: Data from a single Italian center in florence, Italy. Sex Transm Infect. 2024;100 (Suppl 1):A167 to A168$$$$$Y$$$20240820$$HP$IT$IT
242293842$24229384$2$F$$20240821$20240820$20240826$EXP$$GB-MYLANLABS-2024M1076834$MYLAN$$$$$F$Y$$$20240826$$MD$GB$GB
242293851$24229385$1$I$20220101$20240813$20240820$20240820$EXP$$US-GILEAD-2024-0680422$GILEAD$$$$E$M$Y$$$20240820$$CN$US$US
242293862$24229386$2$F$$20240916$20240820$20240925$PER$$US-GSK-US2024100340$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
242293871$24229387$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131105$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240820$$HP$US$US
242293881$24229388$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131584$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240820$$CN$US$US
242293891$24229389$1$I$$20240814$20240820$20240820$EXP$$NVSC2024SA168356$NOVARTIS$$$$$M$Y$$$20240820$$MD$SA$SA
242293901$24229390$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168452$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242293911$24229391$1$I$$20240816$20240820$20240820$EXP$PL-EMA-DD-20240809-7482661-074952$PL-MYLANLABS-2024M1076402$MYLAN$Czarny J., Andrzejewska M., Zajac-Spychala O., Latos-Grazynska E., Pastorczak A., Wypyszczak K., Szczawinska-Poplonyk A., Niewiadomska-Wojnalowicz I., Wziatek A., Marciniak-Stepak P., Dopierala M. Successful Treatment of Large B-Cell Lymphoma in a Child with Compound Heterozygous Mutation in the ATM Gene. International Journal of Molecular Sciences. 2023;24(2):01-13$7$YR$$F$Y$$$20240820$$HP$PL$PL
242293921$24229392$1$I$20240814$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57280$$FDA-CTU$$58$YR$$F$N$20.46$KG$20240820$N$MD$US$
242293931$24229393$1$I$$20240807$20240820$20240820$EXP$$US-CIPLA LTD.-2024US08833$CIPLA$Yeboah?Korang A, Memon A, Patel N, Portocarrero?Castillo A, Osman A, Kleesattel D, et al.. Impact of prior drug allergies on the risk, clinical features, and outcomes of idiosyncratic drug-induced liver injury in adults. Digestive Diseases and Sciences. 2022;67:5262 to 5271$$$$$Y$$$20240820$$HP$US$US
242293941$24229394$1$I$20240701$20240814$20240820$20240820$EXP$FR-AFSSAPS-AVLY2024000130$FR-MYLANLABS-2024M1075762$MYLAN$$22$YR$$F$Y$$$20240820$$MD$FR$FR
242293951$24229395$1$I$$20240813$20240820$20240820$EXP$$CN-MYLANLABS-2024M1076483$MYLAN$Yuan B, Zhang Y, Yang Y, Fan B, Wang W. A Case of Postherpetic Neuralgia Treated with Short-term Spinal Cord Stimulation for More Than 1 Year. Journal of China-Japan Friendship Hospital. 2024;38(4):250-251$59$YR$$F$Y$$$20240820$$MD$CN$CN
242293961$24229396$1$I$$20240808$20240820$20240820$PER$$US-JNJFOC-20240842314$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$MD$US$US
242293971$24229397$1$I$20240513$20240815$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA048358$SANDOZ$$85$YR$$M$Y$$$20240820$$MD$CA$CA
242293981$24229398$1$I$20240813$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164237$AMGEN$$$$$$Y$$$20240820$$PH$US$US
242293991$24229399$1$I$$20240809$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011789$DR REDDYS$$$$$F$Y$$$20240820$$MD$US$US
242294002$24229400$2$F$20240101$20240904$20240820$20240924$PER$$US-SA-2024SA242691$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240924$$MD$US$US
242294011$24229401$1$I$$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164150$AMGEN$$$$$$Y$$$20240820$$CN$US$US
242294022$24229402$2$F$20240816$20240816$20240820$20240826$PER$$US-AMGEN-USASP2024164982$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242294031$24229403$1$I$20231001$20240815$20240820$20240820$EXP$$TW-AstraZeneca-2024A188504$ASTRAZENECA$$25646$DY$$F$Y$$$20240820$$MD$TW$
242294041$24229404$1$I$$20240813$20240820$20240820$EXP$$US-AstraZeneca-2024A185118$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242294051$24229405$1$I$$20240813$20240820$20240820$EXP$$US-GSK-US2024100792$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$US$US
242294061$24229406$1$I$20220129$20240813$20240820$20240820$EXP$$FR-AstraZeneca-2024A184162$ASTRAZENECA$$68$YR$$M$Y$95$KG$20240820$$MD$FR$
242294071$24229407$1$I$$20230524$20240820$20240820$EXP$$US-AstraZeneca-2023A122418$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242294081$24229408$1$I$$20230413$20240820$20240820$EXP$$US-AstraZeneca-2023A087518$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242294091$24229409$1$I$$20230404$20240820$20240820$EXP$$US-AstraZeneca-2023A079905$ASTRAZENECA$$$$$F$Y$$$20240820$$HP$US$
242294101$24229410$1$I$$20240815$20240820$20240820$EXP$$US-AstraZeneca-2024A186748$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242294111$24229411$1$I$$20240819$20240820$20240820$EXP$$US-KYOWAKIRIN-2024KK019459$KYOWA$$$$$$Y$$$20240820$$PH$US$US
242294122$24229412$2$F$20240808$20240919$20240820$20240923$30DAY$$CR-PFIZER INC-202400234833$PFIZER$$7$YR$$M$Y$$$20240923$$HP$CR$CR
242294131$24229413$1$I$20240601$20240813$20240820$20240820$EXP$$PK-PFIZER INC-PV202400076805$PFIZER$$58$YR$$F$Y$54$KG$20240820$$CN$PK$PK
242294142$24229414$2$F$20240814$20240829$20240820$20240903$30DAY$$AR-PFIZER INC-202400237374$PFIZER$$10$YR$$M$Y$$$20240903$$CN$AR$AR
242294152$24229415$2$F$20240416$20240920$20240820$20240920$EXP$ES-AEMPS-1558977$ES-PFIZER INC-202400237998$PFIZER$$79$YR$$M$Y$$$20240920$$MD$ES$ES
242294162$24229416$2$F$$20240828$20240820$20240910$EXP$$US-SA-2024SA243999$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240910$$MD$US$US
242294171$24229417$1$I$$20240812$20240820$20240820$PER$$US-AMGEN-USASP2024163554$AMGEN$$$$$M$Y$$$20240820$$CN$US$US
242294181$24229418$1$I$20201201$20240809$20240820$20240820$PER$$US-SA-2024SA241115$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240820$$MD$US$US
242294191$24229419$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA242818$SANOFI AVENTIS$$65$YR$E$M$Y$114.3$KG$20240820$$HP$US$US
242294201$24229420$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA241798$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240820$$MD$US$US
242294211$24229421$1$I$20240813$20240813$20240820$20240820$EXP$$BR-TAKEDA-2024TUS067377$TAKEDA$$29$YR$$M$Y$$$20240820$$CN$BR$BR
242294222$24229422$2$F$20240801$20240820$20240820$20240829$PER$$US-SA-2024SA241935$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240829$$MD$US$US
242294231$24229423$1$I$20240704$20240813$20240820$20240820$EXP$$US-ABBVIE-5881340$ABBVIE$$82$YR$$F$Y$$$20240820$$CN$US$US
242294242$24229424$2$F$20240101$20240816$20240820$20240911$PER$$US-ABBVIE-5884019$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
242294251$24229425$1$I$20240409$20240814$20240820$20240820$EXP$FR-AFSSAPS-TO2024001522$FR-MYLANLABS-2024M1076114$MYLAN$$85$YR$$F$Y$$$20240820$$PH$FR$FR
242294262$24229426$2$F$20240811$20240812$20240820$20240824$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-16168$IPSEN$$40$YR$A$M$Y$46.5$KG$20240824$$CN$US$US
242294271$24229427$1$I$20240816$20240816$20240820$20240820$EXP$$US-KYOWAKIRIN-2024KK019363$KYOWA$$$$$$Y$$$20240820$$HP$US$US
242294291$24229429$1$I$$20240814$20240820$20240820$EXP$$US-SA-2024SA244299$SANOFI AVENTIS$$$$A$M$Y$$$20240820$$CN$US$US
242294302$24229430$2$F$20240815$20240819$20240820$20240821$PER$$US-JNJFOC-20240843712$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240821$$CN$US$US
242294311$24229431$1$I$$20240806$20240820$20240820$PER$$US-Calliditas-2024CAL01500$CALLIDITAS THERAPEUTICS$$$$E$$Y$$$20240820$$CN$US$US
242294341$24229434$1$I$20240806$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57289$$FDA-CTU$$72$YR$$M$N$$$20240820$Y$PH$US$
242294351$24229435$1$I$$20240813$20240819$20240819$DIR$FDA-CDER-CTU-2024-57003$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242294361$24229436$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57050$$FDA-CTU$$82$YR$$M$N$$$20240819$N$$US$
242294371$24229437$1$I$20240810$20240816$20240819$20240819$DIR$FDA-CDER-CTU-2024-57017$$FDA-CTU$$77$YR$$F$N$$$20240816$N$HP$US$
242294381$24229438$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56976$$FDA-CTU$$61$YR$$M$N$$$20240819$N$$US$
242294391$24229439$1$I$20230101$20230202$20240820$20240820$EXP$$CA-DSJP-DSJ-2023-105387$DAIICHI$$54$YR$$F$Y$65.8$KG$20240820$$HP$CA$CA
242294402$24229440$2$F$$20240819$20240820$20240825$EXP$DE-UCBSA-2023017727$DE-RDY-SPO/DEU/24/0011803$DR REDDYS$Stegherr R, Fietz AK, Hoeltzenbein M, Dathe K, Beyersmann J. How to account for early overly small risk sets in the analysis of pregnancy outcome data?-Comparison of different methods for stabilizing the Aalen-Johansen estimator. Pharmacoepidemiology and Drug Safety. 2023;-:1-7. doi:10.1002/pds.5718$$$A$F$Y$$$20240825$$MD$DE$DE
242294411$24229441$1$I$$20240808$20240820$20240820$EXP$$US-LEX-000428$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
242294421$24229442$1$I$20190101$20240815$20240820$20240820$EXP$$CA-TAKEDA-2018TUS031167$TAKEDA$$35$YR$$F$Y$$$20240820$$MD$CA$CA
242294431$24229443$1$I$$20240816$20240820$20240820$PER$$US-HALEON-2192434$Haleon PLC$$$$$$Y$$$20240820$$CN$US$US
242294441$24229444$1$I$20240812$20240819$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131509$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240820$$CN$US$US
242294451$24229445$1$I$20240816$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131262$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$80$KG$20240820$$PH$US$US
242294461$24229446$1$I$20231129$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131770$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240820$$MD$US$US
242294472$24229447$2$F$$20240913$20240820$20240920$EXP$$NVSC2024BR167165$NOVARTIS$$$$$M$Y$$$20240920$$CN$BR$BR
242294481$24229448$1$I$$20240816$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131668$BRISTOL MYERS SQUIBB$$69$YR$E$$Y$$$20240820$$CN$US$US
242294491$24229449$1$I$$20240716$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN007354$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242294501$24229450$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168384$NOVARTIS$$$$$M$Y$$$20240820$$CN$US$US
242294512$24229451$2$F$$20240911$20240820$20240911$PER$$US-ALXN-202408USA000700US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
242294521$24229452$1$I$$20240812$20240820$20240820$EXP$$US-LEX-000434$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
242294532$24229453$2$F$$20240808$20240820$20240909$30DAY$$CA-VIIV HEALTHCARE LIMITED-US2024AMR102309$VIIV$$$$$M$Y$$$20240909$$CN$CA$US
242294541$24229454$1$I$$20230222$20240820$20240820$EXP$$CA-DSJP-DSJ-2022-146392$DAIICHI$$$$$F$Y$$$20240820$$MD$CA$CA
242294551$24229455$1$I$$20240812$20240820$20240820$EXP$$US-BAYER-2024A116395$BAYER$$31$YR$A$F$Y$$$20240820$$HP$US$US
242294561$24229456$1$I$20240701$20240809$20240820$20240820$PER$$US-SA-2024SA240253$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240820$$MD$US$US
242294571$24229457$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009839$ELI LILLY AND CO$$$$$M$Y$$$20240820$$CN$US$US
242294581$24229458$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA242482$SANOFI AVENTIS$$$$A$M$Y$$$20240820$$MD$US$US
242294591$24229459$1$I$20240701$20240813$20240820$20240820$EXP$$DE-ANIPHARMA-2024-DE-000106$ANI$$$$$F$Y$$$20240820$$CN$DE$DE
242294601$24229460$1$I$20240101$20240814$20240820$20240820$PER$$US-SA-2024SA244523$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240820$$MD$US$US
242294611$24229461$1$I$$20221226$20240820$20240820$EXP$$US-AstraZeneca-2022A418376$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242294621$24229462$1$I$$20220523$20240820$20240820$EXP$$CA-AstraZeneca-2022A151202$ASTRAZENECA$$$$$M$Y$$$20240820$$MD$CA$
242294631$24229463$1$I$20230330$20230406$20240820$20240820$EXP$$US-AstraZeneca-2023A083902$ASTRAZENECA$$19760$DY$$F$Y$$$20240820$$CN$US$
242294641$24229464$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57097$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242294651$24229465$1$I$$20240812$20240820$20240820$EXP$$CA-AstraZeneca-2024A186931$ASTRAZENECA$$71$YR$$F$Y$$$20240820$$MD$CA$
242294661$24229466$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57023$$FDA-CTU$$70$YR$$M$N$89.81$KG$20240819$N$$US$
242294671$24229467$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56973$$FDA-CTU$$63$YR$$M$N$$$20240819$N$$US$
242294681$24229468$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA240905$SANOFI AVENTIS$$$$A$M$Y$$$20240820$$MD$US$US
242294701$24229470$1$I$$20220805$20240820$20240820$EXP$$US-AstraZeneca-2022A246837$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242294712$24229471$2$F$20240815$20240820$20240820$20240824$PER$$US-AMGEN-USASP2024164684$AMGEN$$86$YR$E$F$Y$$$20240824$$CN$US$US
242294721$24229472$1$I$20220627$20240813$20240820$20240820$EXP$$FR-AstraZeneca-2024A184172$ASTRAZENECA$$78$YR$$M$Y$71.5$KG$20240820$$MD$FR$
242294731$24229473$1$I$$20240816$20240820$20240820$EXP$$US-OTSUKA-2024_022859$OTSUKA$$$$$M$Y$$$20240820$$HP$US$US
242294741$24229474$1$I$20240306$20240807$20240820$20240820$PER$$US-BAYER-2024A114565$BAYER$$$$$$Y$$$20240820$$HP$US$US
242294751$24229475$1$I$$20240816$20240819$20240819$DIR$FDA-CDER-CTU-2024-56994$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242294763$24229476$3$F$20240808$20240901$20240820$20240909$EXP$$HU-BAUSCH-BL-2024-012540$BAUSCH AND LOMB$$4$MON$$M$Y$4.3$KG$20240909$$MD$HU$HU
242294771$24229477$1$I$20190201$20240819$20240820$20240820$EXP$$DE-BAUSCH-BL-2024-012539$BAUSCH AND LOMB$$69$YR$$F$Y$$$20240820$$MD$DE$DE
242294781$24229478$1$I$$20240815$20240819$20240819$DIR$FDA-CDER-CTU-2024-56986$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242294791$24229479$1$I$$20240805$20240819$20240819$DIR$FDA-CDER-CTU-2024-56997$$FDA-CTU$$$$$M$N$$$20240805$N$HP$US$
242294801$24229480$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57095$$FDA-CTU$$84$YR$$F$N$$$20240819$N$$US$
242294812$24229481$2$F$20240812$20240820$20240820$20240823$EXP$$US-BAUSCH-BL-2024-012564$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240823$$CN$US$US
242294821$24229482$1$I$20240220$20240817$20240820$20240820$EXP$PL-URPL-DML-MLP.4401.1.174.2024$PL-BAUSCH-BL-2024-012492$BAUSCH AND LOMB$$50$YR$$M$Y$80$KG$20240820$$MD$PL$PL
242294831$24229483$1$I$$20240813$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159839$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242294841$24229484$1$I$$20240813$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159837$BIOMARIN$$$$$$Y$$$20240820$$HP$US$US
242294851$24229485$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56971$$FDA-CTU$$51$YR$$F$N$105.69$KG$20240819$N$$US$
242294861$24229486$1$I$$20240813$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159840$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242294871$24229487$1$I$$20240813$20240820$20240820$EXP$$US-BAUSCH-BL-2024-012310$BAUSCH AND LOMB$$$$$$Y$$$20240820$$PH$US$US
242294881$24229488$1$I$20240811$20240815$20240820$20240820$EXP$$US-SA-2024SA246025$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240820$$MD$US$US
242294891$24229489$1$I$20240801$20240815$20240820$20240820$EXP$$CO-SA-2024SA243961$SANOFI AVENTIS$$67$YR$E$F$Y$71$KG$20240820$$HP$CO$CO
242294901$24229490$1$I$$20221219$20240820$20240820$EXP$$US-AstraZeneca-2022A412077$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242294911$24229491$1$I$20240715$20240815$20240820$20240820$EXP$$FR-AstraZeneca-2024A186235$ASTRAZENECA$$59$YR$$F$Y$$$20240820$$MD$FR$
242294921$24229492$1$I$$20240817$20240820$20240820$EXP$$MX-AstraZeneca-2024A188766$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$MX$
242294931$24229493$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A185208$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242294941$24229494$1$I$$20240812$20240820$20240820$EXP$$US-TAKEDA-2024TUS081956$TAKEDA$Enstrom C, Gast S, Church L, Heflin MK, Moore C, Cook C, et al. Cardiogenic shock due to concomitant use of e-cigarettes and amphetamine/dextroamphetamine-associated cardiomyopathy. US Cardiology Review. 2024;18(1):2$29$YR$$M$Y$$$20240820$$HP$US$US
242294951$24229495$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA243013$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240820$$MD$US$US
242294961$24229496$1$I$$20240815$20240820$20240820$EXP$$CA-AstraZeneca-2024A187700$ASTRAZENECA$$80$YR$$M$Y$$$20240820$$MD$CA$
242294971$24229497$1$I$20240101$20240815$20240820$20240820$EXP$$US-SA-2024SA243985$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240820$$MD$US$US
242294981$24229498$1$I$$20240807$20240820$20240820$PER$$US-RDY-LIT/USA/24/0011821$DR REDDYS$Kane N, Rikard R, McCrory K, Marx AH. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels. Open Forum Infectious Diseases. 2023 Nov 27;10(2): S1108. doi:10.1093/ofid/ofad500.2163.$39$YR$A$F$Y$$$20240820$$PH$US$US
242294991$24229499$1$I$$20240807$20240820$20240820$PER$$US-RDY-LIT/USA/24/0011820$DR REDDYS$Kane N, Rikard R, McCrory K, Marx AH. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels. Open Forum Infectious Diseases. 2023 Nov 27;10(2): S1108. doi:10.1093/ofid/ofad500.2163.$29$YR$A$M$Y$$$20240820$$PH$US$US
242295001$24229500$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA243018$SANOFI AVENTIS$$$$E$F$Y$$$20240820$$MD$US$US
242295011$24229501$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242410$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242295021$24229502$1$I$$20240814$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012390$BAUSCH AND LOMB$$60$YR$$F$Y$$$20240820$$HP$CA$CA
242295031$24229503$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012544$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240820$$CN$CA$CA
242295041$24229504$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012556$BAUSCH AND LOMB$$63$YR$$M$Y$$$20240820$$CN$CA$CA
242295051$24229505$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012547$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240820$$CN$CA$CA
242295061$24229506$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012558$BAUSCH AND LOMB$$82$YR$$M$Y$$$20240820$$CN$CA$CA
242295071$24229507$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012569$BAUSCH AND LOMB$$82$YR$$F$Y$$$20240820$$CN$CA$CA
242295081$24229508$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012559$BAUSCH AND LOMB$$91$YR$$M$Y$$$20240820$$CN$CA$CA
242295093$24229509$3$F$20240716$20240828$20240820$20240830$EXP$$AU-MYLANLABS-2024M1074812$MYLAN$$29$YR$$M$Y$79$KG$20240830$$HP$AU$AU
242295101$24229510$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012570$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240820$$CN$CA$CA
242295111$24229511$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57008$$FDA-CTU$$46$YR$$F$N$$$20240819$N$HP$US$
242295121$24229512$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57012$$FDA-CTU$$63$YR$$F$N$$$20240819$N$$US$
242295131$24229513$1$I$$20240819$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US073871$SANDOZ$$$$$M$Y$$$20240820$$CN$US$US
242295141$24229514$1$I$20240101$20240820$20240820$20240820$PER$$US-GILEAD-2024-0684743$GILEAD$$36$YR$A$F$Y$$$20240820$$CN$US$US
242295161$24229516$1$I$$20240819$20240820$20240820$PER$$US-BAYER-2024A119132$BAYER$$$$$$Y$$$20240820$$CN$US$US
242295171$24229517$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012584$BAUSCH AND LOMB$$46$YR$$M$Y$$$20240820$$CN$CA$CA
242295191$24229519$1$I$$20240812$20240820$20240820$EXP$$US-TAKEDA-2024TUS082025$TAKEDA$Enstrom C, Gast S, Church L, Heflin MK, Moore C, Cook C, et al. Cardiogenic shock due to concomitant use of e-cigarettes and amphetamine/dextroamphetamine-associated cardiomyopathy. US Cardiology Review. 2024;18(1):2$25$YR$$M$Y$$$20240820$$HP$US$US
242295201$24229520$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57033$$FDA-CTU$$61$YR$$F$N$112.49$KG$20240819$N$$US$
242295211$24229521$1$I$$20240816$20240820$20240820$PER$$US-JNJFOC-20240843464$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$PH$US$US
242295221$24229522$1$I$20240807$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57055$$FDA-CTU$$71$YR$$M$N$$$20240819$Y$PH$US$
242295231$24229523$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56991$$FDA-CTU$$72$YR$$F$N$$$20240819$N$$US$
242295241$24229524$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168487$NOVARTIS$$$$$M$Y$$$20240820$$HP$US$US
242295251$24229525$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56975$$FDA-CTU$$62$YR$$F$N$$$20240819$N$$US$
242295261$24229526$1$I$$20240816$20240819$20240819$DIR$FDA-CDER-CTU-2024-57005$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242295271$24229527$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57075$$FDA-CTU$$67$YR$$M$N$$$20240819$N$$US$
242295281$24229528$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56992$$FDA-CTU$$74$YR$$F$N$58.97$KG$20240819$N$$US$
242295291$24229529$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57015$$FDA-CTU$$62$YR$$F$N$$$20240819$N$$US$
242295301$24229530$1$I$20240812$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57104$$FDA-CTU$$50$YR$$F$N$73$KG$20240819$N$HP$US$
242295311$24229531$1$I$$20240813$20240820$20240820$PER$$US-BAUSCH-BL-2024-012274$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240820$$HP$US$US
242295321$24229532$1$I$$20240813$20240820$20240820$PER$$US-BAUSCH-BL-2024-012323$BAUSCH AND LOMB$$87$YR$$M$Y$$$20240820$$MD$US$US
242295332$24229533$2$F$$20240912$20240820$20240919$PER$$US-BAUSCH-BL-2024-012459$BAUSCH AND LOMB$$82$YR$$F$Y$$$20240919$$CN$US$US
242295341$24229534$1$I$$20240731$20240820$20240820$PER$$US-TEVA-VS-3228998$TEVA$$37$YR$$F$Y$$$20240820$$CN$US$US
242295351$24229535$1$I$$20240816$20240820$20240820$PER$$US-BAUSCH-BL-2024-012457$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240820$$HP$US$US
242295361$24229536$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012541$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240820$$CN$CA$CA
242295381$24229538$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012543$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240820$$CN$CA$CA
242295391$24229539$1$I$20240101$20240813$20240820$20240820$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-130485$BRISTOL MYERS SQUIBB$$19$YR$A$M$Y$73$KG$20240820$$HP$BR$BR
242295401$24229540$1$I$$20240813$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128824$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240820$$HP$US$US
242295411$24229541$1$I$20230523$20240812$20240820$20240820$EXP$$CN-TAKEDA-2024TUS081567$TAKEDA$$75$YR$$M$Y$$$20240820$$HP$CN$CN
242295421$24229542$1$I$$20240812$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129079$BRISTOL MYERS SQUIBB$Soror NN, Hemrock L, Shah P, Loges RJ, Tharu B. Brain stem encephalitis in a patient with recurrent small cell lung cancer treated with immune checkpoint inhibitor: case presentation and review of the literature. Cureus. 2021 Jan 31;13(1):1-4. doi:10.7759/cureus.13034.$66$YR$E$F$Y$$$20240820$$HP$US$US
242295431$24229543$1$I$20240617$20240812$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128049$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240820$$HP$US$US
242295461$24229546$1$I$20240517$20240813$20240820$20240820$EXP$$CN-VIIV HEALTHCARE LIMITED-CN2024APC100933$VIIV$$$$$$Y$$$20240820$$HP$CN$CN
242295481$24229548$1$I$20240517$20240813$20240820$20240820$EXP$$CN-GSK-CN2024APC100933$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$HP$CN$CN
242295494$24229549$4$F$20240101$20240909$20240820$20240912$EXP$$ES-MYLANLABS-2024M1075906$MYLAN$$78$YR$$F$Y$40$KG$20240912$$CN$ES$ES
242295501$24229550$1$I$$20240814$20240820$20240820$EXP$$PT-ABBVIE-5883422$ABBVIE$Schon M., Rato ML., Fernandes SR., Correia LA., Ferreira J. CC-22- Rational therapy in multiple sclerosis overlap syndrome and inflammatory bowel disease. Sinapse. 2023;1(23):110-111.$28$YR$$F$Y$$$20240820$$HP$PT$PT
242295513$24229551$3$F$20231001$20240918$20240820$20240924$30DAY$$US-AMGEN-USASP2024162187$AMGEN$$66$YR$E$F$Y$59.9$KG$20240923$$CN$US$US
242295532$24229553$2$F$20170101$20240925$20240820$20240930$EXP$$US-BIOGEN-2024BI01278044$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
242295541$24229554$1$I$$20240813$20240820$20240820$PER$$US-BIOGEN-2024BI01278411$BIOGEN$$$$$F$Y$$$20240820$$CN$US$US
242295551$24229555$1$I$20240801$20240813$20240820$20240820$PER$$US-ABBVIE-5879444$ABBVIE$$$$$F$Y$$$20240820$$HP$US$US
242295561$24229556$1$I$$20240806$20240820$20240820$PER$$US-009507513-2408USA002160$MERCK$$$$$M$Y$$$20240820$$HP$US$US
242295571$24229557$1$I$$20240814$20240820$20240820$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-129375$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240820$$HP$ES$ES
242295581$24229558$1$I$$20240819$20240820$20240820$EXP$$CA-ROCHE-3415824$ROCHE$$$$$F$Y$$$20240820$$MD$CA$CA
242295592$24229559$2$F$$20240826$20240820$20240903$EXP$$IT-TEVA-VS-3233431$TEVA$Diral E, Furnari G, Bruno A, Greco R, Clerici D, Marktel S, et al. Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience. Front-Oncol 2024; 14.; Diral E, Furnari G, Bruno A, Greco R, Clerici D, Marktel S, et al. Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience. Front-Oncol 2024; 14.$$$$$Y$$$20240903$$HP$IT$IT
242295602$24229560$2$F$$20240816$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US073617$SANDOZ$$$$$F$Y$$$20240820$$PH$US$US
242295612$24229561$2$F$$20240902$20240820$20240912$EXP$$AE-LUNDBECK-DKLU4003112$LUNDBECK$$$$$$Y$$$20240912$$CN$AE$AE
242295621$24229562$1$I$$20240812$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128078$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$104.33$KG$20240820$$PH$US$US
242295631$24229563$1$I$20240101$20240813$20240820$20240820$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004528$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240820$$CN$US$US
242295642$24229564$2$F$20240724$20240815$20240820$20240822$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004125$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240822$$CN$US$US
242295651$24229565$1$I$20240816$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238751$PFIZER$$80$YR$$F$Y$$$20240820$$CN$US$US
242295661$24229566$1$I$20240814$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238694$PFIZER$$73$YR$$F$Y$$$20240820$$CN$US$US
242295671$24229567$1$I$20240816$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238695$PFIZER$$44$YR$$M$Y$$$20240820$$CN$US$US
242295681$24229568$1$I$20240814$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238734$PFIZER$$66$YR$$F$Y$$$20240820$$CN$US$US
242295691$24229569$1$I$20240802$20240809$20240820$20240820$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408006675$ELI LILLY AND CO$$75$YR$E$F$Y$36$KG$20240820$$CN$CN$CN
242295701$24229570$1$I$20240627$20240814$20240820$20240820$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408009407$ELI LILLY AND CO$$55$YR$A$F$Y$58$KG$20240820$$CN$CN$CN
242295711$24229571$1$I$20240729$20240816$20240820$20240820$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004105$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240820$$MD$CA$CA
242295721$24229572$1$I$$20240808$20240820$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006302$ELI LILLY AND CO$$$$A$F$Y$$$20240820$$CN$US$US
242295731$24229573$1$I$$20240808$20240820$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006639$ELI LILLY AND CO$$$$$$Y$$$20240820$$MD$US$US
242295741$24229574$1$I$$20240813$20240820$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008320$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240820$$CN$US$US
242295752$24229575$2$F$20240620$20240829$20240820$20240910$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408009876$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240910$$CN$JP$JP
242295761$24229576$1$I$20240730$20240809$20240820$20240820$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408008674$ELI LILLY AND CO$$62$YR$A$M$Y$59$KG$20240820$$CN$DE$CN
242295771$24229577$1$I$20240701$20240815$20240820$20240820$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004613$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240820$$CN$US$US
242295781$24229578$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56993$$FDA-CTU$$65$YR$$F$N$$$20240819$N$$US$
242295791$24229579$1$I$$20240817$20240819$20240819$DIR$FDA-CDER-CTU-2024-56996$$FDA-CTU$$$$$F$N$$$20240817$N$$US$
242295801$24229580$1$I$20240808$20240808$20240820$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005494$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242295811$24229581$1$I$$20240808$20240820$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005521$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$US$US
242295821$24229582$1$I$$20240814$20240820$20240820$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408009287$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$DE$DE
242295831$24229583$1$I$20240806$20240808$20240820$20240820$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408008660$ELI LILLY AND CO$$71$YR$E$M$Y$60$KG$20240820$$CN$DE$CN
242295841$24229584$1$I$20240201$20240814$20240820$20240820$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408009255$ELI LILLY AND CO$$$$$$Y$$$20240820$$CN$JP$JP
242295851$24229585$1$I$20240725$20240809$20240820$20240820$EXP$GR-GREOF-202400870$GR-ELI_LILLY_AND_COMPANY-GR202408006181$ELI LILLY AND CO$$27$YR$A$F$Y$53$KG$20240820$$CN$GR$GR
242295861$24229586$1$I$20240507$20240813$20240820$20240820$EXP$FR-AFSSAPS-AN2024001088$FR-ELI_LILLY_AND_COMPANY-FR202408008865$ELI LILLY AND CO$$77$YR$E$M$Y$65$KG$20240820$$CN$FR$FR
242295871$24229587$1$I$20240816$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238636$PFIZER$$72$YR$$M$Y$$$20240820$$CN$US$US
242295881$24229588$1$I$20240703$20240808$20240820$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202408005906$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$US$US
242295891$24229589$1$I$20240718$20240808$20240820$20240820$EXP$FR-AFSSAPS-GR2024000999$FR-ELI_LILLY_AND_COMPANY-FR202408005359$ELI LILLY AND CO$$20$YR$A$M$Y$70$KG$20240820$$CN$FR$FR
242295901$24229590$1$I$$20240819$20240820$20240820$PER$$US-PFIZER INC-202400239269$PFIZER$$$$$F$Y$$$20240820$$CN$US$US
242295911$24229591$1$I$20240817$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238631$PFIZER$$$$E$F$Y$$$20240820$$CN$US$US
242295921$24229592$1$I$20240815$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238627$PFIZER$$55$YR$$F$Y$$$20240820$$CN$US$US
242295931$24229593$1$I$20240818$20240818$20240820$20240820$PER$$US-PFIZER INC-202400238700$PFIZER$$58$YR$$M$Y$$$20240820$$CN$US$US
242295941$24229594$1$I$20240814$20240819$20240820$20240820$PER$$US-PFIZER INC-PV202400108420$PFIZER$$36$YR$$$Y$120.18$KG$20240820$$CN$US$US
242295953$24229595$3$F$20240817$20240908$20240820$20240910$PER$$US-PFIZER INC-202400238633$PFIZER$$74$YR$$F$Y$81.633$KG$20240910$$CN$US$US
242295961$24229596$1$I$20240101$20240807$20240820$20240820$EXP$$AU-UCBSA-2024039762$UCB$$$$$M$Y$$$20240820$$CN$AU$AU
242295971$24229597$1$I$$20240813$20240820$20240820$PER$$US-BIOGEN-2024BI01278193$BIOGEN$$$$$F$Y$$$20240820$$CN$US$US
242295981$24229598$1$I$$20240815$20240820$20240820$EXP$$CA-MYLANLABS-2024M1076853$MYLAN$$54$YR$$F$Y$$$20240820$$HP$CA$CA
242295992$24229599$2$F$$20240815$20240820$20240822$PER$$US-BIOGEN-2024BI01273026$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242296001$24229600$1$I$20240808$20240814$20240820$20240820$PER$$US-BIOGEN-2020BI00869573$BIOGEN$$38$YR$$F$Y$$$20240820$$CN$US$US
242296011$24229601$1$I$$20240711$20240820$20240820$PER$$US-BIOGEN-2024BI01278691$BIOGEN$$$$$$Y$$$20240820$$CN$US$US
242296023$24229602$3$F$20240101$20240828$20240820$20240902$EXP$$US-ABBVIE-5881250$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242296031$24229603$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131760$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240820$$CN$US$US
242296041$24229604$1$I$$20240819$20240820$20240820$EXP$$CA-ORGANON-O2408CAN001339$ORGANON$$65$YR$$F$Y$$$20240820$$HP$CA$CA
242296051$24229605$1$I$$20240813$20240820$20240820$EXP$$CA-HLS-202402084$HLS THERAPEUTICS$$$$A$F$Y$$$20240820$$MD$CA$CA
242296061$24229606$1$I$$20240704$20240820$20240820$PER$$US-LUNDBECK-DKLU4001288$LUNDBECK$$$$$$Y$$$20240820$$HP$US$US
242296071$24229607$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883563$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242296091$24229609$1$I$20231101$20240814$20240820$20240820$EXP$FR-AFSSAPS-RE2024000779$FR-MYLANLABS-2024M1075793$MYLAN$$62$YR$$F$Y$$$20240820$$HP$FR$FR
242296101$24229610$1$I$20240101$20240722$20240820$20240820$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000150$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240820$$CN$US$US
242296112$24229611$2$F$$20240822$20240820$20240827$EXP$$DE-GILEAD-2024-0684737$GILEAD$$58$YR$A$F$Y$$$20240827$$MD$DE$DE
242296121$24229612$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57002$$FDA-CTU$$55$YR$$F$N$$$20240819$N$$US$
242296131$24229613$1$I$20240801$20240816$20240820$20240820$EXP$$AU-ABBVIE-5884692$ABBVIE$$61$YR$$F$Y$$$20240820$$HP$AU$AU
242296141$24229614$1$I$20240101$20240805$20240820$20240820$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00318$Alora Pharma$$$$$F$Y$73.482$KG$20240820$$CN$US$US
242296151$24229615$1$I$20240101$20240813$20240820$20240820$EXP$$CA-JNJFOC-20240813204$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240820$$HP$CA$CA
242296161$24229616$1$I$20240723$20240813$20240820$20240820$EXP$$CN-ANIPHARMA-2024-CN-000329$ANI$$89$YR$$M$Y$47$KG$20240820$$HP$CN$CN
242296172$24229617$2$F$$20240821$20240820$20240826$EXP$$NVSC2024US168332$NOVARTIS$$$$$F$Y$$$20240826$$MD$US$US
242296181$24229618$1$I$20230911$20240430$20240820$20240820$PER$$US-MEITHEAL-2024MPREG00124$MEITHEAL PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
242296191$24229619$1$I$20220101$20240814$20240820$20240820$EXP$$US-ABBVIE-5881879$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242296201$24229620$1$I$20230801$20240814$20240820$20240820$EXP$$US-ABBVIE-5882192$ABBVIE$$48$YR$$F$Y$$$20240820$$CN$US$US
242296211$24229621$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57011$$FDA-CTU$$57$YR$$F$N$99.79$KG$20240819$N$$US$
242296221$24229622$1$I$20240818$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56989$$FDA-CTU$$68$YR$$F$N$101.6$KG$20240819$N$PH$US$
242296231$24229623$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57029$$FDA-CTU$$83$YR$$F$N$$$20240819$N$$US$
242296241$24229624$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57064$$FDA-CTU$$80$YR$$F$N$$$20240819$N$$US$
242296251$24229625$1$I$20240101$20240810$20240820$20240820$PER$$US-SA-2024SA204691$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240820$$MD$US$US
242296261$24229626$1$I$20240101$20240811$20240820$20240820$PER$$US-SA-2024SA241331$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240820$$MD$US$US
242296271$24229627$1$I$20240101$20240811$20240820$20240820$PER$$US-SA-2024SA241844$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240820$$MD$US$US
242296281$24229628$1$I$$20240802$20240820$20240820$PER$$US-Covis Pharma GmbH-2024COV00961$COVIS PHARMA$$$$$F$Y$65.58$KG$20240820$$CN$US$US
242296291$24229629$1$I$$20240813$20240820$20240820$EXP$$JP-AstraZeneca-2024A187313$ASTRAZENECA$Kakiuchi Y, et al. PP238 Efficacy and safety of combined immunotherapy for advanced small cell lung cancer in patients over 80 years old. The 64th Annual Meeting of the Japanese Respiratory Society 2024;$90$YR$$$Y$$$20240820$$MD$JP$
242296301$24229630$1$I$$20240813$20240820$20240820$EXP$$JP-AstraZeneca-2024A187319$ASTRAZENECA$Kakiuchi Y, et al. PP238 Efficacy and safety of combined immunotherapy for advanced small cell lung cancer in patients over 80 years old. The 64th Annual Meeting of the Japanese Respiratory Society 2024;$90$YR$$$Y$$$20240820$$MD$JP$
242296311$24229631$1$I$$20240813$20240820$20240820$EXP$$JP-AstraZeneca-2024A187317$ASTRAZENECA$Kakiuchi Y, et al. PP238 Efficacy and safety of combined immunotherapy for advanced small cell lung cancer in patients over 80 years old. The 64th Annual Meeting of the Japanese Respiratory Society 2024.$90$YR$$$Y$$$20240820$$MD$JP$
242296321$24229632$1$I$$20240722$20240820$20240820$PER$$US-Covis Pharma GmbH-2024COV00909$COVIS PHARMA$$71$YR$E$M$Y$$$20240820$$HP$US$US
242296331$24229633$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129545$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240820$$CN$US$US
242296341$24229634$1$I$$20240816$20240820$20240820$EXP$$NVSC2024IN167590$NOVARTIS$$65$YR$$M$Y$$$20240820$$MD$IN$IN
242296361$24229636$1$I$$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011235$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240820$$CN$US$US
242296371$24229637$1$I$$20240705$20240820$20240820$PER$$US-LUNDBECK-DKLU4001302$LUNDBECK$$$$$$Y$$$20240820$$HP$US$US
242296381$24229638$1$I$$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011868$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240820$$CN$US$US
242296391$24229639$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009676$ELI LILLY AND CO$$$$$M$Y$$$20240820$$CN$US$US
242296402$24229640$2$F$$20240821$20240820$20240826$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408010303$ELI LILLY AND CO$$72$YR$E$F$Y$56$KG$20240826$$CN$BR$BR
242296412$24229641$2$F$$20240924$20240820$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US073836$SANDOZ$$$$$F$Y$$$20240926$$CN$US$US
242296421$24229642$1$I$$20240813$20240820$20240820$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-140539$DAIICHI$$$$$F$Y$$$20240820$$MD$US$US
242296431$24229643$1$I$$20240813$20240820$20240820$EXP$$US-ABBVIE-5872787$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242296441$24229644$1$I$$20240813$20240820$20240820$PER$$US-009507513-2408USA005556$MERCK$$69$YR$$M$Y$$$20240820$$CN$US$US
242296451$24229645$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131362$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240820$$HP$US$US
242296461$24229646$1$I$$20240818$20240820$20240820$EXP$$NVSC2024US167591$NOVARTIS$$$$$$Y$$$20240820$$CN$US$US
242296472$24229647$2$F$20240816$20240903$20240820$20240904$EXP$$BR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004645$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240904$$HP$BR$BR
242296481$24229648$1$I$$20240813$20240820$20240820$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004515$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240820$$HP$US$US
242296491$24229649$1$I$20240101$20240723$20240820$20240820$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000151$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240820$$CN$US$US
242296501$24229650$1$I$$20240814$20240820$20240820$EXP$$IE-ABBVIE-5883467$ABBVIE$Grechin C, Doheny J, Pilson K, Howard D, Roche M. P006 Tumour necrosis factor- -induced lupus panniculitis: one case report and literature review. British Journal of Dermatology. 2024;191(Supplement1):i17$62$YR$$F$Y$$$20240820$$HP$IE$IE
242296511$24229651$1$I$20240101$20240806$20240820$20240820$PER$$US-MYLANLABS-2024M1074052$MYLAN$$$$$M$Y$$$20240820$$CN$US$US
242296521$24229652$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA241790$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240820$$MD$US$US
242296531$24229653$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56968$$FDA-CTU$$63$YR$$F$N$$$20240819$N$$US$
242296541$24229654$1$I$$20240816$20240820$20240820$EXP$$US-PURDUE PHARMA-USA-2024-0311426$PURDUE$$$$$F$Y$$$20240820$$MD$US$US
242296551$24229655$1$I$20161011$20240816$20240820$20240820$EXP$$US-PURDUE PHARMA-USA-2024-0311425$PURDUE$$53$YR$$M$Y$$$20240820$$MD$US$US
242296561$24229656$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56990$$FDA-CTU$$50$YR$$F$N$110.22$KG$20240819$N$HP$US$
242296572$24229657$2$F$20220216$20240831$20240820$20240904$EXP$$US-PURDUE PHARMA-USA-2024-0311448$PURDUE$$18$YR$$M$Y$$$20240904$$CN$US$US
242296581$24229658$1$I$20240101$20240814$20240820$20240820$EXP$$CN-PURDUE-USA-2024-0311399$PURDUE$$37$YR$$F$Y$$$20240820$$HP$CN$CN
242296601$24229660$1$I$20240101$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024162208$AMGEN$$58$YR$A$M$Y$$$20240820$$MD$US$US
242296611$24229661$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131384$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$86.64$KG$20240820$$HP$US$US
242296621$24229662$1$I$20240601$20240819$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131514$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240820$$CN$US$US
242296631$24229663$1$I$20240615$20240809$20240820$20240820$EXP$$CA-GILEAD-2024-0684517$GILEAD$$67$YR$E$M$Y$$$20240820$$CN$CA$CA
242296641$24229664$1$I$20240808$20240813$20240820$20240820$EXP$$CN-KARYOPHARM-2024KPT001454$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240820$$MD$CN$CN
242296651$24229665$1$I$$20240808$20240820$20240820$EXP$$US-GILEAD-2024-0663991$GILEAD$Spiegel J, Jain M, Nastoupil L, Tamaresis J., Ghobadi A., Lin Y., et al. Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium. Blood. 2023;142 supplement1:1032. doi:https://doi.org/10.1182/blood-2023-179868$$$A$$Y$$$20240820$$HP$US$US
242296661$24229666$1$I$$20240816$20240820$20240820$EXP$$GB-MYLANLABS-2024M1076638$MYLAN$$$$$F$Y$$$20240820$$CN$GB$GB
242296671$24229667$1$I$$20240816$20240820$20240820$PER$$US-PURDUE PHARMA-USA-2024-0311394$PURDUE$$44$YR$$F$Y$$$20240820$$CN$US$US
242296681$24229668$1$I$$20240819$20240820$20240820$PER$$US-PURDUE PHARMA-USA-2024-0311439$PURDUE$$$$$M$Y$$$20240820$$PH$US$US
242296691$24229669$1$I$$20240816$20240820$20240820$PER$$US-PURDUE PHARMA-USA-2024-0311393$PURDUE$$35$YR$$$Y$$$20240820$$CN$US$US
242296701$24229670$1$I$20221020$20240815$20240820$20240820$PER$$US-PURDUE PHARMA-USA-2024-0311365$PURDUE$$$$$M$Y$$$20240820$$CN$US$US
242296711$24229671$1$I$$20240819$20240820$20240820$PER$$US-PURDUE PHARMA-USA-2024-0311440$PURDUE$$$$$M$Y$$$20240820$$PH$US$US
242296721$24229672$1$I$20221005$20240808$20240820$20240820$PER$$US-KARYOPHARM-2024KPT001416$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240820$$CN$US$US
242296732$24229673$2$F$$20240819$20240820$20240822$PER$$US-JNJFOC-20240846694$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$US$US
242296753$24229675$3$F$20240101$20240920$20240820$20240922$PER$$US-JNJFOC-20240836496$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240922$$CN$US$US
242296762$24229676$2$F$$20240819$20240820$20240829$PER$$US-BIOMARINAP-US-2024-159844$BIOMARIN$$$$$$Y$$$20240829$$CN$US$US
242296771$24229677$1$I$$20240813$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159861$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242296781$24229678$1$I$$20240813$20240820$20240820$EXP$$JP-AstraZeneca-2024A187314$ASTRAZENECA$Kakiuchi Y, et al. . PP238 Efficacy and safety of combined immunotherapy for advanced small cell lung cancer in patients over 80 years old. The 64th Annual Meeting of the Japanese Respiratory Society 2024;$90$YR$$$Y$$$20240820$$MD$JP$
242296791$24229679$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A180744$ASTRAZENECA$$$$$F$Y$$$20240820$$CN$US$
242296801$24229680$1$I$$20240808$20240820$20240820$EXP$$US-GILEAD-2024-0684073$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240820$$MD$US$US
242296813$24229681$3$F$$20240821$20240820$20240829$EXP$$KR-INCYTE CORPORATION-2024IN007768$INCYTE$$$$$$Y$$$20240829$$CN$KR$KR
242296821$24229682$1$I$$20240802$20240820$20240820$PER$$US-TEVA-VS-3230879$TEVA$$$$$M$Y$$$20240820$$CN$US$US
242296831$24229683$1$I$$20240729$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN007923$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242296841$24229684$1$I$$20240808$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126623$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$62.14$KG$20240820$$PH$US$US
242296851$24229685$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57007$$FDA-CTU$$68$YR$$F$N$115.21$KG$20240819$N$$US$
242296861$24229686$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-57009$$FDA-CTU$$70$YR$$M$N$350$LBS$20240819$N$$US$
242296871$24229687$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56979$$FDA-CTU$$71$YR$$F$N$84.82$KG$20240819$N$$US$
242296881$24229688$1$I$20240815$20240815$20240820$20240820$PER$$US-JNJFOC-20240840189$JOHNSON AND JOHNSON$$75$YR$E$$Y$$$20240820$$PH$US$US
242296892$24229689$2$F$20130204$20240918$20240820$20240924$EXP$$BR-TAKEDA-2024TUS082659$TAKEDA$$40$YR$$F$Y$$$20240924$$CN$BR$BR
242296902$24229690$2$F$20240101$20240820$20240820$20240824$EXP$$US-ABBVIE-5882182$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242296911$24229691$1$I$$20240808$20240820$20240820$PER$$US-TAKEDA-2024TUS079931$TAKEDA$$$$$F$Y$133$KG$20240820$$MD$US$US
242296921$24229692$1$I$$20240729$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN007925$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242296931$24229693$1$I$$20240808$20240820$20240820$EXP$$US-GILEAD-2024-0684074$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240820$$MD$US$US
242296942$24229694$2$F$$20240729$20240820$20240828$PER$$US-INCYTE CORPORATION-2024IN007930$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242296952$24229695$2$F$$20240820$20240820$20240826$EXP$$GB-SANDOZ INC.-NVSC2020GB259159$SANDOZ$$$$$M$Y$$$20240826$$CN$GB$GB
242296962$24229696$2$F$$20240821$20240820$20240822$EXP$$GB-PFIZER INC-202400238871$PFIZER$$45$YR$$F$Y$$$20240822$$CN$GB$GB
242296971$24229697$1$I$20240101$20240816$20240820$20240820$EXP$$CA-PFIZER INC-202400239126$PFIZER$$61$YR$$F$Y$$$20240820$$HP$CA$CA
242296981$24229698$1$I$20231031$20240815$20240820$20240820$PER$$US-GILEAD-2024-0684353$GILEAD$$54$YR$A$M$Y$99.8$KG$20240820$$HP$US$US
242296991$24229699$1$I$$20240815$20240820$20240820$EXP$$GB-PFIZER INC-202400237305$PFIZER$$10$MON$$M$Y$$$20240820$$MD$GB$GB
242297001$24229700$1$I$$20240808$20240820$20240820$EXP$$US-GILEAD-2024-0684072$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240820$$MD$US$US
242297011$24229701$1$I$$20240814$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010117$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240820$$CN$US$US
242297021$24229702$1$I$$20240816$20240820$20240820$PER$$US-DSJP-DSU-2024-141052$DAIICHI$$$$$M$Y$$$20240820$$HP$US$US
242297031$24229703$1$I$20240807$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408010369$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240820$$CN$US$US
242297051$24229705$1$I$$20240413$20240820$20240820$PER$$AP-2024-US-5863$AILEX PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
242297061$24229706$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130695$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240820$$CN$US$US
242297072$24229707$2$F$20240819$20240909$20240820$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131807$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240913$$MD$US$US
242297091$24229709$1$I$20240101$20240812$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US073847$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
242297101$24229710$1$I$20240708$20240814$20240820$20240820$EXP$$NVSC2024US166383$NOVARTIS$$57$YR$$F$Y$65.76$KG$20240820$$CN$US$US
242297111$24229711$1$I$$20240808$20240820$20240820$EXP$$US-GILEAD-2024-0684075$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240820$$MD$US$US
242297121$24229712$1$I$$20240815$20240820$20240820$PER$$US-ABBVIE-5884090$ABBVIE$$$$$F$Y$$$20240820$$HP$US$US
242297131$24229713$1$I$20240801$20240812$20240820$20240820$PER$$US-SA-2024SA243885$SANOFI AVENTIS$$$$A$M$Y$$$20240820$$MD$US$US
242297141$24229714$1$I$$20240819$20240820$20240820$PER$$US-PFIZER INC-202400239242$PFIZER$$65$YR$$F$Y$$$20240820$$CN$US$US
242297151$24229715$1$I$20240809$20240816$20240820$20240820$PER$$US-PFIZER INC-202400239426$PFIZER$$58$YR$$F$Y$$$20240820$$HP$US$US
242297161$24229716$1$I$$20240819$20240820$20240820$EXP$$US-GILEAD-2024-0684710$GILEAD$$64$YR$A$M$Y$$$20240820$$HP$US$US
242297172$24229717$2$F$$20240829$20240820$20240909$EXP$$JP-AMGEN-JPNSP2024144218$AMGEN$$7$DEC$E$F$Y$$$20240909$$PH$JP$JP
242297181$24229718$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57117$$FDA-CTU$$40$YR$$F$N$90.72$KG$20240820$N$$US$
242297191$24229719$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA242207$SANOFI AVENTIS$$$$A$F$Y$66.6$KG$20240820$$MD$US$US
242297224$24229722$4$F$$20240917$20240820$20240923$PER$$US-PFIZER INC-PV202400106187$PFIZER$$30$YR$$M$Y$$$20240923$$HP$US$US
242297231$24229723$1$I$20240809$20240816$20240820$20240820$EXP$$US-ABBVIE-5885060$ABBVIE$$67$YR$$M$Y$$$20240820$$CN$US$US
242297241$24229724$1$I$$20240808$20240820$20240820$EXP$$US-GILEAD-2024-0684076$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240820$$MD$US$US
242297252$24229725$2$F$$20240829$20240820$20240903$30DAY$$US-MYLANLABS-2024M1074430$MYLAN$$$$$F$Y$$$20240903$$PH$US$US
242297262$24229726$2$F$$20240829$20240820$20240903$30DAY$$US-MYLANLABS-2024M1075439$MYLAN$$$$$M$Y$$$20240903$$CN$US$US
242297272$24229727$2$F$20240812$20240918$20240820$20240923$30DAY$$US-MYLANLABS-2024M1076103$MYLAN$$7$YR$$M$Y$$$20240923$$CN$US$US
242297283$24229728$3$F$20240801$20240919$20240820$20240924$30DAY$$CZ-MYLANLABS-2024M1075452$MYLAN$$$$$F$Y$$$20240924$$CN$CZ$CZ
242297291$24229729$1$I$$20240818$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131276$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$64.86$KG$20240820$$CN$US$US
242297301$24229730$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130374$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240820$$CN$US$US
242297311$24229731$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131042$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240820$$HP$US$US
242297321$24229732$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130811$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240820$$CN$US$US
242297331$24229733$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131216$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240820$$CN$US$US
242297342$24229734$2$F$20240802$20240905$20240820$20240906$EXP$FR-AFSSAPS-MP2024001302$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-131364$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$58.5$KG$20240906$$PH$FR$FR
242297351$24229735$1$I$$20240817$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131023$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$96.16$KG$20240820$$CN$US$US
242297363$24229736$3$F$$20240917$20240820$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131324$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$102.06$KG$20240919$$CN$US$US
242297371$24229737$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131061$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240820$$HP$US$US
242297381$24229738$1$I$20240101$20240814$20240820$20240820$PER$$US-SA-2024SA244053$SANOFI AVENTIS$$6$WK$I$$Y$$$20240820$$MD$US$US
242297391$24229739$1$I$$20240812$20240820$20240820$EXP$$HU-AMGEN-HUNSP2024161360$AMGEN$Molnar T.; Farkas B.; Bacsur P. et al.. Therapeutic challenges in difficult-to-treat, penetrating Crohn^s disease - a multidisciplinary approach. ORVOSI HETILAP. 2024;165(32):1252-1257$20$YR$A$F$Y$$$20240820$$MD$HU$HU
242297401$24229740$1$I$20240801$20240815$20240820$20240820$EXP$$AR-ABBVIE-5883952$ABBVIE$$66$YR$$F$Y$$$20240820$$CN$AR$AR
242297411$24229741$1$I$$20240815$20240820$20240820$PER$$US-ALXN-202408USA000972US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$US$US
242297421$24229742$1$I$$20240813$20240820$20240820$EXP$$US-SAMSUNG BIOEPIS-SB-2024-25089$SAMSUNG BIOEPIS$$$$$M$Y$$$20240820$$CN$US$US
242297431$24229743$1$I$20240620$20240816$20240820$20240820$EXP$$US-ABBVIE-5884229$ABBVIE$$56$YR$$M$Y$$$20240820$$CN$US$US
242297441$24229744$1$I$20240101$20240803$20240820$20240820$PER$$US-009507513-2408USA001609$MERCK$$$$$M$Y$$$20240820$$MD$US$US
242297452$24229745$2$F$$20240821$20240820$20240905$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-25061$SAMSUNG BIOEPIS$$77$YR$E$F$Y$$$20240905$$CN$GB$GB
242297462$24229746$2$F$20240729$20240819$20240820$20240828$PER$$US-Eisai-EC-2024-171616$EISAI$$82$YR$E$M$Y$100$KG$20240828$$MD$US$US
242297471$24229747$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130904$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240820$$CN$US$US
242297482$24229748$2$F$$20240826$20240820$20240904$EXP$$DE-TEVA-VS-3233437$TEVA$Zielinski N, Baiceanu D, Dragomir A, Heyckendorf J, Ibraim E, Kohler N, et al. A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis. Pathog-Immun 2024; 9 (2): 25-42.; Zielinski N, Baiceanu D, Dragomir A, Heyckendorf J, Ibraim E, Kohler N, et al. A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis. Pathog-Immun 2024; 9 (2): 25-42.; Zielinski N, Baiceanu D, Dragomir...$$$A$$Y$$$20240904$$HP$DE$DE
242297492$24229749$2$F$$20240815$20240820$20240826$EXP$$US-BAUSCH-BL-2024-012440$BAUSCH AND LOMB$$46$YR$$F$Y$$$20240826$$CN$US$US
242297501$24229750$1$I$$20240812$20240820$20240820$EXP$$IE-SAMSUNG BIOEPIS-SB-2024-25075$SAMSUNG BIOEPIS$Grechin C, Doheny J, Pilson K. Tumour necrosis factor-alpha-induced lupus panniculitis: one case report and literature review. British Journal of Dermatology. 2024 JUN 28;1:I17. doi:doi.org/10.1093/bjd/ljae090.033$62$YR$A$F$Y$$$20240820$$MD$IE$IE
242297511$24229751$1$I$$20240813$20240820$20240820$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24970$SAMSUNG BIOEPIS$$52$YR$A$F$Y$$$20240820$$CN$GB$GB
242297521$24229752$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012537$BAUSCH AND LOMB$$81$YR$$F$Y$$$20240820$$CN$CA$CA
242297531$24229753$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012590$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240820$$HP$CA$CA
242297541$24229754$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012549$BAUSCH AND LOMB$$51$YR$$F$Y$$$20240820$$CN$CA$CA
242297551$24229755$1$I$$20240819$20240820$20240820$EXP$$CA-BAUSCH-BL-2024-012600$BAUSCH AND LOMB$$82$YR$$M$Y$$$20240820$$CN$CA$CA
242297561$24229756$1$I$20240801$20240816$20240820$20240820$EXP$$US-ABBVIE-5884509$ABBVIE$$56$YR$$F$Y$$$20240820$$CN$US$US
242297571$24229757$1$I$$20240814$20240820$20240820$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408009899$ELI LILLY AND CO$$$$$F$Y$$$20240820$$CN$CN$CN
242297581$24229758$1$I$20230913$20240812$20240820$20240820$EXP$$CN-BAUSCH-BL-2024-012202$BAUSCH AND LOMB$Kou X, An D. A 48-year-old man with fever, nauseous, vomiting, and dizzy: A CARE case report. Medicine. 2024;103(31):1-7. doi:10.1097/MD.0000000000039015$48$YR$$M$Y$$$20240820$$MD$CN$CN
242297591$24229759$1$I$20240803$20240813$20240820$20240820$PER$$US-BAUSCH-BL-2024-012322$BAUSCH AND LOMB$$59$YR$$M$Y$87$KG$20240820$$CN$US$US
242297601$24229760$1$I$20240101$20240808$20240820$20240820$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408005252$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240820$$CN$DE$DE
242297611$24229761$1$I$$20240808$20240820$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006206$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240820$$CN$US$US
242297621$24229762$1$I$20240714$20240808$20240820$20240820$EXP$FR-AFSSAPS-GR2024000998$FR-ELI_LILLY_AND_COMPANY-FR202408005366$ELI LILLY AND CO$$21$YR$A$M$Y$75.5$KG$20240820$$CN$FR$FR
242297631$24229763$1$I$$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011887$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240820$$HP$US$US
242297641$24229764$1$I$$20240808$20240820$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006144$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240820$$CN$US$US
242297651$24229765$1$I$$20240808$20240820$20240820$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006394$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240820$$CN$US$US
242297661$24229766$1$I$20240611$20240814$20240820$20240820$EXP$FR-AFSSAPS-MP2024001265$FR-009507513-2408FRA005213$MERCK$$62$YR$$F$Y$$$20240820$$HP$FR$FR
242297671$24229767$1$I$20240425$20240812$20240820$20240820$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-09678$SAMSUNG BIOEPIS$$61$YR$A$M$Y$74$KG$20240820$$CN$CA$CA
242297691$24229769$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57284$$FDA-CTU$$65$YR$$F$N$$$20240820$N$$US$
242297711$24229771$1$I$20240815$20240815$20240820$20240820$PER$$US-JNJFOC-20240839028$JOHNSON AND JOHNSON$$33$YR$A$$Y$$$20240820$$PH$US$US
242297721$24229772$1$I$20240801$20240812$20240820$20240820$EXP$$CN-AstraZeneca-2024A187419$ASTRAZENECA$$13$YR$$F$Y$42$KG$20240820$$MD$CN$
242297731$24229773$1$I$20200827$20240817$20240820$20240820$EXP$$US-SANDOZ INC.-NVSC2020US107034$SANDOZ$$37$YR$$F$Y$76.19$KG$20240820$$PH$US$US
242297745$24229774$5$F$20231028$20240911$20240820$20240916$EXP$$NVSC2023BR264316$NOVARTIS$$49$YR$$F$Y$$$20240916$$CN$BR$BR
242297751$24229775$1$I$$20240811$20240820$20240820$EXP$$LB-AMGEN-LBNSP2024162465$AMGEN$Tlaiss Y.; Farhat H.; Hasan F. et al.. Complex Presentation of Multicentric Castleman Disease with Coexisting HIV, HHV-8, and Other Opportunistic Infections. Case Reports in Hematology. 2024;1-4$43$YR$A$M$Y$$$20240820$$HP$LB$LB
242297763$24229776$3$F$$20240829$20240820$20240923$PER$$US-SA-2024SA240543$SANOFI AVENTIS$$$$A$M$Y$86.36$KG$20240923$$MD$US$US
242297771$24229777$1$I$$20240808$20240820$20240820$PER$$US-SA-2024SA240706$SANOFI AVENTIS$$$$A$F$Y$$$20240820$$MD$US$US
242297781$24229778$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA243434$SANOFI AVENTIS$$$$C$F$Y$$$20240820$$MD$US$US
242297791$24229779$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA240492$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240820$$MD$US$US
242297801$24229780$1$I$$20240807$20240820$20240820$PER$$US-SA-2024SA237853$SANOFI AVENTIS$$$$E$F$Y$$$20240820$$MD$US$US
242297811$24229781$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241462$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240820$$MD$US$US
242297831$24229783$1$I$$20240813$20240820$20240820$EXP$$US-JNJFOC-20240833842$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240820$$HP$US$US
242297841$24229784$1$I$$20240814$20240820$20240820$PER$$US-JNJFOC-20240838735$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$US$US
242297851$24229785$1$I$$20240816$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2023CA019868$SANDOZ$$$$$M$Y$$$20240820$$CN$CA$CA
242297871$24229787$1$I$$20240814$20240820$20240820$PER$$US-SA-2024SA244063$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240820$$HP$US$US
242297881$24229788$1$I$$20240808$20240820$20240820$EXP$$US-GILEAD-2024-0684077$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240820$$MD$US$US
242297891$24229789$1$I$$20240814$20240820$20240820$30DAY$$KR-PFIZER INC-PV202400106221$PFIZER$$10$YR$$F$Y$$$20240820$$HP$KR$KR
242297901$24229790$1$I$$20240808$20240820$20240820$EXP$$US-GILEAD-2024-0684088$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240820$$MD$US$US
242297911$24229791$1$I$20231202$20240812$20240820$20240820$EXP$FR-AFSSAPS-ST2024001276$FR-TEVA-VS-3233317$TEVA$$68$YR$$M$Y$72$KG$20240820$$MD$FR$FR
242297923$24229792$3$F$20240101$20240830$20240820$20240905$EXP$$US-009507513-2408USA005263$MERCK$$$$$M$Y$73.923$KG$20240905$$HP$US$US
242297932$24229793$2$F$$20240821$20240820$20240827$EXP$$US-ABBVIE-5884768$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242297942$24229794$2$F$20240701$20240820$20240820$20240827$EXP$$US-ABBVIE-5883297$ABBVIE$$42$YR$$F$Y$72$KG$20240827$$CN$US$US
242297951$24229795$1$I$$20240812$20240820$20240820$EXP$FR-EMA-DD-20240806-7482645-120819$NVSC2024FR168262$NOVARTIS$Feuillet S, Meignin V, Briere J, Brice P, Rocha V, Socie G et al.. Endobronchial epstein-barr virus associated posttransplant lymphoproliferative disorder in hematopoietic stem cell transplantation. CLIN-MED-CASE-REP 2009. 2009;2:11-5$39$YR$$M$Y$$$20240820$$HP$FR$FR
242297961$24229796$1$I$$20240808$20240820$20240820$EXP$$US-GILEAD-2024-0684089$GILEAD$Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y et al. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.. Journal of Clinical Oncology. 2024;Unk:Unk. doi:10.1200/JCO.23.02786$$$A$$Y$$$20240820$$MD$US$US
242297982$24229798$2$F$20240101$20240912$20240820$20240923$EXP$$US-BAUSCHBL-2024BNL031808$BAUSCH AND LOMB$$76$YR$$F$Y$59$KG$20240923$$CN$US$US
242298001$24229800$1$I$20240816$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57110$$FDA-CTU$$58$YR$$M$N$101.7$KG$20240819$N$$US$
242298021$24229802$1$I$20240712$20240813$20240820$20240820$EXP$HR-HALMEDAPP-202407131817338570-KSBGP$HR-TEVA-VS-3233453$TEVA$$51$YR$$F$Y$$$20240820$$PH$HR$HR
242298032$24229803$2$F$$20240827$20240820$20240906$EXP$$DE-TEVA-VS-3234128$TEVA$Jansen N, Wulff L, Conty M, Schabitz W-R, Klingebiel R. CHANTER syndrome in the context of pain medication: a case report. BMC-Neurol 2024; 24 (1):.; Jansen N, Wulff L, Conty M, Schabitz W-R, Klingebiel R. CHANTER syndrome in the context of pain medication: a case report. BMC-Neurol 2024; 24 (1):.$62$YR$$M$Y$$$20240906$$HP$DE$DE
242298042$24229804$2$F$$20240822$20240820$20240823$EXP$$GB-LABORATORIOS LICONSA S.A.-2407GB06455$INSUD PHARMA$Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP. A case of human T-lymphotropic virus-1-associated lichenoid dermatitis.. Clinical and Experimental Dermatology. 2024;49(8):916-18$61$YR$$F$Y$$$20240823$$MD$GB$GB
242298051$24229805$1$I$$20240811$20240820$20240820$PER$$NVSC2024US165602$NOVARTIS$$$$$$Y$$$20240820$$CN$US$US
242298062$24229806$2$F$20240815$20240826$20240820$20240828$PER$$US-AMGEN-USASP2024164268$AMGEN$$63$YR$A$F$Y$$$20240828$$MD$US$US
242298071$24229807$1$I$20240105$20240812$20240820$20240820$EXP$FR-AFSSAPS-NT2024001000$FR-TEVA-VS-3233247$TEVA$$35$YR$$F$Y$$$20240820$$MD$FR$FR
242298091$24229809$1$I$$20240815$20240820$20240820$EXP$$CA-GILEAD-2024-0684574$GILEAD$$$$A$F$Y$$$20240820$$CN$CA$CA
242298103$24229810$3$F$20240720$20240819$20240820$20240927$EXP$$US-Eisai-EC-2024-170709$EISAI$$81$YR$E$F$Y$$$20240927$$HP$US$US
242298111$24229811$1$I$$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130595$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240820$$PH$US$US
242298121$24229812$1$I$20210201$20240819$20240820$20240820$EXP$$CA-PFIZER INC-2021201216$PFIZER$$76$YR$$M$Y$$$20240820$$CN$CA$CA
242298131$24229813$1$I$$20240819$20240820$20240820$EXP$$CA-PFIZER INC-202400239320$PFIZER$$50$YR$$M$Y$68$KG$20240820$$HP$CA$CA
242298141$24229814$1$I$20240701$20240812$20240820$20240820$PER$$US-ABBVIE-5878075$ABBVIE$$35$YR$$F$Y$60$KG$20240820$$MD$US$US
242298151$24229815$1$I$$20240808$20240820$20240820$PER$$US-009507513-2408USA003781$MERCK$$$$$M$Y$$$20240820$$CN$US$US
242298162$24229816$2$F$20240807$20240820$20240820$20240830$EXP$$CO-VER-202400006$VERITY PHARMACEUTICALS$$9$YR$C$F$Y$$$20240830$$CN$CO$CO
242298171$24229817$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131147$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240820$$CN$US$US
242298181$24229818$1$I$20240712$20240816$20240820$20240820$EXP$$US-ABBVIE-5884875$ABBVIE$$59$YR$$M$Y$$$20240820$$CN$US$US
242298191$24229819$1$I$20240512$20240812$20240820$20240820$EXP$ES-AEMPS-1557515$ES-TEVA-VS-3233159$TEVA$$66$YR$$M$Y$$$20240820$$HP$ES$ES
242298201$24229820$1$I$20240814$20240814$20240820$20240820$EXP$$US-JNJFOC-20240838934$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240820$$MD$US$US
242298211$24229821$1$I$20240813$20240813$20240820$20240820$EXP$$US-ABBVIE-5879762$ABBVIE$$64$YR$$F$Y$$$20240820$$CN$US$US
242298221$24229822$1$I$20240101$20240812$20240820$20240820$EXP$$US-ALKERMES INC.-ALK-2024-002154$ALKERMES$$$$$M$Y$$$20240820$$CN$US$US
242298232$24229823$2$F$20240813$20240830$20240820$20240909$30DAY$$US-ALKERMES INC.-ALK-2024-002157$ALKERMES$$$$$$Y$$$20240909$$HP$US$US
242298242$24229824$2$F$20240701$20240815$20240820$20240830$EXP$$NVSC2024AR146638$NOVARTIS$$58$YR$$F$Y$$$20240830$$CN$AR$AR
242298251$24229825$1$I$$20240812$20240820$20240820$EXP$$US-ALKERMES INC.-ALK-2024-002129$ALKERMES$$$$$M$Y$$$20240820$$HP$US$US
242298261$24229826$1$I$20240808$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-56966$$FDA-CTU$$65$YR$$M$N$101.5$KG$20240819$N$$US$
242298272$24229827$2$F$20240701$20240814$20240820$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408009714$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240822$$CN$US$US
242298282$24229828$2$F$20141125$20240820$20240820$20240823$EXP$$US-ABBVIE-5884376$ABBVIE$$16$YR$$F$Y$$$20240823$$CN$US$US
242298291$24229829$1$I$20240616$20240812$20240820$20240820$EXP$ES-AEMPS-1556395$ES-TEVA-VS-3233333$TEVA$$77$YR$$F$Y$$$20240820$$MD$ES$ES
242298301$24229830$1$I$20240627$20240814$20240820$20240820$EXP$$CN-009507513-2408CHN005594$MERCK$$55$YR$$F$Y$58$KG$20240820$$HP$CN$CN
242298311$24229831$1$I$20240501$20240813$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408008937$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240820$$CN$US$US
242298321$24229832$1$I$$20240815$20240820$20240820$EXP$$CA-MYLANLABS-2024M1076422$MYLAN$$30$YR$$M$Y$$$20240820$$HP$CA$CA
242298331$24229833$1$I$20240815$20240819$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131411$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240820$$CN$US$US
242298341$24229834$1$I$20240814$20240814$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130192$BRISTOL MYERS SQUIBB$$31$YR$A$M$Y$$$20240820$$CN$US$US
242298351$24229835$1$I$20240515$20240816$20240820$20240820$EXP$$US-ABBVIE-5884937$ABBVIE$$61$YR$$M$Y$$$20240820$$CN$US$US
242298361$24229836$1$I$20240731$20240814$20240820$20240820$EXP$SE-SEMPA-2024-006054$SE-NALPROPION PHARMACEUTICALS INC.-SE-2024CUR003806$CURRAX PHARMACEUTICALS$$26$YR$$F$Y$$$20240820$$MD$SE$SE
242298371$24229837$1$I$20220101$20240814$20240820$20240820$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2022CUR022821$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240820$$CN$CA$CA
242298381$24229838$1$I$20240516$20240819$20240820$20240820$PER$$NVSC2024US168489$NOVARTIS$$57$YR$$F$Y$$$20240820$$HP$US$US
242298391$24229839$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA242866$SANOFI AVENTIS$$$$A$M$Y$76.65$KG$20240820$$MD$US$US
242298421$24229842$1$I$$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57260$$FDA-CTU$$$$$M$N$$$20240819$N$HP$US$
242298431$24229843$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243470$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240820$$MD$US$US
242298441$24229844$1$I$20240801$20240813$20240820$20240820$PER$$US-SA-2024SA244437$SANOFI AVENTIS$$39$YR$A$M$Y$94.9$KG$20240820$$MD$US$US
242298451$24229845$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243487$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240820$$MD$US$US
242298461$24229846$1$I$20240801$20240812$20240820$20240820$PER$$US-SA-2024SA241865$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240820$$MD$US$US
242298471$24229847$1$I$$20240813$20240820$20240820$PER$$US-SA-2024SA243197$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240820$$MD$US$US
242298481$24229848$1$I$20230705$20240812$20240820$20240820$PER$$US-SA-2024SA241134$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240820$$CN$US$US
242298491$24229849$1$I$20240101$20240813$20240820$20240820$PER$$US-SA-2024SA243883$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240820$$MD$US$US
242298501$24229850$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5884998$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242298512$24229851$2$F$20240715$20240909$20240820$20240911$EXP$FR-AFSSAPS-CF2024000417$FR-009507513-2408FRA005423$MERCK$$64$YR$$M$Y$57$KG$20240911$$PH$FR$FR
242298531$24229853$1$I$$20240815$20240820$20240820$EXP$$US-Taiho Oncology Inc-2024-000683$TAIHO ONCOLOGY INC$$$$A$M$Y$$$20240820$$CN$US$US
242298541$24229854$1$I$20240701$20240820$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046733$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240820$$CN$US$US
242298551$24229855$1$I$$20240815$20240820$20240820$EXP$$CA-PFIZER INC-2020314601$MYLAN$$$$$M$Y$$$20240820$$HP$CA$CA
242298561$24229856$1$I$$20240722$20240820$20240820$PER$$US-JNJFOC-20240849291$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240820$$HP$US$US
242298571$24229857$1$I$$20240807$20240820$20240820$PER$$US-JNJFOC-20240842428$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240820$$HP$US$US
242298582$24229858$2$F$$20240905$20240820$20240905$PER$$US-ALXN-202408USA000974US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242298591$24229859$1$I$$20240815$20240820$20240820$EXP$$CA-MYLANLABS-2024M1076926$MYLAN$$60$YR$$M$Y$$$20240820$$CN$CA$CA
242298601$24229860$1$I$20240719$20240814$20240820$20240820$EXP$FR-AFSSAPS-TS2024000892$FR-MYLANLABS-2024M1075768$MYLAN$$78$YR$$F$Y$52$KG$20240820$$MD$FR$FR
242298611$24229861$1$I$20240812$20240813$20240820$20240820$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-013009$JAZZ$$15$YR$$M$Y$$$20240820$$MD$JP$JP
242298622$24229862$2$F$$20240822$20240820$20240826$EXP$$DE-GILEAD-2024-0684741$GILEAD$$$$$F$Y$$$20240826$$MD$DE$DE
242298631$24229863$1$I$$20240815$20240820$20240820$PER$$US-PFIZER INC-202400237442$PFIZER$$$$$F$Y$$$20240820$$CN$US$US
242298641$24229864$1$I$20240601$20240815$20240820$20240820$EXP$$US-MYLANLABS-2024M1061930$MYLAN$$50$YR$$M$Y$$$20240820$$CN$US$US
242298651$24229865$1$I$$20240806$20240820$20240820$EXP$$US-HLS-202400741$HLS THERAPEUTICS$$36$YR$A$F$Y$$$20240820$$HP$US$US
242298661$24229866$1$I$20240808$20240810$20240820$20240820$EXP$$CN-Eisai-EC-2024-171908$EISAI$$60$YR$A$F$Y$60$KG$20240820$$MD$CN$CN
242298671$24229867$1$I$$20240816$20240820$20240820$DIR$FDA-CDER-CTU-2024-57113$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242298681$24229868$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129668$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242298691$24229869$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131817$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240820$$CN$US$US
242298701$24229870$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130314$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240820$$CN$US$US
242298711$24229871$1$I$20240805$20240815$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130268$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$86.18$KG$20240820$$CN$US$US
242298721$24229872$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129670$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242298731$24229873$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129667$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242298741$24229874$1$I$20240809$20240819$20240820$20240820$EXP$$US-OTSUKA-2024_022860$OTSUKA$$75$YR$$M$Y$$$20240820$$CN$US$US
242298751$24229875$1$I$$20240816$20240820$20240820$PER$$US-TAKEDA-2024TUS082926$TAKEDA$$$$$F$Y$$$20240820$$CN$US$US
242298761$24229876$1$I$$20240729$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN007933$INCYTE$$$$$$Y$$$20240820$$CN$US$US
242298771$24229877$1$I$$20240812$20240820$20240820$EXP$$CA-Covis Pharma GmbH-2024COV01005$COVIS PHARMA$$$$$F$Y$$$20240820$$CN$CA$CA
242298781$24229878$1$I$20240708$20240725$20240820$20240820$PER$$US-JNJFOC-20240808166$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240820$$PH$US$US
242298791$24229879$1$I$$20240725$20240820$20240820$PER$$US-JNJFOC-20240808163$JOHNSON AND JOHNSON$$$$$M$Y$$$20240820$$MD$US$US
242298801$24229880$1$I$20240709$20240814$20240820$20240820$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-110903$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240820$$MD$DE$DE
242298811$24229881$1$I$$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57241$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242298831$24229883$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57283$$FDA-CTU$$71$YR$$M$N$$$20240820$N$$US$
242298841$24229884$1$I$20240809$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57112$$FDA-CTU$$55$YR$$F$N$84.8$KG$20240819$N$$US$
242298862$24229886$2$F$20240801$20240906$20240820$20240913$EXP$$US-RIGEL-20240800060$RIGEL PHARMACEUTICALS$$82$YR$$M$Y$64.41$KG$20240913$$HP$US$US
242298871$24229887$1$I$$20240730$20240820$20240820$EXP$$US-RADIUS HEALTH INC.-2024US005278$RADIUS PHARM$$$$$F$Y$$$20240820$$CN$US$US
242298882$24229888$2$F$$20240906$20240820$20240906$PER$$US-ALXN-202408USA000883US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242298891$24229889$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129664$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242298901$24229890$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129660$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242298911$24229891$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129662$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242298921$24229892$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129663$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242298931$24229893$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129661$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242298941$24229894$1$I$20240701$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131273$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240820$$CN$US$US
242298951$24229895$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57269$$FDA-CTU$$60$YR$$F$N$$$20240820$N$$US$
242298961$24229896$1$I$$20240819$20240820$20240820$PER$$US-PURDUE PHARMA-USA-2024-0311441$PURDUE$$$$$F$Y$$$20240820$$PH$US$US
242298971$24229897$1$I$$20240817$20240820$20240820$PER$$US-PURDUE-USA-2024-0311428$PURDUE$$$$$$Y$$$20240820$$CN$US$US
242298981$24229898$1$I$$20240816$20240820$20240820$EXP$$US-AstraZeneca-2024A188000$ASTRAZENECA$$$$$F$Y$54$KG$20240820$$CN$US$
242298991$24229899$1$I$20240606$20240816$20240820$20240820$DIR$FDA-CDER-CTU-2024-56970$$FDA-CTU$$$$$F$N$51.7$KG$20240816$N$$US$
242299001$24229900$1$I$20240805$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-56969$$FDA-CTU$$$$$M$N$91.2$KG$20240819$N$$US$
242299011$24229901$1$I$20000916$20230722$20240820$20240820$EXP$$EU-BAUSCHBL-2023BNL006234$BAUSCH AND LOMB$$86$YR$$F$Y$56$KG$20240820$$CN$EU$EU
242299021$24229902$1$I$20240807$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-56967$$FDA-CTU$$$$$M$N$115.2$KG$20240819$N$$US$
242299031$24229903$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57216$$FDA-CTU$$76$YR$$F$N$62.6$KG$20240820$N$$US$
242299041$24229904$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57245$$FDA-CTU$$51$YR$$M$N$$$20240820$N$PH$US$
242299051$24229905$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57267$$FDA-CTU$$64$YR$$M$N$$$20240820$N$$US$
242299071$24229907$1$I$$20240216$20240820$20240820$PER$$NVSC2024US039929$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242299081$24229908$1$I$$20240816$20240820$20240820$PER$$NVSC2024US167257$NOVARTIS$$$$$$Y$$$20240820$$CN$US$US
242299091$24229909$1$I$$20240816$20240820$20240820$PER$$US-JNJFOC-20240843803$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$US$US
242299101$24229910$1$I$20240614$20240729$20240820$20240820$PER$$US-TOLMAR, INC.-24US050201$TOLMAR$$$$$M$Y$$$20240820$$HP$US$US
242299111$24229911$1$I$20240729$20240729$20240820$20240820$PER$$TR-TOLMAR, INC.-24TR051401$TOLMAR$$78$YR$$M$Y$$$20240820$$MD$TR$TR
242299121$24229912$1$I$20240729$20240729$20240820$20240820$PER$$TR-TOLMAR, INC.-24TR051409$TOLMAR$$89$YR$$M$Y$$$20240820$$PH$TR$TR
242299132$24229913$2$F$20240718$20240829$20240820$20240917$PER$$US-TOLMAR, INC.-24US051182$TOLMAR$$82$YR$$M$Y$$$20240917$$HP$US$US
242299142$24229914$2$F$20240725$20240910$20240820$20240925$PER$$US-TOLMAR, INC.-24US051362$TOLMAR$$76$YR$$M$Y$$$20240924$$HP$US$US
242299152$24229915$2$F$20240729$20240910$20240820$20240925$PER$$US-TOLMAR, INC.-24US051418$TOLMAR$$73$YR$$M$Y$$$20240924$$HP$US$US
242299162$24229916$2$F$20240716$20240910$20240820$20240925$PER$$US-TOLMAR, INC.-24US051439$TOLMAR$$70$YR$$M$Y$$$20240924$$HP$US$US
242299172$24229917$2$F$20240729$20240821$20240820$20240911$PER$$US-TOLMAR, INC.-24US051430$TOLMAR$$69$YR$$M$Y$$$20240911$$PH$US$US
242299192$24229919$2$F$$20240816$20240820$20240828$EXP$$US-SMPA-2024SPA001030$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242299201$24229920$1$I$$20240806$20240820$20240820$EXP$$US-HLS-202400752$HLS THERAPEUTICS$$$$E$M$Y$$$20240820$$HP$US$US
242299211$24229921$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129658$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242299241$24229924$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57282$$FDA-CTU$$67$YR$$F$N$51.26$KG$20240820$N$HP$US$
242299251$24229925$1$I$20240816$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57248$$FDA-CTU$$66$YR$$M$N$59$KG$20240820$N$PH$US$
242299261$24229926$1$I$$20240815$20240820$20240820$EXP$$NVSC2024BR167950$NOVARTIS$$4$MON$$$Y$$$20240820$$MD$BR$BR
242299271$24229927$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883077$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242299281$24229928$1$I$20240819$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57186$$FDA-CTU$$64$YR$$F$N$$$20240819$N$HP$US$
242299291$24229929$1$I$20240817$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57115$$FDA-CTU$$44$YR$$F$N$$$20240819$N$HP$US$
242299301$24229930$1$I$$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57287$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242299311$24229931$1$I$$20240527$20240820$20240820$EXP$$EU-BAUSCHBL-2024BNL027679$BAUSCH AND LOMB$$55$YR$$M$Y$$$20240820$$MD$EU$EU
242299321$24229932$1$I$20240801$20240815$20240820$20240820$EXP$$CA-ABBVIE-5883957$ABBVIE$$76$YR$$F$Y$$$20240820$$CN$CA$CA
242299332$24229933$2$F$20240101$20240904$20240820$20240906$EXP$$US-ABBVIE-5885322$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242299341$24229934$1$I$$20240816$20240820$20240820$PER$$US-AstraZeneca-2024A161640$ASTRAZENECA$$$$$M$Y$$$20240820$$CN$US$
242299351$24229935$1$I$20240722$20240805$20240820$20240820$EXP$HR-IMP-2024000599$HR-IMP-2024000599$Harrow Health$$67$YR$E$F$Y$67$KG$20240820$$PH$HR$HR
242299361$24229936$1$I$$20240812$20240820$20240820$EXP$$US-AstraZeneca-2024A186619$ASTRAZENECA$$$$$M$Y$$$20240820$$MD$US$
242299371$24229937$1$I$$20240807$20240820$20240820$EXP$$US-FMCRTG-FMC-2408-000959$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240820$$CN$US$US
242299381$24229938$1$I$20240724$20240812$20240820$20240820$EXP$ES-FreseniusKabi-FK202412025$ES-FreseniusKabi-FK202412025$FRESENIUS KABI$$60$YR$A$M$Y$$$20240820$$MD$ES$ES
242299391$24229939$1$I$20240801$20240809$20240820$20240820$EXP$$US-FMCRTG-FMC-2408-000966$FRESENIUS MEDICAL CARE$$68$YR$E$M$Y$$$20240820$$CN$US$US
242299401$24229940$1$I$20240806$20240806$20240820$20240820$EXP$$US-FMCRTG-FMC-2408-000956$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240820$$HP$US$US
242299412$24229941$2$F$$20240819$20240820$20240912$PER$$US-IMP-2024000609$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
242299421$24229942$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129659$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242299431$24229943$1$I$20240814$20240814$20240820$20240820$EXP$$US-JNJFOC-20240844882$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240820$$MD$US$US
242299451$24229945$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57210$$FDA-CTU$$69$YR$$F$N$$$20240820$N$$US$
242299461$24229946$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57259$$FDA-CTU$$80$YR$$F$N$$$20240820$N$HP$US$
242299471$24229947$1$I$$20240517$20240820$20240820$PER$$US-009507513-2408USA006587$MERCK$$$$$F$Y$$$20240820$$CN$US$US
242299481$24229948$1$I$$20240816$20240820$20240820$EXP$$SG-ALXN-202408ASI000611SG$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240820$$PH$SG$SG
242299491$24229949$1$I$$20240614$20240820$20240820$EXP$$EU-BAUSCHBL-2024BNL028288$BAUSCH AND LOMB$Hauch R, Jankofsky M, Klohs S, Herden U, Blohm M, Winkler B. Abdominal Aspergillosis - An Underdiagnosed Disease? Three Cases of Abdominal Aspergillosis in Severely Immunocompromised Infants. Klinische Padiatrie. 2024 JAN 30;236(3):189-92. doi:10.1055/a-2233-1021$5$MON$$M$Y$$$20240820$$MD$EU$EU
242299501$24229950$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129641$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242299511$24229951$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129656$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242299521$24229952$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129657$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242299531$24229953$1$I$$20240806$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-120527$BRISTOL MYERS SQUIBB$Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, et al. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 Oct 05;142(14):1243-8. doi:10.1182/blood.2023020571.$$$$$Y$$$20240820$$HP$US$US
242299541$24229954$1$I$$20240814$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159871$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242299551$24229955$1$I$$20240814$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159873$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242299561$24229956$1$I$$20240814$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159843$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242299571$24229957$1$I$20240813$20240815$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159890$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242299581$24229958$1$I$$20240814$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159887$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242299591$24229959$1$I$$20240815$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159877$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242299601$24229960$1$I$20240101$20240816$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159931$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242299611$24229961$1$I$20240801$20240813$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159865$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242299621$24229962$1$I$$20240816$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159903$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242299631$24229963$1$I$$20240815$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US015406$SANDOZ$$$$$M$Y$$$20240820$$CN$US$US
242299641$24229964$1$I$$20240813$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US045041$SANDOZ$$$$$M$Y$$$20240820$$CN$US$US
242299651$24229965$1$I$$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57295$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242299661$24229966$1$I$20240814$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57268$$FDA-CTU$$67$YR$$M$N$$$20240820$Y$PH$US$
242299681$24229968$1$I$20240815$20240816$20240820$20240820$DIR$FDA-CDER-CTU-2024-57111$$FDA-CTU$$61$YR$$M$N$119.5$KG$20240816$N$$US$
242299691$24229969$1$I$$20240816$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US060818$SANDOZ$$$$$M$Y$$$20240820$$CN$US$US
242299711$24229971$1$I$$20240820$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046794$BOEHRINGER INGELHEIM$$$$$$Y$$$20240820$$CN$US$US
242299721$24229972$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130983$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240820$$HP$US$US
242299731$24229973$1$I$$20240813$20240820$20240820$30DAY$$US-NOVOPROD-1251092$NOVO NORDISK$$$$$M$Y$$$20240820$$CN$US$US
242299742$24229974$2$F$$20240821$20240820$20240828$30DAY$$US-NOVOPROD-1264704$NOVO NORDISK$$$$$M$Y$$$20240828$$CN$US$US
242299754$24229975$4$F$$20240917$20240820$20240924$EXP$$US-009507513-2408USA004764$MERCK$$$$$F$Y$$$20240924$$CN$US$US
242299761$24229976$1$I$$20240816$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US073860$SANDOZ$$$$$M$Y$$$20240820$$MD$US$US
242299771$24229977$1$I$20230320$20230419$20240820$20240820$EXP$$CA-DSJP-DSJ-2023-111959$DAIICHI$$71$YR$$F$Y$$$20240820$$PH$CA$CA
242299782$24229978$2$F$$20240903$20240820$20240909$EXP$$US-009507513-2408USA004761$MERCK$$74$YR$$F$Y$$$20240909$$MD$US$US
242299801$24229980$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130912$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240820$$HP$US$US
242299811$24229981$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0664197$GILEAD$Spiegel J, Jain M, Nastoupil L, Tamaresis J., Ghobadi A., Lin Y., et al. Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium. Blood. 2023;142 supplement1:1032. doi:https://doi.org/10.1182/blood-2023-179868$$$A$$Y$$$20240820$$HP$US$US
242299821$24229982$1$I$20240807$20240814$20240820$20240820$EXP$$DE-BIOMARINAP-DE-2024-159798$BIOMARIN$$$$$$Y$$$20240820$$HP$DE$DE
242299831$24229983$1$I$$20240815$20240820$20240820$EXP$$US-PFIZER INC-202400237687$PFIZER$$59$YR$$F$Y$$$20240820$$CN$US$US
242299842$24229984$2$F$20240806$20240909$20240820$20240916$EXP$IT-MINISAL02-998437$IT-PFIZER INC-202400239849$PFIZER$$61$YR$$F$Y$$$20240916$$MD$IT$IT
242299852$24229985$2$F$20240801$20240826$20240820$20240830$EXP$$BR-PFIZER INC-PV202400104763$PFIZER$$71$YR$$F$Y$53.1$KG$20240830$$MD$BR$BR
242299871$24229987$1$I$$20240816$20240820$20240820$EXP$$JP-PFIZER INC-202400238149$PFIZER$$3$DEC$$F$Y$$$20240820$$CN$JP$JP
242299891$24229989$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168396$NOVARTIS$$$$$$Y$$$20240820$$HP$US$US
242299901$24229990$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57251$$FDA-CTU$$42$YR$$F$N$$$20240820$N$$US$
242299911$24229991$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57264$$FDA-CTU$$74$YR$$F$N$160$LBS$20240820$N$$US$
242299921$24229992$1$I$20240627$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57292$$FDA-CTU$$33$YR$$M$N$$$20240820$N$PH$US$
242299931$24229993$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57297$$FDA-CTU$$79$YR$$F$N$$$20240820$N$$US$
242299951$24229995$1$I$20240727$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57261$$FDA-CTU$$53$YR$$F$N$60$KG$20240820$N$HP$US$
242299961$24229996$1$I$$20240817$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131218$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240820$$HP$US$US
242299971$24229997$1$I$20240802$20240814$20240820$20240820$EXP$$US-BIOMARINAP-US-2024-159888$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242299981$24229998$1$I$$20240814$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US073239$SANDOZ$$$$$$Y$$$20240820$$CN$US$US
242299991$24229999$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0664195$GILEAD$Spiegel J, Jain M, Nastoupil L, Tamaresis J., Ghobadi A., Lin Y., et al. Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium. Blood. 2023;142 supplement1:1032. doi:https://doi.org/10.1182/blood-2023-179868$$$A$$Y$$$20240820$$HP$US$US
242300001$24230000$1$I$$20240816$20240820$20240820$EXP$$NVSC2024US167534$NOVARTIS$$$$$F$Y$$$20240820$$CN$US$US
242300011$24230001$1$I$$20240820$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408012206$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240820$$CN$US$US
242300021$24230002$1$I$$20240812$20240820$20240820$EXP$$IT-TEVA-VS-3233432$TEVA$Diral E, Furnari G, Bruno A, Greco R, Clerici D, Marktel S, et al. Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience. Front-Oncol 2024; 14.$$$$$Y$$$20240820$$HP$IT$IT
242300042$24230004$2$F$$20240816$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US073554$SANDOZ$$$$$M$Y$$$20240820$$HP$US$US
242300061$24230006$1$I$$20240815$20240820$20240820$EXP$$US-BIOMARINAP-US-2024-159933$BIOMARIN$$$$$$Y$$$20240820$$CN$US$US
242300071$24230007$1$I$20240201$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57229$$FDA-CTU$$53$YR$$F$N$$$20240820$N$$US$
242300081$24230008$1$I$$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57203$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242300111$24230011$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57227$$FDA-CTU$$39$YR$$F$N$180$LBS$20240820$N$$US$
242300132$24230013$2$F$$20240909$20240820$20240909$EXP$$US-ALXN-202408USA000738US$ALEXION PHARMACEUTICALS$$74$YR$$F$Y$61$KG$20240909$$MD$US$US
242300141$24230014$1$I$$20221019$20240820$20240820$EXP$$CA-DSJP-DSJ-2024-140970$DAIICHI$$$$$F$Y$65$KG$20240820$$MD$CA$CA
242300151$24230015$1$I$$20230915$20240820$20240820$EXP$$CA-DSJP-DSJ-2023-118771$DAIICHI$$$$$F$Y$87$KG$20240820$$MD$CA$CA
242300161$24230016$1$I$20240322$20240820$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-017413$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240820$$CN$US$US
242300171$24230017$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0664189$GILEAD$Spiegel J, Jain M, Nastoupil L, Tamaresis J., Ghobadi A., Lin Y., et al. Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium. Blood. 2023;142 supplement1:1032. doi:https://doi.org/10.1182/blood-2023-179868$$$A$$Y$$$20240820$$HP$US$US
242300191$24230019$1$I$$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408012269$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240820$$CN$US$US
242300201$24230020$1$I$$20240814$20240820$20240820$EXP$$TR-009507513-2408TUR005170$MERCK$Yildirim HC., Guven DC., Ismayilov R., Chalabiyen E., Dizdar O.. Deficient Mismatch Repair Jejunal Cancer Hyperprogression with Pembrolizumab. Journal of Oncological Science. 2024;10:122-4$58$YR$$M$Y$$$20240820$$HP$TR$TR
242300211$24230021$1$I$$20240812$20240820$20240820$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004962$SAREPTA THERAPEUTICS$$$$$M$Y$42.99$KG$20240820$$HP$US$US
242300231$24230023$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0664198$GILEAD$Spiegel J, Jain M, Nastoupil L, Tamaresis J., Ghobadi A., Lin Y., et al. Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium. Blood. 2023;142 supplement1:1032. doi:https://doi.org/10.1182/blood-2023-179868$$$A$$Y$$$20240820$$HP$US$US
242300243$24230024$3$F$20240101$20240805$20240820$20240830$PER$$US-JNJFOC-20240819109$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240830$$HP$US$US
242300251$24230025$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0664196$GILEAD$Spiegel J, Jain M, Nastoupil L, Tamaresis J., Ghobadi A., Lin Y., et al. Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium. Blood. 2023;142 supplement1:1032. doi:https://doi.org/10.1182/blood-2023-179868$$$A$$Y$$$20240820$$HP$US$US
242300261$24230026$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0664199$GILEAD$Spiegel J, Jain M, Nastoupil L, Tamaresis J., Ghobadi A., Lin Y., et al. Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium. Blood. 2023;142 supplement1:1032. doi:https://doi.org/10.1182/blood-2023-179868$$$A$$Y$$$20240820$$HP$US$US
242300281$24230028$1$I$$20240814$20240820$20240820$PER$$US-JNJFOC-20240837174$JOHNSON AND JOHNSON$$$$$$Y$$$20240820$$HP$US$US
242300291$24230029$1$I$20240802$20240807$20240820$20240820$PER$$US-009507513-2408USA002490$MERCK$$42$YR$$M$Y$$$20240820$$CN$US$US
242300302$24230030$2$F$$20240829$20240820$20240904$EXP$$NVSC2024ZA167247$NOVARTIS$$44$YR$$M$Y$$$20240904$$HP$ZA$ZA
242300311$24230031$1$I$$20240709$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131771$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$55$KG$20240820$$CN$US$US
242300322$24230032$2$F$20240101$20240820$20240820$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131270$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$74.39$KG$20240904$$CN$US$US
242300332$24230033$2$F$20240722$20240913$20240820$20240919$PER$$US-ABBVIE-5879465$ABBVIE$$2$YR$$M$Y$12$KG$20240919$$HP$US$US
242300341$24230034$1$I$20240801$20240819$20240820$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012966$JAZZ$$68$YR$$M$Y$$$20240820$$MD$US$US
242300351$24230035$1$I$$20240816$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131126$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240820$$MD$US$US
242300361$24230036$1$I$20240604$20240814$20240820$20240820$EXP$FR-AFSSAPS-DJ2024000913$FR-LUNDBECK-DKLU4003202$LUNDBECK$$$$$$Y$$$20240820$$MD$FR$FR
242300391$24230039$1$I$$20240813$20240820$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012587$JAZZ$$$$$M$Y$$$20240820$$CN$US$US
242300401$24230040$1$I$$20240705$20240820$20240820$PER$$US-LUNDBECK-DKLU4001369$LUNDBECK$$$$$$Y$$$20240820$$CN$US$US
242300421$24230042$1$I$$20240815$20240820$20240820$PER$$US-GILEAD-2024-0684437$GILEAD$$$$A$F$Y$$$20240820$$HP$US$US
242300431$24230043$1$I$$20240807$20240820$20240820$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07929$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240820$$MD$US$US
242300441$24230044$1$I$$20240815$20240820$20240820$PER$$US-GILEAD-2024-0684440$GILEAD$$$$A$M$Y$$$20240820$$MD$US$US
242300452$24230045$2$F$$20240816$20240820$20240930$PER$$US-LUNDBECK-DKLU4002714$LUNDBECK$$$$$$Y$$$20241001$$CN$US$US
242300461$24230046$1$I$$20240813$20240820$20240820$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012600$JAZZ$$$$$F$Y$$$20240820$$CN$US$US
242300471$24230047$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131516$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240820$$HP$US$US
242300481$24230048$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131567$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240820$$HP$US$US
242300491$24230049$1$I$$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408012298$ELI LILLY AND CO$$$$A$F$Y$$$20240820$$CN$US$US
242300501$24230050$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0664193$GILEAD$Spiegel J, Jain M, Nastoupil L, Tamaresis J., Ghobadi A., Lin Y., et al. Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium. Blood. 2023;142 supplement1:1032. doi:https://doi.org/10.1182/blood-2023-179868$$$A$$Y$$$20240820$$HP$US$US
242300511$24230051$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0664194$GILEAD$Spiegel J, Jain M, Nastoupil L, Tamaresis J., Ghobadi A., Lin Y., et al. Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium. Blood. 2023;142 supplement1:1032. doi:https://doi.org/10.1182/blood-2023-179868$$$A$$Y$$$20240820$$HP$US$US
242300521$24230052$1$I$$20240814$20240820$20240820$PER$$US-BIOMARINAP-US-2024-159857$BIOMARIN$$$$$$Y$$$20240820$$HP$US$US
242300531$24230053$1$I$$20240814$20240820$20240820$PER$$US-AstraZeneca-2024A186604$ASTRAZENECA$$$$$F$Y$$$20240821$$MD$US$
242300541$24230054$1$I$$20240813$20240820$20240820$EXP$$AT-AstraZeneca-2024A185613$ASTRAZENECA$$$$$F$Y$$$20240821$$MD$AT$
242300551$24230055$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0664200$GILEAD$Spiegel J, Jain M, Nastoupil L, Tamaresis J., Ghobadi A., Lin Y., et al. Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium. Blood. 2023;142 supplement1:1032. doi:https://doi.org/10.1182/blood-2023-179868$$$A$$Y$$$20240820$$HP$US$US
242300561$24230056$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0684546$GILEAD$Habib, A., Welkie, R., Butman, J., et al. Secondary myeloid malignancy after CAR T cell therapy for non-Hodgkin lymphoma (NHL). unk. 2024;unk:1$61$YR$A$M$Y$$$20240820$$MD$US$US
242300571$24230057$1$I$20200317$20240816$20240820$20240820$30DAY$$GB-SANDOZ INC.-NVSC2020GB083498$SANDOZ$$60$YR$$M$Y$$$20240820$$HP$GB$GB
242300591$24230059$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0684548$GILEAD$Habib, A., Welkie, R., Butman, J., et al. Secondary myeloid malignancy after CAR T cell therapy for non-Hodgkin lymphoma (NHL). unk. 2024;unk:1$41$YR$A$F$Y$$$20240820$$MD$US$US
242300601$24230060$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0684547$GILEAD$Habib, A., Welkie, R., Butman, J., et al. Secondary myeloid malignancy after CAR T cell therapy for non-Hodgkin lymphoma (NHL). unk. 2024;unk:1$65$YR$E$M$Y$$$20240820$$MD$US$US
242300612$24230061$2$F$$20240827$20240820$20240902$PER$$US-AMGEN-USASP2024164218$AMGEN$$79$YR$E$M$Y$$$20240902$$CN$US$US
242300621$24230062$1$I$$20240812$20240820$20240820$PER$$US-SA-2024SA240334$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$HP$US$US
242300631$24230063$1$I$20240812$20240812$20240820$20240820$PER$$US-SA-2024SA242221$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240821$$MD$US$US
242300651$24230065$1$I$$20240815$20240820$20240820$EXP$$US-GILEAD-2024-0684549$GILEAD$Habib, A., Welkie, R., Butman, J., et al. Secondary myeloid malignancy after CAR T cell therapy for non-Hodgkin lymphoma (NHL). unk. 2024;unk:1$61$YR$A$F$Y$$$20240820$$MD$US$US
242300661$24230066$1$I$$20240815$20240820$20240820$EXP$$JP-009507513-2408JPN001862J$MERCK$$6$DEC$$$Y$$$20240820$$HP$JP$JP
242300675$24230067$5$F$20240718$20240920$20240820$20240926$EXP$$DE-GILEAD-2024-0684783$GILEAD$$52$YR$A$F$Y$$$20240926$$MD$DE$DE
242300681$24230068$1$I$20240630$20240819$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046666$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240820$$HP$US$US
242300691$24230069$1$I$20240609$20240815$20240820$20240820$EXP$GB-MHRA-MED-202408151417250140-LZBSF$GB-009507513-2408GBR005636$MERCK$$85$YR$$F$Y$80$KG$20240820$$PH$GB$GB
242300701$24230070$1$I$20240820$20240816$20240820$20240820$EXP$$DE-JNJFOC-20240851408$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240820$$CN$DE$DE
242300711$24230071$1$I$20240812$20240812$20240820$20240820$PER$$US-ALXN-202408USA000712US$ALEXION PHARMACEUTICALS$$61$YR$$F$Y$$$20240820$$CN$COUNTRY NOT SPECIFIED$US
242300721$24230072$1$I$20230314$20240816$20240820$20240820$EXP$DE-PEI-CADR2023318519$DE-JNJFOC-20240851391$JOHNSON AND JOHNSON$$79$YR$E$M$Y$56$KG$20240820$$CN$DE$DE
242300741$24230074$1$I$$20240816$20240820$20240820$30DAY$$US-SANDOZ INC.-SDZ2024US073645$SANDOZ$$$$$M$Y$$$20240820$$HP$US$US
242300751$24230075$1$I$20240101$20240815$20240820$20240820$PER$$US-JNJFOC-20240845293$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240821$$CN$US$US
242300761$24230076$1$I$$20240809$20240820$20240820$EXP$$US-ROCHE-3472615$ROCHE$$$$C$F$Y$$$20240821$$CN$US$US
242300771$24230077$1$I$$20240811$20240820$20240820$EXP$$JP-Prasco Laboratories-PRAS20241099$PRASCO$Abe Y, Kubonishi S, Ri M, Iino M, Sunami K, Ito T, Fukaya M, Kitano T, Ikeda S, Katayama T. An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future Oncol.. 2024;20(17):1191-1205. doi:10.2217/fon-2023-0834$81$YR$E$$Y$$$20240821$$HP$JP$JP
242300781$24230078$1$I$$20240811$20240820$20240820$EXP$$JP-Prasco Laboratories-PRAS20241098$PRASCO$Abe Y, Kubonishi S, Ri M, Iino M, Sunami K, Ito T, Fukaya M, Kitano T, Ikeda S, Katayama T. An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future Oncol.. 2024;20(17):1191-1205. doi:10.2217/fon-2023-0834$76$YR$E$$Y$$$20240821$$HP$JP$JP
242300791$24230079$1$I$$20240811$20240820$20240820$EXP$$JP-Prasco Laboratories-PRAS20241097$PRASCO$Abe Y, Kubonishi S, Ri M, Iino M, Sunami K, Ito T, Fukaya M, Kitano T, Ikeda S, Katayama T. An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future Oncol.. 2024;20(17):1191-1205. doi:10.2217/fon-2023-0834$$$$$Y$$$20240821$$HP$JP$JP
242300801$24230080$1$I$20240801$20240812$20240820$20240820$PER$$CA-ALXN-202408CAN000823US$ALEXION PHARMACEUTICALS$$52$YR$$M$Y$$$20240821$$CN$CA$US
242300811$24230081$1$I$$20240820$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046844$BOEHRINGER INGELHEIM$$$$$$Y$$$20240821$$MD$US$US
242300821$24230082$1$I$20240101$20240812$20240820$20240820$PER$$US-SA-2024SA241848$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240821$$MD$US$US
242300831$24230083$1$I$$20240820$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046845$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240821$$CN$US$US
242300841$24230084$1$I$20240815$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164210$AMGEN$$78$YR$E$M$Y$$$20240820$$CN$US$US
242300851$24230085$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA241711$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240821$$CN$US$US
242300861$24230086$1$I$$20240816$20240820$20240820$EXP$$JP-TAKEDA-2024TJP012021$TAKEDA$$62$YR$$M$Y$$$20240820$$MD$JP$JP
242300872$24230087$2$F$20240101$20240822$20240820$20240831$PER$$US-ABBVIE-5876822$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242300881$24230088$1$I$20240820$20240820$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046847$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240821$$CN$US$US
242300902$24230090$2$F$20240301$20240905$20240820$20240911$EXP$$CA-JNJFOC-20240363696$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240911$$HP$CA$CA
242300911$24230091$1$I$$20240814$20240820$20240820$PER$$US-AMGEN-USASP2024162139$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242300941$24230094$1$I$$20240819$20240820$20240820$EXP$$DE-SANDOZ INC.-NVSC2020DE305652$SANDOZ$$$$$$Y$$$20240820$$MD$DE$DE
242300951$24230095$1$I$20240713$20240806$20240820$20240820$30DAY$$US-AMGEN-USASL2024140261$AMGEN$$76$YR$E$F$Y$$$20240820$$HP$US$US
242300961$24230096$1$I$20240812$20240819$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408012060$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240820$$CN$US$US
242300971$24230097$1$I$$20240819$20240820$20240820$EXP$$AU-SANDOZ INC.-SDZ2024AU073713$SANDOZ$$$$$M$Y$$$20240820$$MD$AU$AU
242300982$24230098$2$F$$20240903$20240820$20240904$PER$$NVSC2024US168537$NOVARTIS$$$$$M$Y$$$20240904$$HP$US$US
242300991$24230099$1$I$20240101$20240819$20240820$20240820$EXP$$US-ABBVIE-5886614$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242301001$24230100$1$I$$20240813$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA072534$SANDOZ$$40$YR$$F$Y$73$KG$20240820$$MD$CA$CA
242301011$24230101$1$I$$20240820$20240820$20240820$PER$$NVSC2024US168538$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242301031$24230103$1$I$$20240820$20240820$20240820$EXP$$NVSC2024ET168429$NOVARTIS$$$$$F$Y$$$20240821$$MD$ET$ET
242301041$24230104$1$I$$20240813$20240820$20240820$EXP$$US-JNJFOC-20240841633$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$MD$US$US
242301051$24230105$1$I$20240601$20240819$20240820$20240820$EXP$$NVSJ2024JP007846$NOVARTIS$$79$YR$$M$Y$$$20240821$$MD$JP$JP
242301061$24230106$1$I$20240805$20240819$20240820$20240820$EXP$$NVSJ2024JP009770$NOVARTIS$$$$$$Y$$$20240821$$MD$JP$JP
242301072$24230107$2$F$$20240903$20240820$20240905$EXP$$PT-SANDOZ INC.-SDZ2024PT073604$SANDOZ$$87$YR$$F$Y$$$20240905$$HP$PT$PT
242301081$24230108$1$I$20240101$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024162886$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242301091$24230109$1$I$$20240817$20240820$20240820$EXP$$NVSJ2023JP008649$NOVARTIS$$$$E$M$Y$$$20240821$$MD$JP$JP
242301101$24230110$1$I$20240801$20240808$20240820$20240820$EXP$$JP-SMPA-2024SMP012099$SUNOVION$$$$$$Y$$$20240820$$CN$JP$JP
242301111$24230111$1$I$20240801$20240819$20240820$20240820$EXP$$DE-SANDOZ INC.-SDZ2024DE073626$SANDOZ$$60$YR$$M$Y$$$20240820$$MD$DE$DE
242301121$24230112$1$I$20240601$20240816$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131753$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240821$$CN$US$US
242301131$24230113$1$I$$20240816$20240820$20240820$PER$$US-JNJFOC-20240846877$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240821$$CN$US$US
242301161$24230116$1$I$$20240718$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN007587$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242301171$24230117$1$I$20231101$20240814$20240820$20240820$EXP$$DE-INCYTE CORPORATION-2024IN008655$INCYTE$$$$$$Y$$$20240821$$MD$DE$DE
242301181$24230118$1$I$$20240814$20240820$20240820$EXP$$VN-INCYTE CORPORATION-2024IN008656$INCYTE$$$$$$Y$$$20240821$$CN$VN$VN
242301191$24230119$1$I$$20240813$20240820$20240820$EXP$$DE-JNJFOC-20240706840$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$DE$DE
242301201$24230120$1$I$20210101$20240813$20240820$20240820$EXP$$US-JNJFOC-20240833922$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
242301212$24230121$2$F$20240301$20240817$20240820$20240822$EXP$$GB-INCYTE CORPORATION-2024IN008662$INCYTE$$$$$$Y$$$20240822$$MD$GB$GB
242301221$24230122$1$I$$20240815$20240820$20240820$PER$$US-JNJFOC-20240841236$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$HP$US$US
242301243$24230124$3$F$$20240829$20240820$20240902$EXP$$NVSJ2024JP009700$NOVARTIS$$69$YR$$M$Y$$$20240903$$PH$JP$JP
242301251$24230125$1$I$20240405$20240816$20240820$20240820$EXP$CH-SM-2024-14087$CH-ORGANON-O2408CHE001250$ORGANON$$28$YR$$F$Y$59$KG$20240820$$CN$CH$CH
242301271$24230127$1$I$20230707$20240814$20240820$20240820$EXP$$IE-AMGEN-IRLSP2024164635$AMGEN$$84$YR$E$F$Y$$$20240820$$CN$IE$IE
242301281$24230128$1$I$20240801$20240816$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408011057$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240820$$CN$US$US
242301291$24230129$1$I$20240702$20240814$20240820$20240820$EXP$FR-AFSSAPS-CF2024000392$FR-SANDOZ INC.-SDZ2024FR073305$SANDOZ$$15$YR$$F$Y$59$KG$20240820$$PH$FR$FR
242301301$24230130$1$I$$20240814$20240820$20240820$EXP$$GB-BIOGEN-2024BI01278373$BIOGEN$$$$A$F$Y$$$20240820$$CN$GB$GB
242301311$24230131$1$I$$20240813$20240820$20240820$PER$$US-JNJFOC-20240836018$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240821$$MD$US$US
242301321$24230132$1$I$20240701$20240815$20240820$20240820$PER$$US-ORGANON-O2408USA001206$ORGANON$$19$YR$$F$Y$$$20240820$$CN$US$US
242301331$24230133$1$I$20240101$20240815$20240820$20240820$EXP$$US-JNJFOC-20240846468$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240821$$HP$US$US
242301342$24230134$2$F$$20240920$20240820$20240925$EXP$$NVSJ2024JP009764$NOVARTIS$$$$E$F$Y$$$20240925$$PH$JP$JP
242301351$24230135$1$I$20240809$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024163961$AMGEN$$82$YR$E$F$Y$$$20240820$$CN$US$US
242301361$24230136$1$I$20240807$20240814$20240820$20240820$EXP$$US-ABBVIE-5882004$ABBVIE$$76$YR$$F$Y$$$20240820$$CN$US$US
242301371$24230137$1$I$$20240807$20240820$20240820$PER$$US-INCYTE CORPORATION-2024IN008303$INCYTE$$$$$$Y$$$20240821$$HP$US$US
242301391$24230139$1$I$20240101$20240814$20240820$20240820$EXP$$CA-ABBVIE-5883968$ABBVIE$$43$YR$$F$Y$$$20240820$$CN$CA$CA
242301401$24230140$1$I$20240809$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408009821$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240820$$CN$US$US
242301412$24230141$2$F$$20240816$20240820$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408011102$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240909$$CN$US$US
242301431$24230143$1$I$$20240820$20240820$20240820$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046862$BOEHRINGER INGELHEIM$$$$$$Y$$$20240821$$CN$US$US
242301441$24230144$1$I$20240801$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164485$AMGEN$$80$YR$E$F$Y$$$20240820$$CN$US$US
242301451$24230145$1$I$20190925$20240815$20240820$20240820$EXP$$JP-GSK-JP2024JPN090802$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$MD$JP$JP
242301461$24230146$1$I$$20240816$20240820$20240820$EXP$$US-ABBVIE-5884844$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242301471$24230147$1$I$20240207$20240816$20240820$20240820$EXP$$GB-ABBVIE-5883941$ABBVIE$$51$YR$$F$Y$108$KG$20240820$$HP$GB$GB
242301481$24230148$1$I$$20240819$20240820$20240820$EXP$$CA-ORGANON-O2408CAN001338$ORGANON$$65$YR$$F$Y$$$20240820$$HP$CA$CA
242301491$24230149$1$I$$20240815$20240820$20240820$EXP$$AU-ABBVIE-5883736$ABBVIE$$70$YR$$M$Y$$$20240820$$MD$AU$AU
242301501$24230150$1$I$20230801$20240814$20240820$20240820$EXP$$CL-ABBVIE-5882613$ABBVIE$$66$YR$$F$Y$$$20240820$$CN$CL$CL
242301511$24230151$1$I$20240815$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164526$AMGEN$$76$YR$E$F$Y$$$20240820$$CN$US$US
242301521$24230152$1$I$$20240809$20240820$20240820$PER$$US-ABBVIE-5876568$ABBVIE$$$$$$Y$$$20240820$$MD$US$US
242301531$24230153$1$I$20240815$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164190$AMGEN$$91$YR$E$M$Y$$$20240820$$CN$US$US
242301542$24230154$2$F$20240807$20240916$20240820$20240917$PER$$US-JNJFOC-20240822087$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240917$$PH$US$US
242301552$24230155$2$F$$20240816$20240820$20240830$PER$$US-SA-2024SA240718$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240830$$MD$US$US
242301563$24230156$3$F$20220829$20240828$20240820$20240901$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-131294$BRISTOL MYERS SQUIBB$Hosoki H. Feasibility of adjuvant chemotherapy with nivolumab for esophageal cancer. The 79th General Meeting of the Japanese Society of Gastroenterological Surgery. 2024.$$$$F$Y$$$20240902$$MD$JP$JP
242301571$24230157$1$I$$20240819$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131139$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$129.27$KG$20240821$$CN$US$US
242301581$24230158$1$I$$20240815$20240820$20240820$PER$$US-ABBVIE-5884045$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242301591$24230159$1$I$20240708$20240813$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012666$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242301601$24230160$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA240916$SANOFI AVENTIS$$$$A$M$Y$97.5$KG$20240821$$MD$US$US
242301611$24230161$1$I$20240501$20240809$20240820$20240820$PER$$US-SA-2024SA241533$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240821$$MD$US$US
242301621$24230162$1$I$$20240809$20240820$20240820$PER$$US-SA-2024SA241057$SANOFI AVENTIS$$$$E$F$Y$$$20240821$$MD$US$US
242301631$24230163$1$I$20240701$20240809$20240820$20240820$PER$$US-SA-2024SA241909$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240821$$MD$US$US
242301643$24230164$3$F$20240809$20240828$20240820$20240905$PER$$US-AMGEN-USASP2024160302$AMGEN$$48$YR$A$F$Y$79.5$KG$20240905$$PH$US$US
242301651$24230165$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA241686$SANOFI AVENTIS$$57$YR$A$F$Y$136$KG$20240821$$MD$US$US
242301661$24230166$1$I$20240816$20240816$20240820$20240820$PER$$US-AMGEN-USASP2024164482$AMGEN$$58$YR$A$F$Y$$$20240820$$CN$US$US
242301672$24230167$2$F$20240703$20240826$20240820$20240829$EXP$IT-MINISAL02-998848$IT-GSK-IT2024101307$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$PH$IT$IT
242301681$24230168$1$I$$20240819$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131227$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240821$$CN$US$US
242301692$24230169$2$F$$20240906$20240820$20240906$PER$$US-ALXN-202408USA000844US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242301701$24230170$1$I$$20240814$20240820$20240820$EXP$$NVSC2024US165563$NOVARTIS$$$$$M$Y$$$20240821$$HP$US$US
242301711$24230171$1$I$$20240816$20240820$20240820$EXP$$US-ABBVIE-5886000$ABBVIE$$$$$F$Y$$$20240820$$MD$US$US
242301721$24230172$1$I$20240630$20240813$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129485$BRISTOL MYERS SQUIBB$$30$YR$A$M$Y$$$20240821$$CN$US$US
242301731$24230173$1$I$20240712$20240813$20240820$20240820$EXP$$US-ABBVIE-5852649$ABBVIE$$30$YR$$M$Y$175$KG$20240820$$CN$US$US
242301743$24230174$3$F$20240814$20240905$20240820$20240906$PER$$US-AMGEN-USASP2024164488$AMGEN$$34$YR$A$F$Y$$$20240906$$HP$US$US
242301751$24230175$1$I$$20240815$20240820$20240820$PER$$US-ABBVIE-5885670$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242301763$24230176$3$F$20240816$20240919$20240820$20240920$PER$$US-AMGEN-USASP2024164674$AMGEN$$64$YR$E$M$Y$$$20240920$$CN$US$US
242301773$24230177$3$F$$20240918$20240820$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA044531$SANDOZ$$$$$F$Y$$$20240923$$MD$CA$CA
242301782$24230178$2$F$20240101$20240814$20240820$20240820$PER$$US-ABBVIE-5884643$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242301801$24230180$1$I$20130401$20240813$20240820$20240820$EXP$$US-BIOGEN-2013BI045648$BIOGEN$$40$YR$$F$Y$$$20240820$$CN$US$US
242301811$24230181$1$I$$20240816$20240820$20240820$EXP$$AU-SANDOZ INC.-SDZ2024AU073470$SANDOZ$$$$N$F$Y$$$20240820$$MD$AU$AU
242301821$24230182$1$I$$20240819$20240820$20240820$EXP$$NVSC2024CA167939$NOVARTIS$$43$YR$$M$Y$$$20240821$$HP$CA$CA
242301832$24230183$2$F$$20240816$20240820$20240821$EXP$$US-JNJFOC-20240846363$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
242301841$24230184$1$I$20230706$20240809$20240820$20240820$PER$$US-SA-2024SA241336$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240821$$MD$US$US
242301852$24230185$2$F$$20240909$20240820$20240918$PER$$US-BAUSCHBL-2024BNL016784$BAUSCH AND LOMB$$$$$F$Y$$$20240918$$CN$US$US
242301861$24230186$1$I$20240816$20240819$20240820$20240820$PER$$US-AMGEN-USASP2024165815$AMGEN$$48$YR$A$F$Y$$$20240820$$CN$US$US
242301871$24230187$1$I$20240814$20240819$20240820$20240820$PER$$US-AMGEN-USASP2024165499$AMGEN$$24$YR$A$$Y$$$20240820$$CN$US$US
242301881$24230188$1$I$20240101$20240813$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US073960$SANDOZ$$65$YR$$F$Y$$$20240820$$CN$US$US
242301891$24230189$1$I$$20240816$20240820$20240820$EXP$$AU-SANDOZ INC.-SDZ2024AU073264$SANDOZ$$$$$M$Y$$$20240820$$HP$AU$AU
242301902$24230190$2$F$$20240917$20240820$20240923$30DAY$$US-JNJFOC-20240842294$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$PH$US$US
242301912$24230191$2$F$20240801$20240829$20240820$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131690$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240902$$CN$US$US
242301921$24230192$1$I$$20240815$20240820$20240820$EXP$$NVSC2024CA097745$NOVARTIS$$55$YR$$F$Y$$$20240821$$CN$CA$CA
242301931$24230193$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883597$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242301941$24230194$1$I$20240101$20240814$20240820$20240820$EXP$$US-ABBVIE-5883839$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242301952$24230195$2$F$20240101$20240826$20240820$20240828$PER$$US-AMGEN-USASP2024165439$AMGEN$$55$YR$A$F$Y$$$20240828$$MD$US$US
242301962$24230196$2$F$20240701$20240820$20240820$20240826$EXP$$US-ABBVIE-5884836$ABBVIE$$68$YR$$F$Y$70$KG$20240826$$CN$US$US
242301981$24230198$1$I$$20240816$20240820$20240820$EXP$$US-ABBVIE-5885511$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242301992$24230199$2$F$20240101$20240820$20240820$20240823$EXP$$US-ABBVIE-5881347$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242302001$24230200$1$I$20240605$20240813$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012684$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242302011$24230201$1$I$20240728$20240819$20240820$20240820$EXP$$US-ABBVIE-5886123$ABBVIE$$95$YR$$M$Y$$$20240820$$CN$US$US
242302021$24230202$1$I$$20240810$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128806$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240821$$MD$US$US
242302031$24230203$1$I$$20240819$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131635$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240821$$CN$US$US
242302041$24230204$1$I$$20240819$20240820$20240820$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131772$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240821$$CN$US$US
242302051$24230205$1$I$20240816$20240816$20240820$20240820$EXP$$NL-ABBVIE-5885807$ABBVIE$$81$YR$$F$Y$$$20240820$$CN$NL$NL
242302061$24230206$1$I$$20240814$20240820$20240820$EXP$$US-ABBVIE-5885441$ABBVIE$$$$$M$Y$$$20240820$$MD$US$US
242302071$24230207$1$I$$20240815$20240820$20240820$PER$$US-TAKEDA-2024TUS082724$TAKEDA$$$$$M$Y$23$KG$20240820$$MD$US$US
242302082$24230208$2$F$$20240903$20240820$20240904$PER$$NVSC2024US167510$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
242302091$24230209$1$I$$20240815$20240820$20240820$EXP$$BR-JNJFOC-20240850816$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$BR$BR
242302101$24230210$1$I$20240101$20240809$20240820$20240820$PER$$US-SA-2024SA242982$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240821$$MD$US$US
242302111$24230211$1$I$$20240819$20240820$20240820$PER$$NVSC2024US168618$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242302121$24230212$1$I$20240101$20240812$20240820$20240820$EXP$$US-ABBVIE-5878750$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242302131$24230213$1$I$20230601$20240814$20240820$20240820$EXP$$US-ABBVIE-5881344$ABBVIE$$55$YR$$F$Y$92.079$KG$20240820$$CN$US$US
242302141$24230214$1$I$20231020$20240814$20240820$20240820$EXP$$US-ABBVIE-5882163$ABBVIE$$33$YR$$M$Y$$$20240820$$CN$US$US
242302152$24230215$2$F$$20240911$20240820$20240916$EXP$$US-ABBVIE-5882695$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
242302162$24230216$2$F$20180625$20240821$20240820$20240828$EXP$$BE-BRISTOL-MYERS SQUIBB COMPANY-2024-128302$BRISTOL MYERS SQUIBB$Sharra I, Lhoir M, Des Grottes J-M, Vaes M, Guerisse F. Recurrent fanconi syndrome induced by lenalidomide: a case report. Cureus. 2024 Aug 04;16(8):1-5. doi:10.7759/cureus.66118.$59$YR$A$F$Y$$$20240828$$HP$BE$BE
242302171$24230217$1$I$$20240818$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131334$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$88.45$KG$20240821$$CN$US$US
242302181$24230218$1$I$$20240818$20240820$20240820$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131081$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$74.84$KG$20240821$$CN$US$US
242302191$24230219$1$I$20230101$20240814$20240820$20240820$EXP$$US-ABBVIE-5627399$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242302202$24230220$2$F$20240101$20240905$20240820$20240910$EXP$$US-ABBVIE-5882241$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
242302211$24230221$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883587$ABBVIE$$$$$M$Y$$$20240820$$CN$US$US
242302222$24230222$2$F$20240814$20240814$20240820$20240823$EXP$$US-GSK-US2024101248$GLAXOSMITHKLINE$$22$YR$$F$Y$$$20240823$$CN$US$US
242302231$24230223$1$I$$20240815$20240820$20240820$EXP$$US-ABBVIE-5883647$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242302241$24230224$1$I$20240101$20240816$20240820$20240820$EXP$$GB-ABBVIE-5883955$ABBVIE$$62$YR$$F$Y$$$20240820$$CN$GB$GB
242302251$24230225$1$I$$20240814$20240820$20240820$EXP$$GB-JNJFOC-20240845333$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$GB$GB
242302261$24230226$1$I$20240101$20240815$20240820$20240820$EXP$$CA-ABBVIE-5884133$ABBVIE$$70$YR$$F$Y$$$20240820$$CN$CA$CA
242302271$24230227$1$I$20240101$20240816$20240820$20240820$EXP$$US-ABBVIE-5885867$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242302291$24230229$1$I$20240601$20240717$20240820$20240820$PER$$US-RDY-SPO/USA/24/0011963$DR REDDYS$$21$YR$A$F$Y$$$20240821$$HP$US$US
242302301$24230230$1$I$20240101$20240816$20240820$20240820$EXP$$US-ABBVIE-5885256$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242302311$24230231$1$I$$20240816$20240820$20240820$EXP$$US-ABBVIE-5885297$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242302321$24230232$1$I$20200816$20240814$20240820$20240820$EXP$DE-CADRBFARM-2022291021$DE-RDY-SPO/GER/22/0149525$DR REDDYS$$28$YR$A$M$Y$83$KG$20240821$$CN$DE$DE
242302331$24230233$1$I$20240611$20240816$20240820$20240820$EXP$$US-ABBVIE-5885257$ABBVIE$$65$YR$$F$Y$$$20240820$$CN$US$US
242302341$24230234$1$I$$20240812$20240820$20240820$EXP$$US-NOVITIUMPHARMA-2024USNVP01615$NOVITIUM PHARMA$Reema Patel.A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma.Cancer Reports.25-JUL-2024;7(7):e2110$84$YR$E$M$Y$$$20240821$$HP$US$US
242302351$24230235$1$I$20240810$20240813$20240820$20240820$EXP$$CN-BEIGENE-BGN-2024-012664$BEIGENE$$$$$$Y$$$20240820$$HP$CN$CN
242302362$24230236$2$F$$20240820$20240820$20240822$EXP$$US-JNJFOC-20240846247$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$US$US
242302371$24230237$1$I$20240617$20240813$20240820$20240820$EXP$$US-ABBVIE-5880990$ABBVIE$$58$YR$$M$Y$$$20240820$$CN$US$US
242302381$24230238$1$I$$20240810$20240820$20240820$PER$$US-BAUSCHBL-2024BNL031640$BAUSCH AND LOMB$$$$$$Y$$$20240821$$CN$US$US
242302391$24230239$1$I$$20240815$20240820$20240820$PER$$US-BAUSCHBL-2024BNL031795$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240821$$MD$US$US
242302401$24230240$1$I$$20240813$20240820$20240820$EXP$$JP-009507513-2408JPN001406J$MERCK$$74$YR$$M$Y$$$20240820$$MD$JP$JP
242302413$24230241$3$F$$20240903$20240820$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046866$BOEHRINGER INGELHEIM$$59$YR$A$M$Y$$$20240905$$CN$US$US
242302421$24230242$1$I$$20240816$20240820$20240820$EXP$$US-AstraZeneca-2024A188082$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242302431$24230243$1$I$$20240814$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA072833$SANDOZ$$47$YR$$F$Y$$$20240820$$PH$CA$CA
242302441$24230244$1$I$20191220$20240816$20240820$20240820$EXP$$CA-SANDOZ INC.-NVSC2019CA084119$SANDOZ$$70$YR$$F$Y$$$20240820$$CN$CA$CA
242302451$24230245$1$I$$20240814$20240820$20240820$PER$$US-JNJFOC-20240840630$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240821$$HP$US$US
242302461$24230246$1$I$20240714$20240816$20240820$20240820$EXP$CH-SM-2024-15136$CH-JNJFOC-20240841165$JOHNSON AND JOHNSON$$81$YR$E$M$Y$69.3$KG$20240821$$MD$CH$CH
242302471$24230247$1$I$20240814$20240815$20240820$20240820$PER$$US-AMGEN-USASP2024164203$AMGEN$$73$YR$E$F$Y$$$20240820$$CN$US$US
242302482$24230248$2$F$20240101$20240902$20240820$20240909$EXP$$US-ABBVIE-5875920$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242302491$24230249$1$I$$20240819$20240820$20240820$PER$$US-ABBVIE-5886964$ABBVIE$$$$$$Y$$$20240820$$HP$US$US
242302501$24230250$1$I$20240101$20240815$20240820$20240820$EXP$$US-ABBVIE-5883585$ABBVIE$$$$$F$Y$$$20240820$$CN$US$US
242302513$24230251$3$F$20240801$20240905$20240820$20240912$PER$$US-ABBVIE-5885133$ABBVIE$$70$YR$$F$Y$$$20240912$$CN$US$US
242302522$24230252$2$F$20240101$20240820$20240820$20240823$EXP$$CA-ABBVIE-5884092$ABBVIE$$31$YR$$M$Y$$$20240823$$CN$CA$CA
242302531$24230253$1$I$$20240812$20240820$20240820$EXP$$US-BAUSCHBL-2024BNL031681$BAUSCH AND LOMB$$$$$M$Y$$$20240821$$CN$US$US
242302542$24230254$2$F$20240701$20240912$20240820$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-131009$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240920$$MD$JP$JP
242302551$24230255$1$I$$20240813$20240820$20240820$EXP$$US-SANDOZ INC.-SDZ2024US058667$SANDOZ$$$$$F$Y$$$20240820$$CN$US$US
242302561$24230256$1$I$$20240816$20240820$20240820$EXP$$CA-SANDOZ INC.-SDZ2024CA073614$SANDOZ$$$$$M$Y$$$20240820$$MD$CA$CA
242302571$24230257$1$I$$20240816$20240820$20240820$PER$$US-ABBVIE-5885605$ABBVIE$$$$$$Y$$$20240820$$CN$US$US
242302581$24230258$1$I$$20240815$20240820$20240820$PER$$US-ELI_LILLY_AND_COMPANY-US202408012395$ELI LILLY AND CO$$43$YR$A$F$Y$104.31$KG$20240820$$CN$US$US
242302591$24230259$1$I$$20240816$20240820$20240820$EXP$$GB-GSK-GB2023EME061808$GLAXOSMITHKLINE$$$$$$Y$$$20240820$$CN$GB$GB
242302601$24230260$1$I$$20240813$20240820$20240820$EXP$$US-ALXN-202408USA000797US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240821$$HP$US$US
242302611$24230261$1$I$$20240811$20240820$20240820$EXP$$US-ABBVIE-5884355$ABBVIE$Krackeler M, Orchanian A, Law L, Lopez A, Buchanan S, Maglinte G. et al. Real-world treatment patterns and outcomes of zanubrutinib in chronic lymphocytic leukemia and small lymphocytic leukemia (CLL/SLL). J Clin Oncol.$$$$$Y$$$20240820$$HP$US$GB
242302621$24230262$1$I$20240814$20240814$20240820$20240820$EXP$$CA-JNJFOC-20240842516$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240821$$HP$CA$CA
242302641$24230264$1$I$$20240816$20240821$20240821$EXP$$US-AstraZeneca-2024A188388$ASTRAZENECA$$$$$$Y$$$20240821$$MD$US$
242302651$24230265$1$I$20240613$20240818$20240821$20240821$EXP$$EU-BAUSCHBL-2024BNL031832$BAUSCH AND LOMB$$77$YR$$M$Y$65$KG$20240821$$MD$EU$EU
242302661$24230266$1$I$$20240725$20240821$20240821$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005564$BIOCON$$$$$$Y$$$20240821$$CN$US$US
242302673$24230267$3$F$$20240913$20240821$20240919$PER$$US-AMGEN-USASP2024163967$AMGEN$$$$$$Y$$$20240918$$HP$US$US
242302682$24230268$2$F$20240814$20240903$20240821$20240906$PER$$US-AMGEN-USASP2024162280$AMGEN$$73$YR$E$F$Y$71.5$KG$20240906$$PH$US$US
242302691$24230269$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129972$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240821$$HP$US$US
242302701$24230270$1$I$$20240816$20240821$20240821$EXP$$US-ABBVIE-5884842$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242302711$24230271$1$I$20240101$20240815$20240821$20240821$EXP$$US-ABBVIE-5883638$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242302721$24230272$1$I$$20240808$20240821$20240821$EXP$$AU-ABBVIE-5881534$ABBVIE$$$$$M$Y$$$20240821$$HP$AU$AU
242302731$24230273$1$I$$20240812$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US073869$SANDOZ$$$$$$Y$$$20240821$$HP$US$US
242302742$24230274$2$F$$20240821$20240821$20240827$EXP$$JP-PFIZER INC-202400239611$PFIZER$$41$YR$$F$Y$$$20240827$$MD$JP$JP
242302751$24230275$1$I$$20240812$20240821$20240821$EXP$$IN-PFIZER INC-202400237336$PFIZER$$84$YR$$M$Y$$$20240820$$CN$IN$IN
242302762$24230276$2$F$20240726$20240913$20240821$20240917$EXP$$JP-TAKEDA-2024TJP012050$TAKEDA$$7$DEC$$M$Y$$$20240917$$MD$JP$JP
242302773$24230277$3$F$20240101$20240827$20240821$20240901$EXP$$CA-PFIZER INC-202300381453$PFIZER$$73$YR$$M$Y$70$KG$20240901$$MD$CA$CA
242302781$24230278$1$I$$20240814$20240821$20240821$EXP$$CA-PFIZER INC-202400236698$PFIZER$$$$$F$Y$$$20240820$$MD$CA$CA
242302791$24230279$1$I$20240601$20240816$20240821$20240821$EXP$$CA-ABBVIE-5886709$ABBVIE$$64$YR$$F$Y$$$20240821$$HP$CA$CA
242302801$24230280$1$I$$20240813$20240821$20240821$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010366$STRIDES$Preka E, Rigby E, Sellathurai G, Kipping L, Koziell A.. OFATUMUMAB PROVIDES A SAFE AND EFFECTIVE ALTERNATIVE IN RITUXIMAB FAILURE.. Pediatr-Nephrol. 2023;38 (Suppl. 2):S80-S81 abstr. Sa-3MP 056$$$$$Y$$$20240821$$HP$GB$GB
242302811$24230281$1$I$$20240812$20240821$20240821$EXP$PT-MLMSERVICE-20240725-PI141748-00270-3$PT-STRIDES ARCOLAB LIMITED-2024SP009863$STRIDES$Brito-Santana L, Medinas RL, Neves A, Gago J. Steroid-induced psychosis: a spectrum of neuropsychiatric glucocorticoid side effects.. BMJ case reports. 2024;17(7):e259134$$$$$Y$$$20240821$$MD$PT$PT
242302821$24230282$1$I$$20240819$20240821$20240821$PER$$US-ROCHE-10000061111$ROCHE$$52$YR$A$F$Y$$$20240821$$CN$US$US
242302831$24230283$1$I$$20240811$20240821$20240821$EXP$IN-MLMSERVICE-20240729-PI144644-00197-3$IN-CHATTEMPRD-2024OHG026714$CHATTEM$Tyagi M, Ahuja R, Patel V, Sahni K, Taneja N, Gupta S.. Fixed Drug Eruptions Due To/Caused by Levocetirizine and Cetirizine: An Uncommon Adverse Cutaneous Drug Reaction to Commonly Used Piperazine Derivatives.. Indian dermatology online journal.. 2024;15(4):678-80. doi:10.4103/idoj.idoj_488_23.$28$YR$A$M$Y$$$20240821$$MD$IN$IN
242302841$24230284$1$I$$20240812$20240821$20240821$EXP$$IT-TEVA-VS-3233417$TEVA$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ-Genom-Precis-Med 2024; 17 (2): E004353.$14$YR$$M$Y$$$20240821$$MD$IT$IT
242302851$24230285$1$I$$20240812$20240821$20240821$EXP$$IT-TEVA-VS-3233418$TEVA$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ-Genom-Precis-Med 2024; 17 (2): E004353.$15$YR$$M$Y$$$20240821$$MD$IT$IT
242302871$24230287$1$I$20190201$20240815$20240821$20240821$EXP$$SG-ABBVIE-5882920$ABBVIE$$65$YR$$M$Y$$$20240821$$HP$SG$SG
242302881$24230288$1$I$20240617$20240816$20240821$20240821$EXP$FR-AFSSAPS-NT2024001039$FR-CHATTEMPRD-2024OHG027572$CHATTEM$$19$YR$A$M$Y$44.8$KG$20240821$$MD$FR$FR
242302891$24230289$1$I$$20240806$20240821$20240821$PER$$US-PCCINC-2024-PPL-000609$PIRAMAL$$$$$$Y$$$20240821$$HP$US$US
242302903$24230290$3$F$20230203$20240909$20240821$20240914$EXP$$CN-ABBVIE-5880307$ABBVIE$$22$YR$$M$Y$63$KG$20240914$$MD$CN$CN
242302911$24230291$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009261$APOTEX$$66$YR$$M$Y$$$20240821$$HP$CA$CA
242302922$24230292$2$F$$20240820$20240821$20240822$EXP$$US-ROCHE-10000061121$ROCHE$$82$YR$E$M$Y$$$20240822$$CN$US$US
242302931$24230293$1$I$$20240813$20240821$20240821$EXP$$US-ABBVIE-5880725$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242302941$24230294$1$I$20240701$20240814$20240821$20240821$EXP$$US-ABBVIE-5840656$ABBVIE$$65$YR$$M$Y$$$20240821$$CN$US$US
242302951$24230295$1$I$$20240816$20240821$20240821$PER$$US-ABBVIE-5887251$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242302961$24230296$1$I$20240101$20240814$20240821$20240821$EXP$$CA-ABBVIE-5881917$ABBVIE$$54$YR$$F$Y$$$20240821$$CN$CA$CA
242302971$24230297$1$I$20240601$20240812$20240821$20240821$EXP$$US-BEH-2024177220$CSL BEHRING$$10$YR$C$F$Y$$$20240821$$HP$US$US
242302981$24230298$1$I$$20240806$20240821$20240821$EXP$$JP-AZURITY PHARMACEUTICALS, INC.-AZR202408-000299$AZURITY PHARMACEUTICALS$$9$DEC$$F$Y$$$20240820$$PH$JP$JP
242302991$24230299$1$I$20240101$20240816$20240821$20240821$EXP$$US-ABBVIE-5885219$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242303012$24230301$2$F$20240524$20240821$20240821$20240826$EXP$$CO-ABBVIE-5883974$ABBVIE$$$$$M$Y$$$20240826$$MD$CO$CO
242303021$24230302$1$I$20220101$20240813$20240821$20240821$EXP$$US-ABBVIE-5881346$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242303031$24230303$1$I$20240810$20240819$20240821$20240821$EXP$$US-ABBVIE-5886541$ABBVIE$$76$YR$$F$Y$$$20240821$$CN$US$US
242303041$24230304$1$I$$20240814$20240821$20240821$EXP$$US-ABBVIE-5882017$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242303051$24230305$1$I$20240401$20240815$20240821$20240821$EXP$$CA-ABBVIE-5883688$ABBVIE$$66$YR$$M$Y$$$20240821$$CN$CA$CA
242303061$24230306$1$I$20240814$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024162104$AMGEN$$67$YR$E$M$Y$$$20240820$$CN$US$US
242303071$24230307$1$I$20240616$20240814$20240821$20240821$EXP$$US-ABBVIE-5881571$ABBVIE$$54$YR$$F$Y$$$20240821$$CN$US$US
242303081$24230308$1$I$20240501$20240816$20240821$20240821$EXP$$US-AstraZeneca-2024A187615$ASTRAZENECA$$944$MON$$$Y$$$20240821$$CN$US$
242303091$24230309$1$I$$20240815$20240821$20240821$PER$$US-TAKEDA-2024TUS082373$TAKEDA$$$$$$Y$$$20240821$$CN$US$US
242303101$24230310$1$I$$20240813$20240821$20240821$EXP$$US-CHATTEMPRD-2024OHG027312$CHATTEM$$$$E$F$Y$$$20240821$$LW$US$US
242303111$24230311$1$I$20240801$20240816$20240821$20240821$EXP$$US-ABBVIE-5885063$ABBVIE$$66$YR$$M$Y$$$20240821$$CN$US$US
242303121$24230312$1$I$20240323$20240814$20240821$20240821$EXP$ES-AEMPS-1561071$ES-ABBVIE-5880003$ABBVIE$$54$YR$$F$Y$$$20240821$$MD$ES$ES
242303132$24230313$2$F$$20240909$20240821$20240917$EXP$$CA-APOTEX-2024AP009290$APOTEX$$31$MON$$$Y$$$20240917$$HP$CA$CA
242303141$24230314$1$I$$20240813$20240821$20240821$EXP$$US-CHATTEMPRD-2024OHG027314$CHATTEM$$$$$M$Y$$$20240821$$LW$US$US
242303151$24230315$1$I$$20240816$20240821$20240821$PER$$US-ABBVIE-5886692$ABBVIE$$$$$F$Y$$$20240821$$MD$US$US
242303161$24230316$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131467$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240821$$CN$US$US
242303172$24230317$2$F$$20240813$20240821$20240826$PER$$US-SA-2024SA243001$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240826$$CN$US$US
242303181$24230318$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA244116$SANOFI AVENTIS$$39$YR$A$M$Y$81$KG$20240821$$MD$US$US
242303191$24230319$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA240790$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240821$$MD$US$US
242303201$24230320$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA241587$SANOFI AVENTIS$$$$T$M$Y$45.35$KG$20240821$$MD$US$US
242303212$24230321$2$F$20240801$20240814$20240821$20240828$PER$$US-SA-2024SA242870$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240828$$CN$US$US
242303221$24230322$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA241828$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242303231$24230323$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA244337$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240821$$MD$US$US
242303241$24230324$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA244641$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240821$$MD$US$US
242303251$24230325$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA242887$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240821$$MD$US$US
242303261$24230326$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241842$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240821$$MD$US$US
242303271$24230327$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241770$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240821$$MD$US$US
242303281$24230328$1$I$$20240808$20240821$20240821$PER$$US-SA-2024SA240530$SANOFI AVENTIS$$$$A$M$Y$45.3$KG$20240821$$MD$US$US
242303291$24230329$1$I$20240801$20240809$20240821$20240821$PER$$US-SA-2024SA241478$SANOFI AVENTIS$$52$YR$A$F$Y$87.9$KG$20240821$$MD$US$US
242303301$24230330$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243004$SANOFI AVENTIS$$$$$M$Y$$$20240821$$CN$US$US
242303311$24230331$1$I$20231001$20240812$20240821$20240821$PER$$US-SA-2024SA242349$SANOFI AVENTIS$$$$C$F$Y$56.6$KG$20240821$$MD$US$US
242303321$24230332$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243466$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240821$$MD$US$US
242303331$24230333$1$I$20240807$20240812$20240821$20240821$PER$$US-SA-2024SA241781$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240821$$MD$US$US
242303341$24230334$1$I$$20240813$20240821$20240821$EXP$$US-CHATTEMPRD-2024OHG027367$CHATTEM$$$$$F$Y$$$20240821$$LW$US$US
242303351$24230335$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244102$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240821$$HP$US$US
242303361$24230336$1$I$20231201$20240809$20240821$20240821$PER$$US-SA-2024SA242135$SANOFI AVENTIS$$$$E$F$Y$$$20240821$$MD$US$US
242303371$24230337$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244489$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240821$$MD$US$US
242303381$24230338$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244458$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240821$$MD$US$US
242303391$24230339$1$I$20240811$20240814$20240821$20240821$PER$$US-SA-2024SA244499$SANOFI AVENTIS$$60$YR$A$F$Y$147$KG$20240821$$MD$US$US
242303401$24230340$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA244606$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240821$$MD$US$US
242303411$24230341$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA242385$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
242303421$24230342$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244532$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240821$$MD$US$US
242303431$24230343$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA242739$SANOFI AVENTIS$$$$A$F$Y$73.936$KG$20240821$$MD$US$US
242303441$24230344$1$I$$20240811$20240821$20240821$EXP$$ES-AMGEN-ESPSP2024163407$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242303451$24230345$1$I$$20240811$20240821$20240821$EXP$$ES-AMGEN-ESPSP2024163406$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242303461$24230346$1$I$$20240816$20240821$20240821$EXP$$CN-ABBVIE-5884498$ABBVIE$$$$$$Y$$$20240821$$MD$CN$CN
242303471$24230347$1$I$$20231030$20240821$20240821$PER$$US-ENDO PHARMACEUTICALS INC-2023-005636$ENDO$$$$$F$Y$$$20240821$$CN$US$US
242303481$24230348$1$I$20231001$20240813$20240821$20240821$PER$$US-AMGEN-USASP2024162014$AMGEN$$54$YR$A$F$Y$$$20240820$$CN$US$US
242303491$24230349$1$I$$20240811$20240821$20240821$EXP$$ES-AMGEN-ESPSP2024163411$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242303501$24230350$1$I$19640101$20240813$20240821$20240821$EXP$$US-CHATTEMPRD-2024OHG027298$CHATTEM$$7$YR$C$F$Y$$$20240821$$LW$US$US
242303511$24230351$1$I$20240706$20240815$20240821$20240821$EXP$$US-ABBVIE-5883882$ABBVIE$$63$YR$$F$Y$$$20240821$$CN$US$US
242303521$24230352$1$I$20240101$20240814$20240821$20240821$EXP$$US-ABBVIE-5881794$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242303531$24230353$1$I$20230101$20240813$20240821$20240821$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010373$STRIDES$Yan J, Xu Y, Zhu Q.. Case Report: Amiodarone-induced multi-organ toxicity.. Front-Cardiovasc-Med. 2024;11$73$YR$$F$Y$$$20240821$$HP$CN$CN
242303541$24230354$1$I$$20240812$20240821$20240821$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP010358$STRIDES$Clark SR, Wilton LR, Dawson JL, Chiew K, Jawahar MC, Toben C, et al.. Dotting the I^s and crossing the T^s: A South Australian perspective on variability in troponin thresholds for myocarditis risk in clozapine treatment.. Schizophr-Res. 2024;268:114-117$22$YR$$M$Y$$$20240821$$HP$AU$AU
242303551$24230355$1$I$20240401$20240819$20240821$20240821$EXP$FR-AFSSAPS-PV2024000734$FR-JNJFOC-20240849731$JOHNSON AND JOHNSON$$30$YR$A$F$Y$71$KG$20240821$$MD$FR$FR
242303571$24230357$1$I$$20240813$20240821$20240821$EXP$$US-JNJFOC-20240833413$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242303581$24230358$1$I$20211022$20240814$20240821$20240821$EXP$FR-AFSSAPS-AM2024000546$FR-ABBVIE-5884361$ABBVIE$$91$YR$$F$Y$$$20240821$$MD$FR$FR
242303591$24230359$1$I$$20240815$20240821$20240821$EXP$$CA-ABBVIE-5883731$ABBVIE$$$$E$$Y$$$20240821$$HP$CA$CA
242303601$24230360$1$I$$20240813$20240821$20240821$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010376$STRIDES$Shang Y, Zhao H, Li D.. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.. Turk-J-Hematol. 2023;40:284-285$76$YR$$F$Y$$$20240821$$MD$CN$CN
242303621$24230362$1$I$$20240816$20240821$20240821$PER$$US-ABBVIE-5887348$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242303631$24230363$1$I$20240811$20240816$20240821$20240821$EXP$$US-AstraZeneca-2024A187716$ASTRAZENECA$$24869$DY$$M$Y$$$20240821$$CN$US$
242303641$24230364$1$I$$20240813$20240821$20240821$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010377$STRIDES$Shang Y, Zhao H, Li D.. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.. Turk-J-Hematol. 2023;40:284-285$72$YR$$M$Y$$$20240821$$MD$CN$CN
242303651$24230365$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA240347$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240821$$MD$US$US
242303661$24230366$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA242999$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240821$$CN$US$US
242303671$24230367$1$I$$20240813$20240821$20240821$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010378$STRIDES$Shang Y, Zhao H, Li D.. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.. Turk-J-Hematol. 2023;40:284-285$71$YR$$F$Y$$$20240821$$MD$CN$CN
242303681$24230368$1$I$$20240816$20240821$20240821$EXP$$BR-ROCHE-10000060722$ROCHE$$$$$$Y$$$20240821$$MD$BR$BR
242303691$24230369$1$I$$20240815$20240821$20240821$EXP$$US-ABBVIE-5882984$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242303702$24230370$2$F$20240706$20240821$20240821$20240826$EXP$$US-ABBVIE-5883033$ABBVIE$$54$YR$$F$Y$81.646$KG$20240826$$CN$US$US
242303711$24230371$1$I$20200101$20240813$20240821$20240821$EXP$$CH-STRIDES ARCOLAB LIMITED-2024SP010385$STRIDES$Oaklander AL, Allen J, Dietliker N, Wilder-Smith EP.. Relapsing-Remitting Immunotherapy Responsive Small-Fiber Neuropathy: Longitudinal Tracking Through 10 Years Including Pregnancies.. Neurol-Neuroimmunol-Neuroinflamm. 2024;11 (5)$4$DEC$$F$Y$$$20240821$$MD$CH$CH
242303721$24230372$1$I$20240101$20240813$20240821$20240821$EXP$$FR-ABBVIE-5882030$ABBVIE$$61$YR$$M$Y$$$20240821$$HP$FR$FR
242303731$24230373$1$I$20240719$20240815$20240821$20240821$PER$$US-ABBVIE-5887327$ABBVIE$$35$YR$$$Y$$$20240821$$HP$US$US
242303741$24230374$1$I$$20240815$20240821$20240821$EXP$$US-ABBVIE-5883194$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242303751$24230375$1$I$$20240813$20240821$20240821$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010353$STRIDES$Alexander H, Malek R, Prieto-Merino D, Gribaleva E, Baden M, Beattie P, et al.. Comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic eczema: results from the UK-Irish A-STAR register.. Br-J-Dermatol. 2024;191 (Suppl. 1):i2-i3 abstr. O03$$$$$Y$$$20240821$$HP$GB$GB
242303761$24230376$1$I$$20240812$20240821$20240821$EXP$$US-HETERO-HET2024US02711$HETERO$$$$$$Y$$$20240821$$PH$US$US
242303771$24230377$1$I$20240701$20240816$20240821$20240821$EXP$$US-ABBVIE-5884817$ABBVIE$$53$YR$$F$Y$$$20240821$$CN$US$US
242303781$24230378$1$I$20240815$20240815$20240821$20240821$EXP$$CA-ABBVIE-5884463$ABBVIE$$45$YR$$F$Y$$$20240821$$CN$CA$CA
242303791$24230379$1$I$20240701$20240816$20240821$20240821$EXP$$GB-ABBVIE-5883932$ABBVIE$$48$YR$$M$Y$$$20240821$$CN$GB$GB
242303812$24230381$2$F$20240411$20240827$20240821$20240831$EXP$$US-ABBVIE-5883561$ABBVIE$$55$YR$$M$Y$$$20240831$$CN$US$US
242303821$24230382$1$I$$20240813$20240821$20240821$EXP$$US-AMGEN-USASP2024163236$AMGEN$$76$YR$E$M$Y$$$20240820$$HP$US$US
242303831$24230383$1$I$20240803$20240812$20240821$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-025130$UNITED THERAPEUTICS$$59$YR$$M$Y$99.773$KG$20240821$$$US$US
242303851$24230385$1$I$20240101$20240815$20240821$20240821$EXP$$US-ABBVIE-5883648$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242303861$24230386$1$I$20240101$20240815$20240821$20240821$EXP$$US-ABBVIE-5883586$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242303871$24230387$1$I$$20240815$20240821$20240821$EXP$$US-ABBVIE-5883559$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242303883$24230388$3$F$$20240904$20240821$20240910$PER$$US-AMGEN-USASP2024163983$AMGEN$$$$$$Y$$$20240909$$HP$US$US
242303893$24230389$3$F$20240731$20240916$20240821$20240924$EXP$$NVSC2024US166639$NOVARTIS$$45$YR$$M$Y$$$20240924$$CN$US$US
242303902$24230390$2$F$20240101$20240822$20240821$20240828$EXP$$US-ABBVIE-5885580$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242303911$24230391$1$I$20240117$20240816$20240821$20240821$EXP$$US-ABBVIE-5885274$ABBVIE$$60$YR$$F$Y$$$20240821$$CN$US$US
242303922$24230392$2$F$20240423$20240923$20240821$20240930$EXP$$IT-HALEON-2192589$Haleon PLC$$66$YR$$F$Y$$$20240928$$MD$IT$IT
242303932$24230393$2$F$20240811$20240905$20240821$20240907$EXP$$US-TAKEDA-2024TUS063680$TAKEDA$$77$YR$$M$Y$$$20240907$$HP$US$US
242303951$24230395$1$I$$20240819$20240821$20240821$EXP$$JP-TAKEDA-2024TJP012082$TAKEDA$$$$$$Y$$$20240821$$CN$JP$JP
242303961$24230396$1$I$$20240814$20240821$20240821$EXP$$US-JNJFOC-20240843250$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240821$$CN$US$US
242303972$24230397$2$F$20240603$20240826$20240821$20240830$EXP$$US-ABBVIE-5886615$ABBVIE$$87$YR$$F$Y$$$20240829$$HP$US$US
242303981$24230398$1$I$$20240815$20240821$20240821$EXP$$CA-ABBVIE-5884250$ABBVIE$$$$A$F$Y$$$20240821$$CN$CA$CA
242304001$24230400$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A184880$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242304011$24230401$1$I$20240714$20240817$20240821$20240821$EXP$$CN-ABBVIE-5884503$ABBVIE$$59$YR$$M$Y$$$20240821$$MD$CN$CN
242304021$24230402$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA242807$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242304031$24230403$1$I$20240701$20240810$20240821$20240821$PER$$US-SA-2024SA242806$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240821$$MD$US$US
242304041$24230404$1$I$$20240808$20240821$20240821$PER$$US-SA-2024SA239188$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240821$$MD$US$US
242304051$24230405$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241883$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240821$$MD$US$US
242304061$24230406$1$I$20240723$20240723$20240821$20240821$EXP$$US-NEBO-665160$PHARMACOSMOS$$28$YR$$F$Y$$$20240821$$MD$US$US
242304071$24230407$1$I$$20240813$20240821$20240821$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010394$STRIDES$Shang Y, Zhao H, Li D.. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.. Turk-J-Hematol. 2023;40:284-285$68$YR$$M$Y$$$20240821$$MD$CN$CN
242304081$24230408$1$I$$20240813$20240821$20240821$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010396$STRIDES$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turk-J-Hematol. 2023;40:284-285$61$YR$$F$Y$$$20240821$$MD$CN$CN
242304092$24230409$2$F$$20240821$20240821$20240823$PER$$NVSC2024US168611$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242304102$24230410$2$F$$20240913$20240821$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001645$BLUEPRINT MEDICINES$$$$$F$Y$$$20240920$$CN$US$US
242304111$24230411$1$I$$20240813$20240821$20240821$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010397$STRIDES$Shang Y, Zhao H, Li D.. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.. Turk-J-Hematol. 2023;40:284-285$75$YR$$F$Y$$$20240821$$MD$CN$CN
242304121$24230412$1$I$$20240813$20240821$20240821$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010398$STRIDES$Shang Y, Zhao H, Li D.. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.. Turk-J-Hematol. 2023;40:284-285$61$YR$$F$Y$$$20240821$$MD$CN$CN
242304141$24230414$1$I$20240423$20240813$20240821$20240821$EXP$$FR-JNJFOC-20240846356$JOHNSON AND JOHNSON$$37$YR$A$F$Y$82$KG$20240821$$MD$FR$FR
242304152$24230415$2$F$20240730$20240904$20240821$20240906$PER$$US-JAZZ PHARMACEUTICALS-2024-US-013061$JAZZ$$17$YR$$M$Y$$$20240906$$HP$US$US
242304162$24230416$2$F$20240819$20240903$20240821$20240905$EXP$$JP-ABBVIE-5885862$ABBVIE$$$$$M$Y$$$20240905$$MD$JP$JP
242304171$24230417$1$I$$20240806$20240821$20240821$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461851$RANBAXY$Gomes S D S, Oliveira S C, Almeida Furtado D T, Melo M L, Dos Santos G S, Braga N S R, et al.. Recurrence of fusocellular subtype GIST with SDHB mutation: A case of SDHB-loss and therapeutic challenges. J Surg Oncol. 2024;Aug 4$62$YR$$M$Y$$$20240821$$HP$BR$BR
242304181$24230418$1$I$$20240814$20240821$20240821$PER$$NVSC2024US165314$NOVARTIS$$$$A$F$Y$$$20240821$$CN$US$US
242304191$24230419$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463421$RANBAXY$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al. Intravenous immunoglobulins for recurrent chronic histiocytic intervillositis: a series of case studies. Am J Reprod Immunol. 2024;92 (1):e13898$$$N$F$Y$1.85$KG$20240821$$HP$FR$FR
242304201$24230420$1$I$20240806$20240806$20240821$20240821$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462526$RANBAXY$$43$YR$$F$Y$84$KG$20240821$$CN$BR$BR
242304221$24230422$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463297$RANBAXY$Mai DD, Pal CA, Teixeira JP. Severe ICU-Acquired Metabolic Acidosis due to Pyroglutamic Acidosis (5-Oxoprolinuria). J Am Soc Nephrol. 2023;34:202 (TH-PO398)$56$YR$$F$Y$$$20240821$$HP$US$US
242304231$24230423$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463419$RANBAXY$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies. Am J Reprod Immunol. 2024;92 (1):e13898$$$N$F$Y$2.45$KG$20240821$$HP$FR$FR
242304241$24230424$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463416$RANBAXY$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies. Am J Reprod Immunol. 2024;92 (1):e13898$$$N$F$Y$2.52$KG$20240821$$HP$FR$FR
242304251$24230425$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463287$RANBAXY$Paredes E, Dane KE, Lindsley J, Naik RPP, Streiff M, Yui JC. A Single Center Experience of 13 Episodes of Acquired Hemophilia A (2019 - 2023). Blood. 2023;142 (Suppl.1):7215$64$YR$$F$Y$61.7$KG$20240821$$HP$US$US
242304261$24230426$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462966$RANBAXY$$$$C$$Y$$$20240821$$HP$US$US
242304271$24230427$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463417$RANBAXY$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies. Am J Reprod Immunol. 2024;92 (1):e13898$37$YR$$F$Y$$$20240821$$HP$FR$FR
242304281$24230428$1$I$$20240806$20240821$20240821$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463286$RANBAXY$Burgos-Blasco B, Yeung SN, Docherty G, Iovieno A.. Topical insulin to treat a conjunctival defect after glaucoma surgery: A case report. Am J Ophthalmol Case Rep. 2024;36 (0):1-3$69$YR$$M$Y$$$20240821$$HP$CA$CA
242304291$24230429$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463303$RANBAXY$Zubair N, Isaac S, Westerman J. Drug?induced Euglycemic Diabetic Ketoacidosis in a Patient with Systemic Sarcoidosis. South Med J. 2023;Jan 116(1):93$78$YR$$F$Y$$$20240821$$MD$US$US
242304301$24230430$1$I$$20240806$20240821$20240821$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462272$RANBAXY$$$$T$F$Y$57.5$KG$20240821$$HP$CN$CN
242304311$24230431$1$I$20240722$20240806$20240821$20240821$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462278$RANBAXY$$19$YR$A$M$Y$50$KG$20240821$$CN$CN$CN
242304321$24230432$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463422$RANBAXY$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al. Intravenous immunoglobulins for recurrent chronic histiocytic intervillositis: a series of case studies. Am J Reprod Immunol. 2024;92 (1):e13898$34$YR$$F$Y$$$20240821$$HP$FR$FR
242304331$24230433$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463415$RANBAXY$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al. Intravenous immunoglobulins for recurrent chronic histiocytic intervillositis: a series of case studies. Am J Reprod Immunol. 2024;92 (1):e13898$27$YR$$F$Y$$$20240821$$HP$FR$FR
242304341$24230434$1$I$20240708$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010214$ELI LILLY AND CO$$34$YR$A$$Y$$$20240821$$CN$US$US
242304351$24230435$1$I$$20240813$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408008700$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240821$$CN$US$US
242304362$24230436$2$F$20240813$20240815$20240821$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408009225$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240822$$CN$US$US
242304371$24230437$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244642$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240821$$MD$US$US
242304381$24230438$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA243675$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240821$$MD$US$US
242304391$24230439$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241430$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240821$$MD$US$US
242304401$24230440$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463418$RANBAXY$Abisror N, Cheloufi M, Cohen J, Coulomb A, McAvoy C, Fain O, et al. Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies. Am J Reprod Immunol. 2024;92 (1):e13898$36$YR$$F$Y$$$20240821$$HP$FR$FR
242304411$24230441$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA241964$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
242304423$24230442$3$F$20240801$20240823$20240821$20240906$PER$$US-SA-2024SA244652$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240906$$MD$US$US
242304441$24230444$1$I$$20240807$20240821$20240821$EXP$$JP-ALVOTECHPMS-2024-ALVOTECHPMS-002116$Alvotech$Shimizu A, Tsuboi N, Haruhara K, Shirai I, Ogawa K, Miura A, Oshiro K, Ueda H, Yokote S, Okabe M, Sasaki T, Ikeda M, Yokoo T. Active flare of IgA nephropathy during long-term therapy with anti-tumor necrosis factor-alpha antibody drugs for Crohn^s disease: three case reports and literature review. CEN Case Rep. 2024 Aug;13(4):249-257. doi: 10.1007/s13730-023-00836-0. Epub 2023 Nov 30. PMID: 38032436; PMCID: PMC11294508.$30$YR$$M$Y$58.2$KG$20240821$$HP$JP$
242304451$24230445$1$I$20240213$20240813$20240821$20240821$EXP$$US-JNJFOC-20240833382$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242304461$24230446$1$I$20240805$20240816$20240821$20240821$EXP$$US-TAKEDA-2024TUS083304$TAKEDA$$52$YR$$M$Y$$$20240821$$MD$US$US
242304472$24230447$2$F$$20240813$20240821$20240828$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463480$RANBAXY$Feletti MP, Ramos AMA, Novo VM, Costa BS, Scardua EFDP, Marcondes SS, et al. Mycosis fungoides refractory to treatment-importance of a multidisciplinary approach. Oral Maxillofac Surg. 2024;0(0):no pagination$62$YR$$F$Y$$$20240828$$HP$BR$BR
242304481$24230448$1$I$20210917$20240806$20240821$20240821$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461640$RANBAXY$Bai G, Bai Y, Guan H, Ren H, Li H, Wang Y. A case report of lymphoproliferative disease in brain following therapies with mycophenolate Mofetil and Fingolimod and literature review. J Neuroimmunol. 2024;394 (0):578410; 1-5$32$YR$$M$Y$$$20240821$$HP$CN$CN
242304491$24230449$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462118$RANBAXY$Chanut M, Bonny V, Joly AC, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Arch Cardiovasc Dis. 2024;117 (4):297-300$78$YR$$F$Y$$$20240821$$HP$FR$FR
242304501$24230450$1$I$$20240812$20240821$20240821$30DAY$$US-GSK-US2024100376$GLAXOSMITHKLINE$$$$$M$Y$$$20240821$$CN$US$US
242304522$24230452$2$F$$20240813$20240821$20240828$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463460$RANBAXY$Santarsieri A, Bennett R, Hopkins D, Lewis KL, Gyansah CN, Cooke L, et al. R-DA-EPOCH Treatment Is Highly Effective Therapy for Primary Mediastinal Large B-Cell Lymphoma: A Real-World Multi-Centre Retrospective Evaluation. Blood. 2022;Nov 15;140(S1):9551-9553;627$$$A$$Y$$$20240828$$HP$GB$GB
242304531$24230453$1$I$$20240814$20240821$20240821$EXP$$GB-AMGEN-GBRSP2024164953$AMGEN$$64$YR$A$M$Y$$$20240820$$PH$GB$GB
242304541$24230454$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA243812$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240821$$MD$US$US
242304551$24230455$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244628$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242304561$24230456$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA244596$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240821$$MD$US$US
242304571$24230457$1$I$20240806$20240812$20240821$20240821$PER$$US-SA-2024SA244816$SANOFI AVENTIS$$71$YR$E$F$Y$77.61$KG$20240821$$MD$US$US
242304581$24230458$1$I$20240101$20240809$20240821$20240821$PER$$US-SA-2024SA241447$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240821$$MD$US$US
242304591$24230459$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244174$SANOFI AVENTIS$$$$C$F$Y$31.2$KG$20240821$$MD$US$US
242304601$24230460$1$I$20240101$20240820$20240821$20240821$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046680$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$65$KG$20240821$$HP$ES$ES
242304611$24230461$1$I$$20240816$20240821$20240821$PER$$US-ROCHE-10000059789$ROCHE$$$$E$F$Y$$$20240821$$CN$US$US
242304621$24230462$1$I$$20240820$20240821$20240821$EXP$$CA-ROCHE-10000061338$ROCHE$$68$YR$E$F$Y$$$20240821$$MD$CA$CA
242304631$24230463$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241131$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240821$$MD$US$US
242304641$24230464$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244619$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240821$$MD$US$US
242304651$24230465$1$I$$20240816$20240821$20240821$PER$$US-ROCHE-10000060165$ROCHE$$60$YR$A$F$Y$$$20240821$$CN$US$US
242304661$24230466$1$I$$20240809$20240821$20240821$EXP$$IN-ROCHE-10000054930$ROCHE$$73$YR$E$F$Y$$$20240821$$CN$IN$IN
242304671$24230467$1$I$$20240813$20240821$20240821$PER$$US-JNJFOC-20240840830$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$MD$US$US
242304681$24230468$1$I$$20240816$20240821$20240821$EXP$$US-JNJFOC-20240844947$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240821$$HP$US$US
242304691$24230469$1$I$$20240809$20240821$20240821$EXP$$CN-ROCHE-10000054477$ROCHE$Chen J, Fan S, Zhang J, Feng H, Xi G, Su Y, et al. Efficacy and safety of neoadjuvant chemotherapy combined with dual-targeted treatment in triple-positive breast cancer. Chinese Journal of Clinical Oncology and Rehabilitation. 2024-Mar;31 (3):164-70. doi:10.13455/j.cnki.cjcor.113494-2024-2024-0048.$$$$$Y$$$20240821$$HP$CN$CN
242304701$24230470$1$I$20240101$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164440$AMGEN$$62$YR$A$F$Y$$$20240820$$CN$US$US
242304711$24230471$1$I$$20240820$20240821$20240821$EXP$$CA-ROCHE-10000061210$ROCHE$$64$YR$A$M$Y$$$20240821$$CN$CA$CA
242304721$24230472$1$I$$20240816$20240821$20240821$PER$$US-ROCHE-10000060071$ROCHE$$48$YR$A$F$Y$$$20240821$$CN$US$US
242304731$24230473$1$I$$20240815$20240821$20240821$EXP$$US-JNJFOC-20240844963$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240821$$HP$US$US
242304741$24230474$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131587$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240821$$CN$US$US
242304752$24230475$2$F$$20240923$20240821$20240926$PER$$US-ROCHE-10000060466$ROCHE$$$$E$F$Y$$$20240926$$CN$US$US
242304762$24230476$2$F$20240814$20240820$20240821$20240822$PER$$US-ROCHE-10000060578$ROCHE$$66$YR$E$F$Y$$$20240822$$CN$US$US
242304771$24230477$1$I$$20240813$20240821$20240821$EXP$$US-BIOGEN-2024BI01274198$BIOGEN$$$$$M$Y$$$20240821$$CN$US$US
242304781$24230478$1$I$$20240813$20240821$20240821$EXP$$CA-BIOGEN-2024BI01278316$BIOGEN$$$$$F$Y$$$20240821$$HP$CA$CA
242304791$24230479$1$I$20240718$20240813$20240821$20240821$PER$$US-SA-2024SA244638$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240821$$MD$US$US
242304801$24230480$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA242918$SANOFI AVENTIS$$$$C$M$Y$$$20240821$$MD$US$US
242304811$24230481$1$I$20240601$20240819$20240821$20240821$EXP$$JP-SA-2024SA226491$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240821$$MD$JP$JP
242304841$24230484$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA242819$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240821$$MD$US$US
242304851$24230485$1$I$20240617$20240812$20240821$20240821$PER$$US-SA-2024SA242630$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240821$$MD$US$US
242304861$24230486$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA242633$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240821$$MD$US$US
242304871$24230487$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA243556$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240821$$CN$US$US
242304881$24230488$1$I$20240701$20240812$20240821$20240821$PER$$US-SA-2024SA242698$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240821$$MD$US$US
242304911$24230491$1$I$20220103$20240812$20240821$20240821$EXP$DE-PEI-CADR2023314674$DE-ROCHE-10000055255$ROCHE$$42$YR$A$F$Y$76$KG$20240821$$CN$DE$DE
242304921$24230492$1$I$20240804$20240813$20240821$20240821$EXP$$AR-BIOGEN-2024BI01278347$BIOGEN$$42$YR$$F$Y$$$20240821$$CN$AR$AR
242304931$24230493$1$I$20240801$20240819$20240821$20240821$PER$$US-ROCHE-10000060780$ROCHE$$43$YR$A$F$Y$$$20240821$$CN$US$US
242304941$24230494$1$I$20240812$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010926$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240821$$CN$US$US
242304951$24230495$1$I$$20240819$20240821$20240821$PER$$US-ROCHE-10000060775$ROCHE$$67$YR$E$F$Y$$$20240821$$CN$US$US
242304962$24230496$2$F$$20240814$20240821$20240822$EXP$$CO-ROCHE-10000060038$ROCHE$$32$YR$A$F$Y$$$20240822$$CN$CO$CO
242304971$24230497$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA244843$SANOFI AVENTIS$$66$YR$E$F$Y$40.8$KG$20240821$$MD$US$US
242304981$24230498$1$I$20230819$20240816$20240821$20240821$EXP$FR-AFSSAPS-LM2024000452$FR-GSK-FR2024102216$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$FR$FR
242304991$24230499$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA242575$SANOFI AVENTIS$$19$YR$A$F$Y$54.43$KG$20240821$$MD$US$US
242305001$24230500$1$I$20240629$20240812$20240821$20240821$PER$$US-SA-2024SA242626$SANOFI AVENTIS$$12$YR$T$F$Y$71.66$KG$20240821$$MD$US$US
242305011$24230501$1$I$$20240819$20240821$20240821$PER$$US-ROCHE-10000061058$ROCHE$$$$$$Y$$$20240821$$PH$US$US
242305021$24230502$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244385$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240821$$MD$US$US
242305032$24230503$2$F$20240801$20240913$20240821$20240919$EXP$$CA-BIOGEN-2024BI01278779$BIOGEN$$35$YR$$M$Y$$$20240919$$HP$CA$CA
242305042$24230504$2$F$20240501$20240813$20240821$20240828$PER$$US-IMP-2024000568$Harrow Health$$$$E$F$Y$$$20240828$$CN$US$US
242305052$24230505$2$F$$20240912$20240821$20240920$30DAY$$US-GSK-US2024101312$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$CN$US$US
242305061$24230506$1$I$20230101$20240814$20240821$20240821$EXP$$IN-BIOGEN-2024BI01278734$BIOGEN$$$$$F$Y$64.014$KG$20240821$$CN$IN$IN
242305071$24230507$1$I$$20240816$20240821$20240821$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001662$BLUEPRINT MEDICINES$$$$$F$Y$$$20240821$$CN$US$US
242305081$24230508$1$I$$20240809$20240821$20240821$EXP$$US-NOVOPROD-1270914$NOVO NORDISK$$$$$M$Y$$$20240821$$CN$US$US
242305091$24230509$1$I$$20240807$20240821$20240821$EXP$$SE-NOVOPROD-1269135$NOVO NORDISK$$$$$$Y$$$20240821$$CN$SE$SE
242305101$24230510$1$I$$20240807$20240821$20240821$EXP$$US-NOVOPROD-1269341$NOVO NORDISK$$74$YR$$F$Y$$$20240821$$CN$US$US
242305111$24230511$1$I$$20240807$20240821$20240821$EXP$$US-NOVOPROD-1269108$NOVO NORDISK$$46$YR$$$Y$$$20240821$$CN$US$US
242305121$24230512$1$I$$20240807$20240821$20240821$EXP$$US-NOVOPROD-1269930$NOVO NORDISK$$$$A$F$Y$$$20240821$$CN$US$US
242305131$24230513$1$I$$20240807$20240821$20240821$EXP$$US-NOVOPROD-1269109$NOVO NORDISK$$50$YR$$$Y$$$20240821$$CN$US$US
242305142$24230514$2$F$20240504$20240813$20240821$20240827$EXP$$DE-NOVOPROD-1269499$NOVO NORDISK$$20$YR$$M$Y$$$20240827$$CN$DE$DE
242305151$24230515$1$I$$20240809$20240821$20240821$EXP$$US-NOVOPROD-1270728$NOVO NORDISK$$$$$F$Y$$$20240821$$CN$US$US
242305161$24230516$1$I$20080101$20240807$20240821$20240821$EXP$$US-NOVOPROD-1269809$NOVO NORDISK$$49$YR$$F$Y$$$20240821$$CN$US$US
242305171$24230517$1$I$20240101$20240807$20240821$20240821$EXP$$US-NOVOPROD-1268757$NOVO NORDISK$$$$$F$Y$$$20240821$$CN$US$US
242305181$24230518$1$I$$20240807$20240821$20240821$EXP$$US-NOVOPROD-1269158$NOVO NORDISK$$69$YR$$$Y$$$20240821$$CN$US$US
242305193$24230519$3$F$$20240819$20240821$20240822$30DAY$$US-SANDOZ INC.-SDZ2024US073759$SANDOZ$$$$$F$Y$$$20240822$$CN$US$US
242305201$24230520$1$I$$20240813$20240821$20240821$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010399$STRIDES$Shang Y, Zhao H, Li D.. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.. Turk-J-Hematol. 2023;40:284-285$62$YR$$F$Y$$$20240821$$MD$CN$CN
242305211$24230521$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006278$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$74$YR$$F$Y$$$20240821$$HP$US$US
242305221$24230522$1$I$20240815$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024163404$AMGEN$$66$YR$E$F$Y$$$20240820$$CN$US$US
242305231$24230523$1$I$$20240809$20240821$20240821$EXP$$US-NOVOPROD-1270266$NOVO NORDISK$$$$$M$Y$$$20240821$$CN$US$US
242305241$24230524$1$I$$20240808$20240821$20240821$EXP$$US-NOVOPROD-1269110$NOVO NORDISK$$$$$M$Y$$$20240821$$CN$US$US
242305252$24230525$2$F$$20240821$20240821$20240902$EXP$$US-NOVOPROD-1270680$NOVO NORDISK$$$$E$F$Y$$$20240902$$MD$US$US
242305261$24230526$1$I$20240701$20240808$20240821$20240821$EXP$CN-NMPA-3305011058938202400410$CN-NOVOPROD-1268210$NOVO NORDISK$$62$YR$$M$Y$53.5$KG$20240821$$HP$CN$CN
242305271$24230527$1$I$$20240810$20240821$20240821$EXP$$EG-NOVOPROD-1270037$NOVO NORDISK$$649$MON$$F$Y$130$KG$20240821$$CN$EG$EG
242305291$24230529$1$I$$20240808$20240821$20240821$EXP$$US-NOVOPROD-1269106$NOVO NORDISK$$$$$F$Y$$$20240821$$CN$US$US
242305301$24230530$1$I$$20240809$20240821$20240821$EXP$GB-MHRA-31436412$GB-NOVOPROD-1267759$NOVO NORDISK$$50$YR$$F$Y$80$KG$20240821$$CN$GB$GB
242305321$24230532$1$I$$20240809$20240821$20240821$EXP$$US-NOVOPROD-1269940$NOVO NORDISK$$$$A$M$Y$$$20240821$$CN$US$US
242305331$24230533$1$I$$20240811$20240821$20240821$EXP$$US-NOVOPROD-1270239$NOVO NORDISK$$59$YR$$$Y$$$20240821$$CN$US$US
242305341$24230534$1$I$$20240808$20240821$20240821$EXP$$US-NOVOPROD-1269832$NOVO NORDISK$$64$YR$$$Y$$$20240821$$CN$US$US
242305351$24230535$1$I$20230601$20240808$20240821$20240821$EXP$$US-NOVOPROD-1268863$NOVO NORDISK$$59$YR$$M$Y$$$20240821$$CN$US$US
242305361$24230536$1$I$20210101$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024164552$AMGEN$$70$YR$E$F$Y$$$20240820$$CN$US$US
242305371$24230537$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006279$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$71$YR$$M$Y$$$20240821$$HP$US$US
242305381$24230538$1$I$$20240813$20240821$20240821$EXP$$AU-TAKEDA-2024TUS081937$TAKEDA$$$$$M$Y$$$20240821$$CN$AU$AU
242305391$24230539$1$I$20240806$20240816$20240821$20240821$EXP$ES-AEMPS-1558862$ES-SA-2024SA244534$SANOFI AVENTIS$$68$YR$E$F$Y$50$KG$20240821$$PH$ES$ES
242305401$24230540$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241280$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240821$$MD$US$US
242305411$24230541$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241100$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240821$$CN$US$US
242305422$24230542$2$F$20210101$20240808$20240821$20240821$EXP$$US-IBSA PHARMA INC.-2024IBS000364$IBSA INSTITUT BIOCHIMIQUE$$$$$$Y$$$20240821$$CN$US$US
242305431$24230543$1$I$$20240814$20240821$20240821$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP010370$STRIDES$MehdipourDalivand M, Abdolazimi R, Alikhani M.. Hypokalemic quadriplegia in Sjogren^s syndrome: A case report.. Clin-Case-Rep. 2024;12 (8):1-5$38$YR$$F$Y$$$20240821$$HP$IR$IR
242305441$24230544$1$I$$20240809$20240821$20240821$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002135$Alvotech$$35$YR$$M$Y$$$20240821$$CN$CA$CA
242305451$24230545$1$I$$20240814$20240821$20240821$EXP$$SA-STRIDES ARCOLAB LIMITED-2024SP010383$STRIDES$Almaqati A, Alharthy F, Almani I, Bakhsh L.. IgG4-RELATED DISEASE IN WESTERN SAUDI ARABIA: A CASE SERIES.. Ann-Rheum-Dis. 2024;83 (Suppl. 1):2058-2059 abstr. AB1409.$18$YR$$F$Y$$$20240821$$HP$SA$SA
242305461$24230546$1$I$$20240813$20240821$20240821$EXP$GB-MHRA-MED-202408131730541400-GQZMH$GB-ESPERIONTHERAPEUTICS-2024GBR01295$ESPERION THERAPEUTICS$$$$$$Y$$$20240821$$PH$GB$GB
242305471$24230547$1$I$20220901$20240812$20240821$20240821$EXP$BE-FAMHP-DHH-N2024-122467$BE-ESPERIONTHERAPEUTICS-2024BEL01297$ESPERION THERAPEUTICS$$57$YR$$M$Y$77$KG$20240821$$MD$BE$BE
242305482$24230548$2$F$$20240925$20240821$20240930$EXP$$US-ESPERIONTHERAPEUTICS-2024USA01289$ESPERION THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
242305491$24230549$1$I$20231001$20240814$20240821$20240821$EXP$GB-MHRA-MED-202408131620243690-VWZPK$GB-ESPERIONTHERAPEUTICS-2024GBR01293$ESPERION THERAPEUTICS$$76$YR$$M$Y$$$20240821$$CN$GB$GB
242305502$24230550$2$F$20240701$20240828$20240821$20240905$EXP$$HN-BIOGEN-2024BI01278723$BIOGEN$$40$YR$$F$Y$50.45$KG$20240905$$CN$HN$HN
242305511$24230551$1$I$20240701$20240724$20240821$20240821$PER$$FR-TOLMAR, INC.-24FR050684$TOLMAR$$88$YR$$M$Y$$$20240821$$PH$FR$FR
242305521$24230552$1$I$20240701$20240726$20240821$20240821$PER$$FR-TOLMAR, INC.-24FR051111$TOLMAR$$$$$M$Y$$$20240821$$PH$FR$FR
242305532$24230553$2$F$$20240726$20240821$20240913$PER$$FR-TOLMAR, INC.-24FR051005$TOLMAR$$$$$M$Y$$$20240913$$PH$FR$FR
242305541$24230554$1$I$$20240724$20240821$20240821$PER$$FR-TOLMAR, INC.-24FR051128$TOLMAR$$90$YR$$M$Y$$$20240821$$PH$FR$FR
242305551$24230555$1$I$20240718$20240725$20240821$20240821$PER$$FR-TOLMAR, INC.-24FR051178$TOLMAR$$56$YR$$M$Y$$$20240821$$PH$FR$FR
242305561$24230556$1$I$20240724$20240726$20240821$20240821$PER$$FR-TOLMAR, INC.-24FR051333$TOLMAR$$78$YR$$M$Y$$$20240821$$HP$FR$FR
242305571$24230557$1$I$$20240724$20240821$20240821$PER$$FR-TOLMAR, INC.-24FR051133$TOLMAR$$$$$M$Y$$$20240821$$PH$FR$FR
242305581$24230558$1$I$20240724$20240725$20240821$20240821$PER$$FR-TOLMAR, INC.-24FR051334$TOLMAR$$69$YR$$M$Y$$$20240821$$PH$FR$FR
242305591$24230559$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006280$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$74$YR$$M$Y$$$20240821$$HP$US$US
242305601$24230560$1$I$$20240816$20240821$20240821$EXP$$US-BIOGEN-2024BI01278792$BIOGEN$$$$$M$Y$$$20240821$$CN$US$US
242305611$24230561$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009312$APOTEX$$74$YR$$M$Y$$$20240821$$HP$CA$CA
242305621$24230562$1$I$$20240815$20240821$20240821$EXP$$US-GSK-US2024AMR102930$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
242305633$24230563$3$F$20230401$20240916$20240821$20240924$PER$$US-ROCHE-10000059328$ROCHE$$80$YR$E$F$Y$$$20240924$$CN$US$US
242305641$24230564$1$I$20240711$20240816$20240821$20240821$EXP$ES-009507513-2407ESP013839$ES-GSK-ES2024GSK104057$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$ES$ES
242305651$24230565$1$I$$20240815$20240821$20240821$PER$$US-BEH-2024177337$CSL BEHRING$$$$E$F$Y$$$20240821$$MD$US$US
242305661$24230566$1$I$$20240816$20240821$20240821$EXP$GB-MHRA-TPP18321594C21206878YC1723194495744$GB-STRIDES ARCOLAB LIMITED-2024SP010401$STRIDES$$67$YR$$M$Y$70$KG$20240821$$MD$GB$GB
242305671$24230567$1$I$$20240819$20240821$20240821$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-131491$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240821$$HP$CA$CA
242305681$24230568$1$I$$20240702$20240821$20240821$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000230$ARCUTIS$$$$$$Y$$$20240820$$MD$US$US
242305691$24230569$1$I$$20240704$20240821$20240821$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000233$ARCUTIS$$$$$$Y$$$20240820$$MD$US$US
242305701$24230570$1$I$$20240710$20240821$20240821$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000238$ARCUTIS$$$$$$Y$$$20240820$$MD$US$US
242305711$24230571$1$I$$20240711$20240821$20240821$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000240$ARCUTIS$$$$$$Y$$$20240820$$MD$US$US
242305721$24230572$1$I$20240601$20240722$20240821$20240821$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000241$ARCUTIS$$$$$$Y$$$20240820$$CN$US$US
242305731$24230573$1$I$$20240716$20240821$20240821$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000244$ARCUTIS$$$$$F$Y$$$20240820$$HP$US$US
242305741$24230574$1$I$$20240722$20240821$20240821$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000247$ARCUTIS$$$$$$Y$$$20240820$$CN$US$US
242305751$24230575$1$I$$20240813$20240821$20240821$EXP$$CO-EMD Serono-2024044500$EMD SERONO INC$$$$A$M$Y$$$20240821$$CN$CO$CO
242305761$24230576$1$I$$20240819$20240821$20240821$EXP$$US-AstraZeneca-2024A189075$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242305771$24230577$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A184847$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242305781$24230578$1$I$20240727$20240816$20240821$20240821$EXP$$ES-AstraZeneca-2024A187157$ASTRAZENECA$$89$YR$$F$Y$$$20240821$$MD$ES$
242305791$24230579$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006281$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$72$YR$$M$Y$$$20240821$$HP$US$US
242305801$24230580$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006282$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$81$YR$$M$Y$$$20240821$$HP$US$US
242305811$24230581$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010815$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240821$$CN$US$US
242305822$24230582$2$F$$20240819$20240821$20240821$PER$$NVSC2024US167385$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
242305831$24230583$1$I$$20240816$20240821$20240821$EXP$$US-TAKEDA-2023TUS094203$TAKEDA$$$$$M$Y$$$20240821$$CN$US$US
242305841$24230584$1$I$20240701$20240818$20240821$20240821$EXP$$US-ABBVIE-5885136$ABBVIE$$56$YR$$F$Y$$$20240821$$CN$US$US
242305851$24230585$1$I$20240723$20240725$20240821$20240821$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000681$PAREXEL$$$$$$Y$$$20240821$$PH$US$US
242305861$24230586$1$I$20240725$20240725$20240821$20240821$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000682$PAREXEL$$$$$$Y$$$20240821$$CN$US$US
242305871$24230587$1$I$20240810$20240814$20240821$20240821$EXP$GB-MHRA-MED-202408131719474290-JHNLS$GB-DEXPHARM-2024-2805$DEXCEL$$39$YR$A$F$Y$$$20240821$$HP$GB$GB
242305881$24230588$1$I$20240701$20240807$20240821$20240821$PER$$US-ARCUTIS BIOTHERAPEUTICS INC-2024AER000250$ARCUTIS$$$$$$Y$$$20240820$$CN$US$US
242305892$24230589$2$F$$20240820$20240821$20240826$PER$$US-ROCHE-10000061085$ROCHE$$$$$F$Y$$$20240826$$CN$US$US
242305901$24230590$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009324$APOTEX$$47$YR$$F$Y$$$20240821$$HP$CA$CA
242305911$24230591$1$I$20240502$20240812$20240821$20240821$EXP$FR-AFSSAPS-PP2024000861$FR-TAKEDA-2024TUS083669$TAKEDA$$90$YR$$F$Y$$$20240821$$HP$FR$FR
242305921$24230592$1$I$20240719$20240812$20240821$20240821$EXP$$US-APOTEX-2024AP009250$APOTEX$$79$YR$E$M$Y$$$20240821$$HP$US$US
242305931$24230593$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006285$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$71$YR$$M$Y$$$20240821$$HP$US$US
242305941$24230594$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006284$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$66$YR$$F$Y$$$20240821$$HP$US$US
242305951$24230595$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006283$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$74$YR$$M$Y$$$20240821$$HP$US$US
242305961$24230596$1$I$20240101$20240816$20240821$20240821$EXP$$US-ABBVIE-5885595$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242305971$24230597$1$I$20220101$20240816$20240821$20240821$EXP$$US-ABBVIE-5884493$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242305982$24230598$2$F$$20240823$20240821$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07366$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242305991$24230599$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006286$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$71$YR$$F$Y$$$20240821$$HP$US$US
242306001$24230600$1$I$20240701$20240813$20240821$20240821$EXP$$US-GSK-US2024100678$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240821$$CN$US$US
242306011$24230601$1$I$20240101$20240816$20240821$20240821$EXP$$US-SA-2024SA245789$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240821$$MD$US$US
242306021$24230602$1$I$$20240807$20240821$20240821$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK093199$GLENMARK$Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP.. A case of human T-lymphotropic virus-1-associated lichenoid dermatitis.. Clinical and Experimental Dermatology.. 2024;49(8):916-18$$$$$Y$$$20240821$$MD$GB$GB
242306031$24230603$1$I$20240301$20240816$20240821$20240821$EXP$$US-ABBVIE-5885574$ABBVIE$$47$YR$$F$Y$$$20240821$$CN$US$US
242306041$24230604$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006287$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$48$YR$$F$Y$$$20240821$$HP$US$US
242306052$24230605$2$F$20240815$20240916$20240821$20240921$PER$$US-JNJFOC-20240842766$JOHNSON AND JOHNSON$$$$$M$Y$$$20240921$$HP$US$US
242306061$24230606$1$I$$20240812$20240821$20240821$PER$$US-JNJFOC-20240828455$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$CN$US$US
242306071$24230607$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462442$RANBAXY$$$$$$Y$$$20240821$$CN$US$US
242306081$24230608$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463301$RANBAXY$Jodeh W, Sparks PJ, Higgins JM, Tom A, Anilovich N, Moit H, et al. Parathyroid hormone-related peptide induced hypercalcemia of pregnancy due to mammary hyperplasia. JBMR Plus. 2024;8 (8):ziae083(1-5)$$$N$$Y$$$20240821$$MD$US$US
242306091$24230609$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462585$RANBAXY$$$$E$M$Y$$$20240821$$CN$US$US
242306101$24230610$1$I$20141001$20240819$20240821$20240821$EXP$$ES-SANDOZ INC.-PHHY2018ES021558$SANDOZ$$60$YR$$M$Y$$$20240821$$MD$ES$ES
242306111$24230611$1$I$$20240813$20240821$20240821$EXP$$AU-TOLMAR, INC.-24AU051811$TOLMAR$$$$$M$Y$$$20240821$$CN$AU$AU
242306121$24230612$1$I$$20240813$20240821$20240821$EXP$$CA-TOLMAR, INC.-24CA051842$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
242306131$24230613$1$I$20240727$20240813$20240821$20240821$EXP$$CA-TOLMAR, INC.-24CA051207$TOLMAR$$90$YR$$M$Y$$$20240821$$CN$CA$CA
242306141$24230614$1$I$$20240813$20240821$20240821$EXP$$CA-TOLMAR, INC.-24CA051847$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
242306151$24230615$1$I$$20240813$20240821$20240821$EXP$$CA-TOLMAR, INC.-24CA051879$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
242306161$24230616$1$I$$20240813$20240821$20240821$EXP$$NL-TOLMAR, INC.-24NL051844$TOLMAR$$$$$M$Y$$$20240821$$CN$NL$NL
242306171$24230617$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006288$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$63$YR$$F$Y$$$20240821$$HP$US$US
242306191$24230619$1$I$20240722$20240816$20240821$20240821$EXP$GB-MHRA-MED-202408161034207350-MKHSF$GB-SANDOZ INC.-SDZ2024GB073324$SANDOZ$$$$$F$Y$67$KG$20240821$$CN$GB$GB
242306202$24230620$2$F$20210101$20240820$20240821$20240823$PER$$US-AMGEN-USASP2024165538$AMGEN$$52$YR$A$F$Y$$$20240823$$CN$US$US
242306212$24230621$2$F$$20240906$20240821$20240912$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001623$BLUEPRINT MEDICINES$$$$$F$Y$$$20240912$$MD$US$US
242306222$24230622$2$F$$20240919$20240821$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-128664$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240927$$MD$JP$JP
242306231$24230623$1$I$20240705$20240812$20240821$20240821$EXP$$US-GSK-US2024100249$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
242306241$24230624$1$I$20230101$20240815$20240821$20240821$EXP$$US-UCBSA-2023050194$UCB$$$$$F$Y$$$20240821$$CN$US$US
242306251$24230625$1$I$$20240814$20240821$20240821$PER$$US-ROCHE-10000058352$ROCHE$$$$A$M$Y$$$20240821$$CN$US$US
242306261$24230626$1$I$20240101$20240815$20240821$20240821$EXP$$US-ABBVIE-5885562$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242306271$24230627$1$I$20240801$20240819$20240821$20240821$EXP$$RO-ABBVIE-5886699$ABBVIE$$56$YR$$M$Y$$$20240821$$CN$RO$RO
242306281$24230628$1$I$20240816$20240816$20240821$20240821$EXP$$JP-ABBVIE-5885650$ABBVIE$$$$$M$Y$$$20240821$$CN$JP$JP
242306291$24230629$1$I$$20240819$20240821$20240821$EXP$$US-JNJFOC-20240849566$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
242306301$24230630$1$I$20240701$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009592$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240821$$CN$US$US
242306311$24230631$1$I$$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408008445$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240821$$CN$US$US
242306323$24230632$3$F$20240816$20240822$20240821$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408011738$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240826$$CN$US$US
242306331$24230633$1$I$$20240807$20240821$20240821$EXP$$US-APOTEX-2024AP009468$APOTEX$$$$$F$Y$$$20240821$$CN$US$US
242306341$24230634$1$I$20240722$20240722$20240821$20240821$PER$$TR-TOLMAR, INC.-24TR051253$TOLMAR$$61$YR$$$Y$$$20240821$$MD$TR$TR
242306351$24230635$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006289$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$76$YR$$F$Y$$$20240821$$HP$US$US
242306361$24230636$1$I$$20240722$20240821$20240821$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024092416$VIIV$$$$$F$Y$99.773$KG$20240821$$HP$US$US
242306371$24230637$1$I$20240801$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024163901$AMGEN$$58$YR$A$M$Y$$$20240820$$CN$US$US
242306382$24230638$2$F$20240815$20240815$20240821$20240826$PER$$US-AMGEN-USASP2024164171$AMGEN$$69$YR$E$F$Y$$$20240826$$CN$US$US
242306391$24230639$1$I$$20240818$20240821$20240821$PER$$US-AMGEN-USASP2024165034$AMGEN$$$$$M$Y$$$20240820$$HP$US$US
242306401$24230640$1$I$$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024164095$AMGEN$$$$$F$Y$$$20240820$$HP$US$US
242306411$24230641$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006290$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$61$YR$$F$Y$$$20240821$$HP$US$US
242306431$24230643$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006291$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$45$YR$$M$Y$$$20240821$$HP$US$US
242306441$24230644$1$I$$20240813$20240821$20240821$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001636$BLUEPRINT MEDICINES$$$$$F$Y$$$20240821$$CN$US$US
242306452$24230645$2$F$20240808$20240912$20240821$20240918$30DAY$$BR-JNJFOC-20240806587$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$HP$BR$BR
242306461$24230646$1$I$20240812$20240813$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US072513$SANDOZ$$14$YR$$M$Y$$$20240821$$CN$US$US
242306471$24230647$1$I$$20240815$20240821$20240821$PER$$US-ABBVIE-5885675$ABBVIE$$$$$$Y$$$20240821$$CN$US$US
242306482$24230648$2$F$$20240812$20240821$20240825$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093200$GLENMARK$Dykes K, Tzachanis D, Koura D.. A Difficult case of calcineurin inhibitor neurotoxicity post-haploidentical HCT with a successful novel solution: Cytotoxic T-lymphocyte-associated protein 4-immunoglobulin blockade for gvhd prophylaxis.. Cell transplantation.. 2024;33:1-7$$$$$Y$$$20240825$$MD$US$US
242306491$24230649$1$I$20230101$20240808$20240821$20240821$EXP$$PL-AUROBINDO-AUR-APL-2024-040654$AUROBINDO$$76$YR$$M$Y$91$KG$20240821$$MD$PL$PL
242306501$24230650$1$I$20240815$20240815$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US073159$SANDOZ$$16$YR$$M$Y$$$20240821$$CN$US$US
242306511$24230651$1$I$$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131711$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240821$$CN$US$US
242306521$24230652$1$I$$20240729$20240821$20240821$PER$$AU-TOLMAR, INC.-24AU051140$TOLMAR$$$$$M$Y$$$20240821$$CN$AU$AU
242306531$24230653$1$I$$20240729$20240821$20240821$PER$$AU-TOLMAR, INC.-24AU051438$TOLMAR$$$$$M$Y$$$20240821$$CN$AU$AU
242306541$24230654$1$I$20240728$20240729$20240821$20240821$PER$$AU-TOLMAR, INC.-24AU051383$TOLMAR$$88$YR$$M$Y$$$20240821$$CN$AU$AU
242306552$24230655$2$F$$20240826$20240821$20240919$PER$$BR-TOLMAR, INC.-24BR051098$TOLMAR$$$$$F$Y$$$20240919$$MD$BR$BR
242306561$24230656$1$I$20240101$20240729$20240821$20240821$PER$$BR-TOLMAR, INC.-24BR051448$TOLMAR$$$$$M$Y$$$20240821$$CN$BR$BR
242306571$24230657$1$I$$20240729$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051017$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
242306581$24230658$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006292$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$73$YR$$M$Y$$$20240821$$HP$US$US
242306591$24230659$1$I$20240101$20240816$20240821$20240821$PER$$US-AMGEN-USASL2024165425$AMGEN$$$$$F$Y$$$20240820$$CN$US$US
242306603$24230660$3$F$20240101$20240905$20240821$20240910$EXP$$US-AMGEN-USASL2024106198$AMGEN$$58$YR$A$F$Y$81.995$KG$20240910$$CN$US$US
242306612$24230661$2$F$20240812$20240826$20240821$20240828$PER$$US-AMGEN-USASP2024163904$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242306621$24230662$1$I$$20240815$20240821$20240821$EXP$$ZA-AMGEN-ZAFSP2024163264$AMGEN$$$$$F$Y$$$20240820$$HP$ZA$ZA
242306631$24230663$1$I$$20240809$20240821$20240821$PER$$US-JNJFOC-20240828571$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242306642$24230664$2$F$20210101$20240814$20240821$20240912$PER$$US-BEH-2024177326$CSL BEHRING$$$$A$F$Y$$$20240912$$CN$US$US
242306651$24230665$1$I$$20240813$20240821$20240821$EXP$$CA-TAKEDA-2024TUS082003$TAKEDA$$$$$M$Y$$$20240821$$CN$CA$CA
242306661$24230666$1$I$$20240816$20240821$20240821$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001663$BLUEPRINT MEDICINES$$$$$F$Y$$$20240821$$CN$US$US
242306671$24230667$1$I$$20240812$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127595$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240821$$CN$US$US
242306681$24230668$1$I$$20240803$20240821$20240821$PER$$NVSC2024US168614$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
242306691$24230669$1$I$$20240812$20240821$20240821$EXP$$US-NOVOPROD-1269019$NOVO NORDISK$$$$$F$Y$$$20240821$$CN$US$US
242306701$24230670$1$I$$20240812$20240821$20240821$EXP$$TR-NOVOPROD-1270553$NOVO NORDISK$$$$$M$Y$$$20240821$$CN$TR$TR
242306711$24230671$1$I$$20240812$20240821$20240821$EXP$AU-TGA-0000783028$AU-NOVOPROD-1270703$NOVO NORDISK$$53$YR$$F$Y$$$20240821$$MD$AU$AU
242306721$24230672$1$I$$20240812$20240821$20240821$EXP$$CN-NOVOPROD-1269379$NOVO NORDISK$$56$YR$$M$Y$77$KG$20240821$$CN$CN$CN
242306731$24230673$1$I$20200101$20240812$20240821$20240821$EXP$$EG-NOVOPROD-1268993$NOVO NORDISK$$636$MON$$M$Y$105$KG$20240821$$CN$EG$EG
242306741$24230674$1$I$$20240812$20240821$20240821$EXP$CA-HEALTHCANVIG-E2B_03027200$CA-NOVOPROD-1269453$NOVO NORDISK$$4$YR$$M$Y$$$20240821$$HP$CA$CA
242306751$24230675$1$I$20230817$20240812$20240821$20240821$EXP$AU-TGA-0000784634$AU-NOVOPROD-1269665$NOVO NORDISK$$60$YR$$F$Y$$$20240821$$MD$AU$AU
242306761$24230676$1$I$$20240812$20240821$20240821$EXP$CA-HEALTHCANVIG-E2B_07225865$CA-NOVOPROD-1269734$NOVO NORDISK$$55$YR$$M$Y$$$20240821$$CN$CA$CA
242306771$24230677$1$I$20240701$20240812$20240821$20240821$EXP$$US-NOVOPROD-1269247$NOVO NORDISK$$$$A$F$Y$$$20240821$$HP$US$US
242306781$24230678$1$I$20230807$20240812$20240821$20240821$EXP$AU-TGA-0000784062$AU-NOVOPROD-1269660$NOVO NORDISK$$24$YR$$F$Y$$$20240821$$CN$AU$AU
242306791$24230679$1$I$20240528$20240812$20240821$20240821$EXP$$US-NOVOPROD-1270673$NOVO NORDISK$$56$YR$$M$Y$94.34$KG$20240821$$CN$US$US
242306801$24230680$1$I$20220801$20240812$20240821$20240821$EXP$SE-SEMPA-2024-006019$SE-NOVOPROD-1269831$NOVO NORDISK$$69$YR$$F$Y$$$20240821$$CN$SE$SE
242306811$24230681$1$I$$20240812$20240821$20240821$EXP$$US-NOVOPROD-1263159$NOVO NORDISK$$$$$$Y$$$20240821$$HP$US$US
242306821$24230682$1$I$$20230522$20240821$20240821$EXP$$US-AstraZeneca-2023A080820$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242306831$24230683$1$I$20240101$20240815$20240821$20240821$EXP$$US-ROCHE-10000060040$ROCHE$$38$YR$A$F$Y$$$20240821$$CN$US$US
242306841$24230684$1$I$$20240816$20240821$20240821$PER$$US-ROCHE-10000060469$ROCHE$$78$YR$E$M$Y$$$20240821$$MD$US$US
242306851$24230685$1$I$20240819$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165465$AMGEN$$42$YR$A$F$Y$$$20240820$$CN$US$US
242306861$24230686$1$I$$20240811$20240821$20240821$EXP$$ES-AMGEN-ESPSP2024163383$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240820$$HP$ES$ES
242306872$24230687$2$F$20240627$20240820$20240821$20240823$EXP$ES-AEMPS-1557574$ES-GSK-ES2024098787$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$ES$ES
242306881$24230688$1$I$$20240812$20240821$20240821$EXP$$FR-NOVOPROD-1233990$NOVO NORDISK$$$$$F$Y$$$20240821$$PH$FR$FR
242306891$24230689$1$I$$20240815$20240821$20240821$EXP$$SI-AMGEN-SVNSP2024163001$AMGEN$$72$YR$E$M$Y$$$20240820$$MD$SI$SI
242306901$24230690$1$I$20240709$20240812$20240821$20240821$EXP$$ES-NOVOPROD-1258221$NOVO NORDISK$$$$$F$Y$81$KG$20240821$$CN$ES$ES
242306911$24230691$1$I$20240314$20240815$20240821$20240821$EXP$$DE-MEN-2024-108096$MENARINI$$78$YR$$F$Y$$$20240821$$CN$DE$DE
242306921$24230692$1$I$$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024164698$AMGEN$$$$$$Y$$$20240820$$CN$US$US
242306931$24230693$1$I$20240801$20240808$20240821$20240821$PER$$US-SA-2024SA241149$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240821$$MD$US$US
242306941$24230694$1$I$20240805$20240808$20240821$20240821$PER$$US-SA-2024SA241428$SANOFI AVENTIS$$15$YR$T$F$Y$54.422$KG$20240821$$MD$US$US
242306951$24230695$1$I$$20240807$20240821$20240821$PER$$US-SA-2024SA239393$SANOFI AVENTIS$$$$E$F$Y$$$20240821$$MD$US$US
242306961$24230696$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA242702$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240821$$MD$US$US
242306971$24230697$1$I$20240801$20240814$20240821$20240821$PER$$US-SA-2024SA244704$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240821$$MD$US$US
242306981$24230698$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243479$SANOFI AVENTIS$$$$E$M$Y$$$20240821$$MD$US$US
242306991$24230699$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244111$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240821$$CN$US$US
242307001$24230700$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA243239$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240821$$MD$US$US
242307011$24230701$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241667$SANOFI AVENTIS$$$$T$M$Y$$$20240821$$MD$US$US
242307021$24230702$1$I$$20240809$20240821$20240821$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-002037$IPCA$Ruben Vaidya, Nabeel Hashmi, Salima Kakshapati et al.. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024;xx-x-xx:1-6$$$$$Y$$$20240821$$MD$US$US
242307031$24230703$1$I$20240701$20240812$20240821$20240821$PER$$US-SA-2024SA242791$SANOFI AVENTIS$$$$C$F$Y$$$20240821$$MD$US$US
242307041$24230704$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA244635$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240821$$MD$US$US
242307051$24230705$1$I$20230101$20240812$20240821$20240821$PER$$US-SA-2024SA244846$SANOFI AVENTIS$$52$YR$A$F$Y$78$KG$20240821$$MD$US$US
242307061$24230706$1$I$20240801$20240819$20240821$20240821$EXP$$JP-009507513-2408JPN001994J$MERCK$$75$YR$$F$Y$$$20240821$$PH$JP$JP
242307071$24230707$1$I$20230101$20240815$20240821$20240821$EXP$$US-UCBSA-2024041337$UCB$$$$$M$Y$$$20240821$$CN$US$US
242307081$24230708$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011150$ELI LILLY AND CO$$$$$F$Y$$$20240821$$CN$US$US
242307091$24230709$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011774$ELI LILLY AND CO$$$$$M$Y$$$20240821$$CN$US$US
242307101$24230710$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011764$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240821$$CN$US$US
242307111$24230711$1$I$20240808$20240809$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011688$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240821$$CN$US$US
242307121$24230712$1$I$20240814$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011540$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240821$$CN$US$US
242307131$24230713$1$I$20240805$20240808$20240821$20240821$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US000152$PAREXEL$$$$$$Y$$$20240821$$CN$US$US
242307141$24230714$1$I$$20240812$20240821$20240821$EXP$$US-GSK-US2024100361$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242307152$24230715$2$F$20240809$20240814$20240821$20240823$30DAY$$US-GSK-US2024100796$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240823$$CN$US$US
242307161$24230716$1$I$20240816$20240819$20240821$20240821$EXP$$MK-ROCHE-10000060680$ROCHE$$8$YR$C$F$Y$12$KG$20240821$$MD$MK$MK
242307181$24230718$1$I$20240627$20240819$20240821$20240821$EXP$$CN-ROCHE-10000060738$ROCHE$$45$YR$A$F$Y$43$KG$20240821$$HP$CN$CN
242307191$24230719$1$I$20240816$20240816$20240821$20240821$PER$$US-JNJFOC-20240843842$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240821$$PH$US$US
242307201$24230720$1$I$$20220426$20240821$20240821$EXP$$US-AstraZeneca-2022A166185$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242307211$24230721$1$I$20240701$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164589$AMGEN$$30$YR$A$F$Y$$$20240820$$CN$US$US
242307222$24230722$2$F$20230107$20240903$20240821$20240905$EXP$$CA-ROCHE-3259939$ROCHE$$28$YR$A$F$Y$$$20240905$$CN$CA$CA
242307231$24230723$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164608$AMGEN$$$$$F$Y$$$20240820$$MD$US$US
242307241$24230724$1$I$20240101$20240809$20240821$20240821$PER$$US-TEVA-VS-3231707$TEVA$$59$YR$$F$Y$$$20240821$$HP$US$US
242307251$24230725$1$I$$20240815$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US073024$SANDOZ$$$$$F$Y$$$20240821$$CN$US$US
242307261$24230726$1$I$$20240820$20240821$20240821$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046916$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240821$$MD$US$US
242307271$24230727$1$I$20240712$20240816$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US065505$SANDOZ$$14$YR$$M$Y$$$20240821$$CN$US$US
242307281$24230728$1$I$$20240814$20240821$20240821$EXP$$CA-JNJFOC-20240747763$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240821$$PH$CA$CA
242307292$24230729$2$F$20230519$20240911$20240821$20240916$EXP$IT-MINISAL02-999173$IT-JNJFOC-20240849361$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240916$$PH$IT$IT
242307301$24230730$1$I$$20240819$20240821$20240821$EXP$$JP-SANDOZ INC.-SDZ2024JP073421$SANDOZ$$$$$$Y$$$20240821$$PH$JP$JP
242307311$24230731$1$I$$20240813$20240821$20240821$PER$$US-BIOGEN-2020BI00838917$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
242307321$24230732$1$I$20160418$20240814$20240821$20240821$PER$$US-BIOGEN-2016BI00234886$BIOGEN$$50$YR$$F$Y$$$20240821$$CN$US$US
242307331$24230733$1$I$20240728$20240816$20240821$20240821$EXP$$GB-SANDOZ INC.-SDZ2024GB027142$SANDOZ$$85$YR$$M$Y$$$20240821$$CN$GB$GB
242307341$24230734$1$I$$20240808$20240821$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-038939$AUROBINDO$Lauffenburger D. Hypocupremia: A Sequela of Bariatric Surgery. South-Med-J. 2023;116608-609$59$YR$$F$Y$$$20240821$$HP$US$US
242307351$24230735$1$I$$20240816$20240821$20240821$EXP$$CA-ROCHE-10000060693$ROCHE$$$$A$F$Y$$$20240821$$CN$CA$CA
242307362$24230736$2$F$20240101$20240808$20240821$20240823$EXP$$US-UCBSA-2024040132$UCB$$$$$F$Y$$$20240823$$CN$US$US
242307371$24230737$1$I$20240801$20240815$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US073242$SANDOZ$$59$YR$$F$Y$$$20240821$$CN$US$US
242307381$24230738$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131221$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240821$$HP$US$US
242307391$24230739$1$I$$20240815$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US073374$SANDOZ$$$$$F$Y$$$20240821$$MD$US$US
242307401$24230740$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009249$APOTEX$$$$$F$Y$$$20240821$$HP$CA$CA
242307411$24230741$1$I$$20240812$20240821$20240821$30DAY$$US-GSK-US2024100372$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242307421$24230742$1$I$20180602$20240813$20240821$20240821$EXP$$UG-DEXPHARM-2024-2866$DEXCEL$Lubega, G.; Lutaakome, J.; Kibirige, M.; Opoka, D.; Atukunda, I.; Ruzagira, E.  Vitamin B12 deficiency presenting as progressive blindness in a 33-year- old HIV-positive female patient on Efavirenz-based regimen: case report. Pan African Medical Journal 2024, V47, P164$33$YR$A$F$Y$$$20240821$$HP$UG$UG
242307432$24230743$2$F$$20240813$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US072685$SANDOZ$$$$$F$Y$$$20240821$$CN$US$US
242307441$24230744$1$I$20221215$20240808$20240821$20240821$EXP$$GB-MACLEODS PHARMA-MAC2024048844$MACLEODS$$38$YR$A$F$Y$$$20240820$$CN$GB$GB
242307453$24230745$3$F$20181201$20240919$20240821$20240930$EXP$$GB-MACLEODS PHARMA-MAC2024048859$MACLEODS$Ibrahim A, Prasad G, Kilpatrick ES, Morris TJ..A case of autoimmune hepatitis associated with the PCSK9 inhibitor alirocumab.Annals of Clinical Biochemistry.2024;00(00):45632241269657$$$$$Y$$$20240930$$MD$GB$GB
242307461$24230746$1$I$20240815$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024164255$AMGEN$$$$$$Y$$$20240820$$HP$US$US
242307473$24230747$3$F$20240812$20240916$20240821$20240921$EXP$$US-ABBVIE-5886179$ABBVIE$$59$YR$$F$Y$$$20240921$$CN$US$US
242307481$24230748$1$I$20240801$20240812$20240821$20240821$PER$$US-ABBVIE-5877970$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242307492$24230749$2$F$$20240814$20240821$20240911$PER$$US-BEH-2024177262$CSL BEHRING$$$$E$M$Y$$$20240911$$HP$US$US
242307501$24230750$1$I$20240818$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165446$AMGEN$$65$YR$E$F$Y$$$20240820$$CN$US$US
242307511$24230751$1$I$$20240813$20240821$20240821$EXP$$CA-CELLTRION INC.-2022CA016580$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
242307521$24230752$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009322$APOTEX$$45$YR$$F$Y$$$20240821$$HP$CA$CA
242307531$24230753$1$I$$20240809$20240821$20240821$PER$$US-ROCHE-10000055363$ROCHE$$$$$$Y$$$20240821$$CN$US$US
242307541$24230754$1$I$20240424$20240815$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US045517$SANDOZ$$20$YR$$M$Y$$$20240821$$HP$US$US
242307551$24230755$1$I$$20240815$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US073255$SANDOZ$$$$$$Y$$$20240821$$CN$US$US
242307562$24230756$2$F$20240701$20240815$20240821$20240822$PER$$US-BIOGEN-2024BI01278456$BIOGEN$$36$YR$$F$Y$$$20240822$$HP$US$US
242307571$24230757$1$I$$20240815$20240821$20240821$PER$$US-BIOGEN-2015BI109988$BIOGEN$$$$$M$Y$$$20240821$$CN$US$US
242307581$24230758$1$I$$20240814$20240821$20240821$PER$$US-BIOGEN-2020BI00960624$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
242307591$24230759$1$I$$20240814$20240821$20240821$PER$$US-BIOGEN-2024BI01278467$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
242307601$24230760$1$I$20240818$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012098$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240821$$CN$US$US
242307611$24230761$1$I$$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012493$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240821$$CN$US$US
242307621$24230762$1$I$20240813$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408008986$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240821$$CN$US$US
242307631$24230763$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011562$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240821$$CN$US$US
242307641$24230764$1$I$20230101$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011828$ELI LILLY AND CO$$$$A$M$Y$$$20240821$$CN$US$US
242307651$24230765$1$I$20240814$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010922$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240821$$CN$US$US
242307661$24230766$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011535$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240821$$CN$US$US
242307671$24230767$1$I$$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011187$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240821$$CN$US$US
242307681$24230768$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009326$APOTEX$$48$YR$$M$Y$$$20240821$$HP$CA$CA
242307691$24230769$1$I$20240818$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408003156$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240821$$CN$US$US
242307701$24230770$1$I$20240819$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011946$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240821$$CN$US$US
242307711$24230771$1$I$$20240813$20240821$20240821$EXP$$FR-SANDOZ INC.-SDZ2024FR072807$SANDOZ$Brehon Alice, Lourenco Jeremy, Badaoui Antoine, Amsler Emmanuelle, Lopez Zaragoza Jose Luis, Soria Angele, Barbaud Annick. Doxycycline-induced fixed drug eruption: The new epidemic?. Journal of the European Academy of Dermatology and Venereology$41$YR$$M$Y$$$20240821$$HP$FR$FR
242307721$24230772$1$I$$20240814$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US073177$SANDOZ$$55$YR$$F$Y$$$20240821$$MD$US$US
242307732$24230773$2$F$20240810$20240830$20240821$20240903$EXP$$CN-ROCHE-10000060960$ROCHE$$89$YR$E$F$Y$50$KG$20240903$$HP$CN$CN
242307741$24230774$1$I$$20240816$20240821$20240821$EXP$$AU-SANDOZ INC.-SDZ2024AU073839$SANDOZ$$$$$$Y$$$20240821$$HP$AU$AU
242307751$24230775$1$I$$20240816$20240821$20240821$PER$$NVSC2024US168494$NOVARTIS$$$$$M$Y$$$20240821$$CN$US$US
242307762$24230776$2$F$$20240131$20240821$20240903$EXP$$GB-TEVA-VS-3230210$TEVA$$48$YR$$M$Y$$$20240903$$CN$GB$GB
242307771$24230777$1$I$20240808$20240809$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US074070$SANDOZ$$58$YR$$F$Y$$$20240821$$CN$US$US
242307781$24230778$1$I$$20240807$20240821$20240821$EXP$GB-MHRA-MED-202408072348525630-ZFNMG$GB-GLENMARK PHARMACEUTICALS-2024GMK093241$GLENMARK$$$$$$Y$$$20240821$$CN$GB$GB
242307791$24230779$1$I$20240815$20240820$20240821$20240821$EXP$$PK-ROCHE-10000061763$ROCHE$$47$YR$A$F$Y$$$20240821$$CN$PK$PK
242307801$24230780$1$I$20240810$20240816$20240821$20240821$EXP$$CN-ROCHE-10000060056$ROCHE$$34$YR$A$F$Y$50$KG$20240821$$HP$CN$CN
242307811$24230781$1$I$$20240808$20240821$20240821$EXP$$IT-AUROBINDO-AUR-APL-2024-040694$AUROBINDO$Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G et al... Stevens-Johnson syndrome associated with drugs and vaccines in children: a case-control study... Plos One. 2013;8(7):e68231-8.$18$MON$$F$Y$$$20240821$$HP$IT$IT
242307821$24230782$1$I$$20240812$20240821$20240821$EXP$$KR-NOVITIUMPHARMA-2024KRNVP01617$NOVITIUM PHARMA$D Nho.Disseminated Saprochaete capitata infection in a hematologic malignancy patient.Journal of Infection and Chemotherapy.30-APR-2023;55(1):1-4$65$YR$A$F$Y$$$20240821$$HP$KR$KR
242307832$24230783$2$F$$20240910$20240821$20240910$EXP$$US-ALXN-202408USA001013US$ALEXION PHARMACEUTICALS$$60$YR$$F$Y$$$20240910$$MD$US$US
242307841$24230784$1$I$20240101$20240816$20240821$20240821$EXP$$US-SA-2024SA245982$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240821$$MD$US$US
242307861$24230786$1$I$20240201$20240808$20240821$20240821$EXP$$IT-AUROBINDO-AUR-APL-2024-040601$AUROBINDO$$75$YR$$F$Y$55$KG$20240821$$MD$IT$IT
242307871$24230787$1$I$$20220916$20240821$20240821$EXP$$US-AstraZeneca-2022A324866$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242307881$24230788$1$I$$20221003$20240821$20240821$EXP$$US-AstraZeneca-2022A337003$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242307891$24230789$1$I$$20210825$20240821$20240821$EXP$$US-AstraZeneca-2021A700801$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242307902$24230790$2$F$20240813$20240904$20240821$20240911$PER$$US-BEH-2024177383$CSL BEHRING$$66$YR$E$F$Y$$$20240911$$HP$US$US
242307911$24230791$1$I$$20220927$20240821$20240821$EXP$$AU-AstraZeneca-2022A334015$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$AU$
242307921$24230792$1$I$20220812$20220812$20240821$20240821$EXP$$US-AstraZeneca-2022A286748$ASTRAZENECA$$26761$DY$$F$Y$$$20240821$$CN$US$
242307931$24230793$1$I$$20230117$20240821$20240821$EXP$$US-AstraZeneca-2023A014738$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242307942$24230794$2$F$20240817$20240823$20240821$20240826$PER$$US-AMGEN-USASP2024165532$AMGEN$$34$YR$A$F$Y$$$20240826$$HP$US$US
242307951$24230795$1$I$$20240809$20240821$20240821$PER$$US-APOTEX-2024AP009194$APOTEX$$$$$F$Y$$$20240821$$CN$US$US
242307971$24230797$1$I$$20240805$20240821$20240821$PER$$US-CHATTEMPRD-2024OHG026303$CHATTEM$$$$$$Y$$$20240821$$CN$US$US
242307981$24230798$1$I$$20240808$20240821$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-040634$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology. 2024;48 (5):299-313$31$YR$$M$Y$$$20240821$$HP$DE$DE
242307991$24230799$1$I$20240101$20240815$20240821$20240821$EXP$$US-009507513-2408USA005873$MERCK$$$$$F$Y$$$20240821$$HP$US$US
242308001$24230800$1$I$$20240808$20240821$20240821$EXP$$GB-AUROBINDO-AUR-APL-2024-040325$AUROBINDO$$79$YR$$F$Y$$$20240821$$HP$GB$GB
242308012$24230801$2$F$20240808$20240916$20240821$20240917$PER$$US-JNJFOC-20240827764$JOHNSON AND JOHNSON$$26$YR$A$$Y$$$20240917$$HP$US$US
242308022$24230802$2$F$$20240913$20240821$20240926$30DAY$$TR-JNJFOC-20240844120$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$TR$TR
242308031$24230803$1$I$$20240808$20240821$20240821$EXP$$CA-AUROBINDO-AUR-APL-2024-040837$AUROBINDO$$42$YR$$F$Y$$$20240821$$HP$CA$CA
242308041$24230804$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009302$APOTEX$$76$YR$$M$Y$$$20240821$$PH$CA$CA
242308051$24230805$1$I$20240606$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010216$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240821$$CN$US$US
242308061$24230806$1$I$$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009844$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240821$$CN$US$US
242308071$24230807$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011968$ELI LILLY AND CO$$$$$M$Y$$$20240821$$CN$US$US
242308081$24230808$1$I$20240816$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011128$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240821$$CN$US$US
242308091$24230809$1$I$20240816$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011040$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240821$$CN$US$US
242308101$24230810$1$I$20240819$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011617$ELI LILLY AND CO$$$$$F$Y$$$20240821$$CN$US$US
242308111$24230811$1$I$$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024163296$AMGEN$$$$$$Y$$$20240821$$HP$US$US
242308121$24230812$1$I$20240406$20240813$20240821$20240821$EXP$$US-ROCHE-10000057830$ROCHE$$70$YR$E$F$Y$55.33$KG$20240821$$CN$US$US
242308131$24230813$1$I$$20240816$20240821$20240821$PER$$US-BEH-2024177384$CSL BEHRING$$$$A$F$Y$$$20240821$$HP$US$US
242308141$24230814$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024159755$AMGEN$Rangarajan H.G.; Shenkar Rakefet.; Kahwash S.B. et.al. Isolated Optic Nerve Relapse in a Pediatric Patient With T-Cell Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 2024;46 (6):e443-e447$12$YR$T$M$Y$$$20240821$$MD$US$US
242308151$24230815$1$I$$20240812$20240821$20240821$PER$$US-ABBVIE-5878672$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242308161$24230816$1$I$$20240814$20240821$20240821$EXP$DE-Gedeon Richter Plc.-2023_GR_002926$DE-DEXPHARM-2023-0566$DEXCEL$$32$YR$A$F$Y$75$KG$20240821$$HP$DE$DE
242308172$24230817$2$F$$20240830$20240821$20240904$PER$$US-JAZZ PHARMACEUTICALS-2024-US-012989$JAZZ$$$$$M$Y$$$20240904$$CN$US$US
242308181$24230818$1$I$20240626$20240809$20240821$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-041056$AUROBINDO$$72$YR$$M$Y$100$KG$20240821$$MD$DE$DE
242308191$24230819$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024162514$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240821$$HP$US$US
242308201$24230820$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024159996$AMGEN$Li X.R.; Kumar D.; Bo A.Y. et.al. A Case of Disseminated Mycobacterium Haemophilum in a Kidney Transplant Recipient Presenting With Subcutaneous Nodules. WMJ : official publication of the State. 2024;123 (3):233-237$63$YR$A$M$Y$$$20240821$$MD$US$US
242308211$24230821$1$I$$20240817$20240821$20240821$PER$$US-AMGEN-USASP2024164778$AMGEN$$$$$$Y$$$20240821$$MD$US$US
242308221$24230822$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024162482$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240821$$HP$US$US
242308231$24230823$1$I$$20240814$20240821$20240821$PER$$US-CHATTEMPRD-2024OHG027576$CHATTEM$$$$$F$Y$$$20240821$$CN$US$US
242308241$24230824$1$I$20240806$20240807$20240821$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07995$LUPIN$$$$$$Y$$$20240821$$CN$US$US
242308253$24230825$3$F$20240813$20240814$20240821$20240823$PER$$US-BIOGEN-2024BI01278870$BIOGEN$$66$YR$$F$Y$$$20240823$$CN$US$US
242308261$24230826$1$I$20240601$20240808$20240821$20240821$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240600032$UPSHER SMITH LABORATORIES$$16$YR$$M$Y$$$20240821$$HP$US$US
242308271$24230827$1$I$20240119$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-084731-2024$RECKITT BENCKISER$$53$YR$$M$Y$90.91$KG$20240821$$CN$US$US
242308281$24230828$1$I$$20240809$20240821$20240821$EXP$$CA-AUROBINDO-AUR-APL-2024-041332$AUROBINDO$$70$YR$$M$Y$$$20240821$$CN$CA$CA
242308291$24230829$1$I$20230701$20240809$20240821$20240821$EXP$$FR-AUROBINDO-AUR-APL-2024-040557$AUROBINDO$$76$YR$$M$Y$94$KG$20240821$$PH$FR$FR
242308301$24230830$1$I$20240718$20240807$20240821$20240821$EXP$$US-UCBSA-2024040195$UCB$$5$YR$$M$Y$24.943$KG$20240821$$HP$US$US
242308312$24230831$2$F$20100101$20240815$20240821$20240823$EXP$$US-ABBVIE-5883652$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242308321$24230832$1$I$$20240811$20240821$20240821$EXP$$FR-AMGEN-FRASP2024162218$AMGEN$Vidal V.. A Single Center Experience of Cladribine, Cytarabine, Filgrastim and Mitoxantrone (CLAG-M regimen) in High-Risk or Relapsed/Refractory, Acute Myelold Leukemia (AML). Blood. 2018;132$$$$$Y$$$20240821$$HP$FR$FR
242308331$24230833$1$I$20240812$20240813$20240821$20240821$PER$$US-AMGEN-USASP2024161023$AMGEN$$73$YR$E$F$Y$$$20240821$$CN$US$US
242308341$24230834$1$I$20240815$20240819$20240821$20240821$PER$$US-ABBVIE-5887362$ABBVIE$$37$YR$$$Y$$$20240821$$HP$US$US
242308351$24230835$1$I$$20240812$20240821$20240821$EXP$$US-ROCHE-3495664$ROCHE$$55$YR$A$F$Y$$$20240821$$CN$US$US
242308361$24230836$1$I$$20240809$20240821$20240821$EXP$$GB-AUROBINDO-AUR-APL-2024-040353$AUROBINDO$$38$YR$$F$Y$64$KG$20240821$$MD$GB$GB
242308371$24230837$1$I$$20240820$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA074077$SANDOZ$$$$$$Y$$$20240821$$HP$CA$CA
242308381$24230838$1$I$$20240815$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US073481$SANDOZ$$$$$F$Y$$$20240821$$CN$US$US
242308391$24230839$1$I$$20240813$20240821$20240821$EXP$$SE-SANDOZ INC.-NVSC2023SE054432$SANDOZ$$59$YR$$$Y$$$20240821$$MD$SE$SE
242308401$24230840$1$I$$20240816$20240821$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012978$JAZZ$$$$$F$Y$11.4$KG$20240821$$CN$US$US
242308411$24230841$1$I$$20240811$20240821$20240821$EXP$$FR-AMGEN-FRASP2024162220$AMGEN$Vidal V.. A Single Center Experience of Cladribine, Cytarabine, Filgrastim and Mitoxantrone (CLAG-M regimen) in High-Risk or Relapsed/Refractory, Acute Myelold Leukemia (AML). Blood. 2018;132$$$$$Y$$$20240821$$HP$FR$FR
242308422$24230842$2$F$20240809$20240821$20240821$20240822$EXP$$CN-ROCHE-10000057739$ROCHE$$77$YR$E$F$Y$$$20240822$$HP$CN$CN
242308431$24230843$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009343$APOTEX$$76$YR$$M$Y$$$20240821$$MD$CA$CA
242308452$24230845$2$F$$20240808$20240821$20240822$EXP$$US-AUROBINDO-AUR-APL-2024-040010$AUROBINDO$Lum EL, Datta N, Beaird O, Zuckerman J, Bunnapradist S, Schaenman J.. Cutaneous Fungal Masses From Prior Environmental Injury Following Kidney Transplant: A Case Report.. Transplantation Proceedings.. 2019;51(9):3087-3091.$63$YR$$M$Y$$$20240822$$MD$US$US
242308461$24230846$1$I$20230505$20240812$20240821$20240821$EXP$$BR-CELLTRION INC.-2023BR002256$CELLTRION$$$$$$Y$$$20240821$$CN$BR$BR
242308471$24230847$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009280$APOTEX$$72$YR$$M$Y$$$20240821$$MD$CA$CA
242308482$24230848$2$F$20240703$20240809$20240821$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-040405$AUROBINDO$$65$YR$$M$Y$90$KG$20240822$$PH$GB$GB
242308491$24230849$1$I$$20240813$20240821$20240821$PER$$US-CHATTEMPRD-2024OHG027349$CHATTEM$$$$A$$Y$$$20240821$$CN$US$US
242308501$24230850$1$I$$20240813$20240821$20240821$PER$$US-CHATTEMPRD-2024OHG027463$CHATTEM$$$$$$Y$$$20240821$$CN$US$US
242308513$24230851$3$F$$20240927$20240821$20240930$PER$$US-JNJFOC-20240842947$JOHNSON AND JOHNSON$$$$$M$Y$$$20240929$$PH$US$US
242308531$24230853$1$I$20240709$20240819$20240821$20240821$EXP$$CN-ROCHE-10000060748$ROCHE$$41$YR$A$F$Y$55.5$KG$20240821$$HP$CN$CN
242308542$24230854$2$F$$20240820$20240821$20240828$EXP$$DE-DENTSPLY-2024SCDP000236$DENTSPLY$$12$WK$$M$Y$$$20240828$$MD$DE$DE
242308551$24230855$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011095$ELI LILLY AND CO$$$$$F$Y$$$20240821$$PH$US$US
242308561$24230856$1$I$20240601$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009812$ELI LILLY AND CO$$$$$F$Y$$$20240821$$CN$US$US
242308571$24230857$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011101$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240821$$CN$US$US
242308581$24230858$1$I$20240817$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011826$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240821$$CN$US$US
242308591$24230859$1$I$$20240817$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011644$ELI LILLY AND CO$$$$$$Y$$$20240821$$MD$US$US
242308601$24230860$1$I$20230101$20240809$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408006880$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240821$$CN$US$US
242308611$24230861$1$I$$20240814$20240821$20240821$EXP$$NVSC2024US165748$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
242308621$24230862$1$I$20240728$20240819$20240821$20240821$EXP$$CN-ROCHE-10000060982$ROCHE$$41$YR$A$F$Y$56.2$KG$20240821$$HP$CN$CN
242308631$24230863$1$I$20200101$20240809$20240821$20240821$EXP$$FR-AUROBINDO-AUR-APL-2024-040815$AUROBINDO$$31$YR$$M$Y$98.5$KG$20240821$$MD$FR$FR
242308641$24230864$1$I$20240808$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164337$AMGEN$$73$YR$E$F$Y$$$20240821$$CN$US$US
242308652$24230865$2$F$20240101$20240814$20240821$20240826$PER$$US-CHATTEMPRD-2024OHG027592$CHATTEM$$$$$F$Y$$$20240826$$CN$US$US
242308661$24230866$1$I$20240619$20240819$20240821$20240821$EXP$$CN-ROCHE-10000060964$ROCHE$$81$YR$E$M$Y$50$KG$20240821$$HP$CN$CN
242308671$24230867$1$I$$20240730$20240821$20240821$PER$$US-TEVA-VS-3234609$TEVA$$$$A$M$Y$$$20240821$$CN$US$US
242308681$24230868$1$I$20240522$20240809$20240821$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-040860$AUROBINDO$$$$E$F$Y$70$KG$20240821$$MD$DE$DE
242308691$24230869$1$I$20231227$20240812$20240821$20240821$EXP$$CN-GSK-CN2024APC100917$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$CN$CN
242308701$24230870$1$I$$20240813$20240821$20240821$30DAY$$US-GSK-US2024AMR100561$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242308711$24230871$1$I$$20230831$20240821$20240821$EXP$$GB-AstraZeneca-2023A200142$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$GB$
242308721$24230872$1$I$$20230712$20240821$20240821$EXP$$US-AstraZeneca-2021A849168$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242308732$24230873$2$F$20240815$20240918$20240821$20240919$PER$$US-AMGEN-USASP2024165977$AMGEN$$$$$F$Y$$$20240919$$HP$US$US
242308741$24230874$1$I$20240815$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164663$AMGEN$$71$YR$E$F$Y$$$20240821$$HP$US$US
242308751$24230875$1$I$20220527$20221215$20240821$20240821$EXP$$TW-AstraZeneca-2022A410234$ASTRAZENECA$$60$YR$$F$Y$$$20240821$$HP$TW$
242308762$24230876$2$F$20240715$20240828$20240821$20240829$EXP$$NVSC2024US168431$NOVARTIS$$46$YR$$F$Y$74$KG$20240829$$HP$US$US
242308771$24230877$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009317$APOTEX$$68$YR$$F$Y$52$KG$20240821$$HP$CA$CA
242308781$24230878$1$I$$20240809$20240821$20240821$PER$$US-APOTEX-2024AP009490$APOTEX$Fesharaki-Zadeh A, Lowe N, Arnsten AFT. Clinical experience with the ??2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in ^Long-COVID19 ^. Neuroimmunology Reports. 2023;3 (100154):1-3$$$A$F$Y$$$20240821$$HP$US$US
242308791$24230879$1$I$$20240815$20240821$20240821$PER$$US-ALXN-202408USA000956US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242308801$24230880$1$I$$20240724$20240821$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07395$LUPIN$$$$$$Y$$$20240821$$CN$US$US
242308811$24230881$1$I$20240701$20240814$20240821$20240821$EXP$$CL-JNJFOC-20240839595$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240821$$CN$CL$CL
242308821$24230882$1$I$$20240815$20240821$20240821$EXP$$US-ROCHE-10000058964$ROCHE$$68$YR$E$F$Y$$$20240821$$CN$US$US
242308831$24230883$1$I$20240725$20240819$20240821$20240821$EXP$$CN-ROCHE-10000060758$ROCHE$$33$YR$A$F$Y$$$20240821$$HP$CN$CN
242308842$24230884$2$F$20240806$20240815$20240821$20240821$PER$$US-ROCHE-10000058922$ROCHE$$34$YR$A$M$Y$65.77$KG$20240821$$CN$US$US
242308851$24230885$1$I$20240730$20240813$20240821$20240821$EXP$$CO-AstraZeneca-2024A188039$ASTRAZENECA$$29118$DY$$F$Y$65$KG$20240821$$CN$CO$
242308862$24230886$2$F$$20240814$20240821$20240826$PER$$US-CHATTEMPRD-2024OHG027585$CHATTEM$$$$E$F$Y$$$20240826$$CN$US$US
242308872$24230887$2$F$20240601$20240820$20240821$20240822$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-113130$REGENERON$$$$$F$Y$$$20240822$$CN$CA$CA
242308881$24230888$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164201$AMGEN$$$$A$F$Y$$$20240821$$CN$US$US
242308891$24230889$1$I$$20240809$20240821$20240821$EXP$$JP-AMGEN-JPNSP2024164826$AMGEN$$$$$$Y$$$20240821$$PH$JP$JP
242308901$24230890$1$I$$20221109$20240821$20240821$EXP$$US-AstraZeneca-2022A371785$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242308911$24230891$1$I$20240809$20240816$20240821$20240821$EXP$$US-AstraZeneca-2024A188259$ASTRAZENECA$$$$$F$Y$$$20240821$$HP$US$
242308922$24230892$2$F$$20240920$20240821$20240927$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001658$BLUEPRINT MEDICINES$$$$$F$Y$$$20240927$$CN$US$US
242308931$24230893$1$I$$20240813$20240821$20240821$EXP$$CA-APOTEX-2024AP009386$APOTEX$$79$YR$$F$Y$$$20240821$$HP$CA$CA
242308941$24230894$1$I$20240815$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164544$AMGEN$$80$YR$E$F$Y$$$20240821$$CN$US$US
242308952$24230895$2$F$20240728$20240917$20240821$20240925$30DAY$$FR-JNJFOC-20240822427$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240926$$PH$FR$FR
242308961$24230896$1$I$$20240814$20240821$20240821$EXP$$US-TAKEDA-2024TUS022493$TAKEDA$$$$$M$Y$$$20240821$$CN$US$US
242308972$24230897$2$F$20240408$20240910$20240821$20240917$EXP$$CA-CELLTRION INC.-2024CA009985$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
242308981$24230898$1$I$$20240813$20240821$20240821$EXP$$PT-DEXPHARM-2024-2865$DEXCEL$Reis, C.; Dias, F.; Grijo, C.; Ribeiro, A.; Almeida, J. PSEUDOMEMBRANOUS COLITIS FOLLOWING HELICOBACTER PILORY ERADICATION WITH THE BISMUTH-BASED QUADRUPLE THERAPY. European Journal of Case Reports in Internal Medicine 2023, V10 (Suppl. 1), P237 abstr. 493$84$YR$E$F$Y$$$20240821$$HP$PT$PT
242308992$24230899$2$F$$20240903$20240821$20240910$EXP$$BR-TAKEDA-2023TUS004520$TAKEDA$$$$$F$Y$$$20240910$$CN$BR$BR
242309002$24230900$2$F$20240815$20240816$20240821$20240822$EXP$$CA-JNJFOC-20240846309$JOHNSON AND JOHNSON$$9$YR$C$M$Y$23$KG$20240822$$HP$CA$CA
242309011$24230901$1$I$$20240814$20240821$20240821$EXP$$US-JNJFOC-20240844972$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$CN$US$US
242309022$24230902$2$F$$20240909$20240821$20240915$EXP$$US-JNJFOC-20240842537$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$CN$US$US
242309031$24230903$1$I$20240730$20240801$20240821$20240821$PER$$US-ALXN-202408USA000090US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
242309041$24230904$1$I$$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-084818-2024$RECKITT BENCKISER$$$$$F$Y$$$20240821$$CN$US$US
242309051$24230905$1$I$$20240810$20240821$20240821$EXP$$US-ROCHE-10000054497$ROCHE$$$$$$Y$$$20240821$$CN$US$US
242309061$24230906$1$I$20240401$20240715$20240821$20240821$EXP$$US-TEVA-VS-3187668$TEVA$$47$YR$$M$Y$$$20240821$$PH$US$US
242309071$24230907$1$I$20240801$20240820$20240821$20240821$EXP$$US-UCBSA-2024042192$UCB$$58$YR$$M$Y$$$20240821$$CN$US$US
242309091$24230909$1$I$$20240812$20240821$20240821$EXP$$DE-SANDOZ INC.-NVSC2021DE109507$SANDOZ$$11$YR$$F$Y$$$20240821$$MD$DE$DE
242309102$24230910$2$F$$20240906$20240821$20240909$PER$$NVSC2024US168893$NOVARTIS$$$$$M$Y$$$20240909$$HP$US$US
242309113$24230911$3$F$20240814$20240827$20240821$20240829$PER$$US-AMGEN-USASP2024164592$AMGEN$$71$YR$E$M$Y$$$20240829$$CN$US$US
242309121$24230912$1$I$$20240813$20240821$20240821$PER$$US-AstraZeneca-2024A184800$ASTRAZENECA$$$$$$Y$$$20240821$$HP$US$
242309131$24230913$1$I$$20240813$20240821$20240821$EXP$$ZA-AstraZeneca-2024A184422$ASTRAZENECA$$14975$DY$$M$Y$$$20240821$$CN$ZA$
242309141$24230914$1$I$$20240813$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408008928$ELI LILLY AND CO$$$$$F$Y$$$20240821$$CN$US$US
242309151$24230915$1$I$20240813$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010673$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240821$$CN$US$US
242309161$24230916$1$I$$20240808$20240821$20240821$PER$$US-SA-2024SA243289$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
242309171$24230917$1$I$20240701$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010135$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240821$$CN$US$US
242309181$24230918$1$I$20240101$20240808$20240821$20240821$PER$$US-SA-2024SA238769$SANOFI AVENTIS$$$$$F$Y$$$20240821$$MD$US$US
242309191$24230919$1$I$20230101$20240807$20240821$20240821$PER$$US-SA-2024SA239821$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240821$$MD$US$US
242309201$24230920$1$I$20240601$20240809$20240821$20240821$PER$$US-SA-2024SA241197$SANOFI AVENTIS$$56$YR$A$F$Y$88$KG$20240821$$MD$US$US
242309211$24230921$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243311$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240821$$MD$US$US
242309221$24230922$1$I$20240801$20240813$20240821$20240821$PER$$US-SA-2024SA243810$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240821$$CN$US$US
242309231$24230923$1$I$20231001$20240812$20240821$20240821$PER$$US-SA-2024SA244825$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240821$$MD$US$US
242309241$24230924$1$I$20200825$20240808$20240821$20240821$EXP$$IN-SANDOZ INC.-NVSC2020IN265902$SANDOZ$$25$YR$$M$Y$$$20240821$$CN$IN$IN
242309251$24230925$1$I$$20240814$20240821$20240821$EXP$$GB-CELLTRION INC.-2024GB019794$CELLTRION$$$$$$Y$$$20240821$$CN$GB$GB
242309261$24230926$1$I$$20240812$20240821$20240821$30DAY$$US-GSK-US2024100373$GLAXOSMITHKLINE$$$$$M$Y$$$20240821$$CN$US$US
242309271$24230927$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA243098$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240821$$MD$US$US
242309281$24230928$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA242093$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240821$$CN$US$US
242309292$24230929$2$F$20240101$20240814$20240821$20240828$PER$$US-SA-2024SA241528$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240828$$CN$US$US
242309301$24230930$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA243677$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240821$$MD$US$US
242309311$24230931$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243880$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242309321$24230932$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009273$APOTEX$$$$$F$Y$$$20240821$$HP$CA$CA
242309332$24230933$2$F$$20240916$20240821$20240924$EXP$$CA-JNJFOC-20240845652$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240924$$HP$CA$CA
242309341$24230934$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243257$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242309352$24230935$2$F$20240101$20240819$20240821$20240829$PER$$US-SA-2024SA232362$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240829$$MD$US$US
242309361$24230936$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243895$SANOFI AVENTIS$$$$E$F$Y$59$KG$20240821$$MD$US$US
242309381$24230938$1$I$$20240818$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131033$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$45.81$KG$20240821$$CN$US$US
242309392$24230939$2$F$20240801$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024164812$AMGEN$$77$YR$E$F$Y$$$20240821$$HP$US$US
242309401$24230940$1$I$20240815$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024162839$AMGEN$$77$YR$E$F$Y$$$20240821$$CN$US$US
242309411$24230941$1$I$20240805$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024162064$AMGEN$$59$YR$A$F$Y$$$20240821$$PH$US$US
242309431$24230943$1$I$20240808$20240811$20240821$20240821$EXP$$GB-Amarin Pharma, Inc-2024AMR000422$AMARIN$$$$$M$Y$$$20240820$$PH$GB$GB
242309446$24230944$6$F$20240814$20240918$20240821$20240924$30DAY$$US-AMGEN-USASP2024162345$AMGEN$$50$YR$A$F$Y$72.12$KG$20240924$$PH$US$US
242309452$24230945$2$F$$20240909$20240821$20240913$EXP$$CA-TAKEDA-2024TUS082668$TAKEDA$$$$$F$Y$$$20240913$$MD$CA$CA
242309462$24230946$2$F$$20240909$20240821$20240913$EXP$$US-ROCHE-10000042899$ROCHE$$66$YR$E$F$Y$$$20240914$$CN$US$US
242309471$24230947$1$I$$20240725$20240821$20240821$PER$$US-JNJFOC-20240778957$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242309485$24230948$5$F$20240801$20240918$20240821$20240927$30DAY$$TR-JNJFOC-20240831782$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240927$$PH$TR$TR
242309491$24230949$1$I$$20240815$20240821$20240821$EXP$$BR-JNJFOC-20240843868$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240821$$MD$BR$BR
242309504$24230950$4$F$20240409$20240919$20240821$20240924$EXP$$US-ABBVIE-5872101$ABBVIE$$52$YR$$F$Y$102.96$KG$20240924$$CN$US$US
242309512$24230951$2$F$20240101$20240821$20240821$20240825$EXP$$US-ABBVIE-5884416$ABBVIE$$$$$F$Y$104$KG$20240825$$CN$US$US
242309521$24230952$1$I$$20240814$20240821$20240821$EXP$$AU-TAKEDA-2024TUS082768$TAKEDA$$$$$M$Y$$$20240821$$CN$AU$AU
242309531$24230953$1$I$20210513$20240815$20240821$20240821$EXP$$CA-TAKEDA-2024TUS082671$TAKEDA$$46$YR$$M$Y$$$20240821$$CN$CA$CA
242309551$24230955$1$I$$20240816$20240821$20240821$PER$$US-ALXN-202408USA000992US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
242309561$24230956$1$I$20240401$20240815$20240821$20240821$EXP$$CA-ABBVIE-5884167$ABBVIE$$$$A$M$Y$$$20240821$$CN$CA$CA
242309571$24230957$1$I$20240816$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131170$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240821$$CN$US$US
242309581$24230958$1$I$$20240816$20240821$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-276857$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240821$$CN$US$US
242309591$24230959$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130938$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$117.93$KG$20240821$$CN$US$US
242309601$24230960$1$I$$20240816$20240821$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-131886$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240821$$MD$JP$JP
242309611$24230961$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130321$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$79.83$KG$20240821$$CN$US$US
242309621$24230962$1$I$20240720$20240809$20240821$20240821$EXP$$ES-AUROBINDO-AUR-APL-2024-040685$AUROBINDO$$64$YR$$F$Y$54$KG$20240821$$MD$ES$ES
242309631$24230963$1$I$$20240815$20240821$20240821$EXP$$US-ROCHE-10000059397$ROCHE$$$$A$M$Y$$$20240821$$CN$US$US
242309641$24230964$1$I$$20240815$20240821$20240821$EXP$$CA-ABBVIE-5884209$ABBVIE$$$$A$F$Y$$$20240821$$CN$CA$CA
242309651$24230965$1$I$20240804$20240809$20240821$20240821$EXP$$CN-VALIDUS PHARMACEUTICALS LLC-CN-VDP-2024-019366$VALIDUS$$$$$$Y$$$20240821$$HP$CN$CN
242309661$24230966$1$I$$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024162808$AMGEN$$$$$M$Y$$$20240821$$CN$US$US
242309691$24230969$1$I$20210101$20240816$20240821$20240821$EXP$$NVSC2024GB168007$NOVARTIS$$45$YR$$M$Y$$$20240821$$CN$GB$GB
242309701$24230970$1$I$20240815$20240815$20240821$20240821$EXP$$US-GSK-US2024103326$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$US$US
242309711$24230971$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131174$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$68.04$KG$20240821$$HP$US$US
242309721$24230972$1$I$20240101$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131182$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$58.97$KG$20240821$$CN$US$US
242309731$24230973$1$I$$20240811$20240821$20240821$EXP$$ES-AMGEN-ESPSP2024163388$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240821$$HP$ES$ES
242309741$24230974$1$I$$20240811$20240821$20240821$EXP$$FR-AMGEN-FRASP2024162833$AMGEN$Laurent D.; Yamdjieu-ngadeu C.; Javier R.M. et al.. NATIONWIDE EPIDEMIOLOGY OF FRACTURE INCIDENCE IN PATIENTS TREATED WITH DENOSUMAB: DATA ON 271 295 PATIENTS FROM THE FRENCH HEALTHCARE INFORMATION SYSTEM. Annals of the Rheumatic Diseases. 2024;83 (SUPPL_1):148$$$$$Y$$$20240821$$HP$FR$FR
242309751$24230975$1$I$$20240818$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US073507$SANDOZ$$$$A$$Y$$$20240821$$CN$US$US
242309771$24230977$1$I$$20240807$20240821$20240821$EXP$$US-RDY-LIT/USA/24/0011818$DR REDDYS$Kane N, Rikard R, McCrory K, Marx AH. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels. Open Forum Infectious Diseases. 2023 Nov 27;10(2): S1108. doi:10.1093/ofid/ofad500.2163.$21$YR$A$M$Y$$$20240821$$PH$US$US
242309781$24230978$1$I$$20240807$20240821$20240821$EXP$$US-RDY-LIT/USA/24/0011816$DR REDDYS$Kane N, Rikard R, McCrory K, Marx AH. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels. Open Forum Infectious Diseases. 2023 Nov 27;10(2): S1108. doi:10.1093/ofid/ofad500.2163.$12$YR$T$M$Y$$$20240821$$PH$US$US
242309791$24230979$1$I$20240101$20240812$20240821$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016191$UNITED THERAPEUTICS$$$$$M$Y$$$20240821$$$US$US
242309801$24230980$1$I$20210407$20240816$20240821$20240821$EXP$$FR-AMGEN-FRANI2024164311$AMGEN$$71$YR$E$F$Y$$$20240821$$MD$FR$FR
242309811$24230981$1$I$$20240807$20240821$20240821$EXP$$US-RDY-LIT/USA/24/0011861$DR REDDYS$Cheng J, Harney S, Toner K, Kube P, Gong S, Ozdemirli M, et al. Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment. Pediatric Blood and Cancer. 2024 Aug;71(8): 1-4. doi:10.1002/pbc.31096.$9$YR$C$M$Y$$$20240821$$HP$US$US
242309821$24230982$1$I$20240807$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131214$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240821$$PH$US$US
242309832$24230983$2$F$20240819$20240916$20240821$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131833$BRISTOL MYERS SQUIBB$$17$YR$T$F$Y$$$20240917$$HP$US$US
242309841$24230984$1$I$20240701$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131513$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240821$$HP$US$US
242309851$24230985$1$I$20240101$20240815$20240821$20240821$EXP$$US-ABBVIE-5885385$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242309872$24230987$2$F$$20240830$20240821$20240905$PER$$US-BIOGEN-2023BI01228153$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
242309881$24230988$1$I$$20240815$20240821$20240821$EXP$$CN-ROCHE-10000058963$ROCHE$Gui R, Li Zhen X, Juan W, Yingling Z, Yanli Z, Jian Z. Efficacy of rituximab on preventing Epstein-Barr virus infection in aplastic anemia patients after allogeneic hematopoietic stem cell transplantation. Journal of Chinese Practical Diagnosis and Therapy. 2024-Jul;38 (7):743-8. doi:10.13507/j.issn.1674-3474.2024.07.018.$$$$$Y$$$20240821$$HP$CN$CN
242309891$24230989$1$I$$20240429$20240821$20240821$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00551$TARO$$$$$$Y$$$20240821$$CN$US$US
242309901$24230990$1$I$$20240522$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202405013989$ELI LILLY AND CO$$$$$F$Y$$$20240821$$CN$US$US
242309911$24230991$1$I$20240801$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009999$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240821$$CN$US$US
242309921$24230992$1$I$$20240815$20240821$20240821$PER$$US-BIOGEN-2024BI01278468$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
242309931$24230993$1$I$$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012673$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240821$$CN$US$US
242309941$24230994$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011024$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240821$$CN$US$US
242309951$24230995$1$I$20240802$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011009$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240821$$CN$US$US
242309961$24230996$1$I$$20240811$20240821$20240821$EXP$$ES-AMGEN-ESPSP2024163392$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240821$$HP$ES$ES
242309971$24230997$1$I$20230804$20240809$20240821$20240821$EXP$$FR-AUROBINDO-AUR-APL-2024-040554$AUROBINDO$$41$YR$$F$Y$$$20240821$$MD$FR$FR
242309981$24230998$1$I$$20240806$20240821$20240821$EXP$$MA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463050$RANBAXY$El Mir K, El Bouchalli W, El Jabiry S-E, Mohammed B. Serotonin syndrome secondary to the association of paroxetine and amitriptyline: a case report. Pan Afr Med J. 2024;48 (0):no pagination$27$YR$$M$Y$$$20240821$$HP$MA$MA
242309991$24230999$1$I$$20240806$20240821$20240821$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463596$RANBAXY$Liang I, Berglund LJ, Brown DA, Suan D, Meybodi F, Lee AYS, et al. Granulomatous mastitis and immunosuppression: Case series at an Australian quaternary referral center. Int J Rheum Diseases. 2024;27:e14884$35$YR$$F$Y$$$20240821$$HP$AU$AU
242310001$24231000$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463464$RANBAXY$Baradei AW, Kalivas B. Two Cases of Valproate Associated Non-Hyperammonemic Subacute Encephalopathy After Prolonged Use. J Acad Consult Liaison Psychiatry. 2023;Nov-Dec; 64(S):S66; 134$5$DEC$$$Y$$$20240821$$HP$US$US
242310011$24231001$1$I$$20240806$20240821$20240821$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463469$RANBAXY$Reyes NGD, Bendahan N, Swinkin E, Lang AE, Bassett AS.. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurol Sci. 2024;0 (0)$53$YR$$F$Y$$$20240821$$HP$CA$CA
242310031$24231003$1$I$$20240806$20240821$20240821$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463384$RANBAXY$$$$T$M$Y$$$20240821$$HP$GB$GB
242310041$24231004$1$I$$20240811$20240821$20240821$PER$$US-AMGEN-USASP2024163259$AMGEN$Ahluwalia M. S.; Ozair A.; Bardhan M. et al.. A multicenter phase I trial of tucatinib, trastuzumab,and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2-positive breast cancer (TUTOR). Journal of Clinical Oncology. 2024;42 (16)$$$$$Y$$$20240821$$HP$US$US
242310052$24231005$2$F$20210101$20240813$20240821$20240828$EXP$$MX-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463459$RANBAXY$Sanchez-Hernandez BE, Calderon-Espinoza I, Martin-Nares E. Challenging the paradigm: a case of early-onset VEXAS syndrome. Rheumatology. 2024;Mar; 63 (3):E99-E100$$$$M$Y$$$20240828$$HP$MX$MX
242310061$24231006$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463282$RANBAXY$Beavin S, Ahmed S. Mind the Gap: Pyroglutamic Acidosis as a Not-so-Rare Cause of High Anion Gap Metabolic Acidosis (HAGMA). J Am Soc Nephrol. 2023;34:202 (TH-PO397)$39$YR$$M$Y$$$20240821$$HP$US$US
242310071$24231007$1$I$$20240806$20240821$20240821$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463428$RANBAXY$$43$YR$$F$Y$68$KG$20240821$$MD$GB$GB
242310081$24231008$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463465$RANBAXY$Baradei AW, Kalivas B. Two Cases of Valproate Associated Non-Hyperammonemic Subacute Encephalopathy After Prolonged Use. J Acad Consult Liaison Psychiatry. 2023;Nov-Dec; 64(S):S66; 134$7$DEC$$$Y$$$20240821$$HP$US$US
242310091$24231009$1$I$20181101$20240806$20240821$20240821$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463366$RANBAXY$Castellano-Damaso S, Vazquez-Gomez F, Moreno-Carrasco JL, Arce B, Borrego P, Lassaletta A. Continuous response despite reduced dose of trametinib as single agent in an adolescent with a relapsed disseminated pediatric low-grade glioma KIAA1549-BRAF fusion positive: a case report and review of the literature. Front Oncol. 2024;14 (0):no pagination$18$YR$$M$Y$$$20240821$$HP$ES$ES
242310101$24231010$1$I$$20240806$20240821$20240821$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463597$RANBAXY$Liang I, Berglund LJ, Brown DA, Suan D, Meybodi F, Lee AYS, et al. Granulomatous mastitis and immunosuppression: Case series at an Australian quaternary referral center. Int J Rheum Diseases. 2024;27:e14884$33$YR$$F$Y$$$20240821$$HP$AU$AU
242310111$24231011$1$I$20240501$20240806$20240821$20240821$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463434$RANBAXY$$59$YR$$M$Y$124$KG$20240821$$MD$GB$GB
242310121$24231012$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463652$RANBAXY$Chanut M, Bonny V, Joly AC, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an oldconcept in the modern era of on cohaematology. Arch Cardiovasc Dis. 2024;117(4):297-300$65$YR$$F$Y$$$20240821$$HP$FR$FR
242310131$24231013$1$I$$20240806$20240821$20240821$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463393$RANBAXY$$$$$M$Y$$$20240821$$CN$GB$GB
242310141$24231014$1$I$$20240806$20240821$20240821$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463431$RANBAXY$$$$$$Y$$$20240821$$CN$GB$GB
242310151$24231015$1$I$$20240806$20240821$20240821$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463353$RANBAXY$Lee H-G, Kwon S, Goto H, Fujimoto M, Kainuma M, Cho K-H. Successful treatment of restless legs syndrome accompanied by headaches for 30 years with herbal prescriptions containing Paeoniae Radix: A case report. Explore NY. 2024;20 (6)$70$YR$$F$Y$$$20240821$$HP$JP$JP
242310161$24231016$1$I$$20240806$20240821$20240821$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463066$RANBAXY$$$$$F$Y$$$20240821$$CN$GB$GB
242310171$24231017$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463466$RANBAXY$Allahyar A, Munoz EP, Molina A, Hsu J, Abbas A. Aplastic Anemia After Long-Acting Injectable Paliperidone: A Case Report. J Acad Consult Liaison Psychiatry. 2023;Nov-Dec; 64(S):S66; 133$62$YR$$M$Y$$$20240821$$HP$US$US
242310181$24231018$1$I$$20240806$20240821$20240821$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463025$RANBAXY$Mitsuya Otsuka, Naoki Tojo , Shuichiro Yanagisawa, Atsushi Hayashi. Gas Tamponade Improved Cilio-Choroidal Effusion Induced by an Ab Interno Trabeculotomy with a Microhook: Two Cases. Int Med Case Rep J. 2024;17 (0):479-486$52$YR$$M$Y$$$20240821$$HP$JP$JP
242310191$24231019$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463650$RANBAXY$Chanut M, Bonny V, Joly AC, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an oldconcept in the modern era of on cohaematology. Arch Cardiovasc Dis. 2024;117(4):297-300$77$YR$$M$Y$$$20240821$$HP$FR$FR
242310201$24231020$1$I$$20240807$20240821$20240821$EXP$$IE-ROCHE-10000058557$ROCHE$$$$$F$Y$$$20240821$$CN$IE$IE
242310211$24231021$1$I$20240801$20240809$20240821$20240821$EXP$$GB-AUROBINDO-AUR-APL-2024-040437$AUROBINDO$$68$YR$$$Y$90$KG$20240821$$CN$GB$GB
242310221$24231022$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463295$RANBAXY$Lee IJ, Pulido JS, Regillo CD, Leys M.. MULTIPLE ORGAN DYSFUNCTION\SYNDROME and DISSEMINATED INTRAVASCULAR COAGULATION CAUSING EXTENSIVE MULTIPLE AMALRIC TRIANGULAR CHOROIDAL INFARCTIONS.. Retin Cases Brief Rep. 2024;18 (2):251-254$$$$F$Y$$$20240821$$MD$US$US
242310231$24231023$1$I$$20240809$20240821$20240821$PER$$US-BEH-2024177096$CSL BEHRING$$$$A$F$Y$56.689$KG$20240821$$HP$US$US
242310241$24231024$1$I$20030101$20240814$20240821$20240821$PER$$US-JNJFOC-20240839396$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240821$$LW$US$US
242310251$24231025$1$I$$20240725$20240821$20240821$PER$$US-JNJFOC-20240771470$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242310261$24231026$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240845502$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240821$$CN$US$US
242310271$24231027$1$I$20211230$20220228$20240821$20240821$EXP$$CO-AstraZeneca-2022A094240$ASTRAZENECA$$18883$DY$$M$Y$80$KG$20240821$$CN$CO$
242310281$24231028$1$I$$20221202$20240821$20240821$EXP$$CA-AstraZeneca-2022A399421$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$CA$
242310291$24231029$1$I$$20221129$20240821$20240821$EXP$$US-AstraZeneca-2022A393645$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242310301$24231030$1$I$20240701$20240807$20240821$20240821$EXP$$GB-UCBSA-2024039872$UCB$$57$YR$$M$Y$$$20240821$$CN$GB$GB
242310311$24231031$1$I$20240801$20240813$20240821$20240821$EXP$$CA-CELLTRION INC.-2024CA019902$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
242310321$24231032$1$I$20240101$20240812$20240821$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021466$UNITED THERAPEUTICS$$$$$F$Y$94.331$KG$20240821$$$US$US
242310341$24231034$1$I$$20240813$20240821$20240821$EXP$$GB-TAKEDA-2024TUS082977$TAKEDA$$$$$M$Y$$$20240821$$CN$GB$GB
242310351$24231035$1$I$20240806$20240816$20240821$20240821$EXP$$CN-JNJFOC-20240846726$JOHNSON AND JOHNSON$$72$YR$E$M$Y$45$KG$20240821$$HP$CN$CN
242310361$24231036$1$I$$20240815$20240821$20240821$EXP$$AU-TAKEDA-2024TUS082275$TAKEDA$$$$$F$Y$$$20240821$$CN$AU$AU
242310371$24231037$1$I$$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-084829-2024$RECKITT BENCKISER$$$$$M$Y$$$20240821$$CN$US$US
242310383$24231038$3$F$20240806$20240919$20240821$20240930$EXP$$GB-TAKEDA-2024TUS077241$TAKEDA$$60$YR$$M$Y$$$20240930$$CN$GB$GB
242310391$24231039$1$I$$20240809$20240821$20240821$EXP$$JP-ROCHE-3546516$ROCHE$Hirama T, Shundo Y, Watanabe T, Ohsumi A, Watanabe T and Okada Y Letermovir prophylaxis for cytomegalovirus in lung-transplant recipients: a comprehensive study with literature review of of-label use and real-world experiences. Doi: 10.1007/s10238-024-01330-2.. Clinical and Experimental Medicine. 2024 Apr 05;24 (1):1-9.$49$YR$A$F$Y$$$20240821$$HP$JP$JP
242310411$24231041$1$I$$20230509$20240821$20240821$EXP$$US-AstraZeneca-2023A108514$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242310421$24231042$1$I$$20240820$20240821$20240821$PER$$NVSC2024US168660$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
242310431$24231043$1$I$20240815$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164598$AMGEN$$$$$F$Y$$$20240821$$HP$US$US
242310441$24231044$1$I$$20240729$20240821$20240821$PER$$US-JNJFOC-20240782672$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$CN$US$US
242310451$24231045$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131754$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240821$$CN$US$US
242310461$24231046$1$I$20240801$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164931$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242310471$24231047$1$I$$20240728$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004053$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242310481$24231048$1$I$$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024164223$AMGEN$$$$$M$Y$$$20240821$$PH$US$US
242310492$24231049$2$F$20211228$20240820$20240821$20240824$EXP$$SG-ROCHE-10000056861$ROCHE$$64$YR$A$F$Y$$$20240824$$CN$SG$SG
242310501$24231050$1$I$20230501$20240813$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408008712$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240821$$CN$US$US
242310511$24231051$1$I$20240815$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009958$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240821$$CN$US$US
242310521$24231052$1$I$$20240813$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408008561$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240821$$CN$US$US
242310531$24231053$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011787$ELI LILLY AND CO$$$$$M$Y$$$20240821$$CN$US$US
242310541$24231054$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011013$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240821$$CN$US$US
242310551$24231055$1$I$$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012535$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240821$$CN$US$US
242310561$24231056$1$I$20240730$20240816$20240821$20240821$EXP$$AU-TAKEDA-2024TUS083034$TAKEDA$$43$YR$$M$Y$$$20240821$$CN$AU$AU
242310571$24231057$1$I$20240816$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011069$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240821$$CN$US$US
242310581$24231058$1$I$$20240816$20240821$20240821$EXP$$US-TAKEDA-2024TUS082843$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
242310592$24231059$2$F$$20240904$20240821$20240904$PER$$US-ALXN-202408USA000959US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
242310601$24231060$1$I$20231201$20240726$20240821$20240821$PER$$BR-TOLMAR, INC.-24BR051416$TOLMAR$$9$YR$$F$Y$$$20240821$$CN$BR$BR
242310611$24231061$1$I$20240506$20240812$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA049654$TOLMAR$$10$YR$$F$Y$68$KG$20240821$$MD$CA$CA
242310621$24231062$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130001$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240821$$HP$US$US
242310631$24231063$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131743$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240821$$CN$US$US
242310641$24231064$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129919$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240821$$CN$US$US
242310651$24231065$1$I$$20240816$20240821$20240821$EXP$$BE-AstraZeneca-2024A187053$ASTRAZENECA$$81$YR$$M$Y$$$20240821$$MD$BE$
242310661$24231066$1$I$$20240818$20240821$20240821$PER$$US-AMGEN-USASP2024164779$AMGEN$$$$A$M$Y$$$20240821$$CN$US$US
242310671$24231067$1$I$$20240812$20240821$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-019024$UNITED THERAPEUTICS$$$$$M$Y$$$20240821$$$US$US
242310681$24231068$1$I$$20240322$20240821$20240821$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089744$GLENMARK$$$$$$Y$$$20240821$$CN$US$US
242310691$24231069$1$I$$20240314$20240821$20240821$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089000$GLENMARK$$$$$$Y$$$20240821$$PH$US$US
242310701$24231070$1$I$20240101$20240812$20240821$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-018059$UNITED THERAPEUTICS$$$$$M$Y$$$20240821$$$US$US
242310711$24231071$1$I$$20240806$20240821$20240821$EXP$$DE-DEXPHARM-2024-2900$DEXCEL$Hoeltzenbein, M.; Slimi, S.; Fietz, A. K.; Stegherr, R.; Onken, M.; Beyersmann, J.; Dathe, K.; Schaefer, C.  Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy 2023, V107, P107-113$$$N$$Y$$$20240821$$HP$DE$DE
242310721$24231072$1$I$$20240429$20240821$20240821$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090591$GLENMARK$$$$$$Y$$$20240821$$CN$US$US
242310731$24231073$1$I$20240101$20240229$20240821$20240821$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089218$GLENMARK$$$$$$Y$$$20240821$$CN$US$US
242310741$24231074$1$I$$20240411$20240821$20240821$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090187$GLENMARK$$$$$$Y$$$20240821$$CN$US$US
242310751$24231075$1$I$$20240806$20240821$20240821$EXP$$DE-DEXPHARM-2024-2879$DEXCEL$Hoeltzenbein, M.; Slimi, S.; Fietz, A. K.; Stegherr, R.; Onken, M.; Beyersmann, J.; Dathe, K.; Schaefer, C.  Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy 2023, V107, P107-113$4$DY$N$$Y$$$20240821$$HP$DE$DE
242310761$24231076$1$I$$20240806$20240821$20240821$EXP$$DE-DEXPHARM-2024-2876$DEXCEL$Hoeltzenbein, M.; Slimi, S.; Fietz, A. K.; Stegherr, R.; Onken, M.; Beyersmann, J.; Dathe, K.; Schaefer, C.  Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy 2023, V107, P107-113$$$N$$Y$$$20240821$$HP$DE$DE
242310772$24231077$2$F$20240201$20240830$20240821$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-011415$UNITED THERAPEUTICS$$68$YR$$F$Y$70.295$KG$20240905$$$US$US
242310781$24231078$1$I$$20240814$20240821$20240821$EXP$$FI-GSK-FI2024EME101600$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$FI$FI
242310791$24231079$1$I$20240815$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164848$AMGEN$$79$YR$E$M$Y$$$20240821$$CN$US$US
242310801$24231080$1$I$20240101$20240814$20240821$20240821$EXP$$US-ABBVIE-5881125$ABBVIE$$$$$M$Y$3.31$KG$20240821$$CN$US$US
242310812$24231081$2$F$20240101$20240823$20240821$20240828$EXP$$US-RIGEL-20240800062$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242310821$24231082$1$I$$20240816$20240821$20240821$PER$$US-ABBVIE-5886273$ABBVIE$$$$$$Y$$$20240821$$HP$US$US
242310831$24231083$1$I$20230717$20230718$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-402468$RANBAXY$$75$YR$E$$Y$$$20240821$$CN$US$US
242310841$24231084$1$I$20240717$20240808$20240821$20240821$EXP$$CN-ROCHE-10000052121$ROCHE$$80$YR$E$F$Y$$$20240821$$CN$CN$CN
242310851$24231085$1$I$$20240814$20240821$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-025380$UNITED THERAPEUTICS$$$$$F$Y$83.9$KG$20240821$$$US$US
242310861$24231086$1$I$$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128256$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240821$$HP$US$US
242310871$24231087$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130849$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240821$$MD$US$US
242310881$24231088$1$I$20240809$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130222$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240821$$CN$US$US
242310891$24231089$1$I$20240728$20240728$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004048$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240821$$CN$US$US
242310901$24231090$1$I$20240803$20240812$20240821$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004562$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240821$$CN$US$US
242310911$24231091$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165317$AMGEN$$44$YR$A$M$Y$$$20240821$$CN$US$US
242310921$24231092$1$I$$20240814$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US073139$SANDOZ$$$$$$Y$$$20240821$$CN$US$US
242310931$24231093$1$I$20230529$20240814$20240821$20240821$EXP$$GB-ARGENX-2024-ARGX-GB006766$ARGENX BVBA$$$$$$Y$$$20240821$$HP$GB$GB
242310941$24231094$1$I$20140101$20240730$20240821$20240821$PER$$US-JNJFOC-20240783782$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240821$$CN$US$US
242310951$24231095$1$I$20240809$20240814$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128973$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$44.91$KG$20240821$$CN$US$US
242310961$24231096$1$I$20240814$20240814$20240821$20240821$EXP$$US-RECORDATI RARE DISEASE INC.-2024006296$RECORDATI$$$$$$Y$$$20240821$$CN$US$US
242310971$24231097$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131116$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240821$$MD$US$US
242310981$24231098$1$I$$20240814$20240821$20240821$EXP$$FI-GSK-FI2024EME101599$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$FI$FI
242311003$24231100$3$F$20240101$20240904$20240821$20240913$EXP$$US-INSMED, INC.-2024-02199-US$INSMED$$$$$M$Y$$$20240913$$CN$US$US
242311011$24231101$1$I$20240815$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010615$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240821$$CN$US$US
242311021$24231102$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012234$ELI LILLY AND CO$$25$YR$A$$Y$$$20240821$$CN$US$US
242311031$24231103$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012249$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240821$$CN$US$US
242311041$24231104$1$I$$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012619$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240821$$CN$US$US
242311051$24231105$1$I$20240818$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011604$ELI LILLY AND CO$$52$YR$A$$Y$$$20240821$$CN$US$US
242311061$24231106$1$I$$20240814$20240821$20240821$PER$$US-AMGEN-USASL2024164139$AMGEN$$$$$F$Y$$$20240821$$MD$US$US
242311071$24231107$1$I$20240722$20240814$20240821$20240821$EXP$$AU-AMGEN-AUSSP2024145868$AMGEN$$76$YR$E$F$Y$$$20240821$$PH$AU$AU
242311081$24231108$1$I$$20240809$20240821$20240821$EXP$$GT-ROCHE-10000056307$ROCHE$$$$A$M$Y$$$20240821$$MD$GT$GT
242311091$24231109$1$I$$20240815$20240821$20240821$EXP$$BR-TAKEDA-2024TUS083343$TAKEDA$$32$YR$$$Y$$$20240821$$CN$BR$BR
242311101$24231110$1$I$$20240813$20240821$20240821$EXP$$TR-ADVANZ PHARMA-201202000659$ADVANZ PHARMA$$$$$$Y$$$20240821$$HP$TR$TR
242311112$24231111$2$F$$20240820$20240821$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004077$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
242311121$24231112$1$I$$20240816$20240821$20240821$PER$$US-GILEAD-2024-0684661$GILEAD$$50$YR$A$M$Y$$$20240821$$CN$US$US
242311131$24231113$1$I$$20240819$20240821$20240821$PER$$NVSC2024US168599$NOVARTIS$$$$$F$Y$60$KG$20240821$$CN$US$US
242311151$24231115$1$I$20240701$20240818$20240821$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-025752$UNITED THERAPEUTICS$$83$YR$$F$Y$64.853$KG$20240821$$$US$US
242311161$24231116$1$I$$20240816$20240821$20240821$PER$$US-JNJFOC-20240843213$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$HP$US$US
242311172$24231117$2$F$20240801$20240828$20240821$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131016$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$65.05$KG$20240906$$PH$US$US
242311181$24231118$1$I$$20240819$20240821$20240821$EXP$$BG-SANDOZ INC.-PHHY2019BG159683$SANDOZ$$31$YR$$M$Y$$$20240821$$MD$BG$BG
242311192$24231119$2$F$20240816$20240827$20240821$20240830$PER$$US-AMGEN-USASP2024165304$AMGEN$$$$$F$Y$$$20240830$$CN$US$US
242311211$24231121$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164885$AMGEN$$$$$$Y$$$20240821$$HP$US$US
242311221$24231122$1$I$$20240819$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US073891$SANDOZ$$$$$F$Y$$$20240821$$CN$US$US
242311231$24231123$1$I$$20240808$20240821$20240821$PER$$US-JNJFOC-20240828362$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242311252$24231125$2$F$20240807$20240923$20240821$20240925$PER$$US-JNJFOC-20240843176$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240925$$PH$US$US
242311261$24231126$1$I$$20240814$20240821$20240821$EXP$$US-GSK-US2024101127$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242311272$24231127$2$F$20240816$20240816$20240821$20240823$EXP$$NVSC2024CN168302$NOVARTIS$$62$YR$$M$Y$$$20240823$$MD$CN$CN
242311283$24231128$3$F$$20240821$20240821$20240827$EXP$$JP-JNJFOC-20240852406$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240827$$MD$JP$JP
242311292$24231129$2$F$$20240910$20240821$20240912$PER$$US-JNJFOC-20240843117$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$US$US
242311301$24231130$1$I$$20240813$20240821$20240821$EXP$$ZA-AstraZeneca-2024A184640$ASTRAZENECA$$75$YR$$F$Y$$$20240821$$CN$ZA$
242311311$24231131$1$I$$20240812$20240821$20240821$30DAY$$US-GSK-US2024100342$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242311321$24231132$1$I$$20240820$20240821$20240821$PER$$NVSC2024US168914$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242311332$24231133$2$F$20240810$20240815$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US073033$SANDOZ$$$$$F$Y$$$20240821$$HP$US$US
242311361$24231136$1$I$20240729$20240806$20240821$20240821$PER$$US-009507513-2408USA002209$MERCK$$$$$F$Y$$$20240821$$CN$US$US
242311372$24231137$2$F$20240807$20240820$20240821$20240830$EXP$FR-AFSSAPS-MP2024001284$FR-UCBSA-2024042109$UCB$$28$YR$$F$Y$78$KG$20240830$$CN$FR$FR
242311381$24231138$1$I$$20240816$20240821$20240821$EXP$FR-STADA-01284960$FR-ROCHE-10000059370$ROCHE$Chanut M, Bonny V, Joly AC, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Arch-Cardiovasc-Dis 2024; 117 (4): 297-300.$72$YR$E$M$Y$$$20240821$$HP$FR$FR
242311391$24231139$1$I$20240626$20240813$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA073039$SANDOZ$$71$YR$$M$Y$$$20240821$$MD$CA$CA
242311411$24231141$1$I$20240801$20240816$20240821$20240821$EXP$$PE-UCBSA-2024041684$UCB$$48$YR$$F$Y$$$20240821$$CN$PE$PE
242311422$24231142$2$F$20240101$20240816$20240821$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131100$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240828$$CN$US$US
242311441$24231144$1$I$$20240814$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129214$BRISTOL MYERS SQUIBB$$26$YR$A$M$Y$$$20240821$$HP$US$US
242311451$24231145$1$I$20240818$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011634$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240821$$CN$US$US
242311461$24231146$1$I$20240813$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010936$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240821$$CN$US$US
242311471$24231147$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011432$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240821$$CN$US$US
242311481$24231148$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011697$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240821$$CN$US$US
242311491$24231149$1$I$$20240809$20240821$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-040955$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$29$YR$$F$Y$$$20240821$$HP$DE$DE
242311501$24231150$1$I$$20240809$20240821$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-034802$AUROBINDO$Paul LD, Brueckner I, Welter-Luedeke J, Zangl A, Graw M. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$23$YR$$M$Y$$$20240821$$HP$DE$DE
242311511$24231151$1$I$20240701$20240816$20240821$20240821$EXP$$US-ABBVIE-5884954$ABBVIE$$81$YR$$F$Y$$$20240821$$CN$US$US
242311531$24231153$1$I$20240724$20240729$20240821$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004062$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240821$$CN$US$US
242311541$24231154$1$I$$20240806$20240821$20240821$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463598$RANBAXY$Liang I, Berglund LJ, Brown DA, Suan D, Meybodi F, Lee AYS, et al. Granulomatous mastitis and immunosuppression: Case series at an Australian quaternary referral center. Int J Rheum Diseases. 2024;27:e14884$38$YR$$F$Y$$$20240821$$HP$AU$AU
242311551$24231155$1$I$$20240806$20240821$20240821$EXP$$LB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463357$RANBAXY$Nasrallah OG, Fawaz MW, Mahdi JH, Armache AK, El Sayegh N, Nasr RW. Peno-scrotal metastasis of colorectal adenocarcinoma: A case report and review of the literature. Int J Surg Case Rep. 2024;122(0):no pagination$68$YR$$M$Y$$$20240821$$HP$LB$LB
242311561$24231156$1$I$$20240806$20240821$20240821$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463600$RANBAXY$Liang I, Berglund LJ, Brown DA, Suan D, Meybodi F, Lee AYS, et al. Granulomatous mastitis and immunosuppression: Case series at an Australian quaternary referral center. Int J Rheum Diseases. 2024;27:e14884;1-6$32$YR$$F$Y$$$20240821$$HP$AU$AU
242311571$24231157$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463308$RANBAXY$Paredes E, Dane KE, Lindsley J, Naik RPP, Streiff M, Yui JC. A Single Center Experience of 13 Episodes of Acquired Hemophilia A (2019 - 2023). Blood. 2023;Nov 02;142 (sp1:7215-7217/901$73$YR$$F$Y$80.6$KG$20240821$$HP$US$US
242311581$24231158$1$I$$20240819$20240821$20240821$PER$$US-ROCHE-10000061809$ROCHE$$38$YR$A$M$Y$$$20240821$$CN$US$US
242311591$24231159$1$I$20240724$20240809$20240821$20240821$EXP$$ES-AUROBINDO-AUR-APL-2024-040679$AUROBINDO$$4$YR$$F$Y$$$20240821$$PH$ES$ES
242311601$24231160$1$I$20240701$20240816$20240821$20240821$EXP$$CA-ABBVIE-5885643$ABBVIE$$75$YR$$M$Y$$$20240821$$CN$CA$CA
242311611$24231161$1$I$20240801$20240818$20240821$20240821$PER$$US-AMGEN-USASP2024165022$AMGEN$$66$YR$E$M$Y$$$20240821$$HP$US$US
242311621$24231162$1$I$$20240806$20240821$20240821$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463360$RANBAXY$$19$YR$$M$Y$$$20240821$$PH$GB$GB
242311631$24231163$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462842$RANBAXY$Homiack DR, Yan LE, Petry LG, Lloyd JR, Najjar F, Cook EH. Successful Electroconvulsive Therapy in a Patient with Catatonia and Maternal Duplication 15q11-13 Syndrome. J ECT. 2024;0 (0):1-3$24$YR$$M$Y$$$20240821$$MD$US$US
242311643$24231164$3$F$$20240826$20240821$20240904$EXP$$CA-ROCHE-10000059568$ROCHE$$$$A$F$Y$$$20240904$$CN$CA$CA
242311651$24231165$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463309$RANBAXY$Paredes E, Dane KE, Lindsley J, Naik RPP, Streiff M, Yui JC. A Single Center Experience of 13 Episodes of Acquired Hemophilia A (2019 - 2023). Blood. 2023;Nov 02;142 (sp1:7215-7217/901$75$YR$$M$Y$76.6$KG$20240821$$HP$US$US
242311661$24231166$1$I$20240709$20240814$20240821$20240821$EXP$FR-AFSSAPS-LY2024001239$FR-SA-2024SA244326$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240821$$PH$FR$FR
242311671$24231167$1$I$20240725$20240815$20240821$20240821$EXP$$US-ABBVIE-5885766$ABBVIE$$41$YR$$M$Y$$$20240821$$CN$US$US
242311681$24231168$1$I$20240601$20240815$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130106$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240821$$CN$US$US
242311691$24231169$1$I$$20240819$20240821$20240821$EXP$$US-JNJFOC-20240848879$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$HP$US$US
242311701$24231170$1$I$$20240816$20240821$20240821$EXP$$DE-JNJFOC-20240845020$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240821$$MD$DE$DE
242311711$24231171$1$I$$20240820$20240821$20240821$EXP$$CA-ABBVIE-5887567$ABBVIE$$66$YR$$M$Y$$$20240821$$PH$CA$CA
242311721$24231172$1$I$$20240813$20240821$20240821$EXP$$DE-JNJFOC-20240800448$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240821$$HP$DE$DE
242311731$24231173$1$I$20240729$20240809$20240821$20240821$EXP$$GB-AUROBINDO-AUR-APL-2024-040446$AUROBINDO$$60$YR$$F$Y$109$KG$20240821$$CN$GB$GB
242311741$24231174$1$I$$20240812$20240821$20240821$EXP$$PL-AMGEN-POLSP2024161454$AMGEN$Drozd-Sokotowska J.. Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation-A Multicenter Report by the Polish Myeloma Study Group. Cancers. 2024;16(14):1-13$$$$$Y$$$20240821$$HP$PL$PL
242311751$24231175$1$I$$20240815$20240821$20240821$EXP$$US-SA-2024SA212448$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240821$$MD$US$US
242311761$24231176$1$I$20240101$20240812$20240821$20240821$EXP$$US-AMGEN-USASP2024161838$AMGEN$$63$YR$A$M$Y$$$20240821$$MD$US$US
242311771$24231177$1$I$$20240809$20240821$20240821$EXP$$IT-AUROBINDO-AUR-APL-2024-040933$AUROBINDO$Romano C.. Schizofrenia e uso di sostanze stupefacenti: un case report. IJOP [Internet]. 2024;10(1 (Suppl. 3)$20$YR$$M$Y$$$20240821$$HP$IT$IT
242311781$24231178$1$I$$20240811$20240821$20240821$EXP$$ES-AMGEN-ESPSP2024163384$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240821$$HP$ES$ES
242311791$24231179$1$I$$20240811$20240821$20240821$EXP$$ES-AMGEN-ESPSP2024163395$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240821$$HP$ES$ES
242311802$24231180$2$F$$20240918$20240821$20240924$30DAY$$US-AMGEN-USASP2024163997$AMGEN$$$$$$Y$$$20240924$$HP$US$US
242311811$24231181$1$I$$20240813$20240821$20240821$EXP$$AU-BIOGEN-2024BI01278061$BIOGEN$$$$$$Y$$$20240821$$HP$AU$AU
242311822$24231182$2$F$20231121$20240910$20240821$20240917$EXP$$US-BIOGEN-2024BI01278119$BIOGEN$$67$YR$$M$Y$$$20240917$$HP$US$US
242311831$24231183$1$I$$20240812$20240821$20240821$EXP$GB-MHRA-MED-202408081122142020-FHWVT$GB-TEVA-VS-3232806$TEVA$$71$YR$$F$Y$63$KG$20240821$$CN$GB$GB
242311841$24231184$1$I$$20240611$20240821$20240821$EXP$$CA-ROCHE-10000060806$ROCHE$$38$YR$A$F$Y$$$20240821$$CN$CA$CA
242311852$24231185$2$F$$20240905$20240821$20240905$PER$$US-ALXN-202408USA000978US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242311891$24231189$1$I$20240810$20240819$20240821$20240821$EXP$$US-GILEAD-2024-0684648$GILEAD$$60$YR$A$M$Y$$$20240821$$CN$US$US
242311921$24231192$1$I$$20240812$20240821$20240821$EXP$$US-GSK-US2024100171$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$MD$US$US
242311931$24231193$1$I$$20240814$20240821$20240821$30DAY$$US-GSK-US2024AMR103095$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
242311943$24231194$3$F$$20240910$20240821$20240917$EXP$$IN-ROCHE-10000054919$ROCHE$$65$YR$E$M$Y$$$20240917$$CN$IN$IN
242311951$24231195$1$I$20220117$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184163$ASTRAZENECA$$71$YR$$F$Y$66$KG$20240821$$MD$FR$
242311961$24231196$1$I$20230101$20240812$20240821$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2023-021804$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240821$$$US$US
242311971$24231197$1$I$20240813$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A185720$ASTRAZENECA$$89$YR$$M$Y$$$20240821$$CN$US$
242311981$24231198$1$I$20240726$20240813$20240821$20240821$EXP$$ZA-AstraZeneca-2024A184605$ASTRAZENECA$$38$YR$$F$Y$$$20240821$$CN$ZA$
242311991$24231199$1$I$20220128$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184228$ASTRAZENECA$$67$YR$$F$Y$65$KG$20240821$$MD$FR$
242312001$24231200$1$I$$20240820$20240821$20240821$PER$$NVSC2024US168996$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242312012$24231201$2$F$$20240916$20240821$20240919$EXP$$US-GILEAD-2024-0684757$GILEAD$$$$E$F$Y$$$20240919$$CN$US$US
242312021$24231202$1$I$$20240819$20240821$20240821$PER$$US-ROCHE-10000061284$ROCHE$$19$YR$A$F$Y$$$20240821$$HP$US$US
242312031$24231203$1$I$20240813$20240816$20240821$20240821$EXP$$US-ABBVIE-5885287$ABBVIE$$71$YR$$F$Y$$$20240821$$CN$US$US
242312051$24231205$1$I$20240706$20240820$20240821$20240821$EXP$$EG-HIKMA PHARMACEUTICALS USA INC.-EG-H14001-24-07903$HIKMA$$41$YR$$F$Y$80$KG$20240821$$HP$EG$EG
242312061$24231206$1$I$20240503$20240814$20240821$20240821$EXP$$IT-AMGEN-ITASP2024162075$AMGEN$$72$YR$E$M$Y$75$KG$20240821$$MD$IT$IT
242312074$24231207$4$F$$20240822$20240821$20240828$EXP$$US-ROCHE-10000026344$ROCHE$$$$E$F$Y$65.77$KG$20240828$$CN$US$US
242312081$24231208$1$I$20230504$20240801$20240821$20240821$EXP$$CA-CELLTRION INC.-2023CA025752$CELLTRION$$$$$$Y$$$20240821$$CN$CA$CA
242312091$24231209$1$I$$20240814$20240821$20240821$EXP$$FR-CHEPLA-2024010573$CHEPLAPHARM$Beurier P, Dallevet CA, Brissot E, Cholet C, Santin A, Lionnet F, et al. Hematopoietic stem cell allograft remission of periarteritis nodosa associated with azacytidine-refractory myelodysplastic syndrome. The Review of Internal Medicine 45. 2024; 512-515. https://doi.org/10.1016/j.revmed.2024.06.002.$32$YR$$M$Y$$$20240821$$MD$COUNTRY NOT SPECIFIED$FR
242312101$24231210$1$I$20240710$20240812$20240821$20240821$EXP$$NVSC2024GB150218$NOVARTIS$$53$YR$$M$Y$$$20240821$$CN$GB$GB
242312111$24231211$1$I$$20240820$20240821$20240821$PER$$NVSC2024US168995$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242312121$24231212$1$I$20240806$20240816$20240821$20240821$EXP$$US-ABBVIE-5885589$ABBVIE$$46$YR$$F$Y$$$20240821$$CN$US$US
242312132$24231213$2$F$20240816$20240823$20240821$20240827$PER$$US-AMGEN-USASP2024163894$AMGEN$$71$YR$E$F$Y$$$20240827$$CN$US$US
242312141$24231214$1$I$20240814$20240814$20240821$20240821$PER$$US-JNJFOC-20240842250$JOHNSON AND JOHNSON$$21$YR$A$$Y$$$20240821$$MD$US$US
242312151$24231215$1$I$20240801$20240815$20240821$20240821$PER$$US-ALXN-202408USA000967US$ALEXION PHARMACEUTICALS$$67$YR$$F$Y$$$20240821$$CN$US$US
242312161$24231216$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131874$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240821$$CN$US$US
242312181$24231218$1$I$$20240815$20240821$20240821$EXP$$CA-ABBVIE-5885103$ABBVIE$$$$A$F$Y$$$20240821$$CN$CA$CA
242312192$24231219$2$F$20240624$20240820$20240821$20240826$EXP$$CA-ABBVIE-5885630$ABBVIE$$42$YR$$M$Y$$$20240826$$CN$CA$CA
242312202$24231220$2$F$$20240911$20240821$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202408011822$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240913$$HP$US$US
242312211$24231221$1$I$$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012652$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240821$$CN$US$US
242312221$24231222$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011539$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240821$$CN$US$US
242312231$24231223$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011723$ELI LILLY AND CO$$64$YR$A$$Y$$$20240821$$CN$US$US
242312241$24231224$1$I$20240813$20240813$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408008500$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240821$$CN$US$US
242312261$24231226$1$I$20240815$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011544$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240821$$CN$US$US
242312271$24231227$1$I$20240101$20240816$20240821$20240821$EXP$$CA-ABBVIE-5885639$ABBVIE$$54$YR$$F$Y$$$20240821$$CN$CA$CA
242312281$24231228$1$I$$20240813$20240821$20240821$EXP$$US-GSK-US2024100714$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
242312301$24231230$1$I$20240101$20240802$20240821$20240821$PER$$US-TEVA-VS-3230254$TEVA$$44$YR$$F$Y$$$20240821$$CN$US$US
242312311$24231231$1$I$$20240815$20240821$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010363$JAZZ$$$$$F$Y$$$20240821$$CN$US$US
242312321$24231232$1$I$20220101$20240812$20240821$20240821$EXP$GB-MHRA-MED-202408121452150490-BJTVR$GB-TEVA-VS-3232888$TEVA$$25$YR$$M$Y$78$KG$20240821$$CN$GB$GB
242312331$24231233$1$I$$20240806$20240821$20240821$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463704$RANBAXY$Margaritis D, Tzikopoulou M, Sanos C, Papathanasiou E, Tsekou Y, Adamopoulos N et al. SACCHAROMYCES CEREVISIAE FUNGEMIA IN A HOSPITALIZED PATIENT RECEIVING PROBIOTICS: A CASE REPORT. Eur J Case Rep Intern Med. 2023;10 (Suppl.):349/752/996$69$YR$$M$Y$$$20240821$$HP$GR$GR
242312341$24231234$1$I$$20240809$20240821$20240821$EXP$$GB-AUROBINDO-AUR-APL-2024-040408$AUROBINDO$$$$$$Y$$$20240821$$CN$GB$GB
242312361$24231236$1$I$20240601$20240729$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004063$ACADIA PHARMACEUTICALS$$84$YR$$F$Y$$$20240821$$CN$US$US
242312371$24231237$1$I$$20240806$20240821$20240821$EXP$$PT-USV-002829$USV PRIVATE$Freitas JG, Ribeiro T, Moreira C, Moreira I, Mariz JM. When Myeloma is not a Myeloma: a case report of malignant bone lymphoma. Porto Biomedical Journal. 2024;9(4): e261$63$YR$A$F$Y$$$20240821$$MD$PT$PT
242312381$24231238$1$I$$20240729$20240821$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004067$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242312391$24231239$1$I$$20240729$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004078$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
242312402$24231240$2$F$$20240904$20240821$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004050$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242312423$24231242$3$F$$20240913$20240821$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004069$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
242312432$24231243$2$F$$20240905$20240821$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004066$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
242312441$24231244$1$I$$20240806$20240821$20240821$EXP$$GE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463665$RANBAXY$Gupta S, Gowda N, Shin D, Gogineni K, Bower D, Greer M. A rare case of pulmonary enteric adenocarcinoma in a 26-year-old female non-smoker. J Thorac Oncol. 2024;19(Suppl)(7):e55/PP01.127$26$YR$$F$Y$$$20240821$$MD$GE$GE
242312451$24231245$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463310$RANBAXY$Paredes E, Dane KE, Lindsley J, Naik RPP, Streiff M, Yui JC. A Single Center Experience of 13 Episodes of Acquired Hemophilia A (2019 - 2023). Blood. 2023;Nov 02;142 (sp1:7215-7217/901$76$YR$$M$Y$107.9$KG$20240821$$HP$US$US
242312471$24231247$1$I$$20240814$20240821$20240821$EXP$$BR-AMGEN-BRASP2024162736$AMGEN$$83$YR$E$F$Y$$$20240821$$CN$BR$BR
242312481$24231248$1$I$20240623$20240729$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004074$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240821$$CN$US$US
242312491$24231249$1$I$$20240811$20240821$20240821$PER$$US-JNJFOC-20240831725$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242312502$24231250$2$F$$20240916$20240821$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004622$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242312511$24231251$1$I$20240705$20240816$20240821$20240821$EXP$$US-AstraZeneca-2024A187552$ASTRAZENECA$$27323$DY$$F$Y$$$20240821$$CN$US$
242312521$24231252$1$I$20220116$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184215$ASTRAZENECA$$49$YR$$F$Y$58$KG$20240821$$MD$FR$
242312531$24231253$1$I$20240813$20240813$20240821$20240821$PER$$US-JNJFOC-20240836437$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240821$$HP$US$US
242312541$24231254$1$I$$20240729$20240821$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004079$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
242312551$24231255$1$I$20240101$20240815$20240821$20240821$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-113542$REGENERON$$55$YR$$M$Y$$$20240821$$HP$CO$CO
242312561$24231256$1$I$20220717$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184182$ASTRAZENECA$$55$YR$$M$Y$85$KG$20240821$$MD$FR$
242312571$24231257$1$I$$20240814$20240821$20240821$30DAY$$US-GSK-US2024101411$GLAXOSMITHKLINE$$$$$M$Y$$$20240821$$CN$US$US
242312581$24231258$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A184586$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242312592$24231259$2$F$20240828$20240828$20240821$20240902$EXP$$CA-TAKEDA-2024TUS081969$TAKEDA$$78$YR$$M$Y$$$20240902$$CN$CA$CA
242312601$24231260$1$I$20240521$20240523$20240821$20240821$PER$$US-AJANTA-2024AJA00101$AJANTA PHARMA$$83$YR$E$F$Y$165$KG$20240820$$CN$US$US
242312612$24231261$2$F$$20240813$20240821$20240912$EXP$$US-BEH-2024177263$CSL BEHRING$$57$YR$A$F$Y$63$KG$20240912$$CN$US$US
242312621$24231262$1$I$20240812$20240815$20240821$20240821$EXP$$CA-ABBVIE-5884196$ABBVIE$$54$YR$$F$Y$$$20240821$$CN$CA$CA
242312631$24231263$1$I$20240801$20240816$20240821$20240821$EXP$$US-ABBVIE-5884929$ABBVIE$$50$YR$$F$Y$$$20240821$$CN$US$US
242312641$24231264$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164436$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242312651$24231265$1$I$20240101$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165058$AMGEN$$79$YR$E$F$Y$$$20240821$$CN$US$US
242312662$24231266$2$F$$20240906$20240821$20240911$EXP$$FR-TAKEDA-2024TUS083517$TAKEDA$$$$$M$Y$$$20240911$$MD$FR$FR
242312671$24231267$1$I$20240710$20240812$20240821$20240821$EXP$$US-GSK-US2024100291$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240821$$CN$US$US
242312691$24231269$1$I$20230101$20240814$20240821$20240821$EXP$$DE-MSNLABS-2023MSNSPO01406$MSN LABORATORIES$$$$$$Y$$$20240821$$MD$DE$DE
242312702$24231270$2$F$$20240827$20240821$20240830$EXP$$US-ABBVIE-5885391$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242312711$24231271$1$I$$20240814$20240821$20240821$EXP$$GB-TAKEDA-2024TUS074106$TAKEDA$$$$$M$Y$$$20240821$$CN$GB$GB
242312721$24231272$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009338$APOTEX$$9$YR$$M$Y$$$20240821$$CN$CA$CA
242312731$24231273$1$I$$20240817$20240821$20240821$PER$$US-AMGEN-USASP2024164844$AMGEN$$$$A$F$Y$$$20240821$$CN$US$US
242312741$24231274$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006294$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$88$YR$$M$Y$$$20240821$$HP$US$US
242312752$24231275$2$F$20240601$20240823$20240821$20240829$EXP$$CA-Orion Corporation ORION PHARMA-24_00031317$ORION$$55$YR$A$M$Y$$$20240829$$MD$CA$
242312761$24231276$1$I$$20231031$20240821$20240821$EXP$$CA-CELLTRION INC.-2021CA019599$CELLTRION$$$$$$Y$$$20240821$$MD$CA$CA
242312771$24231277$1$I$$20240815$20240821$20240821$EXP$$US-ABBVIE-5883708$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242312781$24231278$1$I$20240813$20240816$20240821$20240821$EXP$$US-ABBVIE-5886380$ABBVIE$$27$YR$$M$Y$$$20240821$$HP$US$US
242312791$24231279$1$I$$20240812$20240821$20240821$EXP$$IT-TEVA-VS-3233419$TEVA$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ-Genom-Precis-Med 2024; 17 (2): E004353.$1$YR$$M$Y$$$20240821$$MD$IT$IT
242312801$24231280$1$I$$20240815$20240821$20240821$EXP$$US-ABBVIE-5883411$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242312812$24231281$2$F$$20240910$20240821$20240912$EXP$$CZ-ABBVIE-5882217$ABBVIE$$$$$M$Y$$$20240912$$CN$CZ$CZ
242312821$24231282$1$I$$20240820$20240821$20240821$PER$$NVSC2024US169030$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242312832$24231283$2$F$$20240828$20240821$20240904$EXP$$CA-CHEPLA-2024010611$CHEPLAPHARM$$30$YR$$M$Y$84$KG$20240903$$MD$COUNTRY NOT SPECIFIED$CA
242312841$24231284$1$I$$20240819$20240821$20240821$EXP$$US-ROCHE-10000061175$ROCHE$$68$YR$E$M$Y$$$20240821$$MD$US$US
242312853$24231285$3$F$20240101$20240904$20240821$20240912$EXP$$CA-CELLTRION INC.-2024CA020027$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
242312861$24231286$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006296$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$80$YR$$M$Y$$$20240821$$HP$US$US
242312871$24231287$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006295$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$71$YR$$M$Y$$$20240821$$HP$US$US
242312881$24231288$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006293$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$72$YR$$M$Y$$$20240821$$HP$US$US
242312891$24231289$1$I$$20240814$20240821$20240821$PER$$US-ROCHE-10000057859$ROCHE$$$$A$F$Y$$$20240821$$CN$US$US
242312902$24231290$2$F$$20240828$20240821$20240906$EXP$$IT-TEVA-VS-3233416$TEVA$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ-Genom-Precis-Med 2024; 17 (2): E004353.; Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ-Genom-Precis-Med 2024; 17 (2): E004353.$12$YR$$F$Y$$$20240906$$MD$IT$IT
242312911$24231291$1$I$$20240816$20240821$20240821$EXP$$JP-GSK-JP2024JPN102906$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$JP$JP
242312921$24231292$1$I$20240701$20240819$20240821$20240821$EXP$$CA-ABBVIE-5886126$ABBVIE$$72$YR$$F$Y$$$20240821$$CN$CA$CA
242312931$24231293$1$I$20240814$20240816$20240821$20240821$PER$$US-TAKEDA-2024TUS082956$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
242312941$24231294$1$I$$20240801$20240821$20240821$PER$$US-TEVA-VS-3230575$TEVA$$$$$M$Y$$$20240821$$CN$US$US
242312951$24231295$1$I$$20240813$20240821$20240821$EXP$$CO-ROCHE-10000056495$ROCHE$Medina-Quintero L. Massive stroke in a young male patient as a manifestation of Takayasu?s arteritis. Reumatizam 2023. 2023;2(70): 71-75.$$$A$M$Y$$$20240821$$MD$CO$HR
242312961$24231296$1$I$$20240814$20240821$20240821$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006044$BIOCON$$$$$$Y$$$20240821$$MD$CA$CA
242312971$24231297$1$I$20240713$20240801$20240821$20240821$PER$$US-TEVA-VS-3227716$TEVA$$27$YR$$M$Y$$$20240821$$CN$US$US
242312981$24231298$1$I$$20240819$20240821$20240821$PER$$NVSC2024US168448$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
242312991$24231299$1$I$$20240818$20240821$20240821$PER$$US-JNJFOC-20240849830$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242313001$24231300$1$I$$20240812$20240821$20240821$EXP$$CA-JNJFOC-20240838804$JOHNSON AND JOHNSON$$80$YR$E$M$Y$86$KG$20240821$$HP$CA$CA
242313012$24231301$2$F$$20240909$20240821$20240913$EXP$$JP-JNJFOC-20240852404$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240913$$HP$JP$JP
242313021$24231302$1$I$$20240813$20240821$20240821$EXP$$CA-APOTEX-2024AP009388$APOTEX$$57$YR$$F$Y$$$20240821$$CN$CA$CA
242313031$24231303$1$I$$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024162159$AMGEN$$$$$M$Y$$$20240821$$CN$US$US
242313041$24231304$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164486$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242313051$24231305$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164490$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242313062$24231306$2$F$20240809$20240829$20240821$20240902$30DAY$$US-AMGEN-USASL2024161773$AMGEN$$$$$$Y$$$20240902$$PH$US$US
242313071$24231307$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164563$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242313083$24231308$3$F$20240813$20240827$20240821$20240909$30DAY$$US-AMGEN-USASL2024163616$AMGEN$$51$YR$A$F$Y$$$20240909$$CN$US$US
242313091$24231309$1$I$20240101$20240814$20240821$20240821$PER$$US-ABBVIE-5882898$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242313102$24231310$2$F$$20240819$20240821$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408011630$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240826$$CN$US$US
242313111$24231311$1$I$20240819$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012159$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240821$$CN$US$US
242313121$24231312$1$I$20240814$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010103$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240821$$CN$US$US
242313131$24231313$1$I$20240815$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011857$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240821$$CN$US$US
242313141$24231314$1$I$$20240817$20240821$20240821$PER$$US-TAKEDA-2022TUS081387$TAKEDA$$$$$M$Y$$$20240821$$HP$US$US
242313151$24231315$1$I$20240128$20240809$20240821$20240821$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000807$PAREXEL$$$$$$Y$$$20240821$$HP$CN$CN
242313174$24231317$4$F$20231221$20240917$20240821$20240923$30DAY$$US-AMGEN-USASP2024162216$AMGEN$$65$YR$E$F$Y$68$KG$20240923$$CN$US$US
242313183$24231318$3$F$20231206$20240912$20240821$20240918$30DAY$$US-AMGEN-USASP2024162248$AMGEN$$69$YR$E$F$Y$93$KG$20240918$$CN$US$US
242313191$24231319$1$I$20240808$20240813$20240821$20240821$EXP$GB-MHRA-MED-202408130514228020-JZBTF$GB-TEVA-VS-3232843$TEVA$$$$$$Y$$$20240821$$CN$GB$GB
242313201$24231320$1$I$20240716$20240815$20240821$20240821$EXP$FR-AFSSAPS-RN2024000868$FR-ROCHE-10000058160$ROCHE$$76$YR$E$M$Y$$$20240821$$MD$FR$FR
242313211$24231321$1$I$$20240815$20240821$20240821$EXP$$US-ABBVIE-5885288$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242313221$24231322$1$I$$20240812$20240821$20240821$EXP$$US-APOTEX-2024AP009412$APOTEX$Lee DH, Donkor R, Parvus MN, Dannenbaum MJ, Schefler AC.. Incidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma. JAMA Ophthalmology. 2023;141 (12):1133-1138$$$$$Y$$$20240821$$MD$US$US
242313232$24231323$2$F$$20240906$20240821$20240910$EXP$$AR-ABBVIE-5886458$ABBVIE$$$$$F$Y$$$20240910$$CN$AR$AR
242313241$24231324$1$I$20240502$20240813$20240821$20240821$EXP$ES-AEMPS-1526975$ES-SAMSUNG BIOEPIS-SB-2024-24645$SAMSUNG BIOEPIS$$49$YR$A$M$Y$71$KG$20240821$$CN$ES$ES
242313251$24231325$1$I$$20240806$20240821$20240821$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08005$LUPIN$Nelson N, Masih D, Sabri A, Monika F, Mirza M. Isolated myeloid sarcoma masquerading as scattered abscesses in a septic patient: A case report and literature review. Case Reports in Oncology. 2024;17:39-48$76$YR$$F$Y$$$20240821$$HP$US$US
242313261$24231326$1$I$$20240819$20240821$20240821$EXP$$US-GILEAD-2024-0684671$GILEAD$$$$A$M$Y$$$20240821$$CN$US$US
242313272$24231327$2$F$$20240820$20240821$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-039981$AUROBINDO$Akhdar G, Akpan I, Myles A, Atencah SE. Single Low-Dose Methotrexate and Vitamin B12 Deficiency-Induced Pancytopenia Causing Fatality: A Case Report. Cureus. 2024;16(6):e63528$71$YR$$M$Y$$$20240902$$MD$US$US
242313281$24231328$1$I$$20240806$20240821$20240821$PER$$US-JNJFOC-20240819006$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240821$$CN$US$US
242313292$24231329$2$F$20220101$20240823$20240821$20240828$PER$$US-JNJFOC-20240849096$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240828$$CN$US$US
242313321$24231332$1$I$20240808$20240812$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128075$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240821$$CN$US$US
242313331$24231333$1$I$20240525$20240818$20240821$20240821$EXP$$EU-BAUSCHBL-2024BNL031833$BAUSCH AND LOMB$$77$YR$$M$Y$65$KG$20240821$$MD$EU$EU
242313342$24231334$2$F$20240807$20240912$20240821$20240918$PER$$US-AMGEN-USASP2024163154$AMGEN$$79$YR$E$M$Y$74.5$KG$20240918$$PH$US$US
242313352$24231335$2$F$$20240902$20240821$20240912$EXP$$PL-AMGEN-POLSP2024162354$AMGEN$Razniewska D.. Efficacy of treatment of patients with metastatic colorectal cancer in everyday practice in the face of clinical trial results. 2024;1-2$61$YR$A$M$Y$$$20240912$$MD$PL$PL
242313361$24231336$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164465$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242313371$24231337$1$I$20240615$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165777$AMGEN$$49$YR$A$F$Y$$$20240821$$CN$US$US
242313382$24231338$2$F$$20240819$20240821$20240823$EXP$$NVSC2024CA167026$NOVARTIS$$43$YR$$F$Y$96$KG$20240824$$HP$CA$CA
242313391$24231339$1$I$20240812$20240812$20240821$20240821$30DAY$$US-GSK-US2024100355$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240821$$CN$US$US
242313401$24231340$1$I$$20240815$20240821$20240821$EXP$$NVSC2024US167447$NOVARTIS$$$$$F$Y$$$20240821$$MD$US$US
242313411$24231341$1$I$$20240816$20240821$20240821$EXP$$US-GILEAD-2024-0684715$GILEAD$$$$A$F$Y$$$20240821$$CN$US$US
242313421$24231342$1$I$20240712$20240815$20240821$20240821$EXP$$US-ABBVIE-5883590$ABBVIE$$29$YR$$F$Y$$$20240821$$CN$US$US
242313431$24231343$1$I$$20240819$20240821$20240821$EXP$$US-ABBVIE-5887387$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242313441$24231344$1$I$20240807$20240812$20240821$20240821$EXP$$CN-ROCHE-10000057710$ROCHE$$81$YR$E$F$Y$$$20240821$$HP$CN$CN
242313461$24231346$1$I$$20240402$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA037048$SANDOZ$$$$$F$Y$$$20240821$$CN$CA$CA
242313472$24231347$2$F$$20240826$20240821$20240901$EXP$$US-ABBVIE-5885313$ABBVIE$$$$$M$Y$$$20240901$$CN$US$US
242313491$24231349$1$I$$20240812$20240821$20240821$EXP$$US-SPECGX-T202401726$SPECGX$Ward HB, Barnett BS, Suzuki J. Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report. Subst Abus. 2019;40(2):140-5$38$YR$$F$Y$$$20240821$$MD$US$US
242313502$24231350$2$F$$20240822$20240821$20240827$EXP$$US-ABBVIE-5884830$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242313511$24231351$1$I$$20240815$20240821$20240821$PER$$US-ABBVIE-5884945$ABBVIE$$$$$F$Y$$$20240821$$HP$US$US
242313521$24231352$1$I$$20240819$20240821$20240821$EXP$$BG-ABBVIE-5887402$ABBVIE$$78$YR$$M$Y$$$20240821$$CN$BG$BG
242313531$24231353$1$I$$20240816$20240821$20240821$EXP$$US-ALXN-202408USA000995US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240821$$MD$US$US
242313541$24231354$1$I$$20240811$20240821$20240821$EXP$$ES-AMGEN-ESPSP2024163401$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240821$$HP$ES$ES
242313551$24231355$1$I$20240101$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024164215$AMGEN$$65$YR$E$M$Y$$$20240821$$CN$US$US
242313561$24231356$1$I$20240804$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164468$AMGEN$$$$$M$Y$$$20240821$$HP$US$US
242313571$24231357$1$I$$20240819$20240821$20240821$EXP$$US-GILEAD-2024-0684694$GILEAD$$78$YR$E$F$Y$$$20240821$$CN$US$US
242313581$24231358$1$I$$20240812$20240821$20240821$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001629$BLUEPRINT MEDICINES$$$$$F$Y$$$20240821$$CN$US$US
242313591$24231359$1$I$20240701$20240815$20240821$20240821$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-113690$REGENERON$$77$YR$$M$Y$$$20240821$$HP$CO$CO
242313601$24231360$1$I$$20240808$20240821$20240821$EXP$$US-ROCHE-10000058679$ROCHE$$$$$M$Y$$$20240821$$CN$US$US
242313612$24231361$2$F$20240701$20240826$20240821$20240906$EXP$$US-UCBSA-2024040019$UCB$$56$YR$$F$Y$$$20240906$$HP$US$US
242313623$24231362$3$F$$20240903$20240821$20240904$EXP$$NVSC2024US168882$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242313631$24231363$1$I$20240815$20240816$20240821$20240821$30DAY$$IT-SANDOZ INC.-SDZ2024IT074019$SANDOZ$$10$YR$$M$Y$32$KG$20240821$$CN$IT$IT
242313644$24231364$4$F$20240925$20240926$20240821$20240927$EXP$$CA-SANDOZ INC.-SDZ2023CA019486$SANDOZ$$77$YR$$F$Y$$$20240927$$CN$CA$CA
242313651$24231365$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463313$RANBAXY$Paredes E, Dane KE, Lindsley J, Naik RPP, Streiff M, Yui JC. A Single Center Experience of 13 Episodes of Acquired Hemophilia A (2019 - 2023). Blood. 2023;Nov 2;142 (S1):7215-7217;901$77$YR$$M$Y$99.7$KG$20240821$$HP$US$US
242313661$24231366$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463316$RANBAXY$Paredes E, Dane KE, Lindsley J, Naik RPP, Streiff M, Yui JC. A Single Center Experience of 13 Episodes of Acquired Hemophilia A (2019 - 2023). Blood. 2023;Nov 2;142 (S1):7215-7217;901$57$YR$$F$Y$131.4$KG$20240821$$HP$US$US
242313671$24231367$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463654$RANBAXY$Chanut M, Bonny V, Joly AC, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an oldconcept in the modern era of on cohaematology. Arch Cardiovasc Dis. 2024;117(4):297-300$67$YR$$M$Y$$$20240821$$HP$FR$FR
242313681$24231368$1$I$$20240806$20240821$20240821$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463524$RANBAXY$Kristensen AW, Vestermark V, Kjaerbye-Thygesen A, Eckhardt M-C, Kesmodel US. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring. Acta Obstet Gynecol Scand. 2024;103 (8):1522-1529$$$N$$Y$$$20240821$$HP$DK$DK
242313691$24231369$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463643$RANBAXY$Chanut M, Bonny V, Joly AC, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an oldconcept in the modern era of on cohaematology. Arch Cardiovasc Dis. 2024;117(4):297-300$54$YR$$F$Y$$$20240821$$HP$FR$FR
242313701$24231370$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463317$RANBAXY$Paredes E, Dane KE, Lindsley J, Naik RPP, Streiff M, Yui JC. A Single Center Experience of 13 Episodes of Acquired Hemophilia A (2019 - 2023). Blood. 2023;Nov 2;142 (S1):7215-7217;901$25$YR$$F$Y$89.4$KG$20240821$$HP$US$US
242313711$24231371$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463315$RANBAXY$Paredes E, Dane KE, Lindsley J, Naik RPP, Streiff M, Yui JC. A Single Center Experience of 13 Episodes of Acquired Hemophilia A (2019 - 2023). Blood. 2023;Nov 2;142 (S1):7215-7217;901$82$YR$$F$Y$82.2$KG$20240821$$HP$US$US
242313721$24231372$1$I$$20240806$20240821$20240821$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463636$RANBAXY$Kwok L, Mahmood A, Kumar S, Chang A. Case Report: Macula Structural and Functional Assessment in Nab-Paclitaxel-Related Cystoid Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2024;55(7):1-5$54$YR$$F$Y$$$20240821$$MD$AU$AU
242313731$24231373$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463649$RANBAXY$Chanut M, Bonny V, Joly AC, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an oldconcept in the modern era of on cohaematology. Arch Cardiovasc Dis. 2024;117(4):297-300$72$YR$$M$Y$$$20240821$$HP$FR$FR
242313742$24231374$2$F$$20240806$20240821$20240821$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463820$RANBAXY$Baioni Aylon LF, Stelzer FG, Hoffmann R, Tavares TLG, Sander HH, Santos SHA et al. KLEINE-LEVIN SYNDROME AND BIPOLAR AFFECTIVE DISORDER:A CASE REPORT. Sleep Med. 2023;115:294$26$YR$$M$Y$$$20240821$$HP$BR$BR
242313751$24231375$1$I$$20240806$20240821$20240821$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463782$RANBAXY$Zhang G, Zhou C, Wei A, Zhang R, Zhao Y, Ma H, et al. Ruxolitinib Monotherapy for a Child With HAVCR2 Gene Mutation Associated Subcutaneous Panniculitis-like T-cell Lymphoma: A Case Report. J Pediatr Hematol Oncol. 2024;Jul; 46(5):e327-e330$34$MON$$F$Y$$$20240821$$HP$CN$CN
242313761$24231376$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130016$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240821$$HP$US$US
242313771$24231377$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131885$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240821$$HP$US$US
242313781$24231378$1$I$$20240816$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131808$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240821$$CN$US$US
242313791$24231379$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129865$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240821$$CN$US$US
242313801$24231380$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131655$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240821$$CN$US$US
242313811$24231381$1$I$20240814$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131642$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$66.22$KG$20240821$$PH$US$US
242313821$24231382$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131718$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240821$$HP$US$US
242313831$24231383$1$I$20230529$20240814$20240821$20240821$EXP$$GB-ARGENX-2024-ARGX-GB006767$ARGENX BVBA$$$$$$Y$$$20240821$$HP$GB$GB
242313841$24231384$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131416$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240821$$HP$US$US
242313851$24231385$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130726$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240821$$CN$US$US
242313861$24231386$1$I$20240801$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165309$AMGEN$$64$YR$A$F$Y$$$20240821$$CN$US$US
242313872$24231387$2$F$20240819$20240830$20240821$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408011726$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240903$$CN$US$US
242313881$24231388$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011551$ELI LILLY AND CO$$$$A$M$Y$$$20240821$$CN$US$US
242313891$24231389$1$I$20240805$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011953$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240821$$CN$US$US
242313901$24231390$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010774$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240821$$CN$US$US
242313911$24231391$1$I$20240816$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011587$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240821$$CN$US$US
242313941$24231394$1$I$20240818$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011614$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240821$$CN$US$US
242313951$24231395$1$I$$20240806$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408004095$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240821$$CN$US$US
242313963$24231396$3$F$$20240917$20240821$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202408012385$ELI LILLY AND CO$$80$YR$E$F$Y$72.562$KG$20240920$$CN$US$US
242313971$24231397$1$I$$20240812$20240821$20240821$EXP$$US-JNJFOC-20240835513$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240821$$HP$US$US
242313981$24231398$1$I$20240801$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164602$AMGEN$$63$YR$A$F$Y$$$20240821$$CN$US$US
242313991$24231399$1$I$$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024165255$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242314002$24231400$2$F$20240814$20240823$20240821$20240829$PER$$US-AMGEN-USASP2024162342$AMGEN$$57$YR$A$F$Y$62.5$KG$20240829$$HP$US$US
242314011$24231401$1$I$$20240814$20240821$20240821$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-25203$SAMSUNG BIOEPIS$$84$YR$E$F$Y$$$20240821$$CN$GB$GB
242314021$24231402$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463656$RANBAXY$Chanut M, Bonny V, Joly AC, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an oldconcept in the modern era of on cohaematology. Arch Cardiovasc Dis. 2024;117(4):297-300$71$YR$$M$Y$$$20240821$$HP$FR$FR
242314031$24231403$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463314$RANBAXY$Paredes E, Dane KE, Lindsley J, Naik RPP, Streiff M, Yui JC. A Single Center Experience of 13 Episodes of Acquired Hemophilia A (2019 - 2023). Blood. 2023;Nov 2;142 (S1):7215-7217;901$70$YR$$M$Y$84.6$KG$20240821$$HP$US$US
242314041$24231404$1$I$$20240812$20240821$20240821$EXP$$CA-ABBVIE-5886425$ABBVIE$$43$YR$$F$Y$$$20240821$$HP$CA$CA
242314051$24231405$1$I$$20240808$20240821$20240821$EXP$$GB-UCBSA-2024040259$UCB$$$$$M$Y$$$20240821$$CN$GB$GB
242314091$24231409$1$I$20240401$20240814$20240821$20240821$EXP$$US-JNJFOC-20240845211$JOHNSON AND JOHNSON$$83$YR$E$F$Y$45.4$KG$20240821$$MD$US$US
242314101$24231410$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006297$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$72$YR$$M$Y$$$20240821$$HP$US$US
242314111$24231411$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006299$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$44$YR$$M$Y$$$20240821$$HP$US$US
242314121$24231412$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006298$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$72$YR$$M$Y$$$20240821$$HP$US$US
242314131$24231413$1$I$20220210$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184191$ASTRAZENECA$$44$YR$$M$Y$49$KG$20240821$$MD$FR$
242314141$24231414$1$I$20220123$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184221$ASTRAZENECA$$75$YR$$M$Y$$$20240821$$MD$FR$
242314151$24231415$1$I$$20240813$20240821$20240821$EXP$$JP-AstraZeneca-2024A186622$ASTRAZENECA$$$$$F$Y$$$20240821$$MD$JP$
242314171$24231417$1$I$$20240813$20240821$20240821$PER$$US-AstraZeneca-2024A187848$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242314181$24231418$1$I$20220424$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184254$ASTRAZENECA$$26$YR$$M$Y$68$KG$20240821$$MD$FR$
242314191$24231419$1$I$$20240813$20240821$20240821$EXP$$CN-RDY-LIT/CHN/24/0011993$DR REDDYS$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turkish Journal of Hematology. 2023;40: 284-285. doi:10.4274/tjh.galenos.2023.2023.0263.$66$YR$E$M$Y$$$20240821$$HP$CN$CN
242314201$24231420$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006300$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$80$YR$$F$Y$$$20240821$$HP$US$US
242314211$24231421$1$I$$20240815$20240821$20240821$EXP$$NVSC2024CL167579$NOVARTIS$$$$$F$Y$$$20240821$$MD$CL$CL
242314221$24231422$1$I$20240731$20240814$20240821$20240821$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-25224$SAMSUNG BIOEPIS$$57$YR$A$F$Y$$$20240821$$CN$AU$AU
242314241$24231424$1$I$$20240814$20240821$20240821$EXP$$US-TAKEDA-2024TUS083077$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
242314251$24231425$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131495$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240821$$HP$US$US
242314261$24231426$1$I$20200101$20240819$20240821$20240821$EXP$$ES-SAMSUNG BIOEPIS-SB-2024-25464$SAMSUNG BIOEPIS$Suarez-Diaz S, Yllera-Gutierrez C, Moran-Castano C, Caminal-Montero L. Entities inside one another: VEXAS, a matryoshka-type disease. Reumatologia Clinica. 2024;20(1):57-8. DOI: 10.1016/j.reuma.2023.08.004.$8$DEC$E$M$Y$$$20240821$$MD$ES$ES
242314271$24231427$1$I$20240724$20240813$20240821$20240821$EXP$$CN-ABBVIE-5885270$ABBVIE$$68$YR$$F$Y$64.2$KG$20240821$$HP$CN$CN
242314293$24231429$3$F$$20240909$20240821$20240918$EXP$$CA-JNJFOC-20240801924$JOHNSON AND JOHNSON$$16$YR$T$M$Y$44$KG$20240918$$HP$CA$CA
242314301$24231430$1$I$$20240812$20240821$20240821$PER$$US-AMGEN-USASP2024162506$AMGEN$Faleck D.; Magahis P.T.; Corso T. et al.. Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors. Journal for Immunotherapy of Cancer. 2024;12 (7):1-10$$$$$Y$$$20240821$$MD$US$US
242314311$24231431$1$I$$20240813$20240821$20240821$EXP$$US-AMGEN-USASP2024161738$AMGEN$$$$$$Y$$$20240821$$LW$US$US
242314323$24231432$3$F$20240814$20240905$20240821$20240906$PER$$US-AMGEN-USASP2024164297$AMGEN$$52$YR$A$M$Y$$$20240906$$MD$US$US
242314331$24231433$1$I$$20240814$20240821$20240821$EXP$$US-AMGEN-USASL2024162387$AMGEN$$55$YR$A$F$Y$$$20240821$$CN$US$US
242314342$24231434$2$F$$20240827$20240821$20240829$EXP$$US-AVEO PHARMACEUTICALS, INC.-2024-AVEO-US000617$PAREXEL$$$$$$Y$$$20240829$$CN$US$US
242314351$24231435$1$I$$20240808$20240821$20240821$EXP$$DE-UCBSA-2024040459$UCB$$3$YR$$F$Y$$$20240821$$MD$DE$DE
242314361$24231436$1$I$20240701$20240808$20240821$20240821$EXP$$US-UCBSA-2024040449$UCB$$48$YR$$F$Y$$$20240821$$HP$US$US
242314371$24231437$1$I$$20240816$20240821$20240821$PER$$US-ABBVIE-5886038$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242314382$24231438$2$F$$20240828$20240821$20240902$EXP$$US-ABBVIE-5886403$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242314391$24231439$1$I$20240722$20240806$20240821$20240821$EXP$$RU-SERVIER-S24009941$SERVIER$$$$$$Y$$$20240821$$MD$RU$RU
242314401$24231440$1$I$$20240820$20240821$20240821$PER$$NVSC2024US168878$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242314411$24231441$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006303$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$69$YR$$M$Y$$$20240821$$HP$US$US
242314421$24231442$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006304$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$76$YR$$M$Y$$$20240821$$HP$US$US
242314431$24231443$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006305$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$79$YR$$M$Y$$$20240821$$HP$US$US
242314441$24231444$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006302$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$66$YR$$F$Y$$$20240821$$HP$US$US
242314451$24231445$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006301$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$66$YR$$F$Y$$$20240821$$HP$US$US
242314461$24231446$1$I$$20240813$20240821$20240821$PER$$US-AMGEN-USASP2024162084$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242314481$24231448$1$I$$20240814$20240821$20240821$EXP$$US-GSK-US2024101199$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242314491$24231449$1$I$$20240819$20240821$20240821$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046701$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240821$$HP$US$US
242314503$24231450$3$F$$20240912$20240821$20240912$PER$$US-ALXN-202408USA000999US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
242314511$24231451$1$I$20240501$20240814$20240821$20240821$EXP$$CO-TAKEDA-2024TUS083519$TAKEDA$$62$YR$$$Y$$$20240821$$MD$CO$CO
242314533$24231453$3$F$20240711$20240909$20240821$20240913$EXP$$US-ROCHE-10000052355$ROCHE$$60$YR$A$M$Y$$$20240913$$CN$US$US
242314541$24231454$1$I$$20240815$20240821$20240821$PER$$US-BIOGEN-2024BI01278575$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
242314551$24231455$1$I$20240723$20240806$20240821$20240821$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000799$PAREXEL$$$$$$Y$$$20240821$$HP$CN$CN
242314561$24231456$1$I$20240807$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024163063$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242314583$24231458$3$F$20240730$20240829$20240821$20240906$EXP$$CA-TAKEDA-2024TUS082270$TAKEDA$$61$YR$$F$Y$$$20240906$$CN$CA$CA
242314592$24231459$2$F$20240819$20240822$20240821$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408011699$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240826$$CN$US$US
242314601$24231460$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011803$ELI LILLY AND CO$$69$YR$E$$Y$$$20240821$$CN$US$US
242314611$24231461$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006308$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$71$YR$$M$Y$$$20240821$$HP$US$US
242314622$24231462$2$F$$20240814$20240821$20240827$EXP$$DE-AUROBINDO-AUR-APL-2024-034793$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$41$YR$$M$Y$$$20240827$$HP$DE$DE
242314631$24231463$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006306$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$72$YR$$M$Y$$$20240821$$HP$US$US
242314641$24231464$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006307$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$76$YR$$M$Y$$$20240821$$HP$US$US
242314662$24231466$2$F$20240201$20240821$20240821$20240823$EXP$$JP-JNJFOC-20240852037$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240823$$MD$JP$JP
242314671$24231467$1$I$$20240815$20240821$20240821$EXP$$CA-JNJFOC-20240844619$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240821$$HP$CA$CA
242314682$24231468$2$F$$20240827$20240821$20240901$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001651$BLUEPRINT MEDICINES$$$$$F$Y$$$20240902$$CN$US$US
242314691$24231469$1$I$20240808$20240819$20240821$20240821$EXP$$US-TAKEDA-2024TUS083366$TAKEDA$$67$YR$$M$Y$$$20240821$$CN$US$US
242314701$24231470$1$I$$20240808$20240821$20240821$EXP$$US-UCBSA-2024040464$UCB$$$$$F$Y$$$20240821$$HP$US$US
242314711$24231471$1$I$$20240816$20240821$20240821$EXP$$US-ROCHE-10000060536$ROCHE$$$$$$Y$$$20240821$$CN$US$US
242314721$24231472$1$I$20220817$20240820$20240821$20240821$EXP$$US-UCBSA-2024042099$UCB$$57$YR$$F$Y$$$20240821$$HP$US$US
242314733$24231473$3$F$20240801$20240913$20240821$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131533$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240917$$CN$US$US
242314741$24231474$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131439$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240821$$HP$US$US
242314761$24231476$1$I$20220116$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184187$ASTRAZENECA$$49$YR$$F$Y$58$KG$20240821$$MD$FR$
242314772$24231477$2$F$20240820$20240821$20240821$20240823$PER$$US-AMGEN-USASP2024166317$AMGEN$$37$YR$A$F$Y$$$20240823$$CN$US$US
242314792$24231479$2$F$20230701$20240905$20240821$20240909$EXP$$SG-ROCHE-10000059160$ROCHE$$$$$F$Y$$$20240909$$CN$SG$SG
242314802$24231480$2$F$$20240819$20240821$20240905$PER$$US-AstraZeneca-2024A180103$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242314812$24231481$2$F$$20230405$20240821$20240826$EXP$$US-AstraZeneca-2023A082110$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242314821$24231482$1$I$$20230517$20240821$20240821$EXP$$CA-AstraZeneca-2023A118379$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$CA$
242314831$24231483$1$I$$20240816$20240821$20240821$PER$$US-GILEAD-2024-0684734$GILEAD$$20$YR$A$M$Y$$$20240821$$HP$US$US
242314851$24231485$1$I$20240101$20240818$20240821$20240821$PER$$US-ABBVIE-5886733$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242314861$24231486$1$I$20240819$20240819$20240821$20240821$EXP$GB-MHRA-MED-202408191518260150-GMTBK$GB-SANDOZ INC.-SDZ2024GB073890$SANDOZ$$74$YR$$F$Y$$$20240821$$PH$GB$GB
242314871$24231487$1$I$$20240808$20240821$20240821$EXP$$CA-AUROBINDO-AUR-APL-2024-041009$AUROBINDO$$58$YR$$M$Y$$$20240821$$HP$CA$CA
242314901$24231490$1$I$$20240819$20240821$20240821$EXP$$NVSC2024US168501$NOVARTIS$$$$$$Y$$$20240821$$MD$US$US
242314911$24231491$1$I$$20240818$20240821$20240821$EXP$$NVSC2024US167646$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
242314921$24231492$1$I$$20240808$20240821$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-040000$AUROBINDO$Rechdan M, Svoboda S, Mojica R, Chung M, Motaparthi K, Saikaly SK. Acute vesiculobullous eruption in lupus patient on trimethoprim-sulfamethoxazole. JAAD Case Reports. 2024;50:126-8$48$YR$$F$Y$$$20240821$$MD$US$US
242314931$24231493$1$I$$20240808$20240821$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-039968$AUROBINDO$Vasireddy R, Bilalaga MM, Iding J, Sankineni A. Challenges in Diagnosis: Primary Hepatic Lymphoma Presenting as a Space-Occupying Liver Lesion. ACG Case Reports Journal. 2024;11(7):e01443$85$YR$$F$Y$$$20240821$$MD$US$US
242314941$24231494$1$I$20240701$20240815$20240821$20240821$EXP$$NVSC2024US127647$NOVARTIS$$41$YR$$F$Y$$$20240821$$CN$US$US
242314951$24231495$1$I$20240424$20240820$20240821$20240821$EXP$$NVSC2024FR168412$NOVARTIS$$$$A$F$Y$$$20240821$$MD$FR$FR
242314961$24231496$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006311$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$67$YR$$M$Y$$$20240821$$HP$US$US
242314971$24231497$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006312$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$81$YR$$M$Y$$$20240821$$HP$US$US
242314981$24231498$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006309$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$59$YR$$M$Y$$$20240821$$HP$US$US
242314991$24231499$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006310$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$70$YR$$M$Y$$$20240821$$HP$US$US
242315002$24231500$2$F$$20240819$20240821$20240831$EXP$$US-AUROBINDO-AUR-APL-2024-039986$AUROBINDO$Braun HM, Taylor JL, Axelrath S. Buprenorphine/naloxone ? one formulation that doesn?t fit all: a case report. Harm Reduction Journal. 2024;21(1):143$$$A$F$Y$$$20240831$$MD$US$US
242315011$24231501$1$I$20230724$20240813$20240821$20240821$EXP$$ZA-CELLTRION INC.-2023ZA004889$CELLTRION$$$$$$Y$$$20240821$$MD$ZA$ZA
242315021$24231502$1$I$$20240815$20240821$20240821$EXP$$IN-ROCHE-10000058941$ROCHE$Gogia A, Gupta A, Batra A, Deo S, Mishra A, Sharma D, et al. Neoadjuvant pertuzumab, docetaxel, carboplatin, and trastuzumab (PTCH) regimen in patients with HER2 positive early, locally advanced, and oligometastatic breast cancer: Real-world Indian experience. Journal of Clinical Oncology. 2024-Jun;42 (16):e12556.$$$$$Y$$$20240821$$HP$IN$IN
242315031$24231503$1$I$$20240808$20240821$20240821$EXP$$NL-AUROBINDO-AUR-APL-2024-040659$AUROBINDO$Maarten MD, Vissers YL, Grupa NM, Deben DS, Boselie TF. Bupivacaine pleural efusion mimicking a hemothorax  after a thoracoscopic microdiscectomy with epidural anesthesia. Acta Neurochirurgica. 2024;166 (284):1-5$42$YR$$F$Y$$$20240821$$HP$NL$NL
242315042$24231504$2$F$20240822$20240820$20240821$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004098$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240912$$CN$US$US
242315051$24231505$1$I$$20240722$20240821$20240821$PER$$US-IMP-2024000531$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242315061$24231506$1$I$20240101$20240722$20240821$20240821$PER$$US-IMP-2024000532$Harrow Health$$$$E$M$Y$$$20240821$$CN$US$US
242315082$24231508$2$F$20240101$20240722$20240821$20240826$PER$$US-IMP-2024000542$Harrow Health$$$$E$F$Y$$$20240826$$CN$US$US
242315091$24231509$1$I$$20240811$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127015$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$91.63$KG$20240821$$CN$US$US
242315101$24231510$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131766$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240821$$CN$US$US
242315111$24231511$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131823$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$56.7$KG$20240821$$CN$US$US
242315121$24231512$1$I$$20240820$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA074083$SANDOZ$$$$$$Y$$$20240821$$HP$CA$CA
242315131$24231513$1$I$$20240722$20240821$20240821$PER$$US-IMP-2024000533$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242315141$24231514$1$I$20240813$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024162131$AMGEN$$64$YR$A$F$Y$$$20240821$$CN$US$US
242315151$24231515$1$I$20240811$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164676$AMGEN$$83$YR$E$M$Y$$$20240821$$CN$US$US
242315162$24231516$2$F$$20240829$20240821$20240906$EXP$$IT-TEVA-VS-3233606$TEVA$Potestio L, Patruno C, Genco L, DI Filippo G, Napolitano M. Kaposi^s sarcoma as presentation of HIV in an atopic patient treated with upadacitinib. Ital-J-Dermatol-Venerol 2024; 159 (2): 211-212.; Potestio L, Patruno C, Genco L, DI Filippo G, Napolitano M. Kaposi^s sarcoma as presentation of HIV in an atopic patient treated with upadacitinib. Ital-J-Dermatol-Venerol 2024; 159 (2): 211-212.; Potestio L, Patruno C, Genco L, DI Filippo G, Napolitano M. Kaposi^s sarcoma as presentation of HIV in ...$45$YR$$M$Y$$$20240906$$HP$IT$IT
242315171$24231517$1$I$$20240816$20240821$20240821$EXP$$GB-SANDOZ INC.-SDZ2024GB023207$SANDOZ$$$$$F$Y$$$20240821$$CN$GB$GB
242315181$24231518$1$I$$20240808$20240821$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-039988$AUROBINDO$Sachdeva N, Sun LW, Young J, Chen A.. Early to late explantation of Hydrus microstent MIGS device: A case series. American Journal of Ophthalmology Case Reports. 2024;36:102105$71$YR$$M$Y$$$20240821$$MD$US$US
242315191$24231519$1$I$$20230602$20240821$20240821$EXP$$US-AstraZeneca-2023A089221$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242315201$24231520$1$I$$20230411$20240821$20240821$EXP$$US-AstraZeneca-2023A085575$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242315211$24231521$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006313$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$65$YR$$M$Y$$$20240821$$HP$US$US
242315221$24231522$1$I$$20240809$20240821$20240821$EXP$$CN-ROCHE-10000023778$ROCHE$Tao Y, Ke Y, Rao W, Liu Q. Relationship Between the Early Tumour Shrinkage and Depth of Response and the Efficacy and Prognosis of PD-1 Inhibitors in Combination With Trastuzumab and Chemotherapy as the First-line Treatment of HER-2-positive Advanced Gastric Carcinom. Chinese Journal of Clinical Oncology. 2024;51 (5):236-41. doi:10.12354/j.issn.1000-8179.2024.20240162.$$$$$Y$$$20240821$$HP$CN$CN
242315231$24231523$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006315$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$74$YR$$M$Y$$$20240821$$HP$US$US
242315241$24231524$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006314$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$73$YR$$M$Y$$$20240821$$HP$US$US
242315251$24231525$1$I$20240701$20240722$20240821$20240821$PER$$US-IMP-2024000530$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242315261$24231526$1$I$20240101$20240808$20240821$20240821$PER$$US-JNJFOC-20240823243$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240821$$CN$US$US
242315271$24231527$1$I$$20240812$20240821$20240821$30DAY$$US-GSK-US2024100362$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242315281$24231528$1$I$$20240812$20240821$20240821$PER$$US-ABBVIE-5877735$ABBVIE$$$$$$Y$$$20240821$$CN$US$US
242315291$24231529$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011505$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240821$$CN$US$US
242315301$24231530$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011107$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240821$$CN$US$US
242315311$24231531$1$I$20240808$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010947$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240821$$HP$US$US
242315321$24231532$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011797$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240821$$PH$US$US
242315331$24231533$1$I$$20240813$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012117$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240821$$CN$US$US
242315341$24231534$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011736$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240821$$CN$US$US
242315351$24231535$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010972$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240821$$CN$US$US
242315361$24231536$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011872$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240821$$CN$US$US
242315371$24231537$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011611$ELI LILLY AND CO$$$$$$Y$$$20240821$$CN$US$US
242315381$24231538$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010963$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240821$$CN$US$US
242315391$24231539$1$I$$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010319$ELI LILLY AND CO$$$$A$M$Y$$$20240821$$CN$US$US
242315401$24231540$1$I$$20240817$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012003$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240821$$CN$US$US
242315411$24231541$1$I$20240818$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012782$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240821$$CN$US$US
242315421$24231542$1$I$$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012482$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240821$$MD$US$US
242315431$24231543$1$I$20240801$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011843$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240821$$CN$US$US
242315441$24231544$1$I$$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012715$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240821$$CN$US$US
242315451$24231545$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011757$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240821$$CN$US$US
242315461$24231546$1$I$$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-086024-2024$RECKITT BENCKISER$$$$$M$Y$$$20240821$$CN$US$US
242315471$24231547$1$I$20240623$20240723$20240821$20240821$PER$$US-IMP-2024000546$Harrow Health$$72$YR$E$F$Y$$$20240821$$CN$US$US
242315481$24231548$1$I$$20240808$20240821$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-040012$AUROBINDO$Lum EL, Datta N, Beaird O, Zuckerman J, Bunnapradist S, Schaenman J.. Cutaneous Fungal Masses From Prior Environmental Injury Following Kidney Transplant: A Case Report. Transplantation Proceedings. 2019;51(9):3087-3091$63$YR$$M$Y$$$20240821$$MD$US$US
242315492$24231549$2$F$$20240812$20240821$20240821$EXP$$US-GILEAD-2024-0684031$GILEAD$$76$YR$E$F$Y$$$20240821$$HP$US$US
242315501$24231550$1$I$20240808$20240819$20240821$20240821$EXP$$US-ABBVIE-5887116$ABBVIE$$52$YR$$M$Y$$$20240821$$CN$US$US
242315521$24231552$1$I$20240101$20240724$20240821$20240821$PER$$US-IMP-2024000541$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242315531$24231553$1$I$$20240722$20240821$20240821$PER$$US-IMP-2024000538$Harrow Health$$$$E$M$Y$$$20240821$$CN$US$US
242315541$24231554$1$I$$20240807$20240821$20240821$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000318$AZURITY PHARMACEUTICALS$Enstrom C, Gast S, Church L, Heflin MK, Moore C, Cook C.et al.. Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy. US Cardiology Review. 2024;18 (2)$29$YR$$M$Y$$$20240821$$HP$US$US
242315551$24231555$1$I$$20240806$20240821$20240821$EXP$$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111115$ZYDUS PHARM$Fidan I, Delamotte E, Colombier M, Agossa K.. Non-surgical Treatment of Severe Drug-Influenced Gingival Enlargement: A Report of Two Cases.. Cureus. 2024;16(6):e63214$$$$$Y$$$20240821$$MD$FR$FR
242315561$24231556$1$I$20240713$20240812$20240821$20240821$EXP$FR-AFSSAPS-NC2024000954$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111131$ZYDUS PHARM$$$$$$Y$$$20240821$$MD$FR$FR
242315571$24231557$1$I$20240327$20240812$20240821$20240821$EXP$FR-AFSSAPS-LY2024001233$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111165$ZYDUS PHARM$$$$$$Y$$$20240821$$MD$FR$FR
242315581$24231558$1$I$$20240808$20240821$20240821$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-111078$ZYDUS PHARM$Sharma P, Venkatapura R.. Acute suppression of the hypothalamo-pituitary-adrenal axis from a large singular dose of dexamethasone: A case report on a hypothesis for resistant intraoperative hypotension.. Surg-Neurol-Int. 2024$$$$$Y$$$20240821$$HP$IN$IN
242315591$24231559$1$I$20240101$20240809$20240821$20240821$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111119$ZYDUS PHARM$$$$$$Y$$$20240821$$HP$US$US
242315601$24231560$1$I$20240808$20240812$20240821$20240821$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111188$ZYDUS PHARM$$$$$$Y$$$20240821$$PH$US$US
242315611$24231561$1$I$$20240807$20240821$20240821$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111020$ZYDUS PHARM$Joffe D, Rohan TZ, Mandel J, Suriano J, Banner L, Valiga A, et al.. The development of 2 clonally and histologically distinct subtypes of extranodal B-cell lymphomas in the brain and skin in 1 individual.. JAAD-Case-Reports. 2024;49:51-54$$$$$Y$$$20240821$$HP$US$US
242315621$24231562$1$I$20240801$20240813$20240821$20240821$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111232$ZYDUS PHARM$$$$$$Y$$$20240821$$CN$US$US
242315631$24231563$1$I$$20240812$20240821$20240821$EXP$$AU-CADILA HEALTHCARE LIMITED-AU-ZYDUS-111107$ZYDUS PHARM$$$$$$Y$$$20240821$$HP$AU$AU
242315641$24231564$1$I$$20240711$20240821$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07143$LUPIN$$$$$$Y$$$20240821$$CN$US$US
242315652$24231565$2$F$$20240821$20240821$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-040249$AUROBINDO$Luque-Paz D, Lalanne S, Besombes J, Dorel M, Maamar A, Revest M. Absence of maribavir penetration into the central nervous system: confirmation by multiple cerebrospinal fluid dosages in a solid organ transplant recipient. J-Antimicrob-Chemother. 2024;79(6):1462-1463$59$YR$$F$Y$$$20240831$$HP$FR$FR
242315661$24231566$1$I$$20240808$20240821$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-039086$AUROBINDO$Vikas Munjal, Robert J Macielak.. Leflunomide-Associated Wound Complication After Cochlear Implantation: A Case Report.. Annals of Otology, Rhinology + Laryngology. 2024;00(0):1?4$81$YR$$M$Y$$$20240821$$MD$US$US
242315672$24231567$2$F$$20240927$20240821$20240930$EXP$$US-GILEAD-2024-0684556$GILEAD$$67$YR$E$M$Y$$$20240930$$HP$US$US
242315681$24231568$1$I$$20240723$20240821$20240821$PER$$US-009507513-2408USA006316$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$65$YR$$M$Y$$$20240821$$HP$US$US
242315691$24231569$1$I$$20240723$20240821$20240821$PER$$US-009507513-2407USA014411$MERCK$Yang S, Jayakumaran G, Benhamida J, Febres-Aldana C, Fanaroff R, Chang J, et al. Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 2024;30 (13):2780-9$59$YR$$F$Y$$$20240821$$HP$US$US
242315701$24231570$1$I$20240101$20240724$20240821$20240821$PER$$US-IMP-2024000543$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242315711$24231571$1$I$$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024162879$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242315722$24231572$2$F$$20240828$20240821$20240906$EXP$$US-TEVA-VS-3234252$TEVA$Qadir N, Rulka K, Shirazi I, Durgun A, Trehan M. A Day on the Beach, a Risk for Vibrio Vulnificus Septicemia. Am-J-Respir-Crit-Care-Med 2024; 209.; Qadir N, Rulka K, Shirazi I, Durgun A, Trehan M. A Day on the Beach, a Risk for Vibrio Vulnificus Septicemia. Am-J-Respir-Crit-Care-Med 2024; 209.$61$YR$$M$Y$$$20240906$$HP$US$US
242315741$24231574$1$I$20220101$20240730$20240821$20240821$PER$$US-JNJFOC-20240783605$JOHNSON AND JOHNSON$$7$DEC$E$F$Y$$$20240821$$CN$US$US
242315751$24231575$1$I$$20240808$20240821$20240821$PER$$US-JNJFOC-20240822904$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240821$$CN$US$US
242315762$24231576$2$F$20240810$20240823$20240821$20240830$EXP$$US-CELLTRION INC.-2024US019788$CELLTRION$$$$$$Y$$$20240830$$CN$US$US
242315771$24231577$1$I$20240618$20240812$20240821$20240821$EXP$$GB-TEVA-VS-3232852$TEVA$$72$YR$$M$Y$85$KG$20240821$$MD$GB$GB
242315782$24231578$2$F$$20240813$20240821$20240823$EXP$$NVSC2024BR167144$NOVARTIS$$$$$F$Y$$$20240823$$CN$BR$BR
242315801$24231580$1$I$$20240814$20240821$20240821$EXP$$NVSC2024US165671$NOVARTIS$$$$$M$Y$$$20240821$$CN$US$US
242315811$24231581$1$I$$20240808$20240821$20240821$EXP$$CA-AUROBINDO-AUR-APL-2023-056574$AUROBINDO$Beland B, Hahn C, Jamani K, Chhibber S, White C, Atkins H, et al.. Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti-muscle specific kinase antibodies. Muscle-Nerve. 2023;67(2):154-157$52$YR$$F$Y$$$20240821$$MD$CA$CA
242315821$24231582$1$I$20240812$20240812$20240821$20240821$EXP$$GB-TEVA-VS-3232503$TEVA$$58$YR$$F$Y$80$KG$20240821$$MD$GB$GB
242315831$24231583$1$I$$20240723$20240821$20240821$PER$$US-RK PHARMA, INC-20240700039$RK PHARMA$$$$$$Y$$$20240821$$CN$US$US
242315841$24231584$1$I$20240315$20240816$20240821$20240821$EXP$FR-AFSSAPS-TO2024001551$FR-TAKEDA-2024TUS082340$TAKEDA$$21$YR$$F$Y$$$20240821$$HP$FR$FR
242315851$24231585$1$I$$20240812$20240821$20240821$EXP$$GB-TEVA-VS-3232962$TEVA$$63$YR$$F$Y$60$KG$20240821$$PH$GB$GB
242315861$24231586$1$I$$20240807$20240821$20240821$EXP$24CA000792$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000283$ASSERTIO THERAPEUTICS$$43$YR$$F$Y$$$20240821$$HP$CA$CA
242315891$24231589$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131804$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240821$$CN$US$US
242315911$24231591$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129855$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240821$$HP$US$US
242315921$24231592$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131576$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240821$$CN$US$US
242315931$24231593$1$I$$20240725$20240821$20240821$PER$$US-IMP-2024000559$Harrow Health$$$$E$M$Y$$$20240821$$CN$US$US
242315941$24231594$1$I$$20240814$20240821$20240821$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-129297$BRISTOL MYERS SQUIBB$Fenech M, Ajanaku A, Hsuan J, McCormick A, Shamas S, Ghadiri N. Immune checkpoint inhibitors and the orbit; two cases of reactive dacryoadenitis. Orbit. 2024 Aug 07;1-5. doi:10.1080/01676830.2024.2385010.$69$YR$E$F$Y$$$20240821$$HP$GB$GB
242315951$24231595$1$I$20240729$20240813$20240821$20240821$EXP$ES-AEMPS-1556382$ES-BEH-2024177221$CSL BEHRING$$41$YR$A$F$Y$60$KG$20240821$$CN$ES$ES
242315961$24231596$1$I$20240101$20240725$20240821$20240821$PER$$US-IMP-2024000547$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242315971$24231597$1$I$$20240726$20240821$20240821$PER$$US-IMP-2024000549$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242315981$24231598$1$I$20240601$20240820$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US074065$SANDOZ$$59$YR$$M$Y$$$20240821$$HP$US$US
242315991$24231599$1$I$$20240809$20240821$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-040329$AUROBINDO$Puri I, Ahmed A, Dhillon G. A case of disseminated crypotococcal infection with a rare twist. Journal of Hospital Medicine. 2018;4(1):13$69$YR$$M$Y$$$20240821$$HP$US$US
242316001$24231600$1$I$20240101$20240726$20240821$20240821$PER$$US-IMP-2024000550$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242316011$24231601$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165747$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242316021$24231602$1$I$20240815$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164853$AMGEN$$83$YR$E$F$Y$$$20240821$$CN$US$US
242316031$24231603$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165745$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242316041$24231604$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164238$AMGEN$$$$$M$Y$$$20240821$$HP$US$US
242316051$24231605$1$I$$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024162856$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242316061$24231606$1$I$$20240815$20240821$20240821$EXP$$NL-AMGEN-NLDSP2024163340$AMGEN$$77$YR$E$M$Y$$$20240821$$MD$NL$NL
242316071$24231607$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165736$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242316081$24231608$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165742$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242316091$24231609$1$I$20240101$20240725$20240821$20240821$PER$$US-IMP-2024000557$Harrow Health$$$$$F$Y$$$20240821$$CN$US$US
242316101$24231610$1$I$20240813$20240814$20240821$20240821$EXP$$GB-TAKEDA-2023TUS050806$TAKEDA$$48$YR$$M$Y$$$20240821$$CN$GB$GB
242316111$24231611$1$I$$20240812$20240821$20240821$EXP$$US-SA-2024SA241377$SANOFI AVENTIS$Herbster J, Prada CE, Rasmussen CA, Quadri A, Kuritza V, Viglione M, et al.. Presentation of ichthyosis after substrate reduction therapy in Gaucher type 1.. Am J Med Genet.. 2024;unk:unk$37$YR$A$F$Y$$$20240821$$HP$US$US
242316121$24231612$1$I$20240101$20240726$20240821$20240821$PER$$US-IMP-2024000552$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242316132$24231613$2$F$20240625$20240903$20240821$20240911$EXP$$BR-TAKEDA-2024TUS083286$TAKEDA$$42$YR$$F$Y$$$20240911$$CN$BR$BR
242316141$24231614$1$I$$20240812$20240821$20240821$EXP$$GB-TEVA-VS-3232853$TEVA$$$$$M$Y$$$20240821$$MD$GB$GB
242316151$24231615$1$I$$20240812$20240821$20240821$EXP$$GB-TEVA-VS-3232844$TEVA$$63$YR$$F$Y$60$KG$20240821$$PH$GB$GB
242316161$24231616$1$I$20240426$20240814$20240821$20240821$EXP$$CA-ROCHE-10000058093$ROCHE$$67$YR$E$M$Y$$$20240821$$CN$CA$CA
242316171$24231617$1$I$$20240820$20240821$20240821$PER$$NVSC2024US169000$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242316181$24231618$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131190$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240821$$HP$US$US
242316201$24231620$1$I$20240731$20240808$20240821$20240821$EXP$$DE-COLLEGIUM PHARMACEUTICAL, INC.-20240800608$COLLEGIUM PHARMACEUTICAL$$76$YR$$F$Y$$$20240821$$CN$DE$DE
242316211$24231621$1$I$$20240808$20240821$20240821$EXP$$PT-COLLEGIUM PHARMACEUTICAL, INC.-20240800612$COLLEGIUM PHARMACEUTICAL$Silva P, Ferreira M, Grilo A, Gon?alves F.. S?NDROME SEROTONIN?RGICA:  A PROP?SITO DE UM CASO CL?NICO. Urg?ncia, cuidados interm?dios e doente cr?tico... Abstract of Congress.. 481$48$YR$$F$Y$$$20240821$$HP$PT$PT
242316221$24231622$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131798$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240821$$CN$US$US
242316231$24231623$1$I$20240722$20240819$20240821$20240821$EXP$$US-TAKEDA-2024TUS078530$TAKEDA$$54$YR$$M$Y$$$20240821$$CN$US$US
242316241$24231624$1$I$$20240809$20240821$20240821$EXP$$FR-AUROBINDO-AUR-APL-2024-040656$AUROBINDO$$75$YR$$F$Y$$$20240821$$CN$FR$FR
242316251$24231625$1$I$$20240818$20240821$20240821$PER$$AP-2024-US-001356$AILEX PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242316263$24231626$3$F$$20240906$20240821$20240913$PER$$US-SA-2024SA243702$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240913$$HP$US$US
242316271$24231627$1$I$20240725$20240725$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051325$TOLMAR$$77$YR$$M$Y$$$20240821$$CN$CA$CA
242316281$24231628$1$I$$20240726$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051320$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
242316291$24231629$1$I$20240725$20240725$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051319$TOLMAR$$82$YR$$M$Y$$$20240821$$CN$CA$CA
242316301$24231630$1$I$20240726$20240726$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051328$TOLMAR$$81$YR$$M$Y$$$20240821$$CN$CA$CA
242316312$24231631$2$F$$20240829$20240821$20240906$PER$$US-TOLMAR, INC.-24US051051$TOLMAR$$$$$$Y$$$20240906$$MD$US$US
242316321$24231632$1$I$20240725$20240725$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051326$TOLMAR$$84$YR$$M$Y$$$20240821$$CN$CA$CA
242316331$24231633$1$I$20230201$20240726$20240821$20240821$PER$$US-TOLMAR, INC.-24US051198$TOLMAR$$11$YR$$F$Y$31.293$KG$20240821$$HP$US$US
242316342$24231634$2$F$20240723$20240904$20240821$20240925$PER$$US-TOLMAR, INC.-24US051280$TOLMAR$$9$YR$$F$Y$$$20240925$$HP$US$US
242316351$24231635$1$I$20240724$20240726$20240821$20240821$PER$$US-TOLMAR, INC.-24US051322$TOLMAR$$16$YR$$M$Y$$$20240821$$HP$US$US
242316362$24231636$2$F$20240717$20240906$20240821$20240925$PER$$US-TOLMAR, INC.-24US051411$TOLMAR$$$$$M$Y$$$20240925$$HP$US$US
242316371$24231637$1$I$20240101$20240726$20240821$20240821$PER$$US-TOLMAR, INC.-24US051324$TOLMAR$$$$$$Y$$$20240821$$MD$US$US
242316382$24231638$2$F$20240725$20240905$20240821$20240925$PER$$US-TOLMAR, INC.-24US051434$TOLMAR$$68$YR$$M$Y$$$20240925$$HP$US$US
242316391$24231639$1$I$20240201$20240725$20240821$20240821$PER$$US-TOLMAR, INC.-24US051504$TOLMAR$$9$YR$$F$Y$$$20240821$$HP$US$US
242316402$24231640$2$F$20240726$20240905$20240821$20240925$PER$$US-TOLMAR, INC.-24US051550$TOLMAR$$$$$F$Y$$$20240925$$HP$US$US
242316411$24231641$1$I$$20230530$20240821$20240821$EXP$$US-AstraZeneca-2023A126136$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242316421$24231642$1$I$$20220216$20240821$20240821$EXP$$US-AstraZeneca-2022A077681$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
242316431$24231643$1$I$$20230516$20240821$20240821$EXP$$US-AstraZeneca-2023A114388$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242316442$24231644$2$F$20240812$20240909$20240821$20240917$EXP$$JP-GENMAB-2024-02975$GENMAB$$5$DEC$$M$Y$$$20240917$$MD$JP$JP
242316451$24231645$1$I$$20221026$20240821$20240821$EXP$$US-AstraZeneca-2022A358286$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242316471$24231647$1$I$$20240814$20240821$20240821$EXP$$DE-ABBVIE-5884040$ABBVIE$$$$$$Y$$$20240821$$MD$DE$DE
242316482$24231648$2$F$$20240821$20240821$20240826$PER$$US-LEO Pharma-372851$LEO PHARM$$64$YR$$M$Y$$$20240826$$CN$US$US
242316491$24231649$1$I$20240724$20240727$20240821$20240821$PER$$US-IMP-2024000558$Harrow Health$$93$YR$E$F$Y$$$20240821$$CN$US$US
242316501$24231650$1$I$$20240813$20240821$20240821$PER$$US-ROCHE-10000056750$ROCHE$$60$YR$A$F$Y$113.4$KG$20240821$$CN$US$US
242316521$24231652$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165707$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242316531$24231653$1$I$$20240806$20240821$20240821$EXP$$FR-LEADINGPHARMA-FR-2024LEALIT00352$LEADING PHARMA$F Lescarbotte.Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases.Annales de Chirurgie Plastique et Esthetique.JAN-2024;69:27-33$65$YR$E$F$Y$$$20240821$$HP$FR$FR
242316541$24231654$1$I$20240522$20240812$20240821$20240821$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024100270$VIIV$$43$YR$$F$Y$$$20240821$$HP$US$US
242316552$24231655$2$F$$20240828$20240821$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07324$LUPIN$$$$$$Y$$$20240918$$CN$US$US
242316561$24231656$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132311$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240821$$CN$US$US
242316571$24231657$1$I$$20240815$20240821$20240821$EXP$$CA-TAKEDA-2024TUS082750$TAKEDA$$$$$F$Y$$$20240821$$CN$CA$CA
242316581$24231658$1$I$20160601$20240814$20240821$20240821$EXP$$MX-SA-2024SA244242$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240821$$CN$MX$MX
242316591$24231659$1$I$$20240812$20240821$20240821$EXP$$US-ROCHE-10000055616$ROCHE$$$$$F$Y$$$20240821$$CN$US$US
242316601$24231660$1$I$$20240816$20240821$20240821$PER$$US-ROCHE-10000060624$ROCHE$$46$YR$A$F$Y$$$20240821$$CN$US$US
242316611$24231661$1$I$$20240815$20240821$20240821$EXP$$US-ROCHE-10000059664$ROCHE$Puthenpura M, Batah H, Patel H, Braghieri L, Agdamag C, Sadler D, et al. Cardiac and mortality outcomes in patients with breast cancer undergoing trastuzumab-based therapies. Journal of Clinical Oncology. 2024-Jun;42 (16):$$$$F$Y$$$20240821$$HP$US$US
242316621$24231662$1$I$$20240819$20240821$20240821$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-141050$DAIICHI$$$$$F$Y$$$20240821$$CN$US$US
242316631$24231663$1$I$20220101$20240819$20240821$20240821$EXP$$PL-SANDOZ INC.-SDZ2024PL073460$SANDOZ$$38$YR$$F$Y$$$20240821$$MD$PL$PL
242316641$24231664$1$I$20240614$20240809$20240821$20240821$EXP$$FR-AUROBINDO-AUR-APL-2024-040967$AUROBINDO$$17$YR$$M$Y$$$20240821$$MD$FR$FR
242316651$24231665$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165714$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242316661$24231666$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011537$ELI LILLY AND CO$$50$YR$A$$Y$$$20240821$$LW$US$US
242316671$24231667$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011558$ELI LILLY AND CO$$52$YR$A$$Y$$$20240821$$LW$US$US
242316681$24231668$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011123$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240821$$CN$US$US
242316692$24231669$2$F$$20240815$20240821$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408010181$ELI LILLY AND CO$$53$YR$A$$Y$$$20240827$$LW$US$US
242316711$24231671$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011603$ELI LILLY AND CO$$47$YR$A$$Y$$$20240821$$CN$US$US
242316721$24231672$1$I$$20240820$20240821$20240821$EXP$$AU-GILEAD-2024-0684731$GILEAD$$$$$M$Y$$$20240821$$MD$AU$AU
242316732$24231673$2$F$$20240905$20240821$20240905$PER$$US-ALXN-202408USA001008US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242316745$24231674$5$F$20240817$20240911$20240821$20240916$EXP$$US-AMGEN-USASP2024166306$AMGEN$$57$YR$A$F$Y$$$20240916$$HP$US$US
242316751$24231675$1$I$20240810$20240820$20240821$20240821$PER$$US-AMGEN-USASP2024166249$AMGEN$$63$YR$A$F$Y$$$20240821$$CN$US$US
242316761$24231676$1$I$$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-103866-2023$RECKITT BENCKISER$$$$$$Y$$$20240821$$CN$US$US
242316772$24231677$2$F$$20240905$20240821$20240912$EXP$$JP-AMGEN-JPNSP2024165225$AMGEN$$85$YR$E$M$Y$$$20240912$$HP$JP$JP
242316781$24231678$1$I$20240101$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165755$AMGEN$$77$YR$E$F$Y$$$20240821$$HP$US$US
242316791$24231679$1$I$$20240809$20240821$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-034790$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$48$YR$$M$Y$$$20240821$$HP$DE$DE
242316811$24231681$1$I$$20240817$20240821$20240821$PER$$US-ABBVIE-5886734$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242316821$24231682$1$I$$20240818$20240821$20240821$PER$$NVSC2024US167632$NOVARTIS$$24$YR$$F$Y$$$20240821$$CN$US$US
242316831$24231683$1$I$20240727$20240812$20240821$20240821$EXP$FR-AFSSAPS-BR2024000636$FR-TEVA-VS-3233197$TEVA$$68$YR$$M$Y$66$KG$20240821$$MD$FR$FR
242316841$24231684$1$I$20240722$20240729$20240821$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004128$ACADIA PHARMACEUTICALS$$65$YR$$F$Y$$$20240821$$CN$US$US
242316851$24231685$1$I$20240723$20240819$20240821$20240821$EXP$RO-NMA-2024-SP0523$RO-SA-2024SA245672$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240821$$PH$RO$RO
242316861$24231686$1$I$$20240806$20240821$20240821$EXP$$FR-LEADINGPHARMA-FR-2024LEALIT00353$LEADING PHARMA$F Lescarbotte.Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases.Annales de Chirurgie Plastique et Esthetique.JAN-2024;69:27-33$55$YR$A$F$Y$$$20240821$$HP$FR$FR
242316871$24231687$1$I$20210815$20240528$20240821$20240821$EXP$$CA-CELLTRION INC.-2021CA019600$CELLTRION$$$$$$Y$$$20240821$$CN$CA$CA
242316881$24231688$1$I$$20240809$20240821$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-040332$AUROBINDO$Adams B, Lazarchick J, Medina AM, Willner IR, Neville B, Murphy E et al. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.. American Journal of Hematology. 201085(8):627-629$42$YR$$F$Y$$$20240821$$MD$US$US
242316911$24231691$1$I$20240801$20240814$20240821$20240821$PER$$US-ABBVIE-5882238$ABBVIE$$$$$$Y$$$20240821$$CN$US$US
242316921$24231692$1$I$20240628$20240729$20240821$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004129$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240821$$CN$US$US
242316941$24231694$1$I$$20240816$20240821$20240821$EXP$$JP-009507513-2408JPN002107J$MERCK$$7$DEC$$F$Y$$$20240821$$MD$JP$JP
242316951$24231695$1$I$$20240821$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US074094$SANDOZ$$$$$$Y$$$20240821$$PH$US$US
242316961$24231696$1$I$20240702$20240809$20240821$20240821$EXP$$ES-AUROBINDO-AUR-APL-2024-040674$AUROBINDO$$81$YR$$M$Y$$$20240821$$MD$ES$ES
242316971$24231697$1$I$20240101$20240816$20240821$20240821$EXP$$BR-ABBVIE-5887198$ABBVIE$$$$E$M$Y$$$20240821$$MD$BR$BR
242316981$24231698$1$I$20240801$20240816$20240821$20240821$PER$$US-JNJFOC-20240846297$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240821$$MD$US$US
242316991$24231699$1$I$20240816$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164688$AMGEN$$60$YR$A$M$Y$$$20240821$$CN$US$US
242317001$24231700$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164457$AMGEN$$$$$$Y$$$20240821$$MD$US$US
242317012$24231701$2$F$$20240920$20240821$20240928$EXP$$DE-AUROBINDO-AUR-APL-2024-039034$AUROBINDO$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology. 2024;48:299-313$28$YR$$M$Y$$$20240928$$HP$DE$DE
242317023$24231702$3$F$20240807$20240830$20240821$20240909$PER$$US-AMGEN-USASP2024158414$AMGEN$$76$YR$E$M$Y$83.9$KG$20240908$$PH$US$US
242317031$24231703$1$I$20240529$20240820$20240821$20240821$EXP$$US-UCBSA-2024042145$UCB$$45$YR$$F$Y$$$20240821$$CN$US$US
242317041$24231704$1$I$$20240806$20240821$20240821$EXP$$FR-LEADINGPHARMA-FR-2024LEALIT00354$LEADING PHARMA$F Lescarbotte.Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases.Annales de Chirurgie Plastique et Esthetique.JAN-2024;69:27-33$76$YR$E$F$Y$$$20240821$$HP$FR$FR
242317051$24231705$1$I$$20240814$20240821$20240821$EXP$$US-GSK-US2024101889$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$US$US
242317061$24231706$1$I$$20240819$20240821$20240821$EXP$$US-GILEAD-2024-0684724$GILEAD$$$$A$F$Y$$$20240821$$CN$US$US
242317081$24231708$1$I$$20220728$20240821$20240821$EXP$$US-AstraZeneca-2022A270893$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242317091$24231709$1$I$$20230524$20240821$20240821$EXP$$US-AstraZeneca-2023A122338$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242317101$24231710$1$I$$20230117$20240821$20240821$EXP$$IN-AstraZeneca-2023A015751$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$IN$
242317112$24231711$2$F$$20240814$20240821$20240822$EXP$$US-AstraZeneca-2024A186089$ASTRAZENECA$$$$$F$Y$$$20240822$$HP$US$
242317121$24231712$1$I$$20220711$20240821$20240821$EXP$$ZA-AstraZeneca-2022A252758$ASTRAZENECA$$61$YR$$M$Y$$$20240821$$CN$ZA$
242317131$24231713$1$I$$20240813$20240821$20240821$EXP$$CN-AstraZeneca-2024A186404$ASTRAZENECA$Wang Y. A case report of quetiapine-induced erythema multiforme. Shanghai Archives of Psychiatry 2011;23(4):245-246.$25$YR$$F$Y$$$20240821$$HP$CN$
242317141$24231714$1$I$$20240729$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004131$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242317151$24231715$1$I$20240815$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164536$AMGEN$$76$YR$E$F$Y$$$20240821$$CN$US$US
242317161$24231716$1$I$$20240816$20240821$20240821$EXP$FR-GERMAN-LIT/FRA/24/0011630$FR-ROCHE-10000059338$ROCHE$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024 Apr;117(4): 297-300. doi:10.1016/j.acvd.2024.02.003.$77$YR$E$M$Y$$$20240821$$HP$FR$FR
242317171$24231717$1$I$$20240815$20240821$20240821$EXP$$US-GSK-US2024AMR102835$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
242317181$24231718$1$I$$20240814$20240821$20240821$EXP$$US-GSK-US2024101436$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$US$US
242317191$24231719$1$I$$20240811$20240821$20240821$30DAY$$US-GSK-US2024099849$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240821$$CN$US$US
242317201$24231720$1$I$$20240812$20240821$20240821$EXP$$US-GSK-US2024AMR100670$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240821$$CN$US$US
242317211$24231721$1$I$$20240820$20240821$20240821$PER$$NVSC2024US168981$NOVARTIS$$$$$M$Y$132$KG$20240821$$CN$US$US
242317221$24231722$1$I$20240719$20240809$20240821$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-040535$AUROBINDO$$70$YR$$M$Y$$$20240821$$MD$DE$DE
242317232$24231723$2$F$20240813$20240905$20240821$20240905$PER$$US-ALXN-202408USA000812US$ALEXION PHARMACEUTICALS$$75$YR$$F$Y$$$20240905$$CN$US$US
242317241$24231724$1$I$20240101$20240819$20240821$20240821$EXP$$CA-Orion Corporation ORION PHARMA-24_00031338$ORION$$61$YR$A$F$Y$$$20240821$$HP$CA$
242317251$24231725$1$I$20240101$20240816$20240821$20240821$EXP$$BR-ABBVIE-5885822$ABBVIE$$26$YR$$F$Y$$$20240821$$MD$BR$BR
242317261$24231726$1$I$$20240806$20240821$20240821$EXP$$JP-LEADINGPHARMA-JP-2024LEALIT00357$LEADING PHARMA$T Nishio.A case of lacosamide and mirtazapine self-poisoning.Legal Medicine.JUL-2024;69:1-7$$$A$F$Y$$$20240821$$HP$JP$JP
242317271$24231727$1$I$20240228$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-086621-2024$RECKITT BENCKISER$$85$YR$$F$Y$$$20240821$$CN$US$US
242317281$24231728$1$I$20240101$20240804$20240821$20240821$PER$$US-IMP-2024000586$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242317291$24231729$1$I$20180701$20240812$20240821$20240821$EXP$$CA-TAKEDA-2024TUS083433$TAKEDA$$37$YR$$M$Y$$$20240821$$CN$CA$CA
242317301$24231730$1$I$$20240802$20240821$20240821$PER$$US-IMP-2024000584$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242317311$24231731$1$I$20240701$20240814$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129132$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240821$$HP$US$US
242317322$24231732$2$F$$20240819$20240821$20240822$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-129874$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240822$$HP$TW$TW
242317332$24231733$2$F$20240601$20240913$20240821$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130789$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$CN$US$US
242317341$24231734$1$I$$20240814$20240821$20240821$EXP$$DE-EXELIXIS-XL18424080691$EXELIXIS$$$$$F$Y$$$20240821$$CN$DE$DE
242317351$24231735$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164824$AMGEN$$$$A$F$Y$$$20240821$$CN$US$US
242317361$24231736$1$I$$20240813$20240821$20240821$EXP$$US-TAKEDA-2024TUS083524$TAKEDA$$$$$$Y$$$20240821$$CN$US$US
242317371$24231737$1$I$20240724$20240809$20240821$20240821$EXP$$FR-AUROBINDO-AUR-APL-2024-041513$AUROBINDO$$$$A$M$Y$$$20240821$$MD$FR$FR
242317381$24231738$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024162463$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240821$$HP$US$US
242317401$24231740$1$I$$20240801$20240821$20240821$PER$$US-IMP-2024000580$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242317412$24231741$2$F$$20240909$20240821$20240913$EXP$$CA-APOTEX-2024AP009245$APOTEX$$65$YR$$F$Y$$$20240913$$HP$CA$CA
242317421$24231742$1$I$$20240729$20240821$20240821$EXP$$JP-ROCHE-10000048808$ROCHE$Chinen I, Ono S, Takatsuki M. S27-6 Current status of multidisciplinary treatment for advanced HCC in our institution. The 79th General Meeting of the Japanese Society of Gastroenterological Surgery. 2024;2486.$$$$M$Y$$$20240821$$MD$JP$JP
242317431$24231743$1$I$20240819$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165731$AMGEN$$37$YR$A$F$Y$$$20240821$$CN$US$US
242317451$24231745$1$I$$20240815$20240821$20240821$PER$$US-ABBVIE-5886628$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242317461$24231746$1$I$$20240814$20240821$20240821$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006029$BIOCON$$$$$$Y$$$20240821$$CN$CA$CA
242317471$24231747$1$I$20240711$20240731$20240821$20240821$PER$$US-IMP-2024000576$Harrow Health$$88$YR$E$F$Y$$$20240821$$CN$US$US
242317481$24231748$1$I$20221201$20240813$20240821$20240821$EXP$$CA-CELLTRION INC.-2022CA021308$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
242317491$24231749$1$I$$20240811$20240821$20240821$EXP$$GB-AUROBINDO-AUR-APL-2024-040529$AUROBINDO$$2$YR$$M$Y$$$20240821$$CN$GB$GB
242317501$24231750$1$I$20240813$20240814$20240821$20240821$30DAY$$US-GSK-US2024101423$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242317511$24231751$1$I$20240812$20240812$20240821$20240821$PER$$US-JNJFOC-20240831830$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
242317521$24231752$1$I$$20240729$20240821$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004132$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
242317531$24231753$1$I$$20240816$20240821$20240821$PER$$US-ROCHE-10000059983$ROCHE$$5$YR$C$M$Y$$$20240821$$HP$US$US
242317541$24231754$1$I$20240101$20240806$20240821$20240821$PER$$US-COSETTE-CP2024US000209$COSETTE PHARMACEUTICALS$$59$YR$A$F$Y$52.61$KG$20240821$$CN$US$US
242317551$24231755$1$I$20240803$20240813$20240821$20240821$EXP$$CN-ROCHE-10000056398$ROCHE$$58$YR$A$M$Y$67$KG$20240821$$HP$CN$CN
242317562$24231756$2$F$$20240823$20240821$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004099$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
242317571$24231757$1$I$$20240813$20240821$20240821$PER$$US-TAKEDA-2024TUS083372$TAKEDA$$$$A$F$Y$$$20240821$$CN$US$US
242317581$24231758$1$I$$20240814$20240821$20240821$PER$$US-TAKEDA-2024TUS082344$TAKEDA$$$$$F$Y$57$KG$20240821$$MD$US$US
242317591$24231759$1$I$20240818$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011691$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240821$$CN$US$US
242317601$24231760$1$I$20240801$20240813$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408008551$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240821$$CN$US$US
242317611$24231761$1$I$$20240819$20240821$20240821$PER$$US-ABBVIE-5886888$ABBVIE$$$$$$Y$$$20240821$$CN$US$US
242317631$24231763$1$I$20240814$20240814$20240821$20240821$PER$$US-JNJFOC-20240841163$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
242317641$24231764$1$I$$20240816$20240821$20240821$PER$$US-ABBVIE-5886401$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242317651$24231765$1$I$20240710$20240808$20240821$20240821$EXP$$FR-AUROBINDO-AUR-APL-2024-040136$AUROBINDO$$46$YR$$M$Y$$$20240821$$HP$FR$FR
242317662$24231766$2$F$$20240820$20240821$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA073885$SANDOZ$$12$MON$$M$Y$$$20240823$$CN$CA$CA
242317671$24231767$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024163872$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242317681$24231768$1$I$20240811$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024166163$AMGEN$$54$YR$A$M$Y$$$20240821$$CN$US$US
242317691$24231769$1$I$$20240812$20240821$20240821$PER$$US-AMGEN-USASP2024161950$AMGEN$$78$YR$E$F$Y$$$20240821$$CN$US$US
242317701$24231770$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024162502$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240821$$HP$US$US
242317713$24231771$3$F$$20240829$20240821$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004135$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
242317721$24231772$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024162520$AMGEN$Schonman I.; Sterling C.H.; Baran K.G. et.al. Trainee-led quality improvement (Q1) project examining PCP prophylaxis in patients on chronic, high-dose corticosteroids. Journal of Clinical Oncology. 2024;42 (SUPPL_16):1-5$$$$$Y$$$20240821$$HP$US$US
242317731$24231773$1$I$$20240806$20240821$20240821$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463470$RANBAXY$Reyes NGD, Bendahan N, Swinkin E, Lang AE, Bassett AS.. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurol Sci. 2024;0 (0)$49$YR$$F$Y$$$20240821$$HP$CA$CA
242317741$24231774$1$I$$20240815$20240821$20240821$EXP$CZ-PHARMAGEN-PHARMAGEN20240723a_Lit$CZ-ROCHE-10000058473$ROCHE$Kufa J, Novotna J, Lukasova M, et al. Raritni granulomatozni procesy. Transfuze a hematologie dnes. 2024; 30(2):122-30.$48$YR$A$M$Y$$$20240821$$MD$CZ$CZ
242317751$24231775$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463429$RANBAXY$Nguyen A, Norman M, O^Reilly E, Robinson CL, Fonseca A, Madabhushi S et al. Case Series: Spinal Cord Stimulator Therapy Alleviates Neuropathic Pain in Patients with Failed Back Surgery Syndrome in the Setting of Spinal Cord Injury. Pain Medicine Case Reports. 2023;7(7):337-340$49$YR$$M$Y$$$20240821$$PH$US$US
242317761$24231776$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463463$RANBAXY$Lescarbotte F, Romano G, Balleyguier C, Arfi Rouche J, Ilenko A, Leymarie N. Extensive transfixing skin necrosis after breast biopsy under local anesthesia: About four cases. Ann Chir Plast Esthet. 2024;69:27-33$65$YR$$F$Y$$$20240821$$HP$FR$FR
242317772$24231777$2$F$20220101$20240813$20240821$20240828$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463479$RANBAXY$Iturriagagoitia A, Heggermont W, Van Camp G. A rare cause of syndromic mitral valve prolapse. Eur Heart J Cardiovasc Imaging. 2024;Jul; 25 (7):e184$36$YR$$M$Y$$$20240828$$HP$BE$BE
242317781$24231778$1$I$$20240806$20240821$20240821$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463659$RANBAXY$Chanut M, Bonny V, Joly AC, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an oldconcept in the modern era of on cohaematology. Arch Cardiovasc Dis. 2024;117(4):297-300$75$YR$$F$Y$$$20240821$$HP$FR$FR
242317791$24231779$1$I$$20240806$20240821$20240821$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463247$RANBAXY$Majhi DN, Shetty RA, Nimonkar RA, Pardal MPS. Clinicoepidemiological Profile of a Fatal Case of Scrub Typhus: Our Experience. Int J Pharmac Clin Res. 2024;16(6):1116-1119$37$YR$$F$Y$$$20240821$$HP$IN$IN
242317804$24231780$4$F$20240801$20240905$20240821$20240911$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012957$JAZZ$$54$YR$$F$Y$$$20240911$$CN$US$US
242317811$24231781$1$I$$20240806$20240821$20240821$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463476$RANBAXY$Naka M, Inaba A, Miyasaka H, Suzue K, Ishigaki J, Shibuya H, et al. An elderly case of paraneoplastic anti-NMDA receptor encephalitis associated with large cell neuroendocrine carcinoma of the lung. BMC Pulm Med. 2024;24:336(1-6)$78$YR$$M$Y$$$20240821$$HP$JP$JP
242317821$24231782$1$I$$20240806$20240821$20240821$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463682$RANBAXY$Iannone C, Pellico MR, Campochiaro C, Tescaro L, Zompatori M, Caminati A, et al. The heterogeneity of lung involvement in vacuoles, E1 enzyme, Xlinked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern. Reumatismo. 2024;Feb; 76 (2):130-132$71$YR$$M$Y$$$20240821$$HP$IT$IT
242317831$24231783$1$I$$20240806$20240821$20240821$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463475$RANBAXY$Naka M, Inaba A, Miyasaka H, Suzue K, Ishigaki J, Shibuya H, et al. An elderly case of paraneoplastic anti-NMDA receptor encephalitis associated with large cell neuroendocrine carcinoma of the lung. BMC Pulm Med. 2024;Jul;24:336(1-6)$70$YR$$M$Y$$$20240821$$HP$JP$JP
242317841$24231784$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463296$RANBAXY$Nelson N, Masih D, Sabri A, Monika F, Mirza M. Isolated myeloid sarcoma masquerading as scattered abscesses in a septic patient: a case report and literature review. Case Rep Oncol. 2024;17 (1):39-48$76$YR$$F$Y$$$20240821$$HP$US$US
242317851$24231785$1$I$$20240816$20240821$20240821$EXP$$NVSC2024GB130228$NOVARTIS$$$$$M$Y$$$20240821$$CN$GB$GB
242317862$24231786$2$F$20240201$20240829$20240821$20240903$EXP$$NVSC2024ZA166396$NOVARTIS$$16$YR$$F$Y$$$20240903$$HP$ZA$ZA
242317871$24231787$1$I$$20240819$20240821$20240821$EXP$$NVSC2024US168496$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242317881$24231788$1$I$20240217$20240814$20240821$20240821$EXP$FR-AFSSAPS-AM2024000657$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-128915$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$75.5$KG$20240821$$MD$FR$FR
242317891$24231789$1$I$20240301$20240812$20240821$20240821$EXP$FR-AFSSAPS-TO2024001445$FR-TEVA-VS-3233319$TEVA$$98$YR$$F$Y$58.6$KG$20240821$$PH$FR$FR
242317901$24231790$1$I$$20240812$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128808$BRISTOL MYERS SQUIBB$Trager MH, Coley SM, Dube G, Khan S, Ingham M, Samie FH, et al. Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients. Journal for ImmunoTherapy of Cancer. 2021;9:1-7. doi:10.1136/jitc-2020-000908corr1.$58$YR$A$M$Y$$$20240821$$HP$US$US
242317911$24231791$1$I$20240101$20240815$20240821$20240821$EXP$$US-ABBVIE-5883584$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242317921$24231792$1$I$20240613$20240812$20240821$20240821$EXP$IT-MINISAL02-998182$IT-BAXTER-2024BAX023076$BAXTER$$67$YR$$M$Y$76$KG$20240821$$MD$IT$IT
242317931$24231793$1$I$20240613$20240812$20240821$20240821$EXP$$BR-BAXTER-2024BAX022600$BAXTER$$14$YR$$F$Y$41.3$KG$20240821$$PH$BR$BR
242317941$24231794$1$I$20240101$20240730$20240821$20240821$PER$$US-IMP-2024000570$Harrow Health$$$$A$F$Y$$$20240821$$CN$US$US
242317952$24231795$2$F$$20240828$20240821$20240906$EXP$$US-TEVA-VS-3234250$TEVA$Sevella P, Khan S, Shah S. A Devastating Case of Septic Pulmonary Emboli. Am-J-Respir-Crit-Care-Med 2024; 209.; Sevella P, Khan S, Shah S. A Devastating Case of Septic Pulmonary Emboli. Am-J-Respir-Crit-Care-Med 2024; 209.$73$YR$$M$Y$$$20240906$$HP$US$US
242317961$24231796$1$I$20240726$20240816$20240821$20240821$EXP$$US-AstraZeneca-2024A188609$ASTRAZENECA$$29568$DY$$M$Y$$$20240821$$CN$US$
242317971$24231797$1$I$20240101$20240730$20240821$20240821$PER$$US-IMP-2024000569$Harrow Health$$$$E$M$Y$$$20240821$$CN$US$US
242317981$24231798$1$I$20210215$20220309$20240821$20240821$EXP$$FR-AstraZeneca-2021A330997$ASTRAZENECA$$308$MON$$F$Y$78$KG$20240821$$MD$FR$
242317991$24231799$1$I$$20240813$20240821$20240821$EXP$$ZA-AstraZeneca-2024A185564$ASTRAZENECA$$29220$DY$$M$Y$$$20240821$$CN$ZA$
242318001$24231800$1$I$20240815$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024164540$AMGEN$$$$$$Y$$$20240821$$HP$US$US
242318011$24231801$1$I$$20240816$20240821$20240821$EXP$$US-ABBVIE-5885249$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242318021$24231802$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163512$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242318032$24231803$2$F$20240813$20240903$20240821$20240905$PER$$US-AMGEN-USASP2024165373$AMGEN$$$$$M$Y$$$20240905$$CN$US$US
242318042$24231804$2$F$20240701$20240905$20240821$20240911$EXP$$CA-JNJFOC-20240736231$JOHNSON AND JOHNSON$$32$YR$A$F$Y$59$KG$20240911$$HP$CA$CA
242318051$24231805$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163525$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242318061$24231806$1$I$20240529$20240815$20240821$20240821$EXP$$US-JNJFOC-20240839926$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240821$$CN$US$US
242318081$24231808$1$I$$20240820$20240820$20240820$DIR$715172$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242318092$24231809$2$F$$20240816$20240821$20240821$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-16493$IPSEN$$19$YR$A$M$Y$142.88$KG$20240821$$CN$US$US
242318101$24231810$1$I$20240726$20240729$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004137$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240821$$CN$US$US
242318111$24231811$1$I$$20240814$20240821$20240821$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001649$BLUEPRINT MEDICINES$$$$$F$Y$$$20240821$$CN$US$US
242318121$24231812$1$I$20240101$20240816$20240821$20240821$EXP$$US-ABBVIE-5885376$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242318131$24231813$1$I$20240101$20240815$20240821$20240821$EXP$$GB-ABBVIE-5884041$ABBVIE$$58$YR$$F$Y$$$20240821$$CN$GB$GB
242318141$24231814$1$I$$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-087099-2024$RECKITT BENCKISER$$60$YR$$M$Y$$$20240821$$CN$US$US
242318151$24231815$1$I$20240801$20240814$20240821$20240821$EXP$$CN-EMD Serono-2024044124$EMD SERONO INC$$34$YR$A$F$Y$60$KG$20240821$$HP$CN$CN
242318161$24231816$1$I$20240801$20240816$20240821$20240821$EXP$$US-ABBVIE-5887377$ABBVIE$$52$YR$$M$Y$$$20240821$$CN$US$US
242318171$24231817$1$I$20240723$20240820$20240821$20240821$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046849$BOEHRINGER INGELHEIM$$49$YR$A$M$Y$$$20240821$$HP$SG$SG
242318181$24231818$1$I$$20240809$20240821$20240821$PER$$US-EMD Serono-2024043441$EMD SERONO INC$$$$$M$Y$$$20240821$$CN$US$US
242318191$24231819$1$I$20240815$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024163896$AMGEN$$64$YR$E$F$Y$$$20240821$$CN$US$US
242318201$24231820$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163571$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242318211$24231821$1$I$20231012$20240729$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004138$ACADIA PHARMACEUTICALS$$68$YR$$F$Y$$$20240821$$CN$US$US
242318222$24231822$2$F$20240101$20240910$20240821$20240917$EXP$$CA-CELLTRION INC.-2024CA008189$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
242318232$24231823$2$F$20240701$20240816$20240821$20240822$EXP$DK-DKMA-30737407$DK-009507513-2408DNK005939$MERCK$$63$YR$$M$Y$$$20240822$$MD$DK$DK
242318241$24231824$1$I$$20240724$20240821$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07393$LUPIN$$$$$$Y$$$20240821$$CN$US$US
242318251$24231825$1$I$$20240815$20240821$20240821$PER$$US-ALXN-202408USA000998US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242318261$24231826$1$I$20240627$20240815$20240821$20240821$EXP$ES-AEMPS-1557574$ES-CHEPLA-2024010741$CHEPLAPHARM$$48$YR$$F$Y$$$20240821$$MD$COUNTRY NOT SPECIFIED$ES
242318271$24231827$1$I$$20240729$20240821$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004140$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242318281$24231828$1$I$20240101$20240724$20240821$20240821$PER$$US-JNJFOC-20240850522$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
242318291$24231829$1$I$$20240812$20240821$20240821$EXP$$US-GSK-US2024AMR100687$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
242318301$24231830$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131400$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240821$$HP$US$US
242318321$24231832$1$I$20240715$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130073$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240821$$HP$US$US
242318331$24231833$1$I$20220913$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184253$ASTRAZENECA$$68$YR$$M$Y$65$KG$20240821$$MD$FR$
242318341$24231834$1$I$20231121$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A186956$ASTRAZENECA$$29355$DY$$F$Y$$$20240821$$CN$US$
242318351$24231835$1$I$$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131175$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240821$$HP$US$US
242318361$24231836$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165248$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242318371$24231837$1$I$$20240819$20240821$20240821$EXP$$NVSC2024US167796$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
242318381$24231838$1$I$20240421$20240816$20240821$20240821$EXP$$FR-AstraZeneca-2024A187171$ASTRAZENECA$$83$YR$$M$Y$60$KG$20240821$$MD$FR$
242318393$24231839$3$F$20240801$20240828$20240821$20240902$PER$$US-ABBVIE-5886370$ABBVIE$$72$YR$$F$Y$62$KG$20240902$$CN$US$US
242318401$24231840$1$I$$20240611$20240821$20240821$EXP$$TH-009507513-2408THA005887$MERCK$$63$YR$$M$Y$$$20240821$$MD$TH$TH
242318411$24231841$1$I$20240124$20240814$20240821$20240821$EXP$ES-AEMPS-1557691$ES-009507513-2408ESP005422$MERCK$$38$YR$$F$Y$65$KG$20240821$$MD$ES$ES
242318451$24231845$1$I$20240709$20240812$20240821$20240821$EXP$$BG-IMMUNOCORE, LTD-2024-IMC-002970$IMMUNOCORE$$$$$$Y$$$20240821$$MD$BG$BG
242318481$24231848$1$I$$20240814$20240821$20240821$EXP$$CA-ROCHE-10000061042$ROCHE$$$$$F$Y$$$20240821$$CN$CA$CA
242318491$24231849$1$I$$20240813$20240821$20240821$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004514$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240821$$CN$US$US
242318501$24231850$1$I$20240719$20240725$20240821$20240821$PER$$US-AMGEN-USASP2024149506$AMGEN$$50$YR$A$F$Y$$$20240821$$PH$US$US
242318511$24231851$1$I$$20240806$20240821$20240821$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463300$RANBAXY$Jodeh W, Sparks PJ, Higgins JM, Tom A, Anilovich N, Moit H, et al. Parathyroid hormone-related peptide induced hypercalcemia of pregnancy due to mammary hyperplasia. JBMR Plus. 2024;8 (8):ziae083(1-5)$39$YR$$F$Y$$$20240821$$MD$US$US
242318521$24231852$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163572$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242318531$24231853$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024163090$AMGEN$Elfil M.; Lookian P.; Kumari K et. al. Reversible cerebral vasoconstriction syndrome due to teprotumumab: two case reports. Oxford Medical case Reports. 2024;Vol (8):333-336$71$YR$E$F$Y$$$20240821$$HP$US$US
242318541$24231854$1$I$$20240808$20240821$20240821$EXP$$US-MYLANLABS-2024M1075636$MYLAN$Panthi S, MIles JM, Graves L. Headache, Pituitary Apoplexy and Diabetes insipidus: Suspect Necrotizing Hypophysitis. J-Endocr-Soc 2021; 5 (Suppl.) A585.$34$YR$$F$Y$$$20240821$$MD$US$US
242318551$24231855$1$I$$20240809$20240821$20240821$EXP$$US-MYLANLABS-2024M1076304$MYLAN$Li B, Chawla S, Tong M, Higgins A, Lee R. Temporary Biventricular Mechanical Circulatory Support for Primary Graft Dysfunction after Orthotopic Heart Transplantation. US-Cardiol 2024; 18 (Suppl. 1) 38 (plus Poster) abstr. 75.$51$YR$$M$Y$$$20240821$$MD$US$US
242318571$24231857$1$I$$20240809$20240821$20240821$EXP$$US-MYLANLABS-2024M1076310$MYLAN$Dykes K, Tzachanis D, Koura D. A Difficult Case of Calcineurin Inhibitor Neurotoxicity Post-Haploidentical HCT With a Successful Novel Solution: Cytotoxic T-Lymphocyte-Associated Protein 4-Immunoglobulin Blockade for GVHD Prophylaxis. Cell-Transplant 2024; 33 01-07.$24$YR$$M$Y$$$20240821$$HP$US$US
242318581$24231858$1$I$$20240809$20240821$20240821$EXP$$IT-MYLANLABS-2024M1076249$MYLAN$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series. J-Clin-Med 2023; 12 (1):.$27$YR$$M$Y$$$20240821$$HP$IT$IT
242318591$24231859$1$I$$20240811$20240821$20240821$EXP$$NL-AMGEN-NLDSP2024163412$AMGEN$Cox J.; Dikkenberg M. V.; Achaouch H. E. et al.. EXPLORING THE RELATIONSHIP BETWEEN ADALIMUMAB THROUGH LEVELS AND FIVE PATIENT REPORTED OUTCOME MEASURES IN RHEUMATOID ARTHRITIS THE LADDER STUDY. Annals of the Rheumatic Diseases. 2024;83:2214-2215$$$$$Y$$$20240821$$HP$NL$NL
242318601$24231860$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163584$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242318611$24231861$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163573$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242318621$24231862$1$I$$20240729$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004143$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
242318631$24231863$1$I$20240529$20240816$20240821$20240821$EXP$ES-AEMPS-1559956$ES-ROCHE-10000059001$ROCHE$$70$YR$E$F$Y$$$20240821$$PH$ES$ES
242318641$24231864$1$I$$20240802$20240821$20240821$PER$$US-TEVA-VS-3231479$TEVA$$75$YR$$M$Y$$$20240821$$CN$US$US
242318652$24231865$2$F$$20240821$20240821$20240826$PER$$US-ALXN-202408USA000872US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
242318661$24231866$1$I$$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024162097$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242318672$24231867$2$F$20240817$20240826$20240821$20240828$PER$$US-AMGEN-USASP2024165466$AMGEN$$$$$M$Y$$$20240827$$CN$US$US
242318681$24231868$1$I$20240814$20240815$20240821$20240821$EXP$$US-UCBSA-2024041449$UCB$$44$YR$$F$Y$$$20240821$$CN$US$US
242318691$24231869$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163608$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242318701$24231870$1$I$20240101$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165488$AMGEN$$82$YR$E$F$Y$$$20240821$$CN$US$US
242318711$24231871$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163633$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242318721$24231872$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163586$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242318731$24231873$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163594$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242318741$24231874$1$I$$20240819$20240821$20240821$EXP$$US-GSK-US2024103293$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
242318751$24231875$1$I$$20240811$20240821$20240821$EXP$$TR-AMGEN-TURSP2024164021$AMGEN$Cosan F.; Kimiaei A.; Safaei S. et al.. FOLLOW-UP DATA ON DRUG-INDUCED LUPUS CASES DURING TNF-ALPHA INHIBITOR TREATMENT. Annals of the Rheumatic Diseases. 2024;83:1850-1851$$$$$Y$$$20240821$$HP$TR$TR
242318761$24231876$1$I$$20240806$20240821$20240821$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-111000$ZYDUS PHARM$Cyriac S, V S, Law AD, Penny PTT, Chirayath JJ, Mullapillil R, et al.. Tumor Infiltrating Lymphocytes (TILs) Therapy - Report of the First TILs Therapy Infusion from India, for a Patient of Malignant Melanoma.. Transplantation and Cellular Therapy. 2024;30 (2) abs. 411:S304-S305$$$$$Y$$$20240821$$HP$IN$IN
242318771$24231877$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163628$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242318781$24231878$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163598$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242318791$24231879$1$I$$20240807$20240821$20240821$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111069$ZYDUS PHARM$Abdelal Q, Isern S, Najjar N.. Azith and the Myth.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240821$$HP$US$US
242318801$24231880$1$I$$20240814$20240821$20240821$PER$$US-ABBVIE-5886917$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242318811$24231881$1$I$$20240814$20240821$20240821$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004622$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240821$$CN$FR$FR
242318822$24231882$2$F$$20240910$20240821$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131252$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$112.49$KG$20240911$$CN$US$US
242318831$24231883$1$I$$20240816$20240821$20240821$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-131750$BRISTOL MYERS SQUIBB$$37$YR$A$M$Y$$$20240821$$CN$TW$TW
242318841$24231884$1$I$20240816$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132071$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$56.7$KG$20240821$$PH$US$US
242318881$24231888$1$I$$20240809$20240821$20240821$EXP$$NL-AUROBINDO-AUR-APL-2018-041768$AUROBINDO$Marti AS, Mirsattari SM.. Patterns of propagation in parietal lobe epilepsy. 31st International Congress of Clinical Neurophysiology, ICCN of the IFCN. United States.. Clinical Neurophysiology.. 2018;129 (Suppl 1):e112$64$YR$$F$Y$$$20240821$$MD$NL$NL
242318891$24231889$1$I$20240809$20240816$20240821$20240821$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004632$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240821$$CN$US$US
242318901$24231890$1$I$20240101$20240814$20240821$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022007$UNITED THERAPEUTICS$$$$$F$Y$48.073$KG$20240821$$$US$US
242318912$24231891$2$F$$20240820$20240821$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-009890$UNITED THERAPEUTICS$$$$$F$Y$108.16$KG$20240828$$$US$US
242318924$24231892$4$F$$20240828$20240821$20240909$EXP$$US-HALEON-USCH2024001062$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
242318931$24231893$1$I$$20240722$20240821$20240821$30DAY$$US-VEROBIOTECH-2024USVEROSPO00185$VERO BIOTECH$$$$$$Y$$$20240821$$HP$US$US
242318951$24231895$1$I$20240523$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57207$$FDA-CTU$$$$$$N$$$20240820$N$$US$
242318961$24231896$1$I$20240301$20240814$20240821$20240821$EXP$$US-GSK-US2024101385$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240821$$CN$US$US
242318971$24231897$1$I$$20240729$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004241$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242318981$24231898$1$I$$20240814$20240821$20240821$EXP$$BR-TAKEDA-2024TUS083520$TAKEDA$$$$$M$Y$$$20240821$$CN$BR$BR
242318991$24231899$1$I$20240529$20240814$20240821$20240821$EXP$$CA-JNJFOC-20240838998$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240821$$PH$CA$CA
242319002$24231900$2$F$$20240903$20240821$20240905$EXP$$GB-MYLANLABS-2024M1076704$MYLAN$$$$$M$Y$$$20240905$$CN$GB$GB
242319011$24231901$1$I$$20240816$20240821$20240821$EXP$$US-MYLANLABS-2024M1076612$MYLAN$$$$$F$Y$$$20240821$$PH$US$US
242319022$24231902$2$F$20240101$20240904$20240821$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-024674$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240910$$$US$US
242319031$24231903$1$I$$20240812$20240821$20240821$PER$$US-ROCHE-10000054414$ROCHE$$16$YR$T$M$Y$$$20240821$$CN$US$US
242319041$24231904$1$I$20230101$20240814$20240821$20240821$EXP$$US-ROCHE-10000057957$ROCHE$$50$YR$A$F$Y$86.18$KG$20240821$$CN$US$US
242319051$24231905$1$I$$20240816$20240821$20240821$EXP$$GB-MYLANLABS-2024M1076595$MYLAN$$82$YR$$M$Y$74$KG$20240821$$PH$GB$GB
242319061$24231906$1$I$20130901$20240812$20240821$20240821$EXP$$US-SA-2024SA241227$SANOFI AVENTIS$$$$$F$Y$$$20240821$$CN$US$US
242319071$24231907$1$I$$20240806$20240821$20240821$PER$$US-GRANULES-US-2024GRASPO00367$GRANULES INDIA$$$$$F$Y$$$20240821$$CN$US$US
242319081$24231908$1$I$20240423$20240809$20240821$20240821$EXP$$FR-AUROBINDO-AUR-APL-2024-041116$AUROBINDO$$37$YR$$F$Y$82$KG$20240821$$MD$FR$FR
242319091$24231909$1$I$$20240814$20240821$20240821$PER$$US-ABBVIE-5886404$ABBVIE$$$$$$Y$$$20240821$$HP$US$US
242319101$24231910$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024161663$AMGEN$Willis C.. Emerging Real-World Midostaurin Treatment Patterns and Outcomes in FLT3-Mutated Acute Myeloid Leukemia at a Comprehensive Cancer Center. Annals of the Rheumatic Diseases. 2018;132:1-3$$$$$Y$$$20240821$$HP$US$US
242319111$24231911$1$I$$20240819$20240821$20240821$EXP$$US-TAKEDA-2023TUS085173$TAKEDA$$$$$F$Y$$$20240821$$HP$US$US
242319121$24231912$1$I$$20240820$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA074044$SANDOZ$$$$$$Y$$$20240821$$HP$CA$CA
242319131$24231913$1$I$$20240812$20240821$20240821$EXP$$CA-JNJFOC-20240838805$JOHNSON AND JOHNSON$$76$YR$E$M$Y$75$KG$20240821$$HP$CA$CA
242319143$24231914$3$F$20240101$20240903$20240821$20240911$PER$$US-UNITED THERAPEUTICS-UNT-2024-023572$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240911$$$US$US
242319151$24231915$1$I$$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132105$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240821$$HP$US$US
242319161$24231916$1$I$20240816$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024163907$AMGEN$$67$YR$E$F$Y$$$20240821$$CN$US$US
242319172$24231917$2$F$$20240923$20240821$20240924$PER$$US-AMGEN-USASP2024163857$AMGEN$$$$$M$Y$$$20240924$$PH$US$US
242319182$24231918$2$F$$20240920$20240821$20240928$EXP$$JP-AMGEN-JPNSP2024163706$AMGEN$$$$$$Y$$$20240928$$PH$JP$JP
242319192$24231919$2$F$$20240811$20240821$20240821$PER$$US-AMGEN-USASP2024164217$AMGEN$Tskhakaia I.; Ali R.; Moret Y. G. et al.. COMPARATIVE ANALYSIS OF TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND INTERLEUKIN 17 INHIBITORS IN PSORIATIC ARTERITIS: EXPLORING CARDIOVASCLJLAR OUTCOMES. Annals of the Rheumatic Diseases. 2024;83:169$$$$$Y$$$20240821$$HP$US$US
242319201$24231920$1$I$$20240811$20240821$20240821$EXP$$IT-AMGEN-ITASP2024163587$AMGEN$Fattizzo B.; Pasquale R.; Carpenedo M. et al.. Clinical and Morphologic Predictors of Outcome in a Multicenter Cohort of ITP Patients Treated with Trombopoietin Analogues. Blood. 2018;132 (SUPPL_1):1-5$$$$$Y$$$20240821$$MD$IT$IT
242319211$24231921$1$I$$20240812$20240821$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-024994$UNITED THERAPEUTICS$$$$$F$Y$$$20240821$$$US$US
242319221$24231922$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009294$APOTEX$$$$$F$Y$$$20240821$$CN$CA$CA
242319231$24231923$1$I$20240730$20240820$20240821$20240821$EXP$$US-UCBSA-2024042225$UCB$$75$YR$$F$Y$$$20240821$$CN$US$US
242319241$24231924$1$I$20240816$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011686$ELI LILLY AND CO$$$$$F$Y$$$20240821$$CN$US$US
242319252$24231925$2$F$20240601$20240816$20240821$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011090$ELI LILLY AND CO$$44$YR$A$$Y$$$20240823$$CN$US$US
242319261$24231926$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011839$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240821$$HP$US$US
242319271$24231927$1$I$20240819$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011969$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240821$$CN$US$US
242319281$24231928$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010622$ELI LILLY AND CO$$$$$$Y$$$20240821$$CN$US$US
242319301$24231930$1$I$$20240816$20240821$20240821$EXP$$CA-Orion Corporation ORION PHARMA-24_00031342$ORION$$52$YR$A$F$Y$$$20240821$$HP$CA$
242319311$24231931$1$I$$20221109$20240821$20240821$EXP$$KW-BIOVITRUM-2022KW13372$BIOVITRUM$$$$I$M$Y$$$20240821$$CN$KW$KW
242319322$24231932$2$F$$20240827$20240821$20240902$PER$$US-AMGEN-USASP2024161821$AMGEN$Topilow N.J.; Penteado R.; Ting M. et al.. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Canadian journal ofOphthalmology/Journal Canadien d^Ophtalmologie. 2024;1-6$$$$$Y$$$20240902$$HP$US$US
242319331$24231933$1$I$20200318$20240815$20240821$20240821$EXP$$CA-TAKEDA-2024TUS082803$TAKEDA$$81$YR$$F$Y$$$20240821$$MD$CA$CA
242319341$24231934$1$I$20240801$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011957$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240821$$CN$US$US
242319351$24231935$1$I$$20240809$20240821$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-041088$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$48$YR$$F$Y$$$20240821$$HP$DE$DE
242319361$24231936$1$I$20240620$20240814$20240821$20240821$EXP$$CN-AMGEN-CHNSP2024162347$AMGEN$$71$YR$E$M$Y$77$KG$20240821$$HP$CN$CN
242319371$24231937$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163579$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242319381$24231938$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163581$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242319391$24231939$1$I$20230704$20240814$20240821$20240821$EXP$$US-SA-2024SA244328$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240821$$MD$US$US
242319401$24231940$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024163222$AMGEN$Shah, N.M.. Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas Including AITL and DLBCL: Phase I Results. Blood. 2018;132(Supp 1):2929$$$$$Y$$$20240821$$MD$US$US
242319411$24231941$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165925$AMGEN$$$$$$Y$$$20240821$$HP$US$US
242319421$24231942$1$I$20240101$20240816$20240821$20240821$EXP$ES-AEMPS-1559643$ES-SA-2024SA242938$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240821$$PH$ES$ES
242319441$24231944$1$I$20240605$20240812$20240821$20240821$EXP$FR-AFSSAPS-LY2024000881$FR-MYLANLABS-2024M1074795$MYLAN$$23$YR$$F$Y$43.5$KG$20240821$$PH$FR$FR
242319451$24231945$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130270$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240821$$CN$US$US
242319461$24231946$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130279$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$76.66$KG$20240821$$CN$US$US
242319471$24231947$1$I$$20240809$20240821$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-040284$AUROBINDO$Sheth K, Lee C, Srinivas N, Hasan Y, Myat K. Hydrochlorothiazide-Induced Exfoliative Rash and Sepsis. Cureus. 2024;16(7):e63655$86$YR$$M$Y$$$20240821$$MD$US$US
242319491$24231949$1$I$$20240809$20240821$20240821$EXP$$CA-AUROBINDO-AUR-APL-2024-040878$AUROBINDO$$$$$M$Y$$$20240821$$HP$CA$CA
242319501$24231950$1$I$20240813$20240813$20240821$20240821$PER$$US-JNJFOC-20240835352$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240821$$CN$US$US
242319512$24231951$2$F$$20240821$20240821$20240831$EXP$$FR-AUROBINDO-AUR-APL-2021-000693$AUROBINDO$Auffret M, Descamps A, Thomas C, Bonenfant C, Desmaretz J-L, Canevet C. Neutropenic enterocolitis associated with docetaxel treatment, a rare but frightening side effect: About a case. J-Pharm-Clin. 2012;31(3):163-166$60$YR$$F$Y$103$KG$20240831$$HP$FR$FR
242319521$24231952$1$I$$20240809$20240821$20240821$EXP$$CA-AUROBINDO-AUR-APL-2024-040944$AUROBINDO$$66$YR$$M$Y$$$20240821$$HP$CA$CA
242319531$24231953$1$I$20221201$20221220$20240821$20240821$EXP$$KW-BIOVITRUM-2022KW15806$BIOVITRUM$$5$MON$$F$Y$$$20240821$$CN$KW$KW
242319542$24231954$2$F$20240726$20240814$20240821$20240828$EXP$$US-GSK-US2024101346$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
242319551$24231955$1$I$$20240815$20240821$20240821$EXP$$US-GSK-US2024101777$GLAXOSMITHKLINE$$$$$M$Y$$$20240821$$MD$US$US
242319561$24231956$1$I$20240101$20240816$20240821$20240821$EXP$$US-SA-2024SA246033$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240821$$MD$US$US
242319571$24231957$1$I$$20240809$20240821$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-034837$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$20$YR$$M$Y$$$20240821$$HP$DE$DE
242319591$24231959$1$I$$20240820$20240820$20240820$DIR$715033$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242319601$24231960$1$I$$20240820$20240820$20240820$DIR$715182$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242319621$24231962$1$I$20240101$20240819$20240821$20240821$EXP$$US-SA-2024SA247220$SANOFI AVENTIS$$50$YR$A$M$Y$84.8$KG$20240821$$MD$US$US
242319631$24231963$1$I$$20240819$20240821$20240821$EXP$$DE-SA-2024SA246401$SANOFI AVENTIS$$49$YR$A$F$Y$70$KG$20240821$$MD$DE$DE
242319641$24231964$1$I$20240718$20240819$20240821$20240821$EXP$$US-TAKEDA-2024TUS083316$TAKEDA$$63$YR$$M$Y$$$20240821$$CN$US$US
242319651$24231965$1$I$$20240806$20240821$20240821$EXP$$TR-GLANDPHARMA-TR-2024GLNLIT00629$GLAND PHARMA$$30$YR$A$F$Y$$$20240821$$MD$TR$TR
242319661$24231966$1$I$20240626$20240808$20240821$20240821$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000806$PAREXEL$$$$$$Y$$$20240821$$HP$CN$CN
242319671$24231967$1$I$$20240812$20240821$20240821$EXP$NL-LRB-00994580$NL-TEVA-VS-3233109$TEVA$$77$YR$$F$Y$71.7$KG$20240821$$MD$NL$NL
242319681$24231968$1$I$20240724$20240806$20240821$20240821$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000800$PAREXEL$$$$$$Y$$$20240821$$HP$CN$CN
242319701$24231970$1$I$20240809$20240811$20240821$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012411$JAZZ$$40$YR$$F$Y$$$20240821$$CN$US$US
242319711$24231971$1$I$$20240809$20240821$20240821$EXP$$DE-AUROBINDO-AUR-APL-2024-040986$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology.. 2024;48 (5):299-313.$26$YR$$F$Y$$$20240821$$HP$DE$DE
242319721$24231972$1$I$$20240814$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2023US028718$SANDOZ$$$$$F$Y$$$20240821$$PH$US$US
242319731$24231973$1$I$$20240820$20240820$20240820$DIR$715125$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242319741$24231974$1$I$20230302$20230317$20240821$20240821$EXP$$ZA-BIOVITRUM-2023-ZA-007904$BIOVITRUM$$302$DY$$F$Y$7.6$KG$20240821$$CN$ZA$ZA
242319751$24231975$1$I$20221201$20221219$20240821$20240821$EXP$$KW-BIOVITRUM-2022KW15755$BIOVITRUM$$13$MON$$F$Y$$$20240821$$CN$KW$KW
242319761$24231976$1$I$20230101$20230102$20240821$20240821$EXP$$KW-BIOVITRUM-2023KW00380$BIOVITRUM$$5$MON$$F$Y$$$20240821$$CN$KW$KW
242319771$24231977$1$I$$20221121$20240821$20240821$EXP$$KW-BIOVITRUM-2022KW13987$BIOVITRUM$$$$I$F$Y$$$20240821$$CN$KW$KW
242319783$24231978$3$F$20240601$20240902$20240821$20240906$EXP$$FR-AstraZeneca-2024A186226$ASTRAZENECA$$64$YR$$F$Y$80$KG$20240906$$MD$FR$
242319791$24231979$1$I$20240201$20240819$20240821$20240821$EXP$FR-AFSSAPS-MP2024001288$FR-SA-2024SA244778$SANOFI AVENTIS$$66$YR$E$M$Y$96$KG$20240821$$MD$FR$FR
242319802$24231980$2$F$20240911$20240916$20240821$20240920$EXP$$US-BAYER-2024A116994$BAYER$$54$YR$A$F$Y$78.912$KG$20240920$$CN$US$US
242319811$24231981$1$I$$20230222$20240821$20240821$EXP$$TW-AstraZeneca-2023A045007$ASTRAZENECA$$69$YR$$M$Y$$$20240821$$CN$TW$
242319821$24231982$1$I$20240608$20240813$20240821$20240821$EXP$$SE-AstraZeneca-2024A184205$ASTRAZENECA$$38$YR$$M$Y$85$KG$20240821$$MD$SE$
242319831$24231983$1$I$$20221227$20240821$20240821$EXP$$US-AstraZeneca-2022A418790$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242319841$24231984$1$I$$20240820$20240820$20240820$DIR$715166$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242319851$24231985$1$I$$20240808$20240821$20240821$EXP$$SE-P+L Developments of Newyork Corporation-2160667$PL DEVELOPMENTS$Initial$31$YR$$$Y$$$20240821$$MD$SE$SE
242319871$24231987$1$I$$20240820$20240820$20240820$DIR$715076$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242319881$24231988$1$I$$20240812$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129043$BRISTOL MYERS SQUIBB$Thomas R, Patel H, Scott J. Dermatomyositis flare with immune checkpoint inhibitor therapy for melanoma. Cureus. 2021 Apr 09;13(4):1-3. doi:10.7759/cureus.14387.$36$YR$A$F$Y$$$20240821$$HP$US$US
242319891$24231989$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130651$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$83.91$KG$20240821$$CN$US$US
242319901$24231990$1$I$20240815$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130674$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240821$$CN$US$US
242319921$24231992$1$I$20240816$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164668$AMGEN$$73$YR$E$F$Y$$$20240821$$CN$US$US
242319931$24231993$1$I$$20240816$20240821$20240821$EXP$FR-GERMAN-LIT/FRA/24/0011440$FR-ROCHE-10000059375$ROCHE$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases.. 2024-Apr;117 (4):297-300. doi:10.1016/j.acvd.2024.02.003.$78$YR$E$F$Y$$$20240821$$HP$FR$FR
242319941$24231994$1$I$20240805$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130665$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$71.67$KG$20240821$$PH$US$US
242319951$24231995$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163604$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242319961$24231996$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163591$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242319971$24231997$1$I$20220930$20221004$20240821$20240821$EXP$$NL-TERSERA THERAPEUTICS LLC-2022TRS004389$TERSERA THERAPEUTICS$$$$$$Y$$$20240821$$CN$NL$NL
242319982$24231998$2$F$$20240902$20240821$20240913$EXP$$DE-MACLEODS PHARMA-MAC2024048837$MACLEODS$$$$$$Y$$$20240913$$MD$DE$DE
242319991$24231999$1$I$$20240812$20240821$20240821$EXP$$ES-JNJFOC-20240837861$JOHNSON AND JOHNSON$$43$YR$A$F$Y$62$KG$20240821$$MD$ES$ES
242320001$24232000$1$I$20240617$20240809$20240821$20240821$EXP$$FR-AUROBINDO-AUR-APL-2024-040810$AUROBINDO$$70$YR$$M$Y$61$KG$20240821$$MD$FR$FR
242320011$24232001$1$I$$20240809$20240821$20240821$EXP$$TN-MACLEODS PHARMA-MAC2024048872$MACLEODS$Menif K, Khaldi A, Bouziri A, Hamdi A, Belhadj S, Jaballah NB..Lidocaine toxicity secondary to local anesthesia administered in the community for elective circumcision.Fetal and pediatric pathology.2011;30(6):359-362$23$DY$I$M$Y$$$20240821$$HP$TN$TN
242320022$24232002$2$F$$20240821$20240821$20240902$EXP$$FR-MACLEODS PHARMA-MAC2024048876$MACLEODS$Doye E, Desgranges FP, Stamm D, de Queiroz M, Valla FV, Javouhey E..Severe local anesthetic intoxication in an infant undergoing circumcision.Archives of Pediatrics.MAR-2015;22(3):303-5$$$$$Y$$$20240902$$HP$FR$FR
242320031$24232003$1$I$$20240809$20240821$20240821$EXP$$TN-MACLEODS PHARMA-MAC2024048873$MACLEODS$Menif K, Khaldi A, Bouziri A, Hamdi A, Belhadj S, Jaballah NB.Lidocaine toxicity secondary to local anesthesia administered in the community for elective circumcision.Fetal and pediatric pathology.2011;30(6):359-62$$$$$Y$$$20240821$$HP$TN$TN
242320041$24232004$1$I$$20240809$20240821$20240821$EXP$$TN-MACLEODS PHARMA-MAC2024048871$MACLEODS$Menif K, Khaldi A, Bouziri A, Hamdi A, Belhadj S, Jaballah NB..Lidocaine toxicity secondary to local anesthesia administered in the community for elective circumcision.Fetal and Pediatric Pathology.2011;30(6):359-362$$$$$Y$$$20240821$$HP$TN$TN
242320052$24232005$2$F$$20240911$20240821$20240921$EXP$$NL-AUROBINDO-AUR-APL-2020-054291$AUROBINDO$Rapha?l MF, Versluys AB, Boelens JJ. EBV post transplantation lymphoproliferative disease-associated pneumomediastinum in a pediatric patient with long-lasting low loads of plasma EBV-DNA positivity. Bone Marrow Transplant. 2008;42(8):565-566$3$YR$$M$Y$$$20240921$$HP$NL$NL
242320061$24232006$1$I$$20240809$20240821$20240821$EXP$$US-MACLEODS PHARMA-MAC2024048875$MACLEODS$Moran LR, Hossain T, Insoft RM.Neonatal seizures following lidocaine administration for elective circumcision.Journal of perinatology.2004;24(6):395-6$$$$$Y$$$20240821$$PH$US$US
242320071$24232007$1$I$$20240809$20240821$20240821$EXP$$US-MACLEODS PHARMA-MAC2024048870$MACLEODS$Amitai Y, Whitesell L, Lovejoy Jr FH.Death following accidental lidocaine overdose in a child.The New England journal of medicine..1986;314(3):182-3$$$$$Y$$$20240821$$MD$US$US
242320081$24232008$1$I$$20240809$20240821$20240821$EXP$$CA-MACLEODS PHARMA-MAC2024048874$MACLEODS$Rezvani M, Finkelstein Y, Verjee Z, Railton C, Koren G.Generalized seizures following topical lidocaine administration during circumcision establishing causation.Pediatric Drugs.2027;9(2):125-127$3$MON$I$M$Y$$$20240821$$HP$CA$CA
242320091$24232009$1$I$20230912$20240809$20240821$20240821$EXP$FR-AFSSAPS-PO2024000878$FR-MACLEODS PHARMA-MAC2024048838$MACLEODS$$$$$$Y$$$20240821$$MD$FR$FR
242320103$24232010$3$F$20240801$20240822$20240821$20240906$EXP$GB-MHRA-MED-202408070811079670-GSTDQ$GB-MACLEODS PHARMA-MAC2024048862$MACLEODS$$$$$$Y$$$20240906$$CN$GB$GB
242320111$24232011$1$I$20240710$20240809$20240821$20240821$EXP$GB-MHRA-MIDB-aea73cb5-b1d6-48dd-822a-8a1a84b2a87d$GB-MACLEODS PHARMA-MAC2024048861$MACLEODS$$$$$$Y$$$20240821$$HP$GB$GB
242320122$24232012$2$F$$20240826$20240821$20240905$EXP$$US-MACLEODS PHARMA-MAC2024048858$MACLEODS$Karakus KE, Shah VN, Akturk HK..Tirzepatide-Induced Rapid Weight Loss-Related Thyrotoxicosis.JAMA Internal Medicine.05-AUG-2024$$$$$Y$$$20240905$$MD$US$US
242320131$24232013$1$I$$20240809$20240821$20240821$EXP$$CA-AUROBINDO-AUR-APL-2024-041079$AUROBINDO$$$$$$Y$$$20240821$$CN$CA$CA
242320142$24232014$2$F$$20240826$20240821$20240908$EXP$$DE-MACLEODS PHARMA-MAC2024048869$MACLEODS$$$$$$Y$$$20240907$$MD$DE$DE
242320151$24232015$1$I$$20240808$20240821$20240821$EXP$$US-MACLEODS PHARMA-MAC2024048853$MACLEODS$$$$$$Y$$$20240820$$CN$US$US
242320161$24232016$1$I$$20240809$20240821$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-040318$AUROBINDO$Osorio C, Caceres J, Curcio C, Silverberg M. A case of acute fibrinous and organizing pneumonia. Chest. 2016;150:4(1):808A$53$YR$$F$Y$$$20240821$$HP$US$US
242320171$24232017$1$I$$20240816$20240821$20240821$EXP$$US-ABBVIE-5885241$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242320181$24232018$1$I$$20240814$20240821$20240821$EXP$$IN-MYLANLABS-2024M1077008$MYLAN$Arora V, Sahni A, Bhasin D, Chhabra M, Pankaj R, Avneet, et al. Norethisterone induced drug induced autoimmune hepatitis: a case report. J-Clin-Exp-Hepatol 2024; 14 (Suppl. 1).$44$YR$$F$Y$$$20240821$$HP$IN$IN
242320191$24232019$1$I$$20240814$20240821$20240821$EXP$$IN-MYLANLABS-2024M1077005$MYLAN$Mishra PK, Panda C, Das HS. An atypical liver injury due to phenytoin. J-Clin-Exp-Hepatol 2024; 14 (Suppl. 1).$26$YR$$M$Y$$$20240821$$HP$IN$IN
242320201$24232020$1$I$$20240819$20240821$20240821$PER$$US-JNJFOC-20240853186$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$CN$US$US
242320211$24232021$1$I$$20240814$20240821$20240821$EXP$$UG-MYLANLABS-2024M1077205$MYLAN$Ssemmanda S. Hot cross bun sign in JC-Virus Granule cell neuronopathy in HIV infected patient - a case report. BMC-Neurol 2024; 24.$27$YR$$F$Y$$$20240821$$HP$UG$UG
242320222$24232022$2$F$20221025$20240820$20240821$20240826$EXP$$DE-Novartis Pharma AG-NVSC2022DE241601$SANDOZ$$73$YR$$F$Y$54$KG$20240826$$MD$DE$DE
242320231$24232023$1$I$$20240806$20240821$20240821$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00635$GLAND PHARMA$Shanglong Liu.Chemotherapy-induced pneumatosis intestinalis followed by hepatic portal venous gas. A case report..Journal of International Medical Research.MAR-2024;52: No. 3:1-5$6$DEC$A$M$Y$$$20240821$$HP$CN$CN
242320241$24232024$1$I$$20240813$20240821$20240821$EXP$$CA-CELLTRION INC.-2024CA019933$CELLTRION$$$$$$Y$$$20240821$$HP$CA$CA
242320252$24232025$2$F$20240717$20240821$20240821$20240828$EXP$$DE-JNJFOC-20240780201$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240828$$HP$DE$DE
242320261$24232026$1$I$20240818$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165717$AMGEN$$54$YR$A$F$Y$$$20240821$$CN$US$US
242320271$24232027$1$I$$20240813$20240821$20240821$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010390$STRIDES$Preka E, Rigby E, Sellathurai G, Kipping L, Koziell A.. OFATUMUMAB PROVIDES A SAFE AND EFFECTIVE ALTERNATIVE IN RITUXIMAB FAILURE?.. Pediatr-Nephrol. 2023;38 (Suppl. 2):S80-S81 abstr. Sa-3MP 056$$$$$Y$$$20240821$$HP$GB$GB
242320281$24232028$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163621$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242320291$24232029$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163634$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242320301$24232030$1$I$$20240816$20240821$20240821$EXP$$US-ABBVIE-5884431$ABBVIE$$45$YR$$F$Y$$$20240821$$HP$US$US
242320313$24232031$3$F$$20240830$20240821$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US074129$SANDOZ$$$$$M$Y$$$20240904$$CN$US$US
242320321$24232032$1$I$20240816$20240816$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US073496$SANDOZ$$1$YR$$F$Y$$$20240821$$CN$US$US
242320332$24232033$2$F$$20240829$20240821$20240906$EXP$$TH-TEVA-VS-3234137$TEVA$Wangapakul T, Riley A. Necrotizing Phenomenon in WHO Grade I Meningioma in an SLE Patient Following Immunosuppressive Treatment. J-Neurol-Surg-B-Skull-Base 2024; 85 (Suppl. 1).; Wangapakul T, Riley A. Necrotizing Phenomenon in WHO Grade I Meningioma in an SLE Patient Following Immunosuppressive Treatment. J-Neurol-Surg-B-Skull-Base 2024; 85 (Suppl. 1).$29$YR$$F$Y$$$20240906$$HP$TH$TH
242320341$24232034$1$I$20240101$20240807$20240821$20240821$PER$$US-P+L Developments of Newyork Corporation-2160665$PL DEVELOPMENTS$$$$$F$Y$$$20240821$$$US$US
242320351$24232035$1$I$$20240813$20240821$20240821$EXP$$AT-Hill Dermaceuticals, Inc.-2160654$HILL DERM$$82$YR$$M$Y$$$20240821$$MD$AT$AT
242320361$24232036$1$I$20221004$20240820$20240821$20240821$EXP$$US-UCBSA-2024042172$UCB$$64$YR$$F$Y$$$20240821$$HP$US$US
242320371$24232037$1$I$$20240805$20240821$20240821$PER$$US-Mundipharma Research Limited-2160643$MUNDIPHARMA EDO$$$$$$Y$$$20240821$$PH$US$US
242320381$24232038$1$I$$20240813$20240821$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-002839$UNITED THERAPEUTICS$$$$$M$Y$67.12$KG$20240821$$$US$US
242320391$24232039$1$I$$20240814$20240821$20240821$EXP$$CA-SANDOZ INC.-NVSC2020CA180005$SANDOZ$$71$YR$$F$Y$$$20240821$$CN$CA$CA
242320401$24232040$1$I$$20240807$20240821$20240821$EXP$$OM-Oxford Pharmaceuticals, LLC-2160660$OXFORD PHARMACEUTICALS$Source document$73$YR$$F$Y$$$20240821$$$OM$OM
242320413$24232041$3$F$$20240927$20240821$20240927$30DAY$$GB-PFIZER INC-PV202400103457$PFIZER$$11$YR$$M$Y$$$20240927$$CN$GB$GB
242320431$24232043$1$I$20240809$20240816$20240821$20240821$EXP$$GR-PFIZER INC-PV202400107822$PFIZER$$13$YR$$M$Y$$$20240821$$CN$GR$GR
242320441$24232044$1$I$$20240806$20240821$20240821$EXP$$US-Ascend Therapeutics US, LLC-2160651$ASCEND$$21$YR$$F$Y$$$20240821$$MD$US$US
242320482$24232048$2$F$$20240920$20240821$20240920$30DAY$$US-PFIZER INC-202400237272$PFIZER$$12$YR$$M$Y$$$20240920$$CN$US$US
242320504$24232050$4$F$$20240926$20240821$20240926$30DAY$$US-PFIZER INC-202400237026$PFIZER$$10$YR$$F$Y$$$20240926$$CN$US$US
242320513$24232051$3$F$$20240909$20240821$20240912$EXP$$US-PFIZER INC-PV202400107601$PFIZER$$33$YR$$F$Y$101.61$KG$20240912$$CN$US$US
242320533$24232053$3$F$20240801$20240920$20240821$20240924$30DAY$$US-PFIZER INC-202400234158$PFIZER$$10$YR$$F$Y$$$20240924$$MD$US$US
242320542$24232054$2$F$20240701$20240920$20240821$20240920$30DAY$$US-PFIZER INC-202400235539$PFIZER$$14$YR$$M$Y$$$20240920$$CN$US$US
242320551$24232055$1$I$20240805$20240807$20240821$20240821$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160666$JIANGSU HANSOH PHARMACEUTICAL$$45$YR$$M$Y$66$KG$20240821$$MD$CN$CN
242320562$24232056$2$F$$20240820$20240821$20240823$EXP$$NVSC2024US168553$NOVARTIS$$$$$M$Y$$$20240823$$CN$US$US
242320571$24232057$1$I$20240802$20240805$20240821$20240821$EXP$$US-Nephron Sterile Compounding Center-2160655$NEPHRON STERILE COMPOUNDING CENTER, LLC (NSCC), WEST COLUMBIA, SC$$53$YR$$M$Y$86.2$KG$20240821$$PH$US$US
242320581$24232058$1$I$$20240808$20240821$20240821$EXP$$BR-P+L Developments of Newyork Corporation-2160662$PL DEVELOPMENTS$Initial$56$YR$$F$Y$49$KG$20240821$$$BR$BR
242320591$24232059$1$I$$20240806$20240821$20240821$EXP$$US-WES Pharma Inc-2160640$WES PHARMA$Full text$43$YR$$F$Y$$$20240821$$$US$US
242320601$24232060$1$I$$20240806$20240821$20240821$EXP$$US-Ascend Therapeutics US, LLC-2160649$ASCEND$$21$YR$$F$Y$$$20240821$$MD$US$US
242320611$24232061$1$I$$20240819$20240821$20240821$EXP$$NVSC2024US167937$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
242320621$24232062$1$I$$20240819$20240821$20240821$PER$$NVSC2024US168638$NOVARTIS$$$$$M$Y$$$20240821$$CN$US$US
242320631$24232063$1$I$20240605$20240809$20240821$20240821$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160659$JIANGSU HANSOH PHARMACEUTICAL$$8$YR$$M$Y$20$KG$20240821$$MD$CN$CN
242320641$24232064$1$I$$20240813$20240821$20240821$EXP$$CN-Chongqing Ryan Pharmaceutical Co., Ltd.-2160658$Chongqing Ryan Pharmaceutical$This is a literature case received from a health care professional from Taiwan, China$82$YR$$F$Y$$$20240821$$$CN$CN
242320651$24232065$1$I$$20240813$20240821$20240821$EXP$$US-Pine Pharmaceuticals, LLC-2160668$PINE PHARMACEUTICALS - COMPOUNDING$$$$$F$Y$$$20240821$$MD$US$US
242320661$24232066$1$I$$20240805$20240821$20240821$EXP$$PR-Omnivium Pharmaceuticals LLC-2160639$Omnivium Pharmaceuticals$Full text$66$YR$$M$Y$$$20240821$$MD$PR$PR
242320691$24232069$1$I$20240618$20240820$20240820$20240820$DIR$715057$$FDA-CTU$$74$YR$$M$N$112.1$KG$20240820$N$HP$US$
242320711$24232071$1$I$20240619$20240820$20240820$20240820$DIR$715045$$FDA-CTU$$69$YR$$M$N$70.2$KG$20240820$N$HP$US$
242320721$24232072$1$I$$20240820$20240820$20240820$DIR$715170$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242320731$24232073$1$I$$20240820$20240820$20240820$DIR$715096$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242320781$24232078$1$I$$20240813$20240821$20240821$EXP$$CN-RDY-LIT/CHN/24/0011990$DR REDDYS$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turkish Journal of Hematology. 2023;40: 284-285. doi:10.4274/tjh.galenos.2023.2023.0263.$76$YR$E$F$Y$$$20240821$$HP$CN$CN
242320791$24232079$1$I$20220302$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184260$ASTRAZENECA$$64$YR$$M$Y$70$KG$20240821$$MD$FR$
242320801$24232080$1$I$$20240808$20240821$20240821$PER$$US-AstraZeneca-2024A182829$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
242320812$24232081$2$F$20120101$20240819$20240821$20240824$EXP$$US-AstraZeneca-2024A188644$ASTRAZENECA$$62$YR$$M$Y$$$20240823$$CN$US$
242320821$24232082$1$I$20220101$20240820$20240821$20240821$EXP$$US-UCBSA-2024042092$UCB$$$$$F$Y$$$20240821$$HP$US$US
242320831$24232083$1$I$$20240813$20240821$20240821$EXP$$US-MYLANLABS-2024M1076796$MYLAN$Mark C, Minasyan A, Ebia MI, Abbas A, Ghosh A, Watson R, et al. Painful tongue lesion as an initial presentation of metastatic pancreatic ductal adenocarcinoma: a case report and review of the literature. Ann-Pancreat-Cancer 2023; 6 (8).$91$YR$$M$Y$$$20240821$$HP$US$US
242320842$24232084$2$F$20240101$20240820$20240821$20240826$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011708$JAZZ$$$$$F$Y$$$20240826$$CN$US$US
242320851$24232085$1$I$$20221213$20240821$20240821$EXP$$US-AstraZeneca-2022A407762$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242320861$24232086$1$I$$20240813$20240821$20240821$EXP$$ZA-AstraZeneca-2024A184580$ASTRAZENECA$$23010$DY$$M$Y$$$20240821$$CN$ZA$
242320871$24232087$1$I$20240101$20240813$20240821$20240821$PER$$US-AstraZeneca-2024A185048$ASTRAZENECA$$80$YR$$F$Y$$$20240821$$CN$US$
242320881$24232088$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132428$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240821$$CN$US$US
242320891$24232089$1$I$$20240806$20240821$20240821$EXP$$HR-GLANDPHARMA-HR-2024GLNLIT00632$GLAND PHARMA$Sonja Skiljic.Point of care diagnostic approach in a critically ill patient with severe bleeding from urinary tract.Acta Clinica Croatica.2023;62(2):138-142$73$YR$E$M$Y$$$20240821$$MD$HR$HR
242320902$24232090$2$F$20211201$20240814$20240821$20240823$EXP$$US-ROCHE-10000053671$ROCHE$$54$YR$A$F$Y$66.67$KG$20240823$$CN$US$US
242320921$24232092$1$I$$20240813$20240821$20240821$EXP$$US-ROCHE-10000056446$ROCHE$$66$YR$E$F$Y$$$20240821$$CN$US$US
242320931$24232093$1$I$20240519$20240813$20240821$20240821$PER$$US-JNJFOC-20240833063$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
242320941$24232094$1$I$$20240812$20240821$20240821$PER$$US-JNJFOC-20240828398$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240821$$HP$US$US
242320951$24232095$1$I$20240722$20240722$20240821$20240821$PER$$US-BAYER-2024A119894$BAYER$$21$YR$A$F$Y$$$20240821$$MD$US$US
242320961$24232096$1$I$$20240820$20240820$20240820$DIR$715124$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242320971$24232097$1$I$20240707$20240812$20240821$20240821$EXP$FR-AFSSAPS-GR2024000978$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07806$HIKMA$$$$$$Y$$$20240821$$MD$FR$FR
242320993$24232099$3$F$20240812$20240923$20240821$20240927$30DAY$$US-PFIZER INC-202400236999$PFIZER$$12$YR$$M$Y$$$20240927$$CN$US$US
242321003$24232100$3$F$$20240909$20240821$20240912$30DAY$$GR-PFIZER INC-202400233718$PFIZER$$62$YR$$F$Y$120$KG$20240912$$CN$GR$GR
242321012$24232101$2$F$$20240920$20240821$20240920$30DAY$$US-PFIZER INC-202400236969$PFIZER$$11$YR$$M$Y$$$20240920$$CN$US$US
242321023$24232102$3$F$$20240919$20240821$20240924$30DAY$$SE-PFIZER INC-202400235626$PFIZER$$$$$$Y$$$20240924$$PH$SE$SE
242321031$24232103$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012173$ELI LILLY AND CO$$$$$$Y$$$20240821$$CN$US$US
242321051$24232105$1$I$20240807$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009531$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240821$$CN$US$US
242321062$24232106$2$F$20240818$20240912$20240821$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202408011897$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240916$$CN$US$US
242321071$24232107$1$I$20240716$20240717$20240821$20240821$PER$$CN-IGSA-BIG0029909$GRIFOLS$$73$YR$$F$Y$65$KG$20240821$$HP$CN$CN
242321081$24232108$1$I$20240820$20240820$20240820$20240820$DIR$715234$$FDA-CTU$$67$YR$$M$N$112$KG$20240820$N$HP$US$
242321091$24232109$1$I$20240818$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011909$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240821$$CN$US$US
242321101$24232110$1$I$20240811$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009088$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240821$$CN$US$US
242321111$24232111$1$I$20240819$20240820$20240820$20240820$DIR$715027$$FDA-CTU$$57$YR$$F$N$$$20240820$N$CN$US$
242321121$24232112$1$I$$20240813$20240821$20240821$EXP$$TW-AMGEN-TWNSP2024161359$AMGEN$Niu C.; Chen P.; Chiu P. et al.. Teriparatide alone versus vertebroplasty on pain control and radiographic outcomes after osteoporotic vertebral compression fracture. European Spine Journal. 2024;33 (8):3284-3290$$$$$Y$$$20240821$$HP$TW$TW
242321132$24232113$2$F$20240801$20240820$20240821$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004246$ACADIA PHARMACEUTICALS$$22$YR$$F$Y$$$20240912$$CN$US$US
242321141$24232114$1$I$$20240820$20240821$20240821$EXP$$GB-ROCHE-10000061750$ROCHE$$$$E$F$Y$$$20240821$$CN$GB$GB
242321161$24232116$1$I$20240816$20240820$20240821$20240821$EXP$$NVSC2024US168541$NOVARTIS$$81$YR$$M$Y$$$20240821$$HP$US$US
242321181$24232118$1$I$$20240806$20240821$20240821$EXP$$US-GLANDPHARMA-US-2024GLNLIT00634$GLAND PHARMA$Adam Spitz.LATE-ONSET AMIODARONE-INDUCED THYROTOXICOSIS (AIT) CAUSING RECURRENT HEART  FAILURE WITH REDUCED EJECTION FRACTION. Journal of the American College of Cardiology .02-APR-2024;83(13):3182$58$YR$A$M$Y$$$20240821$$HP$US$US
242321191$24232119$1$I$20240305$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-087182-2024$RECKITT BENCKISER$$87$YR$$F$Y$$$20240821$$CN$US$US
242321211$24232121$1$I$$20240812$20240821$20240821$30DAY$$US-GSK-US2024100287$GLAXOSMITHKLINE$$$$$M$Y$$$20240821$$CN$US$US
242321221$24232122$1$I$$20240811$20240821$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025528$UNITED THERAPEUTICS$Ranalli MA, Shah N, Skeens M, Streby KA, Lamb M, Cole LA, et al.. Preliminary experience of ex-vivo expanded allogeneic universal donor TGF?i NK cell infusions in combination with irinotecan, temozolomide, and dinutuximab in patients with relapsed or refractory neuroblastoma: The Allo - STING trial. J Clin Oncol. 2024;42 (16)$$$C$$Y$$$20240821$$$US$US
242321231$24232123$1$I$20240101$20240812$20240821$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017429$UNITED THERAPEUTICS$$$$$M$Y$$$20240821$$$US$US
242321241$24232124$1$I$$20240812$20240821$20240821$EXP$$CN-ROCHE-10000057041$ROCHE$Li Y, Zhou X, Wang X, Yang C, Wang C, Zhang Y, et al. Successful treatment of massive pericardial effusion after hematopoietic stem cell transplantation with tocilizumab: two cases report. Journal of Clinical Pediatrics. 2024;42 (7):595-9. doi:10.12372/jcp.2024.23e0861.$10$YR$C$F$Y$$$20240821$$HP$CN$CN
242321251$24232125$1$I$$20240807$20240821$20240821$EXP$$NL-AMGEN-NLDNI2024165128$AMGEN$$$$E$F$Y$$$20240821$$HP$NL$NL
242321261$24232126$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A185005$ASTRAZENECA$$$$$F$Y$67.1$KG$20240821$$CN$US$
242321271$24232127$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A185158$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242321281$24232128$1$I$20230510$20240813$20240821$20240821$EXP$$CN-BAYER-2024A117655$BAYER$Ma XQ; Zhang RY; Cai XJ.; Lang YY; Wang HC; Li JM. Plasma Concentrations of Contezolid and Its Efficacy and Safety in Elderly Patients with Multidrug-Resistant Tuberculosis and Renal Insufficiency. Infection and Drug Resistance. 2024;17:3047-3056$90$YR$E$M$Y$56$KG$20240821$$HP$CN$CN
242321291$24232129$1$I$20240816$20240816$20240821$20240821$PER$$US-JNJFOC-20240844212$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240821$$HP$US$US
242321301$24232130$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130901$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240821$$HP$US$US
242321311$24232131$1$I$20240720$20240813$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127979$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240821$$PH$US$US
242321322$24232132$2$F$$20240905$20240821$20240909$PER$$US-BAYER-2024A117560$BAYER$$34$YR$A$F$Y$$$20240909$$CN$US$US
242321331$24232133$1$I$20201101$20240812$20240821$20240821$EXP$GB-MHRA-MED-202408121641507570-NDJLF$GB-862174955-ML2024-04480$MICRO LABS$$22$YR$A$F$Y$67$KG$20240821$$CN$GB$GB
242321341$24232134$1$I$$20240812$20240821$20240821$EXP$GB-MHRA-MED-202408121431509000-KYFPC$GB-862174955-ML2024-04467$MICRO LABS$$51$YR$A$M$Y$$$20240821$$CN$GB$GB
242321351$24232135$1$I$$20240815$20240821$20240821$EXP$GB-MHRA-MED-202408150536153340-FDRHY$GB-862174955-ML2024-04518$MICRO LABS$$$$$F$Y$$$20240821$$CN$GB$GB
242321361$24232136$1$I$20240327$20240814$20240821$20240821$EXP$$CA-TAKEDA-2024TUS074287$TAKEDA$$69$YR$$M$Y$$$20240821$$CN$CA$CA
242321371$24232137$1$I$20231101$20240814$20240821$20240821$EXP$FR-AFSSAPS-RE2024000779$FR-009507513-2408FRA005205$MERCK$$62$YR$$F$Y$$$20240821$$HP$FR$FR
242321381$24232138$1$I$20150101$20240815$20240821$20240821$PER$$US-ABBVIE-5883104$ABBVIE$$$$$F$Y$50$KG$20240821$$CN$US$US
242321391$24232139$1$I$$20240814$20240821$20240821$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101890$VIIV$$$$$$Y$$$20240821$$HP$US$US
242321401$24232140$1$I$$20240819$20240821$20240821$EXP$$NVSC2024CA167911$NOVARTIS$$65$YR$$F$Y$$$20240821$$HP$CA$CA
242321411$24232141$1$I$20240101$20240815$20240821$20240821$EXP$$US-Eisai-EC-2024-172456$EISAI$$44$YR$A$M$Y$100.24$KG$20240821$$CN$US$US
242321421$24232142$1$I$20240819$20240820$20240820$20240820$DIR$715040$$FDA-CTU$$28$YR$$F$N$72.9$KG$20240820$N$CN$US$
242321431$24232143$1$I$20240813$20240820$20240820$20240820$DIR$715024$$FDA-CTU$$40$YR$$F$N$56.25$KG$20240820$N$CN$US$
242321451$24232145$1$I$20240308$20240820$20240820$20240820$DIR$715026$$FDA-CTU$$44$YR$$F$N$139.5$KG$20240820$N$CN$US$
242321471$24232147$1$I$20240809$20240820$20240820$20240820$DIR$715030$$FDA-CTU$$70$YR$$F$N$68.4$KG$20240820$N$HP$US$
242321481$24232148$1$I$20231018$20240209$20240821$20240821$EXP$$CA-ABBVIE-5885026$ABBVIE$$59$YR$$M$Y$$$20240821$$CN$CA$CA
242321491$24232149$1$I$$20240813$20240821$20240821$EXP$$US-LUOXIN-LUX-2024-US-LIT-00046$LUOXIN AUROVITAS PHARMA(CHENGDU)$Pires KD, Su MK, Chiang W.Minimal effects after a massive intravenous terbutaline overdose in a child..BMJ Case Rep.01-AUG-2024;17(8):e259352$$$C$F$Y$22$KG$20240821$$MD$US$US
242321501$24232150$1$I$$20240729$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004105$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242321511$24232151$1$I$$20240815$20240821$20240821$30DAY$$US-GSK-US2024101924$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242321521$24232152$1$I$$20240815$20240821$20240821$EXP$$JP-009507513-2408JPN001847J$MERCK$$$$$F$Y$$$20240821$$HP$JP$JP
242321531$24232153$1$I$20090101$20240817$20240821$20240821$PER$$NVSC2024US167726$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
242321542$24232154$2$F$$20240903$20240821$20240904$EXP$$NVSC2024US163634$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
242321551$24232155$1$I$20230101$20240813$20240821$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-025660$UNITED THERAPEUTICS$$$$$F$Y$115.65$KG$20240821$$$US$US
242321561$24232156$1$I$$20240813$20240821$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012543$JAZZ$$$$$F$Y$$$20240821$$CN$US$US
242321571$24232157$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163649$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242321581$24232158$1$I$$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024163725$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242321591$24232159$1$I$20210907$20240814$20240821$20240821$EXP$$RO-AMGEN-ROUSP2024162498$AMGEN$$62$YR$A$F$Y$88$KG$20240821$$MD$RO$RO
242321601$24232160$1$I$20240601$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165783$AMGEN$$47$YR$A$F$Y$$$20240821$$CN$US$US
242321611$24232161$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163679$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242321631$24232163$1$I$20240815$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024163949$AMGEN$$$$$$Y$$$20240821$$HP$US$US
242321641$24232164$1$I$20240101$20240627$20240821$20240821$30DAY$$JP-PFIZER INC-202400216007$PFIZER$$79$YR$$M$Y$$$20240821$$PH$JP$JP
242321651$24232165$1$I$$20240806$20240821$20240821$EXP$$US-GLANDPHARMA-US-2024GLNLIT00631$GLAND PHARMA$Q Abdelal.Azith and the Myth.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$73$YR$E$F$Y$$$20240821$$HP$US$US
242321661$24232166$1$I$$20240819$20240821$20240821$EXP$$CL-UCBSA-2024042239$UCB$$$$$M$Y$$$20240821$$CN$CL$CL
242321673$24232167$3$F$$20240916$20240821$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131022$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$70.76$KG$20240918$$CN$US$US
242321681$24232168$1$I$$20240808$20240821$20240821$EXP$$IN-B.Braun Medical Inc.-2160669$B BRAUN$Literature Article$10$MON$$F$Y$$$20240821$$$IN$IN
242321691$24232169$1$I$$20240812$20240821$20240821$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010349$STRIDES$Qing W, Huting H, Siyu Q, Yue Z, Yaxin L, Jingjing G, et al.. Efficacy and safety of chidamide-contained protocol for relapsed and refractory peripheral T-cell lymphoma, not otherwise specified.. Zhongliu. 2022;42 (8):562-569$$$$$Y$$$20240821$$HP$CN$CN
242321701$24232170$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163685$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242321721$24232172$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163698$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242321731$24232173$1$I$$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128733$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240821$$PH$US$US
242321751$24232175$1$I$$20240820$20240821$20240821$PER$$NVSC2024US169213$NOVARTIS$$$$$$Y$$$20240821$$MD$US$US
242321762$24232176$2$F$20240801$20240826$20240821$20240829$EXP$$US-AMGEN-USASP2024162488$AMGEN$$60$YR$A$F$Y$$$20240829$$HP$US$US
242321771$24232177$1$I$20240819$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131740$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$103$KG$20240821$$PH$US$US
242321781$24232178$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163681$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242321791$24232179$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163673$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242321801$24232180$1$I$$20240818$20240821$20240821$PER$$US-ABBVIE-5886729$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242321821$24232182$1$I$$20240815$20240821$20240821$EXP$$US-GSK-US2024AMR102857$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
242321831$24232183$1$I$20240814$20240815$20240821$20240821$EXP$$CO-GSK-CO2024AMR090918$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$CO$CO
242321841$24232184$1$I$$20240816$20240821$20240821$EXP$$US-GSK-US2024102688$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242321851$24232185$1$I$$20240812$20240821$20240821$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024100345$VIIV$$$$$M$Y$$$20240821$$MD$US$US
242321861$24232186$1$I$$20240815$20240821$20240821$EXP$$CA-TAKEDA-2024TUS082450$TAKEDA$$75$YR$$F$Y$$$20240821$$HP$CA$CA
242321881$24232188$1$I$$20240808$20240821$20240821$EXP$$US-CIPLA LTD.-2024US08868$CIPLA$$$$$$Y$$$20240821$$CN$US$US
242321911$24232191$1$I$$20240814$20240821$20240821$PER$US-MLMSERVICE-20240807-PI154630-00034-1$US-RDY-SPO/USA/24/0011967$DR REDDYS$Li B, Chawla S, Tong M, Higgins A, Lee R. Temporary Biventricular Mechanical Circulatory Support for Primary Graft Dysfunction after Orthotopic Heart Transplantation. US Cardiology Review. 2024;18(Supplement 1):75. DOI: 10.15420/usc.2024.18.s1.$51$YR$A$M$Y$$$20240821$$MD$US$US
242321921$24232192$1$I$$20240820$20240820$20240820$DIR$715044$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242321931$24232193$1$I$20240820$20240820$20240820$20240820$DIR$715028$$FDA-CTU$$26$YR$$F$N$51.75$KG$20240820$N$CN$US$
242321941$24232194$1$I$$20240813$20240821$20240821$EXP$$CN-RDY-LIT/CHN/24/0011995$DR REDDYS$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turkish Journal of Hematology. 2023;40: 284-285. doi:10.4274/tjh.galenos.2023.2023.0263.$60$YR$A$M$Y$$$20240821$$HP$CN$CN
242321951$24232195$1$I$20240624$20240808$20240821$20240821$EXP$$FR-CIPLA LTD.-2024FR08706$CIPLA$$$$$$Y$$$20240821$$MD$FR$FR
242321961$24232196$1$I$20240614$20240820$20240820$20240820$DIR$715051$$FDA-CTU$$31$YR$$M$N$104.2$KG$20240820$N$HP$US$
242321971$24232197$1$I$20240819$20240820$20240820$20240820$DIR$715053$$FDA-CTU$$58$YR$$F$N$$$20240820$N$$US$
242321981$24232198$1$I$$20240815$20240821$20240821$EXP$$HR-CHEPLA-2024010582$CHEPLAPHARM$Literature Reference:  Dilber I., Tokic M., et al. Intrahepatic portal hypertension caused by oxaliplatin in the treatment of gastric cancer ? patient report and literature review. Med Jad 2024; 54(2):129-134$73$YR$$M$Y$$$20240821$$MD$COUNTRY NOT SPECIFIED$HR
242322001$24232200$1$I$$20240814$20240821$20240821$EXP$$NVSC2024CA167611$NOVARTIS$$43$YR$$F$Y$$$20240821$$CN$CA$CA
242322022$24232202$2$F$20240619$20240913$20240821$20240920$EXP$$NVSC2024FR168560$NOVARTIS$$46$YR$$F$Y$108$KG$20240920$$CN$FR$FR
242322031$24232203$1$I$20230101$20240816$20240821$20240821$EXP$$CA-Orion Corporation ORION PHARMA-24_00031339$ORION$$39$YR$A$F$Y$$$20240821$$HP$CA$
242322041$24232204$1$I$20240701$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024163769$AMGEN$$69$YR$E$M$Y$$$20240821$$CN$US$US
242322054$24232205$4$F$$20240911$20240821$20240917$EXP$$NVSC2024CA167915$NOVARTIS$$31$MON$$$Y$$$20240917$$HP$CA$CA
242322061$24232206$1$I$$20240708$20240821$20240821$PER$$US-LUNDBECK-DKLU4001357$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
242322071$24232207$1$I$$20240819$20240821$20240821$EXP$$NVSC2024CA168154$NOVARTIS$$8$YR$$M$Y$$$20240821$$HP$CA$CA
242322081$24232208$1$I$$20240819$20240821$20240821$EXP$$NVSC2024CA168205$NOVARTIS$$$$$$Y$$$20240821$$HP$CA$CA
242322101$24232210$1$I$20240101$20240815$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US073026$SANDOZ$$12$YR$$F$Y$$$20240821$$CN$US$US
242322111$24232211$1$I$$20240813$20240821$20240821$30DAY$$US-GSK-US2024100831$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242322121$24232212$1$I$$20240814$20240821$20240821$EXP$$US-GSK-US2024AMR102783$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$HP$US$US
242322131$24232213$1$I$$20240814$20240821$20240821$EXP$$PT-BAYER-2024A118469$BAYER$Albuquerque P, Regateiro D, Velho R, Paixao J, Santos L.. S?ndrome maligna dos neurol?pticos: relato de um caso cl?nico. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional. 2024;May 2024:1071$70$YR$E$F$Y$$$20240821$$HP$PT$PT
242322141$24232214$1$I$20240601$20240819$20240821$20240821$EXP$PT-INFARMED-T202408-202$PT-JNJFOC-20240849738$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240821$$PH$PT$PT
242322151$24232215$1$I$$20240813$20240821$20240821$EXP$$GB-CELLTRION INC.-2024GB019764$CELLTRION$$$$$$Y$$$20240821$$CN$GB$GB
242322161$24232216$1$I$20240101$20240816$20240821$20240821$EXP$$US-ABBVIE-5884991$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242322171$24232217$1$I$$20240814$20240821$20240821$EXP$$US-AstraZeneca-2024A188749$ASTRAZENECA$$$$$F$Y$$$20240821$$HP$US$
242322181$24232218$1$I$$20240820$20240821$20240821$PER$$US-GRUNENTHAL-2024-124319$AVERITAS$$$$$M$Y$$$20240821$$MD$US$US
242322191$24232219$1$I$20211229$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184200$ASTRAZENECA$$37$YR$$M$Y$68$KG$20240821$$MD$FR$
242322201$24232220$1$I$20221001$20240820$20240821$20240821$EXP$$US-UCBSA-2024042113$UCB$$62$YR$$F$Y$$$20240821$$HP$US$US
242322212$24232221$2$F$$20240816$20240821$20240906$PER$$US-LUNDBECK-DKLU4002111$LUNDBECK$$$$$$Y$$$20240906$$CN$US$US
242322231$24232223$1$I$$20240819$20240821$20240821$EXP$$NVSC2024CA167907$NOVARTIS$$40$YR$$F$Y$96$KG$20240821$$HP$CA$CA
242322242$24232224$2$F$$20240918$20240821$20240923$EXP$$US-PFIZER INC-PV202400023460$PFIZER$$76$YR$$F$Y$$$20240923$$MD$US$US
242322251$24232225$1$I$20240808$20240816$20240821$20240821$EXP$$CN-PFIZER INC-PV202400107411$PFIZER$$32$YR$$F$Y$55$KG$20240821$$HP$CN$CN
242322271$24232227$1$I$20240731$20240812$20240821$20240821$EXP$GB-MHRA-MED-202408121253124210-BZGYW$GB-PFIZER INC-202400234737$PFIZER$$45$YR$$F$Y$$$20240821$$HP$GB$GB
242322282$24232228$2$F$20240704$20240816$20240821$20240823$EXP$$US-PFIZER INC-202400233105$PFIZER$$61$YR$$M$Y$$$20240823$$CN$US$US
242322291$24232229$1$I$20201001$20240816$20240821$20240821$EXP$FR-AFSSAPS-PO2024000637$FR-PFIZER INC-202400191009$PFIZER$$33$YR$$F$Y$39$KG$20240821$$MD$FR$FR
242322301$24232230$1$I$20240806$20240819$20240821$20240821$EXP$$CN-PFIZER INC-PV202400108013$PFIZER$$59$YR$$M$Y$$$20240821$$HP$CN$CN
242322311$24232231$1$I$20240101$20240819$20240821$20240821$EXP$$SK-PFIZER INC-PV202400107834$PFIZER$$33$YR$$F$Y$$$20240821$$MD$SK$SK
242322321$24232232$1$I$20240708$20240815$20240821$20240821$EXP$$CN-PFIZER INC-PV202400106708$PFIZER$$55$YR$$M$Y$75$KG$20240821$$HP$CN$CN
242322331$24232233$1$I$20220416$20240816$20240821$20240821$EXP$$IT-PFIZER INC-202400237985$PFIZER$$76$YR$$M$Y$71$KG$20240821$$MD$IT$IT
242322342$24232234$2$F$20240701$20240913$20240821$20240917$EXP$$CN-PFIZER INC-PV202400107425$PFIZER$$31$YR$$M$Y$$$20240917$$HP$CN$CN
242322351$24232235$1$I$20240819$20240819$20240821$20240821$EXP$GB-MHRA-MED-202408191518260150-GMTBK$GB-PFIZER INC-202400239275$PFIZER$$74$YR$$F$Y$$$20240821$$PH$GB$GB
242322361$24232236$1$I$20201021$20240816$20240821$20240821$EXP$PL-URPL-1-2523-2020$PL-PFIZER INC-202400237982$PFIZER$$69$YR$$F$Y$58$KG$20240821$$HP$PL$PL
242322371$24232237$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011984$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240821$$CN$US$US
242322381$24232238$1$I$$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012603$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240821$$CN$US$US
242322391$24232239$1$I$$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009335$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240821$$CN$US$US
242322401$24232240$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012459$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240821$$CN$US$US
242322411$24232241$1$I$$20240820$20240820$20240820$DIR$715039$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242322421$24232242$1$I$$20240820$20240820$20240820$DIR$715037$$FDA-CTU$$30$YR$$F$N$$$20240820$N$$US$
242322431$24232243$1$I$$20240817$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012426$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240821$$CN$US$US
242322441$24232244$1$I$$20240820$20240820$20240820$DIR$715055$$FDA-CTU$$50$YR$$F$N$90$KG$20240820$N$CN$US$
242322451$24232245$1$I$20240820$20240820$20240820$20240820$DIR$715064$$FDA-CTU$$64$YR$$F$N$$$20240820$N$$US$
242322461$24232246$1$I$20240820$20240820$20240820$20240820$DIR$715065$$FDA-CTU$$70$YR$$F$N$$$20240820$N$$US$
242322471$24232247$1$I$$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009391$ELI LILLY AND CO$$$$$F$Y$$$20240821$$CN$US$US
242322481$24232248$1$I$20240801$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011141$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240821$$CN$US$US
242322501$24232250$1$I$$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009444$ELI LILLY AND CO$$$$$F$Y$$$20240821$$CN$US$US
242322511$24232251$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011029$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240821$$CN$US$US
242322521$24232252$1$I$20240701$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011112$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240821$$CN$US$US
242322531$24232253$1$I$20240819$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012089$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240821$$CN$US$US
242322541$24232254$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010730$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240821$$CN$US$US
242322551$24232255$1$I$20240816$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010734$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240821$$CN$US$US
242322561$24232256$1$I$$20240809$20240821$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-040311$AUROBINDO$Shaigany S, Dabela E, Husain S, Grossman ME. Herpetic zoster folliculitis in the immunocompromised host. JAAD Case Reports. 2015;1(1):38-40$78$YR$$M$Y$$$20240821$$MD$US$US
242322572$24232257$2$F$20230502$20240911$20240821$20240918$EXP$$US-ROCHE-3352180$ROCHE$$3$YR$C$M$Y$$$20240918$$CN$US$US
242322581$24232258$1$I$$20240814$20240821$20240821$EXP$$AR-009507513-2408ARG005754$MERCK$$51$YR$$M$Y$$$20240821$$MD$AR$AR
242322591$24232259$1$I$20231117$20240814$20240821$20240821$EXP$$CA-GSK-CA2023167680$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$CA$CA
242322601$24232260$1$I$$20240708$20240821$20240821$PER$$US-LUNDBECK-DKLU4001362$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
242322611$24232261$1$I$$20240805$20240821$20240821$PER$$US-TEVA-VS-3231639$TEVA$$44$YR$$$Y$$$20240821$$CN$US$US
242322622$24232262$2$F$20240512$20240819$20240821$20240829$EXP$$NVSC2024US168544$NOVARTIS$$84$YR$$M$Y$$$20240829$$CN$US$US
242322631$24232263$1$I$$20240815$20240821$20240821$PER$$US-BIOGEN-2024BI01278633$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
242322641$24232264$1$I$$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-087268-2024$RECKITT BENCKISER$$29$YR$$F$Y$$$20240821$$CN$US$US
242322651$24232265$1$I$$20240809$20240821$20240821$EXP$$US-AUROBINDO-AUR-APL-2024-040327$AUROBINDO$Velez MG, Suero-Abreu G, Duma N, Gutierrez M, Singh TP.. Immune-related myocarditis and conduction abnormalities secondary to combination immunotherapy treatment with ipilimumab/nivolumab in a patient with merkel cell carcinoma. . DOI:. Journal of the American College of Cardiology.. 2018;71(11)$69$YR$$F$Y$$$20240821$$HP$US$US
242322671$24232267$1$I$$20240708$20240821$20240821$PER$$US-LUNDBECK-DKLU4001465$LUNDBECK$$$$$$Y$$$20240821$$MD$US$US
242322681$24232268$1$I$$20240814$20240821$20240821$30DAY$$US-GSK-US2024101418$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242322691$24232269$1$I$$20240812$20240821$20240821$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010363$STRIDES$Qing W, Huting H, Siyu Q, Yue Z, Yaxin L, Jingjing G, et al.. Efficacy and safety of chidamide-contained protocol for relapsed and refractory peripheral T-cell lymphoma, not otherwise specified.. Zhongliu. 2022;42 (8):562-569$$$$$Y$$$20240821$$HP$CN$CN
242322711$24232271$1$I$$20240809$20240821$20240821$EXP$$CA-AUROBINDO-AUR-APL-2024-040861$AUROBINDO$$$$$F$Y$$$20240821$$HP$CA$CA
242322721$24232272$1$I$$20240813$20240821$20240821$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010380$STRIDES$Shang Y, Zhao H, Li D.. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.. Turk-J-Hematol. 2023;40:284-285$69$YR$$F$Y$$$20240821$$MD$CN$CN
242322731$24232273$1$I$20240701$20240815$20240821$20240821$EXP$$BR-BAYER-2024A119354$BAYER$$37$YR$A$F$Y$$$20240821$$MD$BR$BR
242322741$24232274$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009260$APOTEX$$66$YR$$M$Y$$$20240821$$HP$CA$CA
242322751$24232275$1$I$$20240814$20240821$20240821$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP010432$STRIDES$Tacyildiz N, Ozdemir SI, Canakci CEM, Yigit HI, Maharramova V, Dincaslan H, et al.. Multidisciplinary PAIN management features of pediatric oncology patients in a pediatric cancer center in Turkiye: A developing country experience. J-Clin-Oncol. 2024;42 (Suppl) (16)$$$$$Y$$$20240821$$HP$TR$TR
242322771$24232277$1$I$$20240819$20240821$20240821$EXP$GB-MHRA-MED-202408150536153340-FDRHY$GB-STRIDES ARCOLAB LIMITED-2024SP010459$STRIDES$$$$$F$Y$$$20240821$$CN$GB$GB
242322781$24232278$1$I$$20240811$20240821$20240821$EXP$$ES-AMGEN-ESPSP2024163421$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240821$$HP$ES$ES
242322792$24232279$2$F$$20240918$20240821$20240925$EXP$$JP-AMGEN-JPNSP2024143782$AMGEN$$40$YR$A$F$Y$$$20240925$$MD$JP$JP
242322801$24232280$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165787$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242322811$24232281$1$I$$20240801$20240821$20240821$PER$$US-JNJFOC-20240809607$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240821$$CN$US$US
242322821$24232282$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163710$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242322832$24232283$2$F$$20240821$20240821$20240829$EXP$$TW-ROCHE-10000060979$ROCHE$Yeh S, Shen Y, Chen C, Tang S, Tsai L, Jeng J. Thrombolysis-induced Very Early Neurological  Deterioration in Patients with Acute Ischemic Stroke. Formosan Stroke Journal. 2024-Aug-02;6 (2):160-165. doi:10.6318/FJS.202406_6(2).0006.$70$YR$E$M$Y$$$20240829$$MD$TW$TW
242322841$24232284$1$I$$20240814$20240821$20240821$EXP$$NVSC2024IN168233$NOVARTIS$Kishore S, Kumar M, Tahiliani S. A case of drug-induced autoimmune like hepatitis. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY. 2024;14(s1):S65$50$YR$$F$Y$$$20240821$$HP$IN$IN
242322851$24232285$1$I$20200921$20240809$20240821$20240821$EXP$$PL-AUROBINDO-AUR-APL-2024-040347$AUROBINDO$$79$YR$$M$Y$80$KG$20240821$$CN$PL$PL
242322871$24232287$1$I$20210101$20240813$20240821$20240821$EXP$GB-MHRA-MED-202408131443104660-JLMDZ$GB-TORRENT-00037600$TORRENT$$$$$M$Y$$$20240821$$MD$GB$GB
242322881$24232288$1$I$20240814$20240814$20240821$20240821$EXP$GB-MHRA-MED-202408141134239960-TSMVK$GB-TORRENT-00037603$TORRENT$$49$YR$A$M$Y$78$KG$20240821$$CN$GB$GB
242322891$24232289$1$I$$20240812$20240821$20240821$EXP$GB-MHRA-MED-202408121729244000-BKHSR$GB-TORRENT-00037606$TORRENT$$$$$M$Y$$$20240821$$PH$GB$GB
242322901$24232290$1$I$20240808$20240810$20240821$20240821$EXP$$GB-AUROBINDO-AUR-APL-2024-040507$AUROBINDO$$49$YR$$F$Y$$$20240821$$CN$GB$GB
242322912$24232291$2$F$20240101$20240826$20240821$20240903$EXP$$US-AMGEN-USASP2024163463$AMGEN$$75$YR$E$M$Y$$$20240902$$CN$US$US
242322922$24232292$2$F$20240101$20240906$20240821$20240912$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-12143$IPSEN$$71$YR$E$M$Y$89$KG$20240912$$CN$US$US
242322931$24232293$1$I$20240721$20240821$20240821$20240821$EXP$IT-MINISAL02-999383$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046961$BOEHRINGER INGELHEIM$$94$YR$E$F$Y$$$20240821$$MD$IT$IT
242322941$24232294$1$I$$20240820$20240820$20240820$DIR$715070$$FDA-CTU$$$$$UNK$N$$$20240820$N$HP$US$
242322981$24232298$1$I$$20240820$20240820$20240820$DIR$715074$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242322991$24232299$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57420$$FDA-CTU$$88$YR$$M$N$$$20240820$N$$US$
242323011$24232301$1$I$20240608$20240820$20240820$20240820$DIR$715066$$FDA-CTU$$72$YR$$F$N$89.2$KG$20240820$N$HP$US$
242323021$24232302$1$I$$20240729$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004106$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242323032$24232303$2$F$20240820$20240821$20240821$20240829$PER$$US-AMGEN-USASP2024166219$AMGEN$$60$YR$A$M$Y$$$20240829$$CN$US$US
242323041$24232304$1$I$$20240813$20240821$20240821$EXP$$US-JNJFOC-20240835810$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$HP$US$US
242323051$24232305$1$I$$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57339$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242323061$24232306$1$I$$20240820$20240821$20240821$EXP$$NVSC2024CA168748$NOVARTIS$$69$YR$$M$Y$66$KG$20240821$$HP$CA$CA
242323072$24232307$2$F$$20240816$20240821$20240830$EXP$$US-BAYER-2024A112073$BAYER$Semelka RC, Ramalho M. Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation. Frontiers in Toxicology. 2024;6:1-7$$$A$$Y$$$20240830$$MD$US$US
242323081$24232308$1$I$20240101$20240814$20240820$20240820$DIR$FDA-CDER-CTU-2024-57409$$FDA-CTU$$40$YR$$M$N$$$20240814$N$$US$
242323091$24232309$1$I$$20240816$20240821$20240821$EXP$$CA-ABBVIE-5885138$ABBVIE$$$$A$F$Y$$$20240821$$CN$CA$CA
242323102$24232310$2$F$$20240827$20240821$20240906$EXP$$BE-TEVA-VS-3233405$TEVA$: Ruttens D, Philippet P, Neven B, Lagrou K, Moshous D, Bucciol G, et al. Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide in High-Risk Chronic Granulomatous Disease Patient with Invasive Mucormycosis. J-Clin-Immunol 2023; 43 1758-1765.; Ruttens D, Philippet P, Neven B, Lagrou K, Moshous D, Bucciol G, et al. Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide in High-Risk Chronic Granulomatous Disease Patient with Invasive Muc...$11$YR$$M$Y$$$20240906$$HP$BE$BE
242323111$24232311$1$I$20240101$20240816$20240821$20240821$EXP$$US-ABBVIE-5884015$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242323121$24232312$1$I$20240301$20240815$20240821$20240821$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2024-086913$REGENERON$$$$$F$Y$$$20240821$$CN$CO$CO
242323131$24232313$1$I$20240816$20240816$20240821$20240821$PER$$US-ABBVIE-5887185$ABBVIE$$$$$$Y$$$20240821$$CN$US$US
242323141$24232314$1$I$20191007$20240813$20240821$20240821$EXP$$CO-UCBSA-2024041352$UCB$$71$YR$$F$Y$$$20240821$$CN$CO$CO
242323151$24232315$1$I$20240101$20240819$20240821$20240821$EXP$$US-UCBSA-2024028374$UCB$$$$$M$Y$$$20240821$$CN$US$US
242323161$24232316$1$I$20240802$20240813$20240821$20240821$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025273$UNITED THERAPEUTICS$$72$YR$$F$Y$56.236$KG$20240821$$$US$US
242323171$24232317$1$I$$20240812$20240821$20240821$EXP$$US-VANTIVE-2024VAN019025$Vantive US Healthcare$$$$$M$Y$$$20240821$$CN$US$US
242323181$24232318$1$I$$20240812$20240821$20240821$EXP$$GB-VANTIVE-2024VAN019033$Vantive US Healthcare$$$$$M$Y$74$KG$20240821$$CN$GB$GB
242323191$24232319$1$I$$20240812$20240821$20240821$EXP$$ES-VANTIVE-2024VAN018999$Vantive US Healthcare$$$$$M$Y$$$20240821$$CN$ES$ES
242323201$24232320$1$I$20240704$20240813$20240821$20240821$EXP$$CO-VANTIVE-2024VAN018622$Vantive US Healthcare$$64$YR$$M$Y$64$KG$20240821$$HP$CO$CO
242323221$24232322$1$I$20240716$20240809$20240821$20240821$EXP$ES-AEMPS-1555659$ES-Accord-441367$ACCORD$$51$YR$A$F$Y$$$20240821$$PH$ES$ES
242323231$24232323$1$I$$20240809$20240821$20240821$EXP$$BE-Accord-441718$ACCORD$Verhe M, De Somer T, Defoort B, Vanderstraeten E, Monsaert E, Bouderez V et al. The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report. Case Rep Oncol. 2023;16:453-460.$73$YR$E$M$Y$$$20240821$$HP$BE$BE
242323241$24232324$1$I$$20240809$20240821$20240821$EXP$$CA-AUROBINDO-AUR-APL-2024-040968$AUROBINDO$$77$YR$$F$Y$$$20240821$$HP$CA$CA
242323251$24232325$1$I$$20240809$20240821$20240821$EXP$CA-MHPD-E2B_07177622$CA-Accord-441356$ACCORD$$63$YR$A$M$Y$$$20240821$$HP$CA$CA
242323262$24232326$2$F$20221230$20240819$20240821$20240827$EXP$$CA-CELLTRION INC.-2022CA006742$CELLTRION$$$$$$Y$$$20240827$$MD$CA$CA
242323271$24232327$1$I$$20240811$20240821$20240821$EXP$$DE-JNJFOC-20240832114$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$HP$DE$DE
242323302$24232330$2$F$20240101$20240916$20240821$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131369$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240918$$HP$US$US
242323311$24232331$1$I$$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128441$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240821$$HP$US$US
242323322$24232332$2$F$$20240919$20240821$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130709$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240923$$CN$US$US
242323332$24232333$2$F$$20240913$20240821$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131237$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$54.88$KG$20240917$$HP$US$US
242323342$24232334$2$F$$20240822$20240821$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131505$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240905$$CN$US$US
242323351$24232335$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131855$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240821$$CN$US$US
242323362$24232336$2$F$$20240913$20240821$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129864$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240917$$CN$US$US
242323372$24232337$2$F$$20240828$20240821$20240902$PER$$ZA-REGENERON PHARMACEUTICALS, INC.-2024-113772$REGENERON$$$$$M$Y$$$20240902$$MD$ZA$ZA
242323381$24232338$1$I$$20240812$20240821$20240821$EXP$$US-TEVA-VS-3233561$TEVA$$70$YR$$F$Y$$$20240821$$PH$US$US
242323391$24232339$1$I$20240805$20240809$20240821$20240821$EXP$$US-Accord-442038$ACCORD$$77$YR$E$F$Y$$$20240821$$MD$US$US
242323401$24232340$1$I$20240710$20240809$20240821$20240821$EXP$GB-MHRA-31453196$GB-Accord-441223$ACCORD$$80$YR$E$F$Y$$$20240821$$PH$GB$GB
242323411$24232341$1$I$$20240809$20240821$20240821$EXP$GB-MHRA-TPP42678711C11099026YC1718026725022$GB-Accord-441159$ACCORD$$35$YR$A$F$Y$73$KG$20240821$$PH$GB$GB
242323421$24232342$1$I$20240710$20240809$20240821$20240821$EXP$ES-AEMPS-1555797$ES-Accord-441436$ACCORD$$78$YR$E$M$Y$$$20240821$$MD$ES$ES
242323431$24232343$1$I$$20240809$20240821$20240821$EXP$$US-Accord-441697$ACCORD$$70$YR$E$F$Y$$$20240821$$MD$US$US
242323441$24232344$1$I$20240625$20240807$20240821$20240821$EXP$FR-AFSSAPS-NT2024000968$FR-Accord-440809$ACCORD$$83$YR$E$F$Y$$$20240821$$MD$FR$FR
242323451$24232345$1$I$20240723$20240809$20240821$20240821$EXP$GB-MHRA-TPP10528462C7577969YC1723125497215$GB-Accord-441165$ACCORD$$38$YR$A$F$Y$51$KG$20240821$$HP$GB$GB
242323472$24232347$2$F$$20240827$20240821$20240905$EXP$$US-TEVA-VS-3234787$TEVA$Cheng J, Harney S, Toner K, Kube P, Gong S, Ozdemirli M, et al. Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment. Pediatr-Blood-Cancer 2024; 71 (8): 1-4; Cheng J, Harney S, Toner K, Kube P, Gong S, Ozdemirli M, et al. Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment. Pediatr-Blood-Cancer 2024; 71 (8): 1-4.$9$YR$$M$Y$$$20240905$$HP$US$US
242323481$24232348$1$I$$20240811$20240821$20240821$EXP$$AU-AMGEN-AUSSP2024162810$AMGEN$Arthur, C. K.. Treatment of Elderly and Unfit ANIL Patients with Prolonged Administration of Low Dose Cytarabine and Thioguanine Achieves High Complete Remission Rates in an Outpatient Setting. Blood. 2018;132 (Suppl 1)$$$$$Y$$$20240821$$HP$AU$AU
242323492$24232349$2$F$20240712$20240909$20240821$20240918$30DAY$$HK-AMGEN-HKGSP2024139864$AMGEN$$$$$$Y$$$20240917$$PH$HK$HK
242323501$24232350$1$I$20220101$20240816$20240821$20240821$EXP$$FR-PFIZER INC-PV202400107574$PFIZER$$90$YR$$F$Y$$$20240821$$MD$FR$FR
242323512$24232351$2$F$$20240826$20240821$20240826$EXP$$CN-PFIZER INC-PV202400108354$PFIZER$$$$A$M$Y$$$20240826$$CN$CN$CN
242323521$24232352$1$I$20240812$20240816$20240821$20240821$EXP$$CN-PFIZER INC-PV202400107397$PFIZER$$57$YR$$F$Y$60$KG$20240821$$HP$CN$CN
242323531$24232353$1$I$$20240819$20240821$20240821$EXP$IT-MINISAL02-999138$IT-PFIZER INC-202400238829$PFIZER$$68$YR$$M$Y$$$20240821$$MD$IT$IT
242323541$24232354$1$I$20220101$20240816$20240821$20240821$EXP$$PL-PFIZER INC-202400238143$PFIZER$$38$YR$$F$Y$$$20240821$$MD$PL$PL
242323552$24232355$2$F$20240803$20240826$20240821$20240828$EXP$$CN-PFIZER INC-PV202400106718$PFIZER$$37$YR$$F$Y$62.6$KG$20240828$$HP$CN$CN
242323562$24232356$2$F$$20240819$20240821$20240827$EXP$$JP-PFIZER INC-202400238681$PFIZER$Fujimoto, N.. Takotsubo syndrome in a cancer patient treated with a combination of anti-cancer drugs including immune checkpoint inhibitors: a case report. European Heart Journal. Case reports. 2024;8(8):10.1093/ehjcr/ytae355$66$YR$$F$Y$$$20240827$$MD$JP$JP
242323571$24232357$1$I$$20240813$20240821$20240821$EXP$$GB-AstraZeneca-2024A185087$ASTRAZENECA$$$$$$Y$$$20240821$$CN$GB$
242323581$24232358$1$I$$20240819$20240821$20240821$EXP$$CA-PFIZER INC-202400239940$PFIZER$$$$$M$Y$$$20240821$$HP$CA$CA
242323591$24232359$1$I$20240101$20240816$20240821$20240821$EXP$$CA-PFIZER INC-202400028650$PFIZER$$20$YR$$F$Y$$$20240821$$MD$CA$CA
242323602$24232360$2$F$$20240820$20240821$20240823$EXP$$IT-PFIZER INC-202400239795$PFIZER$Raccagni, A.. Long-term successfull management of recurrent episodes of nontuberculous mycobacterial infection in an apparently healthy Chinese woman. Annals of Clinical Microbiology and Antimicrobials. 2024;23 (1):10.1186/s12941-024-00732-0$51$YR$$F$Y$$$20240823$$MD$IT$IT
242323611$24232361$1$I$$20240819$20240821$20240821$EXP$$CA-PFIZER INC-202400239351$PFIZER$$3$YR$$F$Y$$$20240821$$HP$CA$CA
242323621$24232362$1$I$20240811$20240816$20240821$20240821$EXP$$KR-PFIZER INC-202400234094$PFIZER$$66$YR$$F$Y$$$20240821$$CN$KR$KR
242323631$24232363$1$I$$20240820$20240821$20240821$EXP$$CA-PFIZER INC-202400239993$PFIZER$$78$YR$$M$Y$80$KG$20240821$$HP$CA$CA
242323641$24232364$1$I$20240419$20240816$20240821$20240821$EXP$FR-AFSSAPS-MA2024001364$FR-PFIZER INC-202400238079$PFIZER$$85$YR$$F$Y$46$KG$20240821$$PH$FR$FR
242323651$24232365$1$I$20240401$20240820$20240821$20240821$EXP$$US-PFIZER INC-202400240044$PFIZER$$39$YR$$M$Y$$$20240821$$CN$US$US
242323672$24232367$2$F$20240727$20240828$20240821$20240829$EXP$$FR-PFIZER INC-202400238910$PFIZER$$62$YR$$F$Y$63$KG$20240829$$MD$FR$FR
242323681$24232368$1$I$$20240815$20240821$20240821$EXP$$US-PFIZER INC-202400238009$PFIZER$$77$YR$$F$Y$68.04$KG$20240821$$CN$US$US
242323692$24232369$2$F$20230101$20240826$20240821$20240903$EXP$$PL-PFIZER INC-202400238141$PFIZER$Guziejko, K.. Long-term response to pembrolizumab therapy in a patient with metastatic squamous cell lung carcinoma with programmed cell death ligand 1 (PD-L1) expression below 1%. Oncology in Clinical Practice. 2024;10:C32-C44$66$YR$$F$Y$$$20240903$$MD$PL$PL
242323702$24232370$2$F$$20240821$20240821$20240822$EXP$$US-PFIZER INC-202400239350$PFIZER$$$$$$Y$$$20240822$$MD$US$US
242323711$24232371$1$I$$20240817$20240821$20240821$EXP$$US-PFIZER INC-202400238489$PFIZER$$77$YR$$F$Y$$$20240821$$CN$US$US
242323721$24232372$1$I$$20240816$20240821$20240821$EXP$$FR-PFIZER INC-202400238006$PFIZER$$21$YR$$M$Y$$$20240821$$PH$FR$FR
242323731$24232373$1$I$20240507$20240816$20240821$20240821$EXP$FR-AFSSAPS-AN2024001088$FR-PFIZER INC-202400237928$PFIZER$$77$YR$$M$Y$65$KG$20240821$$MD$FR$FR
242323741$24232374$1$I$20230101$20240816$20240821$20240821$EXP$$DE-PFIZER INC-202400238056$PFIZER$$$$$M$Y$136.2$KG$20240821$$CN$DE$DE
242323751$24232375$1$I$$20240812$20240821$20240821$EXP$$US-TEVA-VS-3232818$TEVA$$68$YR$$M$Y$$$20240821$$CN$US$US
242323761$24232376$1$I$$20240813$20240821$20240821$EXP$$ZA-AstraZeneca-2024A185629$ASTRAZENECA$$28124$DY$$F$Y$$$20240821$$CN$ZA$
242323772$24232377$2$F$$20240813$20240821$20240822$EXP$$US-AstraZeneca-2024A185166$ASTRAZENECA$$53$YR$$M$Y$97.5$KG$20240822$$CN$US$
242323782$24232378$2$F$20240801$20240822$20240821$20240826$EXP$$MX-BAYER-2024A117125$BAYER$$75$YR$E$F$Y$80$KG$20240826$$CN$MX$MX
242323801$24232380$1$I$20070101$20240809$20240821$20240821$EXP$$FR-AUROBINDO-AUR-APL-2024-041021$AUROBINDO$Kluger N, Poirier P, Guilpain P, Baixench M, Cohen P, Paugam A. Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet^s disease. International Journal of Infectious Diseases. International Journal of Infectious Diseases. 2009;13:325$46$YR$$M$Y$$$20240821$$HP$FR$FR
242323811$24232381$1$I$20240701$20240814$20240821$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-022583$UNITED THERAPEUTICS$$4$YR$$M$Y$$$20240821$$$US$US
242323821$24232382$1$I$$20240812$20240821$20240821$EXP$$CA-FreseniusKabi-FK202412423$FRESENIUS KABI$$29$YR$A$F$Y$$$20240821$$PH$CA$CA
242323832$24232383$2$F$$20240830$20240821$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004108$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
242323841$24232384$1$I$$20240807$20240821$20240821$EXP$$AU-LUPIN EUROPE GMBH-2024-08041$LUPIN$Adamson A, Michael A, Patel S, Brown M. First case of drug-Induced pulmonary arterial hypertension: Teriflunomide. Heart, Lung and Circulation. 2024;33:S353$45$YR$$F$Y$$$20240821$$HP$AU$AU
242323852$24232385$2$F$20230101$20240902$20240821$20240910$EXP$$DE-TEVA-VS-3233439$TEVA$$77$YR$$M$Y$76$KG$20240910$$MD$DE$DE
242323861$24232386$1$I$$20240812$20240821$20240821$EXP$$US-ROCHE-10000055613$ROCHE$$61$YR$A$M$Y$$$20240821$$CN$US$US
242323873$24232387$3$F$20240101$20240910$20240821$20240912$EXP$$CO-UCBSA-2024042194$UCB$$$$$F$Y$$$20240912$$CN$CO$CO
242323893$24232389$3$F$20231101$20240905$20240821$20240911$EXP$$US-ABBVIE-5885803$ABBVIE$$63$YR$$F$Y$111$KG$20240911$$CN$US$US
242323901$24232390$1$I$$20240813$20240821$20240821$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-130367$BRISTOL MYERS SQUIBB$Mendes ML, Cam?es S, Da Silva CR, Aparicio D, Costa BS, Marques M, et al. Meningite dissimulada. Congressos da Sociedade Portuguesa de Medicina Interna: 30.o Congresso Nacional. 2024;30:810.$74$YR$E$M$Y$$$20240821$$HP$PT$PT
242323911$24232391$1$I$$20240809$20240821$20240821$EXP$$IT-AUROBINDO-AUR-APL-2024-040662$AUROBINDO$$83$YR$$M$Y$$$20240821$$HP$IT$IT
242323924$24232392$4$F$20240101$20240911$20240821$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025601$UNITED THERAPEUTICS$$$$$M$Y$69.841$KG$20240920$$$US$US
242323931$24232393$1$I$20240803$20240816$20240821$20240821$EXP$$DE-ABBVIE-5885604$ABBVIE$$74$YR$$M$Y$$$20240821$$CN$DE$DE
242323941$24232394$1$I$20240812$20240815$20240821$20240821$EXP$$CO-UCBSA-2024042233$UCB$$52$YR$$F$Y$$$20240821$$CN$CO$CO
242323963$24232396$3$F$20240809$20240917$20240821$20240924$30DAY$$US-AMGEN-USASP2024162329$AMGEN$$75$YR$E$F$Y$69.206$KG$20240924$$PH$US$US
242323991$24232399$1$I$$20240815$20240821$20240821$EXP$$US-BAYER-2024A118006$BAYER$$$$$$Y$$$20240821$$CN$US$US
242324012$24232401$2$F$20240801$20240820$20240821$20240903$PER$$US-Calliditas-2024CAL01547$CALLIDITAS THERAPEUTICS$$53$YR$A$F$Y$99.7$KG$20240903$$CN$US$US
242324022$24232402$2$F$$20240829$20240821$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004109$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
242324031$24232403$1$I$$20240816$20240821$20240821$EXP$$NVSC2024CA167281$NOVARTIS$$57$YR$$M$Y$$$20240821$$CN$CA$CA
242324051$24232405$1$I$$20240815$20240821$20240821$PER$$US-ROCHE-10000058887$ROCHE$$$$$$Y$$$20240821$$CN$US$US
242324061$24232406$1$I$20190816$20240816$20240821$20240821$EXP$$CO-UCBSA-2024042175$UCB$$81$YR$$M$Y$$$20240821$$CN$CO$CO
242324071$24232407$1$I$$20240816$20240821$20240821$EXP$$UM-JNJFOC-20240843314$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$MD$UM$UM
242324081$24232408$1$I$$20240820$20240821$20240821$EXP$$IT-SANDOZ INC.-NVSC2020IT118169$SANDOZ$$6$MON$$F$Y$$$20240821$$MD$IT$IT
242324091$24232409$1$I$$20240809$20240821$20240821$EXP$$CA-AUROBINDO-AUR-APL-2024-040979$AUROBINDO$$67$YR$$F$Y$88$KG$20240821$$MD$CA$CA
242324112$24232411$2$F$$20240820$20240821$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004110$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
242324121$24232412$1$I$$20240814$20240821$20240821$EXP$$US-GSK-US2024101313$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
242324131$24232413$1$I$$20240815$20240821$20240821$EXP$$US-GSK-US2024AMR102863$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
242324141$24232414$1$I$20240617$20240814$20240821$20240821$EXP$$US-GSK-US2024101218$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$US$US
242324152$24232415$2$F$20240101$20240903$20240821$20240923$EXP$$US-SA-2024SA245229$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240923$$MD$US$US
242324161$24232416$1$I$$20240815$20240821$20240821$EXP$$NVSC2024US167056$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
242324171$24232417$1$I$$20240807$20240821$20240821$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00873$CATALYST PHARMA$$$$$M$Y$44.444$KG$20240821$$CN$US$US
242324182$24232418$2$F$20240724$20240816$20240821$20240829$EXP$$NVSC2024CN168177$NOVARTIS$$66$YR$$F$Y$68$KG$20240829$$HP$CN$CN
242324191$24232419$1$I$20240815$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164089$AMGEN$$$$$$Y$$$20240821$$HP$US$US
242324201$24232420$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024163373$AMGEN$Khan M.; Meseeha M.; Richards J. et al.. Long-term follow-up of patients with hairy cell leukemia treated with different modalities at a single institution: Real-life experience over 25 years. Journal of Clinical Oncology. 2024;42 (16):e19023$$$$$Y$$$20240821$$HP$US$US
242324211$24232421$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163668$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242324221$24232422$1$I$$20240811$20240821$20240821$EXP$$CA-AMGEN-CANSP2024163382$AMGEN$Meloche C.; Dinh T.; Spaans J. et al.. Recurrent vulvar squamous cell carcinoma: Outcomes across the treatment spectrum-Are we making progress?. Journal of Clinical Oncology. 2024;42 (16):e17603$$$$F$Y$$$20240821$$HP$CA$CA
242324231$24232423$1$I$$20240815$20240821$20240821$EXP$$US-BAYER-2024A118224$BAYER$$54$YR$A$F$Y$$$20240821$$CN$US$US
242324241$24232424$1$I$20240716$20240819$20240821$20240821$EXP$GB-MHRA-MED-202408180153570310-BLZKV$GB-Orion Corporation ORION PHARMA-24_00031323$ORION$$58$YR$A$F$Y$96$KG$20240821$$MD$GB$
242324251$24232425$1$I$20240101$20240813$20240821$20240821$EXP$$US-ABBVIE-5881335$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242324271$24232427$1$I$20240814$20240819$20240821$20240821$PER$$US-BIOVITRUM-2024-US-011111$BIOVITRUM$$6$MON$$M$Y$$$20240821$$CN$US$US
242324281$24232428$1$I$$20240814$20240821$20240821$EXP$$US-ABBVIE-5882218$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242324291$24232429$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131263$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240821$$CN$US$US
242324301$24232430$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130069$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240821$$CN$US$US
242324311$24232431$1$I$$20240808$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127161$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$76.09$KG$20240821$$PH$US$US
242324321$24232432$1$I$20240708$20240813$20240821$20240821$EXP$$BO-ROCHE-10000048078$ROCHE$$80$YR$E$$Y$$$20240821$$CN$BO$BO
242324331$24232433$1$I$$20240811$20240821$20240821$EXP$$CN-Prasco Laboratories-PRAS20241103$PRASCO$He H, Hou N, Chen X, Song Y, Qiang W, Liu J, Lu J, Fu W, Du J. An open-label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome. Br J Haematol.. 2024;205(2):478-482. doi:10.1111/bjh.19626$$$$$Y$$$20240821$$HP$CN$CN
242324341$24232434$1$I$$20240812$20240821$20240821$EXP$$US-TEVA-VS-3233148$TEVA$$51$YR$$F$Y$$$20240821$$CN$US$US
242324351$24232435$1$I$20240627$20240818$20240821$20240821$EXP$$EG-SA-2024SA246038$SANOFI AVENTIS$$58$YR$A$F$Y$73$KG$20240821$$HP$EG$EG
242324361$24232436$1$I$20230101$20240809$20240821$20240821$EXP$$GB-AUROBINDO-AUR-APL-2024-040299$AUROBINDO$Alharmoodi K, Kathirgamachelvam J, Nafri D.. Prolonged Discontinuation Syndrome of Venlafaxine: A Case Study of Severe Gastrointestinal Manifestations.. Cureus. 2024;16(7):e63560$26$YR$$F$Y$$$20240821$$MD$GB$GB
242324371$24232437$1$I$$20240820$20240821$20240821$PER$$NVSC2024US169280$NOVARTIS$$$$$F$Y$61$KG$20240821$$CN$US$US
242324391$24232439$1$I$20240522$20240815$20240821$20240821$EXP$GB-MHRA-MED-202408101807510540-SWCJB$GB-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2408GB06466$INSUD PHARMA$$38$YR$$F$Y$59$KG$20240821$$CN$GB$GB
242324401$24232440$1$I$20240403$20240812$20240821$20240821$EXP$FR-AFSSAPS-TS2024000885$FR-TEVA-VS-3233241$TEVA$$81$YR$$F$Y$50$KG$20240821$$MD$FR$FR
242324411$24232441$1$I$20240815$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024164551$AMGEN$$65$YR$E$F$Y$$$20240821$$CN$US$US
242324421$24232442$1$I$$20240812$20240821$20240821$PER$$US-ROCHE-10000055914$ROCHE$$$$$$Y$$$20240821$$CN$US$US
242324431$24232443$1$I$20231101$20240814$20240821$20240821$EXP$$AE-ROCHE-10000033098$ROCHE$$41$YR$A$F$Y$$$20240821$$CN$AE$AE
242324441$24232444$1$I$20240725$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57363$$FDA-CTU$$92$YR$$M$N$202$LBS$20240820$N$$US$
242324451$24232445$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57415$$FDA-CTU$$44$YR$$M$N$$$20240820$N$$US$
242324461$24232446$1$I$$20240816$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US073571$SANDOZ$$$$$$Y$$$20240821$$CN$US$US
242324471$24232447$1$I$$20240820$20240821$20240821$EXP$$US-TAKEDA-2024TUS054568$TAKEDA$$$$$F$Y$53$KG$20240821$$MD$US$US
242324493$24232449$3$F$20230111$20240821$20240821$20240829$EXP$$JP-MRZWEB-2024080000148$MERZ$$48$YR$$M$Y$$$20240829$$MD$JP$JP
242324501$24232450$1$I$$20240729$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004112$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
242324511$24232451$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009342$APOTEX$$40$YR$$F$Y$73$KG$20240821$$MD$CA$CA
242324521$24232452$1$I$20240819$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165722$AMGEN$$45$YR$A$F$Y$$$20240821$$CN$US$US
242324531$24232453$1$I$$20240709$20240821$20240821$PER$$US-LUNDBECK-DKLU4001458$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
242324541$24232454$1$I$$20240816$20240821$20240821$EXP$$NVSC2024GB166883$NOVARTIS$$$$$F$Y$$$20240821$$CN$GB$GB
242324561$24232456$1$I$20240806$20240815$20240821$20240821$EXP$$NVSC2024US166005$NOVARTIS$$64$YR$$$Y$$$20240821$$CN$US$US
242324571$24232457$1$I$20240508$20240820$20240821$20240821$EXP$$CA-MYLANLABS-2024M1051752$MYLAN$$66$YR$$M$Y$$$20240821$$PH$CA$CA
242324582$24232458$2$F$20240818$20240823$20240821$20240826$EXP$GB-MHRA-MED-202408191739164600-CKLBQ$GB-MYLANLABS-2024M1077313$MYLAN$$60$YR$$F$Y$$$20240826$$PH$GB$GB
242324591$24232459$1$I$20240101$20240807$20240821$20240821$EXP$$GB-UCBSA-2024040094$UCB$$$$$F$Y$$$20240821$$CN$GB$GB
242324611$24232461$1$I$$20240813$20240821$20240821$EXP$$DE-Bion-013681$BIONPHARMA$$17$YR$T$M$Y$$$20240821$$HP$DE$DE
242324621$24232462$1$I$$20240809$20240821$20240821$EXP$$CA-AUROBINDO-AUR-APL-2024-040937$AUROBINDO$$39$YR$$M$Y$$$20240821$$PH$CA$CA
242324631$24232463$1$I$$20240817$20240821$20240821$EXP$$US-ABBVIE-5886602$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242324641$24232464$1$I$20240101$20240820$20240821$20240821$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046966$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240821$$HP$US$US
242324651$24232465$1$I$20240301$20240809$20240821$20240821$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000942$PAREXEL$$$$$$Y$$$20240821$$CN$US$US
242324661$24232466$1$I$$20240819$20240821$20240821$EXP$$NVSC2024CA167865$NOVARTIS$$43$YR$$F$Y$97$KG$20240821$$HP$CA$CA
242324672$24232467$2$F$20231101$20240905$20240821$20240913$EXP$$ES-TEVA-VS-3233776$TEVA$$69$YR$$F$Y$$$20240913$$CN$ES$ES
242324681$24232468$1$I$$20240816$20240821$20240821$EXP$$US-Bion-013705$BIONPHARMA$$36$YR$A$M$Y$$$20240821$$HP$US$US
242324691$24232469$1$I$$20240729$20240821$20240821$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004114$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242324711$24232471$1$I$$20240812$20240821$20240821$30DAY$$US-GSK-US2024100352$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242324721$24232472$1$I$20240813$20240813$20240821$20240821$30DAY$$US-GSK-US2024100815$GLAXOSMITHKLINE$$66$YR$$M$Y$$$20240821$$MD$US$US
242324731$24232473$1$I$20091031$20240810$20240821$20240821$EXP$$FR-KOANAAP-SML-FR-2024-00850$SHILPA MEDICARE$$69$YR$E$M$Y$$$20240821$$CN$FR$FR
242324741$24232474$1$I$$20240806$20240821$20240821$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-08280$LUPIN$$$$$F$Y$$$20240821$$CN$AU$AU
242324751$24232475$1$I$20240401$20240816$20240821$20240821$EXP$$CA-GSK-CA2021AMR156048$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$CA$CA
242324761$24232476$1$I$$20240529$20240821$20240821$PER$$US-Breckenridge Pharmaceutical, Inc.-2160670$BRECKENRIDGE$$20$YR$$M$Y$32.727$KG$20240821$$$US$US
242324772$24232477$2$F$20240801$20240816$20240821$20240825$PER$$US-AMGEN-USASP2024164321$AMGEN$$$$$$Y$$$20240825$$HP$US$US
242324781$24232478$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011122$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240821$$CN$US$US
242324791$24232479$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011734$ELI LILLY AND CO$$60$YR$A$$Y$$$20240821$$CN$US$US
242324801$24232480$1$I$20240816$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011108$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240821$$CN$US$US
242324811$24232481$1$I$$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-105683-2023$RECKITT BENCKISER$$$$$F$Y$$$20240821$$CN$US$US
242324822$24232482$2$F$20240101$20240902$20240821$20240903$EXP$$JP-ABBVIE-5887531$ABBVIE$$72$YR$$F$Y$$$20240903$$MD$JP$JP
242324831$24232483$1$I$20240209$20240812$20240821$20240821$EXP$FR-AFSSAPS-TO2024001477$FR-TEVA-VS-3233251$TEVA$$75$YR$$M$Y$$$20240821$$PH$FR$FR
242324841$24232484$1$I$20240406$20240815$20240821$20240821$EXP$$NVSC2024US085343$NOVARTIS$$49$YR$$F$Y$$$20240821$$CN$US$US
242324851$24232485$1$I$$20240708$20240821$20240821$PER$$US-LUNDBECK-DKLU4001464$LUNDBECK$$$$$$Y$$$20240821$$MD$US$US
242324861$24232486$1$I$$20240808$20240821$20240821$EXP$$JP-B.Braun Medical Inc.-2160672$B BRAUN$Literature Article$65$YR$$F$Y$61$KG$20240821$$$JP$JP
242324871$24232487$1$I$$20240809$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008428$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242324881$24232488$1$I$$20240809$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008427$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242324891$24232489$1$I$$20240812$20240821$20240821$EXP$$JP-ROCHE-10000056593$ROCHE$Hirano K, Hata A, Yamanaka Y, Sumi T, Tamiya M, Sato Y, et al. Cost-effectiveness study of atezolizumab (ATZ) vs. durvalumab (DUR): Real-world data (RWD) on first-line chemotherapy combined with immune-checkpoint inhibitors (Chemo-ICIs) for extensive disease small-cell lung cancer (ED-SCLC) [Abstract n. Journal of Clinical Oncology. 2024-Jun;42 (16):$$$$$Y$$$20240821$$HP$JP$JP
242324901$24232490$1$I$$20240814$20240821$20240821$EXP$$AU-TAKEDA-2024TUS082758$TAKEDA$$$$$M$Y$$$20240821$$CN$AU$AU
242324911$24232491$1$I$20240813$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024162145$AMGEN$$67$YR$E$$Y$$$20240821$$CN$US$US
242324921$24232492$1$I$$20240809$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008397$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242324931$24232493$1$I$$20240814$20240821$20240821$EXP$$AU-TAKEDA-2024TUS082764$TAKEDA$$$$$M$Y$$$20240821$$CN$AU$AU
242324941$24232494$1$I$$20240813$20240821$20240821$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US001431$PAREXEL$$$$$$Y$$$20240821$$MD$US$US
242324951$24232495$1$I$$20240809$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008399$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242324961$24232496$1$I$$20240814$20240821$20240821$EXP$$CA-JNJFOC-20240847042$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240821$$HP$CA$CA
242324971$24232497$1$I$20240201$20240809$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008396$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242324981$24232498$1$I$20240805$20240812$20240821$20240821$EXP$$PK-ROCHE-10000055615$ROCHE$$54$YR$A$F$Y$$$20240821$$CN$PK$PK
242324991$24232499$1$I$20230701$20240815$20240821$20240821$EXP$$GB-009507513-2408GBR005643$MERCK$Kunnumpurath A, Gjorgjievska-Marsh V. BI31 Pembrolizumab-induced scleroderma in a patient with nonsmall cell lung cancer. British Journal of Dermatology. 2024;192 Supplement1:i152$59$YR$$F$Y$$$20240821$$HP$GB$GB
242325001$24232500$1$I$$20240814$20240821$20240821$EXP$$IT-ROCHE-3544299$ROCHE$Alfano G, Fontana F, Francesca D, Assirati G, Magistri P, Tarantino G. Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature. Transplant Proceeding. 2018;50 (3):905-9.$42$YR$A$F$Y$$$20240821$$MD$IT$IT
242325031$24232503$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57393$$FDA-CTU$$50$YR$$F$N$100.7$KG$20240820$N$$US$
242325041$24232504$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57406$$FDA-CTU$$53$YR$$F$N$$$20240820$N$$US$
242325071$24232507$1$I$20190727$20240815$20240821$20240821$EXP$$CO-UCBSA-2024042211$UCB$$32$YR$$F$Y$$$20240821$$CN$CO$CO
242325081$24232508$1$I$20220624$20240812$20240821$20240821$EXP$ES-AEMPS-1534603$ES-KOANAAP-SML-ES-2024-00851$SHILPA MEDICARE$$65$YR$A$M$Y$$$20240821$$PH$ES$ES
242325092$24232509$2$F$$20240814$20240821$20240827$EXP$$NVSC2024US168350$NOVARTIS$$22$YR$$M$Y$$$20240827$$MD$US$US
242325102$24232510$2$F$$20240819$20240821$20240823$PER$$NVSC2024US168634$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
242325111$24232511$1$I$$20240809$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008394$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242325131$24232513$1$I$20240713$20240814$20240821$20240821$EXP$FR-AFSSAPS-PC2024000651$FR-009507513-2408FRA005012$MERCK$$62$YR$$F$Y$$$20240821$$PH$FR$FR
242325151$24232515$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240846179$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242325161$24232516$1$I$$20240815$20240821$20240821$EXP$$BR-JNJFOC-20240843537$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$BR$BR
242325171$24232517$1$I$$20240809$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008391$INCYTE$$$$$$Y$$$20240821$$HP$US$US
242325181$24232518$1$I$$20240813$20240821$20240821$30DAY$$US-GSK-US2024100837$GLAXOSMITHKLINE$$$$$M$Y$$$20240821$$CN$US$US
242325192$24232519$2$F$$20240906$20240821$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004116$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242325201$24232520$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57401$$FDA-CTU$$70$YR$$M$N$85.73$KG$20240820$N$$US$
242325211$24232521$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57405$$FDA-CTU$$67$YR$$F$N$$$20240820$N$$US$
242325221$24232522$1$I$$20240815$20240821$20240821$EXP$$US-GILEAD-2024-0683451$GILEAD$$35$YR$A$M$Y$$$20240821$$CN$US$US
242325231$24232523$1$I$$20240813$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008493$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242325242$24232524$2$F$$20240823$20240821$20240829$EXP$$PT-MYLANLABS-2024M1076215$MYLAN$Novais C.. Unexpected challenges: Recognize the serious adverse effects of oral antidiabetics.. Portuguese Journal of Family Medicine and General Practice.. 2024;40(Supplem 13):S21-S21$80$YR$$F$Y$$$20240829$$MD$PT$PT
242325251$24232525$1$I$$20240808$20240821$20240821$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-15931$IPSEN$$49$YR$A$F$Y$$$20240821$$HP$US$US
242325261$24232526$1$I$20240527$20240815$20240821$20240821$EXP$FR-AFSSAPS-AVTO2024000110$FR-MYLANLABS-2024M1076272$MYLAN$$37$YR$$M$Y$$$20240821$$MD$FR$FR
242325271$24232527$1$I$20240701$20240815$20240821$20240821$EXP$$FI-MYLANLABS-2024M1076611$MYLAN$$31$YR$$M$Y$$$20240821$$MD$FI$FI
242325281$24232528$1$I$$20240815$20240821$20240821$EXP$$DE-MYLANLABS-2024M1076162$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$23$YR$$M$Y$$$20240821$$HP$DE$DE
242325293$24232529$3$F$20240701$20240827$20240821$20240903$EXP$$FI-MYLANLABS-2024M1076338$MYLAN$$31$YR$$M$Y$$$20240903$$MD$FI$FI
242325301$24232530$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131801$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240821$$CN$US$US
242325321$24232532$1$I$20211016$20240813$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008489$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242325331$24232533$1$I$20240329$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-087278-2024$RECKITT BENCKISER$$59$YR$$M$Y$220$KG$20240821$$CN$US$US
242325341$24232534$1$I$$20240816$20240821$20240821$PER$$US-TAKEDA-2024TUS083704$TAKEDA$$$$$M$Y$$$20240821$$MD$US$US
242325361$24232536$1$I$20240818$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165599$AMGEN$$47$YR$A$F$Y$$$20240821$$CN$US$US
242325372$24232537$2$F$20240714$20240906$20240821$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004117$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240916$$CN$US$US
242325381$24232538$1$I$20240817$20240820$20240820$20240820$DIR$715215$$FDA-CTU$$63$YR$$F$N$109.8$KG$20240820$N$HP$US$
242325391$24232539$1$I$$20240815$20240821$20240821$EXP$$CA-TAKEDA-2024TUS083006$TAKEDA$$$$$F$Y$$$20240821$$CN$CA$CA
242325401$24232540$1$I$20240813$20240819$20240821$20240821$EXP$$NVSC2024CN169044$NOVARTIS$$71$YR$$M$Y$50$KG$20240821$$HP$CN$CN
242325411$24232541$1$I$20240501$20240812$20240821$20240821$EXP$FR-AFSSAPS-TS2024000891$FR-FreseniusKabi-FK202412458$FRESENIUS KABI$$72$YR$E$M$Y$64$KG$20240821$$MD$FR$FR
242325421$24232542$1$I$$20240819$20240821$20240821$PER$$NVSC2024US168492$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
242325431$24232543$1$I$20240722$20240819$20240821$20240821$EXP$$FR-FreseniusKabi-FK202412667$FRESENIUS KABI$$66$YR$E$M$Y$$$20240821$$HP$FR$FR
242325441$24232544$1$I$20240729$20240729$20240821$20240821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004119$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240821$$HP$US$US
242325451$24232545$1$I$$20240709$20240821$20240821$PER$$US-LUNDBECK-DKLU4001459$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
242325461$24232546$1$I$20240401$20240816$20240821$20240821$EXP$$US-GILEAD-2024-0684703$GILEAD$$49$YR$A$M$Y$$$20240821$$CN$US$US
242325471$24232547$1$I$$20240807$20240821$20240821$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000319$AZURITY PHARMACEUTICALS$Enstrom C, Gast S, Church L, Heflin MK, Moore C, Cook C.et al. Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy. US Cardiology Review. 2024;18 (2)$25$YR$$M$Y$$$20240821$$HP$US$US
242325481$24232548$1$I$$20240812$20240821$20240821$EXP$$GB-MYLANLABS-2024M1076781$MYLAN$Botrugno R, Rajlawat B, Finn D, Yesudian PD. Use of roflumilast in erosive oral inflammatory conditions. Br-J-Dermatol 2024; 191 (Suppl. 1) i62-i63 abstr. P099.$34$YR$$F$Y$$$20240821$$HP$GB$GB
242325492$24232549$2$F$20240718$20240823$20240821$20240827$EXP$$GB-MYLANLABS-2024M1068919$MYLAN$$$$$M$Y$$$20240827$$MD$GB$GB
242325501$24232550$1$I$$20240812$20240821$20240821$EXP$$US-MYLANLABS-2024M1076417$MYLAN$Dennee A, Fogarty TP, Howard TS, Hunter RB. Sinus Arrest Related to Dexmedetomidine Infusion in an Infant; a Case Report and Review of Current Literature. [Review]. J-Pharm-Pract 2023; 37 (4): 1026-1031.$11$MON$$F$Y$$$20240821$$MD$US$US
242325511$24232551$1$I$$20240812$20240821$20240821$EXP$$AU-MYLANLABS-2024M1072260$MYLAN$Kwok L, Mahmood A, Kumar S, Chang A. Case Report: Macula Structural and Functional Assessment in Nab-Paclitaxel-Related Cystoid Macular Edema. Ophthalmic-Surg-Lasers-Imaging-Retina 2024; 55 (7): 408-411.$54$YR$$F$Y$$$20240821$$MD$AU$AU
242325521$24232552$1$I$20170403$20240812$20240821$20240821$EXP$$KR-MYLANLABS-2024M1074928$MYLAN$$$$A$M$Y$83.4$KG$20240821$$MD$KR$KR
242325531$24232553$1$I$$20240708$20240821$20240821$PER$$US-LUNDBECK-DKLU4001383$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
242325542$24232554$2$F$$20240913$20240821$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129898$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$72.12$KG$20240918$$CN$US$US
242325551$24232555$1$I$20240509$20240812$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-073286$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240821$$CN$US$US
242325571$24232557$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132486$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240821$$CN$US$US
242325581$24232558$1$I$20240805$20240812$20240821$20240821$EXP$$NL-TEVA-VS-3232226$TEVA$$26$YR$$F$Y$$$20240821$$CN$NL$PT
242325601$24232560$1$I$20240801$20240814$20240821$20240821$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006486$AURINIA PHARMACEUTICALS$$26$YR$$F$Y$$$20240821$$CN$US$US
242325611$24232561$1$I$$20240819$20240821$20240821$EXP$$NVSC2024CA167809$NOVARTIS$$65$YR$$F$Y$$$20240821$$HP$CA$CA
242325621$24232562$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57328$$FDA-CTU$$74$YR$$F$N$$$20240820$N$$US$
242325631$24232563$1$I$20240629$20240820$20240820$20240820$DIR$715099$$FDA-CTU$$71$YR$$F$N$76.5$KG$20240820$N$CN$US$
242325651$24232565$1$I$$20240820$20240820$20240820$DIR$715117$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242325661$24232566$1$I$20240820$20240820$20240820$20240820$DIR$715159$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242325671$24232567$1$I$20240723$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57457$$FDA-CTU$$80$YR$$M$N$$$20240820$N$HP$US$
242325681$24232568$1$I$20240814$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011633$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240821$$CN$US$US
242325691$24232569$1$I$20240812$20240812$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408006998$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240821$$CN$US$US
242325701$24232570$1$I$$20240813$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408008930$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240821$$CN$US$US
242325731$24232573$1$I$$20240808$20240821$20240821$EXP$$IN-B.Braun Medical Inc.-2160673$B BRAUN$Literature Article$70$YR$$F$Y$$$20240821$$$IN$IN
242325741$24232574$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164511$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242325751$24232575$1$I$20240819$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165606$AMGEN$$76$YR$E$M$Y$$$20240821$$CN$US$US
242325771$24232577$1$I$$20240806$20240821$20240821$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-23-001379$AKEBIA THERAPEUTICS$$$$$$Y$$$20240821$$MD$JP$JP
242325783$24232578$3$F$20240725$20240916$20240821$20240924$EXP$AT-BASGAGES-2024-005898$AT-MYLANLABS-2024M1075880$MYLAN$$45$YR$$M$Y$83$KG$20240924$$PH$AT$AT
242325791$24232579$1$I$20230529$20240814$20240821$20240821$EXP$FR-AFSSAPS-AM2024000649$FR-MYLANLABS-2024M1075734$MYLAN$$50$YR$$M$Y$122$KG$20240821$$MD$FR$FR
242325801$24232580$1$I$20240809$20240813$20240821$20240821$EXP$$CA-ROCHE-10000057647$ROCHE$$36$YR$A$F$Y$$$20240821$$HP$CA$CA
242325822$24232582$2$F$20240801$20240820$20240821$20240821$PER$$US-JNJFOC-20240843742$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240821$$CN$US$US
242325831$24232583$1$I$$20240813$20240821$20240821$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US001527$PAREXEL$$$$$$Y$$$20240821$$CN$US$US
242325851$24232585$1$I$20230606$20240819$20240821$20240821$EXP$FR-AFSSAPS-AM2024000651$FR-FreseniusKabi-FK202412697$FRESENIUS KABI$$65$YR$A$M$Y$78$KG$20240821$$MD$FR$FR
242325863$24232586$3$F$$20240820$20240821$20240831$EXP$$CA-Accord-441301$ACCORD$Lebeau J, Leung J, Goettke K, Cherniak V, Alghamdi T, Salvador S, et al. A rare case report of bullous pemphigoid caused by paclitaxel treatment for endometrial cancer. Eur J Obstet Gynecol Reprod Biol. 2024 Jul 31:S0301-2115(24)00422-6.$86$YR$E$F$Y$$$20240831$$MD$CA$CA
242325871$24232587$1$I$$20240809$20240821$20240821$EXP$$ES-Accord-442042$ACCORD$Taibo A, SeoaneEstevez A, MartinezCampayo N, RodriguezMayo M, ArevaloBermudez MDP, Fonseca E. Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain. Mycoses 2023:66 (10): 891-897.$50$YR$A$M$Y$$$20240821$$MD$ES$ES
242325881$24232588$1$I$$20240809$20240821$20240821$EXP$GB-MHRA-MED-202408091442060030-DQZMP$GB-Accord-441260$ACCORD$$$$$M$Y$$$20240821$$CN$GB$GB
242325892$24232589$2$F$$20240905$20240821$20240917$EXP$CA-MHPD-E2B_07176322$CA-Accord-441364$ACCORD$$$$$M$Y$$$20240917$$HP$CA$CA
242325901$24232590$1$I$$20240809$20240821$20240821$EXP$CA-MHPD-E2B_07177661$CA-Accord-441347$ACCORD$$33$YR$A$M$Y$$$20240821$$MD$CA$CA
242325911$24232591$1$I$20240722$20240809$20240821$20240821$EXP$CN-HENLIUS-24CN016381$CN-Accord-442411$ACCORD$$69$YR$E$F$Y$40$KG$20240821$$MD$CN$CN
242325921$24232592$1$I$20240805$20240809$20240821$20240821$EXP$$US-Accord-441649$ACCORD$$47$YR$A$M$Y$$$20240821$$HP$US$US
242325932$24232593$2$F$20240506$20240911$20240821$20240921$EXP$GB-MHRA-MED-202408072019074410-NTCRP$GB-Accord-441210$ACCORD$$68$YR$E$F$Y$$$20240921$$MD$GB$GB
242325951$24232595$1$I$20240602$20240809$20240821$20240821$EXP$ES-AEMPS-1555664$ES-Accord-441338$ACCORD$$52$YR$A$M$Y$$$20240821$$MD$ES$ES
242325961$24232596$1$I$20240805$20240809$20240821$20240821$EXP$$US-Accord-441645$ACCORD$$44$YR$A$M$Y$$$20240821$$HP$US$US
242325971$24232597$1$I$20200725$20240809$20240821$20240821$EXP$PL-URPL-1-1716-2020$PL-Accord-441344$ACCORD$$39$YR$A$F$Y$95$KG$20240821$$MD$PL$PL
242325981$24232598$1$I$20240710$20240809$20240821$20240821$EXP$GB-MHRA-MIDB-aea73cb5-b1d6-48dd-822a-8a1a84b2a87d$GB-Accord-441199$ACCORD$$68$YR$E$$Y$$$20240821$$HP$GB$GB
242325991$24232599$1$I$20240724$20240809$20240821$20240821$EXP$GB-MHRA-31436434$GB-Accord-441221$ACCORD$$7$YR$C$F$Y$30$KG$20240821$$HP$GB$GB
242326001$24232600$1$I$$20240814$20240821$20240821$EXP$$US-MYLANLABS-2024M1077139$MYLAN$Wang D, Lee D, Yeung A. AMI-CS with Misidentification of the Culprit Requiring Delayed Revascularization of LCX, Complicated by MR Requiring IABP and MV TEER. US-Cardiol 2024; 18 (Suppl. 1) 13-14 abstr. 26.$63$YR$$M$Y$$$20240821$$MD$US$US
242326011$24232601$1$I$$20240814$20240821$20240821$EXP$$US-MYLANLABS-2024M1076840$MYLAN$Wynn CW, Burg G, George A, Sawnani H. Persistent Air Leak Treated With Endobronchial Valve in an Adolescent With Hyper-IgE Syndrome. Am-J-Respir-Crit-Care-Med 2023; 207 A2639.$15$YR$$F$Y$$$20240821$$HP$US$US
242326021$24232602$1$I$$20240814$20240821$20240821$EXP$$US-MYLANLABS-2024M1077025$MYLAN$LeSaint KT, Kendric KJ, Logan AA. Successful administration of extended-release buprenorphine in the emergency department. Am-J-Emerg-Med 2024.$38$YR$$M$Y$$$20240821$$MD$US$US
242326031$24232603$1$I$20240809$20240809$20240821$20240821$EXP$GB-MHRA-MED-202408091343505770-CPDHV$GB-Accord-441182$ACCORD$$61$YR$A$F$Y$$$20240821$$PH$GB$GB
242326041$24232604$1$I$$20230724$20240821$20240821$PER$$US-UCBSA-2023038027$UCB$$$$$$Y$$$20240821$$MD$US$US
242326051$24232605$1$I$$20230725$20240821$20240821$PER$$US-UCBSA-2023037832$UCB$$$$$$Y$$$20240821$$MD$US$US
242326061$24232606$1$I$$20230816$20240821$20240821$PER$$US-UCBSA-2023041355$UCB$$$$$M$Y$$$20240821$$MD$US$US
242326071$24232607$1$I$$20230712$20240821$20240821$PER$$US-UCBSA-2023035675$UCB$$17$YR$$M$Y$34.09$KG$20240821$$HP$US$US
242326081$24232608$1$I$$20230818$20240821$20240821$PER$$US-UCBSA-2023041743$UCB$$3$DEC$$F$Y$$$20240821$$HP$US$US
242326091$24232609$1$I$20240820$20240820$20240820$20240820$DIR$715225$$FDA-CTU$$59$YR$$F$N$78.75$KG$20240820$Y$CN$US$
242326111$24232611$1$I$$20240814$20240821$20240821$EXP$$US-MYLANLABS-2024M1076783$MYLAN$Fling C, Granados L, Coruh B. An Ophtha-MALA-gic Anomaly: Metformin Associated Lactic Acidosis Causing Transient Blindness. Am-J-Respir-Crit-Care-Med 2023; 207 A3498 abstr. B48.$62$YR$$M$Y$$$20240821$$HP$US$US
242326122$24232612$2$F$20240701$20240807$20240821$20240916$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-15878$IPSEN$$56$YR$A$M$Y$$$20240916$$CN$US$US
242326131$24232613$1$I$$20240819$20240821$20240821$EXP$$CA-PFIZER INC-202400239279$PFIZER$$16$YR$$F$Y$$$20240821$$HP$CA$CA
242326141$24232614$1$I$20240801$20240816$20240821$20240821$EXP$$US-PFIZER INC-202400239000$PFIZER$$$$A$M$Y$$$20240821$$PH$US$US
242326151$24232615$1$I$20231030$20240819$20240821$20240821$EXP$$CA-PFIZER INC-202400240129$PFIZER$$79$YR$$M$Y$$$20240821$$HP$CA$CA
242326161$24232616$1$I$20240801$20240820$20240821$20240821$EXP$$JP-PFIZER INC-PV202400108600$PFIZER$$$$E$$Y$$$20240821$$MD$JP$JP
242326171$24232617$1$I$20240101$20240816$20240821$20240821$EXP$$CA-PFIZER INC-202400106063$PFIZER$$66$YR$$F$Y$$$20240821$$HP$CA$CA
242326181$24232618$1$I$$20240816$20240821$20240821$EXP$$US-PFIZER INC-PV202400107921$PFIZER$$69$YR$$F$Y$$$20240821$$HP$US$US
242326194$24232619$4$F$20240101$20240906$20240821$20240911$EXP$$CA-PFIZER INC-202400239086$PFIZER$$46$YR$$F$Y$$$20240911$$HP$CA$CA
242326201$24232620$1$I$20240101$20240819$20240821$20240821$EXP$$US-PFIZER INC-PV202400108149$PFIZER$$62$YR$$M$Y$$$20240821$$HP$US$US
242326211$24232621$1$I$20240819$20240819$20240821$20240821$EXP$$AR-PFIZER INC-202400240066$PFIZER$$83$YR$$M$Y$$$20240821$$CN$AR$AR
242326221$24232622$1$I$$20240820$20240821$20240821$EXP$$GB-PFIZER INC-202400239902$PFIZER$$$$$$Y$$$20240821$$CN$GB$GB
242326231$24232623$1$I$$20240819$20240821$20240821$EXP$$US-PFIZER INC-PV202400108382$PFIZER$$65$YR$$M$Y$$$20240821$$HP$US$US
242326241$24232624$1$I$$20240816$20240821$20240821$EXP$$US-PFIZER INC-202400238592$PFIZER$$75$YR$$F$Y$$$20240821$$CN$US$US
242326251$24232625$1$I$20240701$20240820$20240821$20240821$EXP$$JP-PFIZER INC-PV202400108597$PFIZER$$86$YR$$M$Y$$$20240821$$MD$JP$JP
242326261$24232626$1$I$$20240816$20240821$20240821$EXP$$BR-PFIZER INC-PV202400107911$PFIZER$$$$$M$Y$$$20240821$$HP$BR$BR
242326272$24232627$2$F$20240816$20240921$20240821$20240923$EXP$$CA-PFIZER INC-202400227960$PFIZER$$39$YR$$F$Y$$$20240923$$MD$CA$CA
242326281$24232628$1$I$$20240820$20240821$20240821$EXP$$US-PFIZER INC-PV202400108810$PFIZER$$88$YR$$M$Y$$$20240821$$CN$US$US
242326292$24232629$2$F$20240528$20240903$20240821$20240905$EXP$$US-PFIZER INC-PV202400081271$PFIZER$$47$YR$$F$Y$51.7$KG$20240905$$HP$US$US
242326301$24232630$1$I$20240731$20240819$20240821$20240821$EXP$$US-PFIZER INC-202400239779$PFIZER$$91$YR$$F$Y$$$20240821$$CN$US$US
242326311$24232631$1$I$20221007$20240820$20240821$20240821$EXP$$CA-PFIZER INC-202400240095$PFIZER$$85$YR$$F$Y$$$20240821$$CN$CA$CA
242326322$24232632$2$F$20240806$20240827$20240821$20240901$EXP$$BR-PFIZER INC-202400238270$PFIZER$$62$YR$$M$Y$60.9$KG$20240901$$HP$BR$BR
242326332$24232633$2$F$20240813$20240912$20240821$20240917$EXP$LU-ALMPS-202404295$LU-PFIZER INC-202400238852$PFIZER$$61$YR$$F$Y$59$KG$20240917$$PH$LU$LU
242326341$24232634$1$I$$20240819$20240821$20240821$EXP$$US-PFIZER INC-202400239680$PFIZER$$62$YR$$F$Y$$$20240821$$CN$US$US
242326351$24232635$1$I$20240701$20240819$20240821$20240821$EXP$$GB-PFIZER INC-202400239309$PFIZER$$54$YR$$F$Y$$$20240821$$CN$GB$GB
242326361$24232636$1$I$$20240820$20240821$20240821$EXP$$US-PFIZER INC-202400240201$PFIZER$$82$YR$$F$Y$$$20240821$$CN$US$US
242326371$24232637$1$I$20240802$20240819$20240821$20240821$EXP$$CN-PFIZER INC-PV202400107983$PFIZER$$83$YR$$F$Y$55$KG$20240821$$HP$CN$CN
242326381$24232638$1$I$20230403$20240123$20240821$20240821$PER$$US-UCBSA-2024003962$UCB$$6$YR$$F$Y$$$20240821$$CN$US$US
242326391$24232639$1$I$$20240118$20240821$20240821$PER$$US-UCBSA-2024003403$UCB$$$$$$Y$$$20240821$$MD$US$US
242326401$24232640$1$I$20230609$20240123$20240821$20240821$PER$$US-UCBSA-2024003963$UCB$$$$C$M$Y$$$20240821$$CN$US$US
242326411$24232641$1$I$20231127$20240129$20240821$20240821$PER$$US-UCBSA-2024004939$UCB$$$$$F$Y$$$20240821$$CN$US$US
242326421$24232642$1$I$$20240129$20240821$20240821$PER$$US-UCBSA-2024004880$UCB$$$$$$Y$$$20240821$$MD$US$US
242326431$24232643$1$I$$20240205$20240821$20240821$PER$$US-UCBSA-2024006070$UCB$$$$$F$Y$$$20240821$$MD$US$US
242326441$24232644$1$I$$20240220$20240821$20240821$PER$$US-UCBSA-2024008881$UCB$$$$C$$Y$$$20240821$$MD$US$US
242326451$24232645$1$I$$20240220$20240821$20240821$PER$$US-UCBSA-2024008850$UCB$$$$C$$Y$$$20240821$$MD$US$US
242326461$24232646$1$I$$20240220$20240821$20240821$PER$$US-UCBSA-2024009080$UCB$$$$$F$Y$$$20240821$$MD$US$US
242326471$24232647$1$I$$20240312$20240821$20240821$PER$$US-UCBSA-2024012676$UCB$$$$$$Y$$$20240821$$MD$US$US
242326481$24232648$1$I$$20230922$20240821$20240821$PER$$US-UCBSA-2023047099$UCB$$$$$F$Y$$$20240821$$CN$US$US
242326491$24232649$1$I$$20231016$20240821$20240821$PER$$US-UCBSA-2023050181$UCB$$$$$$Y$$$20240821$$CN$US$US
242326501$24232650$1$I$$20231016$20240821$20240821$PER$$US-UCBSA-2023050174$UCB$$$$$$Y$$$20240821$$MD$US$US
242326511$24232651$1$I$$20231111$20240821$20240821$PER$$US-UCBSA-2023054844$UCB$$11$YR$$F$Y$$$20240821$$CN$US$US
242326521$24232652$1$I$$20231212$20240821$20240821$PER$$US-UCBSA-2023059096$UCB$$9$MON$$M$Y$$$20240821$$MD$US$US
242326531$24232653$1$I$$20240319$20240821$20240821$PER$$US-UCBSA-2024014196$UCB$$$$$F$Y$$$20240821$$MD$US$US
242326541$24232654$1$I$$20240408$20240821$20240821$PER$$US-UCBSA-2024017273$UCB$$35$YR$$F$Y$$$20240821$$MD$US$US
242326551$24232655$1$I$$20240507$20240821$20240821$PER$$US-UCBSA-2024023361$UCB$$$$$M$Y$$$20240821$$MD$US$US
242326561$24232656$1$I$$20240513$20240821$20240821$PER$$US-UCBSA-2024024262$UCB$$$$$M$Y$$$20240821$$MD$US$US
242326571$24232657$1$I$$20240531$20240821$20240821$PER$$US-UCBSA-2024027983$UCB$$40$YR$$F$Y$$$20240821$$MD$US$US
242326581$24232658$1$I$$20240613$20240821$20240821$PER$$US-UCBSA-2024030609$UCB$$$$$M$Y$$$20240821$$MD$US$US
242326591$24232659$1$I$$20240621$20240821$20240821$PER$$US-UCBSA-2024032311$UCB$$$$$M$Y$$$20240821$$HP$US$US
242326601$24232660$1$I$$20240819$20240821$20240821$PER$$NVSC2024US168375$NOVARTIS$$$$$M$Y$$$20240821$$HP$US$US
242326612$24232661$2$F$$20240820$20240821$20240822$EXP$$CA-LUNDBECK-DKLU4003186$LUNDBECK$$$$$$Y$$$20240822$$HP$CA$CA
242326621$24232662$1$I$20240101$20240328$20240821$20240821$PER$$US-UCBSA-2024009034$UCB$$$$$F$Y$22.9$KG$20240821$$MD$US$US
242326631$24232663$1$I$$20240611$20240821$20240821$PER$$US-UCBSA-2024029919$UCB$$$$$$Y$$$20240821$$MD$US$US
242326651$24232665$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57337$$FDA-CTU$$64$YR$$F$N$$$20240820$N$$US$
242326671$24232667$1$I$20231120$20240820$20240820$20240820$DIR$715137$$FDA-CTU$$70$YR$$F$N$63$KG$20240820$Y$CN$US$
242326681$24232668$1$I$20240130$20240820$20240820$20240820$DIR$715191$$FDA-CTU$$29$YR$$M$N$72$KG$20240820$Y$CN$US$
242326701$24232670$1$I$20240701$20240820$20240820$20240820$DIR$715162$$FDA-CTU$$84$YR$$F$N$29.38$KG$20240820$N$PH$US$
242326711$24232671$1$I$20240815$20240820$20240820$20240820$DIR$715206$$FDA-CTU$$57$YR$$F$N$67.5$KG$20240820$N$CN$US$
242326721$24232672$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57362$$FDA-CTU$$62$YR$$F$N$$$20240820$N$$US$
242326741$24232674$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57352$$FDA-CTU$$74$YR$$M$N$$$20240820$N$$US$
242326771$24232677$1$I$20240801$20240820$20240820$20240820$DIR$715151$$FDA-CTU$$65$YR$$F$N$$$20240820$N$PH$US$
242326791$24232679$1$I$$20240125$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430159$RANBAXY$$$$$$Y$$$20240821$$PH$US$US
242326801$24232680$1$I$$20240813$20240821$20240821$EXP$$CA-APOTEX-2024AP009383$APOTEX$$74$YR$$F$Y$63.946$KG$20240821$$CN$CA$CA
242326811$24232681$1$I$$20240131$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-431157$RANBAXY$$$$A$F$Y$$$20240821$$PH$US$US
242326821$24232682$1$I$$20240129$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430822$RANBAXY$$$$$$Y$$$20240821$$CN$US$US
242326831$24232683$1$I$$20240418$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-443336$RANBAXY$$$$E$M$Y$$$20240821$$HP$US$US
242326841$24232684$1$I$$20240522$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449588$RANBAXY$$$$$M$Y$$$20240821$$CN$US$US
242326851$24232685$1$I$$20240425$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-444841$RANBAXY$$$$E$M$Y$$$20240821$$HP$US$US
242326861$24232686$1$I$$20240320$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439492$RANBAXY$$$$A$M$Y$$$20240821$$CN$US$US
242326871$24232687$1$I$20240404$20240404$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441443$RANBAXY$$56$YR$A$M$Y$$$20240821$$CN$US$US
242326881$24232688$1$I$$20240401$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440559$RANBAXY$$$$A$M$Y$$$20240821$$CN$US$US
242326891$24232689$1$I$$20240401$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441110$RANBAXY$$$$A$M$Y$$$20240821$$CN$US$US
242326911$24232691$1$I$$20240419$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-444125$RANBAXY$$$$$$Y$$$20240821$$MD$US$US
242326921$24232692$1$I$$20240123$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430101$RANBAXY$$$$$F$Y$$$20240821$$CN$US$US
242326931$24232693$1$I$$20240423$20240821$20240821$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-444422$RANBAXY$$$$A$M$Y$$$20240821$$CN$US$US
242326942$24232694$2$F$20190101$20240830$20240821$20240830$PER$$US-ALXN-202408USA000388US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242326951$24232695$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164413$AMGEN$$$$$F$Y$$$20240821$$MD$US$US
242326961$24232696$1$I$$20240807$20240821$20240821$EXP$$JP-INFO-20240240$INFORLIFE$Shinohara K, Itoi S, Nakamura S, Miyazaki Y, Mutoh Y, Hagiwara S., et al. Micafungin-breakthrough Coniochaeta hoffmannii (Lecythophora hoffmannii) fungemia following cord blood transplant in a patient with acute myeloid leukemia successfully treated with voriconazole. Journal of Infection and Chemotherapy. 2024;30(9):934-7. DOI:10.1016/j.jiac.2024.02.011.$48$YR$A$F$Y$$$20240808$$MD$JP$
242326982$24232698$2$F$$20240920$20240821$20240920$30DAY$$US-PFIZER INC-202400237741$PFIZER$$15$YR$$F$Y$$$20240920$$CN$US$US
242326992$24232699$2$F$20240813$20240920$20240821$20240920$30DAY$$US-PFIZER INC-202400237969$PFIZER$$11$YR$$M$Y$$$20240920$$CN$US$US
242327002$24232700$2$F$$20240920$20240821$20240920$30DAY$$US-PFIZER INC-202400237733$PFIZER$$13$YR$$F$Y$$$20240920$$CN$US$US
242327032$24232703$2$F$20240802$20240821$20240821$20240830$EXP$$IQ-MYLANLABS-2024M1077218$MYLAN$$59$YR$$F$Y$160$KG$20240830$$MD$IQ$IQ
242327052$24232705$2$F$$20240823$20240821$20240920$PER$$US-Eisai-EC-2024-170129$EISAI$$$$$M$Y$$$20240920$$MD$US$US
242327061$24232706$1$I$20240101$20240712$20240821$20240821$PER$$US-Eisai-EC-2024-170753$EISAI$$75$YR$E$F$Y$$$20240821$$HP$US$US
242327072$24232707$2$F$$20240819$20240821$20240903$PER$$US-AMGEN-USASP2024165423$AMGEN$$84$YR$E$F$Y$$$20240902$$CN$US$US
242327081$24232708$1$I$$20240814$20240821$20240821$EXP$$US-009507513-2408USA005204$MERCK$Moore C, Naraine I, Zhang T.. Complete remission following pembrolizumab in a man with mCRPC with both microsatellite instability and BRCA2 mutation. The oncologist. 2024;29:716-720$81$YR$$M$Y$$$20240821$$HP$US$US
242327091$24232709$1$I$20240801$20240820$20240820$20240820$DIR$715058$$FDA-CTU$$64$YR$$M$N$126$KG$20240820$N$MD$US$
242327101$24232710$1$I$$20240813$20240821$20240821$EXP$$GB-EMD Serono-2024044169$EMD SERONO INC$$$$E$F$Y$$$20240821$$MD$GB$GB
242327113$24232711$3$F$$20240925$20240821$20240927$30DAY$$US-PFIZER INC-202400237205$PFIZER$$15$YR$$M$Y$53.52$KG$20240927$$CN$US$US
242327121$24232712$1$I$20240101$20240812$20240821$20240821$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00880$CATALYST PHARMA$$$$$F$Y$136.05$KG$20240821$$CN$US$US
242327142$24232714$2$F$$20240816$20240821$20240823$30DAY$$US-PFIZER INC-202400237310$PFIZER$$12$YR$$M$Y$24.95$KG$20240823$$CN$US$US
242327152$24232715$2$F$$20240921$20240821$20240923$30DAY$$US-PFIZER INC-PV202300169467$PFIZER$$77$YR$$F$Y$$$20240923$$CN$US$US
242327161$24232716$1$I$$20240814$20240821$20240821$30DAY$$US-PFIZER INC-202400237312$PFIZER$$14$YR$$M$Y$$$20240821$$CN$US$US
242327171$24232717$1$I$20170201$20240812$20240821$20240821$EXP$FR-AFSSAPS-TO20171521$FR-SA-2024SA242421$SANOFI AVENTIS$$26$YR$A$F$Y$70$KG$20240821$$HP$FR$FR
242327181$24232718$1$I$20240808$20240812$20240821$20240821$EXP$$CN-SA-2024SA242639$SANOFI AVENTIS$$61$YR$A$F$Y$70$KG$20240821$$HP$CN$CN
242327191$24232719$1$I$20240819$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011616$ELI LILLY AND CO$$$$$$Y$$$20240821$$CN$US$US
242327201$24232720$1$I$$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011179$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240821$$CN$US$US
242327211$24232721$1$I$$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012736$ELI LILLY AND CO$$$$$M$Y$$$20240821$$CN$US$US
242327221$24232722$1$I$$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010134$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240821$$CN$US$US
242327231$24232723$1$I$20240819$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011597$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240821$$CN$US$US
242327241$24232724$1$I$20240818$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011491$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240821$$CN$US$US
242327252$24232725$2$F$$20240916$20240821$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202408012141$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240917$$CN$US$US
242327261$24232726$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165712$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242327272$24232727$2$F$20240804$20240823$20240821$20240830$PER$$US-AMGEN-USASP2024165409$AMGEN$$72$YR$E$F$Y$$$20240829$$CN$US$US
242327281$24232728$1$I$$20240820$20240821$20240821$EXP$$US-GILEAD-2024-0684809$GILEAD$$72$YR$E$M$Y$$$20240821$$HP$US$US
242327291$24232729$1$I$20240101$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165379$AMGEN$$42$YR$A$F$Y$$$20240821$$HP$US$US
242327301$24232730$1$I$$20240819$20240821$20240821$EXP$$DE-SANDOZ INC.-SDZ2024DE073763$SANDOZ$$$$A$M$Y$$$20240821$$MD$DE$DE
242327311$24232731$1$I$$20240403$20240821$20240821$PER$$US-UCBSA-2024017546$UCB$$$$$$Y$$$20240821$$CN$US$US
242327321$24232732$1$I$$20240403$20240821$20240821$PER$$US-UCBSA-2024016677$UCB$$$$$F$Y$$$20240821$$MD$US$US
242327332$24232733$2$F$$20240813$20240821$20240821$PER$$US-ROCHE-10000056615$ROCHE$$$$$$Y$$$20240821$$CN$US$US
242327341$24232734$1$I$$20240717$20240821$20240821$PER$$US-PHARMOBEDIENT-2024PMTSPO00001$Unknown Manufacturer$$$$$M$Y$$$20240820$$CN$US$US
242327351$24232735$1$I$20240807$20240814$20240821$20240821$PER$$US-ORYZAPHARMA-2024ORYSPO-00009$ORYZA PHARMACEUTICALS$$77$YR$E$F$Y$140$KG$20240821$$CN$US$US
242327362$24232736$2$F$$20240923$20240821$20240924$PER$$US-BIOVITRUM-2024-US-011100$BIOVITRUM$$82$YR$$M$Y$$$20240924$$CN$US$US
242327371$24232737$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130552$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240821$$CN$US$US
242327381$24232738$1$I$$20240816$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131670$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240821$$CN$US$US
242327391$24232739$1$I$20240501$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128764$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$95.25$KG$20240821$$CN$US$US
242327401$24232740$1$I$$20240809$20240821$20240821$PER$$US-LEO Pharma-372731$LEO PHARM$$20$YR$$F$Y$$$20240816$$PH$US$US
242327411$24232741$1$I$$20240411$20240821$20240821$PER$$US-UCBSA-2024018261$UCB$$$$$$Y$$$20240821$$PH$US$US
242327421$24232742$1$I$$20240409$20240821$20240821$PER$$US-UCBSA-2024017689$UCB$$$$$M$Y$$$20240821$$CN$US$US
242327431$24232743$1$I$20240417$20240417$20240821$20240821$PER$$US-UCBSA-2024019738$UCB$$$$$M$Y$$$20240821$$MD$US$US
242327441$24232744$1$I$$20240425$20240821$20240821$PER$$US-UCBSA-2024021337$UCB$$$$$$Y$$$20240821$$MD$US$US
242327451$24232745$1$I$20240503$20240506$20240821$20240821$PER$$US-UCBSA-2024023367$UCB$$90$YR$$F$Y$$$20240821$$CN$US$US
242327461$24232746$1$I$$20240508$20240821$20240821$PER$$US-UCBSA-2024023595$UCB$$$$$$Y$$$20240821$$HP$US$US
242327471$24232747$1$I$$20240510$20240821$20240821$PER$$US-UCBSA-2024023880$UCB$$$$$M$Y$$$20240821$$MD$US$US
242327481$24232748$1$I$20240101$20240510$20240821$20240821$PER$$US-UCBSA-2024024073$UCB$$$$A$M$Y$$$20240821$$CN$US$US
242327491$24232749$1$I$$20240513$20240821$20240821$PER$$US-UCBSA-2024024264$UCB$$$$$$Y$$$20240821$$MD$US$US
242327501$24232750$1$I$20240101$20240514$20240821$20240821$PER$$US-UCBSA-2024020795$UCB$$$$$F$Y$89.36$KG$20240821$$HP$US$US
242327511$24232751$1$I$20240101$20240514$20240821$20240821$PER$$US-UCBSA-2024024567$UCB$$$$$M$Y$$$20240821$$HP$US$US
242327521$24232752$1$I$20240508$20240514$20240821$20240821$PER$$US-UCBSA-2024024575$UCB$$46$YR$$F$Y$$$20240821$$CN$US$US
242327531$24232753$1$I$20240101$20240520$20240821$20240821$PER$$US-UCBSA-2024025846$UCB$$$$$M$Y$$$20240821$$HP$US$US
242327541$24232754$1$I$$20240531$20240821$20240821$PER$$US-UCBSA-2024028011$UCB$$$$$F$Y$$$20240821$$HP$US$US
242327551$24232755$1$I$20240513$20240607$20240821$20240821$PER$$US-UCBSA-2024024263$UCB$$86$YR$$M$Y$$$20240821$$MD$US$US
242327561$24232756$1$I$$20240610$20240821$20240821$PER$$US-UCBSA-2024030180$UCB$$$$$M$Y$80$KG$20240821$$HP$US$US
242327571$24232757$1$I$$20240614$20240821$20240821$PER$$US-UCBSA-2024031435$UCB$$$$$$Y$$$20240821$$HP$US$US
242327581$24232758$1$I$20240101$20240621$20240821$20240821$PER$$US-UCBSA-2024032079$UCB$$$$A$F$Y$$$20240821$$HP$US$US
242327591$24232759$1$I$$20240624$20240821$20240821$PER$$US-UCBSA-2024032705$UCB$$$$$F$Y$$$20240821$$MD$US$US
242327601$24232760$1$I$$20240624$20240821$20240821$PER$$US-UCBSA-2024032285$UCB$$$$$F$Y$$$20240821$$MD$US$US
242327611$24232761$1$I$20240101$20240719$20240821$20240821$PER$$US-UCBSA-2024032896$UCB$$61$YR$$F$Y$$$20240821$$CN$US$US
242327621$24232762$1$I$20240101$20240718$20240821$20240821$PER$$US-UCBSA-2024030971$UCB$$$$$F$Y$$$20240821$$HP$US$US
242327631$24232763$1$I$20240501$20240719$20240821$20240821$PER$$US-UCBSA-2024026691$UCB$$31$YR$$F$Y$$$20240821$$HP$US$US
242327641$24232764$1$I$20240811$20240814$20240821$20240821$EXP$$CN-PURDUE-USA-2024-0311446$PURDUE$$76$YR$$M$Y$65$KG$20240821$$HP$CN$CN
242327661$24232766$1$I$20240101$20240814$20240821$20240821$EXP$$US-SA-2024SA243432$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240821$$CN$US$US
242327671$24232767$1$I$$20240816$20240821$20240821$EXP$$NVSC2024CN168362$NOVARTIS$$$$$F$Y$$$20240821$$MD$CN$CN
242327681$24232768$1$I$$20240819$20240821$20240821$EXP$$NVSC2024CA168176$NOVARTIS$$46$YR$$M$Y$$$20240821$$HP$CA$CA
242327691$24232769$1$I$$20240818$20240821$20240821$EXP$$US-PURDUE PHARMA-USA-2024-0311432$PURDUE$$43$YR$$M$Y$$$20240821$$CN$US$US
242327701$24232770$1$I$20230501$20240817$20240821$20240821$EXP$$US-PURDUE PHARMA-USA-2024-0311437$PURDUE$$34$YR$$F$Y$$$20240821$$CN$US$US
242327711$24232771$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165711$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242327721$24232772$1$I$$20240811$20240821$20240821$EXP$$FR-AMGEN-FRASP2024161462$AMGEN$Seve P.; Lequain H.; Streichenberger N. et al.. Granulomatous myositis: characteristics and outcome from a monocentric retrospective cohort study. Neuromuscular Disorders. 2024;42:5-13$$$$$Y$$$20240821$$HP$FR$FR
242327731$24232773$1$I$$20240813$20240821$20240821$EXP$$IN-ROCHE-10000056752$ROCHE$$$$A$F$Y$$$20240821$$MD$IN$IN
242327741$24232774$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57424$$FDA-CTU$$69$YR$$F$N$$$20240820$N$$US$
242327751$24232775$1$I$20240329$20240718$20240821$20240821$DIR$FDA-CDER-CTU-2024-57582$$FDA-CTU$$62$YR$$M$N$$$20240718$N$HP$US$
242327761$24232776$1$I$$20240808$20240820$20240820$DIR$FDA-CDER-CTU-2024-57201$$FDA-CTU$$$$$M$N$$$20240808$N$HP$US$
242327803$24232780$3$F$$20240921$20240821$20240923$30DAY$$US-PFIZER INC-202400238557$PFIZER$$5$YR$$M$Y$14.51$KG$20240923$$HP$US$US
242327813$24232781$3$F$20240724$20240925$20240821$20240927$EXP$$US-PFIZER INC-202400237780$PFIZER$$14$YR$$M$Y$113.4$KG$20240927$$MD$US$US
242327821$24232782$1$I$$20240816$20240821$20240821$30DAY$$CO-PFIZER INC-PV202400107854$PFIZER$$$$$$Y$$$20240821$$CN$CO$CO
242327831$24232783$1$I$$20240817$20240821$20240821$PER$$US-PURDUE PHARMA-USA-2024-0311431$PURDUE$$$$$M$Y$$$20240821$$CN$US$US
242327841$24232784$1$I$20240812$20240820$20240820$20240820$DIR$715207$$FDA-CTU$$26$YR$$UNK$N$63.9$KG$20240820$N$$US$
242327851$24232785$1$I$$20240817$20240821$20240821$PER$$US-PURDUE PHARMA-USA-2024-0311436$PURDUE$$37$YR$$F$Y$$$20240821$$CN$US$US
242327861$24232786$1$I$$20240818$20240821$20240821$PER$$US-PURDUE PHARMA-USA-2024-0311429$PURDUE$$$$$$Y$$$20240821$$CN$US$US
242327871$24232787$1$I$$20240817$20240821$20240821$PER$$US-PURDUE PHARMA-USA-2024-0311435$PURDUE$$$$$M$Y$$$20240821$$CN$US$US
242327881$24232788$1$I$$20240817$20240821$20240821$PER$$US-PURDUE PHARMA-USA-2024-0311430$PURDUE$$35$YR$$M$Y$$$20240821$$CN$US$US
242327911$24232791$1$I$20240603$20240815$20240821$20240821$EXP$CH-SM-2024-13974$CH-SA-2024SA246043$SANOFI AVENTIS$$79$YR$E$M$Y$61$KG$20240821$$PH$CH$CH
242327921$24232792$1$I$$20240817$20240821$20240821$PER$$US-ABBVIE-5886730$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242327942$24232794$2$F$20240813$20240815$20240821$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130898$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240829$$HP$US$US
242327951$24232795$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132022$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240821$$CN$US$US
242327961$24232796$1$I$20240101$20240731$20240821$20240821$PER$$US-Changzhou Pharmaceutical Factory-2160675$CHANGZHOU PHARMACEUTICAL FACTORY$$68$YR$$M$Y$136.36$KG$20240821$$$US$US
242327972$24232797$2$F$20240801$20240823$20240821$20240827$PER$$US-AMGEN-USASP2024164667$AMGEN$$65$YR$E$F$Y$$$20240827$$CN$US$US
242327982$24232798$2$F$$20240826$20240821$20240828$PER$$US-AMGEN-USASP2024165697$AMGEN$$$$$F$Y$$$20240828$$MD$US$US
242327991$24232799$1$I$20240703$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128804$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$66.68$KG$20240821$$HP$US$US
242328001$24232800$1$I$$20240820$20240821$20240821$PER$$US-HALEON-2192944$Haleon PLC$$68$YR$$F$Y$$$20240821$$CN$US$US
242328012$24232801$2$F$$20240827$20240821$20240905$EXP$$US-TEVA-VS-3234483$TEVA$Navari Y, Chinnappan J, Dawood T, Marcus H. WHEN RHYTHM CORRECTION TURNS RISKY: RARE RIGHT-SIDED HAEMORRHAGIC PLEURAL EFFUSION POST MAZE PROCEDURE. Eur-J-Case-Rep-Intern-Med 2024; 11 (7): 1-3.; Navari Y, Chinnappan J, Dawood T, Marcus H. WHEN RHYTHM CORRECTION TURNS RISKY: RARE RIGHT-SIDED HAEMORRHAGIC PLEURAL EFFUSION POST MAZE PROCEDURE. Eur-J-Case-Rep-Intern-Med 2024; 11 (7): 1-3.$54$YR$$F$Y$$$20240905$$HP$US$US
242328021$24232802$1$I$20240813$20240820$20240820$20240820$DIR$715204$$FDA-CTU$$43$YR$$UNK$N$59.3$KG$20240820$N$$US$
242328031$24232803$1$I$$20240806$20240821$20240821$EXP$$CN-RISINGPHARMA-CN-2024RISLIT00287$RISING PHARMACEUTICALS$Liqin Zhang.Cardiac Arrest Due to Capecitabine Toxicosis Treated With ECMO and CRRT: A Case Report.Critical Care Nurse.01-AUG-2024;44(4):57-62$58$YR$A$M$Y$$$20240821$$HP$CN$CN
242328042$24232804$2$F$$20240828$20240821$20240829$EXP$AU-MLMSERVICE-20240812-PI159359-00306-1$AU-SA-2024SA247518$SANOFI AVENTIS$Montarello NL, Irvine I, Warner V, Hare J, Kaye D, Cloud GC.. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report.. BMC neurology.. 2024;24(1):277$51$YR$A$F$Y$$$20240829$$MD$AU$AU
242328051$24232805$1$I$$20240815$20240821$20240821$EXP$$US-ROCHE-10000059056$ROCHE$Liao A, Fajoles-Vasseneix C, Rali A, Ward L, Fernandes A, Patel P, et al. Visual Morbidity and Outcomes of Scleritis Associated with Intraocular Inflammation Compared to Isolated Scleritis. Ocular Immunology and Inflammation. 2024-Jan;32 (6):947-954. doi:10.1080/09273948.2022.2164726.$$$$F$Y$$$20240821$$MD$US$US
242328061$24232806$1$I$$20240816$20240821$20240821$EXP$$US-TAKEDA-2024TUS083035$TAKEDA$$47$YR$$F$Y$$$20240821$$HP$US$US
242328071$24232807$1$I$$20240814$20240821$20240821$EXP$$US-ROCHE-10000057959$ROCHE$$89$YR$E$F$Y$$$20240821$$CN$US$US
242328081$24232808$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57411$$FDA-CTU$$76$YR$$M$N$$$20240820$N$$US$
242328091$24232809$1$I$$20240815$20240821$20240821$PER$$US-PFIZER INC-PV202400100319$PFIZER$$13$YR$$M$Y$$$20240821$$HP$US$US
242328104$24232810$4$F$20240101$20240906$20240821$20240911$PER$$US-PFIZER INC-202400095713$PFIZER$$13$YR$$M$Y$31.75$KG$20240911$$CN$US$US
242328111$24232811$1$I$20240711$20240711$20240821$20240821$EXP$$CO-JNJFOC-20240852241$JOHNSON AND JOHNSON$$59$YR$A$F$Y$78$KG$20240821$$HP$CO$CO
242328122$24232812$2$F$$20240909$20240821$20240912$EXP$$US-JNJFOC-20240846483$JOHNSON AND JOHNSON$$46$YR$A$F$Y$102.6$KG$20240913$$HP$US$US
242328131$24232813$1$I$20240708$20240815$20240821$20240821$EXP$$CA-JNJFOC-20240845083$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240821$$HP$CA$CA
242328142$24232814$2$F$$20240827$20240821$20240906$EXP$$US-TEVA-VS-3234477$TEVA$Sreekumar S, Rubin R. A Case of Pulmonary Mucormycosis Leading to Non-hepatic Hyperammonemia. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).; Sreekumar S, Rubin R. A Case of Pulmonary Mucormycosis Leading to Non-hepatic Hyperammonemia. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$31$YR$$F$Y$$$20240906$$HP$US$US
242328151$24232815$1$I$20230521$20240816$20240821$20240821$EXP$FR-AFSSAPS-LM2024000450$FR-LUNDBECK-DKLU4003194$LUNDBECK$$$$$$Y$$$20240821$$MD$FR$FR
242328161$24232816$1$I$20240812$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024162474$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242328171$24232817$1$I$20240815$20240820$20240820$20240820$DIR$715198$$FDA-CTU$$35$YR$$UNK$N$67.6$KG$20240820$N$$US$
242328181$24232818$1$I$$20240819$20240821$20240821$PER$$US-HALEON-2192895$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242328191$24232819$1$I$$20240726$20240821$20240821$PER$$US-TEVA-VS-3228199$TEVA$$43$YR$$M$Y$$$20240821$$CN$US$US
242328201$24232820$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131697$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$66.22$KG$20240821$$CN$US$US
242328211$24232821$1$I$$20240814$20240821$20240821$EXP$$IN-MYLANLABS-2024M1076998$MYLAN$Nimi G, Kirubakaran KR, John J, Kumar P. Disseminated Protozoa Zopfii Infection in Liver transplant Recipient. J-Clin-Exp-Hepatol 2024; 14 (Suppl.).$62$YR$$M$Y$$$20240821$$HP$IN$IN
242328222$24232822$2$F$$20240823$20240821$20240906$PER$$US-RISINGPHARMA-US-2024RISSPO00284$RISING PHARMACEUTICALS$$57$YR$A$F$Y$200$KG$20240906$$CN$US$US
242328242$24232824$2$F$20240819$20240819$20240821$20240824$EXP$$CA-TAKEDA-2024TUS083936$TAKEDA$$91$YR$$F$Y$$$20240824$$MD$CA$CA
242328251$24232825$1$I$$20240819$20240821$20240821$EXP$$US-JNJFOC-20240849472$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$MD$US$US
242328262$24232826$2$F$$20240920$20240821$20240920$PER$$US-PFIZER INC-202400239391$PFIZER$$$$$$Y$$$20240920$$CN$US$US
242328291$24232829$1$I$$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-087485-2024$RECKITT BENCKISER$$86$YR$$M$Y$85.45$KG$20240821$$CN$US$US
242328301$24232830$1$I$20240511$20240814$20240821$20240821$DIR$FDA-CDER-CTU-2024-57583$$FDA-CTU$$56$YR$$F$N$$$20240814$N$HP$US$
242328311$24232831$1$I$$20240730$20240821$20240821$PER$$US-AstraZeneca-2024A141523$ASTRAZENECA$$$$$$Y$$$20240821$$MD$US$
242328321$24232832$1$I$$20240808$20240821$20240821$PER$$US-AstraZeneca-2024A145171$ASTRAZENECA$$$$$F$Y$$$20240821$$MD$US$
242328331$24232833$1$I$$20240715$20240821$20240821$PER$$US-AstraZeneca-2024A145235$ASTRAZENECA$$$$A$F$Y$$$20240821$$MD$US$
242328341$24232834$1$I$$20240722$20240821$20240821$PER$$US-AstraZeneca-2024A149777$ASTRAZENECA$$$$$F$Y$$$20240821$$HP$US$
242328352$24232835$2$F$$20240809$20240821$20240824$PER$$US-AstraZeneca-2024A156571$ASTRAZENECA$$75$YR$$F$Y$$$20240824$$HP$US$
242328361$24232836$1$I$$20240710$20240821$20240821$PER$$US-AstraZeneca-2024A158660$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242328371$24232837$1$I$$20240719$20240821$20240821$PER$$US-AstraZeneca-2024A165738$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
242328381$24232838$1$I$$20240801$20240821$20240821$PER$$US-AstraZeneca-2024A175917$ASTRAZENECA$$$$$$Y$$$20240821$$MD$US$
242328391$24232839$1$I$$20230623$20240821$20240821$EXP$$IN-AstraZeneca-2023A149745$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$IN$
242328401$24232840$1$I$$20240807$20240821$20240821$PER$$US-AstraZeneca-2024A181224$ASTRAZENECA$$$$$$Y$$$20240821$$PH$US$
242328411$24232841$1$I$20240101$20240806$20240821$20240821$PER$$US-AstraZeneca-2024A181854$ASTRAZENECA$$631$MON$$F$Y$$$20240821$$CN$US$
242328421$24232842$1$I$$20240809$20240821$20240821$PER$$US-AstraZeneca-2024A182061$ASTRAZENECA$$$$$$Y$$$20240821$$MD$US$
242328431$24232843$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A190082$ASTRAZENECA$$53$YR$$M$Y$97.5$KG$20240821$$CN$US$
242328441$24232844$1$I$$20240811$20240821$20240821$PER$$US-AstraZeneca-2024A184154$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
242328451$24232845$1$I$$20240812$20240821$20240821$PER$$US-AstraZeneca-2024A184300$ASTRAZENECA$$$$$$Y$$$20240821$$MD$US$
242328461$24232846$1$I$$20240812$20240821$20240821$PER$$US-AstraZeneca-2024A185359$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
242328471$24232847$1$I$$20240812$20240821$20240821$EXP$$GB-ROCHE-10000057907$ROCHE$Wilson H, MacDonald D, Bryce K. Clearance of Hepatitis C Virus following Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma: Case Report. Case Reports in Gastroenterology. 2024-Jun-27;18 (1):347-351. doi:10.1159/000539646.$42$YR$A$M$Y$$$20240821$$HP$GB$GB
242328481$24232848$1$I$20240803$20240820$20240821$20240821$EXP$GB-MHRA-MED-202408191644485990-RGJVL$GB-MYLANLABS-2024M1077399$MYLAN$$91$YR$$F$Y$27$KG$20240821$$HP$GB$GB
242328491$24232849$1$I$20240626$20240816$20240821$20240821$EXP$GB-MHRA-MED-202408151421501400-KNLRT$GB-MYLANLABS-2024M1076743$MYLAN$$37$YR$$F$Y$$$20240821$$MD$GB$GB
242328501$24232850$1$I$20230216$20240816$20240821$20240821$EXP$$US-MYLANLABS-2024M1077221$MYLAN$$25$YR$$F$Y$$$20240821$$MD$US$US
242328511$24232851$1$I$$20240814$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129318$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240821$$HP$US$US
242328522$24232852$2$F$20230711$20240906$20240821$20240911$EXP$$GB-ABBVIE-5885448$ABBVIE$$57$YR$$M$Y$$$20240911$$MD$GB$GB
242328531$24232853$1$I$$20240819$20240821$20240821$PER$$US-TAKEDA-2024TUS083753$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
242328541$24232854$1$I$$20240809$20240821$20240821$EXP$$AU-OTSUKA-2024_022600$OTSUKA$$$$$$Y$$$20240821$$MD$AU$AU
242328551$24232855$1$I$20240724$20240815$20240821$20240821$EXP$FR-AFSSAPS-LY2024001234$FR-MYLANLABS-2024M1076139$MYLAN$$40$YR$$M$Y$59$KG$20240821$$MD$FR$FR
242328561$24232856$1$I$20201103$20240808$20240821$20240821$EXP$$NVSC2024CN162419$NOVARTIS$$34$YR$$M$Y$60$KG$20240821$$HP$CN$CN
242328571$24232857$1$I$$20240806$20240821$20240821$EXP$$DE-GLANDPHARMA-DE-2024GLNLIT00630$GLAND PHARMA$A Pottharst.Specialized Palliative Care in a 54 y/o pat with RAS G12Cmutated NSCLC in need of high-flow oxygen at dischargement: An ethical and logistic dilemma.Oncology Research and Treatment.OCT-2023;46 (Suppl.):332$56$YR$A$$Y$$$20240821$$HP$DE$DE
242328581$24232858$1$I$$20240815$20240821$20240821$EXP$$CA-MYLANLABS-2024M1076491$MYLAN$$$$$F$Y$$$20240821$$CN$CA$CA
242328591$24232859$1$I$$20240816$20240821$20240821$EXP$$US-TAKEDA-2024TUS060486$TAKEDA$$$$$M$Y$$$20240821$$MD$US$US
242328601$24232860$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024164166$AMGEN$Garcia C. R.; Highsmith K. N.; Knight S. et al.. Single center experience of IDH inhibitors in high-grade gliomas. Journal of Clinical Oncology. 2024;42 (16):e14036$$$$$Y$$$20240821$$MD$US$US
242328611$24232861$1$I$$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-110289-2023$RECKITT BENCKISER$$70$YR$$F$Y$$$20240821$$CN$US$US
242328621$24232862$1$I$20240807$20240820$20240821$20240821$EXP$$CN-ROCHE-10000062273$ROCHE$$7$YR$C$F$Y$27$KG$20240821$$HP$CN$CN
242328631$24232863$1$I$$20240812$20240821$20240821$EXP$$US-TEVA-VS-3233132$TEVA$$$$$M$Y$113.4$KG$20240821$$CN$US$US
242328641$24232864$1$I$$20240820$20240821$20240821$PER$$NVSC2024US169301$NOVARTIS$$$$$M$Y$71$KG$20240821$$CN$US$US
242328651$24232865$1$I$20240812$20240820$20240820$20240820$DIR$715208$$FDA-CTU$$95$YR$$UNK$N$56.2$KG$20240820$N$$US$
242328672$24232867$2$F$20240207$20240821$20240821$20240826$EXP$$JP-PFIZER INC-PV202400021313$PFIZER$$74$YR$$M$Y$$$20240826$$PH$JP$JP
242328691$24232869$1$I$20240722$20240819$20240821$20240821$EXP$$US-PFIZER INC-PV202400098912$PFIZER$$68$YR$$M$Y$$$20240821$$HP$US$US
242328711$24232871$1$I$20240816$20240820$20240820$20240820$DIR$715189$$FDA-CTU$$45$YR$$UNK$N$82.6$KG$20240820$N$$US$
242328742$24232874$2$F$$20240819$20240821$20240826$EXP$$CA-PFIZER INC-202400239352$PFIZER$$85$YR$$F$Y$$$20240826$$HP$CA$CA
242328751$24232875$1$I$20240801$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57340$$FDA-CTU$$65$YR$$F$N$$$20240820$Y$HP$US$
242328761$24232876$1$I$20240815$20240820$20240820$20240820$DIR$715226$$FDA-CTU$$66$YR$$F$N$65.25$KG$20240820$N$CN$US$
242328771$24232877$1$I$$20240816$20240821$20240821$EXP$$US-PFIZER INC-2024SGN03709$PFIZER$$58$YR$$F$Y$$$20240821$$CN$US$US
242328781$24232878$1$I$20240810$20240820$20240820$20240820$DIR$715214$$FDA-CTU$$62$YR$$M$N$70.4$KG$20240820$Y$PH$US$
242328791$24232879$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57349$$FDA-CTU$$$$$M$N$$$20240820$N$HP$US$
242328801$24232880$1$I$20240814$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57332$$FDA-CTU$$55$YR$$F$N$$$20240819$N$HP$US$
242328811$24232881$1$I$20240818$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57390$$FDA-CTU$$51$YR$$M$N$$$20240819$N$HP$US$
242328831$24232883$1$I$$20240724$20240821$20240821$PER$$US-AstraZeneca-2024A169456$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242328841$24232884$1$I$$20230524$20240821$20240821$EXP$$US-AstraZeneca-2023A121572$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242328851$24232885$1$I$$20240812$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008459$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242328861$24232886$1$I$20240815$20240817$20240821$20240821$EXP$GB-MHRA-MED-202408172356121370-JKCPY$GB-MYLANLABS-2024M1076777$MYLAN$$$$$$Y$$$20240821$$CN$GB$GB
242328871$24232887$1$I$$20240816$20240821$20240821$EXP$$DE-EMD Serono-2024044495$EMD SERONO INC$$$$A$F$Y$$$20240821$$CN$DE$DE
242328884$24232888$4$F$20240725$20240917$20240821$20240924$EXP$$NVSC2024CO147149$NOVARTIS$$59$YR$$M$Y$83$KG$20240924$$CN$CO$CO
242328892$24232889$2$F$20220205$20240920$20240821$20240926$EXP$$NVSC2024IT168596$NOVARTIS$$$$A$M$Y$$$20240926$$MD$IT$IT
242328902$24232890$2$F$$20240819$20240821$20240823$EXP$$NVSC2024US168240$NOVARTIS$$$$$M$Y$$$20240823$$CN$US$US
242328911$24232891$1$I$20240801$20240817$20240821$20240821$EXP$$NVSC2024EG167143$NOVARTIS$$22$YR$$F$Y$65$KG$20240821$$CN$EG$EG
242328921$24232892$1$I$20240701$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131970$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240821$$HP$US$US
242328931$24232893$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132540$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240821$$CN$US$US
242328941$24232894$1$I$20240101$20240820$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132238$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240821$$CN$US$US
242328951$24232895$1$I$20240601$20240816$20240821$20240821$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-130914$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240821$$CN$PR$PR
242328961$24232896$1$I$$20240818$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131106$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$72.57$KG$20240821$$CN$US$US
242328971$24232897$1$I$$20240812$20240821$20240821$PER$$US-LEO Pharma-372765$LEO PHARM$$77$YR$$M$Y$88$KG$20240821$$HP$US$US
242328981$24232898$1$I$$20240818$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131142$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$72.12$KG$20240821$$CN$US$US
242329001$24232900$1$I$$20240812$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008456$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242329021$24232902$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57400$$FDA-CTU$$64$YR$$F$N$53.98$KG$20240820$N$$US$
242329031$24232903$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57392$$FDA-CTU$$46$YR$$F$N$86.18$KG$20240820$N$$US$
242329041$24232904$1$I$$20240816$20240820$20240820$DIR$FDA-CDER-CTU-2024-57329$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242329051$24232905$1$I$20240816$20240820$20240820$20240820$DIR$715216$$FDA-CTU$$59$YR$$M$N$80.1$KG$20240820$N$CN$US$
242329061$24232906$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57426$$FDA-CTU$$85$YR$$F$N$63.05$KG$20240820$N$$US$
242329071$24232907$1$I$20240814$20240820$20240820$20240820$DIR$715217$$FDA-CTU$$25$YR$$UNK$N$$$20240820$Y$CN$US$
242329081$24232908$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57440$$FDA-CTU$$65$YR$$F$N$$$20240820$N$$US$
242329091$24232909$1$I$$20240522$20240821$20240821$PER$$US-Dermavant-001187$DERMAVANT SCIENCES$$$$A$M$Y$$$20240820$$HP$US$US
242329101$24232910$1$I$20240809$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165633$AMGEN$$42$YR$A$F$Y$$$20240821$$CN$US$US
242329111$24232911$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57354$$FDA-CTU$$47$YR$$F$N$140.16$KG$20240820$N$$US$
242329121$24232912$1$I$20221130$20240820$20240821$20240821$EXP$$US-UCBSA-2024042375$UCB$$32$YR$$F$Y$$$20240821$$HP$US$US
242329131$24232913$1$I$$20240814$20240821$20240821$PER$$US-ABBVIE-5881582$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242329141$24232914$1$I$$20240813$20240821$20240821$EXP$$CA-JNJFOC-20240645959$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240821$$HP$CA$CA
242329161$24232916$1$I$$20240806$20240821$20240821$EXP$$PT-GLANDPHARMA-PT-2024GLNLIT00637$GLAND PHARMA$Teresa Medeiros.Primary central nervous system lymphoma complicated by cerebral venous sinus thrombosis: a case report.European Journal of Case Reports in Internal Medicine.29-JUL-2023;10(8): 1-5$64$YR$A$F$Y$$$20240821$$HP$PT$PT
242329171$24232917$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57347$$FDA-CTU$$66$YR$$F$N$83.91$KG$20240820$N$$US$
242329182$24232918$2$F$20240801$20240821$20240821$20240829$EXP$$US-Calliditas-2024CAL01239$CALLIDITAS THERAPEUTICS$$87$YR$E$M$Y$90$KG$20240829$$CN$US$US
242329191$24232919$1$I$$20240522$20240821$20240821$PER$$US-Dermavant-001188$DERMAVANT SCIENCES$$$$A$M$Y$$$20240820$$HP$US$US
242329201$24232920$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57355$$FDA-CTU$$63$YR$$F$N$72.57$KG$20240820$N$$US$
242329211$24232921$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024163299$AMGEN$Wainberg Z.A.; Han S.; Lee S. et al.. A randomized study to evaluate etrumadenant based treatment combinations in previously treated metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 2024;42 (16):3508$$$$$Y$$$20240821$$HP$US$US
242329221$24232922$1$I$$20240812$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008445$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242329231$24232923$1$I$$20240520$20240821$20240821$PER$$US-Dermavant-001189$DERMAVANT SCIENCES$$$$A$F$Y$$$20240813$$HP$US$US
242329241$24232924$1$I$$20240819$20240821$20240821$PER$$US-GILEAD-2024-0684709$GILEAD$$31$YR$A$M$Y$$$20240821$$CN$US$US
242329251$24232925$1$I$$20240806$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124572$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240821$$HP$US$US
242329261$24232926$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131726$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240821$$CN$US$US
242329271$24232927$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131450$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240821$$CN$US$US
242329281$24232928$1$I$$20240529$20240821$20240821$PER$$US-Dermavant-001190$DERMAVANT SCIENCES$$$$$$Y$$$20240813$$HP$US$US
242329291$24232929$1$I$$20240806$20240821$20240821$EXP$$US-GLANDPHARMA-US-2024GLNLIT00641$GLAND PHARMA$B M Nguyen.Iris atrophy following intracameral dexamethasone injection: a report of two pediatric cases. Journal of AAPOS.JUN-2024;28: No. 3$10$YR$C$F$Y$$$20240821$$HP$US$US
242329301$24232930$1$I$$20240529$20240821$20240821$PER$$US-Dermavant-001192$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$CN$US$US
242329313$24232931$3$F$$20240925$20240821$20240930$EXP$$IT-AMGEN-ITASP2024162343$AMGEN$Fontana G.; Gozzoli G. I.; Lini D. et al.. EXPLORING THE SAFETY AND EFFECTIVENESS OF BIOSIMILARS BIOLOGICAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS DURING PREGNANCY. Annals of the Rheumatic Diseases. 2024;83:2133$$$$F$Y$$$20240930$$HP$IT$IT
242329321$24232932$1$I$$20240814$20240821$20240821$EXP$$NVSC2024CA168305$NOVARTIS$$8$YR$$M$Y$$$20240821$$HP$CA$CA
242329332$24232933$2$F$20230903$20240913$20240821$20240926$EXP$$KR-SPECTRUM PHARMACEUTICALS, INC.-KR-2024AST000280$SPECTRUM$$71$YR$$M$Y$54.4$KG$20240926$$MD$KR$KR
242329341$24232934$1$I$$20240816$20240821$20240821$EXP$$FR-SANDOZ INC.-SDZ2024FR073443$SANDOZ$$77$YR$$M$Y$$$20240821$$HP$FR$FR
242329351$24232935$1$I$$20240807$20240821$20240821$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000281$ASSERTIO THERAPEUTICS$$36$YR$$F$Y$$$20240821$$HP$CA$CA
242329362$24232936$2$F$20240731$20240829$20240821$20240903$EXP$$NVSC2024ZA163665$NOVARTIS$$44$YR$$M$Y$145$KG$20240903$$HP$ZA$ZA
242329381$24232938$1$I$20240701$20240814$20240821$20240821$EXP$$US-009507513-2407USA007368$MERCK$$73$YR$$F$Y$$$20240821$$HP$US$US
242329401$24232940$1$I$$20240816$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130101$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240821$$HP$US$US
242329411$24232941$1$I$20240701$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130874$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240821$$HP$US$US
242329422$24232942$2$F$$20240828$20240821$20240906$EXP$$FR-TEVA-VS-3233430$TEVA$Fougerousse A-C, Badaoui A. Omalizumab-induced paradoxical urticaria responsive to dupilumab. Ann-Dermatol-Venereol 2023; 150 302-303.; Fougerousse A-C, Badaoui A. Omalizumab-induced paradoxical urticaria responsive to dupilumab. Ann-Dermatol-Venereol 2023; 150 302-303.$47$YR$$F$Y$$$20240906$$HP$FR$FR
242329432$24232943$2$F$$20240829$20240821$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131797$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240904$$HP$US$US
242329442$24232944$2$F$20200227$20240905$20240821$20240912$EXP$$CA-SANDOZ INC.-NVSC2020CA091789$SANDOZ$$37$YR$$F$Y$$$20240912$$CN$CA$CA
242329451$24232945$1$I$20240101$20240815$20240821$20240821$PER$$US-BIOGEN-2024BI01278636$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
242329462$24232946$2$F$20240816$20240910$20240821$20240913$EXP$$US-BAYER-2024A119434$BAYER$$49$YR$A$M$Y$$$20240913$$CN$US$US
242329474$24232947$4$F$20240815$20240920$20240821$20240924$EXP$$CA-INCYTE CORPORATION-2024IN008317$INCYTE$$$$$$Y$$$20240924$$PH$CA$CA
242329481$24232948$1$I$$20240815$20240821$20240821$EXP$$US-AstraZeneca-2024A186786$ASTRAZENECA$$85$YR$$F$Y$$$20240821$$PH$US$
242329491$24232949$1$I$$20240813$20240821$20240821$EXP$$CA-AstraZeneca-2024A184614$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$CA$
242329501$24232950$1$I$$20230804$20240821$20240821$EXP$$US-AstraZeneca-2023A179707$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242329511$24232951$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A185058$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242329521$24232952$1$I$$20240812$20240821$20240821$EXP$$US-LNK INTERNATIONAL, INC.-2160678$LNK INTERNATIONAL$$$$$F$Y$$$20240821$$$US$US
242329541$24232954$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57326$$FDA-CTU$$49$YR$$F$N$$$20240820$N$$US$
242329551$24232955$1$I$20240811$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57351$$FDA-CTU$$68$YR$$M$N$$$20240820$Y$HP$US$
242329561$24232956$1$I$20240814$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57360$$FDA-CTU$$85$YR$$M$N$$$20240820$Y$HP$US$
242329571$24232957$1$I$$20240724$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012814$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240821$$CN$US$US
242329581$24232958$1$I$20240816$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010772$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240821$$CN$US$US
242329591$24232959$1$I$20240801$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011047$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240821$$CN$US$US
242329601$24232960$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024164156$AMGEN$Bhide S.; Roul P.; England B. et al.. SEX DIFFERENCES IN MORTALITY RATES OF FRAIL PATIENTS WITH RBEUMATOID ARTERITIS. Annals of the Rheumatic Diseases. 2024;83 (SUPP_1):755-756$$$$$Y$$$20240821$$HP$US$US
242329611$24232961$1$I$$20240820$20240821$20240821$PER$$US-ROCHE-10000061533$ROCHE$$47$YR$A$M$Y$$$20240821$$CN$US$US
242329621$24232962$1$I$$20240812$20240821$20240821$EXP$$JO-ROCHE-10000056282$ROCHE$$$$$M$Y$$$20240821$$MD$JO$JO
242329631$24232963$1$I$$20240811$20240821$20240821$EXP$$IT-AMGEN-ITASP2024162367$AMGEN$Fontana G.; Gozzoli G. I.; Lini D. et al.. EXPLORING THE SAFETY AND EFFECTIVENESS OF BIOSIMILARS BIOLOGICAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS DURING PREGNANCY. Annals of the Rheumatic Diseases. 2024;83:2133$$$$F$Y$$$20240821$$HP$IT$IT
242329641$24232964$1$I$$20240806$20240821$20240821$EXP$$IN-GLANDPHARMA-IN-2024GLNLIT00644$GLAND PHARMA$UP Holla.SSA mediated endocardial fibroelastosis treated with dexamethasone and IVIG.Indian Journal of Rheumatology .JAN-2023;18 (Suppl. 2):S358-S359$27$YR$A$F$Y$$$20240821$$HP$IN$IN
242329651$24232965$1$I$$20240812$20240821$20240821$EXP$$CA-BAXTER-2024BAX023093$BAXTER$$66$YR$$M$Y$110$KG$20240821$$HP$CA$CA
242329661$24232966$1$I$$20240812$20240821$20240821$PER$$US-ABBVIE-5879010$ABBVIE$$$$$$Y$$$20240821$$CN$US$US
242329671$24232967$1$I$$20240722$20240821$20240821$PER$$US-FMCRTG-FMC-2407-000899$FRESENIUS MEDICAL CARE$$35$YR$A$F$Y$$$20240821$$HP$US$US
242329681$24232968$1$I$$20240719$20240821$20240821$PER$$US-FMCRTG-FMC-2407-000892$FRESENIUS MEDICAL CARE$$62$YR$A$F$Y$72.5$KG$20240821$$HP$US$US
242329691$24232969$1$I$20240717$20240719$20240821$20240821$PER$$US-FMCRTG-FMC-2407-000873$FRESENIUS MEDICAL CARE$$84$YR$E$F$Y$56$KG$20240821$$HP$US$US
242329701$24232970$1$I$20240621$20240725$20240821$20240821$PER$$US-FMCRTG-FMC-2407-000914$FRESENIUS MEDICAL CARE$$59$YR$A$F$Y$76$KG$20240821$$HP$US$US
242329711$24232971$1$I$$20240722$20240821$20240821$PER$$US-FMCRTG-FMC-2407-000879$FRESENIUS MEDICAL CARE$$77$YR$E$F$Y$76.2$KG$20240821$$CN$US$US
242329721$24232972$1$I$20240101$20240812$20240821$20240821$PER$$US-Eisai-EC-2024-171994$EISAI$$75$YR$E$F$Y$$$20240821$$CN$US$US
242329731$24232973$1$I$$20240719$20240821$20240821$PER$$US-FMCRTG-FMC-2407-000871$FRESENIUS MEDICAL CARE$$$$$$Y$$$20240821$$HP$US$US
242329741$24232974$1$I$$20240718$20240821$20240821$PER$$US-FMCRTG-FMC-2407-000870$FRESENIUS MEDICAL CARE$$74$YR$E$M$Y$$$20240821$$HP$US$US
242329751$24232975$1$I$$20240722$20240821$20240821$PER$$US-FMCRTG-FMC-2407-000880$FRESENIUS MEDICAL CARE$$86$YR$E$F$Y$$$20240821$$HP$US$US
242329761$24232976$1$I$$20240719$20240821$20240821$PER$$US-FMCRTG-FMC-2407-000877$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240821$$CN$US$US
242329771$24232977$1$I$$20240722$20240821$20240821$PER$$US-FMCRTG-FMC-2407-000896$FRESENIUS MEDICAL CARE$$77$YR$E$F$Y$$$20240821$$HP$US$US
242329781$24232978$1$I$$20240720$20240821$20240821$PER$$US-FMCRTG-FMC-2407-000893$FRESENIUS MEDICAL CARE$$67$YR$E$F$Y$76$KG$20240821$$HP$US$US
242329801$24232980$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240839183$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$MD$US$US
242329821$24232982$1$I$$20240819$20240821$20240821$EXP$$CH-ABBVIE-5887365$ABBVIE$Dietrich PL, Meier S, Jeger R. Complete heart block without ventricular escape rhythm during left ventriculography. Cardiovascular Medicine. 2024;27(02):55-7.$80$YR$$M$Y$$$20240821$$MD$CH$CH
242329831$24232983$1$I$20240801$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57444$$FDA-CTU$$87$YR$$M$N$$$20240820$Y$HP$US$
242329841$24232984$1$I$$20240809$20240821$20240821$EXP$$CN-Accord-441303$ACCORD$Wang M, Gao F, Wang X, Guo Y, Zhang H. Pure large-cell neuroendocrine carcinoma of the ovary with a somatic BRCA1 mutation: The first reported case and the review of the literature. SAGE open medical case reports. 2024;12:1-5.$72$YR$E$F$Y$$$20240821$$MD$CN$CN
242329851$24232985$1$I$$20240809$20240821$20240821$EXP$CA-MHPD-E2B_07174998$CA-Accord-441354$ACCORD$$60$YR$A$M$Y$$$20240821$$HP$CA$CA
242329861$24232986$1$I$$20240809$20240821$20240821$EXP$CA-MHPD-E2B_07180200$CA-Accord-441351$ACCORD$$5$YR$C$F$Y$$$20240821$$HP$CA$CA
242329871$24232987$1$I$$20240806$20240821$20240821$EXP$$IN-GLANDPHARMA-IN-2024GLNLIT00645$GLAND PHARMA$Praveen Malavade.Hyper magnesaemia, maternal quadriparesis, and encephalopathy: a case report.Indian Journal of Nephrology.2021;31(1): S57-S58$28$YR$A$F$Y$$$20240821$$HP$IN$IN
242329881$24232988$1$I$20240529$20240717$20240821$20240821$EXP$$JP-SANDOZ INC.-SDZ2024JP073845$SANDOZ$$70$YR$$M$Y$$$20240821$$MD$JP$JP
242329892$24232989$2$F$$20240816$20240821$20240930$PER$$US-LUNDBECK-DKLU4003116$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
242329901$24232990$1$I$20230908$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-109312-2023$RECKITT BENCKISER$$29$YR$$M$Y$127.27$KG$20240821$$CN$US$US
242329911$24232991$1$I$20240801$20240809$20240821$20240821$EXP$GB-MHRA-MED-202408070811079670-GSTDQ$GB-Accord-441206$ACCORD$$68$YR$E$$Y$90$KG$20240821$$CN$GB$GB
242329921$24232992$1$I$$20240809$20240821$20240821$EXP$GB-MHRA-MED-202408091843549660-ZLBWM$GB-Accord-441259$ACCORD$$$$$M$Y$$$20240821$$CN$GB$GB
242329931$24232993$1$I$20240719$20240809$20240821$20240821$EXP$ES-AEMPS-1556169$ES-Accord-441535$ACCORD$$50$YR$A$F$Y$$$20240821$$PH$ES$ES
242329941$24232994$1$I$$20240809$20240821$20240821$EXP$$DE-Accord-441796$ACCORD$Ecker ME, Weckauf H, Tebbe S, Schuppert F. Immune-mediated Gastritis in a Patient with metastatic Lung Cancer due to Therapy with the immune Checkpoint Inhibitor Pembrolizumab - Differences and Similarities in Comparison to endogenous autoimmune Type A Gastritis and a review of literature. (Review). Z-Gastroenterol 2023;61 (10): 1385-1393.$54$YR$$F$Y$$$20240821$$HP$DE$DE
242329951$24232995$1$I$$20240809$20240821$20240821$EXP$$JP-Accord-441308$ACCORD$Kudo H, Shiroshita K, Shiozawa Y, Fujita S, Sakamoto M, Nakamura N, et al. Autopsy case of cardiac mantle cell lymphoma presenting with recurrent pulmonary tumor embolism after chemotherapy. Journal of clinical and experimental hematopathology. 2024.$78$YR$E$M$Y$$$20240821$$MD$JP$JP
242329961$24232996$1$I$$20240809$20240821$20240821$EXP$$IN-Accord-441558$ACCORD$Gupta D, Singh L, Kumar S, Singh K, Mendonca S, Chatterjee T. Rare complications of heart transplant: Autopsy findings. Indian Journal of Pathology and Microbiology. 2024;67(3):624-7. DOI: 10.4103/ijpm.ijpm_690_23.$33$YR$A$M$Y$$$20240821$$MD$IN$IN
242329971$24232997$1$I$$20240809$20240821$20240821$EXP$$JP-Accord-441307$ACCORD$Yoshimura Y, Suwabe T, Miki K, Yokoyama T, Kono K, Kinowaki K, et al. Renal cell carcinoma preceded by a rheumatoid-like paraneoplastic syndrome: A case report. Oncology Letters. 2024;28(4):448.$68$YR$E$M$Y$$$20240821$$MD$JP$JP
242329981$24232998$1$I$20200721$20240809$20240821$20240821$EXP$PL-URPL-1-1923-2020$PL-Accord-441355$ACCORD$$48$YR$A$F$Y$80$KG$20240821$$MD$PL$PL
242330001$24233000$1$I$$20240819$20240821$20240821$PER$$NVSC2024US168282$NOVARTIS$$$$$M$Y$$$20240821$$CN$US$US
242330011$24233001$1$I$20240815$20240815$20240821$20240821$EXP$$CA-LEO Pharma-372801$LEO PHARM$$55$YR$$$Y$$$20240821$$CN$CA$CA
242330021$24233002$1$I$20240820$20240820$20240821$20240821$EXP$$CN-BAYER-2024A120054$BAYER$$56$YR$A$F$Y$$$20240821$$HP$CN$CN
242330032$24233003$2$F$$20240909$20240821$20240916$EXP$$GB-TAKEDA-2024TUS082249$TAKEDA$$$$$M$Y$$$20240916$$CN$GB$GB
242330041$24233004$1$I$20220101$20240805$20240821$20240821$EXP$$FR-NORDICGR-057130$NORDIC PHARMA$$$$A$F$Y$75$KG$20240821$$MD$FR$FR
242330051$24233005$1$I$20220101$20240814$20240821$20240821$EXP$$BR-SANDOZ INC.-NVSC2022BR200374$SANDOZ$$43$YR$$F$Y$93.5$KG$20240821$$CN$BR$BR
242330071$24233007$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57367$$FDA-CTU$$66$YR$$M$N$$$20240820$N$$US$
242330081$24233008$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57399$$FDA-CTU$$78$YR$$F$N$$$20240820$N$$US$
242330091$24233009$1$I$20240820$20240820$20240820$20240820$DIR$715155$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242330101$24233010$1$I$$20240816$20240820$20240820$DIR$FDA-CDER-CTU-2024-57330$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242330111$24233011$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57407$$FDA-CTU$$45$YR$$M$N$$$20240820$N$$US$
242330121$24233012$1$I$$20240806$20240821$20240821$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00640$GLAND PHARMA$T Nishio.A case of lacosamide and mirtazapine self-poisoning.Legal Medicine.JUL-2024;69:1-7$3$DEC$A$F$Y$$$20240821$$HP$JP$JP
242330131$24233013$1$I$$20240816$20240821$20240821$EXP$AU-TGA-0000816433$AU-SANDOZ INC.-SDZ2024AU073227$SANDOZ$$$$$F$Y$$$20240821$$CN$AU$AU
242330141$24233014$1$I$20180718$20240816$20240821$20240821$EXP$AU-TGA-0000815669$AU-SANDOZ INC.-SDZ2024AU073272$SANDOZ$$52$YR$$F$Y$$$20240821$$MD$AU$AU
242330151$24233015$1$I$20240808$20240809$20240821$20240821$EXP$$US-Accord-441692$ACCORD$$51$YR$A$F$Y$$$20240821$$HP$US$US
242330161$24233016$1$I$20240807$20240809$20240821$20240821$EXP$$US-Accord-441808$ACCORD$$36$YR$A$M$Y$$$20240821$$HP$US$US
242330171$24233017$1$I$20240807$20240809$20240821$20240821$EXP$CN-HENLIUS-24CN016375$CN-Accord-442389$ACCORD$$62$YR$A$M$Y$64$KG$20240821$$MD$CN$CN
242330181$24233018$1$I$$20240809$20240821$20240821$EXP$$GR-Accord-441797$ACCORD$A. Iliaki, P. Pastras, C. Mousis, E. Koullias, A. Kyritsis, H. Mariolis, et al. A case of an immunosuppressed woman with fever and mucositis in the context of methotrexate treatment, ultimately diagnosed with endocarditis with negative blood cultures. 50th ANNUAL PANHELLENIC MEDICAL CONFERENCE.$60$YR$A$F$Y$$$20240821$$MD$GR$GR
242330191$24233019$1$I$$20240809$20240821$20240821$EXP$GB-MHRA-TPP16744210C21057730YC1723109291858$GB-Accord-441189$ACCORD$$66$YR$E$F$Y$100$KG$20240821$$HP$GB$GB
242330201$24233020$1$I$20240623$20240809$20240821$20240821$EXP$ES-AEMPS-1555114$ES-Accord-441341$ACCORD$$72$YR$E$F$Y$$$20240821$$MD$ES$ES
242330211$24233021$1$I$$20240809$20240821$20240821$EXP$$JP-Accord-441305$ACCORD$Imataki O, Fujita H, Uemura M. Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus. International Journal of Hematology. 2024;120(1):1-2. DOI: 10.1007/s12185-024-03798-w.$58$YR$A$M$Y$$$20240821$$MD$JP$JP
242330221$24233022$1$I$$20240809$20240821$20240821$EXP$CA-MHPD-E2B_07180240$CA-Accord-441360$ACCORD$$72$YR$E$F$Y$$$20240821$$HP$CA$CA
242330231$24233023$1$I$20240730$20240809$20240821$20240821$EXP$GB-MHRA-TPP32696583C10148619YC1723043104873$GB-Accord-441176$ACCORD$$55$YR$A$F$Y$81$KG$20240821$$MD$GB$GB
242330241$24233024$1$I$$20240809$20240821$20240821$EXP$CA-MHPD-E2B_07180218$CA-Accord-441353$ACCORD$$52$YR$A$M$Y$$$20240821$$HP$CA$CA
242330251$24233025$1$I$20240703$20240809$20240821$20240821$EXP$GB-MHRA-EMIS-896-ae62b0d1-2663-46ed-9b51-c1efc141aee0$GB-Accord-441334$ACCORD$$65$YR$E$M$Y$90$KG$20240821$$PH$GB$GB
242330262$24233026$2$F$$20240813$20240821$20240824$EXP$$US-Accord-441699$ACCORD$$64$YR$A$M$Y$$$20240824$$CN$US$US
242330271$24233027$1$I$$20240809$20240821$20240821$EXP$CA-MHPD-E2B_07175059$CA-Accord-441362$ACCORD$$81$YR$E$F$Y$$$20240821$$HP$CA$CA
242330281$24233028$1$I$$20240813$20240821$20240821$EXP$$US-TAKEDA-2024TUS081948$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
242330291$24233029$1$I$$20240809$20240821$20240821$EXP$$US-Accord-441677$ACCORD$$55$YR$A$M$Y$$$20240821$$CN$US$US
242330301$24233030$1$I$20230619$20240809$20240821$20240821$EXP$IE-EMA-DD-20240731-7482675-060550$IE-Accord-441395$ACCORD$$59$YR$A$F$Y$67$KG$20240821$$MD$IE$IE
242330311$24233031$1$I$20240811$20240816$20240821$20240821$EXP$$CO-UCBSA-2024042162$UCB$$80$YR$$F$Y$$$20240821$$CN$CO$CO
242330332$24233033$2$F$20240723$20240820$20240821$20240918$PER$$US-Eisai-EC-2024-171220$EISAI$$74$YR$E$M$Y$85.7$KG$20240918$$CN$US$US
242330341$24233034$1$I$$20240813$20240821$20240821$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07795$HIKMA$$$$$$Y$$$20240821$$CN$US$US
242330351$24233035$1$I$20240801$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024163521$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242330361$24233036$1$I$$20240815$20240821$20240821$EXP$GB-MHRA-MED-202408150536153340-FDRHY$GB-RDY-SPO/GBR/24/0011975$DR REDDYS$$$$$F$Y$$$20240821$$CN$GB$GB
242330381$24233038$1$I$$20240816$20240821$20240821$EXP$$US-SA-2024SA247813$SANOFI AVENTIS$$$$A$M$Y$83$KG$20240821$$MD$US$US
242330391$24233039$1$I$$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132333$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240821$$CN$US$US
242330401$24233040$1$I$$20240815$20240821$20240821$EXP$$US-SA-2024SA247420$SANOFI AVENTIS$$$$A$M$Y$88.8$KG$20240821$$MD$US$US
242330411$24233041$1$I$20240617$20240814$20240821$20240821$EXP$ES-AEMPS-1558386$ES-SA-2024SA245720$SANOFI AVENTIS$$50$YR$A$M$Y$84$KG$20240821$$MD$ES$ES
242330421$24233042$1$I$20240814$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131380$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$$$20240821$$CN$US$US
242330431$24233043$1$I$$20240808$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127164$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240821$$MD$US$US
242330441$24233044$1$I$20240710$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132566$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240821$$MD$US$US
242330451$24233045$1$I$$20240813$20240821$20240821$PER$$US-TAKEDA-2024TUS083497$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
242330461$24233046$1$I$$20240806$20240821$20240821$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00646$GLAND PHARMA$Terasawa R.A Case Study of Successful Breast Cancer Treatment after Recovery from Drug-Induced Interstitial Lung Disease.Gan to Kagaku Ryoho.JAN-2023;50(5):635-637$6$DEC$A$F$Y$$$20240821$$HP$JP$JP
242330471$24233047$1$I$$20240812$20240821$20240821$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07708$HIKMA$$$$$$Y$$$20240821$$PH$US$US
242330482$24233048$2$F$$20240820$20240821$20240823$EXP$$US-PFIZER INC-202400240179$PFIZER$$65$YR$$F$Y$$$20240823$$MD$US$US
242330503$24233050$3$F$$20240821$20240821$20240827$30DAY$$US-PFIZER INC-202400235314$PFIZER$$5$YR$$F$Y$$$20240827$$CN$US$US
242330521$24233052$1$I$$20240820$20240821$20240821$EXP$$US-BAYER-2024A120145$BAYER$$$$$F$Y$$$20240821$$CN$US$US
242330531$24233053$1$I$$20240530$20240821$20240821$PER$$US-Dermavant-001193$DERMAVANT SCIENCES$$$$$M$Y$$$20240813$$MD$US$US
242330541$24233054$1$I$20240801$20240814$20240821$20240821$PER$$US-ROCHE-10000058024$ROCHE$$67$YR$E$F$Y$61.23$KG$20240821$$CN$US$US
242330551$24233055$1$I$$20240816$20240821$20240821$30DAY$$US-GSK-US2024102531$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242330563$24233056$3$F$20240613$20240923$20240821$20240927$EXP$$CA-GSK-CA2024AMR078267$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$HP$CA$CA
242330571$24233057$1$I$$20240812$20240821$20240821$EXP$$CA-EMD Serono-2024043608$EMD SERONO INC$$$$A$F$Y$$$20240821$$CN$CA$CA
242330581$24233058$1$I$$20240604$20240821$20240821$PER$$US-Dermavant-001194$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$CN$US$US
242330591$24233059$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011086$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240821$$CN$US$US
242330601$24233060$1$I$$20240809$20240821$20240821$EXP$$US-ELI_LILLY_AND_COMPANY-US202408006578$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240821$$CN$US$US
242330612$24233061$2$F$$20240923$20240821$20240925$EXP$$NVSC2023TH255041$NOVARTIS$$$$$F$Y$50.2$KG$20240926$$CN$TH$TH
242330622$24233062$2$F$20190101$20240827$20240821$20240906$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408006873$ELI LILLY AND CO$$$$$F$Y$$$20240906$$CN$BR$BR
242330631$24233063$1$I$20230101$20240809$20240821$20240821$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408006512$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240821$$CN$DE$DE
242330642$24233064$2$F$20230101$20240906$20240821$20240913$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406015575$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240913$$CN$JP$JP
242330651$24233065$1$I$$20240809$20240821$20240821$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007411$ELI LILLY AND CO$$43$YR$A$$Y$$$20240821$$LW$US$US
242330661$24233066$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010836$ELI LILLY AND CO$$$$$$Y$$$20240821$$CN$US$US
242330672$24233067$2$F$$20240906$20240821$20240906$PER$$US-ALXN-202408USA000852US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242330681$24233068$1$I$20240811$20240816$20240821$20240821$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010969$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240821$$CN$US$US
242330692$24233069$2$F$20240101$20240827$20240821$20240828$PER$$US-ABBVIE-5886675$ABBVIE$$$$$F$Y$$$20240828$$PH$US$US
242330701$24233070$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57408$$FDA-CTU$$75$YR$$F$N$101.6$KG$20240820$N$$US$
242330711$24233071$1$I$20240810$20240810$20240821$20240821$PER$$US-JNJFOC-20240827135$JOHNSON AND JOHNSON$$24$YR$A$M$Y$59.02$KG$20240821$$CN$US$US
242330721$24233072$1$I$$20240816$20240821$20240821$EXP$$VN-SANDOZ INC.-SDZ2024VN074011$SANDOZ$Ho HV, Nguyen BV, Tran HV, Ha TV. Acute myeloid leukemia after chemotherapy: reporting clinical case series in the department of chemotherapy - center of oncology - 103 military hospital and retrospective literature review. VIETNAM MEDICAL JOURNAL. 2021;506:21-6$37$YR$$F$Y$$$20240821$$HP$VN$VN
242330742$24233074$2$F$20240818$20240923$20240821$20240923$PER$$US-AMGEN-USASP2024165375$AMGEN$$68$YR$E$F$Y$$$20240923$$CN$US$US
242330751$24233075$1$I$20240814$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024163394$AMGEN$$8$YR$C$M$Y$$$20240821$$PH$US$US
242330761$24233076$1$I$$20240816$20240821$20240821$PER$$US-ROCHE-10000059889$ROCHE$$$$E$M$Y$$$20240821$$CN$US$US
242330771$24233077$1$I$$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-109561-2023$RECKITT BENCKISER$$$$$F$Y$$$20240821$$CN$US$US
242330821$24233082$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57434$$FDA-CTU$$38$YR$$M$N$$$20240820$N$$US$
242330842$24233084$2$F$$20240819$20240821$20240827$EXP$$GB-TAKEDA-2024TUS030635$TAKEDA$$$$$M$Y$$$20240827$$CN$GB$GB
242330851$24233085$1$I$$20240604$20240821$20240821$PER$$US-Dermavant-001195$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$CN$US$US
242330861$24233086$1$I$$20240604$20240821$20240821$PER$$US-Dermavant-001196$DERMAVANT SCIENCES$$40$YR$$M$Y$$$20240820$$HP$US$US
242330871$24233087$1$I$$20240611$20240821$20240821$PER$$US-Dermavant-001197$DERMAVANT SCIENCES$$53$YR$$F$Y$$$20240820$$HP$US$US
242330881$24233088$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57365$$FDA-CTU$$62$YR$$F$N$$$20240820$N$$US$
242330891$24233089$1$I$$20240806$20240821$20240821$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00639$GLAND PHARMA$T-R Peng.Gemcitabine-Associated Hyperammonemia in a Patient With Cholangiocarcinoma.American Journal of Therapeutics.JUL-2024;31 No.4:e439-e440$57$YR$A$F$Y$$$20240821$$HP$CN$CN
242330901$24233090$1$I$$20240612$20240821$20240821$PER$$US-Dermavant-001198$DERMAVANT SCIENCES$$$$$M$Y$$$20240820$$CN$US$US
242330921$24233092$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57353$$FDA-CTU$$74$YR$$M$N$$$20240820$N$$US$
242330931$24233093$1$I$20240817$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57430$$FDA-CTU$$72$YR$$F$N$$$20240820$N$HP$US$
242330943$24233094$3$F$$20240925$20240821$20240930$EXP$$NVSC2024US094869$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
242330951$24233095$1$I$20240701$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131393$BRISTOL MYERS SQUIBB$$27$YR$A$F$Y$$$20240821$$HP$US$US
242330961$24233096$1$I$20240814$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024163870$AMGEN$$$$A$M$Y$$$20240821$$PH$US$US
242330971$24233097$1$I$20230910$20240816$20240821$20240821$EXP$$ES-AMGEN-ESPSP2024163450$AMGEN$$67$YR$E$F$Y$52$KG$20240821$$HP$ES$ES
242330981$24233098$1$I$20240613$20240819$20240821$20240821$EXP$FR-AFSSAPS-PC2024000557$FR-ABBVIE-5887027$ABBVIE$$83$YR$$F$Y$$$20240821$$MD$FR$FR
242330991$24233099$1$I$$20240610$20240821$20240821$PER$$US-Dermavant-001199$DERMAVANT SCIENCES$$33$YR$$F$Y$$$20240820$$HP$US$US
242331001$24233100$1$I$$20240817$20240821$20240821$PER$$US-AMGEN-USASP2024165033$AMGEN$$$$$$Y$$$20240821$$HP$US$US
242331012$24233101$2$F$20240805$20240830$20240821$20240903$PER$$US-AMGEN-USASP2024163862$AMGEN$$67$YR$E$F$Y$68.8$KG$20240902$$HP$US$US
242331021$24233102$1$I$20240101$20240815$20240821$20240821$EXP$$US-AMGEN-USASP2024164256$AMGEN$$61$YR$A$M$Y$$$20240821$$HP$US$US
242331031$24233103$1$I$$20240813$20240821$20240821$EXP$GB-MHRA-MED-202408131504528140-TFKLP$GB-TEVA-VS-3233334$TEVA$$$$$F$Y$$$20240821$$PH$GB$GB
242331041$24233104$1$I$20240705$20240820$20240821$20240821$EXP$$CN-BAYER-2024A120168$BAYER$$35$YR$A$F$Y$60$KG$20240821$$HP$CN$CN
242331051$24233105$1$I$$20240807$20240821$20240821$EXP$$US-UCBSA-2024039898$UCB$$$$$$Y$$$20240821$$CN$US$US
242331061$24233106$1$I$$20240610$20240821$20240821$PER$$US-Dermavant-001200$DERMAVANT SCIENCES$$52$YR$$M$Y$$$20240820$$HP$US$US
242331071$24233107$1$I$$20240816$20240821$20240821$PER$$US-JNJFOC-20240846274$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240821$$CN$US$US
242331081$24233108$1$I$$20240815$20240821$20240821$PER$$US-ALXN-202408USA001083US$ALEXION PHARMACEUTICALS$$$$$F$Y$166.44$KG$20240821$$CN$US$US
242331091$24233109$1$I$$20240613$20240821$20240821$PER$$US-Dermavant-001201$DERMAVANT SCIENCES$$$$$F$Y$$$20240820$$HP$US$US
242331102$24233110$2$F$20240814$20240819$20240821$20240916$PER$$US-009507513-2408USA006474$MERCK$$$$C$M$Y$$$20240916$$CN$US$US
242331111$24233111$1$I$20240815$20240816$20240821$20240821$EXP$$US-GSK-US2024102608$GLAXOSMITHKLINE$$$$$M$Y$$$20240821$$CN$US$US
242331123$24233112$3$F$20230301$20240826$20240821$20240902$EXP$$FI-ABBVIE-5885839$ABBVIE$$47$YR$$F$Y$88$KG$20240902$$CN$FI$FI
242331131$24233113$1$I$$20240806$20240821$20240821$EXP$$US-GLANDPHARMA-US-2024GLNLIT00636$GLAND PHARMA$Loc Lam.Recurrent Pain From Chemotherapy-Induced Peripheral Neuropathy After COVID-19 Infection - A Case Report.Pain Medicine Case Reports.DEC-2023;7 No.8:357-359$59$YR$A$M$Y$$$20240821$$MD$US$US
242331141$24233114$1$I$$20240716$20240821$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07352$LUPIN$$$$$$Y$$$20240821$$MD$US$US
242331151$24233115$1$I$$20240815$20240821$20240821$EXP$$SK-AMGEN-SVKSP2024163192$AMGEN$$$$A$$Y$$$20240821$$MD$SK$SK
242331162$24233116$2$F$$20240822$20240821$20240828$EXP$$ES-AMGEN-ESPSP2024163106$AMGEN$Manso L.; Vergote I.; Fujiwara K. et al.. Tisotumab vedotin in 2L/3L recurrent or metastatic cervical cancer: Subsequent therapy data from ENGOT-cx12/GOG-3057/innovaTV 301. Journal of Clinical Oncology. 2024;42 (16):5531$$$$$Y$$$20240828$$HP$ES$ES
242331171$24233117$1$I$20200901$20240815$20240821$20240821$EXP$$IT-AMGEN-ITASP2024163155$AMGEN$$43$YR$A$F$Y$$$20240821$$MD$IT$IT
242331191$24233119$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57372$$FDA-CTU$$67$YR$$F$N$$$20240820$N$$US$
242331211$24233121$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57397$$FDA-CTU$$86$YR$$M$N$$$20240820$N$$US$
242331221$24233122$1$I$$20240816$20240820$20240820$DIR$FDA-CDER-CTU-2024-57331$$FDA-CTU$$$$$F$N$$$20240816$N$$US$
242331231$24233123$1$I$20240401$20240815$20240821$20240821$EXP$ES-AEMPS-1559917$ES-Merck Healthcare KGaA-2024044242$MERCK KGAA$$30$YR$A$$Y$$$20240820$$PH$ES$ES
242331241$24233124$1$I$$20240809$20240821$20240821$EXP$$IN-RDY-LIT/IND/24/0011922$DR REDDYS$Kaur J, Singh A, Shah M, Chandrani P, Chougule A, Shetty O, et al. Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy. Cancer Research, Statistics, and Treatment. 2023;6(2): 288-295. doi:10.4103/crst.crst_176_23.$77$YR$E$M$Y$$$20240821$$HP$IN$IN
242331252$24233125$2$F$20240603$20240820$20240821$20240823$EXP$$ZA-MYLANLABS-2024M1074433$MYLAN$$$$$$Y$$$20240823$$HP$ZA$ZA
242331261$24233126$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240845909$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$CN$US$US
242331271$24233127$1$I$$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130077$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240821$$HP$US$US
242331281$24233128$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131649$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240821$$CN$US$US
242331291$24233129$1$I$20240820$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132151$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240821$$CN$US$US
242331301$24233130$1$I$20240101$20240819$20240821$20240821$EXP$$US-UCBSA-2024021297$UCB$$$$$F$Y$84.36$KG$20240821$$CN$US$US
242331312$24233131$2$F$$20240701$20240821$20240821$PER$$US-Dermavant-001203$DERMAVANT SCIENCES$$$$A$M$Y$$$20240820$$MD$US$US
242331321$24233132$1$I$20240809$20240819$20240821$20240821$EXP$$NVSC2024CN169039$NOVARTIS$$78$YR$$M$Y$57$KG$20240821$$HP$CN$CN
242331333$24233133$3$F$20240819$20240820$20240821$20240826$EXP$$NVSC2024GB167694$NOVARTIS$$67$YR$$M$Y$$$20240826$$HP$GB$GB
242331341$24233134$1$I$20240817$20240820$20240821$20240821$EXP$$NVSC2024US169069$NOVARTIS$$62$YR$$F$Y$$$20240821$$HP$US$US
242331351$24233135$1$I$$20240802$20240821$20240821$PER$$US-TEVA-VS-3229733$TEVA$$48$YR$$F$Y$$$20240821$$CN$US$US
242331361$24233136$1$I$$20240819$20240821$20240821$EXP$$US-GILEAD-2024-0684824$GILEAD$$$$E$M$Y$$$20240821$$CN$US$US
242331371$24233137$1$I$$20240814$20240821$20240821$PER$$US-BIOGEN-2024BI01278442$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
242331381$24233138$1$I$20240201$20240816$20240821$20240821$EXP$FR-AFSSAPS-RE2024000808$FR-ALCON LABORATORIES-ALC2024FR003853$ALCON$$$$$$Y$$$20240821$$HP$FR$FR
242331391$24233139$1$I$$20240816$20240821$20240821$EXP$$GB-SANDOZ INC.-SDZ2023GB049756$SANDOZ$$$$$M$Y$$$20240821$$CN$GB$GB
242331401$24233140$1$I$$20240617$20240821$20240821$PER$$US-Dermavant-001204$DERMAVANT SCIENCES$$$$$M$Y$$$20240820$$MD$US$US
242331411$24233141$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011232$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240821$$CN$US$US
242331421$24233142$1$I$$20240818$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011652$ELI LILLY AND CO$$$$$$Y$$$20240821$$CN$US$US
242331431$24233143$1$I$$20240619$20240821$20240821$PER$$US-Dermavant-001205$DERMAVANT SCIENCES$$$$A$M$Y$$$20240820$$HP$US$US
242331441$24233144$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011017$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240821$$CN$US$US
242331452$24233145$2$F$$20240815$20240821$20240821$EXP$$JP-009507513-2408JPN001730J$MERCK$$74$YR$$F$Y$$$20240821$$MD$JP$JP
242331462$24233146$2$F$20230101$20240909$20240821$20240922$EXP$$US-UCBSA-2023015050$UCB$$$$$F$Y$64.399$KG$20240922$$CN$US$US
242331472$24233147$2$F$$20240823$20240821$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08089$LUPIN$$$$$$Y$$$20240909$$MD$US$US
242331481$24233148$1$I$$20240811$20240821$20240821$EXP$$US-JNJFOC-20240831886$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242331491$24233149$1$I$$20240819$20240821$20240821$EXP$$US-JNJFOC-20240852917$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$CN$US$US
242331501$24233150$1$I$$20240812$20240821$20240821$EXP$$US-Merck Healthcare KGaA-2024043715$MERCK KGAA$Kagan KE, Shah VN, Akturk HK. Tirzepatide-Induced Rapid Weight Loss-Related Thyrotoxicosis. JAMA internal medicine. 2024 Aug 05;E1-E2. doi:10.1001/jamainternmed.2024.2919.$62$YR$A$M$Y$132$KG$20240820$$MD$US$US
242331511$24233151$1$I$20240605$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131479$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240821$$HP$US$US
242331521$24233152$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132135$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240821$$HP$US$US
242331531$24233153$1$I$$20240617$20240821$20240821$PER$$US-Dermavant-001206$DERMAVANT SCIENCES$$$$$$Y$$$20240813$$HP$US$US
242331541$24233154$1$I$$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131523$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240821$$HP$US$US
242331551$24233155$1$I$$20240816$20240821$20240821$EXP$$FR-SANDOZ INC.-SDZ2024FR073191$SANDOZ$$54$YR$$F$Y$$$20240821$$HP$FR$FR
242331561$24233156$1$I$$20240617$20240821$20240821$PER$$US-Dermavant-001207$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$HP$US$US
242331571$24233157$1$I$$20240617$20240821$20240821$PER$$US-Dermavant-001208$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$HP$US$US
242331581$24233158$1$I$$20240806$20240821$20240821$EXP$$AU-GLANDPHARMA-AU-2024GLNLIT00649$GLAND PHARMA$A patient-designed integrative oncology intervention for stage IV locally recurrent rectal cancer: A case report.Explore.2024;20 (No.5):103004$59$YR$A$F$Y$$$20240821$$HP$AU$AU
242331593$24233159$3$F$$20240816$20240821$20240828$EXP$$CA-AstraZeneca-2024A184083$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$CA$
242331601$24233160$1$I$$20240617$20240821$20240821$PER$$US-Dermavant-001209$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$HP$US$US
242331611$24233161$1$I$$20240819$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US073870$SANDOZ$$$$$F$Y$96.599$KG$20240821$$MD$US$US
242331621$24233162$1$I$$20240820$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA074130$SANDOZ$$$$$$Y$$$20240821$$HP$CA$CA
242331631$24233163$1$I$$20240820$20240821$20240821$EXP$$US-PFIZER INC-PV202400108740$PFIZER$$$$$F$Y$$$20240821$$CN$US$US
242331641$24233164$1$I$20240817$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57338$$FDA-CTU$$$$$M$N$$$20240819$N$$US$
242331651$24233165$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57359$$FDA-CTU$$$$$F$N$73.48$KG$20240820$N$$US$
242331663$24233166$3$F$20230207$20240820$20240821$20240827$EXP$$CN-PFIZER INC-202400239662$PFIZER$Sihua, D.. A case of Kounis syndrome induced by azithromycin. Chinese Journal of General Practitioners. 2024;23(8):878-880$72$YR$$F$Y$$$20240827$$MD$CN$CN
242331671$24233167$1$I$20240819$20240819$20240821$20240821$EXP$$US-PFIZER INC-202400239424$PFIZER$$67$YR$$F$Y$82.55$KG$20240821$$HP$US$US
242331681$24233168$1$I$20240810$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57453$$FDA-CTU$$85$YR$$M$N$$$20240820$N$HP$US$
242331701$24233170$1$I$20240818$20240819$20240821$20240821$EXP$$CN-PFIZER INC-PV202400107981$PFIZER$$30$YR$$F$Y$70$KG$20240821$$HP$CN$CN
242331714$24233171$4$F$20240717$20240925$20240821$20240927$EXP$$SE-PFIZER INC-202400228733$PFIZER$$25$YR$$F$Y$$$20240927$$MD$SE$SE
242331731$24233173$1$I$20240101$20240816$20240821$20240821$EXP$$CN-PFIZER INC-PV202400107368$PFIZER$$60$YR$$M$Y$65$KG$20240821$$HP$CN$CN
242331752$24233175$2$F$20240820$20240820$20240821$20240822$EXP$$PR-PFIZER INC-202400240145$PFIZER$$57$YR$$M$Y$$$20240822$$MD$PR$PR
242331761$24233176$1$I$20240808$20240816$20240821$20240821$EXP$$CN-PFIZER INC-PV202400107433$PFIZER$$33$YR$$F$Y$$$20240821$$HP$CN$CN
242331771$24233177$1$I$20240722$20240816$20240821$20240821$EXP$FR-AFSSAPS-BX2024001633$FR-PFIZER INC-202400237937$PFIZER$$69$YR$$M$Y$$$20240821$$MD$FR$FR
242331791$24233179$1$I$$20240811$20240821$20240821$EXP$$ES-AMGEN-ESPSP2024163398$AMGEN$Costa E.; Paredes S.; Taverner D. et al.. FACTORS AFFECTING PERSISTENCE OF DENOSUMAB TREATMENT IN PATIENTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 2024;83:1387-1388$$$$$Y$$$20240821$$HP$ES$ES
242331801$24233180$1$I$$20240814$20240821$20240821$EXP$$US-PFIZER INC-PV202400106466$PFIZER$$73$YR$$F$Y$$$20240821$$HP$US$US
242331811$24233181$1$I$$20240814$20240821$20240821$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006019$BIOCON$$$$$$Y$$$20240821$$MD$CA$CA
242331821$24233182$1$I$$20240617$20240821$20240821$PER$$US-Dermavant-001210$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$HP$US$US
242331831$24233183$1$I$$20240618$20240821$20240821$PER$$US-Dermavant-001211$DERMAVANT SCIENCES$$42$YR$$M$Y$$$20240820$$HP$US$US
242331841$24233184$1$I$20240807$20240819$20240820$20240820$DIR$FDA-CDER-CTU-2024-57345$$FDA-CTU$$82$YR$$M$N$$$20240819$N$HP$US$
242331851$24233185$1$I$20240815$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57389$$FDA-CTU$$$$$F$N$94.4$KG$20240820$N$$US$
242331861$24233186$1$I$$20240815$20240821$20240821$PER$$US-ALXN-202408USA001049US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242331871$24233187$1$I$$20240808$20240821$20240821$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08063$LUPIN$Parmeshwar N, Song S, Alcon A, Kim EA. The incidence of breast cancer after gender-affirming mastectomy in transmen. Annals of Plastic Surgery. 2022;88 (4):S332-S336$$$$$Y$$$20240821$$MD$US$US
242331881$24233188$1$I$$20240625$20240821$20240821$PER$$US-Dermavant-001213$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$MD$US$US
242331891$24233189$1$I$20230101$20240809$20240821$20240821$EXP$$US-UCBSA-2024041252$UCB$$$$$M$Y$2.438$KG$20240821$$CN$US$US
242331911$24233191$1$I$20240721$20240814$20240821$20240821$EXP$$CN-009507513-2408CHN005982$MERCK$$67$YR$$M$Y$69.15$KG$20240821$$HP$CN$CN
242331921$24233192$1$I$20240101$20240813$20240821$20240821$EXP$$JP-009507513-2408JPN001520J$MERCK$$66$YR$$F$Y$$$20240821$$MD$JP$JP
242331931$24233193$1$I$$20240814$20240821$20240821$EXP$$US-TERSERA THERAPEUTICS LLC-2024TRS004122$TERSERA THERAPEUTICS$$$$$$Y$$$20240821$$CN$US$US
242331942$24233194$2$F$$20240815$20240821$20240828$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS003635$TERSERA THERAPEUTICS$$$$$$Y$$$20240828$$CN$CN$CN
242331952$24233195$2$F$20221104$20240903$20240821$20240906$EXP$$DE-TAKEDA-2024TUS083496$TAKEDA$$58$YR$$M$Y$150$KG$20240906$$CN$DE$DE
242331961$24233196$1$I$20240701$20240819$20240821$20240821$PER$$US-JNJFOC-20240847122$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
242331971$24233197$1$I$20240816$20240819$20240821$20240821$EXP$GB-MHRA-MED-202408180153570310-BLZKV$GB-SANDOZ INC.-SDZ2024GB073577$SANDOZ$$58$YR$$F$Y$96$KG$20240821$$MD$GB$GB
242331981$24233198$1$I$20240803$20240814$20240821$20240821$EXP$$CA-TAKEDA-2023TUS081220$TAKEDA$$25$YR$$F$Y$$$20240821$$CN$CA$CA
242331991$24233199$1$I$$20240807$20240821$20240821$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08095$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240821$$MD$US$US
242332003$24233200$3$F$$20240909$20240821$20240923$EXP$$XI-NORDICGR-057235$NORDIC PHARMA$$45$YR$$F$Y$$$20240923$$CN$GB$GB
242332011$24233201$1$I$$20240819$20240821$20240821$EXP$$GB-NORDICGR-057236$NORDIC PHARMA$$68$YR$$F$Y$$$20240821$$CN$GB$GB
242332021$24233202$1$I$20240711$20240816$20240821$20240821$EXP$IT-MINISAL02-997995$IT-009507513-2408ITA005826$MERCK$$77$YR$$M$Y$67$KG$20240821$$MD$IT$IT
242332042$24233204$2$F$$20240913$20240821$20240919$EXP$$JP-009507513-2408JPN002013J$MERCK$$68$YR$$$Y$$$20240919$$MD$JP$JP
242332052$24233205$2$F$20240709$20240828$20240821$20240902$EXP$$JP-009507513-2408JPN001879J$MERCK$$62$YR$$F$Y$48$KG$20240902$$PH$JP$JP
242332071$24233207$1$I$$20240806$20240821$20240821$EXP$$ES-GLANDPHARMA-ES-2024GLNLIT00642$GLAND PHARMA$Marta Gema Solaz-Ruiz.Toxicity to intravitreal melphalan in a patient with retinoblastoma.Romanian Journal of Ophthalmology.JAN-2023;67 No.3:305-308$3$YR$C$M$Y$$$20240821$$MD$ES$ES
242332081$24233208$1$I$20240819$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131413$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$58.06$KG$20240821$$PH$US$US
242332091$24233209$1$I$$20240625$20240821$20240821$PER$$US-Dermavant-001216$DERMAVANT SCIENCES$$67$YR$$F$Y$$$20240820$$HP$US$US
242332101$24233210$1$I$$20240820$20240821$20240821$PER$$NVSC2024US168613$NOVARTIS$$39$YR$$F$Y$70$KG$20240821$$CN$US$US
242332112$24233211$2$F$20080101$20240819$20240821$20240826$EXP$BE-EMA-20170925-pbishtp-102857462$BE-SANDOZ INC.-SDZ2024BE073445$SANDOZ$$52$YR$$F$Y$$$20240826$$HP$BE$BE
242332131$24233213$1$I$$20240814$20240821$20240821$EXP$$BR-TAKEDA-2024TUS083470$TAKEDA$$$$$M$Y$$$20240821$$CN$BR$BR
242332141$24233214$1$I$$20240820$20240821$20240821$30DAY$$US-UCBSA-2024040678$UCB$$$$$F$Y$$$20240821$$CN$US$US
242332151$24233215$1$I$20230101$20240809$20240821$20240821$EXP$$US-UCBSA-2024041253$UCB$$$$$F$Y$1.814$KG$20240821$$CN$US$US
242332161$24233216$1$I$20240501$20240819$20240821$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046654$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$$$20240821$$CN$US$US
242332181$24233218$1$I$$20240814$20240821$20240821$PER$$US-AGIOS-2408US03860$AGIOS PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242332192$24233219$2$F$20240726$20240826$20240821$20240830$EXP$$US-RDY-CLI/USA/24/0012060$DR REDDYS$$19$YR$A$F$Y$$$20240829$$CN$US$US
242332201$24233220$1$I$$20240813$20240821$20240821$EXP$$CN-RDY-LIT/CHN/24/0011992$DR REDDYS$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turkish Journal of Hematology. 2023;40: 284-285. doi:10.4274/tjh.galenos.2023.2023.0263.$71$YR$E$F$Y$$$20240821$$HP$CN$CN
242332212$24233221$2$F$$20240903$20240821$20240905$PER$$NVSC2024US168946$NOVARTIS$$$$$$Y$$$20240906$$HP$US$US
242332221$24233222$1$I$$20240806$20240821$20240821$EXP$$PT-GLANDPHARMA-PT-2024GLNLIT00643$GLAND PHARMA$Marcia Tavares.BURKHOLDERIA CEPACIA COMPLEX: A RARE PERITONITIS CASE REPORT.Clinical Chemistry and Laboratory Medicine.14-APR-2023;62(6): eA175-eA176$87$YR$E$F$Y$$$20240821$$HP$PT$PT
242332231$24233223$1$I$20240811$20240820$20240821$20240821$EXP$$CN-BAYER-2024A120169$BAYER$$68$YR$E$F$Y$58$KG$20240821$$HP$CN$CN
242332241$24233224$1$I$$20240809$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126750$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240821$$HP$US$US
242332251$24233225$1$I$20240403$20240809$20240821$20240821$EXP$$PL-JNJFOC-20240831876$JOHNSON AND JOHNSON$$$$E$M$Y$110$KG$20240821$$MD$PL$PL
242332261$24233226$1$I$$20240815$20240821$20240821$PER$$US-MYLANLABS-2024M1076919$MYLAN$$$$$F$Y$$$20240821$$CN$US$US
242332271$24233227$1$I$$20240625$20240821$20240821$PER$$US-Dermavant-001219$DERMAVANT SCIENCES$$$$$M$Y$$$20240820$$MD$US$US
242332281$24233228$1$I$$20240815$20240821$20240821$PER$$US-ALXN-202408USA000894US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$MD$US$US
242332301$24233230$1$I$$20240809$20240821$20240821$EXP$$US-ELI_LILLY_AND_COMPANY-US202408002586$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240821$$CN$US$US
242332311$24233231$1$I$20240801$20240816$20240821$20240821$EXP$$NVSC2024CN168189$NOVARTIS$$86$YR$$F$Y$63$KG$20240821$$HP$CN$CN
242332321$24233232$1$I$$20240507$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202405003901$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240821$$CN$US$US
242332331$24233233$1$I$20240802$20240820$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US073742$SANDOZ$$66$YR$$F$Y$112$KG$20240821$$MD$US$US
242332341$24233234$1$I$$20240815$20240821$20240821$EXP$$AT-MYLANLABS-2024M1076264$MYLAN$$$$E$F$Y$$$20240821$$MD$AT$AT
242332351$24233235$1$I$$20240815$20240821$20240821$EXP$$DE-MYLANLABS-2024M1076050$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$41$YR$$M$Y$$$20240821$$HP$DE$DE
242332361$24233236$1$I$$20240814$20240821$20240821$EXP$$US-MYLANLABS-2024M1076845$MYLAN$Odigwe C. Suicide Left Ventricle Post -TAVR. South-Med-J 2022; 115 (1): 55.$80$YR$$F$Y$$$20240821$$MD$US$US
242332371$24233237$1$I$20240802$20240815$20240821$20240821$EXP$$CN-MYLANLABS-2024M1076380$MYLAN$$69$YR$$M$Y$56$KG$20240821$$HP$CN$CN
242332381$24233238$1$I$$20240627$20240821$20240821$PER$$US-Dermavant-001220$DERMAVANT SCIENCES$$$$$F$Y$$$20240820$$HP$US$US
242332391$24233239$1$I$$20240812$20240821$20240821$EXP$$US-JNJFOC-20240831726$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242332401$24233240$1$I$$20240729$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051358$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
242332412$24233241$2$F$20240701$20240910$20240821$20240925$PER$$CA-TOLMAR, INC.-24CA051370$TOLMAR$$71$YR$$M$Y$$$20240925$$CN$CA$CA
242332421$24233242$1$I$$20240729$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051423$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
242332431$24233243$1$I$$20240729$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051214$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
242332441$24233244$1$I$$20240729$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051422$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
242332451$24233245$1$I$$20240729$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051392$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
242332461$24233246$1$I$20240729$20240729$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051426$TOLMAR$$68$YR$$M$Y$$$20240821$$CN$CA$CA
242332471$24233247$1$I$20240729$20240729$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051427$TOLMAR$$73$YR$$M$Y$$$20240821$$CN$CA$CA
242332481$24233248$1$I$$20240729$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051428$TOLMAR$$$$$M$Y$$$20240821$$CN$CA$CA
242332501$24233250$1$I$20240729$20240729$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051429$TOLMAR$$79$YR$$M$Y$$$20240821$$CN$CA$CA
242332511$24233251$1$I$20240729$20240729$20240821$20240821$PER$$CA-TOLMAR, INC.-24CA051457$TOLMAR$$70$YR$$M$Y$$$20240821$$CN$CA$CA
242332521$24233252$1$I$$20240814$20240821$20240821$EXP$$BR-GSK-BR2024AMR036268$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$BR$BR
242332532$24233253$2$F$$20240821$20240821$20240911$PER$$PR-TOLMAR, INC.-24PR051009$TOLMAR$$$$$M$Y$$$20240911$$HP$PR$PR
242332541$24233254$1$I$20240728$20240730$20240821$20240821$PER$$FR-TOLMAR, INC.-24FR051443$TOLMAR$$65$YR$$M$Y$$$20240821$$PH$FR$FR
242332551$24233255$1$I$20240729$20240729$20240821$20240821$PER$$NL-TOLMAR, INC.-24NL051442$TOLMAR$$73$YR$$M$Y$$$20240821$$CN$NL$NL
242332561$24233256$1$I$$20240814$20240821$20240821$EXP$$CA-OTSUKA-2024_007715$OTSUKA$$$$$F$Y$$$20240821$$HP$CA$CA
242332571$24233257$1$I$$20240627$20240821$20240821$PER$$US-Dermavant-001221$DERMAVANT SCIENCES$$$$$M$Y$$$20240820$$MD$US$US
242332581$24233258$1$I$$20240814$20240821$20240821$EXP$GB-MHRA-MED-202408140755121390-FBGNK$GB-TEVA-VS-3233425$TEVA$$40$YR$$F$Y$$$20240821$$CN$GB$GB
242332591$24233259$1$I$$20240808$20240821$20240821$PER$$US-SA-2024SA240560$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240821$$MD$US$US
242332611$24233261$1$I$$20240808$20240821$20240821$PER$$US-SA-2024SA239473$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240821$$MD$US$US
242332621$24233262$1$I$20210101$20240808$20240821$20240821$PER$$US-SA-2024SA238656$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240821$$MD$US$US
242332631$24233263$1$I$$20240808$20240821$20240821$PER$$US-SA-2024SA241263$SANOFI AVENTIS$$$$A$F$Y$52.16$KG$20240821$$MD$US$US
242332641$24233264$1$I$20240101$20240808$20240821$20240821$PER$$US-SA-2024SA240942$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240821$$MD$US$US
242332651$24233265$1$I$20240101$20240808$20240821$20240821$PER$$US-SA-2024SA240413$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240821$$MD$US$US
242332661$24233266$1$I$20230215$20240819$20240821$20240821$EXP$AU-TGA-0000815636$AU-SANDOZ INC.-SDZ2024AU073711$SANDOZ$$77$YR$$F$Y$$$20240821$$CN$AU$AU
242332671$24233267$1$I$20240814$20240814$20240821$20240821$EXP$GB-MHRA-MED-202408141134239960-TSMVK$GB-TEVA-VS-3233465$TEVA$$49$YR$$M$Y$78$KG$20240821$$CN$GB$GB
242332682$24233268$2$F$20240816$20240828$20240821$20240829$EXP$$NL-TAKEDA-2024TUS083870$TAKEDA$$11$YR$$F$Y$$$20240829$$HP$NL$NL
242332691$24233269$1$I$$20240810$20240821$20240821$PER$$US-SA-2024SA240675$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240821$$MD$US$US
242332701$24233270$1$I$20240801$20240809$20240821$20240821$PER$$US-SA-2024SA240797$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240821$$MD$US$US
242332711$24233271$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243151$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240821$$CN$US$US
242332721$24233272$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA240794$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240821$$MD$US$US
242332731$24233273$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA242681$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242332741$24233274$1$I$20240802$20240809$20240821$20240821$PER$$US-SA-2024SA242250$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240821$$MD$US$US
242332751$24233275$1$I$20230101$20240809$20240821$20240821$PER$$US-SA-2024SA240500$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240821$$MD$US$US
242332761$24233276$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA245774$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240821$$MD$US$US
242332771$24233277$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA240783$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240821$$MD$US$US
242332781$24233278$1$I$20240807$20240809$20240821$20240821$PER$$US-SA-2024SA241340$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240821$$MD$US$US
242332791$24233279$1$I$20240801$20240809$20240821$20240821$PER$$US-SA-2024SA241183$SANOFI AVENTIS$$19$YR$A$F$Y$79.37$KG$20240821$$MD$US$US
242332801$24233280$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA240042$SANOFI AVENTIS$$$$E$F$Y$$$20240821$$MD$US$US
242332811$24233281$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA242126$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240821$$MD$US$US
242332821$24233282$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245261$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240821$$MD$US$US
242332831$24233283$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57616$$FDA-CTU$$73$YR$$F$N$$$20240821$N$HP$US$
242332841$24233284$1$I$20240801$20240809$20240821$20240821$PER$$US-SA-2024SA242804$SANOFI AVENTIS$$80$YR$E$M$Y$11.429$KG$20240821$$MD$US$US
242332851$24233285$1$I$20240808$20240809$20240821$20240821$PER$$US-SA-2024SA241135$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240821$$CN$US$US
242332861$24233286$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA241292$SANOFI AVENTIS$$$$$$Y$$$20240821$$HP$US$US
242332871$24233287$1$I$20240801$20240809$20240821$20240821$PER$$US-SA-2024SA241794$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240821$$MD$US$US
242332881$24233288$1$I$20240807$20240809$20240821$20240821$PER$$US-SA-2024SA241679$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240821$$MD$US$US
242332891$24233289$1$I$$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57580$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242332901$24233290$1$I$20240809$20240809$20240821$20240821$PER$$US-SA-2024SA240772$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240821$$MD$US$US
242332911$24233291$1$I$$20240626$20240821$20240821$PER$$US-Dermavant-001222$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$CN$US$US
242332921$24233292$1$I$20231101$20240809$20240821$20240821$PER$$US-SA-2024SA240956$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240821$$MD$US$US
242332931$24233293$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA245001$SANOFI AVENTIS$$$$A$F$Y$113$KG$20240821$$MD$US$US
242332941$24233294$1$I$20240720$20240809$20240821$20240821$PER$$US-SA-2024SA241523$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240821$$MD$US$US
242332951$24233295$1$I$$20240816$20240821$20240821$EXP$$NVSC2024BR168772$NOVARTIS$$$$$M$Y$$$20240821$$CN$BR$BR
242332961$24233296$1$I$20240801$20240814$20240821$20240821$PER$$US-SA-2024SA245231$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240821$$MD$US$US
242332971$24233297$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA210831$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240821$$MD$US$US
242332981$24233298$1$I$20240301$20240812$20240821$20240821$PER$$US-SA-2024SA244997$SANOFI AVENTIS$$59$YR$A$F$Y$77.564$KG$20240821$$MD$US$US
242332993$24233299$3$F$20240831$20240909$20240821$20240918$PER$$US-SA-2024SA242872$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240918$$MD$US$US
242333003$24233300$3$F$20240401$20240903$20240821$20240925$PER$$US-SA-2024SA241410$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240925$$MD$US$US
242333011$24233301$1$I$$20240627$20240821$20240821$PER$$US-Dermavant-001223$DERMAVANT SCIENCES$$$$A$F$Y$$$20240820$$MD$US$US
242333021$24233302$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241933$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240821$$MD$US$US
242333031$24233303$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA246472$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240821$$MD$US$US
242333041$24233304$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA245199$SANOFI AVENTIS$$$$A$M$Y$99$KG$20240821$$MD$US$US
242333051$24233305$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA243632$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240821$$MD$US$US
242333061$24233306$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241294$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240821$$CN$US$US
242333071$24233307$1$I$20240801$20240812$20240821$20240821$PER$$US-SA-2024SA241284$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240821$$MD$US$US
242333081$24233308$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241470$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240821$$MD$US$US
242333091$24233309$1$I$20240601$20240812$20240821$20240821$PER$$US-SA-2024SA243566$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240821$$CN$US$US
242333101$24233310$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA245313$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240821$$CN$US$US
242333112$24233311$2$F$$20240821$20240821$20240912$EXP$$US-ROCHE-10000056734$ROCHE$$74$YR$E$F$Y$$$20240912$$MD$US$US
242333122$24233312$2$F$$20240816$20240821$20240829$PER$$US-SA-2024SA245321$SANOFI AVENTIS$$63$YR$A$F$Y$72.57$KG$20240829$$MD$US$US
242333131$24233313$1$I$20220101$20240813$20240821$20240821$PER$$US-SA-2024SA243109$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240821$$CN$US$US
242333141$24233314$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243769$SANOFI AVENTIS$$49$YR$A$M$Y$86$KG$20240821$$MD$US$US
242333151$24233315$1$I$20240701$20240814$20240821$20240821$PER$$US-SA-2024SA246145$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240821$$MD$US$US
242333161$24233316$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243753$SANOFI AVENTIS$$$$A$M$Y$92$KG$20240821$$MD$US$US
242333171$24233317$1$I$20240801$20240814$20240821$20240821$PER$$US-SA-2024SA245279$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240821$$MD$US$US
242333181$24233318$1$I$20240801$20240812$20240821$20240821$PER$$US-SA-2024SA243886$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240821$$MD$US$US
242333191$24233319$1$I$20220101$20240814$20240821$20240821$PER$$US-SA-2024SA245335$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
242333201$24233320$1$I$20240701$20240813$20240821$20240821$PER$$US-SA-2024SA245734$SANOFI AVENTIS$$26$YR$A$F$Y$52.163$KG$20240821$$MD$US$US
242333211$24233321$1$I$20240701$20240812$20240821$20240821$PER$$US-SA-2024SA243026$SANOFI AVENTIS$$$$E$F$Y$$$20240821$$CN$US$US
242333221$24233322$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246147$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242333231$24233323$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA245065$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240821$$MD$US$US
242333241$24233324$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241871$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240821$$MD$US$US
242333251$24233325$1$I$20240701$20240812$20240821$20240821$PER$$US-SA-2024SA243776$SANOFI AVENTIS$$46$YR$A$F$Y$58.9$KG$20240821$$MD$US$US
242333271$24233327$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA245597$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
242333281$24233328$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243674$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240821$$MD$US$US
242333291$24233329$1$I$20240701$20240814$20240821$20240821$PER$$US-SA-2024SA246127$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240821$$MD$US$US
242333301$24233330$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA242348$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240821$$MD$US$US
242333311$24233331$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243744$SANOFI AVENTIS$$$$C$F$Y$26$KG$20240821$$MD$US$US
242333321$24233332$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA245062$SANOFI AVENTIS$$$$A$F$Y$98.883$KG$20240821$$MD$US$US
242333331$24233333$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243492$SANOFI AVENTIS$$$$A$F$Y$54.422$KG$20240821$$MD$US$US
242333341$24233334$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245764$SANOFI AVENTIS$$$$A$M$Y$79$KG$20240821$$MD$US$US
242333351$24233335$1$I$$20240701$20240821$20240821$PER$$US-Dermavant-001224$DERMAVANT SCIENCES$$$$$M$Y$$$20240820$$MD$US$US
242333361$24233336$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165943$AMGEN$$$$$$Y$$$20240821$$HP$US$US
242333371$24233337$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA015288$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240821$$MD$US$US
242333381$24233338$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA245101$SANOFI AVENTIS$$28$YR$A$F$Y$48.53$KG$20240821$$MD$US$US
242333391$24233339$1$I$20240601$20240813$20240821$20240821$PER$$US-SA-2024SA243292$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240821$$MD$US$US
242333401$24233340$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244892$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240821$$CN$US$US
242333411$24233341$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA244853$SANOFI AVENTIS$$$$A$F$Y$86.1$KG$20240821$$MD$US$US
242333421$24233342$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243743$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240821$$MD$US$US
242333431$24233343$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246700$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240821$$MD$US$US
242333451$24233345$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA244633$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240821$$MD$US$US
242333461$24233346$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243554$SANOFI AVENTIS$$$$E$F$Y$68$KG$20240821$$MD$US$US
242333472$24233347$2$F$20231101$20240814$20240821$20240828$PER$$US-SA-2024SA245562$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240828$$MD$US$US
242333481$24233348$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246716$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240821$$CN$US$US
242333491$24233349$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA245173$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240821$$MD$US$US
242333501$24233350$1$I$20240801$20240812$20240821$20240821$PER$$US-SA-2024SA241324$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240821$$MD$US$US
242333511$24233351$1$I$20190801$20240812$20240821$20240821$PER$$US-SA-2024SA245048$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240821$$MD$US$US
242333521$24233352$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA245714$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240821$$HP$US$US
242333531$24233353$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245274$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242333542$24233354$2$F$20240101$20240911$20240821$20240926$PER$$US-SA-2024SA244865$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240926$$MD$US$US
242333551$24233355$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243505$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242333561$24233356$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241137$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240821$$CN$US$US
242333571$24233357$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245323$SANOFI AVENTIS$$$$C$M$Y$31.7$KG$20240821$$MD$US$US
242333582$24233358$2$F$20240801$20240911$20240821$20240917$PER$$US-SA-2024SA243680$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$MD$US$US
242333591$24233359$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245953$SANOFI AVENTIS$$$$A$F$Y$109.7$KG$20240821$$MD$US$US
242333601$24233360$1$I$20240701$20240813$20240821$20240821$PER$$US-SA-2024SA243283$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240821$$MD$US$US
242333611$24233361$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245273$SANOFI AVENTIS$$$$A$M$Y$56.6$KG$20240821$$MD$US$US
242333621$24233362$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245327$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240821$$MD$US$US
242333631$24233363$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244220$SANOFI AVENTIS$$$$C$M$Y$18.1$KG$20240821$$MD$US$US
242333641$24233364$1$I$20240819$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57546$$FDA-CTU$$66$YR$$F$N$$$20240820$N$HP$US$
242333651$24233365$1$I$$20240731$20240821$20240821$DIR$FDA-CDER-CTU-2024-57562$$FDA-CTU$$$$$F$N$$$20240731$N$HP$US$
242333681$24233368$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245275$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240821$$CN$US$US
242333691$24233369$1$I$20240801$20240812$20240821$20240821$PER$$US-SA-2024SA243690$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240821$$MD$US$US
242333711$24233371$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA241335$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240821$$MD$US$US
242333731$24233373$1$I$20231020$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57558$$FDA-CTU$$31$YR$$F$N$72.57$KG$20240820$N$CN$US$
242333741$24233374$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245271$SANOFI AVENTIS$$$$E$F$Y$49$KG$20240821$$MD$US$US
242333751$24233375$1$I$20240731$20240809$20240821$20240821$DIR$FDA-CDER-CTU-2024-57462$$FDA-CTU$$76$YR$$M$N$85.7$KG$20240809$N$MD$US$
242333761$24233376$1$I$20240401$20240812$20240821$20240821$PER$$US-SA-2024SA243231$SANOFI AVENTIS$$74$YR$E$F$Y$99.1$KG$20240821$$MD$US$US
242333771$24233377$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241306$SANOFI AVENTIS$$$$T$F$Y$70$KG$20240821$$MD$US$US
242333781$24233378$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243132$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240821$$MD$US$US
242333791$24233379$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243495$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240821$$MD$US$US
242333801$24233380$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245314$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242333811$24233381$1$I$$20240701$20240821$20240821$PER$$US-Dermavant-001225$DERMAVANT SCIENCES$$31$YR$$M$Y$$$20240820$$HP$US$US
242333822$24233382$2$F$20240814$20240814$20240821$20240828$PER$$US-SA-2024SA243360$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240828$$MD$US$US
242333831$24233383$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA246988$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240821$$MD$US$US
242333841$24233384$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA244890$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240821$$HP$US$US
242333851$24233385$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246070$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240821$$MD$US$US
242333861$24233386$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245269$SANOFI AVENTIS$$$$E$F$Y$76.2$KG$20240821$$MD$US$US
242333871$24233387$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA246416$SANOFI AVENTIS$$33$YR$A$M$Y$86.6$KG$20240821$$MD$US$US
242333881$24233388$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245233$SANOFI AVENTIS$$$$E$F$Y$$$20240821$$MD$US$US
242333891$24233389$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA245167$SANOFI AVENTIS$$78$YR$E$F$Y$57.2$KG$20240821$$MD$US$US
242333901$24233390$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA243768$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240821$$MD$US$US
242333911$24233391$1$I$20240808$20240812$20240821$20240821$PER$$US-SA-2024SA242469$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240821$$MD$US$US
242333921$24233392$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243564$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240821$$MD$US$US
242333931$24233393$1$I$$20240816$20240821$20240821$EXP$$CA-AMX-008135$AMYLYX PHARMACEUTICALS$$50$YR$$M$Y$$$20240821$$CN$CA$CA
242333941$24233394$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241471$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240821$$MD$US$US
242333951$24233395$1$I$20240801$20240812$20240821$20240821$PER$$US-SA-2024SA241899$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240821$$MD$US$US
242333961$24233396$1$I$20240801$20240812$20240821$20240821$PER$$US-SA-2024SA246897$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240821$$MD$US$US
242333971$24233397$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246566$SANOFI AVENTIS$$8$YR$C$M$Y$31.8$KG$20240821$$MD$US$US
242333981$24233398$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243358$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240821$$HP$US$US
242333992$24233399$2$F$20240901$20240918$20240821$20240927$PER$$US-SA-2024SA245266$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240927$$MD$US$US
242334001$24233400$1$I$20240807$20240813$20240821$20240821$PER$$US-SA-2024SA243361$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240821$$MD$US$US
242334011$24233401$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241746$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240821$$MD$US$US
242334021$24233402$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA245186$SANOFI AVENTIS$$84$YR$E$F$Y$83$KG$20240821$$MD$US$US
242334031$24233403$1$I$20240601$20240813$20240821$20240821$PER$$US-SA-2024SA242112$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240821$$HP$US$US
242334041$24233404$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245268$SANOFI AVENTIS$$$$A$F$Y$67.13$KG$20240821$$MD$US$US
242334061$24233406$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA244546$SANOFI AVENTIS$$$$A$F$Y$61.23$KG$20240821$$MD$US$US
242334071$24233407$1$I$20240101$20240816$20240821$20240821$EXP$$US-ABBVIE-5884953$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242334081$24233408$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245205$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240821$$HP$US$US
242334091$24233409$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245230$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240821$$CN$US$US
242334101$24233410$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243472$SANOFI AVENTIS$$$$E$M$Y$$$20240821$$MD$US$US
242334111$24233411$1$I$20240814$20240814$20240821$20240821$PER$$US-SA-2024SA246568$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240821$$MD$US$US
242334121$24233412$1$I$20240801$20240812$20240821$20240821$PER$$US-SA-2024SA241598$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240821$$MD$US$US
242334131$24233413$1$I$$20240703$20240821$20240821$PER$$US-Dermavant-001226$DERMAVANT SCIENCES$$$$$F$Y$$$20240820$$$US$US
242334141$24233414$1$I$20210101$20240816$20240821$20240821$EXP$$NVSC2024US167167$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
242334151$24233415$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245743$SANOFI AVENTIS$$$$E$M$Y$96.16$KG$20240821$$MD$US$US
242334161$24233416$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA245262$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240821$$MD$US$US
242334171$24233417$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243679$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240821$$MD$US$US
242334181$24233418$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA244287$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240821$$MD$US$US
242334191$24233419$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245267$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242334201$24233420$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA244352$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240821$$MD$US$US
242334211$24233421$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245317$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$CN$US$US
242334221$24233422$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241720$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240821$$CN$US$US
242334231$24233423$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA245284$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240821$$MD$US$US
242334241$24233424$1$I$20240801$20240814$20240821$20240821$PER$$US-SA-2024SA244393$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240821$$MD$US$US
242334251$24233425$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA241806$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240821$$CN$US$US
242334261$24233426$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA246909$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240821$$MD$US$US
242334271$24233427$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245131$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240821$$MD$US$US
242334281$24233428$1$I$20240715$20240813$20240821$20240821$PER$$US-SA-2024SA242774$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240821$$HP$US$US
242334291$24233429$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243881$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242334302$24233430$2$F$20240101$20240816$20240821$20240830$PER$$US-SA-2024SA243874$SANOFI AVENTIS$$63$YR$A$F$Y$99.33$KG$20240830$$MD$US$US
242334311$24233431$1$I$20240801$20240814$20240821$20240821$PER$$US-SA-2024SA245246$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240821$$MD$US$US
242334321$24233432$1$I$20240801$20240814$20240821$20240821$PER$$US-SA-2024SA245204$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240821$$MD$US$US
242334331$24233433$1$I$$20240820$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA073975$SANDOZ$$14$YR$$M$Y$$$20240821$$PH$CA$CA
242334351$24233435$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246053$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240821$$CN$US$US
242334361$24233436$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245027$SANOFI AVENTIS$$$$E$M$Y$$$20240821$$MD$US$US
242334371$24233437$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243749$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242334382$24233438$2$F$$20240820$20240821$20240917$PER$$US-SA-2024SA245277$SANOFI AVENTIS$$$$E$M$Y$95$KG$20240918$$MD$US$US
242334401$24233440$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245872$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240821$$MD$US$US
242334411$24233441$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241652$SANOFI AVENTIS$$$$E$F$Y$$$20240821$$MD$US$US
242334421$24233442$1$I$20240801$20240812$20240821$20240821$PER$$US-SA-2024SA244813$SANOFI AVENTIS$$$$T$F$Y$$$20240821$$MD$US$US
242334432$24233443$2$F$20240101$20240826$20240821$20240910$PER$$US-SA-2024SA244801$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240910$$MD$US$US
242334441$24233444$1$I$$20240709$20240821$20240821$PER$$US-Dermavant-001227$DERMAVANT SCIENCES$$$$$M$Y$$$20240820$$CN$US$US
242334451$24233445$1$I$$20240814$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132076$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$75.75$KG$20240821$$MD$US$US
242334461$24233446$1$I$20231101$20240820$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132128$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240821$$CN$US$US
242334471$24233447$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131032$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240821$$CN$US$US
242334481$24233448$1$I$$20240815$20240821$20240821$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-131282$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240821$$MD$JP$JP
242334491$24233449$1$I$20240422$20240821$20240821$20240821$PER$$US-PROD-AS2-212756134-RB-088494-2024$RECKITT BENCKISER$$88$YR$$F$Y$$$20240821$$CN$US$US
242334501$24233450$1$I$$20240815$20240821$20240821$EXP$$US-JNJFOC-20240840307$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$PH$US$US
242334511$24233451$1$I$20240501$20240814$20240821$20240821$PER$$US-SA-2024SA246697$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240821$$MD$US$US
242334521$24233452$1$I$$20240819$20240821$20240821$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210203328$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240821$$HP$CA$CA
242334531$24233453$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA242258$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240821$$CN$US$US
242334541$24233454$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245242$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240821$$MD$US$US
242334551$24233455$1$I$20240701$20240812$20240821$20240821$PER$$US-SA-2024SA243729$SANOFI AVENTIS$$$$C$M$Y$$$20240821$$MD$US$US
242334561$24233456$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244151$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240821$$MD$US$US
242334571$24233457$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA243685$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240821$$MD$US$US
242334581$24233458$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241943$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240821$$MD$US$US
242334591$24233459$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA245341$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240821$$MD$US$US
242334601$24233460$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA242269$SANOFI AVENTIS$$$$$$Y$$$20240821$$HP$US$US
242334611$24233461$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243653$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$HP$US$US
242334621$24233462$1$I$$20240819$20240821$20240821$EXP$$AU-SANDOZ INC.-SDZ2024AU073812$SANDOZ$$40$YR$$M$Y$$$20240821$$HP$AU$AU
242334631$24233463$1$I$20240729$20240805$20240821$20240821$DIR$FDA-CDER-CTU-2024-57464$$FDA-CTU$$50$YR$$F$N$87.4$KG$20240805$N$$US$
242334641$24233464$1$I$20120101$20240820$20240821$20240821$EXP$FR-AFSSAPS-BR2024000678$FR-BAYER-2024A119669$BAYER$$36$YR$A$F$Y$$$20240821$$MD$FR$FR
242334651$24233465$1$I$$20240816$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA073810$SANDOZ$$$$$F$Y$$$20240821$$CN$CA$CA
242334661$24233466$1$I$$20240819$20240821$20240821$EXP$$NVSC2024CA168462$NOVARTIS$$69$YR$$F$Y$$$20240821$$CN$CA$CA
242334671$24233467$1$I$$20240814$20240821$20240821$EXP$$NVSC2024US166305$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
242334681$24233468$1$I$$20240702$20240821$20240821$PER$$US-Dermavant-001228$DERMAVANT SCIENCES$$$$$M$Y$$$20240820$$MD$US$US
242334691$24233469$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57569$$FDA-CTU$$$$$$N$$$20240820$$CN$US$
242334701$24233470$1$I$$20240815$20240821$20240821$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013272$VERTEX$$$$A$F$Y$$$20240821$$CN$GB$GB
242334711$24233471$1$I$$20240815$20240821$20240821$PER$$US-VERTEX PHARMACEUTICALS-2024-013290$VERTEX$$$$$$Y$$$20240821$$CN$US$US
242334721$24233472$1$I$20240617$20240815$20240821$20240821$EXP$FR-AFSSAPS-NC2024000981$FR-VERTEX PHARMACEUTICALS-2024-013261$VERTEX$$2$YR$$M$Y$14$KG$20240821$$HP$FR$FR
242334731$24233473$1$I$$20240814$20240821$20240821$PER$$US-VERTEX PHARMACEUTICALS-2024-012432$VERTEX$$$$$M$Y$85$KG$20240821$$PH$US$US
242334751$24233475$1$I$$20240814$20240821$20240821$30DAY$$EG-SANDOZ INC.-SDZ2024EG067445$SANDOZ$$$$$M$Y$24$KG$20240821$$MD$EG$EG
242334761$24233476$1$I$$20240708$20240821$20240821$PER$$US-Dermavant-001230$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$MD$US$US
242334771$24233477$1$I$$20240819$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA073767$SANDOZ$$66$YR$$M$Y$$$20240821$$HP$CA$CA
242334781$24233478$1$I$$20240814$20240821$20240821$EXP$$US-009507513-2408USA005173$MERCK$$70$YR$$F$Y$$$20240821$$CN$US$US
242334791$24233479$1$I$20240726$20240813$20240821$20240821$EXP$$JP-009507513-2408JPN006011$MERCK$$76$YR$$M$Y$60.8$KG$20240821$$HP$JP$JP
242334801$24233480$1$I$$20240814$20240821$20240821$EXP$$US-009507513-2408USA005037$MERCK$$68$YR$$M$Y$$$20240821$$MD$US$US
242334813$24233481$3$F$$20240822$20240821$20240903$EXP$$TW-009507513-2408TWN005544$MERCK$$75$YR$$M$Y$$$20240903$$MD$TW$TW
242334831$24233483$1$I$$20240815$20240821$20240821$EXP$$CA-TAKEDA-2024TUS082419$TAKEDA$$36$YR$$M$Y$$$20240821$$HP$CA$CA
242334841$24233484$1$I$$20240814$20240821$20240821$EXP$GB-MHRA-MED-202408141047236840-MQVYK$GB-PERRIGO-24GB007693$PERRIGO$$$$$$Y$$$20240821$$MD$GB$GB
242334851$24233485$1$I$20240101$20240812$20240821$20240821$EXP$$GR-PERRIGO-24GR006717$PERRIGO$$$$$F$Y$$$20240821$$PH$GR$GR
242334861$24233486$1$I$$20240808$20240821$20240821$PER$$US-BAYER-2024A115465$BAYER$$$$$M$Y$$$20240821$$CN$US$US
242334871$24233487$1$I$$20240802$20240821$20240821$PER$$US-TEVA-VS-3229819$TEVA$$89$YR$$F$Y$$$20240821$$CN$US$US
242334881$24233488$1$I$$20240712$20240821$20240821$PER$$US-Dermavant-001232$DERMAVANT SCIENCES$$$$$F$Y$$$20240820$$MD$US$US
242334891$24233489$1$I$$20240814$20240821$20240821$PER$$US-ABBVIE-5882507$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242334901$24233490$1$I$20150101$20240819$20240821$20240821$EXP$$FR-SANDOZ INC.-PHHY2018FR114942$SANDOZ$$63$YR$$F$Y$$$20240821$$MD$FR$FR
242334911$24233491$1$I$$20240712$20240821$20240821$PER$$US-Dermavant-001233$DERMAVANT SCIENCES$$$$$F$Y$$$20240820$$MD$US$US
242334921$24233492$1$I$$20240812$20240821$20240821$EXP$$US-SA-2024SA243439$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240821$$PH$US$US
242334931$24233493$1$I$$20240712$20240821$20240821$PER$$US-Dermavant-001234$DERMAVANT SCIENCES$$55$YR$$M$Y$$$20240820$$$US$US
242334942$24233494$2$F$20240612$20240821$20240821$20240828$EXP$FR-AFSSAPS-NT2024001052$FR-OTSUKA-2024_022576$OTSUKA$$52$YR$$F$Y$84$KG$20240828$$MD$FR$FR
242334951$24233495$1$I$$20240811$20240821$20240821$PER$$US-BAYER-2024A115519$BAYER$$$$$$Y$$$20240821$$CN$US$US
242334961$24233496$1$I$$20240711$20240821$20240821$PER$$US-Dermavant-001235$DERMAVANT SCIENCES$$12$YR$$M$Y$$$20240820$$MD$US$US
242334971$24233497$1$I$$20240813$20240821$20240821$PER$$US-ABBVIE-5880322$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242334991$24233499$1$I$20240629$20240731$20240821$20240821$DIR$FDA-CDER-CTU-2024-57544$$FDA-CTU$$53$YR$$F$N$$$20240731$N$HP$US$
242335001$24233500$1$I$$20240712$20240821$20240821$PER$$US-Dermavant-001236$DERMAVANT SCIENCES$$75$YR$$M$Y$$$20240820$$MD$US$US
242335011$24233501$1$I$$20240811$20240821$20240821$EXP$$US-AMGEN-USASP2024163075$AMGEN$Elfil M.; Lookian P.; Kumari K et. al. Reversible cerebral vasoconstriction syndrome due to teprotumumab: two case reports. Oxford Medical case Reports. 2024;Vol (8):333-336$59$YR$A$F$Y$$$20240821$$HP$US$US
242335021$24233502$1$I$$20240819$20240821$20240821$DIR$FDA-CDER-CTU-2024-57524$$FDA-CTU$$$$$M$N$$$20240819$N$HP$US$
242335031$24233503$1$I$$20240812$20240821$20240821$EXP$$BG-AMGEN-BGRSP2024160347$AMGEN$Ivanov K. Z.. MALIGNANT ASCITES AND THE ROLE OF PERITONEAL TUNNELED CATHETERS IN THEIR TREATMENT. Unknown$64$YR$A$F$Y$$$20240821$$MD$BG$BG
242335042$24233504$2$F$$20240829$20240821$20240905$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004594$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240905$$MD$JP$JP
242335052$24233505$2$F$20240802$20240820$20240821$20240826$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004596$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
242335072$24233507$2$F$$20240912$20240821$20240917$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004629$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240917$$CN$US$US
242335081$24233508$1$I$$20240812$20240821$20240821$EXP$$NO-AMGEN-NORSP2024164091$AMGEN$Lysen, A.. Carfilzomib-Based Regimens Are Efficacious and Well Tolerated in Heavily Pre-Treated Multiple Myeloma Patients:Real World Data from a Norwegian Cohort. Blood. 2018;132 (suppl_1):5651$$$$$Y$$$20240821$$HP$NO$NO
242335092$24233509$2$F$$20240823$20240821$20240829$EXP$$AR-GSK-AR2023AMR087954$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$AR$AR
242335101$24233510$1$I$$20240808$20240821$20240821$EXP$GB-MHRA-MED-202408081140126560-YGFTN$GB-LUPIN PHARMACEUTICALS INC.-2024-07955$LUPIN$$$$$$Y$$$20240821$$PH$GB$GB
242335112$24233511$2$F$20231115$20240730$20240821$20240822$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2023000004$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240822$$MD$US$US
242335121$24233512$1$I$20240731$20240802$20240821$20240821$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000022$IOVANCE BIOTHERAPEUTICS$$57$YR$$F$Y$78.1$KG$20240819$$HP$US$US
242335131$24233513$1$I$$20240715$20240821$20240821$PER$$US-Dermavant-001238$DERMAVANT SCIENCES$$$$$M$Y$$$20240820$$MD$US$US
242335141$24233514$1$I$20240101$20240812$20240821$20240821$EXP$$US-SA-2024SA242129$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240821$$CN$US$US
242335151$24233515$1$I$$20240814$20240821$20240821$EXP$$CA-TAKEDA-2024TUS082421$TAKEDA$$$$$F$Y$$$20240821$$MD$CA$CA
242335161$24233516$1$I$20240101$20240813$20240821$20240821$EXP$$US-SA-2024SA246167$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240821$$MD$US$US
242335172$24233517$2$F$20240819$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132582$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240821$$HP$US$US
242335181$24233518$1$I$$20240818$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131231$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$85.73$KG$20240821$$CN$US$US
242335191$24233519$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132278$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240821$$CN$US$US
242335201$24233520$1$I$$20240716$20240821$20240821$PER$$US-Dermavant-001239$DERMAVANT SCIENCES$$$$A$M$Y$$$20240820$$HP$US$US
242335211$24233521$1$I$$20240814$20240821$20240821$EXP$$US-ABBVIE-5882154$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242335223$24233522$3$F$20240712$20240909$20240821$20240923$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202408006623$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240923$$CN$DE$MX
242335231$24233523$1$I$20240816$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011908$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240821$$CN$US$US
242335242$24233524$2$F$$20240827$20240821$20240905$EXP$$US-TEVA-VS-3234484$TEVA$Martin CE, Kuhn AK, Leopold KN, Creo AL, Schoettler PJ, Allen-Rhoades WA. Exogenous steroid replacement in a pediatric patient with adrenocortical carcinoma receiving mitotane. Pediatr-Blood-Cancer 2024; 71 (8):.; Martin CE, Kuhn AK, Leopold KN, Creo AL, Schoettler PJ, Allen-Rhoades WA. Exogenous steroid replacement in a pediatric patient with adrenocortical carcinoma receiving mitotane. Pediatr-Blood-Cancer 2024; 71 (8):.$16$YR$$F$Y$$$20240905$$HP$US$US
242335251$24233525$1$I$$20240718$20240821$20240821$PER$$US-Dermavant-001241$DERMAVANT SCIENCES$$65$YR$$M$Y$$$20240820$$HP$US$US
242335261$24233526$1$I$$20240816$20240821$20240821$EXP$$US-AMERICAN REGENT INC-2024003188$AMERICAN REGENT$Yalamanchili S, Talei B, Azizzadeh B, Auersvald,A., Frankel AS. Wound Healing Complications With Tranexamic Acid: Not the Silver Bullet After All. Aesthetic Surgery Journal. 2023;43(12):1409-1415$59$YR$$F$Y$$$20240821$$MD$US$US
242335291$24233529$1$I$20240702$20240815$20240821$20240821$EXP$CH-SM-2024-14782$CH-009507513-2408CHE005516$MERCK$$70$YR$$M$Y$70$KG$20240821$$MD$CH$CH
242335301$24233530$1$I$20240101$20240813$20240821$20240821$EXP$$US-SA-2024SA243949$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240821$$CN$US$US
242335311$24233531$1$I$20240101$20240814$20240821$20240821$EXP$$US-ABBVIE-5882156$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242335321$24233532$1$I$20240701$20240820$20240821$20240821$EXP$$US-INCYTE CORPORATION-2024IN008714$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242335331$24233533$1$I$$20240814$20240821$20240821$PER$$US-JNJFOC-20240849931$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
242335341$24233534$1$I$$20240815$20240821$20240821$PER$$US-ABBVIE-5884479$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242335351$24233535$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57538$$FDA-CTU$$$$$$N$$$20240820$$CN$US$
242335361$24233536$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57588$$FDA-CTU$$77$YR$$F$N$$$20240821$N$$US$
242335371$24233537$1$I$20220405$20240816$20240821$20240821$EXP$$SG-SANDOZ INC.-NVSC2022SG079795$SANDOZ$$56$YR$$F$Y$59$KG$20240821$$MD$SG$SG
242335381$24233538$1$I$$20240726$20240821$20240821$PER$$US-Dermavant-001242$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$CN$US$US
242335391$24233539$1$I$$20240724$20240821$20240821$PER$$US-Dermavant-001243$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$CN$US$US
242335401$24233540$1$I$$20240813$20240821$20240821$EXP$$CN-TAKEDA-2024TUS083844$TAKEDA$Li J, Wang L, Qiu B, Hu H, Zhang Z. Hydrocodone PCA for the control of severe pain in the acute phase of gout with multiple organ damage. Chinese Journal of Pain Medicine. 2024;30(7)$65$YR$$M$Y$$$20240821$$HP$CN$CN
242335411$24233541$1$I$20240802$20240814$20240821$20240821$EXP$$CN-SA-2024SA244451$SANOFI AVENTIS$$68$YR$E$F$Y$50$KG$20240821$$HP$CN$CN
242335421$24233542$1$I$$20240814$20240821$20240821$EXP$$GB-SA-2024SA243826$SANOFI AVENTIS$$81$YR$E$M$Y$82$KG$20240821$$MD$GB$GB
242335431$24233543$1$I$$20240814$20240821$20240821$EXP$$US-SA-2024SA244717$SANOFI AVENTIS$$64$YR$A$M$Y$64.8$KG$20240821$$MD$US$US
242335481$24233548$1$I$20161013$20240818$20240821$20240821$EXP$GB-MHRA-MED-202408190134368090-SQLMH$GB-OTSUKA-2024_022768$OTSUKA$$41$YR$$F$Y$127$KG$20240821$$CN$GB$GB
242335491$24233549$1$I$$20240816$20240821$20240821$EXP$$US-AMERICAN REGENT INC-2024003191$AMERICAN REGENT$Yalamanchili, S., Talei, B., Azizzadeh, B., Auersvald,A., Frankel AS. Wound Healing Complications With Tranexamic Acid: Not the Silver Bullet After All. Aesthetic Surgery Journal. 2023;43(12):1409-1415$56$YR$$F$Y$$$20240821$$MD$US$US
242335511$24233551$1$I$$20240812$20240821$20240821$EXP$$GB-MYLANLABS-2024M1076778$MYLAN$Botrugno R, Rajlawat B, Finn D, Yesudian PD. Use of roflumilast in erosive oral inflammatory conditions. Br-J-Dermatol 2024; 191 (Suppl. 1) i62-i63 abstr. P099.$78$YR$$F$Y$$$20240821$$HP$GB$GB
242335521$24233552$1$I$$20240816$20240821$20240821$EXP$$SK-MYLANLABS-2024M1077047$MYLAN$Poruban T, Hunavy M, Farkas D, Carnoky S, Jakubova M. A rare Serratia marcescens-associated acute endocarditis of a tricuspid valve in an intravenous drug user: A case report and literature review. Wien-Klin-Wochenschr 2023; 135 (21-22): 631-636.$27$YR$$M$Y$$$20240821$$HP$SK$SK
242335531$24233553$1$I$$20240812$20240821$20240821$EXP$$IT-MYLANLABS-2024M1074344$MYLAN$Corazza M, Pacetti L, Schettini N, Bocchi C, Borghi A.. Airborne Contact Dermatitis Due to Budesonide by Multiple Proxies.. Dermatitis: contact, atopic, occupational, drug.. 2024;35 (3):291-2$$$A$F$Y$$$20240821$$MD$IT$IT
242335552$24233555$2$F$20240808$20240822$20240821$20240830$EXP$$US-GUERBET / LLC-US-20240130$GUERBET$$58$YR$A$F$Y$93.89$KG$20240830$$HP$US$US
242335562$24233556$2$F$20240701$20240807$20240821$20240822$EXP$$FR-Ipsen Biopharmaceuticals, Inc.-2024-14734$IPSEN$$19$YR$A$M$Y$54$KG$20240822$$PH$FR$FR
242335571$24233557$1$I$$20240809$20240821$20240821$EXP$$US-RDY-LIT/USA/24/0011917$DR REDDYS$Dykes K, Tzachanis D, Koura D. A Difficult Case of Calcineurin Inhibitor Neurotoxicity Post-Haploidentical HCT With a Successful Novel Solution: Cytotoxic T-Lymphocyte-Associated Protein 4-Immunoglobulin Blockade for GVHD Prophylaxis. Cell Transplantation. 2024;33: 1-7. doi:10.1177/09636897241265249.$24$YR$A$M$Y$$$20240821$$HP$US$US
242335581$24233558$1$I$$20240809$20240821$20240821$EXP$$US-RDY-LIT/USA/24/0011827$DR REDDYS$Sorabella RA, Gray WH, Dabal RJ, Padilla LA, Hock K, Clark MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2024 Jul 01;70(7): e92-e96. doi:10.1097/MAT.0000000000002102.$17$YR$T$M$Y$85$KG$20240821$$HP$US$US
242335591$24233559$1$I$20230501$20230815$20240821$20240821$PER$$US-PERRIGO-23US009328$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242335601$24233560$1$I$20230801$20230821$20240821$20240821$PER$$US-PERRIGO-23US009410$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242335611$24233561$1$I$20230801$20230803$20240821$20240821$PER$$US-PERRIGO-23US008988$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335621$24233562$1$I$20130101$20230803$20240821$20240821$PER$$US-PERRIGO-23US008762$PERRIGO$$$$$F$Y$42.177$KG$20240821$$CN$US$US
242335631$24233563$1$I$20230808$20230822$20240821$20240821$PER$$US-PERRIGO-23US009411$PERRIGO$$83$YR$$F$Y$67.12$KG$20240821$$CN$US$US
242335641$24233564$1$I$20230801$20230817$20240821$20240821$PER$$US-PERRIGO-23US009506$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335651$24233565$1$I$20230801$20230816$20240821$20240821$PER$$US-PERRIGO-23US009250$PERRIGO$$$$$M$Y$$$20240821$$CN$US$US
242335661$24233566$1$I$20230801$20230817$20240821$20240821$PER$$US-PERRIGO-23US009293$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335671$24233567$1$I$20230801$20230823$20240821$20240821$PER$$US-PERRIGO-23US009491$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335681$24233568$1$I$20230801$20230902$20240821$20240821$PER$$US-PERRIGO-23US010636$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335691$24233569$1$I$20230801$20230825$20240821$20240821$PER$$US-PERRIGO-23US009608$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335701$24233570$1$I$20230701$20230731$20240821$20240821$PER$$US-PERRIGO-23US008614$PERRIGO$$$$$M$Y$$$20240821$$CN$US$US
242335711$24233571$1$I$20230801$20230814$20240821$20240821$PER$$US-PERRIGO-23US009331$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242335721$24233572$1$I$20230801$20230828$20240821$20240821$PER$$US-PERRIGO-23US009577$PERRIGO$$$$$F$Y$54.422$KG$20240821$$CN$US$US
242335731$24233573$1$I$20230401$20230810$20240821$20240821$PER$$US-PERRIGO-23US009167$PERRIGO$$26$YR$$F$Y$$$20240821$$CN$US$US
242335741$24233574$1$I$20230724$20230807$20240821$20240821$PER$$US-PERRIGO-23US008864$PERRIGO$$79$YR$$F$Y$60.317$KG$20240821$$CN$US$US
242335751$24233575$1$I$20230701$20230803$20240821$20240821$PER$$US-PERRIGO-23US008716$PERRIGO$$77$YR$$F$Y$49.887$KG$20240821$$CN$US$US
242335761$24233576$1$I$20240701$20240724$20240821$20240821$PER$$US-AstraZeneca-2024A169482$ASTRAZENECA$$54$YR$$F$Y$110.2$KG$20240821$$HP$US$
242335771$24233577$1$I$20220209$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184165$ASTRAZENECA$$28$YR$$F$Y$57$KG$20240821$$MD$FR$
242335781$24233578$1$I$20240624$20240816$20240821$20240821$EXP$$US-AstraZeneca-2024A187713$ASTRAZENECA$$23820$DY$$M$Y$$$20240821$$MD$US$
242335791$24233579$1$I$$20240725$20240821$20240821$PER$$US-Dermavant-001245$DERMAVANT SCIENCES$$$$$M$Y$$$20240820$$CN$US$US
242335801$24233580$1$I$$20240816$20240821$20240821$PER$$US-BAYER-2024A118764$BAYER$$93$YR$E$M$Y$$$20240821$$CN$US$US
242335811$24233581$1$I$20230901$20230908$20240821$20240821$PER$$US-PERRIGO-23US010933$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335821$24233582$1$I$20230901$20230909$20240821$20240821$PER$$US-PERRIGO-23US010877$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242335831$24233583$1$I$20230901$20230918$20240821$20240821$PER$$US-PERRIGO-23US011289$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335841$24233584$1$I$20230901$20230919$20240821$20240821$PER$$US-PERRIGO-23US011298$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335851$24233585$1$I$20230901$20230922$20240821$20240821$PER$$US-PERRIGO-23US011302$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335861$24233586$1$I$20230901$20230907$20240821$20240821$PER$$US-PERRIGO-23US010754$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242335871$24233587$1$I$20230905$20230908$20240821$20240821$PER$$US-PERRIGO-23US010934$PERRIGO$$39$YR$$F$Y$90.794$KG$20240821$$CN$US$US
242335881$24233588$1$I$20230801$20230820$20240821$20240821$PER$$US-PERRIGO-23US010918$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242335891$24233589$1$I$20230701$20230906$20240821$20240821$PER$$US-PERRIGO-23US010669$PERRIGO$$69$YR$$F$Y$117.91$KG$20240821$$CN$US$US
242335901$24233590$1$I$20230901$20230908$20240821$20240821$PER$$US-PERRIGO-23US010927$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335911$24233591$1$I$20230901$20230831$20240821$20240821$PER$$US-PERRIGO-23US011106$PERRIGO$$87$YR$$F$Y$104.31$KG$20240821$$CN$US$US
242335921$24233592$1$I$20230901$20230922$20240821$20240821$PER$$US-PERRIGO-23US011312$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335931$24233593$1$I$20230908$20230908$20240821$20240821$PER$$US-PERRIGO-23US010769$PERRIGO$$$$A$F$Y$90.703$KG$20240821$$CN$US$US
242335941$24233594$1$I$$20240813$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US072752$SANDOZ$$$$$F$Y$$$20240821$$CN$US$US
242335951$24233595$1$I$$20240813$20240821$20240821$PER$$US-ALXN-202408USA000768US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242335961$24233596$1$I$$20240816$20240821$20240821$EXP$$US-ABBVIE-5880308$ABBVIE$$$$$F$Y$75$KG$20240821$$HP$US$US
242335971$24233597$1$I$$20240808$20240821$20240821$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08062$LUPIN$Parmeshwar N, Song S, Alcon A, Kim EA. The incidence of breast cancer after gender-affirming mastectomy in transmen. Annals of Plastic Surgery. 2022;88(4):S332-S336$54$YR$$F$Y$$$20240821$$MD$US$US
242335981$24233598$1$I$20230901$20230905$20240821$20240821$PER$$US-PERRIGO-23US012367$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242335991$24233599$1$I$$20231020$20240821$20240821$PER$$US-PERRIGO-23US012339$PERRIGO$$$$A$$Y$$$20240821$$$US$US
242336001$24233600$1$I$20231001$20231013$20240821$20240821$PER$$US-PERRIGO-23US012063$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336011$24233601$1$I$20230928$20231018$20240821$20240821$PER$$US-PERRIGO-23US012205$PERRIGO$$49$YR$$F$Y$86.168$KG$20240821$$CN$US$US
242336021$24233602$1$I$20231003$20231023$20240821$20240821$PER$$US-PERRIGO-23US012364$PERRIGO$$57$YR$$F$Y$65.76$KG$20240821$$CN$US$US
242336031$24233603$1$I$20231101$20231117$20240821$20240821$PER$$US-PERRIGO-23US013274$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336041$24233604$1$I$20231001$20231017$20240821$20240821$PER$$US-PERRIGO-23US012546$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336051$24233605$1$I$20230101$20231122$20240821$20240821$PER$$US-PERRIGO-23US013639$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336061$24233606$1$I$20230501$20231101$20240821$20240821$PER$$US-PERRIGO-23US012655$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336071$24233607$1$I$$20231115$20240821$20240821$PER$$US-PERRIGO-23US013199$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336081$24233608$1$I$20231114$20231114$20240821$20240821$PER$$US-PERRIGO-23US013548$PERRIGO$$45$YR$$F$Y$$$20240821$$CN$US$US
242336091$24233609$1$I$20230901$20231010$20240821$20240821$PER$$US-PERRIGO-23US011893$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336101$24233610$1$I$20230901$20230928$20240821$20240821$PER$$US-PERRIGO-23US011549$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336111$24233611$1$I$20230901$20230925$20240821$20240821$PER$$US-PERRIGO-23US011488$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336121$24233612$1$I$20200101$20231005$20240821$20240821$PER$$US-PERRIGO-23US011723$PERRIGO$$$$$F$Y$46.259$KG$20240821$$CN$US$US
242336131$24233613$1$I$$20231023$20240821$20240821$PER$$US-PERRIGO-23US012700$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336151$24233615$1$I$$20240724$20240821$20240821$PER$$US-Dermavant-001246$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$CN$COUNTRY NOT SPECIFIED$US
242336161$24233616$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163569$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242336171$24233617$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163563$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242336181$24233618$1$I$$20240814$20240821$20240821$EXP$$BE-JNJFOC-20240840379$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$MD$BE$BE
242336192$24233619$2$F$$20240820$20240821$20240904$PER$$US-KARYOPHARM-2024KPT001351$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240904$$CN$US$US
242336201$24233620$1$I$$20240729$20240821$20240821$PER$$US-Dermavant-001247$DERMAVANT SCIENCES$$$$$M$Y$$$20240820$$HP$US$US
242336211$24233621$1$I$$20240112$20240821$20240821$PER$$US-PERRIGO-24US000464$PERRIGO$$$$$F$Y$68.934$KG$20240821$$CN$US$US
242336221$24233622$1$I$$20240107$20240821$20240821$PER$$US-PERRIGO-24US000187$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336231$24233623$1$I$$20240116$20240821$20240821$PER$$US-PERRIGO-24US000567$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336241$24233624$1$I$$20231229$20240821$20240821$PER$$US-PERRIGO-23US015103$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336251$24233625$1$I$20231228$20240102$20240821$20240821$PER$$US-PERRIGO-24US000023$PERRIGO$$65$YR$$F$Y$86.168$KG$20240821$$CN$US$US
242336261$24233626$1$I$20200101$20231215$20240821$20240821$PER$$US-PERRIGO-23US014676$PERRIGO$$82$YR$$F$Y$$$20240821$$CN$US$US
242336271$24233627$1$I$20190101$20231228$20240821$20240821$PER$$US-PERRIGO-23US014975$PERRIGO$$$$$F$Y$68.027$KG$20240821$$CN$US$US
242336281$24233628$1$I$20231113$20231204$20240821$20240821$PER$$US-PERRIGO-23US013853$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336291$24233629$1$I$$20231218$20240821$20240821$PER$$US-PERRIGO-23US014685$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336301$24233630$1$I$20231209$20231214$20240821$20240821$PER$$US-PERRIGO-23US014603$PERRIGO$$87$YR$$F$Y$39.456$KG$20240821$$CN$US$US
242336311$24233631$1$I$20230101$20240112$20240821$20240821$PER$$US-PERRIGO-24US000496$PERRIGO$$83$YR$$F$Y$43.084$KG$20240821$$CN$US$US
242336321$24233632$1$I$$20231229$20240821$20240821$PER$$US-PERRIGO-23US015090$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336331$24233633$1$I$$20240819$20240821$20240821$DIR$FDA-CDER-CTU-2024-57576$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242336341$24233634$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57604$$FDA-CTU$$58$YR$$F$N$$$20240821$N$HP$US$
242336351$24233635$1$I$20240101$20240817$20240821$20240821$EXP$$US-SA-2024SA247399$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240821$$CN$US$US
242336361$24233636$1$I$$20240816$20240821$20240821$EXP$$CO-SA-2017SA207950$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240821$$HP$CO$CO
242336371$24233637$1$I$$20240816$20240821$20240821$EXP$$US-SA-2024SA245040$SANOFI AVENTIS$$95$YR$E$F$Y$$$20240821$$HP$US$US
242336382$24233638$2$F$20240101$20240820$20240821$20240826$PER$$US-KARYOPHARM-2024KPT001396$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240826$$CN$US$US
242336391$24233639$1$I$20240101$20240819$20240821$20240821$EXP$$ZA-ABBVIE-5887549$ABBVIE$$53$YR$$F$Y$$$20240821$$CN$ZA$ZA
242336401$24233640$1$I$$20240730$20240821$20240821$PER$$US-Dermavant-001248$DERMAVANT SCIENCES$$48$YR$$F$Y$$$20240820$$HP$US$US
242336411$24233641$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57551$$FDA-CTU$$$$$$N$$$20240820$$CN$US$
242336441$24233644$1$I$$20240202$20240821$20240821$PER$$US-PERRIGO-24US001341$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336451$24233645$1$I$20231101$20240201$20240821$20240821$PER$$US-PERRIGO-24US001193$PERRIGO$$70$YR$$F$Y$102.04$KG$20240821$$CN$US$US
242336461$24233646$1$I$20240122$20240122$20240821$20240821$PER$$US-PERRIGO-24US000756$PERRIGO$$68$YR$$F$Y$54.875$KG$20240821$$CN$US$US
242336471$24233647$1$I$$20240130$20240821$20240821$PER$$US-PERRIGO-24US001107$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336481$24233648$1$I$20231201$20240129$20240821$20240821$PER$$US-PERRIGO-24US001024$PERRIGO$$81$YR$$F$Y$53.515$KG$20240821$$CN$US$US
242336491$24233649$1$I$$20240729$20240821$20240821$PER$$US-Dermavant-001250$DERMAVANT SCIENCES$$$$$F$Y$$$20240820$$HP$US$US
242336501$24233650$1$I$$20240124$20240821$20240821$PER$$US-PERRIGO-24US001456$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336511$24233651$1$I$20231228$20240124$20240821$20240821$PER$$US-PERRIGO-24US000851$PERRIGO$$81$YR$$F$Y$68.027$KG$20240821$$CN$US$US
242336521$24233652$1$I$20140101$20240212$20240821$20240821$PER$$US-PERRIGO-24US001590$PERRIGO$$$$$$Y$$$20240821$$CN$US$US
242336531$24233653$1$I$$20240816$20240821$20240821$EXP$$US-AMERICAN REGENT INC-2024003192$AMERICAN REGENT$Yalamanchili, S., Talei, B., Azizzadeh, B., Auersvald,A., Frankel AS. Wound Healing Complications With Tranexamic Acid: Not the Silver Bullet After All. Aesthetic Surgery Journal. 2023;43(12):1409-1415$53$YR$$F$Y$$$20240821$$MD$US$US
242336541$24233654$1$I$20220101$20240123$20240821$20240821$PER$$US-PERRIGO-24US000817$PERRIGO$$$$$F$Y$44.444$KG$20240821$$CN$US$US
242336551$24233655$1$I$$20240301$20240821$20240821$PER$$US-PERRIGO-24US002546$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336561$24233656$1$I$$20240306$20240821$20240821$PER$$US-PERRIGO-24US002526$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336571$24233657$1$I$20240101$20240308$20240821$20240821$PER$$US-PERRIGO-24US002481$PERRIGO$$67$YR$$F$Y$53.968$KG$20240821$$CN$US$US
242336581$24233658$1$I$20240112$20240306$20240821$20240821$PER$$US-PERRIGO-24US002393$PERRIGO$$58$YR$$F$Y$51.247$KG$20240821$$CN$US$US
242336591$24233659$1$I$20230901$20240305$20240821$20240821$PER$$US-PERRIGO-24US002362$PERRIGO$$53$YR$$F$Y$56.689$KG$20240821$$CN$US$US
242336601$24233660$1$I$$20240308$20240821$20240821$PER$$US-PERRIGO-24US002482$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336611$24233661$1$I$20231115$20240226$20240821$20240821$PER$$US-PERRIGO-24US002097$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336621$24233662$1$I$20240214$20240229$20240821$20240821$PER$$US-PERRIGO-24US002361$PERRIGO$$48$YR$$F$Y$$$20240821$$CN$US$US
242336631$24233663$1$I$$20240401$20240821$20240821$PER$$US-PERRIGO-24US003283$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336641$24233664$1$I$20240201$20240213$20240821$20240821$PER$$US-PERRIGO-24US001653$PERRIGO$$68$YR$$F$Y$72.562$KG$20240821$$CN$US$US
242336651$24233665$1$I$$20240306$20240821$20240821$PER$$US-PERRIGO-24US002395$PERRIGO$$$$$$Y$$$20240821$$CN$US$US
242336661$24233666$1$I$$20240325$20240821$20240821$PER$$US-PERRIGO-24US003137$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336671$24233667$1$I$20240301$20240326$20240821$20240821$PER$$US-PERRIGO-24US003015$PERRIGO$$$$A$$Y$46.259$KG$20240821$$CN$US$US
242336681$24233668$1$I$20240101$20240307$20240821$20240821$PER$$US-PERRIGO-24US002454$PERRIGO$$64$YR$$F$Y$58.957$KG$20240821$$CN$US$US
242336691$24233669$1$I$20240201$20240401$20240821$20240821$PER$$US-PERRIGO-24US003340$PERRIGO$$59$YR$$F$Y$64.399$KG$20240821$$CN$US$US
242336701$24233670$1$I$20240207$20240207$20240821$20240821$PER$$US-PERRIGO-24US001446$PERRIGO$$71$YR$$F$Y$$$20240821$$CN$US$US
242336711$24233671$1$I$$20240731$20240821$20240821$PER$$US-Dermavant-001251$DERMAVANT SCIENCES$$$$$F$Y$$$20240820$$MD$US$US
242336721$24233672$1$I$20240701$20240816$20240821$20240821$EXP$$US-SA-2023SA384581$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240821$$MD$US$US
242336731$24233673$1$I$20240101$20240815$20240821$20240821$EXP$$US-SA-2024SA246466$SANOFI AVENTIS$$35$YR$A$F$Y$95.254$KG$20240821$$MD$US$US
242336751$24233675$1$I$$20240801$20240821$20240821$PER$$US-Dermavant-001252$DERMAVANT SCIENCES$$50$YR$$M$Y$$$20240820$$HP$US$US
242336761$24233676$1$I$20240404$20240404$20240821$20240821$PER$$US-PERRIGO-24US003408$PERRIGO$$$$$$Y$$$20240821$$CN$US$US
242336771$24233677$1$I$20240501$20240507$20240821$20240821$PER$$US-PERRIGO-24US004660$PERRIGO$$40$YR$$$Y$$$20240821$$CN$US$US
242336781$24233678$1$I$20230501$20240528$20240821$20240821$PER$$US-PERRIGO-24US005188$PERRIGO$$84$YR$$F$Y$83.447$KG$20240821$$CN$US$US
242336791$24233679$1$I$20240101$20240604$20240821$20240821$PER$$US-PERRIGO-24US005432$PERRIGO$$73$YR$$F$Y$88.435$KG$20240821$$CN$US$US
242336801$24233680$1$I$$20240527$20240821$20240821$PER$$US-PERRIGO-24US005180$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336811$24233681$1$I$$20240520$20240821$20240821$PER$$US-PERRIGO-24US004983$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242336821$24233682$1$I$20240320$20240603$20240821$20240821$PER$$US-PERRIGO-24US005399$PERRIGO$$84$YR$$F$Y$70.295$KG$20240821$$CN$US$US
242336831$24233683$1$I$$20240429$20240821$20240821$PER$$US-PERRIGO-24US004216$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336842$24233684$2$F$20240701$20240906$20240821$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131998$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240909$$HP$US$US
242336851$24233685$1$I$$20240404$20240821$20240821$PER$$US-PERRIGO-24US003423$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336861$24233686$1$I$$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132265$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$87.18$KG$20240821$$CN$US$US
242336871$24233687$1$I$$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132093$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240821$$CN$US$US
242336881$24233688$1$I$20240701$20240819$20240821$20240821$EXP$$US-SA-2024SA247266$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240821$$MD$US$US
242336891$24233689$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163647$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242336901$24233690$1$I$$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163678$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240821$$HP$US$US
242336911$24233691$1$I$20240816$20240816$20240821$20240821$PER$$US-JNJFOC-20240843716$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240821$$CN$US$US
242336921$24233692$1$I$20240419$20240814$20240821$20240821$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07308$VIFOR$$50$YR$$M$Y$$$20240821$$HP$ZA$ZA
242336931$24233693$1$I$$20240801$20240821$20240821$PER$$US-Dermavant-001254$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$MD$US$US
242336941$24233694$1$I$20240214$20240807$20240821$20240821$EXP$$ES-VER-202400007$VERITY PHARMACEUTICALS$$83$YR$E$M$Y$78$KG$20240821$$HP$ES$ES
242336951$24233695$1$I$$20240819$20240821$20240821$PER$$NVSC2024US168588$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
242336961$24233696$1$I$20240101$20240604$20240821$20240821$PER$$US-PERRIGO-24US005551$PERRIGO$$48$YR$$M$Y$$$20240821$$CN$US$US
242336971$24233697$1$I$20240705$20240709$20240821$20240821$PER$$US-PERRIGO-24US006518$PERRIGO$$88$YR$$F$Y$58.05$KG$20240821$$CN$US$US
242336981$24233698$1$I$$20240626$20240821$20240821$PER$$US-PERRIGO-24US006136$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242336991$24233699$1$I$$20240711$20240821$20240821$PER$$US-PERRIGO-24US006649$PERRIGO$$$$A$$Y$$$20240821$$CN$US$US
242337001$24233700$1$I$$20240722$20240821$20240821$PER$$US-PERRIGO-24US006993$PERRIGO$$96$YR$$F$Y$$$20240821$$CN$US$US
242337011$24233701$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243754$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240821$$MD$US$US
242337021$24233702$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243779$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240821$$MD$US$US
242337031$24233703$1$I$20240622$20240715$20240821$20240821$PER$$US-PERRIGO-24US006714$PERRIGO$$56$YR$$F$Y$47.619$KG$20240821$$CN$US$US
242337041$24233704$1$I$$20240712$20240821$20240821$PER$$US-PERRIGO-24US006614$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242337051$24233705$1$I$20240601$20240722$20240821$20240821$PER$$US-PERRIGO-24US006984$PERRIGO$$42$YR$$F$Y$63.492$KG$20240821$$CN$US$US
242337063$24233706$3$F$20240101$20240816$20240821$20240826$PER$$US-SA-2024SA242839$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240826$$MD$US$US
242337071$24233707$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246076$SANOFI AVENTIS$$$$A$M$Y$108.84$KG$20240821$$MD$US$US
242337081$24233708$1$I$20240801$20240813$20240821$20240821$PER$$US-SA-2024SA244384$SANOFI AVENTIS$$52$YR$A$F$Y$105$KG$20240821$$MD$US$US
242337091$24233709$1$I$20240701$20240812$20240821$20240821$PER$$US-SA-2024SA243213$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240821$$MD$US$US
242337101$24233710$1$I$$20240805$20240821$20240821$PER$$US-Dermavant-001255$DERMAVANT SCIENCES$$$$A$F$Y$$$20240820$$CN$US$US
242337111$24233711$1$I$$20240819$20240821$20240821$PER$$US-TAKEDA-2024TUS083754$TAKEDA$$$$$M$Y$$$20240821$$CN$US$US
242337121$24233712$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA243765$SANOFI AVENTIS$$13$YR$T$M$Y$117.9$KG$20240821$$MD$US$US
242337131$24233713$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA246820$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242337141$24233714$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246181$SANOFI AVENTIS$$$$A$F$Y$102$KG$20240821$$MD$US$US
242337151$24233715$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA075407$SANOFI AVENTIS$$23$YR$A$F$Y$90.159$KG$20240821$$MD$US$US
242337161$24233716$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA179525$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240821$$MD$US$US
242337171$24233717$1$I$20240809$20240813$20240821$20240821$PER$$US-SA-2024SA244808$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240821$$MD$US$US
242337181$24233718$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA243562$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240821$$CN$US$US
242337191$24233719$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243732$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240821$$MD$US$US
242337201$24233720$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246118$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242337212$24233721$2$F$20240801$20240904$20240821$20240928$PER$$US-SA-2024SA245176$SANOFI AVENTIS$$29$YR$A$F$Y$99$KG$20240928$$MD$US$US
242337221$24233722$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA242906$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240821$$MD$US$US
242337231$24233723$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA083304$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240821$$MD$US$US
242337241$24233724$1$I$20240201$20240812$20240821$20240821$PER$$US-SA-2024SA241319$SANOFI AVENTIS$$$$$M$Y$$$20240821$$CN$US$US
242337252$24233725$2$F$$20240828$20240821$20240923$PER$$US-SA-2024SA242994$SANOFI AVENTIS$$17$YR$T$F$Y$63.64$KG$20240923$$MD$US$US
242337261$24233726$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243535$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240821$$CN$US$US
242337271$24233727$1$I$$20240806$20240821$20240821$PER$$US-Dermavant-001256$DERMAVANT SCIENCES$$$$A$M$Y$$$20240820$$MD$US$US
242337281$24233728$1$I$$20240816$20240821$20240821$PER$$US-BAYER-2024A118771$BAYER$$$$$$Y$$$20240821$$CN$US$US
242337301$24233730$1$I$20240101$20240725$20240821$20240821$PER$$US-PERRIGO-24US007100$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242337311$24233731$1$I$20240501$20240730$20240821$20240821$PER$$US-PERRIGO-24US007231$PERRIGO$$$$$F$Y$$$20240821$$CN$US$US
242337321$24233732$1$I$20240624$20240725$20240821$20240821$PER$$US-PERRIGO-24US007128$PERRIGO$$74$YR$$F$Y$53.968$KG$20240821$$CN$US$US
242337331$24233733$1$I$20240720$20240724$20240821$20240821$PER$$US-PERRIGO-24US007080$PERRIGO$$75$YR$$F$Y$82.993$KG$20240821$$CN$US$US
242337341$24233734$1$I$$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024164989$AMGEN$$$$$M$Y$$$20240821$$CN$US$US
242337351$24233735$1$I$$20240814$20240821$20240821$PER$$US-AstraZeneca-2024A186085$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
242337361$24233736$1$I$20240621$20240814$20240821$20240821$PER$$US-SA-2024SA243538$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240821$$CN$US$US
242337371$24233737$1$I$20240817$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57572$$FDA-CTU$$43$YR$$F$N$69.8$KG$20240820$N$PH$US$
242337401$24233740$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA247195$SANOFI AVENTIS$$$$$F$Y$$$20240821$$MD$US$US
242337412$24233741$2$F$20240101$20240916$20240821$20240926$PER$$US-SA-2024SA093467$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240926$$MD$US$US
242337421$24233742$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245066$SANOFI AVENTIS$$$$T$F$Y$$$20240821$$MD$US$US
242337431$24233743$1$I$$20240819$20240821$20240821$EXP$$CA-TEVA-VS-3234314$TEVA$$63$YR$$F$Y$$$20240821$$HP$CA$CA
242337441$24233744$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA057384$SANOFI AVENTIS$$41$YR$A$M$Y$104.3$KG$20240821$$MD$US$US
242337462$24233746$2$F$$20240828$20240821$20240918$PER$$US-SA-2024SA242480$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
242337471$24233747$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA240858$SANOFI AVENTIS$$$$$F$Y$$$20240821$$MD$US$US
242337481$24233748$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA244624$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240821$$MD$US$US
242337491$24233749$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA246892$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240821$$MD$US$US
242337502$24233750$2$F$20210130$20240812$20240821$20240827$PER$$US-SA-2024SA242638$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240827$$MD$US$US
242337521$24233752$1$I$20220221$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184190$ASTRAZENECA$$72$YR$$M$Y$92$KG$20240821$$MD$FR$
242337531$24233753$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243194$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240821$$MD$US$US
242337541$24233754$1$I$$20240813$20240821$20240821$EXP$$ZA-AstraZeneca-2024A184502$ASTRAZENECA$$81$YR$$M$Y$$$20240821$$CN$ZA$
242337552$24233755$2$F$20220101$20240814$20240821$20240828$PER$$US-SA-2024SA244914$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240828$$CN$US$US
242337561$24233756$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA247258$SANOFI AVENTIS$$$$A$F$Y$55$KG$20240821$$MD$US$US
242337571$24233757$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA246233$SANOFI AVENTIS$$$$E$F$Y$$$20240821$$MD$US$US
242337581$24233758$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA246337$SANOFI AVENTIS$$$$E$M$Y$73.48$KG$20240821$$MD$US$US
242337591$24233759$1$I$$20240808$20240821$20240821$EXP$$US-SMPA-2024SPA001121$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242337601$24233760$1$I$$20240808$20240821$20240821$EXP$$US-SMPA-2024SPA001107$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242337611$24233761$1$I$$20240808$20240821$20240821$EXP$$US-SMPA-2024SPA001126$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242337622$24233762$2$F$$20240905$20240821$20240917$EXP$$US-SMPA-2024SPA001015$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
242337641$24233764$1$I$$20240808$20240821$20240821$EXP$$US-SMPA-2024SPA001129$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242337651$24233765$1$I$20240812$20240814$20240821$20240821$30DAY$$AR-PFIZER INC-202400236611$PFIZER$$14$YR$$M$Y$$$20240821$$HP$AR$AR
242337663$24233766$3$F$$20240920$20240821$20240923$30DAY$$CO-PFIZER INC-202400235738$PFIZER$$7$YR$$M$Y$$$20240923$$CN$CO$CO
242337671$24233767$1$I$$20240809$20240821$20240821$EXP$$US-SMPA-2024SPA001125$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242337692$24233769$2$F$20231101$20240815$20240821$20240828$EXP$$US-SMPA-2024SPA001117$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242337702$24233770$2$F$$20240905$20240821$20240917$EXP$$US-SMPA-2022MYSCI0500089$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
242337711$24233771$1$I$20240104$20240814$20240821$20240821$PER$$CN-Eisai-EC-2024-172104$EISAI$$56$YR$A$M$Y$66$KG$20240821$$HP$CN$CN
242337721$24233772$1$I$$20240806$20240821$20240821$PER$$US-Dermavant-001257$DERMAVANT SCIENCES$$50$YR$$F$Y$$$20240820$$HP$US$US
242337741$24233774$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57566$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242337761$24233776$1$I$20150602$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57540$$FDA-CTU$$33$YR$$F$N$61.23$KG$20240820$N$CN$US$
242337771$24233777$1$I$20240820$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57567$$FDA-CTU$$43$YR$$F$N$$$20240820$N$PH$US$
242337841$24233784$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA111017$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240821$$MD$US$US
242337861$24233786$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241450$SANOFI AVENTIS$$$$$F$Y$$$20240821$$CN$US$US
242337871$24233787$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246790$SANOFI AVENTIS$$$$E$F$Y$46.53$KG$20240821$$MD$US$US
242337881$24233788$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244607$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240821$$MD$US$US
242337901$24233790$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243451$SANOFI AVENTIS$$$$E$M$Y$$$20240821$$MD$US$US
242337911$24233791$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245265$SANOFI AVENTIS$$$$T$F$Y$56.689$KG$20240821$$MD$US$US
242337922$24233792$2$F$20240101$20240911$20240821$20240926$PER$$US-SA-2024SA244605$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240926$$MD$US$US
242337931$24233793$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA244793$SANOFI AVENTIS$$$$C$F$Y$$$20240821$$MD$US$US
242337941$24233794$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA242278$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240821$$MD$US$US
242337951$24233795$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA243790$SANOFI AVENTIS$$$$$$Y$$$20240821$$CN$US$US
242337961$24233796$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA243488$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240821$$CN$US$US
242337971$24233797$1$I$20240401$20240813$20240821$20240821$PER$$US-SA-2024SA243751$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240821$$MD$US$US
242337981$24233798$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA245174$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240821$$MD$US$US
242337991$24233799$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA243419$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240821$$CN$US$US
242338002$24233800$2$F$20240101$20240822$20240821$20240902$PER$$US-SA-2024SA243757$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240902$$MD$US$US
242338011$24233801$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA245305$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240821$$MD$US$US
242338021$24233802$1$I$$20240803$20240821$20240821$PER$$US-Dermavant-001258$DERMAVANT SCIENCES$$$$A$F$Y$$$20240820$$HP$US$US
242338031$24233803$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA245177$SANOFI AVENTIS$$$$A$F$Y$52.1$KG$20240821$$MD$US$US
242338041$24233804$1$I$20240811$20240814$20240821$20240821$PER$$US-SA-2024SA245287$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240821$$MD$US$US
242338051$24233805$1$I$20240801$20240812$20240821$20240821$PER$$US-SA-2024SA075418$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240821$$MD$US$US
242338061$24233806$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2023SA023321$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240821$$MD$US$US
242338071$24233807$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243615$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240821$$MD$US$US
242338101$24233810$1$I$20220427$20240814$20240821$20240821$PER$$US-SA-2024SA244346$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240821$$MD$US$US
242338111$24233811$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA245053$SANOFI AVENTIS$$$$A$F$Y$99.79$KG$20240821$$MD$US$US
242338121$24233812$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA246810$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240821$$MD$US$US
242338131$24233813$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243220$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240821$$CN$US$US
242338141$24233814$1$I$20240801$20240812$20240821$20240821$PER$$US-SA-2024SA243144$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240821$$MD$US$US
242338151$24233815$1$I$20240725$20240814$20240821$20240821$PER$$US-SA-2024SA245856$SANOFI AVENTIS$$53$YR$A$M$Y$79$KG$20240821$$MD$US$US
242338161$24233816$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA243552$SANOFI AVENTIS$$$$$M$Y$$$20240821$$CN$US$US
242338171$24233817$1$I$$20240807$20240821$20240821$PER$$US-Dermavant-001260$DERMAVANT SCIENCES$$$$$F$Y$$$20240821$$CN$US$US
242338191$24233819$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243416$SANOFI AVENTIS$$7$YR$C$F$Y$22.6$KG$20240821$$MD$US$US
242338201$24233820$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243152$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240821$$PH$US$US
242338211$24233821$1$I$20240701$20240729$20240821$20240821$PER$$US-009507513-2407USA015163$MERCK$$52$YR$$F$Y$$$20240821$$CN$US$US
242338221$24233822$1$I$$20240819$20240821$20240821$PER$$US-ABBVIE-5887101$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242338231$24233823$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244238$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240821$$CN$US$US
242338241$24233824$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243665$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240821$$MD$US$US
242338251$24233825$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA245051$SANOFI AVENTIS$$$$A$F$Y$83$KG$20240821$$MD$US$US
242338261$24233826$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244233$SANOFI AVENTIS$$61$YR$A$M$Y$67.13$KG$20240821$$CN$US$US
242338271$24233827$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA244584$SANOFI AVENTIS$$65$YR$E$M$Y$106$KG$20240821$$MD$US$US
242338281$24233828$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241074$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
242338291$24233829$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA242775$SANOFI AVENTIS$$$$A$F$Y$94$KG$20240821$$MD$US$US
242338301$24233830$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA244826$SANOFI AVENTIS$$67$YR$E$M$Y$69.39$KG$20240821$$MD$US$US
242338321$24233832$1$I$20240801$20240812$20240821$20240821$PER$$US-SA-2024SA242856$SANOFI AVENTIS$$56$YR$A$F$Y$68.03$KG$20240821$$MD$US$US
242338331$24233833$1$I$20240801$20240813$20240821$20240821$PER$$US-SA-2024SA243893$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240821$$MD$US$US
242338341$24233834$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA242628$SANOFI AVENTIS$$2$YR$C$F$Y$11.3$KG$20240821$$MD$US$US
242338351$24233835$1$I$$20240809$20240821$20240821$PER$$US-Dermavant-001261$DERMAVANT SCIENCES$$$$$M$Y$$$20240820$$HP$US$US
242338361$24233836$1$I$20240811$20240813$20240821$20240821$PER$$US-SA-2024SA245767$SANOFI AVENTIS$$46$YR$A$F$Y$77.1$KG$20240821$$MD$US$US
242338371$24233837$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241949$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240821$$MD$US$US
242338381$24233838$1$I$$20240819$20240821$20240821$PER$$US-BAYER-2024A119626$BAYER$$$$$F$Y$$$20240821$$CN$US$US
242338401$24233840$1$I$20240515$20240815$20240821$20240821$EXP$$AR-ELI_LILLY_AND_COMPANY-AR202408011950$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240821$$CN$DE$AR
242338412$24233841$2$F$20240819$20240819$20240821$20240825$PER$$US-AMGEN-USASP2024165551$AMGEN$$76$YR$E$F$Y$$$20240825$$CN$US$US
242338422$24233842$2$F$20240819$20240829$20240821$20240902$PER$$US-AMGEN-USASP2024166072$AMGEN$$76$YR$E$F$Y$$$20240902$$HP$US$US
242338431$24233843$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA247210$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240821$$CN$US$US
242338441$24233844$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246443$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
242338451$24233845$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246374$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240821$$CN$US$US
242338462$24233846$2$F$20240812$20240819$20240821$20240830$PER$$US-SA-2024SA246278$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240830$$CN$US$US
242338471$24233847$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246750$SANOFI AVENTIS$$$$$$Y$$$20240821$$HP$US$US
242338481$24233848$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246439$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240821$$CN$US$US
242338491$24233849$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA246203$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240821$$MD$US$US
242338502$24233850$2$F$20240101$20240826$20240821$20240909$PER$$US-SA-2024SA246002$SANOFI AVENTIS$$25$YR$A$F$Y$68$KG$20240909$$MD$US$US
242338511$24233851$1$I$20240701$20240815$20240821$20240821$PER$$US-SA-2024SA246465$SANOFI AVENTIS$$30$YR$A$F$Y$52.7$KG$20240821$$MD$US$US
242338521$24233852$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246360$SANOFI AVENTIS$$$$E$M$Y$$$20240821$$MD$US$US
242338533$24233853$3$F$20240815$20240919$20240821$20240930$PER$$US-SA-2024SA243671$SANOFI AVENTIS$$$$$$Y$$$20240930$$CN$US$US
242338541$24233854$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA246795$SANOFI AVENTIS$$68$YR$E$F$Y$95$KG$20240821$$MD$US$US
242338551$24233855$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246967$SANOFI AVENTIS$$92$YR$E$M$Y$$$20240821$$MD$US$US
242338561$24233856$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246097$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240821$$MD$US$US
242338571$24233857$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA247452$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240821$$MD$US$US
242338581$24233858$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA243268$SANOFI AVENTIS$$$$C$$Y$$$20240821$$CN$US$US
242338601$24233860$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA245088$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240821$$MD$US$US
242338611$24233861$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246277$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240821$$MD$US$US
242338622$24233862$2$F$20240101$20240830$20240821$20240913$PER$$US-SA-2024SA246513$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240913$$MD$US$US
242338631$24233863$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA244153$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240821$$CN$US$US
242338643$24233864$3$F$20240101$20240819$20240821$20240829$PER$$US-SA-2024SA246445$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240829$$MD$US$US
242338651$24233865$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA246091$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240821$$MD$US$US
242338665$24233866$5$F$20240101$20240910$20240821$20240926$PER$$US-SA-2024SA246624$SANOFI AVENTIS$$65$YR$E$F$Y$98.88$KG$20240926$$MD$US$US
242338672$24233867$2$F$$20240830$20240821$20240912$PER$$US-SA-2024SA245312$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240912$$MD$US$US
242338681$24233868$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA246877$SANOFI AVENTIS$$64$YR$A$F$Y$80$KG$20240821$$MD$US$US
242338691$24233869$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA246489$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240821$$MD$US$US
242338702$24233870$2$F$$20240826$20240821$20240919$PER$$US-SA-2024SA246519$SANOFI AVENTIS$$$$A$F$Y$74.84$KG$20240919$$MD$US$US
242338711$24233871$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246188$SANOFI AVENTIS$$$$E$F$Y$75$KG$20240821$$MD$US$US
242338721$24233872$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246894$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240821$$MD$US$US
242338732$24233873$2$F$20240701$20240826$20240821$20240830$30DAY$$CO-PFIZER INC-202400235740$PFIZER$$11$YR$$M$Y$34$KG$20240830$$CN$CO$CO
242338741$24233874$1$I$20240101$20240816$20240821$20240821$PER$$US-SA-2024SA246496$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240821$$CN$US$US
242338751$24233875$1$I$$20240813$20240821$20240821$PER$$US-Dermavant-001263$DERMAVANT SCIENCES$$$$$M$Y$$$20240821$$MD$US$
242338761$24233876$1$I$20211216$20240818$20240821$20240821$EXP$$IL-ABBVIE-4145183$ABBVIE$$70$YR$$M$Y$78$KG$20240821$$MD$IL$IL
242338771$24233877$1$I$$20240819$20240821$20240821$PER$$US-SA-2024SA247585$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240821$$CN$US$US
242338781$24233878$1$I$20240802$20240819$20240821$20240821$PER$$US-SA-2024SA246229$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240821$$CN$US$US
242338791$24233879$1$I$$20240816$20240821$20240821$PER$$US-SA-2024SA246806$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240821$$CN$US$US
242338801$24233880$1$I$20240817$20240817$20240821$20240821$PER$$US-SA-2024SA248222$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240821$$MD$US$US
242338811$24233881$1$I$20240101$20240816$20240821$20240821$PER$$US-SA-2024SA246874$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240821$$MD$US$US
242338821$24233882$1$I$$20240816$20240821$20240821$PER$$US-SA-2024SA245518$SANOFI AVENTIS$$$$E$F$Y$$$20240821$$CN$US$US
242338831$24233883$1$I$20221101$20240816$20240821$20240821$PER$$US-SA-2024SA247225$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240821$$MD$US$US
242338841$24233884$1$I$$20240816$20240821$20240821$PER$$US-SA-2024SA246131$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240821$$CN$US$US
242338851$24233885$1$I$$20240816$20240821$20240821$PER$$US-SA-2024SA246263$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240821$$MD$US$US
242338861$24233886$1$I$20240815$20240819$20240821$20240821$PER$$US-SA-2024SA247690$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240821$$CN$US$US
242338871$24233887$1$I$20240816$20240816$20240821$20240821$PER$$US-SA-2024SA243978$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240821$$MD$US$US
242338891$24233889$1$I$20240813$20240813$20240821$20240821$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000085$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240821$$CN$US$US
242338901$24233890$1$I$$20240816$20240821$20240821$EXP$$SG-MYLANLABS-2024M1077411$MYLAN$Huang W. Yeast or mold? A case of Trichosporon fungemia. Pathology 2024; 56 (Suppl. 1) S118.$$$E$F$Y$$$20240821$$HP$SG$SG
242338911$24233891$1$I$$20240815$20240821$20240821$PER$$US-Dermavant-001264$DERMAVANT SCIENCES$$$$A$M$Y$$$20240820$$CN$US$US
242338921$24233892$1$I$$20240816$20240821$20240821$EXP$$FR-MYLANLABS-2024M1076459$MYLAN$$73$YR$$F$Y$$$20240821$$MD$FR$FR
242338931$24233893$1$I$$20240812$20240821$20240821$PER$$US-Dermavant-001265$DERMAVANT SCIENCES$$$$A$M$Y$$$20240820$$MD$US$US
242338941$24233894$1$I$$20240814$20240821$20240821$PER$$US-ABBVIE-5884267$ABBVIE$$$$$$Y$$$20240821$$MD$US$US
242338951$24233895$1$I$20240222$20240814$20240821$20240821$EXP$$US-SA-2024SA244432$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240821$$MD$US$US
242338961$24233896$1$I$$20240814$20240821$20240821$EXP$$US-SA-2024SA244415$SANOFI AVENTIS$$81$YR$E$F$Y$65.3$KG$20240821$$HP$US$US
242338971$24233897$1$I$$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131553$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240821$$CN$US$US
242338981$24233898$1$I$20240607$20240813$20240821$20240821$EXP$SE-SEMPA-2024-005895$SE-TEVA-VS-3233878$TEVA$$73$YR$$F$Y$78$KG$20240821$$CN$SE$SE
242338992$24233899$2$F$20240804$20240819$20240821$20240827$EXP$$US-SA-2024SA247223$SANOFI AVENTIS$$38$YR$A$F$Y$108$KG$20240827$$MD$US$US
242339001$24233900$1$I$$20240815$20240821$20240821$PER$$US-BAYER-2024A118157$BAYER$$$$$F$Y$$$20240821$$CN$US$US
242339011$24233901$1$I$$20240814$20240821$20240821$EXP$$US-AstraZeneca-2024A187246$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242339021$24233902$1$I$20240810$20240815$20240821$20240821$PER$$US-BAYER-2024A118299$BAYER$$24$YR$A$F$Y$$$20240821$$HP$US$US
242339031$24233903$1$I$20240728$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A184622$ASTRAZENECA$$83$YR$$M$Y$90.7$KG$20240821$$CN$US$
242339053$24233905$3$F$$20240918$20240821$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA071461$SANDOZ$$$$$M$Y$$$20240923$$CN$CA$CA
242339061$24233906$1$I$$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57578$$FDA-CTU$$$$$M$N$$$20240820$N$HP$US$
242339071$24233907$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243274$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
242339081$24233908$1$I$20240729$20240814$20240821$20240821$PER$$US-SA-2024SA246115$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240821$$MD$US$US
242339092$24233909$2$F$$20240909$20240821$20240928$PER$$US-SA-2024SA242763$SANOFI AVENTIS$$$$A$M$Y$51.25$KG$20240928$$MD$US$US
242339101$24233910$1$I$$20240816$20240821$20240821$EXP$$CA-TAKEDA-2024TUS083325$TAKEDA$$$$$F$Y$$$20240821$$CN$CA$CA
242339111$24233911$1$I$20240818$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165768$AMGEN$$$$$$Y$$$20240821$$PH$US$US
242339132$24233913$2$F$20240819$20240819$20240821$20240825$PER$$US-AMGEN-USASP2024166152$AMGEN$$70$YR$E$F$Y$$$20240825$$CN$US$US
242339141$24233914$1$I$$20240814$20240821$20240821$EXP$$IN-INCYTE CORPORATION-2024IN008659$INCYTE$$$$$$Y$$$20240821$$CN$IN$IN
242339152$24233915$2$F$$20240829$20240821$20240903$EXP$$DE-MYLANLABS-2024M1076158$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology.. 2024;48 (5):299-313$54$YR$$M$Y$$$20240903$$HP$DE$DE
242339162$24233916$2$F$$20240829$20240821$20240903$EXP$$DE-MYLANLABS-2024M1076159$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$48$YR$$M$Y$$$20240903$$HP$DE$DE
242339171$24233917$1$I$$20240815$20240821$20240821$PER$$US-BAYER-2024A118357$BAYER$$37$YR$A$F$Y$$$20240821$$HP$US$US
242339181$24233918$1$I$$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131572$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240821$$CN$US$US
242339191$24233919$1$I$20240707$20240820$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132198$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240821$$CN$US$US
242339202$24233920$2$F$20240801$20240830$20240821$20240905$EXP$$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-132168$BRISTOL MYERS SQUIBB$$$$E$F$Y$77$KG$20240905$$MD$SE$SE
242339211$24233921$1$I$20240726$20240814$20240821$20240821$EXP$FR-AFSSAPS-RS2024000781$FR-009507513-2408FRA005011$MERCK$$68$YR$$F$Y$$$20240821$$MD$FR$FR
242339221$24233922$1$I$$20240819$20240821$20240821$EXP$$BG-SANDOZ INC.-SDZ2024BG073703$SANDOZ$$74$YR$$M$Y$$$20240821$$MD$BG$BG
242339231$24233923$1$I$$20240819$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA073821$SANDOZ$$70$YR$$F$Y$$$20240821$$HP$CA$CA
242339241$24233924$1$I$$20240815$20240821$20240821$EXP$$DE-MYLANLABS-2024M1076245$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$43$YR$$M$Y$$$20240821$$HP$DE$DE
242339251$24233925$1$I$$20240814$20240821$20240821$EXP$$US-ABBVIE-5881902$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242339262$24233926$2$F$$20240826$20240821$20240909$EXP$$MA-SCIEGENP-2024SCLIT00350$SCIEGEN$Mourabiti H, et al..Paraparesis secondary to metformin: A rare condition to be aware of, with characteristic MRI images.Toxicologie Analytique et Clinique.04-JUL-2024;1(1):1-6$63$YR$A$F$Y$$$20240909$$HP$MA$MA
242339271$24233927$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165558$AMGEN$$$$$M$Y$$$20240821$$CN$US$US
242339281$24233928$1$I$$20240807$20240821$20240821$EXP$$CN-SCIEGENP-2024SCLIT00351$SCIEGEN$Wu S, et al.Risperidone-associated venous thromboembolism in the treatment of schizophrenia:a case report and literature review.Chinese Journal of New Drugs.jun-2023;32 (12):1275-1280$53$YR$A$M$Y$$$20240821$$HP$CN$CN
242339291$24233929$1$I$$20240820$20240821$20240821$PER$$US-BAYER-2024A120068$BAYER$$$$$F$Y$$$20240821$$CN$US$US
242339301$24233930$1$I$$20240819$20240821$20240821$EXP$$AU-SANDOZ INC.-SDZ2024AU073603$SANDOZ$$65$YR$$M$Y$$$20240821$$MD$AU$AU
242339311$24233931$1$I$$20240724$20240821$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07499$LUPIN$$$$$$Y$$$20240821$$CN$US$US
242339321$24233932$1$I$$20240813$20240821$20240821$PER$$US-TAKEDA-2024TUS083843$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
242339331$24233933$1$I$$20240807$20240821$20240821$EXP$$IN-SCIEGENP-2024SCLIT00353$SCIEGEN$Claudine Ancilla L et al..Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy.Journal of Nephropharmacology.29-JUN-2024;13 (2):1-5$55$YR$A$M$Y$$$20240821$$HP$IN$IN
242339342$24233934$2$F$20240208$20240905$20240821$20240909$EXP$$NVSC2024GB031134$NOVARTIS$$48$YR$$F$Y$$$20240909$$CN$GB$GB
242339351$24233935$1$I$20240816$20240816$20240821$20240821$EXP$$US-ABBVIE-5885057$ABBVIE$$63$YR$$M$Y$$$20240821$$CN$US$US
242339361$24233936$1$I$$20240815$20240821$20240821$EXP$$US-ABBVIE-5882988$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242339371$24233937$1$I$$20240807$20240821$20240821$EXP$$IN-SCIEGENP-2024SCLIT00354$SCIEGEN$Claudine Ancilla L et al..Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy.Journal of Nephropharmacology.29-JUN-2024;13 (2):1-5$58$YR$A$M$Y$$$20240821$$HP$IN$IN
242339382$24233938$2$F$20240527$20240903$20240821$20240909$EXP$$KR-MYLANLABS-2024M1048509$MYLAN$$30$YR$$M$Y$$$20240909$$MD$KR$KR
242339392$24233939$2$F$20230101$20240905$20240821$20240909$PER$$US-BIOGEN-2023BI01221211$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
242339401$24233940$1$I$$20240820$20240821$20240821$EXP$$JP-BAYER-2024A119410$BAYER$$8$DEC$E$M$Y$$$20240821$$MD$JP$JP
242339411$24233941$1$I$$20240812$20240821$20240821$EXP$$US-GUERBET / LLC-US-20240133$GUERBET$Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation. Frontiers in Toxicology. 2024 Jul 25;6(1371131): 1-7. doi:10.3389/ftox.2024.1371131.$$$A$$Y$$$20240821$$MD$US$US
242339421$24233942$1$I$$20240812$20240821$20240821$EXP$$US-GUERBET / LLC-US-20240131$GUERBET$Semelka R. Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation. Frontiers in Toxicology. 2024 Jul 25;6(1371131): 1-7. doi:10.3389/ftox.2024.1371131.$$$A$$Y$$$20240821$$MD$US$US
242339431$24233943$1$I$$20240812$20240821$20240821$EXP$$US-GUERBET / LLC-US-20240135$GUERBET$Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation. Frontiers in Toxicology 2024 July 25; 6(1371131): 1-7.$$$A$$Y$$$20240821$$MD$US$US
242339441$24233944$1$I$$20240812$20240821$20240821$EXP$$US-GUERBET / LLC-US-20240134$GUERBET$Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation. Frontiers in Toxicology 2024 July 25; 6(1371131): 1-7.$$$A$$Y$$$20240821$$MD$US$US
242339451$24233945$1$I$$20240812$20240821$20240821$EXP$$US-GUERBET / LLC-US-20240132$GUERBET$Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation. Frontiers in Toxicology. 2024 Jul 25;6(1371131): 1-7. doi:10.3389/ftox.2024.1371131.$$$A$$Y$$$20240821$$MD$US$US
242339461$24233946$1$I$$20240812$20240821$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013140$JAZZ$$$$$F$Y$$$20240821$$CN$US$US
242339474$24233947$4$F$20240812$20240828$20240821$20240830$EXP$$IT-BIOVITRUM-2024-IT-010880$BIOVITRUM$$71$YR$$F$Y$$$20240830$$HP$IT$IT
242339491$24233949$1$I$20240101$20240814$20240821$20240821$EXP$$MA-BIOMARINAP-MA-2024-159988$BIOMARIN$$$$$$Y$$$20240821$$CN$MA$MA
242339501$24233950$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57586$$FDA-CTU$$72$YR$$F$N$68.95$KG$20240821$N$$US$
242339511$24233951$1$I$20200201$20240809$20240821$20240821$PER$$US-BIOMARINAP-US-2024-159944$BIOMARIN$$$$$$Y$$$20240821$$CN$US$US
242339521$24233952$1$I$$20240820$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA074091$SANDOZ$$$$$$Y$$$20240821$$HP$CA$CA
242339541$24233954$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA244427$SANOFI AVENTIS$$50$YR$A$F$Y$112.49$KG$20240821$$MD$US$US
242339551$24233955$1$I$$20240820$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA073982$SANDOZ$$62$WK$$F$Y$$$20240821$$MD$CA$CA
242339561$24233956$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246943$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240821$$MD$US$US
242339571$24233957$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A184952$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
242339581$24233958$1$I$20220318$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184240$ASTRAZENECA$$65$YR$$F$Y$40$KG$20240821$$MD$FR$
242339591$24233959$1$I$20240323$20240816$20240821$20240821$EXP$$FR-AstraZeneca-2024A189623$ASTRAZENECA$$38$YR$$M$Y$97$KG$20240821$$MD$FR$
242339601$24233960$1$I$$20240820$20240821$20240821$EXP$$AR-PFIZER INC-202400240954$PFIZER$$73$YR$$F$Y$$$20240821$$CN$AR$AR
242339611$24233961$1$I$$20240816$20240821$20240821$EXP$$US-PFIZER INC-PV202400107762$PFIZER$Cheney, A.. FROM MULTIPLE MYELOMA TO MYOCARDITIS. Journal of the American College of Cardiology. 2019;73(9 Supple 1):2597$53$YR$$M$Y$$$20240821$$HP$US$US
242339621$24233962$1$I$$20240816$20240821$20240821$EXP$$FR-PFIZER INC-202300350302$PFIZER$$27$YR$$F$Y$$$20240821$$MD$FR$FR
242339632$24233963$2$F$$20240920$20240821$20240920$PER$$US-PFIZER INC-202400238643$PFIZER$$50$YR$$M$Y$$$20240920$$MD$US$US
242339642$24233964$2$F$20240805$20240821$20240821$20240826$EXP$$HK-PFIZER INC-202400239645$PFIZER$$$$$F$Y$$$20240826$$MD$HK$HK
242339651$24233965$1$I$20240813$20240817$20240821$20240821$PER$$US-PFIZER INC-202400238495$PFIZER$$70$YR$$F$Y$$$20240821$$CN$US$US
242339661$24233966$1$I$20240815$20240816$20240821$20240821$PER$$US-PFIZER INC-202400238357$PFIZER$$86$YR$$F$Y$47.17$KG$20240821$$CN$US$US
242339671$24233967$1$I$$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57579$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242339681$24233968$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57614$$FDA-CTU$$67$YR$$M$N$$$20240821$N$$US$
242339692$24233969$2$F$$20240826$20240821$20240828$PER$$US-PFIZER INC-202400238659$PFIZER$$$$A$M$Y$$$20240828$$CN$US$US
242339701$24233970$1$I$$20240816$20240821$20240821$PER$$US-PFIZER INC-202400238438$PFIZER$$74$YR$$F$Y$$$20240821$$CN$US$US
242339711$24233971$1$I$$20240816$20240821$20240821$PER$$US-PFIZER INC-202400238433$PFIZER$$60$YR$$F$Y$$$20240821$$CN$US$US
242339721$24233972$1$I$20240818$20240818$20240821$20240821$PER$$US-PFIZER INC-202400238786$PFIZER$$75$YR$$M$Y$$$20240821$$CN$US$US
242339732$24233973$2$F$20240718$20240826$20240821$20240827$PER$$US-PFIZER INC-PV202400107105$PFIZER$$58$YR$$F$Y$94.347$KG$20240827$$MD$US$US
242339741$24233974$1$I$20240817$20240818$20240821$20240821$PER$$US-PFIZER INC-202400238765$PFIZER$$54$YR$$F$Y$$$20240821$$CN$US$US
242339751$24233975$1$I$$20240817$20240821$20240821$PER$$US-PFIZER INC-202400239333$PFIZER$$$$$$Y$$$20240821$$CN$US$US
242339761$24233976$1$I$$20240817$20240821$20240821$PER$$US-PFIZER INC-PV202400107914$PFIZER$$$$$$Y$$$20240821$$CN$US$US
242339771$24233977$1$I$$20240816$20240821$20240821$PER$$US-PFIZER INC-PV202400008898$PFIZER$$56$YR$$F$Y$$$20240821$$HP$US$US
242339782$24233978$2$F$20240724$20240826$20240821$20240829$EXP$NL-LRB-00994154$NL-PFIZER INC-202400238907$PFIZER$$42$YR$$F$Y$57$KG$20240829$$CN$NL$NL
242339791$24233979$1$I$20240220$20240819$20240821$20240821$EXP$$CA-PFIZER INC-202300175621$PFIZER$$64$YR$$F$Y$$$20240821$$MD$CA$CA
242339801$24233980$1$I$20240801$20240816$20240821$20240821$PER$$US-PFIZER INC-202400238314$PFIZER$$82$YR$$F$Y$$$20240821$$CN$US$US
242339821$24233982$1$I$$20240816$20240821$20240821$PER$$US-PFIZER INC-202400239364$PFIZER$$19$YR$$M$Y$$$20240821$$CN$US$US
242339831$24233983$1$I$$20240814$20240821$20240821$PER$$US-PFIZER INC-202400237860$PFIZER$$73$YR$$F$Y$$$20240821$$HP$US$US
242339841$24233984$1$I$$20240816$20240821$20240821$PER$$US-PFIZER INC-202400238429$PFIZER$$85$YR$$F$Y$$$20240821$$CN$US$US
242339851$24233985$1$I$$20240815$20240821$20240821$PER$$US-PFIZER INC-202400238461$PFIZER$$58$YR$$M$Y$$$20240821$$HP$US$US
242339861$24233986$1$I$20240101$20240814$20240821$20240821$PER$$US-PFIZER INC-PV202400014615$PFIZER$$55$YR$$F$Y$$$20240821$$HP$US$US
242339872$24233987$2$F$20230101$20240919$20240821$20240924$PER$$US-PFIZER INC-PV202400107865$PFIZER$$56$YR$$F$Y$$$20240924$$HP$US$US
242339881$24233988$1$I$20240814$20240816$20240821$20240821$PER$$US-PFIZER INC-202400238609$PFIZER$$60$YR$$M$Y$$$20240821$$CN$US$US
242339891$24233989$1$I$20240813$20240816$20240821$20240821$PER$$US-PFIZER INC-202400238957$PFIZER$$72$YR$$F$Y$$$20240821$$CN$US$US
242339901$24233990$1$I$$20240821$20240821$20240821$EXP$$CN-PFIZER INC-PV202400109041$PFIZER$$$$E$M$Y$$$20240821$$CN$CN$CN
242339912$24233991$2$F$20240809$20240921$20240821$20240923$PER$$US-PFIZER INC-202400238580$PFIZER$$36$YR$$M$Y$$$20240923$$MD$US$US
242339931$24233993$1$I$$20240818$20240821$20240821$PER$$US-PFIZER INC-PV202400108094$PFIZER$$$$$$Y$$$20240821$$CN$US$US
242339941$24233994$1$I$$20240820$20240821$20240821$EXP$$CN-PFIZER INC-PV202400108189$PFIZER$$$$E$F$Y$$$20240821$$CN$CN$CN
242339951$24233995$1$I$$20240815$20240821$20240821$EXP$$US-PFIZER INC-202400238090$PFIZER$Deprez, K.. Endobronchial Infection and Bacterial Lymphadenitis by Gemella morbillorum Leading to Airway Perforation and a Bronchopleural Fistula. Case Reports in Pulmonology. 2024;10.1155/2024/8850287$24$YR$$M$Y$$$20240821$$HP$US$US
242339963$24233996$3$F$$20240913$20240821$20240918$EXP$$US-PFIZER INC-PV202400107281$PFIZER$$33$YR$$M$Y$$$20240918$$HP$US$US
242339971$24233997$1$I$$20240815$20240821$20240821$PER$$US-PFIZER INC-202400237887$PFIZER$$63$YR$$F$Y$$$20240821$$CN$US$US
242339981$24233998$1$I$$20240816$20240821$20240821$PER$$US-PFIZER INC-202400238328$PFIZER$$$$$M$Y$$$20240821$$HP$US$US
242339991$24233999$1$I$20240801$20240816$20240821$20240821$PER$$US-PFIZER INC-202400238744$PFIZER$$62$YR$$M$Y$$$20240821$$CN$US$US
242340001$24234000$1$I$$20240815$20240821$20240821$PER$$US-PFIZER INC-202400237587$PFIZER$$$$$F$Y$$$20240821$$CN$US$US
242340012$24234001$2$F$$20240825$20240821$20240827$PER$$US-PFIZER INC-202400237867$PFIZER$$40$YR$$F$Y$$$20240827$$MD$US$US
242340023$24234002$3$F$$20240904$20240821$20240912$EXP$$IT-PFIZER INC-202400238739$PFIZER$Muggeo, P.. BV-DHAP as salvage treatment for high risk adolescent hodgkin lymphoma.. Klinische Padiatrie. 2020;232 (2 Suppl):106-7$15$YR$$M$Y$$$20240912$$HP$IT$IT
242340031$24234003$1$I$$20240816$20240821$20240821$PER$$US-PFIZER INC-202400238605$PFIZER$$$$$F$Y$$$20240821$$CN$US$US
242340041$24234004$1$I$$20240815$20240821$20240821$PER$$US-PFIZER INC-202400238469$PFIZER$$64$YR$$F$Y$$$20240821$$HP$US$US
242340051$24234005$1$I$20240813$20240819$20240821$20240821$EXP$$CN-PFIZER INC-PV202400108009$PFIZER$$64$YR$$F$Y$60$KG$20240821$$HP$CN$CN
242340071$24234007$1$I$20240818$20240818$20240821$20240821$PER$$US-PFIZER INC-202400238562$PFIZER$$49$YR$$F$Y$$$20240821$$CN$US$US
242340081$24234008$1$I$$20240816$20240821$20240821$PER$$US-PFIZER INC-PV202400048648$PFIZER$$75$YR$$F$Y$$$20240821$$MD$US$US
242340091$24234009$1$I$$20240816$20240821$20240821$PER$$US-PFIZER INC-202400239464$PFIZER$$17$YR$$M$Y$$$20240821$$HP$US$US
242340101$24234010$1$I$20240201$20240815$20240821$20240821$PER$$US-PFIZER INC-202400238050$PFIZER$$53$YR$$M$Y$$$20240821$$CN$US$US
242340111$24234011$1$I$20240805$20240816$20240821$20240821$PER$$US-PFIZER INC-202400238623$PFIZER$$66$YR$$F$Y$$$20240821$$CN$US$US
242340121$24234012$1$I$20240816$20240816$20240821$20240821$PER$$US-PFIZER INC-202400238608$PFIZER$$28$YR$$F$Y$$$20240821$$CN$US$US
242340133$24234013$3$F$20240704$20240905$20240821$20240909$EXP$$FR-PFIZER INC-202400237940$PFIZER$$56$YR$$F$Y$$$20240909$$MD$FR$FR
242340142$24234014$2$F$$20240820$20240821$20240826$EXP$$AU-PFIZER INC-202400239725$PFIZER$Montarello, N.. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report. BMC neurology. 2024;24(1):277$51$YR$$F$Y$$$20240826$$MD$AU$AU
242340153$24234015$3$F$$20240828$20240821$20240904$PER$$US-PFIZER INC-PV202400083821$PFIZER$$66$YR$$F$Y$$$20240904$$CN$US$US
242340161$24234016$1$I$$20240818$20240821$20240821$PER$$US-PFIZER INC-202400239491$PFIZER$$37$YR$$M$Y$$$20240821$$MD$US$US
242340171$24234017$1$I$20240814$20240815$20240821$20240821$PER$$US-BAYER-2024A118585$BAYER$$19$YR$A$F$Y$$$20240821$$HP$US$US
242340184$24234018$4$F$20240801$20240823$20240821$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010612$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240904$$CN$US$US
242340191$24234019$1$I$$20240819$20240821$20240821$PER$$US-ABBVIE-5888316$ABBVIE$$$$$$Y$$$20240821$$CN$US$US
242340201$24234020$1$I$20240816$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011034$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240821$$CN$US$US
242340213$24234021$3$F$$20240914$20240821$20240915$PER$$US-ALXN-202408USA001053US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
242340231$24234023$1$I$$20240813$20240821$20240821$PER$$US-JNJFOC-20240840613$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$MD$US$US
242340241$24234024$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240846204$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$HP$US$US
242340251$24234025$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240839506$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240821$$MD$US$US
242340261$24234026$1$I$20240814$20240814$20240821$20240821$PER$$US-BAYER-2024A118651$BAYER$$$$$F$Y$$$20240821$$MD$US$US
242340271$24234027$1$I$$20240813$20240821$20240821$EXP$$BR-TAKEDA-2024TUS082328$TAKEDA$$$$$M$Y$$$20240821$$CN$BR$BR
242340281$24234028$1$I$$20240809$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008416$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242340291$24234029$1$I$$20240809$20240821$20240821$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08051$LUPIN$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central extracorporeal membrane oxygenation support following calcium channel blocker overdose in children. American Society for Artificial Internal Organs. 2024;70(7):e92-e96$14$YR$$F$Y$129$KG$20240821$$HP$US$US
242340301$24234030$1$I$20240808$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165566$AMGEN$$54$YR$A$M$Y$$$20240821$$CN$US$US
242340311$24234031$1$I$20230720$20230721$20240821$20240821$EXP$$MX-BIOVITRUM-2023-MX-013245$BIOVITRUM$$47$DY$$F$Y$1.5$KG$20240821$$CN$MX$MX
242340321$24234032$1$I$20240101$20240816$20240821$20240821$PER$$US-ABBVIE-5885139$ABBVIE$$$$$M$Y$90$KG$20240821$$CN$US$US
242340331$24234033$1$I$$20240812$20240821$20240821$EXP$$AR-TEVA-VS-3234139$TEVA$Pena C, Costi AC, Garcia L, Garcia M. Severe infections in systemic necrotizing vasculitis. Reumatol-Clin 2024; 20 (5): 237-242.$$$$F$Y$$$20240821$$HP$AR$AR
242340341$24234034$1$I$$20240813$20240821$20240821$EXP$$US-EVOFEM BIOSCIENCES, INC.-2022-EVO-US000022$PAREXEL$$$$$$Y$$$20240821$$MD$US$US
242340351$24234035$1$I$$20240820$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US074082$SANDOZ$$$$$$Y$$$20240821$$CN$US$US
242340371$24234037$1$I$$20240819$20240821$20240821$EXP$$CA-SANDOZ INC.-NVSC2022CA125910$SANDOZ$$$$$M$Y$$$20240821$$CN$CA$CA
242340381$24234038$1$I$$20240816$20240821$20240821$PER$$US-BAYER-2024A119085$BAYER$$46$YR$A$F$Y$$$20240821$$MD$US$US
242340391$24234039$1$I$$20240816$20240821$20240821$EXP$$FR-SANDOZ INC.-SDZ2024FR073197$SANDOZ$$65$YR$$F$Y$$$20240821$$HP$FR$FR
242340401$24234040$1$I$$20240818$20240821$20240821$PER$$US-BAYER-2024A119540$BAYER$$$$$F$Y$$$20240821$$CN$US$US
242340411$24234041$1$I$$20240819$20240821$20240821$PER$$US-HALEON-2192690$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242340421$24234042$1$I$$20240809$20240821$20240821$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08052$LUPIN$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central extracorporeal membrane oxygenation support following calcium channel blocker overdose in children. American Society for Artificial Internal Organs. 2024;70 (7):e92-e96$15$YR$$F$Y$49$KG$20240821$$HP$US$US
242340432$24234043$2$F$20190301$20240924$20240821$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE073873$SANDOZ$$75$YR$$F$Y$$$20240926$$MD$DE$DE
242340441$24234044$1$I$$20240813$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008498$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242340451$24234045$1$I$$20240815$20240821$20240821$PER$$US-HALEON-2192441$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242340461$24234046$1$I$20240801$20240819$20240821$20240821$PER$$US-JNJFOC-20240847601$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242340471$24234047$1$I$20240814$20240819$20240821$20240821$PER$$US-BAYER-2024A119213$BAYER$$29$YR$A$F$Y$$$20240821$$CN$US$US
242340481$24234048$1$I$20240806$20240816$20240821$20240821$EXP$$CN-BAYER-2024A118938$BAYER$$60$YR$A$M$Y$70$KG$20240821$$HP$CN$CN
242340492$24234049$2$F$$20240828$20240821$20240906$EXP$$IE-TEVA-VS-3233422$TEVA$Tudor RM, Ali EM, Khan SU, McDermott J. Klinefelter syndrome presenting as metastatic bilateral breast cancer: missed diagnostic opportunities. BMJ-Case-Rep 2023; 16.; Tudor RM, Ali EM, Khan SU, McDermott J. Klinefelter syndrome presenting as metastatic bilateral breast cancer: missed diagnostic opportunities. BMJ-Case-Rep 2023; 16.$60$YR$$M$Y$$$20240906$$MD$IE$IE
242340501$24234050$1$I$20240820$20240820$20240821$20240821$PER$$US-BAYER-2024A119896$BAYER$$31$YR$A$F$Y$$$20240821$$MD$US$US
242340511$24234051$1$I$20230812$20240814$20240821$20240821$PER$$US-BIOGEN-2023BI01221574$BIOGEN$$16$YR$$F$Y$$$20240821$$CN$US$US
242340521$24234052$1$I$20240813$20240813$20240821$20240821$EXP$$GB-AMGEN-GBRSL2024161873$AMGEN$$43$YR$A$F$Y$$$20240821$$HP$GB$GB
242340532$24234053$2$F$$20240828$20240821$20240905$EXP$$CN-SA-2024SA243980$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240905$$HP$CN$CN
242340541$24234054$1$I$$20240814$20240821$20240821$EXP$$NVSC2024FR168166$NOVARTIS$Amar J, El Kaim P, Scemla B, Boumendil J, Chotard G, Gabison E, et al.. Corneal perforations in patients treated with tyrosine kinase inhibitors. FRENCH JOURNAL OF OPHTHALMOLOGY. 2023;40:1111-3$65$YR$$M$Y$$$20240821$$HP$FR$FR
242340551$24234055$1$I$20240215$20240814$20240821$20240821$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-130548$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$105$KG$20240821$$MD$FR$FR
242340561$24234056$1$I$20240802$20240820$20240821$20240821$EXP$FR-AFSSAPS-TS2024000920$FR-ORGANON-O2408FRA001425$ORGANON$$92$YR$$F$Y$57$KG$20240821$$MD$FR$FR
242340571$24234057$1$I$$20240816$20240821$20240821$PER$$US-JNJFOC-20240846152$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$CN$US$US
242340581$24234058$1$I$20240726$20240807$20240821$20240821$EXP$$US-ALMIRALL, LLC-2024AQU000075$ALMIRALL$$$$$$Y$$$20240821$$CN$US$US
242340591$24234059$1$I$20240717$20240819$20240821$20240821$EXP$IT-MINISAL02-998761$IT-BAYER-2024A119102$BAYER$$69$YR$E$F$Y$$$20240821$$MD$IT$IT
242340602$24234060$2$F$20240820$20240925$20240821$20240927$EXP$$NVSC2024US168992$NOVARTIS$$55$YR$$$Y$$$20240927$$CN$US$US
242340611$24234061$1$I$$20240816$20240821$20240821$EXP$$US-BAYER-2024A118971$BAYER$$65$YR$E$M$Y$$$20240821$$CN$US$US
242340621$24234062$1$I$$20240816$20240821$20240821$PER$$US-ROCHE-10000059909$ROCHE$$48$YR$A$$Y$$$20240821$$CN$US$US
242340631$24234063$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A185144$ASTRAZENECA$$$$$M$Y$$$20240821$$HP$US$
242340641$24234064$1$I$$20240814$20240821$20240821$PER$$US-ROCHE-10000058627$ROCHE$$$$E$F$Y$$$20240821$$CN$US$US
242340651$24234065$1$I$$20240723$20240821$20240821$EXP$$US-AstraZeneca-2024A189550$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
242340681$24234068$1$I$20240812$20240813$20240821$20240821$EXP$$CO-AstraZeneca-2024A186894$ASTRAZENECA$$10758$DY$$F$Y$56$KG$20240821$$CN$CO$
242340691$24234069$1$I$20240515$20240813$20240821$20240821$EXP$$PL-AstraZeneca-2024A184271$ASTRAZENECA$$18$YR$$M$Y$$$20240821$$MD$PL$
242340701$24234070$1$I$20220301$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184227$ASTRAZENECA$$64$YR$$F$Y$68$KG$20240821$$MD$FR$
242340711$24234071$1$I$20220501$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184209$ASTRAZENECA$$47$YR$$F$Y$80$KG$20240821$$MD$FR$
242340721$24234072$1$I$$20240816$20240821$20240821$EXP$$ZA-AstraZeneca-2024A187750$ASTRAZENECA$$$$$M$Y$$$20240821$$PH$ZA$
242340731$24234073$1$I$$20240815$20240821$20240821$EXP$US-MLMSERVICE-20160602-0303115-1$US-RDY-USA/USA/16/0080513$DR REDDYS$Millien VO, Santana L, Kolpakchi A, Lu L. Trading one for another: A case of de novo crohn^s disease after lung transplant. J Gen Intern Med. 2016;31: S769.$71$YR$E$M$Y$$$20240821$$HP$US$US
242340741$24234074$1$I$20220708$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184183$ASTRAZENECA$$69$YR$$M$Y$84$KG$20240821$$MD$FR$
242340751$24234075$1$I$$20240820$20240820$20240820$DIR$715094$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242340762$24234076$2$F$$20240927$20240821$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132465$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$69.85$KG$20240930$$CN$US$US
242340771$24234077$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57642$$FDA-CTU$$80$YR$$M$N$$$20240821$N$HP$US$
242340792$24234079$2$F$20240717$20240821$20240821$20240828$EXP$$RU-Merck Healthcare KGaA-2024042701$MERCK KGAA$$32$YR$A$F$Y$45$KG$20240828$$HP$RU$RU
242340801$24234080$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130471$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240821$$HP$US$US
242340811$24234081$1$I$20240814$20240815$20240821$20240821$EXP$$CN-009507513-2408CHN006213$MERCK$$65$YR$$F$Y$73.4$KG$20240821$$HP$CN$CN
242340821$24234082$1$I$20240627$20240812$20240821$20240821$EXP$FR-AFSSAPS-PV2024000679$FR-TEVA-VS-3233349$TEVA$$$$$$Y$$$20240821$$MD$FR$FR
242340831$24234083$1$I$20201203$20240813$20240821$20240821$EXP$PL-URPL-1-3585-2020$PL-TEVA-VS-3233763$TEVA$$58$YR$$F$Y$41$KG$20240821$$MD$PL$PL
242340841$24234084$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011261$ELI LILLY AND CO$$$$$M$Y$$$20240821$$CN$US$US
242340851$24234085$1$I$$20240808$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408006744$ELI LILLY AND CO$$$$$M$Y$$$20240821$$HP$US$US
242340861$24234086$1$I$$20240816$20240821$20240821$PER$$US-ROCHE-10000060062$ROCHE$$$$C$M$Y$$$20240821$$CN$US$US
242340872$24234087$2$F$20240810$20240904$20240821$20240905$PER$$US-ROCHE-10000060450$ROCHE$$8$YR$C$M$Y$30.3$KG$20240905$$CN$US$US
242340891$24234089$1$I$$20240816$20240821$20240821$PER$$US-ROCHE-10000060236$ROCHE$$$$A$M$Y$$$20240821$$CN$US$US
242340901$24234090$1$I$20240729$20240729$20240821$20240821$PER$$US-BAYER-2024A119524$BAYER$$72$YR$E$F$Y$$$20240821$$CN$US$US
242340912$24234091$2$F$20240729$20240912$20240821$20240914$PER$$US-ROCHE-10000060432$ROCHE$$58$YR$A$M$Y$$$20240914$$CN$US$US
242340921$24234092$1$I$$20240819$20240821$20240821$PER$$US-ROCHE-10000061423$ROCHE$$$$$$Y$$$20240821$$PH$US$US
242340931$24234093$1$I$$20240820$20240821$20240821$PER$$NVSC2024US169370$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242340941$24234094$1$I$$20240709$20240821$20240821$PER$$US-LUNDBECK-DKLU4001460$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
242340951$24234095$1$I$$20240820$20240821$20240821$PER$$US-ROCHE-10000062217$ROCHE$$45$YR$A$M$Y$$$20240821$$HP$US$US
242340962$24234096$2$F$$20240822$20240821$20240822$EXP$$GB-BAYER-2024A117584$BAYER$$$$$F$Y$$$20240822$$MD$GB$GB
242340971$24234097$1$I$20240306$20240807$20240821$20240821$PER$$US-BAYER-2024A114564$BAYER$$$$$$Y$$$20240821$$HP$US$US
242340981$24234098$1$I$$20240603$20240821$20240821$EXP$$NVSC2023IN279939$NOVARTIS$$$$$M$Y$$$20240821$$CN$IN$IN
242340991$24234099$1$I$20240801$20240814$20240821$20240821$EXP$SE-SEMPA-2024-006015$SE-SA-2024SA243017$SANOFI AVENTIS$$86$YR$E$M$Y$65$KG$20240821$$MD$SE$SE
242341011$24234101$1$I$20240801$20240813$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008500$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242341021$24234102$1$I$$20240819$20240821$20240821$EXP$FR-AFSSAPS-PO2024000897$FR-LUNDBECK-DKLU4003230$LUNDBECK$$$$$$Y$$$20240821$$MD$FR$FR
242341032$24234103$2$F$$20240903$20240821$20240912$EXP$$JP-009507513-2408JPN002115J$MERCK$$74$YR$$M$Y$$$20240912$$MD$JP$JP
242341041$24234104$1$I$$20240820$20240821$20240821$PER$$US-HALEON-2192871$Haleon PLC$$$$$F$Y$$$20240821$$CN$US$US
242341052$24234105$2$F$$20240912$20240821$20240913$PER$$US-ROCHE-10000062069$ROCHE$$$$A$M$Y$$$20240913$$CN$US$US
242341061$24234106$1$I$$20240820$20240821$20240821$PER$$US-ROCHE-10000062032$ROCHE$$$$C$M$Y$12.97$KG$20240821$$CN$US$US
242341071$24234107$1$I$20240101$20240815$20240821$20240821$EXP$$US-SA-2024SA245565$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240821$$CN$US$US
242341081$24234108$1$I$$20240709$20240821$20240821$PER$$US-LUNDBECK-DKLU4001462$LUNDBECK$$$$$$Y$$$20240821$$HP$US$US
242341091$24234109$1$I$$20240816$20240821$20240821$PER$$US-ALXN-202408USA001060US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
242341101$24234110$1$I$20240804$20240819$20240821$20240821$EXP$$US-BAYER-2024A119732$BAYER$$91$YR$E$M$Y$$$20240821$$CN$US$US
242341112$24234111$2$F$$20240916$20240821$20240917$PER$$US-ALXN-202408USA001138US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$MD$US$US
242341121$24234112$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245157$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240821$$MD$US$US
242341131$24234113$1$I$20240101$20240816$20240821$20240821$EXP$$CA-ABBVIE-5885200$ABBVIE$$27$YR$$M$Y$$$20240821$$CN$CA$CA
242341141$24234114$1$I$$20240709$20240821$20240821$PER$$US-LUNDBECK-DKLU4001526$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
242341151$24234115$1$I$20240201$20240820$20240821$20240821$PER$$US-ROCHE-10000062030$ROCHE$$30$YR$A$M$Y$$$20240821$$CN$US$US
242341161$24234116$1$I$20240819$20240820$20240820$20240820$DIR$715060$$FDA-CTU$$21$YR$$F$N$100.7$KG$20240820$N$PH$US$
242341171$24234117$1$I$20240820$20240820$20240820$20240820$DIR$715092$$FDA-CTU$$42$YR$$M$N$$$20240820$N$PH$US$
242341181$24234118$1$I$$20240820$20240820$20240820$DIR$715101$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242341191$24234119$1$I$$20240820$20240820$20240820$DIR$715102$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242341202$24234120$2$F$$20240909$20240821$20240918$EXP$$JP-ROCHE-10000057517$ROCHE$Takada H, Osawa L, Komiyama Y, Muraoka M, Suzuki Y, Sato M, et al. Interleukin-7 risk allele, lymphocyte counts, and autoantibodies for prediction of risk of immune-related adverse events in patients receiving Atezolizumab plus Bevacizumab therapy for unresectable hepatocellular carcinoma. Oncology. 2024-Jul-30;1-11. doi:10.1159/000540648.$$$$$Y$$$20240918$$HP$JP$JP
242341212$24234121$2$F$20240813$20240916$20240821$20240918$PER$$US-ROCHE-10000061788$ROCHE$$6$YR$C$M$Y$$$20240918$$CN$US$US
242341221$24234122$1$I$$20240820$20240820$20240820$DIR$715103$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242341231$24234123$1$I$20240813$20240813$20240821$20240821$EXP$$JP-FERRINGPH-2024FE04612$FERRING$$$$$$Y$$$20240821$$PH$JP$JP
242341241$24234124$1$I$20240731$20240815$20240821$20240821$EXP$FR-AFSSAPS-NT2024001051$FR-FERRINGPH-2024FE04581$FERRING$$$$$$Y$$$20240821$$MD$FR$FR
242341251$24234125$1$I$20230701$20240415$20240821$20240821$PER$$US-PERRIGO-24US003731$PERRIGO$$73$YR$$F$Y$54.422$KG$20240821$$CN$US$US
242341261$24234126$1$I$$20240813$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008505$INCYTE$$$$$$Y$$$20240821$$HP$US$US
242341271$24234127$1$I$$20240816$20240821$20240821$EXP$$CN-FERRINGPH-2024FE04635$FERRING$$$$$$Y$$$20240821$$CN$CN$CN
242341281$24234128$1$I$$20240815$20240821$20240821$EXP$$CN-FERRINGPH-2024FE04634$FERRING$$$$$$Y$$$20240821$$CN$CN$CN
242341291$24234129$1$I$$20240820$20240821$20240821$PER$$US-HALEON-2192951$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242341301$24234130$1$I$$20240809$20240821$20240821$EXP$$US-RDY-LIT/USA/24/0011923$DR REDDYS$Bedi R, Das D, Ahmad A, Atallah I, Smart SC, Verma D, et al. MECHANICAL SUPPORT AS A RESCUE BRIDGE TO TAVR IN A PATIENT WITH CARDIOGENIC SHOCK (CS) DUE TO SEVERE AS AND AR. Journal of the American College of Cardiology. 2024;83(13): 3856. doi:10.1016/S0735-1097%2824%2905846-7.$71$YR$E$F$Y$$$20240821$$HP$US$US
242341311$24234131$1$I$$20240814$20240821$20240821$EXP$DE-BoehringerIngelheim-2022-BI-203673$DE-RDY-SPO/GER/23/0160129$DR REDDYS$UNKNOWN U. Medikation unter der Lupe: Tipps und Tricks fur die Medikationsanalyse - Fall 3: Ein Patient mit Missempfindungen. Deutsche Apotheke Zeitung (DAZ). 2022 Nov 17; 28-$71$YR$E$M$Y$120$KG$20240821$$CN$DE$DE
242341321$24234132$1$I$$20240814$20240821$20240821$EXP$$US-RDY-LIT/USA/24/0012010$DR REDDYS$Gallagher K, Ortenberg R, Toprak D. A Rare Pediatric Case of Anti-melanoma Differentiation-associated Gene 5 Rapidly Progressive Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 2023;207: doi:10.1164/ajrccm-conference.2023.C60.$6$YR$C$M$Y$$$20240821$$HP$US$US
242341331$24234133$1$I$$20240809$20240821$20240821$EXP$$US-RDY-LIT/USA/24/0011919$DR REDDYS$Liang J, Bhat ZY, Alrawi O. Rare Case of Exogenous Vasopressin-Induced Hyponatremia. American Journal of Therapeutics. 2023;31(4): e431. doi:10.1097/MJT.0000000000001630.$33$YR$A$F$Y$$$20240821$$HP$US$US
242341341$24234134$1$I$$20240816$20240821$20240821$EXP$$US-ABBVIE-5885336$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242341351$24234135$1$I$$20240813$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008506$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242341361$24234136$1$I$$20240820$20240821$20240821$EXP$$TH-TAKEDA-2024TUS011675$TAKEDA$$52$YR$$F$Y$$$20240821$$CN$TH$TH
242341371$24234137$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245890$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242341381$24234138$1$I$$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024163959$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242341392$24234139$2$F$20240701$20240820$20240821$20240829$EXP$$JP-Eisai-EC-2024-172198$EISAI$$72$YR$E$F$Y$$$20240829$$MD$JP$JP
242341402$24234140$2$F$20240601$20240822$20240821$20240827$EXP$$US-Eisai-EC-2024-164175$EISAI$$76$YR$E$F$Y$$$20240827$$CN$US$US
242341411$24234141$1$I$$20240813$20240821$20240821$EXP$$JP-Eisai-EC-2024-172103$EISAI$Oki Ryosuke. Cases using PEM+LEN therapy at our hospital. Adverse Reaction Management Seminar.$62$YR$A$M$Y$$$20240821$$MD$JP$JP
242341422$24234142$2$F$20240525$20240903$20240821$20240904$PER$$US-ROCHE-10000062451$ROCHE$$11$YR$C$M$Y$$$20240904$$CN$US$US
242341431$24234143$1$I$20240811$20240820$20240821$20240821$PER$$US-ROCHE-10000062106$ROCHE$$35$YR$A$M$Y$$$20240821$$CN$US$US
242341441$24234144$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA242884$SANOFI AVENTIS$$$$$$Y$$$20240821$$PH$US$US
242341451$24234145$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA243727$SANOFI AVENTIS$$38$YR$A$F$Y$128.35$KG$20240821$$MD$US$US
242341461$24234146$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA030557$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240821$$CN$US$US
242341471$24234147$1$I$20240401$20240812$20240821$20240821$PER$$US-SA-2024SA243347$SANOFI AVENTIS$$17$YR$T$F$Y$54.422$KG$20240821$$MD$US$US
242341481$24234148$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA241031$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240821$$CN$US$US
242341491$24234149$1$I$20240601$20240814$20240821$20240821$PER$$US-SA-2024SA245331$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240821$$MD$US$US
242341501$24234150$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA246491$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240821$$CN$US$US
242341511$24234151$1$I$$20240816$20240821$20240821$PER$$US-BAYER-2024A119757$BAYER$$$$$F$Y$$$20240821$$CN$US$US
242341521$24234152$1$I$$20240820$20240821$20240821$PER$$US-HALEON-2192958$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242341531$24234153$1$I$20230811$20240819$20240821$20240821$EXP$FR-AFSSAPS-LM2024000451$FR-LUNDBECK-DKLU4003231$LUNDBECK$$$$$$Y$$$20240821$$MD$FR$FR
242341541$24234154$1$I$$20240813$20240821$20240821$PER$$US-BAYER-2024A117561$BAYER$$$$$F$Y$96.61$KG$20240821$$CN$US$US
242341551$24234155$1$I$$20240812$20240821$20240821$PER$$US-ROCHE-10000056811$ROCHE$$9$MON$I$M$Y$$$20240821$$CN$US$US
242341561$24234156$1$I$$20240716$20240821$20240821$PER$$US-HALEON-2192889$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242341572$24234157$2$F$$20240828$20240821$20240906$EXP$$US-TEVA-VS-3234475$TEVA$Shuster A, Peng C. Neisseria Flavescens Bacteremia in an Otherwise Immunocompetent Host. Am-J-Respir-Crit-Care-Med 2024; 209 A1655.; Shuster A, Peng C. Neisseria Flavescens Bacteremia in an Otherwise Immunocompetent Host. Am-J-Respir-Crit-Care-Med 2024; 209 A1655.$62$YR$$F$Y$$$20240906$$HP$US$US
242341581$24234158$1$I$20240423$20240709$20240821$20240821$PER$$US-LUNDBECK-DKLU4001461$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
242341601$24234160$1$I$$20240813$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008507$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242341621$24234162$1$I$$20240818$20240821$20240821$PER$$US-BAYER-2024A118721$BAYER$$$$$$Y$$$20240821$$CN$US$US
242341631$24234163$1$I$20240805$20240813$20240821$20240821$EXP$$CN-AstraZeneca-2024A186722$ASTRAZENECA$$89$YR$$F$Y$55$KG$20240821$$MD$CN$
242341641$24234164$1$I$20220131$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184250$ASTRAZENECA$$73$YR$$M$Y$67$KG$20240821$$MD$FR$
242341651$24234165$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A185073$ASTRAZENECA$$$$$M$Y$$$20240821$$MD$US$
242341661$24234166$1$I$$20240814$20240821$20240821$PER$$US-BAYER-2024A118297$BAYER$$$$$F$Y$$$20240821$$HP$US$US
242341672$24234167$2$F$$20240827$20240821$20240830$EXP$$US-BAYER-2024A120083$BAYER$$55$YR$A$M$Y$$$20240830$$CN$US$US
242341681$24234168$1$I$20240612$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131373$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240821$$CN$US$US
242341692$24234169$2$F$$20240922$20240821$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132575$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$47.63$KG$20240923$$CN$US$US
242341701$24234170$1$I$$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128922$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240821$$HP$US$US
242341711$24234171$1$I$$20240814$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129651$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240821$$CN$US$US
242341721$24234172$1$I$$20240817$20240821$20240821$PER$$US-BAYER-2024A119538$BAYER$$$$$M$Y$$$20240821$$CN$US$US
242341732$24234173$2$F$20240801$20240910$20240821$20240916$EXP$$NVSC2024IN168645$NOVARTIS$$37$YR$$F$Y$$$20240916$$CN$IN$IN
242341742$24234174$2$F$20240727$20240814$20240821$20240827$EXP$$NVSC2024PA168788$NOVARTIS$$69$YR$$F$Y$$$20240827$$CN$PA$PA
242341751$24234175$1$I$20240820$20240820$20240820$20240820$DIR$715106$$FDA-CTU$$62$YR$$M$N$104.6$KG$20240820$N$PH$US$
242341761$24234176$1$I$20240816$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165567$AMGEN$$75$YR$E$F$Y$$$20240821$$CN$US$US
242341771$24234177$1$I$20240615$20240819$20240821$20240821$EXP$AU-TGA-0000815393$AU-SANDOZ INC.-SDZ2024AU073632$SANDOZ$$29$YR$$F$Y$$$20240821$$HP$AU$AU
242341781$24234178$1$I$$20240819$20240821$20240821$PER$$US-Prasco Laboratories-PRAS20241108$PRASCO$$$$$F$Y$$$20240821$$CN$US$US
242341791$24234179$1$I$20240101$20240819$20240821$20240821$EXP$$US-ABBVIE-5887015$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242341801$24234180$1$I$20240819$20240820$20240821$20240821$PER$$US-HALEON-2192868$Haleon PLC$$64$YR$$M$Y$$$20240821$$CN$US$US
242341811$24234181$1$I$$20240811$20240821$20240821$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US000176$PAREXEL$$$$$$Y$$$20240821$$CN$US$US
242341821$24234182$1$I$20240819$20240820$20240820$20240820$DIR$715090$$FDA-CTU$$81$YR$$F$N$$$20240820$Y$PH$US$
242341831$24234183$1$I$20100101$20240814$20240821$20240821$EXP$FI-FIMEA-202402462$FI-ABBVIE-5884211$ABBVIE$$17$YR$$M$Y$$$20240821$$CN$FI$FI
242341841$24234184$1$I$20240813$20240814$20240821$20240821$PER$$US-AMGEN-USASP2024163190$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242341851$24234185$1$I$20240701$20240816$20240821$20240821$PER$$CN-Eisai-EC-2024-172288$EISAI$$81$YR$E$F$Y$50$KG$20240821$$HP$CN$CN
242341861$24234186$1$I$$20240816$20240821$20240821$EXP$$JP-Eisai-EC-2024-172308$EISAI$Satoshi Umezawa. Experience with lenvatinib + pembrolizumab combination therapy at our hospital (10 cases). Women^s Cancer Expert Seminar; -; .$$$E$F$Y$$$20240821$$MD$JP$JP
242341871$24234187$1$I$20240806$20240816$20240821$20240821$EXP$GB-MHRA-MED-202408160857501920-WLRSC$GB-GSK-GB2024102241$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$CN$GB$GB
242341882$24234188$2$F$$20240909$20240821$20240913$EXP$$CA-GSK-CA2024AMR103598$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$CA$CA
242341892$24234189$2$F$$20240826$20240821$20240827$EXP$$JP-BAYER-2024A119872$BAYER$$8$DEC$E$M$Y$$$20240827$$MD$JP$JP
242341911$24234191$1$I$$20240816$20240821$20240821$EXP$$US-SA-2024SA245490$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240821$$MD$US$US
242341922$24234192$2$F$20240101$20240816$20240821$20240830$PER$$US-SA-2024SA245047$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240830$$MD$US$US
242341931$24234193$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243276$SANOFI AVENTIS$$$$A$M$Y$86$KG$20240821$$MD$US$US
242341941$24234194$1$I$20240801$20240812$20240821$20240821$PER$$US-SA-2024SA245185$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240821$$MD$US$US
242341951$24234195$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA242445$SANOFI AVENTIS$$$$A$M$Y$92.472$KG$20240821$$MD$US$US
242341962$24234196$2$F$20240101$20240923$20240821$20240927$EXP$$CA-BAUSCH-BL-2024-012379$BAUSCH AND LOMB$$78$YR$$M$Y$$$20240927$$CN$CA$CA
242341971$24234197$1$I$20240407$20240820$20240820$20240820$DIR$715098$$FDA-CTU$$56$YR$$F$N$48.15$KG$20240820$N$CN$US$
242341981$24234198$1$I$$20240815$20240821$20240821$EXP$$US-SA-2024SA247130$SANOFI AVENTIS$$$$E$M$Y$92$KG$20240821$$MD$US$US
242341991$24234199$1$I$20240816$20240820$20240820$20240820$DIR$715091$$FDA-CTU$$70$YR$$M$N$$$20240820$Y$PH$US$
242342001$24234200$1$I$$20240820$20240820$20240820$DIR$715111$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242342011$24234201$1$I$20240821$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57647$$FDA-CTU$$27$YR$$F$N$141.52$KG$20240821$N$HP$US$
242342021$24234202$1$I$$20240820$20240820$20240820$DIR$715119$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242342031$24234203$1$I$20230101$20240816$20240821$20240821$PER$$US-SA-2023SA376031$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240821$$MD$US$US
242342041$24234204$1$I$$20240819$20240821$20240821$EXP$$US-ABBVIE-5887563$ABBVIE$$$$$F$Y$$$20240821$$PH$US$US
242342061$24234206$1$I$20240814$20240815$20240821$20240821$PER$$US-SA-2024SA247036$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240821$$CN$US$US
242342071$24234207$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57650$$FDA-CTU$$70$YR$$F$N$62.14$KG$20240821$N$$US$
242342081$24234208$1$I$$20240820$20240820$20240820$DIR$715120$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242342092$24234209$2$F$20240808$20240828$20240821$20240829$PER$$US-BAYER-2024A119827$BAYER$$16$YR$T$F$Y$$$20240829$$MD$US$US
242342101$24234210$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57637$$FDA-CTU$$91$YR$$F$N$77.56$KG$20240821$N$$US$
242342111$24234211$1$I$$20240820$20240820$20240820$DIR$715121$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242342122$24234212$2$F$20240201$20240909$20240821$20240916$EXP$$CA-TAKEDA-2024TUS023870$TAKEDA$$57$YR$$F$Y$$$20240916$$CN$CA$CA
242342131$24234213$1$I$$20240820$20240820$20240820$DIR$715068$$FDA-CTU$$$$$UNK$N$$$20240820$N$PH$US$
242342141$24234214$1$I$20240816$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011626$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240821$$CN$US$US
242342161$24234216$1$I$$20240820$20240820$20240820$DIR$715130$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242342181$24234218$1$I$$20240819$20240821$20240821$EXP$$ES-PFIZER INC-202400239099$PFIZER$Rascon Roig, N.. A raiz de una faringoamigdalitis: sifilis secundaria. AMF. 2024;20(7):1$63$YR$$M$Y$$$20240821$$MD$ES$ES
242342191$24234219$1$I$$20240814$20240821$20240821$PER$$US-JNJFOC-20240853744$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$LW$US$US
242342201$24234220$1$I$$20240818$20240821$20240821$PER$$US-BAYER-2024A119162$BAYER$$$$$F$Y$$$20240821$$CN$US$US
242342211$24234221$1$I$$20240815$20240821$20240821$EXP$$DE-MYLANLABS-2024M1076135$MYLAN$$64$YR$$F$Y$$$20240821$$MD$DE$DE
242342221$24234222$1$I$20240715$20240815$20240821$20240821$EXP$FR-AFSSAPS-CF2024000417$FR-MYLANLABS-2024M1076482$MYLAN$$64$YR$$M$Y$57$KG$20240821$$PH$FR$FR
242342231$24234223$1$I$20240423$20240815$20240821$20240821$EXP$FR-AFSSAPS-TS2024000902$FR-MYLANLABS-2024M1076090$MYLAN$$37$YR$$F$Y$82$KG$20240821$$MD$FR$FR
242342241$24234224$1$I$$20240815$20240821$20240821$EXP$$DE-MYLANLABS-2024M1076055$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology. 2024;48 (5):299-313$48$YR$$F$Y$$$20240821$$HP$DE$DE
242342252$24234225$2$F$$20240829$20240821$20240904$EXP$$DE-MYLANLABS-2024M1076156$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$37$YR$$M$Y$$$20240904$$HP$DE$DE
242342261$24234226$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012630$BAUSCH AND LOMB$$52$YR$$M$Y$$$20240821$$CN$CA$CA
242342271$24234227$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012613$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240821$$HP$CA$CA
242342281$24234228$1$I$$20240815$20240821$20240821$EXP$$CA-MYLANLABS-2024M1077284$MYLAN$$68$YR$$F$Y$$$20240821$$HP$CA$CA
242342292$24234229$2$F$$20240829$20240821$20240904$EXP$$DE-MYLANLABS-2024M1076152$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$43$YR$$M$Y$$$20240904$$HP$DE$DE
242342301$24234230$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012588$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240821$$CN$CA$CA
242342311$24234231$1$I$$20240814$20240821$20240821$EXP$$US-BAYER-2024A117940$BAYER$$68$YR$E$M$Y$$$20240821$$CN$US$US
242342321$24234232$1$I$20240816$20240820$20240821$20240821$PER$$US-BAYER-2024A119845$BAYER$$26$YR$A$F$Y$$$20240821$$MD$US$US
242342331$24234233$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131468$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240821$$CN$US$US
242342342$24234234$2$F$$20240730$20240821$20240828$PER$$AT-INCYTE CORPORATION-2024IN008037$INCYTE$$$$$$Y$$$20240828$$MD$AT$US
242342351$24234235$1$I$$20240815$20240821$20240821$EXP$$US-SA-2024SA247545$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
242342371$24234237$1$I$20240101$20240816$20240821$20240821$EXP$$CO-SA-2024SA247823$SANOFI AVENTIS$$90$YR$E$F$Y$$$20240821$$HP$CO$CO
242342381$24234238$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012663$BAUSCH AND LOMB$$56$YR$$F$Y$$$20240821$$CN$CA$CA
242342391$24234239$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012631$BAUSCH AND LOMB$$82$YR$$M$Y$$$20240821$$CN$CA$CA
242342401$24234240$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012640$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240821$$CN$CA$CA
242342411$24234241$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012638$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240821$$CN$CA$CA
242342421$24234242$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012650$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240821$$CN$CA$CA
242342431$24234243$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012658$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240821$$CN$CA$CA
242342441$24234244$1$I$$20240816$20240821$20240821$EXP$$US-SA-2024SA246486$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240821$$MD$US$US
242342451$24234245$1$I$$20240815$20240821$20240821$EXP$$US-SA-2024SA243834$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240821$$MD$US$US
242342461$24234246$1$I$20240812$20240819$20240821$20240821$EXP$$US-BAUSCH-BL-2024-012598$BAUSCH AND LOMB$$55$YR$$M$Y$$$20240821$$HP$US$US
242342471$24234247$1$I$20240726$20240819$20240821$20240821$EXP$$US-BAUSCH-BL-2024-012599$BAUSCH AND LOMB$$57$YR$$M$Y$$$20240821$$CN$US$US
242342481$24234248$1$I$20240614$20240812$20240821$20240821$EXP$$CN-JNJFOC-20240831835$JOHNSON AND JOHNSON$$74$YR$E$F$Y$60$KG$20240821$$HP$CN$CN
242342491$24234249$1$I$20220126$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184241$ASTRAZENECA$$74$YR$$M$Y$82$KG$20240821$$MD$FR$
242342504$24234250$4$F$20240722$20240904$20240821$20240905$PER$$US-AMGEN-USASP2024165572$AMGEN$$71$YR$E$F$Y$$$20240905$$CN$US$US
242342513$24234251$3$F$20240701$20240827$20240821$20240904$EXP$$JP-AstraZeneca-2024A186287$ASTRAZENECA$$$$$F$Y$$$20240904$$MD$JP$
242342522$24234252$2$F$$20240913$20240821$20240919$EXP$$JP-009507513-2408JPN002023J$MERCK$$82$YR$$$Y$$$20240919$$MD$JP$JP
242342531$24234253$1$I$20240726$20240813$20240821$20240821$EXP$$CN-AstraZeneca-2024A186767$ASTRAZENECA$$21865$DY$$M$Y$$$20240821$$MD$CN$
242342541$24234254$1$I$$20240730$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN007986$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242342551$24234255$1$I$$20240816$20240821$20240821$EXP$$US-AstraZeneca-2024A187887$ASTRAZENECA$$$$$M$Y$$$20240821$$HP$US$
242342561$24234256$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A184850$ASTRAZENECA$$$$$F$Y$97.5$KG$20240821$$MD$US$
242342571$24234257$1$I$20240809$20240814$20240821$20240821$PER$$US-SA-2024SA242847$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240821$$CN$US$US
242342581$24234258$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA245852$SANOFI AVENTIS$$10$YR$C$F$Y$28$KG$20240821$$MD$US$US
242342592$24234259$2$F$$20240813$20240821$20240918$EXP$$ZA-AstraZeneca-2024A185195$ASTRAZENECA$$51$YR$$F$Y$$$20240918$$CN$ZA$
242342601$24234260$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A185057$ASTRAZENECA$$$$E$M$Y$90.7$KG$20240821$$CN$US$
242342611$24234261$1$I$$20240815$20240821$20240821$EXP$$US-ABBVIE-5882930$ABBVIE$$$$$$Y$$$20240821$$CN$US$US
242342621$24234262$1$I$20220627$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184173$ASTRAZENECA$$78$YR$$M$Y$71.5$KG$20240821$$MD$FR$
242342631$24234263$1$I$$20240812$20240821$20240821$EXP$$CA-AstraZeneca-2024A189919$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$CA$
242342641$24234264$1$I$20220207$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184248$ASTRAZENECA$$78$YR$$F$Y$58$KG$20240821$$MD$FR$
242342651$24234265$1$I$20220127$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184272$ASTRAZENECA$$46$YR$$F$Y$97$KG$20240821$$MD$FR$
242342671$24234267$1$I$20240629$20240821$20240821$20240821$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046981$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$70$KG$20240821$$MD$RU$RU
242342681$24234268$1$I$20240702$20240813$20240821$20240821$EXP$$DE-FreseniusKabi-FK202412437$FRESENIUS KABI$$$$A$M$Y$90$KG$20240821$$PH$DE$DE
242342691$24234269$1$I$$20240819$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA073705$SANDOZ$$80$YR$$M$Y$86$KG$20240821$$HP$CA$CA
242342701$24234270$1$I$$20240814$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012388$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240821$$CN$CA$CA
242342711$24234271$1$I$20240814$20240814$20240821$20240821$PER$$US-RDY-SPO/USA/24/0011947$DR REDDYS$$17$YR$T$F$Y$$$20240821$$CN$US$US
242342721$24234272$1$I$$20240815$20240821$20240821$PER$$US-RDY-SPO/USA/24/0012018$DR REDDYS$$22$YR$A$F$Y$$$20240821$$CN$US$US
242342731$24234273$1$I$20240815$20240815$20240821$20240821$PER$$US-RDY-SPO/USA/24/0012016$DR REDDYS$$17$YR$T$F$Y$$$20240821$$MD$US$US
242342741$24234274$1$I$$20240624$20240821$20240821$PER$$US-Dermavant-001218$DERMAVANT SCIENCES$$$$$F$Y$$$20240820$$HP$US$US
242342751$24234275$1$I$$20240816$20240821$20240821$EXP$$JP-009507513-2408JPN002101J$MERCK$$7$DEC$$F$Y$$$20240821$$MD$JP$JP
242342761$24234276$1$I$20240715$20240801$20240821$20240821$DIR$FDA-CDER-CTU-2024-57656$$FDA-CTU$$46$YR$$M$N$$$20240801$N$HP$US$
242342771$24234277$1$I$$20240820$20240820$20240820$DIR$715132$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242342801$24234280$1$I$$20240820$20240820$20240820$DIR$715122$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242342811$24234281$1$I$$20240820$20240820$20240820$DIR$715127$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242342821$24234282$1$I$$20240820$20240820$20240820$DIR$715128$$FDA-CTU$$$$$M$N$$$20240820$N$PH$US$
242342831$24234283$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012550$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240821$$CN$CA$CA
242342841$24234284$1$I$$20240816$20240821$20240821$EXP$$ES-BAUSCH-BL-2024-012495$BAUSCH AND LOMB$Garcia G. Dia 69.. Se ha movido el silencio. AMF. 2024;20(7):1.$78$YR$$M$Y$$$20240821$$MD$ES$ES
242342851$24234285$1$I$20230101$20240814$20240821$20240821$EXP$$US-BAUSCH-BL-2024-012444$BAUSCH AND LOMB$$81$YR$$F$Y$$$20240821$$CN$US$US
242342863$24234286$3$F$$20240830$20240821$20240903$EXP$$US-BAUSCH-BL-2024-012475$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240903$$CN$US$US
242342871$24234287$1$I$20240810$20240820$20240820$20240820$DIR$715077$$FDA-CTU$$79$YR$$F$N$49.5$KG$20240820$N$CN$US$
242342891$24234289$1$I$20240701$20240814$20240821$20240821$EXP$$CN-GSK-CN2024GSK103782$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$CN$CN
242342901$24234290$1$I$$20240820$20240821$20240821$EXP$GB-NORDICGR-057166$GB-SANDOZ INC.-SDZ2024GB073995$SANDOZ$$75$YR$$F$Y$$$20240821$$MD$GB$GB
242342921$24234292$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57617$$FDA-CTU$$64$YR$$F$N$52.62$KG$20240821$N$$US$
242342931$24234293$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57631$$FDA-CTU$$58$YR$$F$N$106.59$KG$20240821$N$$US$
242342941$24234294$1$I$$20240820$20240820$20240820$DIR$715142$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242342952$24234295$2$F$20230101$20240908$20240821$20240911$EXP$$DE-BAUSCH-BL-2024-012471$BAUSCH AND LOMB$$$$$M$Y$136.2$KG$20240911$$CN$DE$DE
242342971$24234297$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57590$$FDA-CTU$$68$YR$$F$N$$$20240821$N$$US$
242342981$24234298$1$I$$20240820$20240820$20240820$DIR$715143$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242342991$24234299$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57634$$FDA-CTU$$42$YR$$F$N$119.29$KG$20240821$N$$US$
242343001$24234300$1$I$$20240820$20240820$20240820$DIR$715144$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242343011$24234301$1$I$20240813$20240820$20240820$20240820$DIR$715152$$FDA-CTU$$62$YR$$M$N$104.6$KG$20240820$N$PH$US$
242343031$24234303$1$I$$20240820$20240821$20240821$PER$$US-HALEON-2192911$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242343041$24234304$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57592$$FDA-CTU$$66$YR$$M$N$$$20240821$N$$US$
242343071$24234307$1$I$$20240816$20240821$20240821$EXP$$FR-PFIZER INC-202400238155$PFIZER$Giraud, L. Vitamins deficiency mimicking guillain barre syndrome in a patient treated by paclitaxel. Supportive Care in Cancer. 2024;32:189-90$64$YR$$F$Y$$$20240821$$HP$FR$FR
242343091$24234309$1$I$$20240802$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008148$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242343101$24234310$1$I$$20240812$20240821$20240821$EXP$$CN-ROCHE-10000058610$ROCHE$Ou Y, Zhang J, Cai Y, Hu H, Xie X, Ling J, et al. Modified FOLFOXIRI plus bevacizumab as a salvage regimen for patients with refractory metastatic colorectal cancer (Abstract no: e15559). Journal of Clinical Oncology. 2024-Jun;42 (16):$$$$$Y$$$20240821$$HP$CN$CN
242343121$24234312$1$I$$20240817$20240821$20240821$PER$$PR-ABBVIE-5887430$ABBVIE$$$$$$Y$$$20240821$$MD$PR$PR
242343131$24234313$1$I$$20240815$20240821$20240821$PER$$US-HALEON-2192293$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242343141$24234314$1$I$$20240814$20240821$20240821$EXP$$PT-VIIV HEALTHCARE LIMITED-PT2024EME102258$VIIV$$$$$$Y$$$20240821$$MD$PT$PT
242343151$24234315$1$I$20200101$20240815$20240821$20240821$EXP$$US-SA-2024SA246435$SANOFI AVENTIS$$23$YR$A$F$Y$63.5$KG$20240821$$MD$US$US
242343161$24234316$1$I$$20240814$20240821$20240821$EXP$$US-GSK-US2024101340$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$HP$US$US
242343171$24234317$1$I$$20240816$20240821$20240821$EXP$$US-SA-2024SA247308$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242343182$24234318$2$F$$20240821$20240821$20240823$PER$$US-HALEON-2192449$Haleon PLC$$$$$M$Y$$$20240823$$CN$US$US
242343191$24234319$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA247010$SANOFI AVENTIS$$$$C$F$Y$$$20240821$$MD$US$US
242343201$24234320$1$I$20240801$20240809$20240821$20240821$PER$$US-SA-2024SA241553$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240821$$MD$US$US
242343211$24234321$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA241825$SANOFI AVENTIS$$$$C$F$Y$$$20240821$$MD$US$US
242343221$24234322$1$I$20240810$20240812$20240821$20240821$PER$$US-SA-2024SA243871$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240821$$MD$US$US
242343231$24234323$1$I$20240811$20240816$20240821$20240821$PER$$US-TAKEDA-2024TUS083454$TAKEDA$$$$$$Y$$$20240821$$CN$US$US
242343241$24234324$1$I$20230616$20240819$20240821$20240821$EXP$$NVSC2024GB168012$NOVARTIS$$56$YR$$M$Y$130$KG$20240821$$HP$GB$GB
242343251$24234325$1$I$20240812$20240816$20240821$20240821$30DAY$$IT-SANDOZ INC.-SDZ2024IT074010$SANDOZ$$5$YR$$$Y$63$KG$20240821$$CN$IT$IT
242343261$24234326$1$I$$20240815$20240821$20240821$EXP$US-MLMSERVICE-20170908-0878246-1$US-RDY-USA/USA/17/0093549$DR REDDYS$Kamal M, Apewokin S, Anand M, Abu Jawdeh BG, Govil A, Sheikh MM et al. Late-Onset Allograft Aspergillosis in an HIV-Positive Renal Transplant Recipient: A Case Report. Transplantation Proceedings. 2017;49(7):1570-1573.$21$YR$A$M$Y$$$20240821$$MD$US$US
242343271$24234327$1$I$$20240814$20240821$20240821$EXP$$US-TAKEDA-2024TUS077274$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
242343281$24234328$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA242435$SANOFI AVENTIS$$$$A$F$Y$67.58$KG$20240821$$MD$US$US
242343291$24234329$1$I$$20240821$20240821$20240821$PER$$US-HALEON-2192960$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242343302$24234330$2$F$$20240910$20240821$20240910$PER$$US-ALXN-202408USA000893US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$MD$US$US
242343311$24234331$1$I$20240811$20240816$20240821$20240821$EXP$$CN-INCYTE CORPORATION-2024IN008711$INCYTE$$$$$$Y$$$20240821$$HP$CN$CN
242343321$24234332$1$I$$20240820$20240821$20240821$PER$$NVSC2024US169388$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242343331$24234333$1$I$$20240817$20240821$20240821$PER$$US-BAYER-2024A119788$BAYER$$$$$F$Y$$$20240821$$CN$US$US
242343341$24234334$1$I$20240805$20240813$20240821$20240821$EXP$$CA-AstraZeneca-2024A177348$ASTRAZENECA$$54$YR$$M$Y$$$20240821$$PH$CA$
242343361$24234336$1$I$20231201$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A186016$ASTRAZENECA$$56$YR$$M$Y$149.7$KG$20240821$$MD$US$
242343371$24234337$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A184771$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242343381$24234338$1$I$$20240814$20240821$20240821$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202408010090$ELI LILLY AND CO$$$$$F$Y$$$20240821$$MD$AE$AE
242343391$24234339$1$I$$20240812$20240821$20240821$EXP$GB-MHRA-MED-202408122302508310-VNBSD$GB-ELI_LILLY_AND_COMPANY-GB202408007866$ELI LILLY AND CO$$43$YR$A$F$Y$69$KG$20240821$$CN$GB$GB
242343401$24234340$1$I$$20240809$20240821$20240821$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007961$ELI LILLY AND CO$$$$$F$Y$$$20240821$$PH$US$US
242343411$24234341$1$I$$20240819$20240821$20240821$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408012358$ELI LILLY AND CO$$$$E$$Y$$$20240821$$CN$JP$JP
242343421$24234342$1$I$20240814$20240820$20240820$20240820$DIR$715138$$FDA-CTU$$50$YR$$F$N$99$KG$20240820$Y$CN$US$
242343431$24234343$1$I$20240727$20240809$20240821$20240821$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408010885$ELI LILLY AND CO$$64$YR$A$F$Y$51$KG$20240821$$CN$DE$CN
242343441$24234344$1$I$$20240815$20240821$20240821$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408011306$ELI LILLY AND CO$$$$$$Y$$$20240821$$MD$CN$CN
242343451$24234345$1$I$20240730$20240813$20240821$20240821$EXP$IT-MINISAL02-998345$IT-ELI_LILLY_AND_COMPANY-IT202408011983$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240821$$CN$DE$IT
242343471$24234347$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57612$$FDA-CTU$$56$YR$$F$N$$$20240821$N$$US$
242343481$24234348$1$I$$20240814$20240821$20240821$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408009562$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240821$$CN$BR$BR
242343491$24234349$1$I$$20240814$20240821$20240821$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009363$ELI LILLY AND CO$$$$$F$Y$$$20240821$$CN$US$US
242343501$24234350$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165476$AMGEN$$$$A$M$Y$$$20240821$$MD$US$US
242343511$24234351$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57613$$FDA-CTU$$59$YR$$M$N$$$20240821$N$$US$
242343522$24234352$2$F$$20240917$20240821$20240918$EXP$$CA-AstraZeneca-2024A185656$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$CA$
242343532$24234353$2$F$$20240918$20240821$20240919$PER$$US-HALEON-2192749$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
242343541$24234354$1$I$$20240809$20240821$20240821$PER$$US-AstraZeneca-2024A182073$ASTRAZENECA$$$$$M$Y$$$20240821$$CN$US$
242343551$24234355$1$I$$20240815$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US073198$SANDOZ$$$$$F$Y$$$20240821$$CN$US$US
242343573$24234357$3$F$20240101$20240918$20240821$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202406011625$ELI LILLY AND CO$$45$YR$A$F$Y$104.31$KG$20240926$$CN$US$US
242343581$24234358$1$I$$20240815$20240821$20240821$PER$$US-HALEON-2192290$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242343592$24234359$2$F$20240815$20240820$20240821$20240830$EXP$$JP-009507513-2408JPN001866J$MERCK$$$$$F$Y$$$20240830$$MD$JP$JP
242343601$24234360$1$I$20240801$20240817$20240821$20240821$EXP$$CN-INCYTE CORPORATION-2024IN008710$INCYTE$$$$$$Y$$$20240821$$HP$CN$CN
242343611$24234361$1$I$20240412$20240816$20240821$20240821$PER$$US-JNJFOC-20240846530$JOHNSON AND JOHNSON$$51$YR$A$F$Y$81.2$KG$20240821$$CN$US$US
242343621$24234362$1$I$20240101$20240815$20240821$20240821$EXP$$US-ABBVIE-5885837$ABBVIE$$61$YR$$F$Y$$$20240821$$CN$US$US
242343631$24234363$1$I$20240816$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024163976$AMGEN$$$$$M$Y$$$20240821$$CN$US$US
242343642$24234364$2$F$$20240816$20240821$20240824$PER$$US-AMGEN-USASP2024165665$AMGEN$$$$$$Y$$$20240824$$MD$US$US
242343651$24234365$1$I$$20240816$20240821$20240821$EXP$$GB-INCYTE CORPORATION-2024IN008658$INCYTE$$$$$$Y$$$20240821$$MD$GB$GB
242343662$24234366$2$F$$20240827$20240821$20240905$EXP$$US-TEVA-VS-3234479$TEVA$Eshak N, Ehikhueme G, Ramesh M, Pixley J. Granulomatous Polyangiitis Refractory to Induction With Rituximab in 3 Patients. J-Investig-Med-High-Impact-Case-Rep 2024; 12.; Eshak N, Ehikhueme G, Ramesh M, Pixley J. Granulomatous Polyangiitis Refractory to Induction With Rituximab in 3 Patients. J-Investig-Med-High-Impact-Case-Rep 2024; 12.$66$YR$$F$Y$$$20240905$$MD$US$US
242343671$24234367$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240845285$JOHNSON AND JOHNSON$$$$$M$Y$$$20240821$$CN$US$US
242343681$24234368$1$I$$20240820$20240821$20240821$PER$$US-ROCHE-10000062299$ROCHE$$$$A$F$Y$$$20240821$$HP$US$US
242343691$24234369$1$I$$20240819$20240821$20240821$EXP$$US-TAKEDA-2024TUS083953$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
242343701$24234370$1$I$$20240816$20240821$20240821$EXP$$JP-009507513-2408JPN002105J$MERCK$$6$DEC$$F$Y$$$20240821$$MD$JP$JP
242343711$24234371$1$I$$20240820$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US074156$SANDOZ$$$$$F$Y$$$20240821$$CN$US$US
242343721$24234372$1$I$$20240814$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US074166$SANDOZ$$$$$$Y$$$20240821$$HP$US$US
242343741$24234374$1$I$20240802$20240814$20240821$20240821$EXP$$US-MYLANLABS-2024M1076934$MYLAN$$64$YR$$F$Y$90.72$KG$20240821$$HP$US$US
242343753$24234375$3$F$20240515$20240829$20240821$20240830$EXP$$DE-SANDOZ INC.-SDZ2024DE061863$SANDOZ$$76$YR$$F$Y$70$KG$20240830$$MD$DE$DE
242343761$24234376$1$I$$20240820$20240820$20240820$DIR$715149$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242343791$24234379$1$I$$20240820$20240821$20240821$EXP$$NVSC2024CA169062$NOVARTIS$$87$YR$$F$Y$$$20240821$$HP$CA$CA
242343803$24234380$3$F$20240501$20240912$20240821$20240918$EXP$$NVSC2024AR168604$NOVARTIS$$73$YR$$F$Y$$$20240918$$CN$AR$AR
242343811$24234381$1$I$$20240819$20240821$20240821$PER$$NVSC2024US168628$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
242343821$24234382$1$I$20240820$20240820$20240820$20240820$DIR$715171$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242343831$24234383$1$I$20240820$20240820$20240820$20240820$DIR$715160$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242343841$24234384$1$I$$20240820$20240820$20240820$DIR$715165$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242343851$24234385$1$I$20170801$20240814$20240821$20240821$EXP$$PHHY2017CA117402$NOVARTIS$$57$YR$$F$Y$$$20240821$$MD$CA$CA
242343861$24234386$1$I$20240201$20240813$20240821$20240821$EXP$FR-AFSSAPS-LM2024000436$FR-TEVA-VS-3233473$TEVA$$61$YR$$F$Y$$$20240821$$MD$FR$FR
242343871$24234387$1$I$$20240821$20240821$20240821$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047052$BOEHRINGER INGELHEIM$$$$$$Y$$$20240821$$CN$US$US
242343881$24234388$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57598$$FDA-CTU$$75$YR$$F$N$$$20240821$N$$US$
242343891$24234389$1$I$20220926$20240820$20240820$20240820$DIR$715087$$FDA-CTU$$62$YR$$F$N$65.25$KG$20240820$N$CN$US$
242343901$24234390$1$I$$20240819$20240821$20240821$PER$$US-FreseniusKabi-FK202412725$FRESENIUS KABI$$$$$F$Y$$$20240821$$HP$US$US
242343911$24234391$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130385$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240821$$CN$US$US
242343921$24234392$1$I$$20240819$20240821$20240821$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-132038$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240821$$PH$BR$BR
242343931$24234393$1$I$20240813$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128748$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240821$$PH$US$US
242343951$24234395$1$I$20240802$20240813$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128164$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240821$$CN$US$US
242343961$24234396$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131290$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240821$$CN$US$US
242343972$24234397$2$F$20240724$20240820$20240821$20240826$EXP$$AR-MYLANLABS-2024M1076325$MYLAN$$66$YR$$M$Y$$$20240826$$MD$AR$AR
242344011$24234401$1$I$$20240820$20240820$20240820$DIR$715173$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242344021$24234402$1$I$20240818$20240820$20240820$20240820$DIR$715158$$FDA-CTU$$65$YR$$F$N$78.75$KG$20240820$N$CN$US$
242344031$24234403$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57597$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
242344041$24234404$1$I$20240819$20240820$20240820$20240820$DIR$715140$$FDA-CTU$$23$YR$$F$N$97$KG$20240820$N$PH$US$
242344051$24234405$1$I$20240820$20240820$20240820$20240820$DIR$715180$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242344061$24234406$1$I$20240820$20240820$20240820$20240820$DIR$715183$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242344071$24234407$1$I$20240319$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57669$$FDA-CTU$$49$YR$$M$N$$$20240821$N$HP$US$
242344091$24234409$1$I$20211130$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57668$$FDA-CTU$$25$YR$$M$N$$$20240821$N$HP$US$
242344111$24234411$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244899$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240821$$MD$US$US
242344121$24234412$1$I$20240718$20240815$20240821$20240821$PER$$US-SA-2024SA247087$SANOFI AVENTIS$$49$YR$A$M$Y$102$KG$20240821$$MD$US$US
242344131$24234413$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA246437$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240821$$MD$US$US
242344141$24234414$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243253$SANOFI AVENTIS$$$$$$Y$$$20240821$$HP$US$US
242344161$24234416$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246955$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240821$$MD$US$US
242344171$24234417$1$I$$20240820$20240821$20240821$PER$$US-HALEON-2192955$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242344191$24234419$1$I$$20240814$20240821$20240821$PER$$US-BIOGEN-2024BI01278545$BIOGEN$$$$$F$Y$$$20240821$$MD$US$US
242344201$24234420$1$I$$20240809$20240821$20240821$PER$$US-ABBVIE-5878940$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242344212$24234421$2$F$$20240821$20240821$20240826$PER$$US-HALEON-2192972$Haleon PLC$$$$$F$Y$$$20240826$$CN$US$US
242344221$24234422$1$I$$20240808$20240821$20240821$EXP$$US-RDY-LIT/USA/24/0011891$DR REDDYS$Sidhu SK, Ciancarelli J, Alviar C, Greco A. A Case of Severe Cardiopulmonary Sarcoidosis and Sub-massive Pulmonary Embolism. US Cardiology Review. 2024 Jul;18(1): 25-26. doi:10.15420/usc.2024.18.s1.$68$YR$E$M$Y$$$20240821$$MD$US$US
242344231$24234423$1$I$$20240814$20240821$20240821$PER$$US-BAYER-2024A117800$BAYER$$$$$F$Y$$$20240821$$CN$US$US
242344241$24234424$1$I$$20240814$20240821$20240821$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR103130$VIIV$$$$$M$Y$$$20240821$$MD$US$US
242344251$24234425$1$I$$20240820$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA074132$SANDOZ$$$$$$Y$$$20240821$$HP$CA$CA
242344261$24234426$1$I$20190201$20240820$20240821$20240821$EXP$$DE-SANDOZ INC.-SDZ2024DE073940$SANDOZ$$69$YR$$F$Y$$$20240821$$MD$DE$DE
242344273$24234427$3$F$20240615$20240828$20240821$20240904$EXP$$PL-SA-2024SA247228$SANOFI AVENTIS$$41$YR$A$F$Y$50$KG$20240904$$CN$PL$PL
242344281$24234428$1$I$$20240816$20240821$20240821$EXP$$JP-009507513-2408JPN002102J$MERCK$$7$DEC$$F$Y$$$20240821$$MD$JP$JP
242344302$24234430$2$F$$20240820$20240821$20240827$EXP$$US-SA-2024SA247409$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240827$$MD$US$US
242344311$24234431$1$I$20240819$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011250$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240821$$CN$US$US
242344322$24234432$2$F$20240814$20240815$20240821$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408009660$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240823$$CN$US$US
242344331$24234433$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011573$ELI LILLY AND CO$$54$YR$A$$Y$$$20240821$$LW$US$US
242344341$24234434$1$I$20240814$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009651$ELI LILLY AND CO$$$$$$Y$$$20240821$$CN$US$US
242344351$24234435$1$I$$20240812$20240821$20240821$PER$$US-ABBVIE-5879174$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242344361$24234436$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243294$SANOFI AVENTIS$$$$A$M$Y$99.773$KG$20240821$$MD$US$US
242344371$24234437$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA243658$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$HP$US$US
242344381$24234438$1$I$20240101$20240812$20240821$20240821$PER$$US-SA-2024SA245206$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240821$$MD$US$US
242344391$24234439$1$I$$20240815$20240821$20240821$PER$$US-BIOGEN-2022BI01171968$BIOGEN$$$$$M$Y$$$20240821$$CN$US$US
242344401$24234440$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA243362$SANOFI AVENTIS$$49$YR$A$M$Y$83.9$KG$20240821$$MD$US$US
242344411$24234441$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA246946$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240821$$MD$US$US
242344424$24234442$4$F$$20240913$20240821$20240926$PER$$US-SA-2024SA246089$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240926$$MD$US$US
242344432$24234443$2$F$$20240821$20240821$20240826$PER$$US-HALEON-2192748$Haleon PLC$$$$$$Y$$$20240826$$CN$US$US
242344441$24234444$1$I$$20240820$20240821$20240821$EXP$$JP-TAKEDA-2024TUS084066$TAKEDA$Kurihara S, Sawa N, Sumida K, Ikuma D, Oba Y, Mizuno H et al.. A case report of dipeptidyl peptidase 4 inhibitor-related kidney disease combined with renal cancer.. Frontiers In Nephrology. 2024$64$YR$$F$Y$45.7$KG$20240821$$MD$JP$JP
242344451$24234445$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA245095$SANOFI AVENTIS$$$$A$F$Y$109$KG$20240821$$MD$US$US
242344482$24234448$2$F$$20240828$20240821$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132281$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240906$$CN$US$US
242344491$24234449$1$I$$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128977$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240821$$CN$US$US
242344501$24234450$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240854708$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240821$$CN$US$US
242344511$24234451$1$I$20240601$20240819$20240821$20240821$EXP$$US-KYOWAKIRIN-2024KK019466$KYOWA$$$$$$Y$$$20240821$$PH$US$US
242344522$24234452$2$F$20240101$20240903$20240821$20240918$EXP$$JP-EAGLE PHARMACEUTICALS, INC.-JP-2024EAG000076$EAGLE$$74$YR$$M$Y$$$20240918$$PH$JP$JP
242344531$24234453$1$I$20240810$20240814$20240821$20240821$EXP$GB-MHRA-MED-202408140853190720-DBCTY$GB-TEVA-VS-3233484$TEVA$$$$$M$Y$95$KG$20240821$$CN$GB$GB
242344561$24234456$1$I$20240802$20240812$20240821$20240821$PER$$US-SA-2024SA244840$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240821$$MD$US$US
242344571$24234457$1$I$$20240820$20240821$20240821$PER$$US-TAKEDA-2024TUS083756$TAKEDA$$9$YR$$M$Y$48$KG$20240821$$MD$US$US
242344581$24234458$1$I$20240701$20240812$20240821$20240821$PER$$US-SA-2024SA243327$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240821$$CN$US$US
242344591$24234459$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA244980$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
242344601$24234460$1$I$20240501$20240814$20240821$20240821$PER$$US-SA-2024SA246952$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240821$$MD$US$US
242344611$24234461$1$I$20240814$20240814$20240821$20240821$PER$$US-SA-2024SA243345$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240821$$MD$US$US
242344621$24234462$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA245213$SANOFI AVENTIS$$$$A$M$Y$92.9$KG$20240821$$MD$US$US
242344631$24234463$1$I$20240701$20240813$20240821$20240821$PER$$US-SA-2024SA246071$SANOFI AVENTIS$$12$YR$T$M$Y$35.1$KG$20240821$$MD$US$US
242344641$24234464$1$I$$20240814$20240821$20240821$EXP$GB-MHRA-31483741$GB-TEVA-VS-3233472$TEVA$$$$$M$Y$$$20240821$$CN$GB$GB
242344651$24234465$1$I$20220901$20240812$20240821$20240821$EXP$CO-MLMSERVICE-20240101-4749710-1$CO-ROCHE-10000056005$ROCHE$Hoyos-Llanos DM, Cortes-Mejia NA, Rico-Bolivar DL, Giraldo-Posada P, Perez-Rengifo FA, Vera-Torres A. Cytomegalovirus-related Guillain-Barre syndrome in an adult liver transplant recipient: a case report. Infectio. 2023;27(3):186-90. DOI: 10.22354/24223794.1144.$67$YR$E$M$Y$$$20240821$$HP$CO$CO
242344671$24234467$1$I$$20240726$20240821$20240821$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07600$LUPIN$$$$$$Y$$$20240821$$CN$US$US
242344681$24234468$1$I$20240801$20240816$20240821$20240821$PER$$US-ABBVIE-5888517$ABBVIE$$$$$$Y$$$20240821$$MD$US$US
242344691$24234469$1$I$$20240814$20240821$20240821$PER$$US-JNJFOC-20240838767$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$MD$US$US
242344701$24234470$1$I$$20240820$20240821$20240821$PER$$US-JNJFOC-20240851920$JOHNSON AND JOHNSON$$$$A$$Y$$$20240821$$MD$US$US
242344711$24234471$1$I$$20240819$20240821$20240821$PER$$US-JNJFOC-20240848609$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242344721$24234472$1$I$20240707$20240819$20240821$20240821$EXP$$AU-TGA-0000816561$SANDOZ$$54$YR$$F$Y$$$20240821$$MD$AU$AU
242344731$24234473$1$I$20240719$20240815$20240821$20240821$EXP$$US-AMGEN-USASL2024146758$AMGEN$$67$YR$E$F$Y$$$20240821$$CN$US$US
242344741$24234474$1$I$20240101$20240816$20240821$20240821$EXP$$US-AMGEN-USASP2024163889$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242344761$24234476$1$I$$20240820$20240821$20240821$EXP$$GB-PFIZER INC-202400239923$PFIZER$$75$YR$$F$Y$$$20240821$$MD$GB$GB
242344771$24234477$1$I$$20240819$20240821$20240821$EXP$$US-PFIZER INC-202400239490$PFIZER$$$$$F$Y$$$20240821$$CN$US$US
242344781$24234478$1$I$20240315$20240819$20240821$20240821$EXP$FR-AFSSAPS-DJ2024000916$FR-PFIZER INC-202400238847$PFIZER$$63$YR$$F$Y$52$KG$20240821$$MD$FR$FR
242344791$24234479$1$I$$20240820$20240821$20240821$EXP$$CA-PFIZER INC-202400240040$PFIZER$$6$YR$$M$Y$37$KG$20240821$$HP$CA$CA
242344801$24234480$1$I$20240806$20240819$20240821$20240821$EXP$ES-AEMPS-1561852$ES-PFIZER INC-202400238876$PFIZER$$61$YR$$F$Y$$$20240821$$PH$ES$ES
242344811$24234481$1$I$$20240820$20240821$20240821$EXP$$CA-PFIZER INC-202400239984$PFIZER$$75$YR$$M$Y$$$20240821$$PH$CA$CA
242344822$24234482$2$F$20240101$20240903$20240821$20240904$EXP$$TR-ABBVIE-5885795$ABBVIE$$$$$F$Y$60$KG$20240904$$CN$TR$TR
242344831$24234483$1$I$20240801$20240814$20240821$20240821$PER$$US-SA-2024SA247043$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240821$$PH$US$US
242344842$24234484$2$F$20240328$20240823$20240821$20240829$PER$$AU-Eisai-EC-2024-172202$EISAI$$$$$M$Y$$$20240829$$MD$AU$AU
242344852$24234485$2$F$20240801$20240916$20240821$20240923$PER$$US-SA-2024SA245164$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240923$$MD$US$US
242344861$24234486$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA246956$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240821$$MD$US$US
242344871$24234487$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130363$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$77.11$KG$20240821$$CN$US$US
242344881$24234488$1$I$20220609$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184257$ASTRAZENECA$$72$YR$$F$Y$44$KG$20240821$$MD$FR$
242344891$24234489$1$I$$20240816$20240821$20240821$EXP$$RU-AstraZeneca-2024A189804$ASTRAZENECA$$73$YR$$M$Y$92$KG$20240821$$MD$RU$
242344901$24234490$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A184919$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$US$
242344912$24234491$2$F$20240101$20240909$20240821$20240917$EXP$$US-AstraZeneca-2024A185042$ASTRAZENECA$$55$YR$$F$Y$$$20240917$$HP$US$
242344921$24234492$1$I$$20240816$20240821$20240821$EXP$$US-AstraZeneca-2024A187470$ASTRAZENECA$$$$$M$Y$$$20240821$$HP$US$
242344931$24234493$1$I$$20240812$20240821$20240821$PER$$US-SA-2024SA245641$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242344943$24234494$3$F$$20240822$20240821$20240830$EXP$$CA-AstraZeneca-2024A189042$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$CA$
242344951$24234495$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A184915$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
242344971$24234497$1$I$$20240814$20240821$20240821$EXP$$IE-ABBVIE-5885845$ABBVIE$$$$$F$Y$$$20240821$$HP$IE$IE
242344981$24234498$1$I$20240101$20240816$20240821$20240821$EXP$$US-ABBVIE-5884445$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242344992$24234499$2$F$20240819$20240910$20240821$20240910$PER$$US-JNJFOC-20240848073$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240910$$CN$US$US
242345003$24234500$3$F$20240809$20240919$20240821$20240930$PER$$US-JNJFOC-20240830370$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240930$$CN$US$US
242345011$24234501$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57396$$FDA-CTU$$61$YR$$F$N$$$20240820$N$$US$
242345021$24234502$1$I$$20240820$20240821$20240821$PER$$US-JNJFOC-20240852124$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$MD$US$US
242345032$24234503$2$F$$20240911$20240821$20240911$PER$$US-ALXN-202408USA001020US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
242345041$24234504$1$I$20240801$20240816$20240821$20240821$EXP$$DE-ABBVIE-5884699$ABBVIE$$75$YR$$F$Y$$$20240821$$CN$DE$DE
242345051$24234505$1$I$$20240816$20240821$20240821$EXP$$NZ-GSK-NZ2024101864$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$NZ$NZ
242345061$24234506$1$I$$20240814$20240821$20240821$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-129992$BRISTOL MYERS SQUIBB$Toulemonde E, Lannoy D, Gautier S, Stefanski M, Miaux C, Azib-Meftah S, et al. Skin testing and drug provocation tests should be performed in the context of drug reaction with eosinophilia and systemic symptoms: a cohort study. Dermatitis. 2024 Jul 01;35(4):415-7. doi:10.1089/derm.2023.0291.$69$YR$E$F$Y$$$20240821$$MD$FR$FR
242345071$24234507$1$I$$20240703$20240821$20240821$EXP$$IT-MYLANLABS-2024M1077183$MYLAN$Agostini N, Guida G, Falcone S, Musazzi A, Castiglioni B. Cardiogenic shock in a patient with severe aortic valve stenosis and multivessel coronary disease: advanced therapeutic strategies. Eur-Heart-J-Suppl 2024; 26 (Suppl. 2) ii135-ii136.$58$YR$$M$Y$$$20240821$$HP$IT$IT
242345082$24234508$2$F$20240101$20240822$20240821$20240827$EXP$$US-ABBVIE-5885033$ABBVIE$$60$YR$$F$Y$$$20240827$$CN$US$US
242345103$24234510$3$F$$20240828$20240821$20240906$EXP$$CA-TAKEDA-2024TUS081656$TAKEDA$$43$YR$$F$Y$96$KG$20240906$$HP$CA$CA
242345121$24234512$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57266$$FDA-CTU$$76$YR$$F$N$104.78$KG$20240820$N$$US$
242345152$24234515$2$F$$20240823$20240821$20240830$PER$US-MLMSERVICE-20240807-PI155767-00034-1$US-RDY-SPO/USA/24/0011938$DR REDDYS$Blackwell JN, Estes NA, Shalaby AA. Help from the little guy: Intramural ischemic ventricular tachycardia ablation leveraging a 2F multipolar catheter in a coronary vein. Heart Rhythm Case Reports. 2024:1-5. DOI: 10.1016/j.hrcr.2024.05.021.$68$YR$E$M$Y$87.3$KG$20240830$$MD$US$US
242345161$24234516$1$I$20240715$20240816$20240821$20240821$EXP$FR-AFSSAPS-PO2024000910$FR-RDY-SPO/FRA/24/0012022$DR REDDYS$$82$YR$E$F$Y$$$20240821$$PH$FR$FR
242345171$24234517$1$I$20240101$20240816$20240821$20240821$EXP$$US-ABBVIE-5885087$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242345181$24234518$1$I$20240807$20240816$20240821$20240821$EXP$$US-SA-2024SA246028$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240821$$MD$US$US
242345191$24234519$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA247075$SANOFI AVENTIS$$$$C$M$Y$$$20240821$$MD$US$US
242345201$24234520$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA242752$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240821$$MD$US$US
242345212$24234521$2$F$20240101$20240828$20240821$20240911$PER$$US-SA-2024SA246634$SANOFI AVENTIS$$65$YR$E$F$Y$127$KG$20240911$$MD$US$US
242345221$24234522$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA245916$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240821$$MD$US$US
242345231$24234523$1$I$$20240816$20240821$20240821$EXP$$US-ABBVIE-5885091$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242345241$24234524$1$I$20240727$20240815$20240821$20240821$EXP$FR-AFSSAPS-RS2024000793$FR-MYLANLABS-2024M1076099$MYLAN$$19$YR$$M$Y$54$KG$20240821$$MD$FR$FR
242345261$24234526$1$I$$20240813$20240821$20240821$EXP$$CN-MYLANLABS-2024M1076980$MYLAN$Xue M, Wang T, Zhou Q.. Effects of rt-PA intravenous thrombolysis on NIHSS score and adverse reactions in patients with acute ischemic stroke.. Clinical Research and Practice. 2024;9(21):29-32$$$E$$Y$$$20240821$$MD$CN$CN
242345271$24234527$1$I$$20240815$20240821$20240821$EXP$$DE-MYLANLABS-2024M1076052$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology. 2024;48 (5):299-313$31$YR$$F$Y$$$20240821$$HP$DE$DE
242345282$24234528$2$F$$20240830$20240821$20240906$EXP$$CN-MYLANLABS-2024M1076663$MYLAN$$38$YR$$M$Y$$$20240906$$CN$CN$CN
242345293$24234529$3$F$$20240917$20240821$20240923$EXP$$IT-MYLANLABS-2024M1076681$MYLAN$Pagni G, Pardini F.. Use of lurasidone in a patient with schizophrenia with obsessive-compulsive disorder and gambling addiction: efficacy and tolerability.. Italian journal of psychiatry. 2024;10(1 (Suppl. 3)$$$A$M$Y$$$20240923$$HP$IT$IT
242345302$24234530$2$F$$20240829$20240821$20240905$EXP$$DE-MYLANLABS-2024M1076161$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$41$YR$$M$Y$$$20240905$$HP$DE$DE
242345311$24234531$1$I$$20240815$20240821$20240821$EXP$$DE-MYLANLABS-2024M1076157$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology. 2024;48 (5):299-313$29$YR$$F$Y$$$20240821$$HP$DE$DE
242345321$24234532$1$I$20240501$20240815$20240821$20240821$EXP$FR-AFSSAPS-AVGR2024000142$FR-MYLANLABS-2024M1076151$MYLAN$$14$YR$$M$Y$$$20240821$$MD$FR$FR
242345331$24234533$1$I$$20240816$20240821$20240821$EXP$$MY-MYLANLABS-2024M1077414$MYLAN$Zarina Banu A, Zahra Alizadeh S, Haseena Munawara MJ, Fathiyah AG, Mohamed Jahangir AW. P 027: A remarkable journey: Prolonged survival in scimitar syndrome. Int-J-Cardiol 2024; 397 (Suppl.) abstr. P 027.$71$YR$$F$Y$$$20240821$$HP$MY$MY
242345341$24234534$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57247$$FDA-CTU$$63$YR$$F$N$40.82$KG$20240820$N$$US$
242345351$24234535$1$I$20240507$20240820$20240820$20240820$DIR$715175$$FDA-CTU$$34$YR$$F$N$69.75$KG$20240820$N$CN$US$
242345361$24234536$1$I$20220709$20240816$20240821$20240821$EXP$ES-AEMPS-1560363$ES-MYLANLABS-2024M1076664$MYLAN$$64$YR$$M$Y$$$20240821$$PH$ES$ES
242345381$24234538$1$I$$20240816$20240821$20240821$EXP$$GB-MYLANLABS-2024M1076788$MYLAN$$$$$F$Y$$$20240821$$CN$GB$GB
242345401$24234540$1$I$20231201$20240815$20240821$20240821$EXP$$DE-MYLANLABS-2024M1076522$MYLAN$$$$A$F$Y$61$KG$20240821$$CN$DE$DE
242345411$24234541$1$I$20240606$20240816$20240821$20240821$EXP$$NZ-MYLANLABS-2024M1052392$MYLAN$$36$YR$$M$Y$$$20240821$$HP$NZ$NZ
242345421$24234542$1$I$20240731$20240815$20240821$20240821$EXP$$CN-PURDUE-USA-2024-0311452$PURDUE$$63$YR$$F$Y$50$KG$20240821$$HP$CN$CN
242345431$24234543$1$I$20240727$20240814$20240821$20240821$EXP$$CN-PURDUE-USA-2024-0311447$PURDUE$$45$YR$$F$Y$$$20240821$$HP$CN$CN
242345441$24234544$1$I$$20240816$20240821$20240821$EXP$$IE-PURDUE-USA-2024-0311451$PURDUE$$59$YR$$F$Y$$$20240821$$CN$IE$IE
242345451$24234545$1$I$20240701$20240813$20240821$20240821$EXP$$CO-ABBVIE-5886096$ABBVIE$$86$YR$$F$Y$35$KG$20240821$$HP$CO$CO
242345462$24234546$2$F$20240815$20240816$20240821$20240826$PER$$US-AMGEN-USASP2024164491$AMGEN$$62$YR$A$F$Y$$$20240826$$PH$US$US
242345471$24234547$1$I$$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024165552$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242345481$24234548$1$I$20240724$20240814$20240821$20240821$EXP$$IT-ABBVIE-5887332$ABBVIE$$63$YR$$F$Y$48$KG$20240821$$MD$IT$IT
242345491$24234549$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012579$BAUSCH AND LOMB$$59$YR$$F$Y$$$20240821$$CN$CA$CA
242345502$24234550$2$F$20240808$20240823$20240821$20240903$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408006702$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240903$$MD$CN$CN
242345511$24234551$1$I$20240801$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011808$ELI LILLY AND CO$$91$YR$E$F$Y$$$20240821$$CN$US$US
242345521$24234552$1$I$20240819$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012041$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240821$$CN$US$US
242345531$24234553$1$I$20240819$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011849$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240821$$CN$US$US
242345541$24234554$1$I$$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009664$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240821$$CN$US$US
242345551$24234555$1$I$$20240813$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408008638$ELI LILLY AND CO$$$$$M$Y$$$20240821$$CN$US$US
242345561$24234556$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012606$BAUSCH AND LOMB$$59$YR$$M$Y$$$20240821$$CN$CA$CA
242345571$24234557$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012618$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240821$$CN$CA$CA
242345581$24234558$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-PV202400108214$PFIZER$$45$YR$$F$Y$$$20240821$$HP$US$US
242345591$24234559$1$I$20240820$20240820$20240821$20240821$PER$$US-PFIZER INC-202400240662$PFIZER$$22$YR$$F$Y$$$20240821$$CN$US$US
242345622$24234562$2$F$$20240913$20240821$20240917$PER$$US-PFIZER INC-202400239681$PFIZER$$60$YR$$M$Y$$$20240917$$HP$US$US
242345631$24234563$1$I$20240808$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239720$PFIZER$$63$YR$$F$Y$$$20240821$$CN$US$US
242345643$24234564$3$F$$20240905$20240821$20240909$PER$$US-PFIZER INC-PV202400108088$PFIZER$$15$YR$$M$Y$56.7$KG$20240909$$HP$US$US
242345651$24234565$1$I$20240818$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239729$PFIZER$$68$YR$$F$Y$$$20240821$$CN$US$US
242345661$24234566$1$I$20240819$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239324$PFIZER$$79$YR$$F$Y$$$20240821$$CN$US$US
242345671$24234567$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-PV202400108201$PFIZER$$76$YR$$M$Y$$$20240821$$CN$US$US
242345681$24234568$1$I$$20240820$20240821$20240821$PER$$US-PFIZER INC-PV202400109035$PFIZER$$$$$F$Y$$$20240821$$CN$US$US
242345691$24234569$1$I$20240819$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239543$PFIZER$$15$YR$$F$Y$$$20240821$$HP$US$US
242345701$24234570$1$I$$20240820$20240821$20240821$PER$$US-PFIZER INC-PV202400108783$PFIZER$$80$YR$$M$Y$$$20240821$$CN$US$US
242345712$24234571$2$F$$20240821$20240821$20240826$PER$$US-PFIZER INC-202400240185$PFIZER$$55$YR$$M$Y$$$20240826$$CN$US$US
242345721$24234572$1$I$20240813$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239400$PFIZER$$71$YR$$F$Y$$$20240821$$CN$US$US
242345731$24234573$1$I$$20240815$20240821$20240821$PER$$US-PFIZER INC-202400237992$PFIZER$$$$$F$Y$$$20240821$$CN$US$US
242345742$24234574$2$F$$20240825$20240821$20240827$PER$$US-PFIZER INC-202400239255$PFIZER$$$$$F$Y$$$20240827$$CN$US$US
242345751$24234575$1$I$$20240820$20240821$20240821$PER$$US-PFIZER INC-PV202400108757$PFIZER$$70$YR$$M$Y$$$20240821$$HP$US$US
242345762$24234576$2$F$$20240819$20240821$20240826$EXP$$US-PFIZER INC-202400239625$PFIZER$$75$YR$$M$Y$$$20240826$$HP$US$US
242345771$24234577$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239733$PFIZER$$68$YR$$F$Y$$$20240821$$CN$US$US
242345782$24234578$2$F$20240101$20240821$20240821$20240827$PER$$US-PFIZER INC-202400230532$PFIZER$$16$YR$$M$Y$$$20240827$$HP$US$US
242345791$24234579$1$I$20240801$20240819$20240821$20240821$PER$$US-PFIZER INC-PV202400108303$PFIZER$$$$$F$Y$$$20240821$$CN$US$US
242345801$24234580$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-PV202400108285$PFIZER$$57$YR$$F$Y$$$20240821$$HP$US$US
242345821$24234582$1$I$20240818$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239651$PFIZER$$65$YR$$F$Y$$$20240821$$CN$US$US
242345841$24234584$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239165$PFIZER$$$$$F$Y$$$20240821$$HP$US$US
242345851$24234585$1$I$20240817$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239397$PFIZER$$55$YR$$F$Y$$$20240821$$CN$US$US
242345861$24234586$1$I$20240801$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239379$PFIZER$$79$YR$$M$Y$$$20240821$$CN$US$US
242345871$24234587$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239773$PFIZER$$$$$$Y$$$20240821$$CN$US$US
242345882$24234588$2$F$20240817$20240906$20240821$20240909$PER$$US-PFIZER INC-202400239840$PFIZER$$80$YR$$M$Y$74.83$KG$20240909$$CN$US$US
242345891$24234589$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-PV202400108190$PFIZER$$75$YR$$F$Y$$$20240821$$HP$US$US
242345903$24234590$3$F$20240818$20240823$20240821$20240828$PER$$US-PFIZER INC-202400239218$PFIZER$$71$YR$$F$Y$58.97$KG$20240828$$CN$US$US
242345912$24234591$2$F$20240801$20240905$20240821$20240906$PER$$US-PFIZER INC-202400239785$PFIZER$$42$YR$$F$Y$117.93$KG$20240906$$CN$US$US
242345922$24234592$2$F$20240801$20240820$20240821$20240827$PER$$US-PFIZER INC-202400239433$PFIZER$$72$YR$$M$Y$61.23$KG$20240827$$HP$US$US
242345931$24234593$1$I$20240728$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239472$PFIZER$$22$YR$$F$Y$$$20240821$$CN$US$US
242345941$24234594$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239484$PFIZER$$5$DEC$$M$Y$$$20240821$$MD$US$US
242345952$24234595$2$F$20240819$20240820$20240821$20240822$PER$$US-PFIZER INC-202400239493$PFIZER$$$$I$$Y$$$20240822$$CN$US$US
242345961$24234596$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239264$PFIZER$$67$YR$$F$Y$$$20240821$$CN$US$US
242345971$24234597$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239910$PFIZER$$$$$F$Y$$$20240821$$CN$US$US
242345981$24234598$1$I$20240811$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239730$PFIZER$$41$YR$$M$Y$$$20240821$$CN$US$US
242345991$24234599$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239731$PFIZER$$49$YR$$F$Y$$$20240821$$CN$US$US
242346002$24234600$2$F$$20240912$20240821$20240916$PER$$US-PFIZER INC-202400239458$PFIZER$$64$YR$$M$Y$$$20240916$$CN$US$US
242346011$24234601$1$I$20240817$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239401$PFIZER$$80$YR$$M$Y$$$20240821$$CN$US$US
242346021$24234602$1$I$20240819$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239626$PFIZER$$75$YR$$M$Y$$$20240821$$CN$US$US
242346031$24234603$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239272$PFIZER$$42$YR$$F$Y$$$20240821$$CN$US$US
242346041$24234604$1$I$20240813$20240819$20240821$20240821$PER$$US-PFIZER INC-PV202400108387$PFIZER$$54$YR$$F$Y$58.957$KG$20240821$$CN$US$US
242346051$24234605$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57364$$FDA-CTU$$$$$M$N$$$20240820$N$HP$US$
242346061$24234606$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57341$$FDA-CTU$$60$YR$$F$N$$$20240820$N$$US$
242346071$24234607$1$I$$20240820$20240820$20240820$DIR$715185$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242346081$24234608$1$I$20240808$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239298$PFIZER$$72$YR$$F$Y$$$20240821$$CN$US$US
242346092$24234609$2$F$20240812$20240814$20240821$20240828$PER$$US-PFIZER INC-202400235437$PFIZER$$77$YR$$F$Y$$$20240828$$CN$US$US
242346101$24234610$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239500$PFIZER$$79$YR$$F$Y$$$20240821$$CN$US$US
242346111$24234611$1$I$$20240820$20240820$20240820$DIR$715115$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242346131$24234613$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239724$PFIZER$$75$YR$$M$Y$$$20240821$$CN$US$US
242346141$24234614$1$I$$20240820$20240821$20240821$PER$$US-PFIZER INC-202400240706$PFIZER$$34$YR$$F$Y$$$20240821$$MD$US$US
242346151$24234615$1$I$$20240820$20240820$20240820$DIR$715187$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242346161$24234616$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-202400240335$PFIZER$$$$$$Y$$$20240821$$MD$US$US
242346172$24234617$2$F$20240101$20240916$20240821$20240920$PER$$US-PFIZER INC-202400233387$PFIZER$$58$YR$$F$Y$$$20240920$$CN$US$US
242346181$24234618$1$I$20240801$20240820$20240820$20240820$DIR$715169$$FDA-CTU$$6$MON$$M$N$96.75$KG$20240820$N$MD$US$
242346192$24234619$2$F$20240101$20240909$20240821$20240911$PER$$US-PFIZER INC-202400076350$PFIZER$$34$YR$$F$Y$$$20240911$$CN$US$US
242346201$24234620$1$I$20240801$20240820$20240821$20240821$PER$$US-PFIZER INC-202400239772$PFIZER$$46$YR$$F$Y$$$20240821$$CN$US$US
242346212$24234621$2$F$$20240819$20240821$20240827$PER$$US-PFIZER INC-PV202400108120$PFIZER$$87$YR$$$Y$$$20240827$$CN$US$US
242346221$24234622$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-PV202400108620$PFIZER$$73$YR$$F$Y$$$20240821$$HP$US$US
242346241$24234624$1$I$20220901$20240814$20240821$20240821$EXP$$US-TAKEDA-2024TUS081778$TAKEDA$$$$A$M$Y$91.3$KG$20240821$$HP$US$US
242346251$24234625$1$I$$20240812$20240821$20240821$EXP$CA-HEALTHCANVIG-E2B_07199941$CA-NOVOPROD-1269705$NOVO NORDISK$$62$YR$$F$Y$70$KG$20240821$$CN$CA$CA
242346261$24234626$1$I$$20240813$20240821$20240821$EXP$$ES-AstraZeneca-2024A185587$ASTRAZENECA$$39$YR$$F$Y$$$20240821$$CN$ES$
242346271$24234627$1$I$20190913$20190916$20240821$20240821$EXP$$CO-AstraZeneca-2019SF33584$ASTRAZENECA$$3189$WK$$M$Y$$$20240821$$CN$CO$
242346281$24234628$1$I$19940101$20240816$20240821$20240821$EXP$$FR-AstraZeneca-2024A189032$ASTRAZENECA$$34$YR$$M$Y$$$20240821$$MD$FR$
242346291$24234629$1$I$$20240813$20240821$20240821$EXP$$CN-AstraZeneca-2024A186580$ASTRAZENECA$Yuan JH, Luo S, Zhang DG, Wang LS.. Early detection of multiple endocrine neoplasia type 1: A case report. World J Gastroenterol 2024;30((26)):3247-3252.$51$YR$$M$Y$$$20240821$$HP$CN$
242346302$24234630$2$F$$20240816$20240821$20240918$EXP$$ZA-AstraZeneca-2024A187762$ASTRAZENECA$$63$YR$$M$Y$$$20240918$$CN$ZA$
242346311$24234631$1$I$$20240725$20240821$20240821$PER$$US-009507513-2407USA015955$MERCK$$72$YR$$F$Y$$$20240821$$CN$US$US
242346321$24234632$1$I$$20240816$20240821$20240821$EXP$$CA-AstraZeneca-2024A189320$ASTRAZENECA$$$$$F$Y$$$20240821$$CN$CA$
242346331$24234633$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012621$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240821$$CN$CA$CA
242346341$24234634$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012624$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240821$$CN$CA$CA
242346352$24234635$2$F$20240723$20240813$20240821$20240828$EXP$$US-AstraZeneca-2024A184742$ASTRAZENECA$$29803$DY$$F$Y$$$20240828$$CN$US$
242346361$24234636$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012626$BAUSCH AND LOMB$$82$YR$$F$Y$$$20240821$$CN$CA$CA
242346371$24234637$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012619$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240821$$CN$CA$CA
242346381$24234638$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012623$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240821$$CN$CA$CA
242346391$24234639$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012628$BAUSCH AND LOMB$$78$YR$$M$Y$$$20240821$$CN$CA$CA
242346401$24234640$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131825$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240821$$CN$US$US
242346411$24234641$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130639$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240821$$CN$US$US
242346421$24234642$1$I$20240805$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129503$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$69.4$KG$20240821$$PH$US$US
242346431$24234643$1$I$$20240813$20240821$20240821$EXP$$JP-AstraZeneca-2024A187321$ASTRAZENECA$Kakiuchi Y, et al.. PP238 Efficacy and safety of combined immunotherapy for advanced small cell lung cancer in patients over 80 years old.. The 64th Annual Meeting of the Japanese Respiratory Society 2024;$90$YR$$$Y$$$20240821$$MD$JP$
242346442$24234644$2$F$20240807$20240830$20240821$20240830$PER$$US-JAZZ PHARMACEUTICALS-2024-US-013097$JAZZ$$20$YR$$M$Y$$$20240830$$MD$US$US
242346451$24234645$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012639$BAUSCH AND LOMB$$68$YR$$F$Y$$$20240821$$CN$CA$CA
242346461$24234646$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012636$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240821$$CN$CA$CA
242346471$24234647$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA246074$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240821$$MD$US$US
242346481$24234648$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012642$BAUSCH AND LOMB$$78$YR$$M$Y$$$20240821$$CN$CA$CA
242346492$24234649$2$F$$20240919$20240821$20240930$PER$$US-SA-2024SA246818$SANOFI AVENTIS$$62$YR$A$F$Y$$$20241001$$CN$US$US
242346501$24234650$1$I$$20240815$20240821$20240821$EXP$$IT-MYLANLABS-2024M1076046$MYLAN$$83$YR$$M$Y$$$20240821$$HP$IT$IT
242346511$24234651$1$I$20240523$20240821$20240821$20240821$EXP$ES-AEMPS-1561645$ES-ROCHE-10000062421$ROCHE$$56$YR$A$F$Y$$$20240821$$MD$ES$ES
242346521$24234652$1$I$20220303$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184255$ASTRAZENECA$$68$YR$$M$Y$$$20240821$$MD$FR$
242346531$24234653$1$I$20220117$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184251$ASTRAZENECA$$85$YR$$M$Y$$$20240821$$MD$FR$
242346541$24234654$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A185056$ASTRAZENECA$$$$$F$Y$58$KG$20240821$$CN$US$
242346551$24234655$1$I$20220810$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184256$ASTRAZENECA$$76$YR$$M$Y$$$20240821$$MD$FR$
242346561$24234656$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012649$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240821$$CN$CA$CA
242346571$24234657$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012648$BAUSCH AND LOMB$$74$YR$$F$Y$$$20240821$$CN$CA$CA
242346582$24234658$2$F$$20240829$20240821$20240904$PER$$US-BIOGEN-2024BI01278616$BIOGEN$$$$$M$Y$$$20240904$$CN$US$US
242346592$24234659$2$F$$20240829$20240821$20240904$PER$$US-BIOGEN-2024BI01277441$BIOGEN$$$$$M$Y$$$20240904$$CN$US$US
242346601$24234660$1$I$20240801$20240815$20240821$20240821$PER$$US-BIOGEN-2024BI01278523$BIOGEN$$43$YR$$F$Y$$$20240821$$CN$US$US
242346611$24234661$1$I$$20240813$20240821$20240821$EXP$$US-AstraZeneca-2024A187547$ASTRAZENECA$$69$YR$$M$Y$$$20240821$$CN$US$
242346621$24234662$1$I$$20240820$20240821$20240821$EXP$$US-ROCHE-10000062478$ROCHE$$$$$F$Y$$$20240821$$CN$US$US
242346641$24234664$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57437$$FDA-CTU$$82$YR$$F$N$$$20240820$N$$US$
242346651$24234665$1$I$20210801$20240820$20240820$20240820$DIR$715164$$FDA-CTU$$73$YR$$M$N$165$KG$20240820$N$CN$US$
242346661$24234666$1$I$$20240814$20240821$20240821$EXP$$NVSC2024CA167670$NOVARTIS$$$$$F$Y$$$20240821$$HP$CA$CA
242346671$24234667$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012651$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240821$$CN$CA$CA
242346681$24234668$1$I$$20240814$20240821$20240821$PER$$US-BAYER-2024A117568$BAYER$$$$$F$Y$$$20240821$$PH$US$US
242346691$24234669$1$I$$20240813$20240821$20240821$PER$$US-ABBVIE-5881642$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242346701$24234670$1$I$$20240814$20240821$20240821$PER$$US-BIOMARINAP-US-2024-159889$BIOMARIN$$$$$$Y$$$20240821$$CN$US$US
242346711$24234671$1$I$$20240820$20240821$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046947$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240821$$CN$US$US
242346722$24234672$2$F$$20240909$20240821$20240912$EXP$$US-BAYER-2024A116164$BAYER$$58$YR$A$F$Y$82.086$KG$20240912$$CN$US$US
242346731$24234673$1$I$$20240818$20240821$20240821$PER$$US-ABBVIE-5886308$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242346741$24234674$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024166567$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242346751$24234675$1$I$$20240819$20240821$20240821$EXP$$US-ROCHE-10000062189$ROCHE$$57$YR$A$F$Y$$$20240821$$PH$US$US
242346761$24234676$1$I$$20240820$20240821$20240821$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046892$BOEHRINGER INGELHEIM$$$$$$Y$$$20240821$$MD$US$US
242346771$24234677$1$I$$20240812$20240821$20240821$PER$$US-MYLANLABS-2024M1076899$MYLAN$$$$$F$Y$87.54$KG$20240821$$CN$US$US
242346781$24234678$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012659$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240821$$CN$CA$CA
242346791$24234679$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012653$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240821$$CN$CA$CA
242346801$24234680$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012655$BAUSCH AND LOMB$$56$YR$$F$Y$$$20240821$$CN$CA$CA
242346811$24234681$1$I$$20240816$20240821$20240821$PER$$US-BAYER-2024A118606$BAYER$$$$$$Y$$$20240821$$CN$US$US
242346821$24234682$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012661$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240821$$CN$CA$CA
242346831$24234683$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012662$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240821$$CN$CA$CA
242346841$24234684$1$I$$20240819$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012656$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240821$$CN$CA$CA
242346851$24234685$1$I$20240525$20240818$20240821$20240821$EXP$$DE-BAUSCH-BL-2024-012515$BAUSCH AND LOMB$$77$YR$$M$Y$65$KG$20240821$$MD$DE$DE
242346861$24234686$1$I$$20240819$20240821$20240821$PER$$US-JNJFOC-20240848301$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$HP$US$US
242346872$24234687$2$F$$20240725$20240821$20240826$PER$$US-Dermavant-001244$DERMAVANT SCIENCES$$$$$M$Y$$$20240820$$HP$US$US
242346881$24234688$1$I$$20240816$20240821$20240821$PER$$NVSC2024US167380$NOVARTIS$$$$$M$Y$$$20240821$$CN$US$US
242346891$24234689$1$I$20240101$20240808$20240821$20240821$EXP$ES-AEMPS-1557359$ES-GLENMARK PHARMACEUTICALS-2024GMK093251$GLENMARK$$$$$$Y$$$20240821$$MD$ES$ES
242346901$24234690$1$I$$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132084$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240821$$CN$US$US
242346911$24234691$1$I$20240617$20240815$20240821$20240821$EXP$FR-AFSSAPS-TO2024001173$FR-009507513-2408FRA005462$MERCK$$70$YR$$M$Y$61$KG$20240821$$MD$FR$FR
242346922$24234692$2$F$20240715$20240822$20240821$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132370$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240823$$CN$US$US
242346931$24234693$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132668$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240821$$CN$US$US
242346941$24234694$1$I$20240806$20240813$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128817$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$70.31$KG$20240821$$PH$US$US
242346952$24234695$2$F$20240803$20240908$20240821$20240909$EXP$$IT-BAUSCH-BL-2024-012616$BAUSCH AND LOMB$$83$YR$$F$Y$$$20240909$$HP$IT$IT
242346961$24234696$1$I$$20240806$20240821$20240821$EXP$$SA-ALXN-202408MES001061SA$ALEXION PHARMACEUTICALS$$$$N$$Y$$$20240821$$MD$SA$SA
242346971$24234697$1$I$$20240819$20240821$20240821$PER$$US-ABBVIE-5888537$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242346982$24234698$2$F$$20240805$20240821$20240905$EXP$$US-RDY-CLI/USA/24/0011602$DR REDDYS$$44$YR$A$M$Y$97$KG$20240905$$CN$US$US
242346991$24234699$1$I$20231101$20240814$20240821$20240821$PER$$CA-Eisai-EC-2024-172341$EISAI$$73$YR$E$M$Y$$$20240821$$CN$CA$CA
242347003$24234700$3$F$$20240805$20240821$20240910$PER$$US-RDY-CLI/USA/24/0011610$DR REDDYS$$12$YR$C$F$Y$33.02$KG$20240910$$CN$US$US
242347012$24234701$2$F$$20240812$20240821$20240823$PER$$US-JNJFOC-20240831511$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$CN$US$US
242347021$24234702$1$I$$20240814$20240821$20240821$PER$$US-BAYER-2024A120385$BAYER$$$$$F$Y$$$20240821$$PH$US$US
242347031$24234703$1$I$20240810$20240820$20240820$20240820$DIR$715190$$FDA-CTU$$50$YR$$F$N$82.8$KG$20240820$N$$US$
242347041$24234704$1$I$$20240820$20240820$20240820$DIR$715110$$FDA-CTU$$$$$UNK$N$$$20240820$$CN$US$
242347053$24234705$3$F$$20240905$20240821$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126736$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240910$$CN$US$US
242347062$24234706$2$F$$20240911$20240821$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130855$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240912$$CN$US$US
242347071$24234707$1$I$20240814$20240814$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129073$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240821$$HP$US$US
242347081$24234708$1$I$$20240815$20240821$20240821$EXP$$US-TAKEDA-2024TUS083265$TAKEDA$$$$$F$Y$90.24$KG$20240821$$MD$US$US
242347091$24234709$1$I$20240629$20240808$20240821$20240821$EXP$$US-GILEAD-2024-0680953$GILEAD$$31$YR$A$M$Y$$$20240821$$HP$US$US
242347101$24234710$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57358$$FDA-CTU$$16$YR$$M$N$118.84$KG$20240820$N$HP$US$
242347121$24234712$1$I$20240805$20240820$20240820$20240820$DIR$715194$$FDA-CTU$$69$YR$$M$N$83.25$KG$20240820$$CN$US$
242347131$24234713$1$I$20240715$20240820$20240820$20240820$DIR$715193$$FDA-CTU$$40$YR$$F$N$59$KG$20240820$N$$US$
242347141$24234714$1$I$$20240814$20240821$20240821$EXP$$US-GSK-US2024101876$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$MD$US$US
242347151$24234715$1$I$$20240812$20240821$20240821$PER$$US-USAntibiotics-000332$USAntibiotics$$$$$M$Y$$$20240821$$CN$US$
242347161$24234716$1$I$$20240819$20240821$20240821$EXP$$BR-DSJP-DSE-2024-141054$DAIICHI$$$$$F$Y$$$20240821$$MD$BR$BR
242347171$24234717$1$I$20240705$20240820$20240820$20240820$DIR$715195$$FDA-CTU$$45$YR$$F$N$86.6$KG$20240820$N$$US$
242347181$24234718$1$I$$20240820$20240820$20240820$DIR$715133$$FDA-CTU$$$$$M$N$76.5$KG$20240820$$CN$US$
242347191$24234719$1$I$20240801$20240820$20240820$20240820$DIR$715174$$FDA-CTU$$64$YR$$F$N$$$20240820$Y$$US$
242347201$24234720$1$I$$20240814$20240821$20240821$EXP$$US-MYLANLABS-2024M1076518$MYLAN$$55$YR$$M$Y$$$20240821$$CN$US$US
242347211$24234721$1$I$$20240820$20240820$20240820$DIR$715192$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242347221$24234722$1$I$$20240710$20240821$20240821$PER$$US-LUNDBECK-DKLU4001519$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
242347231$24234723$1$I$20240812$20240816$20240821$20240821$EXP$$US-AstraZeneca-2024A187931$ASTRAZENECA$$$$$F$Y$$$20240821$$HP$US$
242347241$24234724$1$I$$20240814$20240821$20240821$PER$$US-BAYER-2024A120387$BAYER$$$$$F$Y$$$20240821$$PH$US$US
242347251$24234725$1$I$$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009666$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240821$$CN$US$US
242347261$24234726$1$I$$20240813$20240821$20240821$EXP$$FR-ABBVIE-5884840$ABBVIE$$49$YR$$M$Y$77$KG$20240821$$HP$FR$FR
242347271$24234727$1$I$$20240814$20240821$20240821$PER$$US-BAYER-2024A120386$BAYER$$$$$F$Y$$$20240821$$PH$US$US
242347281$24234728$1$I$$20240815$20240821$20240821$EXP$$US-TAKEDA-2024TUS083128$TAKEDA$$$$$F$Y$86.5$KG$20240821$$MD$US$US
242347291$24234729$1$I$$20240809$20240821$20240821$EXP$NL-LRB-00995812$NL-GLENMARK PHARMACEUTICALS-2024GMK093255$GLENMARK$$$$$$Y$$$20240821$$CN$NL$NL
242347301$24234730$1$I$$20240819$20240821$20240821$EXP$$JP-DSJP-DSJ-2024-129400$DAIICHI$$5$DEC$$F$Y$$$20240821$$MD$JP$JP
242347311$24234731$1$I$$20240818$20240821$20240821$EXP$$DE-DSJP-DSE-2024-140969$DAIICHI$$$$$F$Y$$$20240821$$MD$DE$DE
242347321$24234732$1$I$$20240814$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US072702$SANDOZ$$19$YR$$M$Y$$$20240821$$MD$US$US
242347341$24234734$1$I$$20240814$20240821$20240821$EXP$$US-GSK-US2024101751$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$HP$US$US
242347351$24234735$1$I$20230223$20240819$20240821$20240821$EXP$$JP-PFIZER INC-PV202400108206$PFIZER$$75$YR$$M$Y$61.8$KG$20240821$$MD$JP$JP
242347361$24234736$1$I$20240820$20240820$20240820$20240820$DIR$715178$$FDA-CTU$$73$YR$$F$N$57.15$KG$20240820$N$PH$US$
242347371$24234737$1$I$20240705$20240820$20240820$20240820$DIR$715196$$FDA-CTU$$40$YR$$F$N$58.2$KG$20240820$N$$US$
242347381$24234738$1$I$$20240820$20240820$20240820$DIR$715188$$FDA-CTU$$$$$UNK$N$$$20240820$N$CN$US$
242347391$24234739$1$I$20240717$20240820$20240820$20240820$DIR$715186$$FDA-CTU$$48$YR$$F$N$85.5$KG$20240820$N$CN$US$
242347411$24234741$1$I$$20240820$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US074171$SANDOZ$$$$$F$Y$$$20240821$$MD$US$US
242347421$24234742$1$I$20240809$20240820$20240820$20240820$DIR$715197$$FDA-CTU$$36$YR$$F$N$78.9$KG$20240820$N$$US$
242347431$24234743$1$I$20240801$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57361$$FDA-CTU$$56$YR$$M$N$$$20240820$N$HP$US$
242347442$24234744$2$F$20231001$20240815$20240821$20240827$PER$$US-SA-2024SA243585$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240827$$MD$US$US
242347451$24234745$1$I$20240818$20240820$20240820$20240820$DIR$715199$$FDA-CTU$$93$YR$$F$N$52.65$KG$20240820$N$$US$
242347462$24234746$2$F$20231201$20240823$20240821$20240830$PER$US-MLMSERVICE-20240806-PI154122-00190-1$US-RDY-SPO/USA/24/0011916$DR REDDYS$Avra T, Vasudevan F, Mukherjee R, Morton I, Samuels EA. Off-Label Use of Lamotrigine and Naltrexone in the Treatment of Ketamine Use Disorder: A Case Report. Journal of addiction medicine. 2024. DOI: 10.1097/ADM.0000000000001359.$32$YR$A$M$Y$$$20240830$$MD$US$US
242347471$24234747$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243876$SANOFI AVENTIS$$$$T$M$Y$$$20240821$$MD$US$US
242347481$24234748$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA243657$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242347491$24234749$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA243639$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240821$$MD$US$US
242347501$24234750$1$I$20240601$20240814$20240821$20240821$PER$$US-SA-2024SA245617$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240821$$MD$US$US
242347515$24234751$5$F$20240808$20240918$20240821$20240930$30DAY$$US-JNJFOC-20240821804$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240930$$CN$US$US
242347521$24234752$1$I$20220101$20240716$20240821$20240821$PER$$US-Eisai-EC-2024-170391$EISAI$$41$YR$A$M$Y$$$20240821$$MD$US$US
242347531$24234753$1$I$20231027$20240813$20240821$20240821$PER$$US-SA-2024SA243516$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240821$$MD$US$US
242347541$24234754$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA243602$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240821$$CN$US$US
242347551$24234755$1$I$20240801$20240815$20240821$20240821$PER$$US-SA-2024SA246359$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240821$$MD$US$US
242347561$24234756$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA245244$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240821$$CN$US$US
242347571$24234757$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA245137$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240821$$MD$US$US
242347581$24234758$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243607$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240821$$MD$US$US
242347591$24234759$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131543$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240821$$CN$US$US
242347601$24234760$1$I$$20240813$20240821$20240821$EXP$$DE-VERTEX PHARMACEUTICALS-2024-013352$VERTEX$$$$$F$Y$3$KG$20240821$$MD$DE$DE
242347611$24234761$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132343$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$78.93$KG$20240821$$CN$US$US
242347621$24234762$1$I$$20240808$20240821$20240821$EXP$$GB-MYLANLABS-2024M1075703$MYLAN$Ascott A, Karim E, Lawless R, Woollons A. Response of Widespread Generalized Essential Telangiectasia Following Treatment with Oral Dabigatran. JAMA-Dermatol 2023; 159 (6): 671-673.$52$YR$$F$Y$$$20240821$$HP$GB$GB
242347632$24234763$2$F$20220401$20240913$20240821$20240923$EXP$$PT-BAXTER-2024BAX023270$BAXTER$$60$YR$$F$Y$$$20240923$$HP$PT$PT
242347641$24234764$1$I$$20240819$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US073687$SANDOZ$$$$$$Y$$$20240821$$CN$US$US
242347651$24234765$1$I$$20240723$20240821$20240821$PER$$US-MEITHEAL-2024MPSPO00225$MEITHEAL PHARMACEUTICALS$$$$$$Y$$$20240821$$HP$US$US
242347661$24234766$1$I$20180101$20240813$20240821$20240821$EXP$$US-ABBVIE-5884086$ABBVIE$$28$YR$$F$Y$90.7$KG$20240821$$CN$US$US
242347672$24234767$2$F$$20240827$20240821$20240906$EXP$$FR-TEVA-VS-3233408$TEVA$Luque-Paz D, Lalanne S, Besombes J, Dorel M, Maamar A, Revest M. Absence of maribavir penetration into the central nervous system: confirmation by multiple cerebrospinal fluid dosages in a solid organ transplant recipient. J-Antimicrob-Chemother 2024; 79 (6): 1462-1463.; Luque-Paz D, Lalanne S, Besombes J, Dorel M, Maamar A, Revest M. Absence of maribavir penetration into the central nervous system: confirmation by multiple cerebrospinal fluid dosages in a solid organ transplant recipient. J-...$59$YR$$F$Y$$$20240906$$HP$FR$FR
242347681$24234768$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165104$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242347691$24234769$1$I$$20240815$20240821$20240821$EXP$$DE-MYLANLABS-2024M1076150$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$26$YR$$F$Y$$$20240821$$HP$DE$DE
242347702$24234770$2$F$20211201$20240828$20240821$20240906$EXP$$US-TEVA-VS-3234211$TEVA$Allami N, O^Connor K, Bagley SM. A case of severe opioid and methamphetamine use disorder in a 14 year old. Addict-Sci-Clin-Pract 2024; 19 (1): 54.; Allami N, O^Connor K, Bagley SM. A case of severe opioid and methamphetamine use disorder in a 14 year old. Addict-Sci-Clin-Pract 2024; 19 (1): 54.$14$YR$$F$Y$$$20240906$$HP$US$US
242347711$24234771$1$I$20240705$20240820$20240820$20240820$DIR$715200$$FDA-CTU$$41$YR$$F$N$59$KG$20240820$N$$US$
242347721$24234772$1$I$20240809$20240820$20240820$20240820$DIR$715201$$FDA-CTU$$42$YR$$F$N$68$KG$20240820$N$$US$
242347731$24234773$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57357$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242347741$24234774$1$I$20240820$20240820$20240820$20240820$DIR$715227$$FDA-CTU$$46$YR$$F$N$$$20240820$N$PH$US$
242347751$24234775$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57348$$FDA-CTU$$83$YR$$F$N$54.43$KG$20240820$N$$US$
242347761$24234776$1$I$20240820$20240820$20240820$20240820$DIR$715236$$FDA-CTU$$75$YR$$F$N$$$20240820$Y$CN$US$
242347771$24234777$1$I$20240808$20240820$20240820$20240820$DIR$715203$$FDA-CTU$$55$YR$$F$N$104.7$KG$20240820$N$$US$
242347781$24234778$1$I$20240726$20240820$20240820$20240820$DIR$715202$$FDA-CTU$$29$YR$$F$N$68.9$KG$20240820$N$$US$
242347791$24234779$1$I$20240816$20240820$20240820$20240820$DIR$715220$$FDA-CTU$$84$YR$$M$N$$$20240820$Y$PH$US$
242347811$24234781$1$I$20240813$20240821$20240821$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047067$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240821$$CN$US$US
242347821$24234782$1$I$20230522$20240815$20240821$20240821$EXP$$NL-MYLANLABS-2024M1076277$MYLAN$$9$YR$$M$Y$$$20240821$$CN$NL$NL
242347833$24234783$3$F$20240101$20240913$20240821$20240918$EXP$$US-KYOWAKIRIN-2024KK019452$KYOWA$$$$$$Y$$$20240918$$HP$US$US
242347841$24234784$1$I$$20240813$20240821$20240821$PER$$US-RDY-SPO/USA/24/0011850$DR REDDYS$$$$$F$Y$$$20240821$$CN$US$US
242347851$24234785$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57294$$FDA-CTU$$38$YR$$F$N$60.33$KG$20240820$N$$US$
242347861$24234786$1$I$20240815$20240820$20240820$20240820$DIR$715222$$FDA-CTU$$77$YR$$M$N$$$20240820$Y$PH$US$
242347904$24234790$4$F$$20240827$20240821$20240829$EXP$$US-GILEAD-2024-0684705$GILEAD$$$$E$$Y$$$20240829$$MD$US$US
242347911$24234791$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA247046$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240821$$CN$US$US
242347921$24234792$1$I$20240724$20240820$20240820$20240820$DIR$715205$$FDA-CTU$$47$YR$$F$N$61$KG$20240820$N$$US$
242347931$24234793$1$I$20230901$20240809$20240821$20240821$PER$$US-SA-2024SA241035$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240821$$MD$US$US
242347941$24234794$1$I$20240614$20240815$20240821$20240821$EXP$FR-AFSSAPS-AVGR2024000139$FR-MYLANLABS-2024M1076155$MYLAN$$17$YR$$M$Y$$$20240821$$MD$FR$FR
242347951$24234795$1$I$20240820$20240820$20240820$20240820$DIR$715238$$FDA-CTU$$37$YR$$F$N$$$20240820$N$CN$US$
242347961$24234796$1$I$20240819$20240820$20240820$20240820$DIR$715218$$FDA-CTU$$73$YR$$M$N$$$20240820$N$HP$US$
242347971$24234797$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245884$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240821$$CN$US$US
242347981$24234798$1$I$$20240717$20240821$20240821$PER$$US-Eisai-EC-2024-170399$EISAI$$$$$$Y$$$20240821$$HP$US$US
242347991$24234799$1$I$$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132299$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$$$20240821$$CN$US$US
242348001$24234800$1$I$20240701$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132191$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240821$$HP$US$US
242348011$24234801$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57403$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242348021$24234802$1$I$20240815$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57327$$FDA-CTU$$67$YR$$F$N$$$20240820$N$HP$US$
242348031$24234803$1$I$20200301$20240813$20240821$20240821$EXP$DE-CADRBFARM-2024329655$DE-TEVA-VS-3233449$TEVA$$41$YR$$F$Y$90$KG$20240821$$CN$DE$DE
242348042$24234804$2$F$20240428$20240906$20240821$20240917$EXP$$NVSC2024CZ168612$NOVARTIS$$52$YR$$F$Y$$$20240917$$MD$CZ$CZ
242348051$24234805$1$I$20240812$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012043$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240821$$CN$US$US
242348061$24234806$1$I$$20240814$20240821$20240821$EXP$$US-TAKEDA-2024TUS082034$TAKEDA$$$$E$M$Y$99.2$KG$20240821$$MD$US$US
242348071$24234807$1$I$20240423$20240815$20240821$20240821$EXP$FR-AFSSAPS-TS2024000902$FR-009507513-2408FRA005526$MERCK$$37$YR$$F$Y$82$KG$20240821$$MD$FR$FR
242348082$24234808$2$F$$20240815$20240821$20240823$EXP$$DE-MYLANLABS-2024M1076054$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology.. 2024;48(5):299-313$36$YR$$F$Y$$$20240823$$HP$DE$DE
242348091$24234809$1$I$$20240819$20240821$20240821$PER$$US-PFIZER INC-202400239208$PFIZER$$56$YR$$M$Y$$$20240821$$CN$US$US
242348101$24234810$1$I$$20240816$20240821$20240821$PER$$US-PFIZER INC-PV202400107872$PFIZER$$76$YR$$F$Y$$$20240821$$MD$US$US
242348111$24234811$1$I$20240215$20240816$20240821$20240821$PER$$US-PFIZER INC-202400239296$PFIZER$$38$YR$$F$Y$$$20240821$$HP$US$US
242348121$24234812$1$I$$20240816$20240821$20240821$PER$$US-PFIZER INC-PV202400107648$PFIZER$$11$YR$$M$Y$30.7$KG$20240821$$HP$US$US
242348131$24234813$1$I$$20240816$20240821$20240821$PER$$US-PFIZER INC-202400239752$PFIZER$$64$YR$$F$Y$$$20240821$$HP$US$US
242348141$24234814$1$I$$20240814$20240821$20240821$EXP$GB-MHRA-MED-202408141833324390-BHRPQ$GB-ABBVIE-5887558$ABBVIE$$$$$$Y$$$20240821$$CN$GB$GB
242348151$24234815$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240840124$JOHNSON AND JOHNSON$$$$$F$Y$$$20240821$$CN$US$US
242348162$24234816$2$F$$20240918$20240821$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132181$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240920$$CN$US$US
242348171$24234817$1$I$$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130654$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240821$$CN$US$US
242348181$24234818$1$I$20060413$20240816$20240821$20240821$EXP$$AU-SANDOZ INC.-SDZ2024AU073935$SANDOZ$$68$YR$$F$Y$$$20240821$$MD$AU$AU
242348191$24234819$1$I$$20240815$20240821$20240821$EXP$$DE-MYLANLABS-2024M1076160$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$39$YR$$F$Y$$$20240821$$HP$DE$DE
242348201$24234820$1$I$$20240813$20240821$20240821$EXP$$CA-AstraZeneca-2024A190112$ASTRAZENECA$$43$YR$$F$Y$97$KG$20240821$$MD$CA$
242348211$24234821$1$I$$20240819$20240821$20240821$EXP$$US-BEH-2024177417$CSL BEHRING$$23$YR$A$M$Y$$$20240821$$CN$US$US
242348222$24234822$2$F$$20240813$20240821$20240911$PER$$US-BEH-2024177205$CSL BEHRING$$45$YR$A$M$Y$54$KG$20240911$$PH$US$US
242348231$24234823$1$I$20240627$20240816$20240821$20240821$EXP$FR-AFSSAPS-SE2024000535$FR-BEH-2024175023$CSL BEHRING$$77$YR$E$M$Y$100$KG$20240821$$HP$FR$FR
242348242$24234824$2$F$$20240822$20240821$20240829$EXP$$US-BEH-2024167508$CSL BEHRING$$39$YR$A$F$Y$$$20240829$$HP$US$US
242348254$24234825$4$F$20240811$20240910$20240821$20240911$EXP$$US-BAUSCH-BL-2024-012607$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240911$$CN$US$US
242348263$24234826$3$F$20240801$20240909$20240821$20240913$30DAY$$US-AMGEN-USASP2024162427$AMGEN$$74$YR$E$F$Y$69.1$KG$20240913$$PH$US$US
242348272$24234827$2$F$20240731$20240830$20240821$20240906$30DAY$$US-AMGEN-USASP2024152851$AMGEN$$69$YR$E$M$Y$6$KG$20240906$$PH$US$US
242348282$24234828$2$F$20240813$20240905$20240821$20240911$30DAY$$US-AMGEN-USASP2024162308$AMGEN$$66$YR$E$F$Y$88.435$KG$20240910$$HP$US$US
242348291$24234829$1$I$$20240812$20240821$20240821$EXP$$CA-TEVA-VS-3233041$TEVA$$3$MON$$F$Y$$$20240821$$HP$CA$CA
242348302$24234830$2$F$20240101$20240819$20240821$20240918$EXP$$US-SA-2024SA246237$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240918$$MD$US$US
242348311$24234831$1$I$$20240815$20240821$20240821$EXP$$CA-TAKEDA-2024TUS037464$TAKEDA$$70$YR$$F$Y$$$20240821$$HP$CA$CA
242348321$24234832$1$I$20240617$20240815$20240821$20240821$EXP$FR-AFSSAPS-TO2024001173$FR-MYLANLABS-2024M1076145$MYLAN$$70$YR$$M$Y$61$KG$20240821$$MD$FR$FR
242348331$24234833$1$I$20181110$20240812$20240821$20240821$EXP$$US-SA-2024SA240104$SANOFI AVENTIS$$51$YR$A$F$Y$95$KG$20240821$$CN$US$US
242348341$24234834$1$I$20240708$20240814$20240821$20240821$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-25429$SAMSUNG BIOEPIS$$$$$M$Y$70$KG$20240821$$MD$DE$DE
242348351$24234835$1$I$$20240815$20240821$20240821$EXP$$DE-MYLANLABS-2024M1076149$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$42$YR$$M$Y$$$20240821$$HP$DE$DE
242348361$24234836$1$I$$20240718$20240821$20240821$PER$$US-Eisai-EC-2024-170538$EISAI$$$$$F$Y$$$20240821$$MD$US$US
242348371$24234837$1$I$20240718$20240718$20240821$20240821$PER$$US-Eisai-EC-2024-170498$EISAI$$81$YR$E$M$Y$$$20240821$$CN$US$US
242348381$24234838$1$I$$20240716$20240821$20240821$PER$$US-Eisai-EC-2024-170446$EISAI$$$$E$M$Y$$$20240821$$CN$US$US
242348391$24234839$1$I$20240801$20240819$20240821$20240821$PER$$US-JNJFOC-20240847975$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240821$$CN$US$US
242348405$24234840$5$F$$20240923$20240821$20240924$PER$$NVSC2024US168617$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
242348411$24234841$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA243748$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240821$$MD$US$US
242348421$24234842$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245512$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240821$$MD$US$US
242348431$24234843$1$I$$20240819$20240821$20240821$EXP$$US-KYOWAKIRIN-2024KK019454$KYOWA$$$$$$Y$$$20240821$$HP$US$US
242348452$24234845$2$F$$20240820$20240821$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129702$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240826$$CN$US$US
242348461$24234846$1$I$20240603$20240815$20240821$20240821$EXP$CH-SM-2024-13974$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-130186$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$61$KG$20240821$$PH$CH$CH
242348471$24234847$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131531$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$72.12$KG$20240821$$CN$US$US
242348481$24234848$1$I$20240501$20240814$20240821$20240821$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-16519$SAMSUNG BIOEPIS$$59$YR$A$F$Y$$$20240821$$CN$CA$CA
242348491$24234849$1$I$$20240819$20240821$20240821$EXP$$GB-SANDOZ INC.-PHHY2019GB127847$SANDOZ$$$$$F$Y$$$20240821$$HP$GB$GB
242348501$24234850$1$I$$20240813$20240821$20240821$EXP$NL-LRB-00995906$NL-TEVA-VS-3233682$TEVA$$72$YR$$M$Y$6$KG$20240821$$MD$NL$NL
242348511$24234851$1$I$20240423$20240813$20240821$20240821$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-19154$SAMSUNG BIOEPIS$$63$YR$A$M$Y$90$KG$20240821$$HP$CA$CA
242348522$24234852$2$F$20240812$20240822$20240821$20240828$30DAY$$US-AMGEN-USASP2024162294$AMGEN$$41$YR$A$M$Y$124.7$KG$20240828$$HP$US$US
242348531$24234853$1$I$$20240812$20240821$20240821$PER$$US-ABBVIE-5878570$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242348542$24234854$2$F$$20240919$20240821$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132583$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240923$$CN$US$US
242348551$24234855$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131953$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$103.42$KG$20240821$$CN$US$US
242348561$24234856$1$I$$20240809$20240821$20240821$PER$$US-SA-2024SA242273$SANOFI AVENTIS$$$$T$F$Y$51.25$KG$20240821$$MD$US$US
242348571$24234857$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246026$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240821$$MD$US$US
242348581$24234858$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244851$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240821$$MD$US$US
242348591$24234859$1$I$20240101$20240809$20240821$20240821$PER$$US-SA-2024SA243365$SANOFI AVENTIS$$69$YR$E$M$Y$134$KG$20240821$$MD$US$US
242348601$24234860$1$I$20240809$20240814$20240821$20240821$PER$$US-SA-2024SA246765$SANOFI AVENTIS$$46$YR$A$F$Y$72$KG$20240821$$MD$US$US
242348611$24234861$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246942$SANOFI AVENTIS$$$$A$M$Y$72$KG$20240821$$MD$US$US
242348621$24234862$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245770$SANOFI AVENTIS$$$$E$F$Y$64.4$KG$20240821$$MD$US$US
242348631$24234863$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245260$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240821$$MD$US$US
242348641$24234864$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA245761$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240821$$MD$US$US
242348651$24234865$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245938$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
242348663$24234866$3$F$$20240925$20240821$20240930$EXP$$CA-ROCHE-3410327$ROCHE$$$$A$M$Y$$$20240929$$MD$CA$CA
242348671$24234867$1$I$20240626$20240816$20240821$20240821$EXP$$JP-ABBVIE-5887675$ABBVIE$$9$YR$$F$Y$43.4$KG$20240821$$MD$JP$JP
242348681$24234868$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245046$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240821$$MD$US$US
242348701$24234870$1$I$20240413$20240815$20240821$20240821$PER$$US-SA-2024SA246281$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240821$$MD$US$US
242348711$24234871$1$I$20240816$20240816$20240821$20240821$EXP$$US-TAKEDA-2024TUS077427$TAKEDA$$36$YR$$M$Y$$$20240821$$CN$US$US
242348721$24234872$1$I$20240617$20240808$20240821$20240821$PER$$US-MYLANLABS-2024M1074460$MYLAN$$52$YR$$F$Y$63.04$KG$20240821$$PH$US$US
242348731$24234873$1$I$$20240819$20240821$20240821$EXP$$US-OTSUKA-2024_022855$OTSUKA$$$$$F$Y$$$20240821$$CN$US$US
242348741$24234874$1$I$$20240719$20240821$20240821$PER$$US-Eisai-EC-2024-170617$EISAI$$$$$F$Y$$$20240821$$CN$US$US
242348751$24234875$1$I$20240718$20240719$20240821$20240821$PER$$US-Eisai-EC-2024-170561$EISAI$$72$YR$E$M$Y$$$20240821$$CN$US$US
242348761$24234876$1$I$$20240819$20240821$20240821$PER$$US-JNJFOC-20240852258$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242348771$24234877$1$I$20240801$20240819$20240821$20240821$PER$$PR-JNJFOC-20240851095$JOHNSON AND JOHNSON$$99$YR$E$M$Y$$$20240821$$CN$PR$PR
242348781$24234878$1$I$20240816$20240820$20240821$20240821$PER$$US-JNJFOC-20240850834$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240821$$MD$US$US
242348802$24234880$2$F$20240101$20240822$20240821$20240828$EXP$$US-KARYOPHARM-2024KPT001440$KARYOPHARM THERAPEUTICS$$$$$F$Y$$$20240828$$MD$US$US
242348812$24234881$2$F$$20240830$20240821$20240904$EXP$$PL-BAUSCH-BL-2024-012497$BAUSCH AND LOMB$Molska M, Marta Z, Siwek M. 16 years old girl with infective endocarditis.. Forum Medycyny Rodzinnej. 2024;18(3):95-101.$16$YR$$F$Y$$$20240904$$HP$PL$PL
242348832$24234883$2$F$20240813$20240821$20240821$20240826$EXP$$CA-ROCHE-10000061696$ROCHE$$43$YR$A$F$Y$$$20240826$$CN$CA$CA
242348841$24234884$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131507$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240821$$HP$US$US
242348851$24234885$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132495$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240821$$CN$US$US
242348861$24234886$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132068$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240821$$CN$US$US
242348871$24234887$1$I$20240403$20240813$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128620$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$78.9$KG$20240821$$PH$US$US
242348881$24234888$1$I$$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009655$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240821$$CN$US$US
242348891$24234889$1$I$$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012532$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240821$$CN$US$US
242348901$24234890$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011300$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240821$$CN$US$US
242348911$24234891$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011704$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240821$$CN$US$US
242348921$24234892$1$I$20240814$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011509$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240821$$CN$US$US
242348931$24234893$1$I$$20240820$20240821$20240821$PER$$US-BAYER-2024A119862$BAYER$$$$$$Y$$$20240821$$CN$US$US
242348942$24234894$2$F$20240723$20240911$20240821$20240918$EXP$IT-MINISAL02-998024$IT-TEVA-VS-3232999$TEVA$$76$YR$$F$Y$50$KG$20240918$$MD$IT$IT
242348951$24234895$1$I$20240806$20240812$20240821$20240821$EXP$$IL-SA-2024SA238190$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240821$$CN$IL$IL
242348961$24234896$1$I$$20240820$20240821$20240821$EXP$$CA-SANDOZ INC.-SDZ2024CA074039$SANDOZ$$$$$$Y$$$20240821$$HP$CA$CA
242348971$24234897$1$I$20240701$20240812$20240821$20240821$PER$$US-SA-2024SA243210$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240821$$MD$US$US
242348982$24234898$2$F$$20240912$20240821$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA074090$SANDOZ$$54$YR$$F$Y$48$KG$20240916$$HP$CA$CA
242348991$24234899$1$I$20240723$20240812$20240821$20240821$EXP$IT-MINISAL02-997793$IT-TEVA-VS-3233359$TEVA$$84$YR$$M$Y$$$20240821$$PH$IT$IT
242349001$24234900$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245282$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240821$$MD$US$US
242349011$24234901$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA245071$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240821$$MD$US$US
242349021$24234902$1$I$20240726$20240812$20240821$20240821$EXP$IT-MINISAL02-997759$IT-TEVA-VS-3233121$TEVA$$59$YR$$M$Y$79$KG$20240821$$MD$IT$IT
242349031$24234903$1$I$20240528$20240815$20240821$20240821$EXP$FR-AFSSAPS-BS2024000499$FR-MYLANLABS-2024M1076148$MYLAN$$86$YR$$M$Y$72$KG$20240821$$MD$FR$FR
242349042$24234904$2$F$$20240819$20240821$20240823$PER$$NVSC2024US168322$NOVARTIS$$$$$M$Y$$$20240823$$CN$US$US
242349051$24234905$1$I$20240601$20240627$20240821$20240821$EXP$$CR-AstraZeneca-2024A149664$ASTRAZENECA$$765$MON$$M$Y$$$20240821$$CN$CR$
242349061$24234906$1$I$20240801$20240816$20240821$20240821$PER$$US-Eisai-EC-2024-172423$EISAI$$59$YR$A$F$Y$$$20240821$$CN$US$US
242349071$24234907$1$I$20240704$20240718$20240821$20240821$PER$$US-Eisai-EC-2024-170648$EISAI$$61$YR$A$M$Y$$$20240821$$CN$US$US
242349081$24234908$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA246974$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240821$$MD$US$US
242349091$24234909$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA247384$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240821$$MD$US$US
242349101$24234910$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA246121$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240821$$CN$US$US
242349111$24234911$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA246861$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242349121$24234912$1$I$20240803$20240815$20240821$20240821$PER$$US-SA-2024SA247294$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240821$$MD$US$US
242349131$24234913$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240845410$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240821$$MD$US$US
242349141$24234914$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245290$SANOFI AVENTIS$$$$E$F$Y$$$20240821$$MD$US$US
242349151$24234915$1$I$20240816$20240819$20240821$20240821$DIR$FDA-CDER-CTU-2024-57593$$FDA-CTU$$80$YR$$M$N$$$20240819$N$HP$US$
242349161$24234916$1$I$20240817$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57615$$FDA-CTU$$60$YR$$F$N$$$20240821$N$CN$US$
242349171$24234917$1$I$$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129535$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$100.24$KG$20240821$$CN$US$US
242349181$24234918$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132679$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240821$$CN$US$US
242349192$24234919$2$F$$20240917$20240821$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132001$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240919$$CN$US$US
242349201$24234920$1$I$20240801$20240814$20240821$20240821$EXP$$US-APELLIS-2024-APL-0000746$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240821$$MD$US$US
242349211$24234921$1$I$20140101$20240812$20240821$20240821$EXP$FR-AFSSAPS-RS2024000750$FR-TEVA-VS-3233351$TEVA$$61$YR$$F$Y$51$KG$20240821$$MD$FR$FR
242349221$24234922$1$I$$20240816$20240821$20240821$PER$$US-ABBVIE-5886477$ABBVIE$$$$$$Y$$$20240821$$CN$US$US
242349232$24234923$2$F$$20240815$20240821$20240822$PER$$US-ABBVIE-5883219$ABBVIE$$$$$$Y$$$20240822$$HP$US$US
242349242$24234924$2$F$20240815$20240926$20240821$20240926$30DAY$$CL-PFIZER INC-PV202400107271$PFIZER$$13$YR$$F$Y$$$20240926$$CN$CL$CL
242349251$24234925$1$I$20240803$20240809$20240821$20240821$30DAY$$CL-PFIZER INC-202400240091$PFIZER$$$$$$Y$$$20240821$$CN$CL$CL
242349261$24234926$1$I$$20240816$20240821$20240821$EXP$$CA-SANDOZ INC.-NVSC2023CA135701$SANDOZ$$$$$M$Y$$$20240821$$CN$CA$CA
242349271$24234927$1$I$20240720$20240816$20240821$20240821$EXP$$CN-DSJP-DSJ-2024-140853$DAIICHI$$47$YR$$F$Y$51$KG$20240821$$HP$CN$CN
242349281$24234928$1$I$$20240812$20240821$20240821$EXP$FR-AFSSAPS-PV2024000722$FR-TEVA-VS-3233212$TEVA$$$$N$M$Y$0.32$KG$20240821$$MD$FR$FR
242349291$24234929$1$I$20230201$20240813$20240821$20240821$EXP$$GB-DSJP-DSE-2024-140699$DAIICHI$$49$YR$$F$Y$$$20240821$$HP$GB$GB
242349301$24234930$1$I$$20240813$20240821$20240821$EXP$NL-LRB-00995812$NL-TEVA-VS-3233487$TEVA$$64$YR$$F$Y$64$KG$20240821$$CN$NL$NL
242349311$24234931$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA243437$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240821$$HP$US$US
242349321$24234932$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA245291$SANOFI AVENTIS$$$$A$F$Y$73.482$KG$20240821$$MD$US$US
242349331$24234933$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA243709$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240821$$MD$US$US
242349341$24234934$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA243713$SANOFI AVENTIS$$$$A$F$Y$$$20240821$$MD$US$US
242349351$24234935$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA247334$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240821$$MD$US$US
242349361$24234936$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA244188$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240821$$CN$US$US
242349371$24234937$1$I$$20240819$20240821$20240821$PER$$US-HALEON-2192750$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242349381$24234938$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246508$SANOFI AVENTIS$$$$A$M$Y$$$20240821$$MD$US$US
242349401$24234940$1$I$$20240813$20240821$20240821$EXP$NL-LRB-00994606$NL-TEVA-VS-3233760$TEVA$$69$YR$$M$Y$$$20240821$$MD$NL$NL
242349411$24234941$1$I$20240801$20240816$20240821$20240821$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-141044$DAIICHI$$52$YR$$F$Y$$$20240821$$HP$US$US
242349421$24234942$1$I$20240725$20240814$20240821$20240821$EXP$$CN-DSJP-DSJ-2024-140670$DAIICHI$$64$YR$$F$Y$58$KG$20240821$$HP$CN$CN
242349432$24234943$2$F$20231201$20240816$20240821$20240826$EXP$$US-MYLANLABS-2023M1087217$MYLAN$$50$YR$$F$Y$$$20240826$$CN$US$US
242349441$24234944$1$I$$20240816$20240821$20240821$EXP$$CN-TAKEDA-2024TUS082790$TAKEDA$$$$$M$Y$$$20240821$$CN$CN$CN
242349451$24234945$1$I$20240113$20240813$20240821$20240821$EXP$PT-INFARMED-B202407-1117$PT-TEVA-VS-3233849$TEVA$$31$YR$$F$Y$$$20240821$$MD$PT$PT
242349461$24234946$1$I$20240101$20240722$20240821$20240821$PER$$US-Eisai-EC-2024-170722$EISAI$$76$YR$E$F$Y$70.5$KG$20240821$$CN$US$US
242349471$24234947$1$I$20240701$20240722$20240821$20240821$PER$$US-Eisai-EC-2024-170714$EISAI$$73$YR$E$F$Y$$$20240821$$CN$US$US
242349481$24234948$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA246119$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240821$$MD$US$US
242349491$24234949$1$I$20240328$20240807$20240821$20240821$PER$$US-JNJFOC-20240846545$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240821$$CN$US$US
242349501$24234950$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240843490$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$MD$US$US
242349511$24234951$1$I$$20240813$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132447$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$67.13$KG$20240821$$HP$US$US
242349521$24234952$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132139$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240821$$CN$US$US
242349531$24234953$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240839632$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$MD$US$US
242349543$24234954$3$F$20240627$20240904$20240821$20240913$EXP$ES-AEMPS-1557574$ES-TEVA-VS-3233081$TEVA$$48$YR$$F$Y$$$20240913$$MD$ES$ES
242349552$24234955$2$F$$20240814$20240821$20240823$PER$$US-009507513-2408USA005653$MERCK$$$$$F$Y$$$20240823$$CN$US$US
242349561$24234956$1$I$$20240820$20240821$20240821$PER$$NVSC2024US169240$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
242349571$24234957$1$I$$20240812$20240821$20240821$PER$$US-ABBVIE-5879027$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242349581$24234958$1$I$20240805$20240816$20240821$20240821$EXP$$NVSC2024CN168348$NOVARTIS$$34$YR$$M$Y$70$KG$20240821$$HP$CN$CN
242349591$24234959$1$I$$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408010501$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240821$$HP$US$US
242349601$24234960$1$I$20240817$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012560$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240821$$CN$US$US
242349611$24234961$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011689$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240821$$CN$US$US
242349621$24234962$1$I$20240606$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011511$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240821$$CN$US$US
242349631$24234963$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57628$$FDA-CTU$$71$YR$$F$N$$$20240821$N$$US$
242349641$24234964$1$I$$20240817$20240821$20240821$PER$$US-TAKEDA-2024TUS083512$TAKEDA$$$$$$Y$$$20240821$$CN$US$US
242349651$24234965$1$I$$20240819$20240821$20240821$PER$$NVSC2024US168668$NOVARTIS$$$$$F$Y$$$20240821$$CN$US$US
242349662$24234966$2$F$$20240820$20240821$20240823$PER$$NVSC2024US169093$NOVARTIS$$$$$F$Y$$$20240823$$MD$US$US
242349671$24234967$1$I$$20240819$20240821$20240821$PER$$US-009507513-2408USA006493$MERCK$$$$$M$Y$$$20240821$$HP$US$US
242349681$24234968$1$I$20240522$20240812$20240821$20240821$PER$$US-JNJFOC-20240853955$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240821$$HP$US$US
242349691$24234969$1$I$$20240801$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008083$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242349701$24234970$1$I$$20240612$20240821$20240821$PER$$US-Dermavant-001202$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$CN$US$US
242349711$24234971$1$I$$20240819$20240821$20240821$PER$$US-ABBVIE-5888045$ABBVIE$$$$$$Y$$$20240821$$CN$US$US
242349723$24234972$3$F$20240101$20240917$20240821$20240930$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US002632$PAREXEL$$$$$$Y$$$20240927$$HP$US$US
242349731$24234973$1$I$$20240801$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008081$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242349741$24234974$1$I$$20240812$20240821$20240821$EXP$$NVSC2024CA168524$NOVARTIS$$63$YR$$M$Y$$$20240821$$HP$CA$CA
242349751$24234975$1$I$$20240801$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008071$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242349761$24234976$1$I$20240807$20240814$20240821$20240821$EXP$$US-LANTHEUS-LMI-2024-01019$LANTHEUS MEDICAL IMAGING$$78$YR$$F$Y$112$KG$20240821$$CN$US$US
242349771$24234977$1$I$$20240811$20240821$20240821$EXP$$NVSC2024US164552$NOVARTIS$$$$$$Y$$$20240821$$CN$US$US
242349781$24234978$1$I$$20240620$20240821$20240821$PER$$US-Dermavant-001212$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$HP$US$US
242349791$24234979$1$I$$20240731$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008043$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242349801$24234980$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57589$$FDA-CTU$$57$YR$$M$N$$$20240821$N$$US$
242349811$24234981$1$I$20240705$20240819$20240821$20240821$DIR$FDA-CDER-CTU-2024-57523$$FDA-CTU$$68$YR$$M$N$$$20240819$N$HP$US$
242349821$24234982$1$I$$20240731$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008042$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242349842$24234984$2$F$$20240909$20240821$20240919$PER$$US-INCYTE CORPORATION-2024IN008035$INCYTE$$$$$$Y$$$20240919$$CN$US$US
242349851$24234985$1$I$$20240820$20240821$20240821$EXP$$CL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047012$BOEHRINGER INGELHEIM$$$$$$Y$$$20240821$$MD$CL$CL
242349861$24234986$1$I$$20240626$20240821$20240821$PER$$US-Dermavant-001214$DERMAVANT SCIENCES$$56$YR$$F$Y$$$20240820$$MD$US$US
242349871$24234987$1$I$$20240731$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008028$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242349883$24234988$3$F$$20240830$20240821$20240902$EXP$$US-BAUSCH-BL-2024-012531$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240902$$CN$US$US
242349891$24234989$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA246105$SANOFI AVENTIS$$$$A$F$Y$67$KG$20240821$$MD$US$US
242349901$24234990$1$I$20240727$20240814$20240821$20240821$EXP$FR-AFSSAPS-NC2024000978$FR-SA-2024SA242382$SANOFI AVENTIS$$4$MON$I$M$Y$$$20240821$$MD$FR$FR
242349911$24234991$1$I$20240801$20240813$20240821$20240821$PER$$US-SA-2024SA246082$SANOFI AVENTIS$$$$A$F$Y$102$KG$20240821$$MD$US$US
242349921$24234992$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA246835$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240821$$MD$US$US
242349931$24234993$1$I$20240817$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57662$$FDA-CTU$$68$YR$$F$N$$$20240820$N$$US$
242349941$24234994$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57595$$FDA-CTU$$61$YR$$M$N$$$20240821$N$$US$
242349951$24234995$1$I$20240819$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57387$$FDA-CTU$$$$$M$N$74.4$KG$20240820$N$$US$
242349961$24234996$1$I$20240723$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57466$$FDA-CTU$$29$MON$$F$N$18.5$KG$20240820$N$$US$
242349972$24234997$2$F$$20240827$20240821$20240905$EXP$$US-TEVA-VS-3234480$TEVA$Sharma D, Bashir Hamidu R, Viana Rodriguez G, Canakis A, Chatila A, Goldberg E. Use of Over-the-Scope Clips in the Management of Refractory Postbanding Ulcer Bleed in a Patient After Liver Transplant. ACG-Case-Rep-J 2024; 11 E01241.; Sharma D, Bashir Hamidu R, Viana Rodriguez G, Canakis A, Chatila A, Goldberg E. Use of Over-the-Scope Clips in the Management of Refractory Postbanding Ulcer Bleed in a Patient After Liver Transplant. ACG-Case-Rep-J 2024; 11 E01241.$24$YR$$M$Y$$$20240905$$MD$US$US
242349981$24234998$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132177$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240821$$CN$US$US
242349991$24234999$1$I$$20240814$20240821$20240821$PER$$US-ALXN-202408USA000880US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
242350002$24235000$2$F$20240701$20240905$20240821$20240905$PER$$US-ALXN-202408USA001011US$ALEXION PHARMACEUTICALS$$53$YR$$F$Y$$$20240905$$CN$US$US
242350011$24235001$1$I$20240804$20240813$20240821$20240821$PER$$US-ALXN-202408USA000924US$ALEXION PHARMACEUTICALS$$71$YR$$M$Y$$$20240821$$CN$US$US
242350021$24235002$1$I$$20240821$20240821$20240821$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047078$BOEHRINGER INGELHEIM$$$$$$Y$$$20240821$$CN$US$US
242350031$24235003$1$I$20240819$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57386$$FDA-CTU$$$$$M$N$94.9$KG$20240820$N$$US$
242350041$24235004$1$I$20240416$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57470$$FDA-CTU$$27$YR$$F$N$59.9$KG$20240820$N$$US$
242350052$24235005$2$F$$20240821$20240821$20240822$PER$$NVSC2024US169420$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
242350061$24235006$1$I$20240101$20240814$20240821$20240821$EXP$$US-ABBVIE-5882134$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242350071$24235007$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57639$$FDA-CTU$$45$YR$$F$N$79.83$KG$20240821$N$$US$
242350081$24235008$1$I$$20240812$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128835$BRISTOL MYERS SQUIBB$Trager MH, Coley SM, Dube G, Khan S, Ingham M, Samie FH, et al. Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients. Journal for ImmunoTherapy of Cancer. 2021;9:1-7. doi:10.1136/jitc-2020-000908corr1.$6$DEC$A$M$Y$$$20240821$$HP$US$US
242350091$24235009$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57632$$FDA-CTU$$70$YR$$F$N$$$20240821$N$$US$
242350101$24235010$1$I$$20240813$20240821$20240821$EXP$$US-Indivior Limited-INDV-156074-2024$RECKITT BENCKISER$$$$$$Y$$$20240821$$HP$US$US
242350111$24235011$1$I$20230718$20240819$20240821$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-015367$JAZZ$$8$YR$$M$Y$$$20240821$$CN$US$US
242350121$24235012$1$I$$20240814$20240821$20240821$EXP$$NVSC2024CA168532$NOVARTIS$$14$YR$$M$Y$$$20240821$$HP$CA$CA
242350132$24235013$2$F$$20240829$20240821$20240903$EXP$$DE-MYLANLABS-2024M1076255$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$20$YR$$M$Y$$$20240903$$HP$DE$DE
242350141$24235014$1$I$20240724$20240814$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129591$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$114.31$KG$20240821$$CN$US$US
242350151$24235015$1$I$20240715$20240801$20240821$20240821$DIR$FDA-CDER-CTU-2024-57658$$FDA-CTU$$46$YR$$M$N$$$20240801$N$HP$US$
242350161$24235016$1$I$20240815$20240819$20240821$20240821$DIR$FDA-CDER-CTU-2024-57388$$FDA-CTU$$$$$M$N$61$KG$20240819$N$$US$
242350171$24235017$1$I$20240812$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57667$$FDA-CTU$$74$YR$$F$N$$$20240821$Y$HP$US$
242350182$24235018$2$F$20240801$20240904$20240821$20240911$EXP$$JP-ALXN-202408JPN000838JP$ALEXION PHARMACEUTICALS$$37$YR$$F$Y$$$20240911$$MD$JP$JP
242350191$24235019$1$I$20231001$20240318$20240821$20240821$PER$$US-3M-2024-US-016944$Solventum$$77$YR$$F$Y$65.77$KG$20240821$$CN$US$US
242350201$24235020$1$I$$20240125$20240821$20240821$PER$$US-3M-2024-US-004908$Solventum$$$$$$Y$$$20240821$$HP$US$US
242350211$24235021$1$I$$20240725$20240821$20240821$PER$$US-3M-2024-US-040491$Solventum$$$$$UNK$Y$$$20240821$$CN$US$US
242350221$24235022$1$I$20240501$20240723$20240821$20240821$PER$$US-3M-2024-US-039947$Solventum$$74$YR$$M$Y$58.97$KG$20240821$$CN$US$US
242350231$24235023$1$I$20231101$20240124$20240821$20240821$PER$$US-3M-2024-US-004543$Solventum$$77$YR$$F$Y$63.5$KG$20240821$$CN$US$US
242350241$24235024$1$I$20240522$20240606$20240821$20240821$PER$$US-3M-2024-US-032174$Solventum$$90$YR$$F$Y$56.7$KG$20240821$$CN$US$US
242350251$24235025$1$I$$20240814$20240821$20240821$EXP$$AU-PFIZER INC-202400239190$PFIZER$$$$E$F$Y$$$20240821$$MD$AU$AU
242350261$24235026$1$I$$20240820$20240821$20240821$EXP$$JP-PFIZER INC-PV202400108309$PFIZER$$64$YR$$M$Y$$$20240821$$PH$JP$JP
242350271$24235027$1$I$20240716$20240819$20240821$20240821$EXP$FR-AFSSAPS-AN2024001132$FR-PFIZER INC-202400238906$PFIZER$$75$YR$$M$Y$66$KG$20240821$$MD$FR$FR
242350281$24235028$1$I$$20240817$20240821$20240821$EXP$GB-MHRA-MED-202408171703580750-MPZDK$GB-PFIZER INC-202400238492$PFIZER$$$$$F$Y$$$20240821$$CN$GB$GB
242350291$24235029$1$I$20240809$20240819$20240821$20240821$EXP$$CN-PFIZER INC-PV202400108004$PFIZER$$60$YR$$F$Y$59$KG$20240821$$HP$CN$CN
242350301$24235030$1$I$$20240820$20240821$20240821$EXP$GB-MHRA-MED-202408202115064740-TLHQV$GB-PFIZER INC-202400240119$PFIZER$$43$YR$$$Y$$$20240821$$CN$GB$GB
242350321$24235032$1$I$20240801$20240814$20240821$20240821$EXP$$US-009507513-2408USA005715$MERCK$$$$$M$Y$$$20240821$$MD$US$US
242350331$24235033$1$I$$20240812$20240821$20240821$EXP$FR-AFSSAPS-RS2024000774$FR-TEVA-VS-3233140$TEVA$$72$YR$$M$Y$$$20240821$$MD$FR$FR
242350341$24235034$1$I$20240816$20240820$20240821$20240821$PER$$US-BAUSCH-BL-2024-012696$BAUSCH AND LOMB$$54$YR$$F$Y$$$20240821$$CN$US$US
242350351$24235035$1$I$20240707$20240816$20240821$20240821$EXP$FR-AFSSAPS-AN2024000947$FR-PURDUE-USA-2024-0311493$PURDUE$$71$YR$$M$Y$73$KG$20240821$$MD$FR$FR
242350371$24235037$1$I$$20240819$20240821$20240821$PER$$US-ABBVIE-5888641$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242350382$24235038$2$F$$20240827$20240821$20240909$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-25596$SAMSUNG BIOEPIS$$70$YR$E$F$Y$$$20240909$$CN$GB$GB
242350391$24235039$1$I$$20240821$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132561$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240821$$CN$US$US
242350401$24235040$1$I$20240301$20240812$20240821$20240821$EXP$FR-AFSSAPS-TO2024000455$FR-TEVA-VS-3233255$TEVA$$69$YR$$F$Y$63$KG$20240821$$MD$FR$FR
242350411$24235041$1$I$$20240819$20240821$20240821$EXP$IE-TEVA-VS-3228782$IE-PURDUE-USA-2024-0311477$PURDUE$Murphy D, Waldron D, Kennedy G, Molony J.. Central anticholinergic syndrome from hyoscine hydrobromide in an unresponsive patient. BMJ-Support-Palliat-Care. 2023;13(3):e953-e956$8$DEC$$F$Y$$$20240821$$MD$IE$IE
242350421$24235042$1$I$$20240813$20240821$20240821$EXP$$US-BAUSCH-BL-2024-012362$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240821$$PH$US$US
242350431$24235043$1$I$$20240819$20240821$20240821$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24080$SAMSUNG BIOEPIS$$72$YR$E$M$Y$$$20240821$$CN$GB$GB
242350441$24235044$1$I$20240101$20240815$20240821$20240821$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25377$SAMSUNG BIOEPIS$$45$YR$A$F$Y$$$20240821$$CN$CA$CA
242350453$24235045$3$F$20240806$20240912$20240821$20240919$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25412$SAMSUNG BIOEPIS$$50$YR$A$M$Y$$$20240919$$CN$CA$CA
242350461$24235046$1$I$$20240814$20240821$20240821$EXP$$IT-BAUSCH-BL-2024-012334$BAUSCH AND LOMB$Schulte T, Chaves-Sanjuan A, Speranzini V, Sicking K, Milazzo M, Mazzini G, Rognoni P, Caminito S, Milani P, Marabelli C, Corbelli A, Diomede L, Fiordaliso F, Anastasia L, Pappone C, Merlini G, Bolognesi M, Nuvolone M, Fernandez-Busnadiego R, Palladini G, Ricagno S. Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis. Nature Communications. 2024 JUL 28;15(6359):1-11. doi:10.1038/s41467-024-50686-2$56$YR$$F$Y$$$20240821$$HP$IT$IT
242350471$24235047$1$I$$20240813$20240821$20240821$PER$$US-BAUSCH-BL-2024-012545$BAUSCH AND LOMB$$87$YR$$M$Y$$$20240821$$MD$US$US
242350481$24235048$1$I$$20240817$20240821$20240821$PER$$US-PURDUE PHARMA-USA-2024-0311433$PURDUE$$59$YR$$F$Y$$$20240821$$CN$US$US
242350491$24235049$1$I$20190301$20240819$20240821$20240821$EXP$$DE-BAUSCH-BL-2024-012647$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240821$$MD$DE$DE
242350503$24235050$3$F$20180101$20240822$20240821$20240823$PER$$US-PURDUE PHARMA-USA-2024-0311495$PURDUE$$$$$F$Y$$$20240823$$CN$US$US
242350511$24235051$1$I$20200501$20240818$20240821$20240821$PER$$US-PURDUE PHARMA-USA-2024-0311438$PURDUE$$46$YR$$M$Y$$$20240821$$CN$US$US
242350521$24235052$1$I$$20240820$20240821$20240821$PER$$US-PURDUE PHARMA-USA-2024-0311456$PURDUE$$$$$M$Y$$$20240821$$CN$US$US
242350531$24235053$1$I$$20240820$20240821$20240821$PER$$US-PURDUE PHARMA-USA-2024-0311480$PURDUE$$$$$$Y$$$20240821$$CN$US$US
242350541$24235054$1$I$$20240820$20240821$20240821$PER$$US-PURDUE PHARMA-USA-2024-0311454$PURDUE$$62$YR$$F$Y$$$20240821$$CN$US$US
242350554$24235055$4$F$20180101$20240828$20240821$20240829$PER$$US-PURDUE PHARMA-USA-2024-0311479$PURDUE$$50$YR$$M$Y$$$20240829$$CN$US$US
242350561$24235056$1$I$$20240816$20240821$20240821$EXP$$CA-AMX-008132$AMYLYX PHARMACEUTICALS$$63$YR$$M$Y$$$20240821$$CN$CA$CA
242350571$24235057$1$I$$20240821$20240821$20240821$PER$$US-PURDUE-USA-2024-0311455$PURDUE$$$$$F$Y$$$20240821$$CN$US$US
242350581$24235058$1$I$20211201$20240819$20240821$20240821$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-25457$SAMSUNG BIOEPIS$$$$$$Y$$$20240821$$HP$GB$GB
242350591$24235059$1$I$20240417$20240818$20240821$20240821$EXP$IT-MINISAL02-987540$IT-SAMSUNG BIOEPIS-SB-2024-25353$SAMSUNG BIOEPIS$$68$YR$E$F$Y$$$20240821$$MD$IT$IT
242350601$24235060$1$I$20240219$20240818$20240821$20240821$EXP$IT-MINISAL02-987528$IT-SAMSUNG BIOEPIS-SB-2024-25352$SAMSUNG BIOEPIS$$58$YR$A$F$Y$$$20240821$$MD$IT$IT
242350611$24235061$1$I$20220501$20240814$20240821$20240821$EXP$DE-ALLERGAN-2302825US$DE-ABBVIE-2302825US$ABBVIE$$1$DY$$F$Y$2.268$KG$20240821$$MD$DE$DE
242350631$24235063$1$I$$20240812$20240821$20240821$PER$$US-ABBVIE-5889300$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242350641$24235064$1$I$$20240810$20240821$20240821$PER$$US-BAUSCHBL-2024BNL031796$BAUSCH AND LOMB$$$$$$Y$$$20240821$$CN$US$US
242350651$24235065$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA246840$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240821$$MD$US$US
242350661$24235066$1$I$$20240819$20240821$20240821$PER$$US-SA-2024SA246398$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240821$$CN$US$US
242350671$24235067$1$I$20230101$20240814$20240821$20240821$EXP$$CA-BAUSCH-BL-2024-012697$BAUSCH AND LOMB$$48$YR$$F$Y$66.5$KG$20240821$$MD$CA$CA
242350681$24235068$1$I$$20240814$20240821$20240821$EXP$$US-TAKEDA-2024TUS082805$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
242350691$24235069$1$I$$20240816$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011240$ELI LILLY AND CO$$10$YR$C$F$Y$$$20240821$$CN$US$US
242350701$24235070$1$I$$20240819$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408011572$ELI LILLY AND CO$$86$YR$E$F$Y$$$20240821$$CN$US$US
242350711$24235071$1$I$$20240806$20240821$20240821$EXP$$IN-ACELLA PHARMACEUTICALS, LLC-2024ALO00403$Alora Pharma$Mahadevappa M, Attri LK, Chalasani SH, Syed J.. Dextromethorphan Induced Dystonia: A Rare Case Report. Hospital pharmacy. 2023;58(4):353-6$64$YR$$F$Y$$$20240821$$HP$IN$IN
242350721$24235072$1$I$$20240806$20240821$20240821$EXP$$JP-EAGLE PHARMACEUTICALS, INC.-JP-2024EAG000197$EAGLE$Okazaki H et al. A case of follicular lymphoma in complete remission that presented with hyperosmotic hyperglycemia syndrome and subsequently prolonged COVID-19 infection. The 252nd Meeting of Tokai Branch of the Japanese Society of Internal Medicine. 2024;10$81$YR$$F$Y$$$20240821$$MD$JP$JP
242350741$24235074$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57629$$FDA-CTU$$23$YR$$F$N$$$20240821$N$$US$
242350751$24235075$1$I$20240802$20240810$20240821$20240821$PER$$US-JNJFOC-20240827918$JOHNSON AND JOHNSON$$33$YR$A$$Y$$$20240821$$CN$US$US
242350762$24235076$2$F$20240501$20240820$20240821$20240904$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25302$SAMSUNG BIOEPIS$$22$YR$A$F$Y$92$KG$20240904$$HP$CA$CA
242350771$24235077$1$I$20240426$20240816$20240821$20240821$EXP$ES-AEMPS-1528812$ES-SAMSUNG BIOEPIS-SB-2024-25232$SAMSUNG BIOEPIS$$26$YR$A$M$Y$$$20240821$$MD$ES$ES
242350781$24235078$1$I$$20240816$20240821$20240821$EXP$$IE-SAMSUNG BIOEPIS-SB-2024-25366$SAMSUNG BIOEPIS$$47$YR$A$F$Y$$$20240821$$CN$IE$IE
242350791$24235079$1$I$20230828$20240816$20240821$20240821$EXP$ES-AEMPS-1528490$ES-SAMSUNG BIOEPIS-SB-2024-25241$SAMSUNG BIOEPIS$$72$YR$E$F$Y$$$20240821$$MD$ES$ES
242350801$24235080$1$I$$20240626$20240821$20240821$PER$$US-Dermavant-001215$DERMAVANT SCIENCES$$43$YR$$F$Y$$$20240819$$CN$US$US
242350811$24235081$1$I$$20240705$20240821$20240821$PER$$US-Dermavant-001229$DERMAVANT SCIENCES$$$$$F$Y$$$20240820$$$US$US
242350831$24235083$1$I$20240722$20240812$20240821$20240821$PER$$CN-Eisai-EC-2024-172024$EISAI$$73$YR$E$M$Y$49$KG$20240821$$HP$CN$CN
242350841$24235084$1$I$$20240709$20240821$20240821$PER$$US-Dermavant-001231$DERMAVANT SCIENCES$$$$A$M$Y$$$20240820$$CN$US$US
242350851$24235085$1$I$$20240821$20240821$20240821$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047084$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240821$$CN$US$US
242350861$24235086$1$I$20240801$20240820$20240821$20240821$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047081$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$40$KG$20240821$$HP$CO$CO
242350871$24235087$1$I$$20240715$20240821$20240821$PER$$US-Dermavant-001240$DERMAVANT SCIENCES$$$$A$F$Y$$$20240820$$HP$US$US
242350881$24235088$1$I$20240712$20240816$20240821$20240821$PER$$CN-Eisai-EC-2024-172290$EISAI$$37$YR$A$M$Y$$$20240821$$HP$CN$CN
242350891$24235089$1$I$$20240812$20240821$20240821$PER$$AU-Eisai-EC-2023-153975$EISAI$$56$YR$A$F$Y$$$20240821$$MD$AU$AU
242350931$24235093$1$I$$20240812$20240821$20240821$PER$$US-Dermavant-001262$DERMAVANT SCIENCES$$$$$$Y$$$20240820$$CN$US$US
242350941$24235094$1$I$$20240815$20240821$20240821$PER$$US-JNJFOC-20240842251$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$CN$US$US
242350951$24235095$1$I$$20240808$20240821$20240821$EXP$$JP-ROCHE-10000056813$ROCHE$$8$DEC$E$M$Y$$$20240821$$MD$JP$JP
242350961$24235096$1$I$20240625$20240719$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN006785$INCYTE$$$$$$Y$$$20240821$$CN$US$US
242350971$24235097$1$I$20220118$20240813$20240821$20240821$EXP$$FR-AstraZeneca-2024A184269$ASTRAZENECA$$67$YR$$M$Y$75$KG$20240821$$MD$FR$
242350981$24235098$1$I$20240813$20240814$20240821$20240821$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-130112$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240821$$CN$PR$PR
242350992$24235099$2$F$$20240812$20240821$20240911$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16333$IPSEN$$54$YR$A$F$Y$$$20240911$$CN$US$US
242351001$24235100$1$I$20240806$20240812$20240821$20240821$PER$$RU-Eisai-EC-2024-171891$EISAI$$16$YR$T$F$Y$$$20240821$$MD$RU$RU
242351011$24235101$1$I$20240712$20240816$20240821$20240821$PER$$CN-Eisai-EC-2024-172343$EISAI$$58$YR$A$M$Y$50$KG$20240821$$HP$CN$CN
242351021$24235102$1$I$$20240820$20240821$20240821$PER$$NVSC2024US169458$NOVARTIS$$$$$$Y$$$20240821$$HP$US$US
242351031$24235103$1$I$$20240816$20240821$20240821$PER$$JP-Eisai-EC-2024-172310$EISAI$Satoshi Umezawa. Experience with lenvatinib + pembrolizumab combination therapy at our hospital (10 cases). Women^s Cancer Expert Seminar.$$$E$F$Y$$$20240821$$MD$JP$JP
242351041$24235104$1$I$$20240818$20240821$20240821$EXP$$DE-Aprecia Pharmaceuticals-APRE20241107$APRECIA PHARMACEUTICALS$Nagele H, Rosenkranz M, Nagele M. Hyponatremia-Induced Epileptic Seizure Provoked by Levetiracetam and Pain Medication Intake in a Patient with Central Diabetes Insipidus. Case Rep Neurol. 2024;16:204-207. doi:10.1159/000540320$67$YR$E$M$Y$$$20240821$$HP$DE$DE
242351051$24235105$1$I$20240820$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57585$$FDA-CTU$$64$YR$$F$N$$$20240821$N$PH$US$
242351071$24235107$1$I$$20240815$20240821$20240821$EXP$GB-MHRA-MED-202408151423457690-QRFGW$GB-ELI_LILLY_AND_COMPANY-GB202408010486$ELI LILLY AND CO$$$$$F$Y$$$20240821$$CN$GB$GB
242351081$24235108$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246543$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240821$$MD$US$US
242351091$24235109$1$I$$20240815$20240821$20240821$EXP$$US-OTSUKA-2024_022653$OTSUKA$$$$$M$Y$$$20240821$$PH$US$US
242351103$24235110$3$F$$20240820$20240821$20240828$EXP$$NVSC2024VN165508$NOVARTIS$Luong PT, Nguyen TH. Loan San Xupng Mien Dich Schimke Do Mot Dot Bien Moi Phat Hien O Gen Smarcal1 O Tre Hoi Chung Than Hu Khang Steroid - Bao Cao Ca Benh [A Novel Smarcal1 Mutations Associated With Schimke Immune-Osseous Dysplasia In A Child With Steroid Resistant Nephrotic Syndrome - A Case Report]. VIETNAM MEDICAL JOURNAL. 2024;541(1):294-7$9$YR$$F$Y$$$20240828$$HP$VN$VN
242351111$24235111$1$I$$20240820$20240821$20240821$EXP$$NVSC2024CA169087$NOVARTIS$$70$YR$$F$Y$65$KG$20240821$$PH$CA$CA
242351121$24235112$1$I$20230508$20240806$20240821$20240821$EXP$$FR-PHARMAAND GMBH-2024PHR00470$pharmaAND$$29$YR$$F$Y$$$20240821$$MD$FR$FR
242351131$24235113$1$I$20240630$20240806$20240821$20240821$EXP$$FR-PHARMAAND GMBH-2024PHR00469$pharmaAND$$67$YR$$M$Y$$$20240821$$MD$FR$FR
242351141$24235114$1$I$20240613$20240806$20240821$20240821$EXP$$FR-PHARMAAND GMBH-2024PHR00471$pharmaAND$$60$YR$$F$Y$$$20240821$$MD$FR$FR
242351151$24235115$1$I$$20240815$20240821$20240821$PER$$JP-Eisai-EC-2024-172197$EISAI$$$$A$M$Y$$$20240821$$MD$JP$JP
242351161$24235116$1$I$20240723$20240814$20240821$20240821$PER$$CN-Eisai-EC-2024-172108$EISAI$$29$YR$A$F$Y$41$KG$20240821$$HP$CN$CN
242351172$24235117$2$F$$20240916$20240821$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129179$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$99.34$KG$20240923$$CN$US$US
242351181$24235118$1$I$$20240816$20240821$20240821$EXP$$JP-009507513-2408JPN002098J$MERCK$$7$DEC$$F$Y$$$20240821$$MD$JP$JP
242351191$24235119$1$I$$20240820$20240821$20240821$PER$$US-JNJFOC-20240851923$JOHNSON AND JOHNSON$$$$A$$Y$$$20240821$$MD$US$US
242351201$24235120$1$I$20240801$20240815$20240821$20240821$PER$$US-SA-2024SA246143$SANOFI AVENTIS$$$$$M$Y$$$20240821$$PH$US$US
242351221$24235122$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA247035$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240821$$MD$US$US
242351231$24235123$1$I$20240101$20240813$20240821$20240821$PER$$US-009507513-2408USA004664$MERCK$$$$$$Y$$$20240821$$CN$US$US
242351241$24235124$1$I$$20240816$20240821$20240821$PER$$US-ALXN-202408USA001010US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
242351251$24235125$1$I$$20240816$20240821$20240821$EXP$$ZA-ABBVIE-5885793$ABBVIE$$$$E$F$Y$$$20240821$$MD$ZA$ZA
242351261$24235126$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA246979$SANOFI AVENTIS$$31$YR$A$M$Y$90$KG$20240821$$MD$US$US
242351271$24235127$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA247015$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240821$$MD$US$US
242351281$24235128$1$I$$20240710$20240821$20240821$PER$$US-LUNDBECK-DKLU4001620$LUNDBECK$$$$$$Y$$$20240821$$CN$US$US
242351291$24235129$1$I$20240630$20240817$20240821$20240821$EXP$$NVSC2024CN168686$NOVARTIS$$75$YR$$F$Y$40$KG$20240821$$HP$CN$CN
242351301$24235130$1$I$20240602$20240814$20240821$20240821$EXP$$US-Eisai-EC-2024-172385$EISAI$$77$YR$E$F$Y$73$KG$20240821$$CN$US$US
242351311$24235131$1$I$$20240815$20240821$20240821$PER$$CA-Eisai-EC-2024-172143$EISAI$$3$YR$C$F$Y$$$20240821$$HP$CA$CA
242351322$24235132$2$F$20240819$20240820$20240821$20240825$30DAY$$US-ELI_LILLY_AND_COMPANY-US202408012221$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240825$$CN$US$US
242351332$24235133$2$F$20240701$20240823$20240821$20240903$EXP$$AR-ELI_LILLY_AND_COMPANY-AR202408011200$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240903$$CN$DE$AR
242351341$24235134$1$I$$20240814$20240821$20240821$EXP$$NVSC2024CA166803$NOVARTIS$$$$$M$Y$$$20240821$$HP$CA$CA
242351351$24235135$1$I$20240701$20240814$20240821$20240821$PER$$US-SA-2024SA246623$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240821$$MD$US$US
242351361$24235136$1$I$20240813$20240816$20240821$20240821$PER$$US-ALXN-202408USA001136US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240821$$CN$US$US
242351372$24235137$2$F$$20240911$20240821$20240911$PER$$US-ALXN-202408USA001075US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
242351381$24235138$1$I$$20240815$20240821$20240821$EXP$$AU-GILEAD-2024-0684534$GILEAD$Ramesh M et al. Procalcitonin level threshold and antibiotic use in patients receiving chimeric antigen receptor T-cell therapy. Hematology (United Kingdom). 2021;29:1:unk. doi:10.1080/16078454.2024.2381989$$$A$$Y$$$20240821$$MD$AU$AU
242351392$24235139$2$F$$20240827$20240821$20240905$EXP$$US-TEVA-VS-3234737$TEVA$Cohen A, Coyne M. Should We Consult Palliative? Managing Concurrent Withdrawal and Pain in Patients with Opioid Use Disorder. J-Pain-Symptom-Manage 2024; 67 (5): e748.; Cohen A, Coyne M. Should We Consult Palliative? Managing Concurrent Withdrawal and Pain in Patients with Opioid Use Disorder. J-Pain-Symptom-Manage 2024; 67 (5): e748.$41$YR$$M$Y$$$20240905$$MD$US$US
242351401$24235140$1$I$20240701$20240819$20240821$20240821$PER$$US-009507513-2408USA006527$MERCK$$$$$$Y$$$20240821$$CN$US$US
242351411$24235141$1$I$$20240812$20240821$20240821$EXP$$US-AstraZeneca-2024A188210$ASTRAZENECA$$$$$$Y$$$20240821$$HP$US$
242351424$24235142$4$F$$20240910$20240821$20240915$EXP$$US-JNJFOC-20240849465$JOHNSON AND JOHNSON$$62$YR$A$M$Y$97.519$KG$20240916$$CN$US$US
242351431$24235143$1$I$$20240809$20240821$20240821$PER$$US-JNJFOC-20240849289$JOHNSON AND JOHNSON$$$$$$Y$$$20240821$$HP$US$US
242351462$24235146$2$F$$20240826$20240821$20240909$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00712$Phathom Pharmaceuticals$$81$YR$$M$Y$$$20240909$$PH$JP$JP
242351492$24235149$2$F$20240730$20240923$20240821$20240926$EXP$$DE-009507513-2408DEU006481$MERCK$$61$YR$$F$Y$58.8$KG$20240926$$MD$DE$DE
242351502$24235150$2$F$20240508$20240821$20240821$20240905$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01300$INTRA-CELLULAR THERAPIES$$35$YR$$M$Y$117.91$KG$20240905$$CN$US$US
242351511$24235151$1$I$$20240816$20240821$20240821$PER$$US-ALXN-202408USA001018US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240821$$CN$US$US
242351522$24235152$2$F$$20240905$20240821$20240905$PER$$US-ALXN-202408USA001015US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242351531$24235153$1$I$$20230527$20240821$20240821$EXP$$US-AstraZeneca-2023A124269$ASTRAZENECA$$$$$$Y$$$20240821$$CN$US$
242351541$24235154$1$I$$20240506$20240821$20240821$PER$$US-IMP-2024000255$Harrow Health$$$$$F$Y$$$20240821$$CN$US$US
242351551$24235155$1$I$20240501$20240510$20240821$20240821$PER$$US-IMP-2024000282$Harrow Health$$$$$F$Y$$$20240821$$CN$US$US
242351561$24235156$1$I$20240510$20240515$20240821$20240821$PER$$US-IMP-2024000285$Harrow Health$$$$$F$Y$$$20240821$$CN$US$US
242351571$24235157$1$I$$20240814$20240821$20240821$30DAY$$US-GSK-US2024101866$GLAXOSMITHKLINE$$1$DEC$$$Y$$$20240821$$MD$US$US
242351581$24235158$1$I$$20240819$20240821$20240821$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013130$JAZZ$$$$$M$Y$61.7$KG$20240821$$CN$US$US
242351591$24235159$1$I$$20240612$20240821$20240821$PER$$US-IMP-2024000403$Harrow Health$$$$$M$Y$$$20240821$$MD$US$US
242351601$24235160$1$I$20240601$20240626$20240821$20240821$PER$$US-IMP-2024000437$Harrow Health$$69$YR$E$M$Y$$$20240821$$CN$US$US
242351611$24235161$1$I$$20240715$20240821$20240821$PER$$US-IMP-2024000505$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242351621$24235162$1$I$$20240715$20240821$20240821$PER$$US-IMP-2024000501$Harrow Health$$$$A$F$Y$$$20240821$$CN$US$US
242351631$24235163$1$I$$20240715$20240821$20240821$PER$$US-IMP-2024000503$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242351641$24235164$1$I$$20240812$20240821$20240821$EXP$$CA-Covis Pharma GmbH-2024COV01027$COVIS PHARMA$$80$YR$E$M$Y$89$KG$20240821$$MD$CA$CA
242351661$24235166$1$I$$20240716$20240821$20240821$PER$$US-IMP-2024000511$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242351671$24235167$1$I$$20240716$20240821$20240821$PER$$US-IMP-2024000512$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242351681$24235168$1$I$$20240716$20240821$20240821$PER$$US-IMP-2024000513$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242351691$24235169$1$I$20240101$20240815$20240821$20240821$EXP$$US-009507513-2408USA005641$MERCK$$$$$M$Y$$$20240821$$HP$US$US
242351701$24235170$1$I$20240620$20240716$20240821$20240821$PER$$US-IMP-2024000514$Harrow Health$$74$YR$E$F$Y$$$20240821$$CN$US$US
242351711$24235171$1$I$20240625$20240717$20240821$20240821$PER$$US-IMP-2024000517$Harrow Health$$85$YR$E$F$Y$$$20240821$$CN$US$US
242351721$24235172$1$I$20240319$20240717$20240821$20240821$PER$$US-IMP-2024000518$Harrow Health$$93$YR$E$M$Y$$$20240821$$CN$US$US
242351731$24235173$1$I$$20240814$20240821$20240821$EXP$$AU-009507513-2408AUS004818$MERCK$$32$YR$$M$Y$$$20240821$$MD$AU$AU
242351741$24235174$1$I$20240711$20240718$20240821$20240821$PER$$US-IMP-2024000523$Harrow Health$$82$YR$E$F$Y$$$20240821$$CN$US$US
242351751$24235175$1$I$20240715$20240718$20240821$20240821$PER$$US-IMP-2024000525$Harrow Health$$82$YR$E$F$Y$$$20240821$$CN$US$US
242351764$24235176$4$F$20240101$20240920$20240821$20240924$EXP$$US-SA-2024SA244015$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240924$$CN$US$US
242351771$24235177$1$I$$20240719$20240821$20240821$PER$$US-IMP-2024000526$Harrow Health$$$$E$F$Y$$$20240821$$CN$US$US
242351781$24235178$1$I$20240530$20240815$20240821$20240821$EXP$RU-SA-SAC20240819000940$RU-SA-2024SA245685$SANOFI AVENTIS$$29$YR$A$F$Y$49$KG$20240821$$HP$RU$RU
242351791$24235179$1$I$$20240820$20240821$20240821$PER$$NVSC2024US169304$NOVARTIS$$$$$F$Y$$$20240821$$MD$US$US
242351802$24235180$2$F$$20240815$20240821$20240828$PER$$US-IMP-2024000590$Harrow Health$$$$A$F$Y$$$20240828$$CN$US$US
242351821$24235182$1$I$$20240812$20240821$20240821$PER$$US-GILEAD-2024-0684013$GILEAD$$$$$M$Y$$$20240821$$HP$US$US
242351841$24235184$1$I$$20240809$20240821$20240821$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI08189$NEUROCRINE BIOSCIENCES$$6$DEC$$F$Y$$$20240821$$MD$JP$JP
242351852$24235185$2$F$$20240918$20240821$20240920$30DAY$$CL-PFIZER INC-202400236578$PFIZER$$$$$$Y$$$20240920$$CN$CL$CL
242351861$24235186$1$I$$20240819$20240821$20240821$PER$$NVSC2024US169286$NOVARTIS$$$$$M$Y$$$20240822$$CN$US$US
242351871$24235187$1$I$20220107$20240806$20240821$20240821$EXP$$US-HLS-202400750$HLS THERAPEUTICS$$19$YR$A$F$Y$$$20240821$$CN$US$US
242351882$24235188$2$F$$20240814$20240821$20240822$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045909$BOEHRINGER INGELHEIM$$$$E$F$Y$78.9$KG$20240822$$CN$US$US
242351901$24235190$1$I$20230913$20240816$20240821$20240821$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-112857$REGENERON$$$$$M$Y$$$20240821$$HP$US$US
242351912$24235191$2$F$$20240828$20240821$20240906$EXP$$US-TEVA-VS-3234687$TEVA$Harvey RD, Franz JK, Joseph NS, Kaufman JL, Hitron E, Collins H, et al. A Phase 2 Evaluation of Daratumumab-Based Induction Therapy in Multiple Myeloma Patients with Severe Renal Insufficiency. Blood 2022; 140 (Suppl.) 12633-12634.; Harvey RD, Franz JK, Joseph NS, Kaufman JL, Hitron E, Collins H, et al. A Phase 2 Evaluation of Daratumumab-Based Induction Therapy in Multiple Myeloma Patients with Severe Renal Insufficiency. Blood 2022; 140 (Suppl.) 12633-12634.$$$$$Y$$$20240906$$HP$US$US
242351922$24235192$2$F$$20240826$20240821$20240902$EXP$$CZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046640$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240902$$MD$CZ$CZ
242351931$24235193$1$I$20240101$20240819$20240821$20240821$EXP$$US-ABBVIE-5887095$ABBVIE$$$$$M$Y$$$20240821$$HP$US$US
242351941$24235194$1$I$20230916$20240819$20240821$20240821$EXP$$US-APELLIS-2024-APL-0000772$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240821$$CN$US$US
242351951$24235195$1$I$20240802$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164575$AMGEN$$70$YR$E$F$Y$$$20240821$$CN$US$US
242351961$24235196$1$I$$20240812$20240821$20240821$EXP$$IL-009507513-2408ISR004595$MERCK$$$$$F$Y$$$20240821$$PH$IL$IL
242351971$24235197$1$I$$20240819$20240821$20240821$PER$$US-TAKEDA-2024TUS083752$TAKEDA$$$$$F$Y$$$20240821$$CN$US$US
242351981$24235198$1$I$20240523$20240807$20240821$20240821$EXP$$US-HLS-202400784$HLS THERAPEUTICS$$80$YR$E$F$Y$$$20240821$$PH$US$US
242351991$24235199$1$I$20240101$20240810$20240821$20240821$PER$$US-BIOMARINAP-US-2024-159945$BIOMARIN$$$$$$Y$$$20240821$$CN$US$US
242352002$24235200$2$F$20240402$20240827$20240821$20240902$EXP$$US-APELLIS-2024-APL-0000694$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240902$$MD$US$US
242352011$24235201$1$I$$20240807$20240821$20240821$EXP$$US-HLS-202400775$HLS THERAPEUTICS$$$$A$$Y$$$20240821$$MD$US$US
242352041$24235204$1$I$20240321$20240820$20240821$20240821$PER$$US-GILEAD-2024-0684808$GILEAD$$71$YR$E$F$Y$54.7$KG$20240821$$HP$US$US
242352051$24235205$1$I$$20240815$20240821$20240821$EXP$$AU-GILEAD-2024-0684535$GILEAD$Ramesh M et al. Procalcitonin level threshold and antibiotic use in patients receiving chimeric antigen receptor T-cell therapy. Hematology (United Kingdom). 2024;29:1:unk. doi:10.1080/16078454.2024.2381989$$$A$$Y$$$20240821$$MD$AU$AU
242352061$24235206$1$I$20231006$20240820$20240821$20240821$PER$$US-GILEAD-2024-0684814$GILEAD$$50$YR$A$F$Y$83.5$KG$20240821$$HP$US$US
242352081$24235208$1$I$$20240812$20240821$20240821$PER$$US-APELLIS-2024-APL-0000720$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240821$$CN$US$US
242352091$24235209$1$I$20240819$20240820$20240821$20240821$EXP$GB-MHRA-MED-202408201454267200-SPVGM$GB-ROCHE-10000061784$ROCHE$$67$YR$E$F$Y$$$20240821$$HP$GB$GB
242352101$24235210$1$I$20240804$20240813$20240821$20240821$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-129395$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$52.6$KG$20240821$$CN$CN$CN
242352111$24235211$1$I$20240817$20240819$20240821$20240821$EXP$$US-ROCHE-10000060820$ROCHE$$95$YR$E$M$Y$$$20240821$$CN$US$US
242352121$24235212$1$I$$20240807$20240821$20240821$EXP$$CA-HLS-202401979$HLS THERAPEUTICS$$$$A$F$Y$$$20240821$$PH$CA$CA
242352132$24235213$2$F$20240812$20240812$20240821$20240827$PER$$US-APELLIS-2024-APL-0000731$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240827$$CN$US$US
242352141$24235214$1$I$$20240809$20240821$20240821$EXP$$US-AstraZeneca-2024A184617$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242352151$24235215$1$I$20240721$20240820$20240821$20240821$EXP$$PK-ROCHE-10000061691$ROCHE$$39$YR$A$F$Y$$$20240821$$CN$PK$PK
242352161$24235216$1$I$20240802$20240814$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009641$ELI LILLY AND CO$$$$$F$Y$$$20240821$$CN$US$US
242352171$24235217$1$I$$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009685$ELI LILLY AND CO$$$$$F$Y$$$20240821$$HP$US$US
242352181$24235218$1$I$20240624$20240819$20240821$20240821$EXP$$CN-ROCHE-10000060743$ROCHE$$53$YR$A$F$Y$48$KG$20240821$$HP$CN$CN
242352191$24235219$1$I$20240817$20240819$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US073718$SANDOZ$$57$YR$$F$Y$$$20240821$$CN$US$US
242352201$24235220$1$I$$20240812$20240821$20240821$PER$$US-ABBVIE-5879371$ABBVIE$$$$$$Y$$$20240821$$CN$US$US
242352221$24235222$1$I$$20240815$20240821$20240821$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-130549$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240821$$HP$RU$RU
242352231$24235223$1$I$$20240815$20240821$20240821$EXP$$US-ROCHE-10000059357$ROCHE$$81$YR$E$F$Y$$$20240821$$CN$US$US
242352241$24235224$1$I$$20240820$20240821$20240821$PER$$NVSC2024US169480$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242352261$24235226$1$I$$20240819$20240821$20240821$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046976$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240821$$CN$US$US
242352271$24235227$1$I$$20240820$20240821$20240821$30DAY$$FR-SANDOZ INC.-SDZ2024FR073992$SANDOZ$$14$YR$$F$Y$$$20240821$$CN$FR$FR
242352281$24235228$1$I$20240801$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024162968$AMGEN$$$$$M$Y$$$20240821$$CN$US$US
242352291$24235229$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA245225$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240822$$MD$US$US
242352301$24235230$1$I$20240812$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165293$AMGEN$$60$YR$A$F$Y$$$20240821$$CN$US$US
242352311$24235231$1$I$20240730$20240813$20240821$20240821$PER$$US-SA-2024SA243519$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240822$$MD$US$US
242352322$24235232$2$F$20240101$20240918$20240821$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018602$UNITED THERAPEUTICS$$$$$M$Y$88.435$KG$20240926$$$US$US
242352331$24235233$1$I$$20240818$20240821$20240821$EXP$$PH-JNJFOC-20240853712$JOHNSON AND JOHNSON$$70$YR$E$$Y$$$20240822$$MD$PH$PH
242352341$24235234$1$I$20240101$20240820$20240821$20240821$EXP$$JP-ORGANON-O2406JPN001128$ORGANON$$72$YR$$F$Y$$$20240821$$MD$JP$JP
242352351$24235235$1$I$$20240813$20240821$20240821$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-ITA-20180908769$BRISTOL MYERS SQUIBB$Mauro FR, Carella AM, Molica S, Paoloni F, Liberati AM, Zaja F, et al. Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. a multicenter phase I-II GIMEMA trial. Leukemia + Lymphoma. 2017;58(7):1640-7.doi:10.1080/10428194.2016.1258698.$$$$$Y$$$20240822$$HP$IT$IT
242352361$24235236$1$I$20240225$20240810$20240821$20240821$EXP$$US-JNJFOC-20240828580$JOHNSON AND JOHNSON$$31$YR$A$F$Y$64.014$KG$20240822$$CN$US$US
242352371$24235237$1$I$20240101$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165166$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242352381$24235238$1$I$20200625$20240819$20240821$20240821$EXP$$GB-SANDOZ INC.-NVSC2020GB225502$SANDOZ$$59$YR$$M$Y$$$20240821$$CN$GB$GB
242352391$24235239$1$I$$20240722$20240821$20240821$PER$$US-INCYTE CORPORATION-2022IN006211$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352401$24235240$1$I$20240816$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164846$AMGEN$$81$YR$E$M$Y$$$20240821$$CN$US$US
242352411$24235241$1$I$$20240723$20240821$20240821$PER$$US-INCYTE CORPORATION-2023IN011758$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352421$24235242$1$I$$20240813$20240821$20240821$EXP$$NVSJ2024JP009859$NOVARTIS$$17$YR$$M$Y$$$20240822$$CN$JP$JP
242352431$24235243$1$I$20240818$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165948$AMGEN$$67$YR$E$M$Y$$$20240821$$CN$US$US
242352441$24235244$1$I$20240801$20240806$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008251$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352451$24235245$1$I$$20240730$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN007979$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352461$24235246$1$I$$20240802$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008142$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352471$24235247$1$I$$20240802$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008132$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352481$24235248$1$I$$20240731$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008040$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352491$24235249$1$I$$20240821$20240821$20240821$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047142$BOEHRINGER INGELHEIM$$$$$$Y$$$20240822$$CN$US$US
242352504$24235250$4$F$$20240917$20240821$20240918$EXP$$JP-TAKEDA-2024TJP012085$TAKEDA$$5$DEC$$M$Y$$$20240918$$CN$JP$JP
242352511$24235251$1$I$$20240806$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008255$INCYTE$$$$$$Y$$$20240822$$MD$US$US
242352521$24235252$1$I$20240718$20240808$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008347$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352531$24235253$1$I$$20240808$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008353$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352541$24235254$1$I$$20240808$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008351$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352551$24235255$1$I$$20240806$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008253$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352561$24235256$1$I$$20240808$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008349$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352571$24235257$1$I$$20240807$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008305$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352581$24235258$1$I$$20240806$20240821$20240821$PER$$US-INCYTE CORPORATION-2024IN008254$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242352592$24235259$2$F$$20240910$20240821$20240924$PER$$US-INCYTE CORPORATION-2024IN008207$INCYTE$$$$$$Y$$$20240924$$CN$US$US
242352603$24235260$3$F$$20240904$20240821$20240925$PER$$US-SMPA-2024SPA000320$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242352613$24235261$3$F$$20240815$20240821$20240828$EXP$$US-SMPA-2024SPA000605$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242352622$24235262$2$F$20240101$20240822$20240821$20240918$PER$$US-SMPA-2024SPA000459$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
242352631$24235263$1$I$$20240811$20240821$20240821$PER$$US-SMPA-2024SPA001254$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352641$24235264$1$I$$20240811$20240821$20240821$PER$$US-SMPA-2024SPA001255$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352651$24235265$1$I$$20240730$20240821$20240821$PER$$US-SMPA-2024SPA000446$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352661$24235266$1$I$20240706$20240807$20240821$20240821$PER$$US-SMPA-2024SPA001056$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352671$24235267$1$I$$20240729$20240821$20240821$PER$$US-SMPA-2024SPA000491$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352681$24235268$1$I$$20240726$20240821$20240821$PER$$US-SMPA-2024SPA000337$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352691$24235269$1$I$$20240726$20240821$20240821$PER$$US-SMPA-2024SPA000295$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352701$24235270$1$I$$20240730$20240821$20240821$PER$$US-SMPA-2024SPA000515$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352711$24235271$1$I$$20240809$20240821$20240821$PER$$US-SMPA-2024SPA001222$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352721$24235272$1$I$20240727$20240814$20240821$20240821$PER$$US-SMPA-2024SPA001522$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352732$24235273$2$F$20240805$20240827$20240821$20240916$PER$$US-SMPA-2024SPA000429$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
242352741$24235274$1$I$$20240730$20240821$20240821$PER$$US-SMPA-2024SPA000551$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352752$24235275$2$F$$20240828$20240821$20240927$PER$$US-SMPA-2024SPA001127$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242352761$24235276$1$I$$20240811$20240821$20240821$PER$$US-SMPA-2024SPA001251$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352772$24235277$2$F$$20240909$20240821$20240925$PER$$US-SMPA-2024SPA000975$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242352791$24235279$1$I$$20240723$20240821$20240821$PER$$US-SMPA-2024MYSCI0700955$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352801$24235280$1$I$$20240812$20240821$20240821$PER$$US-SMPA-2024SPA001266$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352813$24235281$3$F$$20240913$20240821$20240930$PER$$US-SMPA-2024SPA000419$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242352821$24235282$1$I$$20240729$20240821$20240821$PER$$US-SMPA-2024SPA000409$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352831$24235283$1$I$20240401$20240723$20240821$20240821$PER$$US-SMPA-2024MYSCI0700966$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352851$24235285$1$I$$20240809$20240821$20240821$PER$$US-SMPA-2024SPA001292$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352861$24235286$1$I$$20240729$20240821$20240821$PER$$US-SMPA-2024SPA000411$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352882$24235288$2$F$$20240820$20240821$20240913$PER$$US-SMPA-2024SPA000474$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
242352891$24235289$1$I$$20240724$20240821$20240821$PER$$US-SMPA-2024MYSCI0701082$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352911$24235291$1$I$$20240724$20240821$20240821$PER$$US-SMPA-2024MYSCI0701059$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352921$24235292$1$I$20240528$20240724$20240821$20240821$PER$$US-SMPA-2024MYSCI0501067$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352931$24235293$1$I$$20240723$20240821$20240821$PER$$US-SMPA-2024MYSCI0300917$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352943$24235294$3$F$$20240903$20240821$20240924$PER$$US-SMPA-2024SPA000431$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242352951$24235295$1$I$$20240812$20240821$20240821$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001618$BLUEPRINT MEDICINES$$$$$F$Y$$$20240822$$CN$US$US
242352961$24235296$1$I$$20240812$20240821$20240821$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001625$BLUEPRINT MEDICINES$$$$$F$Y$$$20240822$$CN$US$US
242352971$24235297$1$I$$20240709$20240821$20240821$PER$$US-SMPA-2024SPA001427$SUNOVION$$$$$$Y$$$20240821$$CN$US$US
242352983$24235298$3$F$$20240911$20240821$20240927$PER$$US-SMPA-2024SPA001342$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242352991$24235299$1$I$$20240813$20240821$20240821$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001644$BLUEPRINT MEDICINES$$$$$M$Y$$$20240822$$CN$US$US
242353002$24235300$2$F$20240715$20240823$20240821$20240829$EXP$$CL-SANDOZ INC.-SDZ2024CL074063$SANDOZ$$52$YR$$F$Y$$$20240829$$CN$CL$CL
242353011$24235301$1$I$$20240816$20240821$20240821$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001670$BLUEPRINT MEDICINES$$$$$$Y$$$20240822$$MD$US$US
242353021$24235302$1$I$20231128$20240814$20240821$20240821$EXP$$JP-009507513-2404JPN000566J$MERCK$$84$YR$$M$Y$$$20240821$$MD$JP$JP
242353031$24235303$1$I$20240814$20240815$20240821$20240821$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001665$BLUEPRINT MEDICINES$$74$YR$E$F$Y$$$20240822$$CN$US$US
242353041$24235304$1$I$$20240819$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131909$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240822$$CN$US$US
242353051$24235305$1$I$$20240814$20240821$20240821$EXP$$GB-BAUSCHBL-2024BNL031776$BAUSCH AND LOMB$Kanji A, Ahmad R, Bala L, Bala L. Cutaneous Post-transplant Lymphoproliferative Disorder. Cureus. 2024 JUL 06;16(7):1-5. doi:10.7759/cureus.63951$36$YR$$M$Y$$$20240822$$MD$GB$GB
242353061$24235306$1$I$$20240813$20240821$20240821$EXP$$US-JNJFOC-20240833203$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$CN$US$US
242353071$24235307$1$I$$20240814$20240821$20240821$EXP$$US-SANDOZ INC.-SDZ2024US074164$SANDOZ$$$$$$Y$$$20240821$$HP$US$US
242353083$24235308$3$F$$20240906$20240821$20240916$PER$$US-BAUSCHBL-2024BNL031810$BAUSCH AND LOMB$$$$$$Y$$$20240916$$CN$US$US
242353092$24235309$2$F$20240716$20240815$20240821$20240903$EXP$ES-AEMPS-1556317$ES-009507513-2408ESP005384$MERCK$$80$YR$$F$Y$$$20240903$$PH$ES$ES
242353101$24235310$1$I$$20240815$20240821$20240821$PER$$US-BAUSCHBL-2024BNL031932$BAUSCH AND LOMB$$$$$F$Y$$$20240822$$CN$US$US
242353111$24235311$1$I$20240814$20240815$20240821$20240821$PER$$US-AMGEN-USASP2024163511$AMGEN$$75$YR$E$F$Y$$$20240821$$CN$US$US
242353121$24235312$1$I$$20240819$20240821$20240821$PER$$US-JNJFOC-20240850055$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$HP$US$US
242353131$24235313$1$I$$20240816$20240821$20240821$PER$$US-JNJFOC-20240844094$JOHNSON AND JOHNSON$$44$YR$A$M$Y$95.34$KG$20240822$$CN$US$US
242353141$24235314$1$I$$20240819$20240821$20240821$EXP$$NVSJ2024JP009779$NOVARTIS$$89$YR$$M$Y$$$20240822$$MD$JP$JP
242353151$24235315$1$I$20240812$20240815$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130240$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240822$$CN$US$US
242353162$24235316$2$F$20240501$20240904$20240821$20240908$EXP$$JP-SA-2024SA242538$SANOFI AVENTIS$$$$$$Y$$$20240909$$MD$JP$JP
242353171$24235317$1$I$20231001$20240814$20240821$20240821$EXP$$US-BAUSCHBL-2024BNL031824$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240822$$CN$US$US
242353191$24235319$1$I$$20240818$20240821$20240821$30DAY$$US-SANDOZ INC.-SDZ2024US045269$SANDOZ$$$$$M$Y$$$20240821$$HP$US$US
242353201$24235320$1$I$20240811$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164222$AMGEN$$61$YR$A$F$Y$$$20240821$$CN$US$US
242353211$24235321$1$I$$20240812$20240821$20240821$EXP$$CA-APOTEX-2024AP009321$APOTEX$$$$$F$Y$$$20240821$$MD$CA$CA
242353222$24235322$2$F$20240101$20240903$20240821$20240910$EXP$$US-BAUSCHBL-2024BNL031889$BAUSCH AND LOMB$$82$YR$$M$Y$$$20240910$$CN$US$US
242353231$24235323$1$I$$20240821$20240821$20240821$PER$$NVSC2024US169387$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242353241$24235324$1$I$$20240819$20240821$20240821$EXP$$JP-TAKEDA-2024TJP012079$TAKEDA$$8$DEC$$M$Y$$$20240821$$PH$JP$JP
242353261$24235326$1$I$20240101$20240813$20240821$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-014396$UNITED THERAPEUTICS$$$$$M$Y$79.365$KG$20240821$$$US$US
242353271$24235327$1$I$20240701$20240813$20240821$20240821$PER$$US-UNITED THERAPEUTICS-UNT-2024-025682$UNITED THERAPEUTICS$$67$YR$$F$Y$65.306$KG$20240821$$$US$US
242353281$24235328$1$I$20240401$20240819$20240821$20240821$EXP$$US-ORGANON-O2408USA001479$ORGANON$$21$YR$$F$Y$54.43$KG$20240821$$CN$US$US
242353293$24235329$3$F$20240801$20240924$20240821$20240928$PER$$US-AMGEN-USASP2024164557$AMGEN$$77$YR$E$M$Y$$$20240927$$CN$US$US
242353301$24235330$1$I$$20240820$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132240$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240822$$CN$US$US
242353313$24235331$3$F$$20240923$20240821$20240927$30DAY$$ES-JNJFOC-20240849892$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$ES$ES
242353321$24235332$1$I$$20240816$20240821$20240821$EXP$$DE-ABBVIE-5885820$ABBVIE$$$$E$M$Y$$$20240821$$CN$DE$DE
242353331$24235333$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244550$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240822$$CN$US$US
242353341$24235334$1$I$$20240817$20240821$20240821$PER$$NVSC2024US167645$NOVARTIS$$$$$$Y$$$20240822$$CN$US$US
242353352$24235335$2$F$20231010$20240903$20240821$20240904$EXP$$NVSJ2024JP009701$NOVARTIS$$61$YR$$M$Y$$$20240905$$MD$JP$JP
242353362$24235336$2$F$$20240822$20240821$20240823$EXP$$BG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046703$BOEHRINGER INGELHEIM$$54$YR$A$F$Y$$$20240823$$MD$BG$BG
242353371$24235337$1$I$20240806$20240814$20240821$20240821$EXP$$CN-BEIGENE-BGN-2024-012753$BEIGENE$$$$$$Y$$$20240821$$HP$CN$CN
242353381$24235338$1$I$$20240807$20240821$20240821$30DAY$$US-JNJFOC-20240844092$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$US$US
242353391$24235339$1$I$$20240819$20240821$20240821$PER$$US-AMGEN-USASP2024165387$AMGEN$$$$A$F$Y$$$20240821$$HP$US$US
242353401$24235340$1$I$20240801$20240821$20240821$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047148$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240822$$CN$US$US
242353411$24235341$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA244208$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240822$$MD$US$US
242353421$24235342$1$I$$20240809$20240821$20240821$PER$$US-JNJFOC-20240828016$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$HP$US$US
242353431$24235343$1$I$20240806$20240820$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132638$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240822$$HP$US$US
242353441$24235344$1$I$20240820$20240821$20240821$20240821$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047071$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$$$20240822$$HP$US$US
242353451$24235345$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA247070$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240822$$CN$US$US
242353461$24235346$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA247040$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240822$$CN$US$US
242353471$24235347$1$I$20240709$20240814$20240821$20240821$EXP$$CN-BEIGENE-BGN-2024-012743$BEIGENE$$$$$$Y$$$20240821$$HP$CN$CN
242353481$24235348$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA245828$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240822$$MD$US$US
242353491$24235349$1$I$20240801$20240815$20240821$20240821$PER$$US-SA-2024SA244181$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240822$$CN$US$US
242353501$24235350$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA244515$SANOFI AVENTIS$$$$A$F$Y$$$20240822$$MD$US$US
242353511$24235351$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA244538$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240822$$MD$US$US
242353524$24235352$4$F$20240813$20240910$20240821$20240917$EXP$$NVSC2024CA058229$NOVARTIS$$83$YR$$F$Y$$$20240917$$CN$CA$CA
242353531$24235353$1$I$20240814$20240814$20240821$20240821$EXP$GB-MHRA-MED-202408141134239960-TSMVK$GB-ABBVIE-5883530$ABBVIE$$49$YR$$M$Y$$$20240821$$CN$GB$GB
242353541$24235354$1$I$20240803$20240814$20240821$20240821$EXP$$CN-BEIGENE-BGN-2024-012738$BEIGENE$$$$$$Y$$$20240821$$HP$CN$CN
242353551$24235355$1$I$20240801$20240814$20240821$20240821$EXP$$US-ABBVIE-5881956$ABBVIE$$22$YR$$F$Y$$$20240821$$CN$US$US
242353561$24235356$1$I$20240801$20240814$20240821$20240821$EXP$$CN-BEIGENE-BGN-2024-012752$BEIGENE$$$$$$Y$$$20240821$$HP$CN$CN
242353571$24235357$1$I$20240723$20240815$20240821$20240821$EXP$$IT-ABBVIE-5886448$ABBVIE$$84$YR$$M$Y$$$20240821$$HP$IT$IT
242353582$24235358$2$F$20240101$20240823$20240821$20240829$PER$$US-AMGEN-USASP2024163946$AMGEN$$62$YR$A$M$Y$$$20240829$$CN$US$US
242353591$24235359$1$I$20240101$20240815$20240821$20240821$EXP$$US-ABBVIE-5883504$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242353601$24235360$1$I$$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132672$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240822$$CN$US$US
242353611$24235361$1$I$20240805$20240816$20240821$20240821$EXP$$US-JNJFOC-20240847508$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240822$$HP$US$US
242353621$24235362$1$I$$20240814$20240821$20240821$EXP$$CN-BEIGENE-BGN-2024-012767$BEIGENE$Hu Y, Lu Q, Yu C. Lupus Erythematosus/Lichen Planus Overlap Syndrome Related to Tirelizumab: A Case Report. The Chinese Journal of Dermatovenereology. 2024$$$$$Y$$$20240821$$MD$CN$CN
242353631$24235363$1$I$20240815$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164143$AMGEN$$74$YR$E$M$Y$$$20240821$$CN$US$US
242353641$24235364$1$I$$20240815$20240821$20240821$PER$$US-BIOGEN-2024BI01277273$BIOGEN$$$$$M$Y$$$20240821$$MD$US$US
242353651$24235365$1$I$20240101$20240816$20240821$20240821$EXP$$CN-ABBVIE-5884508$ABBVIE$$$$$M$Y$63$KG$20240821$$MD$CN$CN
242353661$24235366$1$I$$20240816$20240821$20240821$EXP$$DE-ABBVIE-5885633$ABBVIE$$$$E$F$Y$$$20240821$$CN$DE$DE
242353671$24235367$1$I$20240515$20240820$20240821$20240821$EXP$ES-AEMPS-1557397$ES-JNJFOC-20240854647$JOHNSON AND JOHNSON$$69$YR$E$M$Y$74$KG$20240822$$PH$ES$ES
242353692$24235369$2$F$20240101$20240912$20240821$20240918$EXP$$CH-ABBVIE-5883682$ABBVIE$$77$YR$$F$Y$$$20240918$$MD$CH$CH
242353702$24235370$2$F$20240919$20240919$20240821$20240926$EXP$$US-ABBVIE-5885711$ABBVIE$$52$YR$$F$Y$86.636$KG$20240926$$CN$US$US
242353711$24235371$1$I$20240801$20240814$20240821$20240821$EXP$$CN-BEIGENE-BGN-2024-012742$BEIGENE$$$$$$Y$$$20240821$$HP$CN$CN
242353721$24235372$1$I$20240817$20240819$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132473$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240822$$CN$US$US
242353731$24235373$1$I$20240501$20240815$20240821$20240821$EXP$$NL-ABBVIE-5827809$ABBVIE$$67$YR$$F$Y$75$KG$20240821$$HP$NL$NL
242353741$24235374$1$I$$20240819$20240821$20240821$EXP$$GB-ABBVIE-5885955$ABBVIE$$$$E$F$Y$$$20240821$$CN$GB$GB
242353751$24235375$1$I$20240101$20240819$20240821$20240821$EXP$$US-ABBVIE-5887037$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242353761$24235376$1$I$20240815$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164141$AMGEN$$66$YR$E$F$Y$$$20240821$$CN$US$US
242353771$24235377$1$I$20240601$20240814$20240821$20240821$PER$$US-SA-2024SA247141$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240822$$MD$US$US
242353782$24235378$2$F$$20240904$20240821$20240911$EXP$$US-BIOGEN-2024BI01278666$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
242353791$24235379$1$I$20240101$20240816$20240821$20240821$EXP$$US-ABBVIE-5886345$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242353801$24235380$1$I$20240101$20240816$20240821$20240821$EXP$$US-ABBVIE-5885247$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242353811$24235381$1$I$20230301$20240820$20240821$20240821$EXP$FR-AFSSAPS-NC2024000985$FR-ORGANON-O2408FRA001432$ORGANON$$83$YR$$F$Y$$$20240821$$MD$FR$FR
242353821$24235382$1$I$20240615$20240816$20240821$20240821$EXP$BE-FAMHP-DHH-N2024-122475$BE-ESPERIONTHERAPEUTICS-2024BEL01304$ESPERION THERAPEUTICS$$$$$$Y$$$20240822$$MD$BE$BE
242353831$24235383$1$I$20240315$20240820$20240821$20240821$EXP$FR-AFSSAPS-DJ2024000916$FR-ORGANON-O2408FRA001397$ORGANON$$63$YR$$F$Y$52$KG$20240821$$MD$FR$FR
242353841$24235384$1$I$20240501$20240814$20240821$20240821$EXP$$DE-ESPERIONTHERAPEUTICS-2024DEU01307$ESPERION THERAPEUTICS$$$$$$Y$$$20240822$$CN$DE$DE
242353851$24235385$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244702$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240822$$CN$US$US
242353861$24235386$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA245241$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240822$$MD$US$US
242353871$24235387$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246824$SANOFI AVENTIS$$$$A$F$Y$57.1$KG$20240822$$MD$US$US
242353881$24235388$1$I$$20240816$20240821$20240821$PER$$US-SA-2024SA247361$SANOFI AVENTIS$$$$$F$Y$$$20240822$$LW$US$US
242353891$24235389$1$I$20240725$20240814$20240821$20240821$PER$$US-SA-2024SA246857$SANOFI AVENTIS$$52$YR$A$F$Y$74.84$KG$20240822$$MD$US$US
242353901$24235390$1$I$20240601$20240816$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131265$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240822$$PH$US$US
242353911$24235391$1$I$$20240813$20240821$20240821$EXP$$US-BIOGEN-2024BI01278665$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
242353921$24235392$1$I$20240613$20240819$20240821$20240821$EXP$FR-AFSSAPS-AM2024000665$FR-JNJFOC-20240853263$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20240822$$CN$FR$FR
242353931$24235393$1$I$$20240807$20240821$20240821$30DAY$$BR-JNJFOC-20240843921$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$BR$BR
242353941$24235394$1$I$20130101$20240814$20240821$20240821$PER$$US-JNJFOC-20240842284$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240822$$LW$US$US
242353951$24235395$1$I$20231003$20240813$20240821$20240821$EXP$$US-ABBVIE-5825246$ABBVIE$$69$YR$$M$Y$$$20240821$$CN$US$US
242353972$24235397$2$F$20240101$20240909$20240821$20240914$EXP$$US-ABBVIE-5881083$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
242353981$24235398$1$I$20240810$20240814$20240821$20240821$EXP$$US-ABBVIE-5882733$ABBVIE$$49$YR$$F$Y$$$20240821$$CN$US$US
242353991$24235399$1$I$$20240815$20240821$20240821$EXP$$US-ABBVIE-5883456$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242354001$24235400$1$I$20240605$20240815$20240821$20240821$EXP$$US-ABBVIE-5883298$ABBVIE$$75$YR$$F$Y$$$20240821$$CN$US$US
242354011$24235401$1$I$20230101$20240815$20240821$20240821$EXP$$US-ABBVIE-5507883$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242354023$24235402$3$F$20240816$20240829$20240821$20240903$EXP$$US-AMGEN-USASP2024164582$AMGEN$$78$YR$E$F$Y$$$20240903$$CN$US$US
242354031$24235403$1$I$$20240814$20240821$20240821$EXP$$US-ABBVIE-5884025$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242354041$24235404$1$I$$20240820$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408012896$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240821$$CN$US$US
242354051$24235405$1$I$20240101$20240816$20240821$20240821$EXP$$US-ABBVIE-5885005$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242354061$24235406$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024165046$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242354071$24235407$1$I$$20240820$20240821$20240821$PER$$US-HALEON-2192842$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242354081$24235408$1$I$20240809$20240813$20240821$20240821$EXP$GB-MHRA-MED-202408121426549350-QDTSN$GB-BIOGEN-2024BI01278303$BIOGEN$$57$YR$$M$Y$$$20240821$$HP$GB$GB
242354091$24235409$1$I$20240723$20240820$20240821$20240821$EXP$$JP-TAKEDA-2024TJP012125$TAKEDA$$2$DEC$$M$Y$$$20240821$$MD$JP$JP
242354101$24235410$1$I$20240807$20240813$20240821$20240821$EXP$GB-MHRA-MED-202408081557577390-QKDMY$GB-BIOGEN-2024BI01278225$BIOGEN$$48$YR$$M$Y$$$20240821$$HP$GB$GB
242354111$24235411$1$I$$20240816$20240821$20240821$PER$$NVSC2024US169409$NOVARTIS$$$$$M$Y$$$20240822$$PH$US$US
242354122$24235412$2$F$20240508$20240815$20240821$20240823$EXP$$NVSC2024DE168461$NOVARTIS$$$$E$F$Y$73$KG$20240823$$HP$DE$DE
242354131$24235413$1$I$20240812$20240816$20240821$20240821$EXP$$US-ABBVIE-5885294$ABBVIE$$77$YR$$F$Y$$$20240821$$CN$US$US
242354141$24235414$1$I$$20240816$20240821$20240821$EXP$$US-JNJFOC-20240846669$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240822$$HP$US$US
242354151$24235415$1$I$20240201$20240814$20240821$20240821$EXP$$CA-ABBVIE-5883806$ABBVIE$$$$A$F$Y$$$20240821$$CN$CA$CA
242354161$24235416$1$I$20240808$20240817$20240821$20240821$EXP$$CA-JNJFOC-20240850536$JOHNSON AND JOHNSON$$87$YR$E$M$Y$$$20240822$$HP$CA$CA
242354171$24235417$1$I$$20240808$20240821$20240821$30DAY$$US-JNJFOC-20240845647$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$PH$US$US
242354181$24235418$1$I$20240816$20240816$20240821$20240821$EXP$$US-ABBVIE-5884843$ABBVIE$$65$YR$$F$Y$$$20240821$$CN$US$US
242354191$24235419$1$I$$20240816$20240821$20240821$EXP$$US-ABBVIE-5885516$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242354201$24235420$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA247450$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240822$$MD$US$US
242354211$24235421$1$I$20230301$20240816$20240821$20240821$EXP$$US-ABBVIE-5391481$ABBVIE$$56$YR$$M$Y$$$20240821$$CN$US$US
242354221$24235422$1$I$$20240819$20240821$20240821$EXP$GB-MHRA-MED-202408191743055790-TYRKZ$GB-SANDOZ INC.-SDZ2024GB073958$SANDOZ$$$$$F$Y$64$KG$20240821$$CN$GB$GB
242354231$24235423$1$I$20240101$20240820$20240821$20240821$EXP$$US-ABBVIE-5888230$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242354241$24235424$1$I$$20240821$20240821$20240821$EXP$$DE-SANDOZ INC.-NVSC2020DE305448$SANDOZ$$$$E$$Y$$$20240821$$MD$DE$DE
242354252$24235425$2$F$20240808$20240829$20240821$20240830$PER$$US-AMGEN-USASP2024166798$AMGEN$$$$$F$Y$$$20240830$$CN$US$US
242354261$24235426$1$I$$20240820$20240821$20240821$EXP$$US-ABBVIE-5888789$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242354271$24235427$1$I$$20240819$20240821$20240821$EXP$$CA-ABBVIE-5887595$ABBVIE$$$$A$M$Y$$$20240821$$CN$CA$CA
242354281$24235428$1$I$$20240819$20240821$20240821$EXP$$AU-ABBVIE-5887435$ABBVIE$$$$$F$Y$$$20240821$$HP$AU$AU
242354291$24235429$1$I$20240812$20240814$20240821$20240821$EXP$$US-ABBVIE-5881901$ABBVIE$$24$YR$$M$Y$$$20240821$$CN$US$US
242354301$24235430$1$I$20240601$20240819$20240821$20240821$EXP$$JP-ABBVIE-5844994$ABBVIE$$70$YR$$F$Y$$$20240821$$MD$JP$JP
242354312$24235431$2$F$$20240815$20240821$20240824$EXP$$US-JNJFOC-20240845001$JOHNSON AND JOHNSON$$$$$F$Y$$$20240824$$HP$US$US
242354321$24235432$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA246593$SANOFI AVENTIS$$$$C$F$Y$$$20240822$$MD$US$US
242354341$24235434$1$I$20240803$20240814$20240821$20240821$PER$$US-SA-2024SA246938$SANOFI AVENTIS$$14$YR$T$F$Y$57.01$KG$20240822$$MD$US$US
242354351$24235435$1$I$$20240812$20240821$20240821$30DAY$$US-GSK-US2024AMR100522$GLAXOSMITHKLINE$$$$$M$Y$$$20240821$$CN$US$US
242354361$24235436$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024165254$AMGEN$$$$$$Y$$$20240821$$HP$US$US
242354391$24235439$1$I$$20240819$20240821$20240821$PER$$US-TAKEDA-2024TUS083904$TAKEDA$$$$$$Y$$$20240821$$CN$US$US
242354401$24235440$1$I$$20240816$20240821$20240821$PER$$US-AMGEN-USASP2024164480$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242354411$24235441$1$I$$20240813$20240821$20240821$PER$$US-BIOGEN-2024BI01278354$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
242354422$24235442$2$F$20240624$20240910$20240821$20240916$EXP$PT-INFARMED-T202408-201$PT-JNJFOC-20240853242$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240916$$PH$PT$PT
242354431$24235443$1$I$20130801$20240819$20240821$20240821$PER$$US-JNJFOC-20240850739$JOHNSON AND JOHNSON$$16$YR$$M$Y$$$20240822$$HP$US$US
242354451$24235445$1$I$$20240820$20240821$20240821$PER$$NVSC2024US169542$NOVARTIS$$$$C$M$Y$$$20240822$$MD$US$US
242354461$24235446$1$I$$20240816$20240821$20240821$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001667$BLUEPRINT MEDICINES$$$$$F$Y$$$20240822$$CN$US$US
242354471$24235447$1$I$20240501$20240815$20240821$20240821$EXP$$US-ABBVIE-5883321$ABBVIE$$61$YR$$F$Y$$$20240821$$CN$US$US
242354481$24235448$1$I$$20240813$20240821$20240821$EXP$$US-ABBVIE-5879524$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242354491$24235449$1$I$$20240820$20240821$20240821$EXP$IT-MINISAL02-999437$IT-ABBVIE-5886648$ABBVIE$$37$YR$$M$Y$$$20240821$$MD$IT$IT
242354501$24235450$1$I$20240101$20240814$20240821$20240821$PER$$US-SA-2024SA246599$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240822$$CN$US$US
242354511$24235451$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA247073$SANOFI AVENTIS$$$$C$M$Y$38.9$KG$20240822$$MD$US$US
242354521$24235452$1$I$20240101$20240813$20240821$20240821$PER$$US-SA-2024SA245304$SANOFI AVENTIS$$$$A$F$Y$$$20240822$$MD$US$US
242354531$24235453$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246972$SANOFI AVENTIS$$$$E$M$Y$$$20240822$$MD$US$US
242354541$24235454$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA244737$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240822$$CN$US$US
242354551$24235455$1$I$20240701$20240815$20240821$20240821$PER$$US-SA-2024SA246306$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240822$$MD$US$US
242354561$24235456$1$I$$20240820$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132448$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240822$$CN$US$US
242354571$24235457$1$I$$20240816$20240821$20240821$PER$$US-SA-2024SA248416$SANOFI AVENTIS$$$$E$F$Y$77.56$KG$20240822$$MD$US$US
242354581$24235458$1$I$$20240820$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132536$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240822$$CN$US$US
242354591$24235459$1$I$20240816$20240816$20240821$20240821$PER$$US-HALEON-2192420$Haleon PLC$$$$$F$Y$$$20240821$$CN$US$US
242354601$24235460$1$I$$20240820$20240821$20240821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132484$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240822$$CN$US$US
242354611$24235461$1$I$20240603$20240814$20240821$20240821$EXP$FR-AFSSAPS-BX2024001560$FR-009507513-2408FRA005054$MERCK$$0$YR$$M$Y$$$20240821$$PH$FR$FR
242354621$24235462$1$I$$20240819$20240821$20240821$PER$$US-HALEON-2192687$Haleon PLC$$$$$M$Y$$$20240821$$CN$US$US
242354633$24235463$3$F$20240101$20240913$20240821$20240919$EXP$$US-ABBVIE-5883728$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
242354641$24235464$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA246475$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240822$$MD$US$US
242354651$24235465$1$I$20240101$20240816$20240821$20240821$EXP$$US-ABBVIE-5885070$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242354661$24235466$1$I$20220101$20240815$20240821$20240821$PER$$US-SA-2024SA246911$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240822$$MD$US$US
242354671$24235467$1$I$$20240815$20240821$20240821$PER$$US-ABBVIE-5884761$ABBVIE$$$$A$M$Y$$$20240821$$MD$US$US
242354682$24235468$2$F$20240816$20240924$20240821$20240925$PER$$NVSC2024US169466$NOVARTIS$$53$YR$$F$Y$$$20240925$$CN$US$US
242354692$24235469$2$F$$20240919$20240821$20240919$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047169$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240919$$CN$US$US
242354701$24235470$1$I$20240101$20240820$20240821$20240821$EXP$$US-ABBVIE-5887584$ABBVIE$$$$$M$Y$$$20240821$$HP$US$US
242354712$24235471$2$F$$20240906$20240821$20240909$PER$$US-AMGEN-USASP2024163893$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
242354722$24235472$2$F$20240809$20240821$20240821$20240822$EXP$$US-ABBVIE-5887184$ABBVIE$$23$YR$$M$Y$$$20240822$$CN$US$US
242354731$24235473$1$I$$20240814$20240821$20240821$EXP$$CA-ABBVIE-18K-028-2558053-00$ABBVIE$$$$$F$Y$77$KG$20240821$$CN$CA$CA
242354741$24235474$1$I$20240704$20240807$20240821$20240821$EXP$$CA-HLS-202401974$HLS THERAPEUTICS$$65$YR$E$M$Y$$$20240821$$PH$CA$CA
242354753$24235475$3$F$$20240826$20240821$20240827$PER$$NVSC2024US169592$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242354761$24235476$1$I$$20240815$20240821$20240821$PER$$US-ABBVIE-5883657$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242354781$24235478$1$I$$20240815$20240821$20240821$PER$$US-HALEON-2192245$Haleon PLC$$64$YR$$M$Y$$$20240821$$CN$US$US
242354791$24235479$1$I$$20240820$20240821$20240821$EXP$$US-ABBVIE-5888746$ABBVIE$$$$$M$Y$$$20240821$$CN$US$US
242354801$24235480$1$I$20240601$20240820$20240821$20240821$EXP$$GB-ABBVIE-5887543$ABBVIE$$74$YR$$F$Y$62$KG$20240821$$HP$GB$GB
242354812$24235481$2$F$20230529$20240814$20240821$20240823$EXP$$GB-ARGENX-2024-ARGX-GB006770$ARGENX BVBA$$$$$$Y$$$20240823$$HP$GB$GB
242354821$24235482$1$I$$20240812$20240821$20240821$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01616$NOVITIUM PHARMA$Hiroshi Yamamoto.Successful maintenance treatment of disseminated nocardiosis with cerebral abscess in a severely immunocompromised patient allergic to trimethoprim-sulfamethoxazole using moxifloxacin and high-dose minocycline: A case report.Journal of Infection and Chemotherapy.25-APR-2024;NA:1-6$60$YR$A$M$Y$$$20240822$$HP$JP$JP
242354832$24235483$2$F$20230101$20240823$20240821$20240828$EXP$$US-ABBVIE-5887152$ABBVIE$$$$$M$Y$91$KG$20240828$$CN$US$US
242354841$24235484$1$I$$20240815$20240821$20240821$PER$$US-SA-2024SA247662$SANOFI AVENTIS$$$$A$F$Y$$$20240822$$MD$US$US
242354851$24235485$1$I$20240701$20240813$20240821$20240821$PER$$US-SA-2024SA244601$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240822$$MD$US$US
242354861$24235486$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246962$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240822$$HP$US$US
242354871$24235487$1$I$$20240814$20240821$20240821$PER$$US-SA-2024SA246893$SANOFI AVENTIS$$$$A$M$Y$$$20240822$$MD$US$US
242354881$24235488$1$I$20240101$20240815$20240821$20240821$PER$$US-SA-2024SA246937$SANOFI AVENTIS$$34$YR$A$F$Y$90.71$KG$20240822$$MD$US$US
242354891$24235489$1$I$$20240816$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130877$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240822$$CN$US$US
242354901$24235490$1$I$$20240816$20240821$20240821$PER$$US-HALEON-2192504$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242354911$24235491$1$I$20240501$20240815$20240821$20240821$PER$$US-ELI_LILLY_AND_COMPANY-US202408009927$ELI LILLY AND CO$$$$$M$Y$$$20240821$$CN$US$US
242354922$24235492$2$F$20240816$20240820$20240821$20240826$EXP$$DE-ABBVIE-5885631$ABBVIE$$86$YR$$M$Y$$$20240826$$CN$DE$DE
242354931$24235493$1$I$$20240815$20240821$20240821$EXP$$US-ABBVIE-5884494$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242354941$24235494$1$I$20240101$20240813$20240821$20240821$EXP$$US-ABBVIE-5818290$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242354951$24235495$1$I$20240729$20240816$20240821$20240821$EXP$$US-ABBVIE-5884936$ABBVIE$$61$YR$$M$Y$$$20240821$$CN$US$US
242354961$24235496$1$I$$20240815$20240821$20240821$EXP$$US-ABBVIE-5884971$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242354972$24235497$2$F$20240301$20240815$20240821$20240827$EXP$$US-ABBVIE-5779494$ABBVIE$$66$YR$$F$Y$$$20240827$$CN$US$US
242354981$24235498$1$I$20240808$20240815$20240821$20240821$EXP$$US-ABBVIE-5883846$ABBVIE$$78$YR$$F$Y$$$20240821$$CN$US$US
242354991$24235499$1$I$20240808$20240816$20240821$20240821$EXP$$BE-ABBVIE-5889186$ABBVIE$$79$YR$$M$Y$77$KG$20240821$$HP$BE$BE
242355001$24235500$1$I$20230101$20240814$20240821$20240821$EXP$$CA-ABBVIE-5178257$ABBVIE$$$$$F$Y$$$20240821$$CN$CA$CA
242355011$24235501$1$I$20240601$20240816$20240821$20240821$EXP$$US-ABBVIE-5884970$ABBVIE$$69$YR$$F$Y$$$20240821$$CN$US$US
242355022$24235502$2$F$20240701$20240827$20240821$20240831$EXP$$US-ABBVIE-5885844$ABBVIE$$56$YR$$F$Y$$$20240831$$CN$US$US
242355031$24235503$1$I$$20240816$20240821$20240821$EXP$$US-ABBVIE-5885351$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242355041$24235504$1$I$$20240819$20240821$20240821$EXP$$US-ABBVIE-5887285$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242355051$24235505$1$I$$20240819$20240821$20240821$EXP$$US-ABBVIE-5887309$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242355062$24235506$2$F$$20240822$20240821$20240824$EXP$$US-ABBVIE-5888745$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242355071$24235507$1$I$$20240816$20240821$20240821$EXP$$US-ABBVIE-5887392$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242355081$24235508$1$I$$20240814$20240821$20240821$EXP$$US-SA-2024SA243982$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240822$$CN$US$US
242355091$24235509$1$I$20240818$20240819$20240821$20240821$EXP$$US-ABBVIE-5887437$ABBVIE$$67$YR$$M$Y$$$20240821$$CN$US$US
242355101$24235510$1$I$20240815$20240817$20240821$20240821$PER$$US-ABBVIE-5888503$ABBVIE$$30$YR$$F$Y$$$20240821$$MD$US$US
242355111$24235511$1$I$$20240816$20240821$20240821$PER$$US-HALEON-2192479$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242355121$24235512$1$I$20240614$20240819$20240821$20240821$PER$$US-SA-2024SA247958$SANOFI AVENTIS$$5$MON$I$F$Y$$$20240822$$CN$US$US
242355131$24235513$1$I$$20240813$20240821$20240821$PER$$US-SA-2024SA244370$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240822$$MD$US$US
242355141$24235514$1$I$20240806$20240815$20240821$20240821$PER$$US-SA-2024SA246313$SANOFI AVENTIS$$59$YR$A$F$Y$99.79$KG$20240822$$MD$US$US
242355151$24235515$1$I$$20240819$20240821$20240821$PER$$US-HALEON-2192700$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242355161$24235516$1$I$$20240815$20240821$20240821$EXP$$JP-009507513-2408JPN001888J$MERCK$$57$YR$$F$Y$$$20240821$$MD$JP$JP
242355171$24235517$1$I$$20240821$20240821$20240821$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047147$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240822$$CN$US$US
242355181$24235518$1$I$20240801$20240816$20240821$20240821$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132121$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240822$$CN$US$US
242355191$24235519$1$I$20240101$20240819$20240821$20240821$EXP$$US-ABBVIE-5887192$ABBVIE$$$$$F$Y$$$20240821$$CN$US$US
242355201$24235520$1$I$$20240808$20240821$20240821$EXP$$JP-KVK-TECH, INC-20240800102$KVK-TECH$Maiko Nagaoka. Methylphenidate-Associated Creatine Kinase Level Elevation. American Journal of Therapeutics. 2024;31(4):e498-e502$$$$$Y$$$20240821$$MD$JP$JP
242355211$24235521$1$I$$20240815$20240821$20240821$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000292$EMCURE$$$$$$Y$$$20240821$$PH$US$US
242355221$24235522$1$I$20240601$20240820$20240821$20240821$EXP$$JP-TAKEDA-2024TJP012152$TAKEDA$$$$$F$Y$$$20240821$$MD$JP$JP
242355231$24235523$1$I$20240101$20240816$20240821$20240821$EXP$$CA-PFIZER INC-202400240235$PFIZER$$43$YR$$F$Y$$$20240821$$MD$CA$CA
242355241$24235524$1$I$20240401$20240819$20240821$20240821$EXP$$US-PFIZER INC-202400240538$PFIZER$$57$YR$$M$Y$$$20240821$$HP$US$US
242355261$24235526$1$I$20230101$20240819$20240821$20240821$EXP$$CA-PFIZER INC-PV202400108550$PFIZER$$66$YR$$F$Y$$$20240821$$CN$CA$CA
242355272$24235527$2$F$20240101$20240913$20240821$20240919$EXP$$US-ABBVIE-5887361$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
242355283$24235528$3$F$$20240909$20240821$20240916$PER$$US-AMGEN-USASP2024164460$AMGEN$$$$$$Y$$$20240916$$PH$US$US
242355301$24235530$1$I$20230101$20240816$20240821$20240821$EXP$$FR-PFIZER INC-202400233419$PFIZER$$84$YR$$F$Y$$$20240821$$MD$FR$FR
242355311$24235531$1$I$$20240807$20240821$20240821$EXP$$US-HLS-202400774$HLS THERAPEUTICS$$$$E$M$Y$$$20240821$$PH$US$US
242355321$24235532$1$I$$20240430$20240821$20240821$PER$$US-HALEON-2192946$Haleon PLC$$$$$$Y$$$20240821$$CN$US$US
242355331$24235533$1$I$$20240807$20240821$20240821$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000279$ASSERTIO THERAPEUTICS$$69$YR$$F$Y$$$20240822$$HP$CA$CA
242355341$24235534$1$I$$20240819$20240822$20240822$EXP$$ES-SANDOZ INC.-NVSC2023ES049325$SANDOZ$$21$YR$$M$Y$$$20240821$$MD$ES$ES
242355351$24235535$1$I$20231201$20240815$20240822$20240822$PER$$US-AMGEN-USASP2024162913$AMGEN$$65$YR$E$F$Y$$$20240821$$CN$US$US
242355361$24235536$1$I$$20240819$20240822$20240822$PER$$US-HALEON-2192670$Haleon PLC$$$$$F$Y$$$20240822$$CN$US$US
242355371$24235537$1$I$20240724$20240819$20240822$20240822$EXP$FR-AFSSAPS-MP2024001273$FR-GSK-FR2024103074$GLAXOSMITHKLINE$$$$$$Y$$$20240821$$HP$FR$FR
242355381$24235538$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024100377$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242355391$24235539$1$I$20240809$20240812$20240822$20240822$EXP$$US-GSK-US2024AMR101003$GLAXOSMITHKLINE$$$$$F$Y$$$20240821$$CN$US$US
242355401$24235540$1$I$20130101$20240819$20240822$20240822$PER$$US-JNJFOC-20240850933$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240822$$HP$US$US
242355411$24235541$1$I$20240815$20240815$20240822$20240822$EXP$$US-JNJFOC-20240844922$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240822$$HP$US$US
242355423$24235542$3$F$20240601$20240906$20240822$20240912$EXP$$US-JNJFOC-20240675089$JOHNSON AND JOHNSON$$54$YR$A$F$Y$155.5$KG$20240912$$HP$US$US
242355431$24235543$1$I$$20240819$20240822$20240822$EXP$$JP-JNJFOC-20240852623$JOHNSON AND JOHNSON$Miyu OZAKI et al.; Digestive Diseases Center, Showa University Koto Toyosu Hospital. Hepatocellular dysfunction type drug-induced liver disorder due to ABIRATERONE, a treatment drug for prostate cancer. Proceedings of the 380th Kanto Branch Meeting of the Japanese Society of Gastroenterology;2024.7.27;Chiyoda Tokyo:2024.p.37$75$YR$E$M$Y$$$20240822$$MD$JP$JP
242355441$24235544$1$I$$20240819$20240822$20240822$PER$$US-JNJFOC-20240849558$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$CN$US$US
242355451$24235545$1$I$$20240812$20240822$20240822$PER$$US-JNJFOC-20240828779$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$HP$US$US
242355461$24235546$1$I$$20240819$20240822$20240822$EXP$$IT-JNJFOC-20240850285$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240822$$HP$IT$IT
242355471$24235547$1$I$$20240821$20240822$20240822$EXP$$US-JNJFOC-20240854791$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$US$US
242355481$24235548$1$I$$20240815$20240822$20240822$PER$$US-SA-2024SA246125$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240822$$MD$US$US
242355491$24235549$1$I$$20240815$20240822$20240822$PER$$US-SA-2024SA246407$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240822$$MD$US$US
242355501$24235550$1$I$$20240820$20240822$20240822$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047159$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240822$$CN$US$US
242355511$24235551$1$I$20240101$20240815$20240822$20240822$PER$$US-SA-2024SA247926$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240822$$HP$US$US
242355521$24235552$1$I$$20240821$20240822$20240822$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047172$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240822$$CN$US$US
242355531$24235553$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131154$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240822$$HP$US$US
242355542$24235554$2$F$20240801$20240906$20240822$20240912$EXP$$US-BIOGEN-2024BI01268345$BIOGEN$$38$YR$$F$Y$$$20240912$$HP$US$US
242355551$24235555$1$I$$20240814$20240822$20240822$PER$$US-BIOGEN-2024BI01271601$BIOGEN$$$$$F$Y$$$20240821$$CN$US$US
242355561$24235556$1$I$20220101$20240325$20240822$20240822$EXP$$US-Accord-416515$ACCORD$$67$YR$E$F$Y$$$20240822$$CN$US$US
242355571$24235557$1$I$$20240807$20240822$20240822$EXP$$JP-ADAMAS Pharma-ADM202408-002987$ADAMAS PHARMA$$$$$M$Y$$$20240822$$HP$JP$
242355581$24235558$1$I$$20240807$20240822$20240822$EXP$$US-BAUSCHBL-2024BNL031367$BAUSCH AND LOMB$$$$$M$Y$$$20240822$$CN$US$US
242355591$24235559$1$I$$20240814$20240822$20240822$30DAY$$US-GSK-US2024101396$GLAXOSMITHKLINE$$$$$M$Y$$$20240822$$CN$US$US
242355601$24235560$1$I$20240807$20240819$20240822$20240822$EXP$FR-AFSSAPS-MP2024001284$FR-GSK-FR2024103073$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$FR$FR
242355612$24235561$2$F$$20240913$20240822$20240920$EXP$$CA-GSK-CA2023AMR129337$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CA$CA
242355621$24235562$1$I$20240101$20240813$20240822$20240822$PER$$US-SA-2024SA245301$SANOFI AVENTIS$$71$YR$E$F$Y$135.62$KG$20240822$$MD$US$US
242355632$24235563$2$F$$20240821$20240822$20240828$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047112$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240828$$MD$US$US
242355641$24235564$1$I$$20240818$20240822$20240822$PER$$US-SA-2024SA247172$SANOFI AVENTIS$$$$$F$Y$$$20240822$$CN$US$US
242355651$24235565$1$I$20240101$20240816$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130591$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240822$$CN$US$US
242355661$24235566$1$I$20240803$20240814$20240822$20240822$PER$$US-SA-2024SA246409$SANOFI AVENTIS$$52$YR$A$F$Y$76.2$KG$20240822$$MD$US$US
242355681$24235568$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5887061$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242355692$24235569$2$F$$20240827$20240822$20240906$EXP$$SE-TEVA-VS-3233616$TEVA$Zilg B, Alkass K, Berg S, Druid H. Interpretation of postmortem vitreous concentrations of sodium and chloride. Forensic-Sci-Int 2016; 263 107-113.; Zilg B, Alkass K, Berg S, Druid H. Interpretation of postmortem vitreous concentrations of sodium and chloride. Forensic-Sci-Int 2016; 263 107-113.$22$YR$$F$Y$$$20240906$$HP$SE$SE
242355701$24235570$1$I$$20240816$20240822$20240822$PER$$US-ABBVIE-5887091$ABBVIE$$$$$M$Y$$$20240822$$HP$US$US
242355711$24235571$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131820$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240822$$CN$US$US
242355721$24235572$1$I$20240819$20240820$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132443$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240822$$HP$US$US
242355731$24235573$1$I$20240731$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131776$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240822$$PH$US$US
242355741$24235574$1$I$20240731$20240815$20240822$20240822$PER$$US-JNJFOC-20240839790$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$HP$US$US
242355751$24235575$1$I$$20240814$20240822$20240822$PER$$US-JNJFOC-20240837499$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$US$US
242355761$24235576$1$I$$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024166284$AMGEN$$$$$M$Y$$$20240821$$HP$US$US
242355771$24235577$1$I$$20240821$20240822$20240822$EXP$PL-URPL-1-1863-2020$NVSC2024PL169303$NOVARTIS$$42$MON$$M$Y$$$20240822$$MD$PL$PL
242355781$24235578$1$I$$20240813$20240822$20240822$PER$$US-SA-2024SA244450$SANOFI AVENTIS$$$$A$M$Y$117$KG$20240822$$MD$US$US
242355791$24235579$1$I$$20240813$20240822$20240822$PER$$US-SA-2024SA245308$SANOFI AVENTIS$$$$A$M$Y$79.379$KG$20240822$$HP$US$US
242355801$24235580$1$I$20240101$20240816$20240822$20240822$EXP$$US-ABBVIE-5885767$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242355811$24235581$1$I$$20240819$20240822$20240822$PER$$US-ABBVIE-5888536$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242355821$24235582$1$I$20230601$20240814$20240822$20240822$EXP$$US-ABBVIE-5504910$ABBVIE$$$$$F$Y$68$KG$20240822$$CN$US$US
242355832$24235583$2$F$20240601$20240822$20240822$20240828$EXP$$US-ABBVIE-5887259$ABBVIE$$53$YR$$F$Y$$$20240828$$CN$US$US
242355841$24235584$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5887763$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242355851$24235585$1$I$$20240815$20240822$20240822$EXP$$GB-TAKEDA-2024TUS078065$TAKEDA$$$$$F$Y$$$20240822$$CN$GB$GB
242355872$24235587$2$F$20240812$20240904$20240822$20240908$PER$$US-AMGEN-USASP2024165516$AMGEN$$56$YR$A$F$Y$$$20240908$$CN$US$US
242355881$24235588$1$I$$20240816$20240822$20240822$EXP$$AR-JNJFOC-20240848064$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$MD$AR$AR
242355901$24235590$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130431$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240822$$CN$US$US
242355911$24235591$1$I$20240808$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130516$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$68.95$KG$20240822$$CN$US$US
242355921$24235592$1$I$$20240820$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132539$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240822$$HP$US$US
242355931$24235593$1$I$20220101$20240812$20240822$20240822$EXP$CZ-MLMSERVICE-20240809-PI156291-00271-3$CZ-STRIDES ARCOLAB LIMITED-2024SP010343$STRIDES$Gondova A, Petrousova L. Varicella complications, case reports.. Vaccinology. 2024;18(1):49-53$35$YR$$M$Y$$$20240822$$MD$CZ$CZ
242355941$24235594$1$I$20240801$20240819$20240822$20240822$EXP$$US-JNJFOC-20240849017$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240822$$CN$US$US
242355952$24235595$2$F$20240814$20240815$20240822$20240828$PER$$US-SA-2024SA246225$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240828$$MD$US$US
242355961$24235596$1$I$$20240814$20240822$20240822$PER$$US-SA-2024SA244998$SANOFI AVENTIS$$$$$F$Y$$$20240822$$CN$US$US
242355972$24235597$2$F$$20240821$20240822$20240902$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001660$BLUEPRINT MEDICINES$$$$$F$Y$$$20240829$$CN$US$US
242355992$24235599$2$F$$20240826$20240822$20240903$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010284$STRIDES$Yoshimura Y, Suwabe T, Miki K, Yokoyama T, Kono K, Kinowaki K, et al.. Renal cell carcinoma preceded by a rheumatoid-like paraneoplastic syndrome: A case report. Oncology Letters. 2024;28(4):448$68$YR$$M$Y$54$KG$20240903$$MD$JP$JP
242356001$24235600$1$I$$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164346$AMGEN$$$$$$Y$$$20240821$$HP$US$US
242356013$24235601$3$F$20240814$20240827$20240822$20240829$PER$$US-AMGEN-USASP2024162791$AMGEN$$87$YR$E$F$Y$$$20240829$$CN$US$US
242356021$24235602$1$I$20240611$20240819$20240822$20240822$EXP$$US-TAKEDA-2024TUS060053$TAKEDA$$12$YR$$M$Y$$$20240822$$CN$US$US
242356033$24235603$3$F$$20240815$20240822$20240918$EXP$$US-BEH-2024177296$CSL BEHRING$$$$A$F$Y$$$20240918$$CN$US$US
242356042$24235604$2$F$$20240826$20240822$20240903$PER$$US-AstraZeneca-2024A169735$ASTRAZENECA$$$$$F$Y$$$20240903$$MD$US$
242356051$24235605$1$I$$20240812$20240822$20240822$PER$$US-AMGEN-USASP2024160655$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242356072$24235607$2$F$$20240910$20240822$20240925$30DAY$$CA-JNJFOC-20240846077$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$CA$CA
242356081$24235608$1$I$$20240812$20240822$20240822$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP010293$STRIDES$Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G et al. Stevens-Johnson syndrome associated with drugs and vaccines in children: a case-control study. Plos One. 2013;8(7):e68231-8$18$MON$$F$Y$$$20240822$$HP$IT$IT
242356091$24235609$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130124$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240822$$CN$US$US
242356101$24235610$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130918$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240822$$HP$US$US
242356111$24235611$1$I$20240619$20240816$20240822$20240822$30DAY$$US-SANDOZ INC.-SDZ2024US060140$SANDOZ$$11$YR$$F$Y$$$20240822$$HP$US$US
242356131$24235613$1$I$$20240816$20240822$20240822$PER$$US-ABBVIE-5886748$ABBVIE$$$$$$Y$$$20240822$$HP$US$US
242356142$24235614$2$F$$20240809$20240822$20240822$PER$$US-ROCHE-10000054895$ROCHE$$$$A$F$Y$$$20240822$$CN$US$US
242356151$24235615$1$I$20240819$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024166178$AMGEN$$78$YR$E$M$Y$$$20240821$$CN$US$US
242356162$24235616$2$F$20240816$20240820$20240822$20240822$PER$$NVSC2024US168042$NOVARTIS$$37$YR$$M$Y$$$20240822$$CN$US$US
242356171$24235617$1$I$$20240812$20240822$20240822$PER$$US-HALEON-2192731$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242356191$24235619$1$I$$20240819$20240822$20240822$EXP$$US-BIOGEN-2024BI01279268$BIOGEN$$$$$M$Y$$$20240822$$CN$US$US
242356203$24235620$3$F$20240702$20240911$20240822$20240919$EXP$$CZ-BIOGEN-2024BI01279034$BIOGEN$$31$YR$$F$Y$$$20240919$$MD$CZ$CZ
242356211$24235621$1$I$$20240813$20240822$20240822$PER$$US-SA-2024SA244631$SANOFI AVENTIS$$$$A$M$Y$72.575$KG$20240822$$HP$US$US
242356221$24235622$1$I$$20240813$20240822$20240822$PER$$US-SA-2024SA246297$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240822$$MD$US$US
242356231$24235623$1$I$$20240813$20240822$20240822$PER$$US-SA-2024SA245182$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240822$$CN$US$US
242356241$24235624$1$I$20240202$20240815$20240822$20240822$PER$$US-SA-2024SA245673$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240822$$MD$US$US
242356251$24235625$1$I$20240615$20240815$20240822$20240822$PER$$US-SA-2024SA245302$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240822$$MD$US$US
242356261$24235626$1$I$$20240814$20240822$20240822$PER$$US-ALXN-202408USA000830US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240822$$HP$US$US
242356271$24235627$1$I$$20240702$20240822$20240822$PER$$US-MankindUS-000217$MANKIND PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242356281$24235628$1$I$20240801$20240816$20240822$20240822$PER$$US-ABBVIE-5889091$ABBVIE$$$$$$Y$$$20240822$$HP$US$US
242356291$24235629$1$I$$20240506$20240822$20240822$PER$$US-MankindUS-000182$MANKIND PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242356301$24235630$1$I$$20240813$20240822$20240822$PER$$US-SA-2024SA243339$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240822$$MD$US$US
242356311$24235631$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130814$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240822$$HP$US$US
242356331$24235633$1$I$$20240814$20240822$20240822$EXP$$US-BIOGEN-2024BI01278671$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242356341$24235634$1$I$20240301$20240815$20240822$20240822$EXP$$AR-BIOGEN-2024BI01278757$BIOGEN$$33$YR$$F$Y$$$20240822$$CN$AR$AR
242356351$24235635$1$I$20240701$20240816$20240822$20240822$EXP$SE-SEMPA-2024-006030$SE-CHATTEMPRD-2024OHG028102$CHATTEM$$43$YR$A$F$Y$$$20240822$$MD$SE$SE
242356361$24235636$1$I$$20240724$20240822$20240822$PER$$US-AstraZeneca-2024A169387$ASTRAZENECA$$$$$M$Y$$$20240822$$HP$US$
242356371$24235637$1$I$$20240816$20240822$20240822$30DAY$$US-GSK-US2024102534$GLAXOSMITHKLINE$$$$$M$Y$$$20240822$$HP$US$US
242356381$24235638$1$I$20240719$20240816$20240822$20240822$EXP$$US-ABBVIE-5884967$ABBVIE$$65$YR$$M$Y$$$20240822$$CN$US$US
242356391$24235639$1$I$$20240807$20240822$20240822$EXP$$IN-CIPLA LTD.-2024IN08826$CIPLA$Qureshi SS, Voppuru SR, Smriti V, Baheti A, Shah S, Chinnaswamy G, et al.. Impact of surgical timing (primary, delayed, or second Look) on surgical morbidity and outcomes in malignant germ cell tumor of the ovary in children.. Journal of Pediatric Surgery.. 2024;59:1555 to 1563$$$$$Y$$$20240822$$HP$IN$IN
242356401$24235640$1$I$$20240816$20240822$20240822$PER$$US-SA-2024SA248589$SANOFI AVENTIS$$$$T$M$Y$$$20240822$$MD$US$US
242356421$24235642$1$I$20220101$20240814$20240822$20240822$EXP$$US-ABBVIE-5874296$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242356431$24235643$1$I$$20240813$20240822$20240822$PER$$US-ROCHE-10000056739$ROCHE$$89$YR$E$M$Y$$$20240822$$CN$US$US
242356451$24235645$1$I$20240101$20240815$20240822$20240822$EXP$$CO-ABBVIE-5884210$ABBVIE$$$$$F$Y$63$KG$20240822$$CN$CO$CO
242356461$24235646$1$I$$20240816$20240822$20240822$PER$$US-ROCHE-10000059682$ROCHE$$$$E$M$Y$$$20240822$$CN$US$US
242356472$24235647$2$F$$20240816$20240822$20240822$PER$$US-ABBVIE-5889281$ABBVIE$$$$$F$Y$$$20240822$$HP$US$US
242356481$24235648$1$I$$20240813$20240822$20240822$PER$$US-SA-2024SA245187$SANOFI AVENTIS$$11$YR$C$$Y$$$20240822$$CN$US$US
242356491$24235649$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5886076$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242356501$24235650$1$I$20240101$20240816$20240822$20240822$EXP$$US-ABBVIE-5884911$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242356511$24235651$1$I$$20240319$20240822$20240822$PER$$US-ROCHE-10000062295$ROCHE$$$$$$Y$$$20240822$$HP$US$US
242356521$24235652$1$I$$20240820$20240822$20240822$EXP$$JP-TAKEDA-2024TJP012153AA$TAKEDA$$22$YR$$M$Y$$$20240822$$HP$JP$JP
242356531$24235653$1$I$$20240819$20240822$20240822$PER$$US-ROCHE-RCA5193271$ROCHE$$65$YR$E$M$Y$$$20240822$$CN$US$US
242356541$24235654$1$I$$20240812$20240822$20240822$EXP$$SE-TEVA-VS-3233624$TEVA$Zilg B, Alkass K, Berg S, Druid H. Interpretation of postmortem vitreous concentrations of sodium and chloride. Forensic-Sci-Int 2016; 263 107-113.$21$YR$$F$Y$$$20240822$$HP$SE$SE
242356551$24235655$1$I$$20240819$20240822$20240822$EXP$$US-ORGANON-O2408USA001554$ORGANON$$$$$F$Y$$$20240822$$CN$US$US
242356561$24235656$1$I$20240501$20240819$20240822$20240822$EXP$$US-ABBVIE-5886366$ABBVIE$$70$YR$$F$Y$$$20240822$$CN$US$US
242356571$24235657$1$I$20240816$20240816$20240822$20240822$EXP$$NL-ABBVIE-5887550$ABBVIE$$78$YR$$M$Y$$$20240822$$CN$NL$NL
242356582$24235658$2$F$20240101$20240822$20240822$20240830$EXP$$ES-ABBVIE-5887622$ABBVIE$$89$YR$$F$Y$56$KG$20240830$$MD$ES$ES
242356592$24235659$2$F$20240813$20240919$20240822$20240922$EXP$$US-ABBVIE-5888512$ABBVIE$$91$YR$$F$Y$$$20240922$$CN$US$US
242356602$24235660$2$F$$20240819$20240822$20240825$PER$$US-AMGEN-USASP2024165521$AMGEN$$$$$$Y$$$20240825$$CN$US$US
242356611$24235661$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5886606$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242356622$24235662$2$F$20220704$20240909$20240822$20240913$EXP$$US-ABBVIE-5885242$ABBVIE$$58$YR$$F$Y$108.41$KG$20240913$$CN$US$US
242356631$24235663$1$I$20231201$20240815$20240822$20240822$EXP$$JP-009507513-2408JPN001868J$MERCK$$88$YR$$M$Y$$$20240822$$MD$JP$JP
242356642$24235664$2$F$$20240822$20240822$20240828$EXP$$CA-ABBVIE-5876003$ABBVIE$$$$$M$Y$$$20240828$$CN$CA$CA
242356651$24235665$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5780145$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242356661$24235666$1$I$20240629$20240819$20240822$20240822$EXP$$US-AstraZeneca-2024A188608$ASTRAZENECA$$$$$$Y$$$20240822$$CN$US$
242356672$24235667$2$F$$20240905$20240822$20240917$PER$$US-AstraZeneca-2024A170657$ASTRAZENECA$$$$$F$Y$$$20240917$$HP$US$
242356682$24235668$2$F$$20240820$20240822$20240828$EXP$$GB-TAKEDA-2024TUS083017$TAKEDA$$$$$F$Y$$$20240828$$CN$GB$GB
242356691$24235669$1$I$$20230711$20240822$20240822$EXP$$US-Accord-368892$ACCORD$$69$YR$E$F$Y$90.7$KG$20240822$$CN$US$US
242356701$24235670$1$I$$20240812$20240822$20240822$EXP$$US-TEVA-VS-3234571$TEVA$Wagner CB, Julian K, Bryan B, Steinbach MN, Shewan S, Maxwell L, et al. Carfilzomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (KDCEP) for the Treatment of Relapsed/Refractory Aggressive Plasma Cell Dyscrasias. Blood 2023; 142 (Suppl. 1) 6623 abstr. 652.$$$$$Y$$$20240822$$MD$US$US
242356711$24235671$1$I$20240614$20240820$20240822$20240822$EXP$ES-AEMPS-1556398$ES-HALEON-2192837$Haleon PLC$$46$YR$$M$Y$83.9$KG$20240821$$MD$ES$ES
242356721$24235672$1$I$$20240815$20240822$20240822$PER$$US-JNJFOC-20240840116$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$CN$US$US
242356731$24235673$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5886095$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242356741$24235674$1$I$$20240819$20240822$20240822$PER$$US-HALEON-2192691$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242356751$24235675$1$I$20240813$20240813$20240822$20240822$EXP$$US-HETERO-HET2024US02728$HETERO$$3$YR$$M$Y$$$20240822$$CN$US$US
242356761$24235676$1$I$20240809$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024166058$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242356772$24235677$2$F$20240810$20240911$20240822$20240919$PER$$US-ROCHE-10000059603$ROCHE$$67$YR$E$F$Y$$$20240919$$CN$US$US
242356781$24235678$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024100204$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242356791$24235679$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011701$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240822$$CN$US$US
242356801$24235680$1$I$20240816$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011883$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240822$$CN$US$US
242356812$24235681$2$F$20200101$20240913$20240822$20240917$PER$$US-ROCHE-10000058224$ROCHE$$49$YR$A$F$Y$49.9$KG$20240917$$CN$US$US
242356821$24235682$1$I$$20240809$20240822$20240822$EXP$$US-AUROBINDO-AUR-APL-2024-040297$AUROBINDO$Rattin J, Marigney K, Miranda C, Arrossi AV, Misra A, Wang H. The Brief Case: False-negative Pneumocystis PCR. Journal of Clinical Microbiology. 2024;62(7):e00094-24$76$YR$$M$Y$$$20240822$$MD$US$US
242356831$24235683$1$I$20240101$20240816$20240822$20240822$EXP$$US-UCBSA-2024014174$UCB$$$$$F$Y$63.946$KG$20240822$$CN$US$US
242356841$24235684$1$I$$20240816$20240822$20240822$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001674$BLUEPRINT MEDICINES$$$$$M$Y$$$20240822$$CN$US$US
242356852$24235685$2$F$$20240829$20240822$20240910$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002145$Alvotech$$$$$M$Y$$$20240910$$MD$CA$CA
242356861$24235686$1$I$20221122$20240812$20240822$20240822$EXP$$CA-ALVOTECHPMS-2022-ALVOTECHPMS-000087$Alvotech$$47$YR$$F$Y$$$20240822$$CN$CA$CA
242356871$24235687$1$I$$20240816$20240822$20240822$EXP$$XI-HALEON-2192335$Haleon PLC$$$$$F$Y$$$20240822$$CN$GB$GB
242356881$24235688$1$I$$20240730$20240822$20240822$PER$$AU-TOLMAR, INC.-24AU051433$TOLMAR$$$$$M$Y$$$20240822$$CN$AU$AU
242356891$24235689$1$I$$20240730$20240822$20240822$PER$$AU-TOLMAR, INC.-24AU051440$TOLMAR$$$$$M$Y$$$20240822$$CN$AU$AU
242356901$24235690$1$I$$20240730$20240822$20240822$PER$$BR-TOLMAR, INC.-24BR051501$TOLMAR$$$$$F$Y$$$20240822$$CN$BR$BR
242356911$24235691$1$I$$20240819$20240822$20240822$PER$$US-ROCHE-10000061805$ROCHE$$84$YR$E$F$Y$$$20240822$$CN$US$US
242356921$24235692$1$I$$20240816$20240822$20240822$PER$$US-ROCHE-10000060060$ROCHE$$29$YR$A$F$Y$$$20240822$$HP$US$US
242356931$24235693$1$I$$20240716$20240822$20240822$PER$$US-AMGEN-USASP2024166768$AMGEN$$$$$M$Y$$$20240821$$PH$US$US
242356941$24235694$1$I$$20240816$20240822$20240822$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001668$BLUEPRINT MEDICINES$$$$$M$Y$$$20240822$$CN$US$US
242356951$24235695$1$I$20240809$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165082$AMGEN$$80$YR$E$F$Y$$$20240821$$CN$US$US
242356962$24235696$2$F$$20240912$20240822$20240913$PER$$US-ROCHE-10000060957$ROCHE$$$$$$Y$$$20240913$$PH$US$US
242356971$24235697$1$I$$20230806$20240822$20240822$PER$$US-HALEON-2192760$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242356981$24235698$1$I$$20240807$20240822$20240822$EXP$$US-ChurchDwight-2024-CDW-01297$CHURCH + DWIGHT$$$$$$Y$$$20240821$$CN$US$US
242356991$24235699$1$I$$20240816$20240822$20240822$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001664$BLUEPRINT MEDICINES$$$$$F$Y$$$20240822$$CN$US$US
242357001$24235700$1$I$$20240819$20240822$20240822$PER$$US-ROCHE-10000061048$ROCHE$$52$YR$A$M$Y$$$20240822$$CN$US$US
242357012$24235701$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234570$TEVA$Wagner CB, Julian K, Bryan B, Steinbach MN, Shewan S, Maxwell L, et al. Carfilzomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (KDCEP) for the Treatment of Relapsed/Refractory Aggressive Plasma Cell Dyscrasias. Blood 2023; 142 (Suppl. 1) 6623 abstr. 652.; Wagner CB, Julian K, Bryan B, Steinbach MN, Shewan S, Maxwell L, et al. Carfilzomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (KDCEP) for the Treatment of Relapsed/Refrac...$$$$$Y$$$20240909$$MD$US$US
242357021$24235702$1$I$$20240809$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-040895$AUROBINDO$$37$YR$$F$Y$$$20240822$$HP$CA$CA
242357032$24235703$2$F$20240703$20240902$20240822$20240917$EXP$CZ-CZSUKL-24002064$CZ-Accord-438039$ACCORD$$63$YR$A$M$Y$75$KG$20240917$$HP$CZ$CZ
242357041$24235704$1$I$$20240819$20240822$20240822$EXP$$US-UCBSA-2024041912$UCB$$$$$F$Y$$$20240822$$CN$US$US
242357062$24235706$2$F$20240801$20240814$20240822$20240827$EXP$$CN-SA-2024SA245009$SANOFI AVENTIS$$27$YR$A$F$Y$67$KG$20240827$$HP$CN$CN
242357071$24235707$1$I$20240611$20240814$20240822$20240822$EXP$$CN-SA-2024SA243951$SANOFI AVENTIS$$11$YR$C$M$Y$47$KG$20240822$$HP$CN$CN
242357081$24235708$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000061934$ROCHE$$$$$F$Y$$$20240822$$CN$US$US
242357092$24235709$2$F$$20240906$20240822$20240912$PER$$US-ROCHE-10000062154$ROCHE$$$$E$F$Y$$$20240912$$CN$US$US
242357102$24235710$2$F$$20240911$20240822$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-040274$AUROBINDO$Ra OH, Tan JC, Zhao CW, Burns SL. Transient recurrence of chemotherapy-induced peripheral neuropathy in the immediate postoperative period following gynaecological surgery under general anaesthesia. Anaesthesia Reports. 2024;12(2):e12315$57$YR$$F$Y$$$20240923$$MD$US$US
242357111$24235711$1$I$20220101$20240813$20240822$20240822$PER$$US-SA-2024SA243067$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240822$$CN$US$US
242357121$24235712$1$I$20240501$20240809$20240822$20240822$EXP$$FR-AUROBINDO-AUR-APL-2024-041119$AUROBINDO$$14$YR$$M$Y$$$20240822$$MD$FR$FR
242357131$24235713$1$I$20240101$20240813$20240822$20240822$PER$$US-SA-2024SA245198$SANOFI AVENTIS$$$$A$F$Y$$$20240822$$MD$US$US
242357141$24235714$1$I$$20240814$20240822$20240822$PER$$US-SA-2024SA244171$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240822$$PH$US$US
242357151$24235715$1$I$$20240809$20240822$20240822$EXP$$US-AUROBINDO-AUR-APL-2024-040331$AUROBINDO$Radow M. A case of CMV colitis: Both a cause and consequence of acute renal allograft rejection. American Journal of Gastroenterology. 2019;114:S1658-S1659$46$YR$$M$Y$$$20240822$$HP$US$US
242357161$24235716$1$I$20240811$20240814$20240822$20240822$PER$$US-SA-2024SA243393$SANOFI AVENTIS$$$$$M$Y$$$20240822$$CN$US$US
242357171$24235717$1$I$20240801$20240813$20240822$20240822$PER$$US-SA-2024SA245159$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240822$$MD$US$US
242357181$24235718$1$I$20230601$20240816$20240822$20240822$PER$$US-SA-2024SA247179$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240822$$MD$US$US
242357191$24235719$1$I$20240101$20240814$20240822$20240822$PER$$US-SA-2024SA244160$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240822$$MD$US$US
242357201$24235720$1$I$$20240813$20240822$20240822$PER$$US-SA-2024SA246908$SANOFI AVENTIS$$$$A$M$Y$$$20240822$$MD$US$US
242357211$24235721$1$I$$20240813$20240822$20240822$PER$$US-SA-2024SA245172$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240822$$MD$US$US
242357221$24235722$1$I$$20240815$20240822$20240822$PER$$US-SA-2024SA247039$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240822$$MD$US$US
242357232$24235723$2$F$$20240827$20240822$20240906$PER$$US-Encube-001273$ENCUBE ETHICALS$$89$YR$E$F$Y$$$20240905$$CN$US$
242357241$24235724$1$I$$20240809$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-040888$AUROBINDO$$39$YR$$F$Y$$$20240822$$HP$CA$CA
242357251$24235725$1$I$$20240812$20240822$20240822$PER$$US-AMGEN-USASP2024162505$AMGEN$Faleck D.; Magahis P. T.; Corso T. et al.. Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors. Journal for Immunotherapy of Cancer. 2024;12 (7):1-10$$$$$Y$$$20240821$$MD$US$US
242357261$24235726$1$I$$20240815$20240822$20240822$EXP$$US-UCBSA-2024041507$UCB$$$$$M$Y$$$20240822$$MD$US$US
242357272$24235727$2$F$$20240821$20240822$20240903$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP010464$STRIDES$Nimi G, Kirubakaran KR, John J, Kumar P.. Disseminated Protozoa Zopfii Infection in Liver transplant Recipient.. J-Clin-Exp-Hepatol. 2024;14 (Suppl.).$62$YR$$M$Y$$$20240903$$MD$IN$IN
242357281$24235728$1$I$$20240816$20240822$20240822$PER$$US-SA-2024SA245918$SANOFI AVENTIS$$$$A$F$Y$$$20240822$$MD$US$US
242357291$24235729$1$I$$20240814$20240822$20240822$EXP$$BD-STRIDES ARCOLAB LIMITED-2024SP010473$STRIDES$Hossain MS, Azad MAK, Rahaman MFU, Aftab KA, Rahman IB, Monira S.. A Case of Milk Alkali Syndrome: The Forgotten Diagnosis of Generalized Weakness and Altered Consciousness.. J-Med-Bang. 2024;25 (2):184-186$76$YR$$M$Y$$$20240822$$HP$BD$BD
242357301$24235730$1$I$$20240812$20240822$20240822$PER$$US-ABBVIE-5880845$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242357311$24235731$1$I$20230307$20240819$20240822$20240822$EXP$$CA-TAKEDA-2023TUS011843$TAKEDA$$51$YR$$M$Y$$$20240822$$HP$CA$CA
242357321$24235732$1$I$20230101$20240812$20240822$20240822$EXP$$ES-TAKEDA-2024TUS083817$TAKEDA$$43$YR$$F$Y$62$KG$20240822$$MD$ES$ES
242357331$24235733$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165689$AMGEN$$$$$F$Y$$$20240821$$MD$US$US
242357342$24235734$2$F$20240806$20240910$20240822$20240920$30DAY$$US-GSK-US2024100354$GLAXOSMITHKLINE$$73$YR$$M$Y$$$20240920$$CN$US$US
242357351$24235735$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024100337$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242357362$24235736$2$F$$20240828$20240822$20240904$EXP$$JP-JNJFOC-20240853304$JOHNSON AND JOHNSON$$7$DEC$E$M$Y$$$20240904$$MD$JP$JP
242357371$24235737$1$I$$20240814$20240822$20240822$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010447$STRIDES$Khurshid A, Paranji S, Kapur R, Weber A, Cohen M, Vegunta R, et al.. Outcomes of R-MPV followed by ara-c in primary central nervous system lymphoma: A single-center retrospective analysis.. J-Clin-Oncol. 2024;42 (Suppl.)(16)$$$$$Y$$$20240822$$HP$US$US
242357381$24235738$1$I$$20240814$20240822$20240822$EXP$$SY-STRIDES ARCOLAB LIMITED-2024SP010453$STRIDES$Alaswad M, Hamsho S, Sultan E, Al-Ibrahim M, Merza A, Al-Baroudi Y.. Sulfasalazine^s potential in managing rheumatoid nodules Insights from a case report.. Medicine. 2024;103 (31)$5$DEC$$M$Y$$$20240822$$MD$SY$SY
242357391$24235739$1$I$$20240820$20240822$20240822$EXP$$US-ARGENX-2024-ARGX-US006866$ARGENX BVBA$$$$$$Y$$$20240822$$CN$US$US
242357401$24235740$1$I$$20240813$20240822$20240822$PER$$US-SA-2024SA243006$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240822$$CN$US$US
242357411$24235741$1$I$$20240816$20240822$20240822$PER$$US-SA-2024SA246177$SANOFI AVENTIS$$$$A$M$Y$$$20240822$$HP$US$US
242357421$24235742$1$I$20240810$20240816$20240822$20240822$PER$$US-SA-2024SA246759$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240822$$MD$US$US
242357431$24235743$1$I$20240730$20240813$20240822$20240822$PER$$US-SA-2024SA245170$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240822$$MD$US$US
242357441$24235744$1$I$20240101$20240820$20240822$20240822$EXP$$KW-UCBSA-2024042370$UCB$$30$YR$$F$Y$$$20240822$$HP$KW$KW
242357451$24235745$1$I$$20240816$20240822$20240822$EXP$$MY-STRIDES ARCOLAB LIMITED-2024SP010442$STRIDES$Hazwani I, Raja Abdul Wafy RMR.. P 015: Case report of a pregnant patient with peripartum cardiomyopathy, pulmonary embolism, and cardiac arrest: Lessons learned.. Int-J-Cardiol. 2024;397 (Suppl.):abstr. P015$34$YR$$F$Y$$$20240822$$HP$MY$MY
242357461$24235746$1$I$$20240817$20240822$20240822$PER$$US-HALEON-2192651$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242357471$24235747$1$I$$20240812$20240822$20240822$EXP$$SE-TEVA-VS-3233621$TEVA$Zilg B, Alkass K, Berg S, Druid H. Interpretation of postmortem vitreous concentrations of sodium and chloride. Forensic-Sci-Int 2016; 263 107-113.$63$YR$$M$Y$$$20240822$$HP$SE$SE
242357481$24235748$1$I$$20240812$20240822$20240822$EXP$$SE-TEVA-VS-3233622$TEVA$Zilg B, Alkass K, Berg S, Druid H. Interpretation of postmortem vitreous concentrations of sodium and chloride. Forensic-Sci-Int 2016; 263 107-113.$47$YR$$M$Y$$$20240822$$HP$SE$SE
242357491$24235749$1$I$$20240816$20240822$20240822$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP010443$STRIDES$Temuroglu A, Abakay C, Sevinir B.. LONG-TERM EVALUATION RESULTS OF OUR PATIENTS DIAGNOSED WITH NASOPHARYNGEAL CARCINOMA: A SINGLE CENTER EXPERIENCE.. Hematol-Transfus-Cell-Ther. 2023;45 (Suppl. 3):S30$$$$$Y$$$20240822$$HP$TR$TR
242357501$24235750$1$I$20240701$20240819$20240822$20240822$EXP$FI-FIMEA-202402886$FI-009507513-2408FIN006642$MERCK$$64$YR$$F$Y$$$20240822$$MD$FI$FI
242357511$24235751$1$I$$20240816$20240822$20240822$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP010450$STRIDES$Acar IH, Guvenc B.. RICHTER SYNDROME TRANSFORMATION UNDER VENETOCLAX TREATMENT: A CASE REPORT OF A 51-YEAR-OLD FEMALE WITH CLL.. Hematol-Transfus-Cell-Ther. 2023;45 (Suppl.):S33-S34$51$YR$$F$Y$$$20240822$$HP$TR$TR
242357521$24235752$1$I$$20240821$20240822$20240822$PER$$NVSC2024US169692$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242357541$24235754$1$I$20240815$20240819$20240822$20240822$EXP$GB-MHRA-MED-202408171833329030-DZBNT$GB-STRIDES ARCOLAB LIMITED-2024SP010430$STRIDES$$$$$F$Y$59$KG$20240822$$CN$GB$GB
242357553$24235755$3$F$$20240919$20240822$20240927$30DAY$$CA-JNJFOC-20240826725$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240927$$CN$CA$CA
242357561$24235756$1$I$$20240816$20240822$20240822$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010474$STRIDES$Ogawa K, Honjo M, Sakamoto K, Funamizu N, Tamura K, Shine M, et al.. Epstein-Barr Virus-Associated Latent Malignant Lymphoma With Acute Exacerbation After Living Donor Liver Transplantation: Case Report.. Transplant-Proc. 2023;55 (8):1959-1963$69$YR$$M$Y$$$20240822$$HP$JP$JP
242357582$24235758$2$F$20240501$20240808$20240822$20240823$PER$$US-UCBSA-2024025048$UCB$$23$YR$$F$Y$$$20240823$$HP$US$US
242357591$24235759$1$I$$20240818$20240822$20240822$PER$$US-HALEON-2192741$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242357601$24235760$1$I$$20240819$20240822$20240822$PER$$US-HALEON-2192649$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242357612$24235761$2$F$20240717$20240829$20240822$20240905$EXP$FR-AFSSAPS-GR2024001019$FR-GSK-FR2024101646$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$PH$FR$FR
242357623$24235762$3$F$$20240910$20240822$20240911$PER$$US-AMGEN-USASP2024165627$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
242357632$24235763$2$F$20240816$20240820$20240822$20240823$PER$$US-ABBVIE-5887312$ABBVIE$$22$YR$$F$Y$$$20240823$$MD$US$US
242357652$24235765$2$F$20240101$20240823$20240822$20240830$PER$$US-ABBVIE-5887301$ABBVIE$$$$$F$Y$$$20240830$$HP$US$US
242357672$24235767$2$F$20220822$20240821$20240822$20240828$EXP$$BR-CELLTRION INC.-2022BR012865$CELLTRION$$$$$$Y$$$20240828$$CN$BR$BR
242357682$24235768$2$F$$20240902$20240822$20240902$EXP$$JP-SAKK-2024SA245378AA$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240903$$MD$JP$JP
242357691$24235769$1$I$$20240815$20240822$20240822$PER$$US-ALXN-202408USA000981US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242357702$24235770$2$F$$20240912$20240822$20240924$30DAY$$IN-JNJFOC-20240845609$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$HP$IN$IN
242357712$24235771$2$F$$20240905$20240822$20240906$EXP$$MX-JNJFOC-20240776475$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240906$$MD$MX$MX
242357722$24235772$2$F$$20240822$20240822$20240827$EXP$ES-EMA-DD-20240809-7482655-095404$ES-SA-2024SA244611$SANOFI AVENTIS$Hernani R, Sancho A, Amat P, Hernandez-Boluda J, Perez A, Pinana J. et al.. CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review.. Curr Res Transl Med.. 2021;69(4):1-5$56$YR$A$M$Y$$$20240827$$HP$ES$ES
242357731$24235773$1$I$$20240716$20240822$20240822$PER$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000488$Day One Biopharmaceuticals$$$$A$F$Y$$$20240822$$MD$US$US
242357741$24235774$1$I$$20240716$20240822$20240822$PER$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000489$Day One Biopharmaceuticals$$$$C$M$Y$$$20240822$$MD$US$US
242357751$24235775$1$I$20240516$20240522$20240822$20240822$PER$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000240$Day One Biopharmaceuticals$$16$YR$$F$Y$$$20240822$$CN$US$US
242357761$24235776$1$I$$20240716$20240822$20240822$EXP$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000478$Day One Biopharmaceuticals$$$$$F$Y$$$20240822$$MD$US$US
242357771$24235777$1$I$20240710$20240729$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004080$ACADIA PHARMACEUTICALS$$22$YR$$F$Y$$$20240822$$CN$US$US
242357781$24235778$1$I$$20240815$20240822$20240822$PER$$US-HALEON-2192263$Haleon PLC$$$$$M$Y$$$20240822$$CN$US$US
242357791$24235779$1$I$$20240716$20240822$20240822$PER$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000487$Day One Biopharmaceuticals$$$$$F$Y$$$20240822$$HP$US$US
242357801$24235780$1$I$20240101$20240820$20240822$20240822$PER$$US-ROCHE-10000061990$ROCHE$$16$YR$T$F$Y$$$20240822$$HP$US$US
242357811$24235781$1$I$$20240819$20240822$20240822$PER$$US-HALEON-2192754$Haleon PLC$$$$$M$Y$$$20240822$$CN$US$US
242357821$24235782$1$I$$20240729$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004085$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242357831$24235783$1$I$$20240812$20240822$20240822$PER$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000273$Day One Biopharmaceuticals$$8$YR$$F$Y$$$20240822$$CN$US$US
242357841$24235784$1$I$$20240524$20240822$20240822$PER$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000251$Day One Biopharmaceuticals$$$$$F$Y$$$20240822$$CN$US$US
242357851$24235785$1$I$$20240819$20240822$20240822$EXP$$JP-SANDOZ INC.-SDZ2024JP066825$SANDOZ$$72$YR$$F$Y$$$20240822$$HP$JP$JP
242357861$24235786$1$I$20240630$20240708$20240822$20240822$EXP$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000439$Day One Biopharmaceuticals$$4$YR$$M$Y$20.1$KG$20240822$$HP$US$US
242357872$24235787$2$F$20240819$20240831$20240822$20240903$PER$$US-GILEAD-2024-0684674$GILEAD$$53$YR$A$M$Y$$$20240903$$PH$US$US
242357881$24235788$1$I$$20240802$20240822$20240822$PER$$US-TEVA-VS-3229814$TEVA$$83$YR$$F$Y$$$20240822$$CN$US$US
242357891$24235789$1$I$20200918$20240816$20240822$20240822$EXP$IT-MINISAL02-893709$IT-009507513-2211ITA006140$MERCK$$73$YR$$M$Y$75$KG$20240822$$MD$IT$IT
242357902$24235790$2$F$20240816$20240827$20240822$20240828$PER$$US-AMGEN-USASP2024166875$AMGEN$$56$YR$A$F$Y$$$20240828$$CN$US$US
242357911$24235791$1$I$$20240815$20240822$20240822$PER$$US-ROCHE-10000059299$ROCHE$$$$E$F$Y$$$20240822$$CN$US$US
242357921$24235792$1$I$$20240729$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004086$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242357932$24235793$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234494$TEVA$Tang CJ, Balu R, Thomas CA, King CS, Shlobin OA, Aryal S, et al. Spinal Cord Infarction Associated With VA-ECMO Support. Am-J-Respir-Crit-Care-Med 2024; 209.; Tang CJ, Balu R, Thomas CA, King CS, Shlobin OA, Aryal S, et al. Spinal Cord Infarction Associated With VA-ECMO Support. Am-J-Respir-Crit-Care-Med 2024; 209.$46$YR$$F$Y$$$20240909$$HP$US$US
242357941$24235794$1$I$20221216$20221220$20240822$20240822$EXP$$CO-BIOVITRUM-2022CO15680$BIOVITRUM$$71$DY$$F$Y$$$20240822$$CN$CO$CO
242357951$24235795$1$I$20220509$20220524$20240822$20240822$EXP$$ZA-BIOVITRUM-2022ZA07045$BIOVITRUM$$193$DY$$M$Y$6.6$KG$20240822$$CN$ZA$ZA
242357961$24235796$1$I$20240101$20240805$20240822$20240822$PER$$US-TEVA-VS-3230354$TEVA$$62$YR$$F$Y$45.36$KG$20240822$$CN$US$US
242357971$24235797$1$I$20210101$20240815$20240822$20240822$PER$$US-BIOGEN-2021BI00967727$BIOGEN$$51$YR$$F$Y$$$20240822$$MD$US$US
242357981$24235798$1$I$$20240818$20240822$20240822$PER$$US-HALEON-2192647$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242357991$24235799$1$I$$20240812$20240822$20240822$EXP$$US-PADAGIS-2024PAD01337$PADAGIS$$$$$$Y$$$20240822$$CN$US$US
242358001$24235800$1$I$$20240816$20240822$20240822$EXP$$US-AstraZeneca-2024A188057$ASTRAZENECA$$$$$$Y$$$20240822$$CN$US$
242358011$24235801$1$I$$20240813$20240822$20240822$EXP$$US-PADAGIS-2024PAD01335$PADAGIS$$$$$$Y$$$20240822$$CN$US$US
242358021$24235802$1$I$$20240812$20240822$20240822$EXP$$US-PADAGIS-2024PAD01331$PADAGIS$Babici D., Mohamed A.A., Mattner O., Canosa J., Gan W., Patel P.. Candida dubliniensis meningitis in an immunocompetent patient: A case report and review of the literature. eNeurologicalSci. 2024;36:100519$$$$$Y$$$20240822$$HP$US$US
242358033$24235803$3$F$$20240910$20240822$20240925$EXP$$CA-ROCHE-10000059006$ROCHE$$44$YR$A$F$Y$97$KG$20240925$$MD$CA$CA
242358041$24235804$1$I$20240620$20240729$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004088$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240822$$CN$US$US
242358052$24235805$2$F$$20240821$20240822$20240826$PER$$US-ROCHE-10000062352$ROCHE$$84$YR$E$F$Y$$$20240826$$CN$US$US
242358061$24235806$1$I$$20240816$20240822$20240822$EXP$$US-JNJFOC-20240847712$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240822$$HP$US$US
242358071$24235807$1$I$$20240820$20240822$20240822$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047167$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240822$$CN$US$US
242358081$24235808$1$I$$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132556$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240822$$HP$US$US
242358091$24235809$1$I$$20240814$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130134$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240822$$CN$US$US
242358101$24235810$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131962$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240822$$PH$US$US
242358111$24235811$1$I$20240801$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132266$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240822$$CN$US$US
242358121$24235812$1$I$$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130171$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240822$$HP$US$US
242358132$24235813$2$F$20240101$20240813$20240822$20240826$PER$$US-AMGEN-USASP2024161530$AMGEN$$72$YR$E$F$Y$$$20240826$$CN$US$US
242358141$24235814$1$I$$20240816$20240822$20240822$PER$$US-ROCHE-3459848$ROCHE$Agarwal A, Falcone LM and James AJ Methotrexate-induced hypersensitivity pneumonitis in a patient with bullous pemphigoid. Doi;10.5070/D329461916. Dermatology Online Journal 2023;29 (4):17-.$69$YR$E$F$Y$$$20240822$$HP$US$US
242358152$24235815$2$F$$20240812$20240822$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-041143$AUROBINDO$$64$YR$$F$Y$$$20240823$$HP$CA$CA
242358171$24235817$1$I$20240501$20240820$20240822$20240822$PER$$US-ROCHE-10000062266$ROCHE$$53$YR$A$M$Y$$$20240822$$HP$US$US
242358181$24235818$1$I$$20240821$20240822$20240822$PER$$NVSC2024US169729$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242358191$24235819$1$I$$20240729$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004090$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242358201$24235820$1$I$$20240820$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132415$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240822$$CN$US$US
242358221$24235822$1$I$$20240821$20240822$20240822$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-132564$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240822$$MD$FR$FR
242358231$24235823$1$I$20240813$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132523$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240822$$CN$US$US
242358251$24235825$1$I$20240729$20240809$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004515$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240822$$CN$US$US
242358262$24235826$2$F$20240820$20240821$20240822$20240823$PER$$US-AMGEN-USASP2024166967$AMGEN$$46$YR$A$F$Y$$$20240823$$PH$US$US
242358271$24235827$1$I$$20240812$20240822$20240822$EXP$$US-GSK-US2024100382$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242358281$24235828$1$I$$20240815$20240822$20240822$EXP$$TW-AMGEN-TWNSP2024165469$AMGEN$$$$E$F$Y$$$20240821$$HP$TW$TW
242358291$24235829$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000061998$ROCHE$$$$C$M$Y$$$20240822$$CN$US$US
242358301$24235830$1$I$20240101$20240819$20240822$20240822$EXP$$GB-ORGANON-O2408GBR001500$ORGANON$$$$$F$Y$$$20240822$$PH$GB$GB
242358311$24235831$1$I$20240101$20240813$20240822$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-022989$UNITED THERAPEUTICS$$$$$F$Y$66.667$KG$20240822$$$US$US
242358321$24235832$1$I$$20240813$20240822$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-025408$UNITED THERAPEUTICS$$$$$F$Y$64.399$KG$20240822$$$US$US
242358331$24235833$1$I$20240715$20240820$20240822$20240822$EXP$$JP-TAKEDA-2023TJP017517$TAKEDA$$16$YR$$M$Y$$$20240822$$CN$JP$JP
242358341$24235834$1$I$$20240816$20240822$20240822$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001666$BLUEPRINT MEDICINES$$$$$M$Y$$$20240822$$CN$US$US
242358352$24235835$2$F$$20240830$20240822$20240909$EXP$$CA-TEVA-VS-3234553$TEVA$Reyes NGD, Bendahan N, Swinkin E, Lang AE, Bassett AS. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurol-Sci 2024; 0 (0):.; Reyes NGD, Bendahan N, Swinkin E, Lang AE, Bassett AS. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurol-Sci 2024; 0 (0):.; Reyes NGD, Bendahan N, Swinkin E, Lang AE, Bassett AS. Levodopa-responsive dystonia, parkinsonism, and tr...$53$YR$$F$Y$$$20240909$$HP$CA$CA
242358361$24235836$1$I$20240117$20240119$20240822$20240822$EXP$$US-OCTA-GAM01724$OCTAPHARMA$$75$YR$E$M$Y$103$KG$20240408$$PH$US$US
242358371$24235837$1$I$20240815$20240816$20240822$20240822$PER$$US-HALEON-2192431$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242358381$24235838$1$I$20231201$20240207$20240822$20240822$EXP$$US-OCTA-FIB00124$OCTAPHARMA$$28$YR$A$F$Y$$$20240219$$MD$US$US
242358391$24235839$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165590$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242358401$24235840$1$I$$20240819$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013092$JAZZ$$$$$M$Y$$$20240821$$HP$US$US
242358411$24235841$1$I$$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130154$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$98.88$KG$20240822$$CN$US$US
242358422$24235842$2$F$20240701$20240905$20240822$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132010$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$104.78$KG$20240910$$CN$US$US
242358432$24235843$2$F$20240304$20240910$20240822$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-132230$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240912$$MD$JP$JP
242358441$24235844$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062005$ROCHE$$27$YR$A$F$Y$$$20240822$$HP$US$US
242358451$24235845$1$I$$20240819$20240822$20240822$PER$$US-ROCHE-10000060887$ROCHE$$$$$$Y$$$20240822$$HP$US$US
242358462$24235846$2$F$$20240925$20240822$20240928$PER$$US-HALEON-2192445$Haleon PLC$$$$$$Y$$$20240928$$CN$US$US
242358471$24235847$1$I$$20240814$20240822$20240822$EXP$$CN-GSK-CN2024APC101512$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$CN$CN
242358481$24235848$1$I$20240101$20240816$20240822$20240822$EXP$$US-JNJFOC-20240847416$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240822$$CN$US$US
242358491$24235849$1$I$$20240815$20240822$20240822$PER$$US-ROCHE-10000059185$ROCHE$$$$$$Y$$$20240822$$CN$US$US
242358501$24235850$1$I$20240722$20240729$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004092$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240822$$CN$US$US
242358512$24235851$2$F$20220101$20240902$20240822$20240906$EXP$$US-JNJFOC-20240833824$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$CN$US$US
242358521$24235852$1$I$20190101$20240814$20240822$20240822$EXP$$US-JNJFOC-20240837363$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$CN$US$US
242358532$24235853$2$F$$20240826$20240822$20240910$PER$$US-JNJFOC-20240854162$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
242358541$24235854$1$I$$20240729$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004091$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242358551$24235855$1$I$$20240811$20240822$20240822$PER$$US-AMGEN-USASP2024162817$AMGEN$Shah P.M.; Peersen A.; Jatoi A. et al.. Prognostication  of B-catenin (CTNNB1) in patients with HCC treated with first line immunotherapy. Journal of Clinical Oncology. 2024;42 (16):e15146$$$$$Y$$$20240821$$HP$US$US
242358561$24235856$1$I$20240701$20240819$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013108$JAZZ$$6$YR$$F$Y$$$20240821$$CN$US$US
242358571$24235857$1$I$$20240819$20240822$20240822$EXP$$US-ROCHE-10000061521$ROCHE$$$$E$M$Y$$$20240822$$CN$US$US
242358581$24235858$1$I$$20240816$20240822$20240822$EXP$$US-AstraZeneca-2024A187923$ASTRAZENECA$$$$C$M$Y$17$KG$20240822$$CN$US$
242358591$24235859$1$I$$20240805$20240822$20240822$PER$$US-AstraZeneca-2024A177759$ASTRAZENECA$$$$$$Y$$$20240822$$HP$US$
242358601$24235860$1$I$20240809$20240819$20240822$20240822$EXP$$US-AstraZeneca-2024A188915$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242358611$24235861$1$I$20240813$20240814$20240822$20240822$PER$$US-ABBVIE-5882893$ABBVIE$$23$YR$$F$Y$$$20240822$$HP$US$US
242358621$24235862$1$I$$20240820$20240822$20240822$EXP$$AT-009507513-2408AUT006890$MERCK$$$$$F$Y$$$20240822$$MD$AT$AT
242358631$24235863$1$I$$20240819$20240822$20240822$PER$$US-ROCHE-10000061632$ROCHE$$$$E$M$Y$$$20240822$$CN$US$US
242358641$24235864$1$I$$20240729$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004093$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242358651$24235865$1$I$20240820$20240820$20240822$20240822$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047162$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240822$$CN$US$US
242358661$24235866$1$I$20240709$20240819$20240822$20240822$EXP$$CA-JNJFOC-20240850313$JOHNSON AND JOHNSON$$37$YR$A$F$Y$107$KG$20240822$$HP$CA$CA
242358671$24235867$1$I$20240801$20240813$20240822$20240822$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03000$AMNEAL$$79$YR$$F$Y$$$20240822$$CN$US$US
242358682$24235868$2$F$$20240820$20240822$20240827$PER$$US-AMGEN-USASP2024166782$AMGEN$$$$$F$Y$$$20240826$$HP$US$US
242358691$24235869$1$I$20240812$20240815$20240822$20240822$EXP$$CN-ROCHE-10000058073$ROCHE$$$$A$M$Y$$$20240822$$MD$CN$CN
242358701$24235870$1$I$$20240819$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013099$JAZZ$$$$$F$Y$$$20240821$$CN$US$US
242358711$24235871$1$I$$20240813$20240822$20240822$EXP$$US-HETERO-HET2024US02745$HETERO$$$$$M$Y$$$20240822$$HP$US$US
242358721$24235872$1$I$$20240814$20240822$20240822$EXP$$AR-JNJFOC-20240839288$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$MD$AR$AR
242358732$24235873$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234582$TEVA$Homiack DR, Yan LE, Petry LG, Lloyd JR, Najjar F, Cook EH. Successful Electroconvulsive Therapy in a Patient with Catatonia and Maternal Duplication 15q11-13 Syndrome. J-ECT 2024; 0 (0): 1-2.; Homiack DR, Yan LE, Petry LG, Lloyd JR, Najjar F, Cook EH. Successful Electroconvulsive Therapy in a Patient with Catatonia and Maternal Duplication 15q11-13 Syndrome. J-ECT 2024; 0 (0): 1-2.$24$YR$$M$Y$$$20240909$$MD$US$US
242358741$24235874$1$I$$20240813$20240822$20240822$PER$$US-AstraZeneca-2024A184369$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242358761$24235876$1$I$20240801$20240812$20240822$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-025173$UNITED THERAPEUTICS$$55$YR$$F$Y$63.946$KG$20240822$$$US$US
242358771$24235877$1$I$$20240729$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004094$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242358782$24235878$2$F$$20240923$20240822$20240930$EXP$$US-SANDOZ INC.-SDZ2024US074153$SANDOZ$$$$$F$Y$$$20240929$$HP$US$US
242358791$24235879$1$I$$20240819$20240822$20240822$EXP$$JP-SANDOZ INC.-SDZ2024JP073402$SANDOZ$$40$YR$$F$Y$$$20240822$$MD$JP$JP
242358801$24235880$1$I$$20240819$20240822$20240822$EXP$$CA-JNJFOC-20240850638$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240822$$MD$CA$CA
242358811$24235881$1$I$$20240812$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-041333$AUROBINDO$$78$YR$$F$Y$70$KG$20240822$$MD$CA$CA
242358821$24235882$1$I$$20240821$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-087088-2024$RECKITT BENCKISER$$23$YR$$F$Y$$$20240822$$CN$US$US
242358831$24235883$1$I$$20240814$20240822$20240822$PER$$US-ADVANZ PHARMA-202408006853$ADVANZ PHARMA$$$$$$Y$$$20240822$$CN$US$US
242358843$24235884$3$F$$20240821$20240822$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004100$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
242358851$24235885$1$I$$20240816$20240822$20240822$PER$$US-ABBVIE-5887039$ABBVIE$$$$$$Y$$$20240822$$MD$US$US
242358861$24235886$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062116$ROCHE$$$$$F$Y$$$20240822$$PH$US$US
242358871$24235887$1$I$$20240819$20240822$20240822$PER$$US-ROCHE-3542717$ROCHE$$91$YR$E$F$Y$$$20240822$$CN$US$US
242358881$24235888$1$I$20220101$20240814$20240822$20240822$EXP$$IT-ARGENX-2024-ARGX-IT006769$ARGENX BVBA$Frangiamore R, Rinaldi E, Vanoli F, Andreetta F, Mantegazza R, Antozzi C. Efgartigimod improves triple-negative myasthenia gravis. Neurol Sci. 2024;45:1307-09$$$$$Y$$$20240822$$HP$IT$IT
242358892$24235889$2$F$20240401$20240816$20240822$20240826$PER$$US-AMGEN-USASP2024163882$AMGEN$$$$$M$Y$$$20240826$$MD$US$US
242358901$24235890$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062290$ROCHE$$65$YR$E$F$Y$$$20240822$$CN$US$US
242358911$24235891$1$I$20230101$20240814$20240822$20240822$EXP$$CN-BEIGENE-BGN-2024-012733$BEIGENE$Yu H, Ruan Q, Jiang L. Chronic nonspecific cheilitis associated with tislelizumab treatment in a patient with a history of tongue squamous cell carcinoma: a case report. BMC Oral Health. 2024;24:906$$$$$Y$$$20240822$$MD$CN$CN
242358922$24235892$2$F$20240101$20240903$20240822$20240918$EXP$$US-Axsome Therapeutics, Inc.-AXS202408-001219$AXSOME THERAPEUTICS$$77$YR$E$F$Y$$$20240918$$$US$
242358931$24235893$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A186040$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242358941$24235894$1$I$$20240812$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-041257$AUROBINDO$$$$$F$Y$$$20240822$$MD$CA$CA
242358951$24235895$1$I$$20240821$20240822$20240822$PER$$US-HALEON-2193047$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242358961$24235896$1$I$20240819$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024166442$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242358971$24235897$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165362$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242358981$24235898$1$I$$20240816$20240822$20240822$EXP$$FR-BEH-2024177328$CSL BEHRING$$21$YR$A$M$Y$$$20240822$$PH$FR$FR
242358992$24235899$2$F$$20240829$20240822$20240906$EXP$$US-TEVA-VS-3234151$TEVA$Cheng JJ, Shen J, Suresh Y, Akopyan NA, Kapoor NS. Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy: Case report. Int-J-Surg-Case-Rep 2024; 122.; Cheng JJ, Shen J, Suresh Y, Akopyan NA, Kapoor NS. Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy: Case report. Int-J-Surg-Case-Rep 2024; 122.$72$YR$$M$Y$$$20240906$$HP$US$US
242359001$24235900$1$I$$20240819$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010369$JAZZ$$$$$F$Y$71.2$KG$20240821$$HP$US$US
242359011$24235901$1$I$20240816$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165809$AMGEN$$$$$$Y$$$20240821$$CN$US$US
242359021$24235902$1$I$$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024166201$AMGEN$$66$YR$E$F$Y$$$20240821$$HP$US$US
242359032$24235903$2$F$$20240905$20240822$20240913$EXP$$US-PAREXEL-2021-KAM-US003535$TAKEDA$$$$$F$Y$45$KG$20240913$$CN$US$US
242359051$24235905$1$I$20240709$20240812$20240822$20240822$EXP$$FR-ROCHE-10000060959$ROCHE$$64$YR$A$F$Y$$$20240822$$PH$FR$FR
242359062$24235906$2$F$20240811$20240916$20240822$20240921$PER$$US-ROCHE-10000055970$ROCHE$$58$YR$A$F$Y$48.53$KG$20240921$$CN$US$US
242359101$24235910$1$I$$20240814$20240822$20240822$PER$$US-JNJFOC-20240841594$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$CN$US$US
242359112$24235911$2$F$$20240822$20240822$20240827$PER$$US-JAZZ PHARMACEUTICALS-2024-US-012993$JAZZ$$$$$M$Y$6$KG$20240827$$CN$US$US
242359123$24235912$3$F$20240101$20240823$20240822$20240830$EXP$$US-BIOGEN-2024BI01275767$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
242359131$24235913$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165341$AMGEN$$$$$F$Y$$$20240821$$CN$US$US
242359142$24235914$2$F$20210623$20240819$20240822$20240829$EXP$$SE-AUROBINDO-AUR-APL-2024-041310$AUROBINDO$$16$YR$$F$Y$$$20240829$$CN$SE$SE
242359151$24235915$1$I$$20240820$20240822$20240822$EXP$$PK-ROCHE-10000061443$ROCHE$$76$YR$E$F$Y$$$20240822$$CN$PK$PK
242359162$24235916$2$F$$20240910$20240822$20240912$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046317$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240912$$CN$US$US
242359171$24235917$1$I$$20240817$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012994$JAZZ$$$$$M$Y$$$20240821$$CN$US$US
242359181$24235918$1$I$$20240814$20240822$20240822$EXP$$CN-ROCHE-10000061149$ROCHE$Yan M, Liang W. Treatment of phospholipase A2 receptor associated membranous nephropathy with obinutuzumab: a report of ten cases with a literature review. Journal of Clinical Nephrology. 2024-Jul;24 (7):572-8. doi:10.3969/j.issn.1671-2390.2024.07.007.$62$YR$A$M$Y$$$20240822$$HP$CN$CN
242359191$24235919$1$I$$20240808$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-040869$AUROBINDO$$65$YR$$F$Y$$$20240822$$HP$CA$CA
242359201$24235920$1$I$20240812$20240820$20240822$20240822$EXP$$PK-ROCHE-10000061505$ROCHE$$59$YR$A$M$Y$$$20240822$$CN$PK$PK
242359211$24235921$1$I$20210501$20240817$20240822$20240822$EXP$$CA-JNJFOC-20211150029$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240822$$HP$CA$CA
242359223$24235922$3$F$20220501$20240822$20240822$20240927$EXP$$US-ALVOGEN-2024095331$ALVOGEN$Ambalavanan J, Hubbard C, Khan LZ. Acceleration of Preexisting Aortic Stenosis After Teriparatide Initiation. AACE Clinical Case Reports. 2024 Jul-Aug;10(4): 152-155. doi: https://dx.doi.Org/1 0,1 01 6/j.aace.2024.04.006$84$YR$$F$Y$$$20240927$$MD$US$US
242359231$24235923$1$I$20231222$20240815$20240822$20240822$EXP$$US-BIOGEN-2024BI01278397$BIOGEN$$60$YR$$F$Y$$$20240822$$CN$US$US
242359241$24235924$1$I$$20240814$20240822$20240822$EXP$$US-Bion-013690$BIONPHARMA$$28$YR$A$M$Y$$$20240822$$HP$US$US
242359251$24235925$1$I$$20240814$20240822$20240822$EXP$$US-Bion-013688$BIONPHARMA$$63$YR$A$M$Y$$$20240822$$HP$US$US
242359261$24235926$1$I$$20240812$20240822$20240822$EXP$$CA-APOTEX-2024AP009319$APOTEX$$50$YR$$F$Y$$$20240822$$CN$CA$CA
242359271$24235927$1$I$$20230121$20240822$20240822$EXP$$CA-CELLTRION INC.-2021CA019602$CELLTRION$$$$$$Y$$$20240822$$CN$CA$CA
242359281$24235928$1$I$20240617$20240807$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024098504$VIIV$$42$YR$$M$Y$$$20240822$$HP$US$US
242359291$24235929$1$I$20240731$20240814$20240822$20240822$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045913$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240822$$HP$US$US
242359301$24235930$1$I$$20240812$20240822$20240822$EXP$$EG-NOVOPROD-1269648$NOVO NORDISK$$636$MON$$M$Y$105$KG$20240822$$CN$EG$EG
242359311$24235931$1$I$20240501$20240812$20240822$20240822$EXP$SE-SEMPA-2024-005998$SE-NOVOPROD-1269824$NOVO NORDISK$$67$YR$$F$Y$$$20240822$$MD$SE$SE
242359321$24235932$1$I$$20240812$20240822$20240822$EXP$$US-NOVOPROD-1270070$NOVO NORDISK$$55$YR$$F$Y$$$20240822$$CN$US$US
242359331$24235933$1$I$20240729$20240812$20240822$20240822$EXP$$US-NOVOPROD-1270241$NOVO NORDISK$$71$YR$$F$Y$$$20240822$$CN$US$US
242359341$24235934$1$I$20240714$20240812$20240822$20240822$EXP$ES-AEMPS-1559621$ES-NOVOPROD-1269752$NOVO NORDISK$$60$YR$$M$Y$$$20240822$$MD$ES$ES
242359352$24235935$2$F$$20240822$20240822$20240904$EXP$$DZ-NOVOPROD-1250015$NOVO NORDISK$$57$YR$$F$Y$110$KG$20240904$$CN$DZ$DZ
242359361$24235936$1$I$$20240812$20240822$20240822$EXP$CA-HEALTHCANVIG-001091790$CA-NOVOPROD-1269448$NOVO NORDISK$$61$YR$$M$Y$118$KG$20240822$$HP$CA$CA
242359371$24235937$1$I$20151101$20240812$20240822$20240822$EXP$$US-NOVOPROD-1270068$NOVO NORDISK$$$$$M$Y$$$20240822$$CN$US$US
242359381$24235938$1$I$20230615$20240812$20240822$20240822$EXP$AU-TGA-0000783988$AU-NOVOPROD-1269696$NOVO NORDISK$$33$YR$$F$Y$$$20240822$$CN$AU$AU
242359391$24235939$1$I$20240809$20240811$20240822$20240822$EXP$$US-NOVOPROD-1270522$NOVO NORDISK$$22$YR$$M$Y$$$20240822$$CN$US$US
242359413$24235941$3$F$20240701$20240917$20240822$20240925$EXP$$CA-JNJFOC-20240845133$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240925$$HP$CA$CA
242359431$24235943$1$I$20240726$20240814$20240822$20240822$EXP$ES-AEMPS-1561229$ES-HETERO-AMR2024ES02725$HETERO$$72$YR$$F$Y$$$20240822$$MD$ES$ES
242359442$24235944$2$F$$20240829$20240822$20240906$EXP$$US-TEVA-VS-3234177$TEVA$Maloney N, Novoa R, Yeh JE. Chronic ulcer in a patient with essential thrombocythemia taking hydroxyurea. Dermatol-Online-J 2024; 30 (3):.; Maloney N, Novoa R, Yeh JE. Chronic ulcer in a patient with essential thrombocythemia taking hydroxyurea. Dermatol-Online-J 2024; 30 (3):.; Maloney N, Novoa R, Yeh JE. Chronic ulcer in a patient with essential thrombocythemia taking hydroxyurea. Dermatol-Online-J 2024; 30 (3):.$82$YR$$F$Y$$$20240906$$MD$US$US
242359451$24235945$1$I$20240410$20240528$20240822$20240822$PER$$US-ENDO PHARMACEUTICALS INC-2024-001770$ENDO$$44$YR$$M$Y$$$20240822$$HP$US$US
242359461$24235946$1$I$20231201$20231206$20240822$20240822$PER$$US-ENDO PHARMACEUTICALS INC-2023-006096$ENDO$$$$$M$Y$$$20240822$$CN$US$US
242359471$24235947$1$I$$20240809$20240822$20240822$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-002039$IPCA$Ruben Vaidya, Nabeel Hashmi, Salima Kakshapati et al.. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024;xx-x-xx:1-6$$$$$Y$$$20240822$$MD$US$US
242359481$24235948$1$I$20230101$20231002$20240822$20240822$PER$$US-ENDO PHARMACEUTICALS INC-2023-005252$ENDO$$$$$M$Y$$$20240822$$MD$US$US
242359491$24235949$1$I$20231020$20231024$20240822$20240822$PER$$US-ENDO PHARMACEUTICALS INC-2023-005592$ENDO$$$$$M$Y$$$20240822$$HP$US$US
242359501$24235950$1$I$20240410$20240411$20240822$20240822$PER$$US-ENDO PHARMACEUTICALS INC-2024-001769$ENDO$$55$YR$$M$Y$$$20240822$$HP$US$US
242359511$24235951$1$I$$20240405$20240822$20240822$PER$$US-ENDO PHARMACEUTICALS INC-2024-001122$ENDO$$$$$M$Y$$$20240822$$CN$US$US
242359521$24235952$1$I$20230101$20230912$20240822$20240822$PER$$US-ENDO PHARMACEUTICALS INC-2023-004536$ENDO$$$$$M$Y$104.31$KG$20240822$$HP$US$US
242359531$24235953$1$I$$20230926$20240822$20240822$PER$$US-ENDO PHARMACEUTICALS INC-2023-005183$ENDO$$$$$M$Y$$$20240822$$CN$US$US
242359541$24235954$1$I$$20230803$20240822$20240822$EXP$$US-AstraZeneca-2023A177893$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242359551$24235955$1$I$20230801$20240105$20240822$20240822$PER$$US-ENDO PHARMACEUTICALS INC-2023-004870$ENDO$$$$$M$Y$$$20240822$$HP$US$US
242359561$24235956$1$I$20230101$20240201$20240822$20240822$PER$$US-ENDO PHARMACEUTICALS INC-2023-006217$ENDO$$$$$$Y$$$20240822$$HP$US$US
242359571$24235957$1$I$20230401$20240429$20240822$20240822$PER$$US-ENDO PHARMACEUTICALS INC-2024-001457$ENDO$$43$YR$$M$Y$$$20240822$$CN$US$US
242359582$24235958$2$F$20240814$20240821$20240822$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-025488$UNITED THERAPEUTICS$$75$YR$$F$Y$92.517$KG$20240827$$$US$US
242359591$24235959$1$I$$20240815$20240822$20240822$EXP$$ZA-AstraZeneca-2024A187182$ASTRAZENECA$$83$YR$$F$Y$$$20240822$$CN$ZA$
242359601$24235960$1$I$20240601$20240812$20240822$20240822$EXP$$US-NOVOPROD-1269134$NOVO NORDISK$$73$YR$$F$Y$$$20240822$$CN$US$US
242359613$24235961$3$F$20240720$20240822$20240822$20240829$EXP$$CN-NOVOPROD-1268189$NOVO NORDISK$$42$YR$$M$Y$80$KG$20240829$$CN$CN$CN
242359621$24235962$1$I$$20240812$20240822$20240822$EXP$CA-HEALTHCANVIG-001090325$CA-NOVOPROD-1269445$NOVO NORDISK$$56$YR$$M$Y$$$20240822$$PH$CA$CA
242359631$24235963$1$I$$20240812$20240822$20240822$EXP$CA-HEALTHCANVIG-001091556$CA-NOVOPROD-1269446$NOVO NORDISK$$40$YR$$F$Y$127.01$KG$20240822$$CN$CA$CA
242359641$24235964$1$I$$20240812$20240822$20240822$EXP$$US-NOVOPROD-1269252$NOVO NORDISK$$$$$F$Y$$$20240822$$CN$US$US
242359651$24235965$1$I$$20240814$20240822$20240822$EXP$$US-Bion-013687$BIONPHARMA$$3$YR$C$M$Y$$$20240822$$HP$US$US
242359661$24235966$1$I$$20240812$20240822$20240822$EXP$$US-Bion-013716$BIONPHARMA$$$$$$Y$$$20240822$$CN$US$US
242359671$24235967$1$I$20240816$20240816$20240822$20240822$PER$$US-009507513-2408USA006216$MERCK$$67$YR$$F$Y$$$20240822$$CN$US$US
242359681$24235968$1$I$$20240815$20240822$20240822$EXP$$US-BEH-2024177320$CSL BEHRING$$42$YR$A$F$Y$79$KG$20240822$$MD$US$US
242359691$24235969$1$I$$20240718$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07370$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242359702$24235970$2$F$20240613$20240903$20240822$20240911$30DAY$$US-GSK-US2024100727$GLAXOSMITHKLINE$$43$YR$$F$Y$$$20240911$$CN$US$US
242359711$24235971$1$I$$20240812$20240822$20240822$EXP$$TR-NOVOPROD-1270575$NOVO NORDISK$$$$$M$Y$$$20240822$$CN$TR$TR
242359721$24235972$1$I$$20240812$20240822$20240822$EXP$$US-NOVOPROD-1270329$NOVO NORDISK$$73$YR$$F$Y$$$20240822$$CN$US$US
242359732$24235973$2$F$$20240918$20240822$20240927$EXP$$US-NOVOPROD-1270604$NOVO NORDISK$$$$$$Y$$$20240927$$CN$US$US
242359741$24235974$1$I$$20240812$20240822$20240822$EXP$$US-NOVOPROD-1270265$NOVO NORDISK$$$$A$F$Y$$$20240822$$CN$US$US
242359751$24235975$1$I$$20240812$20240822$20240822$EXP$$FR-NOVOPROD-1271743$NOVO NORDISK$$$$$F$Y$$$20240822$$PH$FR$FR
242359761$24235976$1$I$$20240809$20240822$20240822$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-002040$IPCA$Ruben Vaidya, Nabeel Hashmi, Salima Kakshapati et al.. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024;xx-x-xx:1-6$$$$$Y$$$20240822$$MD$US$US
242359771$24235977$1$I$$20240814$20240822$20240822$EXP$$US-Bion-013700$BIONPHARMA$$$$$F$Y$$$20240819$$HP$US$US
242359781$24235978$1$I$$20240814$20240822$20240822$EXP$$US-Bion-013701$BIONPHARMA$$3$YR$C$M$Y$$$20240819$$CN$US$US
242359791$24235979$1$I$$20240814$20240822$20240822$EXP$$US-JNJFOC-20240854167$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$US$US
242359812$24235981$2$F$$20240814$20240822$20240822$PER$$US-ROCHE-10000059470$ROCHE$$$$$F$Y$$$20240822$$CN$US$US
242359822$24235982$2$F$$20240918$20240822$20240930$30DAY$$US-JNJFOC-20240844162$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$MD$US$US
242359831$24235983$1$I$$20240821$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-081047-2024$RECKITT BENCKISER$$34$YR$$M$Y$$$20240822$$CN$US$US
242359841$24235984$1$I$$20240813$20240822$20240822$EXP$$US-Bion-013702$BIONPHARMA$$$$$$Y$$$20240819$$CN$US$US
242359851$24235985$1$I$20070101$20240814$20240822$20240822$EXP$$US-BIOGEN-2024BI01278358$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242359862$24235986$2$F$20240605$20240830$20240822$20240906$EXP$$EG-BIOGEN-2024BI01278376$BIOGEN$$30$YR$$F$Y$88$KG$20240906$$CN$EG$EG
242359871$24235987$1$I$20240809$20240813$20240822$20240822$PER$$US-BIOGEN-2024BI01278268$BIOGEN$$6$YR$$F$Y$$$20240822$$CN$US$US
242359881$24235988$1$I$20240731$20240820$20240822$20240822$EXP$$JP-ABBVIE-5888283$ABBVIE$$60$YR$$M$Y$$$20240822$$MD$JP$JP
242359892$24235989$2$F$20240727$20240830$20240822$20240831$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046711$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240831$$MD$DE$DE
242359901$24235990$1$I$20240814$20240815$20240822$20240822$PER$$US-AMGEN-USASP2024163699$AMGEN$$59$YR$A$F$Y$$$20240821$$CN$US$US
242359911$24235991$1$I$20240801$20240816$20240822$20240822$EXP$$US-ABBVIE-5886393$ABBVIE$$20$YR$$F$Y$$$20240822$$CN$US$US
242359921$24235992$1$I$20220601$20240816$20240822$20240822$EXP$$FR-AMGEN-FRANI2024163642$AMGEN$$$$E$F$Y$77$KG$20240821$$MD$FR$FR
242359931$24235993$1$I$20240201$20240816$20240822$20240822$EXP$$UY-ABBVIE-5886077$ABBVIE$$67$YR$$M$Y$$$20240822$$CN$UY$UY
242359941$24235994$1$I$$20240819$20240822$20240822$EXP$$SA-SANDOZ INC.-SDZ2024SA073888$SANDOZ$Almegbel M., Alshamardl K., Aleshaiwi L., Almutairi F.. Kounis Syndrome: A Case Report and a Review of Recent Literature. Almegbel et al. Cureus. 2024;16(7):1-5$65$YR$$F$Y$$$20240822$$HP$SA$SA
242359951$24235995$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131898$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240822$$HP$US$US
242359961$24235996$1$I$$20240820$20240822$20240822$EXP$$JP-TAKEDA-2024TJP012147$TAKEDA$$3$DEC$$F$Y$$$20240822$$HP$JP$JP
242359972$24235997$2$F$20240101$20240903$20240822$20240911$EXP$$US-APOTEX-2024AP009411$APOTEX$$$$A$F$Y$60.317$KG$20240911$$MD$US$US
242359981$24235998$1$I$$20240723$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07511$LUPIN$$$$$$Y$$$20240822$$MD$US$US
242360001$24236000$1$I$$20240820$20240822$20240822$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-132547$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240822$$CN$GB$GB
242360011$24236001$1$I$20240815$20240816$20240822$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-025789$UNITED THERAPEUTICS$$75$YR$$M$Y$62.132$KG$20240822$$$US$US
242360024$24236002$4$F$20240101$20240909$20240822$20240917$EXP$$BR-JNJFOC-20240843388$JOHNSON AND JOHNSON$$19$YR$A$M$Y$50$KG$20240917$$CN$BR$BR
242360041$24236004$1$I$$20240816$20240822$20240822$30DAY$$US-SANDOZ INC.-SDZ2024US073495$SANDOZ$$$$$M$Y$$$20240822$$CN$US$US
242360061$24236006$1$I$20240101$20240814$20240822$20240822$EXP$$US-BIOGEN-2024BI01274631$BIOGEN$$$$$M$Y$$$20240822$$CN$US$US
242360083$24236008$3$F$20240810$20240828$20240822$20240904$EXP$$US-AMGEN-USASP2024162112$AMGEN$$79$YR$E$F$Y$$$20240904$$CN$US$US
242360091$24236009$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5886539$ABBVIE$$$$$F$Y$$$20240822$$HP$US$US
242360101$24236010$1$I$$20240812$20240822$20240822$EXP$$US-GSK-US2024100370$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$MD$US$US
242360112$24236011$2$F$20240812$20240826$20240822$20240830$EXP$$US-ABBVIE-5771027$ABBVIE$$41$YR$$M$Y$97$KG$20240830$$CN$US$US
242360121$24236012$1$I$$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130116$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240822$$CN$US$US
242360131$24236013$1$I$$20240807$20240822$20240822$EXP$GB-MHRA-MED-202408061233211950-KGVQH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18518$ALKEM$$$$$M$Y$$$20240822$$CN$GB$GB
242360141$24236014$1$I$$20240812$20240822$20240822$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-130142$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240822$$MD$CA$CA
242360151$24236015$1$I$$20240807$20240822$20240822$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-18727$ALKEM$Furlan V, Parquin JF, Cerrina J, Ladurie LR, Dartevelle P, Taburet AM.. Interaction between tacrolimus and itraconazole in a heart-lung transplant recipient. Transplant Proc. 1998;30:187$$$$$Y$$$20240822$$HP$FR$FR
242360161$24236016$1$I$20210101$20240807$20240822$20240822$EXP$CN-MLMSERVICE-20240730-PI148411-00232-1$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-18582$ALKEM$Bai G, Bai Y, Guan H, Ren H, Li H, Wang Y. A case report of lymphoproliferative disease in brain following therapies with mycophenolate Mofetil and Fingolimod and literature review. Journal of neuroimmunology. 2024;394:578410$32$YR$$M$Y$$$20240822$$MD$CN$CN
242360171$24236017$1$I$20240802$20240807$20240822$20240822$EXP$GB-MHRA-MED-202408031331012830-YMSRD$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18545$ALKEM$$39$YR$$F$Y$$$20240822$$CN$GB$GB
242360182$24236018$2$F$$20240814$20240822$20240828$EXP$FR-MLMSERVICE-20240730-PI148643-00050-2$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-18548$ALKEM$Fidan I, Delamotte E, Colombier M, Agossa K.. Non-surgical Treatment of Severe Drug-Influenced Gingival Enlargement: A Report of Two Cases. Cureus. 2024;16(6):e63214$58$YR$$M$Y$$$20240828$$MD$FR$FR
242360191$24236019$1$I$20240802$20240807$20240822$20240822$EXP$GB-MHRA-MED-202408031304281350-HTYZR$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18570$ALKEM$$39$YR$$F$Y$$$20240822$$CN$GB$GB
242360201$24236020$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130885$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240822$$CN$US$US
242360211$24236021$1$I$$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129617$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240822$$HP$US$US
242360222$24236022$2$F$$20240814$20240822$20240828$EXP$US-MLMSERVICE-20240730-PI148178-00306-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18551$ALKEM$Manuel SL, Sapone J, Lin F.. Tacrolimus-induced recurrent acute coronary syndrome due to an unknown mechanism. Cureus. 2024;16(6):e63266$74$YR$$F$Y$$$20240828$$MD$US$US
242360231$24236023$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130780$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240822$$CN$US$US
242360242$24236024$2$F$$20240826$20240822$20240910$EXP$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18785$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18785$ALKEM$Stawiarski K, Avery R, Strout S, Umapathi P.. Risks of paxlovid in a heart transplant recipient. The Journal of heart and lung transplantation. 2022;42:30-32$76$YR$$M$Y$$$20240910$$MD$US$US
242360251$24236025$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132612$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240822$$CN$US$US
242360261$24236026$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132400$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240822$$CN$US$US
242360272$24236027$2$F$$20240906$20240822$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131956$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$56.25$KG$20240909$$CN$US$US
242360282$24236028$2$F$$20240814$20240822$20240826$EXP$$CN-JNJFOC-20240842080$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$MD$CN$CN
242360291$24236029$1$I$$20230411$20240822$20240822$EXP$$IT-AstraZeneca-2023A086159$ASTRAZENECA$$$$$$Y$$$20240822$$HP$IT$
242360301$24236030$1$I$$20240807$20240822$20240822$PER$$US-AstraZeneca-2024A180311$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242360311$24236031$1$I$$20240809$20240822$20240822$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-002041$IPCA$Ruben Vaidya, Nabeel Hashmi, Salima Kakshapati et al.. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024;xx-x-xx:1-6$$$$$Y$$$20240822$$MD$US$US
242360321$24236032$1$I$$20240809$20240822$20240822$PER$$US-AstraZeneca-2024A182347$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242360331$24236033$1$I$$20230823$20240822$20240822$EXP$$US-AstraZeneca-2023A180683$ASTRAZENECA$$81$YR$$F$Y$$$20240822$$CN$US$
242360341$24236034$1$I$$20240816$20240822$20240822$PER$$US-ABBVIE-5887606$ABBVIE$$$$$$Y$$$20240822$$CN$US$US
242360352$24236035$2$F$20240101$20240822$20240822$20240828$EXP$$US-ABBVIE-5887526$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242360361$24236036$1$I$20240701$20240819$20240822$20240822$EXP$$US-ABBVIE-5887263$ABBVIE$$72$YR$$F$Y$$$20240822$$CN$US$US
242360371$24236037$1$I$$20240813$20240822$20240822$EXP$$CA-APOTEX-2024AP009394$APOTEX$$87$YR$$F$Y$$$20240822$$HP$CA$CA
242360381$24236038$1$I$20240801$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165142$AMGEN$$82$YR$E$M$Y$$$20240822$$CN$US$US
242360391$24236039$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165119$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242360401$24236040$1$I$20190101$20240815$20240822$20240822$EXP$$PA-SANDOZ INC.-NVSC2020PA195820$SANDOZ$$$$$F$Y$61.678$KG$20240822$$CN$PA$PA
242360411$24236041$1$I$$20240819$20240822$20240822$PER$$US-ROCHE-10000061295$ROCHE$$10$YR$C$F$Y$$$20240822$$HP$US$US
242360421$24236042$1$I$$20240821$20240822$20240822$PER$$NVSC2024US169754$NOVARTIS$$$$$M$Y$$$20240822$$MD$US$US
242360431$24236043$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132315$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240822$$CN$US$US
242360441$24236044$1$I$20240819$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131371$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$58.97$KG$20240822$$CN$US$US
242360451$24236045$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132263$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240822$$CN$US$US
242360461$24236046$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132243$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$85.73$KG$20240822$$CN$US$US
242360471$24236047$1$I$20240813$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132599$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$86$KG$20240822$$PH$US$US
242360482$24236048$2$F$$20240820$20240822$20240822$PER$$US-JNJFOC-20240846827$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$CN$US$US
242360491$24236049$1$I$$20240821$20240822$20240822$PER$$US-ROCHE-10000062912$ROCHE$$47$YR$A$F$Y$$$20240822$$CN$US$US
242360503$24236050$3$F$20240614$20240914$20240822$20240919$EXP$$CZ-BIOGEN-2024BI01279046$BIOGEN$$52$YR$$$Y$$$20240919$$MD$CZ$CZ
242360512$24236051$2$F$$20240823$20240822$20240829$PER$$US-BIOGEN-2024BI01275385$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
242360522$24236052$2$F$20240801$20240819$20240822$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025016$UNITED THERAPEUTICS$$66$YR$$F$Y$58.957$KG$20240828$$PH$US$US
242360531$24236053$1$I$$20240813$20240822$20240822$PER$$US-BIOGEN-2024BI01278304$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242360541$24236054$1$I$20240815$20240817$20240822$20240822$PER$$US-BEH-2024177422$CSL BEHRING$$77$YR$E$F$Y$$$20240822$$CN$US$US
242360561$24236056$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165523$AMGEN$$$$$$Y$$$20240822$$HP$US$US
242360572$24236057$2$F$$20240906$20240822$20240906$PER$$US-ALXN-202408USA001001US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242360582$24236058$2$F$$20240911$20240822$20240920$EXP$$US-TEVA-VS-3234703$TEVA$Bass AR, Sama ML. Inflammatory arthritis complicating mogamulizumab treatment of Sezary syndrome. Rheumatology 2024; 63 (3): E113-E114.; Bass AR, Sama ML. Inflammatory arthritis complicating mogamulizumab treatment of Sezary syndrome. Rheumatology 2024; 63 (3): E113-E114.; Bass AR, Sama ML. Inflammatory arthritis complicating mogamulizumab treatment of Sezary syndrome. Rheumatology 2024; 63 (3): E113-E114.$54$YR$$F$Y$$$20240920$$HP$US$US
242360592$24236059$2$F$20240801$20240812$20240822$20240823$EXP$$ES-AUROBINDO-AUR-APL-2024-041087$AUROBINDO$$79$YR$$M$Y$$$20240823$$MD$ES$ES
242360601$24236060$1$I$$20240814$20240822$20240822$PER$$US-ABBVIE-5881535$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242360611$24236061$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131968$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240822$$CN$US$US
242360621$24236062$1$I$20240701$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132567$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240822$$HP$US$US
242360631$24236063$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132500$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240822$$HP$US$US
242360641$24236064$1$I$20231210$20240821$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-080997-2024$RECKITT BENCKISER$$$$$F$Y$$$20240822$$CN$US$US
242360661$24236066$1$I$$20240817$20240822$20240822$PER$$PR-JNJFOC-20240847098$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$CN$PR$PR
242360672$24236067$2$F$$20240924$20240822$20240927$EXP$$US-JNJFOC-20240739504$JOHNSON AND JOHNSON$$$$E$$Y$$$20240927$$CN$US$US
242360681$24236068$1$I$20240702$20240816$20240822$20240822$EXP$$CN-JNJFOC-20240846706$JOHNSON AND JOHNSON$$60$YR$A$F$Y$55$KG$20240822$$HP$CN$CN
242360691$24236069$1$I$$20240812$20240822$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-040954$AUROBINDO$$52$YR$$M$Y$$$20240822$$CN$GB$GB
242360701$24236070$1$I$$20240811$20240822$20240822$EXP$$US-ABBVIE-5887991$ABBVIE$Byer SH, Sivamurugan A, Grewal US, Dominic P. Cardiac arrhythmias and overall outcomes with Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia. Heart Rhythm. 2024;S1547527124028832.$$$$$Y$$$20240822$$MD$US$US
242360712$24236071$2$F$20240201$20240911$20240822$20240916$EXP$$MX-ROCHE-10000060580$ROCHE$$43$YR$A$F$Y$70$KG$20240916$$CN$MX$MX
242360723$24236072$3$F$$20240831$20240822$20240911$EXP$$PT-AUROBINDO-AUR-APL-2024-037304$AUROBINDO$Valente CT, Figueiredo RS, Gon?alves FR, Santos CS, Coelho S, Correia J. VASCULITE DE  PEQUENOS VASOS ? UM CASO DE VASCULITE  LEUCOCITOCL?STICA MEDICAMENTOSA (SMALL VESSEL VASCULITIS ? A  CASE OF DRUG LEUKOCYTOCLASTIC VASCULITIS). Doen?as autoimunes, reumatol?gicas e vasculites | Caso cl?nico (Autoimmune, rhe). 279$70$YR$$F$Y$$$20240911$$MD$PT$PT
242360731$24236073$1$I$20240817$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165455$AMGEN$$$$$$Y$$$20240822$$HP$US$US
242360741$24236074$1$I$$20240819$20240822$20240822$PER$$US-ROCHE-10000060867$ROCHE$$$$E$F$Y$$$20240822$$PH$US$US
242360751$24236075$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163866$AMGEN$$$$A$F$Y$$$20240822$$CN$US$US
242360761$24236076$1$I$19990101$20230103$20240822$20240822$EXP$$US-AstraZeneca-2023A003585$ASTRAZENECA$$72$YR$$F$Y$54.4$KG$20240822$$CN$US$
242360772$24236077$2$F$$20240823$20240822$20240828$30DAY$$NL-UCBSA-2024041664$UCB$$$$$$Y$$$20240828$$PH$NL$NL
242360781$24236078$1$I$20240812$20240814$20240822$20240822$EXP$$CO-AstraZeneca-2024A186844$ASTRAZENECA$$29225$DY$$M$Y$$$20240822$$CN$CO$
242360791$24236079$1$I$20240812$20240812$20240822$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-040874$AUROBINDO$$58$YR$$F$Y$80$KG$20240822$$MD$GB$GB
242360801$24236080$1$I$$20220915$20240822$20240822$EXP$$US-AstraZeneca-2022A321846$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242360812$24236081$2$F$$20240821$20240822$20240902$PER$$US-ROCHE-10000063015$ROCHE$$$$A$F$Y$$$20240902$$CN$US$US
242360821$24236082$1$I$$20240816$20240822$20240822$EXP$$US-ROCHE-10000059668$ROCHE$$78$YR$E$F$Y$$$20240822$$CN$US$US
242360831$24236083$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000061949$ROCHE$$$$A$F$Y$$$20240822$$CN$US$US
242360841$24236084$1$I$$20240812$20240822$20240822$EXP$$GB-ROCHE-10000053806$ROCHE$$$$A$F$Y$$$20240822$$CN$GB$GB
242360853$24236085$3$F$$20240825$20240822$20240828$EXP$$US-ROCHE-10000061049$ROCHE$$75$YR$E$F$Y$$$20240828$$CN$US$US
242360861$24236086$1$I$$20240812$20240822$20240822$EXP$$TH-ROCHE-10000056423$ROCHE$$43$YR$A$M$Y$$$20240822$$HP$TH$TH
242360871$24236087$1$I$20240807$20240813$20240822$20240822$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025319$UNITED THERAPEUTICS$$79$YR$$F$Y$49.887$KG$20240822$$$US$US
242360881$24236088$1$I$$20240820$20240822$20240822$PER$$US-HALEON-2193043$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242360891$24236089$1$I$$20240805$20240822$20240822$PER$$US-TEVA-VS-3230383$TEVA$$38$YR$$F$Y$$$20240822$$CN$US$US
242360901$24236090$1$I$$20240812$20240822$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-040553$AUROBINDO$$66$YR$$M$Y$70$KG$20240822$$PH$GB$GB
242360911$24236091$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024AMR100566$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242360921$24236092$1$I$$20240816$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012245$ELI LILLY AND CO$$$$A$M$Y$$$20240822$$CN$US$US
242360931$24236093$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012803$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240822$$CN$US$US
242360941$24236094$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012514$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240822$$CN$US$US
242360951$24236095$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011924$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240822$$CN$US$US
242360961$24236096$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011798$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240822$$CN$US$US
242360971$24236097$1$I$20240814$20240815$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408009798$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240822$$CN$US$US
242360981$24236098$1$I$$20240812$20240822$20240822$EXP$$NL-AUROBINDO-AUR-APL-2024-041059$AUROBINDO$$65$YR$$F$Y$77$KG$20240822$$PH$NL$NL
242360991$24236099$1$I$20231108$20240816$20240822$20240822$EXP$$BR-JNJFOC-20240150107$JOHNSON AND JOHNSON$$57$YR$A$F$Y$56$KG$20240822$$MD$BR$BR
242361001$24236100$1$I$20240813$20240815$20240822$20240822$EXP$$US-RIGEL-20240800073$RIGEL PHARMACEUTICALS$$87$YR$$M$Y$58.06$KG$20240822$$CN$US$US
242361012$24236101$2$F$20240101$20240827$20240822$20240916$EXP$$US-SA-2024SA248598$SANOFI AVENTIS$$42$YR$A$M$Y$101.59$KG$20240916$$MD$US$US
242361021$24236102$1$I$20240727$20240812$20240822$20240822$EXP$$PK-ROCHE-10000055006$ROCHE$$66$YR$E$M$Y$$$20240822$$CN$PK$PK
242361032$24236103$2$F$$20240919$20240822$20240924$PER$$US-AMGEN-USASP2024166205$AMGEN$$57$YR$A$F$Y$$$20240924$$MD$US$US
242361041$24236104$1$I$$20240815$20240822$20240822$EXP$$JP-AMGEN-JPNSP2024166311$AMGEN$$$$$$Y$$$20240822$$PH$JP$JP
242361051$24236105$1$I$$20240814$20240822$20240822$EXP$$US-AMGEN-USASP2024162190$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242361061$24236106$1$I$$20240813$20240822$20240822$EXP$$FR-GSK-FR2024GSK102947$GLAXOSMITHKLINE$Favreliere S, Mahe J, Veyrac G, Neau JP, Lafay-Chebassier C, Perault-Pochat MC. Drugs associated with reversible cerebral vasoconstriction syndrome: A pharmacovigilance study in vigiBase. Cephalalgia : an international journal of headache. 2024;44 (8):1-9$$$$$Y$$$20240822$$HP$FR$FR
242361071$24236107$1$I$$20240813$20240822$20240822$EXP$$FR-GSK-FR2024GSK103697$GLAXOSMITHKLINE$Favreliere S, Mahe J, Veyrac G, Neau JP, Lafay-Chebassier C, Perault-Pochat MC. Drugs associated with reversible cerebral vasoconstriction syndrome: A pharmacovigilance study in vigiBase. Cephalalgia : an international journal of headache. 2024;44 (8):1-9$$$$$Y$$$20240822$$HP$FR$FR
242361082$24236108$2$F$$20240821$20240822$20240822$PER$$US-ROCHE-10000062861$ROCHE$$$$$$Y$$$20240822$$CN$US$US
242361091$24236109$1$I$20240819$20240819$20240822$20240822$EXP$$US-JNJFOC-20240851048$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240822$$CN$US$US
242361101$24236110$1$I$20240130$20240821$20240822$20240822$EXP$$US-UCBSA-2024009909$UCB$$89$YR$$F$Y$$$20240822$$CN$US$US
242361111$24236111$1$I$$20230418$20240822$20240822$EXP$$US-AstraZeneca-2023A090777$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242361121$24236112$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165048$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242361132$24236113$2$F$20240101$20240820$20240822$20240909$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000686$DECIPHERA PHARMACEUTICALS$$66$YR$A$F$Y$$$20240909$$CN$US$US
242361141$24236114$1$I$20240203$20240812$20240822$20240822$EXP$$ES-AUROBINDO-AUR-APL-2024-041311$AUROBINDO$$84$YR$$F$Y$76$KG$20240822$$MD$ES$ES
242361151$24236115$1$I$$20210701$20240822$20240822$EXP$$AU-AstraZeneca-2021A588777$ASTRAZENECA$$$$$$Y$$$20240822$$HP$AU$
242361161$24236116$1$I$20240813$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164264$AMGEN$$77$YR$E$F$Y$56.2$KG$20240822$$HP$US$US
242361171$24236117$1$I$20240101$20240815$20240822$20240822$EXP$$US-Rigel Pharmaceuticals, Inc.-20240800071$RIGEL PHARMACEUTICALS$$$$$F$Y$97.976$KG$20240822$$CN$US$US
242361181$24236118$1$I$20240601$20240815$20240822$20240822$EXP$$US-VIIV HEALTHCARE LIMITED-US2024101799$VIIV$$49$YR$$F$Y$$$20240822$$CN$US$US
242361191$24236119$1$I$$20240813$20240822$20240822$30DAY$$US-GSK-US2024100828$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242361201$24236120$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5887630$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242361211$24236121$1$I$20240805$20240812$20240822$20240822$EXP$$DE-AUROBINDO-AUR-APL-2024-041277$AUROBINDO$$$$A$F$Y$71$KG$20240822$$MD$DE$DE
242361221$24236122$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165761$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
242361231$24236123$1$I$$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024166190$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
242361241$24236124$1$I$$20240808$20240822$20240822$EXP$$US-UCBSA-2024041008$UCB$$$$$M$Y$$$20240822$$CN$US$US
242361251$24236125$1$I$$20240814$20240822$20240822$EXP$$CA-TAKEDA-2020TUS032018$TAKEDA$$$$$M$Y$$$20240822$$CN$CA$CA
242361261$24236126$1$I$$20240821$20240822$20240822$PER$$NVSC2024US169822$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242361271$24236127$1$I$20240711$20240812$20240822$20240822$EXP$$ES-AUROBINDO-AUR-APL-2024-041089$AUROBINDO$$58$YR$$F$Y$$$20240822$$HP$ES$ES
242361281$24236128$1$I$20240501$20240820$20240822$20240822$EXP$IT-MINISAL02-999205$IT-ROCHE-10000062003$ROCHE$$56$YR$A$F$Y$$$20240822$$MD$IT$IT
242361291$24236129$1$I$$20240806$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07945$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242361302$24236130$2$F$20240818$20240819$20240822$20240826$PER$$US-AMGEN-USASP2024165381$AMGEN$$62$YR$A$F$Y$$$20240826$$CN$US$US
242361312$24236131$2$F$20240808$20240822$20240822$20240823$EXP$$US-TAKEDA-2024TUS083886$TAKEDA$$62$YR$$M$Y$$$20240823$$CN$US$US
242361321$24236132$1$I$20240101$20240814$20240822$20240822$EXP$$SA-SANDOZ INC.-SDZ2024SA073147$SANDOZ$$$$$M$Y$$$20240822$$CN$SA$SA
242361331$24236133$1$I$$20240812$20240822$20240822$EXP$$IT-AUROBINDO-AUR-APL-2024-041238$AUROBINDO$$37$YR$$F$Y$$$20240822$$CN$IT$IT
242361341$24236134$1$I$$20240812$20240822$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-040951$AUROBINDO$$66$YR$$F$Y$$$20240822$$HP$GB$GB
242361351$24236135$1$I$$20240815$20240822$20240822$PER$$US-AMGEN-USASP2024162969$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242361361$24236136$1$I$20240820$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024166886$AMGEN$$62$YR$A$F$Y$$$20240822$$CN$US$US
242361371$24236137$1$I$$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164686$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242361381$24236138$1$I$20231101$20240819$20240822$20240822$EXP$FR-AFSSAPS-BX2024001658$FR-ROCHE-10000060305$ROCHE$$47$YR$A$F$Y$$$20240822$$MD$FR$FR
242361391$24236139$1$I$20211124$20211217$20240822$20240822$EXP$$US-AstraZeneca-2021A886487$ASTRAZENECA$$67$YR$$F$Y$96.6$KG$20240822$$CN$US$
242361401$24236140$1$I$$20240813$20240822$20240822$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025159$UNITED THERAPEUTICS$$$$$F$Y$64.399$KG$20240822$$$US$US
242361411$24236141$1$I$20240806$20240812$20240822$20240822$EXP$$IT-AUROBINDO-AUR-APL-2024-041011$AUROBINDO$$77$YR$$M$Y$$$20240822$$MD$IT$IT
242361421$24236142$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5886306$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242361431$24236143$1$I$$20240811$20240822$20240822$EXP$$US-ABBVIE-5888031$ABBVIE$Faisal M, Kolli V, Soror N, Sarangdhar M, Jatwani K. Risk assessment of cardiovascular adverse events with BTK inhibitors in hematological malignancies: Insights from FAERS. J Clin Oncol.$$$$$Y$$$20240822$$HP$US$US
242361441$24236144$1$I$$20240815$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101896$VIIV$$$$A$F$Y$$$20240822$$MD$US$US
242361451$24236145$1$I$$20240816$20240822$20240822$EXP$$US-ABBVIE-5885161$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242361472$24236147$2$F$$20240904$20240822$20240906$EXP$$GB-TAKEDA-2024TUS011961$TAKEDA$$$$$F$Y$$$20240906$$CN$GB$GB
242361482$24236148$2$F$20240101$20240918$20240822$20240928$EXP$$CA-CELLTRION INC.-2024CA014116$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
242361492$24236149$2$F$$20240910$20240822$20240910$PER$$US-ALXN-202408USA001006US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
242361501$24236150$1$I$20240801$20240819$20240822$20240822$EXP$$US-ABBVIE-5887180$ABBVIE$$25$YR$$F$Y$$$20240822$$CN$US$US
242361511$24236151$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132413$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240822$$CN$US$US
242361521$24236152$1$I$20230704$20240814$20240822$20240822$EXP$$CA-JNJFOC-20240841053$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240822$$HP$CA$CA
242361531$24236153$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062758$ROCHE$$47$YR$A$F$Y$$$20240822$$HP$US$US
242361551$24236155$1$I$$20240812$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-041348$AUROBINDO$$66$YR$$F$Y$$$20240822$$MD$CA$CA
242361571$24236157$1$I$20231128$20240821$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-080663-2024$RECKITT BENCKISER$$88$YR$$F$Y$$$20240822$$CN$US$US
242361581$24236158$1$I$20240701$20240815$20240822$20240822$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046147$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$$$20240822$$CN$US$US
242361591$24236159$1$I$20201101$20240812$20240822$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-040836$AUROBINDO$$22$YR$$F$Y$67$KG$20240822$$CN$GB$GB
242361601$24236160$1$I$$20240808$20240822$20240822$EXP$$US-UCBSA-2024040213$UCB$$$$$F$Y$$$20240822$$HP$US$US
242361611$24236161$1$I$20240814$20240814$20240822$20240822$PER$$US-AMGEN-USASP2024162235$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
242361622$24236162$2$F$$20240821$20240822$20240827$PER$$US-AMGEN-USASP2024165819$AMGEN$$88$YR$E$F$Y$$$20240827$$CN$US$US
242361634$24236163$4$F$20240813$20240903$20240822$20240906$PER$$US-AMGEN-USASP2024162460$AMGEN$$62$YR$A$F$Y$140.6$KG$20240906$$CN$US$US
242361641$24236164$1$I$$20240816$20240822$20240822$PER$$US-HALEON-2192415$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242361651$24236165$1$I$$20240815$20240822$20240822$EXP$$US-ROCHE-10000061421$ROCHE$$$$E$F$Y$$$20240822$$MD$US$US
242361661$24236166$1$I$$20240821$20240822$20240822$PER$$US-GILEAD-2024-0684902$GILEAD$$43$YR$A$M$Y$$$20240822$$PH$US$US
242361681$24236168$1$I$20240811$20240813$20240822$20240822$EXP$$CN-SA-2024SA245991$SANOFI AVENTIS$$87$YR$E$F$Y$50$KG$20240822$$HP$CN$CN
242361691$24236169$1$I$$20240812$20240822$20240822$EXP$$NL-AUROBINDO-AUR-APL-2024-039729$AUROBINDO$Dormans T, Zandijk E, Stals F. LATE TUBERCULOSIS REACTIVATION AFTER SEVERE COVID19. European Journal of Case Reports in Internal Medicine. 2024;11:5$8$DEC$$F$Y$$$20240822$$HP$NL$NL
242361701$24236170$1$I$$20240820$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA074069$SANDOZ$$7$YR$$M$Y$$$20240822$$CN$CA$CA
242361711$24236171$1$I$$20240815$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130365$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240822$$CN$US$US
242361724$24236172$4$F$20240817$20240913$20240822$20240916$PER$$US-AMGEN-USASP2024165678$AMGEN$$69$YR$E$F$Y$$$20240916$$CN$US$US
242361731$24236173$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132683$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240822$$HP$US$US
242361751$24236175$1$I$$20240818$20240822$20240822$PER$$NVSC2024US167852$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
242361761$24236176$1$I$20240101$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012462$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240822$$CN$US$US
242361771$24236177$1$I$20240501$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012290$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240822$$CN$US$US
242361781$24236178$1$I$$20240813$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408009094$ELI LILLY AND CO$$61$YR$A$$Y$$$20240822$$LW$US$US
242361791$24236179$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011498$ELI LILLY AND CO$$$$$F$Y$$$20240822$$HP$US$US
242361802$24236180$2$F$$20240822$20240822$20240831$PER$$US-ABBVIE-5878875$ABBVIE$$$$$$Y$$$20240831$$CN$US$US
242361811$24236181$1$I$20240816$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011954$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240822$$CN$US$US
242361821$24236182$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011805$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240822$$CN$US$US
242361831$24236183$1$I$$20240820$20240822$20240822$EXP$$AR-UCBSA-2024042447$UCB$$$$$M$Y$$$20240822$$CN$AR$AR
242361842$24236184$2$F$$20240821$20240822$20240822$PER$$US-JNJFOC-20240854563$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$US$US
242361851$24236185$1$I$$20240812$20240822$20240822$PER$$US-ABBVIE-5881784$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242361862$24236186$2$F$20240101$20240912$20240822$20240926$EXP$$GB-UCBSA-2024040251$UCB$$$$$F$Y$$$20240926$$HP$GB$GB
242361871$24236187$1$I$$20240813$20240822$20240822$PER$$US-ROCHE-10000058485$ROCHE$$62$YR$A$F$Y$$$20240822$$CN$US$US
242361891$24236189$1$I$20240726$20240816$20240822$20240822$EXP$$GB-JNJFOC-20240849581$JOHNSON AND JOHNSON$$8$YR$C$F$Y$26$KG$20240822$$PH$GB$GB
242361901$24236190$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024100154$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242361911$24236191$1$I$$20240813$20240822$20240822$30DAY$$US-GSK-US2024100843$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242361921$24236192$1$I$$20240812$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR101264$VIIV$$$$$M$Y$$$20240822$$HP$US$US
242361931$24236193$1$I$$20240821$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-084728-2024$RECKITT BENCKISER$$68$YR$$F$Y$56.82$KG$20240822$$CN$US$US
242361941$24236194$1$I$$20240813$20240822$20240822$EXP$$US-INTERCEPT-PM2024001622$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242361951$24236195$1$I$$20240807$20240822$20240822$PER$$US-AstraZeneca-2024A180114$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242361961$24236196$1$I$$20210521$20240822$20240822$EXP$$US-AstraZeneca-2021A459796$ASTRAZENECA$$84$YR$$M$Y$$$20240822$$CN$US$
242361971$24236197$1$I$$20210512$20240822$20240822$EXP$$US-AstraZeneca-2021A429300$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242361981$24236198$1$I$$20230110$20240822$20240822$EXP$$CA-AstraZeneca-2023A008930$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$CA$
242361991$24236199$1$I$$20240820$20240822$20240822$PER$$US-BIOVITRUM-2024-US-011050$BIOVITRUM$$65$YR$$F$Y$$$20240822$$HP$US$US
242362001$24236200$1$I$$20240814$20240822$20240822$EXP$$ZA-AstraZeneca-2024A185742$ASTRAZENECA$$79$YR$$F$Y$$$20240822$$CN$ZA$
242362012$24236201$2$F$20231229$20240902$20240822$20240910$EXP$$JP-UCBSA-2024041405$UCB$$81$YR$$M$Y$45$KG$20240910$$PH$JP$JP
242362021$24236202$1$I$$20220104$20240822$20240822$EXP$$US-AstraZeneca-2022A007663$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242362031$24236203$1$I$$20230807$20240822$20240822$EXP$$US-AstraZeneca-2023A180495$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242362041$24236204$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131896$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240822$$HP$US$US
242362052$24236205$2$F$$20240827$20240822$20240906$EXP$$JP-TEVA-VS-3233087$TEVA$Sakurai T, Yamahara N, Yaguchi T, Baba Y, Nishida H. Immune checkpoint inhibitor-induced Trousseau syndrome: a case report. Acta-Neurol-Belg 2024; 124 (3): 1033-1036; Sakurai T, Yamahara N, Yaguchi T, Baba Y, Nishida H. Immune checkpoint inhibitor-induced Trousseau syndrome: a case report. Acta-Neurol-Belg 2024; 124 (3): 1033-1036.$69$YR$$M$Y$$$20240906$$HP$JP$JP
242362063$24236206$3$F$20240816$20240910$20240822$20240917$EXP$$US-EXELIXIS-CABO-24080602$EXELIXIS$$45$YR$$M$Y$68.481$KG$20240917$$HP$US$US
242362073$24236207$3$F$20230620$20240919$20240822$20240925$EXP$$JP-EXELIXIS-CABO-24080695$EXELIXIS$$73$YR$$M$Y$61$KG$20240925$$MD$JP$JP
242362081$24236208$1$I$$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024166971$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242362091$24236209$1$I$20240819$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165181$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
242362101$24236210$1$I$$20240813$20240822$20240822$EXP$$KW-ROCHE-10000057094$ROCHE$$$$$$Y$$$20240822$$MD$KW$KW
242362111$24236211$1$I$20240501$20240815$20240822$20240822$EXP$$US-EXELIXIS-CABO-24077879$EXELIXIS$$35$YR$$M$Y$$$20240822$$MD$US$US
242362121$24236212$1$I$$20240812$20240822$20240822$PER$$US-ABBVIE-5881111$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242362131$24236213$1$I$$20240813$20240822$20240822$EXP$$SA-ROCHE-10000060987$ROCHE$Mirza A, Alsufyani K, Khojah A. Fatal CMV infection in a 2-month-old Infant with STAT1 Loss of Function Mutation. Clinical Immunology. 2024;262S. doi.org/10.1016/j.clim.2024.110017.$2$MON$I$F$Y$$$20240822$$MD$SA$SA
242362141$24236214$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132391$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240822$$CN$US$US
242362151$24236215$1$I$20240701$20240701$20240822$20240822$30DAY$$US-AMGEN-USASP2024162049$AMGEN$$58$YR$A$F$Y$67$KG$20240822$$PH$US$US
242362161$24236216$1$I$$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024167084$AMGEN$$$$$$Y$$$20240822$$PH$US$US
242362171$24236217$1$I$20240725$20240726$20240822$20240822$PER$$FR-TOLMAR, INC.-24FR051337$TOLMAR$$73$YR$$M$Y$$$20240822$$PH$FR$FR
242362191$24236219$1$I$20240723$20240725$20240822$20240822$PER$$FR-TOLMAR, INC.-24FR051348$TOLMAR$$75$YR$$M$Y$$$20240822$$PH$FR$FR
242362201$24236220$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132306$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240822$$CN$US$US
242362211$24236221$1$I$20240101$20240726$20240822$20240822$PER$$FR-TOLMAR, INC.-24FR051393$TOLMAR$$63$YR$$M$Y$$$20240822$$PH$FR$FR
242362231$24236223$1$I$$20240724$20240822$20240822$PER$$NL-TOLMAR, INC.-24NL051248$TOLMAR$$$$$M$Y$$$20240822$$CN$NL$NL
242362241$24236224$1$I$20240204$20240726$20240822$20240822$PER$$NL-TOLMAR, INC.-24NL051385$TOLMAR$$77$YR$$M$Y$$$20240822$$CN$NL$NL
242362251$24236225$1$I$20240718$20240725$20240822$20240822$PER$$TR-TOLMAR, INC.-24TR051168$TOLMAR$$74$YR$$M$Y$$$20240822$$MD$TR$TR
242362261$24236226$1$I$$20240725$20240822$20240822$PER$$NL-TOLMAR, INC.-24NL051390$TOLMAR$$$$$$Y$$$20240822$$MD$NL$NL
242362271$24236227$1$I$20240724$20240724$20240822$20240822$PER$$TR-TOLMAR, INC.-24TR051266$TOLMAR$$73$YR$$M$Y$$$20240822$$MD$TR$TR
242362281$24236228$1$I$20240724$20240724$20240822$20240822$PER$$TR-TOLMAR, INC.-24TR051283$TOLMAR$$68$YR$$M$Y$$$20240822$$PH$TR$TR
242362291$24236229$1$I$20240724$20240724$20240822$20240822$PER$$TR-TOLMAR, INC.-24TR051271$TOLMAR$$70$YR$$M$Y$$$20240822$$MD$TR$TR
242362301$24236230$1$I$20240724$20240724$20240822$20240822$PER$$TR-TOLMAR, INC.-24TR051287$TOLMAR$$65$YR$$M$Y$$$20240822$$PH$TR$TR
242362311$24236231$1$I$$20240807$20240822$20240822$PER$$US-AstraZeneca-2024A180130$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242362321$24236232$1$I$$20240814$20240822$20240822$PER$$US-CHATTEMPRD-2024OHG027589$CHATTEM$$$$$F$Y$$$20240822$$CN$US$US
242362331$24236233$1$I$$20230913$20240822$20240822$EXP$$CA-AstraZeneca-2023A069653$ASTRAZENECA$$$$$M$Y$$$20240822$$HP$CA$
242362341$24236234$1$I$$20240813$20240822$20240822$PER$$US-ABBVIE-5880453$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242362351$24236235$1$I$$20240815$20240822$20240822$PER$$US-CHATTEMPRD-2024OHG027530$CHATTEM$$$$$$Y$$$20240822$$CN$US$US
242362362$24236236$2$F$20240815$20240830$20240822$20240905$EXP$$US-JNJFOC-20240843402$JOHNSON AND JOHNSON$$44$YR$A$F$Y$80.9$KG$20240905$$PH$US$US
242362382$24236238$2$F$$20240815$20240822$20240916$PER$$US-CHATTEMPRD-2024OHG027975$CHATTEM$$$$$F$Y$$$20240916$$CN$US$US
242362391$24236239$1$I$$20240809$20240822$20240822$PER$$US-Nobelpharma America, LLC-NPA-2024-01404$NOBELPHARMA$$$$$F$Y$$$20240819$$HP$US$US
242362401$24236240$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132585$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240822$$CN$US$US
242362412$24236241$2$F$$20240903$20240822$20240903$EXP$PL-EMA-DD-20240814-7482661-093405$PL-SANDOZ INC.-SDZ2024PL073806$SANDOZ$$22$YR$$F$Y$$$20240903$$HP$PL$PL
242362421$24236242$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165971$AMGEN$$$$$$Y$$$20240822$$PH$US$US
242362431$24236243$1$I$20240819$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165601$AMGEN$$67$YR$E$M$Y$$$20240822$$CN$US$US
242362442$24236244$2$F$$20240910$20240822$20240923$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08197$LUPIN$$$$$$Y$$$20240923$$MD$US$US
242362451$24236245$1$I$20231119$20240813$20240822$20240822$EXP$$JP-ORPHANEU-2023008806$RECORDATI$$$$$$Y$$$20240822$$MD$JP$JP
242362461$24236246$1$I$20240812$20240812$20240822$20240822$PER$$US-ABBVIE-5879672$ABBVIE$$51$YR$$M$Y$$$20240822$$CN$US$US
242362471$24236247$1$I$$20240816$20240822$20240822$EXP$FR-STADA-01284961$FR-ROCHE-10000059345$ROCHE$Chanut M, Bonny V, Joly AC, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Arch-Cardiovasc-Dis 2024; 117 (4): 297-300.$77$YR$E$M$Y$$$20240822$$HP$FR$FR
242362482$24236248$2$F$$20240827$20240822$20240828$PER$$US-JNJFOC-20240822882$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242362491$24236249$1$I$$20240808$20240822$20240822$PER$$US-JNJFOC-20240822373$JOHNSON AND JOHNSON$$31$YR$A$$Y$$$20240822$$CN$US$US
242362501$24236250$1$I$$20240811$20240822$20240822$EXP$$US-JNJFOC-20240841717$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$US$US
242362511$24236251$1$I$$20240819$20240822$20240822$EXP$$NVSC2024US076907$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
242362521$24236252$1$I$$20240808$20240822$20240822$EXP$$US-AMX-008128$AMYLYX PHARMACEUTICALS$$$$$M$Y$$$20240822$$HP$US$US
242362531$24236253$1$I$$20240813$20240822$20240822$EXP$$CA-ROCHE-10000061152$ROCHE$Tien MC, Kaplan AJ. Severe Occlusive Retinal Vasculitis in an Immunocompetent Patient with Chronic CMV Anterior Uveitis. Ocular immunology and inflammation. 2024;1-2. doi: 10.1080/09273948.2024.2389460.$32$YR$A$F$Y$$$20240822$$HP$CA$CA
242362542$24236254$2$F$$20240829$20240822$20240906$EXP$$DE-TEVA-VS-3234175$TEVA$Lorenz G, Schaaf C, Moog P, Bachmann Q, Popp F, Rech J, et al. Brain oedema due to disseminated intravascular coagulation in a patient with adult-onset Still^s disease-associated hemophagocytic lymphohistiocytosis - a case report. Rheumatology 2023; 62 (6): E188-E190.; Lorenz G, Schaaf C, Moog P, Bachmann Q, Popp F, Rech J, et al. Brain oedema due to disseminated intravascular coagulation in a patient with adult-onset Still^s disease-associated hemophagocytic lymphohistiocytosis - a case repo...$23$YR$$F$Y$$$20240906$$HP$DE$DE
242362551$24236255$1$I$20240724$20240816$20240822$20240822$EXP$BE-FAMHP-DHH-N2024-122488$BE-BEH-2024177398$CSL BEHRING$$55$YR$A$F$Y$$$20240822$$HP$BE$BE
242362561$24236256$1$I$$20230611$20240822$20240822$EXP$$CA-AstraZeneca-2023A133776$ASTRAZENECA$$$$$F$Y$$$20240822$$PH$CA$
242362571$24236257$1$I$$20221018$20240822$20240822$EXP$$CA-AstraZeneca-2022A352111$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$CA$
242362581$24236258$1$I$20240517$20240814$20240822$20240822$EXP$$GB-JNJFOC-20240838441$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240822$$CN$GB$GB
242362591$24236259$1$I$20240501$20240819$20240822$20240822$EXP$FR-AFSSAPS-PV2024000733$FR-ABBVIE-5885451$ABBVIE$$41$YR$$F$Y$91$KG$20240822$$MD$FR$FR
242362601$24236260$1$I$$20240814$20240822$20240822$EXP$$US-CELLTRION INC.-2024US020139$CELLTRION$$$$$$Y$$$20240822$$CN$US$US
242362621$24236262$1$I$$20240809$20240822$20240822$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02994$AMNEAL$Nawaz N, Mistretta T, Karime C, Lewis J, Wolf E.. Cholestatic Drug-Induced Liver Injury in a Patient Taking High-Dose Niacin for Hyperlipidemia. J Investig Med High Impact Case Rep.. 2024;12:1-3$79$YR$$M$Y$$$20240822$$MD$US$US
242362631$24236263$1$I$$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132659$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$76.66$KG$20240822$$CN$US$US
242362641$24236264$1$I$$20240814$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129574$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240822$$CN$US$US
242362651$24236265$1$I$$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132643$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$75.75$KG$20240822$$CN$US$US
242362661$24236266$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132464$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240822$$CN$US$US
242362681$24236268$1$I$$20240820$20240822$20240822$EXP$$US-BIOVITRUM-2024-US-011158$BIOVITRUM$$74$YR$$M$Y$$$20240822$$MD$US$US
242362692$24236269$2$F$$20240814$20240822$20240824$EXP$$US-GSK-US2024AMR102785$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242362701$24236270$1$I$20240506$20240816$20240822$20240822$EXP$CH-SM-2024-13016$CH-GSK-CH2024102159$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$MD$CH$CH
242362711$24236271$1$I$20210222$20240817$20240822$20240822$EXP$$US-CHEPLA-1100014432$CHEPLAPHARM$$79$YR$E$M$Y$$$20240822$$CN$COUNTRY NOT SPECIFIED$US
242362722$24236272$2$F$$20240827$20240822$20240904$EXP$$US-EMD Serono-2024037567$EMD SERONO INC$$51$YR$A$F$Y$53$KG$20240904$$CN$US$US
242362732$24236273$2$F$$20240816$20240822$20240826$PER$$US-AMGEN-USASP2024164794$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242362741$24236274$1$I$20231129$20240820$20240822$20240822$EXP$ES-AEMPS-1557399$ES-JNJFOC-20240855509$JOHNSON AND JOHNSON$$44$YR$A$F$Y$75$KG$20240822$$PH$ES$ES
242362752$24236275$2$F$20230101$20240926$20240822$20240930$PER$$US-JNJFOC-20240817107$JOHNSON AND JOHNSON$$10$DEC$E$F$Y$$$20240930$$CN$US$US
242362761$24236276$1$I$$20240819$20240822$20240822$EXP$$GB-JNJFOC-20240852363$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240822$$HP$GB$GB
242362771$24236277$1$I$20240819$20240819$20240822$20240822$PER$$US-JNJFOC-20240847902$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240822$$CN$US$US
242362781$24236278$1$I$20240807$20240808$20240822$20240822$EXP$$US-INSMED, INC.-2024-03256-US$INSMED$$66$YR$$F$Y$$$20240822$$CN$US$US
242362791$24236279$1$I$$20240815$20240822$20240822$EXP$$CA-ABBVIE-5885709$ABBVIE$$$$E$M$Y$$$20240822$$MD$CA$CA
242362801$24236280$1$I$$20240815$20240822$20240822$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07888$HIKMA$Jha V, Jha SK, Aryal B, Dhungel S, Jha S, Brock M.. Jha V, Jha SK, Aryal B, Dhungel S, Jha S, Brock M. A Report of a Rare Case of Kounis Syndrome in a Patient With HIV/AIDS and Mpox.. Cureus.. 2024;16(7):e63957$$$$$Y$$$20240822$$MD$US$US
242362811$24236281$1$I$$20240816$20240822$20240822$PER$$US-ALXN-202408USA001012US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242362822$24236282$2$F$20230101$20240828$20240822$20240905$EXP$$US-ABBVIE-5885866$ABBVIE$$$$$M$Y$60$KG$20240905$$CN$US$US
242362831$24236283$1$I$20240803$20240815$20240822$20240822$EXP$$CN-BEIGENE-BGN-2024-012818$BEIGENE$$$$$$Y$$$20240822$$HP$CN$CN
242362841$24236284$1$I$20240723$20240816$20240822$20240822$PER$$US-HALEON-2192702$Haleon PLC$$61$YR$$F$Y$$$20240822$$CN$US$US
242362851$24236285$1$I$$20240812$20240822$20240822$PER$$US-ABBVIE-5880162$ABBVIE$$$$$$Y$$$20240822$$MD$US$US
242362861$24236286$1$I$20230101$20240816$20240822$20240822$EXP$$US-ABBVIE-5885176$ABBVIE$$67$YR$$M$Y$$$20240822$$CN$US$US
242362871$24236287$1$I$$20240821$20240822$20240822$PER$$NVSC2024US169816$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242362881$24236288$1$I$20240101$20240817$20240822$20240822$PER$$US-AMGEN-USASP2024165024$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242362892$24236289$2$F$20240721$20240913$20240822$20240916$PER$$US-BIOVITRUM-2024-US-011149$BIOVITRUM$$82$YR$$M$Y$$$20240916$$CN$US$US
242362901$24236290$1$I$20240808$20240815$20240822$20240822$EXP$$CN-BEIGENE-BGN-2024-012807$BEIGENE$$$$$$Y$$$20240822$$HP$CN$CN
242362911$24236291$1$I$$20240816$20240822$20240822$EXP$$US-ABBVIE-5884668$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242362922$24236292$2$F$$20240827$20240822$20240830$PER$$US-JNJFOC-20240780380$JOHNSON AND JOHNSON$$18$YR$A$M$Y$87.622$KG$20240830$$MD$US$US
242362931$24236293$1$I$$20240816$20240822$20240822$EXP$$CA-JNJFOC-20240847157$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$CA$CA
242362941$24236294$1$I$20240801$20240819$20240822$20240822$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-131867$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240822$$MD$DE$DE
242362951$24236295$1$I$$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131738$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240822$$MD$US$US
242362961$24236296$1$I$$20240813$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128524$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240822$$CN$US$US
242362971$24236297$1$I$20230812$20240812$20240822$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-040882$AUROBINDO$$62$YR$$M$Y$$$20240822$$CN$GB$GB
242362981$24236298$1$I$20240101$20240816$20240822$20240822$EXP$$US-ABBVIE-5884969$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242362991$24236299$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012534$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240822$$CN$US$US
242363001$24236300$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012230$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240822$$CN$US$US
242363011$24236301$1$I$20240819$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012631$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240822$$CN$US$US
242363021$24236302$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011746$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240822$$CN$US$US
242363032$24236303$2$F$20240719$20240813$20240822$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408007648$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240826$$CN$US$US
242363041$24236304$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011613$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240822$$CN$US$US
242363051$24236305$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012437$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240822$$CN$US$US
242363061$24236306$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012600$ELI LILLY AND CO$$32$YR$A$$Y$$$20240822$$CN$US$US
242363071$24236307$1$I$$20240814$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011223$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240822$$CN$US$US
242363081$24236308$1$I$$20240821$20240822$20240822$PER$$NVSC2024US169912$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242363092$24236309$2$F$$20240906$20240822$20240910$EXP$BG-TEVA-VS-3225664$BG-ROCHE-10000055960$ROCHE$Ivanov K,  Malignant ascites and place of peritoneal tunnel catheters in their treatment.. Journal of the Bulgarian Oncological Scientific Society/Journal of Bulgarian Cancer Scientific Society. 2024-Feb;3-45.$64$YR$A$F$Y$$$20240910$$HP$BG$BG
242363101$24236310$1$I$$20240815$20240822$20240822$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046452$BOEHRINGER INGELHEIM$$$$$$Y$$$20240822$$CN$DE$DE
242363111$24236311$1$I$20230101$20240819$20240822$20240822$EXP$$BR-ABBVIE-5887581$ABBVIE$$$$$F$Y$70$KG$20240822$$CN$BR$BR
242363121$24236312$1$I$$20240813$20240822$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-038753$AUROBINDO$$52$YR$$M$Y$$$20240822$$MD$GB$GB
242363131$24236313$1$I$20120101$20240819$20240822$20240822$PER$$US-JNJFOC-20240852526$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240822$$HP$US$US
242363141$24236314$1$I$20240802$20240815$20240822$20240822$EXP$$CN-BEIGENE-BGN-2024-012804$BEIGENE$$$$$$Y$$$20240822$$HP$CN$CN
242363152$24236315$2$F$20240301$20240822$20240822$20240824$EXP$$US-ABBVIE-5889260$ABBVIE$$60$YR$$F$Y$$$20240824$$CN$US$US
242363162$24236316$2$F$20220101$20240829$20240822$20240906$EXP$$ES-TEVA-VS-3234065$TEVA$Ligero-Lopez J, Villagrasa-Boli P, Bularca E, Portillo A, Oteo JA, Lopez-Alonso B, et al. Emerging challenges: An imported case of Leishmania mexicana with Pseudomonas aeruginosa superinfection. Diagn-Microbiol-Infect-Dis 2024; 110 (1):.; Ligero-Lopez J, Villagrasa-Boli P, Bularca E, Portillo A, Oteo JA, Lopez-Alonso B, et al. Emerging challenges: An imported case of Leishmania mexicana with Pseudomonas aeruginosa superinfection. Diagn-Microbiol-Infect-Dis 2024; 110 (1):.$44$YR$$M$Y$$$20240906$$HP$ES$ES
242363171$24236317$1$I$$20240821$20240822$20240822$PER$$NVSC2024US169915$NOVARTIS$$$$$$Y$$$20240822$$MD$US$US
242363182$24236318$2$F$$20240826$20240822$20240828$PER$$US-AMGEN-USASP2024165424$AMGEN$$$$$$Y$$$20240828$$MD$US$US
242363192$24236319$2$F$20240501$20240913$20240822$20240919$EXP$$NVSC2023CA239149$NOVARTIS$$2$YR$$F$Y$$$20240919$$CN$CA$CA
242363201$24236320$1$I$$20240815$20240822$20240822$EXP$$DE-AMGEN-DEUSP2024166402$AMGEN$$$$E$F$Y$$$20240822$$MD$DE$DE
242363231$24236323$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165351$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242363241$24236324$1$I$$20240612$20240822$20240822$PER$$US-CIPLA LTD.-2024US06604$CIPLA$$$$$$Y$$$20240822$$HP$US$US
242363251$24236325$1$I$20240101$20240820$20240822$20240822$EXP$$US-UCBSA-2024042464$UCB$$$$$M$Y$$$20240822$$CN$US$US
242363261$24236326$1$I$$20240820$20240822$20240822$EXP$$EG-ABBVIE-5888947$ABBVIE$$70$YR$$F$Y$$$20240822$$MD$EG$EG
242363271$24236327$1$I$$20240812$20240822$20240822$EXP$JP-MLMSERVICE-20240808-PI153824-00232-1$JP-STRIDES ARCOLAB LIMITED-2024SP010346$STRIDES$Kou R, Onishi Y, Ogiso S, Kai S, Nakamoto Y.. Emphysematous osteomyelitis of the lumbar spine and sacrum after liver transplantation: A case report.. Cureus. 2024;16(7):e63748$62$YR$$M$Y$$$20240822$$MD$JP$JP
242363282$24236328$2$F$$20240919$20240822$20240920$EXP$$US-GILEAD-2024-0684540$GILEAD$$$$E$F$Y$$$20240920$$CN$US$US
242363291$24236329$1$I$20221129$20240820$20240822$20240822$EXP$$US-UCBSA-2024042203$UCB$$64$YR$$F$Y$$$20240822$$HP$US$US
242363301$24236330$1$I$$20240819$20240822$20240822$PER$$US-JNJFOC-20240847749$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$US$US
242363311$24236331$1$I$$20240807$20240822$20240822$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000282$ASSERTIO THERAPEUTICS$$70$YR$$F$Y$$$20240822$$HP$CA$CA
242363321$24236332$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130902$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$76.6$KG$20240822$$HP$US$US
242363332$24236333$2$F$20240818$20240904$20240822$20240904$PER$$US-AMGEN-USASP2024165693$AMGEN$$66$YR$E$F$Y$$$20240904$$CN$US$US
242363341$24236334$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5887359$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242363351$24236335$1$I$$20240820$20240822$20240822$PER$$US-TAKEDA-2024TUS084388$TAKEDA$$$$$F$Y$$$20240822$$CN$US$US
242363362$24236336$2$F$$20240903$20240822$20240909$EXP$$JP-GSK-JP2024JPN103555$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$PH$JP$JP
242363371$24236337$1$I$$20240723$20240822$20240822$30DAY$$US-VEROBIOTECH-2024USVEROSPO00186$VERO BIOTECH$$$$$M$Y$$$20240822$$HP$US$US
242363381$24236338$1$I$$20240821$20240822$20240822$PER$$NVSC2024US169742$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242363391$24236339$1$I$20240507$20240819$20240822$20240822$EXP$FR-AFSSAPS-AN2024001088$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07926$HIKMA$$$$$$Y$$$20240822$$MD$FR$FR
242363411$24236341$1$I$$20240816$20240822$20240822$PER$$US-GILEAD-2024-0684664$GILEAD$$38$YR$A$M$Y$$$20240822$$CN$US$US
242363422$24236342$2$F$20140101$20240911$20240822$20240917$EXP$$US-ABBVIE-5872473$ABBVIE$$$$$M$Y$96$KG$20240917$$CN$US$US
242363431$24236343$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165487$AMGEN$$$$$F$Y$$$20240822$$HP$US$US
242363441$24236344$1$I$$20240812$20240822$20240822$PER$$US-ROCHE-10000055570$ROCHE$$$$A$M$Y$117.6$KG$20240822$$CN$US$US
242363451$24236345$1$I$20240801$20240820$20240822$20240822$EXP$$CN-ROCHE-10000061864$ROCHE$$49$YR$A$F$Y$$$20240822$$HP$CN$CN
242363461$24236346$1$I$$20240818$20240822$20240822$EXP$$US-INFO-20240253$INFORLIFE$Hassan AM, Hill H, Donley C, Leonelli C. Potential anaphylactoid reaction to nicardipine. J Am Coll Emerg Physicians Open. 2024 Aug 12;5(4):e13271. doi: 10.1002/emp2.13271.$52$YR$A$M$Y$$$20240820$$MD$US$US
242363471$24236347$1$I$20230701$20230821$20240822$20240822$EXP$$CA-AstraZeneca-2023A117115$ASTRAZENECA$$682$MON$$M$Y$$$20240822$$MD$CA$
242363481$24236348$1$I$20240819$20240819$20240822$20240822$PER$$US-AstraZeneca-2024A189047$ASTRAZENECA$$$$$$Y$$$20240822$$CN$US$
242363491$24236349$1$I$$20240816$20240822$20240822$PER$$US-ALXN-202408USA001089US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242363501$24236350$1$I$$20240724$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07436$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242363511$24236351$1$I$$20240819$20240822$20240822$EXP$$CN-ROCHE-10000061283$ROCHE$$48$YR$A$F$Y$$$20240822$$MD$CN$CN
242363521$24236352$1$I$20240101$20240802$20240822$20240822$PER$$US-TEVA-VS-3229713$TEVA$$$$$F$Y$$$20240822$$CN$US$US
242363531$24236353$1$I$20240715$20240808$20240822$20240822$EXP$$CA-HLS-202401995$HLS THERAPEUTICS$$78$YR$E$F$Y$$$20240822$$CN$CA$CA
242363542$24236354$2$F$20240703$20240822$20240822$20240902$EXP$$IT-AUROBINDO-AUR-APL-2024-041152$AUROBINDO$$74$YR$$F$Y$$$20240902$$PH$IT$IT
242363561$24236356$1$I$20240804$20240815$20240822$20240822$EXP$$CN-BEIGENE-BGN-2024-012812$BEIGENE$$$$$$Y$$$20240822$$HP$CN$CN
242363571$24236357$1$I$$20240815$20240822$20240822$PER$$US-JNJFOC-20240840309$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$PH$US$US
242363581$24236358$1$I$$20240819$20240822$20240822$EXP$$CA-JNJFOC-20240850658$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240822$$HP$CA$CA
242363591$24236359$1$I$20240814$20240814$20240822$20240822$EXP$$US-JNJFOC-20240841024$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240822$$MD$US$US
242363601$24236360$1$I$20240814$20240814$20240822$20240822$EXP$$US-AMGEN-USASP2024163260$AMGEN$$70$YR$E$F$Y$$$20240822$$CN$US$US
242363611$24236361$1$I$$20240813$20240822$20240822$PER$$US-JNJFOC-20240844407$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240822$$HP$US$US
242363631$24236363$1$I$20240629$20240813$20240822$20240822$EXP$$FR-AUROBINDO-AUR-APL-2024-041357$AUROBINDO$$21$YR$$M$Y$$$20240822$$MD$FR$FR
242363641$24236364$1$I$$20240815$20240822$20240822$EXP$$CH-GSK-CH2024102302$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$MD$CH$CH
242363652$24236365$2$F$$20240822$20240822$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408011713$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240904$$CN$US$US
242363661$24236366$1$I$$20240815$20240822$20240822$PER$$US-JNJFOC-20240844866$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$CN$US$US
242363671$24236367$1$I$20240101$20240610$20240822$20240822$EXP$$US-CIPLA LTD.-2024US08694$CIPLA$$$$$$Y$$$20240822$$CN$US$US
242363681$24236368$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011999$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240822$$CN$US$US
242363691$24236369$1$I$20240812$20240813$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408008929$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240822$$CN$US$US
242363701$24236370$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011730$ELI LILLY AND CO$$$$$F$Y$$$20240822$$HP$US$US
242363711$24236371$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011702$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242363721$24236372$1$I$20240819$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011628$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240822$$CN$US$US
242363732$24236373$2$F$20240820$20240821$20240822$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012523$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240826$$CN$US$US
242363741$24236374$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011975$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240822$$CN$US$US
242363761$24236376$1$I$20240814$20240815$20240822$20240822$EXP$$CA-CELLTRION INC.-2024CA020168$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
242363772$24236377$2$F$$20240902$20240822$20240908$EXP$$JP-009507513-2408JPN001723J$MERCK$$7$DEC$$$Y$$$20240908$$MD$JP$JP
242363781$24236378$1$I$$20240724$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07477$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242363791$24236379$1$I$$20240814$20240822$20240822$PER$$US-JNJFOC-20240838815$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$HP$US$US
242363801$24236380$1$I$$20240813$20240822$20240822$EXP$$US-PIRAMAL CRITICAL CARE LIMITED-2024-PPL-000619$PIRAMAL$Ra O.H.; Tan J.C.; Zhao C.W.; Burns S.L.. Transient recurrence of chemotherapy-induced peripheral neuropathy in the immediate postoperative period following gynaecological surgery under general anaesthesia.. Anaesthesia Reports. 2024;12:2:e12315$$$$$Y$$$20240822$$MD$US$US
242363815$24236381$5$F$20240101$20240911$20240822$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024619$UNITED THERAPEUTICS$$$$$M$Y$78.458$KG$20240920$$$US$US
242363821$24236382$1$I$$20240807$20240822$20240822$EXP$$CA-ASSERTIO THERAPEUTICS, INC.-CA-2024AST000277$ASSERTIO THERAPEUTICS$$$$$M$Y$$$20240822$$CN$CA$CA
242363831$24236383$1$I$20240816$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164503$AMGEN$$62$YR$A$M$Y$$$20240822$$CN$US$US
242363841$24236384$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163609$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242363851$24236385$1$I$$20240813$20240822$20240822$PER$$US-JNJFOC-20240841007$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$CN$US$US
242363861$24236386$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163575$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242363871$24236387$1$I$$20240815$20240822$20240822$EXP$$RU-SA-2024SA245528$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240822$$MD$RU$RU
242363881$24236388$1$I$20210430$20240815$20240822$20240822$EXP$$US-ORPHANEU-2021001914$RECORDATI$$$$$$Y$$$20240822$$CN$US$US
242363891$24236389$1$I$20220801$20240816$20240822$20240822$EXP$$US-TAKEDA-2024TUS061144$TAKEDA$$43$YR$$F$Y$$$20240822$$CN$US$US
242363901$24236390$1$I$20240808$20240819$20240822$20240822$EXP$$US-TAKEDA-2024TUS083759$TAKEDA$$67$YR$$M$Y$$$20240822$$MD$US$US
242363911$24236391$1$I$$20240815$20240822$20240822$EXP$$AU-ADIENNEP-2024AD000666$ADIENNE PHARMA + BIOTECH$$54$YR$$F$Y$$$20240819$$MD$AU$
242363924$24236392$4$F$20240101$20240910$20240822$20240918$EXP$$CA-CELLTRION INC.-2024CA015120$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
242363932$24236393$2$F$$20240821$20240822$20240827$EXP$$US-INFO-20240252$INFORLIFE$$60$YR$A$F$Y$$$20240823$$PH$US$US
242363951$24236395$1$I$$20230425$20240822$20240822$EXP$$CA-AstraZeneca-2023A052156$ASTRAZENECA$$$$$F$Y$$$20240822$$HP$CA$
242363961$24236396$1$I$$20230123$20240822$20240822$EXP$$US-AstraZeneca-2023A020885$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242363971$24236397$1$I$$20221028$20240822$20240822$EXP$$US-AstraZeneca-2022A326606$ASTRAZENECA$$$$$F$Y$49$KG$20240822$$CN$US$
242363981$24236398$1$I$$20220630$20240822$20240822$EXP$$US-AstraZeneca-2022A241332$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242363992$24236399$2$F$20231001$20240905$20240822$20240913$EXP$$US-ABBVIE-5886629$ABBVIE$$63$YR$$F$Y$111$KG$20240913$$CN$US$US
242364001$24236400$1$I$$20220502$20240822$20240822$EXP$$US-AstraZeneca-2022A119002$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242364011$24236401$1$I$20240712$20240820$20240822$20240822$EXP$$US-TAKEDA-2024TUS084221$TAKEDA$$64$YR$$F$Y$$$20240822$$MD$US$US
242364023$24236402$3$F$20240101$20240912$20240822$20240918$PER$$US-UNITED THERAPEUTICS-UNT-2024-025297$UNITED THERAPEUTICS$$$$$F$Y$47.619$KG$20240918$$$US$US
242364032$24236403$2$F$20240201$20240909$20240822$20240913$EXP$$US-ABBVIE-5885936$ABBVIE$$68$YR$$F$Y$45$KG$20240913$$CN$US$US
242364041$24236404$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163638$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242364051$24236405$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163615$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242364061$24236406$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163626$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242364071$24236407$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163640$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242364081$24236408$1$I$20240415$20240816$20240822$20240822$EXP$$US-TAKEDA-2024TUS015657$TAKEDA$$55$YR$$F$Y$59$KG$20240822$$HP$US$US
242364091$24236409$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163617$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242364101$24236410$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163648$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242364111$24236411$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163610$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242364121$24236412$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163636$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242364131$24236413$1$I$$20240815$20240822$20240822$EXP$$AU-ADIENNEP-2024AD000665$ADIENNE PHARMA + BIOTECH$$$$A$F$Y$$$20240816$$MD$AU$
242364141$24236414$1$I$$20240819$20240822$20240822$EXP$$SY-SNT-000404$SINOTHERAPEUTICS$(Citation: Alhalabi M., Alziadan S.M. A diagnostic dilemma: cytomegalovirus colitis as an uncommon comorbidity in inflammatory bowel disease: a case report. Virol J. 2024; 21(1):188. Doi: 10.1186/s12985-024-02467-y.)$28$YR$A$F$Y$$$20240822$$HP$SY$SY
242364151$24236415$1$I$20240805$20240815$20240822$20240822$EXP$$CN-Orion Corporation ORION PHARMA-ENT 2024-0039$ORION$$87$YR$E$M$Y$58$KG$20240822$$HP$CN$
242364161$24236416$1$I$20240603$20240812$20240822$20240822$EXP$$ES-AUROBINDO-AUR-APL-2024-041013$AUROBINDO$$$$E$F$Y$$$20240822$$MD$ES$ES
242364171$24236417$1$I$20240101$20240820$20240822$20240822$EXP$$US-ABBVIE-5888411$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242364181$24236418$1$I$20231028$20240814$20240822$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-130283$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$81.2$KG$20240822$$PH$JP$JP
242364191$24236419$1$I$$20240820$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132647$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240822$$CN$US$US
242364201$24236420$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132320$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240822$$CN$US$US
242364211$24236421$1$I$$20240821$20240822$20240822$PER$$NVSC2024US169825$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242364221$24236422$1$I$20240701$20240812$20240822$20240822$EXP$$ES-AUROBINDO-AUR-APL-2024-041269$AUROBINDO$$54$YR$$F$Y$$$20240822$$MD$ES$ES
242364231$24236423$1$I$20240811$20240820$20240822$20240822$EXP$$CN-ROCHE-10000061839$ROCHE$$44$YR$A$F$Y$51.5$KG$20240822$$HP$CN$CN
242364241$24236424$1$I$$20240818$20240822$20240822$EXP$$GB-AMGEN-GBRSP2024165013$AMGEN$$29$YR$A$F$Y$$$20240822$$CN$GB$GB
242364251$24236425$1$I$20240802$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164538$AMGEN$$72$YR$E$F$Y$$$20240822$$CN$US$US
242364262$24236426$2$F$20240820$20240910$20240822$20240912$PER$$US-AMGEN-USASP2024167144$AMGEN$$71$YR$E$F$Y$$$20240912$$CN$US$US
242364271$24236427$1$I$20240620$20240821$20240822$20240822$EXP$$US-UCBSA-2024042483$UCB$$40$YR$$F$Y$$$20240822$$CN$US$US
242364281$24236428$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163707$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242364291$24236429$1$I$$20240814$20240822$20240822$EXP$$GB-CELLTRION INC.-2024GB019776$CELLTRION$$$$$$Y$$$20240822$$CN$GB$GB
242364301$24236430$1$I$$20240819$20240822$20240822$EXP$$NVSC2024JM169475$NOVARTIS$$$$$F$Y$$$20240822$$MD$JM$JM
242364311$24236431$1$I$20240425$20240812$20240822$20240822$EXP$$ES-AUROBINDO-AUR-APL-2024-041243$AUROBINDO$$81$YR$$F$Y$$$20240822$$MD$ES$ES
242364322$24236432$2$F$$20240903$20240822$20240922$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07539$LUPIN$$$$$$Y$$$20240922$$MD$US$US
242364331$24236433$1$I$20240101$20240816$20240822$20240822$PER$$US-ABBVIE-5884786$ABBVIE$$$$$F$Y$81.646$KG$20240822$$CN$US$US
242364342$24236434$2$F$$20240912$20240822$20240918$EXP$$CA-TAKEDA-2024TUS083349$TAKEDA$$$$$M$Y$$$20240918$$CN$CA$CA
242364351$24236435$1$I$$20240813$20240822$20240822$EXP$$PE-ROCHE-10000057509$ROCHE$$80$YR$E$F$Y$$$20240822$$CN$PE$PE
242364361$24236436$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5888420$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242364371$24236437$1$I$$20240813$20240822$20240822$EXP$$US-GSK-US2024AMR102775$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242364381$24236438$1$I$20240814$20240814$20240822$20240822$EXP$$US-CELLTRION INC.-2024US019957$CELLTRION$$$$$$Y$$$20240822$$HP$US$US
242364391$24236439$1$I$20240413$20240812$20240822$20240822$EXP$$DE-AUROBINDO-AUR-APL-2024-041064$AUROBINDO$$61$YR$$M$Y$$$20240822$$MD$DE$DE
242364401$24236440$1$I$$20240819$20240822$20240822$EXP$$AU-SANDOZ INC.-SDZ2024AU073657$SANDOZ$$78$YR$$F$Y$$$20240822$$MD$AU$AU
242364411$24236441$1$I$20240620$20240813$20240822$20240822$EXP$$DE-ROCHE-10000057483$ROCHE$$36$YR$A$M$Y$90$KG$20240822$$MD$DE$DE
242364421$24236442$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163709$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242364431$24236443$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130649$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240822$$HP$US$US
242364441$24236444$1$I$20240101$20240813$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128680$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240822$$HP$US$US
242364451$24236445$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131934$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$48.99$KG$20240822$$CN$US$US
242364461$24236446$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131890$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240822$$CN$US$US
242364471$24236447$1$I$$20240816$20240822$20240822$EXP$$CA-TAKEDA-2024TUS083458$TAKEDA$$$$$F$Y$$$20240822$$CN$CA$CA
242364481$24236448$1$I$$20211228$20240822$20240822$EXP$$US-AstraZeneca-2021A908420$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242364491$24236449$1$I$$20230830$20240822$20240822$EXP$$US-AstraZeneca-2023A200289$ASTRAZENECA$$$$$$Y$$$20240822$$CN$US$
242364501$24236450$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A185665$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242364511$24236451$1$I$$20210826$20240822$20240822$EXP$$US-AstraZeneca-2021A613604$ASTRAZENECA$$$$A$F$Y$$$20240822$$CN$US$
242364521$24236452$1$I$20230810$20230830$20240822$20240822$EXP$$CO-AstraZeneca-2023A200314$ASTRAZENECA$$25675$DY$$F$Y$56$KG$20240822$$CN$CO$
242364533$24236453$3$F$$20240910$20240822$20240912$PER$$US-BIOVITRUM-2024-US-011143$BIOVITRUM$$78$YR$$M$Y$$$20240912$$CN$US$US
242364541$24236454$1$I$20240815$20240819$20240822$20240822$EXP$$CA-TAKEDA-2024TUS069914$TAKEDA$$41$YR$$M$Y$$$20240822$$CN$CA$CA
242364551$24236455$1$I$20230901$20240819$20240822$20240822$EXP$$DE-ABBVIE-5887551$ABBVIE$$54$YR$$F$Y$$$20240822$$MD$DE$DE
242364561$24236456$1$I$$20240815$20240822$20240822$PER$$US-ABBVIE-5884263$ABBVIE$$$$$M$Y$$$20240822$$HP$US$US
242364572$24236457$2$F$20240819$20240930$20240822$20240930$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046923$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20241001$$CN$US$US
242364582$24236458$2$F$20240101$20240919$20240822$20240924$EXP$$US-ABBVIE-5883199$ABBVIE$$$$$F$Y$75$KG$20240924$$CN$US$US
242364591$24236459$1$I$20220422$20240820$20240822$20240822$EXP$PT-INFARMED-F202408-133$PT-JNJFOC-20240855657$JOHNSON AND JOHNSON$$55$YR$A$M$Y$75$KG$20240822$$PH$PT$PT
242364601$24236460$1$I$$20240808$20240822$20240822$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-18851$ALKEM$Nosari, A., L. Marbello, L. G. De Carlis, A. De Gasperi, G. Muti, and V. Mancini, et al.. Bone marrow hypoplasia complicating tacrolimus (FK506) therapy. Int. J. Hematol. 2004;79:130-132$$$$$Y$$$20240822$$HP$IT$IT
242364611$24236461$1$I$$20240808$20240822$20240822$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-18990$ALKEM$de-la-Serna-Higuera C, R Barcena Marugan, J Aviles, J Nuno, and A Cantalapiedra. Tacrolimus-induced bone marrow suppression. Lancet. 1997;350:714-715$$$$$Y$$$20240822$$HP$ES$ES
242364621$24236462$1$I$20240625$20240808$20240822$20240822$EXP$GB-MHRA-MED-202408071137307850-HQDSF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18672$ALKEM$$$$$M$Y$$$20240822$$MD$GB$GB
242364641$24236464$1$I$20240812$20240816$20240822$20240822$EXP$$CN-ABBVIE-5887589$ABBVIE$$57$YR$$F$Y$60$KG$20240822$$HP$CN$CN
242364651$24236465$1$I$$20240815$20240822$20240822$EXP$$US-ABBVIE-5883430$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242364661$24236466$1$I$$20240808$20240822$20240822$EXP$US-MLMSERVICE-20220706-3659485-3$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-00249$ALKEM$Mecadon K, Arvanitis P, Farmakiotis D, Rogers R.. Single-center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression. Clin Transpl. 2022;36:e14752$77$YR$$M$Y$$$20240822$$MD$US$US
242364672$24236467$2$F$$20240814$20240822$20240828$EXP$US-MLMSERVICE-20240731-PI149432-00306-3$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18688$ALKEM$Dykes K, Tzachanis D, Koura D. A Difficult Case of Calcineurin Inhibitor Neurotoxicity Post-Haploidentical HCT With a Successful Novel Solution: Cytotoxic T-Lymphocyte-Associated Protein 4-Immunoglobulin Blockade for GVHD Prophylaxis. Cell transplantation. 2024;33:1-7$24$YR$$M$Y$$$20240828$$MD$US$US
242364691$24236469$1$I$$20240812$20240822$20240822$EXP$$IT-AUROBINDO-AUR-APL-2024-041317$AUROBINDO$$73$YR$$$Y$90$KG$20240822$$MD$IT$IT
242364701$24236470$1$I$20220401$20240812$20240822$20240822$EXP$$PT-BIOCON BIOLOGICS LIMITED-BBL2024005923$BIOCON$Henriques C, Melo J, Vasconcelos S, Ramos R, Costa MM.. PO-0552 - (4842) - Respiratory infections: when appearances are deceiving.. Congresses of the Portuguese Society of Internal Medicine: 30th National Congres. 2024;905$$$$$Y$$$20240822$$HP$PT$PT
242364711$24236471$1$I$20240801$20240815$20240822$20240822$EXP$$CN-BEIGENE-BGN-2024-012821$BEIGENE$$$$$$Y$$$20240822$$HP$CN$CN
242364721$24236472$1$I$$20240815$20240822$20240822$EXP$$US-GSK-US2024AMR102843$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242364731$24236473$1$I$20240801$20240819$20240822$20240822$EXP$$US-ABBVIE-5887062$ABBVIE$$71$YR$$M$Y$$$20240822$$CN$US$US
242364742$24236474$2$F$$20240828$20240822$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004124$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
242364751$24236475$1$I$$20240730$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004123$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242364762$24236476$2$F$$20240905$20240822$20240914$EXP$$IN-ROCHE-10000037896$ROCHE$$70$YR$E$F$Y$$$20240914$$MD$IN$IN
242364772$24236477$2$F$20240730$20240918$20240822$20240927$EXP$$DE-AUROBINDO-AUR-APL-2024-041287$AUROBINDO$$61$YR$$F$Y$58.8$KG$20240927$$MD$DE$DE
242364781$24236478$1$I$20240101$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165841$AMGEN$$20$YR$A$M$Y$$$20240822$$CN$US$US
242364791$24236479$1$I$20240101$20240813$20240822$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-025317$UNITED THERAPEUTICS$$$$$M$Y$$$20240822$$$US$US
242364802$24236480$2$F$$20240822$20240822$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07268$LUPIN$$$$$$Y$$$20240909$$CN$US$US
242364813$24236481$3$F$$20240905$20240822$20240920$EXP$$US-Accord-442653$ACCORD$$64$YR$A$M$Y$$$20240920$$CN$US$US
242364822$24236482$2$F$$20240828$20240822$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004126$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
242364831$24236483$1$I$$20240807$20240822$20240822$EXP$$US-GRANULES-US-2024GRALIT00365$GRANULES INDIA$Martino J.Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use.Journal of Pharmacy Practice.JAN-2024$23$YR$A$M$Y$$$20240822$$HP$US$US
242364841$24236484$1$I$20240808$20240813$20240822$20240822$EXP$$GB-ROCHE-10000056004$ROCHE$$45$YR$A$F$Y$$$20240822$$HP$GB$GB
242364851$24236485$1$I$20240812$20240819$20240822$20240822$PER$$US-ROCHE-10000061102$ROCHE$$$$$$Y$$$20240822$$MD$US$US
242364861$24236486$1$I$20240801$20240814$20240822$20240822$EXP$$CA-CELLTRION INC.-2024CA019951$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
242364871$24236487$1$I$20240101$20240812$20240822$20240822$EXP$$DE-ABBVIE-5887439$ABBVIE$$33$YR$$F$Y$$$20240822$$HP$DE$DE
242364881$24236488$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5888633$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242364891$24236489$1$I$$20240807$20240822$20240822$EXP$$JP-ROCHE-10000057278$ROCHE$$$$$F$Y$$$20240822$$CN$JP$JP
242364902$24236490$2$F$$20240823$20240822$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07433$LUPIN$$$$$$Y$$$20240910$$CN$US$US
242364911$24236491$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004133$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242364921$24236492$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004134$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242364931$24236493$1$I$20240101$20240808$20240822$20240822$EXP$$US-UCBSA-2024020971$UCB$$$$$M$Y$115.19$KG$20240822$$CN$US$US
242364941$24236494$1$I$$20240806$20240822$20240822$PER$$US-009507513-2408USA002320$MERCK$$$$$$Y$$$20240822$$CN$US$US
242364951$24236495$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132513$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240822$$HP$US$US
242364961$24236496$1$I$20240101$20240815$20240822$20240822$EXP$$CA-ABBVIE-5884231$ABBVIE$$$$A$M$Y$$$20240822$$MD$CA$CA
242364981$24236498$1$I$20240701$20240816$20240822$20240822$EXP$$US-ABBVIE-5881432$ABBVIE$$82$YR$$F$Y$$$20240822$$CN$US$US
242364991$24236499$1$I$20240810$20240813$20240822$20240822$EXP$$IN-ROCHE-10000057126$ROCHE$$50$YR$A$F$Y$$$20240822$$CN$IN$IN
242365002$24236500$2$F$$20240816$20240822$20240905$PER$$US-ROCHE-10000061695$ROCHE$$$$$$Y$$$20240905$$MD$US$US
242365011$24236501$1$I$$20240814$20240822$20240822$EXP$$ZA-AstraZeneca-2024A185535$ASTRAZENECA$$71$YR$$F$Y$$$20240822$$CN$ZA$
242365021$24236502$1$I$$20221102$20240822$20240822$EXP$$US-AstraZeneca-2022A364219$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242365031$24236503$1$I$$20240726$20240822$20240822$EXP$$US-AstraZeneca-2024A171270$ASTRAZENECA$$$$$F$Y$59$KG$20240822$$CN$US$
242365041$24236504$1$I$20240810$20240814$20240822$20240822$EXP$$IN-AstraZeneca-2024A187761$ASTRAZENECA$$58$YR$$M$Y$65$KG$20240822$$HP$IN$
242365051$24236505$1$I$20200101$20210915$20240822$20240822$EXP$$US-AstraZeneca-2021A730456$ASTRAZENECA$$602$MON$$F$Y$$$20240822$$CN$US$
242365061$24236506$1$I$20220107$20220116$20240822$20240822$EXP$$US-AstraZeneca-2022A027910$ASTRAZENECA$$27077$DY$$M$Y$$$20240822$$CN$US$
242365071$24236507$1$I$20240718$20240815$20240822$20240822$EXP$$CN-BEIGENE-BGN-2024-012825$BEIGENE$$$$$$Y$$$20240822$$HP$CN$CN
242365081$24236508$1$I$20240701$20240819$20240822$20240822$EXP$$US-ABBVIE-5886331$ABBVIE$$72$YR$$F$Y$$$20240822$$CN$US$US
242365091$24236509$1$I$20240803$20240813$20240822$20240822$EXP$$US-GSK-US2024100791$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240822$$CN$US$US
242365101$24236510$1$I$20240809$20240816$20240822$20240822$PER$$US-ROCHE-10000061086$ROCHE$$$$$$Y$$$20240822$$MD$US$US
242365112$24236511$2$F$$20240822$20240822$20240830$PER$$US-ROCHE-10000063166$ROCHE$$$$A$F$Y$$$20240830$$CN$US$US
242365126$24236512$6$F$$20240920$20240822$20240927$EXP$$US-ROCHE-10000061587$ROCHE$$$$A$F$Y$61.69$KG$20240927$$CN$US$US
242365131$24236513$1$I$20240809$20240815$20240822$20240822$EXP$$CN-BEIGENE-BGN-2024-012802$BEIGENE$$$$$$Y$$$20240822$$HP$CN$CN
242365141$24236514$1$I$20240101$20240815$20240822$20240822$EXP$$CO-RECORDATI-2024006349$RECORDATI$$$$$$Y$$$20240822$$CN$CO$CO
242365152$24236515$2$F$20240717$20240913$20240822$20240916$PER$$US-AMGEN-USASP2024165432$AMGEN$$69$YR$E$M$Y$$$20240915$$CN$US$US
242365161$24236516$1$I$$20240815$20240822$20240822$EXP$$US-AMGEN-USASP2024162852$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242365181$24236518$1$I$20240401$20240815$20240822$20240822$EXP$$IL-EMD Serono-2024044344$EMD SERONO INC$$76$YR$E$F$Y$58$KG$20240822$$CN$IL$IL
242365191$24236519$1$I$20240605$20240809$20240822$20240822$EXP$$FR-AUROBINDO-AUR-APL-2024-040342$AUROBINDO$$77$YR$$M$Y$70$KG$20240822$$MD$FR$FR
242365211$24236521$1$I$$20240820$20240822$20240822$PER$$NVSC2024US169607$NOVARTIS$$$$$$Y$$$20240822$$CN$US$US
242365221$24236522$1$I$20240301$20240813$20240822$20240822$EXP$FR-AFSSAPS-RN2024000865$FR-EMD Serono-2024043675$EMD SERONO INC$$37$YR$A$F$Y$$$20240822$$PH$FR$FR
242365231$24236523$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5887303$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242365241$24236524$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5888200$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242365251$24236525$1$I$$20240819$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US073953$SANDOZ$Late Recognition ofCholinergic Delirium in Patient on Donepezil Combination Treatment$69$YR$$M$Y$$$20240822$$MD$US$US
242365262$24236526$2$F$20240801$20240827$20240822$20240901$EXP$$CA-ABBVIE-5885636$ABBVIE$$55$YR$$$Y$$$20240901$$CN$CA$CA
242365271$24236527$1$I$$20240819$20240822$20240822$EXP$$CA-ABBVIE-5886098$ABBVIE$$$$A$M$Y$$$20240822$$CN$CA$CA
242365281$24236528$1$I$$20240815$20240822$20240822$EXP$$US-BIOGEN-2024BI01278807$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242365291$24236529$1$I$20240818$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165518$AMGEN$$81$YR$E$M$Y$$$20240822$$CN$US$US
242365302$24236530$2$F$20240818$20240822$20240822$20240826$PER$$US-AMGEN-USASP2024165221$AMGEN$$84$YR$E$M$Y$$$20240825$$CN$US$US
242365311$24236531$1$I$$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164072$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242365321$24236532$1$I$20240708$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004145$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240822$$CN$US$US
242365331$24236533$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004144$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242365341$24236534$1$I$20240729$20240813$20240822$20240822$EXP$$CN-ROCHE-10000056679$ROCHE$$48$YR$A$F$Y$$$20240822$$HP$CN$CN
242365351$24236535$1$I$20230101$20240819$20240822$20240822$EXP$$US-ABBVIE-5876123$ABBVIE$$$$$F$Y$90.7$KG$20240822$$CN$US$US
242365361$24236536$1$I$20240813$20240821$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074408$SANDOZ$$$$$M$Y$$$20240822$$CN$US$US
242365372$24236537$2$F$20240815$20240823$20240822$20240829$EXP$$US-ABBVIE-5886827$ABBVIE$$78$YR$$M$Y$70$KG$20240829$$CN$US$US
242365381$24236538$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132684$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240822$$CN$US$US
242365392$24236539$2$F$20240701$20240913$20240822$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132276$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240917$$CN$US$US
242365401$24236540$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004150$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242365411$24236541$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5887183$ABBVIE$$52$YR$$F$Y$$$20240822$$CN$US$US
242365423$24236542$3$F$$20240912$20240822$20240917$PER$$US-CHATTEMPRD-2024OHG027898$CHATTEM$$$$$F$Y$$$20240917$$CN$US$US
242365431$24236543$1$I$20240412$20240816$20240822$20240822$EXP$$JP-ABBVIE-5887666$ABBVIE$$47$YR$$M$Y$$$20240822$$MD$JP$JP
242365441$24236544$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004153$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242365451$24236545$1$I$$20240807$20240822$20240822$EXP$$DE-GRANULES-DE-2024GRALIT00363$GRANULES INDIA$Maria Hoeltzenbein.Increasing use of newer antiseizure medication during pregnancy:  An observational study with special focus on lacosamide.Seizure: European Journal of Epilepsy.20-FEB-2023;107:107-113$$$N$$Y$$$20240822$$HP$DE$DE
242365461$24236546$1$I$$20240809$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2023-040322$AUROBINDO$$33$YR$$M$Y$$$20240822$$HP$CA$CA
242365471$24236547$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5887182$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242365481$24236548$1$I$20240731$20240814$20240822$20240822$EXP$$CN-ROCHE-10000058095$ROCHE$$42$YR$A$F$Y$47$KG$20240822$$HP$CN$CN
242365492$24236549$2$F$$20240910$20240822$20240919$30DAY$$US-GSK-US2024100833$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
242365503$24236550$3$F$20240812$20240813$20240822$20240823$EXP$$US-ROCHE-10000057077$ROCHE$$28$YR$A$F$Y$$$20240823$$CN$US$US
242365511$24236551$1$I$$20240810$20240822$20240822$PER$$US-ROCHE-10000055312$ROCHE$$$$$$Y$$$20240822$$CN$US$US
242365522$24236552$2$F$$20240918$20240822$20240919$PER$$US-JNJFOC-20240847191$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$PH$US$US
242365531$24236553$1$I$$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024165041$AMGEN$$$$$$Y$$$20240822$$PH$US$US
242365541$24236554$1$I$$20240816$20240822$20240822$PER$$US-CHATTEMPRD-2024OHG028030$CHATTEM$$$$$M$Y$$$20240822$$CN$US$US
242365552$24236555$2$F$20240830$20240830$20240822$20240904$EXP$$CA-TAKEDA-2023TUS038075$TAKEDA$$69$YR$$M$Y$$$20240904$$CN$CA$CA
242365571$24236557$1$I$20240813$20240815$20240822$20240822$EXP$$CN-BEIGENE-BGN-2024-012822$BEIGENE$$$$$$Y$$$20240822$$HP$CN$CN
242365581$24236558$1$I$$20240724$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07425$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242365591$24236559$1$I$$20240816$20240822$20240822$EXP$$US-ABBVIE-5887313$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242365601$24236560$1$I$20240802$20240819$20240822$20240822$EXP$$IT-ABBVIE-5887818$ABBVIE$$60$YR$$M$Y$$$20240822$$CN$IT$IT
242365611$24236561$1$I$$20240815$20240822$20240822$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-132636$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240822$$PH$GB$GB
242365621$24236562$1$I$$20240812$20240822$20240822$EXP$$BR-RDY-LIT/BRA/24/0012006$DR REDDYS$Scorza CA, corza FA, Finsterer J. Daytime bruxism, tardive orofacial dyskinesia, and dysphagia as side effects to duloxetine use over nine years in an octogenarian. Clinics (Sao Paulo, Brazil). 2024;79: 1-2. doi:10.1016/j.clinsp.2024.100438.$82$YR$E$F$Y$69$KG$20240822$$HP$BR$BR
242365633$24236563$3$F$$20240902$20240822$20240904$EXP$$CA-TAKEDA-2023TUS077745$TAKEDA$$$$$M$Y$$$20240904$$HP$CA$CA
242365642$24236564$2$F$$20240906$20240822$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132641$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$53.98$KG$20240911$$CN$US$US
242365652$24236565$2$F$20240801$20240905$20240822$20240912$EXP$$US-ABBVIE-5887874$ABBVIE$$27$YR$$F$Y$132$KG$20240912$$CN$US$US
242365662$24236566$2$F$$20240829$20240822$20240906$EXP$$PL-TEVA-VS-3234088$TEVA$Filipiuk A, Gonciarz M. Rare extraintestinal manifestations of ulcerative colitis treated with dual biologic therapy: A case report. World-J-Clin-Cases 2024; 12 (23): 5441-5447.; Filipiuk A, Gonciarz M. Rare extraintestinal manifestations of ulcerative colitis treated with dual biologic therapy: A case report. World-J-Clin-Cases 2024; 12 (23): 5441-5447.$47$YR$$M$Y$$$20240906$$MD$PL$PL
242365682$24236568$2$F$$20240912$20240822$20240921$EXP$$GB-CELLTRION INC.-2024GB019785$CELLTRION$$$$$$Y$$$20240921$$CN$GB$GB
242365692$24236569$2$F$$20240828$20240822$20240906$EXP$$GB-TEVA-VS-3233603$TEVA$Madhwapathi V, Tso S. Once in a blue moon?. Br-J-Dermatol 2024; 192 (Suppl.) i121 abstr. BG07.; Madhwapathi V, Tso S. Once in a blue moon?. Br-J-Dermatol 2024; 192 (Suppl.) i121 abstr. BG07.$80$YR$$F$Y$$$20240906$$HP$GB$GB
242365701$24236570$1$I$$20240812$20240822$20240822$EXP$$US-JNJFOC-20220917075$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$HP$US$US
242365711$24236571$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012917$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240822$$CN$US$US
242365721$24236572$1$I$20240818$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012096$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240822$$CN$US$US
242365731$24236573$1$I$20240813$20240816$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011469$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240822$$CN$US$US
242365741$24236574$1$I$20240812$20240812$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408008429$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240822$$CN$US$US
242365751$24236575$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012733$ELI LILLY AND CO$$$$$M$Y$$$20240822$$PH$US$US
242365761$24236576$1$I$20240815$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011703$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240822$$CN$US$US
242365771$24236577$1$I$20240818$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011961$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240822$$CN$US$US
242365781$24236578$1$I$20240816$20240816$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011770$ELI LILLY AND CO$$$$A$M$Y$$$20240822$$CN$US$US
242365791$24236579$1$I$20240819$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012048$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240822$$CN$US$US
242365801$24236580$1$I$$20240814$20240822$20240822$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006046$BIOCON$$$$$$Y$$$20240822$$PH$CA$CA
242365821$24236582$1$I$$20240812$20240822$20240822$EXP$$DE-AUROBINDO-AUR-APL-2024-041262$AUROBINDO$Hoeltzenbein M, Slimi S, Fietz A, Stegherr R, Onken M, Beyersmann J, et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. European Journal of Epilepsy.. 2023;107:107-113.$$$N$$Y$$$20240822$$HP$DE$DE
242365831$24236583$1$I$20230921$20240822$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-114180-2023$RECKITT BENCKISER$$80$YR$$F$Y$$$20240822$$CN$US$US
242365841$24236584$1$I$20240516$20240816$20240822$20240822$EXP$$NVSC2024GB166848$NOVARTIS$$$$$F$Y$$$20240822$$CN$GB$GB
242365851$24236585$1$I$$20240816$20240822$20240822$EXP$$NVSC2024US168698$NOVARTIS$$$$$M$Y$$$20240822$$MD$US$US
242365862$24236586$2$F$20231122$20240826$20240822$20240830$EXP$$CO-RECORDATI-2024003358$RECORDATI$$$$$$Y$$$20240830$$CN$CO$CO
242365891$24236589$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5886276$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242365902$24236590$2$F$20240807$20240828$20240822$20240902$30DAY$$US-AMGEN-USASP2024161371$AMGEN$$63$YR$A$F$Y$$$20240902$$HP$US$US
242365911$24236591$1$I$20240705$20240815$20240822$20240822$EXP$$CN-BEIGENE-BGN-2024-012824$BEIGENE$$$$$$Y$$$20240822$$HP$CN$CN
242365921$24236592$1$I$20240818$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165222$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242365932$24236593$2$F$20240817$20240827$20240822$20240902$PER$$US-AMGEN-USASP2024167271$AMGEN$$56$YR$A$F$Y$$$20240902$$CN$US$US
242365941$24236594$1$I$$20240820$20240822$20240822$EXP$$CA-ABBVIE-5887858$ABBVIE$$77$YR$$M$Y$71$KG$20240822$$PH$CA$CA
242365951$24236595$1$I$$20221026$20240822$20240822$EXP$$US-AstraZeneca-2022A323808$ASTRAZENECA$$19521$DY$$F$Y$$$20240822$$CN$US$
242365964$24236596$4$F$20240101$20240919$20240822$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025519$UNITED THERAPEUTICS$$$$$F$Y$94.331$KG$20240927$$$US$US
242365971$24236597$1$I$$20230303$20240822$20240822$EXP$$CA-AstraZeneca-2023A006772$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$CA$
242365981$24236598$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A186651$ASTRAZENECA$$$$$M$Y$68$KG$20240822$$CN$US$
242365991$24236599$1$I$20210101$20240808$20240822$20240822$EXP$$US-UCBSA-2024041110$UCB$$$$A$F$Y$$$20240822$$CN$US$US
242366011$24236601$1$I$$20240814$20240822$20240822$EXP$$ZA-AstraZeneca-2024A187482$ASTRAZENECA$$43$YR$$F$Y$$$20240822$$CN$ZA$
242366021$24236602$1$I$$20240816$20240822$20240822$EXP$FR-GERMAN-LIT/FRA/24/0011629$FR-ROCHE-10000059834$ROCHE$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024 Apr;117(4): 297-300. doi:10.1016/j.acvd.2024.02.003.$72$YR$E$M$Y$$$20240822$$HP$FR$FR
242366031$24236603$1$I$20240101$20240815$20240822$20240822$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-114471$REGENERON$$73$YR$$F$Y$$$20240822$$CN$CO$CO
242366041$24236604$1$I$20210517$20210521$20240822$20240822$EXP$$US-AstraZeneca-2021A466878$ASTRAZENECA$$3930$WK$$F$Y$$$20240822$$CN$US$
242366051$24236605$1$I$$20230621$20240822$20240822$EXP$$US-AstraZeneca-2023A144107$ASTRAZENECA$$$$$$Y$$$20240822$$CN$US$
242366061$24236606$1$I$$20210827$20240822$20240822$EXP$$US-AstraZeneca-2021A703725$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242366071$24236607$1$I$$20220711$20240822$20240822$EXP$$US-AstraZeneca-2022A252248$ASTRAZENECA$$$$$M$Y$64.8$KG$20240822$$CN$US$
242366081$24236608$1$I$$20220919$20240822$20240822$EXP$$US-AstraZeneca-2022A324139$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242366091$24236609$1$I$$20211029$20240822$20240822$EXP$$US-AstraZeneca-2021A790697$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242366101$24236610$1$I$20220101$20220510$20240822$20240822$EXP$$TH-AstraZeneca-2022A032835$ASTRAZENECA$$685$MON$$M$Y$$$20240822$$HP$TH$
242366111$24236611$1$I$$20230425$20240822$20240822$EXP$$US-AstraZeneca-2023A098345$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242366121$24236612$1$I$$20220610$20240822$20240822$EXP$$US-AstraZeneca-2022A163966$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242366131$24236613$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024AMR101067$GLAXOSMITHKLINE$$$$$M$Y$$$20240822$$CN$US$US
242366141$24236614$1$I$20240817$20240817$20240822$20240822$PER$$US-AMGEN-USASP2024165389$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
242366151$24236615$1$I$20240723$20240724$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07396$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242366161$24236616$1$I$$20240820$20240822$20240822$EXP$$US-GSK-US2024103881$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242366171$24236617$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165442$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242366181$24236618$1$I$$20240814$20240822$20240822$EXP$US-MLMSERVICE-20240807-PI154596-00108-1$US-RDY-SPO/USA/24/0011970$DR REDDYS$St. George Teaford H. Psychotherapeutic Approach to the Treatment of a Youth with Schizophrenia and OCD: A Case Report. Journal of Indian Association for Child and Adolescent Mental Health. 2024;20(2):181-3. DOI:10.1177/09731342241236296.$13$YR$T$M$Y$$$20240822$$MD$US$US
242366191$24236619$1$I$$20240814$20240822$20240822$PER$US-MLMSERVICE-20240807-PI154707-00221-1$US-RDY-SPO/USA/24/0011941$DR REDDYS$Shaikh M, Golzarian H, Hakim FA. Wide QRS tachycardia in a patient with atrial fibrillation: a case report and approach to diagnosis. European heart journal. Case reports. 2024;8(8):ytae328. DOI: 10.1093/ehjcr/ytae328.$87$YR$E$M$Y$$$20240822$$MD$US$US
242366202$24236620$2$F$20240816$20240910$20240822$20240912$PER$$US-AMGEN-USASP2024165719$AMGEN$$79$YR$E$F$Y$$$20240912$$CN$US$US
242366211$24236621$1$I$$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129042$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240822$$CN$US$US
242366221$24236622$1$I$20240727$20240816$20240822$20240822$EXP$$PK-ROCHE-10000059775$ROCHE$$33$YR$A$F$Y$$$20240822$$CN$PK$PK
242366231$24236623$1$I$20240203$20240815$20240822$20240822$EXP$$NL-BIOGEN-2024BI01278768$BIOGEN$$59$YR$$M$Y$$$20240822$$HP$NL$NL
242366242$24236624$2$F$20240101$20240923$20240822$20240928$EXP$$US-ABBVIE-5794714$ABBVIE$$$$$F$Y$92.986$KG$20240928$$CN$US$US
242366251$24236625$1$I$20240818$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165673$AMGEN$$76$YR$E$M$Y$$$20240822$$CN$US$US
242366261$24236626$1$I$20240810$20240813$20240822$20240822$EXP$$TH-ROCHE-10000055973$ROCHE$$62$YR$A$F$Y$$$20240822$$CN$TH$TH
242366271$24236627$1$I$$20240813$20240822$20240822$EXP$$CA-APOTEX-2024AP009387$APOTEX$$79$YR$$M$Y$75$KG$20240822$$PH$CA$CA
242366281$24236628$1$I$$20240809$20240822$20240822$EXP$$US-FARMAPROD-202408-2896$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240821$$CN$US$US
242366291$24236629$1$I$$20240815$20240822$20240822$EXP$$US-GSK-US2024AMR102854$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242366301$24236630$1$I$$20240818$20240822$20240822$PER$$US-JNJFOC-20240849395$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$US$US
242366312$24236631$2$F$20231001$20240906$20240822$20240914$PER$$US-JNJFOC-20240782869$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240914$$CN$US$US
242366321$24236632$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024166049$AMGEN$$$$$$Y$$$20240822$$PH$US$US
242366331$24236633$1$I$20240819$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165392$AMGEN$$67$YR$E$M$Y$$$20240822$$CN$US$US
242366341$24236634$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165699$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242366351$24236635$1$I$$20240812$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-041351$AUROBINDO$$$$$F$Y$$$20240822$$CN$CA$CA
242366361$24236636$1$I$20240101$20240813$20240822$20240822$PER$$US-ABBVIE-5882471$ABBVIE$$$$$F$Y$48$KG$20240822$$CN$US$US
242366371$24236637$1$I$$20230601$20240822$20240822$EXP$$US-AstraZeneca-2023A129069$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242366391$24236639$1$I$$20221021$20240822$20240822$EXP$$US-AstraZeneca-2022A353580$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242366401$24236640$1$I$20240805$20240812$20240822$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-040872$AUROBINDO$$23$MON$$F$Y$$$20240822$$CN$GB$GB
242366411$24236641$1$I$20240414$20240815$20240822$20240822$EXP$$GB-AstraZeneca-2024A185445$ASTRAZENECA$$$$$M$Y$$$20240822$$MD$GB$
242366431$24236643$1$I$$20221118$20240822$20240822$EXP$$US-AstraZeneca-2022A350620$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242366441$24236644$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A187462$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242366451$24236645$1$I$$20240814$20240822$20240822$EXP$$ZA-AstraZeneca-2024A187708$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$ZA$
242366461$24236646$1$I$$20230613$20240822$20240822$EXP$$US-AstraZeneca-2023A138821$ASTRAZENECA$$$$$$Y$$$20240822$$MD$US$
242366471$24236647$1$I$$20240813$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104268$VIIV$$$$$$Y$$$20240822$$HP$US$US
242366481$24236648$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132653$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$73.03$KG$20240822$$CN$US$US
242366491$24236649$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132578$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240822$$HP$US$US
242366501$24236650$1$I$$20240812$20240822$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-040906$AUROBINDO$$51$YR$$M$Y$$$20240822$$CN$GB$GB
242366511$24236651$1$I$$20240816$20240822$20240822$EXP$FR-GERMAN-LIT/FRA/24/0011634$FR-ROCHE-10000059832$ROCHE$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024 Apr;117(4): 297-300. doi:10.1016/j.acvd.2024.02.003.$71$YR$E$M$Y$$$20240822$$HP$FR$FR
242366522$24236652$2$F$20240101$20240905$20240822$20240906$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047187$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240906$$MD$JP$JP
242366531$24236653$1$I$$20230602$20240822$20240822$EXP$$US-AstraZeneca-2023A132132$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242366541$24236654$1$I$$20240813$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130108$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240822$$CN$US$US
242366561$24236656$1$I$20240801$20240819$20240822$20240822$PER$$US-AMGEN-USASL2024166656$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242366571$24236657$1$I$20240815$20240815$20240822$20240822$EXP$$CH-REGENERON PHARMACEUTICALS, INC.-2024-114810$REGENERON$$$$$M$Y$$$20240822$$HP$CH$CH
242366603$24236660$3$F$$20240913$20240822$20240916$PER$$NVSC2024US169484$NOVARTIS$$$$$$Y$$$20240916$$CN$US$US
242366611$24236661$1$I$$20240822$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-135335-2023$RECKITT BENCKISER$$$$$F$Y$$$20240822$$CN$US$US
242366621$24236662$1$I$$20240814$20240822$20240822$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005987$BIOCON$$$$$$Y$$$20240822$$PH$CA$CA
242366631$24236663$1$I$20240101$20240821$20240822$20240822$EXP$$US-UCBSA-2024042480$UCB$$$$$M$Y$$$20240822$$CN$US$US
242366641$24236664$1$I$20240101$20240812$20240822$20240822$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000718$DECIPHERA PHARMACEUTICALS$$64$YR$A$M$Y$$$20240822$$CN$US$US
242366661$24236666$1$I$20240727$20240809$20240822$20240822$EXP$FR-AFSSAPS-BR2024000636$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07725$HIKMA$$68$YR$$M$Y$66$KG$20240822$$MD$FR$FR
242366671$24236667$1$I$20240815$20240815$20240822$20240822$PER$$US-ABBVIE-5882665$ABBVIE$$18$YR$$F$Y$$$20240822$$HP$US$US
242366681$24236668$1$I$$20240819$20240822$20240822$EXP$$SI-JNJFOC-20240848990$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$MD$SI$SI
242366691$24236669$1$I$20221125$20240818$20240822$20240822$EXP$$IL-ABBVIE-5886460$ABBVIE$$62$YR$$F$Y$58$KG$20240822$$MD$IL$IL
242366701$24236670$1$I$20240101$20240814$20240822$20240822$EXP$$BR-ROCHE-10000058346$ROCHE$$71$YR$E$M$Y$$$20240822$$MD$BR$BR
242366711$24236671$1$I$$20230307$20240822$20240822$EXP$$GB-AstraZeneca-2023A055663$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$GB$
242366722$24236672$2$F$20240601$20240827$20240822$20240828$EXP$$TW-ABBVIE-5886430$ABBVIE$$70$YR$$M$Y$48$KG$20240828$$CN$TW$TW
242366731$24236673$1$I$$20230920$20240822$20240822$EXP$$US-AstraZeneca-2023A214887$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242366741$24236674$1$I$$20230714$20240822$20240822$EXP$$US-AstraZeneca-2023A126722$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242366751$24236675$1$I$$20240814$20240822$20240822$EXP$$IL-AstraZeneca-2024A188056$ASTRAZENECA$$$$$F$Y$$$20240822$$MD$IL$
242366761$24236676$1$I$$20230814$20240822$20240822$EXP$$US-AstraZeneca-2023A186577$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242366771$24236677$1$I$20220317$20220603$20240822$20240822$EXP$$US-AstraZeneca-2022A187103$ASTRAZENECA$$23813$DY$$F$Y$$$20240822$$CN$US$
242366784$24236678$4$F$20220201$20240913$20240822$20240920$EXP$$NVSC2024US169479$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
242366791$24236679$1$I$$20240820$20240822$20240822$PER$$NVSC2024US169632$NOVARTIS$$$$$$Y$$$20240822$$CN$US$US
242366801$24236680$1$I$$20240814$20240822$20240822$PER$$US-ALXN-202408USA000930US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242366812$24236681$2$F$$20240809$20240822$20240822$PER$$US-ROCHE-10000055785$ROCHE$$$$$$Y$$$20240822$$CN$US$US
242366822$24236682$2$F$$20240826$20240822$20240829$PER$$US-ROCHE-10000062582$ROCHE$$11$YR$C$M$Y$$$20240829$$CN$US$US
242366831$24236683$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024100343$GLAXOSMITHKLINE$$$$$M$Y$$$20240822$$CN$US$US
242366841$24236684$1$I$$20240812$20240822$20240822$EXP$$US-GSK-US2024100203$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242366851$24236685$1$I$20240809$20240812$20240822$20240822$30DAY$$US-GSK-US2024100341$GLAXOSMITHKLINE$$80$YR$$M$Y$$$20240822$$CN$US$US
242366871$24236687$1$I$$20240805$20240822$20240822$PER$$US-TEVA-VS-3230317$TEVA$$81$YR$$M$Y$$$20240822$$CN$US$US
242366881$24236688$1$I$20240614$20240819$20240822$20240822$EXP$$IN-RDY-SPO/IND/24/0009992$DR REDDYS$$59$YR$A$F$Y$68$KG$20240822$$CN$IN$IN
242366891$24236689$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062900$ROCHE$$59$YR$A$F$Y$$$20240822$$CN$US$US
242366901$24236690$1$I$$20240807$20240822$20240822$EXP$$AU-VERTICAL PHARMACEUTICALS-2024ALO00406$Alora Pharma$$$$$M$Y$$$20240822$$HP$AU$AU
242366912$24236691$2$F$20240729$20240906$20240822$20240913$EXP$$US-ABBVIE-5887300$ABBVIE$$74$YR$$F$Y$$$20240913$$CN$US$US
242366921$24236692$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131975$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240822$$HP$US$US
242366931$24236693$1$I$$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132803$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240822$$HP$US$US
242366941$24236694$1$I$20240703$20240820$20240822$20240822$EXP$$AU-SANDOZ INC.-SDZ2024AU074216$SANDOZ$$77$YR$$M$Y$$$20240822$$MD$AU$AU
242366951$24236695$1$I$20240809$20240812$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128026$BRISTOL MYERS SQUIBB$$19$YR$A$M$Y$$$20240822$$HP$US$US
242366961$24236696$1$I$$20240813$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132550$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240822$$CN$US$US
242366972$24236697$2$F$20240101$20240903$20240822$20240909$EXP$SE-SEMPA-2024-006197$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-132652$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240909$$MD$SE$SE
242366981$24236698$1$I$$20240812$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2023-032093$AUROBINDO$Espino PH, Burneo JG, Moscol G, Gofton T, MacDougall K, Suller Marti A. Long-term outcomes after NORSE: Treatment with vagus nerve stimulation. Epilepsia-Open. 2022;7(4):822-828$33$YR$$M$Y$$$20240822$$HP$CA$CA
242367002$24236700$2$F$20240803$20240817$20240822$20240827$EXP$$CN-VANTIVE-2024VAN019063$Vantive US Healthcare$$$$$$Y$$$20240827$$CN$CN$CN
242367011$24236701$1$I$20240113$20240821$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-082423-2024$RECKITT BENCKISER$$80$YR$$M$Y$83.18$KG$20240822$$CN$US$US
242367021$24236702$1$I$$20240419$20240822$20240822$EXP$$US-009507513-2408USA006801$MERCK$$$$$F$Y$$$20240822$$HP$US$US
242367031$24236703$1$I$20240712$20240812$20240822$20240822$PER$$US-ROCHE-10000055915$ROCHE$$$$$$Y$$$20240822$$HP$US$US
242367041$24236704$1$I$$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164652$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242367051$24236705$1$I$$20240812$20240822$20240822$EXP$$PL-AMGEN-POLSP2024163333$AMGEN$Ussowicz M.; Miskiewicz-bujna J.; Miskiewicz-migon I. et al.. Successful hematopoietic stem cell transplantation in MYH9-related congenital thrombocytopenia. Pediatric Blood + Cancer. 2024;71 (9):1-2$24$MON$C$M$Y$$$20240822$$HP$PL$PL
242367061$24236706$1$I$$20240808$20240822$20240822$EXP$$CN-Nexus Pharma-000303$NEXUS PHARMACEUTICALS$Liu D, Tong J, Chen E, Wang L, Xue L, Zhang X, et.al. Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF. Blood Lymphat Cancer. 2024 Jul 29;14:63-69.$$$$$Y$$$20240822$$HP$CN$CN
242367071$24236707$1$I$$20240808$20240822$20240822$EXP$$CN-Nexus Pharma-000302$NEXUS PHARMACEUTICALS$Liu D, Tong J, Chen E, Wang L, Xue L, Zhang X, et.al. Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF. Blood Lymphat Cancer. 2024 Jul 29;14:63-69.$$$$$Y$$$20240822$$HP$CN$CN
242367081$24236708$1$I$$20240818$20240822$20240822$PER$$US-HALEON-2192713$Haleon PLC$$47$YR$$M$Y$$$20240822$$CN$US$US
242367091$24236709$1$I$$20240819$20240822$20240822$EXP$$CA-Orion Corporation ORION PHARMA-24_00031364$ORION$$3$YR$C$F$Y$$$20240822$$HP$CA$
242367121$24236712$1$I$$20240820$20240822$20240822$EXP$$NVSC2024CA168883$NOVARTIS$$34$YR$$M$Y$$$20240822$$HP$CA$CA
242367131$24236713$1$I$$20240820$20240822$20240822$PER$$NVSC2024US169638$NOVARTIS$$$$$$Y$$$20240822$$MD$US$US
242367141$24236714$1$I$20240807$20240819$20240822$20240822$EXP$$CN-HALEON-2192633$Haleon PLC$$82$YR$$F$Y$$$20240822$$HP$CN$CN
242367151$24236715$1$I$20170801$20240821$20240822$20240822$EXP$$AU-TGA-0000816462$SANDOZ$$35$YR$$F$Y$$$20240822$$CN$AU$AU
242367161$24236716$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5887130$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242367171$24236717$1$I$$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164092$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242367181$24236718$1$I$$20240816$20240822$20240822$EXP$FR-GERMAN-LIT/FRA/24/0011632$FR-ROCHE-10000059360$ROCHE$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024 Apr;117(4): 297-300. doi:10.1016/j.acvd.2024.02.003.$80$YR$E$F$Y$$$20240822$$HP$FR$FR
242367191$24236719$1$I$20240101$20240816$20240822$20240822$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111307$ZYDUS PHARM$$$$$$Y$$$20240822$$PH$US$US
242367201$24236720$1$I$20240701$20240814$20240822$20240822$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111294$ZYDUS PHARM$$$$$$Y$$$20240822$$PH$US$US
242367211$24236721$1$I$$20240813$20240822$20240822$EXP$$CA-APOTEX-2024AP009397$APOTEX$$66$YR$$M$Y$$$20240822$$HP$CA$CA
242367221$24236722$1$I$20240701$20240816$20240822$20240822$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111306$ZYDUS PHARM$$$$$$Y$$$20240822$$PH$US$US
242367231$24236723$1$I$$20240808$20240822$20240822$EXP$$CN-Nexus Pharma-000301$NEXUS PHARMACEUTICALS$Liu D, Tong J, Chen E, Wang L, Xue L, Zhang X, et.al. Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF. Blood Lymphat Cancer. 2024 Jul 29;14:63-69.$$$$$Y$$$20240822$$HP$CN$CN
242367241$24236724$1$I$20240719$20240812$20240822$20240822$EXP$FR-AFSSAPS-TS2024000892$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111176$ZYDUS PHARM$$$$$$Y$$$20240822$$MD$FR$FR
242367251$24236725$1$I$$20240808$20240822$20240822$EXP$$US-CPL-004532$CADILA$Walterscheid B, Batchinsky M, Tarbox M. Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Preceding Toxic Epidermal Necrolysis Secondary to Sildenafil: A Case Report. Cureus. 2024 Jul 5;16(7):e63922.$66$YR$E$F$Y$$$20240822$$HP$US$US
242367261$24236726$1$I$20240513$20240812$20240822$20240822$EXP$FR-AFSSAPS-BR2024000642$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111136$ZYDUS PHARM$$$$$$Y$$$20240822$$MD$FR$FR
242367271$24236727$1$I$20240215$20240812$20240822$20240822$EXP$FR-AFSSAPS-CF2024000407$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111140$ZYDUS PHARM$$$$$$Y$$$20240822$$HP$FR$FR
242367281$24236728$1$I$$20240611$20240822$20240822$EXP$$CA-ROCHE-10000061353$ROCHE$$70$YR$E$M$Y$$$20240822$$HP$CA$CA
242367291$24236729$1$I$20240501$20240812$20240822$20240822$EXP$FR-AFSSAPS-AVGR2024000142$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111213$ZYDUS PHARM$$$$$$Y$$$20240822$$MD$FR$FR
242367301$24236730$1$I$20240201$20240812$20240822$20240822$EXP$FR-AFSSAPS-AN2024001038$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111146$ZYDUS PHARM$$$$$$Y$$$20240822$$MD$FR$FR
242367311$24236731$1$I$20240220$20240812$20240822$20240822$EXP$FR-AFSSAPS-NT2024001005$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111167$ZYDUS PHARM$$$$$$Y$$$20240822$$PH$FR$FR
242367321$24236732$1$I$$20240820$20240822$20240822$EXP$$CA-Orion Corporation ORION PHARMA-24_00031365$ORION$$75$YR$E$M$Y$$$20240822$$PH$CA$
242367331$24236733$1$I$$20240819$20240822$20240822$EXP$$US-ROCHE-3520330$ROCHE$$$$$$Y$$$20240822$$CN$US$US
242367341$24236734$1$I$20240323$20240812$20240822$20240822$EXP$$DE-AUROBINDO-AUR-APL-2024-041067$AUROBINDO$$69$YR$$M$Y$$$20240822$$MD$DE$DE
242367351$24236735$1$I$20211207$20240812$20240822$20240822$EXP$$DE-AUROBINDO-AUR-APL-2024-041057$AUROBINDO$$$$E$F$Y$88$KG$20240822$$HP$DE$DE
242367361$24236736$1$I$$20240815$20240822$20240822$PER$$US-ROCHE-10000059364$ROCHE$$$$A$F$Y$$$20240822$$CN$US$US
242367373$24236737$3$F$$20240910$20240822$20240910$PER$$US-ALXN-202408USA000994US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
242367381$24236738$1$I$$20240816$20240822$20240822$PER$$US-ROCHE-10000059924$ROCHE$$$$$F$Y$$$20240822$$CN$US$US
242367393$24236739$3$F$$20240925$20240822$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131907$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240927$$CN$US$US
242367401$24236740$1$I$$20240808$20240822$20240822$EXP$$JP-UCBSA-2024041132$UCB$$55$YR$$M$Y$$$20240822$$MD$JP$JP
242367411$24236741$1$I$$20240820$20240822$20240822$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-141283$DAIICHI$$$$$F$Y$$$20240822$$HP$US$US
242367421$24236742$1$I$$20240816$20240822$20240822$PER$$US-ROCHE-10000060591$ROCHE$$$$$$Y$$$20240822$$HP$US$US
242367431$24236743$1$I$$20240812$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-041241$AUROBINDO$$58$YR$$F$Y$$$20240822$$CN$CA$CA
242367441$24236744$1$I$20240817$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132739$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$123.38$KG$20240822$$CN$US$US
242367451$24236745$1$I$$20230620$20240822$20240822$EXP$$US-AstraZeneca-2023A144450$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242367461$24236746$1$I$$20221231$20240822$20240822$EXP$$US-AstraZeneca-2023A001805$ASTRAZENECA$$$$$M$Y$$$20240822$$MD$US$
242367471$24236747$1$I$20230808$20230922$20240822$20240822$EXP$$US-AstraZeneca-2023A182711$ASTRAZENECA$$27689$DY$$F$Y$$$20240822$$CN$US$
242367481$24236748$1$I$$20240819$20240822$20240822$EXP$$US-AstraZeneca-2024A189071$ASTRAZENECA$$$$$F$Y$$$20240822$$HP$US$
242367491$24236749$1$I$$20221019$20240822$20240822$EXP$$US-AstraZeneca-2022A351773$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242367501$24236750$1$I$20220416$20240815$20240822$20240822$EXP$IT-STADA-01284939$IT-ROCHE-10000058068$ROCHE$$76$YR$E$M$Y$66$KG$20240822$$HP$IT$IT
242367511$24236751$1$I$$20240817$20240822$20240822$EXP$$US-JNJFOC-20240845761$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240822$$CN$US$US
242367521$24236752$1$I$$20240812$20240822$20240822$PER$$US-JNJFOC-20240832260$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$CN$US$US
242367531$24236753$1$I$$20240815$20240822$20240822$EXP$$US-JNJFOC-20240839644$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$PH$US$US
242367541$24236754$1$I$$20240819$20240822$20240822$PER$$US-LEO Pharma-372877$LEO PHARM$$67$YR$$M$Y$$$20240822$$PH$US$US
242367551$24236755$1$I$20240801$20240815$20240822$20240822$EXP$$CA-JNJFOC-20240845813$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240822$$HP$CA$CA
242367572$24236757$2$F$$20240904$20240822$20240906$PER$$US-ROCHE-10000061179$ROCHE$$$$T$F$Y$$$20240906$$PH$US$US
242367581$24236758$1$I$20240819$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165852$AMGEN$$47$YR$A$M$Y$$$20240822$$CN$US$US
242367611$24236761$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165155$AMGEN$$$$$F$Y$$$20240822$$PH$US$US
242367624$24236762$4$F$20240810$20240904$20240822$20240909$30DAY$$US-AMGEN-USASP2024160316$AMGEN$$46$YR$A$F$Y$$$20240909$$CN$US$US
242367632$24236763$2$F$20240101$20240830$20240822$20240905$PER$$US-AMGEN-USASP2024165900$AMGEN$$56$YR$A$F$Y$124$KG$20240905$$HP$US$US
242367641$24236764$1$I$20240527$20240816$20240822$20240822$EXP$$CO-UCBSA-2024042444$UCB$$75$YR$$F$Y$$$20240822$$CN$CO$CO
242367651$24236765$1$I$20240513$20240812$20240822$20240822$EXP$$DE-AUROBINDO-AUR-APL-2024-041196$AUROBINDO$$83$YR$$M$Y$71.2$KG$20240822$$MD$DE$DE
242367661$24236766$1$I$$20240813$20240822$20240822$EXP$$US-ROCHE-10000057023$ROCHE$$84$YR$E$F$Y$$$20240822$$CN$US$US
242367671$24236767$1$I$$20240813$20240822$20240822$PER$$US-ABBVIE-5879943$ABBVIE$$$$$$Y$$$20240822$$CN$US$US
242367681$24236768$1$I$$20240815$20240822$20240822$EXP$$US-GSK-US2024101935$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$PH$US$US
242367691$24236769$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004115$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242367702$24236770$2$F$$20240909$20240822$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004111$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242367711$24236771$1$I$20240724$20240730$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004096$ACADIA PHARMACEUTICALS$$70$YR$$F$Y$$$20240822$$CN$US$US
242367721$24236772$1$I$20240501$20240730$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004121$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240822$$CN$US$US
242367742$24236774$2$F$20240729$20240816$20240822$20240828$EXP$$DE-AUROBINDO-AUR-APL-2024-041192$AUROBINDO$$65$YR$$F$Y$74$KG$20240828$$HP$DE$DE
242367753$24236775$3$F$20240730$20240904$20240822$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004087$ACADIA PHARMACEUTICALS$$11$YR$$F$Y$$$20240926$$CN$US$US
242367761$24236776$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004104$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242367771$24236777$1$I$20240720$20240730$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004097$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240822$$CN$US$US
242367783$24236778$3$F$20240907$20240909$20240822$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004120$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240919$$CN$US$US
242367791$24236779$1$I$20240719$20240730$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004101$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240822$$CN$US$US
242367801$24236780$1$I$20240701$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004089$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240822$$CN$US$US
242367812$24236781$2$F$20240823$20240903$20240822$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004122$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240926$$CN$US$US
242367821$24236782$1$I$20240727$20240730$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003989$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240822$$CN$US$US
242367832$24236783$2$F$$20240913$20240822$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004118$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242367841$24236784$1$I$$20240819$20240822$20240822$EXP$$CN-ABBVIE-5885714$ABBVIE$Wan Q, Chen Y, Wang S. Acute myeloid leukemia with gastric carcinoma: A case report of a double malignancy. Medicine. 2024;103(32):e39285.$58$YR$$M$Y$$$20240822$$MD$CN$CN
242367851$24236785$1$I$$20240816$20240822$20240822$EXP$$US-JNJFOC-20240843769$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$PH$US$US
242367861$24236786$1$I$20231231$20240821$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-082190-2024$RECKITT BENCKISER$$$$$F$Y$$$20240822$$CN$US$US
242367871$24236787$1$I$20240605$20240820$20240822$20240822$EXP$FR-AFSSAPS-DJ2024000913$FR-UCBSA-2024042151$UCB$$77$YR$$M$Y$70$KG$20240822$$MD$FR$FR
242367881$24236788$1$I$$20240815$20240822$20240822$EXP$$CA-Orion Corporation ORION PHARMA-21_00014996$ORION$$$$$M$Y$$$20240822$$HP$CA$
242367891$24236789$1$I$20240101$20240813$20240822$20240822$30DAY$$DE-UCBSA-2024041217$UCB$$50$YR$$M$Y$$$20240822$$CN$DE$DE
242367901$24236790$1$I$$20240816$20240822$20240822$EXP$$CA-AMX-008134$AMYLYX PHARMACEUTICALS$$66$YR$$F$Y$$$20240822$$CN$CA$CA
242367921$24236792$1$I$$20240814$20240822$20240822$EXP$$CA-TOLMAR, INC.-24CA051890$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242367931$24236793$1$I$$20240822$20240822$20240822$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-038220$BOEHRINGER INGELHEIM$$84$YR$E$M$Y$60$KG$20240822$$CN$AU$AU
242367941$24236794$1$I$20240101$20240814$20240822$20240822$EXP$$US-TOLMAR, INC.-24US051863$TOLMAR$$$$$M$Y$$$20240822$$CN$US$US
242367952$24236795$2$F$$20240926$20240822$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129672$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240930$$CN$US$US
242367961$24236796$1$I$$20240306$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-011984$AUROBINDO$$$$$F$Y$$$20240822$$MD$US$US
242367971$24236797$1$I$$20231004$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2023-063741$AUROBINDO$$36$YR$$F$Y$$$20240822$$MD$US$US
242367981$24236798$1$I$$20240813$20240822$20240822$EXP$$CA-APOTEX-2024AP009396$APOTEX$$59$YR$$F$Y$$$20240822$$HP$CA$CA
242367992$24236799$2$F$$20240823$20240822$20240903$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07832$HIKMA$Blackwell JN, Estes NA, Shalaby AA.. Blackwell JN, Estes NA, Shalaby AA. Help from the little guy: Intramural ischemic ventricular tachycardia ablation leveraging a 2F multipolar catheter in a coronary vein. Heart Rhythm Case Reports. 2024;10(8):1-5$68$YR$$M$Y$87.3$KG$20240903$$MD$US$US
242368001$24236800$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004182$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$HP$US$US
242368011$24236801$1$I$$20240820$20240822$20240822$EXP$$AU-SANDOZ INC.-SDZ2024AU074194$SANDOZ$$55$YR$$F$Y$$$20240822$$MD$AU$AU
242368021$24236802$1$I$$20240617$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-031089$AUROBINDO$$$$$F$Y$$$20240822$$HP$US$US
242368031$24236803$1$I$$20240315$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-013846$AUROBINDO$$$$A$$Y$$$20240822$$HP$US$US
242368041$24236804$1$I$$20240327$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-015199$AUROBINDO$$$$$M$Y$$$20240822$$MD$US$US
242368051$24236805$1$I$20240812$20240814$20240822$20240822$EXP$$CN-JNJFOC-20240844567$JOHNSON AND JOHNSON$$66$YR$E$M$Y$60.9$KG$20240822$$HP$CN$CN
242368062$24236806$2$F$20240818$20240826$20240822$20240828$PER$$US-AMGEN-USASP2024165302$AMGEN$$73$YR$E$F$Y$$$20240828$$CN$US$US
242368071$24236807$1$I$$20240815$20240822$20240822$PER$$US-AMGEN-USASP2024163393$AMGEN$$$$$$Y$$$20240822$$PH$US$US
242368081$24236808$1$I$20240819$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165503$AMGEN$$56$YR$A$M$Y$$$20240822$$CN$US$US
242368101$24236810$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000063366$ROCHE$$$$A$F$Y$72.57$KG$20240822$$CN$US$US
242368121$24236812$1$I$$20240816$20240822$20240822$PER$$US-ROCHE-10000060437$ROCHE$$$$$$Y$$$20240822$$CN$US$US
242368132$24236813$2$F$$20240820$20240822$20240828$EXP$$DE-ROCHE-10000057242$ROCHE$$$$A$F$Y$91$KG$20240828$$MD$DE$DE
242368141$24236814$1$I$20240101$20240818$20240822$20240822$PER$$US-ABBVIE-5889384$ABBVIE$$$$$$Y$$$20240822$$CN$US$US
242368162$24236816$2$F$$20240819$20240822$20240910$EXP$$DE-BEH-2024177428$CSL BEHRING$$$$E$M$Y$115$KG$20240910$$HP$DE$DE
242368173$24236817$3$F$$20240902$20240822$20240904$EXP$JP-MLMSERVICE-20240812-PI154586-00123-3$JP-SA-2024SA244508$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240904$$MD$JP$JP
242368181$24236818$1$I$20090901$20240821$20240822$20240822$EXP$FR-EMA-20140704-balwinderevhp-092554490$FR-GILEAD-2024-0684912$GILEAD$$45$YR$A$M$Y$$$20240822$$MD$FR$FR
242368191$24236819$1$I$$20240809$20240822$20240822$EXP$$US-SHIELD THERAPEUTICS-US-STX-24-00213$IRON THERAPEUTICS$$55$YR$$M$Y$$$20240822$$CN$US$US
242368201$24236820$1$I$20200101$20240507$20240822$20240822$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2022-128939$REGENERON$$$$$M$Y$$$20240822$$CN$US$US
242368211$24236821$1$I$20230101$20231107$20240822$20240822$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-087962$REGENERON$$$$$F$Y$$$20240822$$CN$US$US
242368221$24236822$1$I$$20240314$20240822$20240822$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-014746$REGENERON$$$$$M$Y$$$20240822$$CN$US$US
242368231$24236823$1$I$$20240703$20240822$20240822$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-072397$REGENERON$$$$$$Y$$$20240822$$HP$US$US
242368241$24236824$1$I$$20240703$20240822$20240822$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-073009$REGENERON$$$$$$Y$$$20240822$$HP$US$US
242368251$24236825$1$I$$20240815$20240822$20240822$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-087485$REGENERON$$$$$F$Y$$$20240822$$PH$US$US
242368261$24236826$1$I$$20240814$20240822$20240822$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006020$BIOCON$$$$$$Y$$$20240822$$CN$CA$CA
242368271$24236827$1$I$$20240815$20240822$20240822$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-090209$REGENERON$$$$$M$Y$$$20240822$$CN$US$US
242368281$24236828$1$I$20230101$20240702$20240822$20240822$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-077627$REGENERON$$$$$M$Y$$$20240822$$CN$US$US
242368291$24236829$1$I$20240601$20240815$20240822$20240822$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-089552$REGENERON$$$$$M$Y$$$20240822$$CN$US$US
242368301$24236830$1$I$20230101$20230919$20240822$20240822$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2023-078221$REGENERON$$$$$M$Y$$$20240822$$CN$US$US
242368331$24236833$1$I$20240622$20240820$20240822$20240822$EXP$$AR-UCBSA-2024042475$UCB$$81$YR$$M$Y$$$20240822$$CN$AR$AR
242368341$24236834$1$I$20240728$20240809$20240822$20240822$EXP$$TW-UCBSA-2024041209$UCB$$70$YR$$M$Y$$$20240822$$CN$TW$TW
242368351$24236835$1$I$$20231120$20240822$20240822$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67396$HIKMA$$$$$F$Y$$$20240822$$CN$US$US
242368372$24236837$2$F$$20240827$20240822$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132323$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240903$$HP$US$US
242368381$24236838$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132481$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240822$$HP$US$US
242368391$24236839$1$I$$20240724$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024100310$VIIV$$3$DEC$$M$Y$$$20240822$$HP$US$US
242368401$24236840$1$I$20240501$20240815$20240822$20240822$30DAY$$US-GSK-US2024101910$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240822$$CN$US$US
242368411$24236841$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024AMR100692$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242368431$24236843$1$I$$20240815$20240822$20240822$30DAY$$US-GSK-US2024101897$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242368441$24236844$1$I$20240815$20240820$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132499$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240822$$HP$US$US
242368451$24236845$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132458$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240822$$CN$US$US
242368461$24236846$1$I$$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131657$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240822$$CN$US$US
242368471$24236847$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004186$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242368481$24236848$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004187$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242368491$24236849$1$I$20240101$20240815$20240822$20240822$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-091747$REGENERON$$$$$M$Y$$$20240822$$CN$US$US
242368501$24236850$1$I$20240201$20240814$20240822$20240822$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-093380$REGENERON$$$$$F$Y$$$20240822$$CN$US$US
242368511$24236851$1$I$$20221122$20240822$20240822$EXP$$US-AstraZeneca-2022A386367$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242368521$24236852$1$I$$20240811$20240822$20240822$EXP$$CA-ABBVIE-5889323$ABBVIE$Gerrie A, Yin Y, Rai S, Hilton L, Meissner B, Nakamura H, et al. A single-cell multiomics analysis of IRF4 in mediating treatment resistance in ibrutinib-treated chronic lymphocytic leukemia (CLL). J Clin Oncol$$$$$Y$$$20240822$$HP$CA$CA
242368531$24236853$1$I$20211001$20221024$20240822$20240822$EXP$$US-AstraZeneca-2022A357461$ASTRAZENECA$$722$MON$$M$Y$123.4$KG$20240822$$CN$US$
242368541$24236854$1$I$20240101$20240815$20240822$20240822$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-095084$REGENERON$$$$$F$Y$$$20240822$$CN$US$US
242368551$24236855$1$I$20240321$20240814$20240822$20240822$EXP$$GB-AstraZeneca-2024A185453$ASTRAZENECA$$76$YR$$M$Y$88$KG$20240822$$MD$GB$
242368561$24236856$1$I$$20230720$20240822$20240822$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-63807$HIKMA$$$$$M$Y$$$20240822$$CN$US$US
242368571$24236857$1$I$20180829$20230224$20240822$20240822$EXP$$US-AstraZeneca-2022A412626$ASTRAZENECA$$70$YR$$M$Y$$$20240822$$HP$US$
242368581$24236858$1$I$$20240814$20240822$20240822$EXP$$ZA-AstraZeneca-2024A185409$ASTRAZENECA$$86$YR$$M$Y$$$20240822$$CN$ZA$
242368591$24236859$1$I$$20231011$20240822$20240822$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66320$HIKMA$$$$$F$Y$$$20240822$$CN$US$US
242368601$24236860$1$I$$20240122$20240822$20240822$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00899$HIKMA$$$$$M$Y$$$20240822$$CN$US$US
242368612$24236861$2$F$20240820$20240827$20240822$20240829$PER$$US-AMGEN-USASP2024166321$AMGEN$$23$YR$A$F$Y$$$20240829$$CN$US$US
242368621$24236862$1$I$$20240816$20240822$20240822$EXP$$GB-TAKEDA-2024TUS084185$TAKEDA$$$$$M$Y$$$20240822$$CN$GB$GB
242368631$24236863$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA248189$SANOFI AVENTIS$$$$A$F$Y$56.24$KG$20240822$$MD$US$US
242368641$24236864$1$I$$20240515$20240822$20240822$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-04553$HIKMA$$$$$M$Y$$$20240822$$CN$US$US
242368651$24236865$1$I$20230625$20240812$20240822$20240822$EXP$FR-AFSSAPS-PV2024000593$FR-TEVA-VS-3233187$TEVA$$1$DY$$M$Y$0.28$KG$20240822$$MD$FR$FR
242368661$24236866$1$I$$20240816$20240822$20240822$EXP$$US-TAKEDA-2024TUS083449$TAKEDA$$$$$F$Y$$$20240822$$CN$US$US
242368672$24236867$2$F$20240810$20240820$20240822$20240828$EXP$$CN-ROCHE-10000060046$ROCHE$$12$YR$T$$Y$$$20240828$$MD$CN$CN
242368681$24236868$1$I$$20240813$20240822$20240822$EXP$$US-GSK-US2024AMR101592$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$MD$US$US
242368692$24236869$2$F$20240101$20240904$20240822$20240911$PER$$US-AMGEN-USASP2024165612$AMGEN$$79$YR$E$F$Y$$$20240911$$CN$US$US
242368703$24236870$3$F$20240819$20240828$20240822$20240902$EXP$$US-AMGEN-USASP2024165513$AMGEN$$80$YR$E$M$Y$$$20240902$$CN$US$US
242368711$24236871$1$I$20240817$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024166922$AMGEN$$67$YR$E$F$Y$$$20240822$$CN$US$US
242368721$24236872$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165330$AMGEN$$39$YR$A$M$Y$$$20240822$$CN$US$US
242368731$24236873$1$I$$20240821$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074336$SANDOZ$$68$YR$$M$Y$$$20240822$$MD$US$US
242368751$24236875$1$I$20140101$20240817$20240822$20240822$EXP$$EG-SANDOZ INC.-SDZ2024EG073438$SANDOZ$$$$$F$Y$57$KG$20240822$$CN$EG$EG
242368761$24236876$1$I$20240630$20240812$20240822$20240822$EXP$IT-MINISAL02-994773$IT-TEVA-VS-3223528$TEVA$$8$YR$$F$Y$20.5$KG$20240822$$MD$IT$IT
242368771$24236877$1$I$20240816$20240820$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132651$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240822$$HP$US$US
242368781$24236878$1$I$$20240819$20240822$20240822$EXP$$US-TAKEDA-2024TUS083578$TAKEDA$$$$$F$Y$$$20240822$$CN$US$US
242368801$24236880$1$I$$20240814$20240822$20240822$EXP$$AU-CELLTRION INC.-2024AU020186$CELLTRION$$$$$$Y$$$20240822$$MD$AU$AU
242368811$24236881$1$I$$20240813$20240822$20240822$PER$$US-ABBVIE-5879580$ABBVIE$$$$$$Y$$$20240822$$CN$US$US
242368821$24236882$1$I$$20240819$20240822$20240822$EXP$$NVSC2024PT168468$NOVARTIS$$$$$F$Y$$$20240822$$CN$PT$PT
242368833$24236883$3$F$$20240828$20240822$20240903$PER$$US-ALXN-202408USA001258US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242368842$24236884$2$F$$20240904$20240822$20240905$PER$$US-ALXN-202408USA001102US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242368851$24236885$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004154$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242368871$24236887$1$I$20240522$20240821$20240822$20240822$EXP$SE-SEMPA-2024-006161$SE-NORDICGR-057266$NORDIC PHARMA$$71$YR$$M$Y$$$20240822$$MD$SE$SE
242368881$24236888$1$I$20231123$20240821$20240822$20240822$EXP$$DE-NORDICGR-057265$NORDIC PHARMA$$62$YR$$M$Y$$$20240822$$MD$DE$DE
242368893$24236889$3$F$20240819$20240912$20240822$20240918$EXP$$JP-SA-2024SA244434$SANOFI AVENTIS$$$$$$Y$$$20240919$$MD$JP$JP
242368911$24236891$1$I$20240101$20240809$20240822$20240822$EXP$$SE-UCBSA-2024040793$UCB$$$$$M$Y$$$20240822$$MD$SE$SE
242368921$24236892$1$I$$20240723$20240822$20240822$EXP$$GB-SANDOZ INC.-SDZ2023GB011506$SANDOZ$$$$$M$Y$$$20240822$$CN$GB$GB
242368931$24236893$1$I$$20240807$20240822$20240822$EXP$$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111039$ZYDUS PHARM$Otiniano A, Tassin C, Serris A, Guennouni N, Lanternier F, Servais A, et al.. Emphysematous pyelonephritis in a diabetic patient.. Journal of Nephrology. 2023;36:2621-2624$$$$$Y$$$20240822$$HP$FR$FR
242368941$24236894$1$I$$20240808$20240822$20240822$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111080$ZYDUS PHARM$Lindsay A, Niccum DE.. An Underestimated Toxin: The Case of Intentional Benzonatate Overdose Resulting in Seizure and Cardiac Arrest.. Am-J-Respir-Crit-Care-Med. 2024$$$$$Y$$$20240822$$HP$US$US
242368951$24236895$1$I$20240818$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165339$AMGEN$$53$YR$A$F$Y$$$20240822$$PH$US$US
242368971$24236897$1$I$$20240808$20240822$20240822$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111079$ZYDUS PHARM$Homiack DR, Yan LE, Petry LG, Lloyd JR, Najjar F, Cook EH.. Successful Electroconvulsive Therapy in a Patient with Catatonia and Maternal Duplication 15q11-13 Syndrome.. J-ECT. 2024;00:1-2$$$$$Y$$$20240822$$MD$US$US
242368981$24236898$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004155$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242368991$24236899$1$I$$20240814$20240822$20240822$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP010449$STRIDES$Ayen-Rodriguez A, Gil-Villalba A, Ruiz-Villaverde R, Navarro-Trivino FJ.. Methotrexate Toxicity in Dermatological Patients.. Actas-Dermosifiliogr. 2024;115 (7):741-743$86$YR$$M$Y$$$20240822$$HP$ES$ES
242369001$24236900$1$I$20230426$20240808$20240822$20240822$EXP$$CZ-UCBSA-2023049890$UCB$$78$YR$$F$Y$$$20240822$$MD$CZ$CZ
242369011$24236901$1$I$$20240814$20240822$20240822$EXP$KR-MLMSERVICE-20240802-PI151231-00232-1$KR-STRIDES ARCOLAB LIMITED-2024SP010286$STRIDES$Yang J, Kim Y, Park WY, Jin K, Han S, Kim BH, et al.. Unilateral testicular tuberculosis in a kidney transplant recipient: a case report. Clinical transplantation and research.. 2024$$$A$M$Y$55$KG$20240822$$MD$KR$KR
242369021$24236902$1$I$$20240807$20240822$20240822$EXP$$MA-GRANULES-MA-2024GRALIT00352$GRANULES INDIA$Mourabiti H.Paraparesis secondary to metformin: A rare condition to be aware of, with characteristic MRI images.Toxicologie Analytique et Clinique.JUL-2024;1-6$$$$$Y$$$20240822$$HP$MA$MA
242369031$24236903$1$I$$20240730$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004189$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242369071$24236907$1$I$20240717$20240809$20240822$20240822$EXP$IT-MINISAL02-997746$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-07727$HIKMA$$64$YR$$M$Y$$$20240822$$PH$IT$IT
242369081$24236908$1$I$$20240809$20240822$20240822$EXP$$DE-AUROBINDO-AUR-APL-2024-034787$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$37$YR$$M$Y$$$20240822$$HP$DE$DE
242369091$24236909$1$I$$20240813$20240822$20240822$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010379$STRIDES$Shang Y, Zhao H, Li D.. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.. Turk-J-Hematol. 2023;40:284-285$66$YR$$M$Y$$$20240822$$MD$CN$CN
242369101$24236910$1$I$20240501$20240820$20240822$20240822$EXP$AU-TGA-0000816796$AU-SANDOZ INC.-SDZ2024AU074269$SANDOZ$$$$$F$Y$$$20240822$$MD$AU$AU
242369121$24236912$1$I$20240819$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165760$AMGEN$$65$YR$E$F$Y$$$20240822$$CN$US$US
242369131$24236913$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004156$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242369143$24236914$3$F$$20240919$20240822$20240927$EXP$$BE-BEH-2024177282$CSL BEHRING$$$$E$F$Y$$$20240927$$HP$BE$BE
242369151$24236915$1$I$$20240819$20240822$20240822$EXP$$CA-Orion Corporation ORION PHARMA-24_00028902$ORION$$71$YR$E$F$Y$$$20240822$$HP$CA$
242369161$24236916$1$I$20230101$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132706$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240822$$CN$US$US
242369171$24236917$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131457$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240822$$HP$US$US
242369182$24236918$2$F$$20240828$20240822$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004190$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
242369192$24236919$2$F$20240529$20240828$20240822$20240830$EXP$$PE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047128$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240830$$MD$PE$PE
242369202$24236920$2$F$$20240920$20240822$20240926$EXP$$CO-ROCHE-10000060479$ROCHE$$44$YR$A$F$Y$$$20240926$$CN$CO$CO
242369211$24236921$1$I$$20231223$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2023-066161$AUROBINDO$$$$$$Y$$$20240822$$CN$US$US
242369221$24236922$1$I$$20231117$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2023-074599$AUROBINDO$$27$YR$$F$Y$56.699$KG$20240822$$CN$US$US
242369231$24236923$1$I$$20240819$20240822$20240822$PER$$US-ABBVIE-5889393$ABBVIE$$$$$$Y$$$20240822$$CN$US$US
242369241$24236924$1$I$$20240820$20240822$20240822$PER$$NVSC2024US169624$NOVARTIS$$$$$F$Y$$$20240822$$HP$US$US
242369251$24236925$1$I$$20240818$20240822$20240822$EXP$$NVSC2024PK168394$NOVARTIS$$$$$F$Y$$$20240822$$HP$PK$PK
242369261$24236926$1$I$$20240820$20240822$20240822$EXP$$NVSC2024CA168963$NOVARTIS$$33$YR$$F$Y$$$20240822$$HP$CA$CA
242369271$24236927$1$I$$20240809$20240822$20240822$EXP$$DE-MACLEODS PHARMA-MAC2024048868$MACLEODS$$$$$$Y$$$20240822$$MD$DE$DE
242369281$24236928$1$I$20240808$20240810$20240822$20240822$EXP$$ZA-MACLEODS PHARMA-MAC2024048854$MACLEODS$$$$$$Y$$$20240822$$CN$ZA$ZA
242369291$24236929$1$I$20240701$20240816$20240822$20240822$EXP$$US-UCBSA-2023043673$UCB$$82$YR$$F$Y$$$20240822$$MD$US$US
242369301$24236930$1$I$$20240814$20240822$20240822$EXP$$ZA-AstraZeneca-2024A185648$ASTRAZENECA$$80$YR$$M$Y$$$20240822$$CN$ZA$
242369311$24236931$1$I$20240218$20240306$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-011967$AUROBINDO$$$$$M$Y$$$20240822$$CN$US$US
242369321$24236932$1$I$20240512$20240522$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-026542$AUROBINDO$$63$YR$$F$Y$83.915$KG$20240822$$CN$US$US
242369331$24236933$1$I$$20240209$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-007594$AUROBINDO$$$$$M$Y$$$20240822$$CN$US$US
242369341$24236934$1$I$20240517$20240517$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-026281$AUROBINDO$$80$YR$$F$Y$$$20240822$$HP$US$US
242369351$24236935$1$I$$20231109$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2023-068965$AUROBINDO$$63$YR$$M$Y$79$KG$20240822$$CN$US$US
242369362$24236936$2$F$$20240815$20240822$20240826$30DAY$$US-JNJFOC-20240840010$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240826$$CN$US$US
242369371$24236937$1$I$$20240807$20240822$20240822$EXP$$IN-GRANULES-IN-2024GRALIT00357$GRANULES INDIA$Bala Sundaram.Twin neurological enigmas radiological and medical  insight into a dual encounter with metformin induced  encephalopathy.Journal of Nephropharmacology.29-JUN-2024;13(2):1-5$55$YR$A$M$Y$$$20240822$$HP$IN$IN
242369383$24236938$3$F$20240101$20240903$20240822$20240917$EXP$$US-INSMED, INC.-2024-02559-DE$INSMED$$59$YR$$F$Y$$$20240917$$CN$DE$DE
242369391$24236939$1$I$20240618$20240812$20240822$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-040842$AUROBINDO$$72$YR$$M$Y$85$KG$20240822$$MD$GB$GB
242369401$24236940$1$I$20240722$20240815$20240822$20240822$EXP$$US-ROCHE-10000058882$ROCHE$$79$YR$E$M$Y$$$20240822$$CN$US$US
242369411$24236941$1$I$$20240813$20240822$20240822$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-114211$REGENERON$$$$$F$Y$$$20240822$$HP$CO$CO
242369421$24236942$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131535$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240822$$HP$US$US
242369431$24236943$1$I$20200706$20240807$20240822$20240822$EXP$$FR-SERVIER-S24010063$SERVIER$$$$$$Y$$$20240822$$MD$FR$FR
242369441$24236944$1$I$20240812$20240812$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127919$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240822$$HP$US$US
242369451$24236945$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130098$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240822$$HP$US$US
242369471$24236947$1$I$20240722$20240812$20240822$20240822$EXP$$DE-AUROBINDO-AUR-APL-2024-041279$AUROBINDO$$55$YR$$M$Y$47.8$KG$20240822$$MD$DE$DE
242369481$24236948$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004227$ACADIA PHARMACEUTICALS$$18$YR$$F$Y$$$20240822$$MD$US$US
242369491$24236949$1$I$$20240816$20240822$20240822$EXP$$NVSC2024BR168944$NOVARTIS$$44$YR$$M$Y$$$20240822$$MD$BR$BR
242369501$24236950$1$I$20240802$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132442$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$74.39$KG$20240822$$HP$US$US
242369511$24236951$1$I$20240816$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024165021$AMGEN$$86$YR$E$M$Y$74.83$KG$20240822$$CN$US$US
242369521$24236952$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165657$AMGEN$$$$$F$Y$$$20240822$$HP$US$US
242369591$24236959$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163523$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242369601$24236960$1$I$$20240821$20240822$20240822$PER$$US-AMGEN-USASP2024167357$AMGEN$$58$YR$A$F$Y$$$20240822$$CN$US$US
242369611$24236961$1$I$$20240812$20240822$20240822$EXP$$US-AMGEN-USASP2024164981$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242369621$24236962$1$I$$20240812$20240822$20240822$EXP$$US-JNJFOC-20240835033$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$US$US
242369632$24236963$2$F$$20240911$20240822$20240920$EXP$$US-TEVA-VS-3234697$TEVA$Kim J, Prasad S, Roshan NS, Hasan BF, Gill G, Gunturu S. Sleep disruptions and the pathway to psychosis: An in-depth case and literature review. Clin-Case-Rep 2024; 12 (6):.; Kim J, Prasad S, Roshan NS, Hasan BF, Gill G, Gunturu S. Sleep disruptions and the pathway to psychosis: An in-depth case and literature review. Clin-Case-Rep 2024; 12 (6):.$20$YR$$M$Y$$$20240920$$HP$US$US
242369641$24236964$1$I$$20231030$20240822$20240822$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417089$RANBAXY$$$$$F$Y$$$20240822$$MD$US$US
242369652$24236965$2$F$20200101$20240830$20240822$20240912$EXP$$IT-CIPLA LTD.-2024IT08786$CIPLA$$$$$$Y$$$20240912$$MD$IT$IT
242369661$24236966$1$I$$20240809$20240822$20240822$EXP$$US-CIPLA LTD.-2024US08948$CIPLA$Nakazawa MS, Conley AP, Livingston JA, Zarzour MA, Bishop AJ, Ratan R, et.al. Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort. Rare Tumors. 2024;16:1 to 9$$$$$Y$$$20240822$$HP$US$US
242369671$24236967$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132577$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240822$$HP$US$US
242369681$24236968$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132589$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240822$$MD$US$US
242369691$24236969$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131733$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240822$$CN$US$US
242369702$24236970$2$F$$20240917$20240822$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132348$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240918$$CN$US$US
242369711$24236971$1$I$20230602$20231228$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2023-055163$AUROBINDO$$67$YR$$F$Y$70$KG$20240822$$CN$US$US
242369731$24236973$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132351$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240822$$CN$US$US
242369752$24236975$2$F$20240103$20240829$20240822$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132508$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240911$$CN$US$US
242369761$24236976$1$I$$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131881$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240822$$CN$US$US
242369771$24236977$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130006$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240822$$HP$US$US
242369781$24236978$1$I$$20240813$20240822$20240822$EXP$$PT-AUROBINDO-AUR-APL-2024-039352$AUROBINDO$Marques M, Vilar da Mota R, Salgueiro D, Ferreira I, Gouveia M, Oliveira R et al.. PO-0679 - (4269) - ?Carcinomatose e hipofosfat?mia: a etiologia multifatorial do delirium?.. Congressos da Sociedade Portuguesa de Medicina Interna: 30.? CNMI.. 2024;1024$65$YR$$M$Y$$$20240822$$MD$PT$PT
242369791$24236979$1$I$$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129032$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$77.56$KG$20240822$$PH$US$US
242369801$24236980$1$I$20240701$20240802$20240822$20240822$PER$$US-TEVA-VS-3229815$TEVA$$56$YR$$F$Y$81.65$KG$20240822$$CN$US$US
242369811$24236981$1$I$$20231226$20240822$20240822$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-102277$ZYDUS PHARM$$$$$$Y$$$20240822$$CN$US$US
242369821$24236982$1$I$$20240626$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-032692$AUROBINDO$$55$YR$$M$Y$$$20240822$$MD$US$US
242369831$24236983$1$I$$20240319$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-014375$AUROBINDO$$$$$F$Y$$$20240822$$CN$US$US
242369841$24236984$1$I$$20240618$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-014324$AUROBINDO$$$$$M$Y$$$20240822$$CN$US$US
242369862$24236986$2$F$20240729$20240827$20240822$20240830$EXP$$CA-BEH-2024177200$CSL BEHRING$$78$YR$E$M$Y$$$20240830$$HP$CA$CA
242369871$24236987$1$I$$20240815$20240822$20240822$EXP$$US-ROCHE-10000059242$ROCHE$$42$YR$A$F$Y$$$20240822$$MD$US$US
242369883$24236988$3$F$20240801$20240916$20240822$20240918$EXP$$US-ROCHE-10000058755$ROCHE$$50$YR$A$F$Y$$$20240918$$CN$US$US
242369891$24236989$1$I$$20240809$20240822$20240822$EXP$$US-MAYNE PHARMA-2024MYN000349$MAYNE$$$$$$Y$$$20240822$$CN$US$US
242369912$24236991$2$F$20240815$20240920$20240822$20240921$PER$$US-AMGEN-USASP2024165753$AMGEN$$64$YR$A$F$Y$$$20240921$$CN$US$US
242369921$24236992$1$I$$20231004$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2023-063047$AUROBINDO$$$$$F$Y$$$20240822$$CN$US$US
242369931$24236993$1$I$$20240814$20240822$20240822$EXP$$CA-AMGEN-CANSP2024162254$AMGEN$$$$$$Y$$$20240822$$PH$CA$CA
242369941$24236994$1$I$20240816$20240818$20240822$20240822$PER$$US-HALEON-2192743$Haleon PLC$$69$YR$$M$Y$$$20240822$$CN$US$US
242369962$24236996$2$F$20230101$20240826$20240822$20240903$EXP$$CA-CURRAX PHARMACEUTICALS LLC-CA-2023CUR002927$CURRAX PHARMACEUTICALS$$$$$F$Y$74.83$KG$20240904$$CN$CA$CA
242369971$24236997$1$I$$20230822$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2023-055969$AUROBINDO$$$$$M$Y$$$20240822$$MD$US$US
242369981$24236998$1$I$$20230924$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2023-061226$AUROBINDO$$$$$$Y$$$20240822$$CN$US$US
242369991$24236999$1$I$$20240807$20240822$20240822$EXP$$IN-GRANULES-IN-2024GRALIT00359$GRANULES INDIA$Bala Sundaram.Twin neurological enigmas radiological and medical  insight into a dual encounter with metformin induced  encephalopathy.Journal of Nephropharmacology.29-JUN-2024;13(2):1-5$58$YR$A$M$Y$$$20240822$$HP$IN$IN
242370001$24237000$1$I$$20240814$20240822$20240822$PER$$US-JNJFOC-20240837312$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$US$US
242370011$24237001$1$I$20231009$20240822$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-135348-2023$RECKITT BENCKISER$$72$YR$$M$Y$81.82$KG$20240822$$CN$US$US
242370021$24237002$1$I$20240101$20240812$20240822$20240822$EXP$$US-BANNER LIFE SCIENCES-USBAN24000125$BANNER$$$$$M$Y$$$20240822$$CN$US$US
242370041$24237004$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132477$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240822$$CN$US$US
242370051$24237005$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132623$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240822$$CN$US$US
242370063$24237006$3$F$20240601$20240828$20240822$20240906$PER$$US-ABBVIE-5878267$ABBVIE$$$$$M$Y$79.378$KG$20240906$$CN$US$US
242370071$24237007$1$I$20240725$20240812$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128055$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$97.98$KG$20240822$$PH$US$US
242370091$24237009$1$I$$20240815$20240822$20240822$PER$$US-ROCHE-10000059688$ROCHE$$$$$$Y$$$20240822$$CN$US$US
242370101$24237010$1$I$$20240820$20240822$20240822$EXP$$NVSC2024CA168888$NOVARTIS$$53$YR$$M$Y$$$20240822$$HP$CA$CA
242370111$24237011$1$I$20240810$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A185819$ASTRAZENECA$$61$YR$$F$Y$$$20240822$$HP$US$
242370122$24237012$2$F$$20240826$20240822$20240828$EXP$$CA-AstraZeneca-2024A185839$ASTRAZENECA$$$$$M$Y$$$20240828$$HP$CA$
242370131$24237013$1$I$20220901$20221021$20240822$20240822$EXP$$CA-CELLTRION INC.-2021CA019611$CELLTRION$$$$$$Y$$$20240822$$MD$CA$CA
242370141$24237014$1$I$$20240813$20240822$20240822$PER$$US-ROCHE-10000063754$ROCHE$$60$YR$A$F$Y$$$20240822$$CN$US$US
242370151$24237015$1$I$$20240813$20240822$20240822$EXP$$IE-ROCHE-3155826$ROCHE$$$$$F$Y$$$20240822$$CN$IE$IE
242370161$24237016$1$I$20240101$20240809$20240822$20240822$PER$$US-TEVA-VS-3232235$TEVA$$50$YR$$M$Y$$$20240822$$CN$US$US
242370172$24237017$2$F$$20240822$20240822$20240826$PER$$US-JNJFOC-20240846708$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242370182$24237018$2$F$$20240819$20240822$20240828$EXP$$US-ROCHE-10000060836$ROCHE$$$$A$F$Y$$$20240828$$CN$US$US
242370191$24237019$1$I$20240603$20240620$20240822$20240822$EXP$$CN-AstraZeneca-2024A145474$ASTRAZENECA$$85$YR$$F$Y$35$KG$20240822$$MD$CN$
242370201$24237020$1$I$$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024166542$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242370221$24237022$1$I$$20240808$20240822$20240822$PER$$US-JNJFOC-20240822351$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$CN$US$US
242370231$24237023$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163646$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242370241$24237024$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163655$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242370251$24237025$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163665$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242370261$24237026$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163576$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242370271$24237027$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163651$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242370281$24237028$1$I$$20240807$20240822$20240822$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463799$RANBAXY$Khaw H, Wang A, Leow K, Said C, Wong A. Mesalazine Induced Myocarditis. Heart Lung Circ. 2024;33 (Suppl.):504/S360$52$YR$$M$Y$$$20240822$$HP$AU$AU
242370292$24237029$2$F$$20240809$20240822$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463671$RANBAXY$Nance M, Merten J, Grooms A.. Catatonia: Where to Look When ECT Fails. J Acad Consult Liaison Psychiatry. 2023;64 (Suppl.):S11-S12((022)$65$YR$$F$Y$$$20240823$$HP$US$US
242370301$24237030$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163559$AMGEN$George D.J; Halabi S.; Fleming M.T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242370311$24237031$1$I$20240425$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463833$RANBAXY$$55$YR$$M$Y$63$KG$20240822$$MD$FR$FR
242370321$24237032$1$I$20240518$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463845$RANBAXY$$16$YR$$F$Y$49.5$KG$20240822$$HP$FR$FR
242370332$24237033$2$F$$20240822$20240822$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463928$RANBAXY$Bao L, Lu M-Q, Liu P, Wang Y-T, Zhuang J, Zhang M, et al. Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score }=2: A Prospective Multicenter Study. Blood. 2022;Nov 15;140 (S1):12564-12565/652$$$E$$Y$$$20240906$$MD$CN$CN
242370341$24237034$1$I$$20240807$20240822$20240822$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463395$RANBAXY$Benevolo G, Bertuglia G, Bringhen S, Maletta F, Bruno B.. An atypical presentation of visceral leishmaniasis mimicking multiple myeloma relapse.. Am J Hematol. 2024;99:137-141$79$YR$$M$Y$$$20240822$$HP$IT$IT
242370351$24237035$1$I$20240731$20240807$20240822$20240822$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463828$RANBAXY$$74$YR$$F$Y$103$KG$20240822$$HP$GB$GB
242370361$24237036$1$I$20231203$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463335$RANBAXY$$83$YR$$F$Y$$$20240822$$PH$FR$FR
242370372$24237037$2$F$$20240823$20240822$20240906$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463669$RANBAXY$Mader JA, Martin S, Davey RA, Smith SJ.. Case of nonischemic cardiomyopathy secondary to doxorubicin requiring heart transplant while managing multiple sclerosis on ocrelizumab. Can-J-Hosp-Pharm. 2024;77 (2):23-24/:e3607$49$YR$$F$Y$$$20240906$$HP$CA$CA
242370381$24237038$1$I$$20240807$20240822$20240822$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463531$RANBAXY$$73$YR$$M$Y$67.9$KG$20240822$$MD$NL$NL
242370391$24237039$1$I$20240401$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463337$RANBAXY$$70$YR$$M$Y$72$KG$20240822$$MD$FR$FR
242370401$24237040$1$I$20240101$20240812$20240822$20240822$EXP$$US-862174955-ML2024-04484$MICRO LABS$$$$$F$Y$$$20240822$$CN$US$US
242370411$24237041$1$I$20240512$20240819$20240822$20240822$EXP$GB-MHRA-MED-202408191143490880-GTNKD$GB-RDY-SPO/GBR/24/0012117$DR REDDYS$$69$YR$E$M$Y$98$KG$20240822$$PH$GB$GB
242370432$24237043$2$F$$20240829$20240822$20240909$EXP$$MA-MSNLABS-2024MSNLIT01820$MSN LABORATORIES$Tahri N, Bensalem S, Kaddar K, Belharti K, Zizi N, Dikhaye S.Acute exanthematous pustulosis generalized induced by Erlotinib: about a case.French Journal of Allergology.2024;64:103923$$$$$Y$$$20240909$$HP$MA$MA
242370441$24237044$1$I$$20240807$20240822$20240822$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463822$RANBAXY$Estrada K, Turcu A, Sandouk Z, Esfandiari NH. Concomitant Primary and Secondary Adrenal Insufficiency in the Setting of Immunotherapy. J Endocr Soc. 2022;6(Suppl.):A104-A105/PSAT039$81$YR$$F$Y$$$20240822$$MD$US$US
242370461$24237046$1$I$$20240808$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126539$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240822$$HP$US$US
242370471$24237047$1$I$20240814$20240814$20240822$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-025421$UNITED THERAPEUTICS$$76$YR$$F$Y$95.238$KG$20240822$$$US$US
242370482$24237048$2$F$$20240822$20240822$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463930$RANBAXY$Bao L, Lu M-Q, Liu P, Wang Y-T, Zhuang J, Zhang M, et al. Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score }=2: A Prospective Multicenter Study. Blood. 2022;Nov 15;140 (S1):12564-12565/652$$$E$$Y$$$20240906$$MD$CN$CN
242370491$24237049$1$I$20240502$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463542$RANBAXY$$63$YR$$M$Y$$$20240822$$MD$FR$FR
242370501$24237050$1$I$20231225$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463572$RANBAXY$$37$YR$$M$Y$70$KG$20240822$$MD$FR$FR
242370511$24237051$1$I$$20240807$20240822$20240822$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462936$RANBAXY$$$$E$M$Y$$$20240822$$CN$US$US
242370522$24237052$2$F$$20240822$20240822$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463910$RANBAXY$Bao L, Lu M-Q, Liu P, Wang Y-T, Zhuang J, Zhang M, et al. Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score }=2: A Prospective Multicenter Study. Blood. 2022;Nov 15;140 (S1):12564-12565/652$$$E$$Y$$$20240906$$MD$CN$CN
242370531$24237053$1$I$20240816$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132584$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240822$$CN$US$US
242370541$24237054$1$I$$20240807$20240822$20240822$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463683$RANBAXY$Klein J, Hernandez L. Loeffler^s Endomyocarditis in a Child. J Cardiovasc Magn Reson. 2024;26(Suppl.):101-102(100229)$7$YR$$M$Y$$$20240822$$MD$US$US
242370551$24237055$1$I$$20240807$20240822$20240822$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463853$RANBAXY$Eda Y, Ishii S, Onagi S,Katoh N, Ako J. Coexistence of variant-type transthyretin and immunoglobulin light-chain amyloidosis: a case report. Eur Heart J Case Rep. 2024;May; 8 (6):ytae264(1-6)$78$YR$$F$Y$$$20240822$$HP$JP$JP
242370562$24237056$2$F$$20240822$20240822$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463929$RANBAXY$Bao L, Lu M-Q, Liu P, Wang Y-T, Zhuang J, Zhang M, et al. Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score }=2: A Prospective Multicenter Study. Blood. 2022;Nov 15;140 (S1):12564-12565/652$$$E$$Y$$$20240906$$MD$CN$CN
242370572$24237057$2$F$$20240822$20240822$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463936$RANBAXY$Bao L, Lu M-Q, Liu P, Wang Y-T, Zhuang J, Zhang M, et al. Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score }=2: A Prospective Multicenter Study. Blood. 2022;Nov 15;140 (S1):12564-12565/652$$$E$$Y$$$20240906$$MD$CN$CN
242370581$24237058$1$I$$20240807$20240822$20240822$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463795$RANBAXY$Diong S, Gnanamoorthy P, O^Rourke M, Byrne J, Bergin C, McMenamin M, et al. HIV-associated sarcoidosis as a manifestation of immune reconstitution inflammatory syndrome. Br J Dermatol. 2024;192 (Suppl.):i150;BI26$47$YR$$F$Y$$$20240822$$HP$IE$IE
242370591$24237059$1$I$$20240807$20240822$20240822$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463867$RANBAXY$Abbott M, Valenti G, Gizzi A, Agrenzano S, Ficalora A, Mancuso A, et al.. HBVREACTIVATIONAFTER IMMUNOSUPPRESSIVE THERAPY: AN OPEN QUESTION. Sex Transmit Infect. 2024;100 (Supp1):A271( P-213)$71$YR$$M$Y$$$20240822$$HP$IT$IT
242370601$24237060$1$I$$20240807$20240822$20240822$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463482$RANBAXY$Morisaki Y, Takatani T, Kotsugi M, Yamazaki S, Yokoyama S, Nakase K, et al. Intraoperative monitoring of trigeminal neuralgia: a technical note. Acta Neurochir Wien. 2024;166 (1):1-5$8$DEC$$F$Y$$$20240822$$HP$JP$JP
242370611$24237061$1$I$20231122$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463551$RANBAXY$$75$YR$$F$Y$$$20240822$$PH$FR$FR
242370623$24237062$3$F$$20240905$20240822$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463358$RANBAXY$Teoh YP, Gold A, Yesudian PD. Fats and figures: how abnormal lipids unravel the truth. Br J Dermato. 2024;192 (Suppl.)$22$YR$$M$Y$$$20240920$$HP$GB$GB
242370632$24237063$2$F$$20240912$20240822$20240927$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463146$RANBAXY$$$$E$M$Y$85$KG$20240927$$CN$IT$IT
242370642$24237064$2$F$$20240822$20240822$20240906$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463252$RANBAXY$Tombak Y, Karaahmet OZ Unlu Akyuz E. Intramuscular botulinum toxin-A in complex regional pain syndrome resistant to standard treatment a case report. Wien Klin Wochenschr. 2024;136 (13-14):419-422$53$YR$$F$Y$$$20240906$$MD$TR$TR
242370651$24237065$1$I$$20240807$20240822$20240822$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463688$RANBAXY$Vigano M, Kubal S, Lu Y, Habib S, Samarani S, Cama G, et al.. Impact of Cannabidiol and Exercise on Clinical Outcomes and Gut Microbiota for Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors: A Case Report. Pharmaceuticals. 2024;17(7):834 (1-11)$52$YR$$F$Y$92.1$KG$20240822$$HP$CA$CA
242370661$24237066$1$I$$20240807$20240822$20240822$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463221$RANBAXY$Wang XS, Wang F, Tu CY, Zhou LY, Tu TS, Wang YJ, et al. Rare case of simultaneous occurrence of chronic neutrophil leukemia and Tlymphoblastic lymphoma: case report and literature review. Ann Hematol. 2024;Aug 6:39105740$28$YR$$M$Y$$$20240822$$HP$CN$CN
242370672$24237067$2$F$$20240813$20240822$20240828$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463471$RANBAXY$Pattock A, Elison D, McCabe JM. TRICUSPID TRANSCATHETER EDGE-TO-EDGE REPAIR IN PATIENT WITH CARCINOID HEART DISEASE AND TORRENTIAL TRICUSPID REGURGITATION. J Am Coll Cardiol. 2024;83 (Suppl) (13:3773$43$YR$$F$Y$$$20240828$$HP$US$US
242370682$24237068$2$F$20210201$20240827$20240822$20240911$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463043$RANBAXY$Nagahiro Tokuyama, Sayaka Ikeda, Ryosuke Ishida, Ryoko Futai, Kazutoshi Tobimatsu, Yuzo Kodama. Impaired Consciousness Due to Hyperammonemia During S-1 Administration for Unresectable Pancreatic Cancer. Intern-Med. 2024;0 (0):no pagination$71$YR$$F$Y$$$20240911$$HP$JP$JP
242370692$24237069$2$F$$20240822$20240822$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463935$RANBAXY$Bao L, Lu M-Q, Liu P, Wang Y-T, Zhuang J, Zhang M, et al. Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score }=2: A Prospective Multicenter Study. Blood. 2022;Nov 15;140 (S1):12564-12565/652$$$E$$Y$$$20240906$$MD$CN$CN
242370701$24237070$1$I$$20240807$20240822$20240822$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463380$RANBAXY$Buckling H, Barlow T, Zielinski R, Karve S.. Lorlatinib Induced Severe Hyperlipidaemia: A Case Report.. Heart Lung Circ. 2024;33 (Suppl.):S302$34$YR$$M$Y$$$20240822$$HP$AU$AU
242370711$24237071$1$I$20240304$20240807$20240822$20240822$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463496$RANBAXY$$86$YR$$F$Y$$$20240822$$HP$IT$IT
242370723$24237072$3$F$20240801$20240911$20240822$20240926$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463741$RANBAXY$$62$YR$$M$Y$61.3$KG$20240926$$HP$JP$JP
242370731$24237073$1$I$20231212$20240807$20240822$20240822$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463449$RANBAXY$$83$YR$$F$Y$$$20240822$$MD$ES$ES
242370741$24237074$1$I$20240517$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463455$RANBAXY$$19$YR$$F$Y$65$KG$20240822$$PH$FR$FR
242370751$24237075$1$I$20240502$20240807$20240822$20240822$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463564$RANBAXY$$65$YR$$M$Y$$$20240822$$MD$IT$IT
242370761$24237076$1$I$20240212$20240807$20240822$20240822$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463586$RANBAXY$$70$YR$$F$Y$$$20240822$$MD$ES$ES
242370771$24237077$1$I$20240101$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463407$RANBAXY$$67$YR$$F$Y$$$20240822$$MD$FR$FR
242370782$24237078$2$F$$20240809$20240822$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463667$RANBAXY$Lehmann GC, Thomas J, Schuschke E, Menon D. Complete heart block in a child with repaired congenital heart disease and active COVID-19 infection. Prog Pediatr Cardiol. 2023;71:101683(1-3)$15$MON$$F$Y$$$20240823$$HP$US$US
242370791$24237079$1$I$$20240807$20240822$20240822$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463849$RANBAXY$Qian Y-F, Chen H-P, Ren G-F. Acute therapy-related myelodysplastic syndromes following capecitabine and oxaliplatin therapy in gastric malignant tumor A case report. Medicine. 2024;103(30):1-4$60$YR$$M$Y$$$20240822$$HP$CN$CN
242370811$24237081$1$I$20240805$20240816$20240822$20240822$EXP$$US-ROCHE-10000059813$ROCHE$$52$YR$A$F$Y$$$20240822$$CN$US$US
242370863$24237086$3$F$20231106$20240924$20240822$20240925$EXP$FR-AFSSAPS-NT2024001059$FR-ABBVIE-5887870$ABBVIE$$55$YR$$F$Y$74$KG$20240925$$MD$FR$FR
242370871$24237087$1$I$$20240820$20240822$20240822$PER$$NVSC2024US169389$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
242370883$24237088$3$F$$20240822$20240822$20240826$PER$$NVSC2024US169163$NOVARTIS$$$$$M$Y$$$20240827$$CN$US$US
242370891$24237089$1$I$20240306$20240822$20240822$20240822$EXP$FR-AFSSAPS-PB2024000884$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047204$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$78$KG$20240822$$PH$FR$FR
242370901$24237090$1$I$20240813$20240817$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012952$JAZZ$$30$YR$$F$Y$$$20240822$$CN$US$US
242370911$24237091$1$I$20230712$20240814$20240822$20240822$EXP$$CA-JNJFOC-20230740798$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240822$$CN$CA$CA
242370921$24237092$1$I$$20240814$20240822$20240822$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006049$BIOCON$$$$$$Y$$$20240822$$HP$CA$CA
242370931$24237093$1$I$20230101$20240813$20240822$20240822$PER$$US-ABBVIE-5880399$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242370941$24237094$1$I$$20240820$20240822$20240822$EXP$$US-GILEAD-2024-0684874$GILEAD$$$$A$M$Y$$$20240822$$CN$US$US
242370951$24237095$1$I$$20240820$20240822$20240822$30DAY$$US-SANDOZ INC.-SDZ2024US074326$SANDOZ$$$$$M$Y$$$20240822$$CN$US$US
242370961$24237096$1$I$20231007$20240822$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-135365-2023$RECKITT BENCKISER$$70$YR$$F$Y$59.09$KG$20240822$$CN$US$US
242370981$24237098$1$I$$20240816$20240822$20240822$EXP$$US-ROCHE-10000059895$ROCHE$$$$E$M$Y$72.57$KG$20240822$$CN$US$US
242370991$24237099$1$I$20240727$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130965$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240822$$CN$US$US
242371001$24237100$1$I$$20240807$20240822$20240822$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463781$RANBAXY$Kubba F, Aliyeva-Derraz P, Gradassi AT. An unusual case of drug-induced annular granulomatous vasculitis in a patient with rheumatoid arthritis and type 2 diabetes mellitus. Br J Dermatol. 2024;192(Suppl.):i117-i118/DP24/ ljae090.246$61$YR$$F$Y$$$20240822$$HP$GB$GB
242371011$24237101$1$I$$20240814$20240822$20240822$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-130187$BRISTOL MYERS SQUIBB$$65$YR$E$$Y$64.41$KG$20240822$$CN$PR$PR
242371022$24237102$2$F$20240801$20240826$20240822$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024651$UNITED THERAPEUTICS$$73$YR$$M$Y$106.12$KG$20240830$$$US$US
242371031$24237103$1$I$$20240807$20240822$20240822$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463529$RANBAXY$$63$YR$$M$Y$$$20240822$$PH$IE$IE
242371041$24237104$1$I$20240513$20240807$20240822$20240822$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463577$RANBAXY$$74$YR$$M$Y$$$20240822$$MD$IT$IT
242371051$24237105$1$I$20240502$20240807$20240822$20240822$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463081$RANBAXY$$38$YR$$F$Y$$$20240822$$MD$DE$DE
242371062$24237106$2$F$$20240911$20240822$20240925$EXP$$JP-MSNLABS-2024MSNLIT01821$MSN LABORATORIES$Morisaki Y, Takatani T, Kotsugi M, Yamazaki S, Yokoyama S, Nakase K, Takeshima Y, Nishimura F, Matsuda R, Yamada S, Park YS, Nakagawa I.Intraoperative monitoring of trigeminal neuralgia: a technical note.Acta Neurochirurgica Wien.2024;166 (1):238$$$$$Y$$$20240925$$MD$JP$JP
242371072$24237107$2$F$20240816$20240906$20240822$20240906$PER$$US-ALXN-202408USA001122US$ALEXION PHARMACEUTICALS$$11$YR$$M$Y$$$20240906$$CN$US$US
242371081$24237108$1$I$20220101$20240815$20240822$20240822$PER$$US-ABBVIE-5883201$ABBVIE$$$$$F$Y$$$20240822$$HP$US$US
242371091$24237109$1$I$20240101$20240820$20240822$20240822$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-113825$REGENERON$$$$$F$Y$$$20240822$$HP$US$US
242371121$24237112$1$I$$20240816$20240822$20240822$PER$$US-LEO Pharma-372888$LEO PHARM$$84$YR$$F$Y$$$20240822$$PH$US$US
242371141$24237114$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163713$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242371151$24237115$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163724$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242371161$24237116$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163677$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242371171$24237117$1$I$20240801$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024163897$AMGEN$$48$YR$A$F$Y$$$20240822$$CN$US$US
242371181$24237118$1$I$20240729$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131800$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240822$$CN$US$US
242371191$24237119$1$I$20240816$20240816$20240822$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-131072$BRISTOL MYERS SQUIBB$$74$YR$E$$Y$$$20240822$$MD$JP$JP
242371201$24237120$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132571$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240822$$CN$US$US
242371211$24237121$1$I$$20240816$20240822$20240822$PER$$US-LEO Pharma-372860$LEO PHARM$$74$YR$$M$Y$$$20240822$$CN$US$US
242371221$24237122$1$I$$20240814$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129732$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240822$$CN$US$US
242371231$24237123$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133222$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240822$$CN$US$US
242371241$24237124$1$I$$20240820$20240822$20240822$PER$$NVSC2024US169485$NOVARTIS$$$$$M$Y$$$20240822$$HP$US$US
242371252$24237125$2$F$20240818$20240918$20240822$20240927$PER$$US-GSK-US2024103353$GLAXOSMITHKLINE$$78$YR$$M$Y$$$20240927$$HP$US$US
242371261$24237126$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A187226$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242371271$24237127$1$I$$20211227$20240822$20240822$EXP$$US-AstraZeneca-2021A905099$ASTRAZENECA$$$$$$Y$$$20240822$$CN$US$
242371282$24237128$2$F$20221121$20240815$20240822$20240924$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2022CUR024150$CURRAX PHARMACEUTICALS$$59$YR$$F$Y$$$20240924$$CN$CA$CA
242371291$24237129$1$I$20240619$20240808$20240822$20240822$EXP$GB-MHRA-MED-202407030823125260-LZMNC$GB-LUPIN PHARMACEUTICALS INC.-2024-06052$LUPIN$$$$$$Y$$$20240822$$CN$GB$GB
242371301$24237130$1$I$$20240820$20240822$20240822$EXP$$CA-Orion Corporation ORION PHARMA-24_00031351$ORION$$78$YR$E$M$Y$80$KG$20240822$$HP$CA$
242371311$24237131$1$I$20240802$20240813$20240822$20240822$EXP$$IQ-MYLANLABS-2024M1077544$MYLAN$$29$YR$$M$Y$150$KG$20240822$$MD$IQ$IQ
242371322$24237132$2$F$$20240820$20240822$20240829$EXP$$US-TEVA-VS-3235309$TEVA$$56$YR$$M$Y$$$20240829$$CN$US$US
242371331$24237133$1$I$$20240809$20240822$20240822$EXP$$US-MYLANLABS-2024M1075913$MYLAN$Ware JM, Folio LR, Pittaluga S, Klion A, Khoury P. Resolution of hypereosinophilic syndrome following resection of a schwannoma. J-Allergy-Clin-Immunol-Pract 2023; 11 (4): 1320-1322.$43$YR$$F$Y$$$20240822$$HP$US$US
242371371$24237137$1$I$$20240812$20240822$20240822$EXP$$PT-Encube-001288$ENCUBE ETHICALS$Martins G, Dias A, Guerreiro C. Metronidazole-induced encephalopathy in a patient with spondylodiscitis. Clin Toxicol (Phila). 2024 Aug 7:1-3. doi: 10.1080/15563650.2024.2385683. Epub ahead of print. PMID: 39110127.$63$YR$A$M$Y$$$20240822$$HP$PT$
242371381$24237138$1$I$$20240813$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-041628$AUROBINDO$$90$YR$$F$Y$60$KG$20240822$$HP$CA$CA
242371391$24237139$1$I$$20240820$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074327$SANDOZ$$$$$F$Y$$$20240822$$CN$US$US
242371401$24237140$1$I$$20240809$20240822$20240822$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000980$PAREXEL$$$$$$Y$$$20240822$$CN$US$US
242371411$24237141$1$I$$20240816$20240822$20240822$EXP$$US-GILEAD-2024-0683739$GILEAD$$69$YR$E$F$Y$$$20240822$$CN$US$US
242371421$24237142$1$I$20240101$20240815$20240822$20240822$EXP$$US-SA-2024SA248028$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240822$$MD$US$US
242371431$24237143$1$I$20240812$20240818$20240822$20240822$EXP$SE-SEMPA-2024-006104$SE-LEO Pharma-372810$LEO PHARM$$80$YR$$F$Y$$$20240822$$MD$SE$SE
242371442$24237144$2$F$$20240906$20240822$20240906$PER$$US-ALXN-202408USA001124US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242371451$24237145$1$I$20231010$20240822$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-135370-2023$RECKITT BENCKISER$$70$YR$$M$Y$$$20240822$$CN$US$US
242371461$24237146$1$I$$20240819$20240822$20240822$EXP$$JP-PFIZER INC-202400239632$PFIZER$$$$$$Y$$$20240822$$MD$JP$JP
242371474$24237147$4$F$20240813$20240815$20240822$20240829$EXP$$US-PFIZER INC-202400237835$PFIZER$$76$YR$$M$Y$$$20240829$$HP$US$US
242371481$24237148$1$I$$20240819$20240822$20240822$EXP$$US-AMGEN-USASP2024165315$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242371492$24237149$2$F$20221101$20240827$20240822$20240906$EXP$$BG-TEVA-VS-3233406$TEVA$Mateeva V, Vasilev P, Gospodinova K, Gincheva V, Shahid M, Kostova P, et al. Severe flare of generalized pustular psoriasis treated with spesolimab, an IL-36-directed monoclonal antibody. J-Dtsch-Dermatol-Ges 2024; 22 (5): 696-699.; Mateeva V, Vasilev P, Gospodinova K, Gincheva V, Shahid M, Kostova P, et al. Severe flare of generalized pustular psoriasis treated with spesolimab, an IL-36-directed monoclonal antibody. J-Dtsch-Dermatol-Ges 2024; 22 (5): 696-699.; Mateeva V, Vasilev P, Gospodino...$34$YR$$F$Y$$$20240906$$HP$BG$BG
242371501$24237150$1$I$20240725$20240813$20240822$20240822$EXP$$FR-AUROBINDO-AUR-APL-2024-041508$AUROBINDO$$78$YR$$M$Y$69$KG$20240822$$PH$FR$FR
242371512$24237151$2$F$$20240829$20240822$20240906$EXP$$RS-TEVA-VS-3234132$TEVA$Jovisevic M, Zelen TB, Prica A. HORMON POSITIVE BREAST CANCER WITH EARLY RELAPSE. Breast 2023; 71 (Suppl. 1) S60 abstr. PR129.; Jovisevic M, Zelen TB, Prica A. HORMON POSITIVE BREAST CANCER WITH EARLY RELAPSE. Breast 2023; 71 (Suppl. 1) S60 abstr. PR129.$60$YR$$F$Y$$$20240906$$HP$RS$RS
242371521$24237152$1$I$20240712$20240809$20240822$20240822$EXP$$NZ-MYLANLABS-2024M1077729$MYLAN$$40$YR$$F$Y$$$20240822$$HP$NZ$NZ
242371541$24237154$1$I$$20240820$20240822$20240822$EXP$$US-JNJFOC-20240855076$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$US$US
242371551$24237155$1$I$$20240815$20240822$20240822$EXP$$RS-JNJFOC-20240845025$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$MD$RS$RS
242371562$24237156$2$F$20240601$20240821$20240822$20240919$PER$$US-Eisai-EC-2024-171346$EISAI$$78$YR$E$F$Y$57$KG$20240919$$MD$US$US
242371571$24237157$1$I$$20240811$20240822$20240822$EXP$$AU-JNJFOC-20240842152$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240822$$HP$AU$AU
242371581$24237158$1$I$$20240813$20240822$20240822$EXP$$DE-862174955-ML2024-04528$UNKNOWN$Bingert R, Kolbe V, Boy D, Buttner A. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. Rechtsmedizin. 2023;33(5): 396-402.$17$YR$T$M$Y$$$20240822$$HP$DE$DE
242371591$24237159$1$I$20240815$20240816$20240822$20240822$EXP$GB-MHRA-MED-202408161238414280-FMBWH$GB-862174955-ML2024-04538$Unknown Manufacturer$$60$YR$A$F$Y$$$20240822$$PH$GB$GB
242371601$24237160$1$I$$20240813$20240822$20240822$EXP$$IN-862174955-ML2024-04522$Unknown Manufacturer$Sharma P, Venkatapura R. Acute suppression of the hypothalamo-pituitary-adrenal axis from a large singular dose of dexamethasone: A case report on a hypothesis for resistant intraoperative hypotension. Surgical Neurology International. 2024 Jul 05;1-3. doi:10.25259/SNI_273_2024.$9$YR$C$F$Y$20$KG$20240822$$HP$IN$IN
242371611$24237161$1$I$20240814$20240819$20240822$20240822$PER$$US-ROCHE-10000061170$ROCHE$$28$YR$A$M$Y$$$20240822$$CN$US$US
242371621$24237162$1$I$20240716$20240814$20240822$20240822$PER$$US-ROCHE-10000062542$ROCHE$$65$YR$E$M$Y$$$20240822$$HP$US$US
242371631$24237163$1$I$$20240819$20240822$20240822$EXP$$NVSC2024US168242$NOVARTIS$$$$$$Y$$$20240822$$CN$US$US
242371641$24237164$1$I$$20240819$20240822$20240822$EXP$$AU-ABBVIE-5888613$ABBVIE$$$$$$Y$$$20240822$$MD$AU$AU
242371652$24237165$2$F$$20240829$20240822$20240906$EXP$$ES-TEVA-VS-3234129$TEVA$Vargas Osorio K, Calatayud-Cubes A, Diaz-Lopez EJ, Barbaran-Corral C, Lazare-Iglesias H, Anido-Herranz U, et al. Expression of somatostatin receptors in radioiodine refractory follicular cell derived thyroid carcinomas detected with [68Ga] Ga-DOTA-TOC. Virchows-Arch 2023; 483 (Suppl. 1) S251 abstr. E-PS-09-026.; Vargas Osorio K, Calatayud-Cubes A, Diaz-Lopez EJ, Barbaran-Corral C, Lazare-Iglesias H, Anido-Herranz U, et al. Expression of somatostatin receptors in radioiodine refractory follicu...$41$YR$$M$Y$$$20240906$$HP$ES$ES
242371661$24237166$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024AMR100560$GLAXOSMITHKLINE$$12$YR$$$Y$$$20240822$$HP$US$US
242371671$24237167$1$I$$20240819$20240822$20240822$PER$$US-LEO Pharma-372885$LEO PHARM$$79$YR$$F$Y$$$20240822$$CN$US$US
242371681$24237168$1$I$$20240814$20240822$20240822$EXP$$FR-MYLANLABS-2024M1076999$MYLAN$Malochet-Guinamand S, Fan A, Perrey A, Soubrier M. Apremilast successfully treats cutaneous polyarteritis nodosa associated with SAPHO syndrome. Rheumatology 2024; 63 (8): e224-e225.$53$YR$$M$Y$$$20240822$$HP$FR$FR
242371691$24237169$1$I$$20240814$20240822$20240822$EXP$$US-MYLANLABS-2024M1076782$MYLAN$Gallagher K, Ortenberg R, Toprak D. A Rare Pediatric Case of Anti-melanoma Differentiation-associated Gene 5 Rapidly Progressive Interstitial Lung Disease. Am-J-Respir-Crit-Care-Med 2023; 207.$6$YR$$M$Y$$$20240822$$HP$US$US
242371711$24237171$1$I$20240603$20240820$20240822$20240822$EXP$DE-PEI-CADR2024329850$DE-ROCHE-10000061280$ROCHE$$46$YR$A$F$Y$68$KG$20240822$$CN$DE$DE
242371721$24237172$1$I$20180322$20240814$20240822$20240822$EXP$$CA-TAKEDA-2024TUS084394$TAKEDA$$26$YR$$M$Y$$$20240822$$CN$CA$CA
242371731$24237173$1$I$20240818$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165638$AMGEN$$45$YR$A$M$Y$$$20240822$$CN$US$US
242371741$24237174$1$I$$20240813$20240822$20240822$EXP$$NL-AUROBINDO-AUR-APL-2024-041363$AUROBINDO$$59$YR$$M$Y$98$KG$20240822$$CN$NL$NL
242371781$24237178$1$I$$20240821$20240822$20240822$PER$$NVSC2024US170027$NOVARTIS$$63$YR$$F$Y$$$20240822$$HP$US$US
242371792$24237179$2$F$$20240918$20240822$20240926$30DAY$$IN-JNJFOC-20240853390$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$IN$IN
242371801$24237180$1$I$20240730$20240814$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130167$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$89.36$KG$20240822$$CN$US$US
242371821$24237182$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129924$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240822$$CN$US$US
242371831$24237183$1$I$$20240812$20240822$20240822$EXP$$CA-APOTEX-2024AP009349$APOTEX$$48$YR$$F$Y$$$20240822$$HP$CA$CA
242371861$24237186$1$I$$20240819$20240822$20240822$PER$$US-ROCHE-10000061415$ROCHE$$$$$F$Y$$$20240822$$CN$US$US
242371871$24237187$1$I$20240805$20240820$20240822$20240822$EXP$$US-BIOVITRUM-2024-US-011136$BIOVITRUM$$9$MON$$F$Y$$$20240822$$HP$US$US
242371882$24237188$2$F$$20240924$20240822$20240926$PER$$US-BIOVITRUM-2024-US-011135$BIOVITRUM$$62$YR$$F$Y$$$20240926$$CN$US$US
242371891$24237189$1$I$$20240820$20240822$20240822$EXP$$CA-ROCHE-10000061404$ROCHE$$$$$F$Y$$$20240822$$CN$CA$CA
242371901$24237190$1$I$$20240805$20240822$20240822$EXP$$US-ORPHALAN-US-ORP-24-00125$ORPHALAN$$$$$$Y$$$20240814$$CN$US$US
242371911$24237191$1$I$$20240815$20240822$20240822$EXP$$US-GSK-US2024AMR102855$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242371921$24237192$1$I$$20240817$20240822$20240822$PER$$US-ROCHE-10000061462$ROCHE$$$$$$Y$$$20240822$$PH$US$US
242371931$24237193$1$I$$20240820$20240822$20240822$EXP$$CA-ROCHE-10000061376$ROCHE$$64$YR$A$M$Y$$$20240822$$CN$CA$CA
242371942$24237194$2$F$$20240816$20240822$20240828$EXP$$AU-ROCHE-10000058696$ROCHE$Montarello N, Irvine I, Warner V, Hare J, Kaye D, Cloud G. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report. BMC Neurology. 2024-Dec;24 (1):1-6. doi:10.1186/s12883-024-03780-3.$51$YR$A$F$Y$$$20240828$$HP$AU$AU
242371951$24237195$1$I$20240818$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165176$AMGEN$$74$YR$E$$Y$$$20240822$$CN$US$US
242371962$24237196$2$F$20240819$20240906$20240822$20240909$PER$$US-AMGEN-USASP2024165364$AMGEN$$78$YR$E$M$Y$$$20240909$$CN$US$US
242371971$24237197$1$I$$20240820$20240822$20240822$EXP$AU-TGA-0000815511$AU-SANDOZ INC.-SDZ2024AU073944$SANDOZ$$54$YR$$F$Y$$$20240822$$HP$AU$AU
242371981$24237198$1$I$20240103$20240812$20240822$20240822$EXP$FR-AFSSAPS-LY2024000767$FR-TEVA-VS-3233236$TEVA$$59$YR$$F$Y$$$20240822$$PH$FR$FR
242371991$24237199$1$I$20240101$20240813$20240822$20240822$PER$$US-ABBVIE-5879958$ABBVIE$$$$$$Y$$$20240822$$PH$US$US
242372001$24237200$1$I$$20240815$20240822$20240822$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00430$VELOXIS PHARMACEUTICALS$Farkouh EK, Michel IM, Harrison DJ, Issa N.. Dual donor-derived renal allograft mucormycosis from a single deceased donor. Mayo clinic proceedings. 2024;99(8):1341-42$7$DEC$$F$Y$$$20240822$$MD$US$US
242372011$24237201$1$I$$20240819$20240822$20240822$EXP$$CA-ROCHE-3463007$ROCHE$$$$E$F$Y$$$20240822$$CN$CA$CA
242372021$24237202$1$I$$20240819$20240822$20240822$PER$$US-JNJFOC-20240850392$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240822$$CN$US$US
242372031$24237203$1$I$$20240820$20240822$20240822$PER$$US-HALEON-2193045$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242372041$24237204$1$I$$20240820$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074198$SANDOZ$$43$YR$$F$Y$$$20240822$$MD$US$US
242372051$24237205$1$I$20230801$20230928$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2023-062076$AUROBINDO$$78$YR$$F$Y$58.9$KG$20240822$$CN$US$US
242372071$24237207$1$I$$20240812$20240822$20240822$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07733$HIKMA$$$$$F$Y$$$20240822$$CN$US$US
242372101$24237210$1$I$$20240814$20240822$20240822$EXP$$US-ABBVIE-5881876$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242372111$24237211$1$I$20240519$20240520$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-026115$AUROBINDO$$48$YR$$F$Y$45.3$KG$20240822$$CN$US$US
242372121$24237212$1$I$20240818$20240820$20240822$20240822$EXP$GB-MHRA-MED-202408201917325590-FSPBN$GB-009507513-2408GBR007268$MERCK$$58$YR$$F$Y$170$KG$20240822$$PH$GB$GB
242372131$24237213$1$I$$20240814$20240822$20240822$EXP$$CA-ROCHE-10000058456$ROCHE$$$$A$M$Y$$$20240822$$CN$CA$CA
242372151$24237215$1$I$$20240808$20240822$20240822$EXP$$VE-B.Braun Medical Inc.-2160684$B BRAUN$Literature Article$21$YR$$F$Y$$$20240822$$$VE$VE
242372161$24237216$1$I$$20240524$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2024-017093$AUROBINDO$$$$$F$Y$$$20240822$$CN$US$US
242372181$24237218$1$I$20240722$20240808$20240822$20240822$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160714$JIANGSU HENGRUI MEDICINE$$57$YR$$F$Y$51$KG$20240822$$MD$CN$CN
242372191$24237219$1$I$$20240808$20240822$20240822$EXP$$US-B.Braun Medical Inc.-2160700$B BRAUN$Literature Article$$$$F$Y$$$20240822$$$US$US
242372211$24237221$1$I$$20240812$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-041231$AUROBINDO$$61$YR$$M$Y$$$20240822$$HP$CA$CA
242372221$24237222$1$I$$20240809$20240822$20240822$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111097$ZYDUS PHARM$Belmore L, Ahn T, Nguyen E, Lenz T.. Acute non-ST segment elevation myocardial infarction following intravenous injection of sublingual Suboxone.. Prehosp-Emerg-Care. 2024$$$$$Y$$$20240822$$HP$US$US
242372231$24237223$1$I$20240601$20240819$20240822$20240822$EXP$$CA-ABBVIE-5889130$ABBVIE$$77$YR$$F$Y$$$20240822$$HP$CA$CA
242372242$24237224$2$F$20240801$20240916$20240822$20240923$30DAY$$US-AMGEN-USASP2024164192$AMGEN$$68$YR$E$F$Y$65.4$KG$20240923$$PH$US$US
242372251$24237225$1$I$$20240820$20240822$20240822$EXP$$CA-ABBVIE-5889193$ABBVIE$$$$E$F$Y$$$20240822$$CN$CA$CA
242372271$24237227$1$I$20240805$20240812$20240822$20240822$EXP$CN-NMPACDR-3501821025798202400294$CN-BAXTER-2024BAX023193$BAXTER$$48$YR$$F$Y$68$KG$20240822$$MD$CN$CN
242372281$24237228$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132072$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240822$$PH$US$US
242372291$24237229$1$I$20190724$20240819$20240822$20240822$EXP$$AU-ABBVIE-5887493$ABBVIE$$69$YR$$F$Y$$$20240822$$CN$AU$AU
242372301$24237230$1$I$$20240812$20240822$20240822$EXP$$CA-APOTEX-2024AP009350$APOTEX$$80$YR$$M$Y$89$KG$20240822$$HP$CA$CA
242372321$24237232$1$I$$20240729$20240822$20240822$PER$$US-HBP-2024US031078$HELSINN HEALTHCARE$$$$$F$Y$$$20240822$$CN$US$US
242372331$24237233$1$I$$20240813$20240822$20240822$EXP$$CA-BAXTER-2023BAX038436$BAXTER$$40$YR$$M$Y$$$20240822$$MD$CA$CA
242372341$24237234$1$I$$20230728$20240822$20240822$PER$$US-AUROBINDO-AUR-APL-2023-041127$AUROBINDO$$$$$$Y$$$20240822$$PH$US$US
242372351$24237235$1$I$20240710$20240812$20240822$20240822$EXP$FR-AFSSAPS-GR2024001000$FR-BAXTER-2024BAX023030$BAXTER$$82$YR$$F$Y$$$20240822$$PH$FR$FR
242372361$24237236$1$I$$20240812$20240822$20240822$EXP$GB-MHRA-MED-202408122343535150-GLKZC$GB-BAXTER-2024BAX023111$BAXTER$$24$YR$$$Y$$$20240822$$CN$GB$GB
242372371$24237237$1$I$$20240813$20240822$20240822$EXP$GB-MHRA-31453274$GB-BAXTER-2024BAX023179$BAXTER$$46$YR$$M$Y$120$KG$20240822$$CN$GB$GB
242372381$24237238$1$I$$20240812$20240822$20240822$EXP$$CA-BAXTER-2024BAX023159$BAXTER$$5$YR$$F$Y$$$20240822$$HP$CA$CA
242372391$24237239$1$I$20230917$20240812$20240822$20240822$EXP$FR-AFSSAPS-PP2024000887$FR-BAXTER-2024BAX023034$BAXTER$$23$YR$$F$Y$60$KG$20240822$$PH$FR$FR
242372401$24237240$1$I$$20240812$20240822$20240822$EXP$$CA-BAXTER-2024BAX023091$BAXTER$$67$YR$$F$Y$$$20240822$$HP$CA$CA
242372411$24237241$1$I$$20240815$20240822$20240822$EXP$$GB-MYLANLABS-2024M1071552$MYLAN$$$$$M$Y$$$20240822$$MD$GB$GB
242372424$24237242$4$F$20240807$20240903$20240822$20240913$EXP$$US-BAXTER-2024BAX023104$BAXTER$$22$YR$$M$Y$97.06$KG$20240913$$MD$US$US
242372431$24237243$1$I$$20240410$20240822$20240822$EXP$CA-TEVA-2022-CA-2069374$CA-ABBVIE-2229394US$ABBVIE$$65$YR$$F$Y$69$KG$20240822$$HP$CA$CA
242372441$24237244$1$I$$20240815$20240822$20240822$EXP$$JP-MYLANLABS-2024M1076043$MYLAN$Yamamura K, Morishima T, Toyosawa R, Maeyama K, Tokuchi H, Kinoshita I , et al. A case of acute intoxication due to antihypertensive drugs in which the patient was successfully saved with multidisciplinary treatment. The 8th Tokai-Hokuriku Regional Meeting of JSICM. 2024;78$8$DEC$$F$Y$$$20240822$$MD$JP$JP
242372452$24237245$2$F$$20240821$20240822$20240830$EXP$$IT-BAXTER-2024BAX023190$BAXTER$$$$A$M$Y$88.7$KG$20240830$$HP$IT$IT
242372491$24237249$1$I$$20240813$20240822$20240822$EXP$$CA-BAXTER-2024BAX023255$BAXTER$$51$YR$$F$Y$$$20240822$$MD$CA$CA
242372511$24237251$1$I$20240713$20240820$20240822$20240822$EXP$FR-AFSSAPS-BR2024000681$FR-ORGANON-O2408FRA001463$ORGANON$$75$YR$$F$Y$$$20240822$$MD$FR$FR
242372521$24237252$1$I$20240701$20240812$20240822$20240822$PER$$US-JNJFOC-20240831980$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240822$$CN$US$US
242372531$24237253$1$I$20240814$20240814$20240822$20240822$EXP$GB-MHRA-TPP29293678C9327392YC1723627126774$GB-PERRIGO-24GB007692$PERRIGO$$82$YR$$M$Y$112$KG$20240822$$MD$GB$GB
242372541$24237254$1$I$$20220404$20240822$20240822$EXP$$US-AstraZeneca-2022A076044$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242372551$24237255$1$I$$20240820$20240822$20240822$EXP$$IE-ROCHE-10000061746$ROCHE$$$$$M$Y$$$20240822$$CN$IE$IE
242372561$24237256$1$I$20240506$20240814$20240822$20240822$EXP$$PT-AstraZeneca-2024A184861$ASTRAZENECA$$66$YR$$M$Y$$$20240822$$MD$PT$
242372571$24237257$1$I$$20240814$20240822$20240822$EXP$$PL-AstraZeneca-2024A185707$ASTRAZENECA$$67$YR$$F$Y$$$20240822$$CN$PL$
242372581$24237258$1$I$$20240814$20240822$20240822$EXP$$CZ-ROCHE-2526321$ROCHE$E K, Protus M, Nemcova D, Uchytilova E. Single mutidrug resistant enterobacteriacae donor-derived infection in four solid organ transplant recipients: a case repor. BMCSurg 2019;19 (1):111-.$32$YR$A$M$Y$$$20240822$$HP$CZ$CZ
242372591$24237259$1$I$20240812$20240815$20240822$20240822$EXP$$US-AMGEN-USASP2024164543$AMGEN$$86$YR$E$F$Y$$$20240822$$CN$US$US
242372612$24237261$2$F$20240601$20240903$20240822$20240930$PER$$US-TRAVERE-2024TVT00761$TRAVERE THERAPEUTICS$$36$YR$A$F$Y$$$20240930$$CN$US$US
242372622$24237262$2$F$$20240814$20240822$20240822$PER$$US-TRAVERE-2024TVT00759$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242372632$24237263$2$F$20240617$20240617$20240822$20240822$PER$$US-TRAVERE-2024TVT00584$TRAVERE THERAPEUTICS$$42$YR$A$M$Y$$$20240822$$CN$US$US
242372643$24237264$3$F$$20240923$20240822$20240926$PER$$US-ROCHE-10000063638$ROCHE$$$$$$Y$$$20240926$$PH$US$US
242372651$24237265$1$I$20240814$20240819$20240822$20240822$PER$$US-ALXN-202408USA001128US$ALEXION PHARMACEUTICALS$$76$YR$$M$Y$$$20240822$$CN$US$US
242372662$24237266$2$F$20240819$20240821$20240822$20240828$PER$$US-ROCHE-10000061878$ROCHE$$$$$F$Y$$$20240828$$CN$US$US
242372673$24237267$3$F$20240808$20240917$20240822$20240919$EXP$$NVSC2024CA165804$NOVARTIS$$77$YR$$F$Y$69$KG$20240919$$MD$CA$CA
242372681$24237268$1$I$$20240820$20240822$20240822$PER$$NVSC2024US169640$NOVARTIS$$$$$F$Y$$$20240822$$HP$US$US
242372691$24237269$1$I$20240720$20240729$20240822$20240822$PER$$US-GREER Laboratories, Inc.-2160701$GREER$$40$YR$$M$Y$88.636$KG$20240822$$$US$US
242372701$24237270$1$I$20240201$20240806$20240822$20240822$EXP$$GB-Ascend Therapeutics US, LLC-2160694$ASCEND$$56$YR$$F$Y$$$20240822$$$GB$GB
242372711$24237271$1$I$$20240808$20240822$20240822$EXP$$FR-B.Braun Medical Inc.-2160699$B BRAUN$Literature Article$9$YR$$M$Y$$$20240822$$$FR$FR
242372731$24237273$1$I$20240101$20240812$20240822$20240822$EXP$FR-AFSSAPS-BR2024000638$FR-Accord-441512$ACCORD$$53$YR$A$F$Y$$$20240822$$MD$FR$FR
242372741$24237274$1$I$$20240812$20240822$20240822$EXP$FR-AFSSAPS-PV2024000722$FR-Accord-441527$ACCORD$$$$N$M$Y$0.32$KG$20240822$$MD$FR$FR
242372751$24237275$1$I$$20240811$20240822$20240822$EXP$$JP-Accord-442025$ACCORD$Yamada K, Ida-Ichikawa M, Fujimoto N, Ishida M, Dohi K. Takotsubo syndrome in a cancer patient treated with a combination of anti-cancer drugs including immune checkpoint inhibitors: a case report. Eur Heart J Case Rep. 2024 Jul 23;8(8):ytae355. doi: 10.1093/ehjcr/ytae355.$66$YR$E$F$Y$$$20240822$$HP$JP$JP
242372763$24237276$3$F$20240805$20240920$20240822$20240924$EXP$$US-BEH-2024177100$CSL BEHRING$$28$YR$A$M$Y$129.25$KG$20240924$$HP$US$US
242372771$24237277$1$I$20240101$20240813$20240822$20240822$PER$$US-ABBVIE-5881334$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242372781$24237278$1$I$20240820$20240820$20240822$20240822$EXP$$US-KYOWAKIRIN-2024KK019574$KYOWA$$$$$$Y$$$20240822$$HP$US$US
242372791$24237279$1$I$$20240820$20240822$20240822$PER$$US-Mission Pharmacal Company-2160704$MISSION$$31$YR$$M$Y$$$20240822$$$US$US
242372811$24237281$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062700$ROCHE$$22$YR$A$F$Y$$$20240822$$HP$US$US
242372821$24237282$1$I$20230323$20240806$20240822$20240822$EXP$$DE-SERB S.A.S.-2158608$LABORATOIRES SERB$$38$YR$$F$Y$$$20240822$$MD$DE$DE
242372831$24237283$1$I$$20240808$20240822$20240822$EXP$$US-B.Braun Medical Inc.-2160689$B BRAUN$Literature Article$60$YR$$F$Y$$$20240822$$$US$US
242372841$24237284$1$I$20240807$20240813$20240822$20240822$PER$$US-ABBVIE-5880421$ABBVIE$$$$$$Y$$$20240822$$MD$US$US
242372851$24237285$1$I$20240801$20240816$20240822$20240822$PER$$US-IDORSIA-008369-2024-US$IDORSIA PHARMACEUTICALS$$62$YR$$F$Y$$$20240822$$CN$US$US
242372861$24237286$1$I$$20240808$20240822$20240822$EXP$$US-B.Braun Medical Inc.-2160690$B BRAUN$Literature Article$31$YR$$F$Y$$$20240822$$$US$US
242372881$24237288$1$I$$20240808$20240822$20240822$EXP$$US-B.Braun Medical Inc.-2160687$B BRAUN$Literature Article$62$YR$$F$Y$$$20240822$$$US$US
242372893$24237289$3$F$20240101$20240910$20240822$20240911$EXP$$US-ROCHE-10000061940$ROCHE$$60$YR$A$F$Y$102.06$KG$20240911$$CN$US$US
242372901$24237290$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062944$ROCHE$$65$YR$E$F$Y$$$20240822$$CN$US$US
242372911$24237291$1$I$20240719$20240812$20240822$20240822$EXP$$PT-Integrated Therapeutic Solutions Inc.-2160688$Integrated Therapeutic Solutions$$67$YR$$M$Y$$$20240822$$$PT$PT
242372921$24237292$1$I$$20240808$20240822$20240822$EXP$$TR-B.Braun Medical Inc.-2160695$B BRAUN$Literature Article$67$YR$$M$Y$$$20240822$$$TR$TR
242372932$24237293$2$F$$20240902$20240822$20240904$EXP$$GB-TEVA-VS-3235166$TEVA$$$$$F$Y$$$20240904$$CN$GB$GB
242372941$24237294$1$I$$20240808$20240822$20240822$EXP$$JP-P+L Developments of Newyork Corporation-2160712$PL DEVELOPMENTS$Initial$9$YR$$F$Y$$$20240822$$$JP$JP
242372951$24237295$1$I$20180822$20240808$20240822$20240822$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160715$JIANGSU HENGRUI MEDICINE$$74$YR$$F$Y$$$20240822$$MD$CN$CN
242372961$24237296$1$I$$20240809$20240822$20240822$EXP$$PT-ACI HealthCare Limited-2160717$ACI HEALTHCARE$Full text$80$YR$$F$Y$$$20240822$$$PT$PT
242372971$24237297$1$I$20050101$20240814$20240822$20240822$EXP$$US-TEVA-VS-3233759$TEVA$$49$YR$$F$Y$$$20240822$$CN$US$US
242372981$24237298$1$I$$20240807$20240822$20240822$EXP$$TR-Eywa Pharma Inc.-2160720$EYWA PHARMA$Full text$27$YR$$M$Y$$$20240822$$$TR$TR
242372991$24237299$1$I$$20240809$20240822$20240822$EXP$$US-ACI HealthCare Limited-2160718$ACI HEALTHCARE$Full text$73$YR$$F$Y$$$20240822$$$US$US
242373001$24237300$1$I$$20240819$20240822$20240822$EXP$$NVSC2024CA168317$NOVARTIS$$36$YR$$F$Y$$$20240822$$HP$CA$CA
242373011$24237301$1$I$20240809$20240809$20240822$20240822$EXP$$US-CSL-2024-007595$CSL Plasma$$36$YR$$F$Y$$$20240822$$HP$US$US
242373021$24237302$1$I$20240727$20240812$20240822$20240822$PER$$US-Appco Pharma LLC-2160721$APPCO PHARMA$$$$$F$Y$$$20240822$$$US$US
242373031$24237303$1$I$$20240813$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024100739$VIIV$$$$$M$Y$$$20240822$$MD$US$US
242373041$24237304$1$I$$20240813$20240822$20240822$EXP$$US-AMERICAN REGENT INC-2024003144$AMERICAN REGENT$Shivarajpur A, Valentin RG. Intramuscular Progesterone: A Cause of Acute Eosinophilic Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 2024;209:A2002[abstract]$35$YR$$F$Y$$$20240822$$HP$US$US
242373051$24237305$1$I$20240201$20240812$20240822$20240822$EXP$$DE-AUROBINDO-AUR-APL-2024-041239$AUROBINDO$$71$YR$$M$Y$$$20240822$$PH$DE$DE
242373061$24237306$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000063520$ROCHE$$$$$$Y$$$20240822$$CN$US$US
242373072$24237307$2$F$20240707$20240822$20240822$20240831$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03029$AMNEAL$$71$YR$$M$Y$90.703$KG$20240831$$CN$US$US
242373081$24237308$1$I$20240101$20240819$20240822$20240822$EXP$$US-PFIZER INC-PV202400094142$PFIZER$$24$YR$$F$Y$$$20240822$$HP$US$US
242373091$24237309$1$I$$20240812$20240822$20240822$EXP$$IN-PFIZER INC-2024SGN01585$PFIZER$$59$YR$$M$Y$$$20240822$$CN$IN$IN
242373101$24237310$1$I$$20240807$20240822$20240822$EXP$CH-SM-2024-14399$CH-UCBSA-2024040506$UCB$$50$YR$$F$Y$$$20240822$$PH$CH$CH
242373111$24237311$1$I$20240101$20240814$20240822$20240822$EXP$$BR-JNJFOC-20240841996$JOHNSON AND JOHNSON$$17$YR$T$F$Y$56$KG$20240822$$CN$BR$BR
242373121$24237312$1$I$$20240820$20240822$20240822$EXP$$US-PFIZER INC-PV202300201611$PFIZER$$82$YR$$M$Y$$$20240822$$CN$US$US
242373191$24237319$1$I$$20240802$20240822$20240822$PER$$US-TRAVERE-2024TVT00762$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242373201$24237320$1$I$20240716$20240802$20240822$20240822$PER$$US-TRAVERE-2024TVT00760$TRAVERE THERAPEUTICS$$44$YR$A$F$Y$$$20240822$$CN$US$US
242373211$24237321$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165209$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242373222$24237322$2$F$20240814$20240906$20240822$20240911$PER$$US-AMGEN-USASP2024164085$AMGEN$$77$YR$E$F$Y$69.841$KG$20240911$$HP$US$US
242373232$24237323$2$F$$20240821$20240822$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133210$BRISTOL MYERS SQUIBB$Vangeison CT, Roys JP, Catalanotto MN, Kupperman WI, Kovacs AR, D?rzu DS, et al. Medication-induced mood disorders following epidural steroid injections in patients with pain: a case series. Clinical Case Reports. 2023 Jun 01;11(6):1-4. doi:10.1002/ccr3.7415.$58$YR$A$M$Y$$$20240830$$HP$US$US
242373242$24237324$2$F$20240301$20240830$20240822$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-131298$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240904$$PH$JP$JP
242373251$24237325$1$I$20240815$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163782$AMGEN$$83$YR$E$M$Y$$$20240822$$HP$US$US
242373261$24237326$1$I$$20240807$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07919$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242373281$24237328$1$I$20240304$20240813$20240822$20240822$EXP$$US-MYLANLABS-2024M1075914$MYLAN$$82$YR$$M$Y$92.2$KG$20240822$$CN$US$US
242373291$24237329$1$I$20240706$20240816$20240822$20240822$EXP$$FR-AMERICAN REGENT INC-2024003176$AMERICAN REGENT$$$$$F$Y$$$20240822$$PH$FR$FR
242373302$24237330$2$F$20240801$20240820$20240822$20240826$EXP$$US-ABBVIE-5889525$ABBVIE$$42$YR$$F$Y$$$20240826$$HP$US$US
242373311$24237331$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012541$ELI LILLY AND CO$$$$$F$Y$$$20240822$$HP$US$US
242373322$24237332$2$F$$20240827$20240822$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202408012022$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240908$$CN$US$US
242373331$24237333$1$I$20240816$20240816$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011041$ELI LILLY AND CO$$63$YR$A$$Y$$$20240822$$CN$US$US
242373342$24237334$2$F$$20240904$20240822$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408012510$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240909$$CN$US$US
242373351$24237335$1$I$$20240813$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408008982$ELI LILLY AND CO$$56$YR$A$$Y$$$20240822$$LW$US$US
242373361$24237336$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013535$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240822$$CN$US$US
242373381$24237338$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012719$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242373391$24237339$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012922$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240822$$CN$US$US
242373402$24237340$2$F$$20240917$20240822$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202408012899$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240919$$CN$US$US
242373411$24237341$1$I$$20240814$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408009092$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240822$$CN$US$US
242373421$24237342$1$I$20240811$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012092$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240822$$CN$US$US
242373431$24237343$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012708$ELI LILLY AND CO$$$$$M$Y$$$20240822$$CN$US$US
242373441$24237344$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012583$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242373461$24237346$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5887631$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242373471$24237347$1$I$20240501$20240820$20240822$20240822$EXP$$DE-ROCHE-10000062766$ROCHE$$60$YR$A$F$Y$$$20240822$$MD$DE$DE
242373481$24237348$1$I$$20240425$20240822$20240822$EXP$$CA-ROCHE-10000059884$ROCHE$$65$YR$E$F$Y$$$20240822$$HP$CA$CA
242373491$24237349$1$I$$20240815$20240822$20240822$EXP$$US-JNJFOC-20240845395$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$US$US
242373501$24237350$1$I$$20240821$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-081787-2024$RECKITT BENCKISER$$50$YR$$F$Y$$$20240822$$CN$US$US
242373512$24237351$2$F$$20240816$20240822$20240827$PER$$US-MYLANLABS-2024M1077157$MYLAN$$$$$F$Y$$$20240827$$CN$US$US
242373521$24237352$1$I$$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128986$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$71.67$KG$20240822$$CN$US$US
242373531$24237353$1$I$$20240815$20240822$20240822$30DAY$$CO-UCBSA-2024042441$UCB$$$$$$Y$$$20240822$$CN$CO$CO
242373551$24237355$1$I$$20240319$20240822$20240822$EXP$$SA-UCBSA-2024013880$UCB$Shariff E, Nazish S, Shahid R, Zafar A, Yasawy ZM, AlKhaldi NA et al. Outcomes and predictors of seizure recurrence in post-stroke epilepsy, a retrospective hospital-based study. Clinical Neurology and Neurosurgery. 2024;239:1-8$$$$$Y$$$20240822$$HP$SA$SA
242373561$24237356$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024100321$GLAXOSMITHKLINE$$12$YR$$F$Y$$$20240822$$HP$US$US
242373571$24237357$1$I$$20240816$20240822$20240822$EXP$$BR-GSK-BR2024AMR103138$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$MD$BR$BR
242373581$24237358$1$I$$20240808$20240822$20240822$PER$$US-AstraZeneca-2024A181111$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242373592$24237359$2$F$20240807$20240818$20240822$20240824$EXP$$AU-AstraZeneca-2024A185552$ASTRAZENECA$$78$YR$$M$Y$$$20240823$$MD$AU$
242373601$24237360$1$I$$20240813$20240822$20240822$PER$$US-ABBVIE-5879752$ABBVIE$$$$$$Y$$$20240822$$CN$US$US
242373611$24237361$1$I$$20240610$20240822$20240822$PER$$US-TRAVERE-2024TVT00595$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
242373621$24237362$1$I$$20240805$20240822$20240822$PER$$US-TRAVERE-2024TVT00765$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
242373631$24237363$1$I$$20240816$20240822$20240822$EXP$$ES-JNJFOC-20240454855$JOHNSON AND JOHNSON$$58$YR$A$M$Y$92$KG$20240822$$CN$ES$ES
242373641$24237364$1$I$20240401$20240816$20240822$20240822$EXP$$MX-ROCHE-10000061577$ROCHE$$10$YR$C$M$Y$23$KG$20240822$$CN$MX$MX
242373651$24237365$1$I$20240805$20240805$20240822$20240822$PER$$US-TRAVERE-2024TVT00766$TRAVERE THERAPEUTICS$$52$YR$A$M$Y$$$20240822$$CN$US$US
242373661$24237366$1$I$$20240814$20240822$20240822$30DAY$$BR-JNJFOC-20240852372$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$BR$BR
242373671$24237367$1$I$$20240816$20240822$20240822$EXP$$TR-JNJFOC-20240845368$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240822$$MD$TR$TR
242373682$24237368$2$F$$20240821$20240822$20240901$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133255$BRISTOL MYERS SQUIBB$Vangeison CT, Roys JP, Catalanotto MN, Kupperman WI, Kovacs AR, D?rzu DS, et al. Medication-induced mood disorders following epidural steroid injections in patients with pain: a case series. Clinical Case Reports. 2023 Jun 01;11(6):1-4. doi:10.1002/ccr3.7415.$56$YR$A$M$Y$$$20240902$$HP$US$US
242373691$24237369$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129772$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240822$$CN$US$US
242373701$24237370$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131119$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240822$$CN$US$US
242373711$24237371$1$I$20240720$20240821$20240822$20240822$EXP$$GB-ROCHE-10000062782$ROCHE$$$$$M$Y$$$20240822$$HP$GB$GB
242373722$24237372$2$F$20240617$20240821$20240822$20240823$EXP$$IE-ROCHE-10000062715$ROCHE$$$$$F$Y$$$20240823$$CN$IE$IE
242373743$24237374$3$F$$20240920$20240822$20240923$EXP$$DE-SANDOZ INC.-SDZ2024DE073322$SANDOZ$$80$YR$$M$Y$69$KG$20240923$$HP$DE$DE
242373753$24237375$3$F$20240820$20240827$20240822$20240907$PER$$US-AMGEN-USASP2024166291$AMGEN$$29$YR$A$F$Y$$$20240906$$CN$US$US
242373761$24237376$1$I$$20240812$20240822$20240822$EXP$FR-AFSSAPS-PV2024000590$FR-TEVA-VS-3233263$TEVA$$1$DY$$M$Y$0.79$KG$20240822$$HP$FR$FR
242373771$24237377$1$I$$20240821$20240822$20240822$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047127$BOEHRINGER INGELHEIM$$$$$$Y$$$20240822$$HP$US$US
242373782$24237378$2$F$20240201$20240821$20240822$20240823$EXP$$IE-ROCHE-10000062920$ROCHE$$63$YR$A$F$Y$$$20240823$$CN$IE$IE
242373791$24237379$1$I$$20240822$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-136098-2023$RECKITT BENCKISER$$$$$F$Y$45.35$KG$20240822$$CN$US$US
242373811$24237381$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024AMR101035$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242373823$24237382$3$F$20240724$20240903$20240822$20240904$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047168$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$50$KG$20240904$$PH$JP$JP
242373831$24237383$1$I$20240821$20240822$20240822$20240822$EXP$$AU-MYLANLABS-2024M1077737$MYLAN$$63$YR$$M$Y$$$20240822$$HP$AU$AU
242373841$24237384$1$I$20240811$20240814$20240822$20240822$EXP$$US-009507513-2408USA005473$MERCK$$$$$F$Y$$$20240822$$CN$US$US
242373851$24237385$1$I$$20240808$20240822$20240822$EXP$$US-MankindUS-000236$MANKIND PHARMA$Gamcsik S, Adams KS. Comparison of intramuscular haloperidol and other short-acting injectable antipsychotics for management of acute agitation in an adult inpatient psychiatry unit. Ment Health Clin. 2024 Aug 2;14(4):242-246.$$$A$$Y$$$20240822$$PH$US$US
242373861$24237386$1$I$$20240813$20240822$20240822$EXP$$CZ-AMNEAL PHARMACEUTICALS-2024-AMRX-03036$AMNEAL$Blahova K.. Torsade de pointes as an unexpected result of common medication changes. Pol Arch Intern Med. 2022;132:14-5$$$$F$Y$$$20240822$$HP$CZ$CZ
242373871$24237387$1$I$$20240821$20240822$20240822$PER$$US-ROCHE-10000063177$ROCHE$$$$$F$Y$$$20240822$$CN$US$US
242373881$24237388$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062551$ROCHE$$$$A$F$Y$$$20240822$$CN$US$US
242373891$24237389$1$I$$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024165251$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242373901$24237390$1$I$20240101$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024166721$AMGEN$$$$$$Y$$$20240822$$HP$US$US
242373911$24237391$1$I$$20240805$20240822$20240822$PER$$US-TRAVERE-2024TVT00771$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
242373921$24237392$1$I$$20240805$20240822$20240822$PER$$US-TRAVERE-2024TVT00768$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
242373933$24237393$3$F$20240701$20240819$20240822$20240917$PER$$US-TRAVERE-2024TVT00770$TRAVERE THERAPEUTICS$$36$YR$A$M$Y$$$20240917$$CN$US$US
242373941$24237394$1$I$$20240805$20240822$20240822$PER$$US-TRAVERE-2024TVT00767$TRAVERE THERAPEUTICS$$14$YR$T$M$Y$$$20240822$$CN$US$US
242373952$24237395$2$F$20240105$20240821$20240822$20240826$PER$$US-ABBVIE-5889683$ABBVIE$$26$YR$$F$Y$$$20240826$$MD$US$US
242373961$24237396$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062556$ROCHE$$61$YR$A$M$Y$$$20240822$$CN$US$US
242373971$24237397$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062792$ROCHE$$$$E$M$Y$$$20240822$$CN$US$US
242373981$24237398$1$I$$20240814$20240822$20240822$PER$$US-ALXN-202408USA000850US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242373993$24237399$3$F$20240703$20240828$20240822$20240903$EXP$$US-BIOGEN-2024BI01278727$BIOGEN$$62$YR$$F$Y$$$20240903$$CN$US$US
242374001$24237400$1$I$$20240814$20240822$20240822$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006035$BIOCON$$$$$$Y$$$20240822$$CN$CA$CA
242374011$24237401$1$I$$20240820$20240822$20240822$EXP$$DE-ROCHE-10000062400$ROCHE$$$$$$Y$$$20240822$$CN$DE$DE
242374021$24237402$1$I$$20240821$20240822$20240822$PER$$US-ROCHE-10000063565$ROCHE$$63$YR$A$F$Y$$$20240822$$CN$US$US
242374033$24237403$3$F$$20240920$20240822$20240924$30DAY$$HK-JNJFOC-20240852324$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$HK$HK
242374041$24237404$1$I$20240812$20240812$20240822$20240822$PER$$US-JNJFOC-20240829918$JOHNSON AND JOHNSON$$73$YR$E$$Y$$$20240822$$PH$US$US
242374051$24237405$1$I$20240701$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131020$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240822$$HP$US$US
242374061$24237406$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131832$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240822$$HP$US$US
242374077$24237407$7$F$$20240919$20240822$20240924$EXP$$CA-ROCHE-10000062913$ROCHE$$64$YR$A$F$Y$$$20240924$$CN$CA$CA
242374091$24237409$1$I$$20240821$20240822$20240822$PER$$US-ROCHE-10000063195$ROCHE$$$$$$Y$$$20240822$$PH$US$US
242374101$24237410$1$I$20240401$20240819$20240822$20240822$EXP$$US-GILEAD-2024-0684896$GILEAD$$29$YR$A$$Y$$$20240822$$CN$US$US
242374111$24237411$1$I$$20240815$20240822$20240822$EXP$$US-GSK-US2024AMR102862$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242374121$24237412$1$I$$20240819$20240822$20240822$PER$$US-ABBVIE-5889289$ABBVIE$$40$YR$$M$Y$$$20240822$$PH$US$US
242374131$24237413$1$I$20240605$20240816$20240822$20240822$EXP$IT-MINISAL02-998802$IT-AMGEN-ITASP2024163529$AMGEN$$21$YR$A$M$Y$72$KG$20240822$$MD$IT$IT
242374141$24237414$1$I$$20240814$20240822$20240822$EXP$$DO-AMGEN-DOMSP2024166226$AMGEN$$$$$F$Y$$$20240822$$CN$DO$DO
242374152$24237415$2$F$20240612$20240920$20240822$20240924$PER$$NVSC2024US169440$NOVARTIS$$74$YR$$F$Y$54.9$KG$20240925$$MD$US$US
242374161$24237416$1$I$20221001$20230524$20240822$20240822$EXP$$US-AstraZeneca-2023A128892$ASTRAZENECA$$823$MON$$F$Y$$$20240822$$CN$US$
242374171$24237417$1$I$20220101$20240814$20240822$20240822$EXP$$BR-AstraZeneca-2024A187566$ASTRAZENECA$$72$YR$$F$Y$$$20240822$$CN$BR$
242374181$24237418$1$I$$20240814$20240822$20240822$EXP$$ZA-AstraZeneca-2024A186790$ASTRAZENECA$$79$YR$$F$Y$$$20240822$$CN$ZA$
242374191$24237419$1$I$20231217$20240819$20240822$20240822$EXP$$US-AstraZeneca-2024A188604$ASTRAZENECA$$25592$DY$$M$Y$$$20240822$$HP$US$
242374201$24237420$1$I$20190301$20190830$20240822$20240822$EXP$$BR-AstraZeneca-2019SF26234$ASTRAZENECA$$23009$DY$$F$Y$$$20240822$$CN$BR$
242374211$24237421$1$I$20240515$20240821$20240821$20240821$DIR$715256$$FDA-CTU$$66$YR$$M$N$109.35$KG$20240821$N$CN$US$
242374231$24237423$1$I$$20240821$20240821$20240821$DIR$715265$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242374251$24237425$1$I$$20240821$20240821$20240821$DIR$715267$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242374261$24237426$1$I$$20240821$20240821$20240821$DIR$715269$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242374272$24237427$2$F$20231031$20240819$20240822$20240913$EXP$$US-AstraZeneca-2024A188764$ASTRAZENECA$$24806$DY$$M$Y$$$20240913$$MD$US$
242374291$24237429$1$I$$20230613$20240822$20240822$EXP$$US-AstraZeneca-2023A138826$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242374302$24237430$2$F$20240101$20240822$20240822$20240829$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004477$Unknown Manufacturer$$$$$$Y$$$20240829$$CN$CN$CN
242374311$24237431$1$I$$20240503$20240822$20240822$30DAY$$US-PFIZER INC-202400101304$PFIZER$$14$YR$$F$Y$$$20240822$$CN$US$US
242374321$24237432$1$I$$20240821$20240822$20240822$PER$$US-ROCHE-10000063348$ROCHE$$$$E$F$Y$$$20240822$$CN$US$US
242374333$24237433$3$F$20240801$20240912$20240822$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202408012448$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240918$$CN$US$US
242374341$24237434$1$I$$20240812$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-041133$AUROBINDO$$$$$F$Y$$$20240822$$HP$CA$CA
242374351$24237435$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012593$ELI LILLY AND CO$$15$YR$T$F$Y$$$20240822$$CN$US$US
242374361$24237436$1$I$$20240815$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012435$ELI LILLY AND CO$$$$$$Y$$$20240822$$HP$US$US
242374371$24237437$1$I$20240816$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011504$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240822$$CN$US$US
242374381$24237438$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012447$ELI LILLY AND CO$$$$$F$Y$$$20240822$$HP$US$US
242374391$24237439$1$I$20231101$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202404007174$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240822$$CN$US$US
242374401$24237440$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011517$ELI LILLY AND CO$$$$$$Y$$$20240822$$HP$US$US
242374411$24237441$1$I$20240813$20240814$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011705$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242374432$24237443$2$F$$20240821$20240822$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012168$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240826$$CN$US$US
242374441$24237444$1$I$$20240816$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011543$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242374451$24237445$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012500$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240822$$CN$US$US
242374461$24237446$1$I$20240814$20240814$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408009045$ELI LILLY AND CO$$31$YR$A$$Y$$$20240822$$CN$US$US
242374471$24237447$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012639$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242374481$24237448$1$I$20240801$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013674$ELI LILLY AND CO$$76$YR$E$$Y$$$20240822$$CN$US$US
242374491$24237449$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012568$ELI LILLY AND CO$$89$YR$E$F$Y$$$20240822$$CN$US$US
242374512$24237451$2$F$$20240822$20240822$20240829$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004478$BLUEPRINT MEDICINES$$$$$$Y$$$20240829$$CN$CN$CN
242374521$24237452$1$I$20240818$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024166539$AMGEN$$$$$$Y$$$20240822$$HP$US$US
242374532$24237453$2$F$20240101$20240910$20240822$20240911$PER$$US-AMGEN-USASP2024165758$AMGEN$$73$YR$E$F$Y$$$20240911$$CN$US$US
242374551$24237455$1$I$$20240821$20240822$20240822$PER$$NVSC2024US170047$NOVARTIS$$$$$$Y$$$20240822$$CN$US$US
242374561$24237456$1$I$20240725$20240813$20240822$20240822$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004472$Unknown Manufacturer$$$$$$Y$$$20240822$$HP$US$US
242374572$24237457$2$F$$20240815$20240822$20240822$EXP$$US-ROCHE-10000058841$ROCHE$$$$$$Y$$$20240822$$CN$US$US
242374581$24237458$1$I$$20240814$20240822$20240822$EXP$$IN-ROCHE-10000057396$ROCHE$$53$YR$A$M$Y$$$20240822$$CN$IN$IN
242374591$24237459$1$I$$20240214$20240822$20240822$EXP$$CA-ROCHE-10000060385$ROCHE$$69$YR$E$F$Y$$$20240822$$HP$CA$CA
242374601$24237460$1$I$$20240811$20240822$20240822$EXP$GB-MHRA-MED-202408112206023550-QKDCN$GB-Accord-441239$ACCORD$$2$YR$C$M$Y$$$20240822$$CN$GB$GB
242374611$24237461$1$I$20240810$20240810$20240822$20240822$EXP$GB-MHRA-MED-202408101450059480-VLMWT$GB-Accord-441231$ACCORD$$59$YR$A$M$Y$$$20240822$$CN$GB$GB
242374631$24237463$1$I$$20240822$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-138419-2023$RECKITT BENCKISER$$$$$M$Y$$$20240822$$CN$US$US
242374641$24237464$1$I$$20240812$20240822$20240822$EXP$GB-MHRA-MED-202408121729244000-BKHSR$GB-Accord-441552$ACCORD$$$$$M$Y$$$20240822$$PH$GB$GB
242374651$24237465$1$I$$20240811$20240822$20240822$EXP$$US-Accord-441723$ACCORD$Dao KT, Ghadiya K, Inga Jaco E, Sharma R, Rahimi R, Sukkar M, et al. A case of revelation due to pegfilgrastim. Cureus. 2024;16(7):e63777. DOI: 10.7759/cureus.63777.$68$YR$E$M$Y$$$20240822$$HP$US$US
242374661$24237466$1$I$$20240819$20240822$20240822$EXP$$AU-ABBVIE-5888606$ABBVIE$$$$$$Y$$$20240822$$MD$AU$AU
242374681$24237468$1$I$$20240812$20240822$20240822$EXP$CA-MHPD-001088526$CA-Accord-442001$ACCORD$$68$YR$E$F$Y$73$KG$20240822$$CN$CA$CA
242374691$24237469$1$I$$20240814$20240822$20240822$EXP$$TR-ROCHE-10000058142$ROCHE$$$$$$Y$$$20240822$$MD$TR$TR
242374701$24237470$1$I$$20240820$20240822$20240822$EXP$$JP-GILEAD-2024-0682720$GILEAD$$9$DEC$E$M$Y$$$20240822$$PH$JP$JP
242374711$24237471$1$I$20230101$20240812$20240822$20240822$EXP$FR-AFSSAPS-RS2024000776$FR-Accord-441533$ACCORD$$70$YR$E$F$Y$71$KG$20240822$$MD$FR$FR
242374721$24237472$1$I$20230226$20240812$20240822$20240822$EXP$FR-AFSSAPS-TO2024001482$FR-Accord-441825$ACCORD$$80$YR$E$M$Y$63$KG$20240822$$PH$FR$FR
242374731$24237473$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062062$ROCHE$$$$A$F$Y$$$20240822$$MD$US$US
242374741$24237474$1$I$20240517$20240520$20240822$20240822$30DAY$$GB-PFIZER INC-202400174021$PFIZER$$$$$$Y$$$20240822$$CN$GB$GB
242374751$24237475$1$I$20140101$20240812$20240822$20240822$EXP$FR-AFSSAPS-RS2024000750$FR-Accord-441488$ACCORD$$61$YR$A$F$Y$51$KG$20240822$$MD$FR$FR
242374762$24237476$2$F$$20240819$20240822$20240831$EXP$$AU-Accord-441780$ACCORD$Monticello NL, Irvine I, Warner V, Hare J, Kaye D, Cloud GC. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: therapeutic dilemma: case report. BMC Neurol. 2024 Aug 9;24(1)$51$YR$A$F$Y$$$20240831$$HP$AU$AU
242374771$24237477$1$I$$20240812$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-041177$AUROBINDO$$80$YR$$M$Y$$$20240822$$CN$CA$CA
242374781$24237478$1$I$20240101$20240821$20240822$20240822$EXP$$US-UCBSA-2024042465$UCB$$$$$F$Y$$$20240822$$CN$US$US
242374791$24237479$1$I$$20240805$20240822$20240822$PER$$US-TRAVERE-2024TVT00772$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242374801$24237480$1$I$$20240821$20240822$20240822$EXP$GB-MHRA-MED-202408210945170870-QTPHG$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046979$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$52$KG$20240822$$PH$GB$GB
242374811$24237481$1$I$20240729$20240815$20240822$20240822$EXP$$CN-FreseniusKabi-FK202412631$FRESENIUS KABI$$62$YR$A$F$Y$55$KG$20240822$$HP$CN$CN
242374821$24237482$1$I$20240630$20240815$20240822$20240822$EXP$$CN-FreseniusKabi-FK202412622$FRESENIUS KABI$$46$YR$A$M$Y$$$20240822$$HP$CN$CN
242374831$24237483$1$I$$20240819$20240822$20240822$EXP$$SE-FreseniusKabi-FK202412658$FRESENIUS KABI$$$$C$F$Y$$$20240822$$MD$SE$SE
242374841$24237484$1$I$$20240819$20240822$20240822$EXP$$US-GILEAD-2024-0684866$GILEAD$$$$E$F$Y$$$20240822$$HP$US$US
242374851$24237485$1$I$$20240814$20240822$20240822$EXP$$US-BEH-2024177208$CSL BEHRING$$$$A$F$Y$$$20240822$$MD$US$US
242374861$24237486$1$I$$20240816$20240822$20240822$PER$$US-ROCHE-10000062995$ROCHE$$$$A$M$Y$$$20240822$$HP$US$US
242374873$24237487$3$F$20240716$20240828$20240822$20240904$EXP$$NVSC2024CA147607$NOVARTIS$$34$YR$$F$Y$$$20240904$$CN$CA$CA
242374881$24237488$1$I$$20240815$20240822$20240822$EXP$$DE-ROCHE-10000059337$ROCHE$$$$A$F$Y$$$20240822$$MD$DE$DE
242374891$24237489$1$I$$20240821$20240822$20240822$PER$$NVSC2024US170067$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242374971$24237497$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57817$$FDA-CTU$$81$YR$$M$N$$$20240821$N$$US$
242374981$24237498$1$I$20240817$20240821$20240821$20240821$DIR$715274$$FDA-CTU$$34$YR$$M$N$60.75$KG$20240821$N$CN$US$
242374991$24237499$1$I$$20240821$20240821$20240821$DIR$715266$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242375001$24237500$1$I$$20240821$20240821$20240821$DIR$715276$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242375031$24237503$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57697$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
242375041$24237504$1$I$20240821$20240821$20240821$20240821$DIR$715279$$FDA-CTU$$44$YR$$F$N$$$20240821$N$$US$
242375061$24237506$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57820$$FDA-CTU$$$$$M$N$$$20240821$N$HP$US$
242375071$24237507$1$I$20240817$20240821$20240821$20240821$DIR$715273$$FDA-CTU$$57$YR$$F$N$126$KG$20240821$N$CN$US$
242375081$24237508$1$I$20240701$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57713$$FDA-CTU$$$$$M$N$$$20240820$N$HP$US$
242375091$24237509$1$I$$20240812$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-041221$AUROBINDO$$$$$F$Y$$$20240822$$HP$CA$CA
242375102$24237510$2$F$20190924$20240923$20240822$20240926$EXP$$CO-UCBSA-2024034107$UCB$$63$YR$$F$Y$$$20240926$$CN$CO$CO
242375111$24237511$1$I$$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164345$AMGEN$Sinit R.B.; Aboulafia D.M.; Dorer R.K. et.al. The First 100 Cases of Epstein-Barr Virus-Positive Mucocutaneous Ulcers. Blood. 2018;132 (SUPPL_1):5340$59$YR$A$F$Y$$$20240822$$HP$US$US
242375121$24237512$1$I$20240815$20240821$20240822$20240822$PER$$US-AMGEN-USASP2024167277$AMGEN$$50$YR$A$F$Y$$$20240822$$CN$US$US
242375133$24237513$3$F$20240818$20240828$20240822$20240830$PER$$US-AMGEN-USASP2024165759$AMGEN$$73$YR$E$F$Y$$$20240830$$CN$US$US
242375141$24237514$1$I$$20240818$20240822$20240822$EXP$$IL-REGENERON PHARMACEUTICALS, INC.-2024-114814$REGENERON$$$$$F$Y$$$20240822$$CN$IL$IL
242375152$24237515$2$F$$20240912$20240822$20240919$EXP$$US-GSK-US2024101914$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$US$US
242375161$24237516$1$I$$20240815$20240822$20240822$EXP$$US-GSK-US2024101722$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242375171$24237517$1$I$20231121$20240821$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-081235-2024$RECKITT BENCKISER$$78$YR$$F$Y$$$20240822$$CN$US$US
242375181$24237518$1$I$$20240813$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104770$VIIV$$$$$$Y$$$20240822$$HP$US$US
242375192$24237519$2$F$20230101$20240829$20240822$20240903$EXP$$KR-ABBVIE-5883557$ABBVIE$$43$YR$$F$Y$$$20240903$$MD$KR$KR
242375202$24237520$2$F$$20240925$20240822$20240925$30DAY$$CL-PFIZER INC-202400235875$PFIZER$$$$$$Y$$$20240925$$CN$CL$CL
242375211$24237521$1$I$20230101$20240814$20240822$20240822$EXP$$IT-PFIZER INC-202400238635$PFIZER$Abbott, M.. HBV REACTIVATION AFTER IMMUNOSUPPRESSIVE THERAPY: AN OPEN QUESTION. Sexually Transmitted Infections. 2024;100(Sup1):A271$71$YR$$M$Y$$$20240822$$MD$IT$IT
242375221$24237522$1$I$20240819$20240820$20240822$20240822$EXP$$US-PFIZER INC-PV202400009919$PFIZER$$85$YR$$F$Y$$$20240822$$HP$US$US
242375241$24237524$1$I$$20240819$20240822$20240822$EXP$$KR-PFIZER INC-PV202400108370$PFIZER$$$$$F$Y$$$20240822$$CN$KR$KR
242375251$24237525$1$I$20240701$20240819$20240822$20240822$EXP$$AR-PFIZER INC-202400239315$PFIZER$$20$YR$$F$Y$$$20240822$$CN$AR$AR
242375271$24237527$1$I$20240815$20240818$20240822$20240822$EXP$$CN-PFIZER INC-PV202400107675$PFIZER$$12$YR$$F$Y$$$20240822$$CN$CN$CN
242375291$24237529$1$I$20240819$20240820$20240822$20240822$EXP$GB-MHRA-MED-202408201454267200-SPVGM$GB-PFIZER INC-202400240026$PFIZER$$67$YR$$F$Y$$$20240822$$HP$GB$GB
242375313$24237531$3$F$20240801$20240920$20240822$20240923$30DAY$$CO-PFIZER INC-PV202400105254$PFIZER$$22$YR$$M$Y$28$KG$20240923$$CN$CO$CO
242375342$24237534$2$F$$20240828$20240822$20240829$30DAY$$US-PFIZER INC-PV202400104565$PFIZER$$$$$F$Y$$$20240829$$CN$US$US
242375361$24237536$1$I$20240819$20240820$20240822$20240822$EXP$$CN-PFIZER INC-PV202400108648$PFIZER$$5$YR$$F$Y$$$20240822$$HP$CN$CN
242375371$24237537$1$I$$20240820$20240822$20240822$EXP$$US-PFIZER INC-PV202400108825$PFIZER$$45$YR$$F$Y$$$20240822$$MD$US$US
242375381$24237538$1$I$20240731$20240816$20240822$20240822$EXP$$US-ABBVIE-5775480$ABBVIE$$65$YR$$M$Y$$$20240822$$CN$US$US
242375391$24237539$1$I$$20240816$20240822$20240822$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-114913$REGENERON$$$$$M$Y$$$20240822$$CN$CO$CO
242375401$24237540$1$I$$20240813$20240822$20240822$EXP$$AU-BIOGEN-2024BI01279361$BIOGEN$L-S J. Natalizumab update 2024. Ectriums 2023. 2024 JUL;.$36$YR$$F$Y$$$20240822$$MD$AU$AU
242375411$24237541$1$I$$20240820$20240822$20240822$EXP$$CN-GILEAD-2024-0684762$GILEAD$$59$YR$A$F$Y$$$20240822$$CN$CN$CN
242375422$24237542$2$F$20240811$20240923$20240822$20240923$PER$$US-JNJFOC-20240829822$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240923$$HP$US$US
242375432$24237543$2$F$20200122$20240906$20240822$20240919$EXP$$IT-AUROBINDO-AUR-APL-2024-041135$AUROBINDO$$61$YR$$M$Y$85$KG$20240919$$MD$IT$IT
242375441$24237544$1$I$20230101$20240813$20240822$20240822$EXP$$NVSJ2024JP009854$NOVARTIS$$23$YR$$M$Y$$$20240822$$CN$JP$JP
242375451$24237545$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165182$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242375462$24237546$2$F$20240816$20240820$20240822$20240829$PER$$US-AMGEN-USASP2024165183$AMGEN$$70$YR$E$F$Y$$$20240829$$CN$US$US
242375472$24237547$2$F$20240817$20240918$20240822$20240919$PER$$US-AMGEN-USASP2024165706$AMGEN$$70$YR$E$F$Y$$$20240919$$CN$US$US
242375481$24237548$1$I$$20240819$20240822$20240822$EXP$$NVSC2024CA168149$NOVARTIS$$14$YR$$M$Y$$$20240822$$HP$CA$CA
242375491$24237549$1$I$20210101$20240813$20240822$20240822$EXP$$NVSJ2024JP009857$NOVARTIS$$$$A$M$Y$$$20240822$$CN$JP$JP
242375501$24237550$1$I$$20240814$20240822$20240822$EXP$$US-RECORDATI RARE DISEASE INC.-2024006342$RECORDATI$$$$$$Y$$$20240822$$CN$US$US
242375511$24237551$1$I$$20240820$20240822$20240822$EXP$$NVSC2024CA168782$NOVARTIS$$$$$M$Y$$$20240822$$MD$CA$CA
242375521$24237552$1$I$$20240813$20240822$20240822$EXP$$NVSJ2024JP009856$NOVARTIS$$32$YR$$M$Y$$$20240822$$CN$JP$JP
242375531$24237553$1$I$20240807$20240813$20240822$20240822$EXP$$CN-SA-2024SA244271$SANOFI AVENTIS$$40$YR$A$M$Y$44.4$KG$20240822$$HP$CN$CN
242375541$24237554$1$I$$20240819$20240822$20240822$EXP$$PL-ADIENNEP-2024AD000667$ADIENNE PHARMA + BIOTECH$Rybka J, Kuszczak B, Bogucka-Fedorczuk A. Treatment of primary central nervous system lymphoma (PCNSL) - single center experience and literature review. Acta Haematol Pol. 2024;55(3):151-6. DOI: 10.5603/ahp.99087$$$A$$Y$$$20240819$$MD$PL$
242375551$24237555$1$I$$20240819$20240822$20240822$EXP$$NVSC2024CA168204$NOVARTIS$$67$YR$$F$Y$$$20240822$$CN$CA$CA
242375561$24237556$1$I$$20240819$20240822$20240822$EXP$$NL-GILEAD-2024-0684746$GILEAD$$$$N$$Y$$$20240822$$MD$NL$NL
242375571$24237557$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024100269$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242375581$24237558$1$I$$20240815$20240822$20240822$EXP$$US-GSK-US2024AMR102853$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242375591$24237559$1$I$$20240814$20240822$20240822$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006031$BIOCON$$$$$$Y$$$20240822$$CN$CA$CA
242375601$24237560$1$I$20240722$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57708$$FDA-CTU$$47$YR$$F$N$$$20240821$Y$HP$US$
242375611$24237561$1$I$$20240821$20240822$20240822$EXP$$JP-ABBVIE-5889157$ABBVIE$$70$YR$$$Y$$$20240822$$MD$JP$JP
242375621$24237562$1$I$$20240814$20240822$20240822$EXP$$US-BEH-2024177199$CSL BEHRING$$$$A$F$Y$$$20240822$$CN$US$US
242375631$24237563$1$I$$20240816$20240822$20240822$EXP$$IT-MYLANLABS-2024M1076748$MYLAN$Corazelli G, Cuccaro A, Morelli E, Arcamone M, De Chiara A, Paccone A, et al.. Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVDDD-DI phase II study.. Br J Haematol. 2024;1-6$41$YR$$F$Y$$$20240822$$HP$IT$IT
242375641$24237564$1$I$20240808$20240816$20240822$20240822$EXP$$CN-MYLANLABS-2024M1076970$MYLAN$$85$YR$$M$Y$45$KG$20240822$$HP$CN$CN
242375651$24237565$1$I$20240801$20240805$20240822$20240822$DIR$FDA-CDER-CTU-2024-57832$$FDA-CTU$$17$YR$$F$N$$$20240805$N$HP$US$
242375661$24237566$1$I$20240717$20240718$20240822$20240822$DIR$FDA-CDER-CTU-2024-57833$$FDA-CTU$$29$YR$$F$N$$$20240718$N$$US$
242375671$24237567$1$I$20240501$20240816$20240822$20240822$EXP$FR-AFSSAPS-SE2024000648$FR-MYLANLABS-2024M1076686$MYLAN$$66$YR$$F$Y$$$20240822$$MD$FR$FR
242375681$24237568$1$I$$20240816$20240822$20240822$EXP$$US-MYLANLABS-2024M1077198$MYLAN$Wang NC. Resolution of ventricular tachycardia following cavotricuspid isthmus ablation for atrial flutter: Potential implications of cross-chamber induction on catheter ablation strategies. HeartRhythm-Case-Rep 2023; 9 (3): 165-170.$87$YR$$M$Y$$$20240822$$MD$US$US
242375691$24237569$1$I$20240506$20240816$20240822$20240822$EXP$CH-SM-2024-13016$CH-MYLANLABS-2024M1077125$MYLAN$$29$YR$$F$Y$$$20240822$$MD$CH$CH
242375701$24237570$1$I$$20231103$20240822$20240822$EXP$$US-AstraZeneca-2023A212568$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242375712$24237571$2$F$$20240921$20240822$20240923$30DAY$$US-PFIZER INC-202400236249$PFIZER$$14$YR$$M$Y$$$20240923$$CN$US$US
242375732$24237573$2$F$20240808$20240921$20240822$20240923$30DAY$$US-PFIZER INC-202400235325$PFIZER$$5$YR$$M$Y$$$20240923$$CN$US$US
242375743$24237574$3$F$$20240925$20240822$20240927$30DAY$$US-PFIZER INC-202400037332$PFIZER$$1$YR$$F$Y$$$20240927$$CN$US$US
242375752$24237575$2$F$$20240921$20240822$20240923$30DAY$$US-PFIZER INC-202400236237$PFIZER$$15$YR$$M$Y$$$20240923$$PH$US$US
242375763$24237576$3$F$$20240927$20240822$20240927$30DAY$$US-PFIZER INC-202400234556$PFIZER$$15$YR$$M$Y$$$20240927$$CN$US$US
242375773$24237577$3$F$$20240921$20240822$20240923$30DAY$$US-PFIZER INC-202400234916$PFIZER$$5$YR$$M$Y$15.746$KG$20240923$$PH$US$US
242375794$24237579$4$F$20240811$20240925$20240822$20240927$30DAY$$US-PFIZER INC-202400236299$PFIZER$$2$YR$$F$Y$12.7$KG$20240927$$CN$US$US
242375811$24237581$1$I$20240401$20240814$20240822$20240822$EXP$$ZA-AstraZeneca-2024A185621$ASTRAZENECA$$22$YR$$F$Y$$$20240822$$CN$ZA$
242375821$24237582$1$I$20210101$20230103$20240822$20240822$EXP$$US-AstraZeneca-2023A002401$ASTRAZENECA$$53$YR$$F$Y$$$20240822$$CN$US$
242375841$24237584$1$I$$20221220$20240822$20240822$EXP$$US-AstraZeneca-2022A414138$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242375851$24237585$1$I$$20240810$20240822$20240822$EXP$GB-MHRA-MED-202408100658253420-HDTFK$GB-Accord-441235$ACCORD$$$$$M$Y$$$20240822$$CN$GB$GB
242375862$24237586$2$F$$20240819$20240822$20240827$EXP$$CA-AstraZeneca-2024A190507$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$CA$
242375871$24237587$1$I$$20240812$20240822$20240822$EXP$$GB-AUROBINDO-AUR-APL-2024-040965$AUROBINDO$$$$$M$Y$$$20240822$$MD$GB$GB
242375881$24237588$1$I$$20220811$20240822$20240822$EXP$$US-AstraZeneca-2022A293924$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242375891$24237589$1$I$20230801$20240819$20240822$20240822$EXP$$US-AstraZeneca-2024A189186$ASTRAZENECA$$775$MON$$F$Y$$$20240822$$CN$US$
242375901$24237590$1$I$$20240807$20240822$20240822$EXP$$BG-GRANULES-BG-2024GRALIT00353$GRANULES INDIA$N Grigorov.Metformin intoxication - three clinical cases with lethal outcomes. Recommendations to the general practitioner .General Medicine.JAN-2023;25:45-48$70$YR$E$F$Y$$$20240822$$HP$BG$BG
242375911$24237591$1$I$20240713$20240813$20240822$20240822$30DAY$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03009$AMNEAL$$$$$$Y$$$20240822$$PH$US$US
242375921$24237592$1$I$$20240814$20240822$20240822$EXP$$CA-APOTEX-2023AP010783$APOTEX$$3$MON$$M$Y$$$20240822$$HP$CA$CA
242375932$24237593$2$F$20240801$20240812$20240822$20240822$PER$$US-TRAVERE-2024TVT00773$TRAVERE THERAPEUTICS$$70$YR$E$M$Y$$$20240822$$CN$US$US
242375941$24237594$1$I$$20240806$20240822$20240822$PER$$US-TRAVERE-2024TVT00774$TRAVERE THERAPEUTICS$$40$YR$A$F$Y$$$20240822$$MD$US$US
242375951$24237595$1$I$$20240814$20240822$20240822$PER$$US-ALXN-202408USA001045US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242375961$24237596$1$I$$20240819$20240822$20240822$PER$$US-ABBVIE-5889460$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242375971$24237597$1$I$20240814$20240815$20240822$20240822$PER$$US-HALEON-2192217$Haleon PLC$$22$YR$$F$Y$$$20240822$$CN$US$US
242375981$24237598$1$I$20240729$20240729$20240822$20240822$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000697$PAREXEL$$$$$$Y$$$20240822$$HP$US$US
242375991$24237599$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132364$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$63.5$KG$20240822$$CN$US$US
242376001$24237600$1$I$$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132570$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240822$$CN$US$US
242376011$24237601$1$I$$20240812$20240822$20240822$PER$$US-MYLANLABS-2024M1075805$MYLAN$$$$$F$Y$$$20240822$$CN$US$US
242376021$24237602$1$I$20240816$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165767$AMGEN$$73$YR$E$F$Y$$$20240822$$PH$US$US
242376031$24237603$1$I$$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024166892$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242376041$24237604$1$I$$20240815$20240822$20240822$PER$$US-ROCHE-10000059564$ROCHE$$$$A$F$Y$60.78$KG$20240822$$CN$US$US
242376052$24237605$2$F$$20240926$20240822$20240926$30DAY$$AU-PFIZER INC-202400238553$PFIZER$$63$YR$$F$Y$$$20240926$$CN$AU$AU
242376072$24237607$2$F$20240813$20240921$20240822$20240923$30DAY$$US-PFIZER INC-202400237258$PFIZER$$11$YR$$M$Y$$$20240923$$CN$US$US
242376102$24237610$2$F$20240801$20240924$20240822$20240927$30DAY$$US-PFIZER INC-202400237186$PFIZER$$14$YR$$M$Y$$$20240927$$MD$US$US
242376124$24237612$4$F$$20240925$20240822$20240927$30DAY$$US-PFIZER INC-202400236028$PFIZER$$11$YR$$F$Y$$$20240927$$CN$US$US
242376131$24237613$1$I$$20240815$20240822$20240822$30DAY$$CO-PFIZER INC-PV202400107248$PFIZER$$$$$M$Y$$$20240822$$CN$CO$CO
242376142$24237614$2$F$$20240921$20240822$20240923$30DAY$$US-PFIZER INC-202400237265$PFIZER$$13$YR$$F$Y$$$20240923$$CN$US$US
242376151$24237615$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012688$ELI LILLY AND CO$$$$A$F$Y$$$20240822$$CN$US$US
242376161$24237616$1$I$$20240807$20240822$20240822$EXP$$BG-GRANULES-BG-2024GRALIT00355$GRANULES INDIA$N Grigorov.Metformin intoxication - three clinical cases with lethal outcomes. Recommendations to the general practitioner .General Medicine.JAN-2023;25:45-48$53$YR$A$F$Y$$$20240822$$HP$BG$BG
242376171$24237617$1$I$20240301$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012521$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240822$$CN$US$US
242376181$24237618$1$I$20240819$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012533$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240822$$CN$US$US
242376191$24237619$1$I$20240813$20240814$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408009149$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240822$$CN$US$US
242376201$24237620$1$I$20240817$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012071$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240822$$CN$US$US
242376211$24237621$1$I$20230101$20240807$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408005715$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240822$$MD$US$US
242376222$24237622$2$F$$20240827$20240822$20240906$EXP$$PL-TEVA-VS-3233443$TEVA$Dzwilewski K, Sokolewicz EM, Omieczynska N, Zawadzka M, Mazurkiewicz-Beldzinska M. Drug resistant epilepsy as the consequence of inadequate control of type 1 diabetes. Pediatr-Endocrinol-Diabetes-Metab 2024; 30 (1): 42-44.; Dzwilewski K, Sokolewicz EM, Omieczynska N, Zawadzka M, Mazurkiewicz-Beldzinska M. Drug resistant epilepsy as the consequence of inadequate control of type 1 diabetes. Pediatr-Endocrinol-Diabetes-Metab 2024; 30 (1): 42-44.$11$YR$$M$Y$$$20240906$$HP$PL$PL
242376232$24237623$2$F$$20240822$20240822$20240829$EXP$$GB-CELLTRION INC.-2024GB019777$CELLTRION$$$$$$Y$$$20240829$$CN$GB$GB
242376241$24237624$1$I$$20240812$20240822$20240822$EXP$$DK-Nova Laboratories Limited-2160723$NOVA LABORATORIES$Literature refernced in narrative?Dall-Jepsen C, Moller AZ, Tram L, Gielstrup TCG, Danstrup-Dinesen P, as authors with the title Spontant?epiduralt hematom hos en paediatrisk patient med seglcellesygdom, published in the journal of Ugeskrift for Laeger. 2024 Mar?11;186:V11230703.$15$YR$$F$Y$$$20240822$$MD$DK$DK
242376251$24237625$1$I$$20240814$20240822$20240822$EXP$$JP-OTSUKA-2024_022589$OTSUKA$$3$DEC$$M$Y$$$20240822$$MD$JP$JP
242376261$24237626$1$I$$20240814$20240822$20240822$EXP$$US-JNJFOC-20240837737$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240822$$CN$US$US
242376281$24237628$1$I$$20240819$20240822$20240822$PER$$US-ROCHE-10000061304$ROCHE$- ,  Bevacizumab induced hypothyroidism (abstract number : MON616). ENDO 2024, Endocrine Society^s Annual Meeting. 2024;$60$YR$A$F$Y$$$20240822$$HP$US$US
242376291$24237629$1$I$$20240819$20240822$20240822$PER$$US-ROCHE-10000062866$ROCHE$$$$E$F$Y$$$20240822$$CN$US$US
242376301$24237630$1$I$$20240807$20240822$20240822$EXP$$BG-GRANULES-BG-2024GRALIT00356$GRANULES INDIA$Grigorov N.Metformin intoxication - three clinical cases with lethal outcomes. Recommendations to the general practitioner .General Medicine.JAN-2023;25:45-48$85$YR$E$M$Y$$$20240822$$HP$BG$BG
242376311$24237631$1$I$20240730$20240730$20240822$20240822$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000714$PAREXEL$$$$$$Y$$$20240822$$PH$US$US
242376322$24237632$2$F$$20240823$20240822$20240827$EXP$$CA-Orion Corporation ORION PHARMA-24_00031352$ORION$$85$YR$E$F$Y$$$20240827$$HP$CA$
242376331$24237633$1$I$20230720$20240821$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-103516-2023$RECKITT BENCKISER$$62$YR$$F$Y$$$20240822$$CN$US$US
242376351$24237635$1$I$20240814$20240815$20240822$20240822$EXP$$US-AMGEN-USASP2024163210$AMGEN$$71$YR$E$F$Y$$$20240822$$CN$US$US
242376361$24237636$1$I$20240701$20240815$20240822$20240822$EXP$$DE-AMGEN-DEUSP2024162607$AMGEN$$$$$F$Y$$$20240822$$CN$DE$DE
242376371$24237637$1$I$$20240815$20240822$20240822$EXP$$US-TAKEDA-2024TUS083552$TAKEDA$$$$$M$Y$$$20240822$$CN$US$US
242376381$24237638$1$I$20240821$20240821$20240821$20240821$DIR$715261$$FDA-CTU$$46$YR$$F$N$$$20240821$N$CN$LB$
242376411$24237641$1$I$$20240821$20240822$20240822$PER$$US-ROCHE-10000063629$ROCHE$$$$$F$Y$$$20240822$$CN$US$US
242376431$24237643$1$I$$20240812$20240822$20240822$EXP$$US-GSK-US2024AMR101042$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242376441$24237644$1$I$20240703$20240820$20240822$20240822$EXP$$AU-SANDOZ INC.-SDZ2024AU074100$SANDOZ$$62$YR$$M$Y$$$20240822$$HP$AU$AU
242376462$24237646$2$F$20240101$20240922$20240822$20240923$30DAY$$US-PFIZER INC-202400237365$PFIZER$$9$YR$$M$Y$21.32$KG$20240923$$CN$US$US
242376481$24237648$1$I$$20240814$20240822$20240822$EXP$$ZA-ABBVIE-5887048$ABBVIE$$12$YR$$M$Y$$$20240822$$CN$ZA$ZA
242376491$24237649$1$I$20240101$20240816$20240822$20240822$EXP$$US-SA-2024SA248349$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240822$$MD$US$US
242376501$24237650$1$I$$20240814$20240822$20240822$EXP$$CA-TAKEDA-2024TUS082227$TAKEDA$$$$$F$Y$$$20240822$$CN$CA$CA
242376512$24237651$2$F$$20240830$20240822$20240903$EXP$$JP-BEH-2024177342$CSL BEHRING$$$$$$Y$$$20240903$$PH$JP$JP
242376521$24237652$1$I$$20240807$20240822$20240822$EXP$$US-GRANULES-US-2024GRALIT00351$GRANULES INDIA$E. Mikhail.Survival and Vision Restoration Following Severe Metformin-Associated Metabolic Acidosis With Transient Blindness: A Case Report and Review of the Literature.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A3410$72$YR$E$F$Y$$$20240822$$HP$US$US
242376531$24237653$1$I$$20240821$20240822$20240822$PER$$US-ROCHE-10000063172$ROCHE$$$$$$Y$$$20240822$$CN$US$US
242376541$24237654$1$I$20170101$20240814$20240822$20240822$EXP$$CA-ABBVIE-5863565$ABBVIE$$30$YR$$F$Y$$$20240822$$CN$CA$CA
242376551$24237655$1$I$$20240816$20240822$20240822$EXP$$US-ABBVIE-5885159$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242376561$24237656$1$I$20240722$20240819$20240822$20240822$EXP$$US-ABBVIE-5886773$ABBVIE$$54$YR$$F$Y$$$20240822$$CN$US$US
242376571$24237657$1$I$20240815$20240816$20240822$20240822$EXP$$US-ABBVIE-5887302$ABBVIE$$62$YR$$F$Y$$$20240822$$CN$US$US
242376592$24237659$2$F$20240710$20240921$20240822$20240927$EXP$$FR-TAKEDA-2024TUS083014$TAKEDA$$9$YR$$M$Y$$$20240927$$HP$FR$FR
242376601$24237660$1$I$20240820$20240821$20240821$20240821$DIR$715259$$FDA-CTU$$48$YR$$F$N$96.75$KG$20240821$N$CN$US$
242376611$24237661$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132172$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240822$$CN$US$US
242376621$24237662$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132738$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$55.79$KG$20240822$$CN$US$US
242376631$24237663$1$I$20240601$20240821$20240821$20240821$DIR$715288$$FDA-CTU$$51$YR$$F$N$117$KG$20240821$N$CN$US$
242376642$24237664$2$F$$20240916$20240822$20240918$PER$$US-ROCHE-10000063380$ROCHE$$$$A$F$Y$82$KG$20240918$$CN$US$US
242376651$24237665$1$I$$20240821$20240821$20240821$DIR$715277$$FDA-CTU$$60$YR$$F$N$$$20240821$N$PH$US$
242376672$24237667$2$F$20240815$20240820$20240822$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012912$JAZZ$$29$YR$$F$Y$$$20240825$$MD$US$US
242376682$24237668$2$F$20221101$20240829$20240822$20240906$EXP$$GB-TEVA-VS-3234133$TEVA$Premraj S, Lane S, Camilleri B. IgA crescentic glomerulonephritis in psoriatic arthritis - disease or treatment related?. Clin-Med-London 2024; 24 (Suppl.) 42-43.; Premraj S, Lane S, Camilleri B. IgA crescentic glomerulonephritis in psoriatic arthritis - disease or treatment related?. Clin-Med-London 2024; 24 (Suppl.) 42-43.$$$A$F$Y$$$20240906$$HP$GB$GB
242376691$24237669$1$I$$20240815$20240822$20240822$EXP$$BR-TAKEDA-2024TUS083903$TAKEDA$$$$$F$Y$$$20240822$$CN$BR$BR
242376701$24237670$1$I$$20240807$20240822$20240822$EXP$$JP-GRANULES-JP-2024GRALIT00360$GRANULES INDIA$Yuji Takahashi.Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review.Acute Medicine and Surgery.05-MAR-2024;11:1-5$45$YR$A$F$Y$$$20240822$$HP$JP$JP
242376711$24237671$1$I$$20240812$20240822$20240822$PER$$US-MYLANLABS-2024M1075435$MYLAN$$$$$F$Y$$$20240822$$CN$US$US
242376722$24237672$2$F$$20240815$20240822$20240824$EXP$$US-AstraZeneca-2024A187103$ASTRAZENECA$$$$$M$Y$$$20240823$$MD$US$
242376731$24237673$1$I$$20220809$20240822$20240822$EXP$$US-AstraZeneca-2022A283077$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242376741$24237674$1$I$$20240821$20240822$20240822$EXP$$US-PFIZER INC-PV202400109397$PFIZER$$55$YR$$F$Y$$$20240822$$HP$US$US
242376751$24237675$1$I$$20240809$20240822$20240822$EXP$$FR-B.Braun Medical Inc.-2160724$B BRAUN$$79$YR$$M$Y$61.4$KG$20240822$$MD$FR$FR
242376762$24237676$2$F$$20240821$20240822$20240827$EXP$$US-PFIZER INC-PV202400108787$PFIZER$Vangeison, C.. Medication-induced mood disorders following epidural steroid injections in patients with pain: A case series. Clinical Case Reports. 2023;11(6):10.1002/ccr3.7415$32$YR$$F$Y$$$20240827$$HP$US$US
242376771$24237677$1$I$$20240822$20240822$20240822$EXP$$CN-PFIZER INC-PV202400109447$PFIZER$$$$A$M$Y$$$20240822$$CN$CN$CN
242376781$24237678$1$I$$20240819$20240822$20240822$EXP$$JP-PFIZER INC-PV202400108328$PFIZER$Matsubara, M.. A case of recurrence of methotrexate-associated lymphoproliferative disorder with histological changes after spontaneous resolution. The 42nd Hokuriku Regional Meeting of the Japanese Society of Hematology. 2024;42nd$72$YR$$M$Y$$$20240822$$HP$JP$JP
242376791$24237679$1$I$$20240819$20240822$20240822$EXP$$JP-PFIZER INC-PV202400108122$PFIZER$Koshida, A.. A Case of Multiple Solar Keratosis and Spinocellular Carcinoma Occurring While Taking Oral Voriconazole. The 481st Regular Meeting of the Hokuriku Division of Japanese Dermatological. 2024;481st:5$80$YR$$M$Y$$$20240822$$HP$JP$JP
242376801$24237680$1$I$20230811$20240816$20240822$20240822$EXP$$FR-PFIZER INC-PV202400107694$PFIZER$$1$YR$$F$Y$2.07$KG$20240822$$MD$FR$FR
242376811$24237681$1$I$$20240820$20240822$20240822$EXP$$TW-PFIZER INC-PV202400108852$PFIZER$$$$E$M$Y$$$20240822$$HP$TW$TW
242376821$24237682$1$I$20240801$20240821$20240822$20240822$EXP$$AR-PFIZER INC-202400241145$PFIZER$$84$YR$$F$Y$$$20240822$$CN$AR$AR
242376831$24237683$1$I$$20240820$20240822$20240822$EXP$$US-PFIZER INC-202400241024$PFIZER$$84$YR$$F$Y$$$20240822$$HP$US$US
242376841$24237684$1$I$$20240820$20240822$20240822$EXP$$CN-PFIZER INC-PV202400108410$PFIZER$$$$A$M$Y$$$20240822$$CN$CN$CN
242376851$24237685$1$I$$20240820$20240822$20240822$EXP$$CA-PFIZER INC-202400240023$PFIZER$$34$YR$$M$Y$93$KG$20240822$$HP$CA$CA
242376863$24237686$3$F$20240713$20240906$20240822$20240906$EXP$$DE-PFIZER INC-202400239744$PFIZER$$82$YR$$F$Y$58$KG$20240906$$CN$DE$DE
242376871$24237687$1$I$20240426$20240814$20240822$20240822$EXP$$NVSC2024US165672$NOVARTIS$$68$YR$$M$Y$149.7$KG$20240822$$CN$US$US
242376882$24237688$2$F$$20240821$20240822$20240902$EXP$$ZA-PFIZER INC-PV202400109149$PFIZER$$$$$F$Y$$$20240902$$MD$ZA$ZA
242376892$24237689$2$F$$20240829$20240822$20240902$EXP$$CA-PFIZER INC-PV202400109143$PFIZER$$50$YR$$M$Y$$$20240902$$HP$CA$CA
242376901$24237690$1$I$20210915$20240820$20240822$20240822$EXP$$IN-PFIZER INC-2021622597$PFIZER$$69$YR$$F$Y$$$20240822$$CN$IN$IN
242376911$24237691$1$I$20240816$20240820$20240822$20240822$EXP$$CN-PFIZER INC-PV202400108733$PFIZER$$32$YR$$M$Y$$$20240822$$HP$CN$CN
242376925$24237692$5$F$20240618$20240826$20240822$20240905$EXP$$ES-PFIZER INC-202400238874$PFIZER$$79$YR$$M$Y$78$KG$20240905$$MD$ES$ES
242376941$24237694$1$I$$20240820$20240822$20240822$EXP$$CA-PFIZER INC-202400240035$PFIZER$$3$YR$$F$Y$15$KG$20240822$$HP$CA$CA
242376951$24237695$1$I$$20240821$20240822$20240822$EXP$$CN-PFIZER INC-PV202400109465$PFIZER$$$$E$M$Y$$$20240822$$CN$CN$CN
242376961$24237696$1$I$$20240819$20240822$20240822$EXP$$US-PFIZER INC-PV202400108156$PFIZER$$$$$$Y$$$20240822$$CN$US$US
242376971$24237697$1$I$20240301$20240820$20240822$20240822$EXP$$US-PFIZER INC-202400240808$PFIZER$$69$YR$$F$Y$$$20240822$$HP$US$US
242376981$24237698$1$I$20240810$20240819$20240822$20240822$EXP$$CN-PFIZER INC-PV202400108039$PFIZER$$57$YR$$F$Y$57$KG$20240822$$HP$CN$CN
242377001$24237700$1$I$$20240820$20240822$20240822$EXP$$CA-PFIZER INC-202400240122$PFIZER$$3$DEC$$M$Y$$$20240822$$MD$CA$CA
242377011$24237701$1$I$$20211006$20240822$20240822$EXP$$US-AstraZeneca-2021A767067$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242377021$24237702$1$I$$20240821$20240822$20240822$PER$$NVSC2024US170065$NOVARTIS$$$$$$Y$$$20240822$$PH$US$US
242377031$24237703$1$I$$20240812$20240822$20240822$EXP$$CA-TERSERA THERAPEUTICS LLC-2024TRS004221$TERSERA THERAPEUTICS$$$$$$Y$$$20240822$$HP$CA$CA
242377041$24237704$1$I$$20210616$20240822$20240822$EXP$$US-AstraZeneca-2021A535539$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242377051$24237705$1$I$20240305$20240816$20240822$20240822$EXP$$CO-UCBSA-2024042469$UCB$$52$YR$$F$Y$$$20240822$$CN$CO$CO
242377061$24237706$1$I$20240201$20240816$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012838$JAZZ$$57$YR$$M$Y$$$20240822$$CN$US$US
242377071$24237707$1$I$$20240814$20240822$20240822$EXP$$CA-APOTEX-2024AP009459$APOTEX$$61$YR$$M$Y$$$20240822$$HP$CA$CA
242377081$24237708$1$I$$20240819$20240822$20240822$EXP$$NVSC2024CA168505$NOVARTIS$$$$$F$Y$95$KG$20240822$$CN$CA$CA
242377091$24237709$1$I$$20240812$20240822$20240822$PER$$US-JNJFOC-20240831784$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$US$US
242377101$24237710$1$I$$20240816$20240822$20240822$PER$$US-JNJFOC-20240851595$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$MD$US$US
242377111$24237711$1$I$$20240812$20240822$20240822$EXP$$AU-TEVA-VS-3232775$TEVA$$$$$F$Y$$$20240822$$MD$AU$AU
242377121$24237712$1$I$20240601$20240820$20240822$20240822$EXP$$US-ABBVIE-5888199$ABBVIE$$91$YR$$M$Y$$$20240822$$CN$US$US
242377131$24237713$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131070$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240822$$HP$US$US
242377141$24237714$1$I$$20240820$20240822$20240822$EXP$$CA-ABBVIE-5888033$ABBVIE$$45$YR$$F$Y$$$20240822$$HP$CA$CA
242377151$24237715$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132369$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240822$$CN$US$US
242377162$24237716$2$F$20240806$20240822$20240822$20240823$EXP$$US-009507513-2407USA015199$MERCK$$57$YR$$M$Y$92.5$KG$20240823$$CN$US$US
242377171$24237717$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5888652$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242377181$24237718$1$I$20231201$20240821$20240822$20240822$EXP$IT-MINISAL02-998976$IT-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2408IT06589$INSUD PHARMA$$35$YR$$F$Y$52$KG$20240822$$CN$IT$IT
242377191$24237719$1$I$20240803$20240821$20240822$20240822$EXP$IT-MINISAL02-999209$IT-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2408IT06592$INSUD PHARMA$$24$YR$$F$Y$52$KG$20240822$$CN$IT$IT
242377201$24237720$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062550$ROCHE$$$$A$F$Y$$$20240822$$CN$US$US
242377211$24237721$1$I$20240713$20240817$20240822$20240822$EXP$GB-MHRA-MED-202408170200058900-THSQF$GB-LABORATORIOS LICONSA S.A.-2408GB06501$INSUD PHARMA$$28$YR$$F$Y$$$20240822$$CN$GB$GB
242377222$24237722$2$F$20240101$20240823$20240822$20240828$EXP$$US-ABBVIE-5886844$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242377231$24237723$1$I$20240618$20240812$20240822$20240822$EXP$GB-JNJFOC-20240656553$GB-TORRENT-00037605$TORRENT$$72$YR$E$M$Y$85$KG$20240822$$MD$GB$GB
242377241$24237724$1$I$$20240819$20240822$20240822$EXP$$DE-TORRENT-00027125$TORRENT$$$$$F$Y$$$20240822$$CN$DE$DE
242377251$24237725$1$I$20240808$20240813$20240822$20240822$EXP$GB-MHRA-MED-202408130514228020-JZBTF$GB-TORRENT-00037618$TORRENT$$$$$$Y$$$20240822$$CN$GB$GB
242377261$24237726$1$I$$20240814$20240822$20240822$EXP$$US-TORRENT-00013720$TORRENT$$66$YR$E$F$Y$$$20240822$$MD$US$US
242377271$24237727$1$I$$20240812$20240822$20240822$EXP$GB-MHRA-TPP24020192C8265071YC1721298239574$GB-TORRENT-00037607$TORRENT$$67$YR$E$M$Y$95$KG$20240822$$MD$GB$GB
242377281$24237728$1$I$$20240815$20240822$20240822$EXP$$US-TORRENT-00013719$TORRENT$$62$YR$A$F$Y$$$20240822$$MD$US$US
242377294$24237729$4$F$20240101$20240916$20240822$20240925$EXP$$US-UCBSA-2024042565$UCB$$$$$F$Y$$$20240925$$HP$US$US
242377301$24237730$1$I$$20240820$20240822$20240822$EXP$$NVSC2024US169477$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242377311$24237731$1$I$20240817$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165725$AMGEN$$62$YR$A$F$Y$$$20240822$$CN$US$US
242377352$24237735$2$F$20240130$20240924$20240822$20240926$EXP$$NVSJ2024JP009715$NOVARTIS$$7$YR$$M$Y$$$20240926$$MD$JP$JP
242377361$24237736$1$I$20240812$20240812$20240822$20240822$30DAY$$US-GSK-US2024100239$GLAXOSMITHKLINE$$86$YR$$F$Y$$$20240822$$CN$US$US
242377372$24237737$2$F$$20240904$20240822$20240913$30DAY$$US-GSK-US2024100346$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
242377382$24237738$2$F$$20240910$20240822$20240920$30DAY$$US-GSK-US2024100834$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$PH$US$US
242377391$24237739$1$I$$20240815$20240822$20240822$PER$$US-ALXN-202408USA001024US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242377411$24237741$1$I$20220101$20240813$20240822$20240822$EXP$$SG-ROCHE-10000056673$ROCHE$$85$YR$E$M$Y$$$20240822$$CN$SG$SG
242377421$24237742$1$I$$20240813$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104768$VIIV$$$$$$Y$$$20240822$$HP$US$US
242377431$24237743$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024100371$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242377441$24237744$1$I$$20240820$20240822$20240822$EXP$$PT-HALEON-2192887$Haleon PLC$Ramalho D., Canelas A., Samoes B., Da Costa I. ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-INDUCED. European Journal of Case Reports in Internal Medicine. A CASE. Eur. J. Case Rep. Intern. Med. 2019-01-01; 226. doi:10.12890/2019_V6Supl.$73$YR$$M$Y$$$20240822$$HP$PT$PT
242377452$24237745$2$F$20220227$20240820$20240822$20240828$EXP$$KR-VIVUS LLC-2022V1000435$VIVUS$$43$YR$A$F$Y$$$20240822$$$COUNTRY NOT SPECIFIED$KR
242377461$24237746$1$I$$20240806$20240822$20240822$PER$$US-TRAVERE-2024TVT00782$TRAVERE THERAPEUTICS$$$$$$Y$$$20240822$$CN$US$US
242377472$24237747$2$F$20240801$20240827$20240822$20240917$PER$$US-TRAVERE-2024TVT00795$TRAVERE THERAPEUTICS$$45$YR$A$F$Y$$$20240917$$CN$US$US
242377481$24237748$1$I$20240729$20240821$20240821$20240821$DIR$715289$$FDA-CTU$$76$YR$$F$N$58.5$KG$20240821$N$CN$US$
242377491$24237749$1$I$20240817$20240821$20240821$20240821$DIR$715296$$FDA-CTU$$43$YR$$M$N$$$20240821$Y$$US$
242377501$24237750$1$I$20240721$20240821$20240821$20240821$DIR$715270$$FDA-CTU$$51$YR$$F$N$54.9$KG$20240821$N$CN$US$
242377511$24237751$1$I$$20240812$20240821$20240821$DIR$FDA-CDER-CTU-2024-57722$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242377521$24237752$1$I$20240821$20240821$20240821$20240821$DIR$715293$$FDA-CTU$$38$YR$$F$N$44.5$KG$20240821$Y$MD$US$
242377531$24237753$1$I$20240817$20240819$20240822$20240822$EXP$$CN-FreseniusKabi-FK202412740$FRESENIUS KABI$$62$YR$A$M$Y$59$KG$20240822$$HP$CN$CN
242377541$24237754$1$I$20240814$20240815$20240822$20240822$EXP$$ZA-FreseniusKabi-FK202412580$FRESENIUS KABI$$67$YR$E$M$Y$107$KG$20240822$$PH$ZA$ZA
242377551$24237755$1$I$20240426$20240816$20240822$20240822$EXP$$JP-ABBVIE-5820015$ABBVIE$$61$YR$$M$Y$$$20240822$$MD$JP$JP
242377571$24237757$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57795$$FDA-CTU$$65$YR$$F$N$$$20240821$N$$US$
242377581$24237758$1$I$20240821$20240821$20240821$20240821$DIR$715298$$FDA-CTU$$46$YR$$F$N$65.25$KG$20240821$N$CN$US$
242377591$24237759$1$I$$20240821$20240821$20240821$DIR$715302$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242377602$24237760$2$F$20240820$20240923$20240822$20240926$PER$$US-AMGEN-USASP2024166673$AMGEN$$75$YR$E$M$Y$$$20240926$$CN$US$US
242377611$24237761$1$I$$20240815$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130887$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240822$$PH$US$US
242377621$24237762$1$I$20240819$20240821$20240821$20240821$DIR$715290$$FDA-CTU$$68$YR$$M$N$94.5$KG$20240821$N$CN$US$
242377631$24237763$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57695$$FDA-CTU$$47$YR$$F$N$126.1$KG$20240821$N$$US$
242377641$24237764$1$I$$20240811$20240822$20240822$EXP$$IN-JNJFOC-20240842304$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240822$$HP$IN$IN
242377651$24237765$1$I$$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024165463$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242377661$24237766$1$I$20240809$20240813$20240822$20240822$PER$$US-BAUSCHBL-2024BNL031672$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240822$$CN$US$US
242377671$24237767$1$I$20240818$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165778$AMGEN$$70$YR$E$F$Y$$$20240822$$CN$US$US
242377681$24237768$1$I$20230706$20240821$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-100200-2023$RECKITT BENCKISER$$$$$F$Y$$$20240822$$CN$US$US
242377702$24237770$2$F$20240720$20240910$20240822$20240911$EXP$$US-PFIZER INC-PV202400109528$PFIZER$$72$YR$$M$Y$$$20240911$$CN$US$US
242377711$24237771$1$I$$20240814$20240822$20240822$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07841$HIKMA$Farkouh EK, Michel IM, Harrison DJ, Issa N.. Farkouh EK, Michel IM, Harrison DJ, Issa N. Dual Donor-Derived Renal Allograft Mucormycosis From a Single Deceased Donor.. Mayo Clinic Proceedings. 2024;99(8):1341-1342$$$$$Y$$$20240822$$MD$US$US
242377722$24237772$2$F$$20240919$20240822$20240923$30DAY$$GB-PFIZER INC-PV202400107761$PFIZER$$7$YR$$M$Y$$$20240923$$CN$GB$GB
242377731$24237773$1$I$$20240821$20240822$20240822$EXP$$TW-PFIZER INC-PV202400109505$PFIZER$$$$$F$Y$$$20240822$$HP$TW$TW
242377742$24237774$2$F$$20240827$20240822$20240827$30DAY$$US-PFIZER INC-PV202400108081$PFIZER$$$$$M$Y$$$20240827$$CN$US$US
242377751$24237775$1$I$$20240819$20240822$20240822$EXP$$IT-PFIZER INC-202400239917$PFIZER$$68$YR$$M$Y$$$20240822$$CN$IT$IT
242377761$24237776$1$I$20240816$20240820$20240822$20240822$EXP$$CN-PFIZER INC-PV202400108656$PFIZER$$70$YR$$F$Y$60$KG$20240822$$HP$CN$CN
242377782$24237778$2$F$$20240921$20240822$20240923$30DAY$$US-PFIZER INC-202400237268$PFIZER$$49$YR$$F$Y$$$20240923$$CN$US$US
242377793$24237779$3$F$20240801$20240903$20240822$20240905$EXP$$CA-PFIZER INC-202400240107$PFIZER$$47$YR$$M$Y$$$20240905$$HP$CA$CA
242377802$24237780$2$F$20220523$20240912$20240822$20240919$EXP$$DE-PFIZER INC-202400239884$PFIZER$$62$YR$$M$Y$95.4$KG$20240919$$MD$DE$DE
242377813$24237781$3$F$$20240912$20240822$20240916$EXP$$US-PFIZER INC-PV202400108051$PFIZER$$47$YR$$F$Y$$$20240916$$CN$US$US
242377821$24237782$1$I$$20240820$20240822$20240822$EXP$$AR-PFIZER INC-202400241030$PFIZER$$69$YR$$M$Y$$$20240822$$CN$AR$AR
242377831$24237783$1$I$$20240820$20240822$20240822$EXP$GB-MHRA-MED-202408201425265560-FLHZK$GB-PFIZER INC-202400240027$PFIZER$$45$YR$$F$Y$$$20240822$$PH$GB$GB
242377851$24237785$1$I$$20240820$20240822$20240822$EXP$$US-PFIZER INC-202400240063$PFIZER$$94$YR$$F$Y$$$20240822$$CN$US$US
242377861$24237786$1$I$$20240821$20240822$20240822$EXP$$US-PFIZER INC-202400241121$PFIZER$$77$YR$$F$Y$$$20240822$$CN$US$US
242377881$24237788$1$I$$20240819$20240822$20240822$30DAY$$US-PFIZER INC-202400239250$PFIZER$$75$YR$$F$Y$$$20240822$$CN$US$US
242377892$24237789$2$F$$20240912$20240822$20240920$30DAY$$IL-PFIZER INC-PV202400107630$PFIZER$$7$YR$$M$Y$$$20240920$$HP$IL$IL
242377902$24237790$2$F$20240715$20240919$20240822$20240924$EXP$$CA-PFIZER INC-202400223531$PFIZER$$74$YR$$F$Y$$$20240924$$CN$CA$CA
242377911$24237791$1$I$20240813$20240819$20240822$20240822$EXP$$CN-PFIZER INC-PV202400107966$PFIZER$$56$YR$$F$Y$62.4$KG$20240822$$HP$CN$CN
242377921$24237792$1$I$$20240819$20240822$20240822$EXP$$IT-PFIZER INC-202400239759$PFIZER$Frattari, A.. High viral load VZV encephalitis complicated by super refractory status epilepticus in a vaccinated child with in Acute Lymphocytic Leukemia: Case report and review of the literature. Neuroimmunology Reports. 2024;6:10.1016/j.nerep.2024.100223$6$YR$$M$Y$$$20240822$$HP$IT$IT
242377931$24237793$1$I$20220101$20240820$20240822$20240822$EXP$$CA-PFIZER INC-202400240134$PFIZER$$8$DEC$$M$Y$$$20240822$$CN$CA$CA
242377941$24237794$1$I$$20240820$20240822$20240822$EXP$GB-MHRA-MED-202408202105246000-YGBST$GB-PFIZER INC-202400240120$PFIZER$$43$YR$$F$Y$$$20240822$$CN$GB$GB
242377951$24237795$1$I$20240701$20240819$20240822$20240822$EXP$$US-PFIZER INC-202400240051$PFIZER$$85$YR$$F$Y$$$20240822$$HP$US$US
242377963$24237796$3$F$20240818$20240927$20240822$20240927$30DAY$$US-PFIZER INC-202400239163$PFIZER$$12$YR$$M$Y$$$20240927$$CN$US$US
242377971$24237797$1$I$$20240820$20240822$20240822$EXP$$SA-PFIZER INC-PV202400109103$PFIZER$$62$YR$$F$Y$$$20240822$$MD$SA$SA
242377981$24237798$1$I$$20240815$20240822$20240822$EXP$$US-GSK-US2024AMR102856$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242377992$24237799$2$F$20240815$20240823$20240822$20240828$EXP$$CA-PFIZER INC-202400238881$PFIZER$$24$YR$$F$Y$67$KG$20240828$$HP$CA$CA
242378002$24237800$2$F$20240701$20240822$20240822$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024100266$VIIV$$38$YR$$M$Y$$$20240831$$HP$US$US
242378011$24237801$1$I$$20240813$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024100722$VIIV$$$$$$Y$$$20240822$$CN$US$US
242378021$24237802$1$I$20230918$20240812$20240822$20240822$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07754$HIKMA$$$$$$Y$$$20240822$$CN$US$US
242378031$24237803$1$I$$20240422$20240822$20240822$PER$$US-009507513-2408USA006899$MERCK$$$$$F$Y$$$20240822$$HP$US$US
242378041$24237804$1$I$20240101$20240817$20240822$20240822$PER$$US-009507513-2408USA006574$MERCK$$$$$M$Y$$$20240822$$HP$US$US
242378051$24237805$1$I$20240702$20240813$20240822$20240822$EXP$$FR-AUROBINDO-AUR-APL-2024-041345$AUROBINDO$$53$YR$$M$Y$$$20240822$$MD$FR$FR
242378061$24237806$1$I$$20240816$20240822$20240822$EXP$$CA-ABBVIE-5887693$ABBVIE$$$$$F$Y$$$20240822$$CN$CA$CA
242378073$24237807$3$F$$20240911$20240822$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130646$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240913$$CN$US$US
242378081$24237808$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131091$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240822$$HP$US$US
242378092$24237809$2$F$20240701$20240823$20240822$20240826$EXP$$US-ABBVIE-5888763$ABBVIE$$69$YR$$M$Y$$$20240826$$CN$US$US
242378101$24237810$1$I$$20240822$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-139702-2023$RECKITT BENCKISER$$66$YR$$M$Y$$$20240822$$CN$US$US
242378111$24237811$1$I$20240711$20240808$20240822$20240822$EXP$IT-MINISAL02-997439$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-07683$HIKMA$$$$$$Y$$$20240822$$MD$IT$IT
242378131$24237813$1$I$$20210910$20240822$20240822$EXP$$US-AstraZeneca-2021A723381$ASTRAZENECA$$$$$$Y$$$20240822$$CN$US$
242378141$24237814$1$I$$20240815$20240822$20240822$EXP$$PK-ROCHE-10000058757$ROCHE$$65$YR$E$F$Y$$$20240822$$CN$PK$PK
242378151$24237815$1$I$$20240814$20240822$20240822$PER$$US-AstraZeneca-2024A189967$ASTRAZENECA$$$$E$M$Y$$$20240822$$CN$US$
242378161$24237816$1$I$$20240813$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-041707$AUROBINDO$$41$YR$$F$Y$$$20240822$$MD$CA$CA
242378193$24237819$3$F$$20240927$20240822$20240927$30DAY$$US-PFIZER INC-202400234291$PFIZER$$18$YR$$F$Y$86.18$KG$20240927$$CN$US$US
242378211$24237821$1$I$$20240805$20240822$20240822$PER$$US-TEVA-VS-3230138$TEVA$$15$MON$$M$Y$$$20240822$$CN$US$US
242378221$24237822$1$I$20240811$20240816$20240822$20240822$PER$$US-ROCHE-10000060002$ROCHE$$$$$$Y$$$20240822$$PH$US$US
242378231$24237823$1$I$20240401$20240805$20240822$20240822$PER$$US-TEVA-VS-3230082$TEVA$$68$YR$$M$Y$$$20240822$$CN$US$US
242378241$24237824$1$I$20240509$20240524$20240822$20240822$PER$$US-GE HEALTHCARE-2024CSU005756$GE HEALTHCARE$$$$$F$Y$$$20240822$$HP$US$US
242378251$24237825$1$I$$20240816$20240822$20240822$PER$$US-BIOGEN-2024BI01278873$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242378271$24237827$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024100374$GLAXOSMITHKLINE$$$$$M$Y$$$20240822$$CN$US$US
242378282$24237828$2$F$20240816$20240828$20240822$20240903$EXP$$CA-RDY-CLI/CAN/24/0012074$DR REDDYS$$75$YR$E$F$Y$$$20240903$$CN$CA$CA
242378291$24237829$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57711$$FDA-CTU$$63$YR$$F$N$$$20240821$N$$US$
242378301$24237830$1$I$20230524$20240815$20240822$20240822$EXP$$BR-GSK-BR2022AMR109368$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$BR$BR
242378311$24237831$1$I$$20240813$20240822$20240822$EXP$$CA-AUROBINDO-AUR-APL-2024-041403$AUROBINDO$$79$YR$$M$Y$$$20240822$$CN$CA$CA
242378321$24237832$1$I$$20240816$20240822$20240822$EXP$US-MLMSERVICE-20240812-PI155406-00306-1$US-RDY-SPO/USA/24/0012064$DR REDDYS$Fasanya-Maku H, Petty D, Knapik J, Leon M, Gonsalves C. A case of metastatic HPV-related cervical small cell neuroendocrine carcinoma with varying cytomorphology found in cytological specimens of a solid organ transplant recipient. Diagnostic Cytopathology. 2024;52(9):E202-7.DOI:10.1002/dc.25361.$53$YR$A$F$Y$$$20240822$$MD$US$US
242378331$24237833$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57701$$FDA-CTU$$78$YR$$F$N$73.03$KG$20240821$N$$US$
242378341$24237834$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57809$$FDA-CTU$$62$YR$$F$N$$$20240821$N$$US$
242378361$24237836$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57749$$FDA-CTU$$71$YR$$F$N$122.92$KG$20240821$N$$US$
242378371$24237837$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57690$$FDA-CTU$$58$YR$$F$N$$$20240821$N$$US$
242378381$24237838$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130215$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240822$$CN$US$US
242378391$24237839$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132294$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240822$$HP$US$US
242378401$24237840$1$I$20240501$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129730$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240822$$HP$US$US
242378411$24237841$1$I$20240725$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132748$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$73.48$KG$20240822$$PH$US$US
242378421$24237842$1$I$$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132621$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240822$$CN$US$US
242378441$24237844$1$I$$20240816$20240822$20240822$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-131024$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$59.42$KG$20240822$$CN$PR$PR
242378461$24237846$1$I$$20240812$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06844$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242378471$24237847$1$I$$20240820$20240822$20240822$EXP$$CA-ROCHE-10000062974$ROCHE$$$$A$F$Y$$$20240822$$CN$CA$CA
242378481$24237848$1$I$$20240821$20240822$20240822$PER$$US-ROCHE-10000062994$ROCHE$$$$$$Y$$$20240822$$CN$US$US
242378491$24237849$1$I$20240101$20240816$20240822$20240822$EXP$BE-FAMHP-DHH-N2024-122489$BE-MYLANLABS-2024M1076548$MYLAN$$43$YR$$M$Y$$$20240822$$PH$BE$BE
242378501$24237850$1$I$$20240815$20240822$20240822$EXP$$CA-JNJFOC-20240843074$JOHNSON AND JOHNSON$$15$YR$T$F$Y$46$KG$20240822$$HP$CA$CA
242378511$24237851$1$I$$20240812$20240822$20240822$EXP$E2B_07193379$CA-LUPIN PHARMACEUTICALS INC.-2024-08222$LUPIN$$34$YR$$F$Y$$$20240822$$HP$CA$CA
242378522$24237852$2$F$$20240820$20240822$20240828$EXP$$US-GILEAD-2024-0684821$GILEAD$$$$A$F$Y$$$20240828$$CN$US$US
242378531$24237853$1$I$$20240821$20240822$20240822$PER$$US-ROCHE-10000063154$ROCHE$$$$E$M$Y$$$20240822$$CN$US$US
242378542$24237854$2$F$$20240903$20240822$20240905$EXP$$CA-ROCHE-10000063049$ROCHE$$$$A$F$Y$$$20240905$$CN$CA$CA
242378551$24237855$1$I$$20240816$20240822$20240822$PER$$US-HALEON-2192291$Haleon PLC$$36$YR$$F$Y$$$20240822$$HP$US$US
242378561$24237856$1$I$$20240819$20240822$20240822$PER$$US-ALXN-202408USA001172US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$HP$US$US
242378571$24237857$1$I$20240812$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165193$AMGEN$$66$YR$E$$Y$$$20240822$$HP$US$US
242378581$24237858$1$I$20240721$20240821$20240822$20240822$EXP$$CA-ROCHE-10000063368$ROCHE$$57$YR$A$F$Y$$$20240822$$CN$CA$CA
242378591$24237859$1$I$$20240814$20240822$20240822$30DAY$$US-GSK-US2024101390$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242378601$24237860$1$I$$20240814$20240822$20240822$EXP$$US-ROCHE-10000057855$ROCHE$$69$YR$E$F$Y$$$20240822$$CN$US$US
242378611$24237861$1$I$$20240813$20240822$20240822$30DAY$$US-GSK-US2024AMR101515$GLAXOSMITHKLINE$$98$YR$$F$Y$$$20240822$$CN$US$US
242378621$24237862$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57689$$FDA-CTU$$78$YR$$F$N$$$20240821$N$HP$US$
242378631$24237863$1$I$$20240820$20240822$20240822$EXP$$US-BAUSCH-BL-2024-012692$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240822$$CN$US$US
242378641$24237864$1$I$20240801$20240821$20240822$20240822$PER$$US-ROCHE-10000063322$ROCHE$$32$YR$A$M$Y$$$20240822$$CN$US$US
242378651$24237865$1$I$$20240816$20240822$20240822$EXP$$AU-PERRIGO-24AU007668$PERRIGO$$52$YR$$F$Y$$$20240822$$MD$AU$AU
242378661$24237866$1$I$$20240816$20240822$20240822$EXP$$AU-PERRIGO-24AU007672$PERRIGO$$55$YR$$M$Y$$$20240822$$MD$AU$AU
242378671$24237867$1$I$20240723$20240807$20240822$20240822$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463729$RANBAXY$$$$$M$Y$$$20240822$$PH$GB$GB
242378681$24237868$1$I$20240619$20240807$20240822$20240822$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463848$RANBAXY$$$$$F$Y$$$20240822$$CN$GB$GB
242378691$24237869$1$I$20221211$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463742$RANBAXY$$$$N$F$Y$2$KG$20240822$$MD$FR$FR
242378701$24237870$1$I$20240804$20240807$20240822$20240822$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463702$RANBAXY$$90$YR$$$Y$$$20240822$$HP$GB$GB
242378711$24237871$1$I$20240501$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463601$RANBAXY$$33$YR$$F$Y$77$KG$20240822$$MD$FR$FR
242378721$24237872$1$I$20231031$20240807$20240822$20240822$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463718$RANBAXY$$3$YR$$M$Y$$$20240822$$MD$ES$ES
242378731$24237873$1$I$$20240807$20240822$20240822$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463647$RANBAXY$$$$$$Y$$$20240822$$CN$GB$GB
242378741$24237874$1$I$20240429$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463754$RANBAXY$$78$YR$$M$Y$94$KG$20240822$$MD$FR$FR
242378751$24237875$1$I$$20240807$20240822$20240822$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463744$RANBAXY$Grechin C, Doheny J, Pilson K, Howard D, Roche M. Tumour necrosis factor alpha induced lupus panniculitis: one case report and literature review. Br J Dermatol. 2024;192 (Suppl.):i17$62$YR$$F$Y$$$20240822$$HP$IE$IE
242378761$24237876$1$I$20240512$20240807$20240822$20240822$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463726$RANBAXY$$18$YR$$M$Y$$$20240822$$MD$IT$IT
242378771$24237877$1$I$$20240807$20240822$20240822$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463953$RANBAXY$Mispelbaum R, Hattenhauer T, Bauernfeind F-G, Lau J-F, Brossart P, Heine A. Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden. Front Oncol. 2024;14:01-04$68$YR$$F$Y$$$20240822$$HP$DE$DE
242378784$24237878$4$F$20240101$20240918$20240822$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023379$UNITED THERAPEUTICS$$$$$F$Y$79.365$KG$20240925$$$US$US
242378791$24237879$1$I$20240405$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463582$RANBAXY$$63$YR$$F$Y$$$20240822$$MD$FR$FR
242378801$24237880$1$I$20230107$20240807$20240822$20240822$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463722$RANBAXY$$30$YR$$F$Y$$$20240822$$MD$FR$FR
242378811$24237881$1$I$20240505$20240807$20240822$20240822$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-457215$RANBAXY$$15$YR$$F$Y$$$20240822$$MD$GB$GB
242378821$24237882$1$I$$20240807$20240822$20240822$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463879$RANBAXY$Palkovsky M, Soumarova R. Tolerance of treatment with ribociclib in combination with fulvestrant in an elderly population - case report. Onkol Revue. 2024;11(4):294-297$75$YR$$F$Y$$$20240822$$HP$CZ$CZ
242378831$24237883$1$I$$20240809$20240821$20240821$DIR$FDA-CDER-CTU-2024-57765$$FDA-CTU$$$$$M$N$$$20240809$N$HP$US$
242378841$24237884$1$I$20240801$20240807$20240822$20240822$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463495$RANBAXY$$64$YR$A$F$Y$68$KG$20240822$$MD$CN$CN
242378852$24237885$2$F$$20240918$20240822$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132635$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240925$$HP$US$US
242378861$24237886$1$I$20240812$20240812$20240822$20240822$PER$$US-JNJFOC-20240835289$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$MD$US$US
242378871$24237887$1$I$$20240819$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074342$SANDOZ$$$$$M$Y$$$20240822$$MD$US$US
242378881$24237888$1$I$$20240405$20240822$20240822$EXP$$CA-INCYTE CORPORATION-2024IN008755$INCYTE$$$$$$Y$$$20240822$$HP$CA$CA
242378891$24237889$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57682$$FDA-CTU$$30$YR$$M$N$$$20240821$N$$US$
242378901$24237890$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57771$$FDA-CTU$$75$YR$$M$N$$$20240821$N$$US$
242378911$24237891$1$I$$20210708$20240822$20240822$EXP$$US-AstraZeneca-2021A608902$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242378921$24237892$1$I$$20240809$20240822$20240822$EXP$$RO-B.Braun Medical Inc.-2160726$B BRAUN$$38$YR$$F$Y$$$20240822$$$RO$RO
242378931$24237893$1$I$$20240819$20240822$20240822$EXP$$NVSC2024CA168143$NOVARTIS$$64$YR$$F$Y$$$20240822$$MD$CA$CA
242378941$24237894$1$I$$20240816$20240822$20240822$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407007348$ELI LILLY AND CO$$$$$M$Y$$$20240822$$CN$BR$BR
242378951$24237895$1$I$$20240819$20240822$20240822$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202408012366$ELI LILLY AND CO$$89$YR$E$M$Y$$$20240822$$CN$TW$TW
242378961$24237896$1$I$$20240813$20240822$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009195$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240822$$CN$US$US
242378971$24237897$1$I$20240810$20240813$20240822$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009588$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240822$$CN$US$US
242378981$24237898$1$I$$20240813$20240822$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009381$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242378991$24237899$1$I$$20240813$20240822$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010089$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242379001$24237900$1$I$$20240819$20240822$20240822$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202408012370$ELI LILLY AND CO$$89$YR$E$F$Y$$$20240822$$HP$TW$TW
242379011$24237901$1$I$20240101$20240819$20240822$20240822$EXP$$CA-AMGEN-CANSL2024165653$AMGEN$$67$YR$E$F$Y$$$20240822$$CN$CA$CA
242379021$24237902$1$I$$20240815$20240822$20240822$PER$$US-BIOGEN-2024BI01278574$BIOGEN$$$$$F$Y$$$20240822$$HP$US$US
242379031$24237903$1$I$20240601$20240812$20240822$20240822$EXP$$PL-TEVA-VS-3233801$TEVA$$77$YR$$F$Y$$$20240822$$CN$PL$PL
242379041$24237904$1$I$$20231013$20240822$20240822$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66244$HIKMA$$$$$$Y$$$20240822$$PH$US$US
242379051$24237905$1$I$20240730$20240809$20240822$20240822$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000808$PAREXEL$$$$$$Y$$$20240822$$HP$CN$CN
242379061$24237906$1$I$20231112$20240822$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-139771-2023$RECKITT BENCKISER$$73$YR$$M$Y$$$20240822$$CN$US$US
242379071$24237907$1$I$20240819$20240819$20240822$20240822$PER$$US-ALXN-202408USA001153US$ALEXION PHARMACEUTICALS$$36$YR$$F$Y$$$20240822$$CN$US$US
242379081$24237908$1$I$20231219$20240101$20240822$20240822$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00163$HIKMA$$79$YR$$F$Y$$$20240822$$CN$US$US
242379101$24237910$1$I$$20240318$20240822$20240822$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-02561$HIKMA$$$$$F$Y$$$20240822$$CN$US$US
242379111$24237911$1$I$$20240814$20240822$20240822$30DAY$$CO-JNJFOC-20240852212$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$CN$CO$CO
242379121$24237912$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57824$$FDA-CTU$$23$YR$$F$N$$$20240821$N$$US$
242379131$24237913$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57683$$FDA-CTU$$66$YR$$F$N$$$20240821$N$$US$
242379141$24237914$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57706$$FDA-CTU$$72$YR$$F$N$70.76$KG$20240821$N$HP$US$
242379152$24237915$2$F$$20240826$20240822$20240903$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS004218$TERSERA THERAPEUTICS$$$$$$Y$$$20240903$$HP$AU$AU
242379161$24237916$1$I$$20240328$20240822$20240822$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-02950$HIKMA$$$$$$Y$$$20240822$$HP$US$US
242379171$24237917$1$I$20150921$20240419$20240822$20240822$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03644$HIKMA$$37$YR$$F$Y$$$20240822$$HP$US$US
242379201$24237920$1$I$$20240619$20240822$20240822$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05623$HIKMA$$$$$$Y$$$20240822$$HP$US$US
242379211$24237921$1$I$$20240813$20240822$20240822$EXP$$US-GSK-US2024100763$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242379221$24237922$1$I$$20240807$20240822$20240822$PER$$US-TRAVERE-2024TVT00775$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242379233$24237923$3$F$20240101$20240913$20240822$20240926$EXP$$US-CIPLA LTD.-2024US08907$CIPLA$$$$$$Y$$$20240926$$HP$US$US
242379241$24237924$1$I$$20240812$20240822$20240822$EXP$$CA-APOTEX-2024AP009298$APOTEX$$2$YR$$F$Y$$$20240822$$HP$CA$CA
242379251$24237925$1$I$20150101$20240722$20240822$20240822$PER$$US-Eisai-EC-2024-170717$EISAI$$63$YR$A$M$Y$$$20240822$$CN$US$US
242379262$24237926$2$F$$20240910$20240822$20240916$EXP$$JP-AMGEN-JPNSP2024164098$AMGEN$$92$YR$E$F$Y$$$20240916$$PH$JP$JP
242379271$24237927$1$I$$20240724$20240822$20240822$PER$$US-009507513-2407USA014809$MERCK$$69$YR$$M$Y$66.19$KG$20240822$$MD$US$US
242379281$24237928$1$I$20240701$20240818$20240822$20240822$EXP$$US-Eisai-EC-2024-170975$EISAI$$66$YR$E$F$Y$$$20240822$$CN$US$US
242379291$24237929$1$I$20230528$20240820$20240822$20240822$EXP$FR-AFSSAPS-PO2024000897$FR-UCBSA-2024042115$UCB$$35$YR$$F$Y$$$20240822$$MD$FR$FR
242379302$24237930$2$F$$20240816$20240822$20240828$EXP$$KR-INCYTE CORPORATION-2024IN008761$INCYTE$$$$$$Y$$$20240828$$CN$KR$KR
242379311$24237931$1$I$$20240815$20240822$20240822$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004612$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240822$$CN$US$US
242379321$24237932$1$I$$20240812$20240822$20240822$EXP$$DE-TEVA-VS-3234238$TEVA$Bingert R, Kolbe V, Boy D, Buttner A. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. [German]. Rechtsmedizin 2023; 33 (5): 396-402.$14$YR$$F$Y$$$20240822$$HP$DE$DE
242379331$24237933$1$I$$20240816$20240822$20240822$EXP$$US-ABBVIE-5886771$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242379342$24237934$2$F$$20240911$20240822$20240920$EXP$$CA-TEVA-VS-3234711$TEVA$Aaron M, Ramien ML, Powell J, McCuaig CC, Marcoux D, Piram M, et al. A retrospective single-centre case series of paediatric blistering severe cutaneous adverse reactions: evaluation using new diagnostic classification confirms value of British Association of Dermatologists^ guidelines. Clin-Exp-Dermatol 2023; 48 (5): 550-552.; Aaron M, Ramien ML, Powell J, McCuaig CC, Marcoux D, Piram M, et al. A retrospective single-centre case series of paediatric blistering severe cutaneous adverse reacti...$$$$$Y$$$20240920$$HP$CA$CA
242379351$24237935$1$I$20240524$20240819$20240822$20240822$EXP$$US-PFIZER INC-2020479059$PFIZER$$79$YR$$F$Y$81.65$KG$20240822$$MD$US$US
242379371$24237937$1$I$20200101$20240820$20240822$20240822$EXP$$US-PFIZER INC-202400240734$PFIZER$$$$T$M$Y$46.4$KG$20240822$$HP$US$US
242379382$24237938$2$F$20090101$20240805$20240822$20240831$PER$$US-TEVA-VS-3230981$TEVA$$55$YR$$F$Y$$$20240831$$HP$US$US
242379391$24237939$1$I$20240820$20240820$20240822$20240822$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004660$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240822$$HP$US$US
242379401$24237940$1$I$$20240812$20240822$20240822$EXP$$CA-TAKEDA-2024TUS084047$TAKEDA$$80$YR$$M$Y$86$KG$20240822$$HP$CA$CA
242379411$24237941$1$I$20240722$20240821$20240822$20240822$EXP$FR-AFSSAPS-SE2024000660$FR-ABBVIE-5888190$ABBVIE$$70$YR$$M$Y$$$20240822$$MD$FR$FR
242379421$24237942$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57714$$FDA-CTU$$47$YR$$F$N$73.94$KG$20240821$N$$US$
242379431$24237943$1$I$20240701$20240812$20240822$20240822$EXP$$US-ABBVIE-5878525$ABBVIE$$59$YR$$F$Y$$$20240822$$CN$US$US
242379441$24237944$1$I$$20240819$20240822$20240822$EXP$$US-HALEON-2192950$Haleon PLC$$38$YR$$F$Y$$$20240822$$MD$US$US
242379451$24237945$1$I$20231122$20240814$20240822$20240822$EXP$$CN-OTSUKA-2024_022607$OTSUKA$$18$YR$$F$Y$60$KG$20240822$$HP$CN$CN
242379471$24237947$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57687$$FDA-CTU$$69$YR$$M$N$$$20240821$N$PH$US$
242379481$24237948$1$I$20240820$20240821$20240821$20240821$DIR$715260$$FDA-CTU$$23$YR$$F$N$81$KG$20240821$N$CN$US$
242379491$24237949$1$I$20240101$20240816$20240822$20240822$EXP$$US-ABBVIE-5798705$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242379501$24237950$1$I$20240601$20240814$20240822$20240822$EXP$$CA-INCYTE CORPORATION-2024IN006319$INCYTE$$$$$$Y$$$20240822$$MD$CA$CA
242379511$24237951$1$I$$20240819$20240822$20240822$EXP$$US-ALXN-202408USA001147US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240822$$CN$US$US
242379532$24237953$2$F$20240101$20240822$20240822$20240829$EXP$$US-ABBVIE-5886043$ABBVIE$$$$$F$Y$65$KG$20240829$$CN$US$US
242379541$24237954$1$I$$20240816$20240822$20240822$PER$$US-BEH-2024177437$CSL BEHRING$$47$YR$A$M$Y$$$20240822$$CN$US$US
242379551$24237955$1$I$$20240819$20240822$20240822$EXP$$US-JNJFOC-20240854610$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240822$$HP$US$US
242379561$24237956$1$I$20230801$20240816$20240822$20240822$EXP$$NVSC2024US166787$NOVARTIS$$32$YR$$M$Y$$$20240822$$CN$US$US
242379571$24237957$1$I$$20240813$20240822$20240822$EXP$$BR-SA-2024SA243279$SANOFI AVENTIS$$$$$F$Y$$$20240822$$CN$BR$BR
242379581$24237958$1$I$$20240812$20240822$20240822$EXP$$ES-TAKEDA-2024TUS084067$TAKEDA$$43$YR$$F$Y$62$KG$20240822$$MD$ES$ES
242379591$24237959$1$I$20230718$20240816$20240822$20240822$EXP$IT-MINISAL02-998614$IT-MYLANLABS-2024M1076287$MYLAN$$80$YR$$F$Y$$$20240822$$MD$IT$IT
242379601$24237960$1$I$20240713$20240814$20240822$20240822$EXP$$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07856$HIKMA$$62$YR$$F$Y$$$20240822$$PH$FR$FR
242379611$24237961$1$I$20231109$20240822$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-140616-2023$RECKITT BENCKISER$$80$YR$$F$Y$75$KG$20240822$$CN$US$US
242379623$24237962$3$F$20240805$20240822$20240822$20240917$PER$$US-TRAVERE-2024TVT00776$TRAVERE THERAPEUTICS$$45$YR$A$F$Y$$$20240917$$CN$US$US
242379631$24237963$1$I$$20240807$20240822$20240822$PER$$US-TRAVERE-2024TVT00779$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$MD$US$US
242379641$24237964$1$I$$20240807$20240822$20240822$PER$$US-TRAVERE-2024TVT00777$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
242379651$24237965$1$I$$20240724$20240822$20240822$PER$$US-Eisai-EC-2024-170966$EISAI$$$$$F$Y$$$20240822$$MD$US$US
242379661$24237966$1$I$$20240724$20240822$20240822$PER$$US-Eisai-EC-2024-170938$EISAI$$$$$F$Y$$$20240822$$MD$US$US
242379671$24237967$1$I$$20240813$20240822$20240822$30DAY$$US-GSK-US2024AMR103000$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$HP$US$US
242379681$24237968$1$I$20240811$20240812$20240822$20240822$30DAY$$US-GSK-US2024100380$GLAXOSMITHKLINE$$24$YR$$F$Y$$$20240822$$CN$US$US
242379691$24237969$1$I$$20240816$20240822$20240822$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2016-VEL-00168$VELOXIS PHARMACEUTICALS$Millien VO, Santana LA, Kolpakchi A, Lu L.. Trading one for another: A case of de novo crohn^s disease after lung transplant. Journal of general internal medicine. 2016;31:2(1):S769$71$YR$$M$Y$$$20240822$$HP$US$US
242379712$24237971$2$F$$20240820$20240822$20240826$EXP$$JP-AMGEN-JPNSP2024165289$AMGEN$$$$$$Y$$$20240826$$PH$JP$JP
242379724$24237972$4$F$20240810$20240913$20240822$20240925$30DAY$$US-JNJFOC-20240829576$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240925$$PH$US$US
242379741$24237974$1$I$$20240816$20240822$20240822$EXP$$GB-AMGEN-GBRSL2024165467$AMGEN$$48$YR$A$M$Y$$$20240822$$CN$GB$GB
242379751$24237975$1$I$20240601$20240816$20240822$20240822$EXP$$US-ABBVIE-5884930$ABBVIE$$78$YR$$F$Y$$$20240822$$CN$US$US
242379761$24237976$1$I$20220711$20240820$20240822$20240822$EXP$$DE-INCYTE CORPORATION-2023IN013658$INCYTE$$$$$$Y$$$20240822$$HP$DE$DE
242379773$24237977$3$F$20240910$20240910$20240822$20240913$EXP$$CA-TAKEDA-2023TUS087875$TAKEDA$$71$YR$$F$Y$$$20240913$$MD$CA$CA
242379781$24237978$1$I$$20240817$20240822$20240822$EXP$$CO-SA-2024SA248165$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240822$$HP$CO$CO
242379791$24237979$1$I$20240101$20240812$20240822$20240822$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020723$UNITED THERAPEUTICS$$$$$M$Y$$$20240822$$$US$US
242379801$24237980$1$I$$20240815$20240822$20240822$EXP$$CA-TAKEDA-2023TUS059211$TAKEDA$$$$$F$Y$$$20240822$$CN$CA$CA
242379811$24237981$1$I$$20240812$20240822$20240822$PER$$US-INCYTE CORPORATION-2024IN008457$INCYTE$$$$$$Y$$$20240822$$HP$US$US
242379821$24237982$1$I$$20240819$20240822$20240822$EXP$$PE-EMD Serono-2024034939$EMD SERONO INC$$$$A$F$Y$$$20240822$$CN$PE$PE
242379832$24237983$2$F$20240727$20240916$20240822$20240918$EXP$$US-ABBVIE-5887696$ABBVIE$$72$YR$$F$Y$36$KG$20240918$$CN$US$US
242379841$24237984$1$I$$20240807$20240822$20240822$EXP$$US-PHARMAAND GMBH-2024PHR00473$pharmaAND$$$$$F$Y$$$20240822$$CN$US$US
242379851$24237985$1$I$20240805$20240820$20240822$20240822$EXP$$CN-PFIZER INC-PV202400108663$PFIZER$$72$YR$$M$Y$59$KG$20240822$$HP$CN$CN
242379862$24237986$2$F$20240319$20240823$20240822$20240827$EXP$$DE-PFIZER INC-PV202400097903$PFIZER$$88$YR$$F$Y$$$20240827$$MD$DE$DE
242379881$24237988$1$I$20240816$20240820$20240822$20240822$EXP$$BR-PFIZER INC-202400239959$PFIZER$$58$YR$$F$Y$82.5$KG$20240822$$PH$BR$BR
242379891$24237989$1$I$$20240809$20240822$20240822$EXP$$US-RK PHARMA, INC-20240800047$RK PHARMA$Nikolas P. Foresteire. Tricyclic Antidepressant and Antipsychotic Toxicity: Clomipramine and Ziprasidone Overdose. Cureus.. 2024;16(7):e63691$$$$$Y$$$20240822$$HP$US$US
242379901$24237990$1$I$$20240820$20240822$20240822$EXP$$ES-PFIZER INC-202400239719$PFIZER$$76$YR$$F$Y$$$20240822$$MD$ES$ES
242379911$24237991$1$I$$20240809$20240822$20240822$EXP$$IR-RK PHARMA, INC-20240800046$RK PHARMA$Pouya Ebrahimi. Kounis syndrome type I induced by an intramuscular injection of diclofenac: A literature review based on a case report. Clin Case Rep. 2024;12(7):e9198$51$YR$$M$Y$$$20240822$$HP$IR$IR
242379921$24237992$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012821$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240822$$CN$US$US
242379931$24237993$1$I$$20240506$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202405003092$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240822$$CN$US$US
242379951$24237995$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011858$ELI LILLY AND CO$$$$$M$Y$$$20240822$$CN$US$US
242379961$24237996$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011875$ELI LILLY AND CO$$21$YR$A$$Y$$$20240822$$CN$US$US
242379971$24237997$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013437$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240822$$CN$US$US
242379981$24237998$1$I$$20240816$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408010745$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240822$$CN$US$US
242379991$24237999$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012450$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242380011$24238001$1$I$20240819$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011665$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240822$$CN$US$US
242380021$24238002$1$I$20240814$20240816$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011433$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240822$$CN$US$US
242380031$24238003$1$I$$20240812$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408007153$ELI LILLY AND CO$$41$YR$A$$Y$$$20240822$$LW$US$US
242380041$24238004$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013586$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240822$$CN$US$US
242380051$24238005$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013613$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240822$$CN$US$US
242380061$24238006$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013488$ELI LILLY AND CO$$68$YR$E$$Y$$$20240822$$CN$US$US
242380071$24238007$1$I$$20240812$20240822$20240822$EXP$$US-BAYER-2024A116791$BAYER$$58$YR$A$M$Y$90.703$KG$20240822$$CN$US$US
242380081$24238008$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012588$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242380091$24238009$1$I$20240812$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012489$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242380101$24238010$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011985$ELI LILLY AND CO$$26$YR$A$M$Y$$$20240822$$CN$US$US
242380111$24238011$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012019$ELI LILLY AND CO$$34$YR$A$$Y$$$20240822$$CN$US$US
242380131$24238013$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57774$$FDA-CTU$$38$YR$$F$N$$$20240821$N$$US$
242380141$24238014$1$I$$20240821$20240821$20240821$DIR$715303$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242380151$24238015$1$I$$20240821$20240821$20240821$DIR$715304$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242380161$24238016$1$I$$20240816$20240822$20240822$EXP$$FI-SA-2024SA235791$SANOFI AVENTIS$$$$A$$Y$$$20240822$$MD$FI$FI
242380171$24238017$1$I$$20240816$20240822$20240822$PER$$US-ROCHE-10000060006$ROCHE$$$$$$Y$$$20240822$$MD$US$US
242380181$24238018$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA249190$SANOFI AVENTIS$$$$A$F$Y$$$20240822$$MD$US$US
242380191$24238019$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA247961$SANOFI AVENTIS$$8$YR$C$F$Y$16.78$KG$20240822$$HP$US$US
242380211$24238021$1$I$20191201$20240816$20240822$20240822$EXP$$US-UCBSA-2024031867$UCB$$58$YR$$F$Y$$$20240822$$CN$US$US
242380221$24238022$1$I$$20240812$20240822$20240822$EXP$$CA-APOTEX-2024AP009307$APOTEX$$26$YR$$F$Y$$$20240822$$HP$CA$CA
242380231$24238023$1$I$20240820$20240821$20240821$20240821$DIR$715308$$FDA-CTU$$71$YR$$M$N$69.3$KG$20240821$N$PH$US$
242380241$24238024$1$I$$20240818$20240822$20240822$EXP$$US-SA-2024SA248617$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240822$$MD$US$US
242380251$24238025$1$I$20240819$20240821$20240821$20240821$DIR$715282$$FDA-CTU$$41$YR$$F$N$99.9$KG$20240821$N$CN$US$
242380261$24238026$1$I$$20240821$20240821$20240821$DIR$715314$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242380271$24238027$1$I$$20240821$20240821$20240821$DIR$715268$$FDA-CTU$$56$YR$$F$N$84.15$KG$20240821$N$MD$US$
242380291$24238029$1$I$$20240821$20240821$20240821$DIR$715338$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242380301$24238030$1$I$20240714$20240821$20240821$20240821$DIR$715271$$FDA-CTU$$59$YR$$M$N$61.7$KG$20240821$N$PH$US$
242380311$24238031$1$I$20240818$20240821$20240821$20240821$DIR$715284$$FDA-CTU$$13$YR$$F$N$$$20240821$N$PH$US$
242380321$24238032$1$I$20240821$20240821$20240821$20240821$DIR$715313$$FDA-CTU$$64$YR$$M$N$$$20240821$N$HP$US$
242380331$24238033$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57768$$FDA-CTU$$64$YR$$F$N$$$20240821$N$$US$
242380341$24238034$1$I$20240821$20240821$20240821$20240821$DIR$715297$$FDA-CTU$$59$YR$$F$N$$$20240821$Y$HP$US$
242380352$24238035$2$F$20240701$20240805$20240822$20240905$PER$$US-MYLANLABS-2024M1073315$MYLAN$$6$YR$$M$Y$$$20240905$$CN$US$US
242380361$24238036$1$I$20240821$20240821$20240822$20240822$PER$$US-BAYER-2024A120832$BAYER$$$$$F$Y$$$20240822$$CN$US$US
242380371$24238037$1$I$20240812$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165215$AMGEN$$71$YR$E$$Y$$$20240822$$CN$US$US
242380381$24238038$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA248963$SANOFI AVENTIS$$$$E$F$Y$$$20240822$$MD$US$US
242380391$24238039$1$I$20220101$20240822$20240822$20240822$EXP$DK-DKMA-30729593$DK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047241$BOEHRINGER INGELHEIM$$7$DEC$E$F$Y$$$20240822$$MD$DK$DK
242380422$24238042$2$F$$20240925$20240822$20240925$30DAY$$CL-PFIZER INC-PV202400108573$PFIZER$$10$YR$$F$Y$$$20240925$$CN$CL$CL
242380432$24238043$2$F$$20240917$20240822$20240920$30DAY$$US-PFIZER INC-PV202400072398$PFIZER$$$$$M$Y$$$20240920$$HP$US$US
242380452$24238045$2$F$$20240918$20240822$20240923$30DAY$$CA-PFIZER INC-202400235833$PFIZER$$78$YR$$F$Y$$$20240923$$PH$CA$CA
242380471$24238047$1$I$$20240816$20240822$20240822$EXP$$NVSC2024US168427$NOVARTIS$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M et al.. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. AMERICAN SOCIETY OF CLINICAL ONCOLOGY. 2024;42 (16):e23269$$$E$$Y$$$20240822$$HP$US$US
242380481$24238048$1$I$$20240820$20240822$20240822$EXP$$NVSC2024CA168942$NOVARTIS$$56$YR$$M$Y$$$20240822$$CN$CA$CA
242380491$24238049$1$I$$20240821$20240822$20240822$PER$$US-BAYER-2024A120592$BAYER$$$$$F$Y$$$20240822$$CN$US$US
242380502$24238050$2$F$20240701$20240827$20240822$20240903$EXP$$AR-GSK-AR2024AMR000998$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$AR$AR
242380511$24238051$1$I$$20240807$20240822$20240822$PER$$US-TRAVERE-2024TVT00786$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242380522$24238052$2$F$20240801$20240820$20240822$20240917$PER$$US-TRAVERE-2024TVT00780$TRAVERE THERAPEUTICS$$60$YR$A$M$Y$$$20240917$$CN$US$US
242380544$24238054$4$F$$20240912$20240822$20240930$PER$$US-TRAVERE-2024TVT00788$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
242380561$24238056$1$I$20240101$20240722$20240822$20240822$PER$$US-Eisai-EC-2024-170742$EISAI$$72$YR$E$$Y$$$20240822$$CN$US$US
242380571$24238057$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA248486$SANOFI AVENTIS$$38$YR$A$F$Y$56.25$KG$20240822$$MD$US$US
242380591$24238059$1$I$20211001$20220113$20240822$20240822$EXP$$US-AstraZeneca-2022A023263$ASTRAZENECA$$869$MON$$M$Y$$$20240822$$CN$US$
242380601$24238060$1$I$20240810$20240815$20240822$20240822$EXP$$RU-AstraZeneca-2024A188663$ASTRAZENECA$$2326$DY$$F$Y$$$20240822$$MD$RU$
242380611$24238061$1$I$$20240810$20240822$20240822$EXP$$GB-CIPLA LTD.-2024GB08872$CIPLA$$$$$$Y$$$20240822$$CN$GB$GB
242380621$24238062$1$I$$20240810$20240822$20240822$EXP$$GB-CIPLA LTD.-2024GB08873$CIPLA$$$$$$Y$$$20240822$$CN$GB$GB
242380631$24238063$1$I$20230201$20240819$20240822$20240822$EXP$GB-MHRA-MED-202408191122505950-NYQDW$GB-MYLANLABS-2024M1077074$MYLAN$$32$YR$$F$Y$144$KG$20240822$$PH$GB$GB
242380642$24238064$2$F$20240809$20240916$20240822$20240918$EXP$$RU-AstraZeneca-2024A188286$ASTRAZENECA$$4879$DY$$F$Y$47$KG$20240918$$MD$RU$
242380651$24238065$1$I$$20240820$20240822$20240822$PER$$US-FreseniusKabi-FK202412762$FRESENIUS KABI$$$$$$Y$$$20240822$$CN$US$US
242380661$24238066$1$I$$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131816$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240822$$CN$US$US
242380671$24238067$1$I$20240814$20240820$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133143$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240822$$CN$US$US
242380681$24238068$1$I$20240524$20240822$20240822$20240822$PER$$US-PROD-AS2-212756134-20-24-USA-RB-0000742$RECKITT BENCKISER$$81$YR$$F$Y$75.75$KG$20240822$$CN$US$US
242380692$24238069$2$F$20240701$20240812$20240822$20240823$PER$$US-ABBVIE-5877943$ABBVIE$$55$YR$$F$Y$$$20240823$$CN$US$US
242380701$24238070$1$I$20240808$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57823$$FDA-CTU$$81$YR$$M$N$$$20240821$Y$$US$
242380711$24238071$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165200$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242380721$24238072$1$I$$20240809$20240822$20240822$EXP$FR-ROCHE-10000056946$FR-ROCHE-10000056946$ROCHE$Guitard J, Guilbeau-Frugier C, Roussel M, Kamar N. An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis. Clin-Nephrol 2014; 82(6):392-396.$58$YR$A$F$Y$$$20240822$$MD$FR$FR
242380731$24238073$1$I$$20240520$20240822$20240822$EXP$$US-009507513-2408USA006804$MERCK$$$$$F$Y$$$20240822$$HP$US$US
242380742$24238074$2$F$20240703$20240818$20240822$20240827$EXP$$EE-TEVA-VS-3233810$TEVA$$48$YR$$F$Y$60$KG$20240827$$MD$EE$EE
242380751$24238075$1$I$20240818$20240820$20240822$20240822$PER$$US-GILEAD-2024-0684780$GILEAD$$43$YR$A$M$Y$$$20240822$$CN$US$US
242380761$24238076$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA249153$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240822$$MD$US$US
242380771$24238077$1$I$20240804$20240821$20240821$20240821$DIR$715343$$FDA-CTU$$22$YR$$F$N$63$KG$20240821$N$HP$US$
242380782$24238078$2$F$$20240917$20240822$20240925$PER$$US-GSK-US2024100379$GLAXOSMITHKLINE$$$$$M$Y$$$20240925$$CN$US$US
242380791$24238079$1$I$20240101$20240820$20240822$20240822$EXP$$US-SA-2024SA249030$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240822$$MD$US$US
242380802$24238080$2$F$20240728$20240821$20240822$20240828$EXP$$CA-GSK-CA2024101853$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$CA$CA
242380811$24238081$1$I$$20240813$20240822$20240822$PER$$US-ABBVIE-5880047$ABBVIE$$$$$$Y$$$20240822$$HP$US$US
242380822$24238082$2$F$$20240823$20240822$20240902$PER$$US-ABBVIE-5881428$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242380832$24238083$2$F$20231201$20240822$20240822$20240827$EXP$$US-ABBVIE-5887371$ABBVIE$$62$YR$$M$Y$106.59$KG$20240827$$CN$US$US
242380841$24238084$1$I$20240725$20240821$20240821$20240821$DIR$715300$$FDA-CTU$$76$YR$$M$N$80$KG$20240821$N$PH$US$
242380851$24238085$1$I$20240804$20240816$20240822$20240822$EXP$$CN-AMGEN-CHNSP2024164258$AMGEN$$67$YR$E$M$Y$56$KG$20240822$$HP$CN$CN
242380861$24238086$1$I$20240815$20240819$20240822$20240822$PER$$US-LEO Pharma-372883$LEO PHARM$$65$YR$$M$Y$$$20240822$$CN$US$US
242380871$24238087$1$I$$20240723$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07387$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242380882$24238088$2$F$20240812$20240815$20240822$20240911$EXP$$US-BEH-2024177248$CSL BEHRING$$20$YR$A$F$Y$$$20240911$$HP$US$US
242380891$24238089$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132750$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240822$$HP$US$US
242380901$24238090$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57822$$FDA-CTU$$$$$M$N$$$20240821$N$HP$US$
242380911$24238091$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5887033$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242380921$24238092$1$I$20240709$20240816$20240822$20240822$EXP$IT-MINISAL02-998875$IT-MYLANLABS-2024M1076317$MYLAN$$80$YR$$F$Y$46$KG$20240822$$MD$IT$IT
242380931$24238093$1$I$$20240817$20240822$20240822$EXP$$NVSC2024US168117$NOVARTIS$$$$A$F$Y$$$20240822$$MD$US$US
242380941$24238094$1$I$$20240815$20240822$20240822$EXP$$CA-TAKEDA-2024TUS082806$TAKEDA$$50$YR$$F$Y$$$20240822$$HP$CA$CA
242380951$24238095$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5886814$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242380961$24238096$1$I$$20240820$20240822$20240822$EXP$$NVSC2024CA168736$NOVARTIS$$$$$M$Y$$$20240822$$CN$CA$CA
242380971$24238097$1$I$$20240731$20240822$20240822$PER$$US-B.Braun Medical Inc.-2160728$B BRAUN$$23$YR$$F$Y$$$20240822$$$US$US
242380992$24238099$2$F$$20240821$20240822$20240826$PER$$US-LEO Pharma-372842$LEO PHARM$$54$YR$$M$Y$$$20240826$$CN$US$US
242381001$24238100$1$I$$20240819$20240822$20240822$PER$$US-Mission Pharmacal Company-2160727$MISSION$$67$YR$$M$Y$$$20240822$$$US$US
242381011$24238101$1$I$$20240821$20240821$20240821$DIR$715295$$FDA-CTU$$$$$UNK$N$$$20240821$$CN$US$
242381021$24238102$1$I$20240820$20240820$20240822$20240822$PER$$US-JNJFOC-20240853928$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$HP$US$US
242381031$24238103$1$I$20230101$20240821$20240822$20240822$EXP$$ZA-ABBVIE-5889144$ABBVIE$$69$YR$$F$Y$$$20240822$$MD$ZA$ZA
242381041$24238104$1$I$$20240814$20240822$20240822$PER$$US-AMGEN-USASP2024163915$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242381051$24238105$1$I$20180617$20240816$20240822$20240822$EXP$$CA-TAKEDA-2018TUS021370$TAKEDA$$57$YR$$F$Y$$$20240822$$MD$CA$CA
242381064$24238106$4$F$20221101$20240910$20240822$20240912$EXP$$US-PFIZER INC-PV202400108402$PFIZER$$82$YR$$M$Y$69.8$KG$20240912$$MD$US$US
242381071$24238107$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57813$$FDA-CTU$$$$$M$N$$$20240821$N$HP$US$
242381081$24238108$1$I$20240817$20240821$20240821$20240821$DIR$715280$$FDA-CTU$$56$YR$$F$N$65.25$KG$20240821$N$CN$US$
242381092$24238109$2$F$$20240903$20240822$20240913$PER$$US-INCYTE CORPORATION-2024IN008447$INCYTE$$$$$$Y$$$20240913$$CN$US$US
242381101$24238110$1$I$20240805$20240808$20240822$20240822$PER$$US-TRAVERE-2024TVT00781$TRAVERE THERAPEUTICS$$34$YR$A$M$Y$$$20240822$$CN$US$US
242381111$24238111$1$I$$20240822$20240822$20240822$PER$$US-PROD-AS2-212756134-RB-081745-2024$RECKITT BENCKISER$$$$$F$Y$$$20240822$$CN$US$US
242381121$24238112$1$I$$20240819$20240822$20240822$EXP$$JP-AstraZeneca-2024A189164$ASTRAZENECA$$81$YR$$F$Y$$$20240822$$MD$JP$
242381131$24238113$1$I$20240715$20240817$20240822$20240822$EXP$$GB-AstraZeneca-2024A190776$ASTRAZENECA$$48$YR$$M$Y$79$KG$20240822$$MD$GB$
242381141$24238114$1$I$$20240821$20240821$20240821$DIR$715299$$FDA-CTU$$$$$UNK$N$$$20240821$$CN$US$
242381163$24238116$3$F$$20240826$20240822$20240904$EXP$$CA-HALEON-2192929$Haleon PLC$$44$YR$$M$Y$91$KG$20240903$$HP$CA$CA
242381171$24238117$1$I$$20240723$20240822$20240822$PER$$US-Eisai-EC-2024-170767$EISAI$$$$E$F$Y$$$20240822$$MD$US$US
242381181$24238118$1$I$20240601$20240729$20240822$20240822$PER$$US-Eisai-EC-2024-171075$EISAI$$$$$$Y$$$20240822$$MD$US$US
242381191$24238119$1$I$20240812$20240816$20240822$20240822$PER$$CN-Eisai-EC-2024-172339$EISAI$$39$YR$A$F$Y$36$KG$20240822$$HP$CN$CN
242381201$24238120$1$I$20240606$20240813$20240822$20240822$EXP$ES-AEMPS-1558118$ES-TEVA-VS-3233462$TEVA$$81$YR$$M$Y$$$20240822$$MD$ES$ES
242381212$24238121$2$F$20240101$20240904$20240822$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-025757$UNITED THERAPEUTICS$$$$$F$Y$79.819$KG$20240910$$$US$US
242381221$24238122$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130917$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240822$$CN$US$US
242381231$24238123$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130004$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240822$$CN$US$US
242381241$24238124$1$I$20230101$20240814$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130881$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240822$$CN$US$US
242381251$24238125$1$I$$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129630$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240822$$CN$US$US
242381261$24238126$1$I$$20240821$20240821$20240821$DIR$715348$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242381271$24238127$1$I$$20240821$20240822$20240822$PER$$US-JNJFOC-20240855142$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$MD$US$US
242381281$24238128$1$I$20240725$20240815$20240822$20240822$EXP$$CN-JNJFOC-20240842698$JOHNSON AND JOHNSON$$69$YR$E$M$Y$58$KG$20240822$$HP$CN$CN
242381292$24238129$2$F$$20240912$20240822$20240924$30DAY$$DE-JNJFOC-20240850280$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$PH$DE$DE
242381301$24238130$1$I$20240807$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164590$AMGEN$$82$YR$E$M$Y$$$20240822$$CN$US$US
242381311$24238131$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57693$$FDA-CTU$$83$YR$$F$N$54.43$KG$20240821$N$$US$
242381321$24238132$1$I$$20240819$20240822$20240822$EXP$$US-MYLANLABS-2024M1077539$MYLAN$Shariff H, Luu T, Kavis H, Obuch J. Gastric Signet Ring Cell Adenocarcinoma with Metastasis to the Testicles and Leptomeninges. ACG-Case-Rep-J 2024; 11 (8):.$38$YR$$M$Y$$$20240822$$MD$US$US
242381331$24238133$1$I$$20240816$20240822$20240822$PER$$US-LEO Pharma-372839$LEO PHARM$$47$YR$$F$Y$$$20240822$$CN$US$US
242381341$24238134$1$I$$20240816$20240822$20240822$PER$$US-UNITED THERAPEUTICS-UNT-2024-025835$UNITED THERAPEUTICS$$$$$F$Y$92.971$KG$20240822$$$US$US
242381351$24238135$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57735$$FDA-CTU$$53$YR$$F$N$101.15$KG$20240821$N$$US$
242381361$24238136$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57702$$FDA-CTU$$60$YR$$F$N$$$20240821$N$$US$
242381371$24238137$1$I$20240625$20240820$20240822$20240822$EXP$$AU-SANDOZ INC.-SDZ2024AU073916$SANDOZ$$77$YR$$M$Y$$$20240822$$HP$AU$AU
242381381$24238138$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57757$$FDA-CTU$$82$YR$$F$N$$$20240821$N$$US$
242381391$24238139$1$I$$20240820$20240822$20240822$EXP$$NVSC2024US169596$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
242381401$24238140$1$I$20191001$20240819$20240822$20240822$EXP$$CA-ROCHE-2287771$ROCHE$$35$YR$A$F$Y$$$20240822$$CN$CA$CA
242381411$24238141$1$I$$20240819$20240822$20240822$PER$$US-ABBVIE-5888390$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242381421$24238142$1$I$$20240815$20240822$20240822$PER$$US-ALXN-202408USA000909US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242381432$24238143$2$F$$20240821$20240822$20240826$PER$$US-JAZZ PHARMACEUTICALS-2024-US-013081$JAZZ$$$$$F$Y$$$20240826$$CN$US$US
242381441$24238144$1$I$$20240820$20240822$20240822$EXP$$CA-ROCHE-10000062091$ROCHE$$$$A$F$Y$$$20240822$$CN$CA$CA
242381451$24238145$1$I$$20230707$20240822$20240822$EXP$$US-AstraZeneca-2023A120657$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242381462$24238146$2$F$20240101$20240821$20240822$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-026072$UNITED THERAPEUTICS$$$$$F$Y$$$20240828$$$US$US
242381471$24238147$1$I$20240805$20240819$20240822$20240822$EXP$$US-GILEAD-2024-0684836$GILEAD$$$$$F$Y$$$20240822$$HP$US$US
242381481$24238148$1$I$20190101$20240820$20240822$20240822$EXP$$NL-SANDOZ INC.-NVSC2020NL207592$SANDOZ$$70$YR$$F$Y$$$20240822$$HP$NL$NL
242381491$24238149$1$I$$20240819$20240822$20240822$EXP$CA-LEO Pharma-372831$CA-LEO Pharma-372831$LEO PHARM$$$$$F$Y$$$20240822$$MD$CA$CA
242381501$24238150$1$I$$20240820$20240822$20240822$EXP$$NVSC2024CA168881$NOVARTIS$$33$YR$$F$Y$$$20240822$$PH$CA$CA
242381511$24238151$1$I$$20240819$20240822$20240822$PER$$US-Mission Pharmacal Company-2160730$MISSION$$67$YR$$M$Y$$$20240822$$$US$US
242381521$24238152$1$I$$20240814$20240822$20240822$PER$$US-LEO Pharma-372897$LEO PHARM$$44$YR$$F$Y$$$20240822$$CN$US$US
242381531$24238153$1$I$$20240808$20240822$20240822$PER$$US-TRAVERE-2024TVT00791$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
242381541$24238154$1$I$20230804$20240815$20240822$20240822$EXP$CA-MMM-9NXB3HJ0$CA-GSK-CA2023110641$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$CA$CA
242381551$24238155$1$I$$20240808$20240822$20240822$PER$$US-TRAVERE-2024TVT00783$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242381561$24238156$1$I$$20240808$20240822$20240822$PER$$US-TRAVERE-2024TVT00790$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
242381571$24238157$1$I$$20240722$20240822$20240822$PER$$US-Eisai-EC-2024-170739$EISAI$$$$$$Y$$$20240822$$HP$US$US
242381582$24238158$2$F$20240611$20240828$20240822$20240909$PER$$US-BIOCON-BCN-2024-000168$BIOCON$$70$YR$E$F$Y$62.5$KG$20240909$$CN$US$US
242381592$24238159$2$F$$20240829$20240822$20240906$EXP$$GB-TEVA-VS-3234089$TEVA$Kerkemeyer K, Vyas A, Walker S, Rickaby W. A fatal case of disseminated cutaneous Mycobacterium chelonae infection in an immunocompromised patient. Br-J-Dermatol 2024; 192 (Suppl.) i147.; Kerkemeyer K, Vyas A, Walker S, Rickaby W. A fatal case of disseminated cutaneous Mycobacterium chelonae infection in an immunocompromised patient. Br-J-Dermatol 2024; 192 (Suppl.) i147.$82$YR$$M$Y$$$20240906$$HP$GB$GB
242381601$24238160$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129695$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$79.38$KG$20240822$$CN$US$US
242381611$24238161$1$I$$20240816$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130957$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240822$$CN$US$US
242381622$24238162$2$F$$20240829$20240822$20240906$EXP$$US-TEVA-VS-3234134$TEVA$Shaikh Y, Jamal I, Gumireddy S, Idriss S, Piya S, Jabiev A, et al. #1705929 Treatment refractory hyperthyroidism in an elderly patient and pre-operative management with therapeutic plasma exchange. Endocr-Pract 2024; 30 (Suppl.) (5): S157-S158 abstr. #1705929.; Shaikh Y, Jamal I, Gumireddy S, Idriss S, Piya S, Jabiev A, et al. #1705929 Treatment refractory hyperthyroidism in an elderly patient and pre-operative management with therapeutic plasma exchange. Endocr-Pract 2024; 30 (Suppl.) (5): S...$94$YR$$F$Y$$$20240906$$MD$US$US
242381631$24238163$1$I$20240101$20240806$20240822$20240822$PER$$US-TEVA-VS-3232010$TEVA$$75$YR$$M$Y$$$20240822$$PH$US$US
242381642$24238164$2$F$20240701$20240819$20240822$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132215$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240826$$CN$US$US
242381651$24238165$1$I$20240819$20240821$20240822$20240822$EXP$$GB-JNJFOC-20240854213$JOHNSON AND JOHNSON$$19$YR$A$F$Y$73$KG$20240822$$HP$GB$GB
242381661$24238166$1$I$$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57785$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242381671$24238167$1$I$20240817$20240821$20240821$20240821$DIR$715307$$FDA-CTU$$62$YR$$F$N$108.5$KG$20240821$N$HP$US$
242381681$24238168$1$I$20240712$20240821$20240821$20240821$DIR$715350$$FDA-CTU$$31$YR$$M$N$78.4$KG$20240821$N$HP$US$
242381691$24238169$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57710$$FDA-CTU$$66$YR$$F$N$117.93$KG$20240821$N$$US$
242381711$24238171$1$I$$20240821$20240821$20240821$DIR$715363$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242381721$24238172$1$I$$20240819$20240822$20240822$EXP$$NVSC2024US168264$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
242381731$24238173$1$I$$20240808$20240822$20240822$EXP$$US-Renata Limited-2160731$RENATA LIMITED$Full text$25$YR$$M$Y$$$20240822$$$US$US
242381741$24238174$1$I$20240820$20240821$20240821$20240821$DIR$715336$$FDA-CTU$$45$YR$$F$N$$$20240821$N$HP$US$
242381751$24238175$1$I$$20240807$20240822$20240822$EXP$$US-SERVIER-S24010012$SERVIER$Schultz L., Davis KL, Walkush A., Baggott C., Erickson C., Ramakrishna S. et al.. Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD. Journal for ImmunoTherapy of Cancer 2023. 2023;11 (2)$$$$$Y$$$20240822$$MD$US$US
242381761$24238176$1$I$20230301$20240813$20240822$20240822$EXP$DE-CADRBFARM-2024329756$DE-TEVA-VS-3233651$TEVA$$28$YR$$M$Y$86$KG$20240822$$CN$DE$DE
242381771$24238177$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57782$$FDA-CTU$$89$YR$$M$N$83.46$KG$20240821$N$$US$
242381781$24238178$1$I$$20240821$20240821$20240821$DIR$715342$$FDA-CTU$$$$$M$N$$$20240821$Y$HP$US$
242381801$24238180$1$I$20240718$20240821$20240821$20240821$DIR$715354$$FDA-CTU$$48$YR$$F$N$105.4$KG$20240821$N$HP$US$
242381811$24238181$1$I$$20240821$20240821$20240821$DIR$715364$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242381821$24238182$1$I$20231216$20240820$20240822$20240822$EXP$ES-AEMPS-1471481$ES-UCBSA-2024042153$UCB$$61$YR$$M$Y$102$KG$20240822$$MD$ES$ES
242381831$24238183$1$I$$20240816$20240822$20240822$EXP$$GB-GSK-GB2024EME103013$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$GB$GB
242381843$24238184$3$F$$20240916$20240822$20240918$EXP$$CA-ROCHE-10000061856$ROCHE$$$$$F$Y$$$20240918$$CN$CA$CA
242381852$24238185$2$F$$20240905$20240822$20240913$EXP$$JP-OTSUKA-2024_022584$OTSUKA$Kamimura H, Arai H, Kuwabara H, Matsuo K. A case in which electroconvulsive therapy was performed for schizophrenia complicated by sick sinus syndrome and ventricular tachycardia. Psychiatria et Neurologia Japonica. 2024;00(special edit:1-O3-2$5$DEC$$M$Y$$$20240913$$MD$JP$JP
242381861$24238186$1$I$$20230228$20240822$20240822$EXP$$ZA-BIOVITRUM-2023-ZA-006138$BIOVITRUM$$$$I$M$Y$4.3$KG$20240822$$CN$ZA$ZA
242381871$24238187$1$I$$20240820$20240822$20240822$PER$$US-ROCHE-10000062283$ROCHE$$$$$F$Y$$$20240822$$HP$US$US
242381882$24238188$2$F$20240724$20240823$20240822$20240823$PER$$US-RC Outsourcing, LLC-2159949$RC OUTSOURCING, LLC, LOWELLVILLE, OH$$64$YR$$M$Y$$$20240823$$$US$US
242381892$24238189$2$F$20230101$20240823$20240822$20240826$EXP$$TW-009507513-2408TWN006844$MERCK$$63$YR$$M$Y$$$20240826$$MD$TW$TW
242381901$24238190$1$I$$20240811$20240822$20240822$EXP$$US-AMGEN-USASP2024164103$AMGEN$Costa P A.. SH2B3 mutation as a potential resistance mechanism to oncolytic virus therapy. Journal of Clinical Oncology. 2024;42 (16):2578$80$YR$E$F$Y$$$20240822$$HP$US$US
242381911$24238191$1$I$20240815$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165236$AMGEN$$67$YR$E$F$Y$$$20240822$$CN$US$US
242381921$24238192$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165191$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242381931$24238193$1$I$$20240814$20240822$20240822$EXP$$US-AMGEN-USASP2024164564$AMGEN$DiNardo C. D. Venetoclax in Combination with FLAG-IDA Chemotherapy (FLAG-V-I) for Fit, Relapsed/Refractory AML Patients: Interim Results of a Phase lb/2 Dose Escalation and Expansion Study. Blood. 2018;132 (Suppl-1)$$$$$Y$$$20240822$$MD$US$US
242381941$24238194$1$I$20240701$20240730$20240822$20240822$PER$$US-009507513-2408USA000072$MERCK$$62$YR$$M$Y$$$20240822$$CN$US$US
242381951$24238195$1$I$$20240814$20240822$20240822$EXP$$US-JNJFOC-20240855680$JOHNSON AND JOHNSON$$$$E$M$Y$99.2$KG$20240822$$MD$US$US
242381962$24238196$2$F$20240101$20240821$20240822$20240829$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00879$CATALYST PHARMA$$$$$M$Y$78.884$KG$20240829$$CN$US$US
242381971$24238197$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57818$$FDA-CTU$$47$YR$$F$N$$$20240821$N$$US$
242381981$24238198$1$I$20240601$20240821$20240821$20240821$DIR$715365$$FDA-CTU$$71$YR$$F$N$60.75$KG$20240821$Y$CN$US$
242381991$24238199$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57698$$FDA-CTU$$39$YR$$F$N$208$LBS$20240821$N$$US$
242382001$24238200$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57679$$FDA-CTU$$63$YR$$M$N$$$20240821$N$$US$
242382011$24238201$1$I$20240818$20240821$20240821$20240821$DIR$715369$$FDA-CTU$$70$YR$$F$N$69.75$KG$20240821$N$HP$US$
242382021$24238202$1$I$$20240819$20240822$20240822$PER$$US-HALEON-2192914$Haleon PLC$$58$YR$$M$Y$$$20240822$$HP$US$US
242382041$24238204$1$I$20230531$20240819$20240822$20240822$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-016738$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240822$$CN$CA$CA
242382051$24238205$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57691$$FDA-CTU$$33$YR$$F$N$$$20240821$N$$US$
242382072$24238207$2$F$20240729$20240923$20240822$20240928$PER$$US-RC Outsourcing, LLC-2159948$RC OUTSOURCING, LLC, LOWELLVILLE, OH$$$$$F$Y$$$20240928$$$US$US
242382081$24238208$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131914$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240822$$CN$US$US
242382091$24238209$1$I$$20240819$20240822$20240822$EXP$$NVSC2024CA168047$NOVARTIS$$$$$M$Y$$$20240822$$HP$CA$CA
242382101$24238210$1$I$$20240815$20240822$20240822$EXP$$JP-OTSUKA-2024_022663$OTSUKA$Seto H, Kinoshita Y, Handa M, Hino S, Noguchi S, Shigematsu J. A case of extravasation of rocuronium during electroconvulsive therapy in a hospital with a single department of psychiatry. Psychiatria et Neurologia Japonica. 2024;00(Special):1-P7-3$6$DEC$$M$Y$$$20240822$$MD$JP$JP
242382111$24238211$1$I$20240531$20240812$20240822$20240822$EXP$$FR-ABBVIE-5885857$ABBVIE$$61$YR$$F$Y$94$KG$20240822$$HP$FR$FR
242382121$24238212$1$I$$20230605$20240822$20240822$EXP$$US-AstraZeneca-2023A094428$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242382131$24238213$1$I$$20240814$20240822$20240822$EXP$$ZA-AstraZeneca-2024A187450$ASTRAZENECA$$73$YR$$F$Y$$$20240822$$CN$ZA$
242382141$24238214$1$I$$20230808$20240822$20240822$EXP$$US-AstraZeneca-2023A183650$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242382151$24238215$1$I$$20240807$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07927$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242382162$24238216$2$F$20180101$20240819$20240822$20240829$EXP$$US-ABBVIE-5886088$ABBVIE$$21$YR$$F$Y$$$20240829$$CN$US$US
242382171$24238217$1$I$20221101$20240816$20240822$20240822$EXP$FR-AFSSAPS-LM2024000449$FR-LUNDBECK-DKLU4003257$LUNDBECK$$$$$$Y$$$20240822$$MD$FR$FR
242382182$24238218$2$F$20240101$20240816$20240822$20240830$EXP$$FR-UCBSA-2024040783$UCB$$$$$$Y$$$20240830$$PH$FR$FR
242382192$24238219$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234488$TEVA$An Interesting Case of Drug-Induced Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Pulmonary and Renal Involvement. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).; Elsayed M. An Interesting Case of Drug-Induced Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Pulmonary and Renal Involvement. Am-J-Respir-Crit-Care-Med 2024; 209 (plus Poster).$75$YR$$M$Y$$$20240909$$HP$US$US
242382201$24238220$1$I$20240815$20240815$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011191$ELI LILLY AND CO$$31$YR$A$$Y$$$20240822$$CN$US$US
242382211$24238221$1$I$$20240805$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012424$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242382221$24238222$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013592$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242382231$24238223$1$I$20240624$20240812$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408007684$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240822$$CN$US$US
242382241$24238224$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013424$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240822$$MD$US$US
242382251$24238225$1$I$20240820$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012597$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240822$$CN$US$US
242382262$24238226$2$F$$20240912$20240822$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202408013428$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240917$$CN$US$US
242382271$24238227$1$I$20240820$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012622$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240822$$CN$US$US
242382281$24238228$1$I$20240819$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012691$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240822$$CN$US$US
242382291$24238229$1$I$20240801$20240821$20240822$20240822$EXP$NO-NOMAADVRE-PASRAPP-2024-V7rxq6$NO-GSK-NO2024104361$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$NO$NO
242382302$24238230$2$F$$20240911$20240822$20240911$EXP$$US-ALXN-202408USA000993US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
242382311$24238231$1$I$$20240819$20240822$20240822$PER$$US-ALXN-202408USA001129US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240822$$CN$US$US
242382321$24238232$1$I$$20240816$20240822$20240822$PER$$US-BIOGEN-2024BI01244252$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242382331$24238233$1$I$$20240816$20240822$20240822$PER$$US-BIOGEN-2024BI01275299$BIOGEN$$$$$M$Y$$$20240822$$CN$US$US
242382341$24238234$1$I$$20240815$20240822$20240822$PER$$US-BIOGEN-2020BI00897947$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242382351$24238235$1$I$$20240821$20240821$20240821$DIR$715367$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242382361$24238236$1$I$$20240816$20240822$20240822$PER$$US-BIOGEN-2020BI00911491$BIOGEN$$$$$M$Y$$$20240822$$CN$US$US
242382371$24238237$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57705$$FDA-CTU$$61$YR$$F$N$$$20240821$N$$US$
242382381$24238238$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57803$$FDA-CTU$$56$YR$$F$N$$$20240821$N$$US$
242382391$24238239$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57731$$FDA-CTU$$68$YR$$F$N$262$LBS$20240821$N$$US$
242382401$24238240$1$I$20240101$20240815$20240822$20240822$EXP$$DE-ROCHE-10000059316$ROCHE$$58$YR$A$F$Y$58$KG$20240822$$MD$DE$DE
242382411$24238241$1$I$$20240816$20240822$20240822$EXP$$US-OTSUKA-2024_022712$OTSUKA$$$$$F$Y$$$20240822$$CN$US$US
242382421$24238242$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57707$$FDA-CTU$$70$YR$$M$N$350$LBS$20240821$N$$US$
242382431$24238243$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57686$$FDA-CTU$$54$YR$$M$N$$$20240821$N$HP$US$
242382441$24238244$1$I$20240709$20240821$20240821$20240821$DIR$715309$$FDA-CTU$$54$YR$$F$N$60.75$KG$20240821$N$CN$US$
242382451$24238245$1$I$$20240819$20240822$20240822$EXP$$NVSC2024BR169649$NOVARTIS$$10$MON$$$Y$$$20240822$$MD$BR$BR
242382461$24238246$1$I$$20240815$20240822$20240822$EXP$$CA-MYLANLABS-2024M1076426$MYLAN$$62$YR$$F$Y$$$20240822$$MD$CA$CA
242382471$24238247$1$I$$20240819$20240822$20240822$PER$$US-ABBVIE-5887162$ABBVIE$$$$$M$Y$$$20240822$$HP$US$US
242382481$24238248$1$I$$20240807$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08034$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242382502$24238250$2$F$20240813$20240830$20240822$20240904$30DAY$$US-AMGEN-USASP2024161301$AMGEN$$66$YR$E$F$Y$88.889$KG$20240904$$HP$US$US
242382511$24238251$1$I$$20240821$20240822$20240822$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047230$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240822$$MD$US$US
242382521$24238252$1$I$$20240815$20240822$20240822$PER$$US-LEO Pharma-372846$LEO PHARM$$50$YR$$M$Y$$$20240822$$CN$US$US
242382531$24238253$1$I$$20240816$20240822$20240822$EXP$$US-OTSUKA-2024_022802$OTSUKA$$$$$M$Y$$$20240822$$HP$US$US
242382541$24238254$1$I$$20240814$20240822$20240822$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006043$BIOCON$$$$$$Y$$$20240822$$MD$CA$CA
242382552$24238255$2$F$20240821$20240925$20240822$20240927$EXP$$JP-PFIZER INC-202400240578$PFIZER$$56$YR$$M$Y$85$KG$20240927$$PH$JP$JP
242382561$24238256$1$I$$20240809$20240822$20240822$EXP$$IL-PFIZER INC-202400241383$PFIZER$$61$YR$$M$Y$$$20240822$$MD$IL$IL
242382571$24238257$1$I$$20240821$20240822$20240822$PER$$US-ROCHE-10000063008$ROCHE$$$$$$Y$$$20240822$$MD$US$US
242382581$24238258$1$I$20240810$20240812$20240822$20240822$PER$$US-TEVA-VS-3233127$TEVA$$78$YR$$F$Y$$$20240822$$PH$US$US
242382592$24238259$2$F$$20240919$20240822$20240923$30DAY$$FR-JNJFOC-20240850103$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$PH$FR$FR
242382601$24238260$1$I$$20240821$20240822$20240822$EXP$GB-MHRA-MED-202408211022345950-CSDPH$GB-JNJFOC-20240853803$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$PH$GB$GB
242382611$24238261$1$I$20240101$20240820$20240822$20240822$EXP$$US-ABBVIE-5888412$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242382621$24238262$1$I$20240101$20240814$20240822$20240822$EXP$$CA-CELLTRION INC.-2024CA012870$CELLTRION$$$$$$Y$$$20240822$$HP$CA$CA
242382631$24238263$1$I$20240802$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164665$AMGEN$$78$YR$E$F$Y$$$20240822$$CN$US$US
242382641$24238264$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130472$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240822$$CN$US$US
242382651$24238265$1$I$20231124$20240820$20240822$20240822$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-131065$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$35$KG$20240822$$PH$JP$JP
242382661$24238266$1$I$$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132692$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240822$$CN$US$US
242382671$24238267$1$I$$20240528$20240822$20240822$PER$$US-CHIESI-2024CHF03266$CHIESI$$$$$M$Y$$$20240822$$MD$US$US
242382681$24238268$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57704$$FDA-CTU$$89$YR$$M$N$184$LBS$20240821$N$$US$
242382691$24238269$1$I$20240705$20240821$20240821$20240821$DIR$715311$$FDA-CTU$$83$YR$$F$N$80.55$KG$20240821$N$CN$US$
242382711$24238271$1$I$$20240821$20240821$20240821$DIR$715374$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242382741$24238274$1$I$$20240821$20240821$20240821$DIR$715379$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242382751$24238275$1$I$20240821$20240821$20240821$20240821$DIR$715377$$FDA-CTU$$83$YR$$F$N$$$20240821$N$HP$US$
242382761$24238276$1$I$$20240821$20240821$20240821$DIR$715375$$FDA-CTU$$$$$M$N$$$20240821$N$HP$US$
242382771$24238277$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57788$$FDA-CTU$$65$YR$$F$N$$$20240821$N$$US$
242382781$24238278$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57792$$FDA-CTU$$63$YR$$F$N$$$20240821$N$$US$
242382792$24238279$2$F$$20240830$20240822$20240903$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013057$JAZZ$$30$YR$$F$Y$35.5$KG$20240903$$CN$US$US
242382811$24238281$1$I$$20240819$20240822$20240822$PER$$US-LEO Pharma-372879$LEO PHARM$$$$$M$Y$$$20240822$$CN$US$US
242382821$24238282$1$I$$20240807$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07926$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242382831$24238283$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5886337$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242382841$24238284$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5885913$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242382852$24238285$2$F$$20240825$20240822$20240828$PER$$US-PFIZER INC-202400239474$PFIZER$$$$$M$Y$$$20240828$$MD$US$US
242382862$24238286$2$F$$20240921$20240822$20240923$PER$$US-PFIZER INC-202400240389$PFIZER$$71$YR$$M$Y$$$20240923$$CN$US$US
242382872$24238287$2$F$$20240904$20240822$20240904$PER$$US-PFIZER INC-202400240086$PFIZER$$49$YR$$F$Y$$$20240904$$HP$US$US
242382881$24238288$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-PV202400108726$PFIZER$$74$YR$$F$Y$$$20240822$$CN$US$US
242382891$24238289$1$I$20240711$20240816$20240822$20240822$EXP$ES-AEMPS-1560026$ES-ROCHE-10000059172$ROCHE$$58$YR$A$F$Y$$$20240822$$HP$ES$ES
242382902$24238290$2$F$$20240822$20240822$20240826$30DAY$$US-SANDOZ INC.-SDZ2024US074544$SANDOZ$$$$$M$Y$$$20240826$$HP$US$US
242382911$24238291$1$I$$20240821$20240822$20240822$30DAY$$US-SANDOZ INC.-SDZ2024US074469$SANDOZ$$$$$$Y$$$20240822$$CN$US$US
242382922$24238292$2$F$$20240906$20240822$20240906$PER$$US-ALXN-202408USA001115US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242382931$24238293$1$I$$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57724$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242382941$24238294$1$I$20240805$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57709$$FDA-CTU$$69$YR$$M$N$$$20240820$N$$US$
242382951$24238295$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024AMR101887$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242382962$24238296$2$F$$20240830$20240822$20240903$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013056$JAZZ$$31$YR$$F$Y$90$KG$20240903$$CN$US$US
242382971$24238297$1$I$20240726$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57694$$FDA-CTU$$83$YR$$F$N$$$20240821$N$HP$US$
242382981$24238298$1$I$$20240805$20240822$20240822$PER$$US-TEVA-VS-3231146$TEVA$$$$$$Y$$$20240822$$CN$US$US
242382991$24238299$1$I$20240527$20240813$20240822$20240822$EXP$FR-AFSSAPS-LM2024000438$FR-TEVA-VS-3233812$TEVA$$49$YR$$F$Y$75$KG$20240822$$MD$FR$FR
242383001$24238300$1$I$20240805$20240814$20240822$20240822$EXP$$SG-VANTIVE-2024VAN019068$Vantive US Healthcare$$63$YR$$F$Y$$$20240822$$CN$SG$SG
242383011$24238301$1$I$$20240816$20240822$20240822$EXP$$US-VANTIVE-2024VAN019105$Vantive US Healthcare$$78$YR$$F$Y$$$20240822$$HP$US$US
242383021$24238302$1$I$$20240816$20240822$20240822$EXP$$CN-VANTIVE-2024VAN019125$Vantive US Healthcare$$$$$M$Y$$$20240822$$CN$CN$CN
242383031$24238303$1$I$20240807$20240814$20240822$20240822$EXP$$SG-VANTIVE-2024VAN019064$Vantive US Healthcare$$68$YR$$M$Y$$$20240822$$CN$SG$SG
242383041$24238304$1$I$20240514$20240817$20240822$20240822$EXP$$CO-VANTIVE-2024VAN019106$Vantive US Healthcare$$79$YR$$F$Y$41$KG$20240822$$HP$CO$CO
242383052$24238305$2$F$20221206$20240912$20240822$20240923$EXP$$JP-ROCHE-3327694$ROCHE$$70$YR$E$M$Y$57$KG$20240923$$MD$JP$JP
242383061$24238306$1$I$20240816$20240816$20240822$20240822$EXP$$US-VANTIVE-2024VAN019122$Vantive US Healthcare$$$$$M$Y$$$20240822$$HP$US$US
242383071$24238307$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165072$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242383082$24238308$2$F$20240819$20240830$20240822$20240903$PER$$US-AMGEN-USASP2024165844$AMGEN$$71$YR$E$F$Y$$$20240903$$CN$US$US
242383091$24238309$1$I$$20240710$20240822$20240822$PER$$US-LUNDBECK-DKLU4001524$LUNDBECK$$$$$$Y$$$20240822$$HP$US$US
242383101$24238310$1$I$$20240812$20240822$20240822$EXP$$FR-ROCHE-10000055462$ROCHE$Adhoute X, Gonzalez A, Levi-Strauss T, Mineur L, Penaranda G, Sellier F, et al. Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life study. European journal of gastroenterology + hepatology. 2024-Jul-26;1-11. doi:10.1097/MEG.0000000000002830.$$$$$Y$$$20240822$$MD$FR$FR
242383111$24238311$1$I$20240801$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024163799$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
242383121$24238312$1$I$20240805$20240819$20240822$20240822$PER$$US-JNJFOC-20240850237$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20240822$$CN$US$US
242383141$24238314$1$I$$20240812$20240822$20240822$EXP$$US-TEVA-VS-3235195$TEVA$$52$YR$$F$Y$$$20240822$$CN$US$US
242383151$24238315$1$I$$20240816$20240822$20240822$EXP$$US-ORGANON-O2408USA001330$ORGANON$$$$$F$Y$$$20240822$$CN$US$US
242383171$24238317$1$I$20180101$20240821$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA074335$SANDOZ$$29$YR$$M$Y$89$KG$20240822$$MD$CA$CA
242383181$24238318$1$I$20240801$20240819$20240822$20240822$PER$$JP-Eisai-EC-2024-172511$EISAI$$73$YR$E$F$Y$$$20240822$$PH$JP$JP
242383191$24238319$1$I$20240501$20240820$20240822$20240822$EXP$$AU-SANDOZ INC.-SDZ2024AU073972$SANDOZ$$58$YR$$M$Y$$$20240822$$CN$AU$AU
242383201$24238320$1$I$$20240808$20240822$20240822$PER$$US-Calliditas-2024CAL01526$CALLIDITAS THERAPEUTICS$$50$YR$A$M$Y$108$KG$20240822$$CN$US$US
242383211$24238321$1$I$$20240819$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013055$JAZZ$$5$YR$$M$Y$20.4$KG$20240822$$CN$US$US
242383221$24238322$1$I$20240101$20240820$20240822$20240822$EXP$FR-AFSSAPS-LY2024001204$FR-UCBSA-2024042108$UCB$$60$YR$$M$Y$58.8$KG$20240822$$PH$FR$FR
242383231$24238323$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131232$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240822$$HP$US$US
242383242$24238324$2$F$$20240821$20240822$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132113$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240826$$CN$US$US
242383251$24238325$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012282$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240822$$CN$US$US
242383261$24238326$1$I$$20240820$20240822$20240822$EXP$$IT-UCBSA-2024042008$UCB$Lugli AP, Caldarola G, Falco GM, Montedoro C, Mulas C, De Simone C. Anti-IL-17 monoclonal antibodies and bullous pemphigoid: treatment or causal agents? A case series and review of the literature. Drugs in Context. 2024;13:1-6$68$YR$$F$Y$$$20240822$$HP$IT$IT
242383272$24238327$2$F$$20240912$20240822$20240915$EXP$$JP-ALXN-202408JPN000831JP$ALEXION PHARMACEUTICALS$$60$YR$$M$Y$$$20240915$$MD$JP$JP
242383281$24238328$1$I$$20240819$20240822$20240822$EXP$$GB-MYLANLABS-2024M1062916$MYLAN$$$$$M$Y$$$20240822$$MD$GB$GB
242383291$24238329$1$I$20141001$20240813$20240822$20240822$EXP$$ES-BIOCON BIOLOGICS LIMITED-BBL2024005960$BIOCON$Ruiz De Morales. J, Munoz. F, Hernando. M.. Successful treatment of common variable immunodeficiency-associated inflammatory bowel disease with Ustekinumab.. Journal of Crohns and Colitis.. 2017;11(9):1154-1155$$$$$Y$$$20240822$$MD$ES$ES
242383311$24238331$1$I$20240101$20240806$20240822$20240822$PER$$US-JNJFOC-20240849552$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$CN$US$US
242383322$24238332$2$F$$20240828$20240822$20240830$EXP$$NVSC2024CA090192$NOVARTIS$Aljohani A, Solomon J, Joury A, Cecere R, Giannetti N. Recurrent giant cell myocarditis followingorthotopic heart transplant resulting in urgentredo orthotopic heart transplantation: a case report. EUROPEAN HEART JOURNAL CASE REPORTS. 2023;7 (12):1-6$51$YR$$M$Y$$$20240830$$HP$CA$CA
242383331$24238333$1$I$$20240819$20240822$20240822$PER$$US-ABBVIE-5886829$ABBVIE$$$$$M$Y$$$20240822$$MD$US$US
242383341$24238334$1$I$$20240819$20240822$20240822$EXP$$US-OTSUKA-2024_022865$OTSUKA$$$$$M$Y$$$20240822$$HP$US$US
242383351$24238335$1$I$20240813$20240814$20240822$20240822$EXP$$US-SA-2024SA243960$SANOFI AVENTIS$$81$YR$E$F$Y$65.306$KG$20240822$$MD$US$US
242383361$24238336$1$I$20240816$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024167497$AMGEN$$$$$$Y$$$20240822$$CN$US$US
242383372$24238337$2$F$$20240913$20240822$20240919$PER$$US-AMGEN-USASP2024165504$AMGEN$$$$A$F$Y$$$20240918$$CN$US$US
242383381$24238338$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131944$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240822$$HP$US$US
242383392$24238339$2$F$20240815$20240905$20240822$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130692$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$61.2$KG$20240911$$CN$US$US
242383401$24238340$1$I$$20240709$20240822$20240822$PER$$US-SCIEGENP-2024SCSPO00355$SCIEGEN$$$$$$Y$$$20240822$$CN$US$US
242383441$24238344$1$I$$20240816$20240822$20240822$EXP$$US-TAKEDA-2024TUS082777$TAKEDA$$$$$M$Y$$$20240822$$CN$US$US
242383451$24238345$1$I$20240731$20240816$20240822$20240822$EXP$FR-AFSSAPS-MP2024001277$FR-SA-2024SA244213$SANOFI AVENTIS$$70$YR$E$F$Y$75.6$KG$20240822$$MD$FR$FR
242383461$24238346$1$I$20240501$20240814$20240822$20240822$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006488$AURINIA PHARMACEUTICALS$$38$YR$$F$Y$$$20240822$$MD$US$US
242383471$24238347$1$I$20240101$20240816$20240822$20240822$EXP$$US-TAKEDA-2023TUS075517$TAKEDA$$73$YR$$M$Y$$$20240822$$MD$US$US
242383481$24238348$1$I$$20240809$20240822$20240822$PER$$US-TRAVERE-2024TVT00792$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242383491$24238349$1$I$$20240809$20240822$20240822$PER$$US-TRAVERE-2024TVT00797$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
242383501$24238350$1$I$20230901$20240816$20240822$20240822$EXP$$CO-SA-2024SA249782$SANOFI AVENTIS$$44$YR$A$F$Y$58$KG$20240822$$HP$CO$CO
242383512$24238351$2$F$20240801$20240812$20240822$20240826$PER$$US-JNJFOC-20240831740$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240826$$CN$US$US
242383521$24238352$1$I$$20240819$20240822$20240822$EXP$$US-JNJFOC-20240848912$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$CN$US$US
242383531$24238353$1$I$$20240816$20240822$20240822$EXP$$US-ORGANON-O2408USA001413$ORGANON$$$$I$$Y$$$20240822$$CN$US$US
242383541$24238354$1$I$20240603$20240814$20240822$20240822$EXP$$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-07850$HIKMA$$74$YR$$F$Y$$$20240822$$MD$IT$IT
242383551$24238355$1$I$$20240730$20240822$20240822$PER$$US-Eisai-EC-2024-171154$EISAI$$$$$F$Y$$$20240822$$CN$US$US
242383572$24238357$2$F$$20240816$20240822$20240903$EXP$$US-ORGANON-O2408USA001465$ORGANON$$$$$$Y$$$20240903$$CN$US$US
242383581$24238358$1$I$20240722$20240819$20240822$20240822$EXP$$US-OTSUKA-2024_022978$OTSUKA$$69$YR$$F$Y$54.88$KG$20240822$$CN$US$US
242383591$24238359$1$I$$20240820$20240822$20240822$EXP$$NVSC2024CA168940$NOVARTIS$$41$YR$$F$Y$$$20240822$$PH$CA$CA
242383601$24238360$1$I$$20240820$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013184$JAZZ$$$$$F$Y$$$20240822$$CN$US$US
242383611$24238361$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132297$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240822$$CN$US$US
242383621$24238362$1$I$20240817$20240817$20240822$20240822$PER$$US-AMGEN-USASP2024165325$AMGEN$$81$YR$E$F$Y$$$20240822$$CN$US$US
242383631$24238363$1$I$20240818$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165393$AMGEN$$75$YR$E$F$Y$$$20240822$$CN$US$US
242383641$24238364$1$I$$20240819$20240822$20240822$EXP$$GB-ABBVIE-5888253$ABBVIE$$$$A$M$Y$$$20240822$$CN$GB$GB
242383651$24238365$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A185868$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242383661$24238366$1$I$$20240820$20240822$20240822$EXP$$US-OTSUKA-2024_022960$OTSUKA$$$$$M$Y$$$20240822$$CN$US$US
242383671$24238367$1$I$$20240808$20240822$20240822$PER$$US-AstraZeneca-2024A180988$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242383681$24238368$1$I$$20240814$20240822$20240822$EXP$$ZA-AstraZeneca-2024A185511$ASTRAZENECA$$80$YR$$F$Y$$$20240822$$CN$ZA$
242383691$24238369$1$I$20240806$20240816$20240822$20240822$EXP$DE-CADRBFARM-2024329826$DE-SA-2024SA247734$SANOFI AVENTIS$$38$YR$A$F$Y$60$KG$20240822$$CN$DE$DE
242383701$24238370$1$I$$20240816$20240822$20240822$EXP$$FR-MYLANLABS-2024M1076657$MYLAN$Chanut M, Bonny V, Joly A, Ait-Oufella H, Maury E, Ederhy S, et al.. Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology. Archives of cardiovascular diseases. 2024;117(4):297-300$67$YR$$M$Y$$$20240822$$HP$FR$FR
242383711$24238371$1$I$20240226$20240816$20240822$20240822$EXP$$ES-MYLANLABS-2024M1076713$MYLAN$$4$DEC$$F$Y$67$KG$20240822$$MD$ES$ES
242383722$24238372$2$F$20240301$20240829$20240822$20240903$EXP$$FR-MYLANLABS-2024M1076647$MYLAN$Fidan I, Delamotte E, Colombier M, et al.. Non-surgical Treatment of Severe Drug-Influenced Gingival Enlargement: A Report of Two Cases. Cureus. 2024;16(6):e63214$58$YR$$M$Y$$$20240903$$HP$FR$FR
242383731$24238373$1$I$$20240816$20240822$20240822$EXP$$FR-MYLANLABS-2021M1074254$MYLAN$Lelievre J,Sacre K,Adle-Biassette H,et al.. Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporin therapy for psoriasis: a case of spontaneous regression.. J Am Acad Dermatol.. 2005;52(2):S24-S27$52$YR$$M$Y$$$20240822$$HP$FR$FR
242383741$24238374$1$I$$20240819$20240822$20240822$PER$$US-ALXN-202408USA001142US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240822$$HP$US$US
242383751$24238375$1$I$20240618$20240814$20240822$20240822$EXP$$IT-ALXN-202406EEA001319IT$ALEXION PHARMACEUTICALS$$41$YR$$F$Y$67$KG$20240822$$MD$IT$IT
242383761$24238376$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA249104$SANOFI AVENTIS$$$$E$M$Y$108.63$KG$20240822$$MD$US$US
242383771$24238377$1$I$$20240807$20240822$20240822$EXP$$US-GRANULES-US-2024GRALIT00350$GRANULES INDIA$M. Fortic.Meth, PCP or Both? A Case of Diffuse Alveolar Hemorrhage in the Setting of Combined Amphetamine and Phencyclidine Use.American Journal of Respiratory and Critical Care Medicine.2024;209:A5572$37$YR$A$M$Y$$$20240822$$HP$US$US
242383781$24238378$1$I$20240801$20240820$20240822$20240822$EXP$$US-OTSUKA-2024_022973$OTSUKA$$66$YR$$M$Y$$$20240822$$CN$US$US
242383791$24238379$1$I$20231201$20240819$20240822$20240822$EXP$$US-SA-2024SA249208$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240822$$MD$US$US
242383801$24238380$1$I$20240810$20240821$20240822$20240822$EXP$$US-INCYTE CORPORATION-2024IN008754$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242383831$24238383$1$I$20240819$20240820$20240822$20240822$DIR$FDA-CDER-CTU-2024-57868$$FDA-CTU$$82$YR$$F$N$$$20240820$N$HP$US$
242383841$24238384$1$I$20240806$20240821$20240822$20240822$EXP$$TW-PFIZER INC-PV202400109224$PFIZER$$$$A$F$Y$$$20240822$$HP$TW$TW
242383851$24238385$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57845$$FDA-CTU$$80$YR$$M$N$$$20240822$N$$US$
242383861$24238386$1$I$20240801$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57878$$FDA-CTU$$83$YR$$M$N$$$20240821$N$HP$US$
242383871$24238387$1$I$$20240817$20240822$20240822$EXP$$IN-PFIZER INC-PV202400108482$PFIZER$$40$YR$$M$Y$$$20240822$$CN$IN$IN
242383882$24238388$2$F$20240517$20240821$20240822$20240826$EXP$$HK-PFIZER INC-202400239775$PFIZER$$$$$M$Y$$$20240826$$MD$HK$HK
242383891$24238389$1$I$$20240814$20240822$20240822$EXP$$BR-PFIZER INC-202400240889$PFIZER$$$$$$Y$$$20240822$$MD$BR$BR
242383901$24238390$1$I$$20240821$20240822$20240822$EXP$$US-SA-2024SA249401$SANOFI AVENTIS$$$$$F$Y$$$20240822$$HP$US$US
242383911$24238391$1$I$20240806$20240816$20240822$20240822$EXP$IT-MINISAL02-998639$IT-MYLANLABS-2024M1076607$MYLAN$$77$YR$$M$Y$$$20240822$$MD$IT$IT
242383921$24238392$1$I$20240802$20240802$20240822$20240822$PER$$US-JNJFOC-20240809310$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240822$$CN$US$US
242383941$24238394$1$I$20240808$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57718$$FDA-CTU$$63$YR$$M$N$7.5$KG$20240821$N$$US$
242383971$24238397$1$I$$20240710$20240822$20240822$PER$$US-LUNDBECK-DKLU4001614$LUNDBECK$$$$$$Y$$$20240822$$HP$US$US
242383982$24238398$2$F$20240701$20240912$20240822$20240918$EXP$$US-BAYER-2024A117628$BAYER$$$$$F$Y$$$20240918$$CN$US$US
242383991$24238399$1$I$$20240807$20240822$20240822$EXP$$US-GRANULES-US-2024GRALIT00354$GRANULES INDIA$Sam Beavin.Mind the Gap: Pyroglutamic Acidosis as a Not-so-Rare Cause of High Anion Gap Metabolic Acidosis (HAGMA).Journal of the American Society of Nephrology.NOV-2023;34:TH-PO396$39$YR$A$M$Y$$$20240822$$HP$US$US
242384001$24238400$1$I$$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132480$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240822$$CN$US$US
242384012$24238401$2$F$$20240819$20240822$20240828$EXP$$CA-SANDOZ INC.-NVSC2021CA084539$SANDOZ$$$$$M$Y$$$20240828$$CN$CA$CA
242384022$24238402$2$F$20230101$20240809$20240822$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-114668$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$75.39$KG$20240823$$CN$US$US
242384031$24238403$1$I$$20240815$20240822$20240822$EXP$$US-009507513-2408USA007505$MERCK$Mazloom A, Asturias JA, Manan H, Prodduturvar P.. Investigation of cardiotoxicity with concomitant use of anthracyclines and checkpoint inhibitors. Journal of Clinical Oncology. 2024;42(16):e24022$$$$F$Y$$$20240822$$HP$US$US
242384041$24238404$1$I$$20240710$20240822$20240822$PER$$US-LUNDBECK-DKLU4001522$LUNDBECK$$$$$$Y$$$20240822$$HP$US$US
242384052$24238405$2$F$$20240911$20240822$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202408012685$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240917$$CN$US$US
242384063$24238406$3$F$20240801$20240821$20240822$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408012643$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240828$$CN$US$US
242384071$24238407$1$I$20240817$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011649$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240822$$CN$US$US
242384081$24238408$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012630$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240822$$CN$US$US
242384091$24238409$1$I$20240819$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011901$ELI LILLY AND CO$$$$A$F$Y$$$20240822$$CN$US$US
242384102$24238410$2$F$$20240904$20240822$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202408013430$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240916$$CN$US$US
242384111$24238411$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011728$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240822$$CN$US$US
242384121$24238412$1$I$20240805$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013395$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240822$$CN$US$US
242384131$24238413$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012700$ELI LILLY AND CO$$73$YR$E$$Y$$$20240822$$CN$US$US
242384141$24238414$1$I$$20240820$20240822$20240822$PER$$US-HALEON-2193050$Haleon PLC$$$$$$Y$$$20240822$$CN$US$US
242384151$24238415$1$I$$20240807$20240822$20240822$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07987$LUPIN$$$$$$Y$$$20240822$$CN$US$US
242384161$24238416$1$I$$20240821$20240821$20240821$DIR$715382$$FDA-CTU$$$$$UNK$N$$$20240821$$CN$US$
242384171$24238417$1$I$20240101$20240820$20240822$20240822$EXP$$US-JNJFOC-20240854825$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240822$$HP$US$US
242384181$24238418$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57864$$FDA-CTU$$69$YR$$F$N$167$LBS$20240822$N$$US$
242384192$24238419$2$F$$20240913$20240822$20240924$30DAY$$BE-JNJFOC-20240849979$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$BE$BE
242384201$24238420$1$I$20231028$20231102$20240822$20240822$DIR$FDA-CDER-CTU-2024-57716$$FDA-CTU$$15$YR$$F$N$96.3$KG$20231102$N$$US$
242384222$24238422$2$F$$20240829$20240822$20240903$EXP$$US-AMGEN-USASP2024164410$AMGEN$$$$A$M$Y$$$20240902$$HP$US$US
242384232$24238423$2$F$$20240822$20240822$20240823$PER$$US-AMGEN-USASP2024167087$AMGEN$$$$$$Y$$$20240823$$HP$US$US
242384241$24238424$1$I$$20240821$20240821$20240821$DIR$715380$$FDA-CTU$$$$$UNK$N$$$20240821$$CN$US$
242384251$24238425$1$I$$20240821$20240821$20240821$DIR$715381$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242384261$24238426$1$I$20240808$20240819$20240822$20240822$EXP$$CN-PFIZER INC-PV202400108007$PFIZER$$64$YR$$F$Y$49$KG$20240822$$HP$CN$CN
242384271$24238427$1$I$$20240821$20240821$20240821$DIR$715383$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242384291$24238429$1$I$20240711$20240814$20240822$20240822$EXP$$CN-009507513-2408CHN005861$MERCK$$61$YR$$F$Y$65$KG$20240822$$HP$CN$CN
242384301$24238430$1$I$$20240814$20240822$20240822$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006036$BIOCON$$$$$$Y$$$20240822$$CN$CA$CA
242384311$24238431$1$I$$20240820$20240822$20240822$EXP$ES-EMA-DD-20240516-7482831-105236$ES-MYLANLABS-2024M1047305$MYLAN$Pedro Molto-Balado, Roxana Revert?-Gil.. Aripiprazole: beware of pathological gambling addiction.. Biological psychiatry. 2024;31 (1):100440 (1-2)$32$YR$$M$Y$$$20240822$$MD$ES$ES
242384321$24238432$1$I$$20240821$20240822$20240822$EXP$$CA-MYLANLABS-2024M1077665$MYLAN$$50$YR$$M$Y$81$KG$20240822$$CN$CA$CA
242384331$24238433$1$I$$20240805$20240822$20240822$PER$$US-TEVA-VS-3230439$TEVA$$55$YR$$M$Y$$$20240822$$PH$US$US
242384341$24238434$1$I$$20240815$20240822$20240822$PER$$US-009507513-2408USA005766$MERCK$Mazloom A, Asturias JA, Manan H, Prodduturvar P.. Investigation of cardiotoxicity with concomitant use of anthracyclines and checkpoint inhibitors. Journal of Clinical Oncology. 2024;42(16):e24022$$$$F$Y$$$20240822$$HP$US$US
242384351$24238435$1$I$$20240509$20240822$20240822$PER$$US-CHIESI-2024CHF02722$CHIESI$$$$$M$Y$$$20240822$$CN$US$US
242384361$24238436$1$I$$20240807$20240822$20240822$EXP$$US-GRANULES-US-2024GRALIT00364$GRANULES INDIA$Khaled Alsabbagh Alchirazi.Molecular Adsorbent Recirculating System in Acute Liver Failure.ACG Case Reports Journal.JUL-2024;11:1-3$44$YR$A$M$Y$$$20240822$$MD$US$US
242384371$24238437$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A185927$ASTRAZENECA$$$$$$Y$$$20240822$$CN$US$
242384381$24238438$1$I$20240106$20240619$20240822$20240822$PER$$US-CHIESI-2024CHF02819$CHIESI$$43$YR$$M$Y$$$20240822$$CN$US$US
242384391$24238439$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A187114$ASTRAZENECA$$$$$F$Y$$$20240822$$MD$US$
242384403$24238440$3$F$20240616$20240620$20240822$20240822$PER$$US-Dermavant-001217$DERMAVANT SCIENCES$$66$YR$$F$Y$$$20240820$$CN$US$US
242384412$24238441$2$F$$20240827$20240822$20240916$PER$$CA-TOLMAR, INC.-24CA051099$TOLMAR$$$$$M$Y$$$20240916$$MD$CA$CA
242384421$24238442$1$I$$20240730$20240822$20240822$PER$$CA-TOLMAR, INC.-24CA051048$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242384431$24238443$1$I$$20240730$20240822$20240822$PER$$CA-TOLMAR, INC.-24CA051142$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242384441$24238444$1$I$20240101$20240730$20240822$20240822$PER$$CA-TOLMAR, INC.-24CA051163$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242384451$24238445$1$I$20140101$20240819$20240822$20240822$EXP$AU-TGA-0000814677$AU-SANDOZ INC.-SDZ2024AU073794$SANDOZ$$68$YR$$M$Y$$$20240822$$HP$AU$AU
242384461$24238446$1$I$20240723$20240730$20240822$20240822$PER$$CA-TOLMAR, INC.-24CA051212$TOLMAR$$86$YR$$M$Y$$$20240822$$CN$CA$CA
242384471$24238447$1$I$$20240730$20240822$20240822$PER$$CA-TOLMAR, INC.-24CA051432$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242384491$24238449$1$I$20240501$20240730$20240822$20240822$PER$$CA-TOLMAR, INC.-24CA051481$TOLMAR$$68$YR$$M$Y$$$20240822$$CN$CA$CA
242384501$24238450$1$I$$20240730$20240822$20240822$PER$$CA-TOLMAR, INC.-24CA051475$TOLMAR$$74$YR$$M$Y$$$20240822$$CN$CA$CA
242384511$24238451$1$I$20240101$20240730$20240822$20240822$PER$$CA-TOLMAR, INC.-24CA051483$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242384521$24238452$1$I$20240730$20240730$20240822$20240822$PER$$CA-TOLMAR, INC.-24CA051488$TOLMAR$$66$YR$$M$Y$$$20240822$$CN$CA$CA
242384531$24238453$1$I$20240730$20240730$20240822$20240822$PER$$CA-TOLMAR, INC.-24CA051490$TOLMAR$$78$YR$$M$Y$$$20240822$$CN$CA$CA
242384541$24238454$1$I$$20240730$20240822$20240822$PER$$CA-TOLMAR, INC.-24CA051491$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242384551$24238455$1$I$$20240730$20240822$20240822$PER$$CA-TOLMAR, INC.-24CA051492$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242384564$24238456$4$F$$20240529$20240822$20240822$PER$$US-Dermavant-001191$DERMAVANT SCIENCES$$$$$F$Y$$$20240820$$CN$US$US
242384571$24238457$1$I$$20240812$20240822$20240822$PER$$US-TRAVERE-2024TVT00796$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
242384581$24238458$1$I$$20240812$20240822$20240822$EXP$$DE-TEVA-VS-3234239$TEVA$Bingert R, Kolbe V, Boy D, Buttner A. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. [German]. Rechtsmedizin 2023; 33 (5): 396-402.$17$YR$$F$Y$$$20240822$$HP$DE$DE
242384591$24238459$1$I$$20240814$20240822$20240822$PER$$US-RDY-SPO/USA/24/0011964$DR REDDYS$$22$YR$A$F$Y$$$20240822$$HP$US$US
242384601$24238460$1$I$$20240813$20240822$20240822$EXP$$IN-ROCHE-10000056784$ROCHE$$61$YR$A$M$Y$$$20240822$$MD$IN$IN
242384611$24238461$1$I$$20240821$20240821$20240821$DIR$715385$$FDA-CTU$$$$$UNK$N$$$20240821$$CN$US$
242384621$24238462$1$I$20240820$20240821$20240821$20240821$DIR$715388$$FDA-CTU$$57$YR$$F$N$87.75$KG$20240821$N$$US$
242384641$24238464$1$I$$20240821$20240821$20240821$DIR$715395$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242384651$24238465$1$I$$20240821$20240821$20240821$DIR$715396$$FDA-CTU$$$$$UNK$N$$$20240821$N$CN$US$
242384661$24238466$1$I$20231228$20240821$20240821$20240821$DIR$715390$$FDA-CTU$$74$YR$$F$N$56.25$KG$20240821$N$CN$US$
242384671$24238467$1$I$20240714$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57826$$FDA-CTU$$83$YR$$M$N$55.1$KG$20240821$N$$US$
242384681$24238468$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57891$$FDA-CTU$$73$YR$$F$N$$$20240822$N$$US$
242384691$24238469$1$I$$20240807$20240822$20240822$EXP$$US-GRANULES-US-2024GRALIT00358$GRANULES INDIA$D Gaur.Acetaminophen induced high anion gap metabolic acidosis: a potentially under-recognized consequence from a common medication.Pediatric Nephrology.JUL-2024$12$YR$C$F$Y$$$20240822$$HP$US$US
242384711$24238471$1$I$20240806$20240808$20240822$20240822$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002276$CORCEPT$$$$$$Y$$$20240822$$HP$US$US
242384721$24238472$1$I$$20240819$20240822$20240822$EXP$$AU-ABBVIE-5888601$ABBVIE$$$$$$Y$$$20240822$$MD$AU$AU
242384731$24238473$1$I$$20240815$20240822$20240822$EXP$$US-AMGEN-USASP2024164376$AMGEN$Helis C A.; Zarabi H.; Russell G. et al.. Multi-institutional study of reirradiation for recurrent high grade glioma. Journal of Clinical Oncology. 2024;42 (16):1-4$$$$$Y$$$20240822$$HP$US$US
242384741$24238474$1$I$$20240819$20240822$20240822$PER$$US-ABBVIE-5888091$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242384752$24238475$2$F$20240818$20240923$20240822$20240923$PER$$US-AMGEN-USASP2024165451$AMGEN$$62$YR$A$M$Y$$$20240923$$CN$US$US
242384761$24238476$1$I$$20240819$20240822$20240822$PER$$US-ABBVIE-5889392$ABBVIE$$$$$$Y$$$20240822$$CN$US$US
242384771$24238477$1$I$$20240815$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA073107$SANDOZ$$$$$M$Y$$$20240822$$CN$CA$CA
242384781$24238478$1$I$20240601$20240814$20240822$20240822$EXP$$FR-ORGANON-O2408FRA001284$ORGANON$$84$YR$$F$Y$$$20240822$$CN$FR$FR
242384791$24238479$1$I$20240809$20240812$20240822$20240822$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004960$SAREPTA THERAPEUTICS$$25$YR$$M$Y$83.447$KG$20240822$$HP$US$US
242384802$24238480$2$F$$20240822$20240822$20240917$PER$$US-TRAVERE-2024TVT00801$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240917$$CN$US$US
242384811$24238481$1$I$20240812$20240812$20240822$20240822$PER$$US-TRAVERE-2024TVT00799$TRAVERE THERAPEUTICS$$74$YR$E$F$Y$$$20240822$$CN$US$US
242384821$24238482$1$I$20240807$20240807$20240822$20240822$PER$$US-GRANULES-US-2024GRASPO00361$GRANULES INDIA$$10$YR$C$M$Y$$$20240822$$CN$US$US
242384832$24238483$2$F$$20240906$20240822$20240916$30DAY$$TW-JNJFOC-20240849949$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$TW$TW
242384842$24238484$2$F$20230828$20240827$20240822$20240905$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007350$AEGERION$$56$YR$$M$Y$$$20240905$$MD$US$US
242384851$24238485$1$I$$20240820$20240822$20240822$PER$$US-JNJFOC-20240850892$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$MD$US$US
242384862$24238486$2$F$$20240830$20240822$20240906$PER$$US-RDY-SPO/USA/24/0011969$DR REDDYS$$22$YR$A$F$Y$$$20240906$$CN$US$US
242384871$24238487$1$I$$20240815$20240822$20240822$EXP$$TW-AMGEN-TWNSP2024166372$AMGEN$$$$A$M$Y$$$20240822$$HP$TW$TW
242384882$24238488$2$F$20240801$20240910$20240822$20240920$EXP$$BR-TEVA-VS-3234951$TEVA$$43$YR$$M$Y$89$KG$20240920$$CN$BR$BR
242384891$24238489$1$I$$20240813$20240822$20240822$EXP$$US-ROCHE-10000057486$ROCHE$$42$YR$A$M$Y$$$20240822$$CN$US$US
242384901$24238490$1$I$20240518$20240812$20240822$20240822$EXP$$US-TEVA-VS-3234532$TEVA$$52$YR$$M$Y$95.4$KG$20240822$$HP$US$US
242384911$24238491$1$I$20240401$20240820$20240822$20240822$EXP$$GB-INCYTE CORPORATION-2024IN008753$INCYTE$$$$$$Y$$$20240822$$HP$GB$GB
242384922$24238492$2$F$$20240905$20240822$20240913$PER$$US-AstraZeneca-2024A170486$ASTRAZENECA$$$$$F$Y$$$20240913$$MD$US$
242384931$24238493$1$I$$20240816$20240822$20240822$PER$$US-AstraZeneca-2024A188303$ASTRAZENECA$$$$$F$Y$$$20240822$$MD$US$
242384941$24238494$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A186044$ASTRAZENECA$$$$$M$Y$$$20240822$$MD$US$
242384953$24238495$3$F$$20240910$20240822$20240915$EXP$$CA-AstraZeneca-2024A183434$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$CA$
242384961$24238496$1$I$20240731$20240814$20240822$20240822$EXP$$GB-AstraZeneca-2024A185713$ASTRAZENECA$$88$YR$$M$Y$$$20240822$$CN$GB$
242384972$24238497$2$F$20220304$20240919$20240822$20240925$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408011696$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240925$$CN$JP$JP
242384981$24238498$1$I$20240726$20240812$20240822$20240822$EXP$RO-NMA-2024-SP0502$RO-ELI_LILLY_AND_COMPANY-RO202408011744$ELI LILLY AND CO$$42$YR$A$M$Y$70$KG$20240822$$CN$DE$RO
242384991$24238499$1$I$$20240819$20240822$20240822$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202408011629$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$KR$KR
242385002$24238500$2$F$20240812$20240917$20240822$20240925$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408009922$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240925$$CN$JP$JP
242385011$24238501$1$I$20240813$20240818$20240822$20240822$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408011894$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240822$$CN$CN$CN
242385021$24238502$1$I$20240725$20240820$20240822$20240822$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408004801AA$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240822$$CN$JP$JP
242385031$24238503$1$I$20240807$20240812$20240822$20240822$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408011681$ELI LILLY AND CO$$74$YR$E$M$Y$62$KG$20240822$$CN$DE$CN
242385061$24238506$1$I$20240730$20240802$20240822$20240822$DIR$FDA-CDER-CTU-2024-57870$$FDA-CTU$$21$YR$$M$N$$$20240802$N$HP$US$
242385081$24238508$1$I$$20240812$20240820$20240820$DIR$FDA-CDER-CTU-2024-57382$$FDA-CTU$$72$YR$$F$N$72.57$KG$20240812$N$CN$US$
242385091$24238509$1$I$$20240819$20240822$20240822$PER$$US-JNJFOC-20240848673$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$PH$US$US
242385101$24238510$1$I$20240805$20240807$20240822$20240822$PER$$US-GRANULES-US-2024GRASPO00362$GRANULES INDIA$$80$YR$E$F$Y$90.71$KG$20240822$$CN$US$US
242385112$24238511$2$F$$20240822$20240822$20240826$PER$$NVSC2024US170057$NOVARTIS$$$$$F$Y$$$20240826$$PH$US$US
242385121$24238512$1$I$$20240820$20240822$20240822$EXP$$US-JNJFOC-20240855133$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$HP$US$US
242385131$24238513$1$I$$20240816$20240822$20240822$EXP$$DE-BAYER-2024A119055$BAYER$$84$YR$E$F$Y$$$20240822$$MD$DE$DE
242385143$24238514$3$F$$20240906$20240822$20240912$EXP$$CA-GSK-CA2024AMR025393$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$HP$CA$CA
242385151$24238515$1$I$20240726$20240807$20240822$20240822$PER$$US-GRANULES-US-2024GRASPO00368$GRANULES INDIA$$51$YR$A$F$Y$$$20240822$$CN$US$US
242385162$24238516$2$F$$20240821$20240822$20240827$EXP$$US-TAKEDA-2024TUS052481$TAKEDA$$$$$F$Y$$$20240827$$MD$US$US
242385171$24238517$1$I$$20240820$20240822$20240822$EXP$$US-INCYTE CORPORATION-2024IN008716$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242385181$24238518$1$I$$20240813$20240822$20240822$EXP$$CN-ROCHE-10000055883$ROCHE$Yang P, Luo H, Zhao L, Xiong F, Tang C. Effectiveness and safety of anlotinib plus anti-programmed cell death 1/ligand 1 (anti-PD-1/PD-L1) antibodies as maintenance therapy after first-line chemotherapy combined with anti-PD-1/ PD-L1 antibodies in extensive-stage small cell lung. Journal of Thoracic Disease.16 (7):4391-99. doi:10.21037/jtd-24-394.$$$$$Y$$$20240822$$HP$CN$CN
242385191$24238519$1$I$$20240820$20240822$20240822$EXP$$JP-ABBVIE-5888393$ABBVIE$$70$YR$$F$Y$$$20240822$$MD$JP$JP
242385201$24238520$1$I$$20240821$20240822$20240822$EXP$$RU-PFIZER INC-202400241915$PFIZER$$65$YR$$M$Y$$$20240822$$MD$RU$RU
242385211$24238521$1$I$$20240812$20240822$20240822$PER$$US-TRAVERE-2024TVT00802$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$MD$US$US
242385222$24238522$2$F$20240808$20240920$20240822$20240930$PER$$US-TRAVERE-2024TVT00803$TRAVERE THERAPEUTICS$$33$YR$A$F$Y$$$20240930$$CN$US$US
242385231$24238523$1$I$$20240820$20240822$20240822$EXP$$US-INCYTE CORPORATION-2024IN008715$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242385241$24238524$1$I$$20240814$20240822$20240822$EXP$$US-JNJFOC-20240837154$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$CN$US$US
242385251$24238525$1$I$20240101$20240730$20240822$20240822$PER$$US-Eisai-EC-2024-171249$EISAI$$$$$F$Y$$$20240822$$MD$US$US
242385261$24238526$1$I$$20240806$20240822$20240822$PER$$US-INSUD PHARMA-2408US06279$INSUD PHARMA$$$$$$Y$$$20240822$$CN$US$US
242385271$24238527$1$I$$20240813$20240822$20240822$PER$$US-Eisai-EC-2024-172050$EISAI$$$$$$Y$$$20240822$$HP$US$US
242385281$24238528$1$I$$20240807$20240822$20240822$PER$$US-COSETTE-CP2024US000213$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242385291$24238529$1$I$20240425$20240814$20240820$20240820$DIR$FDA-CDER-CTU-2024-57378$$FDA-CTU$$60$YR$$F$N$64.41$KG$20240814$N$CN$US$
242385301$24238530$1$I$20240801$20240805$20240822$20240822$PER$$US-INSUD PHARMA-2408US06284$INSUD PHARMA$$$$$$Y$$$20240822$$CN$US$US
242385311$24238531$1$I$20240101$20240807$20240822$20240822$PER$$US-INSUD PHARMA-2408US06309$INSUD PHARMA$$$$$$Y$$$20240822$$CN$US$US
242385321$24238532$1$I$20240101$20240806$20240822$20240822$PER$$US-INSUD PHARMA-2408US06281$INSUD PHARMA$$$$$$Y$$$20240822$$CN$US$US
242385331$24238533$1$I$20240101$20240807$20240822$20240822$PER$$US-INSUD PHARMA-2408US06356$INSUD PHARMA$$$$$$Y$$$20240822$$CN$US$US
242385341$24238534$1$I$20240807$20240807$20240822$20240822$PER$$US-INSUD PHARMA-2408US06359$INSUD PHARMA$$$$$$Y$$$20240822$$CN$US$US
242385351$24238535$1$I$20240101$20240806$20240822$20240822$PER$$US-INSUD PHARMA-2408US06283$INSUD PHARMA$$$$$$Y$$$20240822$$HP$US$US
242385361$24238536$1$I$$20240820$20240820$20240820$DIR$FDA-CDER-CTU-2024-57375$$FDA-CTU$$64$YR$$F$N$57.15$KG$20240822$N$CN$US$
242385371$24238537$1$I$$20240821$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133132$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$65.32$KG$20240822$$HP$US$US
242385391$24238539$1$I$20240815$20240817$20240822$20240822$EXP$GB-MHRA-MED-202408172356121370-JKCPY$NVSC2024GB169850$NOVARTIS$$$$$$Y$$$20240822$$CN$GB$GB
242385401$24238540$1$I$20240801$20240820$20240822$20240822$EXP$$US-INCYTE CORPORATION-2024IN008713$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242385412$24238541$2$F$20240101$20240902$20240822$20240917$PER$$US-GLANDPHARMA-US-2024GLNSPO00659$GLAND PHARMA$$$$$F$Y$$$20240917$$PH$US$US
242385421$24238542$1$I$20240806$20240815$20240822$20240822$EXP$$US-Vifor (International) Inc.-VIT-2024-07403$VIFOR$$52$YR$$M$Y$90.5$KG$20240822$$HP$US$US
242385431$24238543$1$I$$20240816$20240822$20240822$EXP$$US-BAYER-2024A119351$BAYER$$87$YR$E$F$Y$$$20240822$$CN$US$US
242385442$24238544$2$F$20230620$20240903$20240822$20240905$EXP$$US-JNJFOC-20240831967$JOHNSON AND JOHNSON$$70$YR$E$M$Y$64$KG$20240905$$HP$US$US
242385461$24238546$1$I$20240101$20240512$20240820$20240820$DIR$FDA-CDER-CTU-2024-57376$$AMGEN$$80$YR$$F$N$90.72$KG$20240512$N$CN$US$
242385471$24238547$1$I$20240718$20240812$20240820$20240820$DIR$FDA-CDER-CTU-2024-57379$$FDA-CTU$$86$YR$$F$N$63.5$KG$20240812$N$CN$US$
242385491$24238549$1$I$20231112$20240815$20240820$20240820$DIR$FDA-CDER-CTU-2024-57380$$FDA-CTU$$78$YR$$M$N$99.79$KG$20240815$Y$CN$US$
242385541$24238554$1$I$20240809$20240821$20240821$20240821$DIR$715344$$FDA-CTU$$77$YR$$F$N$55.8$KG$20240821$N$CN$US$
242385551$24238555$1$I$20240101$20240813$20240822$20240822$PER$$US-ABBVIE-5881421$ABBVIE$$$$$F$Y$$$20240822$$HP$US$US
242385561$24238556$1$I$$20240812$20240822$20240822$EXP$$BR-GSK-BR2024AMR100765$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$BR$BR
242385572$24238557$2$F$20240514$20240819$20240822$20240826$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-132516$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240826$$HP$CO$CO
242385581$24238558$1$I$$20240821$20240822$20240822$PER$$US-BAYER-2024A120669$BAYER$$$$$$Y$$$20240822$$CN$US$US
242385591$24238559$1$I$$20240809$20240822$20240822$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI08188$NEUROCRINE BIOSCIENCES$$6$DEC$$F$Y$$$20240822$$MD$JP$JP
242385601$24238560$1$I$$20240821$20240822$20240822$PER$$US-BAYER-2024A120625$BAYER$$44$YR$A$F$Y$$$20240822$$CN$US$US
242385611$24238561$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57872$$FDA-CTU$$78$YR$$F$N$$$20240822$N$$US$
242385622$24238562$2$F$20240401$20240917$20240822$20240930$PER$$US-TRAVERE-2024TVT00805$TRAVERE THERAPEUTICS$$70$YR$E$F$Y$$$20240930$$CN$US$US
242385631$24238563$1$I$20230130$20240813$20240822$20240822$EXP$ES-AEMPS-1557509$ES-TEVA-VS-3233428$TEVA$$1$HR$$F$Y$3$KG$20240822$$MD$ES$ES
242385641$24238564$1$I$$20240628$20240822$20240822$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004499$BIOCON$$$$$$Y$$$20240822$$PH$US$US
242385661$24238566$1$I$$20240820$20240822$20240822$PER$$US-BAYER-2024A120332$BAYER$$$$$$Y$$$20240822$$CN$US$US
242385671$24238567$1$I$$20240816$20240822$20240822$PER$$US-BIOGEN-2024BI01278837$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242385691$24238569$1$I$20240815$20240815$20240822$20240822$DIR$FDA-CDER-CTU-2024-57888$$FDA-CTU$$57$YR$$F$N$$$20240815$N$PH$US$
242385701$24238570$1$I$20240604$20240625$20240822$20240822$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004083$BIOCON$$$$$$Y$$$20240822$$HP$US$US
242385711$24238571$1$I$$20240807$20240822$20240822$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01314$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240822$$HP$US$US
242385721$24238572$1$I$20240802$20240814$20240822$20240822$EXP$$AU-GE HEALTHCARE-2024CSU008850$GE HEALTHCARE$$57$YR$$M$Y$115$KG$20240822$$HP$AU$AU
242385731$24238573$1$I$20240116$20240821$20240821$20240821$DIR$715357$$FDA-CTU$$40$YR$$F$N$109.35$KG$20240821$N$CN$US$
242385741$24238574$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163643$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242385751$24238575$1$I$$20240816$20240822$20240822$EXP$$DE-AMGEN-DEUSP2024164402$AMGEN$Beutel K.; Gall K.; Wawer A. et. al. Diffuse Large B Cell Lymphoma in an Adolescent: A Challenging Case with Intracerebral and Retinal Involvement. Blood. 2018;132 (SUPPL_1):5422$16$YR$T$F$Y$$$20240822$$MD$DE$DE
242385761$24238576$1$I$20240801$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131916$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240822$$PH$US$US
242385771$24238577$1$I$$20240812$20240822$20240822$EXP$$US-AMGEN-USASP2024162358$AMGEN$Vega R. A.; Park J. B.; Filo J. et al.. Cranial stair-step incision for minimizing postoperative complications in neuro-oncologic surgery: A propensity score-matched analysis. Acta Neurochirurgica. 2024;166(1):1-12$$$$$Y$$$20240822$$HP$US$US
242385781$24238578$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013602$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240822$$CN$US$US
242385791$24238579$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012894$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242385801$24238580$1$I$$20240819$20240822$20240822$PER$$US-BAYER-2024A119610$BAYER$$$$$M$Y$$$20240822$$CN$US$US
242385811$24238581$1$I$20240819$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011918$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240822$$CN$US$US
242385821$24238582$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163632$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242385831$24238583$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013945$ELI LILLY AND CO$$$$$M$Y$$$20240822$$CN$US$US
242385841$24238584$1$I$20240819$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011964$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240822$$CN$US$US
242385851$24238585$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012565$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242385861$24238586$1$I$20240819$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011974$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240822$$CN$US$US
242385871$24238587$1$I$$20240818$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011631$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242385881$24238588$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012846$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240822$$CN$US$US
242385891$24238589$1$I$20180818$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011598$ELI LILLY AND CO$$70$YR$E$$Y$$$20240822$$CN$US$US
242385901$24238590$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013819$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240822$$CN$US$US
242385911$24238591$1$I$20240819$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011581$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240822$$CN$US$US
242385921$24238592$1$I$20240816$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012408$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240822$$CN$US$US
242385931$24238593$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011751$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240822$$CN$US$US
242385942$24238594$2$F$20240817$20240827$20240822$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408011092$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240829$$CN$US$US
242385951$24238595$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024163662$AMGEN$George D.J; Halabi S.; Fleming M. T. et.al. Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024;42 (16):5072$$$$$Y$$$20240822$$HP$US$US
242385961$24238596$1$I$$20240817$20240822$20240822$EXP$$ES-AUROBINDO-AUR-APL-2024-041869$AUROBINDO$$76$YR$$F$Y$$$20240822$$MD$ES$ES
242385971$24238597$1$I$20240802$20240819$20240822$20240822$EXP$$FR-PFIZER INC-202400238941$PFIZER$$68$YR$$M$Y$110$KG$20240822$$MD$FR$FR
242385981$24238598$1$I$$20240818$20240822$20240822$PER$$US-BAYER-2024A119182$BAYER$$$$$$Y$$$20240822$$CN$US$US
242385991$24238599$1$I$20240819$20240819$20240822$20240822$PER$$US-JNJFOC-20240850748$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$MD$US$US
242386002$24238600$2$F$20240402$20240819$20240822$20240829$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001872$SK LIFE SCIENCE$$$$$$Y$$$20240829$$CN$US$US
242386012$24238601$2$F$$20240812$20240822$20240916$EXP$$US-TEVA-VS-3234508$TEVA$Hernandez K, Ahmed T, Liu D, Seiter K, Steinberg A. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. Blood 2023; 142 (Suppl. 1) 7349-7350.; Hernandez K, Ahmed T, Liu D, Seiter K, Steinberg A. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. Blood 2023; 142 (Suppl. 1) 7349-7350.$28$YR$$M$Y$$$20240916$$HP$US$US
242386021$24238602$1$I$20240101$20240815$20240822$20240822$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08248$NEUROCRINE BIOSCIENCES$$59$YR$$M$Y$$$20240822$$PH$US$US
242386032$24238603$2$F$20240101$20240917$20240822$20240920$PER$$US-BIOGEN-2024BI01262080$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
242386041$24238604$1$I$20240731$20240814$20240822$20240822$EXP$$CN-009507513-2408CHN005854$MERCK$$76$YR$$F$Y$$$20240822$$HP$CN$CN
242386051$24238605$1$I$$20240812$20240822$20240822$EXP$$US-TEVA-VS-3234512$TEVA$Hernandez K, Ahmed T, Liu D, Seiter K, Steinberg A. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. Blood 2023; 142 (Suppl. 1) 7349-7350.$37$YR$$M$Y$$$20240822$$HP$US$US
242386061$24238606$1$I$$20240812$20240822$20240822$30DAY$$US-UCBSA-2024039950$UCB$$$$$F$Y$$$20240822$$CN$US$US
242386071$24238607$1$I$20240806$20240821$20240821$20240821$DIR$715402$$FDA-CTU$$$$$F$N$$$20240821$Y$PH$US$
242386091$24238609$1$I$$20240821$20240821$20240821$DIR$715409$$FDA-CTU$$$$$UNK$N$$$20240821$$CN$US$
242386101$24238610$1$I$20240819$20240821$20240821$20240821$DIR$715399$$FDA-CTU$$58$YR$$F$N$62.1$KG$20240821$N$CN$US$
242386131$24238613$1$I$20240807$20240821$20240821$20240821$DIR$715378$$FDA-CTU$$36$YR$$F$N$52.65$KG$20240821$N$$US$
242386141$24238614$1$I$20240815$20240821$20240821$20240821$DIR$715411$$FDA-CTU$$73$YR$$F$N$90$KG$20240821$Y$CN$US$
242386151$24238615$1$I$20240511$20240821$20240821$20240821$DIR$715410$$FDA-CTU$$53$YR$$F$N$67.5$KG$20240821$N$CN$US$
242386161$24238616$1$I$$20240821$20240821$20240821$DIR$715406$$FDA-CTU$$$$$UNK$N$$$20240821$$CN$US$
242386171$24238617$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57852$$FDA-CTU$$63$YR$$F$N$$$20240822$N$$US$
242386191$24238619$1$I$$20240821$20240821$20240821$DIR$715384$$FDA-CTU$$$$$UNK$N$$$20240821$$CN$US$
242386201$24238620$1$I$$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57877$$FDA-CTU$$$$$M$N$$$20240821$N$HP$US$
242386211$24238621$1$I$$20240812$20240822$20240822$EXP$$US-EMD Serono-2024043793$EMD SERONO INC$$$$I$M$Y$4$KG$20240822$$CN$US$US
242386221$24238622$1$I$$20240813$20240822$20240822$EXP$$TW-AMGEN-TWNSP2024161416$AMGEN$Niu C.; Chen P.; Chiu P. et al.. Teriparatide alone versus vertebroplasty on pain control and radiographic outcomes after osteoporotic vertebral compression fracture. European Spine Journal. 2024;33 (8):3284-3290$$$$$Y$$$20240822$$HP$TW$TW
242386231$24238623$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024167176$AMGEN$$$$$$Y$$$20240822$$MD$US$US
242386241$24238624$1$I$$20240820$20240822$20240822$PER$$US-JNJFOC-20240852211$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$CN$US$US
242386251$24238625$1$I$20240729$20240817$20240822$20240822$EXP$$CN-009507513-2408CHN007227$MERCK$$54$YR$$M$Y$$$20240822$$HP$CN$CN
242386261$24238626$1$I$$20240816$20240822$20240822$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013329$VERTEX$$$$C$F$Y$$$20240822$$CN$GB$GB
242386272$24238627$2$F$$20240819$20240822$20240830$EXP$$AU-JNJFOC-20240846663$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240830$$HP$AU$AU
242386281$24238628$1$I$$20240816$20240822$20240822$EXP$$CH-VERTEX PHARMACEUTICALS-2024-013313$VERTEX$$41$YR$$F$Y$$$20240822$$MD$CH$CH
242386291$24238629$1$I$$20240815$20240822$20240822$EXP$$CA-VERTEX PHARMACEUTICALS-2024-013325$VERTEX$$11$YR$$F$Y$$$20240822$$PH$CA$CA
242386301$24238630$1$I$$20240815$20240822$20240822$EXP$$CA-VERTEX PHARMACEUTICALS-2024-013324$VERTEX$$$$$F$Y$$$20240822$$CN$CA$CA
242386311$24238631$1$I$$20240816$20240822$20240822$EXP$$CH-VERTEX PHARMACEUTICALS-2024-013312$VERTEX$$37$YR$$F$Y$$$20240822$$MD$CH$CH
242386321$24238632$1$I$$20240819$20240822$20240822$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013382$VERTEX$$$$A$F$Y$$$20240822$$CN$GB$GB
242386331$24238633$1$I$$20240819$20240822$20240822$PER$$US-VERTEX PHARMACEUTICALS-2024-013418$VERTEX$$$$$F$Y$$$20240822$$CN$US$US
242386341$24238634$1$I$20240223$20240815$20240822$20240822$EXP$FR-AFSSAPS-NC2024000980$FR-VERTEX PHARMACEUTICALS-2024-013260$VERTEX$$3$YR$$F$Y$20$KG$20240822$$HP$FR$FR
242386351$24238635$1$I$20230601$20240816$20240822$20240822$EXP$$CH-VERTEX PHARMACEUTICALS-2024-013362$VERTEX$$41$YR$$F$Y$$$20240822$$MD$CH$CH
242386361$24238636$1$I$$20240820$20240822$20240822$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013452$VERTEX$$$$C$F$Y$$$20240822$$CN$GB$GB
242386371$24238637$1$I$20230101$20230411$20240822$20240822$EXP$$US-AstraZeneca-2023A085629$ASTRAZENECA$$76$YR$$F$Y$$$20240822$$CN$US$
242386381$24238638$1$I$$20240808$20240822$20240822$PER$$US-AstraZeneca-2024A181211$ASTRAZENECA$$$$$F$Y$$$20240822$$MD$US$
242386391$24238639$1$I$$20230320$20240822$20240822$EXP$$US-AstraZeneca-2023A068992$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242386401$24238640$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132092$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240822$$CN$US$US
242386412$24238641$2$F$$20240822$20240822$20240829$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046490$BOEHRINGER INGELHEIM$Nizinska I, Gattner K. Lithium intoxication in patients using angiotensin II receptor antagonists and hydrochlorothiazide: two case reportspis dwoch przypadkow. Farmakoterapia w Psychiatrii i Neurologii. 2024;40(19): 53-60. doi:10.5114/fpn.2024.141961.$72$YR$E$F$Y$$$20240829$$HP$PL$PL
242386421$24238642$1$I$20231101$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131732$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240822$$CN$US$US
242386431$24238643$1$I$$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133482$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240822$$CN$US$US
242386441$24238644$1$I$20230701$20240814$20240822$20240822$EXP$$US-SA-2024SA243972$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240822$$MD$US$US
242386451$24238645$1$I$$20240805$20240822$20240822$PER$$US-TEVA-VS-3232059$TEVA$$20$YR$$M$Y$$$20240822$$HP$US$US
242386461$24238646$1$I$20240701$20240812$20240822$20240822$EXP$$EU-RADIUS HEALTH INC.-2024ES006252$RADIUS PHARM$$78$YR$$F$Y$$$20240822$$PH$EU$ES
242386471$24238647$1$I$20180101$20240814$20240822$20240822$EXP$$US-SA-2019SA313547$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240822$$MD$US$US
242386481$24238648$1$I$$20240814$20240822$20240822$EXP$$IL-JNJFOC-20240841669$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240822$$CN$IL$IL
242386491$24238649$1$I$20200101$20240819$20240822$20240822$EXP$$US-ABBVIE-5886324$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242386502$24238650$2$F$$20240829$20240822$20240906$EXP$$PL-TEVA-VS-3234135$TEVA$Mesjasz A, Trzeciak M, Sroka-Tomaszewska, Zaryczanska A, Nowicki RJ. Erythrodermic Presentation of Atopic Dermatitis in a Patient with Secondary Adrenal Insufficiency Caused by Oral Glucocorticosteroid Abuse. Acta-Dermatovenerol-Croat 2023; 31 103-105.; Mesjasz A , Trzeciak M , Sroka-Tomaszewska , Zaryczanska A , Nowicki RJ. Erythrodermic Presentation of Atopic Dermatitis in a Patient with Secondary Adrenal Insufficiency Caused by Oral Glucocorticosteroid Abuse. Acta-Dermatovenerol-Croat 2023...$35$YR$$M$Y$$$20240906$$HP$PL$PL
242386511$24238651$1$I$20240727$20240812$20240822$20240822$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16228$IPSEN$$$$$F$Y$$$20240822$$HP$US$US
242386521$24238652$1$I$$20240813$20240822$20240822$EXP$$US-ASCENT-2024ASLIT00025$ASCENT$Lindsay A, et al.An Underestimated Toxin: The Case of Intentional Benzonatate Overdose Resulting in Seizure and Cardiac Arrest.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209 (1):A7034$41$YR$A$F$Y$$$20240822$$HP$US$US
242386531$24238653$1$I$$20240812$20240822$20240822$PER$$US-AMGEN-USASP2024162477$AMGEN$Faleck D.; Magahis P. T.; Corso T. et al.. Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors. Journal for Immunotherapy of Cancer. 2024;12 (7):1-10$$$$M$Y$$$20240822$$MD$US$US
242386541$24238654$1$I$$20240813$20240822$20240822$EXP$$DE-ASCENT-2024ASLIT00026$ASCENT$Jansen N, et al..CHANTER syndrome in the context of pain  medication: a case report.BMC Neurology.22-Jul-2024;24 (1):1-5$62$YR$A$M$Y$$$20240822$$HP$DE$DE
242386562$24238656$2$F$20240101$20240829$20240822$20240905$EXP$$CA-GSK-CA2023124454$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$CA$CA
242386571$24238657$1$I$20240806$20240816$20240822$20240822$EXP$ES-AEMPS-1558862$ES-MYLANLABS-2024M1076667$MYLAN$$68$YR$$F$Y$50$KG$20240822$$PH$ES$ES
242386581$24238658$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165468$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242386591$24238659$1$I$$20240821$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074394$SANDOZ$$78$YR$$M$Y$$$20240822$$MD$US$US
242386601$24238660$1$I$20240701$20240816$20240822$20240822$EXP$ES-AEMPS-1560624$ES-MYLANLABS-2024M1076532$MYLAN$$54$YR$$F$Y$$$20240822$$MD$ES$ES
242386611$24238661$1$I$$20240819$20240822$20240822$EXP$$CA-ABBVIE-5887591$ABBVIE$$$$E$F$Y$$$20240822$$CN$CA$CA
242386621$24238662$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239810$PFIZER$$17$YR$$M$Y$39.2$KG$20240822$$HP$US$US
242386631$24238663$1$I$20240816$20240816$20240822$20240822$EXP$$AT-SANDOZ INC.-SDZ2024AT073994$SANDOZ$$$$$F$Y$$$20240822$$CN$AT$AT
242386641$24238664$1$I$$20240820$20240822$20240822$EXP$$CA-SANDOZ INC.-NVSC2023CA030914$SANDOZ$$31$YR$$F$Y$71$KG$20240822$$CN$CA$CA
242386651$24238665$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-PV202400108784$PFIZER$$$$$M$Y$$$20240822$$CN$US$US
242386661$24238666$1$I$20240101$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239547$PFIZER$$41$YR$$F$Y$$$20240822$$CN$US$US
242386671$24238667$1$I$$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241273$PFIZER$$$$$$Y$$$20240822$$MD$US$US
242386682$24238668$2$F$20240603$20240821$20240822$20240822$PER$$US-PFIZER INC-PV202400108939$PFIZER$$$$$$Y$$$20240822$$CN$US$US
242386691$24238669$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239783$PFIZER$$75$YR$$F$Y$$$20240822$$HP$US$US
242386701$24238670$1$I$20240728$20240821$20240821$20240821$DIR$715415$$FDA-CTU$$69$YR$$M$N$85.5$KG$20240821$N$PH$US$
242386711$24238671$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57873$$FDA-CTU$$82$YR$$F$N$147$LBS$20240822$N$$US$
242386722$24238672$2$F$$20240921$20240822$20240923$PER$$US-PFIZER INC-PV202400108756$PFIZER$$71$YR$$$Y$$$20240923$$CN$US$US
242386733$24238673$3$F$20240819$20240904$20240822$20240909$PER$$US-PFIZER INC-202400239486$PFIZER$$$$A$F$Y$$$20240909$$CN$US$US
242386741$24238674$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239503$PFIZER$$69$YR$$M$Y$$$20240822$$PH$US$US
242386751$24238675$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239523$PFIZER$$18$YR$$F$Y$$$20240822$$HP$US$US
242386761$24238676$1$I$$20240815$20240822$20240822$PER$$US-PFIZER INC-202400238465$PFIZER$$$$$M$Y$$$20240822$$HP$US$US
242386771$24238677$1$I$20210101$20240820$20240822$20240822$PER$$US-PFIZER INC-PV202400109209$PFIZER$$57$YR$$F$Y$$$20240822$$HP$US$US
242386781$24238678$1$I$$20240818$20240822$20240822$PER$$US-PFIZER INC-202400239230$PFIZER$$$$$$Y$$$20240822$$CN$US$US
242386801$24238680$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239521$PFIZER$$59$YR$$$Y$$$20240822$$CN$US$US
242386811$24238681$1$I$20240813$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240203$PFIZER$$74$YR$$F$Y$70.31$KG$20240822$$CN$US$US
242386822$24238682$2$F$$20240828$20240822$20240904$PER$$US-PFIZER INC-202400240244$PFIZER$$43$YR$$M$Y$$$20240904$$HP$US$US
242386831$24238683$1$I$20221001$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241223$PFIZER$$$$A$F$Y$$$20240822$$HP$US$US
242386851$24238685$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240113$PFIZER$$70$YR$$F$Y$$$20240822$$CN$US$US
242386861$24238686$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-PV202400071656$PFIZER$$67$YR$$F$Y$$$20240822$$CN$US$US
242386871$24238687$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-PV202400109098$PFIZER$$74$YR$$F$Y$$$20240822$$HP$US$US
242386881$24238688$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240031$PFIZER$$69$YR$$M$Y$$$20240822$$CN$US$US
242386893$24238689$3$F$20240801$20240924$20240822$20240926$PER$$US-PFIZER INC-202400239991$PFIZER$$79$YR$$F$Y$56.69$KG$20240926$$HP$US$US
242386901$24238690$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-PV202400108840$PFIZER$$$$$F$Y$$$20240822$$CN$US$US
242386912$24238691$2$F$20240820$20240906$20240822$20240910$PER$$US-PFIZER INC-202400240117$PFIZER$$80$YR$$F$Y$63.039$KG$20240910$$CN$US$US
242386931$24238693$1$I$20240814$20240819$20240822$20240822$PER$$US-PFIZER INC-PV202400108915$PFIZER$$70$YR$$F$Y$57.2$KG$20240822$$HP$US$US
242386941$24238694$1$I$$20240816$20240822$20240822$PER$$US-PFIZER INC-PV202400107767$PFIZER$$$$$M$Y$$$20240822$$CN$US$US
242386951$24238695$1$I$20240819$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240087$PFIZER$$84$YR$$M$Y$87.54$KG$20240822$$CN$US$US
242386961$24238696$1$I$20240820$20240820$20240822$20240822$PER$$US-PFIZER INC-PV202400108923$PFIZER$$41$YR$$F$Y$172.34$KG$20240822$$CN$US$US
242386971$24238697$1$I$20240820$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240162$PFIZER$$$$$$Y$$$20240822$$CN$US$US
242386981$24238698$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-PV202400108114$PFIZER$$58$YR$$F$Y$$$20240822$$HP$US$US
242386991$24238699$1$I$20240811$20240817$20240822$20240822$PER$$US-PFIZER INC-202400238926$PFIZER$$70$YR$$M$Y$$$20240822$$CN$US$US
242387001$24238700$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-202400240108$PFIZER$$72$YR$$F$Y$$$20240822$$CN$US$US
242387011$24238701$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240394$PFIZER$$69$YR$$F$Y$$$20240822$$HP$US$US
242387022$24238702$2$F$20240101$20240903$20240822$20240906$PER$$US-PFIZER INC-202400044616$PFIZER$$78$YR$$F$Y$$$20240906$$CN$US$US
242387031$24238703$1$I$20240821$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241285$PFIZER$$60$YR$$F$Y$$$20240822$$CN$US$US
242387041$24238704$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240114$PFIZER$$77$YR$$F$Y$$$20240822$$CN$US$US
242387061$24238706$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240716$PFIZER$$62$YR$$F$Y$$$20240822$$CN$US$US
242387072$24238707$2$F$20240727$20240910$20240822$20240912$PER$$US-PFIZER INC-202400241026$PFIZER$$68$YR$$F$Y$58.05$KG$20240912$$CN$US$US
242387081$24238708$1$I$$20240819$20240822$20240822$EXP$$NVSC2024US168877$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
242387091$24238709$1$I$20240818$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239540$PFIZER$$47$YR$$M$Y$$$20240822$$CN$US$US
242387101$24238710$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-202400239975$PFIZER$$$$$F$Y$$$20240822$$HP$US$US
242387111$24238711$1$I$$20240815$20240822$20240822$PER$$US-PFIZER INC-202400239808$PFIZER$$75$YR$$F$Y$$$20240822$$HP$US$US
242387121$24238712$1$I$20240819$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239369$PFIZER$$28$YR$$F$Y$$$20240822$$HP$US$US
242387131$24238713$1$I$20240816$20240817$20240822$20240822$PER$$US-PFIZER INC-202400238883$PFIZER$$34$YR$$M$Y$$$20240822$$CN$US$US
242387151$24238715$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-202400240157$PFIZER$$$$$$Y$$$20240822$$MD$US$US
242387161$24238716$1$I$20240817$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240158$PFIZER$$37$YR$$F$Y$$$20240822$$CN$US$US
242387171$24238717$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-PV202400108230$PFIZER$$62$YR$$F$Y$$$20240822$$HP$US$US
242387181$24238718$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-202400241201$PFIZER$$67$YR$$F$Y$$$20240822$$HP$US$US
242387191$24238719$1$I$20240818$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240123$PFIZER$$82$YR$$M$Y$$$20240822$$CN$US$US
242387201$24238720$1$I$20240815$20240816$20240822$20240822$PER$$US-PFIZER INC-202400238283$PFIZER$$54$YR$$F$Y$70.31$KG$20240822$$HP$US$US
242387212$24238721$2$F$20240701$20240905$20240822$20240906$PER$$US-PFIZER INC-202400239328$PFIZER$$81$YR$$M$Y$81.633$KG$20240906$$CN$US$US
242387221$24238722$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240384$PFIZER$$52$YR$$F$Y$$$20240822$$MD$US$US
242387231$24238723$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-PV202400084628$PFIZER$$77$YR$$F$Y$$$20240822$$HP$US$US
242387241$24238724$1$I$20240701$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239413$PFIZER$$55$YR$$F$Y$61.23$KG$20240822$$CN$US$US
242387251$24238725$1$I$$20240818$20240822$20240822$PER$$US-PFIZER INC-202400238936$PFIZER$$$$$M$Y$$$20240822$$CN$US$US
242387261$24238726$1$I$20240820$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241156$PFIZER$$48$YR$$F$Y$$$20240822$$CN$US$US
242387271$24238727$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239664$PFIZER$$23$YR$$F$Y$$$20240822$$CN$US$US
242387281$24238728$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-PV202400108800$PFIZER$$$$$F$Y$$$20240822$$CN$US$US
242387291$24238729$1$I$20240801$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239247$PFIZER$$45$YR$$F$Y$$$20240822$$HP$US$US
242387301$24238730$1$I$20240101$20240820$20240822$20240822$PER$$US-PFIZER INC-PV202400108975$PFIZER$$$$$$Y$$$20240822$$CN$US$US
242387311$24238731$1$I$20240818$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239222$PFIZER$$62$YR$$F$Y$$$20240822$$CN$US$US
242387321$24238732$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-PV202400108906$PFIZER$$54$YR$$F$Y$$$20240822$$CN$US$US
242387331$24238733$1$I$20240819$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240724$PFIZER$$73$YR$$M$Y$$$20240822$$CN$US$US
242387341$24238734$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-PV202400108554$PFIZER$$56$YR$$F$Y$$$20240822$$HP$US$US
242387351$24238735$1$I$20240820$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240127$PFIZER$$72$YR$$F$Y$$$20240822$$MD$US$US
242387361$24238736$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240090$PFIZER$$46$YR$$F$Y$$$20240822$$MD$US$US
242387372$24238737$2$F$$20240825$20240822$20240827$PER$$US-PFIZER INC-PV202400107615$PFIZER$$10$YR$$$Y$$$20240827$$CN$US$US
242387382$24238738$2$F$20240818$20240905$20240822$20240909$PER$$US-PFIZER INC-202400240668$PFIZER$$68$YR$$M$Y$83.9$KG$20240909$$CN$US$US
242387392$24238739$2$F$$20240822$20240822$20240827$PER$$US-PFIZER INC-202400241081$PFIZER$$21$YR$$F$Y$$$20240827$$CN$US$US
242387402$24238740$2$F$$20240913$20240822$20240917$PER$$US-PFIZER INC-PV202400108749$PFIZER$$31$YR$$M$Y$$$20240917$$CN$US$US
242387411$24238741$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-202400241038$PFIZER$$$$$$Y$$$20240822$$CN$US$US
242387421$24238742$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-PV202400108072$PFIZER$$$$$$Y$$$20240822$$PH$US$US
242387432$24238743$2$F$20240801$20240825$20240822$20240828$PER$$US-PFIZER INC-PV202400108492$PFIZER$$50$YR$$F$Y$$$20240828$$HP$US$US
242387441$24238744$1$I$$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241162$PFIZER$$42$YR$$F$Y$$$20240822$$CN$US$US
242387451$24238745$1$I$$20240816$20240822$20240822$PER$$US-PFIZER INC-202400238432$PFIZER$$7$DEC$$F$Y$$$20240822$$CN$US$US
242387461$24238746$1$I$20240801$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240000$PFIZER$$$$$F$Y$$$20240822$$HP$US$US
242387481$24238748$1$I$20240816$20240819$20240822$20240822$PER$$US-PFIZER INC-202400239610$PFIZER$$71$YR$$M$Y$$$20240822$$PH$US$US
242387491$24238749$1$I$20240815$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240109$PFIZER$$58$YR$$F$Y$$$20240822$$CN$US$US
242387501$24238750$1$I$20240819$20240821$20240821$20240821$DIR$715420$$FDA-CTU$$$$$F$N$$$20240821$N$CN$US$
242387511$24238751$1$I$20240625$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57892$$FDA-CTU$$63$YR$$F$N$$$20240822$N$PH$US$
242387521$24238752$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57896$$FDA-CTU$$60$YR$$F$N$291$LBS$20240822$N$$US$
242387531$24238753$1$I$20240807$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57905$$FDA-CTU$$61$YR$$F$N$72.6$KG$20240822$N$HP$US$
242387551$24238755$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57874$$FDA-CTU$$69$YR$$M$N$$$20240822$N$$US$
242387562$24238756$2$F$$20240830$20240822$20240902$EXP$$MX-AstraZeneca-2024A081476$ASTRAZENECA$$$$$F$Y$$$20240902$$MD$MX$
242387571$24238757$1$I$$20240814$20240822$20240822$PER$$US-RDY-SPO/USA/24/0011950$DR REDDYS$$$$$$Y$$$20240822$$CN$US$US
242387581$24238758$1$I$$20240816$20240822$20240822$EXP$FR-AFSSAPS-TO2024001571$FR-SA-2024SA243011$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240822$$MD$FR$FR
242387601$24238760$1$I$$20240811$20240822$20240822$EXP$$US-AMGEN-USASP2024163714$AMGEN$Karam W.; Alqam A.; Ashkar R. et al.. Outcomes of rituximab as treatment for immune thrombocytopenic purpura in patients who have failed steroids or IVIG: A retrospective study in a community practice. Journal Of Clinical Oncology. 2024;42 (16)$$$$$Y$$$20240822$$HP$US$US
242387611$24238761$1$I$20240819$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165494$AMGEN$$79$YR$E$M$Y$$$20240822$$HP$US$US
242387621$24238762$1$I$20240820$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024167010$AMGEN$$75$YR$E$F$Y$$$20240822$$HP$US$US
242387631$24238763$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132568$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240822$$CN$US$US
242387642$24238764$2$F$20240601$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01105$AVADEL CNS PHARMA$$42$YR$$F$Y$$$20240815$$CN$US$US
242387651$24238765$1$I$20240805$20240816$20240822$20240822$EXP$$CN-TAKEDA-2024TUS083005$TAKEDA$$84$YR$$M$Y$49$KG$20240822$$HP$CN$CN
242387661$24238766$1$I$20240110$20240815$20240822$20240822$EXP$$CA-GSK-CA2024004538$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$CA$CA
242387671$24238767$1$I$$20240816$20240822$20240822$EXP$$US-AMGEN-USASP2024164548$AMGEN$Migdady Y.; Gupta R.; Ediriwickrema A. et. al.. A Case Report of Refractory Immune Thrombocytopenia (ITP) Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) Successfully Treated with Off-Label Use of Daratumumab. Blood. 2018;132 (SUPPL_1):4976$60$YR$A$M$Y$$$20240822$$MD$US$US
242387681$24238768$1$I$$20240809$20240822$20240822$EXP$$US-RedHill Biopharma Inc.-RDH202408-000041$REDHILL BIOPHARMA$$73$YR$E$F$Y$$$20240822$$MD$US$
242387691$24238769$1$I$$20240815$20240822$20240822$EXP$$US-SA-2024SA244423$SANOFI AVENTIS$$$$E$F$Y$$$20240822$$CN$US$US
242387701$24238770$1$I$$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57853$$FDA-CTU$$$$$M$N$$$20240821$N$HP$US$
242387711$24238771$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011690$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240822$$CN$US$US
242387721$24238772$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012536$ELI LILLY AND CO$$$$$F$Y$$$20240822$$HP$US$US
242387732$24238773$2$F$$20240829$20240822$20240902$EXP$$US-AMGEN-USASL2024042997$AMGEN$$81$YR$E$F$Y$39.15$KG$20240902$$CN$US$US
242387741$24238774$1$I$$20240815$20240822$20240822$EXP$$CA-TAKEDA-2024TUS082773$TAKEDA$$$$$M$Y$$$20240822$$HP$CA$CA
242387751$24238775$1$I$$20240817$20240822$20240822$PER$$US-BAYER-2024A118776$BAYER$$$$$$Y$$$20240822$$CN$US$US
242387761$24238776$1$I$20240605$20240813$20240822$20240822$EXP$SE-SEMPA-2024-005947$SE-TEVA-VS-3233853$TEVA$$82$YR$$M$Y$$$20240822$$MD$SE$SE
242387771$24238777$1$I$20240722$20240730$20240822$20240822$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004159$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240822$$CN$US$US
242387781$24238778$1$I$$20240815$20240822$20240822$EXP$$US-SA-2024SA243986$SANOFI AVENTIS$$$$$F$Y$$$20240822$$CN$US$US
242387792$24238779$2$F$$20240905$20240822$20240916$30DAY$$TW-JNJFOC-20240849932$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$TW$TW
242387801$24238780$1$I$20240815$20240815$20240822$20240822$PER$$US-BAYER-2024A117930$BAYER$$$$$F$Y$$$20240822$$CN$US$US
242387814$24238781$4$F$$20240909$20240822$20240917$EXP$$NVSC2024PT166167$NOVARTIS$Brites FM, Ferreira CA. Howell-Jolly Body like Inclusions in Neutrophils and Monocytes. LABORATORY MEDICINE MAGAZINE. 2024;5:82$58$YR$$F$Y$$$20240917$$HP$PT$PT
242387821$24238782$1$I$$20240819$20240822$20240822$EXP$$JP-SA-2024SA248537$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240822$$PH$JP$JP
242387832$24238783$2$F$$20240819$20240822$20240930$EXP$$US-SA-2024SA249110$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240930$$CN$US$US
242387841$24238784$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004160$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242387851$24238785$1$I$20240727$20240814$20240822$20240822$EXP$$MY-AstraZeneca-2024A173295$ASTRAZENECA$$59$YR$$F$Y$$$20240822$$PH$MY$
242387872$24238787$2$F$20240819$20240820$20240822$20240828$EXP$$US-SA-2024SA248966$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240828$$HP$US$US
242387881$24238788$1$I$20240809$20240816$20240822$20240822$PER$$US-BAYER-2024A118513$BAYER$$50$YR$A$F$Y$$$20240822$$CN$US$US
242387891$24238789$1$I$$20240815$20240822$20240822$EXP$$US-AMGEN-USASP2024163199$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242387901$24238790$1$I$20240725$20240814$20240822$20240822$EXP$$CN-AstraZeneca-2024A187444$ASTRAZENECA$$14062$DY$$M$Y$70$KG$20240822$$MD$CN$
242387911$24238791$1$I$20240701$20240819$20240822$20240822$EXP$$US-SA-2024SA248964$SANOFI AVENTIS$$42$YR$A$F$Y$77.47$KG$20240822$$MD$US$US
242387921$24238792$1$I$$20240816$20240822$20240822$PER$$US-BAYER-2024A118644$BAYER$$$$$$Y$$$20240822$$CN$US$US
242387931$24238793$1$I$$20240820$20240822$20240822$EXP$$SK-SA-2024SA166059$SANOFI AVENTIS$Penesova A, Minarik P, Huckova M, Vlcek M, Szantova M, Krizanova O.. 5-Fluorouracil Induced Hypertriglyceridemia During the Colorectal Cancer Treatment in a Patient With Multifactorial Chylomicronemia Syndrome: A Case Report.. Clinical therapeutics. 2024;22(18):1-4$47$YR$A$F$Y$80$KG$20240822$$MD$SK$SK
242387951$24238795$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004161$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$HP$US$US
242387961$24238796$1$I$$20240820$20240822$20240822$EXP$$US-SA-2024SA217238$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240822$$CN$US$US
242387971$24238797$1$I$$20240820$20240822$20240822$EXP$$US-SA-2024SA165682$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240822$$MD$US$US
242387981$24238798$1$I$$20240816$20240822$20240822$PER$$US-BAYER-2024A119266$BAYER$$$$$F$Y$$$20240822$$CN$US$US
242387991$24238799$1$I$$20240819$20240822$20240822$EXP$$IT-ABBVIE-5888428$ABBVIE$$79$YR$$M$Y$$$20240822$$CN$IT$IT
242388001$24238800$1$I$20240810$20240819$20240822$20240822$EXP$$CN-JNJFOC-20240846717$JOHNSON AND JOHNSON$$71$YR$E$F$Y$58$KG$20240822$$HP$CN$CN
242388011$24238801$1$I$$20240820$20240822$20240822$PER$$US-JNJFOC-20240855069$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$PH$US$US
242388021$24238802$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5887396$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242388042$24238804$2$F$$20240903$20240822$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132451$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$62.14$KG$20240905$$HP$US$US
242388071$24238807$1$I$20240818$20240819$20240822$20240822$EXP$$FR-ABBVIE-5889121$ABBVIE$$77$YR$$M$Y$$$20240822$$HP$FR$FR
242388081$24238808$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5888831$ABBVIE$$71$YR$$F$Y$$$20240822$$CN$US$US
242388092$24238809$2$F$$20240830$20240822$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004163$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
242388101$24238810$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004166$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242388114$24238811$4$F$20080101$20240819$20240822$20240906$EXP$$BE-SANDOZ INC.-PHHY2017BE204453$SANDOZ$$52$YR$$F$Y$$$20240906$$MD$BE$BE
242388123$24238812$3$F$$20240909$20240822$20240913$EXP$$CA-ABBVIE-5889198$ABBVIE$$$$E$M$Y$$$20240913$$HP$CA$CA
242388131$24238813$1$I$$20240812$20240822$20240822$PER$$US-BAYER-2024A115918$BAYER$$$$$$Y$$$20240822$$CN$US$US
242388141$24238814$1$I$$20240812$20240822$20240822$EXP$$CN-BAYER-2024A118450$BAYER$Jin S; Shen ZY; Li J; Liu XG; Zhu QF; Li F; Shi YQ; Lin P; Xu XL; Chen XH; Geng XM; Ding XQ; Liu H. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. Journal of Clinical Pathology. 2024;77:7:471-477$6$DEC$A$M$Y$$$20240822$$MD$CN$CN
242388172$24238817$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234653$TEVA$Gillespie L, Diaz M, Gorder K, Shaw C, Ahmad S, Hinckley W, et al. The Successful Rotor Wing Transport of 2 Patients Requiring Biventricular Impella Support: A Case Series and Review. [Review]. Air-Med-J 2023; 42 499-503; Gillespie L, Diaz M, Gorder K, Shaw C, Ahmad S, Hinckley W, et al. The Successful Rotor Wing Transport of 2 Patients Requiring Biventricular Impella Support: A Case Series and Review. [Review]. Air-Med-J 2023; 42 499-503.$81$YR$$F$Y$$$20240909$$HP$US$US
242388183$24238818$3$F$20240814$20240820$20240822$20240830$EXP$$ES-ABBVIE-5889209$ABBVIE$$83$YR$$F$Y$$$20240829$$MD$ES$ES
242388202$24238820$2$F$$20240909$20240822$20240909$PER$$US-BAYER-2024A120791$BAYER$$$$$F$Y$$$20240909$$CN$US$US
242388221$24238822$1$I$$20240809$20240822$20240822$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK093294$GLENMARK$Gupta D, Singh L, Kumar S, Singh K, Mendonca S, Chatterjee T.. Rare complications of heart transplant: Autopsy findings.. Indian Journal of Pathology and Microbiology.. 2024;67 (3):624-7$$$$$Y$$$20240822$$MD$IN$IN
242388231$24238823$1$I$20240704$20240812$20240822$20240822$EXP$$FR-009507513-2408FRA005299$MERCK$$69$YR$$M$Y$$$20240822$$CN$FR$FR
242388241$24238824$1$I$20240706$20240820$20240822$20240822$EXP$AU-TGA-0000816439$AU-SANDOZ INC.-SDZ2024AU073941$SANDOZ$$21$YR$$F$Y$$$20240822$$PH$AU$AU
242388251$24238825$1$I$$20240809$20240822$20240822$PER$$US-BAYER-2024A115560$BAYER$$$$$$Y$$$20240822$$CN$US$US
242388261$24238826$1$I$$20240819$20240822$20240822$PER$$US-ABBVIE-5889497$ABBVIE$$$$$$Y$$$20240822$$HP$US$US
242388271$24238827$1$I$$20240821$20240822$20240822$EXP$$US-INCYTE CORPORATION-2024IN008770$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242388281$24238828$1$I$20240806$20240814$20240822$20240822$EXP$IT-MINISAL02-998526$IT-PFIZER INC-202400236339$PFIZER$$44$YR$$$Y$$$20240822$$MD$IT$IT
242388291$24238829$1$I$$20240816$20240822$20240822$EXP$$CN-PFIZER INC-PV202400107339$PFIZER$$$$A$M$Y$$$20240822$$CN$CN$CN
242388301$24238830$1$I$$20240813$20240822$20240822$EXP$$US-HLS-202400885$HLS THERAPEUTICS$$$$A$$Y$$$20240822$$HP$US$US
242388311$24238831$1$I$20240101$20240807$20240822$20240822$EXP$$US-PARI RESPIRATORY EQUIPMENT, INC.-2024PAR00058$PARI RESPIRATORY EQUIPMENT$$$$$M$Y$28.209$KG$20240822$$HP$US$US
242388322$24238832$2$F$20230728$20240819$20240822$20240826$EXP$$JP-PFIZER INC-202400240156$PFIZER$$72$YR$$$Y$50.2$KG$20240826$$MD$JP$JP
242388331$24238833$1$I$$20240810$20240822$20240822$EXP$$GB-B.Braun Medical Inc.-2160743$B BRAUN$$47$YR$$F$Y$$$20240822$$$GB$GB
242388341$24238834$1$I$$20240821$20240822$20240822$EXP$$US-GILEAD-2024-0684985$GILEAD$$70$YR$E$M$Y$$$20240822$$MD$US$US
242388351$24238835$1$I$20240101$20240814$20240822$20240822$EXP$$US-INDIVIOR US-INDV-156063-2024$RECKITT BENCKISER$$$$$$Y$$$20240822$$CN$US$US
242388361$24238836$1$I$20240719$20240723$20240822$20240822$PER$$US-FMCRTG-FMC-2407-000906$FRESENIUS MEDICAL CARE$$40$YR$A$M$Y$107$KG$20240822$$HP$US$US
242388371$24238837$1$I$$20240720$20240822$20240822$PER$$US-FMCRTG-FMC-2407-000888$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240822$$HP$US$US
242388381$24238838$1$I$$20240719$20240822$20240822$PER$$US-FMCRTG-FMC-2407-000875$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240822$$CN$US$US
242388391$24238839$1$I$$20240718$20240822$20240822$PER$$US-FMCRTG-FMC-2407-000903$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240822$$CN$US$US
242388401$24238840$1$I$$20240619$20240822$20240822$PER$$US-FMCRTG-FMC-2406-000746$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240822$$HP$US$US
242388411$24238841$1$I$20240802$20240814$20240822$20240822$EXP$CN-91110000556821568D-2024DRL001537$CN-RDY-SPO/CHN/24/0011984$DR REDDYS$$71$YR$E$F$Y$50$KG$20240822$$HP$CN$CN
242388421$24238842$1$I$20240718$20240719$20240822$20240822$PER$$US-FMCRTG-FMC-2407-000878$FRESENIUS MEDICAL CARE$$67$YR$E$F$Y$$$20240822$$HP$US$US
242388431$24238843$1$I$20240810$20240816$20240822$20240822$EXP$CN-91110000556821568D-2024DRL001548$CN-RDY-SPO/CHN/24/0012095$DR REDDYS$$83$YR$E$F$Y$$$20240822$$HP$CN$CN
242388441$24238844$1$I$20240726$20240818$20240822$20240822$EXP$CN-91110000556821568D-2024DRL001559$CN-RDY-SPO/CHN/24/0012101$DR REDDYS$$30$YR$A$M$Y$73$KG$20240822$$HP$CN$CN
242388451$24238845$1$I$$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129022$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240822$$HP$US$US
242388471$24238847$1$I$$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129603$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240822$$CN$US$US
242388481$24238848$1$I$$20240820$20240822$20240822$EXP$$LB-BRISTOL-MYERS SQUIBB COMPANY-2024-132358$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240822$$HP$LB$LB
242388491$24238849$1$I$$20240821$20240822$20240822$EXP$$JP-BAYER-2024A118673$BAYER$$$$$F$Y$$$20240822$$PH$JP$JP
242388501$24238850$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A186341$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242388511$24238851$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A187596$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242388522$24238852$2$F$20240301$20240821$20240822$20240823$EXP$$NVSC2024US170024$NOVARTIS$$$$$M$Y$$$20240823$$HP$US$US
242388531$24238853$1$I$20240701$20240819$20240822$20240822$EXP$$JP-AstraZeneca-2024A190167$ASTRAZENECA$$90$YR$$M$Y$$$20240822$$MD$JP$
242388541$24238854$1$I$$20240819$20240822$20240822$EXP$$MX-AstraZeneca-2024A187949$ASTRAZENECA$Chavez Moreira D.;  Grosu H.B.. Airway Injury Related to Radiation Treatment and Durvalumab Treatment: A Case Series. Journal of bronchology +  interventional pulmonology 2024;31(4):$70$YR$$M$Y$$$20240822$$MD$MX$
242388551$24238855$1$I$$20240819$20240822$20240822$EXP$$MX-AstraZeneca-2024A187914$ASTRAZENECA$Chavez Moreira D.;  Grosu H.B.. Airway Injury Related to Radiation Treatment and Durvalumab Treatment: A Case Series. Journal of bronchology +  interventional pulmonology 2024;31(4):$65$YR$$M$Y$$$20240822$$MD$MX$
242388561$24238856$1$I$$20230612$20240822$20240822$EXP$$US-AstraZeneca-2023A137920$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242388571$24238857$1$I$20220101$20240814$20240822$20240822$EXP$$NL-AstraZeneca-2024A184881$ASTRAZENECA$$60$YR$$F$Y$102$KG$20240822$$MD$NL$
242388581$24238858$1$I$20210101$20240813$20240822$20240822$EXP$$US-Amarin Pharma, Inc-2024AMR000431$AMARIN$$61$YR$A$F$Y$$$20240822$$CN$US$US
242388592$24238859$2$F$$20240829$20240822$20240829$EXP$$AU-BAYER-2024A120165$BAYER$$$$$$Y$$$20240829$$HP$AU$AU
242388602$24238860$2$F$$20240809$20240822$20240822$EXP$$GB-B.Braun Medical Inc.-2160744$B BRAUN$$$$$$Y$$$20240822$$$GB$GB
242388611$24238861$1$I$20240109$20240816$20240822$20240822$EXP$$CN-009507513-2408CHN007022$MERCK$$71$YR$$M$Y$$$20240822$$HP$CN$CN
242388642$24238864$2$F$20240801$20240821$20240822$20240829$EXP$$CA-Amarin Pharma, Inc-2024AMR000432$AMARIN$$62$YR$A$M$Y$$$20240829$$CN$CA$CA
242388651$24238865$1$I$20240731$20240820$20240822$20240822$EXP$ES-AEMPS-1561630$ES-JNJFOC-20240855565$JOHNSON AND JOHNSON$$54$YR$A$M$Y$118.6$KG$20240822$$MD$ES$ES
242388661$24238866$1$I$20231116$20240821$20240822$20240822$EXP$$NVSC2024AU169946$NOVARTIS$$30$YR$$M$Y$$$20240822$$PH$AU$AU
242388672$24238867$2$F$20240821$20240823$20240822$20240823$EXP$$CA-BAYER-2024A120620$BAYER$$31$YR$A$F$Y$$$20240823$$HP$CA$CA
242388681$24238868$1$I$20240728$20240813$20240822$20240822$EXP$$CN-ROCHE-10000056402$ROCHE$$56$YR$A$M$Y$70$KG$20240822$$HP$CN$CN
242388691$24238869$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5888307$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242388701$24238870$1$I$20240101$20240819$20240822$20240822$EXP$$FR-SANDOZ INC.-SDZ2024FR071880$SANDOZ$$84$YR$$F$Y$$$20240822$$MD$FR$FR
242388711$24238871$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004177$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242388722$24238872$2$F$20240815$20240820$20240822$20240828$EXP$$US-AMGEN-USASP2024163981$AMGEN$$70$YR$E$F$Y$$$20240828$$CN$US$US
242388731$24238873$1$I$$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57865$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
242388741$24238874$1$I$20240308$20240815$20240822$20240822$EXP$$CO-GSK-CO2024AMR086073$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$CO$CO
242388751$24238875$1$I$$20240815$20240822$20240822$PER$$US-ROCHE-10000060232$ROCHE$$29$YR$A$F$Y$$$20240822$$CN$US$US
242388761$24238876$1$I$20240731$20240815$20240822$20240822$EXP$$CN-GSK-CN2024GSK104098$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$CN$CN
242388791$24238879$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5888302$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242388802$24238880$2$F$$20240913$20240822$20240917$PER$$US-ROCHE-10000060487$ROCHE$$$$I$M$Y$$$20240917$$CN$US$US
242388811$24238881$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57866$$FDA-CTU$$76$YR$$F$N$$$20240822$N$$US$
242388823$24238882$3$F$20240819$20240828$20240822$20240828$EXP$$ZA-BAYER-2024A119017$BAYER$$51$YR$A$F$Y$$$20240828$$CN$ZA$ZA
242388831$24238883$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004139$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242388841$24238884$1$I$$20240813$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA072739$SANDOZ$$40$YR$$F$Y$$$20240822$$HP$CA$CA
242388852$24238885$2$F$20231001$20240819$20240822$20240904$EXP$$US-ORGANON-O2408USA001389$ORGANON$$$$$$Y$$$20240904$$CN$US$US
242388861$24238886$1$I$$20240730$20240822$20240822$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004151$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240822$$CN$US$US
242388871$24238887$1$I$20240801$20240813$20240822$20240822$EXP$$US-HLS-202400880$HLS THERAPEUTICS$$61$YR$A$$Y$$$20240822$$HP$US$US
242388881$24238888$1$I$20240725$20240820$20240822$20240822$EXP$FR-AFSSAPS-MP2024001272$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-131417$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$53$KG$20240822$$PH$FR$FR
242388891$24238889$1$I$20240101$20240820$20240822$20240822$EXP$$US-ABBVIE-5888414$ABBVIE$$$$$$Y$$$20240822$$HP$US$US
242388902$24238890$2$F$20240731$20240904$20240822$20240910$PER$$US-ROCHE-10000062443$ROCHE$$11$YR$C$M$Y$35.2$KG$20240910$$HP$US$US
242388911$24238891$1$I$$20240812$20240822$20240822$EXP$$CN-BAYER-2024A118453$BAYER$Jin S; Shen ZY; Li J; Liu XG; Zhu QF; Li F; Shi YQ; Lin P; Xu XL; Chen XH; Geng XM; Ding XQ; Liu H. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy~. Journal of Clinical Pathology. 2024;77(7):471-477$7$DEC$E$M$Y$$$20240822$$MD$CN$CN
242388921$24238892$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5887409$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242388931$24238893$1$I$$20240821$20240822$20240822$PER$$US-ROCHE-10000062672$ROCHE$$$$A$M$Y$$$20240822$$CN$US$US
242388941$24238894$1$I$$20240821$20240822$20240822$PER$$US-ROCHE-10000063074$ROCHE$$$$A$M$Y$$$20240822$$CN$US$US
242388951$24238895$1$I$$20240809$20240822$20240822$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001174$ALEMBIC$Czech M, Cuellar-Rodriguez J, Patel B.A, Groarke E.M, Cowen E.W, Turturice B. et.al.. Opportunistic Infections, Mortality Risk, and Prevention Strategies in Patients With Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome. Open Forum Infectious Diseases. 2024;11 (7) ofae405:1-9$$$$$Y$$$20240822$$HP$US$US
242388971$24238897$1$I$20240815$20240821$20240822$20240822$EXP$$IL-ABBVIE-5889128$ABBVIE$$84$YR$$M$Y$$$20240822$$CN$IL$IL
242388982$24238898$2$F$$20240829$20240822$20240906$EXP$$US-TEVA-VS-3234485$TEVA$Khattar G, Makram M, Rabah H, Hong C, Khan S, Mourad O, et al. Catastrophic Convergence: Refractory Septic Shock and Multisystem Failure in a Case of Hidradenitis Suppurativa Complicated by Fournier^s Gangrene and Bilateral Pulmonary Embolism. Am-J-Respir-Crit-Care-Med 2024; 209 A1614.; Khattar G, Makram M, Rabah H, Hong C, Khan S, Mourad O, et al. Catastrophic Convergence: Refractory Septic Shock and Multisystem Failure in a Case of Hidradenitis Suppurativa Complicated by Fournier^s Gangrene...$53$YR$$F$Y$$$20240906$$HP$US$US
242388991$24238899$1$I$$20240815$20240822$20240822$EXP$$US-TAKEDA-2024TUS082881$TAKEDA$$$$$M$Y$$$20240822$$CN$US$US
242389001$24238900$1$I$20240101$20240820$20240822$20240822$EXP$$MX-ABBVIE-5889372$ABBVIE$$$$$M$Y$$$20240822$$CN$MX$MX
242389013$24238901$3$F$20190101$20240826$20240822$20240830$EXP$$ZA-PFIZER INC-PV202400109046$PFIZER$$$$$M$Y$$$20240830$$CN$ZA$ZA
242389021$24238902$1$I$20240527$20240816$20240822$20240822$EXP$GB-MHRA-MED-202408161618581580-PRYWC$GB-EMD Serono-2024044420$EMD SERONO INC$$39$YR$A$F$Y$$$20240822$$HP$GB$GB
242389031$24238903$1$I$20240701$20240820$20240822$20240822$EXP$$JP-PFIZER INC-PV202400107935$PFIZER$$77$YR$$F$Y$37.8$KG$20240822$$MD$JP$JP
242389042$24238904$2$F$$20240829$20240822$20240906$EXP$$DE-TEVA-VS-3234237$TEVA$Bingert R, Kolbe V, Boy D, Buttner A. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. [German]. Rechtsmedizin 2023; 33 (5): 396-402.; Bingert R, Kolbe V, Boy D, Buttner A. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. [German]. Rechtsmedizin 2023; 33 (5): 396-402.$17$YR$$M$Y$$$20240906$$HP$DE$DE
242389051$24238905$1$I$$20240723$20240822$20240822$PER$$US-009507513-2407USA013108$MERCK$Thawley J, Colbert C, Eilbert W.. Acute retinal necrosis. American Journal of Emergency Medicine. 2024;82:216.e1- 3$32$YR$$M$Y$$$20240822$$MD$US$US
242389061$24238906$1$I$20240701$20240821$20240821$20240821$DIR$715393$$FDA-CTU$$66$YR$$F$N$103.5$KG$20240821$N$CN$US$
242389071$24238907$1$I$20240814$20240821$20240821$20240821$DIR$715387$$FDA-CTU$$86$YR$$F$N$84.3$KG$20240821$N$PH$US$
242389081$24238908$1$I$20240717$20240821$20240821$20240821$DIR$715436$$FDA-CTU$$25$YR$$F$N$82.35$KG$20240821$N$CN$US$
242389101$24238910$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57914$$FDA-CTU$$91$YR$$F$N$$$20240822$N$$US$
242389111$24238911$1$I$$20240821$20240821$20240821$DIR$715438$$FDA-CTU$$$$$F$N$$$20240821$Y$HP$US$
242389121$24238912$1$I$20240820$20240821$20240821$20240821$DIR$715405$$FDA-CTU$$36$YR$$F$N$69.75$KG$20240821$N$CN$US$
242389131$24238913$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57913$$FDA-CTU$$45$YR$$F$N$$$20240822$N$$US$
242389151$24238915$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57916$$FDA-CTU$$46$YR$$F$N$$$20240822$N$CN$US$
242389161$24238916$1$I$$20240821$20240821$20240821$DIR$715443$$FDA-CTU$$45$YR$$F$N$$$20240821$N$CN$US$
242389181$24238918$1$I$20240628$20240821$20240821$20240821$DIR$715444$$FDA-CTU$$39$YR$$F$N$82.8$KG$20240821$N$CN$US$
242389191$24238919$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57899$$FDA-CTU$$61$YR$$F$N$$$20240822$N$$US$
242389241$24238924$1$I$$20240815$20240822$20240822$EXP$$US-GSK-US2024102378$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242389251$24238925$1$I$20240601$20240815$20240822$20240822$EXP$$US-ABBVIE-5883383$ABBVIE$$81$YR$$M$Y$$$20240822$$CN$US$US
242389261$24238926$1$I$20240812$20240812$20240822$20240822$PER$$US-BAYER-2024A116206$BAYER$$13$YR$T$M$Y$$$20240822$$CN$US$US
242389271$24238927$1$I$20240627$20240814$20240822$20240822$EXP$$CN-SA-2024SA245981$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240822$$HP$CN$CN
242389281$24238928$1$I$20240819$20240819$20240822$20240822$EXP$$GB-MYLANLABS-2024M1077046$MYLAN$$$$$F$Y$$$20240822$$PH$GB$GB
242389293$24238929$3$F$20240701$20240828$20240822$20240902$EXP$$CA-AstraZeneca-2024A189884$ASTRAZENECA$$937$MON$$M$Y$$$20240902$$MD$CA$
242389301$24238930$1$I$$20240814$20240822$20240822$EXP$$GB-SA-2024SA243825$SANOFI AVENTIS$$81$YR$E$M$Y$82$KG$20240822$$MD$GB$GB
242389311$24238931$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A186387$ASTRAZENECA$$$$$F$Y$$$20240822$$HP$US$
242389331$24238933$1$I$$20240821$20240821$20240821$DIR$715407$$FDA-CTU$$$$$UNK$N$$$20240821$$CN$US$
242389341$24238934$1$I$$20240819$20240822$20240822$EXP$$JP-PFIZER INC-PV202400108455$PFIZER$Kumagai, A.. A case of septic shock in a patient with ovarian endometriotic cyst complicated by rheumatoid arthritis, triggered by ovarian abscess. The Journal of Japan Society for Menopause and Women^s Health. 2024;31(4):682-687$45$YR$$F$Y$$$20240822$$HP$JP$JP
242389351$24238935$1$I$20231206$20240814$20240822$20240822$EXP$$ES-AstraZeneca-2024A184824$ASTRAZENECA$$63$YR$$F$Y$$$20240822$$MD$ES$
242389361$24238936$1$I$20240811$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57890$$FDA-CTU$$56$YR$$M$N$$$20240822$N$HP$US$
242389371$24238937$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A185915$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242389381$24238938$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A185701$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242389391$24238939$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57927$$FDA-CTU$$20$YR$$M$N$72.12$KG$20240822$N$$US$
242389401$24238940$1$I$20240821$20240821$20240821$20240821$DIR$715445$$FDA-CTU$$21$YR$$F$N$119.25$KG$20240821$$CN$US$
242389412$24238941$2$F$$20240829$20240822$20240906$EXP$$KR-AstraZeneca-2024A187164$ASTRAZENECA$Park N.H.; Park B.H.; Kwon H.J.; Park S.W.; Byon I.. Bilateral Hemorrhagic Occlusive Retinal Vasculitis Induced by Osimertinib in a Patient with Non-Small Cell Lung Cancer. Ocular Immunology and Inflammation 2024;$58$YR$$F$Y$$$20240906$$HP$KR$
242389421$24238942$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A186382$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242389431$24238943$1$I$$20240814$20240822$20240822$PER$$US-AstraZeneca-2024A185860$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242389441$24238944$1$I$20240809$20240821$20240821$20240821$DIR$715413$$FDA-CTU$$5$YR$$M$N$17.1$KG$20240821$N$PH$US$
242389451$24238945$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57918$$FDA-CTU$$74$YR$$M$N$$$20240822$N$$US$
242389471$24238947$1$I$20240728$20240816$20240822$20240822$EXP$$CN-SA-2024SA248275$SANOFI AVENTIS$$71$YR$E$F$Y$82$KG$20240822$$HP$CN$CN
242389481$24238948$1$I$$20240809$20240822$20240822$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093297$GLENMARK$Velez MG, Suero-Abreu G, Duma N, Gutierrez M, Singh TP.. Immune-related myocarditis and conduction abnormalities secondary to combination immunotherapy treatment with ipilimumab/nivolumab in a patient with merkel cell carcinoma.. Journal of the American College of Cardiology.. 2018;71 (11)$$$$$Y$$$20240822$$HP$US$US
242389491$24238949$1$I$20240808$20240821$20240821$20240821$DIR$715421$$FDA-CTU$$34$YR$$F$N$57$KG$20240821$N$CN$US$
242389501$24238950$1$I$$20240815$20240822$20240822$EXP$$ZA-SANOFI-AVENTIS R+D-2024SA245144$SANOFI AVENTIS$$$$A$F$Y$$$20240822$$HP$ZA$ZA
242389521$24238952$1$I$20240727$20240815$20240822$20240822$EXP$$LB-SA-2024SA245706$SANOFI AVENTIS$$$$$$Y$$$20240822$$MD$LB$LB
242389531$24238953$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130930$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240822$$HP$US$US
242389541$24238954$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132236$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$102.97$KG$20240822$$CN$US$US
242389551$24238955$1$I$20240801$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131980$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240822$$PH$US$US
242389561$24238956$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5889418$ABBVIE$$$$$F$Y$$$20240822$$HP$US$US
242389572$24238957$2$F$$20240814$20240822$20240829$EXP$$IT-INCYTE CORPORATION-2024IN008707$INCYTE$$$$$$Y$$$20240829$$MD$IT$IT
242389591$24238959$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5885998$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242389601$24238960$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013976$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240822$$CN$US$US
242389611$24238961$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012729$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240822$$CN$US$US
242389621$24238962$1$I$20240817$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012530$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240822$$CN$US$US
242389631$24238963$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013784$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240822$$CN$US$US
242389641$24238964$1$I$20240811$20240812$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012083$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242389651$24238965$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013468$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240822$$CN$US$US
242389661$24238966$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012301$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240822$$CN$US$US
242389681$24238968$1$I$$20240814$20240822$20240822$PER$$ZA-REGENERON PHARMACEUTICALS, INC.-2024-114809$REGENERON$$$$$M$Y$$$20240822$$CN$ZA$ZA
242389692$24238969$2$F$$20240819$20240822$20240901$PER$$US-AMGEN-USASP2024165210$AMGEN$$$$$F$Y$$$20240901$$CN$US$US
242389703$24238970$3$F$20240816$20240823$20240822$20240827$PER$$US-AMGEN-USASP2024165150$AMGEN$$77$YR$E$$Y$$$20240827$$CN$US$US
242389711$24238971$1$I$$20240809$20240822$20240822$EXP$$IT-B.Braun Medical Inc.-2160747$B BRAUN$$25$YR$$M$Y$$$20240822$$$IT$IT
242389721$24238972$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA247658$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240822$$MD$US$US
242389732$24238973$2$F$20240802$20240925$20240822$20240930$30DAY$ES-AEMPS-1561335$ES-PFIZER INC-202400238838$PFIZER$$1$YR$$M$Y$11$KG$20240930$$MD$ES$ES
242389741$24238974$1$I$20200610$20240819$20240822$20240822$EXP$$CA-TAKEDA-2020TUS021418$TAKEDA$$50$YR$$F$Y$$$20240822$$MD$CA$CA
242389761$24238976$1$I$$20240815$20240822$20240822$PER$$US-BAYER-2024A118313$BAYER$$$$$F$Y$$$20240822$$CN$US$US
242389771$24238977$1$I$$20240820$20240822$20240822$PER$$US-JNJFOC-20240851700$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$MD$US$US
242389782$24238978$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234593$TEVA$Singh AD, Kurin M. An Unusual Case of Refractory Esophagitis and Esophageal Diverticulum. Dig-Dis-Sci 2024; 69 (6): 1913-1914.; Singh AD, Kurin M. An Unusual Case of Refractory Esophagitis and Esophageal Diverticulum. Dig-Dis-Sci 2024; 69 (6): 1913-1914.; Singh AD, Kurin M. An Unusual Case of Refractory Esophagitis and Esophageal Diverticulum. Dig-Dis-Sci 2024; 69 (6): 1913-1914.$76$YR$$F$Y$$$20240909$$HP$US$US
242389792$24238979$2$F$$20240829$20240822$20240903$EXP$$US-SA-2024SA249492$SANOFI AVENTIS$$$$E$F$Y$$$20240903$$MD$US$US
242389811$24238981$1$I$$20240822$20240822$20240822$DIR$715454$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242389821$24238982$1$I$$20240822$20240822$20240822$DIR$715451$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242389841$24238984$1$I$20240101$20240809$20240822$20240822$EXP$$US-ENDO USA, INC.-2024-003178$ENDO$$$$$M$Y$$$20240822$$CN$US$US
242389851$24238985$1$I$$20240812$20240822$20240822$PER$$US-MYLANLABS-2024M1075899$MYLAN$$$$$F$Y$$$20240822$$CN$US$US
242389861$24238986$1$I$20240401$20240814$20240822$20240822$EXP$$DE-TAKEDA-2024TUS082954$TAKEDA$$60$YR$$M$Y$$$20240822$$CN$DE$DE
242389872$24238987$2$F$$20240926$20240822$20240930$PER$$US-ALXN-202408USA000869US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
242389881$24238988$1$I$$20240815$20240822$20240822$PER$$US-BAYER-2024A118583$BAYER$$23$YR$A$F$Y$$$20240822$$MD$US$US
242389901$24238990$1$I$20240101$20240812$20240822$20240822$EXP$$US-009507513-2408USA004253$MERCK$$$$$M$Y$$$20240822$$HP$US$US
242389912$24238991$2$F$$20240926$20240822$20240926$30DAY$$CL-PFIZER INC-202400236577$PFIZER$$10$YR$$$Y$$$20240926$$CN$CL$CL
242389921$24238992$1$I$$20240723$20240822$20240822$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005215$BIOCON$$$$$$Y$$$20240822$$CN$US$US
242389931$24238993$1$I$$20240712$20240822$20240822$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005225$BIOCON$$$$$$Y$$$20240822$$CN$US$US
242389941$24238994$1$I$$20240808$20240822$20240822$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005453$BIOCON$$$$$$Y$$$20240822$$CN$US$US
242389951$24238995$1$I$$20240801$20240822$20240822$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005493$BIOCON$$$$$$Y$$$20240822$$PH$US$US
242389961$24238996$1$I$$20240729$20240822$20240822$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005359$BIOCON$$$$$$Y$$$20240822$$CN$US$US
242389971$24238997$1$I$$20240805$20240822$20240822$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005594$BIOCON$$$$$$Y$$$20240822$$CN$US$US
242389981$24238998$1$I$$20240814$20240822$20240822$EXP$$CN-TAKEDA-2024TUS083066$TAKEDA$$76$DY$$M$Y$$$20240822$$MD$CN$CN
242389992$24238999$2$F$$20240903$20240822$20240906$EXP$$AT-TAKEDA-2024TUS082268$TAKEDA$$$$A$F$Y$$$20240906$$CN$AT$AT
242390001$24239000$1$I$$20240821$20240822$20240822$EXP$$NVSC2024US169627$NOVARTIS$$$$$$Y$$$20240822$$CN$US$US
242390011$24239001$1$I$20240725$20240725$20240822$20240822$PER$$US-Eisai-EC-2024-170941$EISAI$$$$$F$Y$$$20240822$$CN$US$US
242390021$24239002$1$I$$20240816$20240822$20240822$PER$$US-TPU-TPU-2024-00440$TEIKOKU$$$$$F$Y$81.65$KG$20240822$$CN$US$US
242390031$24239003$1$I$$20240814$20240822$20240822$PER$$US-TPU-TPU-2024-00439$TEIKOKU$$$$$M$Y$$$20240822$$CN$US$US
242390041$24239004$1$I$$20240813$20240822$20240822$PER$$US-TPU-TPU-2024-00438$TEIKOKU$$$$$F$Y$$$20240822$$CN$US$US
242390051$24239005$1$I$$20240819$20240822$20240822$PER$$US-TPU-TPU-2024-00443$TEIKOKU$$$$$F$Y$$$20240822$$CN$US$US
242390061$24239006$1$I$20240812$20240813$20240822$20240822$PER$$US-TPU-TPU-2024-00435$TEIKOKU$$92$YR$E$F$Y$$$20240822$$CN$US$US
242390071$24239007$1$I$20240808$20240813$20240822$20240822$PER$$US-TPU-TPU-2024-00437$TEIKOKU$$60$YR$A$M$Y$$$20240822$$CN$US$US
242390081$24239008$1$I$20200130$20240814$20240822$20240822$PER$$US-TPU-TPU2020-00065$TEIKOKU$$91$YR$E$F$Y$71.67$KG$20240822$$CN$US$US
242390091$24239009$1$I$$20240812$20240822$20240822$PER$$US-RDY-CLI/USA/24/0011945$DR REDDYS$$31$YR$A$F$Y$$$20240822$$CN$US$US
242390101$24239010$1$I$20240812$20240814$20240822$20240822$EXP$$US-INSMED, INC.-2024-03306-US$INSMED$$76$YR$$M$Y$$$20240822$$CN$US$US
242390111$24239011$1$I$$20240814$20240822$20240822$EXP$$US-INSMED, INC.-2024-03307-US$INSMED$$$$$M$Y$$$20240822$$CN$US$US
242390121$24239012$1$I$20240101$20240814$20240822$20240822$EXP$$DE-INSMED-2024-02643-DEAA$INSMED$$67$YR$$M$Y$$$20240822$$HP$DE$DE
242390141$24239014$1$I$20230101$20240813$20240822$20240822$EXP$$US-INSMED, INC.-2023-04204-US$INSMED$$$$$F$Y$$$20240822$$CN$US$US
242390151$24239015$1$I$$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131398$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240822$$CN$US$US
242390161$24239016$1$I$20240701$20240808$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127088$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240822$$CN$US$US
242390171$24239017$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132288$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240822$$HP$US$US
242390181$24239018$1$I$$20240814$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128994$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$98.88$KG$20240822$$CN$US$US
242390191$24239019$1$I$20240405$20240816$20240822$20240822$PER$$US-BAYER-2024A118932$BAYER$$30$YR$A$F$Y$$$20240822$$HP$US$US
242390201$24239020$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5887284$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242390212$24239021$2$F$20240426$20240903$20240822$20240905$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046198$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240905$$CN$US$US
242390221$24239022$1$I$$20240820$20240822$20240822$PER$$US-ABBVIE-5889861$ABBVIE$$$$$$Y$$$20240822$$HP$US$US
242390231$24239023$1$I$$20240819$20240822$20240822$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006500$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242390251$24239025$1$I$$20240809$20240822$20240822$EXP$$NO-TEVA-VS-3235350$TEVA$$26$YR$$M$Y$$$20240822$$MD$NO$NO
242390261$24239026$1$I$$20240811$20240822$20240822$EXP$GB-MHRA-MED-202408112206023550-QKDCN$GB-GLENMARK PHARMACEUTICALS-2024GMK093320$GLENMARK$$$$$$Y$$$20240822$$CN$GB$GB
242390271$24239027$1$I$$20240814$20240822$20240822$EXP$$AU-AstraZeneca-2024A187868$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$AU$
242390281$24239028$1$I$20240801$20240817$20240822$20240822$PER$$US-BAYER-2024A119806$BAYER$$$$$F$Y$$$20240822$$CN$US$US
242390291$24239029$1$I$$20230424$20240822$20240822$EXP$$US-AstraZeneca-2023A057496$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242390301$24239030$1$I$$20240820$20240822$20240822$PER$$US-ABBVIE-5890138$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242390311$24239031$1$I$$20240822$20240822$20240822$DIR$715449$$FDA-CTU$$$$$UNK$N$$$20240822$N$$US$
242390324$24239032$4$F$20240818$20240906$20240822$20240911$EXP$$CA-AstraZeneca-2024A191307$ASTRAZENECA$$25325$DY$$F$Y$$$20240911$$CN$CA$
242390331$24239033$1$I$20240806$20240814$20240822$20240822$EXP$$CN-AstraZeneca-2024A187349$ASTRAZENECA$$71$YR$$M$Y$62$KG$20240822$$MD$CN$
242390341$24239034$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57931$$FDA-CTU$$92$YR$$F$N$$$20240822$N$$US$
242390351$24239035$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57928$$FDA-CTU$$79$YR$$F$N$$$20240822$N$$US$
242390361$24239036$1$I$20240820$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57930$$FDA-CTU$$70$YR$$F$N$$$20240822$N$$US$
242390371$24239037$1$I$$20240816$20240822$20240822$EXP$$PH-AstraZeneca-2024A187382$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$PH$
242390381$24239038$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A187216$ASTRAZENECA$$$$$F$Y$$$20240822$$HP$US$
242390391$24239039$1$I$$20240815$20240822$20240822$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046193$BOEHRINGER INGELHEIM$$$$$M$Y$118$KG$20240822$$CN$US$US
242390401$24239040$1$I$20240802$20240816$20240822$20240822$EXP$FR-AFSSAPS-MP2024001285$NVSC2024FR166542$NOVARTIS$$70$YR$$F$Y$52.5$KG$20240822$$MD$FR$FR
242390412$24239041$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234489$TEVA$Tidwell J, Thakkar B, Nguyen MTT, Parker S, Schoenfeld A. Primary Hepatic Neuroendocrine Carcinoma: A Rare Entity. ACG-Case-Rep-J 2024; 11 (7):.; Tidwell J, Thakkar B, Nguyen MTT, Parker S, Schoenfeld A. Primary Hepatic Neuroendocrine Carcinoma: A Rare Entity. ACG-Case-Rep-J 2024; 11 (7):.$65$YR$$M$Y$$$20240909$$HP$US$US
242390421$24239042$1$I$$20240819$20240822$20240822$PER$$US-MYLANLABS-2024M1077629$MYLAN$$$$$M$Y$$$20240822$$CN$US$US
242390441$24239044$1$I$$20240816$20240822$20240822$PER$$US-ALXN-202408USA001091US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240822$$HP$US$US
242390451$24239045$1$I$20240726$20240813$20240822$20240822$EXP$$DE-TEVA-VS-3233454$TEVA$$66$YR$$F$Y$$$20240822$$MD$DE$DE
242390463$24239046$3$F$$20240827$20240822$20240906$EXP$$IL-TEVA-VS-3229047$TEVA$$77$YR$$M$Y$$$20240906$$HP$IL$IL
242390471$24239047$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57911$$FDA-CTU$$85$YR$$F$N$$$20240822$N$$US$
242390481$24239048$1$I$$20240822$20240822$20240822$DIR$715458$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242390491$24239049$1$I$20240414$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57827$$FDA-CTU$$64$YR$$F$N$74.4$KG$20240821$N$$US$
242390501$24239050$1$I$$20240822$20240822$20240822$DIR$715455$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242390511$24239051$1$I$20240821$20240822$20240822$20240822$DIR$715464$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242390521$24239052$1$I$$20240822$20240822$20240822$DIR$715470$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242390531$24239053$1$I$$20240822$20240822$20240822$DIR$715456$$FDA-CTU$$$$$UNK$N$$$20240822$$CN$US$
242390541$24239054$1$I$$20240822$20240822$20240822$DIR$715460$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242390551$24239055$1$I$20240814$20240820$20240822$20240822$PER$$US-BAYER-2024A120163$BAYER$$29$YR$A$F$Y$$$20240822$$HP$US$US
242390561$24239056$1$I$$20240820$20240822$20240822$PER$$US-BAYER-2024A119874$BAYER$$20$YR$A$F$Y$$$20240822$$MD$US$US
242390571$24239057$1$I$$20240820$20240822$20240822$PER$$US-BAYER-2024A120585$BAYER$$42$YR$A$F$Y$$$20240822$$HP$US$US
242390581$24239058$1$I$20240601$20240621$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00375$AVADEL CNS PHARMA$$34$YR$$F$Y$$$20240822$$CN$US$US
242390591$24239059$1$I$$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00179$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242390601$24239060$1$I$20240601$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01386$AVADEL CNS PHARMA$$53$YR$$F$Y$$$20240821$$CN$US$US
242390611$24239061$1$I$20240101$20240506$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00768$AVADEL CNS PHARMA$$$$$M$Y$$$20240821$$CN$US$US
242390621$24239062$1$I$20240101$20240621$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01044$AVADEL CNS PHARMA$$$$$M$Y$$$20240821$$CN$US$US
242390631$24239063$1$I$20240101$20240531$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00903$AVADEL CNS PHARMA$$$$$F$Y$$$20240821$$CN$US$US
242390641$24239064$1$I$20240101$20240705$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01156$AVADEL CNS PHARMA$$$$$F$Y$$$20240820$$CN$US$US
242390651$24239065$1$I$20240714$20240716$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01246$AVADEL CNS PHARMA$$20$YR$$F$Y$$$20240820$$CN$US$US
242390661$24239066$1$I$20240701$20240719$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01273$AVADEL CNS PHARMA$$29$YR$$M$Y$$$20240820$$CN$US$US
242390671$24239067$1$I$20240701$20240724$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01299$AVADEL CNS PHARMA$$61$YR$$F$Y$$$20240820$$CN$US$US
242390681$24239068$1$I$20240401$20240503$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00752$AVADEL CNS PHARMA$$36$YR$$M$Y$$$20240820$$CN$US$US
242390691$24239069$1$I$20240501$20240613$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00998$AVADEL CNS PHARMA$$23$YR$$F$Y$$$20240820$$CN$US$US
242390701$24239070$1$I$20240601$20240613$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01007$AVADEL CNS PHARMA$$27$YR$$M$Y$$$20240820$$CN$US$US
242390711$24239071$1$I$$20240619$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01034$AVADEL CNS PHARMA$$$$$F$Y$$$20240820$$CN$US$US
242390721$24239072$1$I$$20240626$20240822$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01071$AVADEL CNS PHARMA$$$$$F$Y$$$20240820$$CN$US$US
242390731$24239073$1$I$20240101$20240705$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01151$AVADEL CNS PHARMA$$$$$F$Y$$$20240820$$CN$US$US
242390741$24239074$1$I$20240101$20240510$20240822$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00773$AVADEL CNS PHARMA$$$$$F$Y$$$20240820$$CN$US$US
242390751$24239075$1$I$20240101$20240604$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00994$AVADEL CNS PHARMA$$$$$F$Y$$$20240820$$CN$US$US
242390761$24239076$1$I$$20240517$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00833$AVADEL CNS PHARMA$$$$$F$Y$$$20240819$$CN$US$US
242390771$24239077$1$I$20240101$20240703$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01137$AVADEL CNS PHARMA$$$$$F$Y$$$20240819$$CN$US$US
242390781$24239078$1$I$$20240703$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01138$AVADEL CNS PHARMA$$$$$M$Y$$$20240819$$CN$US$US
242390791$24239079$1$I$20240701$20240708$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01171$AVADEL CNS PHARMA$$53$YR$$F$Y$$$20240819$$CN$US$US
242390801$24239080$1$I$20240701$20240711$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01201$AVADEL CNS PHARMA$$35$YR$$M$Y$$$20240819$$CN$US$US
242390811$24239081$1$I$$20240715$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01221$AVADEL CNS PHARMA$$$$$F$Y$$$20240819$$CN$US$US
242390821$24239082$1$I$20240701$20240716$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01237$AVADEL CNS PHARMA$$25$YR$$M$Y$$$20240819$$CN$US$US
242390831$24239083$1$I$20240709$20240717$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01243$AVADEL CNS PHARMA$$30$YR$$F$Y$$$20240819$$CN$US$US
242390841$24239084$1$I$20240101$20240719$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01277$AVADEL CNS PHARMA$$$$$M$Y$82.993$KG$20240819$$CN$US$US
242390851$24239085$1$I$20240701$20240723$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01290$AVADEL CNS PHARMA$$67$YR$$F$Y$$$20240819$$CN$US$US
242390861$24239086$1$I$20240101$20240723$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01292$AVADEL CNS PHARMA$$$$$F$Y$$$20240819$$CN$US$US
242390871$24239087$1$I$20240701$20240724$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01296$AVADEL CNS PHARMA$$22$YR$$M$Y$$$20240819$$CN$US$US
242390881$24239088$1$I$20240701$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01309$AVADEL CNS PHARMA$$33$YR$$F$Y$$$20240819$$CN$US$US
242390891$24239089$1$I$20240701$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01328$AVADEL CNS PHARMA$$44$YR$$F$Y$$$20240819$$HP$US$US
242390901$24239090$1$I$20240724$20240729$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01379$AVADEL CNS PHARMA$$62$YR$$M$Y$92.971$KG$20240819$$CN$US$US
242390911$24239091$1$I$20240701$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01396$AVADEL CNS PHARMA$$19$YR$$F$Y$57.007$KG$20240819$$HP$US$US
242390921$24239092$1$I$20240718$20240731$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01486$AVADEL CNS PHARMA$$26$YR$$F$Y$$$20240819$$CN$US$US
242390931$24239093$1$I$20240415$20240507$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00763$AVADEL CNS PHARMA$$30$YR$$F$Y$$$20240819$$CN$US$US
242390941$24239094$1$I$20240101$20240517$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00798$AVADEL CNS PHARMA$$$$$M$Y$$$20240819$$CN$US$US
242390951$24239095$1$I$20240501$20240523$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00879$AVADEL CNS PHARMA$$44$YR$$F$Y$63.991$KG$20240819$$CN$US$US
242390961$24239096$1$I$20240101$20240606$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00959$AVADEL CNS PHARMA$$$$$M$Y$$$20240819$$CN$US$US
242390971$24239097$1$I$20240101$20240610$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00972$AVADEL CNS PHARMA$$$$$F$Y$$$20240819$$CN$US$US
242390981$24239098$1$I$20240601$20240613$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00997$AVADEL CNS PHARMA$$57$YR$$F$Y$$$20240819$$CN$US$US
242390991$24239099$1$I$20240601$20240617$20240822$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01014$AVADEL CNS PHARMA$$77$YR$$F$Y$65.76$KG$20240819$$CN$US$US
242391001$24239100$1$I$20240624$20240627$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01089$AVADEL CNS PHARMA$$39$YR$$M$Y$$$20240819$$CN$US$US
242391011$24239101$1$I$$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01102$AVADEL CNS PHARMA$$$$$M$Y$$$20240819$$HP$US$US
242391021$24239102$1$I$20240618$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01116$AVADEL CNS PHARMA$$66$YR$$F$Y$$$20240819$$CN$US$US
242391031$24239103$1$I$20240401$20240503$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00740$AVADEL CNS PHARMA$$33$YR$$F$Y$60.771$KG$20240819$$CN$US$US
242391041$24239104$1$I$20240101$20240503$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00755$AVADEL CNS PHARMA$$$$$F$Y$$$20240819$$CN$US$US
242391051$24239105$1$I$20240101$20240611$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00978$AVADEL CNS PHARMA$$$$$F$Y$$$20240815$$CN$US$US
242391061$24239106$1$I$20240101$20240513$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00799$AVADEL CNS PHARMA$$$$$F$Y$$$20240815$$CN$US$US
242391071$24239107$1$I$20240101$20240530$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00816$AVADEL CNS PHARMA$$$$$F$Y$62.132$KG$20240815$$CN$US$US
242391081$24239108$1$I$20240401$20240522$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00866$AVADEL CNS PHARMA$$16$YR$$M$Y$$$20240815$$CN$US$US
242391091$24239109$1$I$20240101$20240705$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01158$AVADEL CNS PHARMA$$$$$M$Y$$$20240815$$CN$US$US
242391101$24239110$1$I$20240701$20240709$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01177$AVADEL CNS PHARMA$$24$YR$$F$Y$58.957$KG$20240815$$CN$US$US
242391111$24239111$1$I$20240701$20240710$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01188$AVADEL CNS PHARMA$$35$YR$$F$Y$$$20240815$$CN$US$US
242391121$24239112$1$I$20240701$20240710$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01191$AVADEL CNS PHARMA$$21$YR$$F$Y$$$20240815$$CN$US$US
242391131$24239113$1$I$20240101$20240717$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01251$AVADEL CNS PHARMA$$$$$F$Y$$$20240815$$CN$US$US
242391141$24239114$1$I$20240101$20240719$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01271$AVADEL CNS PHARMA$$$$$F$Y$$$20240815$$CN$US$US
242391151$24239115$1$I$20240701$20240722$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01279$AVADEL CNS PHARMA$$20$YR$$F$Y$$$20240815$$CN$US$US
242391161$24239116$1$I$20240701$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01335$AVADEL CNS PHARMA$$38$YR$$F$Y$$$20240815$$CN$US$US
242391171$24239117$1$I$20240701$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01392$AVADEL CNS PHARMA$$37$YR$$F$Y$$$20240815$$CN$US$US
242391181$24239118$1$I$20240101$20240523$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00874$AVADEL CNS PHARMA$$$$$F$Y$73.469$KG$20240815$$CN$US$US
242391191$24239119$1$I$20240101$20240523$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00871$AVADEL CNS PHARMA$$$$$F$Y$$$20240815$$CN$US$US
242391201$24239120$1$I$20240101$20240524$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00875$AVADEL CNS PHARMA$$$$$F$Y$$$20240815$$CN$US$US
242391211$24239121$1$I$20240501$20240531$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00909$AVADEL CNS PHARMA$$29$YR$$F$Y$$$20240815$$CN$US$US
242391221$24239122$1$I$20240601$20240603$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00925$AVADEL CNS PHARMA$$24$YR$$F$Y$$$20240815$$CN$US$US
242391231$24239123$1$I$20240101$20240606$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00955$AVADEL CNS PHARMA$$$$$F$Y$$$20240815$$CN$US$US
242391241$24239124$1$I$20240601$20240625$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01060$AVADEL CNS PHARMA$$36$YR$$F$Y$$$20240815$$CN$US$US
242391251$24239125$1$I$20240624$20240625$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01062$AVADEL CNS PHARMA$$21$YR$$M$Y$$$20240815$$CN$US$US
242391261$24239126$1$I$20240601$20240627$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01086$AVADEL CNS PHARMA$$40$YR$$F$Y$$$20240815$$CN$US$US
242391271$24239127$1$I$20240601$20240702$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01127$AVADEL CNS PHARMA$$28$YR$$M$Y$$$20240815$$CN$US$US
242391281$24239128$1$I$20240101$20240709$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01175$AVADEL CNS PHARMA$$$$$F$Y$$$20240815$$CN$US$US
242391293$24239129$3$F$20240101$20240826$20240822$20240910$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01228$AVADEL CNS PHARMA$$$$$F$Y$61.678$KG$20240910$$CN$US$US
242391301$24239130$1$I$20240821$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57932$$FDA-CTU$$80$YR$$M$N$89.36$KG$20240822$N$PH$US$
242391311$24239131$1$I$20240818$20240822$20240822$20240822$DIR$715459$$FDA-CTU$$54$YR$$M$N$84.6$KG$20240822$Y$CN$US$
242391321$24239132$1$I$20240701$20240820$20240822$20240822$EXP$$US-INCYTE CORPORATION-2024IN008721$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242391331$24239133$1$I$$20240813$20240822$20240822$PER$$CA-HLS-202402056$HLS THERAPEUTICS$$$$$F$Y$$$20240822$$HP$CA$CA
242391341$24239134$1$I$20240101$20240814$20240822$20240822$EXP$FI-FIMEA-202402852$FI-AMGEN-FINSP2024162068$AMGEN$$70$YR$E$F$Y$$$20240822$$MD$FI$FI
242391351$24239135$1$I$20240821$20240822$20240822$20240822$DIR$715466$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242391361$24239136$1$I$$20240822$20240822$20240822$DIR$715462$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242391371$24239137$1$I$$20240822$20240822$20240822$DIR$715467$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242391391$24239139$1$I$20240807$20240820$20240822$20240822$PER$$US-BAYER-2024A120595$BAYER$$22$YR$A$F$Y$$$20240822$$HP$US$US
242391411$24239141$1$I$20240501$20240822$20240822$20240822$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047272$BOEHRINGER INGELHEIM$$$$$$Y$$$20240822$$CN$US$US
242391421$24239142$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A185951$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242391431$24239143$1$I$20240821$20240821$20240822$20240822$PER$$US-BAYER-2024A120547$BAYER$$41$YR$A$F$Y$$$20240822$$MD$US$US
242391441$24239144$1$I$$20240819$20240822$20240822$EXP$$JP-AstraZeneca-2024A190289$ASTRAZENECA$$85$YR$$M$Y$57$KG$20240822$$MD$JP$
242391451$24239145$1$I$20240529$20240816$20240822$20240822$EXP$$FR-AstraZeneca-2024A188983$ASTRAZENECA$$45$YR$$M$Y$$$20240822$$MD$FR$
242391461$24239146$1$I$20240812$20240814$20240822$20240822$EXP$$GB-AstraZeneca-2024A190843$ASTRAZENECA$$64$YR$$F$Y$59$KG$20240822$$MD$GB$
242391471$24239147$1$I$$20240814$20240822$20240822$EXP$$DE-AstraZeneca-2024A188566$ASTRAZENECA$$$$$M$Y$$$20240822$$MD$DE$
242391481$24239148$1$I$$20240815$20240822$20240822$EXP$$CA-AstraZeneca-2024A188880$ASTRAZENECA$$33$YR$$M$Y$$$20240822$$MD$CA$
242391491$24239149$1$I$20240723$20240813$20240822$20240822$PER$$US-ABBVIE-5879591$ABBVIE$$58$YR$$F$Y$63.502$KG$20240822$$CN$US$US
242391501$24239150$1$I$20240101$20240507$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00595$AVADEL CNS PHARMA$$$$$F$Y$81.678$KG$20240822$$CN$US$US
242391511$24239151$1$I$20240101$20240617$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00614$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242391521$24239152$1$I$20240101$20240607$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00709$AVADEL CNS PHARMA$$$$$M$Y$108.84$KG$20240822$$CN$US$US
242391531$24239153$1$I$20240101$20240716$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00514$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242391541$24239154$1$I$20240101$20240722$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00541$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242391551$24239155$1$I$20240101$20240619$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00547$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242391561$24239156$1$I$20240101$20240508$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00591$AVADEL CNS PHARMA$$$$$F$Y$59.864$KG$20240822$$CN$US$US
242391571$24239157$1$I$$20240820$20240822$20240822$EXP$$CA-PFIZER INC-202400240050$PFIZER$$69$YR$$M$Y$$$20240822$$HP$CA$CA
242391591$24239159$1$I$$20240821$20240822$20240822$PER$$US-BAYER-2024A120554$BAYER$$45$YR$A$F$Y$$$20240822$$MD$US$US
242391602$24239160$2$F$$20240904$20240822$20240930$PER$$US-TRAVERE-2024TVT00800$TRAVERE THERAPEUTICS$$51$YR$A$F$Y$$$20240930$$CN$US$US
242391612$24239161$2$F$$20240903$20240822$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131859$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240905$$CN$US$US
242391621$24239162$1$I$20240101$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133279$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240822$$CN$US$US
242391631$24239163$1$I$$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132887$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240822$$CN$US$US
242391642$24239164$2$F$$20240906$20240822$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132334$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$70.31$KG$20240909$$CN$US$US
242391651$24239165$1$I$$20240821$20240822$20240822$PER$$US-BAYER-2024A120556$BAYER$$42$YR$A$F$Y$$$20240822$$MD$US$US
242391661$24239166$1$I$$20240813$20240822$20240822$EXP$$US-ELITEPHARMA-2024ELLIT00208$ELITE$Joffe D, et al. .The development of 2 clonally and histologically distinct subtypes of extranodal B-cell lymphomas in the brain and skin in 1 individual.JAAD Case Reports.JUL-2024;49 (1):51-4$61$YR$A$M$Y$$$20240822$$MD$US$US
242391681$24239168$1$I$$20240822$20240822$20240822$DIR$715471$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242391691$24239169$1$I$20240808$20240822$20240822$20240822$DIR$715452$$FDA-CTU$$66$YR$$F$N$103$KG$20240822$Y$PH$US$
242391712$24239171$2$F$$20240808$20240822$20240826$PER$$US-Calliditas-2024CAL01543$CALLIDITAS THERAPEUTICS$$38$YR$A$F$Y$125$KG$20240826$$HP$US$US
242391721$24239172$1$I$$20240821$20240822$20240822$EXP$$US-JNJFOC-20240855670$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$CN$US$US
242391741$24239174$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165625$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242391751$24239175$1$I$$20240815$20240822$20240822$EXP$$US-GSK-US2024AMR102865$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242391761$24239176$1$I$20240821$20240822$20240822$20240822$DIR$715472$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242391771$24239177$1$I$20240819$20240822$20240822$20240822$DIR$715481$$FDA-CTU$$46$YR$$F$N$136.8$KG$20240822$N$$US$
242391791$24239179$1$I$$20240816$20240822$20240822$EXP$$GR-AMERICAN REGENT INC-2024003177$AMERICAN REGENT$$25$YR$$M$Y$$$20240822$$MD$GR$GR
242391801$24239180$1$I$20240801$20240813$20240822$20240822$PER$$US-ALKERMES INC.-ALK-2024-002133$ALKERMES$$21$YR$$F$Y$$$20240822$$HP$US$US
242391811$24239181$1$I$20240731$20240814$20240822$20240822$EXP$$AR-TAKEDA-2024TUS083542$TAKEDA$$71$YR$$F$Y$$$20240822$$CN$AR$AR
242391822$24239182$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234584$TEVA$Srivastava A, Artiles MEJ, Elbanna M, Abu Sheikha M, Parikh V, Feitell S. Cardiogenic Shock: An Unusual Presentation Of Hydralazine-induced Anca-associated Vasculitis. J-Card-Fail 2024; 30 (1): 149-150.; Srivastava A, Artiles MEJ, Elbanna M, Abu Sheikha M, Parikh V, Feitell S. Cardiogenic Shock: An Unusual Presentation Of Hydralazine-induced Anca-associated Vasculitis. J-Card-Fail 2024; 30 (1): 149-150.$68$YR$$F$Y$$$20240909$$HP$US$US
242391831$24239183$1$I$$20240710$20240822$20240822$PER$$US-LUNDBECK-DKLU4001523$LUNDBECK$$$$$$Y$$$20240822$$HP$US$US
242391841$24239184$1$I$$20240808$20240822$20240822$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07972$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240822$$CN$US$US
242391851$24239185$1$I$$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164391$AMGEN$Sharma A.; Fierro M.E.; Kothare A. et al.. Examining the risk factors for trastuzumab-related cardiotoxicity in a predominantly Hispanic South Texas population: A descriptive study. Journal of Clinical Oncology. 2024;42 (16):e24000$$$$$Y$$$20240822$$HP$US$US
242391861$24239186$1$I$$20240815$20240822$20240822$EXP$$CO-GSK-CO2024AMR103769$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$CO$CO
242391871$24239187$1$I$$20240816$20240822$20240822$EXP$$RS-BAUSCH-BL-2024-012524$BAUSCH AND LOMB$$55$YR$$F$Y$75$KG$20240822$$MD$RS$RS
242391881$24239188$1$I$$20240821$20240822$20240822$PER$$US-BAYER-2024A120608$BAYER$$$$A$F$Y$$$20240822$$MD$US$US
242391902$24239190$2$F$$20240829$20240822$20240903$EXP$$CA-SANDOZ INC.-SDZ2024CA074371$SANDOZ$$43$YR$$F$Y$70$KG$20240903$$HP$CA$CA
242391911$24239191$1$I$$20240813$20240822$20240822$PER$$US-ABBVIE-5881149$ABBVIE$$$$$$Y$$$20240822$$HP$US$US
242391921$24239192$1$I$20240724$20240724$20240822$20240822$PER$$US-FMCRTG-FMC-2407-000910$FRESENIUS MEDICAL CARE$$43$YR$A$F$Y$$$20240822$$HP$US$US
242391931$24239193$1$I$$20240724$20240822$20240822$PER$$US-FMCRTG-FMC-2407-000908$FRESENIUS MEDICAL CARE$$53$YR$A$M$Y$$$20240822$$HP$US$US
242391941$24239194$1$I$$20240820$20240822$20240822$PER$$US-ABBVIE-5889542$ABBVIE$$$$$$Y$$$20240822$$CN$US$US
242391951$24239195$1$I$20240602$20240819$20240822$20240822$EXP$$US-ABBVIE-5888219$ABBVIE$$93$YR$$F$Y$$$20240822$$CN$US$US
242391963$24239196$3$F$20240703$20240913$20240822$20240918$EXP$$US-Taiho Oncology Inc-2024-006565$TAIHO ONCOLOGY INC$$70$YR$E$F$Y$56.25$KG$20240918$$CN$US$US
242391972$24239197$2$F$$20240816$20240822$20240822$PER$$US-TRAVERE-2024TVT00804$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242391981$24239198$1$I$$20240813$20240822$20240822$PER$$US-TRAVERE-2024TVT00806$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
242391991$24239199$1$I$$20240821$20240822$20240822$PER$$NVSC2024US170338$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242392002$24239200$2$F$$20240731$20240822$20240903$EXP$$US-BAYER-2024A118854$BAYER$Semelka RC, Ramalho M. Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation. Frontiers in Toxicology. 2024;6:1-7$$$A$$Y$$$20240903$$MD$US$US
242392011$24239201$1$I$$20240821$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA074450$SANDOZ$$84$YR$$M$Y$49$KG$20240822$$PH$CA$CA
242392021$24239202$1$I$$20240819$20240822$20240822$EXP$$DE-BAUSCH-BL-2024-012633$BAUSCH AND LOMB$$17$YR$$M$Y$$$20240822$$HP$DE$DE
242392031$24239203$1$I$20240101$20240815$20240822$20240822$EXP$$US-BAUSCH-BL-2024-012421$BAUSCH AND LOMB$$68$YR$$F$Y$$$20240822$$CN$US$US
242392043$24239204$3$F$20240101$20240912$20240822$20240918$EXP$$US-BAUSCH-BL-2024-012445$BAUSCH AND LOMB$$81$YR$$F$Y$$$20240918$$CN$US$US
242392051$24239205$1$I$$20240813$20240822$20240822$EXP$$CA-HLS-202402054$HLS THERAPEUTICS$$76$YR$E$F$Y$$$20240822$$HP$CA$CA
242392061$24239206$1$I$$20240820$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074315$SANDOZ$$82$YR$$F$Y$$$20240822$$MD$US$US
242392071$24239207$1$I$$20240819$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA073855$SANDOZ$$$$$F$Y$$$20240822$$CN$CA$CA
242392082$24239208$2$F$20240602$20240904$20240822$20240911$30DAY$$US-GSK-US2024101865$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240911$$MD$US$US
242392091$24239209$1$I$20231014$20240819$20240822$20240822$EXP$$US-AstraZeneca-2024A188757$ASTRAZENECA$$20485$DY$$$Y$$$20240822$$MD$US$
242392101$24239210$1$I$$20230908$20240822$20240822$EXP$$US-AstraZeneca-2023A171283$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242392111$24239211$1$I$$20240814$20240822$20240822$EXP$$ZA-AstraZeneca-2024A185562$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$ZA$
242392122$24239212$2$F$$20240816$20240822$20240824$EXP$$US-AstraZeneca-2024A178344$ASTRAZENECA$$75$YR$$F$Y$77.6$KG$20240823$$CN$US$
242392151$24239215$1$I$$20240821$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA074522$SANDOZ$$64$YR$$M$Y$$$20240822$$PH$CA$CA
242392161$24239216$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012690$ELI LILLY AND CO$$$$A$M$Y$$$20240822$$CN$US$US
242392171$24239217$1$I$20240701$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013485$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240822$$CN$US$US
242392181$24239218$1$I$20240818$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011547$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240822$$CN$US$US
242392191$24239219$1$I$20240819$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012696$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240822$$MD$US$US
242392201$24239220$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013752$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240822$$CN$US$US
242392211$24239221$1$I$20240701$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012615$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240822$$CN$US$US
242392221$24239222$1$I$$20240821$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA074545$SANDOZ$$3$YR$$F$Y$$$20240822$$HP$CA$CA
242392231$24239223$1$I$20240213$20240813$20240822$20240822$EXP$$GB-VER-202400007$VERITY PHARMACEUTICALS$$78$YR$E$M$Y$83$KG$20240822$$CN$GB$GB
242392241$24239224$1$I$$20240815$20240822$20240822$EXP$$US-JNJFOC-20240846112$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240822$$HP$US$US
242392251$24239225$1$I$20240801$20240815$20240822$20240822$EXP$$CN-AMGEN-CHNSP2024164181$AMGEN$$$$A$M$Y$$$20240822$$MD$CN$CN
242392262$24239226$2$F$$20240920$20240822$20240925$PER$$US-AMGEN-USASP2024166699$AMGEN$$65$YR$E$F$Y$$$20240925$$MD$US$US
242392271$24239227$1$I$$20240819$20240822$20240822$PER$$US-JNJFOC-20240850502$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$US$US
242392281$24239228$1$I$$20240821$20240822$20240822$PER$$NVSC2024US170319$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242392291$24239229$1$I$20240816$20240819$20240822$20240822$PER$$US-BAYER-2024A119492$BAYER$$37$YR$A$F$Y$$$20240822$$HP$US$US
242392301$24239230$1$I$20240601$20240814$20240822$20240822$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-114813$REGENERON$$$$$M$Y$$$20240822$$CN$CA$CA
242392311$24239231$1$I$$20240821$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA074460$SANDOZ$$$$$F$Y$$$20240822$$CN$CA$CA
242392321$24239232$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132154$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240822$$CN$US$US
242392331$24239233$1$I$$20240816$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131363$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240822$$CN$US$US
242392341$24239234$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130909$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240822$$HP$US$US
242392351$24239235$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132249$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240822$$HP$US$US
242392361$24239236$1$I$$20240819$20240822$20240822$PER$$US-009507513-2408USA006552$MERCK$$$$$M$Y$$$20240822$$MD$US$US
242392371$24239237$1$I$20240806$20240820$20240822$20240822$EXP$$NVSC2024CN170161$NOVARTIS$$80$YR$$M$Y$70$KG$20240822$$HP$CN$CN
242392381$24239238$1$I$$20240821$20240822$20240822$PER$$US-ABBVIE-5889751$ABBVIE$$$$$F$Y$$$20240822$$HP$US$US
242392401$24239240$1$I$$20240815$20240822$20240822$EXP$$US-GSK-US2024101939$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$US$US
242392422$24239242$2$F$20240721$20240829$20240822$20240829$EXP$$CN-ROCHE-10000063084$ROCHE$$43$YR$A$M$Y$60$KG$20240829$$HP$CN$CN
242392431$24239243$1$I$20240101$20240820$20240822$20240822$PER$$US-DSJP-DSU-2024-141290$DAIICHI$$$$$F$Y$$$20240822$$MD$US$US
242392441$24239244$1$I$$20240812$20240822$20240822$EXP$$CZ-TEVA-VS-3233674$TEVA$Poncov? R. Olaparib - case report. ONKOLOGICK? REVUE. 2024;11(4):285-289; Poncov? R. Olaparib - case report. ONKOLOGICK? REVUE. 2024;11(4):285-289$46$YR$$F$Y$$$20240822$$MD$CZ$CZ
242392451$24239245$1$I$$20240821$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074234$SANDOZ$$54$YR$$M$Y$$$20240822$$MD$US$US
242392461$24239246$1$I$$20240821$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA074429$SANDOZ$$$$$M$Y$$$20240822$$HP$CA$CA
242392472$24239247$2$F$$20240912$20240822$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA074176$SANDOZ$$74$YR$$M$Y$$$20240916$$CN$CA$CA
242392481$24239248$1$I$$20240812$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104766$VIIV$$$$$$Y$$$20240822$$HP$US$US
242392491$24239249$1$I$$20240820$20240822$20240822$EXP$$AU-SANDOZ INC.-SDZ2024AU074139$SANDOZ$$23$YR$$F$Y$$$20240822$$CN$AU$AU
242392501$24239250$1$I$$20240813$20240822$20240822$PER$$US-TRAVERE-2024TVT00809$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242392511$24239251$1$I$$20240814$20240822$20240822$PER$$US-TRAVERE-2024TVT00810$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240822$$CN$US$US
242392522$24239252$2$F$$20240913$20240822$20240930$PER$$US-TRAVERE-2024TVT00808$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
242392531$24239253$1$I$$20240813$20240822$20240822$PER$$US-TRAVERE-2024TVT00807$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242392541$24239254$1$I$20240806$20240809$20240822$20240822$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000170$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240822$$HP$US$US
242392551$24239255$1$I$$20240821$20240822$20240822$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047164$BOEHRINGER INGELHEIM$$55$YR$A$M$Y$$$20240822$$CN$CA$CA
242392562$24239256$2$F$$20240827$20240822$20240906$EXP$$DK-TEVA-VS-3233634$TEVA$Kristensen AW, Vestermark V, Kjaerbye-Thygesen A, Eckhardt M-C, Kesmodel US. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring. Acta-Obstet-Gynecol-Scand 2024; 103 (8): 1522-1529.; Kristensen AW, Vestermark V, Kjaerbye-Thygesen A, Eckhardt M-C, Kesmodel US. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring. Acta-Obstet-Gynecol-Scand 2024; 103 (8): 1522-1529.$$$N$$Y$$$20240906$$HP$DK$DK
242392571$24239257$1$I$$20240821$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133162$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240822$$CN$US$US
242392582$24239258$2$F$$20240911$20240822$20240912$EXP$NO-NOMAADVRE-RELISSO-2024-Vrnbx3$NO-ORGANON-O2408NOR001441$ORGANON$$46$YR$$F$Y$$$20240912$$MD$NO$NO
242392591$24239259$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133548$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240822$$HP$US$US
242392601$24239260$1$I$$20240814$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130403$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240822$$CN$US$US
242392612$24239261$2$F$$20240731$20240822$20240830$EXP$$US-BAYER-2024A118842$BAYER$Semelka RC, Ramalho M. Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation. Frontiers in Toxicology. 2024;6:1-7$$$A$$Y$$$20240830$$MD$US$US
242392621$24239262$1$I$20240809$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131415$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$89.4$KG$20240822$$CN$US$US
242392631$24239263$1$I$20190101$20240819$20240822$20240822$EXP$$CA-SANDOZ INC.-PHHY2019CA216269$SANDOZ$$$$$M$Y$$$20240822$$CN$CA$CA
242392641$24239264$1$I$20240801$20240813$20240822$20240822$PER$$US-ABBVIE-5879645$ABBVIE$$59$YR$$F$Y$60$KG$20240822$$CN$US$US
242392653$24239265$3$F$20240814$20240910$20240822$20240916$EXP$$US-AMGEN-USASP2024163414$AMGEN$$89$YR$E$M$Y$$$20240916$$MD$US$US
242392662$24239266$2$F$20240714$20240816$20240822$20240823$EXP$$US-ABBVIE-5880116$ABBVIE$$64$YR$$M$Y$$$20240823$$CN$US$US
242392681$24239268$1$I$20220901$20240820$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074378$SANDOZ$$5$DEC$$M$Y$$$20240822$$MD$US$US
242392691$24239269$1$I$20240412$20240821$20240822$20240822$EXP$CZ-CZSUKL-24002352$CZ-ABBVIE-5887984$ABBVIE$$59$YR$$F$Y$$$20240822$$MD$CZ$CZ
242392701$24239270$1$I$$20240822$20240822$20240822$DIR$715486$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242392731$24239273$1$I$$20240822$20240822$20240822$DIR$715473$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242392741$24239274$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57942$$FDA-CTU$$101$YR$$F$N$$$20240822$N$$US$
242392751$24239275$1$I$20231109$20240816$20240822$20240822$EXP$$CA-TAKEDA-2023TUS034978$TAKEDA$$51$YR$$F$Y$51$KG$20240822$$CN$CA$CA
242392761$24239276$1$I$20200507$20240822$20240822$20240822$EXP$PL-URPL-1-1610-2020$PL-BAYER-2024A120880$BAYER$$68$YR$E$$Y$$$20240822$$MD$PL$PL
242392771$24239277$1$I$20221008$20240815$20240822$20240822$EXP$$CA-SANDOZ INC.-NVSC2022CA069702$SANDOZ$$57$YR$$M$Y$$$20240822$$CN$CA$CA
242392781$24239278$1$I$20210101$20240814$20240822$20240822$EXP$$CA-TAKEDA-2022TUS018433$TAKEDA$$41$YR$$F$Y$55$KG$20240822$$HP$CA$CA
242392791$24239279$1$I$20240101$20240817$20240822$20240822$EXP$$US-SA-2024SA247722$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240822$$MD$US$US
242392811$24239281$1$I$20240803$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164533$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
242392821$24239282$1$I$20240227$20240815$20240822$20240822$EXP$$TW-ABBVIE-5882228$ABBVIE$$82$YR$$M$Y$50$KG$20240822$$CN$TW$TW
242392831$24239283$1$I$$20240814$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104771$VIIV$$$$$$Y$$$20240822$$HP$US$US
242392841$24239284$1$I$20231128$20240813$20240822$20240822$EXP$$CA-GSK-CA2024100737$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$CN$CA$CA
242392851$24239285$1$I$$20240820$20240822$20240822$EXP$$CA-GSK-CA2024AMR104187$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$PH$CA$CA
242392861$24239286$1$I$20240807$20240814$20240822$20240822$EXP$$GB-TEVA-VS-3233477$TEVA$$67$YR$$F$Y$68$KG$20240822$$MD$GB$GB
242392871$24239287$1$I$$20240821$20240822$20240822$EXP$$JP-PAIPHARMA-2024-JP-000233$PHARMACEUTICAL ASSOC$Masuda H, Yamamoto Y, Kimura S, et al.Spontaneous abdominal wall hematoma: early recurrence without an anticoagulant in an elderly woman receiving chronic corticosteroid treatment..Internal Medicine.2024;63(14):2097-2100.$73$YR$$F$Y$$$20240822$$HP$JP$JP
242392881$24239288$1$I$20230226$20240812$20240822$20240822$EXP$FR-AFSSAPS-TO2024001482$FR-TEVA-VS-3233325$TEVA$$80$YR$$M$Y$63$KG$20240822$$PH$FR$FR
242392892$24239289$2$F$20240726$20240826$20240822$20240830$EXP$$CN-ROCHE-10000061395$ROCHE$$84$YR$E$M$Y$45$KG$20240830$$MD$CN$CN
242392901$24239290$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57933$$FDA-CTU$$50$YR$$F$N$104.33$KG$20240822$N$$US$
242392911$24239291$1$I$$20240814$20240822$20240822$PER$$US-TRAVERE-2024TVT00811$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242392921$24239292$1$I$20240809$20240819$20240822$20240822$EXP$$US-SA-2024SA246054$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240822$$CN$US$US
242392931$24239293$1$I$$20240820$20240822$20240822$PER$$JP-Eisai-EC-2024-172625$EISAI$Yoshikawa Seiichi. Treatment of hepatocellular carcinoma in our hospital$74$YR$E$M$Y$$$20240822$$MD$JP$JP
242392941$24239294$1$I$20200731$20240819$20240822$20240822$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-132912$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$65.9$KG$20240822$$MD$KR$KR
242392951$24239295$1$I$$20240819$20240822$20240822$EXP$$CH-TAKEDA-2024TUS083793$TAKEDA$$80$YR$$F$Y$$$20240822$$CN$CH$CH
242392961$24239296$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA247227$SANOFI AVENTIS$$$$E$F$Y$$$20240822$$MD$US$US
242392972$24239297$2$F$20240801$20240823$20240822$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130606$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240903$$HP$US$US
242392981$24239298$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA247274$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240822$$CN$US$US
242392991$24239299$1$I$20240723$20240820$20240822$20240822$EXP$FR-AFSSAPS-RE2024000839$FR-ORGANON-O2408FRA001443$ORGANON$$78$YR$$M$Y$$$20240822$$MD$FR$FR
242393002$24239300$2$F$$20240826$20240822$20240827$EXP$$NVSC2024GB169975$NOVARTIS$$$$$F$Y$$$20240827$$CN$GB$GB
242393011$24239301$1$I$$20240820$20240822$20240822$EXP$$NVSC2024CA169004$NOVARTIS$$38$YR$$M$Y$$$20240822$$HP$CA$CA
242393021$24239302$1$I$$20240821$20240822$20240822$EXP$$NVSC2024US169614$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
242393031$24239303$1$I$20230101$20240820$20240822$20240822$EXP$$US-ABBVIE-5888519$ABBVIE$$$$$$Y$$$20240822$$CN$US$US
242393042$24239304$2$F$$20240827$20240822$20240905$EXP$$TR-TEVA-VS-3233536$TEVA$Arslan A, Ozkaya OG, Aytemiz F, Altay H, Ozcan EE, Kucukaksu DS, et al. Oral amiodarone and propranolol in maintenance therapy of postimplantation tachycardia: An observational study. Medicine 2024; 103 (28):.; Arslan A, Ozkaya OG, Aytemiz F, Altay H, Ozcan EE, Kucukaksu DS, et al. Oral amiodarone and propranolol in maintenance therapy of postimplantation tachycardia: An observational study. Medicine 2024; 103 (28):.$52$YR$$F$Y$$$20240905$$MD$TR$TR
242393061$24239306$1$I$$20240814$20240822$20240822$EXP$$US-JNJFOC-20240845555$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$CN$US$US
242393071$24239307$1$I$20240813$20240813$20240822$20240822$EXP$GB-MHRA-MED-202408131855428120-BJSZW$GB-TEVA-VS-3233286$TEVA$$36$YR$$M$Y$$$20240822$$HP$GB$GB
242393081$24239308$1$I$20240729$20240814$20240822$20240822$EXP$$US-BAYER-2024A117907$BAYER$$67$YR$E$F$Y$$$20240822$$PH$US$US
242393091$24239309$1$I$20230817$20240815$20240822$20240822$EXP$$DE-ROCHE-3402549$ROCHE$$27$YR$A$F$Y$$$20240822$$CN$DE$DE
242393101$24239310$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5888712$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242393111$24239311$1$I$20220101$20240802$20240822$20240822$PER$$US-TEVA-VS-3229902$TEVA$$48$YR$$F$Y$$$20240822$$CN$US$US
242393121$24239312$1$I$20240815$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57929$$FDA-CTU$$74$YR$$M$N$$$20240822$Y$PH$US$
242393131$24239313$1$I$20240821$20240822$20240822$20240822$DIR$715480$$FDA-CTU$$65$YR$$M$N$65.25$KG$20240822$N$CN$US$
242393141$24239314$1$I$$20240822$20240822$20240822$DIR$715474$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242393151$24239315$1$I$20240822$20240822$20240822$20240822$DIR$715484$$FDA-CTU$$52$YR$$F$N$36.45$KG$20240822$Y$CN$US$
242393161$24239316$1$I$20240224$20240819$20240822$20240822$EXP$$US-ABBVIE-5887308$ABBVIE$$24$YR$$M$Y$$$20240822$$CN$US$US
242393171$24239317$1$I$$20240814$20240822$20240822$PER$$US-TRAVERE-2024TVT00812$TRAVERE THERAPEUTICS$$$$$$Y$$$20240822$$CN$US$US
242393182$24239318$2$F$$20240904$20240822$20240930$PER$$US-TRAVERE-2024TVT00813$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
242393191$24239319$1$I$$20240814$20240822$20240822$PER$$US-TRAVERE-2024TVT00814$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$HP$US$US
242393201$24239320$1$I$$20240815$20240822$20240822$EXP$$MY-FreseniusKabi-FK202412577$FRESENIUS KABI$Oothuman SP. Methotrexate-Induced Posterior Reversible Encephalopathy Syndrome (PRES) in a Paediatric Patient. MADRAC Bulletin. 2024 Aug 15;49(04): 5-6.$6$YR$C$M$Y$14.3$KG$20240822$$HP$MY$MY
242393214$24239321$4$F$$20240829$20240822$20240902$PER$$US-ROCHE-10000063403$ROCHE$$51$YR$A$M$Y$$$20240903$$CN$US$US
242393221$24239322$1$I$$20240819$20240822$20240822$EXP$$CH-BAYER-2024A119735$BAYER$$$$$F$Y$$$20240822$$CN$CH$CH
242393231$24239323$1$I$20240101$20240806$20240822$20240822$PER$$US-Eisai-EC-2024-171667$EISAI$$$$$F$Y$$$20240822$$CN$US$US
242393241$24239324$1$I$$20240805$20240822$20240822$PER$$US-Eisai-EC-2024-171670$EISAI$$$$$$Y$$$20240822$$MD$US$US
242393251$24239325$1$I$$20240806$20240822$20240822$PER$$US-Eisai-EC-2024-171669$EISAI$$67$YR$E$F$Y$$$20240822$$MD$US$US
242393271$24239327$1$I$20240731$20240812$20240822$20240822$EXP$FR-AFSSAPS-BX2024001618$FR-BAXTER-2024BAX023077$BAXTER$$17$MON$$F$Y$9.6$KG$20240822$$HP$FR$FR
242393281$24239328$1$I$$20240813$20240822$20240822$EXP$$CA-BAXTER-2024BAX023224$BAXTER$$44$YR$$F$Y$$$20240822$$MD$CA$CA
242393291$24239329$1$I$20240530$20240812$20240822$20240822$EXP$ES-AEMPS-1559074$ES-BAXTER-2024BAX023032$BAXTER$$$$A$M$Y$$$20240822$$PH$ES$ES
242393301$24239330$1$I$$20240813$20240822$20240822$EXP$$CA-BAXTER-2024BAX023256$BAXTER$$54$YR$$M$Y$$$20240822$$MD$CA$CA
242393311$24239331$1$I$20240316$20240812$20240822$20240822$EXP$ES-AEMPS-1557692$ES-BAXTER-2024BAX023071$BAXTER$$38$YR$$F$Y$65$KG$20240822$$MD$ES$ES
242393321$24239332$1$I$$20240813$20240822$20240822$EXP$$CA-BAXTER-2024BAX023227$BAXTER$$51$YR$$F$Y$$$20240822$$MD$CA$CA
242393331$24239333$1$I$$20240812$20240822$20240822$EXP$$CA-BAXTER-2024BAX023160$BAXTER$$63$YR$$$Y$$$20240822$$CN$CA$CA
242393341$24239334$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132096$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240822$$PH$US$US
242393351$24239335$1$I$$20240816$20240822$20240822$EXP$$US-ABBVIE-5888803$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242393362$24239336$2$F$$20240909$20240822$20240913$EXP$$US-ABBVIE-5887289$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
242393371$24239337$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A186668$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242393381$24239338$1$I$20240618$20240812$20240822$20240822$EXP$FR-AFSSAPS-AN2024001089$FR-BAXTER-2024BAX023046$BAXTER$$69$YR$$F$Y$87$KG$20240822$$PH$FR$FR
242393391$24239339$1$I$$20240819$20240822$20240822$EXP$$JP-AstraZeneca-2024A189526$ASTRAZENECA$$$$$$Y$$$20240822$$HP$JP$
242393401$24239340$1$I$$20230628$20240822$20240822$EXP$$US-AstraZeneca-2023A149787$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242393411$24239341$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A186274$ASTRAZENECA$$40$YR$$F$Y$48.5$KG$20240822$$CN$US$
242393421$24239342$1$I$20240731$20240819$20240822$20240822$EXP$$US-ABBVIE-5887382$ABBVIE$$82$YR$$M$Y$$$20240822$$CN$US$US
242393431$24239343$1$I$$20240814$20240822$20240822$PER$$US-BIOGEN-2024BI01276293$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242393442$24239344$2$F$$20240820$20240822$20240827$EXP$$CA-MYLANLABS-2024M1077907$MYLAN$$$$$M$Y$$$20240827$$CN$CA$CA
242393451$24239345$1$I$20240808$20240819$20240822$20240822$EXP$$CN-PFIZER INC-PV202400107990$PFIZER$$32$YR$$F$Y$56$KG$20240822$$HP$CN$CN
242393461$24239346$1$I$$20240812$20240822$20240822$30DAY$$US-GSK-US2024100353$GLAXOSMITHKLINE$$$$$F$Y$$$20240822$$CN$US$US
242393471$24239347$1$I$20240329$20240820$20240822$20240822$EXP$$CN-PFIZER INC-PV202400108643$PFIZER$$27$YR$$M$Y$$$20240822$$HP$CN$CN
242393481$24239348$1$I$$20240819$20240822$20240822$EXP$FI-FIMEA-202402920$FI-GSK-FI2024103640$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$HP$FI$FI
242393511$24239351$1$I$20240101$20240802$20240822$20240822$PER$$US-TEVA-VS-3230085$TEVA$$50$YR$$M$Y$$$20240822$$CN$US$US
242393522$24239352$2$F$$20240827$20240822$20240906$EXP$$IE-TEVA-VS-3233402$TEVA$Kelliher J, Rahmani G, Carey JJ, Bergin D. Severe atypical iliac wing fracture associated with long-term bisphosphonate use. Skel-Radiol 2024; 0 (0); Kelliher J, Rahmani G, Carey JJ, Bergin D. Severe atypical iliac wing fracture associated with long-term bisphosphonate use. Skel-Radiol 2024; 0 (0):.$63$YR$$F$Y$$$20240906$$HP$IE$IE
242393531$24239353$1$I$20240801$20240815$20240822$20240822$EXP$$CA-CURRAX PHARMACEUTICALS LLC-CA-2024CUR003890$CURRAX PHARMACEUTICALS$$$$$$Y$$$20240822$$CN$CA$CA
242393541$24239354$1$I$20240101$20240819$20240822$20240822$EXP$$US-NALPROPION PHARMACEUTICALS INC.-US-2024CUR003872$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240822$$CN$US$US
242393551$24239355$1$I$20240507$20240820$20240822$20240822$EXP$FI-FIMEA-202403002$FI-NALPROPION PHARMACEUTICALS INC.-FI-2024CUR003871$CURRAX PHARMACEUTICALS$$34$YR$$F$Y$$$20240822$$MD$FI$FI
242393562$24239356$2$F$20240813$20240829$20240822$20240909$EXP$$TN-BIOGEN-2024BI01278764$BIOGEN$$37$YR$$M$Y$$$20240909$$CN$TN$TN
242393572$24239357$2$F$20240801$20240827$20240822$20240910$PER$$US-Calliditas-2024CAL01551$CALLIDITAS THERAPEUTICS$$73$YR$E$M$Y$91.1$KG$20240910$$CN$US$US
242393591$24239359$1$I$$20240819$20240822$20240822$EXP$$DE-ROCHE-10000062688$ROCHE$$$$$F$Y$$$20240822$$PH$DE$DE
242393603$24239360$3$F$$20240823$20240822$20240917$PER$$US-TRAVERE-2024TVT00815$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
242393611$24239361$1$I$$20240813$20240822$20240822$EXP$$CA-TAKEDA-2024TUS082383$TAKEDA$$27$YR$$F$Y$$$20240822$$HP$CA$CA
242393621$24239362$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5887732$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242393631$24239363$1$I$20240816$20240822$20240822$20240822$DIR$715475$$FDA-CTU$$52$YR$$F$N$96.75$KG$20240822$N$CN$US$
242393651$24239365$1$I$$20240822$20240822$20240822$DIR$715476$$FDA-CTU$$$$$F$N$$$20240822$Y$HP$US$
242393661$24239366$1$I$$20240809$20240822$20240822$EXP$$US-SMPA-2024SPA001199$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242393671$24239367$1$I$$20240808$20240822$20240822$EXP$$US-SMPA-2024SPA001156$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242393711$24239371$1$I$$20240809$20240822$20240822$EXP$$US-SMPA-2024SPA001180$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242393722$24239372$2$F$20240717$20240917$20240822$20240930$EXP$$US-SMPA-2024SPA001146$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242393731$24239373$1$I$20240806$20240808$20240822$20240822$EXP$$US-SMPA-2024SPA001131$SUNOVION$$$$$$Y$$$20240822$$HP$US$US
242393741$24239374$1$I$$20240811$20240822$20240822$EXP$$US-SMPA-2024SPA001235$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242393751$24239375$1$I$$20240809$20240822$20240822$EXP$$US-SMPA-2024SPA001178$SUNOVION$$$$$$Y$$$20240822$$MD$US$US
242393762$24239376$2$F$$20240913$20240822$20240926$EXP$$US-SMPA-2024SPA001183$SUNOVION$$$$$$Y$$$20240926$$CN$US$US
242393771$24239377$1$I$$20240809$20240822$20240822$EXP$$US-SMPA-2024SPA001210$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242393781$24239378$1$I$20240627$20240815$20240822$20240822$EXP$$ES-AstraZeneca-2024A190941$ASTRAZENECA$$48$YR$$F$Y$$$20240822$$MD$ES$
242393791$24239379$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A186867$ASTRAZENECA$$$$$F$Y$$$20240822$$HP$US$
242393801$24239380$1$I$20220307$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A186081$ASTRAZENECA$$69$YR$$F$Y$$$20240822$$MD$US$
242393811$24239381$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408014002$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242393821$24239382$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57712$$FDA-CTU$$30$YR$$M$N$$$20240821$N$$US$
242393832$24239383$2$F$20230401$20240826$20240822$20240830$EXP$$US-BIOGEN-2024BI01274690$BIOGEN$$51$YR$$F$Y$$$20240830$$HP$US$US
242393841$24239384$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012034$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240822$$CN$US$US
242393851$24239385$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57738$$FDA-CTU$$$$$M$N$$$20240821$N$HP$US$
242393861$24239386$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012629$ELI LILLY AND CO$$61$YR$A$$Y$$$20240822$$CN$US$US
242393871$24239387$1$I$20240815$20240815$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408010351$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240822$$CN$US$US
242393881$24239388$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012153$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240822$$CN$US$US
242393891$24239389$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011725$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240822$$CN$US$US
242393901$24239390$1$I$20240818$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011556$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240822$$CN$US$US
242393911$24239391$1$I$20240805$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011851$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240822$$CN$US$US
242393921$24239392$1$I$20240801$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012667$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240822$$CN$US$US
242393932$24239393$2$F$$20240816$20240822$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202408010695$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240912$$CN$US$US
242393941$24239394$1$I$$20240805$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011812$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242393951$24239395$1$I$20240818$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011579$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240822$$CN$US$US
242393961$24239396$1$I$$20240814$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408010564$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240822$$CN$US$US
242393971$24239397$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011700$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240822$$CN$US$US
242393981$24239398$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5886903$ABBVIE$$72$YR$$M$Y$$$20240822$$CN$US$US
242393992$24239399$2$F$$20240806$20240822$20240927$PER$$US-TEVA-VS-3231181$TEVA$$26$YR$$F$Y$$$20240927$$CN$US$US
242394001$24239400$1$I$20240101$20240509$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00826$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394011$24239401$1$I$$20240506$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00753$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242394021$24239402$1$I$20240301$20240520$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00848$AVADEL CNS PHARMA$$45$YR$$F$Y$$$20240822$$CN$US$US
242394031$24239403$1$I$$20240521$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00858$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$MD$US$US
242394041$24239404$1$I$20240101$20240516$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00841$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394051$24239405$1$I$$20240522$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00870$AVADEL CNS PHARMA$$$$$F$Y$82.993$KG$20240822$$CN$US$US
242394061$24239406$1$I$20240101$20240523$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00880$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394071$24239407$1$I$$20240522$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00867$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394081$24239408$1$I$20240501$20240513$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00796$AVADEL CNS PHARMA$$32$YR$$F$Y$$$20240822$$CN$US$US
242394091$24239409$1$I$20240101$20240523$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00864$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394101$24239410$1$I$20240101$20240523$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00868$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394111$24239411$1$I$$20240529$20240822$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00894$AVADEL CNS PHARMA$$35$YR$$M$Y$$$20240822$$HP$US$US
242394121$24239412$1$I$20240101$20240620$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01041$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394131$24239413$1$I$20240101$20240521$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00862$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394141$24239414$1$I$20240501$20240528$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00886$AVADEL CNS PHARMA$$23$YR$$F$Y$$$20240822$$CN$US$US
242394151$24239415$1$I$20240701$20240708$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01166$AVADEL CNS PHARMA$$28$YR$$M$Y$$$20240822$$CN$US$US
242394161$24239416$1$I$20240701$20240708$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01170$AVADEL CNS PHARMA$$38$YR$$F$Y$$$20240822$$CN$US$US
242394171$24239417$1$I$20240101$20240709$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01173$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394181$24239418$1$I$20240101$20240710$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01185$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394191$24239419$1$I$20240601$20240710$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01187$AVADEL CNS PHARMA$$39$YR$$F$Y$$$20240822$$CN$US$US
242394201$24239420$1$I$20240701$20240710$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01192$AVADEL CNS PHARMA$$42$YR$$F$Y$175.06$KG$20240822$$CN$US$US
242394211$24239421$1$I$20240701$20240711$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01198$AVADEL CNS PHARMA$$45$YR$$M$Y$$$20240822$$CN$US$US
242394221$24239422$1$I$$20240711$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01199$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394231$24239423$1$I$20240601$20240702$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01129$AVADEL CNS PHARMA$$52$YR$$F$Y$$$20240822$$CN$US$US
242394241$24239424$1$I$20240501$20240702$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01133$AVADEL CNS PHARMA$$35$YR$$F$Y$$$20240822$$CN$US$US
242394251$24239425$1$I$20240101$20240703$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01135$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394261$24239426$1$I$20231222$20240703$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01136$AVADEL CNS PHARMA$$27$YR$$M$Y$$$20240822$$CN$US$US
242394271$24239427$1$I$$20240703$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01139$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394281$24239428$1$I$20240620$20240703$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01132$AVADEL CNS PHARMA$$27$YR$$F$Y$$$20240822$$CN$US$US
242394291$24239429$1$I$20240501$20240703$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01142$AVADEL CNS PHARMA$$28$YR$$M$Y$$$20240822$$CN$US$US
242394301$24239430$1$I$20240101$20240703$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01145$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394311$24239431$1$I$20240601$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01113$AVADEL CNS PHARMA$$53$YR$$F$Y$$$20240822$$CN$US$US
242394321$24239432$1$I$20240601$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01114$AVADEL CNS PHARMA$$41$YR$$M$Y$$$20240822$$CN$US$US
242394331$24239433$1$I$20240101$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01115$AVADEL CNS PHARMA$$$$$F$Y$57.596$KG$20240822$$CN$US$US
242394341$24239434$1$I$20240613$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01117$AVADEL CNS PHARMA$$40$YR$$F$Y$$$20240822$$CN$US$US
242394351$24239435$1$I$20240101$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01119$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$CN$US$US
242394361$24239436$1$I$20240101$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01120$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394371$24239437$1$I$20240101$20240702$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01130$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394381$24239438$1$I$20240101$20240703$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01131$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$HP$US$US
242394391$24239439$1$I$20240601$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01124$AVADEL CNS PHARMA$$19$YR$$F$Y$$$20240822$$CN$US$US
242394401$24239440$1$I$20240601$20240702$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01126$AVADEL CNS PHARMA$$47$YR$$F$Y$$$20240822$$CN$US$US
242394411$24239441$1$I$$20240711$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01200$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394421$24239442$1$I$20240710$20240711$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01205$AVADEL CNS PHARMA$$53$YR$$F$Y$$$20240822$$CN$US$US
242394431$24239443$1$I$20240101$20240711$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01207$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394441$24239444$1$I$20240101$20240712$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01210$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394451$24239445$1$I$$20240712$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01211$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394461$24239446$1$I$20240601$20240703$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01147$AVADEL CNS PHARMA$$22$YR$$F$Y$$$20240822$$CN$US$US
242394471$24239447$1$I$$20240705$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01146$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394481$24239448$1$I$20240101$20240705$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01150$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394491$24239449$1$I$20240101$20240711$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01206$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$HP$US$US
242394501$24239450$1$I$$20240705$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01154$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394511$24239451$1$I$20240622$20240705$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01155$AVADEL CNS PHARMA$$49$YR$$F$Y$$$20240822$$CN$US$US
242394531$24239453$1$I$20240701$20240708$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01165$AVADEL CNS PHARMA$$30$YR$$F$Y$$$20240822$$CN$US$US
242394541$24239454$1$I$20240101$20240708$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01167$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394551$24239455$1$I$20240703$20240708$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01160$AVADEL CNS PHARMA$$37$YR$$M$Y$$$20240822$$CN$US$US
242394561$24239456$1$I$20240101$20240710$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01184$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394571$24239457$1$I$20240630$20240708$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01164$AVADEL CNS PHARMA$$35$YR$$F$Y$97.506$KG$20240822$$CN$US$US
242394581$24239458$1$I$20240101$20240705$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01152$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394591$24239459$1$I$20240601$20240708$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01174$AVADEL CNS PHARMA$$47$YR$$F$Y$$$20240822$$CN$US$US
242394601$24239460$1$I$20240101$20240702$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01128$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394611$24239461$1$I$20240101$20240709$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01186$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394621$24239462$1$I$20231121$20240710$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01190$AVADEL CNS PHARMA$$17$YR$$F$Y$$$20240822$$CN$US$US
242394631$24239463$1$I$20240601$20240705$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01153$AVADEL CNS PHARMA$$44$YR$$F$Y$$$20240822$$CN$US$US
242394641$24239464$1$I$$20240710$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01194$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394651$24239465$1$I$20240601$20240626$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01078$AVADEL CNS PHARMA$$54$YR$$F$Y$$$20240822$$CN$US$US
242394661$24239466$1$I$20240101$20240712$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01209$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394671$24239467$1$I$20240601$20240710$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01193$AVADEL CNS PHARMA$$18$YR$$M$Y$68.027$KG$20240822$$CN$US$US
242394681$24239468$1$I$20240101$20240626$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01075$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394691$24239469$1$I$20240601$20240626$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01076$AVADEL CNS PHARMA$$55$YR$$F$Y$$$20240822$$CN$US$US
242394701$24239470$1$I$$20240626$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01083$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$CN$US$US
242394711$24239471$1$I$20240626$20240627$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01088$AVADEL CNS PHARMA$$41$YR$$M$Y$$$20240822$$CN$US$US
242394721$24239472$1$I$20240601$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01090$AVADEL CNS PHARMA$$36$YR$$F$Y$$$20240822$$CN$US$US
242394731$24239473$1$I$20240601$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01093$AVADEL CNS PHARMA$$42$YR$$F$Y$$$20240822$$CN$US$US
242394741$24239474$1$I$20240601$20240624$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01057$AVADEL CNS PHARMA$$67$YR$$F$Y$$$20240822$$CN$US$US
242394751$24239475$1$I$$20240622$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01058$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$HP$US$US
242394761$24239476$1$I$20240101$20240614$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01059$AVADEL CNS PHARMA$$$$$F$Y$81.179$KG$20240822$$CN$US$US
242394771$24239477$1$I$20240101$20240625$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01064$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242394781$24239478$1$I$20240622$20240626$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01072$AVADEL CNS PHARMA$$19$YR$$M$Y$$$20240822$$CN$US$US
242394791$24239479$1$I$$20240625$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01065$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$MD$US$US
242394801$24239480$1$I$20240601$20240625$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01066$AVADEL CNS PHARMA$$32$YR$$M$Y$$$20240822$$CN$US$US
242394811$24239481$1$I$20240101$20240625$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01068$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394821$24239482$1$I$20240101$20240625$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01070$AVADEL CNS PHARMA$$22$YR$$F$Y$$$20240822$$MD$US$US
242394831$24239483$1$I$20240701$20240709$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01178$AVADEL CNS PHARMA$$53$YR$$F$Y$$$20240822$$CN$US$US
242394841$24239484$1$I$20240101$20240626$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01084$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394851$24239485$1$I$20240101$20240625$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01061$AVADEL CNS PHARMA$$$$$F$Y$68.027$KG$20240822$$CN$US$US
242394861$24239486$1$I$20240101$20240621$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01046$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394871$24239487$1$I$$20240621$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01047$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394881$24239488$1$I$$20240621$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01048$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$HP$US$US
242394891$24239489$1$I$20240201$20240621$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01050$AVADEL CNS PHARMA$$40$YR$$F$Y$$$20240822$$HP$US$US
242394901$24239490$1$I$20240601$20240624$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01052$AVADEL CNS PHARMA$$28$YR$$F$Y$$$20240822$$CN$US$US
242394911$24239491$1$I$20240101$20240705$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01162$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394921$24239492$1$I$20240101$20240710$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01183$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242394931$24239493$1$I$20240101$20240620$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01049$AVADEL CNS PHARMA$$$$$F$Y$74.694$KG$20240822$$CN$US$US
242394941$24239494$1$I$20240601$20240624$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01053$AVADEL CNS PHARMA$$49$YR$$M$Y$$$20240822$$CN$US$US
242394951$24239495$1$I$20240616$20240624$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01056$AVADEL CNS PHARMA$$37$YR$$F$Y$$$20240822$$CN$US$US
242394961$24239496$1$I$20240111$20240626$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01073$AVADEL CNS PHARMA$$42$YR$$M$Y$$$20240822$$CN$US$US
242394971$24239497$1$I$20240601$20240626$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01080$AVADEL CNS PHARMA$$40$YR$$F$Y$$$20240822$$CN$US$US
242394981$24239498$1$I$20240618$20240624$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01055$AVADEL CNS PHARMA$$26$YR$$F$Y$$$20240822$$CN$US$US
242394991$24239499$1$I$20240624$20240626$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01077$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395001$24239500$1$I$20240101$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01091$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242395011$24239501$1$I$20240101$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01112$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242395021$24239502$1$I$20240301$20240604$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00936$AVADEL CNS PHARMA$$18$YR$$F$Y$$$20240822$$HP$US$US
242395031$24239503$1$I$20240101$20240705$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01163$AVADEL CNS PHARMA$$$$$F$Y$68.934$KG$20240822$$CN$US$US
242395041$24239504$1$I$20240101$20240627$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01087$AVADEL CNS PHARMA$$$$$F$Y$55.782$KG$20240822$$CN$US$US
242395051$24239505$1$I$20230101$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01092$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395061$24239506$1$I$20240627$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01095$AVADEL CNS PHARMA$$28$YR$$F$Y$$$20240822$$CN$US$US
242395071$24239507$1$I$20240101$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01097$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242395081$24239508$1$I$$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01100$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395091$24239509$1$I$20240101$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01111$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395101$24239510$1$I$20230101$20240502$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00731$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395111$24239511$1$I$20240101$20240621$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01054$AVADEL CNS PHARMA$$$$$F$Y$47.619$KG$20240822$$CN$US$US
242395121$24239512$1$I$20240601$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01106$AVADEL CNS PHARMA$$23$YR$$M$Y$$$20240822$$CN$US$US
242395131$24239513$1$I$20240101$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01107$AVADEL CNS PHARMA$$$$$M$Y$74.83$KG$20240822$$CN$US$US
242395141$24239514$1$I$20240101$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01109$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395151$24239515$1$I$20240101$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01110$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395161$24239516$1$I$$20240503$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00737$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395171$24239517$1$I$20240101$20240626$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01081$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395181$24239518$1$I$20240101$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01094$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395191$24239519$1$I$20240101$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01099$AVADEL CNS PHARMA$$$$$F$Y$45.351$KG$20240822$$CN$US$US
242395201$24239520$1$I$20240101$20240502$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00734$AVADEL CNS PHARMA$$$$$M$Y$61.224$KG$20240822$$CN$US$US
242395211$24239521$1$I$20230101$20240531$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00912$AVADEL CNS PHARMA$$$$$M$Y$83.9$KG$20240822$$CN$US$US
242395221$24239522$1$I$$20240605$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00948$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395231$24239523$1$I$$20240510$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00795$AVADEL CNS PHARMA$$$$$F$Y$62.086$KG$20240822$$HP$US$US
242395241$24239524$1$I$$20240601$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00931$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242395251$24239525$1$I$$20240601$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00932$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242395261$24239526$1$I$20240101$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01123$AVADEL CNS PHARMA$$$$$F$Y$92.063$KG$20240822$$CN$US$US
242395271$24239527$1$I$20240101$20240626$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01074$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395281$24239528$1$I$20240101$20240520$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00847$AVADEL CNS PHARMA$$$$$M$Y$81.633$KG$20240822$$CN$US$US
242395291$24239529$1$I$20240101$20240503$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00735$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395301$24239530$1$I$20240501$20240520$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00846$AVADEL CNS PHARMA$$31$YR$$F$Y$$$20240822$$CN$US$US
242395311$24239531$1$I$20240501$20240513$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00788$AVADEL CNS PHARMA$$47$YR$$F$Y$$$20240822$$CN$US$US
242395321$24239532$1$I$20240501$20240507$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00756$AVADEL CNS PHARMA$$56$YR$$F$Y$$$20240822$$CN$US$US
242395331$24239533$1$I$20240419$20240513$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00790$AVADEL CNS PHARMA$$43$YR$$F$Y$$$20240822$$CN$US$US
242395341$24239534$1$I$20240605$20240606$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00944$AVADEL CNS PHARMA$$18$YR$$F$Y$$$20240822$$CN$US$US
242395351$24239535$1$I$20240101$20240603$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00920$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395361$24239536$1$I$$20240602$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00911$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$MD$US$US
242395371$24239537$1$I$20240501$20240531$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00913$AVADEL CNS PHARMA$$24$YR$$M$Y$$$20240822$$CN$US$US
242395381$24239538$1$I$20240501$20240515$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00817$AVADEL CNS PHARMA$$31$YR$$F$Y$$$20240822$$CN$US$US
242395391$24239539$1$I$20240101$20240516$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00822$AVADEL CNS PHARMA$$$$$M$Y$99.773$KG$20240822$$CN$US$US
242395401$24239540$1$I$20240101$20240603$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00939$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$MD$US$US
242395411$24239541$1$I$20240501$20240603$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00921$AVADEL CNS PHARMA$$26$YR$$M$Y$108.84$KG$20240822$$CN$US$US
242395421$24239542$1$I$20240101$20240603$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00919$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242395431$24239543$1$I$20240101$20240604$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00922$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395441$24239544$1$I$20240101$20240603$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00926$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242395451$24239545$1$I$20240501$20240606$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00962$AVADEL CNS PHARMA$$37$YR$$M$Y$$$20240822$$CN$US$US
242395461$24239546$1$I$20240101$20240619$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01035$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242395471$24239547$1$I$20240530$20240603$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00918$AVADEL CNS PHARMA$$34$YR$$M$Y$$$20240822$$MD$US$US
242395481$24239548$1$I$20240201$20240517$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00834$AVADEL CNS PHARMA$$47$YR$$F$Y$$$20240822$$CN$US$US
242395491$24239549$1$I$$20240601$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00929$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242395501$24239550$1$I$$20240601$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00930$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242395511$24239551$1$I$$20240601$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00933$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242395521$24239552$1$I$$20240601$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00934$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242395531$24239553$1$I$20240604$20240605$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00940$AVADEL CNS PHARMA$$25$YR$$M$Y$$$20240822$$CN$US$US
242395541$24239554$1$I$$20240701$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01098$AVADEL CNS PHARMA$$$$$F$Y$65.76$KG$20240822$$CN$US$US
242395551$24239555$1$I$20240101$20240605$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00942$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395561$24239556$1$I$$20240604$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00938$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$MD$US$US
242395571$24239557$1$I$$20240606$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00949$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395581$24239558$1$I$20240101$20240501$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00732$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395591$24239559$1$I$20240101$20240506$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00742$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395601$24239560$1$I$20240301$20240617$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01011$AVADEL CNS PHARMA$$43$YR$$M$Y$$$20240822$$CN$US$US
242395611$24239561$1$I$$20240605$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00945$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395621$24239562$1$I$20240501$20240520$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00845$AVADEL CNS PHARMA$$52$YR$$F$Y$$$20240822$$CN$US$US
242395631$24239563$1$I$20240401$20240501$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00720$AVADEL CNS PHARMA$$35$YR$$M$Y$$$20240822$$CN$US$US
242395641$24239564$1$I$20240613$20240617$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00982$AVADEL CNS PHARMA$$31$YR$$M$Y$$$20240822$$CN$US$US
242395651$24239565$1$I$20240501$20240507$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00759$AVADEL CNS PHARMA$$24$YR$$M$Y$$$20240822$$CN$US$US
242395661$24239566$1$I$20240101$20240626$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01082$AVADEL CNS PHARMA$$$$$F$Y$70.295$KG$20240822$$CN$US$US
242395671$24239567$1$I$20240101$20240628$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01096$AVADEL CNS PHARMA$$$$$F$Y$64.671$KG$20240822$$CN$US$US
242395681$24239568$1$I$20240101$20240604$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00927$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395691$24239569$1$I$20240413$20240521$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00855$AVADEL CNS PHARMA$$27$YR$$F$Y$$$20240822$$CN$US$US
242395701$24239570$1$I$20240501$20240520$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00861$AVADEL CNS PHARMA$$46$YR$$M$Y$$$20240822$$CN$US$US
242395711$24239571$1$I$$20240522$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00863$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242395721$24239572$1$I$20240506$20240507$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00760$AVADEL CNS PHARMA$$33$YR$$F$Y$$$20240822$$CN$US$US
242395731$24239573$1$I$20240101$20240502$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00728$AVADEL CNS PHARMA$$$$$F$Y$59.864$KG$20240822$$CN$US$US
242395741$24239574$1$I$$20240517$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00825$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395751$24239575$1$I$20240601$20240612$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00991$AVADEL CNS PHARMA$$28$YR$$F$Y$62.585$KG$20240822$$CN$US$US
242395761$24239576$1$I$20240601$20240612$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00990$AVADEL CNS PHARMA$$22$YR$$M$Y$$$20240822$$CN$US$US
242395771$24239577$1$I$$20240612$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00992$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242395781$24239578$1$I$20240101$20240502$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00738$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395791$24239579$1$I$20240101$20240514$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00812$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395801$24239580$1$I$20240101$20240603$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00914$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242395811$24239581$1$I$20240101$20240611$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00980$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395821$24239582$1$I$20240101$20240620$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01038$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242395831$24239583$1$I$$20240614$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01002$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242395841$24239584$1$I$20240101$20240614$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01006$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$MD$US$US
242395851$24239585$1$I$20240101$20240614$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01026$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395861$24239586$1$I$20240101$20240613$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01001$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395871$24239587$1$I$20240501$20240516$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00824$AVADEL CNS PHARMA$$51$YR$$F$Y$$$20240822$$CN$US$US
242395881$24239588$1$I$20240101$20240501$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00719$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242395891$24239589$1$I$$20240516$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00829$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242395901$24239590$1$I$20231201$20240614$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01004$AVADEL CNS PHARMA$$43$YR$$F$Y$$$20240822$$HP$US$US
242395911$24239591$1$I$$20240610$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00975$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$HP$US$US
242395921$24239592$1$I$20240501$20240607$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00966$AVADEL CNS PHARMA$$18$YR$$M$Y$$$20240822$$CN$US$US
242395931$24239593$1$I$20240611$20240617$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01019$AVADEL CNS PHARMA$$38$YR$$F$Y$$$20240822$$CN$US$US
242395941$24239594$1$I$$20240509$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00767$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242395951$24239595$1$I$20240101$20240510$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00786$AVADEL CNS PHARMA$$$$$F$Y$102.04$KG$20240822$$CN$US$US
242395961$24239596$1$I$20240501$20240515$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00828$AVADEL CNS PHARMA$$53$YR$$F$Y$$$20240822$$CN$US$US
242395971$24239597$1$I$20240501$20240507$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00758$AVADEL CNS PHARMA$$45$YR$$F$Y$56.689$KG$20240822$$CN$US$US
242395981$24239598$1$I$$20240508$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00761$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$HP$US$US
242395991$24239599$1$I$20240612$20240613$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00996$AVADEL CNS PHARMA$$38$YR$$F$Y$$$20240822$$CN$US$US
242396001$24239600$1$I$20240601$20240619$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01036$AVADEL CNS PHARMA$$29$YR$$F$Y$$$20240822$$CN$US$US
242396011$24239601$1$I$20240601$20240611$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00985$AVADEL CNS PHARMA$$52$YR$$F$Y$$$20240822$$CN$US$US
242396021$24239602$1$I$20240101$20240617$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01018$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396031$24239603$1$I$20240601$20240617$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01016$AVADEL CNS PHARMA$$30$YR$$M$Y$85.261$KG$20240822$$CN$US$US
242396041$24239604$1$I$20240501$20240530$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00910$AVADEL CNS PHARMA$$37$YR$$F$Y$$$20240822$$CN$US$US
242396051$24239605$1$I$20240101$20240503$20240822$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00754$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242396061$24239606$1$I$20230901$20240610$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00987$AVADEL CNS PHARMA$$34$YR$$F$Y$87.982$KG$20240822$$CN$US$US
242396081$24239608$1$I$20240101$20240613$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00999$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396091$24239609$1$I$20240101$20240610$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00970$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396101$24239610$1$I$20240101$20240611$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00989$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242396111$24239611$1$I$20240501$20240614$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01024$AVADEL CNS PHARMA$$33$YR$$F$Y$$$20240822$$CN$US$US
242396121$24239612$1$I$20240601$20240614$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01003$AVADEL CNS PHARMA$$35$YR$$F$Y$$$20240822$$CN$US$US
242396131$24239613$1$I$20240501$20240510$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00781$AVADEL CNS PHARMA$$46$YR$$M$Y$$$20240822$$CN$US$US
242396141$24239614$1$I$$20240606$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00958$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396151$24239615$1$I$20240604$20240617$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01012$AVADEL CNS PHARMA$$69$YR$$M$Y$$$20240822$$CN$US$US
242396161$24239616$1$I$20240101$20240614$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01013$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396171$24239617$1$I$20240401$20240509$20240822$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00775$AVADEL CNS PHARMA$$31$YR$$F$Y$71.701$KG$20240822$$CN$US$US
242396181$24239618$1$I$20240101$20240507$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00764$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396191$24239619$1$I$20240501$20240506$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00744$AVADEL CNS PHARMA$$52$YR$$F$Y$$$20240822$$CN$US$US
242396201$24239620$1$I$$20240504$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00746$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242396212$24239621$2$F$20240101$20240831$20240822$20240912$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00787$AVADEL CNS PHARMA$$$$$F$Y$50.385$KG$20240912$$CN$US$US
242396221$24239622$1$I$20240329$20240510$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00785$AVADEL CNS PHARMA$$25$YR$$F$Y$$$20240822$$CN$US$US
242396231$24239623$1$I$20240601$20240607$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00963$AVADEL CNS PHARMA$$64$YR$$M$Y$$$20240822$$CN$US$US
242396241$24239624$1$I$20240101$20240611$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00984$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396251$24239625$1$I$20240101$20240506$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00745$AVADEL CNS PHARMA$$$$$M$Y$95.238$KG$20240822$$CN$US$US
242396261$24239626$1$I$20240101$20240513$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00807$AVADEL CNS PHARMA$$$$$F$Y$79.365$KG$20240822$$CN$US$US
242396271$24239627$1$I$20240501$20240514$20240822$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00809$AVADEL CNS PHARMA$$51$YR$$F$Y$$$20240822$$CN$US$US
242396281$24239628$1$I$$20240502$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00726$AVADEL CNS PHARMA$$17$YR$$F$Y$$$20240822$$MD$US$US
242396291$24239629$1$I$20240430$20240502$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00727$AVADEL CNS PHARMA$$40$YR$$F$Y$$$20240822$$CN$US$US
242396301$24239630$1$I$20240101$20240520$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00844$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396311$24239631$1$I$20240101$20240613$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01009$AVADEL CNS PHARMA$$$$$F$Y$65.306$KG$20240822$$CN$US$US
242396321$24239632$1$I$20240505$20240506$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00747$AVADEL CNS PHARMA$$67$YR$$F$Y$$$20240822$$CN$US$US
242396331$24239633$1$I$20240101$20240517$20240822$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00837$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396341$24239634$1$I$$20240516$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00838$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242396351$24239635$1$I$$20240507$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00771$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242396361$24239636$1$I$20240501$20240514$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00808$AVADEL CNS PHARMA$$35$YR$$F$Y$$$20240822$$CN$US$US
242396371$24239637$1$I$20240401$20240506$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00749$AVADEL CNS PHARMA$$19$YR$$F$Y$$$20240822$$CN$US$US
242396381$24239638$1$I$20240101$20240506$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00743$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396391$24239639$1$I$20240401$20240508$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00772$AVADEL CNS PHARMA$$53$YR$$F$Y$$$20240822$$MD$US$US
242396401$24239640$1$I$20240101$20240509$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00778$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396411$24239641$1$I$$20240509$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00779$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396421$24239642$1$I$20240301$20240502$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00733$AVADEL CNS PHARMA$$34$YR$$F$Y$$$20240822$$CN$US$US
242396431$24239643$1$I$$20240501$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00739$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396441$24239644$1$I$20240511$20240514$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00806$AVADEL CNS PHARMA$$65$YR$$M$Y$$$20240822$$CN$US$US
242396451$24239645$1$I$$20240514$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00810$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$MD$US$US
242396461$24239646$1$I$$20240516$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00823$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396471$24239647$1$I$20240101$20240516$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00821$AVADEL CNS PHARMA$$$$$F$Y$61.678$KG$20240822$$CN$US$US
242396481$24239648$1$I$20240101$20240527$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00885$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396491$24239649$1$I$20240101$20240524$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00878$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396501$24239650$1$I$20240501$20240528$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00887$AVADEL CNS PHARMA$$37$YR$$M$Y$$$20240822$$CN$US$US
242396511$24239651$1$I$20240101$20240529$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00896$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242396521$24239652$1$I$$20240508$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00784$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396531$24239653$1$I$20240101$20240506$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00770$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396541$24239654$1$I$20240501$20240520$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00849$AVADEL CNS PHARMA$$46$YR$$M$Y$$$20240822$$CN$US$US
242396551$24239655$1$I$20240401$20240502$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00730$AVADEL CNS PHARMA$$46$YR$$F$Y$$$20240822$$CN$US$US
242396561$24239656$1$I$$20240503$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00736$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242396571$24239657$1$I$20240608$20240614$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01023$AVADEL CNS PHARMA$$67$YR$$M$Y$79.365$KG$20240822$$CN$US$US
242396581$24239658$1$I$20240101$20240621$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01043$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396591$24239659$1$I$20240501$20240509$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00776$AVADEL CNS PHARMA$$34$YR$$F$Y$$$20240822$$CN$US$US
242396601$24239660$1$I$20240501$20240512$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00792$AVADEL CNS PHARMA$$27$YR$$F$Y$$$20240822$$CN$US$US
242396611$24239661$1$I$20240501$20240515$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00819$AVADEL CNS PHARMA$$44$YR$$F$Y$$$20240822$$CN$US$US
242396621$24239662$1$I$$20240514$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00803$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242396631$24239663$1$I$20240101$20240528$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00889$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396641$24239664$1$I$20240101$20240603$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00916$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396651$24239665$1$I$$20240516$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00839$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396661$24239666$1$I$20240501$20240523$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00865$AVADEL CNS PHARMA$$22$YR$$F$Y$$$20240822$$CN$US$US
242396671$24239667$1$I$$20240514$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00805$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396681$24239668$1$I$20240401$20240507$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00757$AVADEL CNS PHARMA$$22$YR$$F$Y$$$20240822$$CN$US$US
242396691$24239669$1$I$$20240528$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00890$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$HP$US$US
242396701$24239670$1$I$$20240529$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00895$AVADEL CNS PHARMA$$5$DEC$$F$Y$$$20240822$$HP$US$US
242396711$24239671$1$I$$20240601$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00917$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242396721$24239672$1$I$20240501$20240521$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00857$AVADEL CNS PHARMA$$39$YR$$F$Y$$$20240822$$CN$US$US
242396731$24239673$1$I$20240425$20240523$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00869$AVADEL CNS PHARMA$$33$YR$$F$Y$63.492$KG$20240822$$CN$US$US
242396741$24239674$1$I$20240101$20240528$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00884$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396751$24239675$1$I$20240101$20240530$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00901$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396761$24239676$1$I$20240101$20240513$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00801$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396771$24239677$1$I$20240101$20240514$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00804$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$HP$US$US
242396781$24239678$1$I$20240101$20240522$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00859$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396791$24239679$1$I$20240520$20240531$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00906$AVADEL CNS PHARMA$$37$YR$$F$Y$$$20240822$$CN$US$US
242396801$24239680$1$I$20240101$20240530$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00898$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396811$24239681$1$I$20240501$20240531$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00902$AVADEL CNS PHARMA$$48$YR$$M$Y$$$20240822$$CN$US$US
242396821$24239682$1$I$20240501$20240531$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00907$AVADEL CNS PHARMA$$49$YR$$F$Y$$$20240822$$CN$US$US
242396831$24239683$1$I$20240501$20240529$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00897$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396841$24239684$1$I$20240101$20240529$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00893$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396851$24239685$1$I$20240101$20240604$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00946$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396861$24239686$1$I$$20240510$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00793$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242396871$24239687$1$I$$20240515$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00814$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242396881$24239688$1$I$20240518$20240521$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00850$AVADEL CNS PHARMA$$18$YR$$M$Y$$$20240822$$CN$US$US
242396891$24239689$1$I$20240101$20240610$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00851$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396901$24239690$1$I$$20240508$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00783$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242396911$24239691$1$I$20240501$20240524$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00876$AVADEL CNS PHARMA$$28$YR$$F$Y$$$20240822$$CN$US$US
242396921$24239692$1$I$$20240516$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00891$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396931$24239693$1$I$20240101$20240604$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00924$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242396941$24239694$1$I$20240605$20240606$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00953$AVADEL CNS PHARMA$$55$YR$$F$Y$$$20240822$$CN$US$US
242396951$24239695$1$I$20240101$20240620$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01037$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396961$24239696$1$I$20240101$20240514$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00802$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396971$24239697$1$I$20240101$20240517$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00840$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242396981$24239698$1$I$20240101$20240513$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00813$AVADEL CNS PHARMA$$$$$F$Y$57.596$KG$20240822$$CN$US$US
242396991$24239699$1$I$20240101$20240510$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00774$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397001$24239700$1$I$$20240524$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00881$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242397011$24239701$1$I$20240101$20240528$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00888$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397021$24239702$1$I$20240101$20240529$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00892$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397031$24239703$1$I$$20240611$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00977$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397041$24239704$1$I$20240101$20240606$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00956$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$HP$US$US
242397051$24239705$1$I$20240613$20240614$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01025$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242397061$24239706$1$I$20240523$20240530$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00899$AVADEL CNS PHARMA$$36$YR$$F$Y$$$20240822$$CN$US$US
242397071$24239707$1$I$20240217$20240520$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01008$AVADEL CNS PHARMA$$17$YR$$M$Y$$$20240822$$CN$US$US
242397081$24239708$1$I$$20240614$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00976$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397091$24239709$1$I$20240604$20240607$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00961$AVADEL CNS PHARMA$$49$YR$$M$Y$$$20240822$$CN$US$US
242397101$24239710$1$I$$20240607$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00973$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242397111$24239711$1$I$$20240611$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00988$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397121$24239712$1$I$$20240617$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01017$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242397141$24239714$1$I$20240501$20240606$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00951$AVADEL CNS PHARMA$$53$YR$$F$Y$$$20240822$$CN$US$US
242397151$24239715$1$I$20240330$20240611$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00981$AVADEL CNS PHARMA$$47$YR$$F$Y$$$20240822$$CN$US$US
242397161$24239716$1$I$$20240617$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01021$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$HP$US$US
242397171$24239717$1$I$$20240617$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01020$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$HP$US$US
242397181$24239718$1$I$20240101$20240613$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01000$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397191$24239719$1$I$20240101$20240513$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00791$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242397201$24239720$1$I$$20240611$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00986$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242397211$24239721$1$I$20240101$20240506$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00766$AVADEL CNS PHARMA$$$$$M$Y$73.923$KG$20240822$$CN$US$US
242397221$24239722$1$I$20240101$20240617$20240822$20240822$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01028$AVADEL CNS PHARMA$$$$$F$Y$51.111$KG$20240822$$CN$US$US
242397231$24239723$1$I$$20240607$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00974$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$HP$US$US
242397241$24239724$1$I$20240101$20240608$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00967$AVADEL CNS PHARMA$$$$$F$Y$52.599$KG$20240822$$CN$US$US
242397251$24239725$1$I$20240601$20240611$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00979$AVADEL CNS PHARMA$$38$YR$$F$Y$68.027$KG$20240822$$CN$US$US
242397261$24239726$1$I$20240101$20240606$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00957$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$PH$US$US
242397272$24239727$2$F$20240101$20240819$20240822$20240822$PER$$US-ABBVIE-5888688$ABBVIE$$$$$$Y$$$20240822$$MD$US$US
242397281$24239728$1$I$20240101$20240620$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01039$AVADEL CNS PHARMA$$$$$F$Y$158.73$KG$20240822$$CN$US$US
242397291$24239729$1$I$20240613$20240613$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00995$AVADEL CNS PHARMA$$42$YR$$F$Y$72.562$KG$20240822$$CN$US$US
242397301$24239730$1$I$20240701$20240719$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01276$AVADEL CNS PHARMA$$23$YR$$F$Y$$$20240822$$CN$US$US
242397311$24239731$1$I$20240101$20240722$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01283$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397321$24239732$1$I$20240101$20240716$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01240$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397331$24239733$1$I$20240701$20240717$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01242$AVADEL CNS PHARMA$$31$YR$$F$Y$$$20240822$$CN$US$US
242397341$24239734$1$I$20240601$20240617$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01031$AVADEL CNS PHARMA$$53$YR$$M$Y$$$20240822$$MD$US$US
242397351$24239735$1$I$$20240605$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00952$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397361$24239736$1$I$20240101$20240719$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01274$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397371$24239737$1$I$$20240723$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01286$AVADEL CNS PHARMA$$$$T$M$Y$$$20240822$$MD$US$US
242397381$24239738$1$I$20240701$20240721$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01267$AVADEL CNS PHARMA$$32$YR$$F$Y$$$20240822$$CN$US$US
242397391$24239739$1$I$20240701$20240715$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01220$AVADEL CNS PHARMA$$54$YR$$F$Y$$$20240822$$CN$US$US
242397401$24239740$1$I$$20240723$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01289$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242397411$24239741$1$I$20240101$20240723$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01291$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397431$24239743$1$I$20240101$20240612$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00993$AVADEL CNS PHARMA$$$$$F$Y$85.578$KG$20240822$$CN$US$US
242397441$24239744$1$I$20240601$20240722$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01281$AVADEL CNS PHARMA$$53$YR$$F$Y$$$20240822$$CN$US$US
242397451$24239745$1$I$20240701$20240724$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01293$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397461$24239746$1$I$$20240724$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01294$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242397471$24239747$1$I$20240701$20240724$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01298$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397481$24239748$1$I$20240101$20240719$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01266$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397491$24239749$1$I$$20240722$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01268$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242397501$24239750$1$I$$20240719$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01269$AVADEL CNS PHARMA$$$$$M$Y$81.179$KG$20240822$$HP$US$US
242397511$24239751$1$I$$20240719$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01270$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242397521$24239752$1$I$20240701$20240719$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01275$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397531$24239753$1$I$20240701$20240716$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01241$AVADEL CNS PHARMA$$37$YR$$F$Y$$$20240822$$CN$US$US
242397541$24239754$1$I$20240101$20240717$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01245$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397551$24239755$1$I$20240713$20240715$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01218$AVADEL CNS PHARMA$$46$YR$$F$Y$$$20240822$$CN$US$US
242397561$24239756$1$I$20240101$20240715$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01234$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397571$24239757$1$I$20240701$20240718$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01260$AVADEL CNS PHARMA$$36$YR$$F$Y$$$20240822$$CN$US$US
242397581$24239758$1$I$20240101$20240723$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01287$AVADEL CNS PHARMA$$$$$F$Y$56.689$KG$20240822$$CN$US$US
242397591$24239759$1$I$20240701$20240719$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01272$AVADEL CNS PHARMA$$20$YR$$F$Y$$$20240822$$CN$US$US
242397601$24239760$1$I$$20240722$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01280$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397611$24239761$1$I$$20240722$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01282$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$MD$US$US
242397621$24239762$1$I$20240101$20240624$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01063$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397631$24239763$1$I$20240710$20240716$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01239$AVADEL CNS PHARMA$$50$YR$$M$Y$$$20240822$$CN$US$US
242397641$24239764$1$I$$20240717$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01244$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242397651$24239765$1$I$$20240717$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01247$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397661$24239766$1$I$20240701$20240717$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01248$AVADEL CNS PHARMA$$18$YR$$M$Y$$$20240822$$CN$US$US
242397671$24239767$1$I$20240101$20240717$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01249$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397681$24239768$1$I$20240101$20240614$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01010$AVADEL CNS PHARMA$$$$$F$Y$64.853$KG$20240822$$CN$US$US
242397691$24239769$1$I$20240701$20240717$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01250$AVADEL CNS PHARMA$$50$YR$$F$Y$$$20240822$$CN$US$US
242397701$24239770$1$I$$20240715$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01222$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242397711$24239771$1$I$20240101$20240715$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01224$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397721$24239772$1$I$20240701$20240715$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01225$AVADEL CNS PHARMA$$40$YR$$M$Y$$$20240822$$CN$US$US
242397731$24239773$1$I$$20240715$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01226$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397741$24239774$1$I$20240101$20240715$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01227$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397751$24239775$1$I$20240101$20240715$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01229$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397761$24239776$1$I$20240101$20240710$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01216$AVADEL CNS PHARMA$$$$$F$Y$54.422$KG$20240822$$CN$US$US
242397771$24239777$1$I$20240101$20240717$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01253$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242397781$24239778$1$I$20240101$20240712$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01217$AVADEL CNS PHARMA$$$$$F$Y$72.608$KG$20240822$$HP$US$US
242397791$24239779$1$I$20240701$20240717$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01254$AVADEL CNS PHARMA$$32$YR$$M$Y$$$20240822$$CN$US$US
242397801$24239780$1$I$20240101$20240718$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01255$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$HP$US$US
242397811$24239781$1$I$20240101$20240718$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01256$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397821$24239782$1$I$20240717$20240718$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01257$AVADEL CNS PHARMA$$32$YR$$F$Y$$$20240822$$CN$US$US
242397831$24239783$1$I$20240101$20240718$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01258$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242397841$24239784$1$I$20240701$20240718$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01259$AVADEL CNS PHARMA$$51$YR$$F$Y$90.703$KG$20240822$$CN$US$US
242397851$24239785$1$I$20240701$20240718$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01261$AVADEL CNS PHARMA$$38$YR$$F$Y$$$20240822$$CN$US$US
242397861$24239786$1$I$20240101$20240718$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01263$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$CN$US$US
242397872$24239787$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234543$TEVA$Patel R, Elghawy O, Gibbs A, Gupta S, Kaur V. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer-Rep 2024; 7 (7): e2110.; Patel R, Elghawy O, Gibbs A, Gupta S, Kaur V. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer-Rep 2024; 7 (7): e2110.; Patel R, Elghawy O, Gibbs A, Gupta S, Kaur ...$84$YR$$M$Y$$$20240909$$HP$US$US
242397882$24239788$2$F$20240808$20240820$20240822$20240827$EXP$$LB-AstraZeneca-2024A189229$ASTRAZENECA$$19399$DY$$F$Y$$$20240827$$HP$LB$
242397891$24239789$1$I$$20240819$20240822$20240822$EXP$$BR-JNJFOC-20240847934$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$CN$BR$BR
242397901$24239790$1$I$20240812$20240814$20240822$20240822$EXP$$CN-AstraZeneca-2024A187480$ASTRAZENECA$$27264$DY$$M$Y$$$20240822$$MD$CN$
242397913$24239791$3$F$20240716$20240920$20240822$20240926$EXP$$US-SPRINGWORKS THERAPEUTICS-SW-001893$SPRINGWORKS THERAPEUTIC$$26$YR$$F$Y$$$20240926$$HP$US$US
242397922$24239792$2$F$$20240926$20240822$20240926$30DAY$$CL-PFIZER INC-PV202400107922$PFIZER$$11$YR$$M$Y$$$20240926$$CN$CL$CL
242397941$24239794$1$I$$20240816$20240822$20240822$30DAY$$SE-PFIZER INC-202400240880$PFIZER$$$$$$Y$$$20240822$$PH$SE$SE
242397951$24239795$1$I$$20240816$20240822$20240822$30DAY$$CO-PFIZER INC-202400239354$PFIZER$$$$$$Y$$$20240822$$CN$CO$CO
242397961$24239796$1$I$$20240815$20240822$20240822$PER$$US-TRAVERE-2024TVT00816$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242397972$24239797$2$F$$20240821$20240822$20240917$PER$$US-TRAVERE-2024TVT00817$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
242397981$24239798$1$I$20240724$20240821$20240822$20240822$EXP$$US-GILEAD-2024-0684990$GILEAD$$36$YR$A$F$Y$$$20240822$$CN$US$US
242397991$24239799$1$I$20240819$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024166697$AMGEN$$57$YR$A$F$Y$$$20240822$$CN$US$US
242398001$24239800$1$I$20240101$20240712$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01219$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398011$24239801$1$I$20240701$20240712$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01212$AVADEL CNS PHARMA$$19$YR$$F$Y$$$20240822$$CN$US$US
242398021$24239802$1$I$$20240820$20240822$20240822$EXP$$NVSC2024CN169935$NOVARTIS$$51$YR$$F$Y$44$KG$20240822$$HP$CN$CN
242398031$24239803$1$I$20240101$20240625$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA00950$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398041$24239804$1$I$20240809$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57696$$FDA-CTU$$57$YR$$F$N$$$20240821$N$HP$US$
242398051$24239805$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57684$$FDA-CTU$$58$YR$$F$N$126$LBS$20240821$N$$US$
242398062$24239806$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234694$TEVA$Phang CR, Farooqi A, Sangwan Y. Unmasking the Unusual: Cryptococcal Pericarditis in a Patient with Liver Failure - a Rare Occurrence. Am-J-Case-Rep 2024; 25.; Phang CR, Farooqi A, Sangwan Y. Unmasking the Unusual: Cryptococcal Pericarditis in a Patient with Liver Failure - a Rare Occurrence. Am-J-Case-Rep 2024; 25.$47$YR$$M$Y$$$20240909$$HP$US$US
242398071$24239807$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5888238$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242398081$24239808$1$I$$20240821$20240822$20240822$EXP$GB-MHRA-MED-202408211408286570-FQSWV$GB-MYLANLABS-2024M1077742$MYLAN$$82$YR$$F$Y$$$20240822$$HP$GB$GB
242398092$24239809$2$F$20240815$20240822$20240822$20240827$EXP$$CA-BAUSCH-BL-2024-012501$BAUSCH AND LOMB$$23$YR$$F$Y$$$20240827$$CN$CA$CA
242398101$24239810$1$I$$20240819$20240822$20240822$PER$$US-ABBVIE-5889884$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242398111$24239811$1$I$20231101$20240816$20240822$20240822$EXP$$US-ABBVIE-5887506$ABBVIE$$59$YR$$M$Y$$$20240822$$CN$US$US
242398121$24239812$1$I$20240409$20240820$20240822$20240822$EXP$$US-PFIZER INC-PV202300136114$PFIZER$$64$YR$$M$Y$81.65$KG$20240822$$CN$US$US
242398131$24239813$1$I$20220909$20240820$20240822$20240822$EXP$$KR-PFIZER INC-202400239566$PFIZER$$63$YR$$F$Y$$$20240822$$HP$KR$KR
242398141$24239814$1$I$$20240819$20240822$20240822$EXP$$US-PFIZER INC-PV202400090234$PFIZER$$62$YR$$F$Y$$$20240822$$HP$US$US
242398151$24239815$1$I$$20240819$20240822$20240822$EXP$$US-BAUSCH-BL-2024-012519$BAUSCH AND LOMB$Blenkush N, Cunningham M. Elimination of Refractory Aggression and Self-Injury with Contingent Skin Shock. J Neuropsychiatry Clin Neurosci. 2023 FEB 14;35:3:264-268. doi:10.1176/ appi.neuropsych.21020049$$$A$F$Y$$$20240822$$HP$US$US
242398162$24239816$2$F$20240509$20240922$20240822$20240926$EXP$$IT-BAUSCH-BL-2024-012489$BAUSCH AND LOMB$$46$YR$$M$Y$74$KG$20240926$$MD$IT$IT
242398171$24239817$1$I$20240101$20240813$20240822$20240822$EXP$GB-MHRA-MED-202408092132474450-DMWHJ$GB-TEVA-VS-3233270$TEVA$$34$YR$$F$Y$$$20240822$$CN$GB$GB
242398183$24239818$3$F$20240101$20240904$20240822$20240909$EXP$$US-ABBVIE-5889361$ABBVIE$$85$YR$$F$Y$$$20240909$$CN$US$US
242398191$24239819$1$I$20240808$20240813$20240822$20240822$EXP$$GB-TEVA-VS-3233264$TEVA$$43$YR$$F$Y$71$KG$20240822$$MD$GB$GB
242398201$24239820$1$I$20220101$20240813$20240822$20240822$EXP$GB-MHRA-31453274$GB-TEVA-VS-3233323$TEVA$$46$YR$$M$Y$120$KG$20240822$$CN$GB$GB
242398211$24239821$1$I$20240805$20240821$20240822$20240822$EXP$$FR-AMERICAN REGENT INC-2024003230$AMERICAN REGENT$$19$YR$$F$Y$64$KG$20240822$$PH$FR$FR
242398221$24239822$1$I$20240715$20240813$20240822$20240822$EXP$GB-MHRA-MED-202408110913447380-GSJPR$GB-TEVA-VS-3233353$TEVA$$34$YR$$F$Y$65$KG$20240822$$CN$GB$GB
242398231$24239823$1$I$$20240816$20240822$20240822$EXP$$US-BAUSCH-BL-2024-012473$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240822$$CN$US$US
242398241$24239824$1$I$20240805$20240813$20240822$20240822$EXP$GB-MHRA-MED-202408100842521440-PTBJR$GB-TEVA-VS-3233400$TEVA$$72$YR$$F$Y$63$KG$20240822$$CN$GB$GB
242398251$24239825$1$I$$20240820$20240822$20240822$EXP$$US-BAUSCH-BL-2024-012687$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240822$$CN$US$US
242398264$24239826$4$F$20240807$20240917$20240822$20240920$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011918$JAZZ$$24$YR$$M$Y$$$20240920$$HP$US$US
242398271$24239827$1$I$$20240821$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA074482$SANDOZ$$3$YR$$M$Y$$$20240822$$PH$CA$CA
242398282$24239828$2$F$$20240911$20240822$20240921$EXP$$US-ARDELYX-2024ARDX006201$ARDELYX$$$$$M$Y$$$20240921$$HP$US$US
242398291$24239829$1$I$20240101$20240812$20240822$20240822$EXP$$US-ARDELYX-2024ARDX006168$ARDELYX$$$$$M$Y$$$20240822$$CN$US$US
242398301$24239830$1$I$20240817$20240820$20240822$20240822$PER$$US-JNJFOC-20240851697$JOHNSON AND JOHNSON$$31$YR$A$M$Y$99.88$KG$20240822$$HP$US$US
242398311$24239831$1$I$$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165710$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
242398321$24239832$1$I$$20240819$20240822$20240822$PER$$US-BEH-2024177485$CSL BEHRING$$$$$M$Y$$$20240822$$HP$US$US
242398332$24239833$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234585$TEVA$Petric UB, Marks D, Dickman M, Rieger KE, Kibbi N. A Severe Case of Pan-Facial Vitamin C Serum-Induced Foreign Body Granulomatous Reaction. Dermatol-Surg 2024; 50 (6): 590-592.; Petric UB, Marks D, Dickman M, Rieger KE, Kibbi N. A Severe Case of Pan-Facial Vitamin C Serum-Induced Foreign Body Granulomatous Reaction. Dermatol-Surg 2024; 50 (6): 590-592.$53$YR$$F$Y$$$20240909$$HP$US$US
242398341$24239834$1$I$$20240819$20240822$20240822$EXP$$CA-BAUSCH-BL-2024-012632$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240822$$CN$CA$CA
242398351$24239835$1$I$$20240819$20240822$20240822$EXP$$CA-BAUSCH-BL-2024-012622$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240822$$CN$CA$CA
242398361$24239836$1$I$$20240819$20240822$20240822$EXP$$CA-BAUSCH-BL-2024-012654$BAUSCH AND LOMB$$46$YR$$M$Y$$$20240822$$CN$CA$CA
242398371$24239837$1$I$$20240819$20240822$20240822$EXP$$CA-BAUSCH-BL-2024-012641$BAUSCH AND LOMB$$56$YR$$F$Y$$$20240822$$CN$CA$CA
242398381$24239838$1$I$$20240816$20240822$20240822$PER$$US-TRAVERE-2024TVT00820$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240822$$CN$US$US
242398392$24239839$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234524$TEVA$Hesham A, David Kim D, Alshamrani Y, AlOtaibi F, Hyppolito J. The efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy in recurrent head and neck squamous cell carcinoma. Report of a case and review of the literature. Oral-Oncol 2024; 154 (0):.; Hesham A, David Kim D, Alshamrani Y, AlOtaibi F, Hyppolito J. The efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy in recurrent head and neck squamous cell carcinoma. Report of a case and review of the literature. Oral-On...$66$YR$$M$Y$$$20240909$$HP$US$US
242398401$24239840$1$I$$20240822$20240822$20240822$EXP$$JP-BAYER-2024A120925$BAYER$$$$$$Y$$$20240822$$MD$JP$JP
242398411$24239841$1$I$20240716$20240725$20240822$20240822$PER$$US-Eisai-EC-2024-170883$EISAI$$68$YR$E$F$Y$75$KG$20240822$$MD$US$US
242398421$24239842$1$I$$20240807$20240822$20240822$PER$$US-Eisai-EC-2024-171718$EISAI$$$$$F$Y$$$20240822$$HP$US$US
242398431$24239843$1$I$$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01312$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398441$24239844$1$I$20240721$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01326$AVADEL CNS PHARMA$$22$YR$$F$Y$$$20240822$$CN$US$US
242398451$24239845$1$I$20240101$20240731$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01409$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398461$24239846$1$I$20240101$20240731$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01414$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$HP$US$US
242398471$24239847$1$I$$20240718$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01464$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$HP$US$US
242398481$24239848$1$I$20240601$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01310$AVADEL CNS PHARMA$$31$YR$$M$Y$$$20240822$$CN$US$US
242398491$24239849$1$I$20240101$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01311$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398501$24239850$1$I$20240701$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01313$AVADEL CNS PHARMA$$50$YR$$M$Y$$$20240822$$CN$US$US
242398511$24239851$1$I$20240101$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01315$AVADEL CNS PHARMA$$$$$F$Y$61.224$KG$20240822$$CN$US$US
242398521$24239852$1$I$20240701$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01316$AVADEL CNS PHARMA$$50$YR$$F$Y$$$20240822$$CN$US$US
242398531$24239853$1$I$20240101$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01317$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398541$24239854$1$I$20240101$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01325$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398551$24239855$1$I$20240101$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01314$AVADEL CNS PHARMA$$$$$M$Y$68.027$KG$20240822$$CN$US$US
242398561$24239856$1$I$$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01327$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398571$24239857$1$I$$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01330$AVADEL CNS PHARMA$$$$$M$Y$98.503$KG$20240822$$HP$US$US
242398581$24239858$1$I$20240701$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01331$AVADEL CNS PHARMA$$31$YR$$M$Y$$$20240822$$CN$US$US
242398591$24239859$1$I$20240701$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01332$AVADEL CNS PHARMA$$55$YR$$F$Y$$$20240822$$CN$US$US
242398601$24239860$1$I$20240701$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01338$AVADEL CNS PHARMA$$38$YR$$F$Y$$$20240822$$CN$US$US
242398611$24239861$1$I$$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01341$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$MD$US$US
242398621$24239862$1$I$20240701$20240729$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01378$AVADEL CNS PHARMA$$50$YR$$F$Y$$$20240822$$HP$US$US
242398631$24239863$1$I$20240101$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01381$AVADEL CNS PHARMA$$28$YR$$F$Y$$$20240822$$CN$US$US
242398641$24239864$1$I$$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01382$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$CN$US$US
242398651$24239865$1$I$$20240729$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01384$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398661$24239866$1$I$$20240729$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01385$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$MD$US$US
242398671$24239867$1$I$20240701$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01388$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398681$24239868$1$I$20240101$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01391$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398691$24239869$1$I$20240101$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01393$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398701$24239870$1$I$20240701$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01394$AVADEL CNS PHARMA$$23$YR$$M$Y$$$20240822$$CN$US$US
242398711$24239871$1$I$20240101$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01397$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398721$24239872$1$I$20240701$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01398$AVADEL CNS PHARMA$$37$YR$$F$Y$$$20240822$$CN$US$US
242398731$24239873$1$I$20240101$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01400$AVADEL CNS PHARMA$$36$YR$$F$Y$$$20240822$$CN$US$US
242398741$24239874$1$I$20240701$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01401$AVADEL CNS PHARMA$$33$YR$$F$Y$$$20240822$$CN$US$US
242398751$24239875$1$I$$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01336$AVADEL CNS PHARMA$$$$$F$Y$70.295$KG$20240822$$CN$US$US
242398761$24239876$1$I$20240601$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01395$AVADEL CNS PHARMA$$47$YR$$F$Y$$$20240822$$CN$US$US
242398771$24239877$1$I$$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01402$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$CN$US$US
242398781$24239878$1$I$$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01403$AVADEL CNS PHARMA$$$$$$Y$$$20240822$$CN$US$US
242398791$24239879$1$I$20240101$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01405$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398801$24239880$1$I$20240701$20240731$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01406$AVADEL CNS PHARMA$$24$YR$$M$Y$$$20240822$$CN$US$US
242398811$24239881$1$I$20240730$20240731$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01407$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242398821$24239882$1$I$$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129197$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240822$$CN$US$US
242398831$24239883$1$I$$20240820$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133286$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240822$$CN$US$US
242398841$24239884$1$I$20240801$20240816$20240822$20240822$PER$$US-BAUSCH-BL-2024-012498$BAUSCH AND LOMB$$31$YR$$M$Y$63.56$KG$20240822$$CN$US$US
242398851$24239885$1$I$$20240812$20240822$20240822$PER$$US-BAUSCH-BL-2024-012297$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240822$$CN$US$US
242398862$24239886$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234588$TEVA$Murphy M, Jones K, Ruebner RL, Raabe E. Acute Onset of Abdominal Pain in a 3-year-old Boy with Acute Lymphoblastic Leukemia. Pediatr-Rev 2023; 44 (Suppl. 1) S106-S109.; Murphy M, Jones K, Ruebner RL, Raabe E. Acute Onset of Abdominal Pain in a 3-year-old Boy with Acute Lymphoblastic Leukemia. Pediatr-Rev 2023; 44 (Suppl. 1) S106-S109.$3$YR$$M$Y$$$20240909$$MD$US$US
242398872$24239887$2$F$20240101$20240822$20240822$20240827$EXP$$PR-ABBVIE-5887432$ABBVIE$$$$$F$Y$100$KG$20240827$$CN$PR$PR
242398881$24239888$1$I$20230101$20240816$20240822$20240822$PER$$US-VERTEX PHARMACEUTICALS-2024-013337$VERTEX$$$$C$M$Y$$$20240822$$CN$US$US
242398891$24239889$1$I$20240425$20240815$20240822$20240822$EXP$FR-AFSSAPS-NC2024000979$FR-VERTEX PHARMACEUTICALS-2024-013262$VERTEX$$5$YR$$F$Y$21$KG$20240822$$HP$FR$FR
242398901$24239890$1$I$20240702$20240731$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01408$AVADEL CNS PHARMA$$26$YR$$F$Y$$$20240822$$CN$US$US
242398911$24239891$1$I$$20240822$20240822$20240822$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047301$BOEHRINGER INGELHEIM$$$$$$Y$$$20240822$$CN$US$US
242398921$24239892$1$I$$20210625$20240822$20240822$EXP$$US-AstraZeneca-2021A578785$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242398941$24239894$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132146$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240822$$PH$US$US
242398951$24239895$1$I$20240701$20240819$20240822$20240822$PER$$US-BAUSCH-BL-2024-012538$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240822$$CN$US$US
242398961$24239896$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5887458$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242398971$24239897$1$I$$20240820$20240822$20240822$EXP$$CA-ABBVIE-5888318$ABBVIE$$$$A$F$Y$$$20240822$$CN$CA$CA
242398981$24239898$1$I$$20240816$20240822$20240822$EXP$$US-BIOMARINAP-US-2024-159975$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242398992$24239899$2$F$$20240821$20240822$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408011853$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240827$$CN$US$US
242399002$24239900$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234587$TEVA$Nelson N, Masih D, Sabri A, Monika F, Mirza M. Isolated Myeloid Sarcoma Masquerading as Scattered Abscesses in a Septic Patient: A Case Report and Literature Review. Case-Rep-Oncol 2024; 17 (1): 39-48.; Nelson N, Masih D, Sabri A, Monika F, Mirza M. Isolated Myeloid Sarcoma Masquerading as Scattered Abscesses in a Septic Patient: A Case Report and Literature Review. Case-Rep-Oncol 2024; 17 (1): 39-48.$76$YR$$F$Y$$$20240909$$HP$US$US
242399011$24239901$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57746$$FDA-CTU$$66$YR$$F$N$$$20240821$N$$US$
242399021$24239902$1$I$20240401$20240821$20240822$20240822$PER$$US-GILEAD-2024-0685049$GILEAD$$65$YR$E$M$Y$$$20240822$$CN$US$US
242399031$24239903$1$I$20240101$20240816$20240822$20240822$EXP$$US-ABBVIE-5885531$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242399043$24239904$3$F$$20240828$20240822$20240911$EXP$$JP-AMGEN-JPNSP2024162765$AMGEN$$$$$$Y$$$20240911$$PH$JP$JP
242399051$24239905$1$I$$20240821$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133402$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240822$$CN$US$US
242399061$24239906$1$I$20240729$20240820$20240822$20240822$EXP$FR-AFSSAPS-AN2024001101$FR-MYLANLABS-2024M1077349$MYLAN$$20$YR$$M$Y$65$KG$20240822$$PH$FR$FR
242399071$24239907$1$I$20240719$20240820$20240822$20240822$EXP$FR-AFSSAPS-GR2024001015$FR-MYLANLABS-2024M1077364$MYLAN$$53$YR$$F$Y$$$20240822$$PH$FR$FR
242399082$24239908$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234594$TEVA$Sheth S, Matthia E, Naik D. Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer. J-Clin-Lipidol 2024; 18 (Suppl.) (4): e555-e556; Sheth S, Matthia E, Naik D. Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer. J-Clin-Lipidol 2024; 18 (Suppl.) (4): e555-e556.$57$YR$$F$Y$$$20240909$$HP$US$US
242399092$24239909$2$F$$20240820$20240822$20240903$EXP$$IT-MYLANLABS-2024M1077234$MYLAN$$33$YR$$F$Y$90$KG$20240903$$MD$IT$IT
242399101$24239910$1$I$20240701$20240820$20240822$20240822$EXP$FR-AFSSAPS-GR2024001008$FR-MYLANLABS-2024M1077348$MYLAN$$70$YR$$M$Y$$$20240822$$PH$FR$FR
242399111$24239911$1$I$20240701$20240725$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01329$AVADEL CNS PHARMA$$32$YR$$F$Y$$$20240822$$CN$US$US
242399122$24239912$2$F$20230823$20240916$20240822$20240924$EXP$$CA-TAKEDA-2023TUS081373$TAKEDA$$57$YR$$F$Y$$$20240924$$CN$CA$CA
242399131$24239913$1$I$20240101$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01333$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242399141$24239914$1$I$20240724$20240726$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01334$AVADEL CNS PHARMA$$23$YR$$F$Y$$$20240822$$CN$US$US
242399151$24239915$1$I$20240101$20240729$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01380$AVADEL CNS PHARMA$$$$$F$Y$$$20240822$$CN$US$US
242399161$24239916$1$I$20240101$20240730$20240822$20240822$PER$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01410$AVADEL CNS PHARMA$$$$$M$Y$$$20240822$$CN$US$US
242399171$24239917$1$I$$20240814$20240822$20240822$EXP$$MA-BIOMARINAP-MA-2024-159994$BIOMARIN$$$$$$Y$$$20240822$$CN$MA$MA
242399181$24239918$1$I$20240618$20240814$20240822$20240822$EXP$$US-BIOMARINAP-US-2024-159983$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242399192$24239919$2$F$$20240817$20240822$20240828$PER$$US-BIOMARINAP-US-2024-159995$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
242399201$24239920$1$I$20240818$20240819$20240822$20240822$EXP$$US-BIOMARINAP-US-2024-159966$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242399211$24239921$1$I$$20240816$20240822$20240822$EXP$$FR-DSJP-DSE-2024-141260$DAIICHI$$$$A$F$Y$$$20240822$$MD$FR$FR
242399222$24239922$2$F$20240731$20240829$20240822$20240903$EXP$$US-BIOMARIN PHARMACEUTICAL INC.-US-2024-159980$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242399233$24239923$3$F$20240101$20240919$20240822$20240927$EXP$$US-ABBVIE-5883589$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
242399241$24239924$1$I$$20240710$20240822$20240822$PER$$US-LUNDBECK-DKLU4001618$LUNDBECK$$$$$$Y$$$20240822$$CN$US$US
242399251$24239925$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132260$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240822$$CN$US$US
242399261$24239926$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132770$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240822$$HP$US$US
242399273$24239927$3$F$$20240917$20240822$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128554$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240919$$CN$US$US
242399284$24239928$4$F$$20240821$20240822$20240830$EXP$AU-ASPEN-AUS2024AU004795$NVSC2024AU170029$NOVARTIS$Kam I, Prentice D, Kho LK, Dharsono F. Inflammatory epilepsy (FIRES) and haemophagocytic lymphohistiocytosis (HLH): an adult case. BMJ?CASE?REP. 2023;16(1):1?4$40$YR$$M$Y$$$20240830$$HP$AU$AU
242399291$24239929$1$I$20240402$20240725$20240822$20240822$PER$$US-SMPA-2024MYSCI0300791$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242399301$24239930$1$I$$20240724$20240822$20240822$PER$$US-SMPA-2024MYSCI0700207$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242399311$24239931$1$I$$20240813$20240822$20240822$PER$$US-SMPA-2024SPA000537$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242399321$24239932$1$I$$20240730$20240822$20240822$PER$$US-SMPA-2024SPA000573$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242399331$24239933$1$I$$20240808$20240822$20240822$PER$$US-SMPA-2024SPA001142$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242399341$24239934$1$I$$20240812$20240822$20240822$PER$$US-SMPA-2024SPA001410$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242399351$24239935$1$I$$20240730$20240822$20240822$PER$$US-SMPA-2024SPA000608$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242399361$24239936$1$I$$20240812$20240822$20240822$PER$$US-SMPA-2024SPA001392$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242399371$24239937$1$I$$20240806$20240822$20240822$PER$$US-SMPA-2024SPA000903$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242399381$24239938$1$I$20240514$20240808$20240822$20240822$EXP$$US-RADIUS HEALTH INC.-2024US003836$RADIUS PHARM$$54$YR$$F$Y$66.485$KG$20240822$$CN$US$US
242399392$24239939$2$F$20240101$20240829$20240822$20240904$PER$$US-009507513-2407USA012990$MERCK$$$$$F$Y$$$20240904$$CN$US$US
242399401$24239940$1$I$$20240812$20240822$20240822$EXP$$HU-TEVA-VS-3233743$TEVA$Szigethi T, Tanai E, Moln?r L, Zima E, Sax B, Szappanos ?, Becker D, Merkely B. Acute coronary syndrome and drug-induced autoimmune haemolytic anemia. Cardiologia Hungarica Supplementum. 2024/3: 275$68$YR$$M$Y$$$20240822$$MD$HU$HU
242399412$24239941$2$F$$20240812$20240822$20240823$EXP$$CA-TEVA-VS-3234563$TEVA$Reyes NGD, Bendahan N, Swinkin E, Lang AE, Bassett AS. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurol-Sci 2024; 0 (0):.; Reyes NGD, Bendahan N, Swinkin E, Lang AE, Bassett AS. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurol-Sci 2024; 0 (0):.$49$YR$$F$Y$$$20240823$$HP$CA$CA
242399421$24239942$1$I$$20240822$20240822$20240822$DIR$715477$$FDA-CTU$$$$$UNK$N$$$20240822$$CN$US$
242399432$24239943$2$F$20220302$20240920$20240822$20240925$EXP$$NVSC2024IT169393$NOVARTIS$$$$E$F$Y$$$20240926$$MD$IT$IT
242399442$24239944$2$F$20220503$20240920$20240822$20240925$EXP$$NVSC2024IT170293$NOVARTIS$$$$A$M$Y$$$20240926$$MD$IT$IT
242399452$24239945$2$F$20190101$20240829$20240822$20240905$EXP$$AU-ABBVIE-5887488$ABBVIE$$77$YR$$M$Y$98$KG$20240905$$MD$AU$AU
242399461$24239946$1$I$20240101$20240814$20240822$20240822$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025364$UNITED THERAPEUTICS$$$$$F$Y$$$20240822$$$US$US
242399471$24239947$1$I$$20221206$20240822$20240822$EXP$$IN-AstraZeneca-2022A404237$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$IN$
242399483$24239948$3$F$20240101$20240913$20240822$20240918$EXP$$US-ABBVIE-5884531$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
242399491$24239949$1$I$20240101$20240816$20240822$20240822$EXP$$US-ABBVIE-5885789$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242399501$24239950$1$I$$20240812$20240822$20240822$PER$$US-JNJFOC-20240831811$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$CN$US$US
242399511$24239951$1$I$20240821$20240821$20240822$20240822$PER$$US-JNJFOC-20240855055$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240822$$CN$US$US
242399521$24239952$1$I$$20240810$20240822$20240822$EXP$$US-AMGEN-USASP2024159927$AMGEN$$$$A$M$Y$$$20240822$$CN$US$US
242399531$24239953$1$I$$20240822$20240822$20240822$DIR$715479$$FDA-CTU$$$$$UNK$N$$$20240822$$CN$US$
242399541$24239954$1$I$20240712$20240816$20240822$20240822$PER$$CN-Eisai-EC-2024-172346$EISAI$$53$YR$A$F$Y$49$KG$20240822$$HP$CN$CN
242399571$24239957$1$I$20240220$20240819$20240822$20240822$EXP$$GB-MYLANLABS-2024M1017254$MYLAN$$54$YR$$M$Y$$$20240822$$MD$GB$GB
242399581$24239958$1$I$$20240815$20240822$20240822$EXP$$DE-SA-2024SA246390$SANOFI AVENTIS$$$$$F$Y$$$20240822$$MD$DE$DE
242399592$24239959$2$F$20240813$20240830$20240822$20240920$EXP$$ZA-SA-2024SA243838$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240920$$CN$ZA$ZA
242399602$24239960$2$F$$20240821$20240822$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012705$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240826$$CN$US$US
242399611$24239961$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012031$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240822$$CN$US$US
242399621$24239962$1$I$20240819$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012257$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242399631$24239963$1$I$20240815$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011719$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240822$$CN$US$US
242399641$24239964$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012184$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240822$$CN$US$US
242399661$24239966$1$I$20240819$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012255$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242399672$24239967$2$F$20240101$20240822$20240822$20240827$EXP$$US-ABBVIE-5887778$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242399681$24239968$1$I$$20240819$20240822$20240822$EXP$$US-LUNDBECK-DKLU4003254$LUNDBECK$$$$$$Y$$$20240822$$HP$US$US
242399691$24239969$1$I$20240101$20240820$20240822$20240822$EXP$$US-ABBVIE-5888552$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242399701$24239970$1$I$$20240821$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074492$SANDOZ$$$$$$Y$$$20240822$$CN$US$US
242399713$24239971$3$F$20240816$20240922$20240822$20240927$EXP$$VN-TAKEDA-2024TUS083949$TAKEDA$$62$YR$$M$Y$70$KG$20240927$$CN$VN$VN
242399724$24239972$4$F$20240101$20240906$20240822$20240913$EXP$$US-ABBVIE-5887231$ABBVIE$$$$$M$Y$91$KG$20240913$$CN$US$US
242399731$24239973$1$I$20240101$20240820$20240822$20240822$EXP$$US-ABBVIE-5888424$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242399741$24239974$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA249035$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240822$$MD$US$US
242399751$24239975$1$I$20240801$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131351$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240822$$MD$US$US
242399762$24239976$2$F$$20240925$20240822$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131737$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$88.9$KG$20240926$$CN$US$US
242399771$24239977$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132849$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240822$$HP$US$US
242399781$24239978$1$I$$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133434$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$70.76$KG$20240822$$CN$US$US
242399792$24239979$2$F$$20240918$20240822$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132799$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240919$$CN$US$US
242399811$24239981$1$I$$20240819$20240822$20240822$PER$$US-ABBVIE-5888003$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242399821$24239982$1$I$$20240808$20240822$20240822$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08051$NEUROCRINE BIOSCIENCES$$6$DEC$$F$Y$$$20240822$$HP$US$US
242399841$24239984$1$I$20240816$20240819$20240822$20240822$EXP$$CN-SA-2024SA248949$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240822$$HP$CN$CN
242399881$24239988$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA249575$SANOFI AVENTIS$$68$YR$E$M$Y$108.86$KG$20240822$$MD$US$US
242399891$24239989$1$I$$20240819$20240822$20240822$30DAY$$FR-SANDOZ INC.-SDZ2024FR074026$SANDOZ$$11$YR$$M$Y$$$20240822$$PH$FR$FR
242399901$24239990$1$I$$20240819$20240822$20240822$EXP$$CA-LUNDBECK-DKLU4003227$LUNDBECK$$$$$$Y$$$20240822$$HP$CA$CA
242399911$24239991$1$I$$20240805$20240822$20240822$PER$$US-TEVA-VS-3230261$TEVA$$75$YR$$F$Y$$$20240822$$CN$US$US
242399921$24239992$1$I$$20240820$20240822$20240822$EXP$$US-KYOWAKIRIN-2024KK019598$KYOWA$$$$$$Y$$$20240822$$HP$US$US
242399931$24239993$1$I$$20240821$20240822$20240822$PER$$US-JNJFOC-20240854387$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$US$US
242399941$24239994$1$I$$20240812$20240822$20240822$PER$$US-JNJFOC-20240854793$JOHNSON AND JOHNSON$$$$$M$Y$$$20240822$$MD$US$US
242399951$24239995$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA249409$SANOFI AVENTIS$$$$A$M$Y$87.67$KG$20240822$$MD$US$US
242399962$24239996$2$F$$20240829$20240822$20240830$EXP$$FR-SA-2018SA189731$SANOFI AVENTIS$Sarradin V, Dalenc F, Sibaud V, Tournier E, Roche H.. Acute Generalized Exanthematous Pustulosis Induced by Docetaxel and Recurrent With Letrozole: A Case Report. Clin. Breast Cancer.. 2018;unk:e743-76$63$YR$A$F$Y$$$20240830$$MD$FR$FR
242399971$24239997$1$I$20240818$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165845$AMGEN$$62$YR$A$M$Y$$$20240822$$CN$US$US
242399981$24239998$1$I$$20240816$20240822$20240822$PER$$JP-Eisai-EC-2024-172306$EISAI$Satoshi Umezawa. Experience with lenvatinib + pembrolizumab combination therapy at our hospital (10 cases). Women^s Cancer Expert Seminar; -; .$$$E$F$Y$$$20240822$$MD$JP$JP
242399992$24239999$2$F$20240807$20240826$20240822$20240909$EXP$$US-SA-2024SA250051$SANOFI AVENTIS$$78$YR$E$M$Y$63.5$KG$20240909$$MD$US$US
242400001$24240000$1$I$20240731$20240813$20240822$20240822$EXP$SE-SEMPA-2024-005970$SE-TEVA-VS-3233447$TEVA$$51$YR$$F$Y$$$20240822$$MD$SE$SE
242400011$24240001$1$I$$20240818$20240822$20240822$EXP$GB-MHRA-MED-202408181711299420-LSKGF$GB-FreseniusKabi-FK202412674$FRESENIUS KABI$$29$YR$A$F$Y$$$20240822$$CN$GB$GB
242400031$24240003$1$I$20240101$20240820$20240822$20240822$EXP$$US-SA-2024SA249157$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240822$$MD$US$US
242400043$24240004$3$F$20240704$20240909$20240822$20240916$EXP$$FR-FreseniusKabi-FK202412698$FRESENIUS KABI$$56$YR$A$F$Y$$$20240916$$MD$FR$FR
242400051$24240005$1$I$$20240819$20240822$20240822$EXP$$US-BAUSCH-BL-2024-002915$BAUSCH AND LOMB$$75$YR$$M$Y$$$20240822$$CN$US$US
242400061$24240006$1$I$$20240816$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130384$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$93.89$KG$20240822$$CN$US$US
242400071$24240007$1$I$$20240816$20240822$20240822$PER$$US-BAUSCH-BL-2024-012465$BAUSCH AND LOMB$$$$$M$Y$$$20240822$$CN$US$US
242400081$24240008$1$I$$20240821$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133437$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240822$$CN$US$US
242400091$24240009$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132338$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240822$$CN$US$US
242400102$24240010$2$F$20240801$20240919$20240822$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132109$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240920$$CN$US$US
242400112$24240011$2$F$20240831$20240903$20240822$20240904$EXP$$US-BAUSCH-BL-2024-012560$BAUSCH AND LOMB$$80$YR$$M$Y$$$20240904$$CN$US$US
242400121$24240012$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132127$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240822$$CN$US$US
242400132$24240013$2$F$$20240912$20240822$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132558$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240913$$HP$US$US
242400142$24240014$2$F$$20240918$20240822$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133235$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$138.35$KG$20240919$$CN$US$US
242400151$24240015$1$I$20240701$20240816$20240822$20240822$EXP$$IT-BAUSCH-BL-2024-012637$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240822$$MD$IT$IT
242400162$24240016$2$F$$20240910$20240822$20240910$PER$$US-ALXN-202408USA000879US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
242400171$24240017$1$I$20240601$20240813$20240822$20240822$EXP$ES-AEMPS-1557737$ES-TEVA-VS-3233460$TEVA$$88$YR$$F$Y$$$20240822$$MD$ES$ES
242400181$24240018$1$I$$20240819$20240822$20240822$EXP$$NVSC2024CA080060$NOVARTIS$Lamrani Y, Tran TP, Toffa DH, Robert M. Unexpected cardiorespiratory findings postictally and at rest weeks prior to SUDEP. FRONTIERS IN NEUROLOGY. 2023;14$33$YR$$M$Y$$$20240822$$HP$CA$CA
242400191$24240019$1$I$$20240814$20240822$20240822$EXP$$US-MYLANLABS-2024M1077022$MYLAN$Rahim F, Hussain S, Sciamanna C, Pauwaa S, Macaluso G, Cotts W, et al. Appearances Can Be Deceiving- A Challenging Case Of Pulmonary Hypertension. J-Card-Fail 2024; 30 (1): 298-299.$70$YR$$M$Y$$$20240822$$HP$US$US
242400201$24240020$1$I$$20240819$20240822$20240822$EXP$$CA-ABBVIE-5887652$ABBVIE$$$$A$M$Y$$$20240822$$CN$CA$CA
242400212$24240021$2$F$$20240814$20240822$20240828$EXP$$GB-MYLANLABS-2024M1076256$MYLAN$$$$$M$Y$$$20240828$$CN$GB$GB
242400221$24240022$1$I$$20240821$20240822$20240822$PER$$US-PFIZER INC-202400240980$PFIZER$$$$$F$Y$$$20240822$$HP$US$US
242400231$24240023$1$I$$20240819$20240822$20240822$PER$$US-PFIZER INC-PV202300106413$PFIZER$$64$YR$$F$Y$$$20240822$$HP$US$US
242400251$24240025$1$I$20240601$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241417$PFIZER$$59$YR$$M$Y$108.86$KG$20240822$$CN$US$US
242400261$24240026$1$I$20240807$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241280$PFIZER$$50$YR$$F$Y$86.18$KG$20240822$$CN$US$US
242400271$24240027$1$I$20240820$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241040$PFIZER$$35$YR$$F$Y$$$20240822$$CN$US$US
242400281$24240028$1$I$20240820$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241036$PFIZER$$43$YR$$F$Y$$$20240822$$CN$US$US
242400291$24240029$1$I$20240812$20240820$20240822$20240822$EXP$$CN-PFIZER INC-PV202400108678$PFIZER$$63$YR$$M$Y$92$KG$20240822$$HP$CN$CN
242400301$24240030$1$I$20240701$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241756$PFIZER$$$$$M$Y$$$20240822$$CN$US$US
242400311$24240031$1$I$20240819$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241021$PFIZER$$30$YR$$F$Y$$$20240822$$HP$US$US
242400322$24240032$2$F$$20240821$20240822$20240826$PER$$US-PFIZER INC-PV202400109774$PFIZER$$45$YR$$F$Y$$$20240826$$PH$US$US
242400331$24240033$1$I$$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241303$PFIZER$$58$YR$$F$Y$$$20240822$$CN$US$US
242400341$24240034$1$I$20240816$20240820$20240822$20240822$EXP$$CN-PFIZER INC-PV202400108698$PFIZER$$42$YR$$F$Y$62$KG$20240822$$HP$CN$CN
242400351$24240035$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-202400190738$PFIZER$$16$YR$$F$Y$$$20240822$$CN$US$US
242400361$24240036$1$I$20240818$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241208$PFIZER$$52$YR$$F$Y$$$20240822$$CN$US$US
242400371$24240037$1$I$20240701$20240821$20240822$20240822$PER$$PR-PFIZER INC-202400241641$PFIZER$$$$A$F$Y$$$20240822$$MD$PR$PR
242400391$24240039$1$I$20240821$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241252$PFIZER$$45$YR$$F$Y$$$20240822$$HP$US$US
242400401$24240040$1$I$20200309$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241071$PFIZER$$69$YR$$F$Y$$$20240822$$HP$US$US
242400411$24240041$1$I$$20240821$20240822$20240822$EXP$$US-ABBVIE-5889451$ABBVIE$$$$$$Y$$$20240822$$MD$US$US
242400421$24240042$1$I$$20240821$20240822$20240822$PER$$US-PFIZER INC-202400241072$PFIZER$$$$$F$Y$$$20240822$$MD$US$US
242400431$24240043$1$I$20240720$20240820$20240822$20240822$PER$$US-PFIZER INC-202400240161$PFIZER$$70$YR$$F$Y$$$20240822$$CN$US$US
242400441$24240044$1$I$20240801$20240819$20240822$20240822$PER$$US-ABBVIE-5887347$ABBVIE$$37$YR$$F$Y$$$20240822$$MD$US$US
242400451$24240045$1$I$$20230525$20240822$20240822$EXP$$US-AstraZeneca-2023A123215$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242400461$24240046$1$I$$20230921$20240822$20240822$EXP$$US-AstraZeneca-2023A172088$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242400471$24240047$1$I$$20221116$20240822$20240822$EXP$$US-AstraZeneca-2022A380814$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242400481$24240048$1$I$$20220502$20240822$20240822$EXP$$US-AstraZeneca-2022A172672$ASTRAZENECA$$$$$M$Y$66.7$KG$20240822$$CN$US$
242400491$24240049$1$I$$20220808$20240822$20240822$EXP$$US-AstraZeneca-2022A281461$ASTRAZENECA$$$$$$Y$$$20240822$$CN$US$
242400501$24240050$1$I$$20210720$20240822$20240822$EXP$$US-AstraZeneca-2021A635076$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242400511$24240051$1$I$$20240806$20240822$20240822$PER$$US-TEVA-VS-3232331$TEVA$$40$YR$$F$Y$$$20240822$$HP$US$US
242400521$24240052$1$I$$20240818$20240822$20240822$PER$$US-LUNDBECK-DKLU4003256$LUNDBECK$$$$$$Y$$$20240822$$CN$US$US
242400531$24240053$1$I$$20240819$20240822$20240822$EXP$$US-TAKEDA-2024TUS084025$TAKEDA$$$$$M$Y$$$20240822$$CN$US$US
242400541$24240054$1$I$$20240820$20240822$20240822$PER$$NVSC2024US169324$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
242400581$24240058$1$I$20240806$20240820$20240822$20240822$EXP$ES-AEMPS-1561852$ES-FreseniusKabi-FK202412714$FRESENIUS KABI$$61$YR$A$F$Y$$$20240822$$PH$ES$ES
242400592$24240059$2$F$20240730$20240923$20240822$20240925$EXP$$DE-FreseniusKabi-FK202412704$FRESENIUS KABI$$61$YR$A$F$Y$58.8$KG$20240925$$MD$DE$DE
242400601$24240060$1$I$$20240710$20240822$20240822$PER$$US-LUNDBECK-DKLU4001628$LUNDBECK$$$$$$Y$$$20240822$$HP$US$US
242400611$24240061$1$I$20240101$20240822$20240822$20240822$EXP$$CN-BAYER-2024A120992$BAYER$$$$$M$Y$$$20240822$$CN$CN$CN
242400621$24240062$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133460$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240822$$CN$US$US
242400631$24240063$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131960$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$70.76$KG$20240822$$CN$US$US
242400641$24240064$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131963$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240822$$CN$US$US
242400651$24240065$1$I$$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133345$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240822$$HP$US$US
242400661$24240066$1$I$$20240814$20240822$20240822$EXP$$IT-TAKEDA-2024TUS082036$TAKEDA$Levra AG, Jamie G, Cozzi O. Percutaneous left atrial appendage closure in a patient with acquired von willebrand disease and atrial fibrillation. Cureus. 2024;16(7):1-6$74$YR$$M$Y$$$20240822$$HP$IT$IT
242400671$24240067$1$I$$20240821$20240822$20240822$EXP$$US-TAKEDA-2024TUS084632$TAKEDA$$$$$F$Y$$$20240822$$CN$US$US
242400682$24240068$2$F$20240404$20240917$20240822$20240919$EXP$$NO-009507513-2408NOR006157$MERCK$$58$YR$$F$Y$48$KG$20240919$$CN$NO$NO
242400691$24240069$1$I$$20240822$20240822$20240822$PER$$NVSC2024US170360$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242400701$24240070$1$I$$20240812$20240822$20240822$EXP$$CA-TAKEDA-2024TUS084065$TAKEDA$$76$YR$$M$Y$75$KG$20240822$$HP$CA$CA
242400712$24240071$2$F$20240701$20240828$20240822$20240903$EXP$$NVSC2024AR168637$NOVARTIS$$41$YR$$F$Y$$$20240903$$CN$AR$AR
242400721$24240072$1$I$$20240815$20240822$20240822$EXP$$ZA-TAKEDA-2024TUS083368$TAKEDA$$$$$F$Y$$$20240822$$CN$ZA$ZA
242400731$24240073$1$I$20240125$20240815$20240822$20240822$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-031955$REGENERON$$$$$F$Y$$$20240822$$CN$US$US
242400741$24240074$1$I$20230819$20240819$20240822$20240822$EXP$FR-AFSSAPS-LM2024000452$FR-LUNDBECK-DKLU4003316$LUNDBECK$$$$$$Y$$$20240822$$MD$FR$FR
242400751$24240075$1$I$20201201$20240813$20240822$20240822$EXP$PL-URPL-1-3589-2020$PL-TEVA-VS-3233470$TEVA$$77$YR$$M$Y$65$KG$20240822$$MD$PL$PL
242400761$24240076$1$I$$20240820$20240822$20240822$EXP$$CH-ABBVIE-5889350$ABBVIE$$$$$F$Y$$$20240822$$MD$CH$CH
242400771$24240077$1$I$20240722$20240819$20240822$20240822$EXP$$GB-DSJP-DSE-2024-137684$DAIICHI$$56$YR$$F$Y$$$20240822$$HP$GB$GB
242400791$24240079$1$I$$20240821$20240822$20240822$EXP$$US-ABBVIE-5890228$ABBVIE$$$$$M$Y$$$20240822$$HP$US$US
242400801$24240080$1$I$$20211123$20240822$20240822$EXP$$US-AstraZeneca-2021A832228$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242400811$24240081$1$I$19990810$20240819$20240822$20240822$EXP$GB-MHRA-MED-202408190937407510-WZNMH$GB-MYLANLABS-2024M1077056$MYLAN$$37$YR$$$Y$$$20240822$$CN$GB$GB
242400831$24240083$1$I$20240809$20240820$20240822$20240822$EXP$PT-INFARMED-R202408-253$PT-FreseniusKabi-FK202412765$FRESENIUS KABI$$39$YR$A$F$Y$$$20240822$$MD$PT$PT
242400841$24240084$1$I$$20240816$20240822$20240822$EXP$$US-MAYNE PHARMA-2024MYN000359$MAYNE$$$$$$Y$$$20240822$$HP$US$US
242400851$24240085$1$I$20240818$20240819$20240822$20240822$EXP$$SA-TAKEDA-2024TUS083876$TAKEDA$$$$$F$Y$$$20240822$$CN$SA$SA
242400861$24240086$1$I$$20240820$20240822$20240822$EXP$$CN-BAYER-2024A120147$BAYER$$$$$M$Y$$$20240822$$CN$CN$CN
242400871$24240087$1$I$20220404$20240820$20240822$20240822$EXP$$ES-FreseniusKabi-FK202412720$FRESENIUS KABI$$71$YR$E$M$Y$94$KG$20240822$$MD$ES$ES
242400881$24240088$1$I$20230901$20240816$20240822$20240822$EXP$$CA-ABBVIE-5887627$ABBVIE$$76$YR$$M$Y$$$20240822$$CN$CA$CA
242400891$24240089$1$I$20240608$20240813$20240822$20240822$EXP$FR-AFSSAPS-GR2024000974$FR-TEVA-VS-3233481$TEVA$$78$YR$$F$Y$$$20240822$$PH$FR$FR
242400901$24240090$1$I$$20240812$20240822$20240822$PER$$US-INCYTE CORPORATION-2024IN008564$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242400911$24240091$1$I$$20240815$20240822$20240822$EXP$$US-ABBVIE-5883123$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242400921$24240092$1$I$20240201$20240816$20240822$20240822$EXP$$DE-MYLANLABS-2024M1076642$MYLAN$$71$YR$$M$Y$$$20240822$$PH$DE$DE
242400931$24240093$1$I$20230404$20240816$20240822$20240822$EXP$CH-SM-2024-12995$CH-MYLANLABS-2024M1077392$MYLAN$$$$$F$Y$2.16$KG$20240822$$PH$CH$CH
242400942$24240094$2$F$20220101$20240902$20240822$20240906$EXP$$FR-MYLANLABS-2024M1076646$MYLAN$Fidan I, Delamotte E, Colombier ML, Agossa K, et al.. Non-surgical Treatment of Severe Drug-Influenced Gingival Enlargement.. A Report of Two Cases. Cureus. 2024;16(6):e63214$46$YR$$M$Y$80$KG$20240906$$HP$FR$FR
242400951$24240095$1$I$$20240816$20240822$20240822$EXP$$DE-MYLANLABS-2024M1076630$MYLAN$Hoeltzenbein M, Slimi S, Fietz A, Stegherr R, Onken M, Beyersmann J, et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. European Journal of Epilepsy. 2023;107:107-113$$$$F$Y$$$20240822$$HP$DE$DE
242400961$24240096$1$I$20240814$20240819$20240822$20240822$30DAY$$IT-SANDOZ INC.-SDZ2024IT074329$SANDOZ$$11$YR$$F$Y$30$KG$20240822$$CN$IT$IT
242400971$24240097$1$I$20240629$20240816$20240822$20240822$EXP$FR-AFSSAPS-AVLL2024000200$FR-MYLANLABS-2024M1076660$MYLAN$$21$YR$$M$Y$$$20240822$$MD$FR$FR
242400981$24240098$1$I$20240619$20240816$20240822$20240822$EXP$FR-AFSSAPS-AVNY2024000228$FR-MYLANLABS-2024M1077030$MYLAN$$53$YR$$M$Y$60$KG$20240822$$MD$FR$FR
242400991$24240099$1$I$20240601$20240816$20240822$20240822$EXP$CH-SM-2024-15133$CH-MYLANLABS-2024M1077271$MYLAN$$81$YR$$F$Y$67.7$KG$20240822$$MD$CH$CH
242401001$24240100$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57680$$FDA-CTU$$86$YR$$F$N$$$20240821$N$$US$
242401011$24240101$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57715$$FDA-CTU$$55$YR$$F$N$$$20240821$N$$US$
242401031$24240103$1$I$$20240815$20240822$20240822$EXP$$US-ABBVIE-5883081$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242401041$24240104$1$I$20240814$20240815$20240822$20240822$EXP$$US-ABBVIE-5883056$ABBVIE$$28$YR$$F$Y$$$20240822$$CN$US$US
242401051$24240105$1$I$20240104$20240813$20240822$20240822$EXP$FR-AFSSAPS-MA2024001171$FR-TEVA-VS-3233483$TEVA$$52$YR$$F$Y$58$KG$20240822$$PH$FR$FR
242401062$24240106$2$F$$20240827$20240822$20240905$EXP$$US-TEVA-2022-US-2060092$TEVA$andan S, Pauly M, Blum W, Qayed M, Dhodapkar M, Elkhalifa M, et al. BCMA CAR-T AFTER ALLOGENEIC HCT INDUCES REMISSION IN REFRACTORY PLASMABLASTIC LYMPHOMA. Pediatr-Blood-Cancer 2022; 69 (Suppl.) S204-S205.; Raghunandan S, Pauly M, Blum W, Qayed M, Dhodapkar M, Elkhalifa M, et al. BCMA CAR-T AFTER ALLOGENEIC HCT INDUCES REMISSION IN REFRACTORY PLASMABLASTIC LYMPHOMA. Pediatr-Blood-Cancer 2022; 69 (Suppl.) S204-S205.; Raghunandan S, Pauly M, Blum W, Qayed M, Dhodapkar M, Elkhalifa M, et al. BCM...$17$YR$$M$Y$$$20240905$$HP$US$US
242401071$24240107$1$I$20240814$20240815$20240822$20240822$PER$$US-BAYER-2024A117935$BAYER$$67$YR$E$F$Y$$$20240822$$CN$US$US
242401081$24240108$1$I$20240811$20240816$20240822$20240822$EXP$$US-PFIZER INC-2020115264$PFIZER$$81$YR$$M$Y$$$20240822$$CN$US$US
242401091$24240109$1$I$20220129$20240813$20240822$20240822$EXP$$JP-BAUSCH-BL-2024-012644$BAUSCH AND LOMB$$45$YR$$F$Y$$$20240822$$MD$JP$JP
242401102$24240110$2$F$$20240822$20240822$20240828$EXP$$US-INCYTE CORPORATION-2024IN008541$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242401111$24240111$1$I$$20240820$20240822$20240822$EXP$$AU-SANDOZ INC.-SDZ2024AU073910$SANDOZ$$24$YR$$F$Y$$$20240822$$HP$AU$AU
242401121$24240112$1$I$$20240815$20240822$20240822$EXP$$US-ABBVIE-5883602$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242401131$24240113$1$I$20240801$20240815$20240822$20240822$EXP$$US-ABBVIE-5883562$ABBVIE$$73$YR$$M$Y$$$20240822$$CN$US$US
242401141$24240114$1$I$$20240816$20240822$20240822$EXP$$US-ABBVIE-5884594$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242401151$24240115$1$I$$20240820$20240822$20240822$EXP$$NVSC2024AU169558$NOVARTIS$$$$$$Y$$$20240822$$MD$AU$AU
242401161$24240116$1$I$$20240723$20240822$20240822$PER$$US-009507513-2407USA013163$MERCK$Gracia Michael, Hadley Emma, Ramchandar Nanda, Coufal Nicole G. Emerging Role of Plasma Microbial Cell-free DNA in the Diagnosis of Pediatric Mucormycosis. Pediatric Infectious Disease Journal. 2024;43(7):704-7$5$YR$$F$Y$$$20240822$$MD$US$US
242401172$24240117$2$F$$20240829$20240822$20240906$EXP$$US-TEVA-VS-3234162$TEVA$Pang S, Saleh H, Ailawadhi S, Edgar M, Pang M. Acute esophageal stricture after bone marrow transplant. Clin-J-Gastroenterol 2024; 17 1-5.; Pang S, Saleh H, Ailawadhi S, Edgar M, Pang M. Acute esophageal stricture after bone marrow transplant. Clin-J-Gastroenterol 2024; 17 1-5.; Pang S, Saleh H, Ailawadhi S, Edgar M, Pang M. Acute esophageal stricture after bone marrow transplant. Clin-J-Gastroenterol 2024; 17 1-5.$58$YR$$M$Y$$$20240906$$HP$US$US
242401183$24240118$3$F$20240601$20240913$20240822$20240920$EXP$$SE-DAIICHI SANKYO, INC.-DSE-2024-139082$DAIICHI$$$$A$F$Y$63.5$KG$20240920$$HP$SE$SE
242401192$24240119$2$F$$20240920$20240822$20240926$EXP$$US-INCYTE CORPORATION-2024IN008765$INCYTE$$$$$$Y$$$20240926$$CN$US$US
242401201$24240120$1$I$$20240821$20240822$20240822$EXP$$US-INCYTE CORPORATION-2024IN008767$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242401211$24240121$1$I$$20240820$20240822$20240822$PER$$NVSC2024US169216$NOVARTIS$$$$$F$Y$$$20240822$$CN$US$US
242401221$24240122$1$I$20240718$20240813$20240822$20240822$EXP$BE-FAMHP-DHH-N2024-122456$BE-TEVA-VS-3233648$TEVA$$84$YR$$F$Y$67$KG$20240822$$MD$BE$BE
242401242$24240124$2$F$$20240826$20240822$20240903$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-133048$BRISTOL MYERS SQUIBB$A clinical case of a patient with a rare an immuno-mediated complication. Newspaper of the Russian Society of Clinical Oncology. 2024;(07):17-8.$$$$F$Y$$$20240903$$HP$RU$RU
242401251$24240125$1$I$20240810$20240816$20240822$20240822$30DAY$$IT-SANDOZ INC.-SDZ2024IT074261$SANDOZ$$19$YR$$F$Y$50$KG$20240822$$CN$IT$IT
242401261$24240126$1$I$20240809$20240821$20240822$20240822$EXP$$US-DSJP-DSU-2024-141555$DAIICHI$$69$YR$$F$Y$$$20240822$$HP$US$US
242401271$24240127$1$I$$20240822$20240822$20240822$PER$$NVSC2024US170362$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242401292$24240129$2$F$$20240819$20240822$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408012039$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240829$$CN$US$US
242401301$24240130$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012258$ELI LILLY AND CO$$$$$F$Y$$$20240822$$HP$US$US
242401311$24240131$1$I$20240817$20240819$20240822$20240822$EXP$$CN-BAYER-2024A119918$BAYER$$71$YR$E$M$Y$65$KG$20240822$$HP$CN$CN
242401321$24240132$1$I$$20240821$20240822$20240822$EXP$$US-DSJP-DSU-2024-141553$DAIICHI$$7$DEC$$F$Y$$$20240822$$MD$US$US
242401331$24240133$1$I$20240812$20240819$20240822$20240822$EXP$$CN-BAYER-2024A119328$BAYER$$69$YR$E$F$Y$65.5$KG$20240822$$HP$CN$CN
242401341$24240134$1$I$20240717$20240813$20240822$20240822$EXP$DE-CADRBFARM-2024329725$DE-TEVA-VS-3233859$TEVA$$75$YR$$M$Y$75$KG$20240822$$MD$DE$DE
242401352$24240135$2$F$$20240829$20240822$20240906$EXP$$FR-TEVA-VS-3234094$TEVA$Otiniano A, Tassin C, Serris A, Guennouni N, Lanternier F, Servais A, et al. Emphysematous pyelonephritis in a diabetic patient. J-Nephrol 2023; 36 2621-2624.; Otiniano A, Tassin C, Serris A, Guennouni N, Lanternier F, Servais A, et al. Emphysematous pyelonephritis in a diabetic patient. J-Nephrol 2023; 36 2621-2624.; Otiniano A, Tassin C, Serris A, Guennouni N, Lanternier F, Servais A, et al. Emphysematous pyelonephritis in a diabetic patient. J-Nephrol 2023; 36 2621-2624.$56$YR$$M$Y$$$20240906$$HP$FR$FR
242401361$24240136$1$I$20240801$20240819$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011995$JAZZ$$48$YR$$M$Y$$$20240822$$HP$US$US
242401371$24240137$1$I$$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024164776$AMGEN$$$$A$F$Y$$$20240822$$CN$US$US
242401381$24240138$1$I$20240705$20240813$20240822$20240822$EXP$FR-AFSSAPS-PB2024000857$FR-TEVA-VS-3233820$TEVA$$77$YR$$M$Y$$$20240822$$PH$FR$FR
242401391$24240139$1$I$20240601$20240813$20240822$20240822$EXP$LT-SMCA-4773$LT-TEVA-VS-3233427$TEVA$$$$$M$Y$$$20240822$$CN$LT$LT
242401401$24240140$1$I$$20240805$20240822$20240822$PER$$US-INCYTE CORPORATION-2024IN008267$INCYTE$$$$$$Y$$$20240822$$MD$US$US
242401411$24240141$1$I$$20240723$20240822$20240822$PER$$US-009507513-2408USA007186$MERCK$Gracia M, Hadley E, Ramchandar N, Coufal NG. Emerging Role of Plasma Microbial Cell-free DNA in the Diagnosis of Pediatric Mucormycosis. Pediatric Infectious Disease Journal. 2024;43(7):704-7$17$YR$$M$Y$$$20240822$$MD$US$US
242401421$24240142$1$I$$20240815$20240822$20240822$EXP$$NL-ABBVIE-5887718$ABBVIE$$$$$F$Y$$$20240822$$MD$NL$NL
242401431$24240143$1$I$$20240820$20240822$20240822$EXP$$CA-INCYTE CORPORATION-2024IN008763$INCYTE$$$$$$Y$$$20240822$$HP$CA$CA
242401441$24240144$1$I$$20240819$20240822$20240822$EXP$$US-AMGEN-USASP2024165662$AMGEN$$$$$M$Y$$$20240822$$CN$US$US
242401451$24240145$1$I$$20240813$20240822$20240822$EXP$$CA-HLS-202402053$HLS THERAPEUTICS$$$$$M$Y$$$20240822$$HP$CA$CA
242401461$24240146$1$I$20240809$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131280$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240822$$CN$US$US
242401472$24240147$2$F$$20240826$20240822$20240903$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-133062$BRISTOL MYERS SQUIBB$A clinical case of a patient with a rare an immuno-mediated complication. Newspaper of the Russian Society of Clinical Oncology. 2024;(07):17-8.$$$$M$Y$$$20240903$$HP$RU$RU
242401481$24240148$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57700$$FDA-CTU$$51$YR$$F$N$$$20240821$N$$US$
242401502$24240150$2$F$$20240904$20240822$20240905$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012954$JAZZ$$$$$F$Y$$$20240905$$CN$US$US
242401511$24240151$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57685$$FDA-CTU$$66$YR$$F$N$230$LBS$20240821$N$$US$
242401522$24240152$2$F$20230101$20240829$20240822$20240906$EXP$$US-TEVA-VS-3234478$TEVA$Newman MT, Bikhchandani M. A Fatal Case of Immune Checkpoint Inhibitor-Mediated Myasthenia Gravis, Myositis, and Cardiomyopathy Overlap Syndrome in Urothelial Carcinoma. Cancer-Rep 2024; 7 (7):; Newman MT, Bikhchandani M. A Fatal Case of Immune Checkpoint Inhibitor-Mediated Myasthenia Gravis, Myositis, and Cardiomyopathy Overlap Syndrome in Urothelial Carcinoma. Cancer-Rep 2024; 7 (7):.$87$YR$$M$Y$$$20240906$$HP$US$US
242401531$24240153$1$I$20230901$20240816$20240822$20240822$EXP$$CA-PFIZER INC-202400240188$PFIZER$$43$YR$$F$Y$$$20240822$$MD$CA$CA
242401541$24240154$1$I$20240811$20240820$20240822$20240822$EXP$$US-PFIZER INC-202400240679$PFIZER$$80$YR$$F$Y$$$20240822$$CN$US$US
242401561$24240156$1$I$$20240822$20240822$20240822$PER$$NVSC2024US170412$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242401572$24240157$2$F$20240515$20240822$20240822$20240827$EXP$FR-AFSSAPS-TS2024000856$FR-SANDOZ INC.-SDZ2024FR068971$SANDOZ$$64$YR$$M$Y$82$KG$20240827$$MD$FR$FR
242401581$24240158$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57801$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
242401591$24240159$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57600$$FDA-CTU$$46$YR$$M$N$146$LBS$20240821$N$$US$
242401601$24240160$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57807$$FDA-CTU$$63$YR$$F$N$$$20240821$N$$US$
242401611$24240161$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131327$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240822$$CN$US$US
242401621$24240162$1$I$$20240723$20240822$20240822$PER$$US-009507513-2408USA007187$MERCK$Gracia M, Hadley E, Ramchandar N, Coufal NG. Emerging Role of Plasma Microbial Cell-free DNA in the Diagnosis of Pediatric Mucormycosis. Pediatric Infectious Disease Journal. 2024;43(7):704-7$8$YR$$F$Y$$$20240822$$MD$US$US
242401631$24240163$1$I$20240603$20240816$20240822$20240822$EXP$ES-AEMPS-1559623$ES-MYLANLABS-2024M1076549$MYLAN$$$$E$F$Y$$$20240822$$MD$ES$ES
242401641$24240164$1$I$20240719$20240814$20240822$20240822$EXP$$CN-SA-2024SA244001$SANOFI AVENTIS$$33$YR$A$F$Y$73$KG$20240822$$HP$CN$CN
242401651$24240165$1$I$20240805$20240816$20240822$20240822$EXP$$DE-MYLANLABS-2024M1076511$MYLAN$$$$A$F$Y$71$KG$20240822$$MD$DE$DE
242401662$24240166$2$F$20240725$20240829$20240822$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025634$UNITED THERAPEUTICS$$77$YR$$F$Y$80.272$KG$20240906$$$US$US
242401671$24240167$1$I$20240803$20240816$20240822$20240822$EXP$IT-MINISAL02-998797$IT-MYLANLABS-2024M1076324$MYLAN$$78$YR$$M$Y$67$KG$20240822$$MD$IT$IT
242401681$24240168$1$I$20230920$20240816$20240822$20240822$EXP$$FR-MYLANLABS-2024M1076369$MYLAN$$38$YR$$M$Y$$$20240822$$LW$FR$FR
242401691$24240169$1$I$$20240813$20240822$20240822$PER$$US-ABBVIE-5881166$ABBVIE$$$$$$Y$$$20240822$$CN$US$US
242401701$24240170$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57591$$FDA-CTU$$42$YR$$M$N$63.5$KG$20240821$N$$US$
242401711$24240171$1$I$20240624$20240815$20240822$20240822$EXP$$BE-SA-2024SA250451$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240822$$HP$BE$BE
242401721$24240172$1$I$20240726$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129200$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240822$$HP$US$US
242401731$24240173$1$I$$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133365$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240822$$HP$US$US
242401742$24240174$2$F$$20240826$20240822$20240903$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-133063$BRISTOL MYERS SQUIBB$A clinical case of a patient with a rare an immuno-mediated complication. Newspaper of the Russian Society of Clinical Oncology. 2024;(07):17-8.$$$$M$Y$$$20240903$$HP$RU$RU
242401751$24240175$1$I$20240805$20240819$20240822$20240822$EXP$$IT-SA-2024SA248257$SANOFI AVENTIS$$74$YR$E$M$Y$85$KG$20240822$$MD$IT$IT
242401761$24240176$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131343$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$64.41$KG$20240822$$CN$US$US
242401771$24240177$1$I$20240623$20240814$20240822$20240822$PER$$US-BIOGEN-2024BI01278388$BIOGEN$$41$YR$$M$Y$$$20240822$$CN$US$US
242401781$24240178$1$I$$20240820$20240822$20240822$EXP$$NVSC2024CN169932$NOVARTIS$$$$$M$Y$$$20240822$$CN$CN$CN
242401791$24240179$1$I$$20240813$20240822$20240822$EXP$$CA-HLS-202402051$HLS THERAPEUTICS$$$$$M$Y$$$20240822$$HP$CA$CA
242401801$24240180$1$I$$20240816$20240822$20240822$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16520$IPSEN$$$$$F$Y$$$20240822$$CN$US$US
242401811$24240181$1$I$$20240819$20240822$20240822$EXP$$US-SA-2024SA248609$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240822$$CN$US$US
242401821$24240182$1$I$20240709$20240812$20240822$20240822$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408011944$ELI LILLY AND CO$$61$YR$A$M$Y$60$KG$20240822$$CN$DE$CN
242401831$24240183$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011295$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242401841$24240184$1$I$$20240819$20240822$20240822$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408012400$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240822$$CN$JP$JP
242401851$24240185$1$I$$20240810$20240822$20240822$EXP$$KW-ELI_LILLY_AND_COMPANY-KW202408011895$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240822$$CN$DE$KW
242401861$24240186$1$I$$20240819$20240822$20240822$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408012262$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$BR$BR
242401871$24240187$1$I$20240730$20240819$20240822$20240822$EXP$$TR-ABBVIE-5887491$ABBVIE$$$$$F$Y$$$20240822$$MD$TR$TR
242401882$24240188$2$F$$20240912$20240822$20240914$EXP$$IT-SANDOZ INC.-SDZ2024IT073744$SANDOZ$$$$$F$Y$$$20240914$$HP$IT$IT
242401891$24240189$1$I$$20240815$20240822$20240822$EXP$$JP-009507513-2408JPN001708J$MERCK$$5$DEC$$M$Y$$$20240822$$MD$JP$JP
242401903$24240190$3$F$$20240905$20240822$20240912$EXP$$GB-LABORATORIOS LICONSA S.A.-2408GB06404$INSUD PHARMA$Teoh YP, Gold A, Yesudian PD.. Fats and figures: how abnormal lipids unravel the truth.. British Journal of Dermatology. 2024;191 (Suppl. 1):i127-8$22$YR$$M$Y$$$20240912$$MD$GB$GB
242401911$24240191$1$I$$20240809$20240822$20240822$EXP$$FR-B.Braun Medical Inc.-2160751$B BRAUN$$41$YR$$F$Y$$$20240822$$$FR$FR
242401921$24240192$1$I$$20240813$20240822$20240822$EXP$$CA-HLS-202402050$HLS THERAPEUTICS$$$$$F$Y$$$20240822$$HP$CA$CA
242401932$24240193$2$F$20240701$20240817$20240822$20240912$PER$$US-IMP-2024000605$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
242401942$24240194$2$F$20240819$20240904$20240822$20240905$PER$$US-AMGEN-USASP2024166719$AMGEN$$69$YR$E$F$Y$$$20240905$$CN$US$US
242401951$24240195$1$I$$20240808$20240822$20240822$EXP$$NL-ALSI-2024000219$AIRGAS$$3$YR$$M$Y$$$20240822$$$NL$NL
242401971$24240197$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57692$$FDA-CTU$$64$YR$$M$N$$$20240821$N$$US$
242401992$24240199$2$F$20240301$20240910$20240822$20240910$EXP$$US-ALXN-202408USA000846US$ALEXION PHARMACEUTICALS$$77$YR$$F$Y$$$20240910$$CN$US$US
242402001$24240200$1$I$20240609$20240820$20240822$20240822$EXP$$US-APELLIS-2024-APL-0000791$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240822$$CN$US$US
242402022$24240202$2$F$$20240820$20240822$20240828$EXP$$JP-Eisai-EC-2024-172629$EISAI$Yoshikawa Seiichi. Treatment of hepatocellular carcinoma in our hospital$76$YR$E$M$Y$$$20240828$$MD$JP$JP
242402031$24240203$1$I$$20240813$20240822$20240822$PER$$CA-HLS-202402049$HLS THERAPEUTICS$$25$YR$A$M$Y$$$20240822$$HP$CA$CA
242402041$24240204$1$I$$20240723$20240822$20240822$PER$$US-009507513-2408USA007189$MERCK$Gracia M, Hadley E, Ramchandar N, Coufal NG. Emerging Role of Plasma Microbial Cell-free DNA in the Diagnosis of Pediatric Mucormycosis. Pediatric Infectious Disease Journal. 2024;43(7):704-7$13$YR$$F$Y$$$20240822$$MD$US$US
242402052$24240205$2$F$$20240815$20240822$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130897$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240826$$CN$US$US
242402061$24240206$1$I$$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133186$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240822$$CN$US$US
242402071$24240207$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5887373$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242402081$24240208$1$I$$20240813$20240822$20240822$EXP$$CA-HLS-202402048$HLS THERAPEUTICS$$$$$M$Y$$$20240822$$HP$CA$CA
242402091$24240209$1$I$20240819$20240820$20240822$20240822$PER$$JP-PFIZER INC-202400239453$PFIZER$$$$$$Y$$$20240822$$PH$JP$JP
242402102$24240210$2$F$$20240823$20240822$20240823$PER$$US-PFIZER INC-202400239372$PFIZER$$$$$M$Y$$$20240823$$CN$US$US
242402111$24240211$1$I$$20240820$20240822$20240822$PER$$US-PFIZER INC-202400241028$PFIZER$$72$YR$$$Y$$$20240822$$MD$US$US
242402121$24240212$1$I$20240527$20240813$20240822$20240822$EXP$FR-AFSSAPS-BS2024000486$FR-TEVA-VS-3233816$TEVA$$68$YR$$F$Y$$$20240822$$MD$FR$FR
242402132$24240213$2$F$$20240821$20240822$20240826$PER$$US-PURDUE PHARMA-USA-2024-0311502$PURDUE$$$$$M$Y$$$20240826$$CN$US$US
242402141$24240214$1$I$$20240821$20240822$20240822$PER$$US-PURDUE PHARMA-USA-2024-0311494$PURDUE$$$$$F$Y$$$20240822$$CN$US$US
242402151$24240215$1$I$20220301$20240821$20240822$20240822$PER$$US-PURDUE PHARMA-USA-2024-0311504$PURDUE$$45$YR$$M$Y$$$20240822$$CN$US$US
242402161$24240216$1$I$20240401$20240820$20240822$20240822$PER$$US-PURDUE PHARMA-USA-2024-0311497$PURDUE$$62$YR$$F$Y$72.57$KG$20240822$$CN$US$US
242402171$24240217$1$I$$20240723$20240822$20240822$PER$$US-009507513-2408USA007188$MERCK$Gracia M, Hadley E, Ramchandar N, Coufal NG. Emerging Role of Plasma Microbial Cell-free DNA in the Diagnosis of Pediatric Mucormycosis. Pediatric Infectious Disease Journal. 2024;43(7):704-7$16$YR$$M$Y$$$20240822$$MD$US$US
242402181$24240218$1$I$$20240821$20240822$20240822$PER$$US-PURDUE PHARMA-USA-2024-0311496$PURDUE$$$$$M$Y$$$20240822$$CN$US$US
242402211$24240221$1$I$$20240820$20240822$20240822$EXP$$JP-ALXN-202408JPN001175JP$ALEXION PHARMACEUTICALS$$83$YR$$F$Y$$$20240822$$MD$JP$JP
242402221$24240222$1$I$$20240723$20240822$20240822$PER$$US-009507513-2408USA007190$MERCK$Gracia M, Hadley E, Ramchandar N, Coufal NG. Emerging Role of Plasma Microbial Cell-free DNA in the Diagnosis of Pediatric Mucormycosis. Pediatric Infectious Disease Journal. 2024;43(7):704-7$16$YR$$M$Y$$$20240822$$MD$US$US
242402231$24240223$1$I$20240530$20240814$20240822$20240822$EXP$$CN-009507513-2408CHN005804$MERCK$$93$YR$$M$Y$69$KG$20240822$$HP$CN$CN
242402241$24240224$1$I$20240601$20240820$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133238$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240822$$CN$US$US
242402252$24240225$2$F$$20240826$20240822$20240903$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-133040$BRISTOL MYERS SQUIBB$A clinical case of a patient with a rare an immuno-mediated complication. Newspaper of the Russian Society of Clinical Oncology. 2024;(07):17-8.$$$$M$Y$$$20240903$$HP$RU$RU
242402262$24240226$2$F$$20240829$20240822$20240906$EXP$$IT-TEVA-VS-3234083$TEVA$Romano A, Gasparro R, Campana MD, Pinchera B, Di Crescenzo RM, Del Guercio D, et al. COVID-19 as a critical risk factor for osteonecrosis of the jaw: diagnostic challenge and surgical treatment. Curr-Probl-Surg 2024; 61 (9):.; Romano A, Gasparro R, Campana MD, Pinchera B, Di Crescenzo RM, Del Guercio D, et al. COVID-19 as a critical risk factor for osteonecrosis of the jaw: diagnostic challenge and surgical treatment. Curr-Probl-Surg 2024; 61 (9):.; Romano A, Gasparro R, Campana MD, Pinchera ...$74$YR$$M$Y$$$20240906$$MD$IT$IT
242402271$24240227$1$I$$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133613$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240822$$CN$US$US
242402281$24240228$1$I$20240801$20240817$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131591$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240822$$HP$US$US
242402291$24240229$1$I$$20240819$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013093$JAZZ$$$$$F$Y$$$20240822$$CN$US$US
242402311$24240231$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5886394$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242402322$24240232$2$F$$20240911$20240822$20240920$EXP$$CA-TEVA-VS-3234981$TEVA$Pang SA, Elkrief A, Capella MP, Miller WH. Two Cases of Durable and Deep Responses to Immune Checkpoint Inhibition-Refractory Metastatic Melanoma after Addition of Camu Camu Prebiotic. Curr-Oncol 2023; 30 (9): 7852-7859.; Pang SA, Elkrief A, Capella MP, Miller WH. Two Cases of Durable and Deep Responses to Immune Checkpoint Inhibition-Refractory Metastatic Melanoma after Addition of Camu Camu Prebiotic. Curr-Oncol 2023; 30 (9): 7852-7859.; Pang SA, Elkrief A, Capella MP, Miller WH. Two Cases ...$$$E$F$Y$$$20240920$$HP$CA$CA
242402331$24240233$1$I$$20240822$20240822$20240822$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047322$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240822$$CN$US$US
242402342$24240234$2$F$20240101$20240919$20240822$20240924$EXP$$AU-ABBVIE-5889153$ABBVIE$$$$$F$Y$$$20240924$$CN$AU$AU
242402351$24240235$1$I$$20240812$20240822$20240822$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16234$IPSEN$$$$$F$Y$$$20240822$$MD$US$US
242402361$24240236$1$I$20240701$20240816$20240822$20240822$EXP$DK-DKMA-30737450$DK-MYLANLABS-2024M1076453$MYLAN$$48$YR$$F$Y$$$20240822$$MD$DK$DK
242402371$24240237$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408014024$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240822$$CN$US$US
242402381$24240238$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012661$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240822$$CN$US$US
242402391$24240239$1$I$$20240821$20240822$20240822$PER$$NVSC2024US169728$NOVARTIS$$$$$$Y$$$20240822$$CN$US$US
242402401$24240240$1$I$$20240814$20240822$20240822$PER$$US-MYLANLABS-2024M1076678$MYLAN$$$$$M$Y$$$20240822$$MD$US$US
242402411$24240241$1$I$$20240812$20240822$20240822$EXP$$US-CURRAX PHARMACEUTICALS LLC-US-2024CUR003802$CURRAX PHARMACEUTICALS$Lynch DR, Washam JB, Newby LK. QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: A case report and review of the literature. Cardiology Journal. 2012;19(4):434-438$49$YR$$M$Y$$$20240822$$PH$US$US
242402421$24240242$1$I$20240701$20240819$20240822$20240822$EXP$$CN-BAYER-2024A119477$BAYER$$77$YR$E$M$Y$65$KG$20240822$$HP$CN$CN
242402431$24240243$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57925$$FDA-CTU$$55$YR$$M$N$256$LBS$20240822$N$$US$
242402441$24240244$1$I$20240808$20240816$20240822$20240822$DIR$FDA-CDER-CTU-2024-57719$$FDA-CTU$$$$$M$N$71$KG$20240816$N$$US$
242402451$24240245$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57906$$FDA-CTU$$57$YR$$F$N$131$LBS$20240822$N$$US$
242402471$24240247$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57904$$FDA-CTU$$47$YR$$F$N$$$20240822$N$$US$
242402481$24240248$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57854$$FDA-CTU$$71$YR$$M$N$250$LBS$20240822$N$$US$
242402491$24240249$1$I$$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57830$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
242402502$24240250$2$F$20240924$20240926$20240822$20240930$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-133441$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240930$$CN$PR$PR
242402511$24240251$1$I$20240524$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57831$$FDA-CTU$$42$YR$$F$N$249$LBS$20240821$N$$US$
242402521$24240252$1$I$20240820$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133389$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240822$$CN$US$US
242402531$24240253$1$I$$20240821$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133274$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$90.72$KG$20240822$$CN$US$US
242402541$24240254$1$I$$20240710$20240822$20240822$PER$$US-LUNDBECK-DKLU4001617$LUNDBECK$$$$$$Y$$$20240822$$CN$US$US
242402551$24240255$1$I$$20240821$20240822$20240822$PER$$NVSC2024US170055$NOVARTIS$$$$$$Y$$$20240822$$PH$US$US
242402561$24240256$1$I$$20240813$20240822$20240822$PER$$US-JNJFOC-20240834951$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240822$$CN$US$US
242402571$24240257$1$I$$20240810$20240822$20240822$PER$$US-BIOMARINAP-US-2022-159922$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242402581$24240258$1$I$20240724$20240729$20240822$20240822$EXP$$US-GREER Laboratories, Inc.-2160764$GREER$$51$YR$$F$Y$109.09$KG$20240822$$$US$US
242402591$24240259$1$I$$20240814$20240822$20240822$EXP$$US-AstraZeneca-2024A185942$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242402601$24240260$1$I$20210621$20210901$20240822$20240822$EXP$$CO-AstraZeneca-2021A713493$ASTRAZENECA$$12939$DY$$M$Y$62$KG$20240822$$CN$CO$
242402611$24240261$1$I$20211011$20211019$20240822$20240822$EXP$$IL-AstraZeneca-2021A782289$ASTRAZENECA$$77$YR$$F$Y$$$20240822$$HP$IL$
242402621$24240262$1$I$$20230413$20240822$20240822$EXP$$US-AstraZeneca-2023A087132$ASTRAZENECA$$$$$M$Y$$$20240822$$CN$US$
242402631$24240263$1$I$$20230619$20240822$20240822$EXP$$US-AstraZeneca-2023A105250$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242402641$24240264$1$I$$20240809$20240822$20240822$PER$$US-INCYTE CORPORATION-2024IN008405$INCYTE$$$$$$Y$$$20240822$$PH$US$US
242402651$24240265$1$I$20240818$20240819$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132207$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$67.13$KG$20240822$$HP$US$US
242402661$24240266$1$I$$20240819$20240822$20240822$EXP$$MY-INCYTE CORPORATION-2024IN008766$INCYTE$$$$$$Y$$$20240822$$MD$MY$MY
242402671$24240267$1$I$$20231113$20240822$20240822$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2023-140536$REGENERON$$$$$$Y$$$20240822$$HP$US$US
242402681$24240268$1$I$$20240820$20240822$20240822$EXP$$CA-INCYTE CORPORATION-2024IN008757$INCYTE$$$$$$Y$$$20240822$$HP$CA$CA
242402691$24240269$1$I$$20240809$20240822$20240822$PER$$US-INCYTE CORPORATION-2024IN008424$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242402701$24240270$1$I$20240808$20240812$20240822$20240822$EXP$$CN-FOUNDATIONCONSUMERHC-2024-CN-000330$FOUNDATION CONSUMER HEALTHCARE$$$$$F$Y$$$20240822$$CN$CN$CN
242402711$24240271$1$I$$20240809$20240822$20240822$PER$$US-INCYTE CORPORATION-2024IN008413$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242402721$24240272$1$I$$20240809$20240822$20240822$PER$$US-INCYTE CORPORATION-2024IN008415$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242402731$24240273$1$I$$20240809$20240822$20240822$PER$$US-INCYTE CORPORATION-2024IN008412$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242402741$24240274$1$I$$20240809$20240822$20240822$PER$$US-INCYTE CORPORATION-2024IN008408$INCYTE$$$$$$Y$$$20240822$$CN$US$US
242402751$24240275$1$I$20240220$20240502$20240822$20240822$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-043533$REGENERON$$$$$M$Y$$$20240822$$CN$US$US
242402761$24240276$1$I$$20210603$20240822$20240822$EXP$$TW-AstraZeneca-2021A500918$ASTRAZENECA$$69$YR$$F$Y$$$20240822$$CN$TW$
242402774$24240277$4$F$20230101$20240911$20240822$20240925$EXP$$CA-BAUSCH-BL-2023-011636$BAUSCH AND LOMB$$32$YR$$F$Y$$$20240925$$CN$CA$CA
242402781$24240278$1$I$$20210518$20240822$20240822$EXP$$US-AstraZeneca-2021A448182$ASTRAZENECA$$$$$F$Y$$$20240822$$CN$US$
242402791$24240279$1$I$$20240807$20240822$20240822$EXP$$US-HLS-202400771$HLS THERAPEUTICS$$$$E$$Y$$$20240822$$HP$US$US
242402801$24240280$1$I$$20240812$20240822$20240822$EXP$$GR-Calliditas-2024CAL01579$CALLIDITAS THERAPEUTICS$$50$YR$A$M$Y$$$20240822$$MD$GR$GR
242402811$24240281$1$I$20240624$20240820$20240822$20240822$EXP$$US-APELLIS-2024-APL-0000792$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240822$$CN$US$US
242402821$24240282$1$I$$20240821$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133280$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$89.36$KG$20240822$$HP$US$US
242402831$24240283$1$I$$20240819$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131305$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$85.73$KG$20240822$$CN$US$US
242402841$24240284$1$I$20240801$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132986$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$96.62$KG$20240822$$CN$US$US
242402852$24240285$2$F$$20240827$20240822$20240906$EXP$$GB-TEVA-VS-3233409$TEVA$Teoh PJ, McGuire E, Borman AM, Gorton R, Wilson AJ, Merrion C, et al. Invasive Trichoderma longibrachiatum infection in a neutropaenic patient. Med-Mycol-Case-Rep; Teoh PJ, McGuire E, Borman AM, Gorton R, Wilson AJ, Merrion C, et al. Invasive Trichoderma longibrachiatum infection in a neutropaenic patient. Med-Mycol-Case-Reports 2024; 45.$51$YR$$F$Y$$$20240906$$HP$GB$GB
242402861$24240286$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-57744$$FDA-CTU$$66$YR$$F$N$$$20240821$N$CN$US$
242402891$24240289$1$I$20240713$20240814$20240822$20240822$EXP$ES-AEMPS-1558782$ES-TEVA-VS-3233929$TEVA$$10$YR$$M$Y$28$KG$20240822$$MD$ES$ES
242402901$24240290$1$I$20190101$20240819$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013121$JAZZ$$62$YR$$F$Y$$$20240822$$CN$US$US
242402911$24240291$1$I$$20240820$20240822$20240822$PER$$US-DSJP-DSU-2024-141544$DAIICHI$$$$$M$Y$$$20240822$$CN$US$US
242402922$24240292$2$F$20240101$20240904$20240822$20240905$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-141546$DAIICHI$$$$$F$Y$74.39$KG$20240905$$HP$US$US
242402932$24240293$2$F$$20240827$20240822$20240830$EXP$$JP-PFIZER INC-202400240442$PFIZER$$55$YR$$F$Y$$$20240830$$MD$JP$JP
242402941$24240294$1$I$20240725$20240820$20240822$20240822$EXP$$CN-PFIZER INC-PV202400108691$PFIZER$$40$YR$$F$Y$50$KG$20240822$$HP$CN$CN
242402961$24240296$1$I$20240806$20240815$20240822$20240822$EXP$$DE-BIOMARINAP-DE-2024-159907$BIOMARIN$$$$$$Y$$$20240822$$CN$DE$DE
242402971$24240297$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012222$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240822$$CN$US$US
242402981$24240298$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012486$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240822$$CN$US$US
242402991$24240299$1$I$20240101$20240729$20240822$20240822$PER$$US-IMP-2024000565$Harrow Health$$$$E$F$Y$$$20240822$$CN$US$US
242403001$24240300$1$I$20240101$20240729$20240822$20240822$PER$$US-IMP-2024000563$Harrow Health$$$$A$F$Y$$$20240822$$CN$US$US
242403011$24240301$1$I$20240101$20240805$20240822$20240822$PER$$US-INSUD PHARMA-2408US06289$INSUD PHARMA$$$$$$Y$$$20240822$$CN$US$US
242403021$24240302$1$I$$20240820$20240821$20240821$DIR$FDA-CDER-CTU-2024-57577$$FDA-CTU$$$$$M$N$$$20240820$N$HP$US$
242403051$24240305$1$I$20240815$20240815$20240822$20240822$EXP$$NVSC2024BR169671$NOVARTIS$$72$YR$$M$Y$$$20240822$$CN$BR$BR
242403061$24240306$1$I$20240101$20240805$20240822$20240822$PER$$US-IMP-2024000600$Harrow Health$$68$YR$E$F$Y$$$20240822$$CN$US$US
242403081$24240308$1$I$$20240815$20240822$20240822$EXP$$NVSC2024BR169664$NOVARTIS$$$$$F$Y$$$20240822$$CN$BR$BR
242403101$24240310$1$I$$20240814$20240822$20240822$EXP$$TW-AstraZeneca-2024A187373$ASTRAZENECA$$$$E$$Y$$$20240822$$PH$TW$
242403111$24240311$1$I$$20240814$20240822$20240822$EXP$$CN-AstraZeneca-2024A172315$ASTRAZENECA$$$$$F$Y$68$KG$20240822$$CN$CN$
242403121$24240312$1$I$20240624$20240814$20240822$20240822$EXP$$CN-AstraZeneca-2024A187361$ASTRAZENECA$$30011$DY$$M$Y$56$KG$20240822$$MD$CN$
242403131$24240313$1$I$20230401$20230819$20240822$20240822$PER$$US-FERAPHARMA-2023-US-025813$FERA$$80$YR$$F$Y$72.58$KG$20240822$$CN$US$US
242403141$24240314$1$I$$20240805$20240822$20240822$PER$$US-IMP-2024000602$Harrow Health$$$$E$F$Y$$$20240822$$CN$US$US
242403151$24240315$1$I$20240730$20240814$20240822$20240822$PER$$US-009507513-2408USA005117$MERCK$$43$YR$$F$Y$$$20240822$$CN$US$US
242403161$24240316$1$I$20240701$20240806$20240822$20240822$PER$$US-IMP-2024000603$Harrow Health$$$$E$F$Y$$$20240822$$CN$US$US
242403171$24240317$1$I$$20240820$20240822$20240822$PER$$US-JNJFOC-20240854003$JOHNSON AND JOHNSON$$$$$F$Y$$$20240822$$HP$US$US
242403191$24240319$1$I$$20240822$20240822$20240822$PER$$US-BAYER-2024A121136$BAYER$$$$$$Y$$$20240822$$CN$US$US
242403211$24240321$1$I$20240101$20240807$20240822$20240822$PER$$US-IMP-2024000606$Harrow Health$$$$A$F$Y$$$20240822$$CN$US$US
242403221$24240322$1$I$$20240807$20240822$20240822$PER$$US-IMP-2024000607$Harrow Health$$$$A$F$Y$$$20240822$$CN$US$US
242403241$24240324$1$I$$20240822$20240822$20240822$PER$$NVSC2024US170414$NOVARTIS$$$$$$Y$$$20240822$$HP$US$US
242403261$24240326$1$I$20240804$20240807$20240822$20240822$PER$$US-IMP-2024000608$Harrow Health$$76$YR$E$F$Y$$$20240822$$CN$US$US
242403271$24240327$1$I$20240808$20240808$20240822$20240822$PER$$US-IMP-2024000612$Harrow Health$$78$YR$E$M$Y$$$20240822$$PH$US$US
242403281$24240328$1$I$$20240812$20240822$20240822$PER$$US-FARMAPROD-202408-2919$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240822$$CN$US$US
242403291$24240329$1$I$20240101$20240808$20240822$20240822$PER$$US-IMP-2024000611$Harrow Health$$$$E$M$Y$$$20240822$$CN$US$US
242403301$24240330$1$I$$20240820$20240822$20240822$PER$$US-009507513-2408USA007132$MERCK$Knodle R, Pomerantz B, Borgetti S. Disseminated Kaposi sarcoma without primary cutaneous involvement in a kidney transplant recipient. Transplant Infect Dis. 2024;26(4)$69$YR$$M$Y$$$20240822$$HP$US$US
242403311$24240331$1$I$20240101$20240809$20240822$20240822$PER$$US-IMP-2024000613$Harrow Health$$$$E$F$Y$$$20240822$$CN$US$US
242403321$24240332$1$I$20240617$20240807$20240822$20240822$PER$$US-JNJFOC-20240855706$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240822$$HP$US$US
242403332$24240333$2$F$20210801$20240827$20240822$20240906$EXP$$TR-TEVA-VS-3222486$TEVA$Unal S, Yuksek T. A case of concomitant hidradenitis suppurativa and psoriasis successfully treated with guselkumab in a patient with Down syndrome. Turk-Arch-Dermatol-Venereol 2024; 58 48-51.; Unal S, Yuksek T. A case of concomitant hidradenitis suppurativa and psoriasis successfully treated with guselkumab in a patient with Down syndrome. Turk-Arch-Dermatol-Venereol 2024; 58 48-51.; Unal S, Yuksek T. A case of concomitant hidradenitis suppurativa and psoriasis successfully treated with guse...$29$YR$$M$Y$$$20240906$$MD$TR$TR
242403341$24240334$1$I$20240701$20240809$20240822$20240822$PER$$US-IMP-2024000618$Harrow Health$$$$E$F$Y$$$20240822$$CN$US$US
242403351$24240335$1$I$20240101$20240809$20240822$20240822$PER$$US-IMP-2024000619$Harrow Health$$$$E$F$Y$$$20240822$$CN$US$US
242403372$24240337$2$F$$20240911$20240822$20240920$EXP$$US-TEVA-VS-3234980$TEVA$Arce PS, Murad K. Thyroid Storm In Heart Failure: A Case Report. J-Card-Fail 2024; 30 (1): 178.; Arce PS, Murad K. Thyroid Storm In Heart Failure: A Case Report. J-Card-Fail 2024; 30 (1): 178.$36$YR$$M$Y$$$20240920$$HP$US$US
242403382$24240338$2$F$$20240827$20240822$20240906$EXP$$IT-TEVA-VS-3233650$TEVA$Benevolo G, Bertuglia G, Bringhen S, Maletta F, Bruno B. An atypical presentation of visceral leishmaniasis mimicking multiple myeloma relapse. Am-J-Hematol 2024; 99 (1): 137-141.; Benevolo G, Bertuglia G, Bringhen S, Maletta F, Bruno B. An atypical presentation of visceral leishmaniasis mimicking multiple myeloma relapse. Am-J-Hematol 2024; 99 (1): 137-141.$79$YR$$M$Y$$$20240906$$HP$IT$IT
242403391$24240339$1$I$$20240815$20240822$20240822$PER$$US-JNJFOC-20240855717$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240822$$MD$US$US
242403401$24240340$1$I$$20240821$20240822$20240822$PER$$US-JNJFOC-20240857541$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$MD$US$US
242403411$24240341$1$I$$20240816$20240822$20240822$EXP$US-SK LIFE SCIENCE, INC-SKPVG-2024-001116$IT-GSK-IT2024102326$GLAXOSMITHKLINE$$$$$$Y$$$20240822$$MD$IT$IT
242403421$24240342$1$I$20240711$20240822$20240822$20240822$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039727$BOEHRINGER INGELHEIM$$61$YR$A$F$Y$$$20240822$$MD$PL$PL
242403431$24240343$1$I$$20240810$20240822$20240822$PER$$US-IMP-2024000615$Harrow Health$$$$$M$Y$$$20240822$$CN$US$US
242403451$24240345$1$I$20240801$20240810$20240822$20240822$PER$$US-IMP-2024000616$Harrow Health$$$$E$F$Y$$$20240822$$CN$US$US
242403461$24240346$1$I$20240408$20240816$20240822$20240822$EXP$$US-ABBVIE-5885320$ABBVIE$$60$YR$$F$Y$$$20240822$$CN$US$US
242403471$24240347$1$I$20240101$20240810$20240822$20240822$PER$$US-IMP-2024000620$Harrow Health$$$$E$M$Y$$$20240822$$CN$US$US
242403482$24240348$2$F$20240101$20240820$20240822$20240912$PER$$US-IMP-2024000617$Harrow Health$$$$A$F$Y$$$20240912$$CN$US$US
242403493$24240349$3$F$20240801$20240826$20240822$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408013137$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240905$$CN$US$US
242403501$24240350$1$I$$20240815$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408010378$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242403511$24240351$1$I$$20240815$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408010495$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240822$$CN$US$US
242403521$24240352$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013141$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240822$$CN$US$US
242403541$24240354$1$I$20240101$20240813$20240822$20240822$EXP$$US-ABBVIE-5855612$ABBVIE$$$$$M$Y$156.5$KG$20240822$$CN$US$US
242403551$24240355$1$I$20240805$20240806$20240822$20240822$PER$$US-009507513-2408USA002140$MERCK$$67$YR$$M$Y$$$20240822$$CN$US$US
242403562$24240356$2$F$$20240820$20240822$20240827$EXP$$ES-BIOGEN-2024BI01279061$BIOGEN$$$$E$$Y$$$20240827$$MD$ES$ES
242403572$24240357$2$F$$20240829$20240822$20240906$EXP$$US-TEVA-VS-3234482$TEVA$Mullis CE, Heldman M, Bahr NC, Minamoto GY, Puius YA, Malinis M. Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient. Transpl-Infect-Dis 2024; 26 (3):.; Mullis CE, Heldman M, Bahr NC, Minamoto GY, Puius YA, Malinis M. Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient. Transpl-Infect-Dis 2024; 26 (3):.$64$YR$$M$Y$$$20240906$$HP$US$US
242403582$24240358$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234591$TEVA$Attieh RM, Brumble L, Elwasila SM, Wadei HM. Disseminated Monkeypox Infection in a Kidney Transplant Recipient: A Case Report. Transplant-Proc 2023; 55 (3): 667-671.; Attieh RM, Brumble L, Elwasila SM, Wadei HM. Disseminated Monkeypox Infection in a Kidney Transplant Recipient: A Case Report. Transplant-Proc 2023; 55 (3): 667-671.; Attieh RM, Brumble L, Elwasila SM, Wadei HM. Disseminated Monkeypox Infection in a Kidney Transplant Recipient: A Case Report. Transplant-Proc 2023; 55 (3): 667-671.$44$YR$$M$Y$$$20240909$$HP$US$US
242403591$24240359$1$I$20240101$20240816$20240822$20240822$EXP$$US-ABBVIE-5775193$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242403601$24240360$1$I$20240417$20240418$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR102952$VIIV$$$$$$Y$$$20240822$$MD$US$US
242403611$24240361$1$I$20240403$20240418$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR102950$VIIV$$$$$$Y$$$20240822$$MD$US$US
242403621$24240362$1$I$20240404$20240418$20240822$20240822$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR102951$VIIV$$$$$$Y$$$20240822$$MD$US$US
242403632$24240363$2$F$20240401$20240918$20240822$20240928$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR102946$VIIV$$17$YR$$M$Y$56$KG$20240928$$MD$US$US
242403641$24240364$1$I$20240429$20240528$20240822$20240822$PER$$US-GE HEALTHCARE-2024CSU005292$GE HEALTHCARE$$66$YR$$F$Y$86.621$KG$20240822$$HP$US$US
242403651$24240365$1$I$20240201$20240819$20240822$20240822$EXP$$US-ABBVIE-5879949$ABBVIE$$63$YR$$F$Y$141$KG$20240822$$CN$US$US
242403671$24240367$1$I$$20240816$20240822$20240822$EXP$$US-GSK-US2024GSK103842$GLAXOSMITHKLINE$Koh S, Wu C, Cypro A, Castellanos L. Hemophagocytic lymphohistiocytosis-associated takotsubo cardiomyopathy and survival after ventricular fibrillation arrest. Journal of the American College of Cardiology. 2019;73 (9):2599$$$$$Y$$$20240822$$HP$US$US
242403681$24240368$1$I$20240101$20240808$20240822$20240822$EXP$$US-ABBVIE-5874094$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242403692$24240369$2$F$$20240911$20240822$20240920$EXP$$US-TEVA-VS-3234734$TEVA$Alshawa L, Leahy B, Rueckert J, Maskey A, Anstead M, Keshavamurthy S, et al. Hemophagocytic Lymphohistiocytosis: A Rare Diagnosis in the Immediate Aftermath of Lung Transplantation. J-Heart-Lung-Transplant 2024; 43 (Suppl.) (4): S484-S485 abstr. 1040.; Alshawa L, Leahy B, Rueckert J, Maskey A, Anstead M, Keshavamurthy S, et al. Hemophagocytic Lymphohistiocytosis: A Rare Diagnosis in the Immediate Aftermath of Lung Transplantation. J-Heart-Lung-Transplant 2024; 43 (Suppl.) (4): S484-S485 abstr...$63$YR$$M$Y$$$20240920$$HP$US$US
242403701$24240370$1$I$$20240815$20240822$20240822$PER$$US-009507513-2408USA005587$MERCK$Schwartz W, Christiansen AC, Patel SS.. Intraorbital amphotericin B for mucormycosis in an Allo-HSCT recipient. Bone Marrow Transplantation. 2024;59(8):1176-7$68$YR$$M$Y$$$20240822$$HP$US$US
242403712$24240371$2$F$$20240829$20240822$20240906$EXP$$NL-TEVA-VS-3234130$TEVA$Hutten EM, Roeloffzen WW, Lambeck AJ, van den Born-Bondt T, Oude Elberink HN, van de VenAAJ. Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization. J-Investig-Allergol-Clin-Immunol 2024; 34 (3): 214-216.; Hutten EM, Roeloffzen WW, Lambeck AJ, van den Born-Bondt T, Oude Elberink HN, van de VenAAJ. Successful Desensitization to Isatuximab in a Patien...$52$YR$$F$Y$$$20240906$$HP$NL$NL
242403721$24240372$1$I$$20240820$20240822$20240822$PER$$US-JNJFOC-20240850291$JOHNSON AND JOHNSON$$$$$$Y$$$20240822$$HP$US$US
242403732$24240373$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234490$TEVA$Venkatraman S, Mehta T, Deng F. A Rare Neurotoxicity Syndrome Following Opioid Intoxication. Ann-Neurol 2024; 96 (2): 412-415.; Venkatraman S, Mehta T, Deng F. A Rare Neurotoxicity Syndrome Following Opioid Intoxication. Ann-Neurol 2024; 96 (2): 412-415.$55$YR$$F$Y$$$20240909$$HP$US$US
242403741$24240374$1$I$20240215$20240813$20240822$20240822$EXP$FR-AFSSAPS-CF2024000407$FR-TEVA-VS-3233806$TEVA$$58$YR$$F$Y$89$KG$20240822$$HP$FR$FR
242403752$24240375$2$F$20240803$20240905$20240822$20240912$EXP$$US-APELLIS-2024-APL-0000747$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240912$$HP$US$US
242403761$24240376$1$I$$20240822$20240822$20240822$PER$$US-BAYER-2024A121159$BAYER$$$$$$Y$$$20240822$$CN$US$US
242403771$24240377$1$I$$20240814$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129522$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240822$$HP$US$US
242403781$24240378$1$I$$20240820$20240822$20240822$EXP$$US-BIOMARINAP-US-2024-159710$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242403792$24240379$2$F$20240101$20240920$20240822$20240926$PER$$US-009507513-2407USA015885$MERCK$$$$$M$Y$53.515$KG$20240926$$CN$US$US
242403802$24240380$2$F$$20240827$20240822$20240906$EXP$$IT-TEVA-VS-3233438$TEVA$Scala M, Chiera M, Bortolotti B, Rodriguez-Jimenez R, Menchetti M. Aggressive behaviour and diabetes: A clinical case of atypical metabolic improvement during clozapine treatment. J-Intellect-Disabil 2024; 1-8.; Scala M, Chiera M, Bortolotti B, Rodriguez-Jimenez R, Menchetti M. Aggressive behaviour and diabetes: A clinical case of atypical metabolic improvement during clozapine treatment. J-Intellect-Disabil 2024; 1-8.$$$A$M$Y$$$20240906$$HP$IT$IT
242403812$24240381$2$F$20240817$20240903$20240822$20240906$PER$$US-PHARMING-PHAUS2024000712$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242403821$24240382$1$I$20240804$20240816$20240822$20240822$PER$$US-PHARMING-PHAUS2024000710$PHARMING GROUP$$$$$$Y$$$20240822$$CN$US$US
242403832$24240383$2$F$20240801$20240903$20240822$20240906$PER$$US-PHARMING-PHAUS2024000699$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242403842$24240384$2$F$$20240903$20240822$20240906$EXP$$US-PHARMING-PHAUS2024000715$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242403851$24240385$1$I$$20240816$20240822$20240822$PER$$US-PHARMING-PHAUS2024000713$PHARMING GROUP$$$$$$Y$$$20240822$$CN$US$US
242403861$24240386$1$I$$20240814$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013222$ELI LILLY AND CO$$$$A$F$Y$$$20240822$$CN$US$US
242403872$24240387$2$F$$20240821$20240822$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013242$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240827$$CN$US$US
242403881$24240388$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012213$ELI LILLY AND CO$$76$YR$E$$Y$$$20240822$$HP$US$US
242403891$24240389$1$I$$20240821$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013243$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240822$$CN$US$US
242403901$24240390$1$I$20240623$20240813$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408008509$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240822$$CN$US$US
242403911$24240391$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012869$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242403921$24240392$1$I$20210609$20240813$20240822$20240822$EXP$FR-AFSSAPS-ST2024001280$FR-TEVA-VS-3233829$TEVA$$55$YR$$F$Y$54$KG$20240822$$MD$FR$FR
242403931$24240393$1$I$$20240820$20240822$20240822$PER$$US-BIOMARINAP-US-2024-160019$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242403941$24240394$1$I$$20240819$20240822$20240822$PER$$US-BIOMARINAP-US-2024-160023$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242403951$24240395$1$I$$20240819$20240822$20240822$PER$$US-BIOMARINAP-US-2024-159987$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242403961$24240396$1$I$20240822$20240822$20240822$20240822$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047342$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240822$$CN$US$US
242403971$24240397$1$I$20240816$20240821$20240822$20240822$EXP$$CN-GILEAD-2024-0685004$GILEAD$$53$YR$A$F$Y$52$KG$20240822$$HP$CN$CN
242403981$24240398$1$I$$20240816$20240822$20240822$PER$$US-BIOMARINAP-US-2024-159968$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242403991$24240399$1$I$$20240817$20240822$20240822$PER$$US-BIOMARINAP-US-2024-159952$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242404001$24240400$1$I$$20240808$20240822$20240822$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI07997$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240822$$HP$US$US
242404011$24240401$1$I$20231115$20240813$20240822$20240822$EXP$PL-URPL-DML-MLP.4401.1.815.2023$PL-TEVA-VS-3233841$TEVA$$58$YR$$F$Y$63$KG$20240822$$MD$PL$PL
242404021$24240402$1$I$20240521$20240816$20240822$20240822$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012929$JAZZ$$63$YR$$F$Y$$$20240822$$CN$US$US
242404031$24240403$1$I$20240101$20240819$20240822$20240822$PER$$US-AMGEN-USASP2024165482$AMGEN$$63$YR$A$F$Y$$$20240822$$HP$US$US
242404041$24240404$1$I$20240731$20240813$20240822$20240822$EXP$DE-CADRBFARM-2024329732$DE-TEVA-VS-3233702$TEVA$$38$YR$$F$Y$80$KG$20240822$$CN$DE$DE
242404061$24240406$1$I$$20240822$20240822$20240822$PER$$US-GILEAD-2024-0685052$GILEAD$$$$$$Y$$$20240822$$HP$US$US
242404071$24240407$1$I$20240207$20240813$20240822$20240822$EXP$ES-AEMPS-1528950$ES-TEVA-VS-3233867$TEVA$$61$YR$$M$Y$90$KG$20240822$$MD$ES$ES
242404081$24240408$1$I$$20240814$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013225$ELI LILLY AND CO$$$$A$F$Y$$$20240822$$CN$US$US
242404091$24240409$1$I$20240701$20240815$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408010140$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240822$$CN$US$US
242404101$24240410$1$I$$20240820$20240822$20240822$EXP$$NVSC2024CA146939$NOVARTIS$$51$YR$$F$Y$$$20240823$$PH$CA$CA
242404112$24240411$2$F$$20240911$20240822$20240920$EXP$$US-TEVA-VS-3234716$TEVA$Sircy A, Ibeh B, Boutros N, Bolyard J. OTITIS MEDIA TO MENINGITIS: A RARE GROUP A STREPTOCOCCUS MENINGITIS CASE. Crit-Care-Med 2024; 52 (Suppl.) S705.; Sircy A, Ibeh B, Boutros N, Bolyard J. OTITIS MEDIA TO MENINGITIS: A RARE GROUP A STREPTOCOCCUS MENINGITIS CASE. Crit-Care-Med 2024; 52 (Suppl.) S705.$43$YR$$M$Y$$$20240920$$HP$US$US
242404122$24240412$2$F$$20240911$20240822$20240920$EXP$$US-TEVA-VS-3234979$TEVA$Monge J, Razavi M, Bao L, Patel SS. Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. Am-J-Hematol 2023; 99 327-328.; Monge J, Razavi M, Bao L, Patel SS. Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. Am-J-Hematol 2023; 99 327-328.; Monge J, Razavi M, Bao L, Patel SS. Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neo...$78$YR$$M$Y$$$20240920$$HP$US$US
242404131$24240413$1$I$$20240812$20240822$20240822$EXP$$NVSC2024CA167567$NOVARTIS$$43$YR$$F$Y$97$KG$20240823$$HP$CA$CA
242404141$24240414$1$I$$20240816$20240822$20240822$PER$$US-BIOMARINAP-US-2024-159924$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242404151$24240415$1$I$20240809$20240816$20240822$20240822$PER$$US-BIOMARINAP-US-2024-159962$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242404161$24240416$1$I$20240815$20240816$20240822$20240822$PER$$US-BIOMARINAP-US-2024-159930$BIOMARIN$$$$$$Y$$$20240822$$CN$US$US
242404171$24240417$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408013231$ELI LILLY AND CO$$$$$M$Y$$$20240822$$CN$US$US
242404181$24240418$1$I$$20240812$20240822$20240822$EXP$$HU-TEVA-VS-3233754$TEVA$Zs. N?meth Szacituzumab-govitecan: successful treatment of a homron receptor-positive, HER2-negative, metastatic breast cancer patient. Review of further medical education. 2024/7:74-76. Article title in English: Zs N?meth. Sacituzumab-govitecan: successful treatment of a patient with hormone receptor positive, HER2-negative metastatic breast tumor. Review of further medical education. 2024/7:74-76.$39$YR$$F$Y$$$20240822$$MD$HU$HU
242404192$24240419$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234654$TEVA$Lee IJ, Pulido JS, Regillo CD, Leys M. MULTIPLE ORGAN DYSFUNCTION SYNDROME and DISSEMINATED INTRAVASCULAR COAGULATION CAUSING EXTENSIVE MULTIPLE AMALRIC TRIANGULAR CHOROIDAL INFARCTIONS. Retin-Cases-Brief-Rep 2024; 18 (2): 251-254.; Lee IJ, Pulido JS, Regillo CD, Leys M. MULTIPLE ORGAN DYSFUNCTION SYNDROME and DISSEMINATED INTRAVASCULAR COAGULATION CAUSING EXTENSIVE MULTIPLE AMALRIC TRIANGULAR CHOROIDAL INFARCTIONS. Retin-Cases-Brief-Rep 2024; 18 (2): 251-254.; Lee IJ, Pulido JS, Regillo CD, ...$49$YR$$F$Y$$$20240909$$MD$US$US
242404202$24240420$2$F$$20240827$20240822$20240905$EXP$$US-TEVA-2023-US-2874997$TEVA$Kuniyoshi J, Huang R, Choi H, Bernas M, Techasatian W, Nishimura Y. Immune Checkpoint Inhibitor-Induced Myocarditis With Concurrent Myasthenia Gravis. The Canadian journal of cardiology, Nov 2023, 39: 1646-1648, No. 11,; Huang R, Kuniyoshi J, Choi H, Bernas M. NIVOLUMAB ASSOCIATED MYOCARDITIS: ROLE OF SERIAL BIOMARKERS IN MANAGEMENT. J-Am-Coll-Cardiol 2023; 81 (Suppl.) (8): 3606.; Huang R, Kuniyoshi J, Choi H, Bernas M. NIVOLUMAB ASSOCIATED MYOCARDITIS: ROLE OF SERIAL BIOMARKERS IN MANAGEMENT...$67$YR$$M$Y$$$20240905$$MD$US$US
242404212$24240421$2$F$$20240830$20240822$20240909$EXP$$US-TEVA-VS-3234487$TEVA$Shivarajpur A, Valentin RG. Intramuscular Progesterone: A Cause of Acute Eosinophilic Pneumonitis. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.; Shivarajpur A, Valentin RG. Intramuscular Progesterone: A Cause of Acute Eosinophilic Pneumonitis. Am-J-Respir-Crit-Care-Med 2024; 209 (0):.$35$YR$$F$Y$$$20240909$$HP$US$US
242404222$24240422$2$F$$20240911$20240822$20240920$EXP$$US-TEVA-VS-3234750$TEVA$Suffian H, Le T, Pandya A. COMPLICATIONS POST-CHEMOTHERAPY IN A CHILD WITH T-CELL LEUKEMIA AND ATAXIA TELANGIECTASIA. Ann-Allergy-Asthma-Immunol 2023; 131 (Suppl. 1) (5): S156 abstr. M261.; Suffian H, Le T, Pandya A. COMPLICATIONS POST-CHEMOTHERAPY IN A CHILD WITH T-CELL LEUKEMIA AND ATAXIA TELANGIECTASIA. Ann-Allergy-Asthma-Immunol 2023; 131 (Suppl. 1) (5): S156 abstr. M261.$4$YR$$M$Y$$$20240920$$HP$US$US
242404232$24240423$2$F$$20240911$20240822$20240920$EXP$$US-TEVA-VS-3234772$TEVA$Harmouch W, Zhang JR, Peterson JM, Uran DP, Buja LM, Zhao B, et al. A challenging case of eosinophilic myocarditis leading to heart failure and transplantation. Cardiovasc-Pathol 2024; 72.; Harmouch W, Zhang JR, Peterson JM, Uran DP, Buja LM, Zhao B, et al. A challenging case of eosinophilic myocarditis leading to heart failure and transplantation. Cardiovasc-Pathol 2024; 72.$$$A$M$Y$$$20240920$$HP$US$US
242404241$24240424$1$I$$20240722$20240822$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202408004338$ELI LILLY AND CO$$$$$F$Y$$$20240822$$CN$US$US
242404251$24240425$1$I$$20240820$20240822$20240822$EXP$$US-GILEAD-2024-0684901$GILEAD$$49$YR$A$M$Y$$$20240822$$CN$US$US
242404261$24240426$1$I$$20240821$20240822$20240822$EXP$$US-GILEAD-2024-0684965$GILEAD$$$$A$$Y$$$20240822$$HP$US$US
242404271$24240427$1$I$$20240822$20240822$20240822$PER$$NVSC2024US170416$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242404281$24240428$1$I$20240501$20240718$20240822$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202407013444$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240822$$CN$US$US
242404291$24240429$1$I$$20240321$20240822$20240822$EXP$$CA-ROCHE-10000061390$ROCHE$$65$YR$E$F$Y$34$KG$20240823$$HP$CA$CA
242404301$24240430$1$I$20230101$20240719$20240822$20240822$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408011012$ELI LILLY AND CO$$87$YR$E$F$Y$$$20240822$$CN$JP$JP
242404311$24240431$1$I$$20240816$20240822$20240822$PER$$US-ALXN-202408USA001090US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$HP$US$US
242404321$24240432$1$I$$20240821$20240822$20240822$PER$$NVSC2024US170340$NOVARTIS$$$$$$Y$$$20240823$$MD$US$US
242404331$24240433$1$I$$20240820$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133333$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240823$$CN$US$US
242404341$24240434$1$I$$20240510$20240822$20240822$EXP$$CA-ROCHE-10000060200$ROCHE$$65$YR$E$F$Y$$$20240823$$MD$CA$CA
242404351$24240435$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012769$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240822$$CN$US$US
242404361$24240436$1$I$$20240821$20240822$20240822$PER$$NVSC2024US170275$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242404371$24240437$1$I$20240722$20240806$20240822$20240822$PER$$US-TEVA-VS-3230767$TEVA$$63$YR$$F$Y$$$20240822$$CN$US$US
242404381$24240438$1$I$$20240820$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132802$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$82.55$KG$20240823$$CN$US$US
242404392$24240439$2$F$20240101$20240916$20240822$20240922$EXP$$US-JNJFOC-20240768475$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240922$$CN$US$US
242404401$24240440$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012747$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240822$$CN$US$US
242404411$24240441$1$I$$20240821$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074347$SANDOZ$$63$YR$$M$Y$$$20240822$$MD$US$US
242404421$24240442$1$I$$20240821$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074341$SANDOZ$$61$YR$$M$Y$$$20240822$$MD$US$US
242404431$24240443$1$I$$20240822$20240822$20240822$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047348$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240823$$CN$US$US
242404441$24240444$1$I$$20240809$20240822$20240822$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08063$NEUROCRINE BIOSCIENCES$$72$YR$$M$Y$$$20240823$$HP$US$US
242404452$24240445$2$F$$20240820$20240822$20240902$30DAY$$CA-JNJFOC-20240849859$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$HP$CA$CA
242404461$24240446$1$I$$20240820$20240822$20240822$EXP$$AU-SANDOZ INC.-SDZ2024AU073923$SANDOZ$$$$$$Y$$$20240822$$HP$AU$AU
242404471$24240447$1$I$$20240822$20240822$20240822$PER$$NVSC2024US170418$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242404481$24240448$1$I$$20240813$20240822$20240822$EXP$$BR-JNJFOC-20240837574$JOHNSON AND JOHNSON$$33$YR$A$M$Y$75$KG$20240823$$HP$BR$BR
242404491$24240449$1$I$$20240820$20240822$20240822$EXP$US-MLMSERVICE-20240613-PI098018-00232-1$US-SANDOZ INC.-SDZ2024US074241$SANDOZ$$58$YR$$M$Y$$$20240822$$MD$US$US
242404501$24240450$1$I$$20240821$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA074409$SANDOZ$$69$YR$$F$Y$$$20240822$$CN$CA$CA
242404511$24240451$1$I$$20240821$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074256$SANDOZ$$61$YR$$M$Y$$$20240822$$MD$US$US
242404521$24240452$1$I$$20240821$20240822$20240822$EXP$$CA-SANDOZ INC.-SDZ2024CA074441$SANDOZ$$33$YR$$M$Y$$$20240822$$CN$CA$CA
242404531$24240453$1$I$20240730$20240819$20240822$20240822$EXP$$US-ABBVIE-5886368$ABBVIE$$76$YR$$M$Y$$$20240822$$CN$US$US
242404541$24240454$1$I$20240201$20240820$20240822$20240822$EXP$$FR-ORGANON-O2408FRA001406$ORGANON$$70$YR$$M$Y$73$KG$20240822$$PH$FR$FR
242404551$24240455$1$I$20240701$20240819$20240822$20240822$EXP$$US-ABBVIE-5887171$ABBVIE$$58$YR$$F$Y$$$20240822$$CN$US$US
242404562$24240456$2$F$20240806$20240905$20240822$20240906$EXP$$JP-TAKEDA-2024TJP011746$TAKEDA$$9$DEC$$F$Y$$$20240906$$MD$JP$JP
242404571$24240457$1$I$20240818$20240819$20240822$20240822$30DAY$$IT-SANDOZ INC.-SDZ2024IT074294$SANDOZ$$13$YR$$F$Y$48$KG$20240822$$CN$IT$IT
242404581$24240458$1$I$20240721$20240819$20240822$20240822$EXP$$US-ABBVIE-5886843$ABBVIE$$52$YR$$F$Y$$$20240822$$CN$US$US
242404591$24240459$1$I$$20240822$20240822$20240822$PER$$NVSC2024US170419$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242404601$24240460$1$I$20240802$20240821$20240822$20240822$EXP$$NVSJ2024JP009483$NOVARTIS$$76$YR$$M$Y$$$20240823$$PH$JP$JP
242404611$24240461$1$I$20240101$20240821$20240822$20240822$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047331$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240823$$HP$CO$CO
242404622$24240462$2$F$$20240912$20240822$20240915$PER$$US-JNJFOC-20240847547$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$US$US
242404631$24240463$1$I$$20240821$20240822$20240822$EXP$$US-ABBVIE-5890122$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242404641$24240464$1$I$20240101$20240820$20240822$20240822$EXP$DK-DKMA-30737511$DK-AMGEN-DNKSP2024167273$AMGEN$$79$YR$E$F$Y$62$KG$20240822$$MD$DK$DK
242404651$24240465$1$I$$20240813$20240822$20240822$PER$$US-BAUSCHBL-2024BNL031717$BAUSCH AND LOMB$$$$$F$Y$$$20240823$$CN$US$US
242404661$24240466$1$I$$20240821$20240822$20240822$EXP$$CA-ORGANON-O2408CAN001564$ORGANON$Unknown. Unknown. Unknown. Unk$45$YR$$F$Y$$$20240822$$HP$CA$CA
242404672$24240467$2$F$20220401$20240911$20240822$20240916$EXP$$NZ-MYLANLABS-2024M1076984$MYLAN$$67$YR$$M$Y$$$20240916$$MD$NZ$NZ
242404681$24240468$1$I$$20240820$20240822$20240822$EXP$$CA-JNJFOC-20240855215$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240823$$HP$CA$CA
242404692$24240469$2$F$$20240904$20240822$20240906$30DAY$$CH-MYLANLABS-2024M1075036$MYLAN$$$$$M$Y$$$20240906$$CN$CH$CH
242404712$24240471$2$F$$20240919$20240822$20240923$EXP$$DE-MYLANLABS-2024M1074466$MYLAN$$$$$F$Y$$$20240923$$PH$DE$DE
242404721$24240472$1$I$20240101$20240820$20240822$20240822$EXP$$US-ABBVIE-5888312$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242404731$24240473$1$I$20240514$20240514$20240822$20240822$EXP$$MX-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047271$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$$$20240823$$CN$MX$MX
242404743$24240474$3$F$20240712$20240921$20240822$20240927$EXP$$US-BAUSCHBL-2024BNL031996$BAUSCH AND LOMB$$37$YR$$M$Y$77.11$KG$20240927$$CN$US$US
242404752$24240475$2$F$20240101$20240827$20240822$20240827$EXP$$CL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047253$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$$$20240827$$PH$CL$CL
242404771$24240477$1$I$20240812$20240816$20240822$20240822$EXP$GB-MHRA-MED-202408151252047870-MJRZN$GB-ELI_LILLY_AND_COMPANY-GB202408011309$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240822$$CN$GB$GB
242404781$24240478$1$I$20240401$20240820$20240822$20240822$EXP$$US-ABBVIE-5889162$ABBVIE$$75$YR$$F$Y$$$20240822$$CN$US$US
242404791$24240479$1$I$$20240813$20240822$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009573$ELI LILLY AND CO$$$$$$Y$$$20240822$$CN$US$US
242404801$24240480$1$I$20240813$20240813$20240822$20240822$EXP$GB-MHRA-MED-202408131054476480-CBNSJ$GB-ELI_LILLY_AND_COMPANY-GB202408008737$ELI LILLY AND CO$$60$YR$A$F$Y$105$KG$20240822$$CN$GB$GB
242404811$24240481$1$I$$20240819$20240822$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011289$ELI LILLY AND CO$Muddasani R.,Talwar N.,Mambetsariev I.,Fricke J.,Lin M.,Schmolze D.,Yue A.,Rizvi A.,Salgia R..Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series..Cancer Immunology, Immunotherapy 2024;73(10):.DOI:https://doi.org/10.1007/s00262-024-03775-6$71$YR$E$F$Y$$$20240822$$HP$US$US
242404821$24240482$1$I$$20240815$20240822$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010072$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240822$$CN$US$US
242404831$24240483$1$I$$20240814$20240822$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009278$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240822$$CN$US$US
242404841$24240484$1$I$20240806$20240812$20240822$20240822$EXP$$AR-ELI_LILLY_AND_COMPANY-AR202408011473$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240822$$CN$DE$AR
242404861$24240486$1$I$$20240818$20240822$20240822$EXP$GB-MHRA-MED-202408171317532660-BMKSC$GB-ELI_LILLY_AND_COMPANY-GB202408011221$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240822$$CN$GB$GB
242404871$24240487$1$I$20240701$20240821$20240822$20240822$EXP$$US-ABBVIE-5889580$ABBVIE$$54$YR$$F$Y$$$20240822$$CN$US$US
242404881$24240488$1$I$20240815$20240819$20240822$20240822$PER$$US-ORGANON-O2408USA001429$ORGANON$$32$YR$$F$Y$$$20240822$$HP$US$US
242404891$24240489$1$I$20240819$20240819$20240822$20240822$EXP$$FR-ABBVIE-5889813$ABBVIE$$75$YR$$F$Y$$$20240822$$CN$FR$FR
242404901$24240490$1$I$20240801$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012832$ELI LILLY AND CO$$$$$M$Y$$$20240822$$CN$US$US
242404911$24240491$1$I$20240818$20240818$20240822$20240822$PER$$US-AMGEN-USASP2024165388$AMGEN$$82$YR$E$F$Y$$$20240822$$CN$US$US
242404921$24240492$1$I$$20240813$20240822$20240822$EXP$$US-ABBVIE-5885579$ABBVIE$$$$$M$Y$$$20240822$$MD$US$US
242404931$24240493$1$I$$20240820$20240822$20240822$PER$$US-ABBVIE-5888887$ABBVIE$$$$$$Y$$$20240822$$CN$US$US
242404941$24240494$1$I$20240816$20240816$20240822$20240822$PER$$US-AMGEN-USASP2024163797$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242404951$24240495$1$I$$20240813$20240822$20240822$PER$$US-SMPA-2024SPA001346$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242404961$24240496$1$I$$20240726$20240822$20240822$PER$$US-SMPA-2024SPA000310$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242404971$24240497$1$I$$20240725$20240822$20240822$PER$$US-SMPA-2024SPA000365$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242404981$24240498$1$I$20240719$20240726$20240822$20240822$PER$$US-SMPA-2024SPA000299$SUNOVION$$$$$$Y$$$20240822$$CN$US$US
242404993$24240499$3$F$20240818$20240904$20240822$20240918$PER$$US-JNJFOC-20240847926$JOHNSON AND JOHNSON$$66$YR$E$F$Y$104.42$KG$20240918$$HP$US$US
242405002$24240500$2$F$$20240920$20240822$20240925$EXP$$NVSJ2024JP009835$NOVARTIS$$47$YR$$M$Y$$$20240926$$MD$JP$JP
242405012$24240501$2$F$$20240910$20240822$20240918$EXP$$JP-JNJFOC-20240855977$JOHNSON AND JOHNSON$$7$DEC$E$M$Y$$$20240918$$MD$JP$JP
242405021$24240502$1$I$$20240821$20240822$20240822$EXP$$CA-ORGANON-O2408CAN001585$ORGANON$Unknown. Unknown. Unknown$37$YR$$F$Y$$$20240822$$HP$CA$CA
242405031$24240503$1$I$$20240821$20240822$20240822$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047332$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240823$$HP$CO$CO
242405051$24240505$1$I$20240816$20240821$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133494$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240823$$CN$US$US
242405061$24240506$1$I$$20240815$20240822$20240822$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130928$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240823$$HP$US$US
242405071$24240507$1$I$20240727$20240815$20240822$20240822$EXP$$US-JNJFOC-20240844918$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240823$$CN$US$US
242405081$24240508$1$I$20240814$20240821$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133476$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$57.61$KG$20240823$$CN$US$US
242405101$24240510$1$I$20240810$20240815$20240822$20240822$PER$$US-AMGEN-USASP2024164541$AMGEN$$73$YR$E$F$Y$$$20240822$$CN$US$US
242405111$24240511$1$I$$20240820$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408012577$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240822$$CN$US$US
242405122$24240512$2$F$$20240821$20240822$20240827$PER$$US-JNJFOC-20240854960$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$HP$US$US
242405141$24240514$1$I$$20240815$20240822$20240822$EXP$$US-JNJFOC-20240840365$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240823$$CN$US$US
242405151$24240515$1$I$20240729$20240815$20240822$20240822$EXP$$US-JNJFOC-20240846465$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240823$$HP$US$US
242405161$24240516$1$I$$20240816$20240822$20240822$PER$$US-ALXN-202408USA001000US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242405171$24240517$1$I$20240818$20240820$20240822$20240822$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132387$BRISTOL MYERS SQUIBB$$20$YR$A$M$Y$$$20240823$$HP$US$US
242405181$24240518$1$I$20240101$20240815$20240822$20240822$EXP$$US-JNJFOC-20240839284$JOHNSON AND JOHNSON$$78$YR$E$$Y$$$20240823$$CN$US$US
242405191$24240519$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5887299$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242405202$24240520$2$F$20240101$20240912$20240822$20240918$EXP$$US-ABBVIE-5784437$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
242405211$24240521$1$I$20240801$20240820$20240822$20240822$EXP$$US-ABBVIE-5889183$ABBVIE$$77$YR$$F$Y$$$20240822$$CN$US$US
242405221$24240522$1$I$$20240819$20240822$20240822$EXP$$DE-ABBVIE-5889119$ABBVIE$$$$E$M$Y$$$20240822$$CN$DE$DE
242405231$24240523$1$I$20240101$20240820$20240822$20240822$PER$$US-ABBVIE-5887689$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242405241$24240524$1$I$$20240821$20240822$20240822$EXP$$NVSJ2024JP009865$NOVARTIS$$$$$$Y$$$20240823$$MD$JP$JP
242405251$24240525$1$I$20240724$20240820$20240822$20240822$EXP$$CO-ABBVIE-5889421$ABBVIE$$74$YR$$F$Y$$$20240822$$HP$CO$CO
242405262$24240526$2$F$20240717$20240827$20240822$20240830$EXP$$DE-ABBVIE-5850518$ABBVIE$$40$YR$$M$Y$120$KG$20240830$$MD$DE$DE
242405271$24240527$1$I$$20240812$20240822$20240822$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408007580$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240822$$CN$NL$JP
242405281$24240528$1$I$$20240815$20240822$20240822$EXP$$US-ABBVIE-5883284$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242405291$24240529$1$I$20240101$20240819$20240822$20240822$EXP$$US-ABBVIE-5886461$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242405301$24240530$1$I$20240701$20240820$20240822$20240822$EXP$$US-ABBVIE-5888378$ABBVIE$$63$YR$$M$Y$$$20240822$$CN$US$US
242405311$24240531$1$I$$20240712$20240822$20240822$EXP$$CA-ABBVIE-5887487$ABBVIE$$27$YR$$M$Y$$$20240822$$CN$CA$CA
242405321$24240532$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5888416$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242405331$24240533$1$I$$20240819$20240822$20240822$EXP$$DE-ABBVIE-5887720$ABBVIE$$$$A$M$Y$$$20240822$$CN$DE$DE
242405341$24240534$1$I$$20240819$20240822$20240822$EXP$$GB-SANDOZ INC.-NVSC2020GB217866$SANDOZ$$$$$F$Y$$$20240822$$CN$GB$GB
242405351$24240535$1$I$$20240815$20240822$20240822$EXP$$US-SANDOZ INC.-SDZ2024US074582$SANDOZ$$$$$$Y$$$20240822$$HP$US$US
242405361$24240536$1$I$$20240816$20240822$20240822$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001661$BLUEPRINT MEDICINES$$$$$F$Y$$$20240823$$CN$US$US
242405372$24240537$2$F$$20240903$20240822$20240912$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001653$BLUEPRINT MEDICINES$$$$$F$Y$$$20240912$$CN$US$US
242405391$24240539$1$I$20230715$20240819$20240822$20240822$EXP$$JP-ABBVIE-5889484$ABBVIE$$62$YR$$M$Y$$$20240822$$MD$JP$JP
242405401$24240540$1$I$$20240822$20240822$20240822$EXP$$KR-TAKEDA-2024TUS084477$TAKEDA$$$$$$Y$$$20240822$$CN$KR$KR
242405411$24240541$1$I$20230901$20240814$20240822$20240822$EXP$$CA-JNJFOC-20240841418$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240823$$PH$CA$CA
242405421$24240542$1$I$$20240811$20240822$20240822$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009601$ELI LILLY AND CO$Communie A., Valo I., Soulie P., Grimaux X..Abemaciclib-induced lichen planus pigmentosus inversus improving after switching to ribociclib.Anais Brasileiros de Dermatologia 2023;:1-3.DOI:https://doi.org/10.1016/j.abd.2023.11.007$64$YR$A$F$Y$$$20240822$$CN$COUNTRY NOT SPECIFIED$US
242405431$24240543$1$I$$20240821$20240822$20240822$PER$$US-TAKEDA-2024TUS084652$TAKEDA$$$$$F$Y$$$20240822$$HP$US$US
242405441$24240544$1$I$20240731$20240821$20240822$20240822$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047333$BOEHRINGER INGELHEIM$$$$$M$Y$45$KG$20240823$$HP$CO$CO
242405451$24240545$1$I$20240815$20240820$20240822$20240822$PER$$US-AMGEN-USASP2024166610$AMGEN$$30$YR$A$F$Y$$$20240822$$CN$US$US
242405462$24240546$2$F$20231213$20240829$20240822$20240903$EXP$$AT-JNJFOC-20240856175$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$HP$AT$AT
242405471$24240547$1$I$$20240822$20240822$20240822$EXP$GB-MHRA-MED-202408211939013530-PSVHC$GB-ORGANON-O2408GBR001611$ORGANON$$$$$M$Y$$$20240822$$CN$GB$GB
242405481$24240548$1$I$20240726$20240807$20240822$20240822$EXP$$MX-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043086$BOEHRINGER INGELHEIM$$82$YR$E$M$Y$$$20240823$$CN$MX$MX
242405491$24240549$1$I$$20240814$20240822$20240822$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001656$BLUEPRINT MEDICINES$$$$$$Y$$$20240823$$MD$CN$CN
242405501$24240550$1$I$20240302$20240416$20240822$20240822$EXP$$MX-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-012702$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240823$$CN$MX$MX
242405511$24240551$1$I$$20240820$20240822$20240822$PER$$US-ABBVIE-5889050$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242405521$24240552$1$I$$20240816$20240822$20240822$EXP$$AR-AMGEN-ARGSP2024167066$AMGEN$$45$YR$A$F$Y$$$20240822$$CN$AR$AR
242405531$24240553$1$I$20130101$20240819$20240822$20240822$EXP$$US-JNJFOC-20240852690$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$CN$US$US
242405541$24240554$1$I$20230101$20240819$20240822$20240822$EXP$$JP-ABBVIE-5296811$ABBVIE$$54$YR$$M$Y$97$KG$20240822$$MD$JP$JP
242405551$24240555$1$I$$20240816$20240822$20240822$EXP$$US-ABBVIE-5857021$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242405561$24240556$1$I$$20240814$20240822$20240822$EXP$$SE-TAKEDA-2024TUS073048$TAKEDA$$$$$M$Y$$$20240822$$CN$SE$SE
242405571$24240557$1$I$20240802$20240816$20240822$20240822$EXP$$US-ABBVIE-5885243$ABBVIE$$70$YR$$F$Y$$$20240822$$CN$US$US
242405582$24240558$2$F$20220101$20240828$20240822$20240904$EXP$$US-ABBVIE-5886066$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242405591$24240559$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5888744$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242405601$24240560$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5888768$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242405621$24240562$1$I$$20240815$20240822$20240822$EXP$$CA-TAKEDA-2024TUS083003$TAKEDA$$76$YR$$F$Y$$$20240822$$HP$CA$CA
242405631$24240563$1$I$20240101$20240820$20240822$20240822$EXP$$US-ABBVIE-5888433$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242405641$24240564$1$I$$20240813$20240822$20240822$EXP$$US-NOVITIUMPHARMA-2024USNVP01625$NOVITIUM PHARMA$H. Suffian.COMPLICATIONS POST-CHEMOTHERAPY IN A CHILD WITH T-CELL LEUKEMIA AND ATAXIA TELANGIECTASIA.Annals of Allergy, Asthma + Immunology.NOV-2023;131(5):S156$4$YR$C$M$Y$$$20240823$$HP$US$US
242405651$24240565$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5887391$ABBVIE$$$$$M$Y$$$20240822$$CN$US$US
242405661$24240566$1$I$$20240815$20240822$20240822$EXP$$US-AMGEN-USASP2024164565$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242405671$24240567$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5888334$ABBVIE$$$$$M$Y$$$20240822$$HP$US$US
242405681$24240568$1$I$20240613$20240818$20240822$20240822$EXP$IT-MINISAL02-999405$IT-BEIGENE-BGN-2024-013016$BEIGENE$$$$$$Y$$$20240822$$MD$IT$IT
242405691$24240569$1$I$20240808$20240815$20240822$20240822$EXP$$JP-VANTIVE-2024VAN018929$Vantive US Healthcare$$$$$M$Y$$$20240822$$HP$JP$JP
242405701$24240570$1$I$$20240813$20240822$20240822$EXP$$JP-VANTIVE-2024VAN019020$Vantive US Healthcare$$7$DEC$$M$Y$$$20240822$$MD$JP$JP
242405711$24240571$1$I$$20240813$20240822$20240822$EXP$$NL-AMGEN-NLDSP2024164241$AMGEN$$35$YR$A$M$Y$$$20240822$$LW$NL$NL
242405721$24240572$1$I$20240101$20240821$20240822$20240822$EXP$$US-ABBVIE-5889587$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242405731$24240573$1$I$$20240821$20240822$20240822$30DAY$$US-SANDOZ INC.-SDZ2024US074439$SANDOZ$$$$$F$Y$$$20240822$$CN$US$US
242405741$24240574$1$I$20240806$20240821$20240822$20240822$EXP$$US-ABBVIE-5890121$ABBVIE$$71$YR$$F$Y$$$20240822$$CN$US$US
242405751$24240575$1$I$$20240819$20240822$20240822$EXP$$CA-ABBVIE-5890590$ABBVIE$$$$$M$Y$$$20240822$$HP$CA$CA
242405761$24240576$1$I$$20240819$20240822$20240822$EXP$$JP-ABBVIE-5890386$ABBVIE$$$$$M$Y$67.5$KG$20240822$$MD$JP$JP
242405771$24240577$1$I$$20240822$20240822$20240822$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047364$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240823$$MD$US$US
242405781$24240578$1$I$20201001$20240815$20240822$20240822$EXP$$FR-AMGEN-FRASP2024116505$AMGEN$$33$YR$A$F$Y$39$KG$20240822$$MD$FR$FR
242405791$24240579$1$I$$20240814$20240822$20240822$EXP$$DE-AMGEN-DEUSP2024161987$AMGEN$$$$$F$Y$$$20240822$$PH$DE$DE
242405801$24240580$1$I$$20240819$20240822$20240822$PER$$US-ELI_LILLY_AND_COMPANY-US202408011716$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240822$$CN$US$US
242405812$24240581$2$F$$20240826$20240822$20240830$EXP$$US-JNJFOC-20240852663$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$CN$US$US
242405821$24240582$1$I$20240201$20240815$20240822$20240822$EXP$$PL-AMGEN-POLSP2024163276$AMGEN$$60$YR$A$M$Y$79$KG$20240822$$MD$PL$PL
242405831$24240583$1$I$20220101$20240815$20240822$20240822$EXP$$US-AMGEN-USASP2024164157$AMGEN$$71$YR$E$F$Y$$$20240822$$CN$US$US
242405841$24240584$1$I$20231206$20240814$20240822$20240822$EXP$$GB-AMGEN-GBRSP2024162567$AMGEN$$38$YR$A$F$Y$61$KG$20240822$$CN$GB$GB
242405861$24240586$1$I$$20240820$20240822$20240822$EXP$$GB-JNJFOC-20240855446$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240823$$HP$GB$GB
242405871$24240587$1$I$20240816$20240816$20240822$20240822$EXP$$JP-GENMAB-2024-02994$GENMAB$$65$YR$$$Y$$$20240823$$MD$JP$JP
242405881$24240588$1$I$$20240812$20240822$20240822$EXP$$US-RDY-LIT/USA/24/0011977$DR REDDYS$Lee DH, Donkor R, Parvus MN, Dannenbaum MJ, Schefler AC. Incidence and Risk Factors for Neutropenia after Intra-Arterial Chemotherapy for Retinoblastoma. JAMA Ophthalmology. 2023;141(12): 1133-1138. doi:10.1001/jamaophthalmol.2023.4825.$$$$$Y$$$20240823$$MD$US$US
242405891$24240589$1$I$20240809$20240816$20240822$20240822$EXP$$US-ABBVIE-5885244$ABBVIE$$61$YR$$F$Y$$$20240822$$CN$US$US
242405901$24240590$1$I$20240609$20240814$20240822$20240822$EXP$$US-ABBVIE-5845588$ABBVIE$$71$YR$$F$Y$73$KG$20240822$$CN$US$US
242405911$24240591$1$I$$20240813$20240822$20240822$EXP$$US-NOVITIUMPHARMA-2024USNVP01631$NOVITIUM PHARMA$Victoria Garofalo.ANAPLASMOSIS: FROM MULTI-SYSTEM MAYHEM TO VENTRICULAR TACHYCARDIA IN A HEARTBEAT.Journal of the American College of Cardiology.02-APR-2024;83(13):4506$78$YR$E$M$Y$$$20240823$$HP$US$US
242405921$24240592$1$I$$20240820$20240822$20240822$EXP$$US-ABBVIE-5889173$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242405931$24240593$1$I$$20240816$20240822$20240822$EXP$$CH-AMGEN-CHENI2024166756$AMGEN$$$$E$M$Y$$$20240822$$MD$CH$CH
242405941$24240594$1$I$$20240815$20240822$20240822$EXP$$US-BIOGEN-2024BI01278728$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242405951$24240595$1$I$20240801$20240819$20240822$20240822$EXP$$US-ABBVIE-5887246$ABBVIE$$61$YR$$F$Y$$$20240822$$CN$US$US
242405961$24240596$1$I$20240405$20240816$20240822$20240822$EXP$$US-TAKEDA-2024TUS034350$TAKEDA$$56$YR$$F$Y$$$20240822$$MD$US$US
242405971$24240597$1$I$$20240816$20240822$20240822$EXP$$US-009507513-2408USA006208$MERCK$$73$YR$$F$Y$$$20240822$$MD$US$US
242405981$24240598$1$I$$20240819$20240822$20240822$EXP$$US-ABBVIE-5886866$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242405991$24240599$1$I$$20240815$20240822$20240822$EXP$$US-BIOGEN-2024BI01279027$BIOGEN$$$$$F$Y$$$20240822$$CN$US$US
242406002$24240600$2$F$20240801$20240909$20240822$20240916$EXP$$CA-BIOGEN-2024BI01278763$BIOGEN$$44$YR$$F$Y$$$20240916$$CN$CA$CA
242406012$24240601$2$F$20240101$20240827$20240822$20240830$EXP$$US-ABBVIE-5887519$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242406031$24240603$1$I$20240707$20240820$20240822$20240822$EXP$$CA-ABBVIE-5889199$ABBVIE$$59$YR$$M$Y$$$20240822$$HP$CA$CA
242406041$24240604$1$I$$20240816$20240822$20240822$EXP$$US-AstraZeneca-2024A187951$ASTRAZENECA$$$$$M$Y$$$20240823$$MD$US$
242406051$24240605$1$I$$20240813$20240822$20240822$EXP$$US-NOVITIUMPHARMA-2024USNVP01629$NOVITIUM PHARMA$Jorge Monge.Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy..American Journal of Hematology.19-APR-2023;NA:1-6$78$YR$E$M$Y$$$20240823$$HP$US$US
242406062$24240606$2$F$20240801$20240828$20240822$20240902$EXP$$CH-ABBVIE-5889449$ABBVIE$$76$YR$$M$Y$$$20240902$$HP$CH$CH
242406071$24240607$1$I$20240101$20240819$20240822$20240822$EXP$$CA-ABBVIE-5857379$ABBVIE$$78$YR$$M$Y$$$20240822$$HP$CA$CA
242406081$24240608$1$I$$20240816$20240822$20240822$EXP$$US-TAKEDA-2024TUS076861$TAKEDA$$$$$M$Y$$$20240822$$MD$US$US
242406102$24240610$2$F$$20240919$20240822$20240926$EXP$$GB-GSK-GB2024EME104188$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$GB$GB
242406111$24240611$1$I$$20240811$20240822$20240822$EXP$$US-AMGEN-USASP2024164184$AMGEN$Sandhu T.; Meir L.; Ng N. et al.. RITUXIMAB FOR TREATMENT OF SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE AT MOUNT SINAI MEDICAL CENTER. Annals of the Rheumatic Diseases. 2024;83 (SUPPL_1):1918-1919$$$$$Y$$$20240822$$HP$US$US
242406131$24240613$1$I$$20240820$20240822$20240822$EXP$$CA-PFIZER INC-202400240977$PFIZER$$51$YR$$F$Y$$$20240822$$MD$CA$CA
242406141$24240614$1$I$$20240817$20240822$20240822$EXP$$IN-PFIZER INC-PV202400108820$PFIZER$$36$YR$$F$Y$$$20240822$$CN$IN$IN
242406161$24240616$1$I$$20240822$20240822$20240822$PER$$NVSC2024US170449$NOVARTIS$$$$$$Y$$$20240823$$CN$US$US
242406171$24240617$1$I$20240814$20240815$20240822$20240822$EXP$$PA-BIOGEN-2024BI01278759$BIOGEN$$61$YR$$F$Y$$$20240822$$CN$PA$PA
242406181$24240618$1$I$$20240820$20240822$20240822$PER$$US-JNJFOC-20240851955$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$CN$US$US
242406191$24240619$1$I$20240101$20240820$20240822$20240822$EXP$$US-ABBVIE-5888453$ABBVIE$$$$$F$Y$$$20240822$$CN$US$US
242406203$24240620$3$F$20240629$20240911$20240822$20240919$EXP$$CZ-BIOGEN-2024BI01279048$BIOGEN$$44$YR$$F$Y$106$KG$20240919$$MD$CZ$CZ
242406211$24240621$1$I$$20240813$20240822$20240822$EXP$$US-JNJFOC-20240833794$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$CN$US$US
242406221$24240622$1$I$$20240821$20240822$20240822$EXP$$US-JNJFOC-20240855669$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$CN$US$US
242406231$24240623$1$I$20240501$20240821$20240822$20240822$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047371$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240823$$MD$US$US
242406241$24240624$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165095$AMGEN$$$$$M$Y$$$20240822$$PH$US$US
242406251$24240625$1$I$20240819$20240819$20240823$20240823$EXP$$UY-ABBVIE-5886068$ABBVIE$$62$YR$$M$Y$$$20240823$$CN$UY$UY
242406261$24240626$1$I$$20240820$20240823$20240823$EXP$$US-ABBVIE-5882202$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242406271$24240627$1$I$$20240820$20240823$20240823$EXP$$US-ABBVIE-5888842$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242406281$24240628$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024100716$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242406291$24240629$1$I$$20240821$20240823$20240823$EXP$$US-ABBVIE-5889487$ABBVIE$$$$$F$Y$$$20240823$$HP$US$US
242406311$24240631$1$I$20240501$20240821$20240823$20240823$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047370$BOEHRINGER INGELHEIM$$55$YR$A$F$Y$$$20240823$$MD$US$US
242406321$24240632$1$I$20240811$20240819$20240823$20240823$EXP$GB-MHRA-MED-202408161017339730-CRQYV$GB-JNJFOC-20240856241$JOHNSON AND JOHNSON$$87$YR$E$F$Y$51$KG$20240823$$PH$GB$GB
242406331$24240633$1$I$$20240813$20240823$20240823$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000290$EMCURE$Jha V, Jha SK, Aryal B, Dhungel S, Jha S, Brock M.. A Report of a Rare Case of Kounis Syndrome in a Patient With HIV/AIDS and Mpox. Cureus. 2024;16(7):e63957$45$YR$$M$Y$$$20240823$$HP$US$US
242406341$24240634$1$I$20240101$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165622$AMGEN$$71$YR$E$F$Y$$$20240822$$CN$US$US
242406351$24240635$1$I$20240801$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167807$AMGEN$$86$YR$E$F$Y$52.154$KG$20240822$$HP$US$US
242406362$24240636$2$F$20210101$20240815$20240823$20240828$EXP$$AU-BIOGEN-2024BI01279087$BIOGEN$$34$YR$$F$Y$$$20240828$$HP$AU$AU
242406372$24240637$2$F$20200101$20240820$20240823$20240827$EXP$$AU-BIOGEN-2024BI01279085$BIOGEN$$34$YR$$F$Y$$$20240827$$HP$AU$AU
242406381$24240638$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165620$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242406391$24240639$1$I$$20240820$20240823$20240823$EXP$$US-ABBVIE-5889026$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242406401$24240640$1$I$20240101$20240819$20240823$20240823$EXP$$US-ABBVIE-5886784$ABBVIE$$$$$F$Y$$$20240823$$HP$US$US
242406411$24240641$1$I$20240101$20240817$20240823$20240823$EXP$$US-ABBVIE-5885360$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242406421$24240642$1$I$$20240814$20240823$20240823$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010455$STRIDES$Kawajiri-Manako C, Mishina T, Tsujimura H, Maruyama S, Sato A, Sugawara T, et al.. Double-hit follicular lymphoma diagnosed due to central nervous system symptoms.. Ann-Hematol. 2023;102 (5):1281-1282$73$YR$$F$Y$$$20240823$$HP$JP$JP
242406431$24240643$1$I$$20240816$20240823$20240823$EXP$$DE-AMGEN-DEUSP2024167656$AMGEN$$$$A$F$Y$$$20240822$$CN$DE$DE
242406441$24240644$1$I$$20240814$20240823$20240823$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010497$STRIDES$Goyal A, Jakulla RS, Alarfaj M, Tayeb T, Barker S, Bhyan P, et al.. Myasthenia Crisis Complicated with Takotsubo Cardiomyopathy.. US-Cardiol. 2024;18 (Suppl.):7-8$77$YR$$F$Y$$$20240823$$HP$US$US
242406451$24240645$1$I$$20240816$20240823$20240823$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP010483$STRIDES$Fecko M, Klimek M, Zielinski T, Gawrychowski J, Mackiewicz M, Nowosielski K.. An unusual presentation of acute pancreatitis associated with primary hyperparathyroidism in pregnant woman.. Eur-J-Obstet-Gynecol-Reprod-Biol. 2024;293:85$30$YR$$F$Y$$$20240823$$HP$PL$PL
242406471$24240647$1$I$$20240814$20240823$20240823$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010496$STRIDES$Clarke E, Thu K, Bracey T.. Rectal gastric heterotopia with fundic gland polyps, mimicking a high-risk primary anorectal neoplasm: histological evidence of the effects of gastric acid-suppressing medication in a rectal ^outlet patch^.. Diagn-Histopathol. 2024;30 (6):344-347$$$$F$Y$$$20240823$$HP$GB$GB
242406481$24240648$1$I$$20240808$20240823$20240823$EXP$$IT-STERISCIENCE B.V.-2024-ST-001214$Steriscience PTE$Colussi L, Dagri A, Pastore S, Taddio A, Tommasini A.. Effect of the janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma.. Pediatr-Rheumatol. 2023;21 (Suppl.):abstr. P134$11$YR$$F$Y$$$20240823$$HP$IT$IT
242406492$24240649$2$F$20240301$20240909$20240823$20240911$EXP$$NVSC2024GB047665$NOVARTIS$$66$YR$$F$Y$$$20240911$$CN$GB$GB
242406501$24240650$1$I$$20240808$20240823$20240823$EXP$$IT-STERISCIENCE B.V.-2024-ST-001217$Steriscience PTE$Moccaldi B, Binda M, Cuberli A, Favaro M, Zanatta E, Doria A.. PRESENTATION, TREATMENT AND OUTCOME OF SYSTEMIC SCLEROSIS-PRIMARY HEART INVOLVEMENT: DATA FROM A MONOCENTRIC COHORT.. Ann-Rheum-Dis. 2024;83 (Suppl. 1):1943-1944 abstr. AB1212$$$A$$Y$$$20240823$$HP$IT$IT
242406511$24240651$1$I$20220501$20240819$20240823$20240823$EXP$AU-TGA-0000816415$AU-AMGEN-AUSSP2024165646$AMGEN$$77$YR$E$F$Y$$$20240822$$HP$AU$AU
242406521$24240652$1$I$$20240816$20240823$20240823$EXP$$US-BIOGEN-2024BI01279060$BIOGEN$$$$$M$Y$$$20240823$$CN$US$US
242406531$24240653$1$I$$20240816$20240823$20240823$PER$$US-ALXN-202408USA001193US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
242406541$24240654$1$I$20240817$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165540$AMGEN$$82$YR$E$F$Y$$$20240822$$CN$US$US
242406551$24240655$1$I$$20240808$20240823$20240823$EXP$$IT-STERISCIENCE B.V.-2024-ST-001219$Steriscience PTE$Moccaldi B, Binda M, Cuberli A, Favaro M, Zanatta E, Doria A.. PRESENTATION, TREATMENT AND OUTCOME OF SYSTEMIC SCLEROSIS-PRIMARY HEART INVOLVEMENT: DATA FROM A MONOCENTRIC COHORT.. Ann-Rheum-Dis. 2024;83 (Suppl. 1):1943-1944 abstr. AB1212$$$A$$Y$$$20240823$$HP$IT$IT
242406561$24240656$1$I$$20240813$20240823$20240823$EXP$$BR-CHATTEMPRD-2024OHG028086$CHATTEM$Lopes DN, de Oliveira NP, de Campos Augusto KC, Milagres A, Miguez AL, Junior AS et al.. Co-occurrence of oral pemphigus vulgaris and herpes simplex virus infection in a young patient with Crohn^s disease: report of a rare case of oral lesions during anti-TFN alpha and immunomodulator therapy. International Journal of Colorectal Disease.. 2024;39(125):1-10. doi:https://doi.org/10.1007/s00384-024-04673-0$18$YR$A$F$Y$$$20240823$$HP$BR$BR
242406571$24240657$1$I$20180201$20240819$20240823$20240823$EXP$$AU-AMGEN-AUSSP2024165734$AMGEN$$52$YR$A$F$Y$$$20240822$$CN$AU$AU
242406581$24240658$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024166062$AMGEN$$$$$F$Y$$$20240822$$CN$US$US
242406591$24240659$1$I$20240701$20240819$20240823$20240823$EXP$$US-VIIV HEALTHCARE LIMITED-US2024103304$VIIV$$$$$$Y$$$20240823$$CN$US$US
242406611$24240661$1$I$$20240812$20240823$20240823$EXP$$ES-TAKEDA-2024TUS084282$TAKEDA$$43$YR$$F$Y$62$KG$20240823$$MD$ES$ES
242406621$24240662$1$I$$20240819$20240823$20240823$EXP$$US-JNJFOC-20240852975$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$CN$US$US
242406631$24240663$1$I$$20240816$20240823$20240823$EXP$$CA-CHATTEMPRD-2024OHG028487$CHATTEM$$11$YR$C$F$Y$$$20240823$$CN$CA$CA
242406641$24240664$1$I$$20240810$20240823$20240823$EXP$$SA-ALXN-202408MES001065SA$ALEXION PHARMACEUTICALS$$1$YR$$M$Y$$$20240823$$MD$SA$SA
242406651$24240665$1$I$$20240820$20240823$20240823$EXP$$JP-TAKEDA-2024TJP012180$TAKEDA$$$$E$F$Y$$$20240823$$MD$JP$JP
242406661$24240666$1$I$$20240815$20240823$20240823$EXP$$US-ABBVIE-5738011$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242406671$24240667$1$I$$20240813$20240823$20240823$EXP$$GR-STERISCIENCE B.V.-2024-ST-001221$Steriscience PTE$Keffes, N. PENETRATING BRAIN INJURY THROUGH A PRE-EXISTING SKULL DEFECT. 37th ANNUAL CONGRESS OF THE HELLENIC NEUROSURGICAL SOCIETY.. 2024$44$YR$$M$Y$$$20240823$$MD$GR$GR
242406681$24240668$1$I$$20240808$20240823$20240823$EXP$$IT-STERISCIENCE B.V.-2024-ST-001218$Steriscience PTE$Moccaldi B, Binda M, Cuberli A, Favaro M, Zanatta E, Doria A.. PRESENTATION, TREATMENT AND OUTCOME OF SYSTEMIC SCLEROSIS-PRIMARY HEART INVOLVEMENT: DATA FROM A MONOCENTRIC COHORT.. Ann-Rheum-Dis. 2024;83 (Suppl. 1):1943-1944 abstr. AB1212.$$$A$$Y$$$20240823$$HP$IT$IT
242406691$24240669$1$I$20240101$20240813$20240823$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020160$UNITED THERAPEUTICS$$$$$F$Y$71.655$KG$20240823$$$US$US
242406701$24240670$1$I$$20240813$20240823$20240823$EXP$$JP-STERISCIENCE B.V.-2024-ST-001227$Steriscience PTE$Murata S, Mimura K, Kawamura T, Saito H, Ohno H, Tsujii E, et al.. Bloodstream infection caused by Wickerhamiella pararugosa in a patient with intestinal obstruction: A case report.. J-Infect-Chemother. 2024;30 (9):942-945$9$DEC$$F$Y$$$20240823$$HP$JP$JP
242406711$24240671$1$I$$20240815$20240823$20240823$EXP$$US-AstraZeneca-2024A186924$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242406721$24240672$1$I$$20240816$20240823$20240823$EXP$$CA-CHATTEMPRD-2024OHG028505$CHATTEM$$3$YR$C$F$Y$$$20240823$$CN$CA$CA
242406731$24240673$1$I$$20240816$20240823$20240823$EXP$$CA-CHATTEMPRD-2024OHG028506$CHATTEM$$12$MON$I$M$Y$$$20240823$$CN$CA$CA
242406741$24240674$1$I$$20240816$20240823$20240823$PER$$US-AstraZeneca-2024A187633$ASTRAZENECA$$$$$$Y$$$20240823$$CN$US$
242406751$24240675$1$I$$20240819$20240823$20240823$EXP$$MX-AstraZeneca-2024A187936$ASTRAZENECA$Chavez Moreira D.;  Grosu H.B.. Airway Injury Related to Radiation Treatment and Durvalumab Treatment: A Case Series. Journal of bronchology +  interventional pulmonology 2024;31(4):$54$YR$$F$Y$$$20240823$$MD$MX$
242406762$24240676$2$F$$20240905$20240823$20240910$EXP$$NZ-TAKEDA-2024TUS084563$TAKEDA$$$$$M$Y$$$20240910$$CN$NZ$NZ
242406771$24240677$1$I$20240313$20240818$20240823$20240823$EXP$$IL-ABBVIE-5885787$ABBVIE$$66$YR$$F$Y$65$KG$20240823$$MD$IL$IL
242406781$24240678$1$I$20240801$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165727$AMGEN$$77$YR$$F$Y$$$20240822$$PH$US$US
242406791$24240679$1$I$$20240813$20240823$20240823$EXP$$JP-AMGEN-JPNSP2024167145$AMGEN$$$$$M$Y$$$20240822$$CN$JP$JP
242406801$24240680$1$I$20240101$20240820$20240823$20240823$EXP$$US-ABBVIE-5889097$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242406812$24240681$2$F$20240515$20240913$20240823$20240923$EXP$FR-AFSSAPS-BX2024001625$FR-EMD Serono-2024044331$EMD SERONO INC$$69$YR$E$F$Y$$$20240923$$MD$FR$FR
242406822$24240682$2$F$20240801$20240830$20240823$20240909$EXP$$US-Encube-001290$ENCUBE ETHICALS$$$$$F$Y$$$20240906$$CN$US$
242406831$24240683$1$I$$20240813$20240823$20240823$EXP$$MX-NOVOPROD-1269729$NOVO NORDISK$$$$$F$Y$$$20240823$$CN$MX$MX
242406841$24240684$1$I$20240101$20240820$20240823$20240823$EXP$$US-ABBVIE-5888415$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242406852$24240685$2$F$20240819$20240826$20240823$20240828$EXP$$US-ABBVIE-5889627$ABBVIE$$76$YR$$M$Y$$$20240828$$CN$US$US
242406861$24240686$1$I$$20240815$20240823$20240823$PER$$US-ROCHE-10000060063$ROCHE$$76$YR$E$M$Y$$$20240823$$CN$US$US
242406881$24240688$1$I$$20240819$20240823$20240823$EXP$$US-AMGEN-USASP2024166265$AMGEN$$$$E$F$Y$$$20240822$$CN$US$US
242406892$24240689$2$F$$20240822$20240823$20240826$PER$$US-AMGEN-USASP2024167782$AMGEN$$$$$$Y$$$20240825$$MD$US$US
242406901$24240690$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024166046$AMGEN$$$$$$Y$$$20240822$$PH$US$US
242406911$24240691$1$I$20240813$20240820$20240823$20240823$EXP$$JP-TAKEDA-2024TJP012140$TAKEDA$$7$DEC$$M$Y$$$20240823$$HP$JP$JP
242406921$24240692$1$I$$20221025$20240823$20240823$EXP$$US-AstraZeneca-2022A313577$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242406931$24240693$1$I$$20230222$20240823$20240823$EXP$$US-AstraZeneca-2023A045560$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242406941$24240694$1$I$$20240820$20240823$20240823$EXP$$JP-GSK-JP2024JPN104016$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$JP$JP
242406951$24240695$1$I$20240501$20240813$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408008788$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240823$$CN$US$US
242406971$24240697$1$I$20240811$20240821$20240823$20240823$EXP$$CN-ABBVIE-5889658$ABBVIE$$46$YR$$M$Y$76$KG$20240823$$MD$CN$CN
242406991$24240699$1$I$$20240815$20240823$20240823$EXP$$CA-ABBVIE-5884148$ABBVIE$$$$E$M$Y$$$20240823$$CN$CA$CA
242407011$24240701$1$I$20240304$20240815$20240823$20240823$EXP$$US-ABBVIE-5883588$ABBVIE$$52$YR$$F$Y$$$20240823$$CN$US$US
242407051$24240705$1$I$$20240811$20240823$20240823$EXP$$US-JNJFOC-20240846633$JOHNSON AND JOHNSON$Yu R. Exaggerated Increases in the Serum Cortisol Level in a Woman Following Oral Contraceptive Treatment. AACE Clin Case Rep.$50$YR$A$F$Y$$$20240823$$MD$US$US
242407061$24240706$1$I$20240717$20240815$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012826$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242407071$24240707$1$I$$20240819$20240823$20240823$EXP$$US-ABBVIE-5886867$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242407081$24240708$1$I$$20240819$20240823$20240823$EXP$$US-ROCHE-10000060222$ROCHE$$$$$$Y$$$20240823$$MD$US$US
242407092$24240709$2$F$$20240820$20240823$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004532$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
242407101$24240710$1$I$$20240819$20240823$20240823$EXP$$VN-SANDOZ INC.-SDZ2024VN073815$SANDOZ$$65$YR$$F$Y$$$20240823$$MD$VN$VN
242407112$24240711$2$F$$20240918$20240823$20240927$EXP$$CA-ROCHE-10000060395$ROCHE$$35$YR$A$F$Y$$$20240927$$CN$CA$CA
242407123$24240712$3$F$20240804$20240905$20240823$20240915$30DAY$$US-GSK-US2024100733$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240915$$CN$US$US
242407131$24240713$1$I$$20240819$20240823$20240823$EXP$$NO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047231$BOEHRINGER INGELHEIM$Breivik H, Janeras L, Lundeland B, Ringstad GA, Stubhaug A. Long-term intrathecal infusion of low-dose morphine effectively relieves symptoms of severe restless legs syndrome/Willis-Ekbom disease without inducing opioid tolerance. Pain. 2024;1-5. doi:10.1097/j.pain.0000000000003311.$$$$F$Y$$$20240823$$MD$NO$NO
242407141$24240714$1$I$20240101$20240808$20240823$20240823$PER$$US-JNJFOC-20240822281$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240823$$CN$US$US
242407161$24240716$1$I$20240712$20240815$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012828$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242407171$24240717$1$I$$20240821$20240823$20240823$EXP$$NVSJ2024JP009850$NOVARTIS$$31$YR$$F$Y$$$20240823$$HP$JP$JP
242407181$24240718$1$I$20240813$20240819$20240823$20240823$EXP$$US-JNJFOC-20240854676$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240823$$HP$US$US
242407191$24240719$1$I$$20240816$20240823$20240823$EXP$$CN-AMGEN-CHNSP2024164379$AMGEN$$$$$$Y$$$20240822$$MD$CN$CN
242407201$24240720$1$I$$20240821$20240823$20240823$EXP$$US-ROCHE-10000063358$ROCHE$$$$$M$Y$$$20240823$$HP$US$US
242407211$24240721$1$I$20240101$20240813$20240823$20240823$EXP$$US-TEVA-VS-3234641$TEVA$$25$YR$$F$Y$$$20240823$$HP$US$US
242407231$24240723$1$I$20230801$20240816$20240823$20240823$EXP$$CO-TAKEDA-2023TUS077600$TAKEDA$$64$YR$$F$Y$104$KG$20240823$$CN$CO$CO
242407242$24240724$2$F$20230101$20240822$20240823$20240905$EXP$$US-UCBSA-2023030137$UCB$$$$$F$Y$72$KG$20240905$$CN$US$US
242407251$24240725$1$I$20240101$20240820$20240823$20240823$EXP$FR-AFSSAPS-AM2024000628$FR-ABBVIE-5886544$ABBVIE$$64$YR$$M$Y$$$20240823$$PH$FR$FR
242407261$24240726$1$I$$20240813$20240823$20240823$PER$$US-APOTEX-2024AP009452$APOTEX$Mark C, Minasyan A, Ebia MI, Abbas A, Ghosh A, Watson R, et al.. Painful tongue lesion as an initial presentation of metastatic pancreatic ductal adenocarcinoma: a case report and review of the literature. Annals of Pancreatic Cancer. 2023;6:8$91$YR$$M$Y$$$20240823$$MD$US$US
242407271$24240727$1$I$20240812$20240814$20240823$20240823$EXP$GB-MHRA-MED-202408142243426750-NVGPL$GB-ESPERIONTHERAPEUTICS-2024GBR01300$ESPERION THERAPEUTICS$$55$YR$$F$Y$80$KG$20240823$$CN$GB$GB
242407281$24240728$1$I$20240702$20240816$20240823$20240823$EXP$ES-AEMPS-1560453$ES-ESPERIONTHERAPEUTICS-2024ESP01305$ESPERION THERAPEUTICS$$80$YR$$M$Y$$$20240823$$PH$ES$ES
242407291$24240729$1$I$$20240819$20240823$20240823$EXP$$US-VIIV HEALTHCARE LIMITED-US2024103367$VIIV$$$$$$Y$$$20240823$$HP$US$US
242407301$24240730$1$I$20240815$20240816$20240823$20240823$PER$$US-BIOGEN-2024BI01278937$BIOGEN$$$$$M$Y$$$20240823$$MD$US$US
242407311$24240731$1$I$$20240816$20240823$20240823$PER$$US-BIOGEN-2024BI01278987$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
242407321$24240732$1$I$$20240815$20240823$20240823$PER$$US-BIOGEN-2024BI01278642$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
242407331$24240733$1$I$$20240815$20240823$20240823$PER$$US-TAKEDA-2024TUS082334$TAKEDA$$$$$$Y$$$20240823$$CN$US$US
242407341$24240734$1$I$$20240813$20240823$20240823$EXP$$AE-ROCHE-10000057104$ROCHE$$39$YR$A$F$Y$$$20240823$$CN$AE$AE
242407351$24240735$1$I$$20240821$20240823$20240823$PER$$US-ROCHE-10000063062$ROCHE$$$$$F$Y$$$20240823$$MD$US$US
242407362$24240736$2$F$20231201$20240816$20240823$20240824$EXP$$CA-CELLTRION INC.-2024CA014234$CELLTRION$$$$$$Y$$$20240824$$HP$CA$CA
242407371$24240737$1$I$$20240802$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051088$TOLMAR$$$$$M$Y$$$20240823$$CN$CA$CA
242407381$24240738$1$I$20240621$20240801$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051160$TOLMAR$$66$YR$$M$Y$$$20240823$$CN$CA$CA
242407392$24240739$2$F$20240729$20240829$20240823$20240918$PER$$CA-TOLMAR, INC.-24CA051054$TOLMAR$$78$YR$$M$Y$$$20240918$$CN$CA$CA
242407401$24240740$1$I$20240101$20240731$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051203$TOLMAR$$$$$M$Y$$$20240823$$CN$CA$CA
242407412$24240741$2$F$20240823$20240823$20240823$20240910$PER$$CA-TOLMAR, INC.-24CA051273$TOLMAR$$72$YR$$M$Y$$$20240909$$CN$CA$CA
242407421$24240742$1$I$20240724$20240802$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051299$TOLMAR$$67$YR$$M$Y$$$20240823$$CN$CA$CA
242407431$24240743$1$I$20240709$20240801$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051210$TOLMAR$$97$YR$$M$Y$$$20240823$$CN$CA$CA
242407441$24240744$1$I$$20240802$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051349$TOLMAR$$$$$M$Y$$$20240823$$CN$CA$CA
242407451$24240745$1$I$20240727$20240801$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051361$TOLMAR$$84$YR$$M$Y$$$20240823$$CN$CA$CA
242407461$24240746$1$I$20240730$20240731$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051487$TOLMAR$$76$YR$$M$Y$$$20240823$$CN$CA$CA
242407471$24240747$1$I$20240729$20240731$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051517$TOLMAR$$72$YR$$M$Y$$$20240823$$CN$CA$CA
242407481$24240748$1$I$20240101$20240731$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051518$TOLMAR$$$$$M$Y$$$20240823$$CN$CA$CA
242407491$24240749$1$I$$20240731$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051521$TOLMAR$$$$$M$Y$$$20240823$$CN$CA$CA
242407501$24240750$1$I$$20240801$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051523$TOLMAR$$$$$M$Y$$$20240823$$CN$CA$CA
242407521$24240752$1$I$20240423$20240514$20240823$20240823$PER$$US-CELLTRION INC.-2024US010644$CELLTRION$$$$$$Y$$$20240823$$HP$US$US
242407531$24240753$1$I$20240201$20240820$20240823$20240823$EXP$FR-ViiV Healthcare Limited-84420$FR-UCBSA-2024042123$UCB$$70$YR$$M$Y$73$KG$20240823$$PH$FR$FR
242407541$24240754$1$I$$20240813$20240823$20240823$EXP$$CA-APOTEX-2024AP009379$APOTEX$$69$YR$$F$Y$$$20240823$$HP$CA$CA
242407561$24240756$1$I$20240101$20240820$20240823$20240823$EXP$$FI-ROCHE-10000063248$ROCHE$$$$$F$Y$$$20240823$$MD$FI$FI
242407571$24240757$1$I$20240524$20240816$20240823$20240823$EXP$$US-BIOGEN-2024BI01279084$BIOGEN$$68$YR$$M$Y$$$20240823$$CN$US$US
242407612$24240761$2$F$20230101$20240910$20240823$20240916$EXP$$CA-ABBVIE-5883608$ABBVIE$$$$A$F$Y$$$20240916$$CN$CA$CA
242407631$24240763$1$I$$20240820$20240823$20240823$PER$$US-ROCHE-10000063513$ROCHE$$58$YR$A$F$Y$$$20240823$$CN$US$US
242407641$24240764$1$I$20240726$20240812$20240823$20240823$EXP$$EC-NOVOPROD-1268935$NOVO NORDISK$$27$YR$$F$Y$67$KG$20240823$$CN$EC$EC
242407651$24240765$1$I$$20240812$20240823$20240823$EXP$CA-HEALTHCANVIG-03605216$CA-NOVOPROD-1269449$NOVO NORDISK$$39$YR$$F$Y$$$20240823$$CN$CA$CA
242407661$24240766$1$I$20240401$20240812$20240823$20240823$EXP$ES-AEMPS-1559917$ES-NOVOPROD-1269764$NOVO NORDISK$$30$YR$$$Y$$$20240823$$PH$ES$ES
242407671$24240767$1$I$$20240812$20240823$20240823$EXP$$US-NOVOPROD-1270275$NOVO NORDISK$$$$$F$Y$$$20240823$$HP$US$US
242407681$24240768$1$I$20240810$20240812$20240823$20240823$EXP$$MX-NOVOPROD-1270622$NOVO NORDISK$$34$YR$$M$Y$65$KG$20240823$$CN$MX$MX
242407693$24240769$3$F$20220601$20240829$20240823$20240910$EXP$$DE-NOVOPROD-1242093$NOVO NORDISK$$70$YR$$M$Y$125$KG$20240910$$MD$DE$DE
242407701$24240770$1$I$20240813$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011653$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240823$$CN$US$US
242407711$24240771$1$I$$20240814$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408009373$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240823$$CN$US$US
242407721$24240772$1$I$20230101$20240812$20240823$20240823$EXP$$US-NOVOPROD-1271845$NOVO NORDISK$$76$YR$$M$Y$$$20240823$$CN$US$US
242407731$24240773$1$I$$20240813$20240823$20240823$EXP$$BR-NOVOPROD-1269766$NOVO NORDISK$$$$$M$Y$$$20240823$$CN$BR$BR
242407741$24240774$1$I$20240725$20240813$20240823$20240823$EXP$$US-NOVOPROD-1270271$NOVO NORDISK$$42$YR$$F$Y$$$20240823$$CN$US$US
242407751$24240775$1$I$$20240813$20240823$20240823$EXP$GB-MHRA-MED-202408131637007420-ZSMHY$GB-NOVOPROD-1269573$NOVO NORDISK$$$$$F$Y$$$20240823$$HP$GB$GB
242407761$24240776$1$I$20240801$20240813$20240823$20240823$EXP$GB-MHRA-MED-202408131605423580-FQHVJ$GB-NOVOPROD-1269578$NOVO NORDISK$$$$$$Y$$$20240823$$PH$GB$GB
242407771$24240777$1$I$$20240813$20240823$20240823$EXP$$US-NOVOPROD-1270237$NOVO NORDISK$$$$$F$Y$$$20240823$$CN$US$US
242407781$24240778$1$I$20230831$20240813$20240823$20240823$EXP$$US-NOVOPROD-1269992$NOVO NORDISK$$68$YR$$F$Y$$$20240823$$CN$US$US
242407801$24240780$1$I$$20240815$20240823$20240823$PER$$US-ROCHE-10000059401$ROCHE$$64$YR$A$F$Y$$$20240823$$CN$US$US
242407811$24240781$1$I$$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167691$AMGEN$$$$$$Y$$$20240822$$HP$US$US
242407821$24240782$1$I$20230101$20240816$20240823$20240823$EXP$$US-BIOGEN-2024BI01278781$BIOGEN$$$$$M$Y$$$20240823$$CN$US$US
242407831$24240783$1$I$20240223$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012864$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242407841$24240784$1$I$$20240813$20240823$20240823$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104767$VIIV$$$$$$Y$$$20240823$$HP$US$US
242407851$24240785$1$I$$20240812$20240823$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-041260$AUROBINDO$$69$YR$$M$Y$$$20240823$$HP$CA$CA
242407881$24240788$1$I$20240801$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167991$AMGEN$$55$YR$A$F$Y$$$20240822$$CN$US$US
242407891$24240789$1$I$$20240821$20240823$20240823$PER$$US-ROCHE-10000063238$ROCHE$$$$$$Y$$$20240823$$MD$US$US
242407902$24240790$2$F$$20240821$20240823$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-041626$AUROBINDO$Pernin V, Beuzeboc P, Peurien D, Louvet C, Kirova Y. Concurrent association of reirradiation therapy with everolimus for lymph node metastasis of gastroesophageal junction cancer: a case report. Cancer/Radiotherapie. 2014;18:681-684$56$YR$$M$Y$$$20240831$$HP$FR$FR
242407911$24240791$1$I$$20240813$20240823$20240823$PER$$US-ABBVIE-5881581$ABBVIE$$$$$F$Y$$$20240823$$MD$US$US
242407921$24240792$1$I$$20240815$20240823$20240823$EXP$$US-ABBVIE-5885689$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242407931$24240793$1$I$$20240820$20240823$20240823$PER$$US-ROCHE-10000061753$ROCHE$$$$$M$Y$$$20240823$$CN$US$US
242407941$24240794$1$I$20240614$20240709$20240823$20240823$PER$$US-CELLTRION INC.-2024US013228$CELLTRION$$$$$$Y$$$20240823$$CN$US$US
242407951$24240795$1$I$$20240813$20240823$20240823$PER$$US-ABBVIE-5884712$ABBVIE$$$$A$$Y$$$20240823$$CN$US$US
242407971$24240797$1$I$20120101$20240814$20240823$20240823$EXP$$US-ABBVIE-5866042$ABBVIE$$$$$F$Y$186$KG$20240823$$CN$US$US
242407981$24240798$1$I$$20240820$20240823$20240823$EXP$$ES-BEIGENE-BGN-2024-013026$BEIGENE$Carla Marco, Marta Sim?, Montse Alemany, Carlos Casasnovas, Ra?l Dom?nguez,Noelia Vilari?o, Mariona Calvo, Juan Mart?n-Liberal, Jes?s Brenes,Joan Sabater-Riera,Jordi Bruna, Roser Velasco. Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series. Journal of Clinical Medicine. 2023;12(1):130$$$$$Y$$$20240823$$MD$ES$ES
242407991$24240799$1$I$$20240816$20240823$20240823$EXP$$US-BIOGEN-2024BI01279092$BIOGEN$$$$$$Y$$$20240823$$MD$US$US
242408002$24240800$2$F$20240801$20240823$20240823$20240828$PER$$NVSC2024US170411$NOVARTIS$$58$YR$$F$Y$$$20240828$$CN$US$US
242408011$24240801$1$I$$20240821$20240823$20240823$PER$$US-ROCHE-10000063264$ROCHE$$$$$$Y$$$20240823$$CN$US$US
242408021$24240802$1$I$$20240815$20240823$20240823$EXP$$BR-CELLTRION INC.-2024BR020008$CELLTRION$$$$$$Y$$$20240823$$CN$BR$BR
242408031$24240803$1$I$$20240819$20240823$20240823$EXP$$US-JNJFOC-20240848011$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$CN$US$US
242408041$24240804$1$I$$20240813$20240823$20240823$EXP$$IN-NOVITIUMPHARMA-2024INNVP01638$NOVITIUM PHARMA$Prachi Sharma.Acute suppression of the hypothalamo-pituitary-adrenal axis from a large singular dose of dexamethasone: A case report on a hypothesis for resistant intraoperative hypotension.Surgical Neurology International.05-JUL-2024;15(230):1-3$9$YR$C$F$Y$$$20240823$$HP$IN$IN
242408051$24240805$1$I$20230611$20240816$20240823$20240823$EXP$IT-MINISAL02-998771$IT-BIOGEN-2024BI01279283$BIOGEN$$50$YR$$M$Y$64$KG$20240823$$MD$IT$IT
242408061$24240806$1$I$20240814$20240814$20240823$20240823$EXP$$JP-ROCHE-10000060360$ROCHE$$68$YR$E$F$Y$$$20240823$$MD$JP$JP
242408081$24240808$1$I$$20240604$20240823$20240823$PER$$US-CELLTRION INC.-2024US013559$CELLTRION$$$$$$Y$$$20240823$$HP$US$US
242408092$24240809$2$F$20240403$20240904$20240823$20240910$EXP$$CO-TAKEDA-2024TUS036856$TAKEDA$$29$YR$$M$Y$72$KG$20240910$$CN$CO$CO
242408101$24240810$1$I$$20240821$20240823$20240823$PER$$US-HALEON-2193149$Haleon PLC$$$$$$Y$$$20240823$$CN$US$US
242408111$24240811$1$I$20240528$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012898$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242408121$24240812$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012756$ELI LILLY AND CO$$71$YR$E$$Y$$$20240823$$CN$US$US
242408131$24240813$1$I$20240126$20240815$20240823$20240823$EXP$$CA-TAKEDA-2021TUS001139$TAKEDA$$29$YR$$F$Y$$$20240823$$MD$CA$CA
242408151$24240815$1$I$20240702$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024133324$AMGEN$$76$YR$E$F$Y$$$20240822$$CN$US$US
242408161$24240816$1$I$20240128$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-082982-2024$RECKITT BENCKISER$$68$YR$$F$Y$$$20240823$$CN$US$US
242408181$24240818$1$I$20240817$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165906$AMGEN$$58$YR$A$F$Y$$$20240822$$PH$US$US
242408191$24240819$1$I$20240819$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165636$AMGEN$$76$YR$E$$Y$$$20240822$$CN$US$US
242408201$24240820$1$I$$20240819$20240823$20240823$EXP$$GB-SANDOZ INC.-SDZ2024GB074367$SANDOZ$$$$$F$Y$$$20240823$$CN$GB$GB
242408211$24240821$1$I$20240722$20240812$20240823$20240823$EXP$$FR-AUROBINDO-AUR-APL-2024-041115$AUROBINDO$$66$YR$$M$Y$$$20240823$$MD$FR$FR
242408221$24240822$1$I$20190401$20240812$20240823$20240823$EXP$$ES-AUROBINDO-AUR-APL-2020-016944$AUROBINDO$P?rez?Feal P, Pita da Veiga Seijo G, Moreiras?Arias N, Aliste?Santos C, Rodr?guez Granados MT. Systemic photosensitivity due to pregabalin. Photodermatology, Photoimmunology + Photomedicine. 2020;36 (4):313-315$56$YR$$M$Y$$$20240823$$MD$ES$ES
242408232$24240823$2$F$20240701$20240827$20240823$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013126$JAZZ$$12$YR$$M$Y$$$20240902$$CN$US$US
242408243$24240824$3$F$20240501$20240913$20240823$20240927$EXP$$US-Axsome Therapeutics, Inc.-AXS202408-001213$AXSOME THERAPEUTICS$$53$YR$A$F$Y$81$KG$20240927$$CN$US$
242408251$24240825$1$I$$20240813$20240823$20240823$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104764$VIIV$$$$$$Y$$$20240823$$HP$US$US
242408261$24240826$1$I$20230522$20240812$20240823$20240823$EXP$$IT-AUROBINDO-AUR-APL-2024-041315$AUROBINDO$$43$YR$$F$Y$$$20240823$$MD$IT$IT
242408281$24240828$1$I$20240806$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012865$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242408291$24240829$1$I$20221201$20240809$20240823$20240823$EXP$$US-UCBSA-2024040794$UCB$$50$YR$$F$Y$97.959$KG$20240823$$HP$US$US
242408301$24240830$1$I$$20240816$20240823$20240823$PER$$US-ABBVIE-5886509$ABBVIE$$$$$$Y$$$20240823$$MD$US$US
242408312$24240831$2$F$20240710$20240902$20240823$20240904$EXP$$JP-GSK-JP2024JPN086084$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$JP$JP
242408321$24240832$1$I$$20240821$20240823$20240823$EXP$$JP-TAKEDA-2024TJP012254$TAKEDA$$$$$F$Y$$$20240823$$CN$JP$JP
242408331$24240833$1$I$$20240813$20240823$20240823$EXP$$CA-APOTEX-2024AP009393$APOTEX$$85$YR$$F$Y$$$20240823$$CN$CA$CA
242408342$24240834$2$F$$20240904$20240823$20240913$EXP$$JP-AMGEN-JPNSP2024166115$AMGEN$$$$$$Y$$$20240912$$PH$JP$JP
242408351$24240835$1$I$20240818$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165873$AMGEN$$66$YR$E$M$Y$$$20240822$$CN$US$US
242408362$24240836$2$F$20240815$20240823$20240823$20240827$PER$$US-AMGEN-USASP2024166813$AMGEN$$67$YR$E$M$Y$$$20240826$$CN$US$US
242408371$24240837$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164911$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240822$$MD$US$US
242408392$24240839$2$F$$20240821$20240823$20240828$EXP$$GB-CELLTRION INC.-2024GB019996$CELLTRION$$$$$$Y$$$20240828$$HP$GB$GB
242408411$24240841$1$I$$20240819$20240823$20240823$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001678$BLUEPRINT MEDICINES$$$$$M$Y$$$20240823$$CN$US$US
242408422$24240842$2$F$$20240910$20240823$20240912$EXP$$US-BEIGENE-BGN-2024-013152$BEIGENE$$$$$$Y$$$20240912$$CN$US$US
242408431$24240843$1$I$$20240820$20240823$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013205$JAZZ$$$$$M$Y$$$20240822$$CN$US$US
242408442$24240844$2$F$$20240819$20240823$20240823$PER$$US-ROCHE-10000061370$ROCHE$$61$YR$A$M$Y$$$20240823$$CN$US$US
242408451$24240845$1$I$$20240813$20240823$20240823$EXP$$US-GSK-US2024100710$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242408461$24240846$1$I$$20240813$20240823$20240823$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104765$VIIV$$$$$$Y$$$20240823$$HP$US$US
242408471$24240847$1$I$$20240813$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408008962$ELI LILLY AND CO$$45$YR$A$$Y$$$20240823$$LW$US$US
242408482$24240848$2$F$$20240829$20240823$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017763$UNITED THERAPEUTICS$$$$$F$Y$78.458$KG$20240905$$$US$US
242408493$24240849$3$F$$20240913$20240823$20240923$EXP$$CA-GSK-CA2020AMR039681$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$HP$CA$CA
242408501$24240850$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013576$ELI LILLY AND CO$$$$$$Y$$$20240823$$CN$US$US
242408511$24240851$1$I$$20240819$20240823$20240823$EXP$$JP-AMGEN-JPNSP2024167178$AMGEN$$$$$$Y$$$20240822$$PH$JP$JP
242408521$24240852$1$I$$20240813$20240823$20240823$EXP$$TH-NOVITIUMPHARMA-2024THNVP01624$NOVITIUM PHARMA$Thitikan Wangapakul.Necrotizing Phenomenon in WHO Grade I Meningioma in an SLE Patient Following Immunosuppressive Treatment.Journal of Neurological Surgery Part B: Skull Base.05-FEB-2024;85(S01):1-4$29$YR$A$F$Y$$$20240823$$HP$TH$TH
242408531$24240853$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013522$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242408541$24240854$1$I$$20240813$20240823$20240823$EXP$$US-NOVOPROD-1271751$NOVO NORDISK$$$$$M$Y$$$20240823$$CN$US$US
242408551$24240855$1$I$20220101$20240813$20240823$20240823$EXP$$US-NOVOPROD-1270298$NOVO NORDISK$$59$YR$$M$Y$$$20240823$$CN$US$US
242408561$24240856$1$I$$20240813$20240823$20240823$EXP$$US-NOVOPROD-1271330$NOVO NORDISK$$64$YR$$M$Y$$$20240823$$MD$US$US
242408571$24240857$1$I$20240601$20240813$20240823$20240823$EXP$$US-NOVOPROD-1271785$NOVO NORDISK$$54$YR$$M$Y$$$20240823$$CN$US$US
242408582$24240858$2$F$20240815$20240821$20240823$20240829$PER$$US-AMGEN-USASP2024165570$AMGEN$$69$YR$E$F$Y$$$20240829$$CN$US$US
242408591$24240859$1$I$$20240820$20240823$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013183$JAZZ$$$$$F$Y$$$20240822$$CN$US$US
242408601$24240860$1$I$20240101$20240812$20240823$20240823$EXP$FR-AFSSAPS-AVLL2024000195$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111139$ZYDUS PHARM$$$$$$Y$$$20240822$$MD$FR$FR
242408611$24240861$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-100746-2023$RECKITT BENCKISER$$$$$F$Y$$$20240823$$CN$US$US
242408621$24240862$1$I$$20240812$20240823$20240823$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02973$AMNEAL$$$$$$Y$$$20240823$$CN$US$US
242408631$24240863$1$I$$20240813$20240823$20240823$EXP$$CA-NOVOPROD-1270585$NOVO NORDISK$$$$$F$Y$$$20240823$$MD$CA$CA
242408641$24240864$1$I$$20240813$20240823$20240823$EXP$$US-NOVOPROD-1270459$NOVO NORDISK$$53$YR$$M$Y$$$20240823$$MD$US$US
242408651$24240865$1$I$20240119$20240813$20240823$20240823$EXP$$US-NOVOPROD-1270656$NOVO NORDISK$$73$YR$$F$Y$$$20240823$$CN$US$US
242408661$24240866$1$I$20240501$20240813$20240823$20240823$EXP$$US-NOVOPROD-1270961$NOVO NORDISK$$63$YR$$F$Y$$$20240823$$CN$US$US
242408671$24240867$1$I$$20240813$20240823$20240823$EXP$$US-NOVOPROD-1270925$NOVO NORDISK$$50$YR$$F$Y$$$20240823$$MD$US$US
242408681$24240868$1$I$20240201$20240813$20240823$20240823$EXP$FR-AFSSAPS-TO2024001569$FR-NOVOPROD-1270432$NOVO NORDISK$$39$YR$$F$Y$90$KG$20240823$$MD$FR$FR
242408691$24240869$1$I$20240716$20240813$20240823$20240823$EXP$FR-AFSSAPS-NY2024000944$FR-NOVOPROD-1270433$NOVO NORDISK$$33$YR$$F$Y$106$KG$20240823$$PH$FR$FR
242408701$24240870$1$I$20130320$20240813$20240823$20240823$EXP$$US-NOVOPROD-1270342$NOVO NORDISK$$48$YR$$F$Y$$$20240823$$HP$US$US
242408711$24240871$1$I$20090401$20240813$20240823$20240823$EXP$$US-NOVOPROD-1270648$NOVO NORDISK$$58$YR$$M$Y$$$20240823$$CN$US$US
242408721$24240872$1$I$$20240813$20240823$20240823$EXP$$CO-NOVOPROD-1270543$NOVO NORDISK$$69$YR$$M$Y$$$20240823$$CN$CO$CO
242408731$24240873$1$I$20240708$20240815$20240823$20240823$EXP$CN-NMPA-5101851068800202400123$CN-NOVOPROD-1270779$NOVO NORDISK$$32$YR$$F$Y$55$KG$20240823$$HP$CN$CN
242408741$24240874$1$I$$20240814$20240823$20240823$EXP$$US-NOVOPROD-1270762$NOVO NORDISK$$$$$F$Y$$$20240823$$CN$US$US
242408751$24240875$1$I$20240813$20240814$20240823$20240823$EXP$$US-NOVOPROD-1269629$NOVO NORDISK$$$$$M$Y$$$20240823$$CN$US$US
242408761$24240876$1$I$$20240814$20240823$20240823$EXP$$IN-NOVOPROD-1270799$NOVO NORDISK$$648$MON$$$Y$$$20240823$$CN$IN$IN
242408801$24240880$1$I$20240101$20240814$20240823$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019906$UNITED THERAPEUTICS$$$$$F$Y$$$20240823$$$US$US
242408822$24240882$2$F$20200220$20240924$20240823$20240930$EXP$$US-TAKEDA-US202010093$TAKEDA$$57$YR$$F$Y$$$20240930$$HP$US$US
242408841$24240884$1$I$20230101$20240813$20240823$20240823$30DAY$$BR-NOVOPROD-1269666$NOVO NORDISK$$397$MON$$M$Y$$$20240823$$CN$BR$BR
242408851$24240885$1$I$$20240807$20240823$20240823$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR099006$VIIV$$$$$M$Y$$$20240823$$PH$US$US
242408861$24240886$1$I$$20240820$20240823$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013180$JAZZ$$$$$M$Y$$$20240822$$CN$US$US
242408872$24240887$2$F$$20240821$20240823$20240828$PER$$US-GILEAD-2024-0684973$GILEAD$$4$DEC$A$M$Y$$$20240828$$MD$US$US
242408882$24240888$2$F$$20240918$20240823$20240924$EXP$$JP-CHEPLA-2024010744$CHEPLAPHARM$$9$DEC$$M$Y$$$20240924$$MD$COUNTRY NOT SPECIFIED$JP
242408891$24240889$1$I$20240611$20240611$20240823$20240823$PER$$US-CELLTRION INC.-2024US014262$CELLTRION$$$$$$Y$$$20240823$$HP$US$US
242408901$24240890$1$I$$20240815$20240823$20240823$EXP$$JP-ROCHE-10000058986$ROCHE$Igawa Y, Yoshida T, Yoshinami Y, Hibino Y, Arima T, Sato J. Early combination with mycophenolate mofetil for immune-related hepatitis in patients with solid tumors treated with immune checkpoint inhibitors [Poster: 12133]. Journal of Clinical Oncology. 2024-Jun;42 (16):$$$$$Y$$$20240823$$HP$JP$JP
242408921$24240892$1$I$20240812$20240730$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004130$ACADIA PHARMACEUTICALS$$26$YR$$F$Y$$$20240823$$CN$US$US
242408931$24240893$1$I$20240529$20240605$20240823$20240823$PER$$US-CHIESI-2024CHF03395$CHIESI$$48$YR$$F$Y$$$20240823$$CN$US$US
242408941$24240894$1$I$$20240613$20240823$20240823$PER$$US-CHIESI-2024CHF03635$CHIESI$$8$YR$$M$Y$$$20240823$$HP$US$US
242408951$24240895$1$I$$20240816$20240823$20240823$PER$$US-AMGEN-USASP2024164987$AMGEN$$$$$M$Y$$$20240822$$HP$US$US
242408966$24240896$6$F$$20240925$20240823$20240927$EXP$$PT-ABBVIE-5885400$ABBVIE$$$$E$$Y$$$20240927$$HP$PT$PT
242408972$24240897$2$F$$20240820$20240823$20240829$30DAY$$US-GSK-US2024101276$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242408981$24240898$1$I$$20240822$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074675$SANDOZ$$64$YR$$F$Y$$$20240823$$CN$CA$CA
242408991$24240899$1$I$20240101$20240816$20240823$20240823$PER$$US-AMGEN-USASP2024163890$AMGEN$$64$YR$A$F$Y$$$20240822$$PH$US$US
242409002$24240900$2$F$$20240822$20240823$20240830$EXP$$US-BIOGEN-2024BI01278809$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
242409011$24240901$1$I$20240816$20240816$20240823$20240823$EXP$$US-BIOGEN-2024BI01279051$BIOGEN$$25$YR$$F$Y$$$20240823$$PH$US$US
242409021$24240902$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164867$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240822$$MD$US$US
242409032$24240903$2$F$$20240917$20240823$20240920$EXP$$US-TAKEDA-2023TUS066577$TAKEDA$$$$$M$Y$$$20240920$$MD$US$US
242409071$24240907$1$I$$20240405$20240823$20240823$EXP$$GB-UCBSA-2024016775$UCB$$$$$F$Y$$$20240823$$CN$GB$GB
242409081$24240908$1$I$20240809$20240809$20240823$20240823$EXP$$US-UCBSA-2024040789$UCB$$4$YR$$F$Y$16.3$KG$20240823$$MD$US$US
242409091$24240909$1$I$20240720$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012905$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242409102$24240910$2$F$$20240823$20240823$20240830$PER$$US-ROCHE-10000059229$ROCHE$Dana I, Austin E, Asrani F. Mucocutaneous ulcers in an immunocompromised patient. JAAD Case Reports. 2024-Sep;51:48-50. doi:10.1016/j.jdcr.2024.06.016.$49$YR$A$F$Y$$$20240830$$HP$US$US
242409111$24240911$1$I$20240819$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165679$AMGEN$$71$YR$E$M$Y$$$20240822$$CN$US$US
242409121$24240912$1$I$20240820$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012898$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240823$$CN$US$US
242409131$24240913$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012813$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240823$$CN$US$US
242409141$24240914$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013011$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240823$$HP$US$US
242409161$24240916$1$I$20240801$20240815$20240823$20240823$EXP$$US-BIOGEN-2024BI01278785$BIOGEN$$35$YR$$F$Y$$$20240823$$CN$US$US
242409171$24240917$1$I$20240613$20240719$20240823$20240823$PER$$US-CELLTRION INC.-2024US014745$CELLTRION$$$$$$Y$$$20240823$$CN$US$US
242409181$24240918$1$I$20240601$20240814$20240823$20240823$EXP$$US-VIIV HEALTHCARE LIMITED-US2024101245$VIIV$$$$$M$Y$$$20240823$$CN$US$US
242409191$24240919$1$I$$20240821$20240823$20240823$PER$$NVSC2024US170413$NOVARTIS$$55$YR$$M$Y$$$20240823$$HP$US$US
242409201$24240920$1$I$20240809$20240815$20240823$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025632$UNITED THERAPEUTICS$$80$YR$$M$Y$111.11$KG$20240823$$$US$US
242409211$24240921$1$I$20240702$20240816$20240823$20240823$EXP$$US-INTERCEPT-PM2024001648$INTERCEPT PHARMACEUTICALS$$69$YR$$F$Y$$$20240823$$CN$US$US
242409222$24240922$2$F$20230101$20240830$20240823$20240909$EXP$$US-INTERCEPT-PM2024001562$INTERCEPT PHARMACEUTICALS$$$$A$F$Y$$$20240909$$HP$US$US
242409231$24240923$1$I$$20240813$20240823$20240823$EXP$$US-KOANAAP-SML-US-2024-00852$Unknown Manufacturer$Heshama A, Kimb DD, Alshamrani YD, AlOtaibi FD, Hyppolito JD. The efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy in recurrent head and neck squamous cell carcinoma. Report of a case and review of the literature. Oral oncology. 2024 May 30;1-5. doi:10.1016/j.oraloncology.2024.106863.$66$YR$E$M$Y$$$20240823$$MD$US$US
242409241$24240924$1$I$$20240821$20240823$20240823$PER$$NVSC2024US170643$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242409251$24240925$1$I$$20240814$20240823$20240823$EXP$$US-INTERCEPT-PM2024001634$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242409264$24240926$4$F$20240801$20240827$20240823$20240830$EXP$$US-AMGEN-USASP2024168249$AMGEN$$70$YR$E$F$Y$$$20240830$$CN$US$US
242409281$24240928$1$I$$20240813$20240823$20240823$EXP$$GB-INTERCEPT-PM2022002217$INTERCEPT PHARMACEUTICALS$$$$A$F$Y$$$20240823$$HP$GB$GB
242409301$24240930$1$I$$20240808$20240823$20240823$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08092$LUPIN$$$$$$Y$$$20240823$$MD$US$US
242409311$24240931$1$I$$20240812$20240823$20240823$EXP$$DE-MSNLABS-2024MSNLIT01813$MSN LABORATORIES$Bingert R, Kolbe V, Boy D, Buttner A.Suicides of minors -retrospective 22-yearanalysis of the post-mortem and autopsyrecords of the Institute of Forensic MedicineRostock.Forensic Medicine.2023;33 (5):396-402$$$$$Y$$$20240823$$MD$DE$DE
242409321$24240932$1$I$20240620$20240807$20240823$20240823$PER$$US-CELLTRION INC.-2024US015421$CELLTRION$$$$$$Y$$$20240823$$HP$US$US
242409331$24240933$1$I$$20240812$20240823$20240823$EXP$$CA-INTERCEPT-PM2023000556$INTERCEPT PHARMACEUTICALS$$64$YR$$F$Y$$$20240823$$HP$CA$CA
242409341$24240934$1$I$20230901$20240821$20240823$20240823$EXP$$CA-ABBVIE-5890712$ABBVIE$$94$YR$$F$Y$$$20240823$$CN$CA$CA
242409361$24240936$1$I$$20240816$20240823$20240823$EXP$$US-CHEPLA-2024010684$CHEPLAPHARM$$57$YR$$M$Y$$$20240823$$MD$COUNTRY NOT SPECIFIED$US
242409381$24240938$1$I$$20240812$20240823$20240823$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104769$VIIV$$$$$$Y$$$20240823$$HP$US$US
242409391$24240939$1$I$20240724$20240817$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012900$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242409401$24240940$1$I$$20240808$20240823$20240823$PER$$US-JNJFOC-20240827782$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$CN$US$US
242409411$24240941$1$I$20230626$20240812$20240823$20240823$EXP$$PL-AUROBINDO-AUR-APL-2024-041098$AUROBINDO$$40$YR$$M$Y$75$KG$20240823$$MD$PL$PL
242409422$24240942$2$F$20240816$20240901$20240823$20240906$EXP$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000458$REVANCE THERAPEUTICS$$$$$$Y$$$20240906$$MD$US$US
242409431$24240943$1$I$$20240815$20240823$20240823$EXP$$US-BIOGEN-2024BI01278780$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
242409441$24240944$1$I$$20240816$20240823$20240823$PER$$US-BIOGEN-2024BI01279168$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
242409461$24240946$1$I$20240508$20240817$20240823$20240823$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-132950$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240823$$HP$CO$CO
242409471$24240947$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133559$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240823$$CN$US$US
242409481$24240948$1$I$20240819$20240820$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133555$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240823$$PH$US$US
242409491$24240949$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133597$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240823$$CN$US$US
242409501$24240950$1$I$$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133564$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240823$$CN$US$US
242409511$24240951$1$I$$20240820$20240823$20240823$EXP$$JP-JNJFOC-20240858887$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240823$$MD$JP$JP
242409521$24240952$1$I$$20240819$20240823$20240823$PER$$US-JNJFOC-20240847571$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
242409531$24240953$1$I$20240707$20240708$20240823$20240823$PER$$US-CELLTRION INC.-2024US016737$CELLTRION$$$$$$Y$$$20240823$$HP$US$US
242409543$24240954$3$F$$20240822$20240823$20240827$30DAY$$GB-JNJFOC-20240711197$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240827$$HP$GB$GB
242409551$24240955$1$I$20240815$20240815$20240823$20240823$EXP$$GB-ROCHE-10000058555$ROCHE$$28$YR$A$F$Y$$$20240823$$HP$GB$GB
242409562$24240956$2$F$20230101$20240910$20240823$20240916$EXP$$JP-EMD Serono-2024043878$EMD SERONO INC$$9$DEC$E$F$Y$$$20240916$$MD$JP$JP
242409571$24240957$1$I$$20240812$20240823$20240823$EXP$$US-APOTEX-2024AP009496$APOTEX$Shishkina I, Bradshaw D, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2023;142 (Suppl.1):6660-6661$56$YR$$F$Y$$$20240823$$HP$US$US
242409581$24240958$1$I$20240801$20240814$20240823$20240823$EXP$$CA-APOTEX-2024AP009450$APOTEX$$78$YR$E$M$Y$$$20240823$$PH$CA$CA
242409591$24240959$1$I$$20240822$20240823$20240823$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043017$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240823$$MD$US$US
242409601$24240960$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167668$AMGEN$$$$$$Y$$$20240822$$HP$US$US
242409611$24240961$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024AMR101222$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242409621$24240962$1$I$$20240814$20240823$20240823$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR102833$VIIV$$$$$M$Y$$$20240823$$PH$US$US
242409631$24240963$1$I$20240819$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133428$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240823$$CN$US$US
242409642$24240964$2$F$20240709$20240910$20240823$20240916$EXP$$JP-AMGEN-JPNSP2024163451$AMGEN$$76$YR$E$M$Y$$$20240916$$MD$JP$JP
242409651$24240965$1$I$20240701$20240820$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133293$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240823$$CN$US$US
242409663$24240966$3$F$20240610$20240830$20240823$20240903$EXP$FR-AFSSAPS-TO2024001608$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-133275$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$81$KG$20240903$$MD$FR$FR
242409681$24240968$1$I$$20240809$20240823$20240823$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-17912$ALKEM$Tunc A, Akbas AA, Bozkurt B, Oncel S.. Beyond conventional therapies: IVIG in treating severe fingolimod-rebound in a postpartum patient with MS. BMJ Case Rep. 2024;17(7):e259932$4$DEC$$F$Y$$$20240823$$HP$TR$TR
242409691$24240969$1$I$$20240809$20240823$20240823$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14655$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$23$YR$$M$Y$$$20240823$$HP$DE$DE
242409701$24240970$1$I$$20240809$20240823$20240823$EXP$$TW-ALKEM LABORATORIES LIMITED-TW-ALKEM-2024-18935$ALKEM$Chen PY, Lin PY, Tien SC, Chang YY, Lee Y.. Duloxetine-related tardive dystonia and tardive dyskinesia: a case report. Gen Hosp Psychiatry. 2010;32(6):646.e9-646.e11$$$$$Y$$$20240823$$HP$TW$TW
242409711$24240971$1$I$$20240809$20240823$20240823$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-17951$ALKEM$Scorza CA, Scorza FA, Finsterer J. Daytime bruxism, tardive orofacial dyskinesia, and dysphagia as side effects to duloxetine use over nine years in an octogenarian. Clinics. 2024;79:100438$83$YR$$F$Y$69$KG$20240823$$HP$BR$BR
242409721$24240972$1$I$20221215$20240809$20240823$20240823$EXP$GB-MHRA-MED-202309131553585350-RLQSD$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18742$ALKEM$$38$YR$$F$Y$$$20240823$$CN$GB$GB
242409731$24240973$1$I$$20240809$20240823$20240823$EXP$$TN-ALKEM LABORATORIES LIMITED-TN-ALKEM-2024-19013$ALKEM$Mensi A, Trad N, Mansouri R, Ayed W, Mabrouk EB, Said Y, Debbeche R.. Chronic myeloid leukemia in an ulcerative colitis patient receiving azathioprine: A case report. International Journal of Clinical Pharmacology and Therapeutics. 2024;62(9):423-426$51$YR$$M$Y$$$20240823$$HP$TN$TN
242409742$24240974$2$F$$20240821$20240823$20240904$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18932$ALKEM$Cierny M, Feemster J, Hamid M, Battistini HA.. Status cataplecticus induced by an abrupt duloxetine withdrawal-a case report. Clinical Neuropharmacology. 2023;46(5):198-199$77$YR$$F$Y$$$20240904$$MD$US$US
242409751$24240975$1$I$$20240809$20240823$20240823$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2024-19082$ALKEM$Tordjman K, Rosenthal T, Bursztyn M.. Nifedipine induced periorbital edema. Am J Cardiol. 1985;55:1445$58$YR$$F$Y$$$20240823$$HP$IL$IL
242409761$24240976$1$I$$20240809$20240823$20240823$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2024-19081$ALKEM$Tordjman K, Rosenthal T, Bursztyn M. Nifedipine induced periorbital edema. Am J Cardiol. 1985;55:1445$55$YR$$F$Y$$$20240823$$HP$IL$IL
242409781$24240978$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013454$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240823$$CN$US$US
242409791$24240979$1$I$$20240812$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408008648$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240823$$CN$US$US
242409801$24240980$1$I$$20240821$20240823$20240823$PER$$US-ABBVIE-5891070$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242409812$24240981$2$F$20240801$20240827$20240823$20240902$EXP$$US-MSNLABS-2024MSNSPO01809$MSN LABORATORIES$$$$$$Y$$$20240902$$CN$US$US
242409821$24240982$1$I$20240815$20240816$20240823$20240823$PER$$US-AMGEN-USASP2024164854$AMGEN$$68$YR$E$M$Y$$$20240822$$CN$US$US
242409832$24240983$2$F$$20240826$20240823$20240827$PER$$NVSC2024US170655$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242409842$24240984$2$F$$20240903$20240823$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004174$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
242409851$24240985$1$I$20240812$20240814$20240823$20240823$PER$$US-ABBVIE-5881465$ABBVIE$$74$YR$$M$Y$46$KG$20240823$$CN$US$US
242409861$24240986$1$I$$20240820$20240823$20240823$EXP$$US-ABBVIE-5786317$ABBVIE$Silverman AL, Sushil M, Bhasuran B, Ludwig D, Buchanan J, Racz R, et al. Algorithmic identification of treatment emergent adverse events from clinical notes using large language models: a pilot study in inflammatory bowel disease. Clin Pharma and Therapeutics. 2024;115(6):1391-1399.; Silverman AL, Sushil M, Bhasuran B, Ludwig D, Buchanan J, Racz R, et al. Algorithmic identification of treatment emergent adverse events from clinical notes using large language models: a pilot study in inflammat...$$$$F$Y$$$20240823$$HP$US$US
242409871$24240987$1$I$20240801$20240812$20240823$20240823$EXP$$ES-AUROBINDO-AUR-APL-2024-041161$AUROBINDO$$67$YR$$M$Y$$$20240823$$MD$ES$ES
242409881$24240988$1$I$20240713$20240813$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129041$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240823$$CN$US$US
242409891$24240989$1$I$$20240812$20240823$20240823$EXP$$NL-AUROBINDO-AUR-APL-2024-041048$AUROBINDO$$28$YR$$M$Y$88$KG$20240823$$CN$NL$NL
242409901$24240990$1$I$20240813$20240814$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129051$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$37.86$KG$20240823$$PH$US$US
242409911$24240991$1$I$20240806$20240814$20240823$20240823$EXP$$CN-ROCHE-10000057992$ROCHE$$48$YR$A$F$Y$$$20240823$$CN$CN$CN
242409922$24240992$2$F$$20240913$20240823$20240919$PER$$US-JNJFOC-20240847011$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$CN$US$US
242409931$24240993$1$I$20240730$20240819$20240823$20240823$PER$$US-JNJFOC-20240848178$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240823$$CN$US$US
242409941$24240994$1$I$20240417$20240418$20240823$20240823$PER$$US-JNJFOC-20240857171$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$MD$US$US
242409951$24240995$1$I$20240807$20240816$20240823$20240823$EXP$$US-CHIESI-2024CHF05257$CHIESI$$49$YR$$F$Y$58$KG$20240823$$CN$US$US
242409961$24240996$1$I$$20240801$20240823$20240823$PER$$US-CELLTRION INC.-2024US016809$CELLTRION$$$$$$Y$$$20240823$$CN$US$US
242409971$24240997$1$I$$20240822$20240823$20240823$PER$$US-HALEON-2193259$Haleon PLC$$$$$$Y$$$20240823$$CN$US$US
242409981$24240998$1$I$$20240808$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127136$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240823$$PH$US$US
242409991$24240999$1$I$20240701$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004173$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240823$$CN$US$US
242410002$24241000$2$F$$20240921$20240823$20240925$PER$$US-AMGEN-USASP2024167424$AMGEN$$27$YR$A$F$Y$$$20240925$$HP$US$US
242410011$24241001$1$I$20240404$20240418$20240823$20240823$PER$$US-JNJFOC-20240857248$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$MD$US$US
242410021$24241002$1$I$20200101$20240816$20240823$20240823$PER$$US-JNJFOC-20240846626$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$HP$US$US
242410042$24241004$2$F$20240917$20240917$20240823$20240919$EXP$$CA-TAKEDA-2024TUS084397$TAKEDA$$62$YR$$M$Y$$$20240919$$CN$CA$CA
242410051$24241005$1$I$$20240820$20240823$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013193$JAZZ$$$$$M$Y$$$20240822$$CN$US$US
242410061$24241006$1$I$20230925$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-134657-2023$RECKITT BENCKISER$$32$YR$$F$Y$$$20240823$$CN$US$US
242410071$24241007$1$I$20010101$20190724$20240823$20240823$EXP$$MX-TOPROL-2019000712$Unknown Manufacturer$$$$$$Y$$$20240823$$CN$MX$MX
242410082$24241008$2$F$$20240827$20240823$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004175$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
242410092$24241009$2$F$20230301$20240815$20240823$20240827$EXP$$BG-BRISTOL-MYERS SQUIBB COMPANY-2024-130569$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240827$$MD$BG$BG
242410101$24241010$1$I$20240808$20240814$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129476$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240823$$HP$US$US
242410121$24241012$1$I$$20240819$20240823$20240823$PER$$US-BIOGEN-2024BI01279036$BIOGEN$$$$$F$Y$$$20240823$$MD$US$US
242410132$24241013$2$F$$20240906$20240823$20240909$PER$$NVSC2024US170651$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
242410151$24241015$1$I$$20240821$20240823$20240823$PER$$NVSC2024US170470$NOVARTIS$$38$YR$$F$Y$$$20240823$$CN$US$US
242410161$24241016$1$I$20240101$20240801$20240823$20240823$PER$$US-009507513-2408USA000390$MERCK$$60$YR$$F$Y$$$20240823$$CN$US$US
242410171$24241017$1$I$$20240820$20240823$20240823$EXP$$JP-JNJFOC-20240855741$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$MD$JP$JP
242410182$24241018$2$F$$20240923$20240823$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129778$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240927$$MD$US$US
242410192$24241019$2$F$20240821$20240827$20240823$20240829$PER$$US-AMGEN-USASP2024167904$AMGEN$$69$YR$E$F$Y$$$20240829$$CN$US$US
242410201$24241020$1$I$20240812$20240821$20240823$20240823$EXP$$US-UCBSA-2024042510$UCB$$46$YR$$F$Y$$$20240823$$CN$US$US
242410211$24241021$1$I$$20240815$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129935$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$49.44$KG$20240823$$CN$US$US
242410231$24241023$1$I$$20240819$20240823$20240823$EXP$$CA-TAKEDA-2023TUS101241$TAKEDA$$$$$M$Y$$$20240823$$CN$CA$CA
242410241$24241024$1$I$$20240814$20240823$20240823$EXP$$AU-CELLTRION INC.-2024AU012095$CELLTRION$$$$$$Y$$$20240823$$MD$AU$AU
242410261$24241026$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011729$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240823$$CN$US$US
242410271$24241027$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013573$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240823$$CN$US$US
242410281$24241028$1$I$$20240807$20240823$20240823$PER$$US-TEVA-VS-3232300$TEVA$$45$YR$$F$Y$$$20240823$$CN$US$US
242410291$24241029$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013537$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240823$$MD$US$US
242410301$24241030$1$I$20211129$20240814$20240823$20240823$EXP$$CA-APOTEX-2024AP009464$APOTEX$$85$YR$E$M$Y$$$20240823$$PH$CA$CA
242410311$24241031$1$I$20240101$20240814$20240823$20240823$PER$$US-ABBVIE-5881310$ABBVIE$$$$A$F$Y$$$20240823$$CN$US$US
242410321$24241032$1$I$$20240821$20240823$20240823$PER$$US-ROCHE-10000063393$ROCHE$$55$YR$A$F$Y$$$20240823$$MD$US$US
242410331$24241033$1$I$$20240819$20240823$20240823$PER$$US-ALXN-202408USA001144US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
242410341$24241034$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004176$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242410351$24241035$1$I$$20240813$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128614$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240823$$CN$US$US
242410361$24241036$1$I$$20240819$20240823$20240823$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-001830$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$64.3$KG$20240823$$MD$JP$JP
242410391$24241039$1$I$$20240820$20240823$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013189$JAZZ$$$$$M$Y$$$20240823$$HP$US$US
242410402$24241040$2$F$20240822$20240822$20240823$20240829$PER$$US-AMGEN-USASP2024168150$AMGEN$$$$$F$Y$$$20240829$$HP$US$US
242410411$24241041$1$I$$20240710$20240823$20240823$EXP$$PH-MDD US Operations-E2B_00006421$MDD OPERATIONS$$$$A$$Y$$$20240823$$MD$PH$PH
242410422$24241042$2$F$$20240911$20240823$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004178$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
242410441$24241044$1$I$20240523$20240820$20240823$20240823$EXP$$CO-UCBSA-2024042723$UCB$$69$YR$$M$Y$$$20240823$$CN$CO$CO
242410451$24241045$1$I$$20240731$20240823$20240823$PER$$AU-TOLMAR, INC.-24AU051566$TOLMAR$$$$$M$Y$$$20240823$$CN$AU$AU
242410461$24241046$1$I$$20240731$20240823$20240823$PER$$AU-TOLMAR, INC.-24AU051564$TOLMAR$$$$$M$Y$$$20240823$$CN$AU$AU
242410471$24241047$1$I$$20240802$20240823$20240823$PER$$AU-TOLMAR, INC.-24AU051596$TOLMAR$$$$$M$Y$$$20240823$$CN$AU$AU
242410481$24241048$1$I$$20240801$20240823$20240823$PER$$BR-TOLMAR, INC.-24BR051672$TOLMAR$$$$$F$Y$$$20240823$$CN$BR$BR
242410491$24241049$1$I$20240813$20240814$20240823$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025647$UNITED THERAPEUTICS$$55$YR$$M$Y$61.678$KG$20240823$$$US$US
242410501$24241050$1$I$20240712$20240801$20240823$20240823$PER$$BR-TOLMAR, INC.-24BR051664$TOLMAR$$7$YR$$F$Y$$$20240823$$PH$BR$BR
242410511$24241051$1$I$$20240802$20240823$20240823$PER$$BR-TOLMAR, INC.-24BR051710$TOLMAR$$$$$F$Y$$$20240823$$CN$BR$BR
242410522$24241052$2$F$20240717$20240828$20240823$20240917$PER$$US-TOLMAR, INC.-24US051121$TOLMAR$$85$YR$$M$Y$$$20240917$$HP$US$US
242410531$24241053$1$I$20240801$20240801$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA047214$TOLMAR$$67$YR$$M$Y$$$20240823$$CN$CA$CA
242410541$24241054$1$I$$20240802$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA049022$TOLMAR$$$$$M$Y$$$20240823$$CN$CA$CA
242410551$24241055$1$I$20240422$20240813$20240823$20240823$EXP$$FR-AUROBINDO-AUR-APL-2024-041382$AUROBINDO$$14$YR$$F$Y$60$KG$20240823$$MD$FR$FR
242410562$24241056$2$F$20240723$20240905$20240823$20240926$PER$$US-TOLMAR, INC.-24US051269$TOLMAR$$75$YR$$M$Y$$$20240926$$PH$US$US
242410572$24241057$2$F$20240722$20240904$20240823$20240926$PER$$US-TOLMAR, INC.-24US051263$TOLMAR$$80$YR$$M$Y$$$20240926$$PH$US$US
242410581$24241058$1$I$$20240801$20240823$20240823$PER$$US-TOLMAR, INC.-24US051200$TOLMAR$$$$$M$Y$$$20240823$$HP$US$US
242410591$24241059$1$I$20240627$20240731$20240823$20240823$PER$$US-TOLMAR, INC.-24US051465$TOLMAR$$68$YR$$M$Y$$$20240823$$HP$US$US
242410602$24241060$2$F$20240723$20240905$20240823$20240926$PER$$US-TOLMAR, INC.-24US051300$TOLMAR$$$$$M$Y$$$20240926$$HP$US$US
242410612$24241061$2$F$20240730$20240913$20240823$20240930$PER$$US-TOLMAR, INC.-24US051500$TOLMAR$$79$YR$$M$Y$$$20240927$$HP$US$US
242410622$24241062$2$F$20240731$20240912$20240823$20240930$PER$$US-TOLMAR, INC.-24US051511$TOLMAR$$57$YR$$M$Y$$$20240927$$PH$US$US
242410632$24241063$2$F$20240730$20240911$20240823$20240930$PER$$US-TOLMAR, INC.-24US051464$TOLMAR$$95$YR$$M$Y$$$20240927$$HP$US$US
242410642$24241064$2$F$20240730$20240911$20240823$20240930$PER$$US-TOLMAR, INC.-24US051486$TOLMAR$$80$YR$$M$Y$$$20240927$$HP$US$US
242410651$24241065$1$I$$20240801$20240823$20240823$PER$$US-TOLMAR, INC.-24US051559$TOLMAR$$$$$M$Y$78.884$KG$20240823$$HP$US$US
242410662$24241066$2$F$20240726$20240912$20240823$20240930$PER$$US-TOLMAR, INC.-24US051562$TOLMAR$$79$YR$$M$Y$$$20240927$$HP$US$US
242410671$24241067$1$I$20240101$20240819$20240823$20240823$PER$$US-ABBVIE-5889427$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242410681$24241068$1$I$$20240820$20240823$20240823$EXP$$US-ABBVIE-5888844$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242410701$24241070$1$I$20240819$20240820$20240823$20240823$PER$$NVSC2024US170302$NOVARTIS$$$$$$Y$$$20240823$$MD$US$US
242410711$24241071$1$I$$20240821$20240823$20240823$PER$$NVSC2024US170336$NOVARTIS$$$$$F$Y$$$20240823$$HP$US$US
242410722$24241072$2$F$$20240822$20240823$20240823$PER$$NVSC2024US170683$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242410731$24241073$1$I$20240704$20240820$20240823$20240823$EXP$$US-ABBVIE-5888496$ABBVIE$$77$YR$$F$Y$$$20240823$$CN$US$US
242410741$24241074$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004220$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
242410752$24241075$2$F$20240701$20240805$20240823$20240924$PER$$US-TEVA-VS-3230132$TEVA$$57$YR$$M$Y$99.79$KG$20240924$$CN$US$US
242410761$24241076$1$I$$20240814$20240823$20240823$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006045$BIOCON$$$$$$Y$$$20240823$$CN$CA$CA
242410771$24241077$1$I$$20240819$20240823$20240823$PER$$US-ALXN-202408USA001244US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242410782$24241078$2$F$$20240909$20240823$20240919$EXP$$CA-APOTEX-2024AP009247$APOTEX$$44$YR$$F$Y$97$KG$20240919$$HP$CA$CA
242410801$24241080$1$I$20240627$20240717$20240823$20240823$PER$$US-CELLTRION INC.-2024US017109$CELLTRION$$$$$$Y$$$20240823$$HP$US$US
242410811$24241081$1$I$$20240822$20240823$20240823$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047373$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240823$$MD$US$US
242410821$24241082$1$I$20240801$20240816$20240823$20240823$EXP$$US-ABBVIE-5885003$ABBVIE$$40$YR$$F$Y$$$20240823$$CN$US$US
242410831$24241083$1$I$$20240819$20240823$20240823$EXP$$US-ABBVIE-5886019$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242410841$24241084$1$I$$20240816$20240823$20240823$EXP$$US-ABBVIE-5886845$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242410851$24241085$1$I$$20240821$20240823$20240823$EXP$$AU-SANDOZ INC.-SDZ2024AU074298$SANDOZ$$4$DEC$$M$Y$$$20240823$$HP$AU$AU
242410873$24241087$3$F$20240722$20240918$20240823$20240924$30DAY$$US-AMGEN-USASP2024163171$AMGEN$$50$YR$A$F$Y$74.8$KG$20240924$$HP$US$US
242410881$24241088$1$I$$20240814$20240823$20240823$PER$$US-EMD Serono-2024044028$EMD SERONO INC$$38$YR$A$F$Y$$$20240823$$MD$US$US
242410891$24241089$1$I$20240819$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167079$AMGEN$$73$YR$E$F$Y$$$20240823$$CN$US$US
242410901$24241090$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024166340$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242410911$24241091$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133306$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240823$$CN$US$US
242410921$24241092$1$I$20240501$20240814$20240823$20240823$EXP$FR-AFSSAPS-TS2024000891$FR-TEVA-VS-3233902$TEVA$$72$YR$$M$Y$64$KG$20240823$$MD$FR$FR
242410931$24241093$1$I$20240622$20240711$20240823$20240823$PER$$US-CELLTRION INC.-2024US017177$CELLTRION$$$$$$Y$$$20240823$$CN$US$US
242410941$24241094$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012924$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242410951$24241095$1$I$20240820$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013425$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240823$$CN$US$US
242410961$24241096$1$I$$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014406$ELI LILLY AND CO$$87$YR$E$$Y$$$20240823$$CN$US$US
242410971$24241097$1$I$20240801$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012840$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240823$$CN$US$US
242410981$24241098$1$I$20240820$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012675$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240823$$CN$US$US
242410993$24241099$3$F$$20240905$20240823$20240912$EXP$$JP-JNJFOC-20240855975$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240912$$MD$JP$JP
242411003$24241100$3$F$20240817$20240909$20240823$20240920$EXP$$BR-JNJFOC-20240851663$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240920$$PH$BR$BR
242411012$24241101$2$F$20240101$20240912$20240823$20240919$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000722$DECIPHERA PHARMACEUTICALS$$70$YR$E$F$Y$49.887$KG$20240919$$CN$US$US
242411021$24241102$1$I$$20240821$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074573$SANDOZ$$80$YR$$F$Y$$$20240823$$MD$CA$CA
242411032$24241103$2$F$$20240904$20240823$20240909$EXP$$JP-TAKEDA-2024TJP012258$TAKEDA$$8$DEC$$M$Y$$$20240909$$PH$JP$JP
242411041$24241104$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133290$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240823$$MD$US$US
242411051$24241105$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170686$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242411061$24241106$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165060$AMGEN$$$$$M$Y$$$20240823$$CN$US$US
242411071$24241107$1$I$20240816$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166746$AMGEN$$76$YR$E$F$Y$$$20240823$$CN$US$US
242411082$24241108$2$F$20240101$20240820$20240823$20240828$PER$$US-AMGEN-USASP2024166593$AMGEN$$75$YR$E$M$Y$$$20240828$$CN$US$US
242411091$24241109$1$I$$20240819$20240823$20240823$EXP$$US-UCBSA-2024042685$UCB$$$$$M$Y$$$20240823$$CN$US$US
242411101$24241110$1$I$$20240820$20240823$20240823$EXP$$CA-ROCHE-10000061566$ROCHE$$73$YR$E$F$Y$93$KG$20240823$$PH$CA$CA
242411111$24241111$1$I$$20240814$20240823$20240823$EXP$$CA-APOTEX-2024AP009416$APOTEX$$72$YR$$F$Y$$$20240823$$HP$CA$CA
242411122$24241112$2$F$20240701$20240814$20240823$20240829$30DAY$$US-GSK-US2024101378$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240829$$CN$US$US
242411131$24241113$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024100818$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242411141$24241114$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024100787$GLAXOSMITHKLINE$$$$$M$Y$$$20240823$$HP$US$US
242411151$24241115$1$I$$20240822$20240823$20240823$EXP$$NVSC2024US170450$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242411161$24241116$1$I$20240813$20240816$20240823$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025798$UNITED THERAPEUTICS$$75$YR$$F$Y$58.957$KG$20240823$$$US$US
242411171$24241117$1$I$20240731$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004222$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240823$$CN$US$US
242411181$24241118$1$I$$20240814$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129307$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240823$$CN$US$US
242411192$24241119$2$F$20240821$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133297$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240823$$HP$US$US
242411201$24241120$1$I$$20240820$20240823$20240823$EXP$$US-SANDOZ INC.-SDZ2024US074382$SANDOZ$$76$YR$$F$Y$$$20240823$$MD$US$US
242411211$24241121$1$I$20240701$20240820$20240823$20240823$PER$$US-BIOVITRUM-2024-US-011190$BIOVITRUM$$62$YR$$F$Y$$$20240823$$CN$US$US
242411221$24241122$1$I$$20240812$20240823$20240823$EXP$$US-APOTEX-2024AP009497$APOTEX$Shishkina I, Bradshaw D, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2023;142 (Suppl.1):6660-6661$56$YR$$M$Y$$$20240823$$HP$US$US
242411231$24241123$1$I$20240814$20240816$20240823$20240823$PER$$US-ABBVIE-5889414$ABBVIE$$55$YR$$F$Y$$$20240823$$CN$US$US
242411241$24241124$1$I$$20240819$20240823$20240823$EXP$$JP-JNJFOC-20240855979$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240823$$MD$JP$JP
242411251$24241125$1$I$$20240820$20240823$20240823$PER$$US-BIOVITRUM-2024-US-011195$BIOVITRUM$$$$I$F$Y$4.2$KG$20240823$$CN$US$US
242411261$24241126$1$I$20240731$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004223$ACADIA PHARMACEUTICALS$$53$YR$$F$Y$$$20240823$$HP$US$US
242411271$24241127$1$I$20220201$20240821$20240823$20240823$EXP$$NVSC2024US169719$NOVARTIS$$$$$$Y$$$20240823$$CN$US$US
242411282$24241128$2$F$20240715$20240925$20240823$20240927$EXP$$JP-TAKEDA-2024TJP010613$TAKEDA$$8$DEC$$F$Y$$$20240927$$MD$JP$JP
242411291$24241129$1$I$$20240816$20240823$20240823$EXP$$US-EMD Serono-2024044606$EMD SERONO INC$$$$A$M$Y$$$20240823$$HP$US$US
242411301$24241130$1$I$20240701$20240809$20240823$20240823$EXP$$US-UCBSA-2024040947$UCB$$62$YR$$F$Y$$$20240823$$HP$US$US
242411311$24241131$1$I$20220922$20240820$20240823$20240823$EXP$$CO-UCBSA-2024042721$UCB$$33$YR$$F$Y$$$20240823$$CN$CO$CO
242411322$24241132$2$F$20240726$20240823$20240823$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004225$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240916$$CN$US$US
242411334$24241133$4$F$$20240923$20240823$20240927$EXP$$US-ROCHE-10000063289$ROCHE$$84$YR$E$M$Y$$$20240927$$CN$US$US
242411341$24241134$1$I$$20240727$20240823$20240823$PER$$AU-TOLMAR, INC.-24AU051391$TOLMAR$$$$$M$Y$$$20240823$$CN$AU$AU
242411351$24241135$1$I$$20240727$20240823$20240823$PER$$AU-TOLMAR, INC.-24AU051449$TOLMAR$$$$$M$Y$$$20240823$$CN$AU$AU
242411361$24241136$1$I$$20240727$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051354$TOLMAR$$$$$M$Y$$$20240823$$CN$CA$CA
242411371$24241137$1$I$20240727$20240727$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051355$TOLMAR$$73$YR$$M$Y$$$20240823$$CN$CA$CA
242411381$24241138$1$I$20240727$20240727$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051356$TOLMAR$$76$YR$$M$Y$$$20240823$$CN$CA$CA
242411391$24241139$1$I$$20240815$20240823$20240823$PER$$US-ALXN-202408USA001021US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$MD$US$US
242411401$24241140$1$I$$20240816$20240823$20240823$PER$$US-ALXN-202408USA001007US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
242411411$24241141$1$I$$20240819$20240823$20240823$PER$$US-ALXN-202408USA001196US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$HP$US$US
242411421$24241142$1$I$$20240820$20240823$20240823$PER$$US-ABBVIE-5889947$ABBVIE$$$$$$Y$$$20240823$$CN$US$US
242411431$24241143$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133395$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240823$$HP$US$US
242411441$24241144$1$I$20240101$20240809$20240823$20240823$EXP$$US-UCBSA-2024022081$UCB$$$$$F$Y$$$20240823$$CN$US$US
242411452$24241145$2$F$$20240826$20240823$20240827$PER$$US-JNJFOC-20240848189$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$MD$US$US
242411462$24241146$2$F$$20240909$20240823$20240917$EXP$$US-JNJFOC-20240848513$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240917$$CN$US$US
242411471$24241147$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013614$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240823$$CN$US$US
242411481$24241148$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013523$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240823$$CN$US$US
242411492$24241149$2$F$20240819$20240820$20240823$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408012266$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240828$$CN$US$US
242411501$24241150$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013356$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240823$$CN$US$US
242411511$24241151$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012417$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242411521$24241152$1$I$$20240819$20240823$20240823$EXP$$US-SANDOZ INC.-SDZ2024US073915$SANDOZ$$$$$F$Y$$$20240823$$CN$US$US
242411531$24241153$1$I$$20240820$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074432$SANDOZ$$74$YR$$F$Y$63.946$KG$20240823$$CN$CA$CA
242411541$24241154$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-083014-2024$RECKITT BENCKISER$$$$$F$Y$$$20240823$$CN$US$US
242411552$24241155$2$F$$20240829$20240823$20240905$PER$$US-AMGEN-USASP2024166222$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242411561$24241156$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167798$AMGEN$$52$YR$A$F$Y$$$20240823$$MD$US$US
242411572$24241157$2$F$20240815$20240826$20240823$20240830$30DAY$$US-AMGEN-USASP2024165154$AMGEN$$73$YR$E$F$Y$94.7$KG$20240829$$PH$US$US
242411581$24241158$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004316$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242411601$24241160$1$I$$20240819$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132908$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240823$$CN$US$US
242411611$24241161$1$I$20240321$20240820$20240823$20240823$EXP$GB-MHRA-MED-202408201640550890-VNPGS$GB-ABBVIE-5889413$ABBVIE$$38$YR$$$Y$$$20240823$$CN$GB$GB
242411621$24241162$1$I$$20240820$20240823$20240823$EXP$$US-ABBVIE-5888582$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242411631$24241163$1$I$$20240809$20240823$20240823$EXP$$BR-CIPLA LTD.-2024BR08997$CIPLA$Lima K, Santos LAO, Barbosa H SM, Melo AL, Silva APS, Diniz MV.. Megakaryoblastic Acute Myeloid Leukemia Associated with a Testicular Tumour in a Young Adult: A Case Report.. NA. 2024;26 (1):57 to 59$$$$$Y$$$20240823$$HP$BR$BR
242411641$24241164$1$I$$20240813$20240823$20240823$EXP$$NVSC2024CA168378$NOVARTIS$$40$YR$$F$Y$73$KG$20240823$$MD$CA$CA
242411651$24241165$1$I$$20240819$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074193$SANDOZ$$$$$M$Y$$$20240823$$CN$CA$CA
242411661$24241166$1$I$$20240812$20240823$20240823$EXP$GB-MHRA-MED-202408121500517630-NJZBD$GB-GLENMARK PHARMACEUTICALS-2024GMK093351$GLENMARK$$$$$$Y$$$20240823$$HP$GB$GB
242411672$24241167$2$F$20240701$20240823$20240823$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07486$LUPIN$$$$$$Y$$$20240910$$CN$US$US
242411681$24241168$1$I$$20240814$20240823$20240823$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006024$BIOCON$$$$$$Y$$$20240823$$CN$CA$CA
242411691$24241169$1$I$20240702$20240822$20240823$20240823$EXP$$US-TAKEDA-2024TUS057536$TAKEDA$$60$YR$$M$Y$$$20240823$$CN$US$US
242411711$24241171$1$I$$20240801$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-123712$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$78$KG$20240823$$PH$US$US
242411721$24241172$1$I$$20240807$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126493$BRISTOL MYERS SQUIBB$$30$YR$A$M$Y$$$20240823$$HP$US$US
242411731$24241173$1$I$20240819$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133154$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240823$$HP$US$US
242411742$24241174$2$F$20240801$20240918$20240823$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133216$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$114.76$KG$20240923$$CN$US$US
242411751$24241175$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004236$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242411761$24241176$1$I$$20240724$20240823$20240823$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07526$LUPIN$$$$$$Y$$$20240823$$CN$US$US
242411772$24241177$2$F$20220101$20240828$20240823$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-040238$AUROBINDO$Fidan I, Delamotte E, Colombier ML, Agossa K... Non-surgical Treatment of Severe Drug-Influenced Gingival Enlargement: A Report of Two Cases. Cureus. 2024;16(6):e63214$46$YR$$M$Y$80$KG$20240906$$HP$FR$FR
242411781$24241178$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024100826$GLAXOSMITHKLINE$$$$$M$Y$$$20240823$$CN$US$US
242411791$24241179$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024AMR101867$GLAXOSMITHKLINE$$$$$M$Y$$$20240823$$CN$US$US
242411801$24241180$1$I$20220915$20240815$20240823$20240823$EXP$$ES-EMD Serono-2024044208$EMD SERONO INC$$63$YR$A$F$Y$90$KG$20240823$$MD$ES$ES
242411812$24241181$2$F$20240801$20240820$20240823$20240827$PER$$US-AMGEN-USASP2024167577$AMGEN$$66$YR$E$M$Y$$$20240827$$HP$US$US
242411823$24241182$3$F$$20240829$20240823$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004234$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
242411831$24241183$1$I$20240719$20240820$20240823$20240823$EXP$$CN-ROCHE-10000062364$ROCHE$$37$YR$A$F$Y$61$KG$20240823$$HP$CN$CN
242411851$24241185$1$I$20240101$20240808$20240823$20240823$EXP$$US-UCBSA-2024037705$UCB$$32$YR$$F$Y$$$20240823$$HP$US$US
242411862$24241186$2$F$$20240826$20240823$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07437$LUPIN$$$$$$Y$$$20240913$$CN$US$US
242411871$24241187$1$I$$20240731$20240823$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004335$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242411881$24241188$1$I$$20240814$20240823$20240823$EXP$$SG-ROCHE-10000057910$ROCHE$$62$YR$A$F$Y$$$20240823$$CN$SG$SG
242411901$24241190$1$I$$20240813$20240823$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-041481$AUROBINDO$$73$YR$$M$Y$$$20240823$$MD$CA$CA
242411911$24241191$1$I$$20240814$20240823$20240823$EXP$$US-RDY-SPO/USA/24/0012149$DR REDDYS$Kim YJ, Li Z, Maiti A, Tanaka T, Uryu H, Furudate K, et al. Single-cell proteogenomics analysis of AML samples treated with decitabine and venetoclax reveals divergent treatment escape mechanisms. Cancer Research. 2024 Mar;84(6): doi:10.1158/1538-7445.AM2024-3400.$$$$$Y$$$20240823$$HP$US$US
242411921$24241192$1$I$20240723$20240815$20240823$20240823$PER$$US-ROCHE-10000058862$ROCHE$$58$YR$A$F$Y$64.41$KG$20240823$$CN$US$US
242411931$24241193$1$I$$20240815$20240823$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-025618$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240823$$$US$US
242411941$24241194$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004332$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242411951$24241195$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004334$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242411961$24241196$1$I$$20240821$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074598$SANDOZ$$67$YR$$F$Y$$$20240823$$PH$CA$CA
242411971$24241197$1$I$$20240820$20240823$20240823$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-114733$REGENERON$$$$$F$Y$$$20240823$$HP$US$US
242411981$24241198$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013796$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240823$$CN$US$US
242411991$24241199$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004180$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
242412002$24241200$2$F$$20240823$20240823$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014354$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240828$$CN$US$US
242412011$24241201$1$I$20240501$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012680$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240823$$CN$US$US
242412021$24241202$1$I$20240810$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012572$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240823$$CN$US$US
242412031$24241203$1$I$$20240724$20240823$20240823$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07394$LUPIN$$$$$$Y$$$20240823$$CN$US$US
242412042$24241204$2$F$20210810$20240904$20240823$20240909$EXP$$CA-TAKEDA-2021TUS062395$TAKEDA$$27$YR$$F$Y$$$20240909$$CN$CA$CA
242412053$24241205$3$F$20240901$20240911$20240823$20240921$EXP$$AR-JNJFOC-20240850758$JOHNSON AND JOHNSON$$59$YR$A$F$Y$60$KG$20240921$$CN$AR$AR
242412061$24241206$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004329$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242412071$24241207$1$I$$20240814$20240823$20240823$EXP$$CA-APOTEX-2020AP009028$APOTEX$$$$$$Y$$$20240823$$HP$CA$CA
242412081$24241208$1$I$20240101$20240724$20240823$20240823$PER$$US-009507513-2407USA014782$MERCK$$76$YR$$M$Y$$$20240823$$HP$US$US
242412093$24241209$3$F$20240805$20240906$20240823$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004181$ACADIA PHARMACEUTICALS$$16$YR$$F$Y$$$20240916$$CN$US$US
242412101$24241210$1$I$$20240731$20240823$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004327$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242412111$24241211$1$I$20240719$20240814$20240823$20240823$EXP$FR-AFSSAPS-TS2024000892$FR-TEVA-VS-3233903$TEVA$$78$YR$$F$Y$52$KG$20240823$$MD$FR$FR
242412121$24241212$1$I$$20240816$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133507$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240823$$HP$US$US
242412134$24241213$4$F$20240801$20240911$20240823$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-025620$UNITED THERAPEUTICS$$70$YR$$M$Y$100.68$KG$20240917$$$US$US
242412151$24241215$1$I$20240820$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166733$AMGEN$$50$YR$A$F$Y$$$20240823$$CN$US$US
242412162$24241216$2$F$20240820$20240827$20240823$20240830$PER$$US-AMGEN-USASP2024167031$AMGEN$$84$YR$E$M$Y$$$20240830$$PH$US$US
242412171$24241217$1$I$20240820$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166735$AMGEN$$75$YR$E$F$Y$$$20240823$$CN$US$US
242412191$24241219$1$I$$20240813$20240823$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-005968$AUROBINDO$Chaudhry A, Roles C, Lee J.. Sodium Glucose Cotransporter 2 Inhibitor associated  Euglycemic Diabetic Ketoacidosis: Lessons From a Case Series of 4 Patients Undergoing  Coronary Artery Bypass Grafting Surgery.. Canadian Journal of Diabetes. 2022;46(8):843- 850$70$YR$$F$Y$$$20240823$$MD$CA$CA
242412201$24241220$1$I$20240416$20240813$20240823$20240823$EXP$FR-AFSSAPS-PA2024001277$FR-TEVA-VS-3233485$TEVA$$79$YR$$F$Y$75$KG$20240823$$PH$FR$FR
242412211$24241221$1$I$$20240813$20240823$20240823$EXP$$US-GSK-US2024AMR100996$GLAXOSMITHKLINE$$$$$M$Y$$$20240823$$HP$US$US
242412221$24241222$1$I$20240820$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166722$AMGEN$$$$$$Y$$$20240823$$HP$US$US
242412231$24241223$1$I$20210607$20240813$20240823$20240823$EXP$$ES-TEVA-VS-3234618$TEVA$$52$YR$$F$Y$62$KG$20240823$$HP$ES$ES
242412241$24241224$1$I$20240815$20240817$20240823$20240823$EXP$$US-ARGENX-2024-ARGX-US006833$ARGENX BVBA$$$$$$Y$$$20240823$$CN$US$US
242412251$24241225$1$I$20240610$20240819$20240823$20240823$EXP$$AU-ROCHE-10000013660$ROCHE$$2$YR$C$M$Y$13.1$KG$20240823$$MD$AU$AU
242412261$24241226$1$I$20210607$20240813$20240823$20240823$EXP$$ES-TEVA-VS-3235118$TEVA$$52$YR$$F$Y$62$KG$20240823$$HP$ES$ES
242412272$24241227$2$F$$20240823$20240823$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07518$LUPIN$$$$$$Y$$$20240910$$CN$US$US
242412281$24241228$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004324$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242412291$24241229$1$I$20240101$20240819$20240823$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-025991$UNITED THERAPEUTICS$$$$$M$Y$91.156$KG$20240823$$$US$US
242412302$24241230$2$F$$20240903$20240823$20240907$EXP$$US-TAKEDA-2024TUS075017$TAKEDA$$$$$F$Y$$$20240907$$CN$US$US
242412311$24241231$1$I$$20240814$20240823$20240823$EXP$$US-ROCHE-10000057989$ROCHE$$80$YR$E$F$Y$$$20240823$$CN$US$US
242412331$24241233$1$I$20240101$20240819$20240823$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-026004$UNITED THERAPEUTICS$$$$$F$Y$107.48$KG$20240823$$$US$US
242412341$24241234$1$I$$20240815$20240823$20240823$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03032$AMNEAL$$$$$F$Y$$$20240823$$CN$US$US
242412351$24241235$1$I$20240729$20240812$20240823$20240823$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US000398$PAREXEL$$$$$$Y$$$20240823$$CN$US$US
242412362$24241236$2$F$$20240824$20240823$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07453$LUPIN$$$$$$Y$$$20240913$$PH$US$US
242412371$24241237$1$I$20240820$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166693$AMGEN$$80$YR$E$F$Y$$$20240823$$CN$US$US
242412381$24241238$1$I$20240719$20240816$20240823$20240823$EXP$CH-SM-2024-14951$CH-BEH-2024177301$CSL BEHRING$$17$YR$T$F$Y$$$20240823$$MD$CH$CH
242412401$24241240$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024166179$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242412421$24241242$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004305$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242412431$24241243$1$I$20240518$20240814$20240823$20240823$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101399$VIIV$$5$DEC$$M$Y$$$20240823$$HP$US$US
242412441$24241244$1$I$20240701$20240813$20240823$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-026137$UNITED THERAPEUTICS$$71$YR$$F$Y$$$20240823$$$US$US
242412451$24241245$1$I$$20240808$20240823$20240823$EXP$$US-UCBSA-2024042578$UCB$$$$$$Y$$$20240823$$CN$US$US
242412462$24241246$2$F$$20240826$20240823$20240930$PER$$NVSC2024US170751$NOVARTIS$$$$$$Y$$$20240930$$HP$US$US
242412471$24241247$1$I$$20240815$20240823$20240823$PER$$US-JNJFOC-20240842498$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$HP$US$US
242412482$24241248$2$F$$20240903$20240823$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004269$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242412491$24241249$1$I$20230215$20240814$20240823$20240823$EXP$$BR-SERVIER-S24010432$SERVIER$$$$$$Y$$$20240823$$MD$BR$BR
242412501$24241250$1$I$20240801$20240820$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133463$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240823$$CN$US$US
242412511$24241251$1$I$$20240813$20240823$20240823$PER$$US-ABBVIE-5881854$ABBVIE$$43$YR$$F$Y$$$20240823$$HP$US$US
242412521$24241252$1$I$$20240820$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133298$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240823$$CN$US$US
242412531$24241253$1$I$20240712$20240819$20240823$20240823$EXP$$CA-ROCHE-10000061727$ROCHE$$87$YR$E$F$Y$$$20240823$$HP$CA$CA
242412541$24241254$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004185$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242412551$24241255$1$I$20240529$20240529$20240823$20240823$PER$$US-GE HEALTHCARE-2024CSU005924$GE HEALTHCARE$$47$YR$$F$Y$82.54$KG$20240823$$HP$US$US
242412561$24241256$1$I$$20240820$20240823$20240823$EXP$$UY-ROCHE-10000062823$ROCHE$$$$$F$Y$$$20240823$$MD$UY$UY
242412571$24241257$1$I$$20240731$20240823$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004262$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
242412581$24241258$1$I$20230718$20240820$20240823$20240823$EXP$$NVSC2023GB159618$NOVARTIS$$31$YR$$M$Y$$$20240823$$CN$GB$GB
242412591$24241259$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA169066$NOVARTIS$$53$YR$$F$Y$$$20240823$$HP$CA$CA
242412601$24241260$1$I$20180101$20240816$20240823$20240823$EXP$$US-ABBVIE-5868245$ABBVIE$$$$$F$Y$51.2$KG$20240823$$CN$US$US
242412611$24241261$1$I$$20240819$20240823$20240823$EXP$$BR-ROCHE-10000061800$ROCHE$$74$YR$E$F$Y$$$20240823$$MD$BR$BR
242412621$24241262$1$I$20240726$20240820$20240823$20240823$EXP$ES-AEMPS-1561229$ES-ORGANON-O2408ESP001398$ORGANON$$72$YR$$F$Y$$$20240823$$MD$ES$ES
242412631$24241263$1$I$20210101$20240819$20240823$20240823$PER$$US-ORGANON-O2408USA001526$ORGANON$$$$$F$Y$$$20240823$$CN$US$US
242412641$24241264$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170562$NOVARTIS$$$$$F$Y$$$20240823$$HP$US$US
242412651$24241265$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024166395$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242412661$24241266$1$I$$20240816$20240823$20240823$EXP$$AR-GSK-AR2024AMR103728$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$AR$AR
242412671$24241267$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024100835$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242412681$24241268$1$I$$20240814$20240823$20240823$PER$$US-BAUSCHBL-2024BNL031798$BAUSCH AND LOMB$$$$$M$Y$$$20240823$$CN$US$US
242412691$24241269$1$I$20240820$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133327$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240823$$HP$US$US
242412701$24241270$1$I$$20240816$20240823$20240823$EXP$US-MLMSERVICE-20240812-PI156101-00306-1$US-RDY-SPO/USA/24/0012063$DR REDDYS$Trabzonlu L, McDermott S, Pitman MB, Chebib I. Pulmonary Kaposi sarcoma in a patient with bilateral lung transplant: An unexpected diagnosis on transbronchial fine needle aspiration and core biopsy. Diagnostic Cytopathology. 2024;52(9):E215-21. DOI: 10.1002/dc.25368.$70$YR$E$F$Y$$$20240823$$MD$US$US
242412711$24241271$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133097$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$104.33$KG$20240823$$CN$US$US
242412721$24241272$1$I$$20240814$20240823$20240823$EXP$$US-RDY-SPO/USA/24/0012175$DR REDDYS$Kim YJ, Li Z, Maiti A, Tanaka T, Uryu H, Furudate K, et al. Single-cell proteogenomics analysis of AML samples treated with decitabine and venetoclax reveals divergent treatment escape mechanisms. Cancer Research. 2024 Mar;84(6): doi:10.1158/1538-7445.AM2024-3400.$$$$$Y$$$20240823$$HP$US$US
242412731$24241273$1$I$$20240814$20240823$20240823$EXP$US-MLMSERVICE-20240807-PI154441-00232-1$US-RDY-SPO/USA/24/0011940$DR REDDYS$Farkouh EK, Michel IM, Harrison DJ, Issa N. Dual Donor-Derived Renal Allograft Mucormycosis From a Single Deceased Donor. Mayo Clinic Proceedings. 2024;99(8):1341-42. DOI: 10.1016/j.mayocp.2024.04.001.$7$DEC$E$F$Y$$$20240823$$MD$US$US
242412742$24241274$2$F$$20240826$20240823$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004184$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
242412751$24241275$1$I$20240815$20240819$20240823$20240823$EXP$GB-MHRA-MED-202408191101123250-NRMDS$GB-CHATTEMPRD-2024OHG028255$CHATTEM$$49$YR$A$M$Y$$$20240823$$PH$GB$GB
242412761$24241276$1$I$$20240816$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408010956$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240823$$CN$US$US
242412771$24241277$1$I$20231218$20240819$20240823$20240823$EXP$$US-ABBVIE-5885983$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242412782$24241278$2$F$$20240905$20240823$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202408013394$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240908$$CN$US$US
242412791$24241279$1$I$20230823$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013702$ELI LILLY AND CO$$$$A$F$Y$$$20240823$$CN$US$US
242412801$24241280$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012720$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240823$$CN$US$US
242412811$24241281$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012038$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242412821$24241282$1$I$20240816$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012885$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240823$$CN$US$US
242412831$24241283$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004349$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240823$$CN$US$US
242412841$24241284$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012735$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240823$$CN$US$US
242412851$24241285$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012087$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240823$$CN$US$US
242412863$24241286$3$F$20240101$20240820$20240823$20240829$PER$$US-AMGEN-USASP2024165168$AMGEN$$54$YR$A$F$Y$$$20240829$$HP$US$US
242412872$24241287$2$F$$20240910$20240823$20240910$PER$$US-ALXN-202408USA001210US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
242412881$24241288$1$I$$20240724$20240823$20240823$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07382$LUPIN$$$$$$Y$$$20240823$$CN$US$US
242412901$24241290$1$I$$20240820$20240823$20240823$EXP$$US-ABBVIE-5889367$ABBVIE$$$$$F$Y$$$20240823$$HP$US$US
242412911$24241291$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004348$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240823$$CN$US$US
242412922$24241292$2$F$20240801$20240822$20240823$20240827$EXP$$US-ABBVIE-5887233$ABBVIE$$74$YR$$F$Y$99.79$KG$20240827$$CN$US$US
242412931$24241293$1$I$$20240819$20240823$20240823$EXP$$AU-SANDOZ INC.-SDZ2024AU073586$SANDOZ$$$$$M$Y$$$20240823$$HP$AU$AU
242412943$24241294$3$F$$20240915$20240823$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA073752$SANDOZ$$$$$F$Y$$$20240919$$MD$CA$CA
242412951$24241295$1$I$$20240731$20240823$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004341$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242412961$24241296$1$I$20240601$20240813$20240823$20240823$EXP$$CA-GSK-CA2024100781$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$CA$CA
242412971$24241297$1$I$$20240821$20240823$20240823$EXP$$US-ABBVIE-5889604$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242412981$24241298$1$I$$20240815$20240823$20240823$PER$$US-EMD Serono-2024044181$EMD SERONO INC$$66$YR$E$F$Y$$$20240823$$HP$US$US
242412991$24241299$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-081537-2024$RECKITT BENCKISER$$65$YR$$F$Y$$$20240823$$CN$US$US
242413001$24241300$1$I$20240701$20240724$20240823$20240823$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07496$LUPIN$$$$$$Y$$$20240823$$CN$US$US
242413011$24241301$1$I$20240624$20240819$20240823$20240823$EXP$$NVSC2024US141357$NOVARTIS$$27$YR$$F$Y$$$20240823$$CN$US$US
242413021$24241302$1$I$$20240812$20240823$20240823$PER$$US-ABBVIE-5880371$ABBVIE$$$$$F$Y$$$20240823$$HP$US$US
242413031$24241303$1$I$20240101$20240813$20240823$20240823$EXP$FR-AFSSAPS-AVLL2024000195$FR-TEVA-VS-3233809$TEVA$$28$YR$$M$Y$$$20240823$$MD$FR$FR
242413041$24241304$1$I$20231020$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167155$AMGEN$$65$YR$E$F$Y$$$20240823$$CN$US$US
242413063$24241306$3$F$20240821$20240829$20240823$20240902$PER$$US-AMGEN-USASP2024168181$AMGEN$$44$YR$A$M$Y$$$20240901$$CN$US$US
242413072$24241307$2$F$20240730$20240923$20240823$20240926$EXP$DE-SAMSUNG BIOEPIS-SB-2024-24201$DE-ROCHE-10000059742$ROCHE$$61$YR$A$F$Y$58.8$KG$20240926$$MD$DE$DE
242413081$24241308$1$I$$20240813$20240823$20240823$EXP$$US-AMGEN-USASP2024163040$AMGEN$Dao:K.. A Case of Revelation Due to Pegfilgrastim. cureus. 2024;16 (7):1-7$68$YR$E$M$Y$$$20240823$$HP$US$US
242413092$24241309$2$F$$20240916$20240823$20240919$EXP$$US-ABBVIE-5887043$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
242413102$24241310$2$F$$20240815$20240823$20240826$PER$$NVSC2024US166280$NOVARTIS$$$$$$Y$$$20240826$$CN$US$US
242413111$24241311$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004193$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$HP$US$US
242413121$24241312$1$I$$20240724$20240823$20240823$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07392$LUPIN$$$$$$Y$$$20240823$$CN$US$US
242413131$24241313$1$I$$20240814$20240823$20240823$PER$$US-ABBVIE-5882869$ABBVIE$$$$$$Y$$$20240823$$HP$US$US
242413142$24241314$2$F$20240101$20240827$20240823$20240906$EXP$$AU-RECORDATI RARE DISEASE INC.-2024006319$RECORDATI$$$$$$Y$$$20240906$$MD$AU$AU
242413151$24241315$1$I$20240809$20240813$20240823$20240823$PER$$US-ABBVIE-5881864$ABBVIE$$49$YR$$F$Y$$$20240823$$CN$US$US
242413161$24241316$1$I$$20240729$20240823$20240823$PER$$US-JNJFOC-20240782683$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
242413171$24241317$1$I$$20240815$20240823$20240823$PER$$US-ALXN-202408USA000948US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242413182$24241318$2$F$20240101$20240903$20240823$20240916$EXP$$US-UCBSA-2024037636$UCB$$$$$M$Y$$$20240916$$CN$US$US
242413192$24241319$2$F$$20240826$20240823$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07435$LUPIN$$$$$$Y$$$20240913$$CN$US$US
242413201$24241320$1$I$$20240816$20240823$20240823$PER$$US-ALXN-202408USA001191US$ALEXION PHARMACEUTICALS$$$$$F$Y$108$KG$20240823$$CN$US$US
242413211$24241321$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164924$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$F$Y$$$20240823$$MD$US$US
242413221$24241322$1$I$$20240821$20240823$20240823$PER$$NVSC2024US170407$NOVARTIS$$$$$M$Y$$$20240823$$HP$US$US
242413231$24241323$1$I$20240620$20240731$20240823$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004194$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240823$$CN$US$US
242413241$24241324$1$I$$20240814$20240823$20240823$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001642$BLUEPRINT MEDICINES$$$$$M$Y$$$20240823$$CN$US$US
242413251$24241325$1$I$20240101$20240814$20240823$20240823$EXP$$US-TEVA-VS-3235182$TEVA$$17$YR$$F$Y$$$20240823$$HP$US$US
242413261$24241326$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133398$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240823$$HP$US$US
242413272$24241327$2$F$$20240823$20240823$20240827$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-128101$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240827$$HP$DE$DE
242413281$24241328$1$I$20240814$20240821$20240823$20240823$EXP$$US-BIOVITRUM-2024-US-011212$BIOVITRUM$$59$YR$$F$Y$$$20240823$$CN$US$US
242413291$24241329$1$I$20240701$20240816$20240823$20240823$EXP$$CH-ROCHE-10000060681$ROCHE$$$$A$F$Y$$$20240823$$CN$CH$CH
242413301$24241330$1$I$20240101$20240813$20240823$20240823$EXP$$FR-AUROBINDO-AUR-APL-2024-041306$AUROBINDO$$82$YR$$F$Y$61$KG$20240823$$MD$FR$FR
242413311$24241331$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012091$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242413321$24241332$1$I$$20240813$20240823$20240823$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07283$VIFOR$$$$A$F$Y$$$20240823$$CN$ZA$ZA
242413331$24241333$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012740$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240823$$CN$US$US
242413341$24241334$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013716$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240823$$CN$US$US
242413351$24241335$1$I$20240801$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012730$ELI LILLY AND CO$$28$YR$A$M$Y$$$20240823$$CN$US$US
242413361$24241336$1$I$$20240813$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408008431$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240823$$CN$US$US
242413371$24241337$1$I$20240101$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011149$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240823$$CN$US$US
242413381$24241338$1$I$$20240731$20240823$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004201$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
242413391$24241339$1$I$$20240817$20240823$20240823$EXP$$JP-GENMAB-2024-03020$GENMAB$$69$YR$$F$Y$$$20240823$$MD$JP$JP
242413401$24241340$1$I$20240719$20240813$20240823$20240823$EXP$$FR-AUROBINDO-AUR-APL-2024-041326$AUROBINDO$$53$YR$$F$Y$$$20240823$$PH$FR$FR
242413413$24241341$3$F$20240710$20240828$20240823$20240902$EXP$$CA-TAKEDA-2024TUS082184$TAKEDA$$64$YR$$F$Y$$$20240902$$CN$CA$CA
242413421$24241342$1$I$20201123$20240815$20240823$20240823$EXP$$CA-TAKEDA-2024TUS062378$TAKEDA$$36$YR$$F$Y$$$20240823$$MD$CA$CA
242413432$24241343$2$F$$20240822$20240823$20240826$EXP$NL-LRB-00996763$NL-BIOVITRUM-2024-NL-011208$BIOVITRUM$$58$YR$$M$Y$99$KG$20240826$$CN$NL$NL
242413451$24241345$1$I$20240711$20240813$20240823$20240823$EXP$$FR-AUROBINDO-AUR-APL-2024-041328$AUROBINDO$$53$YR$$F$Y$$$20240823$$PH$FR$FR
242413461$24241346$1$I$20231001$20240819$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133515$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240823$$CN$US$US
242413471$24241347$1$I$$20240816$20240823$20240823$EXP$$CA-TAKEDA-2024TUS082795$TAKEDA$$$$$F$Y$$$20240823$$CN$CA$CA
242413481$24241348$1$I$$20240813$20240823$20240823$EXP$$US-KOANAAP-SML-US-2024-00854$SHILPA MEDICARE$Klein J, Hernandez L. Loeffler^s Endomyocarditis in a Child. Journal of Cardiovascular Magnetic Resonance. 2024;26: 101-102. doi:10.1016/j.jocmr.2024.100331.$7$YR$C$M$Y$$$20240823$$MD$US$US
242413502$24241350$2$F$20240808$20240817$20240823$20240826$EXP$$CN-JNJFOC-20240849663$JOHNSON AND JOHNSON$$1$DY$N$M$Y$0.95$KG$20240826$$HP$CN$CN
242413511$24241351$1$I$$20240815$20240823$20240823$EXP$$BR-JNJFOC-20240845094$JOHNSON AND JOHNSON$$$$$F$Y$66$KG$20240823$$MD$BR$BR
242413521$24241352$1$I$20240717$20240813$20240823$20240823$EXP$$FR-AUROBINDO-AUR-APL-2024-041754$AUROBINDO$$$$A$F$Y$$$20240823$$PH$FR$FR
242413531$24241353$1$I$$20240815$20240823$20240823$PER$$US-JNJFOC-20240839816$JOHNSON AND JOHNSON$$71$YR$E$M$Y$85$KG$20240823$$PH$US$US
242413541$24241354$1$I$$20240731$20240823$20240823$PER$$US-BEIGENE-BGN-2024-012050$BEIGENE$$$$$$Y$$$20240823$$CN$US$US
242413551$24241355$1$I$$20240813$20240823$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-041476$AUROBINDO$$52$YR$$F$Y$$$20240823$$HP$CA$CA
242413561$24241356$1$I$$20240813$20240823$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-041557$AUROBINDO$$91$YR$$M$Y$$$20240823$$PH$CA$CA
242413572$24241357$2$F$20240804$20240902$20240823$20240905$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-130024$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240905$$CN$BR$BR
242413581$24241358$1$I$20240624$20240817$20240823$20240823$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-132538$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240823$$HP$CO$CO
242413591$24241359$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131791$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$70.76$KG$20240823$$CN$US$US
242413611$24241361$1$I$20220622$20240820$20240823$20240823$EXP$$CA-SANDOZ INC.-NVSC2022CA145063$SANDOZ$$76$YR$$M$Y$$$20240823$$CN$CA$CA
242413624$24241362$4$F$$20240820$20240823$20240827$EXP$$US-ROCHE-10000061536$ROCHE$Patel G, Limgala P, Patel P, Makar M, Barooah J, Pir M, et al. Embolic Stroke In A Patient With Evans Syndrome Receiving Rituximab Therapy. Journal of the American College of Cardiology. 2019-Mar-12;73 (9):2817. doi:10.1016/S0735-1097(19)33423-0.$36$YR$A$F$Y$$$20240827$$HP$US$US
242413631$24241363$1$I$$20240817$20240823$20240823$PER$$US-ABBVIE-5886262$ABBVIE$$$$$$Y$$$20240823$$CN$US$US
242413641$24241364$1$I$$20240813$20240823$20240823$EXP$$IT-AUROBINDO-AUR-APL-2024-041750$AUROBINDO$Chesi E, Rossi K, Ancora G, Baraldi C, Corradi M, Di Dio F, et al. Patent ductus arteriosus (also non-hemodynamically significant) correlates with poor outcomes in very low birth weight infants. A multicenter cohort study.. Plos one. 2024;19 (7):1-15$$$I$$Y$$$20240823$$HP$IT$IT
242413651$24241365$1$I$20240809$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024166387$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242413661$24241366$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164907$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240823$$MD$US$US
242413671$24241367$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164906$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240823$$MD$US$US
242413681$24241368$1$I$$20240814$20240823$20240823$EXP$$CN-ROCHE-10000057853$ROCHE$$73$YR$E$M$Y$$$20240823$$CN$CN$CN
242413691$24241369$1$I$$20240821$20240823$20240823$PER$$US-GILEAD-2024-0684989$GILEAD$$59$YR$A$M$Y$$$20240823$$CN$US$US
242413701$24241370$1$I$$20240813$20240823$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-041539$AUROBINDO$$41$YR$$M$Y$$$20240823$$CN$CA$CA
242413721$24241372$1$I$$20240812$20240823$20240823$PER$$US-JNJFOC-20240834621$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
242413731$24241373$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024AMR101616$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$PH$US$US
242413741$24241374$1$I$$20240820$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132452$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$112.49$KG$20240823$$CN$US$US
242413751$24241375$1$I$20240814$20240815$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129902$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240823$$PH$US$US
242413761$24241376$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133364$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240823$$HP$US$US
242413771$24241377$1$I$$20240819$20240823$20240823$EXP$$PL-ROCHE-10000060575$ROCHE$Rybka J, Kuszczak B, Bogucka-Fedorczuk A. Treatment of primary central nervous system lymphoma (PCNSL) - single center experience and literature review. Acta Haematologica Polonica. 2024-Jan;55 (3):151-156. doi:10.5603/ahp.99087.$$$$$Y$$$20240823$$HP$PL$PL
242413782$24241378$2$F$20240801$20240821$20240823$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132054$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$68.22$KG$20240826$$PH$US$US
242413791$24241379$1$I$$20240801$20240823$20240823$PER$$US-BEIGENE-BGN-2024-012207$BEIGENE$$$$$$Y$$$20240823$$CN$US$US
242413801$24241380$1$I$20240101$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165740$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242413811$24241381$1$I$$20240816$20240823$20240823$PER$$US-ABBVIE-5884371$ABBVIE$$$$$$Y$$$20240823$$MD$US$US
242413821$24241382$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170789$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242413832$24241383$2$F$20240101$20240917$20240823$20240921$EXP$$US-ABBVIE-5888561$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
242413842$24241384$2$F$20230504$20240902$20240823$20240910$EXP$$CA-VER-202400380$VERITY PHARMACEUTICALS$$77$YR$E$M$Y$$$20240910$$HP$CA$CA
242413851$24241385$1$I$20240601$20240820$20240823$20240823$EXP$$US-ABBVIE-5888961$ABBVIE$$67$YR$$F$Y$$$20240823$$CN$US$US
242413862$24241386$2$F$20240801$20240820$20240823$20240827$EXP$$CA-JNJFOC-20240854377$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240827$$HP$CA$CA
242413873$24241387$3$F$20240709$20240830$20240823$20240907$EXP$$BR-CELLTRION INC.-2024BR019992$CELLTRION$$$$$$Y$$$20240907$$CN$BR$BR
242413881$24241388$1$I$20240817$20240821$20240823$20240823$EXP$$UY-ABBVIE-5889489$ABBVIE$$47$YR$$F$Y$$$20240823$$CN$UY$UY
242413891$24241389$1$I$$20240813$20240823$20240823$EXP$$PT-AUROBINDO-AUR-APL-2024-041654$AUROBINDO$Oliveira R, Abreu C, Cabrita M, et al.. PLASMA CELL LEUKEMIA - AN URGENT DIAGNOSIS.. Laboratory Medicine Magazine. 2024;5:83-4$73$YR$$M$Y$$$20240823$$MD$PT$PT
242413901$24241390$1$I$20230529$20240814$20240823$20240823$EXP$$GB-ARGENX-2024-ARGX-GB006772$ARGENX BVBA$$$$$$Y$$$20240823$$HP$GB$GB
242413911$24241391$1$I$$20240813$20240823$20240823$EXP$GB-MHRA-MED-202408121500517630-NJZBD$GB-MSNLABS-2024MSNSPO01805$MSN LABORATORIES$$$$$$Y$$$20240823$$HP$GB$GB
242413921$24241392$1$I$$20240811$20240823$20240823$EXP$$CA-JNJFOC-20240830580$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$HP$CA$CA
242413931$24241393$1$I$20231101$20240819$20240823$20240823$EXP$$US-ABBVIE-5888985$ABBVIE$$54$YR$$M$Y$$$20240823$$CN$US$US
242413941$24241394$1$I$20240818$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024166700$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242413951$24241395$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133545$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240823$$CN$US$US
242413961$24241396$1$I$20240802$20240816$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124457$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$93$KG$20240823$$HP$US$US
242413971$24241397$1$I$20240709$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012867$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242413981$24241398$1$I$20210101$20240815$20240823$20240823$PER$$US-JNJFOC-20240853152$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
242413991$24241399$1$I$$20240815$20240823$20240823$PER$$NVSC2024US167199$NOVARTIS$$33$YR$$M$Y$$$20240823$$CN$US$US
242414001$24241400$1$I$$20240813$20240823$20240823$EXP$$NL-AUROBINDO-AUR-APL-2024-041459$AUROBINDO$$75$YR$$M$Y$92$KG$20240823$$PH$NL$NL
242414011$24241401$1$I$20240721$20240821$20240823$20240823$EXP$$US-GILEAD-2024-0685073$GILEAD$$44$YR$A$F$Y$$$20240823$$CN$US$US
242414021$24241402$1$I$20240701$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012612$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240823$$CN$US$US
242414031$24241403$1$I$$20240731$20240823$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004204$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242414041$24241404$1$I$$20240813$20240823$20240823$EXP$$PT-AUROBINDO-AUR-APL-2024-041655$AUROBINDO$Teixeira CM, Amaro AM, Dias A, Brito A, Duarte A.. Drug-induced injury secondary to terbinafine.. Italian Medical Journal - Archive for Medical Sciences.. 2024;183:364-6.$92$YR$$M$Y$$$20240823$$HP$PT$PT
242414051$24241405$1$I$20231001$20240814$20240823$20240823$EXP$$CO-AMGEN-COLSP2024166274$AMGEN$$$$$F$Y$$$20240823$$CN$CO$CO
242414061$24241406$1$I$20240726$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012904$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242414072$24241407$2$F$$20240823$20240823$20240902$EXP$$US-GSK-US2024AMR103360$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$HP$US$US
242414081$24241408$1$I$20240701$20240724$20240823$20240823$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00776$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240823$$CN$US$US
242414091$24241409$1$I$20240801$20240813$20240823$20240823$PER$$US-MSNLABS-2024MSNSPO01810$MSN LABORATORIES$$$$$$Y$$$20240823$$CN$US$US
242414101$24241410$1$I$20240801$20240819$20240823$20240823$EXP$$BE-ABBVIE-5890743$ABBVIE$$71$YR$$F$Y$88$KG$20240823$$HP$BE$BE
242414111$24241411$1$I$20240815$20240819$20240823$20240823$EXP$$ZA-TAKEDA-2024TUS041530$TAKEDA$$35$YR$$F$Y$$$20240823$$CN$ZA$ZA
242414121$24241412$1$I$20240726$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012894$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242414131$24241413$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170792$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242414141$24241414$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167968$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242414151$24241415$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004205$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240823$$HP$US$US
242414161$24241416$1$I$20220805$20220927$20240823$20240823$EXP$$CO-BIOVITRUM-2022CO09697$BIOVITRUM$$10$WK$$M$Y$$$20240823$$CN$CO$CO
242414172$24241417$2$F$20230310$20240829$20240823$20240906$EXP$$JP-ARGENX-2022-ARGX-JP002833AA$ARGENX BVBA$$$$$$Y$$$20240906$$MD$JP$JP
242414181$24241418$1$I$20240701$20240813$20240823$20240823$EXP$$FR-AUROBINDO-AUR-APL-2024-041389$AUROBINDO$$68$YR$$F$Y$68$KG$20240823$$PH$FR$FR
242414201$24241420$1$I$$20240813$20240823$20240823$EXP$$GB-AUROBINDO-AUR-APL-2024-041164$AUROBINDO$$66$YR$$F$Y$$$20240823$$PH$GB$GB
242414211$24241421$1$I$20230412$20230425$20240823$20240823$EXP$$ZA-BIOVITRUM-2023-ZA-010049$BIOVITRUM$$470$DY$$F$Y$3.4$KG$20240823$$CN$ZA$ZA
242414221$24241422$1$I$20190206$20240813$20240823$20240823$EXP$GB-MHRA-MED-202406252245009800-ZDLYG$GB-ASPEN-GLO2024GB005580$ASPEN$$$$$$Y$$$20240823$$CN$GB$GB
242414231$24241423$1$I$20240801$20240820$20240823$20240823$EXP$$US-GILEAD-2024-0685011$GILEAD$$82$YR$E$M$Y$$$20240823$$CN$US$US
242414241$24241424$1$I$20240731$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012895$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242414251$24241425$1$I$20240411$20240819$20240823$20240823$EXP$$US-UCBSA-2024041863$UCB$$90$YR$$F$Y$$$20240823$$CN$US$US
242414261$24241426$1$I$$20240813$20240823$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-041454$AUROBINDO$$$$$M$Y$$$20240823$$CN$CA$CA
242414272$24241427$2$F$$20240826$20240823$20240826$PER$$NVSC2024US170787$NOVARTIS$$$$$$Y$$$20240826$$HP$US$US
242414281$24241428$1$I$$20240816$20240823$20240823$EXP$$US-RDY-SPO/USA/24/0012044$DR REDDYS$$62$YR$A$F$Y$$$20240823$$CN$US$US
242414291$24241429$1$I$20240809$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012896$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242414302$24241430$2$F$20240808$20240920$20240823$20240926$EXP$$NVSJ2024JP009805$NOVARTIS$$75$YR$$M$Y$$$20240927$$PH$JP$JP
242414311$24241431$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004203$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
242414321$24241432$1$I$20240729$20240813$20240823$20240823$EXP$$FR-AUROBINDO-AUR-APL-2024-041322$AUROBINDO$$20$YR$$M$Y$65$KG$20240823$$PH$FR$FR
242414331$24241433$1$I$20240304$20240819$20240823$20240823$EXP$$CN-CHEPLA-2024010706$CHEPLAPHARM$$48$YR$A$M$Y$68$KG$20240823$$HP$COUNTRY NOT SPECIFIED$CN
242414341$24241434$1$I$$20240813$20240823$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-041521$AUROBINDO$$66$YR$$F$Y$$$20240823$$CN$CA$CA
242414351$24241435$1$I$$20240821$20240823$20240823$EXP$$US-GILEAD-2024-0684951$GILEAD$$59$YR$A$F$Y$$$20240823$$CN$US$US
242414361$24241436$1$I$20240712$20240820$20240823$20240823$EXP$$CO-UCBSA-2024042711$UCB$$66$YR$$F$Y$$$20240823$$CN$CO$CO
242414382$24241438$2$F$$20240815$20240823$20240823$EXP$$CA-TERSERA THERAPEUTICS LLC-2024TRS004119$TERSERA THERAPEUTICS$$$$$$Y$$$20240823$$CN$CA$CA
242414391$24241439$1$I$$20240812$20240823$20240823$PER$$US-ROCHE-10000055936$ROCHE$$$$$$Y$$$20240823$$PH$US$US
242414401$24241440$1$I$$20240813$20240823$20240823$PER$$US-TEVA-VS-3235054$TEVA$$$$$F$Y$$$20240823$$CN$US$US
242414411$24241441$1$I$$20240813$20240823$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-041417$AUROBINDO$$46$YR$$F$Y$79$KG$20240823$$HP$CA$CA
242414421$24241442$1$I$$20240813$20240823$20240823$EXP$$US-TEVA-VS-3235153$TEVA$$$$A$F$Y$$$20240823$$MD$US$US
242414441$24241444$1$I$$20240729$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004103$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242414451$24241445$1$I$20240101$20240814$20240823$20240823$EXP$$CA-CELLTRION INC.-2024CA018238$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
242414461$24241446$1$I$$20240813$20240823$20240823$EXP$$JP-TEVA-VS-3235613$TEVA$$$$$$Y$$$20240823$$CN$JP$JP
242414471$24241447$1$I$20240709$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012906$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242414481$24241448$1$I$$20240813$20240823$20240823$EXP$$FR-AUROBINDO-AUR-APL-2024-041552$AUROBINDO$$78$YR$$F$Y$$$20240823$$PH$FR$FR
242414491$24241449$1$I$20240709$20240819$20240823$20240823$EXP$IT-MINISAL02-998875$IT-Orion Corporation ORION PHARMA-24_00031330$ORION$$80$YR$E$F$Y$46$KG$20240823$$MD$IT$
242414501$24241450$1$I$$20240819$20240823$20240823$PER$$US-ABBVIE-5889788$ABBVIE$$$$$F$Y$$$20240823$$HP$US$US
242414512$24241451$2$F$$20240820$20240823$20240828$PER$$US-AMGEN-USASP2024166750$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242414521$24241452$1$I$$20240819$20240823$20240823$EXP$$GB-AMGEN-GBRSP2024166093$AMGEN$$$$$M$Y$$$20240823$$HP$GB$GB
242414531$24241453$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164905$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240823$$MD$US$US
242414541$24241454$1$I$20230101$20240724$20240823$20240823$PER$$US-009507513-2407USA013562$MERCK$$$$$M$Y$$$20240823$$CN$US$US
242414551$24241455$1$I$20240101$20240822$20240823$20240823$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047411$BOEHRINGER INGELHEIM$$$$$$Y$$$20240823$$CN$US$US
242414561$24241456$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133585$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$67.13$KG$20240823$$CN$US$US
242414571$24241457$1$I$$20240819$20240823$20240823$EXP$$US-RDY-SPO/USA/24/0012179$DR REDDYS$$23$YR$A$F$Y$$$20240823$$MD$US$US
242414581$24241458$1$I$20240101$20240816$20240823$20240823$PER$$US-ABBVIE-5884243$ABBVIE$$$$$F$Y$79.378$KG$20240823$$CN$US$US
242414591$24241459$1$I$20240701$20240819$20240823$20240823$PER$$US-ALXN-202408USA001252US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
242414601$24241460$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012757$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240823$$CN$US$US
242414611$24241461$1$I$20240723$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012907$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242414621$24241462$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013895$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240823$$CN$US$US
242414641$24241464$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012816$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240823$$CN$US$US
242414651$24241465$1$I$20240819$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013536$ELI LILLY AND CO$$$$A$M$Y$$$20240823$$HP$US$US
242414661$24241466$1$I$20240813$20240813$20240823$20240823$PER$$US-JNJFOC-20240834452$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
242414671$24241467$1$I$$20240813$20240823$20240823$EXP$$US-JNJFOC-20240840097$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240823$$MD$US$US
242414681$24241468$1$I$20240711$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012910$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242414701$24241470$1$I$$20240814$20240823$20240823$EXP$$CN-ROCHE-10000057052$ROCHE$Ji X, Jiang R, Liu T, Provencio M, Lee S, Zhan Q, et al. Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with leptomeningeal metastases harboring targetable mutations. Translational Lung Cancer Research. 2024-Jul-30;13 (7):1695-1707. doi:10.21037/tlcr-24-477.$65$YR$E$M$Y$$$20240823$$HP$CN$CN
242414712$24241471$2$F$$20240905$20240823$20240914$PER$$US-ROCHE-10000060808$ROCHE$$$$$F$Y$$$20240914$$HP$US$US
242414721$24241472$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170793$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242414732$24241473$2$F$$20240830$20240823$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004212$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242414742$24241474$2$F$$20240822$20240823$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004209$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
242414751$24241475$1$I$20240726$20240731$20240823$20240823$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004214$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240823$$CN$US$US
242414762$24241476$2$F$20240301$20240910$20240823$20240923$EXP$$US-UCBSA-2024042705$UCB$$25$YR$$F$Y$$$20240923$$CN$US$US
242414771$24241477$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004217$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
242414781$24241478$1$I$$20240731$20240823$20240823$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004213$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242414791$24241479$1$I$20240219$20240817$20240823$20240823$EXP$$CZ-GSK-CZ2024EME037570$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$MD$CZ$CZ
242414801$24241480$1$I$20240820$20240820$20240823$20240823$PER$$US-JNJFOC-20240855306$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$MD$US$US
242414811$24241481$1$I$$20240819$20240823$20240823$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001677$BLUEPRINT MEDICINES$$$$$M$Y$$$20240823$$CN$US$US
242414821$24241482$1$I$$20240814$20240823$20240823$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006047$BIOCON$$$$$$Y$$$20240823$$HP$CA$CA
242414831$24241483$1$I$$20240813$20240823$20240823$EXP$$US-TEVA-VS-3234710$TEVA$$36$YR$$F$Y$$$20240823$$HP$US$US
242414841$24241484$1$I$$20240821$20240823$20240823$PER$$US-ROCHE-10000063416$ROCHE$$37$YR$A$F$Y$$$20240823$$CN$US$US
242414851$24241485$1$I$20240820$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166718$AMGEN$$78$YR$E$M$Y$$$20240823$$CN$US$US
242414871$24241487$1$I$20240710$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012908$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242414881$24241488$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170791$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242414891$24241489$1$I$$20240821$20240823$20240823$PER$$US-ABBVIE-5890783$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242414902$24241490$2$F$20240815$20240906$20240823$20240909$PER$$US-AMGEN-USASP2024166614$AMGEN$$87$YR$E$F$Y$$$20240909$$CN$US$US
242414911$24241491$1$I$$20240723$20240823$20240823$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07488$LUPIN$$$$$$Y$$$20240823$$CN$US$US
242414921$24241492$1$I$$20240819$20240823$20240823$PER$$US-ROCHE-10000061187$ROCHE$$$$$$Y$$$20240823$$CN$US$US
242414931$24241493$1$I$$20240814$20240823$20240823$EXP$$SA-STERISCIENCE B.V.-2024-ST-001226$Steriscience PTE$Almaqati A, Alharthy F, Almani I, Bakhsh L.. IgG4-RELATED DISEASE IN WESTERN SAUDI ARABIA: A CASE SERIES.. Ann-Rheum-Dis. 2024;83 (Suppl. 1):2058-2059 abstr. AB1409.$18$YR$$F$Y$$$20240823$$HP$SA$SA
242414941$24241494$1$I$$20240819$20240823$20240823$PER$$US-ROCHE-10000062608$ROCHE$$$$$M$Y$$$20240823$$HP$US$US
242414951$24241495$1$I$$20240821$20240823$20240823$PER$$US-ROCHE-10000063732$ROCHE$$$$$$Y$$$20240823$$PH$US$US
242414961$24241496$1$I$$20240816$20240823$20240823$PER$$US-BIOGEN-2024BI01266711$BIOGEN$$$$$M$Y$$$20240823$$CN$US$US
242414971$24241497$1$I$$20240819$20240823$20240823$PER$$US-BIOGEN-2024BI01278941$BIOGEN$$$$$M$Y$$$20240823$$CN$US$US
242415002$24241500$2$F$$20240828$20240823$20240902$PER$$US-ALXN-202408USA001288US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242415011$24241501$1$I$$20240823$20240823$20240823$EXP$IT-MINISAL02-999493$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047415$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$65$KG$20240823$$MD$IT$IT
242415033$24241503$3$F$$20240830$20240823$20240905$EXP$$CA-HALEON-2187491$Haleon PLC$$17$YR$$F$Y$$$20240905$$CN$CA$CA
242415041$24241504$1$I$$20240821$20240823$20240823$PER$$US-ROCHE-10000063456$ROCHE$$32$YR$A$F$Y$$$20240823$$HP$US$US
242415051$24241505$1$I$20240101$20240814$20240823$20240823$EXP$$CA-CELLTRION INC.-2024CA011171$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
242415061$24241506$1$I$$20240819$20240823$20240823$EXP$$NVSC2024CA168072$NOVARTIS$$47$YR$$F$Y$$$20240823$$HP$CA$CA
242415071$24241507$1$I$20211130$20240809$20240823$20240823$EXP$$FR-SERVIER-S24010239$SERVIER$$$$$$Y$$$20240823$$MD$FR$FR
242415081$24241508$1$I$$20240822$20240823$20240823$PER$$US-ROCHE-10000064587$ROCHE$$23$YR$A$M$Y$$$20240823$$HP$US$US
242415091$24241509$1$I$20231001$20240814$20240823$20240823$EXP$$US-CHIESI-2024CHF05212$CHIESI$$30$YR$$F$Y$68$KG$20240823$$CN$US$US
242415101$24241510$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132074$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$73.48$KG$20240823$$CN$US$US
242415111$24241511$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131949$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240823$$CN$US$US
242415121$24241512$1$I$20240701$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133135$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240823$$HP$US$US
242415131$24241513$1$I$20231101$20240806$20240823$20240823$PER$$US-JNJFOC-20240819445$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240823$$CN$US$US
242415141$24241514$1$I$$20240819$20240823$20240823$EXP$$TH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046447$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$$$20240823$$PH$TH$TH
242415151$24241515$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-082318-2024$RECKITT BENCKISER$$$$$$Y$$$20240823$$CN$US$US
242415161$24241516$1$I$$20240816$20240823$20240823$EXP$$GB-AMGEN-GBRSP2024165550$AMGEN$$44$YR$A$F$Y$$$20240823$$CN$GB$GB
242415171$24241517$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133493$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$100.7$KG$20240823$$CN$US$US
242415181$24241518$1$I$20240714$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012866$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242415191$24241519$1$I$$20240820$20240823$20240823$EXP$CA-DRL-USA-SPO/CAN/24/0012139$CA-RDY-SPO/CAN/24/0012139$DR REDDYS$$74$YR$E$F$Y$63.96$KG$20240823$$CN$CA$CA
242415201$24241520$1$I$$20240806$20240823$20240823$PER$$US-009507513-2408USA002367$MERCK$$$$$M$Y$$$20240823$$CN$US$US
242415211$24241521$1$I$20240809$20240813$20240823$20240823$PER$$US-JNJFOC-20240834915$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$CN$US$US
242415221$24241522$1$I$20240701$20240815$20240823$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-022512$UNITED THERAPEUTICS$$54$YR$$M$Y$$$20240823$$$US$US
242415231$24241523$1$I$$20240814$20240823$20240823$30DAY$$US-GSK-US2024AMR101868$GLAXOSMITHKLINE$$$$$M$Y$$$20240823$$CN$US$US
242415241$24241524$1$I$$20240814$20240823$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-023534$UNITED THERAPEUTICS$$$$$F$Y$70.295$KG$20240823$$$US$US
242415261$24241526$1$I$$20240814$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013700$ELI LILLY AND CO$$$$$M$Y$$$20240823$$CN$US$US
242415271$24241527$1$I$$20240814$20240823$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-025502$UNITED THERAPEUTICS$$$$$F$Y$43.537$KG$20240823$$$US$US
242415281$24241528$1$I$$20240819$20240823$20240823$PER$$US-ALXN-202408USA001199US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242415291$24241529$1$I$20240601$20240820$20240823$20240823$EXP$$US-ABBVIE-5889125$ABBVIE$$70$YR$$F$Y$$$20240823$$CN$US$US
242415301$24241530$1$I$$20240814$20240823$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-025490$UNITED THERAPEUTICS$$$$$M$Y$87.982$KG$20240823$$$US$US
242415311$24241531$1$I$20240805$20240822$20240823$20240823$EXP$FR-AFSSAPS-RS2024000816$NVSC2024FR170228$NOVARTIS$$49$YR$$F$Y$50$KG$20240823$$PH$FR$FR
242415323$24241532$3$F$20240101$20240917$20240823$20240920$EXP$$CA-ABBVIE-5890762$ABBVIE$$61$YR$$M$Y$$$20240920$$CN$CA$CA
242415332$24241533$2$F$20240711$20240820$20240823$20240828$EXP$$AU-ABBVIE-5889858$ABBVIE$$68$YR$$M$Y$97$KG$20240828$$CN$AU$AU
242415341$24241534$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133356$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240823$$CN$US$US
242415351$24241535$1$I$20240804$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133254$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$78.02$KG$20240823$$CN$US$US
242415361$24241536$1$I$20240808$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133377$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240823$$CN$US$US
242415371$24241537$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-003195$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240823$$CN$US$US
242415381$24241538$1$I$20240726$20240822$20240823$20240823$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-133486$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$66$KG$20240823$$MD$DE$DE
242415391$24241539$1$I$$20240813$20240823$20240823$EXP$$CA-CHATTEMPRD-2023SA105203$CHATTEM$$31$MON$C$$Y$$$20240823$$CN$CA$CA
242415411$24241541$1$I$$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133579$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240823$$CN$US$US
242415421$24241542$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133291$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240823$$HP$US$US
242415431$24241543$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132435$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240823$$HP$US$US
242415441$24241544$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133455$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240823$$CN$US$US
242415451$24241545$1$I$$20240821$20240823$20240823$EXP$$CN-TAKEDA-2024TUS047328$TAKEDA$$$$$M$Y$$$20240823$$CN$CN$CN
242415461$24241546$1$I$$20240820$20240823$20240823$EXP$$BR-ABBVIE-5889744$ABBVIE$$63$YR$$F$Y$$$20240823$$MD$BR$BR
242415481$24241548$1$I$$20240819$20240823$20240823$PER$$US-LEO Pharma-372908$LEO PHARM$$62$YR$$F$Y$94$KG$20240823$$CN$US$US
242415492$24241549$2$F$20240820$20240906$20240823$20240909$PER$$US-AMGEN-USASP2024166305$AMGEN$$66$YR$E$M$Y$$$20240909$$CN$US$US
242415502$24241550$2$F$$20240819$20240823$20240830$EXP$$DE-AUROBINDO-AUR-APL-2024-040776$AUROBINDO$Bingert R, Kolbe V, Boy D, Buttner A. Suicide of minors-Retrospective 22-year analysis of the postmortem and autopsy material of the Institute of Forensic Medicine Rostock. Rechtsmedizin. 2023;33(5):396-402$14$YR$$F$Y$$$20240830$$MD$DE$DE
242415511$24241551$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170659$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242415521$24241552$1$I$20190901$20190926$20240823$20240823$EXP$$CO-TERSERA THERAPEUTICS LLC-2019TRS002193$TERSERA THERAPEUTICS$$$$$$Y$$$20240823$$CN$CO$CO
242415531$24241553$1$I$20240106$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-082747-2024$RECKITT BENCKISER$$$$$M$Y$$$20240823$$CN$US$US
242415541$24241554$1$I$$20240607$20240823$20240823$PER$$US-CHIESI-2024CHF03495$CHIESI$$20$YR$$M$Y$$$20240823$$CN$US$US
242415551$24241555$1$I$$20240815$20240823$20240823$PER$$US-CHATTEMPRD-2024OHG027971$CHATTEM$$$$$F$Y$$$20240823$$CN$US$US
242415561$24241556$1$I$20240525$20240528$20240823$20240823$PER$$US-CHIESI-2024CHF03159$CHIESI$$27$YR$$M$Y$$$20240823$$HP$US$US
242415571$24241557$1$I$20240401$20240612$20240823$20240823$PER$$US-CHIESI-2024CHF03574$CHIESI$$45$YR$$F$Y$$$20240823$$CN$US$US
242415581$24241558$1$I$20240503$20240603$20240823$20240823$PER$$US-CHIESI-2024CHF03347$CHIESI$$19$YR$$M$Y$$$20240823$$CN$US$US
242415591$24241559$1$I$20240101$20240606$20240823$20240823$PER$$US-CHIESI-2024CHF03453$CHIESI$$$$$F$Y$$$20240823$$CN$US$US
242415601$24241560$1$I$$20240729$20240823$20240823$PER$$US-CHIESI-2024CHF03445$CHIESI$$26$YR$$M$Y$$$20240823$$CN$US$US
242415611$24241561$1$I$20240201$20240614$20240823$20240823$PER$$US-CHIESI-2024CHF03626$CHIESI$$23$YR$$F$Y$$$20240823$$CN$US$US
242415621$24241562$1$I$20240122$20240821$20240823$20240823$EXP$$AU-TAKEDA-2024TUS012045$TAKEDA$$45$YR$$F$Y$$$20240823$$CN$AU$AU
242415631$24241563$1$I$20240806$20240812$20240823$20240823$EXP$GB-MHRA-MED-202408071721281860-WBQZJ$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-07777$HIKMA$$44$YR$$F$Y$$$20240823$$HP$GB$GB
242415641$24241564$1$I$$20240819$20240823$20240823$EXP$$US-ABBVIE-5889020$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242415652$24241565$2$F$20240101$20240822$20240823$20240823$PER$$US-AMGEN-USASP2024165129$AMGEN$$82$YR$E$M$Y$$$20240823$$CN$US$US
242415662$24241566$2$F$20240819$20240920$20240823$20240923$PER$$US-AMGEN-USASP2024166821$AMGEN$$77$YR$E$M$Y$$$20240923$$CN$US$US
242415672$24241567$2$F$$20240815$20240823$20240830$PER$$US-AMGEN-USASP2024167623$AMGEN$$41$YR$A$F$Y$$$20240829$$CN$US$US
242415681$24241568$1$I$20240819$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166732$AMGEN$$74$YR$E$M$Y$$$20240823$$CN$US$US
242415701$24241570$1$I$20240809$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132737$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240823$$CN$US$US
242415711$24241571$1$I$20240820$20240820$20240823$20240823$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-132438$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$74.39$KG$20240823$$CN$PR$PR
242415721$24241572$1$I$20220416$20240819$20240823$20240823$EXP$IT-CELLTRION INC.-2024IT018626$IT-ROCHE-10000060302$ROCHE$$76$YR$E$M$Y$71$KG$20240823$$MD$IT$IT
242415731$24241573$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132280$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$76.2$KG$20240823$$CN$US$US
242415741$24241574$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133536$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240823$$HP$US$US
242415751$24241575$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132065$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240823$$HP$US$US
242415761$24241576$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132159$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240823$$CN$US$US
242415772$24241577$2$F$$20240911$20240823$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133413$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240912$$CN$US$US
242415781$24241578$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132896$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$62.6$KG$20240823$$CN$US$US
242415791$24241579$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133224$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240823$$HP$US$US
242415802$24241580$2$F$$20240918$20240823$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133195$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240920$$HP$US$US
242415811$24241581$1$I$$20240820$20240823$20240823$EXP$$BG-ABBVIE-5887494$ABBVIE$$72$YR$$F$Y$$$20240823$$CN$BG$BG
242415821$24241582$1$I$$20240821$20240823$20240823$PER$$US-ROCHE-10000063535$ROCHE$$28$YR$A$M$Y$$$20240823$$HP$US$US
242415831$24241583$1$I$20240101$20240819$20240823$20240823$EXP$$AU-ABBVIE-5888279$ABBVIE$$$$$F$Y$$$20240823$$CN$AU$AU
242415841$24241584$1$I$$20240818$20240823$20240823$PER$$US-JNJFOC-20240849622$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
242415851$24241585$1$I$20240821$20240821$20240823$20240823$PER$$US-JNJFOC-20240854908$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$CN$US$US
242415862$24241586$2$F$20240109$20240916$20240823$20240923$EXP$$CA-TAKEDA-2024TUS083317$TAKEDA$$82$YR$$M$Y$$$20240923$$CN$CA$CA
242415872$24241587$2$F$$20240810$20240823$20240823$EXP$$CA-TERSERA THERAPEUTICS LLC-2024TRS004094$TERSERA THERAPEUTICS$$$$$$Y$$$20240823$$MD$CA$CA
242415882$24241588$2$F$20240701$20240826$20240823$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07398$LUPIN$$$$$$Y$$$20240913$$CN$US$US
242415891$24241589$1$I$$20240821$20240823$20240823$EXP$$BG-ABBVIE-5890744$ABBVIE$$66$YR$$M$Y$$$20240823$$CN$BG$BG
242415902$24241590$2$F$$20240821$20240823$20240827$PER$$US-AMGEN-USASP2024167950$AMGEN$$$$A$F$Y$$$20240827$$HP$US$US
242415911$24241591$1$I$$20240813$20240823$20240823$EXP$$US-NOVITIUMPHARMA-2024USNVP01634$NOVITIUM PHARMA$Megan Murphy.Acute Onset of Abdominal Pain in a 3-year-old Boy with Acute Lymphoblastic Leukemia.Pediatrics In Review.01-OCT-2023;44(1):S106-S109$3$YR$C$M$Y$$$20240823$$HP$US$US
242415921$24241592$1$I$$20240816$20240823$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-025839$UNITED THERAPEUTICS$$$$$F$Y$61.224$KG$20240823$$$US$US
242415931$24241593$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167510$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242415941$24241594$1$I$20211101$20240702$20240823$20240823$EXP$$CH-ROCHE-10000024494$ROCHE$$74$YR$E$M$Y$$$20240823$$MD$CH$CH
242415951$24241595$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-040648$AUROBINDO$Nettleton E, Sattui SE, Wallace Z, Putman M.. Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide. Arthritis-Care-Res-(Hoboken). 2024;76(2):288-294$79$YR$$F$Y$$$20240823$$HP$US$US
242415971$24241597$1$I$20240806$20240814$20240823$20240823$PER$$US-ABBVIE-5881654$ABBVIE$$33$YR$$F$Y$$$20240823$$CN$US$US
242415981$24241598$1$I$$20240821$20240823$20240823$EXP$$JP-EMD Serono-2024045150$EMD SERONO INC$$$$E$F$Y$$$20240823$$PH$JP$JP
242415991$24241599$1$I$20240101$20240819$20240823$20240823$EXP$$US-ABBVIE-5888904$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242416001$24241600$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-040822$AUROBINDO$Harvey RD, Franz JK, Joseph NS, Kaufman JL, Hitron E, Collins H, et al. A Phase 2 Evaluation of Daratumumab-Based Induction Therapy in Multiple Myeloma Patients with Severe Renal Insufficiency. Blood. 2022;140 (Suppl.):12633-12634$$$$$Y$$$20240823$$HP$US$US
242416031$24241603$1$I$20240101$20240821$20240823$20240823$EXP$$US-ABBVIE-5889682$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242416041$24241604$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133401$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$65.77$KG$20240823$$HP$US$US
242416051$24241605$1$I$20240715$20240815$20240823$20240823$EXP$$US-CHIESI-2024CHF05254$CHIESI$$46$YR$$F$Y$50$KG$20240823$$CN$US$US
242416063$24241606$3$F$$20240903$20240823$20240911$EXP$$US-AUROBINDO-AUR-APL-2024-041567$AUROBINDO$$71$YR$$F$Y$58.9$KG$20240911$$CN$US$US
242416071$24241607$1$I$$20240812$20240823$20240823$EXP$$IT-AUROBINDO-AUR-APL-2024-040745$AUROBINDO$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ-Genom-Precis-Med. 2024;17(2):E004353$1$YR$$M$Y$$$20240823$$HP$IT$IT
242416083$24241608$3$F$20210101$20240813$20240823$20240823$EXP$GB-MLMSERVICE-20240808-PI154234-00270-3$GB-STRIDES ARCOLAB LIMITED-2024SP010414$STRIDES$Illango A, Laws P.. A 12-month history of a progressive rash on a background of significant long-term immunosuppression.. British Journal of Dermatology.. 2024;191(Suppl 1):i153-4$52$YR$$$Y$$$20240823$$HP$GB$GB
242416091$24241609$1$I$20220624$20240812$20240823$20240823$EXP$$ES-AUROBINDO-AUR-APL-2024-041222$AUROBINDO$$65$YR$$M$Y$$$20240823$$PH$ES$ES
242416101$24241610$1$I$$20240810$20240823$20240823$EXP$GB-MHRA-MED-202408091852555040-WQTBF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19042$ALKEM$$$$$M$Y$$$20240823$$CN$GB$GB
242416111$24241611$1$I$$20240810$20240823$20240823$EXP$GB-MHRA-MED-202408091442060030-DQZMP$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19023$ALKEM$$$$$M$Y$$$20240823$$CN$GB$GB
242416121$24241612$1$I$$20240810$20240823$20240823$EXP$GB-MHRA-MED-202408091843549660-ZLBWM$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19041$ALKEM$$$$$M$Y$$$20240823$$CN$GB$GB
242416141$24241614$1$I$20240723$20240810$20240823$20240823$EXP$GB-MHRA-TPP10528462C7577969YC1723125497215$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18961$ALKEM$$38$YR$$F$Y$51$KG$20240823$$HP$GB$GB
242416151$24241615$1$I$20240301$20240816$20240823$20240823$EXP$DK-DKMA-30737279$DK-ROCHE-10000059744$ROCHE$$78$YR$E$F$Y$$$20240823$$MD$DK$DK
242416171$24241617$1$I$20230718$20240812$20240823$20240823$EXP$$IT-AUROBINDO-AUR-APL-2024-041042$AUROBINDO$$80$YR$$F$Y$$$20240823$$MD$IT$IT
242416181$24241618$1$I$$20240810$20240823$20240823$EXP$$SE-ALKEM LABORATORIES LIMITED-SE-ALKEM-2024-19252$ALKEM$Lindblad R, Rodjer S. A case of severe pancytopenia caused by ibuprofen. J Intern Med. 1991;229:281-3$$$$$Y$$$20240823$$HP$SE$SE
242416191$24241619$1$I$$20240821$20240823$20240823$EXP$$NVSC2024NZ170432$NOVARTIS$$$$$$Y$$$20240823$$CN$NZ$NZ
242416201$24241620$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA168833$NOVARTIS$$43$YR$$F$Y$$$20240823$$CN$CA$CA
242416211$24241621$1$I$$20240819$20240823$20240823$PER$$US-BIOGEN-2019BI00680195$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
242416221$24241622$1$I$$20240820$20240823$20240823$EXP$$CA-ORGANON-O2408CAN001510$ORGANON$Unknown. Unknown. Unknown. Unk$45$YR$$F$Y$$$20240823$$HP$CA$CA
242416232$24241623$2$F$$20240826$20240823$20240830$PER$$US-BIOGEN-2024BI01279038$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
242416241$24241624$1$I$20240722$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166691$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242416251$24241625$1$I$$20240815$20240823$20240823$EXP$$CA-AMGEN-CANSP2024166800$AMGEN$$$$$$Y$$$20240823$$MD$CA$CA
242416261$24241626$1$I$20240819$20240819$20240823$20240823$EXP$$PK-ROCHE-10000060490$ROCHE$$26$YR$A$F$Y$$$20240823$$CN$PK$PK
242416271$24241627$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013466$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240823$$CN$US$US
242416281$24241628$1$I$$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014368$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240823$$CN$US$US
242416293$24241629$3$F$20240801$20240826$20240823$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408012232$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240828$$CN$US$US
242416301$24241630$1$I$20240820$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013706$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240823$$CN$US$US
242416311$24241631$1$I$20240229$20240812$20240823$20240823$EXP$$ES-AUROBINDO-AUR-APL-2024-041264$AUROBINDO$$30$YR$$M$Y$$$20240823$$MD$ES$ES
242416321$24241632$1$I$$20240812$20240823$20240823$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07705$HIKMA$$$$$F$Y$$$20240823$$CN$US$US
242416331$24241633$1$I$$20240812$20240823$20240823$EXP$$GB-AUROBINDO-AUR-APL-2024-040900$AUROBINDO$$$$$M$Y$$$20240823$$PH$GB$GB
242416351$24241635$1$I$20240816$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166775$AMGEN$$80$YR$E$F$Y$$$20240823$$CN$US$US
242416363$24241636$3$F$$20240828$20240823$20240906$EXP$$NL-AUROBINDO-AUR-APL-2024-041556$AUROBINDO$$50$YR$$F$Y$113$KG$20240906$$CN$NL$NL
242416371$24241637$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133115$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240823$$CN$US$US
242416381$24241638$1$I$20240701$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132542$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240823$$HP$US$US
242416391$24241639$1$I$20240801$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132029$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$63.39$KG$20240823$$HP$US$US
242416402$24241640$2$F$$20240918$20240823$20240927$EXP$$US-ROCHE-10000017496$ROCHE$$79$YR$E$F$Y$52.62$KG$20240927$$CN$US$US
242416413$24241641$3$F$$20240822$20240823$20240905$PER$$US-ROCHE-10000061103$ROCHE$$$$$$Y$$$20240905$$MD$US$US
242416421$24241642$1$I$20240613$20240814$20240823$20240823$EXP$$JP-ROCHE-10000060446$ROCHE$$82$YR$E$M$Y$55.6$KG$20240823$$PH$JP$JP
242416441$24241644$1$I$$20240819$20240823$20240823$PER$$US-ALXN-202408USA001195US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$HP$US$US
242416451$24241645$1$I$$20240820$20240823$20240823$PER$$US-ALXN-202408USA001226US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242416462$24241646$2$F$20240101$20240917$20240823$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132283$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$61.23$KG$20240918$$CN$US$US
242416471$24241647$1$I$$20240819$20240823$20240823$PER$$US-BIOGEN-2024BI01278872$BIOGEN$$$$$M$Y$$$20240823$$CN$US$US
242416491$24241649$1$I$20240801$20240814$20240823$20240823$PER$$US-ABBVIE-5881829$ABBVIE$$$$$$Y$$$20240823$$CN$US$US
242416501$24241650$1$I$$20240820$20240823$20240823$EXP$$IN-ROCHE-10000062600$ROCHE$$76$YR$E$F$Y$$$20240823$$CN$IN$IN
242416511$24241651$1$I$$20240822$20240823$20240823$PER$$US-GILEAD-2024-0685030$GILEAD$$$$$$Y$$$20240823$$CN$US$US
242416521$24241652$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170837$NOVARTIS$$83$YR$$F$Y$$$20240823$$MD$US$US
242416531$24241653$1$I$20240807$20240812$20240823$20240823$EXP$GB-MHRA-MED-202408121516162620-BZVQH$GB-ADVANZ PHARMA-202408006785$ADVANZ PHARMA$$$$$$Y$$$20240823$$HP$GB$GB
242416541$24241654$1$I$$20240819$20240823$20240823$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001682$BLUEPRINT MEDICINES$$$$$M$Y$$$20240823$$CN$US$US
242416553$24241655$3$F$20240101$20240919$20240823$20240926$EXP$$ES-ABBVIE-5885824$ABBVIE$$$$$F$Y$70$KG$20240926$$HP$ES$ES
242416561$24241656$1$I$20240110$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-083613-2024$RECKITT BENCKISER$$$$$M$Y$$$20240823$$CN$US$US
242416571$24241657$1$I$$20240813$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129544$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240823$$CN$US$US
242416581$24241658$1$I$$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133396$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240823$$CN$US$US
242416591$24241659$1$I$$20240813$20240823$20240823$EXP$$US-TARSUS PHARMACEUTICALS-TSP-US-2024-000342$Tarsus Pharmaceuticals$$93$YR$$F$Y$$$20240823$$MD$US$US
242416601$24241660$1$I$$20240819$20240823$20240823$EXP$$IR-Bion-013717$BIONPHARMA$$38$YR$A$F$Y$$$20240823$$HP$IR$IR
242416611$24241661$1$I$$20240816$20240823$20240823$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001669$BLUEPRINT MEDICINES$$$$$F$Y$$$20240823$$CN$US$US
242416621$24241662$1$I$$20240814$20240823$20240823$EXP$$US-Bion-013715$BIONPHARMA$$$$E$F$Y$$$20240823$$CN$US$US
242416632$24241663$2$F$20240101$20240822$20240823$20240905$EXP$$US-UCBSA-2024041077$UCB$$$$$M$Y$$$20240905$$MD$US$US
242416641$24241664$1$I$20240709$20240816$20240823$20240823$EXP$$CN-BEIGENE-BGN-2024-012909$BEIGENE$$$$$$Y$$$20240823$$HP$CN$CN
242416651$24241665$1$I$$20240810$20240823$20240823$EXP$$GB-CIPLA LTD.-2024GB08875$CIPLA$$$$$$Y$$$20240823$$CN$GB$GB
242416662$24241666$2$F$$20240826$20240823$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07515$LUPIN$$$$$$Y$$$20240913$$CN$US$US
242416671$24241667$1$I$$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167514$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242416681$24241668$1$I$$20240819$20240823$20240823$EXP$$CA-AMGEN-CANSP2024167142$AMGEN$$55$YR$A$F$Y$$$20240823$$HP$CA$CA
242416693$24241669$3$F$$20240819$20240823$20240826$EXP$$US-ROCHE-10000060169$ROCHE$Huda T, Hussain F, Mani H, Gheith S, Skandan S. Rituximab-Associated Liver Toxicity Without Known Viral Reactivation. Cureus. 2024-Jul-11;16 (7):11-5. doi:10.7759/cureus.64331.$52$YR$A$M$Y$$$20240826$$HP$US$US
242416701$24241670$1$I$20200101$20240820$20240823$20240823$EXP$$US-ROCHE-10000062233$ROCHE$$48$YR$A$M$Y$$$20240823$$CN$US$US
242416711$24241671$1$I$20240809$20240820$20240823$20240823$EXP$$CO-UCBSA-2024042717$UCB$$10$YR$$M$Y$$$20240823$$CN$CO$CO
242416722$24241672$2$F$20240315$20240916$20240823$20240919$EXP$IT-MINISAL02-998458$IT-UCBSA-2024042285$UCB$$30$YR$$F$Y$69$KG$20240919$$MD$IT$IT
242416731$24241673$1$I$$20240819$20240823$20240823$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001687$BLUEPRINT MEDICINES$$$$$M$Y$$$20240823$$CN$US$US
242416741$24241674$1$I$$20240814$20240823$20240823$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07834$HIKMA$Walterscheid B, Batchinsky M, Tarbox M. Walterscheid B, Batchinsky M, Tarbox M. Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Preceding Toxic Epidermal Necrolysis Secondary to Sildenafil: A Case Report. Cureus. 2024;16(7):e63922$$$$F$Y$$$20240823$$MD$US$US
242416751$24241675$1$I$$20240816$20240823$20240823$EXP$$AU-CHEPLA-2024010754$CHEPLAPHARM$$62$YR$$M$Y$$$20240823$$HP$COUNTRY NOT SPECIFIED$AU
242416761$24241676$1$I$$20240809$20240823$20240823$EXP$$US-ALVOGEN-2024095327$ALVOGEN$Kim M, Arabi J, McCoy C, D?Souza A, Chhabra S, Abid MB, Thapa B, Dhakal B. Safety of Dapsone for Pneumocystis Jiroveci Pneumonia Prophylaxis in Patients With Multiple Myeloma. Clinical Lymphoma, Myeloma and Leukemia. 2024;000 (xxx):1-4. doi:https://doi.org/10.1016/j.clml.2024.06.010$64$YR$$M$Y$$$20240823$$HP$US$US
242416771$24241677$1$I$$20240815$20240823$20240823$EXP$$US-JNJFOC-20240841232$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$HP$US$US
242416781$24241678$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-087281-2024$RECKITT BENCKISER$$$$$$Y$$$20240823$$CN$US$US
242416791$24241679$1$I$$20240819$20240823$20240823$EXP$$CA-HALEON-2192884$Haleon PLC$$44$YR$$F$Y$97$KG$20240823$$MD$CA$CA
242416801$24241680$1$I$$20240809$20240823$20240823$EXP$$US-ALVOGEN-2024095325$ALVOGEN$Kim M, Arabi J, McCoy C, D?Souza A, Chhabra S, Abid M B, Thapa B, Dhakal B. Safety of Dapsone for Pneumocystis Jiroveci Pneumonia Prophylaxis in Patients With Multiple Myeloma. Clinical Lymphoma, Myeloma and Leukemia. 2024;000 (xxx):1-4. doi:https://doi.org/10.1016/j.clml.2024.06.010$72$YR$$M$Y$$$20240823$$HP$US$US
242416811$24241681$1$I$20240611$20240812$20240823$20240823$EXP$$ES-AUROBINDO-AUR-APL-2024-041163$AUROBINDO$$73$YR$$M$Y$$$20240823$$MD$ES$ES
242416832$24241683$2$F$$20240826$20240823$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07438$LUPIN$$$$$$Y$$$20240913$$CN$US$US
242416841$24241684$1$I$20240701$20240814$20240823$20240823$EXP$FR-AFSSAPS-AVLY2024000130$FR-TEVA-VS-3233895$TEVA$$22$YR$$F$Y$$$20240823$$MD$FR$FR
242416852$24241685$2$F$20240809$20240813$20240823$20240823$PER$$US-TEVA-VS-3234527$TEVA$$12$YR$$F$Y$$$20240823$$CN$US$US
242416861$24241686$1$I$20240801$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133404$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$91.63$KG$20240823$$CN$US$US
242416872$24241687$2$F$20240101$20240917$20240823$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131674$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240918$$HP$US$US
242416883$24241688$3$F$$20240911$20240823$20240923$PER$$US-ROCHE-10000061087$ROCHE$$72$YR$E$M$Y$$$20240923$$MD$US$US
242416891$24241689$1$I$$20240813$20240823$20240823$EXP$$HK-ROCHE-10000060888$ROCHE$$$$$$Y$$$20240823$$MD$HK$HK
242416901$24241690$1$I$$20240813$20240823$20240823$EXP$$US-CORIUM, LLC-2024COR000155$CORIUM$$$$$$Y$$$20240823$$$US$US
242416911$24241691$1$I$20240820$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166786$AMGEN$$69$YR$E$F$Y$$$20240823$$CN$US$US
242416922$24241692$2$F$$20240823$20240823$20240827$PER$$US-AMGEN-USASP2024166482$AMGEN$$$$$M$Y$$$20240826$$CN$US$US
242416931$24241693$1$I$20190101$20240819$20240823$20240823$EXP$$US-009507513-2408USA006878$MERCK$$$$$M$Y$$$20240823$$HP$US$US
242416942$24241694$2$F$20221109$20240906$20240823$20240913$EXP$$US-AMGEN-USASP2024166010$AMGEN$$56$YR$A$F$Y$$$20240913$$LW$US$US
242416952$24241695$2$F$20240809$20240813$20240823$20240903$EXP$$US-BEH-2024177419$CSL BEHRING$$63$YR$A$M$Y$$$20240903$$CN$US$US
242416962$24241696$2$F$$20240826$20240823$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07452$LUPIN$$$$$$Y$$$20240913$$CN$US$US
242416971$24241697$1$I$20240819$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011685$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240823$$CN$US$US
242416981$24241698$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012889$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240823$$CN$US$US
242416992$24241699$2$F$$20240821$20240823$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014573$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240827$$CN$US$US
242417001$24241700$1$I$20240816$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012875$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240823$$CN$US$US
242417011$24241701$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012088$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240823$$CN$US$US
242417021$24241702$1$I$$20240822$20240823$20240823$PER$$US-HALEON-2193258$Haleon PLC$$$$$$Y$$$20240823$$CN$US$US
242417031$24241703$1$I$$20240809$20240823$20240823$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111095$ZYDUS PHARM$Harmouch W, Zhang JR, Peterson JM, Uran DP, Buja LM, Zhao B, et al.. A challenging case of eosinophilic myocarditis leading to heart failure and transplantation.. Cardiovasc-Pathol. 2024$$$$$Y$$$20240823$$HP$US$US
242417042$24241704$2$F$$20240829$20240823$20240907$EXP$$US-AUROBINDO-AUR-APL-2024-028975$AUROBINDO$Sahly AN, Buhas D, Myers KA. MT-TA Pathogenic variants may cause developmental and epileptic encephalopathy without myopathy. Am-J-Med-Genet-A. 2022;188(10):3135-3138$$$$F$Y$$$20240907$$HP$US$US
242417051$24241705$1$I$$20240819$20240823$20240823$PER$$US-ROCHE-10000061794$ROCHE$$66$YR$E$F$Y$$$20240823$$HP$US$US
242417061$24241706$1$I$$20240815$20240823$20240823$EXP$$CA-CELLTRION INC.-2021CA008729$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
242417071$24241707$1$I$20240601$20240820$20240823$20240823$EXP$CH-SM-2024-14333$CH-SANDOZ INC.-SDZ2024CH074025$SANDOZ$$73$YR$$M$Y$90$KG$20240823$$MD$CH$CH
242417081$24241708$1$I$20240819$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167776$AMGEN$$53$YR$A$$Y$$$20240823$$CN$US$US
242417091$24241709$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-140277-2023$RECKITT BENCKISER$$$$$F$Y$$$20240823$$CN$US$US
242417101$24241710$1$I$$20240819$20240823$20240823$EXP$$CA-AMGEN-CANSP2024165447$AMGEN$$48$YR$A$F$Y$$$20240823$$PH$CA$CA
242417111$24241711$1$I$$20240724$20240823$20240823$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07353$LUPIN$$$$$$Y$$$20240823$$CN$US$US
242417131$24241713$1$I$20240701$20240819$20240823$20240823$EXP$$AR-JNJFOC-20240850889$JOHNSON AND JOHNSON$$63$YR$A$F$Y$65$KG$20240823$$CN$AR$AR
242417141$24241714$1$I$$20240814$20240823$20240823$EXP$$CA-JNJFOC-20240849125$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240823$$HP$CA$CA
242417161$24241716$1$I$$20240813$20240823$20240823$EXP$$US-CORIUM, LLC-2024COR000156$CORIUM$$$$T$F$Y$$$20240823$$$US$US
242417173$24241717$3$F$20240924$20240920$20240823$20240928$EXP$$CA-TAKEDA-2024TUS083334$TAKEDA$$65$YR$$F$Y$$$20240928$$CN$CA$CA
242417181$24241718$1$I$$20240821$20240823$20240823$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047274$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240823$$CN$CA$CA
242417191$24241719$1$I$20231010$20240814$20240823$20240823$EXP$$US-ALVOGEN-2024095355$ALVOGEN$$80$YR$$F$Y$$$20240823$$CN$US$US
242417201$24241720$1$I$20240814$20240820$20240823$20240823$EXP$$JP-ROCHE-10000064247$ROCHE$$68$YR$E$F$Y$$$20240823$$PH$JP$JP
242417211$24241721$1$I$20240731$20240814$20240823$20240823$EXP$FR-AFSSAPS-BX2024001618$FR-TEVA-VS-3233873$TEVA$$17$MON$$F$Y$9.6$KG$20240823$$HP$FR$FR
242417221$24241722$1$I$$20240821$20240823$20240823$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-141724$DAIICHI$$$$$F$Y$$$20240823$$CN$US$US
242417231$24241723$1$I$$20240819$20240823$20240823$EXP$$CA-ROCHE-10000060430$ROCHE$$52$YR$A$M$Y$$$20240823$$HP$CA$CA
242417241$24241724$1$I$$20240822$20240823$20240823$PER$$US-GILEAD-2024-0685031$GILEAD$$$$$$Y$$$20240823$$CN$US$US
242417252$24241725$2$F$20240607$20240827$20240823$20240904$PER$$CA-TOLMAR, INC.-24CA051931$TOLMAR$$81$YR$$M$Y$$$20240904$$CN$CA$CA
242417261$24241726$1$I$$20240814$20240823$20240823$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07835$HIKMA$Walterscheid B, Batchinsky M, Tarbox M. Walterscheid B, Batchinsky M, Tarbox M. Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Preceding Toxic Epidermal Necrolysis Secondary to Sildenafil: A Case Report. Cureus. 2024;16(7):e63922$66$YR$$F$Y$$$20240823$$MD$US$US
242417272$24241727$2$F$20240810$20240821$20240823$20240829$EXP$$NL-TOLMAR, INC.-24NL051966$TOLMAR$$76$YR$$M$Y$$$20240829$$CN$NL$NL
242417291$24241729$1$I$$20240724$20240823$20240823$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07517$LUPIN$$$$$$Y$$$20240823$$CN$US$US
242417321$24241732$1$I$20240101$20240809$20240823$20240823$EXP$$US-COOPERSURGICAL, INC.-2024CPS002474$COOPERSURGICAL$$$$$F$Y$69.388$KG$20240822$$HP$US$US
242417331$24241733$1$I$$20240816$20240823$20240823$EXP$$US-GSK-US2024102468$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$US$US
242417341$24241734$1$I$$20240819$20240823$20240823$PER$$US-BIOGEN-2020BI00953621$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
242417351$24241735$1$I$$20240816$20240823$20240823$PER$$US-AMGEN-USASP2024165043$AMGEN$$$$$$Y$$$20240823$$MD$US$US
242417361$24241736$1$I$20240820$20240821$20240823$20240823$EXP$$US-GILEAD-2024-0685062$GILEAD$$39$YR$A$M$Y$$$20240823$$CN$US$US
242417371$24241737$1$I$$20240820$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA015337$SANDOZ$$$$$M$Y$$$20240823$$MD$CA$CA
242417382$24241738$2$F$$20240815$20240823$20240823$PER$$US-ROCHE-10000058493$ROCHE$$$$A$M$Y$$$20240823$$HP$US$US
242417391$24241739$1$I$$20240822$20240823$20240823$PER$$US-HALEON-2193262$Haleon PLC$$66$YR$$F$Y$$$20240823$$CN$US$US
242417401$24241740$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131908$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240823$$CN$US$US
242417411$24241741$1$I$$20240816$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131230$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240823$$CN$US$US
242417431$24241743$1$I$$20240821$20240823$20240823$EXP$$NVSC2024ZA165522$NOVARTIS$$64$YR$$M$Y$$$20240823$$CN$ZA$ZA
242417441$24241744$1$I$20240705$20240820$20240823$20240823$EXP$$CO-JNJFOC-20240854733$JOHNSON AND JOHNSON$$43$YR$A$F$Y$75$KG$20240823$$HP$CO$CO
242417452$24241745$2$F$20240815$20240820$20240823$20240829$PER$$US-AMGEN-USASP2024166666$AMGEN$$83$YR$E$M$Y$$$20240828$$CN$US$US
242417461$24241746$1$I$$20240810$20240823$20240823$EXP$$US-IBSA PHARMA INC.-2024IBS000376$IBSA INSTITUT BIOCHIMIQUE$Mastandrea K, Barnett N, Bononi P. et al.. A Near Miss: Acromegaly in a Patient with Anaphylaxis to Thyroid Hormone Replacement. Endocrine Practice. 2024;30:S105$60$YR$$F$Y$$$20240823$$MD$US$US
242417473$24241747$3$F$20240819$20240910$20240823$20240918$EXP$$US-BEH-2024177128$CSL BEHRING$$39$YR$A$F$Y$60$KG$20240918$$HP$US$US
242417481$24241748$1$I$$20240808$20240823$20240823$EXP$$US-ARDELYX-2024ARDX005324$ARDELYX$$$$$F$Y$$$20240823$$HP$US$US
242417493$24241749$3$F$20240813$20240916$20240823$20240925$EXP$$US-ARDELYX-2024ARDX006299$ARDELYX$$83$YR$$M$Y$87.574$KG$20240925$$HP$US$US
242417502$24241750$2$F$20240101$20240923$20240823$20240930$EXP$$US-SANDOZ INC.-SDZ2024US074797$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
242417511$24241751$1$I$20240806$20240812$20240823$20240823$EXP$$ES-AUROBINDO-AUR-APL-2024-041312$AUROBINDO$$68$YR$$F$Y$50$KG$20240823$$PH$ES$ES
242417521$24241752$1$I$20240712$20240822$20240823$20240823$EXP$CH-MEN-2024-108128$CH-MEN-2024-108128$MENARINI$$$$$M$Y$$$20240823$$MD$CH$CH
242417532$24241753$2$F$$20240828$20240823$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133241$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240906$$CN$US$US
242417541$24241754$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133194$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240823$$HP$US$US
242417552$24241755$2$F$$20240822$20240823$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133158$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240826$$PH$US$US
242417561$24241756$1$I$$20240723$20240823$20240823$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07439$LUPIN$$$$$$Y$$$20240823$$CN$US$US
242417571$24241757$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-139750-2023$RECKITT BENCKISER$$$$$$Y$$$20240823$$CN$US$US
242417581$24241758$1$I$20240601$20240820$20240823$20240823$EXP$$US-KYOWAKIRIN-2024KK019611$KYOWA$$$$$$Y$$$20240823$$HP$US$US
242417591$24241759$1$I$20240731$20240819$20240823$20240823$EXP$$US-GILEAD-2024-0684690$GILEAD$$68$YR$E$M$Y$$$20240823$$CN$US$US
242417601$24241760$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012910$ELI LILLY AND CO$$68$YR$E$M$Y$136$KG$20240823$$CN$US$US
242417611$24241761$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012937$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240823$$CN$US$US
242417621$24241762$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012863$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240823$$CN$US$US
242417631$24241763$1$I$20240822$20240822$20240823$20240823$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047446$BOEHRINGER INGELHEIM$$70$YR$E$$Y$$$20240823$$CN$US$US
242417641$24241764$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012440$ELI LILLY AND CO$$55$YR$A$$Y$$$20240823$$LW$US$US
242417652$24241765$2$F$20240801$20240820$20240823$20240826$30DAY$$US-ELI_LILLY_AND_COMPANY-US202408012761$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240826$$CN$US$US
242417661$24241766$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012992$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240823$$CN$US$US
242417671$24241767$1$I$$20240821$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074615$SANDOZ$$68$YR$$M$Y$64$KG$20240823$$PH$CA$CA
242417691$24241769$1$I$$20240815$20240823$20240823$EXP$$US-JNJFOC-20240842333$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$MD$US$US
242417701$24241770$1$I$$20240816$20240823$20240823$30DAY$$KZ-JNJFOC-20240857161$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$KZ$KZ
242417711$24241771$1$I$20240715$20240816$20240823$20240823$EXP$ES-AEMPS-1556354$ES-ROCHE-10000059166$ROCHE$$61$YR$A$M$Y$132$KG$20240823$$MD$ES$ES
242417721$24241772$1$I$$20240820$20240823$20240823$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-16663$IPSEN$$$$$M$Y$$$20240823$$CN$GB$GB
242417733$24241773$3$F$20240101$20240904$20240823$20240911$EXP$$US-009507513-2407USA014734$MERCK$$36$YR$$M$Y$$$20240911$$MD$US$US
242417741$24241774$1$I$$20240816$20240823$20240823$EXP$$GB-TAKEDA-2024TUS083392$TAKEDA$$$$$F$Y$$$20240823$$CN$GB$GB
242417751$24241775$1$I$$20240821$20240823$20240823$EXP$$US-ABBVIE-5889560$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242417761$24241776$1$I$$20240814$20240823$20240823$EXP$$US-Indivior Limited-INDV-156073-2024$RECKITT BENCKISER$$$$$$Y$$$20240823$$MD$US$US
242417771$24241777$1$I$$20240723$20240823$20240823$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07489$LUPIN$$$$$$Y$$$20240823$$CN$US$US
242417781$24241778$1$I$20231119$20240817$20240823$20240823$EXP$$CO-GSK-CO2023AMR163187$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$CO$CO
242417791$24241779$1$I$20240813$20240813$20240823$20240823$30DAY$$US-GSK-US2024101888$GLAXOSMITHKLINE$$70$YR$$M$Y$$$20240823$$CN$US$US
242417801$24241780$1$I$$20240821$20240823$20240823$PER$$US-ABBVIE-5889855$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242417811$24241781$1$I$$20240820$20240823$20240823$EXP$$CA-JNJFOC-20240853814$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240823$$PH$CA$CA
242417822$24241782$2$F$$20240917$20240823$20240927$PER$$US-GSK-US2024100822$GLAXOSMITHKLINE$$$$$F$Y$88.889$KG$20240927$$HP$US$US
242417832$24241783$2$F$20240501$20240924$20240823$20240928$EXP$$US-ABBVIE-5888516$ABBVIE$$62$YR$$M$Y$$$20240928$$CN$US$US
242417841$24241784$1$I$$20240821$20240823$20240823$EXP$$US-ABBVIE-5890786$ABBVIE$$$$$$Y$$$20240823$$CN$US$US
242417851$24241785$1$I$20240701$20240820$20240823$20240823$EXP$$ZA-ABBVIE-5889718$ABBVIE$$70$YR$$F$Y$$$20240823$$CN$ZA$ZA
242417861$24241786$1$I$20181012$20240815$20240823$20240823$EXP$GB-MHRA-MED-202408151324348930-QWLHN$GB-862174955-ML2024-04510$Unknown Manufacturer$$53$YR$A$F$Y$83$KG$20240823$$CN$GB$GB
242417871$24241787$1$I$20240810$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A188785$ASTRAZENECA$$28001$DY$$M$Y$$$20240823$$CN$US$
242417881$24241788$1$I$$20231106$20240823$20240823$EXP$$US-AstraZeneca-2023A253248$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242417891$24241789$1$I$$20240816$20240823$20240823$EXP$$US-AstraZeneca-2024A187987$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242417901$24241790$1$I$20230508$20240819$20240823$20240823$EXP$$CA-TAKEDA-2024TUS084395$TAKEDA$$39$YR$$F$Y$$$20240823$$CN$CA$CA
242417911$24241791$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133007$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240823$$CN$US$US
242417921$24241792$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-040707$AUROBINDO$Mccormack L, Budnick I, Kearns MT.. Lemierre^s Syndrome Secondary to a Fusobacterium Necrophorum Superinfection Following Influenza B Pharyngitis.. Am-J-Respir-Crit-Care-Med. 2024;209:A7325$43$YR$$M$Y$$$20240823$$HP$US$US
242417931$24241793$1$I$$20240812$20240823$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-041276$AUROBINDO$Sahly AN, Srour M, Buhas D, Scheffer IE, Myers KA.. The epileptology of WiedemannSteiner syndrome: Electroclinical findings in five patients with KMT2A pathogenic variants.. Eur-J-Paediatr-Neurol. 2023;44:46-50$6$MON$$M$Y$$$20240823$$HP$CA$CA
242417942$24241794$2$F$$20240826$20240823$20240903$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-133049$BRISTOL MYERS SQUIBB$A clinical case of a patient with a rare an immuno-mediated complication. Newspaper of the Russian Society of Clinical Oncology. 2024;(07):17-8.$$$$F$Y$$$20240903$$HP$RU$RU
242417951$24241795$1$I$20240101$20240819$20240823$20240823$EXP$$GB-BIOGEN-2024BI01279279$BIOGEN$$$$$M$Y$$$20240823$$HP$GB$GB
242417961$24241796$1$I$20240711$20240819$20240823$20240823$EXP$$BR-AMGEN-BRASP2024141508$AMGEN$$33$YR$A$M$Y$64$KG$20240823$$MD$BR$BR
242417971$24241797$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-041651$AUROBINDO$Fanas RL, Goettemoeller T, Cedeno K, Manavalan AD.. Ectopic Cushing Syndrome Secondary to Diffuse Idiopathic  Neuroendocrine Cell Hyperplasia?A Report of 2 Cases. JCEM Case Reports. 2024;Vol. 2, No. 8:1-5$73$YR$$F$Y$$$20240823$$HP$US$US
242417981$24241798$1$I$$20240812$20240823$20240823$EXP$$CA-AUROBINDO-AUR-APL-2024-041141$AUROBINDO$$57$YR$$M$Y$$$20240823$$HP$CA$CA
242417991$24241799$1$I$20240601$20240819$20240823$20240823$EXP$$TN-ABBVIE-5887934$ABBVIE$$78$YR$$F$Y$$$20240823$$CN$TN$TN
242418002$24241800$2$F$$20240821$20240823$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08065$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242418021$24241802$1$I$$20240815$20240823$20240823$30DAY$$US-GSK-US2024101941$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242418031$24241803$1$I$20240307$20240819$20240823$20240823$EXP$IT-MINISAL02-998992$IT-TAKEDA-2024TUS082944$TAKEDA$$57$YR$$F$Y$$$20240823$$HP$IT$IT
242418041$24241804$1$I$20220709$20240812$20240823$20240823$EXP$$ES-AUROBINDO-AUR-APL-2024-041267$AUROBINDO$$64$YR$$M$Y$$$20240823$$PH$ES$ES
242418053$24241805$3$F$20240818$20240830$20240823$20240905$EXP$$EG-ABBVIE-5890854$ABBVIE$$73$YR$$F$Y$45$KG$20240905$$CN$EG$EG
242418061$24241806$1$I$$20240820$20240823$20240823$PER$$NVSC2024US170333$NOVARTIS$$14$YR$$M$Y$77$KG$20240823$$HP$US$US
242418071$24241807$1$I$$20240814$20240823$20240823$EXP$$GB-JNJFOC-20240841204$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$MD$GB$GB
242418081$24241808$1$I$$20240816$20240823$20240823$PER$$US-JNJFOC-20240846539$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240823$$CN$US$US
242418091$24241809$1$I$20240101$20240816$20240823$20240823$EXP$$US-JNJFOC-20240844029$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$CN$US$US
242418101$24241810$1$I$$20240814$20240823$20240823$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010261$STRIDES$Ogawa S, Amaya F.. A peripherally acting mu-opioid receptor antagonist for treating opioid-associated tinnitus: A case report.. Palliat-Med. 2024$74$YR$$M$Y$$$20240823$$HP$JP$JP
242418112$24241811$2$F$$20240812$20240823$20240827$EXP$$CA-APOTEX-2024AP009265$APOTEX$$65$YR$$F$Y$34$KG$20240827$$HP$CA$CA
242418122$24241812$2$F$20240705$20240912$20240823$20240918$EXP$$CA-ABBVIE-5885608$ABBVIE$$75$YR$$M$Y$$$20240918$$CN$CA$CA
242418131$24241813$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-109790-2023$RECKITT BENCKISER$$73$YR$$M$Y$$$20240823$$CN$US$US
242418141$24241814$1$I$$20240812$20240823$20240823$EXP$$TW-IPCA LABORATORIES LIMITED-IPC-2024-TW-002053$IPCA$Chi-Sheng Su and Chi-Lan Kao. Stevens-Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report. Journal of Medical Case Report. 2024;18(344):1-5$$$$$Y$$$20240823$$HP$TW$TW
242418151$24241815$1$I$$20240820$20240823$20240823$EXP$$US-ABBVIE-5888284$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242418162$24241816$2$F$$20240830$20240823$20240906$EXP$$US-ABBVIE-5888898$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242418171$24241817$1$I$20240624$20240814$20240823$20240823$EXP$FR-AFSSAPS-TS2024000899$FR-TEVA-VS-3233907$TEVA$$73$YR$$F$Y$58$KG$20240823$$MD$FR$FR
242418182$24241818$2$F$$20240829$20240823$20240907$EXP$$CA-AUROBINDO-AUR-APL-2024-012686$AUROBINDO$Sahly AN, Srour M, Buhas D, Scheffer IE, Myers KA. The epileptology of Wiedemann-Steiner syndrome: Electroclinical findings in five patients with KMT2A pathogenic variants. Eur-J-PaediatrNeurol. 2023;44:46-50$6$MON$$M$Y$$$20240907$$HP$CA$CA
242418191$24241819$1$I$$20240821$20240823$20240823$EXP$$CA-ABBVIE-5890777$ABBVIE$$$$A$F$Y$$$20240823$$PH$CA$CA
242418201$24241820$1$I$$20240812$20240823$20240823$30DAY$$US-JNJFOC-20240855143$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
242418211$24241821$1$I$20230901$20240814$20240823$20240823$EXP$FR-AFSSAPS-TS2024000888$FR-TEVA-VS-3233899$TEVA$$70$YR$$M$Y$89$KG$20240823$$CN$FR$FR
242418221$24241822$1$I$20240701$20240816$20240823$20240823$EXP$$CN-AMGEN-CHNSP2024164094$AMGEN$$31$YR$A$M$Y$$$20240823$$HP$CN$CN
242418241$24241824$1$I$$20240617$20240823$20240823$EXP$$CO-ROCHE-10000003954$ROCHE$Canas C, Posso-Osorio I, PErez-Uribe V, Erazo-Mart?nez V. Bronchiectasis, lymphadenopathies related to BAFF overexpression and lymphoplasmacytic cystitis as adverse events associated with prolonged use of rituximab in systemic autoimmune rheumatic diseases. Revista clinica espanola. 2024-Jun-05;1-5. doi:10.1016/j.rceng.2024.06.001.$28$YR$A$F$Y$$$20240823$$MD$CO$CO
242418251$24241825$1$I$$20240731$20240823$20240823$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005050$BIOCON$$$$$$Y$$$20240823$$CN$US$US
242418261$24241826$1$I$$20240802$20240823$20240823$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005206$BIOCON$$$$$$Y$$$20240823$$CN$US$US
242418272$24241827$2$F$$20240826$20240823$20240830$EXP$$AU-ROCHE-10000055275$ROCHE$$$$E$F$Y$$$20240830$$PH$AU$AU
242418281$24241828$1$I$20220513$20240709$20240823$20240823$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004948$BIOCON$$$$$$Y$$$20240823$$PH$US$US
242418292$24241829$2$F$$20240814$20240823$20240823$EXP$$US-ROCHE-10000059640$ROCHE$$65$YR$E$F$Y$$$20240823$$CN$US$US
242418301$24241830$1$I$20220506$20240815$20240823$20240823$EXP$$CN-ROCHE-3106235$ROCHE$$59$YR$A$M$Y$70$KG$20240823$$CN$CN$CN
242418311$24241831$1$I$20220101$20240815$20240823$20240823$EXP$$US-BIOGEN-2024BI01278798$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
242418321$24241832$1$I$$20240815$20240823$20240823$EXP$$CA-TAKEDA-2024TUS082783$TAKEDA$$$$$F$Y$$$20240823$$HP$CA$CA
242418331$24241833$1$I$20240819$20240815$20240823$20240823$EXP$$AU-TAKEDA-2024TUS082942$TAKEDA$$56$YR$$F$Y$$$20240823$$CN$AU$AU
242418341$24241834$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-041573$AUROBINDO$$$$$F$Y$$$20240823$$CN$US$US
242418351$24241835$1$I$20240718$20240813$20240823$20240823$EXP$$FR-AUROBINDO-AUR-APL-2024-041325$AUROBINDO$$19$YR$$$Y$$$20240823$$PH$FR$FR
242418361$24241836$1$I$20240526$20240821$20240823$20240823$EXP$$AU-SANDOZ INC.-SDZ2024AU074504$SANDOZ$$65$YR$$M$Y$$$20240823$$HP$AU$AU
242418371$24241837$1$I$20240821$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167187$AMGEN$$32$YR$A$F$Y$$$20240823$$CN$US$US
242418382$24241838$2$F$20240813$20240906$20240823$20240909$PER$$US-AMGEN-USASP2024165770$AMGEN$$57$YR$A$M$Y$$$20240909$$PH$US$US
242418391$24241839$1$I$$20240812$20240823$20240823$EXP$$IT-HALEON-2192374$Haleon PLC$$18$MON$$F$Y$$$20240823$$HP$IT$IT
242418401$24241840$1$I$$20240725$20240823$20240823$PER$$US-009507513-2407USA014201$MERCK$Stewart MA, Rives TA, Blanton K, Baldwin L. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecologic Oncology Reports. 2024;54:101452$33$YR$$F$Y$$$20240823$$HP$US$US
242418412$24241841$2$F$20240809$20240831$20240823$20240911$EXP$$US-COOPERSURGICAL, INC.-2024CPS002468$COOPERSURGICAL$$31$YR$$F$Y$58.05$KG$20240911$$HP$US$US
242418422$24241842$2$F$20240817$20240823$20240823$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408012067$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240827$$CN$US$US
242418431$24241843$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011980$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240823$$CN$US$US
242418441$24241844$1$I$20240519$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011475$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240823$$CN$US$US
242418451$24241845$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012439$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240823$$CN$US$US
242418462$24241846$2$F$$20240827$20240823$20240909$EXP$$CA-ROCHE-10000061026$ROCHE$$65$YR$E$F$Y$34$KG$20240909$$MD$CA$CA
242418472$24241847$2$F$$20240904$20240823$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408011424$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240909$$CN$US$US
242418481$24241848$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012798$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240823$$CN$US$US
242418491$24241849$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012663$ELI LILLY AND CO$$$$$$Y$$$20240823$$CN$US$US
242418501$24241850$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012909$ELI LILLY AND CO$$62$YR$A$$Y$$$20240823$$CN$US$US
242418511$24241851$1$I$20240815$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011768$ELI LILLY AND CO$$$$$$Y$$$20240823$$CN$US$US
242418521$24241852$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011813$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240823$$CN$US$US
242418531$24241853$1$I$$20240821$20240823$20240823$EXP$$GB-ABBVIE-5890550$ABBVIE$$56$YR$$F$Y$$$20240823$$HP$GB$GB
242418541$24241854$1$I$$20240818$20240823$20240823$EXP$$US-JNJFOC-20240846738$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$MD$US$US
242418552$24241855$2$F$$20240822$20240823$20240826$PER$$US-GILEAD-2024-0685026$GILEAD$$$$$$Y$$$20240825$$CN$US$US
242418561$24241856$1$I$20240101$20240818$20240823$20240823$PER$$US-ABBVIE-5888489$ABBVIE$$$$$$Y$$$20240823$$HP$US$US
242418571$24241857$1$I$$20240729$20240823$20240823$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-07740$LUPIN$Puthumana RM, Mintz J, Perez M, Gaddipati S, Gorman D. Too Much of a Good Thing: A Case of Beta Blocker and Warfarin Toxicity. American Journal of Respiratory and Critical Care. 2024;209 (0):A5692$38$YR$$M$Y$$$20240823$$HP$US$US
242418581$24241858$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131905$BRISTOL MYERS SQUIBB$Stanek K, Hussain MT, Spaulding AC, Borkar S, Shaikh ME. Improving patient safety through proper ordering and administration of andexanet alfa. Mayo Clinic Proceedings: Innovations, Quality and Outcomes. 2024 Aug 01;8(4):407-14. doi:10.1016/j.mayocpiqo.2024.03.003.$99$YR$E$F$Y$$$20240823$$MD$US$US
242418591$24241859$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024AMR103032$GLAXOSMITHKLINE$$$$$M$Y$$$20240823$$CN$US$US
242418601$24241860$1$I$$20240815$20240823$20240823$30DAY$$US-GSK-US2024101769$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242418612$24241861$2$F$$20240923$20240823$20240930$PER$$US-GSK-US2024AMR103736$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$MD$US$US
242418621$24241862$1$I$20240415$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-087825-2024$RECKITT BENCKISER$$67$YR$$F$Y$$$20240823$$CN$US$US
242418631$24241863$1$I$$20240821$20240823$20240823$PER$$US-ABBVIE-5891053$ABBVIE$$$$$$Y$$$20240823$$MD$US$US
242418641$24241864$1$I$$20240820$20240823$20240823$EXP$$NVSC2024ID170072$NOVARTIS$$$$$F$Y$$$20240823$$MD$ID$ID
242418651$24241865$1$I$$20240820$20240823$20240823$EXP$$US-SANDOZ INC.-SDZ2024US074832$SANDOZ$$$$$F$Y$$$20240823$$HP$US$US
242418661$24241866$1$I$$20240819$20240823$20240823$EXP$$FR-NORDICGR-057270$NORDIC PHARMA$Strizzolo R, Seneschal J, Soria A, et al. Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab. World Allergy Organ J. 2024 Jul 4;17(7):100923. https://doi.org/10.1016/j.waojou.2024.100923$$$A$$Y$$$20240823$$MD$FR$FR
242418671$24241867$1$I$20230529$20240814$20240823$20240823$EXP$FR-AFSSAPS-AM2024000649$FR-TEVA-VS-3233897$TEVA$$50$YR$$M$Y$122$KG$20240823$$MD$FR$FR
242418681$24241868$1$I$$20240819$20240823$20240823$EXP$$CA-BIOGEN-2024BI01279114$BIOGEN$$$$$F$Y$$$20240823$$CN$CA$CA
242418691$24241869$1$I$20230801$20240814$20240823$20240823$PER$$US-ABBVIE-5881710$ABBVIE$$62$YR$$M$Y$$$20240823$$CN$US$US
242418701$24241870$1$I$20240801$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167022$AMGEN$$66$YR$E$F$Y$$$20240823$$CN$US$US
242418711$24241871$1$I$20240821$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024168015$AMGEN$$82$YR$E$F$Y$$$20240823$$CN$US$US
242418721$24241872$1$I$$20240821$20240823$20240823$PER$$US-ABBVIE-5890915$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242418731$24241873$1$I$$20240822$20240823$20240823$EXP$$US-JNJFOC-20240857605$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$HP$US$US
242418742$24241874$2$F$$20240916$20240823$20240918$PER$$US-HALEON-2193307$Haleon PLC$$$$$$Y$$$20240918$$CN$US$US
242418751$24241875$1$I$$20240816$20240823$20240823$PER$$US-ALXN-202408USA001063US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240823$$CN$US$US
242418762$24241876$2$F$$20240826$20240823$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR101587$VIIV$$$$$$Y$$$20240905$$MD$US$US
242418771$24241877$1$I$$20240814$20240823$20240823$EXP$$CA-BAXTER-2024BAX023260$BAXTER$$40$YR$$F$Y$54$KG$20240823$$CN$CA$CA
242418781$24241878$1$I$$20240822$20240823$20240823$PER$$US-GILEAD-2024-0685028$GILEAD$$$$$$Y$$$20240823$$CN$US$US
242418791$24241879$1$I$20240626$20240816$20240823$20240823$EXP$$US-BIOGEN-2024BI01278813$BIOGEN$$29$YR$$$Y$$$20240823$$CN$US$US
242418801$24241880$1$I$$20240815$20240823$20240823$EXP$$CA-BAXTER-2024BAX023356$BAXTER$$67$YR$$$Y$$$20240823$$HP$CA$CA
242418811$24241881$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166686$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242418822$24241882$2$F$20240101$20240831$20240823$20240904$EXP$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000766$PAREXEL$$$$$$Y$$$20240904$$CN$US$US
242418831$24241883$1$I$$20240814$20240823$20240823$EXP$$CA-BAXTER-2024BAX023262$BAXTER$$44$YR$$M$Y$$$20240823$$HP$CA$CA
242418841$24241884$1$I$$20240822$20240823$20240823$EXP$$AU-SANDOZ INC.-SDZ2024AU074606$SANDOZ$$7$DEC$$F$Y$50$KG$20240823$$MD$AU$AU
242418851$24241885$1$I$20240801$20240814$20240823$20240823$PER$$US-BAUSCHBL-2024BNL031834$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240823$$CN$US$US
242418871$24241887$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133501$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$102.06$KG$20240823$$CN$US$US
242418881$24241888$1$I$20240619$20240820$20240823$20240823$EXP$$CO-UCBSA-2024042719$UCB$$83$YR$$M$Y$$$20240823$$CN$CO$CO
242418893$24241889$3$F$20240101$20240919$20240823$20240926$EXP$$US-UROGEN PHARMA LTD.-2024-UGN-000117$UROGEN PHARMA$$$$$$Y$$$20240926$$MD$US$US
242418901$24241890$1$I$$20240410$20240823$20240823$EXP$$CA-ROCHE-10000060190$ROCHE$$53$YR$A$F$Y$$$20240823$$CN$CA$CA
242418911$24241891$1$I$$20240822$20240823$20240823$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047460$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240823$$MD$US$US
242418921$24241892$1$I$20240801$20240809$20240823$20240823$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000809$PAREXEL$$$$$$Y$$$20240823$$HP$CN$CN
242418931$24241893$1$I$20240601$20240814$20240823$20240823$EXP$FR-AFSSAPS-NT2024001018$FR-TEVA-VS-3233673$TEVA$$58$YR$$F$Y$65$KG$20240823$$MD$FR$FR
242418941$24241894$1$I$$20240814$20240823$20240823$EXP$$US-MYLANLABS-2024M1076846$MYLAN$Alicea DS, Santana Felipes R, McLellan BN. Management of refractory pruritus in Alagille syndrome with dupilumab treatment: A case report. JAAD-Case-Rep 2024; 51 63-65.$45$YR$$F$Y$$$20240823$$MD$US$US
242418951$24241895$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012551$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240823$$CN$US$US
242418961$24241896$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024AMR101065$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242418971$24241897$1$I$20240821$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014604$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240823$$CN$US$US
242418981$24241898$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013509$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240823$$CN$US$US
242418991$24241899$1$I$20220101$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013739$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240823$$CN$US$US
242419001$24241900$1$I$20240801$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167235$AMGEN$$76$YR$E$F$Y$$$20240823$$CN$US$US
242419011$24241901$1$I$20240724$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024165148$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242419021$24241902$1$I$$20240813$20240823$20240823$PER$$US-ABBVIE-5881181$ABBVIE$$50$YR$$F$Y$$$20240823$$HP$US$US
242419042$24241904$2$F$20240731$20240912$20240823$20240916$EXP$$US-RIGEL-20240800081$RIGEL PHARMACEUTICALS$$93$YR$$F$Y$48.534$KG$20240916$$HP$US$US
242419051$24241905$1$I$$20240816$20240823$20240823$EXP$$US-ABBVIE-5884895$ABBVIE$$$$$M$Y$$$20240823$$HP$US$US
242419062$24241906$2$F$$20240830$20240823$20240902$PER$$US-HALEON-2193109$Haleon PLC$$$$$$Y$$$20240902$$CN$US$US
242419081$24241908$1$I$20240813$20240819$20240823$20240823$PER$$PR-BIOGEN-2024BI01279166$BIOGEN$$58$YR$$F$Y$59.928$KG$20240823$$CN$PR$PR
242419092$24241909$2$F$20240701$20240822$20240823$20240826$PER$$US-AMGEN-USASP2024167836$AMGEN$$$$$$Y$$$20240826$$CN$US$US
242419111$24241911$1$I$$20240809$20240823$20240823$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111103$ZYDUS PHARM$Venkatraman S, Mehta T, Deng F.. A Rare Neurotoxicity Syndrome Following Opioid Intoxication.. American Neurological Association. 2024;96(2):412-415$$$$$Y$$$20240823$$HP$US$US
242419121$24241912$1$I$$20240822$20240823$20240823$EXP$$US-TAKEDA-2024TUS085024$TAKEDA$$$$$M$Y$$$20240823$$CN$US$US
242419131$24241913$1$I$20240229$20240812$20240823$20240823$EXP$ES-AEMPS-1557722$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111223$ZYDUS PHARM$$$$$$Y$$$20240823$$MD$ES$ES
242419141$24241914$1$I$$20240819$20240823$20240823$PER$$US-ABBVIE-5888753$ABBVIE$$$$$F$Y$$$20240823$$HP$US$US
242419151$24241915$1$I$20240101$20240814$20240823$20240823$EXP$$US-JNJFOC-20240845203$JOHNSON AND JOHNSON$$69$YR$E$F$Y$72.64$KG$20240823$$MD$US$US
242419161$24241916$1$I$20240401$20240808$20240823$20240823$PER$$US-JNJFOC-20240822277$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240823$$CN$US$US
242419171$24241917$1$I$20240724$20240814$20240823$20240823$30DAY$$US-GSK-US2024AMR101548$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240823$$CN$US$US
242419181$24241918$1$I$$20240816$20240823$20240823$PER$$US-ABBVIE-5884973$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242419201$24241920$1$I$20240804$20240819$20240823$20240823$PER$$MX-REGENERON PHARMACEUTICALS, INC.-2024-115556$REGENERON$$69$YR$$M$Y$$$20240823$$CN$MX$MX
242419211$24241921$1$I$$20240820$20240823$20240823$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-109934$REGENERON$$$$$$Y$$$20240823$$CN$US$US
242419231$24241923$1$I$$20240819$20240823$20240823$EXP$$DE-SANDOZ INC.-PHHY2019DE090941$SANDOZ$$$$N$M$Y$0.98$KG$20240823$$MD$DE$DE
242419241$24241924$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-089396-2024$RECKITT BENCKISER$$$$$$Y$$$20240823$$CN$US$US
242419251$24241925$1$I$$20240813$20240823$20240823$EXP$$CA-TEVA-VS-3236213$TEVA$$80$YR$$F$Y$69$KG$20240823$$PH$CA$CA
242419271$24241927$1$I$20221215$20240802$20240823$20240823$EXP$$CA-CELLTRION INC.-2021CA019616$CELLTRION$$$$$$Y$$$20240823$$MD$CA$CA
242419281$24241928$1$I$$20240813$20240823$20240823$PER$$US-JNJFOC-20240840679$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240823$$CN$US$US
242419292$24241929$2$F$$20240821$20240823$20240828$PER$$US-AMGEN-USASP2024167820$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242419302$24241930$2$F$20240817$20240819$20240823$20240828$PER$$US-AMGEN-USASP2024165204$AMGEN$$66$YR$E$F$Y$$$20240827$$CN$US$US
242419322$24241932$2$F$20240816$20240826$20240823$20240831$EXP$$US-AMGEN-USASP2024164671$AMGEN$$83$YR$E$F$Y$$$20240831$$CN$US$US
242419331$24241933$1$I$$20240814$20240823$20240823$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006023$BIOCON$$$$$$Y$$$20240823$$CN$CA$CA
242419341$24241934$1$I$20230901$20240813$20240823$20240823$EXP$ES-AEMPS-1558097$ES-TEVA-VS-3233466$TEVA$$66$YR$$M$Y$$$20240823$$MD$ES$ES
242419351$24241935$1$I$20240101$20240820$20240823$20240823$EXP$$US-ABBVIE-5888667$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242419361$24241936$1$I$20240503$20240813$20240823$20240823$EXP$FR-AFSSAPS-PO2024000847$FR-TEVA-VS-3233476$TEVA$$83$YR$$F$Y$79.1$KG$20240823$$MD$FR$FR
242419371$24241937$1$I$20240701$20240816$20240823$20240823$EXP$$US-Rigel Pharmaceuticals, Inc.-20240800079$RIGEL PHARMACEUTICALS$$47$YR$$F$Y$$$20240823$$CN$US$US
242419381$24241938$1$I$20240818$20240819$20240823$20240823$30DAY$$IT-SANDOZ INC.-SDZ2024IT074720$SANDOZ$$53$YR$$M$Y$40$KG$20240823$$CN$IT$IT
242419391$24241939$1$I$$20240812$20240823$20240823$EXP$$JP-ROCHE-10000056377$ROCHE$Ozawa R, Sonehara K, Hachiya T, Nozawa S, Agatsuma T, Yamamoto H, et al. Evaluation of the association between predictive factors and the development of immune-related adverse events and prognostic factors for chemoimmunotherapy in patients with non-small cell lung cancer: A multicenter retrospective study. Cancer Medicine. 2024-Aug;13 (15):1-10. doi:10.1002/cam4.70080.$$$$$Y$$$20240823$$HP$JP$JP
242419401$24241940$1$I$$20240805$20240823$20240823$PER$$US-TEVA-VS-3231381$TEVA$$20$YR$$M$Y$$$20240823$$HP$US$US
242419411$24241941$1$I$20240821$20240822$20240823$20240823$PER$$US-HALEON-2193308$Haleon PLC$$26$YR$$M$Y$$$20240823$$CN$US$US
242419421$24241942$1$I$20240627$20240813$20240823$20240823$EXP$FR-AFSSAPS-GR2024000971$FR-TEVA-VS-3233823$TEVA$$80$YR$$F$Y$70$KG$20240823$$PH$FR$FR
242419432$24241943$2$F$$20240823$20240823$20240827$EXP$$US-KYOWAKIRIN-2024KK019613$KYOWA$$$$$$Y$$$20240827$$HP$US$US
242419441$24241944$1$I$20240723$20240813$20240823$20240823$EXP$FR-AFSSAPS-LY2024001216$FR-TEVA-VS-3233827$TEVA$$61$YR$$F$Y$65$KG$20240823$$PH$FR$FR
242419451$24241945$1$I$$20240819$20240823$20240823$EXP$$GB-MYLANLABS-2024M1077009$MYLAN$$$$$M$Y$$$20240823$$HP$GB$GB
242419461$24241946$1$I$$20240820$20240823$20240823$EXP$$AU-MYLANLABS-2024M1077577$MYLAN$$$$$M$Y$$$20240823$$HP$AU$AU
242419471$24241947$1$I$20240805$20240821$20240823$20240823$EXP$$GB-MYLANLABS-2024M1077736$MYLAN$$$$$F$Y$$$20240823$$CN$GB$GB
242419481$24241948$1$I$$20240815$20240823$20240823$EXP$US-MLMSERVICE-20240809-PI154453-00190-1$US-RDY-SPO/USA/24/0012028$DR REDDYS$Preskorn SH, Masolak DD. Life-threatening Rash Due to Lamotrigine and a Failure to Understand Its Pharmacology: How Forensic Detective Work Uses Medical Knowledge and Clinical Pharmacology to Solve Cases. Journal of Psychiatric Practice. 2024;30(4):273-8. DOI: 10.1097/PRA.0000000000000791.$13$YR$T$M$Y$$$20240823$$MD$US$US
242419491$24241949$1$I$$20240819$20240823$20240823$EXP$$GB-MYLANLABS-2024M1077105$MYLAN$$$$$F$Y$$$20240823$$PH$GB$GB
242419511$24241951$1$I$$20240816$20240823$20240823$EXP$$US-GSK-US2024102583$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$US$US
242419521$24241952$1$I$20240816$20240819$20240823$20240823$EXP$$US-LEO Pharma-372914$LEO PHARM$$79$YR$$F$Y$$$20240823$$PH$US$US
242419531$24241953$1$I$20240201$20240820$20240823$20240823$EXP$FR-AFSSAPS-RE2024000808$FR-MYLANLABS-2024M1077073$MYLAN$$45$YR$$M$Y$59$KG$20240823$$PH$FR$FR
242419541$24241954$1$I$$20240821$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074549$SANDOZ$$89$YR$$F$Y$72$KG$20240823$$HP$CA$CA
242419551$24241955$1$I$$20240819$20240823$20240823$EXP$$GB-MYLANLABS-2024M1077049$MYLAN$$$$$F$Y$$$20240823$$PH$GB$GB
242419561$24241956$1$I$20240720$20240813$20240823$20240823$EXP$ES-AEMPS-1558327$ES-TEVA-VS-3236194$TEVA$$64$YR$$F$Y$54$KG$20240823$$MD$ES$ES
242419571$24241957$1$I$20240101$20240813$20240823$20240823$EXP$SE-SEMPA-2024-005906$SE-TEVA-VS-3233847$TEVA$$30$YR$$F$Y$$$20240823$$MD$SE$SE
242419581$24241958$1$I$$20240814$20240823$20240823$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005988$BIOCON$$$$$$Y$$$20240823$$HP$CA$CA
242419591$24241959$1$I$$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202407002782$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240823$$HP$US$US
242419601$24241960$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011771$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240823$$CN$US$US
242419611$24241961$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012781$ELI LILLY AND CO$$60$YR$A$$Y$$$20240823$$CN$US$US
242419621$24241962$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012616$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240823$$CN$US$US
242419631$24241963$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014018$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240823$$CN$US$US
242419641$24241964$1$I$$20240817$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408008310$ELI LILLY AND CO$$$$$$Y$$$20240823$$HP$US$US
242419652$24241965$2$F$$20240917$20240823$20240924$EXP$$BR-TAKEDA-2024TUS083866$TAKEDA$$$$$M$Y$$$20240924$$CN$BR$BR
242419661$24241966$1$I$20240220$20240814$20240823$20240823$EXP$FR-AFSSAPS-NT2024001005$FR-TEVA-VS-3233790$TEVA$$42$YR$$F$Y$$$20240823$$PH$FR$FR
242419671$24241967$1$I$20190711$20240819$20240823$20240823$EXP$$DE-SANDOZ INC.-NVSC2020DE021863$SANDOZ$$82$YR$$M$Y$83$KG$20240823$$MD$DE$DE
242419681$24241968$1$I$20230701$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024166712$AMGEN$$63$YR$A$F$Y$$$20240823$$HP$US$US
242419692$24241969$2$F$20240701$20240814$20240823$20240828$EXP$$US-UCBSA-2024041227$UCB$$36$YR$$F$Y$$$20240828$$HP$US$US
242419701$24241970$1$I$20240101$20240820$20240823$20240823$PER$$US-ABBVIE-5890071$ABBVIE$$$$$$Y$$$20240823$$CN$US$US
242419711$24241971$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133512$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$110.68$KG$20240823$$CN$US$US
242419721$24241972$1$I$$20240813$20240823$20240823$EXP$$US-GSK-US2024AMR101072$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$MD$US$US
242419732$24241973$2$F$20240910$20240911$20240823$20240913$EXP$$US-TAKEDA-2024TUS085014$TAKEDA$$51$YR$$M$Y$$$20240913$$MD$US$US
242419742$24241974$2$F$$20240920$20240823$20240924$EXP$$CA-SANDOZ INC.-SDZ2024CA074567$SANDOZ$$33$YR$$F$Y$68$KG$20240924$$HP$CA$CA
242419751$24241975$1$I$20140510$20240819$20240823$20240823$EXP$$US-TAKEDA-2014BAX025849$TAKEDA$$4$YR$$F$Y$14$KG$20240823$$HP$US$US
242419762$24241976$2$F$$20240821$20240823$20240904$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-07919$HIKMA$$21$MON$$M$Y$$$20240904$$MD$GB$GB
242419771$24241977$1$I$20240724$20240812$20240823$20240823$EXP$ES-AEMPS-1559081$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111209$ZYDUS PHARM$$$$$$Y$$$20240823$$PH$ES$ES
242419781$24241978$1$I$20230406$20240813$20240823$20240823$EXP$GB-MHRA-MED-202408100732140300-CKYFG$GB-Accord-441624$ACCORD$$60$YR$A$F$Y$$$20240823$$CN$GB$GB
242419791$24241979$1$I$$20240809$20240823$20240823$EXP$$US-Accord-442490$ACCORD$$56$YR$A$M$Y$$$20240823$$CN$US$US
242419801$24241980$1$I$$20240811$20240823$20240823$EXP$$KR-Accord-441900$ACCORD$Jo JH, Lee JW, Seol KH. Assessing the Adequacy of Traditional Vertebral Landmarks as Upper Border of Whole Pelvic Radiotherapy Field for Stage IB2-IIB Cervical Cancer. Cancers (Basel). 2024 Aug 1;16(15):2743.$$$$F$Y$$$20240823$$HP$KR$KR
242419812$24241981$2$F$20240809$20240909$20240823$20240920$EXP$$US-Accord-441671$ACCORD$$64$YR$A$M$Y$$$20240920$$HP$US$US
242419821$24241982$1$I$20240519$20240812$20240823$20240823$EXP$FR-AFSSAPS-SE2024000622$FR-Accord-441510$ACCORD$$64$YR$A$F$Y$60$KG$20240823$$HP$FR$FR
242419831$24241983$1$I$$20240812$20240823$20240823$EXP$$IT-Accord-441717$ACCORD$Rota E, Immovilli P, Pappalardo I, Risso R, Zuccotti G, Agosti S et al. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case-Control Study in a Real-World Setting. Clinical Therapeutics. 2024;e1-5.$88$YR$E$M$Y$$$20240823$$MD$IT$IT
242419841$24241984$1$I$20231101$20240812$20240823$20240823$EXP$IT-MINISAL02-997767$IT-Accord-441539$ACCORD$$62$YR$A$M$Y$$$20240823$$MD$IT$IT
242419851$24241985$1$I$$20240812$20240823$20240823$EXP$$IN-Accord-441707$ACCORD$Kutumbaka T, Varadan S, Sudagar Singh RB. The Atypical Face of Neuroleptic Malignant Syndrome: A Case Report of Ileus and Absent Rigidity. Cureus. 2024;16(7):e63784.$36$YR$A$M$Y$$$20240823$$MD$IN$IN
242419861$24241986$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133452$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240823$$HP$US$US
242419871$24241987$1$I$$20240815$20240823$20240823$EXP$$JP-VANTIVE-2024VAN018630$Vantive US Healthcare$$60$YR$$M$Y$60$KG$20240823$$MD$JP$JP
242419881$24241988$1$I$$20240815$20240823$20240823$EXP$$JP-VANTIVE-2024VAN018974$Vantive US Healthcare$$$$$M$Y$$$20240823$$HP$JP$JP
242419891$24241989$1$I$$20240815$20240823$20240823$EXP$$CA-APOTEX-2024AP009469$APOTEX$$$$E$M$Y$$$20240823$$HP$CA$CA
242419901$24241990$1$I$20240701$20240819$20240823$20240823$EXP$$JP-VANTIVE-2024VAN018767$Vantive US Healthcare$$90$YR$$F$Y$$$20240823$$MD$JP$JP
242419911$24241991$1$I$$20240819$20240823$20240823$EXP$$US-Taiho Oncology Inc-2024-007920$TAIHO ONCOLOGY INC$$50$YR$A$F$Y$90.72$KG$20240823$$CN$US$US
242419921$24241992$1$I$20240601$20240819$20240823$20240823$EXP$$US-TAKEDA-2024TUS083915$TAKEDA$$36$YR$$F$Y$$$20240823$$MD$US$US
242419931$24241993$1$I$20240720$20240812$20240823$20240823$EXP$FR-AFSSAPS-TO2024001537$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111194$ZYDUS PHARM$$$$$$Y$$$20240823$$MD$FR$FR
242419941$24241994$1$I$20240806$20240812$20240823$20240823$EXP$ES-AEMPS-1558862$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111219$ZYDUS PHARM$$$$$$Y$$$20240823$$PH$ES$ES
242419951$24241995$1$I$20240423$20240812$20240823$20240823$EXP$FR-AFSSAPS-TS2024000902$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111199$ZYDUS PHARM$$$$$$Y$$$20240823$$MD$FR$FR
242419971$24241997$1$I$$20240812$20240823$20240823$EXP$$CA-APOTEX-2024AP009278$APOTEX$$$$$F$Y$$$20240823$$MD$CA$CA
242419982$24241998$2$F$20240819$20240826$20240823$20240830$PER$$US-AMGEN-USASP2024165547$AMGEN$$70$YR$E$F$Y$$$20240830$$CN$US$US
242419991$24241999$1$I$$20240814$20240823$20240823$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024005989$BIOCON$$$$$$Y$$$20240823$$HP$CA$CA
242420001$24242000$1$I$$20240815$20240823$20240823$PER$$US-EMD Serono-2024044285$EMD SERONO INC$$55$YR$A$M$Y$87$KG$20240823$$CN$US$US
242420011$24242001$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-089393-2024$RECKITT BENCKISER$$$$$F$Y$$$20240823$$CN$US$US
242420021$24242002$1$I$$20240805$20240823$20240823$EXP$2024-0133781$US-IHL-000601$INVENTIA HEALTHCARE$$$$$F$Y$$$20240807$$CN$US$US
242420031$24242003$1$I$$20240811$20240823$20240823$EXP$$CA-JNJFOC-20240859530$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$HP$CA$CA
242420051$24242005$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57979$$FDA-CTU$$74$YR$$F$N$$$20240822$N$HP$US$
242420061$24242006$1$I$20240804$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58046$$FDA-CTU$$41$YR$$F$N$$$20240822$Y$HP$US$
242420071$24242007$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58088$$FDA-CTU$$54$YR$$F$N$$$20240822$N$$US$
242420101$24242010$1$I$$20240816$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130474$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240823$$CN$US$US
242420112$24242011$2$F$20240826$20240828$20240823$20240902$PER$$US-ABBVIE-5890631$ABBVIE$$$$$F$Y$$$20240902$$PH$US$US
242420121$24242012$1$I$$20240814$20240823$20240823$EXP$$CA-Orion Corporation ORION PHARMA-24_00031357$ORION$$$$$F$Y$$$20240823$$MD$CA$
242420141$24242014$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA168860$NOVARTIS$$47$YR$$F$Y$$$20240823$$HP$CA$CA
242420151$24242015$1$I$20240812$20240822$20240823$20240823$PER$$NVSC2024US170918$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242420161$24242016$1$I$$20240814$20240823$20240823$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006037$BIOCON$$$$$$Y$$$20240823$$MD$CA$CA
242420171$24242017$1$I$20240714$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58100$$FDA-CTU$$36$YR$$M$N$$$20240822$N$PH$US$
242420181$24242018$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-041585$AUROBINDO$$$$A$M$Y$$$20240823$$CN$US$US
242420191$24242019$1$I$20240716$20240819$20240823$20240823$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-112588$REGENERON$$84$YR$$F$Y$$$20240823$$HP$DE$DE
242420202$24242020$2$F$20240727$20240821$20240823$20240924$PER$$US-FDC-2024USSPO00627$FDC LIMITED$$65$YR$E$M$Y$70.3$KG$20240924$$CN$US$US
242420211$24242021$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58076$$FDA-CTU$$57$YR$$M$N$$$20240822$N$$US$
242420221$24242022$1$I$20240503$20240802$20240822$20240822$DIR$FDA-CDER-CTU-2024-58082$$FDA-CTU$$68$YR$$F$N$$$20240802$N$HP$US$
242420231$24242023$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57972$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242420241$24242024$1$I$20231228$20240819$20240823$20240823$EXP$IT-MINISAL02-998990$IT-TAKEDA-2024TUS082947$TAKEDA$$34$YR$$F$Y$$$20240823$$HP$IT$IT
242420251$24242025$1$I$$20240820$20240823$20240823$PER$$US-JNJFOC-20240852107$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$HP$US$US
242420261$24242026$1$I$20240726$20240820$20240823$20240823$EXP$$US-JNJFOC-20240773399$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240823$$CN$US$US
242420271$24242027$1$I$$20240815$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130868$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240823$$HP$US$US
242420281$24242028$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-040749$AUROBINDO$Khattar G, Makram M, Rabah H, Hong C, Khan S, Mourad O, et al.. Catastrophic Convergence: Refractory Septic Shock and Multisystem Failure in a Case of Hidradenitis Suppurativa Complicated by Fournier^s Gangrene and Bilateral Pulmonary Embolism. Am-J-Respir-Crit-Care-Med. 2024;209A:1614$53$YR$$F$Y$$$20240823$$HP$US$US
242420291$24242029$1$I$$20240816$20240823$20240823$EXP$GB-MHRA-TPP25240340C17459774YC1723736655835$GB-RDY-SPO/GBR/24/0012037$DR REDDYS$$82$YR$E$M$Y$74$KG$20240823$$PH$GB$GB
242420301$24242030$1$I$20240807$20240822$20240823$20240823$EXP$FR-AFSSAPS-MP2024001316$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-132982$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$59$KG$20240823$$PH$FR$FR
242420312$24242031$2$F$20201123$20240912$20240823$20240916$EXP$$CO-UCBSA-2024042741$UCB$$65$YR$$F$Y$60$KG$20240916$$CN$CO$CO
242420321$24242032$1$I$$20240820$20240823$20240823$EXP$$GB-Orion Corporation ORION PHARMA-24_00031349$ORION$Islam S, Stribley J. Disseminated nocardiasis nova complicated by COVID pneumonitis in a giant cell arteritis patient treated with second line antibiotic monotherapy. Eur. J. Case Rep. Intern. Med.. 2023 JAN;10 (SUPPL.):311.$75$YR$E$F$Y$$$20240823$$MD$GB$
242420331$24242033$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-040949$AUROBINDO$Sevella P, Khan S, Shah S.. A Devastating Case of Septic Pulmonary Emboli.. Am-J-Respir-CritCare-Med. 2024;209:A1676$73$YR$$M$Y$$$20240823$$HP$US$US
242420342$24242034$2$F$$20240913$20240823$20240926$EXP$$US-AUROBINDO-AUR-APL-2024-040959$AUROBINDO$Kyle D Pires, Mark K Su, William C. Minimal effects after a massive intravenous terbutaline overdose in a child. BMJ Case Rep. 2024;17:e259352$$$$F$Y$22$KG$20240926$$MD$US$US
242420351$24242035$1$I$20240708$20240816$20240823$20240823$EXP$$NVSC2024BR168938$NOVARTIS$$55$YR$$F$Y$81$KG$20240823$$MD$BR$BR
242420361$24242036$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012495$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240823$$CN$US$US
242420371$24242037$1$I$$20240816$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012169$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240823$$CN$US$US
242420381$24242038$1$I$$20240819$20240823$20240823$EXP$$NVSC2024CA168244$NOVARTIS$$60$YR$$M$Y$$$20240823$$HP$CA$CA
242420391$24242039$1$I$$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014331$ELI LILLY AND CO$$87$YR$E$F$Y$$$20240823$$CN$US$US
242420401$24242040$1$I$$20240816$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011053$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240823$$CN$US$US
242420411$24242041$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013458$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240823$$CN$US$US
242420421$24242042$1$I$$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014356$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240823$$CN$US$US
242420431$24242043$1$I$20240818$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011967$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240823$$CN$US$US
242420441$24242044$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013136$ELI LILLY AND CO$$$$A$M$Y$$$20240823$$CN$US$US
242420461$24242046$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012656$ELI LILLY AND CO$$$$$$Y$$$20240823$$CN$US$US
242420471$24242047$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-100728-2023$RECKITT BENCKISER$$58$YR$$F$Y$$$20240823$$CN$US$US
242420481$24242048$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012797$ELI LILLY AND CO$$$$$M$Y$$$20240823$$CN$US$US
242420491$24242049$1$I$$20240821$20240823$20240823$EXP$$US-ABBVIE-5889836$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242420501$24242050$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-041093$AUROBINDO$Latif R, Aloqaily M, Rabadi A, Arshad K, Kurian AI, Obeidat I, et al.. Apixaban-Induced Hemopericardium in a Post-TAVR Patient: A Case Report Highlighting Diagnostic and Management Challenges. Am-J-Case-Rep. 2024;25(1941-5923):e944173$66$YR$$M$Y$$$20240823$$HP$US$US
242420513$24242051$3$F$$20240913$20240823$20240926$EXP$$US-AUROBINDO-AUR-APL-2024-040638$AUROBINDO$Cheng J, Harney S, Toner K, Kube P, Gong S, Wistinghausen B, et al. Pediatric monomorphic posttransplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment. Pediatr-Blood-Cancer. 2024;71(8):1-4, e31096$9$YR$$M$Y$$$20240926$$HP$US$US
242420522$24242052$2$F$20240816$20240922$20240823$20240924$PER$$NVSC2024US168381$NOVARTIS$$12$YR$$F$Y$$$20240924$$HP$US$US
242420531$24242053$1$I$20201122$20240822$20240823$20240823$EXP$FR-AFSSAPS-CN2024000646$NVSC2024FR170054$NOVARTIS$$51$YR$$F$Y$75$KG$20240823$$PH$FR$FR
242420541$24242054$1$I$$20240814$20240823$20240823$PER$$US-ABBVIE-5881777$ABBVIE$$$$$M$Y$$$20240823$$MD$US$US
242420552$24242055$2$F$$20240821$20240823$20240902$EXP$$PT-AUROBINDO-AUR-APL-2024-041256$AUROBINDO$Cabrita SA, Lopo J, Sousa D.. Um Caso Paradigm?tico de S?ndrome de Cushing: Uma Rara Fisiopatologia num Doente Jovem (A Paradigmatic Case of Cushing?s Syndrome: A Rare Physiopathology in a Young Patient).. SPMI Case Reports. 2024;VOL.2 | N.?2 |:84-86$35$YR$$M$Y$$$20240902$$MD$PT$PT
242420561$24242056$1$I$$20240822$20240823$20240823$PER$$US-BAUSCH-BL-2024-012766$BAUSCH AND LOMB$$30$YR$$M$Y$$$20240823$$CN$US$US
242420571$24242057$1$I$20240812$20240812$20240823$20240823$EXP$$US-Accord-442031$ACCORD$$63$YR$A$F$Y$$$20240823$$HP$US$US
242420581$24242058$1$I$$20240812$20240823$20240823$EXP$GB-MHRA-MED-202408121431509000-KYFPC$GB-Accord-441405$ACCORD$$51$YR$A$M$Y$$$20240823$$CN$GB$GB
242420591$24242059$1$I$$20240812$20240823$20240823$EXP$CA-MHPD-E2B_07157226$CA-Accord-442000$ACCORD$$66$YR$E$F$Y$$$20240823$$HP$CA$CA
242420602$24242060$2$F$$20240819$20240823$20240831$EXP$$GB-Accord-441937$ACCORD$Mira AR, Brincat MR, Zalawadia S, Sideris M, Dilley J. Immature ovarian teratoma with gliomatosis peritonei, paraneoplastic hyponatremia and growing teratoma syndrome: a case report and literature review. Annals of medicine and surgery. 2024;86(8):4907-12.$26$YR$A$F$Y$$$20240831$$MD$GB$GB
242420611$24242061$1$I$20240627$20240812$20240823$20240823$EXP$FR-AFSSAPS-PV2024000679$FR-Accord-441550$ACCORD$$$$$$Y$$$20240823$$MD$FR$FR
242420621$24242062$1$I$$20240812$20240823$20240823$EXP$$GR-Accord-442016$ACCORD$G. Oikonomou, E. Mugakou, V. Tzavara.  The importance of pharmacovigilance: a severe example of methotrexate toxicity. A Pathology clinic Korgialenio-Benakio. 266$78$YR$E$F$Y$$$20240823$$MD$GR$GR
242420631$24242063$1$I$20240726$20240822$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133805$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240823$$PH$US$US
242420641$24242064$1$I$20240429$20240822$20240823$20240823$EXP$FR-AFSSAPS-PB2024000898$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-133342$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$65$KG$20240823$$PH$FR$FR
242420651$24242065$1$I$20240813$20240813$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129620$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240823$$PH$US$US
242420672$24242067$2$F$$20240913$20240823$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-040645$AUROBINDO$Nettleton E, Sattui SE, Wallace Z, Putman M.. Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide.. Arthritis Care + Research-(Hoboken). 2024;76(2):288-294$40$YR$$M$Y$$$20240925$$HP$US$US
242420691$24242069$1$I$$20240814$20240823$20240823$EXP$ES-EMA-DD-20240808-7482643-110601$ES-MSNLABS-2024MSNLIT01828$MSN LABORATORIES$Quintero V, Bueno-Sanchez D, Mozo-Del-Castillo Y, Urtasun-Erburu A, Sisinni L, Lopez-Duarte M.Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow Failure.Transplantation and Cellular Therapy.2023;29(10):1-5$$$$$Y$$$20240823$$HP$ES$ES
242420701$24242070$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-040801$AUROBINDO$Garofalo V, Walgamage M, Cuello LN, Wester K, Robinson S, Gemayel CY. ANAPLASMOSIS: FROM MULTI-SYSTEM MAYHEM TO VENTRICULAR TACHYCARDIA IN A HEARTBEAT. J-AmColl-Cardiol. 2024;83 (Suppl.)(13):4506$78$YR$$M$Y$$$20240823$$HP$US$US
242420711$24242071$1$I$$20240802$20240822$20240822$DIR$FDA-CDER-CTU-2024-57971$$FDA-CTU$$$$$F$N$$$20240802$N$HP$US$
242420721$24242072$1$I$20240822$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57982$$FDA-CTU$$41$YR$$F$N$72.57$KG$20240822$N$HP$US$
242420751$24242075$1$I$20240818$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58093$$FDA-CTU$$72$YR$$F$N$71$KG$20240822$Y$PH$US$
242420761$24242076$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58090$$FDA-CTU$$84$YR$$F$N$$$20240822$N$$US$
242420771$24242077$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57951$$FDA-CTU$$71$YR$$F$N$74.84$KG$20240822$N$$US$
242420781$24242078$1$I$$20240819$20240823$20240823$30DAY$$US-GSK-US2024103433$GLAXOSMITHKLINE$$$$$M$Y$$$20240823$$CN$US$US
242420801$24242080$1$I$$20240814$20240823$20240823$EXP$$US-GSK-US2024101295$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242420811$24242081$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57983$$FDA-CTU$$75$YR$$M$N$93.44$KG$20240822$N$$US$
242420822$24242082$2$F$20240821$20240920$20240823$20240923$EXP$$US-BAUSCH-BL-2024-012780$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240923$$CN$US$US
242420831$24242083$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-040940$AUROBINDO$Ahmed T, Liu D, Seiter K, Steinberg A, Hernandez K. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. Blood. 2023;142 (Suppl. 1):7349-7350$37$YR$$M$Y$$$20240823$$MD$US$US
242420841$24242084$1$I$20240714$20240822$20240823$20240823$EXP$$US-BAUSCH-BL-2024-012785$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240823$$CN$US$US
242420851$24242085$1$I$$20240812$20240823$20240823$EXP$$PT-AUROBINDO-AUR-APL-2024-040863$AUROBINDO$Neto M, Reis A, Santos F, Brigas D, Marques S, Serra S, et al.. MISFORTUNE. Eur-J-Case-RepIntern-Med. 2023;10 (Suppl. 1):328$42$YR$$F$Y$$$20240823$$HP$PT$PT
242420861$24242086$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-041031$AUROBINDO$Sreekumar S, Rubin R.. A Case of Pulmonary Mucormycosis Leading to Non-hepatic Hyperammonemia.. Am-J-Respir-Crit-Care-Med. 2024;209:A3563$31$YR$$F$Y$$$20240823$$HP$US$US
242420881$24242088$1$I$20240710$20240816$20240823$20240823$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160774$JIANGSU HENGRUI MEDICINE$$57$YR$$M$Y$57$KG$20240823$$MD$CN$CN
242420892$24242089$2$F$20240726$20240812$20240823$20240823$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160782$JIANGSU HANSOH PHARMACEUTICAL$$55$YR$$M$Y$$$20240823$$MD$CN$CN
242420911$24242091$1$I$$20240807$20240823$20240823$PER$$US-P+L Developments of Newyork Corporation-2160781$PL DEVELOPMENTS$$$$$$Y$$$20240823$$$US$US
242420931$24242093$1$I$$20240817$20240823$20240823$EXP$$PK-Adaptis Pharma Private Limited-2160779$ADAPTIS PHARMA INDIA$Source document$64$YR$$F$Y$$$20240823$$MD$PK$PK
242420941$24242094$1$I$20240801$20240813$20240823$20240823$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160777$JIANGSU HENGRUI MEDICINE$$44$YR$$F$Y$52$KG$20240823$$MD$CX$CN
242420951$24242095$1$I$20240101$20240808$20240823$20240823$PER$$US-JNJFOC-20240822949$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240823$$CN$US$US
242420961$24242096$1$I$$20240812$20240823$20240823$PER$$US-P+L Developments of Newyork Corporation-2160784$PL DEVELOPMENTS$$$$$$Y$$$20240823$$$US$US
242420971$24242097$1$I$20240630$20240809$20240823$20240823$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160780$JIANGSU HANSOH PHARMACEUTICAL$$65$YR$$M$Y$68.7$KG$20240823$$MD$CN$CN
242420981$24242098$1$I$$20240809$20240823$20240823$EXP$$US-ACI HealthCare Limited-2160785$ACI HEALTHCARE$Full text$25$YR$$M$Y$$$20240823$$$US$US
242420991$24242099$1$I$$20240810$20240823$20240823$PER$$US-P+L Developments of Newyork Corporation-2160776$PL DEVELOPMENTS$$$$$$Y$$$20240823$$$US$US
242421001$24242100$1$I$$20240817$20240823$20240823$EXP$$PK-Adaptis Pharma Private Limited-2160778$ADAPTIS PHARMA INDIA$Source document$86$YR$$M$Y$$$20240823$$MD$PK$PK
242421011$24242101$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-082171-2024$RECKITT BENCKISER$$$$$$Y$$$20240823$$CN$US$US
242421021$24242102$1$I$$20240819$20240823$20240823$EXP$$AU-AMGEN-AUSSP2024165609$AMGEN$$56$YR$A$M$Y$$$20240823$$MD$AU$AU
242421031$24242103$1$I$20240726$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133211$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240823$$HP$US$US
242421041$24242104$1$I$$20240814$20240823$20240823$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07825$HIKMA$Farooq O, Lin R, Easow B, Chhabra P, Kaur P.. Farooq O, Lin R, Easow B, Chhabra P, Kaur P. A Rare Case of Cephalosporin Anaphylaxis-Induced Reverse Takotsubo.. Cureus. 2024;16(7):e63987.:1-5$66$YR$$F$Y$$$20240823$$MD$US$US
242421051$24242105$1$I$$20240816$20240823$20240823$EXP$$IN-MYLANLABS-2024M1070598$MYLAN$Madhav S, Panayanthatta S, Athira K. Imatinib Induced Iron Overload. Eur-J-Cardiovasc-Med 2023; 13 (2): 930-932.$60$YR$$M$Y$$$20240823$$HP$IN$IN
242421062$24242106$2$F$20181201$20240830$20240823$20240906$EXP$$GB-MYLANLABS-2024M1076873$MYLAN$Ibrahim A, Prasad G, Kilpatrick ES, Morris TJ. ^A case of autoimmune hepatitis associated with the PCSK9 inhibitor alirocumab^. Ann-Clin-Biochem 2024; 0(0)_1 - 4.$61$YR$$F$Y$$$20240906$$HP$GB$GB
242421071$24242107$1$I$20220101$20240819$20240823$20240823$EXP$$IT-BAUSCH-BL-2024-012567$BAUSCH AND LOMB$Frattari A, De Angelis M, Battilana M, Polilli E, Ferrieri A, Onofrillo D, Santoro N, Sau A, D^Andreagiovanni A, Tocco P, Bosco D, Parruti G. High viral load VZV encephalitis complicated by super refractory status epilepticus in a vaccinated child with in Acute Lymphocytic Leukemia: Case report and review of the literature. Neuroimmunology Reports. 2024 JUL 29;6:1-7. doi:10.1016/j.nerep.2024.100223$6$YR$$M$Y$$$20240823$$HP$IT$IT
242421081$24242108$1$I$$20240816$20240823$20240823$EXP$$AU-MYLANLABS-2024M1077396$MYLAN$Nguyen JK, Holmes Z, Kelly RI. Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum. Australas-J-Dermatol 2023; 64 (2): 221-228.$$$$F$Y$$$20240823$$MD$AU$AU
242421091$24242109$1$I$$20240816$20240823$20240823$EXP$$NZ-MYLANLABS-2024M1077529$MYLAN$Banerji A, Sleigh JW, Termaat J, Voss LJ. Emergence Electroencephalography in an Unresponsiveness Geriatric Patient in the Postanesthesia Care Unit: A Case Report. A-A-Pract 2024; 18 (7): e01813.$78$YR$$F$Y$$$20240823$$MD$NZ$NZ
242421101$24242110$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-041050$AUROBINDO$Abbasi F, Garcia SN, Dean J.. Disseminated Cryptococcosis in an Hiv Negative Patient on Hemodialysis. Am-J-Respir-Crit-Care-Med. 2024$67$YR$$M$Y$$$20240823$$HP$US$US
242421112$24242111$2$F$$20240817$20240823$20240829$EXP$$DE-AUROBINDO-AUR-APL-2024-040774$AUROBINDO$Bingert R, Kolbe V, Boy D, Buttner A. Suizide von Minderj?hrigen ? retrospektive 22-Jahres-Analyse des Leichenschau- und Obduktionsgutes des Instituts f?r Rechtsmedizin Rostock (Suicides of minors - retrospective 22-year analysis of the mortuary and autopsy material from the Rostock Institute for Forensic Medicine). Rechtsmedizin (Forensic medicine). 2023;33:396-402$17$YR$$M$Y$$$20240829$$HP$DE$DE
242421122$24242112$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093452$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242421131$24242113$1$I$20240727$20240819$20240823$20240823$EXP$$AU-TAKEDA-2024TUS084030$TAKEDA$$65$YR$$M$Y$$$20240823$$CN$AU$AU
242421141$24242114$1$I$20240701$20240816$20240823$20240823$EXP$$US-TAKEDA-2024TUS049140$TAKEDA$$47$YR$$F$Y$$$20240823$$HP$US$US
242421153$24242115$3$F$$20240911$20240823$20240924$EXP$$CA-HALEON-2193153$Haleon PLC$$70$YR$$F$Y$$$20240923$$HP$CA$CA
242421161$24242116$1$I$$20240815$20240823$20240823$EXP$$US-TEVA-VS-3235295$TEVA$$15$YR$$M$Y$$$20240823$$HP$US$US
242421171$24242117$1$I$20240813$20240816$20240823$20240823$EXP$$PK-ROCHE-10000059559$ROCHE$$43$YR$A$F$Y$$$20240823$$HP$PK$PK
242421181$24242118$1$I$20220101$20240821$20240823$20240823$EXP$$DE-BAUSCH-BL-2024-012753$BAUSCH AND LOMB$$60$YR$$F$Y$55$KG$20240823$$MD$DE$DE
242421201$24242120$1$I$20240101$20240814$20240823$20240823$EXP$$US-TEVA-VS-3235297$TEVA$$34$YR$$F$Y$$$20240823$$HP$US$US
242421211$24242121$1$I$20240101$20240814$20240823$20240823$EXP$$US-TEVA-VS-3235203$TEVA$$19$YR$$M$Y$$$20240823$$CN$US$US
242421222$24242122$2$F$20240816$20240828$20240823$20240828$EXP$$CO-UCBSA-2024042726$UCB$$36$YR$$M$Y$$$20240828$$CN$CO$CO
242421231$24242123$1$I$$20240812$20240823$20240823$EXP$$US-AUROBINDO-AUR-APL-2024-041036$AUROBINDO$Khan A, Vangara A, Kommineni SS, Gullapalli D, Ganti SS. Fungal Infection in a Patient With Bacterial Pneumonia. Am-J-Respir-Crit-Care-Med. 2024$46$YR$$M$Y$$$20240823$$HP$US$US
242421243$24242124$3$F$$20240911$20240823$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-121178$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240919$$HP$US$US
242421251$24242125$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133199$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240823$$CN$US$US
242421271$24242127$1$I$$20240814$20240823$20240823$EXP$$JP-CARNEGIE-000018$Carnegie Pharmaceuticals$$77$YR$E$F$Y$$$20240817$$MD$JP$JP
242421282$24242128$2$F$20240711$20240816$20240823$20240826$EXP$$AT-PUMA BIOTECHNOLOGY, INC.-2024-PUM-AT001128$PUMA$$64$YR$$F$Y$$$20240826$$MD$AT$AT
242421292$24242129$2$F$$20240911$20240823$20240919$EXP$$NVSC2024CA169059$NOVARTIS$$67$YR$$F$Y$$$20240919$$CN$CA$CA
242421311$24242131$1$I$20240715$20240816$20240823$20240823$EXP$$US-ENDO USA, INC.-2024-003276$ENDO$$94$YR$$M$Y$$$20240823$$HP$US$US
242421322$24242132$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093465$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242421331$24242133$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024AMR102767$GLAXOSMITHKLINE$$$$$F$Y$61.678$KG$20240823$$CN$US$US
242421351$24242135$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57976$$FDA-CTU$$36$YR$$F$N$154.67$KG$20240822$N$$US$
242421381$24242138$1$I$$20240801$20240822$20240822$DIR$FDA-CDER-CTU-2024-57969$$FDA-CTU$$$$$M$N$$$20240801$N$HP$US$
242421391$24242139$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57991$$FDA-CTU$$80$YR$$M$N$$$20240822$N$$US$
242421401$24242140$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57962$$FDA-CTU$$28$YR$$M$N$$$20240822$N$$US$
242421411$24242141$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58049$$FDA-CTU$$$$$M$N$$$20240822$N$HP$US$
242421421$24242142$1$I$$20240812$20240823$20240823$EXP$$DE-MACLEODS PHARMA-MAC2024048882$MACLEODS$$$$$$Y$$$20240823$$MD$DE$DE
242421431$24242143$1$I$$20240812$20240823$20240823$EXP$$DE-MACLEODS PHARMA-MAC2024048883$MACLEODS$$$$$$Y$$$20240823$$MD$DE$DE
242421441$24242144$1$I$$20240812$20240823$20240823$EXP$$LK-MACLEODS PHARMA-MAC2024048896$MACLEODS$Krishnan M, Fernando H, Mohammed HH, Vithanage N.Proton Pump Inhibitor Induced Hypomagnesemia Causing Seizures: A Rare Adverse Effect of a Commonly Used Medication..Cureus.2024;16(7):e64044$$$$$Y$$$20240823$$MD$LK$LK
242421451$24242145$1$I$20140101$20240820$20240823$20240823$EXP$$US-JNJFOC-20240851492$JOHNSON AND JOHNSON$$$$$F$Y$53.572$KG$20240823$$CN$US$US
242421461$24242146$1$I$$20240822$20240823$20240823$PER$$US-JNJFOC-20240856934$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$HP$US$US
242421471$24242147$1$I$$20240813$20240823$20240823$EXP$$CN-MACLEODS PHARMA-MAC2024048891$MACLEODS$Sun XX, Chai JY, Zhu XL, Wu SB, Wang H, Huang B.Real-time evaluation of active bleeding severity in soft-tissue hematomas via contrast-enhanced ultrasound: a case series.Quantitative Imaging in Medicine and Surgery.2024;14(8):6173-9$$$$$Y$$$20240823$$MD$CN$CN
242421482$24242148$2$F$$20240819$20240823$20240830$EXP$$DE-MACLEODS PHARMA-MAC2024048884$MACLEODS$$$$$$Y$$$20240830$$MD$DE$DE
242421491$24242149$1$I$$20240813$20240823$20240823$EXP$$BR-MACLEODS PHARMA-MAC2024048890$MACLEODS$Lopes DN, de Oliveira NP, de Campos Augusto KC, Milagres A, Miguez AL, Junior AS.Co-occurrence of oral pemphigus vulgaris and herpes simplex virus infection in a young patient with Crohn^s disease: report of a rare case of oral lesions during anti-TFN alpha and immunomodulator therapy..International journal of colorectal disease.2024;39(1):125$$$$$Y$$$20240823$$MD$BR$BR
242421501$24242150$1$I$$20240812$20240823$20240823$EXP$$US-MACLEODS PHARMA-MAC2024048887$MACLEODS$Gibbens Y, Lake J, Lim N..A Rare Cause of Acute Liver Failure.Gastroenterology.2024;167(3):446-449$$$$$Y$$$20240823$$MD$US$US
242421511$24242151$1$I$$20240812$20240823$20240823$EXP$$PE-MACLEODS PHARMA-MAC2024048897$MACLEODS$Concepcion-Zavaleta MJ, Quiroz-Aldave JE, Fabian KE, Ildefonso-Najarro SP, Chavez KM, Concepcion-Urteaga LA etal.Methimazole-Induced Pancytopenia in a Patient with Graves Disease: A Case Report and Literature Review..Current drug safety.2024$$$$$Y$$$20240823$$HP$PE$PE
242421522$24242152$2$F$$20240820$20240823$20240831$EXP$$IN-MACLEODS PHARMA-MAC2024048905$MACLEODS$Saini B, Agarwal A, Singh G, Jayachandran S, Jain S..Tramadol-Induced Fatal Angioedema: A Rare Case.Cureus.11-JUL-2024;16(7):e64341$$$$$Y$$$20240831$$HP$IN$IN
242421531$24242153$1$I$$20240812$20240823$20240823$EXP$GB-MHRA-MED-202408121729244000-BKHSR$GB-MACLEODS PHARMA-MAC2024048901$MACLEODS$$$$$$Y$$$20240823$$PH$GB$GB
242421541$24242154$1$I$$20240812$20240823$20240823$EXP$$US-MACLEODS PHARMA-MAC2024048895$MACLEODS$Walterscheid B, Batchinsky M, Tarbox M..Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Preceding Toxic Epidermal Necrolysis Secondary to Sildenafil: A Case Report.Cureus.05-JUL-2024;16(7):e63922$$$$$Y$$$20240823$$MD$US$US
242421551$24242155$1$I$$20240812$20240823$20240823$EXP$GB-MHRA-MED-202408121500517630-NJZBD$GB-MACLEODS PHARMA-MAC2024048900$MACLEODS$$$$$$Y$$$20240823$$HP$GB$GB
242421562$24242156$2$F$20220701$20240912$20240823$20240918$EXP$$NVSJ2024JP009712$NOVARTIS$$51$YR$$F$Y$52.2$KG$20240918$$MD$JP$JP
242421571$24242157$1$I$20240801$20240813$20240823$20240823$EXP$GB-MHRA-MED-202408131135045430-PTZLS$GB-MACLEODS PHARMA-MAC2024048911$MACLEODS$$$$$$Y$$$20240823$$CN$GB$GB
242421581$24242158$1$I$20240601$20240816$20240823$20240823$EXP$$NVSC2024CA168610$NOVARTIS$$29$YR$$F$Y$122$KG$20240823$$MD$CA$CA
242421592$24242159$2$F$$20240911$20240823$20240918$EXP$$NVSC2024CA169008$NOVARTIS$$49$YR$$F$Y$$$20240918$$CN$CA$CA
242421602$24242160$2$F$20240726$20240828$20240823$20240830$EXP$$NVSC2024CO118743$NOVARTIS$$50$YR$$F$Y$60$KG$20240830$$CN$CO$CO
242421612$24242161$2$F$$20240913$20240823$20240925$EXP$$TZ-AUROBINDO-AUR-APL-2024-041103$AUROBINDO$Mwakyula IH, Makarius E, Maro H, Ngatunga C. Pneumoconiosis among artisanal miners in Chunya district, Mbeya, Tanzania. BMJ-Case-Rep. 2024;17:e260481$$$A$M$Y$$$20240925$$MD$TZ$TZ
242421621$24242162$1$I$20240819$20240821$20240823$20240823$EXP$DE-BFARM-24005807$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-133287$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240823$$MD$DE$DE
242421632$24242163$2$F$$20240827$20240823$20240830$EXP$$NVSC2024CA169054$NOVARTIS$$49$YR$$F$Y$$$20240830$$HP$CA$CA
242421641$24242164$1$I$$20240814$20240823$20240823$EXP$$CA-CELLTRION INC.-2024CA020062$CELLTRION$$$$$$Y$$$20240823$$HP$CA$CA
242421653$24242165$3$F$20240818$20240919$20240823$20240925$EXP$$AR-TAKEDA-2024TUS084354$TAKEDA$$10$YR$$F$Y$28$KG$20240925$$CN$AR$AR
242421661$24242166$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167555$AMGEN$$$$A$F$Y$76.2$KG$20240823$$CN$US$US
242421672$24242167$2$F$20240818$20240827$20240823$20240829$PER$$US-AMGEN-USASP2024166302$AMGEN$$86$YR$E$F$Y$$$20240829$$CN$US$US
242421681$24242168$1$I$$20240812$20240823$20240823$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001194$ALEMBIC$Huang C. H, Wick J, Komiya T.. Preliminary results of atezolizumab and pirfenidone in non-small cell lung cancer. Journal of Clinical Oncology. 2024;42 (16)$$$$$Y$$$20240823$$HP$US$US
242421691$24242169$1$I$$20240812$20240823$20240823$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001178$ALEMBIC$Connell B, Hwang C, Folefac E, Lawlor C, Koethe B. Fractionated docetaxel (D) and radium 223 (Ra223) in metastatic castrationresistant prostate cancer (CRPC): A modular phase I trial. Journal of Clinical Oncology. 2024;42 (16)$$$$$Y$$$20240823$$HP$US$US
242421701$24242170$1$I$$20240812$20240823$20240823$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001179$ALEMBIC$Connell B, Hwang C, Folefac E, Lawlor C, Koethe B, Mathew P.. Fractionated docetaxel (D) and radium 223 (Ra223) in metastatic castrationresistant prostate cancer (CRPC): A modular phase I trial. Journal of Clinical Oncology.. 2024;42 (16)$$$$$Y$$$20240823$$HP$US$US
242421711$24242171$1$I$$20240822$20240823$20240823$PER$$US-ROCHE-10000063810$ROCHE$$78$YR$E$F$Y$$$20240823$$CN$US$US
242421722$24242172$2$F$$20240910$20240823$20240916$PER$$US-ROCHE-10000064480$ROCHE$$35$YR$A$F$Y$$$20240916$$CN$US$US
242421731$24242173$1$I$$20240729$20240823$20240823$PER$$US-Apozeal Pharmaceuticals-2160787$Apozeal Pharmaceuticals$$$$$F$Y$$$20240823$$$US$US
242421741$24242174$1$I$$20240813$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408008636$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242421751$24242175$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013538$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240823$$CN$US$US
242421761$24242176$1$I$$20240819$20240823$20240823$EXP$$NVSC2024CA168003$NOVARTIS$$$$$M$Y$$$20240823$$HP$CA$CA
242421771$24242177$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013162$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242421781$24242178$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013478$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242421791$24242179$1$I$20240801$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014453$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240823$$CN$US$US
242421801$24242180$1$I$20240805$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012795$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240823$$CN$US$US
242421812$24242181$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093466$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242421821$24242182$1$I$$20240815$20240823$20240823$PER$$US-ABBVIE-5884415$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242421831$24242183$1$I$$20240816$20240823$20240823$EXP$$US-009507513-2408USA006848$MERCK$Farooqui A, Kao J, Farooqui MW, Danciu OC. Risk of VTE in TNBC treated with neoadjuvant immunotherapy. Journal of Clinical Oncology. 2024;42(16)$$$$F$Y$$$20240823$$HP$US$US
242421841$24242184$1$I$$20240822$20240823$20240823$PER$$US-ROCHE-10000064193$ROCHE$$28$YR$A$F$Y$$$20240823$$CN$US$US
242421851$24242185$1$I$$20240812$20240823$20240823$EXP$$ES-TEYRO-2024-TY-000491$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$M$Y$$$20240823$$HP$ES$ES
242421881$24242188$1$I$20240801$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132958$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240823$$PH$US$US
242421893$24242189$3$F$$20240828$20240823$20240905$EXP$$US-ROCHE-10000055489$ROCHE$$$$E$F$Y$$$20240905$$CN$US$US
242421901$24242190$1$I$20240216$20240816$20240823$20240823$EXP$$IN-ROCHE-3567245$ROCHE$$51$YR$A$F$Y$$$20240823$$CN$IN$IN
242421911$24242191$1$I$$20240822$20240823$20240823$PER$$US-ROCHE-10000064597$ROCHE$$25$YR$A$F$Y$$$20240823$$HP$US$US
242421921$24242192$1$I$$20240815$20240823$20240823$EXP$$US-AMGEN-USASP2024163065$AMGEN$Cappuccio J. M.; Osman K. T,; Burns D et. al. A rare case of polyarthritis panniculitis and pancreatitis. Clinical Journal of Gastroenterology. 2024;Vol (14 ):765-770$67$YR$E$M$Y$$$20240823$$HP$US$US
242421931$24242193$1$I$$20240822$20240823$20240823$PER$$US-ROCHE-10000064577$ROCHE$$$$$$Y$$$20240823$$HP$US$US
242421941$24242194$1$I$20220806$20240819$20240823$20240823$EXP$$VN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046448$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240823$$HP$VN$VN
242421951$24242195$1$I$$20240819$20240823$20240823$30DAY$$US-GSK-US2024103445$GLAXOSMITHKLINE$$$$A$M$Y$$$20240823$$MD$US$US
242421962$24242196$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093467$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242421991$24242199$1$I$20200201$20240820$20240823$20240823$EXP$$US-ROCHE-10000062074$ROCHE$$41$YR$A$M$Y$117.93$KG$20240823$$CN$US$US
242422001$24242200$1$I$20240409$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-087419-2024$RECKITT BENCKISER$$$$$M$Y$$$20240823$$CN$US$US
242422011$24242201$1$I$20240820$20240822$20240823$20240823$PER$$US-ROCHE-10000064426$ROCHE$$32$YR$A$F$Y$$$20240823$$CN$US$US
242422041$24242204$1$I$$20240812$20240823$20240823$EXP$$ES-TEYRO-2024-TY-000488$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$M$Y$$$20240823$$HP$ES$ES
242422053$24242205$3$F$20230801$20240817$20240823$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-041679$AUROBINDO$$53$YR$$F$Y$$$20240831$$HP$FR$FR
242422061$24242206$1$I$$20240822$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074666$SANDOZ$$73$YR$$M$Y$66$KG$20240823$$HP$CA$CA
242422071$24242207$1$I$$20240729$20240823$20240823$PER$$US-Apozeal Pharmaceuticals-2160788$Apozeal Pharmaceuticals$$$$$$Y$$$20240823$$$US$US
242422091$24242209$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58037$$FDA-CTU$$39$YR$$F$N$104.33$KG$20240822$N$CN$US$
242422101$24242210$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58052$$FDA-CTU$$59$YR$$F$N$$$20240822$N$$US$
242422111$24242211$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57974$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242422121$24242212$1$I$$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57964$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
242422141$24242214$1$I$$20240816$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132085$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240823$$HP$US$US
242422151$24242215$1$I$20211001$20240807$20240823$20240823$PER$$CN-Blueprint Medicines Corporation-SP-CN-2024-001717$BLUEPRINT MEDICINES$$30$YR$A$M$Y$$$20240823$$CN$CN$CN
242422162$24242216$2$F$$20240904$20240823$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133354$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240905$$HP$US$US
242422171$24242217$1$I$$20240821$20240823$20240823$EXP$$US-ROCHE-10000063658$ROCHE$$$$E$F$Y$$$20240823$$CN$US$US
242422181$24242218$1$I$$20240821$20240823$20240823$EXP$PL-URPL-1-1835-2020$NVSC2024PL169352$NOVARTIS$$55$YR$$F$Y$78$KG$20240823$$MD$PL$PL
242422192$24242219$2$F$20240706$20240906$20240823$20240910$EXP$$JP-PFIZER INC-PV202400089672$PFIZER$$8$DEC$$F$Y$$$20240910$$MD$JP$JP
242422201$24242220$1$I$$20240822$20240823$20240823$EXP$$CA-ORGANON-O2408CAN001620$ORGANON$$80$YR$$M$Y$89$KG$20240823$$HP$CA$CA
242422212$24242221$2$F$20240819$20240819$20240823$20240827$EXP$$CA-PFIZER INC-202400240978$PFIZER$$91$YR$$F$Y$$$20240827$$HP$CA$CA
242422223$24242222$3$F$20230407$20240821$20240823$20240902$EXP$$CN-PFIZER INC-2023SGN05071$PFIZER$$62$YR$$M$Y$56$KG$20240902$$MD$CN$CN
242422231$24242223$1$I$20240304$20240812$20240823$20240823$EXP$ES-AEMPS-1556659$ES-Accord-441822$ACCORD$$54$YR$A$F$Y$61$KG$20240823$$HP$ES$ES
242422241$24242224$1$I$20230812$20240812$20240823$20240823$EXP$GB-MHRA-WEBRADR-202408120742157310-GKVSR$GB-Accord-441410$ACCORD$$62$YR$A$M$Y$$$20240823$$CN$GB$GB
242422251$24242225$1$I$20240401$20240812$20240823$20240823$EXP$IT-MINISAL02-997842$IT-Accord-441551$ACCORD$$69$YR$E$M$Y$$$20240823$$PH$IT$IT
242422271$24242227$1$I$$20240812$20240823$20240823$EXP$FR-AFSSAPS-RS2024000774$FR-Accord-441544$ACCORD$$72$YR$E$M$Y$$$20240823$$MD$FR$FR
242422283$24242228$3$F$20240718$20240830$20240823$20240911$EXP$FR-AFSSAPS-SE2024000619$FR-Accord-441502$ACCORD$$51$YR$A$F$Y$82$KG$20240911$$MD$FR$FR
242422291$24242229$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58084$$FDA-CTU$$68$YR$$M$N$$$20240822$N$$US$
242422301$24242230$1$I$$20240812$20240823$20240823$EXP$CA-MHPD-E2B_07143299$CA-Accord-441643$ACCORD$$64$YR$A$F$Y$$$20240823$$HP$CA$CA
242422322$24242232$2$F$20100731$20240823$20240823$20240827$EXP$$BR-AMERICAN REGENT INC-2024003197$AMERICAN REGENT$$25$YR$$F$Y$$$20240827$$CN$BR$BR
242422331$24242233$1$I$$20240812$20240823$20240823$EXP$CA-MHPD-E2B_07119389$CA-Accord-441637$ACCORD$$62$YR$A$M$Y$$$20240823$$CN$CA$CA
242422341$24242234$1$I$$20240812$20240823$20240823$EXP$$ES-TEYRO-2024-TY-000481$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$M$Y$$$20240823$$HP$ES$ES
242422352$24242235$2$F$$20240821$20240823$20240823$EXP$$US-ROCHE-10000063718$ROCHE$$$$A$F$Y$$$20240823$$CN$US$US
242422361$24242236$1$I$20240808$20240812$20240823$20240823$EXP$$IN-ROCHE-10000055949$ROCHE$$44$YR$A$M$Y$$$20240823$$MD$IN$IN
242422371$24242237$1$I$$20240811$20240823$20240823$EXP$$KR-Accord-441901$ACCORD$Jo JH, Lee JW, Seol KH. Assessing the Adequacy of Traditional Vertebral Landmarks as Upper Border of Whole Pelvic Radiotherapy Field for Stage IB2-IIB Cervical Cancer. Cancers (Basel). 2024 Aug 1;16(15):2743.$$$$F$Y$$$20240823$$HP$KR$KR
242422382$24242238$2$F$$20240820$20240823$20240830$PER$$US-ROCHE-10000061336$ROCHE$Elfasi A, Newsome S. Rituximab-Associated Immune Colitis in Multiple Sclerosis: Case Report and Literature Review [Abstract:CS01]. 2024 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) - International Journal of MS Case. 2024;26 (S1):20.$54$YR$A$F$Y$$$20240830$$HP$US$US
242422394$24242239$4$F$20240820$20240917$20240823$20240919$EXP$$GB-MYLANLABS-2024M1036480$MYLAN$$$$$F$Y$$$20240919$$CN$GB$GB
242422401$24242240$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166296$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242422411$24242241$1$I$$20240815$20240823$20240823$EXP$$CA-APOTEX-2024AP009462$APOTEX$$$$E$M$Y$$$20240823$$PH$CA$CA
242422421$24242242$1$I$$20240801$20240823$20240823$PER$$US-SLATERUN-2024SRSPO00137$SLATE RUN$$$$$$Y$$$20240823$$CN$US$US
242422431$24242243$1$I$$20240807$20240823$20240823$PER$$US-SLATERUN-2024SRSPO00141$SLATE RUN$$$$$M$Y$$$20240823$$CN$US$US
242422441$24242244$1$I$$20240820$20240823$20240823$EXP$$EG-ROCHE-10000062008$ROCHE$$42$YR$A$F$Y$80$KG$20240823$$CN$EG$EG
242422451$24242245$1$I$20240301$20240820$20240823$20240823$EXP$$DE-ROCHE-10000063777$ROCHE$$54$YR$A$F$Y$62$KG$20240823$$CN$DE$DE
242422461$24242246$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-082214-2024$RECKITT BENCKISER$$$$$$Y$$$20240823$$CN$US$US
242422471$24242247$1$I$$20240729$20240823$20240823$PER$$US-Apozeal Pharmaceuticals-2160789$Apozeal Pharmaceuticals$$$$$F$Y$$$20240823$$$US$US
242422481$24242248$1$I$$20240816$20240823$20240823$PER$$US-ABBVIE-5887013$ABBVIE$$$$$$Y$$$20240823$$CN$US$US
242422501$24242250$1$I$$20240812$20240823$20240823$EXP$$ES-TEYRO-2024-TY-000487$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$M$Y$$$20240823$$HP$ES$ES
242422511$24242251$1$I$20240805$20240812$20240823$20240823$EXP$$US-Accord-442741$ACCORD$$42$YR$A$M$Y$$$20240823$$HP$US$US
242422521$24242252$1$I$20240810$20240812$20240823$20240823$EXP$$US-Accord-442288$ACCORD$$74$YR$E$$Y$$$20240823$$HP$US$US
242422531$24242253$1$I$$20240812$20240823$20240823$EXP$$US-Accord-442046$ACCORD$$55$YR$A$F$Y$$$20240823$$MD$US$US
242422541$24242254$1$I$$20240812$20240823$20240823$EXP$GB-MHRA-EMIS-6849-9a93c674-dcff-4f62-9805-2c875b3e330f$GB-Accord-441489$ACCORD$$66$YR$E$M$Y$70$KG$20240823$$PH$GB$GB
242422551$24242255$1$I$$20240812$20240823$20240823$EXP$CA-MHPD-001087080$CA-Accord-441999$ACCORD$$52$YR$A$F$Y$$$20240823$$HP$CA$CA
242422561$24242256$1$I$20240725$20240725$20240823$20240823$EXP$$US-VIIV HEALTHCARE LIMITED-US2024093544$VIIV$$43$YR$$F$Y$$$20240823$$HP$US$US
242422571$24242257$1$I$20240601$20240816$20240823$20240823$EXP$$CO-GSK-CO2024AMR008322$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$CO$CO
242422581$24242258$1$I$$20240811$20240823$20240823$EXP$$KR-Accord-441899$ACCORD$Jo JH, Lee JW, Seol KH. Assessing the Adequacy of Traditional Vertebral Landmarks as Upper Border of Whole Pelvic Radiotherapy Field for Stage IB2-IIB Cervical Cancer. Cancers (Basel). 2024 Aug 1;16(15):2743.$$$$F$Y$$$20240823$$HP$KR$KR
242422591$24242259$1$I$20240501$20240821$20240823$20240823$30DAY$$US-GSK-US2024104405$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$HP$US$US
242422601$24242260$1$I$$20240814$20240823$20240823$PER$$US-RDY-SPO/USA/24/0012051$DR REDDYS$$$$$M$Y$$$20240823$$CN$US$US
242422611$24242261$1$I$$20240811$20240823$20240823$EXP$$JP-Accord-442294$ACCORD$Yamada K, Ida-Ichikawa M, Fujimoto N, Ishida M, Dohi K. Takotsubo syndrome in a cancer patient treated with a combination of anti-cancer drugs including immune checkpoint inhibitors: a case report. European heart journal. Case reports. 2024;8(8):ytae355.$66$YR$E$F$Y$$$20240823$$HP$JP$JP
242422621$24242262$1$I$20201101$20240812$20240823$20240823$EXP$GB-MHRA-MED-202408121641507570-NDJLF$GB-Accord-441402$ACCORD$$22$YR$A$F$Y$67$KG$20240823$$CN$GB$GB
242422631$24242263$1$I$20240229$20240812$20240823$20240823$EXP$FR-AFSSAPS-TO2024001483$FR-Accord-441670$ACCORD$$81$YR$E$M$Y$58.7$KG$20240823$$PH$FR$FR
242422641$24242264$1$I$$20240814$20240823$20240823$EXP$$US-GSK-US2024AMR102888$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242422651$24242265$1$I$$20240811$20240823$20240823$EXP$$US-Accord-442357$ACCORD$Kim M, Graham C, Stevens RW, Shah A. A Rare Case of Bacterial Meningitis Caused by Hematogenous Spread of Vancomycin-Resistant Enterococcus faecium in an Immunocompromised Patient. Case reports in infectious diseases. 2024:2193650. DOI: 10.1155/2024/2193650.$72$YR$E$M$Y$$$20240823$$MD$US$US
242422661$24242266$1$I$$20240813$20240823$20240823$EXP$$US-NOVITIUMPHARMA-2024USNVP01628$NOVITIUM PHARMA$Jinjun Cheng.Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment.Pediatric Blood + Cancer.22-MAY-2024;71(8):1-4$9$YR$C$M$Y$$$20240823$$HP$US$US
242422671$24242267$1$I$$20240814$20240823$20240823$EXP$$DE-VANTIVE-2024VAN019035$Vantive US Healthcare$$$$$F$Y$$$20240823$$CN$DE$DE
242422681$24242268$1$I$20240818$20240818$20240823$20240823$EXP$$KR-VANTIVE-2024VAN019123$Vantive US Healthcare$$44$YR$$F$Y$$$20240823$$CN$KR$KR
242422692$24242269$2$F$20240817$20240821$20240823$20240828$EXP$$IN-VANTIVE-2024VAN019166$Vantive US Healthcare$$64$YR$$F$Y$$$20240828$$CN$IN$IN
242422701$24242270$1$I$20240812$20240812$20240823$20240823$EXP$$US-Accord-442123$ACCORD$$71$YR$E$M$Y$$$20240823$$HP$US$US
242422711$24242271$1$I$20240713$20240817$20240823$20240823$EXP$$CO-VANTIVE-2024VAN019107$Vantive US Healthcare$$77$YR$$M$Y$62$KG$20240823$$HP$CO$CO
242422721$24242272$1$I$20240809$20240812$20240823$20240823$EXP$GB-MHRA-MED-202408121620151650-FLGZT$GB-Accord-441477$ACCORD$$49$YR$A$F$Y$$$20240823$$HP$GB$GB
242422731$24242273$1$I$$20240811$20240823$20240823$EXP$$IN-Accord-441898$ACCORD$Vempuluru VS, Sinha P, Tanna V, Maniktala Y, Palkonda VAR, Kaliki S. Neoadjuvant chemotherapy for advanced eyelid and periocular sebaceous gland carcinoma: a study of 25 cases. Int Ophthalmol. 2024 Aug 5;44(1):341. doi: 10.1007/s10792-024-03256-w.$50$YR$A$M$Y$$$20240823$$HP$IN$IN
242422741$24242274$1$I$20240809$20240812$20240823$20240823$EXP$$US-Accord-442027$ACCORD$$23$YR$A$M$Y$$$20240823$$PH$US$US
242422751$24242275$1$I$20240406$20240724$20240823$20240823$EXP$$FR-Accord-440709$ACCORD$$$$$$Y$$$20240823$$PH$FR$FR
242422761$24242276$1$I$$20240812$20240823$20240823$EXP$GB-MHRA-MED-202408121500517630-NJZBD$GB-Accord-441492$ACCORD$$66$YR$E$F$Y$$$20240823$$HP$GB$GB
242422771$24242277$1$I$20240812$20240812$20240823$20240823$EXP$$US-Accord-442383$ACCORD$$51$YR$A$M$Y$$$20240823$$PH$US$US
242422781$24242278$1$I$20211116$20240812$20240823$20240823$EXP$PL-URPL-DML-MLP.4401.1.1407.2021$PL-Accord-441557$ACCORD$$76$YR$E$M$Y$75$KG$20240823$$MD$PL$PL
242422791$24242279$1$I$$20240811$20240823$20240823$EXP$$US-Accord-441771$ACCORD$Quan Soon KL, Shah S, Ibrahim R, Alzwahereh K. A Case Report on Iatrogenic Methotrexate Toxicity. Cureus. 2024 Jul 8;16(7):e64081. doi: 10.7759/cureus.64081.$54$YR$A$F$Y$$$20240823$$MD$US$US
242422801$24242280$1$I$20240810$20240812$20240823$20240823$EXP$$US-Accord-442029$ACCORD$$44$YR$A$F$Y$$$20240823$$HP$US$US
242422811$24242281$1$I$$20240805$20240823$20240823$PER$$US-TEVA-VS-3230283$TEVA$$$$$F$Y$$$20240823$$PH$US$US
242422821$24242282$1$I$$20240821$20240823$20240823$PER$$US-ROCHE-10000064297$ROCHE$$$$$$Y$$$20240823$$CN$US$US
242422831$24242283$1$I$$20240819$20240823$20240823$EXP$FR-AFSSAPS-AVMA2024000346$FR-MYLANLABS-2024M1077291$MYLAN$$$$$$Y$$$20240823$$CN$FR$FR
242422841$24242284$1$I$20240802$20240819$20240823$20240823$EXP$$CN-ROCHE-10000064316$ROCHE$$75$YR$E$F$Y$$$20240823$$HP$CN$CN
242422851$24242285$1$I$$20240812$20240823$20240823$EXP$CA-MHPD-E2B_001092065$CA-Accord-441987$ACCORD$$56$YR$A$M$Y$109$KG$20240823$$HP$CA$CA
242422861$24242286$1$I$20240708$20240819$20240823$20240823$EXP$$DE-MYLANLABS-2024M1076971$MYLAN$$$$$F$Y$$$20240823$$CN$DE$DE
242422871$24242287$1$I$20220610$20240814$20240823$20240823$EXP$HU-OGYI-0100924$HU-BAYER-2024A117050$BAYER$$38$YR$A$F$Y$50$KG$20240823$$CN$HU$HU
242422881$24242288$1$I$20240724$20240815$20240823$20240823$EXP$FR-AFSSAPS-LY2024001234$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07867$HIKMA$$40$YR$$M$Y$59$KG$20240823$$MD$FR$FR
242422891$24242289$1$I$$20240822$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074641$SANDOZ$$89$YR$$M$Y$$$20240823$$CN$CA$CA
242422901$24242290$1$I$$20240821$20240823$20240823$EXP$$CA-PFIZER INC-202400241120$PFIZER$$14$YR$$M$Y$$$20240823$$HP$CA$CA
242422911$24242291$1$I$$20240821$20240823$20240823$EXP$$US-PFIZER INC-202400241798$PFIZER$$$$$F$Y$$$20240823$$HP$US$US
242422921$24242292$1$I$$20240821$20240823$20240823$EXP$$US-PFIZER INC-202400241062$PFIZER$$$$$M$Y$$$20240823$$CN$US$US
242422931$24242293$1$I$20240820$20240820$20240823$20240823$EXP$$JP-PFIZER INC-202400239475$PFIZER$$75$YR$$M$Y$$$20240823$$PH$JP$JP
242422941$24242294$1$I$20240501$20240821$20240823$20240823$EXP$$US-PFIZER INC-202400241562$PFIZER$$49$YR$$M$Y$$$20240823$$HP$US$US
242422952$24242295$2$F$20240419$20240904$20240823$20240905$EXP$$FR-PFIZER INC-202400233420$PFIZER$$40$YR$$M$Y$93$KG$20240905$$MD$FR$FR
242422966$24242296$6$F$$20240912$20240823$20240917$EXP$$US-PFIZER INC-202400107540$PFIZER$$84$YR$$M$Y$$$20240917$$CN$US$US
242422971$24242297$1$I$20240801$20240820$20240823$20240823$EXP$$CN-PFIZER INC-PV202400108701$PFIZER$$53$YR$$M$Y$$$20240823$$HP$CN$CN
242422982$24242298$2$F$20240819$20240821$20240823$20240827$EXP$$CA-PFIZER INC-202400240785$PFIZER$$67$YR$$F$Y$$$20240827$$HP$CA$CA
242422991$24242299$1$I$$20240820$20240823$20240823$EXP$$CA-PFIZER INC-202400240112$PFIZER$$7$YR$$M$Y$$$20240823$$HP$CA$CA
242423001$24242300$1$I$20240701$20240822$20240823$20240823$EXP$$JP-PFIZER INC-PV202400109903$PFIZER$$70$YR$$M$Y$$$20240823$$MD$JP$JP
242423011$24242301$1$I$20231201$20240820$20240823$20240823$EXP$$GB-PFIZER INC-PV202400108521$PFIZER$$$$$F$Y$$$20240823$$CN$GB$GB
242423033$24242303$3$F$$20240913$20240823$20240916$EXP$$US-PFIZER INC-202400241699$PFIZER$$51$YR$$F$Y$$$20240916$$HP$US$US
242423041$24242304$1$I$20140201$20240820$20240823$20240823$EXP$$US-PFIZER INC-PV202400108985$PFIZER$$$$T$M$Y$46.4$KG$20240823$$HP$US$US
242423052$24242305$2$F$20240604$20240910$20240823$20240912$EXP$$US-PFIZER INC-202400241387$PFIZER$$71$YR$$M$Y$86.168$KG$20240912$$CN$US$US
242423061$24242306$1$I$$20240821$20240823$20240823$PER$$US-ROCHE-10000057834$ROCHE$$50$YR$A$F$Y$$$20240823$$HP$US$US
242423071$24242307$1$I$$20240821$20240823$20240823$PER$$US-ROCHE-10000063768$ROCHE$$$$E$$Y$$$20240823$$CN$US$US
242423101$24242310$1$I$20240611$20240819$20240823$20240823$EXP$ES-AEMPS-1561569$ES-PFIZER INC-202400238868$PFIZER$$76$YR$$M$Y$$$20240823$$MD$ES$ES
242423111$24242311$1$I$$20240820$20240823$20240823$EXP$$CA-Orion Corporation ORION PHARMA-24_00031382$ORION$$3$DEC$A$M$Y$$$20240823$$MD$CA$
242423121$24242312$1$I$20240806$20240820$20240823$20240823$EXP$$CO-UCBSA-2024042744$UCB$$37$YR$$M$Y$$$20240823$$CN$CO$CO
242423132$24242313$2$F$$20240821$20240823$20240903$EXP$$CA-UCBSA-2024042079$UCB$$$$$F$Y$$$20240903$$CN$CA$CA
242423141$24242314$1$I$$20240812$20240823$20240823$EXP$$ES-TEYRO-2024-TY-000489$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$F$Y$$$20240823$$HP$ES$ES
242423161$24242316$1$I$20240607$20240815$20240823$20240823$EXP$$US-Vifor (International) Inc.-VIT-2024-07453$VIFOR$$51$YR$$M$Y$86$KG$20240823$$HP$US$US
242423171$24242317$1$I$$20240822$20240822$20240822$DIR$715515$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242423181$24242318$1$I$20210101$20240819$20240823$20240823$EXP$$US-AMGEN-USASP2024165704$AMGEN$$77$YR$E$F$Y$$$20240823$$MD$US$US
242423191$24242319$1$I$$20240812$20240823$20240823$EXP$$ES-TEYRO-2024-TY-000514$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Garcia-Carbonero R, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$M$Y$$$20240823$$HP$ES$ES
242423221$24242322$1$I$$20240819$20240823$20240823$PER$$US-GILEAD-2024-0684732$GILEAD$$60$YR$A$F$Y$$$20240823$$MD$US$US
242423231$24242323$1$I$20240817$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013880$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240823$$CN$US$US
242423241$24242324$1$I$20240731$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013698$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240823$$CN$US$US
242423251$24242325$1$I$20240801$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014338$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240823$$CN$US$US
242423261$24242326$1$I$20240820$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013714$ELI LILLY AND CO$$17$YR$T$M$Y$$$20240823$$MD$US$US
242423271$24242327$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013526$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240823$$CN$US$US
242423281$24242328$1$I$$20240821$20240823$20240823$EXP$$GB-EMD Serono-2024045236$EMD SERONO INC$$77$YR$E$M$Y$$$20240823$$MD$GB$GB
242423291$24242329$1$I$$20240816$20240823$20240823$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001675$BLUEPRINT MEDICINES$$$$$F$Y$$$20240823$$CN$US$US
242423301$24242330$1$I$20240811$20240814$20240823$20240823$EXP$$US-BAYER-2024A117408$BAYER$$27$YR$A$F$Y$$$20240823$$CN$US$US
242423311$24242331$1$I$$20240813$20240823$20240823$EXP$$US-GSK-US2024AMR100956$GLAXOSMITHKLINE$$$$$M$Y$$$20240823$$CN$US$US
242423321$24242332$1$I$$20240809$20240823$20240823$PER$$US-RISINGPHARMA-US-2024RISSPO00290$RISING PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242423332$24242333$2$F$20240814$20240923$20240823$20240930$EXP$$CA-GSK-CA2024102466$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$CA$CA
242423351$24242335$1$I$20240701$20240819$20240823$20240823$EXP$$CA-JNJFOC-20240367790$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$80$KG$20240823$$HP$CA$CA
242423371$24242337$1$I$$20240819$20240823$20240823$EXP$$JP-EXELIXIS-CABO-24080749$EXELIXIS$$8$DEC$$F$Y$$$20240823$$MD$JP$JP
242423381$24242338$1$I$$20240817$20240823$20240823$EXP$$US-TAKEDA-2024TUS084058$TAKEDA$$$$$F$Y$$$20240823$$CN$US$US
242423392$24242339$2$F$$20240911$20240823$20240918$EXP$$NVSC2024CA169029$NOVARTIS$$74$YR$$F$Y$70$KG$20240919$$MD$CA$CA
242423401$24242340$1$I$$20240816$20240823$20240823$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2017-VEL-00134$VELOXIS PHARMACEUTICALS$Kamal M, Apewokin S, Anand M, Abu Jawdeh BG, Govil A, Sheikh MM et al.. Late-Onset Allograft Aspergillosis in an HIV-Positive Renal Transplant Recipient: A Case Report.. Transplantation Proceedings.. 2017;49(7):1570-1573$21$YR$$M$Y$$$20240823$$MD$US$US
242423411$24242341$1$I$$20240820$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074420$SANDOZ$$79$YR$$M$Y$75$KG$20240823$$PH$CA$CA
242423421$24242342$1$I$20240205$20240814$20240823$20240823$EXP$$CA-MYLANLABS-2023M1083232$BIOCON$$$$$$Y$$$20240823$$MD$CA$CA
242423431$24242343$1$I$$20240809$20240823$20240823$EXP$$MA-Unichem Pharmaceuticals (USA) Inc-UCM202408-001050$UNICHEM$$$$$$Y$$$20240823$$HP$MA$
242423441$24242344$1$I$$20240812$20240823$20240823$EXP$$ES-TEYRO-2024-TY-000492$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$F$Y$$$20240823$$HP$ES$ES
242423451$24242345$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166303$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242423461$24242346$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166244$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242423472$24242347$2$F$$20240731$20240823$20240903$EXP$$US-BAYER-2024A118967$BAYER$Semelka RC, Ramalho M. Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation. Frontiers in Toxicology. 2024;6:1-7$$$A$$Y$$$20240903$$MD$US$US
242423481$24242348$1$I$$20240819$20240823$20240823$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-131709$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240823$$HP$CA$CA
242423491$24242349$1$I$$20240821$20240823$20240823$PER$$US-ROCHE-3524095$ROCHE$$$$E$F$Y$$$20240823$$CN$US$US
242423511$24242351$1$I$$20240730$20240823$20240823$PER$$US-SCIEGENP-2024SCSPO00346$SCIEGEN$$89$YR$E$F$Y$$$20240823$$CN$US$US
242423521$24242352$1$I$$20240819$20240823$20240823$EXP$$AU-GILEAD-2024-0684676$GILEAD$$$$$M$Y$$$20240823$$MD$AU$AU
242423533$24242353$3$F$20230705$20240904$20240823$20240911$EXP$$CA-GSK-CA2023092821$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$HP$CA$CA
242423541$24242354$1$I$20190801$20240820$20240823$20240823$EXP$$CO-UCBSA-2024042718$UCB$$55$YR$$F$Y$$$20240823$$CN$CO$CO
242423551$24242355$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58070$$FDA-CTU$$70$YR$$F$N$65.77$KG$20240822$N$$US$
242423561$24242356$1$I$20240321$20240813$20240823$20240823$EXP$ES-AEMPS-1559574$ES-TEVA-VS-3236192$TEVA$$74$YR$$M$Y$$$20240823$$MD$ES$ES
242423571$24242357$1$I$$20240815$20240823$20240823$PER$$US-JNJFOC-20240843361$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$HP$US$US
242423601$24242360$1$I$$20240110$20240823$20240823$PER$$US-APOTEX-2024AP001045$APOTEX$Wojkowski J, Palazis A, Ogbogu P, Wessell KR, Roberts P, Newton H. TEMOZOLOMIDE DESENSITIZATION AND CONSIDERATIONS FOR IMPLEMENTATION IN AN ACADEMIC MEDICAL CENTER: A CASE REPORT. Neuro-Oncology. 2023;25 (suppl. 5):v161$42$YR$$F$Y$$$20240823$$HP$US$US
242423621$24242362$1$I$20240701$20240814$20240823$20240823$30DAY$$US-GSK-US2024101204$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240823$$HP$US$US
242423631$24242363$1$I$$20240822$20240822$20240822$DIR$715506$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242423641$24242364$1$I$$20231107$20240823$20240823$PER$$US-APOTEX-2023AP016513$APOTEX$Schaff LR, Kushnirsky M, Lin AL, Nandakumar S, Grommes C, Miller AM, et al.. Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series. Neurology. 2022;99 (17):750-755$54$YR$$M$Y$$$20240823$$MD$US$US
242423651$24242365$1$I$$20240822$20240822$20240822$DIR$715502$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242423671$24242367$1$I$$20230714$20240823$20240823$PER$$US-APOTEX-2023AP010930$APOTEX$McCord M, Lukas RV, Amidei C, Demars N, Gelb A, Horbinski C, et al.. Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient. Neuro-Oncology Advances. 2021;3(1):1-5$$$A$M$Y$$$20240823$$HP$US$US
242423681$24242368$1$I$$20240822$20240822$20240822$DIR$715533$$FDA-CTU$$$$$UNK$N$$$20240822$$CN$US$
242423691$24242369$1$I$$20231107$20240823$20240823$PER$$US-APOTEX-2023AP016514$APOTEX$Schaff LR, Kushnirsky M, Lin AL, Nandakumar S, Grommes C, Miller AM, et al.. Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series. Neurology. 2022;99 (17):750-755$44$YR$$M$Y$$$20240823$$MD$US$US
242423701$24242370$1$I$20240822$20240822$20240822$20240822$DIR$715539$$FDA-CTU$$60$YR$$F$N$53.1$KG$20240822$N$CN$US$
242423711$24242371$1$I$$20231107$20240823$20240823$PER$$US-APOTEX-2023AP016521$APOTEX$Schaff LR, Kushnirsky M, Lin AL, Nandakumar S, Grommes C, Miller AM, et al.. Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series. Neurology. 2022;99 (17):750-755$43$YR$$M$Y$$$20240823$$MD$US$US
242423721$24242372$1$I$$20231107$20240823$20240823$PER$$US-APOTEX-2023AP016522$APOTEX$Schaff LR, Kushnirsky M, Lin AL, Nandakumar S, Grommes C, Miller AM, Gavrilovic IT, Nolan C, Pentsova E, Mellinghoff IK, Kaley TJ. Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series. Neurology. 2022;99 (17):750-755$39$YR$$F$Y$$$20240823$$MD$US$US
242423731$24242373$1$I$$20231107$20240823$20240823$PER$$US-APOTEX-2023AP016527$APOTEX$Schaff LR, Kushnirsky M, Lin AL, Nandakumar S, Grommes C, Miller AM, et al.. Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series. Neurology. 2022;99 (17):750-755$45$YR$$M$Y$$$20240823$$MD$US$US
242423741$24242374$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167393$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242423751$24242375$1$I$$20240821$20240823$20240823$EXP$$US-GILEAD-2024-0684986$GILEAD$$$$A$M$Y$$$20240823$$CN$US$US
242423761$24242376$1$I$$20240812$20240823$20240823$EXP$$ES-TEYRO-2024-TY-000486$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$F$Y$$$20240823$$HP$ES$ES
242423781$24242378$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58056$$FDA-CTU$$57$YR$$M$N$$$20240822$N$$US$
242423791$24242379$1$I$20240822$20240822$20240822$20240822$DIR$715570$$FDA-CTU$$73$YR$$M$N$60.75$KG$20240822$N$$US$
242423801$24242380$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57954$$FDA-CTU$$56$YR$$F$N$103.42$KG$20240822$N$$US$
242423831$24242383$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57953$$FDA-CTU$$23$YR$$F$N$$$20240822$N$$US$
242423881$24242388$1$I$20240802$20240822$20240823$20240823$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-115581$REGENERON$$83$YR$$M$Y$$$20240823$$MD$JP$JP
242423891$24242389$1$I$$20240814$20240823$20240823$EXP$$US-VIIV HEALTHCARE LIMITED-US2024101707$VIIV$$$$$M$Y$$$20240823$$CN$US$US
242423901$24242390$1$I$$20240813$20240823$20240823$EXP$$US-NOVITIUMPHARMA-2024USNVP01620$NOVITIUM PHARMA$Abhishek Singh.IgD Multiple Myeloma, Does It Still Have a Poor Prognosis?.Blood.15-NOV-2022;140(1):12520$63$YR$A$F$Y$$$20240823$$HP$US$US
242423913$24242391$3$F$$20240918$20240823$20240924$PER$$US-ROCHE-10000059455$ROCHE$$$$A$F$Y$$$20240924$$HP$US$US
242423921$24242392$1$I$$20240819$20240823$20240823$EXP$$CA-ROCHE-10000060077$ROCHE$$$$E$F$Y$$$20240823$$CN$CA$CA
242423941$24242394$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170825$NOVARTIS$$78$YR$$M$Y$54.43$KG$20240823$$CN$US$US
242423951$24242395$1$I$$20231107$20240823$20240823$PER$$US-APOTEX-2023AP016526$APOTEX$Schaff LR, Kushnirsky M, Lin AL, Nandakumar S, Grommes C, Miller AM, et al.. Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series. Neurology. 2022;99 (17):750-755$75$YR$$M$Y$$$20240823$$MD$US$US
242423961$24242396$1$I$$20240822$20240823$20240823$EXP$$US-GILEAD-2024-0685078$GILEAD$$$$A$F$Y$$$20240823$$CN$US$US
242423971$24242397$1$I$$20240814$20240823$20240823$EXP$$US-BAXTER-2024BAX023362$BAXTER$$68$YR$$M$Y$$$20240823$$MD$US$US
242423981$24242398$1$I$20240803$20240813$20240823$20240823$EXP$CN-NMPACDR-3305211053318202400183$CN-BAXTER-2024BAX023276$BAXTER$$60$YR$$F$Y$74$KG$20240823$$MD$CN$CN
242423991$24242399$1$I$20230809$20240814$20240823$20240823$EXP$$US-BAXTER-2023BAX028973$BAXTER$$63$YR$$M$Y$$$20240823$$MD$US$US
242424001$24242400$1$I$20240527$20240815$20240823$20240823$EXP$CN-NMPACDR-4602001028168202400165$CN-BAXTER-2024BAX023385$BAXTER$$42$YR$$M$Y$80$KG$20240823$$MD$CN$CN
242424011$24242401$1$I$$20240820$20240823$20240823$EXP$$CA-ARGENX-2024-ARGX-CA006863$ARGENX BVBA$$$$$$Y$$$20240823$$HP$CA$CA
242424021$24242402$1$I$20240723$20240726$20240823$20240823$PER$$US-009507513-2407USA014902$MERCK$$$$$M$Y$$$20240823$$CN$US$US
242424031$24242403$1$I$20240809$20240813$20240823$20240823$EXP$CN-NMPACDR-4406041005095202400086$CN-BAXTER-2024BAX023286$BAXTER$$76$YR$$M$Y$39.7$KG$20240823$$MD$CN$CN
242424042$24242404$2$F$$20240819$20240823$20240827$EXP$$CZ-MYLANLABS-2024M1076955$MYLAN$$$$$M$Y$$$20240827$$CN$CZ$CZ
242424052$24242405$2$F$20210812$20240827$20240823$20240902$EXP$$US-TAKEDA-2024TUS024091$TAKEDA$$74$YR$$M$Y$$$20240902$$HP$US$US
242424061$24242406$1$I$$20240814$20240823$20240823$PER$$US-BAUSCHBL-2024BNL031836$BAUSCH AND LOMB$$$$$F$Y$$$20240823$$CN$US$US
242424072$24242407$2$F$20240801$20240830$20240823$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129917$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240906$$HP$US$US
242424081$24242408$1$I$$20240814$20240823$20240823$PER$$US-BAUSCHBL-2024BNL031885$BAUSCH AND LOMB$$$$$$Y$$$20240823$$MD$US$US
242424091$24242409$1$I$20240101$20240814$20240823$20240823$PER$$US-BAUSCHBL-2024BNL031913$BAUSCH AND LOMB$$$$$F$Y$$$20240823$$CN$US$US
242424101$24242410$1$I$20240814$20240814$20240823$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-025436$UNITED THERAPEUTICS$$$$C$F$Y$$$20240823$$MD$US$US
242424112$24242411$2$F$$20240917$20240823$20240921$PER$$US-ROCHE-10000061804$ROCHE$$54$YR$A$F$Y$$$20240921$$CN$US$US
242424121$24242412$1$I$20000101$20240814$20240823$20240823$EXP$FR-AFSSAPS-NT2024000986$FR-TEVA-VS-3233666$TEVA$$29$YR$$F$Y$$$20240823$$MD$FR$FR
242424131$24242413$1$I$$20240822$20240822$20240822$DIR$715543$$FDA-CTU$$$$$UNK$N$$$20240822$$CN$US$
242424141$24242414$1$I$$20240816$20240823$20240823$EXP$$CA-TAKEDA-2024TUS020329$TAKEDA$$$$$F$Y$$$20240823$$CN$CA$CA
242424151$24242415$1$I$$20240812$20240823$20240823$EXP$$ES-TEYRO-2024-TY-000493$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$M$Y$$$20240823$$HP$ES$ES
242424161$24242416$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58099$$FDA-CTU$$69$YR$$F$N$$$20240822$N$$US$
242424171$24242417$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167454$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242424181$24242418$1$I$20240820$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167680$AMGEN$$$$$M$Y$$$20240823$$CN$US$US
242424191$24242419$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166951$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242424201$24242420$1$I$20240731$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166724$AMGEN$$19$YR$A$M$Y$69.8$KG$20240823$$PH$US$US
242424211$24242421$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58101$$FDA-CTU$$93$YR$$F$N$$$20240822$N$$US$
242424221$24242422$1$I$20240101$20240819$20240823$20240823$EXP$$US-AMGEN-USASP2024165246$AMGEN$$41$YR$A$F$Y$$$20240823$$CN$US$US
242424231$24242423$1$I$20220901$20240820$20240823$20240823$EXP$$US-ABBVIE-5888723$ABBVIE$$58$YR$$F$Y$$$20240823$$CN$US$US
242424241$24242424$1$I$$20240815$20240823$20240823$PER$$US-UNITED THERAPEUTICS-UNT-2024-025494$UNITED THERAPEUTICS$$$$$M$Y$$$20240823$$$US$US
242424251$24242425$1$I$$20240821$20240823$20240823$EXP$$NVSC2024US169563$NOVARTIS$$45$YR$$M$Y$$$20240823$$MD$US$US
242424261$24242426$1$I$20240101$20240814$20240823$20240823$EXP$$US-BAYER-2024A118345$BAYER$$58$YR$A$M$Y$$$20240823$$HP$US$US
242424271$24242427$1$I$$20240819$20240823$20240823$EXP$$JP-ROCHE-10000061009$ROCHE$Ida-Ichikawa M, Fujimoto N, Ishida M, Dohi K. Takotsubo syndrome in a cancer patient treated with a combination of anti-cancer drugs including immune checkpoint inhibitors: A case report. European Heart Journal - Case Reports. 2024-Aug-01;8 (8):1-5. doi:10.1093/ehjcr/ytae355.$66$YR$E$F$Y$$$20240823$$HP$JP$JP
242424281$24242428$1$I$20240809$20240815$20240823$20240823$EXP$$US-TEVA-VS-3235736$TEVA$$41$YR$$F$Y$$$20240823$$HP$US$US
242424291$24242429$1$I$20240816$20240819$20240823$20240823$EXP$$US-JNJFOC-20240848270$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240823$$MD$US$US
242424302$24242430$2$F$20230101$20240909$20240823$20240910$PER$$US-AMGEN-USASP2024165203$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
242424311$24242431$1$I$$20240725$20240823$20240823$30DAY$$US-VEROBIOTECH-2024USVEROSPO00187$VERO BIOTECH$$$$$$Y$$$20240823$$HP$US$US
242424341$24242434$1$I$20240601$20240821$20240823$20240823$EXP$$US-GILEAD-2024-0685083$GILEAD$$12$YR$T$F$Y$$$20240823$$CN$US$US
242424352$24242435$2$F$$20240906$20240823$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128187$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$90.2$KG$20240912$$PH$US$US
242424371$24242437$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132345$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240823$$CN$US$US
242424381$24242438$1$I$$20240819$20240823$20240823$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-121016$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240823$$PH$JP$JP
242424392$24242439$2$F$20240801$20240917$20240823$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133205$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240918$$CN$US$US
242424411$24242441$1$I$$20240806$20240823$20240823$PER$$US-MYLANLABS-2024M1075419$MYLAN$$$$$F$Y$$$20240823$$CN$US$US
242424421$24242442$1$I$$20240812$20240823$20240823$EXP$$ES-TEYRO-2024-TY-000490$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$M$Y$$$20240823$$HP$ES$ES
242424431$24242443$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170893$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242424441$24242444$1$I$20230102$20240813$20240823$20240823$EXP$KR-KAERS-2023000116686$KR-Ipsen Biopharmaceuticals, Inc.-2024-16673$IPSEN$$$$E$F$Y$$$20240823$$HP$KR$KR
242424451$24242445$1$I$20240101$20240812$20240823$20240823$EXP$$US-PYROS PHARMACEUTICALS, INC-2024-PYROS-US000036$Pyros Pharmaceuticals$$$$$M$Y$54.875$KG$20240823$$CN$US$US
242424461$24242446$1$I$$20240820$20240823$20240823$EXP$$CA-ARGENX-2024-ARGX-CA006864$ARGENX BVBA$$$$$$Y$$$20240823$$HP$CA$CA
242424471$24242447$1$I$$20240809$20240823$20240823$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00739$Phathom Pharmaceuticals$$$$$F$Y$$$20240823$$CN$JP$JP
242424482$24242448$2$F$$20240823$20240823$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013832$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240827$$CN$US$US
242424491$24242449$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012674$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240823$$CN$US$US
242424501$24242450$1$I$20240820$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408000164$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240823$$CN$US$US
242424511$24242451$1$I$$20240725$20240823$20240823$30DAY$$US-VEROBIOTECH-2024USVEROSPO00188$VERO BIOTECH$$$$$$Y$$$20240823$$HP$US$US
242424521$24242452$1$I$20230112$20240820$20240823$20240823$EXP$$US-GILEAD-2024-0685007$GILEAD$$31$YR$A$F$Y$$$20240823$$CN$US$US
242424531$24242453$1$I$20240816$20240821$20240823$20240823$PER$$US-TAKEDA-2024TUS084381$TAKEDA$$56$YR$$F$Y$$$20240823$$HP$US$US
242424541$24242454$1$I$$20240813$20240823$20240823$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01663$NOVITIUM PHARMA$Noemie Abisror.Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.American Journal of Reproductive Immunology.08-JUL-2024;92(1):1-6$35$YR$A$F$Y$$$20240823$$HP$FR$FR
242424551$24242455$1$I$$20240814$20240823$20240823$EXP$$US-BAYER-2024A117775$BAYER$$$$$M$Y$$$20240823$$CN$US$US
242424561$24242456$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA168824$NOVARTIS$$37$YR$$F$Y$$$20240823$$HP$CA$CA
242424571$24242457$1$I$20240815$20240816$20240823$20240823$EXP$CN-91320000608398264T-2024CTTQ010009$CN-CHI-000267$CHIA TAI TIANQING PHARMACEUTICAL GROUP$$37$YR$A$F$Y$$$20240823$$CN$CN$CN
242424582$24242458$2$F$20240814$20240905$20240823$20240911$EXP$$NVSC2024DE169576$NOVARTIS$$37$YR$$M$Y$$$20240911$$MD$DE$DE
242424591$24242459$1$I$20240814$20240822$20240823$20240823$EXP$$NVSC2024KE170401$NOVARTIS$$31$YR$$M$Y$$$20240823$$MD$KE$KE
242424601$24242460$1$I$20240301$20240819$20240823$20240823$EXP$FR-AFSSAPS-RE2024000824$FR-ROCHE-10000060325$ROCHE$$36$YR$A$M$Y$92$KG$20240823$$MD$FR$FR
242424612$24242461$2$F$20240622$20240822$20240823$20240827$EXP$$US-PFIZER INC-PV202400110073$PFIZER$$87$YR$$M$Y$$$20240827$$CN$US$US
242424621$24242462$1$I$$20240821$20240823$20240823$EXP$$US-PFIZER INC-PV202400109772$PFIZER$$90$YR$$M$Y$$$20240823$$HP$US$US
242424641$24242464$1$I$$20240502$20240823$20240823$EXP$$TW-ROCHE-10000062267$ROCHE$$$$$$Y$$$20240823$$MD$TW$TW
242424651$24242465$1$I$20240730$20240813$20240823$20240823$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024100726$VIIV$$58$YR$$M$Y$$$20240823$$HP$US$US
242424661$24242466$1$I$$20240822$20240822$20240822$DIR$715523$$FDA-CTU$$75$MON$$F$N$49.76$KG$20240822$N$$US$
242424671$24242467$1$I$20240611$20240822$20240822$20240822$DIR$715511$$FDA-CTU$$65$YR$$M$N$63.9$KG$20240822$N$$US$
242424681$24242468$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57993$$FDA-CTU$$78$YR$$F$N$$$20240822$N$$US$
242424701$24242470$1$I$$20240822$20240822$20240822$DIR$715552$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242424711$24242471$1$I$$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57952$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
242424721$24242472$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58085$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242424731$24242473$1$I$20240801$20240822$20240822$20240822$DIR$715528$$FDA-CTU$$66$YR$$M$N$131.3$KG$20240822$Y$PH$US$
242424741$24242474$1$I$20240822$20240822$20240822$20240822$DIR$715489$$FDA-CTU$$57$YR$$F$N$$$20240822$N$HP$US$
242424752$24242475$2$F$20240818$20240826$20240823$20240902$PER$$US-TAKEDA-2024TUS083563$TAKEDA$$54$YR$$F$Y$$$20240902$$MD$US$US
242424761$24242476$1$I$$20240726$20240823$20240823$30DAY$$US-VEROBIOTECH-2024USVEROSPO00189$VERO BIOTECH$$$$$$Y$$$20240823$$CN$US$US
242424772$24242477$2$F$20240626$20240911$20240823$20240925$EXP$$US-UCBSA-2024042732$UCB$$59$YR$$F$Y$$$20240925$$CN$US$US
242424781$24242478$1$I$$20240822$20240823$20240823$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047385$BOEHRINGER INGELHEIM$$$$$$Y$$$20240823$$CN$US$US
242424791$24242479$1$I$$20240821$20240823$20240823$PER$$US-BAYER-2024A121140$BAYER$$27$YR$A$F$Y$$$20240823$$MD$US$US
242424801$24242480$1$I$20240714$20240819$20240823$20240823$EXP$$US-ABBVIE-5887319$ABBVIE$$64$YR$$F$Y$$$20240823$$CN$US$US
242424811$24242481$1$I$20240822$20240822$20240822$20240822$DIR$715565$$FDA-CTU$$71$YR$$F$N$67.5$KG$20240822$N$CN$US$
242424821$24242482$1$I$20240101$20240822$20240823$20240823$EXP$GB-MHRA-MED-202408221136012750-FZHCR$GB-JNJFOC-20240856503$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$PH$GB$GB
242424831$24242483$1$I$$20240814$20240823$20240823$EXP$$CA-APOTEX-2024AP009418$APOTEX$$82$YR$$M$Y$102$KG$20240823$$MD$CA$CA
242424841$24242484$1$I$$20240819$20240822$20240822$DIR$FDA-CDER-CTU-2024-57960$$FDA-CTU$$$$$M$N$$$20240819$N$HP$US$
242424851$24242485$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57992$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242424861$24242486$1$I$$20240819$20240823$20240823$EXP$$NVSC2024US168465$NOVARTIS$$$$$$Y$$$20240823$$CN$US$US
242424871$24242487$1$I$20240821$20240822$20240822$20240822$DIR$715559$$FDA-CTU$$41$YR$$M$N$67$KG$20240822$N$PH$US$
242424881$24242488$1$I$20240822$20240822$20240822$20240822$DIR$715500$$FDA-CTU$$76$YR$$M$N$84.15$KG$20240822$Y$PH$US$
242424891$24242489$1$I$20240822$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58097$$FDA-CTU$$76$YR$$M$N$$$20240822$Y$HP$US$
242424901$24242490$1$I$$20240812$20240823$20240823$PER$$US-FreseniusKabi-FK202412405$FRESENIUS KABI$$66$YR$E$F$Y$56.2$KG$20240823$$HP$US$US
242424911$24242491$1$I$$20240819$20240823$20240823$EXP$$AU-ABBVIE-5888621$ABBVIE$$$$$$Y$$$20240823$$MD$AU$AU
242424921$24242492$1$I$$20240816$20240823$20240823$PER$$US-AMGEN-USASP2024166994$AMGEN$$$$E$F$Y$$$20240823$$CN$US$US
242424931$24242493$1$I$$20240821$20240823$20240823$PER$$US-BAYER-2024A121145$BAYER$$36$YR$A$F$Y$$$20240823$$MD$US$US
242424941$24242494$1$I$20230222$20240814$20240823$20240823$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001243$AKEBIA THERAPEUTICS$$9$DEC$$M$Y$54.5$KG$20240823$$MD$JP$JP
242424951$24242495$1$I$20240706$20240808$20240823$20240823$EXP$$JP-BAUSCH-BL-2024-012774$BAUSCH AND LOMB$$3$DEC$$M$Y$$$20240823$$MD$JP$JP
242424961$24242496$1$I$$20240819$20240823$20240823$PER$$US-BEH-2024177486$CSL BEHRING$$$$$M$Y$$$20240823$$HP$US$US
242424971$24242497$1$I$20240701$20240809$20240823$20240823$EXP$$US-NIPPON SHINYAKU-NIP-2024-000045$NIPPON SHINYAKU$$1$YR$$M$Y$$$20240823$$HP$US$US
242424991$24242499$1$I$20240822$20240822$20240823$20240823$PER$$US-BAYER-2024A121188$BAYER$$$$$F$Y$$$20240823$$CN$US$US
242425002$24242500$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093468$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242425011$24242501$1$I$20240814$20240820$20240823$20240823$EXP$$CN-ROCHE-10000062037$ROCHE$$72$YR$E$M$Y$60$KG$20240823$$HP$CN$CN
242425021$24242502$1$I$$20240814$20240823$20240823$EXP$GB-MHRA-MED-202408140755121390-FBGNK$GB-TORRENT-00037602$TORRENT$$40$YR$A$F$Y$$$20240823$$CN$GB$GB
242425031$24242503$1$I$$20240819$20240823$20240823$EXP$$DE-TORRENT-00027192$TORRENT$$63$YR$A$F$Y$90$KG$20240823$$CN$DE$DE
242425041$24242504$1$I$20240801$20240820$20240823$20240823$EXP$$US-ABBVIE-5890065$ABBVIE$$51$YR$$M$Y$$$20240823$$CN$US$US
242425051$24242505$1$I$20240101$20240814$20240823$20240823$EXP$GB-MHRA-TPP32478549C22275880YC1723557673429$GB-TORRENT-00037614$TORRENT$$81$YR$E$M$Y$82$KG$20240823$$MD$GB$GB
242425061$24242506$1$I$20240810$20240817$20240823$20240823$EXP$GB-MHRA-MED-202408171121569570-KMTRW$GB-TORRENT-00037638$TORRENT$$39$YR$A$F$Y$$$20240823$$CN$GB$GB
242425071$24242507$1$I$$20240819$20240823$20240823$EXP$GB-MHRA-MED-202408191141120190-NVSHL$GB-TORRENT-00037650$TORRENT$$52$YR$A$M$Y$101$KG$20240823$$CN$GB$GB
242425081$24242508$1$I$$20240814$20240823$20240823$EXP$GB-MHRA-TPP877461C9267012YC1723564002483$GB-TORRENT-00037620$TORRENT$$66$YR$E$F$Y$60$KG$20240823$$MD$GB$GB
242425091$24242509$1$I$$20240812$20240823$20240823$EXP$$IN-TORRENT-00003636$TORRENT$$36$YR$A$M$Y$$$20240823$$MD$IN$IN
242425101$24242510$1$I$20240101$20240814$20240823$20240823$EXP$GB-MHRA-TPP32478549C22275880YC1723557738624$GB-TORRENT-00037632$TORRENT$$81$YR$E$M$Y$82$KG$20240823$$MD$GB$GB
242425112$24242511$2$F$$20240829$20240823$20240904$EXP$$US-TORRENT-00013722$TORRENT$$17$YR$T$F$Y$87$KG$20240904$$MD$US$US
242425121$24242512$1$I$$20240821$20240823$20240823$PER$$US-TAKEDA-2024TUS085143$TAKEDA$$$$$F$Y$$$20240823$$PH$US$US
242425131$24242513$1$I$$20240815$20240823$20240823$EXP$$US-TORRENT-00013721$TORRENT$$13$YR$T$M$Y$$$20240823$$MD$US$US
242425141$24242514$1$I$$20240822$20240823$20240823$PER$$US-BAYER-2024A121208$BAYER$$35$YR$A$F$Y$$$20240823$$MD$US$US
242425151$24242515$1$I$$20240820$20240823$20240823$EXP$$AU-ABBVIE-5889592$ABBVIE$$$$$M$Y$$$20240823$$CN$AU$AU
242425161$24242516$1$I$20240725$20240813$20240823$20240823$EXP$PT-INFARMED-T202407-969$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-07820$HIKMA$$77$YR$$F$Y$100$KG$20240823$$PH$PT$PT
242425172$24242517$2$F$$20240818$20240823$20240823$EXP$$US-ROCHE-10000060328$ROCHE$$$$$$Y$$$20240823$$CN$US$US
242425183$24242518$3$F$20240701$20240905$20240823$20240913$EXP$$CL-ROCHE-10000039818$ROCHE$$$$A$F$Y$$$20240913$$MD$CL$CL
242425191$24242519$1$I$20240808$20240820$20240823$20240823$EXP$$US-OTSUKA-2024_022984$OTSUKA$$87$YR$$F$Y$$$20240823$$CN$US$US
242425201$24242520$1$I$$20240820$20240823$20240823$EXP$$US-ROCHE-10000062169$ROCHE$$67$YR$E$F$Y$75.75$KG$20240823$$CN$US$US
242425211$24242521$1$I$20240730$20240814$20240823$20240823$EXP$FR-AFSSAPS-RS2024000795$FR-TEVA-VS-3233787$TEVA$$74$YR$$F$Y$70$KG$20240823$$PH$FR$FR
242425221$24242522$1$I$20231101$20240820$20240823$20240823$EXP$$AR-JNJFOC-20240854556$JOHNSON AND JOHNSON$$63$YR$A$F$Y$65$KG$20240823$$CN$AR$AR
242425232$24242523$2$F$$20240911$20240823$20240924$30DAY$$ES-JNJFOC-20240854743$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$ES$ES
242425241$24242524$1$I$20220418$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-087217-2024$RECKITT BENCKISER$$66$YR$$$Y$$$20240823$$CN$US$US
242425252$24242525$2$F$20240713$20240820$20240823$20240830$EXP$$DE-JNJFOC-20240802534$JOHNSON AND JOHNSON$$89$YR$E$F$Y$53$KG$20240830$$HP$DE$DE
242425261$24242526$1$I$$20240822$20240823$20240823$PER$$US-BAYER-2024A121214$BAYER$$44$YR$A$F$Y$$$20240823$$MD$US$US
242425272$24242527$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093469$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242425281$24242528$1$I$$20240821$20240823$20240823$PER$$US-BAYER-2024A121217$BAYER$$43$YR$A$F$Y$$$20240823$$CN$US$US
242425292$24242529$2$F$20240701$20240830$20240823$20240904$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013070$JAZZ$$41$YR$$F$Y$$$20240904$$CN$US$US
242425301$24242530$1$I$$20240822$20240822$20240822$DIR$715503$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242425311$24242531$1$I$$20240811$20240823$20240823$EXP$$JP-Inventia-000743$INVENTIA HEALTHCARE$Harada T, Nakanishi T, Kutsuna S, Nakai M. Unexpected Sudden Deaths Following the Co-administration of Ceftriaxone and Lansoprazole: A Case Series. Cureus. 2024 Jul 9;16(7):e64143.$88$YR$E$F$Y$$$20240823$$HP$JP$JP
242425321$24242532$1$I$$20240811$20240823$20240823$EXP$$JP-Inventia-000742$INVENTIA HEALTHCARE$Harada T, Nakanishi T, Kutsuna S, Nakai M. Unexpected Sudden Deaths Following the Co-administration of Ceftriaxone and Lansoprazole: A Case Series. Cureus. 2024 Jul 9;16(7):e64143.$79$YR$E$M$Y$$$20240823$$HP$JP$JP
242425331$24242533$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58087$$FDA-CTU$$54$YR$$F$N$$$20240822$N$$US$
242425341$24242534$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165953$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242425352$24242535$2$F$20140813$20240820$20240823$20240828$PER$$US-AMGEN-USASP2024166726$AMGEN$$29$YR$A$F$Y$$$20240828$$CN$US$US
242425361$24242536$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57989$$FDA-CTU$$74$YR$$F$N$$$20240822$N$$US$
242425371$24242537$1$I$20240521$20240820$20240823$20240823$EXP$FR-AFSSAPS-RN2024000873$FR-UCBSA-2024042120$UCB$$53$YR$$F$Y$83$KG$20240823$$MD$FR$FR
242425381$24242538$1$I$$20240822$20240823$20240823$PER$$US-BAYER-2024A121442$BAYER$$$$$F$Y$$$20240823$$CN$US$US
242425391$24242539$1$I$20240714$20240821$20240823$20240823$EXP$DK-DKMA-30737645$DK-GILEAD-2024-0684914$GILEAD$$79$YR$E$F$Y$$$20240823$$MD$DK$DK
242425401$24242540$1$I$$20240822$20240822$20240822$DIR$715501$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242425411$24242541$1$I$20231026$20240822$20240822$20240822$DIR$715499$$FDA-CTU$$64$YR$$F$N$121.5$KG$20240822$Y$CN$US$
242425421$24242542$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58094$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242425431$24242543$1$I$$20240822$20240822$20240822$DIR$715505$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242425441$24242544$1$I$20240811$20240822$20240822$20240822$DIR$715487$$FDA-CTU$$67$YR$$M$N$101.25$KG$20240822$N$CN$US$
242425452$24242545$2$F$$20240830$20240823$20240903$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013063$JAZZ$$43$YR$$F$Y$$$20240903$$CN$US$US
242425461$24242546$1$I$$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-088525-2024$RECKITT BENCKISER$$77$YR$$M$Y$77.27$KG$20240823$$CN$US$US
242425471$24242547$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58095$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242425481$24242548$1$I$$20240822$20240822$20240822$DIR$715546$$FDA-CTU$$$$$UNK$N$$$20240822$$CN$US$
242425491$24242549$1$I$$20240822$20240822$20240822$DIR$715525$$FDA-CTU$$$$$UNK$N$$$20240822$$CN$US$
242425502$24242550$2$F$20240628$20240824$20240823$20240830$EXP$$CA-JNJFOC-20240634307$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240830$$CN$CA$CA
242425511$24242551$1$I$$20240812$20240823$20240823$EXP$$US-APOTEX-2024AP009499$APOTEX$Shishkina I, Bradshaw D, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2023;142 (Suppl.1):6660-6661$72$YR$$F$Y$$$20240823$$HP$US$US
242425532$24242553$2$F$$20240919$20240823$20240926$30DAY$$US-JNJFOC-20240825250$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
242425541$24242554$1$I$20240101$20240822$20240823$20240823$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047368$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240823$$CN$US$US
242425551$24242555$1$I$$20240816$20240823$20240823$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-118414$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240823$$MD$GB$GB
242425562$24242556$2$F$$20240719$20240823$20240828$EXP$$AT-Eisai-EC-2024-172448$EISAI$$$$$F$Y$$$20240828$$MD$AT$AT
242425581$24242558$1$I$20240101$20240814$20240823$20240823$EXP$$US-TEVA-VS-3233751$TEVA$$24$YR$$F$Y$56.7$KG$20240823$$CN$US$US
242425592$24242559$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093470$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242425601$24242560$1$I$$20240820$20240823$20240823$PER$$US-BAYER-2024A119897$BAYER$$$$$$Y$$$20240823$$CN$US$US
242425612$24242561$2$F$$20240830$20240823$20240904$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013064$JAZZ$$59$YR$$M$Y$$$20240904$$CN$US$US
242425621$24242562$1$I$$20240821$20240823$20240823$EXP$$US-HALEON-2193147$Haleon PLC$$$$$$Y$$$20240823$$CN$US$US
242425631$24242563$1$I$20240801$20240812$20240823$20240823$EXP$$US-UCBSA-2024039167$UCB$$28$YR$$F$Y$83.3$KG$20240823$$CN$US$US
242425642$24242564$2$F$20240515$20240823$20240823$20240829$EXP$SI-JAZMP-NCPHV-2024SI0839_0839$SI-ROCHE-10000061174$ROCHE$$56$YR$A$F$Y$$$20240829$$MD$SI$SI
242425651$24242565$1$I$20240809$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166280$AMGEN$$52$YR$A$F$Y$$$20240823$$CN$US$US
242425661$24242566$1$I$$20240814$20240823$20240823$PER$$US-ROCHE-10000062706$ROCHE$$$$$$Y$$$20240823$$MD$US$US
242425681$24242568$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166911$AMGEN$$$$A$F$Y$$$20240823$$HP$US$US
242425691$24242569$1$I$20240101$20240820$20240823$20240823$PER$$US-BAYER-2024A120550$BAYER$$34$YR$A$F$Y$$$20240823$$MD$US$US
242425701$24242570$1$I$$20240821$20240823$20240823$EXP$$US-ABBVIE-5890157$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242425711$24242571$1$I$$20240820$20240823$20240823$PER$$US-BAYER-2024A120589$BAYER$$43$YR$A$F$Y$$$20240823$$CN$US$US
242425721$24242572$1$I$20240803$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012895$ELI LILLY AND CO$$70$YR$E$$Y$$$20240823$$CN$US$US
242425731$24242573$1$I$20240801$20240821$20240823$20240823$EXP$$IT-ABBVIE-5890731$ABBVIE$$74$YR$$F$Y$$$20240823$$CN$IT$IT
242425741$24242574$1$I$20240721$20240725$20240823$20240823$EXP$$AU-BEH-2024176255$CSL BEHRING$$15$MON$I$M$Y$9$KG$20240823$$MD$AU$AU
242425751$24242575$1$I$20240819$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013567$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240823$$CN$US$US
242425762$24242576$2$F$20240819$20240821$20240823$20240826$PER$$US-AMGEN-USASP2024166679$AMGEN$$73$YR$E$F$Y$$$20240826$$CN$US$US
242425772$24242577$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093471$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242425792$24242579$2$F$20240815$20240822$20240823$20240830$EXP$$LT-BAYER-2024A119494$BAYER$$31$YR$A$F$Y$$$20240830$$CN$LT$LT
242425802$24242580$2$F$20240730$20240920$20240823$20240924$EXP$$DE-AMGEN-DEUSP2024164182$AMGEN$$61$YR$A$F$Y$58.8$KG$20240924$$MD$DE$DE
242425811$24242581$1$I$$20240820$20240823$20240823$PER$$US-HALEON-2193355$Haleon PLC$$52$YR$$$Y$$$20240823$$MD$US$US
242425831$24242583$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57950$$FDA-CTU$$80$YR$$F$N$$$20240822$N$$US$
242425843$24242584$3$F$20240101$20240829$20240823$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025156$UNITED THERAPEUTICS$$$$$F$Y$$$20240906$$$US$US
242425861$24242586$1$I$$20240814$20240823$20240823$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07837$HIKMA$Kim M, Graham C, Stevens RW, Shah A.. Kim M, Graham C, Stevens RW, Shah A. A Rare Case of Bacterial Meningitis Caused by Hematogenous Spread of Vancomycin-Resistant Enterococcus faecium in an Immunocompromised Patient.. Case reports in infectious diseases. 2024;2024:2193650.:5 pgs$72$YR$$M$Y$$$20240823$$MD$US$US
242425871$24242587$1$I$20240201$20240821$20240823$20240823$EXP$$US-ABBVIE-5889563$ABBVIE$$56$YR$$M$Y$$$20240823$$CN$US$US
242425882$24242588$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093472$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242425891$24242589$1$I$20240806$20240816$20240823$20240823$EXP$IT-MINISAL02-998612$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-07909$HIKMA$$82$YR$$F$Y$$$20240823$$MD$IT$IT
242425902$24242590$2$F$20240101$20240905$20240823$20240918$EXP$$JP-AMGEN-JPNSP2024167154$AMGEN$$69$YR$E$M$Y$$$20240918$$PH$JP$JP
242425911$24242591$1$I$20240701$20240820$20240823$20240823$EXP$$JP-ROCHE-10000063127$ROCHE$$8$DEC$E$M$Y$$$20240823$$MD$JP$JP
242425921$24242592$1$I$20240101$20240821$20240823$20240823$EXP$$US-KYOWAKIRIN-2024KK019693$KYOWA$$$$$$Y$$$20240823$$HP$US$US
242425931$24242593$1$I$$20240812$20240822$20240822$DIR$FDA-CDER-CTU-2024-57967$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242425941$24242594$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA168858$NOVARTIS$$86$YR$$M$Y$70$KG$20240823$$PH$CA$CA
242425951$24242595$1$I$$20240812$20240823$20240823$EXP$$US-BEH-2024177534$CSL BEHRING$$$$A$F$Y$$$20240823$$HP$US$US
242425961$24242596$1$I$$20240815$20240823$20240823$EXP$$US-FreseniusKabi-FK202412606$FRESENIUS KABI$$28$YR$A$M$Y$$$20240823$$PH$US$US
242425971$24242597$1$I$20240101$20240820$20240823$20240823$EXP$$US-ABBVIE-5888841$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242425981$24242598$1$I$$20240804$20240822$20240822$DIR$FDA-CDER-CTU-2024-57986$$FDA-CTU$$$$$F$N$$$20240804$N$HP$US$
242425991$24242599$1$I$$20240822$20240822$20240822$DIR$715535$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242426001$24242600$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57958$$FDA-CTU$$81$YR$$M$N$$$20240822$N$$US$
242426011$24242601$1$I$20240804$20240822$20240822$20240822$DIR$715517$$FDA-CTU$$72$YR$$M$N$$$20240822$Y$PH$US$
242426021$24242602$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133900$BRISTOL MYERS SQUIBB$Stanek K, Hussain MT, Spaulding AC, Borkar S, Shaikh ME. Improving patient safety through proper ordering and administration of andexanet alfa. Mayo Clinic Proceedings: Innovations, Quality and Outcomes. 2024 Aug 01;8(4):407-14. doi:10.1016/j.mayocpiqo.2024.03.003.$80$YR$E$M$Y$$$20240823$$MD$US$US
242426031$24242603$1$I$20240813$20240822$20240822$20240822$DIR$715538$$FDA-CTU$$26$YR$$F$N$110$KG$20240822$N$PH$US$
242426041$24242604$1$I$20240101$20240814$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129046$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240823$$CN$US$US
242426052$24242605$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093473$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242426062$24242606$2$F$20240422$20240911$20240823$20240917$EXP$FR-AFSSAPS-NT2024001054$FR-MYLANLABS-2024M1077242$MYLAN$$14$YR$$F$Y$60$KG$20240917$$MD$FR$FR
242426071$24242607$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57949$$FDA-CTU$$74$YR$$F$N$$$20240822$N$$US$
242426081$24242608$1$I$20240716$20240820$20240823$20240823$EXP$FR-AFSSAPS-AVLL2024000198$FR-MYLANLABS-2024M1077306$MYLAN$$13$YR$$M$Y$$$20240823$$MD$FR$FR
242426101$24242610$1$I$20240507$20240820$20240823$20240823$EXP$FR-AFSSAPS-AN2024001088$FR-MYLANLABS-2024M1077174$MYLAN$$77$YR$$M$Y$65$KG$20240823$$MD$FR$FR
242426111$24242611$1$I$20240816$20240820$20240823$20240823$EXP$$CO-JNJFOC-20240854855$JOHNSON AND JOHNSON$$42$YR$A$F$Y$52$KG$20240823$$HP$CO$CO
242426121$24242612$1$I$$20240821$20240823$20240823$PER$$US-HALEON-2193185$Haleon PLC$$$$$$Y$$$20240823$$CN$US$US
242426132$24242613$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093474$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242426141$24242614$1$I$20240222$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-086524-2024$RECKITT BENCKISER$$31$YR$$M$Y$72.73$KG$20240823$$CN$US$US
242426151$24242615$1$I$$20240817$20240823$20240823$PER$$NVSC2024US167643$NOVARTIS$$$$$$Y$$$20240823$$CN$US$US
242426161$24242616$1$I$$20240816$20240823$20240823$PER$$US-009507513-2408USA007170$MERCK$Barnes A, Jaramillo Restrepo V, Hansra B, Levenson J.. Abstracts from the 3rd Annual NYU Langone Critical Care Cardiology Symposium and CardioNerds Poster Session. US Cardiology Review. 2023;18(Suppl 1):12:4$62$YR$$F$Y$$$20240823$$MD$US$US
242426171$24242617$1$I$$20240819$20240823$20240823$EXP$$DE-JNJFOC-20240848380$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240823$$HP$DE$DE
242426181$24242618$1$I$$20240815$20240823$20240823$EXP$$CA-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00856$BIOCRYST PHARMACEUTICALS$$$$$F$Y$$$20240823$$MD$CA$CA
242426191$24242619$1$I$20240101$20240816$20240823$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025870$UNITED THERAPEUTICS$$$$$M$Y$81.633$KG$20240823$$$US$US
242426202$24242620$2$F$$20240829$20240823$20240905$EXP$$CA-GSK-CA2024101125$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$CA$CA
242426211$24242621$1$I$20240807$20240822$20240823$20240823$EXP$FR-AFSSAPS-BS2024000558$FR-SANDOZ INC.-SDZ2024FR074760$SANDOZ$$82$YR$$M$Y$$$20240823$$MD$FR$FR
242426221$24242622$1$I$20240820$20240821$20240823$20240823$EXP$GB-MHRA-MED-202408211406508620-PBTQG$GB-ABBVIE-5890366$ABBVIE$$85$YR$$$Y$$$20240823$$CN$GB$GB
242426232$24242623$2$F$$20240819$20240823$20240827$PER$$US-BIOGEN-2024BI01279128$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
242426241$24242624$1$I$20240810$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166236$AMGEN$$52$YR$A$M$Y$$$20240823$$CN$US$US
242426252$24242625$2$F$20230401$20240815$20240823$20240830$EXP$$US-UCBSA-2024040829$UCB$$$$A$F$Y$$$20240830$$CN$US$US
242426262$24242626$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093475$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242426281$24242628$1$I$$20240820$20240823$20240823$PER$$US-BIOGEN-2024BI01279130$BIOGEN$$$$$M$Y$$$20240823$$CN$US$US
242426311$24242631$1$I$$20240822$20240822$20240822$DIR$715537$$FDA-CTU$$$$$UNK$N$$$20240822$$CN$US$
242426331$24242633$1$I$20240821$20240822$20240822$20240822$DIR$715496$$FDA-CTU$$73$YR$$F$N$67.5$KG$20240822$N$CN$US$
242426351$24242635$1$I$$20240819$20240823$20240823$PER$$US-JNJFOC-20240855297$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$CN$US$US
242426371$24242637$1$I$$20240821$20240823$20240823$PER$$US-JNJFOC-20240854381$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
242426381$24242638$1$I$20240815$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013553$ELI LILLY AND CO$$$$A$F$Y$$$20240823$$CN$US$US
242426391$24242639$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013531$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242426401$24242640$1$I$20240817$20240822$20240822$20240822$DIR$715560$$FDA-CTU$$59$YR$$F$N$$$20240822$N$PH$US$
242426411$24242641$1$I$$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014753$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240823$$CN$US$US
242426421$24242642$1$I$20240801$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012915$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242426451$24242645$1$I$$20240815$20240823$20240823$PER$$US-ABBVIE-5883704$ABBVIE$$$$$F$Y$$$20240823$$MD$US$US
242426462$24242646$2$F$20240602$20240911$20240823$20240923$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00209$OPKO HEALTH$$81$YR$$M$Y$$$20240920$$PH$US$US
242426471$24242647$1$I$$20240816$20240823$20240823$PER$$US-EMD Serono-2024044646$EMD SERONO INC$$62$YR$A$F$Y$$$20240823$$CN$US$US
242426482$24242648$2$F$$20240909$20240823$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128843$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240916$$CN$US$US
242426501$24242650$1$I$$20240815$20240823$20240823$EXP$$US-TAKEDA-2024TUS082784$TAKEDA$$$$$$Y$$$20240823$$PH$US$US
242426512$24242651$2$F$20240826$20240904$20240823$20240909$EXP$$KZ-TAKEDA-2024TUS083430$TAKEDA$$10$MON$$F$Y$7$KG$20240909$$CN$KZ$KZ
242426521$24242652$1$I$$20240820$20240822$20240822$DIR$FDA-CDER-CTU-2024-57955$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242426541$24242654$1$I$$20240812$20240823$20240823$EXP$$US-JNJFOC-20240831713$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$CN$US$US
242426553$24242655$3$F$$20240927$20240823$20240927$30DAY$$US-PFIZER INC-202400235317$PFIZER$$9$YR$$F$Y$$$20240927$$CN$US$US
242426561$24242656$1$I$20221208$20240809$20240823$20240823$EXP$$FR-SERVIER-S24010241$SERVIER$$$$$$Y$$$20240823$$MD$FR$FR
242426574$24242657$4$F$$20240927$20240823$20240927$30DAY$$US-PFIZER INC-202400237560$PFIZER$$82$YR$$F$Y$85.73$KG$20240927$$CN$US$US
242426582$24242658$2$F$$20240909$20240823$20240912$30DAY$$AT-PFIZER INC-202400236463$PFIZER$$$$$$Y$$$20240912$$MD$AT$AT
242426613$24242661$3$F$20240813$20240925$20240823$20240930$30DAY$$US-PFIZER INC-202400237506$PFIZER$$11$YR$$M$Y$$$20240930$$CN$US$US
242426621$24242662$1$I$$20240816$20240823$20240823$EXP$$US-AMGEN-USASP2024164773$AMGEN$Castillo L.E.; Galeotti J.; Grover N.S. et al.. A Retrospective Study on Prephase Therapy Prior to Definitive Multiagent Chemotherapy in Aggressive Lymphomas. Blood. 2018;132$$$$$Y$$$20240823$$MD$US$US
242426631$24242663$1$I$20240701$20240819$20240823$20240823$EXP$$US-PFIZER INC-202400239806$PFIZER$$78$YR$$M$Y$82.1$KG$20240823$$HP$US$US
242426641$24242664$1$I$$20240813$20240823$20240823$30DAY$$US-PFIZER INC-202400236946$PFIZER$$16$YR$$M$Y$$$20240823$$CN$US$US
242426652$24242665$2$F$$20240925$20240823$20240925$30DAY$$US-PFIZER INC-202400236141$PFIZER$$12$YR$$M$Y$$$20240925$$CN$US$US
242426663$24242666$3$F$$20240903$20240823$20240909$30DAY$$GB-PFIZER INC-PV202400106383$PFIZER$$6$YR$$M$Y$$$20240909$$CN$GB$GB
242426671$24242667$1$I$$20240815$20240823$20240823$30DAY$$GB-PFIZER INC-PV202400106577$PFIZER$$16$YR$$M$Y$$$20240823$$CN$GB$GB
242426681$24242668$1$I$20240816$20240822$20240822$20240822$DIR$715553$$FDA-CTU$$70$YR$$F$N$72$KG$20240822$N$CN$US$
242426691$24242669$1$I$20230908$20240823$20240823$20240823$PER$$NZ-PROD-AS2-212756134-RB-109258-2023$RECKITT BENCKISER$$$$$F$Y$$$20240823$$CN$NZ$NZ
242426701$24242670$1$I$20240502$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-089392-2024$RECKITT BENCKISER$$92$YR$$M$Y$$$20240823$$CN$US$US
242426712$24242671$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093477$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242426721$24242672$1$I$20240815$20240815$20240823$20240823$EXP$$US-GSK-US2024101870$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240823$$HP$US$US
242426751$24242675$1$I$20240701$20240815$20240823$20240823$EXP$$US-Eisai-EC-2024-172251$EISAI$$$$$M$Y$$$20240823$$HP$US$US
242426761$24242676$1$I$20240701$20240816$20240823$20240823$PER$$CN-Eisai-EC-2024-172349$EISAI$$44$YR$A$F$Y$$$20240823$$HP$CN$CN
242426781$24242678$1$I$$20240819$20240823$20240823$PER$$US-BAYER-2024A119543$BAYER$$$$$F$Y$$$20240823$$CN$US$US
242426791$24242679$1$I$20240801$20240813$20240823$20240823$PER$$US-ABBVIE-5881032$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242426802$24242680$2$F$20240801$20240925$20240823$20240925$EXP$$CA-PFIZER INC-202400007888$PFIZER$$30$YR$$M$Y$$$20240925$$CN$CA$CA
242426813$24242681$3$F$$20240909$20240823$20240913$EXP$$US-ABBVIE-5891379$ABBVIE$$$$A$M$Y$$$20240913$$MD$US$US
242426911$24242691$1$I$$20240729$20240823$20240823$EXP$$JP-PFIZER INC-PV202400110364$PFIZER$$$$$$Y$$$20240823$$MD$JP$JP
242426951$24242695$1$I$20240701$20240816$20240823$20240823$EXP$CH-SM-2024-15131$CH-009507513-2408CHE005620$MERCK$$81$YR$$M$Y$95$KG$20240823$$MD$CH$CH
242426961$24242696$1$I$20240801$20240816$20240823$20240823$EXP$$CN-GE HEALTHCARE-2024CSU009494$GE HEALTHCARE$$64$YR$$M$Y$70$KG$20240823$$HP$CN$CN
242426971$24242697$1$I$20240807$20240822$20240823$20240823$EXP$GB-MHRA-MED-202408221541519210-KVSGH$GB-JNJFOC-20240857401$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240823$$PH$GB$GB
242426981$24242698$1$I$20240401$20240814$20240823$20240823$EXP$FR-AFSSAPS-AVLY2024000126$FR-TEVA-VS-3233983$TEVA$$24$YR$$F$Y$$$20240823$$MD$FR$FR
242426991$24242699$1$I$20240821$20240822$20240823$20240823$EXP$$NZ-MYLANLABS-2024M1078122$MYLAN$$92$YR$$F$Y$$$20240823$$PH$NZ$NZ
242427001$24242700$1$I$20240809$20240816$20240823$20240823$EXP$$CN-GE HEALTHCARE-2024CSU009518$GE HEALTHCARE$$78$YR$$M$Y$$$20240823$$HP$CN$CN
242427011$24242701$1$I$20230501$20240814$20240823$20240823$EXP$FR-AFSSAPS-TS2024000890$FR-TEVA-VS-3233901$TEVA$$57$YR$$F$Y$100$KG$20240823$$MD$FR$FR
242427023$24242702$3$F$$20240920$20240823$20240925$PER$$US-AMGEN-USASP2024167728$AMGEN$$58$YR$A$F$Y$$$20240925$$MD$US$US
242427031$24242703$1$I$20240818$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166587$AMGEN$$62$YR$A$F$Y$$$20240823$$CN$US$US
242427041$24242704$1$I$$20240819$20240823$20240823$PER$$US-BAYER-2024A119786$BAYER$$$$$F$Y$$$20240823$$CN$US$US
242427051$24242705$1$I$20240809$20240814$20240823$20240823$EXP$$CA-CELLTRION INC.-2024CA019881$CELLTRION$$$$$$Y$$$20240823$$MD$CA$CA
242427061$24242706$1$I$20240714$20240807$20240822$20240822$DIR$FDA-CDER-CTU-2024-57980$$FDA-CTU$$71$YR$$F$N$$$20240807$N$HP$US$
242427071$24242707$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58081$$FDA-CTU$$69$YR$$M$N$$$20240822$N$$US$
242427081$24242708$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57963$$FDA-CTU$$62$YR$$F$N$$$20240822$N$$US$
242427091$24242709$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58073$$FDA-CTU$$74$YR$$F$N$$$20240822$N$$US$
242427101$24242710$1$I$20240822$20240822$20240822$20240822$DIR$715508$$FDA-CTU$$45$YR$$F$N$86.4$KG$20240822$N$CN$US$
242427111$24242711$1$I$20240802$20240822$20240822$20240822$DIR$715483$$FDA-CTU$$49$YR$$M$N$90$KG$20240822$N$CN$US$
242427121$24242712$1$I$$20240801$20240822$20240822$DIR$FDA-CDER-CTU-2024-58068$$FDA-CTU$$$$$M$N$$$20240801$N$HP$US$
242427131$24242713$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58075$$FDA-CTU$$72$YR$$F$N$$$20240822$N$$US$
242427151$24242715$1$I$20080805$20240822$20240822$20240822$DIR$715550$$FDA-CTU$$42$YR$$F$N$72$KG$20240822$N$CN$US$
242427171$24242717$1$I$20240819$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166223$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242427181$24242718$1$I$20240810$20240816$20240823$20240823$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-115364$REGENERON$$50$YR$$M$Y$$$20240823$$HP$CO$CO
242427202$24242720$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093478$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242427211$24242721$1$I$20240801$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132049$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240823$$CN$US$US
242427222$24242722$2$F$$20240815$20240823$20240823$EXP$$US-ROCHE-10000059020$ROCHE$$$$A$F$Y$$$20240823$$CN$US$US
242427231$24242723$1$I$$20240815$20240823$20240823$PER$$US-MYLANLABS-2024M1076534$MYLAN$$$$$M$Y$$$20240823$$CN$US$US
242427251$24242725$1$I$$20240821$20240823$20240823$PER$$NVSC2024US170458$NOVARTIS$$52$YR$$F$Y$63.039$KG$20240823$$CN$US$US
242427272$24242727$2$F$$20240820$20240823$20240828$30DAY$$US-PFIZER INC-202400239468$PFIZER$$96$YR$$F$Y$113.4$KG$20240828$$HP$US$US
242427283$24242728$3$F$$20240917$20240823$20240920$30DAY$$NL-PFIZER INC-202400238300$PFIZER$$$$$$Y$$$20240920$$PH$NL$NL
242427301$24242730$1$I$20240811$20240819$20240823$20240823$30DAY$$US-PFIZER INC-PV202400094997$PFIZER$$69$YR$$F$Y$95.25$KG$20240823$$HP$US$US
242427333$24242733$3$F$$20240927$20240823$20240927$30DAY$$US-PFIZER INC-202400239784$PFIZER$$12$YR$$F$Y$$$20240927$$CN$US$US
242427342$24242734$2$F$20240801$20240905$20240823$20240918$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004966$SAREPTA THERAPEUTICS$$2$YR$$M$Y$14.3$KG$20240918$$CN$US$US
242427351$24242735$1$I$20240205$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-084872-2024$RECKITT BENCKISER$$$$$F$Y$$$20240823$$CN$US$US
242427361$24242736$1$I$$20240813$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008496$INCYTE$$$$$$Y$$$20240823$$HP$US$US
242427371$24242737$1$I$$20240815$20240823$20240823$PER$$US-JNJFOC-20240840351$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$PH$US$US
242427382$24242738$2$F$20240805$20240823$20240823$20240830$EXP$$US-LANTHEUS-LMI-2024-01030$LANTHEUS MEDICAL IMAGING$$63$YR$$F$Y$93$KG$20240830$$HP$US$US
242427402$24242740$2$F$20240815$20240830$20240823$20240908$30DAY$$US-AMGEN-USASP2024164629$AMGEN$$56$YR$A$F$Y$136$KG$20240908$$PH$US$US
242427411$24242741$1$I$20240819$20240819$20240823$20240823$PER$$US-AMGEN-USASL2024166540$AMGEN$$$$$M$Y$$$20240823$$CN$US$US
242427421$24242742$1$I$20240101$20240809$20240823$20240823$EXP$$US-UCBSA-2024041271$UCB$$$$$M$Y$$$20240823$$CN$US$US
242427432$24242743$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093479$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242427441$24242744$1$I$$20240801$20240822$20240822$DIR$FDA-CDER-CTU-2024-58069$$FDA-CTU$$$$$M$N$$$20240801$N$HP$US$
242427451$24242745$1$I$20240601$20240819$20240823$20240823$EXP$GB-MHRA-MED-202408121653247800-JHVNP$GB-MYLANLABS-2024M1076986$MYLAN$$70$YR$$M$Y$$$20240823$$PH$GB$GB
242427461$24242746$1$I$$20240820$20240823$20240823$EXP$$CA-MYLANLABS-2024M1077330$MYLAN$$63$YR$$M$Y$$$20240823$$CN$CA$CA
242427471$24242747$1$I$20230101$20240822$20240823$20240823$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047397$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$$$20240823$$CN$US$US
242427481$24242748$1$I$$20240820$20240823$20240823$EXP$$NVSC2024US168609$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
242427491$24242749$1$I$20240212$20240814$20240823$20240823$EXP$FR-AFSSAPS-TO2024001510$FR-TEVA-VS-3233914$TEVA$$79$YR$$F$Y$52$KG$20240823$$PH$FR$FR
242427501$24242750$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133901$BRISTOL MYERS SQUIBB$Stanek K, Hussain MT, Spaulding AC, Borkar S, Shaikh ME. Improving patient safety through proper ordering and administration of andexanet alfa. Mayo Clinic Proceedings: Innovations, Quality and Outcomes. 2024 Aug 01;8(4):407-14. doi:10.1016/j.mayocpiqo.2024.03.003.$74$YR$E$M$Y$$$20240823$$MD$US$US
242427511$24242751$1$I$$20240813$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129057$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240823$$HP$US$US
242427521$24242752$1$I$20240819$20240822$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134108$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240823$$CN$US$US
242427531$24242753$1$I$20240801$20240820$20240823$20240823$EXP$$CA-ABBVIE-5890730$ABBVIE$$83$YR$$F$Y$$$20240823$$CN$CA$CA
242427552$24242755$2$F$20210429$20240924$20240823$20240930$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-133572$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$55$KG$20241001$$MD$KR$KR
242427573$24242757$3$F$$20240923$20240823$20240927$30DAY$$US-PFIZER INC-202400239532$PFIZER$$13$YR$$F$Y$33.56$KG$20240927$$CN$US$US
242427583$24242758$3$F$20240501$20240928$20240823$20240930$30DAY$$US-PFIZER INC-202400240611$PFIZER$$48$YR$$F$Y$$$20240930$$CN$US$US
242427601$24242760$1$I$$20240819$20240823$20240823$EXP$$US-BAYER-2024A120862$BAYER$$$$$F$Y$$$20240823$$CN$US$US
242427611$24242761$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013939$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240823$$CN$US$US
242427622$24242762$2$F$20240819$20240821$20240823$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013564$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240827$$CN$US$US
242427631$24242763$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013558$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240823$$CN$US$US
242427641$24242764$1$I$20240820$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013591$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240823$$CN$US$US
242427651$24242765$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013539$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240823$$CN$US$US
242427661$24242766$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013837$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240823$$CN$US$US
242427671$24242767$1$I$20240721$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014315$ELI LILLY AND CO$$$$A$F$Y$$$20240823$$CN$US$US
242427682$24242768$2$F$20240703$20240821$20240823$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014424$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240830$$HP$US$US
242427692$24242769$2$F$$20240822$20240823$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408013489$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240829$$CN$US$US
242427702$24242770$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093480$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242427711$24242771$1$I$20240814$20240815$20240823$20240823$30DAY$$US-GSK-US2024101925$GLAXOSMITHKLINE$$22$YR$$M$Y$$$20240823$$CN$US$US
242427721$24242772$1$I$$20240809$20240823$20240823$EXP$$US-UCBSA-2024040965$UCB$$$$$$Y$$$20240823$$CN$US$US
242427731$24242773$1$I$$20240816$20240823$20240823$PER$$US-AMGEN-USASP2024164378$AMGEN$Fabregas J.C.; Carvajal G.. Conservative Management of Idiopathic Hemophagocytic Lymphohistiocytosis (HLH) Achieving Complete Remission. Blood. 2018;132 (SUPPL_1):4963$34$YR$A$M$Y$$$20240823$$MD$US$US
242427742$24242774$2$F$20230101$20240826$20240823$20240906$EXP$$US-UCBSA-2024040816$UCB$$$$$F$Y$$$20240906$$HP$US$US
242427751$24242775$1$I$$20240814$20240823$20240823$EXP$$DE-MYLANLABS-2024M1075885$MYLAN$$91$YR$$F$Y$$$20240823$$PH$DE$DE
242427761$24242776$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164925$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$F$Y$$$20240823$$MD$US$US
242427771$24242777$1$I$20240101$20240819$20240823$20240823$EXP$$US-AMGEN-USASP2024165371$AMGEN$$73$YR$E$M$Y$$$20240823$$CN$US$US
242427782$24242778$2$F$20240730$20240823$20240823$20240906$EXP$$US-MDD US Operations-MDD202407-002798$MDD OPERATIONS$$62$YR$$M$Y$$$20240906$$HP$US$
242427791$24242779$1$I$$20240816$20240823$20240823$PER$$US-ABBVIE-5888309$ABBVIE$$$$$$Y$$$20240823$$CN$US$US
242427811$24242781$1$I$$20240822$20240822$20240822$DIR$715534$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242427831$24242783$1$I$$20240814$20240823$20240823$EXP$$AT-JNJFOC-20240841749$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$MD$AT$AT
242427841$24242784$1$I$$20240819$20240823$20240823$PER$$US-JNJFOC-20240847805$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$HP$US$US
242427861$24242786$1$I$$20240814$20240823$20240823$EXP$$CZ-TEVA-VS-3234865$TEVA$Palkovsk? M. Tolerance of treatment with ribociclib in combination with fulvestrant in elderly population - case report. ONCOLOGY REVIEW. 2024;11(4):294 - 296$75$YR$$F$Y$$$20240823$$MD$CZ$CZ
242427872$24242787$2$F$20240805$20240823$20240823$20240903$EXP$$US-LANTHEUS-LMI-2024-01031$LANTHEUS MEDICAL IMAGING$$69$YR$$F$Y$76$KG$20240830$$HP$US$US
242427881$24242788$1$I$$20240820$20240823$20240823$EXP$GB-MHRA-MED-202408201425265560-FLHZK$GB-ROCHE-10000061783$ROCHE$$45$YR$A$F$Y$$$20240823$$PH$GB$GB
242427891$24242789$1$I$$20240820$20240823$20240823$PER$$US-GILEAD-2024-0685013$GILEAD$$66$YR$E$F$Y$$$20240823$$CN$US$US
242427901$24242790$1$I$20240820$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166264$AMGEN$$40$YR$A$F$Y$$$20240823$$CN$US$US
242427912$24242791$2$F$20240709$20240826$20240823$20240829$EXP$$CO-BAYER-2024A101055$BAYER$$60$YR$A$M$Y$$$20240829$$CN$CO$CO
242427924$24242792$4$F$20240820$20240902$20240823$20240906$PER$$US-AMGEN-USASP2024167078$AMGEN$$86$YR$E$F$Y$$$20240906$$CN$US$US
242427932$24242793$2$F$20240818$20240925$20240823$20240930$EXP$$US-AMGEN-USASP2024165350$AMGEN$$72$YR$E$F$Y$$$20240929$$HP$US$US
242427941$24242794$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164922$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$F$Y$$$20240823$$MD$US$US
242427951$24242795$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024166763$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242427963$24242796$3$F$20240815$20240919$20240823$20240920$PER$$US-AMGEN-USASP2024165973$AMGEN$$74$YR$E$F$Y$$$20240920$$CN$US$US
242427971$24242797$1$I$$20240814$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008570$INCYTE$$$$$$Y$$$20240823$$HP$US$US
242427981$24242798$1$I$$20240809$20240823$20240823$PER$$US-RDY-LIT/USA/24/0012024$DR REDDYS$Li B, Chawla S, Tong M, Higgins A, Lee R. Temporary Biventricular Mechanical Circulatory Support for Primary Graft Dysfunction after Orthotopic Heart Transplantation. US Cardiology Review. 2024 Jul;18(1): doi:10.15420/usc.2024.18.s1.$51$YR$A$M$Y$$$20240823$$MD$US$US
242427992$24242799$2$F$20220101$20240911$20240823$20240920$EXP$$GB-TEVA-VS-3233594$TEVA$Williams H, Thoppuram N, Law KY, Simms J. Post-operative post-cognitive dysfunction: progressive multifocal leukoencephalopathy (PML), an unexpected finding in an elderly patient. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24(Supplement):100041 on 22 Jul 2024$87$YR$$F$Y$$$20240920$$MD$GB$GB
242428011$24242801$1$I$$20240819$20240823$20240823$EXP$$NVSC2024CA168015$NOVARTIS$$$$$F$Y$$$20240823$$HP$CA$CA
242428022$24242802$2$F$$20240819$20240823$20240829$PER$$US-FreseniusKabi-FK202412733$FRESENIUS KABI$$$$$$Y$$$20240829$$PH$US$US
242428031$24242803$1$I$$20240822$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134032$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240823$$CN$US$US
242428041$24242804$1$I$20240701$20240726$20240823$20240823$PER$$US-LEX-000409$LEXICON PHARMACEUTICALS$$70$YR$$M$Y$$$20240823$$CN$US$US
242428051$24242805$1$I$20240801$20240815$20240823$20240823$PER$$US-MYLANLABS-2024M1076521$MYLAN$$66$YR$$F$Y$$$20240823$$CN$US$US
242428061$24242806$1$I$$20240808$20240823$20240823$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460111$RANBAXY$Alzamora M, Castro J, Hanbazazh M, Jacome M. Different kinds of embolization in advanced carcinoma: A review of literature, visual comparison and possible complications. Virchows Arch. 2023;483 (Suppl.)(1):S218-S219(E-PS-07-004)$$$$$Y$$$20240823$$HP$PT$PT
242428071$24242807$1$I$$20240808$20240823$20240823$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463915$RANBAXY$Wang H, Tang Y, Shen Y. Late-Onset Diffuse Lung Disease in an 8-Year-Old Girl. Chest. 2024;165 (3):e71-e74$8$YR$$F$Y$19$KG$20240823$$MD$CN$CN
242428081$24242808$1$I$$20240808$20240823$20240823$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463954$RANBAXY$Ruttens D, Philippet P, Neven B, Lagrou K, Moshous D, Bucciol G, et al. Haploidentical Stem Cell Transplantation with Post?transplantation Cyclophosphamide in High?Risk Chronic Granulomatous Disease Patient with Invasive Mucormycosis. J Clin Immunol. 2023;43:1758-1765$$$$M$Y$$$20240823$$HP$BE$BE
242428091$24242809$1$I$$20240808$20240823$20240823$EXP$$GE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463880$RANBAXY$Brown AC, Evans DD, Tucker P. Is Ketamine an Effective Treatment Acute Agitation in the Emergency Department? Implications for APRN Practice. Advan Emerg Nurs J. 2023;45 (4):253-259$37$YR$$M$Y$$$20240823$$HP$GE$GE
242428101$24242810$1$I$$20240808$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463150$RANBAXY$Oluwole OO, Forcade E, Munoz J, de Guibert S, Vose JM, Bartlett NL, et al. Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of ZUMA-1 Cohort 6. Blood. 2022;140 (Suppl.):10399-10401, S379 (507)$$$$$Y$$$20240823$$MD$US$US
242428111$24242811$1$I$$20240808$20240823$20240823$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462646$RANBAXY$Dalmau I Ribas M, Mendez Rubio M, von Gunten A. Increased sexual function after intake of clomethiazole. BMJ Case Rep. 2024;17 (7):1-4 (e257323)$$$$F$Y$$$20240823$$HP$CH$CH
242428121$24242812$1$I$$20240808$20240823$20240823$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463960$RANBAXY$Colussi L, Dagri A, Pastore S, Taddio A, Tommasini A. Effect of the janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma. Pediatr Rheumatol. 2023;21 (Suppl 2):137; abstr. P134$13$YR$$F$Y$$$20240823$$HP$IT$IT
242428131$24242813$1$I$$20240808$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463256$RANBAXY$$$$$F$Y$$$20240823$$CN$US$US
242428142$24242814$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093481$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242428151$24242815$1$I$20240813$20240814$20240823$20240823$PER$$US-MYLANLABS-2024M1076476$MYLAN$$40$YR$$F$Y$$$20240823$$CN$US$US
242428161$24242816$1$I$20240819$20240820$20240823$20240823$EXP$$NVSC2024BR170555$NOVARTIS$$5$YR$$M$Y$$$20240823$$CN$BR$BR
242428181$24242818$1$I$$20240814$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008545$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242428191$24242819$1$I$20240611$20240812$20240823$20240823$PER$$IT-IGSA-BIG0029433$GRIFOLS$$36$YR$$M$Y$$$20240823$$HP$IT$IT
242428201$24242820$1$I$20230922$20240821$20240823$20240823$EXP$$US-CHIESI-2024CHF05339$CHIESI$$26$YR$$M$Y$48$KG$20240823$$CN$US$US
242428211$24242821$1$I$20240808$20240813$20240823$20240823$EXP$$GB-Waylis Therapeutics LLC-ATNAHS20240802362$Waylis$$43$YR$A$F$Y$71$KG$20240823$$MD$GB$GB
242428221$24242822$1$I$$20240814$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008547$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242428241$24242824$1$I$20230912$20240812$20240823$20240823$EXP$FR-AFSSAPS-PO2024000878$FR-GILEAD-2024-0683848$GILEAD$$$$$F$Y$$$20240823$$MD$FR$FR
242428251$24242825$1$I$20240727$20240727$20240823$20240823$PER$$US-CSL-2024-007262$CSL Plasma$$31$YR$$F$Y$$$20240823$$HP$US$US
242428271$24242827$1$I$20220317$20240809$20240823$20240823$EXP$$FR-SERVIER-S22002939$SERVIER$$$$$$Y$$$20240823$$MD$FR$FR
242428281$24242828$1$I$$20240814$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008544$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242428291$24242829$1$I$$20240808$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464108$RANBAXY$Yoshizaki C, Yoshida Y, Nohmi S, Go Y, Kusakado R, Kawamura S, et al. EGFR-TKI-induced Factor V deficiency in a patient with advanced non-small cell lung cancer: The first case report. Lung Cancer. 2024;194 (0):107869$61$YR$$M$Y$$$20240823$$HP$JP$JP
242428301$24242830$1$I$$20240808$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464158$RANBAXY$Kumar P, Kaliamurthy S, Thomas J. Initiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments. Pediatrics. 2024;Aug, 154 (2):e2024066226, 1-4$17$YR$$F$Y$$$20240823$$HP$US$US
242428312$24242831$2$F$$20240813$20240823$20240828$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464386$RANBAXY$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turk J Haematol. 2023;40:284-285$69$YR$$F$Y$$$20240828$$HP$CN$CN
242428321$24242832$1$I$$20240808$20240823$20240823$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463985$RANBAXY$Colussi L, Dagri A, Pastore S, Taddio A, Tommasini A. Effect of the janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma. Pediatr Rheumatol. 2023;21 (Suppl 2):137; abstr. P134$36$MON$$F$Y$$$20240823$$HP$IT$IT
242428331$24242833$1$I$$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464345$RANBAXY$Abbagoni V. Pregnancy-associated relapse of triple-negative breast cancer. Cancer Res. 2024;84 (Suppl.) (9):Abstract PO2-28-04$38$YR$$F$Y$$$20240823$$HP$US$US
242428341$24242834$1$I$$20240808$20240823$20240823$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464387$RANBAXY$Vermeersch G, Cruyt N, D^Hondt E, Geers J, Hertveldt K, Stockman A, et al. Granulomatous peritoneal disease associated with oxaliplatin-based chemotherapy for ampullary adenocarcinoma: a case report. Acta Gastro Enterologica Belgica. 2023;Jul-Sep; 86:499-501$71$YR$$M$Y$$$20240823$$HP$BE$BE
242428351$24242835$1$I$$20240808$20240823$20240823$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464325$RANBAXY$Uca AU. Ocrelizumab experience in treatment-resistant warts associated with Fingolimod: A case report. Neurol Asia. 2024;Jun; 29(2):489-491$42$YR$$F$Y$$$20240823$$MD$TR$TR
242428362$24242836$2$F$$20240813$20240823$20240828$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464029$RANBAXY$Biswas P, Mandal T, Pal J. An unusual case of monoarthritis and rash. Pol Arch Med Wewn. 2021;131 (Suppl.):18$48$YR$$M$Y$$$20240828$$HP$IN$IN
242428371$24242837$1$I$$20240808$20240823$20240823$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464405$RANBAXY$Alp A, Yildiz MI, Eroglu EO, Isikay A?, Ayhan Y, Ertugrul A. Recurrent Psychotic Depression Associated with Chronic Subdural Haematoma: A Case Report. Arch Neuropsychiatry. 2024$77$YR$$F$Y$$$20240823$$HP$TR$TR
242428381$24242838$1$I$$20240808$20240823$20240823$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464056$RANBAXY$Khojasteh M, Soleimani P, Ghasemi A, Taghizadeh P, Rohani M, Alavi A. JAM2 variants can be more common in primary familial brain calcification (PFBC) cases than those appear; may be due to a founder mutation. Neurol Sci. 2024;45:3829-3844$41$YR$$F$Y$$$20240823$$HP$IR$IR
242428391$24242839$1$I$$20240808$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464276$RANBAXY$Essink J, Niebur H. DELAYED DIAGNOSIS OF COMMON VARIABLE IMMUNODEFICIENCY AND IMPORTANCE OF MULTI-SPECIALTY COLLABORATION. Ann Allergy Asthma Immunol. 2023;131(Suppl.) (5):S158-S159/M270$17$YR$$M$Y$$$20240823$$HP$US$US
242428402$24242840$2$F$$20240813$20240823$20240828$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464382$RANBAXY$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turk J Haematol. 2023;40:284-285$61$YR$$F$Y$$$20240828$$HP$CN$CN
242428411$24242841$1$I$$20240808$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464167$RANBAXY$Panthi S, MIles JM, Graves L. Headache, Pituitary Apoplexy and Diabetes insipidus Suspect Necrotizing Hypophysitis. J Endocr Soc. 2021;Apr-May;5sup:A585$34$YR$$F$Y$$$20240823$$MD$US$US
242428421$24242842$1$I$$20240808$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464156$RANBAXY$Kumar P, Kaliamurthy S, Thomas J. Initiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments. Pediatrics. 2024;Aug, 154 (2):e2024066226, 1-4$16$YR$$M$Y$$$20240823$$HP$US$US
242428432$24242843$2$F$$20240812$20240823$20240827$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463969$RANBAXY$Parmeshwar N, Song S, Alcon A, Kim EA. The Incidence of Breast Cancer After Gender-Affirming Mastectomy in Transmen. Ann Plast Surg. 2022;88 (4):S332-S336$54$YR$$M$Y$$$20240827$$HP$CA$CA
242428441$24242844$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464374$RANBAXY$Sato R, Matsushita Y, Sano A, Watanabe K, Watanabe H, Tamura K, et al.. Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases. In Vivo. 2024;38 (4):1859-1864$74$YR$$F$Y$$$20240823$$HP$JP$JP
242428451$24242845$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464360$RANBAXY$Sato R, Matsushita Y, Sano A, Watanabe K, Watanabe H, Tamura K, et al. Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases. In Vivo. 2024;38 (4):1859-1864$76$YR$$M$Y$$$20240823$$HP$JP$JP
242428461$24242846$1$I$$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464256$RANBAXY$Sorabekka RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO J. 2024;70 (7):e92-e96$15$YR$$F$Y$$$20240823$$HP$US$US
242428471$24242847$1$I$$20240808$20240823$20240823$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464122$RANBAXY$Giannoula E, Koutsouki G, Exadaktylou P, Papadopoulos N, Papanastasiou E, Doumas A, et al. Differentiated thyroid cancer: Case report of false positive 131I uptake on whole body scintigraphy in a patient with bilateral femur osteonecrosis. Hell J Nucl Med. 2023;26 (1):66-69$52$YR$$M$Y$$$20240823$$HP$GR$GR
242428481$24242848$1$I$$20240809$20240823$20240823$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464436$RANBAXY$Deng L, Shi L, Ye X. The culprit of uncontrolled hypertension: A case of monoamine oxidase inhibitor and clonidine interaction. Rev Port Cardiol. 2024;43 (4):223-224$64$YR$$M$Y$$$20240823$$HP$CN$CN
242428491$24242849$1$I$$20240808$20240823$20240823$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463748$RANBAXY$$58$YR$$M$Y$$$20240823$$PH$GB$GB
242428501$24242850$1$I$$20240808$20240823$20240823$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463755$RANBAXY$$$$$M$Y$$$20240823$$MD$DE$DE
242428511$24242851$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464370$RANBAXY$Sato R, Matsushita Y, Sano A, Watanabe K, Watanabe H, Tamura K, et al.. Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases. In Vivo. 2024;38 (4):1859-1864$73$YR$$F$Y$$$20240823$$HP$JP$JP
242428521$24242852$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464375$RANBAXY$Sato R, Matsushita Y, Sano A, Watanabe K, Watanabe H, Tamura K, et al.. Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases. In Vivo. 2024;38 (4):1859-1864$84$YR$$F$Y$$$20240823$$HP$JP$JP
242428531$24242853$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464363$RANBAXY$Sato R, Matsushita Y, Sano A, Watanabe K, Watanabe H, Tamura K, et al. Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases. In Vivo. 2024;38 (4):1859-1864$72$YR$$F$Y$$$20240823$$HP$JP$JP
242428541$24242854$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464364$RANBAXY$Sato R, Matsushita Y, Sano A, Watanabe K, Watanabe H, Tamura K, et al. Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases. In Vivo. 2024;38 (4):1859-1864$67$YR$$M$Y$$$20240823$$HP$JP$JP
242428551$24242855$1$I$$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464208$RANBAXY$Sorabekka RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO J. 2024;70 (7):e92-e96$12$YR$$F$Y$63$KG$20240823$$HP$US$US
242428561$24242856$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464362$RANBAXY$Sato R, Matsushita Y, Sano A, Watanabe K, Watanabe H, Tamura K, et al. Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases. In Vivo. 2024;38 (4):1859-1864$29$YR$$M$Y$$$20240823$$HP$JP$JP
242428573$24242857$3$F$20231201$20240904$20240823$20240911$EXP$$EG-009507513-2408EGY006374$MERCK$$$$A$F$Y$$$20240911$$CN$EG$EG
242428581$24242858$1$I$$20240808$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464191$RANBAXY$Belmore L, Ahn T, Nguyen E, Lenz T. Acute Non-ST Segment Elevation Myocardial Infarction Following Intravenous Injection of Sublingual Suboxone. Prehosp Emerg Care. 2024;23 Jul:1-4$41$YR$$M$Y$$$20240823$$HP$US$US
242428591$24242859$1$I$$20240808$20240823$20240823$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462891$RANBAXY$Lorenz G, Schaaf C, Moog P, Bachmann Q, Popp F, Rech J, et al.. Brain oedema due to disseminated intravascular coagulation in a patient with adult onset Still?s disease associated hemophagocytic lymphohistiocytosis a case report. Rheumatology. 2023;Volume 62 (6):e188?e190$23$YR$$F$Y$$$20240823$$HP$DE$DE
242428602$24242860$2$F$$20240812$20240823$20240827$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463968$RANBAXY$Parmeshwar N, Song S, Alcon A, Kim EA. The Incidence of breast cancer after gender-affirming mastectomy in transmen. [Review]. Ann Plast Surg. 2024;88 (4):S332-S336$49$YR$$M$Y$$$20240827$$HP$CA$CA
242428611$24242861$1$I$$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464456$RANBAXY$Khatri V, Bauschka M, Foley M, Lundberg C, Mehler P. A Multi-Disciplinary Approach to Managing End-Stage Renal Disease in Anorexia Nervosa: A Case Report. Clin Med Insights Case Rep. 2023;16:1-6$54$YR$$F$Y$44.2$KG$20240823$$HP$US$US
242428622$24242862$2$F$$20240822$20240823$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464043$RANBAXY$Zhong S, Wu Z, Chen C, Xiao H, Wang Z. Near fatal asthma in a case of allergic bronchopulmonary aspergillosis (ABPA) treated with ECMO. J Asthma. 2024;61 (8):889-893$40$YR$$M$Y$$$20240906$$MD$CN$CN
242428631$24242863$1$I$$20240808$20240823$20240823$EXP$$GB-SUNPHARMA-2024RR-463855AA$RANBAXY$Htwe S, Holmes S. Mycophenolate mofetil in the management of lichen planus pigmentosus in a woman with frontal fibrosing alopecia. Br J Dermatol. 2024;192:i77$50$YR$$F$Y$$$20240823$$HP$GB$GB
242428641$24242864$1$I$$20240809$20240823$20240823$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464179$RANBAXY$Surendran S, Goyal M. Ayurvedic management of idiopathic small fibre neuropathy- A case report. J Ayurveda Integrat Med. 2023;14(2):1-5/ 100708$37$YR$$M$Y$70$KG$20240823$$HP$IN$IN
242428651$24242865$1$I$$20240808$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464064$RANBAXY$Takegami N, Murai H, Mori H, Yamaguchi-Takegami N, Toda T, Iwata NK, et al. Multiple cortical lesions with grainy enhancement of magnetic resonance imaging in anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated encephalitis with seizures (FLAMES). J Neurol Sci. 2023;451:120729 (1-3)$32$YR$$F$Y$$$20240823$$HP$JP$JP
242428661$24242866$1$I$$20240808$20240823$20240823$EXP$$IE-SUNPHARMA-2024RR-463857AA$RANBAXY$Long A, O^Malley S, Quigley C, Collins S. Isotretinoin under the lens. Br J Dermatol. 2024;192:i129-i130$22$YR$$F$Y$$$20240823$$HP$IE$IE
242428672$24242867$2$F$$20240813$20240823$20240828$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464196$RANBAXY$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turk J Haematol. 2023;40:284-285$76$YR$$F$Y$$$20240828$$HP$CN$CN
242428681$24242868$1$I$20240731$20240808$20240823$20240823$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463661$RANBAXY$$34$YR$$F$Y$$$20240823$$MD$GB$GB
242428691$24242869$1$I$$20240808$20240823$20240823$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463984$RANBAXY$Colussi L, Dagri A, Pastore S, Taddio A, Tommasini A. Effect of the janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma. Pediatr Rheumatol. 2023;21 (Suppl 2):137; abstr. P134$11$YR$$F$Y$$$20240823$$HP$IT$IT
242428702$24242870$2$F$$20240813$20240823$20240828$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464197$RANBAXY$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turk J Haematol. 2023;40:284-285$71$YR$$F$Y$$$20240828$$HP$CN$CN
242428712$24242871$2$F$$20240813$20240823$20240828$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464383$RANBAXY$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turk J Haematol. 2023;40:284-285$62$YR$$F$Y$$$20240828$$HP$CN$CN
242428721$24242872$1$I$$20240814$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008543$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242428732$24242873$2$F$$20240822$20240823$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464169$RANBAXY$Im S, Paz y Mino A, Garces E, Altamimi S. Latent melioidosis activation presenting with urinary tract infection and bacteremia. ID Cases. 2024;36 (0):e02007$68$YR$$F$Y$$$20240906$$HP$US$US
242428742$24242874$2$F$$20240827$20240823$20240911$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463693$RANBAXY$Amagai H, Sasagawa S, Koide Y, Tsukamoto S, Miyazawa Y, Yamakawa H, et al. A Patient with AFPProducing Gastric Cancer and Stenosis Who Regained Oral Intake Capabilities after T-DXd Treatment. Gan To Kagaku Ryoho. 2023;50 (7):813-816$55$YR$$M$Y$$$20240911$$HP$JP$JP
242428751$24242875$1$I$$20240808$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464264$RANBAXY$Gillespie L, Diaz M, Gorder K, Shaw C, Ahmad S, Hinckley W et al. The Successful Rotor Wing Transport of 2 Patients Requiring Biventricular Impella Support: A Case Series and Review. Air Med J. 2023;42:499-503$81$YR$$F$Y$$$20240823$$MD$US$US
242428762$24242876$2$F$$20240813$20240823$20240828$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464381$RANBAXY$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turk J Haematol. 2023;40:284-285$75$YR$$F$Y$$$20240828$$HP$CN$CN
242428771$24242877$1$I$$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464216$RANBAXY$Wang KL, Crum OM, Swanson AA, Johnson EF. Cutaneous metastasis of uterine carcinosarcoma mimicking drug eruption. JAAD Case Rep. 2024;47(0):44-46$71$YR$$F$Y$$$20240823$$HP$US$US
242428781$24242878$1$I$$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464458$RANBAXY$Gondal MUR, Rovenstine L, Ansari F, Kiyani Z, Nair DPJR, Khan T, et al. NAVIGATING A COMPLEX CASE OF MYCOBACTERIUM XENOPI IN A PATIENT WITH BLUE RUBBER BLEB NEVUS SYNDROME. Eur J Case Rep Intern Med. 2024;Feb 5; 11 (6):no pagination$40$YR$$F$Y$$$20240823$$HP$US$US
242428791$24242879$1$I$$20240809$20240823$20240823$EXP$$DZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464439$RANBAXY$Ghodbane NE, Mecibah A, Merzougui Z, Zerguine H, Akakba Z, Slimani S. Nakajo-Nishimura Syndrome: The First African Case. Mediterr J Rheum. 2023;34 (2):262-265$11$YR$$F$Y$25$KG$20240823$$HP$DZ$DZ
242428802$24242880$2$F$$20240813$20240823$20240828$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464195$RANBAXY$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turk J Haematol. 2023;40:284-285$61$YR$$F$Y$$$20240828$$HP$CN$CN
242428811$24242881$1$I$$20240809$20240823$20240823$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464159$RANBAXY$Bhushan S, Mahajan S, Sen A. Rare case of early neonatal sepsis caused by Candida krusei successfully treated with voriconazole. Med Mycol Case Reports. 2024;45 (0):100659(1-3)$$$N$F$Y$1.68$KG$20240823$$HP$IN$IN
242428821$24242882$1$I$$20240808$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464046$RANBAXY$Singh H, Patel P, Mawari S, Caliman N. Cyclosporine-Associated Organizing Pneumonia. Am J Ther. 2024;31 (4):e450-e453$30$YR$$F$Y$$$20240823$$MD$US$US
242428831$24242883$1$I$$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464255$RANBAXY$Sorabekka RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO J. 2024;70 (7):e92-e96$14$YR$$F$Y$$$20240823$$HP$US$US
242428841$24242884$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464366$RANBAXY$Sato R, Matsushita Y, Sano A, Watanabe K, Watanabe H, Tamura K, et al. Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases. In Vivo. 2024;38 (4):1859-1864$34$YR$$M$Y$$$20240823$$HP$JP$JP
242428851$24242885$1$I$$20240808$20240823$20240823$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464080$RANBAXY$Khojasteh M, Soleimani P, Ghasemi A, Taghizadeh P, Rohani M, Alavi A. JAM2 variants can be more common in primary familial brain calcification (PFBC) cases than those appear; may be due to a founder mutation. Neurol Sci. 2024;45:3829-3844$38$YR$$M$Y$$$20240823$$HP$IR$IR
242428861$24242886$1$I$$20240808$20240823$20240823$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464139$RANBAXY$Kwok TSH, Kang H, Zhang L, Abdelhalim T. Mass Confusion. Arthritis Care  Res (Hoboken). 2023;75(4):697-704$18$YR$$M$Y$$$20240823$$MD$CA$CA
242428872$24242887$2$F$$20240813$20240823$20240828$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464385$RANBAXY$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turk J Haematol. 2023;40:284-285$66$YR$$M$Y$$$20240828$$HP$CN$CN
242428882$24242888$2$F$$20240822$20240823$20240906$EXP$$MA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464300$RANBAXY$Unizony S, Matza MA, Jarvie A, O^Dea D, Fernandes AD, Stone JH. Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept study. Lancet Rheumatol. 2023;5:e736-e742$$$$$Y$$$20240906$$HP$MA$MA
242428892$24242889$2$F$$20240813$20240823$20240828$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464035$RANBAXY$Mohamed MS, Wojciechowski K, Osama M, Hashem A, Patel J, Mahmoud A, et al. The Missed Culprit For A Complex Case Of Non-ischemic Cardiomyopathy. J Card Fall. 2024;30:157-158$60$YR$$F$Y$$$20240828$$HP$US$US
242428901$24242890$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464365$RANBAXY$Sato R, Matsushita Y, Sano A, Watanabe K, Watanabe H, Tamura K, et al. Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases. In Vivo. 2024;38 (4):1859-1864$81$YR$$M$Y$$$20240823$$HP$JP$JP
242428911$24242891$1$I$$20240809$20240823$20240823$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464297$RANBAXY$Zhang H-W, Yu H-B. Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case. Front Oncol. 2024;Jul 15; 14 (0):1428370; 1-9$51$YR$$F$Y$$$20240823$$HP$CN$CN
242428921$24242892$1$I$20240101$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463189$RANBAXY$$$$E$M$Y$$$20240823$$CN$US$US
242428931$24242893$1$I$$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464413$RANBAXY$Ali ST, Vanderweele DJ. Prolonged Response to Osimertinib in EGFR-Mutated Metastatic Urothelial Carcinoma, a Case Report. Curr Oncol. 2024;31:4015-4021$48$YR$$F$Y$$$20240823$$HP$US$US
242428941$24242894$1$I$$20240809$20240823$20240823$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464306$RANBAXY$Choi HS, Kim SH, Kang H-C, Lee JS, Kim HD. Efficacy and Safety of Lacosamide in Adolescents with Lennox-Gastaut Syndrome. Ann Child Neurol. 2020;28 (3):93-99$17$YR$$M$Y$$$20240823$$MD$KR$KR
242428952$24242895$2$F$$20240813$20240823$20240828$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464384$RANBAXY$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turk J Haematol. 2023;40:284-285$72$YR$$M$Y$$$20240828$$HP$CN$CN
242428961$24242896$1$I$$20240808$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464163$RANBAXY$Suffian H,Le T,Pandya A. COMPLICATIONSPOST-CHEMOTHERAPY INACHILDWITHT-CELLLEUKEMIA AND ATAXIATELANGIECTASIA. Ann Allergy Asthma Immunol. 2023;131SUP5:S156/M261$4$YR$$M$Y$$$20240823$$HP$US$US
242428971$24242897$1$I$$20240813$20240823$20240823$EXP$$PK-ROCHE-10000056107$ROCHE$$68$YR$E$M$Y$$$20240823$$CN$PK$PK
242428981$24242898$1$I$$20240814$20240823$20240823$PER$$US-TEVA-VS-3234929$TEVA$$36$YR$$M$Y$$$20240823$$CN$US$US
242428991$24242899$1$I$$20240809$20240823$20240823$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464154$RANBAXY$Kaur J, Singh A, Shah M, Chandrani P, Chougule A, Shetty O, et al. Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy. Cancer Res Stat Treat. 2023;6 (2):288-295$77$YR$$M$Y$$$20240823$$HP$IN$IN
242429001$24242900$1$I$$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024166924$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242429011$24242901$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164923$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$F$Y$$$20240823$$MD$US$US
242429021$24242902$1$I$20240330$20240809$20240823$20240823$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463745$RANBAXY$$83$YR$$M$Y$$$20240823$$PH$ES$ES
242429031$24242903$1$I$20240528$20240809$20240823$20240823$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463720$RANBAXY$$50$YR$$F$Y$63$KG$20240823$$CN$DE$DE
242429041$24242904$1$I$20240520$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464055$RANBAXY$$18$YR$$M$Y$75$KG$20240823$$PH$FR$FR
242429051$24242905$1$I$$20240814$20240823$20240823$EXP$$US-JNJFOC-20240855261$JOHNSON AND JOHNSON$$69$YR$E$F$Y$72.64$KG$20240823$$MD$US$US
242429061$24242906$1$I$$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464038$RANBAXY$$49$YR$$F$Y$$$20240823$$MD$FR$FR
242429071$24242907$1$I$20240415$20240809$20240823$20240823$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464002$RANBAXY$$85$YR$$M$Y$$$20240823$$MD$IT$IT
242429081$24242908$1$I$20240730$20240809$20240823$20240823$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463565$RANBAXY$$55$YR$$F$Y$81$KG$20240823$$MD$GB$GB
242429091$24242909$1$I$20240531$20240809$20240823$20240823$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463956$RANBAXY$$31$YR$$F$Y$$$20240823$$MD$DE$DE
242429101$24242910$1$I$20200530$20240809$20240823$20240823$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463933$RANBAXY$$57$YR$$M$Y$68$KG$20240823$$CN$PL$PL
242429121$24242912$1$I$20240815$20240822$20240822$20240822$DIR$715510$$FDA-CTU$$53$YR$$F$N$$$20240822$N$PH$US$
242429131$24242913$1$I$20240221$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463759$RANBAXY$$41$YR$$M$Y$$$20240823$$HP$FR$FR
242429141$24242914$1$I$20240822$20240822$20240822$20240822$DIR$715491$$FDA-CTU$$$$$F$N$$$20240822$N$CN$US$
242429151$24242915$1$I$20240501$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463491$RANBAXY$$23$YR$$F$Y$55$KG$20240823$$MD$FR$FR
242429161$24242916$1$I$20231109$20240809$20240823$20240823$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463798$RANBAXY$$$$$M$Y$$$20240823$$MD$DE$DE
242429172$24242917$2$F$$20240816$20240823$20240830$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463196$RANBAXY$Jang YK, Kim DH, Yoon MS, Shin JU, Lee HJ. Development of desquamation with Staphylococcus aureus colonization in patients with atopic dermatitis under treatment with upadacitinib. Clin Exp Dermatol. 2023;48 (3):240-242$18$YR$$M$Y$$$20240830$$HP$KR$KR
242429182$24242918$2$F$20240528$20240816$20240823$20240830$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463549$RANBAXY$$57$YR$$M$Y$$$20240830$$MD$ES$ES
242429191$24242919$1$I$20240427$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464026$RANBAXY$$75$YR$$M$Y$69$KG$20240823$$PH$FR$FR
242429201$24242920$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57970$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242429211$24242921$1$I$20240822$20240822$20240822$20240822$DIR$715545$$FDA-CTU$$75$YR$$F$N$$$20240822$N$$US$
242429231$24242923$1$I$20240422$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464072$RANBAXY$$53$YR$$F$Y$$$20240823$$PH$FR$FR
242429241$24242924$1$I$20210809$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464060$RANBAXY$$22$YR$$F$Y$72$KG$20240823$$MD$FR$FR
242429252$24242925$2$F$$20240812$20240823$20240827$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448590$RANBAXY$Trindade M, Boavida L, Carvalho J, Serodio J, Favas C, Alves JD. OLMESARTAN INDUCED ENTEROPATHY - A CAUSE FOR DIARRHEA AND MALABSORPTION. Eur J Case Rep Intern Med. 2019;6 (Suppl.1):305(103)$84$YR$$M$Y$$$20240827$$HP$PT$PT
242429261$24242926$1$I$$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463550$RANBAXY$$24$YR$$M$Y$$$20240823$$PH$FR$FR
242429271$24242927$1$I$20240101$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464027$RANBAXY$$31$YR$$F$Y$$$20240823$$PH$FR$FR
242429281$24242928$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58065$$FDA-CTU$$44$YR$$F$N$$$20240822$N$$US$
242429291$24242929$1$I$20230928$20240822$20240822$20240822$DIR$715556$$FDA-CTU$$49$YR$$F$N$82.35$KG$20240822$N$MD$US$
242429301$24242930$1$I$20230219$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463825$RANBAXY$$15$YR$$M$Y$$$20240823$$MD$FR$FR
242429311$24242931$1$I$$20240809$20240823$20240823$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463963$RANBAXY$$35$YR$$F$Y$73$KG$20240823$$PH$GB$GB
242429321$24242932$1$I$20240525$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463850$RANBAXY$$26$YR$$F$Y$54$KG$20240823$$MD$FR$FR
242429331$24242933$1$I$$20240810$20240823$20240823$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462704$RANBAXY$$$$$M$Y$$$20240823$$CN$GB$GB
242429341$24242934$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57990$$FDA-CTU$$59$YR$$F$N$$$20240822$N$$US$
242429351$24242935$1$I$20240521$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463878$RANBAXY$$89$YR$$F$Y$41$KG$20240823$$MD$FR$FR
242429361$24242936$1$I$20240430$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463872$RANBAXY$$60$YR$$M$Y$83$KG$20240823$$PH$FR$FR
242429381$24242938$1$I$20240301$20240809$20240823$20240823$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463829$RANBAXY$$30$YR$$F$Y$56$KG$20240823$$PH$RO$RO
242429391$24242939$1$I$$20240809$20240823$20240823$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464246$RANBAXY$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N.. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series. J-Clin-Med. 2023;12 (1):1-7$27$YR$$M$Y$$$20240823$$HP$IT$IT
242429401$24242940$1$I$20240523$20240809$20240823$20240823$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463892$RANBAXY$$34$YR$$F$Y$$$20240823$$MD$RO$RO
242429411$24242941$1$I$20240809$20240811$20240823$20240823$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462783$RANBAXY$$27$YR$$F$Y$$$20240823$$CN$GB$GB
242429441$24242944$1$I$$20240822$20240822$20240822$DIR$715526$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242429451$24242945$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58083$$FDA-CTU$$63$YR$$F$N$$$20240822$N$$US$
242429461$24242946$1$I$$20240809$20240823$20240823$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464217$RANBAXY$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N.. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series. J-Clin-Med. 2023;12 (1)$29$YR$$M$Y$$$20240823$$HP$IT$IT
242429471$24242947$1$I$20240809$20240822$20240822$20240822$DIR$715490$$FDA-CTU$$$$$F$N$$$20240822$N$CN$US$
242429481$24242948$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463943$RANBAXY$Mimura Y, Komatsu K, Yasushi Y, Seki M, Nakajima S, Uchida H, et al. A case of painful legs and moving toes syndrome mimicking somatic symptom disorder. Psychogeriatrics. 2024;24 (4):1023-1029$8$DEC$$F$Y$$$20240823$$MD$JP$JP
242429491$24242949$1$I$$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463876$RANBAXY$Drouart L, Cabon M, Gominet M, Care W, Antoine M, Andriamanantena D, et al. Pseudo erysipelas secondary to Gemcitabine administration without prior irradiation: a rare differential diagnosis of infectious dermohypodermitis. Rev Med Interne. 2023;44 (Suppl):A415$64$YR$$F$Y$$$20240823$$HP$FR$FR
242429501$24242950$1$I$$20240809$20240823$20240823$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405059$RANBAXY$$$$$M$Y$$$20240823$$CN$CA$CA
242429511$24242951$1$I$$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57957$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
242429521$24242952$1$I$20240803$20240822$20240822$20240822$DIR$715586$$FDA-CTU$$66$YR$$F$N$74.25$KG$20240822$N$CN$US$
242429531$24242953$1$I$20240514$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464059$RANBAXY$$21$YR$$F$Y$77$KG$20240823$$PH$FR$FR
242429541$24242954$1$I$$20240809$20240823$20240823$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464184$RANBAXY$Franquelim C, Romana A, Rachao A, Martins JS, Monteiro JP, Carvalho J.. Early-Onset Dystonia and Visual Impairment Preceding Epileptic Encephalopathy Associated with PIGA Gene Mutation. Neuropediatrics. 2024;55 (4):265-268$8$MON$$M$Y$$$20240823$$HP$PT$PT
242429551$24242955$1$I$$20240822$20240822$20240822$DIR$715478$$FDA-CTU$$$$$UNK$N$$$20240822$$CN$US$
242429561$24242956$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58060$$FDA-CTU$$89$YR$$M$N$$$20240822$N$$US$
242429571$24242957$1$I$$20240822$20240822$20240822$DIR$715529$$FDA-CTU$$$$$UNK$N$$$20240822$N$CN$US$
242429581$24242958$1$I$20240817$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58098$$FDA-CTU$$68$YR$$M$N$$$20240822$N$$US$
242429591$24242959$1$I$20240803$20240822$20240822$20240822$DIR$715577$$FDA-CTU$$72$YR$$M$N$117$KG$20240822$N$CN$US$
242429601$24242960$1$I$20240819$20240822$20240822$20240822$DIR$715562$$FDA-CTU$$$$$UNK$N$$$20240822$N$HP$US$
242429611$24242961$1$I$20240808$20240822$20240822$20240822$DIR$715587$$FDA-CTU$$65$YR$$F$N$54.9$KG$20240822$N$CN$US$
242429621$24242962$1$I$20240822$20240822$20240822$20240822$DIR$715547$$FDA-CTU$$65$YR$$F$N$105.75$KG$20240822$Y$CN$US$
242429631$24242963$1$I$$20240808$20240823$20240823$EXP$$IT-COSETTE-CP2024IT000221$COSETTE PHARMACEUTICALS$$85$YR$E$F$Y$$$20240823$$HP$IT$IT
242429641$24242964$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170745$NOVARTIS$$$$$$Y$$$20240823$$CN$US$US
242429652$24242965$2$F$20240701$20240903$20240823$20240918$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1106$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240918$$HP$US$US
242429661$24242966$1$I$$20240822$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074673$SANDOZ$$70$YR$$F$Y$$$20240823$$HP$CA$CA
242429681$24242968$1$I$20240620$20240813$20240823$20240823$PER$$US-MYLANLABS-2024M1057897$MYLAN$$80$YR$$F$Y$55.79$KG$20240823$$CN$US$US
242429692$24242969$2$F$$20240911$20240823$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA030886$SANDOZ$$31$MON$$$Y$$$20240912$$HP$CA$CA
242429702$24242970$2$F$$20240909$20240823$20240909$PER$$US-ALXN-202408USA000929US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$MD$US$US
242429711$24242971$1$I$$20240802$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128053$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$83.46$KG$20240823$$CN$US$US
242429721$24242972$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132996$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$61.69$KG$20240823$$CN$US$US
242429731$24242973$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133498$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$86.64$KG$20240823$$CN$US$US
242429741$24242974$1$I$$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463354$RANBAXY$$82$YR$$F$Y$$$20240823$$MD$US$US
242429752$24242975$2$F$$20240812$20240823$20240827$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464014$RANBAXY$Suvar T, Music S, Tan M, Mehta N. The Combined Use of Acute Regional and Interventional Pain Offers Superior Quality of Life in Palliative Care. Pain Med case Rep. 2024;Jan;8 (1):25-29$29$YR$$F$Y$$$20240827$$MD$US$US
242429771$24242977$1$I$$20240813$20240823$20240823$EXP$$CO-EXELIXIS-CABO-24080731$EXELIXIS$$$$A$M$Y$$$20240823$$MD$CO$CO
242429781$24242978$1$I$$20240808$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464065$RANBAXY$Terabe T, Ishibashi-Kanno N, Uchida F, Bukawa H. Long-term control of lung metastasis of tongue cancer treated effectively with cetuximab combination chemotherapy. IntJ Oral Maxillofac Surg. 2023;52:1221-1224$60$YR$$M$Y$$$20240823$$HP$JP$JP
242429791$24242979$1$I$$20240808$20240823$20240823$EXP$$MA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463780$RANBAXY$El-Mhadi S, El Hajjaj B, Laktib N, Oukerraj L, Cherti M. A rare case of Lutembacher^s syndrome presenting with low-gradient severe mitral stenosis: case report and literature overview. Eur Heart J Case Rep. 2024;8 (7):no pagination$60$YR$$F$Y$$$20240823$$HP$MA$MA
242429801$24242980$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58033$$FDA-CTU$$55$YR$$F$N$$$20240822$N$$US$
242429811$24242981$1$I$$20240809$20240823$20240823$EXP$$CO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464404$RANBAXY$Ramirez Marmolejo R, Ramirez Isaza S. Emergent Management of Severe Hyperkalemia and Volume Overload in a Maintenance Hemodialysis Patient With Castor Oil and Enemas in the Absence of Accessible Hemodialysis. Kidney Med. 2023;Jan; 5 (1):100576$$$E$M$Y$$$20240823$$MD$CO$CO
242429821$24242982$1$I$20240730$20240822$20240822$20240822$DIR$715588$$FDA-CTU$$44$YR$$F$N$105.75$KG$20240822$N$CN$US$
242429842$24242984$2$F$$20240822$20240823$20240906$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464307$RANBAXY$Panou E, Marinos L, Piperaki E, Migkou M, Stratigos AJ, Nikolaou V. Post-kala-azar dermal leishmaniasis manifestation in a Mediterranean immunosuppressed patient: a rare incident. Clin Exp Dermatol. 2023;48:834-836$74$YR$$M$Y$$$20240906$$HP$GR$GR
242429851$24242985$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464335$RANBAXY$Sato R, Matsushita Y, Sano A, Watanabe K, Watanabe H, Tamura K, et al.. Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases. In Vivo. 2024;38 (4):1859-1864$67$YR$$M$Y$$$20240823$$HP$JP$JP
242429861$24242986$1$I$$20240808$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464147$RANBAXY$Bacorn C, Majidi S, Schultz H, Sulewski ME, Eberhart CG, Mahoney NR. Severe Mpox Infection of the Eye and Periocular Region. Ophthalmic Plast Reconstr Surg. 2023;39(6):e176-e179$41$YR$$M$Y$$$20240823$$MD$US$US
242429871$24242987$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464361$RANBAXY$Sato R, Matsushita Y, Sano A, Watanabe K, Watanabe H, Tamura K, et al. Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases. In Vivo. 2024;38 (4):1859-1864$76$YR$$M$Y$$$20240823$$HP$JP$JP
242429881$24242988$1$I$20240101$20240815$20240823$20240823$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00855$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240823$$CN$US$US
242429892$24242989$2$F$$20240822$20240823$20240906$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464460$RANBAXY$Caminati M, Scarpieri E, Maule M, Pinter P, Schiappoli M, Vaia R, et al. Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis. Rheumatology. 2024;63(6):E96-E98$70$YR$$M$Y$$$20240906$$HP$IT$IT
242429901$24242990$1$I$20240822$20240822$20240822$20240822$DIR$715558$$FDA-CTU$$53$YR$$F$N$$$20240822$Y$PH$US$
242429911$24242991$1$I$$20240805$20240822$20240822$DIR$FDA-CDER-CTU-2024-57978$$FDA-CTU$$$$$M$N$$$20240805$N$HP$US$
242429921$24242992$1$I$20240715$20240822$20240822$20240822$DIR$715571$$FDA-CTU$$48$YR$$F$N$141.75$KG$20240822$N$CN$US$
242429941$24242994$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014064$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240823$$CN$US$US
242429952$24242995$2$F$$20240813$20240823$20240828$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464175$RANBAXY$Shang Y, Zhao H, Li D. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. Turk J Haematol. 2023;40:284-285$68$YR$$M$Y$$$20240828$$HP$CN$CN
242429961$24242996$1$I$$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464242$RANBAXY$Sorabekka RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO J. 2024;70 (7):e92-e96$17$YR$$M$Y$85$KG$20240823$$HP$US$US
242429971$24242997$1$I$$20240809$20240823$20240823$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464352$RANBAXY$Yunze Zhao, Honghao M, Dong W, Hongyun L, Hongyun W, Rui Z. Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis. Chin J Pediatr. 2024;62(1):60-65$$$$M$Y$$$20240823$$HP$CN$CN
242429981$24242998$1$I$$20240816$20240823$20240823$EXP$$US-OTSUKA-2023_029027$OTSUKA$$$$$M$Y$$$20240823$$HP$US$US
242429991$24242999$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57961$$FDA-CTU$$91$YR$$M$N$$$20240822$N$$US$
242430001$24243000$1$I$20220101$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013703$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240823$$CN$US$US
242430011$24243001$1$I$$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014562$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242430021$24243002$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013611$ELI LILLY AND CO$$$$A$F$Y$$$20240823$$CN$US$US
242430031$24243003$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012692$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240823$$CN$US$US
242430041$24243004$1$I$20240731$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58064$$FDA-CTU$$68$YR$$F$N$$$20240822$N$PH$US$
242430051$24243005$1$I$$20240819$20240823$20240823$EXP$$CA-BAUSCH-BL-2024-012608$BAUSCH AND LOMB$$34$YR$$F$Y$$$20240823$$CN$CA$CA
242430061$24243006$1$I$20231001$20240809$20240823$20240823$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463815$RANBAXY$$20$YR$$M$Y$96$KG$20240823$$CN$DE$DE
242430071$24243007$1$I$20240528$20240809$20240823$20240823$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463801$RANBAXY$$13$YR$$F$Y$50$KG$20240823$$MD$DE$DE
242430081$24243008$1$I$20240428$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463939$RANBAXY$$47$YR$$M$Y$$$20240823$$MD$FR$FR
242430091$24243009$1$I$$20240809$20240823$20240823$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463414$RANBAXY$Brusasco M, Feliciani C, de Felici del Giudice MB. A case of chronic granulomatous disease and acne: is isotretinoin a safe treatment?. Dermatol Rep. 2023;15 (2):1-3$25$YR$$M$Y$$$20240823$$HP$IT$IT
242430101$24243010$1$I$20240307$20240809$20240823$20240823$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463962$RANBAXY$$76$YR$$M$Y$$$20240823$$MD$ES$ES
242430111$24243011$1$I$20240503$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464053$RANBAXY$$70$YR$$M$Y$$$20240823$$PH$FR$FR
242430121$24243012$1$I$20221101$20240809$20240823$20240823$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464339$RANBAXY$$38$YR$$M$Y$$$20240823$$HP$IT$IT
242430131$24243013$1$I$$20240809$20240823$20240823$EXP$$PH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463177$RANBAXY$Garcia JJB, Pascual JLV. Cancer-associated stroke from progressive acinic cell carcinoma. BMJ Case Rep. 2024;17(5):1-8$$$A$M$Y$$$20240823$$HP$PH$PH
242430141$24243014$1$I$20240528$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463756$RANBAXY$$24$YR$$F$Y$$$20240823$$MD$FR$FR
242430151$24243015$1$I$$20240809$20240823$20240823$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462983$RANBAXY$Beurier P, Dallevet C A, Brissot E, Cholet C, Santin A, Lionnet F, et al.. [Allogeneic haematopoietic stem cell transplantation induced remission of periarteritis nodosa associated with azacytidine-refractory myelodysplastic syndrome]. Rev Med Interne. 2024;Aug 6:S0248-866$32$YR$$M$Y$$$20240823$$HP$FR$FR
242430161$24243016$1$I$20240730$20240820$20240823$20240823$EXP$$NVSC2024US169552$NOVARTIS$$0$YR$$F$Y$6.803$KG$20240823$$CN$US$US
242430171$24243017$1$I$20240819$20240820$20240823$20240823$PER$$US-GRUNENTHAL-2024-124325$AVERITAS$$$$$M$Y$$$20240823$$HP$US$US
242430183$24243018$3$F$$20240913$20240823$20240924$PER$$US-AMGEN-USASP2024165178$AMGEN$$$$$$Y$$$20240924$$PH$US$US
242430202$24243020$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093482$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242430211$24243021$1$I$$20240807$20240823$20240823$PER$$US-TEVA-VS-3231680$TEVA$$53$YR$$F$Y$$$20240823$$CN$US$US
242430221$24243022$1$I$$20240809$20240823$20240823$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463941$RANBAXY$Sasaki M, Shimura T, Nishie H, Kuroyanagi K, Kanno T, Fukusada S, et al. BRAF K601E-mutated metastatic colorectal cancer in response to combination therapy with encorafenib, binimetinib, and cetuximab: A case report. World J Gastrointest Oncol. 2024;16 (7):3357-3363$59$YR$$F$Y$$$20240823$$HP$JP$JP
242430231$24243023$1$I$20230519$20240820$20240823$20240823$EXP$$GB-TEVA-VS-3235625$TEVA$$74$YR$$F$Y$$$20240823$$CN$GB$GB
242430241$24243024$1$I$$20240809$20240823$20240823$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464230$RANBAXY$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N.. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series. J-Clin-Med. 2023;12 (1)$37$YR$$M$Y$$$20240823$$HP$IT$IT
242430261$24243026$1$I$$20240814$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008539$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242430271$24243027$1$I$$20240819$20240823$20240823$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-132850$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240823$$HP$CA$CA
242430281$24243028$1$I$$20240809$20240823$20240823$EXP$$US-GRANULES-US-2024GRASPO00369$GRANULES INDIA$$$$$F$Y$$$20240823$$CN$US$US
242430291$24243029$1$I$20230701$20240823$20240823$20240823$PER$$US-PROD-AS2-212756134-RB-109447-2023$RECKITT BENCKISER$$75$YR$$M$Y$$$20240823$$CN$US$US
242430301$24243030$1$I$$20240822$20240823$20240823$PER$$US-ROCHE-10000064496$ROCHE$$24$YR$A$F$Y$$$20240823$$HP$US$US
242430311$24243031$1$I$$20240820$20240823$20240823$EXP$$CN-ROCHE-10000062255$ROCHE$Ren G, Wu X, Chen Y, Guan W, Song X, Zhu J. Analysis of Treatment Strategies and Pharmacological Monitoring for Transformation from Lung Adenocarcinoma with Brain Metastasis to Small Cell Lung Carcinoma after Multi-line TKI Resistance. Strait Pharmaceutical Journal. 2024;36 (6):63-7.$51$YR$A$F$Y$60$KG$20240823$$PH$CN$CN
242430321$24243032$1$I$$20240814$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008538$INCYTE$$$$$$Y$$$20240823$$MD$US$US
242430332$24243033$2$F$$20240910$20240823$20240910$PER$$US-ALXN-202408USA001017US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
242430342$24243034$2$F$$20240909$20240823$20240909$PER$$US-ALXN-202408USA000944US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$MD$US$US
242430351$24243035$1$I$20240811$20240816$20240823$20240823$EXP$$CN-FreseniusKabi-FK202412645$FRESENIUS KABI$$16$YR$T$F$Y$55$KG$20240823$$HP$CN$CN
242430361$24243036$1$I$$20240815$20240823$20240823$30DAY$$US-GSK-US2024AMR102765$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$US$US
242430371$24243037$1$I$$20240819$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133899$BRISTOL MYERS SQUIBB$Stanek K, Hussain MT, Spaulding AC, Borkar S, Shaikh ME. Improving patient safety through proper ordering and administration of andexanet alfa. Mayo Clinic Proceedings: Innovations, Quality and Outcomes. 2024 Aug 01;8(4):407-14. doi:10.1016/j.mayocpiqo.2024.03.003.$72$YR$E$M$Y$$$20240823$$MD$US$US
242430381$24243038$1$I$$20240819$20240823$20240823$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-131264$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$91$KG$20240823$$CN$CA$CA
242430391$24243039$1$I$20240819$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132932$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240823$$HP$US$US
242430412$24243041$2$F$$20240823$20240823$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093483$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242430421$24243042$1$I$20231101$20240816$20240823$20240823$EXP$$CA-GSK-CA2023171056$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$CA$CA
242430431$24243043$1$I$20240821$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57959$$FDA-CTU$$80$YR$$M$N$89.36$KG$20240822$N$PH$US$
242430441$24243044$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58067$$FDA-CTU$$71$YR$$M$N$$$20240822$N$$US$
242430451$24243045$1$I$$20240808$20240823$20240823$PER$$US-GLANDPHARMA-US-2024GLNSPO00650$GLAND PHARMA$$20$YR$A$F$Y$$$20240823$$CN$US$US
242430461$24243046$1$I$$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464472$RANBAXY$Cheng J, Harney S, Toner K, Kube P, Gong S, Ozdemirli M, et al.. Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment. Pediatr Pediatr Cancer. 2024;71 (8):e31096 (1-4)$14$YR$$M$Y$$$20240823$$HP$US$US
242430471$24243047$1$I$$20240809$20240823$20240823$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464480$RANBAXY$Cheng J, Harney S, Toner K, Kube P, Gong S, Ozdemirli M, et al.. Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment. Pediatr Pediatr Cancer. 2024;71 (8):e31096 (1-4)$9$YR$$M$Y$$$20240823$$HP$US$US
242430482$24243048$2$F$20240808$20240830$20240823$20240906$EXP$$NVSC2024CR168677$NOVARTIS$$41$YR$$M$Y$68$KG$20240906$$CN$CR$CR
242430491$24243049$1$I$20240812$20240820$20240823$20240823$DIR$FDA-CDER-CTU-2024-58102$$FDA-CTU$$51$YR$$M$N$62.1$KG$20240820$N$$US$
242430501$24243050$1$I$$20240822$20240823$20240823$DIR$FDA-CDER-CTU-2024-58162$$FDA-CTU$$60$YR$$M$N$$$20240822$N$$US$
242430511$24243051$1$I$20240721$20240819$20240823$20240823$EXP$$GB-AMERICAN REGENT INC-2024003194$AMERICAN REGENT$$38$YR$$F$Y$77$KG$20240823$$CN$GB$GB
242430521$24243052$1$I$$20240820$20240823$20240823$EXP$$CA-Orion Corporation ORION PHARMA-24_00031390$ORION$$69$YR$E$M$Y$$$20240823$$HP$CA$
242430532$24243053$2$F$$20240919$20240823$20240925$PER$$US-AMGEN-USASP2024166441$AMGEN$$65$YR$E$F$Y$$$20240925$$MD$US$US
242430541$24243054$1$I$$20240813$20240823$20240823$PER$$US-AMGEN-USASP2024161606$AMGEN$Thandassery R. B.; Mashal F. A.; Awad J. A. et al.. Idiopathic Multicentric Castleman Disease With Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Insufficiency, and Organomegaly (TAFRO) Syndrome in a Liver Transplant Recipient. ACG Case Reports Journal. 2024;11 (8):1-6$68$YR$E$M$Y$$$20240823$$MD$US$US
242430551$24243055$1$I$$20240819$20240823$20240823$EXP$$CA-AMGEN-CANSP2024165501$AMGEN$$85$YR$E$F$Y$$$20240823$$CN$CA$CA
242430561$24243056$1$I$$20240808$20240823$20240823$PER$$US-GLANDPHARMA-US-2024GLNSPO00665$GLAND PHARMA$$$$$$Y$$$20240823$$CN$US$US
242430571$24243057$1$I$$20240816$20240823$20240823$EXP$$CN-OTSUKA-2024_022746$OTSUKA$Zhang D, Bai J. Severe Vincristine-Induced Peripheral Neuropathic Weakness in Both Lower Limbs in an Asian Adolescent with CYP3A4 rs2740574 TT Genotype. Pharmgenomics Pers Med.. 2024;17:125-31$19$YR$$M$Y$$$20240823$$HP$CN$CN
242430581$24243058$1$I$$20240711$20240823$20240823$PER$$US-LUNDBECK-DKLU4001688$LUNDBECK$$$$$$Y$$$20240823$$CN$US$US
242430591$24243059$1$I$$20240812$20240823$20240823$EXP$$US-APOTEX-2024AP009498$APOTEX$Shishkina I, Bradshaw D, Giddens G, Corley C, Green K, Ashley R, et al. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss. Blood. 2023;142 (Suppl.1):6660-6661$69$YR$$M$Y$$$20240823$$HP$US$US
242430601$24243060$1$I$$20240822$20240823$20240823$EXP$$US-GILEAD-2024-0685119$GILEAD$$$$E$M$Y$$$20240823$$MD$US$US
242430611$24243061$1$I$$20240819$20240823$20240823$EXP$$NVSC2024CA168328$NOVARTIS$$67$YR$$M$Y$94$KG$20240823$$PH$CA$CA
242430621$24243062$1$I$$20240823$20240823$20240823$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047472$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240823$$HP$GB$GB
242430631$24243063$1$I$20240403$20240813$20240823$20240823$PER$$PL-Blueprint Medicines Corporation-SP-PL-2024-001643$BLUEPRINT MEDICINES$$67$YR$E$M$Y$$$20240823$$MD$PL$PL
242430641$24243064$1$I$$20240808$20240823$20240823$PER$$US-SERVIER-S24010174$SERVIER$$$$$$Y$$$20240823$$PH$US$US
242430652$24243065$2$F$20240101$20240815$20240823$20240825$EXP$$US-TEVA-VS-3234693$TEVA$$37$YR$$F$Y$$$20240825$$HP$US$US
242430661$24243066$1$I$$20240821$20240823$20240823$EXP$$CN-VANTIVE-2024VAN019234$Vantive US Healthcare$$$$$F$Y$$$20240823$$CN$CN$CN
242430671$24243067$1$I$$20240820$20240823$20240823$EXP$$CN-VANTIVE-2024VAN019195$Vantive US Healthcare$$$$$M$Y$$$20240823$$CN$CN$CN
242430681$24243068$1$I$$20240814$20240823$20240823$EXP$$DE-VANTIVE-2024VAN019067$Vantive US Healthcare$$$$$F$Y$$$20240823$$CN$DE$DE
242430691$24243069$1$I$20240816$20240819$20240823$20240823$EXP$$CA-VANTIVE-2024VAN019178$Vantive US Healthcare$$$$$F$Y$$$20240823$$HP$CA$CA
242430701$24243070$1$I$20240818$20240820$20240823$20240823$EXP$$GB-VANTIVE-2024VAN019230$Vantive US Healthcare$$80$YR$$M$Y$$$20240823$$HP$GB$GB
242430711$24243071$1$I$20240814$20240816$20240823$20240823$EXP$$US-VANTIVE-2024VAN019121$Vantive US Healthcare$$80$YR$$M$Y$$$20240823$$HP$US$US
242430722$24243072$2$F$20240701$20240909$20240823$20240909$PER$$US-ALXN-202408USA001098US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240909$$PH$US$US
242430742$24243074$2$F$$20240911$20240823$20240920$EXP$$US-TEVA-VS-3234026$TEVA$Ables C, Jaramillo C, Wood EL, Stern S, Alashari M, Book L, et al. Subacute liver injury in two young infants following gene replacement therapy for spinal muscular atrophy. Mol-Ther-Methods-Clin-Dev 2024; 32 (3): 1-8.; Ables C, Jaramillo C, Wood EL, Stern S, Alashari M, Book L, et al. Subacute liver injury in two young infants following gene replacement therapy for spinal muscular atrophy. Mol-Ther-Methods-Clin-Dev 2024; 32 (3): 1-8.; Ables C, Jaramillo C, Wood EL, Stern S, Alashari M, Book ...$$$I$F$Y$$$20240920$$HP$US$US
242430751$24243075$1$I$$20240814$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008537$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242430761$24243076$1$I$20240818$20240820$20240823$20240823$EXP$$US-AstraZeneca-2024A189802$ASTRAZENECA$$31592$DY$$F$Y$$$20240823$$CN$US$
242430771$24243077$1$I$$20221212$20240823$20240823$EXP$$AR-AstraZeneca-2022A410362$ASTRAZENECA$$69$YR$$M$Y$$$20240823$$CN$AR$
242430781$24243078$1$I$$20240820$20240823$20240823$EXP$$US-AstraZeneca-2024A189855$ASTRAZENECA$$$$$M$Y$$$20240823$$MD$US$
242430791$24243079$1$I$20220420$20220429$20240823$20240823$EXP$$US-AstraZeneca-2022A170490$ASTRAZENECA$$26152$DY$$F$Y$$$20240823$$CN$US$
242430801$24243080$1$I$$20230523$20240823$20240823$EXP$$US-AstraZeneca-2023A121785$ASTRAZENECA$$$$$$Y$$$20240823$$CN$US$
242430812$24243081$2$F$20240101$20240816$20240823$20240827$EXP$$CN-009507513-2408CHN006717$MERCK$$36$YR$$F$Y$57$KG$20240827$$HP$CN$CN
242430821$24243082$1$I$20240819$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A188887$ASTRAZENECA$$30119$DY$$F$Y$$$20240823$$CN$US$
242430831$24243083$1$I$20220629$20220630$20240823$20240823$EXP$$US-AstraZeneca-2022A240902$ASTRAZENECA$$712$MON$$F$Y$$$20240823$$CN$US$
242430841$24243084$1$I$20240426$20240822$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134078$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240823$$CN$US$US
242430851$24243085$1$I$$20220413$20240823$20240823$EXP$$US-AstraZeneca-2022A151977$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242430861$24243086$1$I$$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A188661$ASTRAZENECA$$$$$$Y$$$20240823$$CN$US$
242430871$24243087$1$I$$20240816$20240823$20240823$EXP$$US-AstraZeneca-2024A188151$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242430881$24243088$1$I$20240229$20240820$20240823$20240823$EXP$$US-AstraZeneca-2024A189946$ASTRAZENECA$$21481$DY$$$Y$$$20240823$$HP$US$
242430891$24243089$1$I$20240813$20240817$20240823$20240823$EXP$$CN-AstraZeneca-2024A188779$ASTRAZENECA$$74$YR$$F$Y$48$KG$20240823$$MD$CN$
242430901$24243090$1$I$20240718$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A188705$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242430911$24243091$1$I$20240816$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165629$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242430921$24243092$1$I$20240628$20240822$20240823$20240823$EXP$FR-AFSSAPS-NT2024001058$NVSC2024FR170096$NOVARTIS$$44$YR$$M$Y$85$KG$20240823$$MD$FR$FR
242430931$24243093$1$I$$20211203$20240823$20240823$EXP$$US-AstraZeneca-2021A788710$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242430941$24243094$1$I$$20240820$20240823$20240823$EXP$$US-AstraZeneca-2024A189708$ASTRAZENECA$$$$$M$Y$$$20240823$$HP$US$
242430952$24243095$2$F$$20240903$20240823$20240910$EXP$$IL-AstraZeneca-2024A188734$ASTRAZENECA$$67$YR$$F$Y$$$20240910$$MD$IL$
242430961$24243096$1$I$$20240807$20240823$20240823$PER$$US-AstraZeneca-2024A009683$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242430971$24243097$1$I$$20240808$20240823$20240823$PER$$US-AstraZeneca-2024A182822$ASTRAZENECA$$$$$$Y$$$20240823$$CN$US$
242430981$24243098$1$I$$20240815$20240823$20240823$EXP$$US-AstraZeneca-2024A186803$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242430991$24243099$1$I$$20240820$20240823$20240823$EXP$$US-AstraZeneca-2024A189616$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242431001$24243100$1$I$20240603$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A189401$ASTRAZENECA$$$$$M$Y$$$20240823$$HP$US$
242431011$24243101$1$I$$20240816$20240823$20240823$EXP$$US-AstraZeneca-2024A188138$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242431021$24243102$1$I$$20240815$20240823$20240823$EXP$$US-AstraZeneca-2024A186647$ASTRAZENECA$$$$C$F$Y$27.2$KG$20240823$$CN$US$
242431031$24243103$1$I$$20240813$20240823$20240823$PER$$US-AstraZeneca-2024A185076$ASTRAZENECA$$$$A$F$Y$65.8$KG$20240823$$MD$US$
242431041$24243104$1$I$$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A188623$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242431051$24243105$1$I$20240814$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A188593$ASTRAZENECA$$21822$DY$$F$Y$$$20240823$$HP$US$
242431061$24243106$1$I$20210428$20240819$20240823$20240823$EXP$$IN-AstraZeneca-2024A190879$ASTRAZENECA$$25767$DY$$F$Y$106.6$KG$20240823$$CN$IN$
242431071$24243107$1$I$$20240819$20240823$20240823$EXP$$ZA-AstraZeneca-2024A188899$ASTRAZENECA$$35$YR$$F$Y$$$20240823$$CN$ZA$
242431081$24243108$1$I$20240814$20240820$20240823$20240823$EXP$$US-AstraZeneca-2024A189698$ASTRAZENECA$$34232$DY$$F$Y$$$20240823$$CN$US$
242431091$24243109$1$I$20240701$20240816$20240823$20240823$EXP$$US-AstraZeneca-2024A190474$ASTRAZENECA$$619$MON$$F$Y$$$20240823$$CN$US$
242431101$24243110$1$I$$20240815$20240823$20240823$EXP$$US-AstraZeneca-2024A186911$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242431111$24243111$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013315$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240823$$CN$US$US
242431121$24243112$1$I$$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A188901$ASTRAZENECA$$$$$$Y$$$20240823$$HP$US$
242431131$24243113$1$I$20240821$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013833$ELI LILLY AND CO$$29$YR$A$M$Y$$$20240823$$CN$US$US
242431141$24243114$1$I$20240818$20240819$20240823$20240823$EXP$$CA-AstraZeneca-2024A189316$ASTRAZENECA$$24617$DY$$F$Y$$$20240823$$CN$CA$
242431151$24243115$1$I$$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A188809$ASTRAZENECA$$$$$$Y$$$20240823$$CN$US$
242431171$24243117$1$I$$20240812$20240823$20240823$DIR$FDA-CDER-CTU-2024-58171$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242431181$24243118$1$I$20240706$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A189853$ASTRAZENECA$$28832$DY$$M$Y$$$20240823$$CN$US$
242431191$24243119$1$I$$20240809$20240823$20240823$PER$$US-AstraZeneca-2024A182803$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242431201$24243120$1$I$20240621$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A188714$ASTRAZENECA$$26781$DY$$$Y$$$20240823$$MD$US$
242431211$24243121$1$I$$20240815$20240823$20240823$EXP$$JP-AstraZeneca-2024A187940$ASTRAZENECA$$74$YR$$M$Y$$$20240823$$MD$JP$
242431221$24243122$1$I$20240213$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A189574$ASTRAZENECA$$$$$$Y$$$20240823$$CN$US$
242431231$24243123$1$I$$20240813$20240823$20240823$PER$$US-AstraZeneca-2024A185285$ASTRAZENECA$$$$$$Y$$$20240823$$PH$US$
242431241$24243124$1$I$$20240815$20240823$20240823$EXP$$CA-AstraZeneca-2024A186728$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$CA$
242431251$24243125$1$I$20231107$20240815$20240823$20240823$EXP$$FR-AstraZeneca-2023A296153$ASTRAZENECA$$52$YR$$F$Y$$$20240823$$MD$FR$
242431261$24243126$1$I$20240819$20240820$20240823$20240823$EXP$$US-AstraZeneca-2024A189686$ASTRAZENECA$$30429$DY$$M$Y$$$20240823$$HP$US$
242431271$24243127$1$I$20240804$20240819$20240823$20240823$EXP$$CN-ROCHE-10000064388$ROCHE$$75$YR$E$F$Y$$$20240823$$HP$CN$CN
242431281$24243128$1$I$$20240820$20240823$20240823$EXP$$ZA-AstraZeneca-2024A190965$ASTRAZENECA$$91$YR$$F$Y$$$20240823$$CN$ZA$
242431291$24243129$1$I$$20240820$20240823$20240823$EXP$$US-AstraZeneca-2024A189639$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242431301$24243130$1$I$$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A188691$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242431311$24243131$1$I$$20240812$20240823$20240823$PER$$US-AstraZeneca-2024A186676$ASTRAZENECA$$$$$$Y$$$20240823$$MD$US$
242431321$24243132$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012997$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240823$$CN$US$US
242431332$24243133$2$F$$20240815$20240823$20240910$EXP$$CA-AstraZeneca-2024A188935$ASTRAZENECA$$70$YR$$F$Y$$$20240910$$MD$CA$
242431341$24243134$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013781$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242431351$24243135$1$I$20240805$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012013$ELI LILLY AND CO$$54$YR$A$$Y$$$20240823$$CN$US$US
242431361$24243136$1$I$20240801$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013673$ELI LILLY AND CO$$31$YR$A$F$Y$139.23$KG$20240823$$CN$US$US
242431371$24243137$1$I$20240701$20240815$20240823$20240823$EXP$$JP-AstraZeneca-2024A177526$ASTRAZENECA$$79$YR$$M$Y$$$20240823$$MD$JP$
242431381$24243138$1$I$$20240816$20240823$20240823$EXP$$ZA-AstraZeneca-2024A187795$ASTRAZENECA$$73$YR$$M$Y$$$20240823$$CN$ZA$
242431391$24243139$1$I$$20240819$20240823$20240823$EXP$$US-AstraZeneca-2024A189761$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242431402$24243140$2$F$20240521$20240820$20240823$20240829$EXP$$US-KYOWAKIRIN-2024KK019695$KYOWA$$$$$$Y$$$20240829$$HP$US$US
242431411$24243141$1$I$20240729$20240729$20240823$20240823$PER$$US-CSL-2024-007203$CSL Plasma$$33$YR$$M$Y$$$20240823$$HP$US$US
242431421$24243142$1$I$20240812$20240814$20240823$20240823$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101696$VIIV$$32$YR$$M$Y$$$20240823$$CN$US$US
242431431$24243143$1$I$$20240819$20240823$20240823$EXP$$US-ABBVIE-5890771$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242431441$24243144$1$I$$20240808$20240823$20240823$PER$$US-GLANDPHARMA-US-2024GLNSPO00663$GLAND PHARMA$$29$YR$A$M$Y$$$20240823$$CN$US$US
242431451$24243145$1$I$20240628$20240820$20240823$20240823$EXP$$CO-UCBSA-2024042797$UCB$$68$YR$$M$Y$$$20240823$$CN$CO$CO
242431461$24243146$1$I$$20240821$20240823$20240823$EXP$$NVSC2024US169893$NOVARTIS$$24$YR$$F$Y$$$20240823$$MD$US$US
242431471$24243147$1$I$20240815$20240821$20240823$20240823$EXP$$CN-BAYER-2024A120918$BAYER$$35$YR$A$F$Y$56$KG$20240823$$HP$CN$CN
242431481$24243148$1$I$20220101$20240808$20240823$20240823$EXP$$SG-ROCHE-10000064507$ROCHE$$$$$F$Y$$$20240823$$CN$SG$SG
242431491$24243149$1$I$20240701$20240814$20240823$20240823$PER$$US-MYLANLABS-2024M1076093$MYLAN$$63$YR$$F$Y$$$20240823$$CN$US$US
242431501$24243150$1$I$$20240808$20240823$20240823$PER$$US-GLANDPHARMA-US-2024GLNSPO00655$GLAND PHARMA$$$$$$Y$$$20240823$$CN$US$US
242431511$24243151$1$I$20240101$20240809$20240823$20240823$EXP$$US-UCBSA-2024041017$UCB$$$$$F$Y$$$20240823$$HP$US$US
242431521$24243152$1$I$20240101$20240816$20240823$20240823$EXP$$CN-FreseniusKabi-FK202412646$FRESENIUS KABI$$73$YR$E$F$Y$50$KG$20240823$$HP$CN$CN
242431531$24243153$1$I$20240801$20240814$20240823$20240823$PER$$US-ABBVIE-5881827$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242431541$24243154$1$I$$20240819$20240823$20240823$EXP$$US-VERTEX PHARMACEUTICALS-2024-013378$VERTEX$$$$$$Y$$$20240823$$HP$US$US
242431551$24243155$1$I$$20240814$20240823$20240823$PER$$US-VERTEX PHARMACEUTICALS-2024-013311$VERTEX$$3$MON$$F$Y$$$20240823$$MD$US$US
242431561$24243156$1$I$20240101$20240821$20240823$20240823$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013499$VERTEX$$$$C$F$Y$$$20240823$$CN$GB$GB
242431581$24243158$1$I$$20240819$20240823$20240823$PER$$US-VERTEX PHARMACEUTICALS-2024-013423$VERTEX$$$$$$Y$$$20240823$$CN$US$US
242431591$24243159$1$I$20240807$20240815$20240823$20240823$PER$$US-BEH-2024177465$CSL BEHRING$$49$YR$A$F$Y$$$20240823$$HP$US$US
242431601$24243160$1$I$$20240821$20240823$20240823$PER$$US-BAYER-2024A120557$BAYER$$39$YR$A$F$Y$$$20240823$$MD$US$US
242431611$24243161$1$I$20240101$20240730$20240823$20240823$PER$$US-Eisai-EC-2024-171251$EISAI$$$$$F$Y$$$20240823$$CN$US$US
242431641$24243164$1$I$20240101$20240805$20240823$20240823$PER$$US-Eisai-EC-2024-171559$EISAI$$76$YR$E$F$Y$$$20240823$$PH$US$US
242431661$24243166$1$I$20240716$20240820$20240823$20240823$EXP$FR-AFSSAPS-GR2024001011$FR-MYLANLABS-2024M1077132$MYLAN$$27$YR$$F$Y$$$20240823$$PH$FR$FR
242431672$24243167$2$F$$20240919$20240823$20240924$EXP$$AU-CHEPLA-2024010743$CHEPLAPHARM$$$$E$F$Y$$$20240924$$CN$COUNTRY NOT SPECIFIED$AU
242431691$24243169$1$I$$20240814$20240823$20240823$EXP$$CA-AMGEN-CANSP2024167861$AMGEN$$$$$$Y$$$20240823$$PH$CA$CA
242431701$24243170$1$I$$20240812$20240823$20240823$EXP$$US-AMGEN-USASP2024161678$AMGEN$Miller A.C.; Temiz L.A.; Adjei S. et al.. Treatment of Bullous Pemphigoid With Dupilumab: A Case Series of 30 Patients. Alimentary Pharmacology + Therapeutics. 2024;23 (6):e144-e148$77$YR$E$M$Y$$$20240823$$MD$US$US
242431711$24243171$1$I$$20240816$20240823$20240823$EXP$$CA-HALEON-2193163$Haleon PLC$$60$YR$$F$Y$$$20240823$$HP$CA$CA
242431721$24243172$1$I$$20240808$20240823$20240823$PER$$US-GLANDPHARMA-US-2024GLNSPO00658$GLAND PHARMA$$$$$M$Y$$$20240823$$CN$US$US
242431731$24243173$1$I$20240711$20240711$20240823$20240823$PER$$US-LUNDBECK-DKLU4001681$LUNDBECK$$$$$$Y$$$20240823$$HP$US$US
242431741$24243174$1$I$$20240812$20240823$20240823$PER$$US-MYLANLABS-2024M1069918$MYLAN$$$$$F$Y$$$20240823$$CN$US$US
242431751$24243175$1$I$20240808$20240814$20240823$20240823$PER$$US-MYLANLABS-2024M1076344$MYLAN$$58$YR$$F$Y$$$20240823$$CN$US$US
242431771$24243177$1$I$$20240814$20240823$20240823$EXP$$US-Merz Pharmaceuticals GmbH-2024080000129$MERZ$$8$DEC$$M$Y$$$20240823$$HP$US$US
242431782$24243178$2$F$20240605$20240906$20240823$20240920$EXP$$US-UCBSA-2024036821$UCB$$25$YR$$F$Y$61$KG$20240920$$CN$US$US
242431793$24243179$3$F$20240725$20240828$20240823$20240905$EXP$$DE-KYOWAKIRIN-2024KK019738$KYOWA$$$$$$Y$$$20240905$$HP$DE$DE
242431801$24243180$1$I$20240101$20240731$20240823$20240823$PER$$US-009507513-2408USA000098$MERCK$$$$$F$Y$74.8$KG$20240823$$HP$US$US
242431861$24243186$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA168873$NOVARTIS$$27$YR$$F$Y$$$20240823$$HP$CA$CA
242431871$24243187$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA169043$NOVARTIS$$$$$M$Y$$$20240823$$HP$CA$CA
242431891$24243189$1$I$$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024163676$AMGEN$Assal A.; George D.; Bhatia M. et.al.. Curative Allogeneic Stem Cell Transplantation Is Safe and Feasible in Adult Patients with Sickle Cell Disease Despite Lack of Matched Sibling Donor and Presence of Sickle Cell-Related Co-Morbidities. Blood. 2018;132 (SUPPL_1):5713$$$A$$Y$$$20240823$$MD$US$US
242431901$24243190$1$I$$20240814$20240823$20240823$EXP$$US-AMGEN-USASP2024164134$AMGEN$Rodriguez-rosa R E.; Ayala rodriguez S.C.; Marquez E.R. et.al. Cerebral vasculitis presenting as acute posterior multifocal placold pigment epitheliopathy in a 16-year-old  male. American Journal of Ophthalmology Case Reports. 2024;36:1-5$16$YR$T$M$Y$$$20240823$$HP$US$US
242431911$24243191$1$I$$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134066$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240823$$CN$US$US
242431921$24243192$1$I$$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024163308$AMGEN$Butterfield J.H.. Successful Long-Term Control of the Syndrome of Episodic Angioedema With Eosinophilia (Gleich Syndrome) With Low-Dose Imatinib Mesylate and Prednisone. Journal of Investigative Medicine High Impact Case Reports. 2021;9:1-5$40$YR$A$M$Y$$$20240823$$MD$US$US
242431931$24243193$1$I$$20240801$20240823$20240823$PER$$US-BEH-2024177418$CSL BEHRING$$$$$F$Y$$$20240823$$CN$US$US
242431941$24243194$1$I$20240713$20240814$20240823$20240823$EXP$FR-AFSSAPS-PC2024000651$FR-TEVA-VS-3233811$TEVA$$62$YR$$F$Y$$$20240823$$PH$FR$FR
242431951$24243195$1$I$$20240820$20240823$20240823$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004680$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240823$$MD$US$US
242431961$24243196$1$I$$20240821$20240823$20240823$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004687$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240823$$CN$US$US
242431971$24243197$1$I$$20240819$20240823$20240823$EXP$$US-TAKEDA-2024TUS078719$TAKEDA$$$$$M$Y$$$20240823$$CN$US$US
242431981$24243198$1$I$$20240822$20240823$20240823$EXP$$AU-UCBSA-2024042528$UCB$$41$YR$$F$Y$$$20240823$$HP$AU$AU
242431991$24243199$1$I$20210801$20240815$20240823$20240823$EXP$$CO-TAKEDA-2021TUS041220$TAKEDA$$37$YR$$M$Y$98$KG$20240823$$CN$CO$CO
242432001$24243200$1$I$$20240809$20240823$20240823$EXP$$DE-QUAGEN-2024QUALIT00245$QUAGEN PHARMACEUTICALS$Maria Hoeltzenbein.Increasing use of newer antiseizure medication during pregnancy:  An observational study with special focus on lacosamide .Seizure: European Journal of Epilepsy.2023;107:107-113$$$N$$Y$$$20240823$$HP$DE$DE
242432011$24243201$1$I$$20240816$20240823$20240823$EXP$$TH-AMGEN-THASP2024164937$AMGEN$$$$$$Y$$$20240823$$MD$TH$TH
242432021$24243202$1$I$20240819$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166285$AMGEN$$$$$M$Y$$$20240823$$CN$US$US
242432031$24243203$1$I$$20240821$20240823$20240823$PER$$US-BAYER-2024A121219$BAYER$$40$YR$A$F$Y$$$20240823$$MD$US$US
242432041$24243204$1$I$20240605$20240809$20240823$20240823$EXP$$US-UCBSA-2024029507$UCB$$55$YR$$F$Y$$$20240823$$CN$US$US
242432051$24243205$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132524$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240823$$HP$US$US
242432062$24243206$2$F$20240812$20240829$20240823$20240909$PER$$US-ABBVIE-5881678$ABBVIE$$55$YR$$M$Y$98$KG$20240909$$CN$US$US
242432071$24243207$1$I$$20240816$20240823$20240823$EXP$$US-AMGEN-USASP2024164315$AMGEN$Sobel R K.; Timtim E..; Barahimi B. et. al. Sebaceous carcinoma masquerading as ocular mucous membrane pemphigoid. Orbit. 2024;43 (4):531-534$95$YR$E$F$Y$$$20240823$$HP$US$US
242432081$24243208$1$I$$20240815$20240823$20240823$EXP$$US-AMGEN-USASP2024164604$AMGEN$Sattui S. E..; Buttgereit F.; Lidar M. et. al.. PRSEVALENCE AND MANAGEMENT OF PATIENTS WITH COMORBIDITIES AND FRAILTY IN NEW ONSET POLYMYALGIA RHEUMATICA. Annals of the Rheumatic Diseases. 2024;83 (SUPPLI_1):1187-1188$$$$$Y$$$20240823$$HP$US$US
242432101$24243210$1$I$20240820$20240822$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133919$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$65.32$KG$20240823$$HP$US$US
242432111$24243211$1$I$$20240815$20240823$20240823$EXP$$US-CHIESI-2024CHF05264$CHIESI$$37$YR$$M$Y$$$20240823$$CN$US$US
242432121$24243212$1$I$$20240821$20240823$20240823$PER$$NVSC2024US170101$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
242432131$24243213$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58145$$FDA-CTU$$69$YR$$F$N$47.63$KG$20240823$N$$US$
242432141$24243214$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58154$$FDA-CTU$$25$YR$$F$N$$$20240823$N$$US$
242432151$24243215$1$I$20240801$20240819$20240823$20240823$EXP$$US-AMGEN-USASP2024166627$AMGEN$$68$YR$E$F$Y$$$20240823$$CN$US$US
242432161$24243216$1$I$20240524$20240822$20240823$20240823$EXP$FR-AFSSAPS-BS2024000551$NVSC2024FR170233$NOVARTIS$$76$YR$$F$Y$40$KG$20240823$$MD$FR$FR
242432171$24243217$1$I$20240820$20240821$20240823$20240823$PER$$US-BAYER-2024A121743$BAYER$$31$YR$A$F$Y$$$20240823$$MD$US$US
242432181$24243218$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408007618$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240823$$CN$US$US
242432191$24243219$1$I$$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014435$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240823$$CN$US$US
242432201$24243220$1$I$20240821$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013464$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240823$$CN$US$US
242432211$24243221$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014403$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240823$$CN$US$US
242432221$24243222$1$I$20240801$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58161$$FDA-CTU$$38$YR$$M$N$$$20240823$N$PH$US$
242432231$24243223$1$I$$20240814$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012202$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242432241$24243224$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014349$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240823$$CN$US$US
242432251$24243225$1$I$20240225$20240820$20240823$20240823$EXP$$AT-GILEAD-2024-0669205$GILEAD$$55$YR$A$M$Y$$$20240823$$MD$AT$AT
242432261$24243226$1$I$$20240809$20240823$20240823$EXP$$DE-QUAGEN-2024QUALIT00246$QUAGEN PHARMACEUTICALS$Maria Hoeltzenbein.Increasing use of newer antiseizure medication during pregnancy:  An observational study with special focus on lacosamide .Seizure: European Journal of Epilepsy.2023;107:107-113$4$DY$N$$Y$$$20240823$$HP$DE$DE
242432271$24243227$1$I$$20240722$20240823$20240823$PER$$US-TEVA-VS-3224924$TEVA$$69$YR$$F$Y$$$20240823$$CN$US$US
242432281$24243228$1$I$$20240822$20240823$20240823$PER$$US-ROCHE-10000064414$ROCHE$$$$A$F$Y$$$20240823$$CN$US$US
242432291$24243229$1$I$$20240821$20240823$20240823$PER$$US-BAYER-2024A121434$BAYER$$$$$F$Y$$$20240823$$CN$US$US
242432301$24243230$1$I$20240814$20240820$20240823$20240823$PER$$US-BAYER-2024A120805$BAYER$$30$YR$A$F$Y$$$20240823$$MD$US$US
242432312$24243231$2$F$20240729$20240918$20240823$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025896$UNITED THERAPEUTICS$$50$YR$$M$Y$$$20240926$$$US$US
242432321$24243232$1$I$$20240819$20240823$20240823$EXP$$NVSC2024CA168208$NOVARTIS$$41$YR$$F$Y$$$20240823$$CN$CA$CA
242432331$24243233$1$I$$20240817$20240823$20240823$PER$$US-TAKEDA-2024TUS083083$TAKEDA$$$$$$Y$$$20240823$$MD$US$US
242432341$24243234$1$I$20240729$20240819$20240823$20240823$PER$$US-BAYER-2024A119370$BAYER$$23$YR$A$F$Y$$$20240823$$MD$US$US
242432351$24243235$1$I$20230623$20240816$20240823$20240823$EXP$$CO-AMGEN-COLSL2023111317$AMGEN$$66$YR$E$F$Y$$$20240823$$CN$CO$CO
242432361$24243236$1$I$20240720$20240809$20240823$20240823$EXP$CH-SM-2024-15015$CH-UCBSA-2024040722$UCB$$57$YR$$M$Y$85$KG$20240823$$MD$CH$CH
242432371$24243237$1$I$20240521$20240819$20240823$20240823$EXP$$CA-TAKEDA-2024TUS048121$TAKEDA$$76$YR$$M$Y$$$20240823$$CN$CA$CA
242432383$24243238$3$F$20231101$20240822$20240823$20240916$EXP$$US-ROCHE-10000064304$ROCHE$$34$YR$A$M$Y$$$20240916$$CN$US$US
242432391$24243239$1$I$20211230$20220210$20240823$20240823$EXP$$IE-BIOVITRUM-2022IE00508$BIOVITRUM$$131$DY$$M$Y$$$20240823$$HP$IE$IE
242432401$24243240$1$I$$20240809$20240823$20240823$EXP$$DE-QUAGEN-2024QUALIT00244$QUAGEN PHARMACEUTICALS$Maria Hoeltzenbein.Increasing use of newer antiseizure medication during pregnancy:  An observational study with special focus on lacosamide.Seizure: European Journal of Epilepsy.20-FEB-2023;107:107-113$$$N$$Y$$$20240823$$HP$DE$DE
242432411$24243241$1$I$$20240821$20240823$20240823$EXP$CA-Accord-263247$CA-SANDOZ INC.-NVSC2022CA277925$SANDOZ$$53$YR$$F$Y$$$20240823$$MD$CA$CA
242432421$24243242$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58182$$FDA-CTU$$53$YR$$M$N$124.74$KG$20240823$N$$US$
242432431$24243243$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58135$$FDA-CTU$$61$YR$$M$N$$$20240823$N$$US$
242432451$24243245$1$I$$20240821$20240823$20240823$EXP$$US-GILEAD-2024-0685001$GILEAD$$$$A$M$Y$$$20240823$$CN$US$US
242432461$24243246$1$I$20240730$20240807$20240823$20240823$DIR$FDA-CDER-CTU-2024-58186$$FDA-CTU$$19$DY$$F$N$$$20240807$N$HP$US$
242432471$24243247$1$I$$20240822$20240823$20240823$PER$$US-ROCHE-10000064680$ROCHE$$$$A$F$Y$99.79$KG$20240823$$CN$US$US
242432481$24243248$1$I$20240820$20240821$20240823$20240823$PER$$US-GRUNENTHAL-2024-124353$AVERITAS$$84$YR$$F$Y$70.748$KG$20240823$$CN$US$US
242432491$24243249$1$I$20240820$20240823$20240823$20240823$DIR$715590$$FDA-CTU$$78$YR$$F$N$63.45$KG$20240823$N$CN$US$
242432501$24243250$1$I$$20240812$20240823$20240823$DIR$FDA-CDER-CTU-2024-58163$$FDA-CTU$$$$$M$N$$$20240812$N$HP$US$
242432511$24243251$1$I$$20240819$20240823$20240823$PER$$US-BAYER-2024A119628$BAYER$$42$YR$A$F$Y$$$20240823$$CN$US$US
242432521$24243252$1$I$20240820$20240823$20240823$20240823$DIR$715594$$FDA-CTU$$40$YR$$F$N$95.4$KG$20240823$N$CN$US$
242432531$24243253$1$I$20240822$20240823$20240823$20240823$DIR$715595$$FDA-CTU$$36$YR$$F$N$73.8$KG$20240823$N$CN$US$
242432541$24243254$1$I$20240819$20240821$20240823$20240823$DIR$FDA-CDER-CTU-2024-58187$$FDA-CTU$$17$YR$$F$N$$$20240821$N$$US$
242432551$24243255$1$I$$20240822$20240823$20240823$EXP$$US-ROCHE-10000064620$ROCHE$$63$YR$A$M$Y$$$20240823$$MD$US$US
242432562$24243256$2$F$$20240826$20240823$20240827$EXP$$JP-ABBVIE-5889662$ABBVIE$Oiwa E, Tsumita K, Kobayashi Y, et al. A case of treatment-related lymphoblastic leukaemia that developed after transformation from myelodysplastic syndrome to acute myeloid leukaemia. Journal of the Japanese Society for Laboratory Hematology/The 25th Annual Meeting of the Japanese Society for Laboratory Hematology. 2024;25:S170.; Oiwa E, Tsumita K, Kobayashi Y, et al. A case of treatment-related lymphoblastic leukaemia that developed after transformation from myelodysplastic syndrome to acut...$69$YR$$F$Y$$$20240827$$MD$JP$JP
242432601$24243260$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58159$$FDA-CTU$$43$YR$$F$N$$$20240823$N$$US$
242432621$24243262$1$I$20240818$20240819$20240823$20240823$PER$$US-BAYER-2024A119647$BAYER$$82$YR$E$F$Y$$$20240823$$CN$US$US
242432631$24243263$1$I$$20240815$20240823$20240823$EXP$$US-GSK-US2024AMR103485$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242432651$24243265$1$I$$20240815$20240823$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012791$JAZZ$$$$$F$Y$$$20240823$$CN$US$US
242432661$24243266$1$I$$20240822$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133751$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240823$$CN$US$US
242432671$24243267$1$I$20240701$20240813$20240823$20240823$EXP$FR-AFSSAPS-CN2024000747$FR-TEVA-VS-3233562$TEVA$$78$YR$$F$Y$$$20240823$$PH$FR$FR
242432681$24243268$1$I$20240722$20240822$20240823$20240823$EXP$$AR-BAYER-2024A121414$BAYER$$51$YR$A$F$Y$$$20240823$$CN$AR$AR
242432691$24243269$1$I$$20240808$20240823$20240823$EXP$$US-Nuvo Pharmaceuticals Inc-2160797$NUVO PHARMACEUTICALS$Source document (Abstract).$43$YR$$F$Y$$$20240823$$$US$US
242432702$24243270$2$F$20240101$20240813$20240823$20240830$EXP$$CA-ABBVIE-5881232$ABBVIE$$44$YR$$F$Y$$$20240830$$CN$CA$CA
242432711$24243271$1$I$$20240812$20240823$20240823$EXP$$CN-B.Braun Medical Inc.-2160793$B BRAUN$$89$YR$$M$Y$$$20240823$$$CN$CN
242432721$24243272$1$I$$20240809$20240823$20240823$EXP$$US-SERB S.A.S.-2160792$LABORATOIRES SERB$Description of a Hydroxocobalamin case$63$YR$$F$Y$$$20240823$$MD$US$US
242432731$24243273$1$I$$20240816$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130354$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240823$$HP$US$US
242432742$24243274$2$F$20230601$20240919$20240823$20240926$EXP$$US-ABBVIE-5885522$ABBVIE$$65$YR$$F$Y$95.25$KG$20240926$$CN$US$US
242432751$24243275$1$I$$20240809$20240823$20240823$EXP$$US-QUAGEN-2024QUALIT00243$QUAGEN PHARMACEUTICALS$Carranza Morales A.A Painful Case of Asthma.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$43$YR$A$F$Y$$$20240823$$HP$US$US
242432761$24243276$1$I$$20240823$20240823$20240823$EXP$$US-SERB S.A.S.-2160794$LABORATOIRES SERB$Description of a Glucarpidase case$41$YR$$M$Y$$$20240823$$MD$US$US
242432771$24243277$1$I$20240807$20240819$20240823$20240823$EXP$PT-INFARMED-T202408-183$PT-TAKEDA-2024TUS082941$TAKEDA$$3$YR$$M$Y$20$KG$20240823$$HP$PT$PT
242432781$24243278$1$I$$20240819$20240823$20240823$EXP$$ES-SANDOZ INC.-SDZ2024ES073498$SANDOZ$$60$YR$$M$Y$$$20240823$$MD$ES$ES
242432791$24243279$1$I$20240630$20240821$20240823$20240823$EXP$$NVSC2024US170437$NOVARTIS$$76$YR$$M$Y$$$20240823$$CN$US$US
242432802$24243280$2$F$$20240826$20240823$20240904$PER$$US-ROCHE-10000061758$ROCHE$Chowdhury R, Shah S, Milford E, Tullius S, Rennke H, Bianchi G. Extramedullary plasmacytoma exclusively localized in transplanted kidney: Post-transplant lymphoproliferative disorder or monoclonal gammopathy of renal significance?. Journal of Onco-Nephrology. 2024-Jun;8 (2):70-4. doi:10.1177/23993693241264079.$44$YR$A$F$Y$$$20240904$$HP$US$US
242432811$24243281$1$I$$20240819$20240823$20240823$PER$$US-BAYER-2024A119760$BAYER$$$$$$Y$$$20240823$$CN$US$US
242432821$24243282$1$I$$20240823$20240823$20240823$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047501$BOEHRINGER INGELHEIM$$$$$$Y$$$20240823$$CN$US$US
242432831$24243283$1$I$$20240821$20240823$20240823$EXP$$RO-MYLANLABS-2024M1077575$MYLAN$Luca I, Voda D, Mitrica M, Petrescu L.. A rare case of multiple thromboses in a pediatric patient with Mycoplasma pneumoniae infection. Ro J Pediatr. 2024;73(2):113-116$2$YR$$F$Y$12.5$KG$20240823$$HP$RO$RO
242432841$24243284$1$I$$20240820$20240823$20240823$EXP$$TR-MYLANLABS-2024M1078273$MYLAN$Yilmaz C, Guvendi Sengor B, Zehir R. Successful treatment of multidrug-resistant hypertension with catheter-based renal denervation in a patient with a renal artery stent. Hyp-Riesgo-Vascular 2023; 40 225-227.$65$YR$$F$Y$$$20240823$$HP$TR$TR
242432851$24243285$1$I$20240818$20240821$20240823$20240823$EXP$$GB-MYLANLABS-2024M1067041$MYLAN$$$$$F$Y$$$20240823$$MD$GB$GB
242432871$24243287$1$I$$20240821$20240823$20240823$EXP$$US-ABBVIE-5890067$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242432881$24243288$1$I$$20240817$20240823$20240823$PER$$US-BAYER-2024A118515$BAYER$$$$$$Y$$$20240823$$CN$US$US
242432891$24243289$1$I$$20240820$20240823$20240823$EXP$$CH-SANDOZ INC.-SDZ2024CH074325$SANDOZ$$33$YR$$M$Y$$$20240823$$MD$CH$CH
242432901$24243290$1$I$$20240812$20240823$20240823$PER$$US-PFM-2024-04597$PIERRE FABRE MEDICAMENT$Elias MD, Brothers JA, Hogarty AN, Martino J, Byrne ML, Patel C et al. Outcomes associated with giant coronary artery aneurysms after kawasaki disease: a single-center united states experience. The journal of pediatrics. 2024;274$1$YR$$M$Y$$$20240823$$HP$US$US
242432911$24243291$1$I$$20240809$20240823$20240823$EXP$$TR-QUAGEN-2024QUALIT00242$QUAGEN PHARMACEUTICALS$Fatma Erseven.Combined Treatment in Severe Valproic Acid Poisoning.Anestezi Dergisi.JAN-2023;31:249-251$27$YR$A$M$Y$$$20240823$$HP$TR$TR
242432922$24243292$2$F$$20240830$20240823$20240906$EXP$$AT-JAZZ PHARMACEUTICALS-2024-AT-012967$JAZZ$$$$$$Y$$$20240906$$MD$AT$AT
242432932$24243293$2$F$20240101$20240917$20240823$20240927$EXP$$US-RADIUS HEALTH, INC.-2024US005975$RADIUS PHARM$$$$$F$Y$$$20240927$$CN$US$US
242432941$24243294$1$I$$20240808$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008358$INCYTE$$$$$$Y$$$20240823$$MD$US$US
242432951$24243295$1$I$$20240822$20240823$20240823$PER$$NVSC2024US171059$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242432961$24243296$1$I$20230521$20240813$20240823$20240823$EXP$$CN-ADMA BIOLOGICS INC.-CN-2024ADM000107$ADMA BIOLOGICS$Weisen W, Chunhua F, Yanqun L, Yi T, Xiaoying B, Xiaojun H.. Multiple cerebral infarctions after intravenous immunoglobulin for Guillain-Barr? syndrome: two case reports and review of the literature. Frontiers in Immunology. 2024;15:1433240$75$YR$$M$Y$$$20240823$$HP$CN$CN
242432971$24243297$1$I$20230521$20240813$20240823$20240823$EXP$$CN-ADMA BIOLOGICS INC.-CN-2024ADM000106$ADMA BIOLOGICS$Weisen W, Chunhua F, Yanqun L, Yi T, Xiaoying B, Xiaojun H.. Multiple cerebral infarctions after intravenous immunoglobulin for Guillain-Barr syndrome: two case reports and review of the literature. Frontiers in Immunology. 2024;15:1433240$75$YR$$M$Y$$$20240823$$HP$CN$CN
242432981$24243298$1$I$$20240817$20240823$20240823$PER$$US-BAYER-2024A118522$BAYER$$$$$$Y$$$20240823$$CN$US$US
242432991$24243299$1$I$20240816$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165565$AMGEN$$71$YR$E$M$Y$$$20240823$$CN$US$US
242433001$24243300$1$I$20240801$20240816$20240823$20240823$PER$$US-ALXN-202408USA001107US$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240823$$MD$US$US
242433011$24243301$1$I$20240801$20240808$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008350$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242433021$24243302$1$I$$20240815$20240823$20240823$PER$$US-BAYER-2024A117933$BAYER$$48$YR$A$M$Y$$$20240823$$CN$US$US
242433041$24243304$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58175$$FDA-CTU$$79$YR$$F$N$$$20240823$N$$US$
242433051$24243305$1$I$20240806$20240812$20240823$20240823$DIR$FDA-CDER-CTU-2024-58137$$FDA-CTU$$42$YR$$F$N$$$20240812$N$HP$US$
242433081$24243308$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58025$$FDA-CTU$$$$$F$N$89$KG$20240823$N$$US$
242433101$24243310$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132719$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240823$$CN$US$US
242433112$24243311$2$F$20240812$20240826$20240823$20240829$EXP$$CA-ROCHE-10000064201$ROCHE$$75$YR$E$M$Y$$$20240829$$CN$CA$CA
242433121$24243312$1$I$20240810$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133467$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240823$$CN$US$US
242433131$24243313$1$I$$20240816$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130812$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240823$$CN$US$US
242433142$24243314$2$F$$20240828$20240823$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133960$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240829$$HP$US$US
242433152$24243315$2$F$$20240821$20240823$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129700$BRISTOL MYERS SQUIBB$Vangeison CT, Roys JP, Catalanotto MN, Kupperman WI, Kovacs AR, D?rzu DS, et al. Medication-induced mood disorders following epidural steroid injections in patients with pain: a case series. Clinical Case Reports. 2023 Jun 01;11(6):1-4. doi:10.1002/ccr3.7415.$32$YR$A$F$Y$$$20240828$$HP$US$US
242433161$24243316$1$I$$20240821$20240823$20240823$EXP$$GB-ROCHE-10000062652$ROCHE$$62$YR$A$$Y$$$20240823$$MD$GB$GB
242433181$24243318$1$I$$20240822$20240823$20240823$PER$$NVSC2024US171004$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
242433191$24243319$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170942$NOVARTIS$$$$$M$Y$102$KG$20240823$$CN$US$US
242433211$24243321$1$I$$20240816$20240823$20240823$PER$$US-BAYER-2024A118647$BAYER$$$$$$Y$$$20240823$$CN$US$US
242433221$24243322$1$I$20240809$20240815$20240823$20240823$PER$$US-BAYER-2024A118040$BAYER$$40$YR$A$F$Y$$$20240823$$MD$US$US
242433231$24243323$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164890$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240823$$MD$US$US
242433241$24243324$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164912$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240823$$MD$US$US
242433251$24243325$1$I$20240821$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167598$AMGEN$$72$YR$E$F$Y$$$20240823$$CN$US$US
242433261$24243326$1$I$$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167863$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242433271$24243327$1$I$20240731$20240809$20240823$20240823$EXP$$GB-ETHYPHARM-2024002178$ETHYPHARM$$$$$$Y$$$20240822$$MD$GB$GB
242433281$24243328$1$I$$20240808$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN007390$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242433291$24243329$1$I$$20240807$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008304$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242433301$24243330$1$I$$20240809$20240823$20240823$PER$$US-EPICPHARMA-US-2024EPCSPO01019$EPIC PHARM$$$$$F$Y$$$20240823$$CN$US$US
242433311$24243331$1$I$$20240821$20240823$20240823$30DAY$$US-SANDOZ INC.-SDZ2024US074568$SANDOZ$$$$$F$Y$$$20240823$$HP$US$US
242433321$24243332$1$I$$20240812$20240823$20240823$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408009404$ELI LILLY AND CO$$73$YR$E$F$Y$60$KG$20240823$$CN$CN$CN
242433351$24243335$1$I$$20240811$20240823$20240823$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408008875$ELI LILLY AND CO$Communie A, Valo I, Soulie P, Grimax X..Abemaciclib-induced lichen planus pigmentosus inversus improving after swithing to ribociclib.Anais Brasileiros de Dermatologia 2024;:1-3.DOI:https://dx.doi.org/10.1016/j.abd.2023.11.007$61$YR$A$F$Y$$$20240823$$MD$FR$FR
242433361$24243336$1$I$$20240813$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008286$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240823$$CN$US$US
242433371$24243337$1$I$20240801$20240813$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008663$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240823$$CN$US$US
242433381$24243338$1$I$$20240812$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008051$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240823$$CN$US$US
242433391$24243339$1$I$$20240812$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007810$ELI LILLY AND CO$$90$YR$E$F$Y$$$20240823$$PH$US$US
242433401$24243340$1$I$20230101$20240813$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008214$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240823$$CN$US$US
242433411$24243341$1$I$$20240812$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008427$ELI LILLY AND CO$$$$A$F$Y$$$20240823$$CN$US$US
242433422$24243342$2$F$$20240828$20240823$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408013244$ELI LILLY AND CO$$$$$F$Y$$$20240903$$CN$US$US
242433431$24243343$1$I$20240201$20240812$20240823$20240823$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408007824$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240823$$CN$DE$DE
242433441$24243344$1$I$$20240814$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010077$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240823$$CN$US$US
242433451$24243345$1$I$$20240812$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007498$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242433461$24243346$1$I$$20240812$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007698$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240823$$CN$US$US
242433471$24243347$1$I$$20240812$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007752$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240823$$CN$US$US
242433481$24243348$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013910$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240823$$CN$US$US
242433492$24243349$2$F$$20240909$20240823$20240923$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202408011992$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240923$$CN$ES$ES
242433501$24243350$1$I$$20240812$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008795$ELI LILLY AND CO$$$$$$Y$$$20240823$$CN$US$US
242433511$24243351$1$I$$20240812$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008633$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240823$$CN$US$US
242433522$24243352$2$F$$20240913$20240823$20240925$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012836$ELI LILLY AND CO$$58$YR$A$F$Y$63$KG$20240925$$CN$US$US
242433531$24243353$1$I$$20240814$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009358$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242433541$24243354$1$I$20240714$20240812$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009369$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240823$$CN$US$US
242433551$24243355$1$I$20170325$20240813$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008421$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240823$$CN$US$US
242433561$24243356$1$I$20240723$20240816$20240823$20240823$EXP$$US-Vifor (International) Inc.-VIT-2024-07434$VIFOR$$24$YR$$F$Y$48.9$KG$20240823$$HP$US$US
242433571$24243357$1$I$$20240819$20240823$20240823$EXP$$NL-MYLANLABS-2024M1078111$MYLAN$de Koning R, Zwart G, Dahan A, Jansen FW, Blikkendaal M, Twijnstra A. Esketamine in the treatment of chronic endometriosis-induced pain: a case report. J-Endometr-Pelvic-Pain-Disord 2023; 15 (1): 49-52.$$$$F$Y$$$20240823$$HP$NL$NL
242433581$24243358$1$I$20200801$20240729$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN007948$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242433591$24243359$1$I$$20240729$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN007947$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242433601$24243360$1$I$$20240724$20240823$20240823$EXP$$TN-JNJFOC-20230806121$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$HP$TN$TN
242433611$24243361$1$I$20240701$20240815$20240823$20240823$PER$$US-BAYER-2024A118366$BAYER$$37$YR$A$F$Y$$$20240823$$CN$US$US
242433621$24243362$1$I$20240731$20240820$20240823$20240823$EXP$$US-GSK-US2024103877$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$US$US
242433631$24243363$1$I$20240820$20240814$20240823$20240823$EXP$$CA-TAKEDA-2024TUS070370$TAKEDA$$43$YR$$M$Y$$$20240823$$CN$CA$CA
242433641$24243364$1$I$20240521$20240822$20240823$20240823$EXP$$NVSC2024CN170798$NOVARTIS$$68$YR$$M$Y$52$KG$20240823$$HP$CN$CN
242433651$24243365$1$I$$20240816$20240823$20240823$PER$$US-BAYER-2024A118503$BAYER$$46$YR$A$F$Y$$$20240823$$CN$US$US
242433661$24243366$1$I$$20240820$20240823$20240823$EXP$$GB-OTSUKA-2024_023089$OTSUKA$$$$$M$Y$$$20240823$$HP$GB$GB
242433671$24243367$1$I$$20240809$20240823$20240823$PER$$US-BAYER-2024A115419$BAYER$$$$$$Y$$$20240823$$CN$US$US
242433681$24243368$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164913$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240823$$MD$US$US
242433691$24243369$1$I$$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167869$AMGEN$$$$$$Y$$$20240823$$MD$US$US
242433702$24243370$2$F$$20240823$20240823$20240827$PER$$US-JNJFOC-20240859876$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$US$US
242433711$24243371$1$I$$20240815$20240823$20240823$PER$$US-MYLANLABS-2024M1077184$MYLAN$$$$$$Y$$$20240823$$CN$US$US
242433721$24243372$1$I$20130503$20240819$20240823$20240823$PER$$US-JNJFOC-20240852792$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240823$$HP$US$US
242433732$24243373$2$F$20240819$20240826$20240823$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133432$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240828$$CN$US$US
242433751$24243375$1$I$20240401$20240816$20240823$20240823$PER$$US-BAYER-2024A119444$BAYER$$35$YR$A$F$Y$$$20240823$$CN$US$US
242433761$24243376$1$I$20240807$20240814$20240823$20240823$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101345$VIIV$$$$$M$Y$$$20240823$$CN$US$US
242433771$24243377$1$I$$20240813$20240823$20240823$EXP$$DE-TEVA-VS-3233489$TEVA$$$$$F$Y$2.5$KG$20240823$$MD$DE$DE
242433781$24243378$1$I$$20240822$20240823$20240823$EXP$PT-MLMSERVICE-20240626-PI112609-00057-1$PT-SANDOZ INC.-SDZ2024PT074648$SANDOZ$$8$DEC$$M$Y$$$20240823$$MD$PT$PT
242433821$24243382$1$I$$20240819$20240823$20240823$EXP$$MX-BAYER-2024A120723$BAYER$$$$$$Y$$$20240823$$CN$MX$MX
242433832$24243383$2$F$$20240822$20240823$20240826$PER$$NVSC2024US170732$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
242433841$24243384$1$I$$20240808$20240823$20240823$EXP$$US-RADIUS HEALTH INC.-2024US003714$RADIUS PHARM$$$$$F$Y$$$20240823$$CN$US$US
242433851$24243385$1$I$$20240822$20240823$20240823$EXP$$NVSC2024US170680$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242433861$24243386$1$I$$20240814$20240823$20240823$PER$$US-ABBVIE-5881720$ABBVIE$$$$$F$Y$$$20240823$$HP$US$US
242433871$24243387$1$I$$20240711$20240823$20240823$PER$$US-LUNDBECK-DKLU4001692$LUNDBECK$$$$$$Y$$$20240823$$HP$US$US
242433881$24243388$1$I$20240801$20240801$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051527$TOLMAR$$72$YR$$M$Y$$$20240822$$CN$CA$CA
242433891$24243389$1$I$$20240801$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051534$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242433901$24243390$1$I$$20240801$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051532$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242433911$24243391$1$I$20240101$20240731$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051578$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242433921$24243392$1$I$$20240731$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051553$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242433931$24243393$1$I$$20240801$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051579$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242433941$24243394$1$I$$20240731$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051586$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242433951$24243395$1$I$20240731$20240731$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051589$TOLMAR$$65$YR$$M$Y$$$20240822$$CN$CA$CA
242433961$24243396$1$I$$20240802$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051600$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242433971$24243397$1$I$$20240802$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051603$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242433981$24243398$1$I$$20240802$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051606$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242433991$24243399$1$I$20240801$20240801$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051621$TOLMAR$$76$YR$$M$Y$$$20240822$$CN$CA$CA
242434001$24243400$1$I$20240802$20240802$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051653$TOLMAR$$73$YR$$M$Y$$$20240822$$CN$CA$CA
242434021$24243402$1$I$$20240820$20240823$20240823$DIR$FDA-CDER-CTU-2024-58127$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242434041$24243404$1$I$$20240805$20240823$20240823$PER$$CA-TOLMAR, INC.-24CA051671$TOLMAR$$$$$M$Y$$$20240822$$CN$CA$CA
242434061$24243406$1$I$$20240819$20240823$20240823$DIR$FDA-CDER-CTU-2024-58193$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242434071$24243407$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58195$$FDA-CTU$$55$YR$$M$N$$$20240823$N$$US$
242434081$24243408$1$I$$20240816$20240823$20240823$EXP$$PT-MYLANLABS-2024M1077535$MYLAN$Carneiro Martins AL, Miguel Martins R, Oliveira RC, Correia JG, Angelo MD, Tomas AR. Dedifferentiated GIST after therapy with imatinib. Eur-J-Surg-Oncol 2024; 50 (2):.$72$YR$$M$Y$$$20240823$$HP$PT$PT
242434092$24243409$2$F$$20240912$20240823$20240919$EXP$$FR-DSJP-DSE-2024-141534$DAIICHI$$70$YR$$F$Y$80$KG$20240919$$MD$FR$FR
242434101$24243410$1$I$$20240820$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074205$SANDOZ$$31$YR$$F$Y$71$KG$20240823$$MD$CA$CA
242434111$24243411$1$I$$20240814$20240823$20240823$PER$$US-BAYER-2024A120276$BAYER$$34$YR$A$F$Y$$$20240823$$HP$US$US
242434121$24243412$1$I$$20240710$20240823$20240823$PER$$US-LUNDBECK-DKLU4001624$LUNDBECK$$$$$$Y$$$20240823$$HP$US$US
242434131$24243413$1$I$20240101$20240809$20240823$20240823$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1124$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240823$$CN$US$US
242434141$24243414$1$I$$20240822$20240823$20240823$EXP$$US-SANDOZ INC.-SDZ2024US074643$SANDOZ$$85$YR$$F$Y$$$20240823$$MD$US$US
242434151$24243415$1$I$20240717$20240814$20240823$20240823$PER$$US-BAYER-2024A120548$BAYER$$23$YR$A$F$Y$$$20240823$$MD$US$US
242434161$24243416$1$I$$20240814$20240823$20240823$EXP$$CA-BAXTER-2024BAX023264$BAXTER$$72$YR$$F$Y$$$20240823$$MD$CA$CA
242434171$24243417$1$I$$20240814$20240823$20240823$EXP$$CA-BAXTER-2024BAX023259$BAXTER$$40$YR$$F$Y$54$KG$20240823$$CN$CA$CA
242434181$24243418$1$I$20240726$20240815$20240823$20240823$EXP$CN-NMPACDR-4404021959075202400002$CN-BAXTER-2024BAX023380$BAXTER$$31$YR$$M$Y$50$KG$20240823$$MD$CN$CN
242434191$24243419$1$I$20240728$20240815$20240823$20240823$EXP$CN-NMPACDR-3713011010660202401235$CN-BAXTER-2024BAX023379$BAXTER$$65$YR$$F$Y$60$KG$20240823$$MD$CN$CN
242434201$24243420$1$I$$20240814$20240823$20240823$EXP$$CA-BAXTER-2024BAX023261$BAXTER$$14$YR$$F$Y$53$KG$20240823$$HP$CA$CA
242434214$24243421$4$F$$20240904$20240823$20240914$EXP$$GB-BAXTER-2024BAX023292$BAXTER$$21$MON$$M$Y$$$20240914$$CN$CH$GB
242434221$24243422$1$I$$20240816$20240823$20240823$EXP$$CA-BAXTER-2024BAX023448$BAXTER$$76$YR$$M$Y$80$KG$20240823$$HP$CA$CA
242434231$24243423$1$I$$20240813$20240823$20240823$EXP$$CA-BAXTER-2024BAX023228$BAXTER$$49$YR$$M$Y$$$20240823$$HP$CA$CA
242434243$24243424$3$F$20240101$20240830$20240823$20240912$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1127$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240912$$HP$US$US
242434251$24243425$1$I$20240501$20240822$20240823$20240823$EXP$$DE-SANDOZ INC.-SDZ2024DE074548$SANDOZ$$74$YR$$M$Y$$$20240823$$MD$DE$DE
242434261$24243426$1$I$20240710$20240711$20240823$20240823$PER$$US-LUNDBECK-DKLU4001677$LUNDBECK$$$$$$Y$$$20240823$$CN$US$US
242434271$24243427$1$I$$20240821$20240823$20240823$EXP$$US-BAYER-2024A120891$BAYER$$76$YR$E$F$Y$$$20240823$$CN$US$US
242434281$24243428$1$I$20240820$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167664$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242434291$24243429$1$I$20240710$20240711$20240823$20240823$PER$$US-LUNDBECK-DKLU4001680$LUNDBECK$$$$$$Y$$$20240823$$HP$US$US
242434301$24243430$1$I$20240808$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132786$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240823$$HP$US$US
242434311$24243431$1$I$20080201$20240816$20240823$20240823$EXP$$CH-JNJFOC-20240848722$JOHNSON AND JOHNSON$$79$YR$E$M$Y$61$KG$20240823$$PH$CH$CH
242434322$24243432$2$F$20240522$20240911$20240823$20240921$EXP$$FR-DSJP-DSE-2024-141040$DAIICHI$$$$E$F$Y$62$KG$20240921$$MD$FR$FR
242434332$24243433$2$F$20230101$20240817$20240823$20240918$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046751$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$102.5$KG$20240918$$HP$US$US
242434341$24243434$1$I$20240723$20240816$20240823$20240823$EXP$$JP-009507513-2407JPN005261J$MERCK$$6$DEC$$M$Y$$$20240823$$MD$JP$JP
242434371$24243437$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58184$$FDA-CTU$$57$YR$$F$N$$$20240823$N$$US$
242434391$24243439$1$I$20240806$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166292$AMGEN$$60$YR$A$F$Y$$$20240823$$CN$US$US
242434401$24243440$1$I$$20240818$20240823$20240823$EXP$$EG-AMGEN-EGYSP2024167074$AMGEN$$50$YR$A$F$Y$$$20240823$$CN$EG$EG
242434411$24243441$1$I$$20240815$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408009856$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240823$$CN$US$US
242434421$24243442$1$I$20240819$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013026$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240823$$CN$US$US
242434431$24243443$1$I$$20240807$20240823$20240823$PER$$US-JNJFOC-20240828258$JOHNSON AND JOHNSON$$$$$F$Y$84.5$KG$20240823$$CN$US$US
242434442$24243444$2$F$20240701$20240821$20240823$20240904$EXP$$US-COOPERSURGICAL, INC.-2024CPS002471$COOPERSURGICAL$$33$YR$$F$Y$127.89$KG$20240904$$CN$US$US
242434451$24243445$1$I$20240501$20240809$20240823$20240823$EXP$$CA-MEDEXUS PHARMA, INC.-2024MED00194$MEDEXUS PHARMA$$6$YR$$F$Y$$$20240823$$HP$CA$CA
242434471$24243447$1$I$20240815$20240821$20240823$20240823$PER$$US-BAYER-2024A120653$BAYER$$40$YR$A$F$Y$$$20240823$$HP$US$US
242434481$24243448$1$I$$20240820$20240823$20240823$PER$$US-HALEON-2193055$Haleon PLC$$$$$$Y$$$20240823$$CN$US$US
242434491$24243449$1$I$$20240821$20240823$20240823$EXP$$US-VANTIVE-2024VAN019221$Vantive US Healthcare$$$$$F$Y$$$20240823$$HP$US$US
242434501$24243450$1$I$$20240821$20240823$20240823$EXP$$CN-VANTIVE-2024VAN019238$Vantive US Healthcare$$$$$M$Y$$$20240823$$CN$CN$CN
242434511$24243451$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133296$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240823$$PH$US$US
242434521$24243452$1$I$20240728$20240819$20240823$20240823$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006382$AURINIA PHARMACEUTICALS$$44$YR$$F$Y$$$20240823$$CN$US$US
242434531$24243453$1$I$20240101$20240821$20240823$20240823$PER$$US-BAYER-2024A120707$BAYER$$$$$F$Y$$$20240823$$HP$US$US
242434541$24243454$1$I$$20240822$20240823$20240823$PER$$US-BAYER-2024A121201$BAYER$$22$YR$A$F$Y$$$20240823$$HP$US$US
242434551$24243455$1$I$$20240812$20240823$20240823$PER$$US-JNJFOC-20240831395$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
242434571$24243457$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024166331$AMGEN$$$$$$Y$$$20240823$$HP$US$US
242434581$24243458$1$I$$20240821$20240823$20240823$PER$$US-HALEON-2193168$Haleon PLC$Pallos VA, Antony M, Kojaoghlanian T, Leg Pain in a 10-year-old Girl, Index Of Suspicion, 2024, 45(8); RefID: 162517, Leg Pain in a 10-year-old Girl?Pallos V.A., Antony M., Kojaoghlanian T.$10$YR$$F$Y$$$20240823$$MD$US$US
242434592$24243459$2$F$20240801$20240820$20240823$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132279$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240902$$PH$US$US
242434601$24243460$1$I$20230825$20230829$20240823$20240823$PER$$US-PFIZER INC-2023SGN09707$PFIZER$$$$$$Y$$$20240823$$CN$US$US
242434611$24243461$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58192$$FDA-CTU$$63$YR$$F$N$$$20240823$N$$US$
242434631$24243463$1$I$$20230821$20240823$20240823$PER$$US-PFIZER INC-2023SGN09463$PFIZER$$$$$F$Y$$$20240823$$PH$US$US
242434641$24243464$1$I$$20240823$20240823$20240823$DIR$715597$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242434651$24243465$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58194$$FDA-CTU$$69$YR$$F$N$$$20240823$N$$US$
242434662$24243466$2$F$$20240922$20240823$20240923$PER$$US-PFIZER INC-PV202400108605$PFIZER$$15$YR$$M$Y$88.9$KG$20240923$$MD$US$US
242434671$24243467$1$I$$20240812$20240823$20240823$EXP$$CN-THE J. MOLNER COMPANY-202408000028$The J.Molner Company$Jifang Zhou. A systematic review of the drug-drug interaction between Statins and Quinolones.. BMC Pharmacol Toxicol. 2024;25(1):39$$$$$Y$$$20240823$$HP$CN$CN
242434681$24243468$1$I$$20240812$20240823$20240823$EXP$$CN-THE J. MOLNER COMPANY-202408000025$The J.Molner Company$Jifang Zhou. A systematic review of the drug-drug interaction between Statins and Quinolones.. BMC Pharmacol Toxicol. 2024;25(1):39$$$$$Y$$$20240823$$HP$CN$CN
242434691$24243469$1$I$$20240812$20240823$20240823$EXP$$CN-THE J. MOLNER COMPANY-202408000027$The J.Molner Company$Jifang Zhou. A systematic review of the drug-drug interaction between Statins and Quinolones.. BMC Pharmacol Toxicol. 2024;25(1):39$$$$$Y$$$20240823$$HP$CN$CN
242434701$24243470$1$I$$20240812$20240823$20240823$EXP$$CN-THE J. MOLNER COMPANY-202408000030$The J.Molner Company$Jifang Zhou. A systematic review of the drug-drug interaction between Statins and Quinolones.. BMC Pharmacol Toxicol. 2024;25(1):39$$$$$Y$$$20240823$$HP$CN$CN
242434711$24243471$1$I$$20240812$20240823$20240823$EXP$$CN-THE J. MOLNER COMPANY-202408000029$The J.Molner Company$Jifang Zhou. A systematic review of the drug-drug interaction between Statins and Quinolones.. BMC Pharmacol Toxicol. 2024;25(1):39$$$$$Y$$$20240823$$HP$CN$CN
242434721$24243472$1$I$$20240812$20240823$20240823$EXP$$CN-THE J. MOLNER COMPANY-202408000026$The J.Molner Company$Jifang Zhou. A systematic review of the drug-drug interaction between Statins and Quinolones.. BMC Pharmacol Toxicol. 2024;25(1):39$$$$$Y$$$20240823$$HP$CN$CN
242434731$24243473$1$I$$20240812$20240823$20240823$EXP$$CN-THE J. MOLNER COMPANY-202408000023$The J.Molner Company$Jifang Zhou. A systematic review of the drug-drug interaction between Statins and Quinolones.. BMC Pharmacol Toxicol. 2024;25(1):39$$$$$Y$$$20240823$$HP$CN$CN
242434741$24243474$1$I$$20240812$20240823$20240823$EXP$$IT-THE J. MOLNER COMPANY-202408000020$The J.Molner Company$Stella Pigni. Late-onset Schmidt^s Syndrome Presenting with Severe Hyponatremia: A Case Report. Endocr Metab Immune Disord Drug Targets. 2024$$$$$Y$$$20240823$$HP$IT$IT
242434751$24243475$1$I$$20240812$20240823$20240823$EXP$$CN-THE J. MOLNER COMPANY-202408000024$The J.Molner Company$Jifang Zhou. A systematic review of the drug-drug interaction between Statins and Quinolones.. BMC Pharmacol Toxicol. 2024;25(1):39$$$$$Y$$$20240823$$HP$CN$CN
242434761$24243476$1$I$$20240812$20240823$20240823$EXP$$CN-THE J. MOLNER COMPANY-202408000031$The J.Molner Company$Jifang Zhou. A systematic review of the drug-drug interaction between Statins and Quinolones.. BMC Pharmacol Toxicol. 2024;25(1):39$$$$$Y$$$20240823$$HP$CN$CN
242434771$24243477$1$I$$20240812$20240823$20240823$EXP$$TW-THE J. MOLNER COMPANY-202408000021$The J.Molner Company$Chin-Fang Chen. Sheehan^s syndrome presenting with panhypopituitarism and central diabetes insipidus: a case report. BMC Endocr Disord. 2024;24(1):120$$$$$Y$$$20240823$$HP$TW$TW
242434781$24243478$1$I$$20240820$20240823$20240823$PER$$US-BAYER-2024A120568$BAYER$$41$YR$A$F$Y$$$20240823$$MD$US$US
242434791$24243479$1$I$$20240821$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074754$SANDOZ$$47$YR$$F$Y$$$20240823$$HP$CA$CA
242434801$24243480$1$I$20240809$20240819$20240823$20240823$PER$$US-BAYER-2024A119761$BAYER$$$$$F$Y$$$20240823$$HP$US$US
242434821$24243482$1$I$20230605$20230906$20240823$20240823$PER$$US-PFIZER INC-2023SGN09969$PFIZER$$$$$F$Y$$$20240823$$PH$US$US
242434831$24243483$1$I$20240812$20240820$20240823$20240823$EXP$GB-MHRA-MED-202408201029395710-FSLQT$GB-MYLANLABS-2024M1077441$MYLAN$$45$YR$$$Y$$$20240823$$CN$GB$GB
242434841$24243484$1$I$20240101$20240802$20240823$20240823$PER$$US-JNJFOC-20240858233$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$CN$US$US
242434853$24243485$3$F$20240802$20240917$20240823$20240926$EXP$$US-JNJFOC-20240838849$JOHNSON AND JOHNSON$$70$YR$E$M$Y$65$KG$20240927$$HP$US$US
242434861$24243486$1$I$$20240819$20240823$20240823$EXP$$DE-SANDOZ INC.-SDZ2024DE073490$SANDOZ$$$$$M$Y$$$20240823$$HP$DE$DE
242434871$24243487$1$I$$20240819$20240823$20240823$EXP$$US-EXELIXIS-CABO-24080678$EXELIXIS$$$$$M$Y$$$20240823$$CN$US$US
242434881$24243488$1$I$$20240822$20240823$20240823$DIR$FDA-CDER-CTU-2024-58139$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242434891$24243489$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58189$$FDA-CTU$$69$YR$$M$N$$$20240823$N$$US$
242434901$24243490$1$I$$20240814$20240823$20240823$DIR$FDA-CDER-CTU-2024-58178$$FDA-CTU$$$$$M$N$$$20240814$N$HP$US$
242434961$24243496$1$I$20240813$20240815$20240823$20240823$PER$$US-MYLANLABS-2024M1076515$MYLAN$$58$YR$$F$Y$$$20240823$$CN$US$US
242434971$24243497$1$I$$20240822$20240823$20240823$PER$$US-AMGEN-USASP2024168511$AMGEN$$$$A$$Y$$$20240823$$CN$US$US
242434981$24243498$1$I$20240101$20240820$20240823$20240823$PER$$US-ABBVIE-5888793$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242434991$24243499$1$I$20240820$20240820$20240823$20240823$PER$$US-PFIZER INC-202400240395$PFIZER$$65$YR$$F$Y$$$20240823$$MD$US$US
242435001$24243500$1$I$$20240822$20240823$20240823$PER$$US-PFIZER INC-202400242254$PFIZER$$60$YR$$F$Y$$$20240823$$PH$US$US
242435011$24243501$1$I$20240819$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241438$PFIZER$$55$YR$$F$Y$$$20240823$$CN$US$US
242435032$24243503$2$F$20240820$20240828$20240823$20240830$PER$$US-PFIZER INC-202400240047$PFIZER$$$$$F$Y$$$20240830$$CN$US$US
242435051$24243505$1$I$$20240820$20240823$20240823$PER$$US-PFIZER INC-202400240099$PFIZER$$$$$F$Y$$$20240823$$CN$US$US
242435062$24243506$2$F$$20240825$20240823$20240827$PER$$US-PFIZER INC-PV202400109952$PFIZER$$$$$$Y$$$20240827$$MD$US$US
242435071$24243507$1$I$$20240820$20240823$20240823$PER$$US-PFIZER INC-PV202400108914$PFIZER$$81$YR$$$Y$$$20240823$$CN$US$US
242435081$24243508$1$I$$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241369$PFIZER$$26$YR$$M$Y$$$20240823$$MD$US$US
242435092$24243509$2$F$$20240821$20240823$20240826$EXP$$US-PFIZER INC-PV202400109616$PFIZER$$$$$$Y$$$20240826$$CN$US$US
242435101$24243510$1$I$$20240819$20240823$20240823$EXP$AU-GENERIC HEALTH PTY. LTD.-2024-06539$AU-SANDOZ INC.-SDZ2024AU073588$SANDOZ$$40$YR$$M$Y$$$20240823$$MD$AU$AU
242435111$24243511$1$I$$20230912$20240823$20240823$PER$$US-PFIZER INC-2023SGN10212$PFIZER$$$$$$Y$$$20240823$$HP$US$US
242435121$24243512$1$I$$20240820$20240823$20240823$PER$$US-PFIZER INC-202400240377$PFIZER$$81$YR$$F$Y$$$20240823$$CN$US$US
242435132$24243513$2$F$$20240916$20240823$20240920$PER$$US-PFIZER INC-PV202400109413$PFIZER$$63$YR$$M$Y$$$20240920$$HP$US$US
242435141$24243514$1$I$20240714$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241489$PFIZER$$71$YR$$F$Y$$$20240823$$CN$US$US
242435151$24243515$1$I$$20230918$20240823$20240823$PER$$US-PFIZER INC-2023SGN10443$PFIZER$$$$$$Y$$$20240823$$HP$US$US
242435161$24243516$1$I$20240801$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241423$PFIZER$$27$YR$$F$Y$$$20240823$$CN$US$US
242435171$24243517$1$I$20240819$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241727$PFIZER$$48$YR$$F$Y$$$20240823$$CN$US$US
242435191$24243519$1$I$20240820$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241299$PFIZER$$54$YR$$F$Y$$$20240823$$HP$US$US
242435201$24243520$1$I$$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241610$PFIZER$$53$YR$$F$Y$$$20240823$$MD$US$US
242435221$24243522$1$I$$20240822$20240823$20240823$PER$$US-PFIZER INC-PV202400109902$PFIZER$$$$$$Y$$$20240823$$CN$US$US
242435241$24243524$1$I$20240817$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241492$PFIZER$$33$YR$$F$Y$$$20240823$$HP$US$US
242435252$24243525$2$F$20240801$20240823$20240823$20240828$PER$$US-PFIZER INC-202400241304$PFIZER$$$$$F$Y$$$20240828$$CN$US$US
242435262$24243526$2$F$20240810$20240905$20240823$20240909$EXP$$US-PFIZER INC-PV202400109646$PFIZER$$74$YR$$F$Y$64.853$KG$20240909$$CN$US$US
242435274$24243527$4$F$20240101$20240918$20240823$20240920$PER$$US-PFIZER INC-202400241059$PFIZER$$80$YR$$F$Y$73.696$KG$20240920$$CN$US$US
242435281$24243528$1$I$20240101$20240822$20240823$20240823$PER$$US-PFIZER INC-202400242325$PFIZER$$79$YR$$F$Y$$$20240823$$CN$US$US
242435292$24243529$2$F$$20240925$20240823$20240930$EXP$$US-PFIZER INC-PV202400109470$PFIZER$$66$YR$$F$Y$$$20240930$$HP$US$US
242435302$24243530$2$F$20240819$20240918$20240823$20240919$PER$$US-PFIZER INC-202400240092$PFIZER$$71$YR$$M$Y$70.3$KG$20240919$$MD$US$US
242435311$24243531$1$I$20240819$20240820$20240823$20240823$PER$$US-PFIZER INC-202400240097$PFIZER$$57$YR$$F$Y$$$20240823$$CN$US$US
242435321$24243532$1$I$20240812$20240820$20240823$20240823$PER$$US-PFIZER INC-202400240370$PFIZER$$$$$$Y$$$20240823$$MD$US$US
242435333$24243533$3$F$$20240924$20240823$20240927$PER$$US-PFIZER INC-202400241335$PFIZER$$46$YR$$F$Y$$$20240927$$MD$US$US
242435341$24243534$1$I$$20240821$20240823$20240823$PER$$US-PFIZER INC-PV202400109840$PFIZER$$43$YR$$F$Y$$$20240823$$CN$US$US
242435351$24243535$1$I$$20240820$20240823$20240823$PER$$US-PFIZER INC-202400240166$PFIZER$$$$$F$Y$$$20240823$$HP$US$US
242435361$24243536$1$I$20240820$20240820$20240823$20240823$PER$$US-PFIZER INC-202400240586$PFIZER$$19$YR$$M$Y$$$20240823$$CN$US$US
242435371$24243537$1$I$20150325$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241070$PFIZER$$63$YR$$F$Y$$$20240823$$HP$US$US
242435381$24243538$1$I$20240810$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241595$PFIZER$$65$YR$$F$Y$$$20240823$$CN$US$US
242435392$24243539$2$F$20240821$20240923$20240823$20240925$PER$$US-PFIZER INC-202400241658$PFIZER$$52$YR$$M$Y$81.6$KG$20240925$$CN$US$US
242435401$24243540$1$I$$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241172$PFIZER$$$$A$$Y$$$20240823$$MD$US$US
242435411$24243541$1$I$$20240822$20240823$20240823$PER$$US-PFIZER INC-202400242526$PFIZER$$$$$$Y$$$20240823$$CN$US$US
242435421$24243542$1$I$20240821$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241486$PFIZER$$77$YR$$F$Y$$$20240823$$CN$US$US
242435432$24243543$2$F$20240818$20240918$20240823$20240923$PER$$US-PFIZER INC-PV202400109605$PFIZER$$76$YR$$M$Y$79.365$KG$20240923$$CN$US$US
242435441$24243544$1$I$$20240821$20240823$20240823$PER$$US-PFIZER INC-202400241415$PFIZER$$13$YR$$F$Y$$$20240823$$CN$US$US
242435451$24243545$1$I$20240816$20240816$20240823$20240823$PER$$US-BAYER-2024A119096$BAYER$$$$$M$Y$$$20240823$$HP$US$US
242435461$24243546$1$I$20220908$20240817$20240823$20240823$EXP$$CA-TAKEDA-CA202019835$TAKEDA$$57$YR$$F$Y$$$20240823$$CN$CA$CA
242435471$24243547$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024100817$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242435481$24243548$1$I$$20240816$20240823$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012981$JAZZ$$$$$M$Y$$$20240823$$CN$US$US
242435491$24243549$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013544$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240823$$CN$US$US
242435501$24243550$1$I$20240818$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012436$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240823$$CN$US$US
242435511$24243551$1$I$$20240815$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408010116$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240823$$CN$US$US
242435522$24243552$2$F$$20240905$20240823$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202408014732$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240906$$CN$US$US
242435531$24243553$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012607$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240823$$HP$US$US
242435541$24243554$1$I$$20240822$20240823$20240823$EXP$$US-BAYER-2024A121422$BAYER$$70$YR$E$M$Y$$$20240823$$CN$US$US
242435552$24243555$2$F$20240816$20240909$20240823$20240917$PER$$US-AMGEN-USASP2024165478$AMGEN$$37$YR$A$F$Y$$$20240917$$CN$US$US
242435561$24243556$1$I$20240701$20240816$20240823$20240823$EXP$$JP-009507513-2408JPN001987J$MERCK$$6$DEC$$F$Y$$$20240823$$MD$JP$JP
242435571$24243557$1$I$20240703$20240821$20240823$20240823$EXP$$CN-GILEAD-2024-0684871$GILEAD$$59$YR$A$F$Y$60$KG$20240823$$HP$CN$CN
242435581$24243558$1$I$20240728$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132876$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$72.5$KG$20240823$$HP$US$US
242435591$24243559$1$I$$20240813$20240823$20240823$EXP$$IN-BLUEPRINT MEDICINES CORPORATION-2024BUS004482$BLUEPRINT MEDICINES$$$$$$Y$$$20240823$$MD$IN$IN
242435601$24243560$1$I$$20240814$20240823$20240823$EXP$$AR-BLUEPRINT MEDICINES CORPORATION-2024BUS004480$BLUEPRINT MEDICINES$$$$$$Y$$$20240823$$MD$AR$AR
242435622$24243562$2$F$20230426$20240820$20240823$20240827$EXP$$NVSC2024DE170187$NOVARTIS$$$$A$F$Y$57$KG$20240827$$HP$DE$DE
242435652$24243565$2$F$20240623$20240914$20240823$20240919$EXP$$CO-TAKEDA-2024TUS055941$TAKEDA$$37$YR$$F$Y$49$KG$20240919$$CN$CO$CO
242435671$24243567$1$I$$20240814$20240823$20240823$EXP$$JP-AMGEN-JPNSP2024165828$AMGEN$$$$$M$Y$$$20240823$$CN$JP$JP
242435681$24243568$1$I$20240806$20240822$20240823$20240823$EXP$$US-GILEAD-2024-0685114$GILEAD$$74$YR$E$F$Y$$$20240823$$CN$US$US
242435691$24243569$1$I$$20240819$20240823$20240823$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-131917$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$70$KG$20240823$$HP$CA$CA
242435701$24243570$1$I$20240808$20240816$20240823$20240823$PER$$PR-BIOGEN-2024BI01279025$BIOGEN$$66$YR$$F$Y$70.37$KG$20240823$$CN$PR$PR
242435711$24243571$1$I$20221221$20230708$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202212-000330$EMMAUS LIFE SCIENCES$$50$YR$A$F$Y$99.79$KG$20240823$$CN$US$
242435721$24243572$1$I$$20230707$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202301-000024$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242435731$24243573$1$I$$20230726$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202305-000113$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242435741$24243574$1$I$20230101$20230817$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202301-000016$EMMAUS LIFE SCIENCES$$59$YR$A$F$Y$85.27$KG$20240823$$CN$US$
242435751$24243575$1$I$20230101$20230716$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202304-000082$EMMAUS LIFE SCIENCES$$18$YR$A$M$Y$$$20240823$$CN$US$
242435761$24243576$1$I$$20230714$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202304-000084$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242435771$24243577$1$I$20230528$20230718$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202306-000117$EMMAUS LIFE SCIENCES$$16$YR$T$M$Y$$$20240823$$CN$US$
242435782$24243578$2$F$20221222$20230717$20240823$20240825$PER$$US-Emmaus Medical, Inc.-EMM202306-000128$EMMAUS LIFE SCIENCES$$7$YR$C$M$Y$$$20240825$$CN$US$
242435791$24243579$1$I$20220101$20230728$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202306-000133$EMMAUS LIFE SCIENCES$$30$YR$A$F$Y$$$20240823$$CN$US$
242435801$24243580$1$I$20230101$20230823$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202306-000139$EMMAUS LIFE SCIENCES$$16$YR$T$F$Y$$$20240823$$CN$US$
242435811$24243581$1$I$20230623$20230815$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000146$EMMAUS LIFE SCIENCES$$24$YR$A$F$Y$$$20240823$$CN$US$
242435821$24243582$1$I$20230529$20230828$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000151$EMMAUS LIFE SCIENCES$$48$YR$A$F$Y$$$20240823$$CN$US$
242435831$24243583$1$I$20230627$20230803$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202306-000123$EMMAUS LIFE SCIENCES$$56$YR$A$F$Y$$$20240823$$CN$US$
242435841$24243584$1$I$20230601$20230711$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202306-000140$EMMAUS LIFE SCIENCES$$20$YR$A$F$Y$$$20240823$$CN$US$
242435851$24243585$1$I$20230101$20230913$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000147$EMMAUS LIFE SCIENCES$$10$YR$C$F$Y$26.6$KG$20240823$$CN$US$
242435861$24243586$1$I$20230601$20230707$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000153$EMMAUS LIFE SCIENCES$$31$YR$A$F$Y$$$20240823$$CN$US$
242435871$24243587$1$I$20230703$20230710$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000154$EMMAUS LIFE SCIENCES$$44$YR$A$F$Y$$$20240823$$CN$US$
242435881$24243588$1$I$$20230710$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000155$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242435891$24243589$1$I$20230101$20230711$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000156$EMMAUS LIFE SCIENCES$$41$YR$A$M$Y$$$20240823$$CN$US$
242435901$24243590$1$I$$20230712$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000157$EMMAUS LIFE SCIENCES$$25$YR$A$F$Y$$$20240823$$CN$US$
242435911$24243591$1$I$$20230714$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000163$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242435921$24243592$1$I$20230601$20230912$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000159$EMMAUS LIFE SCIENCES$$17$YR$T$M$Y$$$20240823$$CN$US$
242435931$24243593$1$I$20230501$20230714$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000164$EMMAUS LIFE SCIENCES$$46$YR$A$F$Y$$$20240823$$CN$US$
242435941$24243594$1$I$20230710$20230912$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000165$EMMAUS LIFE SCIENCES$$6$YR$C$M$Y$$$20240823$$HP$US$
242435951$24243595$1$I$20230705$20230717$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000166$EMMAUS LIFE SCIENCES$$37$YR$A$M$Y$$$20240823$$CN$US$
242435961$24243596$1$I$20230627$20230718$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000168$EMMAUS LIFE SCIENCES$$25$YR$A$F$Y$$$20240823$$CN$US$
242435971$24243597$1$I$20230708$20240327$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000169$EMMAUS LIFE SCIENCES$$14$YR$T$F$Y$40.6$KG$20240823$$CN$US$
242435981$24243598$1$I$20230705$20230719$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000170$EMMAUS LIFE SCIENCES$$43$YR$A$M$Y$$$20240823$$CN$US$
242435991$24243599$1$I$20230701$20230717$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000171$EMMAUS LIFE SCIENCES$$42$YR$A$M$Y$$$20240823$$CN$US$
242436001$24243600$1$I$$20230921$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000172$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242436011$24243601$1$I$20230721$20230721$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000173$EMMAUS LIFE SCIENCES$$29$YR$A$F$Y$$$20240823$$CN$US$
242436021$24243602$1$I$20230703$20230731$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000167$EMMAUS LIFE SCIENCES$$28$YR$A$F$Y$46.2$KG$20240823$$CN$US$
242436031$24243603$1$I$20230717$20230901$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000179$EMMAUS LIFE SCIENCES$$11$YR$C$M$Y$52.3$KG$20240823$$CN$US$
242436041$24243604$1$I$20230701$20230725$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000180$EMMAUS LIFE SCIENCES$$24$YR$A$M$Y$$$20240823$$CN$US$
242436051$24243605$1$I$20230704$20230807$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000181$EMMAUS LIFE SCIENCES$$10$YR$C$M$Y$$$20240823$$CN$US$
242436061$24243606$1$I$20230701$20230725$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000182$EMMAUS LIFE SCIENCES$$9$YR$C$M$Y$$$20240823$$CN$US$
242436071$24243607$1$I$$20230726$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000183$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242436081$24243608$1$I$20230101$20230809$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000184$EMMAUS LIFE SCIENCES$$9$YR$C$M$Y$$$20240823$$CN$US$
242436091$24243609$1$I$20230706$20230823$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000185$EMMAUS LIFE SCIENCES$$13$YR$T$F$Y$$$20240823$$CN$US$
242436101$24243610$1$I$20230601$20230731$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000189$EMMAUS LIFE SCIENCES$$11$YR$C$M$Y$$$20240823$$CN$US$
242436111$24243611$1$I$20230701$20230801$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000190$EMMAUS LIFE SCIENCES$$46$YR$A$F$Y$$$20240823$$CN$US$
242436121$24243612$1$I$20230723$20230801$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000191$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$54.431$KG$20240823$$CN$US$
242436131$24243613$1$I$20230617$20230822$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000192$EMMAUS LIFE SCIENCES$$6$YR$C$M$Y$17.6$KG$20240823$$CN$US$
242436141$24243614$1$I$$20240822$20240823$20240823$PER$$US-HALEON-2193333$Haleon PLC$$$$$$Y$$$20240823$$CN$US$US
242436151$24243615$1$I$$20240813$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129470$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240823$$HP$US$US
242436161$24243616$1$I$$20240809$20240823$20240823$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-08128$LUPIN$Mohod V, Gautam S, Devi Prasad PSD, Rajshree. Anaesthesia considerations of a paediatric patient with recurrent bronchopneumonia in a post-MDR Tb Seqeule: A case report. European Journal of Cardiovascular Medicine. 2023;13(4):526-530$10$YR$$M$Y$21$KG$20240823$$HP$IN$IN
242436171$24243617$1$I$20220101$20230828$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000178$EMMAUS LIFE SCIENCES$$36$YR$A$F$Y$$$20240823$$CN$US$
242436181$24243618$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133104$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240823$$CN$US$US
242436192$24243619$2$F$$20240816$20240823$20240906$PER$$US-JNJFOC-20240854198$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$HP$US$US
242436202$24243620$2$F$$20240816$20240823$20240826$EXP$$NO-BAYER-2024A119406$BAYER$$$$$M$Y$$$20240826$$HP$NO$NO
242436211$24243621$1$I$$20240731$20240823$20240823$PER$$US-009507513-2408USA000237$MERCK$Aykut A, Else T, Demirci H. Belzutifan as the first-line treatment for a challenging von Hippel-Lindau-related retinal hemangioblastoma: successful treatment of a case and review of the literature. Canadian Journal of Ophthalmology. 2024;1-3$$$$F$Y$$$20240823$$HP$US$US
242436221$24243622$1$I$20240813$20240818$20240823$20240823$EXP$$GB-ANIPHARMA-2024-UK-000169$ANI$$$$$F$Y$65$KG$20240823$$CN$GB$GB
242436232$24243623$2$F$20230227$20240902$20240823$20240906$EXP$$BE-ORGANON-O2408BEL001404$ORGANON$$85$YR$$M$Y$$$20240906$$MD$BE$BE
242436241$24243624$1$I$20210101$20240813$20240823$20240823$EXP$$CN-ADMA BIOLOGICS INC.-CN-2024ADM000108$ADMA BIOLOGICS$Weisen W, Chunhua F, Yanqun L, Yi T, Xiaoying B, Xiaojun H.. Multiple cerebral infarctions after intravenous immunoglobulin for Guillain- Barre syndrome: two case reports and review of the literature.. Frontiers in Immunology. 2024;15:1433240$65$YR$$M$Y$$$20240823$$HP$CN$CN
242436263$24243626$3$F$$20240920$20240823$20240930$EXP$$NVSC2024AU170813$NOVARTIS$Kam I, Prentice D, Kho LK, Dharsono F. Inflammatory epilepsy (FIRES) and haemophagocytic lymphohistiocytosis (HLH): an adult case. BMJ-CASE-REP. 2023;16(1):1-4$40$YR$$M$Y$$$20240930$$HP$AU$AU
242436271$24243627$1$I$20240725$20240814$20240823$20240823$EXP$$DE-TEVA-VS-3233880$TEVA$$$$A$F$Y$$$20240823$$CN$DE$DE
242436281$24243628$1$I$$20240813$20240823$20240823$EXP$$IT-BEH-2024177353$CSL BEHRING$$$$N$$Y$1.9$KG$20240823$$HP$IT$IT
242436291$24243629$1$I$$20240815$20240823$20240823$EXP$$CL-AMGEN-CHLSP2024164774$AMGEN$Sarmiento M.. Analysis of apheresis outcomes in a cohort of Chilean patients treated with autologous stem cell transplantation: A single center real-world experience. Transfusion and Apheresis Science. 2024;63:1-3$$$$$Y$$$20240823$$HP$CL$CL
242436301$24243630$1$I$20210101$20240813$20240823$20240823$EXP$$CN-ADMA BIOLOGICS INC.-CN-2024ADM000109$ADMA BIOLOGICS$Weisen W, Chunhua F, Yanqun L, Yi T, Xiaoying B, Xiaojun H.. Multiple cerebral infarctions after intravenous immunoglobulin for Guillain- Barre? syndrome: two case reports and review of the literature.. Frontiers in Immunology. 2024;15:1433240$65$YR$$M$Y$$$20240823$$HP$CN$CN
242436311$24243631$1$I$20240801$20240822$20240823$20240823$EXP$$US-UCBSA-2024042283$UCB$$73$YR$$F$Y$$$20240823$$CN$US$US
242436321$24243632$1$I$$20240822$20240823$20240823$EXP$$US-UCBSA-2024042821$UCB$$$$$F$Y$$$20240823$$CN$US$US
242436331$24243633$1$I$20240822$20240823$20240823$20240823$DIR$715599$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242436341$24243634$1$I$$20240812$20240823$20240823$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000024$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240822$$MD$US$US
242436351$24243635$1$I$$20240813$20240823$20240823$EXP$$GB-STEMLINE THERAPEUTICS, INC-2024-STML-GB001491$PAREXEL$$$$$$Y$$$20240823$$HP$GB$GB
242436361$24243636$1$I$20240808$20240816$20240823$20240823$EXP$$CN-GSK-CN2024APC103008$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$HP$CN$CN
242436371$24243637$1$I$$20240819$20240823$20240823$EXP$$NVSC2024CA168475$NOVARTIS$$68$YR$$F$Y$$$20240823$$HP$CA$CA
242436381$24243638$1$I$$20240815$20240823$20240823$EXP$$AT-AMGEN-AUTSP2024163516$AMGEN$Pereyra, D.. Immunosuppressive Induction Therapy Using the Antithymocyteglobulin Grafalon: A Single-Center Non Interventional Study. Journal of Clinical Medicine. 2024;13:1-10$$$$$Y$$$20240823$$HP$AT$AT
242436393$24243639$3$F$20240817$20240927$20240823$20240930$PER$$US-AMGEN-USASP2024165519$AMGEN$$64$YR$A$F$Y$$$20240929$$CN$US$US
242436401$24243640$1$I$$20240820$20240823$20240823$PER$$US-HALEON-2192870$Haleon PLC$$$$$$Y$$$20240823$$CN$US$US
242436411$24243641$1$I$20240801$20240814$20240823$20240823$EXP$$CA-BEH-2024176793$CSL BEHRING$$57$YR$A$F$Y$$$20240823$$HP$CA$CA
242436421$24243642$1$I$20240808$20240814$20240823$20240823$PER$$US-TEVA-VS-3234312$TEVA$$54$YR$$F$Y$$$20240823$$PH$US$US
242436441$24243644$1$I$$20240811$20240823$20240823$EXP$$CN-Accord-441855$ACCORD$Zhong B, Zhang T, Dong Y, Yin W, Zhang JX, Jin WD. Case report: A case with atypical presentation oftesticular choriocarcinoma. Frontiers in oncology. 2024;14:1223873. DOI:10.3389/fonc.2024.1223873.$29$YR$A$M$Y$$$20240823$$MD$CN$CN
242436452$24243645$2$F$$20240813$20240823$20240828$EXP$ES-EMA-DD-20240809-7482655-095404$ES-GILEAD-2024-0684022$GILEAD$Hernani R et al. Hernani R, Sancho A, Amat P, Hernandez-Boluda J, Perez A, Pinana J, Carretero  C, Goterris R, Gozmez M, Saus A, Ferrer B, Teruel A, Terol M and Solano C. CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review. Current Research in Translational Medicine 2021 Oct;69 (4):1-5. doi:10.1016/j.retram.2021.103304. Current Research in Translational Medicine. 2021;69:unk. doi:https://doi.org/10.1016/j.retram.2021.10$56$YR$A$M$Y$$$20240828$$HP$ES$ES
242436491$24243649$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133504$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240823$$CN$US$US
242436501$24243650$1$I$20240820$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167890$AMGEN$$4$YR$C$M$Y$$$20240823$$CN$US$US
242436511$24243651$1$I$$20240822$20240823$20240823$EXP$$CA-MYLANLABS-2024M1078003$MYLAN$$25$YR$$F$Y$$$20240823$$CN$CA$CA
242436522$24243652$2$F$$20240830$20240823$20240906$EXP$$NL-GSK-NL2024EME103010$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$HP$NL$NL
242436531$24243653$1$I$20240101$20240813$20240823$20240823$EXP$$GB-TEVA-VS-3154286$TEVA$$51$YR$$F$Y$$$20240823$$CN$GB$GB
242436541$24243654$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013995$ELI LILLY AND CO$$$$$F$Y$$$20240823$$HP$US$US
242436551$24243655$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013627$ELI LILLY AND CO$$$$A$M$Y$$$20240823$$CN$US$US
242436561$24243656$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013622$ELI LILLY AND CO$$$$$F$Y$$$20240823$$HP$US$US
242436571$24243657$1$I$$20240815$20240823$20240823$EXP$$BR-TAKEDA-2024TUS084272$TAKEDA$$$$$M$Y$$$20240823$$CN$BR$BR
242436591$24243659$1$I$$20240820$20240823$20240823$EXP$$US-BAYER-2024A058849$BAYER$$60$YR$A$F$Y$145.13$KG$20240823$$CN$US$US
242436601$24243660$1$I$$20240822$20240823$20240823$PER$$US-BAYER-2024A121687$BAYER$$$$$F$Y$$$20240823$$HP$US$US
242436611$24243661$1$I$20240601$20240815$20240823$20240823$EXP$$PE-BIOVITRUM-2024-PE-011223$BIOVITRUM$$4$MON$$M$Y$$$20240823$$CN$PE$PE
242436621$24243662$1$I$20200730$20240809$20240823$20240823$EXP$$PT-SEBELA IRELAND LIMITED-2024SEB00056$SEBELA$Carvalho PR, Gon?alves F, Magalhaes P, .et.al.. Hypertensive emergency secondary to atropine.. Hipertens Riesgo Vasc.. 2024;41(1):58-61$78$YR$$F$Y$$$20240823$$HP$PT$PT
242436631$24243663$1$I$$20240809$20240823$20240823$EXP$$CN-SEBELA IRELAND LIMITED-2024SEB00057$SEBELA$Zhang H, Zhang M, Du Y, He J, Li J. Ventricular tachycardia and acute heart failure induced by atropine in the treatment of bradycardia: A case report and literature review. Medicine (Baltimore).. 2023;102(34):e34775$41$YR$$F$Y$83$KG$20240823$$HP$CN$CN
242436641$24243664$1$I$$20240819$20240823$20240823$EXP$$NVSC2024CA167996$NOVARTIS$$14$YR$$M$Y$$$20240823$$CN$CA$CA
242436653$24243665$3$F$20240601$20240906$20240823$20240916$EXP$DE-CADRBFARM-2024329376$DE-TEVA-VS-3226387$TEVA$$88$YR$$M$Y$68$KG$20240916$$MD$DE$DE
242436661$24243666$1$I$20240801$20240816$20240823$20240823$EXP$$CA-GSK-CA2024102522$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$PH$CA$CA
242436671$24243667$1$I$20240801$20240815$20240823$20240823$EXP$$BR-TAKEDA-2024TUS083309$TAKEDA$$79$YR$$F$Y$78$KG$20240823$$HP$BR$BR
242436691$24243669$1$I$$20240816$20240823$20240823$EXP$$DE-BAYER-2024A119020$BAYER$$61$YR$A$M$Y$$$20240823$$PH$DE$DE
242436701$24243670$1$I$20240701$20240820$20240823$20240823$PER$$US-Eisai-EC-2024-172600$EISAI$$80$YR$E$F$Y$62.5$KG$20240823$$CN$US$US
242436711$24243671$1$I$$20240823$20240823$20240823$PER$$NVSC2024US171198$NOVARTIS$$$$$$Y$$$20240823$$HP$US$US
242436721$24243672$1$I$20240407$20240817$20240823$20240823$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-132861$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240823$$HP$CO$CO
242436731$24243673$1$I$20240809$20240816$20240823$20240823$PER$$US-TAKEDA-2024TUS082663$TAKEDA$$46$YR$$F$Y$31$KG$20240823$$PH$US$US
242436741$24243674$1$I$20240727$20240813$20240823$20240823$PER$$US-Eisai-EC-2024-172085$EISAI$$63$YR$A$F$Y$$$20240823$$CN$US$US
242436751$24243675$1$I$$20240815$20240823$20240823$EXP$$CA-TAKEDA-2024TUS082441$TAKEDA$$30$YR$$M$Y$$$20240823$$HP$CA$CA
242436761$24243676$1$I$20240708$20240823$20240823$20240823$DIR$715598$$FDA-CTU$$29$YR$$F$N$135$KG$20240823$Y$CN$US$
242436781$24243678$1$I$$20240823$20240823$20240823$DIR$715602$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242436821$24243682$1$I$$20240823$20240823$20240823$DIR$715604$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242436841$24243684$1$I$$20240812$20240823$20240823$EXP$$IE-MEITHEAL-2024MPLIT00248$MEITHEAL PHARMACEUTICALS$Kelliher J, et al.Severe atypical iliac wing fracture associated with long-term  bisphosphonate use.Skeletal Radiology.20-JUL-2024;1(1):1-5$63$YR$A$F$Y$$$20240823$$HP$IE$IE
242436851$24243685$1$I$20240101$20240819$20240823$20240823$EXP$$AT-009507513-2408AUT007502$MERCK$$$$$F$Y$$$20240823$$MD$AT$AT
242436861$24243686$1$I$$20240812$20240823$20240823$EXP$$AU-MEITHEAL-2024MPLIT00247$MEITHEAL PHARMACEUTICALS$Montarello et al..Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report.BMC Neurology.09-AUG-2024;24 (1):1-6$51$YR$A$F$Y$$$20240823$$HP$AU$AU
242436871$24243687$1$I$$20240812$20240823$20240823$EXP$$US-MEITHEAL-2024MPLIT00250$MEITHEAL PHARMACEUTICALS$Singh AD, et al..An Unusual Case of Refractory Esophagitis and Esophageal  Diverticulum.Digestive Diseases and Sciences.jun-2024;69 (6):1913-4$76$YR$E$F$Y$$$20240823$$HP$US$US
242436881$24243688$1$I$20240101$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024168058$AMGEN$$51$YR$A$F$Y$$$20240823$$CN$US$US
242436891$24243689$1$I$20240823$20240823$20240823$20240823$DIR$715627$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242436901$24243690$1$I$$20240823$20240823$20240823$DIR$715601$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242436911$24243691$1$I$20240823$20240823$20240823$20240823$DIR$715608$$FDA-CTU$$50$YR$$F$N$72.5$KG$20240823$N$HP$US$
242436921$24243692$1$I$20240321$20240817$20240823$20240823$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-132545$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240823$$HP$CO$CO
242436931$24243693$1$I$$20240823$20240823$20240823$DIR$715626$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242436941$24243694$1$I$20240820$20240820$20240823$20240823$EXP$$NVSC2024US169666$NOVARTIS$$56$YR$$F$Y$$$20240823$$CN$US$US
242436951$24243695$1$I$$20240823$20240823$20240823$DIR$715603$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242436961$24243696$1$I$20240822$20240823$20240823$20240823$DIR$715617$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242436971$24243697$1$I$20240822$20240823$20240823$20240823$DIR$715619$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242436981$24243698$1$I$20240822$20240823$20240823$20240823$DIR$715622$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242436992$24243699$2$F$20240809$20240910$20240823$20240918$EXP$$US-JNJFOC-20240849195$JOHNSON AND JOHNSON$$20$YR$A$F$Y$138.47$KG$20240918$$HP$US$US
242437002$24243700$2$F$20240219$20240906$20240823$20240916$EXP$$CA-JNJFOC-20240845097$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240916$$HP$CA$CA
242437012$24243701$2$F$20240801$20240826$20240823$20240828$PER$$US-JNJFOC-20240858495$JOHNSON AND JOHNSON$$$$$M$Y$$$20240828$$CN$US$US
242437021$24243702$1$I$20240822$20240823$20240823$20240823$DIR$715625$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242437041$24243704$1$I$20240819$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024166141$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242437051$24243705$1$I$$20240822$20240823$20240823$EXP$$CN-VANTIVE-2024VAN019268$Vantive US Healthcare$$$$$M$Y$$$20240823$$CN$CN$CN
242437061$24243706$1$I$20240301$20240730$20240823$20240823$PER$$GB-ALXN-202407USA002237US$ALEXION PHARMACEUTICALS$$82$YR$$M$Y$$$20240823$$CN$GB$US
242437071$24243707$1$I$20240508$20240819$20240823$20240823$PER$$CN-Eisai-EC-2024-172401$EISAI$$85$YR$E$F$Y$51$KG$20240823$$HP$CN$CN
242437082$24243708$2$F$$20240925$20240823$20240927$PER$$US-PFIZER INC-2023SGN10909$PFIZER$$76$YR$$F$Y$$$20240927$$PH$US$US
242437092$24243709$2$F$20240812$20240822$20240823$20240905$EXP$$CH-APELLIS-2024-APL-0000769$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240905$$MD$CH$CH
242437101$24243710$1$I$$20240812$20240823$20240823$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007357$AEGERION$$$$$F$Y$$$20240823$$HP$US$US
242437111$24243711$1$I$$20240814$20240823$20240823$EXP$$CA-GSK-CA2024053252$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$CA$CA
242437121$24243712$1$I$20240701$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013635$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240823$$CN$US$US
242437131$24243713$1$I$20240819$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166801$AMGEN$$55$YR$A$F$Y$$$20240823$$CN$US$US
242437141$24243714$1$I$$20240823$20240823$20240823$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047405$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240823$$PH$JP$JP
242437151$24243715$1$I$20210401$20240819$20240823$20240823$EXP$$TH-009507513-2408THA005845$MERCK$$70$YR$$$Y$$$20240823$$MD$TH$TH
242437171$24243717$1$I$20240823$20240823$20240823$20240823$DIR$715629$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242437181$24243718$1$I$20240823$20240823$20240823$20240823$DIR$715630$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242437191$24243719$1$I$$20240819$20240819$20240819$DIR$714989$$FDA-CTU$$$$$UNK$N$$$20240819$N$PH$US$
242437201$24243720$1$I$$20240819$20240823$20240823$PER$$US-BIOGEN-2024BI01270513$BIOGEN$$$$$F$Y$$$20240823$$CN$US$US
242437211$24243721$1$I$$20240812$20240823$20240823$EXP$FR-AFSSAPS-PV2024000722$FR-ROCHE-10000055097$ROCHE$$37$YR$A$F$Y$$$20240823$$MD$FR$FR
242437221$24243722$1$I$20230803$20230803$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000194$EMMAUS LIFE SCIENCES$$25$YR$A$M$Y$$$20240823$$CN$US$
242437231$24243723$1$I$20230803$20230803$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000196$EMMAUS LIFE SCIENCES$$47$YR$A$F$Y$$$20240823$$CN$US$
242437241$24243724$1$I$20230729$20230805$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000197$EMMAUS LIFE SCIENCES$$22$YR$A$M$Y$$$20240823$$CN$US$
242437251$24243725$1$I$$20230809$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000193$EMMAUS LIFE SCIENCES$$$$$M$Y$61.689$KG$20240823$$CN$US$
242437261$24243726$1$I$20230725$20230825$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000198$EMMAUS LIFE SCIENCES$$5$YR$C$M$Y$25$KG$20240823$$CN$US$
242437271$24243727$1$I$20230725$20230806$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000199$EMMAUS LIFE SCIENCES$$9$YR$C$F$Y$$$20240823$$CN$US$
242437281$24243728$1$I$20230101$20230807$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000200$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242437291$24243729$1$I$20230101$20230807$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000202$EMMAUS LIFE SCIENCES$$42$YR$A$F$Y$$$20240823$$CN$US$
242437301$24243730$1$I$20230101$20230911$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000204$EMMAUS LIFE SCIENCES$$66$YR$E$F$Y$$$20240823$$CN$US$
242437311$24243731$1$I$20230715$20230811$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000205$EMMAUS LIFE SCIENCES$$39$YR$A$M$Y$$$20240823$$CN$US$
242437321$24243732$1$I$20230807$20230814$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000207$EMMAUS LIFE SCIENCES$$40$YR$A$M$Y$$$20240823$$CN$US$
242437331$24243733$1$I$20230801$20230815$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000208$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242437341$24243734$1$I$20230801$20230823$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000209$EMMAUS LIFE SCIENCES$$44$YR$A$M$Y$$$20240823$$CN$US$
242437351$24243735$1$I$20230101$20230816$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000210$EMMAUS LIFE SCIENCES$$33$YR$A$F$Y$$$20240823$$CN$US$
242437361$24243736$1$I$$20230908$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000211$EMMAUS LIFE SCIENCES$$$$$M$Y$59.874$KG$20240823$$CN$US$
242437371$24243737$1$I$20230801$20231005$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000212$EMMAUS LIFE SCIENCES$$18$YR$A$F$Y$$$20240823$$CN$US$
242437381$24243738$1$I$$20230912$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000213$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242437391$24243739$1$I$20230101$20230818$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000215$EMMAUS LIFE SCIENCES$$30$YR$A$F$Y$$$20240823$$CN$US$
242437401$24243740$1$I$20230704$20230819$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000216$EMMAUS LIFE SCIENCES$$33$YR$A$M$Y$$$20240823$$CN$US$
242437411$24243741$1$I$20230807$20230821$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000217$EMMAUS LIFE SCIENCES$$8$YR$C$F$Y$$$20240823$$CN$US$
242437421$24243742$1$I$20230821$20230821$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000218$EMMAUS LIFE SCIENCES$$46$YR$A$F$Y$$$20240823$$CN$US$
242437431$24243743$1$I$20230601$20230823$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000219$EMMAUS LIFE SCIENCES$$29$YR$A$M$Y$$$20240823$$CN$US$
242437441$24243744$1$I$$20230823$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000220$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242437451$24243745$1$I$20230801$20230916$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000221$EMMAUS LIFE SCIENCES$$39$YR$A$F$Y$$$20240823$$CN$US$
242437461$24243746$1$I$20230701$20230918$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000214$EMMAUS LIFE SCIENCES$$27$YR$A$F$Y$58.9$KG$20240823$$CN$US$
242437471$24243747$1$I$20230815$20230829$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000222$EMMAUS LIFE SCIENCES$$24$YR$A$M$Y$$$20240823$$CN$US$
242437481$24243748$1$I$20230701$20230906$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000223$EMMAUS LIFE SCIENCES$$43$YR$A$F$Y$$$20240823$$CN$US$
242437491$24243749$1$I$20230101$20230830$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000224$EMMAUS LIFE SCIENCES$$30$YR$A$M$Y$$$20240823$$CN$US$
242437501$24243750$1$I$20230806$20230831$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000226$EMMAUS LIFE SCIENCES$$30$YR$A$F$Y$$$20240823$$CN$US$
242437511$24243751$1$I$20230101$20231025$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000227$EMMAUS LIFE SCIENCES$$44$YR$A$M$Y$$$20240823$$CN$US$
242437521$24243752$1$I$$20230831$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000228$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242437531$24243753$1$I$20230801$20230901$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000231$EMMAUS LIFE SCIENCES$$52$YR$A$F$Y$$$20240823$$CN$US$
242437541$24243754$1$I$20230601$20230908$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000233$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242437551$24243755$1$I$20230902$20230905$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000234$EMMAUS LIFE SCIENCES$$9$YR$C$F$Y$$$20240823$$CN$US$
242437561$24243756$1$I$20230715$20230902$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000237$EMMAUS LIFE SCIENCES$$10$YR$C$F$Y$$$20240823$$CN$US$
242437571$24243757$1$I$$20230906$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000238$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242437581$24243758$1$I$20230817$20230911$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000245$EMMAUS LIFE SCIENCES$$17$YR$T$F$Y$65.77$KG$20240823$$CN$US$
242437591$24243759$1$I$20230101$20230912$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000246$EMMAUS LIFE SCIENCES$$38$YR$A$F$Y$$$20240823$$CN$US$
242437601$24243760$1$I$20230824$20230831$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000229$EMMAUS LIFE SCIENCES$$25$YR$A$M$Y$$$20240823$$HP$US$
242437611$24243761$1$I$20230101$20230927$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000239$EMMAUS LIFE SCIENCES$$11$YR$C$M$Y$$$20240823$$CN$US$
242437621$24243762$1$I$20230828$20230911$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000244$EMMAUS LIFE SCIENCES$$49$YR$A$F$Y$$$20240823$$CN$US$
242437631$24243763$1$I$20230910$20230927$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000247$EMMAUS LIFE SCIENCES$$26$YR$A$F$Y$$$20240823$$CN$US$
242437641$24243764$1$I$20230101$20230912$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000248$EMMAUS LIFE SCIENCES$$35$YR$A$F$Y$$$20240823$$CN$US$
242437651$24243765$1$I$20230821$20230913$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000249$EMMAUS LIFE SCIENCES$$11$YR$C$F$Y$$$20240823$$CN$US$
242437661$24243766$1$I$20230101$20230914$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000251$EMMAUS LIFE SCIENCES$$40$YR$A$F$Y$$$20240823$$CN$US$
242437671$24243767$1$I$20230906$20230920$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000252$EMMAUS LIFE SCIENCES$$24$YR$A$M$Y$53.977$KG$20240823$$CN$US$
242437681$24243768$1$I$20230101$20230919$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000253$EMMAUS LIFE SCIENCES$$54$YR$A$F$Y$$$20240823$$CN$US$
242437691$24243769$1$I$20230901$20230920$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000254$EMMAUS LIFE SCIENCES$$12$YR$T$F$Y$$$20240823$$CN$US$
242437701$24243770$1$I$20230824$20230905$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000235$EMMAUS LIFE SCIENCES$$12$YR$T$F$Y$39.37$KG$20240823$$CN$US$
242437711$24243771$1$I$20221201$20230912$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000240$EMMAUS LIFE SCIENCES$$43$YR$A$F$Y$$$20240823$$CN$US$
242437721$24243772$1$I$20230101$20230907$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000241$EMMAUS LIFE SCIENCES$$36$YR$A$F$Y$$$20240823$$CN$US$
242437731$24243773$1$I$20230908$20230920$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000256$EMMAUS LIFE SCIENCES$$23$YR$A$F$Y$$$20240823$$CN$US$
242437741$24243774$1$I$20230101$20230921$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000257$EMMAUS LIFE SCIENCES$$42$YR$A$F$Y$$$20240823$$CN$US$
242437751$24243775$1$I$20230101$20230921$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000258$EMMAUS LIFE SCIENCES$$49$YR$A$M$Y$$$20240823$$CN$US$
242437761$24243776$1$I$$20230922$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000260$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242437771$24243777$1$I$20230101$20230925$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000262$EMMAUS LIFE SCIENCES$$7$YR$C$F$Y$$$20240823$$CN$US$
242437781$24243778$1$I$20230913$20230926$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000266$EMMAUS LIFE SCIENCES$$11$YR$C$M$Y$$$20240823$$CN$US$
242437791$24243779$1$I$20230901$20230927$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000269$EMMAUS LIFE SCIENCES$$46$YR$A$F$Y$$$20240823$$CN$US$
242437801$24243780$1$I$20230922$20230927$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000270$EMMAUS LIFE SCIENCES$$38$YR$A$F$Y$$$20240823$$CN$US$
242437811$24243781$1$I$20230912$20230928$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000273$EMMAUS LIFE SCIENCES$$33$YR$A$F$Y$$$20240823$$CN$US$
242437821$24243782$1$I$20230101$20231125$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000275$EMMAUS LIFE SCIENCES$$17$YR$T$F$Y$$$20240823$$CN$US$
242437831$24243783$1$I$20230910$20231121$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000276$EMMAUS LIFE SCIENCES$$13$YR$T$M$Y$$$20240823$$CN$US$
242437841$24243784$1$I$20230929$20231002$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000277$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242437851$24243785$1$I$20230101$20231002$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000279$EMMAUS LIFE SCIENCES$$23$YR$A$M$Y$$$20240823$$$US$
242437861$24243786$1$I$20230801$20231002$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000282$EMMAUS LIFE SCIENCES$$49$YR$A$M$Y$$$20240823$$CN$US$
242437871$24243787$1$I$20230901$20231004$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000284$EMMAUS LIFE SCIENCES$$40$YR$A$M$Y$$$20240823$$CN$US$
242437881$24243788$1$I$20230101$20231003$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000286$EMMAUS LIFE SCIENCES$$31$YR$A$F$Y$$$20240823$$CN$US$
242437891$24243789$1$I$20230901$20231017$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000288$EMMAUS LIFE SCIENCES$$56$YR$A$F$Y$86.636$KG$20240823$$CN$US$
242437901$24243790$1$I$20230901$20230921$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000259$EMMAUS LIFE SCIENCES$$44$YR$A$M$Y$$$20240823$$CN$US$
242437911$24243791$1$I$20220901$20231011$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000289$EMMAUS LIFE SCIENCES$$40$YR$A$F$Y$$$20240823$$CN$US$
242437921$24243792$1$I$20230901$20231005$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000291$EMMAUS LIFE SCIENCES$$10$YR$C$F$Y$$$20240823$$CN$US$
242437931$24243793$1$I$20230101$20231005$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000293$EMMAUS LIFE SCIENCES$$26$YR$A$F$Y$$$20240823$$CN$US$
242437941$24243794$1$I$20210701$20231025$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000285$EMMAUS LIFE SCIENCES$$59$YR$A$F$Y$62.2$KG$20240823$$CN$US$
242437951$24243795$1$I$20230101$20230913$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000250$EMMAUS LIFE SCIENCES$$38$YR$A$M$Y$$$20240823$$CN$US$
242437961$24243796$1$I$20230101$20231009$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000295$EMMAUS LIFE SCIENCES$$27$YR$A$F$Y$$$20240823$$CN$US$
242437971$24243797$1$I$20230918$20231011$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000298$EMMAUS LIFE SCIENCES$$18$YR$A$F$Y$$$20240823$$CN$US$
242437981$24243798$1$I$20230101$20231103$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000299$EMMAUS LIFE SCIENCES$$48$YR$A$F$Y$$$20240823$$CN$US$
242437991$24243799$1$I$20230101$20231014$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000302$EMMAUS LIFE SCIENCES$$44$YR$A$M$Y$$$20240823$$CN$US$
242438001$24243800$1$I$20230101$20231016$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000303$EMMAUS LIFE SCIENCES$$36$YR$A$F$Y$$$20240823$$CN$US$
242438011$24243801$1$I$20230101$20231017$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000305$EMMAUS LIFE SCIENCES$$13$YR$T$F$Y$$$20240823$$CN$US$
242438021$24243802$1$I$20231004$20231018$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000306$EMMAUS LIFE SCIENCES$$29$YR$A$F$Y$$$20240823$$CN$US$
242438031$24243803$1$I$20231001$20231018$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000308$EMMAUS LIFE SCIENCES$$51$YR$A$F$Y$$$20240823$$CN$US$
242438041$24243804$1$I$20231001$20231207$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000309$EMMAUS LIFE SCIENCES$$60$YR$A$F$Y$$$20240823$$CN$US$
242438051$24243805$1$I$20230801$20231023$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000310$EMMAUS LIFE SCIENCES$$30$YR$A$F$Y$$$20240823$$CN$US$
242438061$24243806$1$I$20231001$20231011$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000297$EMMAUS LIFE SCIENCES$$40$YR$A$F$Y$69.4$KG$20240823$$CN$US$
242438071$24243807$1$I$$20231101$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000307$EMMAUS LIFE SCIENCES$$$$$M$Y$97$KG$20240823$$CN$US$
242438081$24243808$1$I$20231001$20231023$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000312$EMMAUS LIFE SCIENCES$$35$YR$A$M$Y$$$20240823$$CN$US$
242438091$24243809$1$I$20230926$20231023$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000313$EMMAUS LIFE SCIENCES$$8$YR$C$M$Y$$$20240823$$CN$US$
242438101$24243810$1$I$20230101$20231023$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000314$EMMAUS LIFE SCIENCES$$53$YR$A$F$Y$$$20240823$$CN$US$
242438111$24243811$1$I$20231016$20231022$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000316$EMMAUS LIFE SCIENCES$$25$YR$A$F$Y$$$20240823$$CN$US$
242438121$24243812$1$I$$20231023$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000304$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242438131$24243813$1$I$20231018$20231024$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000317$EMMAUS LIFE SCIENCES$$26$YR$A$F$Y$$$20240823$$CN$US$
242438141$24243814$1$I$20231019$20231121$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000319$EMMAUS LIFE SCIENCES$$47$YR$A$F$Y$$$20240823$$CN$US$
242438151$24243815$1$I$20231001$20231025$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000321$EMMAUS LIFE SCIENCES$$45$YR$A$M$Y$$$20240823$$CN$US$
242438161$24243816$1$I$20230801$20231026$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000322$EMMAUS LIFE SCIENCES$$21$YR$A$F$Y$$$20240823$$CN$US$
242438171$24243817$1$I$20231001$20231120$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000324$EMMAUS LIFE SCIENCES$$28$YR$A$F$Y$$$20240823$$CN$US$
242438181$24243818$1$I$20231008$20231029$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000326$EMMAUS LIFE SCIENCES$$18$YR$A$M$Y$$$20240823$$CN$US$
242438191$24243819$1$I$20231001$20231031$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000329$EMMAUS LIFE SCIENCES$$16$YR$T$F$Y$$$20240823$$CN$US$
242438201$24243820$1$I$20231001$20231101$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000332$EMMAUS LIFE SCIENCES$$17$YR$T$M$Y$$$20240823$$CN$US$
242438211$24243821$1$I$$20231101$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000334$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242438221$24243822$1$I$20230101$20231024$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000320$EMMAUS LIFE SCIENCES$$12$YR$T$M$Y$$$20240823$$CN$US$
242438231$24243823$1$I$20231001$20231127$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000323$EMMAUS LIFE SCIENCES$$13$YR$T$M$Y$$$20240823$$CN$US$
242438241$24243824$1$I$20231012$20231027$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000325$EMMAUS LIFE SCIENCES$$7$YR$C$F$Y$31.751$KG$20240823$$CN$US$
242438251$24243825$1$I$20230101$20231103$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000337$EMMAUS LIFE SCIENCES$$7$YR$C$M$Y$$$20240823$$CN$US$
242438261$24243826$1$I$$20231103$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000338$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242438271$24243827$1$I$20230101$20231103$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000339$EMMAUS LIFE SCIENCES$$50$YR$A$F$Y$$$20240823$$CN$US$
242438281$24243828$1$I$20231101$20231106$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000340$EMMAUS LIFE SCIENCES$$41$YR$A$F$Y$$$20240823$$CN$US$
242438291$24243829$1$I$20190101$20231106$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000341$EMMAUS LIFE SCIENCES$$1$YR$I$M$Y$$$20240823$$CN$US$
242438301$24243830$1$I$20231001$20231107$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000343$EMMAUS LIFE SCIENCES$$56$YR$A$F$Y$$$20240823$$CN$US$
242438311$24243831$1$I$20230101$20231107$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000346$EMMAUS LIFE SCIENCES$$26$YR$A$F$Y$$$20240823$$CN$US$
242438321$24243832$1$I$20230101$20231103$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000336$EMMAUS LIFE SCIENCES$$12$YR$T$F$Y$$$20240823$$CN$US$
242438331$24243833$1$I$20231026$20231206$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000345$EMMAUS LIFE SCIENCES$$31$YR$A$M$Y$$$20240823$$CN$US$
242438341$24243834$1$I$20230101$20231108$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000347$EMMAUS LIFE SCIENCES$$54$YR$A$F$Y$$$20240823$$CN$US$
242438351$24243835$1$I$20230101$20231109$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000350$EMMAUS LIFE SCIENCES$$30$YR$A$F$Y$$$20240823$$CN$US$
242438361$24243836$1$I$20231016$20231201$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000353$EMMAUS LIFE SCIENCES$$51$YR$A$F$Y$$$20240823$$CN$US$
242438371$24243837$1$I$20230101$20231113$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000354$EMMAUS LIFE SCIENCES$$18$YR$A$F$Y$$$20240823$$MD$US$
242438381$24243838$1$I$20230526$20231113$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000355$EMMAUS LIFE SCIENCES$$56$YR$A$F$Y$$$20240823$$CN$US$
242438391$24243839$1$I$20231017$20231110$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000356$EMMAUS LIFE SCIENCES$$31$YR$A$F$Y$$$20240823$$CN$US$
242438401$24243840$1$I$20231107$20231127$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000357$EMMAUS LIFE SCIENCES$$57$YR$A$F$Y$$$20240823$$CN$US$
242438411$24243841$1$I$20231001$20231114$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000358$EMMAUS LIFE SCIENCES$$41$YR$A$F$Y$$$20240823$$CN$US$
242438421$24243842$1$I$20231110$20231113$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000359$EMMAUS LIFE SCIENCES$$10$YR$C$M$Y$$$20240823$$CN$US$
242438441$24243844$1$I$20230101$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133563$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240823$$CN$US$US
242438451$24243845$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA168732$NOVARTIS$$39$YR$$M$Y$$$20240823$$PH$CA$CA
242438461$24243846$1$I$20231001$20231024$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000318$EMMAUS LIFE SCIENCES$$18$YR$A$M$Y$89.5$KG$20240823$$CN$US$
242438471$24243847$1$I$$20231107$20240823$20240823$PER$$US-PFIZER INC-2023SGN11948$PFIZER$$$$$$Y$$$20240823$$PH$US$US
242438481$24243848$1$I$$20231006$20240823$20240823$PER$$US-PFIZER INC-2023SGN11003$PFIZER$$65$YR$$M$Y$$$20240823$$MD$US$US
242438491$24243849$1$I$20240802$20240816$20240823$20240823$EXP$$CO-GSK-CO2024AMR103834$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$CO$CO
242438501$24243850$1$I$$20240729$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN007924$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242438511$24243851$1$I$20231001$20231115$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000311$EMMAUS LIFE SCIENCES$$52$YR$A$M$Y$$$20240823$$CN$US$
242438521$24243852$1$I$20220101$20240812$20240823$20240823$EXP$$US-JNJFOC-20240831514$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$CN$US$US
242438531$24243853$1$I$20230103$20240816$20240823$20240823$EXP$$DE-JNJFOC-20240535483$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$MD$DE$DE
242438542$24243854$2$F$$20240820$20240823$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134175$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240828$$CN$US$US
242438551$24243855$1$I$$20240816$20240823$20240823$EXP$$PL-AMGEN-POLSP2024164387$AMGEN$Zok J.; Bienkowski M.; Radecka B. et al.. The treatment outcomes of patients with BRAFV600E-mutated metastatic colorectal cancer (mCRC)- The Polish retrospective cohort study. Journal of Clinical Oncology. 2024;42 (16):e15535$$$$$Y$$$20240823$$HP$PL$PL
242438561$24243856$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167483$AMGEN$$$$$$Y$$$20240823$$HP$US$US
242438571$24243857$1$I$20240820$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024168386$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242438581$24243858$1$I$$20240730$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN007983$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242438592$24243859$2$F$20240722$20240821$20240823$20240830$EXP$$CA-JNJFOC-20240849483$JOHNSON AND JOHNSON$$85$YR$E$M$Y$99$KG$20240830$$HP$CA$CA
242438601$24243860$1$I$$20240819$20240823$20240823$EXP$$CA-DSJP-DSJ-2024-141758$DAIICHI$$37$YR$$F$Y$$$20240823$$HP$CA$CA
242438611$24243861$1$I$$20240822$20240823$20240823$EXP$GB-MHRA-MIDB-a8eb119e-06d5-4eb2-bb18-b3cc85e02e58$GB-TEVA-VS-3236117$TEVA$$45$YR$$$Y$$$20240823$$PH$GB$GB
242438621$24243862$1$I$$20240822$20240823$20240823$EXP$$US-BAYER-2024A121416$BAYER$$$$$M$Y$$$20240823$$CN$US$US
242438632$24243863$2$F$20240629$20240917$20240823$20240920$EXP$$JP-OTSUKA-2024_021048$OTSUKA$$89$YR$$F$Y$55.5$KG$20240920$$MD$JP$JP
242438641$24243864$1$I$$20240819$20240823$20240823$EXP$$IT-009507513-2408ITA007514$MERCK$$81$YR$$M$Y$$$20240823$$MD$IT$IT
242438651$24243865$1$I$20240815$20240815$20240823$20240823$PER$$US-AMGEN-USASP2024166822$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242438661$24243866$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024167453$AMGEN$$$$$$Y$$$20240823$$HP$US$US
242438671$24243867$1$I$$20240811$20240823$20240823$EXP$$US-AMGEN-USASP2024163056$AMGEN$Lakshman A.; Jensen J. L.; Chakraborty R. et al.. Second primary B-ALL after exposure to lenalidomide for multiple myeloma: A US multicenter study. Journal of Clinical Oncology. 2024;42(16):1-2$$$$$Y$$$20240823$$HP$US$US
242438681$24243868$1$I$$20240821$20240823$20240823$EXP$$US-ABBVIE-5892007$ABBVIE$$$$A$M$Y$$$20240823$$MD$US$US
242438731$24243873$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58105$$FDA-CTU$$61$YR$$$N$$$20240731$N$$US$
242438741$24243874$1$I$20240816$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58208$$FDA-CTU$$60$YR$$M$N$79.2$KG$20240823$N$HP$US$
242438761$24243876$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58222$$FDA-CTU$$58$YR$$F$N$$$20240823$N$$US$
242438771$24243877$1$I$$20240823$20240823$20240823$DIR$715606$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242438791$24243879$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58146$$FDA-CTU$$46$YR$$F$N$193$LBS$20240823$N$$US$
242438824$24243882$4$F$$20240929$20240823$20240930$30DAY$$US-PFIZER INC-202400235952$PFIZER$$11$YR$$F$Y$$$20240930$$CN$US$US
242438832$24243883$2$F$$20240905$20240823$20240910$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-141743$DAIICHI$$34$YR$$F$Y$$$20240910$$CN$US$US
242438841$24243884$1$I$$20240815$20240823$20240823$EXP$$US-TAKEDA-2024TUS082916$TAKEDA$$$$$M$Y$$$20240823$$CN$US$US
242438854$24243885$4$F$$20240903$20240823$20240911$EXP$$CA-DSJP-DSJ-2024-140140$DAIICHI$$$$$F$Y$52$KG$20240911$$MD$CA$CA
242438861$24243886$1$I$$20240821$20240823$20240823$EXP$$NVSC2024AU169934$NOVARTIS$$$$$$Y$$$20240823$$MD$AU$AU
242438871$24243887$1$I$$20240819$20240823$20240823$EXP$$US-LUNDBECK-DKLU4003315$LUNDBECK$$$$$$Y$$$20240823$$PH$US$US
242438881$24243888$1$I$$20240822$20240823$20240823$PER$$US-HALEON-2193300$Haleon PLC$$$$$$Y$$$20240823$$CN$US$US
242438901$24243890$1$I$$20240812$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008497$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242438911$24243891$1$I$$20240821$20240823$20240823$EXP$$JP-BAYER-2024A120572$BAYER$$68$YR$E$M$Y$$$20240823$$MD$JP$JP
242438921$24243892$1$I$$20240814$20240823$20240823$EXP$$GB-RDY-SPO/GBR/24/0012148$DR REDDYS$Clarke E, Thu K, Bracey T. Rectal gastric heterotopia with fundic gland polyps, mimicking a high-risk primary anorectal neoplasm: histological evidence of the effects of gastric acid-suppressing medication in a rectal ^outlet patch. Diagnostic Histopathology. 2024 Apr 17;30(6): 344-347. doi:10.1016/j.mpdhp.2024.03.005.$78$YR$E$F$Y$$$20240823$$HP$GB$GB
242438931$24243893$1$I$$20240813$20240823$20240823$EXP$$CA-BAXTER-2024BAX023223$BAXTER$$63$YR$$F$Y$72$KG$20240823$$MD$CA$CA
242438942$24243894$2$F$$20240819$20240823$20240828$EXP$$CA-BAXTER-2024BAX023222$BAXTER$$57$YR$$M$Y$$$20240828$$HP$CA$CA
242438951$24243895$1$I$$20240813$20240823$20240823$EXP$$JP-009507513-2408JPN004987$MERCK$$$$$M$Y$$$20240823$$MD$JP$JP
242438961$24243896$1$I$$20240812$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008449$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242438971$24243897$1$I$$20240812$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008450$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242438981$24243898$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58202$$FDA-CTU$$$$$F$N$$$20240823$N$HP$US$
242438991$24243899$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58111$$FDA-CTU$$40$YR$$$N$$$20240731$N$$US$
242439001$24243900$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA169036$NOVARTIS$$71$YR$$F$Y$$$20240823$$HP$CA$CA
242439012$24243901$2$F$$20240822$20240823$20240826$EXP$$GB-JNJFOC-20240855166$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$HP$GB$GB
242439021$24243902$1$I$$20240819$20240823$20240823$EXP$$JP-AMGEN-JPNSP2024165598$AMGEN$$82$YR$E$F$Y$$$20240823$$MD$JP$JP
242439031$24243903$1$I$20240823$20240823$20240823$20240823$DIR$715632$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242439041$24243904$1$I$$20240819$20240823$20240823$DIR$FDA-CDER-CTU-2024-58197$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242439052$24243905$2$F$20230221$20240906$20240823$20240913$EXP$$US-AMGEN-USASP2024166006$AMGEN$$52$YR$A$M$Y$83.2$KG$20240913$$LW$US$US
242439071$24243907$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013145$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240823$$CN$US$US
242439081$24243908$1$I$$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014643$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240823$$CN$US$US
242439091$24243909$1$I$$20240816$20240823$20240823$EXP$$JP-009507513-2408JPN002100J$MERCK$$8$DEC$$F$Y$$$20240823$$MD$JP$JP
242439101$24243910$1$I$20240625$20240813$20240823$20240823$EXP$$US-UCBSA-2024041221$UCB$$34$YR$$M$Y$97.052$KG$20240823$$HP$US$US
242439111$24243911$1$I$$20240814$20240823$20240823$EXP$$IL-TAKEDA-2024TUS084288$TAKEDA$$74$YR$$F$Y$60$KG$20240823$$MD$IL$IL
242439131$24243913$1$I$$20240823$20240823$20240823$DIR$715610$$FDA-CTU$$53$YR$$F$N$60.75$KG$20240823$N$CN$US$
242439141$24243914$1$I$20240814$20240823$20240823$20240823$DIR$715624$$FDA-CTU$$68$YR$$M$N$68.4$KG$20240823$N$HP$US$
242439151$24243915$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012868$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240823$$CN$US$US
242439161$24243916$1$I$$20240819$20240823$20240823$EXP$$US-ABBVIE-5887406$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242439171$24243917$1$I$$20240821$20240823$20240823$EXP$$JP-BAYER-2024A120574$BAYER$$72$YR$E$M$Y$$$20240823$$MD$JP$JP
242439181$24243918$1$I$20240816$20240816$20240823$20240823$EXP$$FR-DSJP-DSE-2024-141253$DAIICHI$$$$A$F$Y$62$KG$20240823$$MD$FR$FR
242439191$24243919$1$I$$20240821$20240823$20240823$PER$$US-ABBVIE-5891316$ABBVIE$$$$$$Y$$$20240823$$MD$US$US
242439201$24243920$1$I$20240815$20240819$20240823$20240823$DIR$FDA-CDER-CTU-2024-58141$$FDA-CTU$$79$YR$$F$N$$$20240819$N$HP$US$
242439211$24243921$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58112$$FDA-CTU$$46$YR$$$N$$$20240731$N$$US$
242439221$24243922$1$I$$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133472$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240823$$CN$US$US
242439232$24243923$2$F$20240401$20240822$20240823$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133810$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$56.25$KG$20240826$$CN$US$US
242439242$24243924$2$F$20170505$20240828$20240823$20240828$EXP$DE-CADRBFARM-2024329969$DE-GILEAD-2024-0685168$GILEAD$$77$YR$E$M$Y$95$KG$20240828$$MD$DE$DE
242439251$24243925$1$I$$20240817$20240823$20240823$EXP$$CA-TAKEDA-2024TUS083394$TAKEDA$$$$$M$Y$$$20240823$$CN$CA$CA
242439262$24243926$2$F$20240801$20240911$20240823$20240918$EXP$$AR-GSK-AR2022AMR025348$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$AR$AR
242439271$24243927$1$I$20240813$20240815$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130159$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$69.85$KG$20240823$$PH$US$US
242439281$24243928$1$I$$20240823$20240823$20240823$DIR$715615$$FDA-CTU$$$$$M$N$$$20240823$N$PH$US$
242439291$24243929$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58242$$FDA-CTU$$40$YR$$F$N$$$20240823$N$$US$
242439301$24243930$1$I$20240729$20240823$20240823$20240823$DIR$715618$$FDA-CTU$$74$YR$$M$N$90$KG$20240823$N$HP$US$
242439311$24243931$1$I$$20240823$20240823$20240823$DIR$715633$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242439321$24243932$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58134$$FDA-CTU$$54$YR$$F$N$$$20240823$N$$US$
242439331$24243933$1$I$$20240809$20240823$20240823$DIR$FDA-CDER-CTU-2024-58185$$FDA-CTU$$$$$F$N$$$20240809$N$HP$US$
242439371$24243937$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58239$$FDA-CTU$$65$YR$$F$N$$$20240823$N$$US$
242439391$24243939$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58120$$FDA-CTU$$63$YR$$M$N$$$20240731$N$$US$
242439401$24243940$1$I$$20240731$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008027$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242439411$24243941$1$I$$20240815$20240823$20240823$EXP$$CA-TAKEDA-2024TUS063045$TAKEDA$$$$$F$Y$$$20240823$$HP$CA$CA
242439421$24243942$1$I$20230711$20240820$20240823$20240823$EXP$$US-OTSUKA-2024_022976$OTSUKA$$92$YR$$F$Y$$$20240823$$CN$US$US
242439451$24243945$1$I$$20240821$20240823$20240823$PER$$US-DSJP-DSU-2024-141733$DAIICHI$$$$$F$Y$$$20240823$$HP$US$US
242439462$24243946$2$F$20240805$20240917$20240823$20240920$EXP$$MX-TAKEDA-2024TUS083900$TAKEDA$$36$YR$$F$Y$87$KG$20240920$$CN$MX$MX
242439471$24243947$1$I$20240815$20240815$20240823$20240823$PER$$US-RDY-SPO/USA/24/0012017$DR REDDYS$$14$YR$T$F$Y$$$20240823$$MD$US$US
242439481$24243948$1$I$$20240821$20240823$20240823$EXP$$JP-BAYER-2024A120575$BAYER$$74$YR$E$M$Y$$$20240823$$MD$JP$JP
242439491$24243949$1$I$20240817$20240817$20240823$20240823$PER$$US-RDY-SPO/USA/24/0012055$DR REDDYS$$14$YR$T$F$Y$$$20240823$$CN$US$US
242439501$24243950$1$I$20240815$20240815$20240823$20240823$PER$$US-RDY-SPO/USA/24/0012023$DR REDDYS$$15$YR$T$F$Y$$$20240823$$MD$US$US
242439511$24243951$1$I$$20240813$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008535$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242439522$24243952$2$F$20231201$20240910$20240823$20240913$EXP$$KE-TAKEDA-2024TUS085079$TAKEDA$$16$YR$$M$Y$$$20240913$$CN$KE$KE
242439531$24243953$1$I$20240716$20240820$20240823$20240823$EXP$$CA-TAKEDA-2024TUS073184$TAKEDA$$71$YR$$F$Y$$$20240823$$CN$CA$CA
242439541$24243954$1$I$$20240820$20240823$20240823$EXP$$US-JNJFOC-20240854968$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$HP$US$US
242439551$24243955$1$I$20240403$20240418$20240823$20240823$PER$$US-JNJFOC-20240857170$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$MD$US$US
242439561$24243956$1$I$$20240820$20240823$20240823$PER$$US-JNJFOC-20240851724$JOHNSON AND JOHNSON$$$$$$Y$$$20240823$$CN$US$US
242439572$24243957$2$F$20240706$20240826$20240823$20240827$EXP$FR-AFSSAPS-AN2024001146$NVSC2024FR170753$NOVARTIS$$39$YR$$F$Y$$$20240827$$MD$FR$FR
242439581$24243958$1$I$$20240806$20240823$20240823$PER$$US-TEVA-VS-3231294$TEVA$$41$YR$$F$Y$$$20240823$$CN$US$US
242439591$24243959$1$I$20240601$20240821$20240823$20240823$EXP$$CH-ANIPHARMA-2024-CH-000035$ANI$$65$YR$$M$Y$$$20240823$$MD$CH$CH
242439602$24243960$2$F$20240801$20240822$20240823$20240916$EXP$$JP-TAKEDA-2024TUS085149$TAKEDA$$15$YR$$M$Y$$$20240916$$CN$JP$JP
242439611$24243961$1$I$$20240814$20240823$20240823$EXP$$US-ALCON LABORATORIES-ALC2024US003837$ALCON$Elise Timtim, Behin Barahimi, Louise A. Mawn + Rachel K. Sobel. Sebaceous carcinoma masquerading as ocular mucous membrane pemphigoid. The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surger. 2024;43:4:531-34$56$YR$$F$Y$$$20240823$$HP$US$US
242439621$24243962$1$I$20231201$20231229$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000004$EMMAUS LIFE SCIENCES$$20$YR$A$F$Y$$$20240823$$CN$US$
242439631$24243963$1$I$20231101$20231229$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000005$EMMAUS LIFE SCIENCES$$12$YR$T$F$Y$$$20240823$$CN$US$
242439641$24243964$1$I$20230901$20240112$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000007$EMMAUS LIFE SCIENCES$$41$YR$A$F$Y$$$20240823$$CN$US$
242439651$24243965$1$I$20231221$20240103$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000013$EMMAUS LIFE SCIENCES$$55$YR$A$M$Y$$$20240823$$CN$US$
242439661$24243966$1$I$20240104$20240105$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000016$EMMAUS LIFE SCIENCES$$19$YR$A$F$Y$$$20240823$$CN$US$
242439671$24243967$1$I$20231219$20240101$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000008$EMMAUS LIFE SCIENCES$$44$YR$A$M$Y$$$20240823$$CN$US$
242439681$24243968$1$I$20231228$20240102$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000009$EMMAUS LIFE SCIENCES$$8$YR$C$M$Y$$$20240823$$CN$US$
242439691$24243969$1$I$$20240102$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000011$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242439701$24243970$1$I$20231001$20240103$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000012$EMMAUS LIFE SCIENCES$$25$YR$A$F$Y$$$20240823$$CN$US$
242439711$24243971$1$I$20231001$20240104$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000015$EMMAUS LIFE SCIENCES$$54$YR$A$M$Y$$$20240823$$CN$US$
242439721$24243972$1$I$20231201$20240105$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000017$EMMAUS LIFE SCIENCES$$27$YR$A$F$Y$$$20240823$$CN$US$
242439731$24243973$1$I$20230101$20240105$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000018$EMMAUS LIFE SCIENCES$$38$YR$A$M$Y$$$20240823$$CN$US$
242439741$24243974$1$I$20240105$20240108$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000019$EMMAUS LIFE SCIENCES$$38$YR$A$F$Y$$$20240823$$CN$US$
242439751$24243975$1$I$$20240105$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000021$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242439761$24243976$1$I$20231221$20240108$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000023$EMMAUS LIFE SCIENCES$$23$YR$A$M$Y$$$20240823$$CN$US$
242439771$24243977$1$I$20240101$20240314$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000014$EMMAUS LIFE SCIENCES$$13$YR$T$M$Y$32.8$KG$20240823$$CN$US$
242439781$24243978$1$I$20240102$20240109$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000024$EMMAUS LIFE SCIENCES$$51$YR$A$F$Y$$$20240823$$CN$US$
242439791$24243979$1$I$20231201$20240110$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000025$EMMAUS LIFE SCIENCES$$25$YR$A$M$Y$$$20240823$$CN$US$
242439801$24243980$1$I$20230101$20240110$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000027$EMMAUS LIFE SCIENCES$$7$YR$C$F$Y$$$20240823$$CN$US$
242439811$24243981$1$I$20240101$20240111$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000028$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242439821$24243982$1$I$20240101$20240117$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000030$EMMAUS LIFE SCIENCES$$49$YR$A$F$Y$$$20240823$$CN$US$
242439831$24243983$1$I$20231201$20240118$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000032$EMMAUS LIFE SCIENCES$$33$YR$A$F$Y$$$20240823$$CN$US$
242439841$24243984$1$I$20231014$20240228$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000035$EMMAUS LIFE SCIENCES$$30$YR$A$M$Y$$$20240823$$CN$US$
242439851$24243985$1$I$20230101$20240223$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000038$EMMAUS LIFE SCIENCES$$60$YR$A$F$Y$$$20240823$$CN$US$
242439861$24243986$1$I$$20240119$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000041$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242439871$24243987$1$I$20231201$20240122$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000037$EMMAUS LIFE SCIENCES$$15$YR$T$F$Y$$$20240823$$CN$US$
242439881$24243988$1$I$20231101$20240228$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000039$EMMAUS LIFE SCIENCES$$20$YR$A$F$Y$$$20240823$$CN$US$
242439891$24243989$1$I$20210101$20240301$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000043$EMMAUS LIFE SCIENCES$$39$YR$A$F$Y$$$20240823$$CN$US$
242439901$24243990$1$I$20240115$20240122$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000044$EMMAUS LIFE SCIENCES$$36$YR$A$F$Y$$$20240823$$CN$US$
242439911$24243991$1$I$$20240318$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000045$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242439921$24243992$1$I$20240111$20240124$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000047$EMMAUS LIFE SCIENCES$$54$YR$A$M$Y$61.3$KG$20240823$$CN$US$
242439931$24243993$1$I$20240103$20240124$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000049$EMMAUS LIFE SCIENCES$$27$YR$A$M$Y$$$20240823$$CN$US$
242439941$24243994$1$I$20240101$20240513$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000050$EMMAUS LIFE SCIENCES$$39$YR$A$F$Y$$$20240823$$CN$US$
242439951$24243995$1$I$20240103$20240125$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000051$EMMAUS LIFE SCIENCES$$28$YR$A$F$Y$$$20240823$$CN$US$
242439961$24243996$1$I$20231001$20240126$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000052$EMMAUS LIFE SCIENCES$$48$YR$A$F$Y$$$20240823$$CN$US$
242439971$24243997$1$I$20240102$20240126$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000054$EMMAUS LIFE SCIENCES$$49$YR$A$M$Y$89.993$KG$20240823$$CN$US$
242439981$24243998$1$I$$20240129$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000058$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242439991$24243999$1$I$20240117$20240129$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000059$EMMAUS LIFE SCIENCES$$51$YR$A$F$Y$$$20240823$$CN$US$
242440001$24244000$1$I$20240113$20240129$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000060$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242440011$24244001$1$I$20240118$20240131$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000061$EMMAUS LIFE SCIENCES$$38$YR$A$F$Y$$$20240823$$CN$US$
242440021$24244002$1$I$20240101$20240131$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000062$EMMAUS LIFE SCIENCES$$51$YR$A$F$Y$$$20240823$$CN$US$
242440031$24244003$1$I$$20240131$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000063$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$PH$US$
242440041$24244004$1$I$20190701$20240201$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000065$EMMAUS LIFE SCIENCES$$12$YR$T$F$Y$$$20240823$$CN$US$
242440051$24244005$1$I$20240128$20240314$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000069$EMMAUS LIFE SCIENCES$$21$YR$A$F$Y$38.7$KG$20240823$$CN$US$
242440061$24244006$1$I$20231201$20240206$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000070$EMMAUS LIFE SCIENCES$$19$YR$A$F$Y$$$20240823$$CN$US$
242440071$24244007$1$I$20231201$20240212$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000068$EMMAUS LIFE SCIENCES$$10$YR$C$F$Y$29.5$KG$20240823$$CN$US$
242440081$24244008$1$I$20240207$20240211$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000071$EMMAUS LIFE SCIENCES$$43$YR$A$F$Y$$$20240823$$CN$US$
242440091$24244009$1$I$20240201$20240223$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000072$EMMAUS LIFE SCIENCES$$32$YR$A$M$Y$62.414$KG$20240823$$CN$US$
242440101$24244010$1$I$20240108$20240213$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000074$EMMAUS LIFE SCIENCES$$49$YR$A$F$Y$$$20240823$$CN$US$
242440111$24244011$1$I$20230101$20231113$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000361$EMMAUS LIFE SCIENCES$$24$YR$A$M$Y$$$20240823$$CN$US$
242440121$24244012$1$I$20231113$20231114$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000363$EMMAUS LIFE SCIENCES$$8$YR$C$M$Y$$$20240823$$CN$US$
242440131$24244013$1$I$20230101$20231220$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000366$EMMAUS LIFE SCIENCES$$36$YR$A$F$Y$$$20240823$$CN$US$
242440141$24244014$1$I$20230701$20231115$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000367$EMMAUS LIFE SCIENCES$$11$YR$C$F$Y$$$20240823$$CN$US$
242440151$24244015$1$I$20230101$20231127$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000368$EMMAUS LIFE SCIENCES$$42$YR$A$M$Y$$$20240823$$CN$US$
242440161$24244016$1$I$20231012$20231115$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000369$EMMAUS LIFE SCIENCES$$49$YR$A$F$Y$$$20240823$$CN$US$
242440171$24244017$1$I$20231101$20231116$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000370$EMMAUS LIFE SCIENCES$$51$YR$A$F$Y$$$20240823$$CN$US$
242440181$24244018$1$I$20231106$20231116$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000371$EMMAUS LIFE SCIENCES$$28$YR$A$F$Y$$$20240823$$CN$US$
242440191$24244019$1$I$20231114$20231118$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000389$EMMAUS LIFE SCIENCES$$14$YR$T$M$Y$$$20240823$$CN$US$
242440201$24244020$1$I$20230101$20231221$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000390$EMMAUS LIFE SCIENCES$$58$YR$A$M$Y$$$20240823$$CN$US$
242440211$24244021$1$I$20230101$20231120$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000391$EMMAUS LIFE SCIENCES$$7$YR$C$F$Y$$$20240823$$CN$US$
242440221$24244022$1$I$20231101$20231120$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000392$EMMAUS LIFE SCIENCES$$11$YR$C$F$Y$$$20240823$$CN$US$
242440231$24244023$1$I$20231101$20231121$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000393$EMMAUS LIFE SCIENCES$$11$YR$C$M$Y$$$20240823$$CN$US$US
242440241$24244024$1$I$20231123$20231124$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000396$EMMAUS LIFE SCIENCES$$45$YR$A$M$Y$$$20240823$$CN$US$
242440251$24244025$1$I$20231101$20231124$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000397$EMMAUS LIFE SCIENCES$$36$YR$A$M$Y$$$20240823$$CN$US$
242440261$24244026$1$I$20231015$20231206$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000398$EMMAUS LIFE SCIENCES$$20$YR$A$M$Y$$$20240823$$CN$US$
242440271$24244027$1$I$20231102$20231125$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000399$EMMAUS LIFE SCIENCES$$39$YR$A$F$Y$$$20240823$$CN$US$
242440281$24244028$1$I$20231101$20231127$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000400$EMMAUS LIFE SCIENCES$$38$YR$A$F$Y$$$20240823$$CN$US$
242440291$24244029$1$I$20231120$20231124$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000401$EMMAUS LIFE SCIENCES$$40$YR$A$M$Y$$$20240823$$CN$US$
242440301$24244030$1$I$20231127$20231128$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000402$EMMAUS LIFE SCIENCES$$43$YR$A$F$Y$$$20240823$$CN$US$
242440311$24244031$1$I$20231001$20231206$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000403$EMMAUS LIFE SCIENCES$$12$YR$T$F$Y$36.4$KG$20240823$$CN$US$
242440321$24244032$1$I$20231111$20231128$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000404$EMMAUS LIFE SCIENCES$$51$YR$A$F$Y$$$20240823$$CN$US$
242440331$24244033$1$I$$20231129$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000405$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242440341$24244034$1$I$20230701$20231130$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000407$EMMAUS LIFE SCIENCES$$11$YR$C$M$Y$$$20240823$$CN$US$
242440351$24244035$1$I$20231101$20231201$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000408$EMMAUS LIFE SCIENCES$$44$YR$A$M$Y$$$20240823$$CN$US$
242440361$24244036$1$I$20230101$20231201$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000409$EMMAUS LIFE SCIENCES$$41$YR$A$F$Y$$$20240823$$CN$US$
242440371$24244037$1$I$20231101$20231204$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000410$EMMAUS LIFE SCIENCES$$32$YR$A$M$Y$$$20240823$$CN$US$
242440381$24244038$1$I$20231101$20231205$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000412$EMMAUS LIFE SCIENCES$$7$YR$C$F$Y$$$20240823$$CN$US$
242440391$24244039$1$I$20230905$20231206$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000414$EMMAUS LIFE SCIENCES$$27$YR$A$F$Y$85.2$KG$20240823$$CN$US$
242440401$24244040$1$I$20231129$20231206$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000416$EMMAUS LIFE SCIENCES$$14$YR$T$M$Y$$$20240823$$CN$US$
242440411$24244041$1$I$20230101$20231221$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000417$EMMAUS LIFE SCIENCES$$57$YR$A$F$Y$$$20240823$$CN$US$
242440421$24244042$1$I$20231204$20231209$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000418$EMMAUS LIFE SCIENCES$$8$YR$C$M$Y$$$20240823$$CN$US$
242440431$24244043$1$I$20231124$20231211$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000420$EMMAUS LIFE SCIENCES$$7$YR$C$F$Y$$$20240823$$CN$US$
242440441$24244044$1$I$20231122$20231213$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000421$EMMAUS LIFE SCIENCES$$56$YR$A$F$Y$$$20240823$$CN$US$
242440451$24244045$1$I$20230101$20231220$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000423$EMMAUS LIFE SCIENCES$$44$YR$A$F$Y$$$20240823$$CN$US$
242440461$24244046$1$I$20230101$20231213$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000424$EMMAUS LIFE SCIENCES$$51$YR$A$F$Y$$$20240823$$CN$US$
242440471$24244047$1$I$20231001$20231122$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000395$EMMAUS LIFE SCIENCES$$46$YR$A$F$Y$$$20240823$$CN$US$
242440481$24244048$1$I$20231206$20231214$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000425$EMMAUS LIFE SCIENCES$$12$YR$T$F$Y$$$20240823$$CN$US$
242440491$24244049$1$I$20221001$20231215$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000426$EMMAUS LIFE SCIENCES$$35$YR$A$M$Y$$$20240823$$CN$US$
242440501$24244050$1$I$20231203$20231218$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000427$EMMAUS LIFE SCIENCES$$12$YR$T$F$Y$$$20240823$$CN$US$
242440511$24244051$1$I$20231216$20231218$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000428$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242440521$24244052$1$I$20230505$20231218$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000429$EMMAUS LIFE SCIENCES$$26$YR$A$F$Y$$$20240823$$CN$US$
242440531$24244053$1$I$20230101$20231220$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000432$EMMAUS LIFE SCIENCES$$38$YR$A$F$Y$$$20240823$$CN$US$
242440541$24244054$1$I$20231222$20231224$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000434$EMMAUS LIFE SCIENCES$$51$YR$A$F$Y$$$20240823$$CN$US$
242440551$24244055$1$I$20231201$20231222$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000435$EMMAUS LIFE SCIENCES$$60$YR$A$F$Y$$$20240823$$CN$US$
242440561$24244056$1$I$20231225$20231226$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000436$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242440571$24244057$1$I$20230101$20240301$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000360$EMMAUS LIFE SCIENCES$$13$YR$T$F$Y$$$20240823$$CN$US$
242440581$24244058$1$I$20231210$20240108$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000437$EMMAUS LIFE SCIENCES$$27$YR$A$M$Y$$$20240823$$CN$US$
242440591$24244059$1$I$20231226$20240112$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000438$EMMAUS LIFE SCIENCES$$24$YR$A$M$Y$51.6$KG$20240823$$CN$US$
242440601$24244060$1$I$20231218$20231225$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000439$EMMAUS LIFE SCIENCES$$20$YR$A$F$Y$$$20240823$$CN$US$
242440611$24244061$1$I$20230101$20231226$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000440$EMMAUS LIFE SCIENCES$$22$YR$A$M$Y$$$20240823$$CN$US$
242440621$24244062$1$I$20231201$20231227$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000441$EMMAUS LIFE SCIENCES$$30$YR$A$M$Y$$$20240823$$CN$US$
242440631$24244063$1$I$20230101$20231227$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000443$EMMAUS LIFE SCIENCES$$26$YR$A$F$Y$$$20240823$$CN$US$
242440641$24244064$1$I$20231217$20231227$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000444$EMMAUS LIFE SCIENCES$$46$YR$A$F$Y$$$20240823$$CN$US$
242440651$24244065$1$I$20230101$20231228$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000001$EMMAUS LIFE SCIENCES$$22$YR$A$M$Y$$$20240823$$CN$US$
242440672$24244067$2$F$20240101$20240906$20240823$20240910$EXP$$US-PFIZER INC-PV202400036950$PFIZER$$76$YR$$M$Y$$$20240910$$HP$US$US
242440682$24244068$2$F$$20240823$20240823$20240825$PER$$US-JNJFOC-20240855195$JOHNSON AND JOHNSON$$$$$$Y$$$20240825$$MD$US$US
242440701$24244070$1$I$$20240820$20240823$20240823$EXP$$US-PFIZER INC-202400241529$PFIZER$Bhandari, B.. Loperamide-Induced Torsades de Pointes. Cureus. 2024;16(7):10.7759/cureus.64427.$27$YR$$F$Y$$$20240823$$MD$US$US
242440711$24244071$1$I$20231114$20240111$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000415$EMMAUS LIFE SCIENCES$$16$YR$T$F$Y$90.5$KG$20240823$$CN$US$
242440721$24244072$1$I$$20231113$20240823$20240823$PER$$US-PFIZER INC-2023SGN12126$PFIZER$$$$$$Y$$$20240823$$MD$US$US
242440742$24244074$2$F$20240427$20240905$20240823$20240906$EXP$$US-PFIZER INC-202400172779$PFIZER$$82$YR$$F$Y$70.31$KG$20240906$$CN$US$US
242440761$24244076$1$I$20240821$20240821$20240823$20240823$PER$$US-JNJFOC-20240854927$JOHNSON AND JOHNSON$$79$YR$E$$Y$$$20240823$$PH$US$US
242440771$24244077$1$I$$20231109$20240823$20240823$PER$$US-PFIZER INC-2023SGN11998$PFIZER$$40$YR$$F$Y$$$20240823$$HP$US$US
242440782$24244078$2$F$20240601$20240826$20240823$20240829$EXP$$TW-DSJP-DSJ-2024-140999$DAIICHI$$70$YR$$F$Y$72$KG$20240829$$HP$TW$TW
242440795$24244079$5$F$20240628$20240910$20240823$20240912$EXP$$SE-DSJP-DSE-2024-141514$DAIICHI$$60$YR$$F$Y$$$20240912$$MD$SE$SE
242440801$24244080$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165032$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242440811$24244081$1$I$$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167856$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242440821$24244082$1$I$$20240813$20240823$20240823$EXP$$TW-AMGEN-TWNSP2024161400$AMGEN$Niu C.; Chen P.; Chiu P. et al.. Teriparatide alone versus vertebroplasty on pain control and radiographic outcomes after osteoporotic vertebral compression fracture. European Spine Journal. 2024;33 (8):3284-3290$78$YR$E$F$Y$$$20240823$$HP$TW$TW
242440832$24244083$2$F$20210225$20240910$20240823$20240922$PER$$US-BEH-2024177511$CSL BEHRING$$40$YR$A$F$Y$$$20240922$$CN$US$US
242440841$24244084$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58129$$FDA-CTU$$36$YR$$F$N$$$20240823$N$$US$
242440851$24244085$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58121$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242440861$24244086$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58140$$FDA-CTU$$41$YR$$F$N$$$20240823$N$$US$
242440871$24244087$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58132$$FDA-CTU$$41$YR$$F$N$$$20240823$N$$US$
242440881$24244088$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58144$$FDA-CTU$$60$YR$$M$N$$$20240731$N$$US$
242440891$24244089$1$I$20240325$20240814$20240823$20240823$EXP$FR-AFSSAPS-LY2024000961$FR-TEVA-VS-3233819$TEVA$$0$YR$$M$Y$$$20240823$$CN$FR$FR
242440902$24244090$2$F$$20240726$20240823$20240905$PER$$US-LUNDBECK-DKLU4002299$LUNDBECK$$$$$$Y$$$20240905$$CN$US$US
242440921$24244092$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58122$$FDA-CTU$$$$$$N$$$20240731$N$$US$
242440941$24244094$1$I$20240201$20240816$20240823$20240823$EXP$$US-GSK-US2024102644$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$US$US
242440951$24244095$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58188$$FDA-CTU$$73$YR$$F$N$$$20240823$N$$US$
242440961$24244096$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58103$$FDA-CTU$$50$YR$$F$N$$$20240731$N$HP$US$
242440981$24244098$1$I$20240821$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167681$AMGEN$$53$YR$A$F$Y$$$20240823$$PH$US$US
242440991$24244099$1$I$20240101$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166301$AMGEN$$76$YR$E$F$Y$$$20240823$$CN$US$US
242441001$24244100$1$I$$20240816$20240823$20240823$EXP$$US-AMGEN-USASP2024164300$AMGEN$Eyada M.; Michael V.; Fellman B. M. et al.. Oral cyclophosphamide plus bevacizumab in recurrent ovarian, fallopian tube and primary peritoneal cancer. Journal of Clinical Oncology. 2024;42 (16):5517$$$$$Y$$$20240823$$HP$US$US
242441011$24244101$1$I$20240822$20240822$20240823$20240823$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-141740$DAIICHI$$55$YR$$F$Y$$$20240823$$PH$US$US
242441031$24244103$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134196$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240823$$CN$US$US
242441041$24244104$1$I$20240301$20240812$20240823$20240823$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-128402$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240823$$MD$DE$DE
242441051$24244105$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132309$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240823$$CN$US$US
242441061$24244106$1$I$$20240821$20240823$20240823$PER$$US-TAKEDA-2024TUS084660$TAKEDA$$$$E$F$Y$$$20240823$$CN$US$US
242441073$24244107$3$F$20240305$20240821$20240823$20240829$EXP$$US-KYOWAKIRIN-2024KK019685$KYOWA$$$$$$Y$$$20240829$$HP$US$US
242441081$24244108$1$I$$20240813$20240823$20240823$PER$$US-JNJFOC-20240833144$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$CN$US$US
242441091$24244109$1$I$20240101$20240823$20240823$20240823$PER$$US-JNJFOC-20240861075$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240823$$CN$US$US
242441102$24244110$2$F$$20240826$20240823$20240905$PER$$US-JNJFOC-20240860233$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$MD$US$US
242441111$24244111$1$I$$20240814$20240823$20240823$PER$$US-JNJFOC-20240859475$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$PH$US$US
242441121$24244112$1$I$$20240821$20240823$20240823$PER$$PR-JNJFOC-20240854841$JOHNSON AND JOHNSON$$$$E$$Y$$$20240823$$MD$PR$PR
242441131$24244113$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012185$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240823$$CN$US$US
242441141$24244114$1$I$$20231113$20240823$20240823$PER$$US-PFIZER INC-2023SGN12147$PFIZER$$$$$$Y$$$20240823$$PH$US$US
242441151$24244115$1$I$20240321$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012759$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240823$$CN$US$US
242441161$24244116$1$I$20230101$20240815$20240823$20240823$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16417$IPSEN$$71$YR$E$M$Y$79$KG$20240823$$CN$US$US
242441171$24244117$1$I$$20240812$20240823$20240823$PER$$US-TEVA-VS-3232647$TEVA$$77$YR$$F$Y$53.52$KG$20240823$$CN$US$US
242441181$24244118$1$I$20211227$20211228$20240823$20240823$EXP$$CO-BIOVITRUM-2022CO00006$BIOVITRUM$$125$DY$$F$Y$3.8$KG$20240823$$CN$CO$CO
242441191$24244119$1$I$20230717$20230717$20240823$20240823$EXP$$AR-BIOVITRUM-2023-AR-013192$BIOVITRUM$$151$DY$$M$Y$$$20240823$$CN$AR$AR
242441201$24244120$1$I$$20240404$20240823$20240823$EXP$$ZA-BIOVITRUM-2023-ZA-008368$BIOVITRUM$$$$I$F$Y$1.9$KG$20240823$$CN$ZA$ZA
242441211$24244121$1$I$20240803$20240811$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013191$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240823$$CN$US$US
242441221$24244122$1$I$20230517$20230704$20240823$20240823$EXP$$CO-BIOVITRUM-2023-CO-011209$BIOVITRUM$$101$DY$$M$Y$5.6$KG$20240823$$CN$CO$CO
242441231$24244123$1$I$$20240815$20240823$20240823$EXP$DK-EMA-20140929-deeptisp-122416997$DK-BAYER-2024A120450$BAYER$$17$YR$T$M$Y$$$20240823$$HP$DK$DK
242441241$24244124$1$I$$20240711$20240823$20240823$PER$$US-LUNDBECK-DKLU4001686$LUNDBECK$$$$$$Y$$$20240823$$HP$US$US
242441251$24244125$1$I$$20240820$20240823$20240823$PER$$US-ABBVIE-5890780$ABBVIE$$$$$$Y$$$20240823$$CN$US$US
242441261$24244126$1$I$20240711$20240726$20240823$20240823$PER$$US-TOLMAR, INC.-24US050994$TOLMAR$$75$YR$$M$Y$$$20240823$$PH$US$US
242441271$24244127$1$I$$20240821$20240823$20240823$EXP$$US-ABBVIE-5891994$ABBVIE$$$$A$$Y$$$20240823$$MD$US$US
242441281$24244128$1$I$$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167652$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242441291$24244129$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58133$$FDA-CTU$$67$YR$$F$N$$$20240823$N$$US$
242441311$24244131$1$I$20190309$20240820$20240823$20240823$EXP$FR-AFSSAPS-ST20191218$FR-ORGANON-1910FRA007220$ORGANON$$70$YR$$F$Y$$$20240823$$MD$FR$FR
242441321$24244132$1$I$20180101$20240820$20240823$20240823$EXP$$NVSC2024US169628$NOVARTIS$$41$YR$$M$Y$$$20240823$$CN$US$US
242441331$24244133$1$I$$20240816$20240823$20240823$EXP$$US-ROCHE-10000059735$ROCHE$$68$YR$E$F$Y$$$20240823$$CN$US$US
242441341$24244134$1$I$20240819$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167779$AMGEN$$88$YR$E$M$Y$$$20240823$$CN$US$US
242441351$24244135$1$I$$20240818$20240823$20240823$EXP$$US-Taiho Oncology Inc-2024-008003$TAIHO ONCOLOGY INC$$44$YR$A$M$Y$73.48$KG$20240823$$CN$US$US
242441371$24244137$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58247$$FDA-CTU$$54$YR$$F$N$$$20240823$N$$US$
242441381$24244138$1$I$20240624$20240814$20240823$20240823$EXP$FR-AFSSAPS-AN2024001040$FR-TEVA-VS-3233805$TEVA$$55$YR$$M$Y$108.5$KG$20240823$$MD$FR$FR
242441391$24244139$1$I$20240809$20240822$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133985$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240823$$CN$US$US
242441411$24244141$1$I$$20240822$20240823$20240823$EXP$$CN-VANTIVE-2024VAN019269$Vantive US Healthcare$$$$$M$Y$$$20240823$$CN$CN$CN
242441421$24244142$1$I$$20240822$20240823$20240823$EXP$$CN-VANTIVE-2024VAN019270$Vantive US Healthcare$$$$$M$Y$$$20240823$$CN$CN$CN
242441432$24244143$2$F$$20240925$20240823$20240927$PER$$US-PFIZER INC-2023SGN12344$PFIZER$$$$A$F$Y$$$20240927$$MD$US$US
242441441$24244144$1$I$20240723$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166603$AMGEN$$58$YR$A$F$Y$$$20240823$$CN$US$US
242441451$24244145$1$I$20240501$20240821$20240823$20240823$EXP$$NVSC2024US170036$NOVARTIS$$83$YR$$M$Y$$$20240823$$MD$US$US
242441461$24244146$1$I$20230401$20240822$20240823$20240823$EXP$$RS-SANDOZ INC.-SDZ2024RS074620$SANDOZ$$32$YR$$M$Y$$$20240823$$MD$RS$RS
242441471$24244147$1$I$20240810$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58244$$FDA-CTU$$83$YR$$F$N$$$20240823$Y$PH$US$
242441481$24244148$1$I$$20240805$20240823$20240823$DIR$FDA-CDER-CTU-2024-58259$$FDA-CTU$$$$$M$N$$$20240805$N$HP$US$
242441491$24244149$1$I$20240707$20240813$20240823$20240823$EXP$FR-AFSSAPS-GR2024000978$FR-TEVA-VS-3233482$TEVA$$65$YR$$F$Y$114$KG$20240823$$MD$FR$FR
242441501$24244150$1$I$20240604$20240821$20240823$20240823$EXP$$US-GSK-US2024071407$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$US$US
242441511$24244151$1$I$20240821$20240821$20240823$20240823$EXP$$TR-ABBVIE-5890761$ABBVIE$$72$YR$$M$Y$$$20240823$$MD$TR$TR
242441521$24244152$1$I$20240819$20240821$20240823$20240823$EXP$$US-ABBVIE-5890826$ABBVIE$$77$YR$$M$Y$$$20240823$$CN$US$US
242441531$24244153$1$I$$20240820$20240823$20240823$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047028$BOEHRINGER INGELHEIM$$$$$$Y$$$20240823$$MD$US$US
242441543$24244154$3$F$20170622$20240828$20240823$20240831$EXP$$ES-ABBVIE-5890148$ABBVIE$$54$YR$$M$Y$$$20240831$$MD$ES$ES
242441551$24244155$1$I$$20240820$20240823$20240823$EXP$$US-ABBVIE-5889370$ABBVIE$$$$$F$Y$$$20240823$$HP$US$US
242441561$24244156$1$I$20240801$20240819$20240823$20240823$EXP$$US-ABBVIE-5888924$ABBVIE$$56$YR$$F$Y$$$20240823$$CN$US$US
242441571$24244157$1$I$$20240819$20240823$20240823$EXP$$US-ROCHE-10000061238$ROCHE$$74$YR$E$F$Y$$$20240823$$CN$US$US
242441581$24244158$1$I$20240713$20240819$20240823$20240823$EXP$FR-AFSSAPS-AVLL2024000205$FR-MYLANLABS-2024M1076894$MYLAN$$$$A$M$Y$$$20240823$$MD$FR$FR
242441591$24244159$1$I$20231001$20240820$20240823$20240823$EXP$$US-ABBVIE-5887592$ABBVIE$$58$YR$$F$Y$77.1$KG$20240823$$CN$US$US
242441601$24244160$1$I$$20231127$20240823$20240823$PER$$US-PFIZER INC-2023SGN12603$PFIZER$$$$$$Y$$$20240823$$MD$US$US
242441611$24244161$1$I$$20240819$20240823$20240823$EXP$$US-ROCHE-10000007482$ROCHE$$42$YR$A$F$Y$$$20240823$$CN$US$US
242441621$24244162$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58108$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242441631$24244163$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58109$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242441641$24244164$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58107$$FDA-CTU$$23$YR$$$N$$$20240731$N$HP$US$
242441652$24244165$2$F$$20240813$20240823$20240905$PER$$US-INCYTE CORPORATION-2024IN008494$INCYTE$$$$$$Y$$$20240905$$CN$US$US
242441661$24244166$1$I$$20231211$20240823$20240823$PER$$US-PFIZER INC-2023SGN13134$PFIZER$$$$$$Y$$$20240823$$HP$US$US
242441671$24244167$1$I$20240814$20240814$20240823$20240823$EXP$$BR-JNJFOC-20240839421$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240823$$CN$BR$BR
242441681$24244168$1$I$20240710$20240820$20240823$20240823$EXP$$CN-PFIZER INC-PV202400108677$PFIZER$$32$YR$$F$Y$64$KG$20240823$$HP$CN$CN
242441691$24244169$1$I$20240101$20240820$20240823$20240823$EXP$FR-AFSSAPS-TO2024001273$FR-PFIZER INC-202400241827$PFIZER$$77$YR$$M$Y$81.9$KG$20240823$$PH$FR$FR
242441701$24244170$1$I$$20240815$20240823$20240823$PER$$US-TEVA-VS-3235930$TEVA$$81$YR$$F$Y$$$20240823$$CN$US$US
242441721$24244172$1$I$$20240820$20240823$20240823$EXP$$CA-PFIZER INC-202400240118$PFIZER$$7$YR$$F$Y$29$KG$20240823$$HP$CA$CA
242441731$24244173$1$I$$20240820$20240823$20240823$EXP$$GT-PFIZER INC-PV202400109805$PFIZER$$29$YR$$F$Y$$$20240823$$CN$GT$GT
242441741$24244174$1$I$20231201$20231204$20240823$20240823$PER$$US-PFIZER INC-2023SGN12813$PFIZER$$$$$$Y$$$20240823$$HP$US$US
242441751$24244175$1$I$$20240819$20240823$20240823$EXP$$US-PFIZER INC-202400241282$PFIZER$$86$YR$$F$Y$$$20240823$$CN$US$US
242441762$24244176$2$F$20240727$20240909$20240823$20240910$EXP$$US-PFIZER INC-PV202400081996$PFIZER$$79$YR$$F$Y$$$20240910$$CN$US$US
242441773$24244177$3$F$20220112$20240919$20240823$20240924$PER$$US-AMGEN-USASP2024167954$AMGEN$$56$YR$A$F$Y$$$20240923$$CN$US$US
242441783$24244178$3$F$20240716$20240910$20240823$20240913$PER$$US-AMGEN-USASP2024157422$AMGEN$$$$$$Y$$$20240913$$PH$US$US
242441811$24244181$1$I$$20240814$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008542$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242441821$24244182$1$I$$20240814$20240823$20240823$PER$$US-INCYTE CORPORATION-2024IN008555$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242441832$24244183$2$F$20240305$20240830$20240823$20240905$EXP$GB-MHRA-MED-202408131609536260-DYWZV$GB-RDY-SPO/GBR/24/0012112$DR REDDYS$$84$YR$E$F$Y$44$KG$20240905$$MD$GB$GB
242441841$24244184$1$I$20231001$20240819$20240823$20240823$EXP$$FR-FreseniusKabi-FK202412453$FRESENIUS KABI$$84$YR$E$F$Y$$$20240823$$MD$FR$FR
242441861$24244186$1$I$20240509$20240819$20240823$20240823$EXP$IT-MINISAL02-998298$IT-FreseniusKabi-FK202412705$FRESENIUS KABI$$64$YR$A$M$Y$73$KG$20240823$$MD$IT$IT
242441871$24244187$1$I$$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165197$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242441882$24244188$2$F$$20240820$20240823$20240828$PER$$US-AMGEN-USASP2024166132$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242441892$24244189$2$F$20240101$20240906$20240823$20240910$PER$$US-AMGEN-USASP2024167269$AMGEN$$44$YR$A$F$Y$$$20240909$$HP$US$US
242441902$24244190$2$F$$20240910$20240823$20240913$PER$$US-AMGEN-USASP2024164261$AMGEN$$58$YR$A$F$Y$$$20240913$$PH$US$US
242441921$24244192$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012970$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240823$$CN$US$US
242441931$24244193$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012945$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240823$$CN$US$US
242441941$24244194$1$I$20240820$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012942$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240823$$CN$US$US
242441952$24244195$2$F$20240726$20240917$20240823$20240924$EXP$$US-GSK-US2024102691$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$US$US
242441961$24244196$1$I$$20240806$20240823$20240823$PER$$US-TEVA-VS-3232297$TEVA$$39$YR$$F$Y$$$20240823$$MD$US$US
242441971$24244197$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58110$$FDA-CTU$$65$YR$$M$N$$$20240731$N$HP$US$
242441982$24244198$2$F$20240813$20240813$20240823$20240826$EXP$$CN-JNJFOC-20240846392$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20240826$$HP$CN$CN
242441992$24244199$2$F$$20240905$20240823$20240919$EXP$$JP-JNJFOC-20240849732$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240919$$HP$JP$JP
242442001$24244200$1$I$$20240821$20240823$20240823$EXP$$US-ROCHE-10000063410$ROCHE$$88$YR$E$F$Y$$$20240823$$CN$US$US
242442011$24244201$1$I$$20240813$20240823$20240823$EXP$GB-MHRA-MIDB-0575d771-8d4d-4fc3-9015-01765a334cc3$GB-TEVA-VS-3233176$TEVA$$66$YR$$F$Y$$$20240823$$PH$GB$GB
242442021$24244202$1$I$$20240819$20240823$20240823$PER$$US-BIOGEN-2024BI01279037$BIOGEN$$$$$F$Y$$$20240823$$MD$US$US
242442031$24244203$1$I$20211108$20240819$20240823$20240823$EXP$$US-BIOGEN-2021BI01076894$BIOGEN$$77$YR$$F$Y$$$20240823$$CN$US$US
242442051$24244205$1$I$20240822$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58272$$FDA-CTU$$49$YR$$F$N$$$20240823$N$PH$US$
242442061$24244206$1$I$20240620$20240816$20240823$20240823$EXP$$US-009507513-2408USA006254$MERCK$$78$YR$$F$Y$$$20240823$$CN$US$US
242442071$24244207$1$I$$20240816$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132160$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240823$$HP$US$US
242442081$24244208$1$I$20240701$20240822$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133972$BRISTOL MYERS SQUIBB$$29$YR$A$F$Y$$$20240823$$HP$US$US
242442091$24244209$1$I$$20240819$20240823$20240823$PER$$US-BIOMARINAP-US-2024-159948$BIOMARIN$$$$$$Y$$$20240823$$CN$US$US
242442101$24244210$1$I$$20240820$20240823$20240823$PER$$US-BIOMARINAP-US-2024-159997$BIOMARIN$$$$$$Y$$$20240823$$MD$US$US
242442111$24244211$1$I$$20240817$20240823$20240823$PER$$US-BIOMARINAP-US-2024-159967$BIOMARIN$$$$$$Y$$$20240823$$CN$US$US
242442121$24244212$1$I$$20240821$20240823$20240823$PER$$US-JNJFOC-20240854706$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$CN$US$US
242442132$24244213$2$F$20240310$20240819$20240823$20240829$EXP$GB-MHRA-MED-202408190134368090-SQLMH$GB-TEVA-VS-3235217$TEVA$$41$YR$$F$Y$127$KG$20240829$$CN$GB$GB
242442143$24244214$3$F$20230928$20240911$20240823$20240918$30DAY$$US-AMGEN-USASP2024163179$AMGEN$$44$YR$A$F$Y$$$20240917$$HP$US$US
242442151$24244215$1$I$$20240816$20240823$20240823$EXP$$VN-SANDOZ INC.-SDZ2024VN074767$SANDOZ$Ho HV, Nguyen BV, Tran HV, Ha TV. Acute myeloid leukemia after chemotherapy: reporting clinical case series in the department of chemotherapy - center of oncology - 103 military hospital and retrospective literature review. VIETNAM MEDICAL JOURNAL. 2021;506:1-2$61$YR$$M$Y$$$20240823$$HP$VN$VN
242442161$24244216$1$I$$20240812$20240823$20240823$EXP$$US-ROCHE-10000055578$ROCHE$$$$E$F$Y$$$20240823$$CN$US$US
242442171$24244217$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133016$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240823$$HP$US$US
242442181$24244218$1$I$20240508$20240817$20240823$20240823$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-132560$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240823$$HP$CO$CO
242442193$24244219$3$F$20240501$20240821$20240823$20240828$EXP$$US-BIOGEN-2024BI01279040$BIOGEN$$54$YR$$F$Y$$$20240828$$CN$US$US
242442201$24244220$1$I$$20240819$20240823$20240823$PER$$US-BIOGEN-2024BI01279039$BIOGEN$$$$$F$Y$$$20240823$$MD$US$US
242442212$24244221$2$F$20240815$20240830$20240823$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131209$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$101.6$KG$20240904$$CN$US$US
242442221$24244222$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170736$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
242442251$24244225$1$I$$20240821$20240823$20240823$EXP$$CN-PFIZER INC-PV202400108926$PFIZER$$$$A$M$Y$$$20240823$$CN$CN$CN
242442262$24244226$2$F$20240407$20240918$20240823$20240920$EXP$$US-PFIZER INC-202400241456$PFIZER$$24$YR$$$Y$75$KG$20240920$$MD$US$US
242442271$24244227$1$I$20240327$20240814$20240823$20240823$EXP$FR-AFSSAPS-LY2024001233$FR-TEVA-VS-3233792$TEVA$$32$YR$$F$Y$$$20240823$$MD$FR$FR
242442281$24244228$1$I$20240821$20240822$20240823$20240823$EXP$$GB-PFIZER INC-202400242055$PFIZER$$77$YR$$F$Y$59$KG$20240823$$HP$GB$GB
242442291$24244229$1$I$$20240804$20240823$20240823$DIR$FDA-CDER-CTU-2024-58270$$FDA-CTU$$$$$M$N$$$20240804$N$HP$US$
242442301$24244230$1$I$20240801$20240821$20240823$20240823$EXP$$KR-PFIZER INC-PV202400109241$PFIZER$$$$$M$Y$$$20240823$$CN$KR$KR
242442321$24244232$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132886$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240823$$HP$US$US
242442331$24244233$1$I$20240305$20240322$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000153$EMMAUS LIFE SCIENCES$$27$YR$A$F$Y$$$20240823$$CN$US$
242442341$24244234$1$I$20240301$20240404$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000151$EMMAUS LIFE SCIENCES$$24$YR$A$M$Y$$$20240823$$CN$US$
242442351$24244235$1$I$20240315$20240326$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000155$EMMAUS LIFE SCIENCES$$60$YR$A$F$Y$$$20240823$$CN$US$
242442361$24244236$1$I$20240325$20240326$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000156$EMMAUS LIFE SCIENCES$$13$YR$T$M$Y$$$20240823$$CN$US$
242442371$24244237$1$I$20240301$20240402$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000158$EMMAUS LIFE SCIENCES$$17$YR$T$M$Y$53$KG$20240823$$CN$US$
242442381$24244238$1$I$$20240329$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000159$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242442391$24244239$1$I$20240320$20240331$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000163$EMMAUS LIFE SCIENCES$$8$YR$C$M$Y$$$20240823$$CN$US$
242442401$24244240$1$I$20240101$20240402$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000166$EMMAUS LIFE SCIENCES$$17$YR$T$F$Y$$$20240823$$CN$US$
242442411$24244241$1$I$$20240403$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000169$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242442421$24244242$1$I$20240322$20240404$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000172$EMMAUS LIFE SCIENCES$$18$YR$A$M$Y$$$20240823$$CN$US$
242442431$24244243$1$I$20240101$20240531$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000175$EMMAUS LIFE SCIENCES$$64$YR$A$F$Y$$$20240823$$CN$US$
242442441$24244244$1$I$20240301$20240412$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000180$EMMAUS LIFE SCIENCES$$40$YR$A$F$Y$$$20240823$$CN$US$
242442451$24244245$1$I$20240326$20240412$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000181$EMMAUS LIFE SCIENCES$$16$YR$T$F$Y$$$20240823$$CN$US$
242442461$24244246$1$I$20240405$20240418$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000182$EMMAUS LIFE SCIENCES$$24$YR$A$F$Y$$$20240823$$CN$US$
242442471$24244247$1$I$20240319$20240415$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000183$EMMAUS LIFE SCIENCES$$34$YR$A$M$Y$$$20240823$$CN$US$
242442481$24244248$1$I$20240101$20240520$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000184$EMMAUS LIFE SCIENCES$$24$YR$A$M$Y$86.183$KG$20240823$$CN$US$
242442491$24244249$1$I$20240401$20240417$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000187$EMMAUS LIFE SCIENCES$$43$YR$A$M$Y$$$20240823$$CN$US$
242442501$24244250$1$I$20240101$20240417$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000188$EMMAUS LIFE SCIENCES$$40$YR$A$F$Y$$$20240823$$CN$US$
242442511$24244251$1$I$$20240418$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000190$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$HP$US$
242442521$24244252$1$I$20240301$20240418$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000192$EMMAUS LIFE SCIENCES$$45$YR$A$F$Y$$$20240823$$CN$US$
242442531$24244253$1$I$20240412$20240419$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000194$EMMAUS LIFE SCIENCES$$18$YR$A$F$Y$$$20240823$$CN$US$
242442541$24244254$1$I$20240311$20240506$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000171$EMMAUS LIFE SCIENCES$$23$YR$A$F$Y$$$20240823$$CN$US$
242442551$24244255$1$I$20230509$20240520$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000185$EMMAUS LIFE SCIENCES$$61$YR$A$F$Y$73.936$KG$20240823$$CN$US$
242442561$24244256$1$I$20240101$20240520$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000186$EMMAUS LIFE SCIENCES$$56$YR$A$F$Y$$$20240823$$CN$US$
242442571$24244257$1$I$20240101$20240418$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000191$EMMAUS LIFE SCIENCES$$53$YR$A$M$Y$$$20240823$$CN$US$
242442581$24244258$1$I$20230501$20240419$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000195$EMMAUS LIFE SCIENCES$$7$YR$C$F$Y$$$20240823$$CN$US$
242442591$24244259$1$I$$20240422$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000197$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242442601$24244260$1$I$20240101$20240422$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000198$EMMAUS LIFE SCIENCES$$44$YR$A$F$Y$$$20240823$$CN$US$
242442611$24244261$1$I$20240409$20240423$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000199$EMMAUS LIFE SCIENCES$$10$YR$C$M$Y$$$20240823$$CN$US$
242442621$24244262$1$I$20240101$20240520$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000200$EMMAUS LIFE SCIENCES$$16$YR$T$M$Y$$$20240823$$CN$US$
242442631$24244263$1$I$20240401$20240423$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000201$EMMAUS LIFE SCIENCES$$30$YR$A$M$Y$$$20240823$$CN$US$
242442641$24244264$1$I$$20240423$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000202$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242442651$24244265$1$I$20240101$20240423$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000203$EMMAUS LIFE SCIENCES$$22$YR$A$F$Y$$$20240823$$CN$US$
242442661$24244266$1$I$20240416$20240424$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000204$EMMAUS LIFE SCIENCES$$60$YR$A$F$Y$$$20240823$$CN$US$
242442671$24244267$1$I$20240101$20240423$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000205$EMMAUS LIFE SCIENCES$$53$YR$A$F$Y$$$20240823$$CN$US$
242442681$24244268$1$I$20240406$20240424$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000206$EMMAUS LIFE SCIENCES$$49$YR$A$F$Y$$$20240823$$CN$US$
242442691$24244269$1$I$20240101$20240425$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000207$EMMAUS LIFE SCIENCES$$44$YR$A$M$Y$$$20240823$$CN$US$
242442701$24244270$1$I$20240401$20240426$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000208$EMMAUS LIFE SCIENCES$$38$YR$A$F$Y$$$20240823$$CN$US$
242442711$24244271$1$I$20240426$20240502$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000209$EMMAUS LIFE SCIENCES$$8$YR$C$M$Y$$$20240823$$CN$US$
242442721$24244272$1$I$20240401$20240428$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000210$EMMAUS LIFE SCIENCES$$18$YR$A$M$Y$$$20240823$$CN$US$
242442731$24244273$1$I$20240201$20240429$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000211$EMMAUS LIFE SCIENCES$$43$YR$A$F$Y$$$20240823$$CN$US$
242442741$24244274$1$I$20240101$20240430$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000213$EMMAUS LIFE SCIENCES$$17$YR$T$F$Y$$$20240823$$CN$US$
242442751$24244275$1$I$20240421$20240430$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000214$EMMAUS LIFE SCIENCES$$45$YR$A$F$Y$$$20240823$$CN$US$
242442761$24244276$1$I$20240427$20240430$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000215$EMMAUS LIFE SCIENCES$$44$YR$A$M$Y$$$20240823$$CN$US$
242442771$24244277$1$I$20240425$20240430$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000216$EMMAUS LIFE SCIENCES$$11$YR$C$M$Y$$$20240823$$CN$US$
242442781$24244278$1$I$20240301$20240430$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000217$EMMAUS LIFE SCIENCES$$54$YR$A$M$Y$$$20240823$$CN$US$
242442791$24244279$1$I$20240401$20240501$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000220$EMMAUS LIFE SCIENCES$$30$YR$A$M$Y$$$20240823$$CN$US$
242442801$24244280$1$I$20240401$20240506$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000224$EMMAUS LIFE SCIENCES$$17$YR$T$F$Y$$$20240823$$CN$US$
242442811$24244281$1$I$20240423$20240505$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000225$EMMAUS LIFE SCIENCES$$17$YR$T$F$Y$$$20240823$$CN$US$
242442821$24244282$1$I$20240423$20240506$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000226$EMMAUS LIFE SCIENCES$$12$YR$T$M$Y$31.5$KG$20240823$$CN$US$
242442831$24244283$1$I$20240501$20240531$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000227$EMMAUS LIFE SCIENCES$$12$YR$T$F$Y$$$20240823$$CN$US$
242442841$24244284$1$I$20240101$20240402$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000167$EMMAUS LIFE SCIENCES$$16$YR$T$M$Y$$$20240823$$CN$US$
242442851$24244285$1$I$20240101$20240506$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000228$EMMAUS LIFE SCIENCES$$32$YR$A$F$Y$$$20240823$$CN$US$
242442861$24244286$1$I$20240401$20240506$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000229$EMMAUS LIFE SCIENCES$$11$YR$C$M$Y$$$20240823$$CN$US$
242442871$24244287$1$I$20240101$20240506$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000230$EMMAUS LIFE SCIENCES$$24$YR$A$M$Y$$$20240823$$CN$US$
242442881$24244288$1$I$20231001$20240213$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000075$EMMAUS LIFE SCIENCES$$7$YR$C$F$Y$22.4$KG$20240823$$CN$US$
242442891$24244289$1$I$$20240213$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000076$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242442901$24244290$1$I$20231001$20240221$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000077$EMMAUS LIFE SCIENCES$$27$YR$A$M$Y$105.8$KG$20240823$$CN$US$
242442911$24244291$1$I$20240206$20240215$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000080$EMMAUS LIFE SCIENCES$$43$YR$A$M$Y$$$20240823$$CN$US$
242442921$24244292$1$I$20240207$20240214$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000081$EMMAUS LIFE SCIENCES$$8$YR$C$M$Y$$$20240823$$CN$US$
242442931$24244293$1$I$20231011$20240223$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000082$EMMAUS LIFE SCIENCES$$20$YR$A$F$Y$73.48$KG$20240823$$CN$US$
242442941$24244294$1$I$$20240222$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000079$EMMAUS LIFE SCIENCES$$$$$M$Y$59.874$KG$20240823$$CN$US$
242442951$24244295$1$I$20240201$20240215$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000084$EMMAUS LIFE SCIENCES$$19$YR$A$F$Y$$$20240823$$CN$US$
242442961$24244296$1$I$$20240215$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000085$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242442971$24244297$1$I$20240223$20240403$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000086$EMMAUS LIFE SCIENCES$$45$YR$A$F$Y$$$20240823$$CN$US$
242442981$24244298$1$I$20240101$20240219$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000087$EMMAUS LIFE SCIENCES$$39$YR$A$M$Y$$$20240823$$CN$US$
242442991$24244299$1$I$20231218$20240221$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000089$EMMAUS LIFE SCIENCES$$37$YR$A$F$Y$$$20240823$$CN$US$
242443001$24244300$1$I$20240201$20240222$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000092$EMMAUS LIFE SCIENCES$$33$YR$A$F$Y$$$20240823$$CN$US$
242443011$24244301$1$I$20240213$20240221$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000093$EMMAUS LIFE SCIENCES$$10$YR$C$M$Y$$$20240823$$CN$US$
242443021$24244302$1$I$20240101$20240222$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000094$EMMAUS LIFE SCIENCES$$20$YR$A$M$Y$$$20240823$$CN$US$
242443031$24244303$1$I$$20240223$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000095$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242443041$24244304$1$I$20240214$20240223$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000096$EMMAUS LIFE SCIENCES$$37$YR$A$F$Y$$$20240823$$CN$US$
242443051$24244305$1$I$20240101$20240408$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000097$EMMAUS LIFE SCIENCES$$45$YR$A$F$Y$$$20240823$$CN$US$
242443061$24244306$1$I$20240101$20240225$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000099$EMMAUS LIFE SCIENCES$$27$YR$A$F$Y$$$20240823$$CN$US$
242443071$24244307$1$I$$20240226$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000100$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242443081$24244308$1$I$20240201$20240226$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000101$EMMAUS LIFE SCIENCES$$57$YR$A$F$Y$$$20240823$$CN$US$
242443091$24244309$1$I$20240224$20240226$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000102$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242443101$24244310$1$I$20240225$20240226$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000103$EMMAUS LIFE SCIENCES$$10$YR$C$M$Y$$$20240823$$CN$US$
242443111$24244311$1$I$20240201$20240402$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000104$EMMAUS LIFE SCIENCES$$34$YR$A$M$Y$69.218$KG$20240823$$CN$US$
242443121$24244312$1$I$20240101$20240401$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000105$EMMAUS LIFE SCIENCES$$30$YR$A$F$Y$68.03$KG$20240823$$CN$US$
242443131$24244313$1$I$$20240306$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000107$EMMAUS LIFE SCIENCES$$$$$M$Y$80.7$KG$20240823$$CN$US$
242443141$24244314$1$I$20240201$20240303$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000110$EMMAUS LIFE SCIENCES$$36$YR$A$F$Y$$$20240823$$CN$US$
242443151$24244315$1$I$$20240302$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000113$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242443161$24244316$1$I$20230302$20240318$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000114$EMMAUS LIFE SCIENCES$$12$YR$T$F$Y$52.2$KG$20240823$$CN$US$
242443171$24244317$1$I$$20240304$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000115$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242443181$24244318$1$I$20240303$20240304$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000116$EMMAUS LIFE SCIENCES$$8$YR$C$M$Y$$$20240823$$CN$US$
242443191$24244319$1$I$20230801$20240412$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000118$EMMAUS LIFE SCIENCES$$33$YR$A$F$Y$$$20240823$$CN$US$
242443201$24244320$1$I$20210601$20240306$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000119$EMMAUS LIFE SCIENCES$$41$YR$A$F$Y$$$20240823$$CN$US$
242443211$24244321$1$I$20240101$20240403$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000120$EMMAUS LIFE SCIENCES$$31$YR$A$F$Y$$$20240823$$CN$US$
242443221$24244322$1$I$20240101$20240306$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000121$EMMAUS LIFE SCIENCES$$25$YR$A$M$Y$$$20240823$$CN$US$
242443231$24244323$1$I$20240302$20240306$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000122$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242443241$24244324$1$I$20240101$20240306$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000123$EMMAUS LIFE SCIENCES$$59$YR$A$F$Y$$$20240823$$CN$US$
242443251$24244325$1$I$20240101$20240306$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000124$EMMAUS LIFE SCIENCES$$18$YR$A$F$Y$$$20240823$$CN$US$
242443261$24244326$1$I$20231001$20240314$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000126$EMMAUS LIFE SCIENCES$$17$YR$T$F$Y$57.6$KG$20240823$$CN$US$
242443271$24244327$1$I$20240219$20240307$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000127$EMMAUS LIFE SCIENCES$$51$YR$A$F$Y$$$20240823$$CN$US$
242443281$24244328$1$I$20240303$20240307$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000128$EMMAUS LIFE SCIENCES$$17$YR$T$F$Y$$$20240823$$CN$US$
242443291$24244329$1$I$$20240307$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000130$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242443301$24244330$1$I$20220201$20240319$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000137$EMMAUS LIFE SCIENCES$$29$YR$A$M$Y$84.35$KG$20240823$$CN$US$
242443311$24244331$1$I$20240208$20240312$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000138$EMMAUS LIFE SCIENCES$$47$YR$A$F$Y$$$20240823$$CN$US$
242443321$24244332$1$I$20240201$20240313$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000139$EMMAUS LIFE SCIENCES$$13$YR$T$F$Y$$$20240823$$CN$US$
242443331$24244333$1$I$20240309$20240313$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000140$EMMAUS LIFE SCIENCES$$54$YR$A$F$Y$$$20240823$$CN$US$
242443341$24244334$1$I$20231227$20240430$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000218$EMMAUS LIFE SCIENCES$$22$YR$A$M$Y$$$20240823$$CN$US$
242443351$24244335$1$I$$20240306$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000125$EMMAUS LIFE SCIENCES$$$$$M$Y$44.91$KG$20240823$$CN$US$
242443361$24244336$1$I$20240228$20240314$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000141$EMMAUS LIFE SCIENCES$$49$YR$A$F$Y$$$20240823$$CN$US$
242443371$24244337$1$I$$20240314$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000142$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242443381$24244338$1$I$20240314$20240429$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000143$EMMAUS LIFE SCIENCES$$37$YR$A$M$Y$89.34$KG$20240823$$CN$US$
242443391$24244339$1$I$20240228$20240322$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000146$EMMAUS LIFE SCIENCES$$19$YR$A$M$Y$$$20240823$$CN$US$
242443401$24244340$1$I$20240318$20240320$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000147$EMMAUS LIFE SCIENCES$$57$YR$A$F$Y$$$20240823$$CN$US$
242443411$24244341$1$I$$20240320$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000148$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242443421$24244342$1$I$20240224$20240321$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000150$EMMAUS LIFE SCIENCES$$33$YR$A$F$Y$$$20240823$$CN$US$
242443431$24244343$1$I$20240419$20240426$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000232$EMMAUS LIFE SCIENCES$$13$YR$T$M$Y$$$20240823$$CN$US$
242443441$24244344$1$I$20231201$20240509$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000236$EMMAUS LIFE SCIENCES$$54$YR$A$M$Y$$$20240823$$CN$US$
242443451$24244345$1$I$20240507$20240509$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000237$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242443461$24244346$1$I$20240415$20240509$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000238$EMMAUS LIFE SCIENCES$$16$YR$T$M$Y$$$20240823$$CN$US$
242443471$24244347$1$I$20240506$20240621$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000239$EMMAUS LIFE SCIENCES$$9$YR$C$M$Y$24.9$KG$20240823$$CN$US$
242443481$24244348$1$I$20240101$20240511$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000240$EMMAUS LIFE SCIENCES$$43$YR$A$F$Y$$$20240823$$CN$US$
242443491$24244349$1$I$20240101$20240512$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000241$EMMAUS LIFE SCIENCES$$35$YR$A$M$Y$$$20240823$$CN$US$
242443501$24244350$1$I$20240101$20240513$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000242$EMMAUS LIFE SCIENCES$$16$YR$T$F$Y$$$20240823$$CN$US$
242443511$24244351$1$I$20240423$20240513$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000243$EMMAUS LIFE SCIENCES$$57$YR$A$F$Y$$$20240823$$CN$US$
242443521$24244352$1$I$20240416$20240513$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000244$EMMAUS LIFE SCIENCES$$50$YR$A$F$Y$$$20240823$$CN$US$
242443531$24244353$1$I$20240512$20240514$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000245$EMMAUS LIFE SCIENCES$$59$YR$A$F$Y$$$20240823$$CN$US$
242443541$24244354$1$I$20240513$20240515$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000249$EMMAUS LIFE SCIENCES$$11$YR$C$M$Y$$$20240823$$CN$US$
242443551$24244355$1$I$20240508$20240530$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000250$EMMAUS LIFE SCIENCES$$9$YR$C$M$Y$$$20240823$$CN$US$
242443561$24244356$1$I$20240501$20240516$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000252$EMMAUS LIFE SCIENCES$$10$YR$C$F$Y$$$20240823$$CN$US$
242443571$24244357$1$I$20240514$20240606$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000253$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242443581$24244358$1$I$20240417$20240520$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000254$EMMAUS LIFE SCIENCES$$18$YR$A$M$Y$$$20240823$$CN$US$
242443591$24244359$1$I$20240509$20240521$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000255$EMMAUS LIFE SCIENCES$$18$YR$A$M$Y$$$20240823$$CN$US$
242443601$24244360$1$I$20240101$20240521$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000256$EMMAUS LIFE SCIENCES$$38$YR$A$M$Y$$$20240823$$CN$US$
242443611$24244361$1$I$20240501$20240528$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000257$EMMAUS LIFE SCIENCES$$49$YR$A$F$Y$$$20240823$$CN$US$
242443621$24244362$1$I$20240516$20240528$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000259$EMMAUS LIFE SCIENCES$$45$YR$A$M$Y$$$20240823$$CN$US$
242443631$24244363$1$I$20240520$20240529$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000262$EMMAUS LIFE SCIENCES$$48$YR$A$F$Y$$$20240823$$CN$US$
242443641$24244364$1$I$20230101$20240529$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000261$EMMAUS LIFE SCIENCES$$31$YR$A$F$Y$$$20240823$$CN$US$
242443651$24244365$1$I$$20240529$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000263$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242443661$24244366$1$I$20240519$20240529$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000265$EMMAUS LIFE SCIENCES$$8$YR$C$M$Y$$$20240823$$CN$US$
242443671$24244367$1$I$20240501$20240529$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000266$EMMAUS LIFE SCIENCES$$13$YR$T$F$Y$$$20240823$$CN$US$
242443681$24244368$1$I$$20240529$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000267$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242443691$24244369$1$I$20240531$20240531$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000269$EMMAUS LIFE SCIENCES$$44$YR$A$M$Y$$$20240823$$CN$US$
242443701$24244370$1$I$20240101$20240601$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000272$EMMAUS LIFE SCIENCES$$38$YR$A$F$Y$$$20240823$$CN$US$
242443711$24244371$1$I$20240424$20240603$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000274$EMMAUS LIFE SCIENCES$$18$YR$A$M$Y$$$20240823$$CN$US$
242443721$24244372$1$I$20240301$20240604$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000275$EMMAUS LIFE SCIENCES$$23$YR$A$M$Y$$$20240823$$CN$US$
242443731$24244373$1$I$20240515$20240603$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000276$EMMAUS LIFE SCIENCES$$13$YR$T$M$Y$$$20240823$$CN$US$
242443741$24244374$1$I$20240101$20240604$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000278$EMMAUS LIFE SCIENCES$$19$YR$A$M$Y$$$20240823$$CN$US$
242443751$24244375$1$I$20240601$20240605$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000279$EMMAUS LIFE SCIENCES$$23$YR$A$F$Y$$$20240823$$CN$US$
242443761$24244376$1$I$20240101$20240605$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000280$EMMAUS LIFE SCIENCES$$7$YR$C$F$Y$$$20240823$$CN$US$
242443771$24244377$1$I$$20240605$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000281$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242443781$24244378$1$I$20240602$20240605$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000282$EMMAUS LIFE SCIENCES$$16$YR$T$F$Y$$$20240823$$CN$US$
242443791$24244379$1$I$20240602$20240606$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000283$EMMAUS LIFE SCIENCES$$25$YR$A$M$Y$$$20240823$$CN$US$
242443801$24244380$1$I$20240510$20240605$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000284$EMMAUS LIFE SCIENCES$$38$YR$A$M$Y$$$20240823$$CN$US$
242443811$24244381$1$I$20240101$20240701$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000285$EMMAUS LIFE SCIENCES$$22$YR$A$F$Y$57.606$KG$20240823$$CN$US$
242443821$24244382$1$I$20240514$20240607$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000286$EMMAUS LIFE SCIENCES$$8$YR$C$F$Y$$$20240823$$CN$US$
242443831$24244383$1$I$20240528$20240611$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000290$EMMAUS LIFE SCIENCES$$15$YR$T$M$Y$$$20240823$$CN$US$
242443841$24244384$1$I$20180101$20240429$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000134$EMMAUS LIFE SCIENCES$$16$YR$T$F$Y$57.73$KG$20240823$$CN$US$
242443851$24244385$1$I$20240601$20240612$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000292$EMMAUS LIFE SCIENCES$$33$YR$A$F$Y$$$20240823$$CN$US$
242443861$24244386$1$I$20240101$20240613$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000295$EMMAUS LIFE SCIENCES$$31$YR$A$M$Y$$$20240823$$CN$US$
242443871$24244387$1$I$20240101$20240613$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000296$EMMAUS LIFE SCIENCES$$39$YR$A$F$Y$$$20240823$$CN$US$
242443881$24244388$1$I$20231201$20240614$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000297$EMMAUS LIFE SCIENCES$$42$YR$A$F$Y$$$20240823$$CN$US$
242443891$24244389$1$I$20240609$20240628$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000298$EMMAUS LIFE SCIENCES$$51$YR$A$F$Y$$$20240823$$CN$US$
242443901$24244390$1$I$20240501$20240617$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000301$EMMAUS LIFE SCIENCES$$23$YR$A$M$Y$$$20240823$$CN$US$
242443911$24244391$1$I$20210101$20240813$20240823$20240823$EXP$GB-MHRA-MED-202408131443104660-JLMDZ$GB-TEVA-VS-3233284$TEVA$$$$$M$Y$$$20240823$$MD$GB$GB
242443921$24244392$1$I$20240506$20240508$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000235$EMMAUS LIFE SCIENCES$$27$YR$A$F$Y$$$20240823$$CN$US$
242443931$24244393$1$I$20240101$20240523$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000258$EMMAUS LIFE SCIENCES$$28$YR$A$F$Y$$$20240823$$CN$US$
242443942$24244394$2$F$20240701$20240905$20240823$20240913$30DAY$$US-GSK-US2024100832$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240913$$CN$US$US
242443952$24244395$2$F$20240802$20240822$20240823$20240824$PER$$US-ABBVIE-5882765$ABBVIE$$44$YR$$M$Y$91$KG$20240824$$MD$US$US
242443962$24244396$2$F$$20240920$20240823$20240920$30DAY$$NL-PFIZER INC-202400224439$PFIZER$$$$$F$Y$$$20240920$$HP$NL$NL
242443971$24244397$1$I$$20240318$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000133$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242443986$24244398$6$F$20240817$20240905$20240823$20240912$EXP$$NVSC2024ZA167446$NOVARTIS$$65$YR$$F$Y$$$20240912$$HP$ZA$ZA
242443991$24244399$1$I$$20240819$20240823$20240823$EXP$$NVSC2024DE170399$NOVARTIS$$$$$M$Y$$$20240823$$MD$DE$DE
242444001$24244400$1$I$$20240822$20240823$20240823$PER$$NVSC2024US170988$NOVARTIS$$$$$F$Y$$$20240823$$HP$US$US
242444011$24244401$1$I$20240501$20240531$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000246$EMMAUS LIFE SCIENCES$$17$YR$T$M$Y$54$KG$20240823$$CN$US$
242444021$24244402$1$I$$20240816$20240823$20240823$30DAY$$US-GSK-US2024102692$GLAXOSMITHKLINE$$$$$M$Y$$$20240823$$HP$US$US
242444031$24244403$1$I$20230505$20240814$20240823$20240823$EXP$$AT-JNJFOC-20240848968$JOHNSON AND JOHNSON$$35$YR$A$F$Y$62$KG$20240823$$MD$AT$AT
242444041$24244404$1$I$20220101$20240819$20240823$20240823$EXP$$CA-AMGEN-CANSL2023172216$AMGEN$$74$YR$E$F$Y$$$20240823$$HP$CA$CA
242444051$24244405$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58113$$FDA-CTU$$28$YR$$M$N$$$20240731$N$HP$US$
242444061$24244406$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58114$$FDA-CTU$$17$YR$$$N$$$20240731$N$HP$US$
242444071$24244407$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58106$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242444081$24244408$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58115$$FDA-CTU$$68$YR$$F$N$$$20240731$N$HP$US$
242444091$24244409$1$I$20240819$20240820$20240823$20240823$PER$$US-PFIZER INC-202400240164$PFIZER$$81$YR$$M$Y$$$20240823$$CN$US$US
242444101$24244410$1$I$20240812$20240813$20240823$20240823$EXP$$GB-TEVA-VS-3233313$TEVA$$57$YR$$F$Y$54$KG$20240823$$HP$GB$GB
242444111$24244411$1$I$$20240820$20240823$20240823$PER$$US-PFIZER INC-202400240615$PFIZER$$$$A$F$Y$$$20240823$$MD$US$US
242444122$24244412$2$F$20240820$20240821$20240823$20240827$PER$$US-PFIZER INC-PV202400109467$PFIZER$$66$YR$$F$Y$$$20240827$$HP$US$US
242444131$24244413$1$I$$20240822$20240823$20240823$PER$$US-PFIZER INC-PV202400109947$PFIZER$$57$YR$$F$Y$$$20240823$$HP$US$US
242444142$24244414$2$F$20240819$20240829$20240823$20240904$PER$$US-PFIZER INC-202400241419$PFIZER$$76$YR$$F$Y$$$20240904$$CN$US$US
242444151$24244415$1$I$$20240819$20240823$20240823$PER$$US-PFIZER INC-PV202400108307$PFIZER$$77$YR$$$Y$$$20240823$$CN$US$US
242444161$24244416$1$I$20240821$20240822$20240823$20240823$PER$$US-PFIZER INC-202400241968$PFIZER$$41$YR$$F$Y$$$20240823$$HP$US$US
242444171$24244417$1$I$20200309$20240821$20240823$20240823$PER$$US-PFIZER INC-PV202400109174$PFIZER$$69$YR$$F$Y$$$20240823$$HP$US$US
242444191$24244419$1$I$$20240105$20240823$20240823$PER$$US-PFIZER INC-2024SGN00109$PFIZER$$$$$$Y$$$20240823$$CN$US$US
242444201$24244420$1$I$20240201$20240813$20240823$20240823$EXP$GB-MHRA-MED-202408131740586450-LSQTJ$GB-TEVA-VS-3233305$TEVA$$38$YR$$F$Y$$$20240823$$MD$GB$GB
242444211$24244421$1$I$$20240813$20240823$20240823$EXP$$US-GSK-US2024AMR101514$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242444221$24244422$1$I$20240201$20240814$20240823$20240823$EXP$FR-AFSSAPS-AN2024001038$FR-TEVA-VS-3233918$TEVA$$80$YR$$M$Y$74$KG$20240823$$MD$FR$FR
242444231$24244423$1$I$20240201$20240814$20240823$20240823$EXP$FR-AFSSAPS-PO2024000889$FR-TEVA-VS-3233934$TEVA$$21$YR$$M$Y$$$20240823$$MD$FR$FR
242444241$24244424$1$I$$20240814$20240823$20240823$PER$$US-ABBVIE-5883615$ABBVIE$$$$$F$Y$$$20240823$$MD$US$US
242444251$24244425$1$I$$20240819$20240823$20240823$EXP$$JP-009507513-2408JPN002283J$MERCK$ARATAKE J, SHIBUTANI T, NARITA M, HAMASAKI K, YAMAMOTO K, KITAI M, et al.. [ORIGINAL] Impact of the number of prior systemic treatment lines on lenvatinib and pembrolizumab combination therapy for advanced or recurrent endometrial cancer : Experience from a single institution in Japan with 21 cases. Advances in Obstetrics and Gynecology. 2024;76(3):222-8$$$$F$Y$$$20240823$$MD$JP$JP
242444261$24244426$1$I$20240101$20240820$20240823$20240823$EXP$$US-009507513-2408USA007163$MERCK$$$$$F$Y$$$20240823$$PH$US$US
242444272$24244427$2$F$20240701$20240829$20240823$20240904$EXP$$NVSC2024US169860$NOVARTIS$$83$YR$$F$Y$83$KG$20240904$$CN$US$US
242444291$24244429$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131703$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240823$$CN$US$US
242444301$24244430$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134272$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240823$$CN$US$US
242444311$24244431$1$I$20230127$20240814$20240823$20240823$EXP$FR-AFSSAPS-AM2023000560$FR-TEVA-VS-3233735$TEVA$$69$YR$$F$Y$73$KG$20240823$$MD$FR$FR
242444331$24244433$1$I$$20240819$20240823$20240823$EXP$$CA-BAUSCH-BL-2024-012620$BAUSCH AND LOMB$$80$YR$$M$Y$89$KG$20240823$$HP$CA$CA
242444341$24244434$1$I$20240701$20240820$20240823$20240823$EXP$$CA-ABBVIE-5889234$ABBVIE$$63$YR$$F$Y$$$20240823$$CN$CA$CA
242444351$24244435$1$I$20240101$20240819$20240823$20240823$EXP$$US-ABBVIE-5887400$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242444361$24244436$1$I$$20240819$20240823$20240823$EXP$$US-ABBVIE-5887812$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242444371$24244437$1$I$$20240813$20240823$20240823$EXP$$FR-TEVA-VS-3233450$TEVA$Vigue p, cidolit s, hamed hadj hamdi s, ben salah m, amalou r, botramamy a, et al.. L^hypoparathyroidie n^a pas d^age de survenue ou l^histoire d^une centenaire robuste (hypoparathyroidism has no age of onset or the history of a robust centenarian). Rev Geriatr. 2024;49(6):349-54$101$YR$$F$Y$$$20240823$$HP$FR$FR
242444382$24244438$2$F$$20240918$20240823$20240923$EXP$$CA-BAUSCH-BL-2024-012737$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240923$$HP$CA$CA
242444391$24244439$1$I$$20240109$20240823$20240823$PER$$US-PFIZER INC-2024SGN00213$PFIZER$$$$$$Y$$$20240823$$HP$US$US
242444401$24244440$1$I$$20240117$20240823$20240823$PER$$US-PFIZER INC-2024SGN00523$PFIZER$$$$$$Y$$$20240823$$HP$US$US
242444411$24244441$1$I$20240125$20240126$20240823$20240823$PER$$US-PFIZER INC-2024SGN00897$PFIZER$$67$YR$$F$Y$$$20240823$$HP$US$US
242444422$24244442$2$F$20240719$20240821$20240823$20240829$PER$$US-AMGEN-USASP2024167721$AMGEN$$82$YR$E$F$Y$$$20240829$$CN$US$US
242444432$24244443$2$F$20240818$20240917$20240823$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202408012614$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240923$$CN$US$US
242444441$24244444$1$I$$20240814$20240823$20240823$EXP$FR-AFSSAPS-TS2024000897$FR-TEVA-VS-3233906$TEVA$$86$YR$$M$Y$$$20240823$$MD$FR$FR
242444451$24244445$1$I$20240805$20240820$20240823$20240823$EXP$$AU-ABBVIE-5888065$ABBVIE$$65$YR$$F$Y$75$KG$20240823$$MD$AU$AU
242444461$24244446$1$I$20231201$20240819$20240823$20240823$EXP$$US-ABBVIE-5886855$ABBVIE$$54$YR$$F$Y$$$20240823$$CN$US$US
242444471$24244447$1$I$20240812$20240819$20240823$20240823$PER$$US-BAUSCH-BL-2024-012534$BAUSCH AND LOMB$$71$YR$$F$Y$50.394$KG$20240823$$CN$US$US
242444483$24244448$3$F$$20240823$20240823$20240826$PER$$NVSC2024US171255$NOVARTIS$$$$$$Y$$$20240826$$HP$US$US
242444491$24244449$1$I$20240101$20240819$20240823$20240823$EXP$$US-AMGEN-USASP2024166050$AMGEN$$$$A$M$Y$$$20240823$$HP$US$US
242444511$24244451$1$I$$20240822$20240823$20240823$EXP$$US-ROCHE-10000064763$ROCHE$$72$YR$E$F$Y$$$20240823$$CN$US$US
242444531$24244453$1$I$20240821$20240821$20240823$20240823$PER$$US-BAUSCH-BL-2024-012719$BAUSCH AND LOMB$$$$$F$Y$$$20240823$$MD$US$US
242444541$24244454$1$I$$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024167959$AMGEN$$$$$F$Y$$$20240823$$HP$US$US
242444551$24244455$1$I$20240816$20240818$20240823$20240823$PER$$US-AMGEN-USASP2024165363$AMGEN$$$$$F$Y$$$20240823$$PH$US$US
242444561$24244456$1$I$20240730$20240813$20240823$20240823$PER$$US-JNJFOC-20240861143$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240823$$HP$US$US
242444571$24244457$1$I$20240717$20240820$20240822$20240822$DIR$FDA-CDER-CTU-2024-57825$$FDA-CTU$$46$YR$$F$N$88$KG$20240820$N$$US$
242444581$24244458$1$I$20240815$20240821$20240822$20240822$DIR$FDA-CDER-CTU-2024-57717$$FDA-CTU$$46$YR$$F$N$94.4$KG$20240821$N$$US$
242444611$24244461$1$I$20240822$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58089$$FDA-CTU$$44$YR$$M$N$77.11$KG$20240822$N$$US$
242444621$24244462$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58116$$FDA-CTU$$65$YR$$F$N$$$20240731$N$HP$US$
242444651$24244465$1$I$20240731$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-57965$$FDA-CTU$$64$YR$$F$N$$$20240822$N$$US$
242444661$24244466$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58117$$FDA-CTU$$59$YR$$F$N$$$20240731$N$HP$US$
242444671$24244467$1$I$20240727$20240819$20240823$20240823$EXP$$US-ABBVIE-5886830$ABBVIE$$79$YR$$M$Y$$$20240823$$CN$US$US
242444681$24244468$1$I$20240101$20240820$20240823$20240823$EXP$$US-ABBVIE-5888923$ABBVIE$$$$$$Y$$$20240823$$CN$US$US
242444691$24244469$1$I$$20240822$20240823$20240823$PER$$NVSC2024US171060$NOVARTIS$$55$YR$$F$Y$$$20240823$$HP$US$US
242444702$24244470$2$F$$20240823$20240823$20240829$EXP$$NL-VER-202400052$VERITY PHARMACEUTICALS$$$$$M$Y$$$20240829$$HP$NL$NL
242444711$24244471$1$I$$20240819$20240823$20240823$EXP$$NVSC2024TR169049$NOVARTIS$Kostekci YE, Kraja E, Ergun E, Okulu E, Ates U, Erdeve O et al.. The Management of Neonatal Chylothorax: Experience of a Tertiary Neonatal Referral Center. ANKARA UNIVERSITESI TIP FAKULTESI MECMUASI. 2024;77(2):137-42$$$I$M$Y$$$20240823$$HP$TR$TR
242444732$24244473$2$F$$20240911$20240823$20240918$PER$$NVSC2024US170928$NOVARTIS$$$$$$Y$104$KG$20240918$$CN$US$US
242444742$24244474$2$F$$20240904$20240823$20240909$EXP$$NVSC2024DE170452$NOVARTIS$$80$YR$$F$Y$$$20240909$$PH$DE$DE
242444751$24244475$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CN171146$NOVARTIS$Sun Y, Tan H, Chi Y.. Systematic therapy for metastatic solid pseudopapillary neoplasm of the pancreas: A single-center experience. GASTROINTESTINAL CANCER GASTROESOPHAGEAL, PANCREATIC, AND HEPATOBILIARY. 2024;e16341$$$A$$Y$$$20240823$$HP$CN$CN
242444762$24244476$2$F$$20240823$20240823$20240829$EXP$$NVSC2024PT167568$NOVARTIS$Pereira P, Ling T, Loureiro A, Pereira A, Guerreiro R, Faisca Silva MJ. Leucemia Mielomonocitica Juvenil Com Monossomia Do Cromossoma 7-Relato De Caso Clinico. MEDICINA LABORATORIAL. 132-3$13$MON$$F$Y$$$20240829$$HP$PT$PT
242444772$24244477$2$F$$20240819$20240823$20240827$EXP$$PHHY2013DE089753$NOVARTIS$Stein J, Tannich E, Hartmann F. An unusual complication in ulcerative colitis during treatment with azathioprine and infliximab: Isospora belli as Casus belli. BMJ Case Reports. 2013;1-2$61$YR$$M$Y$$$20240827$$HP$DE$DE
242444791$24244479$1$I$$20240822$20240823$20240823$EXP$$US-INCYTE CORPORATION-2024IN008809$INCYTE$$$$$$Y$$$20240823$$CN$US$US
242444801$24244480$1$I$$20240816$20240823$20240823$PER$$US-ALXN-202408USA001094US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242444821$24244482$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133456$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240823$$PH$US$US
242444831$24244483$1$I$20240820$20240821$20240823$20240823$EXP$$AE-BRISTOL-MYERS SQUIBB COMPANY-2024-133791$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240823$$MD$AE$AE
242444841$24244484$1$I$20220920$20240820$20240823$20240823$PER$$GB-Eisai-EC-2024-172449$EISAI$$83$YR$E$F$Y$$$20240823$$CN$GB$GB
242444851$24244485$1$I$20200101$20240822$20240823$20240823$EXP$$US-PURDUE PHARMA-USA-2024-0311539$PURDUE$$23$YR$$F$Y$$$20240823$$CN$US$US
242444861$24244486$1$I$$20240820$20240823$20240823$EXP$$IT-PURDUE-USA-2024-0311544$PURDUE$Tarda L., Sacco M, Tarzia P., Verrina M, Calafiore J., Aquila I.. Analysis of toxicological findings related to immunofluorescence investigations. Clinica Terapeutica. 2024;175 Suppl. 2(4):183-186$56$YR$$F$Y$$$20240823$$HP$IT$IT
242444871$24244487$1$I$$20240820$20240823$20240823$EXP$$IT-PURDUE-USA-2024-0311552$PURDUE$Tarda L., Sacco M, Tarzia P., Verrina M, Calafiore J., Aquila I.. Analysis of toxicological findings related to immunofluorescence investigations. Clinica Terapeutica. 2024;175 Suppl. 2(4):183-186$54$YR$$M$Y$$$20240823$$HP$IT$IT
242444881$24244488$1$I$$20240822$20240823$20240823$EXP$$US-PURDUE PHARMA-USA-2024-0311537$PURDUE$$$$$M$Y$$$20240823$$CN$US$US
242444891$24244489$1$I$20210612$20240822$20240823$20240823$EXP$$US-PURDUE PHARMA-USA-2024-0311526$PURDUE$$51$YR$$F$Y$$$20240823$$CN$US$US
242444901$24244490$1$I$20240101$20240814$20240823$20240823$EXP$$US-ABBVIE-5881526$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242444911$24244491$1$I$20141001$20240816$20240823$20240823$EXP$$ES-SHIRE-ES201737043$TAKEDA$$60$YR$$M$Y$$$20240823$$HP$PT$ES
242444921$24244492$1$I$$20240812$20240823$20240823$EXP$$US-GE HEALTHCARE-2024CSU009292$GE HEALTHCARE$$$$$$Y$$$20240823$$MD$PT$US
242444932$24244493$2$F$20230801$20240910$20240823$20240917$EXP$$KE-TAKEDA-2024TUS085084$TAKEDA$$17$YR$$M$Y$$$20240917$$CN$KE$KE
242444941$24244494$1$I$20240101$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165329$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242444964$24244496$4$F$20240208$20240926$20240823$20240930$PER$$NVSC2024US168649$NOVARTIS$$60$YR$$F$Y$$$20240930$$CN$US$US
242444972$24244497$2$F$20240821$20240827$20240823$20240828$EXP$$VN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047177$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$50$KG$20240828$$MD$VN$VN
242444982$24244498$2$F$20240521$20240917$20240823$20240919$EXP$$NVSC2024GB114017$NOVARTIS$$$$$F$Y$$$20240919$$CN$GB$GB
242444991$24244499$1$I$20211203$20240815$20240823$20240823$EXP$$TH-INCYTE CORPORATION-2024IN008606$INCYTE$$$$$$Y$$$20240823$$MD$TH$TH
242445001$24244500$1$I$20220901$20240816$20240823$20240823$EXP$$NVSC2024PL167594$NOVARTIS$$$$A$M$Y$$$20240823$$MD$PL$PL
242445011$24244501$1$I$$20240203$20240823$20240823$PER$$US-PFIZER INC-2024SGN01144$PFIZER$$$$$$Y$$$20240823$$MD$US$US
242445021$24244502$1$I$$20240819$20240823$20240823$EXP$$CN-FERRINGPH-2024FE04672$FERRING$$$$$$Y$$$20240823$$CN$CN$CN
242445031$24244503$1$I$$20240220$20240823$20240823$PER$$US-PFIZER INC-2024SGN01739$PFIZER$$28$YR$$M$Y$$$20240823$$HP$US$US
242445041$24244504$1$I$20240805$20240820$20240823$20240823$EXP$$US-ABBVIE-5888843$ABBVIE$$62$YR$$M$Y$$$20240823$$CN$US$US
242445051$24244505$1$I$$20240815$20240823$20240823$EXP$$NL-FERRINGPH-2024FE04611$FERRING$Kil NMP, ten Donkelaar CS, Wijn RPWF, Veenboer PW.. Case Report: Desmopressin and alcohol: a lifethreatening combination. Tijdschrift voor Urologie. 2024;14(5):120-122$$$$$Y$$$20240823$$MD$NL$NL
242445061$24244506$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164856$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240823$$MD$US$US
242445071$24244507$1$I$20240814$20240814$20240823$20240823$EXP$$US-ALKERMES INC.-ALK-2024-002149$ALKERMES$$$$$M$Y$$$20240823$$MD$US$US
242445081$24244508$1$I$20240101$20240816$20240823$20240823$EXP$$US-ALKERMES INC.-ALK-2024-002163$ALKERMES$$$$$M$Y$$$20240823$$HP$US$US
242445092$24244509$2$F$20240813$20240906$20240823$20240912$30DAY$$US-ALKERMES INC.-ALK-2024-002132$ALKERMES$$30$YR$$M$Y$$$20240913$$HP$US$US
242445102$24244510$2$F$20240801$20240813$20240823$20240823$EXP$$US-ALKERMES INC.-ALK-2024-002126$ALKERMES$$$$$M$Y$$$20240823$$HP$US$US
242445141$24244514$1$I$20240220$20240220$20240823$20240823$PER$$US-PFIZER INC-2024SGN01822$PFIZER$$50$YR$$M$Y$$$20240823$$PH$US$US
242445151$24244515$1$I$20240220$20240221$20240823$20240823$PER$$US-PFIZER INC-2024SGN01782$PFIZER$$$$$$Y$$$20240823$$HP$US$US
242445162$24244516$2$F$$20240826$20240823$20240830$EXP$$MA-INCYTE CORPORATION-2024IN008708$INCYTE$$$$$$Y$$$20240830$$CN$MA$MA
242445171$24244517$1$I$$20240819$20240823$20240823$EXP$$NVSC2024EG170023$NOVARTIS$$$$$$Y$$$20240823$$MD$EG$EG
242445181$24244518$1$I$$20240820$20240823$20240823$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024EME104084$VIIV$$$$$$Y$$$20240823$$HP$GB$GB
242445191$24244519$1$I$20240814$20240821$20240823$20240823$PER$$NVSC2024US170252$NOVARTIS$$58$YR$$F$Y$63$KG$20240823$$CN$US$US
242445201$24244520$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58086$$FDA-CTU$$25$YR$$F$N$$$20240822$N$$US$
242445211$24244521$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58066$$FDA-CTU$$76$YR$$M$N$$$20240822$N$$US$
242445221$24244522$1$I$20240815$20240819$20240823$20240823$EXP$GB-MHRA-MED-202408191101123250-NRMDS$GB-RDY-SPO/GBR/24/0012103$DR REDDYS$$49$YR$A$M$Y$$$20240823$$PH$GB$GB
242445231$24244523$1$I$$20240816$20240823$20240823$PER$$US-ABBVIE-5885344$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242445242$24244524$2$F$20240718$20240905$20240823$20240910$EXP$$AR-TAKEDA-2024TUS077389$TAKEDA$$49$YR$$M$Y$57$KG$20240910$$CN$AR$AR
242445251$24244525$1$I$20240814$20240814$20240823$20240823$PER$$US-ABBVIE-5882764$ABBVIE$$55$YR$$F$Y$$$20240823$$CN$US$US
242445261$24244526$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164863$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240823$$MD$US$US
242445271$24244527$1$I$20240812$20240814$20240823$20240823$EXP$$NP-FreseniusKabi-FK202412598$FRESENIUS KABI$$48$YR$A$M$Y$$$20240823$$MD$NP$NP
242445281$24244528$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134369$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240823$$CN$US$US
242445291$24244529$1$I$20240101$20240815$20240823$20240823$PER$$US-ABBVIE-5882759$ABBVIE$$52$YR$$F$Y$$$20240823$$HP$US$US
242445303$24244530$3$F$$20240920$20240823$20240923$PER$$NVSC2024US171192$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
242445321$24244532$1$I$20240101$20240815$20240823$20240823$PER$$US-TEVA-VS-3234288$TEVA$$$$A$F$Y$$$20240823$$HP$US$US
242445332$24244533$2$F$20240810$20240828$20240823$20240829$PER$$US-BAYER-2024A118206$BAYER$$32$YR$A$$Y$$$20240829$$CN$US$US
242445341$24244534$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014218$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240823$$CN$US$US
242445351$24244535$1$I$$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012326$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240823$$CN$US$US
242445361$24244536$1$I$$20240222$20240823$20240823$PER$$US-PFIZER INC-2024SGN01835$PFIZER$$$$$$Y$$$20240823$$MD$US$US
242445382$24244538$2$F$20240818$20240827$20240823$20240903$PER$$US-JNJFOC-20240847131$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242445391$24244539$1$I$20190201$20240820$20240823$20240823$EXP$$SG-MYLANLABS-2024M1077228$MYLAN$$65$YR$$M$Y$$$20240823$$HP$SG$SG
242445401$24244540$1$I$$20240820$20240823$20240823$EXP$$FR-MYLANLABS-2024M1078246$MYLAN$Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon-Pennamen M-D, Rivet J, et al. Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib. J-Eur-Acad-Dermatol-Venereol 2023; 38 (1): e32-e34.$60$YR$$M$Y$$$20240823$$HP$FR$FR
242445411$24244541$1$I$20230801$20240819$20240823$20240823$EXP$$US-GSK-US2024103425$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$HP$US$US
242445421$24244542$1$I$20240604$20240820$20240823$20240823$EXP$$US-MYLANLABS-2024M1077316$MYLAN$$60$YR$$F$Y$67.68$KG$20240823$$CN$US$US
242445431$24244543$1$I$20240812$20240815$20240823$20240823$EXP$$CA-GSK-CA2024101755$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$CN$CA$CA
242445441$24244544$1$I$20240101$20240823$20240823$20240823$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047516$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240823$$CN$US$US
242445451$24244545$1$I$20240819$20240820$20240823$20240823$EXP$GB-MHRA-MED-202408201602539930-RKHMD$GB-MYLANLABS-2024M1077550$MYLAN$$81$YR$$M$Y$$$20240823$$HP$GB$GB
242445461$24244546$1$I$20240801$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133934$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240823$$CN$US$US
242445471$24244547$1$I$$20240301$20240823$20240823$PER$$US-PFIZER INC-2024SGN02163$PFIZER$$$$$$Y$$$20240823$$PH$US$US
242445481$24244548$1$I$20210411$20220215$20240823$20240823$EXP$$DE-JAZZ PHARMACEUTICALS-2021-DE-006651$JAZZ$$$$$$Y$$$20240823$$MD$DE$DE
242445492$24244549$2$F$$20240915$20240823$20240923$EXP$$AU-MYLANLABS-2024M1077731$MYLAN$$$$E$F$Y$$$20240923$$MD$AU$AU
242445501$24244550$1$I$$20240228$20240823$20240823$PER$$US-PFIZER INC-2024SGN02044$PFIZER$$$$$M$Y$$$20240823$$MD$US$US
242445521$24244552$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164865$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240823$$MD$US$US
242445531$24244553$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164894$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240823$$MD$US$US
242445541$24244554$1$I$$20240818$20240823$20240823$EXP$$AU-MYLANLABS-2024M1077747$MYLAN$$$$E$F$Y$$$20240823$$MD$AU$AU
242445551$24244555$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164892$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240823$$MD$US$US
242445561$24244556$1$I$20240801$20240820$20240823$20240823$PER$$US-DSJP-DSU-2024-141528$DAIICHI$$$$$F$Y$$$20240823$$PH$US$US
242445571$24244557$1$I$$20240819$20240823$20240823$EXP$$US-FreseniusKabi-FK202412819$FRESENIUS KABI$Osama M, Pendela VS, Mohamed M, Parikh V. Trigger-Point Bupivacaine Injection Causing A ?Heart-Break?. Journal of Cardiac Failure. 2024 Jan;30(1): 276-277.$59$YR$A$F$Y$$$20240823$$HP$US$US
242445581$24244558$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132340$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240823$$HP$US$US
242445591$24244559$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134003$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240823$$HP$US$US
242445602$24244560$2$F$$20240902$20240823$20240909$EXP$$BG-TAKEDA-2024TUS083942$TAKEDA$$$$$F$Y$$$20240909$$CN$BG$BG
242445611$24244561$1$I$20240101$20240717$20240823$20240823$PER$$US-Eisai-EC-2024-170393$EISAI$$74$YR$E$F$Y$$$20240823$$CN$US$US
242445622$24244562$2$F$$20240826$20240823$20240903$PER$$US-RDY-SPO/USA/24/0012072$DR REDDYS$$56$YR$A$F$Y$$$20240903$$CN$US$US
242445631$24244563$1$I$$20240815$20240823$20240823$PER$$US-RDY-SPO/USA/24/0011968$DR REDDYS$$$$$$Y$$$20240823$$CN$US$US
242445641$24244564$1$I$$20240819$20240823$20240823$PER$$US-RDY-SPO/USA/24/0012073$DR REDDYS$$$$$F$Y$$$20240823$$CN$US$US
242445651$24244565$1$I$$20240815$20240823$20240823$PER$$US-RDY-SPO/USA/24/0012015$DR REDDYS$$21$YR$A$F$Y$$$20240823$$MD$US$US
242445661$24244566$1$I$20240723$20240816$20240823$20240823$PER$$US-RDY-SPO/USA/24/0012045$DR REDDYS$$70$YR$E$F$Y$$$20240823$$CN$US$US
242445671$24244567$1$I$$20240819$20240823$20240823$PER$$US-RDY-SPO/USA/24/0012058$DR REDDYS$$12$YR$T$F$Y$$$20240823$$HP$US$US
242445681$24244568$1$I$20230221$20240819$20240823$20240823$PER$$US-RDY-SPO/USA/24/0012069$DR REDDYS$$78$YR$E$F$Y$60$KG$20240823$$CN$US$US
242445691$24244569$1$I$$20240819$20240823$20240823$PER$$US-RDY-SPO/USA/24/0012068$DR REDDYS$$15$YR$T$M$Y$$$20240823$$MD$US$US
242445701$24244570$1$I$$20240812$20240823$20240823$EXP$ES-drreddys-LIT/SPN/22/0157437$ES-RDY-LIT/SPN/22/0157437$DR REDDYS$Hernani R, Sancho A, Amat P, Hernandez-Boluda JC, Perez A, Pinana JL, et al. CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review.. Current Research in Translational Medicine. 2021 Oct;69(4): 1-5. doi:10.1016/j.retram.2021.103304.$56$YR$A$M$Y$$$20240823$$HP$ES$ES
242445712$24244571$2$F$20120901$20240918$20240823$20240923$PER$$US-JAZZ PHARMACEUTICALS-2021-US-023836$JAZZ$$58$YR$$F$Y$88$KG$20240922$$MD$US$US
242445731$24244573$1$I$$20240823$20240823$20240823$DIR$715644$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242445741$24244574$1$I$$20240823$20240823$20240823$DIR$715640$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242445751$24244575$1$I$$20240823$20240823$20240823$DIR$715641$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242445761$24244576$1$I$20240701$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58220$$FDA-CTU$$46$YR$$M$N$$$20240823$N$PH$US$
242445771$24244577$1$I$$20240823$20240823$20240823$DIR$715638$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242445781$24244578$1$I$20240820$20240823$20240823$20240823$DIR$715649$$FDA-CTU$$59$YR$$F$N$$$20240823$N$HP$US$
242445791$24244579$1$I$$20240823$20240823$20240823$DIR$715651$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242445801$24244580$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58207$$FDA-CTU$$62$YR$$F$N$$$20240823$N$$US$
242445811$24244581$1$I$$20240823$20240823$20240823$DIR$715643$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242445821$24244582$1$I$$20240823$20240823$20240823$DIR$715645$$FDA-CTU$$74$YR$$M$N$$$20240823$N$HP$US$
242445831$24244583$1$I$$20240823$20240823$20240823$DIR$715654$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242445841$24244584$1$I$$20240823$20240823$20240823$DIR$715642$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242445851$24244585$1$I$$20240823$20240823$20240823$DIR$715639$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242445871$24244587$1$I$20240101$20240820$20240823$20240823$EXP$$BE-ABBVIE-5889585$ABBVIE$$32$YR$$F$Y$$$20240823$$CN$BE$BE
242445881$24244588$1$I$$20240820$20240823$20240823$PER$$US-AMGEN-USASP2024166843$AMGEN$$83$YR$E$F$Y$$$20240823$$MD$US$US
242445891$24244589$1$I$20240312$20240823$20240823$20240823$EXP$$NZ-MYLANLABS-2024M1014561$MYLAN$$25$YR$$M$Y$$$20240823$$PH$NZ$NZ
242445901$24244590$1$I$20240101$20240814$20240823$20240823$EXP$$US-TEVA-VS-3234271$TEVA$$57$YR$$F$Y$$$20240823$$CN$US$US
242445911$24244591$1$I$$20240813$20240823$20240823$EXP$$US-MYLANLABS-2024M1076420$MYLAN$Chetana Shanmukhappa S, Kumar A, Dey A, JVS J, Lokeshwaran S, Kumar K S, et al. Omalizumab rescue therapy in refractory status asthmaticus. J-Asthma 2023; 60 (12): 2243-2247.$39$YR$$M$Y$$$20240823$$MD$US$US
242445921$24244592$1$I$$20240823$20240823$20240823$DIR$715648$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242445931$24244593$1$I$$20230724$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202306-000135$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242445941$24244594$1$I$20230101$20230817$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000161$EMMAUS LIFE SCIENCES$$13$YR$T$F$Y$$$20240823$$CN$US$
242445951$24244595$1$I$20230101$20230817$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000162$EMMAUS LIFE SCIENCES$$17$YR$T$F$Y$$$20240823$$CN$US$
242445961$24244596$1$I$20230101$20230823$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000175$EMMAUS LIFE SCIENCES$$64$YR$A$F$Y$$$20240823$$CN$US$
242445971$24244597$1$I$20230101$20230901$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000203$EMMAUS LIFE SCIENCES$$18$YR$A$F$Y$$$20240823$$CN$US$
242445981$24244598$1$I$20230101$20230830$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000225$EMMAUS LIFE SCIENCES$$49$YR$A$F$Y$$$20240823$$CN$US$
242445991$24244599$1$I$20230101$20230927$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000230$EMMAUS LIFE SCIENCES$$40$YR$A$F$Y$$$20240823$$CN$US$
242446001$24244600$1$I$20230101$20230905$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000232$EMMAUS LIFE SCIENCES$$42$YR$A$F$Y$$$20240823$$CN$US$
242446011$24244601$1$I$20230825$20231006$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000236$EMMAUS LIFE SCIENCES$$40$YR$A$M$Y$$$20240823$$CN$US$
242446021$24244602$1$I$20230915$20230927$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000272$EMMAUS LIFE SCIENCES$$49$YR$A$F$Y$$$20240823$$CN$US$
242446031$24244603$1$I$20230101$20230927$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000274$EMMAUS LIFE SCIENCES$$33$YR$A$F$Y$$$20240823$$CN$US$
242446041$24244604$1$I$20230101$20231226$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000278$EMMAUS LIFE SCIENCES$$45$YR$A$M$Y$$$20240823$$CN$US$
242446051$24244605$1$I$$20231002$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000280$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242446061$24244606$1$I$20231101$20231101$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000335$EMMAUS LIFE SCIENCES$$18$YR$A$F$Y$$$20240823$$CN$US$
242446071$24244607$1$I$20230101$20231114$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000364$EMMAUS LIFE SCIENCES$$65$YR$E$F$Y$$$20240823$$CN$US$
242446081$24244608$1$I$20230101$20230910$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000243$EMMAUS LIFE SCIENCES$$32$YR$A$F$Y$$$20240823$$CN$US$
242446091$24244609$1$I$20230101$20231013$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000301$EMMAUS LIFE SCIENCES$$49$YR$A$F$Y$68.03$KG$20240823$$CN$US$
242446101$24244610$1$I$20231001$20231101$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000330$EMMAUS LIFE SCIENCES$$27$YR$A$F$Y$$$20240823$$CN$US$
242446111$24244611$1$I$20230101$20231101$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000331$EMMAUS LIFE SCIENCES$$58$YR$A$F$Y$$$20240823$$CN$US$
242446121$24244612$1$I$20231001$20231208$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000419$EMMAUS LIFE SCIENCES$$41$YR$A$F$Y$$$20240823$$CN$US$
242446131$24244613$1$I$20230101$20231213$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000422$EMMAUS LIFE SCIENCES$$42$YR$A$M$Y$$$20240823$$CN$US$
242446141$24244614$1$I$20230101$20231218$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000431$EMMAUS LIFE SCIENCES$$38$YR$A$M$Y$$$20240823$$CN$US$
242446151$24244615$1$I$20230101$20231227$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000442$EMMAUS LIFE SCIENCES$$38$YR$A$M$Y$$$20240823$$CN$US$
242446161$24244616$1$I$$20240131$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000064$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446171$24244617$1$I$$20240213$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000078$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446181$24244618$1$I$20240101$20240117$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000034$EMMAUS LIFE SCIENCES$$52$YR$A$F$Y$$$20240823$$CN$US$
242446191$24244619$1$I$20240101$20240228$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000053$EMMAUS LIFE SCIENCES$$58$YR$A$F$Y$$$20240823$$CN$US$
242446201$24244620$1$I$20240101$20240126$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000056$EMMAUS LIFE SCIENCES$$18$YR$A$M$Y$70.2$KG$20240823$$CN$US$
242446211$24244621$1$I$20240101$20240311$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000136$EMMAUS LIFE SCIENCES$$42$YR$A$F$Y$$$20240823$$CN$US$
242446221$24244622$1$I$20240101$20240320$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000149$EMMAUS LIFE SCIENCES$$18$YR$A$M$Y$$$20240823$$CN$US$
242446231$24244623$1$I$20240101$20240404$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000173$EMMAUS LIFE SCIENCES$$60$YR$A$F$Y$$$20240823$$CN$US$
242446241$24244624$1$I$20231201$20240401$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000067$EMMAUS LIFE SCIENCES$$62$YR$A$F$Y$$$20240823$$CN$US$
242446251$24244625$1$I$20240101$20240408$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000176$EMMAUS LIFE SCIENCES$$41$YR$A$M$Y$$$20240823$$CN$US$
242446261$24244626$1$I$20240101$20240506$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000189$EMMAUS LIFE SCIENCES$$37$YR$A$F$Y$$$20240823$$CN$US$
242446271$24244627$1$I$20240401$20240429$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000212$EMMAUS LIFE SCIENCES$$59$YR$A$F$Y$$$20240823$$CN$US$
242446281$24244628$1$I$20240101$20240504$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000222$EMMAUS LIFE SCIENCES$$40$YR$A$F$Y$$$20240823$$CN$US$
242446291$24244629$1$I$20240101$20240506$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000231$EMMAUS LIFE SCIENCES$$29$YR$A$F$Y$$$20240823$$CN$US$
242446301$24244630$1$I$20240101$20240531$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000270$EMMAUS LIFE SCIENCES$$18$YR$A$M$Y$$$20240823$$CN$US$
242446311$24244631$1$I$20180101$20240625$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000293$EMMAUS LIFE SCIENCES$$21$YR$A$F$Y$$$20240823$$CN$US$
242446321$24244632$1$I$$20240703$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202407-000336$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242446331$24244633$1$I$20230101$20231108$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000348$EMMAUS LIFE SCIENCES$$34$YR$A$M$Y$$$20240823$$CN$US$
242446341$24244634$1$I$20230101$20231109$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000352$EMMAUS LIFE SCIENCES$$35$YR$A$F$Y$$$20240823$$CN$US$
242446351$24244635$1$I$20160101$20240102$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202312-000406$EMMAUS LIFE SCIENCES$$20$YR$A$F$Y$57.5$KG$20240823$$CN$US$
242446361$24244636$1$I$$20240110$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000026$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446371$24244637$1$I$20240101$20240118$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000031$EMMAUS LIFE SCIENCES$$45$YR$A$M$Y$$$20240823$$CN$US$
242446381$24244638$1$I$$20240119$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000036$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446391$24244639$1$I$$20240122$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000040$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446401$24244640$1$I$20240101$20240213$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000042$EMMAUS LIFE SCIENCES$$18$YR$A$M$Y$$$20240823$$CN$US$
242446411$24244641$1$I$20240101$20240126$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000055$EMMAUS LIFE SCIENCES$$49$YR$A$F$Y$$$20240823$$CN$US$
242446421$24244642$1$I$$20240229$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202401-000057$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446431$24244643$1$I$20240101$20240213$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000073$EMMAUS LIFE SCIENCES$$25$YR$A$M$Y$$$20240823$$CN$US$
242446441$24244644$1$I$20240601$20240612$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000294$EMMAUS LIFE SCIENCES$$38$YR$A$F$Y$$$20240823$$CN$US$
242446451$24244645$1$I$20240201$20240221$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000088$EMMAUS LIFE SCIENCES$$35$YR$A$M$Y$$$20240823$$CN$US$
242446461$24244646$1$I$20240101$20240221$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000090$EMMAUS LIFE SCIENCES$$9$YR$C$M$Y$$$20240823$$CN$US$
242446471$24244647$1$I$20240101$20240228$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000106$EMMAUS LIFE SCIENCES$$55$YR$A$F$Y$$$20240823$$CN$US$
242446481$24244648$1$I$20240101$20240304$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000111$EMMAUS LIFE SCIENCES$$24$YR$A$F$Y$$$20240823$$CN$US$
242446491$24244649$1$I$$20240302$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000112$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446501$24244650$1$I$20240101$20240307$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000129$EMMAUS LIFE SCIENCES$$42$YR$A$F$Y$$$20240823$$CN$US$
242446511$24244651$1$I$20240201$20240308$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000132$EMMAUS LIFE SCIENCES$$40$YR$A$M$Y$$$20240823$$CN$US$
242446521$24244652$1$I$20240101$20240321$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000152$EMMAUS LIFE SCIENCES$$11$YR$C$F$Y$$$20240823$$CN$US$
242446531$24244653$1$I$20240326$20240329$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000160$EMMAUS LIFE SCIENCES$$16$YR$T$F$Y$$$20240823$$CN$US$
242446541$24244654$1$I$$20240311$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000135$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446551$24244655$1$I$$20240411$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202403-000144$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446561$24244656$1$I$20230101$20240401$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000161$EMMAUS LIFE SCIENCES$$23$YR$A$M$Y$$$20240823$$CN$US$
242446571$24244657$1$I$20240219$20240401$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000162$EMMAUS LIFE SCIENCES$$10$YR$C$F$Y$$$20240823$$CN$US$
242446581$24244658$1$I$20240101$20240417$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000164$EMMAUS LIFE SCIENCES$$14$YR$T$M$Y$$$20240823$$CN$US$
242446591$24244659$1$I$20240101$20240404$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000170$EMMAUS LIFE SCIENCES$$43$YR$A$M$Y$$$20240823$$CN$US$
242446601$24244660$1$I$20240101$20240408$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000177$EMMAUS LIFE SCIENCES$$32$YR$A$M$Y$$$20240823$$CN$US$
242446611$24244661$1$I$20240101$20240408$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000178$EMMAUS LIFE SCIENCES$$11$YR$C$M$Y$$$20240823$$CN$US$
242446621$24244662$1$I$20240407$20240506$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000179$EMMAUS LIFE SCIENCES$$40$YR$A$M$Y$$$20240823$$CN$US$
242446631$24244663$1$I$$20240422$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202404-000193$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446641$24244664$1$I$20240101$20240501$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000219$EMMAUS LIFE SCIENCES$$32$YR$A$M$Y$$$20240823$$CN$US$
242446651$24244665$1$I$20240101$20240515$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000247$EMMAUS LIFE SCIENCES$$12$YR$T$M$Y$$$20240823$$CN$US$
242446661$24244666$1$I$20240101$20240515$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000248$EMMAUS LIFE SCIENCES$$23$YR$A$F$Y$$$20240823$$CN$US$
242446671$24244667$1$I$20240501$20240515$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000251$EMMAUS LIFE SCIENCES$$16$YR$T$F$Y$$$20240823$$CN$US$
242446681$24244668$1$I$20240101$20240527$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000260$EMMAUS LIFE SCIENCES$$50$YR$A$F$Y$$$20240823$$CN$US$
242446691$24244669$1$I$20240101$20240528$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202405-000264$EMMAUS LIFE SCIENCES$$42$YR$A$F$Y$$$20240823$$CN$US$
242446701$24244670$1$I$20240101$20240531$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000268$EMMAUS LIFE SCIENCES$$60$YR$A$F$Y$$$20240823$$CN$US$
242446711$24244671$1$I$20240601$20240603$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000271$EMMAUS LIFE SCIENCES$$46$YR$A$F$Y$$$20240823$$CN$US$
242446721$24244672$1$I$$20240531$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000273$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446731$24244673$1$I$$20240603$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000277$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$$US$
242446741$24244674$1$I$20240101$20240404$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202402-000083$EMMAUS LIFE SCIENCES$$33$YR$A$F$Y$$$20240823$$CN$US$
242446751$24244675$1$I$20240601$20240610$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000287$EMMAUS LIFE SCIENCES$$54$YR$A$M$Y$$$20240823$$CN$US$
242446761$24244676$1$I$20220101$20240612$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000291$EMMAUS LIFE SCIENCES$$45$YR$A$M$Y$$$20240823$$CN$US$
242446771$24244677$1$I$20240101$20240614$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000299$EMMAUS LIFE SCIENCES$$44$YR$A$F$Y$$$20240823$$CN$US$
242446781$24244678$1$I$20240101$20240617$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000303$EMMAUS LIFE SCIENCES$$12$YR$T$M$Y$$$20240823$$CN$US$
242446791$24244679$1$I$$20240617$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000304$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446801$24244680$1$I$20240604$20240621$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000312$EMMAUS LIFE SCIENCES$$13$YR$T$F$Y$$$20240823$$CN$US$
242446811$24244681$1$I$20240601$20240626$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000324$EMMAUS LIFE SCIENCES$$54$YR$A$M$Y$$$20240823$$CN$US$
242446821$24244682$1$I$20240601$20240701$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202407-000332$EMMAUS LIFE SCIENCES$$12$YR$T$M$Y$$$20240823$$CN$US$
242446831$24244683$1$I$20240729$20240823$20240823$20240823$DIR$715652$$FDA-CTU$$48$YR$$F$N$$$20240823$N$CN$US$
242446841$24244684$1$I$20240731$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58246$$FDA-CTU$$69$YR$$F$N$$$20240823$Y$HP$US$
242446851$24244685$1$I$$20230713$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202306-000127$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242446861$24244686$1$I$$20230727$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202307-000187$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242446871$24244687$1$I$20230101$20230807$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000201$EMMAUS LIFE SCIENCES$$7$YR$C$F$Y$$$20240823$$CN$US$
242446881$24244688$1$I$20230101$20230824$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202308-000206$EMMAUS LIFE SCIENCES$$12$YR$T$M$Y$$$20240823$$CN$US$
242446891$24244689$1$I$20230101$20230907$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000242$EMMAUS LIFE SCIENCES$$38$YR$A$F$Y$$$20240823$$CN$US$
242446901$24244690$1$I$$20230920$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000255$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242446911$24244691$1$I$20200101$20240617$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000302$EMMAUS LIFE SCIENCES$$11$YR$C$M$Y$$$20240823$$CN$US$
242446921$24244692$1$I$20220701$20230929$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000263$EMMAUS LIFE SCIENCES$$22$YR$A$F$Y$66.224$KG$20240823$$CN$US$
242446931$24244693$1$I$20230101$20230927$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000267$EMMAUS LIFE SCIENCES$$45$YR$A$M$Y$$$20240823$$CN$US$
242446941$24244694$1$I$20230901$20230927$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202309-000268$EMMAUS LIFE SCIENCES$$20$YR$A$F$Y$$$20240823$$CN$US$
242446951$24244695$1$I$$20231010$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000281$EMMAUS LIFE SCIENCES$$$$$M$Y$27.9$KG$20240823$$CN$US$
242446961$24244696$1$I$20230101$20231129$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000296$EMMAUS LIFE SCIENCES$$39$YR$A$M$Y$$$20240823$$CN$US$
242446971$24244697$1$I$20231001$20231024$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000315$EMMAUS LIFE SCIENCES$$14$YR$T$M$Y$$$20240823$$CN$US$
242446981$24244698$1$I$20231030$20231030$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202310-000327$EMMAUS LIFE SCIENCES$$41$YR$A$M$Y$$$20240823$$CN$US$
242446991$24244699$1$I$20230101$20231030$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000328$EMMAUS LIFE SCIENCES$$50$YR$A$M$Y$$$20240823$$CN$US$
242447001$24244700$1$I$20230101$20231101$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000333$EMMAUS LIFE SCIENCES$$52$YR$A$F$Y$$$20240823$$CN$US$
242447011$24244701$1$I$20231105$20231127$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202311-000342$EMMAUS LIFE SCIENCES$$32$YR$A$M$Y$67.2$KG$20240823$$CN$US$
242447021$24244702$1$I$20240607$20240620$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000309$EMMAUS LIFE SCIENCES$$13$YR$T$M$Y$$$20240823$$CN$US$
242447031$24244703$1$I$20240619$20240620$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000310$EMMAUS LIFE SCIENCES$$9$YR$C$M$Y$$$20240823$$CN$US$
242447041$24244704$1$I$$20240620$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000311$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242447051$24244705$1$I$20240601$20240624$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000313$EMMAUS LIFE SCIENCES$$46$YR$A$F$Y$$$20240823$$CN$US$
242447061$24244706$1$I$20240101$20240624$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000314$EMMAUS LIFE SCIENCES$$18$YR$A$F$Y$$$20240823$$CN$US$
242447071$24244707$1$I$20240609$20240624$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000316$EMMAUS LIFE SCIENCES$$57$YR$A$F$Y$$$20240823$$CN$US$
242447081$24244708$1$I$$20240624$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000317$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242447091$24244709$1$I$20240601$20240625$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000318$EMMAUS LIFE SCIENCES$$27$YR$A$F$Y$$$20240823$$CN$US$
242447101$24244710$1$I$20240623$20240624$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000319$EMMAUS LIFE SCIENCES$$35$YR$A$F$Y$$$20240823$$CN$US$
242447111$24244711$1$I$20240101$20240625$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000320$EMMAUS LIFE SCIENCES$$60$YR$A$F$Y$$$20240823$$CN$US$
242447121$24244712$1$I$20240101$20240625$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000321$EMMAUS LIFE SCIENCES$$39$YR$A$F$Y$$$20240823$$CN$US$
242447131$24244713$1$I$20240601$20240625$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000322$EMMAUS LIFE SCIENCES$$29$YR$A$F$Y$$$20240823$$CN$US$
242447141$24244714$1$I$20240501$20240626$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000323$EMMAUS LIFE SCIENCES$$6$YR$C$M$Y$$$20240823$$CN$US$
242447151$24244715$1$I$$20240626$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000325$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242447161$24244716$1$I$20240601$20240629$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202407-000326$EMMAUS LIFE SCIENCES$$24$YR$A$M$Y$$$20240823$$CN$US$
242447171$24244717$1$I$20240619$20240628$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202407-000327$EMMAUS LIFE SCIENCES$$8$YR$C$M$Y$$$20240823$$CN$US$
242447181$24244718$1$I$20240625$20240629$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202407-000328$EMMAUS LIFE SCIENCES$$38$YR$A$M$Y$$$20240823$$CN$US$
242447191$24244719$1$I$$20240629$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202407-000329$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242447201$24244720$1$I$20240101$20240701$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202407-000330$EMMAUS LIFE SCIENCES$$43$YR$A$F$Y$$$20240823$$CN$US$
242447211$24244721$1$I$20240625$20240702$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202407-000333$EMMAUS LIFE SCIENCES$$41$YR$A$F$Y$$$20240823$$CN$US$
242447221$24244722$1$I$20240622$20240703$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202407-000334$EMMAUS LIFE SCIENCES$$17$YR$T$F$Y$$$20240823$$CN$US$
242447231$24244723$1$I$$20240703$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202407-000338$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240823$$CN$US$
242447241$24244724$1$I$$20240703$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202407-000339$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240823$$CN$US$
242447272$24244727$2$F$20230101$20240826$20240823$20240902$EXP$$US-ABBVIE-5889966$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242447281$24244728$1$I$20191103$20240813$20240823$20240823$EXP$$DE-BAXTER-2024BAX023170$BAXTER$$39$YR$$F$Y$$$20240823$$MD$DE$DE
242447291$24244729$1$I$20240610$20240619$20240823$20240823$PER$$US-Emmaus Medical, Inc.-EMM202406-000307$EMMAUS LIFE SCIENCES$$14$YR$T$M$Y$$$20240823$$CN$US$
242447304$24244730$4$F$20240819$20240919$20240823$20240926$EXP$$DE-BAXTER-2024BAX023404$BAXTER$$43$YR$$M$Y$$$20240926$$HP$DE$DE
242447311$24244731$1$I$$20240820$20240823$20240823$EXP$$US-TAKEDA-2024TUS084053$TAKEDA$$$$$M$Y$$$20240823$$MD$US$US
242447321$24244732$1$I$20240607$20240813$20240823$20240823$EXP$FR-AFSSAPS-NC2024000944$FR-TEVA-VS-3233444$TEVA$$14$YR$$M$Y$64$KG$20240823$$MD$FR$FR
242447332$24244733$2$F$$20240827$20240823$20240828$PER$$US-JNJFOC-20240854971$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$HP$US$US
242447351$24244735$1$I$$20240806$20240823$20240823$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-23-001359$AKEBIA THERAPEUTICS$Imai E, Imai A.. P-020 Comparison of drug cost and adverse reaction between Daprodustat and Vadadustat. The Japanese Journal of Nephrology. The 66th Annual Meeting of the Japanese Soci. 2023;65:3:296$$$$$Y$$$20240823$$HP$JP$JP
242447361$24244736$1$I$$20240813$20240823$20240823$EXP$$US-Daito Pharmaceutical Co., Ltd.-2160800$DAITO PHARMACEUTICALS$Literature reference$61$YR$$M$Y$$$20240823$$MD$US$US
242447371$24244737$1$I$$20240822$20240823$20240823$EXP$NL-LRB-00996614$NL-INCYTE CORPORATION-2024IN008815$INCYTE$$$$$$Y$$$20240823$$MD$NL$NL
242447381$24244738$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA169055$NOVARTIS$$77$YR$$F$Y$65$KG$20240823$$PH$CA$CA
242447391$24244739$1$I$20240821$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134347$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240823$$MD$US$US
242447402$24244740$2$F$$20240828$20240823$20240902$EXP$$BR-TAKEDA-2023TUS009594$TAKEDA$$$$$F$Y$$$20240902$$CN$BR$BR
242447411$24244741$1$I$20240805$20240820$20240823$20240823$PER$$CN-Eisai-EC-2024-172487$EISAI$$58$YR$A$F$Y$44$KG$20240823$$HP$CN$CN
242447421$24244742$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133745$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240823$$CN$US$US
242447432$24244743$2$F$$20240829$20240823$20240830$EXP$$JP-Eisai-EC-2024-172718$EISAI$$$$E$M$Y$$$20240830$$PH$JP$JP
242447451$24244745$1$I$20240101$20240814$20240823$20240823$PER$$US-ABBVIE-5881696$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242447461$24244746$1$I$20230829$20240812$20240823$20240823$EXP$$US-RADIUS HEALTH, INC.-2023US004524$RADIUS PHARM$$73$YR$$F$Y$$$20240823$$CN$US$US
242447471$24244747$1$I$20240728$20240814$20240823$20240823$EXP$ES-AEMPS-1555336$ES-TEVA-VS-3233931$TEVA$$78$YR$$M$Y$$$20240823$$MD$ES$ES
242447491$24244749$1$I$$20220713$20240823$20240823$EXP$$CA-DSJP-DSJ-2022-121846$DAIICHI$$$$$F$Y$$$20240823$$CN$CA$CA
242447501$24244750$1$I$20220101$20220629$20240823$20240823$EXP$$CA-DSJP-DSJ-2022-119890$DAIICHI$$$$$F$Y$$$20240823$$CN$CA$CA
242447511$24244751$1$I$$20240822$20240823$20240823$PER$$NVSC2024US171169$NOVARTIS$$$$$M$Y$$$20240823$$HP$US$US
242447521$24244752$1$I$$20240813$20240823$20240823$30DAY$$US-GSK-US2024AMR102766$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242447531$24244753$1$I$$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013566$ELI LILLY AND CO$$$$$$Y$$$20240823$$CN$US$US
242447541$24244754$1$I$20240617$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408009346$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240823$$MD$US$US
242447552$24244755$2$F$20240716$20240905$20240823$20240909$EXP$FR-AFSSAPS-AN2024001132$FR-MYLANLABS-2024M1077163$MYLAN$$75$YR$$M$Y$66$KG$20240909$$MD$FR$FR
242447561$24244756$1$I$20230701$20240814$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408009197$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240823$$CN$US$US
242447571$24244757$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58196$$FDA-CTU$$$$$$N$$$20240823$N$$US$
242447581$24244758$1$I$20240624$20240814$20240823$20240823$EXP$FR-AFSSAPS-TS2024000893$FR-TEVA-VS-3233904$TEVA$$77$YR$$M$Y$64$KG$20240823$$MD$FR$FR
242447591$24244759$1$I$$20240822$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074752$SANDOZ$$$$$$Y$$$20240823$$CN$CA$CA
242447601$24244760$1$I$20230920$20240821$20240823$20240823$PER$$US-ORGANON-O2408USA001634$ORGANON$$19$YR$$F$Y$46.712$KG$20240823$$CN$US$US
242447611$24244761$1$I$20240805$20240814$20240823$20240823$EXP$$US-GSK-US2024AMR103314$GLAXOSMITHKLINE$$$$$F$Y$$$20240823$$CN$US$US
242447631$24244763$1$I$$20240820$20240823$20240823$EXP$$US-ABBVIE-5797653$ABBVIE$$$$$F$Y$136.08$KG$20240823$$CN$US$US
242447641$24244764$1$I$$20240822$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134187$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240823$$CN$US$US
242447651$24244765$1$I$20231026$20240812$20240823$20240823$EXP$$CN-TAKEDA-2023TUS108175$TAKEDA$$17$YR$$M$Y$$$20240823$$CN$CN$CN
242447661$24244766$1$I$20240325$20240813$20240823$20240823$EXP$FR-AFSSAPS-LY2024001132$FR-TEVA-VS-3233826$TEVA$$82$YR$$M$Y$93$KG$20240823$$PH$FR$FR
242447681$24244768$1$I$20240601$20240820$20240823$20240823$EXP$$US-PFIZER INC-202400241245$PFIZER$$28$YR$$M$Y$$$20240823$$HP$US$US
242447691$24244769$1$I$$20240822$20240823$20240823$EXP$$CA-SANDOZ INC.-SDZ2024CA074657$SANDOZ$$49$YR$$F$Y$$$20240823$$PH$CA$CA
242447701$24244770$1$I$20240801$20240820$20240823$20240823$EXP$$CN-PFIZER INC-PV202400108637$PFIZER$$41$YR$$F$Y$45$KG$20240823$$HP$CN$CN
242447711$24244771$1$I$$20240821$20240823$20240823$EXP$$CA-PFIZER INC-202400241168$PFIZER$$77$YR$$F$Y$73$KG$20240823$$HP$CA$CA
242447721$24244772$1$I$20221025$20240821$20240823$20240823$EXP$$US-PFIZER INC-202400242202$PFIZER$$56$YR$$F$Y$$$20240823$$HP$US$US
242447731$24244773$1$I$$20240814$20240823$20240823$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007359$AEGERION$$$$$M$Y$$$20240823$$CN$US$US
242447742$24244774$2$F$20220801$20240830$20240823$20240906$EXP$$CA-PFIZER INC-202400219374$PFIZER$$33$YR$$$Y$$$20240906$$HP$CA$CA
242447751$24244775$1$I$20240612$20240819$20240823$20240823$EXP$IT-MINISAL02-998042$IT-FreseniusKabi-FK202412662$FRESENIUS KABI$$1$MON$I$F$Y$$$20240823$$HP$IT$IT
242447761$24244776$1$I$20240806$20240815$20240823$20240823$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101869$VIIV$$28$YR$$M$Y$$$20240823$$HP$US$US
242447771$24244777$1$I$20240223$20240813$20240823$20240823$EXP$FR-AFSSAPS-PP2024000862$FR-TEVA-VS-3233478$TEVA$$63$YR$$F$Y$63$KG$20240823$$MD$FR$FR
242447783$24244778$3$F$$20240916$20240823$20240925$EXP$$AU-ABBVIE-5891592$ABBVIE$$$$$M$Y$$$20240925$$HP$AU$AU
242447791$24244779$1$I$20240711$20240718$20240823$20240823$PER$$US-Eisai-EC-2024-163848$EISAI$$68$YR$E$F$Y$$$20240823$$CN$US$US
242447801$24244780$1$I$20240801$20240820$20240823$20240823$EXP$$PT-FreseniusKabi-FK202412770$FRESENIUS KABI$$72$YR$E$F$Y$62$KG$20240823$$MD$PT$PT
242447811$24244781$1$I$20240722$20240722$20240823$20240823$PER$$US-Eisai-EC-2024-170657$EISAI$$$$$M$Y$$$20240823$$HP$US$US
242447821$24244782$1$I$$20240306$20240823$20240823$PER$$US-PFIZER INC-2024SGN02305$PFIZER$$90$YR$$M$Y$$$20240823$$MD$US$US
242447831$24244783$1$I$20190901$20240813$20240823$20240823$EXP$FR-EMA-DD-20240806-7482661-070324$FR-TEVA-VS-3233445$TEVA$$81$YR$$F$Y$49$KG$20240823$$MD$FR$FR
242447841$24244784$1$I$20240802$20240815$20240823$20240823$EXP$FR-AFSSAPS-MP2024001285$FR-AMGEN-FRASP2024164284$AMGEN$$70$YR$E$F$Y$52.5$KG$20240823$$MD$FR$FR
242447851$24244785$1$I$20221227$20240823$20240823$20240823$EXP$$DE-SANDOZ INC.-NVSC2023DE002795$SANDOZ$$82$YR$$M$Y$66$KG$20240823$$MD$DE$DE
242447861$24244786$1$I$$20221206$20240823$20240823$EXP$$CA-DSJP-DSJ-2022-143041$DAIICHI$$$$$F$Y$$$20240823$$MD$CA$CA
242447891$24244789$1$I$$20240819$20240823$20240823$EXP$$US-ABBVIE-5888716$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242447902$24244790$2$F$$20240906$20240823$20240906$PER$$US-ALXN-202407USA002301US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242447912$24244791$2$F$20240801$20240823$20240823$20240828$EXP$$US-KYOWAKIRIN-2024KK019746$KYOWA$$$$$$Y$$$20240828$$HP$US$US
242447922$24244792$2$F$$20240904$20240823$20240911$EXP$$US-TAKEDA-2024TUS081892$TAKEDA$$36$YR$$F$Y$$$20240911$$CN$US$US
242447931$24244793$1$I$20240704$20240820$20240823$20240823$EXP$$SG-MYLANLABS-2024M1077220$MYLAN$$63$YR$$M$Y$$$20240823$$HP$SG$SG
242447941$24244794$1$I$20240723$20240821$20240823$20240823$EXP$FR-AFSSAPS-AN2024001092$FR-MYLANLABS-2024M1077525$MYLAN$$82$YR$$M$Y$80.1$KG$20240823$$MD$FR$FR
242447951$24244795$1$I$$20240818$20240823$20240823$EXP$$BR-TAKEDA-2023TUS072426$TAKEDA$$$$$$Y$$$20240823$$CN$BR$BR
242447961$24244796$1$I$$20240327$20240823$20240823$PER$$US-PFIZER INC-2024SGN03542$PFIZER$$$$$$Y$$$20240823$$HP$US$US
242447971$24244797$1$I$$20240307$20240823$20240823$PER$$US-PFIZER INC-2024SGN02400$PFIZER$$$$$M$Y$$$20240823$$MD$US$US
242447981$24244798$1$I$$20240813$20240823$20240823$EXP$$US-BAYER-2024A117323$BAYER$$54$YR$A$F$Y$$$20240823$$CN$US$US
242447991$24244799$1$I$20240301$20240819$20240823$20240823$EXP$$US-OTSUKA-2024_022873$OTSUKA$$64$YR$$F$Y$$$20240823$$CN$US$US
242448001$24244800$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58118$$FDA-CTU$$60$YR$$M$N$$$20240731$N$HP$US$
242448011$24244801$1$I$20230101$20230629$20240823$20240823$EXP$$CA-DSJP-DSJ-2023-127643$DAIICHI$$$$$F$Y$$$20240823$$MD$CA$CA
242448021$24244802$1$I$20240819$20240819$20240823$20240823$PER$$US-BAYER-2024A119526$BAYER$$$$$M$Y$$$20240823$$CN$US$US
242448031$24244803$1$I$$20240814$20240823$20240823$PER$$US-ABBVIE-5883281$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242448041$24244804$1$I$20240701$20240723$20240823$20240823$PER$$US-Eisai-EC-2024-170784$EISAI$$$$$F$Y$$$20240823$$HP$US$US
242448052$24244805$2$F$20240530$20240924$20240823$20240927$EXP$$IT-TAKEDA-2024TUS083312$TAKEDA$$57$YR$$F$Y$70$KG$20240927$$HP$IT$IT
242448061$24244806$1$I$20240508$20240816$20240823$20240823$EXP$CH-SM-2024-14858$CH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046228$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$90.7$KG$20240823$$PH$CH$CH
242448071$24244807$1$I$20180212$20240812$20240823$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013283$JAZZ$$59$YR$$M$Y$$$20240823$$MD$US$US
242448081$24244808$1$I$$20240808$20240823$20240823$EXP$$US-HLS-202400790$HLS THERAPEUTICS$$$$A$M$Y$$$20240823$$PH$US$US
242448091$24244809$1$I$20240325$20240416$20240823$20240823$PER$$US-PFIZER INC-2024SGN04572$PFIZER$$$$$F$Y$$$20240823$$HP$US$US
242448101$24244810$1$I$20240404$20240416$20240823$20240823$PER$$US-PFIZER INC-2024SGN04539$PFIZER$$$$$M$Y$$$20240823$$HP$US$US
242448111$24244811$1$I$$20240812$20240823$20240823$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16164$IPSEN$$$$$F$Y$65.7$KG$20240823$$CN$US$US
242448121$24244812$1$I$20240820$20240821$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013783$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240823$$HP$US$US
242448131$24244813$1$I$20240819$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408012327$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240823$$CN$US$US
242448141$24244814$1$I$20240723$20240823$20240823$20240823$EXP$FR-AFSSAPS-RE2024000839$FR-SANDOZ INC.-SDZ2024FR074820$SANDOZ$$78$YR$$M$Y$$$20240823$$MD$FR$FR
242448151$24244815$1$I$20240810$20240813$20240823$20240823$EXP$GB-MHRA-MED-202408131719474290-JHNLS$GB-TEVA-VS-3233219$TEVA$$39$YR$$F$Y$$$20240823$$HP$GB$GB
242448162$24244816$2$F$20240815$20240913$20240823$20240923$PER$$US-BIOGEN-2024BI01278769$BIOGEN$$37$YR$$F$Y$$$20240923$$CN$US$US
242448171$24244817$1$I$20230101$20240820$20240823$20240823$EXP$$JP-ORGANON-O2408JPN001694$ORGANON$$81$YR$$F$Y$$$20240823$$HP$JP$JP
242448181$24244818$1$I$$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134241$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240823$$CN$US$US
242448193$24244819$3$F$$20240910$20240823$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129789$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$82.1$KG$20240913$$CN$US$US
242448201$24244820$1$I$$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134234$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240823$$CN$US$US
242448211$24244821$1$I$20240821$20240822$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134178$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240823$$CN$US$US
242448221$24244822$1$I$$20240813$20240823$20240823$30DAY$$CO-PFIZER INC-202400236885$PFIZER$$$$$$Y$$$20240823$$CN$CO$CO
242448231$24244823$1$I$$20240814$20240823$20240823$30DAY$$UY-PFIZER INC-202400236582$PFIZER$$15$YR$$F$Y$$$20240823$$CN$UY$UY
242448242$24244824$2$F$$20240923$20240823$20240925$30DAY$$NL-PFIZER INC-202400235665$PFIZER$$$$$F$Y$$$20240925$$PH$NL$NL
242448252$24244825$2$F$20230101$20240909$20240823$20240911$EXP$$DE-ORGANON-O2408DEU001482$ORGANON$$$$$M$Y$136.2$KG$20240911$$CN$DE$DE
242448263$24244826$3$F$$20240827$20240823$20240827$30DAY$$US-PFIZER INC-PV202400108121$PFIZER$$$$$F$Y$$$20240827$$CN$US$US
242448272$24244827$2$F$$20240823$20240823$20240828$30DAY$$CO-PFIZER INC-202400237390$PFIZER$$13$YR$$M$Y$$$20240828$$CN$CO$CO
242448282$24244828$2$F$$20240821$20240823$20240827$EXP$$IT-PFIZER INC-202400240155$PFIZER$Frattari, A.. High viral load VZV encephalitis complicated by super refractory status epilepticus in a vaccinated child with in Acute Lymphocytic Leukemia: Case report and review of the literature. Neuroimmunology Reports. 2024;6:10.1016/j.nerep.2024.100223$6$YR$$M$Y$$$20240827$$HP$IT$IT
242448291$24244829$1$I$$20240429$20240823$20240823$PER$$US-PFIZER INC-2024SGN05101$PFIZER$$$$$M$Y$$$20240823$$PH$US$US
242448301$24244830$1$I$20170101$20240819$20240823$20240823$EXP$$FR-PFIZER INC-202300028140$PFIZER$Dufayet, L.. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF)Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the Ile-de-France Toxic Death Surveillance System (DCTOX-IdF). Analytical and Clinical Toxicology. 2022;438:1-6$45$YR$$M$Y$$$20240823$$HP$FR$FR
242448312$24244831$2$F$20240705$20240912$20240823$20240916$EXP$$GB-ALXN-202408GBR001177GB$ALEXION PHARMACEUTICALS$$9$YR$$F$Y$24.9$KG$20240916$$MD$GB$GB
242448321$24244832$1$I$$20240819$20240823$20240823$EXP$$IT-PFIZER INC-202400241141$PFIZER$Rosignoli, C.. Efficacy and safety of greater occipital nerve block with a small volume of lidocaine and methylprednisolone in tertiary headache center. Confinia Cephalalgica et Neurologica. 2024;34 (2):10.4081/cc.2024.15770$$$A$$Y$$$20240823$$HP$IT$IT
242448331$24244833$1$I$$20240731$20240822$20240822$DIR$FDA-CDER-CTU-2024-58119$$FDA-CTU$$60$YR$$F$N$$$20240731$N$HP$US$
242448351$24244835$1$I$20201205$20240813$20240823$20240823$EXP$$US-TEVA-VS-3234769$TEVA$$21$YR$$F$Y$30$KG$20240823$$HP$US$CN
242448361$24244836$1$I$$20240816$20240823$20240823$EXP$AU-TGA-0000816433$NVSC2024AU169682$NOVARTIS$$$$$F$Y$$$20240823$$CN$AU$AU
242448371$24244837$1$I$20240802$20240813$20240823$20240823$EXP$GB-MHRA-MED-202408131635375860-ZYKNH$GB-TEVA-VS-3233311$TEVA$$68$YR$$F$Y$$$20240823$$PH$GB$GB
242448381$24244838$1$I$20240820$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133944$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240823$$CN$US$US
242448391$24244839$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133676$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240823$$HP$US$US
242448401$24244840$1$I$20240501$20240819$20240823$20240823$PER$$US-Millicent Holdings Ltd.-MILL20241110$MILLICENT HOLDINGS$$70$YR$E$F$Y$$$20240823$$CN$US$US
242448411$24244841$1$I$$20240429$20240823$20240823$PER$$US-PFIZER INC-2024SGN05149$PFIZER$$$$$$Y$$$20240823$$HP$US$US
242448422$24244842$2$F$$20240820$20240823$20240824$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-141558$DAIICHI$$76$YR$$F$Y$$$20240824$$MD$US$US
242448431$24244843$1$I$$20240819$20240823$20240823$EXP$$US-AMGEN-USASP2024166585$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242448441$24244844$1$I$$20240820$20240823$20240823$PER$$NVSC2024US169155$NOVARTIS$$$$$M$Y$$$20240823$$CN$US$US
242448451$24244845$1$I$$20240817$20240823$20240823$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-132529$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240823$$HP$CO$CO
242448461$24244846$1$I$20240320$20240817$20240823$20240823$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-132779$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240823$$HP$CO$CO
242448471$24244847$1$I$20240429$20240514$20240823$20240823$PER$$US-PFIZER INC-2024SGN05150$PFIZER$$28$YR$$$Y$$$20240823$$HP$US$US
242448481$24244848$1$I$20240820$20240822$20240823$20240823$EXP$$AT-ROCHE-10000064726$ROCHE$$32$YR$A$F$Y$$$20240823$$HP$AT$AT
242448491$24244849$1$I$20231101$20240808$20240823$20240823$EXP$$US-HLS-202400797$HLS THERAPEUTICS$$29$YR$A$F$Y$$$20240823$$PH$US$US
242448502$24244850$2$F$$20240905$20240823$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021991$UNITED THERAPEUTICS$$$$$M$Y$117.91$KG$20240914$$$US$US
242448511$24244851$1$I$$20240729$20240823$20240823$PER$$US-009507513-2407USA015978$MERCK$$$$$$Y$$$20240823$$HP$US$US
242448521$24244852$1$I$20240530$20240607$20240823$20240823$EXP$$CN-ROCHE-10000064032$ROCHE$$82$YR$E$M$Y$66$KG$20240823$$HP$CN$CN
242448531$24244853$1$I$$20240815$20240823$20240823$EXP$$US-MYLANLABS-2024M1076537$MYLAN$$$$$F$Y$$$20240823$$CN$US$US
242448542$24244854$2$F$$20240821$20240823$20240826$PER$$US-MYLANLABS-2024M1077624$MYLAN$$$$$F$Y$$$20240826$$CN$US$US
242448551$24244855$1$I$20220501$20240814$20240823$20240823$EXP$FR-AFSSAPS-RN2024000852$FR-TEVA-VS-3233850$TEVA$$82$YR$$F$Y$$$20240823$$MD$FR$FR
242448561$24244856$1$I$20240416$20240501$20240823$20240823$PER$$US-PFIZER INC-2024SGN05170$PFIZER$$$$$$Y$$$20240823$$HP$US$US
242448572$24244857$2$F$$20240909$20240823$20240912$EXP$$US-ALXN-202408USA001088US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
242448582$24244858$2$F$$20240820$20240823$20240826$EXP$$US-AMGEN-USASP2024166738$AMGEN$$$$$F$Y$$$20240826$$MD$US$US
242448591$24244859$1$I$$20240816$20240823$20240823$PER$$US-INSUD PHARMA-2408US06530$INSUD PHARMA$$$$$$Y$$$20240823$$MD$US$US
242448601$24244860$1$I$$20240816$20240823$20240823$EXP$$US-INSUD PHARMA-2408US06528$INSUD PHARMA$$$$$$Y$$$20240823$$MD$US$US
242448611$24244861$1$I$20240802$20240815$20240823$20240823$PER$$US-BIOGEN-2024BI01278783$BIOGEN$$56$YR$$M$Y$$$20240823$$CN$US$US
242448641$24244864$1$I$$20240822$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133779$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240823$$CN$US$US
242448661$24244866$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133682$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240823$$CN$US$US
242448671$24244867$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133175$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240823$$HP$US$US
242448681$24244868$1$I$20240101$20240821$20240823$20240823$PER$$US-ABBVIE-5889808$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242448691$24244869$1$I$20240323$20240814$20240823$20240823$EXP$FR-AFSSAPS-BR2024000650$FR-TEVA-VS-3233794$TEVA$$38$YR$$M$Y$97$KG$20240823$$PH$FR$FR
242448702$24244870$2$F$20240628$20240916$20240823$20240924$EXP$GB-MHRA-MED-202408141136454400-MKLBD$GB-TEVA-VS-3233469$TEVA$$71$YR$$F$Y$105$KG$20240924$$CN$GB$GB
242448711$24244871$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58150$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242448721$24244872$1$I$$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014407$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240823$$CN$US$US
242448731$24244873$1$I$$20240822$20240823$20240823$PER$$US-ROCHE-10000064398$ROCHE$$43$YR$A$F$Y$$$20240823$$CN$US$US
242448741$24244874$1$I$$20240822$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408014357$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240823$$CN$US$US
242448761$24244876$1$I$$20240815$20240823$20240823$PER$$US-BIOGEN-2024BI01278782$BIOGEN$$$$$M$Y$$$20240823$$MD$US$US
242448771$24244877$1$I$20220401$20240821$20240823$20240823$EXP$$CA-ROCHE-3112671$ROCHE$$71$YR$E$F$Y$$$20240823$$CN$CA$CA
242448792$24244879$2$F$$20240822$20240823$20240828$EXP$$GB-SANDOZ INC.-SDZ2023GB011026$SANDOZ$$$$$F$Y$$$20240828$$CN$GB$GB
242448801$24244880$1$I$$20240814$20240823$20240823$PER$$US-ABBVIE-5882448$ABBVIE$$$$$M$Y$$$20240823$$HP$US$US
242448812$24244881$2$F$20240101$20240817$20240823$20240826$EXP$$US-AMGEN-USASP2024164811$AMGEN$$$$$$Y$$$20240826$$HP$US$US
242448821$24244882$1$I$20240709$20240822$20240823$20240823$EXP$$US-KYOWAKIRIN-2024KK019834$KYOWA$$$$$$Y$$$20240823$$HP$US$US
242448831$24244883$1$I$$20240821$20240823$20240823$EXP$$CA-BAUSCH-BL-2024-012736$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240823$$PH$CA$CA
242448841$24244884$1$I$$20240816$20240823$20240823$PER$$US-BAUSCH-BL-2024-012466$BAUSCH AND LOMB$$$$$M$Y$$$20240823$$CN$US$US
242448852$24244885$2$F$20240621$20240913$20240823$20240925$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00213$OPKO HEALTH$$77$YR$$M$Y$126.98$KG$20240921$$PH$US$US
242448871$24244887$1$I$$20240821$20240823$20240823$30DAY$$US-SANDOZ INC.-SDZ2024US016859$SANDOZ$$$$$F$Y$$$20240823$$CN$US$US
242448882$24244888$2$F$20240606$20240913$20240823$20240925$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00214$OPKO HEALTH$$69$YR$$M$Y$$$20240921$$PH$US$US
242448891$24244889$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA169032$NOVARTIS$$68$YR$$M$Y$$$20240823$$CN$CA$CA
242448911$24244891$1$I$$20240816$20240823$20240823$PER$$US-ALXN-202408USA001101US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242448932$24244893$2$F$20240719$20240916$20240823$20240926$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00215$OPKO HEALTH$$77$YR$$F$Y$$$20240924$$PH$US$US
242448941$24244894$1$I$20240404$20240817$20240823$20240823$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-132491$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240823$$HP$CO$CO
242448951$24244895$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133140$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$$$20240823$$HP$US$US
242448961$24244896$1$I$20240730$20240815$20240823$20240823$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025594$UNITED THERAPEUTICS$$71$YR$$F$Y$111.57$KG$20240823$$$US$US
242449001$24244900$1$I$20240801$20240815$20240823$20240823$PER$$US-ABBVIE-5883204$ABBVIE$$48$YR$$F$Y$39$KG$20240823$$CN$US$US
242449012$24244901$2$F$20240721$20240916$20240823$20240926$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00216$OPKO HEALTH$$85$YR$$F$Y$$$20240924$$PH$US$US
242449021$24244902$1$I$20240428$20240524$20240823$20240823$PER$$US-United Exchange Corporation-2160803$UNITED EXCHANGE$$54$YR$$F$Y$$$20240823$$$US$US
242449041$24244904$1$I$20240501$20240821$20240823$20240823$EXP$$DE-BAUSCH-BL-2024-012767$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240823$$MD$DE$DE
242449052$24244905$2$F$$20240815$20240823$20240913$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2023-27426$IPSEN$$$$$M$Y$$$20240913$$CN$GB$GB
242449061$24244906$1$I$20240810$20240812$20240823$20240823$EXP$$US-RADIUS HEALTH INC.-2024US006334$RADIUS PHARM$$70$YR$$F$Y$$$20240823$$CN$US$US
242449073$24244907$3$F$20240823$20240829$20240823$20240903$EXP$$US-MYLANLABS-2024M1077889$MYLAN$$24$YR$$F$Y$$$20240903$$MD$US$US
242449082$24244908$2$F$$20240909$20240823$20240923$EXP$$CA-HLS-202402012$HLS THERAPEUTICS$$$$A$M$Y$$$20240923$$HP$CA$CA
242449091$24244909$1$I$$20240814$20240823$20240823$EXP$$GB-TEVA-VS-3233694$TEVA$$76$YR$$M$Y$$$20240823$$CN$GB$GB
242449101$24244910$1$I$$20240819$20240823$20240823$EXP$CA-NOVARTIS PHARMA S.A.-NVSC2024CA170815$NVSC2024CA170815$NOVARTIS$$43$YR$$F$Y$96$KG$20240823$$HP$CA$CA
242449122$24244912$2$F$$20240823$20240823$20240826$PER$$NVSC2024US171242$NOVARTIS$$$$$$Y$$$20240826$$HP$US$US
242449134$24244913$4$F$20240724$20240905$20240823$20240909$EXP$$JP-Eisai-EC-2024-171276$EISAI$$23$YR$A$M$Y$$$20240909$$PH$JP$JP
242449141$24244914$1$I$20240802$20240815$20240823$20240823$PER$$CN-Eisai-EC-2024-172286$EISAI$$40$YR$A$F$Y$53$KG$20240823$$HP$CN$CN
242449151$24244915$1$I$$20240822$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134111$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240823$$HP$US$US
242449162$24244916$2$F$$20240815$20240823$20240828$PER$$CA-Eisai-EC-2023-144863$EISAI$$3$MON$I$M$Y$$$20240828$$HP$CA$CA
242449171$24244917$1$I$$20240816$20240823$20240823$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-131592$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240823$$CN$GB$GB
242449181$24244918$1$I$20231025$20240815$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130945$BRISTOL MYERS SQUIBB$$$$$F$Y$50.1$KG$20240823$$MD$US$US
242449191$24244919$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133685$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240823$$HP$US$US
242449201$24244920$1$I$$20240820$20240823$20240823$EXP$$CN-BAYER-2024A120860$BAYER$$69$YR$E$F$Y$$$20240823$$CN$CN$CN
242449221$24244922$1$I$$20240812$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007673$ELI LILLY AND CO$$$$$M$Y$$$20240823$$CN$US$US
242449231$24244923$1$I$20240801$20240812$20240823$20240823$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408008073$ELI LILLY AND CO$$14$YR$T$F$Y$$$20240823$$CN$CN$CN
242449241$24244924$1$I$$20240814$20240823$20240823$EXP$$GB-TEVA-VS-3233505$TEVA$$71$YR$$F$Y$50$KG$20240823$$MD$GB$GB
242449251$24244925$1$I$$20240821$20240823$20240823$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408013364$ELI LILLY AND CO$$$$E$F$Y$$$20240823$$MD$JP$JP
242449262$24244926$2$F$20240501$20240812$20240823$20240826$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408006810$ELI LILLY AND CO$$15$YR$T$M$Y$$$20240826$$CN$DE$DE
242449282$24244928$2$F$$20240828$20240823$20240910$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202408011148$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240910$$CN$ES$ES
242449291$24244929$1$I$$20240812$20240823$20240823$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202310000625$ELI LILLY AND CO$$16$YR$T$F$Y$$$20240823$$CN$NL$AU
242449301$24244930$1$I$20231201$20240812$20240823$20240823$EXP$HR-HALMED-300086237$HR-ELI_LILLY_AND_COMPANY-HR202408012035$ELI LILLY AND CO$$66$YR$E$M$Y$80$KG$20240823$$CN$DE$HR
242449311$24244931$1$I$$20240812$20240823$20240823$EXP$$AT-ELI_LILLY_AND_COMPANY-AT202408007896$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$AT$AT
242449322$24244932$2$F$20240813$20240813$20240823$20240827$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202408012260$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240827$$MD$TW$TW
242449331$24244933$1$I$20240714$20240813$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008725$ELI LILLY AND CO$$51$YR$A$$Y$$$20240823$$CN$US$US
242449341$24244934$1$I$$20240814$20240823$20240823$EXP$GB-MHRA-MED-202408141057137350-NWJRV$GB-ELI_LILLY_AND_COMPANY-GB202408008880$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240823$$CN$GB$GB
242449351$24244935$1$I$20240601$20240812$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408007198$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240823$$CN$US$US
242449361$24244936$1$I$20240528$20240812$20240823$20240823$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408008581$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240823$$CN$CN$CN
242449371$24244937$1$I$$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013584$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240823$$CN$US$US
242449381$24244938$1$I$20240722$20240812$20240823$20240823$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408007899$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240823$$HP$FR$FR
242449392$24244939$2$F$20240507$20240812$20240823$20240827$EXP$$CH-ELI_LILLY_AND_COMPANY-CH202407011567$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240827$$MD$CH$CH
242449401$24244940$1$I$20240722$20240812$20240823$20240823$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408007661$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240823$$CN$CN$CN
242449411$24244941$1$I$$20240813$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010005$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240823$$CN$US$US
242449421$24244942$1$I$$20240814$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011936$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240823$$MD$US$US
242449431$24244943$1$I$20231117$20240812$20240823$20240823$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408007652$ELI LILLY AND CO$$54$YR$A$F$Y$62$KG$20240823$$CN$CN$CN
242449441$24244944$1$I$$20240814$20240823$20240823$EXP$$US-ELI_LILLY_AND_COMPANY-US202408008978$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242449451$24244945$1$I$20240805$20240816$20240823$20240823$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408013747$ELI LILLY AND CO$$72$YR$E$M$Y$48$KG$20240823$$CN$DE$CN
242449471$24244947$1$I$20240819$20240822$20240823$20240823$PER$$US-JNJFOC-20240858188$JOHNSON AND JOHNSON$$$$$M$Y$$$20240823$$HP$US$US
242449481$24244948$1$I$20240618$20240817$20240823$20240823$EXP$$NZ-BIOGEN-2024BI01279496$BIOGEN$$50$YR$$M$Y$$$20240823$$MD$NZ$NZ
242449491$24244949$1$I$$20240821$20240823$20240823$EXP$GB-MHRA-MED-202408211022345950-CSDPH$GB-SANDOZ INC.-SDZ2024GB074652$SANDOZ$$$$$M$Y$$$20240823$$PH$GB$GB
242449511$24244951$1$I$$20240815$20240823$20240823$EXP$$GB-TEVA-VS-3233560$TEVA$$81$YR$$F$Y$65$KG$20240823$$PH$GB$GB
242449521$24244952$1$I$$20240712$20240823$20240823$PER$$US-LUNDBECK-DKLU4001737$LUNDBECK$$$$$$Y$$$20240823$$CN$US$US
242449531$24244953$1$I$20240618$20240814$20240823$20240823$EXP$FR-AFSSAPS-AN2024001089$FR-TEVA-VS-3233911$TEVA$$69$YR$$F$Y$87$KG$20240823$$PH$FR$FR
242449541$24244954$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131121$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240823$$CN$US$US
242449561$24244956$1$I$20240801$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132777$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240823$$PH$US$US
242449571$24244957$1$I$$20240816$20240823$20240823$PER$US-MLMSERVICE-20170908-0878252-1$US-RDY-USA/USA/17/0093554$DR REDDYS$Echeniquea IA, Beltran D, Ramirez-Ruiz L, Najafian N, Agrawal N. Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report. Transplantation Proceedings. 2017;49(7): 1560-1564.$71$YR$E$M$Y$$$20240823$$MD$US$US
242449591$24244959$1$I$20240815$20240821$20240823$20240823$EXP$RU-RZN-2520380$RU-BAYER-2024A121194$BAYER$$67$YR$E$M$Y$80$KG$20240823$$HP$RU$RU
242449601$24244960$1$I$$20240819$20240823$20240823$EXP$$JP-GENMAB-2024-03004$GENMAB$$8$DEC$$M$Y$$$20240823$$MD$JP$JP
242449611$24244961$1$I$$20240821$20240823$20240823$EXP$$US-SANDOZ INC.-SDZ2024US074878$SANDOZ$$$$$M$Y$72.73$KG$20240823$$CN$US$US
242449621$24244962$1$I$$20240820$20240823$20240823$PER$$US-JNJFOC-20240853975$JOHNSON AND JOHNSON$$$$$F$Y$$$20240823$$HP$US$US
242449631$24244963$1$I$20240820$20240822$20240823$20240823$PER$$US-AMGEN-USASP2024168262$AMGEN$$$$$M$Y$$$20240823$$CN$US$US
242449642$24244964$2$F$20240818$20240819$20240823$20240827$PER$$US-AMGEN-USASP2024165705$AMGEN$$47$YR$A$F$Y$$$20240827$$CN$US$US
242449651$24244965$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58148$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242449671$24244967$1$I$$20240813$20240823$20240823$EXP$$CA-TAKEDA-2023TUS072677$TAKEDA$$$$$F$Y$$$20240823$$CN$CA$CA
242449691$24244969$1$I$20240412$20240814$20240823$20240823$EXP$FR-AFSSAPS-TO2024001509$FR-TEVA-VS-3233913$TEVA$$79$YR$$F$Y$$$20240823$$PH$FR$FR
242449701$24244970$1$I$20240729$20240820$20240823$20240823$EXP$$JP-PFIZER INC-202400239844$PFIZER$$5$DEC$$M$Y$$$20240823$$MD$JP$JP
242449712$24244971$2$F$$20240830$20240823$20240906$EXP$$US-BIOGEN-2024BI01279300$BIOGEN$$$$$M$Y$$$20240906$$CN$US$US
242449721$24244972$1$I$20240821$20240822$20240823$20240823$EXP$$US-KYOWAKIRIN-2024KK019848$KYOWA$$$$$$Y$$$20240823$$HP$US$US
242449731$24244973$1$I$$20240531$20240823$20240823$EXP$$US-GILEAD-2024-0675298$GILEAD$$$$E$F$Y$$$20240823$$CN$US$US
242449741$24244974$1$I$20240810$20240812$20240823$20240823$EXP$$US-FARMAPROD-202408-2911$DOMPE FARMACEUTICI$$65$YR$E$M$Y$$$20240823$$CN$US$US
242449751$24244975$1$I$$20240819$20240823$20240823$EXP$$CN-BIOGEN-2024BI01279269$BIOGEN$$$$$F$Y$$$20240823$$MD$CN$CN
242449761$24244976$1$I$20240716$20240819$20240823$20240823$PER$$AU-Eisai-EC-2024-172516$EISAI$$76$YR$E$M$Y$$$20240823$$HP$AU$AU
242449771$24244977$1$I$20240724$20240815$20240823$20240823$PER$$US-Eisai-EC-2024-172245$EISAI$$67$YR$E$F$Y$59$KG$20240823$$CN$US$US
242449781$24244978$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132911$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240823$$HP$US$US
242449792$24244979$2$F$20240801$20240822$20240823$20240901$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132839$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$80.7$KG$20240902$$PH$US$US
242449801$24244980$1$I$20240801$20240815$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130168$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240823$$CN$US$US
242449811$24244981$1$I$$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132225$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240823$$CN$US$US
242449821$24244982$1$I$$20240821$20240823$20240823$EXP$$US-ABBVIE-5890606$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242449841$24244984$1$I$$20240814$20240823$20240823$EXP$$TH-BRISTOL-MYERS SQUIBB COMPANY-2024-133729$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240823$$CN$TH$TH
242449851$24244985$1$I$$20240606$20240823$20240823$PER$$US-GILEAD-2024-0675828$GILEAD$$$$$M$Y$$$20240823$$PH$US$US
242449861$24244986$1$I$$20240819$20240823$20240823$EXP$$JP-KYOWAKIRIN-2024KK019386$KYOWA$$$$$$Y$$$20240823$$HP$JP$JP
242449881$24244988$1$I$20240810$20240820$20240823$20240823$EXP$$CN-PURDUE-USA-2024-0311533$PURDUE$$70$YR$$M$Y$50$KG$20240823$$HP$CN$CN
242449891$24244989$1$I$$20240716$20240823$20240823$PER$$US-GILEAD-2024-0680994$GILEAD$$$$$$Y$$$20240823$$LW$US$US
242449901$24244990$1$I$20240818$20240820$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408013642$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$US$US
242449911$24244991$1$I$20210531$20240818$20240823$20240823$EXP$$IQ-009507513-2408IRQ007089$MERCK$$63$YR$$M$Y$$$20240823$$MD$IQ$IQ
242449921$24244992$1$I$20240815$20240815$20240823$20240823$PER$$US-ALXN-202408USA000991US$ALEXION PHARMACEUTICALS$$81$YR$$F$Y$$$20240823$$CN$US$US
242449931$24244993$1$I$20240101$20240821$20240823$20240823$EXP$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000694$Day One Biopharmaceuticals$$$$C$F$Y$$$20240823$$HP$US$US
242449941$24244994$1$I$$20240821$20240823$20240823$EXP$$DE-PURDUE-USA-2024-0311549$PURDUE$Rissardo JP, Medeiros Araujo de Matos U, Fornari Caprara AL.. Gabapentin-Associated Movement Disorders: A Literature Review. Medicines. 2023$40$YR$$F$Y$$$20240823$$MD$DE$DE
242449951$24244995$1$I$20240101$20240815$20240823$20240823$EXP$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000650$Day One Biopharmaceuticals$$$$C$$Y$$$20240822$$MD$US$US
242449961$24244996$1$I$20240801$20240821$20240823$20240823$PER$$US-JNJFOC-20240855178$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240823$$CN$US$US
242449971$24244997$1$I$20231201$20240816$20240823$20240823$EXP$$US-AMGEN-USASP2024164616$AMGEN$$71$YR$E$F$Y$$$20240823$$CN$US$US
242449981$24244998$1$I$$20240819$20240823$20240823$EXP$$NVSC2024IT168102$NOVARTIS$Trapanese V, Maruca F, Natale MR, Giofre F, Cosentino F, Sergi S et al.. Sodium-glucose co-transporter-2 inhibitor-associated non-diabetic ketoacidosis: a case report. ITALIAN-J-MED. 2024;18 No. 2$26$YR$$M$Y$142$KG$20240823$$HP$IT$IT
242449992$24244999$2$F$20240821$20240823$20240823$20240826$PER$$US-PURDUE-USA-2024-0311559$PURDUE$$41$YR$$F$Y$60.33$KG$20240826$$CN$US$US
242450001$24245000$1$I$20200101$20240822$20240823$20240823$PER$$US-PURDUE PHARMA-USA-2024-0311525$PURDUE$$$$$M$Y$$$20240823$$CN$US$US
242450011$24245001$1$I$20240601$20240822$20240823$20240823$PER$$US-PURDUE PHARMA-USA-2024-0311560$PURDUE$$68$YR$$M$Y$155.1$KG$20240823$$CN$US$US
242450021$24245002$1$I$$20240822$20240823$20240823$PER$$US-PURDUE PHARMA-USA-2024-0311528$PURDUE$$$$$F$Y$$$20240823$$CN$US$US
242450031$24245003$1$I$20240821$20240822$20240823$20240823$PER$$US-PURDUE PHARMA-USA-2024-0311550$PURDUE$$$$$M$Y$$$20240823$$CN$US$US
242450042$24245004$2$F$$20240828$20240823$20240829$PER$$US-PURDUE PHARMA-USA-2024-0311547$PURDUE$$42$YR$$F$Y$$$20240829$$CN$US$US
242450051$24245005$1$I$20210612$20240822$20240823$20240823$PER$$US-PURDUE PHARMA-USA-2024-0311556$PURDUE$$27$YR$$M$Y$$$20240823$$CN$US$US
242450061$24245006$1$I$20230214$20240822$20240823$20240823$PER$$US-PURDUE PHARMA-USA-2024-0311529$PURDUE$$57$YR$$M$Y$$$20240823$$CN$US$US
242450071$24245007$1$I$20230901$20240822$20240823$20240823$PER$$US-PURDUE PHARMA-USA-2024-0311542$PURDUE$$33$YR$$M$Y$$$20240823$$CN$US$US
242450081$24245008$1$I$$20240821$20240823$20240823$PER$$US-PURDUE PHARMA-USA-2024-0311527$PURDUE$$$$$F$Y$$$20240823$$CN$US$US
242450091$24245009$1$I$$20240710$20240823$20240823$EXP$$US-GILEAD-2024-0680311$GILEAD$$$$A$F$Y$$$20240823$$CN$US$US
242450101$24245010$1$I$$20240808$20240823$20240823$PER$$US-009507513-2408USA003204$MERCK$$63$YR$$M$Y$$$20240823$$CN$US$US
242450121$24245012$1$I$20240307$20240814$20240823$20240823$EXP$FR-AFSSAPS-TO2024001519$FR-TEVA-VS-3233922$TEVA$$52$YR$$F$Y$$$20240823$$MD$FR$FR
242450131$24245013$1$I$20240730$20240819$20240823$20240823$EXP$$US-Rigel Pharmaceuticals, Inc.-20240800083$RIGEL PHARMACEUTICALS$$26$YR$$M$Y$70.307$KG$20240823$$CN$US$US
242450161$24245016$1$I$$20240711$20240823$20240823$EXP$$US-GILEAD-2024-0680442$GILEAD$$65$YR$E$F$Y$$$20240823$$HP$US$US
242450171$24245017$1$I$$20240820$20240823$20240823$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134152$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240823$$MD$JP$JP
242450181$24245018$1$I$20240201$20240820$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134392$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240823$$CN$US$US
242450191$24245019$1$I$20240517$20240716$20240823$20240823$PER$$US-GILEAD-2024-0680949$GILEAD$$37$YR$A$M$Y$$$20240823$$HP$US$US
242450201$24245020$1$I$$20240821$20240823$20240823$PER$$US-AMGEN-USASP2024168630$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242450212$24245021$2$F$$20240828$20240823$20240830$PER$$US-AMGEN-USASP2024167763$AMGEN$$$$$F$Y$$$20240830$$CN$US$US
242450223$24245022$3$F$20240730$20240812$20240823$20240912$EXP$$US-BEH-2024177150$CSL BEHRING$$57$YR$A$F$Y$70.295$KG$20240912$$CN$US$US
242450231$24245023$1$I$20231115$20240814$20240823$20240823$EXP$FR-AFSSAPS-LY2024001238$FR-TEVA-VS-3233959$TEVA$$66$YR$$M$Y$64$KG$20240823$$MD$FR$FR
242450241$24245024$1$I$20240101$20240821$20240823$20240823$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-114800$REGENERON$$$$$M$Y$$$20240823$$CN$US$US
242450252$24245025$2$F$$20240913$20240823$20240918$EXP$$US-GILEAD-2024-0680465$GILEAD$$$$E$F$Y$$$20240918$$CN$US$US
242450261$24245026$1$I$20240821$20240822$20240823$20240823$PER$$US-AMGEN-USASP2024168675$AMGEN$$66$YR$E$M$Y$$$20240823$$CN$US$US
242450272$24245027$2$F$$20240911$20240823$20240914$EXP$$TR-TAKEDA-2024TUS074873$TAKEDA$$78$YR$$M$Y$$$20240914$$CN$TR$TR
242450281$24245028$1$I$20240626$20240716$20240823$20240823$EXP$FR-AFSSAPS-LL2024001316$FR-GILEAD-2024-0680926$GILEAD$$68$YR$E$F$Y$55$KG$20240823$$MD$FR$FR
242450301$24245030$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA168843$NOVARTIS$$9$YR$$M$Y$$$20240823$$HP$CA$CA
242450311$24245031$1$I$$20240709$20240823$20240823$PER$$US-GILEAD-2024-0680481$GILEAD$$$$$$Y$$$20240823$$HP$US$US
242450321$24245032$1$I$20240617$20240814$20240823$20240823$EXP$FR-AFSSAPS-PO2024000890$FR-TEVA-VS-3233900$TEVA$$47$YR$$F$Y$$$20240823$$PH$FR$FR
242450332$24245033$2$F$$20240819$20240823$20240906$EXP$$JP-009507513-2408JPN002287J$MERCK$ARATAKE J, SHIBUTANI T, NARITA M, HAMASAKI K, YAMAMOTO K, KITAI M, et al.. [ORIGINAL] Impact of the number of prior systemic treatment lines on lenvatinib and pembrolizumab combination therapy for advanced or recurrent endometrial cancer : Experience from a single institution in Japan with 21 cases. Advances in Obstetrics and Gynecology. 2024;76(3):222-8$$$$F$Y$$$20240906$$MD$JP$JP
242450341$24245034$1$I$$20240812$20240823$20240823$EXP$$NVSC2024IT165131$NOVARTIS$Ricco G, Seminerio R, Andrini E, Malvi D, Gruppioni E, Altimari A, et al.. Braf v600e-mutated large cell neuroendocrine carcinoma responding to targeted therapy: A case report and review of the literature. ANTICANCER-DRUGS. 2023;34:1076-84$46$YR$$M$Y$$$20240823$$HP$IT$IT
242450351$24245035$1$I$20240815$20240822$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133871$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240823$$PH$US$US
242450361$24245036$1$I$$20240711$20240823$20240823$PER$$US-GILEAD-2024-0680496$GILEAD$$$$$M$Y$$$20240823$$CN$US$US
242450372$24245037$2$F$$20240819$20240823$20240906$EXP$$JP-009507513-2408JPN002292J$MERCK$Kono M, Takahashi K, Shimazaki M, Tomita K, Tabata J, Noguchi D, et al.. ORIGINAL ARTICLE A retrospective study of the management of immune-related adverse events in patients with immune checkpoint inhibitors. Tokyo Journal of Obstetrics and Gynecology. 2024;73(3):475-9$53$YR$$F$Y$$$20240906$$HP$JP$JP
242450381$24245038$1$I$$20240724$20240823$20240823$PER$$US-009507513-2407USA013265$MERCK$$40$YR$$F$Y$59.87$KG$20240823$$CN$US$US
242450391$24245039$1$I$$20240709$20240823$20240823$PER$$US-GILEAD-2024-0680503$GILEAD$$$$$$Y$$$20240823$$HP$US$US
242450402$24245040$2$F$$20240912$20240823$20240927$EXP$$JP-SMPA-2024SPA001430$SUNOVION$$$$$$Y$$$20240927$$HP$JP$JP
242450412$24245041$2$F$20240309$20240813$20240823$20240827$EXP$CZ-CZSUKL-24001588$CZ-TEVA-VS-3216440$TEVA$$37$YR$$F$Y$53$KG$20240827$$MD$CZ$CZ
242450421$24245042$1$I$20240801$20240813$20240823$20240823$EXP$GB-MHRA-MED-202408110033223650-VKMJG$GB-ELI_LILLY_AND_COMPANY-GB202408008748$ELI LILLY AND CO$$42$YR$A$F$Y$94$KG$20240823$$CN$GB$GB
242450431$24245043$1$I$20220801$20240812$20240823$20240823$EXP$SE-SEMPA-2024-006019$SE-ELI_LILLY_AND_COMPANY-SE202408007920$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240823$$CN$SE$SE
242450441$24245044$1$I$$20240814$20240823$20240823$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408009326$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240823$$CN$DE$DE
242450451$24245045$1$I$$20240813$20240823$20240823$EXP$GB-MHRA-MED-202408101737189320-BGSMT$GB-ELI_LILLY_AND_COMPANY-GB202408008747$ELI LILLY AND CO$$20$YR$A$F$Y$75$KG$20240823$$CN$GB$GB
242450462$24245046$2$F$20240626$20240820$20240823$20240827$EXP$DE-BFARM-24005741$DE-ELI_LILLY_AND_COMPANY-DE202408011329$ELI LILLY AND CO$$69$YR$E$M$Y$73.8$KG$20240827$$CN$DE$DE
242450471$24245047$1$I$$20240711$20240823$20240823$EXP$$US-GILEAD-2024-0680671$GILEAD$$$$A$M$Y$$$20240823$$CN$US$US
242450481$24245048$1$I$20240720$20240812$20240823$20240823$EXP$$CN-Hugel Aesthetics-2160763$Hugel Aesthetics$$33$YR$$F$Y$$$20240823$$$CN$CN
242450491$24245049$1$I$$20240823$20240823$20240823$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047551$BOEHRINGER INGELHEIM$$$$$$Y$$$20240823$$CN$US$US
242450501$24245050$1$I$20240706$20240822$20240823$20240823$EXP$$US-ABBVIE-5891374$ABBVIE$$80$YR$$F$Y$$$20240823$$CN$US$US
242450511$24245051$1$I$$20240820$20240823$20240823$EXP$$NVSC2024CA170335$NOVARTIS$$$$$$Y$$$20240823$$MD$CA$CA
242450521$24245052$1$I$$20240711$20240823$20240823$EXP$$US-GILEAD-2024-0680687$GILEAD$$36$YR$A$M$Y$$$20240823$$CN$US$US
242450531$24245053$1$I$$20240816$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130951$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240823$$CN$US$US
242450541$24245054$1$I$$20240813$20240823$20240823$EXP$$US-MALLINCKRODT-MNK202405198$MALLINCKRODT$Sidhu S.K, Ciancarelli J, Alviar C, Greco A.A Case of Severe Cardiopulmonary Sarcoidosis and Sub-massive Pulmonary Embolism..US Cardiology Review.JUL-2024;18 (supplement 1):25-26$68$YR$E$M$Y$$$20240823$$MD$US$US
242450551$24245055$1$I$20231001$20240814$20240823$20240823$EXP$FR-AFSSAPS-NY2024000929$FR-TEVA-VS-3233908$TEVA$$43$YR$$F$Y$60$KG$20240823$$MD$FR$FR
242450561$24245056$1$I$20220801$20240822$20240823$20240823$EXP$GB-MHRA-MED-202408221511599270-QZSRF$GB-SANDOZ INC.-SDZ2024GB074804$SANDOZ$$$$$M$Y$92$KG$20240823$$CN$GB$GB
242450574$24245057$4$F$20240801$20240925$20240823$20240927$30DAY$$CO-PFIZER INC-PV202400107223$PFIZER$$7$YR$$F$Y$23$KG$20240927$$CN$CO$CO
242450581$24245058$1$I$$20240816$20240823$20240823$EXP$$US-SANDOZ INC.-SDZ2024US074887$SANDOZ$$$$$$Y$$$20240823$$PH$US$US
242450591$24245059$1$I$$20240821$20240823$20240823$PER$$NVSC2024US170415$NOVARTIS$$38$YR$$F$Y$$$20240823$$CN$US$US
242450601$24245060$1$I$$20240822$20240823$20240823$PER$$NVSC2024US171300$NOVARTIS$$$$$F$Y$$$20240823$$CN$US$US
242450611$24245061$1$I$$20240820$20240823$20240823$PER$$NVSC2024US169488$NOVARTIS$$53$YR$$M$Y$$$20240823$$HP$US$US
242450622$24245062$2$F$$20240903$20240823$20240911$PER$$JP-Eisai-EC-2024-172485$EISAI$Shimamoto Kumi. OS-175 Monitoring of adrenal function during lenvatinib/pembrolizumab therapy. Journal of the Japanese Society of Gynecologic Oncology, The 66th Annual Meeting of Japanese Society of Gynecologic Oncology. 2024; 42(3): 301-.$$$$F$Y$$$20240911$$MD$JP$JP
242450631$24245063$1$I$$20240822$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133753$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240823$$CN$US$US
242450641$24245064$1$I$$20240809$20240823$20240823$EXP$$US-HLS-202400821$HLS THERAPEUTICS$$36$YR$A$M$Y$$$20240823$$HP$US$US
242450651$24245065$1$I$$20240711$20240823$20240823$EXP$$US-GILEAD-2024-0680689$GILEAD$$$$T$M$Y$$$20240823$$CN$US$US
242450671$24245067$1$I$20240501$20240819$20240823$20240823$EXP$$US-BIOGEN-2024BI01279193$BIOGEN$$29$YR$$F$Y$$$20240823$$CN$US$US
242450683$24245068$3$F$20240819$20240826$20240823$20240905$EXP$$AR-BIOMARINAP-AR-2024-160042$BIOMARIN$$$$$$Y$$$20240905$$CN$AR$AR
242450691$24245069$1$I$20240801$20240821$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133568$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240823$$HP$US$US
242450702$24245070$2$F$$20240923$20240823$20240930$EXP$$IE-PFIZER INC-202400242149$PFIZER$Fadlelseed, H.. Vitreoretinal large B- cell lymphoma (VR- LBCL): Clinical and pathological features and treatment outcomes. Pathology Research and Practice. 2024;261:10.1016/j.prp.2024.155500$71$YR$$M$Y$$$20240930$$HP$IE$IE
242450721$24245072$1$I$$20240819$20240823$20240823$EXP$$IT-PFIZER INC-PV202400109199$PFIZER$Rosignoli, C.. Efficacy and safety of greater occipital nerve block with a small volume of lidocaine and methylprednisolone in tertiary headache center. Confinia Cephalalgica et Neurologica. 2024;34(2):10.4081/cc.2024.15770$$$A$$Y$$$20240823$$HP$IT$IT
242450731$24245073$1$I$$20240820$20240823$20240823$EXP$$CN-PFIZER INC-PV202400109071$PFIZER$Lei, B.. YIXUE LUNTAN. 2024;88-90$56$YR$$M$Y$$$20240823$$HP$CN$CN
242450741$24245074$1$I$20240807$20240809$20240823$20240823$EXP$$US-HLS-202400800$HLS THERAPEUTICS$$27$YR$A$F$Y$$$20240823$$HP$US$US
242450761$24245076$1$I$$20240819$20240823$20240823$PER$$US-ABBVIE-5888108$ABBVIE$$$$$$Y$$$20240823$$MD$US$US
242450772$24245077$2$F$$20240911$20240823$20240911$EXP$$US-ALXN-202408USA001105US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
242450781$24245078$1$I$$20240809$20240823$20240823$EXP$$US-HLS-202400822$HLS THERAPEUTICS$$$$E$$Y$$$20240823$$PH$US$US
242450791$24245079$1$I$$20240823$20240823$20240823$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047561$BOEHRINGER INGELHEIM$$$$$$Y$$$20240823$$CN$US$US
242450801$24245080$1$I$$20240814$20240823$20240823$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129592$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240823$$CN$US$US
242450811$24245081$1$I$20240712$20240814$20240823$20240823$EXP$FR-AFSSAPS-AN2024001041$FR-TEVA-VS-3233919$TEVA$$64$YR$$M$Y$92$KG$20240823$$PH$FR$FR
242450821$24245082$1$I$20240815$20240820$20240823$20240823$EXP$$US-OTSUKA-2024_020715$OTSUKA$$69$YR$$M$Y$$$20240823$$CN$US$US
242450832$24245083$2$F$20240806$20240909$20240823$20240923$EXP$$DE-Ascend Therapeutics US, LLC-2160811$ASCEND$$49$YR$$F$Y$$$20240923$$$DE$DE
242450842$24245084$2$F$20240812$20240821$20240823$20240912$PER$$US-IMP-2024000629$Harrow Health$$77$YR$E$F$Y$$$20240912$$CN$US$US
242450851$24245085$1$I$$20240819$20240823$20240823$PER$$US-JNJFOC-20240850171$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240823$$CN$US$US
242450861$24245086$1$I$$20240820$20240823$20240823$EXP$$NVSC2024US170303$NOVARTIS$Tinajero J, Ngo D, Zhang J, Tsai NC, Aribi A, Aldoss I, et al.. High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy. LEUKEMIA AND LYMPHOMA. 2024;65 (7):1020-3$$$$$Y$$$20240823$$HP$US$US
242450873$24245087$3$F$$20240904$20240823$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-133967$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240906$$PH$JP$JP
242450881$24245088$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132926$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240823$$CN$US$US
242450891$24245089$1$I$$20240819$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133459$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240823$$CN$US$US
242450911$24245091$1$I$$20240809$20240823$20240823$EXP$$US-HLS-202400814$HLS THERAPEUTICS$$$$A$$Y$$$20240823$$HP$US$US
242450921$24245092$1$I$20240806$20240814$20240823$20240823$EXP$$CN-GE HEALTHCARE-2024CSU009349$GE HEALTHCARE$$66$YR$$M$Y$65$KG$20240823$$HP$CN$CN
242450931$24245093$1$I$20240813$20240816$20240823$20240823$EXP$$CN-GE HEALTHCARE-2024CSU009493$GE HEALTHCARE$$62$YR$$M$Y$75$KG$20240823$$HP$CN$CN
242450941$24245094$1$I$$20240822$20240823$20240823$PER$$US-GILEAD-2024-0685051$GILEAD$$$$$$Y$$$20240823$$HP$US$US
242450951$24245095$1$I$20240401$20240820$20240823$20240823$EXP$$CN-009507513-2408CHN008094$MERCK$$73$YR$$F$Y$55$KG$20240823$$HP$CN$CN
242450961$24245096$1$I$$20240814$20240823$20240823$EXP$GB-MHRA-MED-202408141608224510-HQNVB$GB-ELI_LILLY_AND_COMPANY-GB202408009456$ELI LILLY AND CO$$$$$F$Y$$$20240823$$CN$GB$GB
242450972$24245097$2$F$20240703$20240827$20240823$20240828$EXP$FR-AFSSAPS-CN2024000728$FR-GILEAD-2024-0685176$GILEAD$$68$YR$E$F$Y$78$KG$20240828$$PH$FR$FR
242450981$24245098$1$I$20240812$20240819$20240823$20240823$PER$$US-ELI_LILLY_AND_COMPANY-US202408011297$ELI LILLY AND CO$$43$YR$A$$Y$$$20240823$$CN$US$US
242450991$24245099$1$I$$20240813$20240823$20240823$EXP$BE-FAMHP-DHH-N2024-122495$BE-ELI_LILLY_AND_COMPANY-BE202408008684$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240823$$CN$BE$BE
242451012$24245101$2$F$$20240904$20240823$20240905$PER$$NVSC2024US171245$NOVARTIS$$$$$$Y$$$20240905$$MD$US$US
242451021$24245102$1$I$$20240822$20240823$20240823$EXP$$US-GILEAD-2024-0685109$GILEAD$$30$YR$A$M$Y$$$20240823$$CN$US$US
242451031$24245103$1$I$20240401$20240819$20240823$20240823$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-032725$JAZZ$$30$YR$$F$Y$$$20240823$$HP$US$US
242451041$24245104$1$I$20240814$20240816$20240823$20240823$EXP$$US-009507513-2408USA008174$MERCK$$35$YR$$F$Y$55.2$KG$20240823$$HP$US$US
242451052$24245105$2$F$20240802$20240917$20240823$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-004477$JAZZ$$64$YR$$F$Y$$$20240920$$CN$US$US
242451061$24245106$1$I$$20240724$20240823$20240823$PER$$US-FMCRTG-FMC-2407-000925$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240823$$CN$US$US
242451071$24245107$1$I$20240724$20240728$20240823$20240823$PER$$US-FMCRTG-FMC-2407-000919$FRESENIUS MEDICAL CARE$$69$YR$E$F$Y$69.5$KG$20240823$$HP$US$US
242451081$24245108$1$I$20240715$20240725$20240823$20240823$PER$$US-FMCRTG-FMC-2407-000928$FRESENIUS MEDICAL CARE$$71$YR$E$M$Y$$$20240823$$HP$US$US
242451091$24245109$1$I$20240717$20240723$20240823$20240823$PER$$US-FMCRTG-FMC-2407-000907$FRESENIUS MEDICAL CARE$$49$YR$A$M$Y$115$KG$20240823$$HP$US$US
242451101$24245110$1$I$20240726$20240729$20240823$20240823$PER$$US-FMCRTG-FMC-2408-000937$FRESENIUS MEDICAL CARE$$75$YR$E$F$Y$85$KG$20240823$$HP$US$US
242451111$24245111$1$I$$20240723$20240823$20240823$PER$$US-FMCRTG-FMC-2407-000922$FRESENIUS MEDICAL CARE$$74$YR$E$F$Y$43.5$KG$20240823$$HP$US$US
242451121$24245112$1$I$$20240724$20240823$20240823$PER$$US-FMCRTG-FMC-2407-000904$FRESENIUS MEDICAL CARE$$$$$$Y$$$20240823$$HP$US$US
242451131$24245113$1$I$20240729$20240813$20240823$20240823$EXP$$US-FMCRTG-FMC-2408-000979$FRESENIUS MEDICAL CARE$$64$YR$A$F$Y$$$20240823$$HP$US$US
242451141$24245114$1$I$$20240723$20240823$20240823$PER$$US-FMCRTG-FMC-2407-000923$FRESENIUS MEDICAL CARE$$66$YR$E$F$Y$$$20240823$$HP$US$US
242451151$24245115$1$I$$20240723$20240823$20240823$PER$$US-FMCRTG-FMC-2407-000901$FRESENIUS MEDICAL CARE$$63$YR$A$M$Y$64$KG$20240823$$HP$US$US
242451161$24245116$1$I$$20240812$20240823$20240823$EXP$$US-FMCRTG-FMC-2408-000999$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240823$$CN$US$US
242451171$24245117$1$I$20240723$20240724$20240823$20240823$PER$$US-FMCRTG-FMC-2407-000911$FRESENIUS MEDICAL CARE$$70$YR$E$F$Y$70$KG$20240823$$HP$US$US
242451181$24245118$1$I$$20240725$20240823$20240823$PER$$US-FMCRTG-FMC-2407-000915$FRESENIUS MEDICAL CARE$$64$YR$A$F$Y$62$KG$20240823$$HP$US$US
242451191$24245119$1$I$20240411$20240729$20240823$20240823$PER$$US-FMCRTG-FMC-2407-000930$FRESENIUS MEDICAL CARE$$74$YR$E$M$Y$119$KG$20240823$$HP$US$US
242451201$24245120$1$I$20120101$20240809$20240823$20240823$EXP$$US-FOUNDATIONCONSUMERHC-2024-US-042875$FOUNDATION CONSUMER HEALTHCARE$$14$YR$$F$Y$$$20240823$$CN$US$US
242451211$24245121$1$I$$20240821$20240823$20240823$PER$$US-DSJP-DSU-2024-141737$DAIICHI$$$$$F$Y$$$20240823$$MD$US$US
242451224$24245122$4$F$20240619$20240923$20240823$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006430$JAZZ$$34$YR$$F$Y$$$20240926$$CN$US$US
242451231$24245123$1$I$$20240819$20240823$20240823$EXP$$AU-009507513-2408AUS007164$MERCK$unknown. unknown. unknown. unk;unk:unk$71$YR$$M$Y$$$20240823$$HP$AU$AU
242451241$24245124$1$I$$20240817$20240823$20240823$EXP$$US-ALXN-202408USA001110US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242451251$24245125$1$I$$20240820$20240823$20240823$PER$$US-009507513-2408USA007143$MERCK$$$$$M$Y$$$20240823$$CN$US$US
242451263$24245126$3$F$20240804$20240905$20240823$20240909$EXP$$DE-BIOMARINAP-DE-2024-159893$BIOMARIN$$$$$$Y$$$20240909$$HP$DE$DE
242451272$24245127$2$F$20110106$20240826$20240823$20240830$EXP$$CA-ALXN-202408CAN001080CA$ALEXION PHARMACEUTICALS$$59$YR$$F$Y$$$20240830$$HP$CA$CA
242451281$24245128$1$I$20230803$20240810$20240823$20240823$EXP$$US-HLS-202400829$HLS THERAPEUTICS$$67$YR$E$M$Y$$$20240823$$HP$US$US
242451291$24245129$1$I$$20240822$20240823$20240823$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047424$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240823$$CN$US$US
242451312$24245131$2$F$20240710$20240827$20240823$20240905$EXP$$JP-CARA THERAPEUTICS, INC.-2024-00364-JP$CARA THERAPEUTICS$$88$YR$$M$Y$72$KG$20240905$$MD$JP$JP
242451322$24245132$2$F$$20240826$20240823$20240906$EXP$$US-HLS-202400830$HLS THERAPEUTICS$$43$YR$A$F$Y$59$KG$20240906$$MD$US$US
242451332$24245133$2$F$20240808$20240903$20240823$20240905$PER$$US-AMGEN-USASP2024159510$AMGEN$$$$$M$Y$$$20240905$$PH$US$US
242451342$24245134$2$F$20240808$20240920$20240823$20240926$30DAY$$US-AMGEN-USASP2024159636$AMGEN$$65$YR$E$F$Y$60.8$KG$20240926$$HP$US$US
242451352$24245135$2$F$20240220$20240819$20240823$20240826$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-030225$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240826$$HP$CO$CO
242451362$24245136$2$F$$20240911$20240823$20240911$EXP$$US-ALXN-202408USA001135US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$HP$US$US
242451373$24245137$3$F$20240808$20240829$20240823$20240904$PER$$US-AMGEN-USASP2024161402$AMGEN$$80$YR$E$M$Y$87.3$KG$20240904$$PH$US$US
242451381$24245138$1$I$$20240820$20240823$20240823$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-099206$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240823$$CN$JP$JP
242451401$24245140$1$I$$20240815$20240823$20240823$PER$$US-ALXN-A202212650$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240823$$CN$US$US
242451421$24245142$1$I$20240710$20240816$20240823$20240823$PER$$US-ALXN-202408USA001073US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240824$$HP$US$US
242451441$24245144$1$I$$20240812$20240823$20240823$EXP$$US-RADIUS HEALTH INC.-2024US006335$RADIUS PHARM$$$$$M$Y$$$20240823$$CN$US$US
242451451$24245145$1$I$20240101$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165604$AMGEN$$79$YR$E$F$Y$$$20240823$$HP$US$US
242451461$24245146$1$I$$20240820$20240823$20240823$EXP$$NVSC2024US168651$NOVARTIS$$$$$M$Y$$$20240824$$CN$US$US
242451471$24245147$1$I$20240520$20240809$20240823$20240823$EXP$$CA-HLS-202402005$HLS THERAPEUTICS$$68$YR$E$M$Y$$$20240823$$PH$CA$CA
242451482$24245148$2$F$20240813$20240910$20240823$20240911$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046975$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240911$$CN$US$US
242451491$24245149$1$I$20240701$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165306$AMGEN$$59$YR$A$F$Y$$$20240823$$CN$US$US
242451501$24245150$1$I$20240809$20240816$20240823$20240823$EXP$$CL-ALXN-202408SAM000963CL$ALEXION PHARMACEUTICALS$$$$$F$Y$36$KG$20240824$$MD$CL$CL
242451511$24245151$1$I$20240810$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165569$AMGEN$$70$YR$E$M$Y$$$20240823$$CN$US$US
242451524$24245152$4$F$$20240919$20240823$20240927$PER$$US-SMPA-2024SPA000538$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242451531$24245153$1$I$$20240731$20240823$20240823$PER$$US-SMPA-2024SPA000478$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451541$24245154$1$I$$20240813$20240823$20240823$PER$$US-SMPA-2024SPA001389$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451551$24245155$1$I$$20240731$20240823$20240823$PER$$US-SMPA-2024SPA000588$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451561$24245156$1$I$20240725$20240731$20240823$20240823$PER$$US-SMPA-2024SPA000587$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451581$24245158$1$I$$20240814$20240823$20240823$PER$$US-SMPA-2024SPA001414$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451601$24245160$1$I$$20240729$20240823$20240823$PER$$US-SMPA-2024SPA000517$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451612$24245161$2$F$$20240919$20240823$20240925$PER$$US-SMPA-2024SPA000654$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242451621$24245162$1$I$$20240809$20240823$20240823$PER$$US-SMPA-2024SPA001197$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451631$24245163$1$I$$20240816$20240823$20240823$PER$$US-SMPA-2024SPA001488$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451642$24245164$2$F$$20240924$20240823$20240930$PER$$US-SMPA-2024SPA001394$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242451651$24245165$1$I$$20240813$20240823$20240823$PER$$US-SMPA-2024SPA001372$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451661$24245166$1$I$$20240813$20240823$20240823$PER$$US-SMPA-2024SPA001380$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451671$24245167$1$I$$20240730$20240823$20240823$PER$$US-SMPA-2024SPA000580$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451681$24245168$1$I$$20240726$20240823$20240823$PER$$US-SMPA-2024SPA000226$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451692$24245169$2$F$$20240830$20240823$20240923$PER$$US-SMPA-2024SPA000312$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242451701$24245170$1$I$$20240815$20240823$20240823$PER$$US-SMPA-2024SPA001612$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451721$24245172$1$I$$20240813$20240823$20240823$PER$$US-SMPA-2024SPA001334$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451731$24245173$1$I$$20240813$20240823$20240823$PER$$US-SMPA-2024SPA001400$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451741$24245174$1$I$$20240812$20240823$20240823$PER$$US-SMPA-2024SPA001356$SUNOVION$$$$$$Y$$$20240823$$HP$US$US
242451751$24245175$1$I$$20240727$20240823$20240823$PER$$US-SMPA-2024SPA000439$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451761$24245176$1$I$$20240731$20240823$20240823$PER$$US-SMPA-2024SPA000651$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451781$24245178$1$I$$20240813$20240823$20240823$PER$$US-SMPA-2024SPA001397$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451791$24245179$1$I$20240101$20240730$20240823$20240823$PER$$US-SMPA-2024SPA000527$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451801$24245180$1$I$$20240731$20240823$20240823$PER$$US-SMPA-2024SPA000410$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451821$24245182$1$I$$20240812$20240823$20240823$PER$$US-SMPA-2024SPA001409$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451831$24245183$1$I$$20240731$20240823$20240823$PER$$US-SMPA-2024SPA000601$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451841$24245184$1$I$$20240814$20240823$20240823$PER$$US-SMPA-2024SPA001538$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451851$24245185$1$I$$20240730$20240823$20240823$PER$$US-SMPA-2024SPA000547$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451861$24245186$1$I$$20240729$20240823$20240823$PER$$US-SMPA-2024SPA000368$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451872$24245187$2$F$$20240911$20240823$20240923$PER$$US-SMPA-2024SPA000646$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242451881$24245188$1$I$$20240726$20240823$20240823$PER$$US-SMPA-2024SPA000329$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451891$24245189$1$I$20240801$20240809$20240823$20240823$PER$$US-SMPA-2024SPA001259$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451901$24245190$1$I$20240629$20240730$20240823$20240823$PER$$US-SMPA-2024SPA000445$SUNOVION$$$$$$Y$$$20240823$$MD$US$US
242451931$24245193$1$I$$20240726$20240823$20240823$PER$$US-SMPA-2024SPA000245$SUNOVION$$$$$$Y$$$20240823$$CN$US$US
242451942$24245194$2$F$$20240909$20240823$20240925$PER$$US-SMPA-2024SPA001154$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242451951$24245195$1$I$$20240814$20240823$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001720$BLUEPRINT MEDICINES$$$$$$Y$$$20240824$$MD$CN$CN
242451961$24245196$1$I$$20240814$20240823$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001719$BLUEPRINT MEDICINES$$$$$$Y$$$20240824$$MD$CN$CN
242451971$24245197$1$I$$20240814$20240823$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001722$BLUEPRINT MEDICINES$$$$$$Y$$$20240824$$MD$CN$CN
242451981$24245198$1$I$$20240814$20240823$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001721$BLUEPRINT MEDICINES$$$$$$Y$$$20240824$$MD$CN$CN
242451991$24245199$1$I$$20240820$20240823$20240823$EXP$$JP-ABBVIE-5887839$ABBVIE$Yamana Y, Kanda T, Matsumoto N, et al. Efficacy of glecaprevir/pibrentasvir for real-world hcv infected patients in the northern part of tokyo, japan. JCM. 2021;10(23):5529.$85$YR$$F$Y$$$20240823$$HP$JP$JP
242452001$24245200$1$I$$20240814$20240823$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001657$BLUEPRINT MEDICINES$$$$$$Y$$$20240824$$MD$CN$CN
242452011$24245201$1$I$$20240814$20240823$20240823$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001723$BLUEPRINT MEDICINES$$$$$$Y$$$20240824$$MD$CN$CN
242452021$24245202$1$I$$20240821$20240823$20240823$EXP$$DE-ROCHE-10000063998$ROCHE$$$$$F$Y$$$20240824$$MD$DE$DE
242452031$24245203$1$I$20240816$20240823$20240823$20240823$EXP$$CN-ROCHE-10000064640$ROCHE$$45$YR$A$F$Y$$$20240824$$HP$CN$CN
242452041$24245204$1$I$$20240822$20240823$20240823$EXP$$CN-ROCHE-10000064617$ROCHE$$52$YR$A$M$Y$$$20240824$$CN$CN$CN
242452051$24245205$1$I$$20240809$20240823$20240823$EXP$$CA-HLS-202402013$HLS THERAPEUTICS$$$$A$F$Y$$$20240823$$HP$CA$CA
242452061$24245206$1$I$20240531$20240821$20240823$20240823$EXP$$US-ABBVIE-5850639$ABBVIE$$57$YR$$F$Y$65.771$KG$20240823$$CN$US$US
242452071$24245207$1$I$$20240814$20240823$20240823$PER$$US-ABBVIE-5881513$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242452081$24245208$1$I$$20240819$20240823$20240823$EXP$$CA-ABBVIE-5887799$ABBVIE$$$$A$M$Y$$$20240823$$CN$CA$CA
242452091$24245209$1$I$20240815$20240816$20240823$20240823$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000241$DENDREON$$$$$$Y$$$20240823$$HP$US$US
242452101$24245210$1$I$$20240819$20240823$20240823$EXP$$US-ABBVIE-5888299$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242452111$24245211$1$I$$20240819$20240823$20240823$EXP$$US-ABBVIE-5887142$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242452121$24245212$1$I$20230101$20240821$20240823$20240823$EXP$$CO-ABBVIE-5891209$ABBVIE$$$$$F$Y$$$20240823$$CN$CO$CO
242452131$24245213$1$I$20240701$20240809$20240823$20240823$EXP$$US-HLS-202400813$HLS THERAPEUTICS$$65$YR$E$F$Y$$$20240823$$PH$US$US
242452141$24245214$1$I$20240822$20240822$20240823$20240823$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047366$BOEHRINGER INGELHEIM$$$$$$Y$$$20240824$$CN$US$US
242452151$24245215$1$I$$20240820$20240823$20240823$EXP$$CA-ABBVIE-5891238$ABBVIE$$$$$M$Y$$$20240823$$HP$CA$CA
242452161$24245216$1$I$20150101$20240816$20240823$20240823$EXP$$CA-ABBVIE-5885627$ABBVIE$$$$E$M$Y$$$20240823$$CN$CA$CA
242452171$24245217$1$I$$20240820$20240823$20240823$EXP$$US-ALXN-202408USA001307US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240824$$HP$US$US
242452181$24245218$1$I$20240101$20240820$20240823$20240823$EXP$$US-ABBVIE-5888972$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242452191$24245219$1$I$20240802$20240822$20240823$20240823$EXP$FR-AFSSAPS-TS2024000920$FR-VIIV HEALTHCARE LIMITED-FR2024104899$VIIV$$$$$$Y$$$20240823$$MD$FR$FR
242452201$24245220$1$I$20240701$20240820$20240823$20240823$EXP$$US-ABBVIE-5889136$ABBVIE$$69$YR$$F$Y$$$20240823$$CN$US$US
242452211$24245221$1$I$20240704$20240820$20240823$20240823$EXP$$NVSC2024GB130239$NOVARTIS$$$$$M$Y$$$20240824$$CN$GB$GB
242452221$24245222$1$I$$20240815$20240823$20240823$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001652$BLUEPRINT MEDICINES$$$$$$Y$$$20240824$$MD$US$US
242452231$24245223$1$I$20230101$20240815$20240823$20240823$PER$$US-ABBVIE-5882641$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242452241$24245224$1$I$20240101$20240821$20240823$20240823$PER$$US-ABBVIE-5890889$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242452251$24245225$1$I$20240101$20240820$20240823$20240823$EXP$$US-ABBVIE-5888722$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242452261$24245226$1$I$20240601$20240822$20240823$20240823$EXP$$SG-ROCHE-10000064701$ROCHE$$61$YR$A$F$Y$$$20240824$$CN$SG$SG
242452271$24245227$1$I$20240807$20240822$20240823$20240823$EXP$$CN-ROCHE-10000064553$ROCHE$$37$YR$A$F$Y$60$KG$20240824$$HP$CN$CN
242452281$24245228$1$I$20240501$20240813$20240823$20240823$PER$$US-ABBVIE-5883342$ABBVIE$$$$A$M$Y$$$20240823$$MD$US$US
242452291$24245229$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133380$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240824$$HP$US$US
242452301$24245230$1$I$$20240819$20240823$20240823$EXP$$DE-ABBVIE-5890838$ABBVIE$$$$$F$Y$$$20240823$$CN$DE$DE
242452312$24245231$2$F$$20240910$20240823$20240913$EXP$$US-ABBVIE-5886557$ABBVIE$$$$$M$Y$122$KG$20240913$$CN$US$US
242452331$24245233$1$I$20240101$20240819$20240823$20240823$EXP$$US-ABBVIE-5874571$ABBVIE$$$$$F$Y$77$KG$20240823$$CN$US$US
242452341$24245234$1$I$20240301$20240820$20240823$20240823$EXP$$SG-ROCHE-10000063394$ROCHE$$$$$F$Y$$$20240824$$CN$SG$SG
242452351$24245235$1$I$20240801$20240820$20240823$20240823$EXP$$US-ABBVIE-5888815$ABBVIE$$63$YR$$F$Y$$$20240823$$CN$US$US
242452361$24245236$1$I$20240820$20240821$20240823$20240823$EXP$$IT-ABBVIE-5890713$ABBVIE$$82$YR$$M$Y$$$20240823$$CN$IT$IT
242452371$24245237$1$I$20240709$20240820$20240823$20240823$EXP$$US-ABBVIE-5889179$ABBVIE$$71$YR$$F$Y$$$20240823$$CN$US$US
242452381$24245238$1$I$$20240821$20240823$20240823$EXP$$NL-ABBVIE-5891281$ABBVIE$$$$E$F$Y$$$20240823$$CN$NL$NL
242452391$24245239$1$I$20240726$20240822$20240823$20240823$EXP$FR-AFSSAPS-PV2024000742$FR-GSK-FR2024104718$GLAXOSMITHKLINE$$$$$$Y$$$20240823$$PH$FR$FR
242452401$24245240$1$I$20240101$20240814$20240823$20240823$PER$$US-ABBVIE-5883319$ABBVIE$$$$$$Y$$$20240823$$CN$US$US
242452411$24245241$1$I$20230101$20240819$20240823$20240823$EXP$$US-ABBVIE-5284199$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242452421$24245242$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164891$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240823$$MD$US$US
242452431$24245243$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164910$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240823$$MD$US$US
242452441$24245244$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164895$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240823$$MD$US$US
242452451$24245245$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164893$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240823$$MD$US$US
242452461$24245246$1$I$20180101$20240811$20240823$20240823$PER$$US-AMGEN-USASP2024164908$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240823$$MD$US$US
242452471$24245247$1$I$20240720$20240819$20240823$20240823$EXP$$US-ABBVIE-5887260$ABBVIE$$73$YR$$F$Y$$$20240823$$CN$US$US
242452481$24245248$1$I$20240101$20240816$20240823$20240823$EXP$$US-ABBVIE-5887597$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242452491$24245249$1$I$20240801$20240819$20240823$20240823$EXP$$US-ABBVIE-5889033$ABBVIE$$63$YR$$M$Y$$$20240823$$CN$US$US
242452501$24245250$1$I$20220101$20240820$20240823$20240823$EXP$$US-ABBVIE-5857272$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242452512$24245251$2$F$20240101$20240919$20240823$20240926$EXP$$US-ABBVIE-5889028$ABBVIE$$$$$F$Y$74$KG$20240926$$CN$US$US
242452521$24245252$1$I$$20240821$20240823$20240823$PER$$US-JNJFOC-20240854815$JOHNSON AND JOHNSON$$$$$F$Y$$$20240824$$CN$US$US
242452531$24245253$1$I$20240101$20240819$20240823$20240823$EXP$$US-ABBVIE-5762133$ABBVIE$$$$$F$Y$$$20240823$$CN$US$US
242452541$24245254$1$I$20230919$20240820$20240823$20240823$EXP$$US-ABBVIE-5774839$ABBVIE$$70$YR$$M$Y$$$20240823$$CN$US$US
242452551$24245255$1$I$20240701$20240820$20240823$20240823$EXP$$US-ABBVIE-5888766$ABBVIE$$54$YR$$M$Y$$$20240823$$CN$US$US
242452561$24245256$1$I$20240819$20240819$20240823$20240823$PER$$US-AMGEN-USASP2024165247$AMGEN$$61$YR$A$F$Y$$$20240823$$CN$US$US
242452571$24245257$1$I$20240610$20240821$20240823$20240823$EXP$$UA-ABBVIE-5890753$ABBVIE$$65$YR$$M$Y$$$20240823$$MD$UA$UA
242452581$24245258$1$I$$20240819$20240823$20240823$EXP$$US-ABBVIE-5888067$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242452591$24245259$1$I$$20240819$20240823$20240823$EXP$$US-ABBVIE-5887281$ABBVIE$$$$$M$Y$$$20240823$$CN$US$US
242452602$24245260$2$F$20240803$20240822$20240824$20240826$EXP$$TW-ABBVIE-5892055$ABBVIE$$43$YR$$M$Y$59$KG$20240826$$HP$TW$TW
242452611$24245261$1$I$20240115$20240820$20240824$20240824$EXP$$DE-ABBVIE-5889219$ABBVIE$$39$YR$$F$Y$91$KG$20240824$$HP$DE$DE
242452621$24245262$1$I$$20240819$20240824$20240824$EXP$$PT-SANDOZ INC.-SDZ2024PT073822$SANDOZ$$25$YR$$M$Y$$$20240824$$MD$PT$PT
242452631$24245263$1$I$$20240814$20240824$20240824$EXP$$GB-AMGEN-GBRSP2024166369$AMGEN$$55$YR$A$F$Y$$$20240823$$CN$GB$GB
242452641$24245264$1$I$$20240821$20240823$20240823$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133560$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240824$$HP$US$US
242452651$24245265$1$I$$20240823$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134327$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240824$$CN$US$US
242452661$24245266$1$I$20240612$20240820$20240824$20240824$EXP$$ES-AstraZeneca-2024A189273$ASTRAZENECA$$74$YR$$F$Y$$$20240823$$MD$ES$
242452671$24245267$1$I$20240501$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A190171$ASTRAZENECA$$24702$DY$$F$Y$$$20240823$$CN$US$
242452681$24245268$1$I$20240815$20240819$20240824$20240824$EXP$$US-AstraZeneca-2024A188995$ASTRAZENECA$$24671$DY$$M$Y$$$20240823$$CN$US$
242452691$24245269$1$I$$20240816$20240824$20240824$EXP$$US-AstraZeneca-2024A188026$ASTRAZENECA$$60$YR$$F$Y$75$KG$20240823$$MD$US$
242452701$24245270$1$I$$20240816$20240824$20240824$EXP$$JP-AstraZeneca-2024A188278$ASTRAZENECA$$74$YR$$F$Y$89$KG$20240823$$MD$JP$
242452711$24245271$1$I$$20240821$20240824$20240824$EXP$$CA-ABBVIE-5892481$ABBVIE$$$$E$M$Y$$$20240824$$MD$CA$CA
242452721$24245272$1$I$$20240815$20240824$20240824$EXP$$CA-AstraZeneca-2024A188750$ASTRAZENECA$$65$YR$$F$Y$34$KG$20240823$$MD$CA$
242452731$24245273$1$I$$20240816$20240824$20240824$EXP$$CA-AstraZeneca-2024A173140$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$CA$
242452741$24245274$1$I$$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A189899$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242452751$24245275$1$I$20240122$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A189917$ASTRAZENECA$$28995$DY$$M$Y$$$20240823$$CN$US$
242452761$24245276$1$I$$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024168962$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242452771$24245277$1$I$$20240815$20240824$20240824$EXP$$ZA-AstraZeneca-2024A188755$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$ZA$
242452781$24245278$1$I$20240819$20240820$20240824$20240824$EXP$$ID-AstraZeneca-2024A192006$ASTRAZENECA$$29220$DY$$F$Y$$$20240823$$CN$ID$
242452791$24245279$1$I$20240720$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A190307$ASTRAZENECA$$26896$DY$$F$Y$$$20240823$$CN$US$
242452801$24245280$1$I$$20240815$20240824$20240824$EXP$$US-AstraZeneca-2024A188326$ASTRAZENECA$$$$$F$Y$$$20240823$$MD$US$
242452811$24245281$1$I$20240807$20240816$20240824$20240824$EXP$$IE-AstraZeneca-2022A177594$ASTRAZENECA$$23302$DY$$F$Y$$$20240823$$HP$IE$
242452822$24245282$2$F$$20240903$20240824$20240911$EXP$$US-AstraZeneca-2024A187242$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
242452831$24245283$1$I$20240523$20240819$20240824$20240824$EXP$$HN-AstraZeneca-2024A163891$ASTRAZENECA$$83$YR$$F$Y$$$20240823$$CN$HN$
242452841$24245284$1$I$20240714$20240820$20240824$20240824$EXP$$IN-AstraZeneca-2024A189531$ASTRAZENECA$$64$YR$$M$Y$64$KG$20240823$$CN$IN$
242452851$24245285$1$I$$20240816$20240824$20240824$EXP$$ZA-AstraZeneca-2024A187836$ASTRAZENECA$$74$YR$$M$Y$$$20240823$$CN$ZA$
242452861$24245286$1$I$$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A189822$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242452871$24245287$1$I$$20240816$20240824$20240824$EXP$$ZA-AstraZeneca-2024A187824$ASTRAZENECA$$59$YR$$M$Y$$$20240823$$CN$ZA$
242452881$24245288$1$I$$20240815$20240824$20240824$EXP$$US-AstraZeneca-2024A187811$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242452891$24245289$1$I$$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A191161$ASTRAZENECA$$$$$F$Y$93$KG$20240823$$CN$US$
242452901$24245290$1$I$$20240815$20240824$20240824$EXP$$ZA-AstraZeneca-2024A187268$ASTRAZENECA$$69$YR$$F$Y$$$20240823$$CN$ZA$
242452911$24245291$1$I$$20240814$20240824$20240824$EXP$$US-AstraZeneca-2024A187159$ASTRAZENECA$$$$$F$Y$$$20240823$$MD$US$
242452921$24245292$1$I$$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A190368$ASTRAZENECA$$$$$F$Y$$$20240823$$HP$US$
242452931$24245293$1$I$$20240807$20240824$20240824$PER$$US-AstraZeneca-2024A179991$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242452942$24245294$2$F$$20240815$20240824$20240828$EXP$$ID-AstraZeneca-2024A188277$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$ID$
242452951$24245295$1$I$$20240815$20240824$20240824$EXP$$US-AstraZeneca-2024A186942$ASTRAZENECA$$$$$$Y$$$20240823$$MD$US$
242452961$24245296$1$I$20240726$20240726$20240824$20240824$PER$$US-AstraZeneca-2024A171635$ASTRAZENECA$$26892$DY$$M$Y$$$20240823$$CN$US$
242452971$24245297$1$I$$20240816$20240824$20240824$EXP$$VN-AstraZeneca-2024A190008$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$VN$
242452981$24245298$1$I$$20240815$20240824$20240824$EXP$$US-AstraZeneca-2024A187786$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242452991$24245299$1$I$20231011$20240816$20240824$20240824$EXP$$JP-AstraZeneca-2024A188324$ASTRAZENECA$$52$YR$$M$Y$95$KG$20240823$$MD$JP$
242453001$24245300$1$I$$20240815$20240824$20240824$EXP$$JP-AstraZeneca-2024A187939$ASTRAZENECA$$82$YR$$M$Y$$$20240823$$MD$JP$
242453011$24245301$1$I$$20240820$20240824$20240824$EXP$$ZA-AstraZeneca-2024A189654$ASTRAZENECA$$76$YR$$M$Y$$$20240823$$CN$ZA$
242453021$24245302$1$I$$20240816$20240824$20240824$EXP$$GB-AstraZeneca-2024A187292$ASTRAZENECA$$76$YR$$M$Y$80$KG$20240823$$MD$GB$
242453031$24245303$1$I$20240818$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A190070$ASTRAZENECA$$24965$DY$$F$Y$$$20240823$$MD$US$
242453041$24245304$1$I$$20240816$20240824$20240824$EXP$$US-AstraZeneca-2024A187534$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242453051$24245305$1$I$$20240815$20240824$20240824$EXP$$US-AstraZeneca-2024A186760$ASTRAZENECA$$$$$$Y$$$20240823$$CN$US$
242453061$24245306$1$I$$20240815$20240824$20240824$EXP$$CA-AstraZeneca-2024A189267$ASTRAZENECA$$83$YR$$F$Y$60$KG$20240823$$MD$CA$
242453081$24245308$1$I$20240803$20240816$20240824$20240824$EXP$$CN-AstraZeneca-2024A187567$ASTRAZENECA$$33$YR$$M$Y$100$KG$20240823$$MD$CN$
242453092$24245309$2$F$$20240917$20240824$20240917$PER$$US-AstraZeneca-2024A185071$ASTRAZENECA$$$$$F$Y$$$20240917$$HP$US$
242453101$24245310$1$I$$20240813$20240824$20240824$PER$$US-AstraZeneca-2024A184961$ASTRAZENECA$$$$$F$Y$$$20240823$$MD$US$
242453111$24245311$1$I$20240723$20240816$20240824$20240824$EXP$$US-AstraZeneca-2024A188980$ASTRAZENECA$$23112$DY$$F$Y$$$20240823$$CN$US$
242453121$24245312$1$I$20240701$20240816$20240824$20240824$EXP$$CN-AstraZeneca-2024A187622$ASTRAZENECA$$31$YR$$M$Y$$$20240823$$MD$CN$
242453131$24245313$1$I$$20240819$20240824$20240824$EXP$$US-AstraZeneca-2024A188858$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242453142$24245314$2$F$$20240903$20240824$20240906$EXP$$IL-AstraZeneca-2024A188746$ASTRAZENECA$$61$YR$$F$Y$$$20240906$$MD$IL$
242453151$24245315$1$I$$20240816$20240824$20240824$EXP$$MY-AstraZeneca-2024A188837$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$MY$
242453161$24245316$1$I$$20240815$20240824$20240824$EXP$$ZA-AstraZeneca-2024A186639$ASTRAZENECA$$83$YR$$F$Y$$$20240823$$CN$ZA$
242453171$24245317$1$I$$20240819$20240824$20240824$EXP$$US-AstraZeneca-2024A188917$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242453181$24245318$1$I$$20240815$20240824$20240824$EXP$$CN-AstraZeneca-2024A188163$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$CN$
242453191$24245319$1$I$$20240816$20240824$20240824$EXP$$US-AstraZeneca-2024A188107$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242453201$24245320$1$I$$20240815$20240824$20240824$EXP$$AU-AstraZeneca-2024A189704$ASTRAZENECA$$$$$M$Y$$$20240823$$PH$AU$
242453211$24245321$1$I$$20240816$20240824$20240824$EXP$$ZA-AstraZeneca-2024A187814$ASTRAZENECA$$62$YR$$F$Y$$$20240823$$CN$ZA$
242453221$24245322$1$I$$20240816$20240824$20240824$EXP$$US-AstraZeneca-2024A187642$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242453231$24245323$1$I$$20240819$20240824$20240824$EXP$$TW-AstraZeneca-2024A191004$ASTRAZENECA$$$$$$Y$$$20240823$$CN$TW$
242453241$24245324$1$I$20240810$20240819$20240824$20240824$EXP$$GB-AstraZeneca-2024A190748$ASTRAZENECA$$39$YR$$F$Y$$$20240823$$MD$GB$
242453251$24245325$1$I$$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A189723$ASTRAZENECA$$$$$$Y$$$20240823$$HP$US$
242453261$24245326$1$I$$20240815$20240824$20240824$EXP$$US-AstraZeneca-2024A187585$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242453271$24245327$1$I$20240728$20240819$20240824$20240824$EXP$$GB-AstraZeneca-2024A188376$ASTRAZENECA$$85$YR$$M$Y$91$KG$20240823$$MD$GB$
242453291$24245329$1$I$20240807$20240820$20240824$20240824$EXP$$ZA-AstraZeneca-2024A190968$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$ZA$
242453301$24245330$1$I$$20240819$20240824$20240824$EXP$$US-AstraZeneca-2024A188835$ASTRAZENECA$$$$$$Y$$$20240823$$HP$US$
242453311$24245331$1$I$20240816$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A189921$ASTRAZENECA$$27216$DY$$F$Y$$$20240823$$CN$US$
242453321$24245332$1$I$20240211$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A189717$ASTRAZENECA$$$$$$Y$$$20240823$$CN$US$
242453331$24245333$1$I$20240525$20240816$20240824$20240824$EXP$$CN-AstraZeneca-2024A187500$ASTRAZENECA$$63$YR$$M$Y$64$KG$20240823$$MD$CN$
242453341$24245334$1$I$$20240816$20240824$20240824$EXP$$ZA-AstraZeneca-2024A187819$ASTRAZENECA$$50$YR$$M$Y$$$20240823$$CN$ZA$
242453351$24245335$1$I$20240817$20240819$20240824$20240824$EXP$$GB-AstraZeneca-2024A188535$ASTRAZENECA$$84$YR$$M$Y$$$20240823$$MD$GB$
242453361$24245336$1$I$$20240815$20240824$20240824$EXP$$US-AstraZeneca-2024A188903$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242453371$24245337$1$I$20240228$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A189707$ASTRAZENECA$$$$$$Y$$$20240823$$CN$US$
242453381$24245338$1$I$20240813$20240815$20240824$20240824$EXP$$GB-AstraZeneca-2024A186504$ASTRAZENECA$$81$YR$$F$Y$$$20240823$$MD$GB$
242453391$24245339$1$I$$20240820$20240824$20240824$EXP$$JP-AstraZeneca-2024A190729$ASTRAZENECA$$72$YR$$F$Y$$$20240823$$MD$JP$
242453401$24245340$1$I$$20240815$20240824$20240824$EXP$$US-AstraZeneca-2024A188033$ASTRAZENECA$$$$$F$Y$137$KG$20240823$$CN$US$
242453411$24245341$1$I$$20240816$20240824$20240824$EXP$$US-AstraZeneca-2024A189905$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242453421$24245342$1$I$20240401$20240815$20240824$20240824$EXP$$FR-AstraZeneca-2024A186210$ASTRAZENECA$$$$E$M$Y$$$20240823$$MD$FR$
242453431$24245343$1$I$$20240815$20240824$20240824$EXP$$ZA-AstraZeneca-2024A187070$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$ZA$
242453441$24245344$1$I$20240325$20240819$20240824$20240824$EXP$$US-AstraZeneca-2024A188900$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242453451$24245345$1$I$$20240815$20240824$20240824$EXP$$US-AstraZeneca-2024A188022$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242453461$24245346$1$I$$20240820$20240824$20240824$EXP$$JP-AstraZeneca-2024A190728$ASTRAZENECA$$73$YR$$F$Y$$$20240823$$MD$JP$
242453481$24245348$1$I$$20240813$20240824$20240824$PER$$US-JNJFOC-20240838912$JOHNSON AND JOHNSON$$$$$M$Y$$$20240824$$CN$US$US
242453501$24245350$1$I$$20240816$20240824$20240824$EXP$$US-AMGEN-USASP2024164793$AMGEN$Jen W.Y. FLAG-IDA + venetoclax in newly diagnosed (ND) or relapsed/refractory (RR) AML. Journal of Clinical Oncology. 2024;42 (16):6519$$$$$Y$$$20240823$$HP$US$US
242453511$24245351$1$I$$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024167614$AMGEN$$$$$$Y$$$20240823$$HP$US$US
242453521$24245352$1$I$$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024168093$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242453532$24245353$2$F$20240101$20240921$20240824$20240930$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025817$UNITED THERAPEUTICS$$$$$F$Y$72.971$KG$20240930$$PH$US$US
242453541$24245354$1$I$$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024168863$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242453554$24245355$4$F$20240801$20240912$20240824$20240917$EXP$FR-PFIZER INC-PV202400104583$FR-ROCHE-10000063745$ROCHE$$67$YR$E$M$Y$82$KG$20240917$$HP$FR$FR
242453561$24245356$1$I$20240724$20240820$20240824$20240824$EXP$$JP-AstraZeneca-2024A191578$ASTRAZENECA$$75$YR$$M$Y$$$20240823$$MD$JP$
242453571$24245357$1$I$$20240819$20240824$20240824$EXP$$US-AstraZeneca-2024A189475$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242453581$24245358$1$I$$20240820$20240824$20240824$EXP$$JP-AstraZeneca-2024A190726$ASTRAZENECA$$64$YR$$F$Y$$$20240823$$MD$JP$
242453591$24245359$1$I$$20240808$20240824$20240824$EXP$$US-AstraZeneca-2024A182897$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242453601$24245360$1$I$$20240815$20240824$20240824$EXP$$CA-AstraZeneca-2024A189347$ASTRAZENECA$$69$YR$$F$Y$$$20240823$$MD$CA$
242453612$24245361$2$F$$20240906$20240824$20240913$EXP$$CA-AstraZeneca-2024A180508$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$CA$
242453621$24245362$1$I$$20240818$20240824$20240824$EXP$$GB-AstraZeneca-2024A187908$ASTRAZENECA$$$$$F$Y$$$20240823$$MD$GB$
242453641$24245364$1$I$$20240819$20240824$20240824$EXP$$US-AstraZeneca-2024A188948$ASTRAZENECA$$$$$$Y$$$20240823$$PH$US$
242453651$24245365$1$I$$20240816$20240824$20240824$EXP$$US-AstraZeneca-2019SE45100$ASTRAZENECA$Kyaw H, Tsai K, Garyali S, Jun Park W, Raju F. TICAGLEROL-INDUCED TRANSAMINITIS: A RARE AND UNEXPECTED PHENOMENON. Journal of the American College of Cardiology 2019;73(9):$60$YR$$M$Y$$$20240823$$HP$US$
242453661$24245366$1$I$$20240822$20240824$20240824$PER$$US-AstraZeneca-2024A192552$ASTRAZENECA$$$$A$M$Y$$$20240823$$MD$US$
242453671$24245367$1$I$20240501$20240815$20240824$20240824$EXP$$US-AstraZeneca-2024A190435$ASTRAZENECA$$25963$DY$$M$Y$$$20240823$$CN$US$
242453681$24245368$1$I$20240803$20240820$20240824$20240824$EXP$$ID-AstraZeneca-2024A192008$ASTRAZENECA$$19785$DY$$F$Y$$$20240823$$CN$ID$
242453691$24245369$1$I$$20240815$20240824$20240824$EXP$$ZA-AstraZeneca-2024A188754$ASTRAZENECA$$70$YR$$M$Y$$$20240823$$CN$ZA$
242453701$24245370$1$I$$20240819$20240824$20240824$EXP$$PT-AstraZeneca-2024A186234$ASTRAZENECA$$$$E$$Y$$$20240823$$MD$PT$
242453711$24245371$1$I$$20240816$20240824$20240824$EXP$$CN-AstraZeneca-2024A189933$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$CN$
242453721$24245372$1$I$$20240816$20240824$20240824$EXP$$NL-AstraZeneca-2024A191134$ASTRAZENECA$$72$YR$$M$Y$$$20240823$$MD$NL$
242453731$24245373$1$I$$20240820$20240824$20240824$EXP$$JP-AstraZeneca-2024A190727$ASTRAZENECA$$70$YR$$F$Y$$$20240823$$MD$JP$
242453741$24245374$1$I$$20240820$20240824$20240824$EXP$$JP-AstraZeneca-2024A190731$ASTRAZENECA$$67$YR$$F$Y$$$20240823$$MD$JP$
242453751$24245375$1$I$$20240816$20240824$20240824$EXP$$JP-AstraZeneca-2024A064264$ASTRAZENECA$$70$YR$$M$Y$$$20240823$$MD$JP$
242453762$24245376$2$F$20230710$20240829$20240824$20240903$EXP$$JP-AstraZeneca-2024A190819$ASTRAZENECA$$77$YR$$F$Y$$$20240903$$MD$JP$
242453771$24245377$1$I$$20240815$20240824$20240824$EXP$$CA-AstraZeneca-2024A189298$ASTRAZENECA$$45$YR$$F$Y$$$20240823$$MD$CA$
242453781$24245378$1$I$$20240815$20240824$20240824$EXP$$DE-AstraZeneca-2024A187695$ASTRAZENECA$$$$$$Y$$$20240823$$MD$DE$
242453791$24245379$1$I$$20240815$20240824$20240824$EXP$$IL-AstraZeneca-2024A188671$ASTRAZENECA$$$$$M$Y$$$20240823$$MD$IL$
242453801$24245380$1$I$20240727$20240815$20240824$20240824$EXP$$CN-AstraZeneca-2024A189621$ASTRAZENECA$$2331$WK$$F$Y$63$KG$20240823$$MD$CN$
242453811$24245381$1$I$20240817$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A189725$ASTRAZENECA$$24289$DY$$F$Y$128.1$KG$20240823$$CN$US$
242453821$24245382$1$I$$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A189913$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242453831$24245383$1$I$$20240815$20240824$20240824$EXP$$US-AstraZeneca-2024A188462$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242453841$24245384$1$I$20240806$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A189765$ASTRAZENECA$$26366$DY$$F$Y$$$20240823$$CN$US$
242453851$24245385$1$I$20240802$20240821$20240824$20240824$EXP$$BE-ABBVIE-5890710$ABBVIE$$85$YR$$F$Y$$$20240824$$HP$BE$BE
242453861$24245386$1$I$20240710$20240822$20240824$20240824$EXP$$GB-AstraZeneca-2024A191656$ASTRAZENECA$$74$YR$$F$Y$90$KG$20240823$$MD$GB$
242453871$24245387$1$I$20240721$20240820$20240824$20240824$EXP$$ID-AstraZeneca-2024A192065$ASTRAZENECA$$22099$DY$$M$Y$$$20240823$$CN$ID$
242453881$24245388$1$I$20240817$20240820$20240824$20240824$EXP$$CO-AstraZeneca-2024A191877$ASTRAZENECA$$33976$DY$$F$Y$$$20240823$$CN$CO$
242453891$24245389$1$I$20240714$20240816$20240824$20240824$EXP$$CH-AstraZeneca-2024A190801$ASTRAZENECA$$81$YR$$M$Y$69.3$KG$20240823$$MD$CH$
242453902$24245390$2$F$$20240821$20240824$20240829$EXP$$US-AstraZeneca-2024A188678$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242453913$24245391$3$F$$20240822$20240824$20240830$EXP$$JP-AstraZeneca-2024A188587$ASTRAZENECA$$81$YR$$M$Y$$$20240830$$PH$JP$
242453921$24245392$1$I$20240810$20240815$20240824$20240824$EXP$$CN-AstraZeneca-2024A187649$ASTRAZENECA$$3329$WK$$F$Y$57$KG$20240823$$MD$CN$
242453951$24245395$1$I$20240617$20240816$20240824$20240824$EXP$$BR-AstraZeneca-2024A189882$ASTRAZENECA$$1941$WK$$F$Y$54$KG$20240823$$MD$BR$
242453961$24245396$1$I$20240806$20240816$20240824$20240824$EXP$$CN-AstraZeneca-2024A187568$ASTRAZENECA$$88$YR$$F$Y$50$KG$20240823$$MD$CN$
242453971$24245397$1$I$20240808$20240821$20240824$20240824$EXP$$CN-ABBVIE-5889156$ABBVIE$$65$YR$$F$Y$58$KG$20240824$$MD$CN$CN
242453981$24245398$1$I$$20240820$20240824$20240824$EXP$$JP-AstraZeneca-2024A190798$ASTRAZENECA$$83$YR$$F$Y$$$20240823$$MD$JP$
242453991$24245399$1$I$20240711$20240819$20240824$20240824$EXP$$US-AstraZeneca-2024A188753$ASTRAZENECA$$30080$DY$$F$Y$$$20240823$$CN$US$
242454001$24245400$1$I$$20240816$20240824$20240824$EXP$$RO-AstraZeneca-2024A187110$ASTRAZENECA$Olimpia Simona Huluban et al. Acrocianosis in the context of oncological treatment: case presentation. vRevista Romanian de Medicina Familiei 2024;7(22):17-21.$71$YR$$F$Y$$$20240823$$MD$RO$
242454011$24245401$1$I$$20240815$20240824$20240824$EXP$$AU-AstraZeneca-2024A187779$ASTRAZENECA$$73$YR$$M$Y$$$20240823$$MD$AU$
242454022$24245402$2$F$20220511$20240704$20240824$20240905$EXP$$JP-AstraZeneca-2024A154912$ASTRAZENECA$$80$YR$$F$Y$$$20240905$$MD$JP$
242454032$24245403$2$F$$20240829$20240824$20240910$EXP$$PT-AstraZeneca-2024A171654$ASTRAZENECA$Pereira I., Ferreira I. M., Barbosa F. R., Pereira D., Gabriel D. F.. Carbamazepine intoxication: cause and/or consequence.. Congresses of the Portuguese Society of Internal Medicine. 2024;1199. Abstract of Congress 2024;1199 .$66$YR$$M$Y$$$20240910$$MD$PT$
242454041$24245404$1$I$20231217$20240816$20240824$20240824$EXP$$ES-AstraZeneca-2024A187083$ASTRAZENECA$$66$YR$$M$Y$$$20240823$$MD$ES$
242454051$24245405$1$I$$20240816$20240824$20240824$EXP$$US-AstraZeneca-2024A187849$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242454061$24245406$1$I$$20240819$20240824$20240824$EXP$$US-AstraZeneca-2024A188704$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242454071$24245407$1$I$$20240103$20240824$20240824$EXP$$US-AstraZeneca-2024A003251$ASTRAZENECA$$$$$$Y$$$20240823$$CN$US$
242454081$24245408$1$I$$20240815$20240824$20240824$EXP$$JP-AstraZeneca-2024A170069$ASTRAZENECA$Toyama T. Survey on influence of drugs on eating and swallowing -to fulfill the role of pharmacists in rehabilitation nutrition. The 13th Japanese Association of Rehabilitation Nutrition annual meeting Program 2024;PS-30.$$$$$Y$$$20240823$$PH$JP$
242454091$24245409$1$I$$20240820$20240824$20240824$EXP$$JP-AstraZeneca-2024A191244$ASTRAZENECA$Hori S, et al.. PS5-1 A case of JAK2 V617F mutation-positive essential thrombocythemia/myeloproliferative neoplasms and EGFR exon19/JAK2 V617F mutation-positive lung adenocarcinoma in which pulmonary hypertension developed.. The 7th Annual Meeting of the Japanese Onco-Cardiology Society 2024;118-.$69$YR$$F$Y$$$20240823$$MD$JP$
242454101$24245410$1$I$20231005$20240819$20240824$20240824$EXP$$JP-AstraZeneca-2024A189984$ASTRAZENECA$$72$YR$$M$Y$69$KG$20240823$$MD$JP$
242454111$24245411$1$I$$20240815$20240824$20240824$EXP$$CA-AstraZeneca-2024A188928$ASTRAZENECA$$44$YR$$M$Y$$$20240823$$MD$CA$
242454121$24245412$1$I$20240731$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A189829$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242454131$24245413$1$I$$20240816$20240824$20240824$EXP$$US-AstraZeneca-2024A188634$ASTRAZENECA$$$$$M$Y$69$KG$20240823$$CN$US$
242454141$24245414$1$I$20240715$20240815$20240824$20240824$PER$$US-ABBVIE-5883999$ABBVIE$$$$A$M$Y$$$20240824$$CN$US$US
242454153$24245415$3$F$$20240905$20240824$20240912$EXP$$CA-AstraZeneca-2024A188882$ASTRAZENECA$$$$$F$Y$$$20240912$$HP$CA$
242454161$24245416$1$I$20240817$20240819$20240824$20240824$EXP$$US-AstraZeneca-2024A188684$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242454171$24245417$1$I$20240510$20240815$20240824$20240824$EXP$$FR-AstraZeneca-2024A186244$ASTRAZENECA$$79$YR$$F$Y$$$20240823$$MD$FR$
242454182$24245418$2$F$$20240918$20240824$20240918$EXP$$AU-AstraZeneca-2024A187780$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$AU$
242454191$24245419$1$I$20240731$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A189843$ASTRAZENECA$$26666$DY$$M$Y$$$20240823$$CN$US$
242454201$24245420$1$I$$20240820$20240824$20240824$EXP$$JP-AstraZeneca-2024A190730$ASTRAZENECA$$57$YR$$F$Y$$$20240823$$MD$JP$
242454211$24245421$1$I$20240809$20240816$20240824$20240824$EXP$$CN-AstraZeneca-2024A187499$ASTRAZENECA$$71$YR$$M$Y$58$KG$20240823$$MD$CN$
242454221$24245422$1$I$$20240817$20240824$20240824$EXP$$US-AstraZeneca-2024A188799$ASTRAZENECA$$$$$F$Y$56.4$KG$20240823$$CN$US$
242454231$24245423$1$I$20190916$20190924$20240824$20240824$EXP$$CO-AstraZeneca-2019SF37545$ASTRAZENECA$$27342$DY$$F$Y$$$20240823$$CN$CO$
242454241$24245424$1$I$20240811$20240815$20240824$20240824$EXP$$CN-AstraZeneca-2024A187653$ASTRAZENECA$$2472$WK$$M$Y$85$KG$20240823$$MD$CN$
242454251$24245425$1$I$$20240816$20240824$20240824$EXP$$CA-AstraZeneca-2024A189019$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$CA$
242454261$24245426$1$I$$20240814$20240824$20240824$EXP$$US-AstraZeneca-2024A186063$ASTRAZENECA$$$$$M$Y$$$20240823$$CN$US$
242454271$24245427$1$I$$20240816$20240824$20240824$EXP$$CN-AstraZeneca-2024A188043$ASTRAZENECA$$66$YR$$F$Y$$$20240823$$MD$CN$
242454281$24245428$1$I$$20240729$20240824$20240824$PER$$US-AstraZeneca-2024A173197$ASTRAZENECA$$70$YR$$F$Y$$$20240823$$MD$US$
242454291$24245429$1$I$$20240816$20240824$20240824$EXP$$ZA-AstraZeneca-2024A187840$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$ZA$
242454301$24245430$1$I$$20210329$20240824$20240824$EXP$$GB-AstraZeneca-2021A250425$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$GB$
242454311$24245431$1$I$20240514$20240819$20240824$20240824$EXP$$FR-AstraZeneca-2024A188312$ASTRAZENECA$$79$YR$$F$Y$60$KG$20240823$$MD$FR$
242454321$24245432$1$I$20240803$20240820$20240824$20240824$EXP$$ID-AstraZeneca-2024A192015$ASTRAZENECA$$25776$DY$$F$Y$$$20240823$$CN$ID$
242454331$24245433$1$I$$20240819$20240824$20240824$EXP$$RU-AstraZeneca-2024A191260$ASTRAZENECA$^, Sagitova G.R., Kasatkina N.V., Sereda V.M., Ugai M.S., Gavrilova Yu.S., Faradzhova D.M. Severe course of whooping cough in a month-old child. Meditsinskiy Sovet 2024;18(11):235?239.$1$MON$$M$Y$$$20240823$$HP$RU$
242454341$24245434$1$I$$20240820$20240824$20240824$EXP$$CO-AstraZeneca-2024A192386$ASTRAZENECA$Zuluaga, J.; Cardona, A.F.; Lima, V.C.D.; Arrieta, O.; Rojas, L.; et al. Early Experience with the FLAURA2 Regimen in Patients with NSCLC and EGFR Mutations in Latin America. 2024 World Conference on Lung Cancer (WCLC) - International Association for the Study of Lung Cancer (IASLC) 2024;$$$$$Y$$$20240823$$HP$CO$
242454351$24245435$1$I$$20240816$20240824$20240824$PER$$US-AstraZeneca-2024A188028$ASTRAZENECA$$$$$F$Y$$$20240823$$MD$US$
242454361$24245436$1$I$$20240820$20240824$20240824$EXP$$JP-AstraZeneca-2024A190755$ASTRAZENECA$$69$YR$$F$Y$$$20240823$$MD$JP$
242454371$24245437$1$I$20230101$20240816$20240824$20240824$EXP$$JP-AstraZeneca-2023A159261$ASTRAZENECA$Seki N.. A step towards the future in stage IV NSCLC treatment: A treatment approach using Imfinzi (durvalumab) + Imjudo (tremelimumab) + chemotherapy learned from post-marketing clinical use cases.. Luncheon seminar 23 in the 64th Annual Meeting of the Japan Lung Cancer Society. 2023;$77$YR$$M$Y$54$KG$20240823$$MD$JP$
242454381$24245438$1$I$20240719$20240817$20240824$20240824$EXP$$CN-AstraZeneca-2024A188505$ASTRAZENECA$$25301$DY$$F$Y$62$KG$20240823$$MD$CN$
242454391$24245439$1$I$$20240815$20240824$20240824$EXP$$US-AstraZeneca-2024A187140$ASTRAZENECA$$$$$F$Y$$$20240823$$HP$US$
242454401$24245440$1$I$20240702$20240819$20240824$20240824$EXP$$US-AstraZeneca-2024A188923$ASTRAZENECA$$21799$DY$$M$Y$$$20240823$$HP$US$
242454411$24245441$1$I$20240709$20240819$20240824$20240824$EXP$$MY-AstraZeneca-2024A190864$ASTRAZENECA$$48$YR$$F$Y$$$20240823$$MD$MY$
242454421$24245442$1$I$$20240820$20240824$20240824$EXP$$ZA-AstraZeneca-2024A189920$ASTRAZENECA$$15705$DY$$F$Y$$$20240823$$CN$ZA$
242454431$24245443$1$I$$20240820$20240824$20240824$EXP$$JP-AstraZeneca-2024A190732$ASTRAZENECA$$78$YR$$F$Y$$$20240823$$MD$JP$
242454441$24245444$1$I$20240810$20240820$20240824$20240824$EXP$$ID-AstraZeneca-2024A192016$ASTRAZENECA$$28275$DY$$M$Y$$$20240823$$CN$ID$
242454452$24245445$2$F$20240805$20240820$20240824$20240829$EXP$$JP-AstraZeneca-2024A190997$ASTRAZENECA$$62$YR$$F$Y$42$KG$20240829$$MD$JP$
242454461$24245446$1$I$$20230712$20240824$20240824$PER$$US-Emmaus Medical, Inc.-EMM202307-000158$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240824$$CN$US$
242454471$24245447$1$I$20230718$20230721$20240824$20240824$PER$$US-Emmaus Medical, Inc.-EMM202307-000176$EMMAUS LIFE SCIENCES$$13$YR$T$F$Y$$$20240824$$CN$US$
242454481$24245448$1$I$20230625$20230722$20240824$20240824$PER$$US-Emmaus Medical, Inc.-EMM202307-000177$EMMAUS LIFE SCIENCES$$45$YR$A$F$Y$$$20240824$$CN$US$
242454491$24245449$1$I$20230701$20230822$20240824$20240824$PER$$US-Emmaus Medical, Inc.-EMM202307-000186$EMMAUS LIFE SCIENCES$$53$YR$A$F$Y$$$20240824$$CN$US$
242454501$24245450$1$I$$20230803$20240824$20240824$PER$$US-Emmaus Medical, Inc.-EMM202308-000195$EMMAUS LIFE SCIENCES$$$$A$F$Y$$$20240824$$CN$US$
242454511$24245451$1$I$$20230925$20240824$20240824$PER$$US-Emmaus Medical, Inc.-EMM202309-000264$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240824$$CN$US$
242454521$24245452$1$I$20230101$20230926$20240824$20240824$PER$$US-Emmaus Medical, Inc.-EMM202309-000265$EMMAUS LIFE SCIENCES$$58$YR$A$F$Y$$$20240824$$CN$US$
242454531$24245453$1$I$20231201$20231228$20240824$20240824$PER$$US-Emmaus Medical, Inc.-EMM202401-000003$EMMAUS LIFE SCIENCES$$25$YR$A$F$Y$$$20240824$$CN$US$
242454541$24245454$1$I$20230101$20231229$20240824$20240824$PER$$US-Emmaus Medical, Inc.-EMM202401-000006$EMMAUS LIFE SCIENCES$$34$YR$A$F$Y$$$20240824$$CN$US$
242454551$24245455$1$I$$20240703$20240824$20240824$PER$$US-Emmaus Medical, Inc.-EMM202407-000340$EMMAUS LIFE SCIENCES$$$$$F$Y$$$20240824$$CN$US$
242454561$24245456$1$I$20240616$20240705$20240824$20240824$PER$$US-Emmaus Medical, Inc.-EMM202407-000341$EMMAUS LIFE SCIENCES$$13$YR$T$M$Y$$$20240824$$CN$US$
242454571$24245457$1$I$20240622$20240705$20240824$20240824$PER$$US-Emmaus Medical, Inc.-EMM202407-000342$EMMAUS LIFE SCIENCES$$32$YR$A$F$Y$$$20240824$$CN$US$
242454581$24245458$1$I$$20240815$20240824$20240824$EXP$$CN-AstraZeneca-2024A190545$ASTRAZENECA$Ren G, Song X, Zhu J. Analysis of treatment strategies and literature review for a case of multi-line TKI-resistant advanced lung cancer transformed into SCLC. Strait Pharmaceutical Journal 2024;36(6):63-67.$51$YR$$F$Y$60$KG$20240823$$HP$CN$
242454591$24245459$1$I$$20240820$20240824$20240824$PER$$US-AstraZeneca-2024A191714$ASTRAZENECA$$$$$F$Y$$$20240823$$CN$US$
242454601$24245460$1$I$$20240802$20240824$20240824$PER$$US-AstraZeneca-2024A177463$ASTRAZENECA$$$$$$Y$$$20240824$$HP$US$
242454611$24245461$1$I$$20240821$20240824$20240824$PER$$US-AstraZeneca-2024A191396$ASTRAZENECA$$$$$$Y$$$20240823$$CN$US$
242454621$24245462$1$I$$20240730$20240824$20240824$PER$$US-AstraZeneca-2024A174283$ASTRAZENECA$$31$YR$$$Y$$$20240823$$MD$US$
242454631$24245463$1$I$$20240731$20240824$20240824$PER$$US-AstraZeneca-2024A175163$ASTRAZENECA$$$$$$Y$$$20240824$$MD$US$
242454641$24245464$1$I$$20240821$20240824$20240824$PER$$US-AstraZeneca-2024A191130$ASTRAZENECA$$$$$F$Y$$$20240824$$MD$US$
242454651$24245465$1$I$$20240813$20240824$20240824$PER$$US-AstraZeneca-2024A186957$ASTRAZENECA$$$$$M$Y$$$20240824$$CN$US$
242454661$24245466$1$I$$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024168858$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242454671$24245467$1$I$20240101$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133951$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240824$$CN$US$US
242454681$24245468$1$I$20240101$20240815$20240824$20240824$EXP$$SE-AstraZeneca-2024A192086$ASTRAZENECA$$30$YR$$F$Y$$$20240823$$MD$SE$
242454691$24245469$1$I$$20240814$20240824$20240824$PER$$US-ABBVIE-5883529$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242454701$24245470$1$I$$20240815$20240824$20240824$EXP$$DE-JNJFOC-20240844520$JOHNSON AND JOHNSON$$$$$M$Y$$$20240824$$MD$DE$DE
242454711$24245471$1$I$20240101$20240819$20240824$20240824$EXP$$RO-ABBVIE-5887393$ABBVIE$$63$YR$$F$Y$57$KG$20240824$$HP$RO$RO
242454721$24245472$1$I$$20240815$20240824$20240824$PER$$US-ROCHE-10000059307$ROCHE$$$$$F$Y$$$20240824$$MD$US$US
242454732$24245473$2$F$20240812$20240827$20240824$20240829$PER$$US-AMGEN-USASP2024167519$AMGEN$$76$YR$E$F$Y$$$20240829$$CN$US$US
242454741$24245474$1$I$$20240819$20240824$20240824$PER$$US-ABBVIE-5889481$ABBVIE$$$$$$Y$$$20240824$$CN$US$US
242454751$24245475$1$I$20230101$20240815$20240824$20240824$EXP$$DE-AMGEN-DEUSP2024163143$AMGEN$$3$YR$C$F$Y$$$20240823$$CN$DE$DE
242454761$24245476$1$I$20240401$20240816$20240824$20240824$PER$$US-JNJFOC-20240846276$JOHNSON AND JOHNSON$$$$$M$Y$$$20240824$$CN$US$US
242454771$24245477$1$I$$20240822$20240824$20240824$EXP$$CA-SANDOZ INC.-SDZ2024CA074661$SANDOZ$$69$YR$$F$Y$61$KG$20240824$$MD$CA$CA
242454781$24245478$1$I$$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024168614$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242454791$24245479$1$I$$20240816$20240824$20240824$PER$$US-JNJFOC-20240846145$JOHNSON AND JOHNSON$$$$$M$Y$$$20240824$$CN$US$US
242454803$24245480$3$F$20240101$20240829$20240824$20240830$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-006816$BOEHRINGER INGELHEIM$$84$YR$E$M$Y$$$20240830$$CN$US$US
242454811$24245481$1$I$20240712$20240814$20240824$20240824$EXP$FR-AFSSAPS-PC2024000653$FR-TEVA-VS-3233659$TEVA$$77$YR$$M$Y$$$20240824$$PH$FR$FR
242454822$24245482$2$F$$20240909$20240824$20240912$EXP$$US-ABBVIE-5890672$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
242454831$24245483$1$I$$20240820$20240824$20240824$EXP$$US-ABBVIE-5888823$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242454841$24245484$1$I$20240728$20240814$20240824$20240824$EXP$PT-INFARMED-R202408-146$PT-TEVA-VS-3233710$TEVA$$20$YR$$F$Y$$$20240824$$PH$PT$PT
242454851$24245485$1$I$20240101$20240815$20240824$20240824$EXP$$US-JNJFOC-20240845590$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240824$$CN$US$US
242454861$24245486$1$I$$20240815$20240824$20240824$30DAY$$US-GSK-US2024101738$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242454871$24245487$1$I$$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167957$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242454881$24245488$1$I$20240101$20240717$20240824$20240824$PER$$US-AMGEN-USASP2024165326$AMGEN$$69$YR$E$M$Y$$$20240823$$CN$US$US
242454891$24245489$1$I$20240716$20240814$20240824$20240824$EXP$FR-AFSSAPS-PC2024000650$FR-TEVA-VS-3233739$TEVA$$33$YR$$F$Y$$$20240824$$PH$FR$FR
242454901$24245490$1$I$$20240816$20240824$20240824$PER$$US-ROCHE-3357695$ROCHE$King R, Sekar P, Patel H, Naveed M, Aqtash S, Adroja S, Jacob D and Riaz T CNS toxoplasmosis, a rare presentation in a patient with Myasthenia Gravis. DOI: 10.1016/j.idcr.2023.e01780. IDCases 2023 Jan;32:1-6.$78$YR$E$M$Y$$$20240824$$HP$US$US
242454912$24245491$2$F$20240801$20240820$20240824$20240828$PER$$US-AMGEN-USASP2024167169$AMGEN$$$$A$F$Y$$$20240827$$CN$US$US
242454921$24245492$1$I$20231101$20240814$20240824$20240824$EXP$FR-AFSSAPS-RE2024000779$FR-TEVA-VS-3233815$TEVA$$62$YR$$F$Y$$$20240824$$HP$FR$FR
242454931$24245493$1$I$20240820$20240821$20240824$20240824$EXP$$US-ABBVIE-5890187$ABBVIE$$78$YR$$F$Y$$$20240824$$CN$US$US
242454941$24245494$1$I$$20240819$20240824$20240824$PER$$US-ABBVIE-5887291$ABBVIE$$$$A$F$Y$$$20240824$$CN$US$US
242454951$24245495$1$I$$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167926$AMGEN$$$$$$Y$$$20240823$$PH$US$US
242454971$24245497$1$I$20240718$20240814$20240824$20240824$EXP$FR-AFSSAPS-GR2024000999$FR-TEVA-VS-3233822$TEVA$$20$YR$$M$Y$70$KG$20240824$$PH$FR$FR
242454981$24245498$1$I$20230301$20240517$20240824$20240824$EXP$$CA-CELLTRION INC.-2021CA019641$CELLTRION$$$$$$Y$$$20240824$$CN$CA$CA
242454991$24245499$1$I$20240621$20240814$20240824$20240824$EXP$FR-AFSSAPS-LL2024001552$FR-TEVA-VS-3233838$TEVA$$18$YR$$F$Y$$$20240824$$PH$FR$FR
242455003$24245500$3$F$$20240828$20240824$20240830$EXP$$GB-SANDOZ INC.-SDZ2024GB074594$SANDOZ$$5$DEC$$F$Y$$$20240830$$MD$GB$GB
242455011$24245501$1$I$20240720$20240814$20240824$20240824$EXP$FR-AFSSAPS-NY2024000923$FR-TEVA-VS-3233855$TEVA$$86$YR$$F$Y$$$20240824$$MD$FR$FR
242455022$24245502$2$F$20240815$20240903$20240824$20240910$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025711$UNITED THERAPEUTICS$$62$YR$$F$Y$86.168$KG$20240910$$$US$US
242455031$24245503$1$I$20240101$20240820$20240824$20240824$EXP$$US-ABBVIE-5888394$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242455041$24245504$1$I$20240730$20240820$20240824$20240824$EXP$$US-ABBVIE-5889181$ABBVIE$$82$YR$$M$Y$$$20240824$$CN$US$US
242455062$24245506$2$F$20240801$20240820$20240824$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-025754$UNITED THERAPEUTICS$$80$YR$$F$Y$65.76$KG$20240828$$$US$US
242455071$24245507$1$I$$20240820$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-025917$UNITED THERAPEUTICS$$$$$M$Y$$$20240824$$$US$US
242455081$24245508$1$I$20240108$20240814$20240824$20240824$EXP$FR-AFSSAPS-TO2024001488$FR-TEVA-VS-3233869$TEVA$$64$YR$$M$Y$62$KG$20240824$$PH$FR$FR
242455091$24245509$1$I$$20240819$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133118$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240824$$CN$US$US
242455101$24245510$1$I$20240801$20240819$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133215$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240824$$CN$US$US
242455112$24245511$2$F$$20240924$20240824$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133378$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240924$$CN$US$US
242455122$24245512$2$F$20240101$20240827$20240824$20240829$EXP$$US-ABBVIE-5888585$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242455132$24245513$2$F$20240101$20240905$20240824$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-025912$UNITED THERAPEUTICS$$$$$F$Y$56.236$KG$20240906$$$US$US
242455142$24245514$2$F$20240529$20240904$20240824$20240913$EXP$FR-AFSSAPS-CF2024000334$FR-TEVA-VS-3233896$TEVA$$45$YR$$M$Y$85$KG$20240913$$PH$FR$FR
242455151$24245515$1$I$$20240814$20240824$20240824$EXP$$US-NOVITIUMPHARMA-2024USNVP01653$NOVITIUM PHARMA$Caroline E Mullis.Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient.Transplant Infectious Disease.11-APR-2024;26(3):e14271$64$YR$A$M$Y$$$20240824$$HP$US$US
242455161$24245516$1$I$20240711$20240814$20240824$20240824$EXP$FR-AFSSAPS-GR2024001006$FR-TEVA-VS-3233910$TEVA$$60$YR$$M$Y$87$KG$20240824$$PH$FR$FR
242455172$24245517$2$F$20240101$20240829$20240824$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-026017$UNITED THERAPEUTICS$$$$$F$Y$65.306$KG$20240904$$$US$US
242455181$24245518$1$I$20240101$20240819$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-025920$UNITED THERAPEUTICS$$$$$M$Y$75.737$KG$20240824$$$US$US
242455193$24245519$3$F$20240101$20240830$20240824$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-025943$UNITED THERAPEUTICS$$$$$F$Y$78.005$KG$20240905$$$US$US
242455201$24245520$1$I$$20240821$20240824$20240824$PER$$US-ROCHE-2511459$ROCHE$Schmitt N, Richmon J, Quon H, Steen V, Pietsch K and Page B. Challenges in management of a patient with oropharyngeal carcinoma and scleroderma. Otolaryngology Case Reports 2020;14:1-2.$70$YR$E$M$Y$$$20240824$$HP$US$US
242455211$24245521$1$I$20240216$20240814$20240824$20240824$EXP$FR-AFSSAPS-MP2024001266$FR-TEVA-VS-3233912$TEVA$$75$YR$$M$Y$$$20240824$$HP$FR$FR
242455221$24245522$1$I$$20240821$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133938$BRISTOL MYERS SQUIBB$$60$YR$A$$Y$$$20240824$$HP$US$US
242455232$24245523$2$F$20240704$20240917$20240824$20240921$PER$$US-ABBVIE-5890002$ABBVIE$$54$YR$$F$Y$$$20240921$$CN$US$US
242455241$24245524$1$I$20240101$20240820$20240824$20240824$EXP$$US-ABBVIE-5888410$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242455251$24245525$1$I$20240812$20240820$20240824$20240824$EXP$$CN-ROCHE-10000062293$ROCHE$$83$YR$E$F$Y$65$KG$20240824$$HP$CN$CN
242455261$24245526$1$I$20240101$20240820$20240824$20240824$EXP$$CA-ABBVIE-5890901$ABBVIE$$$$A$M$Y$$$20240824$$HP$CA$CA
242455271$24245527$1$I$20240801$20240815$20240824$20240824$EXP$$US-JNJFOC-20240846327$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240824$$HP$US$US
242455282$24245528$2$F$20240101$20240822$20240824$20240827$PER$$US-ABBVIE-5887360$ABBVIE$$31$YR$$$Y$113$KG$20240827$$CN$US$US
242455291$24245529$1$I$20240802$20240822$20240824$20240824$PER$$US-ABBVIE-5891565$ABBVIE$$54$YR$$F$Y$59$KG$20240824$$HP$US$US
242455301$24245530$1$I$$20240819$20240824$20240824$PER$$US-AMGEN-USASP2024166736$AMGEN$$$$$$Y$$$20240823$$CN$US$US
242455311$24245531$1$I$20240201$20240814$20240824$20240824$EXP$IT-MINISAL02-998380$IT-TEVA-VS-3233925$TEVA$$75$YR$$F$Y$55$KG$20240824$$MD$IT$IT
242455321$24245532$1$I$$20240820$20240824$20240824$EXP$$US-ABBVIE-5888592$ABBVIE$$$$$M$Y$$$20240824$$CN$US$US
242455332$24245533$2$F$20240101$20240917$20240824$20240921$EXP$$US-ABBVIE-5888756$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
242455344$24245534$4$F$20240101$20240923$20240824$20240927$EXP$$US-ABBVIE-5887394$ABBVIE$$$$$M$Y$108.86$KG$20240927$$CN$US$US
242455351$24245535$1$I$20240603$20240814$20240824$20240824$EXP$IT-MINISAL02-998286$IT-TEVA-VS-3233926$TEVA$$74$YR$$F$Y$$$20240824$$MD$IT$IT
242455362$24245536$2$F$20240701$20240917$20240824$20240920$EXP$$US-ABBVIE-5887746$ABBVIE$$44$YR$$F$Y$$$20240920$$CN$US$US
242455371$24245537$1$I$$20240819$20240824$20240824$PER$$US-ROCHE-10000061737$ROCHE$$41$YR$A$M$Y$$$20240824$$MD$US$US
242455381$24245538$1$I$20240813$20240820$20240824$20240824$EXP$$US-ABBVIE-5888389$ABBVIE$$51$YR$$F$Y$$$20240824$$CN$US$US
242455401$24245540$1$I$20240801$20240820$20240824$20240824$EXP$$US-ABBVIE-5888391$ABBVIE$$79$YR$$M$Y$$$20240824$$CN$US$US
242455411$24245541$1$I$$20240820$20240824$20240824$EXP$$US-ABBVIE-5889093$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242455421$24245542$1$I$20240101$20240819$20240824$20240824$PER$$US-AMGEN-USASP2024165592$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242455431$24245543$1$I$20240801$20240820$20240824$20240824$EXP$$US-ABBVIE-5889150$ABBVIE$$73$YR$$F$Y$$$20240824$$CN$US$US
242455441$24245544$1$I$$20240817$20240824$20240824$EXP$$JP-GENMAB-2024-03019$GENMAB$$71$YR$$F$Y$$$20240824$$MD$JP$JP
242455461$24245546$1$I$$20240815$20240824$20240824$PER$$US-ROCHE-10000060087$ROCHE$$$$$$Y$$$20240824$$CN$US$US
242455471$24245547$1$I$$20240808$20240824$20240824$PER$$US-AstraZeneca-2024A184989$ASTRAZENECA$$$$$F$Y$$$20240824$$CN$US$
242455481$24245548$1$I$20240814$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024168246$AMGEN$$18$YR$A$F$Y$$$20240823$$CN$US$US
242455491$24245549$1$I$20240701$20240822$20240824$20240824$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047520$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240824$$HP$CO$CO
242455501$24245550$1$I$20240701$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134323$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240824$$HP$US$US
242455511$24245551$1$I$$20240821$20240824$20240824$EXP$AU-MYLANLABS-2024M1061495$AU-SANDOZ INC.-SDZ2024AU074414$SANDOZ$$53$YR$$M$Y$$$20240824$$MD$AU$AU
242455521$24245552$1$I$20240101$20240815$20240824$20240824$EXP$$CA-CELLTRION INC.-2024CA006199$CELLTRION$$$$$$Y$$$20240824$$HP$CA$CA
242455531$24245553$1$I$20240812$20240815$20240824$20240824$EXP$$US-VIIV HEALTHCARE LIMITED-US2024101859$VIIV$$38$YR$$M$Y$$$20240824$$CN$US$US
242455542$24245554$2$F$$20240814$20240824$20240829$EXP$$US-GSK-US2024101249$GLAXOSMITHKLINE$$$$$M$Y$$$20240829$$CN$US$US
242455551$24245555$1$I$20230410$20240814$20240824$20240824$30DAY$$US-GSK-US2023054663$GLAXOSMITHKLINE$$30$YR$$F$Y$$$20240824$$CN$US$US
242455561$24245556$1$I$$20240819$20240824$20240824$PER$$US-AMGEN-USASP2024166927$AMGEN$$$$$M$Y$$$20240823$$CN$US$US
242455572$24245557$2$F$20240817$20240821$20240824$20240827$EXP$$IN-ROCHE-10000059390$ROCHE$$66$YR$E$F$Y$$$20240827$$CN$IN$IN
242455581$24245558$1$I$$20240814$20240824$20240824$EXP$$US-NOVITIUMPHARMA-2024USNVP01662$NOVITIUM PHARMA$Matthew T. Newman.A Fatal Case of Immune Checkpoint Inhibitor-Mediated Myasthenia Gravis, Myositis, and Cardiomyopathy Overlap Syndrome in Urothelial Carcinoma.Cancer Reports.23-JUL-2024;7(7):e2140$87$YR$E$M$Y$$$20240824$$HP$US$US
242455591$24245559$1$I$20240101$20240819$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133533$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240824$$MD$US$US
242455601$24245560$1$I$$20240820$20240824$20240824$EXP$$US-GSK-US2024103818$GLAXOSMITHKLINE$$$$$$Y$$$20240824$$MD$US$US
242455611$24245561$1$I$$20240815$20240824$20240824$PER$$US-AstraZeneca-2024A188042$ASTRAZENECA$$$$$$Y$$$20240824$$CN$US$
242455631$24245563$1$I$$20240814$20240824$20240824$PER$$US-ABBVIE-5886943$ABBVIE$$$$A$M$Y$$$20240824$$MD$US$US
242455641$24245564$1$I$$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167410$AMGEN$$$$$F$Y$$$20240823$$CN$US$US
242455651$24245565$1$I$$20240819$20240824$20240824$PER$$US-AMGEN-USASP2024166810$AMGEN$$$$$$Y$$$20240823$$MD$US$US
242455662$24245566$2$F$20240101$20240830$20240824$20240902$PER$$US-AMGEN-USASP2024166254$AMGEN$$79$YR$E$M$Y$$$20240902$$CN$US$US
242455671$24245567$1$I$20240101$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024166811$AMGEN$$75$YR$E$F$Y$$$20240823$$CN$US$US
242455681$24245568$1$I$$20240814$20240824$20240824$PER$$US-ABBVIE-5883395$ABBVIE$$$$$$Y$$$20240824$$CN$US$US
242455702$24245570$2$F$$20240820$20240824$20240828$PER$$US-AMGEN-USASP2024166852$AMGEN$$81$YR$E$F$Y$$$20240827$$PH$US$US
242455713$24245571$3$F$20240901$20240911$20240824$20240918$PER$$US-ROCHE-10000060323$ROCHE$$59$YR$A$F$Y$$$20240918$$CN$US$US
242455721$24245572$1$I$20240308$20240822$20240824$20240824$EXP$$US-ABBVIE-5891367$ABBVIE$$79$YR$$M$Y$$$20240824$$CN$US$US
242455731$24245573$1$I$$20240822$20240824$20240824$EXP$$US-ABBVIE-5892113$ABBVIE$$$$$M$Y$$$20240824$$CN$US$US
242455741$24245574$1$I$$20240807$20240824$20240824$EXP$$DE-ABBVIE-5874731$ABBVIE$$$$E$M$Y$$$20240824$$CN$DE$DE
242455761$24245576$1$I$$20240821$20240824$20240824$EXP$$US-ABBVIE-5890114$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242455771$24245577$1$I$20240801$20240821$20240824$20240824$EXP$$US-ABBVIE-5890076$ABBVIE$$63$YR$$M$Y$$$20240824$$CN$US$US
242455781$24245578$1$I$$20240820$20240824$20240824$EXP$$CA-ABBVIE-5889850$ABBVIE$$24$YR$$M$Y$$$20240824$$CN$CA$CA
242455792$24245579$2$F$20240101$20240827$20240824$20240830$EXP$$US-ABBVIE-5889168$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242455803$24245580$3$F$$20240905$20240824$20240912$EXP$$US-ABBVIE-5889553$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
242455811$24245581$1$I$20240730$20240822$20240824$20240824$EXP$$CA-ABBVIE-5892489$ABBVIE$$63$YR$$M$Y$$$20240824$$CN$CA$CA
242455821$24245582$1$I$20240814$20240814$20240824$20240824$30DAY$$US-GSK-US2024101424$GLAXOSMITHKLINE$$32$YR$$F$Y$$$20240824$$CN$US$US
242455833$24245583$3$F$20240819$20240910$20240824$20240912$PER$$US-ABBVIE-5889507$ABBVIE$$75$YR$$M$Y$$$20240912$$CN$US$US
242455841$24245584$1$I$$20240819$20240824$20240824$PER$$US-AMGEN-USASP2024165729$AMGEN$$$$$$Y$$$20240824$$CN$US$US
242455851$24245585$1$I$$20240814$20240824$20240824$EXP$$GR-NOVITIUMPHARMA-2024GRNVP01666$NOVITIUM PHARMA$Loizos Petrikkos.Successful Treatment of Disseminated Fusariosis in a 15-Month-Old Boy With Refractory Acute Lymphoblastic Leukemia Using High-Dose Voriconazole.The Pediatric Infectious Disease Journal.28-MAY-2024;NA:1-5$15$MON$I$M$Y$$$20240824$$HP$GR$GR
242455861$24245586$1$I$20230701$20240815$20240824$20240824$EXP$$BR-CELLTRION INC.-2023BR024425$CELLTRION$$$$$$Y$$$20240824$$CN$BR$BR
242455871$24245587$1$I$20240101$20240820$20240824$20240824$EXP$$BG-ABBVIE-5887625$ABBVIE$$68$YR$$M$Y$$$20240824$$CN$BG$BG
242455881$24245588$1$I$$20240819$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132091$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240824$$HP$US$US
242455891$24245589$1$I$$20240816$20240824$20240824$EXP$$US-GSK-US2024102684$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$MD$US$US
242455902$24245590$2$F$$20240919$20240824$20240927$PER$$US-GSK-US2024101420$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
242455911$24245591$1$I$20240723$20240822$20240824$20240824$EXP$$US-ABBVIE-5890930$ABBVIE$$68$YR$$F$Y$$$20240824$$CN$US$US
242455922$24245592$2$F$$20240826$20240824$20240827$EXP$$US-ABBVIE-5892353$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242455931$24245593$1$I$$20240814$20240824$20240824$30DAY$$US-GSK-US2024101425$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242455951$24245595$1$I$$20240820$20240824$20240824$EXP$AU-MYLANLABS-2024M1068096$AU-SANDOZ INC.-SDZ2024AU074173$SANDOZ$$28$YR$$M$Y$$$20240824$$HP$AU$AU
242455962$24245596$2$F$$20240821$20240824$20240827$EXP$$US-SANDOZ INC.-SDZ2024US074316$SANDOZ$Holcomb BM, Shah S, Shah R. From Pregnancy Pains to Paralysis: An Erroneous Intrathecal Digoxin Administration Case Report and Review of Medical Errors. Cureus. 2024;16(7)$34$YR$$F$Y$$$20240827$$HP$US$US
242455971$24245597$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134000$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240824$$CN$US$US
242455981$24245598$1$I$20240501$20240821$20240824$20240824$EXP$$US-ABBVIE-5890047$ABBVIE$$69$YR$$F$Y$$$20240824$$CN$US$US
242455991$24245599$1$I$20240401$20240821$20240824$20240824$EXP$$US-ABBVIE-5890573$ABBVIE$$44$YR$$F$Y$$$20240824$$CN$US$US
242456001$24245600$1$I$$20240814$20240824$20240824$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR103144$VIIV$$$$$M$Y$$$20240824$$PH$US$US
242456011$24245601$1$I$20240101$20240821$20240824$20240824$EXP$$US-ABBVIE-5889605$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242456021$24245602$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134145$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$49.44$KG$20240824$$CN$US$US
242456031$24245603$1$I$20240101$20240821$20240824$20240824$EXP$$US-ABBVIE-5890087$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242456051$24245605$1$I$$20240814$20240824$20240824$PER$$US-ABBVIE-5883366$ABBVIE$$$$A$M$Y$$$20240824$$MD$US$US
242456072$24245607$2$F$20240820$20240904$20240824$20240906$PER$$US-AMGEN-USASP2024167128$AMGEN$$68$YR$E$M$Y$$$20240906$$CN$US$US
242456081$24245608$1$I$$20240816$20240824$20240824$30DAY$$US-GSK-US2024102707$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242456092$24245609$2$F$20230801$20240906$20240824$20240913$EXP$$CA-GSK-CA2023089583$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$CA$CA
242456101$24245610$1$I$20240701$20240821$20240824$20240824$EXP$$CA-ABBVIE-5890855$ABBVIE$$78$YR$$M$Y$$$20240824$$CN$CA$CA
242456111$24245611$1$I$$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167324$AMGEN$$$$$F$Y$$$20240824$$CN$US$US
242456122$24245612$2$F$20240818$20240829$20240824$20240902$PER$$US-AMGEN-USASP2024168104$AMGEN$$80$YR$E$F$Y$$$20240901$$CN$US$US
242456132$24245613$2$F$$20240917$20240824$20240923$EXP$$US-ABBVIE-5890423$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
242456141$24245614$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134027$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240824$$CN$US$US
242456151$24245615$1$I$$20240814$20240824$20240824$PER$$US-AstraZeneca-2024A186751$ASTRAZENECA$$$$$F$Y$$$20240824$$HP$US$
242456161$24245616$1$I$$20240812$20240824$20240824$PER$$US-AstraZeneca-2024A183379$ASTRAZENECA$$$$$$Y$$$20240824$$CN$US$
242456171$24245617$1$I$$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024166745$AMGEN$$$$$F$Y$$$20240824$$CN$US$US
242456181$24245618$1$I$$20240815$20240824$20240824$PER$$US-ABBVIE-5885346$ABBVIE$$$$$$Y$$$20240824$$CN$US$US
242456191$24245619$1$I$$20240815$20240824$20240824$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR102992$VIIV$$$$$M$Y$$$20240824$$HP$US$US
242456201$24245620$1$I$$20240814$20240824$20240824$30DAY$$US-GSK-US2024101429$GLAXOSMITHKLINE$$73$YR$$M$Y$$$20240824$$CN$US$US
242456211$24245621$1$I$$20240816$20240824$20240824$30DAY$$US-GSK-US2024102712$GLAXOSMITHKLINE$$$$$$Y$$$20240824$$CN$US$US
242456221$24245622$1$I$$20240801$20240824$20240824$EXP$$US-ABBVIE-5890470$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242456231$24245623$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133943$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$68.95$KG$20240824$$CN$US$US
242456241$24245624$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133997$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240824$$CN$US$US
242456251$24245625$1$I$20240701$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134126$BRISTOL MYERS SQUIBB$$15$YR$T$F$Y$$$20240824$$HP$US$US
242456263$24245626$3$F$20240101$20240827$20240824$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025250$UNITED THERAPEUTICS$$$$$M$Y$122$KG$20240905$$$US$US
242456271$24245627$1$I$$20240820$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133221$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240824$$HP$US$US
242456282$24245628$2$F$$20240916$20240824$20240925$EXP$$AU-ABBVIE-5891407$ABBVIE$$73$YR$$M$Y$$$20240925$$HP$AU$AU
242456291$24245629$1$I$$20240819$20240824$20240824$30DAY$$US-GSK-US2024103246$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242456301$24245630$1$I$$20240813$20240824$20240824$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR101263$VIIV$$$$$M$Y$$$20240824$$HP$US$US
242456311$24245631$1$I$$20240814$20240824$20240824$30DAY$$US-GSK-US2024AMR101871$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242456321$24245632$1$I$$20240814$20240824$20240824$30DAY$$US-GSK-US2024101435$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242456331$24245633$1$I$20240703$20240816$20240824$20240824$EXP$$BR-JNJFOC-20240457426$JOHNSON AND JOHNSON$$33$YR$A$M$Y$75$KG$20240824$$CN$BR$BR
242456341$24245634$1$I$$20240820$20240824$20240824$EXP$$PT-CHATTEMPRD-2024OHG029099$CHATTEM$$$$E$$Y$$$20240824$$HP$PT$PT
242456351$24245635$1$I$$20240818$20240824$20240824$EXP$$BR-CHATTEMPRD-2024OHG028432$CHATTEM$$$$$F$Y$$$20240824$$CN$BR$BR
242456361$24245636$1$I$20240701$20240820$20240824$20240824$EXP$$NVSC2024BR170639$NOVARTIS$$56$YR$$F$Y$$$20240824$$CN$BR$BR
242456382$24245638$2$F$$20240925$20240824$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134065$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240926$$CN$US$US
242456391$24245639$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133764$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240824$$CN$US$US
242456401$24245640$1$I$20240817$20240821$20240824$20240824$EXP$$US-ABBVIE-5889619$ABBVIE$$69$YR$$F$Y$$$20240824$$HP$US$US
242456411$24245641$1$I$$20240815$20240824$20240824$PER$$US-AstraZeneca-2024A188023$ASTRAZENECA$$$$$F$Y$$$20240824$$PH$US$
242456421$24245642$1$I$$20240814$20240824$20240824$PER$$US-JNJFOC-20240849759$JOHNSON AND JOHNSON$$$$$F$Y$$$20240824$$CN$US$US
242456431$24245643$1$I$20240101$20240815$20240824$20240824$EXP$$US-JNJFOC-20240844869$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240824$$HP$US$US
242456441$24245644$1$I$$20240819$20240824$20240824$EXP$$US-ABBVIE-5885775$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242456451$24245645$1$I$$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024168447$AMGEN$$$$A$$Y$$$20240824$$CN$US$US
242456461$24245646$1$I$$20240821$20240824$20240824$PER$$US-ABBVIE-5890874$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242456471$24245647$1$I$20240729$20240821$20240824$20240824$EXP$$CA-ABBVIE-5890816$ABBVIE$$38$YR$$F$Y$$$20240824$$PH$CA$CA
242456482$24245648$2$F$$20240830$20240824$20240906$PER$$US-ABBVIE-5883631$ABBVIE$$$$$M$Y$$$20240906$$HP$US$US
242456491$24245649$1$I$$20240816$20240824$20240824$EXP$$US-JNJFOC-20240846711$JOHNSON AND JOHNSON$$$$$F$Y$$$20240824$$CN$US$US
242456511$24245651$1$I$$20240820$20240824$20240824$EXP$$BR-GENMAB-2024-03060$GENMAB$$$$$M$Y$$$20240824$$MD$BR$BR
242456522$24245652$2$F$$20240822$20240824$20240829$EXP$PL-EMA-DD-20240809-7482661-074952$PL-CHATTEMPRD-2024OHG028682$CHATTEM$Czarny J., Andrzejewska M., Zajac-Spychala O., Latos-Grazynska E., Pastorczak A., Wypyszczak K. et, al.. Successful Treatment of Large B-Cell Lymphoma in a Child with Compound Heterozygous Mutation in the ATM Gene.. International Journal of Molecular Sciences.. 2023;24(2):1-13. doi:10.3390/ijms24021099$7$YR$C$F$Y$$$20240829$$HP$PL$PL
242456531$24245653$1$I$$20240820$20240824$20240824$EXP$$US-ABBVIE-5888854$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242456541$24245654$1$I$$20240819$20240824$20240824$PER$$US-AMGEN-USASP2024167788$AMGEN$$$$$$Y$$$20240824$$MD$US$US
242456552$24245655$2$F$20240416$20240821$20240824$20240828$PER$$US-AMGEN-USASP2024167260$AMGEN$$67$YR$E$F$Y$$$20240828$$CN$US$US
242456561$24245656$1$I$$20240816$20240824$20240824$PER$$US-JNJFOC-20240844155$JOHNSON AND JOHNSON$$$$$$Y$$$20240824$$HP$US$US
242456573$24245657$3$F$20240101$20240903$20240824$20240911$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025838$UNITED THERAPEUTICS$$$$$M$Y$99.32$KG$20240911$$$US$US
242456591$24245659$1$I$$20240820$20240824$20240824$PER$$US-ABBVIE-5889284$ABBVIE$$$$$M$Y$$$20240824$$MD$US$US
242456601$24245660$1$I$$20240814$20240824$20240824$PER$$US-JNJFOC-20240844715$JOHNSON AND JOHNSON$$$$$M$Y$$$20240824$$CN$US$US
242456611$24245661$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134169$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240824$$CN$US$US
242456621$24245662$1$I$20230817$20240821$20240824$20240824$EXP$FR-AFSSAPS-PB2024000896$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-133080$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240824$$PH$FR$FR
242456631$24245663$1$I$$20240820$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133886$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240824$$CN$US$US
242456641$24245664$1$I$$20240820$20240824$20240824$EXP$$CA-GENMAB-2024-03062$GENMAB$$73$YR$$M$Y$$$20240824$$CN$CA$CA
242456651$24245665$1$I$20240101$20240818$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-025196$UNITED THERAPEUTICS$$$$$F$Y$78.005$KG$20240824$$$US$US
242456661$24245666$1$I$$20240821$20240824$20240824$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013234$JAZZ$$$$$F$Y$$$20240824$$CN$US$US
242456671$24245667$1$I$20240101$20240818$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-026028$UNITED THERAPEUTICS$$$$$F$Y$71.655$KG$20240824$$$US$US
242456681$24245668$1$I$20240501$20240604$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-017216$UNITED THERAPEUTICS$$35$YR$$M$Y$113.38$KG$20240824$$$US$US
242456692$24245669$2$F$20240101$20240822$20240824$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-025864$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240831$$$US$US
242456701$24245670$1$I$20240101$20240815$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-010544$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240824$$$US$US
242456711$24245671$1$I$20240523$20240423$20240824$20240824$PER$$US-AMGEN-USASP2024168911$AMGEN$$81$YR$E$M$Y$$$20240824$$CN$US$US
242456722$24245672$2$F$20240809$20240913$20240824$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013232$JAZZ$$47$YR$$F$Y$$$20240917$$CN$US$US
242456731$24245673$1$I$$20240821$20240824$20240824$EXP$$US-ABBVIE-5890189$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242456741$24245674$1$I$$20240821$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133885$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240824$$HP$US$US
242456751$24245675$1$I$20240101$20240820$20240824$20240824$EXP$$US-ABBVIE-5888765$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242456761$24245676$1$I$20240816$20240820$20240824$20240824$EXP$$US-ABBVIE-5889351$ABBVIE$$49$YR$$M$Y$$$20240824$$CN$US$US
242456771$24245677$1$I$$20240820$20240824$20240824$EXP$$US-CHATTEMPRD-2024OHG028582$CHATTEM$$$$$M$Y$$$20240824$$LW$US$US
242456781$24245678$1$I$$20240814$20240824$20240824$30DAY$$US-GSK-US2024101442$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242456791$24245679$1$I$$20240816$20240824$20240824$EXP$$US-CHATTEMPRD-2024OHG028122$CHATTEM$$$$E$F$Y$$$20240824$$LW$US$US
242456801$24245680$1$I$20240401$20240819$20240824$20240824$30DAY$$US-GSK-US2024103362$GLAXOSMITHKLINE$$65$YR$$M$Y$$$20240824$$CN$US$US
242456811$24245681$1$I$$20240822$20240824$20240824$EXP$$GB-ABBVIE-5891306$ABBVIE$$$$E$F$Y$$$20240824$$HP$GB$GB
242456821$24245682$1$I$20240622$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133752$BRISTOL MYERS SQUIBB$$71$YR$E$$Y$$$20240824$$PH$US$US
242456841$24245684$1$I$20240101$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167285$AMGEN$$67$YR$E$F$Y$$$20240824$$CN$US$US
242456851$24245685$1$I$$20240814$20240824$20240824$EXP$$US-GSK-US2024101377$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$MD$US$US
242456861$24245686$1$I$$20240816$20240824$20240824$PER$$US-AstraZeneca-2024A189645$ASTRAZENECA$$$$$$Y$$$20240824$$CN$US$
242456871$24245687$1$I$$20240821$20240824$20240824$PER$$US-AstraZeneca-2024A191600$ASTRAZENECA$$$$$M$Y$$$20240824$$CN$US$
242456882$24245688$2$F$20240804$20240827$20240824$20240909$PER$$US-AstraZeneca-2024A183986$ASTRAZENECA$$26142$DY$$M$Y$$$20240909$$CN$US$
242456891$24245689$1$I$$20240821$20240824$20240824$PER$$US-AstraZeneca-2024A191573$ASTRAZENECA$$$$$F$Y$$$20240824$$CN$US$
242456901$24245690$1$I$$20240820$20240824$20240824$PER$$US-AstraZeneca-2024A190353$ASTRAZENECA$$50$YR$$F$Y$$$20240824$$HP$US$
242456911$24245691$1$I$20240802$20240820$20240824$20240824$EXP$$US-ABBVIE-5889882$ABBVIE$$65$YR$$M$Y$$$20240824$$CN$US$US
242456921$24245692$1$I$20240101$20240821$20240824$20240824$EXP$$US-ABBVIE-5889959$ABBVIE$$$$$M$Y$$$20240824$$CN$US$US
242456931$24245693$1$I$$20240814$20240824$20240824$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101966$VIIV$$$$$$Y$$$20240824$$MD$US$US
242456941$24245694$1$I$$20240815$20240824$20240824$EXP$$GB-CELLTRION INC.-2024GB019965$CELLTRION$$$$$$Y$$$20240824$$CN$GB$GB
242456951$24245695$1$I$20240818$20240819$20240824$20240824$PER$$US-AMGEN-USASP2024165769$AMGEN$$64$YR$A$M$Y$$$20240824$$CN$US$US
242456963$24245696$3$F$$20240904$20240824$20240905$PER$$US-AMGEN-USASP2024166765$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242456971$24245697$1$I$$20240819$20240824$20240824$PER$$US-CHATTEMPRD-2024OHG028591$CHATTEM$$$$$$Y$$$20240824$$CN$US$US
242456981$24245698$1$I$20240701$20240819$20240824$20240824$EXP$$JP-ROCHE-10000063132$ROCHE$$$$E$M$Y$$$20240824$$MD$JP$JP
242456991$24245699$1$I$$20240812$20240824$20240824$EXP$$ES-CIPLA (EU) LIMITED-2024ES09139$CIPLA$Ramos IM, Sanchez AB, Garcia IC, Franco DA, Vera IJ, Tato LP, et al.. Experience of the national cohort of pregnant women with HIV and their children in SPAIN: temporal trends in vertical transmission of HIV and associated infections.. Annals of Pediatrics.. 1 to 23$$$$$Y$$$20240824$$HP$ES$ES
242457001$24245700$1$I$$20240812$20240824$20240824$EXP$$ES-CIPLA (EU) LIMITED-2024ES09140$CIPLA$Illan Ramos M, Berzosa Sanchez A, Carrasco Garcia I, Diaz Franco A, Jarrin Vera I, Prieto Tato L, et al.. Experience of the national cohort of pregnant women with HIV and their Spain children in SPAIN: temporal trends in vertical transmission of HIV and associated infections. Annals of Pediatrics. 2024;1 to 23$$$$$Y$$$20240824$$HP$ES$ES
242457011$24245701$1$I$$20240812$20240824$20240824$EXP$$ES-CIPLA LTD.-2024ES09141$CIPLA$Illan Ramos M, Berzosa Sanchez A, Carrasco Garcia I, Diaz Franco A, Jarrin Vera I, Prieto Tato L, et al.. Experience of the national cohort of pregnant women with HIV and their Spain children in SPAIN: Temporal trends in vertical transmission of HIV and associated infections. Annals of Pediatrics. 2024;1 to 23$$$$$Y$$$20240824$$HP$ES$ES
242457021$24245702$1$I$20240808$20240821$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133838$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240824$$PH$US$US
242457031$24245703$1$I$$20240812$20240824$20240824$EXP$$ES-CIPLA LTD.-2024ES09143$CIPLA$Ramos MI, Sanchez AB, Garcia IC, Franco AD, Vera IJ, Tato LP, et al.. Experience of the national cohort of pregnant women with HIV and their children in Spain: Temporal trends in vertical transmission of HIV and associated infections. Annals of Pediatrics. 2024;1 to 23$$$$$Y$$$20240824$$HP$ES$ES
242457041$24245704$1$I$$20240812$20240824$20240824$EXP$$ES-CIPLA (EU) LIMITED-2024ES09138$CIPLA$Ramos MI, S?nchez AB, Garc?a IC, Franco AD, Vera IJ, Tato LP, et.al. Experience of the national cohort of pregnant women with HIV and their children in Spain: Temporal trends in vertical transmission of HIV and associated infections. Annals of Pediatrics. 2024;1 to 23$$$$$Y$$$20240824$$HP$ES$ES
242457053$24245705$3$F$$20240825$20240824$20240904$PER$$US-AMGEN-USASP2024165023$AMGEN$$$$$$Y$$$20240904$$PH$US$US
242457062$24245706$2$F$20240815$20240903$20240824$20240905$PER$$US-AMGEN-USASP2024165001$AMGEN$$59$YR$A$F$Y$$$20240904$$CN$US$US
242457071$24245707$1$I$$20240812$20240824$20240824$EXP$$ES-CIPLA (EU) LIMITED-2024ES09145$CIPLA$Ramos MI, Sanchez AB, Garcia IC, Franco AD, Vera IJ, Tato LP et al. Experience of the national cohort of pregnant women with HIV and their children in SPAIN: temporal trends in vertical transmission of HIV and associated infections. Annals of Pediatrics. 2024;1 to 23$$$$$Y$$$20240824$$HP$ES$ES
242457081$24245708$1$I$$20240812$20240824$20240824$EXP$$ES-CIPLA (EU) LIMITED-2024ES09144$CIPLA$Ramos IM, Sanchez AB, Garcia IC, Franco DA, Vera IJ, Tato LP, et al.. Experience of the national cohort of pregnant women with HIV and their children in SPAIN: temporal trends in vertical transmission of HIV and associated infections. Annals of Pediatrics.. 2024;1 to 23$$$$$Y$$$20240824$$HP$ES$ES
242457091$24245709$1$I$$20240812$20240824$20240824$EXP$$ES-CIPLA (EU) LIMITED-2024ES09136$CIPLA$Illan Ramos M, Berzosa Sanchez A, Carrasco Garcia I, Diaz Franco A, Jarrn Vera I, Prieto Tato L, et al.. Experience of the national cohort of pregnant women with HIV and their Spain children in SPAIN: Temporal trends in vertical transmission of HIV and associated infections. Annals of Pediatrics. 2024;1 to 23$$$$$Y$$$20240824$$HP$ES$ES
242457101$24245710$1$I$$20240814$20240824$20240824$PER$$US-ABBVIE-5883925$ABBVIE$$$$$F$Y$$$20240824$$HP$US$US
242457112$24245711$2$F$$20240911$20240824$20240920$30DAY$$US-GSK-US2024AMR101488$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
242457121$24245712$1$I$$20240812$20240824$20240824$EXP$$ES-CIPLA (EU) LIMITED-2024ES09113$CIPLA$Illan Ramos M, Berzosa Sanchez A, Carrasco Garcia I, Diaz Franco A, JarrIn Vera I, Prieto Tato L, et al.. Experience of the national cohort of pregnant women with HIV and their Spain children in Spain: Temporal trends in vertical transmission of HIV and associated infections. Annals of Pediatrics. 2024;1 to 23$$$$$Y$$$20240824$$HP$ES$ES
242457132$24245713$2$F$$20240920$20240824$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134135$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$83.46$KG$20240923$$CN$US$US
242457141$24245714$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134096$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240824$$CN$US$US
242457151$24245715$1$I$$20240812$20240824$20240824$EXP$$ES-CIPLA LTD.-2024ES09142$CIPLA$Ramos MI, Sanchez AB, Garcia IC, Franco AD, Vera IJ, Tato LP et al. Experience of the national cohort of pregnant women with HIV and their Spain children in SPAIN: Temporal trends in vertical transmission of HIV and associated infections. Annals of Pediatrics. 2024;1 to 23$$$$$Y$$$20240824$$HP$ES$ES
242457161$24245716$1$I$$20240812$20240824$20240824$EXP$$ES-CIPLA LTD.-2024ES09137$CIPLA$Ramos MI, Sanchez AB, Garcia IC, Franco AD, Vera IJ, Tato LP et al. Experience of the national cohort of pregnant women with HIV and their children in SPAIN: temporal trends in vertical transmission of HIV and associated infections. Annals of Pediatrics. 2024;1 to 23$$$$$Y$$$20240824$$HP$ES$ES
242457171$24245717$1$I$20240819$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024167011$AMGEN$$84$YR$E$M$Y$$$20240824$$CN$US$US
242457182$24245718$2$F$20231201$20240829$20240824$20240905$EXP$$GB-ABBVIE-5887486$ABBVIE$$67$YR$$M$Y$$$20240905$$CN$GB$GB
242457191$24245719$1$I$$20240819$20240824$20240824$PER$$US-AstraZeneca-2024A189053$ASTRAZENECA$$$$$M$Y$$$20240824$$CN$US$
242457201$24245720$1$I$$20240822$20240824$20240824$PER$$US-AstraZeneca-2024A192452$ASTRAZENECA$$$$$F$Y$$$20240824$$CN$US$
242457211$24245721$1$I$$20240816$20240824$20240824$PER$$US-AstraZeneca-2024A188110$ASTRAZENECA$$$$$M$Y$$$20240824$$CN$US$
242457222$24245722$2$F$20240801$20240910$20240824$20240920$30DAY$$US-GSK-US2024AMR101584$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240920$$CN$US$US
242457231$24245723$1$I$$20240814$20240824$20240824$EXP$$US-GSK-US2024AMR103093$GLAXOSMITHKLINE$$$$$F$Y$65.31$KG$20240824$$CN$US$US
242457241$24245724$1$I$20240821$20240821$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134021$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240824$$MD$US$US
242457252$24245725$2$F$20240819$20240821$20240824$20240827$PER$$US-AMGEN-USASP2024167924$AMGEN$$83$YR$E$M$Y$$$20240827$$CN$US$US
242457261$24245726$1$I$20240818$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024166704$AMGEN$$67$YR$E$F$Y$$$20240824$$CN$US$US
242457271$24245727$1$I$20240701$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167492$AMGEN$$68$YR$E$M$Y$$$20240824$$CN$US$US
242457282$24245728$2$F$$20240827$20240824$20240829$PER$$US-AMGEN-USASP2024167457$AMGEN$$$$$$Y$$$20240829$$CN$US$US
242457291$24245729$1$I$20240820$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024166281$AMGEN$$73$YR$E$F$Y$$$20240824$$CN$US$US
242457301$24245730$1$I$20240701$20240819$20240824$20240824$30DAY$$US-GSK-US2024103401$GLAXOSMITHKLINE$$75$YR$$M$Y$$$20240824$$CN$US$US
242457311$24245731$1$I$$20240814$20240824$20240824$EXP$$US-GSK-US2024101428$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240824$$PH$US$US
242457321$24245732$1$I$$20240814$20240824$20240824$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-111446$ZYDUS PHARM$Bajpai J, Munot P, Kota K, Gupta G, Gala K, Gulia A. Evaluation of metronomic therapy as a low-cost, sustainable, standard-of-care option in desmoid fibromatosis: Real-world data from a tertiary care center in India.. JCO-Glob-Oncol. 2024$$$$$Y$$$20240824$$MD$IN$IN
242457331$24245733$1$I$20240702$20240812$20240824$20240824$EXP$ES-AEMPS-1559045$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111206$ZYDUS PHARM$$$$$$Y$$$20240824$$MD$ES$ES
242457341$24245734$1$I$$20240820$20240824$20240824$EXP$$CA-GENMAB-2024-03074$GENMAB$$69$YR$$F$Y$$$20240824$$PH$CA$CA
242457351$24245735$1$I$$20240820$20240824$20240824$EXP$$CA-GENMAB-2024-03063$GENMAB$$56$YR$$M$Y$$$20240824$$CN$CA$CA
242457361$24245736$1$I$$20240813$20240824$20240824$PER$$US-AstraZeneca-2024A184446$ASTRAZENECA$$$$$M$Y$$$20240824$$CN$US$
242457372$24245737$2$F$20240506$20240911$20240824$20240924$EXP$GB-MHRA-MED-202408072019074410-NTCRP$GB-USV-002833$USV PRIVATE$$68$YR$E$F$Y$51$KG$20240924$$MD$GB$GB
242457381$24245738$1$I$$20240811$20240824$20240824$EXP$$OM-MankindUS-000238$MANKIND PHARMA$Ellouze NF, Hazra D, Al Abri S. Baclofen-induced neurotoxicity in a dialysis patient managed with continuous venovenous hemodialysis: A case report and literature review. Turk J Emerg Med. 2024 Jul 1;24(3):176-179.$73$YR$E$F$Y$$$20240824$$HP$OM$OM
242457392$24245739$2$F$$20240813$20240824$20240827$EXP$$FR-JNJFOC-20240859814$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$FR$FR
242457401$24245740$1$I$$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024167987$AMGEN$$$$$$Y$$$20240824$$HP$US$US
242457411$24245741$1$I$20240820$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134219$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$76.2$KG$20240824$$HP$US$US
242457421$24245742$1$I$20240601$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167219$AMGEN$$88$YR$E$F$Y$$$20240824$$CN$US$US
242457431$24245743$1$I$$20240813$20240824$20240824$PER$$US-JNJFOC-20240836207$JOHNSON AND JOHNSON$$$$$M$Y$$$20240824$$CN$US$US
242457451$24245745$1$I$20240726$20240821$20240824$20240824$EXP$$CA-ABBVIE-5890829$ABBVIE$$$$A$F$Y$$$20240824$$PH$CA$CA
242457461$24245746$1$I$20240401$20240814$20240824$20240824$PER$$US-ABBVIE-5881912$ABBVIE$$22$YR$$M$Y$82.553$KG$20240824$$CN$US$US
242457471$24245747$1$I$$20240819$20240824$20240824$EXP$$US-ABBVIE-5889287$ABBVIE$$$$$M$Y$$$20240824$$CN$US$US
242457481$24245748$1$I$$20240819$20240824$20240824$PER$$US-ABBVIE-5887150$ABBVIE$$$$$$Y$$$20240824$$CN$US$US
242457491$24245749$1$I$20220901$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024168347$AMGEN$$57$YR$A$F$Y$$$20240824$$CN$US$US
242457501$24245750$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134320$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240824$$HP$US$US
242457511$24245751$1$I$$20240815$20240824$20240824$EXP$$CA-CELLTRION INC.-2024CA020045$CELLTRION$$$$$$Y$$$20240824$$PH$CA$CA
242457521$24245752$1$I$$20240820$20240824$20240824$EXP$$US-ABBVIE-5889626$ABBVIE$$$$$$Y$$$20240824$$CN$US$US
242457531$24245753$1$I$20240820$20240821$20240824$20240824$EXP$$US-ABBVIE-5890135$ABBVIE$$58$YR$$M$Y$$$20240824$$CN$US$US
242457541$24245754$1$I$$20240807$20240824$20240824$PER$$US-AstraZeneca-2024A179924$ASTRAZENECA$$$$$M$Y$$$20240824$$CN$US$
242457551$24245755$1$I$20240601$20240816$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-017468$UNITED THERAPEUTICS$$77$YR$$M$Y$79.819$KG$20240824$$$US$US
242457562$24245756$2$F$$20240916$20240824$20240925$EXP$$CA-CELLTRION INC.-2024CA019953$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
242457571$24245757$1$I$20240316$20240819$20240824$20240824$EXP$$NVSC2024US059399$NOVARTIS$$40$YR$$F$Y$$$20240824$$CN$US$US
242457581$24245758$1$I$$20240815$20240824$20240824$EXP$$GB-CELLTRION INC.-2023GB009975$CELLTRION$$$$$$Y$$$20240824$$HP$GB$GB
242457591$24245759$1$I$20240330$20240821$20240824$20240824$EXP$$US-ABBVIE-5889711$ABBVIE$$34$YR$$M$Y$$$20240824$$CN$US$US
242457603$24245760$3$F$20240801$20240918$20240824$20240923$EXP$$US-ABBVIE-5890522$ABBVIE$$66$YR$$F$Y$83.914$KG$20240923$$CN$US$US
242457611$24245761$1$I$20240101$20240821$20240824$20240824$EXP$$US-ABBVIE-5890574$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242457621$24245762$1$I$20240603$20240812$20240824$20240824$EXP$$IN-CIPLA LTD.-2024IN08982$CIPLA$$$$$$Y$$$20240824$$CN$IN$IN
242457631$24245763$1$I$20230101$20240815$20240824$20240824$PER$$US-ABBVIE-5883606$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242457641$24245764$1$I$20210412$20211028$20240824$20240824$EXP$$CA-CELLTRION INC.-2021CA019627$CELLTRION$$$$$$Y$$$20240824$$CN$CA$CA
242457651$24245765$1$I$$20240815$20240824$20240824$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101767$VIIV$$$$$F$Y$$$20240824$$CN$US$US
242457671$24245767$1$I$$20240814$20240824$20240824$EXP$$US-GSK-US2024AMR101791$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242457681$24245768$1$I$$20240814$20240824$20240824$30DAY$$US-GSK-US2024101409$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242457691$24245769$1$I$20240101$20240821$20240824$20240824$EXP$$US-ABBVIE-5750567$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242457701$24245770$1$I$$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024168450$AMGEN$$$$$M$Y$$$20240824$$CN$US$US
242457711$24245771$1$I$$20240814$20240824$20240824$PER$$US-ABBVIE-5883375$ABBVIE$$$$A$M$Y$$$20240824$$MD$US$US
242457721$24245772$1$I$20240801$20240816$20240824$20240824$PER$$US-JNJFOC-20240846683$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240824$$CN$US$US
242457742$24245774$2$F$$20240829$20240824$20240902$EXP$$US-ABBVIE-5889917$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242457751$24245775$1$I$$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A190306$ASTRAZENECA$$$$$M$Y$$$20240824$$CN$US$
242457761$24245776$1$I$$20240819$20240824$20240824$PER$$US-ROCHE-10000061079$ROCHE$$45$YR$A$F$Y$68.9$KG$20240824$$CN$US$US
242457781$24245778$1$I$20240101$20240819$20240824$20240824$EXP$$US-ABBVIE-5887399$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242457791$24245779$1$I$$20240814$20240824$20240824$PER$$US-ABBVIE-5883554$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242457802$24245780$2$F$20240701$20240826$20240824$20240830$EXP$$US-ABBVIE-5890425$ABBVIE$$78$YR$$F$Y$59$KG$20240829$$CN$US$US
242457811$24245781$1$I$$20240815$20240824$20240824$PER$$US-ABBVIE-5884425$ABBVIE$$$$$$Y$$$20240824$$CN$US$US
242457822$24245782$2$F$20210101$20240826$20240824$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2021-019752$UNITED THERAPEUTICS$$$$$F$Y$80.272$KG$20240904$$$US$US
242457831$24245783$1$I$20240802$20240819$20240824$20240824$EXP$$US-ABBVIE-5885838$ABBVIE$$53$YR$$M$Y$106$KG$20240824$$CN$US$US
242457841$24245784$1$I$$20240819$20240824$20240824$EXP$$CA-ROCHE-10000060220$ROCHE$$55$YR$A$F$Y$59$KG$20240824$$MD$CA$CA
242457851$24245785$1$I$$20240819$20240824$20240824$PER$$US-AMGEN-USASP2024165730$AMGEN$$$$$M$Y$$$20240824$$MD$US$US
242457862$24245786$2$F$$20240826$20240824$20240904$EXP$$US-GSK-US2024101384$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242457871$24245787$1$I$20200903$20220420$20240824$20240824$EXP$$CA-CELLTRION INC.-2020CA035372$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
242457881$24245788$1$I$$20240816$20240824$20240824$PER$$US-AstraZeneca-2024A188152$ASTRAZENECA$$$$$M$Y$$$20240824$$CN$US$
242457891$24245789$1$I$$20240815$20240824$20240824$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025655$UNITED THERAPEUTICS$$$$$M$Y$$$20240824$$$US$US
242457901$24245790$1$I$20240815$20240815$20240824$20240824$EXP$$US-GSK-US2024101837$GLAXOSMITHKLINE$$49$YR$$M$Y$$$20240824$$CN$US$US
242457911$24245791$1$I$20240101$20240820$20240824$20240824$EXP$$US-ABBVIE-5888915$ABBVIE$$$$$M$Y$$$20240824$$CN$US$US
242457922$24245792$2$F$20240816$20240819$20240824$20240828$PER$$US-AMGEN-USASP2024165804$AMGEN$$78$YR$E$M$Y$$$20240828$$CN$US$US
242457931$24245793$1$I$20240701$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024168755$AMGEN$$47$YR$A$F$Y$$$20240824$$CN$US$US
242457941$24245794$1$I$$20240820$20240824$20240824$EXP$$US-ABBVIE-5888974$ABBVIE$$$$$M$Y$$$20240824$$CN$US$US
242457952$24245795$2$F$20240820$20240905$20240824$20240910$EXP$$TR-ABBVIE-5889444$ABBVIE$$60$YR$$F$Y$$$20240910$$MD$TR$TR
242457961$24245796$1$I$20240627$20240815$20240824$20240824$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020254$UNITED THERAPEUTICS$$79$YR$$F$Y$77.098$KG$20240824$$$US$US
242457972$24245797$2$F$20240818$20240830$20240824$20240904$PER$$US-AMGEN-USASP2024167488$AMGEN$$61$YR$A$F$Y$$$20240904$$CN$US$US
242457981$24245798$1$I$20240821$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167942$AMGEN$$$$$F$Y$$$20240824$$CN$US$US
242457991$24245799$1$I$20240101$20240814$20240824$20240824$30DAY$$US-GSK-US2024101214$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240824$$CN$US$US
242458001$24245800$1$I$20240815$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167797$AMGEN$$71$YR$E$F$Y$$$20240824$$CN$US$US
242458011$24245801$1$I$$20240821$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133718$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$82.1$KG$20240824$$CN$US$US
242458021$24245802$1$I$$20240819$20240824$20240824$PER$$US-ROCHE-10000061052$ROCHE$$54$YR$A$F$Y$$$20240824$$CN$US$US
242458031$24245803$1$I$20240809$20240814$20240824$20240824$30DAY$$US-GSK-US2024101426$GLAXOSMITHKLINE$$41$YR$$F$Y$$$20240824$$HP$US$US
242458042$24245804$2$F$$20240919$20240824$20240927$PER$$US-GSK-US2024101422$GLAXOSMITHKLINE$$$$$M$Y$$$20240927$$CN$US$US
242458052$24245805$2$F$$20240830$20240824$20240909$30DAY$$US-GSK-US2024AMR101872$GLAXOSMITHKLINE$$$$$M$Y$$$20240909$$CN$US$US
242458061$24245806$1$I$$20240820$20240824$20240824$PER$$US-AstraZeneca-2024A190431$ASTRAZENECA$$$$$F$Y$$$20240824$$CN$US$
242458071$24245807$1$I$20240601$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167896$AMGEN$$75$YR$E$M$Y$$$20240824$$CN$US$US
242458082$24245808$2$F$20240101$20240920$20240824$20240930$EXP$$CA-CELLTRION INC.-2023CA018490$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
242458091$24245809$1$I$$20240816$20240824$20240824$EXP$$US-AMGEN-USASP2024164796$AMGEN$Jen W.Y;. FLAG-IDA + venetoclax in newly diagnosed (ND) or relapsed/refractory (RR) AML. Journal of Clinical Oncology. 2024;42 (16):6519$$$$$Y$$$20240824$$HP$US$US
242458121$24245812$1$I$$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167888$AMGEN$$$$$$Y$$$20240824$$PH$US$US
242458132$24245813$2$F$20240801$20240822$20240824$20240828$PER$$US-AMGEN-USASP2024168277$AMGEN$$85$YR$E$F$Y$$$20240827$$CN$US$US
242458141$24245814$1$I$$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024168865$AMGEN$$$$$$Y$$$20240824$$PH$US$US
242458151$24245815$1$I$$20240814$20240824$20240824$EXP$$US-GSK-US2024101383$GLAXOSMITHKLINE$$$$$$Y$$$20240824$$MD$US$US
242458162$24245816$2$F$20240814$20240911$20240824$20240920$30DAY$$US-GSK-US2024101891$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240920$$CN$US$US
242458171$24245817$1$I$$20240816$20240824$20240824$30DAY$$US-GSK-US2024102725$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242458181$24245818$1$I$$20240820$20240824$20240824$30DAY$$US-GSK-US2024103984$GLAXOSMITHKLINE$$$$$M$Y$$$20240824$$CN$US$US
242458191$24245819$1$I$$20240821$20240824$20240824$EXP$$US-ABBVIE-5890705$ABBVIE$$$$$M$Y$$$20240824$$CN$US$US
242458201$24245820$1$I$20240806$20240816$20240824$20240824$EXP$$CN-JNJFOC-20240849620$JOHNSON AND JOHNSON$$45$YR$A$M$Y$78$KG$20240824$$HP$CN$CN
242458211$24245821$1$I$20240720$20240813$20240824$20240824$PER$$US-JNJFOC-20240834784$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240824$$CN$US$US
242458221$24245822$1$I$$20240821$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133664$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240824$$CN$US$US
242458232$24245823$2$F$$20240916$20240824$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134154$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240918$$CN$US$US
242458241$24245824$1$I$$20240815$20240824$20240824$EXP$$BR-AMGEN-BRASP2024164737$AMGEN$Rozza-de-menezes R.E.; Lopes D.N.; De Oliveira N.P. et al.. Co-occurrence of oral pemphigus vulgaris and herpes simplex virus infection in a young patient with Crohn^s disease: report of a rare case of oral lesions during anti-TFN alpha and immunomodulator therapy. International Journal of Colorectal Disease. 2024;39 (1):1-10$18$YR$A$F$Y$$$20240824$$HP$BR$BR
242458251$24245825$1$I$$20240816$20240824$20240824$EXP$$NVSC2024US167251$NOVARTIS$$$$$F$Y$$$20240824$$CN$US$US
242458261$24245826$1$I$20240816$20240817$20240824$20240824$EXP$$US-JNJFOC-20240851349$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240824$$MD$US$US
242458281$24245828$1$I$$20240820$20240824$20240824$30DAY$$US-GSK-US2024104002$GLAXOSMITHKLINE$$$$$M$Y$$$20240824$$CN$US$US
242458291$24245829$1$I$20240716$20240812$20240824$20240824$EXP$FR-AFSSAPS-PC2024000650$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111192$ZYDUS PHARM$$$$$$Y$$$20240824$$PH$FR$FR
242458301$24245830$1$I$20240810$20240814$20240824$20240824$EXP$$US-GSK-US2024101373$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$HP$US$US
242458311$24245831$1$I$20240101$20240816$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-018372$UNITED THERAPEUTICS$$$$$F$Y$53.515$KG$20240824$$$US$US
242458321$24245832$1$I$$20240819$20240824$20240824$30DAY$$US-GSK-US2024103305$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242458331$24245833$1$I$$20240821$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133803$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240824$$CN$US$US
242458341$24245834$1$I$$20240814$20240824$20240824$EXP$$IL-NOVITIUMPHARMA-2024ILNVP01641$NOVITIUM PHARMA$Sigal Shaklai.De-Novo Graves Ophthalmopathy After Total Thyroidectomy With Exacerbation Following Rifampicin Therapy for Latent Tuberculosis: A Call for Attention to Disease Modifying Interventions.Journal of the Endocrine Society.08-MAY-2020;4:A1125$46$YR$A$F$Y$$$20240824$$HP$IL$IL
242458351$24245835$1$I$$20240815$20240824$20240824$PER$$US-ABBVIE-5884790$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242458362$24245836$2$F$20240101$20240829$20240824$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-024828$UNITED THERAPEUTICS$$$$$M$Y$78.458$KG$20240903$$$US$US
242458371$24245837$1$I$$20240817$20240824$20240824$EXP$$AU-JNJFOC-20240859515$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240824$$MD$AU$AU
242458381$24245838$1$I$$20240814$20240824$20240824$EXP$$US-NOVITIUMPHARMA-2024USNVP01657$NOVITIUM PHARMA$Priscilla Sigua Arce.Thyroid Storm In Heart Failure: A Case Report.Journal of Cardiac Failure.JAN-2024;30(1):P178$36$YR$A$M$Y$$$20240824$$HP$US$US
242458391$24245839$1$I$20220101$20240815$20240824$20240824$30DAY$$US-GSK-US2024101844$GLAXOSMITHKLINE$$$$$M$Y$$$20240824$$CN$US$US
242458401$24245840$1$I$$20240820$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-066345$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240824$$HP$US$US
242458411$24245841$1$I$20240819$20240819$20240824$20240824$30DAY$$US-GSK-US2024103454$GLAXOSMITHKLINE$$43$YR$$F$Y$$$20240824$$CN$US$US
242458421$24245842$1$I$20240515$20240816$20240824$20240824$EXP$$US-ABBVIE-5886627$ABBVIE$$56$YR$$F$Y$$$20240824$$CN$US$US
242458431$24245843$1$I$20240801$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024168346$AMGEN$$$$$F$Y$$$20240824$$CN$US$US
242458441$24245844$1$I$$20240822$20240824$20240824$EXP$$US-ABBVIE-5890543$ABBVIE$$$$$M$Y$$$20240824$$HP$US$US
242458451$24245845$1$I$20220429$20240815$20240824$20240824$EXP$$CA-TAKEDA-2022TUS027538$TAKEDA$$75$YR$$F$Y$65.2$KG$20240824$$HP$CA$CA
242458461$24245846$1$I$$20240819$20240824$20240824$PER$$US-AMGEN-USASP2024165818$AMGEN$$$$A$F$Y$$$20240824$$HP$US$US
242458471$24245847$1$I$$20240819$20240824$20240824$30DAY$$US-GSK-US2024103457$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242458481$24245848$1$I$$20240815$20240824$20240824$PER$$PR-ABBVIE-5883136$ABBVIE$$$$E$$Y$$$20240824$$MD$PR$PR
242458491$24245849$1$I$$20240815$20240824$20240824$PER$$US-ABBVIE-5884084$ABBVIE$$$$$$Y$$$20240824$$HP$US$US
242458501$24245850$1$I$20240401$20240815$20240824$20240824$30DAY$$US-GSK-US2024101863$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240824$$CN$US$US
242458511$24245851$1$I$$20240820$20240824$20240824$EXP$$NVSC2024CA168817$NOVARTIS$$57$YR$$F$Y$$$20240824$$HP$CA$CA
242458521$24245852$1$I$$20240813$20240824$20240824$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111315$ZYDUS PHARM$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J. 2024;70(7):e92-e96$$$$$Y$$$20240824$$HP$US$US
242458531$24245853$1$I$$20240812$20240824$20240824$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111150$ZYDUS PHARM$Suffian H, Le T, Pandya A.. omplications post-chemotherapy in a child with t-cell leukemia and ataxia telangiectasia.. Ann-Allergy-Asthma-Immunol. 2023;131 (Suppl. 1):S156$$$$$Y$$$20240824$$HP$US$US
242458551$24245855$1$I$$20240819$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131938$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240824$$CN$US$US
242458561$24245856$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134075$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$62.6$KG$20240824$$CN$US$US
242458571$24245857$1$I$$20240819$20240824$20240824$EXP$$US-ABBVIE-5887380$ABBVIE$$$$$F$Y$$$20240824$$HP$US$US
242458581$24245858$1$I$20240720$20240820$20240824$20240824$EXP$$IT-ABBVIE-5889661$ABBVIE$$75$YR$$M$Y$$$20240824$$CN$IT$IT
242458591$24245859$1$I$$20240819$20240824$20240824$30DAY$$US-GSK-US2024103407$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242458601$24245860$1$I$$20240821$20240824$20240824$PER$$US-AstraZeneca-2024A190831$ASTRAZENECA$$$$$F$Y$$$20240824$$CN$US$
242458611$24245861$1$I$$20240820$20240824$20240824$PER$$US-AstraZeneca-2024A189938$ASTRAZENECA$$$$$F$Y$$$20240824$$CN$US$
242458621$24245862$1$I$$20240815$20240824$20240824$PER$$US-AstraZeneca-2024A186875$ASTRAZENECA$$$$$$Y$$$20240824$$CN$US$
242458631$24245863$1$I$$20240820$20240824$20240824$EXP$$FR-AstraZeneca-2024A140431$ASTRAZENECA$$$$$F$Y$$$20240824$$MD$FR$
242458641$24245864$1$I$$20240819$20240824$20240824$EXP$$NVSC2024CA086451$NOVARTIS$$55$YR$$F$Y$$$20240824$$MD$CA$CA
242458651$24245865$1$I$$20240815$20240824$20240824$PER$$US-ABBVIE-5884251$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242458661$24245866$1$I$$20240814$20240824$20240824$EXP$$BR-NOVITIUMPHARMA-2024BRNVP01655$NOVITIUM PHARMA$Alba R. J. Brandao.Reactivation of cutaneous leishmaniasis after kidney transplantation in the Brazilian Amazon: a case report.International Journal of Dermatology.22-JAN-2024;63(5):664-667$53$YR$A$M$Y$$$20240824$$HP$BR$BR
242458671$24245867$1$I$20240718$20240820$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133588$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$79.83$KG$20240824$$PH$US$US
242458681$24245868$1$I$$20240815$20240824$20240824$30DAY$$US-GSK-US2024101938$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242458691$24245869$1$I$20240801$20240820$20240824$20240824$EXP$$US-ABBVIE-5888764$ABBVIE$$35$YR$$F$Y$$$20240824$$CN$US$US
242458703$24245870$3$F$20240101$20240911$20240824$20240917$EXP$$US-ABBVIE-5881393$ABBVIE$$$$$F$Y$63$KG$20240917$$CN$US$US
242458711$24245871$1$I$20240101$20240821$20240824$20240824$EXP$$US-ABBVIE-5890058$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242458721$24245872$1$I$$20240815$20240824$20240824$30DAY$$US-GSK-US2024AMR103087$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242458731$24245873$1$I$$20240814$20240824$20240824$EXP$$IT-NOVITIUMPHARMA-2024ITNVP01645$NOVITIUM PHARMA$M Abbott.HBV REACTIVATION AFTER IMMUNOSUPPRESSIVE THERAPY: AN OPEN QUESTION.Sexually Transmitted Infections.09-JUL-2024;100:A271$71$YR$E$M$Y$$$20240824$$HP$IT$IT
242458741$24245874$1$I$20240821$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167571$AMGEN$$67$YR$E$F$Y$$$20240824$$CN$US$US
242458751$24245875$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134401$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240824$$HP$US$US
242458761$24245876$1$I$$20240809$20240824$20240824$PER$$US-AstraZeneca-2024A182797$ASTRAZENECA$$$$$M$Y$$$20240824$$CN$US$
242458771$24245877$1$I$$20240822$20240824$20240824$PER$$US-AstraZeneca-2024A192379$ASTRAZENECA$$$$$$Y$$$20240824$$CN$US$
242458782$24245878$2$F$$20240926$20240824$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132775$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240927$$CN$US$US
242458791$24245879$1$I$$20240820$20240824$20240824$PER$$US-AstraZeneca-2024A190234$ASTRAZENECA$$$$$F$Y$$$20240824$$HP$US$
242458801$24245880$1$I$$20240817$20240824$20240824$PER$$US-AMGEN-USASP2024164785$AMGEN$Albano-aluquin S.H.; Malysz J.; Aluquin V. et al.. EXPLORING NOVEL MACROPHAGE SUBTYPES IN EARLY AND LATE GIANT CELL ARTERITIS IMMUNE MICROENVIRONMENT. Annals of the Rheumatic Diseases. 2024;83:1982$$$$$Y$$$20240824$$HP$US$US
242458811$24245881$1$I$20240821$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167517$AMGEN$$53$YR$A$F$Y$$$20240824$$CN$US$US
242458821$24245882$1$I$20240801$20240815$20240824$20240824$PER$$US-ABBVIE-5884195$ABBVIE$$$$$$Y$$$20240824$$MD$US$US
242458832$24245883$2$F$$20240911$20240824$20240915$PER$$US-AstraZeneca-2024A182641$ASTRAZENECA$$$$$F$Y$$$20240915$$CN$US$
242458841$24245884$1$I$$20240821$20240824$20240824$PER$$US-AstraZeneca-2024A191071$ASTRAZENECA$$$$$M$Y$$$20240824$$MD$US$
242458851$24245885$1$I$$20240816$20240824$20240824$PER$$US-ABBVIE-5888423$ABBVIE$$$$$$Y$$$20240824$$HP$US$US
242458871$24245887$1$I$$20240820$20240824$20240824$EXP$$NVSC2024CA115564$NOVARTIS$$51$YR$$F$Y$$$20240824$$CN$CA$CA
242458882$24245888$2$F$$20240829$20240824$20240905$EXP$$PHHY2018PT109463$NOVARTIS$Le M, Ravin K, Hasan A, Clauss H, Muchant D, Pasko J et al. Single donor-derived strongyloidiasis in three solid organ transplant recipients: case series and review of the literature. AMERICAN JOURNAL OF TRANSPLANTATION. 2014;14(5):1199-206$14$YR$$M$Y$$$20240906$$HP$PT$PT
242458892$24245889$2$F$20240801$20240823$20240824$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134210$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240827$$HP$US$US
242458901$24245890$1$I$20240816$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024166588$AMGEN$$70$YR$E$M$Y$$$20240824$$CN$US$US
242458911$24245891$1$I$$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024168930$AMGEN$$$$$M$Y$$$20240824$$MD$US$US
242458922$24245892$2$F$20240805$20240821$20240824$20240826$PER$$US-ABBVIE-5889217$ABBVIE$$45$YR$$F$Y$$$20240826$$MD$US$US
242458931$24245893$1$I$20240819$20240819$20240824$20240824$PER$$US-AMGEN-USASP2024165718$AMGEN$$55$YR$A$F$Y$$$20240824$$CN$US$US
242458951$24245895$1$I$20240101$20240815$20240824$20240824$EXP$$CA-CELLTRION INC.-2024CA004386$CELLTRION$$$$$$Y$$$20240824$$HP$CA$CA
242458961$24245896$1$I$20240603$20240812$20240824$20240824$EXP$ES-AEMPS-1559623$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111216$ZYDUS PHARM$$$$$$Y$$$20240824$$MD$ES$ES
242458971$24245897$1$I$$20240813$20240824$20240824$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111316$ZYDUS PHARM$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J. 2024;70(7):e92-e96$$$$$Y$$$20240824$$HP$US$US
242458981$24245898$1$I$20210101$20240821$20240824$20240824$EXP$$US-ABBVIE-5889690$ABBVIE$$$$$F$Y$108$KG$20240824$$CN$US$US
242458991$24245899$1$I$20240801$20240814$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-024704$UNITED THERAPEUTICS$$73$YR$$F$Y$88.435$KG$20240824$$$US$US
242459001$24245900$1$I$$20240813$20240824$20240824$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111293$ZYDUS PHARM$Robinson CL, Wahab S, Cai V. Delayed Hypersensitivity Reaction to Iodinated-Contrast Following Lumbar Epidural Steroid Injection: Case Report.. Pain-Med-Case-Rep. 2023;7(1):11-14$$$$$Y$$$20240824$$MD$US$US
242459011$24245901$1$I$$20240821$20240824$20240824$EXP$$US-ABBVIE-5889239$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242459021$24245902$1$I$20240621$20240821$20240824$20240824$EXP$$US-ABBVIE-5889767$ABBVIE$$62$YR$$F$Y$$$20240824$$CN$US$US
242459031$24245903$1$I$20240810$20240815$20240824$20240824$PER$$US-ABBVIE-5883353$ABBVIE$$48$YR$$F$Y$$$20240824$$CN$US$US
242459041$24245904$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134022$BRISTOL MYERS SQUIBB$$29$YR$A$F$Y$$$20240824$$HP$US$US
242459051$24245905$1$I$$20240821$20240824$20240824$EXP$$CA-SANDOZ INC.-NVSC2022CA170339$SANDOZ$$$$$M$Y$$$20240824$$CN$CA$CA
242459061$24245906$1$I$$20240812$20240824$20240824$PER$$US-AstraZeneca-2024A183882$ASTRAZENECA$$$$$$Y$$$20240824$$CN$US$
242459081$24245908$1$I$$20240821$20240824$20240824$EXP$$CA-ABBVIE-5890856$ABBVIE$$$$A$M$Y$$$20240824$$CN$CA$CA
242459093$24245909$3$F$20240816$20240903$20240824$20240910$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025861$UNITED THERAPEUTICS$$42$YR$$F$Y$48.526$KG$20240910$$PH$US$US
242459101$24245910$1$I$20240101$20240808$20240824$20240824$PER$$US-JNJFOC-20240822354$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240824$$CN$US$US
242459111$24245911$1$I$20240801$20240820$20240824$20240824$EXP$$CA-ABBVIE-5891400$ABBVIE$$$$E$F$Y$$$20240824$$CN$CA$CA
242459122$24245912$2$F$$20240822$20240824$20240829$PER$$US-AMGEN-USASP2024168946$AMGEN$$$$$F$Y$$$20240829$$HP$US$US
242459142$24245914$2$F$20240506$20240920$20240824$20240926$EXP$$NVSC2024US169092$NOVARTIS$$7$YR$$M$Y$29.8$KG$20240926$$MD$US$US
242459151$24245915$1$I$20240101$20240819$20240824$20240824$EXP$$CA-ABBVIE-5888266$ABBVIE$$47$YR$$F$Y$$$20240824$$CN$CA$CA
242459161$24245916$1$I$$20240820$20240824$20240824$EXP$$US-ABBVIE-5889177$ABBVIE$$$$$M$Y$$$20240824$$CN$US$US
242459171$24245917$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134298$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240824$$CN$US$US
242459182$24245918$2$F$20240801$20240909$20240824$20240916$EXP$CZ-CZSUKL-24002283$CZ-ABBVIE-5883873$ABBVIE$$36$YR$$F$Y$54$KG$20240916$$CN$CZ$CZ
242459191$24245919$1$I$$20240820$20240824$20240824$EXP$FR-AFSSAPS-ST2023001617$FR-JAZZ PHARMACEUTICALS-2024-FR-013360$JAZZ$$$$$$Y$$$20240824$$PH$FR$FR
242459202$24245920$2$F$$20240905$20240824$20240909$PER$$US-AMGEN-USASP2024166857$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
242459222$24245922$2$F$20240920$20240920$20240824$20240925$EXP$$CA-TAKEDA-2022TUS003070$TAKEDA$$53$YR$$F$Y$58$KG$20240925$$CN$CA$CA
242459231$24245923$1$I$$20240819$20240824$20240824$EXP$$US-AMGEN-USASP2024165536$AMGEN$Renteria A. S.; Venugopal S.; Marcellino B. et. al. Dose-Adjusted Intensive Chemotherapy Is Safe and Tolerable in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia. Blood. 2018;132 (1):5158$$$$$Y$$$20240824$$MD$US$US
242459251$24245925$1$I$20240816$20240816$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-025807$UNITED THERAPEUTICS$$75$YR$$F$Y$72.109$KG$20240824$$PH$US$US
242459262$24245926$2$F$$20240903$20240824$20240911$EXP$$US-AstraZeneca-2024A183861$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
242459271$24245927$1$I$$20240819$20240824$20240824$PER$$US-AstraZeneca-2024A189123$ASTRAZENECA$$$$$F$Y$$$20240824$$CN$US$
242459281$24245928$1$I$20230101$20240815$20240824$20240824$EXP$$US-JNJFOC-20240845419$JOHNSON AND JOHNSON$$$$$M$Y$$$20240824$$CN$US$US
242459293$24245929$3$F$20240501$20240906$20240824$20240916$EXP$$CA-CELLTRION INC.-2024CA020283$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
242459301$24245930$1$I$20240301$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024166253$AMGEN$$32$YR$A$F$Y$$$20240824$$CN$US$US
242459311$24245931$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134237$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240824$$CN$US$US
242459321$24245932$1$I$$20240820$20240824$20240824$EXP$$CA-ABBVIE-5889142$ABBVIE$$70$YR$$M$Y$$$20240824$$PH$CA$CA
242459331$24245933$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134271$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240824$$HP$US$US
242459341$24245934$1$I$$20240821$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134384$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$63.96$KG$20240824$$CN$US$US
242459351$24245935$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134186$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240824$$HP$US$US
242459361$24245936$1$I$$20240819$20240824$20240824$EXP$$AU-ABBVIE-5888117$ABBVIE$$10$DEC$$F$Y$$$20240824$$MD$AU$AU
242459371$24245937$1$I$20240810$20240822$20240824$20240824$EXP$GB-MHRA-MED-202408151130394790-TSLYF$GB-TAKEDA-2024TUS084821$TAKEDA$$13$YR$$F$Y$$$20240824$$HP$GB$GB
242459381$24245938$1$I$$20240820$20240824$20240824$PER$$US-AstraZeneca-2024A190005$ASTRAZENECA$$$$$M$Y$$$20240824$$CN$US$
242459391$24245939$1$I$$20240815$20240824$20240824$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025491$UNITED THERAPEUTICS$$20$YR$$F$Y$$$20240824$$$US$US
242459401$24245940$1$I$20240101$20240821$20240824$20240824$EXP$$US-ABBVIE-5890924$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242459411$24245941$1$I$20240710$20240821$20240824$20240824$EXP$$US-ABBVIE-5890524$ABBVIE$$58$YR$$F$Y$$$20240824$$CN$US$US
242459421$24245942$1$I$$20240820$20240824$20240824$EXP$$US-ABBVIE-5889659$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242459431$24245943$1$I$$20240819$20240824$20240824$PER$$US-JNJFOC-20240850256$JOHNSON AND JOHNSON$$$$$M$Y$$$20240824$$CN$US$US
242459441$24245944$1$I$$20240814$20240824$20240824$EXP$$US-TAKEDA-2024TUS082092$TAKEDA$$$$$M$Y$$$20240824$$CN$US$US
242459451$24245945$1$I$20240820$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167203$AMGEN$$59$YR$A$M$Y$$$20240824$$CN$US$US
242459461$24245946$1$I$$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024168699$AMGEN$$$$$$Y$$$20240824$$CN$US$US
242459471$24245947$1$I$$20240812$20240824$20240824$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-111153$ZYDUS PHARM$Krishna S, Vijayaraghavan A, Philip DSJ, Sundaram S, Sukumaran S.. Intrathecal methotrexate induced subacute combined degeneration of spinal cord like presentation in a patient with acute lymphocytic leukaemia.. Acta-Neurol-Belg. 2024;124(2):679-681$$$$$Y$$$20240824$$HP$IN$IN
242459482$24245948$2$F$20240321$20240820$20240824$20240829$EXP$$CA-TAKEDA-2024TUS082674$TAKEDA$$76$YR$$M$Y$$$20240829$$MD$CA$CA
242459492$24245949$2$F$$20240903$20240824$20240912$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-026388$UNITED THERAPEUTICS$$79$YR$$M$Y$$$20240912$$$JP$JP
242459501$24245950$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134424$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240824$$CN$US$US
242459511$24245951$1$I$20240101$20240815$20240824$20240824$PER$$US-ABBVIE-5885068$ABBVIE$$$$A$F$Y$$$20240824$$MD$US$US
242459521$24245952$1$I$$20240821$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133247$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240824$$CN$US$US
242459531$24245953$1$I$$20240821$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134295$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240824$$CN$US$US
242459541$24245954$1$I$20240803$20240819$20240824$20240824$EXP$$AR-ABBVIE-5891326$ABBVIE$$$$$F$Y$$$20240824$$CN$AR$AR
242459551$24245955$1$I$20231001$20240816$20240824$20240824$EXP$$CA-CELLTRION INC.-2023CA021424$CELLTRION$$$$$$Y$$$20240824$$HP$CA$CA
242459562$24245956$2$F$20240815$20240827$20240824$20240830$PER$$US-AMGEN-USASP2024166092$AMGEN$$86$YR$E$F$Y$$$20240830$$CN$US$US
242459571$24245957$1$I$$20240509$20240824$20240824$EXP$$CA-CELLTRION INC.-2021CA019624$CELLTRION$$$$$$Y$$$20240824$$MD$CA$CA
242459581$24245958$1$I$$20240816$20240824$20240824$EXP$$AU-CELLTRION INC.-2024AU020278$CELLTRION$$$$$$Y$$$20240824$$MD$AU$AU
242459592$24245959$2$F$19940101$20240828$20240824$20240903$EXP$$US-ABBVIE-5885512$ABBVIE$$$$$M$Y$53.523$KG$20240903$$CN$US$US
242459601$24245960$1$I$$20240815$20240824$20240824$PER$$US-ABBVIE-5884444$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242459611$24245961$1$I$$20240815$20240824$20240824$PER$$US-ABBVIE-5882761$ABBVIE$$$$$F$Y$$$20240824$$HP$US$US
242459621$24245962$1$I$20240814$20240814$20240824$20240824$PER$$US-AstraZeneca-2024A186142$ASTRAZENECA$$24678$DY$$F$Y$$$20240824$$CN$US$
242459631$24245963$1$I$$20240821$20240824$20240824$EXP$$HK-AMGEN-HKGSP2024167852$AMGEN$$70$YR$E$$Y$$$20240824$$MD$HK$HK
242459641$24245964$1$I$$20240814$20240824$20240824$EXP$$US-AMGEN-USASP2024162275$AMGEN$Chawla SP. An update on SOC-1882: A phase 2 study using talimogene laherparepvec, nivolumab, and trabectedin for advanced leiomyosarcoma. Journal of Clinical Oncology. 2024;42 (16):e23570$$$$$Y$$$20240824$$HP$US$US
242459651$24245965$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134352$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240824$$CN$US$US
242459671$24245967$1$I$$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024169302$AMGEN$$$$$$Y$$$20240824$$MD$US$US
242459681$24245968$1$I$$20240814$20240824$20240824$PER$$US-ABBVIE-5883410$ABBVIE$$$$$F$Y$$$20240824$$HP$US$US
242459691$24245969$1$I$$20240816$20240824$20240824$PER$$US-AstraZeneca-2024A188943$ASTRAZENECA$$$$$M$Y$$$20240824$$CN$US$
242459701$24245970$1$I$$20240815$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-025686$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240824$$$US$US
242459711$24245971$1$I$20240101$20240819$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-021824$UNITED THERAPEUTICS$$$$$F$Y$66.213$KG$20240824$$$US$US
242459721$24245972$1$I$20240101$20240819$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-018874$UNITED THERAPEUTICS$$$$$M$Y$133.33$KG$20240824$$$US$US
242459731$24245973$1$I$$20240820$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013158$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240824$$CN$US$US
242459741$24245974$1$I$$20240816$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-026150$UNITED THERAPEUTICS$$$$$M$Y$93.424$KG$20240824$$$US$US
242459751$24245975$1$I$20240401$20240816$20240824$20240824$PER$$US-UNITED THERAPEUTICS-UNT-2024-008784$UNITED THERAPEUTICS$$66$YR$$F$Y$$$20240824$$PH$US$US
242459761$24245976$1$I$$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024169334$AMGEN$$$$$$Y$$$20240824$$PH$US$US
242459781$24245978$1$I$20240101$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167604$AMGEN$$17$YR$T$F$Y$$$20240824$$HP$US$US
242459791$24245979$1$I$20240101$20240726$20240824$20240824$PER$$US-AMGEN-USASP2024169019$AMGEN$$62$YR$A$$Y$$$20240824$$CN$US$US
242459801$24245980$1$I$$20240822$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408014360$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240824$$CN$US$US
242459811$24245981$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013665$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240824$$CN$US$US
242459822$24245982$2$F$20240815$20240920$20240824$20240924$PER$$US-AMGEN-USASP2024167286$AMGEN$$75$YR$E$F$Y$$$20240923$$PH$US$US
242459831$24245983$1$I$20240821$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013641$ELI LILLY AND CO$$65$YR$E$$Y$$$20240824$$CN$US$US
242459841$24245984$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013638$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240824$$CN$US$US
242459851$24245985$1$I$20240801$20240819$20240824$20240824$PER$$US-AMGEN-USASP2024165428$AMGEN$$65$YR$E$M$Y$$$20240824$$CN$US$US
242459861$24245986$1$I$20240101$20240822$20240824$20240824$PER$$US-AMGEN-USASP2024168356$AMGEN$$39$YR$A$M$Y$$$20240824$$HP$US$US
242459871$24245987$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134379$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240824$$CN$US$US
242459882$24245988$2$F$20240818$20240827$20240824$20240829$PER$$US-AMGEN-USASP2024166840$AMGEN$$64$YR$A$M$Y$$$20240829$$CN$US$US
242459891$24245989$1$I$20240101$20240815$20240824$20240824$PER$$US-ABBVIE-5884401$ABBVIE$$$$$M$Y$$$20240824$$CN$US$US
242459901$24245990$1$I$20240820$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167291$AMGEN$$76$YR$E$F$Y$$$20240824$$CN$US$US
242459921$24245992$1$I$$20240812$20240824$20240824$EXP$$GB-UCBSA-2024040796$UCB$$$$$M$Y$$$20240824$$CN$GB$GB
242459931$24245993$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134413$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240824$$CN$US$US
242459941$24245994$1$I$$20240808$20240824$20240824$PER$$US-AstraZeneca-2024A184615$ASTRAZENECA$$$$A$$Y$$$20240824$$HP$US$
242459952$24245995$2$F$20240821$20240821$20240824$20240827$PER$$US-JNJFOC-20240854499$JOHNSON AND JOHNSON$$63$YR$A$F$Y$88$KG$20240827$$HP$US$US
242459961$24245996$1$I$20240815$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024166277$AMGEN$$77$YR$E$M$Y$$$20240824$$CN$US$US
242459971$24245997$1$I$$20240816$20240824$20240824$PER$$US-AMGEN-USASP2024165081$AMGEN$$$$$$Y$$$20240824$$CN$US$US
242459981$24245998$1$I$$20240816$20240824$20240824$EXP$$US-AMGEN-USASP2024164330$AMGEN$Lee L.X.; Toskic D.; Ma X. et.al.. Senescent CD8+ T Cells in Myeloma Patients: Implications for Cellular Therapies. Blood. 2018;132 (SUPPL_1):5688$$$$$Y$$$20240824$$MD$US$US
242459991$24245999$1$I$20240601$20240821$20240824$20240824$PER$$US-ABBVIE-5890083$ABBVIE$$70$YR$$M$Y$$$20240824$$MD$US$US
242460001$24246000$1$I$20240817$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024167025$AMGEN$$62$YR$A$M$Y$$$20240824$$PH$US$US
242460011$24246001$1$I$20240821$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167909$AMGEN$$57$YR$A$F$Y$$$20240824$$CN$US$US
242460021$24246002$1$I$20240101$20240812$20240824$20240824$EXP$$US-UCBSA-2024041046$UCB$$$$$F$Y$$$20240824$$HP$US$US
242460031$24246003$1$I$$20240816$20240824$20240824$EXP$$US-AMGEN-USASP2024164366$AMGEN$Ali S.S.; George R. et.al.. Experience and Outcome of Patients with Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPBL) over 8 Years. Blood. 2018;132 (SUPPL_1):5352$$$$M$Y$$$20240824$$HP$US$US
242460042$24246004$2$F$20240101$20240816$20240824$20240826$PER$$US-ABBVIE-5884563$ABBVIE$$$$$F$Y$$$20240826$$MD$US$US
242460051$24246005$1$I$$20240813$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129006$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240824$$CN$US$US
242460061$24246006$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013647$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240824$$CN$US$US
242460072$24246007$2$F$20240101$20240910$20240824$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018527$UNITED THERAPEUTICS$$$$$F$Y$69.388$KG$20240918$$$US$US
242460081$24246008$1$I$20240701$20240812$20240824$20240824$EXP$$US-UCBSA-2024041702$UCB$$60$YR$$F$Y$$$20240824$$HP$US$US
242460091$24246009$1$I$$20240812$20240824$20240824$EXP$$US-UCBSA-2024042376$UCB$$$$$$Y$$$20240824$$CN$US$US
242460101$24246010$1$I$$20240819$20240824$20240824$EXP$$NVSC2024CN170284$NOVARTIS$Zhu D. Effect of Dapagliflozin on Elderly Patients with Heart Failure with Preserved Ejection Fraction Combined with Type 2 Diabetes Mellitus. CHINESE AND FOREIGN MEDICAL RESEARCH. 2024;22(20):26-9$$$E$$Y$$$20240824$$HP$CN$CN
242460111$24246011$1$I$$20240822$20240824$20240824$PER$$NVSC2024US171287$NOVARTIS$$$$$M$Y$$$20240824$$HP$US$US
242460121$24246012$1$I$$20240815$20240824$20240824$EXP$$BG-AMGEN-BGRSP2024162858$AMGEN$$27$YR$A$M$Y$$$20240824$$MD$BG$BG
242460131$24246013$1$I$$20240815$20240824$20240824$PER$$US-ABBVIE-5885852$ABBVIE$$$$$$Y$$$20240824$$CN$US$US
242460141$24246014$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013677$ELI LILLY AND CO$$$$$F$Y$$$20240824$$CN$US$US
242460151$24246015$1$I$$20240820$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408012901$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240824$$CN$US$US
242460161$24246016$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013653$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240824$$CN$US$US
242460171$24246017$1$I$$20240819$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408012410$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240824$$CN$US$US
242460181$24246018$1$I$$20240816$20240824$20240824$EXP$$US-ABBVIE-5884391$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242460191$24246019$1$I$20240501$20240819$20240824$20240824$EXP$$DE-ABBVIE-5884650$ABBVIE$$74$YR$$M$Y$$$20240824$$MD$DE$DE
242460201$24246020$1$I$20240801$20240815$20240824$20240824$PER$$US-ABBVIE-5884066$ABBVIE$$46$YR$$M$Y$$$20240824$$CN$US$US
242460212$24246021$2$F$$20240905$20240824$20240917$EXP$CA-MHPD-E2B_07184731$CA-Accord-442160$ACCORD$$75$YR$E$F$Y$$$20240917$$HP$CA$CA
242460221$24246022$1$I$20240729$20240812$20240824$20240824$EXP$FR-AFSSAPS-MA2024001305$FR-Accord-441516$ACCORD$$71$YR$E$F$Y$$$20240824$$PH$FR$FR
242460231$24246023$1$I$20240812$20240814$20240824$20240824$EXP$$US-Accord-442495$ACCORD$$42$YR$A$M$Y$$$20240824$$HP$US$US
242460241$24246024$1$I$$20240814$20240824$20240824$EXP$GB-MHRA-MED-202408140755121390-FBGNK$GB-Accord-442052$ACCORD$$40$YR$A$F$Y$$$20240824$$CN$GB$GB
242460251$24246025$1$I$20240731$20240814$20240824$20240824$EXP$CN-HENLIUS-24CN016447$CN-Accord-442412$ACCORD$$53$YR$A$F$Y$$$20240824$$MD$CN$CN
242460261$24246026$1$I$$20240813$20240824$20240824$EXP$$GB-Accord-441724$ACCORD$Htwe S, Holmes S. Mycophenolate mofetil in the management of lichen planus pigmentosus in a woman with frontal fibrosing alopecia. British Journal of Dermatology. 2024;192(Supplement 1):i77. DOI: 10.1093/bjd/ljae090.156.$50$YR$A$F$Y$$$20240824$$MD$GB$GB
242460271$24246027$1$I$$20240813$20240824$20240824$EXP$CA-MHPD-E2B_07155719$CA-Accord-442162$ACCORD$$57$YR$A$F$Y$$$20240824$$HP$CA$CA
242460282$24246028$2$F$$20240909$20240824$20240920$EXP$CA-APOTEX-2024AP009290$CA-Accord-442582$ACCORD$$31$MON$C$$Y$$$20240920$$HP$CA$
242460291$24246029$1$I$$20240814$20240824$20240824$EXP$GB-MHRA-MED-202408141826266670-DMGBN$GB-Accord-442277$ACCORD$$$$$F$Y$$$20240824$$CN$GB$GB
242460301$24246030$1$I$20240419$20240812$20240824$20240824$EXP$FR-AFSSAPS-TO2024000898$FR-Accord-428348$ACCORD$$60$YR$A$M$Y$$$20240824$$PH$FR$FR
242460311$24246031$1$I$$20240814$20240824$20240824$EXP$AU-TGA-0000815669$AU-Accord-441885$ACCORD$$52$YR$A$F$Y$$$20240824$$MD$AU$AU
242460321$24246032$1$I$20240716$20240813$20240824$20240824$EXP$$US-Accord-442128$ACCORD$$47$YR$A$F$Y$$$20240824$$HP$US$US
242460331$24246033$1$I$20240810$20240813$20240824$20240824$EXP$CN-HENLIUS-24CN016430$CN-Accord-442661$ACCORD$$61$YR$A$F$Y$54$KG$20240824$$MD$CN$CN
242460341$24246034$1$I$$20240814$20240824$20240824$EXP$CA-MHPD-E2B_07181888$CA-Accord-442364$ACCORD$$$$$$Y$$$20240824$$HP$CA$CA
242460351$24246035$1$I$$20240812$20240824$20240824$EXP$CA-MHPD-001090013$CA-Accord-441986$ACCORD$$25$YR$A$M$Y$72$KG$20240824$$HP$CA$CA
242460361$24246036$1$I$20240725$20240814$20240824$20240824$EXP$$US-Accord-440164$ACCORD$$28$YR$A$M$Y$$$20240824$$HP$US$US
242460372$24246037$2$F$$20240905$20240824$20240917$EXP$CA-MHPD-E2B_07184699$CA-Accord-442159$ACCORD$$63$YR$A$M$Y$$$20240917$$HP$CA$CA
242460382$24246038$2$F$$20240904$20240824$20240916$EXP$CA-APOTEX-2024AP009397$CA-Accord-442827$ACCORD$$66$YR$E$M$Y$$$20240916$$HP$CA$CA
242460391$24246039$1$I$20240711$20240812$20240824$20240824$EXP$IT-MINISAL02-997439$IT-Accord-441819$ACCORD$$68$YR$E$F$Y$$$20240824$$MD$IT$IT
242460401$24246040$1$I$$20240812$20240824$20240824$EXP$FR-AFSSAPS-PV2024000590$FR-Accord-441513$ACCORD$$1$DY$N$M$Y$0.79$KG$20240824$$HP$FR$FR
242460411$24246041$1$I$$20240812$20240824$20240824$EXP$$JP-Accord-441704$ACCORD$Kou R, Onishi Y, Ogiso S, Kai S, Nakamoto Y. Emphysematous osteomyelitis of the lumbar spine and sacrum after liver transplantation: A case report. Cureus. 2024;16(7):e63748$62$YR$A$M$Y$$$20240824$$MD$JP$JP
242460423$24246042$3$F$20240101$20240911$20240824$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025783$UNITED THERAPEUTICS$$$$$M$Y$95.238$KG$20240919$$$US$US
242460431$24246043$1$I$20240101$20240814$20240824$20240824$EXP$GB-MHRA-TPP32478549C22275880YC1723557738624$GB-Accord-442170$ACCORD$$81$YR$E$M$Y$82$KG$20240824$$MD$GB$GB
242460441$24246044$1$I$20240807$20240813$20240824$20240824$EXP$GB-MHRA-MED-202408101451121720-CDGJN$GB-Accord-441759$ACCORD$$42$YR$A$F$Y$67$KG$20240824$$CN$GB$GB
242460451$24246045$1$I$$20240814$20240824$20240824$EXP$GB-MHRA-MIDB-1fd64265-e596-424d-91ef-97bb82ad4745$GB-Accord-442169$ACCORD$$80$YR$E$$Y$$$20240824$$PH$GB$GB
242460461$24246046$1$I$20240710$20240812$20240824$20240824$EXP$SE-SEMPA-2024-005876$SE-Accord-441562$ACCORD$$73$YR$E$M$Y$$$20240824$$HP$SE$SE
242460471$24246047$1$I$20240404$20240812$20240824$20240824$EXP$FR-AFSSAPS-AN2024001003$FR-Accord-441499$ACCORD$$60$YR$A$M$Y$$$20240824$$PH$FR$FR
242460481$24246048$1$I$$20240812$20240824$20240824$EXP$$IT-Accord-442036$ACCORD$Dell^Orso G, Grossi A, Penco F, Caorsi R, Palmisani E, Terranova P, et al. Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure. Frontiers in Immunology 2021 Oct 14;12:1-8.$25$YR$A$F$Y$$$20240824$$HP$IT$IT
242460491$24246049$1$I$20240731$20240812$20240824$20240824$EXP$$US-Accord-442743$ACCORD$$62$YR$A$F$Y$$$20240824$$HP$US$US
242460501$24246050$1$I$20210101$20240813$20240824$20240824$EXP$$GB-Accord-441719$ACCORD$Illango A, Laws P. A 12-month history of a progressive rash on a background of significant long-term immunosuppression. British Journal of Dermatology. 2024;191(Supplement 1):i153-4. DOI: 10.1093/bjd/ljae090.323.$52$YR$A$$Y$$$20240824$$HP$GB$GB
242460511$24246051$1$I$20240814$20240814$20240824$20240824$EXP$GB-MHRA-MED-202408141134239960-TSMVK$GB-Accord-442067$ACCORD$$49$YR$A$M$Y$78$KG$20240824$$CN$GB$GB
242460521$24246052$1$I$$20240812$20240824$20240824$EXP$GB-MHRA-MED-202408121027281490-QNJGT$GB-Accord-441433$ACCORD$$35$YR$A$M$Y$82$KG$20240824$$CN$GB$GB
242460531$24246053$1$I$20240101$20240814$20240824$20240824$EXP$GB-MHRA-TPP32478549C22275880YC1723557673429$GB-Accord-442172$ACCORD$$81$YR$E$M$Y$82$KG$20240824$$MD$GB$GB
242460541$24246054$1$I$$20240813$20240824$20240824$EXP$GB-MHRA-MED-202408131504528140-TFKLP$GB-Accord-441907$ACCORD$$$$$F$Y$$$20240824$$PH$GB$GB
242460551$24246055$1$I$$20240813$20240824$20240824$EXP$GB-MHRA-MED-202407311408079480-RQVLB$GB-Accord-439976$ACCORD$$52$YR$A$M$Y$$$20240824$$MD$GB$GB
242460561$24246056$1$I$20240612$20240813$20240824$20240824$EXP$CN-HENLIUS-24CN016435$CN-Accord-442830$ACCORD$$86$YR$E$F$Y$36$KG$20240824$$MD$CN$CN
242460571$24246057$1$I$$20240813$20240824$20240824$EXP$$CN-Accord-441848$ACCORD$Liu J, Dhamija G, Jiang Y, He D, Zhou XC. Gastric cancer metastatic to the breast: A case report. World Journal of Gastrointestinal Oncology. 2024;16(7):3331-40. DOI: 10.4251/wjgo.v16.i7.3331.$43$YR$A$F$Y$$$20240824$$MD$CN$CN
242460581$24246058$1$I$20240520$20240812$20240824$20240824$EXP$PT-INFARMED-F202405-900$PT-Accord-441553$ACCORD$$83$YR$E$M$Y$92$KG$20240824$$MD$PT$PT
242460591$24246059$1$I$20240803$20240813$20240824$20240824$EXP$$US-Accord-442048$ACCORD$$67$YR$E$F$Y$$$20240824$$MD$US$US
242460601$24246060$1$I$$20240812$20240824$20240824$EXP$GB-MHRA-MED-202405051644346530-QGMWK$GB-Accord-441541$ACCORD$$$$$M$Y$89$KG$20240824$$CN$GB$GB
242460611$24246061$1$I$20240807$20240813$20240824$20240824$EXP$$US-Accord-442127$ACCORD$$33$YR$A$F$Y$$$20240824$$HP$US$US
242460621$24246062$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013786$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240824$$CN$US$US
242460631$24246063$1$I$20240801$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013603$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240824$$CN$US$US
242460641$24246064$1$I$20240814$20240822$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408014440$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240824$$CN$US$US
242460651$24246065$1$I$20240821$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013685$ELI LILLY AND CO$$$$$F$Y$$$20240824$$CN$US$US
242460661$24246066$1$I$20240301$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013540$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240824$$CN$US$US
242460671$24246067$1$I$20240812$20240816$20240824$20240824$EXP$$AU-TAKEDA-2024TUS082845$TAKEDA$$65$YR$$F$Y$$$20240824$$HP$AU$AU
242460681$24246068$1$I$$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024168294$AMGEN$$$$$$Y$$$20240824$$CN$US$US
242460691$24246069$1$I$20240701$20240813$20240824$20240824$EXP$$US-UCBSA-2024041059$UCB$$36$YR$$F$Y$$$20240824$$HP$US$US
242460702$24246070$2$F$20240820$20240904$20240824$20240906$PER$$US-AMGEN-USASP2024166199$AMGEN$$78$YR$E$F$Y$$$20240906$$MD$US$US
242460711$24246071$1$I$$20240815$20240824$20240824$PER$$US-ABBVIE-5884166$ABBVIE$$$$$$Y$$$20240824$$CN$US$US
242460721$24246072$1$I$$20240813$20240824$20240824$EXP$$GB-UCBSA-2024041093$UCB$$$$$M$Y$$$20240824$$HP$GB$GB
242460731$24246073$1$I$$20240821$20240824$20240824$EXP$$US-AstraZeneca-2024A191098$ASTRAZENECA$$$$$F$Y$$$20240824$$CN$US$
242460741$24246074$1$I$$20240820$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013471$ELI LILLY AND CO$$$$A$F$Y$$$20240824$$CN$US$US
242460751$24246075$1$I$20240818$20240819$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408012727$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240824$$CN$US$US
242460761$24246076$1$I$20240801$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013599$ELI LILLY AND CO$$26$YR$A$M$Y$$$20240824$$CN$US$US
242460771$24246077$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013709$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240824$$PH$US$US
242460781$24246078$1$I$20240817$20240820$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408012225$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240824$$CN$US$US
242460791$24246079$1$I$$20240815$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408010621$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240824$$CN$US$US
242460801$24246080$1$I$20020817$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013771$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240824$$CN$US$US
242460813$24246081$3$F$20240801$20240829$20240824$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025780$UNITED THERAPEUTICS$$71$YR$$F$Y$108.84$KG$20240906$$$US$US
242460822$24246082$2$F$20221101$20240830$20240824$20240905$EXP$$BG-Accord-442698$ACCORD$Petrusheva, V. Cardiotoxicity in patient with breast cancer treated with HER2 targeted therapy - a case report.. CARDIOVASCULAR DISEASES. 2024,(2):14-23.$54$YR$A$F$Y$$$20240905$$HP$BG$BG
242460831$24246083$1$I$20240814$20240814$20240824$20240824$EXP$$US-Accord-442505$ACCORD$$66$YR$E$F$Y$$$20240824$$HP$US$US
242460841$24246084$1$I$20240103$20240812$20240824$20240824$EXP$FR-AFSSAPS-LY2024000767$FR-Accord-441816$ACCORD$$59$YR$A$F$Y$$$20240824$$PH$FR$FR
242460851$24246085$1$I$$20240814$20240824$20240824$EXP$CA-MHPD-E2B_07181883$CA-Accord-442358$ACCORD$$$$$$Y$$$20240824$$HP$CA$CA
242460862$24246086$2$F$20201226$20240918$20240824$20240928$EXP$FR-AFSSAPS-PV2024000673$FR-Accord-441494$ACCORD$$15$DY$N$M$Y$0.8$KG$20240928$$MD$FR$FR
242460871$24246087$1$I$$20240814$20240824$20240824$EXP$CA-MHPD-E2B_07181884$CA-Accord-442360$ACCORD$$$$$$Y$$$20240824$$HP$CA$CA
242460881$24246088$1$I$20240813$20240814$20240824$20240824$EXP$$US-Accord-442992$ACCORD$$56$YR$A$M$Y$$$20240824$$PH$US$US
242460891$24246089$1$I$$20240812$20240824$20240824$EXP$CA-MHPD-001087654$CA-Accord-442003$ACCORD$$73$YR$E$F$Y$$$20240824$$MD$CA$CA
242460901$24246090$1$I$$20240814$20240824$20240824$EXP$GB-MHRA-TPP38764701C9724933YC1723555656401$GB-Accord-442167$ACCORD$$71$YR$E$F$Y$50$KG$20240824$$MD$GB$GB
242460911$24246091$1$I$20240731$20240813$20240824$20240824$EXP$CN-HENLIUS-24CN016420$CN-Accord-443038$ACCORD$$42$YR$A$F$Y$47$KG$20240824$$MD$CN$CN
242460921$24246092$1$I$20220223$20240812$20240824$20240824$EXP$PL-URPL-DML-MLP.4401.1.752.2022$PL-Accord-441876$ACCORD$$69$YR$E$M$Y$83$KG$20240824$$MD$PL$PL
242460931$24246093$1$I$20240807$20240813$20240824$20240824$EXP$$US-Accord-442124$ACCORD$$47$YR$A$F$Y$$$20240824$$HP$US$US
242460941$24246094$1$I$20240719$20240812$20240824$20240824$EXP$FR-AFSSAPS-NT2024000997$FR-Accord-441567$ACCORD$$71$YR$E$M$Y$$$20240824$$MD$FR$FR
242460951$24246095$1$I$$20240813$20240824$20240824$EXP$NL-LRB-00994572$NL-Accord-442008$ACCORD$$75$YR$E$M$Y$92$KG$20240824$$PH$NL$NL
242460961$24246096$1$I$$20240814$20240824$20240824$EXP$CA-MHPD-E2B_07188201$CA-Accord-442334$ACCORD$$59$YR$A$F$Y$$$20240824$$HP$CA$CA
242460971$24246097$1$I$20240727$20240812$20240824$20240824$EXP$FR-AFSSAPS-BR2024000636$FR-Accord-441503$ACCORD$$68$YR$E$M$Y$66$KG$20240824$$MD$FR$FR
242460991$24246099$1$I$$20240813$20240824$20240824$EXP$$US-UCBSA-2024041203$UCB$$$$$F$Y$$$20240824$$HP$US$US
242461001$24246100$1$I$$20240816$20240824$20240824$PER$$US-ROCHE-10000060356$ROCHE$$$$$$Y$$$20240824$$MD$US$US
242461011$24246101$1$I$$20240821$20240824$20240824$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-141910$DAIICHI$$$$$M$Y$$$20240824$$HP$US$US
242461021$24246102$1$I$$20240816$20240824$20240824$PER$$US-JNJFOC-20240844258$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240824$$CN$US$US
242461031$24246103$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013572$ELI LILLY AND CO$$$$$F$Y$$$20240824$$CN$US$US
242461041$24246104$1$I$$20240820$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408012784$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240824$$CN$US$US
242461051$24246105$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013480$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240824$$CN$US$US
242461061$24246106$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013778$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240824$$CN$US$US
242461071$24246107$1$I$$20240817$20240824$20240824$PER$$US-ABBVIE-5886800$ABBVIE$$$$$F$Y$$$20240824$$MD$US$US
242461091$24246109$1$I$$20240822$20240824$20240824$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134063$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240824$$HP$US$US
242461102$24246110$2$F$20240810$20240909$20240824$20240912$PER$$US-AstraZeneca-2024A187004$ASTRAZENECA$$26260$DY$$F$Y$$$20240912$$CN$US$
242461111$24246111$1$I$20240820$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167328$AMGEN$$70$YR$E$F$Y$$$20240824$$CN$US$US
242461121$24246112$1$I$20240503$20240816$20240824$20240824$EXP$FR-AFSSAPS-LY2024001199$FR-AMGEN-FRASP2024163804$AMGEN$$72$YR$E$F$Y$50$KG$20240824$$CN$FR$FR
242461131$24246113$1$I$20240707$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167205$AMGEN$$70$YR$E$F$Y$$$20240824$$CN$US$US
242461151$24246115$1$I$20240801$20240822$20240824$20240824$PER$$US-ABBVIE-5891526$ABBVIE$$$$$$Y$$$20240824$$MD$US$US
242461161$24246116$1$I$$20240822$20240824$20240824$EXP$$FR-TAKEDA-2024TUS084970$TAKEDA$$$$A$M$Y$$$20240824$$MD$FR$FR
242461171$24246117$1$I$20240812$20240820$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013824$ELI LILLY AND CO$$$$$$Y$$$20240824$$CN$US$US
242461181$24246118$1$I$20240820$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013765$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240824$$CN$US$US
242461191$24246119$1$I$20240821$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013681$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240824$$CN$US$US
242461202$24246120$2$F$$20240916$20240824$20240918$30DAY$$US-ELI_LILLY_AND_COMPANY-US202408013615$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240918$$CN$US$US
242461221$24246122$1$I$$20240820$20240824$20240824$EXP$$US-TAKEDA-US201824766$TAKEDA$$$$$M$Y$79.8$KG$20240824$$CN$US$US
242461231$24246123$1$I$20240726$20240814$20240824$20240824$EXP$CN-NMPACDR-4401051005912202400338$CN-BAXTER-2024BAX023339$BAXTER$$42$YR$$F$Y$45$KG$20240824$$MD$CN$CN
242461241$24246124$1$I$$20240820$20240824$20240824$PER$$US-AstraZeneca-2024A190202$ASTRAZENECA$$$$$F$Y$$$20240824$$HP$US$
242461251$24246125$1$I$20240101$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013578$ELI LILLY AND CO$$$$$F$Y$$$20240824$$CN$US$US
242461261$24246126$1$I$20240201$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013883$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240824$$CN$US$US
242461271$24246127$1$I$20240704$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013840$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240824$$CN$US$US
242461281$24246128$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013985$ELI LILLY AND CO$$65$YR$E$$Y$$$20240824$$HP$US$US
242461291$24246129$1$I$$20240814$20240824$20240824$EXP$$GB-TEVA-VS-3233676$TEVA$$66$YR$$F$Y$60$KG$20240824$$MD$GB$GB
242461301$24246130$1$I$20240701$20240819$20240824$20240824$EXP$$BR-AMGEN-BRASP2024165483$AMGEN$$75$YR$E$M$Y$$$20240824$$CN$BR$BR
242461311$24246131$1$I$20180718$20240814$20240824$20240824$EXP$$AU-TEVA-VS-3234832$TEVA$$52$YR$$F$Y$$$20240824$$MD$AU$AU
242461331$24246133$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013686$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240824$$CN$US$US
242461341$24246134$1$I$20240822$20240822$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408014392$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240824$$CN$US$US
242461351$24246135$1$I$20240722$20240823$20240824$20240824$EXP$FR-AFSSAPS-LM2024000459$FR-ROCHE-10000064681$ROCHE$$66$YR$E$F$Y$79$KG$20240824$$CN$FR$FR
242461361$24246136$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013626$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240824$$CN$US$US
242461371$24246137$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408014343$ELI LILLY AND CO$$$$$M$Y$$$20240824$$CN$US$US
242461381$24246138$1$I$20240101$20240820$20240824$20240824$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-019661$UNITED THERAPEUTICS$$76$YR$$M$Y$43.8$KG$20240824$$PH$JP$JP
242461391$24246139$1$I$$20240820$20240824$20240824$EXP$$US-AstraZeneca-2024A190399$ASTRAZENECA$$$$$F$Y$$$20240824$$CN$US$
242461401$24246140$1$I$20240626$20240823$20240824$20240824$EXP$$CN-ROCHE-10000064627$ROCHE$$70$YR$E$F$Y$$$20240824$$HP$CN$CN
242461411$24246141$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013762$ELI LILLY AND CO$$60$YR$A$$Y$$$20240824$$CN$US$US
242461421$24246142$1$I$20240819$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013777$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240824$$CN$US$US
242461431$24246143$1$I$20240801$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013651$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240824$$CN$US$US
242461451$24246145$1$I$$20240822$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408014434$ELI LILLY AND CO$$19$YR$A$M$Y$$$20240824$$CN$US$US
242461461$24246146$1$I$20240820$20240820$20240824$20240824$PER$$US-AstraZeneca-2024A190517$ASTRAZENECA$$21391$DY$$F$Y$$$20240824$$CN$US$
242461471$24246147$1$I$$20240819$20240824$20240824$PER$$US-AstraZeneca-2024A189201$ASTRAZENECA$$$$$$Y$$$20240824$$CN$US$
242461491$24246149$1$I$20240818$20240818$20240824$20240824$PER$$US-JNJFOC-20240846486$JOHNSON AND JOHNSON$$63$YR$A$$Y$$$20240824$$CN$US$US
242461501$24246150$1$I$$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024166737$AMGEN$$$$$$Y$$$20240824$$PH$US$US
242461511$24246151$1$I$20240502$20240820$20240824$20240824$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034522$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$64.5$KG$20240824$$MD$AU$AU
242461522$24246152$2$F$20240715$20240822$20240824$20240830$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047236$BOEHRINGER INGELHEIM$$61$YR$A$F$Y$$$20240829$$MD$PL$PL
242461531$24246153$1$I$$20240817$20240824$20240824$EXP$$US-AMGEN-USASP2024164771$AMGEN$Sharma V.; Monfasani A.; Steiger D.J. et al.. SYMPTOMATIC PRESENTATION OF MYCOBACTERIUM XENOPI IN A PATIENT WITH SCHAMBERG DISEASE. Chest. 2023;164 (4):1411A$20$YR$A$F$Y$$$20240824$$HP$US$US
242461541$24246154$1$I$$20240817$20240824$20240824$EXP$$US-AMGEN-USASP2024164732$AMGEN$Jhawar N.; Chirila R.; Leoni Moreno J.. Trigeminal Amyloidoma in a Patient With Cardiac Amyloidosis. The Texas Heart Institute Journal. 2023;50 (4):1-4$73$YR$E$M$Y$$$20240824$$MD$US$US
242461551$24246155$1$I$20240601$20240819$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408011780$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240824$$CN$US$US
242461561$24246156$1$I$$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408014321$ELI LILLY AND CO$$$$A$F$Y$$$20240824$$CN$US$US
242461571$24246157$1$I$20240822$20240822$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408014485$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240824$$CN$US$US
242461581$24246158$1$I$20240815$20240821$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408013881$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240824$$CN$US$US
242461591$24246159$1$I$$20240823$20240824$20240824$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046641$BOEHRINGER INGELHEIM$$$$$$Y$$$20240824$$MD$IT$IT
242461601$24246160$1$I$$20240815$20240824$20240824$EXP$GB-MHRA-MED-202408151341096990-VYTKH$GB-TEVA-VS-3234103$TEVA$$60$YR$$F$Y$$$20240824$$HP$GB$GB
242461611$24246161$1$I$$20240815$20240824$20240824$EXP$$GB-TEVA-VS-3233893$TEVA$$10$MON$$M$Y$$$20240824$$MD$GB$GB
242461624$24246162$4$F$$20240904$20240824$20240913$EXP$$GB-TEVA-VS-3233905$TEVA$$21$MON$$M$Y$$$20240913$$MD$GB$GB
242461631$24246163$1$I$$20240817$20240824$20240824$EXP$$US-AMGEN-USASP2024164787$AMGEN$Albano-aluquin S.H.; Malysz J.; Aluquin V. et al.. EXPLORING NOVEL MACROPHAGE SUBTYPES IN EARLY AND LATE GIANT CELL ARTERITIS IMMUNE MICROENVIRONMENT. Annals of the Rheumatic Diseases. 2024;83:1982$$$$$Y$$$20240824$$HP$US$US
242461641$24246164$1$I$$20240816$20240824$20240824$PER$$US-AMGEN-USASP2024164781$AMGEN$Mcnally G.A.; Xu M.; Voorhees T. et.al.. Neurofilament light chains: A biomarker for vincristine-related neuropathy. Journal of Clinical Oncology. 2024;42 (16):12114$$$$$Y$$$20240824$$HP$US$US
242461651$24246165$1$I$$20240816$20240824$20240824$PER$$US-AMGEN-USASP2024164772$AMGEN$Hwang P.H; Chang M.T; Noel J. et. al.. Oral Corticosteroids Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis Without Nasal Polyposis A Randomized Clinical Trial. JAMA Otolaryngology-Head + Neck Surgery. 2021;147 (5):434-441$$$$$Y$$$20240824$$MD$US$US
242461661$24246166$1$I$20231225$20240815$20240824$20240824$EXP$$GB-TEVA-VS-3233608$TEVA$$79$YR$$F$Y$65$KG$20240824$$MD$GB$GB
242461671$24246167$1$I$20240731$20240815$20240824$20240824$EXP$GB-MHRA-MED-202408051624433630-FZQRG$GB-TEVA-VS-3233891$TEVA$$32$YR$$F$Y$80$KG$20240824$$PH$GB$GB
242461681$24246168$1$I$20240817$20240819$20240824$20240824$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026218$UNITED THERAPEUTICS$$37$YR$$M$Y$172.34$KG$20240824$$$US$US
242461691$24246169$1$I$$20240820$20240824$20240824$PER$$US-AMGEN-USASP2024167460$AMGEN$$$$$$Y$$$20240824$$CN$US$US
242461701$24246170$1$I$$20240814$20240824$20240824$EXP$$US-ARDELYX-2024ARDX006191$ARDELYX$$$$$F$Y$$$20240824$$HP$US$US
242461712$24246171$2$F$20240801$20240823$20240824$20240901$EXP$$JP-ARDELYX-2024ARDX006297$ARDELYX$$54$YR$$M$Y$$$20240901$$MD$JP$JP
242461721$24246172$1$I$$20240819$20240824$20240824$EXP$$JP-ARDELYX-2024ARDX006326$ARDELYX$$$$$M$Y$$$20240824$$PH$JP$JP
242461731$24246173$1$I$$20240822$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408014432$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240824$$CN$US$US
242461741$24246174$1$I$$20240816$20240824$20240824$PER$$US-AMGEN-USASP2024165549$AMGEN$$$$$$Y$$$20240824$$HP$US$US
242461751$24246175$1$I$$20240822$20240824$20240824$PER$$US-ELI_LILLY_AND_COMPANY-US202408014458$ELI LILLY AND CO$$$$$$Y$$$20240824$$CN$US$US
242461761$24246176$1$I$$20240815$20240824$20240824$EXP$$CA-TAKEDA-2024TUS073311$TAKEDA$$40$YR$$F$Y$81.6$KG$20240824$$MD$CA$CA
242461771$24246177$1$I$20240301$20240822$20240824$20240824$EXP$FR-AFSSAPS-PB2024000891$FR-ROCHE-10000064333$ROCHE$$75$YR$E$F$Y$58$KG$20240824$$PH$FR$FR
242461781$24246178$1$I$20240816$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167210$AMGEN$$$$$M$Y$$$20240824$$CN$US$US
242461792$24246179$2$F$20240812$20240827$20240824$20240829$PER$$US-AMGEN-USASP2024163823$AMGEN$$73$YR$E$F$Y$$$20240829$$CN$US$US
242461811$24246181$1$I$$20240819$20240824$20240824$PER$$US-ROCHE-10000061623$ROCHE$$$$$F$Y$$$20240824$$CN$US$US
242461821$24246182$1$I$20240801$20240816$20240824$20240824$EXP$$CN-TAKEDA-2024TUS085086$TAKEDA$$67$YR$$M$Y$50$KG$20240824$$HP$CN$CN
242461831$24246183$1$I$20240813$20240814$20240824$20240824$30DAY$$US-GSK-US2024AMR101479$GLAXOSMITHKLINE$$28$YR$$F$Y$$$20240824$$CN$US$US
242461841$24246184$1$I$20240101$20240819$20240824$20240824$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026358$UNITED THERAPEUTICS$$$$$F$Y$$$20240824$$MD$US$US
242461851$24246185$1$I$$20240812$20240824$20240824$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19334$ALKEM$Beckett CG, Hill P, Hine KR.. Leucocytoclastic vasculitis in a patient with azathioprine hypersensitivity. Postgrad Med J. 1996;72(849):437-8$$$$$Y$$$20240825$$HP$GB$GB
242461861$24246186$1$I$$20240812$20240824$20240824$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19332$ALKEM$Bergman SM, Krane NK, Leonard G, Soto-Aguilar MC, Wallin JD. Azathioprine and hypersensitivity vasculitis. Ann Intern Med. 1988;109(1):83-4$$$$$Y$$$20240825$$HP$US$US
242461872$24246187$2$F$$20240826$20240824$20240910$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-19448$ALKEM$Moon KM, Jung SY, Han MS, Cho Y, Rah YM, Kim JW.. Diffuse alveolar hemorrhage confirmed by bronchoalveolar lavage in a patient with haemoptysis after sildenafil use for erectile dysfunction.. The Korean Journal of Critical Care Medicine. 2015;30 (1):31-33$81$YR$$M$Y$$$20240910$$MD$KR$KR
242461882$24246188$2$F$$20240821$20240824$20240904$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-19219$ALKEM$Sharifi P, Moradi A, Moghadasi AN.. Fingolimod-associated Balo^s concentric sclerosis in multiple sclerosis: A case report. Clinical Case Reports. 2024;12(8):e9266$37$YR$$F$Y$$$20240904$$HP$IR$IR
242461892$24246189$2$F$$20240823$20240824$20240905$EXP$IN-MLMSERVICE-20240805-PI152413-00306-1$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-18980$ALKEM$Gupta D, Singh L, Kumar S, Singh K, Mendonca S, Chatterjee T.. Rare complications of heart transplant: Autopsy findings. Indian Journal of Pathology and Microbiology. 2024;67(3):624-7$33$YR$$M$Y$$$20240905$$MD$IN$IN
242461901$24246190$1$I$$20240812$20240824$20240824$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19676$ALKEM$Green KD, Bianco LM, McCleskey BC, Scott KS.. The Emergence of Bromazolam in Jefferson County AL. A Case Series. J Anal Toxicol. 2024;unk:bkae067$30$YR$$M$Y$$$20240825$$MD$US$US
242461912$24246191$2$F$$20240820$20240824$20240903$EXP$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-19195$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-19195$ALKEM$Montarello NL, Irvine I, Warner V, Hare J, Kaye D, Cloud GC.. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report. BMC Neurology. 2024;24(1):277$51$YR$$F$Y$$$20240903$$MD$AU$AU
242461922$24246192$2$F$$20240823$20240824$20240905$EXP$JP-MLMSERVICE-20240802-PI151234-00232-1$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-19044$ALKEM$Yoshimura Y, Suwabe T, Miki K, Yokoyama T, Kono K, Kinowaki K, et al.. Renal cell carcinoma preceded by a rheumatoid-like paraneoplastic syndrome: A case report. Oncology Letters. 2024;28 (4):448$68$YR$$M$Y$54$KG$20240905$$MD$JP$JP
242461931$24246193$1$I$$20240812$20240824$20240824$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19679$ALKEM$Green KD, Bianco LM, McCleskey BC, Scott KS.. The Emergence of Bromazolam in Jefferson County AL. A Case Series. J Anal Toxicol. 2024;unk:unk$20$YR$$M$Y$$$20240825$$MD$US$US
242461941$24246194$1$I$$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167180$AMGEN$$$$$$Y$$$20240824$$CN$US$US
242461951$24246195$1$I$$20240812$20240824$20240824$EXP$$BE-ALKEM LABORATORIES LIMITED-BE-ALKEM-2024-18703$ALKEM$Deprez V, Goeman J, Van Mossevelde S.. Tacrolimus-induced cognitive impairment: a case report. Acta Neurologica Belgica. 2024;124(4):1415-1417$61$YR$$M$Y$$$20240825$$HP$BE$BE
242461961$24246196$1$I$$20240812$20240824$20240824$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19703$ALKEM$Green KD, Bianco LM, McCleskey BC, Scott KS.. The Emergence of Bromazolam in Jefferson County AL. A Case Series. J Anal Toxicol. 2024;unk:unk$41$YR$$F$Y$$$20240825$$MD$US$US
242461971$24246197$1$I$$20240812$20240824$20240824$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19691$ALKEM$Green KD, Bianco LM, McCleskey BC, Scott KS.. The Emergence of Bromazolam in Jefferson County AL. A Case Series. J Anal Toxicol .. 2024;unk:bkae067$34$YR$$F$Y$$$20240825$$MD$US$US
242461991$24246199$1$I$$20240820$20240824$20240824$EXP$$US-ABBVIE-5888990$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242462002$24246200$2$F$20240816$20240826$20240824$20240828$EXP$$NVSC2024PE169685$NOVARTIS$$72$YR$$F$Y$$$20240828$$CN$PE$PE
242462011$24246201$1$I$20240601$20240820$20240824$20240824$EXP$$DO-ABBVIE-5892389$ABBVIE$$53$YR$$M$Y$84$KG$20240824$$HP$DO$DO
242462021$24246202$1$I$20240201$20240822$20240824$20240824$EXP$$DE-ABBVIE-5892483$ABBVIE$$69$YR$$M$Y$$$20240824$$CN$DE$DE
242462031$24246203$1$I$20240708$20240820$20240824$20240824$EXP$$EG-ABBVIE-5892251$ABBVIE$$64$YR$$M$Y$$$20240824$$CN$EG$EG
242462041$24246204$1$I$20240101$20240821$20240824$20240824$EXP$$US-ABBVIE-5890195$ABBVIE$$$$$F$Y$$$20240824$$CN$US$US
242462051$24246205$1$I$$20240821$20240824$20240824$PER$$US-AMGEN-USASP2024167272$AMGEN$$$$$F$Y$$$20240824$$CN$US$US
242462072$24246207$2$F$20240614$20240912$20240824$20240920$EXP$$CN-TAKEDA-2024TUS082407$TAKEDA$$41$YR$$F$Y$63.5$KG$20240920$$MD$CN$CN
242462083$24246208$3$F$20240806$20240913$20240824$20240919$EXP$$DE-TAKEDA-2024TUS085423$TAKEDA$$74$YR$$M$Y$80$KG$20240919$$MD$DE$DE
242462092$24246209$2$F$$20240823$20240824$20240828$PER$$US-AMGEN-USASP2024167259$AMGEN$$$$$M$Y$$$20240827$$CN$US$US
242462102$24246210$2$F$20240101$20240820$20240824$20240828$PER$$US-AMGEN-USASP2024167627$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242462111$24246211$1$I$20240811$20240816$20240824$20240824$EXP$$CN-TAKEDA-2024TUS084429$TAKEDA$$56$YR$$M$Y$64$KG$20240824$$HP$CN$CN
242462131$24246213$1$I$$20240819$20240824$20240824$EXP$$US-JNJFOC-20240852655$JOHNSON AND JOHNSON$$$$$M$Y$$$20240824$$CN$US$US
242462141$24246214$1$I$$20240819$20240824$20240824$PER$$US-JNJFOC-20240850380$JOHNSON AND JOHNSON$$$$$M$Y$$$20240824$$HP$US$US
242462171$24246217$1$I$$20240815$20240824$20240824$30DAY$$US-GSK-US2024101776$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242462181$24246218$1$I$$20240819$20240824$20240824$PER$$US-AMGEN-USASP2024165964$AMGEN$$$$A$M$Y$$$20240824$$MD$US$US
242462191$24246219$1$I$$20240820$20240824$20240824$PER$$US-AstraZeneca-2024A190141$ASTRAZENECA$$$$A$M$Y$$$20240825$$MD$US$
242462201$24246220$1$I$$20240815$20240824$20240824$30DAY$$US-GSK-US2024101904$GLAXOSMITHKLINE$$$$$F$Y$$$20240824$$CN$US$US
242462211$24246221$1$I$$20240822$20240824$20240824$PER$$US-ABBVIE-5892871$ABBVIE$$$$$M$Y$$$20240824$$CN$US$US
242462221$24246222$1$I$$20240816$20240824$20240824$EXP$$US-AMGEN-USASP2024164799$AMGEN$Jen W.Y;. FLAG-IDA + venetoclax in newly diagnosed (ND) or relapsed/refractory (RR) AML. Journal of Clinical Oncology. 2024;42 (16):6519$$$$$Y$$$20240824$$HP$US$US
242462232$24246223$2$F$20240815$20240819$20240825$20240826$EXP$$US-AMGEN-USASP2024165615$AMGEN$$$$$M$Y$$$20240826$$PH$US$US
242462242$24246224$2$F$$20240913$20240825$20240923$PER$$US-GSK-US2024101915$GLAXOSMITHKLINE$$$$$M$Y$$$20240923$$MD$US$US
242462252$24246225$2$F$$20240820$20240825$20240826$EXP$$US-AMGEN-USASP2024166744$AMGEN$$$$$F$Y$$$20240826$$PH$US$US
242462262$24246226$2$F$$20240823$20240825$20240902$EXP$$US-GSK-US2024101921$GLAXOSMITHKLINE$$20$YR$$F$Y$$$20240902$$HP$US$US
242462271$24246227$1$I$$20240813$20240825$20240825$PER$$US-AstraZeneca-2024A186425$ASTRAZENECA$$$$$$Y$$$20240825$$HP$US$
242462281$24246228$1$I$$20240816$20240825$20240825$EXP$$CN-AMGEN-CHNSP2024164730$AMGEN$Hou C.. A case report of systemic lupus erythematosus complicating interstitial lung disease and thickened pericardium treated with tofacitinib. Medicine. 2024;103 (30):1-6$35$YR$A$F$Y$$$20240824$$HP$CN$CN
242462291$24246229$1$I$20240818$20240821$20240825$20240825$PER$$US-AstraZeneca-2024A191070$ASTRAZENECA$$27172$DY$$F$Y$$$20240825$$CN$US$
242462301$24246230$1$I$$20240815$20240825$20240825$30DAY$$US-GSK-US2024AMR102793$GLAXOSMITHKLINE$$$$$F$Y$$$20240825$$CN$US$US
242462312$24246231$2$F$20240510$20240903$20240825$20240909$EXP$$NVSC2024US168725$NOVARTIS$$14$YR$$F$Y$45$KG$20240909$$MD$US$US
242462321$24246232$1$I$$20240819$20240825$20240825$PER$$US-AstraZeneca-2024A190058$ASTRAZENECA$$44$YR$$F$Y$$$20240825$$MD$US$
242462331$24246233$1$I$$20240819$20240825$20240825$EXP$$CN-ROCHE-10000060414$ROCHE$Nie Y, Zhang N, Li J, Wu D, Yang Y, Zhang L, et al. Hypogammaglobulinemia and Infection Events in Patients with Autoimmune Diseases Treated with Rituximab: 10 Years Real-Life Experience. Journal of clinical immunology. 2024-Aug-16;44 (8):179. doi:10.1007/s10875-024-01773-y.$$$$$Y$$$20240825$$HP$CN$CN
242462342$24246234$2$F$20240620$20240820$20240825$20240830$EXP$$DE-ROCHE-10000058330$ROCHE$$36$YR$A$M$Y$$$20240830$$MD$DE$DE
242462351$24246235$1$I$$20240815$20240825$20240825$30DAY$$US-GSK-US2024AMR102887$GLAXOSMITHKLINE$$$$$$Y$$$20240825$$CN$US$US
242462361$24246236$1$I$$20240820$20240825$20240825$PER$$US-AstraZeneca-2024A190483$ASTRAZENECA$$$$A$$Y$$$20240825$$MD$US$
242462371$24246237$1$I$$20240821$20240825$20240825$PER$$US-ROCHE-10000063356$ROCHE$$74$YR$E$F$Y$$$20240825$$HP$US$US
242462382$24246238$2$F$$20240909$20240825$20240913$EXP$$GR-ROCHE-10000060391$ROCHE$Gialouri C, Chalkia A, Koutsianas C, Chavatza K, Argyriou E, Panagiotopoulos A, et al. Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study. Rheumatology. 2024-Aug-06;1-10. doi:10.1093/rheumatology/keae409.$$$$$Y$$$20240913$$HP$GR$GR
242462391$24246239$1$I$20240815$20240815$20240825$20240825$EXP$$IE-ROCHE-10000058872$ROCHE$$$$$M$Y$$$20240825$$CN$IE$IE
242462401$24246240$1$I$20240809$20240814$20240825$20240825$EXP$$US-ROCHE-10000057788$ROCHE$$45$YR$A$M$Y$$$20240825$$CN$US$US
242462411$24246241$1$I$$20240820$20240825$20240825$EXP$CA-DRL-USA-SPO/CAN/24/0012122$CA-RDY-SPO/CAN/24/0012122$DR REDDYS$$72$YR$E$F$Y$$$20240825$$HP$CA$CA
242462421$24246242$1$I$$20240813$20240825$20240825$EXP$DE-AMK-278786$DE-GLENMARK PHARMACEUTICALS-2024GMK093387$GLENMARK$$$$$$Y$$$20240825$$PH$DE$DE
242462431$24246243$1$I$20240816$20240821$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408013723$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240825$$CN$US$US
242462441$24246244$1$I$20240801$20240819$20240825$20240825$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025995$UNITED THERAPEUTICS$$36$YR$$F$Y$81.633$KG$20240825$$$US$US
242462451$24246245$1$I$20240815$20240815$20240825$20240825$EXP$$US-GSK-US2024101779$GLAXOSMITHKLINE$$66$YR$$M$Y$$$20240825$$HP$US$US
242462461$24246246$1$I$$20240819$20240825$20240825$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025998$UNITED THERAPEUTICS$$$$$F$Y$$$20240825$$$US$US
242462471$24246247$1$I$$20240822$20240825$20240825$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026413$UNITED THERAPEUTICS$$$$$M$Y$$$20240825$$$US$US
242462491$24246249$1$I$$20240820$20240825$20240825$EXP$CA-DRL-USA-SPO/CAN/24/0012140$CA-RDY-SPO/CAN/24/0012140$DR REDDYS$$$$$M$Y$$$20240825$$MD$CA$CA
242462501$24246250$1$I$$20240819$20240825$20240825$EXP$$GB-ROCHE-10000061333$ROCHE$Kanigicherla D, Kehagia A, Jamshidi B, Manounah L, Barnes A, Patrick H, et al. Prospective study of the effect of rituximab on kidney function in membranous nephropathy. Clinical Kidney Journal. 2024;17 (8):1-10. doi:10.1093/ckj/sfae179.$$$$$Y$$$20240825$$HP$GB$GB
242462511$24246251$1$I$$20240820$20240825$20240825$EXP$CA-DRL-USA-SPO/CAN/24/0012115$CA-RDY-SPO/CAN/24/0012115$DR REDDYS$$71$YR$E$M$Y$$$20240825$$HP$CA$CA
242462521$24246252$1$I$$20240819$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408012809$ELI LILLY AND CO$$$$$F$Y$$$20240825$$CN$US$US
242462531$24246253$1$I$20240731$20240814$20240825$20240825$PER$$US-JNJFOC-20240837231$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240825$$MD$US$US
242462541$24246254$1$I$20231101$20240820$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408013555$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240825$$CN$US$US
242462551$24246255$1$I$20240820$20240821$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408013801$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240825$$CN$US$US
242462561$24246256$1$I$$20240815$20240825$20240825$30DAY$$US-GSK-US2024101922$GLAXOSMITHKLINE$$$$$M$Y$$$20240825$$CN$US$US
242462571$24246257$1$I$20240815$20240816$20240825$20240825$30DAY$$US-GSK-US2024102408$GLAXOSMITHKLINE$$69$YR$$M$Y$$$20240825$$CN$US$US
242462581$24246258$1$I$$20240718$20240825$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07355$LUPIN$$$$$$Y$$$20240825$$CN$US$US
242462591$24246259$1$I$$20240813$20240825$20240825$PER$$US-AstraZeneca-2024A185155$ASTRAZENECA$$$$$M$Y$$$20240825$$CN$US$
242462601$24246260$1$I$$20240718$20240825$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07269$LUPIN$$$$$$Y$$$20240825$$CN$US$US
242462611$24246261$1$I$$20240820$20240825$20240825$PER$$US-AMGEN-USASP2024167275$AMGEN$$$$$$Y$$$20240825$$HP$US$US
242462621$24246262$1$I$$20240812$20240825$20240825$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08087$LUPIN$$$$$$Y$$$20240825$$CN$US$US
242462631$24246263$1$I$$20240812$20240825$20240825$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08190$LUPIN$$$$$$Y$$$20240825$$CN$US$US
242462641$24246264$1$I$20210519$20210526$20240825$20240825$EXP$$CO-AstraZeneca-2021A480236$ASTRAZENECA$$20404$DY$$F$Y$55$KG$20240825$$CN$CO$
242462651$24246265$1$I$$20240820$20240825$20240825$EXP$CA-DRL-USA-SPO/CAN/24/0012121$CA-RDY-SPO/CAN/24/0012121$DR REDDYS$$80$YR$E$M$Y$86$KG$20240825$$HP$CA$CA
242462662$24246266$2$F$20240818$20240902$20240825$20240905$EXP$$NVSC2024ZA169131$NOVARTIS$$17$YR$$F$Y$$$20240905$$HP$ZA$ZA
242462671$24246267$1$I$$20240821$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408013873$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240825$$CN$US$US
242462681$24246268$1$I$$20240816$20240825$20240825$30DAY$$US-GSK-US2024102702$GLAXOSMITHKLINE$$$$$F$Y$$$20240825$$CN$US$US
242462691$24246269$1$I$20240820$20240821$20240825$20240825$PER$$US-JNJFOC-20240854938$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240825$$CN$US$US
242462701$24246270$1$I$$20240821$20240825$20240825$PER$$US-JNJFOC-20240855161$JOHNSON AND JOHNSON$$$$$$Y$$$20240825$$PH$US$US
242462711$24246271$1$I$$20240812$20240825$20240825$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093363$GLENMARK$$$$$$Y$$$20240825$$CN$US$US
242462721$24246272$1$I$$20240813$20240825$20240825$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093368$GLENMARK$$$$$$Y$$$20240825$$CN$US$US
242462731$24246273$1$I$20240806$20240820$20240825$20240825$PER$$US-JNJFOC-20240851482$JOHNSON AND JOHNSON$$24$YR$A$M$Y$165$KG$20240825$$HP$US$US
242462741$24246274$1$I$20240822$20240822$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408014363$ELI LILLY AND CO$$$$$F$Y$$$20240825$$CN$US$US
242462761$24246276$1$I$$20240821$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408014319$ELI LILLY AND CO$$$$A$F$Y$$$20240825$$CN$US$US
242462771$24246277$1$I$$20240815$20240825$20240825$EXP$$US-GSK-US2024101770$GLAXOSMITHKLINE$$$$$F$Y$$$20240825$$MD$US$US
242462782$24246278$2$F$$20240823$20240825$20240902$EXP$$US-GSK-US2024AMR103359$GLAXOSMITHKLINE$$$$A$F$Y$$$20240902$$HP$US$US
242462791$24246279$1$I$$20240815$20240825$20240825$EXP$$US-GSK-US2024AMR104074$GLAXOSMITHKLINE$$$$$$Y$$$20240825$$HP$US$US
242462801$24246280$1$I$$20240822$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408014456$ELI LILLY AND CO$$$$$$Y$$$20240825$$CN$US$US
242462811$24246281$1$I$$20240822$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408014428$ELI LILLY AND CO$$$$$$Y$$$20240825$$CN$US$US
242462821$24246282$1$I$20240723$20240823$20240825$20240825$EXP$$US-BAUSCH-BL-2024-012845$BAUSCH AND LOMB$$93$YR$$F$Y$$$20240825$$CN$US$US
242462831$24246283$1$I$20240726$20240823$20240825$20240825$EXP$FR-AFSSAPS-TO2024001592$FR-BAUSCH-BL-2024-012844$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240825$$PH$FR$FR
242462841$24246284$1$I$20240101$20240823$20240825$20240825$EXP$$US-BAUSCH-BL-2024-012846$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240825$$CN$US$US
242462852$24246285$2$F$20240915$20240916$20240825$20240926$PER$$US-GSK-US2024101943$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240926$$CN$US$US
242462861$24246286$1$I$20221026$20230728$20240825$20240825$PER$$US-Emmaus Medical, Inc.-EMM202211-000274$EMMAUS LIFE SCIENCES$$33$YR$A$F$Y$$$20240825$$CN$US$
242462871$24246287$1$I$$20240815$20240825$20240825$EXP$$CA-TEVA-VS-3235652$TEVA$$30$YR$$F$Y$$$20240825$$PH$CA$CA
242462882$24246288$2$F$$20240904$20240825$20240911$30DAY$$US-GSK-US2024AMR101228$GLAXOSMITHKLINE$$$$$M$Y$$$20240911$$HP$US$US
242462891$24246289$1$I$$20240820$20240825$20240825$PER$$US-JNJFOC-20240859190$JOHNSON AND JOHNSON$$$$$$Y$$$20240825$$CN$US$US
242462901$24246290$1$I$$20240822$20240825$20240825$PER$$US-AMGEN-USASP2024168119$AMGEN$$$$$$Y$$$20240825$$CN$US$US
242462912$24246291$2$F$$20240920$20240825$20240930$PER$$US-GSK-US2024103434$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$MD$US$US
242462921$24246292$1$I$$20240819$20240825$20240825$30DAY$$US-GSK-US2024103409$GLAXOSMITHKLINE$$$$A$M$Y$$$20240825$$CN$US$US
242462931$24246293$1$I$20240816$20240819$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408012291$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240825$$CN$US$US
242462942$24246294$2$F$20240101$20240925$20240825$20240927$EXP$$US-JNJFOC-20240654950$JOHNSON AND JOHNSON$$23$YR$A$$Y$$$20240927$$CN$US$US
242462951$24246295$1$I$$20240821$20240825$20240825$30DAY$$US-GSK-US2024104594$GLAXOSMITHKLINE$$$$$F$Y$$$20240825$$CN$US$US
242462961$24246296$1$I$$20240819$20240825$20240825$30DAY$$US-GSK-US2024103435$GLAXOSMITHKLINE$$$$$F$Y$$$20240825$$CN$US$US
242462971$24246297$1$I$20240401$20240820$20240825$20240825$EXP$$CO-AMGEN-COLSP2024168493$AMGEN$$74$YR$E$F$Y$$$20240825$$CN$CO$CO
242462981$24246298$1$I$20240729$20240820$20240825$20240825$EXP$$US-JNJFOC-20240778727$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240825$$CN$US$US
242462991$24246299$1$I$$20240820$20240825$20240825$30DAY$$US-GSK-US2024103986$GLAXOSMITHKLINE$$$$$F$Y$$$20240825$$CN$US$US
242463001$24246300$1$I$20240819$20240820$20240825$20240825$PER$$US-AMGEN-USASP2024166537$AMGEN$$59$YR$A$M$Y$$$20240825$$CN$US$US
242463011$24246301$1$I$$20240820$20240825$20240825$EXP$$AU-RDY-SPO/AUS/24/0012287$DR REDDYS$$54$YR$A$F$Y$$$20240825$$CN$AU$AU
242463021$24246302$1$I$$20240815$20240825$20240825$EXP$$US-VIIV HEALTHCARE LIMITED-US2024101804$VIIV$$$$$F$Y$$$20240825$$HP$US$US
242463031$24246303$1$I$$20240820$20240825$20240825$EXP$$AU-RDY-SPO/AUS/24/0012269$DR REDDYS$$45$YR$A$F$Y$$$20240825$$CN$AU$AU
242463041$24246304$1$I$$20240811$20240825$20240825$EXP$$IL-Merck Healthcare KGaA-2024043570$MERCK KGAA$$65$YR$E$$Y$$$20240816$$PH$IL$IL
242463051$24246305$1$I$$20240820$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408012827$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240825$$CN$US$US
242463061$24246306$1$I$$20240811$20240825$20240825$EXP$$IL-Merck Healthcare KGaA-2024043567$MERCK KGAA$$65$YR$E$F$Y$$$20240819$$PH$IL$IL
242463071$24246307$1$I$$20240812$20240825$20240825$EXP$$IL-Merck Healthcare KGaA-2024043742$MERCK KGAA$$53$YR$A$F$Y$$$20240819$$CN$IL$IL
242463081$24246308$1$I$$20240813$20240825$20240825$EXP$$US-DEXPHARM-2024-2868$DEXCEL$Sheth, S.; Matthia, E.; Naik, D.  Severe Medication InduceDyslipidemia in an Adult with Breast Cancer. Journal of Clinical Lipidology 2024, V18 (Suppl.), Pe555-e556.$57$YR$A$F$Y$$$20240825$$HP$US$US
242463091$24246309$1$I$$20240813$20240825$20240825$EXP$$JP-DEXPHARM-2024-2901$DEXCEL$Harada T, Nakanishi T, Kutsuna S, Nakai M. Unexpected sudden deaths following the co-administration of ceftriaxone and Lansoprazole: A case series. Cureus. 2024 Jul 9; doi:10.7759/cureus.64143$81$YR$E$M$Y$$$20240825$$HP$JP$JP
242463101$24246310$1$I$$20240810$20240825$20240825$PER$$US-AstraZeneca-2024A183778$ASTRAZENECA$$$$$$Y$$$20240825$$CN$US$
242463111$24246311$1$I$$20240813$20240825$20240825$EXP$$JP-DEXPHARM-2024-2902$DEXCEL$Harada T, Nakanishi T, Kutsuna S, Nakai M. Unexpected sudden deaths following the co-administration of ceftriaxone and Lansoprazole: A case series. Cureus. 2024 Jul 9; doi:10.7759/cureus.64143$79$YR$E$M$Y$$$20240825$$HP$JP$JP
242463121$24246312$1$I$$20240813$20240825$20240825$EXP$$JP-DEXPHARM-2024-2903$DEXCEL$Harada T, Nakanishi T, Kutsuna S, Nakai M. Unexpected sudden deaths following the co-administration of ceftriaxone and Lansoprazole: A case series. Cureus. 2024 Jul 9; doi:10.7759/cureus.64143$88$YR$E$F$Y$$$20240825$$HP$JP$JP
242463131$24246313$1$I$$20240813$20240825$20240825$EXP$$JP-DEXPHARM-2024-2916$DEXCEL$Nagao S, Yabuuchi Y, Tanaka K, Morihisa Y, Kobayashi T, Akiyama S, et al. Multiple gastric neuroendocrine tumors associated with long-term use of a proton pump inhibitor and a potassium-competitive acid blocker. Internal Medicine. 2024 Jul 15;63(14):2001?10. doi:10.2169/internalmedicine.2857-23$52$YR$A$M$Y$$$20240825$$HP$JP$JP
242463142$24246314$2$F$20240812$20240906$20240825$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101934$VIIV$$43$YR$$F$Y$$$20240911$$HP$US$US
242463152$24246315$2$F$$20240827$20240825$20240904$EXP$$GB-TEVA-VS-3233883$TEVA$$35$YR$$M$Y$$$20240904$$MD$GB$GB
242463161$24246316$1$I$$20240813$20240825$20240825$PER$$US-AstraZeneca-2024A184483$ASTRAZENECA$$$$T$F$Y$$$20240825$$MD$US$
242463172$24246317$2$F$$20240910$20240825$20240921$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08169$LUPIN$$$$$$Y$$$20240921$$CN$US$US
242463181$24246318$1$I$$20240815$20240825$20240825$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR102393$VIIV$$$$$M$Y$$$20240825$$HP$US$US
242463211$24246321$1$I$$20240814$20240825$20240825$EXP$$CA-GILEAD-2024-0681598$GILEAD$$59$YR$A$F$Y$$$20240825$$HP$CA$CA
242463222$24246322$2$F$$20240911$20240825$20240920$EXP$$GB-TEVA-VS-3233655$TEVA$Khan Z, Batchelor T, Rees P. Bronchogenic cyst: a rare cause of palpitations and atrial fibrillation. BMJ Case Reports. 2024;17(3)$$$A$F$Y$$$20240920$$MD$GB$GB
242463231$24246323$1$I$$20240820$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408012839$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240825$$CN$US$US
242463241$24246324$1$I$$20240815$20240825$20240825$PER$$US-AstraZeneca-2024A190348$ASTRAZENECA$$81$YR$$M$Y$70.3$KG$20240825$$CN$US$
242463251$24246325$1$I$20220720$20240813$20240825$20240825$EXP$KR-KAERS-2023000370999$KR-Ipsen Biopharmaceuticals, Inc.-2024-16710$IPSEN$$57$YR$A$M$Y$$$20240825$$HP$KR$KR
242463263$24246326$3$F$20240101$20240909$20240825$20240914$PER$$US-JNJFOC-20240854273$JOHNSON AND JOHNSON$$$$$M$Y$$$20240914$$PH$US$US
242463271$24246327$1$I$20240811$20240822$20240825$20240825$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-16726$IPSEN$$58$YR$A$F$Y$$$20240825$$MD$GB$GB
242463311$24246331$1$I$$20240816$20240825$20240825$EXP$$US-RDY-SPO/USA/24/0012232$DR REDDYS$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, et al. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. Journal of Clinical Oncology. 2024 Aug;42(16):$$$E$$Y$$$20240825$$HP$US$US
242463323$24246332$3$F$20240801$20240906$20240825$20240930$30DAY$$US-JNJFOC-20240807347$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240930$$PH$US$US
242463331$24246333$1$I$$20240820$20240825$20240825$EXP$$AU-RDY-SPO/AUS/24/0012288$DR REDDYS$$50$YR$A$M$Y$$$20240825$$CN$AU$AU
242463352$24246335$2$F$20240815$20240917$20240825$20240923$30DAY$$US-AMGEN-USASP2024164111$AMGEN$$57$YR$A$M$Y$64.7$KG$20240922$$PH$US$US
242463362$24246336$2$F$20240807$20240911$20240825$20240917$30DAY$$US-AMGEN-USASP2024163214$AMGEN$$61$YR$A$F$Y$59$KG$20240916$$PH$US$US
242463371$24246337$1$I$$20240819$20240825$20240825$EXP$$AU-JNJFOC-20240846556$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240825$$CN$AU$AU
242463381$24246338$1$I$20240815$20240817$20240825$20240825$EXP$GB-MHRA-MED-202408172356121370-JKCPY$GB-RDY-SPO/GBR/24/0012052$DR REDDYS$$$$$$Y$$$20240825$$CN$GB$GB
242463391$24246339$1$I$$20240816$20240825$20240825$PER$$US-JNJFOC-20240849110$JOHNSON AND JOHNSON$$$$$$Y$$$20240825$$CN$US$US
242463401$24246340$1$I$$20240821$20240825$20240825$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-16780$IPSEN$$$$$M$Y$$$20240825$$HP$GB$GB
242463412$24246341$2$F$20240819$20240904$20240825$20240910$EXP$$US-JNJFOC-20240854686$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240910$$HP$US$US
242463421$24246342$1$I$$20240822$20240825$20240825$EXP$$AT-SANDOZ INC.-SDZ2024AT074593$SANDOZ$$61$YR$$M$Y$$$20240825$$MD$AT$AT
242463481$24246348$1$I$$20240822$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408014707$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240825$$HP$US$US
242463492$24246349$2$F$20240804$20240826$20240825$20240827$PER$$US-AMGEN-USASP2024166613$AMGEN$$52$YR$A$M$Y$$$20240827$$PH$US$US
242463501$24246350$1$I$$20240820$20240825$20240825$PER$$US-ALXN-202408USA001361US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240825$$CN$US$US
242463511$24246351$1$I$$20240815$20240825$20240825$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024102699$VIIV$$$$$$Y$$$20240825$$MD$US$US
242463521$24246352$1$I$$20240812$20240825$20240825$EXP$$AU-RDY-LIT/AUS/24/0012011$DR REDDYS$Kwok L, Mahmood A, Kumar S, Chang A. Case Report: Macula Structural and Functional Assessment in Nab-Paclitaxel-Related Cystoid Macular Edema. Ophthalmic Surgery, Lasers and Imaging Retina. 2024;55(7): 408-411. doi:10.3928/23258160-20240227-01.$54$YR$A$F$Y$$$20240825$$MD$AU$AU
242463531$24246353$1$I$20240813$20240819$20240825$20240825$EXP$$US-JNJFOC-20240854993$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240825$$MD$US$US
242463551$24246355$1$I$$20240725$20240825$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07535$LUPIN$$$$$$Y$$$20240825$$CN$US$US
242463561$24246356$1$I$$20240725$20240825$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07457$LUPIN$$$$$$Y$$$20240825$$CN$US$US
242463572$24246357$2$F$20240812$20240828$20240825$20240905$PER$$US-AstraZeneca-2024A183946$ASTRAZENECA$$25597$DY$$M$Y$$$20240905$$CN$US$
242463581$24246358$1$I$$20240725$20240825$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07474$LUPIN$$$$$$Y$$$20240825$$CN$US$US
242463591$24246359$1$I$$20240725$20240825$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07464$LUPIN$$$$$$Y$$$20240825$$CN$US$US
242463601$24246360$1$I$$20240811$20240825$20240825$EXP$$IT-JNJFOC-20240857553$JOHNSON AND JOHNSON$$88$YR$E$F$Y$60$KG$20240825$$HP$IT$IT
242463611$24246361$1$I$$20240812$20240825$20240825$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-08215$LUPIN$$$$$$Y$$$20240825$$HP$CA$CA
242463641$24246364$1$I$$20240820$20240825$20240825$EXP$$US-BAUSCHBL-2024BNL032018$BAUSCH AND LOMB$$74$YR$$F$Y$$$20240825$$$COUNTRY NOT SPECIFIED$US
242463671$24246367$1$I$$20240815$20240825$20240825$30DAY$$US-GSK-US2024101830$GLAXOSMITHKLINE$$$$$F$Y$$$20240825$$CN$US$US
242463681$24246368$1$I$$20240816$20240825$20240825$EXP$$PL-RDY-SPO/POL/24/0012260$DR REDDYS$Fecko M, Klimek M, Zielinski T, Gawrychowski J, Mackiewicz M, Nowosielski K. An unusual presentation of acute pancreatitis associated with primary hyperparathyroidism in pregnant woman. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2024 Feb;293(85): doi:10.1016/j.ejogrb.2023.08.241.$30$YR$A$F$Y$$$20240825$$HP$PL$PL
242463691$24246369$1$I$20190301$20240823$20240825$20240825$EXP$$EU-BAUSCHBL-2024BNL032221$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240825$$MD$EU$EU
242463731$24246373$1$I$20240101$20240816$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408010971$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240825$$CN$US$US
242463741$24246374$1$I$20240816$20240816$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408011026$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240825$$CN$US$US
242463751$24246375$1$I$$20240821$20240825$20240825$PER$$US-JNJFOC-20240856907$JOHNSON AND JOHNSON$$$$$$Y$$$20240825$$MD$US$US
242463761$24246376$1$I$$20240812$20240825$20240825$EXP$E2B_07211680$CA-LUPIN PHARMACEUTICALS INC.-2024-08224$LUPIN$$$$$$Y$$$20240825$$MD$CA$CA
242463791$24246379$1$I$$20240812$20240825$20240825$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08235$LUPIN$$$$$$Y$$$20240825$$HP$US$CA
242463802$24246380$2$F$20240821$20240905$20240825$20240906$PER$$US-AMGEN-USASP2024167554$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242463832$24246383$2$F$20240814$20240827$20240825$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408011762$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240829$$CN$US$US
242463841$24246384$1$I$20240817$20240819$20240825$20240825$PER$$US-AstraZeneca-2024A188986$ASTRAZENECA$$23181$DY$$F$Y$$$20240825$$CN$US$
242463851$24246385$1$I$$20240821$20240825$20240825$EXP$$US-AstraZeneca-2024A191132$ASTRAZENECA$$$$$F$Y$$$20240825$$CN$US$
242463871$24246387$1$I$$20240816$20240825$20240825$EXP$$US-RDY-SPO/USA/24/0012216$DR REDDYS$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, et al. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. Journal of Clinical Oncology. 2024 Aug;42(16):$$$E$$Y$$$20240825$$HP$US$US
242463901$24246390$1$I$$20240722$20240825$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07381$LUPIN$$$$$$Y$$$20240825$$CN$US$US
242463911$24246391$1$I$$20240722$20240825$20240825$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07451$LUPIN$$$$$$Y$$$20240825$$CN$US$US
242463921$24246392$1$I$$20240819$20240825$20240825$PER$$US-RDY-SPO/USA/24/0012177$DR REDDYS$$36$YR$A$F$Y$$$20240825$$MD$US$US
242463931$24246393$1$I$20240101$20240813$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408008514$ELI LILLY AND CO$$64$YR$A$$Y$$$20240825$$CN$US$US
242463951$24246395$1$I$20220101$20240816$20240825$20240825$EXP$$RU-GILEAD-2024-0683977$GILEAD$$45$YR$A$M$Y$$$20240825$$MD$RU$RU
242463961$24246396$1$I$$20240815$20240825$20240825$EXP$$RU-GLENMARK PHARMACEUTICALS-2024GMK093420$GLENMARK$$$$$$Y$$$20240825$$MD$RU$RU
242463971$24246397$1$I$$20240821$20240825$20240825$PER$$US-JNJFOC-20240858131$JOHNSON AND JOHNSON$$$$$$Y$$$20240825$$HP$US$US
242463981$24246398$1$I$$20240819$20240825$20240825$EXP$$DE-GILEAD-2024-0684706$GILEAD$$$$$F$Y$$$20240825$$MD$DE$DE
242463991$24246399$1$I$$20240811$20240825$20240825$EXP$$JP-Inventia-000741$INVENTIA HEALTHCARE$Harada T, Nakanishi T, Kutsuna S, Nakai M. Unexpected Sudden Deaths Following the Co-administration of Ceftriaxone and Lansoprazole: A Case Series. Cureus. 2024 Jul 9;16(7):e64143.$81$YR$E$M$Y$$$20240824$$HP$JP$JP
242464001$24246400$1$I$$20240811$20240825$20240825$EXP$$US-Axellia-005318$XELLIA PHARMACEUTICALS$Jha V, Jha SK, Aryal B, Dhungel S, Jha S, Brock M. A Report of a Rare Case of Kounis Syndrome in a Patient With HIV/AIDS and Mpox. Cureus. 2024;16(7):e63957.$45$YR$A$M$Y$$$20240824$$HP$US$US
242464011$24246401$1$I$20240820$20240821$20240825$20240825$EXP$$CH-GILEAD-2024-0685022$GILEAD$$75$YR$E$F$Y$$$20240825$$MD$CH$CH
242464021$24246402$1$I$$20240819$20240825$20240825$PER$$US-AMGEN-USASP2024165986$AMGEN$$$$$$Y$$$20240825$$CN$US$US
242464041$24246404$1$I$$20240819$20240825$20240825$PER$$US-JNJFOC-20240847020$JOHNSON AND JOHNSON$$$$$M$Y$$$20240825$$CN$US$US
242464051$24246405$1$I$$20240821$20240825$20240825$EXP$$US-JNJFOC-20240854963$JOHNSON AND JOHNSON$$$$$$Y$$$20240825$$PH$US$US
242464061$24246406$1$I$$20240814$20240825$20240825$PER$$US-AstraZeneca-2024A185922$ASTRAZENECA$$$$$M$Y$$$20240825$$CN$US$
242464071$24246407$1$I$$20230628$20240825$20240825$EXP$$US-AstraZeneca-2023A149976$ASTRAZENECA$$$$$M$Y$$$20240825$$CN$US$
242464081$24246408$1$I$20240513$20240821$20240825$20240825$EXP$$US-AstraZeneca-2024A191247$ASTRAZENECA$$25332$DY$$M$Y$$$20240825$$MD$US$
242464091$24246409$1$I$20240705$20240820$20240825$20240825$PER$$US-AMGEN-USASP2024167800$AMGEN$$$$A$F$Y$$$20240825$$HP$US$US
242464111$24246411$1$I$$20240821$20240825$20240825$PER$$US-JNJFOC-20240857523$JOHNSON AND JOHNSON$$$$$M$Y$$$20240825$$CN$US$US
242464121$24246412$1$I$$20240822$20240825$20240825$PER$$US-AstraZeneca-2024A192213$ASTRAZENECA$$$$$F$Y$$$20240825$$CN$US$
242464131$24246413$1$I$$20240819$20240825$20240825$PER$$US-AMGEN-USASP2024166325$AMGEN$$$$$$Y$$$20240825$$PH$US$US
242464151$24246415$1$I$$20240820$20240825$20240825$EXP$CA-DRL-USA-SPO/CAN/24/0012128$CA-RDY-SPO/CAN/24/0012128$DR REDDYS$$85$YR$E$F$Y$$$20240825$$CN$CA$CA
242464161$24246416$1$I$$20240814$20240825$20240825$EXP$$DE-RDY-SPO/DEU/24/0012211$DR REDDYS$Dyballa N, Hartel JA, Prangenberg J, Andresen-Streichert H. A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting - clinical, toxicological and forensic aspects. Forensic science, medicine, and pathology. 2024 Aug 01;doi:10.1007/s12024-024-00859-8.$12$WK$I$M$Y$$$20240825$$HP$DE$DE
242464171$24246417$1$I$$20240816$20240825$20240825$EXP$$US-RDY-SPO/USA/24/0012226$DR REDDYS$Fregonese B, Imber BS, Dreyfuss A, Boe LA, Hajj C, Yahalom J. Combined modality for localized gastric diffuse large B-cell lymphoma: Long-term outcomes of 50 patients. Journal of Clinical Oncology. 2024 May 29;42(16): 7079. doi:10.1200/JCO.2024.42.16_suppl.7079.$$$$$Y$$$20240825$$HP$US$US
242464181$24246418$1$I$20240611$20240812$20240825$20240825$EXP$$US-RDY-SPO/USA/24/0012198$DR REDDYS$$37$YR$A$F$Y$$$20240825$$HP$US$US
242464191$24246419$1$I$20240817$20240819$20240825$20240825$PER$$US-AMGEN-USASP2024166394$AMGEN$$29$YR$A$F$Y$$$20240825$$CN$US$US
242464201$24246420$1$I$20240814$20240815$20240825$20240825$PER$$US-ABBVIE-5885183$ABBVIE$$27$YR$$M$Y$$$20240825$$MD$US$US
242464211$24246421$1$I$20240604$20240816$20240825$20240825$EXP$FR-AFSSAPS-TO2024001041$FR-RDY-SPO/FRA/24/0012021$DR REDDYS$$72$YR$E$M$Y$73$KG$20240825$$HP$FR$FR
242464221$24246422$1$I$20240220$20240729$20240825$20240825$PER$$US-RDY-SPO/USA/24/0011231$DR REDDYS$$22$YR$A$$Y$$$20240825$$CN$US$US
242464231$24246423$1$I$$20240813$20240825$20240825$EXP$$US-RDY-LIT/USA/24/0012009$DR REDDYS$Oaklander AL, Allen J, Dietlike N, Wilder-Smith EP. Relapsing-Remitting Immunotherapy Responsive Small-Fiber Neuropathy: Longitudinal Tracking Through 10 Years Including Pregnancies. Neurology: Neuroimmunology and NeuroInflammation. 2024;11(5): doi:10.1212/NXI.0000000000200286.$35$YR$A$F$Y$$$20240825$$MD$US$US
242464241$24246424$1$I$20240720$20240819$20240825$20240825$EXP$GB-MHRA-MED-202408190809519580-PNRSH$GB-RDY-SPO/GBR/24/0012109$DR REDDYS$$66$YR$E$M$Y$74$KG$20240825$$HP$GB$GB
242464251$24246425$1$I$$20240807$20240825$20240825$PER$$US-JNJFOC-20240859218$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240825$$PH$US$US
242464261$24246426$1$I$$20240814$20240825$20240825$PER$$US-RDY-SPO/USA/24/0011965$DR REDDYS$$41$YR$A$F$Y$$$20240825$$HP$US$US
242464271$24246427$1$I$$20240816$20240825$20240825$EXP$$US-RDY-SPO/USA/24/0012215$DR REDDYS$Fregonese B, Imber BS, Dreyfuss A, Boe LA, Hajj C, Yahalom J. Combined modality for localized gastric diffuse large B-cell lymphoma: Long-term outcomes of 50 patients. Journal of Clinical Oncology. 2024 May 29;42(16): 7079. doi:10.1200/JCO.2024.42.16_suppl.7079.$$$$$Y$$$20240825$$HP$US$US
242464291$24246429$1$I$$20240822$20240825$20240825$PER$$US-HALEON-2193274$Haleon PLC$$$$$$Y$$$20240825$$CN$US$US
242464301$24246430$1$I$$20240815$20240825$20240825$PER$$US-RDY-SPO/USA/24/0012013$DR REDDYS$$19$YR$A$F$Y$$$20240825$$HP$US$US
242464311$24246431$1$I$$20240816$20240825$20240825$PER$$US-AstraZeneca-2024A189779$ASTRAZENECA$$$$$$Y$$$20240825$$CN$US$
242464321$24246432$1$I$$20240821$20240825$20240825$PER$$US-JNJFOC-20240856467$JOHNSON AND JOHNSON$$$$$M$Y$$$20240825$$MD$US$US
242464331$24246433$1$I$$20240815$20240825$20240825$EXP$$CA-BAXTER-2024BAX023355$BAXTER$$7$YR$$M$Y$30$KG$20240825$$HP$CA$CA
242464341$24246434$1$I$20240813$20240815$20240825$20240825$EXP$CN-NMPACDR-3501821025798202400304$CN-BAXTER-2024BAX023388$BAXTER$$55$YR$$F$Y$78$KG$20240825$$MD$CN$CN
242464351$24246435$1$I$20240810$20240814$20240825$20240825$EXP$CN-NMPACDR-4403061004846202400168$CN-BAXTER-2024BAX023336$BAXTER$$43$YR$$F$Y$64$KG$20240825$$MD$CN$CN
242464361$24246436$1$I$20240807$20240820$20240825$20240825$EXP$$CN-ROCHE-10000061857$ROCHE$$44$YR$A$F$Y$51$KG$20240825$$HP$CN$CN
242464371$24246437$1$I$$20240819$20240825$20240825$EXP$FR-SEATTLE GENETICS-2023SGN10846$FR-RDY-SPO/FRA/24/0012067$DR REDDYS$$59$YR$A$F$Y$$$20240825$$HP$FR$FR
242464381$24246438$1$I$20240802$20240814$20240825$20240825$EXP$CN-NMPACDR-3305021058330202400024$CN-BAXTER-2024BAX023346$BAXTER$$49$YR$$M$Y$50$KG$20240825$$MD$CN$CN
242464391$24246439$1$I$$20240815$20240825$20240825$EXP$$CA-BAXTER-2024BAX023353$BAXTER$$30$YR$$F$Y$$$20240825$$HP$CA$CA
242464401$24246440$1$I$20190606$20240815$20240825$20240825$EXP$$US-BAXTER-2024BAX023238$BAXTER$$4$YR$$M$Y$17.8$KG$20240825$$MD$US$US
242464411$24246441$1$I$$20240819$20240825$20240825$EXP$$GB-ROCHE-10000060571$ROCHE$$$$A$F$Y$$$20240825$$HP$GB$GB
242464421$24246442$1$I$$20240821$20240825$20240825$PER$$US-JNJFOC-20240854621$JOHNSON AND JOHNSON$$$$$$Y$$$20240825$$CN$US$US
242464431$24246443$1$I$$20240814$20240825$20240825$EXP$$VN-JNJFOC-20240844042$JOHNSON AND JOHNSON$$$$$M$Y$$$20240825$$HP$VN$VN
242464441$24246444$1$I$20240815$20240816$20240825$20240825$PER$$US-AstraZeneca-2024A188035$ASTRAZENECA$$14520$DY$$$Y$$$20240825$$CN$US$
242464451$24246445$1$I$$20240813$20240825$20240825$PER$$US-JNJFOC-20240862843$JOHNSON AND JOHNSON$$$$$M$Y$$$20240825$$HP$US$US
242464461$24246446$1$I$20240101$20240821$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408013556$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240825$$CN$US$US
242464471$24246447$1$I$$20240813$20240825$20240825$EXP$$RU-ROCHE-10000057981$ROCHE$$$$A$F$Y$$$20240825$$MD$RU$RU
242464481$24246448$1$I$$20240813$20240825$20240825$EXP$US-MLMSERVICE-20190815-1901494-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17525$ALKEM$Hampton Z, Shahrestani N, Little A.. Gabapentin-induced Facial Myoclonus in the Setting of Acute on Chronic Kidney Disease. Cureus. 2019;11(5):e4758$82$YR$$M$Y$$$20240825$$HP$US$US
242464491$24246449$1$I$$20240814$20240825$20240825$PER$$US-JNJFOC-20240862951$JOHNSON AND JOHNSON$$$$$$Y$$$20240825$$MD$US$US
242464501$24246450$1$I$20240818$20240821$20240825$20240825$30DAY$$US-SANDOZ INC.-SDZ2024US074486$SANDOZ$$15$YR$$M$Y$$$20240825$$CN$US$US
242464511$24246451$1$I$20240805$20240813$20240825$20240825$EXP$GB-MHRA-MED-202408090733475210-THVZJ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19099$ALKEM$$23$MON$$F$Y$$$20240825$$CN$GB$GB
242464522$24246452$2$F$20180101$20240828$20240825$20240912$EXP$IT-MLMSERVICE-20210524-2869594-1$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-19214$ALKEM$Fraticelli S, Bonometti A, Lucioni M, Capuano F, Meloni F, Arcaini L, Baldanti F, Paulli M.. Late-onset EBV-related post-transplant non-secreting plasma-cell neoplasms: Description of two cases. Leukemia Research. 2021;100:Article Number 106493$44$YR$$F$Y$$$20240912$$MD$IT$IT
242464532$24246453$2$F$$20240828$20240825$20240912$EXP$JP-MLMSERVICE-20240808-PI153824-00232-1$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-19095$ALKEM$Kou R, Onishi Y, Ogiso S, Kai S, Nakamoto Y.. Emphysematous osteomyelitis of the lumbar spine and sacrum after liver transplantation: A case report. Cureus. 2024;16(7):e63748$62$YR$$M$Y$$$20240912$$MD$JP$JP
242464541$24246454$1$I$$20240813$20240825$20240825$EXP$US-MLMSERVICE-20190822-1912815-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18540$ALKEM$Qiu X, Tackett E, Khitan Z.. A case of gabapentin overdose induced rhabdomyolysis requiring renal replacement therapy. Clin Case Rep. 2019;7(8):1596-1599$39$YR$$M$Y$$$20240825$$MD$US$US
242464551$24246455$1$I$20240807$20240813$20240825$20240825$EXP$GB-MHRA-MED-202408121525422230-KCFNG$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19100$ALKEM$$76$YR$$M$Y$$$20240825$$HP$GB$GB
242464583$24246458$3$F$$20240904$20240825$20240914$PER$$US-ROCHE-10000059716$ROCHE$$$$$F$Y$$$20240914$$MD$US$US
242464591$24246459$1$I$20240327$20240820$20240825$20240825$EXP$$NVSC2024US072794$NOVARTIS$$47$YR$$M$Y$$$20240825$$CN$US$US
242464621$24246462$1$I$$20240819$20240825$20240825$PER$$US-JNJFOC-20240853943$JOHNSON AND JOHNSON$$$$$F$Y$$$20240825$$CN$US$US
242464641$24246464$1$I$$20240816$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408011479$ELI LILLY AND CO$$$$$F$Y$$$20240825$$CN$US$US
242464651$24246465$1$I$$20240819$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408015027$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240825$$CN$US$US
242464661$24246466$1$I$20240816$20240821$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408011480$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240825$$CN$US$US
242464671$24246467$1$I$$20240821$20240825$20240825$EXP$$AU-ROCHE-10000062584$ROCHE$$$$$$Y$$$20240825$$CN$AU$AU
242464691$24246469$1$I$20240514$20240822$20240825$20240825$EXP$$PK-ROCHE-10000063911$ROCHE$$27$YR$A$F$Y$$$20240825$$CN$PK$PK
242464711$24246471$1$I$20240815$20240815$20240825$20240825$PER$$US-AstraZeneca-2024A187287$ASTRAZENECA$$17925$DY$$M$Y$$$20240825$$CN$US$
242464721$24246472$1$I$20240201$20240820$20240825$20240825$EXP$$BR-JNJFOC-20240859879$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240825$$CN$BR$BR
242464731$24246473$1$I$20240727$20240819$20240825$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133442$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240825$$CN$US$US
242464751$24246475$1$I$20240101$20240816$20240825$20240825$PER$$US-AMGEN-USASP2024164035$AMGEN$$20$YR$A$F$Y$$$20240825$$HP$US$US
242464804$24246480$4$F$20240817$20240903$20240825$20240911$PER$$US-ABBVIE-5894293$ABBVIE$$51$YR$$F$Y$67$KG$20240911$$HP$US$US
242464811$24246481$1$I$$20240820$20240825$20240825$PER$$US-AstraZeneca-2024A190371$ASTRAZENECA$$$$$M$Y$$$20240825$$CN$US$
242464821$24246482$1$I$$20240820$20240825$20240825$EXP$$ZA-JNJFOC-20240860706$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240825$$CN$ZA$ZA
242464871$24246487$1$I$20240817$20240821$20240825$20240825$PER$$US-AstraZeneca-2024A191284$ASTRAZENECA$$24212$DY$$M$Y$$$20240825$$CN$US$
242464881$24246488$1$I$$20240820$20240825$20240825$EXP$$BR-JNJFOC-20240864776$JOHNSON AND JOHNSON$$$$$F$Y$$$20240825$$CN$BR$BR
242464891$24246489$1$I$$20240822$20240825$20240825$30DAY$$US-ELI_LILLY_AND_COMPANY-US202408015036$ELI LILLY AND CO$$71$YR$E$$Y$$$20240825$$CN$US$US
242464911$24246491$1$I$$20240819$20240825$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132223$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240825$$CN$US$US
242464971$24246497$1$I$$20240822$20240825$20240825$PER$$US-AstraZeneca-2024A192055$ASTRAZENECA$$$$$M$Y$$$20240825$$MD$US$
242464981$24246498$1$I$$20240820$20240825$20240825$PER$$US-AstraZeneca-2024A190090$ASTRAZENECA$$$$$M$Y$$$20240825$$CN$US$
242465011$24246501$1$I$$20240819$20240825$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133420$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$68.04$KG$20240825$$CN$US$US
242465051$24246505$1$I$$20240822$20240825$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133758$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240825$$PH$US$US
242465061$24246506$1$I$$20240821$20240825$20240825$PER$$US-JNJFOC-20240855139$JOHNSON AND JOHNSON$$$$$$Y$$$20240825$$MD$US$US
242465072$24246507$2$F$20240815$20240826$20240825$20240829$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-132197$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$84$KG$20240829$$CN$CN$CN
242465081$24246508$1$I$$20240819$20240825$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133774$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240825$$CN$US$US
242465091$24246509$1$I$$20240820$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408013503$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240825$$CN$US$US
242465111$24246511$1$I$$20240820$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408013482$ELI LILLY AND CO$$7$YR$C$$Y$$$20240825$$CN$US$US
242465131$24246513$1$I$$20240819$20240825$20240825$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132711$BRISTOL MYERS SQUIBB$$38$YR$A$$Y$$$20240825$$MD$US$US
242465161$24246516$1$I$20230101$20240816$20240825$20240825$PER$$US-JNJFOC-20240850101$JOHNSON AND JOHNSON$$9$DEC$E$M$Y$$$20240825$$CN$US$US
242465181$24246518$1$I$$20240821$20240825$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133552$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240825$$CN$US$US
242465191$24246519$1$I$20240101$20240820$20240825$20240825$PER$$US-AMGEN-USASP2024166124$AMGEN$$$$$F$Y$$$20240825$$CN$US$US
242465201$24246520$1$I$$20240820$20240825$20240825$PER$$US-AMGEN-USASP2024166479$AMGEN$$$$$$Y$$$20240825$$MD$US$US
242465211$24246521$1$I$20240612$20240813$20240825$20240825$EXP$$US-JNJFOC-20240756047$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240825$$CN$US$US
242465221$24246522$1$I$20240811$20240814$20240825$20240825$PER$$US-JNJFOC-20240841465$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20240825$$CN$US$US
242465231$24246523$1$I$$20240821$20240825$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133366$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240825$$CN$US$US
242465241$24246524$1$I$$20240814$20240825$20240825$EXP$$US-JNJFOC-20240841928$JOHNSON AND JOHNSON$$$$$$Y$$$20240825$$CN$US$US
242465251$24246525$1$I$$20240822$20240825$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134192$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240825$$HP$US$US
242465261$24246526$1$I$$20240822$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408014876$ELI LILLY AND CO$$$$$M$Y$$$20240825$$CN$US$US
242465271$24246527$1$I$$20240820$20240825$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133503$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240825$$CN$US$US
242465311$24246531$1$I$$20240820$20240825$20240825$EXP$$NVSC2024GB169559$NOVARTIS$$$$$M$Y$$$20240826$$CN$GB$GB
242465361$24246536$1$I$$20240819$20240825$20240825$PER$$US-ALXN-202408USA001201US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242465391$24246539$1$I$$20240820$20240825$20240825$EXP$$US-ALXN-202408USA001470US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$MD$US$US
242465401$24246540$1$I$20240806$20240819$20240825$20240825$PER$$US-JNJFOC-20240850447$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240826$$CN$US$US
242465431$24246543$1$I$$20240819$20240825$20240825$EXP$$DE-AMGEN-DEUSP2024165597$AMGEN$Kramer M.; Frederking F.; Kekow J. et al.. DRUG RETENTION OF TNFi BIOSIMILARS AND BIOORIGINALS IN DAILY RHEUMATOLOGY CARE IN GERMANY: INSIGHTS FROM THE RABBIT REGISTER. Annals of the Rheumatic Diseases. 2024;83:807$$$$$Y$$$20240825$$HP$DE$DE
242465441$24246544$1$I$$20240821$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408013874$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240825$$CN$US$US
242465451$24246545$1$I$$20240811$20240825$20240825$PER$$US-AMGEN-USASP2024164197$AMGEN$Sandhu T.; Meir L.; Ng N. et al.. RITUXIMAB FOR TREATMENT OF SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE AT MOUNT SINAI MEDICAL CENTER. Annals of the Rheumatic Diseases. 2024;83 (SUPPL_1):1918-1919$$$$$Y$$$20240825$$HP$US$US
242465461$24246546$1$I$20240819$20240820$20240825$20240825$PER$$US-AMGEN-USASP2024166218$AMGEN$$79$YR$E$F$Y$$$20240825$$CN$US$US
242465491$24246549$1$I$$20240818$20240825$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134340$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240826$$MD$US$US
242465511$24246551$1$I$20240101$20240822$20240825$20240825$EXP$$CN-JNJFOC-20240859946$JOHNSON AND JOHNSON$$83$YR$E$M$Y$65$KG$20240826$$HP$CN$CN
242465541$24246554$1$I$20231204$20240821$20240825$20240825$EXP$$JP-TAKEDA-2024TJP012213$TAKEDA$$24$YR$$F$Y$$$20240825$$MD$JP$JP
242465551$24246555$1$I$$20240814$20240825$20240825$EXP$$MX-JNJFOC-20240843486$JOHNSON AND JOHNSON$$60$YR$A$M$Y$70$KG$20240826$$CN$MX$MX
242465561$24246556$1$I$20240701$20240813$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408008650$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240825$$CN$US$US
242465571$24246557$1$I$$20240822$20240825$20240825$30DAY$$US-SANDOZ INC.-SDZ2024US074810$SANDOZ$$21$YR$$F$Y$$$20240825$$CN$US$US
242465612$24246561$2$F$20240101$20240917$20240825$20240923$30DAY$$US-AMGEN-USASP2024163111$AMGEN$$$$$$Y$$$20240923$$HP$US$US
242465621$24246562$1$I$$20240820$20240825$20240825$EXP$$US-SANDOZ INC.-SDZ2024US074856$SANDOZ$$$$$$Y$$$20240825$$CN$US$US
242465651$24246565$1$I$$20240815$20240825$20240825$EXP$$US-BAUSCHBL-2024BNL031779$BAUSCH AND LOMB$Timtim E, Barahimi B, Mawn L, Sobel R. Sebaceous carcinoma masquerading as ocular mucous membrane pemphigoid. Orbit. 2024;43(4):531-534. doi:10.1080/01676830.2023.2204489$56$YR$$F$Y$$$20240826$$HP$US$US
242465661$24246566$1$I$$20240821$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408013918$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240825$$CN$US$US
242465671$24246567$1$I$20240801$20240821$20240825$20240825$EXP$$MY-JNJFOC-20240860306$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$MD$MY$MY
242465682$24246568$2$F$$20240827$20240825$20240830$30DAY$$US-SANDOZ INC.-SDZ2024US074938$SANDOZ$$$$$M$Y$$$20240830$$CN$US$US
242465701$24246570$1$I$$20240812$20240825$20240825$EXP$$US-SOLA PHARMACEUTICALS-20240800011$SOLA PHARMACEUTICALS$Numra A Bajwa. Dimethyl Fumarate-Associated Enterocolitis. Am J Ther. 2024;31(4):e448-e450$$$$$Y$$$20240825$$HP$US$US
242465711$24246571$1$I$20230901$20240812$20240825$20240825$EXP$$US-SOLA PHARMACEUTICALS-20240800014$SOLA PHARMACEUTICALS$Darin T Okuda. Underdosed generic specialty medications: A prescription for patient harm?. Mult Scler Relat Disord .. 2024;88:105760$$$$$Y$$$20240825$$HP$US$US
242465721$24246572$1$I$$20240812$20240825$20240825$EXP$$JP-SOLA PHARMACEUTICALS-20240800013$SOLA PHARMACEUTICALS$Satoshi Saito. Clinical Experience with Dimethyl Fumarate and Natalizumab in Pregnant Women with Multiple Sclerosis: A Four-Patient Case Series. Case Rep Neurol Med. 2024;7808140 1-8$$$$$Y$$$20240825$$HP$JP$JP
242465731$24246573$1$I$20230101$20240123$20240825$20240825$PER$$US-KVK-TECH, INC-20240100009$KVK-TECH$$72$YR$$M$Y$$$20240825$$CN$US$US
242465742$24246574$2$F$20240210$20240830$20240825$20240913$EXP$$DE-AMGEN-DEUSP2024169125$AMGEN$$60$YR$A$M$Y$92.1$KG$20240912$$HP$DE$DE
242465771$24246577$1$I$$20240821$20240825$20240825$EXP$$US-JNJFOC-20240856004$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$CN$US$US
242465781$24246578$1$I$20060101$20240821$20240825$20240825$PER$$US-JNJFOC-20170421980$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20240826$$LW$US$US
242465791$24246579$1$I$20220101$20240821$20240825$20240825$EXP$$CO-ABBVIE-5891217$ABBVIE$$$$$F$Y$65$KG$20240825$$CN$CO$CO
242465803$24246580$3$F$20240701$20240904$20240825$20240910$EXP$$US-ABBVIE-5891129$ABBVIE$$78$YR$$M$Y$84.821$KG$20240910$$CN$US$US
242465812$24246581$2$F$20230510$20240826$20240825$20240902$PER$$US-ORGANON-O2408USA001678$ORGANON$$19$YR$$F$Y$$$20240902$$MD$US$US
242465821$24246582$1$I$20240819$20240821$20240825$20240825$EXP$$CA-ABBVIE-5891237$ABBVIE$$51$YR$$F$Y$$$20240825$$CN$CA$CA
242465831$24246583$1$I$$20240823$20240825$20240825$EXP$$NVSC2024MW171281$NOVARTIS$$$$$M$Y$$$20240826$$MD$MW$MW
242465841$24246584$1$I$$20240822$20240825$20240825$30DAY$$US-SANDOZ INC.-SDZ2024US074962$SANDOZ$$$$$F$Y$$$20240825$$CN$US$US
242465851$24246585$1$I$$20240822$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408014728$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240825$$CN$US$US
242465861$24246586$1$I$$20240730$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202407019906$ELI LILLY AND CO$$82$YR$E$$Y$$$20240825$$CN$US$US
242465881$24246588$1$I$20240801$20240821$20240825$20240825$EXP$$JP-TAKEDA-2024TJP012006$TAKEDA$$54$YR$$M$Y$$$20240825$$PH$JP$JP
242465891$24246589$1$I$$20240822$20240825$20240825$EXP$$NVSC2024US171188$NOVARTIS$$$$$$Y$$$20240826$$MD$US$US
242465901$24246590$1$I$20240730$20240821$20240825$20240825$EXP$$CO-JNJFOC-20240860739$JOHNSON AND JOHNSON$$78$YR$E$F$Y$70$KG$20240826$$HP$CO$CO
242465951$24246595$1$I$20240809$20240815$20240825$20240825$PER$$US-ABBVIE-5883064$ABBVIE$$56$YR$$F$Y$107$KG$20240825$$CN$US$US
242465961$24246596$1$I$20240801$20240822$20240825$20240825$EXP$$US-ABBVIE-5891989$ABBVIE$$77$YR$$M$Y$$$20240825$$CN$US$US
242465971$24246597$1$I$20190101$20240820$20240825$20240825$EXP$$DE-ABBVIE-5889735$ABBVIE$$70$YR$$F$Y$103$KG$20240825$$CN$DE$DE
242465981$24246598$1$I$20240701$20240820$20240825$20240825$EXP$$US-ABBVIE-5852301$ABBVIE$$63$YR$$F$Y$$$20240825$$CN$US$US
242465993$24246599$3$F$20240822$20240911$20240825$20240924$PER$$US-JNJFOC-20240858063$JOHNSON AND JOHNSON$$82$YR$E$M$Y$82.1$KG$20240925$$PH$US$US
242466001$24246600$1$I$20240501$20240823$20240825$20240825$EXP$GB-MHRA-MED-202408231258344730-PRSTV$GB-JNJFOC-20240861178$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240826$$PH$GB$GB
242466011$24246601$1$I$20240301$20240819$20240825$20240825$EXP$$AR-AMGEN-ARGSP2024168232$AMGEN$$80$YR$E$F$Y$$$20240825$$CN$AR$AR
242466021$24246602$1$I$20240730$20240820$20240825$20240825$EXP$FR-AFSSAPS-PB2024000881$FR-BEIGENE-BGN-2024-013114$BEIGENE$$$$$$Y$$$20240825$$PH$FR$FR
242466033$24246603$3$F$20240101$20240910$20240825$20240925$30DAY$$AU-JNJFOC-20240808645$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$PH$AU$AU
242466041$24246604$1$I$20240701$20240820$20240825$20240825$EXP$$PR-ABBVIE-5854687$ABBVIE$$70$YR$$F$Y$$$20240825$$CN$PR$PR
242466051$24246605$1$I$20230101$20240812$20240825$20240825$EXP$$US-BAUSCHBL-2024BNL031605$BAUSCH AND LOMB$$$$$M$Y$$$20240826$$CN$US$US
242466062$24246606$2$F$$20240907$20240825$20240913$EXP$$DE-ORGANON-O2408DEU001593$ORGANON$$45$YR$$F$Y$48$KG$20240913$$CN$DE$DE
242466071$24246607$1$I$20240101$20240817$20240825$20240825$EXP$$US-ABBVIE-5885357$ABBVIE$$$$$F$Y$$$20240825$$CN$US$US
242466091$24246609$1$I$$20240822$20240825$20240825$PER$$US-AMGEN-USASP2024168866$AMGEN$$$$$$Y$$$20240825$$PH$US$US
242466101$24246610$1$I$20240112$20240815$20240825$20240825$EXP$$JP-AMGEN-JPNNI2024169126$AMGEN$$49$YR$A$M$Y$85.6$KG$20240825$$MD$JP$JP
242466113$24246611$3$F$20240101$20240906$20240825$20240913$EXP$$US-ABBVIE-5889127$ABBVIE$$$$$M$Y$81.192$KG$20240913$$CN$US$US
242466122$24246612$2$F$20240820$20240905$20240825$20240912$PER$$US-AMGEN-USASP2024166670$AMGEN$$74$YR$E$M$Y$75.5$KG$20240912$$PH$US$US
242466131$24246613$1$I$$20240823$20240825$20240825$EXP$$CA-ORGANON-O2408CAN001755$ORGANON$$$$$M$Y$$$20240825$$HP$CA$CA
242466151$24246615$1$I$20240804$20240820$20240825$20240825$EXP$$US-ABBVIE-5889579$ABBVIE$$72$YR$$M$Y$$$20240825$$CN$US$US
242466161$24246616$1$I$20240815$20240816$20240825$20240825$EXP$$US-JNJFOC-20240844941$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240826$$MD$US$US
242466191$24246619$1$I$20220701$20240822$20240825$20240825$EXP$FR-AFSSAPS-PO2024000918$FR-AMGEN-FRASP2024168233$AMGEN$$72$YR$E$M$Y$71$KG$20240825$$MD$FR$FR
242466201$24246620$1$I$$20240814$20240825$20240825$PER$$US-BAUSCHBL-2024BNL031827$BAUSCH AND LOMB$$$$$F$Y$$$20240826$$MD$US$US
242466211$24246621$1$I$$20240811$20240825$20240825$EXP$$IT-JNJFOC-20240858280$JOHNSON AND JOHNSON$$71$YR$E$M$Y$96$KG$20240826$$HP$IT$IT
242466221$24246622$1$I$$20240819$20240825$20240825$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134113$BRISTOL MYERS SQUIBB$Kondo H, Shimada H, Yamamoto M, Yamashita S, Hara T, Inoue Y, et al. A case of a patient with unknown primary hilar and mediastinal lymph node carcinoma who developed myelodysplastic syndrome after chemotherapy. Proceedings of the 185th Kanto Branch Meeting of the Japanese Society for Tuberculosis and Nontuberculous Mycobacteriosis, the 258th Kanto Regional Meeting of the Japanese Respiratory Society (the 185th Kanto Branch Meeting of the Japanese Society for Tuberculosis and Nontuberculous Myco$71$YR$E$M$Y$$$20240826$$MD$JP$JP
242466231$24246623$1$I$$20240815$20240825$20240825$PER$$US-BAUSCHBL-2024BNL031815$BAUSCH AND LOMB$$$$$F$Y$$$20240826$$CN$US$US
242466271$24246627$1$I$20240820$20240821$20240825$20240825$EXP$$US-AstraZeneca-2024A190849$ASTRAZENECA$$34030$DY$$M$Y$$$20240826$$CN$US$
242466282$24246628$2$F$20240801$20240917$20240825$20240923$PER$$US-BAUSCHBL-2024BNL031847$BAUSCH AND LOMB$$60$YR$$F$Y$$$20240924$$CN$US$US
242466291$24246629$1$I$$20240820$20240825$20240825$EXP$$CA-ABBVIE-5889235$ABBVIE$$$$E$F$Y$$$20240825$$HP$CA$CA
242466302$24246630$2$F$20240101$20240828$20240825$20240903$EXP$$US-ABBVIE-5890421$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242466312$24246631$2$F$20240701$20240823$20240825$20240829$EXP$$US-ABBVIE-5887390$ABBVIE$$63$YR$$M$Y$72.574$KG$20240829$$CN$US$US
242466323$24246632$3$F$$20240827$20240825$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-132927$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240903$$MD$JP$JP
242466331$24246633$1$I$20240101$20240819$20240825$20240825$EXP$$BR-ABBVIE-5887694$ABBVIE$$$$$F$Y$83$KG$20240825$$CN$BR$BR
242466341$24246634$1$I$20240806$20240822$20240825$20240825$EXP$$CN-BEIGENE-BGN-2024-013250$BEIGENE$$$$$$Y$$$20240825$$HP$CN$CN
242466361$24246636$1$I$20240819$20240821$20240825$20240825$EXP$$US-ABBVIE-5892475$ABBVIE$$80$YR$$M$Y$$$20240825$$CN$US$US
242466371$24246637$1$I$$20240820$20240825$20240825$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133500$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240826$$HP$US$US
242466391$24246639$1$I$20210217$20240819$20240825$20240825$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-133431$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240826$$MD$KR$KR
242466412$24246641$2$F$20240804$20240820$20240825$20240829$EXP$$US-ABBVIE-5889332$ABBVIE$$67$YR$$M$Y$$$20240829$$CN$US$US
242466421$24246642$1$I$20240815$20240821$20240825$20240825$EXP$$NVSC2024CN171074$NOVARTIS$$71$YR$$F$Y$51$KG$20240826$$HP$CN$CN
242466441$24246644$1$I$$20240822$20240825$20240825$EXP$$BE-ABBVIE-5892465$ABBVIE$$76$YR$$M$Y$78$KG$20240825$$HP$BE$BE
242466451$24246645$1$I$20240816$20240816$20240825$20240825$EXP$$GB-CELLTRION INC.-2024GB020043$CELLTRION$$$$$$Y$$$20240826$$CN$GB$GB
242466461$24246646$1$I$$20240821$20240825$20240825$EXP$$US-ABBVIE-5891088$ABBVIE$$$$$M$Y$$$20240825$$CN$US$US
242466481$24246648$1$I$$20240821$20240825$20240825$EXP$$CA-ABBVIE-5890807$ABBVIE$$$$A$F$Y$$$20240825$$CN$CA$CA
242466491$24246649$1$I$20240731$20240821$20240825$20240825$EXP$$US-ABBVIE-5889915$ABBVIE$$72$YR$$F$Y$$$20240825$$CN$US$US
242466501$24246650$1$I$20240101$20240820$20240825$20240825$EXP$$US-ABBVIE-5890052$ABBVIE$$$$$F$Y$$$20240825$$HP$US$US
242466511$24246651$1$I$20240101$20240821$20240825$20240825$EXP$$US-ABBVIE-5892631$ABBVIE$$$$$F$Y$$$20240825$$CN$US$US
242466521$24246652$1$I$20240811$20240820$20240825$20240825$EXP$$US-JNJFOC-20240857249$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240826$$HP$US$US
242466542$24246654$2$F$$20240826$20240825$20240903$EXP$$CA-CELLTRION INC.-2024CA020009$CELLTRION$$$$$$Y$$$20240903$$CN$CA$CA
242466561$24246656$1$I$20240404$20240817$20240825$20240825$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-134080$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240826$$HP$CO$CO
242466571$24246657$1$I$$20240819$20240825$20240825$EXP$$US-AstraZeneca-2024A189219$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242466581$24246658$1$I$$20240819$20240825$20240825$EXP$$US-BEIGENE-BGN-2024-013046$BEIGENE$$$$$$Y$$$20240825$$CN$US$US
242466592$24246659$2$F$20240623$20240906$20240825$20240912$EXP$$KR-ABBVIE-5889807$ABBVIE$$29$YR$$M$Y$75$KG$20240912$$MD$KR$KR
242466601$24246660$1$I$$20240819$20240825$20240825$EXP$$NVSC2024US168397$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
242466611$24246661$1$I$20240816$20240820$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408012764$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240825$$CN$US$US
242466621$24246662$1$I$$20240820$20240825$20240825$PER$$US-AMGEN-USASP2024167098$AMGEN$$$$$F$Y$$$20240825$$CN$US$US
242466631$24246663$1$I$$20240816$20240825$20240825$EXP$$PT-NOVITIUMPHARMA-2024PTNVP01677$NOVITIUM PHARMA$Margarida  Neto.A MISFORTUNE.European Journal of Case Reports in Internal Medicine.22-MAY-2023;10(1):328$45$YR$A$F$Y$$$20240826$$HP$PT$PT
242466641$24246664$1$I$$20240805$20240825$20240825$EXP$$ES-JNJFOC-20240851229$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240826$$MD$ES$ES
242466661$24246666$1$I$20240613$20240821$20240825$20240825$EXP$$NVSJ2024JP008910$NOVARTIS$$77$YR$$F$Y$$$20240826$$MD$JP$JP
242466671$24246667$1$I$$20240820$20240825$20240825$EXP$$JP-ORGANON-O2408JPN001760$ORGANON$Tamatani H, et al.. A Case of Cardiac Failure Aggravated by Rapid Atrial Fibrillation Considered to be Caused by Serotonin Syndrome.. Tohoku Regional Meeting of the Japanese Society of Internal Medicine.. 2024;36(1):1$60$YR$$M$Y$$$20240825$$MD$JP$JP
242466681$24246668$1$I$20091201$20240821$20240825$20240825$PER$$US-JNJFOC-20240856551$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240826$$LW$US$US
242466691$24246669$1$I$20240101$20240820$20240825$20240825$EXP$$US-JNJFOC-20240854950$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240826$$HP$US$US
242466701$24246670$1$I$20110101$20240820$20240825$20240825$EXP$$ZA-AstraZeneca-2024A189556$ASTRAZENECA$$71$YR$$M$Y$$$20240826$$CN$ZA$
242466711$24246671$1$I$20240718$20240822$20240825$20240825$EXP$$CA-ABBVIE-5892523$ABBVIE$$48$YR$$M$Y$$$20240825$$CN$CA$CA
242466721$24246672$1$I$$20240820$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408012791$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240825$$CN$US$US
242466731$24246673$1$I$20240815$20240819$20240825$20240825$PER$$US-AMGEN-USASP2024165093$AMGEN$$$$$F$Y$$$20240825$$CN$US$US
242466741$24246674$1$I$$20240818$20240825$20240825$EXP$$US-JNJFOC-20240849828$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$HP$US$US
242466751$24246675$1$I$$20240816$20240825$20240825$EXP$$JP-009507513-2408JPN002103J$MERCK$$8$DEC$$F$Y$$$20240825$$MD$JP$JP
242466761$24246676$1$I$$20240819$20240825$20240825$PER$$US-009507513-2408USA006260$MERCK$$$$$M$Y$$$20240825$$CN$US$US
242466772$24246677$2$F$$20240819$20240825$20240906$EXP$$JP-009507513-2408JPN002293J$MERCK$Kono M, Takahashi K, Shimazaki M, Tomita K, Tabata J, Noguchi D, et al.. ORIGINAL ARITICLE A retrospective study of the management of immune-related adverse events in patients with immune checkpoint inhibitors. Tokyo Journal of Obstetrics and Gynecology. 2024;73(3):475-9$52$YR$$F$Y$$$20240906$$HP$JP$JP
242466781$24246678$1$I$20240701$20240821$20240825$20240825$EXP$$US-ABBVIE-5890613$ABBVIE$$19$YR$$M$Y$$$20240825$$CN$US$US
242466792$24246679$2$F$20240801$20240918$20240825$20240923$EXP$$US-ABBVIE-5890666$ABBVIE$$32$YR$$M$Y$$$20240923$$CN$US$US
242466801$24246680$1$I$$20240816$20240825$20240825$EXP$$IN-NOVITIUMPHARMA-2024INNVP01674$NOVITIUM PHARMA$Ananda Datta.Pyrazinamide-induced Toxic Epidermal Necrolysis.Annals of African Medicine.20-JUL-2024;23(3):494-495$75$YR$E$M$Y$$$20240826$$HP$IN$IN
242466812$24246681$2$F$20240721$20240821$20240825$20240903$EXP$$CN-ORGANON-O2408CHN001642$ORGANON$$91$YR$$F$Y$45$KG$20240903$$HP$CN$CN
242466821$24246682$1$I$$20240819$20240825$20240825$EXP$$AU-AMGEN-AUSSP2024166788$AMGEN$$$$$F$Y$$$20240825$$HP$AU$AU
242466831$24246683$1$I$20240101$20240821$20240825$20240825$EXP$$US-ABBVIE-5890473$ABBVIE$$$$$M$Y$$$20240825$$CN$US$US
242466841$24246684$1$I$20240201$20240819$20240825$20240825$EXP$$NVSC2024US168368$NOVARTIS$$70$YR$$M$Y$$$20240826$$CN$US$US
242466851$24246685$1$I$20240810$20240821$20240825$20240825$EXP$$US-ABBVIE-5882912$ABBVIE$$60$YR$$M$Y$$$20240825$$CN$US$US
242466863$24246686$3$F$20240801$20240920$20240825$20240926$EXP$$PT-ABBVIE-5885823$ABBVIE$$80$YR$$M$Y$$$20240926$$CN$PT$PT
242466873$24246687$3$F$$20240912$20240825$20240930$30DAY$$TR-JNJFOC-20240819902$JOHNSON AND JOHNSON$$$$$F$Y$60$KG$20240930$$CN$TR$TR
242466881$24246688$1$I$$20240815$20240825$20240825$PER$$US-JNJFOC-20240845775$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240826$$HP$US$US
242466891$24246689$1$I$20240805$20240821$20240825$20240825$EXP$$US-ABBVIE-5890474$ABBVIE$$77$YR$$F$Y$$$20240825$$CN$US$US
242466901$24246690$1$I$20040101$20240821$20240825$20240825$EXP$$US-ABBVIE-5892602$ABBVIE$$44$YR$$M$Y$$$20240825$$CN$US$US
242466911$24246691$1$I$20240409$20240822$20240825$20240825$EXP$$US-ABBVIE-5891298$ABBVIE$$64$YR$$F$Y$70.306$KG$20240825$$CN$US$US
242466922$24246692$2$F$$20240821$20240825$20240829$PER$$US-AMGEN-USASP2024167249$AMGEN$$$$$F$Y$$$20240828$$PH$US$US
242466932$24246693$2$F$20240729$20240815$20240825$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130264$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$84.8$KG$20240902$$PH$US$US
242466942$24246694$2$F$$20240823$20240825$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-133658$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240829$$MD$JP$JP
242466961$24246696$1$I$$20240821$20240825$20240825$EXP$$ZA-AstraZeneca-2024A192067$ASTRAZENECA$$76$YR$$M$Y$$$20240826$$CN$ZA$
242466971$24246697$1$I$20240101$20240820$20240825$20240825$PER$$US-AMGEN-USASP2024166823$AMGEN$$41$YR$A$F$Y$$$20240825$$HP$US$US
242466981$24246698$1$I$$20240820$20240825$20240825$PER$$US-ELI_LILLY_AND_COMPANY-US202408012826$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240825$$CN$US$US
242466991$24246699$1$I$$20240816$20240825$20240825$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01680$NOVITIUM PHARMA$Toru Maruyama.Case series of bradycardia, renal failure, atrioventricular nodal blockers, shock and hyperkalemia syndrome in patients with dementia.Geriatrics + Gerontology International .16-MAY-2024;24(7):737-738$94$YR$E$M$Y$$$20240826$$HP$JP$JP
242467001$24246700$1$I$$20240821$20240825$20240825$PER$$US-ALXN-202408USA001383US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
242467012$24246701$2$F$20240101$20240829$20240825$20240901$EXP$$CO-ABBVIE-5854750$ABBVIE$$$$$F$Y$$$20240901$$CN$CO$CO
242467022$24246702$2$F$20240801$20240902$20240825$20240905$EXP$$GB-JNJFOC-20240817575$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240905$$HP$GB$GB
242467031$24246703$1$I$20230801$20240820$20240825$20240825$EXP$$US-ABBVIE-5889094$ABBVIE$$60$YR$$M$Y$$$20240825$$CN$US$US
242467041$24246704$1$I$$20240820$20240825$20240825$EXP$$US-ABBVIE-5889264$ABBVIE$$$$$F$Y$$$20240825$$CN$US$US
242467051$24246705$1$I$$20240819$20240825$20240825$EXP$$JP-AMGEN-JPNSP2024167247$AMGEN$Shibuya R, Baba K, Furuta R, Maesaka H, Hirosawa H, Bando T, et al. Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab. Intern Med. 2024;63:2193-8$83$YR$E$M$Y$$$20240825$$MD$JP$JP
242467062$24246706$2$F$$20240910$20240825$20240917$EXP$$US-ABBVIE-5889176$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
242467071$24246707$1$I$$20240815$20240825$20240825$EXP$$CA-TAKEDA-2024TUS082665$TAKEDA$$$$$F$Y$$$20240825$$CN$CA$CA
242467083$24246708$3$F$20240821$20240905$20240825$20240909$PER$$US-AMGEN-USASP2024168830$AMGEN$$12$YR$T$M$Y$42.3$KG$20240909$$CN$US$US
242467091$24246709$1$I$$20240822$20240825$20240825$EXP$$JP-TAKEDA-2024TJP012371$TAKEDA$$$$$F$Y$$$20240825$$CN$JP$JP
242467101$24246710$1$I$$20240820$20240825$20240825$EXP$$US-SANDOZ INC.-SDZ2024US074493$SANDOZ$$$$$F$Y$$$20240825$$CN$US$US
242467112$24246711$2$F$$20240910$20240825$20240913$EXP$$CA-PFIZER INC-2023SGN12271$PFIZER$$43$YR$$F$Y$$$20240913$$CN$CA$CA
242467121$24246712$1$I$$20240823$20240825$20240825$EXP$$JP-TAKEDA-2024TJP012403$TAKEDA$$6$DEC$$F$Y$$$20240825$$MD$JP$JP
242467131$24246713$1$I$20240604$20240819$20240825$20240825$EXP$FR-AFSSAPS-TO2024001041$FR-PFIZER INC-202400238911$PFIZER$$72$YR$$M$Y$73$KG$20240825$$HP$FR$FR
242467141$24246714$1$I$20240816$20240819$20240825$20240825$EXP$GB-MHRA-MED-202408180153570310-BLZKV$GB-PFIZER INC-202400239207$PFIZER$$58$YR$$F$Y$96$KG$20240825$$MD$GB$GB
242467151$24246715$1$I$$20240815$20240825$20240825$EXP$$ZA-ABBVIE-5892438$ABBVIE$$$$E$M$Y$$$20240825$$CN$ZA$ZA
242467161$24246716$1$I$20240818$20240822$20240825$20240825$EXP$$AT-ABBVIE-5892478$ABBVIE$$77$YR$$F$Y$$$20240825$$CN$AT$AT
242467172$24246717$2$F$$20240830$20240826$20240906$EXP$$JP-AMGEN-JPNSP2024168220$AMGEN$$$$$F$Y$$$20240906$$CN$JP$JP
242467182$24246718$2$F$20240807$20240902$20240826$20240902$EXP$$TW-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047452$BOEHRINGER INGELHEIM$$48$YR$A$F$Y$45$KG$20240902$$CN$TW$TW
242467191$24246719$1$I$$20240821$20240826$20240826$EXP$$JP-SANDOZ INC.-SDZ2024JP074507$SANDOZ$Nakagawa T, Uehata A, Himizu N, Inoue K, Miura N, Aoki H et,al.. A case of severe disseminated intravascular coagulation and multiple cerebral infarctions due to local anesthetic poisoning during dental treatment.. Journal of the Kanto Chapter of the Japanese Society for Acute Medicine. 2024;45(1):D-77$62$YR$$F$Y$$$20240826$$MD$JP$JP
242467201$24246720$1$I$$20240822$20240826$20240826$PER$$NVSC2024US171305$NOVARTIS$$$$$$Y$$$20240826$$CN$US$US
242467211$24246721$1$I$$20240822$20240826$20240826$EXP$$US-SANDOZ INC.-SDZ2024US074899$SANDOZ$$$$$F$Y$$$20240826$$CN$US$US
242467232$24246723$2$F$20240618$20240925$20240826$20240930$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-035578$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240930$$CN$FR$FR
242467241$24246724$1$I$$20240814$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130797$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240826$$CN$US$US
242467251$24246725$1$I$20230904$20240822$20240826$20240826$EXP$$US-ORGANON-O2408USA001576$ORGANON$$$$$F$Y$$$20240826$$CN$US$US
242467261$24246726$1$I$20240524$20240814$20240826$20240826$EXP$$ES-DENTSPLY-2024SCDP000240$DENTSPLY$$70$YR$$F$Y$$$20240826$$MD$ES$ES
242467272$24246727$2$F$20240731$20240828$20240826$20240902$EXP$$US-ABBVIE-5884593$ABBVIE$$64$YR$$M$Y$$$20240902$$CN$US$US
242467281$24246728$1$I$$20240822$20240826$20240826$PER$$NVSC2024US171451$NOVARTIS$$$$$F$Y$$$20240826$$HP$US$US
242467291$24246729$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133595$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240826$$HP$US$US
242467301$24246730$1$I$20240630$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A191076$ASTRAZENECA$$$$$F$Y$$$20240826$$HP$US$
242467311$24246731$1$I$$20240816$20240826$20240826$EXP$$CA-CELLTRION INC.-2024CA020019$CELLTRION$$$$$$Y$$$20240826$$CN$CA$CA
242467321$24246732$1$I$20200101$20240821$20240826$20240826$EXP$$US-ABBVIE-5890178$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242467331$24246733$1$I$$20240816$20240826$20240826$PER$$US-AMGEN-USASP2024164828$AMGEN$Foster R.; Ong S. et al.. Subretinal surprise: Subretinal tractional bands in diabetic tractional retinal detachment. American Journal of Ophthalmology Case Reports. 2024;36:1-2$46$YR$A$F$Y$$$20240825$$HP$US$US
242467341$24246734$1$I$$20240816$20240826$20240826$EXP$$CH-ABBVIE-5889403$ABBVIE$Capoferri G, Ghielmetti G, Glatz B, Mutke MR, Tzankov A, Stephan R, et al. Disseminated, fatal reactivation of bovine tuberculosis in a patient treated with adalimumab: a case report and review of the literature. Infection.2024.$78$YR$$F$Y$$$20240826$$HP$CH$CH
242467351$24246735$1$I$$20240822$20240826$20240826$EXP$$SI-ARGENX-2024-ARGX-SI007035$ARGENX BVBA$$$$$$Y$$$20240826$$MD$SI$SI
242467363$24246736$3$F$$20240825$20240826$20240830$30DAY$$EG-SANDOZ INC.-SDZ2024EG074710$SANDOZ$$$$$M$Y$22$KG$20240830$$CN$EG$EG
242467374$24246737$4$F$20210101$20240906$20240826$20240915$EXP$$FR-ABBVIE-5889362$ABBVIE$$29$YR$$F$Y$54$KG$20240915$$MD$FR$FR
242467381$24246738$1$I$$20240820$20240826$20240826$EXP$$US-ABBVIE-5599917$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242467391$24246739$1$I$$20240807$20240826$20240826$PER$$US-TEVA-VS-3232431$TEVA$$$$$F$Y$$$20240826$$CN$US$US
242467402$24246740$2$F$$20240819$20240826$20240905$EXP$$JP-009507513-2408JPN002262J$MERCK$Iida Y, Nabeta T, Ishii S, Ako J. PS4-4 A case of coronary spastic angina after pembrolizumab use for left renal pelvic cancer. The 7th Annual Meeting of the Japanese Onco-cardiology Society. 116$83$YR$$M$Y$$$20240905$$HP$JP$JP
242467411$24246741$1$I$20240817$20240821$20240826$20240826$EXP$$US-ABBVIE-5890495$ABBVIE$$19$YR$$F$Y$$$20240826$$CN$US$US
242467421$24246742$1$I$$20240807$20240826$20240826$PER$$US-TEVA-VS-3232368$TEVA$$36$YR$$F$Y$$$20240826$$CN$US$US
242467431$24246743$1$I$20240529$20240820$20240826$20240826$EXP$$US-TAKEDA-2024TUS065730$TAKEDA$$53$YR$$F$Y$$$20240826$$MD$US$US
242467441$24246744$1$I$$20240819$20240826$20240826$EXP$$GB-TAKEDA-2024TUS084603$TAKEDA$$$$$M$Y$$$20240826$$CN$GB$GB
242467451$24246745$1$I$$20240821$20240826$20240826$EXP$$US-TAKEDA-2024TUS085082$TAKEDA$$$$$F$Y$$$20240826$$MD$US$US
242467461$24246746$1$I$20240817$20240820$20240826$20240826$EXP$$US-ABBVIE-5889359$ABBVIE$$66$YR$$M$Y$$$20240826$$CN$US$US
242467471$24246747$1$I$20240801$20240819$20240826$20240826$EXP$$US-ABBVIE-5887374$ABBVIE$$63$YR$$F$Y$$$20240826$$CN$US$US
242467482$24246748$2$F$20240527$20240918$20240826$20240920$EXP$IT-MINISAL02-999007$IT-009507513-2408ITA007603$MERCK$$61$YR$$M$Y$80$KG$20240920$$MD$IT$IT
242467491$24246749$1$I$20240811$20240820$20240826$20240826$EXP$$GB-ABBVIE-5889273$ABBVIE$$$$$M$Y$$$20240826$$MD$GB$GB
242467501$24246750$1$I$20240807$20240821$20240826$20240826$EXP$$US-ABBVIE-5891134$ABBVIE$$44$YR$$M$Y$$$20240826$$CN$US$US
242467511$24246751$1$I$$20240820$20240826$20240826$EXP$$US-ABBVIE-5889258$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242467522$24246752$2$F$$20240820$20240826$20240827$EXP$$AU-ABBVIE-5854045$ABBVIE$$$$$M$Y$$$20240827$$MD$AU$AU
242467532$24246753$2$F$20240906$20240906$20240826$20240911$EXP$$CA-TAKEDA-2024TUS023199$TAKEDA$$73$YR$$F$Y$$$20240911$$CN$CA$CA
242467541$24246754$1$I$$20240816$20240826$20240826$EXP$$GB-CELLTRION INC.-2024GB020066$CELLTRION$$$$$$Y$$$20240826$$HP$GB$GB
242467551$24246755$1$I$$20240821$20240826$20240826$EXP$$US-ABBVIE-5890729$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242467561$24246756$1$I$20240101$20240821$20240826$20240826$EXP$$CA-ABBVIE-5890846$ABBVIE$$55$YR$$F$Y$$$20240826$$CN$CA$CA
242467572$24246757$2$F$20240905$20240905$20240826$20240910$EXP$$CA-TAKEDA-2024TUS054343$TAKEDA$$84$YR$$M$Y$$$20240910$$CN$CA$CA
242467581$24246758$1$I$$20240822$20240826$20240826$EXP$$US-SANDOZ INC.-SDZ2024US074929$SANDOZ$$$$$M$Y$$$20240826$$CN$US$US
242467591$24246759$1$I$$20240821$20240826$20240826$EXP$$MX-ABBVIE-5891607$ABBVIE$$$$$F$Y$58$KG$20240826$$CN$MX$MX
242467602$24246760$2$F$20240819$20240823$20240826$20240828$PER$$US-AMGEN-USASP2024169211$AMGEN$$60$YR$A$F$Y$$$20240828$$CN$US$US
242467611$24246761$1$I$$20240821$20240826$20240826$EXP$$GB-JNJFOC-20240857035$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$HP$GB$GB
242467621$24246762$1$I$20240625$20240822$20240826$20240826$EXP$FR-AFSSAPS-NC2024000984$FR-JNJFOC-20240862630$JOHNSON AND JOHNSON$$55$YR$A$F$Y$63$KG$20240826$$MD$FR$FR
242467631$24246763$1$I$$20240819$20240826$20240826$EXP$$CA-JNJFOC-20240856282$JOHNSON AND JOHNSON$$12$YR$T$F$Y$$$20240826$$CN$CA$CA
242467641$24246764$1$I$$20240820$20240826$20240826$EXP$$JP-AMGEN-JPNSP2024167805$AMGEN$$$$E$F$Y$$$20240825$$MD$JP$JP
242467651$24246765$1$I$20240813$20240819$20240826$20240826$EXP$$FR-AMGEN-FRASP2024165417$AMGEN$$65$YR$E$F$Y$$$20240825$$CN$FR$FR
242467661$24246766$1$I$$20240822$20240826$20240826$PER$$NVSC2024US171283$NOVARTIS$$45$YR$$M$Y$86$KG$20240826$$HP$US$US
242467671$24246767$1$I$$20240814$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129579$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$70.8$KG$20240826$$PH$US$US
242467681$24246768$1$I$$20240819$20240826$20240826$EXP$$CA-JNJFOC-20240856419$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240826$$CN$CA$CA
242467691$24246769$1$I$$20240816$20240826$20240826$EXP$$GB-CELLTRION INC.-2024GB020044$CELLTRION$$$$$$Y$$$20240826$$CN$GB$GB
242467701$24246770$1$I$20240101$20240822$20240826$20240826$EXP$$US-ABBVIE-5890929$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242467711$24246771$1$I$20240727$20240822$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134377$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240826$$MD$US$US
242467721$24246772$1$I$$20240819$20240826$20240826$EXP$$CA-JNJFOC-20240856850$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$MD$CA$CA
242467741$24246774$1$I$20240802$20240815$20240826$20240826$EXP$$CN-JNJFOC-20240842361$JOHNSON AND JOHNSON$$16$YR$T$M$Y$66.2$KG$20240826$$HP$CN$CN
242467751$24246775$1$I$$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A191082$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242467761$24246776$1$I$20240711$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A190857$ASTRAZENECA$$23033$DY$$M$Y$$$20240826$$CN$US$
242467771$24246777$1$I$$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A190983$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242467781$24246778$1$I$20240705$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A191138$ASTRAZENECA$$$$$$Y$$$20240826$$CN$US$
242467791$24246779$1$I$$20240822$20240826$20240826$30DAY$$US-ELI_LILLY_AND_COMPANY-US202408015084$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240826$$CN$US$US
242467801$24246780$1$I$20240701$20240821$20240826$20240826$EXP$$CN-ABBVIE-5889493$ABBVIE$$66$YR$$F$Y$44$KG$20240826$$MD$CN$CN
242467811$24246781$1$I$20240820$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167179$AMGEN$$80$YR$E$F$Y$$$20240825$$CN$US$US
242467822$24246782$2$F$20240703$20240902$20240826$20240903$PER$$US-AMGEN-USASP2024162885$AMGEN$$58$YR$A$$Y$$$20240903$$CN$US$US
242467832$24246783$2$F$20240101$20240823$20240826$20240830$EXP$$US-ABBVIE-5889169$ABBVIE$$$$$M$Y$71.213$KG$20240828$$CN$US$US
242467841$24246784$1$I$20240507$20240822$20240826$20240826$EXP$$US-AMGEN-USASP2024168718$AMGEN$$38$YR$A$F$Y$$$20240825$$CN$US$US
242467851$24246785$1$I$$20240822$20240826$20240826$PER$$US-HALEON-2193351$Haleon PLC$$$$$$Y$$$20240826$$CN$US$US
242467861$24246786$1$I$$20240815$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130327$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$77.56$KG$20240826$$CN$US$US
242467871$24246787$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134367$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240826$$CN$US$US
242467881$24246788$1$I$20240823$20240823$20240826$20240826$EXP$$GB-SANDOZ INC.-SDZ2024GB075014$SANDOZ$$60$YR$$F$Y$59$KG$20240826$$MD$GB$GB
242467891$24246789$1$I$$20240819$20240826$20240826$EXP$$CA-JNJFOC-20240856332$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20240826$$CN$CA$CA
242467901$24246790$1$I$$20240816$20240826$20240826$EXP$$IE-STRIDES ARCOLAB LIMITED-2024SP010530$STRIDES$Krawczyk D, Dabrowski F, Kosinska-Kaczynska K.. Preeclampsia is caused by impaired placenta - A case report.. Eur-J-Obstet-Gynecol-Reprod-Biol. 2024;293:57-58$$$$M$Y$$$20240826$$HP$IE$IE
242467911$24246791$1$I$20080101$20240819$20240826$20240826$EXP$$US-ABBVIE-5885911$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242467921$24246792$1$I$$20240818$20240826$20240826$EXP$$US-AstraZeneca-2024A189130$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242467931$24246793$1$I$$20240819$20240826$20240826$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP010507$STRIDES$Singh TP, Narang T, Yakang D.. Central Serous Chorioretinopathy in a Patient with Hansen^s Disease with Type 1 Lepra Reaction-A Case Report.. Indian-J-Lepr. 2024;96:179-183$34$YR$$M$Y$$$20240826$$MD$IN$IN
242467941$24246794$1$I$20240801$20240822$20240826$20240826$EXP$$CO-ABBVIE-5893318$ABBVIE$$70$YR$$F$Y$52$KG$20240826$$CN$CO$CO
242467951$24246795$1$I$$20240819$20240826$20240826$EXP$$US-BIOGEN-2024BI01279070$BIOGEN$$$$$F$Y$$$20240826$$HP$US$US
242467962$24246796$2$F$20240821$20240822$20240826$20240829$EXP$$US-BIOGEN-2024BI01279532$BIOGEN$$42$YR$$F$Y$$$20240829$$CN$US$US
242467981$24246798$1$I$20240812$20240816$20240826$20240826$EXP$$GB-CELLTRION INC.-2024GB019943$CELLTRION$$$$$$Y$$$20240826$$HP$GB$GB
242467991$24246799$1$I$$20240822$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134354$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240826$$CN$US$US
242468001$24246800$1$I$$20240819$20240826$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-118744$BRISTOL MYERS SQUIBB$$6$DEC$A$F$Y$$$20240826$$PH$JP$JP
242468011$24246801$1$I$$20240820$20240826$20240826$EXP$$AR-AMGEN-ARGSP2024168753$AMGEN$$81$YR$E$F$Y$$$20240825$$CN$AR$AR
242468021$24246802$1$I$$20240822$20240826$20240826$PER$$US-HALEON-2193395$Haleon PLC$$$$$$Y$$$20240826$$CN$US$US
242468041$24246804$1$I$20230101$20240820$20240826$20240826$EXP$$CA-BIOGEN-2024BI01279291$BIOGEN$$$$$F$Y$$$20240826$$CN$CA$CA
242468051$24246805$1$I$20240101$20240813$20240826$20240826$EXP$$JP-NOVOPROD-1271454$NOVO NORDISK$$77$YR$$M$Y$$$20240826$$MD$JP$JP
242468061$24246806$1$I$20240802$20240813$20240826$20240826$EXP$$IS-NOVOPROD-1270558$NOVO NORDISK$$$$A$F$Y$$$20240826$$HP$IS$IS
242468071$24246807$1$I$$20240813$20240826$20240826$EXP$$US-NOVOPROD-1271256$NOVO NORDISK$$$$$F$Y$$$20240826$$CN$US$US
242468081$24246808$1$I$20240201$20240813$20240826$20240826$EXP$$CO-NOVOPROD-1245469$NOVO NORDISK$$72$YR$$M$Y$94$KG$20240826$$CN$CO$CO
242468091$24246809$1$I$20240807$20240813$20240826$20240826$EXP$GB-MHRA-MED-202408101022156000-VNZQH$GB-NOVOPROD-1269621$NOVO NORDISK$$30$YR$$F$Y$100$KG$20240826$$CN$GB$GB
242468101$24246810$1$I$$20240819$20240826$20240826$EXP$$US-BIOGEN-2024BI01279122$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242468111$24246811$1$I$$20240813$20240826$20240826$EXP$BE-FAMHP-DHH-N2024-122495$BE-NOVOPROD-1270431$NOVO NORDISK$$45$YR$$M$Y$$$20240826$$PH$BE$BE
242468131$24246813$1$I$20240509$20240813$20240826$20240826$EXP$$AU-NOVOPROD-1269716$NOVO NORDISK$$$$$$Y$$$20240826$$CN$AU$AU
242468141$24246814$1$I$20240328$20240813$20240826$20240826$EXP$$US-NOVOPROD-1270964$NOVO NORDISK$$29$YR$$F$Y$$$20240826$$CN$US$US
242468151$24246815$1$I$$20240814$20240826$20240826$PER$$US-ROCHE-10000058722$ROCHE$$15$YR$T$M$Y$$$20240826$$CN$US$US
242468161$24246816$1$I$20200101$20240819$20240826$20240826$EXP$$US-ABBVIE-5876387$ABBVIE$$$$$F$Y$90.718$KG$20240826$$CN$US$US
242468171$24246817$1$I$20240730$20240814$20240826$20240826$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160834$JIANGSU HANSOH PHARMACEUTICAL$$43$YR$$M$Y$50.9$KG$20240826$$MD$CN$CN
242468181$24246818$1$I$$20240819$20240826$20240826$EXP$$AU-ABBVIE-5892121$ABBVIE$$$$$$Y$$$20240826$$HP$AU$AU
242468191$24246819$1$I$$20240821$20240826$20240826$EXP$$US-ABBVIE-5890168$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242468201$24246820$1$I$$20240816$20240826$20240826$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01681$NOVITIUM PHARMA$Daisuke Kuzume.A case of a young woman with bilateral medial medullary infarcts caused by varicella-zoster virus vasculopathy without skin rash.Rinsho Shinkeigaku .24-JUL-2024;NA:1-5$36$YR$A$F$Y$$$20240826$$HP$JP$JP
242468211$24246821$1$I$20240101$20240819$20240826$20240826$EXP$$US-ABBVIE-5887280$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242468221$24246822$1$I$$20240814$20240826$20240826$EXP$$ZA-ROCHE-10000058040$ROCHE$$$$A$F$Y$$$20240826$$MD$ZA$ZA
242468231$24246823$1$I$$20240814$20240826$20240826$EXP$$EG-NOVOPROD-1269708$NOVO NORDISK$$$$$F$Y$$$20240826$$CN$EG$EG
242468241$24246824$1$I$20240203$20240814$20240826$20240826$EXP$$AR-NOVOPROD-1267826$NOVO NORDISK$$45$YR$$F$Y$$$20240826$$MD$AR$AR
242468252$24246825$2$F$20240402$20240827$20240826$20240909$EXP$$CA-NOVOPROD-1261953$NOVO NORDISK$$67$YR$$F$Y$101.6$KG$20240909$$CN$CA$CA
242468261$24246826$1$I$$20240814$20240826$20240826$EXP$$CA-NOVOPROD-1270567$NOVO NORDISK$$$$$F$Y$$$20240826$$HP$CA$CA
242468271$24246827$1$I$20240803$20240814$20240826$20240826$EXP$GB-MHRA-MED-202408140830139410-ZNJMV$GB-NOVOPROD-1270520$NOVO NORDISK$$87$YR$$F$Y$$$20240826$$PH$GB$GB
242468281$24246828$1$I$$20240814$20240826$20240826$EXP$$US-NOVOPROD-1270279$NOVO NORDISK$$$$A$F$Y$$$20240826$$CN$US$US
242468291$24246829$1$I$20240714$20240814$20240826$20240826$EXP$$GB-NOVOPROD-1270436$NOVO NORDISK$$61$YR$$F$Y$109$KG$20240826$$MD$GB$GB
242468301$24246830$1$I$20240807$20240814$20240826$20240826$EXP$$US-NOVOPROD-1270127$NOVO NORDISK$$$$$F$Y$$$20240826$$CN$US$US
242468312$24246831$2$F$20240804$20240827$20240826$20240904$EXP$$CN-NOVOPROD-1267980$NOVO NORDISK$$7$YR$$$Y$$$20240904$$HP$CN$CN
242468321$24246832$1$I$20240527$20240814$20240826$20240826$EXP$$US-NOVOPROD-1270129$NOVO NORDISK$$80$YR$$F$Y$$$20240826$$CN$US$US
242468331$24246833$1$I$$20240815$20240826$20240826$PER$$US-ABBVIE-5884935$ABBVIE$$$$$$Y$$$20240826$$CN$US$US
242468341$24246834$1$I$$20240819$20240826$20240826$EXP$$ZA-AstraZeneca-2024A189851$ASTRAZENECA$$56$YR$$F$Y$$$20240826$$CN$ZA$
242468351$24246835$1$I$$20240821$20240826$20240826$EXP$$BR-ABBVIE-5891429$ABBVIE$$$$$M$Y$70$KG$20240826$$CN$BR$BR
242468361$24246836$1$I$$20240814$20240826$20240826$PER$$US-BIOGEN-2024BI01278669$BIOGEN$$$$$M$Y$$$20240826$$MD$US$US
242468372$24246837$2$F$20240620$20240924$20240826$20240924$EXP$FR-AFSSAPS-TO2024001593$NVSC2024FR170955$NOVARTIS$$57$YR$$M$Y$75$KG$20240924$$HP$FR$FR
242468382$24246838$2$F$20240813$20240829$20240826$20240903$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024104420$VIIV$$26$YR$$M$Y$$$20240903$$HP$US$US
242468391$24246839$1$I$$20240819$20240826$20240826$PER$$US-BIOGEN-2024BI01279082$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242468401$24246840$1$I$$20240819$20240826$20240826$EXP$$CA-JNJFOC-20240857112$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240826$$HP$CA$CA
242468412$24246841$2$F$20240815$20240923$20240826$20240925$PER$$US-JNJFOC-20240839328$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240925$$PH$US$US
242468421$24246842$1$I$$20240811$20240826$20240826$EXP$$IT-JNJFOC-20240858288$JOHNSON AND JOHNSON$$75$YR$E$M$Y$74$KG$20240826$$HP$IT$IT
242468431$24246843$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041392$AUROBINDO$$53$YR$$F$Y$$$20240826$$HP$CA$CA
242468441$24246844$1$I$$20240821$20240826$20240826$EXP$$DE-ABBVIE-5892409$ABBVIE$$55$YR$$M$Y$$$20240826$$MD$DE$DE
242468452$24246845$2$F$$20240830$20240826$20240903$PER$$US-JNJFOC-20240849328$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$CN$US$US
242468471$24246847$1$I$20240801$20240819$20240826$20240826$EXP$$CL-JNJFOC-20240851560$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240826$$CN$CL$CL
242468483$24246848$3$F$$20240823$20240826$20240909$EXP$$CA-002147023-NVSC2020CA057529$Haleon PLC$$72$YR$$M$Y$$$20240909$$HP$CA$CA
242468501$24246850$1$I$$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024166872$AMGEN$$$$$$Y$$$20240825$$CN$US$US
242468511$24246851$1$I$20240819$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024166668$AMGEN$$$$$F$Y$$$20240825$$CN$US$US
242468521$24246852$1$I$$20240814$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408009883$ELI LILLY AND CO$$54$YR$A$$Y$$$20240826$$LW$US$US
242468531$24246853$1$I$$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013443$ELI LILLY AND CO$$$$$$Y$$$20240826$$CN$US$US
242468542$24246854$2$F$20240701$20240822$20240826$20240826$EXP$$US-ROCHE-10000064324$ROCHE$$54$YR$A$$Y$$$20240826$$HP$US$US
242468551$24246855$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-041650$AUROBINDO$Fanas RL, Goettemoeller T, Cedeno K, Manavalan AD.. Ectopic Cushing Syndrome Secondary to Diffuse Idiopathic  Neuroendocrine Cell Hyperplasia?A Report of 2 Cases. JCEM Case Reports. 2024;Vol. 2, No. 8:1-5$37$YR$$F$Y$$$20240826$$HP$US$US
242468562$24246856$2$F$20240801$20240911$20240826$20240917$EXP$$JP-TAKEDA-2024TJP012286$TAKEDA$$9$DEC$$F$Y$$$20240917$$MD$JP$JP
242468573$24246857$3$F$20220101$20240822$20240826$20240826$EXP$$US-ROCHE-10000063338$ROCHE$$43$YR$A$F$Y$77.11$KG$20240826$$CN$US$US
242468581$24246858$1$I$$20240819$20240826$20240826$EXP$$BR-BIOGEN-2024BI01279501$BIOGEN$$$$$F$Y$$$20240826$$CN$BR$BR
242468601$24246860$1$I$$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134412$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240826$$CN$US$US
242468611$24246861$1$I$$20240819$20240826$20240826$PER$$US-ALXN-A202307445$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240826$$CN$US$US
242468621$24246862$1$I$$20240812$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041136$AUROBINDO$$61$YR$$F$Y$58$KG$20240826$$HP$CA$CA
242468631$24246863$1$I$20240101$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167595$AMGEN$$81$YR$E$F$Y$$$20240825$$CN$US$US
242468641$24246864$1$I$$20240822$20240826$20240826$EXP$$US-AstraZeneca-2024A191968$ASTRAZENECA$$$$$F$Y$$$20240826$$CN$US$
242468651$24246865$1$I$$20240819$20240826$20240826$EXP$$CN-AstraZeneca-2024A189588$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$CN$
242468661$24246866$1$I$$20240820$20240826$20240826$EXP$$US-AstraZeneca-2024A190936$ASTRAZENECA$$$$$F$Y$$$20240826$$MD$US$
242468671$24246867$1$I$20240101$20240815$20240826$20240826$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-130423$BRISTOL MYERS SQUIBB$$80$YR$E$$Y$3.71$KG$20240826$$CN$PR$PR
242468681$24246868$1$I$$20240818$20240826$20240826$PER$$US-ABBVIE-5888354$ABBVIE$$$$$$Y$$$20240826$$CN$US$US
242468691$24246869$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-041101$AUROBINDO$Chan N, Dunn B. Bilateral Spontaneous Pneumothoraces in a Case of Tricuspid Valve Endocarditis and Septic Emboli: A Rare Complication.. Case Reports in Critical Care. 2024;1-3$46$YR$$M$Y$$$20240826$$HP$US$US
242468701$24246870$1$I$20240809$20240821$20240826$20240826$PER$$US-ROCHE-10000063107$ROCHE$$44$YR$A$M$Y$$$20240826$$CN$US$US
242468713$24246871$3$F$20240807$20240916$20240826$20240924$PER$$US-ROCHE-10000063541$ROCHE$$26$YR$A$M$Y$$$20240924$$CN$US$US
242468721$24246872$1$I$$20240822$20240826$20240826$EXP$$CA-ROCHE-10000064591$ROCHE$$$$A$F$Y$$$20240826$$CN$CA$CA
242468731$24246873$1$I$$20240813$20240826$20240826$EXP$$US-ROCHE-10000057950$ROCHE$$$$$F$Y$$$20240826$$HP$US$US
242468741$24246874$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000063766$ROCHE$$$$$M$Y$$$20240826$$CN$US$US
242468751$24246875$1$I$$20240812$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041216$AUROBINDO$Ojukwu K, Cox BK, Larson BK, Guindi M, Waters KM, Hutchings DA.. Capecitabineinduced Gastrointestinal Injury Shows a Graft-Versus-Host Disease (GVHD)-like Pattern.. The American Journal of Surgical Pathology.. 2023;47 (10):1160-1167$62$YR$$M$Y$$$20240826$$MD$CA$CA
242468761$24246876$1$I$$20240812$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041186$AUROBINDO$$79$YR$$F$Y$$$20240826$$HP$CA$CA
242468771$24246877$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000064138$ROCHE$$$$C$M$Y$$$20240826$$CN$US$US
242468781$24246878$1$I$$20240812$20240826$20240826$EXP$$GB-AUROBINDO-AUR-APL-2024-041122$AUROBINDO$Erblich T, Manisty C, Gribben J. Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated Risk. Case Reports in Hematology. 2024;20:241-6$87$YR$$M$Y$$$20240826$$HP$GB$GB
242468792$24246879$2$F$20230101$20240920$20240826$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-040716$AUROBINDO$$38$YR$$M$Y$$$20240927$$CN$FR$FR
242468801$24246880$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000063817$ROCHE$$1$YR$I$M$Y$$$20240826$$CN$US$US
242468812$24246881$2$F$20240727$20240918$20240826$20240919$PER$$US-ROCHE-10000064295$ROCHE$$17$YR$T$M$Y$$$20240919$$CN$US$US
242468821$24246882$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064318$ROCHE$$$$A$M$Y$$$20240826$$CN$US$US
242468831$24246883$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000063804$ROCHE$$7$MON$I$M$Y$$$20240826$$CN$US$US
242468862$24246886$2$F$$20240913$20240826$20240926$EXP$$US-AUROBINDO-AUR-APL-2024-040969$AUROBINDO$Petric UB, Marks D, Dickman M, Rieger KE, Kibbi N.. A Severe Case of Pan-Facial Vitamin C Serum-Induced Foreign Body Granulomatous Reaction. Dermatol-Surg. 2024;50(6):590-592$53$YR$$F$Y$$$20240926$$HP$US$US
242468872$24246887$2$F$$20240913$20240826$20240926$EXP$$US-AUROBINDO-AUR-APL-2024-040751$AUROBINDO$Harmouch W, Zhang JR, Peterson JM, Uran DP, Buja LM, Zhao B, et al. A challenging case of eosinophilic myocarditis leading to heart failure and transplantation. Cardiovasc-Pathol. 2024;72:1-7$$$A$M$Y$$$20240926$$HP$US$US
242468881$24246888$1$I$20240803$20240819$20240826$20240826$EXP$$GB-CELLTRION INC.-2024GB020150$CELLTRION$$$$$$Y$$$20240826$$CN$GB$GB
242468891$24246889$1$I$$20240822$20240826$20240826$PER$$NVSC2024US171238$NOVARTIS$$$$$F$Y$$$20240826$$HP$US$US
242468901$24246890$1$I$20240809$20240817$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-012912$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242468911$24246891$1$I$$20240814$20240826$20240826$EXP$$BR-NOVOPROD-1270657$NOVO NORDISK$$$$$F$Y$$$20240826$$CN$BR$BR
242468921$24246892$1$I$$20240814$20240826$20240826$EXP$$AU-NOVOPROD-1270593$NOVO NORDISK$$35$YR$$F$Y$$$20240826$$MD$AU$AU
242468931$24246893$1$I$$20240814$20240826$20240826$EXP$$US-NOVOPROD-1270578$NOVO NORDISK$$$$$F$Y$$$20240826$$CN$US$US
242468942$24246894$2$F$20240701$20240910$20240826$20240920$EXP$$CA-NOVOPROD-1270644$NOVO NORDISK$$$$$F$Y$68.9$KG$20240920$$CN$CA$CA
242468961$24246896$1$I$$20240814$20240826$20240826$EXP$$CA-NOVOPROD-1270810$NOVO NORDISK$$$$$M$Y$$$20240826$$MD$CA$CA
242468971$24246897$1$I$20240701$20240814$20240826$20240826$EXP$$US-NOVOPROD-1270935$NOVO NORDISK$$84$YR$$F$Y$$$20240826$$CN$US$US
242468981$24246898$1$I$$20240814$20240826$20240826$EXP$$IE-NOVOPROD-1271071$NOVO NORDISK$$$$$$Y$$$20240826$$CN$IE$IE
242468991$24246899$1$I$$20240812$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-040713$AUROBINDO$Siblini L, Schott R, Trensz P, Pencreach E, Bender L.. Primary resistance to ALK inhibitors in KLC1/ALK-rearranged pleural metastatic lung adenocarcinoma: a case report. Transl-Lung-CancerRes. 2023;122342-2346$34$YR$$M$Y$$$20240826$$HP$FR$FR
242469001$24246900$1$I$$20240814$20240826$20240826$EXP$$KR-JNJFOC-20240845151$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$HP$KR$KR
242469012$24246901$2$F$$20240902$20240826$20240913$EXP$$BE-AUROBINDO-AUR-APL-2024-040847$AUROBINDO$Maerten A, Ramon I, Rasmont C, Thomas J, Khelif A, Lemaitre J.. Emergency thyroidectomy for thyroid storm in a patient treated with amiodarone. [French].. Rev-Med-Brux. 2024;45:3$57$YR$$M$Y$$$20240913$$MD$BE$BE
242469021$24246902$1$I$20240813$20240822$20240826$20240826$EXP$$CN-HALEON-2193263$Haleon PLC$$53$YR$$M$Y$89.4$KG$20240823$$HP$CN$CN
242469031$24246903$1$I$20240426$20240822$20240826$20240826$30DAY$$US-SANDOZ INC.-SDZ2024US074881$SANDOZ$$14$YR$$M$Y$$$20240826$$CN$US$US
242469041$24246904$1$I$$20240814$20240826$20240826$EXP$$US-NOVOPROD-1271453$NOVO NORDISK$$$$$F$Y$$$20240826$$CN$US$US
242469052$24246905$2$F$20240701$20240905$20240826$20240917$EXP$$US-NOVOPROD-1271108$NOVO NORDISK$$$$A$F$Y$$$20240917$$CN$US$US
242469061$24246906$1$I$$20240814$20240826$20240826$EXP$$TR-NOVOPROD-1271773$NOVO NORDISK$$$$$M$Y$92$KG$20240826$$CN$TR$TR
242469071$24246907$1$I$20231001$20240814$20240826$20240826$EXP$$US-NOVOPROD-1271112$NOVO NORDISK$$59$YR$$M$Y$$$20240826$$CN$US$US
242469081$24246908$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-040702$AUROBINDO$Shuster A, Peng C.. Neisseria Flavescens Bacteremia in an Otherwise Immunocompetent Host.. Am-J-Respir-Crit-Care-Med. 2024;209A:1655$62$YR$$F$Y$$$20240826$$HP$US$US
242469091$24246909$1$I$$20240814$20240826$20240826$EXP$$US-NOVOPROD-1271160$NOVO NORDISK$$$$$F$Y$$$20240826$$CN$US$US
242469101$24246910$1$I$20220801$20240814$20240826$20240826$EXP$$US-NOVOPROD-1271471$NOVO NORDISK$$46$YR$$M$Y$$$20240826$$CN$US$US
242469111$24246911$1$I$$20240814$20240826$20240826$EXP$$US-NOVOPROD-1271194$NOVO NORDISK$$$$$M$Y$$$20240826$$CN$US$US
242469131$24246913$1$I$20240515$20240814$20240826$20240826$EXP$$US-NOVOPROD-1271841$NOVO NORDISK$$43$YR$$F$Y$$$20240826$$CN$US$US
242469141$24246914$1$I$$20240819$20240826$20240826$EXP$$CA-HALEON-2192903$Haleon PLC$Chiu MH, Jaworska N, Li NL, Yarema M. Massive Acetaminophen Overdose Treated Successfully with N-Acetylcysteine, Fomepizole, and Hemodialysis. Case reports in critical care. 2021:1-5. DOI: 10.1155/2021/6695967$20$YR$$F$Y$68$KG$20240823$$HP$CA$CA
242469151$24246915$1$I$$20240822$20240826$20240826$EXP$$CA-SANDOZ INC.-SDZ2024CA074809$SANDOZ$$2$YR$$F$Y$$$20240826$$CN$CA$CA
242469161$24246916$1$I$20240819$20240822$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134305$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240826$$CN$US$US
242469172$24246917$2$F$$20240925$20240826$20240926$PER$$US-JNJFOC-20240841879$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
242469191$24246919$1$I$$20240812$20240826$20240826$EXP$$CN-AUROBINDO-AUR-APL-2024-040786$AUROBINDO$Zhang L, Zheng Y, Chen G, Zhao F, Li S. Phosphoinositide 3-kinase inhibitor with fulvestrant in a patient with ER+/HER2- metastatic breast carcinoma induced fatal arrhythmias: a preventable event?. Front-Oncol. 2024$73$YR$$F$Y$$$20240826$$HP$CN$CN
242469201$24246920$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-040666$AUROBINDO$Wagner CB, Julian K, Bryan B, Steinbach MN, Shewan S, Maxwell L, et al.. Carfilzomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (KDCEP) for the Treatment of Relapsed/Refractory Aggressive Plasma Cell Dyscrasias. Blood. 2023;142 (Suppl. 1):6623-6625$47$YR$$M$Y$$$20240826$$HP$US$US
242469211$24246921$1$I$$20240820$20240826$20240826$EXP$$US-AstraZeneca-2024A190343$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242469222$24246922$2$F$20230101$20240827$20240826$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408011279$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240902$$PH$US$US
242469231$24246923$1$I$$20240819$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012036$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240826$$CN$US$US
242469242$24246924$2$F$$20240913$20240826$20240926$EXP$$US-AUROBINDO-AUR-APL-2024-040755$AUROBINDO$Belmore L, Ahn T, Nguyen E, Lenz T. Acute non-ST segment elevation myocardial infarction following intravenous injection of sublingual Suboxone. PREHOSPITAL EMERGENCY CARE. 2024;1-3$41$YR$$M$Y$$$20240926$$HP$US$US
242469251$24246925$1$I$$20240806$20240826$20240826$PER$$US-AstraZeneca-2024A192878$ASTRAZENECA$$$$$$Y$$$20240826$$CN$US$
242469261$24246926$1$I$20240820$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024166881$AMGEN$$64$YR$A$F$Y$$$20240825$$CN$US$US
242469271$24246927$1$I$$20240806$20240826$20240826$EXP$JP-ONO-2024JP016429$JP-AMGEN-JPNSP2024168176$AMGEN$$$$$$Y$$$20240825$$PH$JP$JP
242469281$24246928$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-040620$AUROBINDO$Davis RE, Skinner M, Carlberg C, Talbot J. Aerococcus Urinae: A Rare Urinary Bacterium With Fatal Cardiac Complications. Am-J-Respir-Crit-Care-Med. 2024$72$YR$$M$Y$$$20240826$$HP$US$US
242469291$24246929$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-040724$AUROBINDO$Tidwell J, Thakkar B, Nguyen MTT, Parker S, Schoenfeld A. Primary Hepatic Neuroendocrine Carcinoma: A Rare Entity.. ACG-Case-Rep-J. 2024;11:7$65$YR$$M$Y$$$20240826$$MD$US$US
242469301$24246930$1$I$20240814$20240819$20240826$20240826$EXP$$ALC2024DE003872$ALCON$$$$$$Y$$$20240826$$MD$DE$DE
242469321$24246932$1$I$$20240815$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130833$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240826$$CN$US$US
242469331$24246933$1$I$20240813$20240816$20240826$20240826$EXP$$US-VIIV HEALTHCARE LIMITED-US2024102521$VIIV$$38$YR$$M$Y$$$20240826$$HP$US$US
242469342$24246934$2$F$$20240913$20240826$20240926$EXP$$US-AUROBINDO-AUR-APL-2024-040710$AUROBINDO$Monge J, Razavi M, Bao L, Patel SS. Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. Am-J-Hematol. 2023;99:327-328$78$YR$$M$Y$$$20240926$$HP$US$US
242469351$24246935$1$I$20240801$20240816$20240826$20240826$EXP$$US-JNJFOC-20240844453$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240826$$CN$US$US
242469361$24246936$1$I$$20240819$20240826$20240826$EXP$$JP-009507513-2408JPN002474J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$92$YR$$F$Y$$$20240826$$MD$JP$JP
242469371$24246937$1$I$20240819$20240822$20240826$20240826$EXP$GB-MHRA-MED-202408211155518210-RGSYN$GB-DEXPHARM-2024-2925$DEXCEL$$90$YR$E$M$Y$97$KG$20240826$$HP$GB$GB
242469381$24246938$1$I$$20240819$20240826$20240826$EXP$$JP-009507513-2408JPN002473J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$86$YR$$M$Y$$$20240826$$MD$JP$JP
242469391$24246939$1$I$$20240819$20240826$20240826$PER$$US-ALXN-202408USA001346US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242469401$24246940$1$I$$20240819$20240826$20240826$EXP$$DE-HALEON-2192797$Haleon PLC$Nagele H, Rosenkranz M, Nagele MP. Hyponatremia-lnduced Epileptic Seizure Provoked by Levetiracetam and Pain Medication lntake in   Patient with Central Diabetes Insipidus.      reports in neurology. 2024;16:204-207. DOI: 10.1159/000540320.; Nagele H, Rosenkranz M, Nagele MP. Hyponatremia-lnduced Epileptic Seizure Provoked by Levetiracetam and Pain Medication lntake in   Patient with Central Diabetes Insipidus.      reports in neurology. 2024;16:204-207. DOI: 10.1159/000540320.$67$YR$$M$Y$$$20240823$$MD$DE$DE
242469411$24246941$1$I$20240101$20240819$20240826$20240826$EXP$$JP-009507513-2408JPN002236J$MERCK$$6$DEC$$F$Y$$$20240826$$MD$JP$JP
242469421$24246942$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-040699$AUROBINDO$Eshak N, Ehikhueme G, Ramesh M, Pixley J. Granulomatous Polyangiitis Refractory to Induction With Rituximab in 3 Patients. J-Investig-Med-High-Impact-Case-Rep. 2024;12:1?5$66$YR$$F$Y$$$20240826$$MD$US$US
242469431$24246943$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-040680$AUROBINDO$Qadir N, Rulka K, Shirazi I, Durgun A, Trehan M. A Day on the Beach, a Risk for Vibrio Vulnificus Septicemia. Am-J-Respir-Crit-Care-Med. 2024$61$YR$$M$Y$$$20240826$$HP$US$US
242469441$24246944$1$I$$20240819$20240826$20240826$EXP$$HU-GSK-HU2024GSK103152$GLAXOSMITHKLINE$Killik P, Kostyal E, Toth G, Szentmary N, Nagy ZZ, Maneschg OA. A toxikus epidermalis necrolysis szemeszeti vonatkozasai. Orvosi hetil. 2024;165(31):1206-1212$$$$$Y$$$20240826$$MD$HU$HU
242469451$24246945$1$I$$20240627$20240826$20240826$PER$$US-AUROBINDO-AUR-APL-2024-032750$AUROBINDO$$$$$M$Y$$$20240826$$CN$US$US
242469461$24246946$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-040646$AUROBINDO$Nettleton E, Sattui SE, Wallace Z, Putman M. Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide. Arthritis-Care-Res-(Hoboken). 2024;76(2):288-294$61$YR$$F$Y$$$20240826$$HP$US$US
242469471$24246947$1$I$$20240812$20240826$20240826$EXP$$CN-AUROBINDO-AUR-APL-2024-040717$AUROBINDO$Jia S, Wen X, Yu J, Jia R, Fan J, Fan Xet al.. Risk factors for cataract in retinoblastoma management.. Br-J-Ophthalm. 2024;108:571-577$36$MON$$F$Y$$$20240826$$MD$CN$CN
242469491$24246949$1$I$$20240812$20240826$20240826$EXP$$PL-AUROBINDO-AUR-APL-2024-040617$AUROBINDO$Dzwilewski K, Sokolewicz EM, Omieczynska N, Zawadzka M, Mazurkiewicz-Beldzinska M. Drug resistant epilepsy as the consequence of inadequate control of type 1 diabetes. Pediatr-EndocrinolDiabetes-Metab. 2024;30(1):42-44$11$YR$$M$Y$$$20240826$$HP$PL$PL
242469501$24246950$1$I$20231201$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133582$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240826$$CN$US$US
242469511$24246951$1$I$$20240812$20240826$20240826$EXP$$ES-AUROBINDO-AUR-APL-2024-041237$AUROBINDO$Garc?a Velasco G.. Se ha movido el silencio.. Acyualizaci?n en Medicina de Familia.. 2024;20(7):3662$78$YR$$M$Y$$$20240826$$MD$ES$ES
242469521$24246952$1$I$20240801$20240823$20240826$20240826$PER$$US-AMGEN-USASP2024169235$AMGEN$$$$$F$Y$$$20240825$$CN$US$US
242469532$24246953$2$F$20240810$20240903$20240826$20240912$EXP$$US-NOVOPROD-1270350$NOVO NORDISK$$78$YR$$M$Y$$$20240912$$CN$US$US
242469541$24246954$1$I$20240101$20240815$20240826$20240826$EXP$$BR-NOVOPROD-1270907$NOVO NORDISK$$676$MON$$M$Y$$$20240826$$CN$BR$BR
242469553$24246955$3$F$20221101$20240829$20240826$20240910$EXP$$HU-NOVOPROD-1270743$NOVO NORDISK$$80$YR$$M$Y$70$KG$20240910$$CN$HU$HU
242469572$24246957$2$F$$20240912$20240826$20240923$EXP$$IL-NOVOPROD-1270597$NOVO NORDISK$$67$YR$$F$Y$65$KG$20240923$$HP$IL$IL
242469582$24246958$2$F$20240401$20240902$20240826$20240911$EXP$$BR-NOVOPROD-1271114$NOVO NORDISK$$56$YR$$F$Y$62$KG$20240911$$CN$BR$BR
242469591$24246959$1$I$20240718$20240815$20240826$20240826$EXP$$US-NOVOPROD-1271084$NOVO NORDISK$$$$$F$Y$$$20240826$$CN$US$US
242469602$24246960$2$F$20240401$20240823$20240826$20240906$EXP$$EG-NOVOPROD-1269667$NOVO NORDISK$$$$$M$Y$73$KG$20240906$$CN$EG$EG
242469611$24246961$1$I$$20240815$20240826$20240826$EXP$$US-NOVOPROD-1271066$NOVO NORDISK$$$$$F$Y$$$20240826$$CN$US$US
242469621$24246962$1$I$$20240815$20240826$20240826$EXP$$CO-NOVOPROD-1266570$NOVO NORDISK$$40$YR$$F$Y$$$20240826$$MD$CO$CO
242469642$24246964$2$F$20240730$20240913$20240826$20240930$PER$$US-TOLMAR, INC.-24US051452$TOLMAR$$69$YR$$M$Y$$$20240927$$HP$US$US
242469662$24246966$2$F$20240730$20240911$20240826$20240930$PER$$US-TOLMAR, INC.-24US051455$TOLMAR$$74$YR$$M$Y$$$20240927$$HP$US$US
242469671$24246967$1$I$20240730$20240730$20240826$20240826$PER$$US-TOLMAR, INC.-24US051459$TOLMAR$$42$YR$$F$Y$$$20240826$$HP$US$US
242469681$24246968$1$I$20240729$20240730$20240826$20240826$PER$$US-TOLMAR, INC.-24US051514$TOLMAR$$$$$$Y$$$20240826$$HP$US$US
242469691$24246969$1$I$$20240816$20240826$20240826$EXP$$CA-TOLMAR, INC.-24CA051978$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
242469701$24246970$1$I$20210101$20240816$20240826$20240826$EXP$$IN-TOLMAR, INC.-24IN051934$TOLMAR$$30$YR$$F$Y$$$20240826$$MD$IN$IN
242469711$24246971$1$I$20220101$20240812$20240826$20240826$EXP$$KP-TWI PHARMACEUTICAL, INC-20240800074$TWI PHARMACEUTICALS$Kim T.M.; Jo S.J.. Short-term Safety of dimethyl fumarate for psoriasis in Korea. Ann Dermatol.. 2024;36:4:252-254$50$YR$$F$Y$$$20240820$$$KP$KP
242469721$24246972$1$I$20231101$20240815$20240826$20240826$EXP$$US-NOVOPROD-1271166$NOVO NORDISK$$50$YR$$F$Y$$$20240826$$CN$US$US
242469731$24246973$1$I$$20240815$20240826$20240826$EXP$$BR-NOVOPROD-1271455$NOVO NORDISK$$$$$F$Y$$$20240826$$MD$BR$BR
242469742$24246974$2$F$$20240913$20240826$20240926$EXP$$ES-AUROBINDO-AUR-APL-2024-040957$AUROBINDO$Gil MEA, Gonz?lez MC, Linero A. Successful Electroconvulsive Therapy in Aicardi-Gouti?res Syndrome Presenting Psychiatric Symptoms: An Unprecedented Clinical Case. Journal of ECT. 2024;00:00$18$YR$$M$Y$$$20240926$$MD$ES$ES
242469751$24246975$1$I$$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013423$ELI LILLY AND CO$$$$$$Y$$$20240826$$CN$US$US
242469761$24246976$1$I$$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013477$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240826$$CN$US$US
242469771$24246977$1$I$$20240814$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408009834$ELI LILLY AND CO$$43$YR$A$$Y$$$20240826$$LW$US$US
242469781$24246978$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014612$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240826$$CN$US$US
242469791$24246979$1$I$20240819$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012207$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240826$$CN$US$US
242469801$24246980$1$I$20240801$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014471$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240826$$CN$US$US
242469811$24246981$1$I$$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012912$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240826$$CN$US$US
242469821$24246982$1$I$$20240816$20240826$20240826$PER$$US-ABBVIE-5885537$ABBVIE$$24$YR$$F$Y$$$20240826$$CN$US$US
242469832$24246983$2$F$20240508$20240830$20240826$20240909$EXP$$CA-CELLTRION INC.-2024CA013793$CELLTRION$$$$$$Y$$$20240909$$MD$CA$CA
242469841$24246984$1$I$$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024169299$AMGEN$$$$$$Y$$$20240825$$PH$US$US
242469851$24246985$1$I$$20240819$20240826$20240826$EXP$$CA-AMGEN-CANSP2024168117$AMGEN$$45$YR$A$F$Y$$$20240825$$HP$CA$CA
242469861$24246986$1$I$$20240811$20240826$20240826$EXP$$IT-JNJFOC-20240858327$JOHNSON AND JOHNSON$$76$YR$E$M$Y$79$KG$20240826$$HP$IT$IT
242469871$24246987$1$I$$20240821$20240826$20240826$EXP$$US-HALEON-2193329$Haleon PLC$Sabouri AH, Yurgionas B, Khorasani S, Durant EJ, Kafaie J, Hung Y-Y et. al. Acute Kidney Injury in Hospitalized Patients with Exertional Rhabdomyolysis. JAMA network open. 2024;7(8):e2427464.?DOI:10.1001/jamanetworkopen.2024.27464; SabouriAH, YurgionasB, KhorasaniS, et al. Acute Kidney Injury in Hospitalized Patients With Exertional?Rhabdomyolysis. JAMA network open. #PY#;7(8):e2427464. https://dx.doi.org/10.1001/jamanetworkopen.2024.27464$$$A$F$Y$$$20240826$$MD$US$US
242469881$24246988$1$I$20220101$20240815$20240826$20240826$EXP$$CO-NOVOPROD-1271767$NOVO NORDISK$$80$YR$$F$Y$90$KG$20240826$$CN$CO$CO
242469891$24246989$1$I$20240626$20240815$20240826$20240826$EXP$$US-NOVOPROD-1271523$NOVO NORDISK$$66$YR$$M$Y$$$20240826$$CN$US$US
242469901$24246990$1$I$$20240815$20240826$20240826$EXP$$US-NOVOPROD-1272038$NOVO NORDISK$$$$$F$Y$$$20240826$$CN$US$US
242469911$24246991$1$I$$20240815$20240826$20240826$EXP$$US-NOVOPROD-1271520$NOVO NORDISK$$69$YR$$F$Y$$$20240826$$MD$US$US
242469921$24246992$1$I$20230101$20240815$20240826$20240826$EXP$$US-NOVOPROD-1272076$NOVO NORDISK$$69$YR$$F$Y$$$20240826$$CN$US$US
242469931$24246993$1$I$$20240815$20240826$20240826$EXP$$US-NOVOPROD-1272138$NOVO NORDISK$$$$$F$Y$$$20240826$$HP$US$US
242469941$24246994$1$I$20240101$20240815$20240826$20240826$EXP$$US-NOVOPROD-1271760$NOVO NORDISK$$$$A$$Y$$$20240826$$CN$US$US
242469951$24246995$1$I$$20240815$20240826$20240826$EXP$$CA-NOVOPROD-1272478$NOVO NORDISK$$$$$F$Y$$$20240826$$MD$CA$CA
242469961$24246996$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133817$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$61.23$KG$20240826$$CN$US$US
242469971$24246997$1$I$20240627$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024165130$AMGEN$$70$YR$E$F$Y$$$20240825$$PH$US$US
242469991$24246999$1$I$$20210823$20240826$20240826$EXP$$AU-AstraZeneca-2021A695046$ASTRAZENECA$$$$$F$Y$$$20240826$$CN$AU$
242470001$24247000$1$I$20240728$20240813$20240826$20240826$EXP$$ZA-TAKEDA-2024TUS083289$TAKEDA$$$$$$Y$$$20240826$$CN$ZA$ZA
242470011$24247001$1$I$$20240815$20240826$20240826$EXP$$US-Bion-013730$BIONPHARMA$$$$$$Y$$$20240826$$CN$US$US
242470031$24247003$1$I$$20240821$20240826$20240826$EXP$$ID-Bion-013731$BIONPHARMA$$4$YR$C$F$Y$$$20240826$$HP$ID$ID
242470041$24247004$1$I$$20240819$20240826$20240826$EXP$$GB-Bion-013719$BIONPHARMA$$61$YR$A$F$Y$$$20240826$$HP$GB$GB
242470051$24247005$1$I$$20240811$20240826$20240826$EXP$$IT-JNJFOC-20240858306$JOHNSON AND JOHNSON$$75$YR$E$M$Y$83$KG$20240826$$HP$IT$IT
242470061$24247006$1$I$$20240821$20240826$20240826$PER$$US-JNJFOC-20240859224$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$MD$US$US
242470072$24247007$2$F$$20240827$20240826$20240903$EXP$$GB-CELLTRION INC.-2024GB007036$CELLTRION$$$$$$Y$$$20240903$$PH$GB$GB
242470081$24247008$1$I$$20240822$20240826$20240826$EXP$$US-Bion-013733$BIONPHARMA$$3$DEC$A$F$Y$$$20240826$$HP$US$US
242470091$24247009$1$I$$20240821$20240826$20240826$30DAY$$US-GSK-US2024104589$GLAXOSMITHKLINE$$$$A$M$Y$$$20240826$$CN$US$US
242470102$24247010$2$F$20240720$20240823$20240826$20240903$EXP$$GB-AUROBINDO-AUR-APL-2024-041791$AUROBINDO$$$$$F$Y$$$20240903$$MD$GB$GB
242470111$24247011$1$I$$20240823$20240826$20240826$EXP$$US-ROCHE-10000065307$ROCHE$$46$YR$A$F$Y$$$20240826$$MD$US$US
242470121$24247012$1$I$$20240806$20240826$20240826$PER$$US-JNJFOC-20240816781$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242470131$24247013$1$I$20240101$20240813$20240826$20240826$EXP$$US-UCBSA-2024041215$UCB$$$$$F$Y$120.82$KG$20240826$$HP$US$US
242470141$24247014$1$I$$20240731$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004165$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242470151$24247015$1$I$20240401$20240731$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004188$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240826$$CN$US$US
242470171$24247017$1$I$$20240822$20240826$20240826$EXP$$IT-ABBVIE-5892495$ABBVIE$$79$YR$$F$Y$$$20240826$$CN$IT$IT
242470181$24247018$1$I$20240814$20240815$20240826$20240826$PER$$US-AMGEN-USASP2024164466$AMGEN$$79$YR$E$M$Y$$$20240825$$CN$US$US
242470191$24247019$1$I$$20240816$20240826$20240826$EXP$$US-VIIV HEALTHCARE LIMITED-US2024102585$VIIV$$$$$M$Y$$$20240826$$CN$US$US
242470201$24247020$1$I$$20240814$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408010080$ELI LILLY AND CO$$$$A$$Y$$$20240826$$CN$US$US
242470211$24247021$1$I$$20240819$20240826$20240826$EXP$$AU-ABBVIE-5888548$ABBVIE$$$$$M$Y$$$20240826$$MD$AU$AU
242470221$24247022$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014503$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240826$$CN$US$US
242470231$24247023$1$I$20240201$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014310$ELI LILLY AND CO$$$$$$Y$$$20240826$$CN$US$US
242470241$24247024$1$I$$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014646$ELI LILLY AND CO$$$$A$M$Y$$$20240826$$CN$US$US
242470251$24247025$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014807$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240826$$CN$US$US
242470274$24247027$4$F$$20240920$20240826$20240930$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004147$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
242470281$24247028$1$I$$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167398$AMGEN$$77$YR$E$F$Y$$$20240825$$CN$US$US
242470292$24247029$2$F$$20240916$20240826$20240925$30DAY$$CA-JNJFOC-20240855206$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$PH$CA$CA
242470302$24247030$2$F$$20240822$20240826$20240917$PER$$US-ROCHE-10000063688$ROCHE$$43$YR$A$F$Y$$$20240917$$CN$US$US
242470312$24247031$2$F$$20240823$20240826$20240827$PER$$NVSC2024US171532$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242470321$24247032$1$I$$20240822$20240826$20240826$EXP$$JP-GSK-JP2024104857$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$JP$JP
242470331$24247033$1$I$$20240718$20240826$20240826$EXP$$IT-ROCHE-10000033964$ROCHE$Canino F, Barbolini M, Fontana T, GasparI V, Giorgi U, Gianni C, et al. Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study. BMC Cancer. 2024;24 (1):1-18. doi:10.1186/s12885-024-12506-0.$$$$$Y$$$20240826$$HP$IT$IT
242470341$24247034$1$I$20240726$20240731$20240826$20240826$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004167$ACADIA PHARMACEUTICALS$$93$YR$$F$Y$$$20240826$$HP$US$US
242470351$24247035$1$I$$20240731$20240826$20240826$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004152$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242470361$24247036$1$I$$20240813$20240826$20240826$PER$$US-AstraZeneca-2024A185384$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242470371$24247037$1$I$20240228$20240823$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-086949-2024$RECKITT BENCKISER$$$$$M$Y$$$20240826$$CN$US$US
242470381$24247038$1$I$20240801$20240822$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134286$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240826$$MD$US$US
242470401$24247040$1$I$$20240731$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004158$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
242470411$24247041$1$I$$20240822$20240826$20240826$EXP$$GB-SANDOZ INC.-SDZ2024GB074790$SANDOZ$$66$YR$$F$Y$60$KG$20240826$$MD$GB$GB
242470432$24247043$2$F$20231017$20240821$20240826$20240829$EXP$$CA-CELLTRION INC.-2023CA017556$CELLTRION$$$$$$Y$$$20240829$$MD$CA$CA
242470441$24247044$1$I$20240425$20240819$20240826$20240826$EXP$$CA-JNJFOC-20240389506$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240826$$CN$CA$CA
242470451$24247045$1$I$20240731$20240731$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004162$ACADIA PHARMACEUTICALS$$86$YR$$F$Y$$$20240826$$CN$US$US
242470461$24247046$1$I$$20240816$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130608$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240826$$CN$US$US
242470471$24247047$1$I$20231101$20240813$20240826$20240826$EXP$$BE-UCBSA-2024003052$UCB$$62$YR$$F$Y$$$20240826$$MD$BE$BE
242470481$24247048$1$I$$20240805$20240826$20240826$PER$$AU-TOLMAR, INC.-24AU051583$TOLMAR$$$$$M$Y$$$20240826$$CN$AU$AU
242470494$24247049$4$F$$20240916$20240826$20240916$EXP$$US-ROCHE-10000060824$ROCHE$$66$YR$E$F$Y$183$KG$20240916$$CN$US$US
242470501$24247050$1$I$20240101$20240805$20240826$20240826$PER$$BR-TOLMAR, INC.-24BR051723$TOLMAR$$9$YR$$F$Y$$$20240826$$HP$BR$BR
242470511$24247051$1$I$$20240805$20240826$20240826$PER$$CA-TOLMAR, INC.-24CA051610$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
242470521$24247052$1$I$20240805$20240805$20240826$20240826$PER$$CA-TOLMAR, INC.-24CA051651$TOLMAR$$72$YR$$M$Y$$$20240826$$CN$CA$CA
242470531$24247053$1$I$$20240805$20240826$20240826$PER$$CA-TOLMAR, INC.-24CA051654$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
242470541$24247054$1$I$$20240805$20240826$20240826$PER$$CA-TOLMAR, INC.-24CA051643$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
242470551$24247055$1$I$$20240805$20240826$20240826$PER$$CA-TOLMAR, INC.-24CA051644$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
242470561$24247056$1$I$20240805$20240805$20240826$20240826$PER$$CA-TOLMAR, INC.-24CA051649$TOLMAR$$86$YR$$M$Y$$$20240826$$CN$CA$CA
242470571$24247057$1$I$20240405$20240805$20240826$20240826$PER$$CA-TOLMAR, INC.-24CA051660$TOLMAR$$73$YR$$M$Y$$$20240826$$CN$CA$CA
242470581$24247058$1$I$$20240822$20240826$20240826$EXP$$CA-SANDOZ INC.-SDZ2024CA074852$SANDOZ$$87$YR$$M$Y$$$20240826$$CN$CA$CA
242470591$24247059$1$I$$20240731$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004168$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242470601$24247060$1$I$20240820$20240820$20240826$20240826$EXP$$TW-JNJFOC-20240865199$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240826$$MD$TW$TW
242470611$24247061$1$I$20240801$20240822$20240826$20240826$EXP$$PK-ROCHE-10000064793$ROCHE$$34$YR$A$F$Y$$$20240826$$CN$PK$PK
242470622$24247062$2$F$20230901$20240910$20240826$20240916$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047283$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240916$$CN$US$US
242470631$24247063$1$I$20240514$20240816$20240826$20240826$EXP$FR-AFSSAPS-CN2024000729$FR-KOANAAP-SML-FR-2024-00865$SHILPA MEDICARE$$79$YR$E$F$Y$60$KG$20240826$$MD$FR$FR
242470641$24247064$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-040890$AUROBINDO$Dexamethasone/prednisone: Iatrogenic adrenal insufficiency secondary to the hypothalamicpituitary-adrenal axis suppression: case repor. Reactions. 2023;1983$14$YR$$M$Y$$$20240826$$HP$US$US
242470651$24247065$1$I$$20240822$20240826$20240826$PER$$US-AstraZeneca-2024A191976$ASTRAZENECA$$$$$$Y$$$20240826$$MD$US$
242470661$24247066$1$I$$20240819$20240826$20240826$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046656$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$$$20240826$$CN$US$US
242470681$24247068$1$I$20240114$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A191458$ASTRAZENECA$$29332$DY$$F$Y$$$20240826$$CN$US$
242470693$24247069$3$F$20240701$20240830$20240826$20240903$PER$$US-AMGEN-USASP2024166681$AMGEN$$67$YR$E$M$Y$$$20240902$$HP$US$US
242470701$24247070$1$I$$20240812$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2022-033871$AUROBINDO$Ledlie S, Gandhi-Banga S, Shrestha A, Mallett Moore T, Khromava A. Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry. Influenza Other Respi Viruse. 2022;16(1):90-100$34$YR$$F$Y$$$20240826$$HP$CA$CA
242470711$24247071$1$I$20240801$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014715$ELI LILLY AND CO$$$$$$Y$$$20240826$$MD$US$US
242470721$24247072$1$I$20240820$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015043$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240826$$CN$US$US
242470731$24247073$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014590$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242470741$24247074$1$I$20240801$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013607$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240826$$MD$US$US
242470751$24247075$1$I$20240501$20240816$20240826$20240826$EXP$FR-AFSSAPS-AVGR2024000142$FR-TEVA-VS-3234141$TEVA$$14$YR$$M$Y$$$20240826$$MD$FR$FR
242470771$24247077$1$I$$20240819$20240826$20240826$EXP$$CA-CELLTRION INC.-2024CA020160$CELLTRION$$$$$$Y$$$20240826$$MD$CA$CA
242470781$24247078$1$I$$20240815$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129890$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240826$$CN$US$US
242470791$24247079$1$I$$20240821$20240826$20240826$PER$$US-ALXN-202408USA001394US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242470801$24247080$1$I$$20240820$20240826$20240826$PER$$US-ROCHE-10000062751$ROCHE$$62$YR$A$F$Y$$$20240826$$CN$US$US
242470813$24247081$3$F$$20240914$20240826$20240918$EXP$$NVSC2024US171386$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
242470821$24247082$1$I$20230908$20240822$20240826$20240826$PER$$NVSC2024US171587$NOVARTIS$$$$$M$Y$$$20240826$$HP$US$US
242470831$24247083$1$I$$20240820$20240826$20240826$EXP$$FR-JNJFOC-20240854345$JOHNSON AND JOHNSON$$76$YR$E$F$Y$65$KG$20240826$$MD$FR$FR
242470841$24247084$1$I$20240624$20240817$20240826$20240826$EXP$$CO-VANTIVE-2024VAN019108$Vantive US Healthcare$$77$YR$$F$Y$63$KG$20240826$$HP$CO$CO
242470851$24247085$1$I$20240814$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024165030$AMGEN$$$$$M$Y$$$20240825$$CN$US$US
242470862$24247086$2$F$20240819$20240902$20240826$20240903$EXP$$DE-JNJFOC-20240865020$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240904$$CN$DE$DE
242470871$24247087$1$I$20240803$20240819$20240826$20240826$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2024-115608$REGENERON$$71$YR$$M$Y$$$20240826$$CN$GB$GB
242470891$24247089$1$I$$20240819$20240826$20240826$PER$$US-ALXN-202408USA001290US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242470901$24247090$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2021-040531$AUROBINDO$$62$YR$$F$Y$$$20240826$$HP$CA$CA
242470911$24247091$1$I$$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A190967$ASTRAZENECA$$$$$F$Y$$$20240826$$MD$US$
242470921$24247092$1$I$$20240731$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004170$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
242470931$24247093$1$I$$20240812$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041069$AUROBINDO$Reyes NGD, Bendahan N, Swinkin E, Lang AE, Bassett AS. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurol-Sci. 2024$49$YR$$F$Y$$$20240826$$HP$CA$CA
242470942$24247094$2$F$20240821$20240826$20240826$20240829$PER$$US-AMGEN-USASP2024168103$AMGEN$$83$YR$E$F$Y$$$20240829$$CN$US$US
242470951$24247095$1$I$$20240814$20240826$20240826$EXP$$JP-AMGEN-JPNSP2024167376$AMGEN$$$$$M$Y$$$20240826$$CN$JP$JP
242470965$24247096$5$F$$20240916$20240826$20240924$30DAY$$CA-JNJFOC-20240845812$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240924$$PH$CA$CA
242470971$24247097$1$I$$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-082622-2024$RECKITT BENCKISER$$$$$F$Y$$$20240826$$CN$US$US
242470981$24247098$1$I$$20240820$20240826$20240826$PER$$US-ROCHE-10000061188$ROCHE$$52$YR$A$F$Y$$$20240826$$MD$US$US
242471001$24247100$1$I$20240818$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014714$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240826$$CN$US$US
242471011$24247101$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014668$ELI LILLY AND CO$$77$YR$E$$Y$$$20240826$$CN$US$US
242471021$24247102$1$I$20240701$20240813$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408008926$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240826$$CN$US$US
242471031$24247103$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014919$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240826$$CN$US$US
242471041$24247104$1$I$$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013891$ELI LILLY AND CO$$57$YR$A$$Y$$$20240826$$LW$US$US
242471061$24247106$1$I$$20240816$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015013$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240826$$CN$US$US
242471071$24247107$1$I$$20240731$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004172$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242471081$24247108$1$I$20240701$20240820$20240826$20240826$EXP$$US-JNJFOC-20240853437$JOHNSON AND JOHNSON$$43$YR$A$F$Y$170$KG$20240826$$CN$US$US
242471091$24247109$1$I$$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014466$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240826$$CN$US$US
242471101$24247110$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014482$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240826$$CN$US$US
242471111$24247111$1$I$20240816$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013669$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240826$$CN$US$US
242471122$24247112$2$F$$20240819$20240826$20240827$EXP$$CA-JNJFOC-20240851786$JOHNSON AND JOHNSON$$16$YR$T$M$Y$52$KG$20240827$$HP$CA$CA
242471131$24247113$1$I$20240622$20240716$20240826$20240826$PER$$US-ROCHE-10000026956$ROCHE$$$$$F$Y$$$20240826$$CN$US$PR
242471141$24247114$1$I$20240101$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132008$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$81.2$KG$20240826$$PH$US$US
242471152$24247115$2$F$$20240830$20240826$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133526$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240904$$CN$US$US
242471161$24247116$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132678$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240826$$HP$US$US
242471171$24247117$1$I$20221210$20230201$20240826$20240826$EXP$$CO-BIOVITRUM-2022CO15746$BIOVITRUM$$75$DY$$F$Y$3$KG$20240826$$CN$CO$CO
242471181$24247118$1$I$$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167186$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242471191$24247119$1$I$20240816$20240820$20240826$20240826$PER$$US-ROCHE-10000062870$ROCHE$$67$YR$E$F$Y$$$20240826$$HP$US$US
242471201$24247120$1$I$20240819$20240820$20240826$20240826$EXP$$TW-AMGEN-TWNSP2024168078$AMGEN$$66$YR$E$F$Y$$$20240826$$HP$TW$TW
242471212$24247121$2$F$20240726$20240919$20240826$20240925$PER$$US-AMGEN-USASP2024166671$AMGEN$$26$YR$A$F$Y$58.97$KG$20240925$$PH$US$US
242471221$24247122$1$I$$20240814$20240826$20240826$EXP$$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP001193$JUBILANT$Yamaguchi T, Aihara A, Mashiko S, Kurosawa E, Oizumi T, Yamagata T et al.. Exacerbation of delirium and epileptic seizures in an older man with idiopathic Parkinson^s disease due to multiple prescriptions: a case report. Frontiers in Medicine. 2024;11:1415988$8$DEC$$M$Y$$$20240826$$MD$JP$JP
242471231$24247123$1$I$$20240812$20240826$20240826$EXP$$IT-AUROBINDO-AUR-APL-2024-040817$AUROBINDO$De Novellis D, Fontana R, Serio B, Vaccaro E, Guariglia R, Selleri C, et al. Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens. Cancer-Medicine. 2024;13(14):1-8, e7402$$$$$Y$$$20240826$$HP$IT$IT
242471241$24247124$1$I$$20240816$20240826$20240826$EXP$LK-MLMSERVICE-20240809-PI157708-00256-1$LK-JUBILANT CADISTA PHARMACEUTICALS-2024LK001205$JUBILANT$Krishnan M, Fernando H, Mohammed HH, Vithanage N.. Proton Pump Inhibitor Induced Hypomagnesemia Causing Seizures: A Rare Adverse Effect of a Commonly Used Medication.. Cureus. 2024;16(7)$49$YR$$M$Y$$$20240826$$MD$LK$LK
242471251$24247125$1$I$$20240812$20240826$20240826$EXP$IN-MLMSERVICE-20240806-PI153975-00108-1$IN-JUBILANT CADISTA PHARMACEUTICALS-2024IN001182$JUBILANT$Kutumbaka T, Varadan S, Sudagar Singh RB. The Atypical Face of Neuroleptic Malignant Syndrome: A Case Report of Ileus and Absent Rigidity.. Cureus. 2024;16(7)$36$YR$$M$Y$$$20240826$$MD$IN$IN
242471261$24247126$1$I$$20240814$20240826$20240826$EXP$$GB-Appco Pharma LLC-2160837$APPCO PHARMA$Initial$64$YR$$M$Y$75$KG$20240826$$MD$GB$GB
242471271$24247127$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-042315$AUROBINDO$$5$YR$$M$Y$$$20240826$$CN$CA$CA
242471301$24247130$1$I$$20240815$20240826$20240826$EXP$US-MLMSERVICE-20240809-PI154453-00190-1$US-JUBILANT CADISTA PHARMACEUTICALS-2024US001199$JUBILANT$Preskorn SH, Masolak DD. Life-threatening Rash Due to Lamotrigine and a Failure to Understand Its Pharmacology: How Forensic Detective Work Uses Medical Knowledge and Clinical Pharmacology to Solve Cases. Journal of Psychiatric Practice. 2024;30(4)::273-8.$13$YR$$M$Y$$$20240826$$MD$US$US
242471311$24247131$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-042265$AUROBINDO$$45$YR$$F$Y$$$20240826$$CN$CA$CA
242471321$24247132$1$I$$20240822$20240826$20240826$EXP$$US-AstraZeneca-2024A192343$ASTRAZENECA$$$$$F$Y$$$20240826$$CN$US$
242471331$24247133$1$I$$20240812$20240826$20240826$EXP$$IT-JNJFOC-20240858458$JOHNSON AND JOHNSON$$90$YR$E$M$Y$83$KG$20240826$$HP$IT$IT
242471341$24247134$1$I$20240601$20240816$20240826$20240826$PER$$US-ABBVIE-5884947$ABBVIE$$35$YR$$M$Y$68.945$KG$20240826$$CN$US$US
242471351$24247135$1$I$20240727$20240816$20240826$20240826$EXP$FR-AFSSAPS-RS2024000793$FR-TEVA-VS-3234272$TEVA$$19$YR$$M$Y$54$KG$20240826$$MD$FR$FR
242471361$24247136$1$I$$20240815$20240826$20240826$EXP$$US-APOTEX-2024AP009484$APOTEX$$$$$M$Y$$$20240826$$CN$US$US
242471371$24247137$1$I$20240426$20240813$20240826$20240826$EXP$$DE-AUROBINDO-AUR-APL-2024-041364$AUROBINDO$$74$YR$$M$Y$70$KG$20240826$$HP$DE$DE
242471382$24247138$2$F$$20240829$20240826$20240905$EXP$$CA-HALEON-2193102$Haleon PLC$$43$YR$$F$Y$70$KG$20240905$$HP$CA$CA
242471391$24247139$1$I$20240101$20240822$20240826$20240826$EXP$$US-JNJFOC-20240860789$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240826$$HP$US$US
242471401$24247140$1$I$20240802$20240816$20240826$20240826$EXP$CN-91110000556821568D-2024DRL001547$CN-RDY-SPO/CHN/24/0012096$DR REDDYS$$27$YR$A$F$Y$57$KG$20240826$$HP$CN$CN
242471411$24247141$1$I$20240101$20240820$20240826$20240826$EXP$$JP-AMGEN-JPNSP2024112872$AMGEN$$$$E$$Y$$$20240826$$MD$JP$JP
242471421$24247142$1$I$20240101$20240816$20240826$20240826$EXP$$CA-CELLTRION INC.-2024CA005832$CELLTRION$$$$$$Y$$$20240826$$MD$CA$CA
242471431$24247143$1$I$$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-082468-2024$RECKITT BENCKISER$$60$YR$$F$Y$141.82$KG$20240826$$CN$US$US
242471441$24247144$1$I$20240821$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167683$AMGEN$$72$YR$E$F$Y$$$20240826$$CN$US$US
242471451$24247145$1$I$$20240819$20240826$20240826$EXP$$CA-HALEON-2193134$Haleon PLC$$44$YR$$M$Y$91$KG$20240826$$HP$CA$CA
242471461$24247146$1$I$20240822$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014725$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240826$$CN$US$US
242471471$24247147$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015023$ELI LILLY AND CO$$$$$M$Y$$$20240826$$CN$US$US
242471481$24247148$1$I$20230101$20240814$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408010086$ELI LILLY AND CO$$$$$$Y$$$20240826$$CN$US$US
242471491$24247149$1$I$20240821$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014379$ELI LILLY AND CO$$$$$$Y$$$20240826$$PH$US$US
242471502$24247150$2$F$$20240821$20240826$20240827$EXP$$PK-ROCHE-10000061627$ROCHE$$72$YR$E$M$Y$$$20240827$$CN$PK$PK
242471511$24247151$1$I$20240821$20240822$20240826$20240826$EXP$$CN-ROCHE-10000064189$ROCHE$$69$YR$E$F$Y$49$KG$20240826$$HP$CN$CN
242471521$24247152$1$I$$20240813$20240826$20240826$PER$$US-JNJFOC-20240840942$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242471531$24247153$1$I$$20240821$20240826$20240826$EXP$$US-JNJFOC-20240855176$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$HP$US$US
242471551$24247155$1$I$20230101$20240813$20240826$20240826$EXP$$PL-AUROBINDO-AUR-APL-2023-066935$AUROBINDO$Jankowski T. Pembrolizumab with chemotherapy in NSCLC ? long response and treatment of oligoprogression during parenteral nutrition.. Oncology in clinical practice - education. 2023;9(Suppl B):B31-33$68$YR$$F$Y$46$KG$20240826$$MD$PL$PL
242471561$24247156$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064820$ROCHE$$72$YR$E$M$Y$$$20240826$$CN$US$US
242471572$24247157$2$F$20191220$20240816$20240826$20240904$EXP$$CA-HALEON-2193304$Haleon PLC$$70$YR$$F$Y$$$20240904$$HP$CA$CA
242471583$24247158$3$F$$20240829$20240826$20240830$PER$$US-AMGEN-USASP2024168676$AMGEN$$69$YR$E$F$Y$$$20240830$$HP$US$US
242471591$24247159$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041477$AUROBINDO$$45$YR$$F$Y$$$20240826$$HP$CA$CA
242471601$24247160$1$I$20240801$20240816$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132619$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$68.04$KG$20240826$$CN$US$US
242471611$24247161$1$I$20240801$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132761$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$61.23$KG$20240826$$CN$US$US
242471621$24247162$1$I$$20240822$20240826$20240826$EXP$$US-AstraZeneca-2024A191796$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242471631$24247163$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-042227$AUROBINDO$Sircy A, Ibeh B, Boutros N, Bolyard J.. OTITIS MEDIA TO MENINGITIS: A RARE GROUP A STREPTOCOCCUS MENINGITIS CASE. Crit-Care-Med. 2024;52 (Suppl.):S705$43$YR$$M$Y$$$20240826$$HP$US$US
242471641$24247164$1$I$20240730$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A191093$ASTRAZENECA$$$$$F$Y$$$20240826$$CN$US$
242471652$24247165$2$F$20221110$20240913$20240826$20240923$EXP$$CA-CELLTRION INC.-2024CA011706$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
242471661$24247166$1$I$$20240520$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US002622$ALCON$$63$YR$$F$Y$$$20240826$$CN$US$US
242471671$24247167$1$I$$20240123$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US000791$ALCON$$$$$F$Y$$$20240826$$CN$US$US
242471681$24247168$1$I$20230707$20230710$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2023US003325$ALCON$$$$$F$Y$$$20240826$$CN$US$US
242471691$24247169$1$I$$20240821$20240826$20240826$EXP$$ZA-AstraZeneca-2024A191460$ASTRAZENECA$$81$YR$$F$Y$$$20240826$$CN$ZA$
242471701$24247170$1$I$20230912$20230913$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2023US004287$ALCON$$$$$F$Y$$$20240826$$CN$US$US
242471711$24247171$1$I$$20240418$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US002113$ALCON$$$$$M$Y$$$20240826$$CN$US$US
242471721$24247172$1$I$$20240521$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US002517$ALCON$$$$$M$Y$$$20240826$$CN$US$US
242471731$24247173$1$I$$20230808$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2023US003733$ALCON$$$$$F$Y$$$20240826$$CN$US$US
242471741$24247174$1$I$$20230718$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2023US003418$ALCON$$$$$F$Y$$$20240826$$CN$US$US
242471751$24247175$1$I$$20240816$20240826$20240826$30DAY$$US-GSK-US2024102696$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
242471761$24247176$1$I$20240801$20240819$20240826$20240826$30DAY$$US-GSK-US2024103343$GLAXOSMITHKLINE$$64$YR$$M$Y$$$20240826$$CN$US$US
242471771$24247177$1$I$20240821$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167159$AMGEN$$61$YR$A$F$Y$$$20240826$$PH$US$US
242471781$24247178$1$I$$20240814$20240826$20240826$EXP$$DE-OrBion Pharmaceuticals Private Limited-2160838$ORBION PHARMACEUTICALS$Bingert R, Kolbe V, Boy D, Buttner A. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. Rechtsmedizin 2023;33(5):396-402.$14$YR$$F$Y$$$20240826$$MD$DE$DE
242471792$24247179$2$F$$20240826$20240826$20240828$PER$$US-JNJFOC-20240865142$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$CN$US$US
242471801$24247180$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134103$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240826$$CN$US$US
242471811$24247181$1$I$$20240811$20240826$20240826$EXP$$IT-JNJFOC-20240858330$JOHNSON AND JOHNSON$$79$YR$E$M$Y$75$KG$20240826$$HP$IT$IT
242471821$24247182$1$I$20240209$20240209$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US001028$ALCON$$68$YR$$F$Y$$$20240826$$CN$US$US
242471831$24247183$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134097$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240826$$CN$US$US
242471841$24247184$1$I$20231206$20231206$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2023US005619$ALCON$$49$YR$$F$Y$$$20240826$$CN$US$US
242471851$24247185$1$I$20230901$20230913$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2023US004384$ALCON$$71$YR$$F$Y$$$20240826$$CN$US$US
242471861$24247186$1$I$20240421$20240426$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US002268$ALCON$$55$YR$$F$Y$$$20240826$$CN$US$US
242471871$24247187$1$I$20231025$20231030$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2023US004865$ALCON$$71$YR$$F$Y$$$20240826$$CN$US$US
242471881$24247188$1$I$20240724$20240819$20240826$20240826$EXP$$US-RIGEL-20240800086$RIGEL PHARMACEUTICALS$$71$YR$$F$Y$83.461$KG$20240826$$CN$US$US
242471891$24247189$1$I$20230909$20230911$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2023US004226$ALCON$$$$$F$Y$$$20240826$$CN$US$US
242471901$24247190$1$I$$20240401$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US001843$ALCON$$$$$F$Y$$$20240826$$CN$US$US
242471911$24247191$1$I$$20231207$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2023US005588$ALCON$$77$YR$$M$Y$$$20240826$$CN$US$US
242471921$24247192$1$I$$20231215$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2023US005703$ALCON$$$$$F$Y$$$20240826$$CN$US$US
242471931$24247193$1$I$20231116$20231117$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2023US005251$ALCON$$63$YR$$M$Y$$$20240826$$CN$US$US
242471941$24247194$1$I$$20240814$20240826$20240826$EXP$$US-OrBion Pharmaceuticals Private Limited-2160839$ORBION PHARMACEUTICALS$Sorabella RA, Gray WH, Dabal RJ, Padilla LA, Hock K, Clark MG, O^Meara C, Hawkins J, Richter RP, Borasino S, Byrnes JW. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO J. 2024 Jul 1;70(7):e92-e96. doi: 10.1097/MAT.0000000000002102.$12$YR$$F$Y$63$KG$20240826$$MD$US$US
242471951$24247195$1$I$$20240813$20240826$20240826$EXP$$US-BIOCON BIOLOGICS LIMITED-BBL2024006157$BIOCON$Dao KT, Ghadiya K, Inga Jaco E, Sharma R, Rahimi R, Sukkar M, et al. A case of revelation due to pegfilgrastim.. Cureus.. 2024;16 (7):e63777$$$$$Y$$$20240826$$MD$US$US
242471961$24247196$1$I$$20240627$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US002990$ALCON$$67$YR$$F$Y$$$20240826$$CN$US$US
242471971$24247197$1$I$$20240514$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US002502$ALCON$$35$YR$$F$Y$$$20240826$$CN$US$US
242471981$24247198$1$I$$20240814$20240826$20240826$EXP$$US-OrBion Pharmaceuticals Private Limited-2160840$ORBION PHARMACEUTICALS$Sorabella RA, Gray WH, Dabal RJ, Padilla LA, Hock K, Clark MG, O^Meara C, Hawkins J, Richter RP, Borasino S, Byrnes JW. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO J. 2024 Jul 1;70(7):e92-e96. doi: 10.1097/MAT.0000000000002102.$14$YR$$F$Y$129$KG$20240826$$MD$US$US
242471991$24247199$1$I$$20240813$20240826$20240826$EXP$$ES-AUROBINDO-AUR-APL-2023-005724$AUROBINDO$Margarit-Soler A, Deya-Martinez A, Canizales J, Vlagea A, Garcia-Garcia A, Marsal J et.al. Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders. Frontiers in Immunology. 2022;13:1-10$21$YR$$M$Y$$$20240826$$MD$ES$ES
242472001$24247200$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-040936$AUROBINDO$Ahmed T, Liu D, Seiter K, Steinberg A, Hernandez K. Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. Blood. 2023;142 (Suppl. 1):7349-7350$28$YR$$M$Y$$$20240826$$MD$US$US
242472011$24247201$1$I$$20240613$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US002977$ALCON$$$$$M$Y$$$20240826$$HP$US$US
242472021$24247202$1$I$20240103$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-082743-2024$RECKITT BENCKISER$$78$YR$$M$Y$$$20240826$$CN$US$US
242472031$24247203$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134134$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240826$$HP$US$US
242472041$24247204$1$I$$20240613$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US002969$ALCON$$83$YR$$F$Y$$$20240826$$CN$US$US
242472051$24247205$1$I$$20240514$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US002503$ALCON$$13$YR$$M$Y$$$20240826$$CN$US$US
242472061$24247206$1$I$20240101$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133843$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$123.8$KG$20240826$$PH$US$US
242472071$24247207$1$I$20240516$20240606$20240826$20240826$PER$$US-ALCON LABORATORIES-ALC2024US002747$ALCON$$51$YR$$F$Y$$$20240826$$CN$US$US
242472081$24247208$1$I$$20240814$20240826$20240826$EXP$$US-OrBion Pharmaceuticals Private Limited-2160841$ORBION PHARMACEUTICALS$Sorabella RA, Gray WH, Dabal RJ, Padilla LA, Hock K, Clark MG, O^Meara C, Hawkins J, Richter RP, Borasino S, Byrnes JW. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO J. 2024 Jul 1;70(7):e92-e96. doi: 10.1097/MAT.0000000000002102.$15$YR$$F$Y$49$KG$20240826$$MD$US$US
242472092$24247209$2$F$20240518$20240821$20240826$20240902$PER$$US-AstraZeneca-2024A188251$ASTRAZENECA$$43$YR$$F$Y$72.1$KG$20240902$$HP$US$
242472101$24247210$1$I$20240701$20240814$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408009633$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240826$$CN$US$US
242472112$24247211$2$F$20240815$20240823$20240826$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408014550$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240830$$HP$US$US
242472121$24247212$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015016$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240826$$CN$US$US
242472131$24247213$1$I$20240820$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012559$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240826$$CN$US$US
242472141$24247214$1$I$20240819$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014522$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240826$$CN$US$US
242472151$24247215$1$I$20240801$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015047$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240826$$HP$US$US
242472161$24247216$1$I$20240501$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014733$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240826$$CN$US$US
242472171$24247217$1$I$$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012818$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240826$$CN$US$US
242472181$24247218$1$I$20240810$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014641$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240826$$CN$US$US
242472191$24247219$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014780$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240826$$CN$US$US
242472211$24247221$1$I$$20240820$20240826$20240826$EXP$JP-MMM-N0DE69VS$JP-VIIV HEALTHCARE LIMITED-JP2024103744$VIIV$$$$$$Y$$$20240826$$MD$JP$JP
242472221$24247222$1$I$$20240820$20240826$20240826$EXP$JP-MMM-N0DE69VS$JP-GSK-JP2024103744$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$JP$JP
242472231$24247223$1$I$$20240821$20240826$20240826$EXP$$US-OrBion Pharmaceuticals Private Limited-2160842$ORBION PHARMACEUTICALS$Javaheri S, Randerath WJ, Safwan Badr M, Javaheri S. Medication-induced central sleep apnea: a unifying concept. Sleep. 2024 Aug 14;47(8):zsae038. doi: 10.1093/sleep/zsae038.$64$YR$$$Y$$$20240826$$MD$US$US
242472241$24247224$1$I$$20240821$20240826$20240826$EXP$$US-OrBion Pharmaceuticals Private Limited-2160843$ORBION PHARMACEUTICALS$Javaheri S, Randerath WJ, Safwan Badr M, Javaheri S. Medication-induced central sleep apnea: a unifying concept. Sleep. 2024 Aug 14;47(8):zsae038. doi: 10.1093/sleep/zsae038.$9$YR$$M$Y$$$20240826$$MD$US$US
242472252$24247225$2$F$$20240831$20240826$20240910$EXP$$PT-AUROBINDO-AUR-APL-2024-037292$AUROBINDO$Neves AD, Viegas JF, Pinheiro D, Vilas AP.. TRATAR A  HIPERTENS?O,MAS N?O A HIPOTENS?O  ARTERIAL? (TREAT HYPERTENSION, BUT NOT  ARTERIAL HYPOTENSION?). Medicina geri?trica (Geriatric medicine). 2024;30:789$87$YR$$F$Y$$$20240910$$MD$PT$PT
242472261$24247226$1$I$20230905$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-109264-2023$RECKITT BENCKISER$$87$YR$$F$Y$$$20240826$$CN$US$US
242472272$24247227$2$F$20240101$20240827$20240826$20240829$EXP$$US-UCBSA-2024038101$UCB$$$$$M$Y$$$20240829$$CN$US$US
242472281$24247228$1$I$20150101$20240812$20240826$20240826$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00393$MELINTA THERAPEUTICS$$$$$$Y$$$20240826$$CN$BR$BR
242472292$24247229$2$F$20240819$20240821$20240826$20240828$PER$$US-JNJFOC-20240855036$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242472301$24247230$1$I$$20240811$20240826$20240826$EXP$$IT-JNJFOC-20240858366$JOHNSON AND JOHNSON$$79$YR$E$F$Y$75$KG$20240826$$HP$IT$IT
242472311$24247231$1$I$$20240819$20240826$20240826$EXP$NL-002147023-NVSC2020NL017372$NL-SANDOZ INC.-NVSC2020NL017372$SANDOZ$$68$YR$$$Y$$$20240826$$MD$NL$NL
242472321$24247232$1$I$20130101$20240812$20240826$20240826$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00394$MELINTA THERAPEUTICS$$$$$$Y$$$20240826$$CN$BR$BR
242472331$24247233$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133098$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240826$$CN$US$US
242472342$24247234$2$F$$20240916$20240826$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-133692$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240919$$MD$JP$JP
242472351$24247235$1$I$20200101$20240819$20240826$20240826$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-132769$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$51$KG$20240826$$MD$KR$KR
242472361$24247236$1$I$$20240820$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133540$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240826$$CN$US$US
242472372$24247237$2$F$$20240827$20240826$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134235$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240830$$CN$US$US
242472382$24247238$2$F$20230504$20240913$20240826$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-041344$AUROBINDO$$1$DY$$M$Y$3.415$KG$20240925$$HP$FR$FR
242472393$24247239$3$F$20240101$20240904$20240826$20240906$PER$$US-AMGEN-USASP2024169379$AMGEN$$58$YR$A$F$Y$$$20240905$$CN$US$US
242472401$24247240$1$I$$20240816$20240826$20240826$EXP$$TH-ROCHE-10000059443$ROCHE$$68$YR$E$M$Y$$$20240826$$MD$TH$TH
242472411$24247241$1$I$20230801$20240819$20240826$20240826$EXP$FR-SEATTLE GENETICS-2023SGN09779$FR-RDY-SPO/FRA/24/0012066$DR REDDYS$$$$A$F$Y$$$20240826$$HP$FR$FR
242472421$24247242$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134249$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240826$$MD$US$US
242472441$24247244$1$I$$20240821$20240826$20240826$30DAY$$CA-SANDOZ INC.-NVSC2022CA127557$SANDOZ$$$$$F$Y$$$20240826$$CN$CA$CA
242472451$24247245$1$I$$20240816$20240826$20240826$EXP$$VN-SANDOZ INC.-SDZ2024VN074973$SANDOZ$Ho HV, Nguyen BV, Tran HV, Ha TV. Acute myeloid leukemia after chemotherapy: reporting clinical case series in the department of chemotherapy - center of oncology - 103 military hospital and retrospective literature review. VIETNAM MEDICAL JOURNAL. 2021;506:21-6$60$YR$$M$Y$$$20240826$$HP$VN$VN
242472462$24247246$2$F$$20240823$20240826$20240827$PER$$US-JNJFOC-20240859336$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$US$US
242472471$24247247$1$I$20110322$20240812$20240826$20240826$EXP$$DE-AUROBINDO-AUR-APL-2024-041234$AUROBINDO$$$$N$M$Y$2.16$KG$20240826$$MD$DE$DE
242472481$24247248$1$I$$20240822$20240826$20240826$EXP$$CA-SANDOZ INC.-SDZ2024CA074927$SANDOZ$$26$YR$$F$Y$$$20240826$$HP$CA$CA
242472491$24247249$1$I$$20240822$20240826$20240826$EXP$$US-SANDOZ INC.-SDZ2024US074587$SANDOZ$$41$YR$$M$Y$$$20240826$$MD$US$US
242472502$24247250$2$F$$20240911$20240826$20240917$EXP$$JP-GSK-JP2024JPN094377$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$JP$JP
242472511$24247251$1$I$$20240819$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013902$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242472521$24247252$1$I$20240701$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012773$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240826$$CN$US$US
242472531$24247253$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014738$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240826$$CN$US$US
242472541$24247254$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014571$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240826$$CN$US$US
242472551$24247255$1$I$20240816$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167901$AMGEN$$$$$$Y$$$20240826$$HP$US$US
242472561$24247256$1$I$20200101$20240819$20240826$20240826$EXP$$FR-SANDOZ INC.-NVSC2022FR283113$SANDOZ$$50$YR$$F$Y$$$20240826$$MD$FR$FR
242472571$24247257$1$I$$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134282$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240826$$CN$US$US
242472581$24247258$1$I$20240819$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132900$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240826$$CN$US$US
242472591$24247259$1$I$20240101$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133192$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$65.77$KG$20240826$$CN$US$US
242472601$24247260$1$I$$20240822$20240826$20240826$EXP$$CA-SANDOZ INC.-SDZ2024CA074607$SANDOZ$$68$YR$$M$Y$$$20240826$$CN$CA$CA
242472611$24247261$1$I$$20240811$20240826$20240826$EXP$$IT-JNJFOC-20240858376$JOHNSON AND JOHNSON$$75$YR$E$F$Y$73$KG$20240826$$HP$IT$IT
242472621$24247262$1$I$$20240821$20240826$20240826$EXP$$US-JNJFOC-20240855180$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$HP$US$US
242472631$24247263$1$I$$20240819$20240826$20240826$EXP$$CA-JNJFOC-20240856131$JOHNSON AND JOHNSON$$73$YR$E$F$Y$72$KG$20240826$$HP$CA$CA
242472642$24247264$2$F$$20240816$20240826$20240906$PER$$US-ROCHE-10000061705$ROCHE$$$$$$Y$$$20240906$$MD$US$US
242472651$24247265$1$I$20240814$20240815$20240826$20240826$PER$$US-ROCHE-10000058859$ROCHE$$$$E$F$Y$54.88$KG$20240826$$CN$US$US
242472661$24247266$1$I$$20240817$20240826$20240826$PER$$US-ROCHE-10000060174$ROCHE$$66$YR$E$F$Y$$$20240826$$CN$US$US
242472671$24247267$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000063600$ROCHE$$$$E$M$Y$$$20240826$$CN$US$US
242472681$24247268$1$I$$20240821$20240826$20240826$EXP$$RS-ROCHE-10000062991$ROCHE$$50$YR$A$M$Y$$$20240826$$MD$RS$RS
242472691$24247269$1$I$$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132624$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240826$$CN$US$US
242472701$24247270$1$I$20240101$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134321$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240826$$CN$US$US
242472711$24247271$1$I$20240101$20240822$20240826$20240826$PER$$US-ORGANON-O2408USA001770$ORGANON$$$$$F$Y$$$20240826$$MD$US$US
242472721$24247272$1$I$$20240823$20240826$20240826$EXP$GB-MHRA-MIDB-222191ba-f6bf-4a90-93ce-9ba0b3e1c4dc$GB-ORGANON-O2408GBR001808$ORGANON$$59$YR$$F$Y$$$20240826$$PH$GB$GB
242472731$24247273$1$I$$20240823$20240826$20240826$EXP$$PL-SANDOZ INC.-SDZ2024PL074926$SANDOZ$$15$YR$$M$Y$$$20240826$$HP$PL$PL
242472741$24247274$1$I$20201118$20240819$20240826$20240826$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-132835$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$61.5$KG$20240826$$MD$KR$KR
242472751$24247275$1$I$20230901$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-105998-2023$RECKITT BENCKISER$$87$YR$$F$Y$67.27$KG$20240826$$CN$US$US
242472761$24247276$1$I$20240731$20240731$20240826$20240826$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004149$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240826$$CN$US$US
242472771$24247277$1$I$20240101$20240821$20240826$20240826$EXP$$AU-ABBVIE-5891692$ABBVIE$$45$YR$$F$Y$$$20240826$$HP$AU$AU
242472781$24247278$1$I$$20240820$20240826$20240826$PER$$US-ALXN-202408USA001348US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
242472791$24247279$1$I$$20240819$20240826$20240826$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-131521$BRISTOL MYERS SQUIBB$Literature Citation Unavailable$51$YR$A$M$Y$$$20240826$$HP$CA$CA
242472802$24247280$2$F$20240701$20240904$20240826$20240910$EXP$$NVSJ2024JP009179$NOVARTIS$$$$$F$Y$$$20240910$$MD$JP$JP
242472811$24247281$1$I$20240707$20240819$20240826$20240826$EXP$$US-JNJFOC-20240848345$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240826$$CN$US$US
242472821$24247282$1$I$20240821$20240821$20240826$20240826$PER$$US-JNJFOC-20240855087$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$MD$US$US
242472842$24247284$2$F$$20240920$20240826$20240925$PER$$US-AMGEN-USASP2024167669$AMGEN$$50$YR$A$M$Y$$$20240925$$MD$US$US
242472852$24247285$2$F$20240715$20240916$20240826$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-041323$AUROBINDO$$7$YR$$M$Y$$$20240926$$CN$FR$FR
242472861$24247286$1$I$20240101$20240821$20240826$20240826$EXP$$US-JNJFOC-20240855131$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$HP$US$US
242472871$24247287$1$I$$20240812$20240826$20240826$EXP$$CA-TERSERA THERAPEUTICS LLC-2024TRS004217$TERSERA THERAPEUTICS$$$$$$Y$$$20240826$$HP$CA$CA
242472882$24247288$2$F$20240726$20240911$20240826$20240919$EXP$$JP-ROCHE-10000063186$ROCHE$$76$YR$E$M$Y$$$20240919$$MD$JP$JP
242472891$24247289$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015012$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240826$$CN$US$US
242472901$24247290$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014543$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240826$$PH$US$US
242472912$24247291$2$F$20240801$20240823$20240826$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014554$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240828$$CN$US$US
242472921$24247292$1$I$20240822$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014445$ELI LILLY AND CO$$41$YR$A$$Y$$$20240826$$CN$US$US
242472931$24247293$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132234$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240826$$PH$US$US
242472941$24247294$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134405$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240826$$HP$US$US
242472951$24247295$1$I$$20240819$20240826$20240826$PER$$US-ABBVIE-5889099$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242472961$24247296$1$I$20240819$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012817$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240826$$CN$US$US
242472971$24247297$1$I$$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012820$ELI LILLY AND CO$$54$YR$A$$Y$$$20240826$$CN$US$US
242472992$24247299$2$F$$20240910$20240826$20240924$EXP$$LB-Appco Pharma LLC-2160845$APPCO PHARMA$Follow up$57$YR$$F$Y$$$20240924$$$LB$LB
242473001$24247300$1$I$$20240819$20240826$20240826$EXP$$CA-ROCHE-10000060253$ROCHE$$76$YR$E$M$Y$85$KG$20240826$$PH$CA$CA
242473011$24247301$1$I$$20240814$20240826$20240826$EXP$$CA-ROCHE-10000063096$ROCHE$$43$YR$A$F$Y$$$20240826$$CN$CA$CA
242473031$24247303$1$I$$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167970$AMGEN$$$$$$Y$$$20240826$$MD$US$US
242473041$24247304$1$I$20240821$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168715$AMGEN$$$$$$Y$$$20240826$$PH$US$US
242473061$24247306$1$I$20240101$20240814$20240826$20240826$EXP$$US-UCBSA-2024031454$UCB$$$$$M$Y$$$20240826$$HP$US$US
242473072$24247307$2$F$20200823$20240923$20240826$20240930$EXP$$GB-SANDOZ INC.-NVSC2020GB238718$SANDOZ$$62$YR$$F$Y$$$20240930$$CN$GB$GB
242473081$24247308$1$I$20240710$20240816$20240826$20240826$30DAY$$US-GSK-US2024102391$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240826$$CN$US$US
242473091$24247309$1$I$20240820$20240821$20240826$20240826$EXP$$AU-ABBVIE-5890785$ABBVIE$$78$YR$$M$Y$$$20240826$$PH$AU$AU
242473101$24247310$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000065341$ROCHE$$63$YR$A$F$Y$$$20240826$$HP$US$US
242473111$24247311$1$I$$20240815$20240826$20240826$PER$$US-AMGEN-USASP2024164176$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242473121$24247312$1$I$$20240822$20240826$20240826$EXP$$CA-SANDOZ INC.-SDZ2024CA074782$SANDOZ$$$$$$Y$$$20240826$$HP$CA$CA
242473131$24247313$1$I$$20240816$20240826$20240826$EXP$$CA-APOTEX-2024AP009504$APOTEX$$61$YR$$M$Y$$$20240826$$MD$CA$CA
242473141$24247314$1$I$$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133172$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240826$$HP$US$US
242473151$24247315$1$I$$20240607$20240826$20240826$EXP$$US-SANDOZ INC.-SDZ2024US075068$SANDOZ$$$$$F$Y$$$20240826$$CN$US$US
242473171$24247317$1$I$$20240816$20240826$20240826$EXP$$CA-CELLTRION INC.-2024CA020275$CELLTRION$$$$$$Y$$$20240826$$CN$CA$CA
242473181$24247318$1$I$$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024165655$AMGEN$$$$E$F$Y$$$20240826$$CN$US$US
242473191$24247319$1$I$$20240813$20240826$20240826$PER$$US-TAKEDA-2024TUS081466$TAKEDA$$$$E$F$Y$155$KG$20240826$$MD$US$US
242473202$24247320$2$F$20240809$20240912$20240826$20240916$PER$$US-AMGEN-USASP2024167059$AMGEN$$73$YR$E$F$Y$$$20240916$$CN$US$US
242473221$24247322$1$I$$20240820$20240826$20240826$EXP$JP-MMM-JC12HYL9$JP-VIIV HEALTHCARE LIMITED-JP2024103749$VIIV$$$$$$Y$$$20240826$$MD$JP$JP
242473231$24247323$1$I$$20240823$20240826$20240826$EXP$GB-MHRA-MED-202408230904294950-DJCKB$GB-SANDOZ INC.-SDZ2024GB075015$SANDOZ$$$$$M$Y$$$20240826$$PH$GB$GB
242473241$24247324$1$I$$20240819$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132669$BRISTOL MYERS SQUIBB$Jalili MH, Cornman-Homonoff J. Suction thrombectomy for management of pulmonary tumor embolism in the setting of hepatocellular carcinoma with macrovascular invasion. Radiology Case Reports. 2024;19(10):4627-30. doi:10.1016/j.radcr.2024.07.051.$83$YR$E$M$Y$$$20240826$$MD$US$US
242473251$24247325$1$I$20240819$20240819$20240826$20240826$PER$$US-JNJFOC-20240848004$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240826$$HP$US$US
242473261$24247326$1$I$$20240715$20240826$20240826$EXP$$PT-TEVA-VS-3222693$TEVA$Correia AR, Lamas A, Brand?o M. CO-0133 - (4713) - NECROTIZING MYOPATHY IMMUNE-MEDIATED WITH ANTI-HMGCR ANTIBODIES IN A PATIENT WITH MIXED CONNECTIVE TISSUE DISEASE  . Congressos da Sociedade Portuguesa de Medicina Interna: 30.? Congresso Nacional de Medicina Interna - Livro de resumos [CNMI]. 2024 May; 234.$41$YR$$F$Y$$$20240826$$MD$PT$PT
242473271$24247327$1$I$20240603$20240815$20240826$20240826$EXP$$US-JNJFOC-20240850384$JOHNSON AND JOHNSON$$0$YR$$M$Y$$$20240826$$HP$US$US
242473281$24247328$1$I$$20240822$20240826$20240826$PER$$US-HALEON-2193359$Haleon PLC$$66$YR$$M$Y$$$20240826$$CN$US$US
242473291$24247329$1$I$$20240823$20240826$20240826$EXP$$GB-SANDOZ INC.-SDZ2024GB074996$SANDOZ$$$$$M$Y$$$20240826$$HP$GB$GB
242473301$24247330$1$I$$20240819$20240826$20240826$EXP$$CA-ROCHE-10000060449$ROCHE$$66$YR$E$M$Y$$$20240826$$PH$CA$CA
242473311$24247331$1$I$20240820$20240821$20240826$20240826$PER$$US-ALXN-202408USA001387US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242473321$24247332$1$I$20240806$20240814$20240826$20240826$EXP$$CN-ROCHE-10000058273$ROCHE$$35$YR$A$M$Y$87$KG$20240826$$HP$CN$CN
242473332$24247333$2$F$20240712$20240829$20240826$20240903$PER$$US-ALXN-202408USA001363US$ALEXION PHARMACEUTICALS$$72$YR$$F$Y$$$20240904$$CN$US$US
242473342$24247334$2$F$20240612$20240917$20240826$20240924$EXP$$AU-BEH-2024177306$CSL BEHRING$$64$YR$A$F$Y$$$20240924$$MD$AU$AU
242473352$24247335$2$F$20180115$20240916$20240826$20240920$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-16739$IPSEN$$67$YR$E$F$Y$$$20240920$$CN$CA$CA
242473361$24247336$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000063153$ROCHE$$53$YR$A$F$Y$$$20240826$$CN$US$US
242473371$24247337$1$I$$20240820$20240826$20240826$EXP$$US-TAKEDA-2022TUS103252$TAKEDA$$$$$F$Y$$$20240826$$CN$US$US
242473381$24247338$1$I$$20240819$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012028$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240826$$CN$US$US
242473391$24247339$1$I$$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013900$ELI LILLY AND CO$$45$YR$A$$Y$$$20240826$$LW$US$US
242473401$24247340$1$I$$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012767$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240826$$CN$US$US
242473411$24247341$1$I$20240801$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014625$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240826$$CN$US$US
242473421$24247342$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014549$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240826$$CN$US$US
242473431$24247343$1$I$20240821$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014782$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240826$$CN$US$US
242473441$24247344$1$I$$20240815$20240826$20240826$EXP$$TR-ROCHE-10000059247$ROCHE$$67$YR$E$F$Y$$$20240826$$MD$TR$TR
242473451$24247345$1$I$20190101$20240814$20240826$20240826$EXP$$GB-ASPEN-GLO2024GB005734$ASPEN$Mohidin B, Needleman A, Fernando R, Lowe DM, Wechalekar A, Sheaff M, et al.. Renal transplant outcomes in plasma cell dyscrasias and AL amyloidosis after treatment with daratumumab. Journal of Clinical Medicine.. 2024;13 (14):4109$$$$$Y$$$20240826$$MD$GB$GB
242473461$24247346$1$I$20240501$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134225$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240826$$HP$US$US
242473471$24247347$1$I$$20240821$20240826$20240826$EXP$$JP-TAKEDA-2024TJP012415$TAKEDA$Shinya Omori, Eriko Nakano, Kojiro Kataoka, Naohiro Dairaku. Experience with vedolizumab use in Crohn^s disease. 103$25$YR$$M$Y$$$20240826$$MD$JP$JP
242473481$24247348$1$I$$20240822$20240826$20240826$EXP$$JP-TAKEDA-2024TJP012360$TAKEDA$$5$DEC$$F$Y$$$20240826$$MD$JP$JP
242473511$24247351$1$I$20240817$20240820$20240826$20240826$PER$$US-ALXN-202408USA001357US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
242473521$24247352$1$I$$20240821$20240826$20240826$EXP$$US-ABBVIE-5890088$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242473531$24247353$1$I$20240801$20240821$20240826$20240826$EXP$$US-ABBVIE-5890158$ABBVIE$$77$YR$$F$Y$$$20240826$$CN$US$US
242473541$24247354$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134486$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$66.68$KG$20240826$$CN$US$US
242473551$24247355$1$I$20240815$20240816$20240826$20240826$EXP$GB-MHRA-MED-202408161703410070-KGNCW$GB-TEVA-VS-3234966$TEVA$$23$YR$$M$Y$56$KG$20240826$$MD$GB$GB
242473561$24247356$1$I$$20240819$20240826$20240826$EXP$$JP-009507513-2407JPN005239J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$47$YR$$F$Y$$$20240826$$MD$JP$JP
242473571$24247357$1$I$$20240816$20240826$20240826$EXP$$GB-TEVA-VS-3234944$TEVA$$79$YR$$F$Y$68$KG$20240826$$MD$GB$GB
242473581$24247358$1$I$20240609$20240812$20240826$20240826$EXP$$MX-ROCHE-10000056101$ROCHE$$58$YR$A$F$Y$73$KG$20240826$$CN$MX$MX
242473591$24247359$1$I$$20240816$20240826$20240826$EXP$$GB-TEVA-VS-3234947$TEVA$$82$YR$$M$Y$74$KG$20240826$$PH$GB$GB
242473601$24247360$1$I$20231225$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-081921-2024$RECKITT BENCKISER$$39$YR$$F$Y$$$20240826$$CN$US$US
242473611$24247361$1$I$$20240523$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006247$STRIDES$Giles C, Wisniewski B, Hawkins S.. A PEDIATRIC CASE OF TREATMENT EMERGENT CENTRAL SLEEP APNEA DURING HIGH FLOW NASAL CANNULA POLYSOMNOGRAPHY.. Sleep. 2024;47 (Suppl.):A509 abstr. 1191.$12$YR$$M$Y$$$20240826$$HP$US$US
242473621$24247362$1$I$$20240625$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007711$STRIDES$Alsakha A, Marraffa JM.. Ifosfamide neurotoxicity treated with methylene blue complicated by serotonin toxicity. Clin-Toxicol-(Phila). 2023;61:106-107 abstr. 223$54$YR$$F$Y$$$20240826$$HP$US$US
242473631$24247363$1$I$$20240611$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007210$STRIDES$Eudaley ST, Brooks SP, Hamilton LA.. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. J Pharm Pract. 2023;36(6):1523-1527$63$YR$$M$Y$$$20240826$$HP$US$US
242473641$24247364$1$I$$20240821$20240826$20240826$EXP$$CA-ROCHE-10000062898$ROCHE$$$$$F$Y$$$20240826$$HP$CA$CA
242473651$24247365$1$I$$20240816$20240826$20240826$PER$$US-AMGEN-USASP2024164331$AMGEN$$$$$F$Y$$$20240826$$HP$US$US
242473663$24247366$3$F$20240531$20240910$20240826$20240913$EXP$$CA-ABBVIE-5887782$ABBVIE$$81$YR$$F$Y$$$20240913$$CN$CA$CA
242473671$24247367$1$I$$20240823$20240826$20240826$EXP$$PL-SANDOZ INC.-SDZ2024PL074981$SANDOZ$$15$YR$$M$Y$$$20240826$$HP$PL$PL
242473682$24247368$2$F$20240427$20240816$20240826$20240828$EXP$$US-BAXTER-2024BAX023166$BAXTER$$0$YR$$$Y$7$KG$20240828$$HP$US$US
242473691$24247369$1$I$$20240821$20240826$20240826$EXP$$ZA-AstraZeneca-2024A191951$ASTRAZENECA$$63$YR$$F$Y$$$20240826$$CN$ZA$
242473702$24247370$2$F$$20240827$20240826$20240830$EXP$$RU-AstraZeneca-2024A192980$ASTRAZENECA$$44$YR$$M$Y$100$KG$20240830$$MD$RU$
242473711$24247371$1$I$$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024166667$AMGEN$$$$$F$Y$$$20240826$$MD$US$US
242473721$24247372$1$I$20240125$20240820$20240826$20240826$EXP$$CO-UCBSA-2024042922$UCB$$63$YR$$F$Y$$$20240826$$CN$CO$CO
242473732$24247373$2$F$20220814$20240826$20240826$20240829$EXP$$BR-CELLTRION INC.-2023BR002657$CELLTRION$$$$$$Y$$$20240829$$CN$BR$BR
242473742$24247374$2$F$20240101$20240820$20240826$20240830$PER$$US-AMGEN-USASP2024167339$AMGEN$$60$YR$A$M$Y$$$20240830$$MD$US$US
242473751$24247375$1$I$20240811$20240821$20240826$20240826$EXP$$NVSC2024CN171050$NOVARTIS$$63$YR$$M$Y$60$KG$20240826$$HP$CN$CN
242473761$24247376$1$I$20211225$20240821$20240826$20240826$EXP$$AU-SANDOZ INC.-SDZ2024AU074474$SANDOZ$$$$$M$Y$$$20240826$$HP$AU$AU
242473771$24247377$1$I$$20240821$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047550$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240826$$CN$US$US
242473782$24247378$2$F$20240701$20240905$20240826$20240909$EXP$$TR-ABBVIE-5889295$ABBVIE$$79$YR$$F$Y$$$20240909$$CN$TR$TR
242473791$24247379$1$I$20240425$20240812$20240826$20240826$EXP$DE-BFARM-24005514$DE-PBT-009649$PANACEA BIOTEC$$35$YR$A$F$Y$$$20240826$$MD$DE$DE
242473801$24247380$1$I$$20240812$20240826$20240826$EXP$$AU-PBT-009656$PANACEA BIOTEC$Montarello NL, Irvine I, Warner V, Hare J, Kaye D, Cloud GC. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report. BMC Neurol. 2024 Aug 9;24(1):277. doi: 10.1186/s12883-024-03780-3.$51$YR$A$F$Y$$$20240826$$HP$AU$AU
242473811$24247381$1$I$$20240816$20240826$20240826$EXP$$CA-BAXTER-2024BAX023564$BAXTER$$61$YR$$M$Y$86$KG$20240826$$HP$CA$CA
242473821$24247382$1$I$$20240820$20240826$20240826$EXP$$US-AMGEN-USASP2024167435$AMGEN$$$$$$Y$$$20240826$$HP$US$US
242473831$24247383$1$I$20220101$20240821$20240826$20240826$EXP$$US-ABBVIE-5889622$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242473842$24247384$2$F$$20240917$20240826$20240926$EXP$$CA-CELLTRION INC.-2024CA020165$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
242473851$24247385$1$I$$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168805$AMGEN$$$$C$$Y$$$20240826$$HP$US$US
242473861$24247386$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015195$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240826$$HP$US$US
242473871$24247387$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014670$ELI LILLY AND CO$$75$YR$E$$Y$$$20240826$$LW$US$US
242473881$24247388$1$I$$20240823$20240826$20240826$PER$$NVSC2024US171755$NOVARTIS$$$$$$Y$$$20240826$$HP$US$US
242473891$24247389$1$I$$20240819$20240826$20240826$EXP$$JP-009507513-2407JPN005240J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$87$YR$$F$Y$$$20240826$$MD$JP$JP
242473901$24247390$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014721$ELI LILLY AND CO$$29$YR$A$M$Y$$$20240826$$CN$US$US
242473911$24247391$1$I$$20240821$20240826$20240826$EXP$$NVSC2024US169958$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
242473921$24247392$1$I$$20240822$20240826$20240826$PER$$US-HALEON-2193285$Haleon PLC$$75$YR$$$Y$$$20240826$$CN$US$US
242473931$24247393$1$I$$20240821$20240826$20240826$30DAY$$US-SANDOZ INC.-SDZ2024US075074$SANDOZ$$$$$F$Y$$$20240826$$PH$US$US
242473941$24247394$1$I$$20240816$20240826$20240826$EXP$$US-VIIV HEALTHCARE LIMITED-US2024102477$VIIV$$$$$M$Y$$$20240826$$CN$US$US
242473951$24247395$1$I$$20240815$20240826$20240826$EXP$$US-ROCHE-10000059732$ROCHE$Elmariah H, Otoukesh S, Kumar A, Haris A, Shukaib A, Dimaggio E, et al. Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant Cyclophosphamide. Transplantation and cellular therapy. 2024-Aug-03; doi:10.1016/j.jtct.2024.07.024.$$$$$Y$$$20240826$$HP$US$US
242473961$24247396$1$I$$20240815$20240826$20240826$EXP$$US-GSK-US2024101708$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$US$US
242473971$24247397$1$I$20240815$20240815$20240826$20240826$EXP$$US-GSK-US2024AMR103040$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
242473981$24247398$1$I$$20240820$20240826$20240826$EXP$$US-CHATTEMPRD-2024OHG028609$CHATTEM$$$$E$M$Y$$$20240826$$LW$US$US
242473991$24247399$1$I$20220610$20240819$20240826$20240826$EXP$$JP-EMD Serono-9334889$EMD SERONO INC$$48$YR$A$F$Y$92$KG$20240826$$HP$JP$JP
242474001$24247400$1$I$$20240823$20240826$20240826$EXP$$US-ABBVIE-5893434$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242474011$24247401$1$I$$20240820$20240826$20240826$EXP$$US-CHATTEMPRD-2024OHG028518$CHATTEM$$$$$M$Y$$$20240826$$LW$US$US
242474021$24247402$1$I$20240229$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-087192-2024$RECKITT BENCKISER$$$$$M$Y$$$20240826$$CN$US$US
242474031$24247403$1$I$20240622$20240823$20240826$20240826$EXP$$CA-ABBVIE-5893755$ABBVIE$$80$YR$$M$Y$$$20240826$$CN$CA$CA
242474041$24247404$1$I$$20240820$20240826$20240826$EXP$$US-AMGEN-USASP2024167397$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242474051$24247405$1$I$$20240820$20240826$20240826$EXP$$US-CHATTEMPRD-2024OHG028882$CHATTEM$$$$$$Y$$$20240826$$LW$US$US
242474071$24247407$1$I$20240811$20240823$20240826$20240826$EXP$$CA-ABBVIE-5894162$ABBVIE$$93$YR$$M$Y$$$20240826$$CN$CA$CA
242474081$24247408$1$I$$20240821$20240826$20240826$PER$$NVSC2024US170216$NOVARTIS$$$$$$Y$$$20240826$$MD$US$US
242474091$24247409$1$I$$20240823$20240826$20240826$PER$$NVSC2024US171726$NOVARTIS$$$$$$Y$$$20240826$$HP$US$US
242474101$24247410$1$I$20240701$20240814$20240826$20240826$EXP$$US-UCBSA-2024041736$UCB$$66$YR$$F$Y$$$20240826$$HP$US$US
242474111$24247411$1$I$20231227$20240821$20240826$20240826$EXP$$AU-TAKEDA-2024TUS000312$TAKEDA$$64$YR$$M$Y$$$20240826$$CN$AU$AU
242474121$24247412$1$I$20240820$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A190778$ASTRAZENECA$$24736$DY$$M$Y$$$20240826$$PH$US$
242474131$24247413$1$I$$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A191110$ASTRAZENECA$$$$$F$Y$$$20240826$$CN$US$
242474141$24247414$1$I$$20240816$20240826$20240826$EXP$$US-GSK-US2024102719$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$PH$US$US
242474161$24247416$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133723$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240826$$CN$US$US
242474171$24247417$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132999$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240826$$CN$US$US
242474181$24247418$1$I$$20240819$20240826$20240826$EXP$$GR-ROCHE-10000063272$ROCHE$Verrou E, Papageorgiou S, Bouzani M, Sevastoudi A, Triantafyllou T, Daiou A, et al. Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group. Hematological Oncology. 2024-Sep;42 (5): doi:10.1002/hon.3303.$77$YR$E$$Y$$$20240826$$HP$GR$GR
242474191$24247419$1$I$20240821$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167601$AMGEN$$$$$$Y$$$20240826$$PH$US$US
242474201$24247420$1$I$$20240814$20240826$20240826$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS004109$TERSERA THERAPEUTICS$$$$$$Y$$$20240826$$PH$AU$AU
242474211$24247421$1$I$20240306$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-087128-2024$RECKITT BENCKISER$$$$$F$Y$$$20240826$$CN$US$US
242474221$24247422$1$I$20240101$20240813$20240826$20240826$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000721$DECIPHERA PHARMACEUTICALS$$93$YR$E$F$Y$$$20240826$$HP$US$US
242474231$24247423$1$I$20230217$20240821$20240826$20240826$EXP$$DE-ABBVIE-5890860$ABBVIE$$51$YR$$M$Y$91$KG$20240826$$MD$DE$DE
242474241$24247424$1$I$$20240820$20240826$20240826$EXP$$NVSC2024AU169621$NOVARTIS$$$$$M$Y$$$20240826$$MD$AU$AU
242474251$24247425$1$I$$20240822$20240826$20240826$PER$$NVSC2024US171703$NOVARTIS$$$$$F$Y$$$20240826$$MD$US$US
242474261$24247426$1$I$$20240813$20240826$20240826$EXP$PL-EMA-20130614-AUTODUP-355587$PL-Orion Corporation ORION PHARMA-24_00031286$ORION$Jeleniewicz R, Majdan M. Selected problems of biologic therapy in rheumatoid arthritis patients-inefficacy of several biologic therapies. Case reports. Reumatol. 2013;51(1):89-92.$35$YR$A$F$Y$$$20240826$$MD$PL$
242474271$24247427$1$I$20240801$20240815$20240826$20240826$EXP$$GB-ABBVIE-5811458$ABBVIE$$26$YR$$F$Y$$$20240826$$CN$GB$GB
242474281$24247428$1$I$20240704$20240816$20240826$20240826$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS004276$TERSERA THERAPEUTICS$$$$$$Y$$$20240826$$CN$NL$NL
242474291$24247429$1$I$$20240819$20240826$20240826$EXP$$CA-ROCHE-10000060213$ROCHE$$$$$F$Y$$$20240826$$MD$CA$CA
242474301$24247430$1$I$$20240821$20240826$20240826$EXP$$CA-ROCHE-10000063533$ROCHE$$44$YR$A$F$Y$$$20240826$$CN$CA$CA
242474311$24247431$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133397$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240826$$HP$US$US
242474321$24247432$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133575$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240826$$CN$US$US
242474331$24247433$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131374$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240826$$HP$US$US
242474341$24247434$1$I$20240806$20240806$20240826$20240826$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-16635$IPSEN$$89$YR$E$M$Y$$$20240826$$PH$US$US
242474351$24247435$1$I$20240722$20240819$20240826$20240826$EXP$FR-AFSSAPS-BX2024001633$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07928$HIKMA$$$$$$Y$$$20240826$$MD$FR$FR
242474361$24247436$1$I$$20240812$20240826$20240826$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-08278$LUPIN$Swain RN, Arora M, Singh C, Sreedharanunni S. Sideroblastic anemia secondary to anti-tubercular therapy in a patient with acute promyelocytic leukemia. Indian Journal of Hematology and Blood Transfusion. 2024;1-2$27$YR$$F$Y$$$20240826$$HP$IN$IN
242474371$24247437$1$I$$20240819$20240826$20240826$PER$$US-JNJFOC-20240852842$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242474382$24247438$2$F$20240820$20240830$20240826$20240903$EXP$$CA-JNJFOC-20240854584$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240903$$HP$CA$CA
242474391$24247439$1$I$20240101$20240816$20240826$20240826$EXP$$CA-ROCHE-10000059545$ROCHE$$79$YR$E$F$Y$$$20240826$$CN$CA$CA
242474402$24247440$2$F$$20240823$20240826$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015304$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240828$$HP$US$US
242474411$24247441$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014809$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240826$$CN$US$US
242474421$24247442$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014507$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240826$$CN$US$US
242474431$24247443$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015010$ELI LILLY AND CO$$$$$$Y$$$20240826$$CN$US$US
242474441$24247444$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014649$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242474451$24247445$1$I$$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015017$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240826$$CN$US$US
242474461$24247446$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014395$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240826$$CN$US$US
242474471$24247447$1$I$20240819$20240823$20240826$20240826$EXP$$US-UCBSA-2024042924$UCB$$72$YR$$M$Y$$$20240826$$CN$US$US
242474482$24247448$2$F$$20240903$20240826$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004251$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
242474491$24247449$1$I$$20240814$20240826$20240826$EXP$$DE-Appco Pharma LLC-2160847$APPCO PHARMA$Initial$17$YR$$F$Y$$$20240826$$MD$DE$DE
242474501$24247450$1$I$$20240819$20240826$20240826$EXP$$CA-ROCHE-10000064289$ROCHE$$65$YR$E$F$Y$34$KG$20240826$$HP$CA$CA
242474511$24247451$1$I$$20240816$20240826$20240826$EXP$$AR-AMGEN-ARGSP2024167630$AMGEN$$76$YR$E$F$Y$$$20240826$$CN$AR$AR
242474521$24247452$1$I$20240731$20240816$20240826$20240826$EXP$FR-AFSSAPS-MP2024001277$FR-AMGEN-FRASP2024163536$AMGEN$$70$YR$E$F$Y$75.6$KG$20240826$$MD$FR$FR
242474531$24247453$1$I$$20240821$20240826$20240826$EXP$$JP-TAKEDA-2024TJP012450$TAKEDA$Shinya Omori, Eriko Nakano, Kojiro Kataoka, Naohiro Dairaku. Experience with vedolizumab use in Crohn^s disease. 103$29$YR$$F$Y$$$20240826$$MD$JP$JP
242474541$24247454$1$I$20240806$20240826$20240826$20240826$EXP$ES-AEMPS-1560718$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047672$BOEHRINGER INGELHEIM$$35$YR$A$M$Y$$$20240826$$MD$ES$ES
242474551$24247455$1$I$20240809$20240821$20240826$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013185$JAZZ$$46$YR$$F$Y$$$20240825$$CN$US$US
242474561$24247456$1$I$20240617$20240821$20240826$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-011311$JAZZ$$13$YR$$M$Y$$$20240825$$MD$US$US
242474581$24247458$1$I$$20240819$20240826$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012998$JAZZ$$$$$$Y$$$20240825$$PH$US$US
242474592$24247459$2$F$20240101$20240904$20240826$20240910$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013292$JAZZ$$$$$M$Y$$$20240909$$CN$US$US
242474611$24247461$1$I$$20240821$20240826$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013290$JAZZ$$$$$M$Y$$$20240825$$CN$US$US
242474621$24247462$1$I$20210529$20240822$20240826$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013322$JAZZ$$66$YR$$M$Y$$$20240825$$MD$US$US
242474631$24247463$1$I$20240801$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132099$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240826$$CN$US$US
242474641$24247464$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133518$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$74.84$KG$20240826$$HP$US$US
242474661$24247466$1$I$20240501$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167626$AMGEN$$77$YR$E$F$Y$$$20240826$$HP$US$US
242474671$24247467$1$I$$20240816$20240826$20240826$EXP$$CA-APOTEX-2024AP009508$APOTEX$$$$$M$Y$$$20240826$$MD$CA$CA
242474681$24247468$1$I$20240812$20240819$20240826$20240826$PER$$US-JNJFOC-20240850312$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240826$$CN$US$US
242474701$24247470$1$I$$20240821$20240826$20240826$EXP$$US-JNJFOC-20240855674$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$HP$US$US
242474711$24247471$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234416$TEVA$$$$A$F$Y$$$20240826$$MD$CA$CA
242474721$24247472$1$I$20240601$20240813$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-041309$AUROBINDO$$68$YR$$F$Y$68$KG$20240826$$PH$FR$FR
242474731$24247473$1$I$$20240814$20240826$20240826$EXP$$CA-IPCA LABORATORIES LIMITED-IPC-2024-CA-002070$IPCA$Gloria Mak, Mark Tarnopolsky and Jian-Qiang Lu. A case of mixed hereditary gelsolin amyloidosis and hydroxychloroquine induced myopathy. Acta Neurologica Belgica. 2024$$$$$Y$$$20240826$$HP$CA$CA
242474741$24247474$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000065373$ROCHE$$76$YR$E$F$Y$82.1$KG$20240826$$HP$US$US
242474753$24247475$3$F$20240101$20240911$20240826$20240913$EXP$$DO-ROCHE-10000060720$ROCHE$$67$YR$E$F$Y$$$20240913$$CN$DO$DO
242474761$24247476$1$I$20240712$20240814$20240826$20240826$EXP$$CA-TAKEDA-2024TUS077712$TAKEDA$$27$YR$$F$Y$$$20240826$$CN$CA$CA
242474771$24247477$1$I$20240801$20240820$20240826$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134051$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240826$$MD$JP$JP
242474781$24247478$1$I$$20240820$20240826$20240826$EXP$$CA-ABBVIE-5890900$ABBVIE$$$$A$F$Y$$$20240826$$PH$CA$CA
242474792$24247479$2$F$$20240826$20240826$20240830$EXP$$US-ABBVIE-5887801$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242474801$24247480$1$I$20240722$20240813$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-041320$AUROBINDO$$69$YR$$M$Y$$$20240826$$MD$FR$FR
242474812$24247481$2$F$20240703$20240902$20240826$20240918$PER$$US-JNJFOC-20240849134$JOHNSON AND JOHNSON$$31$YR$A$$Y$$$20240918$$CN$US$US
242474821$24247482$1$I$20240101$20240820$20240826$20240826$EXP$$US-ABBVIE-5871197$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242474831$24247483$1$I$20240303$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-087104-2024$RECKITT BENCKISER$$84$YR$$F$Y$$$20240826$$CN$US$US
242474842$24247484$2$F$$20240828$20240826$20240903$EXP$$US-TAKEDA-2024TUS084165$TAKEDA$$$$$M$Y$$$20240903$$CN$US$US
242474851$24247485$1$I$20240101$20240819$20240826$20240826$EXP$$US-ABBVIE-5780367$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242474871$24247487$1$I$20230801$20231116$20240826$20240826$PER$$US-CIPLA LTD.-2023US07350$CIPLA$$$$$$Y$$$20240826$$CN$US$US
242474881$24247488$1$I$20240801$20240822$20240826$20240826$EXP$$ES-ABBVIE-5892944$ABBVIE$$73$YR$$F$Y$$$20240826$$CN$ES$ES
242474891$24247489$1$I$$20240816$20240826$20240826$PER$$US-ROCHE-10000060951$ROCHE$$$$$F$Y$$$20240826$$HP$US$US
242474901$24247490$1$I$$20240820$20240826$20240826$PER$$US-BEH-2024177549$CSL BEHRING$$33$YR$A$M$Y$$$20240826$$HP$US$US
242474912$24247491$2$F$20240701$20240911$20240826$20240916$EXP$$US-ROCHE-10000062744$ROCHE$$69$YR$E$F$Y$111.13$KG$20240916$$CN$US$US
242474921$24247492$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133616$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240826$$HP$US$US
242474931$24247493$1$I$$20240823$20240826$20240826$EXP$$US-SANDOZ INC.-SDZ2024US074978$SANDOZ$$68$YR$$M$Y$84$KG$20240826$$MD$US$US
242474942$24247494$2$F$20240727$20240829$20240826$20240902$EXP$GR-GREOF-202400899$GR-ABBVIE-5889699$ABBVIE$$72$YR$$M$Y$64$KG$20240902$$MD$GR$GR
242474951$24247495$1$I$20240810$20240813$20240826$20240826$EXP$$GB-AUROBINDO-AUR-APL-2024-041187$AUROBINDO$$39$YR$$F$Y$$$20240826$$HP$GB$GB
242474961$24247496$1$I$20240401$20240430$20240826$20240826$PER$$US-CIPLA LTD.-2024US04463$CIPLA$$$$$$Y$$$20240826$$CN$US$US
242474971$24247497$1$I$$20240823$20240826$20240826$EXP$$CA-ORGANON-O2408CAN001779$ORGANON$unknown. unknown. unknown$45$YR$$F$Y$$$20240826$$HP$CA$CA
242474981$24247498$1$I$$20240819$20240826$20240826$EXP$$US-TAKEDA-2024TUS026627$TAKEDA$$$$$F$Y$$$20240826$$MD$US$US
242474991$24247499$1$I$$20240823$20240826$20240826$EXP$$TW-AstraZeneca-2024A192995$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$TW$
242475011$24247501$1$I$20240701$20240820$20240826$20240826$EXP$$MX-JNJFOC-20240817548$JOHNSON AND JOHNSON$$66$YR$E$F$Y$60$KG$20240826$$CN$MX$MX
242475021$24247502$1$I$$20230412$20240826$20240826$EXP$$NL-BIOVITRUM-2023-NL-009508$BIOVITRUM$$$$I$M$Y$8.7$KG$20240826$$HP$NL$NL
242475031$24247503$1$I$$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013974$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240826$$CN$US$US
242475041$24247504$1$I$20240801$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014719$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240826$$CN$US$US
242475052$24247505$2$F$$20240822$20240826$20240827$PER$$NVSC2024US171695$NOVARTIS$$$$$M$Y$$$20240827$$MD$US$US
242475061$24247506$1$I$20210501$20240822$20240826$20240826$EXP$$IT-BIOVITRUM-2023-IT-017062$BIOVITRUM$Lanni MD, Pennese E, Salutari P, Carriero L, Restuccia F, De Filippis AF, et al. Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis. Frontiers in Immunology. 2023 Sep 28;14: 1-5. doi:10.3389/fimmu.2023.1272798.$55$YR$$F$Y$$$20240826$$HP$IT$IT
242475071$24247507$1$I$20240802$20240813$20240826$20240826$EXP$$GB-AUROBINDO-AUR-APL-2024-041142$AUROBINDO$$68$YR$$F$Y$$$20240826$$PH$GB$GB
242475082$24247508$2$F$$20240826$20240826$20240904$EXP$PT-UCBSA-2022048311$PT-AUROBINDO-AUR-APL-2022-034707$AUROBINDO$Costa L, Lopes S, Carvalho I, Morgado C, Lopes M, Machado C, et al.. Epilepsy and ataxia: the hidden infection.. European Journal of Neurology.. 2022;29(1):728$72$YR$$F$Y$$$20240904$$MD$PT$PT
242475091$24247509$1$I$$20240816$20240826$20240826$EXP$$US-Axsome Therapeutics, Inc.-AXS202408-001256$AXSOME THERAPEUTICS$$$$A$F$Y$$$20240826$$$US$
242475101$24247510$1$I$20240808$20240813$20240826$20240826$EXP$$GB-AUROBINDO-AUR-APL-2024-040990$AUROBINDO$$43$YR$$F$Y$71$KG$20240826$$MD$GB$GB
242475112$24247511$2$F$20240728$20240916$20240826$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004221$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240926$$CN$US$US
242475121$24247512$1$I$$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004198$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242475131$24247513$1$I$20240801$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004200$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240826$$CN$US$US
242475141$24247514$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041421$AUROBINDO$$$$$F$Y$$$20240826$$HP$CA$CA
242475161$24247516$1$I$$20240814$20240826$20240826$EXP$$GB-Accord-442092$ACCORD$Orpin S, Patel B. An extensive follicular eruption in a transplant recipient. British Journal of Dermatology. 2024;191(Supplement 1):i152. DOI:10.1093/bjd/ljae090.318.$46$YR$A$F$Y$$$20240826$$MD$GB$GB
242475171$24247517$1$I$20240708$20240813$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-041327$AUROBINDO$$16$YR$$M$Y$50$KG$20240826$$PH$FR$FR
242475181$24247518$1$I$20240813$20240814$20240826$20240826$EXP$GB-MHRA-MED-202408141416176780-DZTKM$GB-Accord-442165$ACCORD$$69$YR$E$M$Y$$$20240826$$HP$GB$GB
242475191$24247519$1$I$$20240814$20240826$20240826$EXP$$US-Accord-442274$ACCORD$St. George Teaford H. Psychotherapeutic Approach to the Treatment of a Youth with Schizophrenia and OCD: A Case Report. Journal of Indian Association for Child and Adolescent Mental Health. 2024;20(2):181-3$13$YR$T$M$Y$$$20240826$$MD$US$US
242475202$24247520$2$F$$20240917$20240826$20240927$EXP$CA-APOTEX-2024AP009416$CA-Accord-442972$ACCORD$$72$YR$E$F$Y$$$20240927$$HP$CA$CA
242475211$24247521$1$I$$20240814$20240826$20240826$EXP$$US-Accord-442276$ACCORD$Farkouh EK, Michel IM, Harrison DJ, Issa N. Dual Donor-Derived Renal Allograft Mucormycosis From a Single Deceased Donor. Mayo Clinic Proceedings. 2024;99(8):1341-42. DOI: 10.1016/j.mayocp.2024.04.001.$7$DEC$E$F$Y$$$20240826$$MD$US$US
242475221$24247522$1$I$$20240815$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131063$BRISTOL MYERS SQUIBB$$$$I$M$Y$$$20240826$$MD$US$US
242475231$24247523$1$I$20240821$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133268$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240826$$HP$US$US
242475242$24247524$2$F$$20240918$20240826$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134339$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240920$$CN$US$US
242475252$24247525$2$F$$20240904$20240826$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004207$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242475261$24247526$1$I$$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004210$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242475271$24247527$1$I$$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004199$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242475281$24247528$1$I$$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004211$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242475291$24247529$1$I$$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004216$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
242475302$24247530$2$F$$20240830$20240826$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004218$ACADIA PHARMACEUTICALS$$$$$F$Y$50$KG$20240924$$CN$US$US
242475311$24247531$1$I$20240730$20240801$20240826$20240826$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004202$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240826$$CN$US$US
242475322$24247532$2$F$$20240819$20240826$20240902$EXP$$AU-TAKEDA-2024TUS084830$TAKEDA$$$$A$F$Y$$$20240902$$HP$AU$AU
242475332$24247533$2$F$$20240830$20240826$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004219$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
242475351$24247535$1$I$20210101$20240806$20240826$20240826$PER$$US-TEVA-VS-3231360$TEVA$$28$YR$$F$Y$$$20240826$$CN$US$US
242475361$24247536$1$I$$20240819$20240826$20240826$EXP$$US-ROCHE-10000061063$ROCHE$Tam L, Cole B, Stasi S, Paulson V, Wright J, Hoeppner C, et al. Somatic Versus Germline: A Case Series of Three Children With ATM-Mutated Medulloblastoma. JCO Precision Oncology. 2024-Jan-01;8:1-7. doi:10.1200/PO.23.00333.$8$YR$C$F$Y$$$20240826$$MD$US$US
242475371$24247537$1$I$$20240819$20240826$20240826$EXP$$JP-JNJFOC-20240860575$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$MD$JP$JP
242475381$24247538$1$I$20240701$20240818$20240826$20240826$PER$$US-JNJFOC-20240849694$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242475392$24247539$2$F$$20240830$20240826$20240910$EXP$$IT-AUROBINDO-AUR-APL-2024-041445$AUROBINDO$Castelli M, Betelli M, Valenti A, Merelli B, Loglio A, Vigan? M, Benetti A.. A Case of Polyserositis, Chylous Ascites and Hepatitis Induced by Immune Checkpoint Inhibitors.. Eur J Case Rep Intern Med.. 2024;11(7):004237$39$YR$$M$Y$$$20240910$$HP$IT$IT
242475402$24247540$2$F$20240814$20240916$20240826$20240923$30DAY$$US-AMGEN-USASP2024163100$AMGEN$$56$YR$A$F$Y$1$KG$20240923$$PH$US$US
242475411$24247541$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041430$AUROBINDO$$70$YR$$M$Y$$$20240826$$MD$CA$CA
242475421$24247542$1$I$20240201$20240816$20240826$20240826$EXP$$CA-CELLTRION INC.-2024CA004891$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
242475441$24247544$1$I$$20240823$20240826$20240826$PER$$NVSC2024US171723$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
242475451$24247545$1$I$20230822$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-105250-2023$RECKITT BENCKISER$$59$YR$$$Y$$$20240826$$CN$US$US
242475471$24247547$1$I$$20240816$20240826$20240826$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101964$VIIV$$$$$$Y$$$20240826$$HP$US$US
242475481$24247548$1$I$$20240812$20240826$20240826$EXP$$ES-TEYRO-2024-TY-000516$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Garcia-Carbonero R et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$M$Y$$$20240826$$HP$ES$ES
242475491$24247549$1$I$20191103$20240813$20240826$20240826$EXP$$DE-HIKMA PHARMACEUTICALS-DE-H14001-24-07792$HIKMA$$$$$$Y$$$20240826$$MD$DE$DE
242475502$24247550$2$F$$20240828$20240826$20240830$PER$$US-JAZZ PHARMACEUTICALS-2024-US-013334$JAZZ$$$$$F$Y$$$20240830$$MD$US$US
242475521$24247552$1$I$$20240821$20240826$20240826$PER$$NVSC2024US169590$NOVARTIS$$9$MON$$F$Y$$$20240826$$CN$US$US
242475531$24247553$1$I$$20240812$20240826$20240826$EXP$$ES-TEYRO-2024-TY-000501$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$M$Y$$$20240826$$HP$ES$ES
242475541$24247554$1$I$$20240815$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130763$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240826$$CN$US$US
242475551$24247555$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134195$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240826$$PH$US$US
242475561$24247556$1$I$20240801$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168576$AMGEN$$53$YR$A$M$Y$$$20240826$$CN$US$US
242475571$24247557$1$I$$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004255$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242475581$24247558$1$I$$20240812$20240826$20240826$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07756$HIKMA$$$$A$F$Y$$$20240826$$MD$US$US
242475601$24247560$1$I$$20240816$20240826$20240826$PER$$US-JNJFOC-20240846627$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242475611$24247561$1$I$$20240823$20240826$20240826$PER$$NVSC2024US171845$NOVARTIS$$$$$$Y$$$20240826$$HP$US$US
242475621$24247562$1$I$20230901$20240818$20240826$20240826$PER$$US-AstraZeneca-2024A188373$ASTRAZENECA$$23174$DY$$F$Y$80.7$KG$20240826$$CN$US$
242475642$24247564$2$F$$20240828$20240826$20240828$EXP$$US-AstraZeneca-2024A182578$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242475653$24247565$3$F$20240801$20240903$20240826$20240905$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012710$JAZZ$$14$YR$$M$Y$$$20240905$$MD$US$US
242475661$24247566$1$I$$20240812$20240826$20240826$EXP$$ES-TEYRO-2024-TY-000499$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$M$Y$$$20240826$$HP$ES$ES
242475671$24247567$1$I$20240702$20240821$20240826$20240826$EXP$$GB-862174955-ML2024-04601$MICRO LABS$$35$YR$A$F$Y$89$KG$20240826$$PH$GB$GB
242475681$24247568$1$I$$20240813$20240826$20240826$EXP$$US-862174955-ML2024-04529$MICRO LABS$Latif R, Aloqaily M, Rabadi A, Arshad K, Kurian AI, Obeidat I, et al. Apixaban-Induced Hemopericardium in a Post-TAVR Patient: A Case Report Highlighting Diagnostic and Management Challenges.. American Journal of Case Reports. 2024 Jul 26;25: 1-5. doi:10.12659/AJCR.944173.$66$YR$E$M$Y$$$20240826$$HP$US$US
242475691$24247569$1$I$20240819$20240819$20240826$20240826$EXP$GB-MHRA-MED-202408191518260150-GMTBK$GB-862174955-ML2024-04576$MICRO LABS$$74$YR$E$F$Y$$$20240826$$PH$GB$GB
242475701$24247570$1$I$$20240822$20240826$20240826$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047653$BOEHRINGER INGELHEIM$$$$$$Y$$$20240826$$MD$DE$DE
242475711$24247571$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000065004$ROCHE$$22$YR$A$M$Y$$$20240826$$MD$US$US
242475722$24247572$2$F$$20240902$20240826$20240910$EXP$$GB-862174955-ML2024-04585$Unknown Manufacturer$$$$$F$Y$$$20240910$$CN$GB$GB
242475732$24247573$2$F$$20240912$20240826$20240924$EXP$$CA-TAKEDA-2024TUS073387$TAKEDA$$$$$M$Y$$$20240924$$CN$CA$CA
242475741$24247574$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041550$AUROBINDO$$22$YR$$M$Y$136$KG$20240826$$HP$CA$CA
242475752$24247575$2$F$$20240829$20240826$20240902$EXP$$JP-ABBVIE-5890904$ABBVIE$$45$YR$$M$Y$$$20240902$$MD$JP$JP
242475771$24247577$1$I$20240823$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015213$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240826$$CN$US$US
242475781$24247578$1$I$20240816$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014692$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240826$$CN$US$US
242475791$24247579$1$I$$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015039$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240826$$CN$US$US
242475801$24247580$1$I$20240822$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014436$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242475811$24247581$1$I$$20240813$20240826$20240826$EXP$$NL-AUROBINDO-AUR-APL-2024-041463$AUROBINDO$$70$YR$$M$Y$92$KG$20240826$$CN$NL$NL
242475821$24247582$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014682$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240826$$CN$US$US
242475831$24247583$1$I$$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014771$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240826$$CN$US$US
242475842$24247584$2$F$$20240912$20240826$20240920$EXP$$JP-TEVA-VS-3235270$TEVA$Kudo H, Shiroshita K, Shiozawa Y, Fujita S, Sakamoto M, Nakamura N, et al. Autopsy case of cardiac mantle cell lymphoma presenting with recurrent pulmonary tumor embolism after chemotherapy. J-Clin-Exp-Hematopathol 2024;.; Kudo H, Shiroshita K, Shiozawa Y, Fujita S, Sakamoto M, Nakamura N, et al. Autopsy case of cardiac mantle cell lymphoma presenting with recurrent pulmonary tumor embolism after chemotherapy. J-Clin-Exp-Hematopathol 2024;.; Kudo H, Shiroshita K, Shiozawa Y, Fujita S, Sakamot...$78$YR$$M$Y$$$20240920$$HP$JP$JP
242475851$24247585$1$I$20240501$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024165528$AMGEN$$20$YR$A$F$Y$$$20240826$$PH$US$US
242475861$24247586$1$I$20240813$20240814$20240826$20240826$PER$$US-ABBVIE-5883206$ABBVIE$$$$$M$Y$$$20240826$$HP$US$US
242475871$24247587$1$I$$20240821$20240826$20240826$EXP$$US-TAKEDA-2022TUS059504$TAKEDA$$$$$F$Y$$$20240826$$CN$US$US
242475881$24247588$1$I$$20240821$20240826$20240826$EXP$$JP-TAKEDA-2024TJP012408$TAKEDA$Takuro Kaji, Kentaro Imamura, Koya Doi, Masaki Urabe, Toshihiro Sakurai, Junichi Tsukada. A case of infectious mononucleosis during treatment with immunosuppressive drug for ulcerative colitis. The 123rd Kyushu Reg Mtg of the JSEG/the 117th Kyushu Reg Mtg of the JGES. 128$3$DEC$$M$Y$$$20240826$$MD$JP$JP
242475891$24247589$1$I$20240801$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132726$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240826$$HP$US$US
242475901$24247590$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134705$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$90.72$KG$20240826$$PH$US$US
242475911$24247591$1$I$$20240816$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130980$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240826$$HP$US$US
242475921$24247592$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133617$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$73.03$KG$20240826$$CN$US$US
242475931$24247593$1$I$$20240816$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130505$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240826$$CN$US$US
242475941$24247594$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133970$BRISTOL MYERS SQUIBB$$26$YR$A$M$Y$$$20240826$$HP$US$US
242475951$24247595$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041405$AUROBINDO$$65$YR$$F$Y$86$KG$20240826$$MD$CA$CA
242475961$24247596$1$I$20220807$20240816$20240826$20240826$EXP$$JP-ROCHE-10000062139$ROCHE$Suda K, Ito M, Ohara S, Fukami T, Hamada A, Chiba M. SPL1-4 Changes in the implementation status of perioperative treatment for lung cancer in the second year of its reform in the reporting hospital. The 67th Annual Meeting of Kansai Thoracic Surgical Association. 2024;98.$68$YR$E$M$Y$44$KG$20240826$$MD$JP$JP
242475971$24247597$1$I$$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004257$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
242475981$24247598$1$I$$20240813$20240826$20240826$EXP$$PT-AUROBINDO-AUR-APL-2024-041653$AUROBINDO$Nogueira JV, Neves CF, Alves DR, Bravo SP, Mesquita P, Eul?lio M, Ferreira FC. De modificador de progn?stico a indutor de morbilidade: gangrena de fournier sob isglt2. Medicina Interna. 2024;30(Sup 1):668$68$YR$$M$Y$$$20240826$$MD$PT$PT
242475991$24247599$1$I$20240701$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024166592$AMGEN$$59$YR$A$F$Y$$$20240826$$CN$US$US
242476001$24247600$1$I$$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024167340$AMGEN$$$$$$Y$$$20240826$$CN$US$US
242476012$24247601$2$F$20240101$20240902$20240826$20240910$EXP$$JP-AMGEN-JPNSP2024167462$AMGEN$$$$$$Y$$$20240909$$PH$JP$JP
242476021$24247602$1$I$$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168683$AMGEN$$$$A$F$Y$$$20240826$$CN$US$US
242476041$24247604$1$I$$20240823$20240826$20240826$PER$$NVSC2024US171858$NOVARTIS$$$$$$Y$$$20240826$$HP$US$US
242476051$24247605$1$I$20240813$20240820$20240826$20240826$EXP$$CN-ROCHE-10000062302$ROCHE$$76$YR$E$F$Y$51$KG$20240826$$HP$CN$CN
242476061$24247606$1$I$$20240816$20240826$20240826$PER$$US-JNJFOC-20240846589$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$CN$US$US
242476072$24247607$2$F$$20240826$20240826$20240904$EXP$$JP-JNJFOC-20240860022$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$JP$JP
242476081$24247608$1$I$20240315$20240816$20240826$20240826$EXP$$CN-JNJFOC-20240846616$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240826$$HP$CN$CN
242476091$24247609$1$I$$20240822$20240826$20240826$PER$$US-JNJFOC-20240857836$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242476101$24247610$1$I$$20240821$20240826$20240826$PER$$US-JNJFOC-20240855383$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242476111$24247611$1$I$20240630$20240819$20240826$20240826$EXP$$US-ABBVIE-5887132$ABBVIE$$64$YR$$F$Y$$$20240826$$CN$US$US
242476131$24247613$1$I$$20240814$20240826$20240826$EXP$$US-Appco Pharma LLC-2160848$APPCO PHARMA$Initial$71$YR$$M$Y$$$20240826$$MD$US$US
242476141$24247614$1$I$$20240820$20240826$20240826$EXP$CA-DRL-USA-SPO/CAN/24/0012137$CA-RDY-SPO/CAN/24/0012137$DR REDDYS$$70$YR$E$M$Y$$$20240826$$PH$CA$CA
242476151$24247615$1$I$20230101$20231019$20240826$20240826$PER$$US-CIPLA LTD.-2023US06709$CIPLA$$$$$$Y$$$20240826$$CN$US$US
242476161$24247616$1$I$20240101$20240822$20240826$20240826$EXP$$US-ABBVIE-5891454$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242476171$24247617$1$I$$20240820$20240826$20240826$PER$$US-LEO Pharma-372957$LEO PHARM$$35$YR$$F$Y$$$20240826$$PH$US$US
242476181$24247618$1$I$20240702$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134691$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$82.55$KG$20240826$$HP$US$US
242476201$24247620$1$I$20240701$20240813$20240826$20240826$EXP$$US-UCBSA-2024041072$UCB$$54$YR$$M$Y$$$20240826$$HP$US$US
242476211$24247621$1$I$$20240823$20240826$20240826$PER$$NVSC2024US171867$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
242476221$24247622$1$I$20231101$20231129$20240826$20240826$PER$$US-APOTEX-2023AP017564$APOTEX$$$$$F$Y$$$20240826$$CN$US$US
242476231$24247623$1$I$20230101$20240112$20240826$20240826$PER$$US-APOTEX-2023AP016552$APOTEX$$$$$F$Y$$$20240826$$CN$US$US
242476241$24247624$1$I$$20240813$20240826$20240826$EXP$$PT-AUROBINDO-AUR-APL-2024-041396$AUROBINDO$$$$E$$Y$$$20240826$$HP$PT$PT
242476251$24247625$1$I$$20240730$20240826$20240826$PER$$US-AstraZeneca-2024A177124$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242476261$24247626$1$I$$20210713$20240826$20240826$EXP$$FR-AstraZeneca-2021A625795$ASTRAZENECA$$$$E$F$Y$$$20240826$$MD$FR$
242476271$24247627$1$I$$20240804$20240826$20240826$PER$$US-AstraZeneca-2024A178052$ASTRAZENECA$$$$$$Y$$$20240826$$HP$US$
242476282$24247628$2$F$$20240826$20240826$20240827$EXP$IE-PFIZER INC-202400232068$IE-UCBSA-2024042124$UCB$$62$YR$$F$Y$$$20240827$$HP$IE$IE
242476291$24247629$1$I$20240731$20240811$20240826$20240826$EXP$$CN-Techdow-J2024HPR000503$SHENZHEN TECHDOW PHARMACEUTICAL$$24$YR$A$F$Y$44$KG$20240826$$MD$CN$CN
242476302$24247630$2$F$20240801$20240826$20240826$20240830$PER$$US-AMGEN-USASP2024169185$AMGEN$$70$YR$E$F$Y$$$20240830$$PH$US$US
242476311$24247631$1$I$$20240813$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-041646$AUROBINDO$Hagenkotter B, Zayet S, Poloni S, Gendrin V, Zanusso M, Stancescu S, et al.. Posterior reversible encephalopathy syndrome in early lyme neuroborreliosis. Ticks and Tick-borne Diseases. 2024;15(6):1-4$69$YR$$M$Y$$$20240826$$HP$FR$FR
242476321$24247632$1$I$20240708$20240801$20240826$20240826$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004259$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240826$$CN$US$US
242476331$24247633$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133738$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240826$$CN$US$US
242476341$24247634$1$I$20240807$20240816$20240826$20240826$EXP$$US-APOTEX-2024AP009492$APOTEX$$80$YR$E$M$Y$$$20240826$$HP$US$US
242476351$24247635$1$I$$20240815$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130473$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$96.16$KG$20240826$$HP$US$US
242476361$24247636$1$I$20240716$20240813$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-041347$AUROBINDO$$13$YR$$M$Y$$$20240826$$MD$FR$FR
242476372$24247637$2$F$20240816$20240827$20240826$20240830$EXP$$AR-TAKEDA-2024TUS085266$TAKEDA$$69$YR$$F$Y$$$20240830$$CN$AR$AR
242476381$24247638$1$I$$20240819$20240826$20240826$EXP$$US-TAKEDA-2024TUS083858$TAKEDA$$$$$M$Y$$$20240826$$CN$US$US
242476391$24247639$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041558$AUROBINDO$$35$YR$$$Y$$$20240826$$CN$CA$CA
242476401$24247640$1$I$20210101$20240813$20240826$20240826$EXP$$GB-ADVANZ PHARMA-202408006812$ADVANZ PHARMA$$$$$$Y$$$20240826$$HP$GB$GB
242476411$24247641$1$I$$20240822$20240826$20240826$EXP$$CA-ROCHE-10000063971$ROCHE$$$$$F$Y$64$KG$20240826$$HP$CA$CA
242476421$24247642$1$I$$20240813$20240826$20240826$EXP$$IT-AUROBINDO-AUR-APL-2024-041748$AUROBINDO$Chesi E, Rossi K, Ancora G, Baraldi C, Corradi M, Di Dio F, et al.. Patent ductus arteriosus (also non-hemodynamically significant) correlates with poor outcomes in very low birth weight infants. A multicenter cohort study. Plos one. 2024;19 (7):1-15$$$I$$Y$$$20240826$$HP$IT$IT
242476431$24247643$1$I$$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024166663$AMGEN$$$$$$Y$$$20240826$$CN$US$US
242476441$24247644$1$I$20240718$20240819$20240826$20240826$EXP$$CN-ROCHE-10000064846$ROCHE$$76$YR$E$M$Y$89$KG$20240826$$HP$CN$CN
242476451$24247645$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041547$AUROBINDO$$55$YR$$F$Y$$$20240826$$CN$CA$CA
242476461$24247646$1$I$$20240819$20240826$20240826$PER$$US-JNJFOC-20240849591$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$CN$US$US
242476472$24247647$2$F$20240820$20240823$20240826$20240828$PER$$US-ABBVIE-5893503$ABBVIE$$27$YR$$F$Y$$$20240828$$MD$US$US
242476481$24247648$1$I$$20240820$20240826$20240826$PER$$US-ABBVIE-5889779$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242476491$24247649$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134595$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240826$$HP$US$US
242476501$24247650$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041829$AUROBINDO$$30$YR$$F$Y$$$20240826$$HP$CA$CA
242476512$24247651$2$F$20230927$20240814$20240826$20240829$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464541$RANBAXY$$98$YR$$F$Y$$$20240829$$MD$CH$CH
242476521$24247652$1$I$20151229$20240820$20240826$20240826$EXP$$AU-TAKEDA-2024TUS084827$TAKEDA$$53$YR$$F$Y$$$20240826$$MD$AU$AU
242476531$24247653$1$I$$20240820$20240826$20240826$EXP$$US-TAKEDA-2021TUS072719$TAKEDA$$$$$F$Y$52$KG$20240826$$CN$US$US
242476541$24247654$1$I$20240818$20240820$20240826$20240826$EXP$$US-JNJFOC-20240854827$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20240826$$HP$US$US
242476552$24247655$2$F$$20240823$20240826$20240829$PER$$US-ROCHE-10000064359$ROCHE$$78$YR$E$F$Y$$$20240829$$CN$US$US
242476571$24247657$1$I$$20240822$20240826$20240826$EXP$$IT-SANDOZ INC.-SDZ2024IT074352$SANDOZ$$50$YR$$M$Y$$$20240826$$MD$IT$IT
242476581$24247658$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041410$AUROBINDO$$73$YR$$F$Y$$$20240826$$PH$CA$CA
242476593$24247659$3$F$20240802$20240917$20240826$20240923$EXP$$RU-TAKEDA-2024TUS083634$TAKEDA$$22$YR$$M$Y$$$20240923$$CN$RU$RU
242476601$24247660$1$I$$20240814$20240826$20240826$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07766$HIKMA$$$$$$Y$$$20240823$$CN$US$US
242476611$24247661$1$I$$20240823$20240826$20240826$EXP$$NZ-ABBVIE-5893162$ABBVIE$$$$$M$Y$$$20240826$$MD$NZ$NZ
242476621$24247662$1$I$20240821$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004260$ACADIA PHARMACEUTICALS$$70$YR$$F$Y$$$20240826$$CN$US$US
242476631$24247663$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134576$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$89.81$KG$20240826$$CN$US$US
242476642$24247664$2$F$20240809$20240905$20240826$20240912$PER$$US-AMGEN-USASP2024168191$AMGEN$$54$YR$A$M$Y$125.6$KG$20240912$$HP$US$US
242476651$24247665$1$I$$20240820$20240826$20240826$EXP$$AU-GSK-AU2024103474$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$HP$AU$AU
242476661$24247666$1$I$20211216$20240819$20240826$20240826$EXP$$AR-GSK-AR2021AMR259399$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$AR$AR
242476671$24247667$1$I$$20240814$20240826$20240826$EXP$$JP-MSNLABS-2024MSNLIT01831$MSN LABORATORIES$Shinohara K, Itoi S, Nakamura S, Miyazaki Y, Mutoh Y, Hagiwara S., et al.Micafungin-breakthrough Coniochaeta hoffmannii (Lecythophora hoffmannii) fungemia following cord blood transplant in a patient with acute myeloid leukemia successfully treated with voriconazole.Journal of Infection and Chemotherapy.2024;30(9):934-7$$$$$Y$$$20240826$$MD$JP$JP
242476681$24247668$1$I$$20240816$20240826$20240826$PER$$US-ABBVIE-5885307$ABBVIE$$$$$$Y$$$20240826$$CN$US$US
242476691$24247669$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041570$AUROBINDO$$86$YR$$F$Y$$$20240826$$MD$CA$CA
242476701$24247670$1$I$20200701$20210312$20240826$20240826$EXP$$US-AstraZeneca-2020SF14693$ASTRAZENECA$$28438$DY$$F$Y$62.1$KG$20240826$$CN$US$
242476711$24247671$1$I$20231031$20240813$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-041375$AUROBINDO$$75$YR$$F$Y$$$20240826$$MD$FR$FR
242476721$24247672$1$I$20240819$20240820$20240826$20240826$EXP$$IN-ROCHE-3562009$ROCHE$$36$YR$A$M$Y$$$20240826$$CN$IN$IN
242476731$24247673$1$I$$20240819$20240826$20240826$EXP$$CA-ROCHE-10000060593$ROCHE$$55$YR$A$F$Y$$$20240826$$HP$CA$CA
242476742$24247674$2$F$$20240821$20240826$20240830$EXP$$NVSC2024US169890$NOVARTIS$$24$YR$$F$Y$$$20240830$$CN$US$US
242476751$24247675$1$I$$20240814$20240826$20240826$EXP$$US-862174955-ML2024-04549$MICRO LABS$Walterscheid B, Batchinsky M, Tarbox M. Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Preceding Toxic Epidermal Necrolysis Secondary to Sildenafil: A Case Report. Cureus. 2024;16(7):e63922. DOI:10.7759/cureus.63922$66$YR$E$F$Y$$$20240826$$MD$US$US
242476761$24247676$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132407$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240826$$HP$US$US
242476771$24247677$1$I$20160825$20240816$20240826$20240826$EXP$$CA-TAKEDA-2024TUS083551$TAKEDA$$45$YR$$M$Y$$$20240826$$CN$CA$CA
242476781$24247678$1$I$20240709$20240820$20240826$20240826$EXP$$US-ABBVIE-5893044$ABBVIE$$71$YR$$M$Y$$$20240826$$MD$US$US
242476791$24247679$1$I$20230406$20240814$20240826$20240826$EXP$GB-MHRA-MED-202408100732140300-CKYFG$GB-MSNLABS-2024MSNSPO01817$MSN LABORATORIES$$$$$$Y$$$20240826$$CN$GB$GB
242476811$24247681$1$I$20201101$20240823$20240826$20240826$EXP$FR-AFSSAPS-NC2024000983$FR-ROCHE-10000064588$ROCHE$$63$YR$A$F$Y$59$KG$20240826$$MD$FR$FR
242476831$24247683$1$I$$20240820$20240826$20240826$EXP$$NVSC2024CA170446$NOVARTIS$$$$$F$Y$$$20240826$$MD$CA$CA
242476841$24247684$1$I$20240730$20240821$20240826$20240826$EXP$$US-TAKEDA-2024TUS084703$TAKEDA$$60$YR$$F$Y$112$KG$20240826$$MD$US$US
242476851$24247685$1$I$20240819$20240819$20240826$20240826$EXP$$CA-TAKEDA-2024TUS083977$TAKEDA$$71$YR$$F$Y$$$20240826$$CN$CA$CA
242476861$24247686$1$I$$20240816$20240826$20240826$EXP$$US-APOTEX-2024AP009736$APOTEX$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, Block MS. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. Journal of Clinical Oncology. 2024;42 (16)$$$E$$Y$$$20240826$$HP$US$US
242476871$24247687$1$I$$20240814$20240826$20240826$EXP$$US-APOTEX-2024AP009596$APOTEX$Fling C, Granados L, Coruh B.. An Ophtha-MALA-gic Anomaly: Metformin Associated Lactic Acidosis Causing Transient Blindness. American Journal of Respiratory and Critical Care Medicine. 2023;207:A3498$62$YR$$M$Y$$$20240826$$HP$US$US
242476891$24247689$1$I$$20240822$20240826$20240826$PER$$US-JNJFOC-20240856797$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242476901$24247690$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134670$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240826$$PH$US$US
242476912$24247691$2$F$$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024164421$AMGEN$$$$E$F$Y$$$20240826$$HP$US$US
242476921$24247692$1$I$$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-103682-2023$RECKITT BENCKISER$$89$YR$$M$Y$$$20240826$$CN$US$US
242476931$24247693$1$I$20240617$20240813$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-041341$AUROBINDO$$19$YR$$M$Y$44.8$KG$20240826$$MD$FR$FR
242476941$24247694$1$I$$20240806$20240826$20240826$PER$$US-TEVA-VS-3231490$TEVA$$$$$F$Y$$$20240826$$CN$US$US
242476963$24247696$3$F$20240101$20240827$20240826$20240906$EXP$$CA-HLS-202402088$HLS THERAPEUTICS$$$$A$M$Y$$$20240906$$HP$CA$CA
242476971$24247697$1$I$$20240813$20240826$20240826$EXP$$JP-GENEYORK-2024PPLIT00049$GENEYORK PHARMA$Hayashino K, et al.Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified.Journal of clinical and experimental hematopathology.28-mar-2024;64 (1):52-8$52$YR$A$M$Y$$$20240826$$HP$JP$JP
242476981$24247698$1$I$$20240821$20240826$20240826$EXP$$NVSC2024CN163183$NOVARTIS$$75$YR$$F$Y$$$20240826$$CN$CN$CN
242476991$24247699$1$I$$20240823$20240826$20240826$PER$$NVSC2024US171415$NOVARTIS$$$$$$Y$$$20240826$$CN$US$US
242477001$24247700$1$I$$20240813$20240826$20240826$EXP$$IT-AUROBINDO-AUR-APL-2024-041515$AUROBINDO$M Sartori, E Barbiero, L Pellizzari.. Hyponatremia. Pharmacovigilance Focus. 2024;118$85$YR$$F$Y$$$20240826$$HP$IT$IT
242477011$24247701$1$I$20240707$20240815$20240826$20240826$EXP$$US-JNJFOC-20240849069$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240826$$HP$US$US
242477021$24247702$1$I$20240805$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167868$AMGEN$$63$YR$A$F$Y$$$20240826$$CN$US$US
242477032$24247703$2$F$20240801$20240822$20240826$20240902$EXP$$CA-AMGEN-CANNI2024169616$AMGEN$$53$YR$A$M$Y$$$20240902$$CN$CA$CA
242477042$24247704$2$F$$20240816$20240826$20240826$PER$$US-ROCHE-10000060384$ROCHE$$$$$F$Y$$$20240826$$MD$US$US
242477051$24247705$1$I$$20240816$20240826$20240826$EXP$$IE-STRIDES ARCOLAB LIMITED-2024SP010529$STRIDES$Krawczyk D, Dabrowski F, Kosinska-Kaczynska K.. Preeclampsia is caused by impaired placenta - A case report.. Eur-J-Obstet-Gynecol-Reprod-Biol. 2024;293:57-58$30$YR$$F$Y$$$20240826$$HP$IE$IE
242477061$24247706$1$I$$20240816$20240826$20240826$EXP$$US-GSK-US2024AMR103729$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
242477071$24247707$1$I$$20240820$20240826$20240826$EXP$$JP-ROCHE-10000065763$ROCHE$$8$DEC$E$M$Y$$$20240826$$MD$JP$JP
242477082$24247708$2$F$20230101$20240820$20240826$20240904$EXP$$US-AstraZeneca-2024A189778$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242477091$24247709$1$I$20240820$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A190751$ASTRAZENECA$$23153$DY$$M$Y$$$20240826$$CN$US$
242477101$24247710$1$I$20240701$20240816$20240826$20240826$EXP$$MX-ROCHE-10000061603$ROCHE$$53$YR$A$F$Y$63$KG$20240826$$CN$MX$MX
242477111$24247711$1$I$20200101$20230419$20240826$20240826$EXP$$GB-AstraZeneca-2023A091398$ASTRAZENECA$$64$YR$$M$Y$68$KG$20240826$$MD$GB$
242477121$24247712$1$I$$20240819$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408011756$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240826$$CN$US$US
242477131$24247713$1$I$20240818$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013775$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240826$$CN$US$US
242477141$24247714$1$I$$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014340$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242477151$24247715$1$I$20240822$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014568$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240826$$CN$US$US
242477161$24247716$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014528$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240826$$CN$US$US
242477171$24247717$1$I$$20240819$20240826$20240826$30DAY$$IT-SANDOZ INC.-SDZ2024IT047619$SANDOZ$$$$$M$Y$$$20240826$$CN$IT$IT
242477181$24247718$1$I$$20240813$20240826$20240826$EXP$DE-ASTELLAS-2021US022517$DE-ROCHE-10000056753$ROCHE$$68$YR$E$M$Y$$$20240826$$HP$DE$DE
242477201$24247720$1$I$20240820$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168335$AMGEN$$54$YR$A$F$Y$$$20240826$$CN$US$US
242477211$24247721$1$I$$20240820$20240826$20240826$EXP$$BG-ABBVIE-5887695$ABBVIE$$69$YR$$F$Y$$$20240826$$CN$BG$BG
242477221$24247722$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014597$ELI LILLY AND CO$$$$A$F$Y$$$20240826$$CN$US$US
242477232$24247723$2$F$$20240906$20240826$20240909$PER$$US-AMGEN-USASP2024167775$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
242477241$24247724$1$I$20240821$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013554$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240826$$CN$US$US
242477251$24247725$1$I$20160101$20240821$20240826$20240826$EXP$$NVSC2024AU171331$NOVARTIS$$$$$M$Y$$$20240826$$MD$AU$AU
242477271$24247727$1$I$20240101$20240821$20240826$20240826$EXP$$US-ABBVIE-5889355$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242477281$24247728$1$I$$20240820$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133531$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240826$$CN$US$US
242477291$24247729$1$I$20240812$20240816$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130534$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240826$$PH$US$US
242477301$24247730$1$I$20240712$20240816$20240826$20240826$EXP$GB-MHRA-MED-202408161009185150-SZRVG$GB-MRZWEB-2024080000191$MERZ$$39$YR$$F$Y$53$KG$20240826$$CN$GB$GB
242477311$24247731$1$I$$20240813$20240826$20240826$EXP$$PL-AUROBINDO-AUR-APL-2024-041649$AUROBINDO$Kluzik A, Gaczkowska A.. Lazarus phenomenon in Poland - 86 years old woman came back to life.. Anestezjologia i Ratownictwo. 2024;18:81-5$86$YR$$F$Y$$$20240826$$MD$PL$PL
242477321$24247732$1$I$20240607$20240822$20240826$20240826$PER$$TW-REGENERON PHARMACEUTICALS, INC.-2024-112094$REGENERON$$67$YR$$F$Y$$$20240826$$CN$TW$TW
242477332$24247733$2$F$20231001$20240904$20240826$20240914$30DAY$$US-GSK-US2024103316$GLAXOSMITHKLINE$$44$YR$$F$Y$79.38$KG$20240914$$MD$US$US
242477351$24247735$1$I$20231225$20240815$20240826$20240826$EXP$$GB-MSNLABS-2024MSNSPO01837$MSN LABORATORIES$$$$$$Y$$$20240826$$MD$GB$GB
242477361$24247736$1$I$$20240819$20240826$20240826$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010539$STRIDES$Wang H, Lang Y, Cai X, Gao L, Yang S, Jin J.. Lessons from Multiple Infections Such as  Lymphoma Complicated with Pneumocystis  Infection: A Case Report. Infection and Drug Resistance. 2024;17:1583-1588$41$YR$$M$Y$$$20240826$$HP$CN$CN
242477381$24247738$1$I$$20240822$20240826$20240826$EXP$$US-ABBVIE-5891798$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242477391$24247739$1$I$20240701$20240813$20240826$20240826$EXP$$US-UCBSA-2024041231$UCB$$62$YR$$F$Y$87.075$KG$20240826$$HP$US$US
242477402$24247740$2$F$20240101$20240903$20240826$20240913$EXP$$US-INSMED, INC.-2024-02137-US$INSMED$$$$$M$Y$$$20240913$$CN$US$US
242477411$24247741$1$I$$20240815$20240826$20240826$EXP$$US-JNJFOC-20240841472$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242477421$24247742$1$I$$20240815$20240826$20240826$EXP$$US-JNJFOC-20240839065$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242477433$24247743$3$F$$20240822$20240826$20240911$30DAY$$US-JNJFOC-20240857472$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
242477441$24247744$1$I$20240130$20240819$20240826$20240826$EXP$RO-NMA-2024-SP0534$RO-ROCHE-10000060530$ROCHE$$69$YR$E$F$Y$$$20240826$$MD$RO$RO
242477451$24247745$1$I$20190711$20240813$20240826$20240826$EXP$$DE-AUROBINDO-AUR-APL-2024-041536$AUROBINDO$$82$YR$$M$Y$83$KG$20240826$$MD$DE$DE
242477461$24247746$1$I$20210101$20240822$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047691$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240826$$CN$US$US
242477471$24247747$1$I$$20240819$20240826$20240826$EXP$GB-MHRA-MED-202408191141120190-NVSHL$GB-MSNLABS-2024MSNSPO01847$MSN LABORATORIES$$$$$$Y$$$20240826$$CN$GB$GB
242477481$24247748$1$I$$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132805$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240826$$HP$US$US
242477492$24247749$2$F$20240818$20240903$20240826$20240903$PER$$US-AMGEN-USASP2024167832$AMGEN$$67$YR$E$F$Y$$$20240903$$CN$US$US
242477501$24247750$1$I$$20240820$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047388$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240826$$CN$US$US
242477511$24247751$1$I$$20240815$20240826$20240826$EXP$$HR-ROCHE-1090725$ROCHE$Piljac A, Fiala, D. Prkacin, I. Skegro, D. Kovacevic Vojtusek, I. Gracin, S. Kardum-Skelin, I. Sustercic, D. Sabljar-Matovinovic, M. and Knotek, M. Disseminated aspergillosis in a patient with simultaneous pancreas and kidney transplant. Acta Medica Croatica 2011 Dec 01;65 (1):203-6.$31$YR$A$F$Y$$$20240826$$HP$HR$HR
242477531$24247753$1$I$$20240819$20240826$20240826$PER$$US-TAKEDA-2024TUS083516$TAKEDA$$$$$M$Y$77$KG$20240826$$MD$US$US
242477542$24247754$2$F$20240801$20240829$20240826$20240829$EXP$BE-FAMHP-DHH-N2024-122520$BE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047705$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$63.5$KG$20240829$$MD$BE$BE
242477551$24247755$1$I$$20240806$20240826$20240826$PER$$US-TEVA-VS-3231384$TEVA$$$$$F$Y$$$20240826$$CN$US$US
242477563$24247756$3$F$$20240916$20240826$20240925$EXP$$CA-TEVA-VS-3234387$TEVA$$11$YR$$F$Y$$$20240925$$HP$CA$CA
242477571$24247757$1$I$20240818$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024168972$AMGEN$$$$$M$Y$$$20240826$$CN$US$US
242477581$24247758$1$I$20240101$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167882$AMGEN$$63$YR$A$F$Y$$$20240826$$CN$US$US
242477591$24247759$1$I$$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004263$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242477601$24247760$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-042327$AUROBINDO$$60$YR$$F$Y$$$20240826$$HP$CA$CA
242477641$24247764$1$I$20240709$20240813$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-041335$AUROBINDO$$85$YR$$M$Y$56.6$KG$20240826$$PH$FR$FR
242477651$24247765$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-042245$AUROBINDO$$46$YR$$F$Y$$$20240826$$HP$CA$CA
242477661$24247766$1$I$$20240816$20240826$20240826$EXP$$US-JNJFOC-20240849092$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242477681$24247768$1$I$$20240822$20240826$20240826$PER$$US-JNJFOC-20240857030$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$MD$US$US
242477691$24247769$1$I$20240731$20240814$20240826$20240826$EXP$$CN-ROCHE-10000057847$ROCHE$$68$YR$E$M$Y$55$KG$20240826$$HP$CN$CN
242477701$24247770$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133624$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240826$$HP$US$US
242477711$24247771$1$I$20240801$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132368$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240826$$CN$US$US
242477721$24247772$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133694$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$71.6$KG$20240826$$PH$US$US
242477741$24247774$1$I$20240101$20240816$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131436$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240826$$CN$US$US
242477751$24247775$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-042402$AUROBINDO$$56$YR$$F$Y$$$20240826$$HP$CA$CA
242477763$24247776$3$F$20240101$20240917$20240826$20240926$EXP$$CA-CELLTRION INC.-2024CA020163$CELLTRION$$$$$$Y$$$20240926$$CN$CA$CA
242477771$24247777$1$I$20240813$20240817$20240826$20240826$EXP$$GB-AstraZeneca-2024A185643$ASTRAZENECA$$50$YR$$M$Y$90$KG$20240826$$CN$GB$
242477781$24247778$1$I$$20240820$20240826$20240826$PER$$US-ROCHE-10000064994$ROCHE$$$$E$M$Y$$$20240826$$CN$US$US
242477791$24247779$1$I$20240729$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A191064$ASTRAZENECA$$25113$DY$$F$Y$63.5$KG$20240826$$HP$US$
242477801$24247780$1$I$$20240821$20240826$20240826$EXP$$JP-AstraZeneca-2024A191812$ASTRAZENECA$$$$E$$Y$$$20240826$$MD$JP$
242477811$24247781$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041444$AUROBINDO$$55$YR$$F$Y$$$20240826$$HP$CA$CA
242477821$24247782$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000063778$ROCHE$$14$YR$T$$Y$$$20240826$$HP$US$US
242477831$24247783$1$I$$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004266$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
242477841$24247784$1$I$$20240815$20240826$20240826$EXP$$CH-ROCHE-10000059729$ROCHE$Hofer K, Wolfensberger N, Bachofner A, Schneidawind C, Stuhler C, Buhler M, et al. B-cell maturation antigen-directed bispecific antibodies in plasmablastic lymphoma. British Journal of Haematology. 2024-Aug;205 (2):722-725. doi:10.1111/bjh.19571.$33$YR$A$M$Y$$$20240826$$HP$CH$CH
242477851$24247785$1$I$$20240817$20240826$20240826$EXP$$MY-ROCHE-10000062457$ROCHE$$$$$$Y$$$20240826$$MD$MY$MY
242477861$24247786$1$I$20240823$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015201$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240826$$HP$US$US
242477872$24247787$2$F$$20240822$20240826$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408013557$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240828$$CN$US$US
242477881$24247788$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014613$ELI LILLY AND CO$$$$A$F$Y$$$20240826$$CN$US$US
242477891$24247789$1$I$20240813$20240814$20240826$20240826$PER$$US-BAUSCHBL-2024BNL031765$BAUSCH AND LOMB$$69$YR$$M$Y$$$20240826$$CN$US$US
242477901$24247790$1$I$$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013481$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240826$$CN$US$US
242477911$24247791$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014662$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240826$$CN$US$US
242477921$24247792$1$I$$20240816$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408010685$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240826$$CN$US$US
242477931$24247793$1$I$$20240821$20240826$20240826$PER$$NVSC2024US170084$NOVARTIS$$$$$$Y$$$20240826$$MD$US$US
242477941$24247794$1$I$$20240821$20240826$20240826$EXP$$NVSC2024US170532$NOVARTIS$$$$$F$Y$$$20240826$$HP$US$US
242477951$24247795$1$I$20240816$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024165617$AMGEN$$63$YR$A$F$Y$$$20240826$$MD$US$US
242477962$24247796$2$F$20240101$20240912$20240826$20240920$EXP$$CA-CELLTRION INC.-2024CA020166$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
242477972$24247797$2$F$$20240822$20240826$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004248$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
242477981$24247798$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-040671$AUROBINDO$Malik S, Brucato MF, Faiver L, Phan T, Yassin MH, Kapoor S et al.. Severe Fatal ARDS Due to Untreated Human Granulocytic Anaplasmosis in a 67-Year-Old Man: A Case Report.. Am-J-Case-Rep. 2024;25 (1941-5923):e943966$67$YR$$M$Y$$$20240826$$HP$US$US
242478001$24247800$1$I$$20240820$20240826$20240826$PER$$US-ABBVIE-5891475$ABBVIE$$$$$$Y$$$20240826$$CN$US$US
242478011$24247801$1$I$20240101$20240821$20240826$20240826$EXP$$US-ABBVIE-5890810$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242478021$24247802$1$I$$20240816$20240826$20240826$EXP$$US-JNJFOC-20240846658$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242478051$24247805$1$I$$20240819$20240826$20240826$EXP$$NVSC2024CA168989$NOVARTIS$$$$N$$Y$$$20240826$$HP$CA$CA
242478061$24247806$1$I$20240701$20240821$20240826$20240826$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-133727$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$65.77$KG$20240826$$CN$PR$PR
242478071$24247807$1$I$$20240819$20240826$20240826$PER$$US-BIOGEN-2024BI01278857$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242478081$24247808$1$I$20240101$20240814$20240826$20240826$PER$$US-BAUSCHBL-2024BNL031818$BAUSCH AND LOMB$$79$YR$$M$Y$$$20240826$$CN$US$US
242478092$24247809$2$F$$20240925$20240826$20240927$PER$$US-BIOGEN-2024BI01273855$BIOGEN$$$$$M$Y$$$20240927$$CN$US$US
242478101$24247810$1$I$20240731$20240822$20240826$20240826$EXP$$US-BEH-2024177622$CSL BEHRING$$61$YR$A$F$Y$$$20240826$$CN$US$US
242478111$24247811$1$I$20240101$20240820$20240826$20240826$EXP$$CA-ROCHE-3498071$ROCHE$$54$YR$A$F$Y$$$20240826$$CN$CA$CA
242478121$24247812$1$I$$20240819$20240826$20240826$EXP$$US-GSK-US2024103241$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$US$US
242478151$24247815$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2022-002411$AUROBINDO$$40$YR$$F$Y$$$20240826$$HP$CA$CA
242478161$24247816$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041488$AUROBINDO$$56$YR$$F$Y$$$20240826$$HP$CA$CA
242478181$24247818$1$I$20230801$20240821$20240826$20240826$EXP$$NVSC2024US170517$NOVARTIS$$39$YR$$M$Y$$$20240826$$CN$US$US
242478191$24247819$1$I$20231101$20240822$20240826$20240826$EXP$$NVSC2024US170972$NOVARTIS$$30$YR$$F$Y$$$20240826$$CN$US$US
242478201$24247820$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-3493707$ROCHE$$46$YR$A$F$Y$$$20240826$$CN$US$US
242478211$24247821$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000065389$ROCHE$$17$YR$T$$Y$$$20240826$$HP$US$US
242478221$24247822$1$I$20240727$20240822$20240826$20240826$PER$$US-ROCHE-3537139$ROCHE$$36$YR$A$F$Y$50.8$KG$20240826$$CN$US$US
242478231$24247823$1$I$20240812$20240822$20240826$20240826$PER$$US-ROCHE-10000064202$ROCHE$$59$YR$A$F$Y$$$20240826$$CN$US$US
242478251$24247825$1$I$$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004270$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242478261$24247826$1$I$20210101$20240813$20240826$20240826$EXP$GB-MHRA-MED-202408131443104660-JLMDZ$GB-MACLEODS PHARMA-MAC2024048916$MACLEODS$$$$$$Y$$$20240826$$MD$GB$GB
242478271$24247827$1$I$20240809$20240813$20240826$20240826$EXP$GB-MHRA-MED-202408121426549350-QDTSN$GB-MACLEODS PHARMA-MAC2024048913$MACLEODS$$$$$$Y$$$20240823$$HP$GB$GB
242478281$24247828$1$I$$20240813$20240826$20240826$EXP$$IN-MACLEODS PHARMA-MAC2024048907$MACLEODS$Keerthana V, Kumar MM, Gautham AK, Kandadai D..Tramadol Induced Angioedema in a Patient with Systemic Lupus  Erythematosus - A Case Report.IOSR Journal of Dental and Medical Sciences.SEP-2020;19(9):04-06$$$$$Y$$$20240826$$HP$IN$IN
242478291$24247829$1$I$20240801$20240813$20240826$20240826$EXP$$GB-MACLEODS PHARMA-MAC2024048912$MACLEODS$$$$$$Y$$$20240823$$MD$GB$GB
242478301$24247830$1$I$20240807$20240813$20240826$20240826$EXP$GB-MHRA-MED-202408081557577390-QKDMY$GB-MACLEODS PHARMA-MAC2024048915$MACLEODS$$48$YR$A$M$Y$$$20240823$$HP$GB$GB
242478311$24247831$1$I$20240718$20240813$20240826$20240826$EXP$GB-MHRA-MED-202408131612008190-LKHFZ$GB-MACLEODS PHARMA-MAC2024048917$MACLEODS$$62$YR$A$M$Y$98$KG$20240826$$HP$GB$GB
242478321$24247832$1$I$$20230821$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2023SP013615$STRIDES$Torrico T, Kahlon A.. Pathophysiology and management of risperidone-induced sialorrhea: case report.. Front-Psychiatry.. 2023$46$YR$$M$Y$$$20240826$$HP$US$US
242478331$24247833$1$I$20240410$20240813$20240826$20240826$EXP$$MD-MACLEODS PHARMA-MAC2024048940$MACLEODS$$$$$$Y$$$20240826$$MD$MD$MD
242478341$24247834$1$I$20240715$20240813$20240826$20240826$EXP$$MD-MACLEODS PHARMA-MAC2024048941$MACLEODS$$$$$$Y$$$20240826$$MD$MD$MD
242478351$24247835$1$I$$20240819$20240826$20240826$EXP$$PL-ROCHE-10000061406$ROCHE$$$$$M$Y$$$20240826$$CN$PL$PL
242478361$24247836$1$I$$20240724$20240826$20240826$PER$$US-Eisai-EC-2024-170824$EISAI$$$$$$Y$$$20240826$$PH$US$US
242478371$24247837$1$I$$20240813$20240826$20240826$PER$$US-TAKEDA-2024TUS082134$TAKEDA$$$$$F$Y$$$20240826$$MD$US$US
242478381$24247838$1$I$$20240423$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005018$STRIDES$Van Kalsbeek D, Anani AR, El-Kersh K.. Pulmonary artery vasodilators for treatment of pulmonary hypertension complicating fibrosing mediastinitis.. Respirat-Med-Case-Report. 2024;49$28$YR$$F$Y$$$20240826$$HP$US$US
242478391$24247839$1$I$$20240709$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008464$STRIDES$Russo T, Kouyoumjian S, Fargaly H. Angioedema: A Possible Complication of Amlodipine Use. Cureus. 2023;15(7):e42202$38$YR$$M$Y$$$20240826$$HP$US$US
242478401$24247840$1$I$$20240624$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007713$STRIDES$Prabhu S, Malempati S, Markowitz D. Amlodipine: Not an Ace in the Hole.. Am-J-Respir-Crit-Care-Med. 2024;209 (0):$56$YR$$M$Y$$$20240826$$HP$US$US
242478411$24247841$1$I$$20240813$20240826$20240826$EXP$$US-MACLEODS PHARMA-MAC2024048906$MACLEODS$Carstairs SD, Williams SR.Overdose of aripiprazole, a new type of antipsychotic.The Journal of emergency medicine.2005;28(3):311-313$$$$$Y$$$20240826$$MD$US$US
242478421$24247842$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041543$AUROBINDO$$701$MON$$M$Y$$$20240826$$CN$CA$CA
242478441$24247844$1$I$$20240821$20240826$20240826$EXP$$US-ABBVIE-5892050$ABBVIE$$$$$$Y$$$20240826$$HP$US$US
242478451$24247845$1$I$$20231229$20240826$20240826$EXP$$US-TEVA-VS-3228018$TEVA$$73$YR$$F$Y$$$20240826$$CN$US$US
242478461$24247846$1$I$20240601$20240821$20240826$20240826$EXP$GB-MHRA-MED-202408211519406250-VGSHN$GB-009507513-2408GBR007247$MERCK$$26$YR$$M$Y$$$20240826$$HP$GB$GB
242478472$24247847$2$F$20240501$20240821$20240826$20240830$PER$$US-AMGEN-USASP2024167592$AMGEN$$62$YR$A$F$Y$$$20240829$$CN$US$US
242478482$24247848$2$F$$20240828$20240826$20240904$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104638$VIIV$$$$$$Y$$$20240904$$HP$US$US
242478491$24247849$1$I$$20240823$20240826$20240826$PER$$NVSC2024US171546$NOVARTIS$$$$$M$Y$$$20240826$$HP$US$US
242478501$24247850$1$I$20231206$20240821$20240826$20240826$EXP$FR-AFSSAPS-LL2024001268$FR-TAKEDA-2024TUS084846$TAKEDA$$47$YR$$M$Y$$$20240826$$HP$FR$FR
242478511$24247851$1$I$20240127$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-082199-2024$RECKITT BENCKISER$$76$YR$$F$Y$77.27$KG$20240826$$CN$US$US
242478521$24247852$1$I$20240607$20240821$20240826$20240826$EXP$HR-HALMED-300086066$HR-TAKEDA-2024TUS084453$TAKEDA$$26$YR$$M$Y$$$20240826$$HP$HR$HR
242478531$24247853$1$I$$20240820$20240826$20240826$EXP$$ES-ORGANON-O2408ESP001449$ORGANON$Garcia Velasco G. Day 69.. The silence has moved.. AMF. 2024;20(7):1$78$YR$$M$Y$$$20240826$$MD$ES$ES
242478541$24247854$1$I$$20240823$20240826$20240826$PER$$US-ROCHE-10000065271$ROCHE$$$$E$F$Y$$$20240826$$CN$US$US
242478553$24247855$3$F$20240822$20240916$20240826$20240918$EXP$$GB-MYLANLABS-2024M1077428$MYLAN$$$$$M$Y$$$20240918$$MD$GB$GB
242478561$24247856$1$I$$20240702$20240826$20240826$EXP$$AU-TEVA-VS-3229064$TEVA$$20$YR$$M$Y$$$20240826$$MD$AU$AU
242478571$24247857$1$I$$20240821$20240826$20240826$EXP$$ZA-AstraZeneca-2024A192042$ASTRAZENECA$$61$YR$$F$Y$$$20240826$$CN$ZA$
242478581$24247858$1$I$20240101$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A191918$ASTRAZENECA$$952$MON$$M$Y$$$20240826$$MD$US$
242478591$24247859$1$I$$20240816$20240826$20240826$EXP$$BR-TAKEDA-2024TUS084578$TAKEDA$$$$$M$Y$$$20240826$$CN$BR$BR
242478601$24247860$1$I$$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004258$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242478611$24247861$1$I$20240501$20240816$20240826$20240826$EXP$$DE-CELLTRION INC.-2024DE014853$CELLTRION$$$$$$Y$$$20240826$$MD$DE$DE
242478621$24247862$1$I$$20240814$20240826$20240826$EXP$$PT-SPC-000472$SOLARIS PHARMA$Martins G, Dias A, Guerreiro C. Metronidazole-induced encephalopathy in a patient with spondylodiscitis. Clin Toxicol (Phila). 2024 Aug 7:1-3. doi: 10.1080/15563650.2024.2385683.$63$YR$A$M$Y$$$20240826$$HP$PT$PT
242478631$24247863$1$I$$20240814$20240826$20240826$EXP$$IN-SPC-000470$SOLARIS PHARMA$Izhar FM, Asrar KF, Haque AA. Metronidazole Associated Acute Encephalopathy. Indian J Pediatr. 2024 Jul 29. doi: 10.1007/s12098-024-05208-9.$14$YR$T$F$Y$$$20240826$$HP$IN$IN
242478641$24247864$1$I$$20240823$20240826$20240826$PER$$US-ROCHE-10000065424$ROCHE$$$$A$$Y$$$20240826$$CN$US$US
242478651$24247865$1$I$$20240814$20240826$20240826$EXP$$AR-ROCHE-10000063657$ROCHE$$65$YR$E$F$Y$$$20240826$$CN$AR$AR
242478662$24247866$2$F$20240815$20240911$20240826$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133884$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240917$$HP$US$US
242478671$24247867$1$I$20240817$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133565$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240826$$HP$US$US
242478681$24247868$1$I$20240703$20240821$20240826$20240826$EXP$$CN-AMGEN-CHNSP2024168310$AMGEN$$70$YR$E$M$Y$$$20240826$$HP$CN$CN
242478701$24247870$1$I$$20240809$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127985$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240826$$CN$US$US
242478711$24247871$1$I$20220101$20240815$20240826$20240826$EXP$$GB-ASPEN-GLO2024GB005662$ASPEN$Williams H, Thoppuram N, Law KY, Simms J. Post-operative post-cognitive dysfunction: progressive multifocal leukoencephalopathy (PML), an unexpected finding in an elderly patient. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24:100041$$$$$Y$$$20240826$$MD$GB$GB
242478721$24247872$1$I$20240603$20240823$20240826$20240826$EXP$ES-AEMPS-1562356$NVSC2024ES170980$NOVARTIS$$58$YR$$M$Y$70$KG$20240826$$CN$ES$ES
242478731$24247873$1$I$20231001$20240819$20240826$20240826$EXP$$NVSC2023SE268415$NOVARTIS$$32$YR$$F$Y$46.2$KG$20240826$$HP$SE$SE
242478741$24247874$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041696$AUROBINDO$$61$YR$$F$Y$125$KG$20240826$$HP$CA$CA
242478751$24247875$1$I$$20240819$20240826$20240826$PER$$US-BIOGEN-2024BI01279057$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242478761$24247876$1$I$$20240819$20240826$20240826$PER$$US-BIOGEN-2024BI01279023$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242478771$24247877$1$I$20240731$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004274$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240826$$CN$US$US
242478792$24247879$2$F$$20240829$20240826$20240905$EXP$$JP-009507513-2408JPN001882J$MERCK$$6$DEC$$F$Y$$$20240905$$MD$JP$JP
242478812$24247881$2$F$20240718$20240812$20240826$20240828$EXP$$SE-AMGEN-SWESP2024167116$AMGEN$$$$A$F$Y$$$20240828$$CN$SE$SE
242478821$24247882$1$I$$20240819$20240826$20240826$EXP$$CA-002147023-NVSC2023CA007230$Haleon PLC$$49$YR$$F$Y$96$KG$20240826$$HP$CA$CA
242478831$24247883$1$I$$20240803$20240826$20240826$PER$$CA-TOLMAR, INC.-24CA051602$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
242478851$24247885$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041400$AUROBINDO$$$$$F$Y$$$20240826$$HP$CA$CA
242478871$24247887$1$I$$20240803$20240826$20240826$PER$$CA-TOLMAR, INC.-24CA051659$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
242478881$24247888$1$I$$20240823$20240826$20240826$PER$$US-ROCHE-10000065466$ROCHE$$44$YR$A$F$Y$$$20240826$$MD$US$US
242478892$24247889$2$F$20240812$20240916$20240826$20240923$PER$$US-ROCHE-10000063404$ROCHE$$30$YR$A$M$Y$$$20240923$$CN$US$US
242478901$24247890$1$I$$20240822$20240826$20240826$EXP$$CA-ROCHE-10000063504$ROCHE$$$$$M$Y$$$20240826$$HP$CA$CA
242478911$24247891$1$I$20240717$20240724$20240826$20240826$PER$$US-Eisai-EC-2024-170835$EISAI$$81$YR$E$M$Y$$$20240826$$CN$US$US
242478923$24247892$3$F$20240722$20240917$20240826$20240920$EXP$$GB-MYLANLABS-2024M1077447$MYLAN$$39$YR$$M$Y$$$20240920$$HP$GB$GB
242478931$24247893$1$I$20240820$20240820$20240826$20240826$EXP$$US-VANTIVE-2024VAN019197$Vantive US Healthcare$$$$$M$Y$$$20240826$$HP$US$US
242478941$24247894$1$I$20220101$20240822$20240826$20240826$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047473$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$$$20240826$$CN$BR$BR
242478961$24247896$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131565$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240826$$CN$US$US
242478971$24247897$1$I$$20240813$20240826$20240826$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08303$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242478983$24247898$3$F$20240802$20240904$20240826$20240910$PER$$US-AMGEN-USASP2024155525$AMGEN$$24$YR$A$M$Y$$$20240910$$CN$US$US
242478991$24247899$1$I$20240715$20240822$20240826$20240826$PER$$US-ROCHE-10000064707$ROCHE$$$$$$Y$$$20240826$$HP$US$US
242479001$24247900$1$I$$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-081978-2024$RECKITT BENCKISER$$$$$$Y$$$20240826$$CN$US$US
242479012$24247901$2$F$20240821$20240912$20240826$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202408014483$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240917$$CN$US$US
242479021$24247902$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064875$ROCHE$$55$YR$A$F$Y$$$20240826$$HP$US$US
242479031$24247903$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000064082$ROCHE$$$$A$F$Y$$$20240826$$CN$US$US
242479041$24247904$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014540$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240826$$HP$US$US
242479051$24247905$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014716$ELI LILLY AND CO$$55$YR$A$$Y$$$20240826$$CN$US$US
242479061$24247906$1$I$$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015464$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240826$$CN$US$US
242479071$24247907$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014449$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240826$$CN$US$US
242479081$24247908$1$I$20240801$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014890$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242479091$24247909$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014666$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240826$$CN$US$US
242479121$24247912$1$I$$20240822$20240826$20240826$EXP$$NVSC2024US170400$NOVARTIS$$30$YR$$F$Y$$$20240826$$HP$US$US
242479131$24247913$1$I$$20240823$20240826$20240826$PER$$NVSC2024US171408$NOVARTIS$$$$$$Y$$$20240826$$CN$US$US
242479141$24247914$1$I$$20240818$20240826$20240826$EXP$$US-JNJFOC-20240850247$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242479151$24247915$1$I$20240101$20240815$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131246$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240826$$MD$US$US
242479161$24247916$1$I$$20240821$20240826$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-133646$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240826$$PH$JP$JP
242479171$24247917$1$I$$20240822$20240826$20240826$EXP$$CA-ROCHE-10000065236$ROCHE$$$$A$F$Y$$$20240826$$CN$CA$CA
242479181$24247918$1$I$$20240814$20240826$20240826$PER$$US-HALEON-2193563$Haleon PLC$$$$$$Y$$$20240826$$CN$US$US
242479191$24247919$1$I$$20240815$20240826$20240826$EXP$$US-INFO-20240254$INFORLIFE$$$$$$Y$$$20240821$$PH$US$
242479201$24247920$1$I$$20240818$20240826$20240826$EXP$$FR-INFO-20240255$INFORLIFE$Eid R, Zamparini E, Ouchrif Y, Snanoudj R, Ottolenghi C, Zaidan M. A case report of Paracetamol related pyroglutamic acidosis: mind the gap in a malnourished patient. BMC Nephrol. 2024 Aug 13;25(1):260. doi: 10.1186/s12882-024-03678-9.$67$YR$E$M$Y$$$20240821$$MD$FR$FR
242479211$24247921$1$I$$20240821$20240826$20240826$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004686$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
242479221$24247922$1$I$20231215$20240819$20240826$20240826$EXP$FR-AFSSAPS-PO2024000878$FR-CHEPLA-2024010881$CHEPLAPHARM$$31$YR$A$F$Y$$$20240826$$MD$COUNTRY NOT SPECIFIED$FR
242479231$24247923$1$I$20240501$20240820$20240826$20240826$EXP$$BR-CHEPLA-2024010756$CHEPLAPHARM$$71$YR$$F$Y$52$KG$20240826$$CN$COUNTRY NOT SPECIFIED$BR
242479241$24247924$1$I$20240101$20240819$20240826$20240826$EXP$DE-CADRBFARM-2024329864$DE-CHEPLA-2024010785$CHEPLAPHARM$$55$YR$$M$Y$78$KG$20240826$$CN$COUNTRY NOT SPECIFIED$DE
242479251$24247925$1$I$20220314$20240819$20240826$20240826$EXP$FR-AFSSAPS-DJ20221116$FR-CHEPLA-9000013121$CHEPLAPHARM$$81$YR$$F$Y$73$KG$20240826$$MD$COUNTRY NOT SPECIFIED$FR
242479261$24247926$1$I$20240719$20240819$20240826$20240826$EXP$$US-CHEPLA-2024010720$CHEPLAPHARM$$58$YR$$F$Y$71.199$KG$20240826$$MD$COUNTRY NOT SPECIFIED$US
242479271$24247927$1$I$20240528$20240821$20240826$20240826$EXP$$CN-CHEPLA-2024010864$CHEPLAPHARM$$68$YR$E$M$Y$68$KG$20240826$$HP$COUNTRY NOT SPECIFIED$CN
242479281$24247928$1$I$$20240822$20240826$20240826$EXP$$US-ROCHE-10000065261$ROCHE$$46$YR$A$F$Y$$$20240826$$HP$US$US
242479292$24247929$2$F$$20240823$20240826$20240827$EXP$$US-ROCHE-10000065415$ROCHE$$43$YR$A$F$Y$$$20240827$$CN$US$US
242479301$24247930$1$I$20240703$20240819$20240826$20240826$EXP$ES-AEMPS-1561072$ES-CHEPLA-2024010808$CHEPLAPHARM$$47$YR$$M$Y$$$20240826$$MD$COUNTRY NOT SPECIFIED$ES
242479311$24247931$1$I$$20240820$20240826$20240826$EXP$$CA-Orion Corporation ORION PHARMA-24_00031386$ORION$$51$YR$A$F$Y$$$20240826$$MD$CA$
242479321$24247932$1$I$20231001$20240820$20240826$20240826$EXP$$CA-HLS-202402113$HLS THERAPEUTICS$$20$YR$A$M$Y$$$20240826$$MD$CA$CA
242479331$24247933$1$I$$20240815$20240826$20240826$EXP$$US-TG THERAPEUTICS INC.-TGT003931$TG THERAPEUTICS$$$$$$Y$$$20240826$$CN$US$US
242479341$24247934$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000065318$ROCHE$$$$$F$Y$$$20240826$$MD$US$US
242479352$24247935$2$F$$20240903$20240826$20240908$PER$$US-ROCHE-10000065444$ROCHE$$57$YR$A$M$Y$$$20240908$$CN$US$US
242479361$24247936$1$I$20240814$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167739$AMGEN$$$$$$Y$$$20240826$$PH$US$US
242479371$24247937$1$I$20240717$20240724$20240826$20240826$PER$$US-Eisai-EC-2024-170857$EISAI$$82$YR$E$M$Y$$$20240826$$CN$US$US
242479382$24247938$2$F$$20240821$20240826$20240827$PER$$US-TAKEDA-2024TUS083356$TAKEDA$$58$YR$$F$Y$64$KG$20240827$$CN$US$US
242479394$24247939$4$F$$20240923$20240826$20240925$EXP$$CA-ROCHE-10000065654$ROCHE$$$$E$F$Y$$$20240925$$HP$CA$CA
242479402$24247940$2$F$20240101$20240823$20240826$20240827$EXP$$US-ROCHE-10000065508$ROCHE$$52$YR$A$F$Y$108.86$KG$20240827$$CN$US$US
242479421$24247942$1$I$20240817$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024168384$AMGEN$$81$YR$E$M$Y$$$20240826$$CN$US$US
242479431$24247943$1$I$$20240823$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047644$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240826$$CN$US$US
242479441$24247944$1$I$$20240819$20240826$20240826$EXP$$US-862174955-ML2024-04547$MICRO LABS$$$$$F$Y$$$20240826$$CN$US$US
242479452$24247945$2$F$$20240823$20240826$20240827$EXP$$US-ROCHE-10000065290$ROCHE$$70$YR$E$F$Y$$$20240827$$MD$US$US
242479461$24247946$1$I$20240630$20240820$20240826$20240826$PER$$US-ABBVIE-5892711$ABBVIE$$30$YR$$F$Y$$$20240826$$MD$US$US
242479471$24247947$1$I$20230101$20240820$20240826$20240826$EXP$$FR-UCBSA-2024042884$UCB$$$$$F$Y$63$KG$20240826$$MD$FR$FR
242479521$24247952$1$I$20240704$20240823$20240826$20240826$EXP$$US-ABBVIE-5893733$ABBVIE$$81$YR$$M$Y$$$20240826$$CN$US$US
242479532$24247953$2$F$20220101$20240830$20240826$20240830$EXP$$BR-ORGANON-O2408BRA001713$ORGANON$$68$YR$$F$Y$66.6$KG$20240830$$CN$BR$BR
242479541$24247954$1$I$$20240801$20240826$20240826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004273$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
242479551$24247955$1$I$20240101$20240816$20240826$20240826$PER$$US-ABBVIE-5887238$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242479561$24247956$1$I$20200428$20240821$20240826$20240826$EXP$PL-URPL-1-1938-2020$PL-TAKEDA-2024TUS084293$TAKEDA$$10$YR$$F$Y$30$KG$20240826$$HP$PL$PL
242479571$24247957$1$I$20240809$20240821$20240826$20240826$EXP$$CN-ORGANON-O2408CHN001573$ORGANON$$61$YR$$F$Y$39$KG$20240826$$HP$CN$CN
242479581$24247958$1$I$20231201$20240823$20240826$20240826$EXP$$US-UCBSA-2024007872$UCB$$68$YR$$F$Y$$$20240826$$CN$US$US
242479591$24247959$1$I$$20240816$20240826$20240826$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR103006$VIIV$$$$$$Y$$$20240826$$MD$US$US
242479601$24247960$1$I$20240417$20240816$20240826$20240826$EXP$FR-AFSSAPS-BS2024000500$FR-TEVA-VS-3234353$TEVA$$80$YR$$F$Y$$$20240826$$MD$FR$FR
242479611$24247961$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132385$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240826$$HP$US$US
242479621$24247962$1$I$$20240816$20240826$20240826$EXP$$CA-APOTEX-2024AP009503$APOTEX$$58$YR$$M$Y$$$20240826$$HP$CA$CA
242479631$24247963$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134724$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240826$$HP$US$US
242479641$24247964$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133502$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240826$$CN$US$US
242479651$24247965$1$I$20240821$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133445$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240826$$HP$US$US
242479661$24247966$1$I$20240101$20240819$20240826$20240826$EXP$$CA-CELLTRION INC.-2024CA020282$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
242479681$24247968$1$I$$20240814$20240826$20240826$EXP$$US-Appco Pharma LLC-2160854$APPCO PHARMA$Initial$54$YR$$M$Y$$$20240826$$$US$US
242479691$24247969$1$I$20240812$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024166278$AMGEN$$77$YR$E$F$Y$$$20240826$$CN$US$US
242479701$24247970$1$I$20240804$20240816$20240826$20240826$30DAY$$US-GSK-US2024102430$GLAXOSMITHKLINE$$73$YR$$M$Y$$$20240826$$CN$US$US
242479713$24247971$3$F$20240717$20240918$20240826$20240923$EXP$$NVSC2024SI159137$NOVARTIS$$60$YR$$M$Y$79$KG$20240923$$MD$SI$SI
242479721$24247972$1$I$$20240814$20240826$20240826$EXP$$US-Appco Pharma LLC-2160853$APPCO PHARMA$Initial$76$YR$$F$Y$$$20240826$$$US$US
242479732$24247973$2$F$20240101$20240820$20240826$20240903$EXP$$DE-MDD US Operations-E2B_00006419$MDD OPERATIONS$$74$YR$$M$Y$$$20240903$$CN$DE$DE
242479742$24247974$2$F$20240820$20240823$20240826$20240905$EXP$$CA-HLS-202402136$HLS THERAPEUTICS$$45$YR$A$M$Y$$$20240905$$CN$CA$CA
242479751$24247975$1$I$20220812$20240821$20240826$20240826$EXP$$CO-UCBSA-2024039984$UCB$$60$YR$$F$Y$$$20240826$$CN$CO$CO
242479761$24247976$1$I$$20240822$20240826$20240826$PER$$US-TAKEDA-2024TUS085329$TAKEDA$$$$$M$Y$68$KG$20240826$$MD$US$US
242479772$24247977$2$F$$20240827$20240826$20240906$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08314$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242479781$24247978$1$I$20240801$20240812$20240826$20240826$EXP$$US-MYLANLABS-2024M1075437$MYLAN$$63$YR$$M$Y$79.38$KG$20240826$$CN$US$US
242479801$24247980$1$I$$20240822$20240826$20240826$PER$$US-TAKEDA-2024TUS085390$TAKEDA$$$$$F$Y$$$20240826$$CN$US$US
242479811$24247981$1$I$$20240814$20240826$20240826$PER$$US-AstraZeneca-2024A186079$ASTRAZENECA$$77$YR$$F$Y$$$20240826$$MD$US$
242479823$24247982$3$F$20240821$20240904$20240826$20240905$PER$$US-AMGEN-USASP2024167284$AMGEN$$57$YR$A$F$Y$$$20240905$$CN$US$US
242479831$24247983$1$I$20240101$20240812$20240826$20240826$PER$$US-AstraZeneca-2024A193769$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242479841$24247984$1$I$$20240821$20240826$20240826$PER$$US-AstraZeneca-2024A191508$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242479851$24247985$1$I$20221007$20221220$20240826$20240826$EXP$$CN-AstraZeneca-2022A416027$ASTRAZENECA$$46$YR$$F$Y$73$KG$20240826$$MD$CN$
242479861$24247986$1$I$$20240819$20240826$20240826$EXP$$CN-AstraZeneca-2024A189702$ASTRAZENECA$$$$$F$Y$$$20240826$$CN$CN$
242479872$24247987$2$F$$20240829$20240826$20240904$EXP$$US-ROCHE-10000064693$ROCHE$$$$A$M$Y$$$20240904$$CN$US$US
242479891$24247989$1$I$20230701$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015030$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240826$$CN$US$US
242479902$24247990$2$F$20240819$20240823$20240826$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014909$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240827$$CN$US$US
242479911$24247991$1$I$$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013867$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242479921$24247992$1$I$20240509$20240820$20240826$20240826$EXP$$NVSC2024CN170803$NOVARTIS$$63$YR$$M$Y$$$20240826$$HP$CN$CN
242479931$24247993$1$I$$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-082181-2024$RECKITT BENCKISER$$$$$$Y$$$20240826$$CN$US$US
242479941$24247994$1$I$20240101$20240819$20240826$20240826$EXP$$CA-CELLTRION INC.-2024CA020286$CELLTRION$$$$$$Y$$$20240826$$HP$CA$CA
242479951$24247995$1$I$20240401$20240823$20240826$20240826$EXP$FR-AFSSAPS-PB2024000895$FR-JNJFOC-20240864782$JOHNSON AND JOHNSON$$86$YR$E$M$Y$65$KG$20240826$$PH$FR$FR
242479961$24247996$1$I$$20240813$20240826$20240826$EXP$$PT-CIPLA LTD.-2024PT09046$CIPLA$Pereira I, Ferreira IM, Barbosa FR, Pereira D, Gabriel DF. Carbamazepine poisoning: cause and/or consequence. Congresses of the Portuguese Society of Internal Medicine. 30th National Congress of Internal Medicine - Book of abstracts May. 2024;1199$$$$$Y$$$20240826$$HP$PT$PT
242479971$24247997$1$I$20240101$20240819$20240826$20240826$EXP$$US-009507513-2408USA006384$MERCK$$$$$M$Y$$$20240826$$CN$US$US
242479981$24247998$1$I$20240812$20240820$20240826$20240826$PER$$US-JNJFOC-20240851338$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240826$$CN$US$US
242479991$24247999$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134492$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240826$$CN$US$US
242480001$24248000$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133562$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240826$$HP$US$US
242480011$24248001$1$I$$20240816$20240826$20240826$30DAY$$US-GSK-US2024102678$GLAXOSMITHKLINE$$$$$M$Y$$$20240826$$CN$US$US
242480021$24248002$1$I$$20240819$20240826$20240826$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-131345$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240826$$HP$CA$CA
242480031$24248003$1$I$$20240820$20240826$20240826$EXP$$NVSC2024CA169064$NOVARTIS$$83$YR$$M$Y$$$20240826$$CN$CA$CA
242480042$24248004$2$F$$20240822$20240826$20240830$EXP$$US-MYLANLABS-2024M1078439$MYLAN$$$$$M$Y$$$20240830$$CN$US$US
242480051$24248005$1$I$$20240819$20240826$20240826$EXP$$NVSC2024TR169888$NOVARTIS$Kostekci YE, Kraja E, Ergun E, Okulu E, Ates U, Erdeve O et al.. The management of neonatal chylothorax: Experience of a tertiary neonatal referral center. ANKARA UNIVERSITESI TIP FAKULTESI MECMUASI. 2024;77(2):137-42$$$I$F$Y$$$20240826$$HP$TR$TR
242480061$24248006$1$I$20230101$20240820$20240826$20240826$EXP$FR-AFSSAPS-LM2024000452$FR-UCBSA-2024042107$UCB$$$$$F$Y$1.81$KG$20240826$$MD$FR$FR
242480072$24248007$2$F$$20240903$20240826$20240911$PER$$US-ABBVIE-5887110$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
242480081$24248008$1$I$$20240819$20240826$20240826$EXP$$JP-AMGEN-JPNSP2024168230$AMGEN$$6$DEC$A$M$Y$$$20240826$$PH$JP$JP
242480102$24248010$2$F$20240814$20240814$20240826$20240826$PER$$US-ROCHE-10000058471$ROCHE$$$$$F$Y$$$20240826$$CN$US$US
242480112$24248011$2$F$$20240824$20240826$20240827$30DAY$$FR-SANDOZ INC.-SDZ2024FR074984$SANDOZ$$4$YR$$F$Y$$$20240827$$CN$FR$FR
242480121$24248012$1$I$$20240816$20240826$20240826$30DAY$$US-GSK-US2024102723$GLAXOSMITHKLINE$$$$$M$Y$$$20240826$$CN$US$US
242480131$24248013$1$I$$20240816$20240826$20240826$EXP$$US-GSK-US2024103411$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$US$US
242480141$24248014$1$I$20240529$20240820$20240826$20240826$EXP$$CA-JNJFOC-20240854640$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240826$$PH$CA$CA
242480151$24248015$1$I$20240815$20240821$20240826$20240826$PER$$US-ROCHE-10000063095$ROCHE$$$$$M$Y$$$20240826$$CN$US$US
242480162$24248016$2$F$20240730$20240820$20240826$20240913$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000490$BECTON DICKINSON$$$$$$Y$$$20240913$$CN$GB$GB
242480181$24248018$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58142$$FDA-CTU$$42$YR$$$N$$$20240731$N$$US$
242480201$24248020$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58170$$FDA-CTU$$50$YR$$F$N$$$20240731$N$HP$US$
242480211$24248021$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58158$$FDA-CTU$$$$$$N$$$20240731$N$$US$
242480221$24248022$1$I$$20240820$20240826$20240826$EXP$$BR-AMGEN-BRASP2024166717$AMGEN$$$$$F$Y$$$20240826$$MD$BR$BR
242480232$24248023$2$F$20240801$20240821$20240826$20240913$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000493$BECTON DICKINSON$$$$$$Y$$$20240913$$CN$GB$GB
242480242$24248024$2$F$20240730$20240820$20240826$20240913$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000491$BECTON DICKINSON$$$$$$Y$$$20240913$$CN$GB$GB
242480251$24248025$1$I$20240619$20240813$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-041356$AUROBINDO$$53$YR$$M$Y$60$KG$20240826$$MD$FR$FR
242480262$24248026$2$F$20240801$20240821$20240826$20240913$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000494$BECTON DICKINSON$$$$$$Y$$$20240913$$CN$GB$GB
242480271$24248027$1$I$$20240822$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134281$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240826$$CN$US$US
242480291$24248029$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58168$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242480301$24248030$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58165$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242480311$24248031$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133464$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240826$$CN$US$US
242480321$24248032$1$I$20240701$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132535$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240826$$HP$US$US
242480331$24248033$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133607$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240826$$HP$US$US
242480341$24248034$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134963$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240826$$CN$US$US
242480352$24248035$2$F$20240916$20240916$20240826$20240923$EXP$$CA-TAKEDA-2024TUS084580$TAKEDA$$31$YR$$F$Y$$$20240923$$MD$CA$CA
242480362$24248036$2$F$20240905$20240912$20240826$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134132$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$44.91$KG$20240916$$CN$US$US
242480372$24248037$2$F$20240801$20240821$20240826$20240913$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000495$BECTON DICKINSON$$$$$$Y$$$20240913$$CN$GB$GB
242480381$24248038$1$I$$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-139541-2023$RECKITT BENCKISER$$42$YR$$M$Y$$$20240826$$CN$US$US
242480392$24248039$2$F$20240801$20240821$20240826$20240913$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000496$BECTON DICKINSON$$$$$$Y$$$20240913$$CN$GB$GB
242480401$24248040$1$I$20240816$20240819$20240826$20240826$EXP$$US-TAKEDA-2024TUS073843$TAKEDA$$47$YR$$M$Y$$$20240826$$CN$US$US
242480421$24248042$1$I$$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-088477-2024$RECKITT BENCKISER$$80$YR$$F$Y$$$20240826$$CN$US$US
242480431$24248043$1$I$$20240806$20240826$20240826$PER$$US-TEVA-VS-3230984$TEVA$$78$YR$$M$Y$77.11$KG$20240826$$CN$US$US
242480441$24248044$1$I$$20240816$20240826$20240826$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-08414$LUPIN$$39$YR$$F$Y$$$20240826$$CN$AU$AU
242480451$24248045$1$I$20240729$20240816$20240826$20240826$EXP$FR-AFSSAPS-PO2024000891$FR-TEVA-VS-3234445$TEVA$$55$YR$$M$Y$$$20240826$$MD$FR$FR
242480461$24248046$1$I$20240716$20240813$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-041342$AUROBINDO$$27$YR$$F$Y$$$20240826$$PH$FR$FR
242480472$24248047$2$F$20240810$20240818$20240826$20240903$PER$$US-AstraZeneca-2024A183394$ASTRAZENECA$$69$YR$$M$Y$$$20240903$$CN$US$
242480483$24248048$3$F$20240116$20240822$20240826$20240829$EXP$$US-AstraZeneca-2024A191931$ASTRAZENECA$$31418$DY$$M$Y$$$20240829$$MD$US$
242480492$24248049$2$F$$20240904$20240826$20240905$EXP$$GB-MYLANLABS-2024M1078484$MYLAN$$$$$M$Y$$$20240905$$CN$GB$GB
242480501$24248050$1$I$$20240823$20240826$20240826$EXP$$KR-MYLANLABS-2024M1078396$MYLAN$$$$$M$Y$$$20240826$$CN$KR$KR
242480512$24248051$2$F$20240730$20240919$20240826$20240923$EXP$$NZ-MYLANLABS-2024M1078123$MYLAN$$48$YR$$F$Y$132$KG$20240923$$CN$NZ$NZ
242480521$24248052$1$I$20240809$20240823$20240826$20240826$EXP$$CN-AstraZeneca-2024A193426$ASTRAZENECA$$19776$DY$$F$Y$$$20240826$$MD$CN$
242480531$24248053$1$I$20240731$20240813$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-041336$AUROBINDO$$70$YR$$F$Y$75.6$KG$20240826$$MD$FR$FR
242480541$24248054$1$I$$20240214$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002065$STRIDES$Chowdhury A, Robince C, Hernandez S, Williams S, Jangam A.. Amlodipine Induced Gingival Hyperplasia: A Case Report and a Review of its Pathogenesis.. South-Med-J. 2022;115 (1):76-77$60$YR$$M$Y$$$20240826$$HP$US$US
242480551$24248055$1$I$$20230905$20240826$20240826$PER$$IN-STRIDES ARCOLAB LIMITED-2023SP014236$STRIDES$Sachdeva V, Ashraf S, Inam S, Shah K, Singla A, Mansuri Z, et al.. Olanzapine-Induced Bradycardia.. Prim-Care-Comp-CNS-Disorders. 2023;25 (4)$34$YR$$M$Y$$$20240826$$MD$IN$US
242480561$24248056$1$I$$20231213$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2023SP018822$STRIDES$Proudan N, Gordon M.. Subclinical Cushing^s Syndrome: Should We Treat?.. J-Endocr-Soc. 2019;3 (Suppl. 1):abstr. SUN-396$66$YR$$F$Y$$$20240826$$MD$US$US
242480571$24248057$1$I$$20240102$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000253$STRIDES$Jenniches D, Kerns AF, DelBianco J, Stripp MP, Philp AS.. Administration of andexanet alfa for traumatic intracranial hemorrhage in the setting of massive apixaban overdose: A case report.. Am-J-Health-Syst-Pharm. 2023;80 (23):1722-1728$69$YR$$F$Y$$$20240826$$PH$US$US
242480581$24248058$1$I$$20240819$20240826$20240826$EXP$$US-TAKEDA-2024TUS083871$TAKEDA$$$$$M$Y$$$20240826$$CN$US$US
242480592$24248059$2$F$$20240830$20240826$20240904$EXP$$US-TAKEDA-2024TUS083396$TAKEDA$$$$$M$Y$$$20240904$$MD$US$US
242480601$24248060$1$I$$20230906$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2023SP014323$STRIDES$Upadhya S, Nunez SE, Muruganandam M, McElwee MK, Emil NS, Sibbitt WL.. Raynaud+amp;apos;s phenomenon secondary to central nervous system stimulants: A therapeutic role of alpha-1 adrenergic blockers. Semin-Arthritis-Rheum. 2022$57$YR$$F$Y$$$20240826$$HP$US$US
242480621$24248062$1$I$$20240723$20240826$20240826$PER$$US-Eisai-EC-2024-170988$EISAI$$$$$$Y$$$20240826$$MD$US$US
242480631$24248063$1$I$$20240812$20240826$20240826$EXP$$ES-TEYRO-2024-TY-000497$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$M$Y$$$20240826$$HP$ES$ES
242480641$24248064$1$I$$20240723$20240826$20240826$PER$$US-Eisai-EC-2024-170987$EISAI$$$$$$Y$$$20240826$$MD$US$US
242480651$24248065$1$I$$20240820$20240826$20240826$EXP$AU-AUS-SPO/AUS/24/0012286$AU-RDY-SPO/AUS/24/0012286$DR REDDYS$$50$YR$A$M$Y$$$20240826$$CN$AU$AU
242480661$24248066$1$I$20240709$20240814$20240826$20240826$EXP$ES-AEMPS-1553620$ES-MELINTA THERAPEUTICS, LLC-ES-MLNT-24-00397$MELINTA THERAPEUTICS$$$$$$Y$$$20240826$$MD$ES$ES
242480681$24248068$1$I$$20240815$20240826$20240826$PER$$NVSC2024US171890$NOVARTIS$$$$$$Y$$$20240826$$MD$US$US
242480691$24248069$1$I$20231031$20240814$20240826$20240826$EXP$$JP-ROCHE-10000060141$ROCHE$$73$YR$E$F$Y$60.5$KG$20240826$$MD$JP$JP
242480711$24248071$1$I$20240801$20240822$20240826$20240826$PER$$US-ABBVIE-5892738$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242480731$24248073$1$I$20240601$20240818$20240826$20240826$EXP$$NVSC2024IL161508$NOVARTIS$$78$YR$$F$Y$$$20240826$$MD$IL$IL
242480742$24248074$2$F$20240601$20240906$20240826$20240909$EXP$$US-TAKEDA-2024TUS085063$TAKEDA$$47$YR$$F$Y$$$20240909$$CN$US$US
242480751$24248075$1$I$$20240820$20240826$20240826$PER$$US-BIOGEN-2024BI01267136$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242480761$24248076$1$I$$20240822$20240826$20240826$EXP$$US-SANDOZ INC.-SDZ2024US074979$SANDOZ$$$$$F$Y$$$20240826$$CN$US$US
242480783$24248078$3$F$$20240925$20240826$20240930$EXP$$US-BIOGEN-2024BI01279127$BIOGEN$$$$$M$Y$$$20240930$$CN$US$US
242480791$24248079$1$I$$20240821$20240826$20240826$EXP$$AU-MYLANLABS-2024M1078232$MYLAN$$$$$M$Y$$$20240826$$HP$AU$AU
242480801$24248080$1$I$$20240821$20240826$20240826$EXP$$GB-MYLANLABS-2024M1078186$MYLAN$$$$$M$Y$$$20240826$$HP$GB$GB
242480811$24248081$1$I$$20240818$20240826$20240826$EXP$$TW-AMGEN-TWNSP2024165723$AMGEN$Yang Y.; Yeh H.; Hondar Wu H. et al.. Optimal body mass index for protecting middle-aged and elderly patients with fatty liver from future fractures. Endocrine Connections. 2024;13 (8):1-10$$$$$Y$$$20240826$$HP$TW$TW
242480821$24248082$1$I$$20240819$20240826$20240826$EXP$$AU-AMGEN-AUSSP2024165880$AMGEN$Lorger S.; Mcclintock G.; Lorger G. et al.. Hepatocellular carcinoma metastasis presenting as a pedunculated bladder mass. Urology Case Reports. 2024;56:1-3$66$YR$E$M$Y$$$20240826$$HP$AU$AU
242480831$24248083$1$I$$20240820$20240826$20240826$EXP$$MA-ORGANON-O2408MAR001422$ORGANON$Lamouri I, Ech-Chebab M, Ayyad A, Messaoudi S, Babakhouya A, Amrani R.. Hypokinetic Hypertrophic Cardiomyopathy: A Rare Case of a Spontaneously Regressive Form in a Newborn.. Cureus.. 2024;16(7)$$$N$F$Y$3.1$KG$20240826$$HP$MA$MA
242480841$24248084$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014489$ELI LILLY AND CO$$32$YR$A$$Y$$$20240826$$CN$US$US
242480861$24248086$1$I$$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015124$ELI LILLY AND CO$$$$$$Y$$$20240826$$CN$US$US
242480871$24248087$1$I$20240201$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014928$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240826$$CN$US$US
242480882$24248088$2$F$$20240823$20240826$20240828$EXP$GB-MHRA-MED-202408232019213860-DWFGK$GB-ABBVIE-5893247$ABBVIE$$$$$F$Y$$$20240828$$CN$GB$GB
242480891$24248089$1$I$20240818$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013768$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240826$$CN$US$US
242480901$24248090$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014602$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240826$$CN$US$US
242480911$24248091$1$I$$20240822$20240826$20240826$PER$$NVSC2024US171974$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
242480921$24248092$1$I$20240810$20240812$20240826$20240826$EXP$$IN-CIPLA LTD.-2024IN09015$CIPLA$$$$$$Y$$$20240826$$CN$IN$IN
242480931$24248093$1$I$20240818$20240822$20240826$20240826$EXP$$US-TAKEDA-2024TUS085170$TAKEDA$$74$YR$$F$Y$$$20240826$$CN$US$US
242480941$24248094$1$I$$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-140608-2023$RECKITT BENCKISER$$76$YR$$F$Y$138$KG$20240826$$CN$US$US
242480952$24248095$2$F$$20240918$20240826$20240924$EXP$$GB-MYLANLABS-2024M1077746$MYLAN$$$$$F$Y$$$20240924$$MD$GB$GB
242480961$24248096$1$I$$20240821$20240826$20240826$EXP$$AU-MYLANLABS-2024M1077761$MYLAN$$$$$F$Y$$$20240826$$HP$AU$AU
242480971$24248097$1$I$$20240821$20240826$20240826$EXP$$GB-MYLANLABS-2024M1077749$MYLAN$$79$YR$$M$Y$100$KG$20240826$$MD$GB$GB
242480983$24248098$3$F$20240820$20240911$20240826$20240912$PER$$US-AMGEN-USASP2024167531$AMGEN$$71$YR$E$F$Y$$$20240912$$CN$US$US
242480991$24248099$1$I$20240601$20240812$20240826$20240826$EXP$$IN-CIPLA LTD.-2024IN09017$CIPLA$$$$$$Y$$$20240826$$CN$IN$IN
242481001$24248100$1$I$$20240819$20240826$20240826$EXP$$TW-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046685$BOEHRINGER INGELHEIM$Lin C, Chen Y. Intravenous thrombolysis following dabigatran reversal in  a patient with acute embolic stroke after atrial fibrillation ablation. Journal of Arrhythmia. 2024;doi:10.1002/joa3.13121.$68$YR$E$M$Y$$$20240826$$MD$TW$TW
242481011$24248101$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041494$AUROBINDO$$54$YR$$F$Y$$$20240826$$HP$CA$CA
242481021$24248102$1$I$20240315$20240822$20240826$20240826$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-134163$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$56$KG$20240826$$HP$DE$DE
242481041$24248104$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133740$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240826$$HP$US$US
242481051$24248105$1$I$$20240816$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130263$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$72.57$KG$20240826$$CN$US$US
242481061$24248106$1$I$20240819$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133489$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240826$$CN$US$US
242481071$24248107$1$I$$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132910$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240826$$HP$US$US
242481082$24248108$2$F$$20240823$20240826$20240901$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134273$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240902$$CN$US$US
242481091$24248109$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134258$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$61.69$KG$20240826$$CN$US$US
242481102$24248110$2$F$$20240827$20240826$20240828$PER$$NVSC2024US171990$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242481112$24248111$2$F$20240801$20240827$20240826$20240831$PER$$US-ABBVIE-5892855$ABBVIE$$76$YR$$F$Y$$$20240831$$CN$US$US
242481122$24248112$2$F$20240101$20240903$20240826$20240909$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR002914$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$CA$CA
242481132$24248113$2$F$20090101$20240903$20240826$20240906$EXP$$CA-Orion Corporation ORION PHARMA-24_00031409$ORION$$39$YR$A$M$Y$$$20240906$$MD$CA$
242481161$24248116$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58164$$FDA-CTU$$$$$$N$$$20240731$N$$US$
242481171$24248117$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58169$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242481191$24248119$1$I$20240701$20240726$20240826$20240826$PER$$US-Eisai-EC-2024-171030$EISAI$$$$$M$Y$$$20240826$$CN$US$US
242481201$24248120$1$I$$20240823$20240826$20240826$EXP$NL-LRB-00996896$NVSC2024NL171001$NOVARTIS$$76$YR$$M$Y$72$KG$20240826$$MD$NL$NL
242481211$24248121$1$I$$20240820$20240826$20240826$EXP$$AU-RDY-SPO/AUS/24/0012254$DR REDDYS$$86$YR$E$F$Y$$$20240826$$CN$AU$AU
242481221$24248122$1$I$$20240820$20240826$20240826$EXP$$CA-RDY-SPO/CAN/24/0012132$DR REDDYS$$80$YR$E$M$Y$$$20240826$$PH$CA$CA
242481231$24248123$1$I$20230101$20240821$20240826$20240826$EXP$$US-UCBSA-2024042474$UCB$$$$$F$Y$$$20240826$$CN$US$US
242481261$24248126$1$I$$20240820$20240826$20240826$EXP$$CA-TAKEDA-2024TUS084350$TAKEDA$$$$$M$Y$$$20240826$$CN$CA$CA
242481271$24248127$1$I$$20240823$20240826$20240826$PER$$US-ROCHE-10000065637$ROCHE$$33$YR$A$F$Y$$$20240826$$HP$US$US
242481282$24248128$2$F$20231011$20240828$20240826$20240902$EXP$$CA-TAKEDA-2023TUS098707$TAKEDA$$56$YR$$M$Y$$$20240902$$MD$CA$CA
242481291$24248129$1$I$$20240820$20240826$20240826$EXP$$GB-002147023-PHFR2016GB004607$MYLAN$$25$YR$$F$Y$$$20240826$$PH$GB$GB
242481301$24248130$1$I$20230101$20240820$20240826$20240826$PER$$US-BIOGEN-2024BI01279180$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242481312$24248131$2$F$$20240813$20240826$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041632$AUROBINDO$$29$YR$$M$Y$68.038$KG$20240827$$CN$CA$CA
242481321$24248132$1$I$$20240814$20240826$20240826$EXP$$US-Appco Pharma LLC-2160855$APPCO PHARMA$Initial$58$YR$$M$Y$$$20240826$$$US$US
242481331$24248133$1$I$$20240816$20240826$20240826$EXP$$US-GSK-US2024102697$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$HP$US$US
242481341$24248134$1$I$20240101$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024166323$AMGEN$$68$YR$E$F$Y$$$20240826$$HP$US$US
242481351$24248135$1$I$$20240820$20240826$20240826$EXP$$FR-MYLANLABS-2024M1078236$MYLAN$Schwarz C, Morel A, Matignon M, Grimbert P, Rondeau E, Ouali N, et al. Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept. Kidney-Int-Rep 2023; 8 (8): 1531-1541.$46$YR$$$Y$$$20240826$$HP$FR$FR
242481361$24248136$1$I$$20240816$20240826$20240826$EXP$$US-AMGEN-USASP2024164731$AMGEN$Soon K.Q. A Case Report on latrogenic Methotrexate Toxicity. Cureus. 2024;16 (7):1-6$54$YR$A$F$Y$$$20240826$$HP$US$US
242481371$24248137$1$I$20240701$20240807$20240826$20240826$PER$$US-AstraZeneca-2024A180021$ASTRAZENECA$$19965$DY$$F$Y$$$20240826$$CN$US$
242481392$24248139$2$F$20240716$20240902$20240826$20240911$EXP$$FR-AUROBINDO-AUR-APL-2024-041339$AUROBINDO$$75$YR$$M$Y$66$KG$20240911$$MD$FR$FR
242481403$24248140$3$F$$20240919$20240826$20240920$EXP$DE-TEVA-VS-3231525$DE-UCBSA-2024042141$UCB$$$$A$F$Y$$$20240920$$HP$DE$DE
242481421$24248142$1$I$$20240820$20240826$20240826$PER$$US-ABBVIE-5889948$ABBVIE$$56$YR$$F$Y$$$20240826$$HP$US$US
242481431$24248143$1$I$20240801$20240819$20240826$20240826$EXP$$US-009507513-2408USA006352$MERCK$$75$YR$$F$Y$$$20240826$$PH$US$US
242481441$24248144$1$I$$20240823$20240826$20240826$PER$$NVSC2024US171979$NOVARTIS$$$$$$Y$$$20240826$$MD$US$US
242481451$24248145$1$I$20240701$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133201$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240826$$CN$US$US
242481461$24248146$1$I$$20240815$20240826$20240826$PER$$US-JNJFOC-20240842065$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242481481$24248148$1$I$20230101$20240819$20240826$20240826$EXP$$US-AMGEN-USASP2024165355$AMGEN$$89$YR$E$F$Y$$$20240826$$CN$US$US
242481491$24248149$1$I$20240501$20240814$20240826$20240826$EXP$$GB-AUROBINDO-AUR-APL-2024-041293$AUROBINDO$$76$YR$$$Y$$$20240826$$CN$GB$GB
242481501$24248150$1$I$$20240703$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008279$STRIDES$Li S, Halloran P, Siref A.. Concurrent Neutrophilic Eccrine Hidradenitis and Leukocytoclastic Vasculitis.. Am-J-Dermatopathol. 2024;46 (Suppl. 7):S20.$58$YR$$F$Y$$$20240826$$HP$US$US
242481511$24248151$1$I$$20240417$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004820$STRIDES$Eftaiha A, Paladugula A, Thakkar A, Das D.. Amlodipine-induced gingival hyperplasia: a rare but important side effect in hypertension management.. Am-J-Med-Sci. 2024;367 (Suppl. 1):S51 abstr. 87$40$YR$$F$Y$$$20240826$$HP$US$US
242481521$24248152$1$I$$20240112$20240826$20240826$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000710$STRIDES$Thi WP, Rao A.. Primary Hyperaldosteronism As A Cause Of PTH Elevation After Parathyroid Surgery.. J-Endocr-Soc. 2023;7 (Suppl.) (1):A236 abstr. THU474.$59$YR$$F$Y$$$20240826$$MD$US$US
242481532$24248153$2$F$$20240830$20240826$20240903$EXP$$CA-SANDOZ INC.-NVSC2020CA046027$SANDOZ$$76$YR$$F$Y$$$20240903$$CN$CA$CA
242481552$24248155$2$F$$20240905$20240826$20240906$PER$$US-ROCHE-10000063003$ROCHE$$$$$$Y$$$20240906$$CN$US$US
242481561$24248156$1$I$20240814$20240820$20240826$20240826$PER$$US-ROCHE-10000062455$ROCHE$$73$YR$E$F$Y$90.71$KG$20240826$$CN$US$US
242481571$24248157$1$I$$20240820$20240826$20240826$PER$$US-ROCHE-10000062376$ROCHE$$$$$F$Y$$$20240826$$MD$US$US
242481581$24248158$1$I$20231113$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-140325-2023$RECKITT BENCKISER$$78$YR$$M$Y$$$20240826$$CN$US$US
242481591$24248159$1$I$20240101$20240823$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047719$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240826$$CN$US$US
242481601$24248160$1$I$$20240812$20240826$20240826$EXP$$CA-LUPIN HEALTHCARE (UK) LIMITED-2024-08223$LUPIN$$80$YR$$M$Y$89$KG$20240826$$HP$CA$CA
242481611$24248161$1$I$20240320$20240821$20240826$20240826$EXP$ES-AEMPS-1549453$ES-ABBVIE-5894505$ABBVIE$$$$$$Y$$$20240826$$MD$ES$ES
242481621$24248162$1$I$$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133553$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240826$$HP$US$US
242481633$24248163$3$F$20240101$20240830$20240826$20240905$EXP$$US-ABBVIE-5891736$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242481641$24248164$1$I$$20240822$20240826$20240826$PER$$US-TAKEDA-2024TUS085293$TAKEDA$$$$$$Y$87.52$KG$20240826$$MD$US$US
242481653$24248165$3$F$20240101$20240902$20240826$20240909$EXP$$US-ABBVIE-5891399$ABBVIE$$74$YR$$M$Y$84.368$KG$20240909$$CN$US$US
242481661$24248166$1$I$$20240821$20240826$20240826$PER$$US-TAKEDA-2024TUS085371$TAKEDA$$$$$F$Y$$$20240826$$MD$US$US
242481671$24248167$1$I$20230420$20240820$20240826$20240826$EXP$$JP-ABBVIE-5851368$ABBVIE$$74$YR$$M$Y$$$20240826$$PH$JP$JP
242481681$24248168$1$I$$20240820$20240826$20240826$EXP$$CA-Orion Corporation ORION PHARMA-24_00031398$ORION$$7$YR$C$F$Y$29$KG$20240826$$HP$CA$
242481691$24248169$1$I$$20240820$20240826$20240826$EXP$$CA-Orion Corporation ORION PHARMA-24_00031384$ORION$$56$YR$A$F$Y$$$20240826$$HP$CA$
242481703$24248170$3$F$20240817$20240910$20240826$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013112$JAZZ$$24$YR$$M$Y$$$20240913$$CN$US$US
242481711$24248171$1$I$20240815$20240816$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014929$ELI LILLY AND CO$$$$$$Y$$$20240826$$CN$US$US
242481721$24248172$1$I$$20240814$20240826$20240826$EXP$$CA-BAYER-2024A117879$BAYER$$87$YR$E$F$Y$$$20240826$$CN$CA$CA
242481731$24248173$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014748$ELI LILLY AND CO$$36$YR$A$$Y$$$20240826$$CN$US$US
242481741$24248174$1$I$$20240812$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015576$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240826$$CN$US$US
242481752$24248175$2$F$20240101$20240823$20240826$20240830$PER$$US-AMGEN-USASP2024169417$AMGEN$$64$YR$A$M$Y$$$20240830$$HP$US$US
242481761$24248176$1$I$$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014366$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240826$$CN$US$US
242481771$24248177$1$I$20240809$20240812$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408007525$ELI LILLY AND CO$$61$YR$A$$Y$$$20240826$$CN$US$US
242481782$24248178$2$F$20240803$20240920$20240826$20240925$30DAY$$US-AMGEN-USASP2024166779$AMGEN$$73$YR$E$M$Y$80$KG$20240925$$PH$US$US
242481791$24248179$1$I$20180101$20240811$20240826$20240826$PER$$US-AMGEN-USASP2024164873$AMGEN$Fei, F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240826$$MD$US$US
242481801$24248180$1$I$20231115$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-139818-2023$RECKITT BENCKISER$$$$$F$Y$$$20240826$$CN$US$US
242481811$24248181$1$I$$20240820$20240826$20240826$PER$$US-ABBVIE-5891290$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242481821$24248182$1$I$$20240814$20240826$20240826$PER$$US-BAYER-2024A117456$BAYER$$$$$M$Y$$$20240826$$CN$US$US
242481831$24248183$1$I$20210915$20210915$20240826$20240826$EXP$$CA-CELLTRION INC.-2021CA019648$CELLTRION$$$$$$Y$$$20240826$$CN$CA$CA
242481851$24248185$1$I$$20240819$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131570$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240826$$HP$US$US
242481881$24248188$1$I$20240701$20240821$20240826$20240826$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-133936$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240826$$MD$DE$DE
242481891$24248189$1$I$20240812$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133772$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$65.77$KG$20240826$$HP$US$US
242481902$24248190$2$F$$20240821$20240826$20240828$EXP$$DE-TORRENT-00027202$TORRENT$$79$YR$E$F$Y$57$KG$20240828$$CN$DE$DE
242481911$24248191$1$I$$20240815$20240826$20240826$EXP$$AU-TORRENT-00000558$TORRENT$$$$$F$Y$$$20240826$$CN$AU$AU
242481921$24248192$1$I$$20240815$20240826$20240826$EXP$$AU-TORRENT-00000559$TORRENT$$$$$F$Y$$$20240826$$CN$AU$AU
242481931$24248193$1$I$20240512$20240819$20240826$20240826$EXP$GB-MHRA-MED-202408191143490880-GTNKD$GB-TORRENT-00037658$TORRENT$$69$YR$E$M$Y$98$KG$20240826$$PH$GB$GB
242481941$24248194$1$I$$20240819$20240826$20240826$EXP$GB-MHRA-TPP12137462C7525509YC1723808538315$GB-TORRENT-00037667$TORRENT$$70$YR$E$F$Y$64$KG$20240826$$MD$GB$GB
242481952$24248195$2$F$20240101$20240828$20240826$20240902$EXP$DE-CADRBFARM-2024329864$DE-TORRENT-00027188$TORRENT$$55$YR$A$M$Y$78$KG$20240902$$CN$DE$DE
242481961$24248196$1$I$$20240820$20240826$20240826$EXP$$IN-TORRENT-00003637$TORRENT$$$$N$M$Y$1$KG$20240826$$MD$IN$IN
242481971$24248197$1$I$20240811$20240814$20240826$20240826$EXP$$US-TORRENT-00013723$TORRENT$$43$YR$A$F$Y$$$20240826$$CN$US$US
242481981$24248198$1$I$20240101$20240820$20240826$20240826$PER$$US-BIOGEN-2024BI01279175$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242481991$24248199$1$I$$20240820$20240826$20240826$PER$$US-BIOGEN-2024BI01278557$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242482001$24248200$1$I$$20240816$20240826$20240826$EXP$$US-TORRENT-00013724$TORRENT$$45$YR$A$F$Y$$$20240826$$HP$US$US
242482011$24248201$1$I$20240310$20240819$20240826$20240826$EXP$GB-MHRA-MED-202408190134368090-SQLMH$GB-TORRENT-00037660$TORRENT$$41$YR$A$F$Y$127$KG$20240826$$CN$GB$GB
242482021$24248202$1$I$$20240814$20240826$20240826$EXP$$US-BAYER-2024A117807$BAYER$$$$$$Y$$$20240826$$CN$US$US
242482031$24248203$1$I$$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167625$AMGEN$$$$$$Y$$$20240826$$PH$US$US
242482041$24248204$1$I$20170101$20240820$20240826$20240826$EXP$$US-AMGEN-USASP2024167711$AMGEN$$69$YR$E$F$Y$$$20240826$$MD$US$US
242482061$24248206$1$I$$20240815$20240826$20240826$PER$$US-ABBVIE-5886613$ABBVIE$$45$YR$$F$Y$$$20240826$$MD$US$US
242482071$24248207$1$I$$20240726$20240826$20240826$PER$$US-Eisai-EC-2024-171048$EISAI$$74$YR$E$M$Y$$$20240826$$MD$US$US
242482081$24248208$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000063961$ROCHE$$39$YR$A$F$Y$$$20240826$$CN$US$US
242482091$24248209$1$I$$20240824$20240826$20240826$PER$$US-ROCHE-10000065644$ROCHE$$35$YR$A$F$Y$$$20240826$$MD$US$US
242482101$24248210$1$I$$20240820$20240826$20240826$PER$$US-TAKEDA-2024TUS076451$TAKEDA$$$$$$Y$$$20240826$$PH$US$US
242482111$24248211$1$I$$20240821$20240826$20240826$EXP$$NVSC2024AU171020$NOVARTIS$$40$YR$$M$Y$$$20240826$$MD$AU$AU
242482161$24248216$1$I$20240801$20240822$20240826$20240826$EXP$$JP-AstraZeneca-2024A180707$ASTRAZENECA$$66$YR$$M$Y$$$20240826$$MD$JP$
242482171$24248217$1$I$$20240822$20240826$20240826$PER$$US-ABBVIE-5894203$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242482181$24248218$1$I$20240101$20240822$20240826$20240826$EXP$$US-JNJFOC-20240862478$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240826$$CN$US$US
242482191$24248219$1$I$$20240814$20240826$20240826$PER$$US-JNJFOC-20240841913$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242482201$24248220$1$I$20240809$20240816$20240826$20240826$PER$$US-ABBVIE-5885773$ABBVIE$$$$$$Y$$$20240826$$CN$US$US
242482211$24248221$1$I$$20240815$20240826$20240826$PER$$US-Appco Pharma LLC-2160856$APPCO PHARMA$$$$$$Y$$$20240826$$$US$US
242482221$24248222$1$I$$20240813$20240826$20240826$EXP$$SA-AUROBINDO-AUR-APL-2024-041232$AUROBINDO$Mirza A, Alsufyani K, Khojah A. 75 Fatal CMV infection in a 2-month-old Infant with STAT1 Loss of Function Mutation. Clin-Immunol. 2024$2$MON$$F$Y$$$20240826$$HP$SA$SA
242482231$24248223$1$I$20220101$20240813$20240826$20240826$EXP$GB-MHRA-31453274$GB-ADVANZ PHARMA-202408006828$ADVANZ PHARMA$$$$$$Y$$$20240826$$CN$GB$GB
242482241$24248224$1$I$$20240815$20240826$20240826$PER$$US-ABBVIE-5884926$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242482251$24248225$1$I$$20240816$20240826$20240826$EXP$$US-AMGEN-USASP2024164792$AMGEN$Jen, W.Y.. FLAG-IDA + venetoclax in newly diagnosed (ND) or relapsed/refractory (RR) AML. Journal of Clinical Oncology. 2024;42 (16):6519$$$$$Y$$$20240826$$HP$US$US
242482261$24248226$1$I$$20240816$20240826$20240826$EXP$$US-MYLANLABS-2024M1077526$MYLAN$$31$YR$$M$Y$$$20240826$$CN$US$US
242482271$24248227$1$I$$20240816$20240826$20240826$EXP$$CA-MYLANLABS-2024M1078040$MYLAN$$$$$M$Y$$$20240826$$MD$CA$CA
242482281$24248228$1$I$$20240816$20240826$20240826$EXP$$JP-MYE-2024M1076958AA$MYLAN$Ogawa K, Honjo M, Sakamoto K, Funamizu N, Tamura K, Shine M, et al. Epstein-Barr Virus-Associated Latent Malignant Lymphoma With Acute Exacerbation After Living Donor Liver Transplantation: Case Report. Transplant-Proc 2023; 55 (8): 1959-1963.. 2023;55 (8):1959-1963$69$YR$$M$Y$$$20240826$$HP$JP$JP
242482301$24248230$1$I$$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133283$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240826$$HP$US$US
242482311$24248231$1$I$20240819$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133649$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$104.33$KG$20240826$$CN$US$US
242482322$24248232$2$F$$20240828$20240826$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131532$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240903$$CN$US$US
242482331$24248233$1$I$20240601$20240819$20240826$20240826$EXP$$US-GSK-US2024103330$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$US$US
242482341$24248234$1$I$$20240820$20240826$20240826$EXP$$NVSC2024US170528$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
242482352$24248235$2$F$$20240920$20240826$20240930$EXP$$US-TAKEDA-2024TUS080966$TAKEDA$$$$$M$Y$71.66$KG$20240930$$CN$US$US
242482361$24248236$1$I$$20240826$20240826$20240826$EXP$$CA-BAYER-2024A118591$BAYER$$$$$F$Y$$$20240826$$HP$CA$CA
242482372$24248237$2$F$$20240823$20240826$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093476$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242482381$24248238$1$I$20230701$20240814$20240826$20240826$EXP$$IT-UCBSA-2024041186$UCB$Atanasio G, German? A, Granata F, Tomaiuolo F, Labate A.. A case of frontal lobe seizures with ?dancing-like? semiology. European Journal of Neurology. 2024;31(9)$45$YR$$F$Y$$$20240826$$HP$IT$IT
242482391$24248239$1$I$$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-110074-2023$RECKITT BENCKISER$$86$YR$$M$Y$$$20240826$$CN$US$US
242482401$24248240$1$I$20240601$20240727$20240826$20240826$PER$$US-Eisai-EC-2024-171054$EISAI$$$$$F$Y$$$20240826$$MD$US$US
242482411$24248241$1$I$20240801$20240822$20240826$20240826$EXP$$US-AMGEN-USASP2024168729$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242482422$24248242$2$F$20240101$20240923$20240826$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134550$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240924$$CN$US$US
242482431$24248243$1$I$$20240823$20240826$20240826$EXP$$CA-ROCHE-10000065127$ROCHE$$36$YR$A$M$Y$$$20240826$$HP$CA$CA
242482441$24248244$1$I$$20240814$20240826$20240826$EXP$$GB-AUROBINDO-AUR-APL-2024-041532$AUROBINDO$$40$YR$$F$Y$$$20240826$$CN$GB$GB
242482461$24248246$1$I$$20240813$20240826$20240826$PER$$US-AstraZeneca-2024A186297$ASTRAZENECA$$$$$$Y$$$20240826$$CN$US$
242482481$24248248$1$I$20240101$20240821$20240826$20240826$EXP$$JP-AstraZeneca-2024A118370$ASTRAZENECA$$$$E$M$Y$$$20240826$$MD$JP$
242482492$24248249$2$F$20240429$20240918$20240826$20240923$EXP$$CA-TAKEDA-2024TUS084996$TAKEDA$$47$YR$$F$Y$$$20240923$$MD$CA$CA
242482501$24248250$1$I$$20240816$20240826$20240826$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR102870$VIIV$$$$$$Y$$$20240826$$HP$US$US
242482511$24248251$1$I$20240501$20240816$20240826$20240826$PER$$US-BAUSCHBL-2024BNL031899$BAUSCH AND LOMB$$61$YR$$F$Y$$$20240826$$CN$US$US
242482521$24248252$1$I$$20240815$20240826$20240826$PER$$US-AstraZeneca-2024A187213$ASTRAZENECA$$$$$F$Y$$$20240826$$CN$US$
242482531$24248253$1$I$20240707$20240821$20240826$20240826$PER$$US-AstraZeneca-2024A191361$ASTRAZENECA$$47$YR$$F$Y$$$20240826$$HP$US$
242482542$24248254$2$F$$20240911$20240826$20240918$EXP$$US-AstraZeneca-2024A186876$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
242482551$24248255$1$I$$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408013115$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240826$$HP$US$US
242482561$24248256$1$I$$20240819$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012190$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240826$$CN$US$US
242482581$24248258$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58348$$FDA-CTU$$$$$F$N$$$20240823$N$$US$
242482591$24248259$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58345$$FDA-CTU$$70$YR$$F$N$$$20240826$Y$$US$
242482601$24248260$1$I$20240731$20240731$20240826$20240826$PER$$US-CSL-2024-007204$CSL Plasma$$43$YR$$M$Y$$$20240826$$HP$US$US
242482611$24248261$1$I$20240101$20240801$20240826$20240826$EXP$$US-Vifor (International) Inc.-VIT-2024-06973$VIFOR$$$$$F$Y$$$20240826$$CN$US$US
242482621$24248262$1$I$20240801$20240817$20240826$20240826$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07509$VIFOR$$66$YR$$M$Y$$$20240826$$MD$ZA$ZA
242482631$24248263$1$I$$20240813$20240826$20240826$PER$$US-JNJFOC-20240833295$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$MD$US$US
242482641$24248264$1$I$20240805$20240815$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129631$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$83.91$KG$20240826$$CN$US$US
242482651$24248265$1$I$$20240821$20240826$20240826$EXP$$NVSC2024US170320$NOVARTIS$$$$$M$Y$$$20240826$$MD$US$US
242482662$24248266$2$F$20190301$20240904$20240826$20240909$EXP$$DE-JNJFOC-20240859518$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240909$$MD$DE$DE
242482671$24248267$1$I$20240810$20240814$20240826$20240826$EXP$$GB-AUROBINDO-AUR-APL-2024-041540$AUROBINDO$$$$$M$Y$95$KG$20240826$$CN$GB$GB
242482682$24248268$2$F$$20240828$20240826$20240830$PER$$US-AMGEN-USASP2024168802$AMGEN$$$$$M$Y$$$20240830$$HP$US$US
242482692$24248269$2$F$20240717$20240829$20240826$20240902$EXP$FR-AFSSAPS-PV2024000712$FR-ROCHE-10000055093$ROCHE$$52$YR$A$F$Y$51$KG$20240902$$MD$FR$FR
242482704$24248270$4$F$20240201$20240916$20240826$20240919$EXP$$US-ROCHE-10000056680$ROCHE$$64$YR$A$F$Y$78.5$KG$20240919$$MD$US$US
242482711$24248271$1$I$$20240816$20240826$20240826$EXP$$NZ-FreseniusKabi-FK202412835$FRESENIUS KABI$Banerji A, Sleigh JW, Termaat J, Voss LJ. Emergence Electroencephalography in an  Unresponsiveness Geriatric Patient in the  Postanesthesia Care Unit: A Case Report. A and A Practice. 2024 Jun 09;18(7): e01813. doi:10.1213/XAA.0000000000001813.$78$YR$E$F$Y$$$20240826$$MD$NZ$NZ
242482721$24248272$1$I$$20240814$20240826$20240826$EXP$$PT-MSNLABS-2024MSNLIT01827$MSN LABORATORIES$Jose SF, Jorge L, Arsenio S, Lelita S.INTERACTION BETWEEN STATIN AND SGLT-2 INHIBITOR: A CASE REPORT.22nd European Congress of Internal Medicine (ECIM) - European Federation of Internal Medicine (EFIM)$$$$$Y$$$20240826$$HP$PT$PT
242482731$24248273$1$I$20200520$20240619$20240826$20240826$EXP$$CA-CELLTRION INC.-2020CA035370$CELLTRION$$$$$$Y$$$20240826$$CN$CA$CA
242482741$24248274$1$I$$20240815$20240826$20240826$PER$$US-BAUSCHBL-2024BNL031929$BAUSCH AND LOMB$$$$$M$Y$$$20240826$$CN$US$US
242482751$24248275$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134345$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$87.09$KG$20240826$$HP$US$US
242482761$24248276$1$I$$20240816$20240826$20240826$EXP$$US-AMGEN-USASP2024164809$AMGEN$Jen W.Y. FLAG-IDA + venetoclax in newly diagnosed (ND) or relapsed/refractory (RR) AML. Journal of Clinical Oncology. 2024;42 (16):6519$$$$$Y$$$20240826$$HP$US$US
242482771$24248277$1$I$$20240816$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131254$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$81.65$KG$20240826$$HP$US$US
242482782$24248278$2$F$20220801$20240830$20240826$20240909$EXP$$CA-Orion Corporation ORION PHARMA-24_00030986$ORION$$33$YR$A$$Y$153.5$KG$20240909$$MD$CA$
242482791$24248279$1$I$$20240816$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130984$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$58.06$KG$20240826$$HP$US$US
242482801$24248280$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131731$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240826$$CN$US$US
242482811$24248281$1$I$$20240816$20240826$20240826$EXP$$US-VIIV HEALTHCARE LIMITED-US2024102682$VIIV$$$$$F$Y$$$20240826$$HP$US$US
242482821$24248282$1$I$20240724$20240816$20240826$20240826$EXP$ES-AEMPS-1559081$ES-TEVA-VS-3234216$TEVA$$4$YR$$F$Y$$$20240826$$PH$ES$ES
242482831$24248283$1$I$$20240821$20240826$20240826$EXP$$NVSC2024GB169587$NOVARTIS$$$$$M$Y$$$20240826$$CN$GB$GB
242482841$24248284$1$I$20211126$20220506$20240826$20240826$EXP$$CA-CELLTRION INC.-2021CA019637$CELLTRION$$$$$$Y$$$20240826$$MD$CA$CA
242482851$24248285$1$I$20240308$20240816$20240826$20240826$30DAY$$US-GSK-US2024102440$GLAXOSMITHKLINE$$69$YR$$M$Y$72$KG$20240826$$CN$US$US
242482863$24248286$3$F$20240819$20240905$20240826$20240914$EXP$$DE-ROCHE-10000063756$ROCHE$$55$YR$A$F$Y$48$KG$20240914$$MD$DE$DE
242482871$24248287$1$I$$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-089398-2024$RECKITT BENCKISER$$71$YR$$F$Y$63.49$KG$20240826$$CN$US$US
242482882$24248288$2$F$$20240813$20240826$20240904$EXP$$US-BEH-2024177340$CSL BEHRING$$$$$$Y$$$20240904$$HP$AT$US
242482901$24248290$1$I$20240808$20240816$20240826$20240826$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-07914$HIKMA$$48$YR$$F$Y$63$KG$20240826$$PH$IT$IT
242482912$24248291$2$F$$20240819$20240826$20240830$EXP$$NVSC2024DE157541$NOVARTIS$$$$A$F$Y$$$20240830$$PH$DE$DE
242482921$24248292$1$I$$20240822$20240826$20240826$EXP$$NVSC2024AU171340$NOVARTIS$$35$YR$$M$Y$$$20240826$$MD$AU$AU
242482941$24248294$1$I$$20240814$20240826$20240826$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-128712$BRISTOL MYERS SQUIBB$Pereira P, Ling T, Loureiro A, Pereira A, Guerreiro R, Faisca Silva MJ. Juvenile myelomonocytic leukemia with chromosome 7 monosomy - clinical case report. Laboratory Medicine Magazine. 2024;5:132-6.$13$MON$I$F$Y$$$20240826$$HP$PT$PT
242482952$24248295$2$F$$20240829$20240826$20240904$EXP$$GB-ROCHE-10000063744$ROCHE$$46$YR$A$F$Y$$$20240904$$HP$GB$GB
242482961$24248296$1$I$20240702$20240731$20240826$20240826$PER$$US-CELLTRION INC.-2024US016579$CELLTRION$$$$$$Y$$$20240826$$CN$US$US
242482971$24248297$1$I$$20240819$20240826$20240826$EXP$$DK-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00237$VELOXIS PHARMACEUTICALS$Loft J, Riis P, Schultz N, Bjerrum S, Schonning K, Pedersen C.. Maribavir for the treatment of cytomegalovirus infection in a liver transplant patient. Ugeskr Laeger. 2024;186:1457-1548$49$YR$$M$Y$$$20240826$$HP$DK$DK
242482991$24248299$1$I$$20240820$20240826$20240826$EXP$$US-AstraZeneca-2024A190333$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242483001$24248300$1$I$$20240823$20240826$20240826$PER$$US-HALEON-2193497$Haleon PLC$$$$$$Y$$$20240826$$CN$US$US
242483011$24248301$1$I$$20240819$20240826$20240826$EXP$$GB-TAKEDA-2024TUS084723$TAKEDA$$$$$F$Y$$$20240826$$CN$GB$GB
242483021$24248302$1$I$$20240820$20240826$20240826$PER$$US-AstraZeneca-2024A191398$ASTRAZENECA$$$$$$Y$$$20240826$$CN$US$
242483041$24248304$1$I$$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024168308$AMGEN$$$$$$Y$$$20240826$$PH$US$US
242483051$24248305$1$I$$20240814$20240826$20240826$EXP$$GB-MSNLABS-2024MSNLIT01830$MSN LABORATORIES$Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP.A case of human T-lymphotropic virus-1-associated lichenoid dermatitis.Clinical and Experimental Dermatology.2024;49(8):916-18$$$$$Y$$$20240826$$MD$GB$GB
242483061$24248306$1$I$20240821$20240821$20240826$20240826$PER$$US-ABBVIE-5893537$ABBVIE$$19$YR$$$Y$$$20240826$$HP$US$US
242483071$24248307$1$I$$20240820$20240826$20240826$PER$$US-BIOGEN-2024BI01270738$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242483081$24248308$1$I$20240729$20240819$20240826$20240826$EXP$$KR-TAKEDA-2024TUS084599$TAKEDA$$65$YR$$M$Y$65$KG$20240826$$MD$KR$KR
242483091$24248309$1$I$20240612$20240724$20240826$20240826$PER$$US-CELLTRION INC.-2024US017106$CELLTRION$$$$$$Y$$$20240826$$CN$US$US
242483101$24248310$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014422$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240826$$CN$US$US
242483111$24248311$1$I$$20240815$20240826$20240826$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101849$VIIV$$$$$M$Y$$$20240826$$PH$US$US
242483121$24248312$1$I$$20240821$20240826$20240826$EXP$$ES-AMGEN-ESPSP2024167714$AMGEN$Garrido G.F.; Barriga L.C.; Ciller B.D. et al.. A REPORT OF DIFFERENT PURPOSES: BLINATUMOMAB WITH PREVIOUS DEBULKING CHEMOTHERAPY TO REACH OR MAINTAIN RESPONSE. HemaSphere. 2018;2 (2):756$21$YR$A$M$Y$$$20240826$$HP$ES$ES
242483131$24248313$1$I$20240812$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024168505$AMGEN$$70$YR$E$M$Y$$$20240826$$CN$US$US
242483141$24248314$1$I$20240820$20240821$20240826$20240826$EXP$$US-TAKEDA-2024TUS028028$TAKEDA$$73$YR$$M$Y$$$20240826$$CN$US$US
242483151$24248315$1$I$$20240824$20240826$20240826$PER$$US-ROCHE-10000065633$ROCHE$$68$YR$E$M$Y$$$20240826$$HP$US$US
242483161$24248316$1$I$20160715$20240820$20240826$20240826$EXP$$CA-TAKEDA-2016TUS012717$TAKEDA$$49$YR$$M$Y$$$20240826$$CN$CA$CA
242483182$24248318$2$F$20231201$20240919$20240826$20240924$EXP$$JP-SA-2024SA245379$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$JP$JP
242483192$24248319$2$F$20240101$20240821$20240826$20240829$EXP$$CA-CELLTRION INC.-2024CA015359$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
242483201$24248320$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134548$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$56.7$KG$20240826$$HP$US$US
242483211$24248321$1$I$20231117$20240826$20240826$20240826$PER$$US-PROD-AS2-212756134-RB-080489-2024$RECKITT BENCKISER$$68$YR$$M$Y$$$20240826$$CN$US$US
242483221$24248322$1$I$20211102$20240816$20240826$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-130529$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$63$KG$20240826$$PH$JP$JP
242483231$24248323$1$I$$20240813$20240826$20240826$EXP$$US-CIPLA LTD.-2024US09085$CIPLA$$$$$$Y$$$20240826$$CN$US$US
242483241$24248324$1$I$20240707$20240729$20240826$20240826$PER$$US-CELLTRION INC.-2024US017197$CELLTRION$$$$$$Y$$$20240826$$CN$US$US
242483252$24248325$2$F$20240201$20240912$20240826$20240920$EXP$$CA-CELLTRION INC.-2024CA004307$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
242483281$24248328$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58143$$FDA-CTU$$40$YR$$M$N$$$20240731$N$PH$US$
242483301$24248330$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58147$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242483331$24248333$1$I$$20240820$20240826$20240826$EXP$$GB-MYLANLABS-2024M1077847$MYLAN$$$$$M$Y$$$20240826$$MD$GB$GB
242483342$24248334$2$F$20240916$20240916$20240826$20240919$EXP$$IE-MYLANLABS-2024M1077472$MYLAN$$$$$F$Y$$$20240919$$HP$IE$IE
242483351$24248335$1$I$20240123$20240820$20240826$20240826$EXP$$CN-MYLANLABS-2024M1077706$MYLAN$$75$YR$$M$Y$68$KG$20240826$$HP$CN$CN
242483361$24248336$1$I$$20240820$20240826$20240826$EXP$$GB-MYLANLABS-2024M1077764$MYLAN$$$$$F$Y$$$20240826$$MD$GB$GB
242483371$24248337$1$I$20230519$20240820$20240826$20240826$EXP$$GB-MYLANLABS-2024M1077397$MYLAN$$74$YR$$F$Y$$$20240826$$CN$GB$GB
242483381$24248338$1$I$$20240819$20240826$20240826$EXP$$US-APOTEX-2024AP009599$APOTEX$Gennaro VL, Maclin J, Weiser P, Stoll ML, Smitherman EA. Juvenile Idiopathic Arthritis With Associated Inflammatory Bowel Disease and CARD8 Mutation. PEDIATRICS. 2023;152 (4):e2022058964 (1-4)$7$YR$$F$Y$$$20240826$$HP$US$US
242483401$24248340$1$I$$20240820$20240826$20240826$EXP$$US-OTSUKA-2024_023001$OTSUKA$$$$$M$Y$$$20240826$$HP$US$US
242483411$24248341$1$I$$20240812$20240826$20240826$EXP$$US-AUROBINDO-AUR-APL-2024-040677$AUROBINDO$Nelson N, Masih D, Sabri A, Monika F, Mirza M.. Isolated Myeloid Sarcoma Masquerading as Scattered Abscesses in a Septic Patient: A Case Report and Literature Review. Case-Rep-Oncol. 2024;17(1):39-48$76$YR$$F$Y$$$20240826$$HP$US$US
242483422$24248342$2$F$20240801$20240826$20240826$20240830$PER$$US-ABBVIE-5894072$ABBVIE$$74$YR$$F$Y$$$20240829$$CN$US$US
242483434$24248343$4$F$20240701$20240917$20240826$20240918$EXP$$JP-SA-2024SA247497$SANOFI AVENTIS$$75$YR$E$$Y$$$20240918$$MD$JP$JP
242483441$24248344$1$I$20240717$20240730$20240826$20240826$PER$$US-Eisai-EC-2024-171244$EISAI$$55$YR$A$M$Y$$$20240826$$HP$US$US
242483451$24248345$1$I$20240720$20240816$20240826$20240826$EXP$FR-AFSSAPS-TO2024001537$FR-TEVA-VS-3234157$TEVA$$77$YR$$M$Y$125$KG$20240826$$MD$FR$FR
242483481$24248348$1$I$$20240819$20240826$20240826$EXP$$JP-009507513-2408JPN002429J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$94$YR$$M$Y$$$20240826$$MD$JP$JP
242483491$24248349$1$I$20240717$20240819$20240826$20240826$EXP$FR-AFSSAPS-GR2024001019$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07927$HIKMA$$$$$$Y$$$20240826$$PH$FR$FR
242483502$24248350$2$F$20240801$20240923$20240826$20240925$EXP$$CA-TAKEDA-2024TUS052626$TAKEDA$$25$YR$$F$Y$$$20240925$$CN$CA$CA
242483521$24248352$1$I$$20240821$20240826$20240826$EXP$$CA-Orion Corporation ORION PHARMA-24_00031413$ORION$$77$YR$E$F$Y$73$KG$20240826$$HP$CA$
242483533$24248353$3$F$$20240916$20240826$20240930$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08269$LUPIN$$$$$$Y$$$20240930$$CN$US$US
242483541$24248354$1$I$$20240808$20240826$20240826$30DAY$$US-VEROBIOTECH-2024USVEROSPO00190$VERO BIOTECH$$23$WK$$$Y$$$20240826$$HP$US$US
242483551$24248355$1$I$$20240711$20240826$20240826$EXP$$US-GILEAD-2024-0680720$GILEAD$$69$YR$E$F$Y$$$20240826$$CN$US$US
242483571$24248357$1$I$20240805$20240822$20240826$20240826$EXP$$IN-ROCHE-3169447$ROCHE$$52$YR$A$F$Y$$$20240826$$CN$IN$IN
242483581$24248358$1$I$$20240816$20240826$20240826$30DAY$$US-GSK-US2024102686$GLAXOSMITHKLINE$$$$$M$Y$$$20240826$$CN$US$US
242483591$24248359$1$I$$20240815$20240826$20240826$EXP$$GB-MSNLABS-2024MSNSPO01836$MSN LABORATORIES$$$$$$Y$$$20240826$$MD$GB$GB
242483602$24248360$2$F$$20240917$20240826$20240921$EXP$$BA-ROCHE-10000065049$ROCHE$$$$$F$Y$$$20240921$$MD$BA$BA
242483611$24248361$1$I$$20240820$20240826$20240826$PER$$US-ABBVIE-5893004$ABBVIE$$$$$$Y$$$20240826$$CN$US$US
242483621$24248362$1$I$$20240821$20240826$20240826$EXP$$US-ROCHE-10000064284$ROCHE$$46$YR$A$F$Y$81.19$KG$20240826$$CN$US$US
242483631$24248363$1$I$$20240822$20240826$20240826$EXP$$PK-TAKEDA-2024TUS085398$TAKEDA$$$$$$Y$$$20240826$$CN$PK$PK
242483641$24248364$1$I$$20230120$20240826$20240826$EXP$$GB-AstraZeneca-2023A017446$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$GB$
242483652$24248365$2$F$20240101$20240820$20240826$20240827$EXP$$US-009507513-2408USA007283$MERCK$$$$$F$Y$$$20240827$$CN$US$US
242483661$24248366$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134547$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240826$$CN$US$US
242483681$24248368$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132670$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240826$$CN$US$US
242483691$24248369$1$I$20240619$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134159$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240826$$CN$US$US
242483701$24248370$1$I$$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131932$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$76.66$KG$20240826$$CN$US$US
242483711$24248371$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000065086$ROCHE$$$$A$F$Y$$$20240826$$CN$US$US
242483721$24248372$1$I$20240708$20240801$20240826$20240826$PER$$US-CELLTRION INC.-2024US017261$CELLTRION$$$$$$Y$$$20240826$$CN$US$US
242483731$24248373$1$I$20240202$20240308$20240826$20240826$PER$$US-Emmaus Medical, Inc.-EMM202403-000131$EMMAUS LIFE SCIENCES$$39$YR$A$F$Y$$$20240826$$CN$US$
242483741$24248374$1$I$$20240819$20240826$20240826$EXP$$JP-009507513-2408JPN002431J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$92$YR$$F$Y$$$20240826$$MD$JP$JP
242483751$24248375$1$I$$20240820$20240826$20240826$EXP$$JP-JNJFOC-20240865010$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240826$$MD$JP$JP
242483762$24248376$2$F$$20240924$20240826$20240927$30DAY$$AU-JNJFOC-20240857260$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$AU$AU
242483771$24248377$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-042334$AUROBINDO$$60$YR$$F$Y$$$20240826$$HP$CA$CA
242483781$24248378$1$I$20240718$20240729$20240826$20240826$PER$$US-JNJFOC-20240783550$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240826$$CN$US$US
242483791$24248379$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58149$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242483811$24248381$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58151$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242483821$24248382$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58152$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242483871$24248387$1$I$20240808$20240814$20240826$20240826$EXP$$US-MACLEODS PHARMA-MAC2024048881$MACLEODS$$$$$$Y$$$20240826$$CN$US$US
242483881$24248388$1$I$$20240814$20240826$20240826$EXP$$ZA-MACLEODS PHARMA-MAC2024048885$MACLEODS$$$$$$Y$$$20240826$$CN$ZA$ZA
242483891$24248389$1$I$$20240814$20240826$20240826$EXP$$ES-MACLEODS PHARMA-MAC2024048927$MACLEODS$Mezquita P, Luna V, Munoz-Torres M, Torres-Vela E, Lopez-Rodriguez F, Callejas JL, Escobar-Jimenez F..Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor.Thyroid.SEP-1998;8(9):791-4$$$$$Y$$$20240826$$HP$ES$ES
242483901$24248390$1$I$20240814$20240814$20240826$20240826$EXP$GB-MHRA-MED-202408141134239960-TSMVK$GB-MACLEODS PHARMA-MAC2024048919$MACLEODS$$$$$$Y$$$20240826$$CN$GB$GB
242483911$24248391$1$I$20240101$20240814$20240826$20240826$EXP$$GB-MACLEODS PHARMA-MAC2024048921$MACLEODS$$$$$$Y$$$20240826$$MD$GB$GB
242483921$24248392$1$I$$20240814$20240826$20240826$EXP$$AR-MACLEODS PHARMA-MAC2024048928$MACLEODS$Breier DV, Rendo P, Gonzalez J, Shilton G, Stivel M, Goldztein S..Massive plasmocytosis due to methimazole-induced bone marrow toxicity..American journal of hematology.AUG-2001;67(4):259-61$$$$$Y$$$20240826$$HP$AR$AR
242483931$24248393$1$I$$20240814$20240826$20240826$EXP$$US-MACLEODS PHARMA-MAC2024048925$MACLEODS$Biswas N, Ahn YH, Goldman JM, Schwartz JM..Aplastic anemia associated with antithyroid drugs..The American journal of the medical sciences.MAR-1991;301(3):190-4$34$YR$A$F$Y$$$20240826$$MD$US$US
242483941$24248394$1$I$$20240730$20240826$20240826$PER$$US-Eisai-EC-2024-171170$EISAI$$$$$M$Y$$$20240826$$MD$US$US
242483951$24248395$1$I$$20240814$20240826$20240826$EXP$$JP-MACLEODS PHARMA-MAC2024048936$MACLEODS$Yamaguchi T, Aihara A, Mashiko S, Kurosawa E, Oizumi T, Yamagata T, et al..Exacerbation of delirium and epileptic seizures in an older man with idiopathic Parkinson^s disease due to multiple prescriptions: a case report..Frontiers in Medicine.2024;11:1415988$$$$$Y$$$20240826$$MD$JP$JP
242483961$24248396$1$I$19951001$20240814$20240826$20240826$EXP$$ES-MACLEODS PHARMA-MAC2024048926$MACLEODS$Escobar-Morreale HF, Bravo P, Garcia-Robles R, Garcia-Larana J, Calle HD, Sancho JM.Methimazole-induced severe aplastic anemia: Unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor..Thyroid.1997;7(1):67-70$$$$$Y$$$20240826$$MD$ES$ES
242483971$24248397$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58156$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242483981$24248398$1$I$20240101$20240814$20240826$20240826$EXP$$GB-MACLEODS PHARMA-MAC2024048922$MACLEODS$$$$$$Y$$$20240826$$MD$GB$GB
242483991$24248399$1$I$$20240824$20240826$20240826$EXP$$IR-ROCHE-10000065404$ROCHE$$$$$$Y$$$20240826$$MD$IR$IR
242484001$24248400$1$I$$20240814$20240826$20240826$EXP$$JP-MACLEODS PHARMA-MAC2024048929$MACLEODS$Yamamoto A, Katayama Y, Tomiyama K, Hosoai H, Hirata F, Kimura F, et al.Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis..Thyroid.2004;14(3):231-5$$$$$Y$$$20240826$$HP$JP$JP
242484022$24248402$2$F$$20240820$20240826$20240904$EXP$$JP-BAUSCH-BL-2024-012786$BAUSCH AND LOMB$Kagurasho M. A case of Sezary syndrome with a CD4-/CD8- phenotype on bone marrow FCM. Journal of the Japanese Society for Laboratory Hematology. 2024;25:S196.$$$E$M$Y$$$20240904$$HP$JP$JP
242484031$24248403$1$I$20240801$20240819$20240826$20240826$EXP$$GB-MYLANLABS-2024M1077461$MYLAN$$$$$F$Y$$$20240826$$PH$GB$GB
242484041$24248404$1$I$$20240819$20240826$20240826$EXP$$US-MYLANLABS-2024M1078219$MYLAN$Torrie AM, Dunitz J, Brookman JC. Apparent Reversal of a Successful Peripheral Neural Blockade With Intravenous Lipid Emulsion After Treatment for Local Anesthetic Systemic Toxicity: A Case Report. A-A-Pract 2020; 14 (13).$42$YR$$F$Y$56.7$KG$20240826$$MD$US$US
242484051$24248405$1$I$$20240819$20240826$20240826$EXP$$TN-MYLANLABS-2024M1077879$MYLAN$Razki K, Ouali U, Najar C, Ben Aissa S, Gargouri Berrechid A, Jomli R, et al. ^From levetiracetam to lithium^: A journey of hope to manage suicidality and depression. J-Neurol-Sci 2023; 455 (Suppl.).$20$YR$$M$Y$$$20240826$$HP$TN$TN
242484061$24248406$1$I$$20240819$20240826$20240826$EXP$$US-MYLANLABS-2024M1078140$MYLAN$Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front-Psychiatry 2024; 14.$$$A$M$Y$$$20240826$$HP$US$US
242484071$24248407$1$I$$20240819$20240826$20240826$EXP$$US-MYLANLABS-2024M1077531$MYLAN$Maresch KJ. Arytenoid Dislocation and Vocal Cord Immobility After Emergent Fiberoptic Intubation: A Case Report. AANA-J 2020; 88 (6): 459-463.$53$YR$$M$Y$$$20240826$$HP$US$US
242484081$24248408$1$I$$20240819$20240826$20240826$EXP$$FR-MYLANLABS-2024M1077870$MYLAN$Saillant A, Rasclard M, Gaume J-B, Souchaud O, Bainaud M. A Case of Anti-3-hydroxy-3-methylglutaryl-coenzyme A Reductase Myopathy Associated With Advanced Cervical Carcinoma. Anticancer-Res 2023; 43 4723-4727.$70$YR$$F$Y$$$20240826$$HP$FR$FR
242484091$24248409$1$I$$20240819$20240826$20240826$EXP$$US-MYLANLABS-2024M1078135$MYLAN$Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front-Psychiatry 2024; 14.$$$A$M$Y$$$20240826$$HP$US$US
242484102$24248410$2$F$$20240912$20240826$20240918$EXP$$GR-MYLANLABS-2024M1077792$MYLAN$$55$YR$$F$Y$$$20240918$$CN$GR$GR
242484111$24248411$1$I$$20240819$20240826$20240826$EXP$$US-MYLANLABS-2024M1078136$MYLAN$Kim EB, Malespini J, Lei M, Branagan AR, Cirstea D, Han SS, et al. Rapid reduction of free light chains and improvement in renal outcomes in patients with newly diagnosed multiple myeloma admitted with acute kidney injury with daratumumab-based therapy and without plasmapheresis. J-Clin-Oncol 2024; 42 (Suppl.) (16):.$87$YR$$$Y$$$20240826$$HP$US$US
242484121$24248412$1$I$$20240819$20240826$20240826$EXP$$US-MYLANLABS-2024M1077541$MYLAN$Aiello M, Roy S, Chitty L, Johnson B, Warrick M. Prolonged administration of intrathecal baclofen in a patient with generalized grade 4 tetanus. Region-Anesth-Pain-Med 2024; 49 (7): 540-542.$62$YR$$F$Y$$$20240826$$HP$US$US
242484131$24248413$1$I$20240816$20240816$20240826$20240826$EXP$$US-KARYOPHARM-2024KPT001449$KARYOPHARM THERAPEUTICS$$45$YR$$M$Y$108.9$KG$20240826$$MD$US$US
242484141$24248414$1$I$$20240820$20240826$20240826$EXP$$CA-TAKEDA-2024TUS084369$TAKEDA$$$$$M$Y$$$20240826$$CN$CA$CA
242484151$24248415$1$I$$20240821$20240826$20240826$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-115551$REGENERON$$$$$M$Y$$$20240826$$HP$CA$CA
242484161$24248416$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131710$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$68.95$KG$20240826$$CN$US$US
242484171$24248417$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131730$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240826$$CN$US$US
242484181$24248418$1$I$$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133532$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240826$$CN$US$US
242484191$24248419$1$I$$20240823$20240826$20240826$EXP$$NVSC2024AU171693$NOVARTIS$$$$$$Y$$$20240826$$MD$AU$AU
242484201$24248420$1$I$$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167463$AMGEN$$$$$$Y$$$20240826$$HP$US$US
242484211$24248421$1$I$$20240820$20240826$20240826$PER$$US-ABBVIE-5891373$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242484221$24248422$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134589$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$90.72$KG$20240826$$CN$US$US
242484231$24248423$1$I$$20240822$20240826$20240826$PER$$US-ABBVIE-5894451$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242484241$24248424$1$I$$20240819$20240826$20240826$EXP$$JP-009507513-2408JPN002460J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$98$YR$$M$Y$$$20240826$$MD$JP$JP
242484251$24248425$1$I$$20240716$20240826$20240826$PER$$US-CELLTRION INC.-2024US017768$CELLTRION$$$$$$Y$$$20240826$$HP$US$US
242484261$24248426$1$I$20240813$20240815$20240826$20240826$EXP$$US-BAYER-2024A118347$BAYER$$20$YR$A$M$Y$$$20240826$$HP$US$US
242484271$24248427$1$I$$20240816$20240826$20240826$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006338$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240826$$HP$US$US
242484291$24248429$1$I$20230804$20240816$20240826$20240826$EXP$FR-AFSSAPS-DJ2024000899$FR-TEVA-VS-3234184$TEVA$$41$YR$$F$Y$$$20240826$$MD$FR$FR
242484301$24248430$1$I$20240812$20240812$20240826$20240826$PER$$US-JNJFOC-20240835463$JOHNSON AND JOHNSON$$65$YR$E$F$Y$88.2$KG$20240826$$CN$US$US
242484311$24248431$1$I$$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015368$ELI LILLY AND CO$$$$$$Y$$$20240826$$CN$US$US
242484321$24248432$1$I$20240817$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014676$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240826$$CN$US$US
242484332$24248433$2$F$20240605$20240826$20240826$20240906$EXP$$CN-ROCHE-10000013246$ROCHE$$40$YR$A$M$Y$$$20240906$$MD$CN$CN
242484341$24248434$1$I$$20240815$20240826$20240826$EXP$$CA-ROCHE-10000059551$ROCHE$Rebic N, De Vera M, Gupta A, Amiri N. Perinatal Use and Discontinuation of Disease-Modifying Antirheumatic Drugs: Outcomes of Patients Seen at a Pregnancy and Rheumatic Diseases Clinic. Journal of Clinical Rheumatology. 2024-Aug-01;30 (5):188-92. doi:10.1097/RHU.0000000000002090.$$$$$Y$$$20240826$$HP$CA$CA
242484361$24248436$1$I$$20240820$20240826$20240826$PER$CA-LEO Pharma-372867$CA-LEO Pharma-372867$LEO PHARM$$36$YR$$F$Y$$$20240826$$CN$CA$CA
242484371$24248437$1$I$$20240821$20240826$20240826$EXP$$US-AMGEN-USASP2024167875$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242484381$24248438$1$I$$20240816$20240826$20240826$EXP$$US-GSK-US2024102641$GLAXOSMITHKLINE$$7$DEC$$F$Y$$$20240826$$HP$US$US
242484391$24248439$1$I$$20240819$20240826$20240826$EXP$$NVSC2024FR169535$NOVARTIS$$60$YR$$F$Y$$$20240826$$MD$FR$FR
242484401$24248440$1$I$20240723$20240813$20240826$20240826$EXP$$FR-AUROBINDO-AUR-APL-2024-040886$AUROBINDO$$67$YR$$M$Y$112$KG$20240826$$MD$FR$FR
242484411$24248441$1$I$20240730$20240730$20240826$20240826$PER$$CA-TOLMAR, INC.-24CA051513$TOLMAR$$82$YR$$M$Y$$$20240826$$CN$CA$CA
242484421$24248442$1$I$$20240802$20240826$20240826$PER$$CA-TOLMAR, INC.-24CA051669$TOLMAR$$$$$M$Y$$$20240826$$CN$CA$CA
242484431$24248443$1$I$20240726$20240801$20240826$20240826$PER$$CO-TOLMAR, INC.-24CO051591$TOLMAR$$81$YR$$M$Y$$$20240826$$CN$CO$CO
242484441$24248444$1$I$$20240730$20240826$20240826$PER$$DO-TOLMAR, INC.-24DO051508$TOLMAR$$$$$M$Y$81.633$KG$20240826$$CN$DO$DO
242484451$24248445$1$I$$20240802$20240826$20240826$PER$$DE-TOLMAR, INC.-24DE051686$TOLMAR$$$$$$Y$$$20240826$$MD$DE$DE
242484461$24248446$1$I$20240701$20240802$20240826$20240826$PER$$CO-TOLMAR, INC.-24CO051668$TOLMAR$$71$YR$$M$Y$$$20240826$$CN$CO$CO
242484471$24248447$1$I$20240716$20240730$20240826$20240826$PER$$FR-TOLMAR, INC.-24FR051065$TOLMAR$$67$YR$$M$Y$$$20240826$$PH$FR$FR
242484483$24248448$3$F$$20240829$20240826$20240918$PER$$ES-TOLMAR, INC.-24ES051374$TOLMAR$$$$$$Y$$$20240918$$MD$ES$ES
242484491$24248449$1$I$20240718$20240731$20240826$20240826$PER$$FR-TOLMAR, INC.-24FR051003$TOLMAR$$$$E$M$Y$82$KG$20240826$$MD$FR$FR
242484501$24248450$1$I$20240731$20240731$20240826$20240826$PER$$FR-TOLMAR, INC.-24FR051503$TOLMAR$$82$YR$$M$Y$$$20240826$$PH$FR$FR
242484511$24248451$1$I$20240731$20240731$20240826$20240826$PER$$FR-TOLMAR, INC.-24FR051568$TOLMAR$$89$YR$$M$Y$$$20240826$$PH$FR$FR
242484521$24248452$1$I$20240701$20240731$20240826$20240826$PER$$FR-TOLMAR, INC.-24FR051169$TOLMAR$$$$$M$Y$$$20240826$$MD$FR$FR
242484531$24248453$1$I$$20240718$20240826$20240826$PER$$US-CELLTRION INC.-2024US017807$CELLTRION$$$$$$Y$$$20240826$$CN$US$US
242484542$24248454$2$F$20240801$20240830$20240826$20240923$PER$$FR-TOLMAR, INC.-24FR051594$TOLMAR$$76$YR$$M$Y$$$20240923$$PH$FR$FR
242484551$24248455$1$I$20240801$20240801$20240826$20240826$PER$$FR-TOLMAR, INC.-24FR051593$TOLMAR$$78$YR$$M$Y$$$20240826$$PH$FR$FR
242484561$24248456$1$I$20240801$20240801$20240826$20240826$PER$$FR-TOLMAR, INC.-24FR051598$TOLMAR$$79$YR$$M$Y$$$20240826$$PH$FR$FR
242484571$24248457$1$I$$20240802$20240826$20240826$PER$$FR-TOLMAR, INC.-24FR051661$TOLMAR$$$$A$M$Y$$$20240826$$PH$FR$FR
242484581$24248458$1$I$20240618$20240730$20240826$20240826$PER$$HN-TOLMAR, INC.-24HN051417$TOLMAR$$83$YR$$M$Y$$$20240826$$CN$HN$HN
242484591$24248459$1$I$$20240820$20240826$20240826$EXP$$FR-MYLANLABS-2024M1078240$MYLAN$Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon-Pennamen M-D, Rivet J, et al. Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib. J-Eur-Acad-Dermatol-Venereol 2023; 38 (1): e32-e34.$49$YR$$F$Y$$$20240826$$HP$FR$FR
242484601$24248460$1$I$20240513$20240730$20240826$20240826$PER$$NI-TOLMAR, INC.-24NI051510$TOLMAR$$9$YR$$F$Y$$$20240826$$CN$NI$NI
242484611$24248461$1$I$20240711$20240730$20240826$20240826$PER$$NI-TOLMAR, INC.-24NI051512$TOLMAR$$8$YR$$F$Y$$$20240826$$CN$NI$NI
242484621$24248462$1$I$20240701$20240730$20240826$20240826$PER$$NL-TOLMAR, INC.-24NL051460$TOLMAR$$$$E$M$Y$$$20240826$$HP$NL$NL
242484631$24248463$1$I$20240701$20240730$20240826$20240826$PER$$US-TOLMAR, INC.-24US050706$TOLMAR$$10$YR$$F$Y$$$20240826$$HP$US$US
242484651$24248465$1$I$$20240730$20240826$20240826$PER$$US-TOLMAR, INC.-24US051419$TOLMAR$$$$$F$Y$$$20240826$$HP$US$US
242484661$24248466$1$I$$20240806$20240826$20240826$PER$$US-TEVA-VS-3229283$TEVA$$$$$F$Y$$$20240826$$CN$US$US
242484671$24248467$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234325$TEVA$$66$YR$$F$Y$$$20240826$$HP$CA$CA
242484681$24248468$1$I$20240101$20240820$20240826$20240826$EXP$$JP-AMGEN-JPNSP2024120656$AMGEN$$$$A$$Y$$$20240826$$MD$JP$JP
242484691$24248469$1$I$20240401$20240813$20240826$20240826$PER$$US-TAKEDA-2024TUS081753$TAKEDA$$$$A$F$Y$68$KG$20240826$$MD$US$US
242484701$24248470$1$I$$20240821$20240826$20240826$EXP$$US-JNJFOC-20240855759$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240826$$HP$US$US
242484712$24248471$2$F$$20240831$20240826$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07654$LUPIN$$$$$$Y$$$20240920$$CN$US$US
242484721$24248472$1$I$20240701$20240729$20240826$20240826$PER$$US-Eisai-EC-2024-171114$EISAI$$$$$M$Y$$$20240826$$MD$US$US
242484731$24248473$1$I$20240701$20240730$20240826$20240826$PER$$US-Eisai-EC-2024-171246$EISAI$$79$YR$E$F$Y$$$20240826$$HP$US$US
242484743$24248474$3$F$$20240828$20240826$20240902$EXP$$CA-ROCHE-10000064634$ROCHE$$$$A$F$Y$$$20240902$$CN$CA$CA
242484761$24248476$1$I$20211007$20240821$20240826$20240826$EXP$$CO-UCBSA-2024042986$UCB$$55$YR$$F$Y$$$20240826$$CN$CO$CO
242484771$24248477$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134262$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$75.75$KG$20240826$$HP$US$US
242484781$24248478$1$I$20240801$20240816$20240826$20240826$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024102579$VIIV$$41$YR$$F$Y$$$20240826$$HP$US$US
242484791$24248479$1$I$20240101$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134652$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240826$$HP$US$US
242484801$24248480$1$I$20240802$20240805$20240826$20240826$PER$$US-AstraZeneca-2024A177773$ASTRAZENECA$$24779$DY$$F$Y$$$20240826$$CN$US$
242484811$24248481$1$I$$20240816$20240826$20240826$EXP$$CA-APOTEX-2024AP009514$APOTEX$$$$A$M$Y$$$20240826$$PH$CA$CA
242484821$24248482$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58153$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242484851$24248485$1$I$$20240819$20240826$20240826$EXP$$PK-ROCHE-10000060314$ROCHE$$38$YR$A$F$Y$$$20240826$$CN$PK$PK
242484883$24248488$3$F$20240819$20240923$20240826$20240926$30DAY$$US-PFIZER INC-202400240602$PFIZER$$15$YR$$M$Y$$$20240926$$MD$US$US
242484912$24248491$2$F$$20240926$20240826$20240926$30DAY$$US-PFIZER INC-202400237393$PFIZER$$$$$$Y$$$20240926$$CN$US$US
242484922$24248492$2$F$$20240925$20240826$20240925$30DAY$$US-PFIZER INC-202400236965$PFIZER$$12$YR$$M$Y$$$20240925$$CN$US$US
242484932$24248493$2$F$20240815$20240925$20240826$20240925$30DAY$$US-PFIZER INC-202400241203$PFIZER$$12$YR$$M$Y$42.18$KG$20240925$$CN$US$US
242484942$24248494$2$F$20240819$20240925$20240826$20240925$30DAY$$US-PFIZER INC-202400240753$PFIZER$$12$YR$$M$Y$52.16$KG$20240925$$CN$US$US
242484963$24248496$3$F$20240818$20240919$20240826$20240924$30DAY$$US-PFIZER INC-PV202400108750$PFIZER$$14$YR$$M$Y$33.57$KG$20240924$$CN$US$US
242484971$24248497$1$I$$20240813$20240826$20240826$30DAY$$US-PFIZER INC-202400236118$PFIZER$$11$YR$$F$Y$$$20240826$$HP$US$US
242484982$24248498$2$F$20240819$20240925$20240826$20240925$30DAY$$US-PFIZER INC-202400240380$PFIZER$$16$YR$$M$Y$$$20240925$$CN$US$US
242484991$24248499$1$I$20240101$20240816$20240826$20240826$PER$$US-ABBVIE-5885508$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242485001$24248500$1$I$$20240821$20240826$20240826$PER$$US-JNJFOC-20240855235$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$CN$US$US
242485031$24248503$1$I$20240711$20240819$20240826$20240826$PER$$US-CELLTRION INC.-2024US018298$CELLTRION$$$$$$Y$$$20240826$$HP$US$US
242485041$24248504$1$I$$20240812$20240826$20240826$EXP$$AU-Vista Pharmaceuticals Inc.-2160858$VISTAPHARM$Full text$18$YR$$F$Y$$$20240826$$$AU$AU
242485051$24248505$1$I$$20240816$20240826$20240826$EXP$$US-GSK-US2024102713$GLAXOSMITHKLINE$$$$$M$Y$$$20240826$$CN$US$US
242485061$24248506$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041559$AUROBINDO$$72$YR$$F$Y$57$KG$20240826$$HP$CA$CA
242485071$24248507$1$I$20240731$20240731$20240826$20240826$PER$$US-CSL-2024-007128$CSL Plasma$$22$YR$$M$Y$$$20240826$$HP$US$US
242485081$24248508$1$I$$20240821$20240826$20240826$EXP$GB-MHRA-MED-202408211939013530-PSVHC$GB-MYLANLABS-2024M1077784$MYLAN$$$$$M$Y$$$20240826$$CN$GB$GB
242485091$24248509$1$I$20240731$20240821$20240826$20240826$EXP$ES-AEMPS-1556577$ES-MYLANLABS-2024M1073986$MYLAN$$42$YR$$F$Y$$$20240826$$PH$ES$ES
242485101$24248510$1$I$$20240821$20240826$20240826$EXP$$TR-MYLANLABS-2024M1078275$MYLAN$Unkar ZA, Pinar E, Ulu E, Ayvaz B, Vural M. Persistent seizures in a 4-day-old newborn. BMJ-Paediatr-Open 2024; 8 (Suppl. 5) A104 abstr. PP-093.$4$DY$$M$Y$$$20240826$$HP$TR$TR
242485111$24248511$1$I$20240101$20240821$20240826$20240826$EXP$$SG-MYLANLABS-2024M1077830$MYLAN$$49$YR$$F$Y$$$20240826$$HP$SG$SG
242485121$24248512$1$I$20240726$20240821$20240826$20240826$EXP$$SG-MYLANLABS-2024M1077628$MYLAN$$64$YR$$M$Y$$$20240826$$HP$SG$SG
242485133$24248513$3$F$$20240902$20240826$20240906$EXP$$PL-MYLANLABS-2024M1077844$MYLAN$Nizinska I, Gattner K.. Lithium intoxication in patients using angiotensin II receptor antagonists and hydrochlorothiazide. Two case reports.. Pharmacotherapy in Psychiatry and Neurology.. 2024;40(1):53-60$72$YR$$F$Y$$$20240906$$HP$PL$PL
242485141$24248514$1$I$20240201$20240821$20240826$20240826$EXP$$FR-MYLANLABS-2024M1077519$MYLAN$$70$YR$$M$Y$73$KG$20240826$$PH$FR$FR
242485151$24248515$1$I$$20240821$20240826$20240826$EXP$GB-MHRA-MED-202408211435335820-FBLQZ$GB-MYLANLABS-2024M1077745$MYLAN$$82$YR$$F$Y$$$20240826$$HP$GB$GB
242485161$24248516$1$I$$20240821$20240826$20240826$EXP$GB-MHRA-MED-202408210341069160-YDTFP$GB-MYLANLABS-2024M1077492$MYLAN$$22$YR$$F$Y$$$20240826$$CN$GB$GB
242485182$24248518$2$F$$20240822$20240826$20240828$PER$$US-BEH-2024177599$CSL BEHRING$$$$E$F$Y$$$20240828$$HP$US$US
242485191$24248519$1$I$$20240813$20240826$20240826$EXP$$CN-B.Braun Medical Inc.-2160859$B BRAUN$$82$YR$$F$Y$53.4$KG$20240826$$$CN$CN
242485201$24248520$1$I$20240101$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024166694$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242485221$24248522$1$I$20240710$20240814$20240826$20240826$EXP$$US-UCBSA-2024041721$UCB$$28$YR$$F$Y$$$20240826$$CN$US$US
242485232$24248523$2$F$20220314$20240826$20240826$20240916$PER$$US-009507513-2408USA007316$MERCK$$$$A$M$Y$$$20240916$$CN$US$US
242485242$24248524$2$F$20221101$20240820$20240826$20240827$EXP$FR-AFSSAPS-LM2024000450$FR-UCBSA-2024042101$UCB$$0$YR$$M$Y$$$20240827$$MD$FR$FR
242485251$24248525$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234328$TEVA$$47$YR$$F$Y$86$KG$20240826$$HP$CA$CA
242485273$24248527$3$F$20240722$20240903$20240826$20240906$EXP$$CN-AMGEN-CHNNI2024168171$AMGEN$$$$$M$Y$54.5$KG$20240906$$MD$CN$CN
242485281$24248528$1$I$20240101$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168590$AMGEN$$$$$$Y$$$20240826$$CN$US$US
242485291$24248529$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041561$AUROBINDO$$79$YR$$M$Y$$$20240826$$PH$CA$CA
242485301$24248530$1$I$20240724$20240812$20240826$20240826$EXP$FR-AFSSAPS-CF2024000404$FR-GUERBET / LLC-FR-20240304$GUERBET$$80$YR$E$M$Y$112$KG$20240826$$MD$FR$FR
242485311$24248531$1$I$20240729$20240729$20240826$20240826$PER$$US-CELLTRION INC.-2024US018495$CELLTRION$$$$$$Y$$$20240826$$HP$US$US
242485321$24248532$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58166$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242485332$24248533$2$F$20240101$20240828$20240826$20240904$EXP$$CA-Eisai-EC-2024-172706$EISAI$$79$YR$E$F$Y$$$20240904$$CN$CA$CA
242485341$24248534$1$I$$20240729$20240826$20240826$PER$$US-Eisai-EC-2024-171080$EISAI$$$$E$F$Y$$$20240826$$MD$US$US
242485351$24248535$1$I$20240701$20240729$20240826$20240826$PER$$US-Eisai-EC-2024-171307$EISAI$$68$YR$E$F$Y$$$20240826$$CN$US$US
242485361$24248536$1$I$$20240726$20240826$20240826$PER$$US-Eisai-EC-2024-171051$EISAI$$$$E$$Y$$$20240826$$MD$US$US
242485371$24248537$1$I$$20240820$20240826$20240826$EXP$$AU-RDY-SPO/AUS/24/0012267$DR REDDYS$$71$YR$E$F$Y$$$20240826$$CN$AU$AU
242485391$24248539$1$I$20240731$20240731$20240826$20240826$PER$$US-CELLTRION INC.-2024US018672$CELLTRION$$$$$$Y$$$20240826$$CN$US$US
242485401$24248540$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-041648$AUROBINDO$$88$YR$$F$Y$$$20240826$$PH$CA$CA
242485411$24248541$1$I$$20240823$20240826$20240826$PER$$US-JNJFOC-20240861572$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242485421$24248542$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014825$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240826$$CN$US$US
242485431$24248543$1$I$20240808$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015029$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240826$$CN$US$US
242485451$24248545$1$I$$20240510$20240826$20240826$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06709$HIKMA$Erdem S, Damlakhy A, Konja K, Bashar S.. Erdem S, Damlakhy A, Konja K, Bashar S. Altered Mental Status in an Octogenarian: How Frequently Should Serotonin Syndrome Be Considered.. Cureus.. 2024;16(4):e57403.:1-7 pgs$89$YR$$F$Y$$$20240826$$MD$US$US
242485481$24248548$1$I$$20240820$20240826$20240826$EXP$$JP-009507513-2408JPN002652J$MERCK$$60$YR$$$Y$$$20240826$$MD$JP$JP
242485491$24248549$1$I$20240801$20240816$20240826$20240826$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03008$AMNEAL$$68$YR$$F$Y$$$20240826$$HP$US$US
242485501$24248550$1$I$20240801$20240816$20240826$20240826$EXP$$CN-009507513-2408CHN006703$MERCK$$61$YR$$F$Y$81$KG$20240826$$HP$CN$CN
242485511$24248551$1$I$$20240820$20240826$20240826$EXP$$CA-BAYER-2024A119875$BAYER$$$$$F$Y$$$20240826$$MD$CA$CA
242485521$24248552$1$I$$20240813$20240826$20240826$EXP$$CA-AUROBINDO-AUR-APL-2024-042267$AUROBINDO$$49$YR$$F$Y$$$20240826$$MD$CA$CA
242485531$24248553$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000063829$ROCHE$$35$YR$A$F$Y$$$20240826$$CN$US$US
242485541$24248554$1$I$$20240822$20240826$20240826$EXP$$NVSC2024US170814$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
242485551$24248555$1$I$$20240822$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133905$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240826$$CN$US$US
242485561$24248556$1$I$20240601$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134664$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240826$$PH$US$US
242485572$24248557$2$F$$20240910$20240826$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134337$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240917$$CN$US$US
242485581$24248558$1$I$$20240816$20240826$20240826$EXP$$US-BAYER-2024A121575$BAYER$Van Horn A.L.; Burgess J.R.. From Blunt Cardiac Injury to Heart Transplant Following Motorcycle Collision. American Surgeon. 2024;90:8:2080-2082$24$YR$A$M$Y$$$20240826$$HP$US$US
242485591$24248559$1$I$20240820$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135113$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240826$$CN$US$US
242485601$24248560$1$I$$20240819$20240826$20240826$EXP$$US-BAYER-2024A119423$BAYER$$34$YR$A$F$Y$$$20240826$$CN$US$US
242485611$24248561$1$I$20240701$20240805$20240826$20240826$PER$$US-CELLTRION INC.-2024US018910$CELLTRION$$$$$$Y$$$20240826$$HP$US$US
242485631$24248563$1$I$$20240715$20240826$20240826$PER$$US-Dermavant-001237$DERMAVANT SCIENCES$$$$$F$Y$$$20240820$$CN$US$US
242485641$24248564$1$I$$20240719$20240826$20240826$PER$$US-INCYTE CORPORATION-2024IN007913$INCYTE$Satta T, Papadopoulos EB, Gyurkocza B, Susman P, Singh A, Calafiore M, et al.,. Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd. Blood. 2023;142 (Suppl.1):7019-21$$$$$Y$$$20240826$$HP$US$US
242485651$24248565$1$I$$20240816$20240826$20240826$PER$$US-JNJFOC-20240846425$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240826$$CN$US$US
242485663$24248566$3$F$20240703$20240826$20240826$20240830$EXP$$CA-JNJFOC-20240855815$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240830$$CN$CA$CA
242485671$24248567$1$I$$20240820$20240826$20240826$EXP$$PK-ROCHE-3534929$ROCHE$$60$YR$A$F$Y$$$20240826$$CN$PK$PK
242485681$24248568$1$I$$20240513$20240826$20240826$EXP$$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-06844$HIKMA$Galli E, Frioni F, Malara T, Attardi E, Bellesi S, Hohaus S et al. Galli E, Frioni F, Malara T, Attardi E, Bellesi S, Hohaus S, Sica S, Sor? F, Chiusolo Pl. FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells. Mediterranean Journal of Hematology and Infectious Diseases. 2024;16(1):e2024029$33$YR$$M$Y$$$20240826$$MD$IT$IT
242485701$24248570$1$I$$20240814$20240826$20240826$PER$US-MLMSERVICE-20240807-PI154978-00175-1$US-RDY-SPO/USA/24/0011939$DR REDDYS$Bessi VA, Olayiwola S, Fuentes F, Reganti S. A CASE REPORT OF SPONTANEOUS AUTOIMMUNE HEPARIN-INDUCED THROMBOCYTOPENIA (aHIT) VS VERY EARLY PRESENTATION OF HEPARIN-INDUCED THROMBOCYTOPENIA. Chest. 2023;164(4):A2806-7. DOI:10.1016/j.chest.2023.07.1848.$64$YR$A$F$Y$$$20240826$$MD$US$US
242485721$24248572$1$I$$20240821$20240826$20240826$EXP$$JP-AMGEN-JPNSP2024167644$AMGEN$$$$$$Y$$$20240826$$PH$JP$JP
242485741$24248574$1$I$$20240813$20240826$20240826$EXP$$SG-ROCHE-10000056743$ROCHE$$66$YR$E$M$Y$$$20240826$$CN$SG$SG
242485753$24248575$3$F$$20240829$20240826$20240905$EXP$$CA-PFIZER INC-202400242233$PFIZER$$63$YR$$F$Y$$$20240905$$HP$CA$CA
242485762$24248576$2$F$20240820$20240904$20240826$20240905$EXP$$IN-PFIZER INC-PV202400110787$PFIZER$$57$YR$$M$Y$$$20240905$$CN$IN$IN
242485771$24248577$1$I$20240801$20240821$20240826$20240826$EXP$$US-PFIZER INC-202400102632$PFIZER$$51$YR$$F$Y$$$20240826$$MD$US$US
242485781$24248578$1$I$$20240822$20240826$20240826$EXP$$CA-PFIZER INC-202400242118$PFIZER$$13$YR$$M$Y$$$20240826$$HP$CA$CA
242485792$24248579$2$F$20240129$20240826$20240826$20240829$EXP$DK-DKMA-30729627$DK-PFIZER INC-202400241617$PFIZER$$49$YR$$F$Y$71$KG$20240829$$MD$DK$DK
242485801$24248580$1$I$$20240821$20240826$20240826$EXP$$US-PFIZER INC-202400242086$PFIZER$$61$YR$$F$Y$$$20240826$$HP$US$US
242485821$24248582$1$I$20240809$20240821$20240826$20240826$EXP$$CN-PFIZER INC-PV202400109322$PFIZER$$14$YR$$F$Y$45$KG$20240826$$HP$CN$CN
242485831$24248583$1$I$$20240821$20240826$20240826$EXP$$US-PFIZER INC-202400241686$PFIZER$$66$YR$$F$Y$$$20240826$$CN$US$US
242485841$24248584$1$I$20210227$20240822$20240826$20240826$EXP$FR-AFSSAPS-PA2023002252$FR-PFIZER INC-202400241614$PFIZER$$41$YR$$F$Y$$$20240826$$MD$FR$FR
242485851$24248585$1$I$20240822$20240822$20240826$20240826$EXP$$PE-PFIZER INC-202400242151$PFIZER$$$$$F$Y$$$20240826$$MD$PE$PE
242485861$24248586$1$I$20240722$20240821$20240826$20240826$EXP$$CN-PFIZER INC-PV202400109373$PFIZER$$51$YR$$F$Y$72.1$KG$20240826$$HP$CN$CN
242485871$24248587$1$I$20220715$20240821$20240826$20240826$EXP$$JP-PFIZER INC-PV202400108613$PFIZER$$83$YR$$F$Y$61.2$KG$20240826$$PH$JP$JP
242485881$24248588$1$I$20240801$20240821$20240826$20240826$EXP$$FR-PFIZER INC-202400239152$PFIZER$$80$YR$$M$Y$$$20240826$$PH$FR$FR
242485891$24248589$1$I$20240201$20240822$20240826$20240826$EXP$$US-PFIZER INC-PV202400110308$PFIZER$$63$YR$$F$Y$$$20240826$$HP$US$US
242485901$24248590$1$I$$20240823$20240826$20240826$EXP$$US-PFIZER INC-202400243147$PFIZER$$79$YR$$F$Y$$$20240826$$CN$US$US
242485911$24248591$1$I$$20240821$20240826$20240826$EXP$$CA-PFIZER INC-202400241077$PFIZER$$14$YR$$M$Y$$$20240826$$HP$CA$CA
242485921$24248592$1$I$$20240822$20240826$20240826$EXP$$US-PFIZER INC-202400242580$PFIZER$$47$YR$$M$Y$$$20240826$$CN$US$US
242485932$24248593$2$F$$20240827$20240826$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134226$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240905$$CN$US$US
242485952$24248595$2$F$$20240823$20240826$20240828$EXP$$CN-PFIZER INC-202400242305$PFIZER$Sun, Y.. Identification of Anncaliia algerae in Ascites in an Immunosuppressed Patient, China.. Open Forum Infectious Diseases.. 2024;11(8):10.1093/ofid/ofae393$63$YR$$F$Y$$$20240828$$MD$CN$CN
242485962$24248596$2$F$$20240821$20240826$20240827$EXP$$US-PFIZER INC-202400241494$PFIZER$$$$$$Y$$$20240827$$CN$US$US
242485971$24248597$1$I$$20240822$20240826$20240826$EXP$$US-PFIZER INC-202400242216$PFIZER$$76$YR$$F$Y$$$20240826$$CN$US$US
242485981$24248598$1$I$$20240821$20240826$20240826$EXP$$CA-PFIZER INC-202200363910$PFIZER$$42$YR$$F$Y$$$20240826$$HP$CA$CA
242485991$24248599$1$I$20240625$20240822$20240826$20240826$EXP$$US-PFIZER INC-202400242020$PFIZER$$75$YR$$F$Y$$$20240826$$MD$US$US
242486001$24248600$1$I$20240730$20240822$20240826$20240826$EXP$SE-SEMPA-2024-006157$SE-PFIZER INC-202400241716$PFIZER$$64$YR$$F$Y$$$20240826$$MD$SE$SE
242486011$24248601$1$I$$20240822$20240826$20240826$EXP$$CA-PFIZER INC-202400242051$PFIZER$$45$YR$$F$Y$$$20240826$$HP$CA$CA
242486021$24248602$1$I$$20240822$20240826$20240826$EXP$$US-PFIZER INC-PV202400110203$PFIZER$$68$YR$$M$Y$$$20240826$$CN$US$US
242486042$24248604$2$F$20240501$20240814$20240826$20240924$EXP$$CA-LEO Pharma-372156$LEO PHARM$$23$YR$$$Y$$$20240924$$CN$CA$CA
242486051$24248605$1$I$$20240823$20240826$20240826$PER$$US-GILEAD-2024-0685293$GILEAD$$$$$$Y$$$20240826$$LW$US$US
242486061$24248606$1$I$20240717$20240822$20240826$20240826$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07601$VIFOR$$55$YR$$M$Y$$$20240826$$HP$ZA$ZA
242486071$24248607$1$I$$20240821$20240826$20240826$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07576$VIFOR$$66$YR$$F$Y$$$20240826$$HP$ZA$ZA
242486081$24248608$1$I$$20240820$20240826$20240826$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07535$VIFOR$$41$YR$$F$Y$$$20240826$$MD$ZA$ZA
242486091$24248609$1$I$$20240821$20240826$20240826$EXP$$CA-ABBVIE-5890837$ABBVIE$$$$E$M$Y$$$20240826$$CN$CA$CA
242486101$24248610$1$I$20240801$20240822$20240826$20240826$EXP$$US-ABBVIE-5891389$ABBVIE$$56$YR$$F$Y$$$20240826$$HP$US$US
242486111$24248611$1$I$20240801$20240819$20240826$20240826$EXP$$NVSC2024ZA168186$NOVARTIS$$51$YR$$F$Y$$$20240826$$HP$ZA$ZA
242486121$24248612$1$I$$20240823$20240826$20240826$PER$$NVSC2024US172005$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
242486133$24248613$3$F$$20240827$20240826$20240906$EXP$$CA-TEVA-VS-3234503$TEVA$$7$YR$$M$Y$$$20240906$$HP$CA$CA
242486181$24248618$1$I$20221101$20240820$20240826$20240826$EXP$FR-AFSSAPS-LM2024000450$FR-UCBSA-2024042870$UCB$$$$$F$Y$68$KG$20240826$$MD$FR$FR
242486201$24248620$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58274$$FDA-CTU$$73$YR$$F$N$$$20240823$N$HP$US$
242486211$24248621$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58338$$FDA-CTU$$51$YR$$F$N$$$20240823$N$$US$
242486221$24248622$1$I$$20240820$20240826$20240826$PER$$US-ABBVIE-5891262$ABBVIE$$$$$$Y$$$20240826$$CN$US$US
242486231$24248623$1$I$$20240820$20240826$20240826$EXP$$JP-PFIZER INC-PV202400108816$PFIZER$Katsuki, K.. Acute mixed-lineage leukemia treated with desensitization therapy prior to HLA-haploidentical transplantation with high donor-specific antibodies. International Journal of Hematology. 2024;120 (2):256-261$43$YR$$F$Y$$$20240826$$HP$JP$JP
242486251$24248625$1$I$20240701$20240817$20240826$20240826$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-133363$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240826$$HP$CO$CO
242486261$24248626$1$I$$20240822$20240826$20240826$EXP$$US-ABBVIE-5892388$ABBVIE$$88$YR$$F$Y$$$20240826$$CN$US$US
242486272$24248627$2$F$$20240904$20240826$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07651$LUPIN$$$$$$Y$$$20240921$$CN$US$US
242486283$24248628$3$F$20231210$20240913$20240826$20240920$30DAY$$US-AMGEN-USASP2024167753$AMGEN$$70$YR$E$M$Y$84$KG$20240919$$HP$US$US
242486291$24248629$1$I$20240821$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167606$AMGEN$$51$YR$A$M$Y$123.8$KG$20240826$$PH$US$US
242486311$24248631$1$I$$20240814$20240826$20240826$EXP$$JP-AMGEN-JPNSP2024167182$AMGEN$$$$$M$Y$$$20240826$$CN$JP$JP
242486321$24248632$1$I$20240701$20240819$20240826$20240826$EXP$FR-AFSSAPS-CN2024000703$FR-MYLANLABS-2024M1076891$MYLAN$$31$YR$$F$Y$$$20240826$$MD$FR$FR
242486341$24248634$1$I$$20240820$20240826$20240826$PER$$US-PFIZER INC-PV202400108850$PFIZER$$63$YR$$F$Y$$$20240826$$CN$US$US
242486352$24248635$2$F$$20240925$20240826$20240925$PER$$US-PFIZER INC-202400238434$PFIZER$$31$YR$$M$Y$$$20240925$$CN$US$US
242486361$24248636$1$I$$20240822$20240826$20240826$EXP$$NVSC2024CN171185$NOVARTIS$$73$YR$$M$Y$$$20240826$$CN$CN$CN
242486371$24248637$1$I$$20240815$20240826$20240826$PER$$US-ABBVIE-5884946$ABBVIE$$$$$$Y$$$20240826$$CN$US$US
242486391$24248639$1$I$$20220830$20240826$20240826$EXP$$GB-AstraZeneca-2022A303963$ASTRAZENECA$$$$$$Y$$$20240826$$MD$GB$
242486401$24248640$1$I$20240806$20240815$20240826$20240826$EXP$$CN-JNJFOC-20240842602$JOHNSON AND JOHNSON$$31$YR$A$F$Y$52$KG$20240826$$HP$CN$CN
242486411$24248641$1$I$$20240817$20240826$20240826$EXP$$JP-ANIPHARMA-2024-JP-000230$ANI$Nagao S, Yabuuchi Y, Tanaka K, et al.Multiple gastric neuroendocrine tumors associated with long-term use of a proton pump inhibitor and a potassium-competitive acid blocker..Internal Medicine.2024;63(14):2001-2010.$52$YR$$M$Y$$$20240826$$HP$JP$JP
242486422$24248642$2$F$20240801$20240904$20240826$20240909$EXP$$JP-AstraZeneca-2024A191811$ASTRAZENECA$$89$YR$$M$Y$$$20240909$$MD$JP$
242486432$24248643$2$F$20240801$20240830$20240826$20240903$PER$$US-BAYER-2024A120314$BAYER$$35$YR$A$F$Y$$$20240903$$CN$US$US
242486441$24248644$1$I$20220901$20240814$20240826$20240826$PER$$US-INCYTE CORPORATION-2024IN008573$INCYTE$$$$$$Y$$$20240826$$CN$US$US
242486451$24248645$1$I$20240208$20240820$20240826$20240826$EXP$$DE-TAKEDA-2024TUS085425$TAKEDA$$$$E$M$Y$76$KG$20240826$$MD$DE$DE
242486461$24248646$1$I$$20240819$20240826$20240826$EXP$$US-ABBVIE-5887316$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242486471$24248647$1$I$$20240822$20240826$20240826$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-017814$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240826$$CN$JP$JP
242486481$24248648$1$I$$20240821$20240826$20240826$EXP$$CA-HALEON-2193353$Haleon PLC$$40$YR$$F$Y$73$KG$20240826$$MD$CA$CA
242486491$24248649$1$I$20240101$20240822$20240826$20240826$EXP$$US-ABBVIE-5893365$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242486502$24248650$2$F$$20240925$20240826$20240925$PER$$US-PFIZER INC-PV202400109666$PFIZER$$$$$F$Y$$$20240925$$CN$US$US
242486512$24248651$2$F$$20240925$20240826$20240925$PER$$US-PFIZER INC-202400238584$PFIZER$$2$YR$$M$Y$$$20240925$$CN$US$US
242486522$24248652$2$F$$20240925$20240826$20240925$PER$$US-PFIZER INC-202400241210$PFIZER$$8$YR$$F$Y$$$20240925$$CN$US$US
242486541$24248654$1$I$20240401$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134318$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240826$$CN$US$US
242486551$24248655$1$I$$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133836$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$79.1$KG$20240826$$MD$US$US
242486562$24248656$2$F$$20240820$20240826$20240903$EXP$$PT-MYLANLABS-2024M1077813$MYLAN$, Cruz AM.. Unexpected challenges: Recognize the serious adverse effects of oral antidiabetics.. Portuguese Journal of Family Medicine and General Practice. 2024;40(Supplem 13):S21-S21$80$YR$$F$Y$$$20240903$$MD$PT$PT
242486572$24248657$2$F$$20240819$20240826$20240905$EXP$$JP-009507513-2408JPN002271J$MERCK$Yui N, Miyamoto T, Nakayama H, Imamoto R, Yamamoto M, Sato Y. PS4-6 Two cases of immune-related myocarditis caused by pembrolizumab. The 7th Annual Meeting of the Japanese Onco-Cardiology Society. 117$58$YR$$F$Y$$$20240905$$MD$JP$JP
242486581$24248658$1$I$$20240506$20240826$20240826$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-06642$HIKMA$Sassine S, Remy A, Demaret T, Ovetchkine P, Kakkar F, Tran TH, et al.. Sassine S, Remy A, Demaret T, Ovetchkine P, Kakkar F, Tran TH, et al. 150 From pancytopenia to hyperleukocytosis, an unexpected presentation of immune reconstitution inflammatory syndrome in an infant with methylmalonic acidemia.. Clinical Immunology.. 2024;262:110092$2$MON$$$Y$$$20240826$$MD$CA$CA
242486591$24248659$1$I$20130901$20240816$20240826$20240826$EXP$PL-URPL-1-3573-2020$PL-TEVA-VS-3234359$TEVA$$18$YR$$F$Y$68$KG$20240826$$MD$PL$PL
242486602$24248660$2$F$$20240821$20240826$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013882$ELI LILLY AND CO$$54$YR$A$$Y$$$20240827$$LW$US$US
242486611$24248661$1$I$20240815$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014730$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240826$$CN$US$US
242486621$24248662$1$I$20240801$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014703$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240826$$CN$US$US
242486642$24248664$2$F$$20240823$20240826$20240826$EXP$$US-GILEAD-2024-0685294$GILEAD$$$$$$Y$$$20240826$$LW$US$US
242486651$24248665$1$I$$20240814$20240826$20240826$EXP$$US-SCIEGENP-2024SCLIT00356$SCIEGEN$Elsayed M..An Interesting Case of Drug-Induced Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Pulmonary and Renal Involvement.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209 (1):A5780$75$YR$E$M$Y$$$20240826$$HP$US$US
242486661$24248666$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234389$TEVA$$85$YR$$M$Y$$$20240826$$HP$CA$CA
242486674$24248667$4$F$20240101$20240913$20240826$20240918$EXP$$US-KARYOPHARM-2024KPT001455$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240918$$CN$US$US
242486681$24248668$1$I$20240626$20240820$20240826$20240826$EXP$$UA-MYLANLABS-2024M1077708$MYLAN$$37$YR$$F$Y$$$20240826$$HP$UA$UA
242486691$24248669$1$I$20240509$20240820$20240826$20240826$EXP$$US-MYLANLABS-2024M1043682$MYLAN$$60$YR$$M$Y$97.052$KG$20240826$$PH$US$US
242486701$24248670$1$I$$20240820$20240826$20240826$EXP$GB-MHRA-MED-202408201337368660-ZYNKS$GB-MYLANLABS-2024M1077474$MYLAN$$65$YR$$$Y$$$20240826$$CN$GB$GB
242486712$24248671$2$F$20240601$20240820$20240826$20240829$EXP$FR-AFSSAPS-AM2024000655$FR-MYLANLABS-2024M1077273$MYLAN$$68$YR$$F$Y$68$KG$20240829$$PH$FR$FR
242486721$24248672$1$I$20240819$20240820$20240826$20240826$EXP$$GB-MYLANLABS-2024M1077436$MYLAN$$70$YR$$F$Y$66$KG$20240826$$MD$GB$GB
242486731$24248673$1$I$$20240820$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132295$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240826$$CN$US$US
242486741$24248674$1$I$$20240821$20240826$20240826$EXP$$US-BAYER-2024A120793$BAYER$$74$YR$E$F$Y$$$20240826$$HP$US$US
242486752$24248675$2$F$$20240923$20240826$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134793$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240925$$CN$US$US
242486761$24248676$1$I$20240811$20240816$20240826$20240826$EXP$GB-MHRA-MED-202408161530078430-TJDPC$GB-TEVA-VS-3234888$TEVA$$58$YR$$F$Y$$$20240826$$PH$GB$GB
242486771$24248677$1$I$20240612$20240823$20240826$20240826$EXP$ES-AEMPS-1562314$NVSC2024ES170957$NOVARTIS$$50$YR$$M$Y$$$20240826$$MD$ES$ES
242486781$24248678$1$I$20240815$20240816$20240826$20240826$EXP$GB-MHRA-MED-202408161238414280-FMBWH$GB-TEVA-VS-3234731$TEVA$$60$YR$$F$Y$$$20240826$$PH$GB$GB
242486801$24248680$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58355$$FDA-CTU$$49$YR$$F$N$$$20240823$N$$US$
242486811$24248681$1$I$20240627$20240821$20240826$20240826$EXP$$US-BAYER-2024A121325$BAYER$$64$YR$A$F$Y$87.982$KG$20240826$$CN$US$US
242486851$24248685$1$I$20240501$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58317$$FDA-CTU$$66$YR$$M$N$$$20240823$N$PH$US$
242486861$24248686$1$I$20240801$20240821$20240823$20240823$DIR$FDA-CDER-CTU-2024-58340$$FDA-CTU$$62$YR$$F$N$$$20240821$N$HP$US$
242486881$24248688$1$I$20240819$20240820$20240826$20240826$EXP$$HN-MYLANLABS-2024M1077998$MYLAN$$64$YR$$F$Y$$$20240826$$CN$HN$HN
242486891$24248689$1$I$20240819$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024166713$AMGEN$$54$YR$A$M$Y$$$20240826$$CN$US$US
242486901$24248690$1$I$$20240823$20240826$20240826$EXP$$US-ABBVIE-5892721$ABBVIE$$$$$M$Y$$$20240826$$HP$US$US
242486912$24248691$2$F$$20240829$20240826$20240830$PER$$US-JNJFOC-20240809668$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$CN$US$US
242486921$24248692$1$I$20240101$20240821$20240826$20240826$EXP$$US-JNJFOC-20240856983$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240826$$HP$US$US
242486931$24248693$1$I$$20240816$20240826$20240826$EXP$GB-MHRA-MIDB-1545c084-217b-4f19-b690-2c2831ea5ee7$GB-TEVA-VS-3234874$TEVA$$37$YR$$F$Y$$$20240826$$PH$GB$GB
242486941$24248694$1$I$20240612$20240821$20240826$20240826$EXP$$ES-AUROBINDO-AUR-APL-2024-042279$AUROBINDO$$72$YR$$M$Y$90$KG$20240826$$MD$ES$ES
242486951$24248695$1$I$20240813$20240821$20240826$20240826$EXP$$US-BAYER-2024A121389$BAYER$$32$YR$A$M$Y$72.562$KG$20240826$$CN$US$US
242486962$24248696$2$F$$20240830$20240826$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07655$LUPIN$$$$$$Y$$$20240919$$CN$US$US
242486972$24248697$2$F$$20240905$20240826$20240908$PER$$US-ALXN-202408USA001373US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240908$$CN$US$US
242486981$24248698$1$I$$20240816$20240826$20240826$EXP$$US-GSK-US2024GSK105775$GLAXOSMITHKLINE$$$$$M$Y$$$20240826$$CN$US$US
242486991$24248699$1$I$$20240816$20240826$20240826$30DAY$$US-GSK-US2024102710$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$HP$US$US
242487002$24248700$2$F$$20240820$20240826$20240828$EXP$$CA-TEVA-VS-3234384$TEVA$$40$YR$$M$Y$$$20240828$$MD$CA$CA
242487011$24248701$1$I$$20240821$20240826$20240826$EXP$$US-BAYER-2024A120889$BAYER$$65$YR$E$$Y$$$20240826$$CN$US$US
242487021$24248702$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58350$$FDA-CTU$$80$YR$$F$N$0$KG$20240823$N$$US$
242487031$24248703$1$I$$20240819$20240826$20240826$EXP$$CA-HALEON-2193387$Haleon PLC$$30$YR$$M$Y$$$20240826$$HP$CA$CA
242487051$24248705$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58336$$FDA-CTU$$50$YR$$F$N$$$20240823$N$$US$
242487071$24248707$1$I$20240725$20240820$20240826$20240826$EXP$$US-ABBVIE-5892948$ABBVIE$$84$YR$$M$Y$$$20240826$$CN$US$US
242487081$24248708$1$I$20240816$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168645$AMGEN$$72$YR$E$M$Y$$$20240826$$HP$US$US
242487093$24248709$3$F$20240101$20240828$20240826$20240830$PER$$US-AMGEN-USASP2024168585$AMGEN$$$$$F$Y$$$20240830$$CN$US$US
242487101$24248710$1$I$$20240821$20240826$20240826$EXP$$US-BAYER-2024A121266$BAYER$$81$YR$E$F$Y$$$20240826$$CN$US$US
242487111$24248711$1$I$20240817$20240819$20240826$20240826$EXP$$CA-TAKEDA-2024TUS084556$TAKEDA$$82$YR$$M$Y$$$20240826$$HP$CA$CA
242487131$24248713$1$I$$20240816$20240826$20240826$EXP$$GB-ROCHE-10000060584$ROCHE$$$$E$F$Y$$$20240826$$CN$GB$GB
242487161$24248716$1$I$$20240822$20240826$20240826$EXP$$NVSC2024AU171286$NOVARTIS$$$$$$Y$$$20240826$$MD$AU$AU
242487171$24248717$1$I$$20240819$20240826$20240826$EXP$$US-TAKEDA-2024TUS084569$TAKEDA$Cheney A, Krieger E, Dardas T, Vincent L. From multiple myeloma to myocarditis. Journal of American College of Cardiology. 2019;73(9):2597$53$YR$$M$Y$$$20240826$$MD$US$US
242487182$24248718$2$F$20240806$20240826$20240826$20240903$EXP$$US-TAKEDA-2024TUS082460$TAKEDA$$40$YR$$F$Y$62$KG$20240903$$HP$US$US
242487191$24248719$1$I$$20240822$20240826$20240826$EXP$$JP-AstraZeneca-2024A192632$ASTRAZENECA$$83$YR$$M$Y$$$20240826$$MD$JP$
242487201$24248720$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234509$TEVA$$47$YR$$M$Y$$$20240826$$HP$CA$CA
242487211$24248721$1$I$20240405$20240815$20240826$20240826$EXP$$JP-AstraZeneca-2024A187910$ASTRAZENECA$$83$YR$$M$Y$57$KG$20240826$$MD$JP$
242487231$24248723$1$I$$20240816$20240826$20240826$EXP$NL-LRB-00995888$NL-TEVA-VS-3234377$TEVA$$74$YR$$M$Y$93.2$KG$20240826$$MD$NL$NL
242487241$24248724$1$I$20240723$20240820$20240826$20240826$EXP$$US-ABBVIE-5892889$ABBVIE$$70$YR$$M$Y$$$20240826$$MD$US$US
242487251$24248725$1$I$$20240821$20240826$20240826$30DAY$$AR-PFIZER INC-202400241885$PFIZER$$78$YR$$F$Y$$$20240826$$CN$AR$AR
242487261$24248726$1$I$$20240821$20240826$20240826$EXP$$US-BAYER-2024A121777$BAYER$$44$YR$A$F$Y$$$20240826$$CN$US$US
242487281$24248728$1$I$20201201$20240820$20240826$20240826$EXP$$RO-BRISTOL-MYERS SQUIBB COMPANY-2024-134057$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240826$$MD$RO$RO
242487291$24248729$1$I$$20240821$20240826$20240826$EXP$$GB-MYLANLABS-2024M1078168$MYLAN$$$$$M$Y$$$20240826$$PH$GB$GB
242487301$24248730$1$I$20240605$20240821$20240826$20240826$EXP$$GB-MYLANLABS-2024M1062960$MYLAN$$$$$M$Y$$$20240826$$CN$GB$GB
242487311$24248731$1$I$$20240821$20240826$20240826$EXP$$SG-MYLANLABS-2024M1077833$MYLAN$$$$$M$Y$$$20240826$$HP$SG$SG
242487321$24248732$1$I$20240820$20240821$20240826$20240826$EXP$$IE-MYLANLABS-2024M1030681$MYLAN$$$$$M$Y$$$20240826$$MD$IE$IE
242487331$24248733$1$I$$20240821$20240826$20240826$EXP$GB-MHRA-MED-202408211022345950-CSDPH$GB-MYLANLABS-2024M1077803$MYLAN$$$$$M$Y$$$20240826$$PH$GB$GB
242487341$24248734$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134893$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240826$$HP$US$US
242487351$24248735$1$I$20240423$20240814$20240826$20240826$EXP$AU-NEBO-666482$AU-NEBO-666482$PHARMACOSMOS$$82$YR$$F$Y$$$20240826$$HP$AU$AU
242487362$24248736$2$F$$20240823$20240826$20240826$PER$$US-GILEAD-2024-0685295$GILEAD$$$$$$Y$$$20240826$$LW$US$US
242487371$24248737$1$I$20240720$20240821$20240826$20240826$EXP$$GB-JNJFOC-20240858999$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240826$$HP$GB$GB
242487381$24248738$1$I$$20240812$20240826$20240826$PER$$US-JNJFOC-20240831342$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242487391$24248739$1$I$$20240810$20240826$20240826$PER$$US-JNJFOC-20240855612$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242487401$24248740$1$I$$20240812$20240826$20240826$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-08382$LUPIN$$111$MON$$M$Y$$$20240826$$HP$CA$CA
242487421$24248742$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58349$$FDA-CTU$$63$YR$$M$N$$$20240823$N$$US$
242487441$24248744$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58394$$FDA-CTU$$61$YR$$F$N$70.76$KG$20240823$N$$US$
242487472$24248747$2$F$20240802$20240823$20240826$20240831$EXP$$US-CELLTRION INC.-2024US019391$CELLTRION$$$$$$Y$$$20240831$$HP$US$US
242487491$24248749$1$I$20240731$20240821$20240826$20240826$PER$$US-TAKEDA-2024TUS084693$TAKEDA$$74$YR$$F$Y$$$20240826$$CN$US$US
242487501$24248750$1$I$20240821$20240823$20240826$20240826$EXP$$CN-ROCHE-10000065499$ROCHE$$60$YR$A$M$Y$$$20240826$$MD$CN$CN
242487511$24248751$1$I$$20240819$20240826$20240826$EXP$$JP-ROCHE-10000037622$ROCHE$Iwata K, Torii Y, Fukuda Y, Haruta K, Suzuki T, Kawada J. P-326 Identification of drug-resistance gene mutations in herpesviridae viruses.. The 98th Annual Meeting of the Japanese Association for Infectious Diseases, The 72nd Annual Meeting of the Japanese Society of Chemotherapy. 2024;$45$YR$A$M$Y$$$20240826$$HP$JP$JP
242487522$24248752$2$F$20240814$20240903$20240826$20240904$EXP$GB-MHRA-MED-202408240546063930-TJYKV$GB-MYLANLABS-2024M1078557$MYLAN$$$$$$Y$$$20240904$$CN$GB$GB
242487541$24248754$1$I$20220101$20240816$20240826$20240826$EXP$$SG-ROCHE-10000060406$ROCHE$$60$YR$A$M$Y$$$20240826$$CN$SG$SG
242487551$24248755$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234507$TEVA$$30$YR$$F$Y$$$20240826$$CN$CA$CA
242487561$24248756$1$I$20240820$20240821$20240826$20240826$EXP$$NVSC2024US049563$NOVARTIS$$53$YR$$M$Y$$$20240826$$CN$US$US
242487571$24248757$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58330$$FDA-CTU$$48$YR$$F$N$71.67$KG$20240823$N$$US$
242487581$24248758$1$I$20240702$20240803$20240823$20240823$DIR$FDA-CDER-CTU-2024-58324$$FDA-CTU$$45$YR$$F$N$$$20240803$N$HP$US$
242487591$24248759$1$I$20230101$20240816$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408011862$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240826$$CN$US$US
242487601$24248760$1$I$20240820$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012610$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240826$$CN$US$US
242487611$24248761$1$I$20240611$20240808$20240826$20240826$PER$$US-JNJFOC-20240822114$JOHNSON AND JOHNSON$$$$A$$Y$$$20240826$$CN$US$US
242487621$24248762$1$I$$20240808$20240826$20240826$PER$$US-JNJFOC-20240820619$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$HP$US$US
242487631$24248763$1$I$$20240816$20240826$20240826$PER$$US-CELLTRION INC.-2024US020011$CELLTRION$$$$$$Y$$$20240826$$CN$US$US
242487641$24248764$1$I$20240707$20240821$20240826$20240826$EXP$$US-BAYER-2024A121816$BAYER$$75$YR$E$M$Y$$$20240826$$HP$US$US
242487652$24248765$2$F$$20240827$20240826$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08256$LUPIN$$$$$$Y$$$20240918$$CN$US$US
242487661$24248766$1$I$20240705$20240820$20240826$20240826$EXP$$US-ABBVIE-5893225$ABBVIE$$74$YR$$M$Y$$$20240826$$MD$US$US
242487671$24248767$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234329$TEVA$$86$YR$$$Y$$$20240826$$MD$CA$CA
242487681$24248768$1$I$20240101$20240822$20240826$20240826$EXP$$US-ABBVIE-5894400$ABBVIE$$$$$$Y$$$20240826$$CN$US$US
242487692$24248769$2$F$$20240923$20240826$20240924$EXP$$GB-MYLANLABS-2024M1023942$MYLAN$$$$$F$Y$$$20240924$$MD$GB$GB
242487701$24248770$1$I$$20240820$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132657$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240826$$CN$US$US
242487711$24248771$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134861$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240826$$CN$US$US
242487721$24248772$1$I$$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134224$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$99.34$KG$20240826$$CN$US$US
242487741$24248774$1$I$$20240819$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131903$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240826$$CN$US$US
242487761$24248776$1$I$$20240816$20240826$20240826$PER$$US-ABBVIE-5885233$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242487782$24248778$2$F$$20240823$20240826$20240826$PER$$US-GILEAD-2024-0685296$GILEAD$$$$$$Y$$$20240826$$LW$US$US
242487791$24248779$1$I$20240801$20240820$20240826$20240826$EXP$$US-ABBVIE-5889035$ABBVIE$$70$YR$$M$Y$$$20240826$$MD$US$US
242487801$24248780$1$I$20240617$20240816$20240826$20240826$EXP$ES-AEMPS-1558386$ES-TEVA-VS-3234249$TEVA$$50$YR$$M$Y$84$KG$20240826$$MD$ES$ES
242487811$24248781$1$I$$20240519$20240826$20240826$PER$$US-009507513-2408USA006871$MERCK$$$$$F$Y$$$20240826$$CN$US$US
242487821$24248782$1$I$$20240820$20240826$20240826$EXP$$US-CHEPLA-1400056911$CHEPLAPHARM$$$$E$F$Y$$$20240826$$CN$COUNTRY NOT SPECIFIED$US
242487831$24248783$1$I$20240701$20240821$20240826$20240826$EXP$$CN-CHEPLA-2024010873$CHEPLAPHARM$$$$A$F$Y$$$20240826$$HP$COUNTRY NOT SPECIFIED$CN
242487841$24248784$1$I$20240625$20240820$20240826$20240826$EXP$$NVSC2024CN171164$NOVARTIS$$33$YR$$M$Y$65$KG$20240826$$HP$CN$CN
242487853$24248785$3$F$20240813$20240918$20240826$20240919$PER$$US-ROCHE-10000061652$ROCHE$$29$YR$A$F$Y$81.73$KG$20240919$$CN$US$US
242487861$24248786$1$I$20240524$20240820$20240826$20240826$EXP$ES-AEMPS-1559630$ES-CHEPLA-2024010832$CHEPLAPHARM$$81$YR$$F$Y$$$20240826$$MD$COUNTRY NOT SPECIFIED$ES
242487871$24248787$1$I$20240806$20240820$20240826$20240826$EXP$ES-AEMPS-1558862$ES-CHEPLA-2024010844$CHEPLAPHARM$$68$YR$$F$Y$50$KG$20240826$$PH$COUNTRY NOT SPECIFIED$ES
242487891$24248789$1$I$20240822$20240822$20240823$20240823$DIR$FDA-CDER-CTU-2024-58353$$FDA-CTU$$49$YR$$F$N$$$20240822$N$PH$US$
242487901$24248790$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58357$$FDA-CTU$$65$YR$$M$N$$$20240823$N$$US$
242487931$24248793$1$I$$20240813$20240826$20240826$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08245$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242487941$24248794$1$I$$20240819$20240826$20240826$EXP$$JP-JNJFOC-20240711881$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240826$$MD$JP$JP
242487951$24248795$1$I$$20240820$20240826$20240826$PER$$US-JNJFOC-20240855458$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242487971$24248797$1$I$20240101$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024167007$AMGEN$$76$YR$E$F$Y$$$20240826$$CN$US$US
242487981$24248798$1$I$$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024166068$AMGEN$$35$YR$A$F$Y$$$20240826$$HP$US$US
242488002$24248800$2$F$$20240920$20240826$20240927$PER$$US-AMGEN-USASP2024169440$AMGEN$$63$YR$A$F$Y$86.18$KG$20240927$$MD$US$US
242488011$24248801$1$I$$20240819$20240826$20240826$EXP$$JP-AMGEN-JPNSP2024167257$AMGEN$$$$$$Y$$$20240826$$MD$JP$JP
242488023$24248802$3$F$$20240822$20240826$20240923$EXP$$US-BEH-2024177625$CSL BEHRING$$$$A$M$Y$$$20240923$$MD$US$US
242488031$24248803$1$I$$20240826$20240826$20240826$EXP$$IL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047708$BOEHRINGER INGELHEIM$$85$YR$E$F$Y$$$20240826$$MD$IL$IL
242488041$24248804$1$I$$20240812$20240826$20240826$PER$$US-TEVA-VS-3233630$TEVA$$79$YR$$F$Y$$$20240826$$MD$US$US
242488051$24248805$1$I$$20240822$20240826$20240826$EXP$$JP-GSK-JP2024105654$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$JP$JP
242488061$24248806$1$I$20240809$20240809$20240826$20240826$PER$$US-BAYER-2024A115486$BAYER$$12$YR$C$F$Y$$$20240826$$CN$US$US
242488081$24248808$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134414$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240826$$HP$US$US
242488092$24248809$2$F$20240813$20240916$20240826$20240917$30DAY$$IT-SANDOZ INC.-SDZ2024IT074670$SANDOZ$$7$YR$$M$Y$29$KG$20240917$$CN$IT$IT
242488101$24248810$1$I$20240822$20240822$20240826$20240826$PER$$US-ROCHE-10000064729$ROCHE$$$$$M$Y$$$20240826$$CN$US$US
242488113$24248811$3$F$$20240826$20240826$20240830$EXP$$CA-ROCHE-10000064461$ROCHE$$$$A$F$Y$$$20240830$$CN$CA$CA
242488121$24248812$1$I$$20240813$20240826$20240826$PER$$US-ROCHE-10000064510$ROCHE$$$$$F$Y$$$20240826$$MD$US$US
242488131$24248813$1$I$20230101$20240819$20240826$20240826$EXP$$US-AMGEN-USASP2024165100$AMGEN$$85$YR$E$F$Y$$$20240826$$CN$US$US
242488141$24248814$1$I$$20240812$20240826$20240826$EXP$$IT-SOCIETAL CDMO GAINESVILLE, LLC-SOC-2024-000021$RECRO PHARMA$Menichelli D, et al.. Incidence of All-Cause, Cardiovascular, and Atrial Fibrillation-Related Hospitalizations. JACC: ADVANCES. 2024;3 (8):1-8$$$$$Y$$$20240826$$MD$IT$IT
242488151$24248815$1$I$20240101$20240820$20240826$20240826$PER$$US-BIOGEN-2024BI01277434$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242488161$24248816$1$I$20240508$20240812$20240826$20240826$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000815$PAREXEL$$$$$$Y$$$20240826$$MD$CN$CN
242488171$24248817$1$I$$20240820$20240826$20240826$PER$$US-BIOGEN-2024BI01279140$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242488181$24248818$1$I$20240611$20240816$20240826$20240826$EXP$FR-AFSSAPS-MP2024001265$FR-TEVA-VS-3234446$TEVA$$62$YR$$F$Y$$$20240826$$HP$FR$FR
242488192$24248819$2$F$$20240920$20240826$20240923$PER$$US-ROCHE-10000062197$ROCHE$$49$YR$A$F$Y$$$20240923$$CN$US$US
242488201$24248820$1$I$20240712$20240712$20240826$20240826$PER$$US-ROCHE-10000027394$ROCHE$$81$YR$E$F$Y$$$20240826$$CN$US$US
242488212$24248821$2$F$$20240829$20240826$20240905$EXP$$JP-JNJFOC-20240859934$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$MD$JP$JP
242488221$24248822$1$I$20230730$20230730$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00542$BRAINTREE$$$$A$F$Y$$$20240823$$CN$US$US
242488231$24248823$1$I$20230821$20230821$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00597$BRAINTREE$$$$A$F$Y$$$20240823$$CN$US$US
242488241$24248824$1$I$20230828$20230829$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00622$BRAINTREE$$$$$F$Y$$$20240823$$CN$US$US
242488251$24248825$1$I$20230731$20230731$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00543$BRAINTREE$$70$YR$$M$Y$$$20240823$$CN$US$US
242488261$24248826$1$I$20230905$20230905$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00638$BRAINTREE$$71$YR$$M$Y$$$20240823$$CN$US$US
242488271$24248827$1$I$$20230912$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00651$BRAINTREE$$$$$$Y$$$20240823$$HP$US$US
242488281$24248828$1$I$$20230926$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00689$BRAINTREE$$$$$F$Y$$$20240823$$CN$US$US
242488291$24248829$1$I$20231114$20231114$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00832$BRAINTREE$$72$YR$$F$Y$$$20240823$$CN$US$US
242488301$24248830$1$I$20180101$20231116$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00850$BRAINTREE$$$$$F$Y$$$20240823$$CN$US$US
242488311$24248831$1$I$20120101$20231118$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00864$BRAINTREE$$$$A$M$Y$$$20240823$$CN$US$US
242488321$24248832$1$I$20231120$20231121$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00873$BRAINTREE$$$$$F$Y$$$20240823$$CN$US$US
242488331$24248833$1$I$$20231128$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00881$BRAINTREE$$$$$F$Y$$$20240823$$CN$US$US
242488341$24248834$1$I$20231210$20231210$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00911$BRAINTREE$$$$$M$Y$$$20240823$$CN$US$US
242488351$24248835$1$I$20210101$20231024$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00751$BRAINTREE$$$$$F$Y$80.272$KG$20240823$$CN$US$US
242488361$24248836$1$I$20231101$20231114$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00833$BRAINTREE$$78$YR$$F$Y$$$20240823$$CN$US$US
242488371$24248837$1$I$20231128$20231128$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00884$BRAINTREE$$$$$F$Y$$$20240823$$CN$US$US
242488381$24248838$1$I$20180101$20231215$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00927$BRAINTREE$$$$$$Y$$$20240823$$CN$US$US
242488391$24248839$1$I$20230101$20240115$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00026$BRAINTREE$$$$$F$Y$$$20240823$$CN$US$US
242488401$24248840$1$I$20240211$20240211$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00078$BRAINTREE$$66$YR$$F$Y$158.76$KG$20240823$$CN$US$US
242488411$24248841$1$I$$20240325$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00156$BRAINTREE$$$$$M$Y$$$20240823$$CN$US$US
242488421$24248842$1$I$20230101$20240410$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00203$BRAINTREE$$$$$M$Y$$$20240823$$CN$US$US
242488431$24248843$1$I$20240415$20240415$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00213$BRAINTREE$$68$YR$$M$Y$$$20240823$$CN$US$US
242488441$24248844$1$I$$20240421$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00232$BRAINTREE$$$$A$F$Y$$$20240823$$CN$US$US
242488451$24248845$1$I$20230702$20231101$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00770$BRAINTREE$$41$YR$$M$Y$$$20240823$$CN$US$US
242488461$24248846$1$I$$20240513$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00280$BRAINTREE$$$$$$Y$$$20240823$$CN$US$US
242488471$24248847$1$I$20240521$20240521$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00295$BRAINTREE$$66$YR$$F$Y$113.4$KG$20240823$$CN$US$US
242488481$24248848$1$I$20240521$20240522$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00298$BRAINTREE$$67$YR$$F$Y$73.469$KG$20240823$$CN$US$US
242488491$24248849$1$I$20240627$20240628$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00403$BRAINTREE$$$$A$F$Y$$$20240823$$CN$US$US
242488501$24248850$1$I$20240627$20240628$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00406$BRAINTREE$$$$$F$Y$$$20240823$$CN$US$US
242488511$24248851$1$I$$20240822$20240826$20240826$EXP$$US-MYLANLABS-2024M1078452$MYLAN$$$$$F$Y$$$20240826$$CN$US$US
242488522$24248852$2$F$$20240822$20240826$20240830$EXP$$US-MYLANLABS-2024M1078558$MYLAN$$$$$$Y$$$20240830$$CN$US$US
242488531$24248853$1$I$$20240822$20240826$20240826$EXP$$US-MYLANLABS-2024M1078554$MYLAN$$$$$$Y$$$20240826$$CN$US$US
242488541$24248854$1$I$20240101$20240104$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00007$BRAINTREE$$$$$M$Y$$$20240823$$CN$US$US
242488551$24248855$1$I$20200519$20240822$20240826$20240826$EXP$PL-URPL-1-1662-2020$PL-MYLANLABS-2024M1077839$MYLAN$$20$YR$$M$Y$56$KG$20240826$$MD$PL$PL
242488562$24248856$2$F$$20240909$20240826$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130706$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$96.62$KG$20240910$$CN$US$US
242488571$24248857$1$I$20240801$20240820$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134310$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240826$$CN$US$US
242488581$24248858$1$I$$20240822$20240826$20240826$EXP$$GB-MYLANLABS-2024M1078129$MYLAN$$66$YR$$F$Y$60$KG$20240826$$MD$GB$GB
242488591$24248859$1$I$$20240822$20240826$20240826$EXP$GB-MHRA-MIDB-e67ea340-cc12-45d5-a6fd-8e42fe8a1b35$GB-MYLANLABS-2024M1078096$MYLAN$$59$YR$$F$Y$$$20240826$$PH$GB$GB
242488601$24248860$1$I$20230816$20230816$20240826$20240826$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00587$BRAINTREE$$64$YR$$F$Y$113.38$KG$20240823$$CN$US$US
242488611$24248861$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134781$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240826$$HP$US$US
242488622$24248862$2$F$$20240823$20240826$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-133660$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240829$$MD$JP$JP
242488632$24248863$2$F$$20240826$20240826$20240903$EXP$$US-BAYER-2024A121470$BAYER$$21$YR$A$M$Y$$$20240903$$CN$US$US
242488652$24248865$2$F$20240101$20240909$20240826$20240911$PER$$US-ROCHE-10000062806$ROCHE$$56$YR$A$M$Y$100$KG$20240911$$CN$US$US
242488661$24248866$1$I$20240701$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015199$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240826$$CN$US$US
242488671$24248867$1$I$20240501$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014410$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240826$$CN$US$US
242488681$24248868$1$I$$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015420$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240826$$CN$US$US
242488691$24248869$1$I$$20240806$20240823$20240823$DIR$FDA-CDER-CTU-2024-58315$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
242488711$24248871$1$I$20240705$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-58492$$FDA-CTU$$44$YR$$M$N$230$LBS$20240821$N$CN$US$
242488721$24248872$1$I$$20240821$20240826$20240826$EXP$$CZ-MYLANLABS-2020M1002827$MYLAN$Markova M, Rahmatova S, Kalina T, Viktorova D, Kouba M, Lesny P et al.. Treatment with CMV-specific (cytomegalovirus) T-lymphocytes in case of a patient after allogenic myeloproliferative cell transplantation with proven viral multiorganic affection. Sbornik.. 12th Symposium on Advances in Molecular Hematology. 2019;27$53$YR$$M$Y$$$20240826$$HP$CZ$CZ
242488731$24248873$1$I$20240801$20240812$20240826$20240826$PER$$US-COSETTE-CP2024US000219$COSETTE PHARMACEUTICALS$$36$YR$A$F$Y$134$KG$20240826$$CN$US$US
242488741$24248874$1$I$$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024167556$AMGEN$$$$$$Y$$$20240826$$CN$US$US
242488761$24248876$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000063123$ROCHE$$$$A$F$Y$$$20240826$$CN$US$US
242488771$24248877$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000063973$ROCHE$$$$E$M$Y$$$20240826$$CN$US$US
242488791$24248879$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234434$TEVA$$3$DEC$$M$Y$$$20240826$$MD$CA$CA
242488802$24248880$2$F$20240801$20240823$20240826$20240830$EXP$$US-BAYER-2024A121511$BAYER$$53$YR$A$F$Y$$$20240830$$CN$US$US
242488821$24248882$1$I$$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-58480$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
242488831$24248883$1$I$$20240814$20240826$20240826$EXP$$JP-UPSHER-SMITH LABORATORIES, LLC-20240800079$UPSHER SMITH LABORATORIES$Yamaguchi T.; Aihara A.; Mashiko S.; Kurosawa E.; Oizumi T.; Yamagata T. et al. Exacerbation of delirium and epileptic seizures in an older man with idiopathic Parkinson^s disease due to multiple prescriptions: a case report. Front. Med. 2024;11:01-05$$$E$M$Y$$$20240826$$$JP$JP
242488851$24248885$1$I$20240814$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-58555$$FDA-CTU$$46$YR$$F$N$$$20240821$N$PH$US$
242488861$24248886$1$I$20240708$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58319$$FDA-CTU$$51$YR$$F$N$$$20240823$N$HP$US$
242488871$24248887$1$I$20111129$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-58481$$FDA-CTU$$72$YR$$F$N$$$20240821$Y$CN$US$
242488891$24248889$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064554$ROCHE$$$$A$F$Y$$$20240826$$CN$US$US
242488901$24248890$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064277$ROCHE$$$$E$F$Y$$$20240826$$CN$US$US
242488911$24248891$1$I$20240101$20240819$20240826$20240826$PER$$US-MYLANLABS-2024M1077540$MYLAN$$$$$F$Y$59.42$KG$20240826$$CN$US$US
242488922$24248892$2$F$$20240823$20240826$20240826$PER$$US-GILEAD-2024-0685297$GILEAD$$$$$$Y$$$20240826$$LW$US$US
242488931$24248893$1$I$$20240822$20240826$20240826$EXP$$JP-AstraZeneca-2024A192153$ASTRAZENECA$$69$YR$$M$Y$$$20240826$$MD$JP$
242488951$24248895$1$I$$20230919$20240826$20240826$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409779$RANBAXY$$$$$M$Y$$$20240826$$CN$US$US
242488961$24248896$1$I$$20240311$20240826$20240826$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-437796$RANBAXY$$$$$F$Y$$$20240826$$PH$US$US
242488981$24248898$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064964$ROCHE$$$$A$F$Y$$$20240826$$CN$US$US
242488991$24248899$1$I$$20240812$20240826$20240826$PER$$US-COSETTE-CP2024US000220$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242489011$24248901$1$I$$20240819$20240826$20240826$EXP$$JP-PFIZER INC-202400239382$PFIZER$$$$$$Y$$$20240826$$MD$JP$JP
242489031$24248903$1$I$$20240821$20240826$20240826$EXP$$JP-PFIZER INC-202400240438$PFIZER$$69$YR$$F$Y$$$20240826$$PH$JP$JP
242489041$24248904$1$I$20240401$20240820$20240826$20240826$EXP$$US-PFIZER INC-PV202400043041$PFIZER$$57$YR$$F$Y$$$20240826$$HP$US$US
242489051$24248905$1$I$20240814$20240821$20240826$20240826$EXP$$CN-PFIZER INC-PV202400109301$PFIZER$$6$YR$$M$Y$27$KG$20240826$$HP$CN$CN
242489071$24248907$1$I$20240601$20240820$20240826$20240826$EXP$CH-SM-2024-14333$CH-PFIZER INC-202400239972$PFIZER$$73$YR$$M$Y$90$KG$20240826$$MD$CH$CH
242489092$24248909$2$F$$20240828$20240826$20240829$EXP$$CA-BAYER-2024A121899$BAYER$$$$$F$Y$$$20240829$$HP$CA$CA
242489103$24248910$3$F$20240101$20240905$20240826$20240910$EXP$$CA-PFIZER INC-202400207000$PFIZER$$20$YR$$M$Y$85.6$KG$20240910$$MD$CA$CA
242489111$24248911$1$I$20240731$20240821$20240826$20240826$EXP$$CN-PFIZER INC-PV202400109315$PFIZER$$45$YR$$M$Y$70$KG$20240826$$HP$CN$CN
242489122$24248912$2$F$20240101$20240821$20240826$20240827$EXP$$CA-PFIZER INC-202400241555$PFIZER$$81$YR$$F$Y$68$KG$20240827$$HP$CA$CA
242489141$24248914$1$I$20240706$20240823$20240826$20240826$EXP$$NVSC2024CN171172$NOVARTIS$$50$YR$$M$Y$80$KG$20240826$$HP$CN$CN
242489161$24248916$1$I$20160101$20240821$20240826$20240826$PER$$NVSC2024US171353$NOVARTIS$$$$$F$Y$$$20240826$$HP$US$US
242489171$24248917$1$I$$20240728$20240826$20240826$PER$$US-Eisai-EC-2024-171057$EISAI$$$$E$F$Y$$$20240826$$MD$US$US
242489181$24248918$1$I$20240320$20240815$20240826$20240826$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000825$PAREXEL$$$$$$Y$$$20240826$$HP$CN$CN
242489191$24248919$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064688$ROCHE$$52$YR$A$F$Y$$$20240826$$CN$US$US
242489201$24248920$1$I$20240614$20240816$20240826$20240826$EXP$FR-AFSSAPS-AVGR2024000139$FR-TEVA-VS-3234281$TEVA$$17$YR$$M$Y$$$20240826$$MD$FR$FR
242489241$24248924$1$I$$20240812$20240826$20240826$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-08233$LUPIN$$$$$$Y$$$20240826$$CN$CA$CA
242489261$24248926$1$I$$20240805$20240823$20240823$DIR$FDA-CDER-CTU-2024-58337$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
242489271$24248927$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58325$$FDA-CTU$$40$YR$$F$N$$$20240823$N$$US$
242489311$24248931$1$I$20240817$20240821$20240821$20240821$DIR$FDA-CDER-CTU-2024-58556$$FDA-CTU$$69$YR$$F$N$$$20240821$N$$US$
242489331$24248933$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58384$$FDA-CTU$$22$YR$$F$N$$$20240823$N$HP$US$
242489341$24248934$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58368$$FDA-CTU$$69$YR$$M$N$$$20240823$N$$US$
242489351$24248935$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135154$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$$$20240826$$CN$US$US
242489361$24248936$1$I$$20240822$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134112$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240826$$MD$US$US
242489371$24248937$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134366$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240826$$CN$US$US
242489381$24248938$1$I$20240601$20240814$20240826$20240826$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240800081$UPSHER SMITH LABORATORIES$$26$YR$$M$Y$74.83$KG$20240826$$MD$US$US
242489391$24248939$1$I$$20240815$20240826$20240826$PER$$US-BIOGEN-2024BI01278767$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242489401$24248940$1$I$20240730$20240731$20240826$20240826$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000715$PAREXEL$$$$$$Y$$$20240826$$HP$US$US
242489412$24248941$2$F$$20240823$20240826$20240830$EXP$$JP-BAYER-2024A121967$BAYER$$21$YR$A$F$Y$$$20240830$$CN$JP$JP
242489421$24248942$1$I$$20240818$20240826$20240826$EXP$$GB-CELLTRION INC.-2024GB020162$CELLTRION$$$$$$Y$$$20240826$$CN$GB$GB
242489431$24248943$1$I$20240814$20240823$20240826$20240826$EXP$$CN-BAYER-2024A122025$BAYER$$53$YR$A$M$Y$66$KG$20240826$$HP$CN$CN
242489441$24248944$1$I$20240101$20240820$20240826$20240826$EXP$$US-VERTEX PHARMACEUTICALS-2024-013492$VERTEX$$33$YR$$F$Y$$$20240826$$HP$US$US
242489451$24248945$1$I$20240607$20240816$20240826$20240826$EXP$FR-AFSSAPS-AVTO2024000111$FR-TEVA-VS-3234170$TEVA$$52$YR$$M$Y$$$20240826$$MD$FR$FR
242489461$24248946$1$I$20240101$20240822$20240826$20240826$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013563$VERTEX$$$$A$M$Y$$$20240826$$CN$GB$GB
242489481$24248948$1$I$20240101$20240820$20240826$20240826$EXP$$US-VERTEX PHARMACEUTICALS-2024-013493$VERTEX$$56$YR$$F$Y$$$20240826$$HP$US$US
242489491$24248949$1$I$$20240820$20240826$20240826$PER$$US-VERTEX PHARMACEUTICALS-2024-013494$VERTEX$$47$YR$$F$Y$$$20240826$$HP$US$US
242489501$24248950$1$I$$20240819$20240826$20240826$EXP$GB-MHRA-MED-202408191552051550-SDZKQ$GB-VERTEX PHARMACEUTICALS-2024-013425$VERTEX$$33$YR$$F$Y$62$KG$20240826$$PH$GB$GB
242489511$24248951$1$I$20240801$20240820$20240826$20240826$EXP$$US-VERTEX PHARMACEUTICALS-2024-013478$VERTEX$$21$YR$$F$Y$$$20240826$$CN$US$US
242489521$24248952$1$I$$20240820$20240826$20240826$EXP$FR-AFSSAPS-LL2024001574$FR-VERTEX PHARMACEUTICALS-2024-013394$VERTEX$$47$YR$$F$Y$56$KG$20240826$$MD$FR$FR
242489531$24248953$1$I$20240803$20240819$20240826$20240826$EXP$$US-VERTEX PHARMACEUTICALS-2024-013424$VERTEX$$4$YR$$M$Y$$$20240826$$CN$US$US
242489541$24248954$1$I$$20240819$20240826$20240826$PER$$US-ABBVIE-5888486$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242489551$24248955$1$I$$20240812$20240826$20240826$EXP$$DE-EPICPHARMA-DE-2024EPCLIT01020$EPIC PHARM$$54$YR$A$$Y$$$20240826$$HP$DE$DE
242489561$24248956$1$I$20240812$20240819$20240826$20240826$EXP$$US-VERTEX PHARMACEUTICALS-2024-013404$VERTEX$$0$YR$$F$Y$$$20240826$$CN$US$US
242489571$24248957$1$I$$20240821$20240826$20240826$PER$$US-VERTEX PHARMACEUTICALS-2024-013534$VERTEX$$$$$$Y$$$20240826$$CN$US$US
242489581$24248958$1$I$$20240822$20240826$20240826$EXP$$JP-AstraZeneca-2024A192280$ASTRAZENECA$$77$YR$$F$Y$$$20240826$$MD$JP$
242489591$24248959$1$I$20240423$20240816$20240826$20240826$EXP$FR-AFSSAPS-TS2024000902$FR-TEVA-VS-3234168$TEVA$$37$YR$$F$Y$82$KG$20240826$$MD$FR$FR
242489601$24248960$1$I$20240724$20240731$20240826$20240826$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000716$PAREXEL$$$$$$Y$$$20240826$$HP$US$US
242489611$24248961$1$I$$20240726$20240826$20240826$PER$$US-Eisai-EC-2024-171050$EISAI$$$$$$Y$$$20240826$$MD$US$US
242489621$24248962$1$I$$20240822$20240826$20240826$EXP$$AU-MYLANLABS-2024M1078197$MYLAN$$$$$F$Y$$$20240826$$PH$AU$AU
242489632$24248963$2$F$$20240823$20240826$20240826$PER$$US-GILEAD-2024-0685298$GILEAD$$$$$$Y$$$20240826$$LW$US$US
242489642$24248964$2$F$$20240823$20240826$20240827$PER$$US-JNJFOC-20240855369$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240827$$HP$US$US
242489651$24248965$1$I$$20240812$20240826$20240826$EXP$$RU-EPICPHARMA-RU-2024EPCLIT01025$EPIC PHARM$EV Gantsgorn.A Clinical Case of Carbamazepine-Induced Hepatitis .Eksperimental^naia i Klinicheskaia Farmakologiia.JAN-2024;87:21-24$31$YR$A$F$Y$$$20240826$$HP$RU$RU
242489661$24248966$1$I$$20240815$20240826$20240826$PER$$US-JNJFOC-20240839596$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$MD$US$US
242489671$24248967$1$I$$20240813$20240826$20240826$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240800078$UPSHER SMITH LABORATORIES$$$$$$Y$$$20240826$$MD$US$US
242489682$24248968$2$F$20240812$20240912$20240826$20240922$PER$$US-GSK-US2024102730$GLAXOSMITHKLINE$$61$YR$$M$Y$$$20240922$$CN$US$US
242489693$24248969$3$F$$20240829$20240826$20240902$EXP$$NVSC2024AU170456$NOVARTIS$$$$$F$Y$$$20240902$$CN$AU$AU
242489701$24248970$1$I$$20240801$20240826$20240826$PER$$AU-TOLMAR, INC.-24AU051496$TOLMAR$$$$$M$Y$$$20240826$$CN$AU$AU
242489711$24248971$1$I$$20240731$20240826$20240826$PER$$AU-TOLMAR, INC.-24AU051563$TOLMAR$$$$$M$Y$$$20240826$$CN$AU$AU
242489721$24248972$1$I$$20240808$20240826$20240826$PER$$US-MYLANLABS-2024M1076498$MYLAN$$$$$F$Y$$$20240826$$CN$US$US
242489731$24248973$1$I$$20240819$20240826$20240826$EXP$$AU-AMGEN-AUSSP2024165860$AMGEN$$17$YR$T$$Y$$$20240826$$MD$AU$AU
242489741$24248974$1$I$20240811$20240821$20240826$20240826$EXP$$GB-AUROBINDO-AUR-APL-2024-042348$AUROBINDO$$78$YR$$M$Y$$$20240826$$PH$GB$GB
242489751$24248975$1$I$$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015205$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240826$$CN$US$US
242489761$24248976$1$I$$20240812$20240826$20240826$EXP$$JP-EPICPHARMA-JP-2024EPCLIT01022$EPIC PHARM$Ryuta Uwatoko.Shiga toxin-producing Escherichia coli-associated hemolytic uremic  syndrome with recurrent acute cholecystitis: a case report.CEN Case Reports.14-NOV-2023;13:215-219$83$YR$E$M$Y$$$20240826$$HP$JP$JP
242489771$24248977$1$I$20240725$20240731$20240826$20240826$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000717$PAREXEL$$$$$$Y$$$20240826$$HP$US$US
242489781$24248978$1$I$$20240814$20240826$20240826$PER$$US-ABBVIE-5885942$ABBVIE$$$$$$Y$$$20240826$$HP$US$US
242489791$24248979$1$I$20240617$20240816$20240826$20240826$EXP$FR-AFSSAPS-TO2024001173$FR-TEVA-VS-3234366$TEVA$$70$YR$$M$Y$61$KG$20240826$$MD$FR$FR
242489801$24248980$1$I$$20240817$20240826$20240826$PER$$US-BAYER-2024A119535$BAYER$$$$$F$Y$$$20240826$$CN$US$US
242489811$24248981$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064823$ROCHE$$$$A$F$Y$$$20240826$$CN$US$US
242489821$24248982$1$I$20110101$20240819$20240826$20240826$EXP$$US-ORGANON-1607USA007809$ORGANON$$$$$F$Y$60.317$KG$20240826$$CN$US$US
242489831$24248983$1$I$$20240819$20240826$20240826$PER$$US-MYLANLABS-2024M1077601$MYLAN$$$$$F$Y$$$20240826$$PH$US$US
242489841$24248984$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133125$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240826$$HP$US$US
242489851$24248985$1$I$$20240820$20240826$20240826$EXP$$US-LEO Pharma-372939$LEO PHARM$$55$YR$$M$Y$$$20240826$$PH$US$US
242489861$24248986$1$I$20240712$20240820$20240826$20240826$PER$$US-ALXN-202408USA001352US$ALEXION PHARMACEUTICALS$$62$YR$$M$Y$$$20240826$$CN$US$US
242489871$24248987$1$I$$20240812$20240826$20240826$EXP$$US-EPICPHARMA-US-2024EPCLIT01023$EPIC PHARM$Q. Abdelal.Azith and the Myth.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A2032$73$YR$E$F$Y$$$20240826$$HP$US$US
242489881$24248988$1$I$$20240823$20240826$20240826$EXP$$NVSC2024AU171942$NOVARTIS$$$$$$Y$$$20240826$$MD$AU$AU
242489891$24248989$1$I$$20240819$20240826$20240826$PER$$US-BAYER-2024A119856$BAYER$$$$$M$Y$$$20240826$$HP$US$US
242489911$24248991$1$I$20221101$20240820$20240826$20240826$EXP$FR-AFSSAPS-LM2024000449$FR-UCBSA-2024042911$UCB$$$$$F$Y$68$KG$20240826$$MD$FR$FR
242489921$24248992$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58379$$FDA-CTU$$56$YR$$M$N$$$20240823$N$$US$
242489931$24248993$1$I$20240820$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58579$$FDA-CTU$$51$DY$$F$N$61.23$KG$20240822$Y$CN$US$
242489941$24248994$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58346$$FDA-CTU$$71$YR$$F$N$104.78$KG$20240823$N$$US$
242489951$24248995$1$I$20240702$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58567$$FDA-CTU$$22$YR$$F$N$$$20240822$N$PH$US$
242489961$24248996$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58318$$FDA-CTU$$56$YR$$F$N$90.72$KG$20240823$N$$US$
242489971$24248997$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58347$$FDA-CTU$$54$YR$$F$N$$$20240823$N$HP$US$
242489981$24248998$1$I$20240612$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58578$$FDA-CTU$$83$YR$$F$N$54.43$KG$20240822$N$MD$US$
242489992$24248999$2$F$20240626$20240911$20240826$20240916$EXP$$US-MYLANLABS-2024M1077203$MYLAN$$69$YR$$F$Y$63.04$KG$20240916$$CN$US$US
242490001$24249000$1$I$$20240822$20240826$20240826$PER$$US-ABBVIE-5892823$ABBVIE$$$$$$Y$$$20240826$$CN$US$US
242490011$24249001$1$I$$20240816$20240826$20240826$EXP$$IN-BIOCON BIOLOGICS LIMITED-BBL2024006172$BIOCON$Negi S, Ranjan P.. Veno occlusive disease (sinusoidal obstruction syndrome) - case series.. Journal of Clinical and Experimental Hepatology. 2024;14(Suppl 1)$$$$$Y$$$20240826$$HP$IN$IN
242490021$24249002$1$I$20240801$20240802$20240826$20240826$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000736$PAREXEL$$$$$$Y$$$20240826$$PH$US$US
242490031$24249003$1$I$20240717$20240802$20240826$20240826$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000749$PAREXEL$$$$$$Y$$$20240826$$PH$US$US
242490041$24249004$1$I$20240101$20240805$20240826$20240826$PER$$US-Eisai-EC-2024-171555$EISAI$$73$YR$E$M$Y$$$20240826$$CN$US$US
242490051$24249005$1$I$$20240814$20240826$20240826$PER$$US-AMGEN-USASP2024166024$AMGEN$$$$$$Y$$$20240826$$PH$US$US
242490061$24249006$1$I$$20240814$20240826$20240826$EXP$$US-AMGEN-USASP2024164567$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242490071$24249007$1$I$20240615$20240823$20240826$20240826$EXP$$US-UCBSA-2024042970$UCB$$55$YR$$F$Y$$$20240826$$CN$US$US
242490081$24249008$1$I$$20240820$20240826$20240826$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004668$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
242490091$24249009$1$I$$20240820$20240826$20240826$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004666$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
242490101$24249010$1$I$20240801$20240822$20240826$20240826$EXP$$RO-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004718$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240826$$MD$RO$RO
242490111$24249011$1$I$$20240801$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047769$BOEHRINGER INGELHEIM$$52$YR$A$F$Y$$$20240826$$CN$US$US
242490121$24249012$1$I$$20240822$20240826$20240826$EXP$$US-BIOVITRUM-2024-US-011192$BIOVITRUM$$72$YR$$F$Y$$$20240826$$HP$US$US
242490131$24249013$1$I$$20240822$20240826$20240826$EXP$$GB-PFIZER INC-202400242346$PFIZER$Millen, G.. Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom. British Journal of Cancer. 2024;131(3):491-497$$$N$$Y$$$20240826$$HP$GB$GB
242490141$24249014$1$I$$20240821$20240826$20240826$EXP$$US-PFIZER INC-PV202400107174$PFIZER$McIntee, M.. ^^The Patient Is Being Pressured!^^ Coercion Versus Relational Autonomy. Journal of Palliative Medicine. 2024;27(7):964-967$70$YR$$M$Y$$$20240826$$MD$US$US
242490151$24249015$1$I$$20240823$20240826$20240826$EXP$$IN-PFIZER INC-PV202200066242$PFIZER$$41$YR$$F$Y$$$20240826$$CN$IN$IN
242490161$24249016$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134895$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240826$$HP$US$US
242490172$24249017$2$F$20240819$20240827$20240826$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134270$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240828$$CN$JP$JP
242490181$24249018$1$I$$20240819$20240826$20240826$EXP$$CA-GSK-CA2020AMR161154$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$CA$CA
242490191$24249019$1$I$$20240816$20240826$20240826$EXP$$DE-TEVA-VS-3234274$TEVA$$32$YR$$F$Y$75$KG$20240826$$MD$DE$DE
242490211$24249021$1$I$$20240819$20240826$20240826$EXP$$NVSC2024CR169538$NOVARTIS$$$$$M$Y$59$KG$20240826$$CN$CR$CR
242490221$24249022$1$I$20240102$20240815$20240826$20240826$EXP$$NVSC2024GB001715$NOVARTIS$$59$YR$$F$Y$$$20240826$$CN$GB$GB
242490232$24249023$2$F$$20240822$20240826$20240827$EXP$DE-DCGMA-24203692$NVSC2024DE171230$NOVARTIS$$$$$$Y$$$20240827$$CN$DE$DE
242490242$24249024$2$F$$20240904$20240826$20240906$EXP$$NVSC2024US171311$NOVARTIS$$$$$F$Y$54.8$KG$20240906$$HP$US$US
242490253$24249025$3$F$20240801$20240913$20240826$20240917$EXP$$NVSC2024CA170864$NOVARTIS$$61$YR$$M$Y$$$20240917$$CN$CA$CA
242490261$24249026$1$I$$20240822$20240826$20240826$EXP$$NVSC2024GB171299$NOVARTIS$Edwards GM, Alejmi AA. Edwards GM, Alejmi AA. Pure red cell aplasia secondary to erythropoietin therapy. CLINICAL MEDICINE. 2024;24 (4):1-3$53$YR$$M$Y$$$20240826$$HP$GB$GB
242490271$24249027$1$I$$20240822$20240826$20240826$EXP$$NVSC2024KR171010$NOVARTIS$$$$$$Y$$$20240826$$MD$KR$KR
242490281$24249028$1$I$$20240821$20240826$20240826$EXP$$NVSC2024CA171275$NOVARTIS$$47$YR$$F$Y$$$20240826$$HP$CA$CA
242490292$24249029$2$F$20240817$20240910$20240826$20240913$EXP$$NVSC2024NL169659$NOVARTIS$$73$YR$$M$Y$$$20240913$$CN$NL$NL
242490301$24249030$1$I$$20240819$20240826$20240826$EXP$$NVSC2024AU169025$NOVARTIS$Khan ZS, Saini SK, Chua WJ, Liao HT, Manikkam S. Kartagener syndrome with pectus excavatum and upper lobar bronchiectasis. RADIOLOGY CASE REPORTS. 2024;19(9):3952-8$$$$M$Y$$$20240826$$HP$AU$AU
242490311$24249031$1$I$$20240822$20240826$20240826$EXP$$NVSC2024US170858$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
242490321$24249032$1$I$20240601$20240822$20240826$20240826$EXP$$NVSC2024RU171362$NOVARTIS$$66$YR$$F$Y$$$20240826$$MD$RU$RU
242490331$24249033$1$I$20240805$20240816$20240826$20240826$EXP$IT-MINISAL02-998475$IT-TEVA-VS-3234209$TEVA$$87$YR$$F$Y$55$KG$20240826$$MD$IT$IT
242490341$24249034$1$I$20230901$20240823$20240826$20240826$EXP$$US-AstraZeneca-2024A193040$ASTRAZENECA$$837$MON$$M$Y$$$20240826$$HP$US$
242490352$24249035$2$F$20240815$20240912$20240826$20240916$PER$$US-ROCHE-10000061388$ROCHE$$31$YR$A$F$Y$$$20240916$$CN$US$US
242490361$24249036$1$I$$20240821$20240826$20240826$EXP$$AU-TAKEDA-2021TUS033207$TAKEDA$$$$$F$Y$$$20240826$$PH$AU$AU
242490371$24249037$1$I$20240101$20240819$20240826$20240826$EXP$$CA-ABBVIE-5887691$ABBVIE$$59$YR$$$Y$$$20240826$$HP$CA$CA
242490381$24249038$1$I$$20240819$20240826$20240826$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037477$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240826$$CN$US$US
242490391$24249039$1$I$$20240823$20240826$20240826$EXP$$US-ABBVIE-5892727$ABBVIE$$$$$F$Y$$$20240826$$HP$US$US
242490411$24249041$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58374$$FDA-CTU$$59$YR$$F$N$$$20240823$N$$US$
242490431$24249043$1$I$20240823$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58400$$FDA-CTU$$88$YR$$F$N$$$20240823$Y$PH$US$
242490441$24249044$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58392$$FDA-CTU$$$$$M$N$$$20240823$N$HP$US$
242490452$24249045$2$F$$20240826$20240826$20240830$PER$$US-BIOVITRUM-2024-US-011204$BIOVITRUM$Tinajero J, Trang D, Ngo D, Ali H. Pacritinib and concurrent azole antifungal therapy is deliverable in patients with hematologic malignancies. Journal of Oncology Pharmacy Practice. 2024;0(0): 1-5. doi:10.1177/1078155224/275205.$8$DEC$$M$Y$$$20240830$$HP$US$US
242490471$24249047$1$I$20240619$20240822$20240826$20240826$EXP$$NVSC2024US170978$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
242490481$24249048$1$I$$20240822$20240826$20240826$EXP$$US-ABBVIE-5891723$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242490491$24249049$1$I$20240722$20240821$20240826$20240826$EXP$$IN-ROCHE-10000015030$ROCHE$$77$YR$E$M$Y$$$20240826$$MD$IN$IN
242490501$24249050$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000063850$ROCHE$$68$YR$E$F$Y$$$20240826$$CN$US$US
242490512$24249051$2$F$$20240826$20240826$20240830$PER$$US-BIOVITRUM-2024-US-011275$BIOVITRUM$Tinajero J, Trang D, Ngo D, Ali H. Pacritinib and concurrent azole antifungal therapy is deliverable in patients with hematologic malignancies. Journal of Oncology Pharmacy Practice. 2024;0(0): 1-5. doi:10.1177/1078155224/275205.$7$DEC$$M$Y$$$20240830$$HP$US$US
242490522$24249052$2$F$$20240826$20240826$20240830$PER$$US-BIOVITRUM-2024-US-011273$BIOVITRUM$Tinajero J, Trang D, Ngo D, Ali H. Pacritinib and concurrent azole antifungal therapy is deliverable in patients with hematologic malignancies. Journal of Oncology Pharmacy Practice. 2024;0(0): 1-5. doi:10.1177/1078155224/275205.$8$DEC$$M$Y$$$20240830$$HP$US$US
242490531$24249053$1$I$$20240814$20240826$20240826$PER$$US-MYLANLABS-2021M1037055$MYLAN$$$$$F$Y$88.9$KG$20240826$$CN$US$US
242490541$24249054$1$I$$20240820$20240826$20240826$EXP$$GB-SANDOZ INC.-SDZ2024GB015093$SANDOZ$$$$$M$Y$$$20240826$$CN$GB$GB
242490561$24249056$1$I$$20240819$20240826$20240826$PER$$US-BAYER-2024A120073$BAYER$$$$$F$Y$$$20240826$$HP$US$US
242490571$24249057$1$I$20240802$20240821$20240826$20240826$EXP$$US-ABBVIE-5890598$ABBVIE$$65$YR$$F$Y$$$20240826$$CN$US$US
242490581$24249058$1$I$$20240814$20240826$20240826$PER$$US-JNJFOC-20240839273$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$HP$US$US
242490592$24249059$2$F$20240731$20240910$20240826$20240916$EXP$$US-ABBVIE-5891383$ABBVIE$$26$YR$$M$Y$63$KG$20240916$$CN$US$US
242490601$24249060$1$I$20240801$20240819$20240826$20240826$EXP$$FR-ABBVIE-5889656$ABBVIE$$82$YR$$M$Y$$$20240826$$CN$FR$FR
242490611$24249061$1$I$20240618$20240823$20240826$20240826$EXP$$CN-BAYER-2024A122153$BAYER$$78$YR$E$M$Y$76$KG$20240826$$HP$CN$CN
242490621$24249062$1$I$20240811$20240816$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130971$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240826$$PH$US$US
242490631$24249063$1$I$$20240812$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128823$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240826$$PH$US$US
242490642$24249064$2$F$20240101$20240827$20240826$20240831$EXP$$US-ABBVIE-5892182$ABBVIE$$$$$M$Y$86$KG$20240831$$CN$US$US
242490652$24249065$2$F$20240722$20240918$20240826$20240923$EXP$$JP-ARGENX-2024-ARGX-JP006217$ARGENX BVBA$$$$$$Y$$$20240923$$CN$JP$JP
242490661$24249066$1$I$20240701$20240821$20240826$20240826$EXP$$US-ABBVIE-5891307$ABBVIE$$67$YR$$M$Y$$$20240826$$CN$US$US
242490671$24249067$1$I$$20240820$20240826$20240826$EXP$$CA-ABBVIE-5892716$ABBVIE$$$$A$M$Y$$$20240826$$CN$CA$CA
242490683$24249068$3$F$$20240823$20240826$20240830$EXP$$NVSC2024GB168825$NOVARTIS$$$$$F$Y$$$20240830$$CN$GB$GB
242490691$24249069$1$I$$20240812$20240826$20240826$EXP$$ET-EPICPHARMA-ET-2024EPCLIT01031$EPIC PHARM$Hagazi Tesfay.Predictors of infective endocarditis associated in-hospital mortality in Ayder Comprehensive Specialized Hospital, Tigray, North Ethiopia: Microbiological,clinical features, and management profiles.PLOS One.02-MAY-2024;19:1-24$$$A$$Y$$$20240826$$HP$ET$ET
242490703$24249070$3$F$20210101$20240903$20240826$20240905$EXP$$NVSC2024ZA170872$NOVARTIS$$$$A$F$Y$$$20240905$$HP$ZA$ZA
242490711$24249071$1$I$$20240822$20240826$20240826$EXP$GB-MHRA-MIDB-0b987871-d6c4-4d3e-955e-e973ea10c63d$GB-MYLANLABS-2024M1077996$MYLAN$$85$YR$$F$Y$$$20240826$$PH$GB$GB
242490721$24249072$1$I$$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024166136$AMGEN$$$$$$Y$$$20240826$$CN$US$US
242490731$24249073$1$I$20240101$20240820$20240826$20240826$EXP$$US-ABBVIE-5888742$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242490741$24249074$1$I$$20240819$20240826$20240826$EXP$$US-TAKEDA-2024TUS084077$TAKEDA$$$$$M$Y$$$20240826$$MD$US$US
242490751$24249075$1$I$20240807$20240816$20240826$20240826$EXP$$CN-009507513-2408CHN007172$MERCK$$65$YR$$F$Y$$$20240826$$HP$CN$CN
242490762$24249076$2$F$20240101$20240823$20240826$20240830$PER$$US-AMGEN-USASP2024169581$AMGEN$$37$YR$A$M$Y$$$20240830$$HP$US$US
242490772$24249077$2$F$$20240823$20240826$20240829$PER$$US-AMGEN-USASP2024169188$AMGEN$$$$$F$Y$$$20240829$$HP$US$US
242490782$24249078$2$F$20240801$20240919$20240826$20240924$EXP$$US-JNJFOC-20240854885$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240924$$CN$US$US
242490791$24249079$1$I$20240814$20240826$20240826$20240826$EXP$SI-JAZMP-NCPHV-2024SI0842_0842$SI-BAYER-2024A122209$BAYER$$62$YR$A$F$Y$$$20240826$$PH$SI$SI
242490801$24249080$1$I$$20240820$20240826$20240826$PER$$US-BAYER-2024A120305$BAYER$$$$$F$Y$$$20240826$$HP$US$US
242490821$24249082$1$I$$20240820$20240826$20240826$EXP$$US-ORG100016242-2024000543$PACIRA$Polycarpou A, Chopko TC, Glasgow AE, McCarthy SR, Hilliker DR, Wilder RT, Klinkner DB. One-year Results of Minimally Invasive Sutured Fixation of the Slipped Ribs in the Pediatric Population. Journal of Pediatric Surgery. 2023 Sep 01;59:9:1703-1707. doi:10.1016/j.jpedsurg.2024.02.027$$$$$Y$$$20240826$$MD$US$US
242490831$24249083$1$I$$20240812$20240826$20240826$EXP$$US-EPICPHARMA-US-2024EPCLIT01024$EPIC PHARM$Fortich M.Meth, PCP or Both? A Case of Diffuse Alveolar Hemorrhage in the Setting of Combined Amphetamine and Phencyclidine Use.American Journal of Respiratory and Critical Care Medicine.2024;209$37$YR$A$M$Y$$$20240826$$HP$US$US
242490841$24249084$1$I$$20240822$20240826$20240826$EXP$$VN-SANDOZ INC.-SDZ2024VN075050$SANDOZ$Nguyen QH, Nguyen TM, Vo VX, Nguyen TTH, Nguyen TTQ. So Sanh Ket Qua Lau Dai Giua Hoa X? Tr? Dong Thoi Phac Do Folfox So Voi Phac Do Cf Trong Dieu Tr? Ung Thu Thuc Quan Giai Do?n Khong Mo Duoc T?i Benh Vien K Va Benh Vien Ung Buou Tinh Thanh Hoa [Comparison Of Long-Term Results Between Definitive Chemoradiotherapy Concurrent with Folfox Versus Cf In Patients With Inoperable Easophageal Cancer At K Hospital And Thanh Hoa Oncology Hospital]. VIETNAM MEDICAL JOURNAL. 2022;517 (1):84-8$$$$$Y$$$20240826$$HP$VN$VN
242490851$24249085$1$I$20240624$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58397$$FDA-CTU$$77$YR$$F$N$$$20240823$Y$PH$US$
242490861$24249086$1$I$$20240812$20240826$20240826$EXP$$CA-LUPIN PHARMA CANADA-2024-03017$LUPIN$Sillcox C, Gabrielli S, O^Keefe A, McCusker C, Abrams EM, Eiwegger T, et al. Assessing pediatric cephalosporin allergic reactions through direct graded oral challenges. American Academy of Allergy, Asthma + Immunology. 2024;12:156-164$$$$$Y$$$20240826$$HP$CA$CA
242490871$24249087$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064422$ROCHE$$$$E$F$Y$67.13$KG$20240826$$CN$US$US
242490882$24249088$2$F$20231010$20240826$20240826$20240902$EXP$$CA-GSK-CA2023139010$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$CA$CA
242490891$24249089$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58356$$FDA-CTU$$76$YR$$F$N$$$20240823$N$$US$
242490902$24249090$2$F$20240809$20240912$20240826$20240924$PER$$US-ALKERMES INC.-ALK-2024-002111$ALKERMES$$44$YR$$F$Y$124.26$KG$20240924$$HP$US$US
242490912$24249091$2$F$$20240917$20240826$20240924$PER$$US-ALKERMES INC.-ALK-2024-002122$ALKERMES$$$$$M$Y$133.79$KG$20240924$$MD$US$US
242490922$24249092$2$F$20240806$20240828$20240826$20240904$EXP$$JP-ARGENX-2024-ARGX-JP006818AA$ARGENX BVBA$$$$$$Y$$$20240904$$MD$JP$JP
242490931$24249093$1$I$20240814$20240820$20240826$20240826$EXP$$NVSC2024DE171105$NOVARTIS$$36$YR$$F$Y$$$20240826$$MD$DE$DE
242490941$24249094$1$I$20240816$20240819$20240826$20240826$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000836$PAREXEL$$$$$$Y$$$20240826$$HP$CN$CN
242490951$24249095$1$I$$20240803$20240826$20240826$PER$$US-Eisai-EC-2024-171888$EISAI$$$$$F$Y$$$20240826$$HP$US$US
242490962$24249096$2$F$$20240925$20240826$20240927$EXP$$US-TAKEDA-2024TUS085116$TAKEDA$$$$$$Y$$$20240927$$MD$US$US
242490971$24249097$1$I$$20240815$20240826$20240826$PER$$US-ROCHE-10000059313$ROCHE$$$$$$Y$$$20240826$$CN$US$US
242490981$24249098$1$I$$20240819$20240826$20240826$EXP$$US-MYLANLABS-2024M1077939$MYLAN$$$$$$Y$$$20240826$$CN$US$US
242490991$24249099$1$I$20240701$20240812$20240826$20240826$PER$$US-ALKERMES INC.-ALK-2024-002115$ALKERMES$$55$YR$$F$Y$77.098$KG$20240826$$CN$US$US
242491001$24249100$1$I$20240813$20240816$20240826$20240826$PER$$US-ABBVIE-5886617$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242491011$24249101$1$I$$20240812$20240826$20240826$EXP$$ET-EPICPHARMA-ET-2024EPCLIT01032$EPIC PHARM$Hagazi Tesfay.Predictors of infective endocarditis associated in-hospital mortality in Ayder Comprehensive Specialized Hospital, Tigray, North Ethiopia: Microbiological,clinical features, and management profiles.PLOS One.02-MAY-2024;19:1-24$$$A$$Y$$$20240826$$HP$ET$ET
242491021$24249102$1$I$$20240815$20240826$20240826$PER$$US-BAYER-2024A118259$BAYER$$12$YR$C$F$Y$$$20240826$$CN$US$US
242491031$24249103$1$I$$20240812$20240823$20240823$DIR$FDA-CDER-CTU-2024-58377$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242491041$24249104$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58383$$FDA-CTU$$$$$F$N$$$20240823$N$HP$US$
242491051$24249105$1$I$20240801$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58326$$FDA-CTU$$73$YR$$F$N$$$20240823$N$PH$US$
242491061$24249106$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58390$$FDA-CTU$$$$$M$N$$$20240823$N$HP$US$
242491071$24249107$1$I$20240823$20240823$20240823$20240823$DIR$715678$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242491081$24249108$1$I$20220101$20240814$20240826$20240826$EXP$$NL-JNJFOC-20240849457$JOHNSON AND JOHNSON$$4$YR$C$F$Y$$$20240826$$CN$NL$US
242491091$24249109$1$I$20240815$20240822$20240826$20240826$PER$$US-JNJFOC-20240857707$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240826$$CN$US$US
242491101$24249110$1$I$$20240822$20240826$20240826$PER$$US-JNJFOC-20240858122$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$CN$US$US
242491111$24249111$1$I$$20240822$20240826$20240826$PER$$US-JNJFOC-20240859415$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242491121$24249112$1$I$$20240813$20240826$20240826$EXP$GB-MHRA-MED-202407311408079480-RQVLB$GB-LUPIN PHARMACEUTICALS INC.-2024-07713$LUPIN$$$$$$Y$$$20240826$$MD$GB$GB
242491131$24249113$1$I$$20240816$20240826$20240826$PER$$US-BAYER-2024A121689$BAYER$$$$$$Y$$$20240826$$CN$US$US
242491142$24249114$2$F$$20240821$20240826$20240906$PER$$US-AstraZeneca-2024A191582$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242491151$24249115$1$I$$20240819$20240826$20240826$EXP$$NVSC2024CA171709$NOVARTIS$$51$YR$$M$Y$83.3$KG$20240826$$HP$CA$CA
242491162$24249116$2$F$20240805$20240822$20240826$20240904$EXP$$NVSC2024CN171201$NOVARTIS$$88$YR$$F$Y$$$20240905$$HP$CN$CN
242491171$24249117$1$I$20240801$20240820$20240826$20240826$EXP$$US-AMGEN-USASP2024166133$AMGEN$$78$YR$E$F$Y$$$20240826$$MD$US$US
242491192$24249119$2$F$20240801$20240820$20240826$20240903$PER$$US-ALKERMES INC.-ALK-2024-002134$ALKERMES$$62$YR$$F$Y$$$20240903$$HP$US$US
242491202$24249120$2$F$20240706$20240827$20240826$20240830$EXP$IT-MINISAL02-999401$IT-JNJFOC-20240859516$JOHNSON AND JOHNSON$$66$YR$E$M$Y$90$KG$20240830$$PH$IT$IT
242491211$24249121$1$I$20240417$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58354$$FDA-CTU$$51$YR$$F$N$$$20240823$Y$PH$US$
242491221$24249122$1$I$20240401$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58328$$FDA-CTU$$56$YR$$M$N$$$20240823$Y$HP$US$
242491231$24249123$1$I$$20240812$20240826$20240826$EXP$$IR-EPICPHARMA-IR-2024EPCLIT01027$EPIC PHARM$Zahra Allameh.Levofloxacin-Induced Oromandibular Dystonia in a 9-Year-Old Patient.Iranian Journal of Child Neurology.JAN-2024;18 No.3:151-157$9$YR$C$M$Y$$$20240826$$HP$IR$IR
242491241$24249124$1$I$$20240819$20240826$20240826$PER$$US-BAYER-2024A119272$BAYER$$$$$$Y$$$20240826$$CN$US$US
242491251$24249125$1$I$$20240820$20240826$20240826$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004667$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
242491261$24249126$1$I$$20240820$20240826$20240826$PER$$US-BAYER-2024A120559$BAYER$$$$$$Y$$$20240826$$CN$US$US
242491271$24249127$1$I$$20240730$20240826$20240826$PER$$US-Eisai-EC-2024-171171$EISAI$$$$E$F$Y$$$20240826$$CN$US$US
242491281$24249128$1$I$$20240812$20240826$20240826$PER$$US-AMGEN-USASP2024163244$AMGEN$Chang S.M.; Clingo M.; Bustamante D. et al.. Hypertrophic pachymeningitis as an unusual presentation of a patient with SLC29A3 spectrum disorder:Considering the use of next-generation sequencing. Pediatric Blood + Cancer. 2024;71 (9):1-3$17$YR$T$M$Y$$$20240826$$HP$US$US
242491291$24249129$1$I$20240101$20240813$20240826$20240826$PER$$US-ALKERMES INC.-ALK-2024-002156$ALKERMES$$$$$M$Y$$$20240826$$MD$US$US
242491301$24249130$1$I$20240813$20240814$20240826$20240826$PER$$US-ALKERMES INC.-ALK-2024-002135$ALKERMES$$40$YR$$F$Y$$$20240826$$PH$US$US
242491311$24249131$1$I$$20240820$20240826$20240826$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004669$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
242491322$24249132$2$F$$20240922$20240826$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134990$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$60.33$KG$20240923$$CN$US$US
242491331$24249133$1$I$$20240820$20240826$20240826$EXP$$CA-TAKEDA-2024TUS075267$TAKEDA$$$$$M$Y$$$20240826$$MD$CA$CA
242491341$24249134$1$I$20240724$20240826$20240826$20240826$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047774$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240826$$CN$US$US
242491351$24249135$1$I$$20240812$20240826$20240826$EXP$$US-PURACAP-US-2024EPCLIT01028$PURACAP$M. Elsayed.An Interesting Case of Drug-Induced Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis with Pulmonary and Renal Involvement .American Journal of Respiratory and Critical Care Medicine.2024;209:A5780$75$YR$E$M$Y$$$20240826$$HP$US$US
242491361$24249136$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064307$ROCHE$$$$E$M$Y$$$20240826$$CN$US$US
242491372$24249137$2$F$$20240905$20240826$20240913$EXP$$CA-TAKEDA-2024TUS083855$TAKEDA$$$$$F$Y$$$20240913$$CN$CA$CA
242491381$24249138$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064607$ROCHE$$$$A$F$Y$$$20240826$$CN$US$US
242491391$24249139$1$I$20240730$20240816$20240826$20240826$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024102617$VIIV$$50$YR$$M$Y$$$20240826$$MD$US$US
242491401$24249140$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014622$ELI LILLY AND CO$$$$$$Y$$$20240826$$CN$US$US
242491421$24249142$1$I$20230428$20240823$20240823$20240823$DIR$715657$$FDA-CTU$$66$YR$$F$N$58.05$KG$20240823$N$CN$US$
242491431$24249143$1$I$20240823$20240823$20240823$20240823$DIR$715679$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242491441$24249144$1$I$20240729$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58351$$FDA-CTU$$76$YR$$M$N$$$20240823$N$PH$US$
242491451$24249145$1$I$$20240712$20240826$20240826$PER$$US-LUNDBECK-DKLU4001740$LUNDBECK$$$$$$Y$$$20240826$$CN$US$US
242491461$24249146$1$I$$20240819$20240826$20240826$PER$$US-ROCHE-10000061504$ROCHE$$$$$$Y$$$20240826$$MD$US$US
242491471$24249147$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000064238$ROCHE$$6$YR$C$F$Y$$$20240826$$CN$US$US
242491481$24249148$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064706$ROCHE$$71$YR$E$M$Y$$$20240826$$CN$US$US
242491491$24249149$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000064713$ROCHE$$34$YR$A$M$Y$$$20240826$$CN$US$US
242491501$24249150$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064683$ROCHE$$80$YR$E$F$Y$$$20240826$$CN$US$US
242491511$24249151$1$I$20240727$20240820$20240826$20240826$EXP$$US-TAKEDA-2024TUS084285$TAKEDA$$52$YR$$M$Y$$$20240826$$CN$US$US
242491521$24249152$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064340$ROCHE$$$$$$Y$$$20240826$$CN$US$US
242491531$24249153$1$I$20240613$20240821$20240826$20240826$PER$$US-BAYER-2024A120938$BAYER$$37$YR$A$F$Y$$$20240826$$HP$US$US
242491541$24249154$1$I$$20240821$20240826$20240826$EXP$$AU-ORGANON-O2408AUS001799$ORGANON$Unknown. Unknown. Unknown$78$YR$$F$Y$$$20240826$$MD$AU$AU
242491551$24249155$1$I$$20240811$20240826$20240826$EXP$$CN-JNJFOC-20240862603$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$HP$CN$CN
242491561$24249156$1$I$$20240820$20240826$20240826$EXP$$US-AstraZeneca-2024A190379$ASTRAZENECA$$$$$F$Y$$$20240826$$HP$US$
242491571$24249157$1$I$$20240821$20240826$20240826$PER$$US-AstraZeneca-2024A191745$ASTRAZENECA$$80$YR$$M$Y$$$20240826$$MD$US$
242491591$24249159$1$I$$20240821$20240826$20240826$EXP$$ZA-AstraZeneca-2024A191987$ASTRAZENECA$$58$YR$$M$Y$$$20240826$$CN$ZA$
242491601$24249160$1$I$20240720$20240816$20240826$20240826$EXP$DE-BFARM-24005464$DE-TEVA-VS-3234344$TEVA$$73$YR$$M$Y$91$KG$20240826$$MD$DE$DE
242491611$24249161$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064668$ROCHE$$$$A$F$Y$$$20240826$$CN$US$US
242491621$24249162$1$I$$20230808$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001903$AMERICAN REGENT$$$$$F$Y$$$20240826$$MD$US$US
242491631$24249163$1$I$20230807$20240405$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001942$AMERICAN REGENT$$17$YR$$F$Y$$$20240826$$PH$US$US
242491641$24249164$1$I$20230807$20240405$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001943$AMERICAN REGENT$$13$YR$$M$Y$$$20240826$$PH$US$US
242491651$24249165$1$I$20230809$20240405$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001940$AMERICAN REGENT$$8$YR$$M$Y$$$20240826$$PH$US$US
242491661$24249166$1$I$20230701$20230728$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001845$AMERICAN REGENT$$$$$$Y$$$20240826$$PH$US$US
242491671$24249167$1$I$$20230807$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001905$AMERICAN REGENT$$$$$$Y$$$20240826$$MD$US$US
242491681$24249168$1$I$20230706$20240405$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001944$AMERICAN REGENT$$15$YR$$F$Y$$$20240826$$PH$US$US
242491691$24249169$1$I$20240814$20240821$20240826$20240826$EXP$$CN-PFIZER INC-PV202400109296$PFIZER$$5$YR$$M$Y$$$20240826$$HP$CN$CN
242491701$24249170$1$I$$20240816$20240826$20240826$EXP$$PH-PFIZER INC-202400241729$PFIZER$$81$YR$$F$Y$$$20240826$$MD$PH$PH
242491711$24249171$1$I$$20240822$20240826$20240826$EXP$$CA-ORGANON-O2408CAN001658$ORGANON$$80$YR$$M$Y$89$KG$20240826$$HP$CA$CA
242491723$24249172$3$F$20240614$20240910$20240826$20240913$EXP$$JP-PFIZER INC-PV202400078779$PFIZER$$62$YR$$M$Y$70.2$KG$20240913$$PH$JP$JP
242491731$24249173$1$I$$20240823$20240826$20240826$EXP$$NVSC2023CL259985$NOVARTIS$$33$YR$$F$Y$$$20240826$$HP$CL$CL
242491741$24249174$1$I$$20240822$20240826$20240826$EXP$$GB-PFIZER INC-202400242945$PFIZER$Millen, G.. Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom. British Journal of Cancer. 2024;131(3):491-497$$$N$$Y$$$20240826$$HP$GB$GB
242491781$24249178$1$I$20220704$20240814$20240826$20240826$EXP$$CN-PFIZER INC-2022SGN06929$PFIZER$$48$YR$$M$Y$57$KG$20240826$$MD$CN$CN
242491791$24249179$1$I$$20240813$20240826$20240826$PER$$US-ALKERMES INC.-ALK-2024-002169$ALKERMES$$$$$F$Y$$$20240826$$CN$US$US
242491801$24249180$1$I$$20240812$20240826$20240826$EXP$$US-SMPA-2022MYSCI0300218$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242491811$24249181$1$I$$20240812$20240826$20240826$EXP$$US-SMPA-2024SPA001268$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242491821$24249182$1$I$$20240812$20240826$20240826$EXP$$US-SMPA-2024SPA001256$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242491833$24249183$3$F$$20240827$20240826$20240909$EXP$$US-SMPA-2023MYSCI0200466$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242491841$24249184$1$I$$20240812$20240826$20240826$EXP$$US-SMPA-2024SPA001265$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242491851$24249185$1$I$20231129$20240812$20240826$20240826$EXP$ES-AEMPS-1461139$HU-SMPA-2024SPA001228$SUNOVION$$$$$$Y$$$20240826$$MD$ES$ES
242491861$24249186$1$I$20231001$20240812$20240826$20240826$EXP$GB-MHRA-MED-202408121316327450-YWMFJ$HU-SMPA-2024SPA001229$SUNOVION$$$$$$Y$$$20240826$$CN$GB$GB
242491871$24249187$1$I$$20240812$20240826$20240826$EXP$$US-SMPA-2024SPA001124$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242491881$24249188$1$I$$20240812$20240826$20240826$EXP$$US-SMPA-2024SPA001092$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242491891$24249189$1$I$20240601$20240802$20240826$20240826$PER$$US-Vifor (International) Inc.-VIT-2024-06976$VIFOR$$79$YR$$F$Y$74.5$KG$20240826$$HP$US$US
242491901$24249190$1$I$$20240820$20240826$20240826$PER$$US-BIOGEN-2023BI01212772$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242491911$24249191$1$I$20240814$20240820$20240826$20240826$PER$$US-BIOGEN-2024BI01279212$BIOGEN$$46$YR$$F$Y$$$20240826$$CN$US$US
242491921$24249192$1$I$20240701$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024166849$AMGEN$$76$YR$E$M$Y$$$20240826$$CN$US$US
242491931$24249193$1$I$$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168503$AMGEN$$$$$M$Y$$$20240826$$CN$US$US
242491941$24249194$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58344$$FDA-CTU$$54$YR$$F$N$83.91$KG$20240823$N$$US$
242491951$24249195$1$I$20240804$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242557$PFIZER$$50$YR$$F$Y$$$20240826$$HP$US$US
242491961$24249196$1$I$$20240822$20240826$20240826$PER$$US-PFIZER INC-PV202400109712$PFIZER$$68$YR$$F$Y$$$20240826$$CN$US$US
242491971$24249197$1$I$20240821$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242579$PFIZER$$$$$F$Y$$$20240826$$CN$US$US
242491981$24249198$1$I$$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242106$PFIZER$$45$YR$$F$Y$$$20240826$$CN$US$US
242491991$24249199$1$I$$20240822$20240826$20240826$PER$$US-PFIZER INC-PV202400110477$PFIZER$$78$YR$$F$Y$$$20240826$$MD$US$US
242492001$24249200$1$I$20240820$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242499$PFIZER$$70$YR$$F$Y$$$20240826$$CN$US$US
242492011$24249201$1$I$$20240820$20240826$20240826$PER$$US-PFIZER INC-202300295007$PFIZER$$20$YR$$M$Y$$$20240826$$HP$US$US
242492021$24249202$1$I$$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242992$PFIZER$$58$YR$$F$Y$$$20240826$$HP$US$US
242492031$24249203$1$I$20240821$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242105$PFIZER$$30$YR$$F$Y$$$20240826$$CN$US$US
242492041$24249204$1$I$$20240820$20240826$20240826$EXP$$US-PFIZER INC-202400239753$PFIZER$Schwartz, W.. Intraorbital amphotericin B for mucormycosis in an Allo-HSCT recipient.. Bone Marrow Transplantation. 2024;59(8):1176-1177$68$YR$$M$Y$$$20240826$$MD$US$US
242492051$24249205$1$I$20240815$20240822$20240826$20240826$PER$$US-PFIZER INC-PV202400110328$PFIZER$$43$YR$$F$Y$$$20240826$$CN$US$US
242492061$24249206$1$I$$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242259$PFIZER$$89$YR$$F$Y$$$20240826$$HP$US$US
242492071$24249207$1$I$20240822$20240825$20240826$20240826$PER$$US-PFIZER INC-202400243529$PFIZER$$49$YR$$M$Y$$$20240826$$CN$US$US
242492091$24249209$1$I$$20240821$20240826$20240826$PER$$US-PFIZER INC-202400242163$PFIZER$$67$YR$$F$Y$$$20240826$$HP$US$US
242492101$24249210$1$I$$20240822$20240826$20240826$PER$$US-PFIZER INC-PV202400109702$PFIZER$$79$YR$$F$Y$$$20240826$$HP$US$US
242492111$24249211$1$I$$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242327$PFIZER$$61$YR$$F$Y$$$20240826$$CN$US$US
242492121$24249212$1$I$$20240821$20240826$20240826$PER$$US-PFIZER INC-202400241496$PFIZER$$57$YR$$F$Y$$$20240826$$MD$US$US
242492131$24249213$1$I$20160101$20240821$20240826$20240826$PER$$US-PFIZER INC-202400241340$PFIZER$$58$YR$$F$Y$$$20240826$$MD$US$US
242492141$24249214$1$I$20240101$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242586$PFIZER$$77$YR$$M$Y$84.82$KG$20240826$$CN$US$US
242492151$24249215$1$I$$20240820$20240826$20240826$PER$$US-PFIZER INC-202400095408$PFIZER$$32$YR$$M$Y$$$20240826$$CN$US$US
242492161$24249216$1$I$$20240824$20240826$20240826$PER$$US-PFIZER INC-202400243520$PFIZER$$31$YR$$F$Y$$$20240826$$HP$US$US
242492171$24249217$1$I$20240101$20240821$20240826$20240826$PER$$US-PFIZER INC-PV202400109639$PFIZER$$33$YR$$M$Y$$$20240826$$HP$US$US
242492181$24249218$1$I$$20240823$20240826$20240826$PER$$US-BAYER-2024A121843$BAYER$$$$$$Y$$$20240826$$CN$US$US
242492201$24249220$1$I$20240823$20240823$20240826$20240826$PER$$US-PFIZER INC-202400242698$PFIZER$$68$YR$$F$Y$$$20240826$$CN$US$US
242492212$24249221$2$F$20240821$20240923$20240826$20240925$PER$$US-PFIZER INC-202400241153$PFIZER$$78$YR$$F$Y$79.38$KG$20240925$$CN$US$US
242492221$24249222$1$I$$20240823$20240826$20240826$PER$$US-PFIZER INC-202400242808$PFIZER$$69$YR$$F$Y$$$20240826$$CN$US$US
242492231$24249223$1$I$20240820$20240821$20240826$20240826$PER$$US-PFIZER INC-202400241448$PFIZER$$77$YR$$F$Y$$$20240826$$CN$US$US
242492241$24249224$1$I$$20240821$20240826$20240826$PER$$US-PFIZER INC-PV202400109599$PFIZER$$75$YR$$M$Y$$$20240826$$CN$US$US
242492252$24249225$2$F$$20240822$20240826$20240828$PER$$US-PFIZER INC-PV202400109886$PFIZER$$74$YR$$F$Y$$$20240828$$CN$US$US
242492261$24249226$1$I$$20240821$20240826$20240826$PER$$US-PFIZER INC-PV202400109824$PFIZER$$50$YR$$M$Y$$$20240826$$HP$US$US
242492271$24249227$1$I$20240726$20240819$20240826$20240826$PER$$US-PFIZER INC-202400239502$PFIZER$$62$YR$$F$Y$$$20240826$$MD$US$US
242492281$24249228$1$I$20240101$20240821$20240826$20240826$PER$$US-PFIZER INC-PV202400109837$PFIZER$$41$YR$$F$Y$$$20240826$$HP$US$US
242492293$24249229$3$F$$20240830$20240826$20240904$PER$$US-PFIZER INC-202400241757$PFIZER$$70$YR$$F$Y$$$20240904$$CN$US$US
242492301$24249230$1$I$$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242135$PFIZER$$$$$M$Y$$$20240826$$HP$US$US
242492312$24249231$2$F$$20240925$20240826$20240925$PER$$US-PFIZER INC-PV202400109484$PFIZER$$$$$F$Y$$$20240925$$CN$US$US
242492321$24249232$1$I$20240819$20240821$20240826$20240826$PER$$US-PFIZER INC-202400241061$PFIZER$$101$YR$$F$Y$$$20240826$$CN$US$US
242492331$24249233$1$I$$20240823$20240826$20240826$PER$$US-PFIZER INC-PV202400110505$PFIZER$$15$YR$$F$Y$$$20240826$$HP$US$US
242492341$24249234$1$I$20240820$20240823$20240826$20240826$PER$$US-PFIZER INC-202400243123$PFIZER$$55$YR$$F$Y$$$20240826$$HP$US$US
242492351$24249235$1$I$20240814$20240823$20240826$20240826$PER$$US-PFIZER INC-202400243131$PFIZER$$65$YR$$F$Y$$$20240826$$CN$US$US
242492361$24249236$1$I$20240801$20240821$20240826$20240826$PER$$PR-PFIZER INC-PV202400109548$PFIZER$$52$YR$$F$Y$118.82$KG$20240826$$CN$PR$PR
242492371$24249237$1$I$$20240823$20240826$20240826$PER$$US-PFIZER INC-PV202400110732$PFIZER$$$$$$Y$$$20240826$$CN$US$US
242492381$24249238$1$I$20240823$20240824$20240826$20240826$PER$$US-PFIZER INC-202400243022$PFIZER$$52$YR$$F$Y$$$20240826$$HP$US$US
242492392$24249239$2$F$20240101$20240923$20240826$20240925$PER$$US-PFIZER INC-202400239471$PFIZER$$80$YR$$F$Y$48.99$KG$20240925$$CN$US$US
242492401$24249240$1$I$20240803$20240820$20240826$20240826$EXP$$CN-PFIZER INC-PV202400108700$PFIZER$$54$YR$$M$Y$$$20240826$$HP$CN$CN
242492411$24249241$1$I$$20240816$20240826$20240826$PER$$US-PFIZER INC-202400242703$PFIZER$$$$E$F$Y$$$20240826$$CN$US$US
242492421$24249242$1$I$20230101$20240821$20240826$20240826$PER$$US-PFIZER INC-202400241247$PFIZER$$13$YR$$F$Y$$$20240826$$MD$US$US
242492431$24249243$1$I$$20240820$20240826$20240826$PER$$US-PFIZER INC-202400241238$PFIZER$$43$YR$$F$Y$$$20240826$$HP$US$US
242492441$24249244$1$I$$20240823$20240826$20240826$PER$$US-PFIZER INC-PV202400110719$PFIZER$$$$$$Y$$$20240826$$CN$US$US
242492451$24249245$1$I$20240823$20240823$20240826$20240826$PER$$US-PFIZER INC-202400243233$PFIZER$$46$YR$$F$Y$$$20240826$$CN$US$US
242492461$24249246$1$I$20240801$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242979$PFIZER$$64$YR$$M$Y$$$20240826$$HP$US$US
242492471$24249247$1$I$20240822$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242601$PFIZER$$53$YR$$M$Y$$$20240826$$CN$US$US
242492483$24249248$3$F$20240822$20240829$20240826$20240904$PER$$US-PFIZER INC-202400242098$PFIZER$$82$YR$$F$Y$72.12$KG$20240904$$CN$US$US
242492491$24249249$1$I$$20240821$20240826$20240826$PER$$US-PFIZER INC-PV202400109779$PFIZER$$$$$$Y$$$20240826$$CN$US$US
242492501$24249250$1$I$$20240821$20240826$20240826$PER$$US-PFIZER INC-202400241680$PFIZER$$40$YR$$M$Y$$$20240826$$HP$US$US
242492511$24249251$1$I$20231201$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242302$PFIZER$$27$YR$$F$Y$$$20240826$$MD$US$US
242492521$24249252$1$I$$20240823$20240826$20240826$PER$$US-PFIZER INC-202400242700$PFIZER$$77$YR$$F$Y$$$20240826$$CN$US$US
242492531$24249253$1$I$$20240823$20240826$20240826$PER$$US-PFIZER INC-202400243210$PFIZER$$$$E$F$Y$$$20240826$$CN$US$US
242492541$24249254$1$I$$20240822$20240826$20240826$EXP$$GB-PFIZER INC-202400242946$PFIZER$Millen, G.. Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom. British Journal of Cancer. 2024;131 (3):491-497$$$N$$Y$$$20240826$$HP$GB$GB
242492551$24249255$1$I$$20240822$20240826$20240826$PER$$US-PFIZER INC-PV202400109890$PFIZER$$83$YR$$M$Y$$$20240826$$CN$US$US
242492561$24249256$1$I$20210101$20240821$20240826$20240826$PER$$US-PFIZER INC-PV202400109855$PFIZER$$55$YR$$F$Y$$$20240826$$HP$US$US
242492571$24249257$1$I$$20240823$20240826$20240826$PER$$US-PFIZER INC-PV202400110742$PFIZER$$61$YR$$F$Y$$$20240826$$CN$US$US
242492581$24249258$1$I$20240823$20240823$20240826$20240826$PER$$US-PFIZER INC-202400243252$PFIZER$$28$YR$$F$Y$$$20240826$$CN$US$US
242492592$24249259$2$F$$20240923$20240826$20240926$PER$$US-PFIZER INC-202400241724$PFIZER$$60$YR$$F$Y$$$20240926$$CN$US$US
242492601$24249260$1$I$$20240823$20240826$20240826$PER$$US-PFIZER INC-PV202400110543$PFIZER$$38$YR$$F$Y$$$20240826$$HP$US$US
242492611$24249261$1$I$20240812$20240821$20240826$20240826$PER$$US-PFIZER INC-202400241422$PFIZER$$69$YR$$F$Y$$$20240826$$CN$US$US
242492621$24249262$1$I$$20240820$20240826$20240826$PER$$US-ROCHE-10000064255$ROCHE$$$$$F$Y$$$20240826$$MD$US$US
242492631$24249263$1$I$$20240816$20240826$20240826$EXP$SE-EMA-DD-20240814-7482827-151801$SE-BIOCON BIOLOGICS LIMITED-BBL2024006084$BIOCON$Parodis I, Dani L, Notarnicola A, Martenhed G, Fernstr?m P, Matikas A et al.. G-CSF-induced aortitis: Two cases and review of the literature. Autoimmunity Reviews. 2019$$$$$Y$$$20240826$$MD$SE$SE
242492641$24249264$1$I$$20240822$20240826$20240826$PER$$NVSC2024US171222$NOVARTIS$$$$$$Y$$$20240826$$CN$US$US
242492651$24249265$1$I$20240520$20240823$20240826$20240826$EXP$$NVSC2024US172098$NOVARTIS$$67$YR$$F$Y$$$20240826$$CN$US$US
242492661$24249266$1$I$20240701$20240822$20240826$20240826$PER$$US-BAYER-2024A121281$BAYER$$25$YR$A$F$Y$$$20240826$$MD$US$US
242492671$24249267$1$I$$20240816$20240826$20240826$EXP$$GB-TEVA-VS-3234464$TEVA$$59$YR$$M$Y$$$20240826$$MD$GB$GB
242492681$24249268$1$I$20230316$20240812$20240826$20240826$EXP$$BR-EPICPHARMA-BR-2024EPCLIT01029$EPIC PHARM$Ezequias Batista Martins.Severe esophagitis induced by antituberculosis drugs: a case report.Revista do Instituto de Medicina Tropical de Sao Paulo.2024;66:1-4$56$YR$A$F$Y$49$KG$20240826$$HP$BR$BR
242492701$24249270$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134974$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$88.45$KG$20240826$$CN$US$US
242492711$24249271$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135199$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240826$$CN$US$US
242492722$24249272$2$F$20240418$20240819$20240826$20240828$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-133260$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240828$$HP$CO$CO
242492741$24249274$1$I$20240823$20240823$20240823$20240823$DIR$715680$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242492751$24249275$1$I$20240823$20240823$20240823$20240823$DIR$715681$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242492761$24249276$1$I$20240822$20240823$20240823$20240823$DIR$715665$$FDA-CTU$$15$YR$$M$N$$$20240823$Y$HP$US$
242492771$24249277$1$I$$20240813$20240826$20240826$PER$$US-ALKERMES INC.-ALK-2024-002137$ALKERMES$$$$$F$Y$58.503$KG$20240826$$CN$US$US
242492781$24249278$1$I$$20240823$20240826$20240826$PER$$US-ROCHE-10000065598$ROCHE$$$$E$F$Y$$$20240826$$HP$US$US
242492791$24249279$1$I$$20240823$20240826$20240826$PER$$US-ROCHE-10000065513$ROCHE$$$$E$F$Y$$$20240826$$CN$US$US
242492802$24249280$2$F$$20240920$20240826$20240923$PER$$US-ROCHE-10000065584$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
242492811$24249281$1$I$20240821$20240822$20240826$20240826$PER$$US-BAYER-2024A121286$BAYER$$31$YR$A$F$Y$$$20240826$$MD$US$US
242492821$24249282$1$I$$20240823$20240826$20240826$PER$$US-BAYER-2024A121856$BAYER$$30$YR$A$M$Y$$$20240826$$CN$US$US
242492831$24249283$1$I$20240819$20240821$20240826$20240826$EXP$$US-PFIZER INC-202400241426$PFIZER$$58$YR$$F$Y$$$20240826$$CN$US$US
242492841$24249284$1$I$$20240819$20240826$20240826$EXP$$AU-VIIV HEALTHCARE LIMITED-AU2024APC105352$VIIV$$$$$$Y$$$20240826$$MD$AU$AU
242492852$24249285$2$F$$20240919$20240826$20240927$EXP$$US-SMPA-2024SPA001309$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242492861$24249286$1$I$$20240812$20240826$20240826$EXP$$US-SMPA-2024SPA001319$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242492871$24249287$1$I$$20240812$20240826$20240826$EXP$$US-SMPA-2024SPA001300$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242492881$24249288$1$I$$20240812$20240826$20240826$EXP$$US-SMPA-2024SPA001269$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242492891$24249289$1$I$$20240813$20240826$20240826$EXP$$US-SMPA-2024SPA000164$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242492901$24249290$1$I$$20240812$20240826$20240826$EXP$$HU-SMPA-2024SPA001388$SUNOVION$$$$$$Y$$$20240826$$MD$DE$DE
242492911$24249291$1$I$$20240812$20240826$20240826$EXP$$US-SMPA-2024SPA001404$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242492921$24249292$1$I$$20240812$20240826$20240826$EXP$$US-SMPA-2024SPA001336$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242492932$24249293$2$F$$20240813$20240826$20240912$EXP$$US-SMPA-2024SPA000590$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
242492941$24249294$1$I$$20240823$20240826$20240826$PER$$US-BAYER-2024A122067$BAYER$$81$YR$E$F$Y$$$20240826$$CN$US$US
242492951$24249295$1$I$20240101$20240815$20240826$20240826$EXP$$US-INDIVIOR US-INDV-156065-2024$RECKITT BENCKISER$$$$$$Y$$$20240826$$CN$US$US
242492962$24249296$2$F$$20240910$20240826$20240924$EXP$$US-SMPA-2024SPA001303$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242492971$24249297$1$I$$20240823$20240823$20240823$DIR$715686$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242492981$24249298$1$I$$20240813$20240823$20240823$DIR$FDA-CDER-CTU-2024-58380$$FDA-CTU$$$$$M$N$$$20240813$N$HP$US$
242492991$24249299$1$I$$20240819$20240826$20240826$EXP$$NVSC2024BR171339$NOVARTIS$$$$$M$Y$$$20240826$$CN$BR$BR
242493001$24249300$1$I$20240717$20240823$20240823$20240823$DIR$715658$$FDA-CTU$$67$YR$$F$N$$$20240823$N$$US$
242493011$24249301$1$I$$20240820$20240823$20240823$DIR$FDA-CDER-CTU-2024-58389$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242493021$24249302$1$I$$20240822$20240826$20240826$EXP$$NVSC2024US170579$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
242493031$24249303$1$I$20240823$20240823$20240826$20240826$PER$$US-BAYER-2024A122274$BAYER$$$$$M$Y$$$20240826$$CN$US$US
242493041$24249304$1$I$20240101$20240822$20240826$20240826$EXP$$US-JNJFOC-20240859485$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240826$$HP$US$US
242493061$24249306$1$I$20240823$20240823$20240826$20240826$PER$$US-ROCHE-10000065556$ROCHE$$$$$M$Y$$$20240826$$CN$US$US
242493071$24249307$1$I$$20240812$20240826$20240826$EXP$$DE-ROCHE-10000058045$ROCHE$Lukac S, Wenzel R, Schochter F, Friebe-Hoffmann U, Huner B, Janni W. Pregnancy after advanced ovarian cancer with spontaneous uterine rupture in second trimester: A case report and review of the literature. International Journal of Gynecology and Obstetrics. 2024;1-6. doi:10.1002/ijgo.15837.$31$YR$A$F$Y$$$20240826$$HP$DE$DE
242493081$24249308$1$I$$20240823$20240826$20240826$EXP$$US-ROCHE-10000065407$ROCHE$$$$A$F$Y$$$20240826$$CN$US$US
242493091$24249309$1$I$20240823$20240823$20240823$20240823$DIR$715691$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242493101$24249310$1$I$$20240812$20240826$20240826$EXP$$US-PURACAP-US-2024EPCLIT01026$PURACAP$S. Beesley.Calcium Channel Overdose and Insulin Therapy Dosing.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$28$YR$A$M$Y$$$20240826$$HP$US$US
242493111$24249311$1$I$20240822$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024169397$AMGEN$$50$YR$A$F$Y$$$20240826$$CN$US$US
242493121$24249312$1$I$$20240805$20240823$20240823$DIR$FDA-CDER-CTU-2024-58398$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
242493131$24249313$1$I$20240819$20240823$20240823$20240823$DIR$715687$$FDA-CTU$$31$YR$$F$N$$$20240823$Y$HP$US$
242493142$24249314$2$F$20240821$20240912$20240826$20240918$PER$$US-BAYER-2024A121437$BAYER$$42$YR$A$F$Y$$$20240918$$HP$US$US
242493151$24249315$1$I$20240217$20240816$20240826$20240826$EXP$$FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2024-019367$VALIDUS$$$$$$Y$$$20240826$$PH$FR$FR
242493161$24249316$1$I$$20240814$20240826$20240826$PER$$US-ALKERMES INC.-ALK-2024-002160$ALKERMES$$$$$M$Y$$$20240826$$CN$US$US
242493171$24249317$1$I$20171001$20240814$20240826$20240826$EXP$PL-EMA-DD-20180921-faizanevprod-135849$PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2019-004495$VALIDUS$Pietraszewska K, Januszko-Giergielewicz B, Arlukowicz T, Jaroslawski J, Kozak L, Skutecki R et al.. Acute pancreatitis after kidney transplantation-serious complication, therapeutic dilemmas - a case report and literature overview.. Nephrology and dialysis therapy Poland. 2018;22(2):81-6$$$$$Y$$$20240826$$MD$PL$PL
242493181$24249318$1$I$$20240816$20240826$20240826$PER$$US-ALKERMES INC.-ALK-2024-002162$ALKERMES$$$$$F$Y$$$20240826$$HP$US$US
242493191$24249319$1$I$20240710$20240726$20240826$20240826$PER$$US-Eisai-EC-2024-171296$EISAI$$76$YR$E$F$Y$$$20240826$$CN$US$US
242493202$24249320$2$F$$20240917$20240826$20240927$PER$$US-ROCHE-10000060025$ROCHE$$$$E$M$Y$$$20240927$$CN$US$US
242493211$24249321$1$I$$20240819$20240826$20240826$PER$$US-ROCHE-10000060981$ROCHE$$$$$$Y$$$20240826$$PH$US$US
242493221$24249322$1$I$20240301$20240816$20240826$20240826$EXP$GB-MHRA-MED-202408161236078710-FQLSC$GB-TEVA-VS-3234918$TEVA$$$$$F$Y$66$KG$20240826$$CN$GB$GB
242493231$24249323$1$I$$20240822$20240826$20240826$PER$$US-BAYER-2024A121781$BAYER$$$$$F$Y$$$20240826$$HP$US$US
242493241$24249324$1$I$$20240824$20240826$20240826$PER$$US-BAYER-2024A121844$BAYER$$$$$$Y$$$20240826$$CN$US$US
242493251$24249325$1$I$20240820$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A190922$ASTRAZENECA$$23153$DY$$M$Y$$$20240826$$CN$US$
242493261$24249326$1$I$$20240822$20240826$20240826$EXP$$US-AstraZeneca-2024A192262$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242493272$24249327$2$F$$20240919$20240826$20240925$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16233$IPSEN$$$$$F$Y$53.5$KG$20240925$$CN$US$US
242493281$24249328$1$I$20240720$20240816$20240826$20240826$EXP$FR-AFSSAPS-RE2024000822$FR-BAXTER-2024BAX023298$BAXTER$$1$MON$$M$Y$2.72$KG$20240826$$PH$FR$FR
242493291$24249329$1$I$$20240816$20240826$20240826$EXP$$CA-BAXTER-2024BAX023410$BAXTER$$39$YR$$M$Y$56$KG$20240826$$MD$CA$CA
242493301$24249330$1$I$$20240816$20240826$20240826$EXP$$GB-TEVA-VS-3234965$TEVA$$71$YR$$M$Y$128$KG$20240826$$PH$GB$GB
242493311$24249331$1$I$$20240816$20240826$20240826$EXP$$CA-BAXTER-2024BAX023411$BAXTER$$25$YR$$F$Y$64$KG$20240826$$HP$CA$CA
242493321$24249332$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133399$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240826$$CN$US$US
242493331$24249333$1$I$20230101$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134198$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$76.2$KG$20240826$$CN$US$US
242493341$24249334$1$I$20240814$20240816$20240826$20240826$EXP$GB-MHRA-MED-202408150220073020-MRHYG$GB-TEVA-VS-3234814$TEVA$$49$YR$$F$Y$38$KG$20240826$$CN$GB$GB
242493352$24249335$2$F$$20240925$20240826$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134349$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240927$$HP$US$US
242493361$24249336$1$I$20240808$20240816$20240826$20240826$EXP$CN-NMPACDR-3708281020400202400584$CN-BAXTER-2024BAX023466$BAXTER$$52$YR$$F$Y$66$KG$20240826$$MD$CN$CN
242493372$24249337$2$F$20240710$20240904$20240826$20240910$PER$$US-BAYER-2024A120957$BAYER$$49$YR$A$F$Y$$$20240910$$HP$US$US
242493381$24249338$1$I$$20240824$20240826$20240826$PER$$US-BAYER-2024A121857$BAYER$$$$$$Y$$$20240826$$CN$US$US
242493391$24249339$1$I$$20240816$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130979$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240826$$CN$US$US
242493401$24249340$1$I$$20240816$20240826$20240826$EXP$$CA-BAXTER-2024BAX023567$BAXTER$$68$YR$$M$Y$64$KG$20240826$$HP$CA$CA
242493411$24249341$1$I$$20240816$20240826$20240826$EXP$$CA-BAXTER-2024BAX023559$BAXTER$$9$YR$$M$Y$$$20240826$$HP$CA$CA
242493421$24249342$1$I$20240715$20240816$20240826$20240826$EXP$CN-NMPACDR-4301011002666202400469$CN-BAXTER-2024BAX023473$BAXTER$$40$YR$$F$Y$50$KG$20240826$$MD$CN$CN
242493431$24249343$1$I$$20240816$20240826$20240826$EXP$$CA-BAXTER-2024BAX023568$BAXTER$$72$YR$$M$Y$79$KG$20240826$$HP$CA$CA
242493441$24249344$1$I$$20240819$20240826$20240826$PER$$US-ROCHE-10000060686$ROCHE$Jhawar N, Chirila R, Leoni Moreno J. Trigeminal Amyloidoma in a Patient With Cardiac Amyloidosis. Texas Heart Institute Journal. 2023-Jul;50 (4):1-4. doi:10.14503/THIJ-22-8071.$73$YR$E$M$Y$$$20240826$$MD$US$US
242493451$24249345$1$I$$20240823$20240826$20240826$PER$$US-JNJFOC-20240861823$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242493461$24249346$1$I$20240820$20240820$20240826$20240826$EXP$$US-JNJFOC-20240855359$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240826$$CN$US$US
242493471$24249347$1$I$20240820$20240820$20240826$20240826$EXP$$US-JNJFOC-20240854913$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240826$$CN$US$US
242493481$24249348$1$I$$20240825$20240826$20240826$PER$$US-BAYER-2024A121904$BAYER$$$$$M$Y$$$20240826$$CN$US$US
242493492$24249349$2$F$$20240904$20240826$20240906$PER$$US-ROCHE-10000063667$ROCHE$$$$E$F$Y$$$20240906$$HP$US$US
242493501$24249350$1$I$20240821$20240821$20240826$20240826$PER$$US-BAYER-2024A120970$BAYER$$38$YR$A$F$Y$$$20240826$$MD$US$US
242493511$24249351$1$I$$20240820$20240826$20240826$PER$$US-ROCHE-3572306$ROCHE$$56$YR$A$M$Y$$$20240826$$CN$US$US
242493521$24249352$1$I$$20240821$20240826$20240826$EXP$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-454054$AU-SANDOZ INC.-SDZ2024AU074484$SANDOZ$$53$YR$$M$Y$$$20240826$$MD$AU$AU
242493531$24249353$1$I$$20240823$20240826$20240826$EXP$$US-SANDOZ INC.-SDZ2024US075154$SANDOZ$$$$$M$Y$$$20240826$$CN$US$US
242493541$24249354$1$I$$20240820$20240826$20240826$PER$$US-ROCHE-10000062881$ROCHE$$$$A$F$Y$$$20240826$$MD$US$US
242493551$24249355$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014527$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240826$$PH$US$US
242493561$24249356$1$I$$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014454$ELI LILLY AND CO$$$$$M$Y$$$20240826$$CN$US$US
242493571$24249357$1$I$$20240820$20240826$20240826$PER$$US-ROCHE-10000061981$ROCHE$$$$$$Y$$$20240826$$HP$US$US
242493581$24249358$1$I$$20240821$20240826$20240826$PER$$NVSC2024US170341$NOVARTIS$$$$$M$Y$$$20240826$$CN$US$US
242493591$24249359$1$I$$20240820$20240826$20240826$PER$$US-ROCHE-10000062007$ROCHE$$$$$$Y$$$20240826$$PH$US$US
242493602$24249360$2$F$$20240904$20240826$20240906$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408011861$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240906$$MD$JP$JP
242493613$24249361$3$F$20240805$20240913$20240826$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU074688$SANDOZ$$82$YR$$M$Y$$$20240920$$MD$AU$AU
242493621$24249362$1$I$$20240821$20240826$20240826$PER$$US-BAYER-2024A121185$BAYER$$44$YR$A$F$Y$$$20240826$$MD$US$US
242493633$24249363$3$F$$20240902$20240826$20240906$PER$$US-BAYER-2024A121963$BAYER$$52$YR$A$F$Y$$$20240906$$CN$US$US
242493641$24249364$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000063656$ROCHE$$$$E$F$Y$$$20240826$$CN$US$US
242493652$24249365$2$F$$20240829$20240826$20240913$EXP$$GB-EXELIXIS-CABO-24080848$EXELIXIS$$75$YR$$M$Y$$$20240913$$MD$GB$GB
242493661$24249366$1$I$$20240821$20240826$20240826$PER$$US-JNJFOC-20240856248$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$CN$US$US
242493671$24249367$1$I$$20240820$20240826$20240826$EXP$$US-SANDOZ INC.-SDZ2024US074888$SANDOZ$$$$$F$Y$$$20240826$$MD$US$US
242493681$24249368$1$I$20240606$20240823$20240823$20240823$DIR$715662$$FDA-CTU$$12$YR$$F$N$45.8$KG$20240823$Y$CN$US$
242493701$24249370$1$I$20240101$20240822$20240826$20240826$PER$$US-BAYER-2024A121190$BAYER$$30$YR$A$F$Y$$$20240826$$CN$US$US
242493711$24249371$1$I$20240823$20240823$20240823$20240823$DIR$715692$$FDA-CTU$$$$$UNK$N$$$20240823$N$CN$US$
242493721$24249372$1$I$20240125$20240823$20240823$20240823$DIR$715661$$FDA-CTU$$62$YR$$F$N$58.5$KG$20240823$N$CN$US$
242493731$24249373$1$I$20240822$20240823$20240823$20240823$DIR$715690$$FDA-CTU$$74$YR$$F$N$$$20240823$N$HP$US$
242493741$24249374$1$I$$20240823$20240823$20240823$DIR$715695$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242493751$24249375$1$I$20240807$20240823$20240823$20240823$DIR$715668$$FDA-CTU$$82$YR$$F$N$$$20240823$N$PH$US$
242493761$24249376$1$I$$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024167484$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242493773$24249377$3$F$20240716$20240909$20240826$20240913$EXP$$FR-TAKEDA-2024TUS085432$TAKEDA$$75$YR$$M$Y$66$KG$20240913$$HP$FR$FR
242493781$24249378$1$I$$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168136$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242493791$24249379$1$I$20240819$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024167996$AMGEN$$$$$$Y$$$20240826$$CN$US$US
242493801$24249380$1$I$20240821$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168464$AMGEN$$58$YR$A$F$Y$$$20240826$$CN$US$US
242493811$24249381$1$I$$20240819$20240826$20240826$EXP$$CN-GSK-CN2024APC103643$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$CN$CN
242493821$24249382$1$I$$20240731$20240826$20240826$PER$$US-Eisai-EC-2024-171303$EISAI$$$$$$Y$$$20240826$$MD$US$US
242493831$24249383$1$I$20240101$20240815$20240826$20240826$PER$$US-Eisai-EC-2024-172241$EISAI$$82$YR$E$M$Y$$$20240826$$CN$US$US
242493841$24249384$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58382$$FDA-CTU$$48$YR$$F$N$103.42$KG$20240823$N$HP$US$
242493851$24249385$1$I$20230101$20240822$20240826$20240826$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-262440$BOEHRINGER INGELHEIM$$88$YR$E$M$Y$$$20240826$$CN$US$US
242493861$24249386$1$I$20240422$20240823$20240823$20240823$DIR$715702$$FDA-CTU$$73$YR$$M$N$94.5$KG$20240823$N$CN$US$
242493871$24249387$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58372$$FDA-CTU$$76$YR$$F$N$$$20240823$N$$US$
242493881$24249388$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58366$$FDA-CTU$$83$YR$$M$N$$$20240823$N$$US$
242493891$24249389$1$I$$20240821$20240826$20240826$PER$$US-ROCHE-10000064001$ROCHE$$69$YR$E$F$Y$58.06$KG$20240826$$CN$US$US
242493901$24249390$1$I$$20240814$20240826$20240826$EXP$$US-SA-2022SA451820$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240826$$MD$US$US
242493911$24249391$1$I$$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168470$AMGEN$$$$A$$Y$$$20240826$$CN$US$US
242493921$24249392$1$I$20230404$20240816$20240826$20240826$EXP$CH-SM-2024-12995$CH-TEVA-VS-3235068$TEVA$$$$$F$Y$2.16$KG$20240826$$PH$CH$CH
242493931$24249393$1$I$$20240819$20240826$20240826$EXP$$KR-AMGEN-KORSP2024169638$AMGEN$$67$YR$E$F$Y$$$20240826$$HP$KR$KR
242493942$24249394$2$F$$20240902$20240826$20240905$EXP$$NVSC2024NZ168657$NOVARTIS$$73$YR$$M$Y$$$20240905$$MD$NZ$NZ
242493951$24249395$1$I$$20240819$20240826$20240826$EXP$$NVSC2024US168721$NOVARTIS$$42$YR$$F$Y$$$20240826$$MD$US$US
242493961$24249396$1$I$$20240823$20240823$20240823$DIR$715696$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242493971$24249397$1$I$$20240819$20240826$20240826$PER$$US-JNJFOC-20240851851$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242493982$24249398$2$F$20240101$20240924$20240826$20240930$EXP$$US-JNJFOC-20240859302$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240930$$HP$US$US
242493991$24249399$1$I$$20240825$20240826$20240826$PER$$US-JNJFOC-20240865544$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242494001$24249400$1$I$$20240821$20240826$20240826$PER$$US-JNJFOC-20240859309$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242494011$24249401$1$I$20240806$20240818$20240826$20240826$EXP$$EG-AstraZeneca-2024A188500$ASTRAZENECA$$72$YR$$F$Y$$$20240826$$CN$EG$
242494021$24249402$1$I$$20240822$20240826$20240826$PER$$US-BAYER-2024A121205$BAYER$$31$YR$A$F$Y$$$20240826$$CN$US$US
242494031$24249403$1$I$$20240820$20240826$20240826$EXP$$US-TAKEDA-2024TUS084669$TAKEDA$$$$$M$Y$$$20240826$$CN$US$US
242494041$24249404$1$I$20240823$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58341$$FDA-CTU$$86$YR$$M$N$$$20240823$N$HP$US$
242494061$24249406$1$I$$20240819$20240826$20240826$EXP$$US-OTSUKA-2024_022925$OTSUKA$Solomon HV. Spotlight on respiratory dyskinesia: Recognizing an overlooked condition. PSYCHIATRY RESEARCH. 2024;337:NIL_0001-0002$73$YR$$M$Y$$$20240826$$HP$US$US
242494071$24249407$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA247619$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240826$$MD$US$US
242494081$24249408$1$I$$20240809$20240826$20240826$PER$$US-SA-2024SA243705$SANOFI AVENTIS$$$$C$F$Y$66$KG$20240826$$MD$US$US
242494091$24249409$1$I$$20240808$20240826$20240826$PER$$US-SA-2024SA238732$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240826$$CN$US$US
242494101$24249410$1$I$20240101$20240809$20240826$20240826$PER$$US-SA-2024SA241483$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240826$$MD$US$US
242494111$24249411$1$I$$20240809$20240826$20240826$PER$$US-SA-2024SA240486$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242494121$24249412$1$I$$20240809$20240826$20240826$PER$$US-SA-2024SA241796$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240826$$MD$US$US
242494131$24249413$1$I$$20240809$20240826$20240826$PER$$US-SA-2024SA241689$SANOFI AVENTIS$$$$A$F$Y$74.83$KG$20240826$$MD$US$US
242494141$24249414$1$I$$20240810$20240826$20240826$PER$$US-SA-2024SA243165$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242494151$24249415$1$I$$20240823$20240823$20240823$DIR$715697$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242494161$24249416$1$I$$20240809$20240826$20240826$PER$$US-SA-2024SA232969$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242494171$24249417$1$I$$20240809$20240826$20240826$PER$$US-SA-2024SA240263$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240826$$CN$US$US
242494181$24249418$1$I$$20240809$20240826$20240826$PER$$US-SA-2024SA240467$SANOFI AVENTIS$$27$YR$A$F$Y$53$KG$20240826$$MD$US$US
242494192$24249419$2$F$20240101$20240905$20240826$20240918$PER$$US-SA-2024SA245258$SANOFI AVENTIS$$55$YR$A$F$Y$111.9$KG$20240918$$MD$US$US
242494201$24249420$1$I$20240701$20240813$20240826$20240826$PER$$US-SA-2024SA243887$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240826$$MD$US$US
242494211$24249421$1$I$20240801$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133755$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240826$$HP$US$US
242494221$24249422$1$I$$20240823$20240823$20240823$DIR$715698$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242494231$24249423$1$I$20240701$20240816$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132156$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240826$$HP$US$US
242494241$24249424$1$I$20240822$20240823$20240823$20240823$DIR$715703$$FDA-CTU$$36$YR$$F$N$$$20240823$N$$US$
242494251$24249425$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA245281$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240826$$CN$US$US
242494281$24249428$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA246474$SANOFI AVENTIS$$14$YR$T$M$Y$41.73$KG$20240826$$MD$US$US
242494291$24249429$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA243634$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242494301$24249430$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA243766$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242494311$24249431$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA244690$SANOFI AVENTIS$$$$A$M$Y$77.11$KG$20240826$$MD$US$US
242494321$24249432$1$I$20240725$20240813$20240826$20240826$PER$$US-SA-2024SA244869$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240826$$MD$US$US
242494331$24249433$1$I$20240101$20240808$20240826$20240826$PER$$US-SA-2024SA245090$SANOFI AVENTIS$$54$YR$A$F$Y$84$KG$20240826$$MD$US$US
242494341$24249434$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA245197$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240826$$CN$US$US
242494351$24249435$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA244162$SANOFI AVENTIS$$$$E$F$Y$$$20240826$$MD$US$US
242494361$24249436$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA245214$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242494371$24249437$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA244861$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240826$$MD$US$US
242494381$24249438$1$I$20240811$20240814$20240826$20240826$PER$$US-SA-2024SA245234$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240826$$MD$US$US
242494391$24249439$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA244592$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240826$$MD$US$US
242494401$24249440$1$I$$20240812$20240826$20240826$PER$$US-SA-2024SA242592$SANOFI AVENTIS$$$$C$$Y$$$20240826$$MD$US$US
242494411$24249441$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA243763$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240826$$MD$US$US
242494421$24249442$1$I$20220725$20240814$20240826$20240826$PER$$US-SA-2024SA246109$SANOFI AVENTIS$$51$YR$A$F$Y$88$KG$20240826$$MD$US$US
242494431$24249443$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA245219$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240826$$HP$US$US
242494441$24249444$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA246930$SANOFI AVENTIS$$54$YR$A$M$Y$136$KG$20240826$$MD$US$US
242494451$24249445$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA246914$SANOFI AVENTIS$$64$YR$A$F$Y$113.3$KG$20240826$$MD$US$US
242494461$24249446$1$I$20240623$20240819$20240823$20240823$DIR$FDA-CDER-CTU-2024-58376$$FDA-CTU$$63$YR$$F$N$$$20240819$N$HP$US$
242494472$24249447$2$F$20240101$20240828$20240826$20240906$PER$$US-SA-2024SA245179$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240906$$HP$US$US
242494481$24249448$1$I$20240809$20240813$20240826$20240826$PER$$US-SA-2024SA246083$SANOFI AVENTIS$$64$YR$A$M$Y$102.04$KG$20240826$$MD$US$US
242494491$24249449$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58385$$FDA-CTU$$77$YR$$F$N$85.73$KG$20240823$N$$US$
242494501$24249450$1$I$20220101$20240814$20240826$20240826$PER$$US-SA-2023SA227887$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240826$$MD$US$US
242494511$24249451$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA244557$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242494521$24249452$1$I$20240801$20240814$20240826$20240826$PER$$US-SA-2024SA245209$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240826$$MD$US$US
242494531$24249453$1$I$$20240823$20240823$20240823$DIR$715693$$FDA-CTU$$$$$UNK$N$$$20240823$$CN$US$
242494541$24249454$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58378$$FDA-CTU$$71$YR$$F$N$77.11$KG$20240823$N$$US$
242494551$24249455$1$I$20240101$20240822$20240826$20240826$PER$$US-BAYER-2024A121224$BAYER$$22$YR$A$F$Y$$$20240826$$HP$US$US
242494561$24249456$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA243374$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240826$$MD$US$US
242494571$24249457$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA245339$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240826$$MD$US$US
242494581$24249458$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA243420$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240826$$MD$US$US
242494591$24249459$1$I$20240816$20240823$20240823$20240823$DIR$715705$$FDA-CTU$$13$YR$$M$N$33.6$KG$20240823$N$HP$US$
242494601$24249460$1$I$$20240820$20240826$20240826$EXP$$US-PFIZER INC-PV202400109437$PFIZER$$$$A$F$Y$$$20240826$$MD$US$US
242494631$24249463$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246055$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242494641$24249464$1$I$$20240819$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133557$BRISTOL MYERS SQUIBB$$91$YR$E$$Y$$$20240826$$CN$US$US
242494651$24249465$1$I$20240701$20240813$20240826$20240826$PER$$US-SA-2023SA034095$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240826$$MD$US$US
242494661$24249466$1$I$20240701$20240814$20240826$20240826$PER$$US-SA-2024SA245517$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240826$$MD$US$US
242494672$24249467$2$F$20240101$20240904$20240826$20240918$PER$$US-SA-2024SA244010$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240918$$MD$US$US
242494681$24249468$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA243676$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240826$$MD$US$US
242494691$24249469$1$I$$20240813$20240826$20240826$PER$$US-SA-2023SA399352$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240826$$MD$US$US
242494703$24249470$3$F$20240801$20240904$20240826$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131708$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240913$$CN$US$US
242494721$24249472$1$I$20240601$20240813$20240826$20240826$PER$$US-SA-2024SA245245$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240826$$MD$US$US
242494731$24249473$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA247025$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242494741$24249474$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA245298$SANOFI AVENTIS$$54$YR$A$M$Y$73.48$KG$20240826$$MD$US$US
242494751$24249475$1$I$$20240812$20240826$20240826$PER$$US-SA-2024SA243889$SANOFI AVENTIS$$$$C$M$Y$$$20240826$$MD$US$US
242494761$24249476$1$I$20240812$20240813$20240826$20240826$PER$$US-SA-2024SA241047$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240826$$CN$US$US
242494771$24249477$1$I$$20240819$20240826$20240826$EXP$$CN-BAUSCH-BL-2024-012802$BAUSCH AND LOMB$Ying L, Bai L, Huixia W, Yufeng L. Four cases of refractory hyponatremia caused by secondary adrenal cortical insufficiency after chemotherapy in children with tumor of lymphoid hematopoietic system. Chin J Appl Clin Pediatr. 2024 AUG;39(8):605-608. doi:10.3760/cma.j.cn101070-20240308-00141$8$YR$$M$Y$$$20240826$$HP$CN$CN
242494781$24249478$1$I$$20240819$20240826$20240826$EXP$$CN-BAUSCH-BL-2024-012552$BAUSCH AND LOMB$Ying L, Bai L, Huixia W, Yufeng L. Four cases of refractory hyponatremia caused by secondary adrenal cortical insufficiency after chemotherapy in children with tumor of lymphoid hematopoietic system. Chin J Appl Clin Pediatr. 2024 AUG;39(8):605-608. doi:10.3760/cma.j.cn101070-20240308-00141$8$YR$$M$Y$$$20240826$$HP$CN$CN
242494791$24249479$1$I$20230101$20240824$20240826$20240826$EXP$$ES-BAUSCH-BL-2024-012851$BAUSCH AND LOMB$$43$YR$$F$Y$62$KG$20240826$$MD$ES$ES
242494801$24249480$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA244799$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240826$$MD$US$US
242494821$24249482$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA245969$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240826$$MD$US$US
242494831$24249483$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA245781$SANOFI AVENTIS$$$$A$F$Y$72.57$KG$20240826$$MD$US$US
242494841$24249484$1$I$$20240819$20240826$20240826$EXP$$CN-BAUSCH-BL-2024-012803$BAUSCH AND LOMB$Ying L, Bai L, Huixia W, Yufeng L. Four cases of refractory hyponatremia caused by secondary adrenal cortical insufficiency after chemotherapy in children with tumor of lymphoid hematopoietic system. Chin J Appl Clin Pediatr. 2024 AUG;39(8):605-608. doi:10.3760/cma.j.cn101070-20240308-00141$4$YR$$M$Y$$$20240826$$HP$CN$CN
242494851$24249485$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA244878$SANOFI AVENTIS$$79$MON$C$F$Y$$$20240826$$CN$US$US
242494861$24249486$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246950$SANOFI AVENTIS$$$$A$F$Y$85.261$KG$20240826$$MD$US$US
242494871$24249487$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA244804$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240826$$MD$US$US
242494881$24249488$1$I$$20240812$20240826$20240826$PER$$US-SA-2024SA243307$SANOFI AVENTIS$$$$E$F$Y$49.433$KG$20240826$$MD$US$US
242494891$24249489$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246836$SANOFI AVENTIS$$$$E$F$Y$75.29$KG$20240826$$MD$US$US
242494901$24249490$1$I$20240611$20240813$20240826$20240826$PER$$US-SA-2024SA245215$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240826$$MD$US$US
242494911$24249491$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA246405$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240826$$MD$US$US
242494922$24249492$2$F$20240601$20240829$20240826$20240919$PER$$US-SA-2024SA243569$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240919$$MD$US$US
242494931$24249493$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA245195$SANOFI AVENTIS$$12$YR$T$F$Y$52.1$KG$20240826$$MD$US$US
242494941$24249494$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA243499$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240826$$MD$US$US
242494951$24249495$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA243890$SANOFI AVENTIS$$5$YR$C$$Y$$$20240826$$MD$US$US
242494961$24249496$1$I$20240604$20240814$20240826$20240826$PER$$US-SA-2024SA245542$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240826$$MD$US$US
242494971$24249497$1$I$20221201$20240813$20240826$20240826$PER$$US-SA-2024SA247013$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240826$$MD$US$US
242494981$24249498$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA245270$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240826$$MD$US$US
242494991$24249499$1$I$20240401$20240812$20240826$20240826$PER$$US-SA-2024SA243305$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240826$$MD$US$US
242495001$24249500$1$I$20230701$20230726$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001819$AMERICAN REGENT$$39$YR$$F$Y$$$20240826$$HP$US$US
242495011$24249501$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA245162$SANOFI AVENTIS$$$$E$M$Y$$$20240826$$MD$US$US
242495021$24249502$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA245540$SANOFI AVENTIS$$$$C$M$Y$30$KG$20240826$$MD$US$US
242495031$24249503$1$I$20240301$20240814$20240826$20240826$PER$$US-SA-2024SA245815$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240826$$MD$US$US
242495041$24249504$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA246976$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240826$$CN$US$US
242495051$24249505$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246080$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240826$$MD$US$US
242495061$24249506$1$I$$20230727$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001821$AMERICAN REGENT$$$$$F$Y$$$20240826$$CN$US$US
242495071$24249507$1$I$$20230814$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001956$AMERICAN REGENT$$$$$$Y$$$20240826$$MD$US$US
242495081$24249508$1$I$20230701$20230726$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001818$AMERICAN REGENT$$60$YR$$F$Y$$$20240826$$HP$US$US
242495091$24249509$1$I$20230729$20230814$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001955$AMERICAN REGENT$$71$YR$$M$Y$$$20240826$$HP$US$US
242495101$24249510$1$I$20230701$20230728$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023001840$AMERICAN REGENT$$$$$$Y$$$20240826$$HP$US$US
242495111$24249511$1$I$$20240822$20240826$20240826$PER$$US-BAYER-2024A121227$BAYER$$45$YR$A$F$Y$$$20240826$$CN$US$US
242495121$24249512$1$I$20240422$20240823$20240826$20240826$EXP$$JP-SANDOZ INC.-SDZ2024JP075136$SANDOZ$$82$YR$$F$Y$$$20240826$$CN$JP$JP
242495131$24249513$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA244579$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240826$$PH$US$US
242495141$24249514$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246923$SANOFI AVENTIS$$$$C$F$Y$14.1$KG$20240826$$MD$US$US
242495151$24249515$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA243666$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240826$$MD$US$US
242495161$24249516$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA246771$SANOFI AVENTIS$$$$C$M$Y$34.47$KG$20240826$$MD$US$US
242495172$24249517$2$F$$20240813$20240826$20240927$PER$$US-SA-2024SA244792$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240927$$CN$US$US
242495182$24249518$2$F$20230101$20240817$20240826$20240829$PER$$US-SA-2024SA246717$SANOFI AVENTIS$$9$YR$C$M$Y$28.12$KG$20240829$$MD$US$US
242495201$24249520$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246093$SANOFI AVENTIS$$$$C$M$Y$$$20240826$$MD$US$US
242495211$24249521$1$I$20240701$20240813$20240826$20240826$PER$$US-SA-2024SA246288$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240826$$MD$US$US
242495221$24249522$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA246558$SANOFI AVENTIS$$$$C$M$Y$$$20240826$$CN$US$US
242495231$24249523$1$I$$20240819$20240826$20240826$EXP$$GB-OTSUKA-2024_022869$OTSUKA$$$$$F$Y$$$20240826$$MD$GB$GB
242495242$24249524$2$F$20240811$20240912$20240826$20240922$PER$$US-SA-2024SA246572$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240922$$MD$US$US
242495251$24249525$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA246158$SANOFI AVENTIS$$$$C$F$Y$$$20240826$$MD$US$US
242495262$24249526$2$F$$20240819$20240826$20240828$PER$$US-SA-2024SA244881$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240828$$CN$US$US
242495271$24249527$1$I$20240822$20240823$20240823$20240823$DIR$715710$$FDA-CTU$$37$YR$$F$N$77.4$KG$20240823$N$HP$US$
242495281$24249528$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246064$SANOFI AVENTIS$$$$C$M$Y$37.6$KG$20240826$$MD$US$US
242495301$24249530$1$I$20240813$20240813$20240826$20240826$PER$$US-SA-2024SA245823$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240826$$MD$US$US
242495311$24249531$1$I$20240612$20240823$20240823$20240823$DIR$715718$$FDA-CTU$$67$YR$$F$N$103.5$KG$20240823$N$CN$US$
242495331$24249533$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA246838$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240826$$MD$US$US
242495341$24249534$1$I$20240801$20240813$20240826$20240826$PER$$US-SA-2024SA245293$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240826$$MD$US$US
242495351$24249535$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246757$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242495361$24249536$1$I$20230401$20240814$20240826$20240826$PER$$US-SA-2024SA246555$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240826$$MD$US$US
242495371$24249537$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA244885$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240826$$MD$US$US
242495381$24249538$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA243561$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240826$$HP$US$US
242495391$24249539$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246317$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240826$$MD$US$US
242495401$24249540$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246536$SANOFI AVENTIS$$$$A$M$Y$111.1$KG$20240826$$MD$US$US
242495411$24249541$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA246589$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240826$$MD$US$US
242495421$24249542$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA245297$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240826$$MD$US$US
242495431$24249543$1$I$20240817$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024165813$AMGEN$$62$YR$A$F$Y$$$20240826$$CN$US$US
242495441$24249544$1$I$$20240819$20240826$20240826$EXP$$ZA-TAKEDA-2024TUS083830$TAKEDA$$15$YR$$M$Y$$$20240826$$PH$ZA$ZA
242495451$24249545$1$I$20240501$20240822$20240826$20240826$EXP$$DE-AMGEN-DEUSP2024168158$AMGEN$$74$YR$E$M$Y$$$20240826$$MD$DE$DE
242495471$24249547$1$I$20231201$20240731$20240826$20240826$PER$$US-Eisai-EC-2024-171305$EISAI$$$$$M$Y$$$20240826$$CN$US$US
242495481$24249548$1$I$20240801$20240813$20240826$20240826$PER$$US-SA-2024SA243384$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240826$$MD$US$US
242495491$24249549$1$I$20240701$20240813$20240826$20240826$PER$$US-SA-2024SA246485$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240826$$MD$US$US
242495501$24249550$1$I$20240101$20240812$20240826$20240826$PER$$US-SA-2024SA243464$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240826$$HP$US$US
242495511$24249551$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA242661$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$CN$US$US
242495521$24249552$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA243752$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240826$$MD$US$US
242495531$24249553$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA244857$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240826$$HP$US$US
242495541$24249554$1$I$20240601$20240812$20240826$20240826$PER$$US-SA-2024SA244834$SANOFI AVENTIS$$70$YR$E$F$Y$107.04$KG$20240826$$MD$US$US
242495551$24249555$1$I$20240101$20240812$20240826$20240826$PER$$US-SA-2024SA247191$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240826$$MD$US$US
242495561$24249556$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA245151$SANOFI AVENTIS$$$$A$F$Y$67.1$KG$20240826$$MD$US$US
242495572$24249557$2$F$20240813$20240815$20240826$20240828$PER$$US-SA-2024SA246473$SANOFI AVENTIS$$15$YR$T$$Y$$$20240828$$CN$US$US
242495581$24249558$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246849$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242495591$24249559$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA243740$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240826$$MD$US$US
242495601$24249560$1$I$$20240819$20240826$20240826$EXP$$CN-BAUSCH-BL-2024-012804$BAUSCH AND LOMB$Ying L, Bai L, Huixia W, Yufeng L. Four cases of refractory hyponatremia caused by secondary adrenal cortical insufficiency after chemotherapy in children with tumor of lymphoid hematopoietic system. Chin J Appl Clin Pediatr. 2024 AUG;39(8):605-608. doi:10.3760/cma.j.cn101070-20240308-00141$6$YR$$M$Y$$$20240826$$HP$CN$CN
242495611$24249561$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA247157$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242495621$24249562$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA246124$SANOFI AVENTIS$$$$T$M$Y$$$20240826$$MD$US$US
242495631$24249563$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA243875$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242495641$24249564$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA246843$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240826$$MD$US$US
242495651$24249565$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA244831$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240826$$PH$US$US
242495661$24249566$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA244795$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242495671$24249567$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA246767$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242495691$24249569$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA246430$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242495701$24249570$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA245289$SANOFI AVENTIS$$62$YR$A$M$Y$70.3$KG$20240826$$MD$US$US
242495711$24249571$1$I$20240301$20240814$20240826$20240826$PER$$US-SA-2024SA244272$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240826$$MD$US$US
242495721$24249572$1$I$20240726$20240814$20240826$20240826$PER$$US-SA-2024SA247149$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240826$$MD$US$US
242495731$24249573$1$I$20240801$20240813$20240826$20240826$PER$$US-SA-2024SA246830$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240826$$MD$US$US
242495741$24249574$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA245059$SANOFI AVENTIS$$54$YR$A$F$Y$45.351$KG$20240826$$MD$US$US
242495751$24249575$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA245320$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240826$$MD$US$US
242495761$24249576$1$I$20240814$20240814$20240826$20240826$PER$$US-SA-2024SA246294$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240826$$MD$US$US
242495771$24249577$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA246101$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240826$$MD$US$US
242495801$24249580$1$I$$20240814$20240826$20240826$PER$$US-SA-2023SA205839$SANOFI AVENTIS$$13$YR$T$M$Y$57$KG$20240826$$MD$US$US
242495811$24249581$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA245202$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240826$$MD$US$US
242495821$24249582$1$I$20240816$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58403$$FDA-CTU$$65$YR$$M$N$$$20240823$N$PH$US$
242495831$24249583$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA245217$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240826$$MD$US$US
242495841$24249584$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA246321$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240826$$MD$US$US
242495861$24249586$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246112$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242495871$24249587$1$I$$20240822$20240823$20240823$DIR$FDA-CDER-CTU-2024-58320$$FDA-CTU$$$$$M$N$$$20240822$N$HP$US$
242495891$24249589$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA246176$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240826$$MD$US$US
242495901$24249590$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA246987$SANOFI AVENTIS$$22$YR$A$F$Y$69.3$KG$20240826$$MD$US$US
242495911$24249591$1$I$20240801$20240813$20240826$20240826$PER$$US-SA-2024SA245169$SANOFI AVENTIS$$18$YR$A$M$Y$108$KG$20240826$$MD$US$US
242495931$24249593$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58352$$FDA-CTU$$$$$F$N$$$20240823$N$HP$US$
242495942$24249594$2$F$20240101$20240815$20240826$20240828$PER$$US-SA-2024SA242635$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240828$$CN$US$US
242495951$24249595$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA245322$SANOFI AVENTIS$$$$A$M$Y$58.96$KG$20240826$$MD$US$US
242495961$24249596$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA245192$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240826$$HP$US$US
242495971$24249597$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA246206$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240826$$CN$US$US
242495981$24249598$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA244616$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240826$$MD$US$US
242495991$24249599$1$I$20240804$20240813$20240826$20240826$PER$$US-SA-2024SA245264$SANOFI AVENTIS$$75$YR$E$F$Y$98.4$KG$20240826$$MD$US$US
242496002$24249600$2$F$$20240904$20240826$20240917$PER$$US-SA-2024SA245178$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240918$$MD$US$US
242496012$24249601$2$F$20240101$20240911$20240826$20240925$PER$$US-SA-2024SA245190$SANOFI AVENTIS$$2$YR$C$M$Y$12.24$KG$20240925$$MD$US$US
242496021$24249602$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA245577$SANOFI AVENTIS$$$$A$F$Y$56.7$KG$20240826$$MD$US$US
242496031$24249603$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA246440$SANOFI AVENTIS$$$$T$F$Y$61.6$KG$20240826$$MD$US$US
242496041$24249604$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA245194$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240826$$MD$US$US
242496051$24249605$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA245196$SANOFI AVENTIS$$$$A$M$Y$115.6$KG$20240826$$MD$US$US
242496061$24249606$1$I$20240701$20240813$20240826$20240826$PER$$US-SA-2024SA245587$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240826$$MD$US$US
242496071$24249607$1$I$20240720$20240813$20240826$20240826$PER$$US-SA-2024SA246968$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240826$$MD$US$US
242496082$24249608$2$F$20240812$20240830$20240826$20240923$PER$$US-SA-2024SA246713$SANOFI AVENTIS$$66$YR$E$F$Y$111.11$KG$20240923$$MD$US$US
242496091$24249609$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135208$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240826$$CN$US$US
242496101$24249610$1$I$$20240816$20240826$20240826$PER$$US-JNJFOC-20240843257$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$HP$US$US
242496111$24249611$1$I$$20240814$20240826$20240826$PER$$US-JNJFOC-20240842363$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242496121$24249612$1$I$$20240819$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047205$BOEHRINGER INGELHEIM$$$$$$Y$$$20240826$$HP$US$US
242496131$24249613$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246310$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240826$$MD$US$US
242496141$24249614$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246737$SANOFI AVENTIS$$$$A$M$Y$149.66$KG$20240826$$MD$US$US
242496152$24249615$2$F$20240101$20240830$20240826$20240918$PER$$US-SA-2024SA245212$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240918$$MD$US$US
242496161$24249616$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA246888$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240826$$MD$US$US
242496171$24249617$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA242768$SANOFI AVENTIS$$$$T$F$Y$$$20240826$$MD$US$US
242496181$24249618$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA245489$SANOFI AVENTIS$$72$YR$E$F$Y$136.07$KG$20240826$$MD$US$US
242496191$24249619$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA245181$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240826$$MD$US$US
242496201$24249620$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA244260$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$CN$US$US
242496211$24249621$1$I$20240801$20240813$20240826$20240826$PER$$US-SA-2024SA246446$SANOFI AVENTIS$$84$YR$E$F$Y$71.202$KG$20240826$$MD$US$US
242496221$24249622$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA244718$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240826$$MD$US$US
242496231$24249623$1$I$20240811$20240814$20240826$20240826$PER$$US-SA-2024SA243530$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240826$$CN$US$US
242496241$24249624$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA073962$SANOFI AVENTIS$$5$YR$C$M$Y$25.7$KG$20240826$$MD$US$US
242496251$24249625$1$I$20220701$20240813$20240826$20240826$PER$$US-SA-2024SA245549$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242496261$24249626$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA245139$SANOFI AVENTIS$$3$YR$C$F$Y$18.14$KG$20240826$$MD$US$US
242496271$24249627$1$I$20240101$20240812$20240826$20240826$PER$$US-SA-2024SA243332$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240826$$MD$US$US
242496281$24249628$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA246126$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240826$$CN$US$US
242496291$24249629$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA245208$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240826$$MD$US$US
242496301$24249630$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246627$SANOFI AVENTIS$$$$E$M$Y$$$20240826$$MD$US$US
242496311$24249631$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246424$SANOFI AVENTIS$$$$A$F$Y$87.982$KG$20240826$$MD$US$US
242496321$24249632$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA245140$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240826$$MD$US$US
242496333$24249633$3$F$20240101$20240916$20240826$20240924$PER$$US-SA-2024SA243386$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240924$$MD$US$US
242496341$24249634$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA246463$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240826$$MD$US$US
242496351$24249635$1$I$20240701$20240813$20240826$20240826$PER$$US-SA-2024SA244618$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240826$$MD$US$US
242496361$24249636$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA247037$SANOFI AVENTIS$$$$T$F$Y$43$KG$20240826$$MD$US$US
242496371$24249637$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246992$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242496381$24249638$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA243414$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240826$$MD$US$US
242496391$24249639$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA245096$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240826$$MD$US$US
242496401$24249640$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA246958$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240826$$MD$US$US
242496421$24249642$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58334$$FDA-CTU$$37$YR$$F$N$$$20240823$N$$US$
242496431$24249643$1$I$20240804$20240823$20240823$20240823$DIR$715730$$FDA-CTU$$18$MON$$M$N$10$KG$20240823$N$PH$US$
242496441$24249644$1$I$20240815$20240823$20240823$20240823$DIR$715731$$FDA-CTU$$44$YR$$F$N$78.75$KG$20240823$N$CN$US$
242496451$24249645$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA245756$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240826$$CN$US$US
242496461$24249646$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA244379$SANOFI AVENTIS$$15$YR$T$F$Y$79.8$KG$20240826$$MD$US$US
242496471$24249647$1$I$$20240822$20240826$20240826$EXP$$CA-PFIZER INC-202400242090$PFIZER$$69$YR$$F$Y$$$20240826$$HP$CA$CA
242496481$24249648$1$I$$20240820$20240826$20240826$EXP$$US-OTSUKA-2024_023124$OTSUKA$$$$$M$Y$$$20240826$$CN$US$US
242496491$24249649$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA244247$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240826$$MD$US$US
242496511$24249651$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA246111$SANOFI AVENTIS$$56$YR$A$F$Y$66.2$KG$20240826$$MD$US$US
242496521$24249652$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA246036$SANOFI AVENTIS$$$$C$M$Y$$$20240826$$MD$US$US
242496531$24249653$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA245840$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240826$$MD$US$US
242496541$24249654$1$I$20240101$20240813$20240826$20240826$PER$$US-SA-2024SA243747$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240826$$MD$US$US
242496551$24249655$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA245917$SANOFI AVENTIS$$$$T$F$Y$117$KG$20240826$$MD$US$US
242496561$24249656$1$I$20240601$20240813$20240826$20240826$PER$$US-SA-2024SA247014$SANOFI AVENTIS$$54$YR$A$M$Y$90.7$KG$20240826$$MD$US$US
242496581$24249658$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA245253$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240826$$MD$US$US
242496591$24249659$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA246444$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240826$$MD$US$US
242496601$24249660$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58339$$FDA-CTU$$52$YR$$M$N$$$20240823$N$$US$
242496611$24249661$1$I$$20240813$20240826$20240826$PER$$US-SA-2024SA245154$SANOFI AVENTIS$$$$A$F$Y$72.5$KG$20240826$$MD$US$US
242496621$24249662$1$I$20220101$20240812$20240826$20240826$PER$$US-SA-2024SA243309$SANOFI AVENTIS$$16$YR$T$M$Y$57.143$KG$20240826$$MD$US$US
242496631$24249663$1$I$20240116$20240819$20240826$20240826$EXP$$SA-GSK-SA2024EME062874$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$SA$SA
242496641$24249664$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246889$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240826$$MD$US$US
242496651$24249665$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA245303$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240826$$MD$US$US
242496661$24249666$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246342$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240826$$CN$US$US
242496671$24249667$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA246539$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240826$$MD$US$US
242496681$24249668$1$I$20240701$20240815$20240826$20240826$PER$$US-SA-2024SA245936$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240826$$MD$US$US
242496701$24249670$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA244536$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240826$$MD$US$US
242496711$24249671$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA246122$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240826$$MD$US$US
242496721$24249672$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA246461$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242496731$24249673$1$I$20231127$20240815$20240826$20240826$PER$$US-SA-2024SA245633$SANOFI AVENTIS$$65$YR$E$F$Y$69.85$KG$20240826$$MD$US$US
242496741$24249674$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA248038$SANOFI AVENTIS$$$$A$M$Y$95.25$KG$20240826$$MD$US$US
242496751$24249675$1$I$20231201$20240815$20240826$20240826$PER$$US-SA-2024SA245961$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240826$$MD$US$US
242496761$24249676$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246295$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240826$$MD$US$US
242496771$24249677$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA247980$SANOFI AVENTIS$$$$E$M$Y$$$20240826$$MD$US$US
242496782$24249678$2$F$20240808$20240821$20240826$20240905$PER$$US-SA-2024SA246648$SANOFI AVENTIS$$90$YR$E$F$Y$$$20240905$$HP$US$US
242496791$24249679$1$I$20240501$20240815$20240826$20240826$PER$$US-SA-2024SA246334$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240826$$MD$US$US
242496801$24249680$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246011$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240826$$MD$US$US
242496821$24249682$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA244241$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240826$$MD$US$US
242496831$24249683$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA246066$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240826$$MD$US$US
242496851$24249685$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246092$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242496861$24249686$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA245605$SANOFI AVENTIS$$$$A$$Y$$$20240826$$MD$US$US
242496871$24249687$1$I$20240801$20240815$20240826$20240826$PER$$US-SA-2024SA246212$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240826$$CN$US$US
242496881$24249688$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246924$SANOFI AVENTIS$$$$$F$Y$$$20240826$$HP$US$US
242496891$24249689$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA245695$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240826$$CN$US$US
242496901$24249690$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246905$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240826$$CN$US$US
242496912$24249691$2$F$20240814$20240820$20240826$20240829$PER$$US-SA-2024SA247850$SANOFI AVENTIS$$$$A$M$Y$$$20240829$$CN$US$US
242496921$24249692$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA245972$SANOFI AVENTIS$$57$YR$A$F$Y$68.9$KG$20240826$$MD$US$US
242496931$24249693$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA247116$SANOFI AVENTIS$$46$YR$A$M$Y$126.98$KG$20240826$$MD$US$US
242496941$24249694$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246478$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242496951$24249695$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA244266$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240826$$MD$US$US
242496961$24249696$1$I$20221014$20240815$20240826$20240826$PER$$US-SA-2024SA244108$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240826$$CN$US$US
242496971$24249697$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA244214$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240826$$CN$US$US
242496981$24249698$1$I$20240101$20240823$20240823$20240823$DIR$715738$$FDA-CTU$$51$YR$$F$N$137.25$KG$20240823$N$CN$US$
242496991$24249699$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA245865$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240826$$MD$US$US
242497001$24249700$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA244186$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240826$$MD$US$US
242497011$24249701$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA247437$SANOFI AVENTIS$$$$C$M$Y$$$20240826$$MD$US$US
242497021$24249702$1$I$20240802$20240815$20240826$20240826$PER$$US-SA-2024SA246087$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240826$$MD$US$US
242497031$24249703$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA245311$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240826$$MD$US$US
242497042$24249704$2$F$20240821$20240821$20240826$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408011262$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240829$$CN$US$US
242497051$24249705$1$I$$20240812$20240826$20240826$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093296$GLENMARK$Shah PJ, Blair JE.. Voriconazole-induced periostitis: A mimicker of skeletal coccidioidomycosis.. The American journal of case reports. 2024;25:e944102-6.$$$$$Y$$$20240826$$MD$US$US
242497061$24249706$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58342$$FDA-CTU$$$$$F$N$$$20240823$N$HP$US$
242497071$24249707$1$I$$20240814$20240826$20240826$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202408015214$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240826$$MD$IN$IN
242497081$24249708$1$I$$20240814$20240826$20240826$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408010208$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240826$$MD$GB$GB
242497091$24249709$1$I$$20240820$20240826$20240826$EXP$$NL-ELI_LILLY_AND_COMPANY-NL202408013317$ELI LILLY AND CO$$$$A$F$Y$$$20240826$$CN$NL$NL
242497101$24249710$1$I$20240527$20240819$20240826$20240826$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202408012023$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240826$$CN$BE$BE
242497111$24249711$1$I$$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009017$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240826$$CN$US$US
242497141$24249714$1$I$20240701$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009068$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240826$$CN$US$US
242497161$24249716$1$I$20231122$20240814$20240826$20240826$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408009680$ELI LILLY AND CO$$18$YR$A$F$Y$60$KG$20240826$$CN$CN$CN
242497171$24249717$1$I$20240731$20240814$20240826$20240826$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408013811$ELI LILLY AND CO$$58$YR$A$F$Y$43$KG$20240826$$CN$DE$CN
242497181$24249718$1$I$$20240813$20240826$20240826$EXP$GB-MHRA-MED-202408131539377870-LSBMT$GB-ELI_LILLY_AND_COMPANY-GB202408008739$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240826$$CN$GB$GB
242497191$24249719$1$I$$20240820$20240826$20240826$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406007716$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240826$$MD$JP$JP
242497201$24249720$1$I$$20240814$20240826$20240826$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202408010159$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240826$$CN$BE$BE
242497211$24249721$1$I$$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009118$ELI LILLY AND CO$$$$A$F$Y$$$20240826$$CN$US$US
242497221$24249722$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA247587$SANOFI AVENTIS$$$$A$M$Y$61.23$KG$20240826$$MD$US$US
242497231$24249723$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246676$SANOFI AVENTIS$$$$T$M$Y$$$20240826$$MD$US$US
242497241$24249724$1$I$20240401$20240815$20240826$20240826$PER$$US-SA-2024SA246658$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240826$$CN$US$US
242497251$24249725$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246136$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240826$$PH$US$US
242497261$24249726$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246800$SANOFI AVENTIS$$$$A$M$Y$81$KG$20240826$$MD$US$US
242497271$24249727$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA247041$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242497281$24249728$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246746$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240826$$MD$US$US
242497292$24249729$2$F$$20240919$20240826$20240923$30DAY$$GB-PFIZER INC-202400237353$PFIZER$$34$YR$$M$Y$$$20240923$$CN$GB$GB
242497301$24249730$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA247139$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240826$$MD$US$US
242497311$24249731$1$I$$20240820$20240826$20240826$EXP$$US-OTSUKA-2024_023161$OTSUKA$$$$$F$Y$$$20240826$$CN$US$US
242497321$24249732$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA247902$SANOFI AVENTIS$$$$A$F$Y$61.2$KG$20240826$$HP$US$US
242497331$24249733$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA246711$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240826$$CN$US$US
242497341$24249734$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246601$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240826$$MD$US$US
242497351$24249735$1$I$20240801$20240815$20240826$20240826$PER$$US-SA-2024SA244311$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240826$$PH$US$US
242497361$24249736$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA243694$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240826$$CN$US$US
242497371$24249737$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA244104$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240826$$CN$US$US
242497381$24249738$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA244026$SANOFI AVENTIS$$$$$M$Y$$$20240826$$CN$US$US
242497391$24249739$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA245155$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240826$$MD$US$US
242497401$24249740$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA244262$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242497411$24249741$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA247056$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240826$$MD$US$US
242497421$24249742$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA244198$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240826$$MD$US$US
242497431$24249743$1$I$20240815$20240815$20240826$20240826$PER$$US-SA-2024SA243350$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240826$$MD$US$US
242497441$24249744$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246931$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240826$$MD$US$US
242497451$24249745$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA244768$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240826$$CN$US$US
242497461$24249746$1$I$20230101$20240815$20240826$20240826$PER$$US-SA-2024SA246279$SANOFI AVENTIS$$55$YR$A$F$Y$107.05$KG$20240826$$HP$US$US
242497471$24249747$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA244096$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242497481$24249748$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246245$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240826$$MD$US$US
242497501$24249750$1$I$20240801$20240815$20240826$20240826$PER$$US-SA-2024SA246139$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240826$$MD$US$US
242497511$24249751$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA245507$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240826$$MD$US$US
242497521$24249752$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246431$SANOFI AVENTIS$$$$E$F$Y$77.11$KG$20240826$$MD$US$US
242497531$24249753$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA244521$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240826$$MD$US$US
242497541$24249754$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA243661$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240826$$CN$US$US
242497551$24249755$1$I$20240801$20240815$20240826$20240826$PER$$US-SA-2024SA247124$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240826$$MD$US$US
242497561$24249756$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246959$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240826$$MD$US$US
242497572$24249757$2$F$20240101$20240821$20240826$20240830$PER$$US-SA-2024SA244191$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240830$$MD$US$US
242497581$24249758$1$I$20240815$20240815$20240826$20240826$PER$$US-SA-2024SA243699$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240826$$MD$US$US
242497591$24249759$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA247082$SANOFI AVENTIS$$$$$M$Y$$$20240826$$CN$US$US
242497601$24249760$1$I$20240808$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167831$AMGEN$$81$YR$E$F$Y$$$20240826$$CN$US$US
242497611$24249761$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA244894$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242497621$24249762$1$I$20230101$20240815$20240826$20240826$PER$$US-SA-2024SA246174$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240826$$MD$US$US
242497631$24249763$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246906$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240826$$CN$US$US
242497641$24249764$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA247090$SANOFI AVENTIS$$$$E$F$Y$$$20240826$$MD$US$US
242497651$24249765$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246099$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240826$$CN$US$US
242497661$24249766$1$I$20220401$20240815$20240826$20240826$PER$$US-SA-2024SA246438$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240826$$MD$US$US
242497671$24249767$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246241$SANOFI AVENTIS$$$$$$Y$$$20240826$$HP$US$US
242497681$24249768$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246100$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242497691$24249769$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA244211$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240826$$MD$US$US
242497701$24249770$1$I$$20240726$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07541$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242497711$24249771$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA246095$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240826$$MD$US$US
242497721$24249772$1$I$20240821$20240819$20240826$20240826$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-16473$IPSEN$$76$YR$E$M$Y$$$20240826$$CN$GB$GB
242497731$24249773$1$I$20240701$20240815$20240826$20240826$PER$$US-SA-2024SA244086$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240826$$CN$US$US
242497741$24249774$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248169$SANOFI AVENTIS$$$$T$F$Y$49.8$KG$20240826$$MD$US$US
242497751$24249775$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA245501$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240826$$CN$US$US
242497761$24249776$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247729$SANOFI AVENTIS$$44$YR$A$M$Y$68.9$KG$20240826$$MD$US$US
242497772$24249777$2$F$20240101$20240913$20240826$20240920$PER$$US-SA-2024SA245945$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240920$$MD$US$US
242497781$24249778$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246369$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240826$$MD$US$US
242497791$24249779$1$I$20240701$20240816$20240826$20240826$PER$$US-SA-2024SA247003$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240826$$MD$US$US
242497801$24249780$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA242996$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240826$$MD$US$US
242497811$24249781$1$I$20230801$20240823$20240823$20240823$DIR$715740$$FDA-CTU$$33$YR$$F$N$$$20240823$N$CN$US$
242497831$24249783$1$I$20240813$20240823$20240823$20240823$DIR$715676$$FDA-CTU$$57$YR$$F$N$98.1$KG$20240823$Y$$US$
242497843$24249784$3$F$20240101$20240912$20240826$20240923$PER$$US-SA-2024SA246773$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240923$$MD$US$US
242497851$24249785$1$I$20240501$20240815$20240826$20240826$PER$$US-SA-2024SA246482$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240826$$MD$US$US
242497871$24249787$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA246981$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240826$$MD$US$US
242497881$24249788$1$I$$20240822$20240823$20240823$DIR$FDA-CDER-CTU-2024-58321$$FDA-CTU$$$$$M$N$$$20240822$N$HP$US$
242497891$24249789$1$I$20240701$20240815$20240826$20240826$PER$$US-SA-2024SA246399$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240826$$MD$US$US
242497901$24249790$1$I$20240815$20240815$20240826$20240826$PER$$US-SA-2024SA244257$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240826$$HP$US$US
242497911$24249791$1$I$20240821$20240823$20240823$20240823$DIR$715739$$FDA-CTU$$24$YR$$F$N$60$KG$20240823$Y$HP$US$
242497921$24249792$1$I$20240711$20240823$20240823$20240823$DIR$715667$$FDA-CTU$$61$YR$$M$N$$$20240823$N$HP$US$
242497931$24249793$1$I$20240801$20240816$20240826$20240826$PER$$US-SA-2024SA248296$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240826$$MD$US$US
242497941$24249794$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA246397$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240826$$CN$US$US
242497951$24249795$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247740$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240826$$MD$US$US
242497971$24249797$1$I$20240810$20240822$20240823$20240823$DIR$FDA-CDER-CTU-2024-58388$$FDA-CTU$$38$YR$$F$N$$$20240822$N$PH$US$
242497982$24249798$2$F$$20240826$20240826$20240915$PER$$US-SA-2024SA248408$SANOFI AVENTIS$$$$A$F$Y$54.43$KG$20240915$$MD$US$US
242497991$24249799$1$I$20240701$20240815$20240826$20240826$PER$$US-SA-2024SA246051$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240826$$MD$US$US
242498021$24249802$1$I$20240819$20240823$20240823$20240823$DIR$715737$$FDA-CTU$$60$YR$$M$N$75.6$KG$20240823$N$CN$US$
242498031$24249803$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA244201$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240826$$CN$US$US
242498041$24249804$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248009$SANOFI AVENTIS$$$$C$F$Y$$$20240826$$MD$US$US
242498051$24249805$1$I$20240516$20240816$20240826$20240826$PER$$US-SA-2024SA247606$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240826$$MD$US$US
242498061$24249806$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA247092$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240826$$MD$US$US
242498071$24249807$1$I$20240812$20240815$20240826$20240826$PER$$US-SA-2024SA245324$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240826$$MD$US$US
242498081$24249808$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247053$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$CN$US$US
242498091$24249809$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58381$$FDA-CTU$$78$YR$$M$N$77.11$KG$20240823$N$$US$
242498101$24249810$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248535$SANOFI AVENTIS$$$$E$F$Y$59.874$KG$20240826$$MD$US$US
242498112$24249811$2$F$20240501$20240918$20240826$20240925$EXP$$JP-AMGEN-JPNSP2024167812$AMGEN$$61$YR$A$F$Y$$$20240925$$MD$JP$JP
242498121$24249812$1$I$20240820$20240823$20240823$20240823$DIR$715735$$FDA-CTU$$34$YR$$F$N$58.5$KG$20240823$N$CN$US$
242498131$24249813$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58387$$FDA-CTU$$83$YR$$M$N$$$20240823$N$$US$
242498141$24249814$1$I$20240804$20240823$20240823$20240823$DIR$715700$$FDA-CTU$$55$YR$$F$N$75.6$KG$20240823$N$CN$US$
242498151$24249815$1$I$20240728$20240826$20240826$20240826$EXP$FR-AFSSAPS-BS2024000563$NVSC2024FR171949$NOVARTIS$$58$YR$$F$Y$39.4$KG$20240826$$MD$FR$FR
242498161$24249816$1$I$20240701$20240822$20240826$20240826$EXP$$NVSC2024MX095757$NOVARTIS$$71$YR$$F$Y$$$20240826$$CN$MX$MX
242498171$24249817$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246839$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$HP$US$US
242498181$24249818$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248015$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240826$$MD$US$US
242498191$24249819$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248263$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240826$$CN$US$US
242498201$24249820$1$I$20240817$20240823$20240823$20240823$DIR$715694$$FDA-CTU$$56$YR$$F$N$87.75$KG$20240823$N$CN$US$
242498211$24249821$1$I$20240819$20240823$20240824$20240824$DIR$FDA-CDER-CTU-2024-58359$$FDA-CTU$$$$$M$N$94.9$KG$20240823$N$$US$
242498221$24249822$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246441$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240826$$MD$US$US
242498231$24249823$1$I$20240821$20240822$20240826$20240826$PER$$US-BAYER-2024A121251$BAYER$$39$YR$A$F$Y$$$20240826$$MD$US$US
242498241$24249824$1$I$20240807$20240807$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126092$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240826$$HP$US$US
242498251$24249825$1$I$$20240822$20240826$20240826$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-134634$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240826$$MD$CA$CA
242498261$24249826$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248250$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240826$$MD$US$US
242498271$24249827$1$I$20240801$20240816$20240826$20240826$PER$$US-SA-2024SA246152$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240826$$CN$US$US
242498281$24249828$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246164$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240826$$CN$US$US
242498291$24249829$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA035718$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242498301$24249830$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247438$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242498311$24249831$1$I$20231201$20240816$20240826$20240826$PER$$US-SA-2024SA246272$SANOFI AVENTIS$$16$YR$T$F$Y$54.4$KG$20240826$$MD$US$US
242498321$24249832$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA246200$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240826$$MD$US$US
242498331$24249833$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247103$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240826$$MD$US$US
242498341$24249834$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248564$SANOFI AVENTIS$$$$T$F$Y$86$KG$20240826$$MD$US$US
242498351$24249835$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246532$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240826$$MD$US$US
242498361$24249836$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248430$SANOFI AVENTIS$$$$C$F$Y$23.8$KG$20240826$$MD$US$US
242498371$24249837$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA247512$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240826$$MD$US$US
242498381$24249838$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246282$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240826$$CN$US$US
242498392$24249839$2$F$20240801$20240829$20240826$20240911$PER$$US-SA-2024SA246560$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240911$$MD$US$US
242498401$24249840$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248531$SANOFI AVENTIS$$$$A$F$Y$59.42$KG$20240826$$MD$US$US
242498411$24249841$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA246400$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240826$$MD$US$US
242498421$24249842$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247315$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240826$$CN$US$US
242498431$24249843$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248199$SANOFI AVENTIS$$$$A$F$Y$83.91$KG$20240826$$MD$US$US
242498441$24249844$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA248553$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240826$$MD$US$US
242498453$24249845$3$F$$20240816$20240826$20240919$PER$$US-SA-2024SA248273$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
242498461$24249846$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247693$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240826$$MD$US$US
242498471$24249847$1$I$20221201$20240816$20240826$20240826$PER$$US-SA-2024SA247261$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240826$$MD$US$US
242498481$24249848$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247125$SANOFI AVENTIS$$$$$F$Y$$$20240826$$CN$US$US
242498491$24249849$1$I$20240701$20240816$20240826$20240826$PER$$US-SA-2024SA248405$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240826$$MD$US$US
242498501$24249850$1$I$20230101$20240816$20240826$20240826$PER$$US-SA-2024SA246980$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240826$$CN$US$US
242498511$24249851$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA246823$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240826$$MD$US$US
242498522$24249852$2$F$20240101$20240909$20240826$20240917$PER$$US-SA-2024SA248831$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240918$$MD$US$US
242498531$24249853$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246786$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240826$$MD$US$US
242498541$24249854$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA247627$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240826$$CN$US$US
242498551$24249855$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247117$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240826$$MD$US$US
242498561$24249856$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247454$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240826$$MD$US$US
242498571$24249857$1$I$20240701$20240816$20240826$20240826$PER$$US-SA-2024SA247028$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240826$$MD$US$US
242498581$24249858$1$I$20240815$20240816$20240826$20240826$PER$$US-SA-2024SA245957$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240826$$MD$US$US
242498591$24249859$1$I$20240502$20240816$20240826$20240826$PER$$US-SA-2024SA246729$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240826$$CN$US$US
242498603$24249860$3$F$$20240913$20240826$20240923$PER$$US-SA-2024SA245846$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240923$$CN$US$US
242498611$24249861$1$I$20240801$20240816$20240826$20240826$PER$$US-SA-2024SA248395$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240826$$MD$US$US
242498621$24249862$1$I$20240824$20240824$20240824$20240824$DIR$FDA-CDER-CTU-2024-58409$$FDA-CTU$$28$YR$$F$N$$$20240824$N$$US$
242498631$24249863$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA248289$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240826$$MD$US$US
242498641$24249864$1$I$$20240824$20240824$20240824$DIR$FDA-CDER-CTU-2024-58407$$FDA-CTU$$63$YR$$F$N$$$20240824$N$$US$
242498651$24249865$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246160$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240826$$CN$US$US
242498661$24249866$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA248121$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240826$$CN$US$US
242498671$24249867$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248624$SANOFI AVENTIS$$$$A$M$Y$79.37$KG$20240826$$MD$US$US
242498681$24249868$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246331$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242498691$24249869$1$I$20240811$20240824$20240824$20240824$DIR$FDA-CDER-CTU-2024-58410$$FDA-CTU$$85$YR$$F$N$$$20240824$Y$HP$US$
242498701$24249870$1$I$20240816$20240816$20240826$20240826$PER$$US-SA-2024SA247685$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240826$$MD$US$US
242498711$24249871$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248283$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240826$$MD$US$US
242498721$24249872$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA245526$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240826$$CN$US$US
242498731$24249873$1$I$20240801$20240816$20240826$20240826$PER$$US-SA-2024SA247648$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240826$$MD$US$US
242498741$24249874$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246779$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240826$$MD$US$US
242498751$24249875$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247096$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242498761$24249876$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248303$SANOFI AVENTIS$$81$YR$E$M$Y$80.73$KG$20240826$$MD$US$US
242498772$24249877$2$F$20240816$20240819$20240826$20240828$PER$$US-SA-2024SA247148$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240828$$CN$US$US
242498781$24249878$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA246198$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240826$$MD$PR$US
242498791$24249879$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA248399$SANOFI AVENTIS$$37$YR$A$F$Y$68$KG$20240826$$MD$US$US
242498811$24249881$1$I$20240716$20240816$20240826$20240826$PER$$US-SA-2024SA247109$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240826$$MD$US$US
242498821$24249882$1$I$20240201$20240821$20240826$20240826$PER$$US-JNJFOC-20240857121$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240826$$CN$US$US
242498841$24249884$1$I$20050301$20240823$20240826$20240826$PER$$US-JNJFOC-20240866026$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240826$$HP$US$US
242498851$24249885$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA247834$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240826$$MD$US$US
242498861$24249886$1$I$$20240819$20240826$20240826$PER$$US-JNJFOC-20240852276$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242498871$24249887$1$I$20240813$20240816$20240826$20240826$PER$$US-SA-2024SA246047$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240826$$HP$US$US
242498882$24249888$2$F$20240601$20240828$20240826$20240909$PER$$US-SA-2024SA245346$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240909$$MD$US$US
242498891$24249889$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA247296$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240826$$MD$US$US
242498901$24249890$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248506$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240826$$MD$US$US
242498911$24249891$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248546$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240826$$MD$US$US
242498921$24249892$1$I$20240601$20240816$20240826$20240826$PER$$US-SA-2024SA248695$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240826$$MD$US$US
242498931$24249893$1$I$20240814$20240816$20240826$20240826$PER$$US-SA-2024SA247638$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240826$$MD$US$US
242498941$24249894$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246353$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240826$$MD$US$US
242498952$24249895$2$F$$20240826$20240826$20240910$PER$$US-SA-2024SA248268$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240910$$MD$US$US
242498971$24249897$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA248085$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240826$$MD$US$US
242498981$24249898$1$I$20240806$20240817$20240826$20240826$PER$$US-SA-2024SA246928$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240826$$MD$US$US
242498991$24249899$1$I$20220901$20240817$20240826$20240826$PER$$US-SA-2024SA248550$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240826$$CN$US$US
242499001$24249900$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA245850$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240826$$CN$US$US
242499011$24249901$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246881$SANOFI AVENTIS$$$$$F$Y$$$20240826$$HP$US$US
242499023$24249902$3$F$20240807$20240826$20240826$20240923$PER$$US-SA-2024SA247976$SANOFI AVENTIS$$57$YR$A$F$Y$81.64$KG$20240923$$MD$US$US
242499031$24249903$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246285$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240826$$HP$US$US
242499044$24249904$4$F$20240813$20240830$20240826$20240911$PER$$US-SA-2024SA242848$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240911$$HP$US$US
242499051$24249905$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA246246$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240826$$MD$US$US
242499061$24249906$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246528$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240826$$CN$US$US
242499071$24249907$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247318$SANOFI AVENTIS$$$$A$F$Y$57$KG$20240826$$MD$US$US
242499081$24249908$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA247583$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240826$$CN$US$US
242499091$24249909$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248622$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240826$$MD$US$US
242499101$24249910$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA249160$SANOFI AVENTIS$$$$E$F$Y$68.9$KG$20240826$$MD$US$US
242499111$24249911$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246612$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240826$$CN$US$US
242499121$24249912$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA246809$SANOFI AVENTIS$$16$YR$T$F$Y$58.96$KG$20240826$$MD$US$US
242499131$24249913$1$I$20240815$20240816$20240826$20240826$PER$$US-SA-2024SA247248$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240826$$MD$US$US
242499141$24249914$1$I$$20240816$20240826$20240826$PER$$US-SA-2024SA248838$SANOFI AVENTIS$$$$A$M$Y$95.2$KG$20240826$$MD$US$US
242499151$24249915$1$I$20240817$20240817$20240826$20240826$PER$$US-SA-2024SA247943$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240826$$MD$US$US
242499162$24249916$2$F$$20240906$20240826$20240912$EXP$$US-GILEAD-2024-0685156$GILEAD$$74$YR$E$F$Y$$$20240912$$MD$US$US
242499171$24249917$1$I$$20240808$20240826$20240826$PER$$US-AstraZeneca-2024A180861$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242499181$24249918$1$I$20240710$20240713$20240826$20240826$EXP$$JO-AstraZeneca-2024A159418$ASTRAZENECA$$65$YR$$F$Y$$$20240826$$MD$JO$
242499191$24249919$1$I$20240101$20240817$20240826$20240826$PER$$US-SA-2024SA248276$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240826$$CN$US$US
242499201$24249920$1$I$20240101$20240817$20240826$20240826$PER$$US-SA-2024SA248690$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240826$$MD$US$US
242499211$24249921$1$I$20240816$20240817$20240826$20240826$PER$$US-SA-2024SA247966$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240826$$MD$US$US
242499221$24249922$1$I$20240701$20240818$20240826$20240826$PER$$US-SA-2024SA247642$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240826$$MD$US$US
242499231$24249923$1$I$20240101$20240818$20240826$20240826$PER$$US-SA-2024SA247992$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240826$$MD$US$US
242499241$24249924$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248571$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240826$$MD$US$US
242499251$24249925$1$I$20220301$20240818$20240826$20240826$PER$$US-SA-2024SA247564$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240826$$MD$US$US
242499262$24249926$2$F$20240101$20240826$20240826$20240906$PER$$US-SA-2024SA247394$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240906$$MD$US$US
242499271$24249927$1$I$$20240818$20240826$20240826$PER$$US-SA-2024SA248382$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240826$$MD$US$US
242499281$24249928$1$I$$20240818$20240826$20240826$PER$$US-SA-2024SA246829$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240826$$MD$US$US
242499291$24249929$1$I$20240101$20240818$20240826$20240826$PER$$US-SA-2024SA247386$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242499301$24249930$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248044$SANOFI AVENTIS$$$$$$Y$$$20240826$$HP$US$US
242499321$24249932$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA248373$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240826$$CN$US$US
242499331$24249933$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA248401$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240826$$CN$US$US
242499341$24249934$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247364$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240826$$MD$US$US
242499351$24249935$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247280$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240826$$MD$US$US
242499361$24249936$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247481$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240826$$CN$US$US
242499371$24249937$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248023$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242499381$24249938$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248010$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240826$$CN$US$US
242499391$24249939$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248367$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$CN$US$US
242499401$24249940$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247410$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240826$$CN$US$US
242499411$24249941$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247500$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240826$$CN$US$US
242499421$24249942$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247528$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240826$$MD$US$US
242499433$24249943$3$F$$20240822$20240826$20240904$PER$$US-SA-2024SA247759$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240904$$HP$US$US
242499441$24249944$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248004$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242499451$24249945$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248456$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242499461$24249946$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248242$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240826$$MD$US$US
242499472$24249947$2$F$20240101$20240822$20240826$20240830$PER$$US-SA-2024SA248315$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240830$$MD$US$US
242499481$24249948$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248342$SANOFI AVENTIS$$$$A$M$Y$115$KG$20240826$$MD$US$US
242499491$24249949$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248265$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240826$$MD$US$US
242499501$24249950$1$I$20240819$20240819$20240826$20240826$PER$$US-SA-2024SA248058$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240826$$CN$US$US
242499511$24249951$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA248556$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240826$$CN$US$US
242499521$24249952$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247415$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240826$$MD$US$US
242499531$24249953$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248321$SANOFI AVENTIS$$$$E$M$Y$$$20240826$$MD$US$US
242499541$24249954$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248372$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240826$$CN$US$US
242499551$24249955$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA248572$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240826$$MD$US$US
242499561$24249956$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247879$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240826$$MD$US$US
242499571$24249957$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247491$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240826$$CN$US$US
242499581$24249958$1$I$$20240822$20240826$20240826$PER$$NVSC2024US172048$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
242499591$24249959$1$I$20240710$20240730$20240826$20240826$PER$$US-Eisai-EC-2024-171312$EISAI$$68$YR$E$F$Y$$$20240826$$HP$US$US
242499601$24249960$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA247368$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240826$$MD$US$US
242499611$24249961$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248774$SANOFI AVENTIS$$36$YR$A$M$Y$56$KG$20240826$$MD$US$US
242499621$24249962$1$I$20240101$20240821$20240826$20240826$PER$$US-SA-2024SA250545$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242499631$24249963$1$I$20240801$20240819$20240826$20240826$PER$$US-SA-2024SA247534$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240826$$MD$US$US
242499641$24249964$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA248195$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240826$$MD$US$US
242499651$24249965$1$I$20240617$20240819$20240826$20240826$PER$$US-SA-2024SA185855$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240826$$MD$US$US
242499661$24249966$1$I$20240702$20240819$20240826$20240826$PER$$US-SA-2024SA248681$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240826$$MD$US$US
242499671$24249967$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248174$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240826$$CN$US$US
242499681$24249968$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248394$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240826$$MD$US$US
242499691$24249969$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA248693$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240826$$MD$US$US
242499701$24249970$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247474$SANOFI AVENTIS$$$$$F$Y$$$20240826$$HP$US$US
242499711$24249971$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248425$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240826$$CN$US$US
242499721$24249972$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247493$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240826$$CN$US$US
242499731$24249973$1$I$20240816$20240819$20240826$20240826$PER$$US-SA-2024SA247928$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240826$$CN$US$US
242499741$24249974$1$I$20240818$20240819$20240826$20240826$PER$$US-SA-2024SA248307$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240826$$MD$US$US
242499751$24249975$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247440$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240826$$MD$US$US
242499761$24249976$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247665$SANOFI AVENTIS$$$$A$F$Y$$$20240826$$MD$US$US
242499771$24249977$1$I$$20240813$20240826$20240826$PER$$US-ABBVIE-5887468$ABBVIE$$$$$$Y$$$20240826$$MD$US$US
242499782$24249978$2$F$20240820$20240827$20240826$20240830$EXP$$US-ABBVIE-5890617$ABBVIE$$77$YR$$F$Y$$$20240830$$CN$US$US
242499791$24249979$1$I$$20240820$20240826$20240826$EXP$$CA-MYLANLABS-2024M1077321$MYLAN$$54$YR$$M$Y$61$KG$20240826$$CN$CA$CA
242499801$24249980$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA247962$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240826$$MD$US$US
242499811$24249981$1$I$20240819$20240819$20240826$20240826$PER$$US-SA-2024SA248403$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240826$$MD$US$US
242499822$24249982$2$F$$20240820$20240826$20240830$PER$$US-SA-2024SA248795$SANOFI AVENTIS$$$$$$Y$$$20240830$$PH$US$US
242499831$24249983$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247400$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240826$$CN$US$US
242499841$24249984$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248144$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240826$$MD$US$US
242499851$24249985$1$I$20240816$20240819$20240826$20240826$PER$$US-SA-2024SA247244$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240826$$MD$US$US
242499861$24249986$1$I$20240818$20240819$20240826$20240826$PER$$US-SA-2024SA246411$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240826$$CN$US$US
242499873$24249987$3$F$20240818$20240913$20240826$20240920$PER$$US-SA-2024SA247580$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240920$$CN$US$US
242499881$24249988$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248363$SANOFI AVENTIS$$$$C$M$Y$$$20240826$$MD$US$US
242499891$24249989$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247548$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242499901$24249990$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA248846$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240826$$MD$US$US
242499911$24249991$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247295$SANOFI AVENTIS$$$$$F$Y$$$20240826$$CN$US$US
242499921$24249992$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA248570$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240826$$MD$US$US
242499931$24249993$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248841$SANOFI AVENTIS$$6$YR$C$M$Y$23$KG$20240826$$MD$US$US
242499941$24249994$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247485$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240826$$CN$US$US
242499951$24249995$1$I$20240801$20240819$20240826$20240826$PER$$US-SA-2024SA248256$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240826$$MD$US$US
242499961$24249996$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247086$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240826$$CN$US$US
242499971$24249997$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA249681$SANOFI AVENTIS$$54$YR$A$M$Y$100$KG$20240826$$MD$US$US
242499981$24249998$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248217$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240826$$MD$US$US
242499991$24249999$1$I$20240601$20240819$20240826$20240826$PER$$US-SA-2024SA248280$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240826$$MD$US$US
242500001$24250000$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA247934$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240826$$MD$US$US
242500011$24250001$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247522$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240826$$MD$US$US
242500021$24250002$1$I$20240816$20240819$20240826$20240826$PER$$US-SA-2024SA247306$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240826$$PH$US$US
242500031$24250003$1$I$20240809$20240821$20240826$20240826$EXP$$US-ABBVIE-5890918$ABBVIE$$26$YR$$F$Y$$$20240826$$CN$US$US
242500041$24250004$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248771$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242500051$24250005$1$I$$20240820$20240826$20240826$PER$$US-SA-2024SA249691$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240826$$MD$US$US
242500061$24250006$1$I$20240815$20240819$20240826$20240826$PER$$US-SA-2024SA247890$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240826$$MD$US$US
242500071$24250007$1$I$$20240820$20240826$20240826$PER$$US-SA-2024SA249708$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240826$$CN$US$US
242500081$24250008$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247669$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240826$$MD$US$US
242500091$24250009$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247484$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240826$$MD$US$US
242500101$24250010$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA248747$SANOFI AVENTIS$$$$$F$Y$$$20240826$$MD$US$US
242500111$24250011$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247372$SANOFI AVENTIS$$$$$F$Y$$$20240826$$CN$US$US
242500122$24250012$2$F$20240816$20240820$20240826$20240829$PER$$US-SA-2024SA249491$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240829$$MD$US$US
242500131$24250013$1$I$20240101$20240819$20240826$20240826$PER$$US-SA-2024SA248325$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240826$$MD$US$US
242500141$24250014$1$I$20240401$20240819$20240826$20240826$PER$$US-SA-2024SA248750$SANOFI AVENTIS$$62$YR$A$F$Y$78.4$KG$20240826$$MD$US$US
242500151$24250015$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248512$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242500162$24250016$2$F$20240101$20240819$20240826$20240827$PER$$US-SA-2024SA247422$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240827$$MD$US$US
242500171$24250017$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248413$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240826$$MD$US$US
242500181$24250018$1$I$$20240718$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07270$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242500191$24250019$1$I$20240819$20240821$20240826$20240826$EXP$$US-ABBVIE-5891137$ABBVIE$$66$YR$$M$Y$$$20240826$$CN$US$US
242500203$24250020$3$F$20240101$20240916$20240826$20240926$EXP$$CA-ABBVIE-5890788$ABBVIE$$57$YR$$M$Y$$$20240926$$CN$CA$CA
242500211$24250021$1$I$20240821$20240824$20240826$20240826$EXP$GB-MHRA-MED-202408241141098570-LGFHR$GB-SANDOZ INC.-SDZ2024GB075127$SANDOZ$$78$YR$$M$Y$73$KG$20240826$$CN$GB$GB
242500221$24250022$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248992$SANOFI AVENTIS$$$$E$F$Y$$$20240826$$MD$US$US
242500231$24250023$1$I$20240101$20240821$20240826$20240826$EXP$$CA-ABBVIE-5892526$ABBVIE$$$$A$F$Y$$$20240826$$CN$CA$CA
242500241$24250024$1$I$20150301$20240822$20240826$20240826$EXP$$US-ABBVIE-5892520$ABBVIE$$45$YR$$F$Y$$$20240826$$CN$US$US
242500251$24250025$1$I$$20240823$20240826$20240826$EXP$$CA-SANDOZ INC.-SDZ2024CA075047$SANDOZ$$54$YR$$M$Y$$$20240826$$PH$CA$CA
242500261$24250026$1$I$$20240820$20240826$20240826$EXP$$US-AMGEN-USASP2024167759$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242500271$24250027$1$I$$20240726$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07603$LUPIN$$$$$$Y$$$20240826$$PH$US$US
242500281$24250028$1$I$20240717$20240820$20240826$20240826$EXP$FR-AFSSAPS-GR2024001019$FR-MYLANLABS-2024M1077244$MYLAN$$48$YR$$F$Y$$$20240826$$PH$FR$FR
242500291$24250029$1$I$$20240824$20240824$20240824$DIR$FDA-CDER-CTU-2024-58408$$FDA-CTU$$46$YR$$F$N$$$20240824$N$$US$
242500301$24250030$1$I$20240807$20240823$20240824$20240824$DIR$FDA-CDER-CTU-2024-58404$$FDA-CTU$$47$YR$$M$N$73.2$KG$20240823$N$$US$
242500311$24250031$1$I$$20240612$20240826$20240826$PER$$US-BAYER-2024A120094$BAYER$Liao C.; Ramani S.; Parkash V.; Kodaman P.H.. Endometriosis in a 22-Year-Old with Premature Ovarian Insufficiency Secondary to Pre-Pubertal Bone Marrow Transplant: a Case Report. Reproductive Sciences. 2024$13$YR$T$F$Y$$$20240826$$HP$US$US
242500331$24250033$1$I$$20240722$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07458$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242500341$24250034$1$I$$20240823$20240826$20240826$EXP$$GB-SANDOZ INC.-SDZ2024GB075033$SANDOZ$$70$YR$$F$Y$63$KG$20240826$$MD$GB$GB
242500351$24250035$1$I$$20240725$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07471$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242500371$24250037$1$I$20240820$20240821$20240826$20240826$EXP$$CN-ORGANON-O2408CHN001696$ORGANON$$54$YR$$F$Y$65$KG$20240826$$HP$CN$CN
242500381$24250038$1$I$20240527$20240816$20240826$20240826$EXP$FR-AFSSAPS-AVTO2024000110$FR-TEVA-VS-3234126$TEVA$$37$YR$$M$Y$$$20240826$$MD$FR$FR
242500391$24250039$1$I$20240815$20240816$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130856$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240826$$CN$US$US
242500401$24250040$1$I$20240726$20240816$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131087$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240826$$HP$US$US
242500411$24250041$1$I$$20240812$20240826$20240826$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08097$NEUROCRINE BIOSCIENCES$$63$YR$$F$Y$$$20240826$$MD$US$US
242500431$24250043$1$I$$20240821$20240826$20240826$EXP$$US-AMGEN-USASL2024167755$AMGEN$$63$YR$A$F$Y$$$20240826$$MD$US$US
242500441$24250044$1$I$$20240726$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07527$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242500451$24250045$1$I$$20230816$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002010$AMERICAN REGENT$$8$DEC$$F$Y$$$20240826$$HP$US$US
242500461$24250046$1$I$20230101$20230822$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002036$AMERICAN REGENT$$$$$$Y$$$20240826$$HP$US$US
242500471$24250047$1$I$$20230821$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002039$AMERICAN REGENT$$20$YR$$F$Y$$$20240826$$MD$US$US
242500481$24250048$1$I$20230826$20230925$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002079$AMERICAN REGENT$$$$$F$Y$$$20240826$$CN$US$US
242500491$24250049$1$I$$20230830$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002117$AMERICAN REGENT$$$$$$Y$$$20240826$$HP$US$US
242500501$24250050$1$I$20230101$20230823$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002044$AMERICAN REGENT$$$$$M$Y$$$20240826$$HP$US$US
242500511$24250051$1$I$20230801$20230822$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002012$AMERICAN REGENT$$42$YR$$F$Y$$$20240826$$CN$US$US
242500521$24250052$1$I$$20230825$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002063$AMERICAN REGENT$$$$T$F$Y$$$20240826$$HP$US$US
242500531$24250053$1$I$20230101$20230822$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002035$AMERICAN REGENT$$$$$$Y$$$20240826$$HP$US$US
242500541$24250054$1$I$$20240725$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07481$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242500551$24250055$1$I$$20230831$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002120$AMERICAN REGENT$$5$DEC$$F$Y$$$20240826$$HP$US$US
242500561$24250056$1$I$20240715$20240816$20240826$20240826$EXP$GB-MHRA-MED-202408152030478670-BPTLK$GB-TEVA-VS-3234467$TEVA$$48$YR$$M$Y$79$KG$20240826$$CN$GB$GB
242500572$24250057$2$F$20230616$20240826$20240826$20240830$EXP$$CA-GSK-CA2023AMR059899$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$HP$CA$CA
242500581$24250058$1$I$20240701$20240726$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07545$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242500591$24250059$1$I$$20240722$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07461$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242500601$24250060$1$I$$20240824$20240824$20240824$DIR$FDA-CDER-CTU-2024-58364$$FDA-CTU$$35$YR$$F$N$$$20240824$N$$US$
242500611$24250061$1$I$$20240625$20240826$20240826$EXP$$GB-BAYER-2024A095404$BAYER$Bruguier H.; Maalouf N.; Smyth S.L.; Damato S.; Reddy P.; Soleymani majd H.. Rare Mullerian adenosarcoma of the uterine cervix arising on a background of endometriosis: A diagnostic challenge with risk of malignant transformation-A case report and review of the current literature. Clinical Case Reports (2024) 12:6 Article Number: e9075. 2024;12:6:e9075$41$YR$A$F$Y$$$20240826$$HP$GB$GB
242500622$24250062$2$F$20240101$20240827$20240826$20240829$PER$$US-ABBVIE-5885144$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242500631$24250063$1$I$$20240821$20240826$20240826$EXP$$US-TAKEDA-2024TUS084848$TAKEDA$$34$YR$$F$Y$$$20240826$$CN$US$US
242500642$24250064$2$F$20240101$20240823$20240826$20240827$EXP$$IE-LUNDBECK-DKLU4003359$LUNDBECK$$$$$$Y$$$20240827$$CN$IE$IE
242500651$24250065$1$I$$20240820$20240826$20240826$EXP$$CA-MYLANLABS-2024M1078005$MYLAN$$$$$F$Y$49$KG$20240826$$CN$CA$CA
242500661$24250066$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135029$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240826$$CN$US$US
242500671$24250067$1$I$$20240822$20240826$20240826$EXP$$US-JNJFOC-20240861217$JOHNSON AND JOHNSON$$$$$F$Y$$$20240826$$HP$US$US
242500681$24250068$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135226$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240826$$CN$US$US
242500691$24250069$1$I$$20240722$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07385$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242500701$24250070$1$I$20240808$20240822$20240826$20240826$EXP$$NZ-MYLANLABS-2024M1074269$MYLAN$$33$YR$$M$Y$$$20240826$$CN$NZ$NZ
242500711$24250071$1$I$$20240822$20240826$20240826$EXP$$CA-MYLANLABS-2024M1078263$MYLAN$$18$YR$$F$Y$$$20240826$$HP$CA$CA
242500721$24250072$1$I$$20240822$20240826$20240826$EXP$$US-MYLANLABS-2024M1078407$MYLAN$$19$YR$$M$Y$$$20240826$$CN$US$US
242500731$24250073$1$I$$20240820$20240826$20240826$EXP$$AU-DSJP-DSJ-2024-141942$DAIICHI$$$$$F$Y$$$20240826$$MD$AU$AU
242500741$24250074$1$I$$20240726$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07543$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242500751$24250075$1$I$20240101$20240823$20240826$20240826$PER$$US-AMGEN-USASP2024169388$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242500761$24250076$1$I$20240808$20240822$20240826$20240826$EXP$$NVSC2024CN171952$NOVARTIS$$53$YR$$F$Y$60$KG$20240826$$HP$CN$CN
242500771$24250077$1$I$$20240731$20240826$20240826$EXP$$US-BAYER-2024A118512$BAYER$Semelka RC, Ramalho M. Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation. Frontiers in Toxicology. 2024;6:1-7$$$A$$Y$$$20240826$$MD$US$US
242500781$24250078$1$I$$20240725$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07523$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242500791$24250079$1$I$$20240812$20240826$20240826$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08098$NEUROCRINE BIOSCIENCES$$4$DEC$$F$Y$$$20240826$$MD$US$US
242500801$24250080$1$I$20240730$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133641$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$100.24$KG$20240826$$PH$US$US
242500811$24250081$1$I$$20240814$20240826$20240826$EXP$CA-BIOCON BIOLOGICS LIMITED-001095539$CA-BIOCON BIOLOGICS LIMITED-BBL2024006016$BIOCON$$$$$$Y$$$20240826$$CN$CA$CA
242500822$24250082$2$F$$20240827$20240826$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07548$LUPIN$$$$$$Y$$$20240918$$CN$US$US
242500842$24250084$2$F$20240815$20240905$20240826$20240906$EXP$$US-ORGANON-O2408USA001618$ORGANON$$71$YR$$F$Y$$$20240906$$CN$US$US
242500851$24250085$1$I$$20240811$20240826$20240826$PER$$US-AMGEN-USASP2024164921$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$F$Y$$$20240826$$MD$US$US
242500861$24250086$1$I$20180101$20240811$20240826$20240826$PER$$US-AMGEN-USASP2024164917$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$F$Y$$$20240826$$MD$US$US
242500871$24250087$1$I$20240701$20240824$20240826$20240826$EXP$$US-BAYER-2024A121891$BAYER$$28$YR$A$F$Y$$$20240826$$CN$US$US
242500882$24250088$2$F$20240801$20240823$20240826$20240906$EXP$$CA-HLS-202402131$HLS THERAPEUTICS$$48$YR$A$M$Y$$$20240906$$PH$CA$CA
242500893$24250089$3$F$$20240912$20240826$20240925$30DAY$$MX-JNJFOC-20240837234$JOHNSON AND JOHNSON$$58$YR$A$F$Y$61$KG$20240925$$CN$MX$MX
242500901$24250090$1$I$$20240725$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07520$LUPIN$$$$$$Y$$$20240826$$PH$US$US
242500911$24250091$1$I$20240101$20240819$20240826$20240826$EXP$$US-JNJFOC-20240809478$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240826$$CN$US$US
242500922$24250092$2$F$20240823$20240829$20240826$20240903$EXP$$GB-MYLANLABS-2024M1077825$MYLAN$$54$YR$$F$Y$$$20240903$$HP$GB$GB
242500931$24250093$1$I$$20240819$20240826$20240826$EXP$$CA-GSK-CA2023117165$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$CA$CA
242500952$24250095$2$F$20240806$20240819$20240826$20240827$30DAY$$GB-PFIZER INC-PV202400107785$PFIZER$$84$YR$$F$Y$$$20240827$$CN$GB$GB
242500961$24250096$1$I$$20240814$20240826$20240826$30DAY$$RO-PFIZER INC-PV202400105845$PFIZER$$$$$M$Y$$$20240826$$CN$RO$RO
242500972$24250097$2$F$$20240917$20240826$20240919$30DAY$$DE-PFIZER INC-202400238232$PFIZER$$$$$$Y$$$20240919$$HP$DE$DE
242500983$24250098$3$F$20240204$20240821$20240826$20240829$EXP$CH-SM-2024-11133$CH-PFIZER INC-202400240780$PFIZER$$87$YR$$F$Y$48$KG$20240829$$MD$CH$CH
242500992$24250099$2$F$$20240913$20240826$20240924$30DAY$$US-PFIZER INC-202400236167$PFIZER$$3$MON$$M$Y$$$20240924$$CN$US$US
242501001$24250100$1$I$20240826$20240822$20240826$20240826$EXP$$US-PFIZER INC-PV202400092844$PFIZER$$69$YR$$F$Y$$$20240826$$MD$US$US
242501033$24250103$3$F$$20240907$20240826$20240910$30DAY$$TW-PFIZER INC-202400236368$PFIZER$$$$$$Y$$$20240910$$HP$TW$TW
242501042$24250104$2$F$$20240908$20240826$20240916$EXP$$IL-BAYER-2024A120809$BAYER$$$$$M$Y$$$20240916$$MD$IL$IL
242501051$24250105$1$I$$20240822$20240826$20240826$EXP$$IT-JNJFOC-20230573635$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240826$$HP$IT$IT
242501061$24250106$1$I$$20240824$20240824$20240824$DIR$FDA-CDER-CTU-2024-58363$$FDA-CTU$$70$YR$$F$N$$$20240824$N$$US$
242501081$24250108$1$I$$20240726$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07661$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242501091$24250109$1$I$20240621$20240819$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-012978$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242501101$24250110$1$I$$20240819$20240826$20240826$EXP$$US-SANDOZ INC.-SDZ2024US075137$SANDOZ$$$$$$Y$$$20240826$$CN$US$US
242501111$24250111$1$I$$20240725$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07537$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242501121$24250112$1$I$20240808$20240820$20240826$20240826$EXP$$AR-SANDOZ INC.-SDZ2024AR073673$SANDOZ$$12$YR$$F$Y$40$KG$20240826$$CN$AR$AR
242501131$24250113$1$I$$20240820$20240826$20240826$EXP$CA-DRL-USA-SPO/CAN/24/0012187$CA-RDY-SPO/CAN/24/0012187$DR REDDYS$$76$YR$E$F$Y$62$KG$20240826$$PH$CA$CA
242501141$24250114$1$I$$20240819$20240826$20240826$PER$$US-RDY-SPO/USA/24/0012322$DR REDDYS$$21$YR$A$F$Y$$$20240826$$CN$US$US
242501152$24250115$2$F$20240101$20240910$20240826$20240917$EXP$$US-AMGEN-USASP2024167158$AMGEN$$$$$M$Y$$$20240916$$CN$US$US
242501161$24250116$1$I$20240716$20240821$20240826$20240826$EXP$FR-AFSSAPS-AN2024001132$FR-BAYER-2024A120980$BAYER$$75$YR$E$M$Y$66$KG$20240826$$MD$FR$FR
242501171$24250117$1$I$$20240819$20240826$20240826$PER$$US-RDY-SPO/USA/24/0012320$DR REDDYS$$78$YR$E$$Y$$$20240826$$MD$US$US
242501181$24250118$1$I$$20240820$20240826$20240826$EXP$CA-DRL-USA-SPO/CAN/24/0012147$CA-RDY-SPO/CAN/24/0012147$DR REDDYS$$79$YR$E$M$Y$75$KG$20240826$$PH$CA$CA
242501191$24250119$1$I$$20240819$20240826$20240826$PER$$US-MYLANLABS-2024M1077989$MYLAN$$$$$M$Y$108.86$KG$20240826$$CN$US$US
242501201$24250120$1$I$20240416$20240821$20240826$20240826$EXP$$NVSC2024GB088448$NOVARTIS$$$$$F$Y$$$20240826$$CN$GB$GB
242501211$24250121$1$I$20240714$20240816$20240826$20240826$EXP$$CH-JNJFOC-20240865775$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240826$$MD$CH$CH
242501221$24250122$1$I$$20240822$20240826$20240826$PER$$US-JNJFOC-20240857820$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$MD$US$US
242501231$24250123$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA245606$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240826$$MD$US$US
242501241$24250124$1$I$$20240726$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07565$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242501251$24250125$1$I$$20240822$20240826$20240826$PER$$US-BAYER-2024A121222$BAYER$$23$YR$A$F$Y$$$20240826$$CN$US$US
242501261$24250126$1$I$20240412$20240822$20240826$20240826$30DAY$$US-SANDOZ INC.-SDZ2024US049284$SANDOZ$$16$YR$$M$Y$$$20240826$$HP$US$US
242501271$24250127$1$I$20240607$20240823$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134700$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240826$$HP$US$US
242501282$24250128$2$F$$20240912$20240826$20240920$EXP$$US-TEVA-VS-3235734$TEVA$Puccio J, Kirven RM, Kaffenberger BH, Chung C, Korman AM. Toxic Flexural Epidermolysis in hospitalized patients. Arch-Dermatol-Res 2024; 316 (7):.; Puccio J, Kirven RM, Kaffenberger BH, Chung C, Korman AM. Toxic Flexural Epidermolysis in hospitalized patients. Arch-Dermatol-Res 2024; 316 (7):.; Puccio J, Kirven RM, Kaffenberger BH, Chung C, Korman AM. Toxic Flexural Epidermolysis in hospitalized patients. Arch-Dermatol-Res 2024; 316 (7):.$$$A$F$Y$$$20240920$$HP$US$US
242501291$24250129$1$I$$20240819$20240826$20240826$EXP$$US-TEVA-VS-3235735$TEVA$Puccio J, Kirven RM, Kaffenberger BH, Chung C, Korman AM. Toxic Flexural Epidermolysis in hospitalized patients. Arch-Dermatol-Res 2024; 316 (7):.; Puccio J, Kirven RM, Kaffenberger BH, Chung C, Korman AM. Toxic Flexural Epidermolysis in hospitalized patients. Arch-Dermatol-Res 2024; 316 (7):.$$$E$F$Y$$$20240826$$HP$US$US
242501301$24250130$1$I$20240724$20240819$20240826$20240826$EXP$$CA-TAKEDA-2024TUS083839$TAKEDA$$72$YR$$F$Y$$$20240826$$CN$CA$CA
242501311$24250131$1$I$20240821$20240822$20240826$20240826$EXP$$GB-MYLANLABS-2024M1078213$MYLAN$$$$$F$Y$$$20240826$$CN$GB$GB
242501321$24250132$1$I$20240221$20240801$20240826$20240826$EXP$$CA-APELLIS-APL-2024-004222$APELLIS PHARMACEUTICALS$$$$$$Y$58$KG$20240826$$HP$CA$CA
242501341$24250134$1$I$$20240821$20240826$20240826$EXP$$NVSC2024US170251$NOVARTIS$$$$$F$Y$$$20240826$$CN$US$US
242501351$24250135$1$I$$20240822$20240826$20240826$EXP$$CA-MYLANLABS-2024M1078387$MYLAN$$60$YR$$M$Y$$$20240826$$CN$CA$CA
242501361$24250136$1$I$20240731$20240819$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-012980$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242501371$24250137$1$I$20220826$20240822$20240826$20240826$PER$$US-BIOGEN-2022BI01170986$BIOGEN$$60$YR$$F$Y$$$20240826$$CN$US$US
242501381$24250138$1$I$20240814$20240821$20240826$20240826$EXP$$US-AMGEN-USASP2024167188$AMGEN$$75$YR$E$M$Y$$$20240826$$HP$US$US
242501391$24250139$1$I$20240305$20240821$20240826$20240826$EXP$$US-OTSUKA-2024_006131$OTSUKA$$$$$M$Y$$$20240826$$CN$US$US
242501401$24250140$1$I$20240819$20240826$20240826$20240826$PER$$US-BAYER-2024A122412$BAYER$$47$YR$A$F$Y$$$20240826$$MD$US$US
242501412$24250141$2$F$20240801$20240822$20240826$20240828$EXP$$US-BAUSCH-BL-2024-012836$BAUSCH AND LOMB$$$$$$Y$$$20240828$$CN$US$US
242501421$24250142$1$I$$20240725$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07522$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242501431$24250143$1$I$$20240729$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07717$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242501441$24250144$1$I$20240820$20240821$20240826$20240826$EXP$$PL-BAYER-2024A121467$BAYER$$64$YR$A$M$Y$89$KG$20240826$$HP$PL$PL
242501451$24250145$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247574$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240826$$CN$US$US
242501461$24250146$1$I$20240401$20240821$20240826$20240826$PER$$US-ORGANON-O2408USA001784$ORGANON$$$$$F$Y$$$20240826$$CN$US$US
242501471$24250147$1$I$20240718$20240820$20240826$20240826$EXP$FR-AFSSAPS-GR2024001016$FR-MYLANLABS-2024M1077366$MYLAN$$19$YR$$$Y$$$20240826$$PH$FR$FR
242501481$24250148$1$I$$20240822$20240826$20240826$PER$$NVSC2024US172224$NOVARTIS$$$$$$Y$$$20240826$$MD$US$US
242501491$24250149$1$I$20240819$20240821$20240826$20240826$PER$$US-ORGANON-O2408USA001656$ORGANON$$36$YR$$F$Y$83$KG$20240826$$MD$US$US
242501501$24250150$1$I$$20240820$20240826$20240826$EXP$BE-FAMHP-DHH-N2024-122495$BE-MYLANLABS-2024M1077252$MYLAN$$45$YR$$M$Y$$$20240826$$PH$BE$BE
242501511$24250151$1$I$20240705$20240820$20240826$20240826$EXP$$FR-MYLANLABS-2024M1077299$MYLAN$$56$YR$$F$Y$$$20240826$$MD$FR$FR
242501522$24250152$2$F$20240101$20240903$20240826$20240909$EXP$$US-AMGEN-USASP2024167204$AMGEN$$87$YR$E$M$Y$$$20240909$$CN$US$US
242501532$24250153$2$F$20240101$20240823$20240826$20240902$PER$$US-AMGEN-USASP2024169578$AMGEN$$63$YR$A$F$Y$$$20240902$$HP$US$US
242501541$24250154$1$I$20240701$20240730$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07692$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242501551$24250155$1$I$$20240818$20240826$20240826$EXP$$US-AstraZeneca-2024A189507$ASTRAZENECA$$$$$$Y$$$20240826$$HP$US$
242501561$24250156$1$I$$20240818$20240826$20240826$EXP$$US-AstraZeneca-2024A189689$ASTRAZENECA$$$$$$Y$$$20240826$$CN$US$
242501572$24250157$2$F$20240101$20240902$20240826$20240905$EXP$$JP-AstraZeneca-2024A192289$ASTRAZENECA$$80$YR$$M$Y$$$20240905$$MD$JP$
242501581$24250158$1$I$20240101$20240730$20240826$20240826$PER$$US-Eisai-EC-2024-171345$EISAI$$84$YR$E$F$Y$$$20240826$$MD$US$US
242501591$24250159$1$I$$20240729$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07647$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242501601$24250160$1$I$20090101$20240816$20240826$20240826$EXP$$US-TEVA-VS-3234383$TEVA$$73$YR$$F$Y$$$20240826$$CN$US$US
242501611$24250161$1$I$20220625$20240820$20240826$20240826$EXP$$JP-GILEAD-2023-0642510$GILEAD$$33$YR$A$M$Y$$$20240826$$MD$JP$JP
242501621$24250162$1$I$20231214$20240815$20240826$20240826$EXP$$BR-GSK-BR2024AMR005015$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$BR$BR
242501631$24250163$1$I$20180101$20240819$20240826$20240826$EXP$$BR-BAUSCH-BL-2024-012615$BAUSCH AND LOMB$de Medeiros Dutra R, Jeronymo Pinto F, Silvino Craveiro M, Baima J, Saad-Hossne R, Romeiro F, Sassaki L. Risks and benefits of anti-TNF therapy for ulcerative colitis in a patient with autoimmune hepatitis-related cirrhosis Case report. Medicine. 2024;103 (31):1-5. doi:10.1097/MD.0000000000039095$$$A$F$Y$$$20240826$$MD$BR$BR
242501641$24250164$1$I$$20240725$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07476$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242501651$24250165$1$I$$20240820$20240826$20240826$EXP$$DE-MYLANLABS-2024M1077502$MYLAN$$55$YR$$F$Y$$$20240826$$MD$DE$DE
242501661$24250166$1$I$$20240812$20240826$20240826$PER$$GB-KARYOPHARM-2024KPT001428$KARYOPHARM THERAPEUTICS$Nini Aung, Margaret Bowers, Gillian Brearton, et al.. Selinexor in combination with dexamethasone with or without bortezomib in heavily pretreated multiple myeloma: A case series. eJHaem. 2024;1-5$$$$$Y$$$20240826$$MD$GB$GB
242501671$24250167$1$I$20240806$20240819$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-012981$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242501681$24250168$1$I$20220902$20240816$20240826$20240826$EXP$$NZ-AstraZeneca-2024A193491$ASTRAZENECA$$$$$$Y$$$20240826$$PH$NZ$
242501691$24250169$1$I$20240824$20240826$20240826$20240826$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047747$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240826$$CN$US$US
242501711$24250171$1$I$20240701$20240822$20240826$20240826$EXP$$US-BAYER-2024A121408$BAYER$$13$YR$T$M$Y$$$20240826$$HP$US$US
242501721$24250172$1$I$$20240725$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07521$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242501731$24250173$1$I$20231201$20240820$20240826$20240826$EXP$FR-AFSSAPS-BR2024000683$FR-ABBVIE-5886590$ABBVIE$$69$YR$$F$Y$$$20240826$$MD$FR$FR
242501741$24250174$1$I$$20240820$20240826$20240826$EXP$$CA-SANDOZ INC.-SDZ2024CA074088$SANDOZ$$11$YR$$F$Y$$$20240826$$CN$CA$CA
242501761$24250176$1$I$$20240729$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07630$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242501771$24250177$1$I$$20240812$20240826$20240826$EXP$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01280$TARO$Thamcharoen N, Rajapakse RP, Rosen RM, D^Agati VD. Steroid May Be an Effective Treatment for Warfarin Related Nephropathy. J Am Soc Nephrol. 2016;27:991A (PUB375)$$$$$Y$$$20240826$$HP$US$US
242501781$24250178$1$I$$20240820$20240826$20240826$EXP$$AU-DSJP-DSJ-2024-141928$DAIICHI$$$$$F$Y$$$20240826$$MD$AU$AU
242501791$24250179$1$I$20130101$20240820$20240826$20240826$EXP$$US-MYLANLABS-2024M1078028$MYLAN$$$$$F$Y$$$20240826$$CN$US$US
242501801$24250180$1$I$$20240816$20240826$20240826$EXP$$GB-TEVA-VS-3234773$TEVA$$62$YR$$M$Y$118$KG$20240826$$MD$GB$GB
242501811$24250181$1$I$$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024165145$AMGEN$$$$$$Y$$$20240826$$CN$US$US
242501821$24250182$1$I$$20240819$20240826$20240826$EXP$$CA-AMGEN-CANSP2024165235$AMGEN$$$$$F$Y$$$20240826$$CN$CA$CA
242501831$24250183$1$I$20240501$20240819$20240826$20240826$EXP$$CA-GSK-CA2024103805$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$CA$CA
242501841$24250184$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247521$SANOFI AVENTIS$$$$$M$Y$$$20240826$$CN$US$US
242501852$24250185$2$F$$20240827$20240826$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07534$LUPIN$$$$$$Y$$$20240918$$CN$US$US
242501871$24250187$1$I$$20240813$20240826$20240826$PER$$US-BAYER-2024A117612$BAYER$$$$$F$Y$$$20240826$$CN$US$US
242501881$24250188$1$I$20240622$20240823$20240824$20240824$DIR$FDA-CDER-CTU-2024-58405$$FDA-CTU$$59$YR$$F$N$64.3$KG$20240823$N$$US$
242501891$24250189$1$I$$20240825$20240825$20240825$DIR$FDA-CDER-CTU-2024-58367$$FDA-CTU$$51$YR$$M$N$$$20240825$N$$US$
242501901$24250190$1$I$$20240825$20240825$20240825$DIR$FDA-CDER-CTU-2024-58411$$FDA-CTU$$75$YR$$M$N$$$20240825$N$$US$
242501912$24250191$2$F$20240801$20240823$20240826$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135283$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$47.17$KG$20240829$$CN$US$US
242501922$24250192$2$F$$20240923$20240826$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129911$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240926$$CN$US$US
242501931$24250193$1$I$$20240729$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07633$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242501941$24250194$1$I$$20240725$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07475$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242501951$24250195$1$I$$20240819$20240826$20240826$EXP$$AU-ABBVIE-5887492$ABBVIE$$$$$$Y$$$20240826$$MD$AU$AU
242501961$24250196$1$I$20240725$20240815$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130582$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$83.46$KG$20240826$$PH$US$US
242501971$24250197$1$I$20240811$20240821$20240826$20240826$EXP$$CO-BIOVITRUM-2024-CO-011280$BIOVITRUM$$252$DY$$M$Y$6$KG$20240826$$CN$CO$CO
242501981$24250198$1$I$$20240821$20240826$20240826$PER$$PR-JNJFOC-20240854852$JOHNSON AND JOHNSON$$11$YR$C$$Y$$$20240826$$MD$PR$PR
242501991$24250199$1$I$20240322$20240820$20240826$20240826$EXP$FR-AFSSAPS-BX2024001655$FR-MYLANLABS-2024M1077226$MYLAN$$59$YR$$M$Y$$$20240826$$MD$FR$FR
242502001$24250200$1$I$20240101$20240815$20240826$20240826$EXP$$SK-JNJFOC-20240847097$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240826$$MD$SK$SK
242502011$24250201$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58656$$FDA-CTU$$83$YR$$M$N$$$20240826$N$$US$
242502031$24250203$1$I$20240805$20240824$20240824$20240824$DIR$715771$$FDA-CTU$$32$YR$$M$N$$$20240824$N$CN$US$
242502051$24250205$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58581$$FDA-CTU$$51$YR$$F$N$$$20240826$N$$US$
242502061$24250206$1$I$20240819$20240824$20240824$20240824$DIR$715756$$FDA-CTU$$95$YR$$F$N$$$20240824$Y$PH$US$
242502071$24250207$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58568$$FDA-CTU$$64$YR$$M$N$$$20240826$N$$US$
242502081$24250208$1$I$20240824$20240824$20240824$20240824$DIR$715773$$FDA-CTU$$51$YR$$F$N$$$20240824$N$CN$US$
242502091$24250209$1$I$20240823$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58663$$FDA-CTU$$70$YR$$F$N$$$20240826$Y$PH$US$
242502101$24250210$1$I$20240824$20240824$20240824$20240824$DIR$715788$$FDA-CTU$$60$YR$$M$N$112.5$KG$20240824$N$CN$US$
242502111$24250211$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58563$$FDA-CTU$$80$YR$$F$N$$$20240826$N$$US$
242502121$24250212$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58513$$FDA-CTU$$61$YR$$F$N$$$20240826$N$$US$
242502141$24250214$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58588$$FDA-CTU$$62$YR$$F$N$187$LBS$20240826$N$$US$
242502151$24250215$1$I$20240529$20240824$20240824$20240824$DIR$715786$$FDA-CTU$$66$YR$$F$N$$$20240824$N$CN$US$
242502161$24250216$1$I$20240813$20240820$20240826$20240826$EXP$$US-PFIZER INC-202300449895$PFIZER$$86$YR$$M$Y$$$20240826$$HP$US$US
242502174$24250217$4$F$$20240830$20240826$20240905$EXP$$NVSC2024US170799$NOVARTIS$$$$$M$Y$$$20240905$$CN$US$US
242502181$24250218$1$I$$20240729$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07646$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242502191$24250219$1$I$$20240826$20240826$20240826$EXP$$NL-SANDOZ INC.-SDZ2024NL075106$SANDOZ$$60$YR$$F$Y$$$20240826$$HP$NL$NL
242502201$24250220$1$I$20240701$20240819$20240826$20240826$EXP$$US-GSK-US2024103418$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$US$US
242502212$24250221$2$F$20240815$20240920$20240826$20240924$EXP$$JP-Eisai-EC-2024-172492$EISAI$$$$$F$Y$$$20240924$$MD$JP$JP
242502221$24250222$1$I$20240418$20240515$20240826$20240826$PER$$US-PHARMAAND GMBH-2024PHR00333$pharmaAND$$63$YR$$F$Y$$$20240802$$CN$US$US
242502231$24250223$1$I$20240501$20240531$20240826$20240826$PER$$US-PHARMAAND GMBH-2024PHR00361$pharmaAND$$60$YR$$F$Y$60.317$KG$20240826$$CN$US$US
242502241$24250224$1$I$20230101$20240607$20240826$20240826$PER$$US-PHARMAAND GMBH-2024PHR00369$pharmaAND$$$$$F$Y$$$20240826$$CN$US$US
242502251$24250225$1$I$$20240521$20240826$20240826$PER$$US-PHARMAAND GMBH-2024PHR00392$pharmaAND$$$$$M$Y$$$20240826$$CN$US$US
242502261$24250226$1$I$$20240522$20240826$20240826$PER$$US-PHARMAAND GMBH-2024PHR00394$pharmaAND$$$$$F$Y$$$20240826$$CN$US$US
242502271$24250227$1$I$$20230710$20240826$20240826$PER$$US-PHARMAAND-2023PHR00069$pharmaAND$$$$$F$Y$$$20240826$$CN$US$US
242502281$24250228$1$I$20230101$20230929$20240826$20240826$EXP$$US-PHARMAAND-2023PHR00120$pharmaAND$$$$$M$Y$$$20240826$$HP$US$US
242502291$24250229$1$I$20230608$20231107$20240826$20240826$EXP$$FR-PHARMAAND-2023PHR00214$pharmaAND$$77$YR$$F$Y$$$20240826$$MD$FR$FR
242502301$24250230$1$I$20230101$20231115$20240826$20240826$PER$$US-PHARMAAND-2023PHR00227$pharmaAND$$$$$M$Y$82.54$KG$20240826$$CN$US$US
242502311$24250231$1$I$20240108$20240223$20240826$20240826$PER$$US-PHARMAAND GMBH-2024PHR00016$pharmaAND$$75$YR$$M$Y$70.295$KG$20240826$$CN$US$US
242502321$24250232$1$I$$20240131$20240826$20240826$PER$$US-PHARMAAND GMBH-2024PHR00152$pharmaAND$$$$$M$Y$95.238$KG$20240826$$MD$US$US
242502331$24250233$1$I$20230101$20240327$20240826$20240826$PER$$US-PHARMAAND GMBH-2024PHR00290$pharmaAND$$$$$F$Y$62.5$KG$20240826$$PH$US$US
242502341$24250234$1$I$$20240726$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07528$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242502351$24250235$1$I$$20240726$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07544$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242502361$24250236$1$I$$20240820$20240826$20240826$PER$$US-ALXN-202408USA001516US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$CN$US$US
242502371$24250237$1$I$$20240819$20240826$20240826$PER$$US-ALXN-202408USA001255US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
242502381$24250238$1$I$$20240111$20240826$20240826$PER$$US-PHARMAAND GMBH-2024PHR00163$pharmaAND$$$$$F$Y$$$20240826$$CN$US$US
242502393$24250239$3$F$$20240913$20240826$20240919$EXP$$PT-MYLANLABS-2024M1077433$MYLAN$Nogueira JV, Neves CF, Alves DR, Bravo SP, Mesquita P, Eul?lio M, Ferreira FC. From prognosis modifier to morbidity inducer: fournier gangrene under isglt2. Internal medicine. 2024;30(Sup 1):668$68$YR$$M$Y$$$20240919$$MD$PT$PT
242502401$24250240$1$I$$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A191025$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$US$
242502411$24250241$1$I$$20231219$20240826$20240826$PER$$US-PHARMAAND GMBH-2024PHR00023$pharmaAND$$$$$F$Y$$$20240826$$CN$US$US
242502431$24250243$1$I$$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A191236$ASTRAZENECA$$$$$$Y$$$20240826$$CN$US$
242502441$24250244$1$I$$20240816$20240826$20240826$PER$$US-ABBVIE-5886480$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242502451$24250245$1$I$20240101$20240823$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047637$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240826$$CN$US$US
242502461$24250246$1$I$$20240822$20240826$20240826$EXP$$US-GSK-US2024105391$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$HP$US$US
242502471$24250247$1$I$$20240820$20240826$20240826$EXP$$GB-TAKEDA-2024TUS075493$TAKEDA$$$$$F$Y$$$20240826$$CN$GB$GB
242502491$24250249$1$I$$20240726$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07546$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242502502$24250250$2$F$20240701$20240827$20240826$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07532$LUPIN$$$$$$Y$$$20240916$$CN$US$US
242502511$24250251$1$I$20240401$20240824$20240826$20240826$EXP$GB-MHRA-MED-202408241631166090-PDJYF$GB-SANDOZ INC.-SDZ2024GB075122$SANDOZ$$41$YR$$M$Y$70$KG$20240826$$CN$GB$GB
242502521$24250252$1$I$$20240816$20240826$20240826$30DAY$$US-GSK-US2024102689$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
242502531$24250253$1$I$20190101$20240812$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128736$BRISTOL MYERS SQUIBB$Trager MH, Coley SM, Dube G, Khan S, Ingham M, Samie FH, et al. Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients. Journal for ImmunoTherapy of Cancer. 2021;9:1-7. doi:10.1136/jitc-2020-000908corr1.$67$YR$E$M$Y$$$20240826$$HP$US$US
242502541$24250254$1$I$$20240816$20240826$20240826$EXP$$IE-BRISTOL-MYERS SQUIBB COMPANY-2024-132423$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240826$$MD$IE$IE
242502551$24250255$1$I$20240321$20240819$20240826$20240826$EXP$$AU-NALPROPION PHARMACEUTICALS INC.-AU-2024CUR003907$CURRAX PHARMACEUTICALS$$43$YR$$M$Y$$$20240826$$PH$AU$AU
242502562$24250256$2$F$$20240823$20240826$20240828$EXP$$US-PFIZER INC-202400242633$PFIZER$$67$YR$$M$Y$$$20240828$$CN$US$US
242502571$24250257$1$I$20240723$20240819$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-012985$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242502582$24250258$2$F$20240623$20240827$20240826$20240829$EXP$$US-PFIZER INC-202400243830$PFIZER$$67$YR$$F$Y$$$20240829$$CN$US$US
242502591$24250259$1$I$$20240821$20240826$20240826$PER$$US-ABBVIE-5890211$ABBVIE$$$$$F$Y$70.306$KG$20240826$$CN$US$US
242502601$24250260$1$I$$20240823$20240826$20240826$PER$$US-MYLANLABS-2024M1078570$MYLAN$$$$$F$Y$$$20240826$$CN$US$US
242502611$24250261$1$I$$20240820$20240826$20240826$EXP$$US-OTSUKA-2024_023206$OTSUKA$$$$$$Y$$$20240826$$MD$US$US
242502622$24250262$2$F$20240814$20240912$20240826$20240922$PER$$US-GSK-US2024102715$GLAXOSMITHKLINE$$69$YR$$M$Y$$$20240922$$CN$US$US
242502631$24250263$1$I$$20240726$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07547$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242502641$24250264$1$I$20240816$20240816$20240826$20240826$PER$$US-TEVA-VS-3234297$TEVA$$$$$F$Y$$$20240826$$CN$US$US
242502651$24250265$1$I$20201005$20240819$20240826$20240826$EXP$$CA-TAKEDA-CA202033231$TAKEDA$$74$YR$$M$Y$$$20240826$$CN$CA$CA
242502661$24250266$1$I$20240714$20240816$20240826$20240826$EXP$FR-AFSSAPS-NY2024000937$FR-TEVA-VS-3234174$TEVA$$93$YR$$F$Y$$$20240826$$MD$FR$FR
242502681$24250268$1$I$20240301$20240824$20240824$20240824$DIR$715784$$FDA-CTU$$65$YR$$F$N$$$20240824$N$CN$US$
242502691$24250269$1$I$20240824$20240824$20240824$20240824$DIR$715774$$FDA-CTU$$40$YR$$F$N$58.95$KG$20240824$N$HP$US$
242502701$24250270$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58614$$FDA-CTU$$31$YR$$F$N$251$LBS$20240826$N$$US$
242502711$24250271$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246350$SANOFI AVENTIS$$$$E$M$Y$73.482$KG$20240826$$HP$US$US
242502742$24250274$2$F$$20240909$20240826$20240912$EXP$$NL-SANDOZ INC.-SDZ2024NL075157$SANDOZ$$24$YR$$M$Y$$$20240912$$HP$NL$NL
242502771$24250277$1$I$$20240729$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07649$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242502801$24250280$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58558$$FDA-CTU$$79$YR$$M$N$$$20240826$N$$US$
242502811$24250281$1$I$$20240816$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132164$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240826$$PH$US$US
242502821$24250282$1$I$20220626$20230626$20240826$20240826$EXP$$CA-NOVOPROD-1271915$NOVO NORDISK$$$$$F$Y$$$20240826$$HP$CA$CA
242502832$24250283$2$F$$20240827$20240826$20240904$EXP$$GB-AMGEN-GBRSP2024166657$AMGEN$$$$$F$Y$$$20240904$$PH$GB$GB
242502841$24250284$1$I$$20240814$20240826$20240826$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001692$BLUEPRINT MEDICINES$$$$$$Y$$$20240826$$MD$CN$CN
242502851$24250285$1$I$$20240814$20240826$20240826$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001691$BLUEPRINT MEDICINES$$$$$$Y$$$20240826$$MD$CN$CN
242502861$24250286$1$I$$20240814$20240826$20240826$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001701$BLUEPRINT MEDICINES$$$$$$Y$$$20240826$$MD$CN$CN
242502871$24250287$1$I$$20240819$20240826$20240826$EXP$$NVSC2024TW170540$NOVARTIS$$31$YR$$M$Y$$$20240826$$MD$TW$TW
242502881$24250288$1$I$$20240819$20240826$20240826$EXP$$US-GSK-US2024AMR104090$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$US$US
242502892$24250289$2$F$20240813$20240827$20240826$20240830$EXP$$NVSC2024IE171153$NOVARTIS$$$$$M$Y$$$20240830$$HP$IE$IE
242502901$24250290$1$I$20240301$20240821$20240826$20240826$EXP$$NVSC2024DE171174$NOVARTIS$$28$YR$$F$Y$45$KG$20240826$$MD$DE$DE
242502911$24250291$1$I$20240805$20240819$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-012989$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242502922$24250292$2$F$20210101$20240828$20240826$20240903$PER$$US-VERTEX PHARMACEUTICALS-2024-013502$VERTEX$$13$YR$$F$Y$$$20240903$$MD$US$US
242502931$24250293$1$I$$20240730$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07687$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242502941$24250294$1$I$$20240819$20240826$20240826$EXP$$US-GSK-US2024103430$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$US$US
242502951$24250295$1$I$$20240816$20240826$20240826$EXP$$US-GSK-US2024AMR102926$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
242502961$24250296$1$I$$20240729$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07628$LUPIN$$$$$$Y$$$20240826$$HP$US$US
242502971$24250297$1$I$$20240826$20240826$20240826$EXP$$FR-SANDOZ INC.-SDZ2024FR075087$SANDOZ$$67$YR$$M$Y$$$20240826$$MD$FR$FR
242502981$24250298$1$I$$20240820$20240826$20240826$EXP$$US-OTSUKA-2024_023074$OTSUKA$Wintering A, Hecht A, Meyer J, Wong EB, H?bner J, Abelson S et.al. LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia. Haematologica. 2024;109(8):2533-41$5$YR$$F$Y$$$20240826$$HP$US$US
242502991$24250299$1$I$$20240817$20240826$20240826$EXP$$FI-AMGEN-FINSP2024166043$AMGEN$Kaprio:E.. Drug-induced pneumonitis risk in diffuse large B-cell/follicular lymphoma patients treated with R-CHOP-like regimen is associated with the use of granulocyte colony-stimulating growth factors. Cancer medicine. 2024;13 (1):1-8$$$$$Y$$$20240826$$HP$FI$FI
242503002$24250300$2$F$20200101$20240923$20240826$20240930$EXP$ES-AEMPS-1547571$ES-TEVA-VS-3234374$TEVA$$75$YR$$F$Y$$$20240930$$PH$ES$ES
242503011$24250301$1$I$$20240821$20240826$20240826$EXP$$US-OTSUKA-2024_023150$OTSUKA$$$$$F$Y$$$20240826$$HP$US$US
242503021$24250302$1$I$$20240822$20240826$20240826$EXP$$US-AstraZeneca-2024A192328$ASTRAZENECA$$$$$$Y$$$20240826$$CN$US$
242503031$24250303$1$I$20240412$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A190885$ASTRAZENECA$$26458$DY$$M$Y$$$20240826$$CN$US$
242503041$24250304$1$I$20240301$20240823$20240826$20240826$EXP$$US-AstraZeneca-2024A193852$ASTRAZENECA$$953$MON$$F$Y$$$20240826$$CN$US$
242503052$24250305$2$F$$20240823$20240826$20240830$EXP$$US-AstraZeneca-2024A193153$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242503061$24250306$1$I$$20240816$20240826$20240826$EXP$$AU-INSUD PHARMA-2408AU06563$INSUD PHARMA$Geara S, Hwang Y, Elias A, Liu W. Medication or illness? Antiviral induced encephalopathy. Journal of the Neurological Sciences. 2023;455:61$$$$$Y$$$20240826$$HP$AU$AU
242503072$24250307$2$F$20240101$20240913$20240826$20240922$EXP$$US-JNJFOC-20240856678$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240922$$CN$US$US
242503081$24250308$1$I$$20230919$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002255$AMERICAN REGENT$$$$$F$Y$$$20240826$$MD$US$US
242503091$24250309$1$I$$20230911$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002193$AMERICAN REGENT$$5$DEC$$F$Y$$$20240826$$MD$US$US
242503101$24250310$1$I$$20230922$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002278$AMERICAN REGENT$$$$$$Y$$$20240826$$MD$US$US
242503111$24250311$1$I$$20230928$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002337$AMERICAN REGENT$$$$$M$Y$$$20240826$$HP$US$US
242503121$24250312$1$I$20240722$20240819$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-012993$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242503131$24250313$1$I$$20230920$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002208$AMERICAN REGENT$$$$$F$Y$$$20240826$$HP$US$US
242503141$24250314$1$I$$20230928$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002336$AMERICAN REGENT$$$$$M$Y$$$20240826$$HP$US$US
242503151$24250315$1$I$20221001$20230921$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002279$AMERICAN REGENT$$$$$F$Y$$$20240826$$HP$US$US
242503161$24250316$1$I$$20230928$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002343$AMERICAN REGENT$$$$$M$Y$$$20240826$$HP$US$US
242503172$24250317$2$F$$20240828$20240826$20240903$EXP$$DE-BAYER-2024A120813$BAYER$$84$YR$E$$Y$$$20240903$$HP$DE$DE
242503181$24250318$1$I$20240201$20240807$20240826$20240826$PER$$US-INSUD PHARMA-2408US06308$INSUD PHARMA$$$$$$Y$$$20240826$$CN$US$US
242503192$24250319$2$F$20240720$20240916$20240826$20240924$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-07395$IPSEN$$71$YR$E$F$Y$$$20240924$$CN$GB$GB
242503201$24250320$1$I$$20240821$20240826$20240826$PER$$US-INSUD PHARMA-2408US06625$INSUD PHARMA$$$$$$Y$$$20240826$$HP$US$US
242503211$24250321$1$I$20240818$20240822$20240826$20240826$PER$$US-INSUD PHARMA-2408US06647$INSUD PHARMA$$$$$$Y$$$20240826$$CN$US$US
242503221$24250322$1$I$20240101$20240820$20240826$20240826$EXP$$US-INSUD PHARMA-2408US06603$INSUD PHARMA$$$$$$Y$$$20240826$$MD$US$US
242503231$24250323$1$I$20240101$20240820$20240826$20240826$PER$$US-INSUD PHARMA-2408US06605$INSUD PHARMA$$$$$$Y$$$20240826$$MD$US$US
242503241$24250324$1$I$$20240822$20240826$20240826$EXP$$US-Taiho Oncology Inc-2024-008074$TAIHO ONCOLOGY INC$$78$YR$E$M$Y$$$20240826$$CN$US$US
242503251$24250325$1$I$$20240821$20240826$20240826$EXP$$US-Taiho Oncology Inc-2024-007871$TAIHO ONCOLOGY INC$$$$E$F$Y$54.66$KG$20240826$$CN$US$US
242503261$24250326$1$I$20240708$20240819$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-012996$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242503271$24250327$1$I$$20240819$20240826$20240826$EXP$$MY-DSJP-DSJ-2024-141931$DAIICHI$$$$$F$Y$$$20240826$$CN$MY$MY
242503281$24250328$1$I$$20240821$20240826$20240826$EXP$$AU-OTSUKA-2024_023164$OTSUKA$$8$DEC$$F$Y$$$20240826$$MD$AU$AU
242503291$24250329$1$I$$20240729$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07659$LUPIN$$$$$$Y$$$20240826$$CN$US$US
242503301$24250330$1$I$$20240819$20240826$20240826$EXP$$NVSC2024BR171375$NOVARTIS$$$$$M$Y$$$20240826$$CN$BR$BR
242503311$24250331$1$I$$20240312$20240826$20240826$EXP$$NVSC2024CA055228$NOVARTIS$$19$MON$$M$Y$10$KG$20240826$$HP$CA$CA
242503321$24250332$1$I$20231201$20240819$20240826$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-038908$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240826$$MD$JP$JP
242503331$24250333$1$I$$20240816$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130823$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240826$$CN$US$US
242503341$24250334$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134950$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$77.56$KG$20240826$$CN$US$US
242503351$24250335$1$I$$20240824$20240824$20240824$DIR$715763$$FDA-CTU$$51$YR$$F$N$$$20240824$N$CN$US$
242503371$24250337$1$I$20240824$20240824$20240824$20240824$DIR$715761$$FDA-CTU$$61$YR$$M$N$78.3$KG$20240824$N$CN$US$
242503412$24250341$2$F$$20240829$20240826$20240903$EXP$$AU-MYLANLABS-2024M1078546$MYLAN$$$$$F$Y$$$20240903$$PH$AU$AU
242503421$24250342$1$I$20230901$20240823$20240826$20240826$EXP$$US-TAKEDA-2022TUS057411$TAKEDA$$64$YR$$M$Y$$$20240826$$MD$US$US
242503431$24250343$1$I$20240526$20240820$20240826$20240826$EXP$AU-TGA-0000814571$AU-SANDOZ INC.-SDZ2024AU074255$SANDOZ$$68$YR$$M$Y$$$20240826$$MD$AU$AU
242503451$24250345$1$I$$20240819$20240826$20240826$EXP$$CA-ROCHE-10000060150$ROCHE$$$$$F$Y$$$20240826$$MD$CA$CA
242503461$24250346$1$I$20240101$20240820$20240826$20240826$EXP$$US-AMGEN-USASP2024166748$AMGEN$$79$YR$E$F$Y$$$20240826$$CN$US$US
242503471$24250347$1$I$$20240819$20240826$20240826$EXP$$CA-SANDOZ INC.-PHHY2018CA061543$SANDOZ$$68$YR$$F$Y$$$20240826$$HP$CA$CA
242503481$24250348$1$I$$20240823$20240826$20240826$PER$$NVSC2024US171558$NOVARTIS$$$$$$Y$$$20240826$$MD$US$US
242503501$24250350$1$I$$20240415$20240826$20240826$EXP$$NVSC2024CA080682$NOVARTIS$$60$YR$$M$Y$$$20240826$$HP$CA$CA
242503511$24250351$1$I$$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168870$AMGEN$$$$$$Y$$$20240826$$PH$US$US
242503521$24250352$1$I$20240726$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58590$$FDA-CTU$$68$YR$$F$N$175$LBS$20240826$Y$$US$
242503531$24250353$1$I$$20240816$20240826$20240826$30DAY$$US-GSK-US2024102690$GLAXOSMITHKLINE$$$$$F$Y$$$20240826$$CN$US$US
242503541$24250354$1$I$20240821$20240824$20240824$20240824$DIR$715769$$FDA-CTU$$62$YR$$F$N$91.35$KG$20240824$N$MD$US$
242503551$24250355$1$I$20210728$20240824$20240824$20240824$DIR$715766$$FDA-CTU$$31$YR$$F$N$47.25$KG$20240824$N$CN$US$
242503561$24250356$1$I$20240819$20240824$20240824$20240824$DIR$715755$$FDA-CTU$$37$YR$$M$N$81$KG$20240824$N$CN$US$
242503571$24250357$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58576$$FDA-CTU$$63$YR$$F$N$$$20240826$N$$US$
242503581$24250358$1$I$20240729$20240819$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-013002$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242503591$24250359$1$I$20240702$20240816$20240826$20240826$EXP$ES-AEMPS-1559045$ES-TEVA-VS-3234879$TEVA$$81$YR$$M$Y$$$20240826$$MD$ES$ES
242503601$24250360$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58593$$FDA-CTU$$70$YR$$F$N$184$LBS$20240826$N$HP$US$
242503611$24250361$1$I$20240803$20240824$20240824$20240824$DIR$715781$$FDA-CTU$$52$YR$$M$N$90$KG$20240824$N$CN$US$
242503621$24250362$1$I$20240802$20240819$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-013000$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242503632$24250363$2$F$$20240627$20240826$20240904$EXP$$NVSC2024CN171171$NOVARTIS$$67$YR$$$Y$$$20240904$$CN$CN$CN
242503642$24250364$2$F$$20240823$20240826$20240828$PER$$US-ABBVIE-5894114$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242503651$24250365$1$I$$20240729$20240826$20240826$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07727$LUPIN$$$$$$Y$$$20240826$$MD$US$US
242503661$24250366$1$I$20240821$20240821$20240826$20240826$PER$$US-JNJFOC-20240855031$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240826$$PH$US$US
242503671$24250367$1$I$$20240819$20240826$20240826$EXP$$CA-ROCHE-10000060405$ROCHE$$$$$F$Y$$$20240826$$MD$CA$CA
242503681$24250368$1$I$$20240819$20240826$20240826$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-141949$DAIICHI$$63$YR$$F$Y$$$20240826$$CN$CA$CA
242503691$24250369$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134541$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240826$$CN$US$US
242503711$24250371$1$I$$20240822$20240826$20240826$PER$$US-ABBVIE-5894385$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242503721$24250372$1$I$$20240822$20240826$20240826$EXP$$US-AstraZeneca-2024A193320$ASTRAZENECA$$$$$F$Y$$$20240826$$MD$US$
242503732$24250373$2$F$$20240819$20240826$20240827$EXP$$US-AstraZeneca-2024A188832$ASTRAZENECA$$$$$M$Y$$$20240827$$MD$US$
242503741$24250374$1$I$$20240807$20240826$20240826$PER$$US-AstraZeneca-2024A182032$ASTRAZENECA$$$$$$Y$$$20240826$$CN$US$
242503763$24250376$3$F$20240309$20240822$20240826$20240830$EXP$$NVSC2024CN171197$NOVARTIS$$16$YR$$F$Y$55$KG$20240830$$HP$CN$CN
242503772$24250377$2$F$$20240912$20240826$20240920$EXP$$US-TEVA-VS-3235564$TEVA$Gallagher K, Ortenberg R, Toprak D. A Rare Pediatric Case of Anti-melanoma Differentiation-associated Gene 5 Rapidly Progressive Interstitial Lung Disease. Am-J-Respir-Crit-Care-Med 2023; 207.; Gallagher K, Ortenberg R, Toprak D. A Rare Pediatric Case of Anti-melanoma Differentiation-associated Gene 5 Rapidly Progressive Interstitial Lung Disease. Am-J-Respir-Crit-Care-Med 2023; 207.$6$YR$$M$Y$$$20240920$$HP$US$US
242503781$24250378$1$I$20240723$20240823$20240826$20240826$EXP$$US-AstraZeneca-2024A192917$ASTRAZENECA$$30077$DY$$M$Y$$$20240826$$CN$US$
242503792$24250379$2$F$$20240828$20240826$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408015370$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240830$$CN$US$US
242503801$24250380$1$I$$20240820$20240826$20240826$EXP$$CA-OTSUKA-2024_007169$OTSUKA$$$$$F$Y$$$20240826$$CN$CA$CA
242503811$24250381$1$I$20230611$20240823$20240826$20240826$EXP$$JP-AstraZeneca-2023A276573$ASTRAZENECA$$73$YR$$M$Y$65$KG$20240826$$MD$JP$
242503821$24250382$1$I$$20240819$20240826$20240826$EXP$$CA-GSK-CA2023AMR187520$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$HP$CA$CA
242503831$24250383$1$I$$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024165337$AMGEN$Rodriguez S.H.; Akbar M.; Avdagic E. et al.. Bevacizumab for Retinopathy of Prematurity Is Not Associated With Systemic Hypertension. Journal of Pediatric Ophthalmology + Strabismus. 2024;1-8$$$$$Y$$$20240826$$MD$US$US
242503842$24250384$2$F$$20240912$20240826$20240920$EXP$$US-TEVA-VS-3235696$TEVA$Panthi S, MIles JM, Graves L. Headache, Pituitary Apoplexy and Diabetes insipidus: Suspect Necrotizing Hypophysitis. J-Endocr-Soc 2021; 5 (Suppl.) A585.; Panthi S, MIles JM, Graves L. Headache, Pituitary Apoplexy and Diabetes insipidus: Suspect Necrotizing Hypophysitis. J-Endocr-Soc 2021; 5 (Suppl.) A585.$34$YR$$F$Y$$$20240920$$MD$US$US
242503851$24250385$1$I$$20240820$20240826$20240826$EXP$$JP-AMGEN-JPNSP2024167921$AMGEN$$$$$$Y$$$20240826$$MD$JP$JP
242503861$24250386$1$I$$20240823$20240826$20240826$PER$$NVSC2024US171728$NOVARTIS$$$$$M$Y$$$20240826$$MD$US$US
242503871$24250387$1$I$$20240819$20240826$20240826$EXP$$US-GSK-US2024103342$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$US$US
242503881$24250388$1$I$$20240820$20240826$20240826$PER$$US-ALXN-202408USA001505US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240826$$CN$US$US
242503893$24250389$3$F$20240817$20240910$20240826$20240913$EXP$$NI-BAYER-2024A122080$BAYER$$41$YR$A$F$Y$$$20240913$$HP$NI$NI
242503901$24250390$1$I$20240812$20240819$20240826$20240826$PER$$US-SA-2024SA248036$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240826$$MD$US$US
242503911$24250391$1$I$$20240814$20240826$20240826$EXP$$US-FARMAPROD-202408-2939$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240826$$CN$US$US
242503921$24250392$1$I$$20240822$20240826$20240826$EXP$$CA-GILEAD-2024-0685279$GILEAD$$$$A$M$Y$$$20240826$$CN$CA$CA
242503931$24250393$1$I$$20240819$20240826$20240826$EXP$$FR-KARYOPHARM-2024KPT001457$KARYOPHARM THERAPEUTICS$Audrey Couturier, Martine Escoffre, Fr?d?rique Leh et al. Parkinson-like neurotoxicity in female patients treated with idecabtagene-vicleucel. HemaSphere. 2024;8:e131:1-5$$$$$Y$$$20240826$$MD$FR$FR
242503941$24250394$1$I$20240813$20240816$20240826$20240826$EXP$$CN-ROCHE-10000063087$ROCHE$$76$YR$E$M$Y$44$KG$20240826$$HP$CN$CN
242503951$24250395$1$I$$20240817$20240826$20240826$EXP$$US-AMGEN-USASP2024166403$AMGEN$El-ghoubaira J.; Drappatz J.; Mantica M.. Retrospective study of ivosidenib for patients with recurrent IDH mutant gliomas. Journal of Clinical Oncology. 2024;2040$$$$$Y$$$20240826$$HP$US$US
242503961$24250396$1$I$$20240822$20240826$20240826$EXP$$RO-JNJFOC-20240861286$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240826$$MD$RO$RO
242503973$24250397$3$F$20200531$20240926$20240826$20240930$PER$$US-JNJFOC-20240836276$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240930$$CN$US$US
242503981$24250398$1$I$$20240815$20240826$20240826$PER$$US-JNJFOC-20240864816$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$MD$US$US
242503991$24250399$1$I$$20240822$20240826$20240826$EXP$$US-PFIZER INC-202400242508$PFIZER$$80$YR$$F$Y$77.11$KG$20240826$$HP$US$US
242504001$24250400$1$I$$20240819$20240826$20240826$EXP$$JP-PFIZER INC-PV202400108211$PFIZER$Matsui, K.. A case of metastatic breast cancer with cardiac failure congestive immediately after initiation of letrozole and palbociclib combination therapy. The 7th Annual Meeting of the Japanese Onco-Cardiology Society. 2024;7th:119$71$YR$$F$Y$$$20240826$$HP$JP$JP
242504011$24250401$1$I$$20240823$20240826$20240826$EXP$$IN-PFIZER INC-PV202400068336$PFIZER$$55$YR$$M$Y$$$20240826$$CN$IN$IN
242504021$24250402$1$I$20240101$20240821$20240826$20240826$EXP$$US-PFIZER INC-202400211362$PFIZER$$35$YR$$F$Y$$$20240826$$CN$US$US
242504031$24250403$1$I$20240818$20240822$20240826$20240826$EXP$$NVSC2024AU109726$NOVARTIS$$$$$F$Y$$$20240826$$HP$AU$AU
242504041$24250404$1$I$$20240816$20240826$20240826$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR103637$VIIV$$$$$M$Y$$$20240826$$CN$US$US
242504052$24250405$2$F$$20240920$20240826$20240925$EXP$$JP-OTSUKA-2024_022945$OTSUKA$$$$$$Y$$$20240925$$PH$JP$JP
242504061$24250406$1$I$20240803$20240819$20240826$20240826$EXP$CN-91110000556821568D-2024DRL001562$CN-RDY-SPO/CHN/24/0012203$DR REDDYS$$54$YR$A$F$Y$73.5$KG$20240826$$HP$CN$CN
242504071$24250407$1$I$$20240820$20240826$20240826$EXP$FR-AFSSAPS-BR2024000672$FR-MYLANLABS-2024M1077264$MYLAN$$82$YR$$F$Y$61$KG$20240826$$MD$FR$FR
242504091$24250409$1$I$20240725$20240816$20240826$20240826$EXP$FR-AFSSAPS-LL2024001563$FR-BAXTER-2024BAX023296$BAXTER$$78$YR$$M$Y$69$KG$20240826$$PH$FR$FR
242504111$24250411$1$I$$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024166473$AMGEN$$$$$M$Y$$$20240826$$CN$US$US
242504121$24250412$1$I$$20240820$20240826$20240826$EXP$$US-AMGEN-USASP2024166365$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242504131$24250413$1$I$$20240812$20240826$20240826$EXP$$TN-Marksans Pharma Limited-2160867$MARKSANS$Laroussi S, Bouattour N, Daoud S, Moalla KS, Sakka S, Damak M, Farhat N, Mhiri C. Reversible dementia and seizures due to metformin-induced vitamin B12 deficiency. Encephale. 2024 Aug;50(4):474-477. doi: 10.1016/j.encep.2023.11.030. PMID: 38369428. (Abstract)$64$YR$$F$Y$$$20240826$$$TN$TN
242504141$24250414$1$I$$20240817$20240826$20240826$EXP$$CA-AMGEN-CANSP2024164860$AMGEN$Seow C.H.; Ernest-suarez K.; Murguia-favela L.E. et al.. LIVE ROTAVIRUS VACCINATION APPEARS LOW-RISK IN INFANTS BORN TO MOTHERS WITH INFLAMMATORY BOWEL DISEASE ON BIOLOGICS. Clinical Gastroenterology and Hepatology. 2024$$$$F$Y$$$20240826$$MD$CA$CA
242504151$24250415$1$I$$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132231$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$95.25$KG$20240826$$CN$US$US
242504161$24250416$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58665$$FDA-CTU$$45$YR$$F$N$$$20240826$N$$US$
242504171$24250417$1$I$$20240820$20240826$20240826$EXP$$CN-OTSUKA-2024_023071$OTSUKA$Liao G, Wei C, Huang Q, Wei M, Li J, Chen Y et.al.. Hyperbilirubinemia in ABO Minor Mismatch Transplantation. Mediterr J Hematol Infect Dis. 2024;16(1):1-3$11$YR$$M$Y$$$20240826$$HP$CN$CN
242504182$24250418$2$F$$20240910$20240826$20240911$PER$$US-JNJFOC-20240858534$JOHNSON AND JOHNSON$$$$$M$Y$$$20240911$$CN$US$US
242504192$24250419$2$F$$20240829$20240826$20240902$EXP$$NVSC2024DE171980$NOVARTIS$$28$YR$$F$Y$45$KG$20240902$$MD$DE$DE
242504211$24250421$1$I$$20240815$20240826$20240826$EXP$$CA-HLS-202402085$HLS THERAPEUTICS$$$$A$M$Y$$$20240826$$PH$CA$CA
242504221$24250422$1$I$$20240819$20240826$20240826$EXP$$US-SA-2024SA249174$SANOFI AVENTIS$$$$C$F$Y$14$KG$20240826$$MD$US$US
242504231$24250423$1$I$20240814$20240824$20240824$20240824$DIR$715768$$FDA-CTU$$76$YR$$F$N$94.5$KG$20240824$N$CN$US$
242504241$24250424$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58668$$FDA-CTU$$72$YR$$M$N$232$LBS$20240826$N$$US$
242504251$24250425$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58586$$FDA-CTU$$59$YR$$F$N$$$20240826$N$HP$US$
242504261$24250426$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58667$$FDA-CTU$$50$YR$$F$N$74.39$KG$20240826$N$HP$US$
242504271$24250427$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58575$$FDA-CTU$$69$YR$$F$N$252$LBS$20240826$N$$US$
242504281$24250428$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58612$$FDA-CTU$$43$YR$$F$N$83.46$KG$20240826$N$$US$
242504291$24250429$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58654$$FDA-CTU$$67$YR$$F$N$$$20240826$N$$US$
242504301$24250430$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58564$$FDA-CTU$$57$YR$$M$N$$$20240826$N$HP$US$
242504311$24250431$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58664$$FDA-CTU$$40$YR$$M$N$$$20240826$N$$US$
242504321$24250432$1$I$20240822$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58662$$FDA-CTU$$69$YR$$F$N$$$20240826$N$$US$
242504331$24250433$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58591$$FDA-CTU$$50$YR$$F$N$126.1$KG$20240826$N$$US$
242504341$24250434$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58605$$FDA-CTU$$73$YR$$F$N$77.11$KG$20240826$N$HP$US$
242504351$24250435$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58604$$FDA-CTU$$61$YR$$F$N$$$20240826$N$$US$
242504361$24250436$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58623$$FDA-CTU$$$$$$N$$$20240826$N$PH$US$
242504371$24250437$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA246549$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240826$$MD$US$US
242504381$24250438$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58583$$FDA-CTU$$76$YR$$F$N$62.6$KG$20240826$N$$US$
242504391$24250439$1$I$$20240814$20240826$20240826$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001703$BLUEPRINT MEDICINES$$$$$$Y$$$20240826$$MD$CN$CN
242504401$24250440$1$I$20240819$20240819$20240826$20240826$PER$$US-ROCHE-10000061355$ROCHE$$$$$$Y$$$20240826$$PH$US$US
242504411$24250441$1$I$$20240814$20240826$20240826$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001705$BLUEPRINT MEDICINES$$$$$$Y$$$20240826$$MD$CN$CN
242504423$24250442$3$F$20240101$20240916$20240826$20240919$EXP$$US-ORGANON-O2408USA001775$ORGANON$$$$$F$Y$73.02$KG$20240919$$HP$US$US
242504431$24250443$1$I$20220222$20240826$20240826$20240826$EXP$$NVSC2024KR171968$NOVARTIS$$$$A$F$Y$$$20240826$$HP$KR$KR
242504441$24250444$1$I$20180501$20240821$20240826$20240826$EXP$$IT-AstraZeneca-2024A190449$ASTRAZENECA$Frezzini S., Tasca G., Borgato L., Sartor L., Ferrero A., Artioli G., Modena A., Baldoni A.. PARP INHIBITORS IN BRAIN METASTASES FROM EPITHELIAL OVARIAN CANCER THROUGH A MULTIMODAL PATIENT JOURNEY: CASE REPORTS AND LITERATURE REVIEW. International Journal of Molecular Sciences 2024;25(14):$47$YR$$F$Y$$$20240826$$HP$IT$
242504451$24250445$1$I$20240815$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A193411$ASTRAZENECA$$27258$DY$$F$Y$$$20240826$$HP$US$
242504462$24250446$2$F$$20240823$20240826$20240902$EXP$$US-AstraZeneca-2024A192189$ASTRAZENECA$$65$YR$$F$Y$$$20240902$$MD$US$
242504471$24250447$1$I$$20240812$20240826$20240826$PER$$US-TEVA-VS-3233727$TEVA$$49$YR$$F$Y$$$20240826$$CN$US$US
242504481$24250448$1$I$20240816$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167733$AMGEN$$$$$$Y$$$20240826$$HP$US$US
242504491$24250449$1$I$$20240823$20240826$20240826$EXP$$US-ANIPHARMA-2024-US-045591$ANI$Demars B, Bates T, Ward M, et al.A case of sarcomatoid carcinoma presenting in the setting of anastrozole use..American Journal of Respiratory and Critical Care Medicine.2024;209A6590.$75$YR$$F$Y$$$20240826$$HP$US$US
242504501$24250450$1$I$$20240823$20240826$20240826$PER$$US-JNJFOC-20240861678$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$HP$US$US
242504511$24250451$1$I$$20240819$20240826$20240826$EXP$$US-VIIV HEALTHCARE LIMITED-US2024103923$VIIV$$$$$$Y$$$20240826$$MD$US$US
242504521$24250452$1$I$$20240814$20240826$20240826$EXP$$CN-Blueprint Medicines Corporation-LT-CN-2024-001706$BLUEPRINT MEDICINES$$$$$$Y$$$20240826$$MD$CN$CN
242504542$24250454$2$F$$20240917$20240826$20240923$EXP$$AU-RDY-SPO/AUS/24/0012276$DR REDDYS$$40$YR$A$F$Y$$$20240923$$CN$AU$AU
242504552$24250455$2$F$$20240904$20240826$20240910$EXP$$IN-VANTIVE-2024VAN019285$Vantive US Healthcare$$51$YR$$M$Y$$$20240910$$CN$IN$IN
242504562$24250456$2$F$$20240916$20240826$20240919$EXP$$IN-VANTIVE-2024VAN019261$Vantive US Healthcare$$40$YR$$M$Y$$$20240919$$CN$IN$IN
242504571$24250457$1$I$$20240820$20240826$20240826$EXP$$AU-RDY-SPO/AUS/24/0012261$DR REDDYS$$59$YR$A$F$Y$$$20240826$$CN$AU$AU
242504581$24250458$1$I$20240101$20240814$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129282$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240826$$HP$US$US
242504601$24250460$1$I$$20240819$20240826$20240826$EXP$$US-ABBVIE-5887900$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242504611$24250461$1$I$20240805$20240816$20240826$20240826$PER$$US-ABBVIE-5885092$ABBVIE$$61$YR$$F$Y$108$KG$20240826$$CN$US$US
242504621$24250462$1$I$$20240823$20240826$20240826$EXP$$US-PFIZER INC-202400242928$PFIZER$$$$$F$Y$$$20240826$$MD$US$US
242504642$24250464$2$F$$20240826$20240826$20240827$EXP$$US-PURDUE PHARMA-USA-2024-0311578$PURDUE$$$$$F$Y$$$20240827$$CN$US$US
242504651$24250465$1$I$$20240823$20240826$20240826$EXP$$US-PURDUE PHARMA-USA-2024-0311570$PURDUE$$$$$M$Y$$$20240826$$CN$US$US
242504661$24250466$1$I$20240726$20240820$20240826$20240826$EXP$$CN-PURDUE-USA-2024-0311557$PURDUE$$59$YR$$M$Y$$$20240826$$HP$CN$CN
242504671$24250467$1$I$$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014677$ELI LILLY AND CO$$62$YR$A$$Y$$$20240826$$LW$US$US
242504681$24250468$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014904$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242504702$24250470$2$F$20240823$20240823$20240826$20240830$EXP$$CA-TAKEDA-2024TUS082673$TAKEDA$$66$YR$$M$Y$$$20240830$$CN$CA$CA
242504712$24250471$2$F$$20240904$20240826$20240904$PER$$US-AMGEN-USASP2024167505$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242504722$24250472$2$F$20240501$20240913$20240826$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2024103371$VIIV$$$$$$Y$$$20240917$$HP$US$US
242504731$24250473$1$I$$20240819$20240826$20240826$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024EME103733$VIIV$$$$$$Y$$$20240826$$CN$GB$GB
242504741$24250474$1$I$20240626$20240816$20240826$20240826$EXP$CH-SM-2024-14638$CH-TEVA-VS-3235086$TEVA$$77$YR$$M$Y$63.3$KG$20240826$$PH$CH$CH
242504751$24250475$1$I$20240810$20240811$20240826$20240826$EXP$$IL-TEVA-VS-3233791$TEVA$$24$YR$$M$Y$$$20240826$$CN$IL$IL
242504761$24250476$1$I$$20240821$20240826$20240826$EXP$$CA-TAKEDA-2024TUS085012$TAKEDA$$$$$F$Y$$$20240826$$CN$CA$CA
242504771$24250477$1$I$$20240822$20240826$20240826$EXP$$US-ABBVIE-5890938$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242504791$24250479$1$I$20240101$20240816$20240826$20240826$EXP$$US-TEVA-VS-3235700$TEVA$$55$YR$$M$Y$$$20240826$$CN$US$US
242504801$24250480$1$I$20240426$20240824$20240824$20240824$DIR$715785$$FDA-CTU$$25$YR$$F$N$90$KG$20240824$N$CN$US$
242504821$24250482$1$I$20240619$20240824$20240824$20240824$DIR$715759$$FDA-CTU$$40$YR$$F$N$75.6$KG$20240824$N$CN$US$
242504831$24250483$1$I$$20240824$20240824$20240824$DIR$715778$$FDA-CTU$$65$YR$$F$N$82.8$KG$20240824$N$CN$US$
242504841$24250484$1$I$20240717$20240824$20240824$20240824$DIR$715790$$FDA-CTU$$28$YR$$F$N$83.25$KG$20240824$N$CN$US$
242504851$24250485$1$I$20240601$20240824$20240824$20240824$DIR$715789$$FDA-CTU$$37$YR$$F$N$57.15$KG$20240824$N$CN$US$
242504861$24250486$1$I$20240720$20240824$20240824$20240824$DIR$715750$$FDA-CTU$$45$YR$$F$N$$$20240824$N$CN$US$
242504891$24250489$1$I$20240711$20240820$20240826$20240826$EXP$FR-AFSSAPS-GR2024001010$FR-MYLANLABS-2024M1077362$MYLAN$$53$YR$$F$Y$$$20240826$$PH$FR$FR
242504912$24250491$2$F$$20240823$20240826$20240827$PER$$NVSC2024US172242$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242504921$24250492$1$I$20240815$20240822$20240826$20240826$EXP$$US-ABBVIE-5892471$ABBVIE$$77$YR$$F$Y$$$20240826$$CN$US$US
242504931$24250493$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA247347$SANOFI AVENTIS$$$$C$F$Y$$$20240826$$MD$US$US
242504952$24250495$2$F$20240801$20240822$20240826$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131124$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240902$$CN$US$US
242504961$24250496$1$I$20240527$20240821$20240826$20240826$EXP$$CA-ABBVIE-5894079$ABBVIE$$90$YR$$M$Y$$$20240826$$CN$CA$CA
242504972$24250497$2$F$$20240520$20240826$20240828$EXP$$CA-INCYTE CORPORATION-2024IN008873$INCYTE$$$$$$Y$$$20240828$$HP$CA$CA
242504981$24250498$1$I$20240101$20240822$20240826$20240826$EXP$$CA-ABBVIE-5892929$ABBVIE$$$$A$F$Y$$$20240826$$CN$CA$CA
242504991$24250499$1$I$20240812$20240816$20240826$20240826$EXP$$CN-ALCON LABORATORIES-ALC2024CN003877$ALCON$$26$YR$$M$Y$95$KG$20240826$$HP$CN$CN
242505001$24250500$1$I$20240823$20240823$20240826$20240826$EXP$$AU-ABBVIE-5893035$ABBVIE$$85$YR$$M$Y$$$20240826$$CN$AU$AU
242505011$24250501$1$I$$20240814$20240826$20240826$EXP$$US-AstraZeneca-2024A185627$ASTRAZENECA$$$$$F$Y$$$20240826$$MD$US$
242505021$24250502$1$I$20240810$20240817$20240826$20240826$EXP$$CN-AstraZeneca-2024A188495$ASTRAZENECA$$73$YR$$F$Y$63$KG$20240826$$MD$CN$
242505031$24250503$1$I$$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A187355$ASTRAZENECA$Ali S.T, VanderWeele D.J.. Prolonged Response to Osimertinib in EGFR-Mutated Metastatic Urothelial Carcinoma, a Case Report. Current Oncology 2024;31(7):(4015-4021.$48$YR$$F$Y$$$20240826$$HP$US$
242505042$24250504$2$F$$20240912$20240826$20240920$EXP$$JP-TEVA-VS-3235266$TEVA$Maruyama T, Kondo S, Nomura H. Case series of bradycardia, renal failure, atrioventricular nodal blockers, shock and hyperkalemia syndrome in patients with dementia. Geriatr-Gerontol-Int 2024; 24 (7): 737-738.; Maruyama T, Kondo S, Nomura H. Case series of bradycardia, renal failure, atrioventricular nodal blockers, shock and hyperkalemia syndrome in patients with dementia. Geriatr-Gerontol-Int 2024; 24 (7): 737-738.$94$YR$$M$Y$$$20240920$$HP$JP$JP
242505051$24250505$1$I$$20240821$20240826$20240826$EXP$$ZA-AstraZeneca-2024A191975$ASTRAZENECA$$54$YR$$F$Y$$$20240826$$CN$ZA$
242505062$24250506$2$F$$20240904$20240826$20240910$EXP$$US-OTSUKA-2024_023038$OTSUKA$$$$$F$Y$$$20240910$$HP$US$US
242505071$24250507$1$I$$20240821$20240826$20240826$EXP$$US-SA-2024SA249245$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240826$$MD$US$US
242505081$24250508$1$I$$20240816$20240826$20240826$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024102623$VIIV$$49$YR$$F$Y$$$20240826$$HP$US$US
242505092$24250509$2$F$$20240819$20240826$20240828$EXP$$AU-JNJFOC-20240848404$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$HP$AU$AU
242505101$24250510$1$I$$20240806$20240826$20240826$PER$$US-TEVA-VS-3230799$TEVA$$$$$$Y$$$20240826$$CN$US$US
242505111$24250511$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA247607$SANOFI AVENTIS$$$$E$F$Y$67.58$KG$20240826$$MD$US$US
242505121$24250512$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234471$TEVA$$4$YR$$M$Y$14$KG$20240826$$HP$CA$CA
242505131$24250513$1$I$$20240717$20240826$20240826$PER$$US-GALDERMA-US2024011634$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505141$24250514$1$I$20240601$20240716$20240826$20240826$PER$$US-GALDERMA-US2024011510$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505151$24250515$1$I$20240301$20240708$20240826$20240826$PER$$US-GALDERMA-US2024011682$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505161$24250516$1$I$$20240708$20240826$20240826$PER$$US-GALDERMA-US2024011719$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505171$24250517$1$I$$20240708$20240826$20240826$PER$$US-GALDERMA-US2024011715$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505183$24250518$3$F$$20240904$20240826$20240909$EXP$$US-GILEAD-2024-0684915$GILEAD$$$$A$M$Y$$$20240909$$HP$US$US
242505191$24250519$1$I$20240201$20240708$20240826$20240826$PER$$US-GALDERMA-US2024011689$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505201$24250520$1$I$$20240708$20240826$20240826$PER$$US-GALDERMA-US2024011718$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505211$24250521$1$I$$20240726$20240826$20240826$PER$$US-GALDERMA-US2024011972$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505221$24250522$1$I$$20240722$20240826$20240826$PER$$US-GALDERMA-US2024012074$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505231$24250523$1$I$$20240719$20240826$20240826$PER$$US-GALDERMA-US2024011876$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505241$24250524$1$I$20220101$20240712$20240826$20240826$PER$$US-GALDERMA-US2024011548$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505251$24250525$1$I$$20240822$20240826$20240826$EXP$$CA-AstraZeneca-2024A193232$ASTRAZENECA$$44$YR$$F$Y$97$KG$20240826$$MD$CA$
242505261$24250526$1$I$$20240729$20240826$20240826$PER$$US-GALDERMA-US2024012393$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505271$24250527$1$I$$20240729$20240826$20240826$PER$$US-GALDERMA-US2024012424$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505281$24250528$1$I$$20240731$20240826$20240826$PER$$US-GALDERMA-US2024012432$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505291$24250529$1$I$20240101$20240724$20240826$20240826$PER$$US-GALDERMA-US2024012264$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505301$24250530$1$I$$20240712$20240826$20240826$PER$$US-GALDERMA-US2024011633$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505311$24250531$1$I$20240601$20240715$20240826$20240826$PER$$US-GALDERMA-US2024011673$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505321$24250532$1$I$$20240720$20240826$20240826$PER$$US-GALDERMA-US2024011905$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505331$24250533$1$I$20240101$20240715$20240826$20240826$PER$$US-GALDERMA-US2024011674$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505341$24250534$1$I$$20240724$20240826$20240826$PER$$US-GALDERMA-US2024012178$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505351$24250535$1$I$$20240715$20240826$20240826$PER$$US-GALDERMA-US2024011643$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505361$24250536$1$I$$20240715$20240826$20240826$PER$$US-GALDERMA-US2024011640$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505371$24250537$1$I$$20240715$20240826$20240826$PER$$US-GALDERMA-US2024011641$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505381$24250538$1$I$$20240728$20240826$20240826$PER$$US-GALDERMA-US2024012133$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505391$24250539$1$I$$20240729$20240826$20240826$PER$$US-GALDERMA-US2024012383$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505401$24250540$1$I$$20240716$20240826$20240826$PER$$US-GALDERMA-US2024011705$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505411$24250541$1$I$$20240716$20240826$20240826$PER$$US-GALDERMA-US2024011780$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505421$24250542$1$I$$20240716$20240826$20240826$PER$$US-GALDERMA-US2024011708$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505431$24250543$1$I$20240805$20240824$20240824$20240824$DIR$715760$$FDA-CTU$$27$YR$$F$N$54$KG$20240824$N$CN$US$
242505441$24250544$1$I$$20240728$20240826$20240826$PER$$US-GALDERMA-US2024012274$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505451$24250545$1$I$$20240716$20240826$20240826$PER$$US-GALDERMA-US2024011949$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505461$24250546$1$I$$20240717$20240826$20240826$PER$$US-GALDERMA-US2024011636$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505471$24250547$1$I$$20240717$20240826$20240826$PER$$US-GALDERMA-US2024011721$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505481$24250548$1$I$$20240717$20240826$20240826$PER$$US-GALDERMA-US2024011777$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505491$24250549$1$I$$20240717$20240826$20240826$PER$$US-GALDERMA-US2024011782$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505501$24250550$1$I$$20240717$20240826$20240826$PER$$US-GALDERMA-US2024011723$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505511$24250551$1$I$20230101$20240717$20240826$20240826$PER$$US-GALDERMA-US2024011781$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505521$24250552$1$I$$20240717$20240826$20240826$PER$$US-GALDERMA-US2024011783$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505531$24250553$1$I$20240101$20240718$20240826$20240826$PER$$US-GALDERMA-US2024011826$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505541$24250554$1$I$$20240718$20240826$20240826$PER$$US-GALDERMA-US2024011878$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505552$24250555$2$F$$20240921$20240826$20240923$PER$$NVSC2024US172211$NOVARTIS$$$$$M$Y$75$KG$20240923$$CN$US$US
242505561$24250556$1$I$$20240718$20240826$20240826$PER$$US-GALDERMA-US2024011951$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505571$24250557$1$I$20230101$20240718$20240826$20240826$PER$$US-GALDERMA-US2024011954$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505581$24250558$1$I$$20240722$20240826$20240826$PER$$US-GALDERMA-US2024012075$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505591$24250559$1$I$$20240722$20240826$20240826$PER$$US-GALDERMA-US2024012076$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505601$24250560$1$I$$20240722$20240826$20240826$PER$$US-GALDERMA-US2024012077$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505611$24250561$1$I$$20240723$20240826$20240826$PER$$US-GALDERMA-US2024012030$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505621$24250562$1$I$$20240723$20240826$20240826$PER$$US-GALDERMA-US2024012031$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505631$24250563$1$I$$20240723$20240826$20240826$PER$$US-GALDERMA-US2024012032$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505641$24250564$1$I$$20240723$20240826$20240826$PER$$US-GALDERMA-US2024012033$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505651$24250565$1$I$$20240723$20240826$20240826$PER$$US-GALDERMA-US2024012057$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505661$24250566$1$I$$20240724$20240826$20240826$PER$$US-GALDERMA-US2024012080$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505671$24250567$1$I$20240101$20240724$20240826$20240826$PER$$US-GALDERMA-US2024012177$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505681$24250568$1$I$$20240724$20240826$20240826$PER$$US-GALDERMA-US2024012083$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505691$24250569$1$I$$20240725$20240826$20240826$PER$$US-GALDERMA-US2024012146$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505701$24250570$1$I$$20240725$20240826$20240826$PER$$US-GALDERMA-US2024012380$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505711$24250571$1$I$$20240725$20240826$20240826$PER$$US-GALDERMA-US2024012184$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505721$24250572$1$I$$20240725$20240826$20240826$PER$$US-GALDERMA-US2024012144$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505731$24250573$1$I$$20240726$20240826$20240826$PER$$US-GALDERMA-US2024011974$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505741$24250574$1$I$$20240729$20240826$20240826$PER$$US-GALDERMA-US2024012426$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505752$24250575$2$F$20240801$20240912$20240826$20240919$EXP$$US-Calliditas-2024CAL01357$CALLIDITAS THERAPEUTICS$$59$YR$A$M$Y$177.3$KG$20240919$$CN$US$US
242505761$24250576$1$I$$20240729$20240826$20240826$PER$$US-GALDERMA-US2024012391$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505771$24250577$1$I$$20240729$20240826$20240826$PER$$US-GALDERMA-US2024012394$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505781$24250578$1$I$$20240726$20240826$20240826$PER$$US-GALDERMA-US2024012378$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505791$24250579$1$I$$20240729$20240826$20240826$PER$$US-GALDERMA-US2024012427$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505801$24250580$1$I$$20240730$20240826$20240826$PER$$US-GALDERMA-US2024012352$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505811$24250581$1$I$$20240730$20240826$20240826$PER$$US-GALDERMA-US2024012353$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505821$24250582$1$I$$20240730$20240826$20240826$PER$$US-GALDERMA-US2024012354$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505831$24250583$1$I$$20240730$20240826$20240826$PER$$US-GALDERMA-US2024012356$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505841$24250584$1$I$$20240731$20240826$20240826$PER$$US-GALDERMA-US2024012430$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505851$24250585$1$I$$20240801$20240826$20240826$PER$$US-GALDERMA-US2024012435$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505861$24250586$1$I$$20240731$20240826$20240826$PER$$US-GALDERMA-US2024012469$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505871$24250587$1$I$$20240802$20240826$20240826$PER$$US-GALDERMA-US2024012569$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505881$24250588$1$I$$20240805$20240826$20240826$PER$$US-GALDERMA-US2024012575$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505891$24250589$1$I$$20240801$20240826$20240826$PER$$US-GALDERMA-US2024012470$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505901$24250590$1$I$$20240805$20240826$20240826$PER$$US-GALDERMA-US2024012584$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505911$24250591$1$I$$20240807$20240826$20240826$PER$$US-GALDERMA-US2024012706$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505921$24250592$1$I$20231001$20240805$20240826$20240826$PER$$US-GALDERMA-US2024012704$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505931$24250593$1$I$$20240805$20240826$20240826$PER$$US-GALDERMA-US2024012576$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505941$24250594$1$I$$20240807$20240826$20240826$PER$$US-GALDERMA-US2024012705$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505951$24250595$1$I$20240801$20240801$20240826$20240826$PER$$US-GALDERMA-US2024012340$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505961$24250596$1$I$$20240729$20240826$20240826$PER$$US-GALDERMA-US2024012381$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505971$24250597$1$I$20240401$20240722$20240826$20240826$PER$$US-GALDERMA-US2024012072$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505981$24250598$1$I$20240401$20240722$20240826$20240826$PER$$US-GALDERMA-US2024012089$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242505991$24250599$1$I$20240501$20240722$20240826$20240826$PER$$US-GALDERMA-US2024012101$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506001$24250600$1$I$$20240722$20240826$20240826$PER$$US-GALDERMA-US2024012099$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506011$24250601$1$I$20240717$20240729$20240826$20240826$PER$$US-GALDERMA-US2024012390$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506021$24250602$1$I$$20240725$20240826$20240826$PER$$US-GALDERMA-US2024012379$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506031$24250603$1$I$$20240724$20240826$20240826$PER$$US-GALDERMA-US2024011957$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506041$24250604$1$I$20240715$20240729$20240826$20240826$PER$$US-GALDERMA-US2024012423$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506051$24250605$1$I$$20240731$20240826$20240826$PER$$US-GALDERMA-US2024012397$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506061$24250606$1$I$20240101$20240731$20240826$20240826$PER$$US-GALDERMA-US2024012468$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506071$24250607$1$I$20200101$20240731$20240826$20240826$PER$$US-GALDERMA-US2024012398$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506081$24250608$1$I$$20240729$20240826$20240826$PER$$US-GALDERMA-US2024012382$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506091$24250609$1$I$$20240728$20240826$20240826$PER$$US-GALDERMA-US2024012053$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506101$24250610$1$I$$20240802$20240826$20240826$PER$$US-GALDERMA-US2024012532$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506111$24250611$1$I$$20240724$20240826$20240826$PER$$US-GALDERMA-US2024012261$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506121$24250612$1$I$$20240725$20240826$20240826$PER$$US-GALDERMA-US2024012267$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506131$24250613$1$I$$20240728$20240826$20240826$PER$$US-GALDERMA-US2024012050$GALDERMA$$$$$$Y$$$20240826$$CN$US$US
242506141$24250614$1$I$$20240822$20240826$20240826$EXP$$TR-GILEAD-2024-0685012$GILEAD$$22$YR$A$F$Y$$$20240826$$MD$TR$TR
242506151$24250615$1$I$20240817$20240825$20240826$20240826$DIR$FDA-CDER-CTU-2024-58609$$FDA-CTU$$68$YR$$M$N$$$20240825$N$$US$
242506161$24250616$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58657$$FDA-CTU$$74$YR$$M$N$$$20240826$N$$US$
242506171$24250617$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58560$$FDA-CTU$$46$YR$$M$N$$$20240826$N$$US$
242506181$24250618$1$I$20240807$20240823$20240826$20240826$PER$$US-JNJFOC-20240861375$JOHNSON AND JOHNSON$$$$$M$Y$$$20240826$$CN$US$US
242506201$24250620$1$I$20240824$20240824$20240824$20240824$DIR$715745$$FDA-CTU$$55$YR$$F$N$65.25$KG$20240824$N$CN$US$
242506211$24250621$1$I$20240823$20240824$20240824$20240824$DIR$715746$$FDA-CTU$$35$YR$$F$N$65.25$KG$20240824$N$CN$US$
242506221$24250622$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58570$$FDA-CTU$$67$YR$$F$N$77.11$KG$20240826$N$$US$
242506231$24250623$1$I$20240722$20240820$20240826$20240826$EXP$$CN-JNJFOC-20240865246$JOHNSON AND JOHNSON$$82$YR$E$F$Y$55$KG$20240826$$HP$CN$CN
242506241$24250624$1$I$$20240820$20240826$20240826$EXP$$FR-DSJP-DSE-2024-141532$DAIICHI$$$$A$F$Y$55$KG$20240826$$MD$FR$FR
242506261$24250626$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58621$$FDA-CTU$$51$YR$$F$N$$$20240826$N$$US$
242506271$24250627$1$I$$20240819$20240826$20240826$EXP$$US-ROCHE-10000065984$ROCHE$Jha K, Nealy Z, Schneider M, Martin B. PARADOXICAL MYOCARDIAL INFARCTION SECONDARY TO USE OF SYSTEMIC THROMBOLYTIC FOR ACUTE ISCHEMIC STROKE. Journal of the American College of Cardiology. 2019;73(9(suppl 1)): 2394. doi:10.1016/S0735-1097%2819%2933000-1.$54$YR$A$M$Y$$$20240826$$HP$US$US
242506281$24250628$1$I$$20240813$20240826$20240826$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004965$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240826$$HP$US$US
242506291$24250629$1$I$$20240819$20240826$20240826$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-141947$DAIICHI$$707$MON$$F$Y$$$20240826$$CN$CA$CA
242506301$24250630$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141945AA$DAIICHI$$$$$F$Y$$$20240826$$CN$CA$CA
242506311$24250631$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141946AA$DAIICHI$$61$YR$$F$Y$$$20240826$$MD$CA$CA
242506321$24250632$1$I$20160101$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009191$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240826$$CN$US$US
242506331$24250633$1$I$20240726$20240814$20240826$20240826$EXP$GB-MHRA-MED-202408141646086170-SZQDP$GB-ELI_LILLY_AND_COMPANY-GB202408009461$ELI LILLY AND CO$$71$YR$E$F$Y$104$KG$20240826$$CN$GB$GB
242506341$24250634$1$I$$20240814$20240826$20240826$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202408009604$ELI LILLY AND CO$$$$$$Y$$$20240826$$MD$CA$CA
242506351$24250635$1$I$$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009867$ELI LILLY AND CO$$46$YR$A$$Y$$$20240826$$LW$US$US
242506361$24250636$1$I$$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009299$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242506372$24250637$2$F$20240813$20240819$20240826$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009996$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240828$$CN$US$US
242506381$24250638$1$I$20240813$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009453$ELI LILLY AND CO$$88$YR$E$F$Y$$$20240826$$CN$US$US
242506391$24250639$1$I$$20240820$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012576$ELI LILLY AND CO$$$$$$Y$$$20240826$$CN$US$US
242506401$24250640$1$I$20220101$20240815$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009755$ELI LILLY AND CO$$$$$M$Y$$$20240826$$CN$US$US
242506411$24250641$1$I$20240811$20240814$20240826$20240826$EXP$GB-MHRA-MED-202408141553591930-LQGCT$GB-ELI_LILLY_AND_COMPANY-GB202408009482$ELI LILLY AND CO$$44$YR$A$M$Y$120$KG$20240826$$CN$GB$GB
242506421$24250642$1$I$$20240814$20240826$20240826$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202408008352$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240826$$MD$AU$AU
242506431$24250643$1$I$$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009262$ELI LILLY AND CO$$$$$M$Y$$$20240826$$CN$US$US
242506441$24250644$1$I$$20240813$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-FR202408008856$ELI LILLY AND CO$$21$YR$A$M$Y$$$20240826$$CN$FR$FR
242506452$24250645$2$F$$20240819$20240826$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010036$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240830$$CN$US$US
242506471$24250647$1$I$$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009746$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240826$$CN$US$US
242506481$24250648$1$I$$20240819$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012446$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242506491$24250649$1$I$20240814$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010304$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240826$$CN$US$US
242506501$24250650$1$I$20240701$20240816$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010910$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240826$$CN$US$US
242506511$24250651$1$I$20240201$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009493$ELI LILLY AND CO$$60$YR$A$F$Y$108.8$KG$20240826$$CN$US$US
242506521$24250652$1$I$$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009399$ELI LILLY AND CO$$52$YR$A$$Y$$$20240826$$CN$US$US
242506531$24250653$1$I$$20240815$20240826$20240826$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408009634$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$BR$BR
242506541$24250654$1$I$$20240814$20240826$20240826$EXP$$PT-ELI_LILLY_AND_COMPANY-PT202408011939$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$PT$PT
242506551$24250655$1$I$$20240815$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010100$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240826$$CN$US$US
242506561$24250656$1$I$$20240814$20240826$20240826$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408008733$ELI LILLY AND CO$$$$$F$Y$$$20240826$$MD$DE$DE
242506571$24250657$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141944$DAIICHI$$$$$F$Y$$$20240826$$CN$CA$CA
242506581$24250658$1$I$20240209$20240823$20240826$20240826$EXP$FR-AFSSAPS-PO2024000913$FR-DAIICHI SANKYO, INC.-DSE-2024-141860$DAIICHI$$70$YR$$F$Y$$$20240826$$PH$FR$FR
242506591$24250659$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064836$ROCHE$$$$C$M$Y$$$20240826$$CN$US$US
242506601$24250660$1$I$20240719$20240816$20240826$20240826$EXP$CH-SM-2024-15270$CH-TEVA-VS-3234733$TEVA$$80$YR$$F$Y$64.1$KG$20240826$$MD$CH$CH
242506611$24250661$1$I$20240531$20240816$20240826$20240826$EXP$CN-NMPACDR-1101061905517202400084$CN-BAXTER-2024BAX023487$BAXTER$$12$YR$$F$Y$30$KG$20240826$$MD$CN$CN
242506621$24250662$1$I$$20240821$20240826$20240826$EXP$$US-GILEAD-2024-0685069$GILEAD$$$$A$F$Y$$$20240826$$CN$US$US
242506631$24250663$1$I$20210718$20240816$20240826$20240826$EXP$$CA-TAKEDA-2024TUS085831$TAKEDA$$74$YR$$F$Y$$$20240826$$MD$CA$CA
242506641$24250664$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134311$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$77.56$KG$20240826$$CN$US$US
242506651$24250665$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141943$DAIICHI$$$$$F$Y$$$20240826$$CN$CA$CA
242506661$24250666$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141941$DAIICHI$$$$$F$Y$$$20240826$$HP$CA$CA
242506673$24250667$3$F$20240704$20240830$20240826$20240909$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-134841$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240909$$MD$GB$GB
242506681$24250668$1$I$$20240820$20240826$20240826$PER$$US-AstraZeneca-2024A190266$ASTRAZENECA$$$$A$$Y$$$20240826$$MD$US$
242506691$24250669$1$I$$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A191037$ASTRAZENECA$$$$$F$Y$$$20240826$$CN$US$
242506701$24250670$1$I$20240601$20240817$20240826$20240826$EXP$$GB-AstraZeneca-2024A186839$ASTRAZENECA$$77$YR$$M$Y$$$20240826$$CN$GB$
242506711$24250671$1$I$$20240818$20240826$20240826$EXP$$CA-AstraZeneca-2024A193552$ASTRAZENECA$$$$$$Y$$$20240826$$CN$CA$
242506721$24250672$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58607$$FDA-CTU$$74$YR$$F$N$$$20240826$N$$US$
242506731$24250673$1$I$$20240816$20240826$20240826$EXP$$CA-BAXTER-2024BAX023561$BAXTER$$72$YR$$M$Y$$$20240826$$HP$CA$CA
242506741$24250674$1$I$$20240823$20240826$20240826$EXP$$TW-AstraZeneca-2024A193010$ASTRAZENECA$$$$$F$Y$$$20240826$$CN$TW$
242506751$24250675$1$I$$20240822$20240826$20240826$PER$$US-ROCHE-10000064623$ROCHE$$68$YR$E$F$Y$$$20240826$$CN$US$US
242506762$24250676$2$F$$20240912$20240826$20240920$EXP$$JP-TEVA-VS-3235269$TEVA$Uwatoko H, Yabe I, Shirai S, Takahashi I, Matsushima M, Kano T, et al. Pseudodystonia in sarcoid myopathy. Neurol-Clin-Neurosci 2017; 5 (1): 34-35.; Uwatoko H, Yabe I, Shirai S, Takahashi I, Matsushima M, Kano T, et al. Pseudodystonia in sarcoid myopathy. Neurol-Clin-Neurosci 2017; 5 (1): 34-35.; Uwatoko H, Yabe I, Shirai S, Takahashi I, Matsushima M, Kano T, et al. Pseudodystonia in sarcoid myopathy. Neurol-Clin-Neurosci 2017; 5 (1): 34-35.$61$YR$$F$Y$$$20240920$$HP$JP$JP
242506771$24250677$1$I$20240823$20240824$20240824$20240824$DIR$715744$$FDA-CTU$$27$YR$$F$N$107.1$KG$20240824$N$CN$US$
242506781$24250678$1$I$20240601$20240806$20240826$20240826$DIR$FDA-CDER-CTU-2024-58536$$FDA-CTU$$46$YR$$F$N$$$20240806$N$HP$US$
242506791$24250679$1$I$20240601$20240820$20240826$20240826$EXP$$CH-AstraZeneca-2024A193359$ASTRAZENECA$$17$YR$$M$Y$50.4$KG$20240826$$MD$CH$
242506801$24250680$1$I$20240801$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58666$$FDA-CTU$$71$YR$$F$N$$$20240826$N$HP$US$
242506811$24250681$1$I$$20240730$20240826$20240826$PER$$US-Eisai-EC-2024-171384$EISAI$$$$$M$Y$$$20240826$$MD$US$US
242506821$24250682$1$I$$20240823$20240826$20240826$PER$$US-ROCHE-10000065744$ROCHE$$$$A$F$Y$$$20240826$$CN$US$US
242506831$24250683$1$I$$20240821$20240826$20240826$EXP$$US-GILEAD-2024-0685142$GILEAD$$$$A$M$Y$$$20240826$$CN$US$US
242506841$24250684$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58661$$FDA-CTU$$76$YR$$F$N$72.57$KG$20240826$N$$US$
242506851$24250685$1$I$$20240820$20240826$20240826$PER$$US-ROCHE-10000065687$ROCHE$$$$$M$Y$$$20240826$$CN$US$US
242506861$24250686$1$I$$20240819$20240826$20240826$EXP$$US-ABBVIE-5889360$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242506871$24250687$1$I$$20240821$20240826$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-JPN-2016110167$BRISTOL MYERS SQUIBB$Minomo S, Tokoro A, Utsumi T, Ishihara M, Akira M, Atagi S. A case of long-term survival after multimodal local treatments of intramedullary spinal cord metastasis of squamous cell lung cancer. Journal of Thoracic Disease. 2016 Aug;8(8):E681-3. doi:10.21037/jtd.2016.06.58.$53$YR$A$M$Y$$$20240826$$MD$JP$JP
242506881$24250688$1$I$$20240822$20240826$20240826$EXP$PL-URPL-1-1872-2020$PL-MYLANLABS-2024M1077891$MYLAN$$20$YR$$M$Y$$$20240826$$MD$PL$PL
242506891$24250689$1$I$$20240819$20240826$20240826$EXP$$CA-SANDOZ INC.-NVSC2021CA085300$SANDOZ$$63$YR$$M$Y$$$20240826$$CN$CA$CA
242506901$24250690$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58630$$FDA-CTU$$26$YR$$M$N$$$20240826$N$$US$
242506911$24250691$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141940$DAIICHI$$$$$F$Y$$$20240826$$CN$CA$CA
242506921$24250692$1$I$$20240816$20240826$20240826$EXP$$US-TEVA-VS-3234516$TEVA$$$$$$Y$$$20240826$$CN$US$US
242506931$24250693$1$I$20240820$20240821$20240826$20240826$PER$$US-BAYER-2024A120846$BAYER$$21$YR$A$F$Y$$$20240826$$MD$US$US
242506941$24250694$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141938$DAIICHI$$57$YR$$F$Y$$$20240826$$PH$CA$CA
242506951$24250695$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141935AA$DAIICHI$$70$YR$$F$Y$$$20240826$$MD$CA$CA
242506962$24250696$2$F$$20240910$20240826$20240912$EXP$$NL-SANDOZ INC.-SDZ2024NL075109$SANDOZ$$72$YR$$M$Y$$$20240912$$HP$NL$NL
242506971$24250697$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141937AA$DAIICHI$$61$YR$$F$Y$$$20240826$$HP$CA$CA
242506982$24250698$2$F$$20240826$20240826$20240827$EXP$$US-GILEAD-2024-0685206$GILEAD$$$$E$F$Y$$$20240827$$CN$US$US
242506992$24250699$2$F$20240101$20240822$20240826$20240902$PER$$US-SA-2024SA246129$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240902$$MD$US$US
242507001$24250700$1$I$20231011$20231013$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00444$MEDEXUS PHARMA$$73$YR$$F$Y$$$20240826$$CN$US$US
242507011$24250701$1$I$20231025$20231102$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00477$MEDEXUS PHARMA$$79$YR$$F$Y$$$20240826$$CN$US$US
242507021$24250702$1$I$20230101$20230802$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00189$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507031$24250703$1$I$$20231023$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00458$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507041$24250704$1$I$20230101$20231027$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00467$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507051$24250705$1$I$20231109$20231110$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00485$MEDEXUS PHARMA$$61$YR$$F$Y$$$20240826$$CN$US$US
242507061$24250706$1$I$20231101$20231114$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00489$MEDEXUS PHARMA$$61$YR$$F$Y$$$20240826$$CN$US$US
242507071$24250707$1$I$20240101$20240117$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00498$MEDEXUS PHARMA$$$$$M$Y$$$20240826$$CN$US$US
242507081$24250708$1$I$20230101$20231215$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00510$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507091$24250709$1$I$20230101$20231207$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00528$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507101$24250710$1$I$20230101$20231213$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00536$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507111$24250711$1$I$20231012$20231012$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00439$MEDEXUS PHARMA$$88$YR$$F$Y$$$20240826$$CN$US$US
242507121$24250712$1$I$20230101$20231018$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00450$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507131$24250713$1$I$20230101$20231026$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00463$MEDEXUS PHARMA$$$$$M$Y$$$20240826$$CN$US$US
242507141$24250714$1$I$20220101$20231115$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00473$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507151$24250715$1$I$$20231107$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00479$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507161$24250716$1$I$20231101$20231114$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00488$MEDEXUS PHARMA$$56$YR$$F$Y$$$20240826$$CN$US$US
242507171$24250717$1$I$20231114$20231115$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00493$MEDEXUS PHARMA$$69$YR$$F$Y$$$20240826$$CN$US$US
242507181$24250718$1$I$20230101$20231201$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00519$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507191$24250719$1$I$20190101$20231212$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00535$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507201$24250720$1$I$$20240104$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00010$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507211$24250721$1$I$$20240708$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00306$MEDEXUS PHARMA$$$$$$Y$$$20240826$$CN$US$US
242507221$24250722$1$I$$20240708$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00307$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507231$24250723$1$I$20230701$20230718$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00256$MEDEXUS PHARMA$$59$YR$$F$Y$$$20240826$$CN$US$US
242507241$24250724$1$I$20230901$20240103$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00007$MEDEXUS PHARMA$$47$YR$$F$Y$$$20240826$$CN$US$US
242507251$24250725$1$I$$20230720$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00266$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507261$24250726$1$I$$20230801$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00285$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507271$24250727$1$I$20230802$20230802$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00286$MEDEXUS PHARMA$$69$YR$$F$Y$$$20240826$$CN$US$US
242507281$24250728$1$I$20230801$20231204$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00500$MEDEXUS PHARMA$$68$YR$$F$Y$86.168$KG$20240826$$CN$US$US
242507291$24250729$1$I$$20230713$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00248$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507301$24250730$1$I$20230101$20240103$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00537$MEDEXUS PHARMA$$$$$F$Y$68.027$KG$20240826$$CN$US$US
242507311$24250731$1$I$$20231218$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00559$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507321$24250732$1$I$20231217$20231219$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00562$MEDEXUS PHARMA$$8$YR$$M$Y$$$20240826$$CN$US$US
242507331$24250733$1$I$$20231222$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00575$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507341$24250734$1$I$20230101$20231226$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00576$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507351$24250735$1$I$20231228$20231229$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00579$MEDEXUS PHARMA$$70$YR$$M$Y$$$20240826$$CN$US$US
242507361$24250736$1$I$20231226$20240110$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00001$MEDEXUS PHARMA$$66$YR$$F$Y$$$20240826$$CN$US$US
242507371$24250737$1$I$20230101$20240103$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00003$MEDEXUS PHARMA$$63$YR$$M$Y$$$20240826$$CN$US$US
242507381$24250738$1$I$20230923$20230925$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00389$MEDEXUS PHARMA$$68$YR$$F$Y$$$20240826$$CN$US$US
242507391$24250739$1$I$20230801$20230925$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00394$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507401$24250740$1$I$20230901$20230927$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00401$MEDEXUS PHARMA$$57$YR$$F$Y$$$20240826$$CN$US$US
242507411$24250741$1$I$$20230927$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00402$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507421$24250742$1$I$20231007$20231009$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00428$MEDEXUS PHARMA$$66$YR$$F$Y$$$20240826$$CN$US$US
242507431$24250743$1$I$20230809$20230810$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00307$MEDEXUS PHARMA$$38$YR$$F$Y$$$20240826$$CN$US$US
242507441$24250744$1$I$20231210$20231218$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00556$MEDEXUS PHARMA$$65$YR$$F$Y$$$20240826$$CN$US$US
242507451$24250745$1$I$20190101$20231009$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00433$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507461$24250746$1$I$20230101$20230810$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00308$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507471$24250747$1$I$20230101$20230816$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00323$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$PH$US$US
242507481$24250748$1$I$20230101$20230818$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00331$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$PH$US$US
242507491$24250749$1$I$20230801$20230831$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00351$MEDEXUS PHARMA$$66$YR$$F$Y$$$20240826$$CN$US$US
242507501$24250750$1$I$20230901$20230912$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00365$MEDEXUS PHARMA$$68$YR$$F$Y$$$20240826$$CN$US$US
242507511$24250751$1$I$20230901$20231013$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00410$MEDEXUS PHARMA$$63$YR$$F$Y$99.773$KG$20240826$$CN$US$US
242507521$24250752$1$I$20231201$20231229$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00580$MEDEXUS PHARMA$$72$YR$$F$Y$$$20240826$$CN$US$US
242507531$24250753$1$I$20200101$20231002$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00414$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507541$24250754$1$I$20230912$20230913$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00366$MEDEXUS PHARMA$$63$YR$$F$Y$$$20240826$$CN$US$US
242507551$24250755$1$I$20230901$20230925$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00387$MEDEXUS PHARMA$$54$YR$$F$Y$56.236$KG$20240826$$CN$US$US
242507561$24250756$1$I$20231229$20240105$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00011$MEDEXUS PHARMA$$66$YR$$F$Y$$$20240826$$CN$US$US
242507571$24250757$1$I$20230701$20230810$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00273$MEDEXUS PHARMA$$60$YR$$F$Y$$$20240826$$CN$US$US
242507581$24250758$1$I$20230101$20230809$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00304$MEDEXUS PHARMA$$$$$F$Y$70.295$KG$20240826$$CN$US$US
242507591$24250759$1$I$20230901$20230928$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00405$MEDEXUS PHARMA$$30$YR$$F$Y$$$20240826$$CN$US$US
242507601$24250760$1$I$20230101$20230928$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00409$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507611$24250761$1$I$$20230920$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00381$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507621$24250762$1$I$20240820$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133609$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240826$$CN$US$US
242507631$24250763$1$I$$20240819$20240826$20240826$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-141933$DAIICHI$$$$$F$Y$$$20240826$$CN$CA$CA
242507641$24250764$1$I$20240803$20240822$20240826$20240826$EXP$$US-GILEAD-2024-0685216$GILEAD$$79$YR$E$F$Y$$$20240826$$CN$US$US
242507651$24250765$1$I$20220101$20230925$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00003$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507661$24250766$1$I$20240516$20240516$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00227$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507671$24250767$1$I$20240101$20240523$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00236$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507681$24250768$1$I$20240511$20240530$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00242$MEDEXUS PHARMA$$47$YR$$F$Y$$$20240826$$CN$US$US
242507691$24250769$1$I$20240101$20240610$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00283$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507701$24250770$1$I$20240101$20240614$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00290$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$PH$US$US
242507711$24250771$1$I$20240101$20240617$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00291$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507721$24250772$1$I$20240101$20240115$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00012$MEDEXUS PHARMA$$74$YR$$F$Y$26.757$KG$20240826$$CN$US$US
242507731$24250773$1$I$20240101$20240708$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00303$MEDEXUS PHARMA$$$$$M$Y$$$20240826$$CN$US$US
242507741$24250774$1$I$$20240116$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00018$MEDEXUS PHARMA$$$$$F$Y$90.703$KG$20240826$$CN$US$US
242507751$24250775$1$I$$20240109$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00023$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507761$24250776$1$I$$20240122$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00025$MEDEXUS PHARMA$$$$$M$Y$$$20240826$$CN$US$US
242507771$24250777$1$I$20240101$20240311$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00042$MEDEXUS PHARMA$$61$YR$$F$Y$$$20240826$$CN$US$US
242507781$24250778$1$I$20240101$20240221$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00110$MEDEXUS PHARMA$$$$$M$Y$$$20240826$$CN$US$US
242507791$24250779$1$I$$20240229$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00127$MEDEXUS PHARMA$$$$$M$Y$$$20240826$$CN$US$US
242507801$24250780$1$I$20230725$20231023$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00295$MEDEXUS PHARMA$$61$YR$$F$Y$79.365$KG$20240826$$CN$US$US
242507811$24250781$1$I$$20240110$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00027$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507821$24250782$1$I$20240207$20240229$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00130$MEDEXUS PHARMA$$85$YR$$F$Y$$$20240826$$CN$US$US
242507831$24250783$1$I$$20240408$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00151$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507841$24250784$1$I$$20240416$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00164$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507851$24250785$1$I$$20240512$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00223$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507861$24250786$1$I$20240119$20240122$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00055$MEDEXUS PHARMA$$47$YR$$M$Y$$$20240826$$CN$US$US
242507871$24250787$1$I$20230101$20240129$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00071$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507881$24250788$1$I$20230814$20230830$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2023MED00332$MEDEXUS PHARMA$$54$YR$$F$Y$61.678$KG$20240826$$CN$US$US
242507891$24250789$1$I$$20240401$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00166$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507901$24250790$1$I$$20240411$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00180$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507911$24250791$1$I$20240409$20240411$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00181$MEDEXUS PHARMA$$74$YR$$F$Y$$$20240826$$CN$US$US
242507921$24250792$1$I$20240401$20240429$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00186$MEDEXUS PHARMA$$62$YR$$F$Y$$$20240826$$CN$US$US
242507931$24250793$1$I$20240301$20240425$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00195$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507941$24250794$1$I$20240419$20240426$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00196$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507951$24250795$1$I$$20240513$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00221$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242507961$24250796$1$I$$20240426$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00197$MEDEXUS PHARMA$$$$$M$Y$$$20240826$$CN$US$US
242507971$24250797$1$I$$20240509$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00202$MEDEXUS PHARMA$$$$$F$Y$54.422$KG$20240826$$CN$US$US
242507981$24250798$1$I$20240507$20240508$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00209$MEDEXUS PHARMA$$27$YR$$F$Y$$$20240826$$CN$US$US
242507991$24250799$1$I$20240301$20240610$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00282$MEDEXUS PHARMA$$50$YR$$F$Y$62.596$KG$20240826$$CN$US$US
242508001$24250800$1$I$20240101$20240123$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00059$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242508011$24250801$1$I$20240207$20240208$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00098$MEDEXUS PHARMA$$68$YR$$F$Y$$$20240826$$CN$US$US
242508021$24250802$1$I$$20240614$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00289$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242508031$24250803$1$I$20240101$20240205$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00063$MEDEXUS PHARMA$$92$YR$$F$Y$63.492$KG$20240826$$CN$US$US
242508041$24250804$1$I$$20240209$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00090$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242508051$24250805$1$I$20230101$20240206$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00094$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242508061$24250806$1$I$$20240822$20240826$20240826$EXP$$CA-ROCHE-10000064035$ROCHE$$63$YR$A$M$Y$$$20240826$$PH$CA$CA
242508071$24250807$1$I$20240812$20240826$20240826$20240826$PER$$US-BAYER-2024A122454$BAYER$$28$YR$A$F$Y$$$20240826$$MD$US$US
242508081$24250808$1$I$$20231130$20240826$20240826$EXP$$US-FERRINGPH-2023FE06003$FERRING$$$$$F$Y$$$20240826$$CN$US$US
242508091$24250809$1$I$20231101$20240508$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00208$MEDEXUS PHARMA$$63$YR$$F$Y$$$20240826$$CN$US$US
242508101$24250810$1$I$$20240131$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00082$MEDEXUS PHARMA$$$$$F$Y$$$20240826$$CN$US$US
242508111$24250811$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141929$DAIICHI$$$$$F$Y$$$20240826$$HP$CA$CA
242508121$24250812$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141926AA$DAIICHI$$$$$F$Y$$$20240826$$CN$CA$CA
242508131$24250813$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141927$DAIICHI$$47$YR$$F$Y$68$KG$20240826$$MD$CA$CA
242508141$24250814$1$I$$20240814$20240826$20240826$EXP$$IT-BAYER-2024A119387$BAYER$$$$$$Y$$$20240826$$MD$IT$IT
242508151$24250815$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141924AA$DAIICHI$$75$YR$$F$Y$$$20240826$$HP$CA$CA
242508161$24250816$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141923$DAIICHI$$67$YR$$F$Y$$$20240826$$MD$CA$CA
242508171$24250817$1$I$20240423$20240424$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00190$MEDEXUS PHARMA$$62$YR$$F$Y$$$20240826$$CN$US$US
242508181$24250818$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134139$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240826$$HP$US$US
242508191$24250819$1$I$20240801$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135320$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$78.93$KG$20240826$$CN$US$US
242508214$24250821$4$F$$20240904$20240826$20240912$EXP$$CO-SANDOZ INC.-NVSC2022CO121161$SANDOZ$$$$$M$Y$70$KG$20240912$$CN$CO$CO
242508231$24250823$1$I$20240813$20240823$20240826$20240826$EXP$$US-INCYTE CORPORATION-2024IN008881$INCYTE$$$$$$Y$$$20240826$$CN$US$US
242508251$24250825$1$I$20240820$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167983$AMGEN$$41$YR$A$F$Y$$$20240826$$CN$US$US
242508261$24250826$1$I$20230801$20240521$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00230$MEDEXUS PHARMA$$78$YR$$F$Y$$$20240826$$CN$US$US
242508271$24250827$1$I$20240501$20240524$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00239$MEDEXUS PHARMA$$67$YR$$F$Y$53.8$KG$20240826$$PH$US$US
242508281$24250828$1$I$20240101$20240201$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00069$MEDEXUS PHARMA$$50$YR$$F$Y$42.63$KG$20240826$$CN$US$US
242508291$24250829$1$I$20240117$20240209$20240826$20240826$EXP$$US-BRACCO-2024US00635$BRACCO$$32$YR$$F$Y$$$20240826$$PH$US$US
242508301$24250830$1$I$20240117$20240209$20240826$20240826$EXP$$US-BRACCO-2024US00707$BRACCO$$61$YR$$F$Y$$$20240826$$PH$US$US
242508311$24250831$1$I$$20240821$20240826$20240826$PER$$US-AstraZeneca-2024A191269$ASTRAZENECA$$$$$F$Y$$$20240826$$MD$US$
242508321$24250832$1$I$$20240822$20240826$20240826$EXP$$US-BAYER-2024A121390$BAYER$$53$YR$A$M$Y$$$20240826$$HP$US$US
242508331$24250833$1$I$$20240823$20240826$20240826$EXP$$US-AstraZeneca-2024A193851$ASTRAZENECA$$$$$F$Y$$$20240826$$CN$US$
242508341$24250834$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58613$$FDA-CTU$$73$YR$$F$N$$$20240826$N$$US$
242508351$24250835$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58649$$FDA-CTU$$56$YR$$F$N$$$20240826$N$$US$
242508361$24250836$1$I$20240826$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58659$$FDA-CTU$$43$YR$$M$N$52.3$KG$20240826$N$HP$US$
242508371$24250837$1$I$20240101$20240213$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00100$MEDEXUS PHARMA$$71$YR$$F$Y$$$20240826$$CN$US$US
242508391$24250839$1$I$20240105$20240105$20240826$20240826$PER$$US-MEDEXUS PHARMA, INC.-2024MED00015$MEDEXUS PHARMA$$54$YR$$F$Y$$$20240826$$CN$US$US
242508401$24250840$1$I$$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015224$ELI LILLY AND CO$$83$YR$E$$Y$$$20240826$$CN$US$US
242508431$24250843$1$I$20240117$20240209$20240826$20240826$EXP$$US-BRACCO-2024US00708$BRACCO$$56$YR$$M$Y$$$20240826$$PH$US$US
242508441$24250844$1$I$20240301$20240307$20240826$20240826$EXP$$US-BRACCO-2024US01203$BRACCO$$$$$$Y$$$20240826$$CN$US$US
242508451$24250845$1$I$20240222$20240307$20240826$20240826$EXP$$US-BRACCO-2024US01108$BRACCO$$$$$$Y$$$20240826$$PH$US$US
242508461$24250846$1$I$20240113$20240111$20240826$20240826$PER$$US-FERAPHARMA-2024-US-001744$FERA$$86$YR$$F$Y$53.98$KG$20240826$$PH$US$US
242508471$24250847$1$I$20240404$20240816$20240826$20240826$EXP$$ES-AstraZeneca-2024A193896$ASTRAZENECA$$19$YR$$F$Y$$$20240826$$MD$ES$
242508481$24250848$1$I$$20240822$20240826$20240826$EXP$$US-BIOMARINAP-US-2024-160081$BIOMARIN$$$$$$Y$$$20240826$$CN$US$US
242508491$24250849$1$I$$20240815$20240826$20240826$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-130093$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240826$$HP$IL$IL
242508501$24250850$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133636$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240826$$HP$US$US
242508512$24250851$2$F$20240305$20240307$20240826$20240826$EXP$$US-BRACCO-2024US01204$BRACCO$$$$$$Y$$$20240826$$CN$US$US
242508521$24250852$1$I$$20240820$20240826$20240826$EXP$$US-SANDOZ INC.-PHEH2019US019221$SANDOZ$$$$$F$Y$68.934$KG$20240826$$CN$US$US
242508531$24250853$1$I$20230711$20231114$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002499$AMERICAN REGENT$$14$YR$$F$Y$47.5$KG$20240826$$HP$US$US
242508541$24250854$1$I$20230101$20231019$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002462$AMERICAN REGENT$$24$YR$$F$Y$$$20240826$$HP$US$US
242508552$24250855$2$F$$20240920$20240826$20240925$EXP$$US-TAKEDA-2024TUS084018$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
242508561$24250856$1$I$20231012$20231013$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002425$AMERICAN REGENT$$$$$M$Y$$$20240826$$HP$US$US
242508571$24250857$1$I$20230901$20231026$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002500$AMERICAN REGENT$$$$$F$Y$$$20240826$$HP$US$US
242508581$24250858$1$I$$20231017$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002444$AMERICAN REGENT$$$$$$Y$$$20240826$$PH$US$US
242508591$24250859$1$I$20230101$20231013$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002431$AMERICAN REGENT$$$$$F$Y$$$20240826$$CN$US$US
242508601$24250860$1$I$20230101$20231017$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002435$AMERICAN REGENT$$$$A$F$Y$$$20240826$$PH$US$US
242508611$24250861$1$I$$20231030$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002516$AMERICAN REGENT$$$$$F$Y$$$20240826$$MD$US$US
242508621$24250862$1$I$20230101$20231017$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002445$AMERICAN REGENT$$$$$$Y$$$20240826$$PH$US$US
242508631$24250863$1$I$20230101$20231018$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002455$AMERICAN REGENT$$$$$F$Y$$$20240826$$HP$US$US
242508641$24250864$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234438$TEVA$$40$YR$$F$Y$$$20240826$$HP$CA$CA
242508651$24250865$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141921$DAIICHI$$51$YR$$F$Y$$$20240826$$HP$CA$CA
242508661$24250866$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141919$DAIICHI$$73$YR$$F$Y$$$20240826$$CN$CA$CA
242508671$24250867$1$I$20240701$20240801$20240826$20240826$PER$$US-Eisai-EC-2024-170482$EISAI$$89$YR$E$M$Y$73.03$KG$20240826$$HP$US$US
242508681$24250868$1$I$$20240816$20240826$20240826$PER$$US-MYLANLABS-2024M1077339$MYLAN$$73$YR$$F$Y$68.49$KG$20240826$$CN$US$US
242508691$24250869$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141922$DAIICHI$$$$$F$Y$$$20240826$$CN$CA$CA
242508702$24250870$2$F$$20240913$20240826$20240921$EXP$$GB-TEVA-VS-3236326$TEVA$Oporto Espuelas M, Burridge S, Bonney D, Watts K, Roddie C, O^Reilly MA, et al. Systematic Intention to Treat Analysis of Real-World Outcomes in Children and Young Adults Receiving Tisagenlecleucel: From Elegibility through Treatment Failure. Blood 2022; 140 (Suppl. 1) 2408-2410.; Oporto Espuelas M, Burridge S, Bonney D, Watts K, Roddie C, O^Reilly MA, et al. Systematic Intention to Treat Analysis of Real-World Outcomes in Children and Young Adults Receiving Tisagenlecleucel: From Elegibility...$$$$$Y$$$20240921$$HP$GB$GB
242508711$24250871$1$I$20240823$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135082$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$36$KG$20240826$$PH$US$US
242508722$24250872$2$F$$20240912$20240826$20240920$EXP$$US-TEVA-VS-3235704$TEVA$Barnes A, Restrepo VJ, Hansra B, Levenson J. Immune Checkpoint Inhibitor Use Leading to Fulminant Myocarditis with Cardiogenic Shock: A Case Series. US-Cardiol 2024; 18 (Suppl.) 4 (plus Poster) abstr. 12.; Barnes A, Restrepo VJ, Hansra B, Levenson J. Immune Checkpoint Inhibitor Use Leading to Fulminant Myocarditis with Cardiogenic Shock: A Case Series. US-Cardiol 2024; 18 (Suppl.) 4 (plus Poster) abstr. 12.$62$YR$$F$Y$$$20240920$$MD$US$US
242508731$24250873$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141932$DAIICHI$$$$$F$Y$$$20240826$$CN$CA$CA
242508741$24250874$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141918AA$DAIICHI$$81$YR$$F$Y$$$20240826$$CN$CA$CA
242508751$24250875$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141878AA$DAIICHI$$$$$F$Y$$$20240826$$CN$CA$CA
242508762$24250876$2$F$$20240912$20240826$20240921$EXP$$GB-TEVA-VS-3236048$TEVA$Orpin S, Patel B. An extensive follicular eruption in a transplant recipient. Br-J-Dermatol 2024; 191 (Suppl. 1) i152 abstr. BI30.; Orpin S, Patel B. An extensive follicular eruption in a transplant recipient. Br-J-Dermatol 2024; 191 (Suppl. 1) i152 abstr. BI30.$46$YR$$F$Y$$$20240921$$HP$GB$GB
242508772$24250877$2$F$$20240912$20240826$20240921$EXP$$US-TEVA-VS-3235619$TEVA$Alagha Z, Crow S, Abdeen AMZ, Alastal M, Alastal A. Cefepime Neurotoxicity in Patients With Normal Renal Function: An Overlooked Cause of Encephalopathy in the Intensive Care Unit. J-Investig-Med-High-Impact-Case-Rep 2024; 12 (0): 1-5.; Alagha Z, Crow S, Abdeen AMZ, Alastal M, Alastal A. Cefepime Neurotoxicity in Patients With Normal Renal Function: An Overlooked Cause of Encephalopathy in the Intensive Care Unit. J-Investig-Med-High-Impact-Case-Rep 2024; 12 (0): 1-5.$69$YR$$F$Y$$$20240921$$MD$US$US
242508782$24250878$2$F$$20240912$20240826$20240920$EXP$$US-TEVA-VS-3235621$TEVA$Ali ST, VanderWeele DJ. Prolonged Response to Osimertinib in EGFR-Mutated Metastatic Urothelial Carcinoma, a Case Report. Curr-Oncol 2024; 31 (7): 4015-4021.; Ali ST, VanderWeele DJ. Prolonged Response to Osimertinib in EGFR-Mutated Metastatic Urothelial Carcinoma, a Case Report. Curr-Oncol 2024; 31 (7): 4015-4021.; Ali ST, VanderWeele DJ. Prolonged Response to Osimertinib in EGFR-Mutated Metastatic Urothelial Carcinoma, a Case Report. Curr-Oncol 2024; 31 (7): 4015-4021.$48$YR$$F$Y$$$20240920$$HP$US$US
242508802$24250880$2$F$$20240823$20240826$20240826$PER$$US-JNJFOC-20240861017$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242508821$24250882$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234311$TEVA$$70$YR$$F$Y$$$20240826$$HP$CA$CA
242508841$24250884$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58594$$FDA-CTU$$75$YR$$F$N$$$20240826$N$$US$
242508851$24250885$1$I$20240703$20240825$20240825$20240825$DIR$715822$$FDA-CTU$$52$YR$$F$N$67.5$KG$20240825$N$CN$US$
242508871$24250887$1$I$20240620$20240825$20240825$20240825$DIR$715821$$FDA-CTU$$38$YR$$F$N$54$KG$20240825$N$CN$US$
242508881$24250888$1$I$20240701$20240825$20240825$20240825$DIR$715825$$FDA-CTU$$32$YR$$F$N$94.5$KG$20240825$N$CN$US$
242508891$24250889$1$I$20240825$20240825$20240825$20240825$DIR$715843$$FDA-CTU$$39$YR$$F$N$60.75$KG$20240825$N$CN$CA$
242508901$24250890$1$I$20240814$20240825$20240825$20240825$DIR$715838$$FDA-CTU$$82$YR$$F$N$63$KG$20240825$Y$CN$US$
242508911$24250891$1$I$20240824$20240825$20240825$20240825$DIR$715810$$FDA-CTU$$79$YR$$M$N$78.3$KG$20240825$N$CN$US$
242508931$24250893$1$I$20240410$20240825$20240825$20240825$DIR$715820$$FDA-CTU$$45$YR$$F$N$$$20240825$N$HP$US$
242508941$24250894$1$I$20240806$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58608$$FDA-CTU$$58$YR$$F$N$$$20240826$N$$US$
242508951$24250895$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133495$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$$$20240826$$CN$US$US
242508963$24250896$3$F$20240803$20240923$20240826$20240924$EXP$$IT-MYLANLABS-2024M1077116$MYLAN$$80$YR$$F$Y$$$20240924$$MD$IT$IT
242508971$24250897$1$I$$20240823$20240826$20240826$EXP$$IT-ABBVIE-5893036$ABBVIE$$71$YR$$M$Y$$$20240826$$CN$IT$IT
242508991$24250899$1$I$20230101$20231115$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002674$AMERICAN REGENT$$$$$F$Y$$$20240826$$HP$US$US
242509001$24250900$1$I$$20231109$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002633$AMERICAN REGENT$$5$DEC$$F$Y$$$20240826$$HP$US$US
242509011$24250901$1$I$$20240819$20240826$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013173$JAZZ$$$$$M$Y$$$20240826$$HP$US$US
242509021$24250902$1$I$$20240819$20240826$20240826$EXP$$US-TEVA-VS-3235705$TEVA$Barnes A, Restrepo VJ, Hansra B, Levenson J. Immune Checkpoint Inhibitor Use Leading to Fulminant Myocarditis with Cardiogenic Shock: A Case Series. US-Cardiol 2024; 18 (Suppl.) 4 (plus Poster) abstr. 12.$72$YR$$F$Y$$$20240826$$MD$US$US
242509031$24250903$1$I$$20240823$20240826$20240826$PER$$US-BIOMARINAP-US-2024-160082$BIOMARIN$$$$$$Y$$$20240826$$CN$US$US
242509041$24250904$1$I$$20240820$20240826$20240826$PER$$US-BIOMARINAP-US-2024-160047$BIOMARIN$$$$$$Y$$$20240826$$CN$US$US
242509051$24250905$1$I$20240821$20240821$20240826$20240826$PER$$US-BIOMARINAP-US-2024-160035$BIOMARIN$$$$$$Y$$$20240826$$CN$US$US
242509061$24250906$1$I$20240817$20240822$20240826$20240826$PER$$US-PFIZER INC-202400242487$PFIZER$$80$YR$$M$Y$$$20240826$$CN$US$US
242509082$24250908$2$F$20240816$20240820$20240826$20240827$PER$$US-PFIZER INC-202400240565$PFIZER$$85$YR$$F$Y$$$20240827$$HP$US$US
242509091$24250909$1$I$$20240822$20240826$20240826$PER$$US-PFIZER INC-PV202400110082$PFIZER$$69$YR$$F$Y$$$20240826$$HP$US$US
242509101$24250910$1$I$$20240823$20240826$20240826$PER$$US-PFIZER INC-202400243238$PFIZER$$42$YR$$F$Y$$$20240826$$CN$US$US
242509112$24250911$2$F$20240821$20240918$20240826$20240919$PER$$US-PFIZER INC-202400242423$PFIZER$$57$YR$$F$Y$78.9$KG$20240919$$CN$US$US
242509121$24250912$1$I$$20240821$20240826$20240826$PER$$US-PFIZER INC-202400242240$PFIZER$$$$$F$Y$77$KG$20240826$$CN$US$US
242509131$24250913$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234390$TEVA$$68$YR$$F$Y$$$20240826$$HP$CA$CA
242509141$24250914$1$I$20240815$20240821$20240826$20240826$PER$$US-PFIZER INC-202400241264$PFIZER$$$$$M$Y$$$20240826$$MD$US$US
242509151$24250915$1$I$20240801$20240822$20240826$20240826$PER$$US-PFIZER INC-202400243007$PFIZER$$87$YR$$M$Y$$$20240826$$HP$US$US
242509161$24250916$1$I$20240823$20240823$20240826$20240826$PER$$US-PFIZER INC-202400243136$PFIZER$$33$YR$$M$Y$$$20240826$$CN$US$US
242509172$24250917$2$F$20240101$20240826$20240826$20240828$PER$$US-PFIZER INC-202400241862$PFIZER$$56$YR$$M$Y$$$20240828$$CN$US$US
242509182$24250918$2$F$$20240827$20240826$20240828$PER$$US-PFIZER INC-202400242370$PFIZER$$80$YR$$F$Y$$$20240828$$CN$US$US
242509191$24250919$1$I$$20240820$20240826$20240826$PER$$US-PFIZER INC-202400241454$PFIZER$$$$$$Y$$$20240826$$CN$US$US
242509201$24250920$1$I$20231019$20240801$20240826$20240826$PER$$US-Eisai-EC-2024-171405$EISAI$$78$YR$E$M$Y$$$20240826$$CN$US$US
242509211$24250921$1$I$20240531$20240820$20240826$20240826$EXP$FR-AFSSAPS-PP2024000897$FR-MYLANLABS-2024M1077251$MYLAN$$81$YR$$F$Y$$$20240826$$MD$FR$FR
242509221$24250922$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA117704$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240826$$MD$US$US
242509232$24250923$2$F$20240101$20240905$20240826$20240913$PER$$US-SA-2024SA249006$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240913$$MD$US$US
242509241$24250924$1$I$$20240814$20240826$20240826$PER$$US-BAYER-2024A118202$BAYER$$$$$$Y$$$20240826$$HP$US$US
242509251$24250925$1$I$20240101$20240816$20240826$20240826$PER$$US-TEVA-VS-3235827$TEVA$$$$$F$Y$$$20240826$$CN$US$US
242509261$24250926$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135339$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240826$$CN$US$US
242509271$24250927$1$I$$20240821$20240826$20240826$PER$$US-ABBVIE-5894024$ABBVIE$$27$YR$$F$Y$$$20240826$$MD$US$US
242509281$24250928$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234309$TEVA$$19$YR$$F$Y$$$20240826$$CN$CA$CA
242509291$24250929$1$I$$20240814$20240826$20240826$PER$$US-INCYTE CORPORATION-2024IN008577$INCYTE$$$$$$Y$$$20240826$$CN$US$US
242509301$24250930$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015033$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240826$$CN$US$US
242509311$24250931$1$I$$20240822$20240826$20240826$PER$$US-PFIZER INC-PV202400110101$PFIZER$$56$YR$$F$Y$$$20240826$$HP$US$US
242509321$24250932$1$I$$20240814$20240826$20240826$EXP$GB-MHRA-MED-202408140808489760-FHLYB$GB-ELI_LILLY_AND_COMPANY-GB202408009517$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240826$$CN$GB$GB
242509332$24250933$2$F$$20240826$20240826$20240830$PER$$US-ALXN-202408USA001557US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242509341$24250934$1$I$20240820$20240820$20240826$20240826$PER$$US-MYLANLABS-2024M1077546$MYLAN$$90$YR$$F$Y$$$20240826$$HP$US$US
242509352$24250935$2$F$$20240918$20240826$20240923$EXP$$US-TAKEDA-2024TUS083939$TAKEDA$$$$$F$Y$$$20240923$$CN$US$US
242509361$24250936$1$I$$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132703$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240826$$CN$US$US
242509371$24250937$1$I$$20240820$20240826$20240826$PER$$US-BIOMARINAP-US-2024-160018$BIOMARIN$$$$$$Y$$$20240826$$CN$US$US
242509382$24250938$2$F$20240727$20240923$20240826$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131420$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$91.63$KG$20240930$$PH$US$US
242509391$24250939$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234304$TEVA$$23$YR$$F$Y$$$20240826$$HP$CA$CA
242509401$24250940$1$I$20240801$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58565$$FDA-CTU$$64$YR$$M$N$$$20240826$Y$HP$US$
242509411$24250941$1$I$$20240124$20240826$20240826$EXP$$CA-MYLANLABS-2024M1077560$MYLAN$$40$YR$$F$Y$$$20240826$$HP$CA$CA
242509421$24250942$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58658$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242509431$24250943$1$I$20240515$20240825$20240825$20240825$DIR$715839$$FDA-CTU$$22$YR$$F$N$54$KG$20240825$N$CN$US$
242509441$24250944$1$I$20240703$20240825$20240825$20240825$DIR$715792$$FDA-CTU$$80$YR$$M$N$119.7$KG$20240825$N$CN$US$
242509451$24250945$1$I$$20240821$20240826$20240826$EXP$$JP-BAYER-2024A120571$BAYER$$63$YR$A$M$Y$$$20240826$$MD$JP$JP
242509461$24250946$1$I$20200610$20240814$20240826$20240826$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2020000003$IOVANCE BIOTHERAPEUTICS$$68$YR$$M$Y$89.8$KG$20240823$$MD$US$US
242509472$24250947$2$F$$20240827$20240826$20240905$EXP$$CA-TEVA-VS-3234386$TEVA$$12$MON$$M$Y$$$20240905$$HP$CA$CA
242509481$24250948$1$I$20240528$20240717$20240826$20240826$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000025$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240823$$CN$US$US
242509491$24250949$1$I$$20240822$20240826$20240826$PER$$US-MYLANLABS-2024M1078434$MYLAN$$79$YR$$F$Y$$$20240826$$MD$US$US
242509512$24250951$2$F$20240701$20240906$20240826$20240911$EXP$$NVSC2024CZ171333$NOVARTIS$$62$YR$$F$Y$$$20240911$$MD$CZ$CZ
242509521$24250952$1$I$$20240819$20240826$20240826$EXP$$CA-TEVA-VS-3234324$TEVA$$55$YR$$F$Y$$$20240826$$HP$CA$CA
242509531$24250953$1$I$$20240821$20240826$20240826$EXP$$JP-BAYER-2024A120573$BAYER$$69$YR$E$M$Y$$$20240826$$MD$JP$JP
242509541$24250954$1$I$$20240821$20240826$20240826$EXP$$JP-BAYER-2024A120576$BAYER$$56$YR$A$M$Y$$$20240826$$MD$JP$JP
242509551$24250955$1$I$$20240821$20240826$20240826$EXP$$JP-BAYER-2024A120577$BAYER$$75$YR$E$M$Y$$$20240826$$MD$JP$JP
242509562$24250956$2$F$$20240904$20240826$20240912$EXP$$US-AstraZeneca-2024A189040$ASTRAZENECA$$5$YR$$M$Y$$$20240912$$CN$US$
242509581$24250958$1$I$$20240819$20240826$20240826$EXP$$JP-ALXN-202408JPN001097JP$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240826$$MD$JP$JP
242509591$24250959$1$I$20240601$20240821$20240826$20240826$EXP$$US-VERTEX PHARMACEUTICALS-2024-011309$VERTEX$$19$YR$$F$Y$85$KG$20240826$$HP$US$US
242509602$24250960$2$F$$20240924$20240826$20240927$PER$$US-VERTEX PHARMACEUTICALS-2024-013432$VERTEX$$$$$$Y$$$20240927$$CN$US$US
242509611$24250961$1$I$20240723$20240819$20240826$20240826$EXP$$FR-TAKEDA-2024TUS084661$TAKEDA$$50$YR$$F$Y$$$20240826$$CN$FR$FR
242509631$24250963$1$I$20220101$20240820$20240826$20240826$EXP$$CA-TAKEDA-2022TUS093237$TAKEDA$$$$$F$Y$$$20240826$$MD$CA$CA
242509641$24250964$1$I$20230101$20231206$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002845$AMERICAN REGENT$$5$DEC$$$Y$$$20240826$$HP$US$US
242509651$24250965$1$I$20230101$20231206$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002841$AMERICAN REGENT$$$$$M$Y$$$20240826$$MD$US$US
242509661$24250966$1$I$20230101$20231206$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002844$AMERICAN REGENT$$5$DEC$$$Y$$$20240826$$HP$US$US
242509671$24250967$1$I$20230101$20231206$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002843$AMERICAN REGENT$$5$DEC$$$Y$$$20240826$$HP$US$US
242509681$24250968$1$I$$20231201$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002809$AMERICAN REGENT$$$$$$Y$$$20240826$$HP$US$US
242509691$24250969$1$I$$20231121$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002723$AMERICAN REGENT$$$$$F$Y$$$20240826$$HP$COUNTRY NOT SPECIFIED$US
242509701$24250970$1$I$20230101$20231206$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002846$AMERICAN REGENT$$5$DEC$$$Y$$$20240826$$HP$US$US
242509711$24250971$1$I$20181101$20231117$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002691$AMERICAN REGENT$$$$A$F$Y$$$20240826$$CN$US$US
242509721$24250972$1$I$$20231205$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002838$AMERICAN REGENT$$4$DEC$$F$Y$$$20240826$$HP$US$US
242509731$24250973$1$I$20240101$20240730$20240826$20240826$PER$$US-Eisai-EC-2024-171385$EISAI$$78$YR$E$M$Y$$$20240826$$MD$US$US
242509751$24250975$1$I$20240601$20240825$20240825$20240825$DIR$715801$$FDA-CTU$$78$YR$$F$N$65.25$KG$20240825$N$CN$US$
242509761$24250976$1$I$20240824$20240825$20240825$20240825$DIR$715845$$FDA-CTU$$45$YR$$F$N$84.6$KG$20240825$N$CN$US$
242509771$24250977$1$I$20240818$20240825$20240825$20240825$DIR$715806$$FDA-CTU$$53$YR$$F$N$75.15$KG$20240825$N$CN$US$
242509781$24250978$1$I$$20240824$20240826$20240826$DIR$FDA-CDER-CTU-2024-58653$$FDA-CTU$$$$$F$N$$$20240824$N$HP$US$
242509791$24250979$1$I$20240526$20240825$20240825$20240825$DIR$715842$$FDA-CTU$$35$YR$$F$N$$$20240825$N$CN$US$
242509801$24250980$1$I$20240806$20240825$20240825$20240825$DIR$715804$$FDA-CTU$$20$YR$$F$N$75.6$KG$20240825$N$CN$US$
242509821$24250982$1$I$20240825$20240825$20240825$20240825$DIR$715828$$FDA-CTU$$77$YR$$M$N$128.9$KG$20240825$N$HP$US$
242509831$24250983$1$I$20240802$20240825$20240825$20240825$DIR$715837$$FDA-CTU$$42$YR$$F$N$81.9$KG$20240825$N$CN$US$
242509841$24250984$1$I$20240815$20240825$20240825$20240825$DIR$715805$$FDA-CTU$$37$YR$$UNK$N$94.95$KG$20240825$N$CN$US$
242509851$24250985$1$I$20240824$20240825$20240825$20240825$DIR$715807$$FDA-CTU$$61$YR$$F$N$54$KG$20240825$N$CN$US$
242509861$24250986$1$I$20240610$20240825$20240825$20240825$DIR$715813$$FDA-CTU$$30$YR$$F$N$60.75$KG$20240825$N$CN$US$
242509881$24250988$1$I$20240201$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58655$$FDA-CTU$$55$YR$$M$N$$$20240826$N$$US$
242509901$24250990$1$I$20240801$20240821$20240826$20240826$EXP$$US-ABBVIE-5889496$ABBVIE$$85$YR$$F$Y$$$20240826$$CN$US$US
242509911$24250991$1$I$$20231211$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002880$AMERICAN REGENT$$$$$F$Y$$$20240826$$MD$US$US
242509922$24250992$2$F$20240101$20240913$20240826$20240920$PER$$US-ALKERMES INC.-ALK-2024-002196$ALKERMES$$$$$F$Y$$$20240920$$HP$US$US
242509931$24250993$1$I$20230101$20231206$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002847$AMERICAN REGENT$$5$DEC$$$Y$$$20240826$$HP$US$US
242509941$24250994$1$I$20231201$20231212$20240826$20240826$PER$$US-AMERICAN REGENT INC-2023002886$AMERICAN REGENT$$$$$F$Y$$$20240826$$HP$US$US
242509951$24250995$1$I$$20240820$20240826$20240826$EXP$$FR-MYLANLABS-2024M1077459$MYLAN$Hagenkotter B, Zayet S, Poloni S, Gendrin V, Zanusso M, Stancescu S, et al. Posterior reversible encephalopathy syndrome in early lyme neuroborreliosis. Ticks and Tick-borne Diseases. 2024;15(6):1-4$69$YR$$M$Y$$$20240826$$HP$FR$FR
242509962$24250996$2$F$20240601$20240917$20240826$20240927$PER$$US-ALKERMES INC.-ALK-2024-002173$ALKERMES$$49$YR$$M$Y$97.415$KG$20240927$$MD$US$US
242509971$24250997$1$I$$20240820$20240826$20240826$EXP$$FR-MYLANLABS-2024M1077505$MYLAN$$78$YR$$F$Y$$$20240826$$PH$FR$FR
242509981$24250998$1$I$20240821$20240821$20240826$20240826$EXP$$CA-BAYER-2024A120751$BAYER$$$$$M$Y$$$20240826$$MD$CA$CA
242509992$24250999$2$F$20240822$20240910$20240826$20240919$PER$$US-JNJFOC-20240858399$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240920$$HP$US$US
242510001$24251000$1$I$$20240819$20240826$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134560$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240826$$MD$JP$JP
242510011$24251001$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014425$ELI LILLY AND CO$$$$$M$Y$$$20240826$$CN$US$US
242510023$24251002$3$F$$20240822$20240826$20240830$30DAY$$US-JNJFOC-20240858559$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240830$$HP$US$US
242510031$24251003$1$I$20240101$20240821$20240826$20240826$EXP$$US-ABBVIE-5891717$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242510041$24251004$1$I$$20240814$20240826$20240826$PER$$US-ALKERMES INC.-ALK-2024-002144$ALKERMES$$3$DEC$$M$Y$$$20240826$$HP$US$US
242510052$24251005$2$F$$20240827$20240826$20240829$PER$$US-ABBVIE-5892003$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242510061$24251006$1$I$$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167822$AMGEN$$45$YR$A$F$Y$$$20240826$$PH$US$US
242510071$24251007$1$I$$20240812$20240826$20240826$PER$$US-009507513-2408USA004702$MERCK$$$$$M$Y$$$20240826$$MD$US$US
242510081$24251008$1$I$20240101$20240821$20240826$20240826$PER$$US-ABBVIE-5891877$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242510091$24251009$1$I$20240101$20240620$20240826$20240826$PER$$US-Eisai-EC-2024-158167$EISAI$$2$YR$C$M$Y$$$20240826$$CN$US$US
242510101$24251010$1$I$$20240823$20240826$20240826$EXP$$CA-SANDOZ INC.-SDZ2024CA075063$SANDOZ$$70$YR$$F$Y$$$20240826$$HP$CA$CA
242510112$24251011$2$F$$20240904$20240826$20240909$PER$$US-ABBVIE-5892598$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242510122$24251012$2$F$20240830$20240902$20240826$20240917$PER$$US-SA-2024SA247151$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240918$$MD$US$US
242510131$24251013$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA246983$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240826$$CN$US$US
242510152$24251015$2$F$20240808$20240906$20240826$20240912$EXP$$US-ABBVIE-5892565$ABBVIE$$44$YR$$M$Y$$$20240912$$CN$US$US
242510161$24251016$1$I$$20240816$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130623$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240826$$HP$US$US
242510181$24251018$1$I$20240601$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58589$$FDA-CTU$$71$YR$$F$N$$$20240826$N$$US$
242510201$24251020$1$I$20240515$20240825$20240825$20240825$DIR$715802$$FDA-CTU$$38$YR$$F$N$74.7$KG$20240825$N$CN$US$
242510221$24251022$1$I$20240824$20240825$20240825$20240825$DIR$715798$$FDA-CTU$$64$YR$$F$N$80.1$KG$20240825$N$CN$US$
242510241$24251024$1$I$20240620$20240825$20240825$20240825$DIR$715811$$FDA-CTU$$68$YR$$M$N$94.5$KG$20240825$N$CN$US$
242510271$24251027$1$I$20240710$20240821$20240826$20240826$EXP$$US-ABBVIE-5892783$ABBVIE$$84$YR$$F$Y$$$20240826$$CN$US$US
242510281$24251028$1$I$$20240821$20240826$20240826$PER$$US-ABBVIE-5892462$ABBVIE$$$$$$Y$$$20240826$$HP$US$US
242510291$24251029$1$I$$20240819$20240826$20240826$EXP$$US-MYLANLABS-2024M1078131$MYLAN$Kim EB, Malespini J, Lei M, Branagan AR, Cirstea D, Han SS, et al. Rapid reduction of free light chains and improvement in renal outcomes in patients with newly diagnosed multiple myeloma admitted with acute kidney injury with daratumumab-based therapy and without plasmapheresis. J-Clin-Oncol 2024; 42 (Suppl.) (16):.$86$YR$$$Y$$$20240826$$HP$US$US
242510301$24251030$1$I$$20240821$20240826$20240826$PER$$US-ABBVIE-5892556$ABBVIE$$$$$$Y$$$20240826$$CN$US$US
242510311$24251031$1$I$$20240821$20240826$20240826$PER$$US-ABBVIE-5892189$ABBVIE$$$$$$Y$$$20240826$$HP$US$US
242510321$24251032$1$I$20240701$20240815$20240826$20240826$PER$$US-SA-2024SA246915$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240826$$MD$US$US
242510331$24251033$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134987$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240826$$CN$US$US
242510341$24251034$1$I$20240101$20240821$20240826$20240826$EXP$$US-ABBVIE-5873827$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242510351$24251035$1$I$20240801$20240816$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131090$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$116.57$KG$20240826$$CN$US$US
242510361$24251036$1$I$$20240821$20240826$20240826$PER$$US-ABBVIE-5891612$ABBVIE$$$$$$Y$$$20240826$$HP$US$US
242510371$24251037$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135055$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240826$$PH$US$PR
242510381$24251038$1$I$20240101$20240822$20240826$20240826$EXP$$US-ABBVIE-5893142$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242510401$24251040$1$I$20240101$20240822$20240826$20240826$EXP$$US-ABBVIE-5892957$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242510412$24251041$2$F$20240523$20240911$20240826$20240920$EXP$$IE-BLUEPRINT MEDICINES CORPORATION-2024BUS004491$BLUEPRINT MEDICINES$$$$$$Y$$$20240918$$PH$IE$IE
242510421$24251042$1$I$$20240822$20240826$20240826$EXP$$GB-MYLANLABS-2024M1078211$MYLAN$$$$$F$Y$$$20240826$$PH$GB$GB
242510431$24251043$1$I$20240718$20240822$20240826$20240826$EXP$$SG-MYLANLABS-2024M1077953$MYLAN$$59$YR$$F$Y$$$20240826$$HP$SG$SG
242510441$24251044$1$I$$20240821$20240826$20240826$PER$$PR-ABBVIE-5891573$ABBVIE$$$$A$M$Y$$$20240826$$CN$PR$PR
242510451$24251045$1$I$$20240820$20240826$20240826$30DAY$$US-SANDOZ INC.-SDZ2024US074479$SANDOZ$$$$$F$Y$$$20240826$$CN$US$US
242510461$24251046$1$I$20240822$20240822$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134125$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240826$$HP$US$US
242510471$24251047$1$I$$20240816$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131403$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240826$$CN$US$US
242510482$24251048$2$F$20240819$20240819$20240826$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131473$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240902$$CN$US$US
242510492$24251049$2$F$20240713$20240830$20240826$20240905$EXP$$IT-TAKEDA-2024TUS054839$TAKEDA$$$$$$Y$$$20240905$$CN$IT$IT
242510501$24251050$1$I$20240801$20240814$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009732$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240826$$CN$US$US
242510511$24251051$1$I$$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015358$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240826$$CN$US$US
242510521$24251052$1$I$20240622$20240821$20240826$20240826$EXP$$DE-BIOMARINAP-DE-2024-160050$BIOMARIN$$$$$$Y$$$20240826$$CN$DE$DE
242510561$24251056$1$I$$20240627$20240826$20240826$EXP$$NVSC2024CN171173$NOVARTIS$$$$$$Y$$$20240826$$CN$CN$CN
242510571$24251057$1$I$20240816$20240821$20240826$20240826$PER$$US-PHARMING-PHAUS2024000727$PHARMING GROUP$$$$$$Y$$$20240826$$CN$US$US
242510581$24251058$1$I$$20240819$20240826$20240826$PER$$US-PHARMING-PHAUS2024000714$PHARMING GROUP$$$$$$Y$$$20240826$$CN$US$US
242510591$24251059$1$I$$20240819$20240826$20240826$PER$$US-PHARMING-PHAUS2024000721$PHARMING GROUP$$$$$$Y$$$20240826$$CN$US$US
242510621$24251062$1$I$$20240822$20240826$20240826$EXP$$US-ABBVIE-5892521$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242510631$24251063$1$I$20240801$20240820$20240826$20240826$EXP$$US-Eisai-EC-2024-172563$EISAI$$73$YR$E$F$Y$$$20240826$$CN$US$US
242510641$24251064$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246826$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240826$$MD$US$US
242510652$24251065$2$F$$20240912$20240826$20240920$PER$$US-SA-2024SA246934$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240920$$CN$US$US
242510661$24251066$1$I$$20240816$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130237$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240826$$CN$US$US
242510671$24251067$1$I$20240811$20240816$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131086$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240826$$CN$US$US
242510681$24251068$1$I$$20240822$20240826$20240826$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-134889$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240826$$PH$CA$CA
242510691$24251069$1$I$20240801$20240822$20240826$20240826$EXP$$US-ABBVIE-5892235$ABBVIE$$62$YR$$F$Y$$$20240826$$CN$US$US
242510711$24251071$1$I$$20240725$20240826$20240826$DIR$FDA-CDER-CTU-2024-58633$$FDA-CTU$$$$$$N$$$20240725$N$HP$US$
242510721$24251072$1$I$$20240823$20240826$20240826$EXP$$US-INCYTE CORPORATION-2024IN008884$INCYTE$$$$$$Y$$$20240826$$CN$US$US
242510731$24251073$1$I$20231201$20240822$20240826$20240826$EXP$$US-ABBVIE-5893141$ABBVIE$$61$YR$$F$Y$$$20240826$$CN$US$US
242510741$24251074$1$I$20240801$20240819$20240826$20240826$EXP$$NVSC2024BR171489$NOVARTIS$$$$$F$Y$$$20240826$$MD$BR$BR
242510761$24251076$1$I$$20240819$20240826$20240826$30DAY$$CA-SANDOZ INC.-SDZ2024CA073852$SANDOZ$$$$$F$Y$$$20240826$$CN$CA$CA
242510771$24251077$1$I$20240801$20240821$20240826$20240826$EXP$$US-KYOWAKIRIN-2024KK019860$KYOWA$$$$$$Y$$$20240826$$HP$US$US
242510781$24251078$1$I$$20240822$20240826$20240826$EXP$$GR-ABBVIE-5479841$ABBVIE$$$$$M$Y$$$20240826$$CN$GR$GR
242510801$24251080$1$I$$20240821$20240826$20240826$EXP$$CA-MYLANLABS-2024M1078042$MYLAN$$62$YR$$M$Y$114$KG$20240826$$HP$CA$CA
242510811$24251081$1$I$$20240821$20240826$20240826$EXP$$IR-MYLANLABS-2024M1078729$MYLAN$Ebrahimi P, Nazari R, Senobari N, Mousavinezhad SM, Ghadimi DJ, Soleimani H. Kounis syndrome type I induced by an intramuscular injection of diclofenac: A literature review based on a case report. Clin-Case-Rep 2024; 12 (7):.$51$YR$$M$Y$$$20240826$$HP$IR$IR
242510823$24251082$3$F$$20240911$20240826$20240917$EXP$$US-ABBVIE-5889340$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
242510832$24251083$2$F$$20240821$20240826$20240911$EXP$$US-MYLANLABS-2024M1076717$MYLAN$$27$YR$$M$Y$45.36$KG$20240911$$CN$US$US
242510841$24251084$1$I$20240601$20240819$20240826$20240826$EXP$GB-MHRA-MED-202408121653247800-JHVNP$GB-TEVA-VS-3235367$TEVA$$70$YR$$M$Y$$$20240826$$PH$GB$GB
242510852$24251085$2$F$20240110$20240918$20240826$20240924$EXP$FR-AFSSAPS-PO2024000870$FR-MYLANLABS-2024M1077612$MYLAN$$1$DY$$M$Y$3.415$KG$20240924$$HP$FR$FR
242510861$24251086$1$I$20230101$20240819$20240826$20240826$EXP$$US-Eisai-EC-2024-172455$EISAI$$69$YR$E$M$Y$$$20240826$$MD$US$US
242510873$24251087$3$F$20240701$20240905$20240826$20240909$EXP$$JP-Eisai-EC-2024-172618$EISAI$$$$$$Y$$$20240909$$MD$JP$JP
242510881$24251088$1$I$20240701$20240822$20240826$20240826$EXP$$US-Eisai-EC-2024-172733$EISAI$$71$YR$E$M$Y$$$20240826$$MD$US$US
242510891$24251089$1$I$20240719$20240819$20240826$20240826$PER$$CN-Eisai-EC-2024-172699$EISAI$$49$YR$A$F$Y$54$KG$20240826$$HP$CN$CN
242510901$24251090$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246606$SANOFI AVENTIS$$$$A$M$Y$$$20240826$$MD$US$US
242510911$24251091$1$I$$20240822$20240826$20240826$EXP$$US-SANDOZ INC.-SDZ2024US034667$SANDOZ$$$$$M$Y$$$20240826$$CN$US$US
242510921$24251092$1$I$$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135367$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240826$$HP$US$US
242510931$24251093$1$I$$20240823$20240826$20240826$EXP$$AU-MYLANLABS-2024M1078573$MYLAN$$$$$M$Y$$$20240826$$PH$AU$AU
242510941$24251094$1$I$$20240823$20240826$20240826$EXP$$AU-MYLANLABS-2024M1078660$MYLAN$$$$$M$Y$$$20240826$$CN$AU$AU
242510951$24251095$1$I$$20240821$20240826$20240826$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014105$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240826$$MD$US$US
242510961$24251096$1$I$$20240814$20240826$20240826$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408010186$ELI LILLY AND CO$$$$$$Y$$$20240826$$MD$CN$CN
242510971$24251097$1$I$$20240816$20240826$20240826$EXP$$AT-ELI_LILLY_AND_COMPANY-AT202408011848$ELI LILLY AND CO$$$$$F$Y$$$20240826$$MD$AT$AT
242510981$24251098$1$I$20240823$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015371$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240826$$CN$US$US
242510991$24251099$1$I$$20240813$20240826$20240826$PER$$US-Calliditas-2024CAL01574$CALLIDITAS THERAPEUTICS$$63$YR$A$M$Y$$$20240826$$CN$US$US
242511002$24251100$2$F$20240712$20240830$20240826$20240911$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408004512$ELI LILLY AND CO$$$$$M$Y$93$KG$20240911$$CN$FR$FR
242511011$24251101$1$I$$20240820$20240826$20240826$EXP$$JP-009507513-2408JPN002468J$MERCK$$78$YR$$M$Y$$$20240826$$MD$JP$JP
242511021$24251102$1$I$20240801$20240816$20240826$20240826$PER$$US-SA-2024SA247008$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240826$$CN$US$US
242511031$24251103$1$I$$20240821$20240826$20240826$EXP$$US-PFIZER INC-PV202400095020$PFIZER$$70$YR$$F$Y$$$20240826$$HP$US$US
242511042$24251104$2$F$20240701$20240924$20240826$20240927$EXP$$GB-MYLANLABS-2024M1078522$MYLAN$$70$YR$$M$Y$$$20240927$$MD$GB$GB
242511062$24251106$2$F$$20240912$20240826$20240920$EXP$$US-TEVA-VS-3235670$TEVA$Friedman R, Joshi S. PROPHYLACTIC TXA FOR A PATIENT WITH LATE-ONSET HAE-PLG. Ann-Allergy-Asthma-Immunol 2023; 131 (Suppl.) (5): S125 abstr. M121.; Friedman R, Joshi S. PROPHYLACTIC TXA FOR A PATIENT WITH LATE-ONSET HAE-PLG. Ann-Allergy-Asthma-Immunol 2023; 131 (Suppl.) (5): S125 abstr. M121.$66$YR$$M$Y$$$20240920$$HP$US$US
242511071$24251107$1$I$20240731$20240820$20240826$20240826$EXP$$US-ABBVIE-5887580$ABBVIE$$43$YR$$M$Y$$$20240826$$CN$US$US
242511082$24251108$2$F$20240301$20240829$20240826$20240906$EXP$$DE-AstraZeneca-2024A153842$ASTRAZENECA$$66$YR$$M$Y$77$KG$20240906$$MD$DE$
242511091$24251109$1$I$20240101$20240822$20240826$20240826$EXP$$US-KYOWAKIRIN-2024KK019870$KYOWA$$$$$$Y$$$20240826$$CN$US$US
242511101$24251110$1$I$20240818$20240822$20240826$20240826$EXP$$US-ABBVIE-5891758$ABBVIE$$18$YR$$F$Y$$$20240826$$CN$US$US
242511111$24251111$1$I$$20240822$20240826$20240826$30DAY$$US-SANDOZ INC.-SDZ2024US061249$SANDOZ$$$$$$Y$$$20240826$$CN$US$US
242511123$24251112$3$F$20230601$20240827$20240826$20240905$EXP$$JP-009507513-2307JPN003088J$MERCK$Okamoto M, Furukawa M, Ikeda S, Funaishi S. EP-1117 Two cases of pituitary-adrenal insufficiency caused by perioperative pembrolizumab therapy. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 457$5$DEC$$F$Y$$$20240905$$MD$JP$JP
242511131$24251113$1$I$$20240814$20240826$20240826$PER$$US-ALKERMES INC.-ALK-2024-002150$ALKERMES$$$$$$Y$$$20240826$$HP$US$US
242511141$24251114$1$I$$20240823$20240826$20240826$EXP$$IT-SANDOZ INC.-SDZ2024IT074839$SANDOZ$$27$YR$$M$Y$$$20240826$$HP$IT$IT
242511171$24251117$1$I$$20240723$20240826$20240826$DIR$FDA-CDER-CTU-2024-58631$$FDA-CTU$$$$$$N$$$20240723$N$HP$US$
242511201$24251120$1$I$$20240730$20240826$20240826$DIR$FDA-CDER-CTU-2024-58643$$FDA-CTU$$$$$$N$$$20240730$N$PH$US$
242511211$24251121$1$I$$20240819$20240826$20240826$EXP$$US-APELLIS-2024-APL-0000784$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240826$$HP$US$US
242511221$24251122$1$I$$20240820$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131999$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240826$$HP$US$US
242511232$24251123$2$F$20240701$20240820$20240826$20240903$PER$$US-ALKERMES INC.-ALK-2024-002158$ALKERMES$$54$YR$$F$Y$$$20240903$$PH$US$US
242511241$24251124$1$I$20240213$20240821$20240826$20240826$EXP$$JP-009507513-2408JPN002506J$MERCK$$56$YR$$M$Y$79$KG$20240826$$PH$JP$JP
242511251$24251125$1$I$$20240819$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131996$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$77.11$KG$20240826$$CN$US$US
242511262$24251126$2$F$20240519$20240820$20240826$20240830$EXP$PT-INFARMED-R202408-359$PT-ELI_LILLY_AND_COMPANY-PT202408008884$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240830$$CN$PT$PT
242511271$24251127$1$I$$20240821$20240826$20240826$EXP$$CA-SANDOZ INC.-SDZ2024CA074563$SANDOZ$$35$YR$$F$Y$$$20240826$$HP$CA$CA
242511291$24251129$1$I$$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A193995$ASTRAZENECA$Mundluru J, Ingawale S, Dhanjal K, Torka P, Dhanjal S.. BTK Inhibitors: A Double-Edged Sword in Richter^s Transformation to Plasmablastic Lymphoma Case Report. 2024 Annual Meeting of the Society of Hematologic Oncology (SOHO) 2024;$57$YR$$M$Y$$$20240826$$MD$US$
242511301$24251130$1$I$$20240816$20240826$20240826$PER$$US-ALKERMES INC.-ALK-2024-002198$ALKERMES$$$$$M$Y$$$20240826$$CN$US$US
242511321$24251132$1$I$20240819$20240820$20240826$20240826$EXP$$US-BAUSCH-BL-2024-012725$BAUSCH AND LOMB$$53$YR$$M$Y$70.37$KG$20240826$$CN$US$US
242511331$24251133$1$I$20240101$20240816$20240826$20240826$PER$$US-ALKERMES INC.-ALK-2024-002193$ALKERMES$$$$$F$Y$$$20240826$$CN$US$US
242511341$24251134$1$I$$20240825$20240826$20240826$PER$$NVSC2024US172292$NOVARTIS$$$$$$Y$$$20240826$$CN$US$US
242511351$24251135$1$I$$20240823$20240826$20240826$PER$$US-PURDUE PHARMA-USA-2024-0311569$PURDUE$$$$$M$Y$$$20240826$$CN$US$US
242511361$24251136$1$I$$20240823$20240826$20240826$PER$$US-PURDUE PHARMA-USA-2024-0311571$PURDUE$$34$YR$$F$Y$$$20240826$$CN$US$US
242511371$24251137$1$I$20240101$20240809$20240826$20240826$PER$$US-009507513-2408USA003630$MERCK$$$$$F$Y$$$20240826$$CN$US$US
242511381$24251138$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA246709$SANOFI AVENTIS$$45$YR$A$M$Y$90.71$KG$20240826$$MD$US$US
242511391$24251139$1$I$$20240820$20240826$20240826$PER$$US-SA-2024SA249123$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240826$$MD$US$US
242511401$24251140$1$I$$20240823$20240826$20240826$EXP$$US-KYOWAKIRIN-2024KK019929$KYOWA$$$$$$Y$$$20240826$$HP$US$US
242511411$24251141$1$I$$20240826$20240826$20240826$PER$$NVSC2024US172268$NOVARTIS$$$$$$Y$$$20240826$$HP$US$US
242511421$24251142$1$I$20240101$20240821$20240826$20240826$EXP$$US-ABBVIE-5891293$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242511431$24251143$1$I$$20240826$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047821$BOEHRINGER INGELHEIM$$$$$$Y$$$20240826$$CN$US$US
242511441$24251144$1$I$20240801$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134771$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240826$$HP$US$US
242511452$24251145$2$F$20240801$20240823$20240826$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134927$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$81.65$KG$20240828$$CN$US$US
242511461$24251146$1$I$20240101$20240821$20240826$20240826$EXP$$US-ABBVIE-5890756$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242511482$24251148$2$F$$20240912$20240826$20240920$EXP$$ES-TEVA-VS-3236062$TEVA$Posado-Dominguez L, Figuero-Perez L, Olivares-Hernandez A, Chinchilla-Tabora L, Antunez-Plaza P, Rivas-Hernandez R, et al. Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review. Chin-Clin-Oncol 2024; 13 (3):.; Posado-Dominguez L, Figuero-Perez L, Olivares-Hernandez A, Chinchilla-Tabora L, Antunez-Plaza P, Rivas-Hernandez R, et al. Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review. Chin-Clin-Oncol...$65$YR$$M$Y$$$20240920$$MD$ES$ES
242511491$24251149$1$I$$20240823$20240826$20240826$EXP$$CN-AstraZeneca-2024A193999$ASTRAZENECA$$$$$M$Y$$$20240826$$CN$CN$
242511501$24251150$1$I$$20240821$20240826$20240826$EXP$$PL-AstraZeneca-2024A193291$ASTRAZENECA$$84$YR$$F$Y$$$20240826$$MD$PL$
242511521$24251152$1$I$$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014927$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240826$$CN$US$US
242511531$24251153$1$I$$20240819$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408012328$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240826$$CN$US$US
242511541$24251154$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA248994$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240826$$MD$US$US
242511551$24251155$1$I$20240701$20240813$20240826$20240826$PER$$US-SA-2024SA246412$SANOFI AVENTIS$$59$YR$A$F$Y$70$KG$20240826$$MD$US$US
242511561$24251156$1$I$$20240824$20240826$20240826$PER$$NVSC2024US172182$NOVARTIS$$$$$$Y$$$20240826$$CN$US$US
242511571$24251157$1$I$$20240802$20240826$20240826$PER$$US-SMPA-2024SPA000945$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511581$24251158$1$I$20240125$20240819$20240826$20240826$EXP$$FR-DSJP-DSE-2024-123522$DAIICHI$$$$E$F$Y$$$20240826$$MD$FR$FR
242511592$24251159$2$F$$20240822$20240826$20240913$PER$$US-SMPA-2024SPA000572$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
242511612$24251161$2$F$$20240917$20240826$20240924$PER$$US-SMPA-2024SPA000773$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242511622$24251162$2$F$$20240830$20240826$20240916$PER$$US-SMPA-2024SPA001320$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
242511641$24251164$1$I$$20240730$20240826$20240826$PER$$US-SMPA-2024SPA000554$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511651$24251165$1$I$$20240802$20240826$20240826$PER$$US-SMPA-2024SPA000803$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511662$24251166$2$F$20240101$20240827$20240826$20240923$PER$$US-SMPA-2024SPA000557$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242511671$24251167$1$I$$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000476$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511681$24251168$1$I$$20240731$20240826$20240826$PER$$US-SMPA-2024SPA000685$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511691$24251169$1$I$20240101$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000495$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511701$24251170$1$I$$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000378$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511721$24251172$1$I$$20240802$20240826$20240826$PER$$US-SMPA-2024SPA000816$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511731$24251173$1$I$$20240730$20240826$20240826$PER$$US-SMPA-2024SPA000434$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511742$24251174$2$F$20240101$20240826$20240826$20240919$PER$$US-SMPA-2024SPA000606$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
242511751$24251175$1$I$$20240802$20240826$20240826$PER$$US-SMPA-2024SPA000890$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511761$24251176$1$I$$20240801$20240826$20240826$PER$$US-SMPA-2024SPA000706$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511771$24251177$1$I$20240101$20240801$20240826$20240826$PER$$US-SMPA-2024SPA000433$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511781$24251178$1$I$$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000356$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511801$24251180$1$I$$20240802$20240826$20240826$PER$$US-SMPA-2024SPA000805$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511811$24251181$1$I$20240501$20240730$20240826$20240826$PER$$US-SMPA-2024SPA000540$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511821$24251182$1$I$$20240802$20240826$20240826$PER$$US-SMPA-2024SPA000845$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511831$24251183$1$I$$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000451$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511841$24251184$1$I$$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000366$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511852$24251185$2$F$$20240830$20240826$20240923$PER$$US-SMPA-2024SPA000427$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242511861$24251186$1$I$$20240730$20240826$20240826$PER$$US-SMPA-2024SPA000536$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511881$24251188$1$I$$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000369$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511891$24251189$1$I$$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000313$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511902$24251190$2$F$$20240903$20240826$20240923$PER$$US-SMPA-2024SPA000363$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242511911$24251191$1$I$$20240802$20240826$20240826$PER$$US-SMPA-2024SPA000776$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511923$24251192$3$F$$20240913$20240826$20240926$EXP$$US-SMPA-2024SPA000420$SUNOVION$$$$$$Y$$$20240926$$CN$US$US
242511931$24251193$1$I$$20240820$20240826$20240826$PER$$US-SMPA-2024SPA001705$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511941$24251194$1$I$20240101$20240815$20240826$20240826$PER$$US-SMPA-2024SPA001460$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511951$24251195$1$I$$20240801$20240826$20240826$PER$$US-SMPA-2024SPA000687$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511961$24251196$1$I$20240801$20240809$20240826$20240826$PER$$US-SMPA-2024SPA001186$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511981$24251198$1$I$$20240728$20240826$20240826$PER$$US-SMPA-2024SPA000401$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242511991$24251199$1$I$$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000314$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242512002$24251200$2$F$$20240829$20240826$20240923$PER$$US-SMPA-2024SPA000677$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242512011$24251201$1$I$20240723$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000404$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242512021$24251202$1$I$$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000475$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242512031$24251203$1$I$$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000361$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242512041$24251204$1$I$20240101$20240801$20240826$20240826$PER$$US-SMPA-2024SPA000740$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242512061$24251206$1$I$$20240730$20240826$20240826$PER$$US-SMPA-2024SPA000735$SUNOVION$$$$$$Y$$$20240826$$HP$US$US
242512071$24251207$1$I$$20240729$20240826$20240826$PER$$US-SMPA-2024SPA000322$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242512081$24251208$1$I$$20240730$20240826$20240826$PER$$US-SMPA-2024SPA000604$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242512091$24251209$1$I$20240724$20240819$20240826$20240826$PER$$US-SMPA-2024SPA001077$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242512101$24251210$1$I$$20240814$20240826$20240826$PER$$US-SMPA-2024SPA001550$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242512111$24251211$1$I$$20240730$20240826$20240826$PER$$US-SMPA-2024SPA000566$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242512122$24251212$2$F$20240812$20240905$20240826$20240918$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08178$NEUROCRINE BIOSCIENCES$$70$YR$$F$Y$$$20240918$$MD$US$US
242512131$24251213$1$I$20240722$20240822$20240826$20240826$EXP$$NVSC2024CN171971$NOVARTIS$$46$YR$$F$Y$52.5$KG$20240826$$HP$CN$CN
242512142$24251214$2$F$20240726$20240727$20240826$20240904$EXP$$AR-GILEAD-2024-0679986$GILEAD$$74$YR$E$M$Y$$$20240904$$CN$AR$AR
242512161$24251216$1$I$20240814$20240822$20240826$20240826$EXP$$US-KYOWAKIRIN-2024KK019861$KYOWA$$$$$$Y$$$20240826$$HP$US$US
242512171$24251217$1$I$$20240806$20240826$20240826$EXP$$US-SMPA-2024SPA001027$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242512181$24251218$1$I$$20240819$20240826$20240826$EXP$$CA-DSJP-DSJ-2024-141806$DAIICHI$$$$$F$Y$56$KG$20240826$$MD$CA$CA
242512191$24251219$1$I$$20240712$20240826$20240826$PER$$US-LUNDBECK-DKLU4001753$LUNDBECK$$$$$$Y$$$20240826$$CN$US$US
242512201$24251220$1$I$$20240809$20240826$20240826$PER$$US-TAKEDA-2024TUS081032$TAKEDA$$37$YR$$M$Y$$$20240826$$CN$US$US
242512211$24251221$1$I$20190201$20240819$20240826$20240826$EXP$$EU-BAUSCHBL-2024BNL031965$BAUSCH AND LOMB$$69$YR$$F$Y$$$20240826$$MD$EU$EU
242512221$24251222$1$I$20220629$20240812$20240826$20240826$EXP$FR-AFSSAPS-ST2024001284$FR-SK LIFE SCIENCE, INC-SKPVG-2024-001922$SK LIFE SCIENCE$$$$$$Y$$$20240826$$MD$FR$FR
242512231$24251223$1$I$$20240812$20240826$20240826$EXP$$GB-ACRAF SpA-2024-035455$SK LIFE SCIENCE$$$$$$Y$$$20240826$$HP$GB$GB
242512242$24251224$2$F$$20240904$20240826$20240910$EXP$$JP-DSJP-DSJ-2024-141357$DAIICHI$$49$YR$$M$Y$120$KG$20240910$$PH$JP$JP
242512251$24251225$1$I$$20240822$20240826$20240826$30DAY$$US-SANDOZ INC.-SDZ2023US076029$SANDOZ$$$$$F$Y$$$20240826$$CN$US$US
242512261$24251226$1$I$20240814$20240823$20240826$20240826$EXP$$US-KYOWAKIRIN-2024KK019939$KYOWA$$$$$$Y$$$20240826$$HP$US$US
242512271$24251227$1$I$$20240821$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408014115$ELI LILLY AND CO$$$$A$F$Y$$$20240826$$CN$US$US
242512283$24251228$3$F$20240101$20240906$20240826$20240918$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-001059$SK LIFE SCIENCE$$$$$$Y$$$20240918$$HP$CA$CA
242512292$24251229$2$F$$20240813$20240826$20240827$PER$$US-Calliditas-2024CAL01566$CALLIDITAS THERAPEUTICS$$44$YR$A$M$Y$118.3$KG$20240827$$CN$US$US
242512301$24251230$1$I$20240705$20240819$20240826$20240826$EXP$$US-009507513-2408USA006472$MERCK$$$$$F$Y$$$20240826$$CN$US$US
242512311$24251231$1$I$20240801$20240819$20240826$20240826$EXP$GB-MHRA-MED-202408161150349810-SDKNY$GB-009507513-2408GBR006639$MERCK$$77$YR$$M$Y$$$20240826$$MD$GB$GB
242512322$24251232$2$F$$20240912$20240826$20240920$EXP$$US-TEVA-VS-3236239$TEVA$Shaker N, Amadi CC, Welliver M, Otterson GA, Liebner DA, Shilo K. A Case of Mediastinal Carcinosarcoma With Beta-HCG Production and KRAS Mutation. Int-J-Surg-Pathol 2023; 31 (8): 1598-1604.; Shaker N, Amadi CC, Welliver M, Otterson GA, Liebner DA, Shilo K. A Case of Mediastinal Carcinosarcoma With Beta-HCG Production and KRAS Mutation. Int-J-Surg-Pathol 2023; 31 (8): 1598-1604.; Shaker N, Amadi CC, Welliver M, Otterson GA, Liebner DA, Shilo K. A Case of Mediastinal Carcinosarcoma With Beta-HC...$44$YR$$F$Y$$$20240920$$MD$US$US
242512331$24251233$1$I$$20240821$20240826$20240826$EXP$$BR-DSJP-DSE-2024-141536$DAIICHI$$47$YR$$F$Y$$$20240826$$MD$BR$BR
242512341$24251234$1$I$$20240824$20240826$20240826$EXP$$ES-BAUSCH-BL-2024-012849$BAUSCH AND LOMB$$43$YR$$F$Y$62$KG$20240826$$MD$ES$ES
242512361$24251236$1$I$$20240816$20240826$20240826$EXP$$US-SMPA-2024SPA001565$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242512371$24251237$1$I$$20240809$20240826$20240826$PER$$US-INSUD PHARMA-2408US06389$INSUD PHARMA$$$$$$Y$$$20240826$$CN$US$US
242512381$24251238$1$I$20240101$20240809$20240826$20240826$PER$$US-INSUD PHARMA-2408US06390$INSUD PHARMA$$$$$$Y$$$20240826$$CN$US$US
242512391$24251239$1$I$20240101$20240809$20240826$20240826$PER$$US-INSUD PHARMA-2408US06395$INSUD PHARMA$$$$$$Y$$$20240826$$CN$US$US
242512401$24251240$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134835$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240826$$CN$US$US
242512411$24251241$1$I$$20240812$20240826$20240826$PER$$US-INSUD PHARMA-2408US06401$INSUD PHARMA$$$$$$Y$$$20240826$$CN$US$US
242512421$24251242$1$I$20240801$20240811$20240826$20240826$PER$$US-INSUD PHARMA-2408US06399$INSUD PHARMA$$$$$$Y$$$20240826$$CN$US$US
242512431$24251243$1$I$20240101$20240810$20240826$20240826$PER$$US-INSUD PHARMA-2408US06397$INSUD PHARMA$$$$$$Y$$$20240826$$CN$US$US
242512441$24251244$1$I$$20240729$20240826$20240826$EXP$$AU-CHIESI USA, INC.-2024CHF05354$CHIESI$Elizabeth M. Forbes, Peter B. McNaughton. Omenn Syndrome can occur during enzyme therapy for Adenosine Deaminase Deficiency. Journal of Clinical Immunology. 2024;44:162:1-3$17$DY$$F$Y$$$20240826$$HP$AU$AU
242512451$24251245$1$I$20240701$20240813$20240826$20240826$EXP$$US-IMP-2024000631$Harrow Health$$33$YR$A$F$Y$154$KG$20240826$$CN$US$US
242512461$24251246$1$I$$20240825$20240826$20240826$EXP$$ES-BAUSCH-BL-2024-012882$BAUSCH AND LOMB$$43$YR$$F$Y$62$KG$20240826$$MD$ES$ES
242512471$24251247$1$I$20240822$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58401$$FDA-CTU$$$$$M$N$56.7$KG$20240823$Y$HP$US$
242512491$24251249$1$I$$20240715$20240826$20240826$PER$$US-LUNDBECK-DKLU4001811$LUNDBECK$$$$$$Y$$$20240826$$CN$US$US
242512501$24251250$1$I$20240101$20240819$20240826$20240826$EXP$$US-JNJFOC-20240851390$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240826$$CN$US$US
242512511$24251251$1$I$20240814$20240816$20240826$20240826$EXP$$US-LANTHEUS-LMI-2024-01039$LANTHEUS MEDICAL IMAGING$$51$YR$$M$Y$155$KG$20240826$$CN$US$US
242512521$24251252$1$I$20240720$20240821$20240826$20240826$EXP$$CN-DSJP-DSJ-2024-141617$DAIICHI$$56$YR$$M$Y$50.3$KG$20240826$$HP$CN$CN
242512541$24251254$1$I$20240712$20240820$20240826$20240826$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202408014538$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240826$$CN$CO$CO
242512551$24251255$1$I$$20240826$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047844$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240826$$CN$US$US
242512561$24251256$1$I$$20240822$20240826$20240826$EXP$$US-HLS-202401057$HLS THERAPEUTICS$$$$A$$Y$$$20240826$$MD$US$US
242512571$24251257$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58660$$FDA-CTU$$$$$M$N$$$20240826$N$HP$US$
242512581$24251258$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58569$$FDA-CTU$$47$YR$$F$N$77.11$KG$20240826$N$$US$
242512591$24251259$1$I$$20240520$20240826$20240826$PER$$US-IMP-2024000298$Harrow Health$$$$$F$Y$$$20240826$$CN$US$US
242512601$24251260$1$I$$20240822$20240826$20240826$PER$$US-ABBVIE-5893745$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242512612$24251261$2$F$$20240823$20240826$20240904$EXP$$CA-HLS-202402115$HLS THERAPEUTICS$$44$YR$A$F$Y$53$KG$20240904$$MD$CA$CA
242512621$24251262$1$I$20240101$20240816$20240826$20240826$EXP$$DE-ABBVIE-5721922$ABBVIE$$76$YR$$M$Y$$$20240826$$CN$DE$DE
242512641$24251264$1$I$20220418$20240823$20240826$20240826$EXP$FR-AFSSAPS-MA2024001373$FR-GILEAD-2024-0685183$GILEAD$$81$YR$E$F$Y$$$20240826$$HP$FR$FR
242512651$24251265$1$I$$20240528$20240826$20240826$PER$$US-IMP-2024000323$Harrow Health$$$$$M$Y$$$20240826$$CN$US$US
242512661$24251266$1$I$20240710$20240821$20240826$20240826$EXP$$US-AstraZeneca-2024A190760$ASTRAZENECA$$31980$DY$$F$Y$$$20240826$$CN$US$
242512671$24251267$1$I$$20240818$20240826$20240826$EXP$$US-AstraZeneca-2024A188942$ASTRAZENECA$$$$$$Y$$$20240826$$CN$US$
242512681$24251268$1$I$20240101$20240707$20240826$20240826$PER$$US-IMP-2024000475$Harrow Health$$$$E$F$Y$$$20240826$$CN$US$US
242512691$24251269$1$I$20240101$20240708$20240826$20240826$PER$$US-IMP-2024000480$Harrow Health$$$$E$F$Y$$$20240826$$CN$US$US
242512701$24251270$1$I$20240101$20240711$20240826$20240826$PER$$US-IMP-2024000506$Harrow Health$$$$E$M$Y$$$20240826$$CN$US$US
242512711$24251271$1$I$20240701$20240715$20240826$20240826$PER$$US-IMP-2024000507$Harrow Health$$$$E$F$Y$$$20240826$$CN$US$US
242512721$24251272$1$I$20240711$20240715$20240826$20240826$PER$$US-IMP-2024000509$Harrow Health$$$$E$F$Y$$$20240826$$CN$US$US
242512731$24251273$1$I$20240101$20240716$20240826$20240826$PER$$US-IMP-2024000519$Harrow Health$$$$E$F$Y$$$20240826$$CN$US$US
242512741$24251274$1$I$20240101$20240716$20240826$20240826$PER$$US-IMP-2024000520$Harrow Health$$$$E$F$Y$$$20240826$$CN$US$US
242512751$24251275$1$I$20240101$20240717$20240826$20240826$PER$$US-IMP-2024000521$Harrow Health$$$$E$F$Y$$$20240826$$CN$US$US
242512761$24251276$1$I$$20240716$20240826$20240826$PER$$US-LUNDBECK-DKLU4001806$LUNDBECK$$$$$$Y$$$20240826$$CN$US$US
242512771$24251277$1$I$$20240812$20240826$20240826$EXP$$CA-HLS-202402015$HLS THERAPEUTICS$$$$A$M$Y$$$20240826$$HP$CA$CA
242512801$24251280$1$I$$20240715$20240826$20240826$PER$$US-LUNDBECK-DKLU4001864$LUNDBECK$$$$$$Y$$$20240826$$CN$US$US
242512811$24251281$1$I$20240825$20240826$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015710$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242512821$24251282$1$I$20240822$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015741$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240826$$CN$US$US
242512831$24251283$1$I$$20240714$20240826$20240826$PER$$US-LUNDBECK-DKLU4001868$LUNDBECK$$$$$$Y$$$20240826$$CN$US$US
242512841$24251284$1$I$20240101$20240715$20240826$20240826$PER$$US-LUNDBECK-DKLU4001863$LUNDBECK$$$$$$Y$$$20240826$$CN$US$US
242512871$24251287$1$I$20240701$20240820$20240826$20240826$PER$$US-JNJFOC-20240854219$JOHNSON AND JOHNSON$$64$YR$A$M$Y$72.64$KG$20240826$$CN$US$US
242512881$24251288$1$I$$20240819$20240826$20240826$PER$$US-AMGEN-USASP2024165112$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242512891$24251289$1$I$$20240819$20240826$20240826$PER$$US-BIOMARINAP-US-2024-158041$BIOMARIN$$$$$$Y$$$20240826$$CN$US$US
242512901$24251290$1$I$$20240820$20240826$20240826$EXP$$US-009507513-2408USA008254$MERCK$$$$E$F$Y$$$20240826$$CN$US$US
242512911$24251291$1$I$20240101$20240820$20240826$20240826$EXP$$US-ABBVIE-5889178$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242512922$24251292$2$F$20240820$20240822$20240826$20240828$EXP$$US-ABBVIE-5890070$ABBVIE$$17$YR$$F$Y$$$20240828$$CN$US$US
242512931$24251293$1$I$20240101$20240816$20240826$20240826$PER$$US-SA-2024SA246822$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240827$$CN$US$US
242512942$24251294$2$F$20240812$20240830$20240826$20240902$EXP$$CN-GILEAD-2024-0684340$GILEAD$$30$YR$A$M$Y$$$20240902$$CN$CN$CN
242512951$24251295$1$I$$20240822$20240826$20240826$EXP$$US-GILEAD-2024-0685228$GILEAD$Othman T., Koller P., Pourhassan H., Aldoss I. et al. Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia.. British Journal of Haematology. 2024;205:711?715. doi:10.1111/bjh.19551$33$YR$A$M$Y$$$20240826$$MD$US$US
242512962$24251296$2$F$20240823$20240909$20240826$20240916$PER$$US-ABBVIE-5894513$ABBVIE$$85$YR$$F$Y$64$KG$20240916$$CN$US$US
242512971$24251297$1$I$20240813$20240813$20240826$20240826$EXP$$US-FMCRTG-FMC-2408-000997$FRESENIUS MEDICAL CARE$$72$YR$E$F$Y$50$KG$20240826$$HP$US$US
242512981$24251298$1$I$20240810$20240814$20240826$20240826$EXP$$US-FMCRTG-FMC-2408-001023$FRESENIUS MEDICAL CARE$$82$YR$E$M$Y$77$KG$20240826$$HP$US$US
242512991$24251299$1$I$$20240813$20240826$20240826$EXP$$US-FMCRTG-FMC-2408-000982$FRESENIUS MEDICAL CARE$$30$YR$A$M$Y$$$20240826$$HP$US$US
242513001$24251300$1$I$20230101$20240826$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-269343$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$$$20240826$$CN$US$US
242513011$24251301$1$I$20240801$20240816$20240826$20240826$PER$$US-JNJFOC-20240865939$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240826$$HP$US$US
242513021$24251302$1$I$20240701$20240820$20240826$20240826$EXP$$DE-009507513-2408DEU008092$MERCK$$72$YR$$F$Y$$$20240826$$MD$DE$DE
242513032$24251303$2$F$$20240828$20240826$20240905$PER$$US-JNJFOC-20240865727$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$HP$US$US
242513041$24251304$1$I$$20240823$20240826$20240826$PER$$US-GILEAD-2024-0685254$GILEAD$$78$YR$E$M$Y$$$20240826$$CN$US$US
242513052$24251305$2$F$20240815$20240912$20240826$20240925$EXP$$CA-HLS-202402121$HLS THERAPEUTICS$$35$YR$A$M$Y$$$20240925$$CN$CA$CA
242513061$24251306$1$I$20240826$20240826$20240826$20240826$EXP$$SE-GILEAD-2024-0685324$GILEAD$$$$$M$Y$$$20240826$$MD$SE$SE
242513071$24251307$1$I$$20240822$20240826$20240826$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013381$JAZZ$$$$$M$Y$20.8$KG$20240826$$CN$US$US
242513081$24251308$1$I$20240811$20240822$20240826$20240826$EXP$$CN-AstraZeneca-2024A193578$ASTRAZENECA$$11868$DY$$M$Y$72$KG$20240826$$MD$CN$
242513091$24251309$1$I$$20240812$20240826$20240826$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08106$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240826$$PH$US$US
242513102$24251310$2$F$$20240903$20240826$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135260$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$89.36$KG$20240905$$CN$US$US
242513111$24251311$1$I$$20240823$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047647$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240826$$MD$US$US
242513121$24251312$1$I$$20240821$20240826$20240826$PER$$US-AstraZeneca-2024A191283$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242513131$24251313$1$I$$20240822$20240826$20240826$EXP$$JP-009507513-2408JPN002944J$MERCK$$8$DEC$$M$Y$$$20240826$$MD$JP$JP
242513141$24251314$1$I$$20240817$20240826$20240826$PER$$US-JNJFOC-20240846722$JOHNSON AND JOHNSON$$$$$$Y$$$20240826$$CN$US$US
242513151$24251315$1$I$$20240812$20240826$20240826$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08161$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240826$$HP$US$US
242513161$24251316$1$I$20240801$20240822$20240826$20240826$EXP$$DE-JNJFOC-20240865491$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240826$$CN$DE$DE
242513171$24251317$1$I$$20240826$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047862$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240826$$CN$US$US
242513181$24251318$1$I$$20240823$20240826$20240826$PER$$NVSC2024US172323$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242513191$24251319$1$I$$20240823$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047602$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240826$$CN$US$US
242513201$24251320$1$I$$20240819$20240826$20240826$PER$$US-BIOGEN-2024BI01279080$BIOGEN$$$$$M$Y$$$20240826$$CN$US$US
242513211$24251321$1$I$$20240816$20240826$20240826$PER$$US-BIOGEN-2024BI01256577$BIOGEN$$$$$F$Y$$$20240826$$CN$US$US
242513221$24251322$1$I$$20240821$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134744$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240826$$CN$US$US
242513231$24251323$1$I$$20240821$20240826$20240826$PER$$US-AstraZeneca-2024A192825$ASTRAZENECA$$$$$$Y$$$20240827$$CN$US$
242513241$24251324$1$I$$20240815$20240826$20240826$PER$$US-BIOGEN-2024BI01279904$BIOGEN$$$$$F$Y$$$20240826$$HP$US$US
242513251$24251325$1$I$20240101$20240813$20240826$20240826$PER$$US-INSUD PHARMA-2408US06435$INSUD PHARMA$$$$$$Y$$$20240827$$CN$US$US
242513261$24251326$1$I$20240101$20240813$20240826$20240826$PER$$US-INSUD PHARMA-2408US06437$INSUD PHARMA$$$$$$Y$$$20240827$$CN$US$US
242513271$24251327$1$I$$20240814$20240826$20240826$PER$$US-INSUD PHARMA-2408US06486$INSUD PHARMA$$$$$$Y$$$20240827$$CN$US$US
242513282$24251328$2$F$$20240827$20240826$20240904$PER$$US-INSUD PHARMA-2408US06487$INSUD PHARMA$$$$$$Y$$$20240904$$CN$US$US
242513291$24251329$1$I$$20240813$20240826$20240826$PER$$US-INSUD PHARMA-2408US06438$INSUD PHARMA$$$$$$Y$$$20240827$$CN$US$US
242513301$24251330$1$I$$20240815$20240826$20240826$PER$$US-INSUD PHARMA-2408US06449$INSUD PHARMA$$$$$$Y$$$20240827$$CN$US$US
242513311$24251331$1$I$$20240813$20240826$20240826$PER$$US-INSUD PHARMA-2408US06436$INSUD PHARMA$$$$$$Y$$$20240827$$HP$US$US
242513321$24251332$1$I$20240101$20240815$20240826$20240826$PER$$US-INSUD PHARMA-2408US06490$INSUD PHARMA$$$$$$Y$$$20240827$$CN$US$US
242513332$24251333$2$F$$20240827$20240826$20240829$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047764$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240829$$CN$IT$IT
242513341$24251334$1$I$$20240819$20240826$20240826$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-133119$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240827$$HP$CA$CA
242513351$24251335$1$I$20240414$20240819$20240826$20240826$EXP$$PL-009507513-2408POL006983$MERCK$$83$YR$$M$Y$$$20240826$$MD$PL$PL
242513361$24251336$1$I$20240822$20240823$20240826$20240826$EXP$$AR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047726$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240827$$CN$AR$AR
242513371$24251337$1$I$$20240816$20240826$20240826$PER$$US-JNJFOC-20240851737$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$MD$US$US
242513381$24251338$1$I$$20240821$20240826$20240826$EXP$$NVSC2024US170253$NOVARTIS$$$$$M$Y$$$20240827$$CN$US$US
242513391$24251339$1$I$20240206$20240821$20240826$20240826$EXP$$US-APELLIS-2024-APL-0000823$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
242513402$24251340$2$F$20240820$20240909$20240826$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134772$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240917$$PH$JP$JP
242513412$24251341$2$F$20240814$20240906$20240826$20240911$EXP$GB-MHRA-MED-202408240949589110-FRWHK$GB-SANDOZ INC.-SDZ2024GB075036$SANDOZ$$$$$M$Y$89$KG$20240911$$CN$GB$GB
242513421$24251342$1$I$$20240823$20240826$20240826$EXP$$NVSJ2024JP009963$NOVARTIS$$$$$$Y$$$20240827$$MD$JP$JP
242513431$24251343$1$I$$20240823$20240826$20240826$EXP$$JP-ORGANON-O2408JPN001725$ORGANON$$85$YR$$M$Y$$$20240826$$PH$JP$JP
242513441$24251344$1$I$$20240813$20240826$20240826$EXP$$US-JNJFOC-20240866241$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$PH$US$US
242513451$24251345$1$I$20240506$20240821$20240826$20240826$EXP$$US-APELLIS-2024-APL-0000824$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240826$$CN$US$US
242513461$24251346$1$I$$20240823$20240826$20240826$EXP$$NVSJ2024JP009964$NOVARTIS$$$$$$Y$$$20240827$$MD$JP$JP
242513471$24251347$1$I$$20240823$20240826$20240826$PER$$NVSC2024US172339$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242513481$24251348$1$I$$20240826$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015799$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242513491$24251349$1$I$$20240819$20240826$20240826$EXP$$US-JNJFOC-20240848031$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$US$US
242513501$24251350$1$I$$20240814$20240826$20240826$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08199$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240827$$HP$US$US
242513512$24251351$2$F$$20240925$20240826$20240926$EXP$$NVSJ2024JP009965$NOVARTIS$$$$$$Y$$$20240927$$MD$JP$JP
242513523$24251352$3$F$$20240910$20240826$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US074562$SANDOZ$$$$$$Y$$$20240912$$CN$US$US
242513532$24251353$2$F$$20240827$20240826$20240828$EXP$$IT-SANDOZ INC.-SDZ2024IT075102$SANDOZ$$59$YR$$$Y$$$20240828$$MD$IT$IT
242513541$24251354$1$I$$20240821$20240826$20240826$EXP$AU-TGA-0000814457$AU-ORGANON-O2408AUS001695$ORGANON$Kamsani SH, Middeldorp ME, Chiang G, Stefil M, Evans S, et. al.. Safety of outpatient commencement of sotalol. Heart rhythm O2. 2024;5:6:341-50$78$YR$$F$Y$$$20240826$$MD$AU$AU
242513551$24251355$1$I$20240801$20240816$20240826$20240826$EXP$$BR-BIOMARINAP-BR-2024-159998$BIOMARIN$$$$$$Y$$$20240826$$CN$BR$BR
242513561$24251356$1$I$20231027$20240816$20240826$20240826$PER$$US-009507513-2408USA007307$MERCK$$$$E$F$Y$$$20240826$$MD$US$US
242513571$24251357$1$I$20240811$20240822$20240826$20240826$PER$$CN-KARYOPHARM-2024KPT001468$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240827$$MD$CN$CN
242513583$24251358$3$F$20240723$20240909$20240826$20240910$EXP$$DE-SANDOZ INC.-SDZ2024DE075098$SANDOZ$$$$E$M$Y$80$KG$20240910$$MD$DE$DE
242513591$24251359$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA224215$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240827$$MD$US$US
242513603$24251360$3$F$20240812$20240903$20240826$20240913$30DAY$$US-AMGEN-USASP2024165910$AMGEN$$53$YR$A$F$Y$80.9$KG$20240912$$PH$US$US
242513613$24251361$3$F$20240801$20240924$20240826$20240930$30DAY$$US-AMGEN-USASP2024165429$AMGEN$$67$YR$E$M$Y$82.8$KG$20240930$$HP$US$US
242513621$24251362$1$I$$20240816$20240826$20240826$EXP$$US-HLS-202400957$HLS THERAPEUTICS$$53$YR$A$M$Y$$$20240826$$HP$US$US
242513631$24251363$1$I$20231120$20240820$20240826$20240826$EXP$ES-AEMPS-1461795$ES-AMGEN-ESPSP2024168395$AMGEN$$67$YR$E$F$Y$72$KG$20240826$$MD$ES$ES
242513641$24251364$1$I$$20240821$20240826$20240826$EXP$$US-JNJFOC-20240856022$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$CN$US$US
242513651$24251365$1$I$$20240816$20240826$20240826$EXP$$US-HLS-202400947$HLS THERAPEUTICS$$$$A$$Y$$$20240826$$MD$US$US
242513671$24251367$1$I$20240101$20240822$20240826$20240826$EXP$$US-ABBVIE-5851665$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242513681$24251368$1$I$$20240816$20240826$20240826$PER$$US-BAUSCHBL-2024BNL031872$BAUSCH AND LOMB$$$$$M$Y$$$20240827$$MD$US$US
242513691$24251369$1$I$20240101$20240823$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134784$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240827$$MD$US$US
242513701$24251370$1$I$$20240726$20240826$20240826$PER$$US-SMPA-2024SPA000333$SUNOVION$$$$$$Y$$$20240826$$CN$US$US
242513712$24251371$2$F$$20240906$20240826$20240916$PER$$US-BAUSCHBL-2024BNL031901$BAUSCH AND LOMB$$86$YR$$F$Y$$$20240916$$CN$US$US
242513721$24251372$1$I$$20240821$20240826$20240826$EXP$$US-ABBVIE-5891163$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242513731$24251373$1$I$$20240821$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134830$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240827$$CN$US$US
242513741$24251374$1$I$$20240823$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135040$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240827$$CN$US$US
242513761$24251376$1$I$20240806$20240820$20240826$20240826$EXP$$US-ABBVIE-5889292$ABBVIE$$44$YR$$M$Y$$$20240826$$CN$US$US
242513771$24251377$1$I$$20240826$20240826$20240826$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047884$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240827$$CN$US$US
242513781$24251378$1$I$20240820$20240823$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135071$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240827$$CN$US$US
242513791$24251379$1$I$$20240822$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135358$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240827$$CN$US$US
242513802$24251380$2$F$$20240826$20240826$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134076$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240829$$CN$US$US
242513811$24251381$1$I$20240801$20240822$20240826$20240826$EXP$$US-PFIZER INC-202400242588$PFIZER$$28$YR$$F$Y$$$20240826$$CN$US$US
242513821$24251382$1$I$20240708$20240821$20240826$20240826$EXP$$CN-PFIZER INC-PV202400109358$PFIZER$$4$YR$$F$Y$16.3$KG$20240826$$HP$CN$CN
242513841$24251384$1$I$$20240822$20240826$20240826$EXP$$CA-PFIZER INC-202400031375$PFIZER$$79$YR$$M$Y$$$20240826$$MD$CA$CA
242513861$24251386$1$I$$20240821$20240826$20240826$EXP$$US-PFIZER INC-202400241192$PFIZER$$$$$M$Y$$$20240826$$MD$US$US
242513871$24251387$1$I$$20240822$20240826$20240826$EXP$$SK-PFIZER INC-202400234500$PFIZER$$$$$F$Y$$$20240826$$MD$SK$SK
242513882$24251388$2$F$20230901$20240827$20240826$20240829$EXP$$US-ABBVIE-5892789$ABBVIE$$16$YR$$F$Y$$$20240829$$CN$US$US
242513891$24251389$1$I$20240813$20240820$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-013096$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242513901$24251390$1$I$20240822$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168917$AMGEN$$64$YR$A$F$Y$$$20240826$$CN$US$US
242513912$24251391$2$F$$20240828$20240826$20240902$EXP$$CA-TAKEDA-2024TUS085643$TAKEDA$$$$$M$Y$$$20240902$$MD$CA$CA
242513921$24251392$1$I$$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167568$AMGEN$$$$A$F$Y$$$20240826$$CN$US$US
242513931$24251393$1$I$$20240819$20240826$20240826$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001673$BLUEPRINT MEDICINES$$$$$M$Y$$$20240827$$CN$US$US
242513941$24251394$1$I$$20240819$20240826$20240826$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001686$BLUEPRINT MEDICINES$$$$$F$Y$$$20240827$$CN$US$US
242513951$24251395$1$I$20240817$20240819$20240826$20240826$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001679$BLUEPRINT MEDICINES$$74$YR$E$F$Y$$$20240827$$CN$US$US
242513961$24251396$1$I$20240613$20240820$20240826$20240826$EXP$$GB-BIOGEN-2024BI01279276$BIOGEN$$$$$F$Y$$$20240826$$HP$GB$GB
242513972$24251397$2$F$20240809$20240904$20240826$20240906$EXP$$CR-BIOGEN-2024BI01279524$BIOGEN$$46$YR$$F$Y$65$KG$20240906$$CN$CR$CR
242513981$24251398$1$I$20240723$20240820$20240826$20240826$EXP$$NL-BIOGEN-2024BI01279494$BIOGEN$$70$YR$$F$Y$$$20240826$$HP$NL$NL
242513991$24251399$1$I$$20240822$20240826$20240826$EXP$$US-ABBVIE-5892800$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242514001$24251400$1$I$$20240816$20240826$20240826$EXP$$JP-BIOGEN-2024BI01278806$BIOGEN$$$$A$F$Y$$$20240826$$PH$JP$JP
242514011$24251401$1$I$20240711$20240820$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-013091$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242514031$24251403$1$I$$20240815$20240826$20240826$PER$$US-BAUSCHBL-2024BNL031794$BAUSCH AND LOMB$$$$$F$Y$$$20240827$$CN$US$US
242514042$24251404$2$F$20240101$20240909$20240826$20240911$EXP$$NVSJ2024JP009961$NOVARTIS$$82$YR$$F$Y$$$20240912$$MD$JP$JP
242514051$24251405$1$I$20240801$20240812$20240826$20240826$EXP$$US-MALLINCKRODT-MNK202405114$MALLINCKRODT$$44$YR$A$M$Y$$$20240827$$HP$US$US
242514061$24251406$1$I$20240101$20240812$20240826$20240826$EXP$$US-MALLINCKRODT-MNK202404952$MALLINCKRODT$$$$A$M$Y$$$20240827$$CN$US$US
242514071$24251407$1$I$$20240812$20240826$20240826$EXP$$US-MALLINCKRODT-MNK202405126$MALLINCKRODT$$$$$M$Y$$$20240827$$CN$US$US
242514082$24251408$2$F$20240819$20240826$20240826$20240830$PER$$US-AMGEN-USASP2024166602$AMGEN$$56$YR$A$F$Y$$$20240830$$CN$US$US
242514091$24251409$1$I$20240813$20240820$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-013092$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242514101$24251410$1$I$$20240820$20240826$20240826$PER$$US-AMGEN-USASP2024166653$AMGEN$$$$$$Y$$$20240826$$CN$US$US
242514121$24251412$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247799$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240827$$CN$US$US
242514141$24251414$1$I$20240815$20240823$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134887$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240827$$CN$US$US
242514152$24251415$2$F$$20240821$20240826$20240830$PER$$US-AMGEN-USASP2024168546$AMGEN$$$$$M$Y$$$20240830$$CN$US$US
242514161$24251416$1$I$$20240822$20240826$20240826$EXP$$US-ABBVIE-5891309$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242514172$24251417$2$F$20240801$20240910$20240826$20240924$PER$$US-BAUSCHBL-2024BNL031928$BAUSCH AND LOMB$$$$E$M$Y$$$20240924$$CN$US$US
242514182$24251418$2$F$20240701$20240815$20240826$20240906$PER$$US-BAUSCHBL-2024BNL031849$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240906$$CN$US$US
242514191$24251419$1$I$20240801$20240814$20240826$20240826$PER$$US-BAUSCHBL-2024BNL031892$BAUSCH AND LOMB$$84$YR$$F$Y$52.16$KG$20240827$$CN$US$US
242514202$24251420$2$F$$20240917$20240826$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202408015812$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240920$$CN$US$US
242514212$24251421$2$F$20231001$20240910$20240826$20240920$PER$$US-BAUSCHBL-2024BNL031904$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240920$$CN$US$US
242514221$24251422$1$I$20240816$20240821$20240826$20240826$EXP$$CA-ABBVIE-5891322$ABBVIE$$$$A$F$Y$$$20240826$$PH$CA$CA
242514232$24251423$2$F$$20240829$20240826$20240908$PER$$US-BAUSCHBL-2024BNL031863$BAUSCH AND LOMB$$$$$M$Y$$$20240909$$CN$US$US
242514241$24251424$1$I$$20240815$20240826$20240826$PER$$US-BAUSCHBL-2024BNL031882$BAUSCH AND LOMB$$$$$F$Y$$$20240827$$CN$US$US
242514252$24251425$2$F$20240708$20240820$20240826$20240828$EXP$$CA-JNJFOC-20240854500$JOHNSON AND JOHNSON$$16$YR$T$M$Y$62$KG$20240828$$HP$CA$CA
242514261$24251426$1$I$20240101$20240822$20240826$20240826$EXP$$US-JNJFOC-20240859308$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240827$$CN$US$US
242514271$24251427$1$I$20220101$20240819$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133005$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240827$$CN$US$US
242514281$24251428$1$I$$20240820$20240826$20240826$EXP$$ZA-ABBVIE-5892110$ABBVIE$$67$YR$$M$Y$$$20240826$$CN$ZA$ZA
242514291$24251429$1$I$20240701$20240819$20240826$20240826$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000242$DENDREON$$$$$$Y$$$20240826$$CN$US$US
242514301$24251430$1$I$20240101$20240822$20240826$20240826$EXP$$US-ABBVIE-5892492$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242514322$24251432$2$F$20240706$20240828$20240826$20240901$EXP$$US-ABBVIE-5892114$ABBVIE$$46$YR$$M$Y$113.39$KG$20240901$$CN$US$US
242514331$24251433$1$I$20240805$20240822$20240826$20240826$EXP$$US-ABBVIE-5890932$ABBVIE$$55$YR$$F$Y$$$20240826$$CN$US$US
242514344$24251434$4$F$20240810$20240902$20240826$20240904$EXP$$NVSJ2024JP009971$NOVARTIS$$68$YR$$F$Y$$$20240905$$MD$JP$JP
242514352$24251435$2$F$20230501$20240918$20240826$20240919$EXP$$IT-009507513-2408ITA007288$MERCK$Rimoldi SG, Nodari R, Rizzo A, Tamoni A, Longobardi C, Pagani C, et al. First imported case of Candida auris infection in Milan, Italy: genomic characterisation. Infection. 2024;52 (4):1633-8$80$YR$$M$Y$$$20240919$$HP$IT$IT
242514361$24251436$1$I$$20240820$20240826$20240826$EXP$$PT-009507513-2408PRT008137$MERCK$Simoes FDO et al.. PO-0583-(4332)-BCGITIS-A RARE CASE. Abstract book - 30 CMNI. 2024;929$86$YR$$M$Y$$$20240826$$MD$PT$PT
242514372$24251437$2$F$20240821$20240827$20240826$20240829$PER$$US-AMGEN-USASP2024167649$AMGEN$$70$YR$E$M$Y$$$20240828$$CN$US$US
242514383$24251438$3$F$20240818$20240912$20240826$20240913$PER$$US-AMGEN-USASP2024165405$AMGEN$$71$YR$E$F$Y$$$20240913$$HP$US$US
242514391$24251439$1$I$$20240823$20240826$20240826$PER$$US-AMGEN-USASP2024169250$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242514401$24251440$1$I$20240101$20240822$20240826$20240826$EXP$$US-ABBVIE-5892560$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242514411$24251441$1$I$20240101$20240821$20240826$20240826$EXP$$CA-ABBVIE-5891128$ABBVIE$$$$$M$Y$$$20240826$$CN$CA$CA
242514421$24251442$1$I$20240723$20240822$20240826$20240826$EXP$$US-ABBVIE-5893217$ABBVIE$$71$YR$$F$Y$$$20240826$$CN$US$US
242514431$24251443$1$I$$20240823$20240826$20240826$PER$$US-ROCHE-10000065743$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242514441$24251444$1$I$20240701$20240820$20240826$20240826$EXP$$US-ABBVIE-5890510$ABBVIE$$66$YR$$F$Y$70.306$KG$20240826$$CN$US$US
242514451$24251445$1$I$$20240822$20240826$20240826$EXP$$US-ABBVIE-5892181$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242514471$24251447$1$I$20240814$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024168121$AMGEN$$71$YR$E$F$Y$$$20240826$$CN$US$US
242514482$24251448$2$F$20240101$20240829$20240826$20240904$EXP$$US-ABBVIE-5890687$ABBVIE$$$$$F$Y$64$KG$20240904$$CN$US$US
242514491$24251449$1$I$20240101$20240821$20240826$20240826$EXP$$CA-ABBVIE-5830537$ABBVIE$$69$YR$$M$Y$$$20240826$$HP$CA$CA
242514501$24251450$1$I$$20240823$20240826$20240826$EXP$$CA-SANDOZ INC.-SDZ2023CA073435$SANDOZ$$62$YR$$M$Y$$$20240826$$MD$CA$CA
242514511$24251451$1$I$20240822$20240823$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134989$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240827$$CN$US$US
242514521$24251452$1$I$$20240821$20240826$20240826$EXP$$US-ABBVIE-5890835$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242514532$24251453$2$F$$20240902$20240826$20240903$PER$$NVSC2024US172057$NOVARTIS$$$$$F$Y$$$20240904$$HP$US$US
242514541$24251454$1$I$$20240813$20240826$20240826$EXP$$JP-Unichem Pharmaceuticals (USA) Inc-UCM202408-001040$UNICHEM$$36$YR$A$F$Y$$$20240827$$HP$JP$
242514551$24251455$1$I$$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167587$AMGEN$Rosmarin D.. Recalcitrant Seborrheic Dermatitis Successfully Treated With Apremilast. Journal of Cutaneous Medicine and Surgery. 2020;24 (1):90-91$47$YR$A$F$Y$$$20240826$$HP$US$US
242514561$24251456$1$I$$20240821$20240826$20240826$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-133937$BRISTOL MYERS SQUIBB$$75$YR$E$$Y$$$20240827$$MD$JP$JP
242514571$24251457$1$I$20240315$20240821$20240826$20240826$EXP$$CN-BEIGENE-BGN-2024-013186$BEIGENE$$$$$$Y$$$20240826$$HP$CN$CN
242514581$24251458$1$I$20240814$20240822$20240826$20240826$EXP$$US-ABBVIE-5892524$ABBVIE$$73$YR$$F$Y$$$20240826$$CN$US$US
242514601$24251460$1$I$$20240815$20240826$20240826$PER$$US-SA-2024SA246382$SANOFI AVENTIS$$$$A$M$Y$$$20240827$$HP$US$US
242514611$24251461$1$I$20230101$20240823$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135056$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240827$$CN$US$US
242514621$24251462$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247506$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240827$$CN$US$US
242514632$24251463$2$F$20240801$20240826$20240826$20240905$EXP$$JP-ABBVIE-5895364$ABBVIE$$70$YR$$F$Y$$$20240905$$MD$JP$JP
242514641$24251464$1$I$$20240814$20240826$20240826$PER$$US-TAKEDA-2024TUS081525$TAKEDA$$$$$$Y$$$20240826$$CN$US$US
242514651$24251465$1$I$$20240821$20240826$20240826$PER$$US-AMGEN-USASP2024167575$AMGEN$Rosmarin D.. Recalcitrant Seborrheic Dermatitis Successfully Treated With Apremilast. Journal of Cutaneous Medicine and Surgery. 2020;24 (1):90-91$25$YR$A$M$Y$$$20240826$$HP$US$US
242514661$24251466$1$I$$20240819$20240826$20240826$PER$$US-PHARMING-PHAUS2024000717$PHARMING GROUP$$$$$$Y$$$20240827$$CN$US$US
242514671$24251467$1$I$$20240821$20240826$20240826$EXP$$US-JNJFOC-20240855003$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242514681$24251468$1$I$$20240819$20240826$20240826$EXP$$CA-JNJFOC-20240856375$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240827$$CN$CA$CA
242514691$24251469$1$I$20240101$20240822$20240826$20240826$EXP$$US-ABBVIE-5893241$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242514701$24251470$1$I$$20240822$20240826$20240826$EXP$$US-JNJFOC-20240857562$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$CN$US$US
242514711$24251471$1$I$20240101$20240820$20240826$20240826$EXP$$US-JNJFOC-20240857669$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$MD$US$US
242514721$24251472$1$I$20210101$20240812$20240826$20240826$PER$$US-SA-2023SA301904$SANOFI AVENTIS$$$$A$F$Y$100$KG$20240827$$MD$US$US
242514731$24251473$1$I$20240701$20240814$20240826$20240826$PER$$US-SA-2024SA014252$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240827$$MD$US$US
242514741$24251474$1$I$20240101$20240815$20240826$20240826$PER$$US-SA-2024SA246531$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240827$$MD$US$US
242514761$24251476$1$I$$20240819$20240826$20240826$PER$$US-PHARMING-PHAUS2024000718$PHARMING GROUP$$$$$$Y$$$20240827$$CN$US$US
242514771$24251477$1$I$$20240822$20240826$20240826$PER$$US-AMGEN-USASP2024169018$AMGEN$$$$$$Y$$$20240826$$CN$US$US
242514781$24251478$1$I$20240616$20240823$20240826$20240826$EXP$$US-ABBVIE-5892942$ABBVIE$$53$YR$$M$Y$$$20240826$$CN$US$US
242514791$24251479$1$I$20240821$20240822$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015046$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240826$$CN$US$US
242514801$24251480$1$I$$20240823$20240826$20240826$PER$$US-ELI_LILLY_AND_COMPANY-US202408015516$ELI LILLY AND CO$$$$$F$Y$$$20240826$$CN$US$US
242514811$24251481$1$I$20240722$20240821$20240826$20240826$EXP$$US-JNJFOC-20240855599$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240827$$CN$US$US
242514821$24251482$1$I$$20240822$20240826$20240826$EXP$$CA-ABBVIE-5892704$ABBVIE$$$$A$F$Y$$$20240826$$CN$CA$CA
242514831$24251483$1$I$$20240821$20240826$20240826$PER$$US-ALXN-202408USA001488US$ALEXION PHARMACEUTICALS$$$$$F$Y$57.143$KG$20240827$$CN$US$US
242514842$24251484$2$F$$20240826$20240826$20240827$PER$$US-TAKEDA-2024TUS085719$TAKEDA$$$$$F$Y$62$KG$20240827$$MD$US$US
242514852$24251485$2$F$20240724$20240904$20240826$20240906$EXP$$US-GSK-US2024105565$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$US$US
242514861$24251486$1$I$20240617$20240819$20240826$20240826$EXP$$DE-ABBVIE-5890866$ABBVIE$$71$YR$$F$Y$$$20240826$$HP$DE$DE
242514871$24251487$1$I$20240501$20240814$20240826$20240826$PER$$US-SA-2024SA246799$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240827$$MD$US$US
242514881$24251488$1$I$20240101$20240814$20240826$20240826$PER$$US-SA-2024SA246891$SANOFI AVENTIS$$94$YR$E$M$Y$$$20240827$$MD$US$US
242514891$24251489$1$I$20240219$20240823$20240826$20240826$EXP$IS-IMA-8780$IS-BRISTOL-MYERS SQUIBB COMPANY-2024-134383$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240827$$PH$IS$IS
242514903$24251490$3$F$20240710$20240916$20240826$20240920$PER$$US-AMGEN-USASP2024165156$AMGEN$$73$YR$E$F$Y$$$20240920$$CN$US$US
242514911$24251491$1$I$$20240820$20240826$20240826$PER$$US-ABBVIE-5889041$ABBVIE$$$$$$Y$$$20240826$$CN$US$US
242514921$24251492$1$I$$20240814$20240826$20240826$PER$$US-SA-2024SA240740$SANOFI AVENTIS$$16$YR$T$F$Y$62$KG$20240827$$MD$US$US
242514931$24251493$1$I$$20240819$20240826$20240826$PER$$US-SA-2024SA247840$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240827$$MD$US$US
242514941$24251494$1$I$20240101$20240822$20240826$20240826$EXP$$US-ABBVIE-5892547$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242514951$24251495$1$I$20240801$20240823$20240826$20240826$EXP$$RO-ABBVIE-5895502$ABBVIE$$78$YR$$F$Y$$$20240826$$MD$RO$RO
242514961$24251496$1$I$$20240822$20240826$20240826$EXP$$US-ABBVIE-5894478$ABBVIE$$$$$F$Y$$$20240826$$CN$US$US
242514971$24251497$1$I$20240101$20240823$20240826$20240826$EXP$$US-ABBVIE-5892926$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242514981$24251498$1$I$$20240822$20240826$20240826$EXP$$US-AstraZeneca-2024A192413$ASTRAZENECA$$$$$M$Y$68.5$KG$20240827$$CN$US$
242514992$24251499$2$F$20240701$20240822$20240826$20240829$EXP$$US-ABBVIE-5886890$ABBVIE$$54$YR$$F$Y$90$KG$20240829$$CN$US$US
242515002$24251500$2$F$20240826$20240826$20240826$20240902$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185338$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240902$$MD$CA$CA
242515011$24251501$1$I$$20240820$20240826$20240826$PER$$US-JNJFOC-20240854886$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$HP$US$US
242515021$24251502$1$I$$20240823$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135355$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240827$$CN$US$US
242515031$24251503$1$I$$20240822$20240826$20240826$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133968$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240827$$CN$US$US
242515041$24251504$1$I$20240801$20240816$20240826$20240826$EXP$$US-ABBVIE-5884647$ABBVIE$$69$YR$$F$Y$$$20240826$$CN$US$US
242515061$24251506$1$I$20240801$20240823$20240826$20240826$EXP$$US-ABBVIE-5893732$ABBVIE$$79$YR$$F$Y$$$20240826$$CN$US$US
242515071$24251507$1$I$20240401$20240812$20240826$20240826$EXP$$ES-IBSA PHARMA INC.-2024IBS000380$IBSA INSTITUT BIOCHIMIQUE$$$$$$Y$$$20240826$$PH$ES$ES
242515082$24251508$2$F$$20240921$20240826$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134478$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$107.05$KG$20240923$$CN$US$US
242515091$24251509$1$I$$20240819$20240826$20240826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131645$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240827$$HP$US$US
242515102$24251510$2$F$20240623$20240909$20240826$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009796$JAZZ$$31$YR$$F$Y$$$20240912$$CN$US$US
242515111$24251511$1$I$20240416$20240823$20240826$20240826$EXP$$DE-GSK-DE2024105381$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$MD$DE$DE
242515121$24251512$1$I$$20240826$20240826$20240826$EXP$$CA-ORGANON-O2408CAN001853$ORGANON$$12$YR$$F$Y$$$20240826$$MD$CA$CA
242515131$24251513$1$I$20240101$20240819$20240826$20240826$EXP$$US-ABBVIE-5887385$ABBVIE$$$$$M$Y$$$20240826$$CN$US$US
242515141$24251514$1$I$20240815$20240815$20240826$20240826$PER$$US-SA-2024SA246990$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240827$$HP$US$US
242515151$24251515$1$I$20240816$20240819$20240826$20240826$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-013454$JAZZ$$59$YR$$M$Y$$$20240826$$MD$JP$JP
242515172$24251517$2$F$$20240822$20240826$20240827$EXP$$CA-JNJFOC-20240855244$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240828$$HP$CA$CA
242515181$24251518$1$I$20240101$20240822$20240826$20240826$EXP$$BG-ABBVIE-5893065$ABBVIE$$25$YR$$M$Y$$$20240826$$CN$BG$BG
242515191$24251519$1$I$20231001$20240822$20240827$20240827$EXP$FR-AFSSAPS-PA2024001440$FR-VIIV HEALTHCARE LIMITED-FR2024104894$VIIV$$$$$$Y$$$20240826$$MD$FR$FR
242515201$24251520$1$I$$20240819$20240826$20240826$EXP$$GB-ABBVIE-5887952$ABBVIE$$$$$F$Y$$$20240826$$HP$GB$GB
242515211$24251521$1$I$20240814$20240823$20240827$20240827$EXP$IT-MINISAL02-999561$IT-GSK-IT2024105393$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$PH$IT$IT
242515222$24251522$2$F$20210101$20240903$20240827$20240906$EXP$$US-ABBVIE-5885157$ABBVIE$$$$$F$Y$77$KG$20240906$$CN$US$US
242515231$24251523$1$I$$20240823$20240827$20240827$EXP$FR-AFSSAPS-NY2024000979$FR-GSK-FR2024105189$GLAXOSMITHKLINE$$$$$$Y$$$20240826$$CN$FR$FR
242515241$24251524$1$I$20240101$20240819$20240827$20240827$EXP$$US-ABBVIE-5888193$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242515261$24251526$1$I$$20240822$20240827$20240827$PER$$US-ROCHE-10000064916$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242515272$24251527$2$F$20240101$20240904$20240827$20240909$EXP$$US-JNJFOC-20240857806$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240910$$CN$US$US
242515291$24251529$1$I$20240809$20240823$20240827$20240827$EXP$$JP-TAKEDA-2024TJP012455$TAKEDA$$8$DEC$$F$Y$$$20240827$$MD$JP$JP
242515301$24251530$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135142$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240827$$CN$US$US
242515311$24251531$1$I$20240429$20240823$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075182$SANDOZ$$69$YR$$F$Y$$$20240827$$CN$US$US
242515331$24251533$1$I$20240801$20240815$20240827$20240827$PER$$US-SA-2024SA247002$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240827$$MD$US$US
242515341$24251534$1$I$$20240821$20240827$20240827$EXP$$US-ABBVIE-5891159$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242515351$24251535$1$I$20240101$20240821$20240827$20240827$EXP$$US-ABBVIE-5890605$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242515361$24251536$1$I$20240101$20240815$20240827$20240827$PER$$US-Umedica-000097$UMEDICA LABS$$55$YR$$$Y$$$20240824$$CN$US$
242515371$24251537$1$I$20230101$20240814$20240827$20240827$EXP$$IN-CIPLA LTD.-2024IN09364$CIPLA$Gaekwad G, Mali KA, Dwivedi J, Nimbkar AR.. The ?O? Dilemma: A case series on obstetric oncological clinical vignettes.. Journal of South Asian Federation of Obstetrics and Gynaecology.. 2024;16 (4):406 to 411$$$$$Y$$$20240827$$HP$IN$IN
242515381$24251538$1$I$$20240819$20240826$20240826$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-135247$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$96$KG$20240827$$HP$CA$CA
242515391$24251539$1$I$$20240822$20240827$20240827$EXP$$TW-AMGEN-TWNSP2024169320$AMGEN$$$$E$F$Y$$$20240826$$HP$TW$TW
242515401$24251540$1$I$$20240823$20240827$20240827$PER$$US-TAKEDA-2024TUS085734$TAKEDA$$$$$M$Y$65.2$KG$20240827$$MD$US$US
242515411$24251541$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246794$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240827$$MD$US$US
242515421$24251542$1$I$20240815$20240815$20240827$20240827$PER$$US-SA-2024SA098982$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240827$$MD$US$US
242515431$24251543$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247593$SANOFI AVENTIS$$$$C$M$Y$$$20240827$$MD$US$US
242515441$24251544$1$I$$20240817$20240827$20240827$PER$$US-PCCINC-2024-PPL-000638$PIRAMAL$$$$$$Y$$$20240827$$HP$US$US
242515451$24251545$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA247047$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240827$$MD$US$US
242515461$24251546$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA247634$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240827$$CN$US$US
242515471$24251547$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247535$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240827$$MD$US$US
242515481$24251548$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA245251$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240827$$MD$US$US
242515491$24251549$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246887$SANOFI AVENTIS$$$$E$F$Y$$$20240827$$MD$US$US
242515501$24251550$1$I$20240801$20240814$20240827$20240827$PER$$US-SA-2024SA246060$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240827$$MD$US$US
242515511$24251551$1$I$$20240819$20240827$20240827$EXP$$CA-TOLMAR, INC.-24CA051959$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
242515521$24251552$1$I$$20240819$20240827$20240827$EXP$$CA-TOLMAR, INC.-24CA051961$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
242515531$24251553$1$I$$20240819$20240827$20240827$EXP$$CA-TOLMAR, INC.-24CA052000$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
242515541$24251554$1$I$$20240819$20240827$20240827$EXP$$NL-TOLMAR, INC.-24NL051964$TOLMAR$$$$$M$Y$$$20240827$$HP$NL$NL
242515551$24251555$1$I$$20240823$20240827$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US075160$SANDOZ$$$$$$Y$$$20240827$$CN$US$US
242515561$24251556$1$I$20240822$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168637$AMGEN$$77$YR$E$F$Y$$$20240826$$CN$US$US
242515571$24251557$1$I$20240101$20240820$20240827$20240827$EXP$$CA-ABBVIE-5889188$ABBVIE$$62$YR$$M$Y$$$20240827$$CN$CA$CA
242515581$24251558$1$I$$20240819$20240827$20240827$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210203345$BRISTOL MYERS SQUIBB$$60$YR$E$F$Y$$$20240827$$CN$CA$CA
242515601$24251560$1$I$$20240819$20240827$20240827$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010586$STRIDES$Kline K, Chen W, Kallen ME, Koka R, Omili D, Fan X, et al.. Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD).. Hum-Vaccin-Immunother. 2023;19 (2)$$$$$Y$$$20240827$$HP$US$US
242515611$24251561$1$I$$20240814$20240827$20240827$EXP$$US-CIPLA LTD.-2024US09182$CIPLA$Kim M, Graham C, Stevens RW, Shah A.. A rare case of bacterial meningitis caused by hematogenous spread of vancomycin-resistant enterococcus faecium in an immunocompromised patient. Case reports in infectious diseases. 2024;2193650$$$$$Y$$$20240827$$MD$US$US
242515621$24251562$1$I$$20240819$20240827$20240827$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-134801$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240827$$HP$CA$CA
242515631$24251563$1$I$$20240822$20240827$20240827$PER$$US-HALEON-2193618$Haleon PLC$$35$YR$$M$Y$$$20240827$$HP$US$US
242515641$24251564$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5892936$ABBVIE$$$$$F$Y$$$20240827$$HP$US$US
242515664$24251566$4$F$20240819$20240924$20240827$20240927$30DAY$$US-SANDOZ INC.-SDZ2024US074446$SANDOZ$$10$YR$$M$Y$$$20240927$$CN$US$US
242515671$24251567$1$I$20220101$20240817$20240827$20240827$EXP$$EG-ABBVIE-5887736$ABBVIE$$29$YR$$M$Y$$$20240827$$CN$EG$EG
242515681$24251568$1$I$$20240819$20240827$20240827$EXP$$MY-STRIDES ARCOLAB LIMITED-2024SP010584$STRIDES$Tee TY, Tan YY, Husin M, Ibrahim KA, Rahman AKA, Nasir MNM, et al.. Case report of chronic meningitis secondary to histoplasmosis in an immunocompromised patient.. J-Neurol-Sci. 2023;455 (Suppl.):77 abstr. 121353$53$YR$$M$Y$$$20240827$$HP$MY$MY
242515691$24251569$1$I$$20240819$20240827$20240827$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010599$STRIDES$Schwartz AH, Sieminski S.. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event.. Am-J-Ophthalmol-Case-Rep. 2023;30:1-4$59$YR$$F$Y$$$20240827$$HP$US$US
242515701$24251570$1$I$20240627$20240823$20240827$20240827$EXP$$GB-ABBVIE-5895601$ABBVIE$$39$YR$$F$Y$$$20240827$$CN$GB$GB
242515711$24251571$1$I$20240711$20240822$20240827$20240827$EXP$$US-ABBVIE-5892904$ABBVIE$$55$YR$$F$Y$$$20240827$$CN$US$US
242515722$24251572$2$F$$20240902$20240827$20240905$EXP$$GB-ABBVIE-5893193$ABBVIE$$$$A$F$Y$$$20240905$$CN$GB$GB
242515732$24251573$2$F$20240201$20240821$20240827$20240902$EXP$$US-NOVOPROD-1272115$NOVO NORDISK$$$$A$M$Y$$$20240902$$CN$US$US
242515741$24251574$1$I$20240701$20240819$20240827$20240827$30DAY$$US-GSK-US2024103255$GLAXOSMITHKLINE$$80$YR$$M$Y$$$20240827$$CN$US$US
242515751$24251575$1$I$$20240821$20240827$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US074896$SANDOZ$$$$$F$Y$$$20240827$$CN$US$US
242515761$24251576$1$I$$20240823$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135366$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240827$$CN$US$US
242515772$24251577$2$F$20240802$20240918$20240827$20240921$PER$$US-ROCHE-10000063699$ROCHE$$81$YR$E$F$Y$79.37$KG$20240921$$CN$US$US
242515782$24251578$2$F$$20240819$20240827$20240904$EXP$$CA-BEH-2024177547$CSL BEHRING$$$$A$F$Y$66$KG$20240904$$MD$CA$CA
242515792$24251579$2$F$20240821$20240821$20240827$20240830$PER$$US-AMGEN-USASP2024168105$AMGEN$$65$YR$E$F$Y$$$20240830$$CN$US$US
242515802$24251580$2$F$$20240920$20240827$20240927$EXP$$JP-AMGEN-JPNSP2024165797$AMGEN$Yasuko Nakamura. A case of asymptomatic primary hyperparathyroidism which became evident after the use of teriparatide. Gunma Igaku. 2023;118:65-69$90$YR$E$F$Y$$$20240927$$MD$JP$JP
242515811$24251581$1$I$$20240819$20240827$20240827$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP010590$STRIDES$Kasperczak M, Dabrowski F, Kosinska-Kaczynska K.. Emergency cervical cerclage performed at 25 weeks with favorable materno-fetal outcomes: a case report.. Eur-J-Obstet-Gynecol-Reprod-Biol. 2024;293:93$$$$F$Y$$$20240827$$HP$PL$PL
242515831$24251583$1$I$20240817$20240823$20240827$20240827$PER$$US-ROCHE-10000065546$ROCHE$$1$YR$I$M$Y$$$20240827$$CN$US$US
242515842$24251584$2$F$$20240827$20240827$20240828$PER$$US-HALEON-2193640$Haleon PLC$$$$$F$Y$$$20240828$$CN$US$US
242515852$24251585$2$F$20240101$20240912$20240827$20240921$EXP$$US-ABBVIE-5884171$ABBVIE$$$$$F$Y$75$KG$20240921$$CN$US$US
242515861$24251586$1$I$20240101$20240820$20240827$20240827$EXP$$US-ABBVIE-5889762$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242515872$24251587$2$F$$20240905$20240827$20240912$EXP$$US-ABBVIE-5891213$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
242515881$24251588$1$I$$20240819$20240827$20240827$EXP$$JP-VANTIVE-2024VAN018897$Vantive US Healthcare$$$$$F$Y$$$20240827$$MD$JP$JP
242515891$24251589$1$I$20240806$20240819$20240827$20240827$EXP$$JP-VANTIVE-2024VAN018869$Vantive US Healthcare$$$$$F$Y$$$20240827$$MD$JP$JP
242515901$24251590$1$I$$20240826$20240827$20240827$EXP$$CA-ORGANON-O2408CAN001854$ORGANON$$$$$M$Y$22$KG$20240827$$PH$CA$CA
242515912$24251591$2$F$20240801$20240911$20240827$20240921$PER$$US-ABBVIE-5886894$ABBVIE$$72$YR$$F$Y$76.657$KG$20240921$$CN$US$US
242515922$24251592$2$F$20240801$20240905$20240827$20240911$EXP$$CA-ABBVIE-5889182$ABBVIE$$69$YR$$F$Y$$$20240911$$CN$CA$CA
242515931$24251593$1$I$$20240820$20240827$20240827$EXP$$US-ABBVIE-5889232$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242515951$24251595$1$I$20240101$20240822$20240827$20240827$EXP$$US-ABBVIE-5892527$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242515971$24251597$1$I$20231001$20240822$20240827$20240827$EXP$$US-ABBVIE-5891166$ABBVIE$$69$YR$$F$Y$$$20240827$$CN$US$US
242515982$24251598$2$F$20210101$20240828$20240827$20240831$EXP$$US-ABBVIE-5894369$ABBVIE$$$$$F$Y$50$KG$20240831$$CN$US$US
242515991$24251599$1$I$$20240820$20240827$20240827$EXP$$GB-ABBVIE-5889450$ABBVIE$$$$A$F$Y$$$20240827$$CN$GB$GB
242516001$24251600$1$I$20240101$20240822$20240827$20240827$EXP$$CA-ABBVIE-5892931$ABBVIE$$$$A$F$Y$$$20240827$$MD$CA$CA
242516011$24251601$1$I$20240101$20240819$20240827$20240827$EXP$$US-ABBVIE-5887372$ABBVIE$$$$$F$Y$$$20240827$$HP$US$US
242516021$24251602$1$I$$20240823$20240827$20240827$PER$$US-ROCHE-10000065586$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242516031$24251603$1$I$20240101$20240819$20240827$20240827$EXP$$US-ABBVIE-5771617$ABBVIE$$69$YR$$F$Y$136.07$KG$20240827$$CN$US$US
242516041$24251604$1$I$20240817$20240821$20240827$20240827$EXP$$US-ABBVIE-5890917$ABBVIE$$80$YR$$M$Y$$$20240827$$CN$US$US
242516051$24251605$1$I$$20240814$20240827$20240827$EXP$$CN-NOVOPROD-1270692$NOVO NORDISK$LIN Yu-yanl et,al. The Clinical Pharmacist Participated in the Clinical Practice of 1 Case of Exogenous Insulin Autoimmune Syndrome. Strait Pharmaceutical Journal. 2024;36(6):82-84$78$YR$$F$Y$64$KG$20240827$$HP$CN$CN
242516061$24251606$1$I$20231001$20240815$20240827$20240827$EXP$$US-NOVOPROD-1271994$NOVO NORDISK$$64$YR$$F$Y$$$20240827$$MD$US$US
242516071$24251607$1$I$20240801$20240815$20240827$20240827$EXP$CN-NMPA-4403111916256202400527$CN-NOVOPROD-1270776$NOVO NORDISK$$26$YR$$F$Y$69.5$KG$20240827$$HP$CN$CN
242516081$24251608$1$I$$20240815$20240827$20240827$EXP$$US-NOVOPROD-1271175$NOVO NORDISK$$$$A$F$Y$$$20240827$$CN$US$US
242516091$24251609$1$I$$20240814$20240827$20240827$EXP$$US-NOVOPROD-1272925$NOVO NORDISK$$$$$F$Y$$$20240827$$CN$US$US
242516101$24251610$1$I$$20240815$20240827$20240827$EXP$$CO-NOVOPROD-1271098$NOVO NORDISK$$$$$$Y$$$20240827$$MD$CO$CO
242516111$24251611$1$I$$20240814$20240827$20240827$EXP$$US-NOVOPROD-1270229$NOVO NORDISK$$47$YR$$F$Y$$$20240827$$PH$US$US
242516122$24251612$2$F$$20240905$20240827$20240913$EXP$$CN-NOVOPROD-1271059$NOVO NORDISK$$$$$M$Y$64$KG$20240913$$CN$CN$CN
242516131$24251613$1$I$$20240815$20240827$20240827$EXP$$US-NOVOPROD-1271096$NOVO NORDISK$$46$YR$$$Y$$$20240827$$CN$US$US
242516141$24251614$1$I$$20240822$20240827$20240827$EXP$$US-ABBVIE-5892430$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242516151$24251615$1$I$$20240821$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075225$SANDOZ$$$$$F$Y$$$20240827$$MD$US$US
242516161$24251616$1$I$20220510$20240820$20240827$20240827$EXP$$US-009507513-2408USA007742$MERCK$$76$YR$$M$Y$$$20240827$$HP$US$US
242516171$24251617$1$I$$20220927$20240827$20240827$EXP$$GB-AstraZeneca-2022A286716$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$GB$
242516181$24251618$1$I$20240807$20240824$20240827$20240827$EXP$$CN-ABBVIE-5895065$ABBVIE$$17$YR$$M$Y$70$KG$20240827$$MD$CN$CN
242516191$24251619$1$I$20240813$20240822$20240827$20240827$EXP$$CN-ABBVIE-5893749$ABBVIE$$37$YR$$M$Y$83$KG$20240827$$MD$CN$CN
242516201$24251620$1$I$$20231004$20240827$20240827$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00497$PRINSTON PHARMACEUTICAL$$$$$F$Y$72.562$KG$20240809$$CN$US$US
242516211$24251621$1$I$20231101$20240308$20240827$20240827$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00119$PRINSTON PHARMACEUTICAL$$67$YR$$F$Y$99.79$KG$20240809$$CN$US$US
242516222$24251622$2$F$$20240904$20240827$20240910$EXP$$CA-TAKEDA-2024TUS075807$TAKEDA$$$$$M$Y$$$20240910$$CN$CA$CA
242516231$24251623$1$I$$20240819$20240827$20240827$PER$$US-AMGEN-USASP2024167024$AMGEN$Roberts J.; Carlin K.; Hayward K. et al.. ASSOCIATION OF BELIMUMAB USE WITH ORAL CORTICOSTEROID DOSE AND DISEASE ACTIVITY IN CHILDHOOD-ONSET LUPUS: OUTCOMES FROM A NESTED-CASE CONTROL ANALYSIS IN THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE REGISTRY. Annals of the Rheumatic Diseases. 2024;83 (SUPPL_1):230$$$$$Y$$$20240826$$HP$US$US
242516241$24251624$1$I$20240101$20240820$20240827$20240827$EXP$$CN-ABBVIE-5887454$ABBVIE$$$$$M$Y$66$KG$20240827$$MD$CN$CN
242516251$24251625$1$I$$20240820$20240827$20240827$EXP$$US-ABBVIE-5893451$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242516271$24251627$1$I$20240815$20240815$20240827$20240827$EXP$$US-ABBVIE-5883210$ABBVIE$$63$YR$$F$Y$$$20240827$$CN$US$US
242516281$24251628$1$I$$20240825$20240827$20240827$EXP$$CA-SANDOZ INC.-SDZ2024US075285$SANDOZ$$$$$F$Y$$$20240827$$CN$CA$US
242516291$24251629$1$I$20240101$20240821$20240827$20240827$EXP$$NVSC2024MX032156$NOVARTIS$$34$YR$$M$Y$83$KG$20240827$$CN$MX$MX
242516301$24251630$1$I$20240816$20240819$20240827$20240827$30DAY$$US-GSK-US2024103297$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240827$$CN$US$US
242516312$24251631$2$F$20240501$20240827$20240827$20240903$EXP$$US-ABBVIE-5892233$ABBVIE$$76$YR$$M$Y$65.77$KG$20240903$$CN$US$US
242516323$24251632$3$F$$20240904$20240827$20240915$30DAY$$GB-JNJFOC-20240845087$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240916$$CN$GB$GB
242516333$24251633$3$F$20240820$20240903$20240827$20240904$PER$$US-AMGEN-USASP2024169558$AMGEN$$83$YR$E$M$Y$$$20240904$$CN$US$US
242516342$24251634$2$F$20230909$20240830$20240827$20240910$EXP$$DK-NOVOPROD-1135455$NOVO NORDISK$$69$YR$$F$Y$144$KG$20240910$$CN$DK$DK
242516351$24251635$1$I$$20240815$20240827$20240827$EXP$$US-NOVOPROD-1272284$NOVO NORDISK$$$$$F$Y$$$20240827$$CN$US$US
242516361$24251636$1$I$$20240820$20240827$20240827$EXP$$US-CHATTEMPRD-2024OHG028498$CHATTEM$$$$$M$Y$$$20240827$$LW$US$US
242516371$24251637$1$I$20230101$20240816$20240827$20240827$EXP$$US-NOVOPROD-1140134$NOVO NORDISK$$75$YR$$M$Y$$$20240827$$CN$US$US
242516391$24251639$1$I$20240101$20240814$20240827$20240827$EXP$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240800637$COLLEGIUM PHARMACEUTICAL$$$$$F$Y$$$20240826$$PH$US$US
242516401$24251640$1$I$$20240823$20240827$20240827$EXP$$CN-TAKEDA-2024TUS085679$TAKEDA$$$$$M$Y$$$20240827$$CN$CN$CN
242516411$24251641$1$I$20240126$20240819$20240827$20240827$EXP$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240800646$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240826$$CN$US$US
242516421$24251642$1$I$20210901$20240815$20240827$20240827$PER$$US-JNJFOC-20240842017$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240827$$CN$US$US
242516431$24251643$1$I$$20240822$20240827$20240827$EXP$$CA-TAKEDA-2024TUS085550$TAKEDA$$$$$F$Y$$$20240827$$CN$CA$CA
242516441$24251644$1$I$$20240821$20240827$20240827$EXP$$NVSC2024US169945$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242516451$24251645$1$I$20240824$20240825$20240827$20240827$EXP$$MY-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047641$BOEHRINGER INGELHEIM$$46$YR$A$M$Y$$$20240827$$MD$MY$MY
242516461$24251646$1$I$$20240821$20240827$20240827$EXP$$JP-GSK-JP2024JPN104612$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$PH$JP$JP
242516471$24251647$1$I$$20240802$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127117$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240827$$HP$US$US
242516481$24251648$1$I$$20240820$20240827$20240827$EXP$$US-JNJFOC-20240855277$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242516491$24251649$1$I$20240823$20240823$20240827$20240827$EXP$$AU-ABBVIE-5894112$ABBVIE$$91$YR$$F$Y$$$20240827$$CN$AU$AU
242516501$24251650$1$I$20240101$20240822$20240827$20240827$EXP$$US-ABBVIE-5893197$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242516511$24251651$1$I$20240409$20240821$20240827$20240827$EXP$FR-AFSSAPS-NT2024000977$FR-HALEON-2193139$Haleon PLC$$15$YR$$F$Y$55.8$KG$20240826$$MD$FR$FR
242516521$24251652$1$I$20240822$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168981$AMGEN$$63$YR$A$F$Y$$$20240826$$CN$US$US
242516531$24251653$1$I$20240815$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168159$AMGEN$$74$YR$E$M$Y$$$20240826$$CN$US$US
242516561$24251656$1$I$$20240812$20240827$20240827$PER$$US-TEVA-VS-3232794$TEVA$$$$$M$Y$$$20240827$$HP$US$US
242516571$24251657$1$I$20240201$20240811$20240827$20240827$EXP$$DE-ABBVIE-5886214$ABBVIE$$74$YR$$F$Y$$$20240827$$CN$DE$DE
242516581$24251658$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA243663$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$CN$US$US
242516591$24251659$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246381$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240827$$MD$US$US
242516611$24251661$1$I$$20240816$20240827$20240827$EXP$GB-MHRA-MED-202408161707416910-TSFMN$GB-NOVOPROD-1270438$NOVO NORDISK$$$$$F$Y$$$20240827$$PH$GB$GB
242516621$24251662$1$I$$20240816$20240827$20240827$EXP$$TR-NOVOPROD-1271740$NOVO NORDISK$$$$$$Y$$$20240827$$PH$TR$TR
242516632$24251663$2$F$$20240827$20240827$20240909$EXP$$LB-NOVOPROD-1271733$NOVO NORDISK$$6$YR$$M$Y$35$KG$20240909$$MD$LB$LB
242516641$24251664$1$I$$20240816$20240827$20240827$EXP$$TR-NOVOPROD-1271750$NOVO NORDISK$$$$$M$Y$$$20240827$$CN$TR$TR
242516651$24251665$1$I$$20240816$20240827$20240827$EXP$$US-NOVOPROD-1271755$NOVO NORDISK$$$$A$F$Y$$$20240827$$CN$US$US
242516661$24251666$1$I$20240701$20240816$20240827$20240827$EXP$$US-NOVOPROD-1271756$NOVO NORDISK$$68$YR$$M$Y$$$20240827$$CN$US$US
242516671$24251667$1$I$$20240816$20240827$20240827$EXP$$TR-NOVOPROD-1271778$NOVO NORDISK$$$$$M$Y$$$20240827$$CN$TR$TR
242516681$24251668$1$I$$20240816$20240827$20240827$EXP$$GB-NOVOPROD-1270778$NOVO NORDISK$$37$YR$$F$Y$$$20240827$$CN$GB$GB
242516691$24251669$1$I$20240601$20240816$20240827$20240827$EXP$$TR-NOVOPROD-1271745$NOVO NORDISK$$$$$M$Y$$$20240827$$PH$TR$TR
242516701$24251670$1$I$20150101$20240816$20240827$20240827$EXP$$US-NOVOPROD-1271150$NOVO NORDISK$$86$YR$$F$Y$$$20240827$$CN$US$US
242516711$24251671$1$I$$20240816$20240827$20240827$EXP$$TR-NOVOPROD-1271788$NOVO NORDISK$$$$$F$Y$61$KG$20240827$$HP$TR$TR
242516721$24251672$1$I$$20240823$20240827$20240827$EXP$$US-ARGENX-2024-ARGX-US007045$ARGENX BVBA$$$$$$Y$$$20240827$$HP$US$US
242516732$24251673$2$F$20240807$20240906$20240827$20240918$EXP$$US-NOVOPROD-1271879$NOVO NORDISK$$$$$F$Y$$$20240918$$CN$US$US
242516741$24251674$1$I$$20240816$20240827$20240827$EXP$$US-NOVOPROD-1271853$NOVO NORDISK$$$$$F$Y$$$20240827$$CN$US$US
242516753$24251675$3$F$$20240829$20240827$20240903$PER$$US-AMGEN-USASP2024170222$AMGEN$$$$$F$Y$$$20240902$$HP$US$US
242516761$24251676$1$I$20240101$20240816$20240827$20240827$EXP$SE-SEMPA-2024-006069$SE-NOVOPROD-1271806$NOVO NORDISK$$51$YR$$F$Y$80$KG$20240827$$MD$SE$SE
242516772$24251677$2$F$20240817$20240905$20240827$20240913$EXP$$KR-CELLTRION INC.-2024KR020050$CELLTRION$$$$$$Y$$$20240913$$HP$KR$KR
242516781$24251678$1$I$20240726$20240822$20240827$20240827$EXP$FR-AFSSAPS-PA2024001474$FR-VIIV HEALTHCARE LIMITED-FR2024104897$VIIV$$$$$$Y$$$20240827$$PH$FR$FR
242516791$24251679$1$I$$20230517$20240827$20240827$EXP$$IT-AstraZeneca-2023A118399$ASTRAZENECA$$$$$$Y$$$20240827$$MD$IT$
242516801$24251680$1$I$$20240819$20240827$20240827$EXP$$CA-HALEON-2193380$Haleon PLC$$$$$F$Y$$$20240826$$HP$CA$CA
242516811$24251681$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169930$AMGEN$$$$$$Y$$$20240826$$MD$US$US
242516822$24251682$2$F$$20240824$20240827$20240829$PER$$NVSC2024US172312$NOVARTIS$$$$$$Y$$$20240829$$CN$US$US
242516832$24251683$2$F$$20240910$20240827$20240917$EXP$$US-ABBVIE-5890176$ABBVIE$$$$$M$Y$102.05$KG$20240917$$CN$US$US
242516841$24251684$1$I$20240713$20240823$20240827$20240827$EXP$SE-SEMPA-2024-006259$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-134216$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240827$$MD$SE$SE
242516851$24251685$1$I$20240504$20240821$20240827$20240827$EXP$$US-TAKEDA-2024TUS045684$TAKEDA$$14$YR$$F$Y$$$20240827$$MD$US$US
242516861$24251686$1$I$20240801$20240816$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131080$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$81.37$KG$20240827$$PH$US$US
242516882$24251688$2$F$20240101$20240826$20240827$20240830$EXP$$US-ABBVIE-5891836$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242516891$24251689$1$I$20240821$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168229$AMGEN$$73$YR$E$F$Y$$$20240826$$CN$US$US
242516901$24251690$1$I$20240801$20240821$20240827$20240827$EXP$$CN-JNJFOC-20240865626$JOHNSON AND JOHNSON$$72$YR$E$M$Y$80$KG$20240827$$HP$CN$CN
242516912$24251691$2$F$$20240827$20240827$20240902$EXP$$CA-HALEON-2193158$Haleon PLC$$40$YR$$F$Y$96$KG$20240902$$HP$CA$CA
242516922$24251692$2$F$$20240913$20240827$20240918$EXP$$NVSJ2024JP009938$NOVARTIS$$$$E$M$Y$$$20240918$$MD$JP$JP
242516931$24251693$1$I$$20240813$20240827$20240827$EXP$$US-MALLINCKRODT-MNK202405143$MALLINCKRODT$$$$$F$Y$$$20240827$$CN$US$US
242516941$24251694$1$I$$20240826$20240827$20240827$EXP$$CA-ORGANON-O2408USA001848$ORGANON$Unknown. Unknown. Unknown$43$YR$$F$Y$$$20240827$$HP$CA$CA
242516952$24251695$2$F$20240806$20240821$20240827$20240829$EXP$$CA-ABBVIE-5892905$ABBVIE$$$$A$M$Y$$$20240829$$CN$CA$CA
242516962$24251696$2$F$20240624$20240918$20240827$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202406017783$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240919$$CN$US$US
242516971$24251697$1$I$$20240822$20240827$20240827$EXP$$US-ABBVIE-5892549$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242516981$24251698$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041529$AUROBINDO$$74$YR$$F$Y$$$20240827$$MD$CA$CA
242516991$24251699$1$I$$20240816$20240827$20240827$EXP$$US-NOVOPROD-1272278$NOVO NORDISK$$$$$F$Y$$$20240827$$CN$US$US
242517001$24251700$1$I$20240701$20240816$20240827$20240827$EXP$$US-NOVOPROD-1273169$NOVO NORDISK$$71$YR$$F$Y$$$20240827$$CN$US$US
242517011$24251701$1$I$20240703$20240816$20240827$20240827$EXP$$US-NOVOPROD-1272628$NOVO NORDISK$$75$YR$$F$Y$$$20240827$$CN$US$US
242517021$24251702$1$I$$20240816$20240827$20240827$EXP$$US-NOVOPROD-1272210$NOVO NORDISK$$$$$F$Y$$$20240827$$CN$US$US
242517031$24251703$1$I$20240401$20240816$20240827$20240827$EXP$$US-NOVOPROD-1272674$NOVO NORDISK$$$$$F$Y$$$20240827$$CN$US$US
242517041$24251704$1$I$$20240816$20240827$20240827$30DAY$$US-NOVOPROD-1271782$NOVO NORDISK$$$$$F$Y$$$20240827$$CN$US$US
242517051$24251705$1$I$20230101$20240816$20240827$20240827$EXP$$US-NOVOPROD-1272345$NOVO NORDISK$$59$YR$$F$Y$$$20240827$$CN$US$US
242517061$24251706$1$I$$20240816$20240827$20240827$EXP$$US-NOVOPROD-1272274$NOVO NORDISK$$46$YR$$$Y$$$20240827$$CN$US$US
242517071$24251707$1$I$$20240816$20240827$20240827$EXP$$US-NOVOPROD-1272499$NOVO NORDISK$$$$A$M$Y$$$20240827$$CN$US$US
242517081$24251708$1$I$20240101$20240819$20240827$20240827$PER$$US-AMGEN-USASP2024165696$AMGEN$$77$YR$E$F$Y$$$20240826$$CN$US$US
242517092$24251709$2$F$$20240821$20240827$20240827$EXP$$US-AMGEN-USASP2024167752$AMGEN$$$$A$$Y$$$20240827$$HP$US$US
242517101$24251710$1$I$$20240816$20240827$20240827$EXP$$AR-AMGEN-ARGSP2024167585$AMGEN$$54$YR$A$F$Y$$$20240826$$CN$AR$AR
242517111$24251711$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-042010$AUROBINDO$$62$YR$$M$Y$$$20240827$$HP$CA$CA
242517121$24251712$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041416$AUROBINDO$$56$YR$$F$Y$$$20240827$$HP$CA$CA
242517131$24251713$1$I$20240731$20240813$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-041176$AUROBINDO$$15$YR$$F$Y$70$KG$20240827$$MD$GB$GB
242517141$24251714$1$I$20240206$20240820$20240827$20240827$EXP$$CN-BEIGENE-BGN-2024-013074$BEIGENE$$$$$$Y$$$20240827$$HP$CN$CN
242517152$24251715$2$F$20240601$20240905$20240827$20240916$EXP$$JP-AMGEN-JPNSP2024168970$AMGEN$$6$DEC$A$F$Y$$$20240916$$MD$JP$JP
242517161$24251716$1$I$20240819$20240820$20240827$20240827$PER$$US-AMGEN-USASP2024166762$AMGEN$$76$YR$E$M$Y$$$20240826$$PH$US$US
242517171$24251717$1$I$$20240826$20240827$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047917$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240827$$MD$US$US
242517181$24251718$1$I$20240701$20240822$20240827$20240827$EXP$$GB-ABBVIE-5893148$ABBVIE$$85$YR$$F$Y$$$20240827$$CN$GB$GB
242517191$24251719$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041815$AUROBINDO$$67$YR$$M$Y$$$20240827$$CN$CA$CA
242517201$24251720$1$I$$20240814$20240827$20240827$EXP$$IN-IPCA LABORATORIES LIMITED-IPC-2024-IN-002073$IPCA$Jyotsna Sharma, Sasirekha Rengaraj, Mashumathi Veeramuthu, et al.. Diagnostic challenges of Thrombotic Microangiopathy (TMA) in a pregnant woman remote from term and a case report of atypical TTP. An International Journal of Women^s Cardiovascular Health. 2024;36:49$$$$$Y$$$20240827$$HP$IN$IN
242517211$24251721$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041496$AUROBINDO$$77$YR$$F$Y$$$20240827$$HP$CA$CA
242517221$24251722$1$I$$20240806$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051692$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
242517231$24251723$1$I$$20240816$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051691$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
242517241$24251724$1$I$$20240806$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051690$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
242517251$24251725$1$I$20240806$20240806$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051696$TOLMAR$$89$YR$$M$Y$$$20240827$$CN$CA$CA
242517261$24251726$1$I$$20240806$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051698$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
242517271$24251727$1$I$20240101$20240816$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051693$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
242517281$24251728$1$I$20240806$20240806$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051742$TOLMAR$$84$YR$$M$Y$$$20240827$$CN$CA$CA
242517291$24251729$1$I$20240806$20240806$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051744$TOLMAR$$73$YR$$M$Y$$$20240827$$CN$CA$CA
242517301$24251730$1$I$$20240806$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051743$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
242517311$24251731$1$I$$20240806$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051749$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
242517321$24251732$1$I$$20240822$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135159$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240827$$CN$US$US
242517341$24251734$1$I$$20240814$20240827$20240827$EXP$US-MLMSERVICE-20230706-4397840-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-17174$ALKEM$Maynard RD, Bates P, Korpi-Steiner N. Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient. Practical Laboratory Medicine. 2023;36:e00322$69$YR$$F$Y$$$20240827$$HP$US$US
242517351$24251735$1$I$$20240814$20240827$20240827$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19656$ALKEM$Gupta S, Sharma S, Menon N, Ahuja S, Dahdouh M. Case report of vancomycin induced pancytopenia. Rev Soc Bras Med Trop. 2016;49(2):258-9$$$$$Y$$$20240827$$HP$US$US
242517361$24251736$1$I$$20240814$20240827$20240827$EXP$CA-MLMSERVICE-20240807-PI156099-00306-1$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-19172$ALKEM$Zhang J, Suarez A. Envarsus Induced Thrombotic Microangiopathy in an Adult Kidney Transplant Patient. Canadian Journal of Hospital Pharmacy. 2024;77(2):24$57$YR$$F$Y$$$20240827$$MD$CA$CA
242517371$24251737$1$I$$20240814$20240827$20240827$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-18479$ALKEM$Dyballa N, Hartel JA, Prangenberg J, Andresen-Streichert H.. A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting - clinical, toxicological and forensic aspects. Forensic Sci Med Pathol. 2024;unk:unk$12$WK$$M$Y$$$20240827$$HP$DE$DE
242517381$24251738$1$I$20240809$20240814$20240827$20240827$EXP$GB-MHRA-MED-202408091839511120-WQPMY$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19173$ALKEM$$28$YR$$M$Y$77$KG$20240827$$CN$GB$GB
242517391$24251739$1$I$$20240814$20240827$20240827$EXP$$IN-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19614$ALKEM$Gaensbauer JT, Dash N, Verma S, Hall DJ, Adler-Shohet FC, Li G, Lee G, Dinnes L, Wendorf K.. Multidrug-resistant tuberculosis in children: A practical update on epidemiology, diagnosis, treatment and prevention. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2024;36:100449$11$YR$$F$Y$12$KG$20240827$$HP$IN$IN
242517421$24251742$1$I$$20240820$20240827$20240827$EXP$$GB-CELLTRION INC.-2024GB020280$CELLTRION$$$$$$Y$$$20240827$$CN$GB$GB
242517431$24251743$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172521$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242517442$24251744$2$F$$20240822$20240827$20240827$EXP$$US-AMGEN-USASP2024168605$AMGEN$$$$$F$Y$$$20240827$$PH$US$US
242517452$24251745$2$F$$20240822$20240827$20240827$EXP$$US-AMGEN-USASP2024168602$AMGEN$$$$$$Y$$$20240827$$PH$US$US
242517461$24251746$1$I$20240101$20240820$20240827$20240827$EXP$$JP-JNJFOC-20240865015$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240827$$PH$JP$JP
242517471$24251747$1$I$20231014$20240819$20240827$20240827$EXP$$CA-JNJFOC-20240858757$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240827$$HP$CA$CA
242517482$24251748$2$F$$20240905$20240827$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-19220$ALKEM$$$$$M$Y$136.2$KG$20240919$$MD$DE$DE
242517491$24251749$1$I$20240601$20240813$20240827$20240827$EXP$$FR-AUROBINDO-AUR-APL-2024-040929$AUROBINDO$$63$YR$$F$Y$$$20240827$$CN$FR$FR
242517501$24251750$1$I$$20240822$20240827$20240827$PER$$US-ROCHE-10000064953$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242517512$24251751$2$F$$20240829$20240827$20240909$EXP$$PT-AUROBINDO-AUR-APL-2024-037210$AUROBINDO$Lopes B, Furtado D, Freitas J, Azevedo S, Caley L, Pedro F. CO-0247 - (4553) - OLMESARTAN ENTEROPATHY ? A RARE CAUSE OF CHRONIC DIARRHEA. Gastroenterological diseases and liver diseases. 2024;340$72$YR$$F$Y$$$20240909$$MD$PT$PT
242517521$24251752$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-042280$AUROBINDO$$43$YR$$F$Y$129$KG$20240827$$MD$CA$CA
242517531$24251753$1$I$20240101$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168666$AMGEN$$76$YR$E$M$Y$$$20240826$$CN$US$US
242517541$24251754$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013666$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240827$$CN$US$US
242517552$24251755$2$F$$20240821$20240827$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202309013644$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240830$$CN$US$US
242517561$24251756$1$I$$20240814$20240827$20240827$EXP$$IN-IPCA LABORATORIES LIMITED-IPC-2024-IN-002085$IPCA$Jyotsna Sharma, Sasirekha Rengaraj, Mashumathi Veeramuthu, et al. Diagnostic challenges of Thrombotic Microangiopathy (TMA) in a pregnant woman remote from term and a case report of atypical TTP. An International Journal of Women^s Cardiovascular Health. 2024;36:49$$$$$Y$$$20240827$$HP$IN$IN
242517571$24251757$1$I$$20240813$20240827$20240827$EXP$$US-UCBSA-2024041254$UCB$$$$$F$Y$$$20240827$$HP$US$US
242517581$24251758$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134561$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$45.81$KG$20240827$$CN$US$US
242517591$24251759$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041491$AUROBINDO$$61$YR$$M$Y$$$20240827$$HP$CA$CA
242517621$24251762$1$I$20240701$20240819$20240827$20240827$PER$$US-ABBVIE-5886876$ABBVIE$$$$$M$Y$$$20240827$$HP$US$US
242517631$24251763$1$I$20240517$20240813$20240827$20240827$EXP$$FR-AUROBINDO-AUR-APL-2024-040972$AUROBINDO$$68$YR$$M$Y$89$KG$20240827$$MD$FR$FR
242517643$24251764$3$F$20240822$20240827$20240827$20240903$EXP$$US-ROCHE-10000065868$ROCHE$$84$YR$E$M$Y$$$20240903$$CN$US$US
242517651$24251765$1$I$$20240814$20240827$20240827$EXP$$CA-JNJFOC-20230443950$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240827$$HP$CA$CA
242517661$24251766$1$I$$20240819$20240827$20240827$EXP$$FR-Orion Corporation ORION PHARMA-TREX2024-0219$ORION$Strizzolo R, Seneschal J. Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab. World Allergy Organ J. 2024 JUL 04;17(7):.$$$A$$Y$$$20240827$$MD$FR$
242517671$24251767$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172525$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242517681$24251768$1$I$20240805$20240820$20240827$20240827$EXP$$NVSC2024US170097$NOVARTIS$$59$YR$$M$Y$190$KG$20240827$$CN$US$US
242517691$24251769$1$I$$20240813$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-040652$AUROBINDO$Boozel T, Moran J, Godil S, Lenivy C, Musco K, Lustgarten DS.. What about the rash? a case of disseminated varicella zoster virus leading to ards. Chest. 2020;158(4):A2047-A2048$58$YR$$F$Y$$$20240827$$MD$US$US
242517701$24251770$1$I$$20240821$20240827$20240827$EXP$$JP-SANDOZ INC.-SDZ2024JP074535$SANDOZ$Miyoshi T, Kubokawa C, Suzuki J, Motomura H. A case of substance-induced psychotic disorder in which cycloserine treatment for pulmonary tuberculosis caused hallucinations-delusions. The 120th Annual Meeting of the Japanese Neuropsychiatric Society (2024.06.20-20. 2024;1-P12-3$25$YR$$M$Y$$$20240827$$MD$JP$JP
242517711$24251771$1$I$$20240820$20240827$20240827$PER$$US-AMGEN-USASP2024166206$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242517721$24251772$1$I$$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168236$AMGEN$$$$$F$Y$$$20240826$$CN$US$US
242517731$24251773$1$I$20240821$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168221$AMGEN$$62$YR$A$F$Y$$$20240826$$HP$US$US
242517741$24251774$1$I$$20240822$20240827$20240827$PER$$US-GILEAD-2024-0685158$GILEAD$$54$YR$A$$Y$$$20240826$$MD$US$US
242517751$24251775$1$I$$20240813$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-041083$AUROBINDO$Tang CJ, Balu R, Thomas CA, King CS, Shlobin OA, Aryal S, et al.. Spinal Cord Infarction Associated With VA-ECMO Suppor. Am-J-Respir-Crit-Care-Med. 2024$46$YR$$F$Y$$$20240827$$HP$US$US
242517761$24251776$1$I$$20240812$20240827$20240827$EXP$CA-MHPD-001088765$CA-Accord-441985$ACCORD$$25$YR$A$M$Y$77$KG$20240824$$HP$CA$CA
242517771$24251777$1$I$$20240816$20240827$20240827$EXP$$PH-GSK-PH2024APC102340$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$PH$PH
242517782$24251778$2$F$20231221$20240820$20240827$20240901$EXP$$US-ABBVIE-5893061$ABBVIE$$83$YR$$F$Y$86$KG$20240901$$MD$US$US
242517791$24251779$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041460$AUROBINDO$$75$YR$$M$Y$$$20240827$$PH$CA$CA
242517801$24251780$1$I$$20240815$20240827$20240827$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS004281$TERSERA THERAPEUTICS$$$$$$Y$$$20240827$$CN$AU$AU
242517811$24251781$1$I$20240116$20240823$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134649$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240827$$CN$US$US
242517821$24251782$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041544$AUROBINDO$$79$YR$$M$Y$$$20240827$$MD$CA$CA
242517831$24251783$1$I$$20240821$20240827$20240827$EXP$$BG-TAKEDA-2023TUS077006$TAKEDA$$$$$M$Y$$$20240827$$CN$BG$BG
242517841$24251784$1$I$$20240814$20240827$20240827$EXP$$IT-UCBSA-2024042029$UCB$$$$E$F$Y$$$20240827$$CN$IT$IT
242517851$24251785$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192618$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242517861$24251786$1$I$$20240823$20240827$20240827$EXP$$JP-TAKEDA-2024TJP012457$TAKEDA$$8$DEC$$F$Y$$$20240827$$MD$JP$JP
242517872$24251787$2$F$$20240827$20240827$20240905$EXP$$US-AUROBINDO-AUR-APL-2024-041848$AUROBINDO$$52$YR$$F$Y$$$20240905$$PH$US$US
242517881$24251788$1$I$20240814$20240816$20240827$20240827$EXP$$CN-SA-2024SA248266$SANOFI AVENTIS$$14$YR$T$M$Y$52$KG$20240827$$HP$CN$CN
242517892$24251789$2$F$20231201$20240912$20240827$20240924$EXP$$CA-APOTEX-2024AP001701$APOTEX$$54$YR$A$F$Y$$$20240924$$PH$CA$CA
242517902$24251790$2$F$$20240807$20240827$20240909$PER$$US-RDY-CLI/USA/24/0011702$DR REDDYS$$47$YR$A$F$Y$$$20240909$$HP$US$US
242517911$24251791$1$I$$20240809$20240827$20240827$PER$$US-RDY-CLI/USA/24/0011946$DR REDDYS$$34$YR$A$M$Y$$$20240827$$CN$US$US
242517921$24251792$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041600$AUROBINDO$$54$YR$$M$Y$$$20240827$$HP$CA$CA
242517931$24251793$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135340$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240827$$CN$US$US
242517941$24251794$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135359$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240827$$HP$US$US
242517951$24251795$1$I$20240809$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168510$AMGEN$$$$$$Y$$$20240826$$PH$US$US
242517961$24251796$1$I$$20240819$20240827$20240827$EXP$$US-BIOGEN-2024BI01279310$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
242517971$24251797$1$I$$20240724$20240827$20240827$PER$$US-HALEON-2193595$Haleon PLC$$75$YR$$M$Y$$$20240827$$CN$US$US
242517981$24251798$1$I$$20240806$20240827$20240827$PER$$US-UniquePharma-US-2024UPLSPO00028$UNIQUE PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242517991$24251799$1$I$20240821$20240821$20240827$20240827$EXP$$US-JNJFOC-20240859455$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240827$$MD$US$US
242518001$24251800$1$I$$20240819$20240827$20240827$EXP$$BR-BIOGEN-2024BI01279218$BIOGEN$$$$$F$Y$63$KG$20240827$$CN$BR$BR
242518011$24251801$1$I$20231025$20240821$20240827$20240827$EXP$ES-AEMPS-1548244$ES-TAKEDA-2024TUS085582$TAKEDA$$80$YR$$F$Y$$$20240827$$HP$ES$ES
242518021$24251802$1$I$$20240813$20240827$20240827$EXP$$US-PADAGIS-2024PAD01338$PADAGIS$$$$$$Y$$$20240827$$CN$US$US
242518031$24251803$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-042407$AUROBINDO$$5$YR$$M$Y$$$20240827$$HP$CA$CA
242518041$24251804$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015615$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242518051$24251805$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013913$ELI LILLY AND CO$$61$YR$A$$Y$$$20240827$$LW$US$US
242518061$24251806$1$I$20240813$20240814$20240827$20240827$EXP$$US-Accord-442133$ACCORD$$61$YR$A$M$Y$$$20240824$$HP$US$US
242518071$24251807$1$I$20240812$20240812$20240827$20240827$EXP$$US-Accord-442988$ACCORD$$59$YR$A$F$Y$$$20240824$$HP$US$US
242518081$24251808$1$I$20240730$20240814$20240827$20240827$EXP$$US-Accord-442510$ACCORD$$61$YR$A$M$Y$$$20240824$$HP$US$US
242518091$24251809$1$I$20240531$20240813$20240827$20240827$EXP$CN-HENLIUS-24CN016417$CN-Accord-443040$ACCORD$$41$YR$A$F$Y$$$20240824$$MD$CN$CN
242518101$24251810$1$I$$20240812$20240827$20240827$EXP$$PT-Accord-441574$ACCORD$Ferreira IP, Sousa C, Silva IF, Borges J, Sousa A, Queijo C et al. CO-0261 - (4630) - Pauci-immune glomerulonephritis in an immunocompromised patient- about a clinical case. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of?abstracts(CNMI). 2024 May;353.$70$YR$E$M$Y$$$20240824$$MD$PT$PT
242518111$24251811$1$I$$20240813$20240827$20240827$EXP$GB-MHRA-MED-202407231322292240-HFTRG$GB-Accord-441617$ACCORD$$57$YR$A$F$Y$67$KG$20240824$$CN$GB$GB
242518121$24251812$1$I$20100404$20240813$20240827$20240827$EXP$GB-MHRA-MED-202407221232258900-WJLGD$GB-Accord-441786$ACCORD$$26$YR$A$F$Y$$$20240824$$CN$GB$GB
242518131$24251813$1$I$$20240814$20240827$20240827$EXP$CA-MHPD-E2B_07181886$CA-Accord-442438$ACCORD$$$$$$Y$$$20240824$$MD$CA$CA
242518141$24251814$1$I$$20240813$20240827$20240827$EXP$GB-MHRA-MIDB-0575d771-8d4d-4fc3-9015-01765a334cc3$GB-Accord-441633$ACCORD$$66$YR$E$F$Y$$$20240824$$PH$GB$GB
242518151$24251815$1$I$20240731$20240813$20240827$20240827$EXP$GB-MHRA-MED-202408131405064460-JNKSH$GB-Accord-441758$ACCORD$$42$YR$A$F$Y$$$20240824$$PH$GB$GB
242518161$24251816$1$I$$20240813$20240827$20240827$EXP$NL-LRB-00996332$NL-Accord-441716$ACCORD$$70$YR$E$M$Y$92$KG$20240824$$CN$NL$NL
242518171$24251817$1$I$$20240814$20240827$20240827$EXP$CA-MHPD-E2B_07185934$CA-Accord-442330$ACCORD$$49$YR$A$M$Y$$$20240824$$HP$CA$CA
242518181$24251818$1$I$20240723$20240813$20240827$20240827$EXP$GB-MHRA-MED-202408131043158700-MPBTV$GB-Accord-441621$ACCORD$$58$YR$A$F$Y$81$KG$20240824$$CN$GB$GB
242518191$24251819$1$I$20240823$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169530$AMGEN$$$$$F$Y$$$20240826$$HP$US$US
242518201$24251820$1$I$20240807$20240813$20240827$20240827$EXP$GB-MHRA-MED-202408081158340560-CGTMZ$GB-Accord-441618$ACCORD$$57$YR$A$M$Y$$$20240824$$HP$GB$GB
242518211$24251821$1$I$20240802$20240813$20240827$20240827$EXP$GB-MHRA-MED-202408131635375860-ZYKNH$GB-Accord-441765$ACCORD$$68$YR$E$F$Y$$$20240824$$PH$GB$GB
242518221$24251822$1$I$$20240825$20240827$20240827$PER$$NVSC2024US172218$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
242518233$24251823$3$F$20221212$20240910$20240827$20240911$PER$$US-BIOVITRUM-2024-US-011308$BIOVITRUM$$75$YR$$M$Y$$$20240911$$MD$US$US
242518241$24251824$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-042264$AUROBINDO$$45$YR$$F$Y$$$20240827$$CN$CA$CA
242518253$24251825$3$F$20240214$20240919$20240827$20240925$EXP$$US-TAKEDA-2024TUS015232$TAKEDA$$62$YR$$F$Y$$$20240925$$CN$US$US
242518261$24251826$1$I$20240101$20240819$20240827$20240827$EXP$$CA-CELLTRION INC.-2023CA025173$CELLTRION$$$$$$Y$$$20240827$$MD$CA$CA
242518276$24251827$6$F$20230901$20240920$20240827$20240926$EXP$$BR-BIOGEN-2024BI01279110$BIOGEN$$80$YR$$M$Y$$$20240926$$HP$BR$BR
242518281$24251828$1$I$$20240812$20240827$20240827$EXP$$CA-LUPIN HEALTHCARE (UK) LIMITED-2024-08238$LUPIN$$48$YR$$F$Y$$$20240827$$HP$CA$CA
242518301$24251830$1$I$20240101$20240814$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-041525$AUROBINDO$$81$YR$$M$Y$82$KG$20240827$$MD$GB$GB
242518311$24251831$1$I$20240703$20240814$20240827$20240827$EXP$$ES-AUROBINDO-AUR-APL-2024-041484$AUROBINDO$$47$YR$$M$Y$$$20240827$$MD$ES$ES
242518321$24251832$1$I$20201021$20240814$20240827$20240827$EXP$$PL-AUROBINDO-AUR-APL-2024-041582$AUROBINDO$$69$YR$$F$Y$58$KG$20240827$$HP$PL$PL
242518331$24251833$1$I$20240726$20240820$20240827$20240827$EXP$$US-BEH-2024177464$CSL BEHRING$$18$YR$A$M$Y$$$20240827$$CN$US$US
242518351$24251835$1$I$$20240821$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133927$BRISTOL MYERS SQUIBB$$31$YR$A$F$Y$$$20240827$$HP$US$US
242518361$24251836$1$I$$20240819$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135539$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240827$$CN$US$US
242518371$24251837$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-042320$AUROBINDO$$57$YR$$M$Y$$$20240827$$HP$CA$CA
242518383$24251838$3$F$20240816$20240829$20240827$20240902$EXP$$CA-ROCHE-10000065733$ROCHE$$21$YR$A$F$Y$$$20240902$$CN$CA$CA
242518391$24251839$1$I$$20240820$20240827$20240827$EXP$$US-BIOGEN-2024BI01279393$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
242518401$24251840$1$I$20240527$20240820$20240827$20240827$EXP$$DE-BIOGEN-2024BI01279485$BIOGEN$$35$YR$$F$Y$78$KG$20240827$$MD$DE$DE
242518411$24251841$1$I$20240801$20240815$20240827$20240827$EXP$$US-BIOGEN-2024BI01278802$BIOGEN$$32$YR$$F$Y$$$20240827$$CN$US$US
242518421$24251842$1$I$$20240816$20240827$20240827$PER$$US-AMGEN-USASP2024164414$AMGEN$Jones J.T.; Espinoza-gutarra M.R.; Kakarla S. et.al.. Veterans Treated with R-CHOP for Diffuse Large B Cell Lymphoma Compared to Neighboring Hospital- An Interesting Discovery for Treatment Outcomes. Blood. 2018;132 (SUPPL_1):3604$$$$$Y$$$20240826$$MD$US$US
242518431$24251843$1$I$20240821$20240821$20240827$20240827$PER$$US-AMGEN-USASP2024169024$AMGEN$$$$$$Y$$$20240826$$CN$US$US
242518442$24251844$2$F$20240701$20240821$20240827$20240912$PER$$US-AMGEN-USASP2024167077$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
242518451$24251845$1$I$$20240814$20240827$20240827$EXP$$IT-AUROBINDO-AUR-APL-2024-041809$AUROBINDO$$68$YR$$M$Y$$$20240827$$CN$IT$IT
242518461$24251846$1$I$$20240822$20240827$20240827$EXP$$GB-JNJFOC-20240860974$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240827$$HP$GB$GB
242518471$24251847$1$I$$20240814$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-041282$AUROBINDO$$71$YR$$F$Y$50$KG$20240827$$MD$GB$GB
242518481$24251848$1$I$$20240813$20240827$20240827$EXP$$US-PADAGIS-2024PAD01340$PADAGIS$$$$$$Y$$$20240827$$CN$US$US
242518491$24251849$1$I$20231226$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-081944-2024$RECKITT BENCKISER$$$$$F$Y$$$20240827$$CN$US$US
242518501$24251850$1$I$$20240802$20240827$20240827$PER$$US-AstraZeneca-2024A177010$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242518511$24251851$1$I$20240601$20240821$20240827$20240827$PER$$US-AMGEN-USASP2024167494$AMGEN$$65$YR$E$F$Y$$$20240826$$CN$US$US
242518521$24251852$1$I$20230101$20240820$20240827$20240827$EXP$$US-AMGEN-USASP2024166730$AMGEN$$78$YR$E$F$Y$$$20240826$$CN$US$US
242518531$24251853$1$I$20240101$20240822$20240827$20240827$PER$$US-ABBVIE-5893798$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242518552$24251855$2$F$$20240916$20240827$20240917$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047643$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240917$$CN$US$US
242518561$24251856$1$I$20240821$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168795$AMGEN$$49$YR$A$F$Y$$$20240826$$CN$US$US
242518571$24251857$1$I$$20240814$20240827$20240827$EXP$$US-CHATTEMPRD-2024OHG027979$CHATTEM$Green KD, Bianco LM, Mccleskey BC, Scott KS. The Emergence of Bromazolam in Jefferson County AL. A Case Series. Journal of analytical toxicology. 2024. doi:10.1093/jat/bkae067/7725379.$34$YR$A$F$Y$$$20240827$$HP$US$US
242518581$24251858$1$I$20240101$20240822$20240827$20240827$PER$$US-ABBVIE-5893841$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242518591$24251859$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134555$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$63.05$KG$20240827$$CN$US$US
242518601$24251860$1$I$20240713$20240823$20240827$20240827$EXP$SE-SEMPA-2024-006257$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-135111$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240827$$MD$SE$SE
242518611$24251861$1$I$$20240820$20240827$20240827$EXP$CA-DRL-USA-SPO/CAN/24/0012127$CA-RDY-SPO/CAN/24/0012127$DR REDDYS$$76$YR$E$M$Y$75$KG$20240827$$HP$CA$CA
242518622$24251862$2$F$20240821$20240826$20240827$20240829$PER$$US-AMGEN-USASP2024169271$AMGEN$$59$YR$A$M$Y$$$20240829$$CN$US$US
242518631$24251863$1$I$20240823$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015303$ELI LILLY AND CO$$$$A$F$Y$$$20240827$$CN$US$US
242518641$24251864$1$I$20240821$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013821$ELI LILLY AND CO$$41$YR$A$$Y$$$20240827$$CN$US$US
242518651$24251865$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015048$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240827$$CN$US$US
242518661$24251866$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015172$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240827$$CN$US$US
242518671$24251867$1$I$20240614$20240822$20240827$20240827$EXP$$BE-AUROBINDO-AUR-APL-2024-042457$AUROBINDO$$18$YR$$F$Y$$$20240827$$HP$BE$BE
242518681$24251868$1$I$20240628$20240820$20240827$20240827$EXP$$US-BEH-2024177472$CSL BEHRING$$$$$M$Y$$$20240827$$PH$US$US
242518692$24251869$2$F$20240813$20240827$20240827$20240829$EXP$$GB-009507513-2408GBR008347$MERCK$$$$E$M$Y$$$20240829$$HP$GB$GB
242518701$24251870$1$I$20240816$20240820$20240827$20240827$EXP$$US-BEH-2024177553$CSL BEHRING$$54$YR$A$F$Y$$$20240827$$CN$US$US
242518711$24251871$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004224$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242518721$24251872$1$I$20240801$20240814$20240827$20240827$EXP$$DE-AUROBINDO-AUR-APL-2024-041667$AUROBINDO$$60$YR$$M$Y$$$20240827$$MD$DE$DE
242518731$24251873$1$I$$20240822$20240827$20240827$PER$$US-TAKEDA-2024TUS085846$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
242518741$24251874$1$I$20240809$20240823$20240827$20240827$EXP$$US-ABBVIE-5893354$ABBVIE$$87$YR$$F$Y$$$20240827$$CN$US$US
242518751$24251875$1$I$$20240815$20240827$20240827$EXP$$AU-AMNEAL PHARMACEUTICALS-2024-AMRX-03044$AMNEAL$Montarello N.L, Irvine I, Warner V, Hare J, Kaye D, et al.. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report. BMC Neurology. 2024;24:1:277$51$YR$$F$Y$$$20240827$$HP$AU$AU
242518761$24251876$1$I$20240730$20240822$20240827$20240827$EXP$$SE-AstraZeneca-2024A191217$ASTRAZENECA$$64$YR$$F$Y$$$20240827$$MD$SE$
242518771$24251877$1$I$$20240818$20240827$20240827$EXP$$US-AMGEN-USASP2024168752$AMGEN$Mokhtari S.; Verma N.; Jaffer M. et al.. Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis. Cureus. 2021;13 (7):1-5$70$YR$E$F$Y$$$20240826$$HP$US$US
242518781$24251878$1$I$20240208$20240823$20240827$20240827$EXP$$US-ABBVIE-5892935$ABBVIE$$44$YR$$M$Y$$$20240827$$CN$US$US
242518791$24251879$1$I$20240510$20240819$20240827$20240827$EXP$$CA-JNJFOC-20240843723$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240827$$PH$CA$CA
242518803$24251880$3$F$20240820$20240829$20240827$20240903$PER$$US-JNJFOC-20240851791$JOHNSON AND JOHNSON$$66$YR$E$F$Y$38.3$KG$20240903$$PH$US$US
242518811$24251881$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004226$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242518831$24251883$1$I$20240801$20240822$20240827$20240827$EXP$$US-ABBVIE-5892552$ABBVIE$$27$YR$$F$Y$$$20240827$$CN$US$US
242518841$24251884$1$I$20240801$20240822$20240827$20240827$PER$$US-ROCHE-10000064302$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242518851$24251885$1$I$20240627$20240823$20240827$20240827$EXP$$DE-AMGEN-DEUSP2024169165$AMGEN$$73$YR$E$F$Y$$$20240826$$MD$DE$DE
242518861$24251886$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004228$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242518871$24251887$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004277$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242518883$24251888$3$F$20240724$20240925$20240827$20240927$EXP$$CA-ROCHE-3435368$ROCHE$$43$YR$A$F$Y$$$20240927$$CN$CA$CA
242518891$24251889$1$I$$20240820$20240827$20240827$EXP$$AU-RDY-SPO/AUS/24/0012284$DR REDDYS$$54$YR$A$F$Y$$$20240827$$CN$AU$AU
242518901$24251890$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134869$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$78.93$KG$20240827$$HP$US$US
242518911$24251891$1$I$20240801$20240820$20240827$20240827$PER$$US-BIOGEN-2024BI01279172$BIOGEN$$71$YR$$F$Y$$$20240827$$CN$US$US
242518922$24251892$2$F$$20240820$20240827$20240827$EXP$$US-BIOGEN-2024BI01279208$BIOGEN$$$$$F$Y$75.818$KG$20240827$$CN$US$US
242518931$24251893$1$I$$20240815$20240827$20240827$EXP$$US-PADAGIS-2024PAD01350$PADAGIS$$$$$$Y$$$20240827$$CN$US$US
242518941$24251894$1$I$20240101$20240820$20240827$20240827$PER$$US-BIOGEN-2024BI01279207$BIOGEN$$$$$M$Y$$$20240827$$HP$US$US
242518951$24251895$1$I$$20240819$20240827$20240827$EXP$$CA-HALEON-2193095$Haleon PLC$$43$YR$$F$Y$97$KG$20240827$$HP$CA$CA
242518961$24251896$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004229$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242518971$24251897$1$I$20240611$20240801$20240827$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004278$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240827$$CN$US$US
242518981$24251898$1$I$$20240823$20240827$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US067026$SANDOZ$$$$$M$Y$$$20240827$$CN$US$US
242518991$24251899$1$I$$20240820$20240827$20240827$PER$$US-JNJFOC-20240851561$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$HP$US$US
242519002$24251900$2$F$$20240808$20240827$20240829$PER$$US-JNJFOC-20240822829$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242519011$24251901$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004279$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242519021$24251902$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004232$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242519031$24251903$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004233$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242519041$24251904$1$I$$20240822$20240827$20240827$PER$$NVSC2024US171379$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242519051$24251905$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004281$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242519062$24251906$2$F$20240801$20240913$20240827$20240920$EXP$$US-BEH-2024177561$CSL BEHRING$$65$YR$E$F$Y$$$20240920$$CN$US$US
242519071$24251907$1$I$20240808$20240816$20240827$20240827$EXP$$US-ROCHE-10000060342$ROCHE$$49$YR$A$M$Y$$$20240827$$CN$US$US
242519082$24251908$2$F$20240101$20240906$20240827$20240912$EXP$$US-AMGEN-USASP2024167771$AMGEN$$60$YR$A$M$Y$122$KG$20240912$$HP$US$US
242519091$24251909$1$I$20240822$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168240$AMGEN$$55$YR$A$F$Y$$$20240826$$PH$US$US
242519101$24251910$1$I$$20240822$20240827$20240827$EXP$$IN-CIPLA (EU) LIMITED-2024IN07966$CIPLA$Kapoor R, Tyagi M, Sadda S.. Suspected retinal toxicity after multiple intravitreal ganciclovir injections in a patient of CMV retinitis. Ocular Immunology and Inflammation. 2024;32 (5):525 to 528$$$$$Y$$$20240827$$HP$IN$IN
242519111$24251911$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004285$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242519122$24251912$2$F$$20240923$20240827$20240930$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001681$BLUEPRINT MEDICINES$$$$$F$Y$$$20240930$$CN$US$US
242519131$24251913$1$I$20240809$20240816$20240827$20240827$EXP$$US-PADAGIS-2024PAD01355$PADAGIS$$$$$$Y$$$20240827$$CN$US$US
242519141$24251914$1$I$20240721$20240816$20240827$20240827$EXP$$US-PADAGIS-2024PAD01352$PADAGIS$$$$$$Y$$$20240827$$CN$US$US
242519151$24251915$1$I$20240814$20240826$20240827$20240827$EXP$$CN-ROCHE-10000066407$ROCHE$$61$YR$A$F$Y$60$KG$20240827$$HP$CN$CN
242519161$24251916$1$I$$20240816$20240827$20240827$EXP$$US-PADAGIS-2024PAD01354$PADAGIS$$$$$$Y$$$20240827$$HP$US$US
242519171$24251917$1$I$$20240820$20240827$20240827$EXP$CA-DRL-USA-SPO/CAN/24/0012159$CA-RDY-SPO/CAN/24/0012159$DR REDDYS$$82$YR$E$M$Y$$$20240827$$PH$CA$CA
242519181$24251918$1$I$$20240820$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132724$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240827$$CN$US$US
242519191$24251919$1$I$20240801$20240801$20240827$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004238$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240827$$CN$US$US
242519201$24251920$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004235$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242519211$24251921$1$I$20240813$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192056$ASTRAZENECA$$31906$DY$$M$Y$$$20240827$$CN$US$
242519221$24251922$1$I$20230101$20240817$20240827$20240827$EXP$$NZ-ROCHE-10000060527$ROCHE$$46$YR$A$F$Y$$$20240827$$MD$NZ$NZ
242519231$24251923$1$I$20240822$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015179$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240827$$CN$US$US
242519241$24251924$1$I$20240601$20240815$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408011637$ELI LILLY AND CO$$$$$F$Y$$$20240827$$MD$US$US
242519251$24251925$1$I$20240814$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015037$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240827$$CN$US$US
242519261$24251926$1$I$20240821$20240821$20240827$20240827$PER$$US-JNJFOC-20240857739$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$PH$US$US
242519281$24251928$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004286$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242519292$24251929$2$F$20230528$20240823$20240827$20240904$EXP$$TR-ALXN-202401GLO001762TR$ALEXION PHARMACEUTICALS$$30$YR$$F$Y$60$KG$20240904$$CN$TR$TR
242519301$24251930$1$I$$20240814$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-041546$AUROBINDO$$$$$F$Y$$$20240827$$CN$GB$GB
242519321$24251932$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004351$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242519331$24251933$1$I$$20240819$20240827$20240827$EXP$$CA-ROCHE-10000060550$ROCHE$$50$YR$A$F$Y$96$KG$20240827$$HP$CA$CA
242519342$24251934$2$F$$20240830$20240827$20240909$EXP$$JP-TEVA-VS-3235274$TEVA$Tokuchi M, Yonishi H, Namba-Hamano T. Successful treatment of a renal allograft abscess with antimicrobial agents alone and appropriate follow-up imaging. Transpl-Infect-Dis 2024; 26 (3):.; Tokuchi M, Yonishi H, Namba-Hamano T. Successful treatment of a renal allograft abscess with antimicrobial agents alone and appropriate follow-up imaging. Transpl-Infect-Dis 2024; 26 (3):.; Tokuchi M, Yonishi H, Namba-Hamano T. Successful treatment of a renal allograft abscess with antimicrobial agents alo...$21$YR$$F$Y$$$20240909$$HP$JP$JP
242519351$24251935$1$I$$20240809$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08162$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242519361$24251936$1$I$$20240822$20240827$20240827$EXP$$JP-ROCHE-10000065537$ROCHE$$$$$$Y$$$20240827$$PH$JP$JP
242519372$24251937$2$F$20220128$20240823$20240827$20240906$EXP$GB-MHRA-MED-202408151029268990-YCFTZ$GB-UCBSA-2024041435$UCB$$21$YR$$F$Y$$$20240906$$CN$GB$GB
242519381$24251938$1$I$$20240506$20240827$20240827$EXP$$CA-ROCHE-10000060946$ROCHE$$40$YR$A$M$Y$$$20240827$$CN$CA$CA
242519391$24251939$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004243$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$HP$US$US
242519401$24251940$1$I$$20240822$20240827$20240827$EXP$$SG-ROCHE-10000065148$ROCHE$$$$$M$Y$$$20240827$$CN$SG$SG
242519411$24251941$1$I$$20240815$20240827$20240827$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101927$VIIV$$$$$$Y$$$20240827$$HP$US$US
242519422$24251942$2$F$$20240830$20240827$20240909$EXP$$JP-TEVA-VS-3235272$TEVA$Dobashi N, Sada K-E, Kanemori G, Okada T, Tarutani Y, Yamamoto M, et al. Pulmonary alveolar proteinosis during treatment of immune-mediated necrotizing myopathy. Int-J-Rheum-Diseases 2024; 27 (2):.; Dobashi N, Sada K-E, Kanemori G, Okada T, Tarutani Y, Yamamoto M, et al. Pulmonary alveolar proteinosis during treatment of immune-mediated necrotizing myopathy. Int-J-Rheum-Diseases 2024; 27 (2):.; Dobashi N, Sada K-E, Kanemori G, Okada T, Tarutani Y, Yamamoto M, et al. Pulmonary alveolar protein...$71$YR$$F$Y$$$20240909$$HP$JP$JP
242519432$24251943$2$F$20240101$20240828$20240827$20240830$EXP$$US-UCBSA-2024026964$UCB$$$$$F$Y$79.3$KG$20240830$$CN$US$US
242519451$24251945$1$I$$20240823$20240827$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US075153$SANDOZ$$$$$F$Y$$$20240827$$CN$US$US
242519461$24251946$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004239$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$HP$US$US
242519471$24251947$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004244$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242519482$24251948$2$F$$20240819$20240827$20240917$EXP$$US-009507513-2408USA006277$MERCK$$$$$F$Y$$$20240917$$MD$US$US
242519493$24251949$3$F$20240101$20240917$20240827$20240926$EXP$$CA-CELLTRION INC.-2023CA021413$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
242519504$24251950$4$F$$20240912$20240827$20240925$EXP$$IL-REGENERON PHARMACEUTICALS, INC.-2024-115748$REGENERON$$87$YR$$F$Y$$$20240925$$MD$IL$IL
242519511$24251951$1$I$$20240822$20240827$20240827$EXP$$JP-GSK-JP2024104861$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$JP$JP
242519521$24251952$1$I$$20240812$20240827$20240827$EXP$$CA-LUPIN HEALTHCARE (UK) LIMITED-2024-08214$LUPIN$$$$$$Y$$$20240827$$HP$CA$CA
242519531$24251953$1$I$20240720$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168860$AMGEN$$68$YR$E$M$Y$$$20240826$$CN$US$US
242519542$24251954$2$F$20240823$20240826$20240827$20240903$PER$$US-AMGEN-USASP2024169546$AMGEN$$84$YR$E$F$Y$44.898$KG$20240903$$HP$US$US
242519551$24251955$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169623$AMGEN$$$$E$F$Y$$$20240826$$CN$US$US
242519561$24251956$1$I$20240801$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169689$AMGEN$$80$YR$E$F$Y$$$20240826$$CN$US$US
242519574$24251957$4$F$20240816$20240917$20240827$20240924$PER$$US-AMGEN-USASP2024166703$AMGEN$$88$YR$E$F$Y$$$20240924$$CN$US$US
242519581$24251958$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134484$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240827$$HP$US$US
242519591$24251959$1$I$20240801$20240802$20240827$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004325$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240827$$CN$US$US
242519601$24251960$1$I$$20240823$20240827$20240827$PER$$US-HALEON-2193596$Haleon PLC$$$$$F$Y$$$20240827$$CN$US$US
242519611$24251961$1$I$$20240823$20240827$20240827$PER$$NVSC2024US172573$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242519621$24251962$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5892722$ABBVIE$$$$$F$Y$$$20240827$$HP$US$US
242519631$24251963$1$I$$20240819$20240827$20240827$PER$$US-BIOGEN-2024BI01278819$BIOGEN$$$$$M$Y$$$20240827$$CN$US$US
242519642$24251964$2$F$$20240826$20240827$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004264$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
242519651$24251965$1$I$$20240822$20240827$20240827$EXP$$US-ABBVIE-5892299$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242519661$24251966$1$I$$20240819$20240827$20240827$EXP$$US-SA-2024SA248651$SANOFI AVENTIS$$$$A$F$Y$77.11$KG$20240827$$MD$US$US
242519671$24251967$1$I$$20240820$20240827$20240827$PER$$US-ABBVIE-5892847$ABBVIE$$$$$$Y$$$20240827$$CN$US$US
242519681$24251968$1$I$20240816$20240820$20240827$20240827$EXP$$US-INTERCEPT-PM2024001681$INTERCEPT PHARMACEUTICALS$$76$YR$$F$Y$$$20240827$$CN$US$US
242519691$24251969$1$I$$20240821$20240827$20240827$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03057$AMNEAL$$$$$$Y$$$20240827$$CN$US$US
242519702$24251970$2$F$20240820$20240905$20240827$20240907$EXP$$IT-JAZZ PHARMACEUTICALS-2024-IT-013356$JAZZ$$$$$$Y$$$20240907$$HP$IT$IT
242519712$24251971$2$F$$20240823$20240827$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004326$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
242519721$24251972$1$I$$20240822$20240827$20240827$EXP$$US-JNJFOC-20240862498$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$CN$US$US
242519732$24251973$2$F$20220209$20240905$20240827$20240911$EXP$$JP-JNJFOC-20240656512$JOHNSON AND JOHNSON$$76$YR$E$M$Y$53$KG$20240911$$MD$JP$JP
242519741$24251974$1$I$$20240823$20240827$20240827$PER$$US-GILEAD-2024-0685251$GILEAD$$$$$M$Y$$$20240827$$CN$US$US
242519751$24251975$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135153$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$92.99$KG$20240827$$CN$US$US
242519761$24251976$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134481$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$79.83$KG$20240827$$HP$US$US
242519771$24251977$1$I$$20240802$20240827$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004328$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$HP$US$US
242519781$24251978$1$I$20240819$20240819$20240827$20240827$PER$$US-AMGEN-USASP2024165207$AMGEN$$62$YR$A$F$Y$192.8$KG$20240827$$PH$US$US
242519792$24251979$2$F$20240822$20240823$20240827$20240830$PER$$US-AMGEN-USASP2024169170$AMGEN$$71$YR$E$F$Y$$$20240830$$CN$US$US
242519801$24251980$1$I$20240229$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-087191-2024$RECKITT BENCKISER$$$$$F$Y$$$20240827$$CN$US$US
242519811$24251981$1$I$20240101$20240820$20240827$20240827$PER$$US-009507513-2408USA006759$MERCK$$$$$F$Y$$$20240827$$CN$US$US
242519821$24251982$1$I$20240815$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015144$ELI LILLY AND CO$$$$A$F$Y$$$20240827$$CN$US$US
242519831$24251983$1$I$20240822$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015404$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240827$$CN$US$US
242519841$24251984$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015270$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240827$$CN$US$US
242519851$24251985$1$I$$20240820$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408012837$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240827$$CN$US$US
242519861$24251986$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015353$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240827$$CN$US$US
242519871$24251987$1$I$$20240823$20240827$20240827$PER$$US-009507513-2408USA008408$MERCK$$$$$F$Y$53.5$KG$20240827$$CN$US$US
242519881$24251988$1$I$20240801$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015336$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240827$$CN$US$US
242519891$24251989$1$I$20240825$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015736$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240827$$CN$US$US
242519901$24251990$1$I$$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004231$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242519911$24251991$1$I$$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004330$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242519922$24251992$2$F$20240501$20240822$20240827$20240830$EXP$$GB-JNJFOC-20240864764$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240830$$HP$GB$GB
242519931$24251993$1$I$20240201$20240816$20240827$20240827$EXP$$BR-JNJFOC-20240864036$JOHNSON AND JOHNSON$$49$YR$A$F$Y$80$KG$20240827$$MD$BR$BR
242519951$24251995$1$I$$20240819$20240827$20240827$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-131688$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240827$$HP$CA$CA
242519961$24251996$1$I$$20240823$20240827$20240827$PER$$US-HALEON-2193528$Haleon PLC$$$$$$Y$$$20240827$$CN$US$US
242519971$24251997$1$I$20240822$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168974$AMGEN$$25$YR$A$F$Y$$$20240827$$CN$US$US
242519984$24251998$4$F$20240808$20240910$20240827$20240913$PER$$US-AMGEN-USASP2024168247$AMGEN$$77$YR$E$F$Y$$$20240912$$CN$US$US
242519991$24251999$1$I$$20240814$20240827$20240827$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08143$LUPIN$Walterscheid B, Batchinsky M, Tarbox M. Drug reaction with eosinophilia and systemic symptoms syndrome preceding toxic epidermal necrolysis secondary to sildenafil: A case report. Cureus. 2024;16(7):1-5$$$$$Y$$$20240827$$MD$US$US
242520001$24252000$1$I$$20240802$20240827$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004331$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242520011$24252001$1$I$$20240821$20240827$20240827$EXP$$CA-APOTEX-2024AP009694$APOTEX$$$$$M$Y$$$20240827$$HP$CA$CA
242520022$24252002$2$F$$20240903$20240827$20240904$PER$$US-HALEON-2193641$Haleon PLC$$$$$$Y$$$20240904$$CN$US$US
242520032$24252003$2$F$20240724$20240904$20240827$20240911$EXP$$US-ARGENX-2024-ARGX-US006025$ARGENX BVBA$$$$$$Y$$$20240911$$CN$US$US
242520041$24252004$1$I$$20240819$20240827$20240827$EXP$$ZA-AstraZeneca-2024A189606$ASTRAZENECA$$58$YR$$F$Y$$$20240827$$CN$ZA$
242520052$24252005$2$F$20240809$20240917$20240827$20240930$EXP$$US-LUPIN EUROPE GMBH-2024-08111$LUPIN$$$$$$Y$$$20240930$$CN$US$US
242520062$24252006$2$F$20240624$20240820$20240827$20240829$EXP$$US-Axsome Therapeutics, Inc.-AXS202407-001040$AXSOME THERAPEUTICS$$$$$F$Y$$$20240829$$CN$US$
242520072$24252007$2$F$$20240905$20240827$20240910$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013345$JAZZ$$8$YR$$F$Y$$$20240909$$HP$US$US
242520081$24252008$1$I$20231110$20240821$20240827$20240827$EXP$$JP-GSK-JP2024JPN061353$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$JP$JP
242520092$24252009$2$F$$20240824$20240827$20240828$PER$$NVSC2024US172451$NOVARTIS$$$$$$Y$$$20240828$$CN$US$US
242520102$24252010$2$F$$20240909$20240827$20240915$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132783$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240916$$CN$US$US
242520111$24252011$1$I$20240814$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135059$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240827$$PH$US$US
242520121$24252012$1$I$20240701$20240823$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134930$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240827$$CN$US$US
242520131$24252013$1$I$$20240821$20240827$20240827$EXP$$US-AMGEN-USASP2024167703$AMGEN$Molnar M.; Yamauchi J.; Azhar A.et al.. Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2-Infected versus Noninfected Deceased Donors. Clinical journal of the American Society of Nephrology. 2023;18 (11):1466-1475$$$$$Y$$$20240827$$HP$US$US
242520161$24252016$1$I$20240101$20240822$20240827$20240827$EXP$$US-ABBVIE-5892407$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242520171$24252017$1$I$$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002352$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242520181$24252018$1$I$20180111$20240822$20240827$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013421$JAZZ$$50$YR$$M$Y$$$20240827$$HP$US$US
242520191$24252019$1$I$$20240819$20240827$20240827$EXP$$IL-EMD Serono-2024044714$EMD SERONO INC$$$$A$F$Y$$$20240827$$CN$IL$IL
242520202$24252020$2$F$20240101$20240923$20240827$20240930$EXP$$NVSC2024DE170569$NOVARTIS$$27$YR$$F$Y$$$20240930$$MD$DE$DE
242520211$24252021$1$I$$20240815$20240827$20240827$EXP$$GB-ASPEN-GLO2024GB005790$ASPEN$$$$$$Y$$$20240827$$CN$GB$GB
242520221$24252022$1$I$20240101$20240820$20240827$20240827$EXP$$CA-CELLTRION INC.-2024CA020413$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
242520231$24252023$1$I$$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004337$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242520251$24252025$1$I$20240814$20240814$20240827$20240827$PER$$US-RDY-SPO/USA/24/0011948$DR REDDYS$$$$$F$Y$$$20240827$$CN$US$US
242520261$24252026$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-109316-2023$RECKITT BENCKISER$$$$$$Y$$$20240827$$CN$US$US
242520271$24252027$1$I$20240801$20240821$20240827$20240827$EXP$$US-AMGEN-USASP2024167584$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242520281$24252028$1$I$$20240612$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-027886$AUROBINDO$$$$$F$Y$$$20240827$$HP$US$US
242520291$24252029$1$I$$20240814$20240827$20240827$EXP$$US-RDY-SPO/USA/24/0012120$DR REDDYS$Shahab MH, Prasad SH, Kalli SH, Usmani SS, Liaqat S, Umer M, et al. Treatment of a resistant case of schizoaffective disorder with lumateperone: A case report. SAGE Open Medical Case Reports. 2024 Jul 26;12: doi:10.1177/2050313X241266502.$22$YR$A$F$Y$$$20240827$$HP$US$US
242520301$24252030$1$I$$20240820$20240827$20240827$EXP$$US-EMD Serono-2024045367$EMD SERONO INC$$47$YR$A$M$Y$$$20240827$$CN$US$US
242520311$24252031$1$I$20240821$20240821$20240827$20240827$PER$$US-AMGEN-USASP2024167745$AMGEN$$45$YR$A$F$Y$72$KG$20240827$$PH$US$US
242520321$24252032$1$I$$20240822$20240827$20240827$EXP$$US-AMGEN-USASP2024168322$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242520331$24252033$1$I$20240811$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168778$AMGEN$$79$YR$E$F$Y$$$20240827$$CN$US$US
242520342$24252034$2$F$$20240830$20240827$20240909$EXP$$US-TEVA-VS-3235664$TEVA$Bedi R, Das D, Ahmad A, Atallah I, Smart SC, Verma D, et al. MECHANICAL SUPPORT AS A RESCUE BRIDGE TO TAVR IN A PATIENT WITH CARDIOGENIC SHOCK (CS) DUE TO SEVERE AS AND AR. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3856.; Bedi R, Das D, Ahmad A, Atallah I, Smart SC, Verma D, et al. MECHANICAL SUPPORT AS A RESCUE BRIDGE TO TAVR IN A PATIENT WITH CARDIOGENIC SHOCK (CS) DUE TO SEVERE AS AND AR. J-Am-Coll-Cardiol 2024; 83 (Suppl.) (13): 3856.$71$YR$$F$Y$$$20240909$$HP$US$US
242520351$24252035$1$I$20240801$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015996$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240827$$CN$US$US
242520361$24252036$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015225$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240827$$CN$US$US
242520371$24252037$1$I$$20240820$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015519$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242520381$24252038$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015732$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240827$$HP$US$US
242520391$24252039$1$I$$20240805$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015552$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242520401$24252040$1$I$$20240802$20240827$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004339$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242520411$24252041$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015495$ELI LILLY AND CO$$45$YR$A$$Y$$$20240827$$CN$US$US
242520421$24252042$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015136$ELI LILLY AND CO$$$$$$Y$$$20240827$$CN$US$US
242520431$24252043$1$I$$20240820$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013453$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240827$$CN$US$US
242520441$24252044$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134942$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240827$$CN$US$US
242520451$24252045$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134467$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$72.57$KG$20240827$$CN$US$US
242520461$24252046$1$I$$20240820$20240827$20240827$EXP$$CA-APOTEX-2024AP009603$APOTEX$$11$YR$$F$Y$$$20240827$$HP$CA$CA
242520471$24252047$1$I$20240822$20240822$20240827$20240827$EXP$$PH-AstraZeneca-2024A191904$ASTRAZENECA$$$$$M$Y$$$20240827$$MD$PH$
242520481$24252048$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A191768$ASTRAZENECA$$$$$$Y$$$20240827$$CN$US$
242520511$24252051$1$I$$20240819$20240827$20240827$EXP$$AU-GSK-AU2024APC105352$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$AU$AU
242520521$24252052$1$I$$20240822$20240827$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013392$JAZZ$$$$$F$Y$$$20240827$$CN$US$US
242520532$24252053$2$F$$20240904$20240827$20240905$PER$$US-AMGEN-USASP2024169800$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
242520541$24252054$1$I$20240801$20240818$20240827$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-025849$UNITED THERAPEUTICS$$34$YR$$F$Y$76.19$KG$20240827$$$US$US
242520551$24252055$1$I$20240726$20240821$20240827$20240827$EXP$$TW-AMGEN-TWNSP2024169562$AMGEN$$65$YR$E$F$Y$$$20240827$$HP$TW$TW
242520561$24252056$1$I$20240801$20240822$20240827$20240827$EXP$$AT-JNJFOC-20240863748$JOHNSON AND JOHNSON$$40$YR$A$$Y$$$20240827$$MD$AT$AT
242520573$24252057$3$F$$20240823$20240827$20240830$PER$$NVSC2024US172186$NOVARTIS$$$$$F$Y$$$20240830$$HP$US$US
242520581$24252058$1$I$$20240824$20240827$20240827$PER$$US-HALEON-2193610$Haleon PLC$$$$$$Y$$$20240827$$CN$US$US
242520591$24252059$1$I$$20240821$20240827$20240827$PER$$US-ALXN-202408USA001558US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242520601$24252060$1$I$$20240815$20240827$20240827$EXP$GB-MHRA-MED-202408141826266670-DMGBN$GB-LUPIN PHARMACEUTICALS INC.-2024-08133$LUPIN$$$$$$Y$$$20240827$$CN$GB$GB
242520611$24252061$1$I$20240726$20240814$20240827$20240827$EXP$$ES-AUROBINDO-AUR-APL-2024-041440$AUROBINDO$$72$YR$$F$Y$$$20240827$$MD$ES$ES
242520621$24252062$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135218$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$98.88$KG$20240827$$CN$US$US
242520632$24252063$2$F$20240811$20240826$20240827$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135323$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240828$$HP$US$US
242520641$24252064$1$I$$20240823$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135067$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240827$$CN$US$US
242520651$24252065$1$I$$20240823$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135000$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240827$$CN$US$US
242520661$24252066$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135048$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240827$$CN$US$US
242520673$24252067$3$F$$20240925$20240827$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134939$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240926$$CN$US$US
242520681$24252068$1$I$20240717$20240826$20240827$20240827$EXP$IT-MINISAL02-999898$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-134920$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240827$$MD$IT$IT
242520691$24252069$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172601$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242520701$24252070$1$I$$20240819$20240827$20240827$PER$$US-TRIS PHARMA, INC.-24US011596$TRIS PHARM$$$$$$Y$$$20240827$$CN$US$US
242520711$24252071$1$I$$20240816$20240827$20240827$PER$$US-TRIS PHARMA, INC.-24US011595$TRIS PHARM$$$$$$Y$$$20240827$$CN$US$US
242520721$24252072$1$I$$20240816$20240827$20240827$PER$$US-TRIS PHARMA, INC.-24US011594$TRIS PHARM$$$$$$Y$$$20240827$$HP$US$US
242520733$24252073$3$F$20240101$20240903$20240827$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-025694$UNITED THERAPEUTICS$$$$$F$Y$81.633$KG$20240917$$$US$US
242520741$24252074$1$I$20210517$20240822$20240827$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013427$JAZZ$$54$YR$$F$Y$$$20240827$$HP$US$US
242520752$24252075$2$F$20240526$20240916$20240827$20240924$EXP$$AU-JNJFOC-20240846496$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240924$$HP$AU$AU
242520761$24252076$1$I$$20240820$20240827$20240827$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001696$BLUEPRINT MEDICINES$$$$$M$Y$$$20240827$$CN$US$US
242520772$24252077$2$F$20240531$20240919$20240827$20240924$EXP$$JP-TAKEDA-2024TJP010513$TAKEDA$$73$YR$$F$Y$36.5$KG$20240924$$MD$JP$JP
242520781$24252078$1$I$$20240816$20240827$20240827$EXP$816462$AU-LUPIN PHARMACEUTICALS INC.-2024-08422$LUPIN$$$$$$Y$$$20240827$$CN$AU$AU
242520792$24252079$2$F$20230207$20240912$20240827$20240923$EXP$$DE-AUROBINDO-AUR-APL-2024-041665$AUROBINDO$$63$YR$$M$Y$83$KG$20240923$$MD$DE$DE
242520801$24252080$1$I$$20240812$20240827$20240827$PER$$US-CHATTEMPRD-2024OHG027111$CHATTEM$$$$$$Y$$$20240827$$CN$US$US
242520811$24252081$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135258$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240827$$PH$US$US
242520821$24252082$1$I$20240815$20240819$20240827$20240827$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001676$BLUEPRINT MEDICINES$$66$YR$E$F$Y$$$20240827$$CN$US$US
242520831$24252083$1$I$$20240822$20240827$20240827$PER$$US-AstraZeneca-2024A191777$ASTRAZENECA$$$$$$Y$$$20240827$$MD$US$
242520841$24252084$1$I$20240101$20240814$20240827$20240827$EXP$$DE-AUROBINDO-AUR-APL-2024-041710$AUROBINDO$$55$YR$$M$Y$78$KG$20240827$$CN$DE$DE
242520861$24252086$1$I$$20240814$20240827$20240827$EXP$$PT-AUROBINDO-AUR-APL-2024-041742$AUROBINDO$Brito, I.. PO-33 - THE CLINICAL SPECTRUM OF THE KCNQ2 GENE-ASSOCIATED DISEASES.. Sinapse.. 2023;93$9$MON$$F$Y$$$20240827$$MD$PT$PT
242520871$24252087$1$I$$20240819$20240827$20240827$PER$$US-CHATTEMPRD-2024OHG028881$CHATTEM$$$$$M$Y$$$20240827$$CN$US$US
242520881$24252088$1$I$$20240819$20240827$20240827$PER$$US-CHATTEMPRD-2024OHG028930$CHATTEM$$$$$$Y$$$20240827$$CN$US$US
242520891$24252089$1$I$20171108$20240822$20240827$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013418$JAZZ$$56$YR$$M$Y$$$20240827$$MD$US$US
242520901$24252090$1$I$$20240814$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041730$AUROBINDO$$40$YR$$F$Y$$$20240827$$PH$CA$CA
242520911$24252091$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015230$ELI LILLY AND CO$$$$$$Y$$$20240827$$HP$US$US
242520921$24252092$1$I$20240822$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014427$ELI LILLY AND CO$$$$$$Y$$$20240827$$CN$US$US
242520931$24252093$1$I$20240823$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015434$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240827$$CN$US$US
242520941$24252094$1$I$20240822$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015247$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240827$$CN$US$US
242520951$24252095$1$I$20240823$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015428$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240827$$CN$US$US
242520961$24252096$1$I$20240101$20240806$20240827$20240827$PER$$AU-TOLMAR, INC.-24AU051656$TOLMAR$$$$$M$Y$$$20240827$$CN$AU$AU
242520971$24252097$1$I$20240101$20240806$20240827$20240827$PER$$AU-TOLMAR, INC.-24AU051701$TOLMAR$$$$$M$Y$$$20240827$$CN$AU$AU
242520981$24252098$1$I$$20240806$20240827$20240827$PER$$AU-TOLMAR, INC.-24AU051728$TOLMAR$$$$$M$Y$$$20240827$$CN$AU$AU
242520993$24252099$3$F$20240801$20240909$20240827$20240916$PER$$US-CHATTEMPRD-2024OHG028412$CHATTEM$$22$YR$A$F$Y$$$20240916$$CN$US$US
242521001$24252100$1$I$$20240809$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126905$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$96.16$KG$20240827$$CN$US$US
242521011$24252101$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135081$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240827$$CN$US$US
242521021$24252102$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135115$BRISTOL MYERS SQUIBB$$68$YR$A$M$Y$$$20240827$$HP$US$US
242521031$24252103$1$I$$20240813$20240827$20240827$EXP$$CA-ROCHE-10000062642$ROCHE$$65$YR$E$F$Y$34$KG$20240827$$HP$CA$CA
242521042$24252104$2$F$20240101$20240829$20240827$20240905$PER$$US-JNJFOC-20240857968$JOHNSON AND JOHNSON$$71$YR$E$F$Y$71$KG$20240906$$PH$US$US
242521052$24252105$2$F$20240801$20240913$20240827$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132909$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$75.5$KG$20240917$$PH$US$US
242521064$24252106$4$F$20240830$20240911$20240827$20240917$EXP$$JP-TAKEDA-2024TJP012465$TAKEDA$$$$$$Y$$$20240917$$MD$JP$JP
242521072$24252107$2$F$$20240905$20240827$20240918$EXP$$PT-AUROBINDO-AUR-APL-2024-041870$AUROBINDO$Brites FM, Ferreira CA.. Howell-Jolly Body like Inclusions in Neutrophils and Monocytes.. Laboratory Medicine Magazine.. 2024;5:82$58$YR$$F$Y$$$20240918$$MD$PT$PT
242521083$24252108$3$F$20240814$20240830$20240827$20240903$PER$$US-JNJFOC-20240849969$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240903$$CN$US$US
242521091$24252109$1$I$$20240821$20240827$20240827$EXP$$CA-RDY-CLI/CAN/24/0012386$DR REDDYS$$64$YR$E$F$Y$$$20240827$$CN$CA$CA
242521101$24252110$1$I$$20240819$20240827$20240827$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006164$BIOCON$$$$$$Y$$$20240827$$CN$CA$CA
242521111$24252111$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135044$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240827$$CN$US$US
242521121$24252112$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135006$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240827$$CN$US$US
242521131$24252113$1$I$20231201$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134294$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240827$$MD$US$US
242521141$24252114$1$I$$20240819$20240827$20240827$EXP$$US-RDY-SPO/USA/24/0012256$DR REDDYS$Shariff H, Luu T, Kavis H, Obuch J. Gastric Signet Ring Cell Adenocarcinoma with Metastasis to the Testicles and Leptomeninges. ACG Case Reports Journal. 2024 Jul 27;11(8): doi:10.14309/crj.0000000000001419.$38$YR$A$M$Y$$$20240827$$MD$US$US
242521151$24252115$1$I$20240814$20240820$20240827$20240827$EXP$$US-BEH-2024177538$CSL BEHRING$$74$YR$E$F$Y$$$20240827$$HP$US$US
242521161$24252116$1$I$20240101$20240820$20240827$20240827$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000736$DECIPHERA PHARMACEUTICALS$$66$YR$A$M$Y$48$KG$20240827$$CN$US$US
242521171$24252117$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172637$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242521181$24252118$1$I$20240720$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168578$AMGEN$$80$YR$E$F$Y$$$20240827$$CN$US$US
242521191$24252119$1$I$20230514$20240814$20240827$20240827$EXP$$FR-AUROBINDO-AUR-APL-2024-041428$AUROBINDO$$1$DY$$M$Y$3.5$KG$20240827$$HP$FR$FR
242521202$24252120$2$F$20240801$20240827$20240827$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-025578$UNITED THERAPEUTICS$$74$YR$$F$Y$71.202$KG$20240904$$$US$US
242521211$24252121$1$I$$20240823$20240827$20240827$EXP$$JP-GENMAB-2024-01619AA$GENMAB$$9$DEC$$M$Y$$$20240827$$MD$JP$JP
242521221$24252122$1$I$20240101$20240820$20240827$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-026043$UNITED THERAPEUTICS$$$$$M$Y$$$20240827$$$US$US
242521231$24252123$1$I$20240801$20240819$20240827$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-025965$UNITED THERAPEUTICS$$70$YR$$F$Y$97.506$KG$20240827$$$US$US
242521241$24252124$1$I$$20240814$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-041296$AUROBINDO$$$$$$Y$$$20240827$$MD$GB$GB
242521251$24252125$1$I$$20240820$20240827$20240827$EXP$$GB-CELLTRION INC.-2024GB020296$CELLTRION$$$$$$Y$$$20240827$$PH$GB$GB
242521261$24252126$1$I$$20240826$20240827$20240827$EXP$$NVSC2024GH172381$NOVARTIS$$$$$M$Y$$$20240827$$MD$GH$GH
242521271$24252127$1$I$$20240815$20240827$20240827$PER$$US-JNJFOC-20240865104$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$CN$US$US
242521282$24252128$2$F$$20240925$20240827$20240930$30DAY$$US-JNJFOC-20240855155$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$PH$US$US
242521291$24252129$1$I$$20240812$20240827$20240827$PER$$US-TEVA-VS-3233078$TEVA$$$$$F$Y$$$20240827$$CN$US$US
242521301$24252130$1$I$20240701$20240814$20240827$20240827$EXP$$US-SA-2024SA245221$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240827$$HP$US$US
242521311$24252131$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-103818-2023$RECKITT BENCKISER$$$$$$Y$$$20240827$$CN$US$US
242521333$24252133$3$F$20240812$20240906$20240827$20240916$PER$$US-AstraZeneca-2024A187967$ASTRAZENECA$$29853$DY$$F$Y$135$KG$20240916$$CN$US$
242521341$24252134$1$I$$20240819$20240827$20240827$EXP$$GB-AstraZeneca-2024A189763$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$GB$
242521351$24252135$1$I$$20240814$20240827$20240827$EXP$$FR-AUROBINDO-AUR-APL-2024-041773$AUROBINDO$Bourgon N, Lopez R, Fourgeaud J, Guilleminot T, Bussieres L, Magny J-F et al.. In utero treatment of congenital cytomegalovirus infection with valganciclovir: an observational study on safety and effectiveness.. The Journal of antimicrobial chemotherapy.. 2024$$$N$$Y$$$20240827$$HP$FR$FR
242521361$24252136$1$I$20240101$20240819$20240827$20240827$PER$$US-JNJFOC-20240849590$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$CN$US$US
242521371$24252137$1$I$20240101$20240819$20240827$20240827$EXP$$CA-CELLTRION INC.-2023CA020401$CELLTRION$$$$$$Y$$$20240827$$MD$CA$CA
242521382$24252138$2$F$20240830$20240923$20240827$20240926$EXP$$CA-TAKEDA-2020TUS056992$TAKEDA$$54$YR$$M$Y$$$20240926$$CN$CA$CA
242521391$24252139$1$I$$20240820$20240827$20240827$PER$$US-ABBVIE-5889533$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242521401$24252140$1$I$20240825$20240826$20240827$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047957$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240827$$CN$US$US
242521411$24252141$1$I$$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004344$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242521421$24252142$1$I$20240101$20240820$20240827$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-025546$UNITED THERAPEUTICS$$$$$M$Y$74.376$KG$20240827$$$US$US
242521431$24252143$1$I$$20240822$20240827$20240827$EXP$$US-ABBVIE-5890544$ABBVIE$$$$$F$Y$$$20240827$$HP$US$US
242521451$24252145$1$I$$20240825$20240827$20240827$PER$$NVSC2024US172356$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242521461$24252146$1$I$20240819$20240819$20240827$20240827$EXP$$CN-VANTIVE-2024VAN019212$Vantive US Healthcare$$$$$F$Y$39$KG$20240827$$CN$CN$CN
242521472$24252147$2$F$20240819$20240917$20240827$20240918$PER$$US-AMGEN-USASP2024168660$AMGEN$$72$YR$E$F$Y$$$20240918$$PH$US$US
242521481$24252148$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015038$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240827$$CN$US$US
242521491$24252149$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015122$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240827$$CN$US$US
242521501$24252150$1$I$$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168366$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242521511$24252151$1$I$20240819$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014672$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240827$$CN$US$US
242521521$24252152$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134855$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240827$$MD$US$US
242521531$24252153$1$I$$20240822$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133770$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240827$$HP$US$US
242521541$24252154$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134711$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$163.3$KG$20240827$$CN$US$US
242521551$24252155$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135180$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240827$$HP$US$US
242521561$24252156$1$I$$20240815$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129873$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240827$$HP$US$US
242521571$24252157$1$I$$20240819$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132967$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240827$$CN$US$US
242521581$24252158$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134975$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240827$$CN$US$US
242521591$24252159$1$I$$20240821$20240827$20240827$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-132686$BRISTOL MYERS SQUIBB$Literature article can^t be requested due to no citation$$$$$Y$$$20240827$$HP$CA$CA
242521601$24252160$1$I$20240814$20240822$20240827$20240827$EXP$$NVSC2024CN172091$NOVARTIS$$86$YR$$F$Y$48$KG$20240827$$HP$CN$CN
242521611$24252161$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172604$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242521622$24252162$2$F$$20240827$20240827$20240906$30DAY$$US-GSK-US2024103992$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242521631$24252163$1$I$$20240812$20240827$20240827$EXP$$US-PURACAP-US-2024EPCLIT01021$PURACAP$A Lindsay.An Underestimated Toxin: The Case of Intentional Benzonatate Overdose Resulting in Seizure and Cardiac Arrest.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$41$YR$A$F$Y$$$20240827$$HP$US$US
242521642$24252164$2$F$20240821$20240925$20240827$20240926$PER$$US-AMGEN-USASP2024168471$AMGEN$$68$YR$E$F$Y$$$20240926$$CN$US$US
242521653$24252165$3$F$20240816$20240911$20240827$20240916$30DAY$$US-AMGEN-USASP2024166332$AMGEN$$71$YR$E$M$Y$$$20240916$$HP$US$US
242521661$24252166$1$I$$20240815$20240827$20240827$EXP$$US-ABBVIE-5892888$ABBVIE$$$$$F$Y$104$KG$20240827$$CN$US$US
242521671$24252167$1$I$$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004354$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242521681$24252168$1$I$20240801$20240819$20240827$20240827$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001680$BLUEPRINT MEDICINES$$66$YR$E$M$Y$$$20240827$$CN$US$US
242521691$24252169$1$I$20180124$20240814$20240827$20240827$EXP$$BE-AUROBINDO-AUR-APL-2018-027998$AUROBINDO$$25$YR$$F$Y$$$20240827$$MD$BE$BE
242521701$24252170$1$I$$20240822$20240827$20240827$EXP$$US-ROCHE-10000065467$ROCHE$Ngo T, Hang A, Virk J, Moussa K, Moshiri A, Naeini P, et al. Real-world experience using intravitreal Faricimab for previously treated neovascular age-related macular degeneration [Abstract number: 261 - B0324]. Investigative Ophthalmology + Visual Science. 2024-Jun;65 (261):$$$$$Y$$$20240827$$HP$US$US
242521711$24252171$1$I$20240101$20240812$20240827$20240827$EXP$$US-UCBSA-2024041045$UCB$$$$$$Y$$$20240827$$HP$US$US
242521731$24252173$1$I$$20240814$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-041233$AUROBINDO$$$$$F$Y$$$20240827$$CN$GB$GB
242521741$24252174$1$I$$20240812$20240827$20240827$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16638$ALKEM$$$$$M$Y$88.435$KG$20240827$$CN$US$US
242521751$24252175$1$I$$20240816$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130860$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240827$$CN$US$US
242521762$24252176$2$F$20240101$20240905$20240827$20240913$EXP$$CA-ABBVIE-5890848$ABBVIE$$$$A$M$Y$$$20240913$$CN$CA$CA
242521781$24252178$1$I$$20240823$20240827$20240827$PER$$NVSC2024US172428$NOVARTIS$$42$YR$$$Y$$$20240827$$CN$US$US
242521791$24252179$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024168810$AMGEN$$$$$$Y$$$20240827$$PH$US$US
242521801$24252180$1$I$$20240812$20240827$20240827$EXP$$US-EPICPHARMA-US-2024EPCLIT01036$EPIC PHARM$Maerten A.Emergency thyroidectomy for thyroid storm in a patient treated with amiodarone.Revue Medicale de Bruxelles.JUN-2024;45$57$YR$A$M$Y$$$20240827$$HP$US$US
242521811$24252181$1$I$$20240815$20240827$20240827$PER$$US-ROCHE-10000059717$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242521821$24252182$1$I$$20240820$20240827$20240827$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001690$BLUEPRINT MEDICINES$$$$$F$Y$$$20240827$$CN$US$US
242521841$24252184$1$I$20240624$20240826$20240827$20240827$EXP$GB-MHRA-MED-202408261330327800-LHBSQ$GB-SANDOZ INC.-SDZ2024GB075198$SANDOZ$$76$YR$$F$Y$$$20240827$$CN$GB$GB
242521851$24252185$1$I$$20240820$20240827$20240827$PER$$US-PCCINC-2024-PPL-000635$PIRAMAL$$$$$$Y$$$20240827$$HP$US$US
242521861$24252186$1$I$20240815$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134679$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240827$$MD$US$US
242521871$24252187$1$I$$20240822$20240827$20240827$EXP$$US-ABBVIE-5891975$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242521882$24252188$2$F$$20240826$20240827$20240827$PER$$US-JNJFOC-20240862067$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$MD$US$US
242521891$24252189$1$I$20240709$20240820$20240827$20240827$EXP$$CA-JNJFOC-20240855981$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240827$$HP$CA$CA
242521901$24252190$1$I$20240101$20240822$20240827$20240827$EXP$$US-ABBVIE-5891743$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242521921$24252192$1$I$20240726$20240819$20240827$20240827$EXP$$TW-RECORDATI-2024006058$RECORDATI$$$$$$Y$$$20240827$$HP$TW$TW
242521931$24252193$1$I$20240812$20240822$20240827$20240827$EXP$$US-ABBVIE-5892250$ABBVIE$$19$YR$$F$Y$$$20240827$$CN$US$US
242521941$24252194$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-103672-2023$RECKITT BENCKISER$$$$$F$Y$$$20240827$$CN$US$US
242521951$24252195$1$I$$20240824$20240827$20240827$PER$$NVSC2024US172391$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
242521961$24252196$1$I$$20240812$20240827$20240827$EXP$$IN-EPICPHARMA-IN-2024EPCLIT01033$EPIC PHARM$Shekharjyoti Gogoi.Permanent pacemaker implantation with beta blocker as alternative to ICD in patients presented with ventricular tachycardia.Indian Heart Journal.2023;75:S119-S120$61$YR$A$F$Y$$$20240827$$HP$IN$IN
242521971$24252197$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5894319$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242521991$24252199$1$I$20240723$20240802$20240827$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004256$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240827$$HP$US$US
242522002$24252200$2$F$20240729$20240831$20240827$20240903$EXP$$US-ABBVIE-5892398$ABBVIE$$67$YR$$F$Y$58$KG$20240903$$CN$US$US
242522011$24252201$1$I$20240401$20240821$20240827$20240827$EXP$$US-BIOCON-BCN-2024-000175$BIOCON$$$$$F$Y$$$20240827$$CN$US$US
242522021$24252202$1$I$20240602$20240802$20240827$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004254$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240827$$CN$US$US
242522032$24252203$2$F$$20240826$20240827$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004250$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
242522041$24252204$1$I$20240712$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004267$ACADIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240827$$CN$US$US
242522051$24252205$1$I$$20240802$20240827$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004265$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242522061$24252206$1$I$$20240822$20240827$20240827$PER$$US-JNJFOC-20240858358$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$MD$US$US
242522071$24252207$1$I$$20240820$20240827$20240827$PER$$US-PCCINC-2024-PPL-000636$PIRAMAL$$$$$$Y$$$20240827$$HP$US$US
242522081$24252208$1$I$20240701$20240821$20240827$20240827$EXP$$AU-TAKEDA-2024TUS084203$TAKEDA$$69$YR$$M$Y$$$20240827$$HP$AU$AU
242522091$24252209$1$I$$20240826$20240827$20240827$EXP$GB-MHRA-MED-202408260747453490-ZHSNB$GB-SANDOZ INC.-SDZ2024GB075148$SANDOZ$$29$YR$$F$Y$56$KG$20240827$$CN$GB$GB
242522102$24252210$2$F$$20240911$20240827$20240917$EXP$$US-ABBVIE-5544242$ABBVIE$$32$YR$$F$Y$72$KG$20240917$$CN$GB$GB
242522111$24252211$1$I$20240819$20240821$20240827$20240827$PER$$US-AMGEN-USASP2024167270$AMGEN$$69$YR$E$M$Y$$$20240827$$CN$US$US
242522121$24252212$1$I$20240227$20240405$20240827$20240827$PER$$US-ROCHE-3517744$ROCHE$$68$YR$E$F$Y$$$20240827$$PH$US$US
242522131$24252213$1$I$$20240819$20240827$20240827$EXP$$US-ROCHE-10000062015$ROCHE$$27$YR$A$F$Y$$$20240827$$MD$US$US
242522141$24252214$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07650$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242522152$24252215$2$F$20240816$20240821$20240827$20240830$EXP$$JP-ROCHE-10000061951$ROCHE$$88$YR$E$F$Y$$$20240830$$PH$JP$JP
242522161$24252216$1$I$$20240820$20240827$20240827$EXP$$US-ABBVIE-5889764$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242522171$24252217$1$I$20240802$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015400$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240827$$HP$US$US
242522181$24252218$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015461$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240827$$CN$US$US
242522191$24252219$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015212$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240827$$CN$US$US
242522201$24252220$1$I$20240801$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015330$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240827$$CN$US$US
242522211$24252221$1$I$20240822$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015332$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240827$$CN$US$US
242522221$24252222$1$I$20240701$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015008$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240827$$CN$US$US
242522231$24252223$1$I$20240821$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015192$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240827$$CN$US$US
242522241$24252224$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015278$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240827$$CN$US$US
242522251$24252225$1$I$$20240817$20240827$20240827$PER$$US-AMGEN-USASP2024164820$AMGEN$Stewart Iv J..H. Phase I trial of talimogene laherparepvec for the treatment of peritoneal surface malignancies (TEMPO). Journal of Clinical Oncology. 2024;42 (16):2668$$$$$Y$$$20240827$$HP$US$US
242522272$24252227$2$F$$20240910$20240827$20240920$EXP$$CA-APOTEX-2024AP009623$APOTEX$$$$$F$Y$$$20240920$$HP$CA$CA
242522281$24252228$1$I$$20240812$20240827$20240827$EXP$$US-EPICPHARMA-US-2024EPCLIT01035$EPIC PHARM$Justin Seltzer.Case Files from the University of California San Diego Medical  Toxicology Fellowship: Neonatal Flecainide Toxicity from an Accidental  Dosing Error.Journal of Medical Toxicology-official journal of the American College of Medical Toxicology .11-JUL-2024;20:314-323$22$DY$$M$Y$3.65$KG$20240827$$HP$US$US
242522291$24252229$1$I$20240809$20240819$20240827$20240827$EXP$$JP-GENMAB-2024-03014$GENMAB$$6$DEC$$$Y$$$20240827$$MD$JP$JP
242522301$24252230$1$I$20200101$20240823$20240827$20240827$EXP$SE-SEMPA-2024-006094$NVSC2024SE170742$NOVARTIS$$$$$M$Y$$$20240827$$MD$SE$SE
242522311$24252231$1$I$$20240816$20240827$20240827$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-08399$LUPIN$$$$$$Y$$$20240827$$CN$AU$AU
242522322$24252232$2$F$20240701$20240828$20240827$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134067$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240902$$HP$US$US
242522331$24252233$1$I$$20240821$20240827$20240827$EXP$$US-JNJFOC-20240855304$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$HP$US$US
242522341$24252234$1$I$20240701$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07631$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242522351$24252235$1$I$$20240819$20240827$20240827$EXP$$FR-BIOCON BIOLOGICS LIMITED-BBL2023002140$BIOCON$$$$$$Y$$$20240827$$HP$FR$FR
242522361$24252236$1$I$20240807$20240816$20240827$20240827$EXP$$IN-GE HEALTHCARE-2024CSU009126$GE HEALTHCARE$$58$YR$$M$Y$$$20240827$$HP$IN$IN
242522372$24252237$2$F$$20240819$20240827$20240910$EXP$$US-ALXN-202408USA001369US$ALEXION PHARMACEUTICALS$$46$YR$$M$Y$102$KG$20240910$$CN$US$US
242522381$24252238$1$I$20240807$20240814$20240827$20240827$EXP$$CN-GE HEALTHCARE-2024CSU009356$GE HEALTHCARE$$72$YR$$M$Y$60$KG$20240827$$HP$CN$CN
242522393$24252239$3$F$20240501$20240829$20240827$20240906$EXP$$DE-CELLTRION INC.-2024DE020228$CELLTRION$$$$$$Y$$$20240906$$HP$DE$DE
242522401$24252240$1$I$20240813$20240821$20240827$20240827$EXP$$US-ABBVIE-5891101$ABBVIE$$61$YR$$F$Y$$$20240827$$CN$US$US
242522413$24252241$3$F$20220101$20240820$20240827$20240902$EXP$$PT-009507513-2408PRT007884$MERCK$Henriques SP et al. CO-0258 - (4177) - PEMBROLIZUMAB ? A RARE CAUSE OF DISTAL RENAL TUBULAR ACIDOSIS. Abstract book - 30? CNMI. 2024;350$79$YR$$M$Y$$$20240902$$MD$PT$PT
242522421$24252242$1$I$$20240813$20240827$20240827$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111317$ZYDUS PHARM$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J. 2024;70(7):e92-e96$$$$$Y$$$20240827$$HP$US$US
242522431$24252243$1$I$$20240813$20240827$20240827$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111318$ZYDUS PHARM$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J. 2024;70(7):e92-e96$$$$$Y$$$20240827$$HP$US$US
242522443$24252244$3$F$20240101$20240911$20240827$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-024798$UNITED THERAPEUTICS$$$$$F$Y$69.841$KG$20240914$$$US$US
242522451$24252245$1$I$$20240812$20240827$20240827$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111124$ZYDUS PHARM$Nelson N, Masih D, Sabri A, Monika F, Mirza M.. Isolated Myeloid Sarcoma Masquerading as Scattered Abscesses in a Septic Patient: A Case Report and Literature Review.. Case-Rep-Oncol. 2024;17(1):39-48$$$$$Y$$$20240827$$HP$US$US
242522461$24252246$1$I$20240101$20240822$20240827$20240827$EXP$$US-ABBVIE-5891751$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242522471$24252247$1$I$20240817$20240822$20240827$20240827$PER$$US-009507513-2408USA008370$MERCK$$$$$F$Y$$$20240827$$CN$US$US
242522481$24252248$1$I$$20240820$20240827$20240827$PER$$US-ABBVIE-5890270$ABBVIE$$$$$F$Y$$$20240827$$MD$US$US
242522491$24252249$1$I$20240101$20240820$20240827$20240827$EXP$$US-ABBVIE-5889989$ABBVIE$$62$YR$$M$Y$$$20240827$$CN$US$US
242522501$24252250$1$I$$20240628$20240827$20240827$PER$$US-CHIESI-2024CHF03949$CHIESI$$34$YR$$F$Y$58$KG$20240827$$CN$US$US
242522511$24252251$1$I$20240101$20240621$20240827$20240827$PER$$US-CHIESI-2024CHF03809$CHIESI$$$$$F$Y$$$20240827$$CN$US$US
242522521$24252252$1$I$20240530$20240613$20240827$20240827$PER$$US-CHIESI-2024CHF03636$CHIESI$$37$YR$$M$Y$$$20240827$$CN$US$US
242522531$24252253$1$I$$20240621$20240827$20240827$PER$$US-CHIESI-2024CHF03780$CHIESI$$51$YR$$M$Y$$$20240827$$CN$US$US
242522541$24252254$1$I$$20240730$20240827$20240827$PER$$US-CHIESI-2024CHF03643$CHIESI$$$$$$Y$$$20240827$$MD$US$US
242522551$24252255$1$I$$20240822$20240827$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US047049$SANDOZ$$12$YR$$M$Y$$$20240827$$CN$US$US
242522561$24252256$1$I$20240808$20240823$20240827$20240827$PER$$US-JNJFOC-20240861326$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240827$$MD$US$US
242522581$24252258$1$I$20240814$20240822$20240827$20240827$EXP$$DE-GSK-DE2024EME104903$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$DE$DE
242522591$24252259$1$I$$20240820$20240827$20240827$EXP$$CL-JNJFOC-20240854385$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$MD$CL$CL
242522601$24252260$1$I$$20240826$20240827$20240827$EXP$$CA-HALEON-2193538$Haleon PLC$$$$$F$Y$$$20240827$$HP$CA$CA
242522621$24252262$1$I$20240818$20240819$20240827$20240827$PER$$US-AMGEN-USASP2024165980$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242522631$24252263$1$I$$20240820$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134655$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240827$$CN$US$US
242522642$24252264$2$F$$20240909$20240827$20240913$PER$$NVSC2024US172651$NOVARTIS$$$$$$Y$$$20240913$$PH$US$US
242522651$24252265$1$I$20240101$20240822$20240827$20240827$EXP$$JP-JNJFOC-20240864670$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240827$$MD$JP$JP
242522661$24252266$1$I$$20240820$20240827$20240827$EXP$$CN-BEIGENE-BGN-2024-013246$BEIGENE$$$$$$Y$$$20240827$$MD$CN$CN
242522671$24252267$1$I$$20240826$20240827$20240827$EXP$$CA-HALEON-2193600$Haleon PLC$$65$YR$$F$Y$107$KG$20240827$$PH$CA$CA
242522681$24252268$1$I$20240621$20240819$20240827$20240827$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-19968$SAMSUNG BIOEPIS$$77$YR$E$M$Y$83$KG$20240827$$HP$CA$CA
242522701$24252270$1$I$$20240822$20240827$20240827$EXP$$NVSC2024US152290$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242522711$24252271$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135100$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240827$$CN$US$US
242522721$24252272$1$I$20240101$20240822$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134926$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$46.72$KG$20240827$$HP$US$US
242522742$24252274$2$F$20230101$20240821$20240827$20240829$EXP$$US-ABBVIE-5889924$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242522751$24252275$1$I$20240826$20240826$20240827$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047966$BOEHRINGER INGELHEIM$$$$$$Y$$$20240827$$CN$US$US
242522761$24252276$1$I$$20240419$20240827$20240827$PER$$US-SP-2024-38604533P2$SUNNY PHARMTECH$Literature reference: Sarah C Cromack, Lulu Yu, Magdy P Milad. Prostaglandin Injection for Myoma Expulsion (PRIME): Case series of a novel approach to hysteroscopic resection of FIGO type 2 myomas. Journal of minimally invasive gynecology. 2024;   S1553-4650(24)00157-2. doi: https://doi.org/10.1016/j.jmig.2024.03.011$32$YR$$F$Y$$$20240827$$MD$US$US
242522771$24252277$1$I$$20240819$20240827$20240827$EXP$$CA-JNJFOC-20240856604$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240827$$HP$CA$CA
242522781$24252278$1$I$20240812$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015110$ELI LILLY AND CO$$$$$$Y$$$20240827$$CN$US$US
242522791$24252279$1$I$20240801$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015267$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240827$$CN$US$US
242522801$24252280$1$I$20240823$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015737$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240827$$CN$US$US
242522811$24252281$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015042$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240827$$CN$US$US
242522821$24252282$1$I$20240823$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015392$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240827$$CN$US$US
242522831$24252283$1$I$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015943$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240827$$CN$US$US
242522841$24252284$1$I$20240822$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015255$ELI LILLY AND CO$$$$$$Y$$$20240827$$CN$US$US
242522851$24252285$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172619$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242522863$24252286$3$F$20240101$20240917$20240827$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA056187$SANDOZ$$$$$F$Y$$$20240923$$CN$CA$CA
242522871$24252287$1$I$$20240822$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075058$SANDOZ$$39$YR$$M$Y$$$20240827$$HP$US$US
242522881$24252288$1$I$20230101$20240822$20240827$20240827$EXP$$US-ABBVIE-5891363$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242522891$24252289$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134133$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$57.15$KG$20240827$$CN$US$US
242522902$24252290$2$F$20240809$20240917$20240827$20240924$30DAY$$US-AMGEN-USASL2024164121$AMGEN$$54$YR$A$F$Y$$$20240924$$PH$US$US
242522911$24252291$1$I$20210215$20240822$20240827$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013425$JAZZ$$23$YR$$F$Y$$$20240827$$HP$US$US
242522922$24252292$2$F$20240801$20240828$20240827$20240904$EXP$$PT-ABBVIE-5893051$ABBVIE$$76$YR$$M$Y$$$20240904$$CN$PT$PT
242522931$24252293$1$I$$20240820$20240827$20240827$EXP$$US-EXELIXIS-CABO-24078866$EXELIXIS$$$$$M$Y$$$20240827$$CN$US$US
242522941$24252294$1$I$20240201$20240820$20240827$20240827$EXP$$US-EXELIXIS-CABO-24080737$EXELIXIS$$81$YR$$M$Y$$$20240827$$CN$US$US
242522951$24252295$1$I$20240725$20240826$20240827$20240827$EXP$GB-MHRA-MED-202408261027403310-MWDPF$GB-SANDOZ INC.-SDZ2024GB075203$SANDOZ$$$$$F$Y$$$20240827$$CN$GB$GB
242522961$24252296$1$I$$20240806$20240827$20240827$PER$$US-APOTEX-2024AP009168$APOTEX$$$$$$Y$$$20240827$$CN$US$US
242522972$24252297$2$F$20240101$20240822$20240827$20240902$PER$$US-AMGEN-USASP2024168341$AMGEN$$$$$M$Y$$$20240902$$MD$US$US
242522981$24252298$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169576$AMGEN$$$$$$Y$$$20240827$$HP$US$US
242522991$24252299$1$I$20231229$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-082139-2024$RECKITT BENCKISER$$18$YR$$F$Y$$$20240827$$CN$US$US
242523004$24252300$4$F$$20240826$20240827$20240829$PER$$US-ROCHE-10000065795$ROCHE$$$$T$F$Y$$$20240829$$CN$US$US
242523011$24252301$1$I$$20240822$20240827$20240827$EXP$$ZA-HALEON-2193392$Haleon PLC$$$$$$Y$$$20240827$$CN$ZA$ZA
242523021$24252302$1$I$20240101$20240820$20240827$20240827$EXP$$CA-CELLTRION INC.-2024CA020433$CELLTRION$$$$$$Y$$$20240827$$HP$CA$CA
242523031$24252303$1$I$$20240822$20240827$20240827$EXP$$CA-SANDOZ INC.-SDZ2024CA075172$SANDOZ$$$$$M$Y$$$20240827$$CN$CA$CA
242523041$24252304$1$I$20240802$20240826$20240827$20240827$EXP$$DE-SANDOZ INC.-SDZ2024DE075240$SANDOZ$$61$YR$$M$Y$$$20240827$$MD$DE$DE
242523051$24252305$1$I$20240101$20240823$20240827$20240827$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-115618$REGENERON$$$$$F$Y$$$20240827$$CN$US$US
242523061$24252306$1$I$20240101$20240820$20240827$20240827$PER$$US-JNJFOC-20240851496$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$HP$US$US
242523071$24252307$1$I$20240101$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168797$AMGEN$$75$YR$E$F$Y$$$20240827$$CN$US$US
242523081$24252308$1$I$20240514$20240802$20240827$20240827$PER$$US-GLK-002370$GLAUKOS$$20$YR$$M$Y$$$20240827$$MD$US$US
242523092$24252309$2$F$20240729$20240903$20240827$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01030$EPIC PHARM$$71$YR$E$F$Y$61.23$KG$20240918$$CN$US$US
242523101$24252310$1$I$$20240823$20240827$20240827$PER$$NVSC2024US172502$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
242523111$24252311$1$I$$20240821$20240827$20240827$EXP$$BR-ROCHE-10000064018$ROCHE$$$$$F$Y$$$20240827$$CN$BR$BR
242523121$24252312$1$I$$20240822$20240827$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US075166$SANDOZ$$$$$$Y$$$20240827$$CN$US$US
242523131$24252313$1$I$$20240822$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075273$SANDOZ$$$$$M$Y$$$20240827$$MD$US$US
242523141$24252314$1$I$$20240815$20240827$20240827$EXP$$US-FARMAPROD-202408-2947$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240826$$CN$US$US
242523152$24252315$2$F$$20240823$20240827$20240827$EXP$$US-ROCHE-10000065595$ROCHE$$$$E$M$Y$$$20240827$$CN$US$US
242523161$24252316$1$I$$20240816$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135019$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$116.57$KG$20240827$$CN$US$US
242523171$24252317$1$I$$20240815$20240827$20240827$PER$$US-FARMAPROD-202408-2948$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240826$$CN$US$US
242523181$24252318$1$I$$20240812$20240827$20240827$EXP$$TR-HALOCARBON LIFE SCIENCES, LLC-20240800007$Halocarbon Life Sciences$Fazilcan Zirek. Diagnosis of interstitial lung disease after surgery in an adolescent. Pediatric Pulmonology. 2024;59(7):2002-2008$$$$$Y$$$20240827$$MD$TR$TR
242523191$24252319$1$I$$20240822$20240827$20240827$EXP$$US-TAKEDA-2024TUS085337$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
242523201$24252320$1$I$20240101$20240819$20240827$20240827$EXP$$US-SA-2024SA248613$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240827$$PH$US$US
242523211$24252321$1$I$20240117$20240813$20240827$20240827$EXP$$IN-LUPIN LIMITED-2024-08231$LUPIN$$$$$$Y$$$20240827$$CN$IN$IN
242523221$24252322$1$I$$20240812$20240827$20240827$EXP$$KP-HALOCARBON LIFE SCIENCES, LLC-20240800006$Halocarbon Life Sciences$Moon Ok Lee. Does drug-induced liver injury still occur after sevoflurane anesthesia? -A case report. Anesth Pain Med. 2024;19(3:227-232$$$$$Y$$$20240827$$MD$KP$KP
242523231$24252323$1$I$$20240823$20240827$20240827$EXP$$AT-JNJFOC-20240868562$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$AT$AT
242523241$24252324$1$I$20240820$20240820$20240827$20240827$EXP$$US-JNJFOC-20240855443$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240827$$MD$US$US
242523252$24252325$2$F$20240101$20240907$20240827$20240918$PER$$US-APOTEX-2024AP009227$APOTEX$$72$YR$$F$Y$$$20240918$$CN$US$US
242523261$24252326$1$I$$20240815$20240827$20240827$PER$$US-BAUSCHBL-2024BNL032003$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240827$$MD$US$US
242523273$24252327$3$F$$20240826$20240827$20240829$PER$$NVSC2024US172153$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
242523281$24252328$1$I$20240715$20240820$20240827$20240827$EXP$$NVSC2024US169580$NOVARTIS$$76$YR$$F$Y$$$20240827$$CN$US$US
242523291$24252329$1$I$$20240821$20240827$20240827$EXP$GB-MHRA-MED-202408211344193490-JDYTS$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-002096$IPCA$$$$$$Y$$$20240827$$HP$GB$GB
242523301$24252330$1$I$20240816$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015362$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240827$$CN$US$US
242523311$24252331$1$I$$20240820$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015316$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242523321$24252332$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014687$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240827$$CN$US$US
242523331$24252333$1$I$20240701$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015341$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240827$$CN$US$US
242523341$24252334$1$I$$20240823$20240827$20240827$EXP$$US-JNJFOC-20240865362$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242523351$24252335$1$I$$20240819$20240827$20240827$EXP$$US-BIOCON BIOLOGICS LIMITED-BBL2024006107$BIOCON$$$$$$Y$$$20240827$$CN$US$US
242523371$24252337$1$I$20240822$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168476$AMGEN$$$$$F$Y$$$20240827$$PH$US$US
242523381$24252338$1$I$$20240820$20240827$20240827$PER$$US-ALXN-202408USA001291US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242523393$24252339$3$F$20240823$20240910$20240827$20240912$PER$$US-AMGEN-USASP2024169200$AMGEN$$79$YR$E$F$Y$$$20240912$$CN$US$US
242523402$24252340$2$F$$20240904$20240827$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135303$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$79.38$KG$20240906$$CN$US$US
242523411$24252341$1$I$20240819$20240821$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134342$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240827$$CN$US$US
242523421$24252342$1$I$$20240820$20240827$20240827$EXP$$PH-JNJFOC-20240852507$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$MD$PH$PH
242523431$24252343$1$I$$20240820$20240827$20240827$EXP$$NVSC2024IR171635$NOVARTIS$Sharifi P, Moradi A, Moghadasi AN. Fingolimod-associated Balo^s concentric sclerosis in multiple sclerosis: A case report. CLINICAL CASE REPORTS. 2024;12 (8):1-5$37$YR$$F$Y$$$20240827$$HP$IR$IR
242523441$24252344$1$I$$20240823$20240827$20240827$PER$$NVSC2024US172393$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
242523454$24252345$4$F$$20240906$20240827$20240914$EXP$$US-ROCHE-10000065519$ROCHE$$$$A$F$Y$$$20240914$$CN$US$US
242523461$24252346$1$I$$20240826$20240827$20240827$EXP$GB-MHRA-MED-202408260842069110-ZMTLW$GB-SANDOZ INC.-SDZ2024GB075204$SANDOZ$$$$$F$Y$$$20240827$$CN$GB$GB
242523471$24252347$1$I$$20240815$20240827$20240827$EXP$BR-MLMSERVICE-20240808-PI156439-00306-1$BR-STRIDES ARCOLAB LIMITED-2024SP010490$STRIDES$Honorato CM, Carrascoza GG, Abed NM, Moya FG. Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor. Anais brasileiros de dermatologia. 2024$72$YR$$M$Y$$$20240827$$MD$BR$BR
242523481$24252348$1$I$20230817$20240824$20240827$20240827$EXP$$US-GILEAD-2024-0685341$GILEAD$$73$YR$E$F$Y$$$20240827$$CN$US$US
242523491$24252349$1$I$$20240822$20240827$20240827$EXP$$JP-GSK-JP2024105702$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$JP$JP
242523512$24252351$2$F$$20240903$20240827$20240912$EXP$$TR-CELLTRION INC.-2024TR020248$CELLTRION$Onder T, Karacin C. Trastuzumab-induced optic neuritis: ^blindness^ side effect. Journal of Oncology Pharmacy Practice. 2024;1-4$$$$$Y$$$20240912$$HP$TR$TR
242523521$24252352$1$I$$20240813$20240827$20240827$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07797$HIKMA$$$$$M$Y$97.5$KG$20240827$$CN$US$US
242523533$24252353$3$F$20231123$20240910$20240827$20240917$EXP$$US-ABBVIE-5890925$ABBVIE$$61$YR$$M$Y$$$20240917$$CN$US$US
242523541$24252354$1$I$$20240822$20240827$20240827$EXP$$US-ABBVIE-5892579$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242523551$24252355$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-100908-2023$RECKITT BENCKISER$$$$$$Y$$$20240827$$CN$US$US
242523561$24252356$1$I$20240812$20240819$20240827$20240827$EXP$$CN-SA-2024SA249720$SANOFI AVENTIS$$69$YR$E$M$Y$59$KG$20240827$$HP$CN$CN
242523572$24252357$2$F$20210801$20240913$20240827$20240919$EXP$$CA-TAKEDA-2021TUS050328$TAKEDA$$45$YR$$M$Y$$$20240919$$CN$CA$CA
242523581$24252358$1$I$20240719$20240826$20240827$20240827$EXP$$US-UCBSA-2024027606$UCB$$37$YR$$F$Y$$$20240827$$MD$US$US
242523591$24252359$1$I$$20240819$20240827$20240827$EXP$US-MLMSERVICE-20240813-PI156517-00306-1$US-RDY-SPO/USA/24/0012124$DR REDDYS$Schwartz W, Christiansen AC, Patel SS. Intraorbital amphotericin B for mucormycosis in an Allo-HSCT recipient. Bone Marrow Transplantation. 2024;59(8):1176-7. DOI:10.1038/s41409-024-02287-2.$68$YR$E$M$Y$$$20240827$$MD$US$US
242523601$24252360$1$I$$20240819$20240827$20240827$EXP$$BR-CELLTRION INC.-2024BR005930$CELLTRION$$$$$$Y$$$20240827$$CN$BR$BR
242523611$24252361$1$I$$20240821$20240827$20240827$EXP$$US-ABBVIE-5891308$ABBVIE$$$$$$Y$$$20240827$$CN$US$US
242523621$24252362$1$I$20240802$20240819$20240827$20240827$EXP$IT-MINISAL02-998697$IT-TEVA-VS-3234860$TEVA$$54$YR$$M$Y$$$20240827$$MD$IT$IT
242523631$24252363$1$I$$20240819$20240827$20240827$EXP$$US-RDY-SPO/USA/24/0012257$DR REDDYS$Maresch KJ. Arytenoid Dislocation and Vocal Cord Immobility After Emergent Fiberoptic Intubation: A Case Report. AANA Journal. 2020 Dec 01;88(6): 459-463.$53$YR$A$M$Y$82$KG$20240827$$HP$US$US
242523642$24252364$2$F$20240823$20240827$20240827$20240902$PER$$US-AMGEN-USASP2024169549$AMGEN$$71$YR$E$F$Y$$$20240901$$CN$US$US
242523651$24252365$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169937$AMGEN$$$$$$Y$$$20240827$$MD$US$US
242523661$24252366$1$I$$20240821$20240827$20240827$PER$$US-AMGEN-USASP2024167588$AMGEN$Rosmarin D.. Recalcitrant Seborrheic Dermatitis Successfully Treated With Apremilast. Journal of Cutaneous Medicine and Surgery. 2020;24 (1):90-91$66$YR$E$M$Y$$$20240827$$HP$US$US
242523671$24252367$1$I$$20240811$20240827$20240827$PER$$US-AMGEN-USASP2024167125$AMGEN$Tavitian E.. Continuous Mobile Wearable Bio-Monitoring of Newly DiagnosedMultiple Myeloma Patients Undergoing Initial Chemotherapy. Blood. 2018;132(Supp 1):4751$$$$$Y$$$20240827$$HP$US$US
242523681$24252368$1$I$20240822$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168245$AMGEN$$79$YR$E$M$Y$$$20240827$$CN$US$US
242523691$24252369$1$I$20240817$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168502$AMGEN$$73$YR$E$$Y$$$20240827$$CN$US$US
242523703$24252370$3$F$$20240902$20240827$20240904$EXP$$US-BIOVITRUM-2024-US-011302$BIOVITRUM$$$$E$M$Y$$$20240904$$MD$US$US
242523711$24252371$1$I$$20240826$20240827$20240827$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047905$BOEHRINGER INGELHEIM$$$$$$Y$$$20240827$$MD$JP$JP
242523721$24252372$1$I$20240101$20240819$20240827$20240827$EXP$$US-SA-2024SA248536$SANOFI AVENTIS$$$$$F$Y$$$20240827$$HP$US$US
242523731$24252373$1$I$20240808$20240820$20240827$20240827$EXP$$CA-JNJFOC-20240857432$JOHNSON AND JOHNSON$$51$YR$A$M$Y$76$KG$20240827$$HP$CA$CA
242523741$24252374$1$I$$20240822$20240827$20240827$EXP$$US-GSK-US2024104968$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
242523752$24252375$2$F$$20240913$20240827$20240915$PER$$US-ALXN-202408USA001408US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
242523762$24252376$2$F$$20240821$20240827$20240917$EXP$$US-BEH-2024177592$CSL BEHRING$$$$E$M$Y$$$20240917$$HP$US$US
242523771$24252377$1$I$20230421$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192238$ASTRAZENECA$$25940$DY$$M$Y$$$20240827$$CN$US$
242523781$24252378$1$I$$20240822$20240827$20240827$EXP$$CA-ABBVIE-5892914$ABBVIE$$76$YR$$M$Y$$$20240827$$CN$CA$CA
242523791$24252379$1$I$$20240815$20240827$20240827$EXP$IN-MLMSERVICE-20220404-3479622-2$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-17457$ALKEM$Latief M, Bhat M, Wani M, Shafi O, Goud L, Abbas F, Wani M. Gabapentin Toxicity and Role of Dialysis: Case Series and Literature Review. Journal of Renal and Hepatic Disorders. 2022;6(1):7-9$64$YR$$M$Y$$$20240827$$HP$IN$IN
242523801$24252380$1$I$$20240813$20240827$20240827$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111320$ZYDUS PHARM$Monge J, Razavi M, Bao L, Patel SS. Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. Am-J-Hematol. 2023;99:327-328$$$$$Y$$$20240827$$HP$US$US
242523811$24252381$1$I$20240819$20240820$20240827$20240827$EXP$$GB-CELLTRION INC.-2024GB020294$CELLTRION$$$$$$Y$$$20240827$$HP$GB$GB
242523831$24252383$1$I$20190901$20240812$20240827$20240827$EXP$FR-EMA-DD-20240806-7482661-070324$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111215$ZYDUS PHARM$$$$$$Y$$$20240827$$MD$FR$FR
242523841$24252384$1$I$$20240823$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135064$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240827$$CN$US$US
242523851$24252385$1$I$20240822$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135089$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240827$$HP$US$US
242523861$24252386$1$I$20201216$20240821$20240827$20240827$EXP$$CA-TAKEDA-2024TUS071622$TAKEDA$$48$YR$$M$Y$$$20240827$$CN$CA$CA
242523871$24252387$1$I$$20240812$20240827$20240827$EXP$$BR-PHATHOM PHARMACEUTICALS INC.-2024PHT00746$Phathom Pharmaceuticals$$$$$F$Y$$$20240827$$MD$BR$BR
242523881$24252388$1$I$$20240822$20240827$20240827$EXP$$JP-JNJFOC-20240868369$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240827$$PH$JP$JP
242523891$24252389$1$I$20210716$20240822$20240827$20240827$EXP$$CA-TAKEDA-CA202016084$TAKEDA$$67$YR$$M$Y$$$20240827$$CN$CA$CA
242523901$24252390$1$I$20240718$20240812$20240827$20240827$EXP$$CN-PHATHOM PHARMACEUTICALS INC.-2024PHT00727$Phathom Pharmaceuticals$$66$YR$$F$Y$68$KG$20240827$$HP$CN$CN
242523911$24252391$1$I$$20240821$20240827$20240827$EXP$$CA-TAKEDA-2023TUS046558$TAKEDA$$$$$F$Y$$$20240827$$CN$CA$CA
242523922$24252392$2$F$20240814$20240822$20240827$20240829$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013330$JAZZ$$38$YR$$F$Y$$$20240829$$CN$US$US
242523931$24252393$1$I$20210519$20240819$20240827$20240827$EXP$$CN-CHEPLA-2024010726$CHEPLAPHARM$Chen Y, Liu C, Wen X, Wang C, He J. Treatment of HER2-Positive Breast Cancer with Brain Metastases Using Anlotinib and Trastuzumab Deruxtecan: A Case Report. International journal of women^s health. 2024;16:1277-1283. doi:10.2147/IJWH.S472628.$37$YR$$F$Y$$$20240827$$HP$COUNTRY NOT SPECIFIED$CN
242523942$24252394$2$F$20211118$20240826$20240827$20240903$EXP$$CA-TAKEDA-2023TUS101272$TAKEDA$$61$YR$$F$Y$$$20240903$$CN$CA$CA
242523961$24252396$1$I$$20240822$20240827$20240827$EXP$$NVSC2024US171428$NOVARTIS$$$$$F$Y$$$20240827$$MD$US$US
242523971$24252397$1$I$$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133903$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240827$$CN$US$US
242523981$24252398$1$I$$20240819$20240827$20240827$EXP$$IE-BIOCON BIOLOGICS LIMITED-BBL2024006115$BIOCON$Grechin C.. Tumour necrosis factor-alpha-induced lupus panniculitis: one case report and literature review.. British Journal of Dermatology.. 2024;192(Suppl 1):i17$$$$$Y$$$20240827$$HP$IE$IE
242524011$24252401$1$I$20240101$20240807$20240827$20240827$PER$$US-009507513-2408USA002219$MERCK$$$$$F$Y$65.8$KG$20240827$$CN$US$US
242524021$24252402$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015423$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240827$$CN$US$US
242524031$24252403$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015727$ELI LILLY AND CO$$$$$M$Y$$$20240827$$CN$US$US
242524041$24252404$1$I$20240729$20240819$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408011859$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240827$$CN$US$US
242524051$24252405$1$I$20240823$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015170$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240827$$CN$US$US
242524062$24252406$2$F$20240823$20240906$20240827$20240910$EXP$$JP-GILEAD-2024-0685134$GILEAD$$88$YR$E$F$Y$$$20240910$$PH$JP$JP
242524071$24252407$1$I$$20231002$20240827$20240827$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03871$AMNEAL$$$$$F$Y$$$20240827$$MD$US$US
242524081$24252408$1$I$20230819$20231115$20240827$20240827$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03035$AMNEAL$$$$$F$Y$$$20240827$$CN$US$US
242524091$24252409$1$I$$20230807$20240827$20240827$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-02802$AMNEAL$$$$$M$Y$$$20240827$$CN$US$US
242524101$24252410$1$I$$20231011$20240827$20240827$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04086$AMNEAL$$$$$$Y$$$20240827$$CN$US$US
242524111$24252411$1$I$20231103$20231107$20240827$20240827$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04211$AMNEAL$$$$$F$Y$$$20240827$$CN$US$US
242524121$24252412$1$I$20240806$20240817$20240827$20240827$30DAY$$US-GSK-US2024102831$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240827$$CN$US$US
242524131$24252413$1$I$$20240325$20240827$20240827$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00231$AMNEAL$$$$$F$Y$$$20240827$$CN$US$US
242524141$24252414$1$I$20231001$20240819$20240827$20240827$PER$$US-BIOGEN-2024BI01278800$BIOGEN$$47$YR$$F$Y$$$20240827$$CN$US$US
242524161$24252416$1$I$$20240821$20240827$20240827$EXP$$NVSC2024AT171457$NOVARTIS$$$$$F$Y$$$20240827$$MD$AT$AT
242524171$24252417$1$I$$20240823$20240827$20240827$PER$$US-HALEON-2193622$Haleon PLC$$$$$F$Y$$$20240827$$CN$US$US
242524181$24252418$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-083608-2024$RECKITT BENCKISER$$91$YR$$M$Y$$$20240827$$CN$US$US
242524192$24252419$2$F$20240823$20240925$20240827$20240926$PER$$US-AMGEN-USASP2024169096$AMGEN$$69$YR$E$F$Y$$$20240926$$CN$US$US
242524201$24252420$1$I$$20240822$20240827$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013394$JAZZ$$$$$F$Y$46$KG$20240827$$CN$US$US
242524211$24252421$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024170278$AMGEN$$$$$$Y$$$20240827$$PH$US$US
242524221$24252422$1$I$20240726$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169342$AMGEN$$72$YR$E$F$Y$$$20240827$$CN$US$US
242524241$24252424$1$I$20240101$20240823$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075346$SANDOZ$$$$$M$Y$$$20240827$$CN$US$US
242524251$24252425$1$I$$20240819$20240827$20240827$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024006098$BIOCON$$$$$$Y$$$20240827$$CN$AU$AU
242524262$24252426$2$F$$20240913$20240827$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-041197$AUROBINDO$Beytout Q, Dutheil A, Cristofari S, Barbaud A, Chasset F, Senet P. Intra-arterial facial injection of hyaluronic acid complicated by Nicolau^s dermatitis: Treatment with iloprost.. J-Eur-Acad-DermatolVenereol. 2023;37:e1314-e1315$54$YR$$F$Y$$$20240926$$HP$FR$FR
242524271$24252427$1$I$$20240826$20240827$20240827$EXP$$DE-GILEAD-2024-0685059$GILEAD$$$$$F$Y$$$20240827$$MD$DE$DE
242524281$24252428$1$I$20240730$20240814$20240827$20240827$EXP$$ES-AUROBINDO-AUR-APL-2024-041571$AUROBINDO$$88$YR$$M$Y$59.3$KG$20240827$$MD$ES$ES
242524291$24252429$1$I$$20240827$20240827$20240827$EXP$FI-FIMEA-202402807$FI-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047970$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240827$$CN$FI$FI
242524301$24252430$1$I$20240814$20240814$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-041534$AUROBINDO$$49$YR$$M$Y$78$KG$20240827$$CN$GB$GB
242524311$24252431$1$I$$20240819$20240827$20240827$EXP$$ZA-AstraZeneca-2024A190354$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$ZA$
242524321$24252432$1$I$20240818$20240818$20240827$20240827$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025758$UNITED THERAPEUTICS$$54$YR$$F$Y$77.098$KG$20240827$$PH$US$US
242524331$24252433$1$I$$20231127$20240827$20240827$PER$$US-Accord-394916$ACCORD$$$$$M$Y$$$20240827$$CN$US$US
242524341$24252434$1$I$$20230828$20240827$20240827$PER$$US-Accord-377184$ACCORD$$$$$M$Y$$$20240827$$PH$US$US
242524351$24252435$1$I$20231217$20231220$20240827$20240827$PER$$US-Accord-401797$ACCORD$$79$YR$E$M$Y$$$20240827$$CN$US$US
242524361$24252436$1$I$20240815$20240817$20240827$20240827$EXP$GB-MHRA-MED-202408171833329030-DZBNT$GB-TEVA-VS-3234852$TEVA$$$$$F$Y$59$KG$20240827$$CN$GB$GB
242524371$24252437$1$I$$20240820$20240827$20240827$EXP$$CA-APOTEX-2024AP009629$APOTEX$$$$$F$Y$$$20240827$$HP$CA$CA
242524381$24252438$1$I$20240810$20240817$20240827$20240827$EXP$GB-MHRA-MED-202408171121569570-KMTRW$GB-TEVA-VS-3234841$TEVA$$39$YR$$F$Y$$$20240827$$CN$GB$GB
242524391$24252439$1$I$20240815$20240817$20240827$20240827$EXP$GB-MHRA-MED-202408172356121370-JKCPY$GB-TEVA-VS-3234901$TEVA$$$$$$Y$$$20240827$$CN$GB$GB
242524401$24252440$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134925$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240827$$CN$US$US
242524411$24252441$1$I$$20240817$20240827$20240827$EXP$GB-MHRA-MED-202408170702368450-SLYHV$GB-TEVA-VS-3234833$TEVA$$$$$M$Y$$$20240827$$CN$GB$GB
242524421$24252442$1$I$$20240822$20240827$20240827$EXP$$US-ABBVIE-5890542$ABBVIE$$$$$M$Y$$$20240827$$HP$US$US
242524432$24252443$2$F$20240801$20240828$20240827$20240902$EXP$$ZA-ABBVIE-5887462$ABBVIE$$16$YR$$F$Y$$$20240902$$MD$ZA$ZA
242524441$24252444$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041397$AUROBINDO$$$$$F$Y$$$20240827$$MD$CA$CA
242524451$24252445$1$I$$20240821$20240827$20240827$PER$$US-009507513-2408USA007215$MERCK$$$$$F$Y$$$20240827$$CN$US$US
242524461$24252446$1$I$20240101$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168626$AMGEN$$58$YR$A$F$Y$$$20240827$$CN$US$US
242524471$24252447$1$I$20240101$20240818$20240827$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-025833$UNITED THERAPEUTICS$$$$$F$Y$49.433$KG$20240827$$$US$US
242524481$24252448$1$I$$20240817$20240827$20240827$EXP$$CA-AMGEN-CANSP2023218655$AMGEN$Seow C. H.; Constantineseu C.; Murguia-favela L. et al.. Live rotavirus vaccination appears safe in biologic exposed infants born to mothers with inflammatory bowel disease. Gastroenterology. 2023;164:S-1108$$$$$Y$$$20240827$$MD$CA$CA
242524492$24252449$2$F$20240820$20240827$20240827$20240903$EXP$$JP-AMGEN-JPNSP2024169330$AMGEN$$8$DEC$E$M$Y$$$20240903$$MD$JP$JP
242524501$24252450$1$I$$20240812$20240827$20240827$PER$$US-TEVA-VS-3233155$TEVA$$33$YR$$M$Y$$$20240827$$CN$US$US
242524511$24252451$1$I$$20240823$20240827$20240827$EXP$$CA-TAKEDA-2024TUS086047$TAKEDA$$$$$F$Y$$$20240827$$CN$CA$CA
242524522$24252452$2$F$20240801$20240919$20240827$20240925$EXP$$JP-GSK-JP2024JPN105115$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$JP$JP
242524541$24252454$1$I$$20240823$20240827$20240827$EXP$$IN-ROCHE-3552624$ROCHE$$73$YR$E$M$Y$$$20240827$$MD$IN$IN
242524551$24252455$1$I$$20240820$20240827$20240827$EXP$$AU-CELLTRION INC.-2024AU020151$CELLTRION$$$$$$Y$$$20240827$$HP$AU$AU
242524561$24252456$1$I$$20240820$20240827$20240827$EXP$$CN-BEIGENE-BGN-2024-013264$BEIGENE$$$$$$Y$$$20240827$$MD$CN$CN
242524571$24252457$1$I$20230801$20240819$20240827$20240827$EXP$$FR-BIOCON BIOLOGICS LIMITED-BBL2023002139$BIOCON$$$$$$Y$$$20240827$$HP$FR$FR
242524581$24252458$1$I$20240515$20240822$20240827$20240827$EXP$FR-AFSSAPS-TS2024000856$FR-ROCHE-10000063709$ROCHE$$64$YR$A$M$Y$82$KG$20240827$$MD$FR$FR
242524591$24252459$1$I$20190301$20240820$20240827$20240827$EXP$$CA-CELLTRION INC.-2022CA012286$CELLTRION$$$$$$Y$$$20240827$$MD$CA$CA
242524602$24252460$2$F$$20240904$20240827$20240912$EXP$$JP-AMGEN-JPNSP2024168992$AMGEN$$$$$$Y$$$20240912$$PH$JP$JP
242524612$24252461$2$F$$20240823$20240827$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-133661$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240830$$MD$JP$JP
242524621$24252462$1$I$$20240820$20240827$20240827$EXP$$US-ABBVIE-5889527$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242524631$24252463$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041560$AUROBINDO$$66$YR$$M$Y$110$KG$20240827$$PH$CA$CA
242524642$24252464$2$F$$20240822$20240827$20240830$PER$$US-AMGEN-USASP2024168529$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242524661$24252466$1$I$20190301$20240821$20240827$20240827$EXP$$DE-AMGEN-DEUSP2024167200$AMGEN$$75$YR$E$F$Y$$$20240827$$MD$DE$DE
242524671$24252467$1$I$20240101$20240820$20240827$20240827$EXP$$RO-AMGEN-ROUSL2024152976$AMGEN$$69$YR$E$M$Y$$$20240827$$MD$RO$RO
242524681$24252468$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-103520-2023$RECKITT BENCKISER$$$$$M$Y$$$20240827$$CN$US$US
242524692$24252469$2$F$20240806$20240920$20240827$20240930$EXP$$JP-009507513-2408JPN002625J$MERCK$$86$YR$$M$Y$65$KG$20240930$$MD$JP$JP
242524701$24252470$1$I$$20240814$20240827$20240827$EXP$$IT-AUROBINDO-AUR-APL-2024-041807$AUROBINDO$Clarissa Corniello, Fedele Dono, Giacomo Evangelista, Sara Cipollone, Stefano Consoli, Stefano L. Sensi.. Safety and effectiveness of cenobamate in down syndrome: a case report.. Neurological Sciences. 2024$28$YR$$M$Y$$$20240827$$MD$IT$IT
242524711$24252471$1$I$$20240812$20240827$20240827$EXP$$IN-SEBELA IRELAND LIMITED-2024SEB00058$SEBELA$Handa S, Mehta H, Bishnoi A, Raj D, De D.. Efficacy and safety of azathioprine versus mycophenolate mofetil in chronic actinic dermatitis in skin of color: results of a randomized controlled trial. Int. J. Dermatol.. 2024$$$$M$Y$$$20240827$$HP$IN$IN
242524731$24252473$1$I$$20240821$20240827$20240827$EXP$$CA-ABBVIE-5891193$ABBVIE$$$$A$F$Y$$$20240827$$CN$CA$CA
242524741$24252474$1$I$20240822$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168522$AMGEN$$41$YR$A$F$Y$$$20240827$$CN$US$US
242524752$24252475$2$F$$20240822$20240827$20240830$PER$$US-AMGEN-USASP2024168520$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242524761$24252476$1$I$20240101$20240822$20240827$20240827$EXP$$US-ABBVIE-5891745$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242524771$24252477$1$I$20240801$20240801$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004191$ACADIA PHARMACEUTICALS$$86$YR$$F$Y$$$20240827$$CN$US$US
242524781$24252478$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-042341$AUROBINDO$$21$YR$$F$Y$$$20240827$$HP$CA$CA
242524791$24252479$1$I$$20240825$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134471$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$96.16$KG$20240827$$CN$US$US
242524801$24252480$1$I$20240818$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134946$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240827$$HP$US$US
242524812$24252481$2$F$$20240823$20240827$20240828$PER$$NVSC2024US172001$NOVARTIS$$$$$$Y$$$20240828$$CN$US$US
242524821$24252482$1$I$$20240813$20240827$20240827$EXP$$US-ENDO USA, INC.-2024-003203$ENDO$Enstrom C, Gast S, Church L, Heflin MK, Moore C, Cook C, et al.. Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy. US Cardiology Review. 2024;18(Suppl 1):01:2$29$YR$$M$Y$$$20240827$$HP$US$US
242524831$24252483$1$I$$20240718$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07341$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242524841$24252484$1$I$$20240822$20240827$20240827$EXP$$US-ABBVIE-5892688$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242524852$24252485$2$F$20240728$20240913$20240827$20240923$EXP$$US-RECORDATI RARE DISEASE INC.-2024006486$RECORDATI$$$$$$Y$$$20240923$$CN$US$US
242524861$24252486$1$I$$20240819$20240827$20240827$EXP$$JP-AstraZeneca-2024A191001$ASTRAZENECA$$$$$F$Y$$$20240827$$MD$JP$
242524871$24252487$1$I$$20240822$20240827$20240827$PER$$US-ABBVIE-5891861$ABBVIE$$$$$F$Y$$$20240827$$PH$US$US
242524891$24252489$1$I$$20240823$20240827$20240827$PER$$NVSC2024US172012$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242524904$24252490$4$F$20240101$20240912$20240827$20240918$EXP$$GB-ABBVIE-5893096$ABBVIE$$78$YR$$F$Y$$$20240918$$CN$GB$GB
242524911$24252491$1$I$$20240819$20240827$20240827$30DAY$$US-GSK-US2024103413$GLAXOSMITHKLINE$$$$$M$Y$$$20240827$$CN$US$US
242524921$24252492$1$I$$20240814$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-041245$AUROBINDO$$80$YR$$$Y$$$20240827$$PH$GB$GB
242524931$24252493$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013680$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240827$$CN$US$US
242524941$24252494$1$I$$20240820$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408012651$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240827$$CN$US$US
242524951$24252495$1$I$20240501$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014743$ELI LILLY AND CO$$68$YR$E$$Y$$$20240827$$CN$US$US
242524961$24252496$1$I$20240823$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015417$ELI LILLY AND CO$$62$YR$A$$Y$$$20240827$$CN$US$US
242524971$24252497$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015294$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240827$$CN$US$US
242524981$24252498$1$I$20240816$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014936$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240827$$CN$US$US
242524991$24252499$1$I$20240821$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015441$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240827$$CN$US$US
242525001$24252500$1$I$$20240813$20240827$20240827$EXP$$US-ENDO USA, INC.-2024-003204$ENDO$Enstrom C, Gast S, Church L, Heflin MK, Moore C, Cook C, et al.. Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy. US Cardiology Review. 2024;18(Suppl 1):01:2$25$YR$$M$Y$$$20240827$$HP$US$US
242525011$24252501$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015755$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240827$$CN$US$US
242525022$24252502$2$F$20240101$20240826$20240827$20240912$PER$$US-IMP-2024000633$Harrow Health$$76$YR$E$F$Y$$$20240912$$CN$US$US
242525031$24252503$1$I$$20240823$20240827$20240827$EXP$$JP-ABBVIE-5892879$ABBVIE$$74$YR$$M$Y$$$20240827$$CN$JP$JP
242525041$24252504$1$I$20240722$20240823$20240827$20240827$EXP$$US-ABBVIE-5894424$ABBVIE$$74$YR$$F$Y$$$20240827$$CN$US$US
242525051$24252505$1$I$$20240814$20240827$20240827$EXP$GB-MLMSERVICE-20240807-PI154832-00059-1$GB-STRIDES ARCOLAB LIMITED-2024SP010417$STRIDES$Kanji A, Ahmad R, Bala L, Mallon E. Cutaneous Post-transplant Lymphoproliferative Disorder.. Cureus. 2024;16(7):e63951$36$YR$$M$Y$$$20240827$$MD$GB$GB
242525071$24252507$1$I$20240101$20240821$20240827$20240827$PER$$US-ABBVIE-5892943$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242525082$24252508$2$F$$20240823$20240827$20240906$EXP$$PT-AUROBINDO-AUR-APL-2024-041520$AUROBINDO$Martins G, Dias A, Guerreiro C. Metronidazole-induced encephalopathy in a patient with spondylodiscitis. CLINICAL TOXICOLOGY (Phila). 2024$63$YR$$M$Y$$$20240906$$HP$PT$PT
242525091$24252509$1$I$$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133626$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240827$$HP$US$US
242525101$24252510$1$I$$20240813$20240827$20240827$PER$$US-APOTEX-2024AP009485$APOTEX$Oaklander AL, Allen J, Dietliker N, Wilder-Smith EP. Relapsing-Remitting Immunotherapy Responsive Small-Fiber Neuropathy: Longitudinal Tracking Through 10 Years Including Pregnancies. Neurology Neuroimmunology + Neuroinflammation. 2024;11(5):e200286(1-5)$30$YR$$F$Y$$$20240827$$MD$US$US
242525121$24252512$1$I$$20240820$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133809$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240827$$HP$US$US
242525132$24252513$2$F$20240819$20240829$20240827$20240901$PER$$US-JNJFOC-20240866405$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240901$$HP$US$US
242525141$24252514$1$I$20240701$20240821$20240827$20240827$EXP$$CA-JNJFOC-20240770680$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240827$$HP$CA$CA
242525151$24252515$1$I$$20240820$20240827$20240827$EXP$$CA-JNJFOC-20240856281$JOHNSON AND JOHNSON$$11$YR$C$M$Y$34$KG$20240827$$HP$CA$CA
242525161$24252516$1$I$$20240813$20240827$20240827$EXP$$IL-Merck Healthcare KGaA-2024044723$MERCK KGAA$$70$YR$E$F$Y$$$20240822$$CN$IL$IL
242525183$24252518$3$F$20240824$20240827$20240827$20240903$PER$$US-AMGEN-USASP2024170096$AMGEN$$65$YR$E$F$Y$$$20240902$$CN$US$US
242525201$24252520$1$I$20240717$20240814$20240827$20240827$EXP$$DE-AUROBINDO-AUR-APL-2024-041681$AUROBINDO$$62$YR$$M$Y$71$KG$20240827$$HP$DE$DE
242525211$24252521$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-088145-2024$RECKITT BENCKISER$$$$$$Y$$$20240827$$CN$US$US
242525221$24252522$1$I$20240821$20240822$20240827$20240827$EXP$$PK-ROCHE-10000063407$ROCHE$$35$YR$A$F$Y$$$20240827$$CN$PK$PK
242525231$24252523$1$I$20230811$20240820$20240827$20240827$EXP$FR-AFSSAPS-LM2024000451$FR-UCBSA-2024042105$UCB$$35$YR$$F$Y$63$KG$20240827$$MD$FR$FR
242525241$24252524$1$I$$20240815$20240827$20240827$EXP$GB-ABBVIE-5875930$GB-ROCHE-10000058386$ROCHE$$$$$M$Y$$$20240827$$HP$GB$GB
242525251$24252525$1$I$20240711$20240819$20240827$20240827$EXP$$ES-HIKMA PHARMACEUTICALS USA INC.-ES-H14001-24-07930$HIKMA$$58$YR$$F$Y$$$20240827$$HP$ES$ES
242525271$24252527$1$I$$20240820$20240827$20240827$EXP$$US-AMGEN-USASP2024167331$AMGEN$$$$$$Y$$$20240827$$MD$US$US
242525281$24252528$1$I$$20240821$20240827$20240827$EXP$$TW-AMGEN-TWNSP2024169318$AMGEN$$$$$M$Y$$$20240827$$HP$TW$TW
242525291$24252529$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134641$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240827$$CN$US$US
242525302$24252530$2$F$$20240909$20240827$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135123$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240916$$CN$US$US
242525311$24252531$1$I$$20230322$20240827$20240827$EXP$$SI-002147023-NVSC2022SI163393$Haleon PLC$Ota S, Tajnsek TV, Jeverica AK, Markelj G, Blazina S, Dragos V et al,?Stevens-Johnsonov sindrom in toksicna epidermalna nekroliza pri otrocih: prikaz primerov in pregled literature?[Stevens-Johnson syndrome and toxic epidermal necrolysis in children: A case series and review of the literature]. Zdravniski Vestnik [Slovenian Medical Journal] 2022; 91 (5-6): 196-204; Ota S, Tajnsek TV, Jeverica AK, Markelj G, Blazina S, Dragos V.Stevens-Johnson syndrome and toxic epidermal necrolysis in childre...$6$YR$$M$Y$$$20240827$$HP$SI$SI
242525321$24252532$1$I$$20240816$20240827$20240827$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP010421$STRIDES$Chesi E, Rossi K, Ancora G, Baraldi C, Corradi M, Di Dio F, et al. Patent ductus arteriosus (also non-hemodynamically significant) correlates with poor outcomes in very low birth weight infants. A multicenter cohort study. Plos one.. 2024;19 (7):1-15$$$I$$Y$$$20240827$$HP$IT$IT
242525332$24252533$2$F$20240821$20240826$20240827$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134619$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240829$$HP$US$US
242525341$24252534$1$I$$20240814$20240827$20240827$EXP$$PT-AUROBINDO-AUR-APL-2018-048637$AUROBINDO$Le M, Ravin K, Hasan A, Clauss H, Muchant D, Pasko J, et al.. Single donor-derived strongyloidiasis in three solid organ transplant recipients: case series and review of the literature.. Am J Transplant. 2014;14(5):1199-206$14$YR$$M$Y$$$20240827$$HP$PT$PT
242525351$24252535$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041686$AUROBINDO$unknown. unknown. unknown$68$YR$$M$Y$$$20240827$$HP$CA$CA
242525361$24252536$1$I$20231001$20240822$20240827$20240827$30DAY$$US-GSK-US2024105056$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240827$$CN$US$US
242525371$24252537$1$I$20240801$20240813$20240827$20240827$EXP$GB-MHRA-MED-202408131135045430-PTZLS$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-07787$HIKMA$$36$YR$$F$Y$73$KG$20240827$$CN$GB$GB
242525391$24252539$1$I$$20240821$20240827$20240827$PER$$US-GILEAD-2024-0684975$GILEAD$$$$$F$Y$$$20240827$$MD$US$US
242525402$24252540$2$F$$20240830$20240827$20240903$EXP$$US-TAKEDA-2024TUS084971$TAKEDA$$$$$F$Y$$$20240903$$CN$US$US
242525411$24252541$1$I$$20240724$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07397$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242525421$24252542$1$I$$20240826$20240827$20240827$EXP$$CA-HALEON-2193473$Haleon PLC$$54$YR$$M$Y$$$20240827$$PH$CA$CA
242525441$24252544$1$I$$20240820$20240827$20240827$EXP$$JP-JNJFOC-20240867774$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240827$$MD$JP$JP
242525451$24252545$1$I$$20240814$20240827$20240827$EXP$$GB-STRIDES PHARMA UK LTD.-2024SP010180$STRIDES$Kubba F, Aliyeva-Derraz P, Gradassi AT. An unusual case of drug-induced annular granulomatous vasculitis in a patient with rheumatoid arthritis and type 2 diabetes mellitus.. Br-J-Dermatol. 2024;191 Supplement1:i117-i118$61$YR$$F$Y$$$20240827$$MD$GB$GB
242525462$24252546$2$F$20240820$20240828$20240827$20240830$PER$$US-AMGEN-USASP2024168939$AMGEN$$62$YR$A$F$Y$$$20240830$$CN$US$US
242525471$24252547$1$I$$20240819$20240827$20240827$EXP$$US-AMGEN-USASP2024165335$AMGEN$$$$$F$Y$$$20240827$$MD$US$US
242525481$24252548$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-042287$AUROBINDO$$62$YR$$F$Y$$$20240827$$HP$CA$CA
242525491$24252549$1$I$20240822$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168327$AMGEN$$77$YR$E$F$Y$$$20240827$$CN$US$US
242525501$24252550$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172691$NOVARTIS$$$$$M$Y$$$20240827$$MD$US$US
242525531$24252553$1$I$$20240722$20240827$20240827$EXP$$ES-TEVA-VS-3226277$TEVA$Mestres Catal? C. Improvement of adherence and health status of a young patient?with multiple pathologies through the follow-up service with SPD in a community pharmacy. Community?Farms. 2024 Jul 15; 16(3):43-48.$36$YR$$F$Y$83.3$KG$20240827$$PH$ES$ES
242525541$24252554$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192395$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242525551$24252555$1$I$$20231113$20240827$20240827$PER$$US-APOTEX-2023AP016755$APOTEX$Kennedy K, Lee M, Sathe M, Ueng C-S, Sharma P.. Evaluation of the Use of Appetite Stimulants in Pediatric Patients with Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 2023;77(4):565-572$$$C$$Y$$$20240827$$PH$US$US
242525561$24252556$1$I$$20231113$20240827$20240827$PER$$US-APOTEX-2023AP016705$APOTEX$Kennedy K, Lee M, Sathe M, Ueng C-S, Sharma P.. Evaluation of the Use of Appetite Stimulants in Pediatric Patients with Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 2023;77(4):565-572$$$C$$Y$$$20240827$$PH$US$US
242525571$24252557$1$I$$20240822$20240827$20240827$EXP$$GB-TAKEDA-2024TUS086019$TAKEDA$$$$$F$Y$$$20240827$$CN$GB$GB
242525584$24252558$4$F$$20240912$20240827$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004954$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
242525591$24252559$1$I$$20240822$20240827$20240827$PER$$US-ROCHE-10000064643$ROCHE$$$$A$F$Y$$$20240827$$PH$US$US
242525602$24252560$2$F$20240612$20240930$20240827$20240930$EXP$ES-AEMPS-1563529$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047931$BOEHRINGER INGELHEIM$$84$YR$E$F$Y$60$KG$20240930$$MD$ES$ES
242525611$24252561$1$I$20240823$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169685$AMGEN$$73$YR$E$M$Y$$$20240827$$CN$US$US
242525621$24252562$1$I$$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133955$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$87.09$KG$20240827$$CN$US$US
242525631$24252563$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-042343$AUROBINDO$$21$YR$$F$Y$$$20240827$$HP$CA$CA
242525641$24252564$1$I$20240717$20240814$20240827$20240827$EXP$$FR-AUROBINDO-AUR-APL-2024-041431$AUROBINDO$$93$YR$$F$Y$76$KG$20240827$$PH$FR$FR
242525651$24252565$1$I$20240224$20240823$20240827$20240827$EXP$$NVSC2024US036701$NOVARTIS$$75$YR$$M$Y$$$20240827$$HP$US$US
242525662$24252566$2$F$$20240913$20240827$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202408015540$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240925$$CN$US$US
242525671$24252567$1$I$$20240507$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-023529$AUROBINDO$$64$YR$$M$Y$$$20240827$$PH$US$US
242525681$24252568$1$I$20240406$20240826$20240827$20240827$EXP$FR-AFSSAPS-RE2024000850$NVSC2024FR171775$NOVARTIS$$53$YR$$M$Y$77.5$KG$20240827$$MD$FR$FR
242525691$24252569$1$I$$20240814$20240827$20240827$EXP$$JP-PBT-009653$PANACEA BIOTEC$Shionoya K, Koizumi K, Masuda S, Kubota J, Kimura K, Makazu M. A Case of Spurting Bleeding After Endoscopic Papillary Balloon Dilation. Gastro Hep Adv. 2023 Jul 18;2(7):889-892. doi: 10.1016/j.gastha.2023.07.005.$58$YR$A$M$Y$$$20240827$$MD$JP$JP
242525702$24252570$2$F$20240101$20240829$20240827$20240916$EXP$$LB-SA-2024SA247297$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240916$$PH$LB$LB
242525711$24252571$1$I$20240823$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015537$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240827$$CN$US$US
242525721$24252572$1$I$$20240521$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-026642$AUROBINDO$$72$YR$$F$Y$90.718$KG$20240827$$CN$US$US
242525731$24252573$1$I$$20240705$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-024877$AUROBINDO$$72$YR$$M$Y$102.05$KG$20240827$$CN$US$US
242525741$24252574$1$I$$20240814$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041752$AUROBINDO$Bhatt C, Doleeb Z, Bapat P, Pagnoux C. Drug-induced haemolysis: another reason to be cautious with nitrofurantoin. BMJ-Case-Rep. 2023;16:No. 1$7$DEC$$F$Y$$$20240827$$HP$CA$CA
242525751$24252575$1$I$$20240520$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-026111$AUROBINDO$$$$$F$Y$$$20240827$$CN$US$US
242525761$24252576$1$I$20240616$20240517$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-026042$AUROBINDO$$72$YR$$F$Y$$$20240827$$CN$US$US
242525771$24252577$1$I$20240103$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-082744-2024$RECKITT BENCKISER$$70$YR$$F$Y$$$20240827$$CN$US$US
242525781$24252578$1$I$$20240820$20240827$20240827$30DAY$$US-GSK-US2024103982$GLAXOSMITHKLINE$$$$$M$Y$$$20240827$$CN$US$US
242525791$24252579$1$I$20240101$20240814$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-041519$AUROBINDO$$81$YR$$M$Y$82$KG$20240827$$MD$GB$GB
242525802$24252580$2$F$20240919$20240919$20240827$20240923$EXP$$CA-TAKEDA-2024TUS059870$TAKEDA$$56$YR$$F$Y$$$20240923$$CN$CA$CA
242525812$24252581$2$F$20240817$20240826$20240827$20240902$EXP$$CA-TAKEDA-2024TUS083945$TAKEDA$$75$YR$$M$Y$64$KG$20240902$$CN$CA$CA
242525821$24252582$1$I$$20240710$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-035591$AUROBINDO$$$$$F$Y$$$20240827$$CN$US$US
242525831$24252583$1$I$$20240806$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-031724$AUROBINDO$$$$$F$Y$$$20240827$$CN$US$US
242525841$24252584$1$I$$20240619$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-031516$AUROBINDO$$$$$M$Y$$$20240827$$PH$US$US
242525851$24252585$1$I$$20240730$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-036404$AUROBINDO$$59$YR$$F$Y$$$20240827$$PH$US$US
242525861$24252586$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041413$AUROBINDO$$60$YR$$M$Y$$$20240827$$HP$CA$CA
242525871$24252587$1$I$20240702$20240814$20240827$20240827$EXP$$IT-AUROBINDO-AUR-APL-2024-041658$AUROBINDO$$44$YR$$M$Y$$$20240827$$MD$IT$IT
242525881$24252588$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135316$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240827$$CN$US$US
242525891$24252589$1$I$$20240821$20240827$20240827$PER$$US-ABBVIE-5892302$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242525901$24252590$1$I$20240301$20240817$20240827$20240827$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-133166$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240827$$HP$CO$CO
242525911$24252591$1$I$20240820$20240820$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133705$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240827$$CN$US$US
242525921$24252592$1$I$$20240814$20240827$20240827$EXP$$PT-AUROBINDO-AUR-APL-2024-041722$AUROBINDO$Varela O, Malheiro B, Castro AP, et al.. PLASMA CELL LEUKEMIA ? CLINICAL CASE.. Laboratory Medicine Magazine.. 2024;5:141-5$71$YR$$F$Y$$$20240827$$MD$PT$PT
242525931$24252593$1$I$$20240823$20240827$20240827$EXP$$NVSC2024US172006$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
242525942$24252594$2$F$20240808$20240820$20240827$20240827$PER$$US-ROCHE-10000061754$ROCHE$$34$YR$A$M$Y$$$20240827$$CN$US$US
242525951$24252595$1$I$20240526$20240822$20240827$20240827$EXP$$CN-GSK-CN2024APC105133$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$HP$CN$CN
242525971$24252597$1$I$$20240726$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07567$LUPIN$$$$$$Y$$$20240827$$MD$US$US
242525981$24252598$1$I$$20240814$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041758$AUROBINDO$$38$YR$$F$Y$64$KG$20240827$$HP$CA$CA
242525991$24252599$1$I$$20240822$20240827$20240827$EXP$$KR-AMGEN-KORSP2024169311$AMGEN$$$$$$Y$$$20240827$$PH$KR$KR
242526001$24252600$1$I$20240627$20240819$20240827$20240827$PER$$US-AMGEN-USASP2024165648$AMGEN$$72$YR$E$M$Y$$$20240827$$CN$US$US
242526011$24252601$1$I$$20240725$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07480$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242526021$24252602$1$I$20220105$20220127$20240827$20240827$EXP$$CA-CELLTRION INC.-2021CA019650$CELLTRION$$$$$$Y$$$20240827$$MD$CA$CA
242526031$24252603$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07729$LUPIN$$$$$$Y$$$20240827$$MD$US$US
242526041$24252604$1$I$$20240823$20240827$20240827$EXP$$NVSC2024US172223$NOVARTIS$$$$$F$Y$$$20240827$$MD$US$US
242526052$24252605$2$F$$20240823$20240827$20240828$PER$$NVSC2024US171981$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
242526061$24252606$1$I$$20240821$20240827$20240827$EXP$$NVSC2024US085586$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242526071$24252607$1$I$20240701$20240819$20240827$20240827$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240800090$RIGEL PHARMACEUTICALS$$64$YR$$M$Y$70$KG$20240827$$MD$JP$JP
242526081$24252608$1$I$20240101$20240822$20240827$20240827$EXP$$AU-ABBVIE-5892709$ABBVIE$$$$$F$Y$$$20240827$$CN$AU$AU
242526091$24252609$1$I$$20240814$20240827$20240827$EXP$GB-MLMSERVICE-20240807-PI154535-00270-1$GB-STRIDES ARCOLAB LIMITED-2024SP010419$STRIDES$Madhwapathi V, Tso S.. Once in a blue moon?. British Journal of Dermatology. 2024;191(Supplement1:i121$80$YR$$F$Y$$$20240827$$MD$GB$GB
242526101$24252610$1$I$20240803$20240820$20240827$20240827$EXP$$US-RIGEL-20240800088$RIGEL PHARMACEUTICALS$$84$YR$$F$Y$69.4$KG$20240827$$CN$US$US
242526111$24252611$1$I$$20240826$20240827$20240827$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047889$BOEHRINGER INGELHEIM$$7$DEC$E$F$Y$$$20240827$$PH$JP$JP
242526121$24252612$1$I$$20240822$20240827$20240827$PER$$US-TAKEDA-2024TUS085583$TAKEDA$$$$$F$Y$136$KG$20240827$$MD$US$US
242526131$24252613$1$I$$20240621$20240827$20240827$PER$$US-JNJFOC-20240859644$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$US$US
242526141$24252614$1$I$20240819$20240819$20240827$20240827$PER$$US-JNJFOC-20240855518$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242526151$24252615$1$I$20240624$20240823$20240827$20240827$EXP$$US-JNJFOC-20240865781$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240827$$HP$US$US
242526161$24252616$1$I$$20240821$20240827$20240827$PER$$US-AMGEN-USASP2024167545$AMGEN$$88$YR$E$M$Y$$$20240827$$CN$US$US
242526171$24252617$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07762$LUPIN$$$$$$Y$$$20240827$$MD$US$US
242526181$24252618$1$I$$20240818$20240827$20240827$PER$$US-AMGEN-USASP2024169766$AMGEN$Hussaini S.. Calcitonin Gene-Related Peptide Inhibitor: Role in Treatment of Hemicrania Continua, with Potential Benefit in Controlling Diarrhea. Journal of Pain. 2019;20 (4):S47$61$YR$A$F$Y$$$20240827$$HP$US$US
242526191$24252619$1$I$$20240822$20240827$20240827$EXP$$JP-GSK-JP2024105718$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$JP$JP
242526201$24252620$1$I$$20240812$20240827$20240827$EXP$$ES-TEYRO-2024-TY-000498$Teyro Labs$Riesco-Martinez MC, Capdevila J, Alonso V, Jimenez-Fonseca P, Teule A, Grande E, Sevilla I, et al..Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)..Nat Commun.2024;15:6753$$$$M$Y$$$20240827$$HP$ES$ES
242526211$24252621$1$I$$20240814$20240827$20240827$EXP$$GB-ADVANZ PHARMA-202408006841$ADVANZ PHARMA$$$$$$Y$$$20240827$$MD$GB$GB
242526221$24252622$1$I$$20240819$20240827$20240827$EXP$$DE-AstraZeneca-2024A188824$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$DE$
242526231$24252623$1$I$20240604$20240820$20240827$20240827$EXP$FR-AFSSAPS-TO2024001041$FR-ROCHE-10000061237$ROCHE$$72$YR$E$M$Y$73$KG$20240827$$HP$FR$FR
242526241$24252624$1$I$20240801$20240815$20240827$20240827$EXP$$CA-CELLTRION INC.-2024CA020313$CELLTRION$$$$$$Y$$$20240827$$PH$CA$CA
242526251$24252625$1$I$20240806$20240823$20240827$20240827$EXP$$CN-HALEON-2193491$Haleon PLC$$50$YR$$M$Y$68$KG$20240827$$HP$CN$CN
242526261$24252626$1$I$$20240731$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07896$LUPIN$$$$$$Y$$$20240827$$MD$US$US
242526271$24252627$1$I$20240813$20240821$20240827$20240827$EXP$$US-JNJFOC-20240855107$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240827$$PH$US$US
242526281$24252628$1$I$20240101$20240822$20240827$20240827$EXP$$US-ABBVIE-5891369$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242526291$24252629$1$I$$20240725$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07472$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242526301$24252630$1$I$20240101$20240822$20240827$20240827$EXP$$US-ABBVIE-5892002$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242526312$24252631$2$F$$20240903$20240827$20240903$EXP$$IR-SA-2024SA250736$SANOFI AVENTIS$$$$I$F$Y$$$20240903$$MD$IR$IR
242526321$24252632$1$I$20240701$20240822$20240827$20240827$EXP$$US-ABBVIE-5892513$ABBVIE$$80$YR$$M$Y$$$20240827$$CN$US$US
242526333$24252633$3$F$$20240920$20240827$20240927$EXP$$US-ABBVIE-5892410$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
242526341$24252634$1$I$20240319$20240819$20240827$20240827$EXP$$CN-BAXTER-2024BAX023494$BAXTER$$56$YR$$M$Y$65.8$KG$20240827$$MD$CN$CN
242526351$24252635$1$I$$20240820$20240827$20240827$EXP$$US-GSK-US2024AMR105345$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
242526361$24252636$1$I$20240823$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169343$AMGEN$$73$YR$E$$Y$$$20240827$$CN$US$US
242526371$24252637$1$I$$20240725$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07519$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242526381$24252638$1$I$$20240819$20240827$20240827$EXP$$CA-APOTEX-2024AP009577$APOTEX$$62$YR$$M$Y$$$20240827$$HP$CA$CA
242526411$24252641$1$I$20240101$20240822$20240827$20240827$EXP$$US-ABBVIE-5892794$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242526421$24252642$1$I$$20240822$20240827$20240827$EXP$CZ-EMA-DD-20240821-7482701-075318$CZ-RDY-SPO/CZE/24/0012323$DR REDDYS$$75$YR$E$$Y$$$20240827$$HP$CZ$CZ
242526431$24252643$1$I$$20240801$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07832$LUPIN$$$$$$Y$$$20240827$$MD$US$US
242526443$24252644$3$F$20240823$20240911$20240827$20240913$EXP$$JP-ABBVIE-5895515$ABBVIE$$50$YR$$M$Y$$$20240913$$HP$JP$JP
242526451$24252645$1$I$$20240825$20240827$20240827$PER$$NVSC2024US172497$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242526461$24252646$1$I$20240523$20240826$20240827$20240827$EXP$FR-AFSSAPS-PC2024000667$NVSC2024FR171861$NOVARTIS$$71$YR$$M$Y$87$KG$20240827$$MD$FR$FR
242526471$24252647$1$I$20240815$20240825$20240827$20240827$EXP$$GB-ABBVIE-5895918$ABBVIE$$83$YR$$F$Y$$$20240827$$CN$GB$GB
242526481$24252648$1$I$20240716$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013806$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240827$$CN$US$US
242526491$24252649$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015551$ELI LILLY AND CO$$$$$$Y$$$20240827$$CN$US$US
242526501$24252650$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014895$ELI LILLY AND CO$$$$A$F$Y$$$20240827$$CN$US$US
242526511$24252651$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015447$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240827$$CN$US$US
242526522$24252652$2$F$$20240822$20240827$20240830$PER$$US-AMGEN-USASP2024168526$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242526531$24252653$1$I$20240813$20240813$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408008827$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240827$$CN$US$US
242526541$24252654$1$I$$20240817$20240827$20240827$EXP$$US-AMGEN-USASP2024166385$AMGEN$El-ghoubaira J.; Drappatz J.; Mantica M.. Retrospective study of ivosidenib for patients with recurrent IDH mutant gliomas. Journal of Clinical Oncology. 2024;2040$$$$$Y$$$20240827$$HP$US$US
242526552$24252655$2$F$20160101$20240826$20240827$20240829$EXP$$US-JNJFOC-20240862367$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242526561$24252656$1$I$20230814$20240819$20240827$20240827$EXP$$KR-AMGEN-KORSP2024169652$AMGEN$$69$YR$E$F$Y$$$20240827$$HP$KR$KR
242526571$24252657$1$I$20240801$20240827$20240827$20240827$EXP$DK-DKMA-30737850$DK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047973$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$$$20240827$$MD$DK$DK
242526584$24252658$4$F$20240101$20240916$20240827$20240925$EXP$$CA-CELLTRION INC.-2024CA020427$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
242526591$24252659$1$I$20240730$20240822$20240827$20240827$EXP$$CO-VANTIVE-2024VAN019137$Vantive US Healthcare$$60$YR$$M$Y$59$KG$20240827$$HP$CO$CO
242526601$24252660$1$I$20240716$20240820$20240827$20240827$EXP$$IN-VANTIVE-2024VAN018428$Vantive US Healthcare$$41$YR$$F$Y$$$20240827$$CN$IN$IN
242526611$24252661$1$I$20240819$20240820$20240827$20240827$EXP$$CA-CELLTRION INC.-2024CA020367$CELLTRION$$$$$$Y$$$20240827$$CN$CA$CA
242526622$24252662$2$F$$20240826$20240827$20240830$EXP$$US-ABBVIE-5895923$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242526632$24252663$2$F$$20240827$20240827$20240902$PER$$US-MSNLABS-2024MSNSPO01814$MSN LABORATORIES$$$$$$Y$$$20240902$$CN$US$US
242526643$24252664$3$F$20240101$20240829$20240827$20240904$PER$$US-AMGEN-USASP2024169778$AMGEN$$52$YR$A$F$Y$49.887$KG$20240903$$CN$US$US
242526651$24252665$1$I$20240801$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024170002$AMGEN$$$$$F$Y$$$20240827$$PH$US$US
242526661$24252666$1$I$$20240822$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134900$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240827$$CN$US$US
242526671$24252667$1$I$20240101$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134370$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240827$$HP$US$US
242526681$24252668$1$I$20240701$20240821$20240827$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-021083$UNITED THERAPEUTICS$$54$YR$$M$Y$63.039$KG$20240827$$$US$US
242526701$24252670$1$I$20240201$20240826$20240827$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047887$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240827$$CN$US$US
242526711$24252671$1$I$$20240801$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07857$LUPIN$$$$$$Y$$$20240827$$MD$US$US
242526721$24252672$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07629$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242526731$24252673$1$I$20240813$20240814$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-041533$AUROBINDO$$69$YR$$M$Y$$$20240827$$HP$GB$GB
242526742$24252674$2$F$20240806$20240829$20240827$20240830$EXP$IT-MINISAL02-999767$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-134174$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$43$KG$20240830$$MD$IT$IT
242526751$24252675$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07634$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242526761$24252676$1$I$$20240819$20240827$20240827$30DAY$$US-GSK-US2024103431$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
242526773$24252677$3$F$20240814$20240903$20240827$20240905$EXP$GB-MHRA-MED-202408240546063930-TJYKV$GB-ABBVIE-5895653$ABBVIE$$$$$$Y$$$20240905$$CN$GB$GB
242526781$24252678$1$I$$20240812$20240827$20240827$PER$$US-JNJFOC-20240831215$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242526791$24252679$1$I$20240101$20240807$20240827$20240827$PER$$US-TEVA-VS-3231545$TEVA$$69$YR$$F$Y$$$20240827$$CN$US$US
242526801$24252680$1$I$$20240820$20240827$20240827$EXP$$US-GSK-US2024AMR104760$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
242526821$24252682$1$I$$20240819$20240827$20240827$EXP$$JP-EXELIXIS-CABO-24080793$EXELIXIS$$9$DEC$$M$Y$$$20240827$$MD$JP$JP
242526831$24252683$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-082438-2024$RECKITT BENCKISER$$$$$$Y$$$20240827$$CN$US$US
242526841$24252684$1$I$$20240822$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135292$BRISTOL MYERS SQUIBB$$99$YR$E$F$Y$$$20240827$$CN$US$US
242526852$24252685$2$F$$20240816$20240827$20240916$PER$$US-BEH-2024177433$CSL BEHRING$$$$E$M$Y$$$20240916$$HP$US$US
242526871$24252687$1$I$$20240819$20240827$20240827$EXP$$PT-TEVA-VS-3236398$TEVA$Novais C, Cruz AM. CO 55 | Unexpected challenges: recognizing the serious adverse effects of oral antidiabetics. Portuguese Journal of General and Family Medicine. April 2024; 40(Supp. 13): S21.$80$YR$$F$Y$$$20240827$$MD$PT$PT
242526882$24252688$2$F$$20240829$20240827$20240830$EXP$$FR-SA-2024SA250546$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240830$$HP$FR$FR
242526891$24252689$1$I$$20240130$20240827$20240827$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00325$AMNEAL$$$$$$Y$$$20240827$$CN$US$US
242526902$24252690$2$F$20240801$20240826$20240827$20240903$EXP$$CA-CELLTRION INC.-2024CA020374$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
242526921$24252692$1$I$$20230824$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2023-054067$AUROBINDO$$$$$$Y$$$20240827$$CN$US$US
242526931$24252693$1$I$20240807$20240814$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-041206$AUROBINDO$$67$YR$$F$Y$68$KG$20240827$$MD$GB$GB
242526941$24252694$1$I$$20240822$20240827$20240827$EXP$$NVSC2024CH152721$NOVARTIS$$85$YR$$M$Y$$$20240827$$HP$CH$CH
242526951$24252695$1$I$$20240815$20240827$20240827$PER$$US-TAKEDA-2024TUS083703$TAKEDA$$$$$$Y$$$20240827$$PH$US$US
242526961$24252696$1$I$$20231123$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2023-076137$AUROBINDO$$$$$F$Y$$$20240827$$CN$US$US
242526971$24252697$1$I$20231007$20231008$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2023-063540$AUROBINDO$$74$YR$$M$Y$$$20240827$$CN$US$US
242526981$24252698$1$I$$20230908$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2023-058678$AUROBINDO$$$$$F$Y$$$20240827$$CN$US$US
242526991$24252699$1$I$$20230908$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2023-058734$AUROBINDO$$82$YR$$F$Y$62$KG$20240827$$CN$US$US
242527001$24252700$1$I$$20240209$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-007620$AUROBINDO$$$$$M$Y$$$20240827$$CN$US$US
242527011$24252701$1$I$20240125$20240131$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-005780$AUROBINDO$$65$YR$$M$Y$86.18$KG$20240827$$CN$US$US
242527021$24252702$1$I$20240817$20240819$20240827$20240827$EXP$$CA-ROCHE-10000064250$ROCHE$$52$YR$A$M$Y$$$20240827$$CN$CA$CA
242527031$24252703$1$I$20240505$20240507$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-023527$AUROBINDO$$14$YR$$M$Y$65.7$KG$20240827$$CN$US$US
242527041$24252704$1$I$$20240518$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-026097$AUROBINDO$$50$YR$$F$Y$$$20240827$$CN$US$US
242527051$24252705$1$I$$20240411$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-019499$AUROBINDO$$57$YR$$F$Y$95.25$KG$20240827$$CN$US$US
242527061$24252706$1$I$20240425$20240426$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-021878$AUROBINDO$$$$$M$Y$$$20240827$$CN$US$US
242527071$24252707$1$I$$20240517$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-026059$AUROBINDO$$$$$F$Y$$$20240827$$CN$US$US
242527081$24252708$1$I$20240517$20240517$20240827$20240827$PER$$US-AUROBINDO-AUR-APL-2024-026057$AUROBINDO$$20$YR$$F$Y$58.05$KG$20240827$$CN$US$US
242527092$24252709$2$F$20240823$20240917$20240827$20240919$PER$$US-AMGEN-USASP2024169314$AMGEN$$48$YR$A$F$Y$$$20240918$$CN$US$US
242527101$24252710$1$I$20240701$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07642$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242527111$24252711$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07643$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242527121$24252712$1$I$$20240820$20240827$20240827$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2024AMR104131$VIIV$$$$$$Y$$$20240827$$HP$CA$CA
242527132$24252713$2$F$$20240903$20240827$20240908$EXP$$US-JNJFOC-20240860976$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240909$$HP$US$US
242527142$24252714$2$F$20160101$20240820$20240827$20240827$EXP$$US-GILEAD-2024-0684878$GILEAD$$49$YR$A$M$Y$$$20240827$$CN$US$US
242527151$24252715$1$I$20240817$20240823$20240827$20240827$EXP$$NVSC2024IE171520$NOVARTIS$$20$YR$$F$Y$$$20240827$$CN$IE$IE
242527171$24252717$1$I$$20240820$20240827$20240827$EXP$$SA-RDY-SPO/SAU/24/0012310$DR REDDYS$Ruah Alyamany, Chams Alkhalaf Albachir, Sarah Alsaleh, Alaa Hamad, Sameeha Kaiser Abdulwali, Ahmad S. Alotaibi, Syed Osman Ahmed, Mansour Alfayez. Unraveling the Rare Entity of KIT D816V-Negative Systemic Mastocytosis. Journal of Hematology. 2024, June;:. doi:10.14740/jh1279$40$YR$A$M$Y$$$20240827$$HP$SA$SA
242527181$24252718$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07667$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242527191$24252719$1$I$20240808$20240818$20240827$20240827$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-07901$HIKMA$$29$YR$$F$Y$62$KG$20240827$$HP$EG$EG
242527201$24252720$1$I$$20240819$20240827$20240827$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP010589$STRIDES$Kasperczak M, Dabrowski F, Kosinska-Kaczynska K.. Emergency cervical cerclage performed at 25 weeks with favorable materno-fetal outcomes: a case report.. Eur-J-Obstet-Gynecol-Reprod-Biol. 2024;293:93$38$YR$$F$Y$$$20240827$$HP$PL$PL
242527211$24252721$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192535$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242527221$24252722$1$I$$20240807$20240827$20240827$PER$$US-AstraZeneca-2024A179977$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242527231$24252723$1$I$$20240819$20240827$20240827$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP010603$STRIDES$Movahedi M, Goharian M, Kabiri A, Zamansaraei S.. Comorbidity of Mitral Valve Stenosis with Influenza in  Pregnancy, A Case Report. Advanced Biomedical Research. 2023;12:252$44$YR$$F$Y$80.5$KG$20240827$$HP$IR$IR
242527241$24252724$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015359$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242527251$24252725$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015465$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240827$$CN$US$US
242527261$24252726$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015307$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240827$$CN$US$US
242527271$24252727$1$I$$20240820$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408012515$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240827$$CN$US$US
242527281$24252728$1$I$20240812$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015559$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240827$$CN$US$US
242527291$24252729$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013143$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240827$$CN$US$US
242527301$24252730$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015415$ELI LILLY AND CO$$$$$$Y$$$20240827$$CN$US$US
242527311$24252731$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015298$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240827$$CN$US$US
242527322$24252732$2$F$$20240819$20240827$20240905$PER$$US-JNJFOC-20240856201$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20240905$$MD$US$US
242527331$24252733$1$I$$20240805$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07981$LUPIN$$$$$$Y$$$20240827$$MD$US$US
242527341$24252734$1$I$$20240823$20240827$20240827$PER$$US-JNJFOC-20240865272$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242527351$24252735$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-087487-2024$RECKITT BENCKISER$$$$$$Y$$$20240827$$CN$US$US
242527372$24252737$2$F$20240101$20240826$20240827$20240827$PER$$NVSC2024US172544$NOVARTIS$$74$YR$$M$Y$$$20240827$$CN$US$US
242527381$24252738$1$I$20200501$20240819$20240827$20240827$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010587$STRIDES$Zhu D.. Acute urinary retention with secondary acute kidney injury caused by paracetamol, pseudoepherine hydrochloride, dextromethorphan hydrobromide and chlorphenamine maleate in a patient with prostatic calculus. [Chinese].. Advers-Drug-React-J. 2021;23 (6):330-332$54$YR$$M$Y$$$20240827$$HP$CN$CN
242527393$24252739$3$F$20240101$20240906$20240827$20240914$EXP$$US-AMGEN-USASP2024167700$AMGEN$$76$YR$E$M$Y$80$KG$20240914$$HP$US$US
242527401$24252740$1$I$20240706$20240820$20240827$20240827$EXP$$CN-ROCHE-10000061845$ROCHE$$43$YR$A$F$Y$47$KG$20240827$$HP$CN$CN
242527411$24252741$1$I$20240101$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168954$AMGEN$$79$YR$E$F$Y$$$20240827$$CN$US$US
242527421$24252742$1$I$$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024169425$AMGEN$$53$YR$A$F$Y$$$20240827$$MD$US$US
242527433$24252743$3$F$20240806$20240909$20240827$20240916$PER$$US-AMGEN-USASP2024167569$AMGEN$$49$YR$A$F$Y$85.5$KG$20240916$$HP$US$US
242527441$24252744$1$I$$20240822$20240827$20240827$EXP$$JP-GSK-JP2024105739$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$JP$JP
242527451$24252745$1$I$$20240816$20240827$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004803$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242527461$24252746$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135158$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240827$$CN$US$US
242527471$24252747$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07644$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242527491$24252749$1$I$$20240824$20240827$20240827$PER$$US-HALEON-2193635$Haleon PLC$$$$$F$Y$53.1$KG$20240827$$CN$US$US
242527501$24252750$1$I$$20240820$20240827$20240827$EXP$$GB-CELLTRION INC.-2024GB020293$CELLTRION$$$$$$Y$$$20240827$$CN$GB$GB
242527511$24252751$1$I$20190101$20240821$20240827$20240827$EXP$$US-TAKEDA-2019TUS033250$TAKEDA$$$$$F$Y$$$20240827$$MD$US$US
242527522$24252752$2$F$$20240821$20240827$20240902$PER$$US-AMGEN-USASP2024167515$AMGEN$$$$$F$Y$$$20240902$$PH$US$US
242527533$24252753$3$F$20240903$20240903$20240827$20240909$EXP$$CA-TAKEDA-2024TUS065638$TAKEDA$$39$YR$$F$Y$$$20240909$$CN$CA$CA
242527541$24252754$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07656$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242527551$24252755$1$I$$20240823$20240827$20240827$EXP$$US-TAKEDA-2024TUS085645$TAKEDA$$$$$M$Y$$$20240827$$CN$US$US
242527561$24252756$1$I$$20240819$20240827$20240827$EXP$$DK-STRIDES ARCOLAB LIMITED-2024SP010570$STRIDES$Skajaa T, Faerch M, Hasle H.. Acute kidney injury in a child treated with cisplatin and amphotericin B.. Cancer-Chemother-Pharmacol. 2024$17$YR$$F$Y$$$20240827$$HP$DK$DK
242527571$24252757$1$I$$20240819$20240827$20240827$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP010604$STRIDES$Movahedi M, Goharian M, Kabiri A, Zamansaraei S.. Comorbidity of mitral valve stenosis with influenza in pregnancy, a case report.. Advanced Biomedical Research. 2023;12:252$$$$F$Y$$$20240827$$HP$IR$IR
242527581$24252758$1$I$$20240818$20240827$20240827$PER$$US-TAKEDA-2024TUS083129$TAKEDA$$$$$F$Y$$$20240827$$MD$US$US
242527601$24252760$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3234987$TEVA$$34$YR$$M$Y$93$KG$20240827$$HP$CA$CA
242527614$24252761$4$F$20240526$20240828$20240827$20240829$EXP$$US-ROCHE-10000060726$ROCHE$$6$YR$C$M$Y$$$20240829$$CN$US$US
242527622$24252762$2$F$$20240822$20240827$20240904$EXP$$PT-AUROBINDO-AUR-APL-2024-040773$AUROBINDO$Peixoto M, Alves D, Lopes A, Queir?z L, Almeida M. Fluoropyrimidine Toxicities and DPYD Genotyping: A Clinical Case. Cureus. 2024;16(7):e63814$52$YR$$F$Y$$$20240904$$MD$PT$PT
242527631$24252763$1$I$$20240819$20240827$20240827$EXP$$AE-STRIDES ARCOLAB LIMITED-2024SP010713$STRIDES$Castillo-Aleman YM, Bencomo-Hernandez AA, Ventura-Carmenate Y, Villegas-Valverde CA, Rivero-Jimenez RA, Al Amin MT, et al.. Refractory pemphigus vulgaris and high-intensity extracorporeal photopheresis: A case report.. Photodermatol-Photoimmunol-Photomed. 2022;39 (3):296-300$36$YR$$M$Y$$$20240827$$HP$AE$AE
242527643$24252764$3$F$20240627$20240916$20240827$20240921$PER$$US-ROCHE-10000060851$ROCHE$$76$YR$E$M$Y$$$20240921$$HP$US$US
242527651$24252765$1$I$$20240822$20240827$20240827$EXP$GB-MHRA-MED-202408201337368660-ZYNKS$GB-STRIDES ARCOLAB LIMITED-2024SP010567$STRIDES$$65$YR$$$Y$$$20240827$$CN$GB$GB
242527661$24252766$1$I$$20240814$20240827$20240827$PER$$US-ABBVIE-5893889$ABBVIE$$44$YR$$F$Y$$$20240827$$HP$US$US
242527681$24252768$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07648$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242527691$24252769$1$I$20240731$20240816$20240827$20240827$EXP$$CN-JNJFOC-20240846716$JOHNSON AND JOHNSON$$54$YR$A$M$Y$70$KG$20240827$$HP$CN$CN
242527701$24252770$1$I$20230101$20240814$20240827$20240827$PER$$US-ABBVIE-5894004$ABBVIE$$27$YR$$F$Y$$$20240827$$HP$US$US
242527711$24252771$1$I$20230101$20240814$20240827$20240827$PER$$US-ABBVIE-5893900$ABBVIE$$45$YR$$F$Y$$$20240827$$HP$US$US
242527721$24252772$1$I$$20240823$20240827$20240827$PER$$US-ABBVIE-5894765$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242527731$24252773$1$I$20240820$20240822$20240827$20240827$30DAY$$IT-SANDOZ INC.-SDZ2024IT075333$SANDOZ$$12$YR$$M$Y$29$KG$20240827$$CN$IT$IT
242527741$24252774$1$I$$20240807$20240827$20240827$PER$$US-TEVA-VS-3232216$TEVA$$44$YR$$F$Y$$$20240827$$HP$US$US
242527751$24252775$1$I$20240514$20240823$20240827$20240827$EXP$$CN-ROCHE-10000065484$ROCHE$$45$YR$A$F$Y$47$KG$20240827$$HP$CN$CN
242527771$24252777$1$I$$20240823$20240827$20240827$EXP$GB-MHRA-MED-202408211022345950-CSDPH$GB-STRIDES ARCOLAB LIMITED-2024SP010614$STRIDES$$$$$M$Y$$$20240827$$PH$GB$GB
242527782$24252778$2$F$$20240823$20240827$20240902$EXP$$US-IMMUNOCORE, LTD-2024-IMC-003003$IMMUNOCORE$$$$$$Y$$$20240902$$HP$US$US
242527791$24252779$1$I$20240818$20240822$20240827$20240827$EXP$JP-MMM-JNU27IH1$JP-GSK-JP2024104752$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$JP$JP
242527801$24252780$1$I$$20240819$20240827$20240827$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-134180$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240827$$HP$CA$CA
242527811$24252781$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07658$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242527821$24252782$1$I$$20240813$20240827$20240827$EXP$$CN-AMNEAL PHARMACEUTICALS-2024-AMRX-03059$AMNEAL$Ding S, Li W.. A case of Kounis syndrome induced by azithromycin. Chinese journal of general practitioners. 2024;23(8):878-880$$$$$Y$$$20240827$$HP$CN$CN
242527831$24252783$1$I$$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024167900$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242527841$24252784$1$I$$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168506$AMGEN$$$$A$$Y$$$20240827$$CN$US$US
242527852$24252785$2$F$20240701$20240916$20240827$20240921$30DAY$$US-AMGEN-USASP2024167908$AMGEN$$63$YR$A$F$Y$117.5$KG$20240920$$HP$US$US
242527861$24252786$1$I$$20240805$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124415$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$68.04$KG$20240827$$CN$US$US
242527872$24252787$2$F$$20240911$20240827$20240911$PER$$US-ALXN-202408USA001119US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
242527882$24252788$2$F$20240701$20240924$20240827$20240925$EXP$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-114012$GB-SANDOZ INC.-SDZ2024GB075037$SANDOZ$$70$YR$$M$Y$$$20240925$$MD$GB$GB
242527891$24252789$1$I$20240701$20240816$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130714$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240827$$CN$US$US
242527901$24252790$1$I$$20240822$20240827$20240827$EXP$$CA-Orion Corporation ORION PHARMA-24_00031421$ORION$$40$YR$A$M$Y$$$20240827$$HP$CA$
242527911$24252791$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07657$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242527922$24252792$2$F$$20240826$20240827$20240830$PER$$NVSC2024US172759$NOVARTIS$$$$$F$Y$72.12$KG$20240830$$HP$US$US
242527931$24252793$1$I$$20240814$20240827$20240827$EXP$$US-UCBSA-2024042495$UCB$$$$$$Y$$$20240827$$CN$US$US
242527942$24252794$2$F$$20240831$20240827$20240906$EXP$$CA-ROCHE-10000064350$ROCHE$$25$YR$A$F$Y$$$20240906$$CN$CA$CA
242527961$24252796$1$I$20180101$20240811$20240827$20240827$PER$$US-AMGEN-USASP2024164875$AMGEN$Fei F. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$M$Y$$$20240827$$MD$US$US
242527971$24252797$1$I$20230601$20240822$20240827$20240827$PER$$US-JNJFOC-20240857219$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240827$$HP$US$US
242527981$24252798$1$I$$20240822$20240827$20240827$EXP$$US-JNJFOC-20240862494$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$CN$US$US
242527991$24252799$1$I$$20240821$20240827$20240827$EXP$$US-DEXPHARM-2024-2936$DEXCEL$Murphy, M.; Jones, K.; Ruebner, R. L.; Raabe, E.  Acute Onset of   Abdominal Pain in a 3-year-old Boy with Acute Lymphoblastic Leukemia. Pediatrics in Review 2023, V44 (Suppl. 1), PS106-S109.$3$YR$C$M$Y$$$20240827$$HP$US$US
242528003$24252800$3$F$$20240926$20240827$20240930$30DAY$$TR-JNJFOC-20240862629$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$PH$TR$TR
242528012$24252801$2$F$20240814$20240829$20240827$20240902$PER$$US-AMGEN-USASP2024169688$AMGEN$$72$YR$E$F$Y$$$20240902$$CN$US$US
242528021$24252802$1$I$20240624$20240819$20240827$20240827$EXP$RO-NMA-2024-SP0537$RO-SA-2024SA249335$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240827$$PH$RO$RO
242528041$24252804$1$I$$20240819$20240827$20240827$30DAY$$US-GSK-US2024103448$GLAXOSMITHKLINE$$$$$M$Y$$$20240827$$CN$US$US
242528061$24252806$1$I$$20240816$20240827$20240827$PER$$US-ABBVIE-5887094$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242528072$24252807$2$F$$20240828$20240827$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07685$LUPIN$$$$$$Y$$$20240912$$CN$US$US
242528081$24252808$1$I$20240801$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016150$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242528091$24252809$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3234992$TEVA$$6$YR$$M$Y$37$KG$20240827$$HP$CA$CA
242528103$24252810$3$F$20140101$20240927$20240827$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202408016289$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240930$$CN$US$US
242528111$24252811$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015667$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240827$$CN$US$US
242528121$24252812$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015582$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240827$$CN$US$US
242528131$24252813$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015388$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240827$$CN$US$US
242528141$24252814$1$I$$20240820$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408012906$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240827$$CN$US$US
242528151$24252815$1$I$20210101$20240820$20240827$20240827$EXP$$CN-SA-2024SA247325$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240827$$HP$CN$CN
242528161$24252816$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015132$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240827$$CN$US$US
242528171$24252817$1$I$20240701$20240819$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408012051$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240827$$CN$US$US
242528181$24252818$1$I$20240826$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016065$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240827$$CN$US$US
242528191$24252819$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015334$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240827$$CN$US$US
242528201$24252820$1$I$20240801$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014891$ELI LILLY AND CO$$$$$M$Y$$$20240827$$CN$US$US
242528211$24252821$1$I$20240101$20240820$20240827$20240827$EXP$$FI-SA-2024SA250339$SANOFI AVENTIS$$$$$F$Y$$$20240827$$MD$FI$FI
242528222$24252822$2$F$20231101$20240902$20240827$20240917$EXP$$CZ-SA-2024SA249142$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240917$$MD$CZ$CZ
242528231$24252823$1$I$20240821$20240821$20240827$20240827$PER$$US-AMGEN-USASP2024167276$AMGEN$$$$$M$Y$$$20240827$$CN$US$US
242528241$24252824$1$I$20240724$20240820$20240827$20240827$EXP$$DE-CELLTRION INC.-2024DE020161$CELLTRION$$$$$$Y$$$20240827$$MD$DE$DE
242528251$24252825$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07663$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242528262$24252826$2$F$$20240829$20240827$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07722$LUPIN$$$$$$Y$$$20240912$$CN$US$US
242528272$24252827$2$F$$20240821$20240827$20240904$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093385$GLENMARK$Preskorn SH, Masolak DD.. Life-threatening Rash Due to Lamotrigine and a Failure to Understand Its Pharmacology: How Forensic Detective Work Uses Medical Knowledge and Clinical Pharmacology to Solve Cases.. Journal of Psychiatric Practice.. 2024;30 (4):273-8$$$$$Y$$$20240904$$MD$US$US
242528281$24252828$1$I$$20240809$20240827$20240827$PER$$US-MYLANLABS-2024M1074407$MYLAN$$$$$F$Y$$$20240827$$CN$US$US
242528291$24252829$1$I$$20240819$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132142$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240827$$HP$US$US
242528301$24252830$1$I$$20240815$20240827$20240827$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003896$PAREXEL$$74$YR$$F$Y$$$20240827$$CN$US$US
242528311$24252831$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-088548-2024$RECKITT BENCKISER$$$$$$Y$$$20240827$$CN$US$US
242528321$24252832$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-088575-2024$RECKITT BENCKISER$$27$YR$$F$Y$$$20240827$$CN$US$US
242528331$24252833$1$I$$20240821$20240827$20240827$EXP$$US-ORGANON-O2408USA001673$ORGANON$Furcich J., Boucher A.A., Grace J.. Onset of Acute Intermittent Porphyria After Etonogestrel Implant Insertion: A Case Report. Journal of Pediatric Hematology/Oncology. 2024;46:321$17$YR$$F$Y$$$20240827$$HP$US$US
242528341$24252834$1$I$20240502$20240820$20240827$20240827$EXP$FR-AFSSAPS-PP2024000861$FR-TEVA-VS-3235079$TEVA$$90$YR$$F$Y$$$20240827$$MD$FR$FR
242528351$24252835$1$I$20240825$20240826$20240827$20240827$PER$$US-HALEON-2193779$Haleon PLC$$$$$$Y$$$20240827$$CN$US$US
242528361$24252836$1$I$$20240819$20240827$20240827$EXP$$CA-002147023-PHHY2018CA061543$Haleon PLC$$68$YR$$F$Y$$$20240827$$HP$CA$CA
242528381$24252838$1$I$$20240823$20240827$20240827$PER$$US-009507513-2408USA008745$MERCK$$$$$F$Y$$$20240827$$HP$US$US
242528392$24252839$2$F$20240819$20240918$20240827$20240927$EXP$$CA-CELLTRION INC.-2024CA020370$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
242528401$24252840$1$I$$20240823$20240827$20240827$30DAY$$US-GSK-US2024105573$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
242528411$24252841$1$I$20240823$20240826$20240827$20240827$PER$$US-JNJFOC-20240868388$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240827$$CN$US$US
242528421$24252842$1$I$20180101$20240811$20240827$20240827$PER$$US-AMGEN-USASP2024164862$AMGEN$Fei F. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240827$$MD$US$US
242528431$24252843$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169234$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242528441$24252844$1$I$20180101$20240811$20240827$20240827$PER$$US-AMGEN-USASP2024164868$AMGEN$Fei F. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240827$$MD$US$US
242528451$24252845$1$I$20180101$20240811$20240827$20240827$PER$$US-AMGEN-USASP2024164866$AMGEN$Fei F. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240827$$MD$US$US
242528461$24252846$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169506$AMGEN$$$$$F$Y$$$20240827$$MD$US$US
242528471$24252847$1$I$20180101$20240811$20240827$20240827$PER$$US-AMGEN-USASP2024164864$AMGEN$Fei F. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240827$$MD$US$US
242528481$24252848$1$I$$20240814$20240827$20240827$EXP$$IN-STERISCIENCE B.V.-2024-ST-001225$Steriscience PTE$Gupta D, Singh L, Kumar S, Singh K, Mendonca S, Chatterjee T.. Rare complications of heart transplant: Autopsy findings.. Indian-J-Pathol-Microbiol. 2024;67 (3):624-627.$33$YR$$M$Y$$$20240827$$HP$IN$IN
242528491$24252849$1$I$$20240724$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07524$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242528501$24252850$1$I$20240101$20240816$20240827$20240827$EXP$$US-INSMED, INC.-2024-03340-US$INSMED$$$$$F$Y$$$20240827$$CN$US$US
242528511$24252851$1$I$$20240815$20240827$20240827$EXP$$CA-TAKEDA-2024TUS082434$TAKEDA$$$$$$Y$$$20240827$$HP$CA$CA
242528522$24252852$2$F$$20240826$20240827$20240828$EXP$$NVSC2024US172600$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242528532$24252853$2$F$$20240926$20240827$20240927$PER$$NVSC2024US172741$NOVARTIS$$$$$M$Y$$$20240927$$MD$US$US
242528541$24252854$1$I$20240823$20240826$20240827$20240827$PER$$NVSC2024US172758$NOVARTIS$$$$$M$Y$$$20240827$$MD$US$US
242528551$24252855$1$I$$20240826$20240827$20240827$PER$$US-HALEON-2193774$Haleon PLC$$$$$F$Y$$$20240827$$CN$US$US
242528561$24252856$1$I$$20240819$20240827$20240827$EXP$$AU-TEVA-VS-3236309$TEVA$$25$YR$$F$Y$$$20240827$$HP$AU$AU
242528571$24252857$1$I$$20240819$20240827$20240827$EXP$$ZA-AstraZeneca-2024A188752$ASTRAZENECA$$10$YR$$M$Y$$$20240827$$CN$ZA$
242528581$24252858$1$I$20140101$20240822$20240827$20240827$PER$$US-AstraZeneca-2024A192173$ASTRAZENECA$$74$YR$$M$Y$$$20240827$$CN$US$
242528593$24252859$3$F$20240101$20240926$20240827$20240927$PER$$US-AMGEN-USASP2024167631$AMGEN$$49$YR$A$F$Y$$$20240927$$PH$US$US
242528601$24252860$1$I$$20240821$20240827$20240827$PER$$US-AMGEN-USASP2024167566$AMGEN$$52$YR$A$M$Y$$$20240827$$MD$US$US
242528611$24252861$1$I$20240627$20240823$20240827$20240827$EXP$$US-AstraZeneca-2024A192941$ASTRAZENECA$$31287$DY$$F$Y$$$20240827$$CN$US$
242528621$24252862$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A191901$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242528631$24252863$1$I$20211026$20230124$20240827$20240827$EXP$$CA-CELLTRION INC.-2021CA019644$CELLTRION$$$$$$Y$$$20240827$$CN$CA$CA
242528641$24252864$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07652$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242528651$24252865$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07662$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242528661$24252866$1$I$20240201$20240814$20240827$20240827$EXP$$FR-AUROBINDO-AUR-APL-2024-041777$AUROBINDO$$70$YR$$M$Y$73$KG$20240827$$PH$FR$FR
242528671$24252867$1$I$20240826$20240826$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075380$SANDOZ$$82$YR$$F$Y$$$20240827$$CN$US$US
242528683$24252868$3$F$20240802$20240830$20240827$20240911$EXP$$US-UCBSA-2024041260$UCB$$82$YR$$F$Y$86$KG$20240911$$HP$US$US
242528691$24252869$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135290$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240827$$CN$US$US
242528701$24252870$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-087205-2024$RECKITT BENCKISER$$$$$$Y$$$20240827$$CN$US$US
242528711$24252871$1$I$20230528$20240814$20240827$20240827$EXP$$FR-AUROBINDO-AUR-APL-2024-041429$AUROBINDO$$35$YR$$F$Y$$$20240827$$MD$FR$FR
242528721$24252872$1$I$20221130$20240826$20240827$20240827$EXP$$US-UCBSA-2024043378$UCB$$40$YR$$F$Y$$$20240827$$HP$US$US
242528731$24252873$1$I$20240808$20240821$20240827$20240827$EXP$$MX-ROCHE-10000066168$ROCHE$$61$YR$A$F$Y$$$20240827$$CN$MX$MX
242528741$24252874$1$I$$20240819$20240827$20240827$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16713$IPSEN$$$$$$Y$$$20240827$$HP$US$US
242528762$24252876$2$F$20240617$20240917$20240827$20240926$EXP$$DE-AUROBINDO-AUR-APL-2024-041490$AUROBINDO$$76$YR$$M$Y$$$20240926$$MD$DE$DE
242528781$24252878$1$I$20240619$20240826$20240827$20240827$EXP$PT-INFARMED-J202408-242$PT-SANDOZ INC.-SDZ2024PT075218$SANDOZ$$51$YR$$F$Y$$$20240827$$PH$PT$PT
242528791$24252879$1$I$$20240821$20240827$20240827$EXP$PT-EMA-DD-20240820-7482675-100131$PT-RDY-SPO/PRT/24/0012245$DR REDDYS$$13$MON$I$F$Y$$$20240827$$HP$PT$PT
242528811$24252881$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-042419$AUROBINDO$$32$YR$$F$Y$$$20240827$$HP$CA$CA
242528821$24252882$1$I$$20240725$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07483$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242528832$24252883$2$F$20240804$20240904$20240827$20240924$PER$$CA-TOLMAR, INC.-24CA051608$TOLMAR$$81$YR$$M$Y$$$20240924$$MD$CA$CA
242528841$24252884$1$I$$20240803$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051662$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
242528851$24252885$1$I$$20240803$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051665$TOLMAR$$$$$M$Y$$$20240827$$CN$CA$CA
242528861$24252886$1$I$$20240819$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132673$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$79.38$KG$20240827$$CN$US$US
242528871$24252887$1$I$$20240821$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135306$BRISTOL MYERS SQUIBB$$59$YR$A$$Y$$$20240827$$HP$US$US
242528881$24252888$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134359$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240827$$CN$US$US
242528891$24252889$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135001$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240827$$CN$US$US
242528901$24252890$1$I$20240821$20240821$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134299$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240827$$HP$US$US
242528911$24252891$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135427$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240827$$PH$US$US
242528921$24252892$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134918$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240827$$CN$US$US
242528932$24252893$2$F$20240823$20240919$20240827$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135423$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240926$$CN$US$US
242528941$24252894$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-042337$AUROBINDO$$60$YR$$F$Y$$$20240827$$PH$CA$CA
242528951$24252895$1$I$$20240813$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041447$AUROBINDO$$61$YR$$F$Y$$$20240827$$HP$CA$CA
242528971$24252897$1$I$20240823$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015742$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240827$$CN$US$US
242528981$24252898$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07720$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242528991$24252899$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07723$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242529002$24252900$2$F$20240101$20240814$20240827$20240903$PER$$US-TEVA-VS-3231315$TEVA$$81$YR$$M$Y$106.59$KG$20240903$$CN$US$US
242529012$24252901$2$F$20240817$20240917$20240827$20240918$PER$$US-AMGEN-USASP2024168186$AMGEN$$51$YR$A$F$Y$$$20240918$$CN$US$US
242529021$24252902$1$I$20240101$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169292$AMGEN$$82$YR$E$F$Y$$$20240827$$CN$US$US
242529031$24252903$1$I$$20240823$20240827$20240827$PER$$US-HALEON-2193520$Haleon PLC$$78$YR$$$Y$$$20240827$$CN$US$US
242529041$24252904$1$I$$20240812$20240827$20240827$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000714$DECIPHERA PHARMACEUTICALS$$72$YR$E$F$Y$$$20240827$$CN$US$US
242529052$24252905$2$F$$20240819$20240827$20240830$30DAY$$US-GSK-US2024AMR103715$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$US$US
242529061$24252906$1$I$20240821$20240821$20240827$20240827$PER$$US-JNJFOC-20240861957$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$MD$US$US
242529071$24252907$1$I$20231107$20240821$20240827$20240827$EXP$ES-AEMPS-1545468$ES-ABBVIE-5890614$ABBVIE$$$$$$Y$$$20240827$$MD$ES$ES
242529081$24252908$1$I$20240301$20240819$20240827$20240827$EXP$$BR-JNJFOC-20240851708$JOHNSON AND JOHNSON$$51$YR$A$F$Y$48$KG$20240827$$CN$BR$BR
242529091$24252909$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-088165-2024$RECKITT BENCKISER$$$$$F$Y$$$20240827$$CN$US$US
242529101$24252910$1$I$20240614$20240814$20240827$20240827$EXP$$IT-AUROBINDO-AUR-APL-2024-041657$AUROBINDO$$46$YR$$F$Y$59$KG$20240827$$MD$IT$IT
242529112$24252911$2$F$$20240828$20240827$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07721$LUPIN$$$$$$Y$$$20240912$$CN$US$US
242529121$24252912$1$I$$20240808$20240827$20240827$PER$$US-AstraZeneca-2024A182776$ASTRAZENECA$$$$$$Y$$$20240827$$CN$US$
242529131$24252913$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189182$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242529141$24252914$1$I$$20240812$20240827$20240827$EXP$$US-COOPERSURGICAL, INC.-2024CPS002571$COOPERSURGICAL$$$$$F$Y$$$20240827$$MD$US$US
242529151$24252915$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3234995$TEVA$$18$YR$$F$Y$72$KG$20240827$$HP$CA$CA
242529162$24252916$2$F$$20240830$20240827$20240909$EXP$$US-TEVA-VS-3235675$TEVA$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J 2024; 70 (7): e92-e96.; Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J 2024; 70 (7): e92-e96.$12$YR$$F$Y$$$20240909$$HP$US$US
242529171$24252917$1$I$20240702$20240819$20240827$20240827$EXP$$CN-ROCHE-10000060744$ROCHE$$62$YR$A$M$Y$$$20240827$$HP$CN$CN
242529181$24252918$1$I$20240513$20240819$20240827$20240827$EXP$$CA-GILEAD-2024-0684760$GILEAD$$$$A$F$Y$$$20240827$$MD$CA$CA
242529191$24252919$1$I$$20240730$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06717$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242529201$24252920$1$I$$20240814$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041747$AUROBINDO$$69$YR$$F$Y$$$20240827$$HP$CA$CA
242529211$24252921$1$I$$20231204$20240827$20240827$EXP$$US-ABBVIE-5533679$ABBVIE$Dima D, Orland M, Ullah F, Anwer F, Mazzoni S, Raza S, et al. Clinical efficacy of retreatment with venetoclax-based therapy in relapsed-refractory t(11;14) multiple myeloma. Clinical Lymphoma Myeloma and Leukemia. 2023;23(11):857-60.$$$A$$Y$$$20240827$$MD$US$US
242529221$24252922$1$I$$20240814$20240827$20240827$EXP$$DE-AUROBINDO-AUR-APL-2024-041702$AUROBINDO$Rissardo JP, Medeiros Araujo  U, Fornari Caprara AL. Gabapentin-Associated Movement Disorders: A Literature Review. Medicines. 2023;10:52$40$YR$$F$Y$$$20240827$$MD$DE$DE
242529231$24252923$1$I$$20240815$20240827$20240827$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000727$DECIPHERA PHARMACEUTICALS$$70$YR$E$F$Y$$$20240827$$CN$US$US
242529241$24252924$1$I$$20240819$20240827$20240827$PER$$US-ALXN-202408USA001356US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242529251$24252925$1$I$$20240819$20240827$20240827$EXP$$US-TEVA-VS-3235677$TEVA$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J 2024; 70 (7): e92-e96.$14$YR$$F$Y$$$20240827$$HP$US$US
242529261$24252926$1$I$$20240819$20240827$20240827$EXP$$CA-JNJFOC-20240856681$JOHNSON AND JOHNSON$$1$YR$I$F$Y$$$20240827$$CN$CA$CA
242529271$24252927$1$I$20240530$20240814$20240827$20240827$EXP$$US-UCBSA-2024041746$UCB$$25$YR$$F$Y$90.748$KG$20240827$$HP$US$US
242529281$24252928$1$I$20240129$20240827$20240827$20240827$EXP$ES-AEMPS-1486399$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047955$BOEHRINGER INGELHEIM$$42$YR$A$F$Y$$$20240827$$MD$ES$ES
242529291$24252929$1$I$$20240817$20240827$20240827$30DAY$$US-GSK-US2024AMR103483$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
242529311$24252931$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07689$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242529341$24252934$1$I$$20240819$20240827$20240827$EXP$$US-TEVA-VS-3235676$TEVA$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J 2024; 70 (7): e92-e96.$17$YR$$M$Y$$$20240827$$HP$US$US
242529351$24252935$1$I$$20240819$20240827$20240827$EXP$$US-TEVA-VS-3235678$TEVA$Sorabella RA, Gray WH, Dabak RJ, Padikka KA, Hocl L, Ckarl MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO-J 2024; 70 (7): e92-e96.$15$YR$$F$Y$$$20240827$$HP$US$US
242529362$24252936$2$F$20240823$20240923$20240827$20240923$PER$$US-AMGEN-USASP2024169370$AMGEN$$78$YR$E$F$Y$$$20240923$$CN$US$US
242529371$24252937$1$I$$20240814$20240827$20240827$EXP$$JP-IPCA LABORATORIES LIMITED-IPC-2024-JP-002051$IPCA$Fumiya Inoue, Yuji Okazaki, Kyungko Huh, et.al.. Pharmacobezoar associated prolonged clinical course in a patient with immediate release quetiapine overdose. Journal of Medical Toxicology. 2024$$$$$Y$$$20240827$$HP$JP$JP
242529382$24252938$2$F$$20240913$20240827$20240917$EXP$$NVSC2023TH199857$NOVARTIS$$$$$F$Y$$$20240917$$CN$TH$TH
242529392$24252939$2$F$$20240913$20240827$20240926$EXP$$US-AUROBINDO-AUR-APL-2024-041224$AUROBINDO$Srivastava A, Artiles MEJ, Elbanna M, Abu Sheikha M, Parikh V, Feitell S. Unusual Presentation Of Hydralazine-induced Anca-associated. Journal of Cardiac Failure. 2024;30(1):149-150$68$YR$$F$Y$$$20240926$$HP$US$US
242529401$24252940$1$I$20240812$20240820$20240827$20240827$EXP$$CN-ROCHE-10000061842$ROCHE$$51$YR$A$F$Y$55$KG$20240827$$HP$CN$CN
242529411$24252941$1$I$$20240812$20240827$20240827$EXP$$DE-AFAXYS PHARMA, LLC-2024AFX00009$AFAXYS$Dyballa N, Hartel J.A, Prangenberg J,, Andresen-Streichert, H.. A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting - clinical, toxicological and forensic aspects. Forensic Sci Med Pathol. 2024$12$WK$$M$Y$$$20240827$$HP$DE$DE
242529431$24252943$1$I$$20240620$20240827$20240827$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007633$STRIDES$Hassan SA, Kasem A, Elsayed M, Perry C, Flomenhoft D, Barrett T.. UPADACITINIB RESOLVES DIARRHEA AND FECAL CALPROTECTIN ABNORMALITIES IN BUDESONIDE-DEPENDENT MICROSCOPIC COLITIS.. Inflamm-Bowel-Dis. 2024;30 (Suppl.):S91$82$YR$$F$Y$$$20240827$$HP$US$US
242529441$24252944$1$I$$20240620$20240827$20240827$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007632$STRIDES$Hassan SA, Kasem A, Elsayed M, Perry C, Flomenhoft D, Barrett T.. UPADACITINIB RESOLVES DIARRHEA AND FECAL CALPROTECTIN ABNORMALITIES IN BUDESONIDE-DEPENDENT MICROSCOPIC COLITIS.. Inflamm-Bowel-Dis. 2024;30 (Suppl.):S91$67$YR$$M$Y$$$20240827$$HP$US$US
242529451$24252945$1$I$$20210217$20240827$20240827$PER$$US-TAKEDA-2021TUS010774$TAKEDA$$$$$M$Y$$$20240827$$CN$US$US
242529462$24252946$2$F$20240501$20240913$20240827$20240918$EXP$$US-JNJFOC-20240866789$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240919$$HP$US$US
242529481$24252948$1$I$20240101$20240819$20240827$20240827$EXP$$US-ABBVIE-5891284$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242529492$24252949$2$F$20231201$20240909$20240827$20240917$EXP$$CA-BEH-2023165199$CSL BEHRING$$84$YR$E$F$Y$70.295$KG$20240917$$HP$CA$CA
242529501$24252950$1$I$$20240813$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-041072$AUROBINDO$Sokol Z, Oselkin M.. Spinal subarachnoid hemorrhage as a consequence of dissection with pseudoaneurysm in a cervical radiculomedullary branch of the anterior spinal artery. Radiology Case Reports. 2024;19(1):403-407$58$YR$$M$Y$$$20240827$$MD$US$US
242529511$24252951$1$I$20240621$20240819$20240827$20240827$EXP$PT-INFARMED-J202408-231$PT-TEVA-VS-3234659$TEVA$$79$YR$$F$Y$52$KG$20240827$$PH$PT$PT
242529521$24252952$1$I$$20240820$20240827$20240827$EXP$$CL-MYLANLABS-2024M1078619$MYLAN$Zavadzki G, Robles JI, Martin MFS, Torres WG, Ramos-Rojas JT, Gauna-Cordero J, et al. Managing Superwarfarin Poisoning: A Challenging Case. [Spanish]. Rev-Med-Chil 2023; 151 (6): 797-800.$42$YR$$M$Y$$$20240827$$HP$CL$CL
242529541$24252954$1$I$$20240819$20240827$20240827$EXP$$US-MYLANLABS-2024M1077893$MYLAN$Hoover E, Corlin T, Lohr J, Sabol B, Yamamura Y, Jacobs K, et al. TAVR Beyond Fetal Viability: An Alternative to Preterm Delivery in Symptomatic Severe Aortic Stenosis. JACC-Case-Rep 2023; 27.$33$YR$$F$Y$$$20240827$$MD$US$US
242529551$24252955$1$I$$20240819$20240827$20240827$EXP$$US-MYLANLABS-2024M1078117$MYLAN$Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front-Psychiatry 2024; 14.$$$A$M$Y$$$20240827$$HP$US$US
242529561$24252956$1$I$20230101$20240814$20240827$20240827$PER$$US-ABBVIE-5893917$ABBVIE$$53$YR$$M$Y$$$20240827$$HP$US$US
242529571$24252957$1$I$$20240819$20240827$20240827$EXP$$US-MYLANLABS-2024M1078134$MYLAN$Kline K, Chen W, Kallen ME, Koka R, Omili D, Fan X, et al. Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD). Hum-Vaccin-Immunother 2023; 19 (2):.$55$YR$$F$Y$$$20240827$$HP$US$US
242529581$24252958$1$I$$20240819$20240827$20240827$EXP$$JP-UCBSA-2024041856$UCB$Hagino T, Onda M, Saeki H, Fujimoto E, Kanda N.. Effectiveness of bimekizumab for genital, nail, and scalp lesions with psoriasis: A 24-week real-world study. The Journal of dermatology. 2024;00:1-7$$$$$Y$$$20240827$$HP$JP$JP
242529591$24252959$1$I$$20240820$20240827$20240827$EXP$$CA-ROCHE-10000061286$ROCHE$$42$YR$A$F$Y$$$20240827$$HP$CA$CA
242529601$24252960$1$I$$20240813$20240827$20240827$EXP$$DE-AUROBINDO-AUR-APL-2024-041044$AUROBINDO$Paschen S, Becktepe JS, Hobert MA, Zeuner KE, Helmers A-K, Berg D, et al. The Challenge of Choosing the Right Stimulation Target for Dystonic Tremor-A Series of Instructive Cases. MovDisord-Clin-Pract. 2023;101478-1484$71$YR$$F$Y$$$20240827$$HP$DE$DE
242529611$24252961$1$I$20240819$20240820$20240827$20240827$EXP$$AU-MYLANLABS-2024M1077583$MYLAN$$40$YR$$M$Y$$$20240827$$HP$AU$AU
242529621$24252962$1$I$$20240817$20240827$20240827$EXP$GB-MHRA-MED-202408170831401780-YPFJT$GB-862174955-ML2024-04546$MICRO LABS$$58$YR$A$F$Y$74$KG$20240827$$CN$GB$GB
242529631$24252963$1$I$$20240820$20240827$20240827$EXP$$US-RDY-SPO/USA/24/0012347$DR REDDYS$Heering G, Lin Z, Rosman M, Shakil F, Georgostathis D, Hara N. Side Effects of Stem Cell Transplant Mimicking Symptoms of Known Amyloidosis. Case Reports in Gastroenterology. 2024 May 21;18(1): 273-278. doi:10.1159/000538947.$67$YR$E$F$Y$$$20240827$$HP$US$US
242529651$24252965$1$I$$20240820$20240827$20240827$30DAY$$US-GSK-US2024103990$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
242529661$24252966$1$I$20220917$20240826$20240827$20240827$EXP$$NVSC2024KR172152$NOVARTIS$$$$A$M$Y$$$20240827$$HP$KR$KR
242529671$24252967$1$I$20240706$20240814$20240827$20240827$EXP$$FR-AUROBINDO-AUR-APL-2024-041426$AUROBINDO$$79$YR$$F$Y$$$20240827$$MD$FR$FR
242529681$24252968$1$I$$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004291$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242529691$24252969$1$I$$20240819$20240827$20240827$EXP$$US-RDY-SPO/USA/24/0012342$DR REDDYS$Kline K, Chen W, Kallen ME, Koka R, Omili D, Fan X, et al. Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD). Human Vaccines and Immunotherapeutics. 2023 Jun 06;19(2): doi:10.1080/21645515.2023.2216116.$55$YR$A$F$Y$$$20240827$$MD$US$US
242529711$24252971$1$I$20240729$20240821$20240827$20240827$PER$$US-BEH-2024177548$CSL BEHRING$$64$YR$A$F$Y$$$20240827$$HP$US$US
242529722$24252972$2$F$$20240829$20240827$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA036768$SANDOZ$$$$$M$Y$$$20240902$$HP$CA$CA
242529731$24252973$1$I$20240701$20240820$20240827$20240827$EXP$$JP-AMGEN-JPNSP2024167670$AMGEN$$$$$$Y$$$20240827$$MD$JP$JP
242529751$24252975$1$I$$20240817$20240827$20240827$PER$$US-AMGEN-USASP2024164834$AMGEN$Stewart Iv J.. Phase I trial of talimogene laherparepvec for the treatment of peritoneal surface malignancies (TEMPO). Journal of Clinical Oncology. 2024;42 (16):2668$$$$$Y$$$20240827$$HP$US$US
242529761$24252976$1$I$20240728$20240823$20240827$20240827$EXP$$US-ABBVIE-5894382$ABBVIE$$63$YR$$F$Y$$$20240827$$CN$US$US
242529771$24252977$1$I$20240813$20240819$20240827$20240827$EXP$GB-MHRA-MED-202408191522393670-QCFJP$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-07968$HIKMA$$61$YR$$F$Y$52$KG$20240827$$CN$GB$GB
242529781$24252978$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014420$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240827$$CN$US$US
242529791$24252979$1$I$20240823$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015185$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240827$$CN$US$US
242529801$24252980$1$I$20240701$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015402$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242529811$24252981$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015583$ELI LILLY AND CO$$$$$$Y$$$20240827$$CN$US$US
242529821$24252982$1$I$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015938$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242529831$24252983$1$I$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016432$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240827$$CN$US$US
242529841$24252984$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013763$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242529851$24252985$1$I$$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004268$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242529861$24252986$1$I$$20240819$20240827$20240827$EXP$$ZA-AstraZeneca-2024A188729$ASTRAZENECA$$64$YR$$F$Y$$$20240827$$CN$ZA$
242529871$24252987$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192049$ASTRAZENECA$$$$$F$Y$$$20240827$$HP$US$
242529881$24252988$1$I$20240816$20240821$20240827$20240827$EXP$$CN-SANDOZ INC.-SDZ2024CN075045$SANDOZ$$83$YR$$F$Y$62$KG$20240827$$HP$CN$CN
242529891$24252989$1$I$20220314$20240819$20240827$20240827$EXP$FR-AFSSAPS-DJ20221116$FR-ROCHE-3094484$ROCHE$$81$YR$E$F$Y$73$KG$20240827$$MD$FR$FR
242529911$24252991$1$I$$20240531$20240827$20240827$EXP$$GB-TEVA-VS-3218606$TEVA$$48$YR$$F$Y$$$20240827$$HP$GB$GB
242529921$24252992$1$I$$20240730$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07688$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242529931$24252993$1$I$$20240703$20240827$20240827$EXP$$US-BAUSCHBL-BL-2022-000828$BAUSCH AND LOMB$Moshirfar M, West Jr W, Milner D, McCabe S, Ronquillo Y, Hoopes P. Delayed Epithelial Healing with Corneal Edema and Haze After Photorefractive Keratectomy Using Intraoperative Mitomycin C. International Medical Case Reports Journal. 2021 DEC 24;14:863-870. doi:10.2147/1MCRJ.S342774$50$YR$$F$Y$$$20240827$$HP$US$US
242529951$24252995$1$I$20240809$20240815$20240827$20240827$EXP$$US-BEH-2024177297$CSL BEHRING$$45$YR$A$F$Y$117.91$KG$20240827$$CN$US$US
242529962$24252996$2$F$$20240825$20240827$20240829$PER$$NVSC2024US172461$NOVARTIS$$$$$$Y$$$20240829$$CN$US$US
242529971$24252997$1$I$20240101$20240814$20240827$20240827$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US001559$PAREXEL$$$$$$Y$$$20240827$$CN$US$US
242529983$24252998$3$F$$20240909$20240827$20240911$PER$$US-AMGEN-USASP2024169682$AMGEN$$78$YR$E$F$Y$$$20240911$$HP$US$US
242529994$24252999$4$F$20240816$20240831$20240827$20240903$PER$$US-AMGEN-USASP2024169683$AMGEN$$79$YR$E$F$Y$$$20240903$$CN$US$US
242530001$24253000$1$I$20160101$20240821$20240827$20240827$EXP$$US-AMGEN-USASP2024167525$AMGEN$$75$YR$E$M$Y$$$20240827$$CN$US$US
242530011$24253001$1$I$$20240821$20240827$20240827$PER$$NVSC2024US171620$NOVARTIS$$$$$F$Y$46.8$KG$20240827$$PH$US$US
242530022$24253002$2$F$20240801$20240906$20240827$20240917$PER$$US-Calliditas-2024CAL01569$CALLIDITAS THERAPEUTICS$$45$YR$A$F$Y$$$20240917$$CN$US$US
242530032$24253003$2$F$20240727$20240827$20240827$20240829$PER$$US-AMGEN-USASP2024170135$AMGEN$$57$YR$A$M$Y$$$20240829$$CN$US$US
242530042$24253004$2$F$$20240828$20240827$20240830$EXP$$CA-JNJFOC-20240859479$JOHNSON AND JOHNSON$$41$YR$A$M$Y$75$KG$20240830$$HP$CA$CA
242530051$24253005$1$I$$20240822$20240827$20240827$PER$$US-ABBVIE-5895346$ABBVIE$$$$$$Y$$$20240827$$CN$US$US
242530061$24253006$1$I$$20240819$20240827$20240827$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP010553$STRIDES$Kim HJ, Jung YJ, Lee JH, Lee HJ, Maeng CH, Baek SK, et al.. Severe acquired hemophilia A associated with COVID-19 vaccination: A case report and literature review. [Review].. Medicine. 2024;103 (31):e39166$56$YR$$M$Y$$$20240827$$HP$KR$KR
242530071$24253007$1$I$20240807$20240820$20240827$20240827$EXP$$CN-ROCHE-10000062151$ROCHE$$52$YR$A$F$Y$67$KG$20240827$$HP$CN$CN
242530082$24253008$2$F$$20240913$20240827$20240923$PER$$US-GSK-US2024AMR103692$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
242530091$24253009$1$I$$20240819$20240827$20240827$30DAY$$US-GSK-US2024AMR104355$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
242530101$24253010$1$I$$20240823$20240827$20240827$EXP$$IT-SANDOZ INC.-SDZ2024IT074862$SANDOZ$$37$YR$$M$Y$$$20240827$$HP$IT$IT
242530112$24253011$2$F$20231010$20240826$20240827$20240906$EXP$$JP-UCBSA-2024041558$UCB$$57$YR$$M$Y$$$20240906$$MD$JP$JP
242530122$24253012$2$F$$20240830$20240827$20240910$PER$$US-ABBVIE-5888638$ABBVIE$$$$$$Y$$$20240910$$CN$US$US
242530131$24253013$1$I$$20240814$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041794$AUROBINDO$$7$DEC$$F$Y$$$20240827$$HP$CA$CA
242530141$24253014$1$I$20200101$20240823$20240827$20240827$EXP$$PH-MYLANLABS-2024M1078745$MYLAN$Dorado CA, Kingking NJ, Nolasco RTP, Dadua-Ecal M, Fonte JS. Chorea Hyperglycemia Basal Ganglia Syndrome: A Case Report of a Rare Diabetes Complication. Phil-J-Intern-Med 2024; 62 (1): 326-330.$$$A$M$Y$$$20240827$$HP$PH$PH
242530152$24253015$2$F$$20240830$20240827$20240903$EXP$$GB-MYLANLABS-2024M1073913$MYLAN$$$$$F$Y$$$20240903$$CN$GB$GB
242530161$24253016$1$I$20240801$20240823$20240827$20240827$EXP$$AU-MYLANLABS-2024M1078535$MYLAN$$50$YR$$M$Y$$$20240827$$PH$AU$AU
242530171$24253017$1$I$20240812$20240823$20240827$20240827$EXP$$SG-MYLANLABS-2024M1078293$MYLAN$$50$YR$$M$Y$$$20240827$$HP$SG$SG
242530181$24253018$1$I$20240820$20240826$20240827$20240827$EXP$$AU-MYLANLABS-2024M1078897$MYLAN$$50$YR$$M$Y$$$20240827$$HP$AU$AU
242530191$24253019$1$I$$20240821$20240827$20240827$EXP$$CA-TAKEDA-2024TUS019909$TAKEDA$$$$$M$Y$$$20240827$$CN$CA$CA
242530201$24253020$1$I$20000101$20240820$20240827$20240827$EXP$$AU-TAKEDA-2024TUS085785$TAKEDA$$59$YR$$M$Y$$$20240827$$MD$AU$AU
242530211$24253021$1$I$20240804$20240819$20240827$20240827$EXP$$US-VANTIVE-2024VAN019154$Vantive US Healthcare$$52$YR$$F$Y$$$20240827$$HP$US$US
242530221$24253022$1$I$20240818$20240820$20240827$20240827$EXP$$US-VANTIVE-2024VAN019215$Vantive US Healthcare$$$$$F$Y$$$20240827$$CN$US$US
242530231$24253023$1$I$$20240826$20240827$20240827$PER$$US-ROCHE-10000066540$ROCHE$$$$A$F$Y$185$KG$20240827$$PH$US$US
242530241$24253024$1$I$$20240819$20240827$20240827$EXP$$US-RDY-SPO/USA/24/0012345$DR REDDYS$Kim E, Malespini J, Lei M, Branagan AR, Cirstea DR, Han SS, et al. Rapid reduction of free light chains and improvement in renal outcomes in patients with newly diagnosed multiple myeloma admitted with acute kidney injury with daratumumab-based therapy and without plasmapheresis. Journal of Clinical Oncology. 2024 Jun;42(16): doi:10.1200/JCO.2024.42.16_suppl.7525.$86$YR$E$$Y$$$20240827$$HP$US$US
242530251$24253025$1$I$$20240815$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-041602$AUROBINDO$$81$YR$$F$Y$65$KG$20240827$$PH$GB$GB
242530271$24253027$1$I$$20240507$20240827$20240827$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06627$HIKMA$Nepal N, Patel D, Omosebi O, Shin Y.. Nepal N, Patel D, Omosebi O, Shin Y. Type II Heparin-Induced Thrombocytopenia Manifesting As Cardiac Arrest Following Intravenous Heparin Bolus During an Elective Procedure: A Case Report and Literature Review.. Cureus. 2024;16(3):1-4$8$DEC$$F$Y$$$20240827$$MD$US$US
242530281$24253028$1$I$$20240826$20240827$20240827$PER$$US-ROCHE-10000067021$ROCHE$$$$A$F$Y$$$20240827$$HP$US$US
242530291$24253029$1$I$$20240730$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07690$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242530301$24253030$1$I$$20240820$20240827$20240827$EXP$$CA-JNJFOC-20240856854$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$CA$CA
242530312$24253031$2$F$$20240906$20240827$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004292$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
242530321$24253032$1$I$20230101$20240814$20240827$20240827$PER$$US-ABBVIE-5894504$ABBVIE$$38$YR$$F$Y$$$20240827$$HP$US$US
242530331$24253033$1$I$20240815$20240817$20240827$20240827$EXP$GB-MHRA-MED-202408161238414280-FMBWH$GB-MSNLABS-2024MSNSPO01842$MSN LABORATORIES$$$$$$Y$$$20240827$$PH$GB$GB
242530341$24253034$1$I$$20240826$20240827$20240827$EXP$$CA-ROCHE-10000065708$ROCHE$$74$YR$E$F$Y$54$KG$20240827$$HP$CA$CA
242530351$24253035$1$I$20230101$20240814$20240827$20240827$PER$$US-ABBVIE-5893771$ABBVIE$$55$YR$$F$Y$$$20240827$$HP$US$US
242530361$24253036$1$I$$20240826$20240827$20240827$PER$$US-HALEON-2193784$Haleon PLC$$$$$$Y$$$20240827$$CN$US$US
242530372$24253037$2$F$20240819$20240920$20240827$20240928$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-026591$UNITED THERAPEUTICS$$74$YR$$M$Y$36.4$KG$20240928$$$JP$JP
242530381$24253038$1$I$20240820$20240822$20240827$20240827$30DAY$$IT-SANDOZ INC.-SDZ2024IT075278$SANDOZ$$9$YR$$M$Y$25$KG$20240827$$CN$IT$IT
242530401$24253040$1$I$$20240815$20240827$20240827$PER$$US-ROCHE-10000058900$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242530411$24253041$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58322$$FDA-CTU$$68$YR$$M$N$$$20240823$N$$US$
242530421$24253042$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58323$$FDA-CTU$$41$YR$$F$N$$$20240823$N$$US$
242530431$24253043$1$I$$20240815$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130794$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240827$$HP$US$US
242530441$24253044$1$I$$20240815$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041905$AUROBINDO$$83$YR$$F$Y$71$KG$20240827$$PH$CA$CA
242530451$24253045$1$I$$20240821$20240827$20240827$PER$$US-ROCHE-10000063570$ROCHE$$27$YR$A$F$Y$$$20240827$$HP$US$US
242530461$24253046$1$I$20240816$20240819$20240827$20240827$PER$$US-ABBVIE-5887737$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242530471$24253047$1$I$$20240821$20240827$20240827$EXP$$TR-AMGEN-TURSP2024167392$AMGEN$Yildirim M.. Clinical Approach and Anatomical Results in the Treatment of Retinopathy of Prematurity. The Eurasian Journal of Medicine. 2024;56 (1):52-55$$$$$Y$$$20240827$$HP$TR$TR
242530481$24253048$1$I$20221012$20240826$20240827$20240827$EXP$$US-UCBSA-2024043348$UCB$$67$YR$$F$Y$$$20240827$$HP$US$US
242530491$24253049$1$I$$20240820$20240827$20240827$EXP$$US-GSK-US2024AMR105344$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
242530501$24253050$1$I$$20240821$20240827$20240827$PER$$US-MYLANLABS-2024M1078442$MYLAN$$$$E$F$Y$$$20240827$$CN$US$US
242530511$24253051$1$I$$20231204$20240827$20240827$EXP$$US-ABBVIE-5533678$ABBVIE$Dima D, Orland M, Ullah F, Anwer F, Mazzoni S, Raza S, et al. Clinical efficacy of retreatment with venetoclax-based therapy in relapsed-refractory t(11;14) multiple myeloma. Clinical Lymphoma Myeloma and Leukemia. 2023;23(11):857-60.$$$A$$Y$$$20240827$$MD$US$US
242530521$24253052$1$I$$20240806$20240827$20240827$PER$$US-AstraZeneca-2024A179456$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242530531$24253053$1$I$$20240821$20240827$20240827$EXP$$US-AstraZeneca-2024A191488$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242530541$24253054$1$I$$20240822$20240827$20240827$EXP$$ZA-AstraZeneca-2024A193163$ASTRAZENECA$$59$YR$$F$Y$$$20240827$$CN$ZA$
242530551$24253055$1$I$$20240823$20240827$20240827$PER$$US-TAKEDA-2024TUS086049$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
242530561$24253056$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A190321$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242530572$24253057$2$F$$20240821$20240827$20240829$EXP$$CA-AstraZeneca-2024A169546$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$CA$
242530581$24253058$1$I$$20240807$20240827$20240827$PER$$US-AstraZeneca-2024A183953$ASTRAZENECA$$78$YR$$M$Y$$$20240827$$CN$US$
242530591$24253059$1$I$$20240823$20240827$20240827$PER$$US-ROCHE-10000065987$ROCHE$$62$YR$A$F$Y$$$20240827$$MD$US$US
242530601$24253060$1$I$20240101$20240826$20240827$20240827$EXP$ES-AEMPS-1561406$ES-ABBVIE-5894918$ABBVIE$$86$YR$$F$Y$51.2$KG$20240827$$MD$ES$ES
242530611$24253061$1$I$20240815$20240823$20240827$20240827$EXP$IT-MINISAL02-999575$NVSC2024IT170816$NOVARTIS$$82$YR$$M$Y$$$20240827$$MD$IT$IT
242530621$24253062$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5892966$ABBVIE$$$$$M$Y$$$20240827$$HP$US$US
242530631$24253063$1$I$$20240730$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07693$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242530641$24253064$1$I$$20240826$20240827$20240827$EXP$$DE-SANDOZ INC.-NVSC2020DE053711$SANDOZ$$80$YR$$F$Y$$$20240827$$MD$DE$DE
242530651$24253065$1$I$$20240819$20240827$20240827$PER$$US-MYLANLABS-2024M1077345$MYLAN$$$$$F$Y$$$20240827$$CN$US$US
242530671$24253067$1$I$20240701$20240822$20240827$20240827$EXP$$US-ABBVIE-5893099$ABBVIE$$38$YR$$F$Y$$$20240827$$MD$US$US
242530681$24253068$1$I$$20240822$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134153$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240827$$HP$US$US
242530692$24253069$2$F$$20240823$20240827$20240831$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03064$AMNEAL$$$$$M$Y$$$20240831$$CN$US$US
242530702$24253070$2$F$20220101$20240828$20240827$20240903$EXP$$US-AMGEN-USASP2024166327$AMGEN$$76$YR$E$F$Y$$$20240903$$CN$US$US
242530711$24253071$1$I$20240812$20240813$20240827$20240827$PER$$US-TEVA-VS-3235236$TEVA$$45$YR$$F$Y$$$20240827$$CN$US$US
242530721$24253072$1$I$$20240820$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132665$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240827$$CN$US$US
242530731$24253073$1$I$20240801$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134940$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240827$$CN$US$US
242530741$24253074$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134873$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240827$$CN$US$US
242530751$24253075$1$I$$20240810$20240823$20240823$DIR$FDA-CDER-CTU-2024-58393$$FDA-CTU$$$$$F$N$$$20240810$N$HP$US$
242530761$24253076$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-084386-2024$RECKITT BENCKISER$$$$$$Y$$$20240827$$CN$US$US
242530771$24253077$1$I$$20240820$20240827$20240827$EXP$$JP-CHEPLA-2024010926$CHEPLAPHARM$Nohara S, et al. A Case of Loffler Endocarditis Complicated During Treatment of Eosinophilic Leukemia. The 7th Annual Meeting of the Japanese Society of Oncology and Cardiology. 2024;122.$61$YR$$M$Y$$$20240827$$MD$COUNTRY NOT SPECIFIED$JP
242530781$24253078$1$I$20240808$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58371$$FDA-CTU$$67$YR$$F$N$$$20240823$Y$$US$
242530801$24253080$1$I$20240731$20240819$20240827$20240827$EXP$ES-AEMPS-1561630$ES-CHEPLA-2024010772$CHEPLAPHARM$$54$YR$$M$Y$118.59$KG$20240827$$MD$COUNTRY NOT SPECIFIED$ES
242530811$24253081$1$I$$20240823$20240827$20240827$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-134283$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$62$KG$20240827$$MD$ES$ES
242530821$24253082$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015442$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240827$$HP$US$US
242530831$24253083$1$I$$20240815$20240827$20240827$EXP$$US-MACLEODS PHARMA-MAC2024048942$MACLEODS$$$$$$Y$$$20240827$$CN$US$US
242530841$24253084$1$I$20240701$20240821$20240827$20240827$EXP$FR-AFSSAPS-AVLL2024000198$FR-CHEPLA-2024010845$CHEPLAPHARM$$13$YR$$M$Y$$$20240827$$MD$COUNTRY NOT SPECIFIED$FR
242530851$24253085$1$I$$20240814$20240827$20240827$EXP$$GB-MACLEODS PHARMA-MAC2024048937$MACLEODS$Madhwapathi V, Tso S..Once in a blue moon?.British Journal of Dermatology.2024;191(Supplement 1):i121$$$$$Y$$$20240827$$MD$GB$GB
242530861$24253086$1$I$$20240814$20240827$20240827$EXP$$GB-MACLEODS PHARMA-MAC2024048938$MACLEODS$Khanna D, Bardhan A, Heagerty A, Harper N..A topical matter: iatrogenic adrenal crisis following excessive prescription corticosteroid use..British Journal of Dermatology..2024;192(1):188$$$$$Y$$$20240827$$MD$GB$GB
242530872$24253087$2$F$$20240827$20240827$20240910$EXP$$GB-MACLEODS PHARMA-MAC2024048943$MACLEODS$$$$$$Y$$$20240910$$MD$GB$GB
242530881$24253088$1$I$$20240813$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-041202$AUROBINDO$Scullin D, Goetz R, Wille K, Rusanov V, Gongora E, Orozco Hernandez E, et al. Acute Graft versus Host Disease in a Lung Transplan. The Journal of Heart and Lung Transplantation. 2024;43 (Suppl.)(4):S489- S490$64$YR$$M$Y$$$20240827$$HP$US$US
242530891$24253089$1$I$20240101$20240819$20240827$20240827$EXP$$NVSC2024CN171086$NOVARTIS$$50$YR$$M$Y$$$20240827$$MD$CN$CN
242530902$24253090$2$F$$20240816$20240827$20240829$PER$$US-ABBVIE-5886534$ABBVIE$$$$A$F$Y$$$20240829$$HP$US$US
242530911$24253091$1$I$$20240825$20240827$20240827$PER$$NVSC2024US172389$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
242530921$24253092$1$I$20200116$20240814$20240827$20240827$EXP$$DE-AUROBINDO-AUR-APL-2020-026875$AUROBINDO$$19$YR$$F$Y$$$20240827$$MD$DE$DE
242530932$24253093$2$F$$20240911$20240827$20240919$EXP$$IN-ROCHE-10000056947$ROCHE$$20$YR$A$M$Y$$$20240919$$CN$IN$IN
242530941$24253094$1$I$$20240819$20240827$20240827$PER$$US-MSNLABS-2024MSNSPO01839$MSN LABORATORIES$$$$$$Y$$$20240827$$CN$US$US
242530951$24253095$1$I$$20240822$20240827$20240827$EXP$$US-TAKEDA-US202032619$TAKEDA$$$$$F$Y$$$20240827$$HP$US$US
242530961$24253096$1$I$$20240823$20240827$20240827$PER$$US-TAKEDA-2024TUS085905$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
242530971$24253097$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-087428-2024$RECKITT BENCKISER$$$$$F$Y$$$20240827$$CN$US$US
242530981$24253098$1$I$20220905$20240820$20240827$20240827$EXP$$CO-UCBSA-2024042991$UCB$$55$YR$$F$Y$$$20240827$$CN$CO$CO
242530992$24253099$2$F$$20240822$20240827$20240827$EXP$$CA-JNJFOC-20240855247$JOHNSON AND JOHNSON$$$$$M$Y$$$20240828$$HP$CA$CA
242531011$24253101$1$I$$20240820$20240827$20240827$EXP$$DE-ROCHE-10000062956$ROCHE$$$$E$M$Y$$$20240827$$MD$DE$DE
242531021$24253102$1$I$$20240820$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132363$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240827$$HP$US$US
242531031$24253103$1$I$$20240822$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134727$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240827$$CN$US$US
242531051$24253105$1$I$$20240823$20240827$20240827$EXP$$IN-SANDOZ INC.-SDZ2024IN075294$SANDOZ$$$$$M$Y$$$20240827$$CN$IN$IN
242531062$24253106$2$F$20230101$20240905$20240827$20240913$EXP$$DE-AUROBINDO-AUR-APL-2024-041720$AUROBINDO$$$$$M$Y$136.2$KG$20240913$$MD$DE$DE
242531071$24253107$1$I$$20240816$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131088$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240827$$CN$US$US
242531081$24253108$1$I$$20240820$20240827$20240827$EXP$$CA-EMD Serono-2024044965$EMD SERONO INC$$$$A$F$Y$$$20240827$$CN$CA$CA
242531101$24253110$1$I$$20240816$20240827$20240827$EXP$$US-BAYER-2024A078180$BAYER$$44$YR$A$F$Y$63.492$KG$20240827$$CN$US$US
242531111$24253111$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58395$$FDA-CTU$$$$$M$N$$$20240823$N$HP$US$
242531121$24253112$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58275$$FDA-CTU$$$$$F$N$$$20240823$N$$US$
242531131$24253113$1$I$20240812$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58396$$FDA-CTU$$72$YR$$F$N$67.59$KG$20240823$N$PH$US$
242531141$24253114$1$I$20240819$20240823$20240824$20240824$DIR$FDA-CDER-CTU-2024-58360$$FDA-CTU$$$$$F$N$53.7$KG$20240823$N$$US$
242531151$24253115$1$I$20240814$20240816$20240824$20240824$DIR$FDA-CDER-CTU-2024-58361$$FDA-CTU$$$$$F$N$107.5$KG$20240816$N$$US$
242531161$24253116$1$I$20220101$20240822$20240827$20240827$EXP$$NVSC2024CZ172466$NOVARTIS$$$$A$F$Y$$$20240827$$MD$CZ$CZ
242531172$24253117$2$F$$20240826$20240827$20240829$EXP$$US-SANDOZ INC.-SDZ2024US062192$SANDOZ$$$$$$Y$$$20240829$$HP$US$US
242531181$24253118$1$I$20240812$20240813$20240824$20240824$DIR$FDA-CDER-CTU-2024-58362$$FDA-CTU$$$$$$N$$$20240813$N$$US$
242531191$24253119$1$I$$20240819$20240827$20240827$EXP$NL-LRB-00996245$NL-TEVA-VS-3234642$TEVA$$55$YR$$F$Y$55$KG$20240827$$CN$NL$NL
242531201$24253120$1$I$20240605$20240823$20240824$20240824$DIR$FDA-CDER-CTU-2024-58406$$FDA-CTU$$69$YR$$F$N$62.6$KG$20240823$N$$US$
242531212$24253121$2$F$$20240812$20240827$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-041066$AUROBINDO$Reyes NGD, Bendahan N, Swinkin E, Lang AE, Bassett AS. Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome. Neurological Sciences. 2024$53$YR$$F$Y$$$20240828$$HP$CA$CA
242531221$24253122$1$I$$20240730$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07694$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242531231$24253123$1$I$$20240824$20240824$20240824$DIR$FDA-CDER-CTU-2024-58365$$FDA-CTU$$37$YR$$M$N$$$20240824$N$$US$
242531241$24253124$1$I$$20240819$20240827$20240827$EXP$$CA-AMGEN-CANSP2024167880$AMGEN$$40$YR$A$F$Y$96$KG$20240827$$HP$CA$CA
242531252$24253125$2$F$$20240912$20240827$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004295$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
242531262$24253126$2$F$20240612$20240826$20240827$20240912$PER$$US-IMP-2024000621$Harrow Health$$56$YR$A$F$Y$$$20240912$$CN$US$US
242531271$24253127$1$I$$20240730$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07695$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242531282$24253128$2$F$$20240830$20240827$20240902$PER$$US-JNJFOC-20240865279$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240902$$CN$US$US
242531291$24253129$1$I$$20240812$20240827$20240827$PER$$US-JNJFOC-20240831505$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240827$$CN$US$US
242531301$24253130$1$I$$20240820$20240827$20240827$30DAY$$US-GSK-US2024104422$GLAXOSMITHKLINE$$85$YR$$F$Y$$$20240827$$MD$US$US
242531311$24253131$1$I$$20240822$20240827$20240827$EXP$$NVSC2024CA171422$NOVARTIS$$$$$$Y$$$20240827$$MD$CA$CA
242531323$24253132$3$F$$20240901$20240827$20240906$PER$$NVSC2024US172510$NOVARTIS$$$$$$Y$$$20240906$$CN$US$US
242531331$24253133$1$I$$20240815$20240827$20240827$EXP$$US-BAYER-2024A118781$BAYER$$$$$$Y$$$20240827$$CN$US$US
242531342$24253134$2$F$20240717$20240827$20240827$20240829$PER$$US-AMGEN-USASP2024169822$AMGEN$$56$YR$A$M$Y$$$20240828$$CN$US$US
242531351$24253135$1$I$$20240816$20240827$20240827$PER$$US-AMGEN-USASP2024167977$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242531361$24253136$1$I$20240529$20240822$20240827$20240827$EXP$$SG-MYLANLABS-2024M1078089$MYLAN$$76$YR$$F$Y$$$20240827$$HP$SG$SG
242531381$24253138$1$I$$20240822$20240827$20240827$EXP$$SG-MYLANLABS-2024M1078010$MYLAN$$$$$F$Y$$$20240827$$HP$SG$SG
242531391$24253139$1$I$$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004297$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242531401$24253140$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-082279-2024$RECKITT BENCKISER$$$$$M$Y$$$20240827$$CN$US$US
242531411$24253141$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189856$ASTRAZENECA$$70$YR$$F$Y$58.5$KG$20240827$$CN$US$
242531421$24253142$1$I$$20240730$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07691$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242531431$24253143$1$I$$20240130$20240827$20240827$PER$$US-SOMERSET-2024-US-000102$ODIN PHARMACEUTICALS$$$$$UNK$Y$$$20240827$$HP$US$US
242531441$24253144$1$I$20240701$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004301$ACADIA PHARMACEUTICALS$$62$YR$$M$Y$$$20240827$$CN$US$US
242531451$24253145$1$I$$20240822$20240827$20240827$PER$$US-ALXN-202408USA001560US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242531461$24253146$1$I$$20240821$20240827$20240827$PER$$US-ALXN-202408USA001406US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242531481$24253148$1$I$20230101$20240814$20240827$20240827$PER$$US-ABBVIE-5893420$ABBVIE$$55$YR$$M$Y$$$20240827$$HP$US$US
242531492$24253149$2$F$20240216$20240830$20240827$20240906$EXP$$AR-GSK-AR2023AMR126162$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$AR$AR
242531501$24253150$1$I$$20240819$20240827$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-025964$UNITED THERAPEUTICS$$$$$F$Y$37.188$KG$20240827$$$US$US
242531511$24253151$1$I$20240801$20240819$20240827$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-026022$UNITED THERAPEUTICS$$58$YR$$M$Y$122.45$KG$20240827$$$US$US
242531521$24253152$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135555$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240827$$CN$US$US
242531541$24253154$1$I$20240816$20240823$20240827$20240827$EXP$$US-ABBVIE-5893807$ABBVIE$$38$YR$$F$Y$$$20240827$$CN$US$US
242531551$24253155$1$I$20240715$20240822$20240827$20240827$EXP$$SG-MYLANLABS-2024M1077957$MYLAN$$41$YR$$F$Y$$$20240827$$HP$SG$SG
242531561$24253156$1$I$$20240730$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07746$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242531571$24253157$1$I$$20240813$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-041188$AUROBINDO$Lee IJ, Pulido JS, Regillo CD, Leys M. MULTIPLE ORGAN DYSFUNCTION SYNDROME and DISSEMINATED INTRAVASCULAR COAGULATION CAUSING EXTENSIVE MULTIPLE AMALRIC TRIANGULAR CHOROIDAL INFARCTIONS.. RETINAL CASES + BRIEF REPORTS. 2024;18(2):251-254$49$YR$$F$Y$$$20240827$$MD$US$US
242531581$24253158$1$I$$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004315$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242531591$24253159$1$I$$20240815$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041914$AUROBINDO$$49$YR$$M$Y$$$20240827$$PH$CA$CA
242531601$24253160$1$I$$20240816$20240827$20240827$EXP$$US-BAYER-2024A122221$BAYER$Allihien S.-M.; Ibrahim S.; Singireddy S.; Haithcock D.B.; Magruder T.; Marti C.N.. A terrible bloody tamponade: A case of delayed hemorrhagic cardiac tamponade post left atrial appendage occlusion. HeartRhythm Case Reports (2024) 10:8 (549-552). 2024;10:8:(549-552)$67$YR$E$F$Y$$$20240827$$MD$US$US
242531611$24253161$1$I$20240806$20240815$20240827$20240827$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160894$JIANGSU HENGRUI MEDICINE$$73$YR$$M$Y$61$KG$20240827$$MD$CN$CN
242531621$24253162$1$I$$20240812$20240827$20240827$PER$$US-TEVA-VS-3233716$TEVA$$83$YR$$F$Y$$$20240827$$CN$US$US
242531631$24253163$1$I$$20240814$20240827$20240827$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2160887$BRECKENRIDGE$$$$$F$Y$$$20240827$$$ES$A1
242531641$24253164$1$I$20240801$20240826$20240826$20240826$DIR$715847$$FDA-CTU$$52$YR$$F$N$81$KG$20240826$N$CN$US$
242531661$24253166$1$I$$20240826$20240826$20240826$DIR$715857$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242531671$24253167$1$I$20240825$20240826$20240826$20240826$DIR$715850$$FDA-CTU$$33$YR$$F$N$56.7$KG$20240826$N$CN$US$
242531681$24253168$1$I$$20240730$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07814$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242531691$24253169$1$I$20240720$20240826$20240826$20240826$DIR$715856$$FDA-CTU$$41$YR$$F$N$$$20240826$N$HP$US$
242531701$24253170$1$I$20240730$20240826$20240826$20240826$DIR$715848$$FDA-CTU$$53$YR$$F$N$$$20240826$N$CN$US$
242531711$24253171$1$I$$20240822$20240827$20240827$EXP$$GB-MYLANLABS-2024M1078208$MYLAN$$$$$M$Y$$$20240827$$MD$GB$GB
242531721$24253172$1$I$$20240822$20240827$20240827$PER$$US-Mission Pharmacal Company-2160886$MISSION$$27$YR$$F$Y$$$20240827$$$US$US
242531731$24253173$1$I$$20240814$20240827$20240827$PER$$US-P+L Developments of Newyork Corporation-2160896$PL DEVELOPMENTS$$$$$$Y$$$20240827$$$US$US
242531741$24253174$1$I$$20240822$20240827$20240827$PER$$US-Mission Pharmacal Company-2160885$MISSION$$27$YR$$F$Y$$$20240827$$$US$US
242531751$24253175$1$I$$20240813$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-041218$AUROBINDO$Dutcher D, Hicks S, Hoppe M, Whitten S, Falk K. 10021 Combined Robotic and Hysteroscopic Repair of Isthmocele Containing Retained Products of Conception. J-Minim-Invasive-Gynecol. 2023;30 (Suppl.)(11):S99$31$YR$$F$Y$$$20240827$$HP$US$US
242531761$24253176$1$I$20240813$20240815$20240827$20240827$EXP$$CN-Shanghai Hengrui Pharmaceutical Co., Ltd.-2160901$SHANGHAI HENGRUI PHARMACEUTICAL$$30$YR$$M$Y$52$KG$20240827$$MD$CN$CN
242531771$24253177$1$I$$20240826$20240826$20240826$DIR$715858$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242531781$24253178$1$I$$20240812$20240827$20240827$EXP$$DE-Saptalis Pharmaceuticals LLC-2160884$SAPTALIS PHARMACEUTICALS$Attaching the Full Text Article of a Case Report (Forign) received by Pubmed search . Brain MRI gave a rapid and accurate identification of vasogenic oedema consistent with PRES, which could otherwise be missed on CT alone. Early recognition and appropriate management of PRES is necessary to eliminate any predisposing causes. This would lead to a shorter recovery time, reduced need for intensive care and overall better clinical outcomes.$55$YR$$F$Y$$$20240827$$$US$DE
242531791$24253179$1$I$$20240826$20240826$20240826$DIR$715859$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242531802$24253180$2$F$20240617$20240826$20240827$20240905$EXP$$FR-Jiangsu Hengrui Medicine Co., Ltd.-2160895$JIANGSU HENGRUI MEDICINE$$65$YR$$M$Y$102.4$KG$20240905$$MD$FR$FR
242531811$24253181$1$I$$20240814$20240827$20240827$EXP$$IN-Oxford Pharmaceuticals, LLC-2160898$OXFORD PHARMACEUTICALS$Source document$55$YR$$F$Y$$$20240827$$$IN$IN
242531821$24253182$1$I$$20240816$20240827$20240827$EXP$$US-Avondale Pharmaceuticals, LLC-2160899$AVONDALE PHARMACEUTICALS$Initial$94$YR$$F$Y$$$20240827$$MD$US$US
242531831$24253183$1$I$$20240814$20240827$20240827$PER$$US-P+L Developments of Newyork Corporation-2160897$PL DEVELOPMENTS$$$$$$Y$$$20240827$$$US$US
242531841$24253184$1$I$20240726$20240816$20240827$20240827$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000850$PAREXEL$$$$$$Y$$$20240827$$HP$CN$CN
242531851$24253185$1$I$20240706$20240816$20240827$20240827$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000842$PAREXEL$$$$$$Y$$$20240827$$HP$CN$CN
242531861$24253186$1$I$20240731$20240814$20240827$20240827$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000829$PAREXEL$$$$$$Y$$$20240827$$HP$CN$CN
242531872$24253187$2$F$20240801$20240904$20240827$20240911$PER$$US-ABBVIE-5893650$ABBVIE$$79$YR$$F$Y$$$20240911$$CN$US$US
242531881$24253188$1$I$$20240813$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-041086$AUROBINDO$Joffe D, Rohan TZ, Mandel J, Suriano J, Banner L, Valiga A, et al. The development of 2 clonally and histologically distinct subtypes of extranodal B-cell lymphomas in the brain and skin in 1 individual. JAAD-Case-Rep. 2024;49:51-54$61$YR$$M$Y$$$20240827$$MD$US$US
242531891$24253189$1$I$$20240821$20240827$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-026520$UNITED THERAPEUTICS$$$$$F$Y$65.76$KG$20240827$$$US$US
242531903$24253190$3$F$20240301$20240911$20240827$20240918$EXP$$NVSC2024DE170278$NOVARTIS$$$$E$F$Y$60$KG$20240918$$HP$DE$DE
242531912$24253191$2$F$$20240830$20240827$20240909$EXP$$US-TEVA-VS-3235627$TEVA$Li B, Chawla S, Tong M, Higgins A, Lee R. Temporary Biventricular Mechanical Circulatory Support for Primary Graft Dysfunction after Orthotopic Heart Transplantation. US-Cardiol 2024; 18 (Suppl. 1) 38 (plus Poster) abstr. 75.; Li B, Chawla S, Tong M, Higgins A, Lee R. Temporary Biventricular Mechanical Circulatory Support for Primary Graft Dysfunction after Orthotopic Heart Transplantation. US-Cardiol 2024; 18 (Suppl. 1) 38 (plus Poster) abstr. 75.; Li B, Chawla S, Tong M, Higgins A, Lee R. T...$51$YR$$M$Y$$$20240909$$MD$US$US
242531922$24253192$2$F$20240723$20240821$20240827$20240829$PER$$US-AMGEN-USASP2024167709$AMGEN$$$$$F$Y$$$20240829$$CN$US$US
242531931$24253193$1$I$$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004317$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242531941$24253194$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5894135$ABBVIE$$$$$F$Y$$$20240827$$HP$US$US
242531951$24253195$1$I$20240801$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015107$ELI LILLY AND CO$$$$A$M$Y$$$20240827$$CN$US$US
242531961$24253196$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015098$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242531971$24253197$1$I$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016009$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240827$$CN$US$US
242531981$24253198$1$I$20240508$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014599$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240827$$CN$US$US
242531991$24253199$1$I$20240825$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016067$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240827$$CN$US$US
242532003$24253200$3$F$$20240830$20240827$20240903$EXP$$IT-JNJFOC-20240861040$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240903$$HP$IT$IT
242532012$24253201$2$F$$20240828$20240827$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408015595$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240902$$CN$US$US
242532021$24253202$1$I$20240801$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015272$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240827$$CN$US$US
242532031$24253203$1$I$$20240826$20240827$20240827$EXP$$DE-SANDOZ INC.-NVSC2020DE180881$SANDOZ$$70$YR$$M$Y$$$20240827$$MD$DE$DE
242532041$24253204$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015350$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240827$$CN$US$US
242532051$24253205$1$I$20240822$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015183$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242532061$24253206$1$I$$20240813$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-041209$AUROBINDO$Narula S, Snodgrass C. Botulinum Treatment Induced Dropped Head Syndrome in a Patient With Chronic Migraines and Multiple Sclerosis. Pain Medicine Case Reports. 2024;8(4):157-160$$$$F$Y$$$20240827$$MD$US$US
242532071$24253207$1$I$$20240802$20240827$20240827$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004318$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242532081$24253208$1$I$$20240813$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-031336$AUROBINDO$Gondal MUR, Rovenstine L, Ansari F, Kiyani Z, Jyothi Ramachandran Nair DP, Khan T, et al. Navigating a complex case of Mycobacterium xenopi in a patient with blue rubber bleb nevus syndrome.. European Journal of Case Reports in Internal Medicine. 2024;11(6)$40$YR$$F$Y$$$20240827$$MD$US$US
242532091$24253209$1$I$$20240731$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07779$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242532101$24253210$1$I$$20240821$20240827$20240827$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07571$VIFOR$$$$E$F$Y$$$20240827$$CN$ZA$ZA
242532111$24253211$1$I$20240802$20240815$20240827$20240827$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000838$PAREXEL$$$$$$Y$$$20240827$$HP$CN$CN
242532121$24253212$1$I$$20240821$20240827$20240827$EXP$$IT-MYLANLABS-2024M1078645$MYLAN$Frattari A, De Angelis MV, Battilana M, Polilli E, Ferrieri A, Onofrillo D, et al. High viral load VZV encephalitis complicated by super refractory status epilepticus in a vaccinated child with in Acute Lymphocytic Leukemia: Case report and review of the literature. Neuroimmunol-Rep 2024; 6 (0).$6$YR$$M$Y$$$20240827$$HP$IT$IT
242532141$24253214$1$I$$20240812$20240827$20240827$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405230$RANBAXY$Dennee A, Fogarty PT, Howard ST, Hunter BR. Sinus Arrest Related to Dexmedetomidine Infusion in an Infant; a Case Report and Review of Current Literature. J Pharm Pract. 2023;Aug 4:Online ahead of print$11$MON$$F$Y$$$20240827$$MD$US$US
242532151$24253215$1$I$$20240812$20240827$20240827$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-387579$RANBAXY$Monge J, Razavi M, Bao L, Patel SS. Two p53s in a Pod: co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. Am J Hematol. 2023;Apr 19; 99:327-328$78$YR$$M$Y$$$20240827$$HP$US$US
242532161$24253216$1$I$20210801$20240812$20240827$20240827$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-327210$RANBAXY$$66$YR$$F$Y$71.655$KG$20240827$$CN$US$US
242532181$24253218$1$I$20240701$20240802$20240827$20240827$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004321$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240827$$CN$US$US
242532191$24253219$1$I$$20240822$20240827$20240827$EXP$$CA-Orion Corporation ORION PHARMA-24_00031420$ORION$$45$YR$A$F$Y$$$20240827$$HP$CA$
242532202$24253220$2$F$20240101$20240913$20240827$20240913$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047938$BOEHRINGER INGELHEIM$$55$YR$A$M$Y$$$20240913$$CN$DE$DE
242532211$24253221$1$I$$20240826$20240826$20240826$DIR$715861$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242532221$24253222$1$I$$20240820$20240827$20240827$EXP$$US-GSK-US2024AMR105346$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
242532232$24253223$2$F$20240814$20240820$20240827$20240909$EXP$$CN-GSK-CN2024APC103572$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$CN$CN$CN
242532241$24253224$1$I$$20240826$20240826$20240826$DIR$715860$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242532251$24253225$1$I$$20240819$20240827$20240827$EXP$NL-LRB-00996070$NL-TEVA-VS-3234604$TEVA$$65$YR$$F$Y$77$KG$20240827$$PH$NL$NL
242532261$24253226$1$I$20240815$20240815$20240827$20240827$EXP$GB-MHRA-TPP26690923C7870270YC1723707934374$GB-Accord-442278$ACCORD$$63$YR$A$M$Y$114$KG$20240827$$MD$GB$GB
242532281$24253228$1$I$20210714$20240815$20240827$20240827$EXP$PL-URPL-DML-MLP.4401.1.4982.2021$PL-Accord-442527$ACCORD$$74$YR$E$F$Y$65$KG$20240827$$MD$PL$PL
242532291$24253229$1$I$20240102$20240826$20240826$20240826$DIR$715876$$FDA-CTU$$76$YR$$M$N$76.7$KG$20240826$N$HP$US$
242532311$24253231$1$I$20231201$20240815$20240827$20240827$EXP$FR-AFSSAPS-RE2024000807$FR-Accord-442291$ACCORD$$66$YR$E$M$Y$77$KG$20240827$$MD$FR$FR
242532321$24253232$1$I$20240512$20240815$20240827$20240827$EXP$ES-AEMPS-1557515$ES-Accord-442739$ACCORD$$66$YR$E$M$Y$$$20240827$$HP$ES$ES
242532341$24253234$1$I$20240627$20240815$20240827$20240827$EXP$ES-AEMPS-1557574$ES-Accord-442352$ACCORD$$48$YR$A$F$Y$$$20240827$$MD$ES$ES
242532351$24253235$1$I$20240818$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A193019$ASTRAZENECA$$25900$DY$$F$Y$$$20240827$$CN$US$
242532361$24253236$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192519$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242532371$24253237$1$I$20240626$20240815$20240827$20240827$EXP$FR-AFSSAPS-PO2024000866$FR-Accord-442290$ACCORD$$72$YR$E$F$Y$46.2$KG$20240827$$MD$FR$FR
242532381$24253238$1$I$$20240820$20240827$20240827$EXP$$US-MYLANLABS-2024M1078139$MYLAN$Shaikh M, Golzarian H, Hakim FA. Wide QRS tachycardia in a patient with atrial fibrillation: A case report and approach to diagnosis. Eur-Heart-J-Case-Rep 2024; 8 (8):.$87$YR$$M$Y$$$20240827$$HP$US$US
242532391$24253239$1$I$$20240820$20240827$20240827$EXP$$US-MYLANLABS-2024M1078227$MYLAN$Pechacek J, Schmitt MM, Ferre EMN, Webb T, Goldberg J, Pathan S, et al. Successful Treatment of Refractory Cutaneous Protothecosis With MAT2203, an Oral Lipid Nanocrystal Formulation of Amphotericin B. Open-Forum-Infect-Dis 2024; 11 (8):.$71$YR$$M$Y$$$20240827$$HP$US$US
242532401$24253240$1$I$20240801$20240820$20240827$20240827$EXP$$KR-MALLINCKRODT-MNK202405303$MALLINCKRODT$$0$DY$N$M$Y$0.6$KG$20240827$$HP$KR$KR
242532413$24253241$3$F$20230101$20240920$20240827$20240924$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046746$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$105$KG$20240924$$CN$BR$BR
242532421$24253242$1$I$$20240815$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-042005$AUROBINDO$$59$YR$$F$Y$$$20240827$$CN$CA$CA
242532431$24253243$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192377$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242532441$24253244$1$I$$20240820$20240827$20240827$EXP$$US-ABBVIE-5890309$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242532451$24253245$1$I$$20240814$20240827$20240827$PER$$US-Nobelpharma America, LLC-NPA-2024-00734$NOBELPHARMA$$$$$F$Y$$$20240827$$HP$US$US
242532461$24253246$1$I$$20240814$20240827$20240827$PER$$US-Nobelpharma America, LLC-NPA-2024-01422$NOBELPHARMA$$$$$M$Y$$$20240827$$HP$COUNTRY NOT SPECIFIED$US
242532471$24253247$1$I$$20240820$20240827$20240827$EXP$$US-MYLANLABS-2024M1077875$MYLAN$Heering G, Lin Z, Rosman M, Hara N, Shakil F, Georgostathis D. Side Effects of Stem Cell Transplant Mimicking Symptoms of Known Amyloidosis. Case-Rep-Gastroenterol 2024; 18 (1): 273-278.$67$YR$$F$Y$$$20240827$$HP$US$US
242532481$24253248$1$I$$20240820$20240827$20240827$EXP$$US-MYLANLABS-2024M1078623$MYLAN$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J-Drugs-Dermatol 2023; 22 (11): e12-e16.$26$YR$$F$Y$$$20240827$$HP$US$US
242532491$24253249$1$I$$20240820$20240827$20240827$EXP$$US-MYLANLABS-2024M1078657$MYLAN$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J-Drugs-Dermatol 2023; 22 (11): e12-e16.$41$YR$$F$Y$$$20240827$$HP$US$US
242532501$24253250$1$I$$20240820$20240827$20240827$EXP$$AU-MYLANLABS-2024M1078242$MYLAN$See AYS, Lau AZ-B, Thiruvengadam S. Pyroglutamic acidosis in the setting of Staphylococcus aureus bacteremia treated with flucloxacillin-An uncommon cause of high anion gap metabolic acidosis. Clin-Case-Rep 2024; 12 (8):.$64$YR$$M$Y$$$20240827$$HP$AU$AU
242532511$24253251$1$I$$20240820$20240827$20240827$EXP$$US-MYLANLABS-2024M1078278$MYLAN$Yu R. Exaggerated Increases in the Serum Cortisol Level in a Woman Following Oral Contraceptive Treatment. AACE-Clin-Case-Rep 2024.$50$YR$$F$Y$$$20240827$$MD$US$US
242532521$24253252$1$I$$20240820$20240827$20240827$EXP$$US-MYLANLABS-2024M1078633$MYLAN$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J-Drugs-Dermatol 2023; 22 (11): e12-e16.$51$YR$$F$Y$$$20240827$$HP$US$US
242532531$24253253$1$I$$20240820$20240827$20240827$EXP$$US-MYLANLABS-2024M1078624$MYLAN$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J-Drugs-Dermatol 2023; 22 (11): e12-e16.$57$YR$$F$Y$$$20240827$$HP$US$US
242532541$24253254$1$I$$20240820$20240827$20240827$EXP$$US-MYLANLABS-2024M1078625$MYLAN$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J-Drugs-Dermatol 2023; 22 (11): e12-e16.$33$YR$$F$Y$$$20240827$$HP$US$US
242532552$24253255$2$F$20240717$20240911$20240827$20240927$30DAY$$US-BECTON DICKINSON-US-BD-24-000489$BECTON DICKINSON$$$$$$Y$$$20240927$$CN$US$US
242532561$24253256$1$I$20230714$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-100766-2023$RECKITT BENCKISER$$$$$F$Y$$$20240827$$CN$US$US
242532571$24253257$1$I$20200224$20240813$20240827$20240827$EXP$$FR-SERVIER-S24010396$SERVIER$$$$$$Y$$$20240827$$MD$FR$FR
242532581$24253258$1$I$20240823$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169446$AMGEN$$67$YR$E$F$Y$$$20240827$$PH$US$US
242532591$24253259$1$I$20240822$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168825$AMGEN$$$$$$Y$$$20240827$$HP$US$US
242532601$24253260$1$I$$20240820$20240827$20240827$EXP$$JP-009507513-2408JPN002655J$MERCK$$63$YR$$$Y$$$20240827$$MD$JP$JP
242532621$24253262$1$I$20240801$20240821$20240827$20240827$EXP$$US-AMGEN-USASP2024167749$AMGEN$$$$$$Y$$$20240827$$HP$US$US
242532631$24253263$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3235033$TEVA$$$$$$Y$$$20240827$$HP$CA$CA
242532641$24253264$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024170294$AMGEN$$$$$$Y$$$20240827$$HP$US$US
242532671$24253267$1$I$$20240821$20240827$20240827$EXP$$US-MYLANLABS-2024M1078713$MYLAN$Kotamarti V. Disentangling the Diagnoses of Psychotic Depression, Catatonia, Neurocognitive Disorders, and Delirium: A Multidisciplinary Approach. Am-J-Geriatr-Psychiatry 2024; 32 (Suppl.) (4): S35-S36.$77$YR$$M$Y$$$20240827$$MD$US$US
242532681$24253268$1$I$20240708$20240823$20240827$20240827$EXP$FR-AFSSAPS-LM2024000468$FR-SANDOZ INC.-SDZ2024FR075133$SANDOZ$$68$YR$$M$Y$59.7$KG$20240827$$MD$FR$FR
242532692$24253269$2$F$$20240904$20240827$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004323$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
242532701$24253270$1$I$$20240821$20240827$20240827$EXP$$US-MYLANLABS-2024M1078736$MYLAN$Chang C, Guimaraes A, Mayasy S. Dynamic atrioventricular block: a rare complication of thyroid storm. J-Am-Coll-Cardiol 2019; 73 (Suppl. 1) (9): 2453.$28$YR$$F$Y$$$20240827$$HP$US$US
242532711$24253271$1$I$$20240821$20240827$20240827$EXP$$AU-MYLANLABS-2024M1078706$MYLAN$Hoang BH, Tang TV, Phan NDN, Nguyen AD, Dinh MMQ. Airway breathing circulation dengue: a case of multifactorial shock due to major trauma and severe dengue infection. Int-J-Emerg-Med 2024; 17 (1):.$49$YR$$F$Y$$$20240827$$HP$AU$AU
242532721$24253272$1$I$20240815$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134221$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240827$$PH$US$US
242532731$24253273$1$I$$20240731$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07750$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242532741$24253274$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135534$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240827$$HP$US$US
242532752$24253275$2$F$$20240918$20240827$20240927$PER$$US-GSK-US2024104587$GLAXOSMITHKLINE$$$$$M$Y$$$20240927$$CN$US$US
242532761$24253276$1$I$$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168397$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242532771$24253277$1$I$$20240820$20240827$20240827$EXP$$US-GILEAD-2024-0684776$GILEAD$$$$$F$Y$$$20240827$$CN$US$US
242532781$24253278$1$I$20240810$20240826$20240827$20240827$EXP$$US-UCBSA-2024043376$UCB$$79$YR$$M$Y$$$20240827$$CN$US$US
242532791$24253279$1$I$20240731$20240731$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07752$LUPIN$$$$$$Y$$$20240827$$PH$US$US
242532801$24253280$1$I$$20240815$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041977$AUROBINDO$$68$YR$$M$Y$$$20240827$$HP$CA$CA
242532811$24253281$1$I$$20240816$20240827$20240827$PER$$US-JNJFOC-20240846446$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242532831$24253283$1$I$$20240826$20240826$20240826$DIR$715875$$FDA-CTU$$$$$UNK$N$$$20240826$$CN$US$
242532841$24253284$1$I$20231114$20240826$20240826$20240826$DIR$715866$$FDA-CTU$$67$YR$$F$N$31.27$KG$20240826$Y$MD$US$
242532851$24253285$1$I$$20240819$20240827$20240827$PER$$US-ABBVIE-5887800$ABBVIE$$$$$$Y$$$20240827$$CN$US$US
242532861$24253286$1$I$20240819$20240826$20240827$20240827$EXP$$CA-GILEAD-2024-0685329$GILEAD$$41$YR$A$F$Y$$$20240827$$CN$CA$CA
242532871$24253287$1$I$$20240821$20240827$20240827$EXP$$US-MYLANLABS-2024M1078922$MYLAN$Cowling M, Poliak-Tunis M. Low Dose Naltrexone for Neuropathic Pain Related to an Electrical Burn Injury: A Case Study. J-Pain 2019; 20 (Suppl.) (4): S66.$36$YR$$M$Y$$$20240827$$HP$US$US
242532891$24253289$1$I$20230101$20240814$20240827$20240827$PER$$US-ABBVIE-5893804$ABBVIE$$65$YR$$M$Y$$$20240827$$HP$US$US
242532901$24253290$1$I$20240526$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464095$RANBAXY$$$$A$M$Y$$$20240827$$CN$FR$FR
242532911$24253291$1$I$20240720$20240816$20240827$20240827$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000826$PAREXEL$$$$$$Y$$$20240827$$HP$CN$CN
242532921$24253292$1$I$20240101$20240812$20240827$20240827$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463613$RANBAXY$$$$E$M$Y$$$20240827$$CN$US$US
242532931$24253293$1$I$$20240812$20240827$20240827$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464547$RANBAXY$Lee SY, Kim HS, Jung MH, Chang S, Kim M, Youn JC,et al. Genetic predisposition in chemotherapy-induced cardiomyopathy in a 65-year-old female with metastatic breast cancer. ESC Heart Failure. 2024;11 (4):2410-2414.$65$YR$$F$Y$$$20240827$$HP$KR$KR
242532941$24253294$1$I$$20240812$20240827$20240827$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464519$RANBAXY$Pai HL, Liu CY, Yeh MH.. Scleroderma-like Lesions in a Patient Undergoing Combined Pembrolizumab and Routine Chemotherapy: A Case Report and Literature Review. Medicina Kaunas. 2024;60 (7):1092(2-8)$54$YR$$F$Y$$$20240827$$HP$TW$TW
242532951$24253295$1$I$$20240812$20240827$20240827$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464576$RANBAXY$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ Genom Precis Med. 2024;Apr; 17:e004353/164-165$1$YR$$M$Y$$$20240827$$MD$IT$IT
242532961$24253296$1$I$20230101$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464296$RANBAXY$$20$YR$$F$Y$55.8$KG$20240827$$MD$FR$FR
242532971$24253297$1$I$$20240812$20240827$20240827$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464570$RANBAXY$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ Genom Precis Med. 2024;Apr; 17:e004353/164-165$5$YR$$F$Y$$$20240827$$MD$IT$IT
242532981$24253298$1$I$$20240812$20240827$20240827$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464550$RANBAXY$Bozca BC, Alpsoy A, Bilgic A, Bassorgun CI, Unal B, Alpsoy E. Clinicopathological analysis of patients diagnosed with DRESS. Turk Arch Dermatol Venereol. 2023;23:101-107$$$$$Y$$$20240827$$HP$TR$TR
242532991$24253299$1$I$20240513$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464245$RANBAXY$$21$YR$$F$Y$$$20240827$$MD$FR$FR
242533011$24253301$1$I$20231021$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463902$RANBAXY$$74$YR$$M$Y$$$20240827$$PH$FR$FR
242533021$24253302$1$I$$20240812$20240827$20240827$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464544$RANBAXY$Scorza CA, Scorza FA, Finsterer J. Daytime bruxism, tardive orofacial dyskinesia, and dysphagia as side effects to duloxetine use over nine years in an octogenarian. Clinics. 2024;79 (0):100438$83$YR$$F$Y$69$KG$20240827$$HP$BR$BR
242533031$24253303$1$I$$20240812$20240827$20240827$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464532$RANBAXY$Stawarz K, Galazka A, Gorzelnik A, Durzynska M, Bienkowska-Pluta K, Zwolinski J. et all. Case report: An uncommon presentation of extramedullary plasmacytoma without a concurrent diagnosis of multiple myeloma. Front Oncol. 2024;14 (0):1353943(1-7)$72$YR$$M$Y$$$20240827$$HP$PL$PL
242533041$24253304$1$I$$20240812$20240827$20240827$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464494$RANBAXY$He S, Wang L, Sun Y, Du H, Yu X. Case Report: Successful immune checkpoint inhibitor-based rechallenge in a patient with advanced renal clear cell cancer. Front Immunol. 2023;Oct; 14:1270828(1-5)$34$YR$$F$Y$$$20240827$$HP$CN$CN
242533051$24253305$1$I$$20240812$20240827$20240827$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463420$RANBAXY$$$$$M$Y$$$20240827$$CN$US$US
242533061$24253306$1$I$$20240812$20240827$20240827$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464573$RANBAXY$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ Genom Precis Med. 2024;Apr; 17:e004353/164-165$5$YR$$M$Y$$$20240827$$MD$IT$IT
242533071$24253307$1$I$$20240812$20240827$20240827$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464476$RANBAXY$Petrikkos L, Kourti M, Stathi A, Antoniadi K, Ampatzidou M, Stefanaki K, et al. Successful Treatment of Disseminated Fusariosis in a 15-Month-Old Boy With Refractory Acute Lymphoblastic Leukemia Using High-Dose Voriconazole. Pediatr Infect Dis J. 2024;-:1-5$15$MON$$M$Y$$$20240827$$MD$GR$GR
242533081$24253308$1$I$20200205$20240812$20240827$20240827$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464079$RANBAXY$$66$YR$$F$Y$$$20240827$$PH$PL$PL
242533091$24253309$1$I$$20240812$20240827$20240827$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464645$RANBAXY$Juneja P, Swor D. An Evidence-Based Approach to Diagnosis and Prognosis in a Young Woman with New-Onset Super-Refractory Status Epilepticus:A Case Report. Case Rep Neurol. 2022;14 (1):5-11$24$YR$$F$Y$$$20240827$$HP$US$US
242533101$24253310$1$I$$20240812$20240827$20240827$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464695$RANBAXY$Chin A, Butte M. Atypical Presentation of Stat1 Gain-Of-Function Characterized by Autoimmunity Without Chronic Mucocutaneous Candidiasis. Ann Allergy Asthma Immunol. 2023;131(Suppl.) (5):S159-S160(M272)$19$YR$$F$Y$$$20240827$$HP$US$US
242533111$24253311$1$I$$20240812$20240827$20240827$EXP$$UA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464501$RANBAXY$Bychkova S, Dyachenko V, Sydorova N, Petukhova I, Sydorova L. A case of successful treatment of diffuse post-coronavirus pulmonary fibrosis with pirfenidone. Polish Ann Med. 2023;30(2)$51$YR$$M$Y$$$20240827$$HP$UA$UA
242533121$24253312$1$I$$20240812$20240827$20240827$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464722$RANBAXY$Eizadi-Mood N, Khademi N, Haddad S, Aliabadi MG, Golshiri P, Meamar R. Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs. J Isfahan Med Sch. 2022;40 (692):857-864$$$$$Y$$$20240827$$HP$IR$IR
242533131$24253313$1$I$20240205$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464221$RANBAXY$$27$YR$$M$Y$82$KG$20240827$$MD$FR$FR
242533141$24253314$1$I$20240823$20240826$20240826$20240826$DIR$715871$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242533151$24253315$1$I$20240816$20240826$20240826$20240826$DIR$715889$$FDA-CTU$$72$YR$$F$N$79.4$KG$20240826$N$HP$US$
242533161$24253316$1$I$$20240812$20240827$20240827$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464502$RANBAXY$Eizadi-Mood N, Khademi N, Haddad S, Aliabadi MG, Golshiri P, Meamar R. Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs. J Isfahan Med Sch. 2022;40 (692):857-864$$$$$Y$$$20240827$$HP$IR$IR
242533171$24253317$1$I$$20240812$20240827$20240827$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464571$RANBAXY$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ Genom Precis Med. 2024;Apr; 17:e004353/164-165$14$YR$$M$Y$$$20240827$$MD$IT$IT
242533191$24253319$1$I$20240213$20240812$20240827$20240827$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464688$RANBAXY$$40$YR$$F$Y$62$KG$20240827$$CN$DE$DE
242533201$24253320$1$I$20240527$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463800$RANBAXY$$47$YR$$F$Y$61.2$KG$20240827$$MD$FR$FR
242533211$24253321$1$I$20240804$20240812$20240827$20240827$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464489$RANBAXY$$79$YR$$F$Y$$$20240827$$PH$GB$GB
242533221$24253322$1$I$$20240812$20240827$20240827$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464569$RANBAXY$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ Genom Precis Med. 2024;Apr; 17:e004353/164-165$14$YR$$M$Y$$$20240827$$MD$IT$IT
242533231$24253323$1$I$20240312$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464143$RANBAXY$$27$DY$$M$Y$$$20240827$$HP$FR$FR
242533241$24253324$1$I$20240518$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464199$RANBAXY$$37$YR$$F$Y$$$20240827$$HP$FR$FR
242533251$24253325$1$I$$20240812$20240827$20240827$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464495$RANBAXY$Eizadi-Mood N, Khademi N, Haddad S, Aliabadi MG, Golshiri P, Meamar R. Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs. J Isfahan Med Sch. 2022;40 (692):857-864$28$YR$$M$Y$$$20240827$$HP$IR$IR
242533261$24253326$1$I$$20240812$20240827$20240827$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464469$RANBAXY$Maruyama T, Kondo S, Nomura H. Case series of bradycardia, renal failure, atrioventricular nodal blockers, shock and hyperkalemia syndrome in patients with dementia. Geriatr Gerontol Int. 2024;24(7):737-738$94$YR$$M$Y$$$20240827$$HP$JP$JP
242533271$24253327$1$I$$20240812$20240827$20240827$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464438$RANBAXY$$$$$F$Y$$$20240827$$CN$GB$GB
242533281$24253328$1$I$$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464086$RANBAXY$$64$YR$$F$Y$109$KG$20240827$$MD$FR$FR
242533291$24253329$1$I$20240130$20240812$20240827$20240827$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464083$RANBAXY$$56$YR$$F$Y$$$20240827$$PH$PT$PT
242533301$24253330$1$I$20240319$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464652$RANBAXY$$62$YR$$M$Y$86$KG$20240827$$MD$FR$FR
242533311$24253331$1$I$20240618$20240812$20240827$20240827$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464398$RANBAXY$$72$YR$$M$Y$85$KG$20240827$$MD$GB$GB
242533332$24253333$2$F$$20240823$20240827$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464602$RANBAXY$Song L, Zhu N, Pan Y, Wang W, Gao Y, Yin Y, et al. Possible role of a malfunctioning immune system in discordant lymphoma with peripheral T-cell lymphoma secondary to classical Hodgkin lymphoma: A case report. Oncol Lett. 2024;28 (4):-$73$YR$$M$Y$$$20240906$$HP$CN$CN
242533341$24253334$1$I$$20240812$20240827$20240827$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464649$RANBAXY$Shaker N, Amadi CC, Welliver M, Otterson GA, Liebner DA, Shilo K. A Case of Mediastinal Carcinosarcoma With Beta-HCG Production and KRAS Mutation. Int J Surg Pathol. 2023;31:1598-1604$44$YR$$F$Y$$$20240827$$MD$US$US
242533351$24253335$1$I$$20240812$20240827$20240827$EXP$FR-EMA-DD-20240606-7482655-103230$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464215$RANBAXY$$34$YR$$F$Y$$$20240827$$MD$FR$FR
242533361$24253336$1$I$20240808$20240812$20240827$20240827$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463573$RANBAXY$$70$YR$E$F$Y$$$20240827$$MD$US$US
242533371$24253337$1$I$20060101$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464098$RANBAXY$$58$YR$$F$Y$$$20240827$$MD$FR$FR
242533381$24253338$1$I$$20240812$20240827$20240827$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464288$RANBAXY$$93$YR$$F$Y$$$20240827$$HP$GB$GB
242533391$24253339$1$I$$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464504$RANBAXY$Padovani P, Benbrik N, Baruteau A-E. Late aortic obstruction due to ductal vasoconstriction on pulmonic end after transcatheter patent ductus arteriosus closure in an extremely low-birth-weight infant. Cardiol Young. 2023;Apr; 33:2113-2115$27$WK$$M$Y$$$20240827$$HP$FR$FR
242533401$24253340$1$I$$20240812$20240827$20240827$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464575$RANBAXY$Bennati E, Capponi G, Favilli S, Girolami F, Gozzini A, Spaziani G, et al. Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy. Circ Genom Precis Med. 2024;Apr; 17:e004353/164-165$10$YR$$M$Y$$$20240827$$MD$IT$IT
242533411$24253341$1$I$20221101$20240812$20240827$20240827$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464244$RANBAXY$$79$YR$$M$Y$$$20240827$$PH$IT$IT
242533431$24253343$1$I$20240229$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463779$RANBAXY$$$$$$Y$$$20240827$$MD$FR$FR
242533441$24253344$1$I$20230717$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464461$RANBAXY$$55$YR$$M$Y$75$KG$20240827$$MD$FR$FR
242533452$24253345$2$F$$20240822$20240827$20240906$EXP$$FR-ALXN-202408EEA001469FR$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240906$$PH$FR$FR
242533461$24253346$1$I$$20240812$20240827$20240827$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464654$RANBAXY$$57$YR$$M$Y$$$20240827$$CN$IT$IT
242533471$24253347$1$I$20240101$20240820$20240827$20240827$EXP$$NL-JNJFOC-20240856244$JOHNSON AND JOHNSON$$55$YR$A$F$Y$52.1$KG$20240827$$MD$NL$NL
242533481$24253348$1$I$20240601$20240819$20240827$20240827$PER$$US-ROCHE-10000061165$ROCHE$$75$YR$E$F$Y$86.18$KG$20240827$$CN$US$US
242533491$24253349$1$I$$20240825$20240827$20240827$PER$$NVSC2024US172476$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
242533502$24253350$2$F$$20240903$20240827$20240910$EXP$$NVSC2024BR171626$NOVARTIS$$93$YR$$F$Y$$$20240910$$CN$BR$BR
242533512$24253351$2$F$20240626$20240826$20240827$20240829$EXP$FR-AFSSAPS-LL2024001626$NVSC2024FR171820$NOVARTIS$$35$YR$$F$Y$$$20240829$$MD$FR$FR
242533522$24253352$2$F$$20240926$20240827$20240926$30DAY$$US-PFIZER INC-PV202400106806$PFIZER$$$$$M$Y$$$20240926$$CN$US$US
242533542$24253354$2$F$$20240926$20240827$20240926$30DAY$$US-PFIZER INC-202400241528$PFIZER$$$$$$Y$$$20240926$$CN$US$US
242533552$24253355$2$F$$20240926$20240827$20240926$30DAY$$US-PFIZER INC-202400241424$PFIZER$$13$YR$$M$Y$$$20240926$$CN$US$US
242533561$24253356$1$I$$20240812$20240827$20240827$EXP$$US-ITALFARMACO SPA-2160903$ITALFARMACO$$63$YR$$F$Y$$$20240827$$$US$US
242533571$24253357$1$I$20200101$20240815$20240827$20240827$EXP$$CA-Accord-442608$ACCORD$Dery C, Labrecque G, Bouchard M. Oral Levodopa, Vitamin B6, and Polyneuropathy: A Case Series. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2024;51(3):472-3.$81$YR$E$F$Y$$$20240827$$MD$CA$CA
242533581$24253358$1$I$$20240814$20240827$20240827$EXP$$US-ITALFARMACO SPA-2160904$ITALFARMACO$$62$YR$$M$Y$$$20240827$$$US$US
242533592$24253359$2$F$20240813$20240815$20240827$20240930$EXP$$CA-PFIZER INC-202400236502$PFIZER$$40$YR$$F$Y$$$20240930$$HP$CA$CA
242533601$24253360$1$I$20240803$20240815$20240827$20240827$EXP$$US-Accord-442406$ACCORD$$53$YR$A$M$Y$$$20240827$$HP$US$US
242533611$24253361$1$I$20240104$20240815$20240827$20240827$EXP$FR-AFSSAPS-MA2024001171$FR-Accord-442047$ACCORD$$52$YR$A$F$Y$58$KG$20240827$$PH$FR$FR
242533621$24253362$1$I$20230401$20240816$20240827$20240827$EXP$FR-AFSSAPS-LM2024000440$FR-Accord-442587$ACCORD$$76$YR$E$F$Y$39.5$KG$20240827$$MD$FR$FR
242533631$24253363$1$I$$20240815$20240827$20240827$EXP$$PT-Accord-442540$ACCORD$Governa J, Marques B, Avelar P, Ribeiro M, Simoes L, Borges S, et al. PO0116 - (4016) - Drug Intoxication By Quetiapine - Beyond Anamnesis. Emergency, intermediate care and the critically ill, Clinical case. 2024:486.$61$YR$A$F$Y$$$20240827$$HP$PT$PT
242533641$24253364$1$I$20231225$20240815$20240827$20240827$EXP$GB-MHRA-TPP12271851C7216619YC1723634581216$GB-Accord-441964$ACCORD$$79$YR$E$F$Y$65$KG$20240827$$MD$GB$GB
242533661$24253366$1$I$20240814$20240815$20240827$20240827$EXP$$US-BAYER-2024A118050$BAYER$$33$YR$A$F$Y$$$20240827$$MD$US$US
242533671$24253367$1$I$$20240820$20240827$20240827$EXP$$JP-AMGEN-JPNSP2024167053$AMGEN$$95$YR$E$F$Y$$$20240827$$HP$JP$JP
242533681$24253368$1$I$20240817$20240818$20240827$20240827$EXP$GB-MHRA-MED-202408181219054660-JHCSB$GB-TEVA-VS-3234870$TEVA$$24$YR$$F$Y$50$KG$20240827$$CN$GB$GB
242533691$24253369$1$I$20220401$20240823$20240827$20240827$EXP$FR-AFSSAPS-MA2024001374$FR-GILEAD-2024-0685166$GILEAD$$72$YR$E$F$Y$$$20240827$$HP$FR$FR
242533701$24253370$1$I$$20240819$20240827$20240827$30DAY$$US-PFIZER INC-202400238582$PFIZER$$10$YR$$F$Y$$$20240827$$CN$US$US
242533712$24253371$2$F$20240701$20240904$20240827$20240906$EXP$$CA-PFIZER INC-202400220730$PFIZER$$52$YR$$M$Y$$$20240906$$HP$CA$CA
242533741$24253374$1$I$$20211018$20240827$20240827$EXP$$AU-TERSERA THERAPEUTICS LLC-2021TRS005076$TERSERA THERAPEUTICS$$$$$$Y$$$20240827$$CN$AU$AU
242533753$24253375$3$F$$20240926$20240827$20240930$30DAY$$US-PFIZER INC-202400237234$PFIZER$$14$YR$$M$Y$49.887$KG$20240930$$CN$US$US
242533761$24253376$1$I$$20240816$20240827$20240827$PER$$US-TAKEDA-2024TUS082989$TAKEDA$$$$$M$Y$$$20240827$$CN$US$US
242533781$24253378$1$I$$20240819$20240827$20240827$30DAY$$US-GSK-US2024103416$GLAXOSMITHKLINE$$$$$M$Y$$$20240827$$CN$US$US
242533791$24253379$1$I$20240525$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464250$RANBAXY$$51$YR$$M$Y$$$20240827$$PH$FR$FR
242533801$24253380$1$I$20240519$20240812$20240827$20240827$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464239$RANBAXY$$52$YR$$M$Y$$$20240827$$PH$IT$IT
242533811$24253381$1$I$20240101$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463803$RANBAXY$$82$YR$$F$Y$63$KG$20240827$$PH$FR$FR
242533822$24253382$2$F$$20240816$20240827$20240830$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464697$RANBAXY$Alsaati N, Lee J, Jyonouchi S. REFRACTORY EARLY ONSET SYSTEMIC LUPUS ERYTHEMATOSUS DUE C1Q DEFICIENCY. Ann Allergy Asthma Immunol. 2023;131(Suppl.) (5):S160/M274$$$I$M$Y$$$20240830$$HP$US$US
242533831$24253383$1$I$$20240812$20240827$20240827$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463735$RANBAXY$$66$YR$$F$Y$$$20240827$$HP$GB$GB
242533841$24253384$1$I$20240521$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463797$RANBAXY$$91$YR$$F$Y$$$20240827$$MD$FR$FR
242533851$24253385$1$I$$20240812$20240827$20240827$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463989$RANBAXY$$79$YR$$F$Y$75$KG$20240827$$PH$PL$PL
242533861$24253386$1$I$20240129$20240812$20240827$20240827$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464392$RANBAXY$$69$YR$$F$Y$$$20240827$$MD$ES$ES
242533871$24253387$1$I$20240525$20240812$20240827$20240827$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464206$RANBAXY$$73$YR$$M$Y$$$20240827$$MD$IT$IT
242533881$24253388$1$I$20240525$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464274$RANBAXY$$83$YR$$F$Y$49.9$KG$20240827$$PH$FR$FR
242533892$24253389$2$F$$20240830$20240827$20240913$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464574$RANBAXY$Prasad P, Corsten MN, Shebak SS, Makki Y. A Rare Case of Phentermine-Related Tardive Dyskinesia. Prim Care Companion CNS Disord. 2024;26 (3):1-2, 24cr03710$79$YR$$F$Y$$$20240913$$MD$IN$IN
242533901$24253390$1$I$20240523$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464124$RANBAXY$$81$YR$$F$Y$$$20240827$$PH$FR$FR
242533911$24253391$1$I$20240716$20240823$20240827$20240827$EXP$SE-SEMPA-2024-006256$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-134245$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240827$$MD$SE$SE
242533921$24253392$1$I$$20240812$20240827$20240827$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464116$RANBAXY$Yoshitani S, Kaneda K, Nishida M, Komura K, Moriwaki S, Fukunaga A. A case of urothelial carcinoma with successful continuation of enfortumab vedotin without dose reduction despite grade 3 diffuse erythema with fever. Eur J Dermatol. 2024;34 (2):214-216$71$YR$$M$Y$$$20240827$$HP$JP$JP
242533931$24253393$1$I$$20240812$20240827$20240827$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464142$RANBAXY$He W, Jape D, Nanayakkara S, Shaw J. Adherence to Statin Therapy Post Percutaneous Coronary Intervention Amongst Patients Presenting With Recurrent Acute Coronary Syndrome. Heart Lung Circ. 2024;33 (Suppl.):S506$$$$$Y$$$20240827$$HP$AU$AU
242533941$24253394$1$I$$20240812$20240827$20240827$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464500$RANBAXY$Eizadi-Mood N, Khademi N, Haddad S, Aliabadi MG, Golshiri P, Meamar R. Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs. J Isfahan Med Sch. 2022;40 (692):857-864$28$YR$$F$Y$$$20240827$$HP$IR$IR
242533951$24253395$1$I$20240402$20240812$20240827$20240827$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464395$RANBAXY$$58$YR$$F$Y$$$20240827$$MD$ES$ES
242533962$24253396$2$F$$20240904$20240827$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464498$RANBAXY$Rui H, Wenlong Q, Xihong Z, Longhai Z, Li L, Jianfeng X, et al. Management of immunocompromised renal transplant patients infected with coronavirus disease 2019. Chin Crit Care Med. 2022;May; 34(5):492-496$49$YR$$M$Y$$$20240919$$HP$CN$CN
242533971$24253397$1$I$$20240826$20240826$20240826$DIR$715896$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242533981$24253398$1$I$$20240823$20240827$20240827$EXP$$US-BAYER-2024A122120$BAYER$$70$YR$E$F$Y$$$20240827$$MD$US$US
242533991$24253399$1$I$$20240826$20240826$20240826$DIR$715897$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242534012$24253401$2$F$20240101$20240910$20240827$20240923$EXP$$US-UCBSA-2024043269$UCB$$$$$M$Y$$$20240923$$CN$US$US
242534021$24253402$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-081686-2024$RECKITT BENCKISER$$$$$F$Y$$$20240827$$CN$US$US
242534031$24253403$1$I$20240821$20240826$20240826$20240826$DIR$715888$$FDA-CTU$$52$YR$$M$N$98.1$KG$20240826$N$CN$US$
242534061$24253406$1$I$20240609$20240820$20240827$20240827$EXP$ES-AEMPS-1561634$ES-JNJFOC-20240853961$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240827$$MD$ES$ES
242534071$24253407$1$I$$20240822$20240827$20240827$PER$$US-JNJFOC-20240857920$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240827$$MD$US$US
242534081$24253408$1$I$$20240819$20240827$20240827$EXP$$JP-EXELIXIS-CABO-24080802$EXELIXIS$$8$DEC$$M$Y$$$20240827$$MD$JP$JP
242534091$24253409$1$I$$20240822$20240827$20240827$PER$$US-ROCHE-10000065143$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242534101$24253410$1$I$20240823$20240826$20240827$20240827$EXP$$US-BAYER-2024A122471$BAYER$$42$YR$A$F$Y$$$20240827$$HP$US$US
242534111$24253411$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A188879$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242534122$24253412$2$F$$20240821$20240827$20240829$EXP$$US-AstraZeneca-2024A190889$ASTRAZENECA$$$$$M$Y$$$20240829$$MD$US$
242534131$24253413$1$I$20240801$20240821$20240827$20240827$EXP$$US-ALKERMES INC.-ALK-2024-002188$ALKERMES$$33$YR$$M$Y$57.596$KG$20240827$$HP$US$US
242534141$24253414$1$I$20240701$20240822$20240827$20240827$EXP$$ZA-AstraZeneca-2024A192881$ASTRAZENECA$$67$YR$$M$Y$$$20240827$$CN$ZA$
242534151$24253415$1$I$20220518$20240823$20240827$20240827$EXP$FR-AFSSAPS-MA2024001372$FR-GILEAD-2024-0685173$GILEAD$$75$YR$E$F$Y$$$20240827$$HP$FR$FR
242534161$24253416$1$I$$20240823$20240827$20240827$EXP$$GB-PFIZER INC-PV202400110379$PFIZER$$$$$F$Y$$$20240827$$CN$GB$GB
242534171$24253417$1$I$20240803$20240819$20240827$20240827$EXP$$US-PFIZER INC-202400240299$PFIZER$$10$YR$$M$Y$22.68$KG$20240827$$CN$US$US
242534181$24253418$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A188778$ASTRAZENECA$$$$$$Y$$$20240827$$CN$US$
242534191$24253419$1$I$$20240819$20240827$20240827$EXP$$CN-AstraZeneca-2024A189516$ASTRAZENECA$$$$E$F$Y$52.8$KG$20240827$$MD$CN$
242534201$24253420$1$I$$20240816$20240827$20240827$PER$$US-ABBVIE-5886570$ABBVIE$$$$$M$Y$$$20240827$$HP$US$US
242534211$24253421$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015396$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240827$$CN$US$US
242534221$24253422$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015594$ELI LILLY AND CO$$$$$$Y$$$20240827$$PH$US$US
242534231$24253423$1$I$$20240815$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408010161$ELI LILLY AND CO$$42$YR$A$$Y$$$20240827$$LW$US$US
242534241$24253424$1$I$20240401$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015448$ELI LILLY AND CO$$45$YR$A$$Y$$$20240827$$CN$US$US
242534251$24253425$1$I$$20240816$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015099$ELI LILLY AND CO$$$$$M$Y$$$20240827$$CN$US$US
242534261$24253426$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015249$ELI LILLY AND CO$$$$E$M$Y$$$20240827$$CN$US$US
242534271$24253427$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015900$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240827$$CN$US$US
242534282$24253428$2$F$$20240910$20240827$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202408016193$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240912$$CN$US$US
242534291$24253429$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014457$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240827$$CN$US$US
242534301$24253430$1$I$$20240814$20240827$20240827$EXP$$US-B.Braun Medical Inc.-2160905$B BRAUN$Literature Article$68$YR$$M$Y$$$20240827$$$US$US
242534311$24253431$1$I$20240101$20240821$20240827$20240827$EXP$$US-ALKERMES INC.-ALK-2024-002200$ALKERMES$$$$$M$Y$$$20240827$$CN$US$US
242534321$24253432$1$I$$20240731$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07781$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242534341$24253434$1$I$20240701$20240731$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07753$LUPIN$$$$$$Y$$$20240827$$PH$US$US
242534351$24253435$1$I$20240406$20240815$20240827$20240827$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000830$PAREXEL$$$$$$Y$$$20240827$$HP$CN$CN
242534361$24253436$1$I$20211014$20240813$20240827$20240827$EXP$$US-COOPERSURGICAL, INC.-2024CPS002513$COOPERSURGICAL$$$$$F$Y$$$20240827$$LW$US$US
242534372$24253437$2$F$20240817$20240828$20240827$20240902$PER$$US-AMGEN-USASP2024169993$AMGEN$$59$YR$A$F$Y$$$20240902$$PH$US$US
242534382$24253438$2$F$$20240830$20240827$20240909$EXP$$US-TEVA-VS-3235620$TEVA$Dennee A, Fogarty TP, Howard TS, Hunter RB. Sinus Arrest Related to Dexmedetomidine Infusion in an Infant; a Case Report and Review of Current Literature. [Review]. J-Pharm-Pract 2023; 37 (4): 1026-1031.; Dennee A, Fogarty TP, Howard TS, Hunter RB. Sinus Arrest Related to Dexmedetomidine Infusion in an Infant; a Case Report and Review of Current Literature. [Review]. J-Pharm-Pract 2023; 37 (4): 1026-1031.$11$MON$$F$Y$$$20240909$$MD$US$US
242534391$24253439$1$I$20240823$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169687$AMGEN$$53$YR$A$M$Y$$$20240827$$CN$US$US
242534411$24253441$1$I$20240819$20240823$20240827$20240827$EXP$$CA-JNJFOC-20240863944$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20240827$$CN$CA$CA
242534421$24253442$1$I$20200324$20240812$20240827$20240827$EXP$$FR-SERVIER-S24001922$SERVIER$$$$$$Y$$$20240827$$MD$FR$FR
242534431$24253443$1$I$$20240822$20240827$20240827$EXP$$DE-ABBVIE-5895154$ABBVIE$$$$$F$Y$$$20240827$$MD$DE$DE
242534442$24253444$2$F$20240819$20240828$20240827$20240904$EXP$$CO-GSK-CO2024AMR106065$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$CO$CO
242534451$24253445$1$I$$20240815$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041957$AUROBINDO$$35$YR$$M$Y$$$20240827$$HP$CA$CA
242534471$24253447$1$I$20240801$20240820$20240827$20240827$EXP$RO-NMA-2024-SP0540$RO-ROCHE-10000062526$ROCHE$$68$YR$E$F$Y$66$KG$20240827$$MD$RO$RO
242534481$24253448$1$I$$20240820$20240827$20240827$EXP$$BR-ROCHE-10000061812$ROCHE$$17$YR$T$F$Y$$$20240827$$MD$BR$BR
242534491$24253449$1$I$$20240813$20240827$20240827$EXP$JP-MLMSERVICE-20240808-PI153824-00232-1$JP-ROCHE-10000056123$ROCHE$Kou R, Onishi Y, Ogiso S, Kai S, Nakamoto Y. Emphysematous osteomyelitis of the lumbar spine and sacrum after liver transplantation: A case report. Cureus. 2024;16(7):e63748. DOI:10.7759/cureus.63748.$62$YR$A$M$Y$$$20240827$$HP$JP$JP
242534501$24253450$1$I$$20240822$20240827$20240827$EXP$$US-MYLANLABS-2024M1078636$MYLAN$Bdiwi M, Ramaseshan K, Uddin M, Goel M, Razzaq S, Alrayyashi M, et al. Carcinoid heart disease: A potentially fatal complication of carcinoid syndrome. BMJ-Case-Rep 2023; 16 (12): 1-5.$6$DEC$$M$Y$$$20240827$$MD$US$US
242534511$24253451$1$I$20140214$20240816$20240827$20240827$EXP$$US-ROCHE-10000059912$ROCHE$$32$YR$A$F$Y$92.53$KG$20240827$$CN$US$US
242534521$24253452$1$I$$20240821$20240827$20240827$EXP$$GB-ROCHE-10000062906$ROCHE$$$$$M$Y$$$20240827$$MD$GB$GB
242534531$24253453$1$I$$20240822$20240827$20240827$EXP$$US-MYLANLABS-2024M1078815$MYLAN$$$$$F$Y$$$20240827$$CN$US$US
242534542$24253454$2$F$$20240830$20240827$20240904$PER$$US-TRAVERE-2024TVT00829$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240904$$CN$US$US
242534552$24253455$2$F$20240101$20240822$20240827$20240904$PER$$DE-TRAVERE-2024TVT00833$TRAVERE THERAPEUTICS$$25$YR$A$M$Y$76$KG$20240904$$HP$DE$DE
242534562$24253456$2$F$$20240906$20240827$20240910$EXP$$DE-UNITED THERAPEUTICS-UNT-2024-026623$UNITED THERAPEUTICS$$$$E$$Y$$$20240910$$$DE$DE
242534581$24253458$1$I$$20240815$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-041890$AUROBINDO$$56$YR$$F$Y$69$KG$20240827$$MD$CA$CA
242534591$24253459$1$I$20240820$20240820$20240827$20240827$EXP$$DE-BAXTER-2024BAX023676$BAXTER$$66$YR$$M$Y$$$20240827$$HP$DE$DE
242534603$24253460$3$F$$20240926$20240827$20240926$30DAY$$US-PFIZER INC-202400235016$PFIZER$$15$YR$$M$Y$$$20240926$$CN$US$US
242534613$24253461$3$F$$20240926$20240827$20240926$30DAY$$US-PFIZER INC-202400239776$PFIZER$$16$YR$$M$Y$$$20240926$$CN$US$US
242534622$24253462$2$F$$20240917$20240827$20240920$30DAY$$US-PFIZER INC-202400241703$PFIZER$$15$YR$$M$Y$$$20240920$$CN$US$US
242534631$24253463$1$I$20240701$20240823$20240827$20240827$PER$$US-ABBVIE-5893941$ABBVIE$$71$YR$$M$Y$$$20240827$$HP$US$US
242534641$24253464$1$I$$20240820$20240827$20240827$EXP$$AU-TAKEDA-2024TUS084450$TAKEDA$$$$$F$Y$$$20240827$$CN$AU$AU
242534651$24253465$1$I$20240806$20240826$20240827$20240827$EXP$$US-BAYER-2024A122499$BAYER$$$$$M$Y$$$20240827$$MD$US$US
242534661$24253466$1$I$$20240809$20240827$20240827$EXP$$KR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047952$BOEHRINGER INGELHEIM$$$$E$$Y$$$20240827$$MD$KR$KR
242534681$24253468$1$I$$20240817$20240827$20240827$PER$$US-ABBVIE-5887097$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242534691$24253469$1$I$20240101$20240822$20240827$20240827$EXP$$US-JNJFOC-20240859389$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240827$$CN$US$US
242534701$24253470$1$I$$20240731$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07754$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242534711$24253471$1$I$$20240820$20240827$20240827$EXP$$CA-SANDOZ INC.-NVSC2020CA091510$SANDOZ$$49$YR$$F$Y$$$20240827$$HP$CA$CA
242534722$24253472$2$F$$20240828$20240827$20240829$30DAY$$US-PFIZER INC-PV202400109270$PFIZER$$$$$M$Y$$$20240829$$CN$US$US
242534733$24253473$3$F$$20240930$20240827$20240930$30DAY$$US-PFIZER INC-202400238543$PFIZER$$12$YR$$F$Y$88.45$KG$20240930$$CN$US$US
242534761$24253476$1$I$$20240821$20240827$20240827$EXP$$US-PFIZER INC-202400242160$PFIZER$$61$YR$$F$Y$$$20240827$$HP$US$US
242534772$24253477$2$F$20240514$20240924$20240827$20240930$EXP$$CA-PFIZER INC-202300283320$PFIZER$$84$YR$$F$Y$154$KG$20240930$$CN$CA$CA
242534781$24253478$1$I$20240801$20240821$20240827$20240827$EXP$$US-PFIZER INC-202400242209$PFIZER$$62$YR$$F$Y$$$20240827$$HP$US$US
242534791$24253479$1$I$$20240821$20240827$20240827$EXP$$US-PFIZER INC-PV202400110084$PFIZER$$59$YR$$F$Y$$$20240827$$CN$US$US
242534813$24253481$3$F$20240801$20240927$20240827$20240927$30DAY$$US-PFIZER INC-202400241318$PFIZER$$13$YR$$F$Y$31.293$KG$20240927$$CN$US$US
242534824$24253482$4$F$$20240929$20240827$20240930$30DAY$$US-PFIZER INC-202400239983$PFIZER$$13$YR$$F$Y$$$20240930$$CN$US$US
242534832$24253483$2$F$$20240927$20240827$20240927$30DAY$$US-PFIZER INC-202400241265$PFIZER$$11$YR$$M$Y$$$20240927$$CN$US$US
242534843$24253484$3$F$$20240928$20240827$20240930$30DAY$$US-PFIZER INC-202400239385$PFIZER$$17$YR$$M$Y$$$20240930$$CN$US$US
242534851$24253485$1$I$20240616$20240819$20240827$20240827$EXP$ES-AEMPS-1561565$ES-PFIZER INC-202400243138$PFIZER$$73$YR$$F$Y$$$20240827$$MD$ES$ES
242534863$24253486$3$F$$20240925$20240827$20240930$30DAY$$US-PFIZER INC-202400239221$PFIZER$$12$YR$$M$Y$$$20240930$$HP$US$US
242534871$24253487$1$I$20240803$20240821$20240827$20240827$EXP$$CN-PFIZER INC-PV202400109294$PFIZER$$14$YR$$M$Y$$$20240827$$HP$CN$CN
242534882$24253488$2$F$20240801$20240924$20240827$20240926$EXP$$MX-PFIZER INC-202400242802$PFIZER$$55$YR$$F$Y$83$KG$20240926$$HP$MX$MX
242534901$24253490$1$I$$20240731$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07787$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242534913$24253491$3$F$20240624$20240826$20240827$20240910$EXP$$US-ALIMERA SCIENCES INC.-US-A16013-24-000461$ALIMERA$$75$YR$$F$Y$$$20240910$$MD$US$US
242534931$24253493$1$I$$20240813$20240827$20240827$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0328$GRAVITI PHARMACEUTICALS$Welch L, Maldonado L, Banadera F, Trapane P, Hasan R, Benson M, et al.Severe Hyperparathyroidism in a Newborn: Response to Cinacalcet.Journal of the Endocrine Society.2022;6 (1):A233$39$WK$I$F$Y$$$20240827$$MD$US$US
242534941$24253494$1$I$$20240812$20240827$20240827$PER$$US-AMGEN-USASP2024167969$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242534951$24253495$1$I$20220401$20240823$20240827$20240827$EXP$FR-AFSSAPS-MA2024001375$FR-GILEAD-2024-0685174$GILEAD$$44$YR$A$F$Y$$$20240827$$HP$FR$FR
242534961$24253496$1$I$$20240823$20240827$20240827$EXP$$GB-MYLANLABS-2024M1078474$MYLAN$$$$$F$Y$$$20240827$$CN$GB$GB
242534971$24253497$1$I$20240101$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168837$AMGEN$$40$YR$A$M$Y$$$20240827$$CN$US$US
242534981$24253498$1$I$20240822$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169690$AMGEN$$75$YR$E$M$Y$$$20240827$$CN$US$US
242534991$24253499$1$I$$20240819$20240827$20240827$PER$$US-AMGEN-USASP2024165576$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242535011$24253501$1$I$$20240624$20240827$20240827$EXP$$CA-AMGEN-CANSP2024169081$AMGEN$$40$YR$A$F$Y$$$20240827$$HP$CA$CA
242535021$24253502$1$I$20240101$20240815$20240827$20240827$EXP$SE-SEMPA-2024-005906$SE-Accord-442354$ACCORD$$30$YR$A$F$Y$$$20240827$$MD$SE$SE
242535031$24253503$1$I$20240807$20240815$20240827$20240827$EXP$$US-Accord-442666$ACCORD$$59$YR$A$F$Y$$$20240827$$HP$US$US
242535041$24253504$1$I$$20240815$20240827$20240827$EXP$$US-Accord-442729$ACCORD$Millien VO, Santana LA, Kolpakchi A, Lu L. Trading one for another: A case of de novo crohn^s disease after lung transplant. Journal of General Internal Medicine. 2016; 31:2(1):S769$71$YR$E$M$Y$$$20240827$$HP$US$US
242535051$24253505$1$I$$20240815$20240827$20240827$EXP$GB-MHRA-MED-202408150536153340-FDRHY$GB-Accord-441968$ACCORD$$$$$F$Y$$$20240827$$CN$GB$GB
242535061$24253506$1$I$$20240815$20240827$20240827$EXP$NL-LRB-00995812$NL-Accord-442316$ACCORD$$64$YR$A$F$Y$64$KG$20240827$$CN$NL$NL
242535071$24253507$1$I$20240707$20240815$20240827$20240827$EXP$FR-AFSSAPS-GR2024000978$FR-Accord-442285$ACCORD$$65$YR$E$F$Y$114$KG$20240827$$MD$FR$FR
242535081$24253508$1$I$20200101$20240815$20240827$20240827$EXP$$DE-Accord-442613$ACCORD$Hollein A., Bojko P., Schulz S., Neitz J., Stotzer O., Pihusch R., et al. Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study. Acta Oncol. 2021 60:1 (24-27).$42$YR$A$F$Y$$$20240827$$MD$DE$DE
242535091$24253509$1$I$20240516$20240823$20240827$20240827$EXP$$US-BAYER-2024A122038$BAYER$$25$YR$A$F$Y$$$20240827$$MD$US$US
242535101$24253510$1$I$$20240819$20240827$20240827$EXP$NL-LRB-00996238$NL-TEVA-VS-3235125$TEVA$$28$YR$$M$Y$88$KG$20240827$$CN$NL$NL
242535111$24253511$1$I$20240823$20240823$20240827$20240827$EXP$$SG-VANTIVE-2024VAN019263$Vantive US Healthcare$$76$YR$$M$Y$$$20240827$$CN$SG$SG
242535121$24253512$1$I$20240802$20240820$20240827$20240827$EXP$IT-MINISAL02-998877$IT-009507513-2408ITA007497$MERCK$$55$YR$$F$Y$$$20240827$$MD$IT$IT
242535131$24253513$1$I$20240820$20240823$20240827$20240827$EXP$$SG-VANTIVE-2024VAN019271$Vantive US Healthcare$$72$YR$$M$Y$$$20240827$$CN$SG$SG
242535141$24253514$1$I$$20240823$20240827$20240827$EXP$$DE-MYLANLABS-2024M1078359$MYLAN$$$$E$F$Y$$$20240827$$CN$DE$DE
242535151$24253515$1$I$20221111$20240823$20240827$20240827$EXP$$AR-MYLANLABS-2024M1004479$MYLAN$$17$YR$$M$Y$$$20240827$$CN$AR$AR
242535161$24253516$1$I$$20240823$20240827$20240827$EXP$GB-MHRA-MED-202408231918201240-SFTWV$GB-MYLANLABS-2024M1078655$MYLAN$$4$YR$$F$Y$16$KG$20240827$$CN$GB$GB
242535171$24253517$1$I$$20240807$20240827$20240827$PER$$US-TEVA-VS-3231936$TEVA$$$$$$Y$$$20240827$$PH$US$US
242535181$24253518$1$I$20240811$20240816$20240827$20240827$EXP$$US-MYLANLABS-2024M1077394$MYLAN$$78$YR$$F$Y$81.6$KG$20240827$$HP$US$US
242535211$24253521$1$I$$20240821$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US074773$SANDOZ$$$$$M$Y$$$20240827$$MD$US$US
242535221$24253522$1$I$$20240813$20240827$20240827$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0329$GRAVITI PHARMACEUTICALS$$17$YR$T$F$Y$$$20240827$$HP$US$US
242535241$24253524$1$I$$20240815$20240827$20240827$EXP$$BR-Accord-442526$ACCORD$Honorato CM, Carrascoza GG, Abed NM, Moya FG. Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor. Anais brasileiros de dermatologia. 2024$72$YR$E$M$Y$$$20240827$$MD$BR$BR
242535252$24253525$2$F$20240814$20240912$20240827$20240924$EXP$$US-Accord-442401$ACCORD$$69$YR$E$F$Y$$$20240924$$HP$US$US
242535261$24253526$1$I$20230818$20240815$20240827$20240827$EXP$PL-URPL-DML-MLP.4401.1.814.2023$PL-Accord-442298$ACCORD$$67$YR$E$M$Y$$$20240827$$MD$PL$PL
242535271$24253527$1$I$20240416$20240815$20240827$20240827$EXP$FR-AFSSAPS-PA2024001277$FR-Accord-442292$ACCORD$$79$YR$E$F$Y$75$KG$20240827$$PH$FR$FR
242535281$24253528$1$I$$20240815$20240827$20240827$EXP$$BR-Accord-442528$ACCORD$Honorato CM, Carrascoza GG, Abed NM, Moya FG. Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor.  Anais brasileiros de dermatologia. 2024 . DOI:10.1016/j.abd.2023.10.006.$60$YR$A$M$Y$$$20240827$$MD$BR$BR
242535291$24253529$1$I$$20240822$20240827$20240827$EXP$$DE-MYLANLABS-2024M1077971$MYLAN$Groth, Olwen; Roider, Gabriele; Graw, Matthias.. Drug-induced deaths in renal insufficiency. M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166(13):48-51$67$YR$$M$Y$$$20240827$$HP$DE$DE
242535301$24253530$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189044$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242535311$24253531$1$I$20240801$20240823$20240827$20240827$EXP$$CN-ROCHE-10000065487$ROCHE$$40$YR$A$M$Y$75$KG$20240827$$HP$CN$CN
242535321$24253532$1$I$$20240822$20240827$20240827$PER$$US-ROCHE-10000064522$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242535331$24253533$1$I$20240715$20240821$20240827$20240827$EXP$$US-009507513-2408USA007385$MERCK$$74$YR$$F$Y$$$20240827$$HP$US$US
242535341$24253534$1$I$20231212$20240816$20240827$20240827$EXP$$IN-ROCHE-10000051165$ROCHE$$$$$F$Y$$$20240827$$MD$IN$IN
242535354$24253535$4$F$$20240928$20240827$20240930$30DAY$$AR-PFIZER INC-202400242710$PFIZER$$15$YR$$F$Y$$$20240930$$CN$AR$AR
242535361$24253536$1$I$$20240820$20240827$20240827$EXP$NL-LRB-00994791$NL-TEVA-VS-3235504$TEVA$$22$YR$$F$Y$52$KG$20240827$$CN$NL$NL
242535371$24253537$1$I$$20240815$20240827$20240827$EXP$$GB-AUROBINDO-AUR-APL-2024-040510$AUROBINDO$$$$$M$Y$$$20240827$$PH$GB$GB
242535381$24253538$1$I$20240801$20240818$20240827$20240827$30DAY$$GB-PFIZER INC-PV202400109125$PFIZER$$16$YR$$M$Y$$$20240827$$CN$GB$GB
242535391$24253539$1$I$20240821$20240822$20240827$20240827$30DAY$$CO-PFIZER INC-PV202400110402$PFIZER$$13$YR$$M$Y$$$20240827$$CN$CO$CO
242535411$24253541$1$I$$20240822$20240827$20240827$EXP$$AR-PFIZER INC-202400239258$PFIZER$$10$YR$$F$Y$$$20240827$$CN$AR$AR
242535421$24253542$1$I$$20240822$20240827$20240827$PER$$US-LEO Pharma-372981$LEO PHARM$$44$YR$$F$Y$$$20240827$$PH$US$US
242535432$24253543$2$F$$20240910$20240827$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07780$LUPIN$$$$$$Y$$$20240921$$CN$US$US
242535442$24253544$2$F$20240401$20240822$20240827$20240903$EXP$$SG-MYLANLABS-2024M1078021$MYLAN$$54$YR$$F$Y$$$20240903$$HP$SG$SG
242535451$24253545$1$I$20240821$20240822$20240827$20240827$EXP$GB-MHRA-MED-202408221624042960-LPFHY$GB-MYLANLABS-2024M1078002$MYLAN$$45$YR$$F$Y$68$KG$20240827$$MD$GB$GB
242535475$24253547$5$F$20230101$20240923$20240827$20240926$PER$$US-ROCHE-10000065331$ROCHE$$62$YR$A$F$Y$88.45$KG$20240926$$CN$US$US
242535481$24253548$1$I$$20240819$20240827$20240827$EXP$$ID-BAUSCH-BL-2024-012813$BAUSCH AND LOMB$Permatasanti A, Sufiawati I. Case Series of HIV-Associated Oral Lesions Across Different Clinical Stages in People Living with HIV. HIV/AIDS-Research and Palliative Care. 2024 JUL 26;16:289-299. doi:10.2147/HIV.S478366$11$YR$$F$Y$$$20240827$$HP$ID$ID
242535492$24253549$2$F$20240308$20240908$20240827$20240910$EXP$FR-AFSSAPS-AVMA2024000349$FR-BAUSCH-BL-2024-012853$BAUSCH AND LOMB$$32$YR$$M$Y$$$20240910$$PH$FR$FR
242535501$24253550$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-083521-2024$RECKITT BENCKISER$$$$$M$Y$$$20240827$$CN$US$US
242535512$24253551$2$F$$20240917$20240827$20240927$EXP$$CA-APOTEX-2024AP009552$APOTEX$$$$$F$Y$$$20240927$$HP$CA$CA
242535521$24253552$1$I$$20240731$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07788$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242535532$24253553$2$F$$20240828$20240827$20240829$PER$$NVSC2024US172407$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
242535542$24253554$2$F$$20240903$20240827$20240909$EXP$$CA-TAKEDA-2024TUS084579$TAKEDA$$$$$M$Y$$$20240909$$CN$CA$CA
242535551$24253555$1$I$20240612$20240822$20240827$20240827$EXP$ES-AEMPS-1560503$ES-CHEPLA-2024010906$CHEPLAPHARM$$59$YR$$M$Y$$$20240827$$MD$COUNTRY NOT SPECIFIED$ES
242535561$24253556$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3235039$TEVA$$56$YR$$M$Y$$$20240827$$HP$CA$CA
242535572$24253557$2$F$20240409$20240827$20240827$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-034594$AUROBINDO$$77$YR$$M$Y$81.9$KG$20240905$$PH$FR$FR
242535591$24253559$1$I$20240514$20240822$20240827$20240827$EXP$FR-AFSSAPS-CN2024000729$FR-CHEPLA-2024010975$CHEPLAPHARM$$79$YR$$F$Y$60$KG$20240827$$MD$COUNTRY NOT SPECIFIED$FR
242535602$24253560$2$F$20240405$20240904$20240827$20240911$EXP$$CA-TAKEDA-2024TUS084752$TAKEDA$$19$YR$$M$Y$$$20240911$$CN$CA$CA
242535611$24253561$1$I$20240730$20240730$20240827$20240827$PER$$US-CSL-2024-007239$CSL Plasma$$24$YR$$M$Y$$$20240827$$HP$US$US
242535652$24253565$2$F$$20240918$20240827$20240920$30DAY$$CH-PFIZER INC-202400243667$PFIZER$$62$YR$$F$Y$80$KG$20240920$$CN$CH$CH
242535662$24253566$2$F$$20240823$20240827$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA075199$SANDOZ$$76$YR$$M$Y$$$20240830$$CN$CA$CA
242535671$24253567$1$I$20240101$20240816$20240827$20240827$30DAY$$KR-PFIZER INC-PV202400107491$PFIZER$$7$YR$$F$Y$$$20240827$$HP$KR$KR
242535682$24253568$2$F$20240715$20240827$20240827$20240829$EXP$$US-ABBVIE-5891788$ABBVIE$$67$YR$$F$Y$$$20240829$$CN$US$US
242535691$24253569$1$I$20231201$20240815$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408010873$ELI LILLY AND CO$$$$A$F$Y$$$20240827$$MD$US$US
242535701$24253570$1$I$$20240826$20240827$20240827$PER$$US-HALEON-2193728$Haleon PLC$$80$YR$$F$Y$$$20240827$$CN$US$US
242535711$24253571$1$I$$20240823$20240827$20240827$EXP$$US-KAMADA LIMITED-2017US012436$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
242535721$24253572$1$I$20240822$20240822$20240827$20240827$EXP$$CN-PFIZER INC-PV202400109971$PFIZER$$27$YR$$F$Y$$$20240827$$HP$CN$CN
242535731$24253573$1$I$$20240819$20240827$20240827$EXP$$BE-SA-2024SA239126$SANOFI AVENTIS$$$$$F$Y$$$20240827$$PH$BE$BE
242535742$24253574$2$F$20171106$20240828$20240827$20240912$EXP$$FR-SERVIER-S24010293$SERVIER$$$$$$Y$$$20240912$$MD$FR$FR
242535751$24253575$1$I$$20240819$20240827$20240827$EXP$$CA-APOTEX-2024AP009590$APOTEX$$46$YR$$F$Y$$$20240827$$MD$CA$CA
242535761$24253576$1$I$$20240814$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-042277$AUROBINDO$$80$YR$$F$Y$96.16$KG$20240827$$MD$US$US
242535771$24253577$1$I$20240801$20240826$20240827$20240827$EXP$$JP-GILEAD-2024-0685266$GILEAD$$87$YR$E$F$Y$$$20240827$$PH$JP$JP
242535783$24253578$3$F$20240820$20240904$20240827$20240905$PER$$US-AMGEN-USASP2024169841$AMGEN$$71$YR$E$M$Y$$$20240905$$CN$US$US
242535791$24253579$1$I$20240716$20240822$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134868$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240827$$CN$US$US
242535801$24253580$1$I$$20240819$20240827$20240827$EXP$$US-TEVA-VS-3235280$TEVA$$$$$$Y$$$20240827$$HP$US$US
242535813$24253581$3$F$20240803$20240828$20240827$20240905$EXP$$GB-BLUEPRINT MEDICINES CORPORATION-2024BUS004492$Unknown Manufacturer$$$$$$Y$$$20240903$$PH$GB$GB
242535822$24253582$2$F$20240701$20240827$20240827$20240828$EXP$$US-PFIZER INC-PV202400003439$PFIZER$$74$YR$$F$Y$96.4$KG$20240828$$HP$US$US
242535832$24253583$2$F$$20240903$20240827$20240906$EXP$$PH-PFIZER INC-2024SGN02325$PFIZER$$52$YR$$M$Y$$$20240906$$CN$PH$PH
242535841$24253584$1$I$20240701$20240731$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07802$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242535851$24253585$1$I$$20240815$20240827$20240827$EXP$$CA-AUROBINDO-AUR-APL-2024-042002$AUROBINDO$Shi T, Shea LJ.. A case of fatal overdose involving both hydromorphone and kratom. J Forensic Sci. 2023$44$YR$$M$Y$$$20240827$$MD$CA$CA
242535861$24253586$1$I$20160902$20240819$20240827$20240827$EXP$$CA-PFIZER INC-202400063308$PFIZER$$72$YR$$F$Y$$$20240827$$CN$CA$CA
242535891$24253589$1$I$$20240826$20240826$20240826$DIR$715931$$FDA-CTU$$$$$F$N$$$20240826$Y$HP$US$
242535912$24253591$2$F$20240201$20240910$20240827$20240920$EXP$$JP-INSMED, INC.-2024-03363-JP$INSMED$Michiko Yoshioka. Treatment of pulmonary MAC disease and regional cooperation in the Aira-Kirishima area. Seminar. 2024$8$DEC$$F$Y$$$20240920$$HP$JP$JP
242535921$24253592$1$I$20240823$20240823$20240827$20240827$PER$$US-HALEON-2193561$Haleon PLC$$$$$F$Y$$$20240827$$CN$US$US
242535933$24253593$3$F$$20240827$20240827$20240904$PER$$US-HALEON-2193758$Haleon PLC$$38$YR$$F$Y$$$20240904$$CN$US$US
242535941$24253594$1$I$$20240820$20240827$20240827$PER$$US-GILEAD-2024-0678416$GILEAD$$$$$F$Y$$$20240827$$CN$US$US
242535951$24253595$1$I$20240628$20240826$20240827$20240827$EXP$IT-MINISAL02-999790$NVSC2024IT171743$NOVARTIS$$70$YR$$F$Y$$$20240827$$MD$IT$IT
242535961$24253596$1$I$20220801$20240826$20240827$20240827$EXP$$US-UCBSA-2022056205$UCB$$30$YR$$F$Y$$$20240827$$CN$US$US
242535981$24253598$1$I$20240822$20240822$20240827$20240827$EXP$$US-009507513-2408USA007942$MERCK$$$$$F$Y$$$20240827$$CN$US$US
242536001$24253600$1$I$20240821$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135198$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240827$$CN$US$US
242536011$24253601$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135075$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240827$$HP$US$US
242536021$24253602$1$I$20240101$20240823$20240827$20240827$EXP$$US-ABBVIE-5893934$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242536031$24253603$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135368$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240827$$HP$US$US
242536041$24253604$1$I$20240817$20240820$20240827$20240827$PER$$US-BAYER-2024A121667$BAYER$$30$YR$A$F$Y$$$20240827$$PH$US$US
242536051$24253605$1$I$$20240821$20240827$20240827$30DAY$$US-GSK-US2024104571$GLAXOSMITHKLINE$$$$$M$Y$$$20240827$$CN$US$US
242536061$24253606$1$I$$20240819$20240827$20240827$EXP$$TH-ROCHE-10000062380$ROCHE$$70$YR$E$M$Y$$$20240827$$CN$TH$TH
242536071$24253607$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58795$$FDA-CTU$$$$$F$N$$$20240826$N$$US$
242536081$24253608$1$I$20230101$20240814$20240827$20240827$PER$$US-ABBVIE-5894343$ABBVIE$$50$YR$$M$Y$$$20240827$$HP$US$US
242536091$24253609$1$I$$20240826$20240827$20240827$EXP$$CA-PFIZER INC-202400243998$PFIZER$$64$YR$$M$Y$$$20240827$$HP$CA$CA
242536101$24253610$1$I$$20240801$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07798$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242536111$24253611$1$I$20240101$20240823$20240827$20240827$EXP$$US-GILEAD-2024-0685245$GILEAD$$48$YR$A$M$Y$$$20240827$$CN$US$US
242536121$24253612$1$I$20240809$20240826$20240826$20240826$DIR$715851$$FDA-CTU$$64$YR$$M$N$109.3$KG$20240826$N$HP$US$
242536131$24253613$1$I$20240805$20240826$20240826$20240826$DIR$715935$$FDA-CTU$$40$YR$$F$N$56.25$KG$20240826$N$HP$US$
242536141$24253614$1$I$20240814$20240823$20240826$20240826$DIR$FDA-CDER-CTU-2024-58815$$FDA-CTU$$70$YR$$F$N$$$20240823$N$$US$
242536171$24253617$1$I$$20240823$20240827$20240827$PER$$US-ROCHE-10000065093$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242536181$24253618$1$I$$20240823$20240827$20240827$PER$$US-TAKEDA-2024TUS085740$TAKEDA$$$$$F$Y$$$20240827$$HP$US$US
242536191$24253619$1$I$20240819$20240820$20240827$20240827$EXP$GB-MHRA-TPP17761064C9489811YC1724084081235$GB-TORRENT-00037680$TORRENT$$70$YR$E$F$Y$66$KG$20240827$$MD$GB$GB
242536201$24253620$1$I$20240820$20240826$20240826$20240826$DIR$715936$$FDA-CTU$$73$YR$$M$N$$$20240826$Y$CN$US$
242536211$24253621$1$I$20240629$20240816$20240827$20240827$EXP$GB-MHRA-MED-202408152030478670-BPTLK$GB-TORRENT-00037645$TORRENT$$48$YR$A$M$Y$79$KG$20240827$$CN$GB$GB
242536221$24253622$1$I$$20240819$20240827$20240827$EXP$GB-MYLANLABS-2024M1048983$GB-TORRENT-00037683$TORRENT$$$$$F$Y$$$20240827$$MD$GB$GB
242536231$24253623$1$I$$20240821$20240827$20240827$EXP$GB-MHRA-MED-202408210341069160-YDTFP$GB-TORRENT-00037687$TORRENT$$22$YR$A$F$Y$$$20240827$$CN$GB$GB
242536242$24253624$2$F$$20240829$20240827$20240911$EXP$$US-TORRENT-00013727$TORRENT$$21$YR$A$F$Y$56$KG$20240911$$PH$US$US
242536251$24253625$1$I$$20240815$20240827$20240827$EXP$$US-TORRENT-00013725$TORRENT$$$$$M$Y$$$20240827$$CN$US$US
242536261$24253626$1$I$20240101$20240819$20240827$20240827$EXP$$US-SA-2024SA155207$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240827$$MD$US$US
242536271$24253627$1$I$$20240827$20240827$20240827$EXP$GR-GREOF-202400888$GR-BAYER-2024A122900$BAYER$$69$YR$E$F$Y$69$KG$20240827$$MD$GR$GR
242536281$24253628$1$I$$20240813$20240827$20240827$PER$$US-AstraZeneca-2024A185128$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242536291$24253629$1$I$20240815$20240822$20240827$20240827$EXP$$ZA-AstraZeneca-2024A192902$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$ZA$
242536302$24253630$2$F$20240805$20240826$20240827$20240909$PER$$US-AstraZeneca-2024A179228$ASTRAZENECA$$12604$DY$$M$Y$$$20240909$$CN$US$
242536311$24253631$1$I$20240819$20240819$20240827$20240827$PER$$US-ABBVIE-5886392$ABBVIE$$81$YR$$M$Y$$$20240827$$HP$US$US
242536322$24253632$2$F$20240822$20240823$20240827$20240829$EXP$$NVSC2024GB171525$NOVARTIS$$52$YR$$F$Y$$$20240829$$CN$GB$GB
242536332$24253633$2$F$20240101$20240905$20240827$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000210$MERZ$$$$$$Y$$$20240925$$HP$US$US
242536341$24253634$1$I$$20240820$20240827$20240827$EXP$$US-GSK-US2024103882$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
242536351$24253635$1$I$$20240819$20240827$20240827$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006166$BIOCON$$$$$$Y$$$20240827$$HP$CA$CA
242536361$24253636$1$I$$20240821$20240827$20240827$EXP$$JP-009507513-2402JPN002674J$MERCK$$7$DEC$$F$Y$$$20240827$$MD$JP$JP
242536371$24253637$1$I$20240101$20240822$20240827$20240827$PER$$US-ABBVIE-5894448$ABBVIE$$$$$F$Y$$$20240827$$MD$US$US
242536381$24253638$1$I$$20240820$20240827$20240827$PER$$US-JNJFOC-20240854989$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242536391$24253639$1$I$$20240821$20240827$20240827$PER$$US-BAYER-2024A120614$BAYER$$$$$$Y$$$20240827$$CN$US$US
242536401$24253640$1$I$$20240816$20240827$20240827$PER$$US-BAYER-2024A118744$BAYER$$30$YR$A$F$Y$$$20240827$$HP$US$US
242536411$24253641$1$I$$20240821$20240827$20240827$EXP$$US-TAKEDA-2024TUS032004$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
242536421$24253642$1$I$$20240826$20240827$20240827$EXP$$NL-ABBVIE-5894875$ABBVIE$$$$$M$Y$$$20240827$$HP$NL$NL
242536491$24253649$1$I$20240820$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58751$$FDA-CTU$$71$YR$$M$N$$$20240826$Y$PH$US$
242536501$24253650$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58796$$FDA-CTU$$77$YR$$F$N$$$20240826$N$$US$
242536511$24253651$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58807$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242536521$24253652$1$I$$20240820$20240827$20240827$PER$$US-BIOGEN-2024BI01279147$BIOGEN$$$$$$Y$$$20240827$$CN$US$US
242536531$24253653$1$I$$20240820$20240827$20240827$PER$$US-BAYER-2024A119863$BAYER$$$$$$Y$$$20240827$$CN$US$US
242536541$24253654$1$I$$20240820$20240827$20240827$PER$$US-AGIOS-2408US03865$AGIOS PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242536551$24253655$1$I$$20240819$20240827$20240827$PER$$US-AGIOS-2408US03864$AGIOS PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242536561$24253656$1$I$20240723$20240822$20240827$20240827$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-099955$REGENERON$$$$$M$Y$$$20240827$$CN$US$US
242536571$24253657$1$I$20240807$20240821$20240827$20240827$EXP$CN-91110000556821568D-2024DRL001568$CN-RDY-SPO/CHN/24/0012361$DR REDDYS$$75$YR$E$M$Y$48$KG$20240827$$HP$CN$CN
242536581$24253658$1$I$20240822$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169242$AMGEN$$33$YR$A$M$Y$$$20240827$$CN$US$US
242536591$24253659$1$I$$20240823$20240827$20240827$PER$$US-ROCHE-10000066038$ROCHE$$77$YR$E$F$Y$$$20240827$$CN$US$US
242536601$24253660$1$I$$20240821$20240827$20240827$PER$$US-ABBVIE-5891314$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242536611$24253661$1$I$20240801$20240822$20240827$20240827$PER$$US-ROCHE-10000065293$ROCHE$$33$YR$A$F$Y$$$20240827$$MD$US$US
242536621$24253662$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-080197-2024$RECKITT BENCKISER$$52$YR$$F$Y$$$20240827$$CN$US$US
242536641$24253664$1$I$$20240821$20240827$20240827$EXP$$FR-HBP-2024FR031127$HELSINN HEALTHCARE$$60$YR$$F$Y$$$20240827$$MD$FR$FR
242536651$24253665$1$I$20240821$20240821$20240827$20240827$PER$$US-BAYER-2024A121200$BAYER$$74$YR$E$M$Y$$$20240827$$CN$US$US
242536662$24253666$2$F$20240101$20240827$20240827$20240831$PER$$US-AMGEN-USASP2024168206$AMGEN$$77$YR$E$M$Y$$$20240830$$PH$US$US
242536672$24253667$2$F$20240401$20240826$20240827$20240829$EXP$$US-KYOWAKIRIN-2024KK019948$KYOWA$$$$$$Y$$$20240829$$HP$US$US
242536681$24253668$1$I$$20240801$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07760$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242536691$24253669$1$I$$20240820$20240827$20240827$30DAY$$US-GSK-US2024104006$GLAXOSMITHKLINE$$$$$M$Y$$$20240827$$CN$US$US
242536701$24253670$1$I$$20240823$20240827$20240827$EXP$$CA-GSK-CA2023AMR090543$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$HP$CA$CA
242536711$24253671$1$I$$20240801$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07790$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242536721$24253672$1$I$$20240819$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408011712$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240827$$CN$US$US
242536732$24253673$2$F$$20240826$20240827$20240902$EXP$$US-ELI_LILLY_AND_COMPANY-US202408015064$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240902$$CN$US$US
242536741$24253674$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015419$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240827$$CN$US$US
242536751$24253675$1$I$20240708$20240816$20240827$20240827$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408014777$ELI LILLY AND CO$$41$YR$A$M$Y$51$KG$20240827$$CN$DE$CN
242536761$24253676$1$I$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016297$ELI LILLY AND CO$$$$$M$Y$$$20240827$$CN$US$US
242536781$24253678$1$I$$20240822$20240827$20240827$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408014465$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240827$$CN$JP$JP
242536791$24253679$1$I$20240813$20240816$20240827$20240827$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408015263$ELI LILLY AND CO$$69$YR$E$M$Y$67$KG$20240827$$CN$DE$CN
242536801$24253680$1$I$$20240820$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408012604$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240827$$CN$US$US
242536811$24253681$1$I$$20240815$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408010791$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242536821$24253682$1$I$$20240813$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-041280$AUROBINDO$Eshak N, Ehikhueme G, Ramesh M, Pixley J. Granulomatous Polyangiitis Refractory to Induction With Rituximab in 3 Patients. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-5$66$YR$$F$Y$$$20240827$$MD$US$US
242536831$24253683$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3235094$TEVA$$60$YR$$F$Y$$$20240827$$CN$CA$CA
242536841$24253684$1$I$20240818$20240825$20240827$20240827$EXP$$NVSC2024EG172210$NOVARTIS$$12$YR$$M$Y$$$20240827$$PH$EG$EG
242536851$24253685$1$I$20220222$20240826$20240827$20240827$EXP$$NVSC2024KR172000$NOVARTIS$$$$A$F$Y$$$20240827$$HP$KR$KR
242536861$24253686$1$I$20240821$20240822$20240827$20240827$PER$$US-BAYER-2024A121206$BAYER$$43$YR$A$F$Y$$$20240827$$MD$US$US
242536871$24253687$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5893397$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242536881$24253688$1$I$$20240813$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-041261$AUROBINDO$Zayat N, Arora A, O^Brien J, Bal J, Sugarman R, Rivera L, et al. Pregnancy-Associated Onset of Adult-Onset Still^s Disease. AJP-Rep. 2024;14(2):E145-E155$29$YR$$F$Y$$$20240827$$MD$US$US
242536891$24253689$1$I$20240101$20240826$20240827$20240827$PER$$US-AMGEN-USASP2024170276$AMGEN$$65$YR$E$F$Y$$$20240827$$HP$US$US
242536901$24253690$1$I$20240801$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168601$AMGEN$$68$YR$E$F$Y$$$20240827$$PH$US$US
242536921$24253692$1$I$20240821$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136018$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240827$$CN$US$US
242536931$24253693$1$I$$20240822$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134787$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240827$$CN$US$US
242536941$24253694$1$I$$20240823$20240827$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-135541$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240827$$PH$JP$JP
242536951$24253695$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-080331-2024$RECKITT BENCKISER$$$$$M$Y$$$20240827$$CN$US$US
242536961$24253696$1$I$$20240821$20240827$20240827$PER$$US-BAYER-2024A121475$BAYER$$30$YR$A$F$Y$$$20240827$$CN$US$US
242536971$24253697$1$I$$20240820$20240827$20240827$EXP$$US-VIIV HEALTHCARE LIMITED-US2024103918$VIIV$$$$$M$Y$$$20240827$$CN$US$US
242536981$24253698$1$I$20230101$20240820$20240827$20240827$EXP$$US-ROCHE-10000062238$ROCHE$$55$YR$A$F$Y$$$20240827$$HP$US$US
242536991$24253699$1$I$20220301$20240820$20240827$20240827$EXP$$US-ROCHE-10000061980$ROCHE$$51$YR$A$F$Y$70.3$KG$20240827$$CN$US$US
242537001$24253700$1$I$$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133300$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240827$$PH$US$US
242537011$24253701$1$I$$20240823$20240827$20240827$PER$$US-PFIZER INC-202400242761$PFIZER$$$$$F$Y$$$20240827$$MD$US$US
242537022$24253702$2$F$$20240926$20240827$20240926$PER$$US-PFIZER INC-PV202400109435$PFIZER$$13$YR$$F$Y$$$20240926$$MD$US$US
242537032$24253703$2$F$$20240926$20240827$20240926$PER$$US-PFIZER INC-PV202400109247$PFIZER$$13$YR$$F$Y$$$20240926$$MD$US$US
242537041$24253704$1$I$$20240820$20240827$20240827$EXP$$US-GSK-US2024103922$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
242537051$24253705$1$I$$20240813$20240827$20240827$EXP$$US-AUROBINDO-AUR-APL-2024-041522$AUROBINDO$Ahmad A T, Steven A, Francesca B. Disseminated histoplasmosis mimicking post-vaccination side effects in an immunocompromised person with multiple sclerosis. Multiple Sclerosis Journal? Experimental, Translational and Clinical. 2024;1?4$58$YR$$M$Y$$$20240827$$HP$US$US
242537061$24253706$1$I$20150101$20240820$20240827$20240827$EXP$ES-AEMPS-1560617$ES-TEVA-VS-3235502$TEVA$$65$YR$$F$Y$$$20240827$$MD$ES$ES
242537071$24253707$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58813$$FDA-CTU$$43$YR$$F$N$$$20240826$N$$US$
242537081$24253708$1$I$$20240719$20240827$20240827$PER$$NVSC2024US172336$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242537091$24253709$1$I$$20240819$20240827$20240827$EXP$$US-JNJFOC-20240848115$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242537101$24253710$1$I$20240201$20240327$20240827$20240827$PER$$US-JNJFOC-20240828352$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240827$$CN$US$US
242537112$24253711$2$F$$20240822$20240827$20240829$PER$$US-JNJFOC-20240851480$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$HP$US$US
242537121$24253712$1$I$20190101$20240815$20240827$20240827$EXP$$CA-Accord-442602$ACCORD$Dery C, Labrecque G, Bouchard M. Oral Levodopa, Vitamin B6, and Polyneuropathy: A Case Series. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2024;51(3):472-3.$71$YR$E$F$Y$$$20240827$$MD$CA$CA
242537131$24253713$1$I$20240716$20240815$20240827$20240827$EXP$FR-AFSSAPS-GR2024000979$FR-Accord-442518$ACCORD$$77$YR$E$F$Y$53$KG$20240827$$PH$FR$FR
242537141$24253714$1$I$$20240815$20240827$20240827$EXP$GB-MHRA-TPP21929512C6827883YC1723650273416$GB-Accord-441966$ACCORD$$81$YR$E$F$Y$65$KG$20240827$$PH$GB$GB
242537151$24253715$1$I$$20240815$20240827$20240827$EXP$$HR-Accord-442287$ACCORD$Dilber I., Tokic M., et al. Intrahepatic portal hypertension caused by oxaliplatin in the treatment of gastric cancer - patient report and literature review. Med Jad 2024;54(2):129-134$73$YR$E$M$Y$$$20240827$$MD$HR$HR
242537161$24253716$1$I$$20240822$20240827$20240827$EXP$$ZA-AstraZeneca-2024A192904$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$ZA$
242537171$24253717$1$I$20240617$20240819$20240827$20240827$EXP$$JP-AstraZeneca-2024A154106$ASTRAZENECA$$77$YR$$M$Y$63$KG$20240827$$MD$JP$
242537181$24253718$1$I$$20240819$20240827$20240827$EXP$$ZA-AstraZeneca-2024A189642$ASTRAZENECA$$31046$DY$$F$Y$$$20240827$$CN$ZA$
242537192$24253719$2$F$$20240822$20240827$20240828$PER$$US-BIOGEN-2024BI01279154$BIOGEN$$$$$F$Y$82.174$KG$20240828$$CN$US$US
242537202$24253720$2$F$20240101$20240827$20240827$20240830$PER$$US-BIOGEN-2024BI01279322$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
242537211$24253721$1$I$20220408$20240819$20240827$20240827$EXP$$KR-AstraZeneca-2024A189700$ASTRAZENECA$$70$YR$$M$Y$$$20240827$$MD$KR$
242537221$24253722$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189666$ASTRAZENECA$$$$$M$Y$$$20240827$$HP$US$
242537231$24253723$1$I$$20240813$20240827$20240827$EXP$$NL-AUROBINDO-AUR-APL-2024-041316$AUROBINDO$Posma RA, Bakker SJL, Nijsten MW, Touw DJ, Tsikas D. Comprehensive GC-MS Measurement of Amino Acids, Metabolites, and Malondialdehyde in Metformin-Associated Lactic Acidosis at Admission and during Renal Replacement Treatment. J-Clin-Med. 2024;13No:13$70$YR$$F$Y$84$KG$20240827$$HP$NL$NL
242537242$24253724$2$F$$20240816$20240827$20240827$EXP$$US-AMGEN-USASP2024169486$AMGEN$$$$$$Y$$$20240827$$PH$US$US
242537251$24253725$1$I$$20240815$20240827$20240827$EXP$$US-Accord-442547$ACCORD$Toubasi AA, Allon S, Bagnato F. Disseminated histoplasmosis mimicking post-vaccination side effects in an immunocompromised person with multiple sclerosis. Mult Scler J Exp Transl Clin. 2024 Aug 7;10(3):20552173241271790.$58$YR$A$M$Y$$$20240827$$HP$US$US
242537261$24253726$1$I$20240807$20240815$20240827$20240827$EXP$$US-Accord-442664$ACCORD$$39$YR$A$M$Y$$$20240827$$HP$US$US
242537272$24253727$2$F$20240807$20240823$20240827$20240904$EXP$$US-Accord-441435$ACCORD$$61$YR$A$M$Y$$$20240904$$HP$US$US
242537281$24253728$1$I$$20240815$20240827$20240827$EXP$$IN-Accord-442697$ACCORD$Mittal R, De C. Eye on Hydrochlorothiazide: Unraveling the Mystery of Choroidal-Effusion. Ophthalmology. 2024 Aug 11:S0161-6420(24)00435-4. doi: 10.1016/j.ophtha.2024.07.024.$55$YR$A$F$Y$$$20240827$$MD$IN$IN
242537291$24253729$1$I$$20240815$20240827$20240827$EXP$$SK-Accord-442567$ACCORD$Pecova T, Vorcakova K, Adamicova K. Extremely Severe Form of Psoriasis - Rebus of Therapy (case Report). Martin BEMER. 2017;5:7-11.$46$YR$A$M$Y$80$KG$20240827$$MD$SK$SK
242537301$24253730$1$I$20240821$20240826$20240827$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US075344$SANDOZ$$12$YR$$M$Y$$$20240827$$MD$US$US
242537312$24253731$2$F$20240601$20240916$20240827$20240917$EXP$CZ-CZSUKL-24002288$CZ-UCBSA-2024043169$UCB$$10$YR$$M$Y$34$KG$20240917$$CN$CZ$CZ
242537321$24253732$1$I$20240814$20240823$20240827$20240827$EXP$GB-MHRA-MED-202408231607265850-WDBYV$GB-MYLANLABS-2024M1078508$MYLAN$$30$YR$$F$Y$$$20240827$$HP$GB$GB
242537331$24253733$1$I$20240601$20240822$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135193$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240827$$CN$US$US
242537341$24253734$1$I$20240816$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135327$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$78.02$KG$20240827$$PH$US$US
242537351$24253735$1$I$20240718$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58812$$FDA-CTU$$34$YR$$M$N$$$20240826$N$PH$US$
242537361$24253736$1$I$20240702$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58687$$FDA-CTU$$64$YR$$M$N$$$20240826$N$PH$US$
242537371$24253737$1$I$20240810$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58685$$FDA-CTU$$67$YR$$M$N$$$20240826$N$PH$US$
242537381$24253738$1$I$$20240816$20240827$20240827$EXP$$PL-PFIZER INC-2019SGN00596$PFIZER$Macioch, M.. Nivolumab therapy for refractory and relapsed Hodgkin^s lymphoma - case report. Oncology in Clinical Practice. 2018;14(4):232-236$34$YR$$M$Y$$$20240827$$MD$PL$PL
242537392$24253739$2$F$$20240816$20240827$20240827$EXP$$US-AMGEN-USASP2024169477$AMGEN$$$$$$Y$$$20240827$$PH$US$US
242537401$24253740$1$I$20240820$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169798$AMGEN$$$$$$Y$$$20240827$$PH$US$US
242537411$24253741$1$I$20240726$20240820$20240827$20240827$EXP$$US-AMGEN-USASP2024166571$AMGEN$$72$YR$E$M$Y$$$20240827$$CN$US$US
242537422$24253742$2$F$20240101$20240905$20240827$20240912$EXP$$TR-ABBVIE-5895667$ABBVIE$$78$YR$$M$Y$$$20240912$$MD$TR$TR
242537431$24253743$1$I$$20240821$20240827$20240827$PER$$US-BAYER-2024A120609$BAYER$$$$$F$Y$$$20240827$$CN$US$US
242537441$24253744$1$I$20240725$20240816$20240827$20240827$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000843$PAREXEL$$$$$$Y$$$20240827$$HP$CN$CN
242537451$24253745$1$I$$20240815$20240827$20240827$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003959$PAREXEL$$$$$$Y$$$20240827$$CN$US$US
242537462$24253746$2$F$$20240830$20240827$20240909$EXP$$CH-TEVA-VS-3224722$TEVA$Burgener A-V, Seth-Smith HMB, Kern-Baumann S, Durovic A, Blaich A, Menter T, et al. A Case Study of Zoonotic Chlamydia abortus Infection: Diagnostic Challenges From Clinical and Microbiological Perspectives. Open-Forum-Infect-Dis 2022; 9 (10): ofac524.; Burgener A-V, Seth-Smith HMB, Kern-Baumann S, Durovic A, Blaich A, Menter T, et al. A Case Study of Zoonotic Chlamydia abortus Infection: Diagnostic Challenges From Clinical and Microbiological Perspectives. Open-Forum-Infect-Dis 2022; 9 (10):...$33$YR$$F$Y$$$20240909$$MD$CH$CH
242537471$24253747$1$I$$20240821$20240827$20240827$PER$$US-BAYER-2024A120643$BAYER$$$$$$Y$$$20240827$$CN$US$US
242537491$24253749$1$I$20240101$20240821$20240827$20240827$PER$$US-BAYER-2024A121817$BAYER$$29$YR$A$F$Y$$$20240827$$HP$US$US
242537501$24253750$1$I$20240803$20240818$20240827$20240827$EXP$$EG-009507513-2408EGY006990$MERCK$$26$YR$$F$Y$80$KG$20240827$$HP$EG$EG
242537511$24253751$1$I$20240810$20240821$20240827$20240827$EXP$$GB-MYLANLABS-2024M1077791$MYLAN$$$$$M$Y$$$20240827$$HP$GB$GB
242537521$24253752$1$I$$20240801$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07783$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242537531$24253753$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172633$NOVARTIS$$30$YR$$$Y$$$20240827$$MD$US$US
242537542$24253754$2$F$$20240903$20240827$20240909$EXP$$NVSC2024ZA170987$NOVARTIS$$71$YR$$F$Y$75$KG$20240909$$MD$ZA$ZA
242537551$24253755$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58727$$FDA-CTU$$62$YR$$M$N$$$20240826$N$$US$
242537561$24253756$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58788$$FDA-CTU$$50$YR$$M$N$$$20240826$N$$US$
242537571$24253757$1$I$$20240321$20240827$20240827$EXP$$NVSC2024CA066102$NOVARTIS$$43$YR$$F$Y$$$20240827$$MD$CA$CA
242537581$24253758$1$I$20240816$20240816$20240827$20240827$PER$$US-PFIZER INC-PV202400107345$PFIZER$$$$$$Y$$$20240827$$CN$US$US
242537591$24253759$1$I$$20240821$20240827$20240827$PER$$US-PFIZER INC-2024SGN01542$PFIZER$$77$YR$$F$Y$$$20240827$$CN$US$US
242537601$24253760$1$I$$20240822$20240827$20240827$EXP$$CA-PFIZER INC-202400241992$PFIZER$$$$$M$Y$$$20240827$$HP$CA$CA
242537611$24253761$1$I$$20240821$20240827$20240827$EXP$$CA-PFIZER INC-202400241142$PFIZER$$14$YR$$M$Y$$$20240827$$HP$CA$CA
242537622$24253762$2$F$$20240828$20240827$20240904$PER$$US-PFIZER INC-202400241137$PFIZER$$32$YR$$F$Y$83.91$KG$20240904$$CN$US$US
242537631$24253763$1$I$20240801$20240821$20240827$20240827$PER$$US-PFIZER INC-202400242208$PFIZER$$68$YR$$F$Y$$$20240827$$HP$US$US
242537641$24253764$1$I$20240418$20240820$20240827$20240827$EXP$$IN-PFIZER INC-PV202400043753$PFIZER$$40$YR$$F$Y$$$20240827$$CN$IN$IN
242537653$24253765$3$F$20150707$20240830$20240827$20240913$EXP$$FR-PFIZER INC-2016SGN00616$PFIZER$Tudesq, J.. Cytomegalovirus infection with retinitis after brentuximab vedotin treatment for CD30+ lymphoma. Open Forum Infectious Diseases. 2017;4(2):1-3$44$YR$$M$Y$$$20240913$$MD$FR$FR
242537671$24253767$1$I$$20240822$20240827$20240827$PER$$US-BAYER-2024A121613$BAYER$$$$$M$Y$$$20240827$$CN$US$US
242537682$24253768$2$F$20210721$20240920$20240827$20240926$EXP$$NVSC2024IT171343$NOVARTIS$$$$A$F$Y$$$20240926$$MD$IT$IT
242537701$24253770$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-136699-2023$RECKITT BENCKISER$$$$$M$Y$$$20240827$$CN$US$US
242537711$24253771$1$I$20240806$20240819$20240827$20240827$EXP$ES-AEMPS-1558862$ES-TEVA-VS-3234763$TEVA$$68$YR$$F$Y$50$KG$20240827$$PH$ES$ES
242537721$24253772$1$I$$20240826$20240827$20240827$EXP$$US-UCBSA-2024043432$UCB$$$$$F$Y$$$20240827$$HP$US$US
242537732$24253773$2$F$$20240816$20240827$20240827$EXP$$US-AMGEN-USASP2024169480$AMGEN$$$$$$Y$$$20240827$$PH$US$US
242537741$24253774$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169995$AMGEN$$$$$$Y$$$20240827$$MD$US$US
242537751$24253775$1$I$20240101$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169639$AMGEN$$25$YR$A$M$Y$$$20240827$$MD$US$US
242537761$24253776$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169371$AMGEN$$67$YR$E$F$Y$$$20240827$$HP$US$US
242537771$24253777$1$I$$20240823$20240827$20240827$EXP$$NVSC2024US172232$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242537781$24253778$1$I$$20240821$20240827$20240827$PER$$US-BAYER-2024A122839$BAYER$$$$$$Y$$$20240827$$CN$US$US
242537792$24253779$2$F$$20240816$20240827$20240827$EXP$$US-AMGEN-USASP2024169479$AMGEN$$$$$$Y$$$20240827$$PH$US$US
242537801$24253780$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135776$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240827$$CN$US$US
242537811$24253781$1$I$$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133580$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240827$$HP$US$US
242537821$24253782$1$I$$20240814$20240827$20240827$EXP$$GB-ADVANZ PHARMA-202408006843$ADVANZ PHARMA$$$$$$Y$$$20240827$$MD$GB$GB
242537851$24253785$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5892954$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242537862$24253786$2$F$$20240916$20240827$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08295$LUPIN$$$$$$Y$$$20240930$$CN$US$US
242537872$24253787$2$F$$20240902$20240827$20240906$EXP$$JP-AstraZeneca-2024A193831$ASTRAZENECA$$83$YR$$M$Y$$$20240906$$MD$JP$
242537881$24253788$1$I$$20240820$20240827$20240827$PER$$US-ROCHE-10000062057$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242537901$24253790$1$I$20240101$20240822$20240827$20240827$EXP$$JP-AstraZeneca-2024A191335$ASTRAZENECA$$$$E$F$Y$$$20240827$$MD$JP$
242537911$24253791$1$I$$20240819$20240827$20240827$EXP$$JP-AstraZeneca-2024A192164$ASTRAZENECA$$$$$F$Y$$$20240827$$MD$JP$
242537922$24253792$2$F$$20240816$20240827$20240827$EXP$$US-AMGEN-USASP2024169482$AMGEN$$$$$$Y$$$20240827$$PH$US$US
242537931$24253793$1$I$20240101$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168484$AMGEN$$83$YR$E$M$Y$$$20240827$$MD$US$US
242537941$24253794$1$I$$20240814$20240827$20240827$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08144$LUPIN$Yu R. Exaggerated increases in the serum cortisol level in a woman following oral contraceptive treatment. AACE Clinical Case Report. 2024;1-4$50$YR$$F$Y$$$20240827$$MD$US$US
242537951$24253795$1$I$20240823$20240823$20240827$20240827$PER$$US-AvKARE-2160907$AVKARE$$59$YR$$M$Y$$$20240827$$$US$US
242537962$24253796$2$F$20240101$20240918$20240827$20240926$EXP$$US-UCBSA-2024043431$UCB$$$$$F$Y$$$20240926$$CN$US$US
242537982$24253798$2$F$$20240812$20240827$20240911$EXP$$NVSC2023US258217$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
242537991$24253799$1$I$20240801$20240822$20240827$20240827$PER$$US-BAYER-2024A121976$BAYER$$44$YR$A$F$Y$$$20240827$$HP$US$US
242538002$24253800$2$F$$20240830$20240827$20240909$EXP$$ID-TEVA-VS-3236379$TEVA$Kinesya B, Al-Farabi MJ, Mannagalli Y, Oktaviono YH. Unstable angina pectoris in a young male after first dose of COVID-19 MRNAvaccine. J-Pak-Med-Assoc 2024; 74 (6) (6): S85-S87.; Kinesya B, Al-Farabi MJ, Mannagalli Y, Oktaviono YH. Unstable angina pectoris in a young male after first dose of COVID-19 MRNAvaccine. J-Pak-Med-Assoc 2024; 74 (6) (6): S85-S87.; Kinesya B, Al-Farabi MJ, Mannagalli Y, Oktaviono YH. Unstable angina pectoris in a young male after first dose of COVID-19 MRNAvaccine. J...$25$YR$$M$Y$$$20240909$$HP$ID$ID
242538012$24253801$2$F$$20240816$20240827$20240827$EXP$$US-AMGEN-USASP2024169485$AMGEN$$$$$$Y$$$20240827$$PH$US$US
242538022$24253802$2$F$$20240830$20240827$20240909$EXP$$US-TEVA-VS-3235643$TEVA$Fesharaki-Zadeh A, Lowe N, Arnsten AFT. Clinical experience with the alpha2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in ^Long-COVID19^. Neuroimmunol-Rep 2023; 3.; Fesharaki-Zadeh A, Lowe N, Arnsten AFT. Clinical experience with the alpha2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in ^Long-COVID19^. Neuroimmunol-Rep 2023; 3.$$$$$Y$$$20240909$$HP$US$US
242538041$24253804$1$I$$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168949$AMGEN$$$$$M$Y$$$20240827$$CN$US$US
242538051$24253805$1$I$$20240821$20240827$20240827$EXP$$PT-MYLANLABS-2024M1077787$MYLAN$Brito, I. The clinical spectrum of the KCNQ2 gene-associated diseases. Sinapse. 2023;93$9$MON$$F$Y$$$20240827$$MD$PT$PT
242538061$24253806$1$I$20240801$20240801$20240827$20240827$PER$$US-CSL-2024-007263$CSL Plasma$$26$YR$$M$Y$$$20240827$$HP$US$US
242538071$24253807$1$I$$20240825$20240827$20240827$PER$$NVSC2024US172425$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
242538081$24253808$1$I$$20240819$20240827$20240827$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006142$BIOCON$$$$$$Y$$$20240827$$MD$CA$CA
242538091$24253809$1$I$20240822$20240823$20240827$20240827$PER$$US-BAYER-2024A121980$BAYER$$43$YR$A$F$Y$$$20240827$$CN$US$US
242538111$24253811$1$I$$20240730$20240827$20240827$EXP$$FR-INCYTE CORPORATION-2024IN008972$INCYTE$$$$$$Y$$$20240827$$PH$FR$FR
242538121$24253812$1$I$20240818$20240819$20240827$20240827$EXP$$US-VIIV HEALTHCARE LIMITED-US2024103315$VIIV$$61$YR$$M$Y$$$20240827$$CN$US$US
242538131$24253813$1$I$$20240819$20240827$20240827$PER$$US-ALXN-202408USA001259US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242538142$24253814$2$F$$20240911$20240827$20240912$PER$$US-ALXN-202408USA001330US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
242538151$24253815$1$I$$20240819$20240827$20240827$PER$$US-ALXN-202408USA001260US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242538161$24253816$1$I$$20240814$20240827$20240827$EXP$$US-UCBSA-2024041859$UCB$$$$$$Y$$$20240827$$CN$US$US
242538172$24253817$2$F$$20240915$20240827$20240918$PER$$IQ-REGENERON PHARMACEUTICALS, INC.-2024-115988$REGENERON$$69$YR$$M$Y$$$20240918$$CN$IQ$IQ
242538181$24253818$1$I$$20240801$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07827$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242538191$24253819$1$I$20240720$20240814$20240827$20240827$EXP$$CN-SA-2024SA244559$SANOFI AVENTIS$$4$YR$C$M$Y$18.5$KG$20240827$$HP$CN$CN
242538202$24253820$2$F$20240713$20240904$20240827$20240905$EXP$$DE-BAUSCH-BL-2024-012899$BAUSCH AND LOMB$$89$YR$$F$Y$53$KG$20240905$$MD$DE$DE
242538211$24253821$1$I$20240814$20240826$20240827$20240827$PER$$US-BAYER-2024A122437$BAYER$$77$YR$E$F$Y$$$20240827$$HP$US$US
242538222$24253822$2$F$$20240827$20240827$20240829$PER$$US-AMGEN-USASP2024170026$AMGEN$$$$$$Y$$$20240829$$CN$US$US
242538231$24253823$1$I$$20240820$20240827$20240827$EXP$$US-AMGEN-USASP2024168808$AMGEN$$$$$$Y$$$20240827$$MD$US$US
242538251$24253825$1$I$20240301$20240806$20240827$20240827$PER$$US-MYLANLABS-2024M1073762$MYLAN$$69$YR$$F$Y$$$20240827$$CN$US$US
242538271$24253827$1$I$20240802$20240815$20240827$20240827$EXP$$CN-SA-2024SA245897$SANOFI AVENTIS$$87$YR$E$M$Y$65$KG$20240827$$HP$CN$CN
242538281$24253828$1$I$20240711$20240821$20240827$20240827$EXP$CH-SM-2024-14785$CH-ROCHE-10000063959$ROCHE$$37$YR$A$F$Y$$$20240827$$MD$CH$CH
242538291$24253829$1$I$20240826$20240826$20240827$20240827$PER$$US-BAYER-2024A122568$BAYER$$60$YR$A$M$Y$$$20240827$$CN$US$US
242538301$24253830$1$I$$20240731$20240827$20240827$PER$$US-BEIGENE-BGN-2024-012077$BEIGENE$$$$$$Y$$$20240827$$PH$US$US
242538312$24253831$2$F$20240130$20240831$20240827$20240903$EXP$$FR-BAUSCH-BL-2024-004837$BAUSCH AND LOMB$$76$YR$$M$Y$70$KG$20240903$$HP$FR$FR
242538321$24253832$1$I$$20240823$20240827$20240827$PER$$US-ROCHE-10000066276$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242538331$24253833$1$I$20240726$20240823$20240827$20240827$EXP$$US-ABBVIE-5894306$ABBVIE$$63$YR$$M$Y$$$20240827$$CN$US$US
242538341$24253834$1$I$$20240815$20240827$20240827$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08141$LUPIN$Preskorn SH, Masolak DD. Life-threatening Rash due to Lamotrigine and a failure to understand its Pharmacology: how forensic detective work uses medical knowledge and clinical pharmacology to solve cases. Journal of Psychiatric Practice. 2024;30(4):273-278$13$YR$$M$Y$$$20240827$$MD$US$US
242538351$24253835$1$I$20240722$20240821$20240827$20240827$EXP$$CN-PFIZER INC-PV202400109297$PFIZER$$7$YR$$M$Y$$$20240827$$HP$CN$CN
242538361$24253836$1$I$$20240821$20240827$20240827$EXP$$MX-PFIZER INC-PV202400109810$PFIZER$$72$YR$$F$Y$$$20240827$$CN$MX$MX
242538371$24253837$1$I$$20240819$20240827$20240827$EXP$$CN-PFIZER INC-PV202400104741$PFIZER$Gong, Y.. Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib. Annals of Hematology. 2024;103(8):3239-3242$59$YR$$M$Y$$$20240827$$HP$CN$CN
242538381$24253838$1$I$20240101$20240821$20240827$20240827$EXP$CH-SM-2024-15058$CH-PFIZER INC-202400241563$PFIZER$$40$YR$$F$Y$$$20240827$$MD$CH$CH
242538391$24253839$1$I$$20240821$20240827$20240827$EXP$$CA-PFIZER INC-PV202400110440$PFIZER$$40$YR$$M$Y$$$20240827$$HP$CA$CA
242538402$24253840$2$F$$20240828$20240827$20240829$PER$$NVSC2024US171220$NOVARTIS$$$$$$Y$$$20240829$$CN$US$US
242538411$24253841$1$I$$20240801$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07828$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242538421$24253842$1$I$20240729$20240823$20240827$20240827$PER$$US-BAYER-2024A122523$BAYER$$28$YR$A$F$Y$$$20240827$$MD$US$US
242538431$24253843$1$I$$20240826$20240827$20240827$PER$$US-BAYER-2024A122575$BAYER$$$$$$Y$$$20240827$$CN$US$US
242538441$24253844$1$I$20240601$20240807$20240827$20240827$PER$$US-TEVA-VS-3232169$TEVA$$$$$$Y$$$20240827$$CN$US$US
242538452$24253845$2$F$20240814$20240822$20240827$20240830$EXP$$CA-AstraZeneca-2024A191418$ASTRAZENECA$$16620$DY$$F$Y$$$20240830$$CN$CA$
242538471$24253847$1$I$$20240826$20240827$20240827$PER$$US-ROCHE-10000066418$ROCHE$$59$YR$A$F$Y$$$20240827$$MD$US$US
242538481$24253848$1$I$$20240822$20240827$20240827$EXP$$ZA-AstraZeneca-2024A192955$ASTRAZENECA$$62$YR$$F$Y$$$20240827$$CN$ZA$
242538491$24253849$1$I$$20240819$20240827$20240827$EXP$$TW-AstraZeneca-2024A190654$ASTRAZENECA$Tsai C.M., Lin C.H., Chou Y.Y., Jen H.Y., Jain S.. CLINICAL  APPLICATIONS OF COMPREHENSIVE GENOMIC PROFILING IN ADVANCED NON-SMALL-CELL LUNG CANCER-A CASE SERIES. Current Oncology 2024;31:3161?3176.$56$YR$$F$Y$$$20240827$$HP$TW$
242538501$24253850$1$I$$20240819$20240827$20240827$EXP$$TW-AstraZeneca-2024A190655$ASTRAZENECA$Tsai C.M., Lin C.H., Chou Y.Y., Jen H.Y., Jain S.. CLINICAL  APPLICATIONS OF COMPREHENSIVE GENOMIC PROFILING IN ADVANCED NON-SMALL-CELL LUNG CANCER-A CASE SERIES. Current Oncology 2024;31(6):3161?3176.$51$YR$$M$Y$$$20240827$$HP$TW$
242538512$24253851$2$F$$20240906$20240827$20240917$EXP$$US-ROCHE-10000061381$ROCHE$$84$YR$E$F$Y$$$20240917$$CN$US$US
242538521$24253852$1$I$$20240824$20240827$20240827$PER$$US-HALEON-2193634$Haleon PLC$$$$$$Y$$$20240827$$CN$US$US
242538531$24253853$1$I$$20240820$20240827$20240827$EXP$$US-AMERICAN REGENT INC-2024003242$AMERICAN REGENT$$$$A$F$Y$$$20240827$$HP$US$US
242538541$24253854$1$I$20230707$20240823$20240827$20240827$EXP$$CA-TAKEDA-2024TUS086108$TAKEDA$$74$YR$$M$Y$$$20240827$$CN$CA$CA
242538551$24253855$1$I$20240314$20240823$20240827$20240827$EXP$$US-GILEAD-2024-0685235$GILEAD$$75$YR$E$M$Y$$$20240827$$CN$US$US
242538561$24253856$1$I$20240731$20240823$20240827$20240827$PER$$US-BAYER-2024A122529$BAYER$$19$YR$A$F$Y$$$20240827$$MD$US$US
242538571$24253857$1$I$$20240820$20240827$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134464$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240827$$MD$JP$JP
242538581$24253858$1$I$$20240826$20240827$20240827$PER$$US-BAYER-2024A122591$BAYER$$$$$$Y$$$20240827$$CN$US$US
242538591$24253859$1$I$$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008600$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242538601$24253860$1$I$20230427$20240827$20240827$20240827$EXP$$GB-UCBSA-2024043428$UCB$$48$YR$$M$Y$84.2$KG$20240827$$HP$GB$GB
242538612$24253861$2$F$20240801$20240826$20240827$20240901$EXP$$FR-AUROBINDO-AUR-APL-2024-042286$AUROBINDO$$73$YR$$M$Y$$$20240901$$CN$FR$FR
242538621$24253862$1$I$20240101$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024169385$AMGEN$$61$YR$A$M$Y$$$20240827$$HP$US$US
242538631$24253863$1$I$$20240823$20240827$20240827$EXP$$NVSC2024US172123$NOVARTIS$$$$$F$Y$$$20240827$$HP$US$US
242538642$24253864$2$F$20240701$20240826$20240827$20240829$EXP$$US-KYOWAKIRIN-2024KK019951$KYOWA$$$$$$Y$$$20240829$$PH$US$US
242538651$24253865$1$I$$20240826$20240827$20240827$PER$$US-ROCHE-10000066620$ROCHE$$$$A$M$Y$$$20240827$$CN$US$US
242538661$24253866$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015207$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242538671$24253867$1$I$$20240820$20240827$20240827$EXP$$CA-JNJFOC-20240856302$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$HP$CA$CA
242538681$24253868$1$I$20240815$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015320$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242538691$24253869$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015352$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240827$$CN$US$US
242538701$24253870$1$I$$20240814$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408009638$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240827$$CN$US$US
242538712$24253871$2$F$$20240830$20240827$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408015299$ELI LILLY AND CO$$$$$M$Y$$$20240902$$CN$US$US
242538721$24253872$1$I$20231210$20240820$20240827$20240827$EXP$$DE-SA-2024SA250430$SANOFI AVENTIS$$$$$$Y$$$20240827$$MD$DE$DE
242538731$24253873$1$I$$20240820$20240827$20240827$EXP$$US-ABBVIE-5889207$ABBVIE$$$$$$Y$$$20240827$$CN$US$US
242538751$24253875$1$I$$20240823$20240827$20240827$PER$$US-BAYER-2024A122821$BAYER$$$$$F$Y$$$20240827$$CN$US$US
242538761$24253876$1$I$$20230906$20240827$20240827$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004688$AZURITY PHARMACEUTICALS$$$$$F$Y$$$20240809$$PH$US$US
242538771$24253877$1$I$20240201$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008598$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242538781$24253878$1$I$$20231020$20240827$20240827$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004836$AZURITY PHARMACEUTICALS$$2$YR$C$F$Y$$$20240809$$CN$US$US
242538791$24253879$1$I$20240124$20240124$20240827$20240827$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000098$AZURITY PHARMACEUTICALS$$42$YR$A$M$Y$$$20240809$$CN$US$US
242538801$24253880$1$I$$20240820$20240827$20240827$EXP$$CA-GALDERMA-CA2024013076$GALDERMA$$$$$$Y$$$20240827$$HP$CA$CA
242538811$24253881$1$I$$20240821$20240827$20240827$EXP$$US-PFIZER INC-202400242641$PFIZER$$$$$F$Y$$$20240827$$CN$US$US
242538821$24253882$1$I$20240101$20240821$20240827$20240827$EXP$$CA-PFIZER INC-202400179366$PFIZER$$80$YR$$M$Y$$$20240827$$PH$CA$CA
242538831$24253883$1$I$$20240819$20240827$20240827$EXP$$CA-ROCHE-10000060568$ROCHE$$47$YR$A$M$Y$$$20240827$$HP$CA$CA
242538842$24253884$2$F$$20240823$20240827$20240829$EXP$$ID-PFIZER INC-202400242265$PFIZER$Sufiawati, I.. Case Series of HIV-Associated Oral Lesions Across Different Clinical Stages in People Living with HIV. HIV/AIDS - Research and Palliative Care. 2024;16:289-299$34$YR$$F$Y$$$20240829$$MD$ID$ID
242538851$24253885$1$I$20240101$20240813$20240827$20240827$EXP$$GB-UCBSA-2024040935$UCB$$$$$M$Y$$$20240827$$CN$GB$GB
242538861$24253886$1$I$20240109$20240423$20240827$20240827$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000175$AZURITY PHARMACEUTICALS$$11$YR$C$F$Y$40$KG$20240809$$PH$US$US
242538871$24253887$1$I$$20240820$20240827$20240827$EXP$$AU-SA-2024SA248560$SANOFI AVENTIS$$$$A$$Y$$$20240827$$CN$AU$AU
242538881$24253888$1$I$$20240819$20240827$20240827$EXP$$US-TEVA-VS-3235708$TEVA$Parmeshwar N, Song S, Alcon A, Kim EA. The Incidence of Breast Cancer After Gender-Affirming Mastectomy in Transmen. [Review]. Ann-Plast-Surg 2022; 88 (4): S332-S336.$54$YR$$F$Y$$$20240827$$MD$US$US
242538892$24253889$2$F$$20240830$20240827$20240909$EXP$$US-TEVA-VS-3235707$TEVA$Parmeshwar N, Song S, Alcon A, Kim EA. The Incidence of Breast Cancer After Gender-Affirming Mastectomy in Transmen. [Review]. Ann-Plast-Surg 2022; 88 (4): S332-S336.; Parmeshwar N, Song S, Alcon A, Kim EA. The Incidence of Breast Cancer After Gender-Affirming Mastectomy in Transmen. [Review]. Ann-Plast-Surg 2022; 88 (4): S332-S336.$49$YR$$F$Y$$$20240909$$MD$US$US
242538901$24253890$1$I$$20240822$20240827$20240827$EXP$$NVSC2024GB172343$NOVARTIS$$$$$F$Y$$$20240827$$CN$GB$GB
242538911$24253891$1$I$20240101$20240821$20240827$20240827$EXP$$US-PFIZER INC-202400241939$PFIZER$$72$YR$$F$Y$$$20240827$$HP$US$US
242538921$24253892$1$I$20240806$20240826$20240827$20240827$PER$$US-BAYER-2024A122632$BAYER$$75$YR$E$M$Y$$$20240827$$CN$US$US
242538931$24253893$1$I$$20240824$20240827$20240827$PER$$US-BAYER-2024A122689$BAYER$$$$$F$Y$$$20240827$$CN$US$US
242538941$24253894$1$I$$20240801$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07837$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242538951$24253895$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169677$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242538963$24253896$3$F$20140808$20240903$20240827$20240906$EXP$$FR-PFIZER INC-2016SGN00133$PFIZER$Clarivet, B.. Adverse effects to brentuximab: a systematic retrospective study.. Fundamental and Clinical Pharmacology. 2017;31:(Suppl.1):52$83$YR$$M$Y$$$20240906$$HP$FR$FR
242538971$24253897$1$I$$20240816$20240827$20240827$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-08418$LUPIN$$$$$F$Y$$$20240827$$CN$AU$AU
242538982$24253898$2$F$20240821$20240828$20240827$20240829$PER$$US-AMGEN-USASP2024168841$AMGEN$$77$YR$E$F$Y$$$20240829$$HP$US$US
242538991$24253899$1$I$$20240812$20240827$20240827$PER$$US-MYLANLABS-2024M1075727$MYLAN$$$$$$Y$$$20240827$$CN$US$US
242539001$24253900$1$I$20240802$20240823$20240827$20240827$EXP$$US-ABBVIE-5894313$ABBVIE$$54$YR$$M$Y$$$20240827$$CN$US$US
242539011$24253901$1$I$20240101$20240820$20240827$20240827$EXP$$US-SA-2024SA249180$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240827$$MD$US$US
242539021$24253902$1$I$$20240824$20240827$20240827$PER$$US-BAYER-2024A122812$BAYER$$$$$F$Y$$$20240827$$CN$US$US
242539031$24253903$1$I$$20240822$20240827$20240827$EXP$$CA-PFIZER INC-202400242108$PFIZER$$29$YR$$F$Y$$$20240827$$PH$CA$CA
242539041$24253904$1$I$20230101$20240819$20240827$20240827$EXP$$JP-PFIZER INC-PV202300164423$PFIZER$$75$YR$$F$Y$46$KG$20240827$$MD$JP$JP
242539061$24253906$1$I$20240301$20240308$20240827$20240827$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000269$AZURITY PHARMACEUTICALS$$$$$$Y$$$20240809$$PH$US$US
242539071$24253907$1$I$$20240412$20240827$20240827$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000451$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240809$$CN$US$US
242539081$24253908$1$I$$20240822$20240827$20240827$EXP$GB-MHRA-MED-202408221705016070-LKDHS$GB-009507513-2408GBR008074$MERCK$$74$YR$$M$Y$$$20240827$$MD$GB$GB
242539091$24253909$1$I$$20240529$20240827$20240827$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000682$AZURITY PHARMACEUTICALS$$$$$F$Y$109$KG$20240615$$CN$US$US
242539101$24253910$1$I$$20240820$20240827$20240827$EXP$$US-SA-2024SA249356$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240827$$MD$US$US
242539111$24253911$1$I$$20240604$20240827$20240827$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000706$AZURITY PHARMACEUTICALS$$$$$$Y$$$20240809$$CN$US$US
242539121$24253912$1$I$$20240826$20240827$20240827$PER$$US-BAYER-2024A122947$BAYER$$84$YR$E$M$Y$$$20240827$$CN$US$US
242539131$24253913$1$I$$20240607$20240827$20240827$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000718$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240615$$HP$US$US
242539141$24253914$1$I$$20240820$20240827$20240827$PER$US-MLMSERVICE-20240813-PI161239-00217-1$US-RDY-SPO/USA/24/0012244$DR REDDYS$Modi B, Suravajjala DP, Case J, Velumani P. Metformin-Induced Nightmares: An Uncommon Event. Cureus. 2024;16(7):e64251. DOI: 10.7759/cureus.64251.$$$$M$Y$$$20240827$$MD$US$US
242539151$24253915$1$I$20200324$20240821$20240827$20240827$EXP$$MX-TAKEDA-MX202011698$TAKEDA$$17$YR$$M$Y$49$KG$20240827$$CN$MX$MX
242539161$24253916$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169838$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242539171$24253917$1$I$$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168871$AMGEN$$$$$M$Y$$$20240827$$HP$US$US
242539183$24253918$3$F$$20240906$20240827$20240910$PER$$US-BIOGEN-2024BI01279837$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
242539191$24253919$1$I$20231101$20240820$20240827$20240827$PER$$US-BIOGEN-2024BI01279330$BIOGEN$$53$YR$$M$Y$$$20240827$$CN$US$US
242539201$24253920$1$I$$20240822$20240827$20240827$PER$$US-BIOGEN-2024BI01279836$BIOGEN$$$$$F$Y$$$20240827$$HP$US$US
242539211$24253921$1$I$20240821$20240821$20240827$20240827$PER$$US-BIOGEN-2024BI01279489$BIOGEN$$33$YR$$F$Y$$$20240827$$CN$US$US
242539221$24253922$1$I$$20240821$20240827$20240827$PER$$US-BIOGEN-2020BI00899100$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
242539232$24253923$2$F$20230810$20240819$20240827$20240830$EXP$$KR-009507513-2408KOR005902$MERCK$$83$YR$$M$Y$$$20240830$$MD$KR$KR
242539241$24253924$1$I$$20240820$20240827$20240827$PER$$US-BIOGEN-2020BI00866752$BIOGEN$$$$$M$Y$$$20240827$$CN$US$US
242539251$24253925$1$I$20240801$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135786$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240827$$HP$US$US
242539262$24253926$2$F$20240401$20240911$20240827$20240912$PER$$US-ALXN-202408USA001376US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
242539271$24253927$1$I$20240101$20240823$20240827$20240827$PER$$US-BAUSCH-BL-2024-012864$BAUSCH AND LOMB$$$$$M$Y$$$20240827$$CN$US$US
242539282$24253928$2$F$$20240904$20240827$20240908$EXP$$DE-TAKEDA-2024TUS085346$TAKEDA$$$$A$M$Y$$$20240908$$MD$DE$DE
242539291$24253929$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192302$ASTRAZENECA$$$$$F$Y$$$20240827$$HP$US$
242539301$24253930$1$I$20240811$20240819$20240827$20240827$EXP$$JP-AstraZeneca-2024A191439$ASTRAZENECA$$$$$F$Y$$$20240827$$MD$JP$
242539311$24253931$1$I$20240717$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192312$ASTRAZENECA$$26362$DY$$F$Y$$$20240827$$CN$US$
242539321$24253932$1$I$$20240819$20240827$20240827$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024006097$BIOCON$$$$$$Y$$$20240827$$CN$AU$AU
242539331$24253933$1$I$$20240826$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075382$SANDOZ$$$$$M$Y$$$20240827$$CN$US$US
242539342$24253934$2$F$20240823$20240823$20240827$20240829$PER$$US-AMGEN-USASP2024169828$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242539351$24253935$1$I$$20240821$20240827$20240827$EXP$$CA-SANDOZ INC.-NVSC2019CA054134$SANDOZ$$$$$F$Y$$$20240827$$CN$CA$CA
242539361$24253936$1$I$$20240822$20240827$20240827$EXP$$JP-GSK-JP2024105703$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$JP$JP
242539381$24253938$1$I$$20240728$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07627$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242539391$24253939$1$I$$20240822$20240827$20240827$PER$$NVSC2024US171237$NOVARTIS$$$$$$Y$$$20240827$$CN$US$US
242539402$24253940$2$F$$20240901$20240827$20240910$EXP$$CA-TEVA-VS-3235579$TEVA$Mader JA, Martin S, Davey RA, Smith SJ. Case of Nonischemic Cardiomyopathy Secondary to Doxorubicin Requiring Heart Transplant while Managing Multiple Sclerosis on Ocrelizumab. Can-J-Hosp-Pharm 2024; 77 (2): 23-24.; Mader JA, Martin S, Davey RA, Smith SJ. Case of Nonischemic Cardiomyopathy Secondary to Doxorubicin Requiring Heart Transplant while Managing Multiple Sclerosis on Ocrelizumab. Can-J-Hosp-Pharm 2024; 77 (2): 23-24.$49$YR$$F$Y$$$20240910$$HP$CA$CA
242539411$24253941$1$I$$20240825$20240827$20240827$PER$$US-BAYER-2024A122753$BAYER$$$$$F$Y$$$20240827$$CN$US$US
242539423$24253942$3$F$$20240905$20240827$20240910$EXP$$MY-OTSUKA-2024_023406$OTSUKA$$$$$$Y$$$20240910$$PH$MY$MY
242539442$24253944$2$F$$20240826$20240827$20240829$PER$$US-BIOGEN-2024BI01279112$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
242539451$24253945$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3235016$TEVA$$3$YR$$$Y$$$20240827$$HP$CA$CA
242539461$24253946$1$I$20200825$20240820$20240827$20240827$EXP$$CA-TAKEDA-2024TUS084470$TAKEDA$$75$YR$$M$Y$$$20240827$$CN$CA$CA
242539471$24253947$1$I$$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008584$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242539491$24253949$1$I$$20240813$20240827$20240827$PER$$US-Calliditas-2024CAL01417$CALLIDITAS THERAPEUTICS$$68$YR$E$M$Y$110$KG$20240827$$CN$US$US
242539501$24253950$1$I$$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008594$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242539511$24253951$1$I$$20240822$20240827$20240827$PER$$US-ABBVIE-5893144$ABBVIE$$$$$M$Y$$$20240827$$MD$US$US
242539531$24253953$1$I$$20240815$20240827$20240827$PER$$US-MYLANLABS-2024M1076728$MYLAN$$$$$M$Y$$$20240827$$CN$US$US
242539541$24253954$1$I$$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008595$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242539552$24253955$2$F$20240501$20240919$20240827$20240924$EXP$$CA-JNJFOC-20240854814$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240924$$CN$CA$CA
242539561$24253956$1$I$$20240813$20240827$20240827$PER$$US-ROCHE-10000056610$ROCHE$$$$A$F$Y$$$20240827$$HP$US$US
242539582$24253958$2$F$20240101$20240828$20240827$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134912$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$$$20240830$$CN$US$US
242539591$24253959$1$I$20240101$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134355$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240827$$HP$US$US
242539601$24253960$1$I$$20240819$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131714$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240827$$CN$US$US
242539611$24253961$1$I$$20240820$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132993$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240827$$CN$US$US
242539622$24253962$2$F$20240816$20240822$20240827$20240830$EXP$$JP-TEVA-VS-3236268$TEVA$$9$YR$$F$Y$$$20240830$$PH$JP$JP
242539631$24253963$1$I$$20240821$20240827$20240827$EXP$$CA-APOTEX-2024AP009685$APOTEX$$47$YR$$F$Y$$$20240827$$HP$CA$CA
242539642$24253964$2$F$20240729$20240916$20240827$20240918$PER$$US-ROCHE-10000066115$ROCHE$$37$YR$A$M$Y$$$20240918$$CN$US$US
242539651$24253965$1$I$$20240823$20240827$20240827$PER$$US-ROCHE-10000065655$ROCHE$$$$A$F$Y$63$KG$20240827$$CN$US$US
242539661$24253966$1$I$20240701$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008597$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242539671$24253967$1$I$20240708$20240821$20240827$20240827$EXP$FR-AFSSAPS-SE2024000571$FR-MYLANLABS-2024M1068303$MYLAN$$61$YR$$F$Y$$$20240827$$MD$FR$FR
242539681$24253968$1$I$20240817$20240826$20240827$20240827$PER$$US-ROCHE-10000066369$ROCHE$$27$YR$A$M$Y$$$20240827$$CN$US$US
242539691$24253969$1$I$$20240820$20240827$20240827$EXP$$GB-ROCHE-10000061714$ROCHE$$$$A$F$Y$$$20240827$$HP$GB$GB
242539701$24253970$1$I$$20240820$20240827$20240827$PER$$US-ROCHE-10000066071$ROCHE$$$$$M$Y$$$20240827$$CN$US$US
242539711$24253971$1$I$$20240820$20240827$20240827$PER$$US-ROCHE-10000066082$ROCHE$$$$$M$Y$$$20240827$$CN$US$US
242539723$24253972$3$F$$20240820$20240827$20240906$EXP$$PT-009507513-2408PRT007860$MERCK$Jesus G, Soares I, Silva S, Barreira R, Murteira F. PO-0581 - (4804) - BCGitis - A CASE OF SERIOUS SEPSIS AFTER INTRAVESICAL IMMUNOTHERAPY.. Abstract book - 30? CNMI.. 2024;927$65$YR$$M$Y$$$20240906$$HP$PT$PT
242539731$24253973$1$I$20240824$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016445$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240827$$CN$US$US
242539741$24253974$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015203$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240827$$CN$US$US
242539751$24253975$1$I$20240822$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015015$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240827$$CN$US$US
242539761$24253976$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015466$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240827$$CN$US$US
242539771$24253977$1$I$20240814$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016371$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240827$$CN$US$US
242539782$24253978$2$F$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016376$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240827$$CN$US$US
242539791$24253979$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015361$ELI LILLY AND CO$$63$YR$A$$Y$$$20240827$$LW$US$US
242539801$24253980$1$I$20240501$20240822$20240827$20240827$EXP$$US-KYOWAKIRIN-2024KK019926$KYOWA$$$$$$Y$$$20240827$$HP$US$US
242539811$24253981$1$I$$20240822$20240827$20240827$EXP$$NVSC2024US171413$NOVARTIS$$48$YR$$F$Y$$$20240827$$HP$US$US
242539821$24253982$1$I$20240817$20240826$20240827$20240827$PER$$US-ROCHE-10000066255$ROCHE$$48$YR$A$M$Y$$$20240827$$CN$US$US
242539831$24253983$1$I$$20240820$20240827$20240827$PER$$US-ROCHE-10000066098$ROCHE$$7$YR$C$M$Y$$$20240827$$CN$US$US
242539841$24253984$1$I$20240804$20240826$20240827$20240827$EXP$GB-MHRA-MED-202408261556527850-PVMZD$GB-JNJFOC-20240866390$JOHNSON AND JOHNSON$$55$YR$A$F$Y$67$KG$20240827$$CN$GB$GB
242539851$24253985$1$I$$20240819$20240827$20240827$30DAY$$US-GSK-US2024103449$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
242539861$24253986$1$I$20230128$20240731$20240827$20240827$PER$$US-JNJFOC-20240864823$JOHNSON AND JOHNSON$$52$YR$A$F$Y$72.57$KG$20240827$$HP$US$US
242539871$24253987$1$I$$20240726$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07605$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242539881$24253988$1$I$$20240826$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075393$SANDOZ$$$$$M$Y$$$20240827$$CN$US$US
242539892$24253989$2$F$20240806$20240926$20240827$20240930$EXP$$US-ROCHE-10000065630$ROCHE$$49$YR$A$F$Y$87.54$KG$20240930$$CN$US$US
242539901$24253990$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192206$ASTRAZENECA$$$$$$Y$$$20240827$$CN$US$
242539911$24253991$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A191896$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242539921$24253992$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A191767$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242539931$24253993$1$I$$20240823$20240827$20240827$EXP$$NVSC2024TR172335$NOVARTIS$$43$YR$$M$Y$$$20240827$$CN$TR$TR
242539941$24253994$1$I$20240611$20240820$20240827$20240827$EXP$ES-AEMPS-1560619$ES-FreseniusKabi-FK202412717$FRESENIUS KABI$$73$YR$E$M$Y$$$20240827$$MD$ES$ES
242539951$24253995$1$I$20240725$20240819$20240827$20240827$EXP$FR-AFSSAPS-LL2024001563$FR-FreseniusKabi-FK202412672$FRESENIUS KABI$$78$YR$E$M$Y$69$KG$20240827$$PH$FR$FR
242539961$24253996$1$I$$20240820$20240827$20240827$PER$$US-JNJFOC-20240854089$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$US$US
242539971$24253997$1$I$20240101$20240823$20240827$20240827$EXP$$US-JNJFOC-20240867344$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240827$$HP$US$US
242539981$24253998$1$I$$20240821$20240827$20240827$EXP$$NZ-TAKEDA-2024TUS084868$TAKEDA$$$$$F$Y$$$20240827$$PH$NZ$NZ
242539992$24253999$2$F$$20230524$20240827$20240827$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00445$TARO$$$$$$Y$$$20240827$$CN$US$US
242540003$24254000$3$F$$20240814$20240827$20240830$EXP$$US-B.Braun Medical Inc.-2160908$B BRAUN$Literature Article$46$YR$$M$Y$$$20240830$$$US$US
242540011$24254001$1$I$$20240821$20240827$20240827$EXP$$CA-APOTEX-2024AP009686$APOTEX$$69$YR$$F$Y$$$20240827$$CN$CA$CA
242540023$24254002$3$F$20240712$20240909$20240827$20240912$EXP$$FR-FreseniusKabi-FK202412456$FRESENIUS KABI$$$$A$M$Y$93$KG$20240912$$MD$FR$FR
242540031$24254003$1$I$$20240819$20240827$20240827$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006146$BIOCON$$$$$$Y$$$20240827$$CN$CA$CA
242540041$24254004$1$I$$20240819$20240827$20240827$EXP$$ZA-TAKEDA-2024TUS084585$TAKEDA$$$$$F$Y$$$20240827$$CN$ZA$ZA
242540051$24254005$1$I$$20240822$20240827$20240827$PER$$US-ALXN-202408USA001577US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240827$$HP$US$US
242540061$24254006$1$I$$20240820$20240827$20240827$EXP$$US-AMGEN-USASP2024166197$AMGEN$$$$$M$Y$$$20240827$$CN$US$US
242540071$24254007$1$I$$20240817$20240827$20240827$PER$$US-JNJFOC-20240849177$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$US$US
242540081$24254008$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3235022$TEVA$$35$YR$$F$Y$$$20240827$$HP$CA$CA
242540093$24254009$3$F$20240806$20240910$20240827$20240911$EXP$$US-KYOWAKIRIN-2024KK019953$KYOWA$$$$$$Y$$$20240911$$CN$US$US
242540101$24254010$1$I$$20240819$20240827$20240827$EXP$$CN-UCBSA-2022009383$UCB$Yang L, Jiang M, Yu R, Hu R, Xiong F, Li J. A case report of precocious puberty related to Rett syndrome and a literature review. Pharmazie. 2021;76:559-61$$$C$F$Y$21$KG$20240827$$MD$CN$CN
242540111$24254011$1$I$$20240816$20240827$20240827$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004982$SAREPTA THERAPEUTICS$$$$$M$Y$81.633$KG$20240827$$HP$US$US
242540121$24254012$1$I$20240722$20240820$20240827$20240827$PER$$US-BIOGEN-2024BI01275170$BIOGEN$$36$YR$$F$Y$$$20240827$$CN$US$US
242540131$24254013$1$I$$20240821$20240827$20240827$PER$$US-BIOGEN-2024BI01279462$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
242540141$24254014$1$I$$20240826$20240827$20240827$PER$$US-BAYER-2024A122531$BAYER$$44$YR$A$F$Y$$$20240827$$HP$US$US
242540151$24254015$1$I$$20240822$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135165$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240827$$CN$US$US
242540161$24254016$1$I$$20240826$20240827$20240827$PER$$US-BAYER-2024A122532$BAYER$$28$YR$A$F$Y$$$20240827$$CN$US$US
242540171$24254017$1$I$20200101$20240813$20240827$20240827$EXP$$US-UCBSA-2024041213$UCB$$48$YR$$F$Y$$$20240827$$HP$US$US
242540181$24254018$1$I$$20240820$20240827$20240827$EXP$$US-MYLANLABS-2024M1078631$MYLAN$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J-Drugs-Dermatol 2023; 22 (11): e12-e16.$50$YR$$M$Y$$$20240827$$HP$US$US
242540191$24254019$1$I$20240813$20240822$20240827$20240827$EXP$$NVSC2024DE171606$NOVARTIS$$45$YR$$F$Y$$$20240827$$MD$DE$DE
242540201$24254020$1$I$$20240826$20240827$20240827$PER$$US-BAYER-2024A122534$BAYER$$44$YR$A$F$Y$$$20240827$$MD$US$US
242540211$24254021$1$I$$20240820$20240827$20240827$EXP$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-23-00786$MELINTA THERAPEUTICS$$$$$$Y$$$20240827$$CN$US$US
242540221$24254022$1$I$$20240820$20240827$20240827$EXP$GB-MHRA-MED-202305131225320690-RVSDL$GB-RDY-SPO/GBR/24/0012225$DR REDDYS$$$$$$Y$$$20240827$$CN$GB$GB
242540231$24254023$1$I$$20240826$20240827$20240827$PER$$US-BAYER-2024A122537$BAYER$$25$YR$A$F$Y$$$20240827$$MD$US$US
242540242$24254024$2$F$$20240823$20240827$20240830$PER$$US-AMGEN-USASP2024169781$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242540251$24254025$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135898$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240827$$HP$US$US
242540262$24254026$2$F$$20240828$20240827$20240902$PER$$US-ALXN-202408USA001262US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242540271$24254027$1$I$20240620$20240822$20240827$20240827$EXP$$NVSC2024CN172107$NOVARTIS$$37$YR$$M$Y$60$KG$20240827$$HP$CN$CN
242540321$24254032$1$I$20240716$20240726$20240826$20240826$DIR$FDA-CDER-CTU-2024-58638$$FDA-CTU$$$$$$N$$$20240726$N$HP$US$
242540331$24254033$1$I$20230101$20240813$20240827$20240827$EXP$$US-CHIESI-2024CHF05157$CHIESI$$52$YR$$M$Y$$$20240827$$CN$US$US
242540361$24254036$1$I$$20240814$20240827$20240827$EXP$$US-UCBSA-2024041794$UCB$$$$$$Y$$$20240827$$CN$US$US
242540373$24254037$3$F$20240822$20240913$20240827$20240917$PER$$US-AMGEN-USASP2024169117$AMGEN$$73$YR$E$M$Y$$$20240917$$CN$US$US
242540381$24254038$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189242$ASTRAZENECA$$$$$M$Y$72$KG$20240827$$CN$US$
242540391$24254039$1$I$$20240823$20240827$20240827$EXP$$JP-AstraZeneca-2024A193835$ASTRAZENECA$$75$YR$$M$Y$$$20240827$$MD$JP$
242540401$24254040$1$I$20240730$20240822$20240827$20240827$EXP$$US-BAYER-2024A121306$BAYER$$78$YR$E$M$Y$$$20240827$$CN$US$US
242540411$24254041$1$I$$20240820$20240827$20240827$EXP$$CN-TAKEDA-2024TUS084842$TAKEDA$$$$$M$Y$$$20240827$$CN$CN$CN
242540421$24254042$1$I$$20240717$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07249$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242540431$24254043$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014413$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240827$$CN$US$US
242540441$24254044$1$I$$20240826$20240827$20240827$PER$$US-ROCHE-10000066368$ROCHE$$$$$F$Y$$$20240827$$CN$US$US
242540461$24254046$1$I$20240823$20240826$20240827$20240827$PER$$US-BAYER-2024A122750$BAYER$$41$YR$A$F$Y$$$20240827$$MD$US$US
242540471$24254047$1$I$$20240820$20240827$20240827$PER$$US-ROCHE-10000062301$ROCHE$$$$$F$Y$$$20240827$$PH$US$US
242540481$24254048$1$I$$20240823$20240827$20240827$EXP$$US-UCBSA-2024026929$UCB$$$$$M$Y$$$20240827$$CN$US$US
242540491$24254049$1$I$$20240823$20240827$20240827$PER$$US-ROCHE-10000065690$ROCHE$$49$YR$A$F$Y$$$20240827$$HP$US$US
242540501$24254050$1$I$20240731$20240826$20240827$20240827$PER$$US-BAYER-2024A122840$BAYER$$32$YR$A$F$Y$$$20240827$$HP$US$US
242540511$24254051$1$I$$20240817$20240827$20240827$30DAY$$US-GSK-US2024AMR104334$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
242540522$24254052$2$F$20240815$20240827$20240827$20240829$PER$$US-AMGEN-USASP2024170747$AMGEN$$66$YR$E$M$Y$$$20240829$$CN$US$US
242540531$24254053$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169784$AMGEN$$$$$$Y$$$20240827$$PH$US$US
242540541$24254054$1$I$$20240821$20240827$20240827$EXP$$US-BIOVITRUM-2024-US-011274$BIOVITRUM$Tinajero J, Trang D, Ngo D, Ali H. Pacritinib and concurrent azole antifungal therapy is deliverable in patients with hematologic malignancies. Journal of Oncology Pharmacy Practice. 2024;0(0): 1-5. doi:10.1177/1078155224/275205.$7$DEC$$M$Y$$$20240827$$HP$US$US
242540551$24254055$1$I$$20240821$20240827$20240827$EXP$$US-AMGEN-USASP2024167705$AMGEN$Molnar M.; Yamauchi J.; Azhar A.et al.. Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2-Infected versus Noninfected Deceased Donors. Clinical journal of the American Society of Nephrology. 2023;18 (11):1466-1475$$$$$Y$$$20240827$$HP$US$US
242540561$24254056$1$I$20240731$20240731$20240827$20240827$PER$$TR-TOLMAR, INC.-24TR051499$TOLMAR$$73$YR$$M$Y$$$20240827$$MD$TR$TR
242540571$24254057$1$I$20240730$20240731$20240827$20240827$PER$$TR-TOLMAR, INC.-24TR051573$TOLMAR$$68$YR$$$Y$$$20240827$$MD$TR$TR
242540581$24254058$1$I$20240730$20240731$20240827$20240827$PER$$TR-TOLMAR, INC.-24TR051587$TOLMAR$$$$A$M$Y$$$20240827$$HP$TR$TR
242540592$24254059$2$F$$20240829$20240827$20240917$PER$$TR-TOLMAR, INC.-24TR051666$TOLMAR$$42$YR$$F$Y$$$20240917$$PH$TR$TR
242540611$24254061$1$I$$20240822$20240827$20240827$PER$$US-BAYER-2024A121944$BAYER$$$$$M$Y$$$20240827$$CN$US$US
242540621$24254062$1$I$20231231$20240822$20240827$20240827$EXP$$EG-CHEPLA-2024010889$CHEPLAPHARM$$50$YR$$F$Y$$$20240827$$MD$COUNTRY NOT SPECIFIED$EG
242540631$24254063$1$I$$20240818$20240827$20240827$EXP$$US-AMGEN-USASP2024167520$AMGEN$Yeh S.; Liao A.; Vasseneix C.F. et. al. Visual Morbidity and Outcomes of Scleritis Associated with Intraocular Inflammation Compared to Isolated Scleritis. Ocular Immunology and Inflammation. 2024;32 (6):947-954$$$$F$Y$$$20240827$$MD$US$US
242540641$24254064$1$I$$20240821$20240827$20240827$EXP$$GR-MYLANLABS-2024M1078903$MYLAN$Dimitrakopoulos F-I, Goussia A, Koliou G-A, Dadouli K, Batistatou A, Kourea HP, et al. Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide + epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes. Breast 2024; 73.$$$$F$Y$$$20240827$$HP$GR$GR
242540652$24254065$2$F$$20240826$20240827$20240829$PER$$US-BIOVITRUM-2024-US-011276$BIOVITRUM$Tinajero J, Trang D, Ngo D, Ali H. Pacritinib and concurrent azole antifungal therapy is deliverable in patients with hematologic malignancies. Journal of Oncology Pharmacy Practice. 2024;0(0): 1-5. doi:10.1177/1078155224/275205.$6$DEC$$F$Y$$$20240829$$HP$US$US
242540661$24254066$1$I$$20240822$20240827$20240827$PER$$US-ROCHE-10000066056$ROCHE$$4$YR$C$M$Y$$$20240827$$CN$US$US
242540671$24254067$1$I$20240825$20240826$20240827$20240827$PER$$US-BAYER-2024A122887$BAYER$$27$YR$A$F$Y$$$20240827$$HP$US$US
242540683$24254068$3$F$$20240910$20240827$20240925$PER$$US-BIOVITRUM-2024-US-011330$BIOVITRUM$$72$YR$$F$Y$$$20240925$$MD$US$US
242540691$24254069$1$I$$20240823$20240827$20240827$PER$$US-HALEON-2193530$Haleon PLC$$$$$$Y$$$20240827$$CN$US$US
242540701$24254070$1$I$$20240822$20240827$20240827$PER$$US-ROCHE-10000066075$ROCHE$$$$$M$Y$$$20240827$$CN$US$US
242540711$24254071$1$I$20240404$20240822$20240827$20240827$EXP$FR-AFSSAPS-LL2024001589$FR-PFIZER INC-202400241598$PFIZER$$35$YR$$F$Y$$$20240827$$MD$FR$FR
242540721$24254072$1$I$20240726$20240822$20240827$20240827$EXP$FR-AFSSAPS-CN2024000805$FR-PFIZER INC-202400241691$PFIZER$$81$YR$$M$Y$141$KG$20240827$$PH$FR$FR
242540741$24254074$1$I$$20240822$20240827$20240827$EXP$$GB-PFIZER INC-202400241929$PFIZER$$3$DEC$$F$Y$$$20240827$$MD$GB$GB
242540771$24254077$1$I$$20240826$20240827$20240827$EXP$$MA-PFIZER INC-PV202400111111$PFIZER$$$$$F$Y$$$20240827$$CN$MA$MA
242540791$24254079$1$I$$20240822$20240827$20240827$EXP$$US-PFIZER INC-202400242817$PFIZER$$77$YR$$F$Y$$$20240827$$HP$US$US
242540801$24254080$1$I$$20240823$20240827$20240827$PER$$US-ROCHE-10000065624$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242540811$24254081$1$I$20240101$20240822$20240827$20240827$EXP$$AU-PFIZER INC-PV202400109891$PFIZER$$65$YR$$F$Y$$$20240827$$MD$AU$AU
242540821$24254082$1$I$20240702$20240822$20240827$20240827$EXP$$CN-PFIZER INC-PV202400110013$PFIZER$$67$YR$$F$Y$$$20240827$$HP$CN$CN
242540831$24254083$1$I$$20240822$20240827$20240827$EXP$$JP-PFIZER INC-202400241688$PFIZER$$$$$$Y$$$20240827$$MD$JP$JP
242540841$24254084$1$I$20240819$20240822$20240827$20240827$EXP$$CN-PFIZER INC-PV202400110020$PFIZER$$36$YR$$F$Y$$$20240827$$HP$CN$CN
242540851$24254085$1$I$$20240823$20240827$20240827$EXP$$JP-PFIZER INC-202400242587$PFIZER$$$$$$Y$$$20240827$$MD$JP$JP
242540871$24254087$1$I$20210504$20240822$20240827$20240827$EXP$$BE-PFIZER INC-202400241932$PFIZER$$47$YR$$M$Y$$$20240827$$CN$BE$BE
242540881$24254088$1$I$20220601$20240821$20240827$20240827$EXP$$US-PFIZER INC-202400241130$PFIZER$$$$A$F$Y$$$20240827$$MD$US$US
242540891$24254089$1$I$20240621$20240822$20240827$20240827$EXP$FR-AFSSAPS-CN2024000724$FR-PFIZER INC-202400241618$PFIZER$$72$YR$$F$Y$73$KG$20240827$$MD$FR$FR
242540901$24254090$1$I$20240715$20240822$20240827$20240827$EXP$FR-AFSSAPS-LM2024000463$FR-PFIZER INC-202400241602$PFIZER$$78$YR$$M$Y$60$KG$20240827$$MD$FR$FR
242540911$24254091$1$I$$20240822$20240827$20240827$EXP$$CA-PFIZER INC-202400243211$PFIZER$$63$YR$$F$Y$$$20240827$$CN$CA$CA
242540921$24254092$1$I$$20240822$20240827$20240827$EXP$$IN-PFIZER INC-PV202400110307$PFIZER$$$$$$Y$$$20240827$$MD$IN$IN
242540931$24254093$1$I$20240112$20240822$20240827$20240827$EXP$FR-AFSSAPS-LL2024001576$FR-PFIZER INC-202400241643$PFIZER$$57$YR$$M$Y$$$20240827$$PH$FR$FR
242540941$24254094$1$I$$20240819$20240827$20240827$EXP$$BR-TAKEDA-BR202024875$TAKEDA$$$$$M$Y$92$KG$20240827$$MD$BR$BR
242540961$24254096$1$I$20240822$20240822$20240827$20240827$EXP$$CA-PFIZER INC-202400243664$PFIZER$$35$YR$$F$Y$$$20240827$$HP$CA$CA
242540971$24254097$1$I$$20240729$20240826$20240826$DIR$FDA-CDER-CTU-2024-58639$$FDA-CTU$$$$$$N$$$20240729$N$HP$US$
242540981$24254098$1$I$20240101$20240816$20240827$20240827$EXP$$CA-ROCHE-10000061943$ROCHE$$69$YR$E$F$Y$$$20240827$$CN$CA$CA
242540992$24254099$2$F$$20240919$20240827$20240930$PER$$US-MYLANLABS-2024M1077930$MYLAN$$$$$F$Y$$$20240930$$CN$US$US
242541001$24254100$1$I$$20240823$20240827$20240827$EXP$$GB-MYLANLABS-2024M1078683$MYLAN$$$$$M$Y$$$20240827$$HP$GB$GB
242541011$24254101$1$I$20240814$20240823$20240827$20240827$EXP$GB-MHRA-MED-202408231607265850-WDBYV$GB-INDIVIOR US-INDV-156184-2024$RECKITT BENCKISER$$$$$$Y$$$20240827$$HP$GB$GB
242541022$24254102$2$F$$20240829$20240827$20240902$PER$$US-AMGEN-USASP2024169415$AMGEN$$$$$F$Y$$$20240902$$PH$US$US
242541032$24254103$2$F$20240819$20240906$20240827$20240916$EXP$$JP-AMGEN-JPNSP2024168989$AMGEN$$80$YR$E$F$Y$$$20240916$$PH$JP$JP
242541041$24254104$1$I$20240728$20240822$20240827$20240827$EXP$FR-AFSSAPS-LM2024000470$FR-PFIZER INC-202400241648$PFIZER$$68$YR$$M$Y$59.7$KG$20240827$$MD$FR$FR
242541053$24254105$3$F$20240819$20240926$20240827$20240926$PER$$US-BAYER-2024A120817$BAYER$$32$YR$A$F$Y$$$20240926$$HP$US$US
242541071$24254107$1$I$20230801$20240821$20240827$20240827$EXP$$US-PFIZER INC-202400241452$PFIZER$$84$YR$$M$Y$$$20240827$$CN$US$US
242541081$24254108$1$I$$20240821$20240827$20240827$EXP$$US-AMGEN-USASP2024167706$AMGEN$Molnar M.; Yamauchi J.; Azhar A.et.al. Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2-Infected versus Noninfected Deceased Donors. Clinical journal of the American Society of Nephrology. 2023;18 (11):1466-1475$$$$$Y$$$20240827$$HP$US$US
242541091$24254109$1$I$20240723$20240820$20240827$20240827$EXP$$CN-PFIZER INC-PV202400108731$PFIZER$$28$YR$$F$Y$69$KG$20240827$$HP$CN$CN
242541101$24254110$1$I$20211012$20240820$20240827$20240827$EXP$$KR-PFIZER INC-202400239568$PFIZER$$52$YR$$F$Y$$$20240827$$MD$KR$KR
242541111$24254111$1$I$20220601$20240819$20240827$20240827$EXP$FR-AFSSAPS-ST2024001303$FR-PFIZER INC-202400244229$PFIZER$$69$YR$$M$Y$$$20240827$$MD$FR$FR
242541121$24254112$1$I$20230926$20240823$20240827$20240827$EXP$$PK-PFIZER INC-PV202300175337$PFIZER$$29$YR$$F$Y$64$KG$20240827$$CN$PK$PK
242541141$24254114$1$I$$20240823$20240827$20240827$EXP$$US-PFIZER INC-PV202400110717$PFIZER$$44$YR$$F$Y$117.9$KG$20240827$$MD$US$US
242541151$24254115$1$I$20240101$20240823$20240827$20240827$EXP$$US-Eisai-EC-2024-172858$EISAI$$58$YR$A$M$Y$73$KG$20240827$$CN$US$US
242541161$24254116$1$I$$20240820$20240827$20240827$EXP$$CA-JNJFOC-20240856338$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240827$$PH$CA$CA
242541171$24254117$1$I$$20240820$20240827$20240827$PER$$US-ALXN-202408USA001283US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242541181$24254118$1$I$20240712$20240821$20240827$20240827$EXP$$AU-JNJFOC-20240865165$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240827$$MD$AU$AU
242541191$24254119$1$I$20160101$20240826$20240827$20240827$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047974$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240827$$CN$US$US
242541201$24254120$1$I$$20240723$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07512$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242541211$24254121$1$I$$20240815$20240827$20240827$EXP$$US-Accord-442667$ACCORD$$70$YR$$F$Y$$$20240827$$MD$US$US
242541221$24254122$1$I$$20240823$20240827$20240827$EXP$$ZA-BAYER-2024A122245$BAYER$$42$YR$A$F$Y$$$20240827$$CN$ZA$ZA
242541241$24254124$1$I$$20240821$20240827$20240827$EXP$$ES-ROCHE-10000062338$ROCHE$Albarran V, Guerrero P, De Quevedo C, Gonz?lez C, Chamorro J, Rosero D, et al. Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent. Cancer Immunology, Immunotherapy. 2024-Oct;73 (186):1-9. doi:10.1007/s00262-024-03772-9.$$$$$Y$$$20240827$$HP$ES$ES
242541251$24254125$1$I$$20240827$20240827$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048026$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$$$20240827$$CN$US$US
242541261$24254126$1$I$20240817$20240819$20240827$20240827$PER$$US-ABBVIE-5887572$ABBVIE$$79$YR$$F$Y$$$20240827$$CN$US$US
242541272$24254127$2$F$20240823$20240828$20240827$20240902$PER$$US-AMGEN-USASP2024169627$AMGEN$$55$YR$A$F$Y$$$20240902$$CN$US$US
242541291$24254129$1$I$20240816$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169449$AMGEN$$62$YR$A$F$Y$$$20240827$$CN$US$US
242541301$24254130$1$I$20240701$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169475$AMGEN$$72$YR$E$F$Y$$$20240827$$CN$US$US
242541311$24254131$1$I$20240809$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169378$AMGEN$$82$YR$E$F$Y$$$20240827$$CN$US$US
242541321$24254132$1$I$$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134085$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$64.41$KG$20240827$$CN$US$US
242541331$24254133$1$I$$20240819$20240827$20240827$EXP$$GB-AstraZeneca-2024A190438$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$GB$
242541341$24254134$1$I$$20240726$20240826$20240826$DIR$FDA-CDER-CTU-2024-58642$$FDA-CTU$$$$$$N$$$20240726$N$HP$US$
242541361$24254136$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135720$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240827$$CN$US$US
242541372$24254137$2$F$$20240829$20240827$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136057$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240902$$CN$US$US
242541391$24254139$1$I$20240101$20240820$20240827$20240827$EXP$$US-009507513-2408USA006840$MERCK$$$$$M$Y$$$20240827$$CN$US$US
242541411$24254141$1$I$$20240819$20240827$20240827$EXP$$JP-AstraZeneca-2024A190737$ASTRAZENECA$$74$YR$$M$Y$$$20240827$$MD$JP$
242541421$24254142$1$I$20240611$20240820$20240827$20240827$EXP$ES-AEMPS-1561569$ES-ROCHE-10000061264$ROCHE$$76$YR$E$M$Y$$$20240827$$MD$ES$ES
242541431$24254143$1$I$$20240731$20240826$20240826$DIR$FDA-CDER-CTU-2024-58645$$FDA-CTU$$30$YR$$F$N$$$20240731$N$HP$US$
242541441$24254144$1$I$20240805$20240816$20240827$20240827$EXP$GB-MHRA-MIDB-9942e313-ef91-42b5-b8e9-c9e9f3831a23$GB-SA-2024SA245120$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240827$$PH$GB$GB
242541451$24254145$1$I$$20240815$20240827$20240827$EXP$$US-FreseniusKabi-FK202412613$FRESENIUS KABI$Gaunt MJ, Bertagnoli S, Shastay A, Jew RK. Wrong patient error results in ED visit for an adolescent child. ISMP Medication Safety Alert! Community/Ambulatory Care. 2024 Aug;23(8): 1-4.$$$$F$Y$$$20240827$$PH$US$US
242541461$24254146$1$I$$20240819$20240827$20240827$EXP$$US-SA-2024SA247523$SANOFI AVENTIS$Kong S, Nagraj S, Cooper DL, Ferrick KJ, Zhang L.. A case report of fludarabine associated ectopic atrial bradycardia and literature review of fludarabine induced bradycardia.. Cardio-Oncology. 2024;10(50):1-8$30$YR$A$F$Y$$$20240827$$HP$US$US
242541471$24254147$1$I$$20240823$20240827$20240827$PER$$US-ABBVIE-5895613$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242541481$24254148$1$I$20231121$20240226$20240827$20240827$PER$$US-AMERICAN REGENT INC-2023002779$AMERICAN REGENT$$$$$F$Y$$$20240827$$CN$US$US
242541491$24254149$1$I$$20240821$20240827$20240827$PER$$US-ALXN-202408USA001523US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242541502$24254150$2$F$20231101$20240911$20240827$20240912$PER$$US-ALXN-202408USA001566US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240912$$MD$US$US
242541511$24254151$1$I$20240512$20240819$20240827$20240827$EXP$GB-MHRA-MED-202408191143490880-GTNKD$GB-SA-2024SA247054$SANOFI AVENTIS$$69$YR$E$M$Y$98$KG$20240827$$PH$GB$GB
242541521$24254152$1$I$$20240822$20240827$20240827$EXP$$JP-009507513-2408JPN002942J$MERCK$$7$DEC$$M$Y$$$20240827$$MD$JP$JP
242541531$24254153$1$I$20240823$20240823$20240827$20240827$PER$$US-GILEAD-2024-0685260$GILEAD$$$$$M$Y$$$20240827$$MD$US$US
242541541$24254154$1$I$$20240822$20240827$20240827$EXP$$CA-SANDOZ INC.-SDZ2024CA075190$SANDOZ$$23$YR$$M$Y$$$20240827$$CN$CA$CA
242541551$24254155$1$I$$20240819$20240827$20240827$EXP$$GB-TEVA-VS-3235254$TEVA$$70$YR$$F$Y$64$KG$20240827$$MD$GB$GB
242541561$24254156$1$I$$20240725$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07473$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242541571$24254157$1$I$$20240819$20240827$20240827$EXP$$US-SA-2024SA248700$SANOFI AVENTIS$$$$$M$Y$$$20240827$$MD$US$US
242541581$24254158$1$I$20240214$20240822$20240827$20240827$EXP$SE-SEMPA-2024-005471$SE-VERTEX PHARMACEUTICALS-2024-013521$VERTEX$$45$YR$$F$Y$$$20240827$$MD$SE$SE
242541591$24254159$1$I$$20240822$20240827$20240827$PER$$US-VERTEX PHARMACEUTICALS-2024-013561$VERTEX$$$$$$Y$$$20240827$$CN$US$US
242541601$24254160$1$I$$20240819$20240827$20240827$EXP$GB-MHRA-MED-202408191141120190-NVSHL$GB-TEVA-VS-3235265$TEVA$$52$YR$$M$Y$101$KG$20240827$$CN$GB$GB
242541611$24254161$1$I$$20240820$20240827$20240827$EXP$$US-VERTEX PHARMACEUTICALS-2024-013533$VERTEX$$$$$F$Y$$$20240827$$CN$US$US
242541621$24254162$1$I$20240101$20240822$20240827$20240827$EXP$$PT-VERTEX PHARMACEUTICALS-2024-013536$VERTEX$$30$YR$$M$Y$$$20240827$$HP$PT$PT
242541631$24254163$1$I$$20240822$20240827$20240827$PER$$US-VERTEX PHARMACEUTICALS-2024-013625$VERTEX$$$$$$Y$$$20240827$$CN$US$US
242541642$24254164$2$F$20240101$20240903$20240827$20240906$PER$$US-VERTEX PHARMACEUTICALS-2024-013527$VERTEX$$$$$$Y$$$20240906$$CN$US$US
242541651$24254165$1$I$20220531$20240821$20240827$20240827$EXP$FR-AFSSAPS-LL2024001572$FR-VERTEX PHARMACEUTICALS-2024-013477$VERTEX$$0$YR$$M$Y$12$KG$20240827$$MD$FR$FR
242541661$24254166$1$I$$20240823$20240827$20240827$PER$$US-BAYER-2024A122527$BAYER$$31$YR$A$F$Y$$$20240827$$MD$US$US
242541671$24254167$1$I$20240601$20240820$20240827$20240827$EXP$CH-SM-2024-14333$CH-SA-2024SA249963$SANOFI AVENTIS$$73$YR$E$M$Y$90$KG$20240827$$HP$CH$CH
242541681$24254168$1$I$20240301$20240822$20240827$20240827$EXP$GB-MHRA-MED-202408220847046280-KQGYJ$GB-VERTEX PHARMACEUTICALS-2024-013579$VERTEX$$3$YR$$M$Y$$$20240827$$PH$GB$GB
242541691$24254169$1$I$20240101$20240820$20240827$20240827$EXP$$CA-SA-2024SA067654$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240827$$HP$CA$CA
242541701$24254170$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172970$NOVARTIS$$$$$$Y$$$20240827$$MD$US$US
242541711$24254171$1$I$$20240820$20240827$20240827$EXP$$NVSC2024AU171102$NOVARTIS$$$$$$Y$$$20240827$$MD$AU$AU
242541721$24254172$1$I$$20240814$20240827$20240827$EXP$$GB-INCYTE CORPORATION-2024IN008880$INCYTE$Duminuco A, Nardo A, Palumbo GA.. Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point?. HEMATOLOGICAL ONCOLOGY.. 2024;e3259:1-4$$$$$Y$$$20240827$$HP$GB$GB
242541731$24254173$1$I$$20240814$20240827$20240827$EXP$$GB-INCYTE CORPORATION-2024IN008876$INCYTE$Duminuco A, Nardo A, Palumbo GA.. Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point?. HEMATOLOGICAL ONCOLOGY. 2024;e3259:1-4$$$$$Y$$$20240827$$HP$GB$GB
242541742$24254174$2$F$$20240904$20240827$20240905$EXP$$US-TAKEDA-2024TUS086240$TAKEDA$$$$$M$Y$$$20240905$$CN$US$US
242541752$24254175$2$F$20240801$20240828$20240827$20240906$PER$$US-BIOGEN-2024BI01278815$BIOGEN$$32$YR$$F$Y$$$20240906$$CN$US$US
242541761$24254176$1$I$20240709$20240716$20240827$20240827$PER$$US-LUNDBECK-DKLU4001855$LUNDBECK$$$$$$Y$$$20240827$$CN$US$US
242541771$24254177$1$I$$20240814$20240827$20240827$EXP$$GB-ADVANZ PHARMA-202408006954$ADVANZ PHARMA$$$$$$Y$$$20240827$$MD$GB$GB
242541781$24254178$1$I$$20240820$20240827$20240827$EXP$$US-SA-2024SA249114$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242541791$24254179$1$I$$20240812$20240827$20240827$PER$$US-GLANDPHARMA-US-2024GLNSPO00686$GLAND PHARMA$$$$$M$Y$$$20240827$$CN$US$US
242541802$24254180$2$F$$20240918$20240827$20240920$EXP$$DE-MYLANLABS-2024M1075973$MYLAN$$84$YR$$F$Y$$$20240920$$CN$DE$DE
242541811$24254181$1$I$$20240820$20240827$20240827$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-115785$REGENERON$$$$$F$Y$$$20240827$$CN$CA$CA
242541821$24254182$1$I$$20230420$20240827$20240827$EXP$$US-NOVOPROD-1246807$NOVO NORDISK$$$$$M$Y$$$20240827$$CN$US$US
242541831$24254183$1$I$20221020$20240826$20240827$20240827$EXP$$US-UCBSA-2024043302$UCB$$70$YR$$F$Y$$$20240827$$HP$US$US
242541841$24254184$1$I$20240101$20240812$20240827$20240827$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1153$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240827$$CN$US$US
242541872$24254187$2$F$20240726$20240826$20240827$20240910$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1154$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240910$$HP$US$US
242541881$24254188$1$I$20220613$20240819$20240827$20240827$EXP$$CA-TAKEDA-CA201923206$TAKEDA$$68$YR$$F$Y$$$20240827$$CN$CA$CA
242541891$24254189$1$I$$20240821$20240827$20240827$EXP$$US-INCYTE CORPORATION-2024IN008771$INCYTE$$$$$$Y$$$20240827$$PH$US$US
242541902$24254190$2$F$$20240923$20240827$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135763$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240924$$CN$US$US
242541911$24254191$1$I$20240101$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135261$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240827$$CN$US$US
242541921$24254192$1$I$$20240823$20240827$20240827$EXP$$CN-PFIZER INC-PV202400110281$PFIZER$$$$A$M$Y$$$20240827$$CN$CN$CN
242541932$24254193$2$F$20190605$20240918$20240827$20240927$EXP$$CA-TAKEDA-2024TUS085587$TAKEDA$$98$YR$$F$Y$$$20240927$$MD$CA$CA
242541941$24254194$1$I$$20240819$20240827$20240827$EXP$$GB-AstraZeneca-2024A188375$ASTRAZENECA$$52$YR$$M$Y$101$KG$20240827$$MD$GB$
242541951$24254195$1$I$$20240823$20240827$20240827$EXP$$JP-PFIZER INC-PV202400110846$PFIZER$$70$YR$$F$Y$$$20240827$$MD$JP$JP
242541961$24254196$1$I$$20240826$20240827$20240827$EXP$$EG-PFIZER INC-PV202400111091$PFIZER$$76$YR$$F$Y$$$20240827$$CN$EG$EG
242541991$24254199$1$I$20240801$20240823$20240827$20240827$EXP$$CA-PFIZER INC-202400243983$PFIZER$$70$YR$$F$Y$$$20240827$$HP$CA$CA
242542001$24254200$1$I$20240808$20240823$20240827$20240827$EXP$FR-AFSSAPS-LL2024001596$FR-PFIZER INC-202400242705$PFIZER$$84$YR$$M$Y$85$KG$20240827$$PH$FR$FR
242542011$24254201$1$I$$20240821$20240827$20240827$EXP$$US-INCYTE CORPORATION-2024IN008769$INCYTE$$$$$$Y$$$20240827$$PH$US$US
242542021$24254202$1$I$$20240819$20240827$20240827$EXP$$JP-PFIZER INC-PV202400108175$PFIZER$Hirai, T.. Electrolyte abnormalities. The Pharmaceuticals. 2024;66(11):2188-2193$60$YR$$M$Y$69$KG$20240827$$HP$JP$JP
242542032$24254203$2$F$20240201$20240903$20240827$20240904$EXP$$IT-PFIZER INC-202400242475$PFIZER$$84$YR$$M$Y$75$KG$20240904$$MD$IT$IT
242542041$24254204$1$I$$20240826$20240827$20240827$EXP$$IN-PFIZER INC-PV202400111566$PFIZER$$60$YR$$M$Y$$$20240827$$CN$IN$IN
242542051$24254205$1$I$$20240823$20240827$20240827$EXP$$CA-PFIZER INC-PV202400111131$PFIZER$$$$$M$Y$$$20240827$$MD$CA$CA
242542061$24254206$1$I$$20240826$20240827$20240827$EXP$$GB-PFIZER INC-PV202400111133$PFIZER$$73$YR$$F$Y$$$20240827$$CN$GB$GB
242542073$24254207$3$F$20240101$20240827$20240827$20240830$EXP$$US-PFIZER INC-202400242948$PFIZER$$$$$M$Y$$$20240830$$CN$US$US
242542081$24254208$1$I$$20240822$20240827$20240827$EXP$$US-PFIZER INC-PV202400110479$PFIZER$$65$YR$$M$Y$$$20240827$$CN$US$US
242542091$24254209$1$I$$20240823$20240827$20240827$EXP$$IT-PFIZER INC-202400243962$PFIZER$Castelli, B.. ROLES OF GEMCITABINE-OXALIPLATIN (GEMOX) ADD-ON THERAPY IN INFANT-TYPE BRAIN TUMORS: A SINGLE CENTER EXPERIENCE. Neuro-Oncology. 2024;26(Supplement 4:iv194$$$I$$Y$$$20240827$$HP$IT$IT
242542101$24254210$1$I$20210101$20240823$20240827$20240827$EXP$$TR-PFIZER INC-PV202400111167$PFIZER$Onder, T.. Trastuzumab-induced optic neuritis: ^blindness^ side effect. Journal of Oncology Pharmacy Practice. 2024;1-4$60$YR$$F$Y$$$20240827$$HP$TR$TR
242542111$24254211$1$I$20240701$20240823$20240827$20240827$EXP$$US-PFIZER INC-202400006853$PFIZER$$77$YR$$M$Y$$$20240827$$CN$US$US
242542121$24254212$1$I$$20240821$20240827$20240827$PER$$US-EMD Serono-2024045363$EMD SERONO INC$$73$YR$E$F$Y$47$KG$20240827$$CN$US$US
242542131$24254213$1$I$$20240726$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07731$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242542141$24254214$1$I$$20240818$20240827$20240827$EXP$$BR-TAKEDA-2024TUS083979$TAKEDA$$$$$$Y$$$20240827$$CN$BR$BR
242542151$24254215$1$I$20240801$20240820$20240827$20240827$EXP$$CN-BEIGENE-BGN-2024-013082$BEIGENE$$$$$$Y$$$20240827$$HP$CN$CN
242542162$24254216$2$F$20240401$20240828$20240827$20240831$EXP$$NVSC2024GB089374$NOVARTIS$$22$YR$$F$Y$$$20240831$$CN$GB$GB
242542171$24254217$1$I$20210331$20240819$20240827$20240827$EXP$$US-Axsome Therapeutics, Inc.-AXS202211-001190$AXSOME THERAPEUTICS$$4$MON$I$M$Y$5.805$KG$20240827$$$COUNTRY NOT SPECIFIED$US
242542181$24254218$1$I$20240724$20240820$20240827$20240827$EXP$PT-INFARMED-T202408-204$PT-FreseniusKabi-FK202412769$FRESENIUS KABI$$76$YR$E$F$Y$$$20240827$$PH$PT$PT
242542191$24254219$1$I$20240821$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169240$AMGEN$$65$YR$E$F$Y$$$20240827$$CN$US$US
242542202$24254220$2$F$20240601$20240919$20240827$20240926$EXP$$JP-009507513-2408JPN002631J$MERCK$$72$YR$$F$Y$53$KG$20240926$$MD$JP$JP
242542211$24254221$1$I$$20240821$20240827$20240827$30DAY$$US-PFIZER INC-PV202400109574$PFIZER$$12$YR$$M$Y$32.2$KG$20240827$$CN$US$US
242542221$24254222$1$I$$20240823$20240827$20240827$PER$$US-TAKEDA-2024TUS085953$TAKEDA$$$$$F$Y$$$20240827$$CN$US$US
242542231$24254223$1$I$$20240823$20240827$20240827$EXP$GB-MHRA-MED-202408231240082650-MBJYR$GB-TAKEDA-2024TUS085494$TAKEDA$$14$YR$$M$Y$90$KG$20240827$$HP$GB$GB
242542241$24254224$1$I$20240801$20240816$20240827$20240827$30DAY$$CO-PFIZER INC-202400239907$PFIZER$$$$$M$Y$$$20240827$$CN$CO$CO
242542271$24254227$1$I$$20240819$20240827$20240827$PER$$US-MYLANLABS-2024M1077616$MYLAN$$$$$F$Y$$$20240827$$CN$US$US
242542282$24254228$2$F$19970101$20240819$20240827$20240913$EXP$$BR-MYLANLABS-2024M1077928$MYLAN$Souza G.S, Alfieri D.F, Gianjacomo T.R.F, Girotto E.. Microvascular and macrovascular complications and pharmacotherapy of diabetes mellitus: a case report.. Portuguese Journal of  Family Medicine and General Practice. 2024;40 (3):285?93$57$YR$$M$Y$87$KG$20240913$$PH$BR$BR
242542291$24254229$1$I$$20240730$20240826$20240826$DIR$FDA-CDER-CTU-2024-58644$$FDA-CTU$$50$YR$$F$N$$$20240730$N$$US$
242542301$24254230$1$I$$20240726$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07822$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242542312$24254231$2$F$20240820$20240905$20240827$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026149$UNITED THERAPEUTICS$$54$YR$$F$Y$81.633$KG$20240913$$MD$US$US
242542321$24254232$1$I$20240814$20240821$20240827$20240827$EXP$$CO-VANTIVE-2024VAN019072$Vantive US Healthcare$$74$YR$$F$Y$41$KG$20240827$$HP$CO$CO
242542331$24254233$1$I$20240602$20240819$20240827$20240827$EXP$$US-VANTIVE-2024VAN019150$Vantive US Healthcare$$61$YR$$F$Y$97$KG$20240827$$HP$US$US
242542341$24254234$1$I$$20240823$20240827$20240827$EXP$$DE-MYLANLABS-2024M1078207$MYLAN$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Drug-induced deaths in renal insufficiency. M?nchener Medizinische Wochenschrift ? Fortsschritt der Medizin. 2024;166 (13):48-51$79$YR$$M$Y$$$20240827$$HP$DE$DE
242542351$24254235$1$I$$20240731$20240826$20240826$DIR$FDA-CDER-CTU-2024-58646$$FDA-CTU$$60$YR$$F$N$$$20240731$N$$US$
242542371$24254237$1$I$20240801$20240823$20240827$20240827$EXP$DE-BFARM-24005822$DE-PFIZER INC-202400242450$PFIZER$$56$YR$$M$Y$72$KG$20240827$$MD$DE$DE
242542381$24254238$1$I$20240722$20240822$20240827$20240827$EXP$FR-AFSSAPS-PB2024000879$FR-PFIZER INC-202400241694$PFIZER$$41$YR$$F$Y$$$20240827$$MD$FR$FR
242542391$24254239$1$I$20240803$20240821$20240827$20240827$EXP$$US-INCYTE CORPORATION-2024IN008768$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242542402$24254240$2$F$20240824$20240827$20240827$20240829$PER$$US-AMGEN-USASP2024170298$AMGEN$$$$$$Y$$$20240828$$CN$US$US
242542411$24254241$1$I$$20240821$20240827$20240827$PER$$US-ROCHE-10000063975$ROCHE$$69$YR$E$F$Y$$$20240827$$CN$US$US
242542421$24254242$1$I$$20240821$20240827$20240827$PER$$US-PHARMING-PHAUS2024000726$PHARMING GROUP$$$$$$Y$$$20240827$$CN$US$US
242542431$24254243$1$I$$20240813$20240827$20240827$EXP$$US-GLANDPHARMA-US-2024GLNLIT00672$GLAND PHARMA$A Maerten.Emergency thyroidectomy for thyroid storm in a patient treated with amiodarone.Revue Medicale de Bruxelles.JUN-2024;45:3$57$YR$A$M$Y$$$20240827$$HP$US$US
242542441$24254244$1$I$$20240822$20240827$20240827$EXP$$US-PHARMING-PHAUS2024000725$PHARMING GROUP$$$$$$Y$$$20240827$$CN$US$US
242542451$24254245$1$I$$20240819$20240827$20240827$EXP$$US-PHARMING-PHAUS2024000719$PHARMING GROUP$$$$$$Y$$$20240827$$CN$US$US
242542461$24254246$1$I$$20240820$20240827$20240827$EXP$$US-PHARMING-PHAUS2024000722$PHARMING GROUP$$$$$$Y$$$20240827$$CN$US$US
242542471$24254247$1$I$$20240819$20240827$20240827$EXP$$JP-TAKEDA-2024TUS085970$TAKEDA$Moue C, et al. 89 a case of colitis ulcerative developed pleurisy suspected to be related to 5-aminosalicylic acid preparation. The 380th Kanto Branch Regular Meeting Of The Japanese Society Of Gastroenterolo. 2024;46$66$YR$$F$Y$$$20240827$$MD$JP$JP
242542481$24254248$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3235003$TEVA$$36$YR$$F$Y$$$20240827$$HP$CA$CA
242542491$24254249$1$I$$20240723$20240826$20240826$DIR$FDA-CDER-CTU-2024-58625$$FDA-CTU$$$$$$N$$$20240723$N$$US$
242542501$24254250$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189537$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242542511$24254251$1$I$$20240819$20240827$20240827$EXP$$JP-AstraZeneca-2024A190757$ASTRAZENECA$$54$YR$$F$Y$$$20240827$$MD$JP$
242542521$24254252$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A188786$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242542531$24254253$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189250$ASTRAZENECA$$$$E$F$Y$68.4$KG$20240827$$CN$US$
242542552$24254255$2$F$20240822$20240828$20240827$20240902$PER$$US-AMGEN-USASP2024168145$AMGEN$$68$YR$E$F$Y$$$20240902$$CN$US$US
242542561$24254256$1$I$$20240729$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07726$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242542571$24254257$1$I$$20240813$20240827$20240827$EXP$$IN-GLANDPHARMA-IN-2024GLNLIT00653$GLAND PHARMA$Shekharjyoti Gogoi.Permanent pacemaker implantation with beta blocker as alternative to icd in patients presented with ventricular tachycardia.Indian Heart Journal.DEC-2023; 75:S119-S120$61$YR$A$F$Y$$$20240827$$HP$IN$IN
242542592$24254259$2$F$20240305$20240830$20240827$20240909$EXP$GB-MHRA-MED-202408131609536260-DYWZV$GB-TEVA-VS-3235345$TEVA$$84$YR$$F$Y$44$KG$20240909$$MD$GB$GB
242542601$24254260$1$I$20240101$20240821$20240827$20240827$EXP$$US-ABBVIE-5890112$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242542612$24254261$2$F$$20240823$20240827$20240911$EXP$$JP-B.Braun Medical Inc.-2160909$B BRAUN$Literature Article$66$YR$$M$Y$$$20240911$$$JP$JP
242542621$24254262$1$I$$20240821$20240827$20240827$EXP$$US-ABBVIE-5890167$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242542631$24254263$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135328$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240827$$CN$US$US
242542642$24254264$2$F$20240810$20240901$20240827$20240906$EXP$$IR-BIOGEN-2024BI01279515$BIOGEN$$39$YR$$M$Y$$$20240906$$PH$IR$IR
242542652$24254265$2$F$$20240829$20240827$20240904$PER$$US-MYLANLABS-2024M1077631$MYLAN$$$$$F$Y$57.6$KG$20240904$$CN$US$US
242542661$24254266$1$I$$20240822$20240827$20240827$PER$$US-ROCHE-10000065897$ROCHE$$49$YR$A$F$Y$$$20240827$$CN$US$US
242542671$24254267$1$I$20240816$20240816$20240827$20240827$PER$$US-TEVA-VS-3234683$TEVA$$77$YR$$F$Y$$$20240827$$CN$US$US
242542681$24254268$1$I$20240807$20240821$20240827$20240827$EXP$$CN-BEIGENE-BGN-2024-013193$BEIGENE$$$$$$Y$$$20240827$$HP$CN$CN
242542691$24254269$1$I$20240822$20240822$20240827$20240827$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-134733$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240827$$CN$DE$DE
242542711$24254271$1$I$$20240823$20240827$20240827$PER$$US-ROCHE-10000065918$ROCHE$$$$A$F$Y$$$20240827$$CN$US$US
242542721$24254272$1$I$$20240724$20240826$20240826$DIR$FDA-CDER-CTU-2024-58632$$FDA-CTU$$$$$$N$$$20240724$N$HP$US$
242542731$24254273$1$I$$20240813$20240827$20240827$EXP$$US-GLANDPHARMA-US-2024GLNLIT00660$GLAND PHARMA$L. Benes.Lemierre^s Syndrome Complicated by Tension Hemothorax in the Setting of the Concomitant Use of Intrapleural Fibrinolytics and Systemic Anticoagulation.American Journal of Respiratory and Critical Care Medicine.MAY-2023;207$20$YR$A$M$Y$$$20240827$$HP$US$US
242542742$24254274$2$F$20240821$20240927$20240827$20240930$PER$$US-AMGEN-USASP2024168801$AMGEN$$60$YR$A$F$Y$$$20240929$$CN$US$US
242542751$24254275$1$I$20240603$20240819$20240827$20240827$EXP$ES-AEMPS-1559623$ES-TEVA-VS-3234752$TEVA$$$$E$F$Y$$$20240827$$MD$ES$ES
242542761$24254276$1$I$20240818$20240822$20240827$20240827$EXP$$US-OTSUKA-2024_023261$OTSUKA$$75$YR$$M$Y$$$20240827$$CN$US$US
242542771$24254277$1$I$$20240822$20240827$20240827$EXP$$US-MYLANLABS-2024M1078574$MYLAN$$57$YR$$F$Y$$$20240827$$CN$US$US
242542791$24254279$1$I$20240728$20240823$20240827$20240827$EXP$$CA-ABBVIE-5895412$ABBVIE$$55$YR$$M$Y$$$20240827$$CN$CA$CA
242542801$24254280$1$I$$20240813$20240827$20240827$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00671$GLAND PHARMA$Xiumei Cui.Immediate fever during anaesthesia recovery after surgical procedure with  scoliosis: A case report and literature review.International Journal of Surgery Case Reports.09-JUL-2024;121:1-6$15$YR$T$F$Y$$$20240827$$HP$CN$CN
242542812$24254281$2$F$20240823$20240826$20240827$20240829$PER$$NVSC2024US172972$NOVARTIS$$40$YR$$F$Y$$$20240829$$CN$US$US
242542821$24254282$1$I$$20240819$20240827$20240827$EXP$$US-MYLANLABS-2024M1077599$MYLAN$$72$YR$$F$Y$$$20240827$$CN$US$US
242542831$24254283$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135738$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240827$$CN$US$US
242542841$24254284$1$I$20240820$20240821$20240827$20240827$PER$$US-JNJFOC-20240855199$JOHNSON AND JOHNSON$$54$YR$A$$Y$$$20240827$$CN$US$US
242542852$24254285$2$F$20240820$20240920$20240827$20240923$PER$$US-JNJFOC-20240855122$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240923$$HP$US$US
242542861$24254286$1$I$$20240823$20240827$20240827$PER$$NVSC2024US172614$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242542871$24254287$1$I$$20240813$20240827$20240827$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00670$GLAND PHARMA$$60$YR$A$F$Y$$$20240827$$HP$CN$CN
242542881$24254288$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58797$$FDA-CTU$$58$YR$$M$N$$$20240826$N$$US$
242542891$24254289$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192449$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242542901$24254290$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58698$$FDA-CTU$$63$YR$$F$N$101.6$KG$20240826$N$$US$
242542911$24254291$1$I$20240101$20240812$20240827$20240827$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1226$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240826$$MD$US$US
242542921$24254292$1$I$20240812$20240821$20240827$20240827$EXP$$CN-MYLANLABS-2024M1078076$MYLAN$$50$YR$$F$Y$56$KG$20240827$$HP$CN$CN
242542931$24254293$1$I$$20240819$20240827$20240827$EXP$$US-MYLANLABS-2024M1077333$MYLAN$$$$$F$Y$$$20240827$$CN$US$US
242542941$24254294$1$I$$20240813$20240827$20240827$EXP$$US-SMPA-2024SPA001366$SUNOVION$$$$$$Y$$$20240827$$HP$US$US
242542952$24254295$2$F$$20240917$20240827$20240930$EXP$$US-SMPA-2024SPA001330$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242542971$24254297$1$I$20240724$20240813$20240827$20240827$EXP$$US-SMPA-2024SPA001341$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242542981$24254298$1$I$20211221$20240814$20240827$20240827$EXP$$US-SMPA-2022MYSCI0100180$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242542992$24254299$2$F$20240201$20240308$20240827$20240829$EXP$$GB-SMPA-2024SPA001843$SUNOVION$$$$$$Y$$$20240829$$HP$GR$GR
242543001$24254300$1$I$$20240813$20240827$20240827$EXP$$US-SMPA-2024SPA001343$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242543011$24254301$1$I$$20240813$20240827$20240827$EXP$$US-SMPA-2024SPA001359$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242543021$24254302$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015886$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240827$$CN$US$US
242543031$24254303$1$I$$20240820$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408012205$ELI LILLY AND CO$$17$YR$T$M$Y$$$20240827$$PH$US$US
242543044$24254304$4$F$20240821$20240904$20240827$20240905$PER$$US-AMGEN-USASP2024170496$AMGEN$$73$YR$E$F$Y$$$20240905$$CN$US$US
242543052$24254305$2$F$$20240911$20240827$20240925$EXP$$US-SMPA-2024SPA001377$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242543062$24254306$2$F$20240822$20240828$20240827$20240902$PER$$US-AMGEN-USASP2024168723$AMGEN$$75$YR$E$F$Y$$$20240902$$CN$US$US
242543071$24254307$1$I$$20240824$20240827$20240827$PER$$US-AMGEN-USASP2024170309$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242543081$24254308$1$I$20240711$20240820$20240827$20240827$EXP$ES-AEMPS-1560026$ES-TEVA-VS-3235608$TEVA$$58$YR$$F$Y$$$20240827$$HP$ES$ES
242543091$24254309$1$I$20240821$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013812$ELI LILLY AND CO$$$$$F$Y$$$20240827$$HP$US$US
242543101$24254310$1$I$$20240801$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07868$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242543121$24254312$1$I$$20240827$20240827$20240827$PER$$NVSC2024US172967$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242543131$24254313$1$I$$20240814$20240827$20240827$EXP$$IN-CIPLA LTD.-2024IN07805$CIPLA$Janiani P, Gurunathan D, Manohar R. Comparative evaluation of intranasal Dexmedetomidine, intranasal Midazolam, and Nitrous oxide for conscious sedation of anxious children undergoing dental treatment: A randomized cross-over trial.. Journal of Indian Society of Pedodontics and Preventive Dentistry. 2024;42 (2):141 to 148$$$$$Y$$$20240827$$MD$IN$IN
242543141$24254314$1$I$20240517$20240822$20240827$20240827$EXP$$US-OTSUKA-2024_020724$OTSUKA$$88$YR$$F$Y$76.65$KG$20240827$$HP$US$US
242543151$24254315$1$I$$20240820$20240827$20240827$EXP$$US-MYLANLABS-2024M1078635$MYLAN$Winston DJ, Young PA, Schlamm HT, Schiller GJ. Fosmanogepix Therapy of Disseminated Fusarium Infection. Clin-Infect-Dis 2023; 77 848-850.$26$YR$$F$Y$$$20240827$$HP$US$US
242543161$24254316$1$I$$20240816$20240827$20240827$EXP$$US-MYLANLABS-2024M1077639$MYLAN$$$$$M$Y$$$20240827$$CN$US$US
242543171$24254317$1$I$20240815$20240826$20240826$20240826$DIR$715873$$FDA-CTU$$73$YR$$F$N$74.4$KG$20240826$N$HP$US$
242543181$24254318$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58719$$FDA-CTU$$72$YR$$F$N$$$20240826$N$$US$
242543191$24254319$1$I$$20240819$20240827$20240827$EXP$PT-EMA-DD-20240812-7482701-080355$PT-BAYER-2024A119828$BAYER$Velho RM, Maia M, Pascoa F, et al... Severe hyponatraemia secondary to ciprofloxacin... Congresses of the Portuguese Society of Internal Medicine: 30th National Congres. 2024;PO-0097:469$84$YR$E$M$Y$$$20240827$$HP$PT$PT
242543201$24254320$1$I$20240807$20240826$20240826$20240826$DIR$715930$$FDA-CTU$$78$YR$$F$N$57.15$KG$20240826$Y$CN$US$
242543211$24254321$1$I$$20240814$20240827$20240827$PER$$US-Calliditas-2024CAL01581$CALLIDITAS THERAPEUTICS$$30$YR$A$M$Y$70.3$KG$20240827$$CN$US$US
242543221$24254322$1$I$20240301$20240821$20240827$20240827$EXP$$DE-INCYTE CORPORATION-2024IN008756$INCYTE$$$$$$Y$$$20240827$$CN$DE$DE
242543231$24254323$1$I$$20240826$20240827$20240827$EXP$$NVSC2024FR172439$NOVARTIS$$67$YR$$M$Y$$$20240827$$MD$FR$FR
242543241$24254324$1$I$$20240826$20240827$20240827$EXP$$US-PFIZER INC-202400244367$PFIZER$$66$YR$$F$Y$$$20240827$$PH$US$US
242543252$24254325$2$F$20230301$20240904$20240827$20240905$EXP$$GB-ORGANON-O2408GBR001607$ORGANON$$18$YR$$F$Y$$$20240905$$MD$GB$GB
242543271$24254327$1$I$$20240813$20240827$20240827$EXP$$GB-GLANDPHARMA-GB-2024GLNLIT00669$GLAND PHARMA$Penelope J. Teoh.Invasive Trichoderma longibrachiatum infection in a neutropaenic patient.Medical Mycology Case Reports.14-JUN-2024;45:1-5$51$YR$A$F$Y$$$20240827$$HP$GB$GB
242543281$24254328$1$I$$20240820$20240827$20240827$EXP$$US-TAKEDA-US202030898$TAKEDA$$$$$F$Y$71.202$KG$20240827$$CN$US$US
242543293$24254329$3$F$$20240830$20240827$20240909$EXP$$US-TAKEDA-2024TUS075860$TAKEDA$$$$$F$Y$$$20240909$$MD$US$US
242543301$24254330$1$I$$20240808$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08210$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242543311$24254331$1$I$20230812$20240812$20240827$20240827$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464477$RANBAXY$$62$YR$$M$Y$$$20240827$$CN$GB$GB
242543321$24254332$1$I$20240701$20240821$20240827$20240827$EXP$GB-MHRA-MED-202408211021291520-FZBYR$GB-TEVA-VS-3236035$TEVA$$57$YR$$F$Y$81$KG$20240827$$CN$GB$GB
242543331$24254333$1$I$$20240814$20240827$20240827$EXP$$US-CIPLA LTD.-2024US09207$CIPLA$Ho H, Mohan S. Tissue injury secondary to peripheral xenobiotic administration. JACEP Open. 2023;4: e12972:1 to 2$$$$$Y$$$20240827$$MD$US$US
242543342$24254334$2$F$$20240828$20240827$20240912$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464433$RANBAXY$$86$YR$$M$Y$$$20240912$$PH$GB$GB
242543351$24254335$1$I$$20240813$20240827$20240827$EXP$$US-GLANDPHARMA-US-2024GLNLIT00661$GLAND PHARMA$S Khan.Avoiding Premature Brain Death Declaration in Patients With Suspected Baclofen Overdose.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A7027$58$YR$A$M$Y$$$20240827$$HP$US$US
242543361$24254336$1$I$$20240812$20240827$20240827$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464470$RANBAXY$Maruyama T, Kondo S, Nomura H. Case series of bradycardia, renal failure, atrioventricular nodal blockers, shock and hyperkalemia syndrome in patients with dementia. Geriatr Gerontol Int. 2024;24(7):737-738$97$YR$$M$Y$$$20240827$$HP$JP$JP
242543372$24254337$2$F$20240213$20240823$20240827$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464510$RANBAXY$$53$YR$$M$Y$104$KG$20240906$$PH$FR$FR
242543381$24254338$1$I$20240306$20240812$20240827$20240827$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464496$RANBAXY$$72$YR$$M$Y$65$KG$20240827$$CN$GB$GB
242543391$24254339$1$I$20240822$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58801$$FDA-CTU$$77$YR$$F$N$$$20240826$N$HP$US$
242543401$24254340$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58794$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242543421$24254342$1$I$20240515$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464262$RANBAXY$$100$YR$$F$Y$64$KG$20240827$$HP$FR$FR
242543431$24254343$1$I$$20240812$20240827$20240827$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464512$RANBAXY$$$$$M$Y$$$20240827$$MD$GB$GB
242543441$24254344$1$I$20240411$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464522$RANBAXY$$77$YR$$F$Y$$$20240827$$MD$FR$FR
242543451$24254345$1$I$20240412$20240812$20240827$20240827$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464411$RANBAXY$$78$YR$$M$Y$$$20240827$$MD$FR$FR
242543462$24254346$2$F$20240201$20240828$20240827$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464506$RANBAXY$$61$YR$$M$Y$$$20240912$$MD$FR$FR
242543471$24254347$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58708$$FDA-CTU$$76$YR$$M$N$$$20240826$N$$US$
242543481$24254348$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58803$$FDA-CTU$$43$YR$$M$N$$$20240826$N$$US$
242543493$24254349$3$F$$20240924$20240827$20240930$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004727$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240930$$HP$FR$FR
242543501$24254350$1$I$$20240822$20240827$20240827$EXP$$US-TAKEDA-2024TUS085129$TAKEDA$$$$$M$Y$$$20240827$$MD$US$US
242543511$24254351$1$I$20231127$20240816$20240827$20240827$EXP$ES-AEMPS-1468138$ES-SA-2024SA244957$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240827$$MD$ES$ES
242543521$24254352$1$I$$20240822$20240827$20240827$EXP$$JP-AMGEN-JPNSP2024169702$AMGEN$$$$$$Y$$$20240827$$PH$JP$JP
242543535$24254353$5$F$20240801$20240912$20240827$20240913$PER$$US-AMGEN-USASP2024170497$AMGEN$$57$YR$A$M$Y$$$20240913$$CN$US$US
242543543$24254354$3$F$20240720$20240910$20240827$20240912$EXP$$DE-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004570$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240912$$MD$DE$DE
242543551$24254355$1$I$20230801$20240821$20240827$20240827$EXP$$US-TAKEDA-2021TUS067700$TAKEDA$$38$YR$$F$Y$62$KG$20240827$$HP$US$US
242543561$24254356$1$I$20240501$20240815$20240827$20240827$EXP$$US-SA-2024SA247100$SANOFI AVENTIS$$58$YR$A$F$Y$72$KG$20240827$$MD$US$US
242543571$24254357$1$I$20240701$20240822$20240827$20240827$EXP$FR-AFSSAPS-MP2024001298$FR-009507513-2408FRA007882$MERCK$$79$YR$$M$Y$66$KG$20240827$$MD$FR$FR
242543581$24254358$1$I$20240813$20240815$20240827$20240827$EXP$$US-SA-2024SA244021$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240827$$CN$US$US
242543592$24254359$2$F$$20240901$20240827$20240910$EXP$$CN-JNJFOC-20240862296$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240910$$HP$CN$CN
242543601$24254360$1$I$20160401$20240821$20240827$20240827$PER$$US-BIOGEN-2016BI00227651$BIOGEN$$69$YR$$F$Y$$$20240827$$CN$US$US
242543611$24254361$1$I$$20240813$20240827$20240827$EXP$$PT-GLANDPHARMA-PT-2024GLNLIT00657$GLAND PHARMA$Catarina Reis.Pseudomembranous colitis following helicobacter pilory eradication with the bismuth-based quadruple therapy.European Journal of Case Reports in Internal Medicine.MAY-2023;10 (Suppl. 1):237$84$YR$E$F$Y$$$20240827$$HP$PT$PT
242543631$24254363$1$I$$20240823$20240827$20240827$EXP$$US-TAKEDA-2024TUS055749$TAKEDA$$$$$M$Y$$$20240827$$MD$US$US
242543641$24254364$1$I$$20240819$20240827$20240827$EXP$$FR-SA-2024SA246530$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240827$$HP$FR$FR
242543651$24254365$1$I$20240712$20240819$20240827$20240827$EXP$FR-AFSSAPS-LY2024001252$FR-SA-2024SA246235$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240827$$MD$FR$FR
242543661$24254366$1$I$$20240820$20240827$20240827$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007321$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240827$$MD$DE$DE
242543674$24254367$4$F$$20240912$20240827$20240912$EXP$$US-ALXN-202408USA001071US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
242543681$24254368$1$I$20240101$20240820$20240827$20240827$EXP$$US-ABBVIE-5883459$ABBVIE$$$$$M$Y$134$KG$20240827$$CN$US$US
242543691$24254369$1$I$$20240819$20240827$20240827$EXP$$RU-SA-2024SA246521$SANOFI AVENTIS$Slukhanchuk EV, Bitsadze VO, Solopova AG, Khizroeva JK, Degtyareva ND, Gruzdeva DA et al.. Hereditary and acquired thrombophilia in a patient with endometrial adenocarcinoma.. Gynecology, Obsterics and perinatology.. 2024;23(3):131-7.$46$YR$A$F$Y$$$20240827$$MD$RU$RU
242543701$24254370$1$I$$20240819$20240827$20240827$EXP$$AU-TAKEDA-2024TUS085868$TAKEDA$$$$$$Y$$$20240827$$HP$AU$AU
242543711$24254371$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58705$$FDA-CTU$$64$YR$$F$N$$$20240826$N$$US$
242543721$24254372$1$I$20240820$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58711$$FDA-CTU$$55$YR$$F$N$$$20240826$N$$US$
242543741$24254374$1$I$$20240823$20240827$20240827$EXP$$IT-PFIZER INC-PV202400111171$PFIZER$Castelli, B.. ROLES OF GEMCITABINE-OXALIPLATIN (GEMOX) ADD-ON THERAPY IN INFANT-TYPE BRAIN TUMORS: A SINGLE CENTER EXPERIENCE. Neuro-Oncology. 2024;26(Supplement 4:iv194$$$I$$Y$$$20240827$$HP$IT$IT
242543751$24254375$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58768$$FDA-CTU$$49$YR$$M$N$$$20240826$N$$US$
242543761$24254376$1$I$$20240826$20240826$20240826$DIR$715962$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242543771$24254377$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58761$$FDA-CTU$$61$YR$$M$N$$$20240826$N$$US$
242543781$24254378$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58741$$FDA-CTU$$37$YR$$M$N$167.83$KG$20240826$N$HP$US$
242543791$24254379$1$I$$20240821$20240827$20240827$EXP$$PH-PFIZER INC-202400241406$PFIZER$Luceno, V.. Severe COVID-19 Infection in a Lupus Nephritis Patient on Treatment for Multidrug-Resistant Disseminated Tuberculosis. Phillippine Journal of Internal Medicine. 2024;62(2):106-109$24$YR$$F$Y$$$20240827$$MD$PH$PH
242543801$24254380$1$I$$20240826$20240826$20240826$DIR$715963$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242543812$24254381$2$F$$20240911$20240827$20240911$PER$$US-ALXN-202408USA001241US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$MD$US$US
242543821$24254382$1$I$20240826$20240826$20240826$20240826$DIR$715906$$FDA-CTU$$39$YR$$UNK$N$$$20240826$N$$US$
242543831$24254383$1$I$20240322$20240826$20240826$20240826$DIR$715938$$FDA-CTU$$52$YR$$F$N$$$20240826$Y$HP$US$
242543842$24254384$2$F$$20240830$20240827$20240909$EXP$$IT-TEVA-VS-3236055$TEVA$Brusasco M, Feliciani C, de Felici del Giudice MB. A case of chronic granulomatous disease and acne: is isotretinoin a safe treatment?. Dermatol-Rep 2023; 15 (2):.; Brusasco M, Feliciani C, de Felici del Giudice MB. A case of chronic granulomatous disease and acne: is isotretinoin a safe treatment?. Dermatol-Rep 2023; 15 (2):.$25$YR$$M$Y$$$20240909$$HP$IT$IT
242543851$24254385$1$I$$20240821$20240827$20240827$EXP$$NVSC2024US170254$NOVARTIS$$$$$F$Y$$$20240827$$HP$US$US
242543861$24254386$1$I$$20240820$20240827$20240827$EXP$$US-SA-2024SA249381$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240827$$MD$US$US
242543871$24254387$1$I$$20240820$20240827$20240827$EXP$$AT-ROCHE-10000062492$ROCHE$$$$$$Y$$$20240827$$MD$AT$AT
242543881$24254388$1$I$$20240813$20240827$20240827$EXP$$US-GLANDPHARMA-US-2024GLNLIT00652$GLAND PHARMA$Hasan Saleh.Acute esophageal stricture after bone marrow transplant.Clinical Journal of Gastroenterology .FEB-2024;17:1-5$58$YR$A$M$Y$$$20240827$$MD$US$US
242543892$24254389$2$F$20240731$20240830$20240827$20240911$EXP$$ES-Accord-442094$ACCORD$$72$YR$E$F$Y$66.5$KG$20240911$$HP$ES$ES
242543901$24254390$1$I$$20240819$20240827$20240827$EXP$$AU-TAKEDA-2024TUS085968$TAKEDA$$$$$$Y$$$20240827$$HP$AU$AU
242543921$24254392$1$I$20240101$20240822$20240827$20240827$EXP$$CA-PFIZER INC-202300166586$PFIZER$$38$YR$$F$Y$94.331$KG$20240827$$MD$CA$CA
242543931$24254393$1$I$20230309$20230310$20240827$20240827$EXP$$CO-BIOVITRUM-2023-CO-007111$BIOVITRUM$$112$DY$$M$Y$3.6$KG$20240827$$CN$CO$CO
242543941$24254394$1$I$20240812$20240822$20240827$20240827$EXP$$US-ABBVIE-5892849$ABBVIE$$53$YR$$F$Y$$$20240827$$CN$US$US
242543951$24254395$1$I$$20240823$20240827$20240827$PER$$US-JNJFOC-20240862153$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242543961$24254396$1$I$$20240814$20240827$20240827$EXP$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01314$TARO$Yousaf Z, Jyothi Ramachandran Nair D, Kamel A. Nystatin Induced Laryngeal Edema - First Reported Case. Am J Respir Crit Care Med. 2024;209 (0):A1360$$$$$Y$$$20240827$$HP$US$US
242543971$24254397$1$I$$20240821$20240827$20240827$EXP$GB-MHRA-MED-202408211331256540-HZWRL$GB-SA-2024SA249376$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240827$$HP$GB$GB
242543981$24254398$1$I$$20240822$20240826$20240826$DIR$FDA-CDER-CTU-2024-58738$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242543991$24254399$1$I$20240814$20240826$20240826$20240826$DIR$715917$$FDA-CTU$$43$YR$$M$N$$$20240826$N$PH$US$
242544011$24254401$1$I$$20240826$20240826$20240826$DIR$715966$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242544021$24254402$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58805$$FDA-CTU$$58$YR$$M$N$$$20240826$N$$US$
242544031$24254403$1$I$$20240826$20240826$20240826$DIR$715967$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242544041$24254404$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58754$$FDA-CTU$$73$YR$$M$N$$$20240826$N$$US$
242544051$24254405$1$I$20240508$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58817$$FDA-CTU$$60$YR$$F$N$$$20240826$Y$HP$US$
242544061$24254406$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58789$$FDA-CTU$$60$YR$$M$N$$$20240826$N$$US$
242544071$24254407$1$I$20240825$20240826$20240826$20240826$DIR$716021$$FDA-CTU$$$$$F$N$117$KG$20240826$N$CN$US$
242544083$24254408$3$F$$20240927$20240827$20240927$30DAY$$US-PFIZER INC-202400241199$PFIZER$$14$YR$$M$Y$57.61$KG$20240927$$CN$US$US
242544093$24254409$3$F$$20240927$20240827$20240927$30DAY$$US-PFIZER INC-202400242562$PFIZER$$7$YR$$M$Y$$$20240927$$CN$US$US
242544103$24254410$3$F$$20240906$20240827$20240911$EXP$$GB-PFIZER INC-PV202400110912$PFIZER$Hall, R.. Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin^s lymphoma, complicated by anthracycline-induced cardiomyopathy. BMJ Case Reports. 2024;17(8):10.1136/bcr-2023-257523$3$DEC$$F$Y$$$20240911$$HP$GB$GB
242544112$24254411$2$F$$20240927$20240827$20240927$30DAY$$US-PFIZER INC-2018229461$PFIZER$$12$YR$$F$Y$131.09$KG$20240927$$CN$US$US
242544121$24254412$1$I$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016206$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240827$$HP$US$US
242544131$24254413$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015920$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240827$$CN$US$US
242544141$24254414$1$I$$20240820$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408012936$ELI LILLY AND CO$$$$A$F$Y$$$20240827$$CN$US$US
242544151$24254415$1$I$$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133714$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$73.03$KG$20240827$$CN$US$US
242544161$24254416$1$I$$20240826$20240826$20240826$DIR$715971$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242544171$24254417$1$I$20231114$20240824$20240826$20240826$DIR$FDA-CDER-CTU-2024-58809$$FDA-CTU$$49$YR$$F$N$$$20240824$N$HP$US$
242544181$24254418$1$I$20230831$20240826$20240826$20240826$DIR$715975$$FDA-CTU$$64$YR$$F$N$54$KG$20240826$Y$CN$US$
242544191$24254419$1$I$20240824$20240826$20240826$20240826$DIR$715977$$FDA-CTU$$71$YR$$F$N$48.15$KG$20240826$N$CN$US$
242544201$24254420$1$I$20240703$20240823$20240826$20240826$DIR$FDA-CDER-CTU-2024-58690$$FDA-CTU$$60$YR$$F$N$$$20240823$N$HP$US$
242544211$24254421$1$I$$20240826$20240826$20240826$DIR$715968$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242544221$24254422$1$I$$20240823$20240826$20240826$DIR$FDA-CDER-CTU-2024-58696$$FDA-CTU$$$$$F$N$$$20240823$N$HP$US$
242544231$24254423$1$I$20240826$20240826$20240826$20240826$DIR$715969$$FDA-CTU$$61$YR$$F$N$62.1$KG$20240826$Y$HP$US$
242544241$24254424$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58764$$FDA-CTU$$56$YR$$F$N$60$LBS$20240826$N$$US$
242544261$24254426$1$I$20240826$20240826$20240826$20240826$DIR$715993$$FDA-CTU$$73$YR$$M$N$$$20240826$N$HP$US$
242544271$24254427$1$I$$20240825$20240827$20240827$PER$$US-AMGEN-USASP2024170332$AMGEN$$$$$M$Y$$$20240827$$CN$US$US
242544281$24254428$1$I$$20240823$20240827$20240827$EXP$$IN-CHIESI-2024CHF05407$CHIESI$$$$N$$Y$$$20240827$$MD$IN$IN
242544291$24254429$1$I$20180101$20240815$20240827$20240827$EXP$$CA-Accord-442605$ACCORD$Dery C, Labrecque G, Bouchard M. Oral Levodopa, Vitamin B6, and Polyneuropathy: A Case Series. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2024;51(3):472-3.$68$YR$E$M$Y$$$20240827$$MD$CA$CA
242544301$24254430$1$I$$20240815$20240827$20240827$EXP$$CA-Accord-442604$ACCORD$Dery C, Labrecque G, Bouchard M. Oral Levodopa, Vitamin B6, and Polyneuropathy: A Case Series. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2024;51(3):472-3.$79$YR$E$M$Y$$$20240827$$MD$CA$CA
242544311$24254431$1$I$20240503$20240815$20240827$20240827$EXP$FR-AFSSAPS-PO2024000847$FR-Accord-442269$ACCORD$$83$YR$E$F$Y$79.1$KG$20240827$$MD$FR$FR
242544321$24254432$1$I$20200101$20240822$20240827$20240827$EXP$$US-ABBVIE-5892427$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242544331$24254433$1$I$$20240820$20240827$20240827$PER$$US-ABBVIE-5888995$ABBVIE$$$$$$Y$$$20240827$$CN$US$US
242544341$24254434$1$I$$20240815$20240827$20240827$EXP$IT-EMA-DD-20240805-7482711-125940$IT-Accord-442482$ACCORD$Giaimo M, Prezioso L, Rinaldi A, Falcioni F, Palma BD, Cambo B et al. EBV Colitis Post Hematopoietic Stem Cell Transplantation in Patient with Aplastic Anemia. Bone Marrow Transplant. 2021 56: (250-251). Doi: 10.1038/s41409-021-01343-5$46$YR$A$M$Y$$$20240827$$HP$IT$IT
242544361$24254436$1$I$20240528$20240815$20240827$20240827$EXP$ES-AEMPS-1557508$ES-Accord-442321$ACCORD$$87$YR$E$F$Y$82$KG$20240827$$HP$ES$ES
242544371$24254437$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172677$NOVARTIS$$$$$$Y$$$20240827$$HP$US$US
242544381$24254438$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58792$$FDA-CTU$$62$YR$$F$N$$$20240826$N$$US$
242544401$24254440$1$I$$20240826$20240826$20240826$DIR$715974$$FDA-CTU$$$$$M$N$$$20240826$N$PH$US$
242544411$24254441$1$I$20240704$20240826$20240826$20240826$DIR$715953$$FDA-CTU$$56$YR$$F$N$98.55$KG$20240826$N$HP$US$
242544441$24254444$1$I$$20240826$20240827$20240827$EXP$$CA-ORGANON-O2408CAN001885$ORGANON$$65$YR$$F$Y$34$KG$20240827$$HP$CA$CA
242544461$24254446$1$I$20240824$20240826$20240826$20240826$DIR$715972$$FDA-CTU$$32$YR$$F$N$44.55$KG$20240826$N$CN$US$
242544471$24254447$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58688$$FDA-CTU$$57$YR$$F$N$$$20240826$N$$US$
242544482$24254448$2$F$20240823$20240823$20240827$20240901$PER$$US-AMGEN-USASP2024169232$AMGEN$$76$YR$E$M$Y$$$20240901$$CN$US$US
242544491$24254449$1$I$20240801$20240815$20240827$20240827$EXP$$US-BRAEBURN-US-BRA-24-000757$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240827$$HP$US$US
242544501$24254450$1$I$20240819$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58811$$FDA-CTU$$75$YR$$F$N$55.79$KG$20240826$N$HP$US$
242544511$24254451$1$I$20240628$20240819$20240827$20240827$EXP$$GB-AstraZeneca-2024A188441$ASTRAZENECA$$68$YR$$F$Y$65$KG$20240827$$MD$GB$
242544521$24254452$1$I$20240624$20240821$20240827$20240827$EXP$PT-INFARMED-T202408-201$PT-MYLANLABS-2024M1077812$MYLAN$$65$YR$$M$Y$$$20240827$$PH$PT$PT
242544531$24254453$1$I$$20240820$20240827$20240827$PER$$US-ABBVIE-5889994$ABBVIE$$$$$$Y$$$20240827$$CN$US$US
242544541$24254454$1$I$20240822$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169020$AMGEN$$47$YR$A$F$Y$$$20240827$$CN$US$US
242544551$24254455$1$I$$20240823$20240827$20240827$EXP$$CA-ROCHE-10000065738$ROCHE$$$$A$F$Y$$$20240827$$PH$CA$CA
242544581$24254458$1$I$$20240819$20240827$20240827$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024103957$VIIV$$$$$$Y$$$20240827$$CN$US$US
242544591$24254459$1$I$$20240821$20240827$20240827$EXP$$IT-MYLANLABS-2024M1077633$MYLAN$$68$YR$$M$Y$$$20240827$$CN$IT$IT
242544601$24254460$1$I$$20240823$20240827$20240827$EXP$$DE-MYLANLABS-2024M1078262$MYLAN$Groth, Olwen; Roider, Gabriele; Graw. Fatalities associated with failure to adjust drug dose in patients with renal insufficiency. A retrospective study at the Institute of Forensic Medicine in Munich (2019-2023. 2024;166 (13):48-51$84$YR$$F$Y$$$20240827$$HP$DE$DE
242544611$24254461$1$I$$20240823$20240827$20240827$EXP$$DE-MYLANLABS-2024M1078264$MYLAN$Groth O, Roider G, Graw M. Drug-induced deaths in renal insufficiency. Munich Medical Weekly - Advances in Medicine. 2024;166 (13):48-51$80$YR$$F$Y$$$20240827$$HP$DE$DE
242544622$24254462$2$F$20211225$20240826$20240827$20240829$EXP$$GB-SANDOZ INC.-NVSC2021GB300149$SANDOZ$$61$YR$$F$Y$$$20240829$$CN$GB$GB
242544651$24254465$1$I$20210412$20240824$20240827$20240827$EXP$$CA-SANDOZ INC.-NVSC2021CA084764$SANDOZ$$80$YR$$F$Y$$$20240827$$CN$CA$CA
242544661$24254466$1$I$20240820$20240826$20240826$20240826$DIR$715979$$FDA-CTU$$59$YR$$F$N$$$20240826$N$HP$US$
242544681$24254468$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58734$$FDA-CTU$$55$YR$$F$N$123$LBS$20240826$N$$US$
242544691$24254469$1$I$$20240826$20240826$20240826$DIR$715985$$FDA-CTU$$$$$M$N$$$20240826$Y$HP$US$
242544701$24254470$1$I$20240826$20240826$20240826$20240826$DIR$715982$$FDA-CTU$$38$YR$$M$N$122.4$KG$20240826$N$$US$
242544711$24254471$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58808$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242544721$24254472$1$I$20240611$20240826$20240826$20240826$DIR$715980$$FDA-CTU$$49$YR$$F$N$86.4$KG$20240826$Y$CN$US$
242544731$24254473$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58799$$FDA-CTU$$77$YR$$F$N$$$20240826$N$$US$
242544741$24254474$1$I$20240815$20240826$20240826$20240826$DIR$715986$$FDA-CTU$$5$MON$$F$N$$$20240826$N$PH$US$
242544751$24254475$1$I$20240808$20240826$20240826$20240826$DIR$715991$$FDA-CTU$$88$YR$$M$N$$$20240826$Y$HP$US$
242544761$24254476$1$I$$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168237$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242544791$24254479$1$I$20240806$20240824$20240827$20240827$EXP$$US-Eisai-EC-2024-171830$EISAI$$72$YR$E$F$Y$82$KG$20240827$$HP$US$US
242544811$24254481$1$I$20240714$20240819$20240827$20240827$EXP$GB-MHRA-MED-202408191706192040-QKZGN$GB-TEVA-VS-3235442$TEVA$$$$$F$Y$$$20240827$$CN$GB$GB
242544822$24254482$2$F$$20240830$20240827$20240902$PER$$NVSC2024US172977$NOVARTIS$$$$$F$Y$$$20240902$$MD$US$US
242544841$24254484$1$I$20230201$20240819$20240827$20240827$EXP$GB-MHRA-MED-202408191122505950-NYQDW$GB-TEVA-VS-3235165$TEVA$$32$YR$$F$Y$144$KG$20240827$$PH$GB$GB
242544851$24254485$1$I$$20240821$20240827$20240827$EXP$$DE-MYLANLABS-2024M1077604$MYLAN$Rissardo JP, Medeiros Araujo de Matos U, Fornari Caprara AL... Gabapentin-Associated Movement Disorders: A Literature Review.. Medicines. 2023;1052$40$YR$$F$Y$$$20240827$$MD$DE$DE
242544861$24254486$1$I$$20240826$20240827$20240827$PER$$US-HALEON-2193731$Haleon PLC$$$$$$Y$$$20240827$$CN$US$US
242544871$24254487$1$I$$20240823$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075189$SANDOZ$$$$$$Y$$$20240827$$CN$US$US
242544881$24254488$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58757$$FDA-CTU$$70$YR$$F$N$190$LBS$20240826$N$$US$
242544891$24254489$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58816$$FDA-CTU$$46$YR$$M$N$$$20240826$N$$US$
242544911$24254491$1$I$$20240822$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US074645$SANDOZ$$27$YR$$M$Y$$$20240827$$MD$US$US
242544931$24254493$1$I$20240625$20240826$20240826$20240826$DIR$715976$$FDA-CTU$$$$$UNK$N$$$20240826$N$$US$
242544951$24254495$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58793$$FDA-CTU$$66$YR$$F$N$$$20240826$N$$US$
242544961$24254496$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58744$$FDA-CTU$$66$YR$$M$N$$$20240826$N$$US$
242544971$24254497$1$I$20240530$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58695$$FDA-CTU$$35$YR$$M$N$$$20240826$N$HP$US$
242544981$24254498$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58725$$FDA-CTU$$62$YR$$M$N$$$20240826$N$$US$
242544991$24254499$1$I$20240826$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58702$$FDA-CTU$$65$YR$$F$N$$$20240826$N$$US$
242545001$24254500$1$I$$20240821$20240827$20240827$EXP$GB-MHRA-MED-202408210341069160-YDTFP$GB-TEVA-VS-3236003$TEVA$$22$YR$$F$Y$$$20240827$$CN$GB$GB
242545011$24254501$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015209$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240827$$CN$US$US
242545021$24254502$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014476$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240827$$CN$US$US
242545031$24254503$1$I$20220101$20240825$20240827$20240827$EXP$$NVSC2024EG172554$NOVARTIS$$76$YR$$M$Y$113$KG$20240827$$CN$EG$EG
242545041$24254504$1$I$$20240823$20240827$20240827$EXP$$TR-SANDOZ INC.-SDZ2024TR075021$SANDOZ$$16$YR$$M$Y$$$20240827$$CN$TR$TR
242545052$24254505$2$F$20230807$20240919$20240827$20240927$EXP$$NL-TEVA-VS-3235956$TEVA$$55$YR$$F$Y$$$20240927$$CN$NL$NL
242545061$24254506$1$I$20240815$20240823$20240827$20240827$EXP$$PK-ROCHE-10000040807$ROCHE$$59$YR$A$F$Y$$$20240827$$CN$PK$PK
242545071$24254507$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013757$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240827$$CN$US$US
242545081$24254508$1$I$20240815$20240815$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408011342$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240827$$CN$US$US
242545091$24254509$1$I$20240826$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016025$ELI LILLY AND CO$$58$YR$A$$Y$$$20240827$$CN$US$US
242545101$24254510$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014371$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240827$$CN$US$US
242545112$24254511$2$F$20240815$20240927$20240827$20240927$30DAY$$US-PFIZER INC-202400241316$PFIZER$$19$YR$$F$Y$$$20240927$$CN$US$US
242545121$24254512$1$I$$20240816$20240827$20240827$PER$$US-FARMAPROD-202407-2668$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240827$$CN$US$US
242545131$24254513$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135810$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240827$$CN$US$US
242545141$24254514$1$I$20240823$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135369$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240827$$CN$US$US
242545151$24254515$1$I$$20240819$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135330$BRISTOL MYERS SQUIBB$Patil R, Yongue C, James L, Zhou F, Saric M, Vaynblat M. Presentation and management of marantic endocarditis: a case series. Echocardiography. 2024 Aug 01;41(8):1-12. doi:10.1111/echo.15891.$60$YR$A$M$Y$$$20240827$$MD$US$US
242545161$24254516$1$I$$20240815$20240827$20240827$EXP$$US-CIPLA LTD.-2024US09279$CIPLA$Hui J, Zhan X, Bashir A, Policeni F, Kim Hsieh S.. Epithelial-myoepithelial carcinoma occurrence in the site of previously treated ductal carcinoma in situ of the breast: Imaging features with histopathologic correlation, a case report and review of the literature. Clinical Case Reports. 2024;12:e9270:1 to 6$$$$$Y$$$20240827$$HP$US$US
242545171$24254517$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58686$$FDA-CTU$$75$YR$$M$N$$$20240826$N$$US$
242545181$24254518$1$I$20240826$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58821$$FDA-CTU$$76$YR$$F$N$$$20240826$N$$US$
242545191$24254519$1$I$20240825$20240825$20240826$20240826$DIR$FDA-CDER-CTU-2024-58716$$FDA-CTU$$66$YR$$F$N$$$20240825$N$$US$
242545201$24254520$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58820$$FDA-CTU$$85$YR$$F$N$$$20240826$N$$US$
242545211$24254521$1$I$20240819$20240821$20240827$20240827$PER$$US-BAUSCH-BL-2024-012763$BAUSCH AND LOMB$$58$YR$$M$Y$$$20240827$$CN$US$US
242545222$24254522$2$F$20220601$20240827$20240827$20240831$EXP$$US-ABBVIE-5888825$ABBVIE$$74$YR$$F$Y$82.1$KG$20240831$$CN$US$US
242545232$24254523$2$F$20240325$20240916$20240827$20240919$EXP$$US-SANDOZ INC.-PHEH2019US033495$SANDOZ$$41$YR$$F$Y$$$20240919$$HP$US$US
242545241$24254524$1$I$$20240819$20240827$20240827$EXP$$PL-BAUSCH-BL-2024-012754$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240827$$MD$PL$PL
242545251$24254525$1$I$$20240819$20240827$20240827$EXP$$ID-BAUSCH-BL-2024-012595$BAUSCH AND LOMB$Permatasanti A, Sufiawati I. Case Series of HIV-Associated Oral Lesions Across Different Clinical Stages in People Living with HIV. HIV/AIDS-Research and Palliative Care. 2024 JUL 26;16:289-299. doi:10.2147/HIV.S478366$34$YR$$F$Y$$$20240827$$HP$ID$ID
242545261$24254526$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172971$NOVARTIS$$$$$$Y$$$20240827$$PH$US$US
242545271$24254527$1$I$$20240826$20240827$20240827$EXP$$NVSC2024AU172385$NOVARTIS$$$$$F$Y$$$20240827$$CN$AU$AU
242545281$24254528$1$I$$20240821$20240827$20240827$EXP$$US-JNJFOC-20240855200$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240827$$PH$US$US
242545291$24254529$1$I$$20240806$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07891$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242545302$24254530$2$F$$20240822$20240827$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07838$LUPIN$$$$$$Y$$$20240909$$CN$US$US
242545311$24254531$1$I$$20240821$20240827$20240827$PER$$US-AstraZeneca-2024A192835$ASTRAZENECA$$$$$$Y$$$20240827$$CN$US$
242545321$24254532$1$I$20240101$20240812$20240827$20240827$PER$$US-AstraZeneca-2024A184033$ASTRAZENECA$$59$YR$$M$Y$$$20240827$$CN$US$
242545332$24254533$2$F$$20240927$20240827$20240927$30DAY$$US-PFIZER INC-202400241351$PFIZER$$12$YR$$M$Y$$$20240927$$CN$US$US
242545351$24254535$1$I$20240401$20240820$20240827$20240827$EXP$$AR-SANDOZ INC.-SDZ2024AR075341$SANDOZ$$62$YR$$F$Y$$$20240827$$CN$AR$AR
242545361$24254536$1$I$$20240822$20240827$20240827$EXP$$US-PFIZER INC-202400242272$PFIZER$$37$YR$$F$Y$$$20240827$$HP$US$US
242545371$24254537$1$I$$20240729$20240827$20240827$PER$$US-JNJFOC-20240782784$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$US$US
242545381$24254538$1$I$$20240823$20240827$20240827$PER$$US-JNJFOC-20240866243$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$MD$US$US
242545391$24254539$1$I$20240815$20240826$20240827$20240827$PER$$US-JNJFOC-20240867040$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242545401$24254540$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58798$$FDA-CTU$$49$YR$$F$N$$$20240826$N$$US$
242545411$24254541$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58692$$FDA-CTU$$$$$M$N$$$20240826$N$HP$US$
242545421$24254542$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172829$NOVARTIS$$$$$M$Y$$$20240827$$MD$US$US
242545431$24254543$1$I$20240724$20240821$20240827$20240827$EXP$$AU-MYLANLABS-2024M1078958$MYLAN$$16$YR$$M$Y$$$20240827$$HP$AU$AU
242545442$24254544$2$F$20170101$20240919$20240827$20240925$EXP$$US-AMGEN-USASP2024169174$AMGEN$$5$YR$C$F$Y$$$20240925$$MD$US$US
242545451$24254545$1$I$20240101$20240821$20240827$20240827$EXP$$GB-AMGEN-GBRSP2024167608$AMGEN$$84$YR$E$F$Y$$$20240827$$CN$GB$GB
242545461$24254546$1$I$$20240821$20240827$20240827$EXP$$FR-MYLANLABS-2024M1077713$MYLAN$Bourgon N, Lopez R, Fourgeaud J, Guilleminot T, Bussieres L, Magny J-F et al.. In utero treatment of congenital cytomegalovirus infection with valganciclovir: an observational study on safety and effectiveness. The Journal of antimicrobial chemotherapy. 2024$$$N$$Y$$$20240827$$HP$FR$FR
242545471$24254547$1$I$$20240819$20240827$20240827$PER$$US-ABBVIE-5888681$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242545481$24254548$1$I$$20240821$20240827$20240827$EXP$$ES-MYLANLABS-2024M1076616$MYLAN$Garc?a Velasco G. Silence has been moved. Actualizaci?n en Medicina de Familia. 2024;20(7):3662$78$YR$$M$Y$$$20240827$$MD$ES$ES
242545491$24254549$1$I$20240701$20240822$20240827$20240827$EXP$$US-ABBVIE-5891787$ABBVIE$$69$YR$$F$Y$$$20240827$$CN$US$US
242545511$24254551$1$I$20240630$20240718$20240827$20240827$PER$$US-IMP-2024000534$Harrow Health$$82$YR$E$F$Y$$$20240827$$CN$US$US
242545521$24254552$1$I$$20240822$20240827$20240827$EXP$$US-ABBVIE-5891811$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242545532$24254553$2$F$$20240830$20240827$20240906$EXP$$AT-INCYTE CORPORATION-2024IN008874$INCYTE$$$$$$Y$$$20240906$$CN$AT$AT
242545551$24254555$1$I$20240801$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135364$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240827$$CN$US$US
242545571$24254557$1$I$$20240822$20240827$20240827$EXP$$TR-ROCHE-10000064754$ROCHE$Onder T, Karacin C. Trastuzumab-induced optic neuritis: ^blindness^ side effect. Journal of Oncology Pharmacy Practice. 2024-Jan; doi:10.1177/10781552241275538.$60$YR$A$F$Y$$$20240827$$HP$TR$TR
242545581$24254558$1$I$$20240801$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07900$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242545592$24254559$2$F$$20240828$20240827$20240902$EXP$$BE-SANDOZ INC.-SDZ2024BE074677$SANDOZ$$32$YR$$F$Y$$$20240902$$MD$BE$BE
242545601$24254560$1$I$$20240823$20240827$20240827$PER$$US-ABBVIE-5895148$ABBVIE$$67$YR$$F$Y$$$20240827$$CN$US$US
242545611$24254561$1$I$20220101$20240819$20240827$20240827$EXP$$US-ABBVIE-5889673$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242545621$24254562$1$I$20240803$20240820$20240827$20240827$EXP$IT-MINISAL02-998859$IT-TEVA-VS-3235401$TEVA$$36$YR$$F$Y$57$KG$20240827$$MD$IT$IT
242545632$24254563$2$F$$20240830$20240827$20240904$30DAY$$KR-PFIZER INC-PV202400110712$PFIZER$$7$YR$$M$Y$$$20240904$$CN$KR$KR
242545641$24254564$1$I$$20240823$20240827$20240827$EXP$GB-MHRA-MED-202408231727176690-VJDKG$GB-PFIZER INC-202400242855$PFIZER$$22$YR$$F$Y$$$20240827$$CN$GB$GB
242545651$24254565$1$I$$20240823$20240827$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US075272$SANDOZ$$$$$F$Y$$$20240827$$CN$US$US
242545661$24254566$1$I$20240801$20240822$20240827$20240827$PER$$US-UNITED THERAPEUTICS-UNT-2024-026469$UNITED THERAPEUTICS$$40$YR$$F$Y$$$20240827$$$US$US
242545671$24254567$1$I$$20240821$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133046$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240827$$HP$US$US
242545681$24254568$1$I$$20240819$20240827$20240827$EXP$$JP-ROCHE-10000061438$ROCHE$Osuna M, Nakajima Y, Ogiwara K, Nogami K. Changes in coagulation potential over time after administration of recombinant activated factor VII in an emicizumab-treated hemophilia A patient with inhibitors. International Journal of Hematology. 2024-Jan; doi:10.1007/s12185-024-03828-7.$67$YR$E$M$Y$$$20240827$$HP$JP$JP
242545691$24254569$1$I$$20240822$20240827$20240827$EXP$$NVSC2024GB171297$NOVARTIS$Edwards GM, Alejmi AA. Pure red cell aplasia secondary to erythropoietin therapy. CLINICAL MEDICINE. 2024;24:1-3$65$YR$$F$Y$$$20240827$$HP$GB$GB
242545701$24254570$1$I$20230721$20240820$20240827$20240827$EXP$$AR-GSK-AR2023AMR101598$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$AR$AR
242545721$24254572$1$I$$20240819$20240827$20240827$EXP$$JP-JNJFOC-20240754107$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240827$$PH$JP$JP
242545731$24254573$1$I$20240701$20240826$20240827$20240827$PER$$US-JNJFOC-20240867334$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$CN$US$US
242545743$24254574$3$F$$20240828$20240827$20240904$EXP$$CA-TAKEDA-2024TUS085788$TAKEDA$$21$YR$$F$Y$$$20240904$$HP$CA$CA
242545751$24254575$1$I$20240101$20240726$20240827$20240827$PER$$US-IMP-2024000566$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242545761$24254576$1$I$$20240823$20240827$20240827$EXP$$NVSC2024IN172358$NOVARTIS$$$$$F$Y$$$20240827$$CN$IN$IN
242545771$24254577$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58689$$FDA-CTU$$52$YR$$F$N$$$20240826$N$HP$US$
242545782$24254578$2$F$$20240821$20240827$20240830$EXP$$IT-MYLANLABS-2024M1077815$MYLAN$Monti B, Soria A, Saladini F, Lapadula G, Squillace N, Giammarino F, et al.. Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests.. Journal of Medical Virology.. 2024;96(8)$60$YR$$F$Y$$$20240830$$HP$IT$IT
242545811$24254581$1$I$$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168463$AMGEN$$$$A$$Y$$$20240827$$CN$US$US
242545821$24254582$1$I$20240821$20240821$20240827$20240827$PER$$US-AMGEN-USASP2024168264$AMGEN$$$$$F$Y$$$20240827$$PH$US$US
242545831$24254583$1$I$20240822$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168905$AMGEN$$56$YR$A$M$Y$$$20240827$$CN$US$US
242545842$24254584$2$F$$20240829$20240827$20240904$PER$$US-RDY-SPO/USA/24/0012186$DR REDDYS$$26$YR$A$F$Y$$$20240904$$CN$US$US
242545851$24254585$1$I$20240101$20240808$20240827$20240827$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1125$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240827$$CN$US$US
242545861$24254586$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135914$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240827$$CN$US$US
242545871$24254587$1$I$20230101$20240820$20240827$20240827$PER$$US-JNJFOC-20240853984$JOHNSON AND JOHNSON$$16$YR$T$M$Y$117.9$KG$20240827$$CN$US$US
242545881$24254588$1$I$$20240821$20240827$20240827$PER$$US-AMGEN-USASP2024170577$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242545891$24254589$1$I$20240101$20240819$20240827$20240827$PER$$US-AMGEN-USASP2024169400$AMGEN$$$$$M$Y$$$20240827$$CN$US$US
242545902$24254590$2$F$$20240924$20240827$20240926$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-045013$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240926$$CN$US$US
242545921$24254592$1$I$$20240823$20240827$20240827$EXP$$NVSC2024CN172879$NOVARTIS$$70$YR$$F$Y$$$20240827$$HP$CN$CN
242545931$24254593$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3234997$TEVA$$60$YR$$F$Y$$$20240827$$HP$CA$CA
242545941$24254594$1$I$$20240818$20240827$20240827$EXP$$SA-ACS-20240306$ACS DOBFAR$Almegbel M, Alshamardl K, Aleshaiwi L, Almutairi F. Kounis Syndrome: A Case Report and a Review of Recent Literature. Cureus. 2024 Jul 16;16(7):e64627. doi: 10.7759/cureus.64627.$65$YR$A$F$Y$$$20240820$$MD$SA$
242545951$24254595$1$I$20240813$20240816$20240827$20240827$EXP$$US-INFO-20240251$INFORLIFE$$53$YR$A$F$Y$83.9$KG$20240820$$HP$US$
242545981$24254598$1$I$$20240822$20240827$20240827$PER$$US-AstraZeneca-2024A193586$ASTRAZENECA$$$$$$Y$$$20240827$$MD$US$
242545991$24254599$1$I$20240101$20240823$20240827$20240827$EXP$$US-ABBVIE-5893856$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242546002$24254600$2$F$$20240923$20240827$20240926$EXP$$CA-SANDOZ INC.-SDZ2024CA075399$SANDOZ$$$$$F$Y$$$20240926$$MD$CA$CA
242546011$24254601$1$I$20240820$20240820$20240827$20240827$EXP$$DE-BAXTER-2024BAX023498$BAXTER$$64$YR$$M$Y$$$20240827$$HP$DE$DE
242546021$24254602$1$I$20240810$20240810$20240827$20240827$PER$$US-JNJFOC-20240834231$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242546031$24254603$1$I$20240101$20240807$20240827$20240827$PER$$US-TEVA-VS-3231393$TEVA$$$$E$F$Y$$$20240827$$CN$US$US
242546041$24254604$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015487$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240827$$CN$US$US
242546051$24254605$1$I$20240101$20240821$20240827$20240827$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-001332$AMGEN$$32$YR$A$F$Y$$$20240827$$CN$US$US
242546061$24254606$1$I$$20240819$20240827$20240827$EXP$$CA-BAXTER-2024BAX023629$BAXTER$$$$$$Y$$$20240827$$HP$CA$CA
242546072$24254607$2$F$20240815$20240815$20240827$20240829$EXP$$US-BAXTER-2024BAX023417$BAXTER$$$$$$Y$$$20240829$$PH$US$US
242546082$24254608$2$F$$20240906$20240827$20240906$EXP$$CN-BAYER-2024A122951$BAYER$$67$YR$E$M$Y$$$20240906$$CN$CN$CN
242546091$24254609$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242797$PFIZER$$65$YR$$$Y$$$20240827$$CN$US$US
242546101$24254610$1$I$20240821$20240824$20240827$20240827$PER$$US-PFIZER INC-202400243249$PFIZER$$68$YR$$M$Y$$$20240827$$CN$US$US
242546111$24254611$1$I$20240801$20240826$20240827$20240827$PER$$US-PFIZER INC-202400244222$PFIZER$$56$YR$$F$Y$$$20240827$$HP$US$US
242546121$24254612$1$I$20240824$20240825$20240827$20240827$PER$$US-PFIZER INC-202400243192$PFIZER$$50$YR$$F$Y$$$20240827$$PH$US$US
242546131$24254613$1$I$20240801$20240826$20240827$20240827$PER$$US-PFIZER INC-PV202400111385$PFIZER$$55$YR$$F$Y$$$20240827$$HP$US$US
242546141$24254614$1$I$$20240819$20240827$20240827$EXP$$CA-BAXTER-2024BAX023625$BAXTER$$63$YR$$F$Y$$$20240827$$CN$CA$CA
242546152$24254615$2$F$20210922$20240902$20240827$20240903$EXP$$NL-SANDOZ INC.-SDZ2024NL075282$SANDOZ$$75$YR$$F$Y$98$KG$20240903$$HP$NL$NL
242546161$24254616$1$I$20240823$20240824$20240827$20240827$PER$$US-PFIZER INC-202400243311$PFIZER$$76$YR$$F$Y$$$20240827$$HP$US$US
242546171$24254617$1$I$$20240826$20240827$20240827$PER$$US-PFIZER INC-PV202400111435$PFIZER$$67$YR$$F$Y$$$20240827$$HP$US$US
242546181$24254618$1$I$$20240823$20240827$20240827$PER$$US-PFIZER INC-PV202400111209$PFIZER$$72$YR$$F$Y$$$20240827$$HP$US$US
242546191$24254619$1$I$$20240823$20240827$20240827$PER$$US-PFIZER INC-202400244045$PFIZER$$62$YR$$F$Y$$$20240827$$HP$US$US
242546202$24254620$2$F$$20240904$20240827$20240906$PER$$US-PFIZER INC-202400243890$PFIZER$$68$YR$$F$Y$$$20240906$$CN$US$US
242546211$24254621$1$I$$20240826$20240827$20240827$PER$$US-PFIZER INC-202400244271$PFIZER$$64$YR$$F$Y$$$20240827$$CN$US$US
242546221$24254622$1$I$$20240820$20240827$20240827$EXP$$CA-GSK-CA2024AMR104925$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$CA$CA
242546231$24254623$1$I$$20240826$20240827$20240827$PER$$US-PFIZER INC-202400244050$PFIZER$$79$YR$$F$Y$$$20240827$$CN$US$US
242546241$24254624$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242971$PFIZER$$58$YR$$F$Y$$$20240827$$HP$US$US
242546251$24254625$1$I$$20240826$20240827$20240827$PER$$US-PFIZER INC-202400244223$PFIZER$$69$YR$$F$Y$$$20240827$$CN$US$US
242546262$24254626$2$F$$20240827$20240827$20240903$PER$$US-PFIZER INC-202400243921$PFIZER$$82$YR$$F$Y$$$20240903$$CN$US$US
242546271$24254627$1$I$20240823$20240823$20240827$20240827$PER$$US-PFIZER INC-202400243165$PFIZER$$44$YR$$F$Y$$$20240827$$HP$US$US
242546281$24254628$1$I$$20240826$20240827$20240827$PER$$US-PFIZER INC-PV202400111402$PFIZER$$51$YR$$F$Y$$$20240827$$HP$US$US
242546291$24254629$1$I$$20240826$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US048189$SANDOZ$$$$$F$Y$$$20240827$$CN$US$US
242546301$24254630$1$I$20240430$20240821$20240827$20240827$EXP$FR-AFSSAPS-TO2024001230$FR-ABBVIE-5890592$ABBVIE$$$$$$Y$$$20240827$$PH$FR$FR
242546311$24254631$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136184$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240827$$CN$US$US
242546321$24254632$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135826$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240827$$HP$US$US
242546331$24254633$1$I$$20240821$20240827$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134160$BRISTOL MYERS SQUIBB$Asou C, Sakamoto T, Suzuki K, Okuda I, Osaki A, Abe R, et al. Transformation into acute myeloid leukemia with T(8;21)(q22;q22.1); RUNX1::RUNX1T1 from JAK2-mutated essential thrombocythemia: a case report. Journal of Medical Case Reports. 2024 Aug 18;18(1):1-5. doi:10.1186/s13256-024-04691-0.$72$YR$E$F$Y$$$20240827$$HP$JP$JP
242546341$24254634$1$I$$20240820$20240827$20240827$EXP$$US-BAYER-2024A119889$BAYER$$17$YR$T$M$Y$$$20240827$$HP$US$US
242546351$24254635$1$I$20230915$20230915$20240827$20240827$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00997$TARO$$$$$$Y$$$20240827$$CN$US$US
242546361$24254636$1$I$$20230816$20240827$20240827$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00893$TARO$$$$$$Y$$$20240827$$CN$US$US
242546371$24254637$1$I$$20231213$20240827$20240827$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01229$TARO$$$$$$Y$$$20240827$$CN$US$US
242546381$24254638$1$I$$20231211$20240827$20240827$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01317$TARO$$$$$$Y$$$20240827$$CN$US$US
242546391$24254639$1$I$$20240329$20240827$20240827$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00421$TARO$$$$$$Y$$$20240827$$CN$US$US
242546401$24254640$1$I$$20240611$20240827$20240827$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00795$TARO$$$$$$Y$$$20240827$$CN$US$US
242546412$24254641$2$F$$20240830$20240827$20240909$EXP$$GR-TEVA-VS-3236054$TEVA$Panou E, Marinos L, Piperaki E, Migkou M, Stratigos AJ, Nikolaou V. Post-kala-azar dermal leishmaniasis manifestation in a Mediterranean immunosuppressed patient: a rare incident. Clin-Exp-Dermatol 2023; 48 834-836.; Panou E, Marinos L, Piperaki E, Migkou M, Stratigos AJ, Nikolaou V. Post-kala-azar dermal leishmaniasis manifestation in a Mediterranean immunosuppressed patient: a rare incident. Clin-Exp-Dermatol 2023; 48 834-836.$74$YR$$M$Y$$$20240909$$HP$GR$GR
242546421$24254642$1$I$$20240304$20240827$20240827$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00294$TARO$$$$$$Y$$$20240827$$CN$US$US
242546431$24254643$1$I$$20231010$20240827$20240827$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01074$TARO$$$$$M$Y$$$20240827$$CN$US$US
242546442$24254644$2$F$20240813$20240919$20240827$20240924$PER$$US-PFIZER INC-202400243228$PFIZER$$71$YR$$M$Y$103.87$KG$20240924$$CN$US$US
242546452$24254645$2$F$$20240819$20240827$20240916$EXP$$US-TEVA-VS-3236237$TEVA$Juneja P, Swor D. An Evidence-Based Approach to Diagnosis and Prognosis in a Young Woman with New-Onset Super-Refractory Status Epilepticus: A Case Report. Case-Rep-Neurol 2022; 14 (1): 5-11.; Juneja P, Swor D. An Evidence-Based Approach to Diagnosis and Prognosis in a Young Woman with New-Onset Super-Refractory Status Epilepticus: A Case Report. Case-Rep-Neurol 2022; 14 (1): 5-11.$24$YR$$F$Y$$$20240916$$HP$US$US
242546461$24254646$1$I$$20240822$20240827$20240827$EXP$$DE-JNJFOC-20240858890$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$MD$DE$DE
242546472$24254647$2$F$20240101$20240919$20240827$20240927$EXP$$US-TEVA-VS-3229696$TEVA$$73$YR$$F$Y$$$20240927$$CN$US$US
242546481$24254648$1$I$$20240811$20240827$20240827$EXP$$AT-ASTELLAS-AER-2024-020616$ASTELLAS$$65$YR$E$M$Y$$$20240826$$HP$AT$AT
242546492$24254649$2$F$$20240827$20240827$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134880$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$72.57$KG$20240902$$CN$US$US
242546511$24254651$1$I$20240701$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135027$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240827$$CN$US$US
242546521$24254652$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134917$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240827$$CN$US$US
242546531$24254653$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172959$NOVARTIS$$$$$$Y$$$20240827$$MD$US$US
242546541$24254654$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-135685-2023$RECKITT BENCKISER$$$$$F$Y$$$20240827$$CN$US$US
242546551$24254655$1$I$20240718$20240727$20240827$20240827$PER$$US-IMP-2024000571$Harrow Health$$80$YR$E$F$Y$$$20240827$$CN$US$US
242546561$24254656$1$I$$20240819$20240827$20240827$EXP$$VN-SANDOZ INC.-SDZ2024VN075459$SANDOZ$$65$YR$$F$Y$$$20240827$$MD$VN$VN
242546571$24254657$1$I$20240301$20240827$20240827$20240827$EXP$IT-MINISAL02-999947$IT-SANDOZ INC.-SDZ2024IT075423$SANDOZ$$52$YR$$F$Y$62$KG$20240827$$MD$IT$IT
242546581$24254658$1$I$20240101$20240821$20240827$20240827$EXP$$CA-JNJFOC-20240855966$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240827$$HP$CA$CA
242546592$24254659$2$F$$20240920$20240827$20240927$EXP$$TW-GSK-TW2023APC084872$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$TW$TW
242546602$24254660$2$F$20240703$20240830$20240827$20240905$EXP$FR-AFSSAPS-TO2024001273$FR-MYLANLABS-2024M1065999$MYLAN$$77$YR$$M$Y$82$KG$20240905$$PH$FR$FR
242546621$24254662$1$I$$20240821$20240827$20240827$EXP$$IT-MYLANLABS-2024M1077798$MYLAN$Trapanese V, Maruca F, Natale MR, Giofre F, Cosentino F, Sergi S, et al.. Sodium-glucose co-transporter-2 inhibitor-associated non-diabetic ketoacidosis: a case report.. Italian-J-Med. 2024;18:No. 2.$26$YR$$M$Y$142$KG$20240827$$HP$IT$IT
242546631$24254663$1$I$$20240827$20240827$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048046$BOEHRINGER INGELHEIM$$$$$$Y$$$20240827$$CN$US$US
242546641$24254664$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400243003$PFIZER$$78$YR$$F$Y$$$20240827$$HP$US$US
242546651$24254665$1$I$20240101$20240821$20240827$20240827$EXP$DE-CADRBFARM-2024329864$DE-MYLANLABS-2024M1077970$MYLAN$$55$YR$$M$Y$78$KG$20240827$$CN$DE$DE
242546661$24254666$1$I$$20240826$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075228$SANDOZ$$$$$$Y$$$20240827$$CN$US$US
242546671$24254667$1$I$$20240823$20240827$20240827$PER$$US-ROCHE-10000065943$ROCHE$$66$YR$E$M$Y$$$20240827$$CN$US$US
242546681$24254668$1$I$$20240819$20240827$20240827$PER$$US-AMGEN-USASP2024167952$AMGEN$Peikert T.; Varghese C.; Johnson G.B. et al.. A Retrospective Evaluation of the Treatment Effects of Rituximab in Patients with Progressive and Symptomatic Fibrosing Mediastinitis. Annals of the American Thoracic Society. 2024;1-32$$$$$Y$$$20240827$$MD$US$US
242546691$24254669$1$I$$20240822$20240827$20240827$EXP$$US-MYLANLABS-2024M1078987$MYLAN$$$$$$Y$$$20240827$$CN$US$US
242546701$24254670$1$I$$20240823$20240827$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047763$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240827$$MD$US$US
242546711$24254671$1$I$20240101$20240727$20240827$20240827$PER$$US-IMP-2024000567$Harrow Health$$$$A$M$Y$$$20240827$$CN$US$US
242546721$24254672$1$I$$20240819$20240827$20240827$EXP$$ZA-AstraZeneca-2024A189582$ASTRAZENECA$$75$YR$$M$Y$$$20240827$$CN$ZA$
242546731$24254673$1$I$$20240823$20240827$20240827$EXP$$CN-AstraZeneca-2024A194474$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$CN$
242546741$24254674$1$I$$20240822$20240827$20240827$EXP$$HR-AstraZeneca-2024A193205$ASTRAZENECA$$$$$M$Y$$$20240827$$MD$HR$
242546751$24254675$1$I$20231031$20240823$20240827$20240827$EXP$$JP-AstraZeneca-2024A039970$ASTRAZENECA$$70$YR$$M$Y$$$20240827$$MD$JP$
242546761$24254676$1$I$$20240822$20240827$20240827$PER$$US-AstraZeneca-2024A192589$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242546771$24254677$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189841$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242546781$24254678$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192524$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242546791$24254679$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3235044$TEVA$$$$$F$Y$$$20240827$$HP$CA$CA
242546811$24254681$1$I$20240801$20240822$20240827$20240827$EXP$$US-Eisai-EC-2024-172736$EISAI$$74$YR$E$M$Y$$$20240827$$MD$US$US
242546821$24254682$1$I$20240827$20240827$20240827$20240827$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048031$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$$$20240827$$CN$US$US
242546831$24254683$1$I$20240401$20240823$20240827$20240827$EXP$$US-OTSUKA-2024_015350$OTSUKA$$28$YR$$F$Y$92.08$KG$20240827$$CN$US$US
242546841$24254684$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136162$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240827$$MD$US$US
242546852$24254685$2$F$$20240916$20240827$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131681$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240918$$CN$US$US
242546861$24254686$1$I$$20240822$20240827$20240827$EXP$$JP-009507513-2408JPN002950J$MERCK$$8$DEC$$F$Y$$$20240827$$MD$JP$JP
242546871$24254687$1$I$20240727$20240823$20240827$20240827$EXP$$NVSC2024CN172781$NOVARTIS$$4$YR$$M$Y$14.5$KG$20240827$$HP$CN$CN
242546881$24254688$1$I$$20240819$20240827$20240827$EXP$$PL-MYLANLABS-2024M1077873$MYLAN$Kawalec A, Cichon L, Wilczynski K, Janas-Kozik M. First onset of persistent neutropenia in patient undergoing long-term clozapine treatment after vaccination against COVID-19 and SARS-CoV-2 infection in short interval - a case report. Psychiatr-Pol 2024; 1-11.$23$YR$$F$Y$$$20240827$$HP$PL$PL
242546891$24254689$1$I$20240623$20240820$20240827$20240827$EXP$$CN-ABBVIE-5895556$ABBVIE$$41$YR$$M$Y$81$KG$20240827$$HP$CN$CN
242546901$24254690$1$I$20240817$20240820$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132393$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240827$$PH$US$US
242546912$24254691$2$F$$20240905$20240827$20240912$EXP$$CA-TAKEDA-CA202023853$TAKEDA$$$$$M$Y$$$20240912$$HP$CA$CA
242546921$24254692$1$I$20240714$20240823$20240827$20240827$EXP$$NVSC2024CN172742$NOVARTIS$$57$YR$$M$Y$$$20240827$$HP$CN$CN
242546931$24254693$1$I$$20240817$20240827$20240827$EXP$$FI-AMGEN-FINSP2024168885$AMGEN$Kaprio:E.. Drug-induced pneumonitis risk in diffuse large B-cell/follicular lymphoma patients treated with R-CHOP-like regimen is associated with the use of granulocyte colony-stimulating growth factors. Cancer medicine. 2024;13 (1):1-8$$$$$Y$$$20240827$$HP$FI$FI
242546942$24254694$2$F$20240201$20240827$20240827$20240903$EXP$$US-GSK-US2024103944$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
242546953$24254695$3$F$$20240916$20240827$20240923$EXP$$US-BIOVITRUM-2024-US-011284$BIOVITRUM$$78$YR$$F$Y$$$20240923$$CN$US$US
242546961$24254696$1$I$20240814$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015337$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240827$$CN$US$US
242546971$24254697$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014104$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240827$$CN$US$US
242546981$24254698$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013731$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240827$$CN$US$US
242546991$24254699$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014129$ELI LILLY AND CO$$$$$$Y$$$20240827$$CN$US$US
242547001$24254700$1$I$$20240826$20240827$20240827$30DAY$$US-ELI_LILLY_AND_COMPANY-US202408016527$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240827$$CN$US$US
242547011$24254701$1$I$20240101$20240731$20240827$20240827$PER$$US-IMP-2024000578$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242547021$24254702$1$I$$20240802$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07456$LUPIN$$$$$$Y$$$20240827$$PH$US$US
242547032$24254703$2$F$20240101$20240904$20240827$20240906$PER$$US-BIOGEN-2024BI01279357$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242547042$24254704$2$F$20240310$20240402$20240827$20240827$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00093$Alora Pharma$$50$YR$$F$Y$$$20240827$$CN$US$US
242547051$24254705$1$I$$20240402$20240827$20240827$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00105$Alora Pharma$$$$$$Y$$$20240827$$CN$US$US
242547062$24254706$2$F$20240301$20240528$20240827$20240827$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00235$Alora Pharma$$62$YR$$M$Y$$$20240827$$CN$US$US
242547071$24254707$1$I$$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133337$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240827$$CN$US$US
242547081$24254708$1$I$20240819$20240820$20240827$20240827$EXP$$AR-BIOMARINAP-AR-2024-160071$BIOMARIN$$$$$$Y$$$20240827$$CN$AR$AR
242547091$24254709$1$I$$20240822$20240827$20240827$PER$$US-ABBVIE-5894359$ABBVIE$$$$$$Y$$$20240827$$CN$US$US
242547101$24254710$1$I$$20240814$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008536$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242547111$24254711$1$I$$20240820$20240827$20240827$EXP$$US-GSK-US2024AMR105164$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
242547121$24254712$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024170702$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242547131$24254713$1$I$$20240820$20240827$20240827$EXP$$CA-GSK-CA2024AMR104708$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$HP$CA$CA
242547141$24254714$1$I$$20240821$20240827$20240827$PER$$US-MYLANLABS-2024M1078714$MYLAN$$$$$F$Y$$$20240827$$HP$US$US
242547151$24254715$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3234988$TEVA$$77$YR$$M$Y$$$20240827$$PH$CA$CA
242547161$24254716$1$I$20240821$20240822$20240827$20240827$EXP$$US-OTSUKA-2024_023203$OTSUKA$$61$YR$$F$Y$$$20240827$$CN$US$US
242547171$24254717$1$I$$20240731$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07789$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242547181$24254718$1$I$$20240822$20240827$20240827$PER$$US-JNJFOC-20240862527$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$CN$US$US
242547191$24254719$1$I$20240101$20240826$20240827$20240827$EXP$SE-SEMPA-2024-006170$SE-GILEAD-2024-0685375$GILEAD$$26$YR$A$M$Y$$$20240827$$MD$SE$SE
242547202$24254720$2$F$20240817$20240930$20240827$20240930$EXP$$PH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047922$BOEHRINGER INGELHEIM$$8$DEC$E$M$Y$$$20240930$$MD$PH$PH
242547211$24254721$1$I$20240101$20240820$20240827$20240827$EXP$$US-TG THERAPEUTICS INC.-TGT003926$TG THERAPEUTICS$$$$$$Y$$$20240827$$CN$US$US
242547221$24254722$1$I$20240801$20240826$20240827$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047894$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240827$$CN$US$US
242547231$24254723$1$I$$20240820$20240827$20240827$EXP$$CA-MYLANLABS-2024M1077322$MYLAN$$54$YR$$M$Y$$$20240827$$MD$CA$CA
242547241$24254724$1$I$$20240820$20240827$20240827$EXP$$CA-ABBVIE-5893221$ABBVIE$$$$E$M$Y$$$20240827$$CN$CA$CA
242547251$24254725$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135011$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240827$$HP$US$US
242547261$24254726$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135404$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240827$$CN$US$US
242547271$24254727$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136036$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240827$$CN$US$US
242547293$24254729$3$F$$20240920$20240827$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136101$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240930$$CN$US$US
242547301$24254730$1$I$20221012$20230428$20240827$20240827$EXP$$NVSC2023US281016$NOVARTIS$$$$$M$Y$$$20240827$$CN$US$US
242547311$24254731$1$I$20240120$20240816$20240827$20240827$PER$$US-ROCHE-10000061785$ROCHE$$81$YR$E$F$Y$74.842$KG$20240827$$CN$US$US
242547331$24254733$1$I$20240819$20240826$20240827$20240827$PER$$US-JNJFOC-20240867497$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$US$US
242547342$24254734$2$F$$20240827$20240827$20240828$PER$$US-JNJFOC-20240866416$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$HP$US$US
242547351$24254735$1$I$20230801$20240822$20240827$20240827$EXP$$BR-JNJFOC-20240863629$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240827$$CN$BR$BR
242547361$24254736$1$I$$20240820$20240827$20240827$EXP$$US-GSK-US2024103975$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
242547371$24254737$1$I$$20240819$20240827$20240827$EXP$$ZA-AstraZeneca-2024A189287$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$ZA$
242547381$24254738$1$I$20240813$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A191946$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242547391$24254739$1$I$20240804$20240822$20240827$20240827$EXP$$ZA-AstraZeneca-2024A192044$ASTRAZENECA$$24837$DY$$M$Y$$$20240827$$CN$ZA$
242547402$24254740$2$F$20240808$20240829$20240827$20240906$EXP$$JP-AstraZeneca-2024A191334$ASTRAZENECA$$80$YR$$M$Y$$$20240906$$MD$JP$
242547411$24254741$1$I$$20240820$20240827$20240827$EXP$$US-GSK-US2024103876$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
242547421$24254742$1$I$20240419$20240819$20240827$20240827$EXP$$CN-AstraZeneca-2024A190659$ASTRAZENECA$$72$YR$$F$Y$72$KG$20240827$$MD$CN$
242547431$24254743$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189402$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242547441$24254744$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-135328-2023$RECKITT BENCKISER$$$$$F$Y$$$20240827$$CN$US$US
242547451$24254745$1$I$$20240819$20240827$20240827$EXP$$GB-AstraZeneca-2024A192143$ASTRAZENECA$$$$$M$Y$$$20240827$$HP$GB$
242547461$24254746$1$I$$20240822$20240827$20240827$EXP$$CA-AstraZeneca-2024A194481$ASTRAZENECA$$76$YR$$M$Y$$$20240827$$MD$CA$
242547473$24254747$3$F$$20240815$20240827$20240918$PER$$US-BIOMARINAP-US-2024-160020$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
242547481$24254748$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189514$ASTRAZENECA$$$$$F$Y$94.8$KG$20240827$$CN$US$
242547492$24254749$2$F$$20240827$20240827$20240901$EXP$$US-TAKEDA-2024TUS056925$TAKEDA$$$$$F$Y$$$20240901$$CN$US$US
242547503$24254750$3$F$$20240923$20240827$20240925$PER$$US-BIOVITRUM-2024-US-011286$BIOVITRUM$$54$YR$$F$Y$$$20240925$$CN$US$US
242547511$24254751$1$I$20240825$20240825$20240827$20240827$EXP$$KR-VANTIVE-2024VAN019320$Vantive US Healthcare$$64$YR$$M$Y$$$20240827$$CN$KR$KR
242547521$24254752$1$I$20240825$20240827$20240827$20240827$EXP$$SG-VANTIVE-2024VAN019330$Vantive US Healthcare$$76$YR$$F$Y$$$20240827$$CN$SG$SG
242547531$24254753$1$I$$20240822$20240827$20240827$EXP$$US-LUNDBECK-DKLU4003417$LUNDBECK$$$$$$Y$$$20240827$$CN$US$US
242547541$24254754$1$I$20240801$20240821$20240827$20240827$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-16738$IPSEN$$2$YR$C$M$Y$7.9$KG$20240827$$CN$US$US
242547551$24254755$1$I$20240101$20240731$20240827$20240827$PER$$US-IMP-2024000579$Harrow Health$$$$A$F$Y$$$20240827$$CN$US$US
242547561$24254756$1$I$20240823$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169949$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242547572$24254757$2$F$$20240821$20240827$20240829$EXP$$CA-ROCHE-10000061672$ROCHE$$44$YR$A$F$Y$$$20240829$$HP$CA$CA
242547581$24254758$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3235081$TEVA$$49$YR$$F$Y$$$20240827$$MD$CA$CA
242547591$24254759$1$I$$20240820$20240827$20240827$EXP$$US-GSK-US2024AMR105348$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
242547601$24254760$1$I$20240806$20240820$20240827$20240827$EXP$IT-MINISAL02-998870$IT-TEVA-VS-3234921$TEVA$$67$YR$$F$Y$50$KG$20240827$$MD$IT$IT
242547611$24254761$1$I$20240701$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189216$ASTRAZENECA$$893$MON$$M$Y$$$20240827$$CN$US$
242547621$24254762$1$I$20240815$20240822$20240827$20240827$EXP$$CN-AstraZeneca-2024A193013$ASTRAZENECA$$22930$DY$$M$Y$$$20240827$$MD$CN$
242547631$24254763$1$I$20240822$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A193284$ASTRAZENECA$$26967$DY$$M$Y$$$20240827$$MD$US$
242547641$24254764$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A191854$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242547651$24254765$1$I$20240812$20240814$20240827$20240827$PER$$US-JNJFOC-20240842181$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240827$$CN$US$US
242547661$24254766$1$I$$20240730$20240827$20240827$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07858$LUPIN$$$$$$Y$$$20240827$$CN$US$US
242547671$24254767$1$I$$20240716$20240827$20240827$PER$$US-LUNDBECK-DKLU4001850$LUNDBECK$$$$$$Y$$$20240827$$HP$US$US
242547682$24254768$2$F$20240808$20240820$20240827$20240830$EXP$$LB-DSJP-DSJ-2024-141753$DAIICHI$$53$YR$$F$Y$$$20240830$$HP$LB$LB
242547691$24254769$1$I$20240101$20240820$20240827$20240827$EXP$$KR-ABBVIE-5892349$ABBVIE$$$$$$Y$$$20240827$$CN$KR$KR
242547711$24254771$1$I$$20240823$20240827$20240827$EXP$$CA-ABBVIE-5893946$ABBVIE$$$$E$F$Y$$$20240827$$CN$CA$CA
242547721$24254772$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3235190$TEVA$$70$YR$$M$Y$90$KG$20240827$$HP$CA$CA
242547732$24254773$2$F$20240223$20240826$20240827$20240902$EXP$$CO-GSK-CO2024AMR026222$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$CO$CO
242547741$24254774$1$I$20230514$20240821$20240827$20240827$EXP$FR-AFSSAPS-PO2024000903$FR-MYLANLABS-2024M1077641$MYLAN$$1$DY$$M$Y$3.5$KG$20240827$$HP$FR$FR
242547761$24254776$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015429$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240827$$CN$US$US
242547771$24254777$1$I$$20240816$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408011668$ELI LILLY AND CO$$$$A$F$Y$$$20240827$$CN$US$US
242547783$24254778$3$F$$20240906$20240827$20240916$EXP$$GB-TEVA-VS-3236049$TEVA$Teoh YP, Gold A, Yesudian PD. Fats and figures: how abnormal lipids unravel the truth. Br-J-Dermatol 2024; 191 (Suppl. 1) i127-i128 abstr. PA12.; Teoh YP, Gold A, Yesudian PD. Fats and figures: how abnormal lipids unravel the truth. Br-J-Dermatol 2024; 191 (Suppl. 1) i127-i128 abstr. PA12.$22$YR$$M$Y$$$20240916$$HP$GB$GB
242547791$24254779$1$I$$20240826$20240827$20240827$EXP$$US-PFIZER INC-202400244039$PFIZER$$64$YR$$F$Y$$$20240827$$CN$US$US
242547802$24254780$2$F$$20240905$20240827$20240909$EXP$$GB-PFIZER INC-202400241628$PFIZER$Finnegan, R.. Risk-benefit profile of onasemnogene abeparvovec in older and heavier children with spinal muscular atrophy type 1. Neuromuscular Disorders. 2024;42:22-26$8$YR$$F$Y$20$KG$20240909$$MD$GB$GB
242547813$24254781$3$F$$20240906$20240827$20240911$EXP$$GB-PFIZER INC-202400243653$PFIZER$Hall, R.. Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin^s lymphoma, complicated by anthracycline-induced cardiomyopathy. BMJ Case Reports. 2024;17(8):10.1136/bcr-2023-257523$3$DEC$$F$Y$$$20240911$$HP$GB$GB
242547826$24254782$6$F$20240801$20240919$20240827$20240924$EXP$$US-PFIZER INC-PV202400110762$PFIZER$$84$YR$$F$Y$$$20240924$$CN$US$US
242547831$24254783$1$I$20240518$20240823$20240827$20240827$EXP$FR-AFSSAPS-PB2024000866$FR-PFIZER INC-202400242448$PFIZER$$90$YR$$F$Y$55$KG$20240827$$MD$FR$FR
242547842$24254784$2$F$20240201$20240905$20240827$20240913$EXP$$JP-FERRINGPH-2024FE04805$FERRING$$$$$$Y$$$20240913$$PH$JP$JP
242547851$24254785$1$I$20240722$20240821$20240827$20240827$EXP$$KR-TAKEDA-2024TUS084150$TAKEDA$$82$YR$$M$Y$$$20240827$$CN$KR$KR
242547861$24254786$1$I$$20240821$20240827$20240827$EXP$$DE-MYLANLABS-2024M1075856$MYLAN$$46$YR$$M$Y$$$20240827$$CN$DE$DE
242547872$24254787$2$F$20190426$20240904$20240827$20240913$EXP$$CO-FERRINGPH-2024FE04800$FERRING$$$$$$Y$$$20240913$$CN$CO$CO
242547882$24254788$2$F$$20240828$20240827$20240902$PER$$US-ALXN-202408USA001282US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242547892$24254789$2$F$$20240814$20240827$20240827$PER$$US-ALXN-202407USA002004US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242547921$24254792$1$I$$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169772$AMGEN$$$$$F$Y$$$20240827$$MD$US$US
242547931$24254793$1$I$$20240815$20240827$20240827$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08253$NEUROCRINE BIOSCIENCES$$63$YR$$F$Y$$$20240827$$HP$US$US
242547941$24254794$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A190426$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242547951$24254795$1$I$$20240807$20240827$20240827$PER$$US-TEVA-VS-3231401$TEVA$$54$YR$$F$Y$$$20240827$$HP$US$US
242547961$24254796$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A190057$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242547971$24254797$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189833$ASTRAZENECA$$$$$F$Y$86.6$KG$20240827$$CN$US$
242547981$24254798$1$I$20240403$20240819$20240827$20240827$EXP$$ES-AstraZeneca-2024A188270$ASTRAZENECA$$81$YR$$F$Y$92$KG$20240827$$MD$ES$
242547993$24254799$3$F$$20240905$20240827$20240909$30DAY$$AR-PFIZER INC-202400240974$PFIZER$$68$YR$$F$Y$$$20240909$$CN$AR$AR
242548002$24254800$2$F$$20240923$20240827$20240927$EXP$$GB-PFIZER INC-PV202400108485$PFIZER$$$$$M$Y$$$20240927$$HP$GB$GB
242548012$24254801$2$F$$20240819$20240827$20240830$EXP$$US-AstraZeneca-2024A189184$ASTRAZENECA$$$$$$Y$$$20240830$$CN$US$
242548021$24254802$1$I$20240817$20240819$20240827$20240827$EXP$$BR-AstraZeneca-2024A193225$ASTRAZENECA$$79$YR$$F$Y$$$20240827$$CN$BR$
242548031$24254803$1$I$$20240823$20240827$20240827$PER$$US-AstraZeneca-2024A193069$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242548041$24254804$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189870$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242548051$24254805$1$I$$20240817$20240827$20240827$PER$$US-ABBVIE-5887297$ABBVIE$$$$$F$Y$$$20240827$$HP$US$US
242548061$24254806$1$I$20240723$20240823$20240827$20240827$PER$$JP-Eisai-EC-2024-172812$EISAI$$$$$F$Y$$$20240827$$MD$JP$JP
242548071$24254807$1$I$$20240815$20240827$20240827$EXP$$JP-Accord-442534$ACCORD$Tamura T, Kanemasa Y, Nakamura S, Okuya T, Yagi YU, Matsuda S, et al. Management of HER2-positive and microsatellite instability-high advanced gastric cancer: a case report. International Cancer Conference Journal. 2024. DOI: 10.1007/s13691-024-00707-0.$75$YR$E$M$Y$$$20240827$$MD$JP$JP
242548081$24254808$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135312$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240827$$CN$US$US
242548091$24254809$1$I$20240101$20240822$20240827$20240827$EXP$$US-VERTEX PHARMACEUTICALS-2024-013592$VERTEX$$$$$$Y$$$20240827$$CN$US$US
242548101$24254810$1$I$20211223$20240814$20240827$20240827$EXP$$CA-VER-202200371$VERITY PHARMACEUTICALS$$87$YR$E$M$Y$$$20240827$$HP$CA$CA
242548112$24254811$2$F$$20240902$20240827$20240906$EXP$$NVSC2024BR171604$NOVARTIS$$$$$F$Y$$$20240906$$CN$BR$BR
242548121$24254812$1$I$20240816$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135291$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240827$$CN$US$US
242548131$24254813$1$I$$20240824$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075267$SANDOZ$$$$$$Y$$$20240827$$CN$US$US
242548141$24254814$1$I$20240101$20240816$20240827$20240827$EXP$$US-ABBVIE-5886657$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242548151$24254815$1$I$20240801$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008571$INCYTE$$$$$$Y$$$20240827$$PH$US$US
242548161$24254816$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015512$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240827$$CN$US$US
242548171$24254817$1$I$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016145$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242548181$24254818$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014103$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240827$$CN$US$US
242548192$24254819$2$F$20240401$20240828$20240827$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408014495$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240904$$CN$US$US
242548201$24254820$1$I$20240713$20240819$20240827$20240827$EXP$$CN-TAKEDA-2024TUS085601$TAKEDA$$53$YR$$F$Y$46$KG$20240827$$HP$CN$CN
242548221$24254822$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-135255-2023$RECKITT BENCKISER$$$$$F$Y$$$20240827$$CN$US$US
242548231$24254823$1$I$20240809$20240822$20240827$20240827$EXP$$CN-PFIZER INC-PV202400110012$PFIZER$$58$YR$$M$Y$$$20240827$$HP$CN$CN
242548241$24254824$1$I$20240724$20240820$20240827$20240827$EXP$$US-BEH-2024177457$CSL BEHRING$$58$YR$A$M$Y$$$20240827$$HP$US$US
242548251$24254825$1$I$20240717$20240822$20240827$20240827$EXP$$NVSC2024CN171961$NOVARTIS$$32$YR$$F$Y$$$20240827$$HP$CN$CN
242548261$24254826$1$I$20240809$20240820$20240827$20240827$EXP$PT-INFARMED-R202408-253$PT-TEVA-VS-3235324$TEVA$$39$YR$$F$Y$$$20240827$$MD$PT$PT
242548271$24254827$1$I$$20240826$20240827$20240827$EXP$$CN-PFIZER INC-PV202400110874$PFIZER$$$$A$M$Y$$$20240827$$CN$CN$CN
242548281$24254828$1$I$$20240826$20240827$20240827$EXP$$CN-PFIZER INC-PV202400110895$PFIZER$$$$A$F$Y$$$20240827$$CN$CN$CN
242548291$24254829$1$I$20240722$20240821$20240827$20240827$EXP$$CN-TAKEDA-2024TUS085821$TAKEDA$$80$YR$$M$Y$60$KG$20240827$$HP$CN$CN
242548301$24254830$1$I$$20240820$20240827$20240827$EXP$$US-GSK-US2024103965$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
242548311$24254831$1$I$20240703$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58802$$FDA-CTU$$60$YR$$M$N$$$20240826$N$PH$US$
242548331$24254833$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172460$NOVARTIS$$$$$M$Y$$$20240827$$CN$US$US
242548341$24254834$1$I$$20240826$20240826$20240826$DIR$715956$$FDA-CTU$$$$$F$N$$$20240826$N$PH$US$
242548351$24254835$1$I$20240814$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58804$$FDA-CTU$$70$YR$$M$N$$$20240826$Y$HP$US$
242548361$24254836$1$I$$20240823$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075186$SANDOZ$$$$$F$Y$$$20240827$$MD$US$US
242548371$24254837$1$I$20240601$20240826$20240826$20240826$DIR$715964$$FDA-CTU$$74$YR$$F$N$68.85$KG$20240826$N$CN$US$
242548381$24254838$1$I$20240823$20240826$20240826$20240826$DIR$716000$$FDA-CTU$$61$YR$$F$N$$$20240826$Y$HP$US$
242548391$24254839$1$I$$20240821$20240827$20240827$EXP$$US-JNJFOC-20240865575$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$HP$US$US
242548401$24254840$1$I$$20240823$20240827$20240827$PER$$US-JNJFOC-20240865812$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242548422$24254842$2$F$$20240827$20240827$20240903$EXP$$US-GSK-US2024103930$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
242548431$24254843$1$I$$20240820$20240827$20240827$EXP$$NVSC2024BR172469$NOVARTIS$$$$$$Y$$$20240827$$MD$BR$BR
242548441$24254844$1$I$$20240819$20240827$20240827$EXP$$JP-009507513-2408JPN002425J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$89$YR$$F$Y$$$20240827$$MD$JP$JP
242548451$24254845$1$I$$20240819$20240827$20240827$EXP$$JP-009507513-2408JPN002436J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$88$YR$$F$Y$$$20240827$$MD$JP$JP
242548461$24254846$1$I$$20240813$20240827$20240827$EXP$$CN-Merck Healthcare KGaA-2024043805$MERCK KGAA$$$$$F$Y$$$20240822$$CN$CN$CN
242548471$24254847$1$I$$20240826$20240827$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US075436$SANDOZ$$$$$M$Y$$$20240827$$HP$US$US
242548481$24254848$1$I$20240607$20240815$20240827$20240827$EXP$FR-AFSSAPS-AVTO2024000111$FR-MYLANLABS-2024M1076626$MYLAN$$52$YR$$M$Y$$$20240827$$MD$FR$FR
242548493$24254849$3$F$20240603$20240830$20240827$20240912$EXP$$CL-Merck Healthcare KGaA-2024044147$MERCK KGAA$$64$YR$A$F$Y$64$KG$20240909$$CN$CL$CL
242548501$24254850$1$I$20240805$20240823$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075061$SANDOZ$$74$YR$$M$Y$85$KG$20240827$$CN$US$US
242548511$24254851$1$I$$20240826$20240827$20240827$EXP$$HU-SANDOZ INC.-SDZ2024HU075299$SANDOZ$$20$YR$$F$Y$$$20240827$$MD$HU$HU
242548522$24254852$2$F$20240820$20240820$20240827$20240829$EXP$$US-VIIV HEALTHCARE LIMITED-US2024103872$VIIV$$$$$$Y$$$20240829$$HP$US$US
242548531$24254853$1$I$$20240826$20240826$20240826$DIR$715970$$FDA-CTU$$$$$UNK$N$$$20240826$N$CN$US$
242548541$24254854$1$I$20240811$20240826$20240826$20240826$DIR$715998$$FDA-CTU$$85$YR$$F$N$51.75$KG$20240826$Y$CN$US$
242548551$24254855$1$I$20200101$20240813$20240827$20240827$EXP$$CO-SA-2023SA403726$SANOFI AVENTIS$$63$YR$A$F$Y$75$KG$20240827$$CN$CO$CO
242548561$24254856$1$I$20240605$20240802$20240827$20240827$EXP$$CA-GILEAD-2024-0677103$GILEAD$$67$YR$E$F$Y$$$20240827$$CN$CA$CA
242548571$24254857$1$I$$20240826$20240826$20240826$DIR$715999$$FDA-CTU$$27$YR$$F$N$$$20240826$N$PH$US$
242548581$24254858$1$I$$20240819$20240827$20240827$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16530$IPSEN$$$$$M$Y$$$20240827$$CN$US$US
242548591$24254859$1$I$20240726$20240826$20240826$20240826$DIR$715994$$FDA-CTU$$39$YR$$F$N$$$20240826$N$HP$US$
242548601$24254860$1$I$$20240822$20240827$20240827$PER$$US-ABBVIE-5893839$ABBVIE$$$$$F$Y$$$20240827$$MD$US$US
242548611$24254861$1$I$20240716$20240802$20240827$20240827$PER$$US-IMP-2024000588$Harrow Health$$64$YR$A$F$Y$$$20240827$$CN$US$US
242548621$24254862$1$I$$20240819$20240827$20240827$EXP$$JP-009507513-2408JPN002470J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$90$YR$$F$Y$$$20240827$$MD$JP$JP
242548631$24254863$1$I$$20240819$20240827$20240827$EXP$$JP-009507513-2408JPN002450J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$91$YR$$F$Y$$$20240827$$MD$JP$JP
242548641$24254864$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136037$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240827$$HP$US$US
242548651$24254865$1$I$20240826$20240826$20240826$20240826$DIR$716007$$FDA-CTU$$46$YR$$F$N$83.25$KG$20240826$N$HP$US$
242548671$24254867$1$I$20240806$20240826$20240826$20240826$DIR$716009$$FDA-CTU$$70$YR$$F$N$72$KG$20240826$Y$CN$US$
242548681$24254868$1$I$20240802$20240826$20240826$20240826$DIR$716003$$FDA-CTU$$48$YR$$F$N$110.7$KG$20240826$N$CN$US$
242548691$24254869$1$I$$20240823$20240826$20240826$DIR$FDA-CDER-CTU-2024-58772$$FDA-CTU$$$$$F$N$$$20240823$N$HP$US$
242548701$24254870$1$I$20240826$20240826$20240826$20240826$DIR$716018$$FDA-CTU$$52$YR$$F$N$81$KG$20240826$N$CN$US$
242548711$24254871$1$I$20220519$20240826$20240826$20240826$DIR$716010$$FDA-CTU$$61$YR$$F$N$54.9$KG$20240826$N$CN$US$
242548751$24254875$1$I$$20240826$20240826$20240826$DIR$716012$$FDA-CTU$$63$YR$$F$N$65.25$KG$20240826$N$CN$US$
242548771$24254877$1$I$20240617$20240812$20240827$20240827$EXP$FR-AFSSAPS-PO2024000890$FR-ASTELLAS-2024EU008004$ASTELLAS$$47$YR$A$F$Y$$$20240821$$PH$FR$FR
242548782$24254878$2$F$$20240812$20240827$20240902$EXP$$US-ASTELLAS-2024-AER-000461$ASTELLAS$$$$E$M$Y$$$20240902$$CN$US$US
242548791$24254879$1$I$$20240811$20240827$20240827$EXP$$DE-ASTELLAS-2024US022969$ASTELLAS$$$$$F$Y$$$20240823$$CN$DE$DE
242548801$24254880$1$I$$20240812$20240827$20240827$EXP$$AU-ASTELLAS-2024US023033$ASTELLAS$Montarello NL, Irvine I, Warner V, Hare J, Kaye D, Cloud GC. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report. BMC Neurology. 2024;24(277): 1-6. doi:10.1186/s12883-024-03780-3.$51$YR$A$F$Y$$$20240822$$HP$AU$AU
242548812$24254881$2$F$$20240810$20240827$20240903$EXP$$AU-ASTELLAS-AER-2024-020540$ASTELLAS$$52$YR$A$F$Y$$$20240903$$MD$AU$AU
242548821$24254882$1$I$20240627$20240812$20240827$20240827$EXP$$FR-ASTELLAS-2024EU008066$ASTELLAS$$54$YR$A$F$Y$47$KG$20240827$$MD$FR$FR
242548831$24254883$1$I$20240523$20240822$20240827$20240827$EXP$$US-APELLIS-2024-APL-0000832$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240827$$CN$US$US
242548841$24254884$1$I$20240706$20240819$20240827$20240827$EXP$RO-NMA-2024-SP0538$RO-SA-2024SA244496$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240827$$MD$RO$RO
242548851$24254885$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A164771$ASTRAZENECA$$$$$F$Y$$$20240827$$MD$US$
242548862$24254886$2$F$20240306$20240910$20240827$20240913$EXP$$US-AstraZeneca-2024A192502$ASTRAZENECA$$30449$DY$$F$Y$66.7$KG$20240913$$HP$US$
242548871$24254887$1$I$20240819$20240821$20240827$20240827$EXP$$US-PFIZER INC-202400241430$PFIZER$$68$YR$$F$Y$$$20240827$$CN$US$US
242548881$24254888$1$I$20240823$20240823$20240827$20240827$EXP$$US-PFIZER INC-PV202400110563$PFIZER$$68$YR$$F$Y$$$20240827$$CN$US$US
242548891$24254889$1$I$20240817$20240826$20240827$20240827$EXP$$US-PFIZER INC-PV202300107977$PFIZER$$71$YR$$M$Y$$$20240827$$CN$US$US
242548901$24254890$1$I$20240801$20240822$20240827$20240827$EXP$$CN-PFIZER INC-PV202400110008$PFIZER$$56$YR$$F$Y$$$20240827$$HP$CN$CN
242548911$24254891$1$I$$20240802$20240827$20240827$PER$$US-IMP-2024000589$Harrow Health$$$$E$M$Y$$$20240827$$CN$US$US
242548921$24254892$1$I$20240708$20240821$20240827$20240827$EXP$FR-AFSSAPS-RE2024000810$FR-MYLANLABS-2024M1077856$MYLAN$$81$YR$$M$Y$83$KG$20240827$$MD$FR$FR
242548931$24254893$1$I$20201101$20240821$20240827$20240827$EXP$PL-URPL-1-2493-2020$PL-MYLANLABS-2024M1077831$MYLAN$$17$YR$$F$Y$52$KG$20240827$$MD$PL$PL
242548952$24254895$2$F$20240814$20240827$20240827$20240903$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR104466$VIIV$$$$$$Y$$$20240903$$HP$US$US
242548963$24254896$3$F$20240901$20240924$20240827$20240930$EXP$$US-PFIZER INC-PV202400111194$PFIZER$$45$YR$$M$Y$$$20240930$$HP$US$US
242548971$24254897$1$I$$20240821$20240827$20240827$EXP$DE-BFARM-24005696$DE-MYLANLABS-2024M1077913$MYLAN$$$$$F$Y$$$20240827$$CN$DE$DE
242548992$24254899$2$F$$20240826$20240827$20240830$EXP$$DE-MYLANLABS-2024M1078206$MYLAN$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Drug-induced deaths in renal insufficiency. Munich Medical Weekly - Advances in Medicine. 2024;166 (13):48-51$89$YR$$M$Y$$$20240830$$HP$DE$DE
242549001$24254900$1$I$$20240823$20240827$20240827$EXP$$DE-MYLANLABS-2024M1078202$MYLAN$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Drug-induced daeths in renal insufficiency. M?nchener Medizinsche Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$80$YR$$M$Y$$$20240827$$HP$DE$DE
242549011$24254901$1$I$20240804$20240826$20240826$20240826$DIR$716005$$FDA-CTU$$67$YR$$F$N$$$20240826$Y$$US$
242549031$24254903$1$I$20240101$20240820$20240827$20240827$EXP$$US-SA-2024SA250476$SANOFI AVENTIS$$$$A$$Y$$$20240827$$HP$US$US
242549041$24254904$1$I$$20240820$20240827$20240827$EXP$$CA-INCYTE CORPORATION-2024IN008764$INCYTE$$$$$$Y$$$20240827$$HP$CA$CA
242549051$24254905$1$I$$20240821$20240827$20240827$EXP$$DE-INCYTE CORPORATION-2024IN008835$INCYTE$$$$$$Y$$$20240827$$PH$DE$DE
242549062$24254906$2$F$$20240907$20240827$20240910$PER$$US-ALXN-202408USA001604US$ALEXION PHARMACEUTICALS$$$$$M$Y$108.84$KG$20240910$$CN$US$US
242549071$24254907$1$I$20240823$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169396$AMGEN$$69$YR$E$F$Y$$$20240827$$CN$US$US
242549081$24254908$1$I$$20240820$20240827$20240827$PER$$US-RDY-SPO/USA/24/0012327$DR REDDYS$$77$YR$E$F$Y$$$20240827$$MD$US$US
242549091$24254909$1$I$$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133376$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$81.65$KG$20240827$$CN$US$US
242549101$24254910$1$I$20240606$20240823$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136111$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240827$$CN$US$US
242549111$24254911$1$I$20240818$20240823$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135822$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240827$$CN$US$US
242549121$24254912$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136015$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$154.22$KG$20240827$$CN$US$US
242549132$24254913$2$F$$20240918$20240827$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135833$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240920$$CN$US$US
242549141$24254914$1$I$$20240822$20240827$20240827$EXP$$BR-INCYTE CORPORATION-2024IN008939$INCYTE$$$$$$Y$$$20240827$$MD$BR$BR
242549151$24254915$1$I$20191230$20240820$20240827$20240827$EXP$$CA-TAKEDA-2024TUS084630$TAKEDA$$67$YR$$F$Y$$$20240827$$CN$CA$CA
242549161$24254916$1$I$20240801$20240822$20240827$20240827$EXP$$FR-INCYTE CORPORATION-2024IN008892$INCYTE$$$$$$Y$$$20240827$$PH$FR$FR
242549171$24254917$1$I$$20240805$20240827$20240827$PER$$US-IMP-2024000591$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242549181$24254918$1$I$$20240818$20240827$20240827$PER$$US-ROCHE-10000063660$ROCHE$Liang L, Mao M, Wu L. Efficacy and Drug Resistance Analysis of ALK Inhibitors in Combination with Stereotactic Body Radiation Therapy for Treating Lung Squamous Carcinoma Patient Harboring EML4-ALK Rearrangement. Onco Targets and Therapy. 2021;14:5385-9.$35$YR$A$M$Y$$$20240827$$HP$US$US
242549191$24254919$1$I$20240708$20240827$20240827$20240827$EXP$$DE-SANDOZ INC.-SDZ2024DE075445$SANDOZ$$$$$M$Y$70$KG$20240827$$MD$DE$DE
242549201$24254920$1$I$$20240821$20240827$20240827$EXP$$PT-MYLANLABS-2024M1077779$MYLAN$Brito, I.. PO-33 - THE CLINICAL SPECTRUM OF THE KCNQ2 GENE-ASSOCIATED DISEASES. Sinapse. 2023;93$9$MON$$F$Y$$$20240827$$MD$PT$PT
242549211$24254921$1$I$$20240821$20240827$20240827$EXP$$GR-MYLANLABS-2024M1078210$MYLAN$Angelousi A, Jouinot A, Bourgioti C, Tokmakidis P, Bertherat J, Kaltsas G. Transformation of a Benign Adrenocortical Adenoma to a Metastatic Adrenocortical Carcinoma Is Rare But It Happens. JCEM Case Rep. 2024;2(8):luae131$64$YR$$M$Y$$$20240827$$HP$GR$GR
242549221$24254922$1$I$20231114$20240819$20240827$20240827$EXP$$CA-JNJFOC-20231269370$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240827$$CN$CA$CA
242549231$24254923$1$I$20240801$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169293$AMGEN$$76$YR$E$F$Y$$$20240827$$CN$US$US
242549251$24254925$1$I$20200101$20240815$20240827$20240827$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408011325$ELI LILLY AND CO$Dai M, Chen Y, Qin J..Atrioventricular re-entrant tachycardia and atrioventricular node re-entrant tachycardia in a patient with cancer under chemotherapy: a case report and literature review..Frontiers in Cardiovascular Medicine 2024;:.DOI:10.3389/fcvm.2024.1367893$44$YR$A$F$Y$$$20240827$$CN$COUNTRY NOT SPECIFIED$CN
242549261$24254926$1$I$$20240820$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408013120$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240827$$CN$US$US
242549271$24254927$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014099$ELI LILLY AND CO$$26$YR$A$M$Y$$$20240827$$CN$US$US
242549281$24254928$1$I$$20240822$20240827$20240827$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-141913$DAIICHI$$$$$F$Y$$$20240827$$MD$US$US
242549291$24254929$1$I$20240822$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014100$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240827$$CN$US$US
242549301$24254930$1$I$$20240827$20240827$20240827$PER$$US-PROD-AS2-212756134-RB-135198-2023$RECKITT BENCKISER$$$$$M$Y$$$20240827$$CN$US$US
242549311$24254931$1$I$$20240822$20240822$20240822$DIR$FDA-CDER-CTU-2024-58930$$FDA-CTU$$$$$$N$$$20240822$N$CN$US$
242549321$24254932$1$I$$20240823$20240827$20240827$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013471$JAZZ$$$$$F$Y$$$20240827$$CN$US$US
242549331$24254933$1$I$$20240731$20240823$20240823$DIR$FDA-CDER-CTU-2024-58167$$FDA-CTU$$53$YR$$$N$$$20240731$N$HP$US$
242549341$24254934$1$I$20240101$20240805$20240827$20240827$PER$$US-IMP-2024000592$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242549351$24254935$1$I$$20240819$20240827$20240827$EXP$$JP-009507513-2408JPN002442J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$97$YR$$F$Y$$$20240827$$MD$JP$JP
242549361$24254936$1$I$20240820$20240821$20240827$20240827$PER$$US-BIOMARINAP-US-2024-160055$BIOMARIN$$$$$$Y$$$20240827$$CN$US$US
242549371$24254937$1$I$20240816$20240816$20240827$20240827$PER$$US-BIOMARINAP-US-2024-159964$BIOMARIN$$$$$$Y$$$20240827$$CN$US$US
242549384$24254938$4$F$20240810$20240924$20240827$20240927$EXP$$AT-BEIGENE-BGN-2024-012649$BEIGENE$$$$$$Y$$$20240927$$MD$AT$AT
242549391$24254939$1$I$20240101$20240821$20240827$20240827$EXP$$US-AMGEN-USASP2024167671$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242549401$24254940$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242465$PFIZER$$77$YR$$M$Y$$$20240827$$HP$US$US
242549412$24254941$2$F$$20240826$20240827$20240829$PER$$US-PFIZER INC-PV202400110727$PFIZER$$66$YR$$F$Y$$$20240829$$CN$US$US
242549421$24254942$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-PV202400110083$PFIZER$$62$YR$$F$Y$$$20240827$$HP$US$US
242549432$24254943$2$F$20190101$20240826$20240827$20240830$PER$$US-PFIZER INC-202400242983$PFIZER$$65$YR$$F$Y$$$20240830$$HP$US$US
242549442$24254944$2$F$$20240827$20240827$20240830$PER$$US-PFIZER INC-202400243164$PFIZER$$$$$$Y$$$20240830$$MD$US$US
242549451$24254945$1$I$20221005$20240817$20240827$20240827$PER$$US-PFIZER INC-PV202400111706$PFIZER$$23$YR$$$Y$52.154$KG$20240827$$CN$US$US
242549461$24254946$1$I$20240809$20240823$20240827$20240827$PER$$US-PFIZER INC-202400243253$PFIZER$$7$YR$$M$Y$$$20240827$$CN$US$US
242549471$24254947$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242552$PFIZER$$53$YR$$M$Y$$$20240827$$HP$US$US
242549482$24254948$2$F$$20240927$20240827$20240927$PER$$US-PFIZER INC-202400242982$PFIZER$$67$YR$$F$Y$$$20240927$$HP$US$US
242549491$24254949$1$I$20240801$20240823$20240827$20240827$PER$$US-PFIZER INC-PV202400110559$PFIZER$$$$$F$Y$$$20240827$$CN$US$US
242549501$24254950$1$I$20240101$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242985$PFIZER$$61$YR$$M$Y$$$20240827$$HP$US$US
242549511$24254951$1$I$20240801$20240821$20240827$20240827$PER$$US-PFIZER INC-202400242284$PFIZER$$47$YR$$F$Y$$$20240827$$HP$US$US
242549521$24254952$1$I$20240801$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242058$PFIZER$$$$$M$Y$$$20240827$$PH$US$US
242549531$24254953$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242318$PFIZER$$53$YR$$M$Y$$$20240827$$HP$US$US
242549541$24254954$1$I$20240820$20240821$20240827$20240827$PER$$US-PFIZER INC-202400242268$PFIZER$$33$YR$$F$Y$$$20240827$$HP$US$US
242549552$24254955$2$F$$20240828$20240827$20240829$PER$$US-PFIZER INC-PV202400109814$PFIZER$$$$$$Y$$$20240829$$CN$US$US
242549561$24254956$1$I$20240101$20240822$20240827$20240827$PER$$US-PFIZER INC-PV202400110176$PFIZER$$24$YR$$F$Y$$$20240827$$HP$US$US
242549581$24254958$1$I$20240822$20240823$20240827$20240827$PER$$US-PFIZER INC-202400243171$PFIZER$$40$YR$$M$Y$$$20240827$$CN$US$US
242549591$24254959$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400243857$PFIZER$$$$T$F$Y$$$20240827$$HP$US$US
242549601$24254960$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-PV202400110113$PFIZER$$$$$M$Y$$$20240827$$CN$US$US
242549611$24254961$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242258$PFIZER$$66$YR$$F$Y$$$20240827$$CN$US$US
242549623$24254962$3$F$$20240911$20240827$20240918$EXP$$CA-TEVA-VS-3236902$TEVA$$43$YR$$F$Y$96$KG$20240918$$HP$CA$CA
242549632$24254963$2$F$$20240827$20240827$20240829$PER$$US-PFIZER INC-202400239465$PFIZER$$62$YR$$F$Y$$$20240829$$CN$US$US
242549641$24254964$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-PV202400110241$PFIZER$$51$YR$$F$Y$$$20240827$$HP$US$US
242549652$24254965$2$F$$20240917$20240827$20240919$EXP$$US-PFIZER INC-202400242975$PFIZER$$22$YR$$F$Y$$$20240919$$CN$US$US
242549661$24254966$1$I$20240819$20240821$20240827$20240827$PER$$US-PFIZER INC-202400242175$PFIZER$$43$YR$$F$Y$$$20240827$$HP$US$US
242549671$24254967$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242745$PFIZER$$53$YR$$M$Y$127.01$KG$20240827$$CN$US$US
242549682$24254968$2$F$$20240829$20240827$20240904$PER$$US-PFIZER INC-202400242381$PFIZER$$85$YR$$F$Y$$$20240904$$MD$US$US
242549691$24254969$1$I$$20240821$20240827$20240827$PER$$US-PFIZER INC-PV202300191792$PFIZER$$84$YR$$F$Y$$$20240827$$CN$US$US
242549701$24254970$1$I$20240801$20240822$20240827$20240827$PER$$US-PFIZER INC-PV202400110288$PFIZER$$39$YR$$F$Y$$$20240827$$HP$US$US
242549711$24254971$1$I$$20240823$20240827$20240827$PER$$US-PFIZER INC-PV202400110721$PFIZER$$62$YR$$F$Y$$$20240827$$HP$US$US
242549721$24254972$1$I$20220601$20240821$20240827$20240827$PER$$US-PFIZER INC-202400241768$PFIZER$$$$A$F$Y$$$20240827$$MD$US$US
242549731$24254973$1$I$20240819$20240822$20240827$20240827$PER$$US-PFIZER INC-PV202400110289$PFIZER$$36$YR$$M$Y$$$20240827$$CN$US$US
242549742$24254974$2$F$$20240926$20240827$20240926$PER$$US-PFIZER INC-PV202400110264$PFIZER$$$$$$Y$$$20240926$$HP$US$US
242549751$24254975$1$I$20240803$20240823$20240827$20240827$PER$$US-PFIZER INC-202400243202$PFIZER$$51$YR$$F$Y$$$20240827$$CN$US$US
242549761$24254976$1$I$20240818$20240823$20240827$20240827$PER$$US-PFIZER INC-202400243198$PFIZER$$42$YR$$M$Y$$$20240827$$CN$US$US
242549771$24254977$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242122$PFIZER$$$$$M$Y$$$20240827$$MD$US$US
242549782$24254978$2$F$$20240910$20240827$20240912$PER$$US-PFIZER INC-PV202400110486$PFIZER$$48$YR$$$Y$$$20240912$$CN$US$US
242549792$24254979$2$F$$20240916$20240827$20240920$PER$$US-PFIZER INC-PV202400110124$PFIZER$$74$YR$$M$Y$$$20240920$$HP$US$US
242549801$24254980$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242354$PFIZER$$70$YR$$M$Y$$$20240827$$MD$US$US
242549811$24254981$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400231775$PFIZER$$62$YR$$F$Y$$$20240827$$HP$US$US
242549821$24254982$1$I$$20240821$20240827$20240827$PER$$US-PFIZER INC-202400241190$PFIZER$$50$YR$$F$Y$$$20240827$$CN$US$US
242549831$24254983$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-PV202400110301$PFIZER$$66$YR$$F$Y$$$20240827$$HP$US$US
242549841$24254984$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-PV202300133471$PFIZER$$66$YR$$F$Y$$$20240827$$MD$US$US
242549851$24254985$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242564$PFIZER$$$$E$$Y$$$20240827$$CN$US$US
242549862$24254986$2$F$$20240910$20240827$20240912$PER$$US-PFIZER INC-202400243117$PFIZER$$68$YR$$F$Y$$$20240912$$CN$US$US
242549871$24254987$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-PV202400110493$PFIZER$$64$YR$$F$Y$$$20240827$$HP$US$US
242549881$24254988$1$I$20220101$20240823$20240827$20240827$PER$$US-PFIZER INC-PV202400110303$PFIZER$$30$YR$$M$Y$81.633$KG$20240827$$CN$US$US
242549891$24254989$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400231556$PFIZER$$61$YR$$F$Y$$$20240827$$MD$US$US
242549902$24254990$2$F$20240101$20240924$20240827$20240927$PER$$US-PFIZER INC-PV202400110744$PFIZER$$62$YR$$F$Y$$$20240927$$HP$US$US
242549911$24254991$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242828$PFIZER$$36$YR$$F$Y$$$20240827$$CN$US$US
242549921$24254992$1$I$$20240821$20240827$20240827$PER$$US-PFIZER INC-202400242203$PFIZER$$25$YR$$F$Y$$$20240827$$HP$US$US
242549931$24254993$1$I$$20240823$20240827$20240827$PER$$US-PFIZER INC-202400242696$PFIZER$$59$YR$$F$Y$$$20240827$$CN$US$US
242549941$24254994$1$I$20240823$20240823$20240827$20240827$PER$$US-PFIZER INC-202400243168$PFIZER$$65$YR$$F$Y$$$20240827$$CN$US$US
242549951$24254995$1$I$$20240820$20240827$20240827$EXP$CA-DRL-USA-SPO/CAN/24/0012185$CA-RDY-SPO/CAN/24/0012185$DR REDDYS$$74$YR$E$M$Y$67$KG$20240827$$PH$CA$CA
242549961$24254996$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-PV202400110283$PFIZER$$75$YR$$F$Y$66.7$KG$20240827$$MD$US$US
242549971$24254997$1$I$20240801$20240821$20240827$20240827$PER$$US-PFIZER INC-202400242166$PFIZER$$63$YR$$F$Y$$$20240827$$HP$US$US
242549981$24254998$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242569$PFIZER$$52$YR$$$Y$$$20240827$$HP$US$US
242549991$24254999$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242343$PFIZER$$$$$$Y$$$20240827$$HP$US$US
242550001$24255000$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-PV202400110291$PFIZER$$33$YR$$F$Y$$$20240827$$HP$US$US
242550011$24255001$1$I$20240819$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242560$PFIZER$$68$YR$$F$Y$$$20240827$$CN$US$US
242550021$24255002$1$I$$20240820$20240827$20240827$EXP$US-MLMSERVICE-20240813-PI161012-00128-1$US-RDY-SPO/USA/24/0012247$DR REDDYS$Glezerman I, Salvatore S, Tap W, Kelly C, Brauer Ornelas CM, Shaikh A. Pegylated Liposomal Doxorubicin Causes Kidney-limited Thrombotic Microangiopathy. American journal of kidney diseases. 2024;83(4):549-53. DOI: 10.1053/j.ajkd.2023.08.014.$72$YR$E$F$Y$$$20240827$$MD$US$US
242550031$24255003$1$I$20240801$20240822$20240827$20240827$PER$$KR-PFIZER INC-PV202400109543$PFIZER$$$$$F$Y$$$20240827$$CN$KR$KR
242550041$24255004$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135496$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240827$$HP$US$US
242550052$24255005$2$F$20240805$20240822$20240827$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135389$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240905$$HP$US$US
242550071$24255007$1$I$20240820$20240822$20240827$20240827$PER$$US-BAYER-2024A121684$BAYER$$$$$F$Y$$$20240827$$MD$US$US
242550081$24255008$1$I$20240801$20240807$20240827$20240827$PER$$US-IMP-2024000610$Harrow Health$$$$A$F$Y$$$20240827$$CN$US$US
242550091$24255009$1$I$$20240821$20240827$20240827$EXP$$US-ABBVIE-5889768$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242550101$24255010$1$I$$20240822$20240827$20240827$EXP$$US-ABBVIE-5893674$ABBVIE$$77$YR$$F$Y$$$20240827$$CN$US$US
242550111$24255011$1$I$$20240819$20240827$20240827$EXP$$TW-AstraZeneca-2024A190649$ASTRAZENECA$Tsai C.M., Lin C.H., Chou Y.Y., Jen H.Y., Jain S.. CLINICAL  APPLICATIONS OF COMPREHENSIVE GENOMIC PROFILING IN ADVANCED NON-SMALL-CELL LUNG CANCER-A CASE SERIES. Current Oncology 2024;31:3161?3176.$56$YR$$M$Y$$$20240827$$HP$TW$
242550121$24255012$1$I$$20240823$20240827$20240827$PER$$US-PFIZER INC-202400244220$PFIZER$$48$YR$$F$Y$$$20240827$$HP$US$US
242550131$24255013$1$I$20240824$20240826$20240827$20240827$PER$$US-PFIZER INC-202400243924$PFIZER$$89$YR$$M$Y$$$20240827$$CN$US$US
242550143$24255014$3$F$$20240918$20240827$20240923$PER$$US-PFIZER INC-PV202400111390$PFIZER$$67$YR$$F$Y$$$20240923$$HP$US$US
242550152$24255015$2$F$20240819$20240828$20240827$20240904$PER$$US-PFIZER INC-202400243185$PFIZER$$30$YR$$F$Y$79.365$KG$20240904$$CN$US$US
242550161$24255016$1$I$20240823$20240823$20240827$20240827$PER$$US-PFIZER INC-202400243274$PFIZER$$66$YR$$M$Y$$$20240827$$CN$US$US
242550171$24255017$1$I$$20240823$20240827$20240827$PER$$US-PFIZER INC-202400242922$PFIZER$$50$YR$$F$Y$55.34$KG$20240827$$CN$US$US
242550181$24255018$1$I$20240101$20240823$20240827$20240827$PER$$US-PFIZER INC-PV202400092080$PFIZER$$82$YR$$F$Y$$$20240827$$HP$US$US
242550191$24255019$1$I$$20240826$20240827$20240827$PER$$US-PFIZER INC-PV202400111260$PFIZER$$90$YR$$F$Y$$$20240827$$CN$US$US
242550202$24255020$2$F$$20240904$20240827$20240906$EXP$$JP-PFIZER INC-202400244346$PFIZER$$$$$$Y$$$20240906$$PH$JP$JP
242550221$24255022$1$I$$20240822$20240827$20240827$EXP$$CA-ANIPHARMA-2020-CA-001577$ANI$$77$YR$$F$Y$$$20240827$$CN$CA$CA
242550231$24255023$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135803$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240827$$CN$US$US
242550241$24255024$1$I$20240813$20240822$20240827$20240827$EXP$$CA-LUNDBECK-DKLU4003405$LUNDBECK$$$$$$Y$$$20240827$$HP$CA$CA
242550252$24255025$2$F$20230101$20240911$20240827$20240917$EXP$$DE-MYLANLABS-2024M1077682$MYLAN$$$$$M$Y$136.2$KG$20240917$$CN$DE$DE
242550261$24255026$1$I$$20240820$20240827$20240827$PER$$US-ABBVIE-5890461$ABBVIE$$$$$$Y$$$20240827$$CN$US$US
242550271$24255027$1$I$20240703$20240821$20240827$20240827$EXP$ES-AEMPS-1561072$ES-MYLANLABS-2024M1077783$MYLAN$$47$YR$$M$Y$$$20240827$$MD$ES$ES
242550281$24255028$1$I$$20240822$20240827$20240827$EXP$$CA-SANDOZ INC.-SDZ2024CA075158$SANDOZ$$44$YR$$F$Y$97$KG$20240827$$HP$CA$CA
242550291$24255029$1$I$20200813$20240820$20240827$20240827$EXP$$NVSC2024PL169427$NOVARTIS$$44$YR$$F$Y$$$20240827$$MD$PL$PL
242550301$24255030$1$I$$20240820$20240827$20240827$EXP$$CA-GSK-CA2024103880$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$CA$CA
242550311$24255031$1$I$$20240820$20240827$20240827$EXP$$NVSC2024SI170939$NOVARTIS$$80$YR$$F$Y$$$20240827$$MD$SI$SI
242550321$24255032$1$I$$20240819$20240827$20240827$EXP$$US-JNJFOC-20240848032$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$US$US
242550331$24255033$1$I$$20240826$20240827$20240827$PER$$US-JNJFOC-20240867460$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$HP$US$US
242550351$24255035$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58806$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242550361$24255036$1$I$$20240826$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075493$SANDOZ$$$$$F$Y$$$20240827$$CN$US$US
242550371$24255037$1$I$20240805$20240826$20240827$20240827$EXP$$CN-ROCHE-10000066530$ROCHE$$52$YR$A$M$Y$$$20240827$$HP$CN$CN
242550381$24255038$1$I$$20240826$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135926$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240827$$CN$US$US
242550391$24255039$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172989$NOVARTIS$$$$$$Y$$$20240827$$PH$US$US
242550401$24255040$1$I$$20240821$20240827$20240827$PER$$US-BIOGEN-2024BI01279443$BIOGEN$$$$$F$Y$$$20240827$$HP$US$US
242550411$24255041$1$I$$20240822$20240827$20240827$PER$$US-ABBVIE-5895237$ABBVIE$$$$$F$Y$$$20240827$$MD$US$US
242550421$24255042$1$I$20240723$20240823$20240827$20240827$EXP$FR-AFSSAPS-RE2024000839$FR-MYLANLABS-2024M1078199$MYLAN$$78$YR$$M$Y$$$20240827$$MD$FR$FR
242550432$24255043$2$F$20240712$20240912$20240827$20240917$PER$$US-GILEAD-2024-0685281$GILEAD$$73$YR$E$M$Y$59.8$KG$20240916$$MD$US$US
242550441$24255044$1$I$$20240819$20240827$20240827$30DAY$$US-GSK-US2024AMR104093$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
242550451$24255045$1$I$$20240819$20240827$20240827$30DAY$$US-GSK-US2024AMR104633$GLAXOSMITHKLINE$$$$$F$Y$$$20240827$$CN$US$US
242550461$24255046$1$I$$20240822$20240827$20240827$EXP$$US-LUNDBECK-DKLU4003406$LUNDBECK$$$$$$Y$$$20240827$$CN$US$US
242550472$24255047$2$F$20240823$20240823$20240827$20240902$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408006805$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$BR$BR
242550481$24255048$1$I$20220101$20240819$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012148$ELI LILLY AND CO$$93$YR$E$F$Y$$$20240827$$CN$US$US
242550491$24255049$1$I$$20240822$20240827$20240827$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408015339$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$CN$CN
242550501$24255050$1$I$$20240815$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010152$ELI LILLY AND CO$$$$A$F$Y$$$20240827$$CN$US$US
242550512$24255051$2$F$$20240917$20240827$20240927$EXP$$CA-TEVA-VS-3236905$TEVA$$40$YR$$F$Y$96$KG$20240927$$HP$CA$CA
242550521$24255052$1$I$$20240814$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009307$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240827$$CN$US$US
242550532$24255053$2$F$20240813$20240819$20240827$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009900$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240830$$CN$US$US
242550541$24255054$1$I$$20240815$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010157$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240827$$CN$US$US
242550551$24255055$1$I$$20240816$20240827$20240827$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202408011001$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$KR$KR
242550563$24255056$3$F$20240529$20240828$20240827$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408015598$ELI LILLY AND CO$$$$$M$Y$$$20240905$$CN$US$US
242550571$24255057$1$I$$20240815$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012151$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240827$$CN$US$US
242550581$24255058$1$I$$20240815$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013071$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240827$$CN$US$US
242550602$24255060$2$F$20240101$20240905$20240827$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010069$ELI LILLY AND CO$$$$$F$Y$89.79$KG$20240917$$CN$US$US
242550611$24255061$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015133$ELI LILLY AND CO$$$$$M$Y$$$20240827$$CN$US$US
242550621$24255062$1$I$20240628$20240814$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009879$ELI LILLY AND CO$$$$A$F$Y$$$20240827$$CN$US$US
242550631$24255063$1$I$$20240815$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010785$ELI LILLY AND CO$$$$$$Y$$$20240827$$CN$US$US
242550642$24255064$2$F$$20240912$20240827$20240917$30DAY$$DE-ELI_LILLY_AND_COMPANY-DE202408009291$ELI LILLY AND CO$$$$$F$Y$$$20240917$$PH$DE$DE
242550651$24255065$1$I$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016127$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$US$US
242550662$24255066$2$F$$20240830$20240827$20240906$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408010455$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240906$$CN$BR$BR
242550671$24255067$1$I$$20240821$20240827$20240827$EXP$$NVSC2024AU169578$NOVARTIS$$$$$F$Y$$$20240827$$HP$AU$AU
242550681$24255068$1$I$20240812$20240821$20240827$20240827$EXP$$CN-ROCHE-10000066039$ROCHE$$62$YR$A$F$Y$55$KG$20240827$$HP$CN$CN
242550691$24255069$1$I$20230101$20240815$20240827$20240827$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2024-001893$SK LIFE SCIENCE$$$$$$Y$$$20240827$$CN$US$US
242550703$24255070$3$F$$20240903$20240827$20240906$EXP$$KR-TAKEDA-2024TUS084999$TAKEDA$$76$YR$$F$Y$$$20240906$$MD$KR$KR
242550721$24255072$1$I$$20220119$20240827$20240827$EXP$$GB-AstraZeneca-2022A031987$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$GB$
242550731$24255073$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A190556$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242550741$24255074$1$I$20240701$20240819$20240827$20240827$EXP$$ES-AstraZeneca-2024A194918$ASTRAZENECA$$54$YR$$F$Y$$$20240827$$MD$ES$
242550751$24255075$1$I$20240807$20240819$20240827$20240827$EXP$$PE-AstraZeneca-2024A190868$ASTRAZENECA$$22007$DY$$M$Y$$$20240827$$CN$PE$
242550762$24255076$2$F$$20240919$20240827$20240924$PER$$US-LUNDBECK-DKLU4001872$LUNDBECK$$$$$$Y$$$20240924$$CN$US$US
242550771$24255077$1$I$20240701$20240820$20240827$20240827$EXP$$US-ANIPHARMA-2024-US-044886$ANI$$50$YR$$F$Y$99.79$KG$20240827$$HP$US$US
242550781$24255078$1$I$$20240819$20240827$20240827$EXP$$US-ANIPHARMA-2024-US-044584$ANI$$$$$M$Y$$$20240827$$HP$US$US
242550791$24255079$1$I$20240804$20240820$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133017$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$84.82$KG$20240827$$CN$US$US
242550801$24255080$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135777$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240827$$CN$US$US
242550821$24255082$1$I$20240801$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58800$$FDA-CTU$$36$YR$$$N$$$20240826$N$HP$US$
242550831$24255083$1$I$$20240811$20240827$20240827$PER$$US-IMP-2024000623$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242550841$24255084$1$I$20220501$20240822$20240827$20240827$EXP$$CN-SANDOZ INC.-SDZ2024CN074579$SANDOZ$$52$YR$$M$Y$$$20240827$$MD$CN$CN
242550852$24255085$2$F$20240101$20240829$20240827$20240904$PER$$US-ALXN-202408USA001264US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$MD$US$US
242550861$24255086$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5892732$ABBVIE$$$$$F$Y$$$20240827$$HP$US$US
242550871$24255087$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3235155$TEVA$$35$YR$$F$Y$64$KG$20240827$$HP$CA$CA
242550891$24255089$1$I$$20240805$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051697$TOLMAR$$$$$M$Y$$$20240823$$CN$CA$CA
242550903$24255090$3$F$$20240913$20240827$20240918$EXP$$PL-NALPROPION PHARMACEUTICALS INC.-PL-2024CUR003887$CURRAX PHARMACEUTICALS$Woron J., Siwek M.. Sore throat as an adverse consequence of drug interactions used in the treatment of a patient suffering from depression and obesity. Medycyna Praktyczna - Psychiatria. 2024;4:37-39$31$YR$$F$Y$$$20240918$$MD$PL$PL
242550911$24255091$1$I$20240805$20240805$20240827$20240827$PER$$CA-TOLMAR, INC.-24CA051828$TOLMAR$$78$YR$$M$Y$$$20240823$$CN$CA$CA
242550921$24255092$1$I$20240801$20240805$20240827$20240827$PER$$TR-TOLMAR, INC.-24TR051712$TOLMAR$$67$YR$$M$Y$$$20240823$$PH$TR$TR
242550931$24255093$1$I$20240805$20240805$20240827$20240827$PER$$FR-TOLMAR, INC.-24FR051722$TOLMAR$$81$YR$$M$Y$$$20240823$$PH$FR$FR
242550941$24255094$1$I$20240805$20240805$20240827$20240827$PER$$FR-TOLMAR, INC.-24FR051685$TOLMAR$$82$YR$$M$Y$$$20240823$$PH$FR$FR
242550962$24255096$2$F$$20240904$20240827$20240911$PER$$US-TOLMAR, INC.-24US051313$TOLMAR$$$$$M$Y$$$20240911$$HP$US$US
242550971$24255097$1$I$20240719$20240805$20240827$20240827$PER$$US-TOLMAR, INC.-24US051190$TOLMAR$$$$$$Y$$$20240823$$PH$US$US
242550982$24255098$2$F$20240725$20240905$20240827$20240926$PER$$US-TOLMAR, INC.-24US051344$TOLMAR$$76$YR$$M$Y$$$20240926$$PH$US$US
242550991$24255099$1$I$20240601$20240805$20240827$20240827$PER$$US-TOLMAR, INC.-24US051597$TOLMAR$$$$C$$Y$$$20240823$$HP$US$US
242551001$24255100$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172962$NOVARTIS$$$$$M$Y$$$20240827$$PH$US$US
242551011$24255101$1$I$20240814$20240823$20240827$20240827$EXP$$NVSC2024CN172904$NOVARTIS$$53$YR$$M$Y$66$KG$20240827$$HP$CN$CN
242551021$24255102$1$I$$20240822$20240827$20240827$EXP$$NVSC2024US170921$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242551031$24255103$1$I$20220920$20240826$20240827$20240827$EXP$$NVSC2024KR172188$NOVARTIS$$$$A$M$Y$$$20240827$$HP$KR$KR
242551041$24255104$1$I$20240101$20240826$20240827$20240827$EXP$$IL-KARYOPHARM-2024KPT001471$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240827$$CN$IL$IL
242551051$24255105$1$I$$20240811$20240827$20240827$PER$$US-IMP-2024000624$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242551061$24255106$1$I$$20240822$20240827$20240827$EXP$$JP-009507513-2408JPN002952J$MERCK$$7$DEC$$M$Y$$$20240827$$MD$JP$JP
242551071$24255107$1$I$$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008557$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242551081$24255108$1$I$20220101$20240821$20240827$20240827$EXP$$US-MYLANLABS-2024M1078912$MYLAN$Cooper J, Soneji D, Rieger K, Narala S, Kim Y. Primary Cutaneous CD30+ Large T Cell Lymphoproliferative Disorder Associated With Prolonged Exposure to Fingolimod. Mult-Scler-J 2023; 29 (Suppl. 3) (3): 969 abstr. P1519/117.$67$YR$$F$Y$$$20240827$$HP$US$US
242551091$24255109$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58722$$FDA-CTU$$62$YR$$M$N$$$20240826$N$$US$
242551101$24255110$1$I$$20240823$20240826$20240826$DIR$FDA-CDER-CTU-2024-58776$$FDA-CTU$$$$$F$N$68.49$KG$20240823$N$PH$US$
242551111$24255111$1$I$$20240812$20240827$20240827$PER$$US-IMP-2024000625$Harrow Health$$$$A$F$Y$$$20240827$$CN$US$US
242551121$24255112$1$I$$20240820$20240827$20240827$EXP$$CA-TEVA-VS-3235149$TEVA$$63$YR$$M$Y$$$20240827$$MD$CA$CA
242551131$24255113$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58936$$FDA-CTU$$$$$M$N$$$20240823$N$HP$US$
242551141$24255114$1$I$$20240820$20240827$20240827$PER$$US-RDY-SPO/USA/24/0012375$DR REDDYS$$42$YR$A$F$Y$$$20240827$$MD$US$US
242551151$24255115$1$I$20240821$20240821$20240827$20240827$PER$$US-ABBVIE-5894279$ABBVIE$$38$YR$$F$Y$$$20240827$$HP$US$US
242551161$24255116$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58938$$FDA-CTU$$$$$$N$$$20240823$N$CN$US$
242551171$24255117$1$I$$20240820$20240827$20240827$EXP$$US-AstraZeneca-2024A192126$ASTRAZENECA$$50$YR$$F$Y$$$20240827$$MD$US$
242551184$24255118$4$F$$20240912$20240827$20240917$PER$$US-HALEON-2193502$Haleon PLC$$$$$F$Y$104.33$KG$20240917$$CN$US$US
242551191$24255119$1$I$20240601$20240822$20240827$20240827$EXP$$KR-GILEAD-2024-0685035$GILEAD$$$$E$M$Y$$$20240827$$CN$KR$KR
242551201$24255120$1$I$20210101$20240819$20240827$20240827$EXP$$GB-AstraZeneca-2024A188552$ASTRAZENECA$$74$YR$$M$Y$77$KG$20240827$$MD$GB$
242551211$24255121$1$I$$20240819$20240827$20240827$EXP$$ES-AstraZeneca-2024A188792$ASTRAZENECA$Bautista-Villanueva, S.; Mateos-Salvador, M.; Arrojo Fuentes, R.; Rial, M.J.. Successful Desensitization to Tezepelumab in a Polysorbate-Allergic Patient. Journal of Investigational Allergy and Clinical Immunology2024 2024;34(6):$47$YR$$M$Y$$$20240827$$HP$ES$
242551221$24255122$1$I$$20240822$20240827$20240827$EXP$$US-AstraZeneca-2024A192316$ASTRAZENECA$$$$$F$Y$$$20240827$$CN$US$
242551231$24255123$1$I$$20240814$20240827$20240827$PER$$US-MYLANLABS-2024M1076359$MYLAN$$$$$M$Y$$$20240827$$CN$US$US
242551241$24255124$1$I$20201029$20240822$20240827$20240827$EXP$IT-MLMSERVICE-20240708-PI126636-00306-1$IT-SANDOZ INC.-SDZ2024IT074711$SANDOZ$$28$YR$$F$Y$$$20240827$$MD$IT$IT
242551261$24255126$1$I$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016392$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240827$$HP$US$US
242551271$24255127$1$I$20240826$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015200$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240827$$PH$US$US
242551281$24255128$1$I$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015926$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240827$$CN$US$US
242551291$24255129$1$I$20220401$20240823$20240827$20240827$EXP$FR-AFSSAPS-MA2024001378$FR-GILEAD-2024-0685188$GILEAD$$51$YR$A$F$Y$$$20240827$$HP$FR$FR
242551301$24255130$1$I$20240801$20240812$20240827$20240827$PER$$US-IMP-2024000632$Harrow Health$$$$$F$Y$$$20240827$$CN$US$US
242551311$24255131$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135136$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$151.95$KG$20240827$$CN$US$US
242551321$24255132$1$I$20240701$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136000$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240827$$CN$US$US
242551331$24255133$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135163$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$63.5$KG$20240827$$CN$US$US
242551341$24255134$1$I$20200127$20240819$20240827$20240827$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-133403$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240827$$MD$KR$KR
242551351$24255135$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136006$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240827$$CN$US$US
242551361$24255136$1$I$$20240821$20240827$20240827$PER$$US-AMGEN-USASP2024168054$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242551371$24255137$1$I$$20240820$20240827$20240827$PER$$US-MYLANLABS-2024M1077559$MYLAN$$$$$F$Y$55.79$KG$20240827$$CN$US$US
242551381$24255138$1$I$$20240812$20240827$20240827$PER$$US-IMP-2024000647$Harrow Health$$$$A$F$Y$$$20240827$$CN$US$US
242551391$24255139$1$I$20240104$20240822$20240827$20240827$EXP$CZ-CZSUKL-24002381$CZ-ABBVIE-5889965$ABBVIE$$56$YR$$F$Y$68$KG$20240827$$MD$CZ$CZ
242551402$24255140$2$F$$20240807$20240827$20240910$PER$$US-TEVA-VS-3231030$TEVA$$$$$$Y$$$20240910$$HP$US$US
242551411$24255141$1$I$20240826$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58790$$FDA-CTU$$42$YR$$F$N$71.67$KG$20240826$Y$HP$US$
242551421$24255142$1$I$20240809$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58691$$FDA-CTU$$38$YR$$F$N$52.16$KG$20240826$N$HP$US$
242551431$24255143$1$I$20231218$20240814$20240827$20240827$EXP$$FR-CIPLA LTD.-2024FR06019$CIPLA$$$$$$Y$$$20240827$$MD$FR$FR
242551441$24255144$1$I$$20240820$20240827$20240827$EXP$$US-AMERICAN REGENT INC-2024003223$AMERICAN REGENT$Sidhu SK, Ciancarelli J, Alviar C, Greco A.. A case of severe cardiopulmonary sarcoidosis and sub-massive pulmonary embolism. US Cardiology Review. 2024;18 (Suppl 1):25-26 abstract 49$68$YR$$M$Y$$$20240827$$MD$US$US
242551451$24255145$1$I$$20240820$20240827$20240827$EXP$$US-GSK-US2024AMR105347$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$CN$US$US
242551471$24255147$1$I$20240823$20240823$20240827$20240827$PER$$US-JNJFOC-20240865884$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240827$$CN$US$US
242551481$24255148$1$I$$20240826$20240827$20240827$EXP$$US-TAKEDA-2024TUS033601$TAKEDA$$$$$M$Y$$$20240827$$CN$US$US
242551491$24255149$1$I$$20240821$20240827$20240827$PER$$US-009507513-2408USA008195$MERCK$$65$YR$$F$Y$$$20240827$$MD$US$US
242551501$24255150$1$I$20240801$20240813$20240827$20240827$PER$$US-IMP-2024000648$Harrow Health$$55$YR$A$F$Y$$$20240827$$CN$US$US
242551511$24255151$1$I$20240425$20240823$20240827$20240827$EXP$$CH-AMERICAN REGENT INC-2024003268$AMERICAN REGENT$$$$$F$Y$$$20240827$$MD$CH$CH
242551521$24255152$1$I$20240101$20240823$20240827$20240827$PER$$US-DSJP-DSU-2024-141917$DAIICHI$$7$DEC$$M$Y$$$20240827$$MD$US$US
242551531$24255153$1$I$20240127$20240820$20240827$20240827$EXP$CH-SM-2024-14112$CH-GSK-CH2024103792$GLAXOSMITHKLINE$$$$$$Y$$$20240827$$MD$CH$CH
242551541$24255154$1$I$20240713$20240816$20240827$20240827$EXP$FR-AFSSAPS-BX2024001573$FR-SA-2024SA244440$SANOFI AVENTIS$$84$YR$E$M$Y$60$KG$20240827$$PH$FR$FR
242551552$24255155$2$F$$20240830$20240827$20240910$EXP$$CA-SA-2024SA250692$SANOFI AVENTIS$Veettil S, Khan O, Durocher DP.. Takotsubo Cardiomyopathy After Oxaliplatin Chemotherapy Exposure: A Case Report.. CJC Open.. 2024;unknown:1-4$69$YR$E$F$Y$$$20240910$$MD$CA$CA
242551562$24255156$2$F$20221113$20240829$20240827$20240830$EXP$DE-PEI-202200155537$DE-GILEAD-2024-0685379$GILEAD$$75$YR$E$M$Y$$$20240830$$MD$DE$DE
242551581$24255158$1$I$$20240822$20240827$20240827$PER$$US-JNJFOC-20240860073$JOHNSON AND JOHNSON$$84$YR$E$F$Y$58.1$KG$20240827$$CN$US$US
242551591$24255159$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58626$$FDA-CTU$$36$YR$$F$N$$$20240826$N$$US$
242551601$24255160$1$I$20240816$20240825$20240826$20240826$DIR$FDA-CDER-CTU-2024-58549$$FDA-CTU$$14$YR$$M$N$$$20240825$N$HP$US$
242551611$24255161$1$I$20231223$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58823$$FDA-CTU$$$$$M$N$71.9$KG$20240826$N$$US$
242551641$24255164$1$I$20240820$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58940$$FDA-CTU$$74$YR$$M$N$$$20240827$N$$US$
242551651$24255165$1$I$20240824$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58824$$FDA-CTU$$$$$F$N$$$20240826$N$$US$
242551661$24255166$1$I$$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58877$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242551671$24255167$1$I$20240622$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58828$$FDA-CTU$$$$$F$N$64.3$KG$20240826$N$$US$
242551681$24255168$1$I$20240101$20240814$20240827$20240827$PER$$US-IMP-2024000649$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242551691$24255169$1$I$20240801$20240820$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133583$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240827$$PH$US$US
242551702$24255170$2$F$$20240911$20240827$20240912$PER$$US-ALXN-202408USA001240US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
242551711$24255171$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189509$ASTRAZENECA$$$$$M$Y$$$20240827$$CN$US$
242551722$24255172$2$F$$20240830$20240827$20240909$EXP$$IT-TEVA-VS-3236047$TEVA$Abbott M, Valenti G, Gizzi A, Agrenzano S, Ficalora A, Mancuso A, et al. HBV REACTIVATION AFTER IMMUNOSUPPRESSIVE THERAPY: AN OPEN QUESTION. Sex-Transmit-Infect 2024; 100 (Suppl. 1) A271 abstr. P-213.; Abbott M, Valenti G, Gizzi A, Agrenzano S, Ficalora A, Mancuso A, et al. HBV REACTIVATION AFTER IMMUNOSUPPRESSIVE THERAPY: AN OPEN QUESTION. Sex-Transmit-Infect 2024; 100 (Suppl. 1) A271 abstr. P-213.$71$YR$$M$Y$$$20240909$$HP$IT$IT
242551741$24255174$1$I$20240816$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58825$$FDA-CTU$$$$$F$N$89$KG$20240826$N$$US$
242551751$24255175$1$I$20230511$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58829$$FDA-CTU$$$$$F$N$306$KG$20240826$N$$US$
242551761$24255176$1$I$20230510$20240822$20240827$20240827$EXP$$NVSC2023BR109731$NOVARTIS$$64$YR$$F$Y$$$20240827$$CN$BR$BR
242551772$24255177$2$F$20240101$20240902$20240827$20240906$PER$$US-AMGEN-USASP2024168700$AMGEN$$87$YR$E$$Y$$$20240906$$MD$US$US
242551782$24255178$2$F$20240101$20240918$20240827$20240926$EXP$$JP-AMGEN-JPNSP2024168007$AMGEN$$$$E$F$Y$$$20240926$$MD$JP$JP
242551791$24255179$1$I$$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168667$AMGEN$$$$E$F$Y$$$20240827$$MD$US$US
242551801$24255180$1$I$$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008596$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242551811$24255181$1$I$$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008593$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242551821$24255182$1$I$$20240827$20240827$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048059$BOEHRINGER INGELHEIM$$$$$$Y$$$20240827$$CN$US$US
242551832$24255183$2$F$20240813$20240820$20240827$20240830$EXP$$CA-GILEAD-2024-0684972$GILEAD$$61$YR$A$F$Y$$$20240830$$HP$CA$CA
242551841$24255184$1$I$20240708$20240708$20240827$20240827$PER$$US-JNJFOC-20240849659$JOHNSON AND JOHNSON$$2$YR$C$F$Y$$$20240827$$CN$US$US
242551851$24255185$1$I$20240822$20240822$20240827$20240827$EXP$$US-JNJFOC-20240861502$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$MD$US$US
242551861$24255186$1$I$$20240826$20240827$20240827$PER$$US-JNJFOC-20240866324$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$HP$US$US
242551871$24255187$1$I$20240313$20240823$20240827$20240827$PER$$US-JNJFOC-20240865859$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240827$$CN$US$US
242551881$24255188$1$I$$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008582$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242551892$24255189$2$F$20240515$20240826$20240827$20240830$EXP$$BR-ORGANON-O2408BRA001908$ORGANON$$32$YR$$F$Y$$$20240830$$MD$BR$BR
242551901$24255190$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014102$ELI LILLY AND CO$$26$YR$A$$Y$$$20240827$$HP$US$US
242551911$24255191$1$I$20240825$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016536$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240827$$CN$US$US
242551921$24255192$1$I$20220101$20240815$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010285$ELI LILLY AND CO$$73$YR$E$$Y$$$20240827$$MD$US$US
242551931$24255193$1$I$$20240822$20240827$20240827$EXP$$GB-TAKEDA-2024TUS085664$TAKEDA$$75$YR$$F$Y$$$20240827$$MD$GB$GB
242551941$24255194$1$I$$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008572$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242551951$24255195$1$I$$20240819$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135268$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240827$$CN$US$US
242551962$24255196$2$F$$20240829$20240827$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135935$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$78.458$KG$20240909$$HP$US$US
242551971$24255197$1$I$$20240823$20240827$20240827$EXP$$US-AMGEN-USASP2024169393$AMGEN$$67$YR$E$F$Y$$$20240827$$HP$US$US
242551981$24255198$1$I$20240803$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58827$$FDA-CTU$$$$$M$N$89.9$KG$20240826$N$$US$
242551991$24255199$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58927$$FDA-CTU$$54$YR$$F$N$$$20240827$N$$US$
242552001$24255200$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58899$$FDA-CTU$$65$YR$$F$N$$$20240827$N$$US$
242552011$24255201$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58849$$FDA-CTU$$42$YR$$F$N$$$20240827$N$$US$
242552021$24255202$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58848$$FDA-CTU$$38$YR$$F$N$$$20240827$N$$US$
242552041$24255204$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58924$$FDA-CTU$$69$YR$$F$N$78.02$KG$20240827$N$$US$
242552061$24255206$1$I$$20240815$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008568$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242552071$24255207$1$I$20240827$20240827$20240827$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048077$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240827$$MD$US$US
242552081$24255208$1$I$20240702$20240821$20240827$20240827$EXP$$GB-TEVA-VS-3236297$TEVA$$35$YR$$F$Y$89$KG$20240827$$PH$GB$GB
242552092$24255209$2$F$$20240827$20240827$20240830$EXP$$US-KYOWAKIRIN-2024KK019990$KYOWA$$$$$$Y$$$20240830$$PH$US$US
242552101$24255210$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135300$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$81.19$KG$20240827$$CN$US$US
242552111$24255211$1$I$20240701$20240823$20240827$20240827$EXP$$US-ABBVIE-5895477$ABBVIE$$43$YR$$F$Y$$$20240827$$CN$US$US
242552131$24255213$1$I$20240826$20240826$20240827$20240827$PER$$US-JNJFOC-20240866341$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$US$US
242552141$24255214$1$I$20240701$20240822$20240827$20240827$PER$$US-JNJFOC-20240860245$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240827$$CN$US$US
242552151$24255215$1$I$20240819$20240821$20240827$20240827$PER$$US-JNJFOC-20240858113$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$HP$US$US
242552171$24255217$1$I$$20240820$20240827$20240827$EXP$$US-MYLANLABS-2024M1077673$MYLAN$$$$$M$Y$$$20240827$$CN$US$US
242552181$24255218$1$I$$20240826$20240827$20240827$EXP$$US-KYOWAKIRIN-2024KK020014$KYOWA$$$$$$Y$$$20240827$$HP$US$US
242552191$24255219$1$I$20201224$20240819$20240827$20240827$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-132810$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$54$KG$20240827$$MD$KR$KR
242552201$24255220$1$I$20240501$20240821$20240827$20240827$EXP$$DE-PFIZER INC-202400240713$PFIZER$$74$YR$$M$Y$$$20240827$$MD$DE$DE
242552211$24255221$1$I$20240601$20240824$20240826$20240826$DIR$FDA-CDER-CTU-2024-58562$$FDA-CTU$$55$YR$$F$N$98.88$KG$20240824$N$$US$
242552221$24255222$1$I$20240814$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58926$$FDA-CTU$$64$YR$$$N$$$20240827$N$$US$
242552231$24255223$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58911$$FDA-CTU$$43$YR$$M$N$$$20240827$N$$US$
242552251$24255225$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58913$$FDA-CTU$$71$YR$$F$N$$$20240827$N$$US$
242552271$24255227$1$I$20240531$20240603$20240827$20240827$EXP$$US-GUERBET / LLC-US-20240092$GUERBET$$52$YR$A$F$Y$81.6$KG$20240827$$HP$US$US
242552281$24255228$1$I$$20240823$20240827$20240827$EXP$$JP-ALXN-202408JPN001399JP$ALEXION PHARMACEUTICALS$$75$YR$$M$Y$$$20240827$$PH$JP$JP
242552291$24255229$1$I$$20240822$20240827$20240827$EXP$GB-MHRA-MIDB-2c0fbe7b-e7fd-4d51-9fc6-9b5ec93da3a2$GB-DSJP-DSE-2024-141722$DAIICHI$$80$YR$$F$Y$$$20240827$$PH$GB$GB
242552301$24255230$1$I$$20240820$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136099$BRISTOL MYERS SQUIBB$Kathuria-Prakash N, Lopez LP, Raman S, Ye H, Anaokar J, Sisk A, et al. ALK inhibition with alectinib for refractory metastatic renal cell carcinoma with alk rearrangement: a rare case report and literature review. JCO Precision Oncology. 2024 Jun 17;8:1-6. doi:10.1200/PO.24.00154.$64$YR$A$M$Y$$$20240827$$MD$US$US
242552311$24255231$1$I$20240825$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136168$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$58.97$KG$20240827$$CN$US$US
242552321$24255232$1$I$$20240819$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131335$BRISTOL MYERS SQUIBB$Verma N, Jaffer M, Pina Y, Peguero E, Mokhtari S. Rituximab for immune checkpoint inhibitor myasthenia gravis. Cureus. 2021 Jul 12;13(7):1-5. doi:10.7759/cureus.16337.$70$YR$E$F$Y$$$20240827$$HP$US$US
242552331$24255233$1$I$$20240820$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132378$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240827$$HP$US$US
242552342$24255234$2$F$20240801$20240919$20240827$20240926$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-132169$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240926$$PH$PR$PR
242552392$24255239$2$F$$20240813$20240827$20240904$30DAY$$JP-SA-2024SA248620$SANOFI AVENTIS$$$$A$$Y$$$20240904$$HP$JP$JP
242552401$24255240$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015178$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240827$$HP$US$US
242552411$24255241$1$I$$20240820$20240827$20240827$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202408016397$ELI LILLY AND CO$$$$$$Y$$$20240827$$MD$IN$IN
242552421$24255242$1$I$$20240820$20240827$20240827$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408013012$ELI LILLY AND CO$$$$$F$Y$$$20240827$$CN$BR$BR
242552432$24255243$2$F$20240809$20240925$20240827$20240930$EXP$FR-AFSSAPS-MA2024001376$FR-ELI_LILLY_AND_COMPANY-FR202408010230$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240930$$CN$FR$FR
242552442$24255244$2$F$20240401$20240902$20240827$20240913$EXP$$IL-ELI_LILLY_AND_COMPANY-IL202408012983$ELI LILLY AND CO$$62$YR$A$M$Y$96$KG$20240913$$CN$IL$IL
242552451$24255245$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58915$$FDA-CTU$$62$YR$$F$N$$$20240827$N$$US$
242552461$24255246$1$I$20240816$20240822$20240827$20240827$EXP$$CN-PURDUE-USA-2024-0311595$PURDUE$$74$YR$$M$Y$$$20240827$$HP$CN$CN
242552471$24255247$1$I$$20240820$20240827$20240827$EXP$$JP-DSJP-DSJ-2024-141221$DAIICHI$Okubo R, Shimizu T, Oogushi K, Saitou T, Kita A, Ishiwatari S, et al. 75 A case of endoscopic biliary drainage for common bile duct stones complicated with Hirschsprung disease-related diseases, The 380th Regular Meeting of the Kanto Branch of the Japanese Society of Gastroenterology. See Journal Title following Article Title. 2024;42$3$DEC$$M$Y$$$20240827$$MD$JP$JP
242552481$24255248$1$I$20240625$20240820$20240827$20240827$EXP$$JP-DSJP-DSJ-2024-141363$DAIICHI$$59$YR$$M$Y$55.6$KG$20240827$$HP$JP$JP
242552493$24255249$3$F$20240720$20240920$20240827$20240923$EXP$$US-BIOMARINAP-US-2024-160061$BIOMARIN$$$$$$Y$$$20240923$$CN$US$US
242552501$24255250$1$I$$20240826$20240827$20240827$EXP$$US-KYOWAKIRIN-2024KK020020$KYOWA$$$$$$Y$$$20240827$$HP$US$US
242552512$24255251$2$F$20240814$20240823$20240827$20240829$EXP$$GB-PURDUE-USA-2024-0311613$PURDUE$$30$YR$$F$Y$$$20240829$$HP$GB$GB
242552531$24255253$1$I$20240624$20240824$20240827$20240827$EXP$$US-PURDUE PHARMA-USA-2024-0311624$PURDUE$$$$$M$Y$$$20240827$$CN$US$US
242552541$24255254$1$I$$20240820$20240827$20240827$EXP$$JP-DSJP-DSJ-2024-117432$DAIICHI$$7$DEC$$F$Y$$$20240827$$PH$JP$JP
242552562$24255256$2$F$$20240909$20240827$20240912$EXP$$SE-DSJP-DSE-2024-141673$DAIICHI$$66$YR$$F$Y$$$20240913$$CN$SE$SE
242552572$24255257$2$F$20240901$20240906$20240827$20240912$EXP$$US-ABBVIE-5890827$ABBVIE$$55$YR$$M$Y$$$20240912$$CN$US$US
242552582$24255258$2$F$$20240919$20240827$20240923$EXP$CA-HEALTHCANVIG-E2B_07232555$CA-PURDUE-USA-2024-0311589$PURDUE$$44$YR$$F$Y$97$KG$20240923$$HP$CA$CA
242552591$24255259$1$I$$20240821$20240827$20240827$EXP$$PH-DAIICHI SANKYO, INC.-DSJ-2024-141925$DAIICHI$$$$$F$Y$$$20240827$$MD$PH$PH
242552601$24255260$1$I$20220420$20240821$20240827$20240827$EXP$$CO-TAKEDA-2022TUS030960$TAKEDA$$26$YR$$M$Y$52$KG$20240827$$CN$CO$CO
242552611$24255261$1$I$20240101$20240823$20240827$20240827$EXP$$US-KYOWAKIRIN-2024KK020002$KYOWA$$$$$$Y$$$20240827$$PH$US$US
242552621$24255262$1$I$20240606$20240606$20240827$20240827$EXP$$US-GUERBET / LLC-US-20240094$GUERBET$$69$YR$E$F$Y$$$20240827$$HP$US$US
242552631$24255263$1$I$20240604$20240604$20240827$20240827$EXP$$US-GUERBET / LLC-US-20240093$GUERBET$$63$YR$A$F$Y$$$20240827$$HP$US$US
242552641$24255264$1$I$$20240809$20240827$20240827$PER$$US-APELLIS-2024-APL-0000803$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240827$$HP$US$US
242552652$24255265$2$F$$20240913$20240827$20240918$EXP$$CA-PURDUE-USA-2024-0311615$PURDUE$$65$YR$$F$Y$69$KG$20240918$$HP$CA$CA
242552661$24255266$1$I$20240711$20240819$20240827$20240827$EXP$$AU-DAIICHI SANKYO, INC.-DSJ-2024-142034$DAIICHI$$67$YR$$F$Y$120$KG$20240827$$MD$AU$AU
242552681$24255268$1$I$$20240822$20240827$20240827$EXP$$JP-DSJP-DSJ-2024-139013$DAIICHI$$86$YR$$M$Y$$$20240827$$PH$JP$JP
242552701$24255270$1$I$20240101$20240812$20240827$20240827$PER$$US-JNJFOC-20240867387$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$HP$US$US
242552711$24255271$1$I$$20240819$20240827$20240827$PER$$US-ALXN-A202304537$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240827$$HP$US$US
242552721$24255272$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136211$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240827$$CN$US$US
242552731$24255273$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135806$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240827$$CN$US$US
242552741$24255274$1$I$20240101$20240821$20240827$20240827$EXP$$US-ABBVIE-5891331$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242552751$24255275$1$I$$20240826$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136034$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240827$$CN$US$US
242552761$24255276$1$I$20240406$20240826$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135755$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240827$$CN$US$US
242552771$24255277$1$I$$20240805$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124616$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240827$$CN$US$US
242552781$24255278$1$I$20240801$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58876$$FDA-CTU$$72$YR$$M$N$$$20240826$N$HP$US$
242552791$24255279$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58592$$FDA-CTU$$$$$M$N$$$20240826$N$HP$US$
242552801$24255280$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58919$$FDA-CTU$$42$YR$$F$N$81.65$KG$20240827$N$$US$
242552811$24255281$1$I$$20240814$20240827$20240827$PER$$US-JNJFOC-20240837787$JOHNSON AND JOHNSON$$$$$F$Y$$$20240827$$CN$US$US
242552822$24255282$2$F$$20240909$20240827$20240909$PER$$US-BAYER-2024A120765$BAYER$$$$$F$Y$$$20240909$$CN$US$US
242552831$24255283$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58810$$FDA-CTU$$43$YR$$F$N$$$20240826$N$$US$
242552841$24255284$1$I$$20240819$20240827$20240827$EXP$$CA-DSJP-DSJ-2024-141970$DAIICHI$$$$$F$Y$$$20240827$$MD$CA$CA
242552851$24255285$1$I$$20240812$20240827$20240827$EXP$$CA-HLS-202402019$HLS THERAPEUTICS$$$$E$M$Y$$$20240827$$HP$CA$CA
242552861$24255286$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58909$$FDA-CTU$$62$YR$$M$N$$$20240827$N$$US$
242552871$24255287$1$I$20230101$20240826$20240827$20240827$EXP$$US-BAUSCH-BL-2024-012895$BAUSCH AND LOMB$$$$$M$Y$$$20240827$$CN$US$US
242552881$24255288$1$I$20240818$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58910$$FDA-CTU$$75$YR$$F$N$$$20240826$N$HP$US$
242552891$24255289$1$I$$20240819$20240827$20240827$EXP$$CA-DSJP-DSJ-2024-141968$DAIICHI$$55$YR$$F$Y$$$20240827$$HP$CA$CA
242552901$24255290$1$I$20240101$20240820$20240827$20240827$PER$$US-ABBVIE-5889758$ABBVIE$$6$MON$$$Y$$$20240827$$HP$US$US
242552911$24255291$1$I$$20240819$20240827$20240827$EXP$$CA-DSJP-DSJ-2024-141963$DAIICHI$$$$$F$Y$94$KG$20240827$$CN$CA$CA
242552921$24255292$1$I$20240101$20240826$20240827$20240827$EXP$$KR-GILEAD-2024-0685361$GILEAD$$$$$F$Y$$$20240827$$CN$KR$KR
242552931$24255293$1$I$20240814$20240820$20240827$20240827$EXP$$FR-DSJP-DSE-2024-141701$DAIICHI$$$$A$F$Y$76$KG$20240827$$MD$FR$FR
242552941$24255294$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA246858$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240827$$MD$US$US
242552951$24255295$1$I$20240101$20240813$20240827$20240827$PER$$US-SA-2024SA245263$SANOFI AVENTIS$$66$YR$E$F$Y$61.235$KG$20240827$$MD$US$US
242552961$24255296$1$I$20240101$20240813$20240827$20240827$PER$$US-SA-2024SA243755$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240827$$MD$US$US
242552971$24255297$1$I$20240201$20240814$20240827$20240827$PER$$US-SA-2024SA246997$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240827$$MD$US$US
242552983$24255298$3$F$20240801$20240904$20240827$20240925$PER$$US-SA-2024SA244424$SANOFI AVENTIS$$55$YR$A$F$Y$82.735$KG$20240925$$MD$US$US
242552991$24255299$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA250372$SANOFI AVENTIS$$$$$F$Y$$$20240827$$CN$US$US
242553001$24255300$1$I$20240401$20240814$20240827$20240827$PER$$US-SA-2024SA247048$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240827$$MD$US$US
242553011$24255301$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA192214$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240827$$CN$US$US
242553021$24255302$1$I$20240801$20240814$20240827$20240827$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08195$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240827$$HP$US$US
242553031$24255303$1$I$20240201$20240813$20240827$20240827$PER$$US-SA-2024SA246635$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240827$$MD$US$US
242553041$24255304$1$I$$20240813$20240827$20240827$PER$$US-SA-2024SA183204$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240827$$MD$US$US
242553051$24255305$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA245160$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240827$$MD$US$US
242553061$24255306$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246984$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240827$$MD$US$US
242553071$24255307$1$I$20240101$20240813$20240827$20240827$PER$$US-SA-2024SA245252$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240827$$MD$US$US
242553081$24255308$1$I$20240801$20240813$20240827$20240827$PER$$US-SA-2024SA246468$SANOFI AVENTIS$$77$YR$E$M$Y$83.447$KG$20240827$$MD$US$US
242553091$24255309$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA244962$SANOFI AVENTIS$$$$$M$Y$$$20240827$$MD$US$US
242553101$24255310$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA245166$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240827$$MD$US$US
242553111$24255311$1$I$20240101$20240813$20240827$20240827$PER$$US-SA-2024SA245255$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240827$$MD$US$US
242553121$24255312$1$I$20240501$20240814$20240827$20240827$PER$$US-SA-2024SA207042$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240827$$MD$US$US
242553131$24255313$1$I$$20240803$20240827$20240827$PER$$US-009507513-2408USA001196$MERCK$$$$$M$Y$90.7$KG$20240827$$HP$US$US
242553141$24255314$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA247444$SANOFI AVENTIS$$$$A$F$Y$99.79$KG$20240827$$MD$US$US
242553151$24255315$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246920$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240827$$MD$US$US
242553161$24255316$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA245923$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240827$$MD$US$US
242553171$24255317$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246954$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240827$$MD$US$US
242553181$24255318$1$I$20240719$20240814$20240827$20240827$PER$$US-SA-2024SA246862$SANOFI AVENTIS$$5$YR$C$M$Y$21.7$KG$20240827$$MD$US$US
242553191$24255319$1$I$20240805$20240814$20240827$20240827$PER$$US-SA-2024SA244883$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240827$$MD$US$US
242553201$24255320$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246895$SANOFI AVENTIS$$$$A$M$Y$75.56$KG$20240827$$MD$US$US
242553211$24255321$1$I$$20240812$20240827$20240827$PER$$US-SA-2024SA241061$SANOFI AVENTIS$$$$E$F$Y$$$20240827$$CN$US$US
242553221$24255322$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246588$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240827$$MD$US$US
242553232$24255323$2$F$$20240822$20240827$20240923$PER$$US-SA-2024SA247933$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240923$$MD$US$US
242553241$24255324$1$I$20240318$20240814$20240827$20240827$PER$$US-SA-2024SA241605$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240827$$MD$US$US
242553251$24255325$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246007$SANOFI AVENTIS$$$$$F$Y$$$20240827$$CN$US$US
242553261$24255326$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA246966$SANOFI AVENTIS$$15$YR$T$M$Y$58.96$KG$20240827$$MD$US$US
242553271$24255327$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA246113$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240827$$MD$US$US
242553281$24255328$1$I$$20240813$20240827$20240827$PER$$US-SA-2024SA245247$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240827$$MD$US$US
242553291$24255329$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA244900$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240827$$MD$US$US
242553301$24255330$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246899$SANOFI AVENTIS$$44$YR$A$F$Y$91.62$KG$20240827$$MD$US$US
242553311$24255331$1$I$20240801$20240814$20240827$20240827$PER$$US-SA-2024SA245496$SANOFI AVENTIS$$70$YR$E$F$Y$66.67$KG$20240827$$MD$US$US
242553321$24255332$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA246949$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240827$$MD$US$US
242553331$24255333$1$I$20240731$20240731$20240827$20240827$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00806$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240827$$CN$US$US
242553341$24255334$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA246421$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240827$$MD$US$US
242553352$24255335$2$F$20240101$20240826$20240827$20240918$PER$$US-SA-2024SA245249$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240918$$MD$US$US
242553362$24255336$2$F$$20240828$20240827$20240918$PER$$US-SA-2024SA246527$SANOFI AVENTIS$$$$A$M$Y$97.5$KG$20240918$$MD$US$US
242553371$24255337$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246933$SANOFI AVENTIS$$$$A$M$Y$68$KG$20240827$$MD$US$US
242553381$24255338$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA246855$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240827$$MD$US$US
242553391$24255339$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA246598$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240827$$CN$US$US
242553411$24255341$1$I$$20240812$20240827$20240827$PER$$US-SA-2024SA092916$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242553421$24255342$1$I$20240704$20240814$20240827$20240827$PER$$US-SA-2024SA246793$SANOFI AVENTIS$$15$YR$T$F$Y$45.35$KG$20240827$$MD$US$US
242553431$24255343$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA245203$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240827$$MD$US$US
242553441$24255344$1$I$20240701$20240814$20240827$20240827$PER$$US-SA-2024SA247457$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240827$$MD$US$US
242553452$24255345$2$F$20200928$20240924$20240827$20240926$30DAY$$US-SANDOZ INC.-NVSC2020US264734$SANDOZ$$59$YR$$F$Y$$$20240926$$CN$US$US
242553461$24255346$1$I$$20240820$20240827$20240827$PER$$US-ALXN-202408USA001284US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240827$$HP$US$US
242553471$24255347$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58847$$FDA-CTU$$81$YR$$F$N$$$20240827$N$$US$
242553481$24255348$1$I$20240801$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58898$$FDA-CTU$$85$YR$$F$N$93.4$KG$20240827$N$CN$US$
242553491$24255349$1$I$$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58912$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242553501$24255350$1$I$20240724$20240822$20240827$20240827$EXP$$KR-AstraZeneca-2024A192808$ASTRAZENECA$$4828$DY$T$M$Y$$$20240827$$CN$KR$
242553511$24255351$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA121333$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240827$$MD$US$US
242553521$24255352$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246814$SANOFI AVENTIS$$$$E$M$Y$$$20240827$$MD$US$US
242553531$24255353$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246605$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240827$$MD$US$US
242553541$24255354$1$I$$20240812$20240827$20240827$EXP$$CA-HLS-202402020$HLS THERAPEUTICS$$$$A$M$Y$$$20240827$$HP$CA$CA
242553551$24255355$1$I$20240101$20240812$20240827$20240827$PER$$US-SA-2024SA247603$SANOFI AVENTIS$$$$$M$Y$$$20240827$$CN$US$US
242553561$24255356$1$I$20240812$20240813$20240827$20240827$PER$$US-SA-2024SA246706$SANOFI AVENTIS$$1$YR$I$M$Y$11.7$KG$20240827$$MD$US$US
242553571$24255357$1$I$20240701$20240814$20240827$20240827$PER$$US-SA-2024SA247093$SANOFI AVENTIS$$$$A$F$Y$180$KG$20240827$$CN$US$US
242553581$24255358$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA201061$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240827$$CN$US$US
242553591$24255359$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA246615$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240827$$MD$US$US
242553601$24255360$1$I$20240813$20240813$20240827$20240827$PER$$US-SA-2024SA246072$SANOFI AVENTIS$$36$YR$A$F$Y$68.03$KG$20240827$$MD$US$US
242553611$24255361$1$I$20240813$20240814$20240827$20240827$PER$$US-SA-2024SA245592$SANOFI AVENTIS$$$$$M$Y$$$20240827$$CN$US$US
242553621$24255362$1$I$20240806$20240814$20240827$20240827$PER$$US-SA-2024SA246941$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240827$$MD$US$US
242553631$24255363$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA247576$SANOFI AVENTIS$$25$YR$A$M$Y$90.7$KG$20240827$$MD$US$US
242553641$24255364$1$I$$20240813$20240827$20240827$PER$$US-SA-2024SA246451$SANOFI AVENTIS$$$$E$F$Y$71.655$KG$20240827$$MD$US$US
242553651$24255365$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58863$$FDA-CTU$$45$YR$$F$N$102.97$KG$20240827$N$$US$
242553661$24255366$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA246304$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240827$$MD$US$US
242553671$24255367$1$I$20240801$20240815$20240827$20240827$PER$$US-SA-2024SA247198$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240827$$MD$US$US
242553681$24255368$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58845$$FDA-CTU$$23$YR$$F$N$63.5$KG$20240827$N$$US$
242553691$24255369$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA170717$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240827$$MD$US$US
242553701$24255370$1$I$$20240823$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014931$ELI LILLY AND CO$$$$$$Y$$$20240827$$CN$US$US
242553711$24255371$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58850$$FDA-CTU$$28$YR$$M$N$77.11$KG$20240827$N$$US$
242553721$24255372$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246851$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240827$$MD$US$US
242553731$24255373$1$I$$20240813$20240827$20240827$PER$$US-SA-2024SA246720$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240827$$MD$US$US
242553741$24255374$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247113$SANOFI AVENTIS$$$$A$F$Y$49.8$KG$20240827$$MD$US$US
242553752$24255375$2$F$20240813$20240816$20240827$20240829$PER$$US-SA-2024SA244725$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240829$$CN$US$US
242553761$24255376$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA246432$SANOFI AVENTIS$$69$YR$E$F$Y$65.7$KG$20240827$$MD$US$US
242553771$24255377$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA246718$SANOFI AVENTIS$$64$YR$A$M$Y$97.052$KG$20240827$$MD$US$US
242553781$24255378$1$I$$20240813$20240827$20240827$PER$$US-SA-2024SA245224$SANOFI AVENTIS$$$$A$F$Y$58$KG$20240827$$MD$US$US
242553791$24255379$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA246132$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240827$$MD$US$US
242553801$24255380$1$I$$20240814$20240827$20240827$PER$$US-SA-2024SA245306$SANOFI AVENTIS$$$$T$F$Y$45.351$KG$20240827$$MD$US$US
242553811$24255381$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246562$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240827$$MD$US$US
242553821$24255382$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA244626$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240827$$MD$US$US
242553831$24255383$1$I$20240807$20240814$20240827$20240827$PER$$US-SA-2024SA245908$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240827$$MD$US$US
242553841$24255384$1$I$20240101$20240813$20240827$20240827$PER$$US-SA-2024SA240584$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240827$$MD$US$US
242553861$24255386$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA247095$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240827$$MD$US$US
242553871$24255387$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246377$SANOFI AVENTIS$$10$YR$C$M$Y$30.39$KG$20240827$$MD$US$US
242553881$24255388$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247030$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240827$$CN$US$US
242553891$24255389$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246428$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240827$$MD$US$US
242553901$24255390$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA244312$SANOFI AVENTIS$$$$$M$Y$$$20240827$$HP$US$US
242553911$24255391$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246540$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240827$$MD$US$US
242553921$24255392$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA248411$SANOFI AVENTIS$$$$A$M$Y$91$KG$20240827$$MD$US$US
242553931$24255393$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247499$SANOFI AVENTIS$$$$E$F$Y$$$20240827$$MD$US$US
242553942$24255394$2$F$20240801$20240815$20240827$20240829$PER$$US-SA-2024SA245123$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240829$$MD$US$US
242553952$24255395$2$F$20240101$20240903$20240827$20240930$PER$$US-SA-2024SA246373$SANOFI AVENTIS$$91$YR$E$F$Y$43.5$KG$20240930$$MD$US$US
242553961$24255396$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246703$SANOFI AVENTIS$$$$E$M$Y$$$20240827$$MD$US$US
242553971$24255397$1$I$20240809$20240815$20240827$20240827$PER$$US-SA-2024SA247582$SANOFI AVENTIS$$27$YR$A$F$Y$89.81$KG$20240827$$MD$US$US
242553981$24255398$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247268$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242554001$24255400$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247649$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242554011$24255401$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247143$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242554021$24255402$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA247112$SANOFI AVENTIS$$42$YR$A$F$Y$92$KG$20240827$$MD$US$US
242554031$24255403$1$I$20240701$20240815$20240827$20240827$PER$$US-SA-2024SA246238$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240827$$MD$US$US
242554041$24255404$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246741$SANOFI AVENTIS$$$$A$M$Y$113$KG$20240827$$MD$US$US
242554051$24255405$1$I$20230101$20240815$20240827$20240827$PER$$US-SA-2024SA247089$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240827$$MD$US$US
242554061$24255406$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA245469$SANOFI AVENTIS$$$$$$Y$$$20240827$$HP$US$US
242554071$24255407$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246103$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240827$$MD$US$US
242554081$24255408$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246748$SANOFI AVENTIS$$$$C$F$Y$34.014$KG$20240827$$MD$US$US
242554091$24255409$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247293$SANOFI AVENTIS$$$$E$F$Y$70.3$KG$20240827$$MD$US$US
242554101$24255410$1$I$20240806$20240815$20240827$20240827$PER$$US-SA-2024SA247476$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240827$$MD$US$US
242554122$24255412$2$F$$20240904$20240827$20240911$EXP$NL-LRB-00994141$NL-TEVA-VS-3235470$TEVA$$50$YR$$F$Y$113$KG$20240911$$CN$NL$NL
242554131$24255413$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246284$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240827$$MD$US$US
242554141$24255414$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA177985$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240827$$MD$US$US
242554151$24255415$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA247052$SANOFI AVENTIS$$47$YR$A$F$Y$74.83$KG$20240827$$MD$US$US
242554161$24255416$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247251$SANOFI AVENTIS$$2$YR$C$M$Y$11$KG$20240827$$MD$US$US
242554171$24255417$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246886$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240827$$MD$US$US
242554181$24255418$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA106857$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240827$$MD$US$US
242554191$24255419$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA243156$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240827$$MD$US$US
242554201$24255420$1$I$20240401$20240815$20240827$20240827$PER$$US-SA-2024SA247686$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240827$$MD$US$US
242554211$24255421$1$I$20240801$20240815$20240827$20240827$PER$$US-SA-2024SA247670$SANOFI AVENTIS$$27$YR$A$M$Y$68.03$KG$20240827$$MD$US$US
242554221$24255422$1$I$20240814$20240815$20240827$20240827$PER$$US-SA-2024SA246687$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240827$$MD$US$US
242554231$24255423$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246925$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240827$$MD$US$US
242554241$24255424$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247019$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240827$$CN$US$US
242554251$24255425$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247618$SANOFI AVENTIS$$$$C$F$Y$$$20240827$$MD$US$US
242554261$24255426$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246329$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240827$$MD$US$US
242554271$24255427$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA247077$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240827$$MD$US$US
242554281$24255428$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247150$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240827$$MD$US$US
242554291$24255429$1$I$20240814$20240815$20240827$20240827$PER$$US-SA-2024SA246547$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240827$$MD$US$US
242554301$24255430$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246630$SANOFI AVENTIS$$$$$$Y$$$20240827$$PH$US$US
242554311$24255431$1$I$20240701$20240815$20240827$20240827$PER$$US-SA-2024SA247660$SANOFI AVENTIS$$$$A$F$Y$116.12$KG$20240827$$MD$US$US
242554321$24255432$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246541$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240827$$MD$US$US
242554331$24255433$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58897$$FDA-CTU$$56$YR$$M$N$$$20240827$N$$US$
242554341$24255434$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58918$$FDA-CTU$$37$YR$$M$N$$$20240827$N$$US$
242554351$24255435$1$I$$20240815$20240827$20240827$PER$$US-SA-2023SA150818$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240827$$MD$US$US
242554361$24255436$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247241$SANOFI AVENTIS$$$$A$M$Y$104$KG$20240827$$MD$US$US
242554371$24255437$1$I$20240810$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58833$$FDA-CTU$$76$YR$$F$N$$$20240827$N$PH$US$
242554381$24255438$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA244043$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$CN$US$US
242554392$24255439$2$F$$20240918$20240827$20240927$PER$$US-SA-2024SA247730$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
242554401$24255440$1$I$$20240820$20240827$20240827$EXP$$JP-MFDS-2021000061-2408JPN000807J$MERCK$$$$E$F$Y$$$20240827$$PH$JP$JP
242554411$24255441$1$I$20240601$20240815$20240827$20240827$PER$$US-SA-2024SA246564$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240827$$MD$US$US
242554421$24255442$1$I$20240801$20240815$20240827$20240827$PER$$US-SA-2024SA245329$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240827$$MD$US$US
242554431$24255443$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA247984$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240827$$MD$US$US
242554441$24255444$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA247695$SANOFI AVENTIS$$13$YR$T$M$Y$63.04$KG$20240827$$MD$US$US
242554451$24255445$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA244251$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240827$$CN$US$US
242554461$24255446$1$I$20240813$20240815$20240827$20240827$PER$$US-SA-2024SA246561$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240827$$PH$US$US
242554481$24255448$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246351$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240827$$MD$US$US
242554491$24255449$1$I$20240701$20240815$20240827$20240827$PER$$US-SA-2024SA246356$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240827$$MD$US$US
242554501$24255450$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246452$SANOFI AVENTIS$$$$A$M$Y$$$20240827$$CN$US$US
242554511$24255451$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247080$SANOFI AVENTIS$$$$T$F$Y$$$20240827$$MD$US$US
242554521$24255452$1$I$20240801$20240815$20240827$20240827$PER$$US-SA-2024SA247156$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240827$$MD$US$US
242554531$24255453$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246516$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$CN$US$US
242554541$24255454$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246756$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$CN$US$US
242554551$24255455$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246723$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240827$$MD$US$US
242554561$24255456$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246695$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240827$$MD$US$US
242554571$24255457$1$I$20180101$20240815$20240827$20240827$PER$$US-SA-2024SA247252$SANOFI AVENTIS$$21$YR$A$F$Y$77$KG$20240827$$MD$US$US
242554581$24255458$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA248029$SANOFI AVENTIS$$$$T$F$Y$42$KG$20240827$$MD$US$US
242554591$24255459$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA245631$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242554601$24255460$1$I$20201015$20240815$20240827$20240827$PER$$US-SA-2024SA154835$SANOFI AVENTIS$$26$YR$A$M$Y$99.79$KG$20240827$$CN$US$US
242554611$24255461$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246776$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240827$$MD$US$US
242554621$24255462$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA248422$SANOFI AVENTIS$$$$A$$Y$$$20240827$$PH$US$US
242554641$24255464$1$I$20231201$20240815$20240827$20240827$PER$$US-SA-2024SA246730$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240827$$MD$US$US
242554651$24255465$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246760$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240827$$MD$US$US
242554661$24255466$1$I$20231201$20240815$20240827$20240827$PER$$US-SA-2024SA245929$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240827$$MD$US$US
242554671$24255467$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246389$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240827$$MD$US$US
242554681$24255468$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246000$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240827$$MD$US$US
242554692$24255469$2$F$20240101$20240905$20240827$20240914$PER$$US-SA-2024SA246978$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240914$$MD$US$US
242554701$24255470$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247085$SANOFI AVENTIS$$$$$F$Y$$$20240827$$MD$US$US
242554711$24255471$1$I$20240801$20240815$20240827$20240827$PER$$US-SA-2024SA247084$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240827$$MD$US$US
242554721$24255472$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246998$SANOFI AVENTIS$$$$E$M$Y$$$20240827$$MD$US$US
242554731$24255473$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246309$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240827$$MD$US$US
242554741$24255474$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA248682$SANOFI AVENTIS$$$$A$F$Y$112.9$KG$20240827$$MD$US$US
242554751$24255475$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246477$SANOFI AVENTIS$$18$YR$A$F$Y$70.5$KG$20240827$$MD$US$US
242554761$24255476$1$I$20231201$20240815$20240827$20240827$PER$$US-SA-2024SA246692$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240827$$MD$US$US
242554771$24255477$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246896$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240827$$MD$US$US
242554781$24255478$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246912$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240827$$MD$US$US
242554791$24255479$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA134769$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240827$$MD$US$US
242554801$24255480$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246973$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240827$$CN$US$US
242554811$24255481$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246361$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240827$$MD$US$US
242554822$24255482$2$F$20240801$20240820$20240827$20240831$PER$$US-SA-2024SA244320$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240831$$CN$US$US
242554832$24255483$2$F$$20240815$20240827$20240910$PER$$US-SA-2024SA246571$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240910$$MD$US$US
242554841$24255484$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246788$SANOFI AVENTIS$$$$A$M$Y$$$20240827$$MD$US$US
242554851$24255485$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246841$SANOFI AVENTIS$$$$A$M$Y$$$20240827$$MD$US$US
242554861$24255486$1$I$20210110$20240806$20240827$20240827$PER$$US-JNJFOC-20240816287$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240827$$CN$US$US
242554871$24255487$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA244090$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240827$$CN$US$US
242554881$24255488$1$I$20240812$20240815$20240827$20240827$PER$$US-SA-2024SA246622$SANOFI AVENTIS$$61$YR$A$M$Y$97.5$KG$20240827$$MD$US$US
242554891$24255489$1$I$20230901$20240815$20240827$20240827$PER$$US-SA-2024SA246936$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240827$$MD$US$US
242554901$24255490$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247514$SANOFI AVENTIS$$$$A$F$Y$123$KG$20240827$$MD$US$US
242554911$24255491$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246939$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240827$$MD$US$US
242554921$24255492$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247571$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240827$$MD$US$US
242554931$24255493$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247750$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240827$$MD$US$US
242554941$24255494$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247000$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240827$$CN$US$US
242554951$24255495$1$I$$20240816$20240827$20240827$PER$$US-SA-2023SA284742$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240827$$HP$US$US
242554961$24255496$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246791$SANOFI AVENTIS$$40$YR$A$F$Y$83$KG$20240827$$MD$US$US
242554971$24255497$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA246811$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240827$$MD$US$US
242554981$24255498$1$I$20240101$20240815$20240827$20240827$PER$$US-SA-2024SA247123$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240827$$MD$US$US
242555001$24255500$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA247569$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240827$$MD$US$US
242555011$24255501$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246738$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240827$$MD$US$US
242555021$24255502$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247291$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240827$$CN$US$US
242555031$24255503$1$I$20240808$20240816$20240827$20240827$PER$$US-SA-2024SA245216$SANOFI AVENTIS$$6$MON$I$F$Y$$$20240827$$MD$US$US
242555041$24255504$1$I$20240812$20240816$20240827$20240827$PER$$US-SA-2024SA247024$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240827$$MD$US$US
242555051$24255505$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA248205$SANOFI AVENTIS$$19$YR$A$F$Y$140$KG$20240827$$MD$US$US
242555061$24255506$1$I$20240801$20240816$20240827$20240827$PER$$US-SA-2024SA246780$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240827$$CN$US$US
242555071$24255507$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA245967$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240827$$MD$US$US
242555091$24255509$1$I$20240801$20240816$20240827$20240827$PER$$US-SA-2024SA248224$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240827$$MD$US$US
242555101$24255510$1$I$20240801$20240816$20240827$20240827$PER$$US-SA-2024SA246533$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240827$$MD$US$US
242555112$24255511$2$F$20240101$20240816$20240827$20240830$PER$$US-SA-2024SA247012$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240830$$HP$US$US
242555121$24255512$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA247180$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240827$$MD$US$US
242555131$24255513$1$I$20240301$20240816$20240827$20240827$PER$$US-SA-2024SA247363$SANOFI AVENTIS$$33$YR$A$M$Y$86$KG$20240827$$MD$US$US
242555141$24255514$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246340$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240827$$MD$US$US
242555161$24255516$1$I$20240701$20240816$20240827$20240827$PER$$US-SA-2024SA247022$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240827$$MD$US$US
242555171$24255517$1$I$20240701$20240816$20240827$20240827$PER$$US-SA-2024SA248001$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240827$$MD$US$US
242555181$24255518$1$I$20240816$20240816$20240827$20240827$PER$$US-SA-2024SA247097$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240827$$MD$US$US
242555191$24255519$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA248849$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240827$$CN$US$US
242555201$24255520$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA248839$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240827$$MD$US$US
242555211$24255521$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247081$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240827$$MD$US$US
242555221$24255522$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA248543$SANOFI AVENTIS$$72$YR$E$F$Y$112$KG$20240827$$MD$US$US
242555231$24255523$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246734$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242555241$24255524$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA247654$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240827$$MD$US$US
242555251$24255525$1$I$20240801$20240816$20240827$20240827$PER$$US-SA-2024SA246654$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240827$$CN$US$US
242555261$24255526$1$I$20190901$20240816$20240827$20240827$PER$$US-SA-2024SA247078$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240827$$MD$US$US
242555271$24255527$1$I$20240815$20240816$20240827$20240827$PER$$US-SA-2024SA247265$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240827$$MD$US$US
242555281$24255528$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA247374$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240827$$MD$US$US
242555291$24255529$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246346$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240827$$MD$US$US
242555301$24255530$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247566$SANOFI AVENTIS$$$$C$F$Y$$$20240827$$MD$US$US
242555311$24255531$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA246305$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240827$$MD$US$US
242555321$24255532$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247369$SANOFI AVENTIS$$21$YR$A$$Y$$$20240827$$CN$US$US
242555331$24255533$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246280$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240827$$MD$US$US
242555341$24255534$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247239$SANOFI AVENTIS$$$$A$M$Y$92.9$KG$20240827$$MD$US$US
242555351$24255535$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA246792$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240827$$CN$US$US
242555361$24255536$1$I$20240501$20240816$20240827$20240827$PER$$US-SA-2024SA249003$SANOFI AVENTIS$$5$YR$C$M$Y$18.1$KG$20240827$$MD$US$US
242555371$24255537$1$I$20240816$20240816$20240827$20240827$PER$$US-SA-2024SA247955$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240827$$CN$US$US
242555381$24255538$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA248387$SANOFI AVENTIS$$$$C$F$Y$27.982$KG$20240827$$MD$US$US
242555391$24255539$1$I$20240801$20240816$20240827$20240827$PER$$US-SA-2024SA247302$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240827$$MD$US$US
242555401$24255540$1$I$20240801$20240816$20240827$20240827$PER$$US-SA-2024SA247260$SANOFI AVENTIS$$$$A$F$Y$95.2$KG$20240827$$MD$US$US
242555411$24255541$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA247270$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240827$$MD$US$US
242555421$24255542$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247042$SANOFI AVENTIS$$$$E$M$Y$76$KG$20240827$$MD$US$US
242555431$24255543$1$I$20240601$20240816$20240827$20240827$PER$$US-SA-2024SA247212$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240827$$MD$US$US
242555441$24255544$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58925$$FDA-CTU$$66$YR$$F$N$72.57$KG$20240827$N$$US$
242555451$24255545$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58914$$FDA-CTU$$44$YR$$M$N$$$20240827$N$$US$
242555461$24255546$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58858$$FDA-CTU$$$$$F$N$$$20240827$N$$US$
242555471$24255547$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246449$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240827$$MD$US$US
242555481$24255548$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA245948$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240827$$CN$US$US
242555491$24255549$1$I$20240801$20240816$20240827$20240827$PER$$US-SA-2024SA246768$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240827$$MD$US$US
242555501$24255550$1$I$20240816$20240816$20240827$20240827$PER$$US-SA-2024SA247104$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240827$$CN$US$US
242555511$24255551$1$I$20240801$20240816$20240827$20240827$PER$$US-SA-2024SA246845$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240827$$MD$US$US
242555521$24255552$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246168$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240827$$CN$US$US
242555531$24255553$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246290$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242555541$24255554$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247853$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240827$$MD$US$US
242555551$24255555$1$I$20240701$20240816$20240827$20240827$PER$$US-SA-2024SA247621$SANOFI AVENTIS$$$$A$M$Y$$$20240827$$MD$US$US
242555561$24255556$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA248433$SANOFI AVENTIS$$39$YR$A$F$Y$83.91$KG$20240827$$MD$US$US
242555571$24255557$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247083$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240827$$MD$US$US
242555582$24255558$2$F$20240701$20240916$20240827$20240923$PER$$US-SA-2024SA247065$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240923$$MD$US$US
242555591$24255559$1$I$20230101$20240816$20240827$20240827$PER$$US-SA-2024SA247091$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240827$$MD$US$US
242555601$24255560$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247313$SANOFI AVENTIS$$56$YR$A$F$Y$145$KG$20240827$$MD$US$US
242555611$24255561$1$I$20220101$20240816$20240827$20240827$PER$$US-SA-2024SA247407$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240827$$MD$US$US
242555621$24255562$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA248060$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240827$$MD$US$US
242555631$24255563$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247289$SANOFI AVENTIS$$$$T$F$Y$$$20240827$$MD$US$US
242555641$24255564$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247960$SANOFI AVENTIS$$$$A$F$Y$74.8$KG$20240827$$MD$US$US
242555651$24255565$1$I$20240701$20240816$20240827$20240827$PER$$US-SA-2024SA247088$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240827$$MD$US$US
242555671$24255567$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA245959$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240827$$MD$US$US
242555681$24255568$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA247020$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240827$$MD$US$US
242555692$24255569$2$F$$20240816$20240827$20240829$PER$$US-SA-2024SA247320$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240829$$CN$US$US
242555702$24255570$2$F$20240801$20240823$20240827$20240904$PER$$US-SA-2024SA246368$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240904$$CN$US$US
242555711$24255571$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246999$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240827$$MD$US$US
242555721$24255572$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA246302$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240827$$MD$US$US
242555731$24255573$1$I$20240801$20240816$20240827$20240827$PER$$US-SA-2024SA247872$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240827$$MD$US$US
242555741$24255574$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA245804$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240827$$CN$US$US
242555751$24255575$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247453$SANOFI AVENTIS$$$$E$M$Y$81$KG$20240827$$MD$US$US
242555761$24255576$1$I$20240718$20240816$20240827$20240827$PER$$US-SA-2024SA246102$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240827$$CN$US$US
242555771$24255577$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA246971$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240827$$CN$US$US
242555781$24255578$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246538$SANOFI AVENTIS$$$$E$F$Y$$$20240827$$MD$US$US
242555791$24255579$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247469$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240827$$MD$US$US
242555801$24255580$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA247286$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240827$$MD$US$US
242555811$24255581$1$I$20240801$20240816$20240827$20240827$PER$$US-SA-2024SA246763$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240827$$MD$US$US
242555821$24255582$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA246916$SANOFI AVENTIS$$$$$$Y$$$20240827$$HP$US$US
242555831$24255583$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246307$SANOFI AVENTIS$$$$T$M$Y$$$20240827$$MD$US$US
242555841$24255584$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA246752$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240827$$HP$US$US
242555851$24255585$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246783$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240827$$CN$US$US
242555861$24255586$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247060$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240827$$CN$US$US
242555871$24255587$1$I$20240601$20240816$20240827$20240827$PER$$US-SA-2024SA246325$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240827$$MD$US$US
242555882$24255588$2$F$20240101$20240904$20240827$20240916$PER$$US-SA-2024SA247820$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240916$$MD$US$US
242555891$24255589$1$I$20240801$20240816$20240827$20240827$PER$$US-SA-2024SA246764$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240827$$MD$US$US
242555901$24255590$1$I$20240701$20240816$20240827$20240827$PER$$US-SA-2024SA246501$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240827$$MD$US$US
242555913$24255591$3$F$$20240919$20240827$20240930$PER$$US-SA-2024SA247612$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240930$$CN$US$US
242555921$24255592$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249155$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240827$$MD$US$US
242555931$24255593$1$I$20240818$20240818$20240827$20240827$PER$$US-SA-2024SA249270$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240827$$MD$US$US
242555941$24255594$1$I$20240101$20240818$20240827$20240827$PER$$US-SA-2024SA247989$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240827$$MD$US$US
242555951$24255595$1$I$$20240817$20240827$20240827$PER$$US-SA-2024SA247494$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240827$$MD$US$US
242555961$24255596$1$I$20240101$20240818$20240827$20240827$PER$$US-SA-2024SA056753$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240827$$MD$US$US
242555971$24255597$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249108$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240827$$MD$US$US
242555981$24255598$1$I$20240809$20240817$20240827$20240827$PER$$US-SA-2024SA247640$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240827$$MD$US$US
242555991$24255599$1$I$20220301$20240818$20240827$20240827$PER$$US-SA-2024SA247342$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240827$$MD$US$US
242556001$24255600$1$I$20240812$20240819$20240827$20240827$PER$$US-SA-2024SA249939$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240827$$MD$US$US
242556011$24255601$1$I$$20240818$20240827$20240827$PER$$US-SA-2024SA247171$SANOFI AVENTIS$$$$$M$Y$$$20240827$$CN$US$US
242556021$24255602$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA248781$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240827$$MD$US$US
242556031$24255603$1$I$20240801$20240818$20240827$20240827$PER$$US-SA-2024SA248141$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240827$$MD$US$US
242556042$24255604$2$F$$20240818$20240827$20240902$PER$$US-SA-2024SA247380$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240902$$CN$US$US
242556051$24255605$1$I$$20240818$20240827$20240827$PER$$US-SA-2024SA247848$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242556062$24255606$2$F$20240818$20240818$20240827$20240829$PER$$US-SA-2024SA247430$SANOFI AVENTIS$$$$$M$Y$$$20240829$$CN$US$US
242556071$24255607$1$I$20240101$20240817$20240827$20240827$PER$$US-SA-2024SA250374$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240827$$MD$US$US
242556091$24255609$1$I$20240101$20240818$20240827$20240827$PER$$US-SA-2024SA248220$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240827$$MD$US$US
242556101$24255610$1$I$20240601$20240817$20240827$20240827$PER$$US-SA-2024SA248397$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240827$$MD$US$US
242556111$24255611$1$I$20240601$20240819$20240827$20240827$PER$$US-SA-2024SA247931$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240827$$CN$US$US
242556122$24255612$2$F$20240809$20240819$20240827$20240902$PER$$US-SA-2024SA245869$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240902$$MD$US$US
242556131$24255613$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA247835$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240827$$MD$US$US
242556143$24255614$3$F$20240510$20240821$20240827$20240830$PER$$US-SA-2024SA247373$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240830$$CN$US$US
242556151$24255615$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249363$SANOFI AVENTIS$$$$A$M$Y$150.59$KG$20240827$$MD$US$US
242556161$24255616$1$I$20240801$20240821$20240827$20240827$PER$$DE-Eisai-EC-2024-172648$EISAI$$84$YR$E$F$Y$50$KG$20240827$$PH$DE$DE
242556171$24255617$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA247556$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240827$$MD$US$US
242556181$24255618$1$I$20240801$20240819$20240827$20240827$PER$$US-SA-2024SA248602$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240827$$MD$US$US
242556191$24255619$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249210$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240827$$MD$US$US
242556201$24255620$1$I$20240801$20240819$20240827$20240827$PER$$US-SA-2024SA250254$SANOFI AVENTIS$$38$YR$A$F$Y$122$KG$20240827$$MD$US$US
242556211$24255621$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA248822$SANOFI AVENTIS$$59$YR$A$F$Y$77.11$KG$20240827$$MD$US$US
242556221$24255622$1$I$20240101$20240820$20240827$20240827$PER$$US-SA-2024SA249216$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240827$$MD$US$US
242556231$24255623$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249181$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240827$$MD$US$US
242556242$24255624$2$F$20240801$20240821$20240827$20240829$PER$$US-SA-2024SA248595$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240829$$CN$US$US
242556251$24255625$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA250307$SANOFI AVENTIS$$74$YR$E$F$Y$59.42$KG$20240827$$MD$US$US
242556261$24255626$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249368$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240827$$MD$US$US
242556271$24255627$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249526$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240827$$MD$US$US
242556281$24255628$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA247511$SANOFI AVENTIS$$$$$F$Y$$$20240827$$HP$US$US
242556291$24255629$1$I$20240802$20240819$20240827$20240827$PER$$US-SA-2024SA249483$SANOFI AVENTIS$$$$$F$Y$$$20240827$$CN$US$US
242556301$24255630$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA247651$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240827$$MD$US$US
242556311$24255631$1$I$20240401$20240819$20240827$20240827$PER$$US-SA-2024SA249472$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240827$$MD$US$US
242556321$24255632$1$I$20240501$20240819$20240827$20240827$PER$$US-SA-2024SA249732$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240827$$MD$US$US
242556331$24255633$1$I$20240101$20240820$20240827$20240827$PER$$US-SA-2024SA249233$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240827$$CN$US$US
242556341$24255634$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249347$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240827$$MD$US$US
242556351$24255635$1$I$20240701$20240819$20240827$20240827$PER$$US-SA-2024SA249193$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240827$$MD$US$US
242556361$24255636$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249087$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240827$$MD$US$US
242556371$24255637$1$I$20231201$20240819$20240827$20240827$PER$$US-SA-2024SA248759$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240827$$MD$US$US
242556381$24255638$1$I$20240801$20240819$20240827$20240827$PER$$US-SA-2024SA247561$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240827$$MD$US$US
242556391$24255639$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249173$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240827$$MD$US$US
242556401$24255640$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA246643$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240827$$CN$US$US
242556411$24255641$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249422$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240827$$MD$US$US
242556421$24255642$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249581$SANOFI AVENTIS$$$$E$M$Y$79.3$KG$20240827$$MD$US$US
242556431$24255643$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249404$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240827$$CN$US$US
242556441$24255644$1$I$20240101$20240820$20240827$20240827$PER$$US-SA-2024SA249241$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240827$$MD$US$US
242556451$24255645$1$I$20240701$20240820$20240827$20240827$PER$$US-SA-2024SA249236$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240827$$MD$US$US
242556461$24255646$1$I$20240801$20240819$20240827$20240827$PER$$US-SA-2024SA249855$SANOFI AVENTIS$$7$YR$C$F$Y$31.746$KG$20240827$$MD$US$US
242556471$24255647$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58859$$FDA-CTU$$76$YR$$F$N$$$20240827$N$$US$
242556481$24255648$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249952$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240827$$MD$US$US
242556491$24255649$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249821$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240827$$MD$US$US
242556501$24255650$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA248827$SANOFI AVENTIS$$$$E$F$Y$$$20240827$$MD$US$US
242556511$24255651$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249277$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240827$$MD$US$US
242556521$24255652$1$I$20240809$20240819$20240827$20240827$PER$$US-SA-2024SA248249$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240827$$MD$US$US
242556531$24255653$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248826$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$HP$US$US
242556541$24255654$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA247791$SANOFI AVENTIS$$$$$M$Y$$$20240827$$HP$US$US
242556551$24255655$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249322$SANOFI AVENTIS$$$$$F$Y$$$20240827$$CN$US$US
242556561$24255656$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248900$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240827$$MD$US$US
242556571$24255657$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA248811$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240827$$MD$US$US
242556581$24255658$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA250193$SANOFI AVENTIS$$$$E$F$Y$$$20240827$$CN$US$US
242556591$24255659$1$I$20240101$20240826$20240827$20240827$PER$$US-Eisai-EC-2024-172897$EISAI$$66$YR$E$F$Y$70.76$KG$20240827$$CN$US$US
242556601$24255660$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA250001$SANOFI AVENTIS$$$$A$M$Y$94.8$KG$20240827$$MD$US$US
242556611$24255661$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA248847$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240827$$MD$US$US
242556621$24255662$1$I$20240815$20240819$20240827$20240827$PER$$US-SA-2024SA249854$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240827$$MD$US$US
242556631$24255663$1$I$20240101$20240820$20240827$20240827$PER$$US-SA-2024SA249604$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240827$$CN$US$US
242556642$24255664$2$F$$20240920$20240827$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135360$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240923$$CN$US$US
242556651$24255665$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135284$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240827$$CN$US$US
242556661$24255666$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA248799$SANOFI AVENTIS$$7$YR$C$F$Y$26.5$KG$20240827$$MD$US$US
242556671$24255667$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248346$SANOFI AVENTIS$$$$C$F$Y$$$20240827$$MD$US$US
242556681$24255668$1$I$20240101$20240820$20240827$20240827$PER$$US-SA-2024SA249137$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240827$$MD$US$US
242556692$24255669$2$F$$20240821$20240827$20240916$PER$$US-SA-2024SA247957$SANOFI AVENTIS$$25$YR$A$M$Y$79.55$KG$20240916$$HP$US$US
242556701$24255670$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA250287$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240827$$MD$US$US
242556711$24255671$1$I$20240101$20240820$20240827$20240827$PER$$US-SA-2024SA250192$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240827$$MD$US$US
242556721$24255672$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA247479$SANOFI AVENTIS$$$$$F$Y$$$20240827$$HP$US$US
242556731$24255673$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249971$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240827$$MD$US$US
242556741$24255674$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA247987$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240827$$MD$US$US
242556751$24255675$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249834$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240827$$MD$US$US
242556761$24255676$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249723$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240827$$MD$US$US
242556771$24255677$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA247601$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240827$$CN$US$US
242556781$24255678$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA250258$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240827$$MD$US$US
242556791$24255679$1$I$20240817$20240819$20240827$20240827$PER$$US-SA-2024SA248046$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240827$$PH$US$US
242556801$24255680$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248358$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240827$$CN$US$US
242556812$24255681$2$F$20240101$20240821$20240827$20240904$PER$$US-SA-2024SA248760$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240904$$MD$US$US
242556821$24255682$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA248973$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240827$$HP$US$US
242556831$24255683$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248824$SANOFI AVENTIS$$$$$M$Y$$$20240827$$HP$US$US
242556842$24255684$2$F$20240101$20240826$20240827$20240909$PER$$US-SA-2024SA249315$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240909$$MD$US$US
242556851$24255685$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249495$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242556861$24255686$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249014$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240827$$MD$US$US
242556871$24255687$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249103$SANOFI AVENTIS$$$$I$M$Y$$$20240827$$MD$US$US
242556881$24255688$1$I$20240101$20240820$20240827$20240827$PER$$US-SA-2024SA249220$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240827$$MD$US$US
242556891$24255689$1$I$20230101$20240819$20240827$20240827$PER$$US-SA-2024SA249956$SANOFI AVENTIS$$20$YR$A$F$Y$58.967$KG$20240827$$MD$US$US
242556901$24255690$1$I$20240701$20240819$20240827$20240827$PER$$US-SA-2024SA249511$SANOFI AVENTIS$$37$YR$A$F$Y$74.84$KG$20240827$$MD$US$US
242556911$24255691$1$I$$20240821$20240827$20240827$PER$$US-SA-2024SA249552$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240827$$CN$US$US
242556921$24255692$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249366$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240827$$CN$US$US
242556941$24255694$1$I$20240810$20240819$20240827$20240827$PER$$US-SA-2024SA246932$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240827$$CN$US$US
242556951$24255695$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249403$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240827$$MD$US$US
242556961$24255696$1$I$20240807$20240819$20240827$20240827$DIR$FDA-CDER-CTU-2024-58826$$FDA-CTU$$60$YR$$F$N$96.2$KG$20240819$N$$US$
242556971$24255697$1$I$20220408$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58830$$FDA-CTU$$79$YR$$F$N$55.7$KG$20240826$N$$US$
242556981$24255698$1$I$20240101$20240820$20240827$20240827$PER$$US-SA-2024SA249063$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240827$$MD$US$US
242556991$24255699$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248252$SANOFI AVENTIS$$46$YR$A$$Y$$$20240827$$CN$US$US
242557001$24255700$1$I$20240101$20240820$20240827$20240827$PER$$US-SA-2024SA249374$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240827$$MD$US$US
242557011$24255701$1$I$20240801$20240819$20240827$20240827$PER$$US-SA-2024SA248895$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240827$$MD$US$US
242557021$24255702$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249341$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240827$$MD$US$US
242557031$24255703$1$I$20240801$20240819$20240827$20240827$PER$$US-SA-2024SA249391$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240827$$MD$US$US
242557041$24255704$1$I$20240816$20240819$20240827$20240827$PER$$US-SA-2024SA247473$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240827$$MD$US$US
242557051$24255705$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249389$SANOFI AVENTIS$$$$A$F$Y$47$KG$20240827$$MD$US$US
242557061$24255706$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA250261$SANOFI AVENTIS$$$$A$F$Y$80.73$KG$20240827$$MD$US$US
242557071$24255707$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA248829$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240827$$MD$US$US
242557081$24255708$1$I$20230401$20240819$20240827$20240827$PER$$US-SA-2024SA248351$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240827$$MD$US$US
242557091$24255709$1$I$20240817$20240820$20240827$20240827$PER$$US-SA-2024SA248499$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240827$$CN$US$US
242557101$24255710$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA247433$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240827$$MD$US$US
242557111$24255711$1$I$20230101$20240819$20240827$20240827$PER$$US-SA-2024SA247990$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240827$$MD$US$US
242557131$24255713$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249940$SANOFI AVENTIS$$$$A$F$Y$65$KG$20240827$$MD$US$US
242557141$24255714$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248035$SANOFI AVENTIS$$4$YR$C$F$Y$20$KG$20240827$$MD$US$US
242557151$24255715$1$I$$20240823$20240827$20240827$PER$$US-HALEON-2193642$Haleon PLC$$$$$$Y$$$20240827$$CN$US$US
242557161$24255716$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA247487$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240827$$MD$US$US
242557171$24255717$1$I$$20240823$20240827$20240827$EXP$$NVSC2024TR172574$NOVARTIS$Cebisli E, Ulgen-Tekerek N, Dursun O, Koker A, Kisaoglu A, Artan R et al.. Intestinal Mucormycosis in a Child With Maple Syrup Urine Disease After Orthotopic Liver Transplant. EXPERIMENTAL AND CLINICAL TRANSPLANTATION. 2023;21 (4):375-9$3$YR$$F$Y$10$KG$20240827$$HP$TR$TR
242557184$24255718$4$F$20240101$20240923$20240827$20240926$EXP$$CA-PFIZER INC-PV202400109841$PFIZER$$59$YR$$F$Y$$$20240926$$PH$CA$CA
242557202$24255720$2$F$20240813$20240829$20240827$20240902$EXP$$CN-PFIZER INC-PV202400109337$PFIZER$$64$YR$$F$Y$60$KG$20240902$$HP$CN$CN
242557211$24255721$1$I$$20240826$20240827$20240827$EXP$$JP-ABBVIE-5895287$ABBVIE$$30$YR$$$Y$$$20240827$$MD$JP$JP
242557221$24255722$1$I$$20240812$20240827$20240827$EXP$$US-HLS-202400842$HLS THERAPEUTICS$$$$A$M$Y$$$20240827$$MD$US$US
242557231$24255723$1$I$$20240826$20240827$20240827$PER$$US-HALEON-2193750$Haleon PLC$$$$$$Y$$$20240827$$CN$US$US
242557241$24255724$1$I$20231218$20240819$20240827$20240827$EXP$IT-MINISAL02-998637$IT-TEVA-VS-3234646$TEVA$$44$YR$$F$Y$60$KG$20240827$$PH$IT$IT
242557251$24255725$1$I$$20240823$20240827$20240827$EXP$$DE-MYLANLABS-2024M1078303$MYLAN$Groth, Olwen; Roider, Gabriele; Graw, Matthias.. Drug-induced deaths in renal insufficiency. Munchener Medizinische Wochenschrift - Fortschritte der Medizin. 2024;166 (13):48-51$59$YR$$F$Y$$$20240827$$HP$DE$DE
242557261$24255726$1$I$$20240816$20240827$20240827$PER$$US-BIOMARINAP-US-2024-159974$BIOMARIN$$$$$$Y$$$20240827$$CN$US$US
242557272$24255727$2$F$20240820$20240920$20240827$20240926$PER$$US-BIOMARINAP-US-2024-160014$BIOMARIN$$$$$$Y$$$20240926$$CN$US$US
242557281$24255728$1$I$20240701$20240819$20240827$20240827$EXP$DK-DKMA-30737450$DK-TEVA-VS-3234676$TEVA$$48$YR$$F$Y$$$20240827$$MD$DK$DK
242557291$24255729$1$I$$20240819$20240827$20240827$EXP$$US-AstraZeneca-2024A189166$ASTRAZENECA$$$$T$M$Y$63$KG$20240827$$CN$US$
242557302$24255730$2$F$20240801$20240919$20240827$20240924$EXP$$US-BIOMARINAP-US-2024-159989$BIOMARIN$$$$$$Y$$$20240924$$CN$US$US
242557311$24255731$1$I$20240101$20240816$20240827$20240827$PER$$US-SA-2024SA246506$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240827$$MD$US$US
242557323$24255732$3$F$20240101$20240902$20240827$20240930$PER$$US-SA-2024SA245146$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240930$$MD$US$US
242557331$24255733$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246947$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240827$$MD$US$US
242557341$24255734$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA248585$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$HP$US$US
242557351$24255735$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247461$SANOFI AVENTIS$$$$A$M$Y$67$KG$20240827$$MD$US$US
242557361$24255736$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA246614$SANOFI AVENTIS$$$$E$M$Y$$$20240827$$MD$US$US
242557371$24255737$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA246545$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240827$$MD$US$US
242557381$24255738$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA245821$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240827$$PH$US$US
242557391$24255739$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247031$SANOFI AVENTIS$$$$$$Y$$$20240827$$MD$US$US
242557401$24255740$1$I$20240101$20240814$20240827$20240827$PER$$US-SA-2024SA247021$SANOFI AVENTIS$$6$YR$C$M$Y$39$KG$20240827$$MD$US$US
242557411$24255741$1$I$20240801$20240815$20240827$20240827$EXP$$NVSC2024MX167704$NOVARTIS$$50$YR$$M$Y$71$KG$20240827$$CN$MX$MX
242557421$24255742$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA246426$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240827$$CN$US$US
242557431$24255743$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249587$SANOFI AVENTIS$$$$A$F$Y$54$KG$20240827$$MD$US$US
242557441$24255744$1$I$$20240815$20240827$20240827$PER$$US-SA-2024SA247678$SANOFI AVENTIS$$53$YR$A$F$Y$70$KG$20240827$$MD$US$US
242557451$24255745$1$I$20240801$20240820$20240827$20240827$PER$$US-SA-2024SA250369$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240827$$MD$US$US
242557461$24255746$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248756$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240827$$CN$US$US
242557471$24255747$1$I$20240618$20240820$20240827$20240827$PER$$US-SA-2024SA248789$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240827$$MD$US$US
242557481$24255748$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248928$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240827$$CN$US$US
242557491$24255749$1$I$20230101$20240819$20240827$20240827$PER$$US-SA-2024SA249675$SANOFI AVENTIS$$$$E$F$Y$$$20240827$$MD$US$US
242557501$24255750$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248655$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242557512$24255751$2$F$$20240822$20240827$20240904$PER$$US-SA-2024SA248995$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240904$$MD$US$US
242557521$24255752$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA248850$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240827$$MD$US$US
242557531$24255753$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA248835$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240827$$MD$US$US
242557541$24255754$1$I$20240801$20240820$20240827$20240827$PER$$US-SA-2024SA248897$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240827$$MD$US$US
242557551$24255755$1$I$20240701$20240819$20240827$20240827$PER$$US-SA-2024SA249383$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240827$$MD$US$US
242557561$24255756$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249133$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240827$$MD$US$US
242557572$24255757$2$F$20240101$20240904$20240827$20240930$PER$$US-SA-2024SA248772$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240930$$MD$US$US
242557581$24255758$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA248832$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240827$$HP$US$US
242557591$24255759$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA247842$SANOFI AVENTIS$$$$$M$Y$$$20240827$$HP$US$US
242557601$24255760$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249129$SANOFI AVENTIS$$$$A$F$Y$86.1$KG$20240827$$MD$US$US
242557611$24255761$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248947$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240827$$HP$US$US
242557631$24255763$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58916$$FDA-CTU$$62$YR$$F$N$$$20240827$N$$US$
242557641$24255764$1$I$20240801$20240819$20240827$20240827$PER$$US-SA-2024SA249746$SANOFI AVENTIS$$45$YR$A$F$Y$80$KG$20240827$$MD$US$US
242557651$24255765$1$I$20240725$20240819$20240827$20240827$PER$$US-SA-2024SA249562$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240827$$MD$US$US
242557662$24255766$2$F$$20240819$20240827$20240828$PER$$US-SA-2024SA248533$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$CN$US$US
242557672$24255767$2$F$$20240920$20240827$20240925$30DAY$$AU-PFIZER INC-202400237917$PFIZER$$64$YR$$F$Y$$$20240925$$PH$AU$AU
242557681$24255768$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA248013$SANOFI AVENTIS$$$$E$F$Y$$$20240827$$MD$US$US
242557691$24255769$1$I$$20240812$20240827$20240827$EXP$$US-HLS-202400844$HLS THERAPEUTICS$$$$E$$Y$$$20240827$$PH$US$US
242557701$24255770$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249679$SANOFI AVENTIS$$$$E$F$Y$122.45$KG$20240827$$MD$US$US
242557711$24255771$1$I$$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58896$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242557721$24255772$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249943$SANOFI AVENTIS$$$$A$F$Y$87.982$KG$20240827$$MD$US$US
242557731$24255773$1$I$20240601$20240820$20240827$20240827$PER$$US-SA-2024SA248644$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240827$$MD$US$US
242557741$24255774$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA247982$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240827$$MD$US$US
242557752$24255775$2$F$20240819$20240819$20240827$20240902$PER$$US-SA-2024SA247825$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240902$$MD$US$US
242557761$24255776$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249501$SANOFI AVENTIS$$51$YR$A$F$Y$97.506$KG$20240827$$MD$US$US
242557772$24255777$2$F$20240801$20240821$20240827$20240903$PER$$US-SA-2024SA248259$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240903$$CN$US$US
242557781$24255778$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249227$SANOFI AVENTIS$$$$$$Y$$$20240827$$HP$US$US
242557791$24255779$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA247510$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240827$$CN$US$US
242557801$24255780$1$I$20240701$20240819$20240827$20240827$PER$$US-SA-2024SA247255$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240827$$MD$US$US
242557821$24255782$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA248979$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240827$$MD$US$US
242557841$24255784$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248523$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240827$$MD$US$US
242557852$24255785$2$F$20240101$20240826$20240827$20240903$EXP$$JP-009507513-2408JPN003103J$MERCK$$61$YR$$F$Y$$$20240903$$MD$JP$JP
242557861$24255786$1$I$20240601$20240820$20240827$20240827$PER$$US-SA-2024SA249244$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240827$$MD$US$US
242557871$24255787$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA248809$SANOFI AVENTIS$$$$E$F$Y$99.7$KG$20240827$$MD$US$US
242557881$24255788$1$I$20240801$20240820$20240827$20240827$PER$$US-SA-2024SA249285$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240827$$MD$US$US
242557891$24255789$1$I$20170801$20240819$20240827$20240827$PER$$US-SA-2024SA250059$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240827$$MD$US$US
242557901$24255790$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249183$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240827$$MD$US$US
242557911$24255791$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248376$SANOFI AVENTIS$$$$$$Y$$$20240827$$PH$US$US
242557921$24255792$1$I$20230718$20240819$20240827$20240827$EXP$IT-MINISAL02-998614$IT-TEVA-VS-3234725$TEVA$$80$YR$$F$Y$$$20240827$$MD$IT$IT
242557931$24255793$1$I$20240301$20240820$20240827$20240827$PER$$US-SA-2024SA249789$SANOFI AVENTIS$$60$YR$A$M$Y$43.04$KG$20240827$$MD$US$US
242557941$24255794$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249416$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240827$$MD$US$US
242557951$24255795$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248936$SANOFI AVENTIS$$$$$$Y$$$20240827$$HP$US$US
242557961$24255796$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249840$SANOFI AVENTIS$$$$E$F$Y$73.923$KG$20240827$$MD$US$US
242557971$24255797$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249231$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240827$$MD$US$US
242557981$24255798$1$I$20240801$20240819$20240827$20240827$PER$$US-SA-2024SA248853$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240827$$MD$US$US
242557991$24255799$1$I$20240801$20240819$20240827$20240827$PER$$US-SA-2024SA248959$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240827$$MD$US$US
242558002$24255800$2$F$20240101$20240916$20240827$20240924$PER$$US-SA-2024SA249261$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240924$$CN$US$US
242558011$24255801$1$I$20240409$20240819$20240827$20240827$PER$$US-SA-2024SA247996$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240827$$MD$US$US
242558021$24255802$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249635$SANOFI AVENTIS$$48$YR$A$F$Y$79.37$KG$20240827$$MD$US$US
242558031$24255803$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA248790$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240827$$CN$US$US
242558041$24255804$1$I$20240601$20240819$20240827$20240827$PER$$US-SA-2024SA249892$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240827$$MD$US$US
242558051$24255805$1$I$20240801$20240819$20240827$20240827$PER$$US-SA-2024SA248586$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240827$$MD$US$US
242558061$24255806$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249429$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242558071$24255807$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249211$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240827$$MD$US$US
242558081$24255808$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249627$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242558091$24255809$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249487$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240827$$MD$US$US
242558101$24255810$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249283$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240827$$MD$US$US
242558111$24255811$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249405$SANOFI AVENTIS$$$$$$Y$$$20240827$$PH$US$US
242558121$24255812$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA248657$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240827$$CN$US$US
242558131$24255813$1$I$20240818$20240820$20240827$20240827$PER$$US-SA-2024SA248837$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240827$$CN$US$US
242558141$24255814$1$I$20240819$20240819$20240827$20240827$PER$$US-SA-2024SA249201$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240827$$HP$US$US
242558151$24255815$1$I$$20240819$20240827$20240827$PER$$US-009507513-2408USA006671$MERCK$$$$T$$Y$$$20240827$$MD$US$US
242558171$24255817$1$I$$20240820$20240827$20240827$PER$$US-MYLANLABS-2024M1077659$MYLAN$$$$$F$Y$74.84$KG$20240827$$CN$US$US
242558181$24255818$1$I$20240801$20240819$20240827$20240827$EXP$PT-INFARMED-J202408-34$PT-TEVA-VS-3234748$TEVA$$60$YR$$F$Y$$$20240827$$HP$PT$PT
242558193$24255819$3$F$20240701$20240910$20240827$20240925$EXP$$US-SMPA-2024SPA000507$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242558201$24255820$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000542$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558211$24255821$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000324$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558221$24255822$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000526$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558231$24255823$1$I$20240614$20240730$20240827$20240827$PER$$US-SMPA-202406-URV-000914$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558241$24255824$1$I$$20240819$20240827$20240827$EXP$$AU-ABBVIE-5887483$ABBVIE$$36$YR$$F$Y$$$20240827$$MD$AU$AU
242558251$24255825$1$I$20240729$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000568$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558262$24255826$2$F$$20240903$20240827$20240924$PER$$US-SMPA-2024SPA000918$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242558281$24255828$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000576$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558291$24255829$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000543$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558301$24255830$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000703$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558311$24255831$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000435$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558322$24255832$2$F$$20240917$20240827$20240925$PER$$US-SMPA-2024SPA000584$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242558351$24255835$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000528$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558361$24255836$1$I$$20240805$20240827$20240827$PER$$US-SMPA-2024SPA000949$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558382$24255838$2$F$$20240906$20240827$20240920$PER$$US-SMPA-2024SPA000880$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
242558391$24255839$1$I$$20240805$20240827$20240827$PER$$US-SMPA-2024SPA000952$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558411$24255841$1$I$20240127$20240819$20240827$20240827$EXP$ES-AEMPS-1557688$ES-TEVA-VS-3234762$TEVA$$52$YR$$M$Y$98.4$KG$20240827$$MD$ES$ES
242558421$24255842$1$I$20240820$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014208$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240827$$CN$US$US
242558441$24255844$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000579$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558452$24255845$2$F$$20240828$20240827$20240915$PER$$US-SMPA-2024SPA000767$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
242558462$24255846$2$F$$20240823$20240827$20240913$PER$$US-SMPA-2024SPA000731$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
242558472$24255847$2$F$$20240906$20240827$20240923$PER$$US-SMPA-2024SPA000512$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242558481$24255848$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000520$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558491$24255849$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000449$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558501$24255850$1$I$$20240802$20240827$20240827$PER$$US-SMPA-2024SPA000752$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558512$24255851$2$F$$20240820$20240827$20240913$PER$$US-SMPA-2024SPA000783$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
242558531$24255853$1$I$$20240805$20240827$20240827$PER$$US-SMPA-2024SPA000865$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558551$24255855$1$I$$20240731$20240827$20240827$PER$$US-SMPA-2024SPA000613$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558562$24255856$2$F$$20240906$20240827$20240927$PER$$US-SMPA-2024SPA000432$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242558571$24255857$1$I$$20240805$20240827$20240827$PER$$US-SMPA-2024SPA000822$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558581$24255858$1$I$$20240802$20240827$20240827$PER$$US-SMPA-2024SPA000876$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558591$24255859$1$I$$20240805$20240827$20240827$PER$$US-SMPA-2024SPA000907$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558601$24255860$1$I$$20240731$20240827$20240827$PER$$US-SMPA-2024SPA000648$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558611$24255861$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000452$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558622$24255862$2$F$$20240907$20240827$20240927$PER$$US-SMPA-2024SPA000953$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242558641$24255864$1$I$$20240805$20240827$20240827$PER$$US-SMPA-2024SPA000854$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558652$24255865$2$F$$20240803$20240827$20240918$PER$$US-SMPA-2024SPA000807$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
242558661$24255866$1$I$$20240731$20240827$20240827$PER$$US-SMPA-2024SPA000658$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558671$24255867$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000414$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558681$24255868$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000530$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558691$24255869$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000541$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558701$24255870$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000513$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558711$24255871$1$I$$20240731$20240827$20240827$PER$$US-SMPA-2024SPA000615$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558731$24255873$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000535$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558751$24255875$1$I$$20240731$20240827$20240827$PER$$US-SMPA-2024SPA000582$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558761$24255876$1$I$$20240804$20240827$20240827$PER$$US-SMPA-2024SPA000794$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558771$24255877$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000546$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558781$24255878$1$I$$20240805$20240827$20240827$PER$$US-SMPA-2024SPA000847$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558791$24255879$1$I$$20240730$20240827$20240827$PER$$US-SMPA-2024SPA000555$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558811$24255881$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58862$$FDA-CTU$$65$YR$$F$N$$$20240827$N$$US$
242558821$24255882$1$I$$20240805$20240827$20240827$PER$$US-SMPA-2024SPA000886$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558831$24255883$1$I$$20240812$20240827$20240827$EXP$$US-HLS-202400847$HLS THERAPEUTICS$$$$T$$Y$$$20240827$$PH$US$US
242558841$24255884$1$I$20240101$20240804$20240827$20240827$PER$$US-SMPA-2024SPA000793$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558852$24255885$2$F$$20240904$20240827$20240906$EXP$$US-MYLANLABS-2024M1078033$MYLAN$$$$$F$Y$$$20240906$$CN$US$US
242558861$24255886$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249754$SANOFI AVENTIS$$$$A$F$Y$$$20240827$$MD$US$US
242558871$24255887$1$I$20240101$20240822$20240827$20240827$EXP$$US-PFIZER INC-202400242238$PFIZER$$63$YR$$F$Y$$$20240827$$MD$US$US
242558881$24255888$1$I$$20240812$20240827$20240827$EXP$2024R1-440807$CA-SMPA-2024SPA001734$SUNOVION$$$$$$Y$$$20240827$$CN$CA$CA
242558891$24255889$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-58861$$FDA-CTU$$83$YR$$M$N$$$20240827$N$$US$
242558901$24255890$1$I$$20240822$20240827$20240827$EXP$$US-MYLANLABS-2024M1078545$MYLAN$$$$$M$Y$$$20240827$$CN$US$US
242558912$24255891$2$F$$20240812$20240827$20240827$EXP$$US-HLS-202400852$HLS THERAPEUTICS$$$$A$M$Y$$$20240827$$HP$US$US
242558921$24255892$1$I$$20240821$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133620$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240827$$CN$US$US
242558931$24255893$1$I$$20240819$20240827$20240827$PER$$US-009507513-2408USA006672$MERCK$$$$T$$Y$$$20240827$$MD$US$US
242558941$24255894$1$I$20240805$20240814$20240827$20240827$EXP$$US-SMPA-2024SPA001363$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558951$24255895$1$I$$20240814$20240827$20240827$EXP$$US-SMPA-2024SPA001416$SUNOVION$$$$$$Y$$$20240827$$MD$US$US
242558961$24255896$1$I$$20240814$20240827$20240827$EXP$$US-SMPA-2024SPA001499$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242558971$24255897$1$I$$20240823$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135416$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240827$$CN$US$US
242558981$24255898$1$I$20240728$20240813$20240827$20240827$EXP$$JP-SMPA-2024SPA001730$SUNOVION$$$$$$Y$$$20240827$$MD$JP$JP
242558991$24255899$1$I$20240801$20240820$20240827$20240827$PER$$US-SA-2024SA249310$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240827$$MD$US$US
242559001$24255900$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249413$SANOFI AVENTIS$$$$T$F$Y$83.91$KG$20240827$$MD$US$US
242559011$24255901$1$I$$20240820$20240827$20240827$EXP$$FR-PFIZER INC-2018280974$PFIZER$Sarradin, V.. Acute Generalized Exanthematous Pustulosis Induced by Docetaxel and Recurrent With Letrozole: A Case Report. Clinical Breast Cancer. 2018;18 (5):e743-e746$63$YR$$F$Y$$$20240827$$MD$FR$FR
242559021$24255902$1$I$$20240819$20240827$20240827$PER$$US-009507513-2408USA006673$MERCK$$$$T$$Y$$$20240827$$MD$US$US
242559031$24255903$1$I$$20240814$20240827$20240827$EXP$$US-SMPA-2024SPA001503$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242559041$24255904$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400233264$PFIZER$$72$YR$$M$Y$$$20240827$$CN$US$US
242559051$24255905$1$I$20240816$20240823$20240827$20240827$PER$$US-PFIZER INC-202400244078$PFIZER$$51$YR$$F$Y$$$20240827$$HP$US$US
242559061$24255906$1$I$$20240822$20240827$20240827$PER$$US-PFIZER INC-202400242507$PFIZER$$19$YR$$F$Y$$$20240827$$HP$US$US
242559072$24255907$2$F$$20240829$20240827$20240904$PER$$US-PFIZER INC-202400244142$PFIZER$$64$YR$$M$Y$$$20240904$$HP$US$US
242559081$24255908$1$I$20240824$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58846$$FDA-CTU$$18$YR$$F$N$$$20240826$N$HP$US$
242559091$24255909$1$I$$20240812$20240827$20240827$EXP$$US-HLS-202401088$HLS THERAPEUTICS$$$$A$$Y$$$20240827$$PH$US$US
242559101$24255910$1$I$20240101$20240812$20240827$20240827$PER$$US-IMP-2024000622$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242559111$24255911$1$I$$20240820$20240827$20240827$EXP$$BR-PURDUE-USA-2024-0311611$PURDUE$Scorza C A, Finsterer J, Scorza F A;. Takotsubo syndrome is triggered by hypoactive delirium and recognized by increased catecholamine requirement in the ICU. Clinics. 2024;79$60$YR$$F$Y$75$KG$20240827$$HP$BR$BR
242559121$24255912$1$I$$20240812$20240827$20240827$PER$$US-IMP-2024000626$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242559131$24255913$1$I$20240801$20240812$20240827$20240827$PER$$US-IMP-2024000627$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242559141$24255914$1$I$20240101$20240812$20240827$20240827$PER$$US-IMP-2024000628$Harrow Health$$$$A$F$Y$$$20240827$$CN$US$US
242559152$24255915$2$F$$20240912$20240827$20240913$PER$$US-ALXN-202408USA001518US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$HP$US$US
242559161$24255916$1$I$$20240823$20240827$20240827$PER$$US-PURDUE PHARMA-USA-2024-0311577$PURDUE$$$$$$Y$$$20240827$$CN$US$US
242559171$24255917$1$I$$20240826$20240827$20240827$PER$$US-PURDUE-USA-2024-0311621$PURDUE$$$$$F$Y$$$20240827$$CN$US$US
242559181$24255918$1$I$$20240823$20240827$20240827$PER$$US-PURDUE PHARMA-USA-2024-0311576$PURDUE$$$$$$Y$$$20240827$$CN$US$US
242559191$24255919$1$I$$20240823$20240827$20240827$PER$$US-PURDUE PHARMA-USA-2024-0311603$PURDUE$$$$$$Y$$$20240827$$CN$US$US
242559201$24255920$1$I$$20240824$20240827$20240827$PER$$US-PURDUE PHARMA-USA-2024-0311623$PURDUE$$42$YR$$M$Y$$$20240827$$CN$US$US
242559211$24255921$1$I$$20240824$20240827$20240827$PER$$US-PURDUE PHARMA-USA-2024-0311599$PURDUE$$67$YR$$M$Y$$$20240827$$CN$US$US
242559221$24255922$1$I$$20240825$20240827$20240827$PER$$US-PURDUE PHARMA-USA-2024-0311596$PURDUE$$29$YR$$M$Y$$$20240827$$CN$US$US
242559231$24255923$1$I$$20240823$20240827$20240827$PER$$US-PURDUE PHARMA-USA-2024-0311575$PURDUE$$$$$$Y$$$20240827$$CN$US$US
242559241$24255924$1$I$$20240826$20240827$20240827$PER$$US-PURDUE PHARMA-USA-2024-0311597$PURDUE$$$$$M$Y$$$20240827$$CN$US$US
242559251$24255925$1$I$$20240826$20240827$20240827$PER$$US-PURDUE PHARMA-USA-2024-0311598$PURDUE$$$$$M$Y$$$20240827$$CN$US$US
242559262$24255926$2$F$$20240828$20240827$20240829$PER$$US-PURDUE PHARMA-USA-2024-0311622$PURDUE$$79$YR$$F$Y$$$20240829$$CN$US$US
242559271$24255927$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172948$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242559301$24255930$1$I$$20240812$20240827$20240827$EXP$$US-HLS-202400853$HLS THERAPEUTICS$$28$YR$A$F$Y$$$20240827$$PH$US$US
242559311$24255931$1$I$$20240820$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133492$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240827$$MD$US$US
242559321$24255932$1$I$$20240813$20240827$20240827$PER$$US-IMP-2024000630$Harrow Health$$$$A$F$Y$$$20240827$$CN$US$US
242559331$24255933$1$I$$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134168$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240827$$CN$US$US
242559341$24255934$1$I$20240101$20240814$20240827$20240827$PER$$US-IMP-2024000634$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242559351$24255935$1$I$20240601$20240814$20240827$20240827$PER$$US-IMP-2024000637$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242559371$24255937$1$I$$20240814$20240827$20240827$PER$$US-IMP-2024000636$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242559382$24255938$2$F$$20240826$20240827$20240828$PER$$NVSC2024US172750$NOVARTIS$$29$YR$$F$Y$$$20240828$$HP$US$US
242559391$24255939$1$I$$20240820$20240827$20240827$PER$$US-SA-2024SA249312$SANOFI AVENTIS$$91$YR$E$M$Y$$$20240827$$MD$US$US
242559401$24255940$1$I$$20240815$20240827$20240827$PER$$US-APELLIS-2024-APL-0000755$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240827$$CN$US$US
242559421$24255942$1$I$20240821$20240821$20240827$20240827$PER$$US-ALXN-202408USA001519US$ALEXION PHARMACEUTICALS$$83$YR$$F$Y$$$20240827$$CN$US$US
242559431$24255943$1$I$20240101$20240814$20240827$20240827$PER$$US-IMP-2024000635$Harrow Health$$$$$F$Y$$$20240827$$CN$US$US
242559441$24255944$1$I$$20240814$20240827$20240827$PER$$US-IMP-2024000638$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242559452$24255945$2$F$20240719$20240911$20240827$20240918$EXP$$JP-009507513-2408JPN002507J$MERCK$$64$YR$$F$Y$$$20240918$$MD$JP$JP
242559461$24255946$1$I$20240101$20240814$20240827$20240827$PER$$US-IMP-2024000645$Harrow Health$$$$E$M$Y$$$20240827$$CN$US$US
242559471$24255947$1$I$$20240812$20240827$20240827$EXP$$US-RADIUS HEALTH INC.-2024US006386$RADIUS PHARM$$$$$F$Y$$$20240827$$CN$US$US
242559482$24255948$2$F$$20240826$20240827$20240902$EXP$$JP-009507513-2408JPN003101J$MERCK$$$$$F$Y$$$20240902$$MD$JP$JP
242559491$24255949$1$I$20190628$20240823$20240827$20240827$EXP$$CN-PFIZER INC-PV202400110612$PFIZER$$75$YR$$F$Y$47$KG$20240827$$HP$CN$CN
242559501$24255950$1$I$$20240710$20240827$20240827$PER$$US-IMP-2024000493$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242559512$24255951$2$F$20230701$20240828$20240827$20240904$EXP$$US-ABBVIE-5890926$ABBVIE$$51$YR$$F$Y$76$KG$20240904$$CN$US$US
242559521$24255952$1$I$$20240822$20240827$20240827$EXP$$JP-009507513-2408JPN002966J$MERCK$$7$DEC$$M$Y$$$20240827$$MD$JP$JP
242559531$24255953$1$I$$20240822$20240827$20240827$EXP$$JP-009507513-2408JPN002929J$MERCK$$6$DEC$$M$Y$$$20240827$$MD$JP$JP
242559541$24255954$1$I$$20240826$20240827$20240827$PER$$US-ROCHE-10000067134$ROCHE$$4$YR$C$M$Y$$$20240827$$CN$US$US
242559551$24255955$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5893788$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242559562$24255956$2$F$20240712$20240906$20240827$20240910$EXP$$FR-009507513-2408FRA003914$MERCK$$40$YR$$M$Y$93$KG$20240910$$MD$FR$FR
242559571$24255957$1$I$$20240815$20240827$20240827$PER$$US-ABBVIE-5884028$ABBVIE$$$$$$Y$$$20240827$$CN$US$US
242559581$24255958$1$I$$20240814$20240827$20240827$PER$$US-IMP-2024000643$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242559591$24255959$1$I$20240101$20240815$20240827$20240827$PER$$US-IMP-2024000644$Harrow Health$$$$A$F$Y$$$20240827$$CN$US$US
242559601$24255960$1$I$20240729$20240816$20240827$20240827$PER$$US-009507513-2408USA006151$MERCK$$$$$$Y$$$20240827$$CN$US$US
242559611$24255961$1$I$$20240822$20240827$20240827$EXP$$PL-009507513-2408POL008582$MERCK$$39$YR$$F$Y$$$20240827$$MD$PL$PL
242559621$24255962$1$I$20240101$20240817$20240827$20240827$PER$$US-IMP-2024000650$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242559632$24255963$2$F$20240801$20240829$20240827$20240912$PER$$US-IMP-2024000651$Harrow Health$$94$YR$E$F$Y$$$20240912$$CN$US$US
242559651$24255965$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135849$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240827$$CN$US$US
242559661$24255966$1$I$20240101$20240819$20240827$20240827$PER$$US-IMP-2024000652$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242559671$24255967$1$I$$20240819$20240827$20240827$PER$$US-IMP-2024000654$Harrow Health$$$$E$F$Y$$$20240827$$CN$US$US
242559681$24255968$1$I$$20240813$20240827$20240827$PER$$US-INCYTE CORPORATION-2024IN008490$INCYTE$$$$$$Y$$$20240827$$CN$US$US
242559691$24255969$1$I$$20240711$20240827$20240827$PER$$US-IMP-2024000498$Harrow Health$$$$A$M$Y$$$20240827$$CN$US$US
242559701$24255970$1$I$$20240821$20240827$20240827$PER$$US-ALXN-202408USA001610US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242559711$24255971$1$I$$20240819$20240827$20240827$EXP$$JP-009507513-2408JPN002456J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$86$YR$$F$Y$$$20240827$$MD$JP$JP
242559721$24255972$1$I$20231201$20240825$20240827$20240827$EXP$$IL-TAKEDA-2024TUS086242$TAKEDA$$81$YR$$M$Y$$$20240827$$CN$IL$IL
242559731$24255973$1$I$20240827$20240827$20240827$20240827$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048090$BOEHRINGER INGELHEIM$$75$YR$E$$Y$$$20240827$$CN$US$US
242559741$24255974$1$I$$20240826$20240827$20240827$PER$$NVSC2024US172969$NOVARTIS$$$$$F$Y$$$20240827$$CN$US$US
242559752$24255975$2$F$20240614$20240714$20240827$20240827$PER$$US-IMP-2024000500$Harrow Health$$76$YR$E$F$Y$$$20240827$$CN$US$US
242559761$24255976$1$I$$20240823$20240827$20240827$PER$$US-JNJFOC-20240860754$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$PH$US$US
242559771$24255977$1$I$$20240815$20240827$20240827$PER$$US-JNJFOC-20240868495$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$HP$US$US
242559781$24255978$1$I$$20240822$20240827$20240827$PER$$US-ALXN-202408USA001568US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240827$$PH$US$US
242559791$24255979$1$I$$20240816$20240827$20240827$PER$$US-JNJFOC-20240866790$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240827$$HP$US$US
242559801$24255980$1$I$$20240816$20240827$20240827$PER$$US-JNJFOC-20240865566$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$HP$US$US
242559811$24255981$1$I$20240730$20240816$20240827$20240827$PER$$US-JNJFOC-20240866251$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240827$$MD$US$US
242559821$24255982$1$I$$20240821$20240827$20240827$PER$$US-BIOGEN-2024BI01279433$BIOGEN$$$$$M$Y$$$20240827$$CN$US$US
242559831$24255983$1$I$$20240819$20240827$20240827$PER$$US-JNJFOC-20240870100$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$CN$US$US
242559841$24255984$1$I$$20240715$20240827$20240827$PER$$US-IMP-2024000516$Harrow Health$$$$A$F$Y$$$20240827$$CN$US$US
242559851$24255985$1$I$$20240822$20240827$20240827$PER$$US-ALXN-202408USA001608US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242559861$24255986$1$I$$20240822$20240827$20240827$PER$$US-ALXN-202408USA001584US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240827$$HP$US$US
242559871$24255987$1$I$$20240703$20240827$20240827$PER$$US-BAUSCHBL-2023BNL001260$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240827$$CN$US$US
242559881$24255988$1$I$$20240819$20240827$20240827$PER$$US-BIOGEN-2024BI01279094$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
242559891$24255989$1$I$$20240823$20240827$20240827$PER$$US-JNJFOC-20240865567$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240827$$HP$US$US
242559901$24255990$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015785$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240827$$CN$US$US
242559911$24255991$1$I$$20240822$20240827$20240827$PER$$US-ALXN-202408USA001607US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242559932$24255993$2$F$$20240716$20240827$20240827$PER$$US-IMP-2024000528$Harrow Health$$$$E$F$Y$$$20240827$$PH$US$US
242559942$24255994$2$F$20240719$20240910$20240827$20240917$EXP$$JP-ASTELLAS-2024-AER-001756$ASTELLAS$$$$$F$Y$$$20240917$$PH$JP$JP
242559961$24255996$1$I$20240811$20240812$20240827$20240827$EXP$$US-ASTELLAS-2024-AER-000164$ASTELLAS$$72$YR$E$M$Y$68$KG$20240827$$CN$US$US
242559971$24255997$1$I$20161101$20240703$20240827$20240827$PER$$US-BAUSCHBL-BL-2016-030166$BAUSCH AND LOMB$$85$YR$$F$Y$56.296$KG$20240827$$CN$US$US
242559991$24255999$1$I$20210101$20240703$20240827$20240827$PER$$US-BAUSCHBL-BL-2021-042108$BAUSCH AND LOMB$$$$E$F$Y$$$20240827$$CN$US$US
242560001$24256000$1$I$20170518$20240703$20240827$20240827$PER$$US-BAUSCHBL-BL-2017-018315$BAUSCH AND LOMB$$8$DEC$$F$Y$$$20240827$$CN$US$US
242560011$24256001$1$I$$20240821$20240827$20240827$EXP$$IE-BIOMARINAP-IE-2024-160057$BIOMARIN$$$$$$Y$$$20240827$$CN$IE$IE
242560021$24256002$1$I$$20240819$20240827$20240827$PER$$US-BIOGEN-2024BI01278808$BIOGEN$$$$$M$Y$$$20240827$$CN$US$US
242560031$24256003$1$I$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016585$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240827$$CN$US$US
242560051$24256005$1$I$20240101$20240823$20240827$20240827$EXP$$US-ABBVIE-5894360$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242560061$24256006$1$I$$20240819$20240827$20240827$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-135768$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$70$KG$20240827$$HP$CA$CA
242560071$24256007$1$I$20240801$20240820$20240827$20240827$PER$$US-JNJFOC-20240852027$JOHNSON AND JOHNSON$$$$$M$Y$$$20240827$$CN$US$US
242560082$24256008$2$F$$20240909$20240827$20240912$PER$$US-ALXN-202408USA001614US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
242560091$24256009$1$I$$20240812$20240827$20240827$EXP$$US-HLS-202400869$HLS THERAPEUTICS$Robin Bouttelgier. Deep brain stimulation for essential tremor in patients with ventriculomega. Surg Neurol Int.. 2024;15:249$69$YR$E$F$Y$$$20240827$$$COUNTRY NOT SPECIFIED$US
242560101$24256010$1$I$20240101$20240812$20240827$20240827$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1247$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240827$$MD$US$US
242560111$24256011$1$I$20240101$20240820$20240827$20240827$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-013549$JAZZ$$58$YR$$M$Y$$$20240827$$MD$JP$JP
242560121$24256012$1$I$$20240812$20240827$20240827$EXP$$US-HLS-202400867$HLS THERAPEUTICS$Robin Bouttelgier. Deep brain stimulation for essential tremor in patients with ventriculomega. Surg Neurol Int.. 2024;15:249$72$YR$E$F$Y$$$20240827$$$COUNTRY NOT SPECIFIED$US
242560131$24256013$1$I$$20240826$20240827$20240827$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047975$BOEHRINGER INGELHEIM$$$$$$Y$$$20240827$$CN$US$US
242560141$24256014$1$I$$20240812$20240827$20240827$EXP$$US-HLS-202400525$HLS THERAPEUTICS$$33$YR$A$$Y$$$20240827$$PH$US$US
242560151$24256015$1$I$$20240819$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131476$BRISTOL MYERS SQUIBB$Ghous G, Shoukat H, Tarar Z, Zafar M, McGreevy JW. Encephalitis associated with hemophagocytic lymphohistiocytosis secondary to immune checkpoint inhibitors: an unfamiliar spin-off. Cureus. 2021 Jun 30;13(6):1-8. doi:10.7759/cureus.16079.$33$YR$A$M$Y$$$20240827$$HP$US$US
242560162$24256016$2$F$20240815$20240917$20240827$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202408012303$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240925$$CN$US$US
242560171$24256017$1$I$20221023$20240819$20240827$20240827$EXP$$KR-009507513-2408KOR005896$MERCK$$$$$F$Y$68.7$KG$20240827$$HP$KR$KR
242560181$24256018$1$I$$20240812$20240827$20240827$EXP$$US-HLS-202400850$HLS THERAPEUTICS$$$$A$M$Y$$$20240827$$MD$US$US
242560191$24256019$1$I$$20240822$20240827$20240827$EXP$$JP-009507513-2408JPN002925J$MERCK$$7$DEC$$M$Y$$$20240827$$MD$JP$JP
242560201$24256020$1$I$20240803$20240819$20240827$20240827$PER$$US-AMGEN-USASP2024166814$AMGEN$$50$YR$A$F$Y$$$20240827$$CN$US$US
242560211$24256021$1$I$$20240819$20240827$20240827$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-132422$BRISTOL MYERS SQUIBB$Sohail S, Farah G. Type 3c diabetes secondary to immunotherapy. British Journal of Diabetes. 2024 Jun 01;24(1):5.$71$YR$E$M$Y$$$20240827$$HP$GB$GB
242560222$24256022$2$F$20070101$20240904$20240827$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-030074$JAZZ$$$$$F$Y$$$20240906$$MD$US$US
242560231$24256023$1$I$$20240820$20240827$20240827$EXP$$PT-009507513-2408PRT008270$MERCK$Alves A.. NEFRITE TUBULO-INTERSTICIAL AGUDA ASSOCIADA A PEMBROLIZUMAB.. 30 CNMI Congresso Nacional de Medicina Interna - Livro de Resumos. 2024;433$58$YR$$M$Y$$$20240827$$MD$PT$PT
242560241$24256024$1$I$$20240826$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408016618$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240827$$CN$US$US
242560253$24256025$3$F$20240820$20240916$20240827$20240930$EXP$$IT-APELLIS-2024-APL-0000844$APELLIS PHARMACEUTICALS$$$$$$Y$84$KG$20240930$$MD$IT$IT
242560261$24256026$1$I$$20240813$20240827$20240827$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08219$NEUROCRINE BIOSCIENCES$$4$DEC$$F$Y$$$20240827$$HP$US$US
242560271$24256027$1$I$20240827$20240827$20240827$20240827$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048118$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240827$$CN$US$US
242560281$24256028$1$I$20240719$20240814$20240827$20240827$EXP$$US-FMCRTG-FMC-2408-001011$FRESENIUS MEDICAL CARE$$54$YR$A$M$Y$$$20240827$$HP$US$US
242560291$24256029$1$I$$20240805$20240827$20240827$PER$$US-FMCRTG-FMC-2408-000953$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240827$$HP$US$US
242560301$24256030$1$I$$20240805$20240827$20240827$PER$$US-FMCRTG-FMC-2408-000947$FRESENIUS MEDICAL CARE$$76$YR$E$M$Y$74$KG$20240827$$HP$US$US
242560311$24256031$1$I$20240801$20240815$20240827$20240827$EXP$$US-FMCRTG-FMC-2408-001007$FRESENIUS MEDICAL CARE$$79$YR$E$F$Y$104$KG$20240827$$HP$US$US
242560321$24256032$1$I$$20240814$20240827$20240827$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08237$NEUROCRINE BIOSCIENCES$$4$DEC$$F$Y$$$20240827$$HP$US$US
242560331$24256033$1$I$$20240814$20240827$20240827$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08238$NEUROCRINE BIOSCIENCES$$51$YR$$M$Y$$$20240827$$HP$US$US
242560341$24256034$1$I$$20240814$20240827$20240827$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08239$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240827$$PH$US$US
242560351$24256035$1$I$$20240814$20240827$20240827$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08169$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240827$$HP$US$US
242560361$24256036$1$I$20240827$20240827$20240827$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048122$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240827$$CN$US$US
242560371$24256037$1$I$20240601$20240822$20240827$20240827$EXP$$JP-009507513-2408JPN002851J$MERCK$$79$YR$$F$Y$$$20240827$$MD$JP$JP
242560381$24256038$1$I$$20240814$20240827$20240827$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08204$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240827$$HP$US$US
242560391$24256039$1$I$$20240815$20240827$20240827$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08209$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240827$$HP$US$US
242560401$24256040$1$I$$20240823$20240827$20240827$PER$$US-JNJFOC-20240861728$JOHNSON AND JOHNSON$$$$$$Y$$$20240827$$HP$US$US
242560411$24256041$1$I$20240813$20240820$20240827$20240827$EXP$$US-Bion-013737$BIONPHARMA$$58$YR$A$F$Y$$$20240828$$CN$US$US
242560421$24256042$1$I$$20240826$20240827$20240827$EXP$$DE-SANDOZ INC.-NVSC2020DE275975$SANDOZ$$32$YR$$F$Y$$$20240827$$MD$DE$DE
242560431$24256043$1$I$20240816$20240820$20240827$20240827$EXP$$CN-JNJFOC-20240854740$JOHNSON AND JOHNSON$$21$YR$A$F$Y$55.2$KG$20240828$$HP$CN$CN
242560441$24256044$1$I$20240801$20240820$20240827$20240827$PER$$US-AMGEN-USASP2024166956$AMGEN$$76$YR$E$F$Y$$$20240827$$CN$US$US
242560451$24256045$1$I$20240811$20240812$20240827$20240827$EXP$$US-009507513-2408USA004069$MERCK$$69$YR$$F$Y$$$20240827$$PH$US$US
242560461$24256046$1$I$$20240822$20240827$20240827$EXP$$JP-009507513-2408JPN003099J$MERCK$$59$YR$$F$Y$$$20240827$$MD$JP$JP
242560472$24256047$2$F$$20240823$20240827$20240827$30DAY$$US-SANDOZ INC.-SDZ2024US075060$SANDOZ$$$$$F$Y$$$20240827$$CN$US$US
242560481$24256048$1$I$20240813$20240813$20240827$20240827$EXP$$US-HLS-202400891$HLS THERAPEUTICS$$63$YR$A$M$Y$$$20240827$$HP$US$US
242560491$24256049$1$I$$20240822$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US074631$SANDOZ$$64$YR$$F$Y$$$20240827$$MD$US$US
242560511$24256051$1$I$$20240820$20240827$20240827$EXP$$US-ARGENX-2024-ARGX-US007041$ARGENX BVBA$$$$$$Y$$$20240827$$CN$US$US
242560521$24256052$1$I$$20240827$20240827$20240827$PER$$NVSC2024US173079$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242560531$24256053$1$I$$20240823$20240827$20240827$EXP$$US-JNJFOC-20240865344$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242560541$24256054$1$I$$20240823$20240827$20240827$EXP$$GB-SANDOZ INC.-SDZ2024GB037750$SANDOZ$$75$YR$$F$Y$$$20240827$$CN$GB$GB
242560551$24256055$1$I$20240821$20240821$20240827$20240827$PER$$US-TPU-TPU-2024-00448$TEIKOKU$$76$YR$E$F$Y$$$20240828$$CN$US$US
242560561$24256056$1$I$$20240820$20240827$20240827$PER$$US-TPU-TPU-2024-00445$TEIKOKU$$$$$F$Y$$$20240828$$CN$US$US
242560572$24256057$2$F$20240101$20240910$20240827$20240918$EXP$$CA-JNJFOC-20240534225$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240918$$CN$CA$CA
242560581$24256058$1$I$$20240820$20240827$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134460$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$MD$JP$JP
242560591$24256059$1$I$$20240821$20240827$20240827$EXP$$US-HLS-202401016$HLS THERAPEUTICS$$$$A$$Y$$$20240827$$HP$US$US
242560601$24256060$1$I$$20240827$20240827$20240827$PER$$NVSC2024US173077$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242560611$24256061$1$I$$20240827$20240827$20240827$PER$$NVSC2024US173081$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242560621$24256062$1$I$$20240824$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075292$SANDOZ$$$$$$Y$$$20240827$$CN$US$US
242560632$24256063$2$F$20240801$20240830$20240827$20240902$PER$$US-AMGEN-USASP2024170033$AMGEN$$77$YR$E$F$Y$$$20240902$$CN$US$US
242560641$24256064$1$I$$20240822$20240827$20240827$EXP$$CA-HLS-202402127$HLS THERAPEUTICS$$$$E$F$Y$$$20240827$$PH$CA$CA
242560651$24256065$1$I$$20240827$20240827$20240827$PER$$NVSC2024US173078$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242560663$24256066$3$F$20230101$20240828$20240827$20240906$EXP$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-134544$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-134544$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240906$$CN$DE$DE
242560671$24256067$1$I$20240814$20240815$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010118$ELI LILLY AND CO$$1$YR$I$M$Y$$$20240827$$CN$US$US
242560681$24256068$1$I$$20240816$20240827$20240827$EXP$GB-MHRA-MED-202408161458552540-MQFPH$GB-ELI_LILLY_AND_COMPANY-GB202408011208$ELI LILLY AND CO$$$$$$Y$$$20240827$$CN$GB$GB
242560691$24256069$1$I$20240701$20240815$20240827$20240827$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202408010144$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240827$$MD$AE$AE
242560701$24256070$1$I$$20240815$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009780$ELI LILLY AND CO$$$$A$F$Y$$$20240827$$CN$US$US
242560721$24256072$1$I$20240130$20240815$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010767$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240827$$CN$US$US
242560731$24256073$1$I$20240601$20240815$20240827$20240827$EXP$GB-MHRA-MED-202408150840570970-LVYHR$GB-ELI_LILLY_AND_COMPANY-GB202408010247$ELI LILLY AND CO$$43$YR$A$F$Y$90$KG$20240827$$CN$GB$GB
242560741$24256074$1$I$$20240821$20240827$20240827$EXP$$US-JNJFOC-20240854572$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242560751$24256075$1$I$$20240819$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011290$ELI LILLY AND CO$Muddasani R.,Talwar N.,Mambetsariev I.,Fricke J.,Lin M.,Schmolze D.,Yue A.,Rizvi A.,Salgia R..Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series..Cancer Immunology, Immunotherapy 2024;73(10):.DOI:https://doi.org/10.1007/s00262-024-03775-6$60$YR$A$F$Y$$$20240827$$HP$US$US
242560761$24256076$1$I$$20240815$20240827$20240827$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009761$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240827$$CN$US$US
242560771$24256077$1$I$$20240821$20240827$20240827$EXP$$US-JNJFOC-20240855059$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$HP$US$US
242560791$24256079$1$I$20240314$20240819$20240827$20240827$EXP$$AU-009507513-2408AUS008331$MERCK$$23$YR$$F$Y$$$20240827$$HP$AU$AU
242560801$24256080$1$I$$20240816$20240827$20240827$PER$$US-SA-2024SA247905$SANOFI AVENTIS$$$$$$Y$$$20240828$$HP$US$US
242560812$24256081$2$F$20240501$20240917$20240827$20240924$EXP$$JP-GSK-JP2024JPN061376$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
242560822$24256082$2$F$20240610$20240919$20240827$20240925$EXP$$CA-JNJFOC-20240680251$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240925$$HP$CA$CA
242560831$24256083$1$I$$20240822$20240827$20240827$EXP$$JP-SA-2024SA248986$SANOFI AVENTIS$$$$$$Y$$$20240828$$MD$JP$JP
242560841$24256084$1$I$$20240823$20240827$20240827$EXP$$NVSJ2024JP009981$NOVARTIS$$$$E$M$Y$$$20240828$$MD$JP$JP
242560852$24256085$2$F$$20240820$20240827$20240906$EXP$$US-ABBVIE-5894876$ABBVIE$Preliminary safety and efficacy of BOVEN (Zanubrutinib, Obinutuzumab, and Venetoclax) for frontline therapy for older patients with mantle cell lymphoma [Abstract number: P1138]. . European Hematology Association. . 2024; -$$$$$Y$$$20240906$$HP$US$US
242560861$24256086$1$I$20240101$20240819$20240827$20240827$PER$$US-SA-2024SA249019$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240828$$MD$US$US
242560871$24256087$1$I$$20240817$20240827$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-132736$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240828$$MD$JP$JP
242560881$24256088$1$I$$20240819$20240827$20240827$EXP$$CA-APOTEX-2024AP009568$APOTEX$$64$YR$$F$Y$$$20240827$$CN$CA$CA
242560891$24256089$1$I$20240827$20240827$20240827$20240827$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048106$BOEHRINGER INGELHEIM$$76$YR$E$$Y$$$20240828$$HP$US$US
242560901$24256090$1$I$$20240819$20240827$20240827$PER$$US-BIOGEN-2024BI01279522$BIOGEN$$$$$M$Y$$$20240827$$CN$US$US
242560911$24256091$1$I$$20240827$20240827$20240827$EXP$$MX-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048101$BOEHRINGER INGELHEIM$$92$YR$E$F$Y$$$20240828$$MD$MX$MX
242560921$24256092$1$I$20160101$20240820$20240827$20240827$EXP$$US-JNJFOC-20240869272$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240828$$CN$US$US
242560931$24256093$1$I$20240101$20240822$20240827$20240827$EXP$$GB-ABBVIE-5891595$ABBVIE$$$$A$M$Y$$$20240827$$CN$GB$GB
242560941$24256094$1$I$20240601$20240822$20240827$20240827$EXP$$NVSJ2024JP009931$NOVARTIS$$$$$$Y$$$20240828$$MD$JP$JP
242560962$24256096$2$F$20240101$20240826$20240827$20240830$EXP$$ES-ABBVIE-5892044$ABBVIE$$$$$F$Y$$$20240830$$CN$ES$ES
242560981$24256098$1$I$$20240821$20240827$20240827$EXP$$CA-JNJFOC-20240854899$JOHNSON AND JOHNSON$$63$YR$A$F$Y$54$KG$20240828$$HP$CA$CA
242560991$24256099$1$I$20240101$20240822$20240827$20240827$EXP$$US-ABBVIE-5891750$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242561002$24256100$2$F$20240503$20240904$20240827$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US046398$SANDOZ$$61$YR$$F$Y$$$20240909$$CN$US$US
242561011$24256101$1$I$$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014932$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240827$$CN$US$US
242561021$24256102$1$I$20240808$20240822$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015135$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240827$$CN$US$US
242561032$24256103$2$F$20240214$20240903$20240827$20240910$EXP$$CL-JNJFOC-20240316088$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240911$$CN$CL$CL
242561041$24256104$1$I$$20240821$20240827$20240827$EXP$$NVSC2024JP172825$NOVARTIS$$33$YR$$$Y$$$20240828$$MD$JP$JP
242561053$24256105$3$F$20240801$20240830$20240827$20240902$EXP$$NVSJ2024JP010029$NOVARTIS$$$$$M$Y$$$20240903$$MD$JP$JP
242561061$24256106$1$I$20230809$20240820$20240827$20240827$EXP$$US-009507513-2408USA007047$MERCK$$66$YR$$M$Y$$$20240827$$CN$US$US
242561072$24256107$2$F$$20240828$20240827$20240902$PER$$US-ALXN-202408USA001576US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240902$$MD$US$US
242561081$24256108$1$I$$20240822$20240827$20240827$EXP$$US-JNJFOC-20240862475$JOHNSON AND JOHNSON$$$$$M$Y$$$20240828$$CN$US$US
242561091$24256109$1$I$20240820$20240821$20240827$20240827$EXP$$CN-ABBVIE-5890161$ABBVIE$$78$YR$$F$Y$46$KG$20240827$$MD$CN$CN
242561101$24256110$1$I$20231201$20240821$20240827$20240827$EXP$$US-ABBVIE-5890819$ABBVIE$$74$YR$$F$Y$$$20240827$$CN$US$US
242561111$24256111$1$I$20240101$20240822$20240827$20240827$EXP$$CA-ABBVIE-5892857$ABBVIE$$59$YR$$F$Y$$$20240827$$CN$CA$CA
242561121$24256112$1$I$20240801$20240822$20240827$20240827$EXP$$US-ABBVIE-5856610$ABBVIE$$67$YR$$M$Y$$$20240827$$CN$US$US
242561131$24256113$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5893734$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242561141$24256114$1$I$20210101$20240823$20240827$20240827$EXP$$AR-ABBVIE-5895988$ABBVIE$$$$$M$Y$$$20240827$$CN$AR$AR
242561151$24256115$1$I$$20240821$20240827$20240827$PER$$US-JNJFOC-20240855079$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$PH$US$US
242561181$24256118$1$I$$20240822$20240827$20240827$EXP$$US-ABBVIE-5893249$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242561191$24256119$1$I$$20240821$20240827$20240827$EXP$$CA-ABBVIE-5864296$ABBVIE$$$$A$F$Y$$$20240827$$CN$CA$CA
242561211$24256121$1$I$20240824$20240826$20240827$20240827$EXP$$US-ABBVIE-5896814$ABBVIE$$83$YR$$F$Y$$$20240827$$CN$US$US
242561221$24256122$1$I$$20240818$20240827$20240827$PER$$US-ABBVIE-5888662$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242561231$24256123$1$I$$20240820$20240827$20240827$EXP$$US-BIOGEN-2024BI01278372$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
242561241$24256124$1$I$20240722$20240821$20240827$20240827$EXP$$AE-ABBVIE-5894002$ABBVIE$$$$N$M$Y$2.9$KG$20240827$$CN$AE$AE
242561251$24256125$1$I$20240101$20240821$20240827$20240827$EXP$$US-ABBVIE-5873149$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242561262$24256126$2$F$$20240809$20240827$20240829$PER$$US-TEVA-VS-3232236$TEVA$$$$$M$Y$$$20240829$$CN$US$US
242561271$24256127$1$I$20240101$20240823$20240827$20240827$EXP$$US-ABBVIE-5894309$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242561282$24256128$2$F$$20240827$20240827$20240831$PER$$US-AMGEN-USASP2024170749$AMGEN$$$$$F$Y$$$20240831$$HP$US$US
242561291$24256129$1$I$$20240827$20240827$20240827$PER$$NVSC2024US173067$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
242561301$24256130$1$I$20240726$20240823$20240827$20240827$PER$$US-AMGEN-USASP2024169585$AMGEN$$21$YR$A$F$Y$$$20240827$$HP$US$US
242561311$24256131$1$I$$20240826$20240827$20240827$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048153$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240828$$MD$US$US
242561321$24256132$1$I$$20240826$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US061287$SANDOZ$$$$$$Y$$$20240827$$CN$US$US
242561333$24256133$3$F$$20240912$20240827$20240914$EXP$$BG-ABBVIE-5891186$ABBVIE$$84$YR$$M$Y$$$20240914$$HP$BG$BG
242561341$24256134$1$I$20240201$20240822$20240827$20240827$EXP$FR-AFSSAPS-BX2024001668$FR-PFIZER INC-202400241692$PFIZER$$66$YR$$M$Y$68$KG$20240827$$MD$FR$FR
242561351$24256135$1$I$20240801$20240822$20240827$20240827$EXP$$US-PFIZER INC-202400184704$PFIZER$$75$YR$$F$Y$$$20240827$$CN$US$US
242561361$24256136$1$I$20240810$20240821$20240827$20240827$EXP$$CN-PFIZER INC-PV202400109374$PFIZER$$43$YR$$F$Y$64$KG$20240827$$HP$CN$CN
242561371$24256137$1$I$20240811$20240821$20240827$20240827$EXP$$CN-PFIZER INC-PV202400109341$PFIZER$$69$YR$$M$Y$58$KG$20240827$$HP$CN$CN
242561381$24256138$1$I$20240726$20240821$20240827$20240827$EXP$$CN-PFIZER INC-PV202400109351$PFIZER$$31$YR$$M$Y$77.3$KG$20240827$$HP$CN$CN
242561391$24256139$1$I$20240101$20240821$20240827$20240827$EXP$$US-PFIZER INC-202400241372$PFIZER$$76$YR$$F$Y$79.38$KG$20240827$$CN$US$US
242561402$24256140$2$F$20240730$20240828$20240827$20240905$EXP$$US-ABBVIE-5894375$ABBVIE$$48$YR$$F$Y$99$KG$20240905$$CN$US$US
242561411$24256141$1$I$$20240819$20240827$20240827$PER$$US-AMGEN-USASP2024168478$AMGEN$Arnold S. E.; Hendrix S.; Johnson J. N. et al.. Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer^s disease. Alzheimer^s and Dementia: Translational Research and Clinical Interventions. 2024;10 (3):1-13$$$$$Y$$$20240827$$HP$US$US
242561421$24256142$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5897069$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242561431$24256143$1$I$$20240826$20240827$20240827$EXP$$CA-ORGANON-O2408CAN001877$ORGANON$$20$YR$$M$Y$$$20240827$$CN$CA$CA
242561441$24256144$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA247898$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240828$$CN$US$US
242561451$24256145$1$I$$20240819$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408015333$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240827$$CN$US$US
242561461$24256146$1$I$20240822$20240822$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134810$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$HP$US$US
242561471$24256147$1$I$$20240819$20240827$20240827$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-131460$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$70$KG$20240828$$HP$CA$CA
242561481$24256148$1$I$$20240819$20240827$20240827$PER$$US-SA-2024SA249127$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240828$$MD$US$US
242561491$24256149$1$I$$20240823$20240827$20240827$EXP$$JP-SAKK-2024SA247187AA$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240828$$PH$JP$JP
242561501$24256150$1$I$20240101$20240823$20240827$20240827$EXP$$BE-ABBVIE-5884871$ABBVIE$$$$E$F$Y$$$20240827$$HP$BE$BE
242561511$24256151$1$I$20240711$20240823$20240827$20240827$EXP$$NVSC2024ZA144342$NOVARTIS$$45$YR$$F$Y$$$20240828$$HP$ZA$ZA
242561522$24256152$2$F$$20240927$20240827$20240930$EXP$$NVSJ2024JP009958$NOVARTIS$$69$YR$$F$Y$$$20241001$$MD$JP$JP
242561531$24256153$1$I$$20240822$20240827$20240827$EXP$$US-ABBVIE-5892450$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242561542$24256154$2$F$20240822$20240827$20240827$20240903$EXP$$PR-ABBVIE-5894461$ABBVIE$$84$YR$$M$Y$$$20240903$$CN$PR$PR
242561562$24256156$2$F$20200101$20240904$20240827$20240910$EXP$$US-ABBVIE-5893851$ABBVIE$$$$$M$Y$94$KG$20240910$$CN$US$US
242561571$24256157$1$I$$20240822$20240827$20240827$EXP$$KR-JNJFOC-20240860725$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$MD$KR$KR
242561581$24256158$1$I$$20240826$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075605$SANDOZ$$$$$F$Y$$$20240827$$MD$US$US
242561592$24256159$2$F$20230101$20240905$20240827$20240910$EXP$$US-ABBVIE-5894325$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
242561601$24256160$1$I$$20240814$20240827$20240827$EXP$$TR-Unichem Pharmaceuticals (USA) Inc-UCM202408-001054$UNICHEM$$6$YR$C$M$Y$$$20240828$$HP$TR$
242561611$24256161$1$I$$20240827$20240827$20240827$EXP$$CA-ORGANON-O2408CAN001937$ORGANON$$87$YR$$F$Y$$$20240827$$PH$CA$CA
242561621$24256162$1$I$$20240813$20240827$20240827$EXP$$IT-Unichem Pharmaceuticals (USA) Inc-UCM202408-001065$UNICHEM$$82$YR$E$M$Y$$$20240828$$MD$IT$
242561631$24256163$1$I$$20240816$20240827$20240827$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202408-001059$UNICHEM$$45$YR$A$F$Y$$$20240828$$HP$US$
242561641$24256164$1$I$20240101$20240821$20240827$20240827$EXP$$CA-ABBVIE-5892397$ABBVIE$$$$E$M$Y$$$20240827$$HP$CA$CA
242561651$24256165$1$I$20240808$20240822$20240827$20240827$EXP$$DE-ABBVIE-5892937$ABBVIE$$60$YR$$F$Y$$$20240827$$CN$DE$DE
242561661$24256166$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5892922$ABBVIE$$$$$F$Y$$$20240827$$HP$US$US
242561671$24256167$1$I$20240814$20240823$20240827$20240827$EXP$$US-ABBVIE-5894322$ABBVIE$$59$YR$$F$Y$$$20240827$$CN$US$US
242561681$24256168$1$I$20240817$20240819$20240827$20240827$PER$$US-SA-2024SA249033$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240828$$MD$US$US
242561691$24256169$1$I$$20240826$20240827$20240827$EXP$$US-SANDOZ INC.-SDZ2024US075591$SANDOZ$$10$YR$$F$Y$$$20240827$$CN$US$US
242561701$24256170$1$I$$20240824$20240827$20240827$PER$$US-AMGEN-USASP2024169873$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242561711$24256171$1$I$20240819$20240821$20240827$20240827$PER$$US-ABBVIE-5893534$ABBVIE$$22$YR$$F$Y$$$20240827$$HP$US$US
242561721$24256172$1$I$20240101$20240821$20240827$20240827$EXP$$NVSC2024AR140168$NOVARTIS$$$$$F$Y$$$20240828$$CN$AR$AR
242561732$24256173$2$F$$20240903$20240827$20240911$EXP$$US-BIOGEN-2024BI01279335$BIOGEN$$$$$M$Y$$$20240911$$CN$US$US
242561741$24256174$1$I$$20240816$20240827$20240827$EXP$$US-SMPA-2024SPA001592$SUNOVION$$$$$$Y$$$20240827$$CN$US$US
242561751$24256175$1$I$20240723$20240819$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132209$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$55.34$KG$20240828$$PH$US$US
242561761$24256176$1$I$20180509$20240821$20240827$20240827$EXP$$DE-BIOGEN-2024BI01279729$BIOGEN$$61$YR$$M$Y$71$KG$20240827$$CN$DE$DE
242561771$24256177$1$I$$20240827$20240827$20240827$PER$$NVSC2024US173126$NOVARTIS$$$$$M$Y$$$20240828$$HP$US$US
242561782$24256178$2$F$20240801$20240826$20240827$20240901$PER$$US-AMGEN-USASP2024170157$AMGEN$$77$YR$E$F$Y$$$20240901$$CN$US$US
242561791$24256179$1$I$$20240820$20240827$20240827$EXP$$US-BIOGEN-2024BI01279402$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
242561801$24256180$1$I$$20240822$20240827$20240827$PER$$US-AMGEN-USASP2024168399$AMGEN$$$$$$Y$$$20240827$$HP$US$US
242561824$24256182$4$F$20240101$20240826$20240827$20240830$EXP$$US-AMGEN-USASP2024169364$AMGEN$$$$E$F$Y$$$20240830$$MD$US$US
242561832$24256183$2$F$20230102$20240830$20240827$20240904$EXP$$CN-PFIZER INC-PV202400110676$PFIZER$$35$YR$$F$Y$55$KG$20240904$$HP$CN$CN
242561841$24256184$1$I$$20240823$20240827$20240827$EXP$GB-MHRA-MED-202408231529510300-JZSYF$GB-PFIZER INC-202400242838$PFIZER$$26$YR$$F$Y$$$20240827$$HP$GB$GB
242561851$24256185$1$I$$20240823$20240827$20240827$EXP$$CA-PFIZER INC-202400244003$PFIZER$$82$YR$$F$Y$$$20240827$$MD$CA$CA
242561861$24256186$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5889084$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242561871$24256187$1$I$20230101$20240819$20240827$20240827$PER$$US-BIOGEN-2023BI01240304$BIOGEN$$$$$M$Y$$$20240827$$CN$US$US
242561881$24256188$1$I$20240712$20240823$20240827$20240827$EXP$$BR-JNJFOC-20240866723$JOHNSON AND JOHNSON$$13$YR$T$M$Y$67$KG$20240828$$CN$BR$BR
242561892$24256189$2$F$20240101$20240903$20240827$20240906$EXP$$AU-ABBVIE-5893589$ABBVIE$$$$$M$Y$$$20240906$$HP$AU$AU
242561901$24256190$1$I$$20240820$20240827$20240827$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134527$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240828$$PH$JP$JP
242561911$24256191$1$I$$20240826$20240827$20240827$EXP$$US-ABBVIE-5896220$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242561921$24256192$1$I$$20240826$20240827$20240827$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135709$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240828$$HP$US$US
242561931$24256193$1$I$$20240827$20240827$20240827$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048158$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240828$$CN$US$US
242561941$24256194$1$I$20240101$20240822$20240827$20240827$EXP$$US-ABBVIE-5891471$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242561951$24256195$1$I$$20240824$20240827$20240827$EXP$$US-ABBVIE-5895705$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242561961$24256196$1$I$20240825$20240826$20240827$20240827$EXP$$TW-ABBVIE-5895539$ABBVIE$$56$YR$$$Y$103$KG$20240827$$CN$TW$TW
242561971$24256197$1$I$$20240821$20240827$20240827$PER$$US-ELI_LILLY_AND_COMPANY-US202408014908$ELI LILLY AND CO$$$$$F$Y$$$20240827$$MD$US$US
242561981$24256198$1$I$20240101$20240823$20240827$20240827$EXP$$CA-ABBVIE-5894223$ABBVIE$$36$YR$$$Y$$$20240827$$CN$CA$CA
242561991$24256199$1$I$$20240820$20240827$20240827$EXP$$CA-AMGEN-CANNI2024170174$AMGEN$$$$$F$Y$$$20240827$$CN$CA$CA
242562002$24256200$2$F$$20240826$20240827$20240829$PER$$NVSC2024US172836$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
242562012$24256201$2$F$20240801$20240913$20240827$20240919$EXP$$US-ABBVIE-5892184$ABBVIE$$78$YR$$F$Y$$$20240919$$CN$US$US
242562021$24256202$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5893818$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242562032$24256203$2$F$20240816$20240830$20240827$20240910$PER$$US-JNJFOC-20240861808$JOHNSON AND JOHNSON$$77$YR$E$M$Y$75.4$KG$20240910$$PH$US$US
242562042$24256204$2$F$20240501$20240917$20240827$20240924$EXP$$US-ABBVIE-5784579$ABBVIE$$65$YR$$M$Y$$$20240924$$CN$US$US
242562051$24256205$1$I$$20240819$20240827$20240827$EXP$$IR-NOVITIUMPHARMA-2024IRNVP01686$NOVITIUM PHARMA$Mahsa Mehdipour Dalivand.Hypokalemic quadriplegia in Sjogren^s syndrome: A case report.Clinical Case Reports.31-JUL-2024;12(8):1-5$38$YR$A$F$Y$$$20240828$$HP$IR$IR
242562061$24256206$1$I$$20240823$20240827$20240827$PER$$US-JNJFOC-20240862487$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$PH$US$US
242562072$24256207$2$F$20240101$20240819$20240827$20240912$PER$$US-ABBVIE-5887455$ABBVIE$$$$$F$Y$52$KG$20240912$$HP$US$US
242562082$24256208$2$F$$20240827$20240827$20240829$PER$$NVSC2024US173064$NOVARTIS$$$$$$Y$$$20240829$$CN$US$US
242562092$24256209$2$F$20240101$20240909$20240827$20240916$PER$$US-SA-2024SA249565$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240916$$MD$US$US
242562101$24256210$1$I$20240201$20240823$20240827$20240827$EXP$$US-ABBVIE-5892986$ABBVIE$$72$YR$$M$Y$139.7$KG$20240827$$CN$US$US
242562111$24256211$1$I$$20240716$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133497$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$MD$US$US
242562121$24256212$1$I$20240222$20240826$20240827$20240827$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135634$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240828$$CN$US$US
242562131$24256213$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5894383$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242562141$24256214$1$I$20240601$20240819$20240827$20240827$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-093506$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240828$$MD$DE$DE
242562151$24256215$1$I$$20240821$20240827$20240827$EXP$$GB-BIOGEN-2024BI01279531$BIOGEN$$$$$F$Y$$$20240827$$MD$GB$GB
242562161$24256216$1$I$$20240821$20240827$20240827$EXP$$US-BIOGEN-2024BI01279530$BIOGEN$$$$$F$Y$$$20240827$$CN$US$US
242562171$24256217$1$I$$20240821$20240827$20240827$EXP$$US-ABBVIE-5890830$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242562182$24256218$2$F$20240821$20240826$20240827$20240829$30DAY$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133930$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240829$$CN$US$US
242562191$24256219$1$I$20240101$20240823$20240827$20240827$EXP$$US-ABBVIE-5895587$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242562201$24256220$1$I$$20240820$20240827$20240827$EXP$$JP-AMGEN-JPNSP2024170210$AMGEN$Hayashi K, Hanabayashi A, Kimata N. 2-Po3-P32-6 Case report: Bilateral femoral incomplete fractures potentially associated with SSBT during long-term anti-resorptive agent therapy. Fracture/ The 50th annual Meeting of the Japanese Society for Fracture repair. 2024;46:S432$71$YR$E$F$Y$$$20240827$$MD$JP$JP
242562211$24256221$1$I$20240822$20240822$20240827$20240827$EXP$$JP-JNJFOC-20240871401$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$PH$JP$JP
242562221$24256222$1$I$20240824$20240826$20240827$20240827$PER$$US-AMGEN-USASP2024170503$AMGEN$$75$YR$E$F$Y$$$20240827$$CN$US$US
242562231$24256223$1$I$$20240814$20240827$20240827$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093379$GLENMARK$Yu R.. Exaggerated Increases in the Serum Cortisol Level in a Woman Following Oral Contraceptive Treatment.. AACE Clinical Case Rep.. 2024$$$$$Y$$$20240828$$MD$US$US
242562241$24256224$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5894212$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242562251$24256225$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5893366$ABBVIE$$$$$M$Y$$$20240827$$CN$US$US
242562261$24256226$1$I$$20240823$20240827$20240827$EXP$$US-ABBVIE-5893081$ABBVIE$$$$$F$Y$$$20240827$$CN$US$US
242562274$24256227$4$F$20230921$20240926$20240827$20240930$EXP$$JP-GSK-JP2024JPN104703$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$JP$JP
242562281$24256228$1$I$20240805$20240819$20240827$20240827$PER$$US-SA-2024SA249047$SANOFI AVENTIS$$9$YR$C$F$Y$44$KG$20240828$$MD$US$US
242562294$24256229$4$F$20231001$20240923$20240827$20240926$EXP$$US-ABBVIE-5580277$ABBVIE$$80$YR$$F$Y$75$KG$20240926$$CN$US$US
242562301$24256230$1$I$20240819$20240826$20240827$20240827$EXP$$US-TAKEDA-2024TUS086144$TAKEDA$$83$YR$$M$Y$$$20240827$$CN$US$US
242562311$24256231$1$I$20240809$20240823$20240827$20240827$EXP$$US-ABBVIE-5893374$ABBVIE$$66$YR$$M$Y$$$20240827$$CN$US$US
242562321$24256232$1$I$$20240826$20240828$20240828$PER$$US-ABBVIE-5896037$ABBVIE$$$$$F$Y$$$20240828$$MD$US$US
242562331$24256233$1$I$$20240816$20240828$20240828$EXP$$US-INSMED, INC.-2024-03342-US$INSMED$$$$$F$Y$39.456$KG$20240828$$CN$US$US
242562341$24256234$1$I$$20240801$20240828$20240828$EXP$$US-Vifor (International) Inc.-VIT-2024-06981$VIFOR$$$$$F$Y$$$20240828$$HP$US$US
242562351$24256235$1$I$$20240826$20240828$20240828$PER$$NVSC2024US173056$NOVARTIS$$$$$$Y$$$20240828$$CN$US$US
242562361$24256236$1$I$20230725$20240812$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133671$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240828$$HP$US$US
242562373$24256237$3$F$20240101$20240827$20240828$20240903$EXP$$ES-ABBVIE-5881304$ABBVIE$$$$$M$Y$105$KG$20240903$$CN$ES$ES
242562391$24256239$1$I$20240826$20240826$20240828$20240828$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-135409$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$81.65$KG$20240828$$CN$PR$PR
242562402$24256240$2$F$20240825$20240919$20240828$20240923$PER$$US-AMGEN-USASP2024170761$AMGEN$$42$YR$A$M$Y$$$20240923$$CN$US$US
242562411$24256241$1$I$20240801$20240822$20240828$20240828$EXP$$US-ABBVIE-5893239$ABBVIE$$74$YR$$M$Y$$$20240828$$CN$US$US
242562423$24256242$3$F$20240821$20240926$20240828$20240930$PER$$US-AMGEN-USASP2024168146$AMGEN$$52$YR$A$F$Y$$$20240930$$CN$US$US
242562431$24256243$1$I$20240812$20240822$20240828$20240828$EXP$$US-ABBVIE-5891466$ABBVIE$$74$YR$$M$Y$$$20240828$$CN$US$US
242562441$24256244$1$I$20240813$20240814$20240828$20240828$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093372$GLENMARK$$$$$$Y$$$20240828$$CN$US$US
242562451$24256245$1$I$20240601$20240822$20240828$20240828$EXP$$US-ABBVIE-5883324$ABBVIE$$53$YR$$M$Y$107$KG$20240828$$CN$US$US
242562461$24256246$1$I$$20240821$20240828$20240828$EXP$$EG-ROCHE-10000062632$ROCHE$$45$YR$A$F$Y$75$KG$20240828$$CN$EG$EG
242562471$24256247$1$I$20240601$20240820$20240828$20240828$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001689$BLUEPRINT MEDICINES$$30$YR$A$F$Y$$$20240828$$CN$US$US
242562481$24256248$1$I$20240801$20240819$20240828$20240828$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001683$BLUEPRINT MEDICINES$$75$YR$E$M$Y$$$20240828$$CN$US$US
242562491$24256249$1$I$20230501$20240822$20240828$20240828$EXP$$US-ABBVIE-5892379$ABBVIE$$61$YR$$F$Y$$$20240828$$CN$US$US
242562501$24256250$1$I$$20240826$20240828$20240828$EXP$$CA-ORGANON-O2408CAN001860$ORGANON$$36$YR$$F$Y$$$20240827$$HP$CA$CA
242562521$24256252$1$I$20240701$20240823$20240828$20240828$EXP$$US-ABBVIE-5893364$ABBVIE$$63$YR$$M$Y$$$20240828$$CN$US$US
242562531$24256253$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA249088$SANOFI AVENTIS$$58$YR$A$M$Y$86.18$KG$20240828$$MD$US$US
242562541$24256254$1$I$20240819$20240819$20240828$20240828$PER$$US-SA-2024SA249889$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240828$$MD$US$US
242562551$24256255$1$I$$20240821$20240828$20240828$PER$$US-AMGEN-USASP2024167845$AMGEN$Rashidi A.; Wanchoo R.; Izzedine H. et al.. How I Manage Hypertension and Proteinuria Associated with VEGF Inhibitor. Clinical journal of the American Society of Nephrology. 2023;18 (1):121-123$64$YR$A$F$Y$$$20240827$$HP$US$US
242562561$24256256$1$I$$20240818$20240828$20240828$PER$$US-AMGEN-USASP2024167810$AMGEN$Paulus Y.M.; Yu J.; Ballouz D.. Bevacizumab and External Beam Radiation Therapy for Diffuse Choroidal Hemangioma in Sturge-Weber Syndrome: A Case Report. Case Reports in Ophthalmology. 2024;15 (1):590-594$37$YR$A$M$Y$$$20240827$$HP$US$US
242562571$24256257$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA246363$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240828$$MD$US$US
242562591$24256259$1$I$$20240825$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135483$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$97.52$KG$20240828$$CN$US$US
242562601$24256260$1$I$20240401$20240823$20240828$20240828$EXP$$DE-ABBVIE-5895716$ABBVIE$$29$YR$$F$Y$$$20240828$$CN$DE$DE
242562611$24256261$1$I$20240601$20240822$20240828$20240828$PER$$US-ALXN-202408USA001613US$ALEXION PHARMACEUTICALS$$73$YR$$F$Y$$$20240828$$HP$US$US
242562621$24256262$1$I$$20240823$20240828$20240828$EXP$$US-ALXN-202408USA001646US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242562631$24256263$1$I$20240801$20240820$20240828$20240828$EXP$$US-ABBVIE-5888895$ABBVIE$$59$YR$$F$Y$$$20240828$$CN$US$US
242562641$24256264$1$I$20240101$20240822$20240828$20240828$EXP$$AR-ABBVIE-5523727$ABBVIE$$$$$F$Y$$$20240828$$CN$AR$AR
242562671$24256267$1$I$20240715$20240816$20240828$20240828$EXP$GB-MHRA-MED-202408152030478670-BPTLK$GB-Accord-442338$ACCORD$$48$YR$A$M$Y$79$KG$20240827$$CN$GB$GB
242562681$24256268$1$I$$20240821$20240828$20240828$EXP$$CA-JNJFOC-20240340385$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240828$$HP$CA$CA
242562691$24256269$1$I$$20240822$20240828$20240828$EXP$$US-ABBVIE-5892510$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242562701$24256270$1$I$$20240814$20240828$20240828$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093380$GLENMARK$Farkouh EK, Michel IM, Harrison DJ, Issa N.. Dual Donor-Derived Renal Allograft Mucormycosis From a Single Deceased Donor. Mayo Clinic Proceedings. 2024;99 (8):1341-42$$$$$Y$$$20240828$$MD$US$US
242562712$24256271$2$F$20240726$20240909$20240828$20240927$PER$$US-TOLMAR, INC.-24US051352$TOLMAR$$63$YR$$M$Y$$$20240927$$HP$US$US
242562722$24256272$2$F$20240718$20240827$20240828$20240917$PER$$US-TOLMAR, INC.-24US051286$TOLMAR$$74$YR$$M$Y$$$20240917$$HP$US$US
242562741$24256274$1$I$20240731$20240806$20240828$20240828$PER$$US-TOLMAR, INC.-24US051650$TOLMAR$$75$YR$$M$Y$$$20240827$$HP$US$US
242562751$24256275$1$I$20240801$20240820$20240828$20240828$PER$$US-SA-2024SA250335$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240828$$MD$US$US
242562761$24256276$1$I$20240824$20240825$20240828$20240828$EXP$$MY-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047642$BOEHRINGER INGELHEIM$$46$YR$A$M$Y$$$20240828$$MD$MY$MY
242562771$24256277$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170854$AMGEN$$$$$$Y$$$20240827$$HP$US$US
242562781$24256278$1$I$20240821$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135985$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240828$$CN$US$US
242562791$24256279$1$I$$20240822$20240828$20240828$EXP$$HK-EMD Serono-2024045370$EMD SERONO INC$$$$C$F$Y$$$20240828$$CN$HK$HK
242562801$24256280$1$I$20220101$20240821$20240828$20240828$EXP$$US-ABBVIE-5828887$ABBVIE$$$$$F$Y$80$KG$20240828$$CN$US$US
242562811$24256281$1$I$20240101$20240812$20240828$20240828$PER$$US-TEVA-VS-3233278$TEVA$$71$YR$$M$Y$$$20240828$$CN$US$US
242562823$24256282$3$F$20240101$20240918$20240828$20240923$EXP$$US-ABBVIE-5886238$ABBVIE$$$$$F$Y$58.966$KG$20240923$$CN$US$US
242562831$24256283$1$I$20240816$20240816$20240828$20240828$PER$$US-AMGEN-USASP2024170717$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242562841$24256284$1$I$20240601$20240821$20240828$20240828$EXP$$US-ABBVIE-5891727$ABBVIE$$63$YR$$F$Y$$$20240828$$CN$US$US
242562861$24256286$1$I$20201122$20240822$20240828$20240828$EXP$$FR-AstraZeneca-2024A191143$ASTRAZENECA$$51$YR$$F$Y$75$KG$20240828$$MD$FR$
242562871$24256287$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA250210$SANOFI AVENTIS$$$$A$F$Y$99.7$KG$20240828$$MD$US$US
242562881$24256288$1$I$20240101$20240821$20240828$20240828$EXP$$CA-ABBVIE-5891635$ABBVIE$$$$A$F$Y$$$20240828$$CN$CA$CA
242562901$24256290$1$I$20240101$20240820$20240828$20240828$EXP$$GB-ABBVIE-5889488$ABBVIE$$83$YR$$F$Y$$$20240828$$CN$GB$GB
242562912$24256291$2$F$$20240906$20240828$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127459$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240912$$MD$JP$JP
242562921$24256292$1$I$$20240819$20240828$20240828$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-133808$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240828$$MD$KR$KR
242562931$24256293$1$I$$20240826$20240828$20240828$EXP$$CA-ORGANON-O2408CAN001851$ORGANON$$$$$F$Y$$$20240828$$HP$CA$CA
242562941$24256294$1$I$$20240822$20240828$20240828$EXP$$US-ABBVIE-5892234$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242562951$24256295$1$I$$20240823$20240828$20240828$EXP$$US-ABBVIE-5744570$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242562962$24256296$2$F$$20240909$20240828$20240914$EXP$$GB-TAKEDA-2024TUS050529$TAKEDA$$$$$F$Y$$$20240914$$CN$GB$GB
242562971$24256297$1$I$20240801$20240821$20240828$20240828$PER$$US-ABBVIE-5891982$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242562982$24256298$2$F$20240826$20240925$20240828$20240926$PER$$US-AMGEN-USASP2024170726$AMGEN$$65$YR$E$F$Y$$$20240926$$CN$US$US
242562992$24256299$2$F$20240823$20240830$20240828$20240903$PER$$US-AMGEN-USASP2024170604$AMGEN$$70$YR$E$F$Y$$$20240903$$CN$US$US
242563002$24256300$2$F$20240801$20240912$20240828$20240918$EXP$$CH-ABBVIE-5892961$ABBVIE$$61$YR$$F$Y$$$20240918$$CN$CH$CH
242563011$24256301$1$I$20240819$20240821$20240828$20240828$EXP$GB-MHRA-MED-202408211229036410-ZWTHB$GB-TEVA-VS-3236227$TEVA$$80$YR$$F$Y$$$20240828$$HP$GB$GB
242563021$24256302$1$I$20240101$20240820$20240828$20240828$EXP$$US-ABBVIE-5889936$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242563031$24256303$1$I$$20240222$20240828$20240828$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202403-000237$UNICHEM$$$$$M$Y$$$20240828$$CN$US$
242563041$24256304$1$I$$20240513$20240828$20240828$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202405-000528$UNICHEM$$77$YR$E$F$Y$58.5$KG$20240828$$CN$US$
242563051$24256305$1$I$20240101$20240815$20240828$20240828$EXP$$US-Emmaus Medical, Inc.-EMM202408-000409$EMMAUS LIFE SCIENCES$$29$YR$A$M$Y$$$20240828$$CN$US$
242563061$24256306$1$I$$20240822$20240828$20240828$PER$$US-ALXN-202408USA001605US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242563071$24256307$1$I$$20240822$20240828$20240828$EXP$$US-ABBVIE-5892428$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242563082$24256308$2$F$$20240920$20240828$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US075255$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
242563091$24256309$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248977$SANOFI AVENTIS$$$$A$M$Y$102.05$KG$20240828$$MD$US$US
242563101$24256310$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249246$SANOFI AVENTIS$$$$C$M$Y$14.515$KG$20240828$$MD$US$US
242563111$24256311$1$I$20240819$20240820$20240828$20240828$PER$$US-SA-2024SA248299$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240828$$CN$US$US
242563121$24256312$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA250067$SANOFI AVENTIS$$$$A$M$Y$$$20240828$$MD$US$US
242563131$24256313$1$I$20240730$20240826$20240828$20240828$EXP$$US-ABBVIE-5896113$ABBVIE$$62$YR$$F$Y$$$20240828$$CN$US$US
242563141$24256314$1$I$20240825$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170327$AMGEN$$21$YR$A$M$Y$$$20240827$$CN$US$US
242563151$24256315$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA250286$SANOFI AVENTIS$$$$A$M$Y$84.821$KG$20240828$$MD$US$US
242563161$24256316$1$I$20240801$20240819$20240828$20240828$PER$$US-SA-2024SA250340$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240828$$MD$US$US
242563173$24256317$3$F$20190101$20240911$20240828$20240919$EXP$$US-ABBVIE-5891291$ABBVIE$$$$$M$Y$205$KG$20240919$$CN$US$US
242563181$24256318$1$I$20240823$20240823$20240828$20240828$EXP$$US-ABBVIE-5893621$ABBVIE$$58$YR$$F$Y$$$20240828$$CN$US$US
242563191$24256319$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170862$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242563203$24256320$3$F$20240101$20240916$20240828$20240917$PER$$US-AMGEN-USASP2024170951$AMGEN$$59$YR$A$F$Y$$$20240917$$CN$US$US
242563211$24256321$1$I$$20240819$20240828$20240828$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP010708$STRIDES$Kostrzanowski M, Kosinska-Kaczynska K, Dabrowski F.. Pregestational diabetes - the importance of pregestational counseling - case report.. Eur-J-Obstet-Gynecol-Reprod-Biol. 2024;293:210$$$$F$Y$$$20240828$$HP$PL$PL
242563222$24256322$2$F$20240719$20240925$20240828$20240926$EXP$$NVSC2024US151233$NOVARTIS$$61$YR$$F$Y$$$20240926$$CN$US$US
242563231$24256323$1$I$20240730$20240826$20240828$20240828$EXP$$AT-ABBVIE-5895711$ABBVIE$$84$YR$$F$Y$$$20240828$$CN$AT$AT
242563242$24256324$2$F$20240701$20240828$20240828$20240903$EXP$$US-ABBVIE-5891799$ABBVIE$$48$YR$$M$Y$109$KG$20240903$$CN$US$US
242563251$24256325$1$I$$20240820$20240828$20240828$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP010706$STRIDES$Honorato CMA, Carrascoza GG, Abed NM, Moya FG.. Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor.. Anais-Brasil-Dermatol. 2024$60$YR$$M$Y$$$20240828$$HP$BR$BR
242563261$24256326$1$I$$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134403$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240828$$HP$US$US
242563272$24256327$2$F$$20240826$20240828$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136147$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240829$$CN$US$US
242563281$24256328$1$I$$20240820$20240828$20240828$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP010707$STRIDES$Honorato CMA, Carrascoza GG, Abed NM, Moya FG.. Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor.. Anais-Brasil-Dermatol. 2024$62$YR$$M$Y$$$20240828$$HP$BR$BR
242563291$24256329$1$I$$20240824$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135825$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240828$$PH$US$US
242563301$24256330$1$I$20180301$20240820$20240828$20240828$EXP$$AU-TAKEDA-2024TUS086128$TAKEDA$$61$YR$$F$Y$$$20240828$$MD$AU$AU
242563312$24256331$2$F$20220101$20240905$20240828$20240912$EXP$$SE-ABBVIE-5895728$ABBVIE$$$$$M$Y$75$KG$20240912$$HP$SE$SE
242563321$24256332$1$I$20240101$20240822$20240828$20240828$EXP$$US-ABBVIE-5691009$ABBVIE$$80$YR$$F$Y$45.359$KG$20240828$$CN$US$US
242563331$24256333$1$I$20221111$20240820$20240828$20240828$EXP$$IR-STRIDES ARCOLAB LIMITED-2024SP010642$STRIDES$Basiri R, Ziaei Moghaddam A, Rikhtegar A, Jafarian AH.. Primary Pulmonary Angiosarcoma Found Incidentally in a Complicated Patient: A Rare Case Report.. Clin-Respir-J. 2024;18 (8)$33$YR$$F$Y$$$20240828$$HP$IR$IR
242563341$24256334$1$I$$20240824$20240828$20240828$PER$$NVSC2024US173068$NOVARTIS$$$$$$Y$$$20240828$$CN$US$US
242563351$24256335$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5857026$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242563361$24256336$1$I$20240518$20240819$20240828$20240828$PER$$US-AstraZeneca-2024A188660$ASTRAZENECA$$20191$DY$$F$Y$$$20240828$$CN$US$
242563371$24256337$1$I$$20240821$20240828$20240828$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010644$STRIDES$Hu J, Zhao J, Wang C, Jia M, Su M, Li S.. Epstein-Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation.. Ann-Hematol.. 2023;102:3593-3601$31$YR$$M$Y$$$20240828$$HP$CN$CN
242563381$24256338$1$I$$20240822$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014442$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240828$$CN$US$US
242563395$24256339$5$F$20240820$20240920$20240828$20240926$EXP$$PT-ABBVIE-5892820$ABBVIE$$69$YR$$F$Y$$$20240926$$MD$PT$PT
242563401$24256340$1$I$20240702$20240823$20240828$20240828$EXP$GB-MHRA-TPP60357783C18085649YC1724151055904$GB-STRIDES ARCOLAB LIMITED-2024SP010653$STRIDES$$35$YR$$F$Y$89$KG$20240828$$PH$GB$GB
242563411$24256341$1$I$20240701$20240820$20240828$20240828$EXP$$US-ABBVIE-5887967$ABBVIE$$83$YR$$$Y$$$20240828$$CN$US$US
242563422$24256342$2$F$20240801$20240919$20240828$20240926$EXP$$US-ABBVIE-5892132$ABBVIE$$82$YR$$F$Y$$$20240926$$CN$US$US
242563432$24256343$2$F$$20240823$20240828$20240830$EXP$$ES-SANDOZ INC.-PHHY2019ES027625$SANDOZ$$13$YR$$M$Y$$$20240830$$MD$ES$ES
242563441$24256344$1$I$20240821$20240822$20240828$20240828$EXP$$CN-AMGEN-CHNSP2024168684$AMGEN$$70$YR$E$F$Y$$$20240827$$PH$CN$CN
242563451$24256345$1$I$$20240819$20240828$20240828$EXP$$US-AMGEN-USASP2024165527$AMGEN$Renteria A.S.; Venugopal S.; Marcellino B. et. al. Dose-Adjusted Intensive Chemotherapy Is Safe and Tolerable in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia. Blood. 2018;132 (1):5158$$$$$Y$$$20240827$$MD$US$US
242563461$24256346$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5894199$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242563473$24256347$3$F$20240823$20240911$20240828$20240919$EXP$$KR-UNITED THERAPEUTICS-UNT-2024-026450$UNITED THERAPEUTICS$$19$YR$$M$Y$73.8$KG$20240919$$$KR$KR
242563481$24256348$1$I$20211113$20240820$20240828$20240828$EXP$DE-PFIZER INC-202200535898$DE-ROCHE-10000062052$ROCHE$$52$YR$A$F$Y$$$20240828$$CN$DE$DE
242563491$24256349$1$I$$20240825$20240828$20240828$PER$$US-ROCHE-10000066858$ROCHE$$$$$$Y$$$20240828$$CN$US$US
242563501$24256350$1$I$20240823$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169548$AMGEN$$81$YR$E$M$Y$$$20240827$$HP$US$US
242563511$24256351$1$I$$20240819$20240828$20240828$EXP$$JP-AMGEN-JPNSP2024169821$AMGEN$Oshita, H.. A case of non-tuberculous mycobacterial pulmonary disease that flared up during pregnancy and was difficult to detect early. Annals of the Japanese Respiratory Society. 2024;13 (4):165-169$45$YR$A$F$Y$44$KG$20240827$$HP$JP$JP
242563521$24256352$1$I$$20240823$20240828$20240828$EXP$$US-ABBVIE-5894454$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242563531$24256353$1$I$$20240826$20240828$20240828$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-136174$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240828$$PH$PR$PR
242563541$24256354$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5894065$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242563551$24256355$1$I$20240101$20240822$20240828$20240828$EXP$$US-ABBVIE-5892684$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242563561$24256356$1$I$20200301$20240823$20240828$20240828$EXP$$AR-JNJFOC-20240709347$JOHNSON AND JOHNSON$$31$YR$A$M$Y$79$KG$20240828$$CN$AR$AR
242563582$24256358$2$F$20231201$20240823$20240828$20240830$EXP$$US-ABBVIE-5893327$ABBVIE$$61$YR$$M$Y$$$20240829$$CN$US$US
242563591$24256359$1$I$20240101$20240814$20240828$20240828$EXP$$US-MALLINCKRODT-MNK202405170$MALLINCKRODT$$51$YR$A$F$Y$$$20240827$$HP$US$US
242563601$24256360$1$I$20240730$20240823$20240828$20240828$EXP$$CA-ABBVIE-5894363$ABBVIE$$60$YR$$F$Y$$$20240828$$CN$CA$CA
242563611$24256361$1$I$$20240815$20240828$20240828$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093384$GLENMARK$Millien VO, Santana LA, Kolpakchi A, Lu L.. Trading one for another: A case of de novo crohn^s disease after lung transplant.. Journal of General Internal Medicine.. 2016;31:2(1):S769$$$$$Y$$$20240828$$HP$US$US
242563621$24256362$1$I$$20240814$20240828$20240828$PER$$US-ABBVIE-5893706$ABBVIE$$28$YR$$F$Y$$$20240828$$CN$US$US
242563631$24256363$1$I$20240101$20240826$20240828$20240828$EXP$$US-ABBVIE-5897281$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242563641$24256364$1$I$20240101$20240823$20240828$20240828$EXP$$CA-ABBVIE-5894057$ABBVIE$$77$YR$$$Y$$$20240828$$HP$CA$CA
242563651$24256365$1$I$20230101$20240820$20240828$20240828$EXP$$US-ABBVIE-5435847$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242563662$24256366$2$F$20231220$20240918$20240828$20240925$EXP$$CA-TAKEDA-2022TUS014782$TAKEDA$$83$YR$$M$Y$$$20240925$$HP$CA$CA
242563672$24256367$2$F$$20240827$20240828$20240829$PER$$US-ROCHE-10000066575$ROCHE$$$$$M$Y$$$20240829$$CN$US$US
242563691$24256369$1$I$$20240823$20240828$20240828$EXP$$BR-JNJFOC-20240866839$JOHNSON AND JOHNSON$$13$YR$T$M$Y$67$KG$20240828$$CN$BR$BR
242563701$24256370$1$I$20240801$20240820$20240828$20240828$EXP$$US-JNJFOC-20240854553$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240828$$CN$US$US
242563714$24256371$4$F$20240818$20240825$20240828$20240829$PER$$US-JNJFOC-20240849001$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240829$$CN$US$US
242563731$24256373$1$I$$20240820$20240828$20240828$EXP$$US-ABBVIE-5879235$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242563741$24256374$1$I$$20240820$20240828$20240828$EXP$$CL-JNJFOC-20240857756$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240828$$MD$CL$CL
242563751$24256375$1$I$$20240821$20240828$20240828$EXP$$CA-TAKEDA-2024TUS085057$TAKEDA$$$$$F$Y$$$20240828$$MD$CA$CA
242563761$24256376$1$I$$20240802$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004272$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242563771$24256377$1$I$$20240802$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004271$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242563781$24256378$1$I$$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A193377$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242563791$24256379$1$I$20240817$20240823$20240828$20240828$EXP$$US-ABBVIE-5894085$ABBVIE$$80$YR$$F$Y$$$20240828$$CN$US$US
242563801$24256380$1$I$$20240819$20240828$20240828$EXP$$US-NOVOPROD-1272963$NOVO NORDISK$$$$$F$Y$$$20240828$$CN$US$US
242563811$24256381$1$I$$20240818$20240828$20240828$EXP$$IL-NOVOPROD-1271728$NOVO NORDISK$$$$$F$Y$$$20240828$$MD$IL$IL
242563821$24256382$1$I$$20240818$20240828$20240828$EXP$$IL-NOVOPROD-1272421$NOVO NORDISK$$$$$F$Y$$$20240828$$MD$IL$IL
242563831$24256383$1$I$$20240816$20240828$20240828$EXP$$US-NOVOPROD-1272285$NOVO NORDISK$$65$YR$$F$Y$$$20240828$$CN$US$US
242563841$24256384$1$I$$20240818$20240828$20240828$EXP$$IL-NOVOPROD-1272237$NOVO NORDISK$$$$$F$Y$$$20240828$$MD$IL$IL
242563851$24256385$1$I$20240711$20240817$20240828$20240828$EXP$$US-NOVOPROD-1272485$NOVO NORDISK$$53$YR$$M$Y$$$20240828$$PH$US$US
242563861$24256386$1$I$$20240819$20240828$20240828$EXP$$US-NOVOPROD-1272903$NOVO NORDISK$$$$$$Y$$$20240828$$CN$US$US
242563872$24256387$2$F$20240501$20240830$20240828$20240910$EXP$$US-NOVOPROD-1272890$NOVO NORDISK$$78$YR$$M$Y$$$20240910$$MD$US$US
242563881$24256388$1$I$$20240818$20240828$20240828$EXP$$CN-NOVOPROD-1271715$NOVO NORDISK$$$$$M$Y$$$20240828$$CN$CN$CN
242563891$24256389$1$I$$20240818$20240828$20240828$EXP$$BR-NOVOPROD-1272242$NOVO NORDISK$$$$$F$Y$$$20240828$$CN$BR$BR
242563902$24256390$2$F$20240726$20240916$20240828$20240926$EXP$IT-MINISAL02-999410$IT-NOVOPROD-1272829$NOVO NORDISK$$67$YR$$M$Y$$$20240926$$MD$IT$IT
242563911$24256391$1$I$20240805$20240815$20240828$20240828$30DAY$$US-NOVOPROD-1271265$NOVO NORDISK$$85$YR$$F$Y$$$20240828$$CN$US$US
242563921$24256392$1$I$20240718$20240816$20240828$20240828$EXP$$US-NOVOPROD-1272266$NOVO NORDISK$$66$YR$$F$Y$$$20240828$$CN$US$US
242563931$24256393$1$I$$20240819$20240828$20240828$EXP$$GB-NOVOPROD-1271370$NOVO NORDISK$$68$YR$$M$Y$116$KG$20240828$$MD$GB$GB
242563941$24256394$1$I$20240620$20240819$20240828$20240828$EXP$$US-NOVOPROD-1255181$NOVO NORDISK$$80$YR$$M$Y$$$20240828$$CN$US$US
242563951$24256395$1$I$20240601$20240816$20240828$20240828$EXP$$MX-NOVOPROD-1273898$NOVO NORDISK$$76$YR$$F$Y$85$KG$20240828$$CN$MX$MX
242563961$24256396$1$I$$20240818$20240828$20240828$EXP$$IL-NOVOPROD-1272425$NOVO NORDISK$$$$$F$Y$$$20240828$$MD$IL$IL
242563971$24256397$1$I$20240701$20240819$20240828$20240828$EXP$RO-NMA-2024-SP0536$RO-SA-2024SA244747$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240828$$MD$RO$RO
242563981$24256398$1$I$$20240826$20240828$20240828$PER$$US-HALEON-2193727$Haleon PLC$$$$$$Y$$$20240828$$CN$US$US
242563991$24256399$1$I$$20240823$20240828$20240828$EXP$$US-ABBVIE-5894323$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242564001$24256400$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA250046$SANOFI AVENTIS$$$$E$F$Y$77.11$KG$20240828$$MD$US$US
242564011$24256401$1$I$$20240802$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004275$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242564021$24256402$1$I$20240101$20240816$20240828$20240828$PER$$US-SA-2024SA250063$SANOFI AVENTIS$$$$A$F$Y$77$KG$20240828$$CN$US$US
242564031$24256403$1$I$20190503$20240822$20240828$20240828$EXP$$CA-TAKEDA-2022TUS043299$TAKEDA$$50$YR$$M$Y$$$20240828$$CN$CA$CA
242564042$24256404$2$F$$20240919$20240828$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004280$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242564051$24256405$1$I$20240401$20240819$20240828$20240828$EXP$$US-NOVOPROD-1273250$NOVO NORDISK$$72$YR$$F$Y$$$20240828$$CN$US$US
242564062$24256406$2$F$$20240823$20240828$20240828$30DAY$$US-SANDOZ INC.-SDZ2024US075250$SANDOZ$$$$$M$Y$$$20240828$$CN$US$US
242564071$24256407$1$I$$20240819$20240828$20240828$EXP$$US-NOVOPROD-1273035$NOVO NORDISK$$$$$M$Y$$$20240828$$MD$US$US
242564081$24256408$1$I$$20240826$20240828$20240828$EXP$$CA-ROCHE-10000066870$ROCHE$$86$YR$E$M$Y$$$20240828$$MD$CA$CA
242564092$24256409$2$F$$20240823$20240828$20240904$EXP$$US-NOVOPROD-1273437$NOVO NORDISK$$$$A$F$Y$$$20240904$$CN$US$US
242564101$24256410$1$I$$20240819$20240828$20240828$EXP$$US-NOVOPROD-1273332$NOVO NORDISK$$63$YR$$$Y$$$20240828$$HP$US$US
242564111$24256411$1$I$$20240819$20240828$20240828$EXP$$US-NOVOPROD-1273186$NOVO NORDISK$$50$YR$$F$Y$$$20240828$$HP$US$US
242564121$24256412$1$I$$20240819$20240828$20240828$EXP$$US-NOVOPROD-1273156$NOVO NORDISK$$$$A$F$Y$$$20240828$$CN$US$US
242564131$24256413$1$I$$20240819$20240828$20240828$EXP$$US-NOVOPROD-1273149$NOVO NORDISK$$$$A$F$Y$$$20240828$$CN$US$US
242564141$24256414$1$I$20240701$20240819$20240828$20240828$EXP$$US-NOVOPROD-1273539$NOVO NORDISK$$60$YR$$F$Y$$$20240828$$CN$US$US
242564151$24256415$1$I$$20240819$20240828$20240828$EXP$$US-NOVOPROD-1273056$NOVO NORDISK$$72$YR$$M$Y$$$20240828$$CN$US$US
242564161$24256416$1$I$20240702$20240823$20240828$20240828$EXP$$NVSC2024CN172715$NOVARTIS$$68$YR$$F$Y$$$20240828$$HP$CN$CN
242564171$24256417$1$I$$20240823$20240828$20240828$EXP$$JP-TAKEDA-2024TJP012500$TAKEDA$$65$YR$$M$Y$54.9$KG$20240828$$MD$JP$JP
242564181$24256418$1$I$20240805$20240805$20240828$20240828$PER$$CA-TOLMAR, INC.-24CA052060$TOLMAR$$96$YR$$M$Y$$$20240828$$CN$CA$CA
242564191$24256419$1$I$20240801$20240805$20240828$20240828$PER$$US-TOLMAR, INC.-24US051613$TOLMAR$$80$YR$$M$Y$$$20240828$$HP$US$US
242564211$24256421$1$I$$20240805$20240828$20240828$PER$$US-TOLMAR, INC.-24US051719$TOLMAR$$$$$F$Y$$$20240828$$MD$US$US
242564221$24256422$1$I$20230201$20240805$20240828$20240828$PER$$US-TOLMAR, INC.-24US051718$TOLMAR$$56$YR$$F$Y$$$20240828$$HP$US$US
242564231$24256423$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015520$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240828$$CN$US$US
242564242$24256424$2$F$$20240902$20240828$20240910$EXP$$US-TEVA-VS-3236244$TEVA$Mark C, Minasyan A, Ebia MI, Abbas A, Ghosh A, Watson R, et al. Painful tongue lesion as an initial presentation of metastatic pancreatic ductal adenocarcinoma: a case report and review of the literature. Ann-Pancreat-Cancer 2023; 6 (8):.; Mark C, Minasyan A, Ebia MI, Abbas A, Ghosh A, Watson R, et al. Painful tongue lesion as an initial presentation of metastatic pancreatic ductal adenocarcinoma: a case report and review of the literature. Ann-Pancreat-Cancer 2023; 6 (8):.$91$YR$$M$Y$$$20240910$$HP$US$US
242564251$24256425$1$I$20231015$20231016$20240828$20240828$PER$$US-AUROBINDO-AUR-APL-2023-064891$AUROBINDO$$19$YR$$F$Y$36$KG$20240828$$CN$US$US
242564261$24256426$1$I$$20240224$20240828$20240828$PER$$US-AUROBINDO-AUR-APL-2024-003476$AUROBINDO$$25$YR$$F$Y$52.163$KG$20240828$$CN$US$US
242564271$24256427$1$I$$20231019$20240828$20240828$PER$$US-AUROBINDO-AUR-APL-2023-065643$AUROBINDO$$$$$F$Y$$$20240828$$CN$US$US
242564282$24256428$2$F$$20240902$20240828$20240910$EXP$$US-TEVA-VS-3236225$TEVA$Mohamed MS, Wojciechowski K, Osama M, Hashem A, Patel J, Mahmoud A, et al. The Missed Culprit For A Complex Case Of Non-ischemic Cardiomyopathy. J-Card-Fail 2024; 30 (1): 157-158.; Mohamed MS, Wojciechowski K, Osama M, Hashem A, Patel J, Mahmoud A, et al. The Missed Culprit For A Complex Case Of Non-ischemic Cardiomyopathy. J-Card-Fail 2024; 30 (1): 157-158.$60$YR$$F$Y$$$20240910$$HP$US$US
242564291$24256429$1$I$$20240823$20240828$20240828$EXP$$IN-ROCHE-10000065408$ROCHE$$33$YR$A$M$Y$$$20240828$$CN$IN$IN
242564301$24256430$1$I$20240728$20240802$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004287$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240828$$CN$US$US
242564311$24256431$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA250298$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240828$$MD$US$US
242564321$24256432$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249053$SANOFI AVENTIS$$$$A$F$Y$86.1$KG$20240828$$MD$US$US
242564331$24256433$1$I$$20240819$20240828$20240828$EXP$$BR-ROCHE-10000060740$ROCHE$$80$YR$E$F$Y$$$20240828$$MD$BR$BR
242564341$24256434$1$I$$20240821$20240828$20240828$EXP$$CA-TAKEDA-2024TUS085120$TAKEDA$$$$$F$Y$$$20240828$$MD$CA$CA
242564351$24256435$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA250351$SANOFI AVENTIS$$$$A$M$Y$$$20240828$$MD$US$US
242564361$24256436$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170836$AMGEN$$$$$$Y$$$20240827$$HP$US$US
242564373$24256437$3$F$20240826$20240829$20240828$20240831$PER$$US-AMGEN-USASP2024170646$AMGEN$$79$YR$E$$Y$$$20240831$$CN$US$US
242564381$24256438$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169537$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242564392$24256439$2$F$$20240827$20240828$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004284$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
242564401$24256440$1$I$20240718$20240826$20240828$20240828$EXP$FR-AFSSAPS-NT2024001063$FR-GSK-FR2024105903$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$FR$FR
242564411$24256441$1$I$20240701$20240819$20240828$20240828$EXP$$AR-EMD Serono-2024044700$EMD SERONO INC$$15$YR$T$M$Y$$$20240828$$CN$AR$AR
242564421$24256442$1$I$$20240815$20240828$20240828$EXP$$CN-Accord-442437$ACCORD$Sun L, Mu J, Wang Y, He H. Perioperative dexmedetomidine-induced delirium in a patient with schizophrenia: a case report. BMC Anesthesiol. 2024 Aug 9;24(1):278.$75$YR$E$F$Y$60$KG$20240827$$MD$CN$CN
242564431$24256443$1$I$$20240820$20240828$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-026189$UNITED THERAPEUTICS$$$$$F$Y$64.853$KG$20240828$$$US$US
242564441$24256444$1$I$20190927$20191120$20240828$20240828$EXP$$CO-AstraZeneca-2019SF66708$ASTRAZENECA$$23134$DY$$F$Y$$$20240828$$CN$CO$
242564451$24256445$1$I$$20240821$20240828$20240828$PER$$US-AstraZeneca-2024A191308$ASTRAZENECA$$$$$$Y$$$20240828$$HP$US$
242564481$24256448$1$I$20240101$20240717$20240828$20240828$PER$$US-IMP-2024000527$Harrow Health$$$$A$F$Y$$$20240828$$CN$US$US
242564491$24256449$1$I$20240815$20240823$20240828$20240828$EXP$$PK-ROCHE-10000065447$ROCHE$$44$YR$A$F$Y$$$20240828$$CN$PK$PK
242564512$24256451$2$F$$20240903$20240828$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004299$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
242564522$24256452$2$F$$20240830$20240828$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132919$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240905$$HP$US$US
242564531$24256453$1$I$$20240825$20240828$20240828$PER$$US-AMGEN-USASP2024169849$AMGEN$$$$A$F$Y$$$20240827$$CN$US$US
242564541$24256454$1$I$$20240813$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-041078$AUROBINDO$Patel R, Elghawy O, Gibbs A, Gupta S, Kaur V. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer-Rep. 2024;7(7):e2110$84$YR$$M$Y$$$20240828$$HP$US$US
242564551$24256455$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA250223$SANOFI AVENTIS$$$$T$M$Y$43.68$KG$20240828$$MD$US$US
242564561$24256456$1$I$$20240827$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-134670-2023$RECKITT BENCKISER$$$$$F$Y$$$20240828$$CN$US$US
242564571$24256457$1$I$$20240718$20240828$20240828$PER$$US-IMP-2024000537$Harrow Health$$$$E$F$Y$$$20240828$$CN$US$US
242564582$24256458$2$F$$20240826$20240828$20240831$EXP$$CA-ABBVIE-5896887$ABBVIE$$81$YR$$$Y$49$KG$20240831$$HP$CA$CA
242564591$24256459$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135816$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$80.29$KG$20240828$$HP$US$US
242564601$24256460$1$I$$20240727$20240828$20240828$PER$$US-IMP-2024000561$Harrow Health$$$$E$F$Y$$$20240828$$CN$US$US
242564611$24256461$1$I$$20240814$20240828$20240828$PER$$US-ABBVIE-5894388$ABBVIE$$28$YR$$F$Y$$$20240828$$CN$US$US
242564621$24256462$1$I$$20240826$20240828$20240828$EXP$$JP-TAKEDA-2024TJP012529$TAKEDA$$10$DEC$$F$Y$$$20240828$$MD$JP$JP
242564633$24256463$3$F$20240823$20240923$20240828$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136232$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240925$$CN$US$US
242564641$24256464$1$I$$20240730$20240828$20240828$PER$$US-IMP-2024000582$Harrow Health$$$$A$F$Y$$$20240828$$CN$US$US
242564651$24256465$1$I$$20240820$20240828$20240828$EXP$$JP-AMGEN-JPNSP2024167905$AMGEN$$$$$$Y$$$20240827$$MD$JP$JP
242564661$24256466$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015348$ELI LILLY AND CO$$35$YR$A$$Y$$$20240828$$CN$US$US
242564671$24256467$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016257$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242564681$24256468$1$I$20240823$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015549$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240828$$CN$US$US
242564691$24256469$1$I$20240721$20240805$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003626$ACADIA PHARMACEUTICALS$$36$YR$$F$Y$$$20240828$$CN$US$US
242564702$24256470$2$F$$20240913$20240828$20240918$EXP$$CO-ROCHE-10000064094$ROCHE$$53$YR$A$F$Y$$$20240918$$CN$CO$CO
242564711$24256471$1$I$20240101$20240805$20240828$20240828$PER$$US-IMP-2024000597$Harrow Health$$$$A$F$Y$$$20240828$$CN$US$US
242564721$24256472$1$I$20240804$20240805$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004288$ACADIA PHARMACEUTICALS$$88$YR$$F$Y$$$20240828$$CN$US$US
242564731$24256473$1$I$20240824$20240824$20240828$20240828$PER$$US-AMGEN-USASP2024170007$AMGEN$$65$YR$E$F$Y$$$20240827$$CN$US$US
242564741$24256474$1$I$$20240814$20240828$20240828$EXP$$ES-AUROBINDO-AUR-APL-2024-037969$AUROBINDO$Garcia-Cebrian MJ, Fontan-Atalaya IM, Garcia-Perez J, Fernandez-Torres B. Extensive extradural pneumorrhachis related to obstetric analgesia. [Review]. Rev-Espanol-Anestes-Reanim. 2024;71(6):491-495$37$YR$$F$Y$80$KG$20240828$$HP$ES$ES
242564751$24256475$1$I$$20240814$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-040977$AUROBINDO$Li B, Chawla S, Tong M, Higgins A, Lee R. Temporary Biventricular Mechanical Circulatory Support for Primary Graft Dysfunction after Orthotopic Heart Transplantation. US Cardiology Review. 2024;18(Supplement 1:75$51$YR$$M$Y$$$20240828$$MD$US$US
242564761$24256476$1$I$$20240813$20240828$20240828$EXP$$IT-AUROBINDO-AUR-APL-2024-041024$AUROBINDO$Abbott M, Valenti G, Gizzi A, Agrenzano S, Ficalora A, Mancuso A, et al.. HBV REACTIVATION AFTER IMMUNOSUPPRESSIVE THERAPY: AN OPEN QUESTION.. Sex Transm Infect. 2024;100 (Suppl 1):A1?A281$71$YR$$M$Y$$$20240828$$HP$IT$IT
242564771$24256477$1$I$$20240818$20240828$20240828$PER$$US-AstraZeneca-2024A189664$ASTRAZENECA$$$$$$Y$$$20240828$$CN$US$
242564781$24256478$1$I$$20240813$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-041180$AUROBINDO$Phang CR, Farooqi A, Sangwan Y. Unmasking the Unusual: Cryptococcal Pericarditis in a Patient with Liver Failure - a Rare Occurrence. American Journal of Case Reports. 2024;25:e943530$47$YR$$M$Y$$$20240828$$HP$US$US
242564791$24256479$1$I$20240804$20240805$20240828$20240828$PER$$US-IMP-2024000598$Harrow Health$$71$YR$E$F$Y$$$20240828$$CN$US$US
242564801$24256480$1$I$$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A193530$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242564811$24256481$1$I$$20240826$20240828$20240828$PER$$US-TAKEDA-2024TUS086177$TAKEDA$$$$$$Y$$$20240828$$CN$US$US
242564821$24256482$1$I$20240701$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004290$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240828$$CN$US$US
242564831$24256483$1$I$20240625$20240822$20240828$20240828$EXP$$US-ABBVIE-5891992$ABBVIE$$35$YR$$F$Y$$$20240828$$CN$US$US
242564841$24256484$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249079$SANOFI AVENTIS$$$$A$F$Y$58.05$KG$20240828$$MD$US$US
242564851$24256485$1$I$$20240815$20240828$20240828$PER$$US-SA-2024SA243924$SANOFI AVENTIS$$$$$M$Y$$$20240828$$CN$US$US
242564861$24256486$1$I$20240403$20240823$20240828$20240828$EXP$$CN-ROCHE-10000065761$ROCHE$$59$YR$A$F$Y$60$KG$20240828$$HP$CN$CN
242564871$24256487$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004294$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242564881$24256488$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135581$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$81.65$KG$20240828$$CN$US$US
242564891$24256489$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249764$SANOFI AVENTIS$$$$A$M$Y$94.8$KG$20240828$$MD$US$US
242564901$24256490$1$I$$20240814$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-041052$AUROBINDO$Kim M, Graham C, Stevens RW, Shah A. A Rare Case of Bacterial Meningitis Caused by Hematogenous Spread of Vancomycin-Resistant Enterococcus faecium in an Immunocompromised Patient.  :. .. Case reports in infectious diseases. 2024;2193650:1 to 5$72$YR$$M$Y$$$20240828$$MD$US$US
242564912$24256491$2$F$20240819$20240820$20240828$20240830$EXP$$US-JNJFOC-20240859390$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240830$$MD$US$US
242564921$24256492$1$I$20240813$20240820$20240828$20240828$EXP$$IE-JNJFOC-20240862703$JOHNSON AND JOHNSON$$87$YR$E$M$Y$$$20240828$$CN$IE$IE
242564931$24256493$1$I$20240101$20240822$20240828$20240828$EXP$$BR-ABBVIE-5895841$ABBVIE$$74$YR$$M$Y$$$20240828$$MD$BR$BR
242564941$24256494$1$I$$20240813$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-040624$AUROBINDO$Dao KT, Ghadiya K, Inga Jaco E, Sharma R, Rahimi R, Sukkar M, et al. A case of revelation due to pegfilgrastim. Cureus. 2024;16(7):e63777$68$YR$$M$Y$$$20240828$$MD$US$US
242564951$24256495$1$I$$20240821$20240828$20240828$PER$$US-ROCHE-10000063757$ROCHE$$3$YR$C$M$Y$$$20240828$$CN$US$US
242564961$24256496$1$I$20240801$20240820$20240828$20240828$PER$$US-SA-2024SA248322$SANOFI AVENTIS$$$$$$Y$$$20240828$$HP$US$US
242564971$24256497$1$I$$20240815$20240828$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-041961$AUROBINDO$$$$$M$Y$$$20240828$$HP$CA$CA
242564981$24256498$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248308$SANOFI AVENTIS$$$$A$M$Y$63.5$KG$20240828$$MD$US$US
242564991$24256499$1$I$$20240822$20240828$20240828$PER$$US-ROCHE-10000064856$ROCHE$$$$C$M$Y$$$20240828$$CN$US$US
242565001$24256500$1$I$$20240819$20240828$20240828$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024103953$VIIV$$$$$F$Y$$$20240828$$MD$US$US
242565011$24256501$1$I$20240816$20240816$20240828$20240828$PER$$US-SA-2024SA249910$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240828$$MD$US$US
242565021$24256502$1$I$$20240823$20240828$20240828$PER$$US-ROCHE-10000066102$ROCHE$$63$YR$A$M$Y$$$20240828$$CN$US$US
242565031$24256503$1$I$$20240823$20240828$20240828$PER$$US-ROCHE-10000066354$ROCHE$$$$A$M$Y$$$20240828$$CN$US$US
242565041$24256504$1$I$20240824$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170775$AMGEN$$74$YR$E$F$Y$$$20240827$$CN$US$US
242565052$24256505$2$F$$20240919$20240828$20240920$PER$$NVSC2024US173238$NOVARTIS$$$$$F$Y$$$20240920$$HP$US$US
242565062$24256506$2$F$$20240904$20240828$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004296$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242565071$24256507$1$I$$20240823$20240828$20240828$PER$$US-ABBVIE-5893575$ABBVIE$$$$$F$Y$$$20240828$$MD$US$US
242565081$24256508$1$I$20240712$20240820$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013111$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242565091$24256509$1$I$$20240821$20240828$20240828$EXP$$GB-ROCHE-10000064285$ROCHE$$41$YR$A$F$Y$$$20240828$$MD$GB$GB
242565101$24256510$1$I$$20240822$20240828$20240828$PER$$US-ROCHE-10000066063$ROCHE$$3$YR$C$M$Y$$$20240828$$CN$US$US
242565113$24256511$3$F$$20240914$20240828$20240926$EXP$BR-MLMSERVICE-20240808-PI156439-00306-2$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-19360$ALKEM$Honorato CMA, Carrascoza GG, Abed NM, Moya FG.. Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor. Brazilian Annals of Dermatology. 2024;99:1-4$60$YR$$M$Y$$$20240926$$MD$BR$BR
242565121$24256512$1$I$20240601$20240820$20240828$20240828$EXP$$IN-BIOGEN-2024BI01279298$BIOGEN$$20$YR$$F$Y$$$20240828$$CN$IN$IN
242565132$24256513$2$F$$20240923$20240828$20240927$EXP$$US-BIOGEN-2024BI01279735$BIOGEN$$$$$F$Y$$$20240927$$CN$US$US
242565143$24256514$3$F$$20240914$20240828$20240926$EXP$BR-MLMSERVICE-20240808-PI156439-00306-1$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-19363$ALKEM$Honorato CM, Carrascoza GG, Abed NM, Moya FG.. Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor. Brazilian Annals of Dermatology. 2024;unk:1-4$72$YR$$M$Y$$$20240926$$MD$BR$BR
242565152$24256515$2$F$$20240902$20240828$20240905$EXP$$ZA-HALEON-2193389$Haleon PLC$$$$$$Y$$$20240905$$CN$ZA$ZA
242565162$24256516$2$F$$20240828$20240828$20240912$EXP$US-MLMSERVICE-20240807-PI154441-00232-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19483$ALKEM$Farkouh EK, Michel IM, Harrison DJ, Issa N.. Dual Donor-Derived Renal Allograft Mucormycosis From a Single Deceased Donor. Mayo Clinic Proceedings.. 2024;99(8):1339-1346$7$DEC$$F$Y$$$20240912$$HP$US$US
242565171$24256517$1$I$20240801$20240823$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047676$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240828$$CN$US$US
242565182$24256518$2$F$20240520$20240918$20240828$20240920$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-029008$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$$$20240920$$CN$CA$CA
242565191$24256519$1$I$20240818$20240820$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013083$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242565201$24256520$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248501$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242565211$24256521$1$I$20240801$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135960$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240828$$CN$US$US
242565231$24256523$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135694$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240828$$HP$US$US
242565241$24256524$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-134211-2023$RECKITT BENCKISER$$51$YR$$M$Y$$$20240828$$CN$US$US
242565251$24256525$1$I$$20240819$20240828$20240828$EXP$DE-DCGMA-24203347$DE-ROCHE-10000060172$ROCHE$$83$YR$E$F$Y$61$KG$20240828$$MD$DE$DE
242565261$24256526$1$I$20240801$20240821$20240828$20240828$PER$$US-AstraZeneca-2024A191211$ASTRAZENECA$$79$YR$$M$Y$$$20240828$$CN$US$
242565272$24256527$2$F$$20240826$20240828$20240903$EXP$$US-AstraZeneca-2024A194450$ASTRAZENECA$$$$$F$Y$$$20240903$$HP$US$
242565281$24256528$1$I$20240825$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015989$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240828$$CN$US$US
242565292$24256529$2$F$$20240829$20240828$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004298$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
242565301$24256530$1$I$$20240826$20240828$20240828$EXP$$CA-HALEON-2193504$Haleon PLC$$71$YR$$F$Y$$$20240827$$CN$CA$CA
242565311$24256531$1$I$$20240826$20240828$20240828$EXP$$NVSC2024DE173041$NOVARTIS$$$$A$F$Y$$$20240828$$MD$DE$DE
242565321$24256532$1$I$20181012$20240815$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041625$AUROBINDO$$53$YR$$F$Y$83$KG$20240828$$CN$GB$GB
242565331$24256533$1$I$$20240823$20240828$20240828$EXP$$CA-ROCHE-10000066372$ROCHE$$$$A$M$Y$$$20240828$$CN$CA$CA
242565351$24256535$1$I$$20240822$20240828$20240828$PER$$US-ABBVIE-5893233$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242565361$24256536$1$I$20240714$20240722$20240828$20240828$PER$$US-IMP-2024000539$Harrow Health$$74$YR$E$F$Y$$$20240828$$CN$US$US
242565372$24256537$2$F$20240101$20240822$20240828$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-018907$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240830$$$US$US
242565381$24256538$1$I$20240609$20240820$20240828$20240828$EXP$$ES-HALEON-2193210$Haleon PLC$$73$YR$$F$Y$$$20240827$$MD$ES$ES
242565391$24256539$1$I$$20240820$20240828$20240828$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024103871$VIIV$$3$DEC$$M$Y$$$20240828$$MD$US$US
242565401$24256540$1$I$$20240826$20240828$20240828$PER$$US-ROCHE-10000066930$ROCHE$$$$$F$Y$$$20240828$$HP$US$US
242565411$24256541$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136005$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$92.53$KG$20240828$$HP$US$US
242565423$24256542$3$F$$20240918$20240828$20240921$PER$$US-ROCHE-10000066897$ROCHE$$$$E$M$Y$$$20240921$$CN$US$US
242565431$24256543$1$I$$20240821$20240828$20240828$EXP$$US-JNJFOC-20240855386$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240828$$CN$US$US
242565442$24256544$2$F$20240101$20240917$20240828$20240923$EXP$$US-JNJFOC-20240869498$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240924$$HP$US$US
242565451$24256545$1$I$$20240826$20240828$20240828$EXP$$CA-HALEON-2193572$Haleon PLC$$66$YR$$M$Y$$$20240827$$CN$CA$CA
242565461$24256546$1$I$$20240823$20240828$20240828$PER$$US-ROCHE-10000065592$ROCHE$$$$A$F$Y$$$20240828$$CN$US$US
242565471$24256547$1$I$20240728$20240803$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004261$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240828$$CN$US$US
242565481$24256548$1$I$$20240815$20240828$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-042037$AUROBINDO$Wynnychuk L, Huynh L, Stilos K... Challenges in nursing care for patients with  cancer and severe mental illness: A case report. CANADIAN ONCOLOGY NURSING JOURNAL. 2023;33(3):373-376$34$YR$$M$Y$$$20240828$$HP$CA$CA
242565491$24256549$1$I$20240811$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024168548$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242565501$24256550$1$I$20240723$20240822$20240828$20240828$EXP$$CN-HALEON-2193295$Haleon PLC$$59$YR$$F$Y$59$KG$20240827$$HP$CN$CN
242565511$24256551$1$I$$20240731$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07866$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242565521$24256552$1$I$$20240814$20240828$20240828$PER$$US-ABBVIE-5894389$ABBVIE$$48$YR$$F$Y$$$20240828$$CN$US$US
242565531$24256553$1$I$$20240826$20240828$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013526$JAZZ$$$$$$Y$$$20240827$$PH$US$US
242565541$24256554$1$I$$20240822$20240828$20240828$EXP$$ZA-AstraZeneca-2024A192966$ASTRAZENECA$$88$YR$$M$Y$$$20240828$$CN$ZA$
242565551$24256555$1$I$$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A193369$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242565561$24256556$1$I$$20240823$20240828$20240828$EXP$$CA-ROCHE-10000066373$ROCHE$$$$A$F$Y$$$20240828$$CN$CA$CA
242565571$24256557$1$I$$20240820$20240828$20240828$EXP$$MX-JNJFOC-20240857082$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240828$$HP$MX$MX
242565581$24256558$1$I$20240410$20240827$20240828$20240828$EXP$$PK-ROCHE-10000067230$ROCHE$$62$YR$A$F$Y$$$20240828$$MD$PK$PK
242565591$24256559$1$I$20210101$20240821$20240828$20240828$EXP$$US-AMGEN-USASP2024167870$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242565611$24256561$1$I$$20240821$20240828$20240828$EXP$$US-ROCHE-10000063519$ROCHE$$17$YR$T$F$Y$$$20240828$$CN$US$US
242565622$24256562$2$F$20240801$20240830$20240828$20240903$EXP$$US-AMGEN-USASP2024169438$AMGEN$$94$YR$E$F$Y$$$20240903$$MD$US$US
242565631$24256563$1$I$$20240731$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07864$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242565651$24256565$1$I$20240730$20240819$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-012999$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242565661$24256566$1$I$20240825$20240826$20240828$20240828$PER$$US-ROCHE-10000066455$ROCHE$$59$YR$A$F$Y$$$20240828$$CN$US$US
242565671$24256567$1$I$$20240823$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135908$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240828$$CN$US$US
242565683$24256568$3$F$20240820$20240920$20240828$20240926$PER$$US-AMGEN-USASP2024167035$AMGEN$$80$YR$E$M$Y$$$20240926$$CN$US$US
242565691$24256569$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016073$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$US$US
242565701$24256570$1$I$$20240820$20240828$20240828$EXP$$US-AMGEN-USASP2024167042$AMGEN$Ronsley R.; Tam L.T.; Cole B. et al.. Somatic Versus Germline: A Case Series of Three Children With ATM-Mutated Medulloblastoma. JCO Precision Oncology. 2024;8:1-9$8$YR$C$F$Y$$$20240827$$MD$US$US
242565712$24256571$2$F$$20240827$20240828$20240828$PER$$US-ROCHE-10000067728$ROCHE$$$$$$Y$$$20240828$$CN$US$US
242565722$24256572$2$F$20240901$20240920$20240828$20240925$EXP$$US-AMGEN-USASP2024169775$AMGEN$$20$YR$$M$Y$$$20240925$$CN$US$US
242565731$24256573$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170830$AMGEN$$$$$$Y$$$20240827$$HP$US$US
242565741$24256574$1$I$$20240826$20240828$20240828$EXP$$CN-HALEON-2193702$Haleon PLC$Tang M. ^Universal painkiller^ Ibuprofen, Taking the wrong dose is dangerous. Zhu Nin Jian Kang. 2024 August; 30-31.; Tang M. ^Universal painkiller^ Ibuprofen, Taking the wrong dose is dangerous. Zhu Nin Jian Kang. 2024; 30-31.$$$$$Y$$$20240827$$HP$CN$CN
242565771$24256577$1$I$$20240819$20240828$20240828$EXP$$CA-HALEON-2193291$Haleon PLC$$$$$F$Y$$$20240828$$MD$CA$CA
242565781$24256578$1$I$20240101$20240822$20240828$20240828$EXP$$US-ABBVIE-5892385$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242565791$24256579$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170693$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242565801$24256580$1$I$$20240813$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-041200$AUROBINDO$Schlatter MI, Yandamuri SS, O^Connor KC, Nowak RJ, Pham MC, Richard N, et al. Remission of severe myasthenia gravis after autologous stem cell transplantation. Annals of Clinical and Translational Neurology. 2023;10(11):2105?2113$33$YR$$F$Y$$$20240828$$HP$US$US
242565812$24256581$2$F$20240724$20240827$20240828$20240828$PER$$US-JNJFOC-20240816621$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240828$$CN$US$US
242565821$24256582$1$I$20240601$20240824$20240828$20240828$PER$$US-AMGEN-USASP2024170401$AMGEN$$71$YR$E$F$Y$$$20240827$$CN$US$US
242565831$24256583$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004304$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242565841$24256584$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173248$NOVARTIS$$$$$F$Y$$$20240828$$HP$US$US
242565862$24256586$2$F$20240821$20240822$20240828$20240829$PER$$US-AMGEN-USASP2024169247$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242565872$24256587$2$F$$20240902$20240828$20240911$EXP$$GB-TEVA-VS-3236260$TEVA$Farag M, Bahra A. Secondary cough headache: Independent course of headache and response to a COX-2 inhibitor. Clin-Neurol-Neurosurg 2023; 227 107646.; Farag M, Bahra A. Secondary cough headache: Independent course of headache and response to a COX-2 inhibitor. Clin-Neurol-Neurosurg 2023; 227 107646.; Farag M, Bahra A. Secondary cough headache: Independent course of headache and response to a COX-2 inhibitor. Clin-Neurol-Neurosurg 2023; 227 107646.$51$YR$$F$Y$$$20240911$$HP$GB$GB
242565891$24256589$1$I$$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131976$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240828$$CN$US$US
242565901$24256590$1$I$$20240817$20240828$20240828$EXP$$US-ALVOGEN-2024095370$ALVOGEN$$$$$F$Y$$$20240828$$CN$US$US
242565911$24256591$1$I$20240703$20240820$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013104$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242565921$24256592$1$I$$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131940$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$102.51$KG$20240828$$HP$US$US
242565941$24256594$1$I$$20240821$20240828$20240828$EXP$$US-AMGEN-USASP2024167704$AMGEN$Molnar M.; Yamauchi J.; Azhar A.et al.. Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2-Infected versus Noninfected Deceased Donors. Clinical journal of the American Society of Nephrology. 2023;18 (11):1466-1475$$$$$Y$$$20240827$$HP$US$US
242565952$24256595$2$F$$20240827$20240828$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004313$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242565972$24256597$2$F$20231101$20240829$20240828$20240906$EXP$$US-SPECGX-T202401453$SPECGX$$45$YR$$M$Y$113.38$KG$20240906$$CN$US$US
242565982$24256598$2$F$$20240820$20240828$20240925$PER$$US-BEH-2024177466$CSL BEHRING$$$$$$Y$$$20240925$$CN$US$US
242565992$24256599$2$F$$20240918$20240828$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004314$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242566001$24256600$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004312$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242566012$24256601$2$F$20240825$20240826$20240828$20240902$PER$$US-HALEON-2193775$Haleon PLC$$$$$$Y$$$20240902$$CN$US$US
242566031$24256603$1$I$20240801$20240812$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08213$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242566042$24256604$2$F$$20240920$20240828$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004319$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242566051$24256605$1$I$20240802$20240821$20240828$20240828$EXP$$CN-JNJFOC-20240859520$JOHNSON AND JOHNSON$$$$N$M$Y$1.35$KG$20240828$$HP$CN$CN
242566063$24256606$3$F$20240806$20240916$20240828$20240925$30DAY$$US-JNJFOC-20240817984$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240925$$CN$US$US
242566081$24256608$1$I$$20240827$20240828$20240828$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048151$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240828$$HP$SG$SG
242566091$24256609$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004320$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242566101$24256610$1$I$$20240813$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08167$LUPIN$$$$$$Y$$$20240828$$MD$US$US
242566111$24256611$1$I$20220627$20240819$20240828$20240828$EXP$$JP-EMD Serono-2024045180$EMD SERONO INC$$48$YR$A$F$Y$92$KG$20240828$$MD$JP$JP
242566121$24256612$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170707$AMGEN$$$$$F$Y$$$20240827$$HP$US$US
242566131$24256613$1$I$$20240823$20240828$20240828$PER$$US-ROCHE-10000067267$ROCHE$$62$YR$A$F$Y$$$20240828$$CN$US$US
242566141$24256614$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004336$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242566151$24256615$1$I$20240701$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004322$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240828$$CN$US$US
242566161$24256616$1$I$$20240814$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129426$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$PH$US$US
242566171$24256617$1$I$20240723$20240819$20240828$20240828$EXP$$CL-EMD Serono-2024044715$EMD SERONO INC$$33$YR$A$F$Y$$$20240828$$CN$CL$CL
242566181$24256618$1$I$$20240819$20240828$20240828$30DAY$$US-GSK-US2024103426$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$CN$US$US
242566191$24256619$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004343$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242566201$24256620$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016171$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240828$$CN$US$US
242566211$24256621$1$I$$20240816$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408011450$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242566221$24256622$1$I$$20240820$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014893$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242566231$24256623$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015960$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240828$$CN$US$US
242566241$24256624$1$I$$20240823$20240828$20240828$EXP$$IN-ROCHE-10000065409$ROCHE$$76$YR$E$F$Y$$$20240828$$CN$IN$IN
242566251$24256625$1$I$$20240821$20240828$20240828$EXP$$US-ROCHE-10000063423$ROCHE$$73$YR$E$F$Y$$$20240828$$CN$US$US
242566261$24256626$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170825$AMGEN$$$$$$Y$$$20240827$$CN$US$US
242566271$24256627$1$I$20240701$20240814$20240828$20240828$EXP$$US-UCBSA-2024041368$UCB$$61$YR$$F$Y$$$20240828$$HP$US$US
242566281$24256628$1$I$$20240826$20240828$20240828$EXP$$NVSJ2024JP010036$NOVARTIS$$9$YR$$$Y$17$KG$20240828$$MD$JP$JP
242566292$24256629$2$F$$20240828$20240828$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004345$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
242566301$24256630$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173309$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242566311$24256631$1$I$$20240824$20240828$20240828$PER$$NVSC2024US172463$NOVARTIS$$$$$$Y$$$20240828$$CN$US$US
242566323$24256632$3$F$20240801$20240909$20240828$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004306$ACADIA PHARMACEUTICALS$$11$YR$$F$Y$$$20240927$$CN$US$US
242566332$24256633$2$F$20230912$20240906$20240828$20240909$EXP$IE-HPRA-2024-114882$IE-JNJFOC-20240869288$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240910$$PH$IE$IE
242566351$24256635$1$I$20240804$20240825$20240828$20240828$EXP$GB-MHRA-MED-202408251452442570-LZHFP$GB-ORGANON-O2408GBR001818$ORGANON$$39$YR$$M$Y$$$20240828$$PH$GB$GB
242566361$24256636$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004342$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242566371$24256637$1$I$$20240823$20240828$20240828$EXP$$US-EMD Serono-2024045875$EMD SERONO INC$$$$E$F$Y$$$20240828$$CN$US$US
242566381$24256638$1$I$$20240801$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07756$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242566392$24256639$2$F$$20240902$20240828$20240917$EXP$$TH-ALKEM LABORATORIES LIMITED-TH-ALKEM-2024-19787$ALKEM$Thumtecho S, Wainipitapong S, Suteparuk S. Escitalopram, bupropion, lurasidone, lamotrigine and possible vortioxetine overdose presented with serotonin syndrome and diffuse encephalopathy: A case report. Toxicol Rep. 2021;8:1846-8$20$YR$$F$Y$$$20240917$$HP$TH$TH
242566401$24256640$1$I$20240606$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004347$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240828$$CN$US$US
242566411$24256641$1$I$20240824$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135856$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$77.56$KG$20240828$$CN$US$US
242566422$24256642$2$F$$20240821$20240828$20240903$EXP$$PS-BEIGENE-BGN-2024-013355$BEIGENE$$$$$$Y$$$20240903$$MD$PS$PS
242566431$24256643$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004346$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242566441$24256644$1$I$20240811$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136137$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240828$$CN$US$US
242566451$24256645$1$I$$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136206$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240828$$CN$US$US
242566461$24256646$1$I$$20240804$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07884$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242566471$24256647$1$I$20240821$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024168550$AMGEN$$57$YR$A$M$Y$$$20240827$$CN$US$US
242566482$24256648$2$F$$20240924$20240828$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132041$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240927$$CN$US$US
242566492$24256649$2$F$20240101$20240822$20240828$20240918$30DAY$$US-UCBSA-2024040098$UCB$$$$$M$Y$$$20240918$$CN$US$US
242566502$24256650$2$F$20240823$20240918$20240828$20240919$PER$$US-AMGEN-USASP2024169389$AMGEN$$74$YR$E$F$Y$$$20240919$$HP$US$US
242566511$24256651$1$I$$20240821$20240828$20240828$PER$$US-BEH-2024177579$CSL BEHRING$$$$A$F$Y$$$20240828$$PH$US$US
242566522$24256652$2$F$20240301$20240903$20240828$20240910$PER$$US-AMGEN-USASP2024167971$AMGEN$$32$YR$A$M$Y$120$KG$20240909$$HP$US$US
242566531$24256653$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173310$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242566543$24256654$3$F$20240821$20240904$20240828$20240909$30DAY$$US-AMGEN-USASP2024168507$AMGEN$$73$YR$E$M$Y$53.968$KG$20240909$$HP$US$US
242566551$24256655$1$I$20240303$20240312$20240828$20240828$PER$$US-AUROBINDO-AUR-APL-2024-012864$AUROBINDO$$35$YR$$F$Y$49$KG$20240828$$CN$US$US
242566561$24256656$1$I$$20240803$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004350$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242566581$24256658$1$I$$20240802$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07835$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242566591$24256659$1$I$$20240827$20240828$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA075608$SANDOZ$$$$$F$Y$$$20240828$$HP$CA$CA
242566601$24256660$1$I$20240809$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169205$AMGEN$$54$YR$A$F$Y$$$20240827$$CN$US$US
242566611$24256661$1$I$$20240819$20240828$20240828$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006150$BIOCON$$$$$$Y$$$20240828$$CN$CA$CA
242566621$24256662$1$I$20240601$20240820$20240828$20240828$EXP$$US-JNJFOC-20240854888$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240828$$CN$US$US
242566631$24256663$1$I$20240723$20240822$20240828$20240828$PER$$US-JNJFOC-20240857982$JOHNSON AND JOHNSON$$37$YR$A$$Y$$$20240828$$CN$US$US
242566641$24256664$1$I$$20240823$20240828$20240828$EXP$$US-JNJFOC-20240866529$JOHNSON AND JOHNSON$$$$$M$Y$$$20240828$$CN$US$US
242566651$24256665$1$I$$20240813$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-041062$AUROBINDO$Goyal A, Jakula RS, Hans K, Kolbeck MC, Yarrarapu SN, Bhyan P, et al. Accidental Minoxidil Ingestion Causing Refractory Shock, Pulmonary Edema, and Significant EKG Changes. US Cardiology Review. 2024;18(Supplement 1:23-4$51$YR$$M$Y$$$20240828$$MD$US$US
242566661$24256666$1$I$$20240823$20240828$20240828$PER$$US-ALXN-202408USA001645US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$US$US
242566673$24256667$3$F$20240723$20240830$20240828$20240904$EXP$$CA-JNJFOC-20240774727$JOHNSON AND JOHNSON$$17$YR$T$M$Y$63$KG$20240904$$CN$CA$CA
242566691$24256669$1$I$$20240815$20240828$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-042019$AUROBINDO$$34$YR$$M$Y$$$20240828$$HP$CA$CA
242566702$24256670$2$F$20240809$20240910$20240828$20240913$EXP$$US-JNJFOC-20240858302$JOHNSON AND JOHNSON$$35$YR$A$M$Y$64.9$KG$20240913$$MD$US$ZA
242566711$24256671$1$I$20240101$20240826$20240828$20240828$PER$$US-BAUSCH-BL-2024-012933$BAUSCH AND LOMB$$$$$F$Y$$$20240828$$CN$US$US
242566721$24256672$1$I$$20240802$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07834$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242566731$24256673$1$I$$20240820$20240828$20240828$EXP$GB-MHRA-TPP25321237C9512001YC1724056330270$GB-RDY-SPO/GBR/24/0012208$DR REDDYS$$54$YR$A$F$Y$116$KG$20240828$$MD$GB$GB
242566741$24256674$1$I$$20240812$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128646$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240828$$CN$US$US
242566752$24256675$2$F$20240823$20240911$20240828$20240912$PER$$US-AMGEN-USASP2024170708$AMGEN$$79$YR$E$F$Y$$$20240912$$CN$US$US
242566761$24256676$1$I$20240726$20240821$20240828$20240828$PER$$US-AMGEN-USASP2024167780$AMGEN$$72$YR$E$F$Y$60$KG$20240827$$HP$US$US
242566771$24256677$1$I$20240825$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016095$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240828$$CN$US$US
242566781$24256678$1$I$$20240821$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408013879$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240828$$CN$US$US
242566791$24256679$1$I$20240101$20240821$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014945$ELI LILLY AND CO$$$$$M$Y$$$20240828$$CN$US$US
242566801$24256680$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016159$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240828$$CN$US$US
242566811$24256681$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016136$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242566821$24256682$1$I$20240818$20240818$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015523$ELI LILLY AND CO$$66$YR$E$F$Y$86.621$KG$20240828$$CN$US$US
242566831$24256683$1$I$20240819$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016447$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240828$$CN$US$US
242566841$24256684$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016372$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240828$$CN$US$US
242566851$24256685$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016158$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240828$$CN$US$US
242566861$24256686$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015982$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240828$$CN$US$US
242566871$24256687$1$I$20240701$20240822$20240828$20240828$EXP$$US-ABBVIE-5891362$ABBVIE$$51$YR$$F$Y$$$20240828$$CN$US$US
242566902$24256690$2$F$$20240827$20240828$20240830$PER$$NVSC2024US173149$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
242566911$24256691$1$I$$20240819$20240828$20240828$EXP$$US-TEVA-VS-3235522$TEVA$Rios IP, Nguyen CHL, Misra SS, Ryan MS, Nair SS, Khamash HA. Foscarnet-induced nephropathy in a kidney transplant recipient. Kidney-Int 2024; 106 (1): 156.$53$YR$$M$Y$$$20240828$$HP$US$US
242566922$24256692$2$F$20240605$20240925$20240828$20240930$EXP$$CA-ABBVIE-5892404$ABBVIE$$36$YR$$M$Y$90$KG$20240930$$CN$CA$CA
242566931$24256693$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170137$AMGEN$$$$$F$Y$$$20240827$$CN$US$US
242566941$24256694$1$I$$20240819$20240828$20240828$30DAY$$US-GSK-US2024103406$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$CN$US$US
242566951$24256695$1$I$20240601$20240821$20240828$20240828$EXP$$US-VIIV HEALTHCARE LIMITED-US2024104475$VIIV$$30$YR$$M$Y$$$20240828$$CN$US$US
242566961$24256696$1$I$$20240819$20240828$20240828$EXP$$BE-BRISTOL-MYERS SQUIBB COMPANY-2024-132101$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240828$$MD$BE$BE
242566971$24256697$1$I$$20240825$20240828$20240828$EXP$$US-ABBVIE-5895824$ABBVIE$$$$$F$Y$$$20240828$$HP$US$US
242566982$24256698$2$F$$20240913$20240828$20240924$30DAY$$GB-JNJFOC-20240854797$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$GB$GB
242566991$24256699$1$I$20240101$20240820$20240828$20240828$EXP$$JP-AMGEN-JPNSP2024167866$AMGEN$$$$E$F$Y$$$20240827$$MD$JP$JP
242567001$24256700$1$I$20240801$20240826$20240828$20240828$EXP$$US-ABBVIE-5896394$ABBVIE$$84$YR$$M$Y$$$20240828$$CN$US$US
242567011$24256701$1$I$20240704$20240820$20240828$20240828$EXP$GB-MHRA-MED-202408121729198790-MRLPQ$GB-RDY-SPO/GBR/24/0012205$DR REDDYS$$$$$M$Y$82$KG$20240828$$HP$GB$GB
242567021$24256702$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136007$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240828$$MD$US$US
242567031$24256703$1$I$$20240816$20240828$20240828$EXP$$SE-AUROBINDO-AUR-APL-2024-041825$AUROBINDO$Zilg B, Alkass K, Berg S, Druid H.. Interpretation of postmortem vitreous concentrations of sodium and chloride.. Forensic-Sci-Int. 2016;263:107-113.$55$YR$$F$Y$$$20240828$$HP$SE$SE
242567042$24256704$2$F$20240809$20240916$20240828$20240926$PER$$US-GSK-US2024103410$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240926$$CN$US$US
242567052$24256705$2$F$20240824$20240903$20240828$20240905$PER$$US-AMGEN-USASP2024170352$AMGEN$$73$YR$E$F$Y$$$20240905$$CN$US$US
242567071$24256707$1$I$20230601$20240823$20240828$20240828$EXP$$US-ABBVIE-5894427$ABBVIE$$58$YR$$M$Y$$$20240828$$CN$US$US
242567081$24256708$1$I$20240803$20240821$20240828$20240828$PER$$US-BIOGEN-2024BI01279340$BIOGEN$$58$YR$$F$Y$$$20240828$$CN$US$US
242567091$24256709$1$I$$20240822$20240828$20240828$PER$$US-BIOGEN-2024BI01246638$BIOGEN$$$$$M$Y$$$20240828$$CN$US$US
242567102$24256710$2$F$$20240904$20240828$20240909$PER$$US-BIOGEN-2024BI01279705$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
242567111$24256711$1$I$20240815$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024168754$AMGEN$$68$YR$E$F$Y$$$20240827$$CN$US$US
242567122$24256712$2$F$20240816$20240823$20240828$20240904$EXP$$JP-ABBVIE-5892882$ABBVIE$$82$YR$$F$Y$$$20240904$$MD$JP$JP
242567152$24256715$2$F$$20240830$20240828$20240909$EXP$$GB-CELLTRION INC.-2024GB020259$CELLTRION$$$$$$Y$$$20240909$$CN$GB$GB
242567161$24256716$1$I$$20240820$20240828$20240828$PER$$US-AstraZeneca-2024A190753$ASTRAZENECA$$$$$F$Y$$$20240828$$HP$US$
242567171$24256717$1$I$$20240816$20240828$20240828$PER$$US-AstraZeneca-2024A191615$ASTRAZENECA$$24$YR$$F$Y$$$20240828$$CN$US$
242567181$24256718$1$I$$20240820$20240828$20240828$PER$$US-AstraZeneca-2024A190934$ASTRAZENECA$$$$$F$Y$$$20240828$$HP$US$
242567191$24256719$1$I$20240316$20240820$20240828$20240828$EXP$$CO-AstraZeneca-2024A191094$ASTRAZENECA$$26485$DY$$F$Y$62$KG$20240828$$CN$CO$
242567202$24256720$2$F$20240809$20240827$20240828$20240828$PER$$US-AMGEN-USASP2024170643$AMGEN$$77$YR$E$F$Y$$$20240828$$CN$US$US
242567211$24256721$1$I$20240301$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024168369$AMGEN$$64$YR$A$M$Y$$$20240828$$CN$US$US
242567221$24256722$1$I$$20240822$20240828$20240828$EXP$$US-JNJFOC-20240859398$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240828$$HP$US$US
242567231$24256723$1$I$$20240822$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047936$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240828$$CN$US$US
242567242$24256724$2$F$$20240902$20240828$20240912$EXP$$US-APOTEX-2024AP009595$APOTEX$$$$A$F$Y$83.9$KG$20240912$$CN$US$US
242567251$24256725$1$I$$20240822$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134197$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240828$$CN$US$US
242567271$24256727$1$I$$20240815$20240828$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-042009$AUROBINDO$$50$YR$$M$Y$$$20240828$$HP$CA$CA
242567282$24256728$2$F$$20240822$20240828$20240830$30DAY$$US-GSK-US2024105070$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$HP$US$US
242567291$24256729$1$I$20240821$20240821$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015535$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240828$$CN$US$US
242567301$24256730$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016034$ELI LILLY AND CO$$46$YR$A$$Y$$$20240828$$CN$US$US
242567311$24256731$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016075$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240828$$CN$US$US
242567323$24256732$3$F$20240101$20240917$20240828$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-025629$UNITED THERAPEUTICS$$$$$F$Y$73.923$KG$20240924$$$US$US
242567331$24256733$1$I$$20240816$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408010777$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240828$$CN$US$US
242567341$24256734$1$I$$20240822$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015045$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240828$$CN$US$US
242567351$24256735$1$I$20240816$20240827$20240828$20240828$EXP$$CN-ROCHE-10000067068$ROCHE$$56$YR$A$F$Y$59$KG$20240828$$HP$CN$CN
242567361$24256736$1$I$$20240821$20240828$20240828$EXP$$NVSC2024GB170510$NOVARTIS$$$$E$M$Y$$$20240828$$CN$GB$GB
242567372$24256737$2$F$20240801$20240926$20240828$20240930$EXP$$NVSJ2024JP009986$NOVARTIS$$$$$$Y$$$20240930$$MD$JP$JP
242567381$24256738$1$I$$20240826$20240828$20240828$PER$$US-ROCHE-10000067248$ROCHE$$61$YR$A$F$Y$$$20240828$$HP$US$US
242567391$24256739$1$I$20240725$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2024-041592$AUROBINDO$$76$YR$$F$Y$55$KG$20240828$$MD$FR$FR
242567401$24256740$1$I$20240713$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2024-041868$AUROBINDO$$$$A$M$Y$$$20240828$$MD$FR$FR
242567422$24256742$2$F$20240604$20240903$20240828$20240908$EXP$$JP-GSK-JP2024JPN098181$GLAXOSMITHKLINE$$$$$$Y$$$20240908$$MD$JP$JP
242567431$24256743$1$I$20230607$20240816$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041731$AUROBINDO$$76$YR$$M$Y$103$KG$20240828$$HP$GB$GB
242567442$24256744$2$F$20240709$20240822$20240828$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-041692$AUROBINDO$$61$YR$$M$Y$$$20240903$$MD$DE$DE
242567451$24256745$1$I$$20240819$20240828$20240828$EXP$$CA-APOTEX-2024AP009523$APOTEX$$62$YR$$M$Y$$$20240828$$HP$CA$CA
242567462$24256746$2$F$$20240815$20240828$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-041952$AUROBINDO$Costa T, Hannah M, Cuperfain A, Chopra N. Maintaining evidence-based opioid  agonist treatment during a methadone to buprenorphine rotation with slow-release oral morphine. Canadian Journal of Addiction. 2023;14(1):15-8$34$YR$$M$Y$$$20240829$$MD$CA$CA
242567471$24256747$1$I$$20240819$20240828$20240828$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046662$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240828$$MD$US$US
242567481$24256748$1$I$20240514$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2024-041672$AUROBINDO$$79$YR$$F$Y$60$KG$20240828$$MD$FR$FR
242567491$24256749$1$I$$20240705$20240828$20240828$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR105626$VIIV$$$$$M$Y$$$20240828$$CN$US$US
242567501$24256750$1$I$$20240823$20240828$20240828$EXP$$NVSJ2024JP009980$NOVARTIS$$$$$$Y$$$20240828$$MD$JP$JP
242567511$24256751$1$I$$20240820$20240828$20240828$PER$$US-ABBVIE-5890912$ABBVIE$$$$$F$Y$$$20240828$$HP$US$US
242567521$24256752$1$I$20240101$20240821$20240828$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-023927$UNITED THERAPEUTICS$$$$$F$Y$97.506$KG$20240828$$$US$US
242567531$24256753$1$I$$20240817$20240828$20240828$EXP$$NL-AUROBINDO-AUR-APL-2024-042146$AUROBINDO$$62$YR$$F$Y$94$KG$20240828$$CN$NL$NL
242567541$24256754$1$I$20240819$20240822$20240828$20240828$PER$$US-BIOGEN-2024BI01279611$BIOGEN$$42$YR$$F$Y$$$20240828$$CN$US$US
242567551$24256755$1$I$20230101$20240821$20240828$20240828$PER$$US-EMD Serono-2024045382$EMD SERONO INC$$38$YR$A$F$Y$$$20240828$$MD$US$US
242567561$24256756$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136025$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$80.74$KG$20240828$$CN$US$US
242567571$24256757$1$I$20240815$20240816$20240828$20240828$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-132045$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$81.65$KG$20240828$$CN$PR$PR
242567581$24256758$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136030$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240828$$CN$US$US
242567591$24256759$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135527$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240828$$HP$US$US
242567602$24256760$2$F$20240821$20240826$20240828$20240829$EXP$$US-ROCHE-10000066552$ROCHE$$1$YR$I$M$Y$11.2$KG$20240829$$CN$US$US
242567611$24256761$1$I$20240813$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A192999$ASTRAZENECA$$33919$DY$$F$Y$$$20240828$$CN$US$
242567621$24256762$1$I$20240713$20240817$20240828$20240828$EXP$$DE-AUROBINDO-AUR-APL-2024-042138$AUROBINDO$$82$YR$$F$Y$58$KG$20240828$$CN$DE$DE
242567641$24256764$1$I$$20240820$20240828$20240828$PER$$US-ABBVIE-5894354$ABBVIE$$$$$$Y$$$20240828$$CN$US$US
242567661$24256766$1$I$20190501$20191127$20240828$20240828$EXP$$JP-GSK-JP2018JPN158302$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$JP$JP
242567671$24256767$1$I$20240611$20240821$20240828$20240828$EXP$$ES-JNJFOC-20240868961$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240828$$MD$ES$ES
242567681$24256768$1$I$$20240806$20240828$20240828$PER$$US-JNJFOC-20240816682$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242567701$24256770$1$I$20240420$20240827$20240828$20240828$EXP$$PK-ROCHE-10000067229$ROCHE$$61$YR$A$F$Y$$$20240828$$CN$PK$PK
242567721$24256772$1$I$$20240805$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004396$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242567731$24256773$1$I$$20240815$20240828$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-041974$AUROBINDO$$23$YR$$F$Y$$$20240828$$HP$CA$CA
242567742$24256774$2$F$$20240917$20240828$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-025341$UNITED THERAPEUTICS$$$$$F$Y$113.38$KG$20240921$$$US$US
242567751$24256775$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173333$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242567761$24256776$1$I$20240814$20240815$20240828$20240828$EXP$$US-MDD US Operations-MDD202408-003038$MDD OPERATIONS$$69$YR$$M$Y$$$20240828$$HP$US$
242567771$24256777$1$I$$20240801$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07757$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242567781$24256778$1$I$$20240821$20240828$20240828$EXP$$CA-APOTEX-2024AP009689$APOTEX$$48$YR$$F$Y$$$20240828$$HP$CA$CA
242567791$24256779$1$I$$20240814$20240828$20240828$PER$$US-ABBVIE-5893996$ABBVIE$$31$YR$$M$Y$$$20240828$$CN$US$US
242567801$24256780$1$I$20240727$20240805$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004309$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240828$$CN$US$US
242567813$24256781$3$F$20240101$20240913$20240828$20240918$PER$$US-UNITED THERAPEUTICS-UNT-2024-026534$UNITED THERAPEUTICS$$$$$M$Y$102.04$KG$20240918$$$US$US
242567821$24256782$1$I$20240101$20240820$20240828$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-016551$UNITED THERAPEUTICS$$$$$M$Y$79.365$KG$20240828$$$US$US
242567831$24256783$1$I$$20240822$20240828$20240828$EXP$$JP-009507513-2408JPN002685J$MERCK$$9$DEC$$M$Y$$$20240828$$HP$JP$JP
242567841$24256784$1$I$20240810$20240820$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013076$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242567851$24256785$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170968$AMGEN$$$$$$Y$$$20240828$$CN$US$US
242567861$24256786$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135638$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240828$$PH$US$US
242567871$24256787$1$I$$20240826$20240828$20240828$PER$$US-ROCHE-10000067328$ROCHE$$$$$$Y$$$20240828$$CN$US$US
242567881$24256788$1$I$$20240815$20240828$20240828$EXP$$NL-ROCHE-10000058260$ROCHE$Minnee R, Sakamoto S, Fukuda A, Uchida H, Hirukawa K, Honda M, et al. Long-Term Outcomes of Living Donor Liver Transplantation for Methylmalonic Acidemia. Pediatric Transplantation. 2024;28 (6):1-7. doi:10.1111/petr.14834.$$$$$Y$$$20240828$$HP$NL$NL
242567892$24256789$2$F$$20240827$20240828$20240830$PER$$US-ROCHE-10000067212$ROCHE$$$$$$Y$$$20240830$$CN$US$US
242567901$24256790$1$I$20240401$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024168738$AMGEN$$71$YR$E$F$Y$$$20240828$$CN$US$US
242567911$24256791$1$I$20240822$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169436$AMGEN$$63$YR$A$F$Y$$$20240828$$CN$US$US
242567921$24256792$1$I$20240823$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170600$AMGEN$$36$YR$A$M$Y$$$20240828$$CN$US$US
242567931$24256793$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170367$AMGEN$$$$$$Y$$$20240828$$PH$US$US
242567941$24256794$1$I$20240808$20240820$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013079$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242567961$24256796$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173324$NOVARTIS$$$$$F$Y$$$20240828$$HP$US$US
242567972$24256797$2$F$$20240913$20240828$20240923$PER$$US-GSK-US2024AMR103632$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
242567981$24256798$1$I$20231207$20240815$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041630$AUROBINDO$$36$YR$$M$Y$80$KG$20240828$$CN$GB$GB
242567991$24256799$1$I$$20240821$20240828$20240828$EXP$$CA-ROCHE-10000062914$ROCHE$$$$$F$Y$$$20240828$$HP$CA$CA
242568002$24256800$2$F$$20240902$20240828$20240911$EXP$$IT-TEVA-VS-3236527$TEVA$Moccaldi B, Binda M, Cuberli A, Favaro M, Zanatta E, Doria A. PRESENTATION, TREATMENT AND OUTCOME OF SYSTEMIC SCLEROSIS-PRIMARY HEART INVOLVEMENT: DATA FROM A MONOCENTRIC COHORT. Ann-Rheum-Dis 2024; 83 (Suppl. 1) 1943-1944 abstr. AB1212.; Moccaldi B, Binda M, Cuberli A, Favaro M, Zanatta E, Doria A. PRESENTATION, TREATMENT AND OUTCOME OF SYSTEMIC SCLEROSIS-PRIMARY HEART INVOLVEMENT: DATA FROM A MONOCENTRIC COHORT. Ann-Rheum-Dis 2024; 83 (Suppl. 1) 1943-1944 abstr. AB1212.$$$A$$Y$$$20240911$$HP$IT$IT
242568011$24256801$1$I$$20240115$20240828$20240828$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429069$RANBAXY$$$$$M$Y$$$20240828$$CN$US$US
242568021$24256802$1$I$$20240814$20240828$20240828$PER$$US-ABBVIE-5893922$ABBVIE$$36$YR$$F$Y$$$20240828$$CN$US$US
242568031$24256803$1$I$$20240821$20240828$20240828$EXP$$US-TAKEDA-2024TUS018220$TAKEDA$$$$$M$Y$$$20240828$$MD$US$US
242568041$24256804$1$I$$20240819$20240828$20240828$PER$$US-AstraZeneca-2024A188850$ASTRAZENECA$$$$$$Y$$$20240828$$CN$US$
242568051$24256805$1$I$$20240819$20240828$20240828$PER$$US-AstraZeneca-2024A188592$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242568061$24256806$1$I$$20240815$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041631$AUROBINDO$$51$YR$$F$Y$$$20240828$$HP$GB$GB
242568072$24256807$2$F$$20240829$20240828$20240904$EXP$$US-EMD Serono-2024045567$EMD SERONO INC$$44$YR$A$F$Y$$$20240904$$CN$US$US
242568081$24256808$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-138938-2023$RECKITT BENCKISER$$$$$F$Y$$$20240828$$CN$US$US
242568092$24256809$2$F$20240801$20240827$20240828$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-025944$UNITED THERAPEUTICS$$80$YR$$F$Y$86.168$KG$20240829$$$US$US
242568101$24256810$1$I$20240609$20240815$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041684$AUROBINDO$$85$YR$$F$Y$80$KG$20240828$$PH$GB$GB
242568111$24256811$1$I$$20240815$20240828$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-041950$AUROBINDO$$51$YR$$F$Y$$$20240828$$CN$CA$CA
242568121$24256812$1$I$$20240822$20240828$20240828$EXP$$DE-ABBVIE-5894311$ABBVIE$$$$$$Y$$$20240828$$MD$DE$DE
242568131$24256813$1$I$20240101$20240808$20240828$20240828$PER$$US-TEVA-VS-3231702$TEVA$$$$$F$Y$$$20240828$$CN$US$US
242568141$24256814$1$I$20240506$20240816$20240828$20240828$PER$$US-JNJFOC-20240846148$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240828$$CN$US$US
242568151$24256815$1$I$$20240821$20240828$20240828$PER$$US-AMGEN-USASP2024167658$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242568162$24256816$2$F$20230101$20240918$20240828$20240927$EXP$$CA-CELLTRION INC.-2023CA025317$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
242568171$24256817$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004398$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242568181$24256818$1$I$20240725$20240827$20240828$20240828$EXP$$PK-ROCHE-10000067126$ROCHE$$88$YR$E$F$Y$$$20240828$$CN$PK$PK
242568191$24256819$1$I$20240601$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169386$AMGEN$$74$YR$E$M$Y$$$20240828$$CN$US$US
242568201$24256820$1$I$$20240822$20240828$20240828$30DAY$$US-GSK-US2024105082$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$CN$US$US
242568212$24256821$2$F$20240517$20240827$20240828$20240830$PER$$US-AMGEN-USASP2024170713$AMGEN$$66$YR$E$F$Y$$$20240830$$HP$US$US
242568221$24256822$1$I$20240628$20240820$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013077$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242568241$24256824$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004399$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242568251$24256825$1$I$$20240814$20240828$20240828$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-08218$LUPIN$Kishore S, Kumar M, Tahiliani S. A case of drug-induced autoimmune like hepatitis. Journal of clinical and experimental hepatology. 2024;14(1):101995:S65$50$YR$$F$Y$$$20240828$$HP$IN$IN
242568264$24256826$4$F$$20240916$20240828$20240919$PER$$US-HALEON-2193966$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
242568271$24256827$1$I$$20240823$20240828$20240828$EXP$$US-TAKEDA-2024TUS060301$TAKEDA$$$$$F$Y$$$20240828$$CN$US$US
242568281$24256828$1$I$$20240815$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041635$AUROBINDO$$$$$F$Y$$$20240828$$CN$GB$GB
242568291$24256829$1$I$$20240815$20240828$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-042021$AUROBINDO$$74$YR$$F$Y$$$20240828$$PH$CA$CA
242568301$24256830$1$I$20240818$20240823$20240828$20240828$EXP$$CN-ROCHE-10000065718$ROCHE$$$$$F$Y$$$20240828$$HP$CN$CN
242568311$24256831$1$I$20240727$20240820$20240828$20240828$EXP$$US-BEH-2024177540$CSL BEHRING$$44$YR$A$M$Y$$$20240828$$HP$US$US
242568321$24256832$1$I$20190515$20240822$20240828$20240828$EXP$$US-TAKEDA-2022TUS059762$TAKEDA$$45$YR$$M$Y$63.039$KG$20240828$$HP$US$US
242568331$24256833$1$I$20240716$20240820$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013081$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242568341$24256834$1$I$$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131348$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240828$$HP$US$US
242568351$24256835$1$I$20240701$20240822$20240828$20240828$EXP$$CA-JNJFOC-20240861042$JOHNSON AND JOHNSON$$7$DEC$E$F$Y$69$KG$20240828$$HP$CA$CA
242568362$24256836$2$F$20240805$20240917$20240828$20240927$30DAY$$JP-JNJFOC-20240821618$JOHNSON AND JOHNSON$$86$YR$E$F$Y$42.3$KG$20240927$$MD$JP$JP
242568371$24256837$1$I$$20240813$20240828$20240828$PER$$US-APOTEX-2024AP009424$APOTEX$$$$$F$Y$$$20240828$$CN$US$US
242568381$24256838$1$I$$20240813$20240828$20240828$PER$$US-AstraZeneca-2024A185967$ASTRAZENECA$$45$YR$$F$Y$$$20240828$$MD$US$
242568391$24256839$1$I$$20240820$20240828$20240828$PER$$US-AstraZeneca-2024A189849$ASTRAZENECA$$$$$$Y$$$20240828$$PH$US$
242568402$24256840$2$F$20240821$20240920$20240828$20240921$PER$$US-AMGEN-USASP2024168582$AMGEN$$81$YR$E$F$Y$$$20240921$$HP$US$US
242568411$24256841$1$I$20240101$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170588$AMGEN$$43$YR$A$M$Y$$$20240828$$CN$US$US
242568421$24256842$1$I$$20240821$20240828$20240828$EXP$$GB-CELLTRION INC.-2024GB020335$CELLTRION$$$$$$Y$$$20240828$$CN$GB$GB
242568441$24256844$1$I$20240824$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016143$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242568451$24256845$1$I$$20240821$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014744$ELI LILLY AND CO$$$$$M$Y$$$20240828$$CN$US$US
242568462$24256846$2$F$20210101$20240905$20240828$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202408016422$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240911$$CN$US$US
242568471$24256847$1$I$20240801$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016342$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240828$$CN$US$US
242568481$24256848$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015305$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240828$$CN$US$US
242568491$24256849$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017040$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240828$$CN$US$US
242568501$24256850$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016504$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240828$$CN$US$US
242568511$24256851$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016227$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240828$$CN$US$US
242568521$24256852$1$I$20240401$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015992$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240828$$CN$US$US
242568531$24256853$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169997$AMGEN$$$$$$Y$$$20240828$$PH$US$US
242568543$24256854$3$F$$20240905$20240828$20240911$PER$$US-JNJFOC-20240851256$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
242568551$24256855$1$I$20240823$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169574$AMGEN$$75$YR$E$F$Y$$$20240828$$CN$US$US
242568562$24256856$2$F$20240101$20240917$20240828$20240923$EXP$$US-JNJFOC-20240867627$JOHNSON AND JOHNSON$$68$YR$E$F$Y$74.456$KG$20240923$$HP$US$US
242568571$24256857$1$I$$20240822$20240828$20240828$EXP$$AU-ABBVIE-5892887$ABBVIE$$$$$M$Y$$$20240828$$HP$AU$AU
242568581$24256858$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5894462$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242568601$24256860$1$I$20240822$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169134$AMGEN$$61$YR$A$F$Y$$$20240828$$CN$US$US
242568611$24256861$1$I$$20240808$20240828$20240828$PER$$US-TEVA-VS-3232025$TEVA$$40$YR$$M$Y$$$20240828$$CN$US$US
242568621$24256862$1$I$$20240815$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041615$AUROBINDO$$66$YR$$F$Y$$$20240828$$PH$GB$GB
242568631$24256863$1$I$20180101$20240811$20240828$20240828$PER$$US-AMGEN-USASP2024164869$AMGEN$Fei, F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$M$Y$$$20240828$$MD$US$US
242568642$24256864$2$F$20240101$20240828$20240828$20240830$EXP$$US-ABBVIE-5894381$ABBVIE$$64$YR$$M$Y$52$KG$20240830$$CN$US$US
242568651$24256865$1$I$20231227$20240816$20240828$20240828$EXP$$ES-AUROBINDO-AUR-APL-2024-041883$AUROBINDO$$48$YR$$M$Y$$$20240828$$MD$ES$ES
242568662$24256866$2$F$$20240829$20240828$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07758$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242568671$24256867$1$I$$20240820$20240828$20240828$EXP$$US-ROCHE-10000062232$ROCHE$$65$YR$E$F$Y$$$20240828$$HP$US$US
242568681$24256868$1$I$20240823$20240823$20240828$20240828$EXP$$CN-TAKEDA-2024TUS085270$TAKEDA$$80$YR$$M$Y$60$KG$20240828$$CN$CN$CN
242568691$24256869$1$I$$20240823$20240828$20240828$EXP$$US-ABBVIE-5893276$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242568701$24256870$1$I$20240808$20240823$20240828$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012383$JAZZ$$40$YR$$F$Y$$$20240828$$HP$US$US
242568711$24256871$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5893832$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242568721$24256872$1$I$20240101$20240822$20240828$20240828$EXP$$US-ABBVIE-5893360$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242568731$24256873$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5894228$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242568742$24256874$2$F$20200101$20240829$20240828$20240903$EXP$$US-ABBVIE-5894165$ABBVIE$$55$YR$$M$Y$$$20240903$$CN$US$US
242568751$24256875$1$I$$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136201$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240828$$CN$US$US
242568761$24256876$1$I$$20240821$20240828$20240828$EXP$BE-FAMHP-DHH-N2024-122495$BE-CHEPLA-2024010791$CHEPLAPHARM$$45$YR$$M$Y$$$20240828$$PH$COUNTRY NOT SPECIFIED$BE
242568771$24256877$1$I$$20240814$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-041095$AUROBINDO$Syrop IP, Yao KV, Custodio CM. Median and radial neuropathy following vesicant chemotherapy extravasation: A case report. PM and R. 2015;7:9(1):S168$65$YR$$M$Y$$$20240828$$HP$US$US
242568781$24256878$1$I$$20240822$20240828$20240828$EXP$$DE-ROCHE-10000064762$ROCHE$$47$YR$A$F$Y$$$20240828$$MD$DE$DE
242568791$24256879$1$I$20240228$20240814$20240828$20240828$EXP$$US-UCBSA-2024010694$UCB$$53$YR$$F$Y$72.562$KG$20240828$$CN$US$US
242568802$24256880$2$F$20190509$20240906$20240828$20240912$EXP$$CA-TAKEDA-2019TUS027747$TAKEDA$$36$YR$$M$Y$$$20240912$$HP$CA$CA
242568811$24256881$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-080464-2024$RECKITT BENCKISER$$$$$M$Y$$$20240828$$CN$US$US
242568821$24256882$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170831$AMGEN$$$$$$Y$$$20240828$$CN$US$US
242568831$24256883$1$I$20240705$20240823$20240828$20240828$EXP$$US-ABBVIE-5894001$ABBVIE$$32$YR$$F$Y$$$20240828$$CN$US$US
242568841$24256884$1$I$$20240801$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07759$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242568851$24256885$1$I$$20240823$20240828$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013513$JAZZ$$$$$M$Y$$$20240828$$CN$US$US
242568861$24256886$1$I$$20240823$20240828$20240828$EXP$$US-KYOWAKIRIN-2024KK019950$KYOWA$$$$$$Y$$$20240828$$PH$US$US
242568872$24256887$2$F$$20240827$20240828$20240909$EXP$$US-UCBSA-2024041731$UCB$$$$$$Y$$$20240909$$CN$US$US
242568881$24256888$1$I$20221007$20240826$20240828$20240828$EXP$$US-UCBSA-2024043425$UCB$$57$YR$$F$Y$$$20240828$$HP$US$US
242568891$24256889$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173389$NOVARTIS$$$$$F$Y$$$20240828$$MD$US$US
242568901$24256890$1$I$20240803$20240819$20240828$20240828$PER$$US-ABBVIE-5888714$ABBVIE$$53$YR$$F$Y$$$20240828$$CN$US$US
242568911$24256891$1$I$20240824$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170583$AMGEN$$67$YR$E$F$Y$$$20240828$$CN$US$US
242568921$24256892$1$I$20240523$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004402$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240828$$CN$US$US
242568931$24256893$1$I$$20240818$20240828$20240828$EXP$$US-AMGEN-USASP2024167495$AMGEN$Yeh S.; Liao A.; Vasseneix C.F. et al.. Visual Morbidity and Outcomes of Scleritis Associated with Intraocular Inflammation Compared to Isolated Scleritis. Ocular Immunology and Inflammation. 2024;32 (6):947-954$63$YR$A$F$Y$$$20240828$$MD$US$US
242568952$24256895$2$F$$20240830$20240828$20240905$PER$$US-AstraZeneca-2024A188618$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242568961$24256896$1$I$20240816$20240826$20240828$20240828$EXP$$US-AstraZeneca-2024A194529$ASTRAZENECA$$$$$M$Y$$$20240828$$HP$US$
242568971$24256897$1$I$$20240820$20240828$20240828$EXP$$PK-SKF-000137$ESKAYEF PHARMACEUTICALS$$86$YR$E$M$Y$$$20240821$$MD$PK$PK
242568981$24256898$1$I$20240817$20240820$20240828$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026248$UNITED THERAPEUTICS$$71$YR$$F$Y$82.54$KG$20240828$$$US$US
242568991$24256899$1$I$$20240814$20240828$20240828$EXP$$US-UCBSA-2024042397$UCB$$$$$$Y$$$20240828$$CN$US$US
242569001$24256900$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004588$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242569012$24256901$2$F$$20240906$20240828$20240910$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013508$JAZZ$$$$$F$Y$$$20240910$$MD$US$US
242569024$24256902$4$F$20240401$20240906$20240828$20240912$EXP$$CA-JNJFOC-20240869043$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240912$$HP$CA$CA
242569031$24256903$1$I$20231201$20240822$20240828$20240828$EXP$$US-ABBVIE-5851774$ABBVIE$$69$YR$$M$Y$113$KG$20240828$$CN$US$US
242569041$24256904$1$I$$20240801$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07761$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242569052$24256905$2$F$$20240815$20240828$20240918$EXP$$US-HALEON-2192499$Haleon PLC$$$$$F$Y$$$20240917$$LW$US$US
242569061$24256906$1$I$20240821$20240827$20240828$20240828$PER$$NVSC2024US173368$NOVARTIS$$4$YR$$F$Y$$$20240828$$CN$US$US
242569071$24256907$1$I$$20240822$20240828$20240828$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024105587$VIIV$$$$$$Y$$$20240828$$PH$US$US
242569081$24256908$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016063$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$US$US
242569091$24256909$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016547$ELI LILLY AND CO$$$$$M$Y$$$20240828$$CN$US$US
242569101$24256910$1$I$$20240824$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016296$ELI LILLY AND CO$$90$YR$E$F$Y$$$20240828$$MD$US$US
242569111$24256911$1$I$$20240824$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016436$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240828$$CN$US$US
242569121$24256912$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015191$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240828$$CN$US$US
242569131$24256913$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015629$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240828$$CN$US$US
242569141$24256914$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015951$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240828$$CN$US$US
242569151$24256915$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016011$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$US$US
242569161$24256916$1$I$20240818$20240820$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408012880$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240828$$CN$US$US
242569171$24256917$1$I$20240814$20240815$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408013950$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240828$$CN$US$US
242569181$24256918$1$I$$20240822$20240828$20240828$EXP$$US-ABBVIE-5892066$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242569192$24256919$2$F$$20240925$20240828$20240930$30DAY$$DE-UCBSA-2024043542$UCB$$83$YR$$F$Y$$$20240930$$PH$DE$DE
242569201$24256920$1$I$20240801$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016610$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240828$$CN$US$US
242569211$24256921$1$I$20240801$20240822$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014922$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240828$$CN$US$US
242569221$24256922$1$I$20240808$20240821$20240828$20240828$EXP$$CN-AMGEN-CHNSP2024168563$AMGEN$$66$YR$E$F$Y$35$KG$20240828$$MD$CN$CN
242569231$24256923$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135797$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240828$$HP$US$US
242569241$24256924$1$I$$20240825$20240828$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013517$JAZZ$$$$$F$Y$$$20240828$$CN$US$US
242569251$24256925$1$I$$20240801$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07784$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242569261$24256926$1$I$$20240823$20240828$20240828$PER$$US-HALEON-2193578$Haleon PLC$$$$$$Y$$$20240828$$CN$US$US
242569271$24256927$1$I$20240727$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136215$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240828$$CN$US$US
242569281$24256928$1$I$20240101$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136254$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240828$$CN$US$US
242569301$24256930$1$I$20240621$20240818$20240828$20240828$EXP$$US-ARDELYX-2024ARDX005107$ARDELYX$$48$YR$$M$Y$80$KG$20240828$$HP$US$US
242569311$24256931$1$I$$20240816$20240828$20240828$EXP$$ES-AUROBINDO-AUR-APL-2024-041820$AUROBINDO$Rasc?n Roig N, Gauch?a Mulet C, Garrido Calvo L... A ra?z de una far?ngoamigdalitis: s?filis secundaria. AMF. 2024;20(7):1$63$YR$$M$Y$$$20240828$$MD$ES$ES
242569322$24256932$2$F$20240801$20240910$20240828$20240917$EXP$$CA-GSK-CA2024104370$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$CA$CA
242569332$24256933$2$F$$20240906$20240828$20240910$EXP$$NVSC2024US171490$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
242569341$24256934$1$I$$20240818$20240828$20240828$EXP$$US-AMGEN-USASP2024167521$AMGEN$Yeh S.; Liao A.; Vasseneix C.F. et. al. Visual Morbidity and Outcomes of Scleritis Associated with Intraocular Inflammation Compared to Isolated Scleritis. Ocular Immunology and Inflammation. 2024;32 (6):947-954$45$YR$A$M$Y$$$20240828$$MD$US$US
242569351$24256935$1$I$$20240826$20240828$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013523$JAZZ$$$$$$Y$$$20240828$$HP$US$US
242569371$24256937$1$I$$20240821$20240828$20240828$EXP$GB-MHRA-MED-202408211009281770-SNWZK$GB-RDY-SPO/GBR/24/0012308$DR REDDYS$$41$YR$A$F$Y$$$20240828$$HP$GB$GB
242569382$24256938$2$F$$20240830$20240828$20240905$EXP$$US-RDY-CLI/USA/24/0012371$DR REDDYS$$28$YR$A$F$Y$$$20240905$$MD$US$US
242569391$24256939$1$I$20240815$20240818$20240828$20240828$EXP$GB-MHRA-MED-202408172356121370-JKCPY$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19377$ALKEM$$$$$$Y$$$20240828$$CN$GB$GB
242569401$24256940$1$I$20240810$20240818$20240828$20240828$EXP$GB-MHRA-MED-202408171121569570-KMTRW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19462$ALKEM$$39$YR$$F$Y$$$20240828$$CN$GB$GB
242569411$24256941$1$I$20240805$20240819$20240828$20240828$PER$$US-ABBVIE-5886503$ABBVIE$$73$YR$$F$Y$90$KG$20240828$$CN$US$US
242569421$24256942$1$I$$20240819$20240828$20240828$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006200$BIOCON$$$$$$Y$$$20240828$$CN$CA$CA
242569431$24256943$1$I$$20240817$20240828$20240828$EXP$GB-MHRA-TPP25240340C17459774YC1723736655835$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19387$ALKEM$$82$YR$$M$Y$74$KG$20240828$$HP$GB$GB
242569441$24256944$1$I$20240815$20240816$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041851$AUROBINDO$$60$YR$$F$Y$$$20240828$$PH$GB$GB
242569451$24256945$1$I$$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2024-041872$AUROBINDO$$29$YR$$F$Y$$$20240828$$MD$FR$FR
242569462$24256946$2$F$$20240823$20240828$20240903$EXP$$NL-AUROBINDO-AUR-APL-2024-041873$AUROBINDO$$42$YR$$F$Y$57$KG$20240903$$CN$NL$NL
242569471$24256947$1$I$$20240823$20240828$20240828$EXP$GB-MHRA-MED-202408230904294950-DJCKB$GB-AMGEN-GBRSP2024168874$AMGEN$$$$$M$Y$$$20240828$$PH$GB$GB
242569481$24256948$1$I$$20240822$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135691$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240828$$CN$US$US
242569491$24256949$1$I$20240801$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133823$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$PH$US$US
242569501$24256950$1$I$$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132883$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240828$$CN$US$US
242569511$24256951$1$I$$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132505$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$HP$US$US
242569522$24256952$2$F$$20240923$20240828$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135808$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240925$$CN$US$US
242569531$24256953$1$I$$20240812$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128610$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240828$$CN$US$US
242569541$24256954$1$I$20240801$20240822$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135704$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240828$$PH$US$US
242569551$24256955$1$I$$20240802$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07824$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242569561$24256956$1$I$20240809$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2024-041856$AUROBINDO$$78$YR$$M$Y$102$KG$20240828$$MD$FR$FR
242569571$24256957$1$I$20230918$20240816$20240828$20240828$EXP$$DE-AUROBINDO-AUR-APL-2024-041691$AUROBINDO$$56$YR$$F$Y$$$20240828$$MD$DE$DE
242569581$24256958$1$I$20230822$20240821$20240828$20240828$EXP$$KR-JNJFOC-20240856287$JOHNSON AND JOHNSON$$$$$M$Y$53.1$KG$20240828$$HP$KR$KR
242569591$24256959$1$I$20240723$20240816$20240828$20240828$EXP$$IT-AUROBINDO-AUR-APL-2024-042299$AUROBINDO$$89$YR$$F$Y$60$KG$20240828$$MD$IT$IT
242569601$24256960$1$I$$20240726$20240828$20240828$PER$US-MEN-2024-063861$US-MEN-2024-063861$MENARINI$$44$YR$$M$Y$$$20240828$$MD$US$US
242569611$24256961$1$I$20240825$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170781$AMGEN$$43$YR$A$F$Y$$$20240828$$CN$US$US
242569621$24256962$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-080526-2024$RECKITT BENCKISER$$$$$M$Y$$$20240828$$CN$US$US
242569631$24256963$1$I$20240821$20240821$20240828$20240828$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001711$BLUEPRINT MEDICINES$$$$$F$Y$$$20240828$$CN$US$US
242569641$24256964$1$I$20220222$20240823$20240828$20240828$EXP$$CA-TAKEDA-2022TUS013255$TAKEDA$$46$YR$$F$Y$$$20240828$$MD$CA$CA
242569652$24256965$2$F$$20240902$20240828$20240911$EXP$$TR-TEVA-VS-3235311$TEVA$Bozca BC, Alpsoy A, Bilgic A, Bassorgun CI, Unal B, Alpsoy E. Clinicopathological analysis of patients diagnosed with DRESS. Turk-Arch-Dermatol-Venereol 2023; 57 101-107.; Bozca BC, Alpsoy A, Bilgic A, Bassorgun CI, Unal B, Alpsoy E. Clinicopathological analysis of patients diagnosed with DRESS. Turk-Arch-Dermatol-Venereol 2023; 57 101-107.$$$$$Y$$$20240911$$HP$TR$TR
242569661$24256966$1$I$20240820$20240823$20240828$20240828$EXP$$US-ABBVIE-5893991$ABBVIE$$52$YR$$F$Y$$$20240828$$CN$US$US
242569671$24256967$1$I$$20240821$20240828$20240828$EXP$$AU-AMGEN-AUSSP2024167867$AMGEN$$$$$F$Y$$$20240828$$HP$AU$AU
242569691$24256969$1$I$20240815$20240820$20240828$20240828$EXP$$AU-BEH-2024177557$CSL BEHRING$$74$YR$E$M$Y$77$KG$20240828$$HP$AU$AU
242569701$24256970$1$I$$20240827$20240828$20240828$PER$$US-HALEON-2193875$Haleon PLC$$$$$$Y$$$20240828$$CN$US$US
242569711$24256971$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-080774-2024$RECKITT BENCKISER$$$$$F$Y$$$20240828$$CN$US$US
242569721$24256972$1$I$20240808$20240820$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013090$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242569731$24256973$1$I$20240101$20240826$20240828$20240828$EXP$$US-ABBVIE-5896203$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242569741$24256974$1$I$20240825$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016181$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240828$$CN$US$US
242569751$24256975$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016272$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240828$$CN$US$US
242569761$24256976$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015575$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240828$$CN$US$US
242569771$24256977$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016266$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240828$$CN$US$US
242569781$24256978$1$I$20240201$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016187$ELI LILLY AND CO$$$$A$$Y$$$20240828$$CN$US$US
242569791$24256979$1$I$20240301$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016614$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240828$$CN$US$US
242569801$24256980$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016275$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240828$$CN$US$US
242569811$24256981$1$I$20240823$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015394$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240828$$CN$US$US
242569822$24256982$2$F$$20240910$20240828$20240913$PER$$NVSC2024US173246$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
242569831$24256983$1$I$$20240826$20240828$20240828$PER$$US-HALEON-2193838$Haleon PLC$$$$$$Y$$$20240828$$CN$US$US
242569841$24256984$1$I$$20240814$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129497$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240828$$PH$US$US
242569851$24256985$1$I$20240810$20240817$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041668$AUROBINDO$$39$YR$$F$Y$$$20240828$$CN$GB$GB
242569871$24256987$1$I$$20240826$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075644$SANDOZ$$$$$M$Y$$$20240828$$CN$US$US
242569882$24256988$2$F$$20240912$20240828$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134410$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240916$$CN$US$US
242569891$24256989$1$I$$20240821$20240828$20240828$EXP$$US-JNJFOC-20240855252$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242569901$24256990$1$I$$20240822$20240828$20240828$EXP$$NVSC2024MX172394$NOVARTIS$$$$$F$Y$69$KG$20240828$$CN$MX$MX
242569911$24256991$1$I$20240721$20240827$20240828$20240828$EXP$FR-AFSSAPS-NC2024000988$FR-GSK-FR2024106541$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$FR$FR
242569921$24256992$1$I$$20240815$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-042256$AUROBINDO$$45$YR$$F$Y$$$20240828$$HP$US$US
242569931$24256993$1$I$$20240821$20240828$20240828$EXP$$DE-EMD Serono-2024045244$EMD SERONO INC$$$$E$F$Y$$$20240828$$CN$DE$DE
242569941$24256994$1$I$$20240822$20240828$20240828$EXP$$US-ABBVIE-5891825$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242569961$24256996$1$I$$20240813$20240828$20240828$EXP$$JP-RISINGPHARMA-JP-2024RISLIT00294$RISING PHARMACEUTICALS$$37$YR$A$M$Y$$$20240828$$HP$JP$JP
242569971$24256997$1$I$20230101$20240827$20240828$20240828$EXP$$HR-SANDOZ INC.-SDZ2024HR007843$SANDOZ$$63$YR$$M$Y$$$20240828$$MD$HR$HR
242569982$24256998$2$F$$20240919$20240828$20240926$EXP$$JP-EMD Serono-2024045832$EMD SERONO INC$$4$DEC$A$M$Y$$$20240926$$MD$JP$JP
242569992$24256999$2$F$20240101$20240911$20240828$20240917$EXP$$GB-ABBVIE-5892932$ABBVIE$$33$YR$$F$Y$$$20240917$$CN$GB$GB
242570001$24257000$1$I$20240823$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170581$AMGEN$$$$$$Y$$$20240828$$PH$US$US
242570022$24257002$2$F$20240825$20240826$20240828$20240902$PER$$US-AMGEN-USASP2024170551$AMGEN$$51$YR$A$F$Y$$$20240902$$CN$US$US
242570031$24257003$1$I$$20240820$20240828$20240828$PER$$US-AMGEN-USASP2024166791$AMGEN$Nguyen Q.D.; Uludag G.; Karaca I. et al.. Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFa Therapies. Ocular Immunology and Inflammation. 2024;32 (6):891-897$14$YR$T$M$Y$$$20240828$$MD$US$US
242570051$24257005$1$I$20240816$20240821$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013182$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242570061$24257006$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5883555$ABBVIE$$$$$F$Y$97$KG$20240828$$CN$US$US
242570071$24257007$1$I$$20240819$20240828$20240828$PER$$US-BAUSCHBL-2024BNL031986$BAUSCH AND LOMB$$76$YR$$F$Y$55$KG$20240828$$CN$US$US
242570081$24257008$1$I$20211125$20220511$20240828$20240828$EXP$$CA-CELLTRION INC.-2021CA019663$CELLTRION$$$$$$Y$$$20240828$$CN$CA$CA
242570091$24257009$1$I$20240605$20240823$20240828$20240828$EXP$$US-ABBVIE-5894423$ABBVIE$$86$YR$$F$Y$$$20240828$$CN$US$US
242570101$24257010$1$I$$20240813$20240828$20240828$EXP$$DE-RISINGPHARMA-DE-2024RISLIT00293$RISING PHARMACEUTICALS$Samir Abu Rumeileh.Posterior reversible encephalopathy syndrome associated  with antibiotic therapy: a case report and systematic review.Neurological Sciences.29-APR-2024;45:4151-4159$55$YR$A$F$Y$$$20240828$$HP$DE$DE
242570111$24257011$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A189923$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242570122$24257012$2$F$$20240910$20240828$20240912$EXP$$DE-SANDOZ INC.-NVSC2020DE070859$SANDOZ$$81$YR$$M$Y$$$20240912$$MD$DE$DE
242570131$24257013$1$I$20240827$20240827$20240828$20240828$PER$$US-AMGEN-USASP2024171188$AMGEN$$49$YR$A$M$Y$$$20240828$$CN$US$US
242570141$24257014$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004303$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242570151$24257015$1$I$$20240826$20240828$20240828$30DAY$$US-SANDOZ INC.-SDZ2024US048160$SANDOZ$$$$$F$Y$$$20240828$$HP$US$US
242570161$24257016$1$I$$20240821$20240828$20240828$EXP$$US-BAUSCHBL-2024BNL032068$BAUSCH AND LOMB$Gabbay J, Place A, Ilowite M, Zhu J. Use of the osmolal gap in diagnosing mixed physiology hyponatremia in a child with B-cell acute lymphoblastic leukemia. Clinical Case Reports. 2023;11(6):1-4. doi:10.1002/ccr3.7428$12$YR$$M$Y$$$20240828$$MD$US$US
242570171$24257017$1$I$20240801$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136136$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240828$$CN$US$US
242570181$24257018$1$I$20240820$20240822$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134144$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240828$$HP$US$US
242570201$24257020$1$I$20240802$20240821$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013187$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242570211$24257021$1$I$20240517$20240823$20240828$20240828$EXP$$US-ABBVIE-5894216$ABBVIE$$66$YR$$F$Y$$$20240828$$CN$US$US
242570231$24257023$1$I$20220101$20240821$20240828$20240828$EXP$$EU-BAUSCHBL-2024BNL032130$BAUSCH AND LOMB$$60$YR$$F$Y$55$KG$20240828$$MD$EU$EU
242570242$24257024$2$F$20240101$20240909$20240828$20240918$EXP$$US-UCBSA-2024043523$UCB$$$$$F$Y$$$20240918$$CN$US$US
242570251$24257025$1$I$20240801$20240819$20240828$20240828$PER$$US-ABBVIE-5888623$ABBVIE$$$$$F$Y$$$20240828$$HP$US$US
242570261$24257026$1$I$20240731$20240821$20240828$20240828$EXP$$JP-GENMAB-2024-03039$GENMAB$$8$DEC$$$Y$$$20240828$$MD$JP$JP
242570271$24257027$1$I$$20240815$20240828$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-041975$AUROBINDO$Merette S A M, Kim S,Davis M D, Shapiro A M. Desalkylgidazepam blood concentrations in 63 forensic investigation cases. Journal of Analytical Toxicology. 2023;47(9):858-866$49$YR$$M$Y$$$20240828$$HP$CA$CA
242570281$24257028$1$I$20240501$20240821$20240828$20240828$EXP$$EU-BAUSCHBL-2024BNL032131$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240828$$MD$EU$EU
242570302$24257030$2$F$$20240906$20240828$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07831$LUPIN$$$$$$Y$$$20240923$$CN$US$US
242570311$24257031$1$I$$20240819$20240828$20240828$PER$$US-ABBVIE-5887168$ABBVIE$$$$$F$Y$$$20240828$$HP$US$US
242570321$24257032$1$I$$20240819$20240828$20240828$PER$$US-ABBVIE-5888165$ABBVIE$$$$$F$Y$$$20240828$$HP$US$US
242570331$24257033$1$I$$20240819$20240828$20240828$EXP$$GB-TEVA-VS-3235225$TEVA$$$$$M$Y$$$20240828$$CN$GB$GB
242570341$24257034$1$I$20240101$20240815$20240828$20240828$EXP$$SK-TAKEDA-2024TUS085925$TAKEDA$$68$YR$$F$Y$$$20240828$$MD$SK$SK
242570351$24257035$1$I$20240101$20240823$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075052$SANDOZ$$$$$F$Y$$$20240828$$HP$US$US
242570361$24257036$1$I$20240801$20240823$20240828$20240828$EXP$$DE-ABBVIE-5895665$ABBVIE$$71$YR$$M$Y$$$20240828$$CN$DE$DE
242570372$24257037$2$F$$20240827$20240828$20240830$EXP$$US-UCBSA-2024043593$UCB$$$$$M$Y$$$20240830$$CN$US$US
242570381$24257038$1$I$20231201$20240823$20240828$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA075263$SANDOZ$$49$YR$$M$Y$$$20240828$$MD$CA$CA
242570391$24257039$1$I$$20240821$20240828$20240828$EXP$$GB-TEVA-VS-3236161$TEVA$$56$YR$$F$Y$60$KG$20240828$$HP$GB$GB
242570401$24257040$1$I$$20240813$20240828$20240828$EXP$$US-GLANDPHARMA-US-2024GLNLIT00651$GLAND PHARMA$M. Elsayed.An Interesting Case of Drug-Induced Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Pulmonary and Renal Involvement.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209$75$YR$E$M$Y$$$20240828$$HP$US$US
242570411$24257041$1$I$20240819$20240820$20240828$20240828$EXP$GB-MHRA-MED-202408201602539930-RKHMD$GB-TEVA-VS-3235820$TEVA$$81$YR$$M$Y$$$20240828$$HP$GB$GB
242570421$24257042$1$I$20231223$20240821$20240828$20240828$EXP$GB-MHRA-MED-202408210814043160-TNFZC$GB-TEVA-VS-3236020$TEVA$$50$YR$$M$Y$92$KG$20240828$$CN$GB$GB
242570461$24257046$1$I$20211101$20240826$20240828$20240828$EXP$ES-AEMPS-1561534$ES-UCBSA-2024043206$UCB$$21$YR$$F$Y$59$KG$20240828$$HP$ES$ES
242570481$24257048$1$I$$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135016$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$41.28$KG$20240828$$HP$US$US
242570501$24257050$1$I$20240626$20240821$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013179$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242570511$24257051$1$I$$20240814$20240828$20240828$PER$$US-Encube-001294$ENCUBE ETHICALS$$$$$$Y$$$20240827$$CN$US$
242570521$24257052$1$I$$20240821$20240828$20240828$EXP$$NVSC2024AU169527$NOVARTIS$$$$$F$Y$$$20240828$$HP$AU$AU
242570531$24257053$1$I$$20240820$20240828$20240828$EXP$$MY-AstraZeneca-2024A193899$ASTRAZENECA$$$$$F$Y$$$20240828$$MD$MY$
242570541$24257054$1$I$$20240820$20240828$20240828$EXP$$ZA-AstraZeneca-2024A190944$ASTRAZENECA$$30681$DY$$M$Y$$$20240828$$CN$ZA$
242570551$24257055$1$I$20240101$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190437$ASTRAZENECA$$64$YR$$M$Y$$$20240828$$CN$US$
242570563$24257056$3$F$$20240909$20240828$20240923$EXP$$JP-AMGEN-JPNSP2024159937$AMGEN$$$$E$$Y$$$20240922$$MD$JP$JP
242570571$24257057$1$I$$20240823$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075231$SANDOZ$$$$$$Y$$$20240828$$CN$US$US
242570581$24257058$1$I$$20240821$20240828$20240828$30DAY$$US-SANDOZ INC.-SDZ2024US074834$SANDOZ$$$$$$Y$$$20240828$$CN$US$US
242570591$24257059$1$I$$20240823$20240828$20240828$30DAY$$US-SANDOZ INC.-SDZ2023US075927$SANDOZ$$$$$M$Y$$$20240828$$CN$US$US
242570602$24257060$2$F$20230620$20240823$20240828$20240830$EXP$$JP-AstraZeneca-2024A191433$ASTRAZENECA$$50$YR$$M$Y$$$20240830$$MD$JP$
242570611$24257061$1$I$20240701$20240821$20240828$20240828$EXP$GB-MHRA-MED-202408211021291520-FZBYR$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-002088$IPCA$$$$$$Y$$$20240828$$CN$GB$GB
242570622$24257062$2$F$$20240827$20240828$20240901$EXP$$US-ABBVIE-5895157$ABBVIE$$$$$F$Y$$$20240901$$CN$US$US
242570631$24257063$1$I$20240817$20240826$20240828$20240828$EXP$IT-MINISAL02-999710$IT-UCBSA-2024043202$UCB$$58$YR$$F$Y$$$20240828$$MD$IT$IT
242570641$24257064$1$I$$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2024-041866$AUROBINDO$$$$$$Y$$$20240828$$CN$FR$FR
242570651$24257065$1$I$20240819$20240821$20240828$20240828$PER$$US-009507513-2408USA007262$MERCK$$59$YR$$M$Y$$$20240828$$CN$US$US
242570661$24257066$1$I$$20240417$20240828$20240828$PER$$US-WW-2024-38629004$WOODWARD PHARMA SERVICES$Nehzati, A., Hefelfinger, D., Fonte, E., and Scott, J. Musculoskeletal Coccidioidomycosis in the Setting of Adalimumab: A Case Report. Cureus, 2024, 16(3), e56321. https://doi.org/10.7759/cureus.56321$53$YR$$F$Y$$$20240828$$MD$US$US
242570671$24257067$1$I$20240801$20240822$20240828$20240828$EXP$$US-ABBVIE-5891724$ABBVIE$$70$YR$$F$Y$$$20240828$$CN$US$US
242570681$24257068$1$I$20240818$20240822$20240828$20240828$EXP$$US-ABBVIE-5892022$ABBVIE$$26$YR$$M$Y$$$20240828$$CN$US$US
242570702$24257070$2$F$20240101$20240924$20240828$20240927$EXP$$JP-009507513-2408JPN002645J$MERCK$$55$YR$$M$Y$$$20240927$$MD$JP$JP
242570711$24257071$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-113450-2023$RECKITT BENCKISER$$$$$F$Y$$$20240828$$CN$US$US
242570721$24257072$1$I$20240823$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014417$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240828$$CN$US$US
242570731$24257073$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016636$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$US$US
242570741$24257074$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016037$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240828$$CN$US$US
242570751$24257075$1$I$20240827$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016882$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240828$$CN$US$US
242570761$24257076$1$I$$20240822$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015946$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$US$US
242570771$24257077$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016385$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240828$$CN$US$US
242570781$24257078$1$I$20240628$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016402$ELI LILLY AND CO$$63$YR$A$$Y$$$20240828$$CN$US$US
242570791$24257079$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016096$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240828$$CN$US$US
242570801$24257080$1$I$20240808$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016424$ELI LILLY AND CO$$$$$M$Y$$$20240828$$CN$US$US
242570811$24257081$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017111$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240828$$CN$US$US
242570821$24257082$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016153$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240828$$CN$US$US
242570831$24257083$1$I$20240826$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016189$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242570841$24257084$1$I$20240826$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016015$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240828$$CN$US$US
242570851$24257085$1$I$20240101$20240821$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014953$ELI LILLY AND CO$$$$$M$Y$$$20240828$$CN$US$US
242570861$24257086$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016517$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240828$$CN$US$US
242570871$24257087$1$I$20240101$20240822$20240828$20240828$EXP$$US-ABBVIE-5893092$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242570882$24257088$2$F$$20240823$20240828$20240828$EXP$$US-AMGEN-USASP2024169862$AMGEN$$$$$F$Y$$$20240828$$MD$US$US
242570891$24257089$1$I$20240808$20240821$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408013954$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240828$$CN$US$US
242570901$24257090$1$I$20240826$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170647$AMGEN$$80$YR$E$F$Y$$$20240828$$CN$US$US
242570911$24257091$1$I$$20240819$20240828$20240828$EXP$$US-AMGEN-USASP2024167804$AMGEN$Kim,S.; Andrews H.; Nair A. et.al. A 1-Year Retrospective Case Series of Fluocinolone Acetonide 0.18-mg Injectable Intravitreal Implant in Chronic Uveitis. AMERICAN JOURNAL OF OPHTHALMOLOGY. 2023;246:251-257$$$$$Y$$$20240828$$HP$US$US
242570922$24257092$2$F$$20240826$20240828$20240910$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001237$AKEBIA THERAPEUTICS$$99$YR$$F$Y$$$20240910$$PH$JP$JP
242570931$24257093$1$I$20240501$20240823$20240828$20240828$EXP$$PR-ABBVIE-5893069$ABBVIE$$20$YR$$M$Y$58$KG$20240828$$CN$PR$PR
242570941$24257094$1$I$$20240822$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135251$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$HP$US$US
242570952$24257095$2$F$20240805$20240909$20240828$20240919$EXP$$PT-AUROBINDO-AUR-APL-2024-042367$AUROBINDO$$83$YR$$F$Y$70$KG$20240919$$PH$PT$PT
242570961$24257096$1$I$20240809$20240821$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013205$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242570971$24257097$1$I$$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024169524$AMGEN$$$$$$Y$$$20240828$$CN$US$US
242570981$24257098$1$I$$20240805$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07635$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242570992$24257099$2$F$$20240830$20240828$20240904$PER$$US-JNJFOC-20240865258$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$HP$US$US
242571011$24257101$1$I$$20240813$20240828$20240828$EXP$$BR-GLANDPHARMA-BR-2024GLNLIT00654$GLAND PHARMA$DFC Landim.Selective Laser Trabeculoplasty (SLT) for IOP Control in a Patient with Bilateral Acute Iris Transillumination (BAIT).Ocular Immunology and Inflammation.JAN-2023$60$YR$A$M$Y$$$20240828$$HP$BR$BR
242571021$24257102$1$I$20240715$20240816$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041797$AUROBINDO$$48$YR$$M$Y$79$KG$20240828$$CN$GB$GB
242571031$24257103$1$I$20220401$20240820$20240828$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-133754$BRISTOL MYERS SQUIBB$Matsuo K, Nishihara H, Sato R, Oishi M, Shimizu F, Koga M, et al. A case of 45-year-old male with inclusion body myositis diagnosed during investigation of elevated muscle leaking enzyme levels observed after the start of tyrosine kinase inhibitor therapy. The 114th Annual Meeting of Japanese Society of Neurology Chugoku-Shikoku Branch (Programs and Abstracts). 2023;35.$45$YR$A$M$Y$$$20240828$$MD$JP$JP
242571041$24257104$1$I$20240826$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136169$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240828$$CN$US$US
242571051$24257105$1$I$20240728$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136131$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$78.93$KG$20240828$$PH$US$US
242571062$24257106$2$F$20240802$20240827$20240828$20240902$EXP$$US-ABBVIE-5891100$ABBVIE$$70$YR$$F$Y$108$KG$20240902$$CN$US$US
242571071$24257107$1$I$20220101$20240823$20240828$20240828$PER$$US-ABBVIE-5892977$ABBVIE$$$$$M$Y$140$KG$20240828$$CN$US$US
242571081$24257108$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135939$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240828$$PH$US$US
242571091$24257109$1$I$20240402$20240813$20240828$20240828$EXP$$CO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-442118$RANBAXY$$71$YR$E$F$Y$$$20240828$$CN$CO$CO
242571101$24257110$1$I$20240512$20240822$20240828$20240828$EXP$$BR-CELLTRION INC.-2023BR003157$CELLTRION$$$$$$Y$$$20240828$$CN$BR$BR
242571111$24257111$1$I$$20240820$20240828$20240828$PER$$US-ABBVIE-5890039$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242571121$24257112$1$I$$20240814$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-041075$AUROBINDO$Rivkin AC, Khan AH, Mellgren AF, Perez-Tamayo AM, Chaudhry V, Bianchi EM, et al. Pelvic Necrosis with Formation of a Pelvic ?Cloaca? and Necrotizing Soft Tissue Infection After Radiation for Anal Squamous Cell Carcinoma. American Journal of Case Reports. 2024;25:e943599$66$YR$$F$Y$$$20240828$$MD$US$US
242571141$24257114$1$I$$20240813$20240828$20240828$PER$$US-AstraZeneca-2024A184366$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242571151$24257115$1$I$$20240809$20240828$20240828$PER$$US-AstraZeneca-2024A182282$ASTRAZENECA$$$$$$Y$$$20240828$$CN$US$
242571161$24257116$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-113409-2023$RECKITT BENCKISER$$58$YR$$M$Y$$$20240828$$CN$US$US
242571171$24257117$1$I$$20240814$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041590$AUROBINDO$Hopcroft K. Case of the Month answers: Find out what was wrong with this elderly woman with back pain. Pulse$73$YR$$F$Y$$$20240828$$HP$GB$GB
242571181$24257118$1$I$$20240822$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075155$SANDOZ$$$$$$Y$$$20240828$$CN$US$US
242571192$24257119$2$F$20240101$20240829$20240828$20240904$EXP$$US-ABBVIE-5893893$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242571201$24257120$1$I$$20240823$20240828$20240828$EXP$$CA-ABBVIE-5894276$ABBVIE$$$$A$F$Y$$$20240828$$CN$CA$CA
242571212$24257121$2$F$$20240820$20240828$20240830$EXP$$NL-SA-2024SA249674$SANOFI AVENTIS$$$$$F$Y$$$20240830$$CN$NL$NL
242571221$24257122$1$I$$20240815$20240828$20240828$EXP$$DE-ADVANZ PHARMA-202408006941$ADVANZ PHARMA$$$$$$Y$$$20240828$$PH$DE$DE
242571231$24257123$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135885$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$86.64$KG$20240828$$HP$US$US
242571241$24257124$1$I$$20240813$20240828$20240828$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00666$GLAND PHARMA$Qiong Liu.HHV-6B- and HHV-7-associated choroiditis secondary to acute myelogenous leukemia: a case report.International Medical Research.13-SEP-2023;51(10):1-7$42$YR$A$F$Y$$$20240828$$MD$CN$CN
242571251$24257125$1$I$20230102$20240821$20240828$20240828$EXP$$CA-TERSERA THERAPEUTICS LLC-2023TRS003652$TERSERA THERAPEUTICS$$$$$$Y$$$20240828$$CN$CA$CA
242571271$24257127$1$I$20240812$20240821$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013188$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242571281$24257128$1$I$20240611$20240821$20240828$20240828$EXP$$JP-EMD Serono-2024045561$EMD SERONO INC$$62$YR$A$M$Y$$$20240828$$PH$JP$JP
242571291$24257129$1$I$$20240815$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041644$AUROBINDO$$$$$M$Y$$$20240828$$HP$GB$GB
242571301$24257130$1$I$20240808$20240813$20240828$20240828$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464657$RANBAXY$$$$$$Y$$$20240828$$CN$GB$GB
242571311$24257131$1$I$$20240813$20240828$20240828$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461004$RANBAXY$Akao S, Akao K, Rokutanda R, Suzuki T. Renal perivasculitis induced by sulfasalazine. J Nephrol. 2024;37:1161-1164$54$YR$$F$Y$$$20240828$$HP$JP$JP
242571321$24257132$1$I$$20240813$20240828$20240828$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464770$RANBAXY$Zilg B, Alkass K, Berg S, Druid H. Interpretation of postmortem vitreous concentrations of sodium and chloride. Forensic Sci Int. 2016;263:107-113$54$YR$$M$Y$$$20240828$$HP$SE$SE
242571331$24257133$1$I$$20240813$20240828$20240828$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464134$RANBAXY$$$$$F$Y$56$KG$20240828$$CN$GB$GB
242571341$24257134$1$I$$20240813$20240828$20240828$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463412$RANBAXY$$25$YR$$F$Y$$$20240828$$MD$RU$RU
242571351$24257135$1$I$$20240813$20240828$20240828$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462833$RANBAXY$Ceylan ME, Unsalver BO, Ceylan HZ. A Bell^s Palsy Case Probably Related to Sertraline Use. Psychopharmacol Bull. 2024;54 (2):51-52$53$YR$$M$Y$$$20240828$$HP$TR$TR
242571361$24257136$1$I$$20240813$20240828$20240828$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458540$RANBAXY$Pilkova A, Hartinger J, Slanar O, Matoulek M. Pharmacotherapy of carbamazepine-treated patient after bariatric surgery: a complex interplay between altered absorption and drug-drug interactions. Eur J Hosp Pharm. 2024;Jul 17:1-4$6$DEC$$F$Y$$$20240828$$HP$CZ$CZ
242571371$24257137$1$I$$20240813$20240828$20240828$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464466$RANBAXY$Kudo H, Shiroshita K, Shiozawa Y, Fujita S, Sakamoto M, Nakamura N, et al. Autopsy case of cardiac mantle cell lymphoma presenting with recurrent pulmonary tumor embolism after chemotherapy. J Clin Exp Hematopathol. 2024;0 (0):1-10$78$YR$$M$Y$$$20240828$$HP$JP$JP
242571381$24257138$1$I$$20240813$20240828$20240828$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464301$RANBAXY$$$$$M$Y$$$20240828$$CN$SE$SE
242571391$24257139$1$I$$20240813$20240828$20240828$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464705$RANBAXY$Filtes P, Beckerman MA, Austin K, Buckley PS, Swan KG. Surgical Management of a Torn ACL and Bucket - Handle Meniscal Tear in the Pregnant Patient A Case Report. JBJS Case Connect. 2024;14 (2):1-6$36$YR$$F$Y$$$20240828$$MD$US$US
242571401$24257140$1$I$20240809$20240813$20240828$20240828$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464459$RANBAXY$$24$YR$$F$Y$$$20240828$$CN$GB$GB
242571411$24257141$1$I$$20240813$20240828$20240828$EXP$$KW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464587$RANBAXY$Naguy A, Al-Khadhari S. Anismus-A Very Unusual Extrapyramidal Side Effect of Paliperidone Palmitate in an Adolescent with Schizo-Affective Disorder. Psychopharmacol Bull. 2024;54(3):100-102$16$YR$$M$Y$$$20240828$$HP$KW$KW
242571421$24257142$1$I$$20240813$20240828$20240828$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464620$RANBAXY$Banasiak KA, Stanczyk MB, Szczepanik E, Krawiranda KM, Janus A, Koscielny KP, et  al. Feeding difficulties in infancy as an early symptom of different forms of diabetes insipidus - a series of cases. Ped Polska. 2024;99(2):158-163$2$MON$$F$Y$3.9$KG$20240828$$HP$PL$PL
242571431$24257143$1$I$$20240813$20240828$20240828$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464708$RANBAXY$Revuelta-Salgado F, Jimenez-Gomez M, Garcia-Lujan R. Giant Tracheoesophageal Fistula: What to Do When There is Little Else That Can be Done. Arch Bronconeumol. 2024;60(6):376-377$51$YR$$F$Y$$$20240828$$HP$ES$ES
242571441$24257144$1$I$$20240813$20240828$20240828$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458292$RANBAXY$Carratala MR, de Amezaga Tomas LP, Carazo MS, Cervera GR. Meropenem for the management of valproic acid intoxication: a case reportand a review of the literature. Med Intensiva (Engl Ed). 2024;Jul 11:Online ahead print(61)$59$YR$$F$Y$$$20240828$$HP$ES$ES
242571451$24257145$1$I$$20240813$20240828$20240828$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-462328$RANBAXY$$52$YR$$M$Y$$$20240828$$MD$GB$GB
242571461$24257146$1$I$$20240813$20240828$20240828$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464583$RANBAXY$Tudor RM, Ali EM, Khan SU, McDermott J. Klinefelter syndrome presenting as metastatic bilateral breast cancer: missed diagnostic opportunities. BMJ Case Rep. 2023;16:e255703 (1-4)$$$A$M$Y$$$20240828$$MD$IE$IE
242571471$24257147$1$I$$20240813$20240828$20240828$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464554$RANBAXY$Torres-ruiz T A, Wharry L, Simo K A.. Marginal Ulcer Following Completion Pancreatectomy Complicated by Portal Vein Erosion. The American Surgeon. 2023;Vol. 89(12):6334?6337$57$YR$$F$Y$$$20240828$$MD$US$US
242571481$24257148$1$I$$20240823$20240828$20240828$EXP$$US-ABBVIE-5894006$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242571501$24257150$1$I$$20240826$20240828$20240828$EXP$$US-ABBVIE-5896168$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242571511$24257151$1$I$$20240805$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07889$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242571521$24257152$1$I$$20240826$20240828$20240828$EXP$$US-ABBVIE-5896313$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242571531$24257153$1$I$20240628$20240827$20240828$20240828$EXP$$CA-GILEAD-2024-0685495$GILEAD$$51$YR$A$F$Y$$$20240828$$PH$CA$CA
242571541$24257154$1$I$$20240813$20240828$20240828$EXP$$US-GLANDPHARMA-US-2024GLNLIT00656$GLAND PHARMA$M Abdelsalam.High dose dexamethasone for edema associated with brain tumor leading to acute sigmoid diverticular perforation.American Journal of the Medical Sciences.22-FEB-2024;367:S1-S212$65$YR$A$F$Y$$$20240828$$HP$US$US
242571551$24257155$1$I$20240826$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016074$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240828$$PH$US$US
242571561$24257156$1$I$20240823$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015947$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242571571$24257157$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016047$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240828$$CN$US$US
242571581$24257158$1$I$$20240822$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015044$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240828$$CN$US$US
242571591$24257159$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016077$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240828$$CN$US$US
242571601$24257160$1$I$$20240822$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015137$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242571611$24257161$1$I$$20240813$20240828$20240828$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01346$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240828$$HP$US$US
242571621$24257162$1$I$$20240813$20240828$20240828$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01348$INTRA-CELLULAR THERAPIES$$18$YR$$F$Y$$$20240828$$HP$US$US
242571631$24257163$1$I$20240726$20240826$20240828$20240828$EXP$$CN-HALEON-2193709$Haleon PLC$$51$YR$$F$Y$54$KG$20240828$$HP$CN$CN
242571641$24257164$1$I$20240618$20240822$20240828$20240828$EXP$$JP-GSK-JP2024JPN104643$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$JP$JP
242571652$24257165$2$F$$20240828$20240828$20240831$EXP$$US-ABBVIE-5892900$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242571662$24257166$2$F$$20240827$20240828$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07890$LUPIN$$$$$$Y$$$20240918$$CN$US$US
242571671$24257167$1$I$$20240819$20240828$20240828$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-132729$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240828$$PH$BR$BR
242571681$24257168$1$I$$20240827$20240828$20240828$EXP$$US-GILEAD-2024-0685485$GILEAD$$$$$F$Y$$$20240828$$HP$US$US
242571691$24257169$1$I$20240809$20240821$20240828$20240828$EXP$$CN-BEIGENE-BGN-2024-013180$BEIGENE$$$$$$Y$$$20240828$$HP$CN$CN
242571702$24257170$2$F$20240101$20240828$20240828$20240906$EXP$$US-SPECGX-T202401755$SPECGX$$$$$F$Y$$$20240906$$CN$US$US
242571712$24257171$2$F$20240825$20240902$20240828$20240903$PER$$US-AMGEN-USASP2024170419$AMGEN$$60$YR$A$F$Y$$$20240903$$CN$US$US
242571723$24257172$3$F$20240825$20240913$20240828$20240916$PER$$US-AMGEN-USASP2024170967$AMGEN$$77$YR$E$F$Y$$$20240915$$MD$US$US
242571731$24257173$1$I$20240809$20240823$20240828$20240828$EXP$$ZA-AstraZeneca-2024A193408$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$ZA$
242571741$24257174$1$I$$20240820$20240828$20240828$EXP$$ES-AstraZeneca-2024A191045$ASTRAZENECA$$72$YR$$F$Y$$$20240828$$MD$ES$
242571752$24257175$2$F$$20240827$20240828$20240829$PER$$NVSC2024US172840$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
242571761$24257176$1$I$20240810$20240819$20240828$20240828$EXP$$GB-TEVA-VS-3235418$TEVA$$39$YR$$M$Y$73$KG$20240828$$HP$GB$GB
242571771$24257177$1$I$$20240813$20240828$20240828$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00674$GLAND PHARMA$Kenta Hayashino.Extranodal natural killer/T-cell lymphoma coexisting with  peripheral T-cell lymphoma, not otherwise specified.Journal of clinical and experimental hematopathology.28-MAR-2024; 64 No. 1:52-58$52$YR$A$M$Y$$$20240828$$HP$JP$JP
242571781$24257178$1$I$$20240819$20240828$20240828$30DAY$$US-GSK-US2024103422$GLAXOSMITHKLINE$$$$$M$Y$$$20240828$$CN$US$US
242571791$24257179$1$I$$20240805$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07903$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242571802$24257180$2$F$$20240914$20240828$20240915$EXP$$US-ALXN-202408USA001678US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$MD$US$US
242571811$24257181$1$I$$20240827$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048234$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240828$$CN$US$US
242571821$24257182$1$I$20240701$20240819$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132026$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240828$$HP$US$US
242571832$24257183$2$F$$20240822$20240828$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07665$LUPIN$$$$$$Y$$$20240910$$CN$US$US
242571841$24257184$1$I$20240805$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024168609$AMGEN$$80$YR$E$F$Y$$$20240828$$CN$US$US
242571851$24257185$1$I$$20240814$20240828$20240828$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001218$ALEMBIC$Arens A.M, Sheikh Said H, Driver B.E, Cole J.B.. Physostigmine reversal of delirium from second generation antipsychotic exposure: a retrospective cohort study from a regional poison center. Clinical Toxicology. 2024;62 (7):463?467$$$$$Y$$$20240828$$HP$US$US
242571861$24257186$1$I$$20240822$20240828$20240828$EXP$$JP-AMGEN-JPNSP2024169424$AMGEN$$$$$$Y$$$20240828$$PH$JP$JP
242571872$24257187$2$F$$20240822$20240828$20240831$PER$$US-AMGEN-USASP2024168628$AMGEN$$$$$$Y$$$20240831$$PH$US$US
242571881$24257188$1$I$20240801$20240819$20240828$20240828$EXP$$US-TEVA-VS-3235374$TEVA$$21$YR$$$Y$$$20240828$$PH$US$US
242571891$24257189$1$I$$20240819$20240828$20240828$EXP$$GB-TEVA-VS-3235459$TEVA$$14$YR$$M$Y$82$KG$20240828$$HP$GB$GB
242571901$24257190$1$I$$20240814$20240828$20240828$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001082$ALEMBIC$Preskorn S.H, Masolak D.D. Life-threatening Rash Due to Lamotrigine and a Failure to Understand Its Pharmacology: How Forensic Detective Work Uses Medical Knowledge and Clinical Pharmacology to Solve Cases. Journal of Psychiatric Practice. 2024;30 (4):273-278$$$$$Y$$$20240828$$MD$US$US
242571911$24257191$1$I$$20240819$20240828$20240828$EXP$$AU-TEVA-VS-3236416$TEVA$$62$YR$$F$Y$$$20240828$$HP$AU$AU
242571922$24257192$2$F$$20240828$20240828$20240829$PER$$US-JNJFOC-20240855126$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$MD$US$US
242571931$24257193$1$I$$20240814$20240828$20240828$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001078$ALEMBIC$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of neonatal-perinatal medicine. 2024;1-6$$$$$Y$$$20240828$$MD$US$US
242571942$24257194$2$F$20240101$20240822$20240828$20240830$EXP$$ES-ABBVIE-5812495$ABBVIE$$$$$F$Y$$$20240828$$CN$ES$ES
242571962$24257196$2$F$$20240905$20240828$20240909$EXP$$JP-GILEAD-2024-0683361$GILEAD$$93$YR$E$F$Y$$$20240909$$PH$JP$JP
242571971$24257197$1$I$20240817$20240819$20240828$20240828$EXP$$TH-EXELIXIS-CABO-24080884$EXELIXIS$$57$YR$$M$Y$$$20240828$$CN$TH$TH
242571981$24257198$1$I$$20240819$20240828$20240828$EXP$$GB-TEVA-VS-3235405$TEVA$$84$YR$$F$Y$62$KG$20240828$$MD$GB$GB
242571991$24257199$1$I$$20240814$20240828$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-041756$AUROBINDO$$73$YR$$F$Y$99$KG$20240828$$HP$CA$CA
242572001$24257200$1$I$$20240813$20240828$20240828$EXP$$US-GLANDPHARMA-US-2024GLNLIT00662$GLAND PHARMA$Raphel J Leo.Clozapine-Related Cecal Volvulus.The primary care companion for CNS disorders.11-JUL-2024;26(4):03729$58$YR$A$F$Y$$$20240828$$MD$US$US
242572012$24257201$2$F$$20240903$20240828$20240912$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001069$ALEMBIC$Zhu A, Kuhnly N, Chen L, Dulu A.O. A Case study of polypharmacy-induced serotonin syndrome in a cancer patient. Journal of the American Association of Nurse Practitioners. 2024;00:1?5$$$$$Y$$$20240912$$HP$US$US
242572021$24257202$1$I$20240826$20240826$20240828$20240828$30DAY$$US-SANDOZ INC.-SDZ2024US075570$SANDOZ$$2$YR$$$Y$$$20240828$$CN$US$US
242572031$24257203$1$I$$20220506$20240828$20240828$EXP$$CA-CELLTRION INC.-2021CA019662$CELLTRION$$$$$$Y$$$20240828$$MD$CA$CA
242572041$24257204$1$I$20240806$20240820$20240828$20240828$EXP$$CO-BIOVITRUM-2024-CO-011370$BIOVITRUM$$142$DY$$M$Y$4.8$KG$20240828$$CN$CO$CO
242572051$24257205$1$I$$20240822$20240828$20240828$EXP$GB-MHRA-MED-202408221445263120-FVRSW$GB-ABBVIE-5891249$ABBVIE$$33$YR$$F$Y$$$20240828$$HP$GB$GB
242572061$24257206$1$I$20140101$20240823$20240828$20240828$EXP$$US-ABBVIE-5894109$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242572071$24257207$1$I$20240801$20240820$20240828$20240828$PER$$US-RDY-SPO/USA/24/0012369$DR REDDYS$$15$YR$T$$Y$$$20240828$$HP$US$US
242572081$24257208$1$I$20240801$20240822$20240828$20240828$EXP$$US-ABBVIE-5892778$ABBVIE$$79$YR$$F$Y$$$20240828$$CN$US$US
242572091$24257209$1$I$$20240820$20240828$20240828$PER$$US-RDY-SPO/USA/24/0012313$DR REDDYS$$$$$$Y$$$20240828$$HP$US$US
242572102$24257210$2$F$$20240826$20240828$20240902$PER$$US-AMGEN-USASP2024169206$AMGEN$$82$YR$E$F$Y$$$20240901$$CN$US$US
242572111$24257211$1$I$$20240820$20240828$20240828$EXP$US-DRL-USA-SPO/USA/24/0012370$US-RDY-SPO/USA/24/0012370$DR REDDYS$Glezerman I, Salvatore S, Tap W, Kelly C, Brauer Ornelas CM, Shaikh A. Pegylated Liposomal Doxorubicin Causes Kidney-limited Thrombotic Microangiopathy. American journal of kidney diseases. 2024;83(4):549-53. DOI: 10.1053/j.ajkd.2023.08.014.$72$YR$E$F$Y$$$20240828$$MD$US$US
242572121$24257212$1$I$20240801$20240822$20240828$20240828$EXP$$US-ABBVIE-5891324$ABBVIE$$85$YR$$M$Y$$$20240828$$CN$US$US
242572141$24257214$1$I$$20240821$20240828$20240828$PER$$US-ALXN-202408USA001711US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242572152$24257215$2$F$$20240914$20240828$20240920$EXP$FR-002147023-NVSC2024FR164697$FR-LEO Pharma-372809$LEO PHARM$Fargeas M, Devouassoux G, Gerfaud-Valentin M. Onset of eosinophilic granulomatosis with polyangiitis (EGPA) after anti-Th2 biotherapy initiation in severe asthma patients: Report of 3 cases. RESPIR-MED-RES. 2024;85:1-3. doi:10.1016/j.resmer.2023.101070$63$YR$$F$Y$$$20240920$$HP$FR$FR
242572162$24257216$2$F$$20240902$20240828$20240910$EXP$$US-TEVA-VS-3235526$TEVA$Difiore E, Pittman J. A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting. Case-Rep-Psychiatry 2024; 2024 (0):.; Difiore E, Pittman J. A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting. Case-Rep-Psychiatry 2024; 2024 (0):.; Difiore E, Pittman J. A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting. Case-Rep-Psychiatry 2024; 2024 (0):.$54$YR$$M$Y$$$20240910$$HP$US$US
242572171$24257217$1$I$$20240820$20240828$20240828$EXP$$US-AMGEN-USASP2024166805$AMGEN$$53$YR$A$M$Y$$$20240828$$HP$US$US
242572181$24257218$1$I$20240820$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169127$AMGEN$$62$YR$A$F$Y$$$20240828$$CN$US$US
242572191$24257219$1$I$$20240822$20240828$20240828$EXP$$GB-AMGEN-GBRSP2024169700$AMGEN$$76$YR$E$F$Y$$$20240828$$CN$GB$GB
242572201$24257220$1$I$20240822$20240823$20240828$20240828$EXP$$NVSC2024CA172481$NOVARTIS$$74$YR$$M$Y$$$20240828$$CN$CA$CA
242572212$24257221$2$F$20231101$20240829$20240828$20240905$EXP$$US-ABBVIE-5897255$ABBVIE$$60$YR$$F$Y$$$20240905$$CN$US$US
242572221$24257222$1$I$$20240730$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07777$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242572234$24257223$4$F$20240801$20240919$20240828$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-025371$UNITED THERAPEUTICS$$59$YR$$F$Y$70.295$KG$20240925$$$US$US
242572241$24257224$1$I$20240301$20240820$20240828$20240828$PER$$US-ROCHE-10000062577$ROCHE$$65$YR$E$M$Y$127.01$KG$20240828$$CN$US$US
242572251$24257225$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190924$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242572261$24257226$1$I$$20240808$20240828$20240828$PER$$US-AstraZeneca-2024A180920$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242572271$24257227$1$I$$20240822$20240828$20240828$PER$$US-ABBVIE-5894530$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242572281$24257228$1$I$20230101$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015956$ELI LILLY AND CO$$$$A$M$Y$$$20240828$$CN$US$US
242572291$24257229$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015902$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240828$$CN$US$US
242572301$24257230$1$I$20240801$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016277$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240828$$CN$US$US
242572311$24257231$1$I$$20240823$20240828$20240828$PER$$US-HALEON-2193541$Haleon PLC$$56$YR$$F$Y$$$20240828$$CN$US$US
242572321$24257232$1$I$20240825$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016254$ELI LILLY AND CO$$41$YR$A$$Y$$$20240828$$CN$US$US
242572332$24257233$2$F$$20240909$20240828$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202408016302$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240912$$CN$US$US
242572341$24257234$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004375$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242572351$24257235$1$I$$20240805$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004157$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$HP$US$US
242572361$24257236$1$I$$20240816$20240828$20240828$PER$$US-APOTEX-2024AP009651$APOTEX$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, Block MS. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. Journal of Clinical Oncology. 2024;42 (16)$$$E$$Y$$$20240828$$HP$US$US
242572372$24257237$2$F$$20240821$20240828$20240902$EXP$$NL-AUROBINDO-AUR-APL-2024-041593$AUROBINDO$$64$YR$$M$Y$118$KG$20240902$$CN$NL$NL
242572381$24257238$1$I$$20240819$20240828$20240828$PER$$US-ABBVIE-5888442$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242572391$24257239$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170765$AMGEN$$$$$$Y$$$20240828$$PH$US$US
242572403$24257240$3$F$$20240910$20240828$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA075396$SANDOZ$$$$$F$Y$$$20240913$$MD$CA$CA
242572411$24257241$1$I$$20240826$20240828$20240828$30DAY$$US-SANDOZ INC.-SDZ2024US075560$SANDOZ$$$$$F$Y$$$20240828$$CN$US$US
242572421$24257242$1$I$$20240819$20240828$20240828$EXP$$KR-CELLTRION INC.-2024KR020143$CELLTRION$Bae JH, Park JB, Baek JE, Hong SW, Park SH, Yang DH, et al.. Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure. Gut and Liver. 2024;18(4):667-676$$$$$Y$$$20240828$$MD$KR$KR
242572431$24257243$1$I$20230701$20230818$20240828$20240828$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406361$RANBAXY$$54$YR$A$F$Y$$$20240828$$CN$US$US
242572441$24257244$1$I$$20240621$20240828$20240828$PER$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-003944$PHARMAESSENTIA$$$$$F$Y$$$20240828$$HP$US$US
242572451$24257245$1$I$20240501$20240813$20240828$20240828$PER$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-003900$PHARMAESSENTIA$$$$$F$Y$$$20240828$$HP$US$US
242572461$24257246$1$I$$20240516$20240828$20240828$PER$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-003794$PHARMAESSENTIA$$$$$M$Y$$$20240828$$HP$US$US
242572471$24257247$1$I$$20240802$20240828$20240828$PER$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-003999$PHARMAESSENTIA$$$$$F$Y$$$20240828$$CN$US$US
242572481$24257248$1$I$$20240605$20240828$20240828$PER$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-004055$PHARMAESSENTIA$$$$$$Y$$$20240828$$HP$US$US
242572491$24257249$1$I$$20240603$20240828$20240828$PER$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-003914$PHARMAESSENTIA$$$$$$Y$$$20240828$$HP$US$US
242572501$24257250$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5894378$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242572511$24257251$1$I$$20240807$20240828$20240828$PER$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-004275$PHARMAESSENTIA$$$$$M$Y$$$20240828$$CN$US$US
242572521$24257252$1$I$$20240613$20240828$20240828$PER$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-004056$PHARMAESSENTIA$$$$$$Y$$$20240828$$HP$US$US
242572531$24257253$1$I$$20240725$20240828$20240828$PER$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-004218$PHARMAESSENTIA$$$$$M$Y$$$20240828$$CN$US$US
242572541$24257254$1$I$20220501$20240801$20240828$20240828$PER$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-004250$PHARMAESSENTIA$$$$$F$Y$$$20240828$$CN$US$US
242572551$24257255$1$I$20240101$20240726$20240828$20240828$PER$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-004224$PHARMAESSENTIA$$$$$$Y$$$20240828$$HP$US$US
242572561$24257256$1$I$20230101$20240809$20240828$20240828$PER$$US-PHARMAESSENTIA CORPORATION-US-2024-PEC-004098$PHARMAESSENTIA$$$$$F$Y$$$20240828$$HP$US$US
242572571$24257257$1$I$$20240816$20240828$20240828$PER$$US-APOTEX-2024AP009729$APOTEX$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, Block MS. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. Journal of Clinical Oncology. 2024;42 (16)$$$E$$Y$$$20240828$$HP$US$US
242572581$24257258$1$I$$20240826$20240828$20240828$EXP$$US-GSK-US2024106080$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
242572591$24257259$1$I$$20240819$20240828$20240828$30DAY$$US-GSK-US2024103436$GLAXOSMITHKLINE$$$$A$F$Y$$$20240828$$CN$US$US
242572601$24257260$1$I$$20240813$20240828$20240828$EXP$$IE-GLANDPHARMA-IE-2024GLNLIT00664$GLAND PHARMA$John Kelliher.Severe atypical iliac wing fracture associated with long-term bisphosphonate use.Skeletal Radiology.JAN-2024;1-5$63$YR$A$F$Y$$$20240828$$HP$IE$IE
242572611$24257261$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004377$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242572641$24257264$1$I$$20240809$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06952$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242572651$24257265$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004376$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242572661$24257266$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004378$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242572671$24257267$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5894169$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242572681$24257268$1$I$20230101$20240820$20240828$20240828$EXP$$RO-AMGEN-ROUSP2024167718$AMGEN$$$$A$F$Y$$$20240828$$PH$RO$RO
242572691$24257269$1$I$20240726$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170273$AMGEN$$72$YR$E$M$Y$$$20240828$$CN$US$US
242572701$24257270$1$I$$20240815$20240828$20240828$PER$$US-JNJFOC-20240848978$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$CN$US$US
242572711$24257271$1$I$$20240814$20240828$20240828$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07836$HIKMA$Rivkin AC, Khan AH, Mellgren AF, Perez-Tamayo AM, Chaudhry V, Bianchi EM et al.. Rivkin AC, Khan AH, Mellgren AF, Perez-Tamayo AM, Chaudhry V, Bianchi EM, et al. Pelvic Necrosis with Formation of a Pelvic ^Cloaca^ and Necrotizing Soft Tissue Infection After Radiation for Anal Squamous Cell Carcinoma. American Journal of Case Reports. 2024;25:e943599$66$YR$$F$Y$$$20240828$$MD$US$US
242572722$24257272$2$F$20240522$20240819$20240828$20240906$EXP$$CA-BEH-2024173203$CSL BEHRING$$61$YR$A$F$Y$40$KG$20240906$$HP$CA$CA
242572732$24257273$2$F$20240820$20240905$20240828$20240911$EXP$$JP-GSK-JP2024JPN104758$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$MD$JP$JP
242572742$24257274$2$F$20240821$20240924$20240828$20240926$PER$$US-AMGEN-USASP2024168248$AMGEN$$74$YR$E$F$Y$$$20240925$$CN$US$US
242572751$24257275$1$I$$20240821$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134686$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$MD$US$US
242572761$24257276$1$I$$20240805$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004380$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242572771$24257277$1$I$20230701$20240822$20240828$20240828$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-135053$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240828$$MD$DE$DE
242572781$24257278$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004379$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242572791$24257279$1$I$20240823$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169154$AMGEN$$85$YR$E$F$Y$$$20240828$$CN$US$US
242572801$24257280$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004381$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242572811$24257281$1$I$$20240816$20240828$20240828$PER$$US-APOTEX-2024AP009730$APOTEX$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, Block MS. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. Journal of Clinical Oncology. 2024;42 (16)$$$E$$Y$$$20240828$$HP$US$US
242572821$24257282$1$I$20240703$20240723$20240828$20240828$PER$$US-CHIESI-2024CHF04079$CHIESI$$28$YR$$M$Y$$$20240828$$HP$US$US
242572831$24257283$1$I$20240701$20240713$20240828$20240828$PER$$US-CHIESI-2024CHF04297$CHIESI$$16$YR$$F$Y$$$20240828$$CN$US$US
242572841$24257284$1$I$20240805$20240805$20240828$20240828$PER$$US-CHIESI-2024CHF04901$CHIESI$$33$YR$$F$Y$$$20240828$$CN$US$US
242572851$24257285$1$I$$20240813$20240828$20240828$EXP$$US-GLANDPHARMA-US-2024GLNSPO00690$GLAND PHARMA$$$$$F$Y$$$20240828$$CN$US$US
242572862$24257286$2$F$$20240821$20240828$20240830$PER$$US-ABBVIE-5891110$ABBVIE$$$$$F$Y$$$20240830$$HP$US$US
242572871$24257287$1$I$$20240814$20240828$20240828$EXP$$US-UCBSA-2024041830$UCB$$$$$M$Y$83$KG$20240828$$HP$US$US
242572902$24257290$2$F$20120201$20240830$20240828$20240913$EXP$$US-PARTNER THERAPEUTICS-2024PTX00045$SYMOGEN$McNeel D, Eickhoff J, Johnson L, et al.. Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer. Journal of Clinical Oncology. 2019$$$$M$Y$$$20240913$$MD$US$US
242572912$24257291$2$F$20160824$20240830$20240828$20240913$EXP$$US-PARTNER THERAPEUTICS-2024PTX00046$SYMOGEN$McNeel D, Eickhoff J, Johnson L, et al.. Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer.. Journal of Clinical Oncology.. 2019$$$$M$Y$$$20240913$$HP$US$US
242572921$24257292$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-138951-2023$RECKITT BENCKISER$$3$YR$$F$Y$$$20240828$$CN$US$US
242572931$24257293$1$I$$20240813$20240828$20240828$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111314$ZYDUS PHARM$Leung BW, Fay CJ, Said JT, Sheets AR, Lian CG, Brown JR. Localized upper extremity edema secondary to Bruton^s tyrosine kinase inhibition. Leukemia + Lymphoma. 2023;64(12):2047-2050$$$$$Y$$$20240828$$HP$US$US
242572943$24257294$3$F$$20240913$20240828$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134170$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240923$$CN$US$US
242572951$24257295$1$I$$20240823$20240828$20240828$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-136388$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$58$KG$20240828$$HP$CA$CA
242572981$24257298$1$I$$20240821$20240828$20240828$EXP$$US-TAKEDA-2024TUS084392$TAKEDA$$$$$F$Y$$$20240828$$MD$US$US
242572991$24257299$1$I$$20240820$20240828$20240828$EXP$$PK-SKF-000138$ESKAYEF PHARMACEUTICALS$$64$YR$A$F$Y$$$20240821$$MD$PK$PK
242573002$24257300$2$F$$20240911$20240828$20240917$PER$$US-MTPC-MTDA2024-0017674$MITSUBISHI TANABE PHARMA$$$$A$$Y$$$20240917$$CN$US$US
242573012$24257301$2$F$20240807$20240909$20240828$20240912$PER$$US-MTPC-MTDA2024-0017704$Unknown Manufacturer$$61$YR$$F$Y$$$20240912$$CN$US$US
242573022$24257302$2$F$20210101$20240918$20240828$20240925$EXP$$CN-SA-2024SA245800$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240925$$HP$CN$CN
242573031$24257303$1$I$20240816$20240821$20240828$20240828$PER$$US-AMGEN-USASP2024170510$AMGEN$$$$$$Y$$$20240828$$HP$US$US
242573041$24257304$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016939$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240828$$CN$US$US
242573051$24257305$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016175$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240828$$CN$US$US
242573061$24257306$1$I$20240826$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016616$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240828$$CN$US$US
242573071$24257307$1$I$20240826$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017151$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240828$$CN$US$US
242573081$24257308$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016051$ELI LILLY AND CO$$80$YR$E$$Y$$$20240828$$CN$US$US
242573091$24257309$1$I$20240821$20240828$20240828$20240828$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044255$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240828$$CN$JP$JP
242573102$24257310$2$F$20240101$20240829$20240828$20240903$EXP$$US-ABBVIE-5891742$ABBVIE$$$$$M$Y$90.718$KG$20240903$$CN$US$US
242573111$24257311$1$I$$20240815$20240828$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-013035$AUROBINDO$Agarwal S,M , Margaret KH, Prasad F, De R, Korann V, Chintoh AF, et al. Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series. Ther Adv Psychopharmacol. 2023;13:1?10$23$YR$$F$Y$$$20240828$$HP$CA$CA
242573124$24257312$4$F$20240101$20240924$20240828$20240928$EXP$$US-SA-2024SA248943$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240928$$CN$US$US
242573131$24257313$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004382$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242573142$24257314$2$F$20220531$20240912$20240828$20240918$EXP$$JP-ABBVIE-5895497$ABBVIE$$21$YR$$M$Y$$$20240918$$MD$JP$JP
242573151$24257315$1$I$$20240820$20240828$20240828$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-133870$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240828$$MD$AU$AU
242573161$24257316$1$I$$20240820$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133586$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240828$$HP$US$US
242573172$24257317$2$F$20170101$20240827$20240828$20240830$EXP$$CA-TAKEDA-2017TUS015886$TAKEDA$$$$$F$Y$$$20240830$$HP$CA$CA
242573181$24257318$1$I$$20240813$20240828$20240828$EXP$$US-GLANDPHARMA-US-2024GLNSPO00678$GLAND PHARMA$$$$$F$Y$$$20240828$$CN$US$US
242573191$24257319$1$I$$20240827$20240828$20240828$EXP$$US-GILEAD-2024-0685492$GILEAD$$$$$F$Y$$$20240828$$HP$US$US
242573201$24257320$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004383$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242573211$24257321$1$I$20210101$20240814$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-041099$AUROBINDO$Kroll MR, Au C, Slostad J, Christ TN, Papas SG, Tan A.. Case report: Metastatic BRAF V600E-mutated adult Wilms^ tumor with robust response to BRAF/MEK inhibitor therapy. Frontiers in Oncology. 2024;14:1376270$37$YR$$F$Y$$$20240828$$MD$US$US
242573221$24257322$1$I$$20240820$20240828$20240828$EXP$$US-RDY-LIT/USA/24/0012416$DR REDDYS$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. Journal of drugs in dermatology : JDD. 2023 Nov;22(11): e12-e16. doi:10.36849/JDD.4936.$41$YR$A$F$Y$$$20240828$$HP$US$US
242573232$24257323$2$F$20240723$20240820$20240828$20240916$PER$$US-BEH-2024177559$CSL BEHRING$$72$YR$E$M$Y$$$20240916$$CN$US$US
242573241$24257324$1$I$$20240820$20240828$20240828$EXP$$US-RDY-LIT/USA/24/0012415$DR REDDYS$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. Journal of drugs in dermatology : JDD. 2023 Nov;22(11): e12-e16. doi:10.36849/JDD.4936.$51$YR$A$F$Y$$$20240828$$HP$US$US
242573251$24257325$1$I$20240626$20240821$20240828$20240828$EXP$$KR-TAKEDA-2024TUS084123$TAKEDA$$67$YR$$M$Y$$$20240828$$CN$KR$KR
242573261$24257326$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004384$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242573271$24257327$1$I$$20240819$20240828$20240828$EXP$$AU-MSNLABS-2024MSNLIT01845$MSN LABORATORIES$Adamson A, Michael A, Patel S, Brown M.First case of Drug-Induced Pulmonary ArterialHypertension: Teriflunomide.Heart, Lung and Circulation.2024;33:S353$$$$$Y$$$20240828$$HP$AU$AU
242573281$24257328$1$I$$20240815$20240828$20240828$EXP$$ZA-ADVANZ PHARMA-202408007030$ADVANZ PHARMA$$$$$$Y$$$20240828$$HP$ZA$ZA
242573291$24257329$1$I$$20240814$20240828$20240828$PER$$US-JNJFOC-20240846379$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$MD$US$US
242573301$24257330$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A191686$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242573321$24257332$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190793$ASTRAZENECA$$$$$F$Y$$$20240828$$HP$US$
242573332$24257333$2$F$$20240820$20240828$20240909$PER$$US-AstraZeneca-2024A188949$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242573341$24257334$1$I$$20240822$20240828$20240828$EXP$$ZA-AstraZeneca-2024A192871$ASTRAZENECA$$79$YR$$F$Y$$$20240828$$CN$ZA$
242573351$24257335$1$I$20240826$20240826$20240828$20240828$EXP$$US-AstraZeneca-2024A194563$ASTRAZENECA$$$$$F$Y$$$20240828$$HP$US$
242573361$24257336$1$I$$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A193097$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242573371$24257337$1$I$$20240819$20240828$20240828$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07947$HIKMA$$$$$M$Y$$$20240828$$CN$US$US
242573381$24257338$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169191$AMGEN$$$$$$Y$$$20240828$$CN$US$US
242573391$24257339$1$I$20240809$20240821$20240828$20240828$PER$$US-AMGEN-USASP2024167734$AMGEN$$$$$$Y$$$20240828$$PH$US$US
242573401$24257340$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-088562-2024$RECKITT BENCKISER$$$$$F$Y$$$20240828$$CN$US$US
242573411$24257341$1$I$$20240826$20240828$20240828$PER$$NVSC2024US173151$NOVARTIS$$$$$F$Y$$$20240828$$MD$US$US
242573421$24257342$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5893995$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242573431$24257343$1$I$20230601$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2024-041876$AUROBINDO$$76$YR$$M$Y$88$KG$20240828$$CN$FR$FR
242573441$24257344$1$I$20240801$20240822$20240828$20240828$EXP$$US-ABBVIE-5891358$ABBVIE$$66$YR$$F$Y$$$20240828$$CN$US$US
242573451$24257345$1$I$$20240820$20240828$20240828$EXP$$US-GSK-US2024103841$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$HP$US$US
242573461$24257346$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136338$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240828$$CN$US$US
242573471$24257347$1$I$$20240813$20240828$20240828$EXP$$US-LEADINGPHARMA-US-2024LEALIT00358$LEADING PHARMA$Nolan Maloney.Chronic ulcer in a patient with essential thrombocythemia taking hydroxyurea.Dermatology Online Journal.2024;30 (3):1-3$82$YR$E$F$Y$$$20240828$$MD$US$US
242573481$24257348$1$I$$20240823$20240828$20240828$EXP$$US-ABBVIE-5700413$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242573492$24257349$2$F$20240615$20240916$20240828$20240926$EXP$$PL-AUROBINDO-AUR-APL-2024-041996$AUROBINDO$$67$YR$$F$Y$$$20240926$$MD$PL$PL
242573502$24257350$2$F$20240101$20240912$20240828$20240912$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048192$BOEHRINGER INGELHEIM$$9$DEC$E$M$Y$$$20240912$$PH$JP$JP
242573511$24257351$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170842$AMGEN$$$$$$Y$$$20240828$$CN$US$US
242573521$24257352$1$I$20240101$20240827$20240828$20240828$PER$$US-AMGEN-USASP2024171131$AMGEN$$74$YR$E$F$Y$$$20240828$$CN$US$US
242573541$24257354$1$I$20240703$20240827$20240828$20240828$EXP$$US-UCBSA-2024043583$UCB$$54$YR$$F$Y$$$20240828$$CN$US$US
242573551$24257355$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5894449$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242573562$24257356$2$F$20240101$20240829$20240828$20240903$EXP$$US-ABBVIE-5892781$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242573571$24257357$1$I$20240101$20240822$20240828$20240828$EXP$$GR-ABBVIE-5874161$ABBVIE$$$$$M$Y$74$KG$20240828$$CN$GR$GR
242573581$24257358$1$I$$20240823$20240828$20240828$EXP$$CA-JNJFOC-20240863436$JOHNSON AND JOHNSON$$40$YR$A$F$Y$55$KG$20240828$$HP$CA$CA
242573591$24257359$1$I$$20240814$20240828$20240828$EXP$$US-PDX-000385$PHARMADAX$Malik N, Vadher A, Panikottu K, Kambhatla S, Harder W. Post-Myocardial Infarction (MI) Left Ventricular Free Wall Rupture Managed Conservatively. Cureus. 2024 Jul 12;16(7):e64395. doi: 10.7759/cureus.64395.$78$YR$E$M$Y$$$20240828$$HP$US$US
242573601$24257360$1$I$$20240823$20240828$20240828$EXP$$US-ABBVIE-5894606$ABBVIE$$$$$M$Y$$$20240828$$HP$US$US
242573611$24257361$1$I$20240820$20240822$20240828$20240828$EXP$$RU-GILEAD-2024-0684727$GILEAD$$56$YR$A$M$Y$$$20240828$$MD$RU$RU
242573621$24257362$1$I$$20240816$20240828$20240828$EXP$$IT-AUROBINDO-AUR-APL-2024-042260$AUROBINDO$Trapanese V, Maruca F, Natale MR, Giofre F, Cosentino F, Sergi S, et al. Sodium-glucose co-transporter-2 inhibitor-associated non-diabetic ketoacidosis: a case report. Italian-J-Med. 2024;18 (2)$26$YR$$M$Y$142$KG$20240828$$HP$IT$IT
242573631$24257363$1$I$$20240815$20240828$20240828$EXP$$IT-AUROBINDO-AUR-APL-2023-039966$AUROBINDO$Falcicchio G, Lattanzi S, Negri F,de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox?Gastaut Syndrome: A Case Series. Journal of Clinical Medicine. 2023;12 (129):1-7$37$YR$$M$Y$$$20240828$$HP$IT$IT
242573641$24257364$1$I$$20240820$20240828$20240828$EXP$$CA-TOLMAR, INC.-24CA052019$TOLMAR$$$$$M$Y$$$20240828$$MD$CA$CA
242573653$24257365$3$F$$20240909$20240828$20240911$EXP$$NVSC2024US172808$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
242573661$24257366$1$I$$20240813$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08170$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242573671$24257367$1$I$20240101$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2024-041867$AUROBINDO$$13$YR$$M$Y$$$20240828$$MD$FR$FR
242573681$24257368$1$I$$20240815$20240828$20240828$EXP$$CA-AUROBINDO-AUR-APL-2024-041927$AUROBINDO$$14$YR$$F$Y$46$KG$20240828$$HP$CA$CA
242573691$24257369$1$I$20240819$20240826$20240828$20240828$EXP$FR-AFSSAPS-CF2024000428$FR-BEH-2024177734$CSL BEHRING$$81$YR$E$M$Y$61$KG$20240828$$HP$FR$FR
242573702$24257370$2$F$20240701$20240905$20240828$20240910$PER$$US-AMGEN-USASP2024171177$AMGEN$$39$YR$A$M$Y$$$20240910$$PH$US$US
242573711$24257371$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170688$AMGEN$$$$T$M$Y$$$20240828$$CN$US$US
242573721$24257372$1$I$$20240827$20240828$20240828$PER$$US-AMGEN-USASP2024171391$AMGEN$$$$$F$Y$$$20240828$$MD$US$US
242573731$24257373$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135910$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240828$$CN$US$US
242573741$24257374$1$I$$20240820$20240828$20240828$EXP$$US-LEO Pharma-372922$LEO PHARM$$64$YR$$M$Y$$$20240828$$PH$US$US
242573752$24257375$2$F$20240101$20240829$20240828$20240829$EXP$$US-ABBVIE-5896209$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242573761$24257376$1$I$$20240805$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004385$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242573771$24257377$1$I$$20240827$20240828$20240828$EXP$$US-ABBVIE-5897422$ABBVIE$$$$$M$Y$$$20240828$$HP$US$US
242573781$24257378$1$I$$20240823$20240828$20240828$PER$$US-GILEAD-2024-0685299$GILEAD$$$$$$Y$$$20240828$$LW$US$US
242573791$24257379$1$I$$20240816$20240828$20240828$EXP$$PL-AUROBINDO-AUR-APL-2024-042084$AUROBINDO$Podgorski Pawel. The use of tacrolimus in the treatment of exacerbation of lupus nephritis- a case report. Nefrologia i Dializoterapia Polska Nr 3/2016. 2016;20:227-9$22$YR$$F$Y$$$20240828$$HP$PL$PL
242573801$24257380$1$I$20240811$20240823$20240828$20240828$EXP$FR-AFSSAPS-LL2024001602$FR-ABBVIE-5896058$ABBVIE$$67$YR$$M$Y$$$20240828$$MD$FR$FR
242573811$24257381$1$I$$20240823$20240828$20240828$PER$$US-TAKEDA-2024TUS085726$TAKEDA$$$$$M$Y$119$KG$20240828$$MD$US$US
242573821$24257382$1$I$$20240821$20240828$20240828$PER$$US-TAKEDA-2024TUS085602$TAKEDA$$$$$M$Y$$$20240828$$MD$US$US
242573832$24257383$2$F$20240815$20240830$20240828$20240906$EXP$$US-ABBVIE-5890365$ABBVIE$$75$YR$$M$Y$$$20240906$$CN$US$US
242573841$24257384$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015567$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240828$$CN$US$US
242573851$24257385$1$I$20240701$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016433$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240828$$CN$US$US
242573861$24257386$1$I$20240824$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016232$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240828$$CN$US$US
242573871$24257387$1$I$20240827$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017069$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240828$$CN$US$US
242573881$24257388$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016188$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240828$$CN$US$US
242573891$24257389$1$I$20240826$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016139$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240828$$CN$US$US
242573901$24257390$1$I$20240818$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016926$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240828$$CN$US$US
242573911$24257391$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-109973-2023$RECKITT BENCKISER$$$$$F$Y$$$20240828$$CN$US$US
242573922$24257392$2$F$$20240814$20240828$20240828$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111442$ZYDUS PHARM$Alshawa L, Leahy B, Rueckert J, Maskey A, Anstead M, Keshavamurthy S, et al. Hemophagocytic Lymphohistiocytosis: A Rare Diagnosis in the Immediate Aftermath of Lung Transplantation. JHeart- Lung-Transplant. 2024;43 (Suppl.)(4):S484-S485 abstr. 1040$$$$$Y$$$20240828$$HP$US$US
242573931$24257393$1$I$20231001$20240820$20240828$20240828$EXP$FR-AFSSAPS-PA2024001440$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111403$ZYDUS PHARM$$$$$$Y$$$20240828$$MD$FR$FR
242573941$24257394$1$I$20240422$20240820$20240828$20240828$EXP$FR-AFSSAPS-NT2024001054$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111369$ZYDUS PHARM$$$$$$Y$$$20240828$$MD$FR$FR
242573951$24257395$1$I$20240713$20240820$20240828$20240828$EXP$FR-AFSSAPS-BR2024000681$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111368$ZYDUS PHARM$$$$$$Y$$$20240828$$MD$FR$FR
242573961$24257396$1$I$$20240821$20240828$20240828$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026313$UNITED THERAPEUTICS$$$$$F$Y$129.25$KG$20240828$$$US$US
242573971$24257397$1$I$20240729$20240820$20240828$20240828$EXP$FR-AFSSAPS-AN2024001101$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111345$ZYDUS PHARM$$$$$$Y$$$20240828$$PH$FR$FR
242573981$24257398$1$I$$20240826$20240828$20240828$EXP$$US-ABBVIE-5896068$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242573991$24257399$1$I$$20240820$20240828$20240828$EXP$$JP-VANTIVE-2024VAN019116$Vantive US Healthcare$$90$YR$$F$Y$33$KG$20240828$$HP$JP$JP
242574003$24257400$3$F$$20240919$20240828$20240927$EXP$$CA-VANTIVE-2024VAN017959$Vantive US Healthcare$$$$$M$Y$$$20240927$$HP$CA$CA
242574012$24257401$2$F$20230504$20240916$20240828$20240924$EXP$FR-AFSSAPS-PO2024000870$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111353$ZYDUS PHARM$$$$$$Y$$$20240924$$HP$FR$FR
242574021$24257402$1$I$20240814$20240820$20240828$20240828$EXP$$JP-VANTIVE-2024VAN019056$Vantive US Healthcare$$83$YR$$M$Y$$$20240828$$HP$JP$JP
242574031$24257403$1$I$20240731$20240820$20240828$20240828$EXP$FR-AFSSAPS-MP2024001277$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111339$ZYDUS PHARM$$$$$$Y$$$20240828$$MD$FR$FR
242574041$24257404$1$I$20240826$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170755$AMGEN$$73$YR$E$M$Y$$$20240828$$CN$US$US
242574051$24257405$1$I$$20240817$20240828$20240828$EXP$$US-AMGEN-USASP2024164835$AMGEN$Stewart Iv, J.H.. Phase I trial of talimogene laherparepvec for the treatment of peritoneal surface malignancies (TEMPO). Journal of Clinical Oncology. 2024;42 (16):2668$$$$$Y$$$20240828$$HP$US$US
242574061$24257406$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136061$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240828$$HP$US$US
242574071$24257407$1$I$$20240815$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130040$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240828$$HP$US$US
242574081$24257408$1$I$$20240822$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135215$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240828$$CN$US$US
242574091$24257409$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136110$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240828$$HP$US$US
242574101$24257410$1$I$$20240815$20240828$20240828$EXP$$JP-ADVANZ PHARMA-202408006907$ADVANZ PHARMA$$$$$$Y$$$20240828$$MD$JP$JP
242574121$24257412$1$I$20240728$20240805$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004386$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240828$$CN$US$US
242574131$24257413$1$I$20240823$20240823$20240828$20240828$PER$$NVSC2024US173243$NOVARTIS$$12$YR$$F$Y$130$KG$20240828$$HP$US$US
242574141$24257414$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173394$NOVARTIS$$$$$F$Y$$$20240828$$MD$US$US
242574151$24257415$1$I$20240701$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170569$AMGEN$$79$YR$E$M$Y$$$20240828$$PH$US$US
242574161$24257416$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-088553-2024$RECKITT BENCKISER$$75$YR$$F$Y$$$20240828$$CN$US$US
242574173$24257417$3$F$20240601$20240906$20240828$20240911$EXP$$US-EXELIXIS-CABO-24080832$EXELIXIS$$62$YR$$M$Y$61.678$KG$20240911$$CN$US$US
242574181$24257418$1$I$$20240827$20240828$20240828$EXP$$US-GILEAD-2024-0685490$GILEAD$$$$$F$Y$$$20240828$$HP$US$US
242574191$24257419$1$I$$20240821$20240828$20240828$EXP$$JP-EXELIXIS-CABO-24080875$EXELIXIS$$7$DEC$$F$Y$$$20240828$$MD$JP$JP
242574201$24257420$1$I$$20240818$20240828$20240828$EXP$$US-SKG-000001$SKG Pharma$$52$YR$A$M$Y$$$20240820$$MD$US$US
242574211$24257421$1$I$20240101$20240820$20240828$20240828$PER$$US-ABBVIE-5892707$ABBVIE$$$$$F$Y$$$20240828$$HP$US$US
242574221$24257422$1$I$$20240818$20240828$20240828$EXP$$CN-VKT-000584$VKT PHARMA PRIVATE LIMITED$$3$YR$C$F$Y$$$20240821$$HP$CN$CN
242574231$24257423$1$I$$20240822$20240828$20240828$EXP$US-MLMSERVICE-20240815-PI164305-00123-1$US-RDY-SPO/USA/24/0012384$DR REDDYS$Hui J, Zhan X, Bashir A, Policeni F, Kim Hsieh SU. Epithelial-myoepithelial carcinoma occurrence in the site of previously treated ductal carcinoma in situ of the breast: Imaging features with histopathologic correlation, a case report and review of the literature. Clinical Case Reports. 2024;12(8):e9270. DOI: 10.1002/ccr3.9270.$75$YR$E$F$Y$$$20240828$$MD$US$US
242574241$24257424$1$I$$20240818$20240828$20240828$EXP$$DE-VKT-000583$VKT PHARMA PRIVATE LIMITED$$67$YR$E$M$Y$$$20240821$$MD$DE$DE
242574251$24257425$1$I$$20240816$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131536$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$112.04$KG$20240828$$CN$US$US
242574261$24257426$1$I$$20240814$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131111$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$90.7$KG$20240828$$PH$US$US
242574271$24257427$1$I$$20240827$20240828$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA075590$SANDOZ$$29$YR$$F$Y$$$20240828$$HP$CA$CA
242574281$24257428$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004387$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242574291$24257429$1$I$20240524$20240817$20240828$20240828$EXP$$ES-AUROBINDO-AUR-APL-2024-042222$AUROBINDO$$88$YR$$M$Y$$$20240828$$MD$ES$ES
242574301$24257430$1$I$20240823$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170380$AMGEN$$$$$$Y$$$20240828$$HP$US$US
242574321$24257432$1$I$20240501$20240814$20240828$20240828$EXP$FR-AFSSAPS-TS2024000891$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-07848$HIKMA$$72$YR$$M$Y$64$KG$20240828$$MD$FR$FR
242574341$24257434$1$I$$20240822$20240828$20240828$EXP$$CA-GILEAD-2024-0685284$GILEAD$$$$A$F$Y$$$20240828$$CN$CA$CA
242574351$24257435$1$I$20240816$20240821$20240828$20240828$EXP$$US-ABBVIE-5891148$ABBVIE$$63$YR$$F$Y$$$20240828$$CN$US$US
242574371$24257437$1$I$20240807$20240820$20240828$20240828$EXP$$GB-MSNLABS-2024MSNSPO01852$MSN LABORATORIES$$$$$$Y$$$20240828$$HP$GB$GB
242574381$24257438$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004392$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242574391$24257439$1$I$20240823$20240826$20240828$20240828$EXP$$NVSC2024CO173138$NOVARTIS$$46$YR$$F$Y$51$KG$20240828$$CN$CO$CO
242574401$24257440$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136187$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240828$$HP$US$US
242574411$24257441$1$I$20240101$20240825$20240828$20240828$PER$$US-JNJFOC-20240866386$JOHNSON AND JOHNSON$$60$YR$A$F$Y$58.5$KG$20240828$$CN$US$US
242574421$24257442$1$I$$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135250$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240828$$CN$US$US
242574431$24257443$1$I$20240623$20240822$20240828$20240828$EXP$FR-AFSSAPS-DJ2024000932$FR-LEO Pharma-372916$LEO PHARM$$58$YR$$M$Y$$$20240828$$MD$FR$FR
242574441$24257444$1$I$$20240819$20240828$20240828$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024103251$VIIV$$$$$$Y$$$20240828$$HP$US$US
242574451$24257445$1$I$20240724$20240805$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004393$ACADIA PHARMACEUTICALS$$68$YR$$F$Y$$$20240828$$CN$US$US
242574462$24257446$2$F$$20240916$20240828$20240917$PER$$US-ALXN-202408USA001657US$ALEXION PHARMACEUTICALS$$$$$F$Y$61.224$KG$20240917$$CN$US$US
242574471$24257447$1$I$20240101$20240818$20240828$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-023184$UNITED THERAPEUTICS$$$$$F$Y$$$20240828$$$US$US
242574481$24257448$1$I$$20240823$20240828$20240828$PER$$US-GILEAD-2024-0685300$GILEAD$$$$$$Y$$$20240828$$LW$US$US
242574492$24257449$2$F$$20240827$20240828$20240906$EXP$$JP-ALK-ABELLO A/S-2024AA003213$ALK-ABELLO$$$$$$Y$$$20240906$$HP$JP$JP
242574501$24257450$1$I$$20240820$20240828$20240828$EXP$$CA-JNJFOC-20240855340$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240828$$CN$CA$CA
242574511$24257451$1$I$20240129$20240822$20240828$20240828$EXP$$DK-JNJFOC-20240865329$JOHNSON AND JOHNSON$$49$YR$A$F$Y$71$KG$20240828$$MD$DK$DK
242574521$24257452$1$I$$20240806$20240828$20240828$PER$$US-JNJFOC-20240816448$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20240828$$CN$US$US
242574531$24257453$1$I$$20240819$20240828$20240828$PER$$US-AMGEN-USASP2024166147$AMGEN$$63$YR$A$F$Y$$$20240828$$HP$US$US
242574541$24257454$1$I$$20240822$20240828$20240828$PER$$US-TAKEDA-2024TUS084772$TAKEDA$$$$$$Y$$$20240828$$CN$US$US
242574551$24257455$1$I$20240117$20240826$20240828$20240828$EXP$$NVSC2024US102277$NOVARTIS$$38$YR$$M$Y$$$20240828$$CN$US$US
242574561$24257456$1$I$$20240819$20240828$20240828$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010696$STRIDES$Zeng DH, Chen XH, Li Y, Zhu XY, Wang BL, Ma XG, et al.. Clinical and pathological characteristics of acute kidney injury caused by diquat poisoning.. Clin-Toxicol-(Phila). 2023;61 (9):705-708$17$YR$$F$Y$$$20240828$$HP$CN$CN
242574571$24257457$1$I$19680816$20240819$20240828$20240828$EXP$$GB-TEVA-VS-3235420$TEVA$$65$YR$$F$Y$85$KG$20240828$$MD$GB$GB
242574591$24257459$1$I$$20240824$20240828$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013498$JAZZ$$$$$F$Y$$$20240828$$CN$US$US
242574601$24257460$1$I$20240816$20240820$20240828$20240828$EXP$GB-MHRA-MED-202408200924553280-HTJPM$GB-TEVA-VS-3235808$TEVA$$61$YR$$F$Y$70$KG$20240828$$CN$GB$GB
242574611$24257461$1$I$20240801$20240820$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133136$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$63.5$KG$20240828$$CN$US$US
242574621$24257462$1$I$$20240814$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130050$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240828$$PH$US$US
242574631$24257463$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135888$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240828$$HP$US$US
242574642$24257464$2$F$$20240827$20240828$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004787$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
242574651$24257465$1$I$20230101$20240823$20240828$20240828$EXP$$US-ABBVIE-5895152$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242574661$24257466$1$I$20240801$20240820$20240828$20240828$EXP$GB-MHRA-MED-202408201851071400-RTNMV$GB-TEVA-VS-3235852$TEVA$$68$YR$$F$Y$51$KG$20240828$$CN$GB$GB
242574671$24257467$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-088502-2024$RECKITT BENCKISER$$$$$F$Y$$$20240828$$CN$US$US
242574681$24257468$1$I$$20240820$20240828$20240828$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010699$STRIDES$Xin H, Xiaoyun C, Yaping L, Xingkun L, Guiying Z, Ying Z, et al.. Efficacy and safety of dupilumab in the treatment of 123 cases of atopic dermatitis. [Chinese].. Chin-J-Dermatol. 2022;55 (6):486-493$4$YR$$F$Y$$$20240828$$HP$CN$CN
242574691$24257469$1$I$$20240820$20240828$20240828$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010655$STRIDES$Credo R, Kesey J, Bharadia D, Griswold J, Pang A.. Acute Intermittent Porphyria in a Burn Patient: Case Study and Review of the Literature. [Review].. J-Burn-Care-Res. 2024;45 (3):790-795$60$YR$$M$Y$$$20240828$$HP$US$US
242574701$24257470$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170119$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242574711$24257471$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A193830$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242574721$24257472$1$I$$20230705$20240828$20240828$EXP$$GB-AstraZeneca-2023A154462$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$GB$
242574731$24257473$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5893942$ABBVIE$$54$YR$$F$Y$$$20240828$$HP$US$US
242574741$24257474$1$I$20240825$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015893$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240828$$CN$US$US
242574751$24257475$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015913$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240828$$CN$US$US
242574761$24257476$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016950$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240828$$CN$US$US
242574771$24257477$1$I$20240826$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016249$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240828$$CN$US$US
242574782$24257478$2$F$20240801$20240827$20240828$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408014525$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240905$$CN$US$US
242574791$24257479$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016049$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240828$$CN$US$US
242574801$24257480$1$I$20240815$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015277$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240828$$CN$US$US
242574811$24257481$1$I$20240825$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016040$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240828$$CN$US$US
242574821$24257482$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015999$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240828$$CN$US$US
242574831$24257483$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016943$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240828$$MD$US$US
242574841$24257484$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015877$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240828$$CN$US$US
242574851$24257485$1$I$20240601$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016060$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240828$$CN$US$US
242574861$24257486$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016228$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240828$$CN$US$US
242574871$24257487$1$I$20240801$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016948$ELI LILLY AND CO$$$$$M$Y$$$20240828$$MD$US$US
242574881$24257488$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016521$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240828$$CN$US$US
242574891$24257489$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5894091$ABBVIE$$25$YR$$F$Y$$$20240828$$HP$US$US
242574901$24257490$1$I$20240627$20240821$20240828$20240828$EXP$$SA-REGENERON PHARMACEUTICALS, INC.-2024-095588$REGENERON$$68$YR$$M$Y$$$20240828$$CN$SA$SA
242574911$24257491$1$I$20240825$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016038$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240828$$CN$US$US
242574921$24257492$1$I$$20240822$20240828$20240828$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010702$STRIDES$Brakenhoff SM, Chi H, Friederich P, Doukas M, Den Hoed C, Flink HJ, et al.. A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report.. Case-Rep-Gastroenterol. 2024;18 (1):252-259$64$YR$$M$Y$$$20240828$$HP$NL$NL
242574931$24257493$1$I$$20240823$20240828$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013393$JAZZ$$7$YR$$M$Y$$$20240828$$CN$US$US
242574941$24257494$1$I$20240701$20240816$20240828$20240828$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS004294$TERSERA THERAPEUTICS$$$$$$Y$$$20240828$$MD$CN$CN
242574951$24257495$1$I$$20240822$20240828$20240828$EXP$$RU-STRIDES ARCOLAB LIMITED-2024SP010673$STRIDES$Malyshev SM, Popov KD, Simakov KV, Marichev AO, Topuzova MP, Smirnova AY, et al.. [Status epilepticus in a pregnant patient with a previously unrecognized POLG-associated disease]. [Russian]. Zh-Nevropatol-Psikhiatr-Im-S-S-Korsakova. 2023;123 (10):129-135$$$$F$Y$$$20240828$$HP$RU$RU
242574961$24257496$1$I$20240819$20240823$20240828$20240828$EXP$GB-MHRA-MED-202408211229036410-ZWTHB$GB-STRIDES ARCOLAB LIMITED-2024SP010652$STRIDES$$80$YR$$F$Y$$$20240828$$HP$GB$GB
242574971$24257497$1$I$20240726$20240819$20240828$20240828$EXP$$AU-BEH-2024176622$CSL BEHRING$$83$YR$E$M$Y$96.3$KG$20240828$$HP$AU$AU
242574981$24257498$1$I$20240713$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2024-042079$AUROBINDO$$75$YR$$F$Y$$$20240828$$MD$FR$FR
242574991$24257499$1$I$$20240826$20240828$20240828$EXP$$US-GILEAD-2024-0685406$GILEAD$$38$YR$A$M$Y$$$20240828$$HP$US$US
242575001$24257500$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5894339$ABBVIE$$52$YR$$F$Y$$$20240828$$HP$US$US
242575011$24257501$1$I$$20240819$20240828$20240828$PER$$US-ABBVIE-5888345$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242575023$24257502$3$F$20240817$20240826$20240828$20240903$EXP$$GB-JNJFOC-20240854462$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240903$$CN$GB$GB
242575031$24257503$1$I$$20240827$20240828$20240828$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048160$BOEHRINGER INGELHEIM$$$$$$Y$$$20240828$$PH$JP$JP
242575041$24257504$1$I$20240821$20240821$20240828$20240828$EXP$$GB-CELLTRION INC.-2024GB020360$CELLTRION$$$$$$Y$$$20240828$$HP$GB$GB
242575051$24257505$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136245$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$HP$US$US
242575061$24257506$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169561$AMGEN$$$$$M$Y$$$20240828$$HP$US$US
242575071$24257507$1$I$$20240823$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135949$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240828$$CN$US$US
242575082$24257508$2$F$$20240913$20240828$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136157$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240917$$HP$US$US
242575091$24257509$1$I$20240101$20240819$20240828$20240828$PER$$US-ABBVIE-5888304$ABBVIE$$$$$$Y$$$20240828$$CN$US$US
242575101$24257510$1$I$$20240725$20240828$20240828$PER$$US-CELLTRION INC.-2024US018724$CELLTRION$$$$$$Y$$$20240828$$CN$US$US
242575111$24257511$1$I$$20240723$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07389$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242575121$24257512$1$I$$20240816$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041802$AUROBINDO$$82$YR$$M$Y$74$KG$20240828$$PH$GB$GB
242575131$24257513$1$I$20221204$20240816$20240828$20240828$EXP$$ES-AUROBINDO-AUR-APL-2024-041706$AUROBINDO$$74$YR$$M$Y$83$KG$20240828$$MD$ES$ES
242575151$24257515$1$I$20240807$20240808$20240828$20240828$PER$$US-TEVA-VS-3231466$TEVA$$19$YR$$F$Y$$$20240828$$CN$US$US
242575161$24257516$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-109613-2023$RECKITT BENCKISER$$$$$M$Y$$$20240828$$CN$US$US
242575171$24257517$1$I$$20240816$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131085$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240828$$CN$US$US
242575181$24257518$1$I$$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135723$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240828$$CN$US$US
242575191$24257519$1$I$$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135836$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240828$$CN$US$US
242575201$24257520$1$I$$20240820$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132994$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240828$$CN$US$US
242575212$24257521$2$F$$20240906$20240828$20240912$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001700$BLUEPRINT MEDICINES$$$$$F$Y$$$20240912$$CN$US$US
242575221$24257522$1$I$20240209$20240820$20240828$20240828$EXP$$DE-TAKEDA-2024TUS085984$TAKEDA$$9$DEC$$M$Y$73$KG$20240828$$MD$DE$DE
242575231$24257523$1$I$$20240820$20240828$20240828$EXP$$PK-Encube-001297$ENCUBE ETHICALS$Muhammad ZA, Ahmad T, Rashid H. Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-a cohort study. Expert Opin Drug Saf. 2024 Aug 19:1-8. doi: 10.1080/14740338.2024.2392863.$75$YR$E$F$Y$$$20240827$$MD$PK$
242575241$24257524$1$I$20240715$20240822$20240828$20240828$EXP$$US-GSK-US2024105028$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
242575251$24257525$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-110457-2023$RECKITT BENCKISER$$$$$M$Y$$$20240828$$CN$US$US
242575261$24257526$1$I$20240809$20240822$20240828$20240828$PER$$US-CELLTRION INC.-2024US019846$CELLTRION$$$$$$Y$$$20240828$$CN$US$US
242575271$24257527$1$I$20240101$20240820$20240828$20240828$EXP$$JP-AstraZeneca-2024A173363$ASTRAZENECA$$73$YR$$F$Y$$$20240828$$MD$JP$
242575281$24257528$1$I$$20240823$20240828$20240828$PER$$US-AstraZeneca-2024A193059$ASTRAZENECA$$$$$$Y$$$20240828$$CN$US$
242575291$24257529$1$I$$20240820$20240828$20240828$EXP$$ZA-AstraZeneca-2024A190977$ASTRAZENECA$$55$YR$$F$Y$$$20240828$$CN$ZA$
242575301$24257530$1$I$$20240806$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07895$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242575321$24257532$1$I$$20240523$20240828$20240828$PER$$US-CHIESI-2024CHF03785$CHIESI$$70$YR$$F$Y$$$20240828$$CN$US$US
242575341$24257534$1$I$$20240821$20240828$20240828$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001710$BLUEPRINT MEDICINES$$$$$F$Y$$$20240828$$CN$US$US
242575351$24257535$1$I$20240813$20240822$20240828$20240828$PER$$US-CELLTRION INC.-2024US019894$CELLTRION$$$$$$Y$$$20240828$$CN$US$US
242575361$24257536$1$I$$20240823$20240828$20240828$PER$$US-ABBVIE-5893956$ABBVIE$$$$$F$Y$$$20240828$$MD$US$US
242575371$24257537$1$I$$20240827$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048185$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240828$$CN$US$US
242575381$24257538$1$I$$20240818$20240828$20240828$EXP$$US-AMGEN-USASP2024166633$AMGEN$Chang S.D.; Chou K.; Park D.J. et al.. Stereotactic body radiotherapy for painful spinal metastases: a decade of experience at a single institution. Journal of neurosurgery.Spine. 2024;1-9$$$$$Y$$$20240828$$MD$US$US
242575401$24257540$1$I$$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024168234$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242575411$24257541$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135471$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240828$$HP$US$US
242575421$24257542$1$I$$20240824$20240828$20240828$EXP$GB-MHRA-MED-202408231918201240-SFTWV$GB-ORGANON-O2408GBR001842$ORGANON$$4$YR$$F$Y$16$KG$20240828$$CN$GB$GB
242575431$24257543$1$I$$20230922$20240828$20240828$EXP$$TW-UCBSA-2024040154$UCB$Lin SY, Huang Y, Lin F, Huang CF, Tang S, Jeng J. Impact of levetiracetam on clinical outcomes among elderly atrial fibrillation patients under direct oral anticoagulant therapy. European Stroke Journal. 2023;8(2):245-246$$$E$$Y$$$20240828$$HP$TW$TW
242575441$24257544$1$I$$20240611$20240828$20240828$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450329$RANBAXY$$$$$F$Y$$$20240828$$CN$US$US
242575451$24257545$1$I$$20240819$20240828$20240828$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024103438$VIIV$$$$$M$Y$$$20240828$$CN$US$US
242575461$24257546$1$I$20240101$20240816$20240828$20240828$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US003753$PAREXEL$$$$$$Y$$$20240828$$CN$US$US
242575473$24257547$3$F$$20240830$20240828$20240903$PER$$US-HALEON-2193773$Haleon PLC$$$$$$Y$$$20240903$$CN$US$US
242575521$24257552$1$I$$20240821$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015024$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240828$$CN$US$US
242575531$24257553$1$I$20220111$20240826$20240828$20240828$EXP$$NL-SANDOZ INC.-NVSC2022NL059240$SANDOZ$$75$YR$$F$Y$98$KG$20240828$$HP$NL$NL
242575551$24257555$1$I$20240825$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016088$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240828$$CN$US$US
242575572$24257557$2$F$20240815$20240906$20240828$20240910$EXP$$US-SANDOZ INC.-SDZ2024US075719$SANDOZ$$61$YR$$F$Y$44$KG$20240910$$CN$US$US
242575581$24257558$1$I$$20240822$20240828$20240828$EXP$$CA-ABBVIE-5892958$ABBVIE$$$$A$M$Y$$$20240828$$CN$CA$CA
242575591$24257559$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024170245$AMGEN$$$$A$F$Y$$$20240828$$CN$US$US
242575601$24257560$1$I$20240613$20240819$20240828$20240828$EXP$$CA-TAKEDA-2024TUS083391$TAKEDA$$54$YR$$F$Y$$$20240828$$CN$CA$CA
242575613$24257561$3$F$20240701$20240912$20240828$20240918$EXP$$US-TAKEDA-2024TUS085669$TAKEDA$$22$YR$$M$Y$$$20240918$$CN$US$US
242575621$24257562$1$I$$20240822$20240828$20240828$EXP$$CA-TAKEDA-2024TUS059313$TAKEDA$$$$$F$Y$$$20240828$$CN$CA$CA
242575632$24257563$2$F$20240712$20240830$20240828$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-040600$AUROBINDO$$$$$M$Y$93$KG$20240910$$MD$FR$FR
242575641$24257564$1$I$20240815$20240822$20240828$20240828$PER$$US-CELLTRION INC.-2024US020002$CELLTRION$$$$$$Y$$$20240828$$CN$US$US
242575651$24257565$1$I$$20240814$20240828$20240828$PER$$US-JNJFOC-20240842350$JOHNSON AND JOHNSON$$$$$M$Y$$$20240828$$CN$US$US
242575661$24257566$1$I$20240810$20240822$20240828$20240828$EXP$$JP-JNJFOC-20240871566$JOHNSON AND JOHNSON$$$$$M$Y$$$20240828$$MD$JP$JP
242575672$24257567$2$F$$20240826$20240828$20240903$EXP$$US-ABBVIE-5893399$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242575682$24257568$2$F$20220101$20240904$20240828$20240908$EXP$$US-ABBVIE-5895874$ABBVIE$$$$$F$Y$79.378$KG$20240908$$CN$US$US
242575701$24257570$1$I$$20240823$20240828$20240828$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-136159$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240828$$HP$DE$DE
242575711$24257571$1$I$20240816$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135980$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240828$$CN$US$US
242575721$24257572$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5893989$ABBVIE$$46$YR$$M$Y$$$20240828$$HP$US$US
242575741$24257574$1$I$$20240826$20240828$20240828$PER$$NVSC2024US172816$NOVARTIS$$$$$M$Y$$$20240828$$MD$US$US
242575751$24257575$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024170536$AMGEN$$$$$$Y$$$20240828$$PH$US$US
242575761$24257576$1$I$$20240819$20240828$20240828$EXP$$AU-TEVA-VS-3235913$TEVA$$$$$$Y$$$20240828$$HP$AU$AU
242575771$24257577$1$I$$20240827$20240828$20240828$PER$$US-HALEON-2193951$Haleon PLC$$$$$$Y$$$20240828$$CN$US$US
242575781$24257578$1$I$$20240808$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08036$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242575792$24257579$2$F$20240101$20240822$20240828$20240829$EXP$$CA-BIOGEN-2024BI01279533$BIOGEN$$54$YR$$F$Y$$$20240829$$CN$CA$CA
242575801$24257580$1$I$20240801$20240821$20240828$20240828$EXP$$DE-BIOGEN-2024BI01279728$BIOGEN$$32$YR$$M$Y$$$20240828$$CN$DE$DE
242575811$24257581$1$I$$20240819$20240828$20240828$PER$$US-ALXN-202408USA001709US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242575821$24257582$1$I$$20240816$20240828$20240828$EXP$$CN-BEH-2024177341$CSL BEHRING$$$$$M$Y$$$20240828$$CN$CN$CN
242575831$24257583$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190232$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242575843$24257584$3$F$20160101$20240906$20240828$20240919$PER$$US-ABBVIE-5890289$ABBVIE$$$$$F$Y$64$KG$20240919$$CN$US$US
242575851$24257585$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-109451-2023$RECKITT BENCKISER$$$$$M$Y$$$20240828$$CN$US$US
242575861$24257586$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170144$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242575871$24257587$1$I$20230101$20240819$20240828$20240828$EXP$$CH-AMGEN-CHESP2024121893$AMGEN$Glatz B.; Capoferri G.; Labhardt N. et al.. Challenges in diagnosing a Mycobacterium bovis infection in a patient under Adalimumab Therapy: Navigating the Diagnostic Maze. Swiss Medical Weekly. 2024;154:28S-29S$78$YR$E$F$Y$$$20240828$$HP$CH$CH
242575881$24257588$1$I$$20240819$20240828$20240828$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006198$BIOCON$$$$$$Y$$$20240828$$MD$CA$CA
242575893$24257589$3$F$20240613$20240923$20240828$20240927$30DAY$$US-AMGEN-USASP2024168950$AMGEN$$67$YR$E$F$Y$$$20240927$$HP$US$US
242575902$24257590$2$F$20240821$20240903$20240828$20240909$PER$$US-AMGEN-USASP2024168302$AMGEN$$62$YR$A$F$Y$114$KG$20240909$$HP$US$US
242575911$24257591$1$I$20240820$20240820$20240828$20240828$EXP$$AU-009507513-2408AUS007402$MERCK$$57$YR$$F$Y$$$20240828$$PH$AU$AU
242575921$24257592$1$I$$20240819$20240828$20240828$EXP$$JP-009507513-2408JPN002439J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$92$YR$$F$Y$$$20240828$$MD$JP$JP
242575931$24257593$1$I$$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136246$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240828$$CN$US$US
242575941$24257594$1$I$$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136257$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240828$$CN$US$US
242575951$24257595$1$I$$20240814$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-041249$AUROBINDO$Farkouh EK, Issa N, Michel IM, Harrison DJ. Dual Donor-Derived Renal Allograft Mucormycosis From a Single Deceased Donor. Mayo Clinic Proceedings. 2024;99(8):1341-42$7$DEC$$F$Y$$$20240828$$MD$US$US
242575961$24257596$1$I$$20240821$20240828$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134651$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240828$$MD$JP$JP
242575971$24257597$1$I$20240812$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135902$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240828$$HP$US$US
242575981$24257598$1$I$$20240823$20240828$20240828$PER$$US-TAKEDA-2024TUS085888$TAKEDA$$$$$F$Y$97$KG$20240828$$MD$US$US
242575992$24257599$2$F$$20240820$20240828$20240828$EXP$$IN-AMNEAL PHARMACEUTICALS-2024-AMRX-03086$AMNEAL$Kishore S, Kumar M, Tahiliani S.. A Case of Drug-Induced Autoimmune Like Hepatitis. J Clin Exp Hepatol.. 2024;14:1$50$YR$$F$Y$$$20240828$$HP$IN$IN
242576002$24257600$2$F$20240810$20240903$20240828$20240909$EXP$$US-BIOGEN-2024BI01279727$BIOGEN$$74$YR$$M$Y$$$20240909$$CN$US$US
242576011$24257601$1$I$$20240823$20240828$20240828$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-135481$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240828$$HP$CA$CA
242576021$24257602$1$I$$20240820$20240828$20240828$EXP$$US-BIOGEN-2024BI01279301$BIOGEN$$$$$M$Y$$$20240828$$CN$US$US
242576031$24257603$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00696$GLAND PHARMA$$$$$$Y$$$20240828$$CN$US$US
242576041$24257604$1$I$$20240827$20240828$20240828$PER$$US-AMGEN-USASP2024171155$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242576051$24257605$1$I$20240820$20240822$20240828$20240828$EXP$$GB-JNJFOC-20240859462$JOHNSON AND JOHNSON$$45$YR$A$F$Y$68$KG$20240828$$MD$GB$GB
242576071$24257607$1$I$20240823$20240826$20240828$20240828$PER$$US-JNJFOC-20240866368$JOHNSON AND JOHNSON$$17$YR$T$$Y$$$20240828$$CN$US$US
242576081$24257608$1$I$$20240821$20240828$20240828$EXP$$CL-JNJFOC-20240863850$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240828$$CN$CL$CL
242576091$24257609$1$I$$20240823$20240828$20240828$EXP$$US-JNJFOC-20240862013$JOHNSON AND JOHNSON$$$$$M$Y$$$20240828$$CN$US$US
242576101$24257610$1$I$$20240821$20240828$20240828$PER$$US-JNJFOC-20240860284$JOHNSON AND JOHNSON$$$$$M$Y$$$20240828$$CN$US$US
242576112$24257611$2$F$$20240821$20240828$20240829$EXP$$CA-JNJFOC-20240859091$JOHNSON AND JOHNSON$$64$YR$A$F$Y$96$KG$20240829$$HP$CA$CA
242576121$24257612$1$I$20240609$20240816$20240828$20240828$EXP$$ES-AUROBINDO-AUR-APL-2024-042033$AUROBINDO$$73$YR$$F$Y$$$20240828$$MD$ES$ES
242576131$24257613$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135715$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240828$$CN$US$US
242576142$24257614$2$F$$20240919$20240828$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136143$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240920$$CN$US$US
242576151$24257615$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00688$GLAND PHARMA$$$$$$Y$$$20240828$$CN$US$US
242576161$24257616$1$I$20240825$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135553$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240828$$PH$US$US
242576171$24257617$1$I$20240101$20240820$20240828$20240828$EXP$$US-BIOGEN-2024BI01279261$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
242576181$24257618$1$I$20240527$20240826$20240828$20240828$EXP$$JP-TAKEDA-2024TJP012479$TAKEDA$$14$YR$$M$Y$42$KG$20240828$$MD$JP$JP
242576191$24257619$1$I$20230101$20240813$20240828$20240828$EXP$$US-UCBSA-2023043336$UCB$$$$$F$Y$50.2$KG$20240828$$CN$US$US
242576201$24257620$1$I$$20240823$20240828$20240828$EXP$$DE-ABBVIE-5895688$ABBVIE$$$$$M$Y$$$20240828$$HP$DE$DE
242576211$24257621$1$I$20240814$20240822$20240828$20240828$EXP$IT-MINISAL02-999622$IT-ALXN-202408GLO001392IT$ALEXION PHARMACEUTICALS$$64$YR$$M$Y$$$20240828$$MD$IT$IT
242576221$24257622$1$I$20240816$20240816$20240828$20240828$EXP$$US-Accord-443067$ACCORD$$22$YR$A$M$Y$$$20240828$$PH$US$US
242576231$24257623$1$I$20240806$20240816$20240828$20240828$EXP$$ES-AUROBINDO-AUR-APL-2024-042035$AUROBINDO$$61$YR$$F$Y$$$20240828$$PH$ES$ES
242576241$24257624$1$I$$20240821$20240828$20240828$PER$$US-JNJFOC-20240855095$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$MD$US$US
242576251$24257625$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00673$GLAND PHARMA$$$$$M$Y$$$20240828$$CN$US$US
242576261$24257626$1$I$$20240822$20240828$20240828$EXP$$US-AMGEN-USASP2024168852$AMGEN$$$$$$Y$$$20240828$$MD$US$US
242576272$24257627$2$F$20240805$20240814$20240828$20240829$EXP$$US-ACORDA-ACO_177778_2024$ACORDA$$78$YR$$F$Y$$$20240829$$CN$US$US
242576281$24257628$1$I$20240101$20240822$20240828$20240828$EXP$$US-AMGEN-USASP2024168789$AMGEN$$25$YR$A$F$Y$$$20240828$$HP$US$US
242576291$24257629$1$I$$20240827$20240828$20240828$PER$$US-AMGEN-USASL2024171317$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242576301$24257630$1$I$$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2020-052814$AUROBINDO$Dubois M, Morel G, Tone A, Gaboriau L, Gautier S, Lazrek M, et al.. Meningoradiculitis due to varicella zoster virus reactivation in a patient treated with ixekizumab.. Ann-Dermatol-Venereol. 2020;147 (10):667-671$51$YR$$F$Y$$$20240828$$MD$FR$FR
242576311$24257631$1$I$20230913$20240816$20240828$20240828$EXP$$DE-TERSERA THERAPEUTICS LLC-2024TRS004295$TERSERA THERAPEUTICS$$$$$$Y$$$20240828$$MD$DE$DE
242576321$24257632$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135929$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240828$$CN$US$US
242576331$24257633$1$I$$20240818$20240828$20240828$EXP$$IL-TEVA-VS-3236532$TEVA$$83$YR$$M$Y$$$20240828$$CN$IL$IL
242576341$24257634$1$I$20240401$20240822$20240828$20240828$EXP$$US-JNJFOC-20240857442$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240828$$CN$US$US
242576351$24257635$1$I$$20240821$20240828$20240828$EXP$$US-GSK-US2024104489$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
242576361$24257636$1$I$$20240812$20240828$20240828$PER$$US-AstraZeneca-2024A185601$ASTRAZENECA$$$$$$Y$$$20240828$$HP$US$
242576371$24257637$1$I$20240101$20240820$20240828$20240828$PER$$US-TRIS PHARMA, INC.-24US011600$TRIS PHARM$$$$$$Y$$$20240828$$MD$US$US
242576381$24257638$1$I$$20240820$20240828$20240828$EXP$$ZA-AstraZeneca-2024A190966$ASTRAZENECA$$86$YR$$F$Y$$$20240828$$CN$ZA$
242576391$24257639$1$I$20240819$20240820$20240828$20240828$EXP$$CN-AstraZeneca-2024A192299$ASTRAZENECA$$12451$DY$$F$Y$88$KG$20240828$$MD$CN$
242576401$24257640$1$I$$20240815$20240828$20240828$EXP$$CA-AUROBINDO-AUR-APL-2023-066180$AUROBINDO$Sharma V, Subramanian P. Prevention of mania in a primigravida at ultra-high risk of postpartum recurrence. Bipolar-Disord. 2023;25(4):342-345$29$YR$$F$Y$$$20240828$$HP$CA$CA
242576411$24257641$1$I$$20240822$20240828$20240828$EXP$$CA-ANIPHARMA-2024-CA-003768$ANI$$76$YR$$M$Y$$$20240828$$CN$CA$CA
242576421$24257642$1$I$20220902$20240823$20240828$20240828$EXP$$NZ-ANIPHARMA-2024-NZ-000019$ANI$$$$$UNK$Y$$$20240828$$PH$NZ$NZ
242576431$24257643$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024171211$AMGEN$$$$$$Y$$$20240828$$PH$US$US
242576441$24257644$1$I$$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024169057$AMGEN$$$$E$F$Y$$$20240828$$HP$US$US
242576451$24257645$1$I$20240715$20240813$20240828$20240828$PER$$US-EPICPHARMA-US-2024EPCSPO01034$EPIC PHARM$$32$YR$A$M$Y$90.71$KG$20240828$$CN$US$US
242576471$24257647$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-088416-2024$RECKITT BENCKISER$$$$$F$Y$$$20240828$$CN$US$US
242576481$24257648$1$I$$20240823$20240828$20240828$PER$$US-BAUSCH-BL-2024-012839$BAUSCH AND LOMB$$76$YR$$$Y$$$20240828$$MD$US$US
242576491$24257649$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136301$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240828$$HP$US$US
242576502$24257650$2$F$$20240905$20240828$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136178$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240906$$HP$US$US
242576512$24257651$2$F$20221201$20240830$20240828$20240910$EXP$$IT-AUROBINDO-AUR-APL-2024-042100$AUROBINDO$Monti B, Soria A, Saladini F, Lapadula G, Squillace N, Giammarino F, et al. Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests. Journal of Medical Virology. 2024;96(8):1-3.$60$YR$$F$Y$$$20240910$$HP$IT$IT
242576523$24257652$3$F$20200713$20240917$20240828$20240924$EXP$$CA-TAKEDA-2020TUS030677$TAKEDA$$71$YR$$F$Y$$$20240924$$HP$CA$CA
242576531$24257653$1$I$20240701$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2024-042040$AUROBINDO$$31$YR$$F$Y$$$20240828$$MD$FR$FR
242576541$24257654$1$I$20240616$20240826$20240828$20240828$EXP$FR-AFSSAPS-AM2024000693$FR-BAUSCH-BL-2024-012930$BAUSCH AND LOMB$$81$YR$$F$Y$63$KG$20240828$$MD$FR$FR
242576551$24257655$1$I$20240624$20240826$20240828$20240828$EXP$FR-AFSSAPS-AVPO2024000159$FR-BAUSCH-BL-2024-012898$BAUSCH AND LOMB$$59$YR$$F$Y$$$20240828$$PH$FR$FR
242576561$24257656$1$I$20240801$20240822$20240828$20240828$PER$$US-ABBVIE-5891781$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242576573$24257657$3$F$20240821$20240903$20240828$20240906$EXP$$NVSC2024ZA172431$NOVARTIS$$50$YR$$M$Y$111$KG$20240906$$MD$ZA$ZA
242576591$24257659$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173570$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
242576603$24257660$3$F$20240415$20240831$20240828$20240904$EXP$$NVSC2024EG173110$NOVARTIS$$37$YR$$M$Y$65$KG$20240904$$CN$EG$EG
242576611$24257661$1$I$20240808$20240826$20240828$20240828$EXP$$US-BAUSCH-BL-2024-012903$BAUSCH AND LOMB$$74$YR$$F$Y$$$20240828$$CN$US$US
242576621$24257662$1$I$$20240822$20240828$20240828$EXP$$CA-Orion Corporation ORION PHARMA-24_00031439$ORION$$$$$M$Y$$$20240828$$HP$CA$
242576641$24257664$1$I$$20240819$20240828$20240828$EXP$$AU-TEVA-VS-3236141$TEVA$$73$YR$$M$Y$$$20240828$$HP$AU$AU
242576651$24257665$1$I$20240817$20240817$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041670$AUROBINDO$$35$YR$$F$Y$66$KG$20240828$$CN$GB$GB
242576661$24257666$1$I$$20240817$20240828$20240828$EXP$$IT-AUROBINDO-AUR-APL-2024-042240$AUROBINDO$De Rose DU, Landolfo F, Flaminia P, Giliberti P, Santisi A, Columbo C et al. Use of N-Acetylcysteine in Preterm Neonates with Enteral Feeding Intolerance and Intestinal Obstruction: A Case Series and Review of the Literature. Children. 2024;11:873$23$WK$$M$Y$0.7$KG$20240828$$HP$IT$IT
242576671$24257667$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00698$GLAND PHARMA$$$$$$Y$$$20240828$$CN$US$US
242576681$24257668$1$I$$20240826$20240828$20240828$EXP$$CA-HALEON-2193496$Haleon PLC$$34$YR$$F$Y$$$20240828$$HP$CA$CA
242576691$24257669$1$I$$20240731$20240828$20240828$EXP$$US-TEVA-VS-3229196$TEVA$$25$YR$$F$Y$$$20240828$$PH$US$US
242576701$24257670$1$I$$20240826$20240828$20240828$EXP$$NVSC2024US172626$NOVARTIS$$$$$M$Y$$$20240828$$CN$US$US
242576711$24257671$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5893615$ABBVIE$$56$YR$$F$Y$$$20240828$$HP$US$US
242576721$24257672$1$I$20240430$20240813$20240828$20240828$EXP$$CH-Allegis Pharmaceuticals, LLC-APL202408-000096$ALLEGIS PHARMACEUTICALS$$67$YR$E$M$Y$$$20240828$$HP$CH$
242576731$24257673$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00677$GLAND PHARMA$$$$$M$Y$$$20240828$$CN$US$US
242576741$24257674$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169202$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242576751$24257675$1$I$20240812$20240819$20240828$20240828$PER$$US-AMGEN-USASP2024169297$AMGEN$$$$$$Y$$$20240828$$PH$US$US
242576761$24257676$1$I$20240101$20240817$20240828$20240828$EXP$$ES-AUROBINDO-AUR-APL-2024-042226$AUROBINDO$$62$YR$$M$Y$65$KG$20240828$$HP$ES$ES
242576772$24257677$2$F$$20240902$20240828$20240910$EXP$$US-TEVA-VS-3235529$TEVA$Dykes K, Tzachanis D, Koura D. A Difficult Case of Calcineurin Inhibitor Neurotoxicity Post-Haploidentical HCT With a Successful Novel Solution: Cytotoxic T-Lymphocyte-Associated Protein 4-Immunoglobulin Blockade for GVHD Prophylaxis. Cell-Transplant 2024; 33 01-07.; Dykes K, Tzachanis D, Koura D. A Difficult Case of Calcineurin Inhibitor Neurotoxicity Post-Haploidentical HCT With a Successful Novel Solution: Cytotoxic T-Lymphocyte-Associated Protein 4-Immunoglobulin Blockade for GVHD Prophyl...$24$YR$$M$Y$$$20240910$$HP$US$US
242576781$24257678$1$I$$20240819$20240828$20240828$PER$$US-AMGEN-USASP2024168479$AMGEN$Arnold S. E.; Hendrix S.; Johnson J. N. et al.. Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer^s disease. Alzheimer^s and Dementia: Translational Research and Clinical Interventions. 2024;10 (3):1-13$$$$$Y$$$20240828$$HP$US$US
242576791$24257679$1$I$20240801$20240825$20240828$20240828$EXP$$ZA-ABBVIE-5897226$ABBVIE$$53$YR$$F$Y$$$20240828$$CN$ZA$ZA
242576801$24257680$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-081272-2024$RECKITT BENCKISER$$$$$F$Y$$$20240828$$CN$US$US
242576811$24257681$1$I$20240816$20240820$20240828$20240828$EXP$$US-TEVA-VS-3236437$TEVA$$79$YR$$F$Y$$$20240828$$MD$US$US
242576821$24257682$1$I$$20240820$20240828$20240828$EXP$$CA-TEVA-VS-3234991$TEVA$$3$YR$$F$Y$15$KG$20240828$$HP$CA$CA
242576831$24257683$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00679$GLAND PHARMA$$$$$$Y$$$20240828$$CN$US$US
242576841$24257684$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-109317-2023$RECKITT BENCKISER$$$$$M$Y$$$20240828$$CN$US$US
242576851$24257685$1$I$$20240819$20240828$20240828$EXP$$DK-UCBSA-2024042068$UCB$Gjerulfsen CE, Nikanorova M, Olofsson K, Johannessen Landmark C, Rubboli G, Moller RS.. Fenfluramine treatment in pediatric patients with Dravet syndrome reduces seizure burden and overall healthcare costs: A retrospective and observational real-world study. Epilepsia open. 2024;0:1-10$$$$$Y$$$20240828$$HP$DK$DK
242576861$24257686$1$I$$20240823$20240828$20240828$EXP$$JP-JNJFOC-20240871652$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240828$$PH$JP$JP
242576871$24257687$1$I$20240807$20240814$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-041831$AUROBINDO$$59$YR$$M$Y$114.3$KG$20240828$$HP$US$US
242576881$24257688$1$I$$20240821$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135018$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240828$$CN$US$US
242576891$24257689$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135854$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$82.55$KG$20240828$$CN$US$US
242576901$24257690$1$I$20240715$20240716$20240828$20240828$PER$$US-CHIESI-2024CHF04384$CHIESI$$33$YR$$F$Y$$$20240828$$CN$US$US
242576911$24257691$1$I$$20240819$20240828$20240828$EXP$$AU-TEVA-VS-3236350$TEVA$$$$$M$Y$$$20240828$$HP$AU$AU
242576923$24257692$3$F$$20240923$20240828$20240926$EXP$$CA-BAUSCH-BL-2024-012676$BAUSCH AND LOMB$$44$YR$$F$Y$97$KG$20240926$$HP$CA$CA
242576931$24257693$1$I$$20240820$20240828$20240828$EXP$$CA-JNJFOC-20240857065$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240828$$CN$CA$CA
242576941$24257694$1$I$$20240715$20240828$20240828$PER$$US-CHIESI-2024CHF04338$CHIESI$$24$YR$$M$Y$$$20240828$$CN$US$US
242576951$24257695$1$I$$20240715$20240828$20240828$PER$$US-CHIESI-2024CHF04335$CHIESI$$55$YR$$M$Y$$$20240828$$CN$US$US
242576961$24257696$1$I$20240701$20240730$20240828$20240828$PER$$US-CHIESI-2024CHF04728$CHIESI$$24$YR$$F$Y$$$20240828$$CN$US$US
242576971$24257697$1$I$$20240819$20240828$20240828$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006143$BIOCON$$$$$$Y$$$20240828$$MD$CA$CA
242576992$24257699$2$F$20240401$20240829$20240828$20240905$EXP$$US-ABBVIE-5896601$ABBVIE$$71$YR$$F$Y$63$KG$20240905$$CN$US$US
242577001$24257700$1$I$$20240814$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-041128$AUROBINDO$Lisi D, Martin R. Comparison Of Pharmacist-directed And Protocol-driven Warfarin Management In Ambulatory Patients With Left Ventricular Assist Device. J-Card-Fail. 2024;30(1):139-140$$$$$Y$$$20240828$$HP$US$US
242577012$24257701$2$F$$20240822$20240828$20240917$PER$$US-AstraZeneca-2024A179164$ASTRAZENECA$$78$YR$$F$Y$67.7$KG$20240917$$CN$US$
242577021$24257702$1$I$$20240812$20240828$20240828$PER$$US-AstraZeneca-2024A183347$ASTRAZENECA$$$$$$Y$$$20240828$$CN$US$
242577031$24257703$1$I$$20240814$20240828$20240828$EXP$$US-GRANULES-US-2024GRALIT00378$GRANULES INDIA$S. Khan.Avoiding Premature Brain Death Declaration in Patients With Suspected Baclofen Overdose.American Journal of Respiratory and Critical Care Medicine.MAY-2024;209:A7027$58$YR$A$M$Y$$$20240828$$HP$US$US
242577042$24257704$2$F$$20240829$20240828$20240902$PER$$US-AMGEN-USASP2024170160$AMGEN$$$$$F$Y$$$20240901$$CN$US$US
242577051$24257705$1$I$$20240819$20240828$20240828$EXP$$AU-TEVA-VS-3236206$TEVA$$$$$$Y$$$20240828$$HP$AU$AU
242577061$24257706$1$I$$20240820$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408008300$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240828$$CN$US$US
242577071$24257707$1$I$20240801$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016352$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$US$US
242577081$24257708$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017198$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240828$$CN$US$US
242577091$24257709$1$I$20240824$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016459$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240828$$CN$US$US
242577101$24257710$1$I$$20240816$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408011458$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$US$US
242577111$24257711$1$I$20240801$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016205$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240828$$CN$US$US
242577121$24257712$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015529$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240828$$CN$US$US
242577131$24257713$1$I$20240802$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015997$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240828$$CN$US$US
242577141$24257714$1$I$20240826$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016081$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240828$$CN$US$US
242577151$24257715$1$I$20240827$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017081$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240828$$CN$US$US
242577161$24257716$1$I$20240822$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015491$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240828$$CN$US$US
242577171$24257717$1$I$20240826$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016311$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240828$$CN$US$US
242577181$24257718$1$I$20240824$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016704$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240828$$CN$US$US
242577191$24257719$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015894$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240828$$CN$US$US
242577201$24257720$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016284$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242577211$24257721$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015963$ELI LILLY AND CO$$$$A$F$Y$$$20240828$$CN$US$US
242577222$24257722$2$F$$20240821$20240828$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408014015$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240829$$CN$US$US
242577231$24257723$1$I$20240725$20240821$20240828$20240828$PER$$US-AMGEN-USASP2024170880$AMGEN$$$$A$$Y$$$20240828$$PH$US$US
242577242$24257724$2$F$$20240902$20240828$20240911$EXP$$TR-TEVA-VS-3235312$TEVA$Uca AU. Ocrelizumab experience in treatment-resistant warts associated with Fingolimod: A case report. Neurol-Asia 2024; 29 (2): 489-491.; Uca AU. Ocrelizumab experience in treatment-resistant warts associated with Fingolimod: A case report. Neurol-Asia 2024; 29 (2): 489-491.$30$YR$$F$Y$$$20240911$$MD$TR$TR
242577251$24257725$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135855$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$87.54$KG$20240828$$CN$US$US
242577262$24257726$2$F$$20240923$20240828$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135878$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240925$$CN$US$US
242577271$24257727$1$I$$20240823$20240828$20240828$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-135415$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240828$$CN$CA$CA
242577281$24257728$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-081304-2024$RECKITT BENCKISER$$$$$M$Y$$$20240828$$CN$US$US
242577302$24257730$2$F$20240823$20240829$20240828$20240903$PER$$US-AMGEN-USASP2024169418$AMGEN$$76$YR$E$M$Y$$$20240902$$CN$US$US
242577311$24257731$1$I$$20240814$20240828$20240828$EXP$$KR-GRANULES-KR-2024GRALIT00374$GRANULES INDIA$Jae Sung Ko.Efficacy and safety of D-penicillamine, trientine, and zinc in pediatric Wilson disease  patients.Orphanet Journal of Rare Diseases .2024;19:1-8$$$$$Y$$$20240828$$HP$KR$KR
242577321$24257732$1$I$$20240823$20240828$20240828$EXP$$JP-AMGEN-JPNSP2024133707$AMGEN$$74$YR$E$M$Y$$$20240828$$PH$JP$JP
242577341$24257734$1$I$20221101$20240820$20240828$20240828$EXP$FR-AFSSAPS-LM2024000449$FR-UCBSA-2024042157$UCB$$0$YR$$M$Y$0.96$KG$20240828$$MD$FR$FR
242577351$24257735$1$I$$20240819$20240828$20240828$30DAY$$US-GSK-US2024AMR105120$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
242577361$24257736$1$I$20240101$20240808$20240828$20240828$PER$$US-TEVA-VS-3232040$TEVA$$67$YR$$F$Y$$$20240828$$PH$US$US
242577381$24257738$1$I$20240101$20240821$20240828$20240828$EXP$$US-TEVA-VS-3236296$TEVA$$32$YR$$F$Y$$$20240828$$HP$US$US
242577391$24257739$1$I$20240101$20240821$20240828$20240828$PER$$US-ABBVIE-5889610$ABBVIE$$$$$$Y$47$KG$20240828$$CN$US$US
242577401$24257740$1$I$$20240826$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048255$BOEHRINGER INGELHEIM$$$$$$Y$$$20240828$$CN$US$US
242577411$24257741$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00676$GLAND PHARMA$$$$$$Y$$$20240828$$CN$US$US
242577421$24257742$1$I$20210301$20240820$20240828$20240828$EXP$$BR-BIOGEN-2024BI01279523$BIOGEN$$0$YR$$M$Y$2.4$KG$20240828$$CN$BR$BR
242577452$24257745$2$F$20240806$20240906$20240828$20240911$EXP$$US-TAKEDA-2024TUS085684$TAKEDA$$54$YR$$M$Y$103.86$KG$20240911$$HP$US$US
242577471$24257747$1$I$20240417$20240821$20240828$20240828$EXP$$CL-JNJFOC-20240647154$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240828$$CN$CL$CL
242577501$24257750$1$I$20240801$20240827$20240828$20240828$EXP$$GB-MYLANLABS-2024M1075316$MYLAN$$$$$M$Y$$$20240828$$MD$GB$GB
242577511$24257751$1$I$$20240820$20240828$20240828$EXP$$US-MYLANLABS-2024M1078224$MYLAN$Credo R, Kesey J, Bharadia D, Griswold J, Pang A. Acute Intermittent Porphyria in a Burn Patient: Case Study and Review of the Literature. [Review]. J-Burn-Care-Res 2024; 45 (3): 790-795.$60$YR$$M$Y$$$20240828$$HP$US$US
242577521$24257752$1$I$$20240819$20240828$20240828$EXP$$US-MYLANLABS-2024M1077898$MYLAN$Schwartz AH, Sieminski S. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event. Am-J-Ophthalmol-Case-Rep 2023; 30 1-4.$59$YR$$F$Y$$$20240828$$HP$US$US
242577531$24257753$1$I$$20240820$20240828$20240828$EXP$$US-MYLANLABS-2024M1078654$MYLAN$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J-Drugs-Dermatol 2023; 22 (11): e12-e16.$37$YR$$F$Y$$$20240828$$HP$US$US
242577541$24257754$1$I$$20240823$20240828$20240828$EXP$$AU-MYLANLABS-2024M1078681$MYLAN$$$$$F$Y$$$20240828$$PH$AU$AU
242577551$24257755$1$I$20240301$20240409$20240828$20240828$PER$$US-AMGEN-USASP2024170958$AMGEN$$35$YR$A$M$Y$$$20240828$$CN$US$US
242577563$24257756$3$F$$20240918$20240828$20240923$EXP$$US-TAKEDA-2024TUS086500$TAKEDA$$$$$M$Y$$$20240923$$CN$US$US
242577591$24257759$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136318$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240828$$CN$US$US
242577601$24257760$1$I$20240201$20240820$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132202$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240828$$CN$US$US
242577611$24257761$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136430$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240828$$CN$US$US
242577621$24257762$1$I$20240701$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136382$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240828$$HP$US$US
242577631$24257763$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00694$GLAND PHARMA$$$$$M$Y$$$20240828$$CN$US$US
242577642$24257764$2$F$20230904$20240903$20240828$20240910$EXP$$NVSC2024FR127837$NOVARTIS$$$$E$F$Y$67$KG$20240910$$MD$FR$FR
242577651$24257765$1$I$20240728$20240821$20240828$20240828$EXP$$NVSC2023ZA086071$NOVARTIS$$$$T$M$Y$$$20240828$$CN$ZA$ZA
242577661$24257766$1$I$$20240803$20240828$20240828$PER$$US-JNJFOC-20240818957$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242577671$24257767$1$I$$20240822$20240828$20240828$EXP$$CA-TAKEDA-2024TUS085647$TAKEDA$$$$$F$Y$$$20240828$$MD$CA$CA
242577681$24257768$1$I$20230124$20240821$20240828$20240828$EXP$$CA-TAKEDA-2024TUS085074$TAKEDA$$78$YR$$F$Y$$$20240828$$MD$CA$CA
242577691$24257769$1$I$20240201$20240813$20240828$20240828$EXP$$FR-CIPLA LTD.-2024FR08998$CIPLA$$$$$$Y$$$20240828$$MD$FR$FR
242577701$24257770$1$I$$20240823$20240828$20240828$EXP$$CA-ABBVIE-5894068$ABBVIE$$22$YR$$F$Y$$$20240828$$CN$CA$CA
242577711$24257771$1$I$20220103$20240814$20240828$20240828$EXP$$IN-GRANULES-IN-2024GRALIT00375$GRANULES INDIA$PRATIK CHABHADIYA.Acetaminophen-Induced Toxic Epidermal Necrolysis In Pediatric Patients-A Case Series.International Journal of Pharmacy and Pharmaceutical Science.14-MAY-2024;16 (7):50-53$7$YR$C$M$Y$19$KG$20240828$$HP$IN$IN
242577721$24257772$1$I$$20240819$20240828$20240828$EXP$$AU-TEVA-VS-3236347$TEVA$$78$YR$$F$Y$$$20240828$$HP$AU$AU
242577731$24257773$1$I$20240825$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170980$AMGEN$$83$YR$E$F$Y$$$20240828$$CN$US$US
242577743$24257774$3$F$20240701$20240923$20240828$20240923$PER$$US-AMGEN-USASP2024170695$AMGEN$$72$YR$E$F$Y$$$20240923$$CN$US$US
242577751$24257775$1$I$$20240820$20240828$20240828$PER$$US-AMGEN-USASP2024169294$AMGEN$Kimball A.B.; Gibson R.S.; Snyder C.L. et al.. Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study. International Journal of  Women^s Dermatology. 2024;10 (3):1-4$$$$$Y$$$20240828$$MD$US$US
242577761$24257776$1$I$$20240820$20240828$20240828$EXP$$CA-TEVA-VS-3234998$TEVA$$14$YR$$M$Y$$$20240828$$HP$CA$CA
242577771$24257777$1$I$$20240820$20240828$20240828$EXP$$JP-AMGEN-JPNSP2024168597$AMGEN$Nakayasu S, Tanji M, Uto M, Takeuchi Y, Makino Y, Yamamoto Hattori E, et al.. Hypofractionated radiotherapy combined with bevacizumab plus low-dose ifosfamide, carboplatin, and etoposide as second-line chemoradiotherapy for progressing spinal diffuse midline glioma, H3K27-altered: illustrative case. Journal of Neurosurgery (JNS): Case Lessons. 2024;8$45$YR$A$M$Y$$$20240828$$MD$JP$JP
242577782$24257778$2$F$20240520$20240820$20240828$20240902$PER$$US-ABBVIE-5894506$ABBVIE$$72$YR$$F$Y$$$20240902$$CN$US$US
242577791$24257779$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00695$GLAND PHARMA$$$$$$Y$$$20240828$$CN$US$US
242577801$24257780$1$I$$20240822$20240828$20240828$EXP$$IN-ROCHE-10000064705$ROCHE$$$$E$F$Y$$$20240828$$MD$IN$IN
242577812$24257781$2$F$$20240819$20240828$20240828$EXP$$US-ROCHE-10000060749$ROCHE$Knodle R, Pomerantz B, Borgetti S. Disseminated Kaposi sarcoma without primary cutaneous involvement in a kidney transplant recipient. Transplant Infectious Disease. 2024-Aug;26 (4):1-3. doi:10.1111/tid.14323.$69$YR$E$M$Y$$$20240828$$HP$US$US
242577821$24257782$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5894005$ABBVIE$$56$YR$$F$Y$$$20240828$$HP$US$US
242577831$24257783$1$I$20240701$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136144$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240828$$HP$US$US
242577841$24257784$1$I$$20240820$20240828$20240828$EXP$$US-RDY-LIT/USA/24/0012404$DR REDDYS$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. Journal of drugs in dermatology : JDD. 2023 Nov;22(11): e12-e16. doi:10.36849/JDD.4936.$37$YR$A$F$Y$$$20240828$$HP$US$US
242577851$24257785$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136419$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240828$$CN$US$US
242577861$24257786$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173581$NOVARTIS$$$$$$Y$$$20240828$$CN$US$US
242577883$24257788$3$F$$20240906$20240828$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136463$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240912$$CN$US$US
242577891$24257789$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169084$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242577903$24257790$3$F$20240701$20240904$20240828$20240909$PER$$US-AMGEN-USASP2024170723$AMGEN$$66$YR$E$F$Y$$$20240909$$CN$US$US
242577911$24257791$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5893987$ABBVIE$$27$YR$$F$Y$$$20240828$$HP$US$US
242577931$24257793$1$I$$20240624$20240828$20240828$EXP$$CA-AMGEN-CANSP2024169080$AMGEN$$40$YR$A$F$Y$96$KG$20240828$$HP$CA$CA
242577941$24257794$1$I$$20240823$20240828$20240828$PER$$US-BAUSCH-BL-2024-012817$BAUSCH AND LOMB$$$$$$Y$$$20240828$$CN$US$US
242577961$24257796$1$I$20220426$20240821$20240828$20240828$EXP$$GB-MYLANLABS-2022M1033619$MYLAN$$$$A$M$Y$$$20240828$$PH$GB$GB
242577971$24257797$1$I$20240715$20240816$20240828$20240828$EXP$CH-SM-2024-15296$CH-ROCHE-10000060283$ROCHE$$57$YR$A$M$Y$$$20240828$$MD$CH$CH
242577981$24257798$1$I$$20240819$20240828$20240828$EXP$JP-MLMSERVICE-20240814-PI156937-00328-2$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP001207$JUBILANT$Takahashi K, Kobayashi R, Morikawa K, Maeda M, Samura O, Okamoto A.. Overdose of angiotensin II receptor blocker in the third trimester of pregnancy: A case report.. Journal of Obstetrics and Gynaecology Research. 2024;50(8):1425-8.$23$YR$$F$Y$$$20240828$$MD$JP$JP
242577991$24257799$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-087358-2024$RECKITT BENCKISER$$$$$M$Y$$$20240828$$CN$US$US
242578001$24257800$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00681$GLAND PHARMA$$$$$$Y$$$20240828$$CN$US$US
242578011$24257801$1$I$20240701$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017286$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240828$$CN$US$US
242578021$24257802$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016952$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242578031$24257803$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016050$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240828$$CN$US$US
242578041$24257804$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017054$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240828$$CN$US$US
242578051$24257805$1$I$20240821$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016505$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240828$$CN$US$US
242578061$24257806$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015901$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240828$$CN$US$US
242578071$24257807$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017119$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240828$$CN$US$US
242578091$24257809$1$I$$20240823$20240828$20240828$PER$$US-ABBVIE-5896099$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242578102$24257810$2$F$$20240904$20240828$20240925$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004276$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
242578111$24257811$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170252$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242578121$24257812$1$I$20221101$20240814$20240828$20240828$EXP$$IN-GRANULES-IN-2024GRALIT00372$GRANULES INDIA$PRATIK CHABHADIYA.Acetaminophen-Induced Toxic Epidermal Necrolysis In Pediatric Patients-A Case Series.International Journal of Pharmacy and Pharmaceutical Science.2024;16 (7):50-53$5$MON$I$F$Y$$$20240828$$HP$IN$IN
242578131$24257813$1$I$$20240820$20240828$20240828$EXP$$US-BAYER-2024A120555$BAYER$$$$$F$Y$$$20240828$$CN$US$US
242578141$24257814$1$I$$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131453$BRISTOL MYERS SQUIBB$Giese D, Elkhedr A, Jnaneswaran G, Ernste KM. Nivolumab-induced diabetic ketoacidosis: a case report. Cureus. 2024 Jul 11;16(7):1-4. doi:10.7759/cureus.64319.$68$YR$E$M$Y$$$20240828$$HP$US$US
242578151$24257815$1$I$20240101$20240827$20240828$20240828$EXP$$US-UCBSA-2024043668$UCB$$$$$F$Y$$$20240828$$CN$US$US
242578161$24257816$1$I$20240101$20240819$20240828$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-021474$UNITED THERAPEUTICS$$$$$F$Y$61.224$KG$20240828$$$US$US
242578172$24257817$2$F$20231201$20240911$20240828$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-008052$UNITED THERAPEUTICS$$73$YR$$M$Y$100.23$KG$20240919$$$US$US
242578183$24257818$3$F$20240401$20240912$20240828$20240919$EXP$$KZ-BIOGEN-2024BI01279287$BIOGEN$$$$$M$Y$$$20240919$$MD$KZ$KZ
242578192$24257819$2$F$$20240913$20240828$20240919$EXP$$US-BIOGEN-2024BI01278676$BIOGEN$$$$$F$Y$$$20240919$$CN$US$US
242578221$24257822$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004356$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242578231$24257823$1$I$$20240820$20240828$20240828$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024103794$VIIV$$$$$M$Y$$$20240828$$MD$US$US
242578241$24257824$1$I$$20240827$20240828$20240828$EXP$$NVSC2024US173314$NOVARTIS$$$$A$F$Y$$$20240828$$MD$US$US
242578252$24257825$2$F$20240701$20240827$20240828$20240830$EXP$$CN-GSK-CN2024GSK106437$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$CN$CN
242578271$24257827$1$I$$20240827$20240828$20240828$PER$$US-TAKEDA-2024TUS086446$TAKEDA$$$$$M$Y$$$20240828$$MD$US$US
242578281$24257828$1$I$20240822$20240822$20240828$20240828$PER$$US-BEH-2024177648$CSL BEHRING$$51$YR$A$F$Y$$$20240828$$MD$US$US
242578291$24257829$1$I$$20240821$20240828$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA074498$SANDOZ$$41$YR$$F$Y$$$20240828$$HP$CA$CA
242578301$24257830$1$I$$20240821$20240828$20240828$EXP$$US-MYLANLABS-2024M1078626$MYLAN$Gardner SM, Pavisian B, Ho PA, Rustad JK, Kasick DP, Stern TA. Dynamic Evolution of Catatonia in the Context of Cerebral Venous Sinus Thrombosis. Prim-Care-Comp-CNS-Disorders 2023; 25.$70$YR$$F$Y$$$20240828$$MD$US$US
242578311$24257831$1$I$$20240821$20240828$20240828$EXP$$AU-MYLANLABS-2024M1078905$MYLAN$Montarello NL, Irvine I, Warner V, Hare J, Kaye D, Cloud GC. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report. BMC-Neurol 2024; 24 1-6.$51$YR$$F$Y$$$20240828$$HP$AU$AU
242578321$24257832$1$I$$20240821$20240828$20240828$EXP$$US-MYLANLABS-2024M1078894$MYLAN$Patel N, Madi P, Monteiro I, Shah SP. The anesthetic management of a child with ohtahara syndrome and severe stridor: a case report. BMC-Pediatr 2024; 24 (1):.$$$I$M$Y$$$20240828$$HP$US$US
242578331$24257833$1$I$20240809$20240823$20240828$20240828$EXP$$US-ABBVIE-5894180$ABBVIE$$58$YR$$M$Y$$$20240828$$CN$US$US
242578351$24257835$1$I$$20240821$20240828$20240828$EXP$$US-MYLANLABS-2024M1078921$MYLAN$Assante WJ, Kapoor A. Steroid-Dependent Minimal Change Disease in an Adult Responsive to Rituximab. J-Am-Soc-Nephrol 2023; 34 (Suppl. 11) 302 (plus Poster) abstr. TH-PO761.$30$YR$$M$Y$$$20240828$$HP$US$US
242578361$24257836$1$I$$20240816$20240828$20240828$EXP$$MY-STERISCIENCE B.V.-2024-ST-001230$Steriscience PTE$Hazwani I, Raja Abdul Wafy RMR.. P 015: Case report of a pregnant patient with peripartum cardiomyopathy, pulmonary embolism, and cardiac arrest: Lessons learned.. Int-J-Cardiol. 2024;397 (Suppl.):abstr. P015$34$YR$$F$Y$$$20240828$$HP$MY$MY
242578371$24257837$1$I$$20240820$20240828$20240828$EXP$$US-RDY-LIT/USA/24/0012401$DR REDDYS$Winston DJ, Young PA, Schlamm HT, Schiller GJ. Fosmanogepix Therapy of Disseminated Fusarium Infection. Clinical Infectious Diseases. 2023 Sep 15;77: 848-850. doi:10.1093/cid/ciad309.$26$YR$A$F$Y$$$20240828$$HP$US$US
242578381$24257838$1$I$$20240826$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047899$BOEHRINGER INGELHEIM$$$$$$Y$$$20240828$$HP$US$US
242578391$24257839$1$I$20240501$20240821$20240828$20240828$EXP$$US-BAYER-2024A071835$BAYER$$65$YR$E$F$Y$$$20240828$$CN$US$US
242578401$24257840$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136084$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240828$$HP$US$US
242578411$24257841$1$I$20240802$20240802$20240828$20240828$PER$$US-CSL-2024-007468$CSL Plasma$$57$YR$$F$Y$$$20240828$$HP$US$US
242578422$24257842$2$F$$20240831$20240828$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-135735$BRISTOL MYERS SQUIBB$Oiwa E, et al. A case of treatment-related lymphoblastic leukemia after transition from myelodysplastic syndrome to acute myeloid leukemia. The 25th Annual Meeting of the Japanese Society for Laboratory Hematology. 2024;S170.$69$YR$E$F$Y$$$20240905$$HP$JP$JP
242578441$24257844$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-087354-2024$RECKITT BENCKISER$$$$$M$Y$$$20240828$$CN$US$US
242578451$24257845$1$I$20240519$20240827$20240828$20240828$EXP$GB-MHRA-MED-202408271224164140-BHJKV$GB-ORGANON-O2408GBR002016$ORGANON$$67$YR$$F$Y$86$KG$20240828$$MD$GB$GB
242578461$24257846$1$I$$20240819$20240828$20240828$EXP$$AU-ABBVIE-5897645$ABBVIE$$25$YR$$F$Y$$$20240828$$HP$AU$AU
242578471$24257847$1$I$20240724$20240821$20240828$20240828$EXP$ES-AEMPS-1561564$ES-MYLANLABS-2024M1077829$MYLAN$$77$YR$$M$Y$$$20240828$$MD$ES$ES
242578481$24257848$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-105535-2023$RECKITT BENCKISER$$85$YR$$M$Y$$$20240828$$CN$US$US
242578492$24257849$2$F$$20240827$20240828$20240829$PER$$NVSC2024US173580$NOVARTIS$$$$$$Y$$$20240829$$MD$US$US
242578501$24257850$1$I$$20240806$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07949$LUPIN$$$$$$Y$$$20240828$$$US$US
242578511$24257851$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169521$AMGEN$$79$YR$E$F$Y$$$20240828$$CN$US$US
242578521$24257852$1$I$20240425$20240823$20240828$20240828$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2024-116532$REGENERON$$84$YR$$F$Y$$$20240828$$CN$CO$CO
242578532$24257853$2$F$$20240830$20240828$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004359$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
242578541$24257854$1$I$$20240819$20240828$20240828$PER$$US-MYLANLABS-2024M1078571$MYLAN$$$$$F$Y$$$20240828$$CN$US$US
242578551$24257855$1$I$$20240816$20240828$20240828$EXP$$SK-STERISCIENCE B.V.-2024-ST-001232$Steriscience PTE$Poruban T, Hunavy M, Farkas D, Carnoky S, Jakubova M.. A rare Serratia marcescens-associated acute endocarditis of a tricuspid valve in an intravenous drug user: A case report and literature review.. Wien-Klin-Wochenschr. 2023;135 (21-22):631-636$27$YR$$M$Y$$$20240828$$HP$SK$SK
242578561$24257856$1$I$20240415$20240709$20240828$20240828$EXP$$AT-TEVA-VS-3194252$TEVA$$88$YR$$M$Y$70$KG$20240828$$PH$AT$AT
242578572$24257857$2$F$20240818$20240905$20240828$20240909$PER$$US-AMGEN-USASP2024170019$AMGEN$$68$YR$E$F$Y$$$20240908$$CN$US$US
242578581$24257858$1$I$20240622$20240822$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134806$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240828$$CN$US$US
242578591$24257859$1$I$20240826$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136247$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$76.2$KG$20240828$$CN$US$US
242578601$24257860$1$I$$20240819$20240828$20240828$EXP$$JP-ROCHE-10000065970$ROCHE$Sato S, Sato H, Yamashita N, Takahashi Y, Kishi K, Fukuhara H. O7-1 A case of effective post-treatment on advanced HCC after irAE of atezolizumab and bevacizumab. The 60th Annual Meeting of Japan Liver Cancer Association. 2024;142.$9$DEC$E$M$Y$$$20240828$$MD$JP$JP
242578611$24257861$1$I$$20240822$20240828$20240828$EXP$$BR-JNJFOC-20240863361$JOHNSON AND JOHNSON$$59$YR$A$M$Y$38$KG$20240828$$CN$BR$BR
242578621$24257862$1$I$$20240816$20240828$20240828$EXP$$ID-STERISCIENCE B.V.-2024-ST-001235$Steriscience PTE$Yang N, Hartanto YB.. Insidious mastoiditis in children with clinical onset of intracranial complication: A case series.. J-Neurol-Sci. 2023;455 (Suppl.):50-51 abstr. 121296.$4$YR$$F$Y$$$20240828$$MD$ID$ID
242578631$24257863$1$I$$20240822$20240828$20240828$PER$$US-MYLANLABS-2024M1078586$MYLAN$$22$YR$$M$Y$$$20240828$$CN$US$US
242578641$24257864$1$I$$20240702$20240828$20240828$EXP$$US-LATINA PHARMA S.P.A-US-2024COR000001$Latina Pharma$Carlen A Yuen, Melike Pekmezci, Silin Bao, Xiao-Tang Kong. Metastatic glioblastoma to the lungs: a case report and literature review. CNS Oncology. 2024;13:1:1-15$$$$$Y$$$20240828$$HP$US$US
242578651$24257865$1$I$20240501$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004362$ACADIA PHARMACEUTICALS$$61$YR$$M$Y$$$20240828$$CN$US$US
242578661$24257866$1$I$$20240820$20240828$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA074963$SANDOZ$$$$$F$Y$$$20240828$$MD$CA$CA
242578671$24257867$1$I$20240725$20240823$20240828$20240828$EXP$$SG-AMERICAN REGENT INC-2024003247$AMERICAN REGENT$$44$YR$$F$Y$$$20240828$$HP$SG$SG
242578681$24257868$1$I$20240609$20240822$20240828$20240828$EXP$$PK-ROCHE-3553626$ROCHE$$73$YR$E$F$Y$$$20240828$$CN$PK$PK
242578691$24257869$1$I$20240726$20240816$20240828$20240828$EXP$$US-ROCHE-10000042913$ROCHE$$75$YR$E$F$Y$$$20240828$$CN$US$US
242578721$24257872$1$I$$20240816$20240828$20240828$EXP$$IN-STERISCIENCE B.V.-2024-ST-001240$Steriscience PTE$Newbigging NS, Lenin A, Jasmine S, Alexander S, Thomas N, Livingstone J.. Secondary hyperaldosteronism due to renal agenesis: Rare cause of secondary hypertension in pregnancy.. Pregnancy-Hypertens. 2024;36 (Suppl. 1):31-32$21$YR$$F$Y$$$20240828$$HP$IN$IN
242578731$24257873$1$I$20240731$20240822$20240828$20240828$EXP$$CN-MYLANLABS-2024M1078418$MYLAN$$75$YR$$M$Y$50$KG$20240828$$HP$CN$CN
242578741$24257874$1$I$$20240822$20240828$20240828$EXP$$US-MYLANLABS-2024M1079249$MYLAN$Haidry A, Kabra N, Bhinder J, Gass A. Utilizing ecmo for recurrent idiopathic ventricular fibrillation. J-Am-Coll-Cardiol 2019; 73 (Suppl.) (9): 2598.$44$YR$$F$Y$$$20240828$$HP$US$US
242578751$24257875$1$I$20231019$20240822$20240828$20240828$PER$$US-MYLANLABS-2024M1079107$MYLAN$$92$YR$$M$Y$$$20240828$$MD$US$US
242578761$24257876$1$I$$20240822$20240828$20240828$EXP$$BR-MYLANLABS-2024M1078445$MYLAN$$$$$F$Y$$$20240828$$CN$BR$BR
242578781$24257878$1$I$$20240822$20240828$20240828$EXP$$GB-MYLANLABS-2024M1078639$MYLAN$Edwards GM, Alejmi AA. Pure red cell aplasia secondary to erythropoietin therapy. Clin-Med-London 2024; 24 (4):.$53$YR$$M$Y$$$20240828$$HP$GB$GB
242578791$24257879$1$I$20240722$20240822$20240828$20240828$EXP$$CN-MYLANLABS-2024M1078289$MYLAN$$79$YR$$M$Y$$$20240828$$HP$CN$CN
242578801$24257880$1$I$$20240822$20240828$20240828$EXP$$JP-VIATRISJAPAN-2024M1077840AA$MYLAN$Yodoshi M, Iwasaki H , Fujiwara K, and Takegami M. P-7 A case of generalised drug eruption and liver disorder suspected to be due to use of oral pregabalin. The 10th Annual Meeting of Japan Society of Drug Safety. 2024;83$7$DEC$$F$Y$$$20240828$$PH$JP$JP
242578811$24257881$1$I$20240607$20240814$20240828$20240828$EXP$EU-AFSSAPS-AVTO2024000111$EU-ETHYPHARM-2024002217$ETHYPHARM$$$$$$Y$$$20240827$$MD$EU$
242578821$24257882$1$I$20240801$20240820$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132396$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240828$$HP$US$US
242578831$24257883$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135790$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240828$$CN$US$US
242578841$24257884$1$I$$20240820$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132289$BRISTOL MYERS SQUIBB$Kathuria-Prakash N, Lopez LP, Raman S, Ye H, Anaokar J, Sisk A, et al. ALK inhibition with alectinib for refractory metastatic renal cell carcinoma with alk rearrangement: a rare case report and literature review. JCO Precision Oncology. 2024 Jun 17;8:1-6. doi:10.1200/PO.24.00154.$64$YR$A$M$Y$$$20240828$$MD$US$US
242578851$24257885$1$I$20210101$20240823$20240828$20240828$PER$$US-ORGANON-O2408USA001852$ORGANON$$31$YR$$F$Y$66$KG$20240828$$MD$US$US
242578862$24257886$2$F$$20240920$20240828$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131204$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$75$KG$20240924$$HP$US$US
242578881$24257888$1$I$20240722$20240822$20240828$20240828$EXP$FR-AFSSAPS-LM2024000459$FR-AMGEN-FRASP2024168154$AMGEN$$66$YR$E$F$Y$79$KG$20240828$$CN$FR$FR
242578892$24257889$2$F$20240605$20240823$20240828$20240903$EXP$$CA-LUNDBECK-DKLU4003424$LUNDBECK$$$$$$Y$$$20240903$$HP$CA$CA
242578901$24257890$1$I$20240801$20240820$20240828$20240828$PER$$US-ABBVIE-5889117$ABBVIE$$$$$M$Y$$$20240828$$MD$US$US
242578921$24257892$1$I$$20240819$20240828$20240828$EXP$$CN-ROCHE-10000061065$ROCHE$Yuan F, Li M, Wei X, Fu Y. Co-transplantation of umbilical cord mesenchymal stem cells and peripheral blood stem cells in children and adolescents with refractory or relapsed severe aplastic anemia. Pediatric Hematology and Oncology. 2024-Jan;41 (5):322-335. doi:10.1080/08880018.2024.2324394.$$$$$Y$$$20240828$$HP$CN$CN
242578931$24257893$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016920$ELI LILLY AND CO$$57$YR$A$$Y$$$20240828$$CN$US$US
242578941$24257894$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016963$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240828$$CN$US$US
242578951$24257895$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016071$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240828$$CN$US$US
242578961$24257896$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016520$ELI LILLY AND CO$$$$A$F$Y$$$20240828$$CN$US$US
242578971$24257897$1$I$$20240821$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014012$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$US$US
242578982$24257898$2$F$$20240829$20240828$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408016173$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240902$$CN$US$US
242578991$24257899$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016320$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240828$$CN$US$US
242579001$24257900$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016007$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240828$$CN$US$US
242579011$24257901$1$I$20240216$20240821$20240828$20240828$EXP$$CA-GSK-CA2024026848$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$CA$CA
242579021$24257902$1$I$20230101$20240816$20240828$20240828$EXP$DE-BFARM-24005521$DE-Accord-442774$ACCORD$$77$YR$E$M$Y$76$KG$20240828$$MD$DE$DE
242579031$24257903$1$I$20240429$20240826$20240828$20240828$EXP$FR-AFSSAPS-RS2024000822$FR-GSK-FR2024105968$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$FR$FR
242579041$24257904$1$I$20240730$20240816$20240828$20240828$EXP$FR-AFSSAPS-RS2024000795$FR-Accord-442519$ACCORD$$74$YR$E$F$Y$70$KG$20240828$$PH$FR$FR
242579051$24257905$1$I$20240216$20240816$20240828$20240828$EXP$FR-AFSSAPS-MP2024001266$FR-Accord-442361$ACCORD$$75$YR$E$M$Y$$$20240828$$HP$FR$FR
242579061$24257906$1$I$20240201$20240816$20240828$20240828$EXP$IT-MINISAL02-998380$IT-Accord-442589$ACCORD$$75$YR$E$F$Y$55$KG$20240828$$MD$IT$IT
242579071$24257907$1$I$$20240815$20240828$20240828$EXP$$US-Accord-442668$ACCORD$$$$$F$Y$$$20240828$$MD$US$US
242579082$24257908$2$F$20240618$20240828$20240828$20240909$EXP$FR-AFSSAPS-AN2024001089$FR-Accord-442445$ACCORD$$69$YR$E$F$Y$87$KG$20240909$$PH$FR$FR
242579091$24257909$1$I$$20240819$20240828$20240828$PER$$US-MYLANLABS-2024M1077341$MYLAN$$$$$M$Y$81.65$KG$20240828$$CN$US$US
242579101$24257910$1$I$$20240820$20240828$20240828$EXP$$US-AUROBINDO-AUR-APL-2024-042137$AUROBINDO$Lee DH, Donkor R, Parvus MN, Dannenbaum MJ, Schefler AC. Incidence and Risk Factors for Neutropenia after Intra-Arterial Chemotherapy for Retinoblastoma. JAMA-Ophthalmol. 2023;141(12):1133-1138$$$$$Y$$$20240828$$HP$US$US
242579112$24257911$2$F$20240818$20240823$20240828$20240903$EXP$$GB-AUROBINDO-AUR-APL-2024-041997$AUROBINDO$$60$YR$$F$Y$$$20240903$$PH$GB$GB
242579121$24257912$1$I$$20240819$20240828$20240828$EXP$$TN-AMNEAL PHARMACEUTICALS-2024-AMRX-03088$AMNEAL$Mensi A, Trad N, Mansouri R, Ayed W, BelHadj Mabrouk E et al.. Chronic myeloid leukemia in an ulcerative colitis patient receiving azathioprine: A case report. Int J Clin Pharmacol Ther.. 2024;62(9):423-426$51$YR$$$Y$$$20240828$$HP$TN$TN
242579132$24257913$2$F$20230814$20240826$20240828$20240910$EXP$$RU-AZURITY PHARMACEUTICALS, INC.-AZR202408-000398$AZURITY PHARMACEUTICALS$Shalaeva DD, Pereverzeva KG, Fomina OA, Yakushin SS.. BRASH syndrome: a clinical case.. Rational Pharmacotherapy in Cardiology. 2024;20(3):367-73$85$YR$$F$Y$$$20240910$$HP$RU$RU
242579141$24257914$1$I$$20240822$20240828$20240828$EXP$$BR-ROCHE-10000064600$ROCHE$Prestes-Carneiro L, Carrilho P, Torelli D, Bressa J, Parizi A, Vieira P. Infectious Diseases and Secondary Antibody Deficiency in Patients from a Mesoregion of Sao Paulo State, Brazil. Tropicalmedicine and infectious disease. 2024-May;9 (5):1-13. doi:10.3390/tropicalmed9050104.$$$$$Y$$$20240828$$HP$BR$BR
242579151$24257915$1$I$$20240819$20240828$20240828$EXP$$US-APCER-AZR202408-000316$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242579161$24257916$1$I$20240616$20240823$20240828$20240828$EXP$$AE-LUNDBECK-DKLU4003458$LUNDBECK$$$$$$Y$$$20240828$$MD$AE$AE
242579181$24257918$1$I$20240821$20240821$20240828$20240828$PER$$US-MYLANLABS-2024M1077923$MYLAN$$77$YR$$F$Y$63.05$KG$20240828$$CN$US$US
242579191$24257919$1$I$$20240820$20240828$20240828$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000399$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240827$$CN$US$US
242579201$24257920$1$I$$20240823$20240828$20240828$EXP$$NVSJ2024JP009955$NOVARTIS$$73$YR$$F$Y$$$20240828$$MD$JP$JP
242579211$24257921$1$I$20240821$20240821$20240828$20240828$PER$$US-AMGEN-USASP2024167975$AMGEN$$$$$F$Y$$$20240828$$HP$US$US
242579221$24257922$1$I$$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024170031$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242579231$24257923$1$I$$20240826$20240828$20240828$EXP$$NVSC2024PL173063$NOVARTIS$$$$$M$Y$$$20240828$$MD$PL$PL
242579241$24257924$1$I$$20240822$20240828$20240828$EXP$$US-JNJFOC-20240857835$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242579251$24257925$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004364$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242579261$24257926$1$I$20240708$20240816$20240828$20240828$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000847$PAREXEL$$$$$$Y$$$20240828$$HP$CN$CN
242579274$24257927$4$F$$20240830$20240828$20240905$EXP$$US-SANDOZ INC.-SDZ2024US075432$SANDOZ$$$$$F$Y$66.667$KG$20240905$$CN$US$US
242579281$24257928$1$I$$20240806$20240828$20240828$PER$$US-ALK-ABELLO A/S-2024AA003135$ALK-ABELLO$$$$$$Y$$$20240828$$HP$US$US
242579291$24257929$1$I$$20240806$20240828$20240828$PER$$US-ALK-ABELLO A/S-2024AA003139$ALK-ABELLO$$$$$$Y$$$20240828$$HP$US$US
242579301$24257930$1$I$$20240806$20240828$20240828$PER$$US-ALK-ABELLO A/S-2024AA003137$ALK-ABELLO$$$$$$Y$$$20240828$$HP$US$US
242579311$24257931$1$I$$20240806$20240828$20240828$PER$$US-ALK-ABELLO A/S-2024AA003138$ALK-ABELLO$$$$$$Y$$$20240828$$CN$US$US
242579321$24257932$1$I$$20240815$20240828$20240828$EXP$$IN-CIPLA LTD.-2024IN09272$CIPLA$Das K, Singal DK, Hussain A.. Cholestatic jaundice in a fitness enthusiast. Journal of Clinical and Experimental Hepatology. 2024;14 (1):1 to 3$$$$$Y$$$20240828$$HP$IN$IN
242579331$24257933$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-087226-2024$RECKITT BENCKISER$$$$$F$Y$$$20240828$$CN$US$US
242579341$24257934$1$I$20240412$20240412$20240828$20240828$PER$$US-AUROBINDO-AUR-APL-2024-019718$AUROBINDO$$$$$F$Y$$$20240828$$CN$US$US
242579351$24257935$1$I$20240806$20240826$20240828$20240828$EXP$$US-GILEAD-2024-0685441$GILEAD$$59$YR$A$M$Y$$$20240828$$CN$US$US
242579361$24257936$1$I$20240801$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170738$AMGEN$$33$YR$A$M$Y$$$20240828$$HP$US$US
242579381$24257938$1$I$$20240816$20240828$20240828$EXP$$FR-ROCHE-10000060615$ROCHE$CESBRON C,  Risk Of Unknown Interaction With Tocilizumab [Roactemra]. Unknown.$74$YR$E$$Y$$$20240828$$HP$FR$FR
242579391$24257939$1$I$$20240814$20240828$20240828$EXP$$US-B.Braun Medical Inc.-2160927$B BRAUN$Literature Article$76$YR$$F$Y$$$20240828$$$US$US
242579401$24257940$1$I$$20240819$20240828$20240828$PER$$US-AMGEN-USASP2024167402$AMGEN$Peikert T.; Varghese C.; Johnson G.B. et al.. A Retrospective Evaluation of the Treatment Effects of Rituximab in Patients with Progressive and Symptomatic Fibrosing Mediastinitis. Annals of the American Thoracic Society. 2024;1-32$$$$$Y$$$20240828$$MD$US$US
242579421$24257942$1$I$$20240827$20240828$20240828$EXP$$US-GILEAD-2024-0685497$GILEAD$$$$A$F$Y$$$20240828$$HP$US$US
242579431$24257943$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136288$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240828$$CN$US$US
242579441$24257944$1$I$$20240816$20240828$20240828$EXP$ES-EMA-DD-20240809-7482655-095404$ES-ROCHE-10000059748$ROCHE$Hernani R, Sancho A, Amat P, Hernandez-Boluda J, Perez A, Pinana J, Carretero  C, Goterris R, Gozmez M, Saus A, Ferrer B, Teruel A, Terol M and Solano C. CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review. Current Research in Translational Medicine 2021 Oct;69 (4):1-5. doi:10.1016/j.retram.2021.103304$56$YR$A$M$Y$$$20240828$$HP$ES$ES
242579452$24257945$2$F$$20240820$20240828$20240829$EXP$$US-TEVA-VS-3235308$TEVA$$$$$M$Y$$$20240829$$MD$US$US
242579461$24257946$1$I$$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135658$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240828$$CN$US$US
242579481$24257948$1$I$$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58954$$FDA-CTU$$$$$$N$$$20240823$N$CN$US$
242579511$24257951$1$I$$20240814$20240828$20240828$EXP$$US-B.Braun Medical Inc.-2160928$B BRAUN$Literature Article$47$YR$$M$Y$$$20240828$$$US$US
242579523$24257952$3$F$20240903$20240912$20240828$20240920$EXP$$US-Calliditas-2024CAL01640$CALLIDITAS THERAPEUTICS$$52$YR$A$M$Y$$$20240920$$CN$US$US
242579551$24257955$1$I$$20240822$20240828$20240828$EXP$$US-BAYER-2024A122481$BAYER$$54$YR$A$F$Y$$$20240828$$CN$US$US
242579571$24257957$1$I$$20240814$20240828$20240828$EXP$$KR-B.Braun Medical Inc.-2160924$B BRAUN$Literature Article$65$YR$$F$Y$$$20240828$$$KR$KR
242579583$24257958$3$F$20240501$20240910$20240828$20240916$EXP$$US-JNJFOC-20240867675$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240917$$CN$US$US
242579591$24257959$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004365$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242579611$24257961$1$I$$20240821$20240828$20240828$EXP$$CA-GSK-CA2022145928$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$CA$CA
242579621$24257962$1$I$20240822$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024168536$AMGEN$$72$YR$E$M$Y$$$20240828$$CN$US$US
242579631$24257963$1$I$$20240814$20240828$20240828$EXP$$US-B.Braun Medical Inc.-2160922$B BRAUN$Literature Article$53$YR$$F$Y$$$20240828$$$US$US
242579641$24257964$1$I$$20240814$20240828$20240828$EXP$$US-B.Braun Medical Inc.-2160923$B BRAUN$Literature Article$53$YR$$F$Y$$$20240828$$$US$US
242579662$24257966$2$F$$20240814$20240828$20240830$EXP$$US-B.Braun Medical Inc.-2160919$B BRAUN$Literature Article$46$YR$$M$Y$$$20240830$$$US$US
242579681$24257968$1$I$$20240814$20240828$20240828$EXP$$KR-B.Braun Medical Inc.-2160925$B BRAUN$Literature Article$65$YR$$F$Y$$$20240828$$$KR$KR
242579691$24257969$1$I$$20240821$20240828$20240828$EXP$$JP-EXELIXIS-CABO-24080841$EXELIXIS$$8$DEC$$M$Y$$$20240828$$MD$JP$JP
242579701$24257970$1$I$$20240820$20240828$20240828$PER$$US-EMD Serono-2024044959$EMD SERONO INC$$62$YR$A$F$Y$$$20240828$$CN$US$US
242579711$24257971$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004366$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242579721$24257972$1$I$$20240805$20240828$20240828$PER$$US-B.Braun Medical Inc.-2160939$B BRAUN$$37$YR$$F$Y$$$20240828$$$US$US
242579731$24257973$1$I$20240812$20240815$20240828$20240828$PER$$US-Xttrium Laboratories, Inc-2160918$XTTRIUM$$$$$F$Y$$$20240828$$$US$US
242579741$24257974$1$I$$20240821$20240828$20240828$EXP$$GR-MYLANLABS-2024M1078477$MYLAN$$59$YR$$F$Y$$$20240828$$CN$GR$GR
242579751$24257975$1$I$$20240814$20240828$20240828$EXP$$PT-AUROBINDO-AUR-APL-2024-041229$AUROBINDO$Peixoto M, Alves D, Lopes A, Queir?z L, Almeida M. Fluoropyrimidine Toxicities and DPYD Genotyping: A Clinical Case. Cureus. 2024;16(7):e63814$52$YR$$F$Y$$$20240828$$HP$PT$PT
242579761$24257976$1$I$20240319$20240823$20240828$20240828$EXP$$CN-BAYER-2024A122328$BAYER$$52$YR$A$F$Y$$$20240828$$HP$CN$CN
242579771$24257977$1$I$$20240821$20240828$20240828$EXP$$IN-ROCHE-10000064103$ROCHE$$60$YR$A$F$Y$$$20240828$$CN$IN$IN
242579781$24257978$1$I$$20240819$20240828$20240828$EXP$$JP-ROCHE-10000064518$ROCHE$Shiota M, Hosaka T, Sezaki H, Yamamoto S, Erikuson Y, Kawamura Y et al.. 61 A case in which clinical complete response was achieved by concomitant use of combination immunotherapy and TACE for advanced hepatocellular carcinoma with Vp4 portal vein tumour thrombus. The 380th Kanto Branch Regular Meeting of the Japanese Society of Gastroenterolo. 2024;39$70$YR$E$M$Y$$$20240828$$MD$JP$JP
242579821$24257982$1$I$20240809$20240820$20240828$20240828$EXP$$CA-JNJFOC-20240858904$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240828$$HP$CA$CA
242579841$24257984$1$I$$20240821$20240828$20240828$EXP$GB-MHRA-TPP19046C10120137YC1724069641256$GB-TORRENT-00037702$TORRENT$$56$YR$A$F$Y$60$KG$20240828$$HP$GB$GB
242579851$24257985$1$I$20240823$20240823$20240828$20240828$EXP$GB-MHRA-MED-202408231135595490-CSTNM$GB-TORRENT-00037712$TORRENT$$25$YR$A$M$Y$105$KG$20240828$$CN$GB$GB
242579862$24257986$2$F$$20240902$20240828$20240911$EXP$$IT-TEVA-VS-3236057$TEVA$Corazza M, Pacetti L, Schettini N, Bocchi C, Borghi A. Airborne Contact Dermatitis Due to Budesonide by Multiple Proxies. Dermatitis 2024; 35 (3): 291-292.; Corazza M, Pacetti L, Schettini N, Bocchi C, Borghi A. Airborne Contact Dermatitis Due to Budesonide by Multiple Proxies. Dermatitis 2024; 35 (3): 291-292.; Corazza M, Pacetti L, Schettini N, Bocchi C, Borghi A. Airborne Contact Dermatitis Due to Budesonide by Multiple Proxies. Dermatitis 2024; 35 (3): 291-292.$$$A$F$Y$$$20240911$$HP$IT$IT
242579871$24257987$1$I$20240725$20240816$20240828$20240828$EXP$$US-TORRENT-00013726$TORRENT$$84$YR$E$F$Y$41$KG$20240828$$CN$US$US
242579881$24257988$1$I$$20240821$20240828$20240828$EXP$GB-MHRA-MED-202408211551196500-ZQBYP$GB-TORRENT-00037705$TORRENT$$$$$M$Y$$$20240828$$CN$GB$GB
242579911$24257991$1$I$$20240826$20240828$20240828$EXP$$NVSC2021PL159196$NOVARTIS$Kopon M, Klopocka M. Choroba Stilla u doroslych w praktyce gastrenterologicznej - opis przypadku [Still^s disease in adults in gastroenterological practice - a case report]. GASTROENTEROLOGIA PRAKTYCZNA. 2021;50(1):71-4$33$YR$$F$Y$$$20240828$$HP$PL$PL
242579921$24257992$1$I$$20240815$20240828$20240828$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000376$AZURITY PHARMACEUTICALS$$$$$F$Y$$$20240827$$CN$US$US
242579931$24257993$1$I$20240803$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004367$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240828$$CN$US$US
242579941$24257994$1$I$$20240819$20240828$20240828$EXP$$US-RDY-SPO/USA/24/0012346$DR REDDYS$Kim E, Malespini J, Lei M, Branagan AR, Cirstea DR, Han SS, et al. Rapid reduction of free light chains and improvement in renal outcomes in patients with newly diagnosed multiple myeloma admitted with acute kidney injury with daratumumab-based therapy and without plasmapheresis. Journal of Clinical Oncology. 2024 Jun;42(16): doi:10.1200/JCO.2024.42.16_suppl.7525.$87$YR$E$$Y$$$20240828$$HP$US$US
242579951$24257995$1$I$20240801$20240819$20240828$20240828$EXP$CN-NMPACDR-4301011002666202400474$CN-BAXTER-2024BAX023523$BAXTER$$58$YR$$F$Y$60$KG$20240828$$MD$CN$CN
242579961$24257996$1$I$20240802$20240819$20240828$20240828$EXP$CN-NMPACDR-3304011037915202400216$CN-BAXTER-2024BAX023532$BAXTER$$58$YR$$F$Y$65$KG$20240828$$MD$CN$CN
242579971$24257997$1$I$$20240823$20240828$20240828$EXP$$IT-ROCHE-545916$ROCHE$PELOSINI M, FOCOSI D R. PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY: REPORT OF THREE CASES IN HIV-NEGATIVE HEMATOLOGICAL PATIENTS AND REVIEW OF LITERATURE.. ANNALS OF HEMATOLOGY.. 2007;$60$YR$A$M$Y$$$20240828$$MD$IT$IT
242579981$24257998$1$I$20240804$20240819$20240828$20240828$EXP$CN-NMPACDR-1308011010306202400171$CN-BAXTER-2024BAX023530$BAXTER$$69$YR$$M$Y$75$KG$20240828$$MD$CN$CN
242580011$24258001$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-081542-2024$RECKITT BENCKISER$$$$$M$Y$$$20240828$$CN$US$US
242580022$24258002$2$F$20240101$20240916$20240828$20240926$EXP$$US-MALLINCKRODT-MNK202405174$MALLINCKRODT$$75$YR$E$F$Y$$$20240926$$HP$US$US
242580031$24258003$1$I$20240815$20240827$20240828$20240828$EXP$$US-ABBVIE-5898073$ABBVIE$$78$YR$$$Y$48$KG$20240828$$HP$US$US
242580041$24258004$1$I$$20240821$20240828$20240828$EXP$$US-ABBVIE-5892548$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242580051$24258005$1$I$20240801$20240826$20240828$20240828$EXP$$GB-AMERICAN REGENT INC-2024003271$AMERICAN REGENT$$37$YR$$F$Y$59$KG$20240828$$HP$GB$GB
242580061$24258006$1$I$20240129$20240816$20240828$20240828$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000840$PAREXEL$$$$$$Y$$$20240828$$HP$CN$CN
242580071$24258007$1$I$20240821$20240822$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014534$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240828$$CN$US$US
242580081$24258008$1$I$20240824$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016628$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240828$$HP$US$US
242580091$24258009$1$I$20230901$20240821$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014691$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242580121$24258012$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5893866$ABBVIE$$41$YR$$F$Y$$$20240828$$HP$US$US
242580131$24258013$1$I$20240530$20240821$20240828$20240828$PER$$US-JNJFOC-20240854391$JOHNSON AND JOHNSON$$61$YR$A$F$Y$49$KG$20240828$$HP$US$US
242580141$24258014$1$I$$20240808$20240828$20240828$PER$$US-TEVA-VS-3233540$TEVA$$$$$$Y$$$20240828$$CN$US$US
242580151$24258015$1$I$20240725$20240826$20240828$20240828$EXP$$DE-SANDOZ INC.-SDZ2024DE075226$SANDOZ$$67$YR$$F$Y$$$20240828$$MD$DE$DE
242580161$24258016$1$I$20240101$20240826$20240828$20240828$EXP$$US-ABBVIE-5896393$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242580171$24258017$1$I$20240801$20240823$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135589$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240828$$CN$US$US
242580181$24258018$1$I$20240101$20240821$20240828$20240828$EXP$FR-AFSSAPS-AVCN2024000533$FR-ABBVIE-5890588$ABBVIE$$20$YR$$M$Y$$$20240828$$MD$FR$FR
242580201$24258020$1$I$$20240805$20240828$20240828$PER$$US-B.Braun Medical Inc.-2160940$B BRAUN$$$$$$Y$$$20240828$$$US$US
242580211$24258021$1$I$$20240823$20240828$20240828$EXP$$US-ABBVIE-5894099$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242580231$24258023$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024171239$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242580241$24258024$1$I$20130101$20240815$20240828$20240828$EXP$AU-TGA-0000814855$AU-OCTA-GAM25824$OCTAPHARMA$$$$$F$Y$$$20240827$$CN$AU$AU
242580251$24258025$1$I$$20240819$20240828$20240828$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006151$BIOCON$$$$$$Y$$$20240828$$HP$CA$CA
242580261$24258026$1$I$$20240816$20240828$20240828$EXP$$AU-LUPIN EUROPE GMBH-2024-08378$LUPIN$$$$$$Y$$$20240828$$CN$AU$AU
242580271$24258027$1$I$20230720$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-104580-2023$RECKITT BENCKISER$$74$YR$$F$Y$$$20240828$$CN$US$US
242580281$24258028$1$I$20240820$20240823$20240828$20240828$PER$$US-IDORSIA-008378-2024-US$IDORSIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240828$$CN$US$US
242580301$24258030$1$I$20240711$20240816$20240828$20240828$EXP$CN-HENLIUS-24CN016484$CN-Accord-443042$ACCORD$$35$YR$A$M$Y$$$20240828$$MD$CN$CN
242580312$24258031$2$F$$20240828$20240828$20240911$EXP$$US-Accord-443509$ACCORD$$27$YR$A$M$Y$$$20240911$$MD$US$US
242580321$24258032$1$I$20240717$20240816$20240828$20240828$EXP$DE-BFARM-24005480$DE-Accord-442583$ACCORD$$75$YR$E$M$Y$75$KG$20240828$$MD$DE$DE
242580331$24258033$1$I$20150317$20240816$20240828$20240828$EXP$FR-EMA-DD-20240807-7482707-111145$FR-Accord-442575$ACCORD$$68$YR$E$M$Y$117$KG$20240828$$HP$FR$FR
242580341$24258034$1$I$20231101$20240816$20240828$20240828$EXP$FR-AFSSAPS-RE2024000779$FR-Accord-442564$ACCORD$$62$YR$A$F$Y$$$20240828$$HP$FR$FR
242580351$24258035$1$I$20240815$20240816$20240828$20240828$EXP$GB-MHRA-MED-202408161238414280-FMBWH$GB-Accord-442433$ACCORD$$60$YR$A$F$Y$$$20240828$$PH$GB$GB
242580361$24258036$1$I$$20240820$20240828$20240828$EXP$$CA-TEVA-VS-3235099$TEVA$$65$YR$$F$Y$$$20240828$$HP$CA$CA
242580371$24258037$1$I$$20240816$20240828$20240828$EXP$$US-Accord-442731$ACCORD$Trabzonlu L, McDermott S, Pitman MB, Chebib I. Pulmonary Kaposi sarcoma in a patient with bilateral lung transplant: An unexpected diagnosis on transbronchial fine needle aspiration and core biopsy. Diagnostic Cytopathology. 2024;52(9): E215-21.$70$YR$E$F$Y$$$20240828$$MD$US$US
242580381$24258038$1$I$20240501$20240816$20240828$20240828$EXP$FR-AFSSAPS-TS2024000891$FR-Accord-442508$ACCORD$$72$YR$E$M$Y$64$KG$20240828$$MD$FR$FR
242580401$24258040$1$I$$20240816$20240828$20240828$EXP$$PL-Accord-442978$ACCORD$Wlodarczyk A, Korkosz M and Szczeklik W. Perioperative care of a patient with inflammatory rheumatic disease. PRAKTYKA KLINICZNA 2021 Apr,:53-58.$34$YR$A$F$Y$$$20240828$$MD$PL$PL
242580412$24258041$2$F$20240725$20240909$20240828$20240920$EXP$IT-MINISAL02-998259$IT-Accord-442593$ACCORD$$78$YR$E$M$Y$100$KG$20240920$$MD$IT$IT
242580421$24258042$1$I$$20240819$20240828$20240828$EXP$$CN-BIOCON BIOLOGICS LIMITED-BBL2024006277$BIOCON$Liu C,  Zhu H,  Nuerlan S.. EP08.02-095 Successful Treatment of EGFR Exon 19 Deletion with TP53 and ERBB2 20ins Mutation in Stage IVB NSCLC Patient with Aumolertinib.. Journal of Thoracic Oncology. 2022;17(9):S446-S447$$$$$Y$$$20240828$$HP$CN$CN
242580432$24258043$2$F$$20240902$20240828$20240911$EXP$$FR-TEVA-VS-3236101$TEVA$Beytout Q, Dutheil A, Cristofari S, Barbaud A, Chasset F, Senet P. Intra-arterial facial injection of hyaluronic acid complicated by Nicolau^s dermatitis: Treatment with iloprost. J-Eur-Acad-Dermatol-Venereol 2023; 37 e1314-e1315.; Beytout Q, Dutheil A, Cristofari S, Barbaud A, Chasset F, Senet P. Intra-arterial facial injection of hyaluronic acid complicated by Nicolau^s dermatitis: Treatment with iloprost. J-Eur-Acad-Dermatol-Venereol 2023; 37 e1314-e1315.$54$YR$$M$Y$$$20240911$$HP$FR$FR
242580442$24258044$2$F$$20240827$20240828$20240904$EXP$$CN-GILEAD-2024-0682048$GILEAD$$47$YR$A$M$Y$60$KG$20240904$$CN$CN$CN
242580451$24258045$1$I$20240101$20240808$20240828$20240828$PER$$US-TEVA-VS-3231719$TEVA$$51$YR$$F$Y$64$KG$20240828$$CN$US$US
242580461$24258046$1$I$20240723$20240823$20240828$20240828$EXP$$US-AMERICAN REGENT INC-2024003251$AMERICAN REGENT$$24$YR$$F$Y$48.9$KG$20240828$$HP$US$US
242580471$24258047$1$I$20240801$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131863$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240828$$CN$US$US
242580481$24258048$1$I$$20240815$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130837$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$PH$US$US
242580491$24258049$1$I$20240701$20240819$20240828$20240828$EXP$$JP-009507513-2408JPN002232J$MERCK$$8$DEC$$M$Y$$$20240828$$MD$JP$JP
242580581$24258058$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-59135$$FDA-CTU$$65$YR$$F$N$$$20240826$N$$US$
242580611$24258061$1$I$20240822$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-59117$$FDA-CTU$$54$YR$$F$N$$$20240826$N$HP$US$
242580651$24258065$1$I$20240824$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170345$AMGEN$$84$YR$E$F$Y$$$20240828$$CN$US$US
242580661$24258066$1$I$$20240818$20240828$20240828$EXP$$IT-AMGEN-ITASP2024167806$AMGEN$Caprioli F.; Dragoni G.; Innocenti T. et al.. Rates of Adverse Events in Patients with Ulcerative Colitis Undergoing Colectomy during Treatment with Tofacitinib vs Biologics: A Multicenter Observational Study. American Journal of Gastroenterology. 2024;119:1525-1535$$$$$Y$$$20240828$$MD$IT$IT
242580671$24258067$1$I$20240728$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170658$AMGEN$$70$YR$E$F$Y$$$20240828$$CN$US$US
242580692$24258069$2$F$20240824$20240829$20240828$20240902$PER$$US-AMGEN-USASP2024170361$AMGEN$$79$YR$E$F$Y$$$20240902$$CN$US$US
242580701$24258070$1$I$20240710$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2024-041803$AUROBINDO$$79$YR$$M$Y$98.5$KG$20240828$$MD$FR$FR
242580711$24258071$1$I$$20240816$20240828$20240828$EXP$GB-MHRA-MIDB-1545c084-217b-4f19-b690-2c2831ea5ee7$GB-ADVANZ PHARMA-202408006894$ADVANZ PHARMA$$$$$$Y$$$20240828$$PH$GB$GB
242580721$24258072$1$I$20240721$20240816$20240828$20240828$EXP$CH-SM-2024-15252$CH-ROCHE-10000060367$ROCHE$$35$YR$A$F$Y$62$KG$20240828$$PH$CH$CH
242580731$24258073$1$I$20240801$20240822$20240828$20240828$EXP$$CL-JNJFOC-20240861855$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240828$$CN$CL$CL
242580741$24258074$1$I$20240101$20240819$20240828$20240828$EXP$$US-ROCHE-10000061088$ROCHE$$64$YR$A$M$Y$45.81$KG$20240828$$CN$US$US
242580752$24258075$2$F$20240821$20240928$20240828$20240930$30DAY$$US-PFIZER INC-202400242187$PFIZER$$12$YR$$M$Y$53.52$KG$20240930$$HP$US$US
242580762$24258076$2$F$$20240917$20240828$20240920$30DAY$$GB-PFIZER INC-202400240017$PFIZER$$6$YR$$M$Y$$$20240920$$CN$GB$GB
242580773$24258077$3$F$$20240912$20240828$20240917$30DAY$$CR-PFIZER INC-PV202400111166$PFIZER$$10$YR$$M$Y$$$20240917$$HP$CR$CR
242580782$24258078$2$F$$20240928$20240828$20240930$30DAY$$US-PFIZER INC-202400239454$PFIZER$$10$YR$$M$Y$$$20240930$$CN$US$US
242580801$24258080$1$I$20240823$20240823$20240823$20240823$DIR$FDA-CDER-CTU-2024-58953$$FDA-CTU$$38$YR$$F$N$135.5$KG$20240823$N$HP$US$
242580811$24258081$1$I$20240726$20240828$20240827$20240827$DIR$FDA-CDER-CTU-2024-59089$$FDA-CTU$$39$YR$$M$N$$$20240828$N$$US$
242580823$24258082$3$F$$20240918$20240828$20240927$30DAY$$US-PFIZER INC-PV202400044593$PFIZER$$14$YR$$M$Y$41.1$KG$20240927$$MD$US$US
242580831$24258083$1$I$20240101$20240825$20240828$20240828$EXP$$CA-PFIZER INC-202400070543$PFIZER$$15$YR$$M$Y$$$20240828$$MD$CA$CA
242580862$24258086$2$F$$20240923$20240828$20240927$EXP$$CA-PFIZER INC-202400242103$PFIZER$$$$$M$Y$$$20240927$$CN$CA$CA
242580881$24258088$1$I$20240703$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59115$$FDA-CTU$$75$YR$$F$N$$$20240827$N$$US$
242580902$24258090$2$F$$20240920$20240828$20240920$30DAY$$US-PFIZER INC-202400239173$PFIZER$$13$YR$$F$Y$$$20240920$$CN$US$US
242580911$24258091$1$I$$20240816$20240828$20240828$EXP$$US-PFIZER INC-202400243576$PFIZER$$$$A$M$Y$$$20240828$$CN$US$US
242580922$24258092$2$F$$20240823$20240828$20240903$EXP$$US-PFIZER INC-PV202400110480$PFIZER$$7$YR$$M$Y$$$20240903$$MD$US$US
242580943$24258094$3$F$$20240929$20240828$20240930$30DAY$$US-PFIZER INC-202400242278$PFIZER$$7$YR$$F$Y$24.95$KG$20240930$$CN$US$US
242580951$24258095$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59079$$FDA-CTU$$67$YR$$F$N$93.89$KG$20240827$N$$US$
242580961$24258096$1$I$20240816$20240821$20240828$20240828$30DAY$$CA-PFIZER INC-202400241160$PFIZER$$8$YR$$F$Y$$$20240828$$HP$CA$CA
242580972$24258097$2$F$20240822$20240910$20240828$20240916$30DAY$$GR-PFIZER INC-PV202400111078$PFIZER$$11$YR$$F$Y$40$KG$20240916$$CN$GR$GR
242580982$24258098$2$F$$20240929$20240828$20240930$30DAY$$US-PFIZER INC-202400241366$PFIZER$$14$YR$$M$Y$$$20240930$$MD$US$US
242580993$24258099$3$F$$20240927$20240828$20240927$30DAY$$US-PFIZER INC-202400242494$PFIZER$$11$YR$$F$Y$$$20240927$$CN$US$US
242581001$24258100$1$I$$20240807$20240828$20240828$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR099353$VIIV$$$$$M$Y$$$20240828$$HP$US$US
242581031$24258103$1$I$20240301$20240823$20240828$20240828$30DAY$$GR-PFIZER INC-PV202400111076$PFIZER$$8$YR$$M$Y$22$KG$20240828$$CN$GR$GR
242581051$24258105$1$I$$20240816$20240828$20240828$30DAY$$KR-PFIZER INC-202400244386$PFIZER$$$$$$Y$$$20240828$$CN$KR$KR
242581101$24258110$1$I$20240101$20240820$20240828$20240828$EXP$FR-AFSSAPS-AM2024000628$FR-BIOCON BIOLOGICS LIMITED-BBL2024006136$BIOCON$$$$$$Y$$$20240828$$PH$FR$FR
242581111$24258111$1$I$20220129$20240828$20240828$20240828$EXP$$NVSC2022DE027446$NOVARTIS$$80$YR$$F$Y$60$KG$20240828$$HP$DE$DE
242581121$24258112$1$I$$20240826$20240828$20240828$EXP$$NVSC2024US172676$NOVARTIS$$63$YR$$M$Y$74.84$KG$20240828$$CN$US$US
242581131$24258113$1$I$20220307$20240816$20240828$20240828$EXP$$PL-AUROBINDO-AUR-APL-2024-042047$AUROBINDO$Omyla-staszewska J. A case of a 63-year-old female patient with initially inoperable advanced sigmoid and rectosigmoid junction cancer with metastases to lymph nodes and liver. Colon cancer- Case report.. 2024;1-3$63$YR$$F$Y$$$20240828$$MD$PL$PL
242581141$24258114$1$I$$20240821$20240828$20240828$EXP$$IT-ROCHE-10000063988$ROCHE$$$$$F$Y$$$20240828$$MD$IT$IT
242581151$24258115$1$I$$20240820$20240828$20240828$EXP$$JP-ROCHE-10000064268$ROCHE$$8$DEC$E$F$Y$$$20240828$$MD$JP$JP
242581161$24258116$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136233$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240828$$HP$US$US
242581171$24258117$1$I$20240803$20240803$20240828$20240828$PER$$US-CSL-2024-007243$CSL Plasma$$29$YR$$F$Y$$$20240828$$HP$US$US
242581191$24258119$1$I$$20240815$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130461$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$86.18$KG$20240828$$CN$US$US
242581201$24258120$1$I$$20240826$20240828$20240828$EXP$$US-ABBVIE-5897129$ABBVIE$$$$$M$Y$$$20240828$$HP$US$US
242581211$24258121$1$I$20240709$20240816$20240828$20240828$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000848$PAREXEL$$$$$$Y$$$20240828$$HP$CN$CN
242581221$24258122$1$I$20220201$20240814$20240828$20240828$EXP$$PL-TASMAN PHARMA, INC.-2024TSM00223$TASMAN PHARMA$Kawalec A, Cichon L, Wilczynski K, Janas-Kozik M.. First onset of persistent neutropenia in patient undergoing long-term clozapine treatment after vaccination against COVID-19 and SARS-CoV-2 infection in short interval - a case report. Psychiatr Pol. 2024;1-11$23$YR$$F$Y$$$20240828$$HP$PL$PL
242581232$24258123$2$F$$20240913$20240828$20240924$EXP$$JP-ROCHE-10000064540$ROCHE$Fukuoka N, Yoshikawa S, Hashimoto R, Kojima S, Sasaki G, Sato A et al.. 45 A case of irAE encephalitis which developed after administration of atezolizumab and bevacizumab. The 380th Regular Meeting of the Japanese Society of Gastroenterology Kanto Chap. 2024;35$78$YR$E$M$Y$$$20240924$$MD$JP$JP
242581242$24258124$2$F$$20240927$20240828$20240927$30DAY$$US-PFIZER INC-202400239519$PFIZER$$16$YR$$M$Y$$$20240927$$CN$US$US
242581262$24258126$2$F$$20240927$20240828$20240927$30DAY$$US-PFIZER INC-202400238363$PFIZER$$14$YR$$M$Y$$$20240927$$CN$US$US
242581274$24258127$4$F$$20240918$20240828$20240923$30DAY$$US-PFIZER INC-202400235980$PFIZER$$16$YR$$M$Y$63.5$KG$20240923$$CN$US$US
242581282$24258128$2$F$$20240928$20240828$20240930$30DAY$$US-PFIZER INC-202400238396$PFIZER$$14$YR$$M$Y$$$20240930$$CN$US$US
242581292$24258129$2$F$20240201$20240909$20240828$20240913$EXP$$NVSC2024MX170782$NOVARTIS$$58$YR$$F$Y$71$KG$20240913$$CN$MX$MX
242581301$24258130$1$I$20240801$20240824$20240828$20240828$EXP$$NVSC2024FR173042$NOVARTIS$$82$YR$$F$Y$$$20240828$$PH$FR$FR
242581311$24258131$1$I$20240601$20240610$20240828$20240828$PER$$US-AMGEN-USASP2024170928$AMGEN$$75$YR$E$F$Y$$$20240828$$CN$US$US
242581322$24258132$2$F$$20240826$20240828$20240831$PER$$US-AMGEN-USASP2024170083$AMGEN$$$$$F$Y$$$20240831$$PH$US$US
242581332$24258133$2$F$$20240826$20240828$20240830$PER$$US-ROCHE-10000065558$ROCHE$$54$YR$A$F$Y$$$20240830$$CN$US$US
242581342$24258134$2$F$$20240808$20240828$20240910$PER$$US-TEVA-VS-3232572$TEVA$$25$YR$$M$Y$$$20240910$$HP$US$US
242581351$24258135$1$I$$20240820$20240828$20240828$EXP$$BG-UCBSA-2024043232$UCB$Vasilev P, Viteva E. Clinical Cases Of Paradoxical Seizure Aggravation From Brivaracetam. Bulgarian Neurology. 2024;25:50-1$21$YR$$F$Y$$$20240828$$MD$BG$BG
242581372$24258137$2$F$$20240917$20240828$20240924$PER$$US-ROCHE-10000068045$ROCHE$$37$YR$A$F$Y$$$20240924$$HP$US$US
242581391$24258139$1$I$$20240822$20240828$20240828$PER$$US-ROCHE-10000064569$ROCHE$$$$A$F$Y$$$20240828$$CN$US$US
242581401$24258140$1$I$$20220711$20240828$20240828$EXP$$US-BIOCODEX2-2022000235$BIOCODEX$$11$YR$$F$Y$25.4$KG$20240827$$CN$US$US
242581411$24258141$1$I$20240613$20240822$20240828$20240828$EXP$$AU-TAKEDA-2024TUS076901$TAKEDA$$73$YR$$M$Y$$$20240828$$MD$AU$AU
242581421$24258142$1$I$$20240820$20240828$20240828$EXP$$US-RDY-LIT/USA/24/0012405$DR REDDYS$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. Journal of drugs in dermatology : JDD. 2023 Nov;22(11): e12-e16. doi:10.36849/JDD.4936.$26$YR$A$F$Y$$$20240828$$HP$US$US
242581432$24258143$2$F$$20240910$20240828$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129451$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240912$$HP$US$US
242581441$24258144$1$I$$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135201$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$106.59$KG$20240828$$HP$US$US
242581452$24258145$2$F$20240730$20240917$20240828$20240925$EXP$$US-LEO Pharma-372992$LEO PHARM$$65$YR$$M$Y$61$KG$20240925$$CN$US$US
242581462$24258146$2$F$20240101$20240910$20240828$20240917$EXP$$US-SA-2024SA247899$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240917$$MD$US$US
242581471$24258147$1$I$20240101$20240827$20240828$20240828$PER$$US-AMGEN-USASP2024171511$AMGEN$$66$YR$E$F$Y$$$20240828$$CN$US$US
242581481$24258148$1$I$20240701$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170197$AMGEN$$57$YR$A$F$Y$$$20240828$$CN$US$US
242581491$24258149$1$I$$20240817$20240828$20240828$EXP$$DE-AUROBINDO-AUR-APL-2024-042068$AUROBINDO$$17$YR$$M$Y$$$20240828$$HP$DE$DE
242581502$24258150$2$F$$20240905$20240828$20240909$EXP$$DE-ADIENNEP-2024AD000690$ADIENNE PHARMA + BIOTECH$Obermaier B, Braun C, Hensen L, Ahmad O, Faul C, Lang P et al. Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience. Transpl Infect Dis. 2024;26(4):e14296. DOI: 10.1111/tid.14296$70$YR$$$Y$$$20240905$$MD$DE$
242581511$24258151$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016223$ELI LILLY AND CO$$65$YR$E$$Y$$$20240828$$CN$US$US
242581521$24258152$1$I$20200101$20240822$20240828$20240828$EXP$$US-CHEPLA-2024011002$CHEPLAPHARM$$$$$F$Y$$$20240828$$CN$COUNTRY NOT SPECIFIED$US
242581531$24258153$1$I$$20240825$20240828$20240828$EXP$$NVSC2024US172399$NOVARTIS$$51$YR$$$Y$$$20240828$$CN$US$US
242581541$24258154$1$I$$20240821$20240828$20240828$EXP$$US-AMGEN-USASP2024169362$AMGEN$$$$C$M$Y$$$20240828$$HP$US$US
242581551$24258155$1$I$20240723$20240816$20240828$20240828$EXP$$FR-AUROBINDO-AUR-APL-2024-041879$AUROBINDO$$82$YR$$M$Y$80.1$KG$20240828$$MD$FR$FR
242581561$24258156$1$I$$20240821$20240828$20240828$EXP$$CA-CHEPLA-2024010919$CHEPLAPHARM$$60$YR$$F$Y$$$20240828$$MD$COUNTRY NOT SPECIFIED$CA
242581571$24258157$1$I$20240101$20240820$20240828$20240828$EXP$$US-SA-2024SA212198$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240828$$MD$US$US
242581581$24258158$1$I$20240101$20240821$20240828$20240828$EXP$$US-SA-2024SA250985$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240828$$MD$US$US
242581591$24258159$1$I$$20240826$20240828$20240828$EXP$$DE-SANDOZ INC.-NVSC2020DE297909$SANDOZ$$50$YR$$F$Y$$$20240828$$MD$DE$DE
242581601$24258160$1$I$$20240820$20240828$20240828$EXP$$BR-CHEPLA-2024010843$CHEPLAPHARM$$$$A$M$Y$$$20240828$$HP$COUNTRY NOT SPECIFIED$BR
242581612$24258161$2$F$$20240905$20240828$20240909$EXP$$DE-ADIENNEP-2024AD000691$ADIENNE PHARMA + BIOTECH$Obermaier B, Braun C, Hensen L, Ahmad O, Faul C, Lang P et al. Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience. Transpl Infect Dis. 2024;26(4):e14296. DOI: 10.1111/tid.14296$56$YR$$$Y$$$20240905$$MD$DE$
242581621$24258162$1$I$$20240816$20240828$20240828$EXP$$GB-AUROBINDO-AUR-APL-2024-041787$AUROBINDO$$71$YR$$M$Y$128$KG$20240828$$PH$GB$GB
242581631$24258163$1$I$$20240819$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131813$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240828$$CN$US$US
242581642$24258164$2$F$20240815$20240827$20240828$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135884$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240829$$PH$US$US
242581661$24258166$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59074$$FDA-CTU$$63$YR$$M$N$$$20240827$N$$US$
242581671$24258167$1$I$20240208$20240824$20240824$20240824$DIR$FDA-CDER-CTU-2024-58976$$FDA-CTU$$24$YR$$F$N$52.16$KG$20240824$N$CN$US$
242581681$24258168$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59098$$FDA-CTU$$5$YR$$F$N$$$20240827$N$$US$
242581691$24258169$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5893931$ABBVIE$$23$YR$$F$Y$$$20240828$$HP$US$US
242581711$24258171$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59101$$FDA-CTU$$75$YR$$F$N$$$20240827$N$$US$
242581731$24258173$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59068$$FDA-CTU$$68$YR$$F$N$53.98$KG$20240827$N$$US$
242581741$24258174$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59069$$FDA-CTU$$65$YR$$F$N$$$20240827$N$$US$
242581761$24258176$1$I$$20240819$20240828$20240828$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006134$BIOCON$$$$$$Y$$$20240828$$HP$CA$CA
242581781$24258178$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59091$$FDA-CTU$$43$YR$$M$N$$$20240827$N$$US$
242581791$24258179$1$I$20240822$20240825$20240825$20240825$DIR$FDA-CDER-CTU-2024-58982$$FDA-CTU$$36$YR$$F$N$177$LBS$20240825$N$CN$US$
242581801$24258180$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59108$$FDA-CTU$$69$YR$$F$N$$$20240827$N$$US$
242581811$24258181$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59092$$FDA-CTU$$79$YR$$F$N$$$20240827$N$$US$
242581821$24258182$1$I$$20240805$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004369$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242581831$24258183$1$I$$20240819$20240828$20240828$EXP$$CA-ROCHE-10000061296$ROCHE$$76$YR$E$F$Y$102$KG$20240828$$HP$CA$CA
242581841$24258184$1$I$$20240822$20240828$20240828$EXP$$SE-MYLANLABS-2024M1079226$MYLAN$Glimelius B, Khan T, Adolfsson K, Angenete E, Berglund A, Bonde K, et al. Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US). EClinicalMedicine 2024; 75.$61$YR$$M$Y$$$20240828$$HP$SE$SE
242581861$24258186$1$I$20210501$20240822$20240828$20240828$EXP$FR-AFSSAPS-AN20211823$FR-RDY-SPO/FRA/23/0182064$DR REDDYS$$71$YR$E$M$Y$$$20240828$$MD$FR$FR
242581871$24258187$1$I$$20240823$20240828$20240828$PER$$US-ROCHE-10000008445$ROCHE$Song E,  Case Report: Approaches for managing resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplantation recipients. Frontiers in Pediatrics. 2024;12: doi:10.3389/fped.2024.1394006.$12$YR$T$M$Y$$$20240828$$HP$US$US
242581881$24258188$1$I$$20240820$20240828$20240828$EXP$$CA-TEVA-VS-3235178$TEVA$$14$YR$$M$Y$$$20240828$$HP$CA$CA
242581891$24258189$1$I$20240805$20240822$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133841$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$63.5$KG$20240828$$CN$US$US
242581901$24258190$1$I$$20240822$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134556$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240828$$CN$US$US
242581911$24258191$1$I$20240723$20240816$20240828$20240828$EXP$$IT-AUROBINDO-AUR-APL-2024-041725$AUROBINDO$$76$YR$$F$Y$$$20240828$$MD$IT$IT
242581932$24258193$2$F$20130201$20240902$20240828$20240903$EXP$GB-MHRA-MED-202408271105123500-BTHWR$GB-MYLANLABS-2024M1079108$MYLAN$$41$YR$$M$Y$92$KG$20240903$$CN$GB$GB
242581941$24258194$1$I$$20240823$20240828$20240828$EXP$$PT-MYLANLABS-2024M1078911$MYLAN$Juliao M, Ulrich J, Calaveiras P, Costa E, Lucas I, Faria de SousaP. Ketamine subcutaneous continuous infusion for non-cancer neuropathic pain at home: a case report. BMJ-Support-Palliat-Care 2023; 13 (3): e902-e907.$94$YR$$F$Y$$$20240828$$HP$PT$PT
242581961$24258196$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004370$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$HP$US$US
242581972$24258197$2$F$20240820$20240905$20240828$20240907$PER$$US-AMGEN-USASP2024170050$AMGEN$$75$YR$E$F$Y$$$20240907$$CN$US$US
242581982$24258198$2$F$$20240828$20240828$20240830$PER$$US-AMGEN-USASP2024169203$AMGEN$$$$$$Y$$$20240830$$CN$US$US
242582001$24258200$1$I$20240809$20240819$20240828$20240828$EXP$CN-NMPACDR-5001061005066202400573$CN-BAXTER-2024BAX023533$BAXTER$$19$YR$$M$Y$51.5$KG$20240828$$MD$CN$CN
242582011$24258201$1$I$$20240826$20240828$20240828$EXP$$US-GILEAD-2024-0685482$GILEAD$$$$E$F$Y$$$20240828$$CN$US$US
242582031$24258203$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59120$$FDA-CTU$$70$YR$$M$N$192$LBS$20240827$N$$US$
242582042$24258204$2$F$20231121$20240829$20240828$20240830$EXP$$JP-BAYER-2024A122509$BAYER$$45$YR$A$M$Y$$$20240830$$MD$JP$JP
242582051$24258205$1$I$20240607$20240823$20240828$20240828$EXP$$US-AMERICAN REGENT INC-2024003252$AMERICAN REGENT$$51$YR$$M$Y$86$KG$20240828$$HP$US$US
242582061$24258206$1$I$20240117$20240817$20240828$20240828$EXP$$JP-EMD Serono-2024044976$EMD SERONO INC$$76$YR$E$F$Y$50$KG$20240828$$MD$JP$JP
242582071$24258207$1$I$20240821$20240825$20240825$20240825$DIR$FDA-CDER-CTU-2024-58984$$FDA-CTU$$62$YR$$F$N$203$LBS$20240825$N$HP$US$
242582081$24258208$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59081$$FDA-CTU$$55$YR$$F$N$$$20240827$N$$US$
242582091$24258209$1$I$20230515$20240805$20240828$20240828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004371$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240828$$CN$US$US
242582101$24258210$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59085$$FDA-CTU$$80$YR$$F$N$$$20240827$N$$US$
242582111$24258211$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59104$$FDA-CTU$$43$YR$$M$N$108.86$KG$20240827$N$HP$US$
242582121$24258212$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59082$$FDA-CTU$$78$YR$$M$N$$$20240827$N$$US$
242582131$24258213$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59103$$FDA-CTU$$62$YR$$F$N$$$20240827$N$$US$
242582141$24258214$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59073$$FDA-CTU$$64$YR$$F$N$$$20240827$N$$US$
242582151$24258215$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59121$$FDA-CTU$$73$YR$$F$N$$$20240827$N$$US$
242582161$24258216$1$I$$20240822$20240828$20240828$EXP$$GB-009507513-2408GBR008866$MERCK$$44$YR$$F$Y$$$20240828$$CN$GB$GB
242582171$24258217$1$I$$20240826$20240828$20240828$PER$$US-TAKEDA-2024TUS086318$TAKEDA$$22$YR$$M$Y$32$KG$20240828$$MD$US$US
242582181$24258218$1$I$20240827$20240827$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048155$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240828$$CN$US$US
242582191$24258219$1$I$$20240819$20240828$20240828$EXP$$JP-ROCHE-10000064887$ROCHE$Tsunoda A, Sukeno K, Oka H, Tono Y, Saito K, Yamada K et al.. PS4-5 A case of carcinoma of unknown primary in which acute myocarditis developed as a complication during use of immune checkpoint inhibitors. The 7th Annual Meeting of the Japanese Onco-cardiology Society. 2024;117$79$YR$E$M$Y$$$20240828$$MD$JP$JP
242582201$24258220$1$I$$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136428$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240828$$CN$US$US
242582211$24258221$1$I$20240808$20240819$20240828$20240828$EXP$CN-NMPACDR-3601031026240202400878$CN-BAXTER-2024BAX023522$BAXTER$$64$YR$$F$Y$49$KG$20240828$$MD$CN$CN
242582221$24258222$1$I$$20240819$20240828$20240828$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07991$HIKMA$$$$$F$Y$$$20240828$$CN$US$US
242582231$24258223$1$I$$20240826$20240828$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013522$JAZZ$$$$$$Y$$$20240828$$HP$US$US
242582241$24258224$1$I$20240726$20240826$20240828$20240828$EXP$$CN-BAYER-2024A122640$BAYER$$61$YR$A$M$Y$64$KG$20240828$$HP$CN$CN
242582261$24258226$1$I$20240809$20240822$20240828$20240828$EXP$$US-EXELIXIS-CABO-24080773$EXELIXIS$$57$YR$$M$Y$$$20240828$$CN$US$US
242582271$24258227$1$I$$20240818$20240828$20240828$EXP$$US-GSK-US2024103294$GLAXOSMITHKLINE$$$$$M$Y$$$20240828$$CN$US$US
242582281$24258228$1$I$20240813$20240821$20240828$20240828$EXP$CN-NMPACDR-4301011002666202400496$CN-BAXTER-2024BAX023678$BAXTER$$48$YR$$F$Y$55$KG$20240828$$MD$CN$CN
242582291$24258229$1$I$20240501$20240820$20240828$20240828$EXP$$DE-EXELIXIS-XL18424078719$EXELIXIS$$$$$$Y$$$20240828$$MD$DE$DE
242582301$24258230$1$I$$20240823$20240828$20240828$EXP$$US-TAKEDA-US201843569$TAKEDA$$$$$F$Y$$$20240828$$HP$US$US
242582311$24258231$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015620$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240828$$CN$US$US
242582322$24258232$2$F$20240820$20240822$20240828$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408013755$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240829$$CN$US$US
242582331$24258233$1$I$$20240819$20240828$20240828$EXP$$JP-009507513-2408JPN002447J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$97$YR$$F$Y$$$20240828$$MD$JP$JP
242582341$24258234$1$I$20240101$20240827$20240828$20240828$EXP$$US-UCBSA-2024043573$UCB$$$$$F$Y$$$20240828$$CN$US$US
242582351$24258235$1$I$20240819$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015445$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240828$$CN$US$US
242582361$24258236$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016540$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240828$$CN$US$US
242582371$24258237$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015940$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240828$$CN$US$US
242582381$24258238$1$I$20240815$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-59007$$FDA-CTU$$79$YR$$F$N$39.6$KG$20240826$N$HP$US$
242582393$24258239$3$F$$20240827$20240828$20240906$EXP$$ZA-ROCHE-10000063529$ROCHE$$$$E$F$Y$$$20240906$$MD$ZA$ZA
242582401$24258240$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59100$$FDA-CTU$$$$$F$N$$$20240827$N$HP$US$
242582411$24258241$1$I$20240818$20240823$20240827$20240827$DIR$FDA-CDER-CTU-2024-59119$$FDA-CTU$$73$YR$$F$N$$$20240823$N$HP$US$
242582421$24258242$1$I$$20240806$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07943$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242582431$24258243$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-087166-2024$RECKITT BENCKISER$$57$YR$$F$Y$$$20240828$$CN$US$US
242582441$24258244$1$I$$20240819$20240828$20240828$EXP$$AU-TEVA-VS-3235905$TEVA$$$$$F$Y$$$20240828$$HP$AU$AU
242582451$24258245$1$I$$20240819$20240828$20240828$EXP$$JP-ROCHE-10000066141$ROCHE$Yoshino Y, Nakamura Y, Ogawa H, Yamamoto Y. P3-4 A case of large hepatocellular carcinoma with repeated intraparenchymal tumor hemorrhage during atezolizumab and bevacizumab treatment. The 60th Annual Meeting of Japan Liver Cancer Association. 2024;170.$8$DEC$E$M$Y$$$20240828$$MD$JP$JP
242582461$24258246$1$I$$20240815$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130816$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$PH$US$US
242582471$24258247$1$I$20240819$20240819$20240828$20240828$EXP$GB-MHRA-MED-202408191518260150-GMTBK$GB-TEVA-VS-3235431$TEVA$$74$YR$$F$Y$$$20240828$$PH$GB$GB
242582481$24258248$1$I$20240424$20240826$20240828$20240828$EXP$$CO-UCBSA-2024043588$UCB$$54$YR$$M$Y$$$20240828$$CN$CO$CO
242582491$24258249$1$I$$20240819$20240828$20240828$EXP$$AU-TEVA-VS-3235926$TEVA$$$$$$Y$$$20240828$$HP$AU$AU
242582501$24258250$1$I$$20240819$20240828$20240828$EXP$$AU-TEVA-VS-3236368$TEVA$$$$$M$Y$$$20240828$$HP$AU$AU
242582511$24258251$1$I$$20240823$20240828$20240828$EXP$$GB-MYLANLABS-2024M1079061$MYLAN$$$$$M$Y$$$20240828$$HP$GB$GB
242582522$24258252$2$F$$20240826$20240828$20240905$EXP$$US-MYLANLABS-2024M1079132$MYLAN$$34$YR$$F$Y$$$20240905$$CN$US$US
242582531$24258253$1$I$$20240814$20240828$20240828$EXP$$NVSC2024CA173127$NOVARTIS$$3$YR$$F$Y$$$20240828$$HP$CA$CA
242582541$24258254$1$I$$20240820$20240828$20240828$EXP$$CA-TEVA-VS-3235181$TEVA$$65$YR$$F$Y$$$20240828$$HP$CA$CA
242582551$24258255$1$I$$20240826$20240828$20240828$PER$$US-BIOVITRUM-2024-US-011361$BIOVITRUM$$84$YR$$F$Y$$$20240828$$HP$US$US
242582562$24258256$2$F$$20240903$20240828$20240904$PER$$US-AMGEN-USASP2024170488$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242582571$24258257$1$I$20240823$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169327$AMGEN$$77$YR$E$F$Y$$$20240828$$CN$US$US
242582591$24258259$1$I$20240615$20240823$20240828$20240828$EXP$FR-AFSSAPS-LL2024001531$FR-GILEAD-2024-0685171$GILEAD$$64$YR$A$F$Y$66$KG$20240828$$MD$FR$FR
242582601$24258260$1$I$20240716$20240823$20240828$20240828$EXP$$FR-AMERICAN REGENT INC-2024003256$AMERICAN REGENT$$21$YR$$F$Y$73$KG$20240828$$PH$FR$FR
242582611$24258261$1$I$20240815$20240817$20240828$20240828$EXP$GB-MHRA-MED-202408171833329030-DZBNT$GB-ADVANZ PHARMA-202408006898$ADVANZ PHARMA$$$$$$Y$$$20240828$$CN$GB$GB
242582621$24258262$1$I$$20240816$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008649$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242582631$24258263$1$I$$20240823$20240828$20240828$PER$$US-ROCHE-10000065346$ROCHE$$$$$$Y$$$20240828$$CN$US$US
242582641$24258264$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59125$$FDA-CTU$$67$YR$$M$N$$$20240827$N$$US$
242582651$24258265$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59122$$FDA-CTU$$73$YR$$F$N$$$20240827$N$$US$
242582681$24258268$1$I$20240821$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-59086$$FDA-CTU$$58$YR$$F$N$$$20240826$N$HP$US$
242582691$24258269$1$I$20240826$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-59055$$FDA-CTU$$23$YR$$F$N$104.33$KG$20240826$Y$CN$US$
242582701$24258270$1$I$20240301$20240822$20240828$20240828$EXP$$NVSC2024MX155945$NOVARTIS$$67$YR$$F$Y$45$KG$20240828$$CN$MX$MX
242582731$24258273$1$I$$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-59066$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242582751$24258275$1$I$$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134884$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240828$$CN$US$US
242582761$24258276$1$I$$20240826$20240826$20240826$DIR$FDA-CDER-CTU-2024-58994$$FDA-CTU$$30$YR$$F$N$89.58$KG$20240826$Y$$US$
242582771$24258277$1$I$$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131947$BRISTOL MYERS SQUIBB$Pitter D, Mejico L, Latorre JG, Cuello-Oderiz C. New-onset refractory status epilepticus (NORSE) as a recurrence of anti-neuronal nuclear antibody 2 (ANNA-2) encephalitis after immune checkpoint inhibition therapy. Cureus. 2021 Jun 30;13(6):1-5. doi:10.7759/cureus.16074.$69$YR$E$F$Y$$$20240828$$HP$US$US
242582782$24258278$2$F$$20240826$20240828$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004373$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
242582792$24258279$2$F$20240822$20240919$20240828$20240925$EXP$$GB-MYLANLABS-2024M1078630$MYLAN$$$$$M$Y$$$20240925$$PH$GB$GB
242582811$24258281$1$I$$20240805$20240828$20240828$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004374$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242582823$24258282$3$F$$20240829$20240828$20240910$30DAY$$CR-JNJFOC-20240838694$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$PH$CR$CR
242582831$24258283$1$I$20240727$20240815$20240828$20240828$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024101903$VIIV$$58$YR$$M$Y$$$20240828$$CN$US$US
242582841$24258284$1$I$20240101$20240826$20240828$20240828$EXP$$NVSC2024SG172731$NOVARTIS$$43$YR$$F$Y$$$20240828$$MD$SG$SG
242582851$24258285$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-087164-2024$RECKITT BENCKISER$$71$YR$$M$Y$$$20240828$$CN$US$US
242582861$24258286$1$I$$20240819$20240828$20240828$EXP$$JP-009507513-2408JPN002475J$MERCK$Hirata T, Oji A.. [Observational Study on the Efficacy and Safety of Molnupiravir and Ensitrelvir Fumaric Acid in Outpatients with Mild to Moderate COVID-19 in Clinical Practice]. The Journal of the Japan Medical Association. 2024;153(4):445-8$84$YR$$M$Y$$$20240828$$MD$JP$JP
242582871$24258287$1$I$$20240823$20240828$20240828$EXP$$CA-LUNDBECK-DKLU4003455$LUNDBECK$$$$$$Y$$$20240828$$CN$CA$CA
242582881$24258288$1$I$$20240827$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136663$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240828$$CN$US$US
242582891$24258289$1$I$$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135789$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240828$$CN$US$US
242582902$24258290$2$F$$20240911$20240828$20240912$PER$$US-ALXN-202408USA001602US$ALEXION PHARMACEUTICALS$$$$A$M$Y$$$20240912$$MD$US$US
242582911$24258291$1$I$20240630$20240822$20240828$20240828$EXP$$CN-PFIZER INC-PV202400109968$PFIZER$$46$YR$$M$Y$55$KG$20240828$$HP$CN$CN
242582922$24258292$2$F$$20240902$20240828$20240906$EXP$$PL-PFIZER INC-202400243707$PFIZER$Miskiewicz?Bujna, J.. Successful hematopoietic stem cell transplantation in MYH9-related congenital thrombocytopenia. Pediatric Blood + Cancer. 2024;71 (9):1-2$24$MON$$M$Y$$$20240906$$HP$PL$PL
242582931$24258293$1$I$$20240820$20240828$20240828$EXP$$BR-PFIZER INC-PV202400110381$PFIZER$$31$YR$$F$Y$$$20240828$$CN$BR$BR
242582942$24258294$2$F$20240417$20240823$20240828$20240830$EXP$$CN-DSJP-DSJ-2024-118803$DAIICHI$$5$DEC$$F$Y$61.6$KG$20240830$$MD$CN$CN
242582951$24258295$1$I$$20240821$20240828$20240828$EXP$$CN-PFIZER INC-PV202400109917$PFIZER$Chen, A.. Sweet Syndrome Concurrent with Erythema Nodosum: A Case Report. The Chinese Journal of Dermatovenereology. 2024;38(8):911-915$55$YR$$M$Y$$$20240828$$HP$CN$CN
242582972$24258297$2$F$20231129$20240828$20240828$20240902$EXP$$CA-PFIZER INC-202300319245$PFIZER$$28$YR$$F$Y$58$KG$20240902$$MD$CA$CA
242582982$24258298$2$F$20240731$20240827$20240828$20240902$EXP$FR-AFSSAPS-PB2024000882$FR-PFIZER INC-202400241698$PFIZER$$58$YR$$F$Y$$$20240902$$MD$FR$FR
242582992$24258299$2$F$$20240827$20240828$20240903$EXP$$US-PFIZER INC-202400243681$PFIZER$Kim, K.. Finding the Balance: Venous Thromboembolism Prophylaxis during Hematochezia in Crohn^s Disease. Case Reports in Gastroenterology. 2024;18(1):367-372$39$YR$$F$Y$$$20240903$$MD$US$US
242583001$24258300$1$I$20240708$20240822$20240828$20240828$EXP$FR-AFSSAPS-LM2024000468$FR-PFIZER INC-202400241647$PFIZER$$68$YR$$M$Y$59.7$KG$20240828$$MD$FR$FR
242583012$24258301$2$F$$20240826$20240828$20240830$EXP$$CN-PFIZER INC-202400243201$PFIZER$Liu, Y.. Four cases of refractory hyponatremia caused by secondary adrenal cortical insufficiency after chemotherapy in children with tumours of lymphoid hematopoietic system. Chinese Journal of Applied Clinical Pediatrics. 2024;39(8):605-608$4$YR$$M$Y$$$20240830$$MD$CN$CN
242583022$24258302$2$F$$20240830$20240828$20240904$EXP$$US-LUNDBECK-DKLU4003421$LUNDBECK$$$$$$Y$$$20240904$$CN$US$US
242583031$24258303$1$I$$20240822$20240828$20240828$PER$$US-LEO Pharma-372980$LEO PHARM$$22$YR$$M$Y$$$20240828$$MD$US$US
242583041$24258304$1$I$20231227$20240823$20240828$20240828$EXP$$JP-Eisai-EC-2024-164705$EISAI$Ichikawa Y. Slide Review at Gynecologic Cancer Seminar from Shizuoka.$76$YR$E$F$Y$$$20240828$$MD$JP$JP
242583051$24258305$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170812$AMGEN$$$$$M$Y$$$20240828$$HP$US$US
242583061$24258306$1$I$$20240819$20240828$20240828$EXP$$SE-TEVA-VS-3237119$TEVA$$$$$F$Y$$$20240828$$HP$SE$SE
242583071$24258307$1$I$20240703$20240821$20240828$20240828$EXP$$CN-ROCHE-10000063330$ROCHE$$31$YR$A$F$Y$56$KG$20240828$$HP$CN$CN
242583081$24258308$1$I$$20240827$20240828$20240828$PER$$US-HALEON-2193844$Haleon PLC$$$$$$Y$$$20240828$$CN$US$US
242583091$24258309$1$I$$20240822$20240828$20240828$PER$$US-ABBVIE-5893864$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242583101$24258310$1$I$$20240816$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008650$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242583111$24258311$1$I$20220101$20240819$20240828$20240828$EXP$PL-EMA-DD-20240301-7482655-074919$PL-Pharmaxis-001229$PHARMAXIS$$$$E$M$Y$$$20240821$$MD$PL$PL
242583121$24258312$1$I$20240701$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136066$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240828$$HP$US$US
242583132$24258313$2$F$20240101$20240903$20240828$20240917$EXP$$JP-INSMED, INC.-2024-03395-JP$INSMED$$71$YR$$F$Y$$$20240917$$CN$JP$JP
242583141$24258314$1$I$$20240816$20240828$20240828$PER$$US-MYLANLABS-2024M1078346$MYLAN$$$$$F$Y$$$20240828$$HP$US$US
242583161$24258316$1$I$$20240819$20240828$20240828$EXP$CA-NOVARTIS PHARMA S.A.-NVSC2024CA170815$CA-AMGEN-CANSP2024169667$AMGEN$$43$YR$A$F$Y$96$KG$20240828$$HP$CA$CA
242583171$24258317$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59087$$FDA-CTU$$75$YR$$F$N$130$LBS$20240827$N$$US$
242583181$24258318$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59075$$FDA-CTU$$58$YR$$M$N$125.19$KG$20240827$N$$US$
242583191$24258319$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59093$$FDA-CTU$$39$YR$$M$N$$$20240827$N$$US$
242583213$24258321$3$F$$20240924$20240828$20240927$EXP$$DE-SANDOZ INC.-SDZ2024DE075547$SANDOZ$$80$YR$$M$Y$69$KG$20240927$$HP$DE$DE
242583221$24258322$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016030$ELI LILLY AND CO$$$$A$F$Y$$$20240828$$CN$US$US
242583231$24258323$1$I$$20240820$20240828$20240828$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16823$IPSEN$$28$YR$A$F$Y$$$20240828$$CN$US$US
242583241$24258324$1$I$$20240815$20240828$20240828$PER$$US-JNJFOC-20240842570$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$CN$US$US
242583251$24258325$1$I$$20240823$20240828$20240828$PER$$US-JNJFOC-20240862084$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$MD$US$US
242583261$24258326$1$I$20240223$20240820$20240828$20240828$EXP$IT-MINISAL02-999027$IT-ROCHE-10000061520$ROCHE$$53$YR$A$F$Y$$$20240828$$MD$IT$IT
242583271$24258327$1$I$$20240722$20240828$20240828$EXP$$PH-ROCHE-10000066486$ROCHE$$$$$$Y$$$20240828$$CN$PH$PH
242583281$24258328$1$I$20240101$20240816$20240828$20240828$EXP$$RU-SERVIER-S24010543$SERVIER$$$$$$Y$$$20240828$$MD$RU$RU
242583291$24258329$1$I$$20240821$20240828$20240828$EXP$$CA-GSK-CA2019AMR225693$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$CA$CA
242583301$24258330$1$I$20240809$20240820$20240828$20240828$30DAY$$US-GSK-US2024103903$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240828$$CN$US$US
242583311$24258331$1$I$20240101$20240808$20240828$20240828$PER$$US-TEVA-VS-3231460$TEVA$$57$YR$$F$Y$$$20240828$$CN$US$US
242583321$24258332$1$I$$20240826$20240828$20240828$EXP$$US-BAYER-2024A122988$BAYER$$42$YR$A$M$Y$$$20240828$$HP$US$US
242583331$24258333$1$I$$20240815$20240828$20240828$PER$$US-ABBVIE-5894356$ABBVIE$$34$YR$$F$Y$116$KG$20240828$$HP$US$US
242583341$24258334$1$I$$20230907$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2021-VEL-00727$VELOXIS PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242583361$24258336$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00675$GLAND PHARMA$$$$$M$Y$$$20240828$$CN$US$US
242583371$24258337$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59077$$FDA-CTU$$64$YR$$F$N$$$20240827$N$$US$
242583381$24258338$1$I$20240729$20240803$20240828$20240828$PER$$US-CSL-2024-007325$CSL Plasma$$59$YR$$F$Y$$$20240828$$HP$US$US
242583391$24258339$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-081668-2024$RECKITT BENCKISER$$$$$$Y$$$20240828$$CN$US$US
242583401$24258340$1$I$20240601$20240826$20240828$20240828$EXP$$US-ABBVIE-5896748$ABBVIE$$64$YR$$M$Y$$$20240828$$CN$US$US
242583421$24258342$1$I$$20240821$20240828$20240828$PER$$US-PFIZER INC-PV202400090139$PFIZER$$36$YR$$F$Y$$$20240828$$CN$US$US
242583431$24258343$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-202200571882$PFIZER$$68$YR$$F$Y$61.23$KG$20240828$$MD$US$US
242583441$24258344$1$I$20231001$20240822$20240828$20240828$PER$$US-PFIZER INC-202400242454$PFIZER$$$$T$M$Y$$$20240828$$MD$US$US
242583451$24258345$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-202400242474$PFIZER$$65$YR$$M$Y$$$20240828$$HP$US$US
242583461$24258346$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-202400242304$PFIZER$$1$YR$$M$Y$$$20240828$$CN$US$US
242583471$24258347$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-202400243836$PFIZER$$$$A$$Y$$$20240828$$CN$US$US
242583481$24258348$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-PV202400109954$PFIZER$$$$A$$Y$$$20240828$$CN$US$US
242583491$24258349$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-PV202400110240$PFIZER$$69$YR$$F$Y$$$20240828$$HP$US$US
242583501$24258350$1$I$$20240821$20240828$20240828$PER$$US-PFIZER INC-202400242173$PFIZER$$68$YR$$F$Y$$$20240828$$CN$US$US
242583511$24258351$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-PV202400075174$PFIZER$$62$YR$$F$Y$83.01$KG$20240828$$CN$US$US
242583521$24258352$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-202400242138$PFIZER$$$$$M$Y$$$20240828$$PH$US$US
242583541$24258354$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-PV202400110251$PFIZER$$74$YR$$M$Y$$$20240828$$CN$US$US
242583551$24258355$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-PV202400110340$PFIZER$$12$YR$$$Y$$$20240828$$MD$US$US
242583563$24258356$3$F$$20240927$20240828$20240927$PER$$US-PFIZER INC-202400242519$PFIZER$$69$YR$$M$Y$$$20240927$$HP$US$US
242583571$24258357$1$I$$20240827$20240828$20240828$PER$$US-BAYER-2024A122982$BAYER$$$$$F$Y$$$20240828$$CN$US$US
242583591$24258359$1$I$20240821$20240821$20240828$20240828$EXP$$AU-GE HEALTHCARE-2024CSU009616$GE HEALTHCARE$$71$YR$$F$Y$$$20240828$$HP$AU$AU
242583602$24258360$2$F$20240815$20240828$20240828$20240906$EXP$$BR-CELLTRION INC.-2024BR020359$CELLTRION$$$$$$Y$$$20240906$$CN$BR$BR
242583611$24258361$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-104303-2023$RECKITT BENCKISER$$$$$M$Y$$$20240828$$CN$US$US
242583621$24258362$1$I$20231201$20240816$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008645$INCYTE$$$$$$Y$$$20240828$$HP$US$US
242583631$24258363$1$I$20240827$20240827$20240828$20240828$EXP$$JP-BAYER-2024A123221$BAYER$$$$$$Y$$$20240828$$MD$JP$JP
242583641$24258364$1$I$$20240816$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008644$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242583651$24258365$1$I$20240101$20240820$20240828$20240828$PER$$US-BAYER-2024A120851$BAYER$$28$YR$A$F$Y$66.032$KG$20240828$$CN$US$US
242583671$24258367$1$I$20220306$20240823$20240828$20240828$EXP$FR-AFSSAPS-MA2024001379$FR-GILEAD-2024-0685186$GILEAD$$33$YR$A$F$Y$$$20240828$$HP$FR$FR
242583681$24258368$1$I$$20240816$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008641$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242583691$24258369$1$I$20240616$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170329$AMGEN$$62$YR$A$F$Y$$$20240828$$CN$US$US
242583701$24258370$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00683$GLAND PHARMA$$$$$M$Y$$$20240828$$CN$US$US
242583721$24258372$1$I$20240822$20240823$20240828$20240828$PER$$US-PFIZER INC-202400243320$PFIZER$$$$E$F$Y$$$20240828$$CN$US$US
242583731$24258373$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-202400242132$PFIZER$$14$YR$$M$Y$$$20240828$$MD$US$US
242583741$24258374$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-PV202400111174$PFIZER$$$$$F$Y$$$20240828$$CN$US$US
242583751$24258375$1$I$$20240729$20240828$20240828$PER$$US-009507513-2407USA015077$MERCK$$$$$F$Y$49.9$KG$20240828$$CN$US$US
242583761$24258376$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-PV202400110110$PFIZER$$56$YR$$F$Y$$$20240828$$CN$US$US
242583771$24258377$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-202400242069$PFIZER$$66$YR$$F$Y$$$20240828$$CN$US$US
242583782$24258378$2$F$$20240826$20240828$20240829$PER$$US-PFIZER INC-PV202400078647$PFIZER$$76$YR$$F$Y$$$20240829$$HP$US$US
242583791$24258379$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-202400242973$PFIZER$$69$YR$$F$Y$$$20240828$$HP$US$US
242583801$24258380$1$I$20240819$20240823$20240828$20240828$PER$$US-PFIZER INC-202400243341$PFIZER$$56$YR$$F$Y$$$20240828$$CN$US$US
242583811$24258381$1$I$20240101$20240823$20240828$20240828$PER$$US-PFIZER INC-202400242845$PFIZER$$$$$M$Y$$$20240828$$CN$US$US
242583821$24258382$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-202400242995$PFIZER$$76$YR$$F$Y$$$20240828$$MD$US$US
242583831$24258383$1$I$20230101$20240822$20240828$20240828$PER$$US-PFIZER INC-202400242245$PFIZER$$73$YR$$M$Y$$$20240828$$MD$US$US
242583841$24258384$1$I$$20240818$20240828$20240828$EXP$$SA-JNJFOC-20240847002$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$HP$SA$SA
242583851$24258385$1$I$20240322$20240808$20240828$20240828$PER$$US-JNJFOC-20240822701$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240828$$CN$US$US
242583861$24258386$1$I$20240326$20240823$20240828$20240828$EXP$$AR-JNJFOC-20240490435$JOHNSON AND JOHNSON$$74$YR$E$F$Y$54$KG$20240828$$CN$AR$AR
242583871$24258387$1$I$20240101$20240822$20240828$20240828$EXP$$BR-JNJFOC-20240823143$JOHNSON AND JOHNSON$$18$YR$A$M$Y$33$KG$20240828$$CN$BR$BR
242583882$24258388$2$F$20240515$20240831$20240828$20240903$EXP$$IT-JNJFOC-20240713963$JOHNSON AND JOHNSON$$78$YR$E$M$Y$70$KG$20240903$$HP$IT$IT
242583891$24258389$1$I$$20240816$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008633$INCYTE$$$$$$Y$$$20240828$$HP$US$US
242583901$24258390$1$I$$20240822$20240828$20240828$30DAY$$US-GSK-US2024AMR105431$GLAXOSMITHKLINE$$$$$M$Y$$$20240828$$CN$US$US
242583911$24258391$1$I$$20240822$20240828$20240828$EXP$$CA-GSK-CA2024042018$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$CA$CA
242583932$24258393$2$F$20240104$20240822$20240828$20240829$PER$$US-ALXN-202408USA001580US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240829$$HP$US$US
242583941$24258394$1$I$20240822$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024169560$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242583952$24258395$2$F$20240826$20240826$20240828$20240901$PER$$US-AMGEN-USASP2024170623$AMGEN$$65$YR$E$M$Y$$$20240901$$CN$US$US
242583961$24258396$1$I$20240824$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170363$AMGEN$$$$$$Y$$$20240828$$PH$US$US
242583972$24258397$2$F$20240824$20240912$20240828$20240913$PER$$US-AMGEN-USASP2024170387$AMGEN$$70$YR$E$F$Y$$$20240912$$CN$US$US
242583982$24258398$2$F$20240820$20240830$20240828$20240904$EXP$$JP-AMGEN-JPNSP2024169760$AMGEN$$71$YR$E$F$Y$$$20240904$$PH$JP$JP
242583991$24258399$1$I$$20240820$20240828$20240828$EXP$$ID-AstraZeneca-2024A193078$ASTRAZENECA$$$$$M$Y$70$KG$20240828$$MD$ID$
242584001$24258400$1$I$20240701$20240820$20240828$20240828$EXP$$JP-AstraZeneca-2024A190774$ASTRAZENECA$$$$A$M$Y$$$20240828$$MD$JP$
242584011$24258401$1$I$$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A193533$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242584022$24258402$2$F$20240805$20240826$20240828$20240905$PER$$US-AstraZeneca-2024A177710$ASTRAZENECA$$25738$DY$$F$Y$$$20240905$$CN$US$
242584031$24258403$1$I$$20240815$20240828$20240828$PER$$US-AstraZeneca-2024A188081$ASTRAZENECA$$$$$F$Y$$$20240828$$PH$US$
242584041$24258404$1$I$$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A193489$ASTRAZENECA$$$$$$Y$$$20240828$$CN$US$
242584051$24258405$1$I$$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A193357$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242584062$24258406$2$F$$20240916$20240828$20240918$PER$$US-AstraZeneca-2024A193133$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
242584071$24258407$1$I$$20240823$20240828$20240828$EXP$$RO-AstraZeneca-2024A193001$ASTRAZENECA$$$$$M$Y$$$20240828$$MD$RO$
242584081$24258408$1$I$20240815$20240820$20240828$20240828$EXP$$ZA-AstraZeneca-2024A191459$ASTRAZENECA$$77$YR$$F$Y$$$20240828$$CN$ZA$
242584092$24258409$2$F$20240512$20240826$20240828$20240903$PER$$US-AstraZeneca-2024A149539$ASTRAZENECA$$28310$DY$$F$Y$$$20240903$$HP$US$
242584101$24258410$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190226$ASTRAZENECA$$$$$F$Y$$$20240828$$HP$US$
242584111$24258411$1$I$20240822$20240823$20240828$20240828$EXP$$CA-AstraZeneca-2024A193776$ASTRAZENECA$$22443$DY$$F$Y$$$20240828$$CN$CA$
242584121$24258412$1$I$$20240820$20240828$20240828$EXP$$JP-AstraZeneca-2024A190766$ASTRAZENECA$$$$E$F$Y$$$20240828$$MD$JP$
242584131$24258413$1$I$$20240802$20240828$20240828$PER$$US-AstraZeneca-2024A176525$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242584141$24258414$1$I$20240805$20240822$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110063$PFIZER$$68$YR$$M$Y$66$KG$20240828$$HP$CN$CN
242584151$24258415$1$I$20240819$20240822$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110060$PFIZER$$64$YR$$M$Y$80$KG$20240828$$HP$CN$CN
242584161$24258416$1$I$$20230526$20240828$20240828$EXP$$US-AstraZeneca-2023A125732$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242584171$24258417$1$I$20240722$20240822$20240828$20240828$EXP$FR-AFSSAPS-LM2024000459$FR-PFIZER INC-202400241649$PFIZER$$66$YR$$F$Y$79$KG$20240828$$CN$FR$FR
242584182$24258418$2$F$$20240830$20240828$20240905$EXP$$PL-PFIZER INC-202400242610$PFIZER$Adamczuk-nurzynska, A.. Electrolyte disturbances in an elderly patient with colon cancer. Unknown. 2024;1-3$73$YR$$M$Y$$$20240905$$MD$PL$PL
242584191$24258419$1$I$$20240823$20240828$20240828$EXP$$CA-PFIZER INC-202400243963$PFIZER$$82$YR$$F$Y$$$20240828$$MD$CA$CA
242584201$24258420$1$I$20240807$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190153$ASTRAZENECA$$72$YR$$F$Y$$$20240828$$CN$US$
242584223$24258422$3$F$$20240928$20240828$20240930$PER$$US-PFIZER INC-202400242372$PFIZER$$14$YR$$M$Y$32.4$KG$20240930$$CN$US$US
242584241$24258424$1$I$$20240822$20240828$20240828$EXP$$US-PFIZER INC-202300248654$PFIZER$$13$YR$$M$Y$34.95$KG$20240828$$MD$US$US
242584251$24258425$1$I$$20240822$20240828$20240828$EXP$$US-PFIZER INC-202400242861$PFIZER$Fogel, L.. Aicardi-Goutieres syndrome presenting with pneumocystis jirovecii pneumonia. Pediatric Allergy and Immunology. 2023;34 (6):10.1111/pai.13968$3$MON$$M$Y$2.76$KG$20240828$$HP$US$US
242584261$24258426$1$I$$20240822$20240828$20240828$EXP$$US-PFIZER INC-PV202400110495$PFIZER$$62$YR$$M$Y$$$20240828$$HP$US$US
242584272$24258427$2$F$20230612$20240827$20240828$20240830$EXP$$CN-PFIZER INC-202400243682$PFIZER$Bu, S.. Application of eculizumab, a terminal complement inhibitor, in the management of atypical hemolytic uremic syndrome in a 14-month-old Chinese pediatric patient: a case report.. Frontiers in Pediatrics. 2024;12:1404725$1$YR$$F$Y$9$KG$20240830$$PH$CN$CN
242584291$24258429$1$I$20240816$20240822$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110009$PFIZER$$45$YR$$F$Y$61.5$KG$20240828$$HP$CN$CN
242584301$24258430$1$I$$20240823$20240828$20240828$PER$$US-AstraZeneca-2024A193472$ASTRAZENECA$$74$YR$$F$Y$85$KG$20240828$$HP$US$
242584312$24258431$2$F$$20240916$20240828$20240925$EXP$$CA-TEVA-VS-3235093$TEVA$$12$MON$$M$Y$$$20240925$$HP$CA$CA
242584321$24258432$1$I$$20240724$20240828$20240828$PER$$US-AstraZeneca-2024A187640$ASTRAZENECA$$$$$$Y$$$20240828$$MD$US$
242584331$24258433$1$I$$20240823$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110163$PFIZER$Wang, D.. Intracranial hemorrhage with Trichosporon asahii infection after left ventricular assist device implantation: a case report. Zhejiang Journal of Traumatic Surgery. 2024;29(7):1383-1386$58$YR$$M$Y$$$20240828$$HP$CN$CN
242584341$24258434$1$I$20240705$20240822$20240828$20240828$EXP$FR-AFSSAPS-LM2024000469$FR-PFIZER INC-202400241646$PFIZER$$68$YR$$M$Y$59.7$KG$20240828$$MD$FR$FR
242584351$24258435$1$I$$20240820$20240828$20240828$EXP$$KR-AstraZeneca-2024A193701$ASTRAZENECA$$$$$M$Y$$$20240828$$MD$KR$
242584361$24258436$1$I$$20240820$20240828$20240828$EXP$$ZA-AstraZeneca-2024A189515$ASTRAZENECA$$31046$DY$$M$Y$$$20240828$$CN$ZA$
242584371$24258437$1$I$$20240819$20240828$20240828$EXP$$JP-AstraZeneca-2024A190770$ASTRAZENECA$$$$$$Y$$$20240828$$PH$JP$
242584381$24258438$1$I$20240823$20240826$20240828$20240828$EXP$$GB-AstraZeneca-2024A195265$ASTRAZENECA$$$$A$M$Y$105$KG$20240828$$MD$GB$
242584391$24258439$1$I$$20221117$20240828$20240828$PER$$US-BIOCODEX2-2021001129$BIOCODEX$$15$YR$$M$Y$55$KG$20240827$$CN$US$US
242584401$24258440$1$I$$20220211$20240828$20240828$EXP$$US-BIOCODEX2-2022000011$BIOCODEX$$$$$M$Y$18$KG$20240827$$CN$US$US
242584411$24258441$1$I$$20220804$20240828$20240828$EXP$$US-BIOCODEX2-2022000525$BIOCODEX$$$$$F$Y$22.8$KG$20240827$$CN$US$US
242584421$24258442$1$I$$20211216$20240828$20240828$PER$$US-BIOCODEX2-2021000604$BIOCODEX$$$$$M$Y$38.6$KG$20240827$$CN$US$US
242584431$24258443$1$I$20240101$20240821$20240828$20240828$PER$$US-MYLANLABS-2024M1078024$MYLAN$$$$$F$Y$63.5$KG$20240828$$CN$US$US
242584441$24258444$1$I$20240801$20240820$20240828$20240828$EXP$$US-SA-2024SA250957$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240828$$MD$US$US
242584451$24258445$1$I$20240822$20240822$20240828$20240828$EXP$$IE-TAKEDA-2024TUS086011$TAKEDA$$32$YR$$F$Y$$$20240828$$MD$IE$IE
242584461$24258446$1$I$20231120$20240821$20240828$20240828$EXP$$PA-AMGEN-PANSP2023209314$AMGEN$$62$YR$A$F$Y$$$20240828$$CN$PA$PA
242584471$24258447$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-081713-2024$RECKITT BENCKISER$$40$YR$$F$Y$$$20240828$$CN$US$US
242584481$24258448$1$I$$20240827$20240828$20240828$EXP$$NVSC2024GB036035$NOVARTIS$$$$A$M$Y$$$20240828$$CN$GB$GB
242584491$24258449$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017092$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240828$$HP$US$US
242584501$24258450$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016229$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240828$$CN$US$US
242584512$24258451$2$F$20240601$20240903$20240828$20240906$EXP$FR-AFSSAPS-AN2024001042$FR-CHATTEMPRD-2024OHG029157$CHATTEM$$64$YR$A$F$Y$80$KG$20240906$$MD$FR$FR
242584521$24258452$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016080$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240828$$CN$US$US
242584531$24258453$1$I$20240801$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016359$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240828$$CN$US$US
242584541$24258454$1$I$$20240815$20240828$20240828$EXP$GB-MHRA-MED-202408151612412430-NTVQD$GB-ELI_LILLY_AND_COMPANY-GB202408010276$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$GB$GB
242584551$24258455$1$I$$20240815$20240828$20240828$EXP$GB-MHRA-MED-202408151555542600-CWPHK$GB-ELI_LILLY_AND_COMPANY-GB202408010266$ELI LILLY AND CO$$$$$F$Y$92$KG$20240828$$CN$GB$GB
242584561$24258456$1$I$$20240815$20240828$20240828$EXP$GB-MHRA-MED-202408151026014530-JHZLB$GB-ELI_LILLY_AND_COMPANY-GB202408010359$ELI LILLY AND CO$$$$$M$Y$$$20240828$$CN$GB$GB
242584571$24258457$1$I$$20240816$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011648$ELI LILLY AND CO$$$$A$F$Y$$$20240828$$CN$US$US
242584581$24258458$1$I$20240801$20240816$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010927$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240828$$CN$US$US
242584592$24258459$2$F$$20240829$20240828$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408014561$ELI LILLY AND CO$$26$YR$A$M$Y$$$20240902$$CN$US$US
242584601$24258460$1$I$$20240815$20240828$20240828$PER$$US-JNJFOC-20240855812$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242584611$24258461$1$I$$20240826$20240828$20240828$EXP$$US-GILEAD-2024-0685277$GILEAD$$$$$$Y$$$20240828$$CN$US$US
242584621$24258462$1$I$20240821$20240821$20240828$20240828$PER$$US-AMGEN-USASP2024171677$AMGEN$$$$$$Y$$$20240828$$HP$US$US
242584631$24258463$1$I$$20240822$20240828$20240828$EXP$$FR-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2408FR06644$INSUD PHARMA$$$$$F$Y$$$20240828$$MD$FR$FR
242584641$24258464$1$I$$20240716$20240828$20240828$PER$$US-LUNDBECK-DKLU4001871$LUNDBECK$$$$$$Y$$$20240828$$CN$US$US
242584651$24258465$1$I$$20240822$20240828$20240828$PER$$US-MYLANLABS-2024M1079149$MYLAN$$$$$$Y$$$20240828$$MD$US$US
242584661$24258466$1$I$$20240821$20240828$20240828$EXP$$NVSC2024US172914$NOVARTIS$Cooper J, Soneji D, Rieger K, Narala S, Kim Y. Primary Cutaneous CD30+ Large T Cell Lymphoproliferative Disorder Associated With Prolonged Exposure to Fingolimod. MULTIPLE SCLEROSIS JOURNAL. 2023;29 (3S):968-71$67$YR$$F$Y$$$20240828$$HP$US$US
242584673$24258467$3$F$20240101$20240918$20240828$20240926$PER$$US-ABBVIE-5890214$ABBVIE$$$$$F$Y$51.255$KG$20240926$$CN$US$US
242584681$24258468$1$I$$20240812$20240828$20240828$PER$$US-ALMUS-US-2024-2066$ALMUS$$$$$$Y$$$20240828$$HP$US$US
242584691$24258469$1$I$$20240821$20240828$20240828$PER$$US-ABBVIE-5892713$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242584701$24258470$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-PV202400110950$PFIZER$$$$$F$Y$$$20240828$$MD$US$US
242584711$24258471$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-202400243285$PFIZER$$69$YR$$F$Y$$$20240828$$CN$US$US
242584721$24258472$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-202400203548$PFIZER$$67$YR$$M$Y$$$20240828$$CN$US$US
242584731$24258473$1$I$20240823$20240823$20240828$20240828$PER$$US-PFIZER INC-202400243241$PFIZER$$31$YR$$F$Y$$$20240828$$HP$US$US
242584741$24258474$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-PV202400110914$PFIZER$$$$$$Y$$$20240828$$CN$US$US
242584751$24258475$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-PV202400110577$PFIZER$$$$$$Y$$$20240828$$CN$US$US
242584761$24258476$1$I$20240819$20240823$20240828$20240828$PER$$US-PFIZER INC-202400243213$PFIZER$$31$YR$$F$Y$$$20240828$$CN$US$US
242584771$24258477$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-202400242795$PFIZER$$81$YR$$F$Y$$$20240828$$CN$US$US
242584781$24258478$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-202400242783$PFIZER$$$$$F$Y$$$20240828$$CN$US$US
242584801$24258480$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-202400242932$PFIZER$$51$YR$$M$Y$95.25$KG$20240828$$CN$US$US
242584812$24258481$2$F$20240822$20240923$20240828$20240926$PER$$US-PFIZER INC-202400243544$PFIZER$$73$YR$$F$Y$76.66$KG$20240926$$CN$US$US
242584821$24258482$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-202400243149$PFIZER$$$$$M$Y$$$20240828$$CN$US$US
242584831$24258483$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-PV202400110898$PFIZER$$56$YR$$F$Y$$$20240828$$CN$US$US
242584842$24258484$2$F$$20240912$20240828$20240913$PER$$US-PFIZER INC-202400243034$PFIZER$$40$YR$$M$Y$$$20240913$$HP$US$US
242584851$24258485$1$I$20240821$20240823$20240828$20240828$PER$$US-PFIZER INC-202400243273$PFIZER$$31$YR$$F$Y$$$20240828$$CN$US$US
242584861$24258486$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-202400243504$PFIZER$$68$YR$$F$Y$$$20240828$$CN$US$US
242584871$24258487$1$I$$20240820$20240828$20240828$30DAY$$US-GSK-US2024104011$GLAXOSMITHKLINE$$$$$M$Y$$$20240828$$CN$US$US
242584882$24258488$2$F$$20240828$20240828$20240904$PER$$US-ROCHE-10000066094$ROCHE$$$$$F$Y$$$20240904$$CN$US$US
242584891$24258489$1$I$$20240827$20240828$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA004016$SANDOZ$$73$YR$$M$Y$67$KG$20240828$$HP$CA$CA
242584901$24258490$1$I$20240712$20240826$20240828$20240828$EXP$$CO-UCBSA-2024043577$UCB$$58$YR$$M$Y$$$20240828$$CN$CO$CO
242584912$24258491$2$F$20120101$20240917$20240828$20240926$EXP$$US-UCBSA-2024043214$UCB$$$$$F$Y$115.5$KG$20240926$$CN$US$US
242584921$24258492$1$I$$20240823$20240828$20240828$EXP$$CA-JNJFOC-20240869071$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240828$$HP$CA$CA
242584931$24258493$1$I$$20240820$20240828$20240828$EXP$$US-RDY-LIT/USA/24/0012413$DR REDDYS$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. Journal of drugs in dermatology : JDD. 2023 Nov;22(11): e12-e16. doi:10.36849/JDD.4936.$50$YR$A$M$Y$$$20240828$$HP$US$US
242584941$24258494$1$I$20131013$20240827$20240828$20240828$EXP$$DE-SANDOZ INC.-GXKR2014DE003892$SANDOZ$$23$YR$$F$Y$$$20240828$$MD$DE$DE
242584952$24258495$2$F$$20240828$20240828$20240831$PER$$US-AMGEN-USASP2024171438$AMGEN$$$$$M$Y$$$20240831$$PH$US$US
242584971$24258497$1$I$$20240827$20240828$20240828$PER$$US-AMGEN-USASP2024171421$AMGEN$$$$$$Y$$$20240828$$HP$US$US
242584991$24258499$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00692$GLAND PHARMA$$$$$M$Y$$$20240828$$CN$US$US
242585001$24258500$1$I$20240527$20240827$20240828$20240828$EXP$$DE-SANDOZ INC.-SDZ2024DE054860$SANDOZ$$74$YR$$M$Y$103$KG$20240828$$MD$DE$DE
242585011$24258501$1$I$$20240822$20240828$20240828$EXP$$US-AstraZeneca-2024A192727$ASTRAZENECA$$$$$F$Y$$$20240828$$HP$US$
242585021$24258502$1$I$$20240826$20240828$20240828$PER$$US-ABBVIE-5896708$ABBVIE$$$$$$Y$$$20240828$$CN$US$US
242585031$24258503$1$I$$20240827$20240828$20240828$EXP$$PL-SANDOZ INC.-SDZ2024PL075410$SANDOZ$$24$MON$$M$Y$$$20240828$$HP$PL$PL
242585041$24258504$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-081736-2024$RECKITT BENCKISER$$$$$M$Y$$$20240828$$CN$US$US
242585051$24258505$1$I$20240708$20240823$20240828$20240828$EXP$$UY-JNJFOC-20240861582$JOHNSON AND JOHNSON$$34$YR$A$F$Y$100$KG$20240828$$CN$UY$UY
242585061$24258506$1$I$20240710$20240717$20240828$20240828$PER$$US-LUNDBECK-DKLU4001847$LUNDBECK$$$$$$Y$$$20240828$$CN$US$US
242585072$24258507$2$F$$20240912$20240828$20240919$PER$$US-ROCHE-10000058676$ROCHE$$$$$$Y$$$20240919$$PH$US$US
242585093$24258509$3$F$20240819$20240918$20240828$20240920$PER$$US-AMGEN-USASP2024169291$AMGEN$$51$YR$A$F$Y$$$20240920$$CN$US$US
242585111$24258511$1$I$20240813$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-58860$$FDA-CTU$$63$YR$$F$N$$$20240826$N$$US$
242585121$24258512$1$I$20240801$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170325$AMGEN$$78$YR$E$F$Y$$$20240828$$CN$US$US
242585132$24258513$2$F$$20240917$20240828$20240919$PER$$US-AMGEN-USASP2024171674$AMGEN$$$$$F$Y$$$20240919$$CN$US$US
242585141$24258514$1$I$$20240820$20240828$20240828$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006520$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242585151$24258515$1$I$20240812$20240826$20240828$20240828$PER$$NVSC2024US173030$NOVARTIS$$58$YR$$F$Y$64.41$KG$20240828$$CN$US$US
242585161$24258516$1$I$20240723$20240823$20240828$20240828$EXP$$NVSC2024RU173133$NOVARTIS$$67$YR$$F$Y$67$KG$20240828$$HP$RU$RU
242585171$24258517$1$I$$20230908$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00600$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$US$US
242585181$24258518$1$I$$20230901$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00581$VELOXIS PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242585191$24258519$1$I$$20230901$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00582$VELOXIS PHARMACEUTICALS$$$$$F$Y$$$20240828$$HP$US$US
242585201$24258520$1$I$$20230911$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00601$VELOXIS PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242585211$24258521$1$I$$20230927$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00576$VELOXIS PHARMACEUTICALS$$$$$M$Y$$$20240828$$PH$US$US
242585221$24258522$1$I$$20230906$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00571$VELOXIS PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242585231$24258523$1$I$20220701$20230802$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00516$VELOXIS PHARMACEUTICALS$$52$YR$$F$Y$$$20240828$$CN$US$US
242585241$24258524$1$I$20230829$20230829$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00573$VELOXIS PHARMACEUTICALS$$38$YR$$M$Y$$$20240828$$CN$US$US
242585251$24258525$1$I$$20230814$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00536$VELOXIS PHARMACEUTICALS$$$$$F$Y$$$20240828$$PH$US$US
242585261$24258526$1$I$$20230816$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00538$VELOXIS PHARMACEUTICALS$$$$$M$Y$108.9$KG$20240828$$CN$US$US
242585271$24258527$1$I$$20240819$20240828$20240828$PER$$US-ABBVIE-5888567$ABBVIE$$$$$$Y$$$20240828$$CN$US$US
242585281$24258528$1$I$$20240823$20240828$20240828$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-135424$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240828$$HP$CA$CA
242585291$24258529$1$I$$20231102$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00685$VELOXIS PHARMACEUTICALS$$3$DEC$$M$Y$$$20240828$$CN$US$US
242585301$24258530$1$I$20230925$20231020$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00623$VELOXIS PHARMACEUTICALS$$45$YR$$M$Y$$$20240828$$HP$US$US
242585311$24258531$1$I$$20231027$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00680$VELOXIS PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242585321$24258532$1$I$$20230925$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00621$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$PH$US$US
242585331$24258533$1$I$$20231009$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00642$VELOXIS PHARMACEUTICALS$$16$YR$$F$Y$$$20240828$$CN$US$US
242585341$24258534$1$I$$20231023$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00726$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$HP$US$US
242585351$24258535$1$I$$20230922$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00620$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$HP$US$US
242585361$24258536$1$I$$20230925$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00622$VELOXIS PHARMACEUTICALS$$16$YR$$F$Y$$$20240828$$CN$US$US
242585371$24258537$1$I$$20231025$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00679$VELOXIS PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242585381$24258538$1$I$$20240822$20240828$20240828$PER$$US-BIOGEN-2024BI01279637$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
242585391$24258539$1$I$20240101$20240821$20240828$20240828$PER$$US-BIOGEN-2024BI01279662$BIOGEN$$46$YR$$F$Y$$$20240828$$CN$US$US
242585401$24258540$1$I$$20240822$20240828$20240828$PER$$US-BIOGEN-2024BI01279655$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
242585411$24258541$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00693$GLAND PHARMA$$$$$$Y$$$20240828$$CN$US$US
242585421$24258542$1$I$20230918$20231027$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00612$VELOXIS PHARMACEUTICALS$$57$YR$$F$Y$$$20240828$$HP$US$US
242585431$24258543$1$I$20231108$20240402$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00793$VELOXIS PHARMACEUTICALS$$66$YR$$M$Y$$$20240828$$HP$US$US
242585441$24258544$1$I$$20231213$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00801$VELOXIS PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242585451$24258545$1$I$$20240320$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00140$VELOXIS PHARMACEUTICALS$$$$E$F$Y$$$20240828$$PH$US$US
242585461$24258546$1$I$$20240131$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00048$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$PH$US$US
242585471$24258547$1$I$$20240118$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00023$VELOXIS PHARMACEUTICALS$$$$$F$Y$$$20240828$$HP$US$US
242585481$24258548$1$I$$20240123$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00029$VELOXIS PHARMACEUTICALS$$$$$F$Y$$$20240828$$MD$US$US
242585491$24258549$1$I$$20240105$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00006$VELOXIS PHARMACEUTICALS$$$$$M$Y$$$20240828$$HP$US$US
242585501$24258550$1$I$$20240206$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00066$VELOXIS PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242585511$24258551$1$I$20220602$20240429$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00173$VELOXIS PHARMACEUTICALS$$67$YR$$F$Y$40.3$KG$20240828$$MD$US$US
242585521$24258552$1$I$$20240401$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00182$VELOXIS PHARMACEUTICALS$$56$YR$$F$Y$$$20240828$$CN$US$US
242585531$24258553$1$I$$20240208$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00071$VELOXIS PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242585541$24258554$1$I$$20231219$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00811$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$US$US
242585551$24258555$1$I$$20231219$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00810$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$US$US
242585561$24258556$1$I$20231207$20231221$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00817$VELOXIS PHARMACEUTICALS$$52$YR$$F$Y$$$20240828$$CN$US$US
242585571$24258557$1$I$$20231226$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00828$VELOXIS PHARMACEUTICALS$$$$$M$Y$$$20240828$$HP$US$US
242585581$24258558$1$I$20240101$20240426$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00235$VELOXIS PHARMACEUTICALS$$59$YR$$F$Y$$$20240828$$CN$US$US
242585591$24258559$1$I$20240101$20240402$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00185$VELOXIS PHARMACEUTICALS$$49$YR$$F$Y$72.562$KG$20240828$$HP$US$US
242585601$24258560$1$I$20240106$20240206$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00068$VELOXIS PHARMACEUTICALS$$59$YR$$M$Y$$$20240828$$CN$US$US
242585611$24258561$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-086763-2024$RECKITT BENCKISER$$$$$F$Y$$$20240828$$CN$US$US
242585621$24258562$1$I$20240801$20240821$20240828$20240828$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006428$AURINIA PHARMACEUTICALS$$48$YR$$F$Y$$$20240828$$CN$US$US
242585632$24258563$2$F$20240801$20240821$20240828$20240925$PER$$US-BEH-2024177543$CSL BEHRING$$77$YR$E$F$Y$$$20240925$$CN$US$US
242585641$24258564$1$I$20240306$20240425$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00151$VELOXIS PHARMACEUTICALS$$55$YR$$M$Y$$$20240828$$PH$US$US
242585651$24258565$1$I$20230730$20240219$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00027$VELOXIS PHARMACEUTICALS$$71$YR$$F$Y$$$20240828$$CN$US$US
242585661$24258566$1$I$20240712$20240823$20240828$20240828$EXP$SE-SEMPA-2024-005603$SE-ABBVIE-5897007$ABBVIE$$33$YR$$F$Y$$$20240828$$MD$SE$SE
242585671$24258567$1$I$20240524$20240529$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00300$VELOXIS PHARMACEUTICALS$$46$YR$$M$Y$$$20240828$$PH$US$US
242585681$24258568$1$I$$20240605$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00322$VELOXIS PHARMACEUTICALS$$$$$F$Y$$$20240828$$HP$US$US
242585691$24258569$1$I$$20240521$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00291$VELOXIS PHARMACEUTICALS$$$$$M$Y$$$20240828$$MD$US$US
242585701$24258570$1$I$$20240530$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00302$VELOXIS PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242585711$24258571$1$I$$20240603$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00315$VELOXIS PHARMACEUTICALS$$$$C$$Y$$$20240828$$PH$US$US
242585721$24258572$1$I$$20240603$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00314$VELOXIS PHARMACEUTICALS$$$$C$$Y$$$20240828$$PH$US$US
242585731$24258573$1$I$$20240710$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00379$VELOXIS PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242585741$24258574$1$I$$20240508$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00249$VELOXIS PHARMACEUTICALS$$$$$M$Y$68$KG$20240828$$CN$US$US
242585751$24258575$1$I$$20240604$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00319$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$MD$US$US
242585761$24258576$1$I$$20240603$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00318$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$HP$US$US
242585771$24258577$1$I$20230101$20231215$20240828$20240828$PER$$US-AMERICAN REGENT INC-2023002946$AMERICAN REGENT$$18$YR$$F$Y$$$20240828$$PH$US$US
242585781$24258578$1$I$20240104$20240104$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000042$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242585791$24258579$1$I$$20240105$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000056$AMERICAN REGENT$$5$DEC$$F$Y$$$20240828$$HP$US$US
242585801$24258580$1$I$20230901$20240111$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000140$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242585811$24258581$1$I$$20240109$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000105$AMERICAN REGENT$$68$YR$$F$Y$$$20240828$$HP$US$US
242585821$24258582$1$I$20230101$20240110$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000138$AMERICAN REGENT$$$$$M$Y$$$20240828$$HP$US$US
242585831$24258583$1$I$20240101$20240820$20240828$20240828$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-013548$JAZZ$$$$E$M$Y$$$20240828$$MD$JP$JP
242585841$24258584$1$I$20240201$20240820$20240828$20240828$EXP$FR-AFSSAPS-BX2024001668$FR-KOANAAP-SML-FR-2024-00874$Unknown Manufacturer$$66$YR$E$M$Y$68$KG$20240828$$MD$FR$FR
242585851$24258585$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136219$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240828$$CN$US$US
242585861$24258586$1$I$$20240822$20240828$20240828$EXP$$BR-TAKEDA-2024TUS086166$TAKEDA$$73$YR$$F$Y$$$20240828$$CN$BR$BR
242585881$24258588$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016956$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240828$$CN$US$US
242585891$24258589$1$I$20240826$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016126$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240828$$CN$US$US
242585901$24258590$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016633$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240828$$CN$US$US
242585911$24258591$1$I$20240824$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016383$ELI LILLY AND CO$$49$YR$A$$Y$$$20240828$$CN$US$US
242585921$24258592$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015939$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$US$US
242585931$24258593$1$I$$20240822$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014797$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240828$$CN$US$US
242585941$24258594$1$I$$20240828$20240828$20240828$PER$$US-PROD-AS2-212756134-RB-086717-2024$RECKITT BENCKISER$$$$$F$Y$$$20240828$$CN$US$US
242585951$24258595$1$I$20240824$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016003$ELI LILLY AND CO$$60$YR$A$$Y$$$20240828$$CN$US$US
242585961$24258596$1$I$$20240824$20240828$20240828$PER$$US-AMGEN-USASP2024169898$AMGEN$$$$$M$Y$$$20240828$$HP$US$US
242585972$24258597$2$F$20240101$20240812$20240828$20240912$EXP$$US-GILEAD-2024-0685431$GILEAD$$51$YR$A$F$Y$102.04$KG$20240912$$CN$US$US
242585981$24258598$1$I$$20240803$20240828$20240828$PER$$US-JNJFOC-20240809538$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242585991$24258599$1$I$20240807$20240823$20240828$20240828$EXP$$PK-ROCHE-10000064799$ROCHE$$74$YR$E$M$Y$$$20240828$$CN$PK$PK
242586001$24258600$1$I$20231018$20240826$20240828$20240828$EXP$$CO-UCBSA-2024043614$UCB$$68$YR$$M$Y$$$20240828$$CN$CO$CO
242586011$24258601$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170484$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242586023$24258602$3$F$20240826$20240916$20240828$20240919$PER$$US-AMGEN-USASP2024170474$AMGEN$$74$YR$E$M$Y$$$20240918$$CN$US$US
242586031$24258603$1$I$$20240827$20240828$20240828$PER$$US-TAKEDA-2024TUS086334$TAKEDA$$$$$F$Y$$$20240828$$HP$US$US
242586041$24258604$1$I$$20240823$20240828$20240828$EXP$$GB-MYLANLABS-2024M1078576$MYLAN$$$$$M$Y$$$20240828$$MD$GB$GB
242586051$24258605$1$I$20231001$20240826$20240828$20240828$EXP$$NO-GILEAD-2024-0685372$GILEAD$$59$YR$A$M$Y$$$20240828$$MD$NO$NO
242586061$24258606$1$I$20190301$20240819$20240828$20240828$PER$$US-TAKEDA-2024TUS083498$TAKEDA$$23$YR$$F$Y$$$20240828$$CN$US$US
242586072$24258607$2$F$$20240827$20240828$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08040$LUPIN$$$$$$Y$$$20240918$$CN$US$US
242586081$24258608$1$I$$20240826$20240828$20240828$EXP$$US-GILEAD-2024-0685389$GILEAD$$56$YR$A$M$Y$$$20240828$$CN$US$US
242586091$24258609$1$I$$20240806$20240828$20240828$PER$$US-AstraZeneca-2024A179368$ASTRAZENECA$$$$$$Y$$$20240828$$MD$US$
242586102$24258610$2$F$$20240905$20240828$20240906$PER$$US-AstraZeneca-2024A174805$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242586111$24258611$1$I$$20240802$20240828$20240828$EXP$$AU-Covis Pharma GmbH-2024COV00966$COVIS PHARMA$$$$$F$Y$$$20240828$$CN$AU$AU
242586121$24258612$1$I$$20240808$20240828$20240828$PER$$US-Covis Pharma GmbH-2024COV00988$COVIS PHARMA$$37$YR$A$M$Y$$$20240828$$CN$US$US
242586151$24258615$1$I$$20200424$20240828$20240828$EXP$$US-Covis Pharma GmbH-2024COV00936$COVIS PHARMA$$52$YR$A$M$Y$$$20240828$$$COUNTRY NOT SPECIFIED$US
242586161$24258616$1$I$20240814$20240819$20240828$20240828$EXP$$US-IMMUNOGEN, INC.-US-IMGN-24-00648$IMMUNOGEN$$68$YR$$F$Y$$$20240828$$CN$US$US
242586171$24258617$1$I$20240801$20240820$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075860$SANDOZ$$$$$F$Y$$$20240828$$CN$US$US
242586181$24258618$1$I$20220901$20240819$20240828$20240828$EXP$$US-JNJFOC-20240852503$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240828$$MD$US$US
242586192$24258619$2$F$$20240916$20240828$20240917$PER$$US-JNJFOC-20240872012$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$US$US
242586202$24258620$2$F$$20240913$20240828$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136310$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240917$$HP$US$US
242586211$24258621$1$I$$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136690$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240828$$CN$US$US
242586221$24258622$1$I$$20240820$20240828$20240828$EXP$$CA-JNJFOC-20240859043$JOHNSON AND JOHNSON$$15$YR$T$F$Y$46$KG$20240828$$HP$CA$CA
242586233$24258623$3$F$20240101$20240903$20240828$20240904$PER$$US-AMGEN-USASP2024170223$AMGEN$$75$YR$E$F$Y$$$20240904$$CN$US$US
242586241$24258624$1$I$20240819$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169768$AMGEN$$67$YR$E$F$Y$$$20240828$$PH$US$US
242586251$24258625$1$I$20240727$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170392$AMGEN$$74$YR$E$M$Y$$$20240828$$CN$US$US
242586262$24258626$2$F$20210313$20240904$20240828$20240917$EXP$$JP-EXELIXIS-CABO-21080756$EXELIXIS$$53$YR$$M$Y$89.1$KG$20240917$$MD$JP$JP
242586272$24258627$2$F$$20240906$20240828$20240911$EXP$$US-PFIZER INC-202400243380$PFIZER$$79$YR$$F$Y$$$20240910$$CN$US$US
242586281$24258628$1$I$20240701$20240823$20240828$20240828$EXP$$JP-PFIZER INC-PV202400110715$PFIZER$$79$YR$$F$Y$$$20240828$$HP$JP$JP
242586291$24258629$1$I$20240101$20240823$20240828$20240828$EXP$$CA-PFIZER INC-202400244276$PFIZER$$58$YR$$F$Y$$$20240828$$HP$CA$CA
242586301$24258630$1$I$20190101$20240823$20240828$20240828$EXP$$US-PFIZER INC-2020231708$PFIZER$$70$YR$$F$Y$70.31$KG$20240828$$CN$US$US
242586312$24258631$2$F$20230810$20240904$20240828$20240906$EXP$$CA-PFIZER INC-202300213946$PFIZER$$38$YR$$F$Y$96$KG$20240906$$MD$CA$CA
242586321$24258632$1$I$20240707$20240823$20240828$20240828$EXP$$US-PFIZER INC-PV202400105795$PFIZER$$25$YR$$F$Y$$$20240828$$MD$US$US
242586331$24258633$1$I$$20240823$20240828$20240828$EXP$$US-PFIZER INC-202400242866$PFIZER$$52$YR$$$Y$$$20240828$$HP$US$US
242586342$24258634$2$F$20231009$20240905$20240828$20240910$EXP$$BE-PFIZER INC-PV202400110414$PFIZER$$24$YR$$M$Y$$$20240910$$MD$BE$BE
242586351$24258635$1$I$20231226$20240823$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110592$PFIZER$$55$YR$$M$Y$60$KG$20240828$$HP$CN$CN
242586361$24258636$1$I$20240821$20240823$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110620$PFIZER$$61$YR$$F$Y$62$KG$20240828$$HP$CN$CN
242586371$24258637$1$I$20240216$20240823$20240828$20240828$EXP$$CA-PFIZER INC-202400051453$PFIZER$$35$YR$$M$Y$$$20240828$$HP$CA$CA
242586391$24258639$1$I$$20240820$20240828$20240828$EXP$$CA-TEVA-VS-3235084$TEVA$$$$$F$Y$$$20240828$$MD$CA$CA
242586402$24258640$2$F$$20240826$20240828$20240903$EXP$$TR-PFIZER INC-202400242467$PFIZER$Mertoglu, S.. During treatment with methylprednisolone in a sixteen-year-old male patient diagnosed with multiple sclerosis, staphylococcus aureus was isolated in the cerebrospinal fluid and brain abscess development.. BMJ Paediatrics Open. 2024;8(Suppl 5):A58-A59$16$YR$$M$Y$$$20240903$$MD$TR$TR
242586411$24258641$1$I$20220920$20240823$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110622$PFIZER$$32$YR$$F$Y$55$KG$20240828$$HP$CN$CN
242586421$24258642$1$I$$20240823$20240828$20240828$EXP$$JP-PFIZER INC-202400242896$PFIZER$$$$$$Y$$$20240828$$PH$JP$JP
242586431$24258643$1$I$$20240823$20240828$20240828$EXP$NL-LRB-00997005$NL-PFIZER INC-202400242498$PFIZER$$36$YR$$M$Y$95$KG$20240828$$CN$NL$NL
242586442$24258644$2$F$$20240826$20240828$20240903$EXP$$US-PFIZER INC-202400242470$PFIZER$Hui, J.. Epithelial-myoepithelial carcinoma occurrence in the site of previously treated ductal carcinoma in situ of the breast: Imaging features with histopathologic correlation, a case report and review of the literature.. Clinical Case Reports. 2024;12(8):10.1002/ccr3.9270$75$YR$$F$Y$$$20240903$$MD$US$US
242586452$24258645$2$F$$20240902$20240828$20240911$EXP$$IE-TEVA-VS-3236251$TEVA$Carroll E, Leahy M, Dhonncha EN. SCAR: more than just a mark on the skin. Br-J-Dermatol 2024; 192 (Suppl. 1) i146-i147 abstr. BI19.; Carroll E, Leahy M, Dhonncha EN. SCAR: more than just a mark on the skin. Br-J-Dermatol 2024; 192 (Suppl. 1) i146-i147 abstr. BI19.$34$YR$$F$Y$$$20240911$$HP$IE$IE
242586463$24258646$3$F$20240725$20240919$20240828$20240920$EXP$FR-AFSSAPS-AM2024000680$FR-PFIZER INC-202400242501$PFIZER$$67$YR$$M$Y$125$KG$20240920$$MD$FR$FR
242586481$24258648$1$I$$20240823$20240828$20240828$EXP$$FR-AMGEN-FRASP2024169354$AMGEN$$$$$F$Y$$$20240828$$PH$FR$FR
242586501$24258650$1$I$20210112$20240816$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008612$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242586511$24258651$1$I$20220101$20240821$20240828$20240828$EXP$$CA-GSK-CA2022123116$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$CA$CA
242586521$24258652$1$I$$20240823$20240828$20240828$PER$$US-BAYER-2024A122429$BAYER$$29$YR$A$F$Y$$$20240828$$MD$US$US
242586542$24258654$2$F$$20240902$20240828$20240911$EXP$$TR-TEVA-VS-3235313$TEVA$Tamer F, Kocer B, Ogut B, Erdem O. Generalized and patch granuloma annulare in a patient with psoriasis and multiple sclerosis after treatment with fingolimod. Prz-Dermatol 2023; 110 (6): 716-718.; Tamer F, Kocer B, Ogut B, Erdem O. Generalized and patch granuloma annulare in a patient with psoriasis and multiple sclerosis after treatment with fingolimod. Prz-Dermatol 2023; 110 (6): 716-718.$32$YR$$F$Y$$$20240911$$HP$TR$TR
242586551$24258655$1$I$19910101$20240826$20240828$20240828$EXP$FR-AFSSAPS-AVTO2024000123$FR-INDIVIOR UK LIMITED-INDV-156193-2024$RECKITT BENCKISER$$$$$$Y$$$20240828$$MD$FR$FR
242586561$24258656$1$I$20240601$20240820$20240828$20240828$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036267$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240828$$CN$US$US
242586572$24258657$2$F$$20240826$20240828$20240830$EXP$$NVSC2024US172828$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
242586581$24258658$1$I$$20240825$20240828$20240828$PER$$US-JNJFOC-20240868045$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242586602$24258660$2$F$20240801$20240916$20240828$20240924$EXP$$CA-JNJFOC-20240861796$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240924$$HP$CA$CA
242586611$24258661$1$I$$20240826$20240828$20240828$EXP$$US-Indivior Limited-INDV-156198-2024$RECKITT BENCKISER$$$$$$Y$$$20240828$$HP$US$US
242586621$24258662$1$I$20240814$20240820$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133120$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240828$$PH$US$US
242586631$24258663$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136641$BRISTOL MYERS SQUIBB$$21$YR$A$F$Y$$$20240828$$HP$US$US
242586641$24258664$1$I$$20240827$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136711$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240828$$CN$US$US
242586652$24258665$2$F$$20240826$20240828$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013501$JAZZ$$$$$M$Y$$$20240830$$CN$US$US
242586661$24258666$1$I$20230901$20240111$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000141$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242586671$24258667$1$I$20240101$20240822$20240828$20240828$EXP$$CA-UCBSA-2024028297$UCB$$$$$F$Y$$$20240828$$CN$CA$CA
242586681$24258668$1$I$$20240813$20240828$20240828$EXP$$US-Accord-442397$ACCORD$$41$YR$A$M$Y$$$20240828$$MD$US$US
242586691$24258669$1$I$20240704$20240820$20240828$20240828$EXP$$CN-AstraZeneca-2024A191701$ASTRAZENECA$$32904$DY$$M$Y$84$KG$20240828$$MD$CN$
242586701$24258670$1$I$$20240822$20240828$20240828$PER$$US-ROCHE-10000064811$ROCHE$$79$YR$E$M$Y$$$20240828$$CN$US$US
242586711$24258671$1$I$$20240822$20240828$20240828$PER$$US-ROCHE-10000065094$ROCHE$$$$E$M$Y$$$20240828$$CN$US$US
242586722$24258672$2$F$$20240815$20240828$20240921$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK092845$GLENMARK$$$$$$Y$$$20240921$$HP$GB$GB
242586731$24258673$1$I$$20240823$20240828$20240828$PER$$US-BAYER-2024A122545$BAYER$$18$YR$A$F$Y$$$20240828$$MD$US$US
242586741$24258674$1$I$$20240808$20240828$20240828$PER$$US-TEVA-VS-3233124$TEVA$$58$YR$$M$Y$$$20240828$$CN$US$US
242586761$24258676$1$I$$20240822$20240828$20240828$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004725$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$US$US
242586771$24258677$1$I$$20240819$20240828$20240828$EXP$$TR-SANDOZ INC.-SDZ2024TR075678$SANDOZ$Temelturk RD. Acute dystonic reaction following methylphenidate discontinuation during combination therapy with risperidone:  A Case Study. ANKARA UNIVERSITESI TIP FAKULTESI MECMUASI. 2024;77 (2):222-6$6$YR$$M$Y$$$20240828$$HP$TR$TR
242586781$24258678$1$I$$20240812$20240828$20240828$PER$$US-009507513-2408USA003886$MERCK$$$$$F$Y$66.2$KG$20240828$$HP$US$US
242586791$24258679$1$I$$20240820$20240828$20240828$EXP$$CA-TEVA-VS-3235053$TEVA$$68$YR$$M$Y$$$20240828$$HP$CA$CA
242586801$24258680$1$I$$20240825$20240828$20240828$PER$$US-BAYER-2024A122808$BAYER$$$$$F$Y$$$20240828$$CN$US$US
242586811$24258681$1$I$$20240814$20240828$20240828$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-00896$CATALYST PHARMA$$$$$F$Y$$$20240828$$CN$US$US
242586831$24258683$1$I$$20240826$20240828$20240828$EXP$$NVSC2024US172652$NOVARTIS$$$$$M$Y$$$20240828$$CN$US$US
242586842$24258684$2$F$20240810$20240828$20240828$20240904$EXP$$CN-AMGEN-CHNSP2024166640$AMGEN$$58$YR$A$F$Y$69$KG$20240904$$HP$CN$CN
242586851$24258685$1$I$$20240819$20240828$20240828$EXP$$US-ABBVIE-5898102$ABBVIE$Parmeshwar N, Song S, Alcon A, Kim EA. The incidence of breast cancer after gender-affirming mastectomy in transmen. Ann Plast Surg. 2022;88(4):S332-6.$54$YR$$F$Y$$$20240828$$MD$US$US
242586861$24258686$1$I$20240806$20240827$20240828$20240828$PER$$US-AMGEN-USASP2024171090$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242586871$24258687$1$I$20240216$20240828$20240828$20240828$EXP$ES-AEMPS-1489826$NVSC2024ES173378$NOVARTIS$$16$YR$$F$Y$$$20240828$$MD$ES$ES
242586881$24258688$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173603$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
242586891$24258689$1$I$$20240821$20240828$20240828$EXP$$US-TAKEDA-2024TUS085033$TAKEDA$$$$$F$Y$80.091$KG$20240828$$MD$US$US
242586902$24258690$2$F$$20240903$20240828$20240906$30DAY$$DE-UCBSA-2024043594$UCB$$78$YR$$F$Y$$$20240906$$PH$DE$DE
242586912$24258691$2$F$20240801$20240910$20240828$20240914$EXP$$US-ABBVIE-5896249$ABBVIE$$31$YR$$M$Y$$$20240914$$CN$US$US
242586921$24258692$1$I$20240726$20240826$20240828$20240828$PER$$US-BAYER-2024A122410$BAYER$$27$YR$A$F$Y$$$20240828$$MD$US$US
242586931$24258693$1$I$$20240822$20240828$20240828$EXP$$US-ABBVIE-5892136$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242586951$24258695$1$I$$20240820$20240828$20240828$EXP$$CA-TEVA-VS-3235028$TEVA$$53$YR$$F$Y$$$20240828$$HP$CA$CA
242586961$24258696$1$I$$20240826$20240828$20240828$EXP$$CA-ABBVIE-5896579$ABBVIE$$$$A$M$Y$$$20240828$$CN$CA$CA
242586971$24258697$1$I$20221001$20240821$20240828$20240828$EXP$$PA-AMGEN-PANSP2022176670$AMGEN$$61$YR$A$M$Y$$$20240828$$CN$PA$PA
242586981$24258698$1$I$20240825$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170358$AMGEN$$79$YR$E$F$Y$$$20240828$$CN$US$US
242586991$24258699$1$I$$20240822$20240828$20240828$EXP$$CA-ROCHE-10000064760$ROCHE$$97$YR$E$F$Y$$$20240828$$HP$CA$CA
242587001$24258700$1$I$20231229$20240821$20240828$20240828$EXP$$US-GSK-US2024000703$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
242587011$24258701$1$I$20210101$20240821$20240828$20240828$EXP$$US-GSK-US2024104452$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
242587022$24258702$2$F$$20240913$20240828$20240923$PER$$US-GSK-US2024AMR103772$GLAXOSMITHKLINE$$$$$M$Y$$$20240923$$CN$US$US
242587033$24258703$3$F$$20240906$20240828$20240916$EXP$$US-GSK-US2024AMR106512$GLAXOSMITHKLINE$$$$$F$Y$77$KG$20240916$$CN$US$US
242587041$24258704$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136737$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240828$$HP$US$US
242587051$24258705$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136281$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240828$$HP$US$US
242587061$24258706$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-PV202400111205$PFIZER$$$$$$Y$$$20240828$$MD$US$US
242587071$24258707$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-202400242986$PFIZER$$61$YR$$M$Y$$$20240828$$HP$US$US
242587082$24258708$2$F$20240823$20240918$20240828$20240919$PER$$US-PFIZER INC-202400243295$PFIZER$$78$YR$$M$Y$88.45$KG$20240919$$CN$US$US
242587101$24258710$1$I$20240801$20240823$20240828$20240828$PER$$US-PFIZER INC-202400242944$PFIZER$$49$YR$$F$Y$56.7$KG$20240828$$CN$US$US
242587111$24258711$1$I$20240824$20240824$20240828$20240828$PER$$US-PFIZER INC-202400243302$PFIZER$$51$YR$$M$Y$$$20240828$$CN$US$US
242587122$24258712$2$F$20240822$20240918$20240828$20240920$PER$$US-PFIZER INC-202400243314$PFIZER$$71$YR$$F$Y$77.11$KG$20240920$$CN$US$US
242587131$24258713$1$I$20240101$20240821$20240828$20240828$PER$$US-PFIZER INC-202400242242$PFIZER$$69$YR$$F$Y$$$20240828$$HP$US$US
242587141$24258714$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-202400243450$PFIZER$$$$A$M$Y$$$20240828$$CN$US$US
242587151$24258715$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-202400049244$PFIZER$$14$YR$$M$Y$$$20240828$$MD$US$US
242587161$24258716$1$I$$20240824$20240828$20240828$PER$$US-PFIZER INC-PV202400110539$PFIZER$$65$YR$$$Y$$$20240828$$CN$US$US
242587171$24258717$1$I$20240823$20240823$20240828$20240828$PER$$US-PFIZER INC-202400243257$PFIZER$$51$YR$$F$Y$$$20240828$$CN$US$US
242587181$24258718$1$I$20240823$20240824$20240828$20240828$PER$$US-PFIZER INC-202400243309$PFIZER$$65$YR$$F$Y$$$20240828$$CN$US$US
242587201$24258720$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-PV202400110500$PFIZER$$39$YR$$F$Y$$$20240828$$CN$US$US
242587211$24258721$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-202400243696$PFIZER$$75$YR$$F$Y$48.76$KG$20240828$$CN$US$US
242587222$24258722$2$F$$20240828$20240828$20240919$30DAY$$MX-BECTON DICKINSON-MX-BD-24-000497$BECTON DICKINSON$$$$$$Y$$$20240919$$CN$MX$MX
242587231$24258723$1$I$20240824$20240824$20240828$20240828$PER$$US-PFIZER INC-202400243368$PFIZER$$63$YR$$F$Y$$$20240828$$CN$US$US
242587241$24258724$1$I$20240821$20240823$20240828$20240828$PER$$US-PFIZER INC-202400243283$PFIZER$$53$YR$$F$Y$$$20240828$$CN$US$US
242587251$24258725$1$I$20240821$20240824$20240828$20240828$PER$$US-PFIZER INC-202400243578$PFIZER$$68$YR$$F$Y$$$20240828$$CN$US$US
242587261$24258726$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-PV202400110561$PFIZER$$$$$M$Y$$$20240828$$HP$US$US
242587272$24258727$2$F$$20240828$20240828$20240919$30DAY$$MX-BECTON DICKINSON-MX-BD-24-000498$BECTON DICKINSON$$$$$$Y$$$20240919$$CN$MX$MX
242587292$24258729$2$F$$20240829$20240828$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08186$LUPIN$$$$$$Y$$$20240918$$CN$US$US
242587301$24258730$1$I$$20240823$20240828$20240828$EXP$$NVSC2024DE173435$NOVARTIS$$$$A$M$Y$$$20240828$$MD$DE$DE
242587311$24258731$1$I$$20240813$20240828$20240828$PER$$US-CHATTEMPRD-2024OHG027587$CHATTEM$$$$$$Y$$$20240828$$PH$US$US
242587321$24258732$1$I$$20240825$20240828$20240828$PER$$US-ROCHE-10000066952$ROCHE$$$$$$Y$$$20240828$$CN$US$US
242587331$24258733$1$I$$20240820$20240828$20240828$PER$$US-CHATTEMPRD-2024OHG028978$CHATTEM$$$$$$Y$$$20240828$$CN$US$US
242587341$24258734$1$I$20240822$20240823$20240828$20240828$EXP$$CA-JNJFOC-20240870221$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240828$$CN$CA$CA
242587352$24258735$2$F$$20240905$20240828$20240912$EXP$$US-LUNDBECK-DKLU4001931$LUNDBECK$$$$$$Y$$$20240912$$CN$US$US
242587371$24258737$1$I$20240819$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59123$$FDA-CTU$$32$YR$$F$N$$$20240827$Y$PH$US$
242587391$24258739$1$I$20240820$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59080$$FDA-CTU$$61$YR$$M$N$$$20240827$Y$PH$US$
242587421$24258742$1$I$$20240819$20240828$20240828$EXP$$US-GSK-US2024103444$GLAXOSMITHKLINE$$$$$F$Y$$$20240828$$MD$US$US
242587441$24258744$1$I$$20240821$20240828$20240828$EXP$$AU-VERTEX PHARMACEUTICALS-2024-013497$VERTEX$$20$YR$$F$Y$$$20240828$$HP$AU$AU
242587462$24258746$2$F$20210101$20240905$20240828$20240911$PER$$US-VERTEX PHARMACEUTICALS-2024-013622$VERTEX$$$$$$Y$$$20240911$$CN$US$US
242587471$24258747$1$I$$20240822$20240828$20240828$PER$$US-VERTEX PHARMACEUTICALS-2024-013576$VERTEX$$$$$$Y$$$20240828$$CN$US$US
242587481$24258748$1$I$20240810$20240820$20240828$20240828$EXP$GB-MHRA-MED-202408201541096440-JDBYV$GB-VERTEX PHARMACEUTICALS-2024-013486$VERTEX$$19$YR$$M$Y$$$20240828$$HP$GB$GB
242587492$24258749$2$F$$20240919$20240828$20240925$PER$$US-VERTEX PHARMACEUTICALS-2024-013624$VERTEX$$$$A$$Y$$$20240925$$CN$US$US
242587502$24258750$2$F$20230101$20240903$20240828$20240906$EXP$$US-VERTEX PHARMACEUTICALS-2024-013701$VERTEX$$$$$F$Y$$$20240906$$MD$US$US
242587512$24258751$2$F$20240812$20240814$20240828$20240829$EXP$$US-UCBSA-2024043242$UCB$$4$YR$$F$Y$10.9$KG$20240829$$MD$US$US
242587521$24258752$1$I$20240801$20240820$20240828$20240828$EXP$$CO-SA-2024SA250990$SANOFI AVENTIS$$31$YR$A$F$Y$64$KG$20240828$$CN$CO$CO
242587531$24258753$1$I$$20240821$20240828$20240828$PER$$US-CHATTEMPRD-2024OHG028981$CHATTEM$$$$$$Y$$$20240828$$CN$US$US
242587541$24258754$1$I$$20240820$20240828$20240828$PER$$US-BIOGEN-2024BI01279366$BIOGEN$$$$$M$Y$$$20240828$$CN$US$US
242587561$24258756$1$I$$20240815$20240828$20240828$EXP$$BR-GLENMARK PHARMACEUTICALS-2024GMK093381$GLENMARK$Honorato CM, Carrascoza GG, Abed NM, Moya FG.. Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor.. Anais brasileiros de dermatologia.. 2024$$$$$Y$$$20240828$$MD$BR$BR
242587571$24258757$1$I$20240101$20240822$20240828$20240828$EXP$$US-AMGEN-USASP2024168737$AMGEN$$$$$$Y$$$20240828$$MD$US$US
242587583$24258758$3$F$20240826$20240915$20240828$20240917$PER$$US-AMGEN-USASP2024171127$AMGEN$$62$YR$A$M$Y$$$20240917$$CN$US$US
242587592$24258759$2$F$$20240821$20240828$20240927$EXP$$PT-SA-2024SA249750$SANOFI AVENTIS$Reis HH, Foreman N, Guimaraes C, Matias P, Dias M, Almeida J.. Hypocoagulation Complications in Chronic Liver Disease.. Medicina Interna - Congressos Nacionais, 30CNMI. 2024;05:1033$58$YR$A$M$Y$$$20240927$$HP$PT$PT
242587601$24258760$1$I$$20240821$20240828$20240828$EXP$$PT-SA-2024SA249778$SANOFI AVENTIS$Conceicao P, Lopes T, Nogueira D, Reinas A.. Cholestatic Injury: A Rare Case of Drug Induced Liver Injury (DILI) from Enoxaparin.. Medicina Interna - Congressos Nacionais, 30CNMI. 2024;05:1031$86$YR$E$F$Y$$$20240828$$HP$PT$PT
242587621$24258762$1$I$20240820$20240820$20240828$20240828$PER$$US-BAYER-2024A122287$BAYER$$86$YR$E$M$Y$$$20240828$$CN$US$US
242587631$24258763$1$I$20240807$20240827$20240828$20240828$EXP$GB-MHRA-MED-202408261731134380-MGSZV$GB-SANDOZ INC.-SDZ2024GB075802$SANDOZ$$63$YR$$F$Y$100$KG$20240828$$CN$GB$GB
242587661$24258766$1$I$20240612$20240823$20240828$20240828$EXP$SE-SEMPA-2024-006205$SE-FreseniusKabi-FK202412832$FRESENIUS KABI$$76$YR$E$F$Y$$$20240828$$MD$SE$SE
242587671$24258767$1$I$$20240826$20240828$20240828$EXP$$IR-SA-2024SA251560$SANOFI AVENTIS$Zonooz YA, Alizadehasl A, Davani DN, Jebelli SF, Aliabadi AY, Najdaghi S and all. Cardiac interventricular septum hemangioma in a colon cancer patient treated with Capecitabine: A case report and review of literature. Clinical Case Reports. 2024;12:8$21$YR$A$M$Y$$$20240828$$MD$IR$IR
242587681$24258768$1$I$20240101$20240206$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000437$AMERICAN REGENT$$$$$M$Y$$$20240828$$HP$US$US
242587691$24258769$1$I$$20240205$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000426$AMERICAN REGENT$$$$$F$Y$$$20240828$$CN$US$US
242587701$24258770$1$I$20240101$20240208$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000468$AMERICAN REGENT$$$$E$F$Y$$$20240828$$PH$US$US
242587711$24258771$1$I$$20240129$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000324$AMERICAN REGENT$$$$$F$Y$$$20240828$$MD$US$US
242587721$24258772$1$I$20240827$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59116$$FDA-CTU$$66$YR$$F$N$$$20240827$Y$HP$US$
242587731$24258773$1$I$20240731$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59071$$FDA-CTU$$78$YR$$F$N$$$20240827$Y$HP$US$
242587751$24258775$1$I$$20240129$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000327$AMERICAN REGENT$$5$DEC$$F$Y$$$20240828$$HP$US$US
242587762$24258776$2$F$$20240826$20240828$20240905$EXP$$CA-TEVA-VS-3236044$TEVA$$76$YR$$F$Y$$$20240905$$HP$CA$CA
242587771$24258777$1$I$$20240819$20240828$20240828$EXP$$CA-APOTEX-2024AP009541$APOTEX$$$$$$Y$$$20240828$$HP$CA$CA
242587781$24258778$1$I$$20240208$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000474$AMERICAN REGENT$$$$$F$Y$$$20240828$$CN$US$US
242587791$24258779$1$I$$20240203$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000408$AMERICAN REGENT$$$$$F$Y$$$20240828$$MD$US$US
242587801$24258780$1$I$20240801$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169513$AMGEN$$74$YR$E$F$Y$$$20240828$$CN$US$US
242587811$24258781$1$I$20240821$20240821$20240828$20240828$PER$$US-AMGEN-USASP2024171048$AMGEN$$75$YR$E$M$Y$$$20240828$$PH$US$US
242587821$24258782$1$I$$20240826$20240828$20240828$EXP$$US-TAKEDA-2024TUS055946$TAKEDA$$$$$F$Y$$$20240828$$HP$US$US
242587831$24258783$1$I$$20240821$20240828$20240828$PER$$US-JNJFOC-20240856493$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$HP$US$US
242587841$24258784$1$I$20240817$20240821$20240828$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134633$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240828$$PH$JP$JP
242587851$24258785$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136611$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240828$$HP$US$US
242587861$24258786$1$I$20240705$20240816$20240828$20240828$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004435$PAREXEL$$$$$$Y$$$20240828$$CN$US$US
242587871$24258787$1$I$20240101$20240822$20240828$20240828$PER$$US-BIOGEN-2024BI01279719$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
242587881$24258788$1$I$$20240816$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408013397$ELI LILLY AND CO$$38$YR$A$$Y$$$20240828$$LW$US$US
242587891$24258789$1$I$20240813$20240819$20240828$20240828$EXP$$CN-009507513-2408CHN007200$MERCK$$65$YR$$M$Y$55$KG$20240828$$HP$CN$CN
242587901$24258790$1$I$20240821$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016048$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240828$$CN$US$US
242587911$24258791$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016108$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240828$$CN$US$US
242587921$24258792$1$I$20240101$20240821$20240828$20240828$EXP$$US-ABBVIE-5891535$ABBVIE$$$$$F$Y$56.7$KG$20240828$$CN$US$US
242587931$24258793$1$I$$20240826$20240828$20240828$PER$$US-BAYER-2024A123541$BAYER$$$$$F$Y$$$20240828$$CN$US$US
242587951$24258795$1$I$$20240827$20240828$20240828$EXP$$US-JNJFOC-20240870848$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$HP$US$US
242587961$24258796$1$I$$20240827$20240828$20240828$PER$$US-BAYER-2024A123200$BAYER$$$$$$Y$$$20240828$$CN$US$US
242588001$24258800$1$I$20240827$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59110$$FDA-CTU$$79$YR$$M$N$$$20240827$Y$HP$US$
242588011$24258801$1$I$20240809$20240816$20240828$20240828$EXP$$US-Accord-442672$ACCORD$$59$YR$A$M$Y$$$20240828$$HP$US$US
242588021$24258802$1$I$$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-59114$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242588031$24258803$1$I$$20240816$20240828$20240828$EXP$$US-Accord-442730$ACCORD$Fasanya-Maku H, Petty D, Knapik J, Leon M, Gonsalves C. A case of metastatic HPV-related cervical small cell neuroendocrine carcinoma with varying cytomorphology found in cytological specimens of a solid organ transplant recipient. Diagnostic Cytopathology. 2024;52(9):E202-7.DOI:10.1002/dc.25361.$53$YR$A$F$Y$$$20240828$$MD$US$US
242588041$24258804$1$I$20240702$20240816$20240828$20240828$EXP$CN-HENLIUS-24CN016473$CN-Accord-443041$ACCORD$$62$YR$A$M$Y$$$20240828$$MD$CN$CN
242588051$24258805$1$I$20240713$20240816$20240828$20240828$EXP$FR-AFSSAPS-PC2024000651$FR-Accord-442511$ACCORD$$62$YR$A$F$Y$$$20240828$$PH$FR$FR
242588061$24258806$1$I$20230928$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59056$$FDA-CTU$$66$YR$$M$N$69.8$KG$20240827$N$PH$US$
242588071$24258807$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59094$$FDA-CTU$$50$YR$$F$N$78.47$KG$20240827$N$$US$
242588081$24258808$1$I$20240501$20240816$20240828$20240828$EXP$IT-MINISAL02-998293$IT-Accord-442425$ACCORD$$40$YR$A$F$Y$49$KG$20240828$$MD$IT$IT
242588091$24258809$1$I$20240814$20240816$20240828$20240828$EXP$$US-Accord-442673$ACCORD$$61$YR$A$M$Y$$$20240828$$HP$US$US
242588101$24258810$1$I$20200301$20240816$20240828$20240828$EXP$DE-BFARM-24005352$DE-Accord-442579$ACCORD$$41$YR$A$F$Y$90$KG$20240828$$CN$DE$DE
242588111$24258811$1$I$20240812$20240814$20240828$20240828$EXP$$US-Accord-442925$ACCORD$$24$YR$A$F$Y$$$20240828$$HP$US$US
242588121$24258812$1$I$$20240816$20240828$20240828$EXP$$US-Accord-443015$ACCORD$$66$YR$E$M$Y$$$20240828$$HP$US$US
242588131$24258813$1$I$20240705$20240816$20240828$20240828$EXP$CN-HENLIUS-24CN016483$CN-Accord-443212$ACCORD$$79$YR$E$M$Y$45$KG$20240828$$MD$CN$CN
242588141$24258814$1$I$$20240826$20240828$20240828$PER$$US-ABBVIE-5897679$ABBVIE$$$$$$Y$$$20240828$$CN$US$US
242588151$24258815$1$I$$20240827$20240828$20240828$PER$$US-BAYER-2024A123244$BAYER$$$$$$Y$$$20240828$$CN$US$US
242588161$24258816$1$I$$20240819$20240828$20240828$PER$$US-ABBVIE-5887780$ABBVIE$$$$$$Y$$$20240828$$CN$US$US
242588171$24258817$1$I$$20240822$20240828$20240828$EXP$$US-AMGEN-USASP2024168659$AMGEN$Hahn NM. Neoadjuvant Cisplatin, Gemeitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis. Bladder Cancer. 2024;10 (2):133-143$$$$$Y$$$20240828$$MD$US$US
242588181$24258818$1$I$$20240823$20240828$20240828$EXP$$GB-AMGEN-GBRSP2024169633$AMGEN$$$$$F$Y$$$20240828$$CN$GB$GB
242588211$24258821$1$I$20240823$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243359$PFIZER$$48$YR$$F$Y$$$20240828$$CN$US$US
242588221$24258822$1$I$20240825$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243197$PFIZER$$28$YR$$F$Y$$$20240828$$CN$US$US
242588231$24258823$1$I$$20240820$20240828$20240828$EXP$$NVSC2024BR171751$NOVARTIS$Honorato CMA, Carrascoza GG, Abed NM, Moya FG.. Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor. ANAIS BRASILEIROS DE DERMATOLOGIA. 2024;1-4$60$YR$$M$Y$$$20240828$$HP$BR$BR
242588241$24258824$1$I$$20240821$20240828$20240828$EXP$$NVSC2024HU171598$NOVARTIS$$$$$$Y$$$20240828$$MD$HU$HU
242588261$24258826$1$I$$20240823$20240828$20240828$PER$$US-ABBVIE-5895724$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242588271$24258827$1$I$20240820$20240824$20240828$20240828$PER$$US-PFIZER INC-202400243299$PFIZER$$80$YR$$F$Y$$$20240828$$CN$US$US
242588281$24258828$1$I$20240821$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243355$PFIZER$$72$YR$$M$Y$$$20240828$$CN$US$US
242588291$24258829$1$I$20240824$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243371$PFIZER$$62$YR$$M$Y$$$20240828$$CN$US$US
242588301$24258830$1$I$20240826$20240825$20240828$20240828$PER$$US-PFIZER INC-202400244175$PFIZER$$45$YR$$M$Y$77.1$KG$20240828$$CN$US$US
242588313$24258831$3$F$20240823$20240924$20240828$20240926$PER$$US-PFIZER INC-PV202400110935$PFIZER$$$$A$M$Y$$$20240926$$CN$US$US
242588321$24258832$1$I$20240824$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243661$PFIZER$$33$YR$$F$Y$$$20240828$$CN$US$US
242588331$24258833$1$I$20240801$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243332$PFIZER$$64$YR$$F$Y$$$20240828$$HP$US$US
242588341$24258834$1$I$20240801$20240825$20240828$20240828$PER$$US-PFIZER INC-PV202400110917$PFIZER$$88$YR$$$Y$$$20240828$$CN$US$US
242588353$24258835$3$F$20240101$20240923$20240828$20240925$PER$$US-PFIZER INC-202400243304$PFIZER$$78$YR$$F$Y$59.864$KG$20240925$$CN$US$US
242588362$24258836$2$F$20240801$20240924$20240828$20240927$PER$$US-PFIZER INC-202400243551$PFIZER$$59$YR$$M$Y$90.249$KG$20240927$$CN$US$US
242588371$24258837$1$I$20240823$20240824$20240828$20240828$PER$$US-PFIZER INC-202400243577$PFIZER$$68$YR$$F$Y$$$20240828$$CN$US$US
242588381$24258838$1$I$20240822$20240824$20240828$20240828$PER$$US-PFIZER INC-202400243378$PFIZER$$43$YR$$F$Y$$$20240828$$CN$US$US
242588391$24258839$1$I$20240801$20240824$20240828$20240828$PER$$US-PFIZER INC-202400243507$PFIZER$$76$YR$$M$Y$$$20240828$$CN$US$US
242588401$24258840$1$I$20240825$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243362$PFIZER$$23$YR$$F$Y$$$20240828$$CN$US$US
242588411$24258841$1$I$20240820$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243648$PFIZER$$66$YR$$F$Y$$$20240828$$CN$US$US
242588421$24258842$1$I$20240718$20240819$20240828$20240828$EXP$FR-AFSSAPS-AM2024000661$FR-FreseniusKabi-FK202412722$FRESENIUS KABI$$55$YR$A$F$Y$74$KG$20240828$$MD$FR$FR
242588431$24258843$1$I$$20240826$20240828$20240828$EXP$$NVSC2024US173014$NOVARTIS$$$$$M$Y$$$20240828$$HP$US$US
242588442$24258844$2$F$20240805$20240910$20240828$20240913$EXP$$NVSC2024US172939$NOVARTIS$$53$YR$$M$Y$$$20240913$$MD$US$US
242588451$24258845$1$I$$20240826$20240828$20240828$PER$$NVSC2024US173436$NOVARTIS$$$$$$Y$$$20240828$$MD$US$US
242588461$24258846$1$I$20240822$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243583$PFIZER$$70$YR$$M$Y$$$20240828$$CN$US$US
242588471$24258847$1$I$20240304$20240820$20240828$20240828$EXP$DK-DKMA-30737660$DK-FreseniusKabi-FK202412701$FRESENIUS KABI$$17$YR$T$F$Y$109$KG$20240828$$MD$DK$DK
242588481$24258848$1$I$$20240827$20240828$20240828$PER$$US-BAYER-2024A123255$BAYER$$$$$$Y$$$20240828$$CN$US$US
242588511$24258851$1$I$20240826$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170370$AMGEN$$60$YR$A$F$Y$$$20240828$$CN$US$US
242588521$24258852$1$I$$20240820$20240828$20240828$EXP$$KR-AstraZeneca-2024A189648$ASTRAZENECA$$$$A$M$Y$$$20240828$$CN$KR$
242588531$24258853$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190095$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242588541$24258854$1$I$$20240827$20240828$20240828$PER$$US-BAYER-2024A123415$BAYER$$17$YR$T$F$Y$$$20240828$$CN$US$US
242588552$24258855$2$F$$20240917$20240828$20240923$EXP$$GB-MYLANLABS-2024M1078540$MYLAN$$$$$F$Y$$$20240923$$MD$GB$GB
242588562$24258856$2$F$$20240906$20240828$20240912$EXP$$JP-009507513-2408JPN002708J$MERCK$$8$DEC$$M$Y$$$20240912$$MD$JP$JP
242588571$24258857$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136551$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$56.25$KG$20240828$$CN$US$US
242588581$24258858$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136533$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240828$$HP$US$US
242588591$24258859$1$I$$20240814$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129479$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$HP$US$US
242588601$24258860$1$I$20240822$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136715$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240828$$HP$US$US
242588611$24258861$1$I$$20240827$20240828$20240828$EXP$$CA-ORGANON-O2408CAN002004$ORGANON$$81$YR$$F$Y$86$KG$20240828$$HP$CA$CA
242588621$24258862$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136358$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$69.85$KG$20240828$$CN$US$US
242588631$24258863$1$I$$20240816$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130439$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240828$$HP$US$US
242588641$24258864$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59106$$FDA-CTU$$63$YR$$F$N$127.01$KG$20240827$N$$US$
242588661$24258866$1$I$$20240823$20240828$20240828$PER$$US-BIOVITRUM-2024-US-011306$BIOVITRUM$$50$YR$$M$Y$$$20240828$$CN$US$US
242588672$24258867$2$F$$20240912$20240828$20240920$EXP$$NL-TEVA-VS-3236915$TEVA$$75$YR$$M$Y$$$20240920$$CN$NL$NL
242588681$24258868$1$I$20240817$20240822$20240828$20240828$EXP$$NL-TERSERA THERAPEUTICS LLC-2024TRS004343$TERSERA THERAPEUTICS$$$$$$Y$$$20240828$$CN$NL$NL
242588691$24258869$1$I$20240826$20240827$20240827$20240827$DIR$716063$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242588701$24258870$1$I$20220305$20230201$20240828$20240828$EXP$$AU-SANDOZ INC.-NVSC2022AU083741$SANDOZ$$2$YR$$F$Y$16$KG$20240828$$MD$AU$AU
242588711$24258871$1$I$$20240819$20240828$20240828$EXP$$CH-TEVA-VS-3236524$TEVA$Martin VE , Vulli?moz S , Momjian S , Rossetti A , Vassallo P. Pharmacodrug-resistant epilepsy with diffuse lesions. Schweiz-Med-Forum 2024; 24 (22): 280-81.$19$YR$$M$Y$$$20240828$$MD$CH$CH
242588721$24258872$1$I$20230912$20240724$20240828$20240828$EXP$$CN-Ipsen Biopharmaceuticals, Inc.-2024-14814$IPSEN$XIANCHENG W, KEMIN Y, YANG S, XIANG X, XIANXI M, WENBO L, et al. Severe subcutaneous hematoma after injection of botulinum toxin into the masseter muscle: a case report and literature review. Chinese Journal of Plastic Surgery. 668-672. doi:10. 3760/cma. j. 14453-20240113-00020.$29$YR$A$M$Y$$$20240828$$HP$CN$CN
242588731$24258873$1$I$$20240823$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047929$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240828$$CN$US$US
242588742$24258874$2$F$20240808$20240903$20240828$20240916$EXP$$HU-FreseniusKabi-FK202412759$FRESENIUS KABI$$4$MON$I$M$Y$4.3$KG$20240916$$PH$HU$HU
242588761$24258876$1$I$$20240827$20240827$20240827$DIR$716165$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242588781$24258878$1$I$$20240827$20240827$20240827$DIR$716154$$FDA-CTU$$$$$F$N$$$20240827$N$HP$US$
242588791$24258879$1$I$20240822$20240827$20240827$20240827$DIR$716079$$FDA-CTU$$68$YR$$M$N$$$20240827$N$PH$US$
242588801$24258880$1$I$20240827$20240827$20240827$20240827$DIR$716159$$FDA-CTU$$49$YR$$UNK$N$$$20240827$N$$US$
242588821$24258882$1$I$20240801$20240823$20240828$20240828$EXP$IT-MINISAL02-998884$IT-FreseniusKabi-FK202412842$FRESENIUS KABI$$57$YR$A$F$Y$56$KG$20240828$$MD$IT$IT
242588831$24258883$1$I$20240809$20240820$20240828$20240828$EXP$$CN-FreseniusKabi-FK202412793$FRESENIUS KABI$$65$YR$E$F$Y$60$KG$20240828$$HP$CN$CN
242588841$24258884$1$I$20240809$20240822$20240828$20240828$EXP$$US-009507513-2408USA008072$MERCK$$66$YR$$F$Y$$$20240828$$CN$US$US
242588851$24258885$1$I$$20240222$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000671$AMERICAN REGENT$$$$A$F$Y$$$20240828$$MD$US$US
242588861$24258886$1$I$$20240305$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000819$AMERICAN REGENT$$6$DEC$$F$Y$$$20240828$$MD$US$US
242588871$24258887$1$I$$20240214$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000558$AMERICAN REGENT$$$$$$Y$$$20240828$$HP$US$US
242588881$24258888$1$I$20231101$20240229$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000770$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242588891$24258889$1$I$$20240214$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000559$AMERICAN REGENT$$$$$$Y$$$20240828$$HP$US$US
242588901$24258890$1$I$20220101$20240228$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000752$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242588911$24258891$1$I$20240818$20240819$20240828$20240828$EXP$$US-JNJFOC-20240852843$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240828$$CN$US$US
242588921$24258892$1$I$20240209$20240308$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000771$AMERICAN REGENT$$43$YR$$F$Y$$$20240828$$HP$US$US
242588931$24258893$1$I$20240826$20240826$20240828$20240828$PER$$US-JNJFOC-20240866194$JOHNSON AND JOHNSON$$44$YR$A$$Y$$$20240828$$HP$US$US
242588941$24258894$1$I$$20240822$20240828$20240828$EXP$$CA-TAKEDA-2024TUS070136$TAKEDA$$$$$M$Y$$$20240828$$CN$CA$CA
242588952$24258895$2$F$20240801$20240829$20240828$20240903$PER$$US-AMGEN-USASP2024169374$AMGEN$$66$YR$E$M$Y$$$20240902$$PH$US$US
242588961$24258896$1$I$$20240826$20240828$20240828$PER$$NVSC2024US173028$NOVARTIS$$$$$F$Y$$$20240828$$MD$US$US
242588971$24258897$1$I$20240816$20240821$20240828$20240828$EXP$$CN-009507513-2408CHN008111$MERCK$$65$YR$$F$Y$$$20240828$$HP$CN$CN
242588982$24258898$2$F$$20240822$20240828$20240902$EXP$$BR-GENMAB-2024-03113$GENMAB$$51$YR$$M$Y$$$20240902$$MD$BR$BR
242588991$24258899$1$I$$20240827$20240828$20240828$EXP$$CA-ORGANON-O2408CAN002001$ORGANON$$40$YR$$F$Y$73$KG$20240828$$MD$CA$CA
242589003$24258900$3$F$20240826$20240829$20240828$20240831$PER$$US-AMGEN-USASP2024171367$AMGEN$$33$YR$A$F$Y$$$20240831$$PH$US$US
242589011$24258901$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024171456$AMGEN$$$$$$Y$$$20240828$$PH$US$US
242589021$24258902$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015163$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240828$$CN$US$US
242589031$24258903$1$I$$20240819$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011759$ELI LILLY AND CO$$53$YR$A$$Y$$$20240828$$HP$US$US
242589042$24258904$2$F$20190101$20240903$20240828$20240913$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408012229$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240913$$CN$BR$BR
242589051$24258905$1$I$20240801$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016481$ELI LILLY AND CO$$45$YR$A$$Y$$$20240828$$CN$US$US
242589061$24258906$1$I$$20240823$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408015189$ELI LILLY AND CO$$$$$$Y$$$20240828$$HP$US$US
242589071$24258907$1$I$$20240816$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010946$ELI LILLY AND CO$$61$YR$A$$Y$$$20240828$$LW$US$US
242589081$24258908$1$I$20240201$20240822$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014569$ELI LILLY AND CO$$$$A$M$Y$$$20240828$$CN$US$US
242589091$24258909$1$I$$20240816$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016799$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240828$$CN$US$US
242589101$24258910$1$I$$20240815$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010651$ELI LILLY AND CO$$$$$M$Y$$$20240828$$HP$US$US
242589111$24258911$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59118$$FDA-CTU$$50$YR$$F$N$88.45$KG$20240827$N$$US$
242589121$24258912$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015890$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240828$$CN$US$US
242589131$24258913$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017255$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240828$$CN$US$US
242589141$24258914$1$I$$20240827$20240827$20240827$DIR$716106$$FDA-CTU$$32$YR$$F$N$63$KG$20240827$N$CN$US$
242589151$24258915$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59099$$FDA-CTU$$68$YR$$F$N$$$20240827$N$$US$
242589162$24258916$2$F$20240822$20240828$20240828$20240903$EXP$$CA-PFIZER INC-202400242857$PFIZER$$53$YR$$M$Y$$$20240902$$MD$CA$CA
242589171$24258917$1$I$$20240820$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014824$ELI LILLY AND CO$$39$YR$A$$Y$$$20240828$$CN$US$US
242589181$24258918$1$I$20220622$20240823$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110681$PFIZER$$36$YR$$M$Y$79$KG$20240828$$HP$CN$CN
242589191$24258919$1$I$20240801$20240826$20240828$20240828$EXP$$US-PFIZER INC-202400244106$PFIZER$$18$YR$$F$Y$53.98$KG$20240828$$CN$US$US
242589202$24258920$2$F$20220101$20240924$20240828$20240926$EXP$$US-PFIZER INC-PV202400110708$PFIZER$$61$YR$$F$Y$$$20240926$$HP$US$US
242589211$24258921$1$I$20240627$20240823$20240828$20240828$EXP$FR-AFSSAPS-PV2024000769$FR-PFIZER INC-202400242506$PFIZER$$10$YR$$M$Y$27$KG$20240828$$MD$FR$FR
242589221$24258922$1$I$$20240827$20240828$20240828$EXP$GB-MHRA-MIDB-2475276d-cc81-4d9e-974d-6a8f7058aee0$GB-ORGANON-O2408GBR002015$ORGANON$$89$YR$$F$Y$$$20240828$$PH$GB$GB
242589241$24258924$1$I$20230102$20240823$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110598$PFIZER$$77$YR$$F$Y$40$KG$20240828$$HP$CN$CN
242589251$24258925$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59072$$FDA-CTU$$58$YR$$M$N$63.5$KG$20240827$N$$US$
242589261$24258926$1$I$$20240827$20240827$20240827$DIR$716056$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242589271$24258927$1$I$$20240823$20240828$20240828$EXP$$US-PFIZER INC-202400243960$PFIZER$$67$YR$$F$Y$$$20240828$$HP$US$US
242589291$24258929$1$I$$20240827$20240828$20240828$EXP$$CN-PFIZER INC-PV202400111642$PFIZER$$$$A$F$Y$$$20240828$$CN$CN$CN
242589301$24258930$1$I$20240516$20240823$20240828$20240828$EXP$FR-AFSSAPS-LL2024001593$FR-PFIZER INC-202400242518$PFIZER$$60$YR$$F$Y$50.6$KG$20240828$$MD$FR$FR
242589311$24258931$1$I$20240401$20240823$20240828$20240828$EXP$$US-PFIZER INC-PV202300039156$PFIZER$$79$YR$$M$Y$$$20240828$$CN$US$US
242589321$24258932$1$I$20240101$20240825$20240828$20240828$EXP$$IN-PFIZER INC-PV202400108243$PFIZER$$32$YR$$M$Y$$$20240828$$CN$IN$IN
242589341$24258934$1$I$20210106$20240823$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110619$PFIZER$$54$YR$$F$Y$65$KG$20240828$$HP$CN$CN
242589351$24258935$1$I$$20240826$20240828$20240828$EXP$$CN-PFIZER INC-PV202400111494$PFIZER$$37$YR$$M$Y$$$20240828$$CN$CN$CN
242589361$24258936$1$I$$20240827$20240828$20240828$EXP$$US-PFIZER INC-PV202400112009$PFIZER$$92$YR$$M$Y$$$20240828$$CN$US$US
242589371$24258937$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59078$$FDA-CTU$$73$YR$$F$N$65.77$KG$20240827$N$$US$
242589381$24258938$1$I$20240827$20240827$20240827$20240827$DIR$716182$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242589391$24258939$1$I$20240820$20240826$20240828$20240828$EXP$$CN-PFIZER INC-PV202400111345$PFIZER$$34$YR$$F$Y$36$KG$20240828$$HP$CN$CN
242589401$24258940$1$I$20240810$20240825$20240828$20240828$EXP$$US-PFIZER INC-202400243437$PFIZER$$82$YR$$F$Y$$$20240828$$CN$US$US
242589412$24258941$2$F$$20240923$20240828$20240926$EXP$$US-PFIZER INC-202400244090$PFIZER$$66$YR$$F$Y$$$20240926$$CN$US$US
242589421$24258942$1$I$20180101$20240823$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110669$PFIZER$$54$YR$$M$Y$100$KG$20240828$$HP$CN$CN
242589431$24258943$1$I$20180802$20240823$20240828$20240828$EXP$$ZA-PFIZER INC-2018305404$PFIZER$$74$YR$$F$Y$80$KG$20240828$$MD$ZA$ZA
242589454$24258945$4$F$$20240924$20240828$20240927$EXP$$US-PFIZER INC-2021044645$PFIZER$$80$YR$$F$Y$49.887$KG$20240927$$CN$US$US
242589461$24258946$1$I$20240725$20240826$20240828$20240828$EXP$FR-AFSSAPS-BX2024001678$FR-PFIZER INC-202400243570$PFIZER$$63$YR$$F$Y$44$KG$20240828$$PH$FR$FR
242589481$24258948$1$I$$20240826$20240828$20240828$EXP$$CA-PFIZER INC-202400244768$PFIZER$$32$YR$$M$Y$$$20240828$$MD$CA$CA
242589491$24258949$1$I$$20240827$20240828$20240828$EXP$$JP-PFIZER INC-PV202400111859$PFIZER$$$$$$Y$$$20240828$$MD$JP$JP
242589501$24258950$1$I$$20240821$20240828$20240828$PER$$US-MYLANLABS-2024M1078287$MYLAN$$$$$F$Y$$$20240828$$CN$US$US
242589511$24258951$1$I$$20240827$20240828$20240828$EXP$$JP-PFIZER INC-202400244280$PFIZER$$$$$$Y$$$20240828$$PH$JP$JP
242589521$24258952$1$I$$20240827$20240828$20240828$EXP$$CA-PFIZER INC-202400244945$PFIZER$$60$YR$$M$Y$101$KG$20240828$$HP$CA$CA
242589531$24258953$1$I$$20240819$20240828$20240828$EXP$$US-JNJFOC-20240856039$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$CN$US$US
242589541$24258954$1$I$$20240820$20240828$20240828$EXP$$CA-TEVA-VS-3235001$TEVA$$14$YR$$M$Y$$$20240828$$HP$CA$CA
242589551$24258955$1$I$$20240820$20240828$20240828$EXP$$BG-UCBSA-2024043233$UCB$Vasilev P, Viteva E. Clinical cases of paradoxical seizure aggravation from brivaracetam. Bulgarian Neurology. 2024;25:50-51$66$YR$$M$Y$$$20240828$$MD$BG$BG
242589561$24258956$1$I$$20240806$20240828$20240828$PER$$US-AstraZeneca-2024A179495$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242589571$24258957$1$I$20240805$20240806$20240828$20240828$PER$$US-AstraZeneca-2024A179278$ASTRAZENECA$$26323$DY$$F$Y$$$20240828$$CN$US$
242589581$24258958$1$I$$20240807$20240828$20240828$PER$$US-AstraZeneca-2024A180672$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242589591$24258959$1$I$$20240823$20240828$20240828$PER$$US-LEO Pharma-373029$LEO PHARM$$77$YR$$F$Y$$$20240828$$PH$US$US
242589601$24258960$1$I$20231217$20240823$20240828$20240828$EXP$PL-URPL-DML-MLP.4401.2.181.2024$PL-BAUSCH-BL-2024-012828$BAUSCH AND LOMB$$6$WK$$M$Y$4.678$KG$20240828$$CN$PL$PL
242589622$24258962$2$F$20240822$20240827$20240828$20240830$PER$$US-ABBVIE-5893666$ABBVIE$$23$YR$$F$Y$$$20240830$$HP$US$US
242589631$24258963$1$I$20220518$20240822$20240828$20240828$EXP$$PL-BAUSCH-BL-2024-012810$BAUSCH AND LOMB$$$$A$M$Y$$$20240828$$HP$PL$PL
242589643$24258964$3$F$$20240911$20240828$20240913$30DAY$$AT-PFIZER INC-202400239839$PFIZER$$$$$$Y$$$20240913$$CN$AT$AT
242589652$24258965$2$F$20200101$20240909$20240828$20240911$EXP$NO-NOMAADVRE-PASRAPP-2024-Vzb3pj$NO-PFIZER INC-202400241599$PFIZER$$42$YR$$F$Y$91$KG$20240911$$CN$NO$NO
242589661$24258966$1$I$$20240822$20240828$20240828$30DAY$$KR-PFIZER INC-PV202400110733$PFIZER$$$$$$Y$$$20240828$$CN$KR$KR
242589681$24258968$1$I$20240622$20240824$20240828$20240828$EXP$ES-AEMPS-1562975$ES-BAUSCH-BL-2024-012850$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240828$$MD$ES$ES
242589691$24258969$1$I$20240820$20240820$20240828$20240828$EXP$$JP-AMGEN-JPNSP2024168413$AMGEN$$$$E$F$Y$$$20240828$$MD$JP$JP
242589701$24258970$1$I$20240208$20240820$20240828$20240828$EXP$$CA-GSK-CA2024018306$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$CA$CA
242589711$24258971$1$I$$20240823$20240828$20240828$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-135626$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$MD$CA$CA
242589721$24258972$1$I$$20240826$20240828$20240828$PER$$NVSC2024US173035$NOVARTIS$$$$$M$Y$$$20240828$$CN$US$US
242589731$24258973$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136411$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240828$$PH$US$US
242589752$24258975$2$F$20240813$20240827$20240828$20240904$EXP$$US-BAYER-2024A118958$BAYER$$62$YR$A$M$Y$$$20240904$$CN$US$US
242589781$24258978$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59105$$FDA-CTU$$57$YR$$M$N$$$20240827$N$$US$
242589791$24258979$1$I$20231126$20240827$20240827$20240827$DIR$716076$$FDA-CTU$$46$YR$$M$N$98.1$KG$20240827$N$PH$US$
242589801$24258980$1$I$20240723$20240827$20240827$20240827$DIR$716071$$FDA-CTU$$57$YR$$F$N$67.2$KG$20240827$N$HP$US$
242589811$24258981$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59088$$FDA-CTU$$6$YR$$M$N$19.05$KG$20240827$N$HP$US$
242589821$24258982$1$I$20240722$20240827$20240827$20240827$DIR$716073$$FDA-CTU$$53$YR$$F$N$71.9$KG$20240827$N$HP$US$
242589841$24258984$1$I$$20240822$20240828$20240828$EXP$$US-MYLANLABS-2024M1079253$MYLAN$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.$60$YR$$F$Y$$$20240828$$HP$US$US
242589851$24258985$1$I$$20240822$20240828$20240828$EXP$$ES-MYLANLABS-2024M1078212$MYLAN$$76$YR$$F$Y$$$20240828$$MD$ES$ES
242589861$24258986$1$I$$20240822$20240828$20240828$EXP$$IL-MYLANLABS-2024M1079317$MYLAN$Liran R, Garra W, Carmi O, Levy Y, Einbinder Y. A Severe Acute Kidney Injury Following Zoledronic Acid Therapy Leading to Chronic Hemodialysis Treatment: A Case Report. Isr-Med-Assoc-J 2023; 25 828-829.$78$YR$$F$Y$$$20240828$$MD$IL$IL
242589871$24258987$1$I$$20240827$20240828$20240828$EXP$GB-MHRA-MED-202408260754075230-QCTSY$GB-ORGANON-O2408GBR002019$ORGANON$$46$YR$$F$Y$60$KG$20240828$$CN$GB$GB
242589881$24258988$1$I$$20240822$20240828$20240828$EXP$$US-PFIZER INC-PV202400111190$PFIZER$Ho, H.. Tissue injury secondary to peripheral xenobiotic administration. JACEP Open. 2023;4(3):10.1002/emp2.12972$57$YR$$F$Y$$$20240828$$MD$US$US
242589891$24258989$1$I$$20240819$20240828$20240828$PER$$US-PFM-2024-04658$PIERRE FABRE MEDICAMENT$Carney MC, Karolcik BA, Gupta A, Arora G, Beerman BL, Follansbee CW. A case of persistent junctional reciprocating tachycardia coincident with cor triatriatum sinister. World Journal for Pediatric and Congenital Heart Surgery. 2024;15:525-27$5$MON$$M$Y$$$20240828$$HP$US$US
242589902$24258990$2$F$$20240902$20240828$20240909$EXP$$NVSC2024CZ153122$NOVARTIS$$$$A$M$Y$$$20240909$$MD$CZ$CZ
242589911$24258991$1$I$20220101$20240826$20240828$20240828$EXP$$US-UCBSA-2024043457$UCB$$$$$F$Y$$$20240828$$HP$US$US
242589921$24258992$1$I$$20240812$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08102$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242589931$24258993$1$I$20240809$20240816$20240828$20240828$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004438$PAREXEL$$$$$$Y$$$20240828$$CN$US$US
242589951$24258995$1$I$20240827$20240827$20240827$20240827$DIR$716190$$FDA-CTU$$40$YR$$M$N$100.35$KG$20240827$N$CN$US$
242589961$24258996$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5894305$ABBVIE$$55$YR$$M$Y$$$20240828$$HP$US$US
242589971$24258997$1$I$$20240822$20240828$20240828$PER$$US-ABBVIE-5895231$ABBVIE$$$$A$$Y$$$20240828$$PH$US$US
242589981$24258998$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-202400243115$PFIZER$$59$YR$$F$Y$$$20240828$$CN$US$US
242589992$24258999$2$F$$20240925$20240828$20240930$PER$$US-PFIZER INC-PV202300122052$PFIZER$$83$YR$$F$Y$$$20240930$$CN$US$US
242590001$24259000$1$I$20240823$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243683$PFIZER$$53$YR$$M$Y$$$20240828$$CN$US$US
242590011$24259001$1$I$20240822$20240826$20240828$20240828$PER$$US-PFIZER INC-202400243840$PFIZER$$57$YR$$F$Y$$$20240828$$CN$US$US
242590021$24259002$1$I$20240727$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243346$PFIZER$$66$YR$$F$Y$$$20240828$$CN$US$US
242590041$24259004$1$I$20240825$20240826$20240828$20240828$PER$$US-PFIZER INC-202400244012$PFIZER$$68$YR$$M$Y$$$20240828$$CN$US$US
242590051$24259005$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-PV202400110554$PFIZER$$80$YR$$F$Y$$$20240828$$CN$US$US
242590061$24259006$1$I$20240825$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243668$PFIZER$$74$YR$$F$Y$$$20240828$$CN$US$US
242590071$24259007$1$I$20240824$20240826$20240828$20240828$PER$$US-PFIZER INC-202400243899$PFIZER$$61$YR$$F$Y$$$20240828$$HP$US$US
242590081$24259008$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59070$$FDA-CTU$$45$YR$$F$N$$$20240827$N$$US$
242590091$24259009$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-202400244138$PFIZER$$68$YR$$F$Y$70.295$KG$20240828$$CN$US$US
242590101$24259010$1$I$20240801$20240824$20240828$20240828$PER$$US-PFIZER INC-202400243319$PFIZER$$73$YR$$F$Y$$$20240828$$CN$US$US
242590111$24259011$1$I$20211015$20240826$20240828$20240828$PER$$US-PFIZER INC-PV202400110894$PFIZER$$30$YR$$F$Y$64.853$KG$20240828$$CN$US$US
242590121$24259012$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-202400244046$PFIZER$$$$$F$Y$$$20240828$$CN$US$US
242590131$24259013$1$I$20240813$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59113$$FDA-CTU$$59$YR$$M$N$$$20240827$N$HP$US$
242590141$24259014$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-PV202400111666$PFIZER$$$$$F$Y$$$20240828$$CN$US$US
242590151$24259015$1$I$$20240826$20240828$20240828$PER$$PL-PFIZER INC-202400243746$PFIZER$$$$$M$Y$$$20240828$$MD$PL$PL
242590171$24259017$1$I$20240824$20240826$20240828$20240828$PER$$US-PFIZER INC-202400244393$PFIZER$$40$YR$$F$Y$$$20240828$$HP$US$US
242590181$24259018$1$I$20240821$20240826$20240828$20240828$PER$$US-PFIZER INC-202400244010$PFIZER$$67$YR$$M$Y$$$20240828$$CN$US$US
242590201$24259020$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-202400244655$PFIZER$$53$YR$$F$Y$$$20240828$$CN$US$US
242590211$24259021$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-202400244252$PFIZER$$75$YR$$F$Y$$$20240828$$CN$US$US
242590221$24259022$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-202400244166$PFIZER$$$$A$F$Y$$$20240828$$MD$US$US
242590231$24259023$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00702$GLAND PHARMA$$$$$M$Y$$$20240828$$CN$US$US
242590251$24259025$1$I$$20240822$20240828$20240828$PER$$US-009507513-2408USA008659$MERCK$$$$$F$Y$$$20240828$$HP$US$US
242590281$24259028$1$I$20240112$20240826$20240828$20240828$EXP$FR-AFSSAPS-LL2024001576$FR-FreseniusKabi-FK202412915$FRESENIUS KABI$$57$YR$A$M$Y$$$20240828$$PH$FR$FR
242590301$24259030$1$I$$20240822$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US074868$SANDOZ$$$$$$Y$$$20240828$$CN$US$US
242590311$24259031$1$I$$20240812$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08117$LUPIN$$$$$$Y$$$20240828$$PH$US$US
242590331$24259033$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00689$GLAND PHARMA$$$$$F$Y$$$20240828$$CN$US$US
242590351$24259035$1$I$20240722$20240822$20240828$20240828$EXP$$US-BAYER-2024A107926$BAYER$$68$YR$E$M$Y$67.12$KG$20240828$$CN$US$US
242590361$24259036$1$I$$20240820$20240828$20240828$EXP$$ZA-AstraZeneca-2024A189796$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$ZA$
242590371$24259037$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59097$$FDA-CTU$$27$YR$$M$N$$$20240827$N$$US$
242590381$24259038$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015587$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240828$$CN$US$US
242590392$24259039$2$F$$20240816$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408010906$ELI LILLY AND CO$$71$YR$E$$Y$$$20240828$$LW$US$US
242590402$24259040$2$F$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016135$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240828$$CN$US$US
242590411$24259041$1$I$20240826$20240827$20240827$20240827$DIR$716178$$FDA-CTU$$5$YR$$M$N$22.51$KG$20240827$N$CN$US$
242590421$24259042$1$I$20240825$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59109$$FDA-CTU$$68$YR$$F$N$$$20240827$N$$US$
242590431$24259043$1$I$$20240808$20240828$20240828$PER$$US-TEVA-VS-3231476$TEVA$$$$$F$Y$$$20240828$$CN$US$US
242590442$24259044$2$F$20240701$20240822$20240828$20240904$EXP$$US-ABBVIE-5892386$ABBVIE$$60$YR$$F$Y$$$20240904$$CN$US$US
242590451$24259045$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00699$GLAND PHARMA$$$$$F$Y$$$20240828$$CN$US$US
242590461$24259046$1$I$20231106$20240827$20240827$20240827$DIR$716084$$FDA-CTU$$38$YR$$F$N$109.8$KG$20240827$N$PH$US$
242590471$24259047$1$I$20240821$20240821$20240828$20240828$EXP$$GB-ROCHE-10000062836$ROCHE$$39$YR$A$M$Y$$$20240828$$CN$GB$GB
242590481$24259048$1$I$20240227$20240821$20240828$20240828$EXP$$AR-GSK-AR2024AMR031323$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$AR$AR
242590491$24259049$1$I$20240720$20240819$20240828$20240828$EXP$GB-MHRA-MED-202408190809519580-PNRSH$GB-BAXTER-2024BAX023421$BAXTER$$66$YR$$M$Y$74$KG$20240828$$HP$GB$GB
242590501$24259050$1$I$$20240814$20240828$20240828$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240800082$UPSHER SMITH LABORATORIES$$$$$$Y$$$20240828$$MD$US$US
242590511$24259051$1$I$20240612$20240611$20240828$20240828$EXP$$US-BRACCO-2024US03468$BRACCO$$$$$M$Y$$$20240828$$HP$US$US
242590521$24259052$1$I$20240523$20240523$20240828$20240828$EXP$$US-BRACCO-2024US03480$BRACCO$$$$$M$Y$$$20240828$$MD$US$US
242590541$24259054$1$I$$20240813$20240828$20240828$PER$$US-GLANDPHARMA-US-2024GLNSPO00680$GLAND PHARMA$$$$$F$Y$$$20240828$$CN$US$US
242590551$24259055$1$I$20240806$20240826$20240828$20240828$EXP$FR-AFSSAPS-NY2024000966$FR-FreseniusKabi-FK202412919$FRESENIUS KABI$$70$YR$E$F$Y$$$20240828$$PH$FR$FR
242590562$24259056$2$F$$20240909$20240828$20240919$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240800085$UPSHER SMITH LABORATORIES$$$$$F$Y$68.027$KG$20240919$$MD$US$US
242590571$24259057$1$I$20220101$20240826$20240828$20240828$EXP$$US-ABBVIE-5896520$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242590581$24259058$1$I$$20240308$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000857$AMERICAN REGENT$$5$YR$$F$Y$$$20240828$$CN$US$US
242590591$24259059$1$I$20240101$20240326$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001144$AMERICAN REGENT$$$$$F$Y$$$20240828$$CN$US$US
242590601$24259060$1$I$$20240314$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000982$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242590611$24259061$1$I$$20240315$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001002$AMERICAN REGENT$$$$$F$Y$$$20240828$$MD$US$US
242590621$24259062$1$I$$20240327$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001181$AMERICAN REGENT$$$$$$Y$$$20240828$$HP$US$US
242590631$24259063$1$I$$20240315$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000992$AMERICAN REGENT$$5$DEC$$F$Y$$$20240828$$HP$US$US
242590641$24259064$1$I$$20240313$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000983$AMERICAN REGENT$$$$$$Y$$$20240828$$HP$US$US
242590651$24259065$1$I$20240101$20240311$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024000887$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242590661$24259066$1$I$$20240319$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001024$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242590671$24259067$1$I$20231001$20240327$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001164$AMERICAN REGENT$$$$$$Y$$$20240828$$HP$US$US
242590681$24259068$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173667$NOVARTIS$$49$YR$$$Y$$$20240828$$CN$US$US
242590691$24259069$1$I$20240814$20240814$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130027$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$PH$US$US
242590701$24259070$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136595$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240828$$HP$US$US
242590711$24259071$1$I$$20240819$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132148$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240828$$CN$US$US
242590721$24259072$1$I$20240101$20240822$20240828$20240828$PER$$US-BIOGEN-2024BI01270047$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
242590731$24259073$1$I$$20240814$20240828$20240828$PER$$US-PHARMING-PHAUS2024000693$PHARMING GROUP$$$$$$Y$$$20240822$$CN$US$US
242590751$24259075$1$I$20240701$20240823$20240828$20240828$EXP$$US-INCYTE CORPORATION-2024IN008889$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242590761$24259076$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-202400244472$PFIZER$$71$YR$$F$Y$$$20240828$$CN$US$US
242590771$24259077$1$I$$20240827$20240828$20240828$PER$$US-PFIZER INC-202400245179$PFIZER$$66$YR$$F$Y$$$20240828$$CN$US$US
242590782$24259078$2$F$20240824$20240904$20240828$20240904$PER$$US-PFIZER INC-202400245203$PFIZER$$66$YR$$F$Y$$$20240904$$CN$US$US
242590801$24259080$1$I$20240822$20240827$20240828$20240828$PER$$US-PFIZER INC-202400245182$PFIZER$$$$E$F$Y$$$20240828$$CN$US$US
242590811$24259081$1$I$$20240827$20240828$20240828$PER$$US-PFIZER INC-PV202400111899$PFIZER$$46$YR$$F$Y$$$20240828$$HP$US$US
242590821$24259082$1$I$20240701$20240826$20240828$20240828$PER$$US-PFIZER INC-PV202400111490$PFIZER$$63$YR$$F$Y$$$20240828$$HP$US$US
242590831$24259083$1$I$$20240827$20240828$20240828$PER$$US-PFIZER INC-202400245116$PFIZER$$51$YR$$F$Y$$$20240828$$MD$US$US
242590851$24259085$1$I$$20240827$20240828$20240828$PER$$US-PFIZER INC-PV202400112158$PFIZER$$20$YR$$F$Y$$$20240828$$CN$US$US
242590861$24259086$1$I$$20240827$20240828$20240828$PER$$US-PFIZER INC-202400245218$PFIZER$$74$YR$$F$Y$$$20240828$$CN$US$US
242590871$24259087$1$I$20240823$20240825$20240828$20240828$PER$$US-PFIZER INC-202400243692$PFIZER$$72$YR$$F$Y$$$20240828$$CN$US$US
242590881$24259088$1$I$$20240827$20240828$20240828$PER$$US-PFIZER INC-PV202400112031$PFIZER$$49$YR$$M$Y$$$20240828$$HP$US$US
242590891$24259089$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-202400245096$PFIZER$$67$YR$$M$Y$$$20240828$$MD$US$US
242590901$24259090$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-PV202400111543$PFIZER$$69$YR$$F$Y$$$20240828$$HP$US$US
242590911$24259091$1$I$$20240827$20240828$20240828$PER$$US-PFIZER INC-202400245219$PFIZER$$$$$$Y$$$20240828$$CN$US$US
242590921$24259092$1$I$20240826$20240827$20240828$20240828$PER$$US-PFIZER INC-202400245206$PFIZER$$45$YR$$M$Y$$$20240828$$CN$US$US
242590931$24259093$1$I$20240826$20240826$20240828$20240828$PER$$US-PFIZER INC-202400195664$PFIZER$$69$YR$$F$Y$$$20240828$$HP$US$US
242590951$24259095$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-202400244210$PFIZER$$69$YR$$F$Y$$$20240828$$CN$US$US
242590961$24259096$1$I$20240824$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170384$AMGEN$$71$YR$E$F$Y$$$20240828$$CN$US$US
242590971$24259097$1$I$20240704$20240813$20240828$20240828$PER$$US-LEADINGPHARMA-US-2024LEASPO00362$LEADING PHARMA$$$$$F$Y$$$20240828$$CN$US$US
242590981$24259098$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59084$$FDA-CTU$$$$$F$N$$$20240827$N$HP$US$
242590991$24259099$1$I$$20240826$20240828$20240828$EXP$$US-TAKEDA-2024TUS086008$TAKEDA$$$$$M$Y$$$20240828$$CN$US$US
242591001$24259100$1$I$$20240814$20240828$20240828$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08185$LUPIN$Fling C, Granados L, Coruh B. An ophtha-MALA-gic anomaly: Metformin associated lactic acidosis causing transient blindness. American Journal of Respiratory and Critical Care Medicine. 2023;207$62$YR$$M$Y$$$20240828$$HP$US$US
242591021$24259102$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59096$$FDA-CTU$$73$YR$$F$N$$$20240827$N$$US$
242591031$24259103$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59095$$FDA-CTU$$76$YR$$F$N$$$20240827$N$$US$
242591041$24259104$1$I$20240823$20240826$20240827$20240827$DIR$FDA-CDER-CTU-2024-59102$$FDA-CTU$$72$YR$$F$N$$$20240826$N$$US$
242591051$24259105$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59111$$FDA-CTU$$71$YR$$F$N$73.48$KG$20240827$N$HP$US$
242591061$24259106$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59067$$FDA-CTU$$67$YR$$F$N$$$20240827$N$$US$
242591071$24259107$1$I$20240822$20240822$20240827$20240827$DIR$FDA-CDER-CTU-2024-59112$$FDA-CTU$$52$YR$$F$N$$$20240822$N$HP$US$
242591081$24259108$1$I$$20240820$20240828$20240828$EXP$$US-SA-2024SA251161$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240828$$MD$US$US
242591092$24259109$2$F$20240101$20240906$20240828$20240926$EXP$$FI-SA-2024SA249197$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240926$$CN$FI$FI
242591101$24259110$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59225$$FDA-CTU$$46$YR$$M$N$$$20240828$N$$US$
242591111$24259111$1$I$20240710$20240820$20240828$20240828$EXP$FR-AFSSAPS-AN2024001095$FR-SA-2024SA250968$SANOFI AVENTIS$$79$YR$E$M$Y$98.5$KG$20240828$$MD$FR$FR
242591121$24259112$1$I$20240710$20240821$20240828$20240828$EXP$$US-OTSUKA-2023_011038$OTSUKA$$61$YR$$M$Y$$$20240828$$CN$US$US
242591132$24259113$2$F$20240801$20240830$20240828$20240906$EXP$$GB-JNJFOC-20240854051$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$MD$GB$GB
242591142$24259114$2$F$$20240822$20240828$20240828$EXP$$CA-JNJFOC-20240856578$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$CN$CA$CA
242591162$24259116$2$F$$20240916$20240828$20240924$EXP$$NVSC2024BR173326$NOVARTIS$$$$$F$Y$$$20240924$$CN$BR$BR
242591171$24259117$1$I$$20240827$20240828$20240828$EXP$$DE-ROCHE-771777$ROCHE$WOBSER M, Kneitz H, Broecker E, and Becker J. Primary cutaneous diffuse large b-cell lymphoma, leg-type, treated with a modified r-chop immunochemotherapy - diagnostic and therapeutic challenges.. JDDG - Journal Of The German Society Of Dermatology 2011;9 (3):204-11.$81$YR$E$M$Y$$$20240828$$MD$DE$DE
242591182$24259118$2$F$20240823$20240917$20240828$20240920$EXP$$US-SA-2024SA251038$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240920$$MD$US$US
242591201$24259120$1$I$20240316$20240820$20240828$20240828$EXP$$CA-OTSUKA-2023_022912$OTSUKA$$23$YR$$F$Y$$$20240828$$HP$CA$CA
242591211$24259121$1$I$$20240820$20240828$20240828$EXP$$US-PERRIGO-24US007899$PERRIGO$Bhandari B, Siddique S, Tahir S, Link MG. Loperamide-Induced Torsades de Pointes. Cureus. 2024;16(7):e64427. DOI: 10.7759/cureus.64427.$27$YR$$F$Y$$$20240828$$MD$US$US
242591221$24259122$1$I$$20240821$20240828$20240828$EXP$$ID-PERRIGO-24ID007900$PERRIGO$Permatasanti A, Sufiawati I. Case Series of HIV-Associated Oral Lesions Across Different Clinical Stages in People Living with HIV. HIV/AIDS - Research and Palliative Care. 2024;16:289-99. DOI:10.2147/HIV.S478366.$34$YR$$F$Y$$$20240828$$MD$ID$ID
242591231$24259123$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142139$DAIICHI$$62$YR$$F$Y$52$KG$20240828$$MD$CA$CA
242591241$24259124$1$I$20240819$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024168499$AMGEN$$72$YR$E$F$Y$$$20240828$$CN$US$US
242591251$24259125$1$I$20240825$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170611$AMGEN$$70$YR$E$F$Y$$$20240828$$CN$US$US
242591261$24259126$1$I$$20240823$20240828$20240828$EXP$$GB-AMGEN-GBRSP2024169632$AMGEN$$$$$M$Y$$$20240828$$CN$GB$GB
242591271$24259127$1$I$$20240822$20240828$20240828$EXP$$US-PERRIGO-24US007902$PERRIGO$Parikh SV, Madhavan S, Shapiro J, Knight R, Rosenberg AZ, Parikh CR, et al. Characterization of Glomerular and Tubulointerstitial Proteomes in a Case of Nonsteroidal Anti-Inflammatory Drug?Attributed Acute Kidney Injury A Clinical Pathologic Molecular Correlation. Clinical Journal of the American Society of Nephrology. 2023;18(3):402-10. DOI:10.2215/CJN.09260822.$38$YR$$F$Y$$$20240828$$MD$US$US
242591281$24259128$1$I$$20240728$20240828$20240828$PER$$AT-TRAVERE-2024TVT00843$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240828$$MD$AT$AT
242591291$24259129$1$I$20240712$20240730$20240828$20240828$PER$$DE-TRAVERE-2024TVT00852$TRAVERE THERAPEUTICS$$27$YR$A$M$Y$84$KG$20240828$$MD$DE$DE
242591301$24259130$1$I$20240625$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170606$AMGEN$$81$YR$E$F$Y$$$20240828$$CN$US$US
242591311$24259131$1$I$20240101$20240813$20240828$20240828$PER$$US-GRANULES-US-2024GRASPO00376$GRANULES INDIA$$$$$M$Y$$$20240828$$CN$US$US
242591321$24259132$1$I$$20240823$20240828$20240828$EXP$$US-TAKEDA-2024TUS085701$TAKEDA$$$$$M$Y$$$20240828$$CN$US$US
242591331$24259133$1$I$20240815$20240816$20240828$20240828$EXP$$US-Accord-442674$ACCORD$$30$YR$A$M$Y$$$20240828$$HP$US$US
242591341$24259134$1$I$$20240816$20240828$20240828$EXP$$IT-Accord-442663$ACCORD$Celardo G, Scaffei E, Buchignani B, Donatelli G, Costagli M, Cristofani P, et al. Case report: Exploring chemoradiotherapy-induced leukoencephalopathy with 7T imaging and quantitative susceptibility mapping. Front-Neurol 2024; 15 1-6.$9$YR$C$M$Y$$$20240828$$HP$IT$IT
242591351$24259135$1$I$$20240816$20240828$20240828$EXP$$IT-Accord-442600$ACCORD$Tovo P, Garazzino S, Saglio F, Scolfaro C, Bustamante J, Badolato R. et al. Successful Hematopoietic Stem Cell Transplantation in a Patient with Complete IFN-lambda Receptor 2 Deficiency: a Case Report and Literature Review. Journal of Clinical Immunology. 2020;40:1191-1195$4$YR$C$M$Y$$$20240828$$MD$IT$IT
242591361$24259136$1$I$20240813$20240816$20240828$20240828$EXP$$US-Accord-443502$ACCORD$$54$YR$A$$Y$$$20240828$$HP$US$US
242591371$24259137$1$I$$20240816$20240828$20240828$EXP$$CZ-Accord-442772$ACCORD$Charvatova M, Krejci V. Clinical benefit of TOM antipsychotics for personalized medicine. Ceska a Slovenska Psychiatrie. 2024;120(3):143-50.$62$YR$A$M$Y$$$20240828$$MD$CZ$CZ
242591381$24259138$1$I$$20240816$20240828$20240828$EXP$$DE-Accord-442952$ACCORD$Bergner CG, Schafer L, Vucinic V, Schetschorke B, Lier J, Scherlach C et al. Case report: Treatment of advanced CSF1-receptor associated leukoencephalopathy with hematopoietic stem cell transplant. Front Neurol. 2023,14.$42$YR$A$M$Y$$$20240828$$MD$DE$DE
242591391$24259139$1$I$$20240816$20240828$20240828$EXP$$PT-Accord-442532$ACCORD$Carrilho M, Nobre MB, Santos MC, Silva RC, Martins JR. CO-0062 - (4147) - MYOCARDITIS A CMV .Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts (CNMI). 2024 May, 162.$72$YR$E$F$Y$$$20240828$$MD$PT$PT
242591403$24259140$3$F$20240802$20240912$20240828$20240924$EXP$$CN-Accord-443504$ACCORD$$44$YR$A$F$Y$45.8$KG$20240924$$MD$CN$CN
242591411$24259141$1$I$20240801$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132475$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240828$$HP$US$US
242591421$24259142$1$I$$20240821$20240828$20240828$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-133988$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240828$$MD$DE$DE
242591431$24259143$1$I$$20240822$20240828$20240828$EXP$$MY-Accord-443444$ACCORD$Ding CH, Wahab WA, Saaid MS, Mokhtar MN, Abdullah FA, Azaharuddin I. Septicaemia due to Vibrio vulnificus: A tropical infection not to be taken lightly. Trop Biomed. 2024 Jun 1;41(2):157-159.$67$YR$E$M$Y$$$20240828$$HP$MY$MY
242591441$24259144$1$I$$20240820$20240828$20240828$EXP$$US-HLS-202400997$HLS THERAPEUTICS$$$$A$F$Y$$$20240828$$HP$GB$US
242591451$24259145$1$I$$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131912$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$87.54$KG$20240828$$CN$US$US
242591461$24259146$1$I$$20240821$20240828$20240828$EXP$$US-OTSUKA-2024_023160$OTSUKA$$$$$F$Y$$$20240828$$CN$US$US
242591471$24259147$1$I$20240826$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170399$AMGEN$$63$YR$A$F$Y$$$20240828$$CN$US$US
242591481$24259148$1$I$$20240820$20240828$20240828$EXP$$NVSC2024FR173090$NOVARTIS$$$$$$Y$$$20240828$$MD$FR$FR
242591491$24259149$1$I$20240813$20240814$20240828$20240828$PER$$US-JNJFOC-20240841853$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240828$$CN$US$US
242591501$24259150$1$I$20240817$20240827$20240828$20240828$PER$$US-BAYER-2024A123528$BAYER$$38$YR$A$M$Y$$$20240828$$CN$US$US
242591511$24259151$1$I$20240701$20240820$20240828$20240828$EXP$$CA-TAKEDA-2024TUS084355$TAKEDA$$75$YR$$F$Y$$$20240828$$CN$CA$CA
242591521$24259152$1$I$$20240820$20240828$20240828$PER$$US-BIOGEN-2024BI01275759$BIOGEN$$$$$M$Y$$$20240828$$CN$US$US
242591531$24259153$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016973$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240828$$CN$US$US
242591541$24259154$1$I$20240826$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016230$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240828$$CN$US$US
242591551$24259155$1$I$20240825$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015921$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240828$$CN$US$US
242591561$24259156$1$I$$20240827$20240828$20240828$EXP$$NVSC2024CA173331$NOVARTIS$$36$YR$$F$Y$$$20240828$$CN$CA$CA
242591571$24259157$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015936$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$US$US
242591581$24259158$1$I$20240824$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016596$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240828$$CN$US$US
242591591$24259159$1$I$20240818$20240819$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408011583$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240828$$CN$US$US
242591601$24259160$1$I$$20240828$20240828$20240828$PER$$US-BAYER-2024A123783$BAYER$$75$YR$E$M$Y$$$20240828$$CN$US$US
242591611$24259161$1$I$$20240821$20240828$20240828$EXP$$US-HALEON-2193616$Haleon PLC$$$$$$Y$$$20240827$$HP$US$US
242591622$24259162$2$F$20240820$20240905$20240828$20240909$EXP$$JP-009507513-2408JPN002484J$MERCK$$75$YR$$F$Y$$$20240909$$PH$JP$JP
242591631$24259163$1$I$20240801$20240826$20240828$20240828$EXP$$US-INCYTE CORPORATION-2024IN008947$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242591641$24259164$1$I$20240424$20240821$20240828$20240828$EXP$FR-AFSSAPS-AM2024000660$FR-009507513-2408FRA007588$MERCK$$71$YR$$M$Y$74$KG$20240828$$MD$FR$FR
242591651$24259165$1$I$20200618$20240822$20240828$20240828$EXP$PL-URPL-1-1874-2020$PL-MYLANLABS-2024M1078198$MYLAN$$20$YR$$M$Y$120$KG$20240828$$MD$PL$PL
242591661$24259166$1$I$$20240822$20240828$20240828$EXP$$FR-MYLANLABS-2024M1078043$MYLAN$$$$$M$Y$84$KG$20240828$$MD$FR$FR
242591671$24259167$1$I$20240404$20240822$20240828$20240828$EXP$$NL-MYLANLABS-2024M1078009$MYLAN$$55$YR$$F$Y$52.1$KG$20240828$$MD$NL$NL
242591681$24259168$1$I$$20240821$20240828$20240828$EXP$$JP-OTSUKA-2024_023187$OTSUKA$$$$$$Y$$$20240828$$MD$JP$JP
242591691$24259169$1$I$20240816$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59130$$FDA-CTU$$$$$F$N$19.5$KG$20240827$N$$US$
242591721$24259172$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59242$$FDA-CTU$$71$YR$$F$N$68.04$KG$20240828$N$$US$
242591731$24259173$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59216$$FDA-CTU$$55$YR$$F$N$116.57$KG$20240828$N$$US$
242591761$24259176$1$I$$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59295$$FDA-CTU$$$$$F$N$$$20240827$N$HP$US$
242591773$24259177$3$F$20240812$20240828$20240828$20240925$EXP$$MX-BEH-2024177694$CSL BEHRING$$29$YR$A$F$Y$86$KG$20240925$$CN$MX$MX
242591781$24259178$1$I$$20240818$20240828$20240828$EXP$$US-JNJFOC-20240855419$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240828$$HP$US$US
242591811$24259181$1$I$20240824$20240825$20240828$20240828$EXP$$US-SERB S.A.S.-2160947$LABORATOIRES SERB$$53$YR$$F$Y$$$20240828$$$US$US
242591821$24259182$1$I$$20240726$20240828$20240828$PER$$US-Breckenridge Pharmaceutical, Inc.-2160948$BRECKENRIDGE$$32$YR$$M$Y$68.182$KG$20240828$$$US$US
242591831$24259183$1$I$$20240822$20240828$20240828$PER$$US-Karo Pharma-2160945$Karo Pharma$$36$YR$$F$Y$$$20240828$$PH$US$US
242591851$24259185$1$I$$20240808$20240828$20240828$PER$$US-TEVA-VS-3234064$TEVA$$$$$M$Y$$$20240828$$CN$US$US
242591861$24259186$1$I$$20240816$20240828$20240828$EXP$$US-B.Braun Medical Inc.-2160946$B BRAUN$Literature Article$57$YR$$M$Y$$$20240828$$$US$US
242591871$24259187$1$I$20240823$20240827$20240828$20240828$PER$$US-BAYER-2024A123290$BAYER$$77$YR$E$F$Y$$$20240828$$CN$US$US
242591891$24259189$1$I$$20240820$20240828$20240828$PER$$US-ALXN-202408USA001276US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242591911$24259191$1$I$$20240822$20240828$20240828$PER$$US-TAKEDA-2024TUS085271$TAKEDA$$$$A$F$Y$$$20240828$$MD$US$US
242591921$24259192$1$I$$20240821$20240828$20240828$EXP$$CA-GSK-CA2024104524$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$CA$CA
242591931$24259193$1$I$$20240819$20240828$20240828$EXP$$CA-JNJFOC-20240849526$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240828$$HP$CA$CA
242591941$24259194$1$I$$20240824$20240828$20240828$PER$$US-TAKEDA-2024TUS086104$TAKEDA$$$$$F$Y$$$20240828$$CN$US$US
242591951$24259195$1$I$20240520$20240826$20240828$20240828$EXP$$ZA-ABBVIE-5896753$ABBVIE$$53$YR$$F$Y$$$20240828$$CN$ZA$ZA
242591961$24259196$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190812$ASTRAZENECA$Chattopadhyay, P.; Sureshkumar, K.; Kareff, S.; Rodriguez, E.. Exploring Clinical Characteristics and Treatment Outcomes of Squamous Cell Lung Cancers Harboring EGFR and ALK Mutations: A Case Series. World Conference on Lung Cancer (WCLC) - International Association for the Study of Lung Cancer (IASLC) 2024;$$$$F$Y$$$20240828$$HP$US$
242591971$24259197$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A189676$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242591981$24259198$1$I$20240730$20240822$20240828$20240828$EXP$FR-AFSSAPS-PB2024000874$FR-OTSUKA-2024_023190$OTSUKA$$48$YR$$F$Y$$$20240828$$MD$FR$FR
242591991$24259199$1$I$20240802$20240820$20240828$20240828$EXP$$AR-AstraZeneca-2024A187741$ASTRAZENECA$$16593$DY$$M$Y$$$20240828$$CN$AR$
242592001$24259200$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A192603$ASTRAZENECA$Aggarwal, V.; Kim, C.. MET Point Mutations as the Mechanism of Resistance to EGFR-TKI Therapy: A Case Report of MET H1094Y-Mediated Resistance to Osimertinib Overcome by Capmatinib and a Systematic Review. 2024 World Conference on Lung Cancer (WCLC) - International Association for the Study of Lung Cancer (IASLC) 2024;$69$YR$$M$Y$$$20240828$$HP$US$
242592011$24259201$1$I$$20240820$20240828$20240828$EXP$$CN-AstraZeneca-2024A189757$ASTRAZENECA$Guo Y.; Zhang R.; Meng Y.; Wang L.; Zheng L.; You J.. Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer. Frontiers in Pharmacology 2024;15.$71$YR$$F$Y$$$20240828$$HP$CN$
242592021$24259202$1$I$$20240820$20240828$20240828$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007326$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240828$$MD$DE$DE
242592041$24259204$1$I$20240814$20240827$20240828$20240828$PER$$US-AMGEN-USASP2024171690$AMGEN$$87$YR$E$F$Y$$$20240828$$CN$US$US
242592051$24259205$1$I$$20240826$20240828$20240828$EXP$$US-BIOVITRUM-2024-US-011339$BIOVITRUM$$$$A$$Y$$$20240828$$MD$US$US
242592062$24259206$2$F$$20240910$20240828$20240912$PER$$NVSC2024US173651$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
242592071$24259207$1$I$$20240827$20240828$20240828$EXP$$US-PURDUE-USA-2024-0311633$PURDUE$$$$$M$Y$$$20240828$$CN$US$US
242592083$24259208$3$F$$20240911$20240828$20240925$EXP$$CA-HALEON-2193660$Haleon PLC$$58$YR$$F$Y$$$20240925$$MD$CA$CA
242592092$24259209$2$F$20240314$20240909$20240828$20240913$EXP$$ES-PURDUE-USA-2024-0311614$PURDUE$$56$YR$$M$Y$$$20240913$$MD$ES$ES
242592101$24259210$1$I$20200101$20240823$20240828$20240828$EXP$$US-PURDUE PHARMA-USA-2024-0311606$PURDUE$$$$$F$Y$$$20240828$$CN$US$US
242592111$24259211$1$I$$20240819$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131727$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240828$$CN$US$US
242592121$24259212$1$I$20220801$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135143$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240828$$CN$US$US
242592131$24259213$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136705$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$89.81$KG$20240828$$CN$US$US
242592141$24259214$1$I$$20240822$20240828$20240828$EXP$$CA-PURDUE-USA-2024-0311602$PURDUE$$49$YR$$F$Y$$$20240828$$HP$CA$CA
242592151$24259215$1$I$$20240824$20240828$20240828$EXP$GB-MHRA-MED-202408241343045230-HPZKN$GB-BAYER-2024A122023$BAYER$$31$YR$A$M$Y$86$KG$20240828$$CN$GB$GB
242592161$24259216$1$I$$20240827$20240828$20240828$PER$$US-TAKEDA-2024TUS086574$TAKEDA$$$$$M$Y$104$KG$20240828$$CN$US$US
242592181$24259218$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59294$$FDA-CTU$$66$YR$$M$N$$$20240828$N$$US$
242592191$24259219$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59219$$FDA-CTU$$61$YR$$F$N$$$20240828$N$$US$
242592211$24259221$1$I$20231001$20240821$20240828$20240828$PER$$US-ABBVIE-5895971$ABBVIE$$89$YR$$F$Y$$$20240828$$CN$US$US
242592221$24259222$1$I$20240828$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59287$$FDA-CTU$$11$YR$$M$N$58.06$KG$20240828$N$CN$US$
242592231$24259223$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59161$$FDA-CTU$$57$YR$$F$N$127.01$KG$20240828$N$$US$
242592241$24259224$1$I$$20240824$20240828$20240828$PER$$US-ABBVIE-5897250$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242592251$24259225$1$I$20240825$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170626$AMGEN$$75$YR$E$F$Y$$$20240828$$CN$US$US
242592261$24259226$1$I$20240523$20240822$20240828$20240828$EXP$$US-BAYER-2024A122914$BAYER$$$$$M$Y$$$20240828$$LW$US$US
242592281$24259228$1$I$$20240820$20240828$20240828$EXP$$NVSC2024TR171179$NOVARTIS$Yazdali Koylu N, Koc NS, Sancar EN, Sarinc S, Altun B. Everolimus-Related Chylothorax: A Rare Case Report. EXPERIMENTAL AND CLINICAL TRANSPLANTATION. 2024;22(6):471-4$27$YR$$M$Y$$$20240828$$HP$TR$TR
242592291$24259229$1$I$$20240826$20240828$20240828$EXP$$NVSC2024US166429$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
242592301$24259230$1$I$20240820$20240823$20240828$20240828$EXP$$NVSC2024IN173108$NOVARTIS$$55$YR$$M$Y$$$20240828$$CN$IN$IN
242592311$24259231$1$I$$20240820$20240828$20240828$EXP$$US-BAYER-2024A120558$BAYER$$65$YR$E$M$Y$$$20240828$$CN$US$US
242592321$24259232$1$I$$20240822$20240828$20240828$EXP$$US-INCYTE CORPORATION-2024IN008871$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242592331$24259233$1$I$$20240812$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08135$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242592341$24259234$1$I$$20240820$20240828$20240828$EXP$$ES-AMGEN-ESPSP2024161848$AMGEN$$65$YR$E$F$Y$$$20240828$$CN$ES$ES
242592351$24259235$1$I$20240201$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170368$AMGEN$$80$YR$E$M$Y$$$20240828$$CN$US$US
242592373$24259237$3$F$20240826$20240903$20240828$20240905$PER$$US-BIOGEN-2024BI01280058$BIOGEN$$46$YR$$F$Y$$$20240905$$CN$US$US
242592381$24259238$1$I$$20240821$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014887$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240828$$CN$US$US
242592391$24259239$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016021$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242592401$24259240$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016154$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240828$$CN$US$US
242592411$24259241$1$I$$20240821$20240828$20240828$EXP$$US-AMGEN-USASP2024168533$AMGEN$$$$$$Y$$$20240828$$MD$US$US
242592421$24259242$1$I$20240826$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016008$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240828$$CN$US$US
242592431$24259243$1$I$$20240822$20240828$20240828$EXP$$US-INCYTE CORPORATION-2024IN008819$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242592441$24259244$1$I$20240821$20240823$20240828$20240828$PER$$US-HALEON-2193536$Haleon PLC$$31$YR$$M$Y$$$20240828$$CN$US$US
242592451$24259245$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136597$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240828$$CN$US$US
242592461$24259246$1$I$$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136228$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240828$$CN$US$US
242592471$24259247$1$I$$20240827$20240828$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA075668$SANDOZ$$63$YR$$M$Y$$$20240828$$HP$CA$CA
242592482$24259248$2$F$$20240918$20240828$20240924$EXP$$US-INCYTE CORPORATION-2024IN008818$INCYTE$$$$$$Y$$$20240924$$CN$US$US
242592491$24259249$1$I$$20240826$20240828$20240828$EXP$$US-AstraZeneca-2024A195280$ASTRAZENECA$$$$$$Y$$$20240828$$HP$US$
242592501$24259250$1$I$$20191030$20240828$20240828$EXP$$IN-AstraZeneca-2019SF55609$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$IN$
242592511$24259251$1$I$$20240821$20240828$20240828$EXP$$US-AstraZeneca-2024A192441$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242592521$24259252$1$I$$20240731$20240828$20240828$PER$$US-AstraZeneca-2024A175298$ASTRAZENECA$$$$$$Y$$$20240828$$MD$US$
242592531$24259253$1$I$$20240820$20240828$20240828$EXP$$JP-AstraZeneca-2024A190276$ASTRAZENECA$Miura H.; Miura J.; Goto S.; Yamamoto T.. Osimertinib-induced BRAF mutation in a single metastatic lesion among multiple pulmonary lesions in a case of lung cancer with EGFR exon 19 deletion. Respirology Case Reports 2024;12(8):$54$YR$$F$Y$$$20240828$$HP$JP$
242592541$24259254$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A192463$ASTRAZENECA$Nakazawa S, Pecci F, Gazgalis D, Gottlieb F, Ricciuti B, Alessi J, Di Federico A, Aldea M, Garbo E, Gandhi M, Saini A, Feng W, Facchinetti F, Makarem M, Haradon D, Che J, Awad M, Janne P.. MET Fusions in NSCLC: Prevalence, Oncogenicity, and Resistance Mechanism. World Conference on Lung Cancer (WCLC) - International Association for the Study of Lung Cancer (IASLC) 2024;$$$$$Y$$$20240828$$HP$US$
242592551$24259255$1$I$$20240823$20240828$20240828$PER$$US-JNJFOC-20240862579$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$MD$US$US
242592561$24259256$1$I$$20240820$20240828$20240828$EXP$$CN-AstraZeneca-2024A191386$ASTRAZENECA$$71$YR$$M$Y$$$20240828$$CN$CN$
242592581$24259258$1$I$20190501$20240822$20240828$20240828$EXP$$US-INCYTE CORPORATION-2024IN008814$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242592591$24259259$1$I$$20240822$20240828$20240828$EXP$$JP-BAYER-2024A121573$BAYER$$$$$M$Y$$$20240828$$MD$JP$JP
242592602$24259260$2$F$20240712$20240920$20240828$20240925$PER$$JP-Eisai-EC-2024-172989$EISAI$$77$YR$E$F$Y$$$20240925$$MD$JP$JP
242592611$24259261$1$I$$20240808$20240828$20240828$PER$$US-TEVA-VS-3231425$TEVA$$$$$$Y$$$20240828$$CN$US$US
242592621$24259262$1$I$$20231208$20240828$20240828$PER$$US-KOWA-23US002354$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592631$24259263$1$I$$20230920$20240828$20240828$PER$$US-KOWA-23US001376$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592641$24259264$1$I$$20230912$20240828$20240828$PER$$US-KOWA-23US001334$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592651$24259265$1$I$$20230721$20240828$20240828$PER$$US-KOWA-23US001070$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592661$24259266$1$I$$20230915$20240828$20240828$PER$$US-KOWA-23US001349$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592671$24259267$1$I$$20230907$20240828$20240828$PER$$US-KOWA-23US001333$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592681$24259268$1$I$20231004$20231017$20240828$20240828$PER$$US-KOWA-23US001766$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592691$24259269$1$I$$20230825$20240828$20240828$PER$$US-KOWA-23US001237$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592701$24259270$1$I$20231002$20231006$20240828$20240828$PER$$US-KOWA-23US001567$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592711$24259271$1$I$$20231128$20240828$20240828$PER$$US-KOWA-23US002332$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592721$24259272$1$I$20230930$20231005$20240828$20240828$PER$$US-KOWA-23US001546$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592731$24259273$1$I$20231121$20231122$20240828$20240828$PER$$US-KOWA-23US002281$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592741$24259274$1$I$$20231107$20240828$20240828$PER$$US-KOWA-23US002093$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592751$24259275$1$I$$20231102$20240828$20240828$PER$$US-KOWA-23US001929$KOWA PHARM$$$$$$Y$$$20240828$$HP$US$US
242592761$24259276$1$I$$20231129$20240828$20240828$EXP$$US-KOWA-23US002307$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592771$24259277$1$I$20230726$20230821$20240828$20240828$PER$$US-KOWA-23US001199$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592781$24259278$1$I$20230927$20231009$20240828$20240828$PER$$US-KOWA-23US001594$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592791$24259279$1$I$20230721$20230728$20240828$20240828$PER$$US-KOWA-23US001078$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592801$24259280$1$I$20230912$20230929$20240828$20240828$PER$$US-KOWA-23US001348$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592811$24259281$1$I$20230725$20230824$20240828$20240828$PER$$US-KOWA-23US001236$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592821$24259282$1$I$20231112$20231211$20240828$20240828$PER$$US-KOWA-23US002353$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592831$24259283$1$I$20230601$20231009$20240828$20240828$PER$$US-KOWA-23US001499$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592841$24259284$1$I$$20231118$20240828$20240828$PER$$US-KOWA-23US002248$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592851$24259285$1$I$20230901$20231011$20240828$20240828$PER$$US-KOWA-23US001352$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592861$24259286$1$I$$20231218$20240828$20240828$PER$$US-KOWA-23US002352$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592871$24259287$1$I$$20240812$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08187$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242592881$24259288$1$I$20230601$20240822$20240828$20240828$EXP$$BR-BAYER-2023A097633$BAYER$$21$YR$A$F$Y$60$KG$20240828$$CN$BR$BR
242592891$24259289$1$I$20240821$20240827$20240828$20240828$PER$$US-AMGEN-USASP2024171475$AMGEN$$68$YR$E$F$Y$$$20240828$$CN$US$US
242592901$24259290$1$I$20231001$20231024$20240828$20240828$PER$$US-KOWA-23US001763$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592911$24259291$1$I$20220101$20230912$20240828$20240828$PER$$US-KOWA-23US001285$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592921$24259292$1$I$20231108$20231201$20240828$20240828$PER$$US-KOWA-23US002312$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242592931$24259293$1$I$20240818$20240827$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136386$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240828$$HP$US$US
242592943$24259294$3$F$$20240918$20240828$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136681$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240919$$CN$US$US
242592951$24259295$1$I$$20240827$20240828$20240828$EXP$$FR-SANDOZ INC.-NVSC2019FR060261$SANDOZ$$47$YR$$F$Y$$$20240828$$MD$FR$FR
242592962$24259296$2$F$$20240902$20240828$20240910$EXP$$US-TEVA-VS-3235618$TEVA$Braun HM, Taylor JL, Axelrath S. Buprenorphine/naloxone - one formulation that doesn^t fit all: a case report. Harm-Reduct-J 2024; 21 (1):.; Braun HM, Taylor JL, Axelrath S. Buprenorphine/naloxone - one formulation that doesn^t fit all: a case report. Harm-Reduct-J 2024; 21 (1):.$$$A$F$Y$$$20240910$$HP$US$US
242592972$24259297$2$F$$20240902$20240828$20240911$EXP$$GB-TEVA-VS-3236246$TEVA$Ntatsaki E, Aboul Hossn T, Khaddage B, Vassiliou V, Vayalambrone D. HYDROXYCHLOROQUINE MONITORING- RETINAL TOXICITY RATES AND SERVICE CHALLENGES. Ann-Rheum-Dis 2024; 83 (Suppl.) 2022.; Ntatsaki E, Aboul Hossn T, Khaddage B, Vassiliou V, Vayalambrone D. HYDROXYCHLOROQUINE MONITORING- RETINAL TOXICITY RATES AND SERVICE CHALLENGES. Ann-Rheum-Dis 2024; 83 (Suppl.) 2022.$$$E$$Y$$$20240911$$HP$GB$GB
242592982$24259298$2$F$$20240828$20240828$20240904$PER$$US-BIOMARINAP-US-2024-160030$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242592992$24259299$2$F$$20240903$20240828$20240909$EXP$$CA-HALEON-2193531$Haleon PLC$$65$YR$$F$Y$$$20240909$$MD$CA$CA
242593001$24259300$1$I$$20231118$20240828$20240828$PER$$US-KOWA-23US002249$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242593012$24259301$2$F$$20240820$20240828$20240830$EXP$$JP-ROCHE-3570850$ROCHE$Shioiri N, Kikuchi R, Matsumoto I, Furukawa K, Kobayashi K and Abe S. Effective treatment of steroid-resistant immune checkpoint inhibitor pneumonitis with mycophenolate mofetil, DOI: 10.1002/RCR2.1356. Respirology case reports 2024 Apr 15;12 (4):1-5.$73$YR$E$M$Y$$$20240830$$HP$JP$JP
242593031$24259303$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59229$$FDA-CTU$$54$YR$$F$N$62.14$KG$20240828$N$$US$
242593051$24259305$1$I$20240826$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59127$$FDA-CTU$$$$$M$N$68.6$KG$20240827$N$$US$
242593111$24259311$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59279$$FDA-CTU$$29$YR$$F$N$77.11$KG$20240828$N$$US$
242593121$24259312$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59151$$FDA-CTU$$65$YR$$F$N$$$20240828$N$$US$
242593131$24259313$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59212$$FDA-CTU$$72$YR$$M$N$$$20240828$N$$US$
242593141$24259314$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59215$$FDA-CTU$$58$YR$$F$N$$$20240828$N$$US$
242593152$24259315$2$F$20240808$20240917$20240828$20240927$30DAY$$AU-JNJFOC-20240829111$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240927$$HP$AU$AU
242593161$24259316$1$I$20240815$20240820$20240828$20240828$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000844$PAREXEL$$$$$$Y$$$20240828$$HP$CN$CN
242593172$24259317$2$F$$20240905$20240828$20240910$EXP$$DE-MYLANLABS-2024M1078338$MYLAN$$80$YR$$F$Y$$$20240910$$CN$DE$DE
242593191$24259319$1$I$$20240827$20240828$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA075827$SANDOZ$$$$$F$Y$$$20240828$$MD$CA$CA
242593201$24259320$1$I$$20240822$20240828$20240828$30DAY$$US-SANDOZ INC.-SDZ2024US075165$SANDOZ$$$$$$Y$$$20240828$$CN$US$US
242593211$24259321$1$I$$20240827$20240828$20240828$30DAY$$US-SANDOZ INC.-SDZ2024US075761$SANDOZ$$$$$M$Y$$$20240828$$CN$US$US
242593222$24259322$2$F$$20240830$20240828$20240903$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048298$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240903$$CN$US$US
242593232$24259323$2$F$20221121$20240902$20240828$20240904$EXP$DE-PEI-202200154357$DE-GILEAD-2024-0685376$GILEAD$$64$YR$A$M$Y$$$20240904$$MD$DE$DE
242593241$24259324$1$I$$20240819$20240828$20240828$EXP$$US-BAYER-2024A123373$BAYER$$77$YR$E$M$Y$$$20240828$$MD$US$US
242593251$24259325$1$I$20240807$20240823$20240828$20240828$EXP$$US-AMGEN-USASL2024169490$AMGEN$$32$YR$A$M$Y$$$20240828$$CN$US$US
242593261$24259326$1$I$$20240826$20240828$20240828$PER$$US-BAYER-2024A122605$BAYER$$$$$F$Y$$$20240828$$CN$US$US
242593271$24259327$1$I$$20240819$20240828$20240828$EXP$$US-ABBVIE-5898100$ABBVIE$Parmeshwar N, Song S, Alcon A, Kim EA. The incidence of breast cancer after gender-affirming mastectomy in transmen. Ann Plast Surg. 2022;88(4):S332-6.$49$YR$$F$Y$$$20240828$$MD$US$US
242593281$24259328$1$I$20230101$20240808$20240828$20240828$PER$$US-TEVA-VS-3233753$TEVA$$63$YR$$F$Y$64$KG$20240828$$CN$US$US
242593301$24259330$1$I$20230501$20240822$20240828$20240828$EXP$$NVSC2024CO129174$NOVARTIS$$46$YR$$F$Y$68$KG$20240828$$CN$CO$CO
242593311$24259331$1$I$$20240819$20240828$20240828$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16677$IPSEN$$$$$$Y$$$20240828$$HP$US$US
242593321$24259332$1$I$$20240820$20240828$20240828$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007327$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240828$$MD$DE$DE
242593331$24259333$1$I$$20240821$20240828$20240828$EXP$$US-GSK-US2024104585$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
242593341$24259334$1$I$$20240826$20240828$20240828$EXP$$AU-GILEAD-2024-0685571$GILEAD$$$$A$$Y$$$20240828$$HP$AU$AU
242593351$24259335$1$I$20240711$20240821$20240828$20240828$EXP$CH-SM-2024-14785$CH-GSK-CH2024104232$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$CH$CH
242593361$24259336$1$I$$20240816$20240828$20240828$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093419$GLENMARK$$$$$$Y$$$20240828$$CN$US$US
242593371$24259337$1$I$$20240826$20240828$20240828$EXP$$US-JNJFOC-20240871966$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240828$$CN$US$US
242593383$24259338$3$F$20240101$20240909$20240828$20240917$EXP$$CA-JNJFOC-20240581821$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240917$$PH$CA$CA
242593391$24259339$1$I$20240723$20240823$20240828$20240828$30DAY$$CA-SANDOZ INC.-SDZ2024CA068139$SANDOZ$$31$YR$$F$Y$$$20240828$$MD$CA$CA
242593401$24259340$1$I$$20240827$20240828$20240828$EXP$$LB-SANDOZ INC.-SDZ2024LB075799$SANDOZ$$$$$F$Y$$$20240828$$HP$LB$LB
242593411$24259341$1$I$20240716$20240819$20240828$20240828$EXP$$RS-TEVA-VS-3235992$TEVA$$60$YR$$M$Y$$$20240828$$MD$RS$RS
242593421$24259342$1$I$$20240827$20240828$20240828$30DAY$$US-SANDOZ INC.-SDZ2024US075896$SANDOZ$$$$$F$Y$$$20240828$$CN$US$US
242593431$24259343$1$I$20240827$20240827$20240828$20240828$PER$$US-BAYER-2024A123617$BAYER$$82$YR$E$F$Y$$$20240828$$CN$US$US
242593441$24259344$1$I$20240516$20240821$20240828$20240828$EXP$$FR-DSJP-DSE-2024-141849$DAIICHI$$$$A$F$Y$$$20240828$$MD$FR$FR
242593451$24259345$1$I$$20240820$20240828$20240828$EXP$$US-BAYER-2024A120454$BAYER$$55$YR$A$M$Y$$$20240828$$CN$US$US
242593463$24259346$3$F$20240827$20240926$20240828$20240926$PER$$US-AMGEN-USASP2024171749$AMGEN$$77$YR$E$M$Y$$$20240926$$CN$US$US
242593471$24259347$1$I$$20240821$20240828$20240828$EXP$$ES-AMGEN-ESPSP2024167815$AMGEN$Garbayo-salmons P.; Martinez-losa M.M.; Exposito-serrano V. et al.. Insights into new-onset arthritis in patients with hidradenitis suppurativa. Acta dermato-venereologica. 2024;104:1-2$28$YR$A$F$Y$$$20240828$$HP$ES$ES
242593481$24259348$1$I$20240605$20240822$20240828$20240828$EXP$ES-AEMPS-1561855$ES-MYLANLABS-2024M1078292$MYLAN$$80$YR$$M$Y$$$20240828$$MD$ES$ES
242593491$24259349$1$I$$20240822$20240828$20240828$PER$$US-ABBVIE-5894261$ABBVIE$$$$$$Y$$$20240828$$HP$US$US
242593501$24259350$1$I$$20240822$20240828$20240828$EXP$$DE-MYLANLABS-2024M1078357$MYLAN$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al.. Valproate: Aortic arch anomaly and complex malformations: 2 case reports. Reactions. 2019;1772$$$$$Y$$$20240828$$HP$DE$DE
242593511$24259351$1$I$$20240827$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075776$SANDOZ$$$$$$Y$$$20240828$$CN$US$US
242593522$24259352$2$F$20240815$20240829$20240828$20240904$EXP$$CN-ABBVIE-5898018$ABBVIE$$62$YR$$M$Y$68$KG$20240904$$HP$CN$CN
242593531$24259353$1$I$$20240820$20240828$20240828$EXP$$ZA-AstraZeneca-2024A189626$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$ZA$
242593541$24259354$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190163$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242593551$24259355$1$I$$20240820$20240828$20240828$EXP$$JP-AstraZeneca-2024A190993$ASTRAZENECA$Ishii H, et al.. 78 A case of hepatocellular carcinoma in which hepatitis E infection was persisted during the treatment with an immune checkpoint inhibitor.. The 380th Annual Meeting of the Kanto Branch of the Japanese Society of Gastroenterology 2024;43-.$80$YR$$M$Y$$$20240828$$MD$JP$
242593561$24259356$1$I$20240823$20240827$20240827$20240827$DIR$716129$$FDA-CTU$$30$YR$$M$N$61.4$KG$20240827$Y$MD$US$
242593571$24259357$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59191$$FDA-CTU$$72$YR$$F$N$100.24$KG$20240828$N$$US$
242593581$24259358$1$I$$20240827$20240827$20240827$DIR$716028$$FDA-CTU$$14$YR$$F$N$$$20240827$N$CN$US$
242593591$24259359$1$I$20240819$20240827$20240827$20240827$DIR$716032$$FDA-CTU$$36$YR$$F$N$117$KG$20240827$Y$CN$US$
242593601$24259360$1$I$$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59282$$FDA-CTU$$$$$F$N$$$20240827$N$HP$US$
242593631$24259363$1$I$20240813$20240822$20240828$20240828$EXP$$US-BAYER-2024A119284$BAYER$$51$YR$A$M$Y$$$20240828$$CN$US$US
242593641$24259364$1$I$$20240822$20240828$20240828$EXP$$US-ALXN-202408USA001695US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$MD$US$US
242593651$24259365$1$I$20240820$20240821$20240828$20240828$EXP$GB-MHRA-MED-202408211234224730-MHWVS$GB-ROCHE-10000062955$ROCHE$$17$DY$N$F$Y$$$20240828$$PH$GB$GB
242593662$24259366$2$F$$20240914$20240828$20240915$EXP$$US-ALXN-202408USA001612US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$MD$US$US
242593671$24259367$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016355$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240828$$CN$US$US
242593681$24259368$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59158$$FDA-CTU$$83$YR$$F$N$$$20240828$N$$US$
242593691$24259369$1$I$20240825$20240827$20240827$20240827$DIR$716207$$FDA-CTU$$59$YR$$F$N$81$KG$20240827$N$CN$US$
242593711$24259371$1$I$20240823$20240827$20240827$20240827$DIR$716100$$FDA-CTU$$63$YR$$F$N$85.5$KG$20240827$N$HP$US$
242593721$24259372$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016345$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240828$$CN$US$US
242593731$24259373$1$I$20240619$20240819$20240828$20240828$EXP$FR-AFSSAPS-TO2024001269$FR-EXELIXIS-CABO-24079493$EXELIXIS$$88$YR$$M$Y$82.1$KG$20240828$$PH$FR$FR
242593763$24259376$3$F$20240822$20240912$20240828$20240913$PER$$US-AMGEN-USASP2024170338$AMGEN$$64$YR$A$F$Y$$$20240913$$CN$US$US
242593791$24259379$1$I$$20240823$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134494$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240828$$CN$US$US
242593801$24259380$1$I$$20240731$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122868$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240828$$CN$US$US
242593811$24259381$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136753$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$70.76$KG$20240828$$CN$US$US
242593831$24259383$1$I$$20240815$20240828$20240828$EXP$$US-SMPA-2024MYSCI0600528$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242593841$24259384$1$I$$20240814$20240828$20240828$EXP$$US-SMPA-2024SPA001533$SUNOVION$$$$$$Y$$$20240828$$PH$US$US
242593851$24259385$1$I$$20240814$20240828$20240828$EXP$$US-SMPA-2024SPA001534$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242593861$24259386$1$I$$20240814$20240828$20240828$EXP$$US-SMPA-2024SPA001556$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242593873$24259387$3$F$20240601$20240906$20240828$20240918$EXP$$JP-SMPA-2024SPA001750$SUNOVION$$$$$$Y$$$20240918$$HP$JP$JP
242593881$24259388$1$I$20240630$20240814$20240828$20240828$EXP$$US-SMPA-2024SPA001520$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242593891$24259389$1$I$$20240815$20240828$20240828$EXP$$US-SMPA-2024SPA000242$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242593901$24259390$1$I$$20240814$20240828$20240828$EXP$$US-HLS-202400919$HLS THERAPEUTICS$$35$YR$A$M$Y$$$20240828$$HP$US$US
242593911$24259391$1$I$20240819$20240827$20240828$20240828$PER$$US-ABBVIE-5898047$ABBVIE$$49$YR$$F$Y$$$20240828$$HP$US$US
242593921$24259392$1$I$20211004$20240826$20240828$20240828$EXP$$CA-TAKEDA-2024TUS086563$TAKEDA$$59$YR$$F$Y$$$20240828$$CN$CA$CA
242593932$24259393$2$F$20240823$20240905$20240828$20240911$EXP$$JP-009507513-2408JPN002915J$MERCK$$82$YR$$F$Y$$$20240911$$PH$JP$JP
242593941$24259394$1$I$20240816$20240822$20240828$20240828$EXP$$JP-009507513-2408JPN002845J$MERCK$$72$YR$$F$Y$$$20240828$$MD$JP$JP
242593961$24259396$1$I$20240822$20240826$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075588$SANDOZ$$57$YR$$F$Y$$$20240828$$CN$US$US
242593971$24259397$1$I$$20240822$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075056$SANDOZ$$39$YR$$M$Y$$$20240828$$HP$US$US
242593981$24259398$1$I$$20240827$20240828$20240828$EXP$$DE-SANDOZ INC.-SDZ2024DE065659$SANDOZ$$20$YR$$M$Y$$$20240828$$HP$DE$DE
242593991$24259399$1$I$$20240821$20240828$20240828$EXP$$US-AMGEN-USASP2024167694$AMGEN$Molnar M.; Yamauchi J.; Azhar A.et.al. Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2-Infected versus Noninfected Deceased Donors. Clinical journal of the American Society of Nephrology. 2023;18 (11):1466-1475$$$$$Y$$$20240828$$MD$US$US
242594001$24259400$1$I$$20240822$20240828$20240828$EXP$US-MLMSERVICE-20240815-PI164864-00306-1$US-RDY-SPO/USA/24/0012385$DR REDDYS$Attieh RM, Roach D, Wadei HM, Parikh N, Me HM, Durvasula RV, et al. Case Report: Early-Onset Adenovirus Nephritis Without Hemorrhagic Cystitis Following Kidney Transplantation. Transplantation Proceedings. 2024;56(5):1196-9. DOI:10.1016/j.transproceed.2024.05.018.$35$YR$A$M$Y$$$20240828$$MD$US$US
242594011$24259401$1$I$$20240821$20240828$20240828$PER$$US-RDY-SPO/USA/24/0012441$DR REDDYS$$16$YR$T$F$Y$$$20240828$$MD$US$US
242594021$24259402$1$I$$20240814$20240828$20240828$EXP$$US-HLS-202400909$HLS THERAPEUTICS$$36$YR$A$F$Y$$$20240828$$HP$US$US
242594031$24259403$1$I$20240827$20240827$20240828$20240828$EXP$GB-MHRA-TPP43375797C15132979YC1724759043401$GB-SANDOZ INC.-SDZ2024GB075656$SANDOZ$$41$YR$$F$Y$67$KG$20240828$$MD$GB$GB
242594051$24259405$1$I$$20240827$20240828$20240828$PER$$US-BAYER-2024A123744$BAYER$$$$$$Y$$$20240828$$CN$US$US
242594061$24259406$1$I$20240701$20240816$20240828$20240828$EXP$LT-SMCA-4775$LT-Accord-442595$ACCORD$$65$YR$E$M$Y$$$20240828$$MD$LT$LT
242594071$24259407$1$I$20240806$20240816$20240828$20240828$EXP$$CN-SA-2024SA248301$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240828$$HP$CN$CN
242594081$24259408$1$I$$20240821$20240828$20240828$EXP$$US-AMGEN-USASP2024167715$AMGEN$Srivastava S. K.; Hamdan A.; Sharma S. et. al. Management of Uveitis Patients on Anti-TNF Agents Who Develop Demvelinatina Disease-A Case Series. Journal of Ophthalmic Inflammation and Infection. 2024;14 (1):1-8$$$$F$Y$$$20240828$$HP$US$US
242594091$24259409$1$I$$20240821$20240828$20240828$PER$$US-AMGEN-USASP2024167960$AMGEN$Zhang T.; Moore C.; Naraine I.. Complete remission following pembrolizumab in a man with mCRPC with both microsatellite instability and BRCA2 mutation. Oncologist. 2024;29 (8):716-720$81$YR$E$M$Y$$$20240828$$MD$US$US
242594101$24259410$1$I$$20240423$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001493$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242594111$24259411$1$I$20240101$20240411$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001349$AMERICAN REGENT$$6$DEC$$F$Y$$$20240828$$HP$US$US
242594121$24259412$1$I$$20240404$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001258$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242594131$24259413$1$I$$20240418$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001466$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242594141$24259414$1$I$20240326$20240403$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001235$AMERICAN REGENT$$51$YR$$F$Y$$$20240828$$HP$US$US
242594161$24259416$1$I$20240101$20240815$20240828$20240828$EXP$$BR-JNJFOC-20240855090$JOHNSON AND JOHNSON$$75$YR$E$F$Y$68$KG$20240828$$MD$BR$BR
242594172$24259417$2$F$$20240903$20240828$20240909$EXP$$US-ABBVIE-5897652$ABBVIE$$60$YR$$F$Y$$$20240909$$MD$US$US
242594181$24259418$1$I$20240825$20240827$20240827$20240827$DIR$716194$$FDA-CTU$$54$YR$$F$N$112.5$KG$20240827$N$CN$US$
242594191$24259419$1$I$20240827$20240827$20240827$20240827$DIR$716177$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242594201$24259420$1$I$20240730$20240820$20240828$20240828$DIR$FDA-CDER-CTU-2024-59131$$FDA-CTU$$21$YR$$F$N$84.6$KG$20240820$N$$US$
242594221$24259422$1$I$20240826$20240827$20240827$20240827$DIR$716094$$FDA-CTU$$39$YR$$F$N$$$20240827$Y$$US$
242594231$24259423$1$I$$20240827$20240827$20240827$DIR$716059$$FDA-CTU$$$$$UNK$N$$$20240827$$CN$US$
242594241$24259424$1$I$20240131$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59209$$FDA-CTU$$29$YR$$F$N$80.1$KG$20240827$N$HP$US$
242594251$24259425$1$I$20240813$20240827$20240827$20240827$DIR$716108$$FDA-CTU$$75$YR$$F$N$47.7$KG$20240827$N$CN$US$
242594261$24259426$1$I$$20240827$20240827$20240827$DIR$716130$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242594271$24259427$1$I$20240825$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59290$$FDA-CTU$$82$YR$$M$N$$$20240828$N$$US$
242594281$24259428$1$I$20240821$20240827$20240827$20240827$DIR$716107$$FDA-CTU$$72$YR$$F$N$67.5$KG$20240827$N$CN$US$
242594291$24259429$1$I$20240801$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59256$$FDA-CTU$$61$YR$$F$N$$$20240827$N$HP$US$
242594301$24259430$1$I$20240709$20240827$20240827$20240827$DIR$716078$$FDA-CTU$$74$YR$$F$N$65.7$KG$20240827$N$CN$US$
242594311$24259431$1$I$20240814$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59289$$FDA-CTU$$67$YR$$M$N$$$20240827$N$HP$US$
242594321$24259432$1$I$$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59147$$FDA-CTU$$$$$M$N$$$20240827$N$HP$US$
242594331$24259433$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59198$$FDA-CTU$$44$YR$$F$N$197$LBS$20240828$N$$US$
242594341$24259434$1$I$20240818$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59128$$FDA-CTU$$36$YR$$F$N$117.2$KG$20240827$N$$US$
242594351$24259435$1$I$$20240822$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133854$BRISTOL MYERS SQUIBB$$7$YR$C$M$Y$$$20240828$$HP$US$US
242594361$24259436$1$I$$20240816$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132354$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240828$$CN$US$US
242594373$24259437$3$F$20240823$20240904$20240828$20240909$EXP$$DE-ABBVIE-5895916$ABBVIE$$69$YR$$M$Y$$$20240909$$HP$DE$DE
242594381$24259438$1$I$$20240823$20240828$20240828$EXP$$CA-SANDOZ INC.-NVSC2022CA207375$SANDOZ$$$$$F$Y$$$20240828$$CN$CA$CA
242594391$24259439$1$I$20240819$20240827$20240828$20240828$EXP$GB-MHRA-MED-202408271421162720-HFRKS$GB-SANDOZ INC.-SDZ2024GB075806$SANDOZ$$37$YR$$F$Y$62$KG$20240828$$CN$GB$GB
242594401$24259440$1$I$20240825$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170429$AMGEN$$80$YR$E$F$Y$$$20240828$$CN$US$US
242594411$24259441$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169405$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242594421$24259442$1$I$20240826$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170857$AMGEN$$73$YR$E$F$Y$$$20240828$$CN$US$US
242594431$24259443$1$I$$20240815$20240828$20240828$EXP$$US-SMPA-2024SPA001516$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242594441$24259444$1$I$20240704$20240815$20240828$20240828$EXP$$US-SMPA-2024SPA001468$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242594452$24259445$2$F$$20240916$20240828$20240930$EXP$$US-SMPA-2024SPA001585$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242594471$24259447$1$I$$20240816$20240828$20240828$EXP$$US-SMPA-2024SPA001461$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242594481$24259448$1$I$$20240816$20240828$20240828$EXP$$US-SMPA-2024SPA001603$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242594491$24259449$1$I$$20240815$20240828$20240828$EXP$$US-SMPA-2024SPA001442$SUNOVION$$$$$$Y$$$20240828$$HP$US$US
242594502$24259450$2$F$20240908$20240917$20240828$20240930$EXP$$US-SMPA-2024SPA001525$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242594511$24259451$1$I$$20240815$20240828$20240828$EXP$$US-SMPA-2024SPA001529$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242594521$24259452$1$I$$20240815$20240828$20240828$EXP$$US-SMPA-2024SPA001497$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242594532$24259453$2$F$$20240913$20240828$20240926$EXP$$US-SMPA-2024SPA001507$SUNOVION$$$$$$Y$$$20240926$$CN$US$US
242594541$24259454$1$I$$20240815$20240828$20240828$EXP$$US-SMPA-2024SPA001548$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242594551$24259455$1$I$$20240815$20240828$20240828$EXP$$US-SMPA-2024SPA001439$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242594561$24259456$1$I$$20240815$20240828$20240828$EXP$$US-SMPA-2024SPA001465$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242594571$24259457$1$I$$20240815$20240828$20240828$EXP$$US-SMPA-2024SPA001459$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242594581$24259458$1$I$$20240816$20240828$20240828$EXP$$US-SMPA-2024SPA001485$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242594591$24259459$1$I$$20240826$20240828$20240828$PER$$US-ROCHE-10000066718$ROCHE$$$$A$F$Y$$$20240828$$CN$US$US
242594601$24259460$1$I$$20240820$20240828$20240828$EXP$$MX-AstraZeneca-2024A190166$ASTRAZENECA$$$$$F$Y$$$20240828$$MD$MX$
242594611$24259461$1$I$$20240823$20240828$20240828$EXP$$JP-AstraZeneca-2024A192412$ASTRAZENECA$$$$$M$Y$$$20240828$$MD$JP$
242594621$24259462$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190264$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242594641$24259464$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190179$ASTRAZENECA$$$$$F$Y$$$20240828$$HP$US$
242594651$24259465$1$I$$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A193312$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242594661$24259466$1$I$20240515$20240826$20240828$20240828$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048051$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$51$KG$20240828$$HP$CO$CO
242594671$24259467$1$I$20240724$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A193523$ASTRAZENECA$$23224$DY$$$Y$$$20240828$$HP$US$
242594691$24259469$1$I$$20240827$20240828$20240828$PER$$US-ROCHE-10000067841$ROCHE$$$$$$Y$$$20240828$$CN$US$US
242594711$24259471$1$I$20240101$20240826$20240828$20240828$EXP$DK-DKMA-30737801$DK-DSJP-DSE-2024-142063$DAIICHI$$61$YR$$F$Y$90$KG$20240828$$MD$DK$DK
242594721$24259472$1$I$20240524$20240605$20240828$20240828$PER$$US-United Exchange Corporation-2160952$UNITED EXCHANGE$$61$YR$$M$Y$$$20240828$$$US$US
242594731$24259473$1$I$$20240826$20240828$20240828$PER$$US-ROCHE-10000067518$ROCHE$$$$$$Y$$$20240828$$CN$US$US
242594741$24259474$1$I$20240822$20240822$20240828$20240828$EXP$$GB-TEVA-VS-3236575$TEVA$$53$YR$$M$Y$79$KG$20240828$$MD$GB$GB
242594763$24259476$3$F$$20240828$20240828$20240926$EXP$$CA-GSK-CA2024GSK105706$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$CA$CA
242594771$24259477$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142148$DAIICHI$$$$$F$Y$$$20240828$$CN$CA$CA
242594781$24259478$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142212$DAIICHI$$$$$F$Y$$$20240828$$MD$CA$CA
242594801$24259480$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142236$DAIICHI$$$$$F$Y$$$20240828$$MD$CA$CA
242594811$24259481$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142150$DAIICHI$$$$$F$Y$76$KG$20240828$$CN$CA$CA
242594821$24259482$1$I$20240826$20240826$20240828$20240828$PER$$US-ROCHE-10000067965$ROCHE$$39$YR$A$F$Y$$$20240828$$CN$US$US
242594831$24259483$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142153$DAIICHI$$$$$F$Y$$$20240828$$CN$CA$CA
242594841$24259484$1$I$$20240814$20240828$20240828$EXP$$US-HLS-202400908$HLS THERAPEUTICS$$66$YR$E$M$Y$$$20240828$$HP$US$US
242594852$24259485$2$F$20230701$20240902$20240828$20240911$EXP$$GB-TEVA-VS-3236253$TEVA$Kunnumpurath A, Gjorgjievska-Marsh V. Pembrolizumab-induced scleroderma in a patient with nonsmall cell lung cancer. Br-J-Dermatol 2024; 191 (Suppl. 1) i152 abstr. BI31.; Kunnumpurath A, Gjorgjievska-Marsh V. Pembrolizumab-induced scleroderma in a patient with nonsmall cell lung cancer. Br-J-Dermatol 2024; 191 (Suppl. 1) i152 abstr. BI31.$59$YR$$F$Y$$$20240911$$HP$GB$GB
242594861$24259486$1$I$20240801$20240823$20240828$20240828$EXP$$JP-009507513-2408JPN002855J$MERCK$$4$DEC$$F$Y$$$20240828$$MD$JP$JP
242594871$24259487$1$I$$20240819$20240828$20240828$EXP$$FR-TEVA-VS-3236100$TEVA$Pattou M, Neuzillet Y, Lebret T, Yonneau L, Madec FX. [Penile necrosis, a specific complication of prostatic artery embolization]. [French]. Prog-Urol 2023; 33 407-411.$75$YR$$M$Y$$$20240828$$HP$FR$FR
242594881$24259488$1$I$20240808$20240826$20240828$20240828$EXP$FI-FIMEA-202403025$FI-UCBSA-2024043212$UCB$$47$YR$$F$Y$$$20240828$$CN$FI$FI
242594892$24259489$2$F$20240604$20240924$20240828$20240930$EXP$$JP-EXELIXIS-CABO-24080155$EXELIXIS$$74$YR$$F$Y$$$20240930$$MD$JP$JP
242594901$24259490$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015788$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240828$$CN$US$US
242594911$24259491$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142157$DAIICHI$$59$YR$$F$Y$$$20240828$$MD$CA$CA
242594921$24259492$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016197$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240828$$CN$US$US
242594931$24259493$1$I$20240827$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017093$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240828$$CN$US$US
242594941$24259494$1$I$$20240820$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408013235$ELI LILLY AND CO$$33$YR$A$$Y$$$20240828$$CN$US$US
242594951$24259495$1$I$$20240821$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014921$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$US$US
242594961$24259496$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142143$DAIICHI$$73$YR$$F$Y$84$KG$20240828$$HP$CA$CA
242594971$24259497$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142147$DAIICHI$$54$YR$$F$Y$$$20240828$$HP$CA$CA
242594981$24259498$1$I$$20240814$20240828$20240828$PER$$US-PHARMING-PHAUS2024000694$PHARMING GROUP$$$$$$Y$$$20240822$$CN$US$US
242594991$24259499$1$I$$20240814$20240828$20240828$PER$$US-ABBVIE-5893833$ABBVIE$$77$YR$$F$Y$$$20240828$$HP$US$US
242595001$24259500$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142135$DAIICHI$$$$$M$Y$$$20240828$$CN$CA$CA
242595011$24259501$1$I$$20240822$20240828$20240828$EXP$$NL-ROCHE-10000065136$ROCHE$$53$YR$A$F$Y$$$20240828$$HP$NL$NL
242595031$24259503$1$I$$20240825$20240828$20240828$EXP$$US-ROCHE-10000066291$ROCHE$$$$$F$Y$$$20240828$$CN$US$US
242595041$24259504$1$I$$20240822$20240828$20240828$EXP$$CA-BEIGENE-BGN-2024-013417$BEIGENE$$$$$$Y$$$20240828$$CN$CA$CA
242595051$24259505$1$I$$20240820$20240828$20240828$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-132593$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$81.19$KG$20240828$$CN$PR$PR
242595061$24259506$1$I$20221101$20240827$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075840$SANDOZ$$52$YR$$M$Y$$$20240828$$MD$US$US
242595071$24259507$1$I$20240822$20240822$20240828$20240828$PER$$US-AMGEN-USASP2024169280$AMGEN$$37$YR$A$F$Y$$$20240828$$HP$US$US
242595081$24259508$1$I$$20240821$20240828$20240828$EXP$$KR-AMGEN-KORSP2024170231$AMGEN$$$$$F$Y$$$20240828$$MD$KR$KR
242595091$24259509$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59299$$FDA-CTU$$72$YR$$F$N$90.72$KG$20240828$N$$US$
242595101$24259510$1$I$$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132995$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$72.57$KG$20240828$$CN$US$US
242595111$24259511$1$I$$20240822$20240828$20240828$EXP$$US-AMGEN-USASP2024168656$AMGEN$Hahn N.. Neoadjuvant Cisplatin, Gemeitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis. Bladder Cancer. 2024;10 (2):133-143$$$$$Y$$$20240828$$MD$US$US
242595121$24259512$1$I$$20240827$20240827$20240827$DIR$716173$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242595131$24259513$1$I$20240819$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59292$$FDA-CTU$$57$YR$$F$N$$$20240828$N$$US$
242595141$24259514$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59193$$FDA-CTU$$59$YR$$F$N$166$LBS$20240828$N$$US$
242595151$24259515$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59250$$FDA-CTU$$67$YR$$F$N$$$20240828$N$HP$US$
242595161$24259516$1$I$20240823$20240827$20240827$20240827$DIR$716042$$FDA-CTU$$40$YR$$M$N$83.25$KG$20240827$N$CN$US$
242595171$24259517$1$I$$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59278$$FDA-CTU$$61$YR$$F$N$$$20240827$N$$US$
242595181$24259518$1$I$20240827$20240827$20240827$20240827$DIR$716053$$FDA-CTU$$82$YR$$F$N$$$20240827$Y$$US$
242595191$24259519$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59281$$FDA-CTU$$65$YR$$M$N$$$20240828$N$$US$
242595201$24259520$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59276$$FDA-CTU$$28$YR$$M$N$77.11$KG$20240828$N$$US$
242595211$24259521$1$I$20240821$20240827$20240827$20240827$DIR$716060$$FDA-CTU$$62$YR$$M$N$$$20240827$N$PH$US$
242595221$24259522$1$I$20240825$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59291$$FDA-CTU$$82$YR$$M$N$$$20240828$N$$US$
242595231$24259523$1$I$20240221$20240827$20240827$20240827$DIR$716029$$FDA-CTU$$46$YR$$M$N$79.65$KG$20240827$N$CN$US$
242595241$24259524$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142129$DAIICHI$$$$$F$Y$61$KG$20240828$$MD$CA$CA
242595251$24259525$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142132$DAIICHI$$$$$F$Y$$$20240828$$PH$CA$CA
242595261$24259526$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142133$DAIICHI$$$$$F$Y$73$KG$20240828$$CN$CA$CA
242595271$24259527$1$I$$20240827$20240827$20240827$DIR$716067$$FDA-CTU$$$$$UNK$N$$$20240827$$CN$US$
242595281$24259528$1$I$$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59222$$FDA-CTU$$$$$M$N$$$20240827$N$HP$US$
242595291$24259529$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142126$DAIICHI$$$$$F$Y$$$20240828$$CN$CA$CA
242595301$24259530$1$I$$20240824$20240828$20240828$EXP$$RU-ROCHE-10000067124$ROCHE$$$$$F$Y$$$20240828$$CN$RU$RU
242595311$24259531$1$I$$20240822$20240828$20240828$EXP$$CN-AMGEN-CHNSP2024168651$AMGEN$Guo C.; Huang H.; Qiao Q. et al.. Efficacy of submental island flap closing advanced mandibular MRONJ lesion in malignancy patients. Head + Neck. 2024;46:2315-2326$$$$$Y$$$20240828$$MD$CN$CN
242595321$24259532$1$I$$20240826$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136265$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$66.68$KG$20240828$$CN$US$US
242595331$24259533$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136230$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240828$$CN$US$US
242595341$24259534$1$I$20240813$20240827$20240828$20240828$EXP$$GB-GILEAD-2024-0685440$GILEAD$$$$E$M$Y$$$20240828$$HP$GB$GB
242595351$24259535$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142112$DAIICHI$$$$$F$Y$$$20240828$$HP$CA$CA
242595371$24259537$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142119$DAIICHI$$$$$F$Y$61$KG$20240828$$CN$CA$CA
242595381$24259538$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142114$DAIICHI$$68$YR$$F$Y$79$KG$20240828$$CN$CA$CA
242595392$24259539$2$F$20240702$20240823$20240828$20240830$EXP$$US-AstraZeneca-2024A194395$ASTRAZENECA$$38$YR$$F$Y$104.8$KG$20240830$$MD$US$
242595401$24259540$1$I$$20240826$20240828$20240828$EXP$$IT-ABBVIE-5897405$ABBVIE$$71$YR$$M$Y$$$20240828$$CN$IT$IT
242595411$24259541$1$I$$20240820$20240828$20240828$EXP$$NL-AstraZeneca-2024A195346$ASTRAZENECA$$72$YR$$M$Y$65$KG$20240828$$MD$NL$
242595421$24259542$1$I$$20240823$20240828$20240828$EXP$$BR-AstraZeneca-2024A195569$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$BR$
242595431$24259543$1$I$20240601$20240820$20240828$20240828$EXP$$JP-AstraZeneca-2024A190855$ASTRAZENECA$$60$YR$$F$Y$$$20240828$$MD$JP$
242595441$24259544$1$I$20240731$20240820$20240828$20240828$EXP$$CN-AstraZeneca-2024A192889$ASTRAZENECA$$22229$DY$$M$Y$64$KG$20240828$$MD$CN$
242595461$24259546$1$I$$20240820$20240828$20240828$EXP$$SY-AstraZeneca-2024A195955$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$SY$
242595471$24259547$1$I$$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A193172$ASTRAZENECA$$69$YR$$F$Y$59$KG$20240828$$CN$US$
242595501$24259550$1$I$$20240820$20240828$20240828$EXP$$UA-AstraZeneca-2024A193475$ASTRAZENECA$$26663$DY$$F$Y$46$KG$20240828$$CN$UA$
242595511$24259551$1$I$$20240821$20240828$20240828$EXP$$US-JNJFOC-20240857084$JOHNSON AND JOHNSON$$$$$M$Y$$$20240828$$CN$US$US
242595521$24259552$1$I$$20240827$20240828$20240828$PER$$US-JNJFOC-20240871234$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$HP$US$US
242595531$24259553$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59253$$FDA-CTU$$69$YR$$M$N$$$20240828$N$$US$
242595541$24259554$1$I$$20240826$20240828$20240828$PER$$US-JNJFOC-20240868436$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$MD$US$US
242595551$24259555$1$I$$20240809$20240828$20240828$30DAY$$CL-JNJFOC-20240828853$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$CL$CL
242595561$24259556$1$I$$20240820$20240828$20240828$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007331$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240828$$MD$DE$DE
242595571$24259557$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142110$DAIICHI$$$$$F$Y$$$20240828$$HP$CA$CA
242595581$24259558$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136408$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240828$$PH$US$US
242595591$24259559$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136646$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$106.59$KG$20240828$$CN$US$US
242595601$24259560$1$I$20240801$20240821$20240828$20240828$EXP$$CN-009507513-2408CHN008036$MERCK$$77$YR$$M$Y$171$KG$20240828$$HP$CN$CN
242595611$24259561$1$I$$20240822$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134297$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240828$$CN$US$US
242595621$24259562$1$I$20240819$20240822$20240828$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-135877$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240828$$MD$JP$JP
242595654$24259565$4$F$20240801$20240913$20240828$20240920$EXP$$CA-TAKEDA-2024TUS086551$TAKEDA$$66$YR$$F$Y$112$KG$20240920$$MD$CA$CA
242595661$24259566$1$I$$20240827$20240828$20240828$EXP$$DE-SANDOZ INC.-SDZ2024DE075529$SANDOZ$$30$YR$$M$Y$$$20240828$$HP$DE$DE
242595671$24259567$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169540$AMGEN$$$$$F$Y$$$20240828$$PH$US$US
242595681$24259568$1$I$$20240819$20240828$20240828$PER$$US-ABBVIE-5887807$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242595691$24259569$1$I$20240601$20240816$20240828$20240828$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000849$PAREXEL$$$$$$Y$$$20240828$$HP$CN$CN
242595701$24259570$1$I$$20240816$20240828$20240828$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093422$GLENMARK$Trabzonlu L, McDermott S, Pitman MB, Chebib I.. Pulmonary Kaposi sarcoma in a patient with bilateral lung transplant: An unexpected diagnosis on transbronchial fine needle aspiration and core biopsy.. Diagnostic Cytopathology.. 2024;52 (9):E215-21$$$$$Y$$$20240828$$MD$US$US
242595711$24259571$1$I$$20240826$20240828$20240828$PER$$US-BIOVITRUM-2024-US-011356$BIOVITRUM$$60$YR$$M$Y$$$20240828$$CN$US$US
242595731$24259573$1$I$$20240826$20240828$20240828$DIR$FDA-CDER-CTU-2024-59204$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242595751$24259575$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173777$NOVARTIS$$$$$$Y$$$20240828$$MD$US$US
242595761$24259576$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142106$DAIICHI$$$$$F$Y$$$20240828$$MD$CA$CA
242595771$24259577$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142108$DAIICHI$$65$YR$$F$Y$89$KG$20240828$$CN$CA$CA
242595781$24259578$1$I$$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131893$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240828$$HP$US$US
242595791$24259579$1$I$$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59154$$FDA-CTU$$$$$M$N$$$20240827$N$HP$US$
242595801$24259580$1$I$20240724$20240822$20240828$20240828$EXP$$JP-009507513-2408JPN003118J$MERCK$$68$YR$$F$Y$$$20240828$$MD$JP$JP
242595811$24259581$1$I$$20240823$20240828$20240828$EXP$$US-AMGEN-USASP2024169309$AMGEN$Aldoss I.; Othman T.; Koller P. et al.. Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia. British Journal of Haematology. 2024;205 (2):711-715$29$YR$A$M$Y$$$20240828$$HP$US$US
242595821$24259582$1$I$20240701$20240824$20240828$20240828$EXP$$GB-009507513-2408GBR009573$MERCK$$88$YR$$F$Y$53$KG$20240828$$CN$GB$GB
242595831$24259583$1$I$$20240816$20240828$20240828$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093423$GLENMARK$Fasanya-Maku H, Petty D, Knapik J, Leon M, Gonsalves C.. A case of metastatic HPV-related cervical small cell neuroendocrine carcinoma with varying cytomorphology found in cytological specimens of a solid organ transplant recipient. Diagnostic Cytopathology.. Diagnostic Cytopathology. 2024;52(9):E202-7$$$$$Y$$$20240828$$MD$US$US
242595853$24259585$3$F$20240801$20240918$20240828$20240924$EXP$$DE-009507513-2408DEU008083$MERCK$$76$YR$$F$Y$$$20240924$$MD$DE$DE
242595861$24259586$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016435$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240828$$MD$US$US
242595871$24259587$1$I$20240101$20240821$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014951$ELI LILLY AND CO$$$$$M$Y$$$20240828$$CN$US$US
242595881$24259588$1$I$20240819$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015239$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240828$$HP$US$US
242595891$24259589$1$I$20220101$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015623$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240828$$CN$US$US
242595901$24259590$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142104$DAIICHI$$61$YR$$M$Y$102$KG$20240828$$CN$CA$CA
242595911$24259591$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142105$DAIICHI$$$$$F$Y$$$20240828$$CN$CA$CA
242595921$24259592$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142101$DAIICHI$$$$$F$Y$$$20240828$$MD$CA$CA
242595931$24259593$1$I$20240101$20240814$20240828$20240828$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00904$CATALYST PHARMA$$$$$M$Y$38.549$KG$20240828$$CN$US$US
242595941$24259594$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142097$DAIICHI$$$$$F$Y$$$20240828$$CN$CA$CA
242595951$24259595$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142100$DAIICHI$$$$$F$Y$68$KG$20240828$$CN$CA$CA
242595961$24259596$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142099AA$DAIICHI$$$$$F$Y$$$20240828$$CN$CA$CA
242595971$24259597$1$I$$20240823$20240828$20240828$EXP$$GB-SANDOZ INC.-SDZ2024GB075219$SANDOZ$$$$$M$Y$$$20240828$$CN$GB$GB
242595991$24259599$1$I$20240810$20240823$20240828$20240828$EXP$ES-AEMPS-1561916$ES-009507513-2408ESP008688$MERCK$$49$YR$$M$Y$94$KG$20240828$$PH$ES$ES
242596001$24259600$1$I$$20240820$20240828$20240828$EXP$$ES-AstraZeneca-2024A190835$ASTRAZENECA$$17897$DY$$M$Y$$$20240828$$MD$ES$
242596011$24259601$1$I$20180101$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A193880$ASTRAZENECA$$70$YR$$M$Y$75.3$KG$20240828$$HP$US$
242596021$24259602$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A189932$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242596031$24259603$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142087$DAIICHI$$$$$F$Y$41$KG$20240828$$CN$CA$CA
242596041$24259604$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142094$DAIICHI$$$$$F$Y$$$20240828$$CN$CA$CA
242596051$24259605$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142091$DAIICHI$$$$$F$Y$$$20240828$$CN$CA$CA
242596061$24259606$1$I$$20240821$20240828$20240828$EXP$$US-GSK-US2024104530$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
242596071$24259607$1$I$20240817$20240821$20240828$20240828$EXP$$CN-GSK-CN2024APC104794$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$CN$CN
242596081$24259608$1$I$20240201$20240821$20240828$20240828$EXP$$US-GSK-US2024104399$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
242596102$24259610$2$F$20240731$20240827$20240828$20240903$PER$$US-AMGEN-USASP2024171672$AMGEN$$66$YR$E$F$Y$$$20240902$$PH$US$US
242596111$24259611$1$I$$20240801$20240828$20240828$PER$$US-PHARMING-PHAUS2024000657$PHARMING GROUP$$$$$$Y$$$20240805$$CN$US$US
242596122$24259612$2$F$20240601$20240816$20240828$20240829$EXP$$US-PHARMING-PHAUS2024000652$PHARMING GROUP$$$$$$Y$$$20240829$$CN$US$US
242596131$24259613$1$I$20240101$20240731$20240828$20240828$EXP$$US-PHARMING-PHAUS2024000655$PHARMING GROUP$$$$$$Y$$$20240802$$CN$US$US
242596141$24259614$1$I$$20240730$20240828$20240828$PER$$US-PHARMING-PHAUS2024000524$PHARMING GROUP$$$$$$Y$$$20240802$$CN$US$US
242596151$24259615$1$I$$20240819$20240828$20240828$EXP$$CA-DSJP-DSJ-2024-142066$DAIICHI$$53$YR$$F$Y$$$20240828$$MD$CA$CA
242596161$24259616$1$I$$20240819$20240828$20240828$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-142005$DAIICHI$$$$$F$Y$$$20240828$$PH$CA$CA
242596171$24259617$1$I$20240817$20240822$20240828$20240828$EXP$$CN-DSJP-DSJ-2024-141810$DAIICHI$$33$YR$$F$Y$73$KG$20240828$$HP$CN$CN
242596181$24259618$1$I$$20240819$20240828$20240828$EXP$$CA-DAIICHI SANKYO, INC.-DSJ-2024-142049$DAIICHI$$$$$F$Y$$$20240828$$CN$CA$CA
242596191$24259619$1$I$$20240824$20240828$20240828$EXP$$US-JNJFOC-20240868589$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242596201$24259620$1$I$$20240813$20240828$20240828$30DAY$$GB-JNJFOC-20240705206$JOHNSON AND JOHNSON$$$$$M$Y$$$20240828$$CN$GB$GB
242596221$24259622$1$I$20240818$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132003$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240828$$HP$US$US
242596232$24259623$2$F$20220101$20240909$20240828$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133490$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$$$20240917$$CN$US$US
242596241$24259624$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136459$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$57.61$KG$20240828$$CN$US$US
242596253$24259625$3$F$20240813$20240911$20240828$20240923$EXP$$NVSC2024IT171438$NOVARTIS$$13$YR$$M$Y$27.85$KG$20240923$$MD$IT$IT
242596261$24259626$1$I$$20240827$20240827$20240827$DIR$716095$$FDA-CTU$$$$$F$N$63$KG$20240827$N$CN$US$
242596271$24259627$1$I$$20240813$20240828$20240828$EXP$$CA-HLS-202402029$HLS THERAPEUTICS$$76$YR$E$M$Y$$$20240828$$PH$CA$CA
242596281$24259628$1$I$20240731$20240827$20240827$20240827$DIR$716077$$FDA-CTU$$17$YR$$F$N$44.7$KG$20240827$N$$US$
242596301$24259630$1$I$20240707$20240823$20240828$20240828$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000860$PAREXEL$$$$$$Y$$$20240828$$HP$CN$CN
242596311$24259631$1$I$20240819$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170523$AMGEN$$$$$$Y$$$20240828$$PH$US$US
242596322$24259632$2$F$20240817$20240828$20240828$20240830$PER$$US-AMGEN-USASP2024171234$AMGEN$$33$YR$A$M$Y$$$20240829$$CN$US$US
242596331$24259633$1$I$20240101$20240826$20240828$20240828$EXP$$US-ABBVIE-5896841$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242596341$24259634$1$I$$20240821$20240828$20240828$EXP$$US-GSK-US2024104490$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
242596351$24259635$1$I$$20240827$20240828$20240828$EXP$$US-ABBVIE-5897649$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242596361$24259636$1$I$20230101$20240822$20240828$20240828$EXP$$US-ABBVIE-5893213$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242596371$24259637$1$I$$20240823$20240828$20240828$EXP$$IT-PFIZER INC-PV202400111153$PFIZER$Neirotti, A.. Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients. Frontiers in Pediatrics. 2024;12:10.3389/fped.2024.1434493$61$MON$$M$Y$$$20240828$$HP$IT$IT
242596381$24259638$1$I$$20240820$20240828$20240828$EXP$$AU-PFIZER INC-202400245171$PFIZER$$$$$$Y$$$20240828$$MD$AU$AU
242596391$24259639$1$I$$20240823$20240828$20240828$EXP$$IT-PFIZER INC-202400244783$PFIZER$Neirotti, A.. Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients. Frontiers in Pediatrics. 2024;12:10.3389/fped.2024.1434493$37$MON$$F$Y$$$20240828$$HP$IT$IT
242596401$24259640$1$I$$20240820$20240828$20240828$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007332$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240828$$MD$DE$DE
242596411$24259641$1$I$20240820$20240822$20240828$20240828$EXP$$GB-DSJP-DSE-2024-141894$DAIICHI$$$$$F$Y$$$20240828$$CN$GB$GB
242596422$24259642$2$F$$20240902$20240828$20240911$EXP$$AT-TEVA-VS-3236565$TEVA$Scorza CA, Scorza FA, Finsterer J. Daytime bruxism, tardive orofacial dyskinesia, and dysphagia as side effects to duloxetine use over nine years in an octogenarian. Clinics 2024; 79 1-2.; Scorza CA, Scorza FA, Finsterer J. Daytime bruxism, tardive orofacial dyskinesia, and dysphagia as side effects to duloxetine use over nine years in an octogenarian. Clinics 2024; 79 1-2.; Scorza CA, Scorza FA, Finsterer J. Daytime bruxism, tardive orofacial dyskinesia, and dysphagia as side effects to dulo...$82$YR$$F$Y$$$20240911$$HP$AT$AT
242596431$24259643$1$I$$20240827$20240828$20240828$EXP$$TH-ROCHE-10000067431$ROCHE$$48$YR$A$F$Y$$$20240828$$HP$TH$TH
242596441$24259644$1$I$20231201$20240822$20240828$20240828$EXP$GB-MHRA-MED-202408221445263120-FVRSW$GB-AMGEN-GBRSP2024168314$AMGEN$$33$YR$A$F$Y$$$20240828$$HP$GB$GB
242596451$24259645$1$I$20240826$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024171459$AMGEN$$49$YR$A$F$Y$$$20240828$$HP$US$US
242596461$24259646$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136514$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240828$$HP$US$US
242596471$24259647$1$I$20240117$20240827$20240827$20240827$DIR$716062$$FDA-CTU$$4$YR$$F$N$57$KG$20240827$N$PH$US$
242596481$24259648$1$I$20240805$20240826$20240828$20240828$EXP$$SG-TAKEDA-2024TUS086483$TAKEDA$$77$YR$$F$Y$$$20240828$$HP$SG$SG
242596492$24259649$2$F$20231012$20240917$20240828$20240927$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2023-144012$DAIICHI$$49$YR$$F$Y$$$20240927$$MD$JP$JP
242596512$24259651$2$F$20240701$20240904$20240828$20240910$EXP$$JP-ROCHE-10000066032$ROCHE$$7$DEC$E$F$Y$$$20240910$$MD$JP$JP
242596521$24259652$1$I$20240430$20240826$20240828$20240828$EXP$ES-AEMPS-1563319$ES-DSJP-DSE-2024-142079$DAIICHI$$99$YR$$M$Y$61.5$KG$20240828$$HP$ES$ES
242596531$24259653$1$I$$20240825$20240828$20240828$EXP$$RU-ALXN-202408RUS001680RU$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240828$$HP$RU$RU
242596541$24259654$1$I$$20240823$20240828$20240828$PER$$US-ABBVIE-5896288$ABBVIE$$$$$F$Y$$$20240828$$HP$US$US
242596551$24259655$1$I$$20240826$20240828$20240828$PER$$US-HALEON-2193990$Haleon PLC$$$$$F$Y$166$KG$20240828$$CN$US$US
242596564$24259656$4$F$20200101$20240903$20240828$20240905$PER$$US-BIOGEN-2019BI00809756$BIOGEN$$47$YR$$F$Y$$$20240905$$CN$US$US
242596572$24259657$2$F$$20240902$20240828$20240910$EXP$$US-TEVA-VS-3235570$TEVA$Fling C, Granados L, Coruh B. An Ophtha-MALA-gic Anomaly: Metformin Associated Lactic Acidosis Causing Transient Blindness. Am-J-Respir-Crit-Care-Med 2023; 207 A3498 abstr. B48.; Fling C, Granados L, Coruh B. An Ophtha-MALA-gic Anomaly: Metformin Associated Lactic Acidosis Causing Transient Blindness. Am-J-Respir-Crit-Care-Med 2023; 207 A3498 abstr. B48.$62$YR$$M$Y$$$20240910$$HP$US$US
242596581$24259658$1$I$20240717$20240826$20240828$20240828$EXP$FR-AFSSAPS-AM2024000663$FR-SANDOZ INC.-SDZ2024FR075295$SANDOZ$$77$YR$$M$Y$58$KG$20240828$$PH$FR$FR
242596591$24259659$1$I$$20240809$20240828$20240828$PER$$AU-TOLMAR, INC.-24AU051814$TOLMAR$$$$$M$Y$$$20240828$$CN$AU$AU
242596601$24259660$1$I$20240807$20240808$20240828$20240828$PER$$AU-TOLMAR, INC.-24AU051823$TOLMAR$$94$YR$$M$Y$$$20240828$$CN$AU$AU
242596611$24259661$1$I$$20240808$20240828$20240828$PER$$AU-TOLMAR, INC.-24AU051791$TOLMAR$$$$$M$Y$$$20240828$$CN$AU$AU
242596621$24259662$1$I$20230915$20240809$20240828$20240828$PER$$BR-TOLMAR, INC.-24BR051588$TOLMAR$$8$YR$$F$Y$$$20240828$$CN$BR$BR
242596631$24259663$1$I$20240719$20240809$20240828$20240828$PER$$BR-TOLMAR, INC.-24BR051312$TOLMAR$$8$YR$$F$Y$$$20240828$$CN$BR$BR
242596651$24259665$1$I$20240802$20240808$20240828$20240828$PER$$BR-TOLMAR, INC.-24BR051793$TOLMAR$$7$YR$$F$Y$$$20240828$$CN$BR$BR
242596661$24259666$1$I$$20240807$20240828$20240828$PER$$BR-TOLMAR, INC.-24BR051765$TOLMAR$$$$$F$Y$$$20240828$$CN$BR$BR
242596671$24259667$1$I$$20240826$20240828$20240828$EXP$DE-ROCHE-771212$DE-SANDOZ INC.-SDZ2024DE075177$SANDOZ$$74$YR$$F$Y$$$20240828$$HP$DE$DE
242596681$24259668$1$I$20240613$20240821$20240828$20240828$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000859$PAREXEL$$$$$$Y$$$20240828$$HP$CN$CN
242596691$24259669$1$I$$20240820$20240828$20240828$PER$$US-AstraZeneca-2024A190091$ASTRAZENECA$$$$$F$Y$$$20240828$$MD$US$
242596701$24259670$1$I$20240722$20240816$20240828$20240828$PER$$US-AMGEN-USASP2024166371$AMGEN$$49$YR$A$F$Y$$$20240828$$HP$US$US
242596711$24259671$1$I$$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A194188$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$US$
242596721$24259672$1$I$20240811$20240823$20240828$20240828$EXP$$IL-AstraZeneca-2024A195539$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$IL$
242596731$24259673$1$I$$20240822$20240828$20240828$PER$$US-AstraZeneca-2024A192710$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242596741$24259674$1$I$20240401$20240820$20240828$20240828$PER$$US-AstraZeneca-2024A190115$ASTRAZENECA$$1019$MON$$F$Y$$$20240828$$CN$US$
242596751$24259675$1$I$$20240820$20240828$20240828$EXP$$JP-AstraZeneca-2024A191771$ASTRAZENECA$Yamazaki M, et al.. O28-3 Study of cases of novel coronavirus (COVID-19) delayed infection and reactivation.. The 39th Annual Meeting of Japanese Society for Infection Prevention and Control. 2024;314-.$65$YR$$M$Y$$$20240828$$MD$JP$
242596761$24259676$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190571$ASTRAZENECA$$$$$$Y$$$20240828$$PH$US$
242596771$24259677$1$I$20240607$20240822$20240828$20240828$EXP$$JP-AMGEN-JPNSP2024120183$AMGEN$$87$YR$E$F$Y$$$20240828$$MD$JP$JP
242596781$24259678$1$I$20240815$20240827$20240827$20240827$DIR$716068$$FDA-CTU$$73$YR$$F$N$74.4$KG$20240827$N$PH$US$
242596791$24259679$1$I$$20240823$20240828$20240828$EXP$$NVSC2024US172995$NOVARTIS$Mansour MK, King JD, Chen ST, Fishman JA, Nazarian RM. Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes. THE NEW ENGLAND JOURNAL OF MEDICINE. 2023;388 (10):926-37$70$YR$$M$Y$$$20240828$$HP$US$US
242596801$24259680$1$I$$20240822$20240828$20240828$EXP$$JP-AMGEN-JPNSP2024168357$AMGEN$Ishikawa K.. The potential effect of romosozumab on perioperative management for instrumentation surgery. JOR spine. 2024;7 (3):1-11$$$$$Y$$$20240828$$HP$JP$JP
242596811$24259681$1$I$20240827$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59297$$FDA-CTU$$32$YR$$F$N$$$20240827$N$HP$US$
242596821$24259682$1$I$20240101$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016113$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240828$$CN$US$US
242596831$24259683$1$I$$20240827$20240828$20240828$EXP$$FR-SANDOZ INC.-SDZ2024FR075427$SANDOZ$$$$$M$Y$$$20240828$$HP$FR$FR
242596841$24259684$1$I$$20240823$20240828$20240828$EXP$$BR-JNJFOC-20240867359$JOHNSON AND JOHNSON$$54$YR$A$F$Y$99$KG$20240828$$CN$BR$BR
242596852$24259685$2$F$$20240905$20240828$20240909$EXP$$IT-JNJFOC-20240871298$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240909$$HP$IT$IT
242596861$24259686$1$I$20230101$20240823$20240828$20240828$PER$$US-009507513-2408USA008588$MERCK$$$$$M$Y$$$20240828$$PH$US$US
242596871$24259687$1$I$$20240815$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130884$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$HP$US$US
242596881$24259688$1$I$$20240820$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132795$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240828$$CN$US$US
242596891$24259689$1$I$20230901$20240821$20240828$20240828$EXP$$US-AMGEN-USASP2024167678$AMGEN$Kuntz M.; Maddock J.; Roller L. et al.. Unique Papillary Thyroid Cancer (PTC) Metastasis to the Skin- A Case Report. Journal of Radiology Case Reports. 2024;18 (4):13-26$77$YR$E$F$Y$$$20240828$$HP$US$US
242596903$24259690$3$F$20240807$20240917$20240828$20240924$EXP$$JP-AMGEN-JPNSP2024169473$AMGEN$$77$YR$E$F$Y$69$KG$20240924$$MD$JP$JP
242596911$24259691$1$I$20240101$20240822$20240828$20240828$EXP$$US-ABBVIE-5822209$ABBVIE$$57$YR$$M$Y$$$20240828$$CN$US$US
242596921$24259692$1$I$20240101$20240823$20240828$20240828$EXP$$CA-ABBVIE-5894273$ABBVIE$$21$YR$$M$Y$68$KG$20240828$$CN$CA$CA
242596931$24259693$1$I$20240729$20240827$20240828$20240828$EXP$FR-AFSSAPS-NC2024000991$FR-SANDOZ INC.-SDZ2024FR075587$SANDOZ$$53$YR$$F$Y$70$KG$20240828$$MD$FR$FR
242596941$24259694$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136239$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240828$$PH$US$US
242596951$24259695$1$I$$20240820$20240828$20240828$EXP$$US-ASCENT-2024ASLIT00027$ASCENT$$49$YR$A$F$Y$$$20240828$$MD$US$US
242596963$24259696$3$F$$20240828$20240828$20240902$PER$$US-HALEON-2194042$Haleon PLC$$48$YR$$F$Y$$$20240902$$CN$US$US
242596971$24259697$1$I$20240707$20240822$20240828$20240828$EXP$$US-ABBVIE-5892330$ABBVIE$$35$YR$$F$Y$$$20240828$$CN$US$US
242596981$24259698$1$I$20240820$20240821$20240828$20240828$EXP$$US-GSK-US2024104436$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$MD$US$US
242596991$24259699$1$I$20231214$20240808$20240828$20240828$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024099164$VIIV$$7$DEC$$M$Y$$$20240828$$CN$US$US
242597001$24259700$1$I$20230101$20240815$20240828$20240828$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-23-00714$CATALYST PHARMA$$$$$M$Y$88.435$KG$20240828$$CN$US$US
242597011$24259701$1$I$$20240821$20240828$20240828$EXP$$US-JNJFOC-20240860090$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$CN$US$US
242597032$24259703$2$F$20240802$20240906$20240828$20240916$PER$$US-PHARMING-PHAUS2024000666$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
242597041$24259704$1$I$$20240801$20240828$20240828$PER$$US-PHARMING-PHAUS2024000661$PHARMING GROUP$$$$$$Y$$$20240806$$CN$US$US
242597051$24259705$1$I$$20240801$20240828$20240828$EXP$$US-PHARMING-PHAUS2024000654$PHARMING GROUP$$$$$$Y$$$20240806$$CN$US$US
242597061$24259706$1$I$$20240801$20240828$20240828$PER$$US-PHARMING-PHAUS2024000663$PHARMING GROUP$$$$$$Y$$$20240806$$CN$US$US
242597071$24259707$1$I$20240101$20240826$20240828$20240828$PER$$US-JNJFOC-20240866061$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240828$$CN$US$US
242597091$24259709$1$I$20240822$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59277$$FDA-CTU$$72$YR$$F$N$$$20240827$N$HP$US$
242597111$24259711$1$I$20240822$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59280$$FDA-CTU$$72$YR$$F$N$78.47$KG$20240827$N$$US$
242597121$24259712$1$I$$20240813$20240828$20240828$EXP$$CA-HLS-202402062$HLS THERAPEUTICS$$$$A$M$Y$$$20240828$$MD$CA$CA
242597131$24259713$1$I$$20240819$20240828$20240828$EXP$$JP-ROCHE-10000066062$ROCHE$Kozaki K, Matsuki Y, Ishida M, Tanaka M, Atoji E, Kazama T.. P2-071 Urinary tract infection due to multidrug resistant Pseudomonas aeruginosa which developed after living donor renal retransplant. The 39th Annual Meeting of Japanese Society for infection Prevention and Control. 2024;400$36$YR$A$F$Y$$$20240828$$MD$JP$JP
242597141$24259714$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170994$AMGEN$$$$$$Y$$$20240828$$MD$US$US
242597161$24259716$1$I$$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169790$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242597171$24259717$1$I$20240401$20240822$20240828$20240828$EXP$$US-MYLANLABS-2024M1079042$MYLAN$$28$YR$$F$Y$$$20240828$$CN$US$US
242597181$24259718$1$I$20240801$20240822$20240828$20240828$EXP$$US-ABBVIE-5896054$ABBVIE$$66$YR$$M$Y$$$20240828$$CN$US$US
242597191$24259719$1$I$$20240821$20240828$20240828$EXP$$CA-BAUSCH-BL-2024-012742$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240828$$HP$CA$CA
242597201$24259720$1$I$$20240820$20240828$20240828$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007333$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240828$$MD$DE$DE
242597212$24259721$2$F$$20240906$20240828$20240911$EXP$$US-AMGEN-USASP2024169538$AMGEN$$$$$$Y$$$20240911$$PH$US$US
242597221$24259722$1$I$20240808$20240815$20240828$20240828$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00898$CATALYST PHARMA$$65$YR$$F$Y$$$20240828$$CN$US$US
242597231$24259723$1$I$20240101$20240823$20240828$20240828$EXP$$JP-AMGEN-JPNSP2024168767$AMGEN$$$$$$Y$$$20240828$$PH$JP$JP
242597241$24259724$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5895563$ABBVIE$$27$YR$$F$Y$$$20240828$$HP$US$US
242597251$24259725$1$I$20240817$20240821$20240828$20240828$EXP$$US-GSK-US2024104560$GLAXOSMITHKLINE$$36$YR$$F$Y$$$20240828$$HP$US$US
242597262$24259726$2$F$$20240912$20240828$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132735$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240918$$CN$US$US
242597271$24259727$1$I$$20240826$20240828$20240828$EXP$$CA-BAUSCH-BL-2024-012921$BAUSCH AND LOMB$Lagace-Thomassin F, Nateghi A, Kechichian E, Veilleux M. Topical imiquimod adverse event: Beyond the local skin reaction-A case report. SAGE Open Medical Case Reports. 2024;12:1-3. doi:10.1177/2050313X241274916$82$YR$$M$Y$$$20240828$$HP$CA$CA
242597282$24259728$2$F$$20240830$20240828$20240903$EXP$$CA-TAKEDA-2024TUS002940$TAKEDA$$$$$M$Y$$$20240903$$CN$CA$CA
242597291$24259729$1$I$$20240820$20240828$20240828$EXP$$FR-INCYTE CORPORATION-2024IN009017$INCYTE$Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon Pennamen MD, Rivet J, et al.. Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024;38:e32-4$$$$$Y$$$20240828$$HP$FR$FR
242597301$24259730$1$I$20170607$20240821$20240828$20240828$EXP$$AU-TAKEDA-2024TUS086236$TAKEDA$$73$YR$$F$Y$$$20240828$$MD$AU$AU
242597312$24259731$2$F$$20240903$20240828$20240909$PER$$US-ABBVIE-5896071$ABBVIE$$$$$$Y$$$20240909$$HP$US$US
242597321$24259732$1$I$$20240813$20240828$20240828$EXP$$US-HLS-202400882$HLS THERAPEUTICS$$$$A$M$Y$$$20240828$$MD$US$US
242597331$24259733$1$I$20240301$20240822$20240828$20240828$EXP$$BR-SA-2024SA251344$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240828$$CN$BR$BR
242597341$24259734$1$I$$20240820$20240828$20240828$EXP$$ZA-AstraZeneca-2024A190969$ASTRAZENECA$$27759$DY$$M$Y$$$20240828$$CN$ZA$
242597351$24259735$1$I$20240809$20240820$20240828$20240828$EXP$$CN-AstraZeneca-2024A191698$ASTRAZENECA$$3790$WK$$F$Y$45$KG$20240828$$MD$CN$
242597361$24259736$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190004$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242597371$24259737$1$I$$20240715$20240828$20240828$EXP$$RO-AstraZeneca-2024A162492$ASTRAZENECA$$65$YR$$F$Y$$$20240828$$MD$RO$
242597381$24259738$1$I$$20240820$20240828$20240828$PER$$US-AstraZeneca-2024A190014$ASTRAZENECA$$$$$$Y$$$20240828$$MD$US$
242597391$24259739$1$I$$20240820$20240828$20240828$EXP$$ZA-AstraZeneca-2024A190131$ASTRAZENECA$$67$YR$$F$Y$$$20240828$$CN$ZA$
242597401$24259740$1$I$20240813$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A187618$ASTRAZENECA$$$$$$Y$$$20240828$$CN$US$
242597411$24259741$1$I$20240814$20240817$20240828$20240828$PER$$US-BIOMARINAP-US-2024-159953$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
242597421$24259742$1$I$20240101$20240823$20240828$20240828$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004735$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$CA$CA
242597431$24259743$1$I$20240101$20240823$20240828$20240828$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004733$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$CA$CA
242597441$24259744$1$I$20120820$20240821$20240828$20240828$EXP$$ES-AstraZeneca-2024A194663$ASTRAZENECA$$82$YR$$F$Y$$$20240828$$MD$ES$
242597452$24259745$2$F$$20240902$20240828$20240911$EXP$$AU-TEVA-VS-3236273$TEVA$Chey SY, O^Sullivan N-A, Beer T, Leong WK, Kermode AG. Cutaneous presentation of cryptococcal infection with subclinical central nervous system involvement secondary to fingolimod therapy. Mult-Scler-J-Exp-Transl-Clin 2023; 9 (3):; Chey SY, O^Sullivan N-A, Beer T, Leong WK, Kermode AG. Cutaneous presentation of cryptococcal infection with subclinical central nervous system involvement secondary to fingolimod therapy. Mult-Scler-J-Exp-Transl-Clin 2023; 9 (3):.; Chey SY, O^Sullivan N-A, Beer T,...$56$YR$$F$Y$$$20240911$$HP$AU$AU
242597461$24259746$1$I$$20240822$20240828$20240828$EXP$$US-GSK-US2024AMR105361$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$US$US
242597472$24259747$2$F$$20240902$20240828$20240911$EXP$$BE-TEVA-VS-3236285$TEVA$Vermeersch G, Cruyt N, D^hondt E, Geers J, Hertveldt K, Stockman A, et al. Granulomatous peritoneal disease associated with oxaliplatin-based chemotherapy for ampullary adenocarcinoma: a case report. Acta-Gastroenterol-Belg 2023; 86 (3): 499-501.; Vermeersch G, Cruyt N, D^hondt E, Geers J, Hertveldt K, Stockman A, et al. Granulomatous peritoneal disease associated with oxaliplatin-based chemotherapy for ampullary adenocarcinoma: a case report. Acta-Gastroenterol-Belg 2023; 86 (3): 499-501.$71$YR$$M$Y$$$20240911$$HP$BE$BE
242597482$24259748$2$F$20240801$20240828$20240828$20240926$PER$$US-KARYOPHARM-2024KPT001426$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240926$$CN$US$US
242597491$24259749$1$I$$20240821$20240828$20240828$EXP$GB-MHRA-MIDB- 591df38a-2137-42ad-80a4-e56f0a791d6f$GB-TEVA-VS-3236357$TEVA$$86$YR$$M$Y$$$20240828$$PH$GB$GB
242597501$24259750$1$I$20240806$20240819$20240828$20240828$EXP$IT-MINISAL02-998699$IT-TEVA-VS-3234819$TEVA$$72$YR$$$Y$$$20240828$$MD$IT$IT
242597511$24259751$1$I$$20240808$20240828$20240828$PER$$US-JNJFOC-20240827923$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240828$$CN$US$US
242597521$24259752$1$I$20240718$20240820$20240828$20240828$EXP$$TW-JNJFOC-20240760061$JOHNSON AND JOHNSON$$55$YR$A$M$Y$82$KG$20240828$$CN$TW$TW
242597531$24259753$1$I$$20240815$20240828$20240828$PER$$US-JNJFOC-20240849113$JOHNSON AND JOHNSON$$$$$F$Y$70.188$KG$20240828$$CN$US$US
242597552$24259755$2$F$$20240916$20240828$20240924$EXP$GR-EMA-DD-20240814-7482661-140029$GR-BAXTER-2024BAX023574$BAXTER$$75$YR$$M$Y$$$20240924$$HP$GR$GR
242597561$24259756$1$I$20240823$20240823$20240828$20240828$PER$$US-JNJFOC-20240866190$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$MD$US$US
242597574$24259757$4$F$20240101$20240923$20240828$20240926$PER$$US-BIOGEN-2024BI01280036$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
242597581$24259758$1$I$$20240814$20240828$20240828$EXP$$US-HLS-202400622$HLS THERAPEUTICS$$75$YR$E$M$Y$$$20240828$$PH$US$US
242597591$24259759$1$I$$20240814$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08270$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242597601$24259760$1$I$$20240826$20240828$20240828$EXP$$US-ABBVIE-5897200$ABBVIE$$$$$M$Y$$$20240828$$HP$US$US
242597611$24259761$1$I$20240828$20240828$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048306$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240828$$HP$US$US
242597621$24259762$1$I$20240824$20240827$20240828$20240828$EXP$$GB-SANDOZ INC.-SDZ2024GB075831$SANDOZ$$65$YR$$M$Y$73$KG$20240828$$MD$GB$GB
242597632$24259763$2$F$20240715$20240823$20240828$20240923$PER$$US-BAUSCH-BL-2024-012857$BAUSCH AND LOMB$$62$YR$$M$Y$78$KG$20240923$$CN$US$US
242597641$24259764$1$I$20240304$20240816$20240828$20240828$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408014713$ELI LILLY AND CO$$48$YR$A$M$Y$68$KG$20240828$$CN$DE$CN
242597651$24259765$1$I$20240721$20240822$20240828$20240828$EXP$IT-MINISAL02-999383$IT-MYLANLABS-2024M1078046$MYLAN$$94$YR$$F$Y$$$20240828$$MD$IT$IT
242597661$24259766$1$I$$20240822$20240828$20240828$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408014380$ELI LILLY AND CO$$$$$$Y$$$20240828$$PH$JP$JP
242597672$24259767$2$F$$20240910$20240828$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202408015389$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240911$$CN$US$US
242597683$24259768$3$F$20240711$20240913$20240828$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407011985$ELI LILLY AND CO$$86$YR$E$M$Y$41$KG$20240920$$CN$JP$JP
242597692$24259769$2$F$20240801$20240912$20240828$20240919$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408013697$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240919$$CN$JP$JP
242597701$24259770$1$I$$20240826$20240828$20240828$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408016224$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$JP$JP
242597711$24259771$1$I$$20240819$20240828$20240828$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408012792$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240828$$CN$JP$JP
242597722$24259772$2$F$20240819$20240920$20240828$20240925$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408015809$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240925$$CN$JP$JP
242597731$24259773$1$I$$20240816$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011991$ELI LILLY AND CO$$$$A$M$Y$$$20240828$$CN$US$US
242597741$24259774$1$I$$20240816$20240828$20240828$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408012107$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240828$$CN$CN$CN
242597751$24259775$1$I$$20240816$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011005$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240828$$HP$US$US
242597761$24259776$1$I$20240706$20240816$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011269$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240828$$CN$US$US
242597771$24259777$1$I$20240806$20240822$20240828$20240828$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408016497$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240828$$CN$DE$CN
242597781$24259778$1$I$20240403$20240816$20240828$20240828$EXP$CH-SM-2024-15112$CH-ELI_LILLY_AND_COMPANY-CH202408012212$ELI LILLY AND CO$$87$YR$E$F$Y$$$20240828$$CN$CH$CH
242597791$24259779$1$I$$20240816$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011989$ELI LILLY AND CO$$$$A$F$Y$$$20240828$$CN$US$US
242597801$24259780$1$I$20240624$20240815$20240828$20240828$EXP$PT-INFARMED-T202408-203$PT-ELI_LILLY_AND_COMPANY-PT202408010327$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240828$$CN$PT$PT
242597811$24259781$1$I$$20240823$20240828$20240828$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202408014734$ELI LILLY AND CO$$$$$M$Y$$$20240828$$CN$KR$KR
242597821$24259782$1$I$20240826$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017179$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240828$$CN$US$US
242597831$24259783$1$I$20240816$20240816$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011461$ELI LILLY AND CO$$$$$$Y$$$20240828$$CN$US$US
242597841$24259784$1$I$$20240820$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408012598$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240828$$CN$US$US
242597851$24259785$1$I$20240822$20240822$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408014383$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240828$$CN$US$US
242597861$24259786$1$I$20240815$20240816$20240828$20240828$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408012938$ELI LILLY AND CO$$$$$F$Y$$$20240828$$CN$CN$CN
242597871$24259787$1$I$20240820$20240820$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408013221$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240828$$CN$US$US
242597881$24259788$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016351$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240828$$CN$US$US
242597891$24259789$1$I$$20240717$20240828$20240828$PER$$US-LUNDBECK-DKLU4001853$LUNDBECK$$$$$$Y$$$20240828$$CN$US$US
242597901$24259790$1$I$$20240813$20240828$20240828$EXP$$US-HLS-202400878$HLS THERAPEUTICS$$$$A$M$Y$$$20240828$$PH$US$US
242597911$24259791$1$I$20231101$20240821$20240828$20240828$EXP$$JP-AMGEN-JPNSP2024168847$AMGEN$$70$YR$E$F$Y$$$20240828$$MD$JP$JP
242597921$24259792$1$I$$20240826$20240828$20240828$EXP$$EG-TAKEDA-2024TUS086211$TAKEDA$$$$$M$Y$$$20240828$$MD$EG$EG
242597931$24259793$1$I$$20240815$20240828$20240828$PER$$US-Calliditas-2024CAL01599$CALLIDITAS THERAPEUTICS$$25$YR$A$M$Y$$$20240828$$HP$US$US
242597941$24259794$1$I$20240710$20240717$20240828$20240828$PER$$US-LUNDBECK-DKLU4001919$LUNDBECK$$$$$$Y$$$20240828$$CN$US$US
242597951$24259795$1$I$$20240718$20240828$20240828$PER$$US-LUNDBECK-DKLU4002078$LUNDBECK$$$$$$Y$$$20240828$$CN$US$US
242597961$24259796$1$I$$20240813$20240828$20240828$EXP$$US-BIOMARINAP-US-2024-160145$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
242597971$24259797$1$I$$20240820$20240828$20240828$EXP$$US-AMGEN-USASP2024166789$AMGEN$Nguyen Q.D.; Uludag G.; Karaca I. et al.. Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFa Therapies. Ocular Immunology and Inflammation. 2024;32 (6):891-897$24$YR$A$F$Y$$$20240828$$MD$US$US
242597981$24259798$1$I$$20240820$20240828$20240828$PER$$US-AMGEN-USASP2024166783$AMGEN$Nguyen Q.D.; Uludag G.; Karaca I. et al.. Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFa Therapies. Ocular Immunology and Inflammation. 2024;32 (6):891-897$15$YR$T$F$Y$$$20240828$$MD$US$US
242597991$24259799$1$I$20240816$20240820$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132251$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$104$KG$20240828$$PH$US$US
242598001$24259800$1$I$$20240820$20240828$20240828$EXP$$US-AMGEN-USASP2024166790$AMGEN$Nguyen Q.D.; Uludag G.; Karaca I. et al.. Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFa Therapies. Ocular Immunology and Inflammation. 2024;32 (6):891-897$14$YR$T$M$Y$$$20240828$$MD$US$US
242598011$24259801$1$I$$20240826$20240828$20240828$EXP$$US-KYOWAKIRIN-2024KK020035$KYOWA$$$$$$Y$$$20240828$$HP$US$US
242598022$24259802$2$F$20240727$20240904$20240828$20240906$EXP$$NVSC2024CA170874$NOVARTIS$$67$YR$$F$Y$$$20240907$$MD$CA$CA
242598032$24259803$2$F$20240812$20240830$20240828$20240904$EXP$$US-TRAVERE-2024TVT00832$TRAVERE THERAPEUTICS$$49$YR$A$M$Y$$$20240904$$CN$US$US
242598042$24259804$2$F$$20240827$20240828$20240908$EXP$$US-TRAVERE-2024TVT00836$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240908$$CN$US$US
242598051$24259805$1$I$$20240821$20240828$20240828$PER$$JP-Eisai-EC-2024-172708$EISAI$$$$$F$Y$$$20240828$$MD$JP$JP
242598061$24259806$1$I$$20240719$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07423$LUPIN$$$$$$Y$$$20240828$$PH$US$US
242598072$24259807$2$F$$20240826$20240828$20240902$EXP$$JP-009507513-2408JPN003102J$MERCK$$$$$F$Y$$$20240902$$MD$JP$JP
242598081$24259808$1$I$$20240822$20240828$20240828$EXP$$HK-PFIZER INC-202400242162$PFIZER$$$$$M$Y$$$20240828$$MD$HK$HK
242598091$24259809$1$I$20240715$20240823$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110611$PFIZER$$42$YR$$F$Y$57$KG$20240828$$HP$CN$CN
242598101$24259810$1$I$$20240827$20240828$20240828$EXP$$CA-PFIZER INC-202400244908$PFIZER$$72$YR$$F$Y$$$20240828$$CN$CA$CA
242598111$24259811$1$I$$20240823$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110351$PFIZER$$$$A$M$Y$$$20240828$$CN$CN$CN
242598121$24259812$1$I$$20240827$20240828$20240828$EXP$$US-PFIZER INC-PV202400111896$PFIZER$$87$YR$$M$Y$$$20240828$$CN$US$US
242598131$24259813$1$I$20240701$20240826$20240828$20240828$EXP$FR-AFSSAPS-LY2024001325$FR-PFIZER INC-202400243599$PFIZER$$59$YR$$M$Y$128$KG$20240828$$PH$FR$FR
242598141$24259814$1$I$20240812$20240826$20240828$20240828$EXP$$US-PFIZER INC-202400245106$PFIZER$$83$YR$$F$Y$$$20240828$$HP$US$US
242598161$24259816$1$I$20240101$20240828$20240828$20240828$EXP$$JP-PFIZER INC-202400245183$PFIZER$$$$$$Y$$$20240828$$PH$JP$JP
242598171$24259817$1$I$20240810$20240823$20240828$20240828$EXP$$JP-PFIZER INC-PV202400110516$PFIZER$$80$YR$$$Y$$$20240828$$MD$JP$JP
242598181$24259818$1$I$20240601$20240827$20240828$20240828$EXP$CH-SM-2024-14733$CH-PFIZER INC-202400244727$PFIZER$$67$YR$$F$Y$$$20240828$$MD$CH$CH
242598191$24259819$1$I$20240812$20240823$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110642$PFIZER$$51$YR$$M$Y$52$KG$20240828$$HP$CN$CN
242598202$24259820$2$F$20240812$20240830$20240828$20240830$EXP$$CN-PFIZER INC-PV202400110662$PFIZER$$69$YR$$F$Y$54$KG$20240830$$HP$CN$CN
242598211$24259821$1$I$20240709$20240822$20240828$20240828$EXP$$ES-PFIZER INC-202400242464$PFIZER$$32$YR$$F$Y$$$20240828$$HP$ES$ES
242598221$24259822$1$I$20240723$20240823$20240828$20240828$EXP$FR-AFSSAPS-RE2024000839$FR-PFIZER INC-202400243731$PFIZER$$78$YR$$M$Y$$$20240828$$MD$FR$FR
242598241$24259824$1$I$20240826$20240826$20240828$20240828$EXP$$CA-PFIZER INC-202400244977$PFIZER$$51$YR$$M$Y$$$20240828$$HP$CA$CA
242598251$24259825$1$I$$20240826$20240828$20240828$EXP$$US-PFIZER INC-202300449953$PFIZER$$74$YR$$F$Y$$$20240828$$MD$US$US
242598261$24259826$1$I$$20240825$20240828$20240828$EXP$$PH-PFIZER INC-PV202400111578$PFIZER$$$$$F$Y$$$20240828$$CN$PH$PH
242598271$24259827$1$I$$20240826$20240828$20240828$PER$$US-ABBVIE-5897658$ABBVIE$$$$$$Y$$$20240828$$MD$US$US
242598281$24259828$1$I$20231129$20240821$20240828$20240828$EXP$DE-DCGMA-24203698$DE-RDY-SPO/DEU/24/0012235$DR REDDYS$$12$YR$C$M$Y$24$KG$20240828$$MD$DE$DE
242598291$24259829$1$I$20240818$20240822$20240828$20240828$EXP$IT-MINISAL02-999710$IT-RDY-SPO/ITA/24/0012324$DR REDDYS$$58$YR$A$F$Y$$$20240828$$MD$IT$IT
242598301$24259830$1$I$$20240819$20240828$20240828$PER$$US-RDY-SPO/USA/24/0012343$DR REDDYS$Sumransub N, Bachanova V, Linden MA. Kikuchi-Fujimoto disease mimicking T-cell lymphoma after COVID-19 vaccination. American Journal of Clinical Pathology. 2024 Aug;162(2): 210. doi:10.1093/ajcp/aqae016.$45$YR$A$F$Y$$$20240828$$MD$US$US
242598311$24259831$1$I$$20240820$20240828$20240828$PER$$US-RDY-LIT/USA/24/0012414$DR REDDYS$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. Journal of drugs in dermatology : JDD. 2023 Nov;22(11): e12-e16. doi:10.36849/JDD.4936.$42$YR$A$F$Y$$$20240828$$HP$US$US
242598321$24259832$1$I$$20240820$20240828$20240828$EXP$$US-RDY-LIT/USA/24/0012417$DR REDDYS$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. Journal of drugs in dermatology : JDD. 2023 Nov;22(11): e12-e16. doi:10.36849/JDD.4936.$33$YR$A$F$Y$$$20240828$$HP$US$US
242598331$24259833$1$I$$20240820$20240828$20240828$PER$$US-RDY-SPO/USA/24/0012373$DR REDDYS$$29$YR$A$M$Y$$$20240828$$MD$US$US
242598342$24259834$2$F$20240731$20240904$20240828$20240905$EXP$$PT-AMERICAN REGENT INC-2024003290$AMERICAN REGENT$$57$YR$$F$Y$$$20240905$$PH$PT$PT
242598351$24259835$1$I$20220301$20240827$20240828$20240828$EXP$$US-PURDUE PHARMA-USA-2024-0311506$PURDUE$$$$$$Y$$$20240828$$CN$US$US
242598361$24259836$1$I$$20240814$20240828$20240828$30DAY$$US-SA-2024SA242746$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240828$$HP$US$US
242598381$24259838$1$I$$20240731$20240828$20240828$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07859$LUPIN$$$$$$Y$$$20240828$$CN$US$US
242598391$24259839$1$I$20231021$20240819$20240828$20240828$EXP$DK-DKMA-30737026$DK-TEVA-VS-3234669$TEVA$$29$YR$$F$Y$68$KG$20240828$$CN$DK$DK
242598402$24259840$2$F$$20240911$20240828$20240918$PER$$US-AstraZeneca-2024A187978$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
242598411$24259841$1$I$$20240822$20240828$20240828$PER$$US-AstraZeneca-2024A192640$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242598421$24259842$1$I$$20240816$20240828$20240828$EXP$$US-AstraZeneca-2024A194411$ASTRAZENECA$$$$$F$Y$$$20240828$$MD$US$
242598432$24259843$2$F$$20240822$20240828$20240910$PER$$US-AstraZeneca-2024A192652$ASTRAZENECA$$$$$$Y$$$20240910$$CN$US$
242598441$24259844$1$I$20240729$20240820$20240828$20240828$EXP$$ZA-AstraZeneca-2024A189681$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$ZA$
242598451$24259845$1$I$$20240820$20240828$20240828$EXP$$US-AstraZeneca-2024A190301$ASTRAZENECA$$$$$$Y$$$20240828$$CN$US$
242598461$24259846$1$I$$20240820$20240828$20240828$EXP$$GB-AstraZeneca-2024A190926$ASTRAZENECA$$$$$F$Y$$$20240828$$CN$GB$
242598471$24259847$1$I$$20240821$20240828$20240828$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16660$IPSEN$$$$$$Y$$$20240828$$MD$US$US
242598481$24259848$1$I$$20240802$20240828$20240828$PER$$US-PHARMING-PHAUS2024000670$PHARMING GROUP$$$$$$Y$$$20240808$$CN$US$US
242598492$24259849$2$F$$20240821$20240828$20240902$PER$$US-PHARMING-PHAUS2024000671$PHARMING GROUP$$$$$$Y$$$20240902$$CN$US$US
242598502$24259850$2$F$20240501$20240819$20240828$20240902$PER$$US-PHARMING-PHAUS2024000662$PHARMING GROUP$$$$$$Y$$$20240902$$CN$US$US
242598521$24259852$1$I$$20240805$20240828$20240828$PER$$US-PHARMING-PHAUS2024000673$PHARMING GROUP$$$$$$Y$$$20240808$$CN$US$US
242598531$24259853$1$I$$20240805$20240828$20240828$PER$$US-PHARMING-PHAUS2024000672$PHARMING GROUP$$$$$$Y$$$20240808$$CN$US$US
242598541$24259854$1$I$$20240823$20240828$20240828$EXP$$US-ABBVIE-5894062$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242598551$24259855$1$I$$20240813$20240828$20240828$EXP$$US-BIOMARINAP-US-2024-160146$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
242598561$24259856$1$I$$20240813$20240828$20240828$EXP$$US-BIOMARINAP-US-2024-160147$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
242598571$24259857$1$I$$20240827$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136637$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240828$$CN$US$US
242598581$24259858$1$I$$20240819$20240828$20240828$EXP$NL-LRB-00996029$NL-TEVA-VS-3234622$TEVA$$60$YR$$F$Y$$$20240828$$MD$NL$NL
242598591$24259859$1$I$$20240826$20240828$20240828$PER$$US-TAKEDA-2024TUS086185$TAKEDA$$$$$F$Y$$$20240828$$CN$US$US
242598601$24259860$1$I$$20240827$20240828$20240828$EXP$$US-GILEAD-2024-0685537$GILEAD$$75$YR$E$M$Y$$$20240828$$MD$US$US
242598611$24259861$1$I$$20240822$20240828$20240828$PER$$US-ABBVIE-5896272$ABBVIE$$$$A$$Y$$$20240828$$PH$US$US
242598621$24259862$1$I$$20240820$20240828$20240828$EXP$$US-AMGEN-USASP2024166793$AMGEN$Nguyen Q.D.; Uludag G.; Karaca I. et al.. Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFa Therapies. Ocular Immunology and Inflammation. 2024;32 (6):891-897$7$YR$C$M$Y$$$20240828$$MD$US$US
242598631$24259863$1$I$$20240820$20240828$20240828$EXP$$US-AMGEN-USASP2024167716$AMGEN$Safavi P.S.; Hegde P.; Nawras Y. et al.. Cocaine-Associated Antiglomerular Basement Membrane Antibody Syndrome Successfully Treated With Plasmapheresis and Mycophenolate. American Journal of Therapeutics. 2024;31 (4):e445-e448$29$YR$A$M$Y$133.8$KG$20240828$$MD$US$US
242598641$24259864$1$I$$20240820$20240828$20240828$EXP$$US-AMGEN-USASP2024166792$AMGEN$Nguyen Q.D.; Uludag G.; Karaca I. et al.. Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFa Therapies. Ocular Immunology and Inflammation. 2024;32 (6):891-897$13$YR$T$F$Y$$$20240828$$MD$US$US
242598651$24259865$1$I$20240814$20240822$20240828$20240828$EXP$$CN-ROCHE-10000068012$ROCHE$$73$YR$E$M$Y$90$KG$20240828$$HP$CN$CN
242598661$24259866$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5894030$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242598671$24259867$1$I$20240826$20240828$20240828$20240828$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048299$BOEHRINGER INGELHEIM$$88$YR$E$M$Y$$$20240828$$HP$US$US
242598682$24259868$2$F$20220101$20240904$20240828$20240911$EXP$$US-ABBVIE-5894206$ABBVIE$$$$$F$Y$68$KG$20240911$$CN$US$US
242598691$24259869$1$I$$20240827$20240828$20240828$EXP$$GB-MYLANLABS-2024M1039285$MYLAN$$$$$F$Y$$$20240828$$MD$GB$GB
242598702$24259870$2$F$20240101$20240822$20240828$20240906$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1175$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240906$$CN$US$US
242598713$24259871$3$F$20240826$20240905$20240828$20240906$PER$$US-AMGEN-USASP2024171448$AMGEN$$65$YR$E$F$Y$$$20240906$$CN$US$US
242598731$24259873$1$I$$20240827$20240827$20240827$DIR$716117$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242598741$24259874$1$I$$20240827$20240827$20240827$DIR$716048$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242598761$24259876$1$I$$20240827$20240827$20240827$DIR$716061$$FDA-CTU$$$$$UNK$N$$$20240827$$CN$US$
242598771$24259877$1$I$20230101$20240822$20240828$20240828$PER$$JP-Eisai-EC-2023-133877$EISAI$$74$YR$E$F$Y$$$20240828$$MD$JP$JP
242598781$24259878$1$I$20230509$20240822$20240828$20240828$PER$$JP-Eisai-EC-2024-172730$EISAI$$77$YR$E$F$Y$$$20240828$$MD$JP$JP
242598791$24259879$1$I$20240323$20240827$20240827$20240827$DIR$716099$$FDA-CTU$$37$YR$$F$N$101$KG$20240827$N$PH$US$
242598811$24259881$1$I$$20240821$20240828$20240828$EXP$GB-MHRA-MED-202408211939013530-PSVHC$GB-RDY-SPO/GBR/24/0012250$DR REDDYS$$$$$M$Y$$$20240828$$CN$GB$GB
242598821$24259882$1$I$$20240826$20240828$20240828$EXP$$CA-ABBVIE-5895720$ABBVIE$$53$YR$$F$Y$$$20240828$$CN$CA$CA
242598841$24259884$1$I$20240304$20240827$20240827$20240827$DIR$716203$$FDA-CTU$$65$YR$$F$N$94.95$KG$20240827$N$CN$US$
242598851$24259885$1$I$20240624$20240822$20240828$20240828$EXP$SE-SEMPA-2024-006098$SE-MYLANLABS-2024M1078054$MYLAN$$26$YR$$F$Y$$$20240828$$MD$SE$SE
242598861$24259886$1$I$20240815$20240827$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136879$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240828$$CN$US$US
242598871$24259887$1$I$20240804$20240825$20240828$20240828$EXP$GB-MHRA-MED-202408251452442570-LZHFP$GB-MYLANLABS-2024M1078634$MYLAN$$39$YR$$M$Y$$$20240828$$PH$GB$GB
242598881$24259888$1$I$20240304$20240822$20240828$20240828$EXP$DK-DKMA-30737660$DK-MYLANLABS-2024M1078551$MYLAN$$17$YR$$F$Y$109$KG$20240828$$MD$DK$DK
242598891$24259889$1$I$20240811$20240820$20240828$20240828$EXP$$AU-ROCHE-10000060110$ROCHE$$60$YR$A$F$Y$65$KG$20240828$$MD$AU$AU
242598902$24259890$2$F$$20240828$20240828$20240830$EXP$$US-KYOWAKIRIN-2024KK020090$KYOWA$$$$$$Y$$$20240830$$HP$US$US
242598921$24259892$1$I$20240101$20240811$20240828$20240828$PER$$US-SA-2024SA166970$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240828$$MD$US$US
242598931$24259893$1$I$$20240827$20240828$20240828$EXP$$AU-GILEAD-2024-0685609$GILEAD$$$$A$$Y$$$20240828$$HP$AU$AU
242598941$24259894$1$I$$20240828$20240828$20240828$EXP$$GB-GILEAD-2024-0685579$GILEAD$$67$YR$E$M$Y$$$20240828$$CN$GB$GB
242598951$24259895$1$I$$20240816$20240828$20240828$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010584$ELI LILLY AND CO$$46$YR$A$$Y$$$20240828$$LW$US$US
242598961$24259896$1$I$20240731$20240823$20240828$20240828$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408015846$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240828$$CN$JP$JP
242598971$24259897$1$I$20240708$20240828$20240828$20240828$EXP$DE-SAMSUNG BIOEPIS-SB-2024-25429$DE-ROCHE-10000067921$ROCHE$$$$$M$Y$70$KG$20240828$$MD$DE$DE
242598981$24259898$1$I$$20240814$20240828$20240828$PER$$US-SA-2022SA444481$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240828$$MD$US$US
242598991$24259899$1$I$$20240814$20240828$20240828$PER$$US-SA-2024SA246944$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240828$$MD$US$US
242599012$24259901$2$F$20240816$20240826$20240828$20240906$EXP$$CN-ROCHE-10000066595$ROCHE$$59$YR$A$F$Y$54$KG$20240906$$HP$CN$CN
242599021$24259902$1$I$20240127$20240827$20240827$20240827$DIR$716091$$FDA-CTU$$44$YR$$F$N$94.2$KG$20240827$N$PH$US$
242599032$24259903$2$F$$20240819$20240828$20240909$EXP$$JP-009507513-2408JPN002254J$MERCK$Kato R, Sakakibara R, Hota T, Shirai T, Ishizuka M, Furusawa H, et al.. 16 A case of lung adenocarcinoma requiring pericardiotomy for re-retention of pericardial fluid after administration of pembrolizumab. The 199th Kanto Branch Meeting of the Japan Lung Cancer Society. 13$81$YR$$M$Y$$$20240909$$MD$JP$JP
242599051$24259905$1$I$20240801$20240827$20240827$20240827$DIR$716088$$FDA-CTU$$65$YR$$F$N$47.7$KG$20240827$N$CN$US$
242599071$24259907$1$I$20240825$20240827$20240827$20240827$DIR$716039$$FDA-CTU$$28$YR$$F$N$83.25$KG$20240827$N$CN$US$
242599081$24259908$1$I$$20240827$20240827$20240827$DIR$716193$$FDA-CTU$$$$$UNK$N$$$20240827$$CN$US$
242599091$24259909$1$I$$20240819$20240828$20240828$EXP$$CA-APOTEX-2024AP009526$APOTEX$$62$YR$$M$Y$$$20240828$$CN$CA$CA
242599101$24259910$1$I$$20240828$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048319$BOEHRINGER INGELHEIM$$$$$$Y$$$20240828$$CN$US$US
242599111$24259911$1$I$20201101$20240813$20240828$20240828$EXP$FR-AFSSAPS-NY2024000933$FR-PHARMAAND GMBH-2024PHR00481$pharmaAND$$54$YR$$M$Y$90$KG$20240828$$MD$FR$FR
242599131$24259913$1$I$$20240815$20240828$20240828$PER$$US-INSUD PHARMA-2408US06529$INSUD PHARMA$$$$$$Y$$$20240828$$CN$US$US
242599141$24259914$1$I$20240801$20240818$20240828$20240828$PER$$US-INSUD PHARMA-2408US06531$INSUD PHARMA$$$$$$Y$$$20240828$$CN$US$US
242599151$24259915$1$I$20220101$20240815$20240828$20240828$PER$$US-SA-2021SA344933$SANOFI AVENTIS$$59$YR$A$F$Y$72.7$KG$20240828$$MD$US$US
242599162$24259916$2$F$20240812$20240822$20240828$20240829$PER$$US-SA-2024SA245546$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240829$$CN$US$US
242599171$24259917$1$I$20240809$20240816$20240828$20240828$PER$$US-IGSA-BIG0030374$GRIFOLS$$59$YR$$F$Y$$$20240828$$CN$US$US
242599181$24259918$1$I$$20240815$20240828$20240828$PER$$US-SA-2024SA247946$SANOFI AVENTIS$$$$A$F$Y$71.6$KG$20240828$$MD$US$US
242599191$24259919$1$I$20240101$20240815$20240828$20240828$PER$$US-SA-2024SA247624$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240828$$MD$US$US
242599211$24259921$1$I$$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135710$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240828$$HP$US$US
242599221$24259922$1$I$20240101$20240815$20240828$20240828$PER$$US-SA-2024SA169625$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240828$$MD$US$US
242599231$24259923$1$I$$20240815$20240828$20240828$PER$$US-SA-2024SA247972$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242599241$24259924$1$I$$20240815$20240828$20240828$PER$$US-SA-2024SA247700$SANOFI AVENTIS$$$$C$M$Y$$$20240828$$MD$US$US
242599251$24259925$1$I$20240811$20240815$20240828$20240828$PER$$US-SA-2024SA248662$SANOFI AVENTIS$$59$YR$A$F$Y$87$KG$20240828$$MD$US$US
242599271$24259927$1$I$$20240815$20240828$20240828$PER$$US-SA-2024SA249027$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$CN$US$US
242599281$24259928$1$I$$20240815$20240828$20240828$PER$$US-SA-2024SA246735$SANOFI AVENTIS$$$$E$M$Y$$$20240828$$MD$US$US
242599291$24259929$1$I$$20240819$20240828$20240828$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-136866$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240828$$HP$CA$CA
242599301$24259930$1$I$$20240820$20240828$20240828$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007322$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240828$$MD$DE$DE
242599311$24259931$1$I$$20240815$20240828$20240828$PER$$US-SA-2024SA244811$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240828$$CN$US$US
242599321$24259932$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59090$$FDA-CTU$$46$YR$$F$N$$$20240827$N$$US$
242599341$24259934$1$I$20240716$20240820$20240828$20240828$EXP$FR-AFSSAPS-AVLL2024000198$FR-TEVA-VS-3235348$TEVA$$13$YR$$M$Y$$$20240828$$MD$FR$FR
242599351$24259935$1$I$20240604$20240827$20240827$20240827$DIR$716186$$FDA-CTU$$84$YR$$M$N$116.1$KG$20240827$Y$HP$US$
242599361$24259936$1$I$20240819$20240827$20240827$20240827$DIR$716188$$FDA-CTU$$76$YR$$F$N$$$20240827$Y$HP$US$
242599371$24259937$1$I$20240601$20240815$20240828$20240828$PER$$US-SA-2024SA246078$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240828$$MD$US$US
242599381$24259938$1$I$20240101$20240815$20240828$20240828$PER$$US-SA-2024SA244054$SANOFI AVENTIS$$43$YR$A$F$Y$158.75$KG$20240828$$MD$US$US
242599392$24259939$2$F$20240101$20240829$20240828$20240917$PER$$US-SA-2024SA247999$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$MD$US$US
242599401$24259940$1$I$20240804$20240827$20240827$20240827$DIR$716074$$FDA-CTU$$41$YR$$M$N$$$20240827$N$HP$US$
242599411$24259941$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA247815$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240828$$MD$US$US
242599421$24259942$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA247971$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242599431$24259943$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248087$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240828$$MD$US$US
242599441$24259944$1$I$20240718$20240816$20240828$20240828$PER$$US-SA-2024SA245392$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240828$$MD$US$US
242599451$24259945$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248153$SANOFI AVENTIS$$$$A$M$Y$98$KG$20240828$$MD$US$US
242599461$24259946$1$I$20240815$20240815$20240828$20240828$PER$$US-SA-2024SA038788$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240828$$CN$US$US
242599471$24259947$1$I$20240601$20240816$20240828$20240828$PER$$US-SA-2024SA248143$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240828$$MD$US$US
242599481$24259948$1$I$20240801$20240816$20240828$20240828$PER$$US-SA-2024SA248020$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240828$$MD$US$US
242599491$24259949$1$I$20240801$20240815$20240828$20240828$PER$$US-SA-2024SA246798$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240828$$MD$US$US
242599501$24259950$1$I$$20240814$20240828$20240828$PER$$US-ABBVIE-5894034$ABBVIE$$64$YR$$F$Y$$$20240828$$HP$US$US
242599511$24259951$1$I$$20240827$20240828$20240828$PER$$US-HALEON-2194044$Haleon PLC$$$$$$Y$$$20240828$$CN$US$US
242599522$24259952$2$F$$20240916$20240828$20240926$EXP$$US-MALLINCKRODT-MNK202404384$MALLINCKRODT$$$$$F$Y$$$20240926$$CN$US$US
242599531$24259953$1$I$20240801$20240816$20240828$20240828$PER$$US-SA-2024SA248391$SANOFI AVENTIS$$10$YR$C$F$Y$41.2$KG$20240828$$MD$US$US
242599541$24259954$1$I$20240101$20240814$20240828$20240828$EXP$$US-MALLINCKRODT-MNK202405175$MALLINCKRODT$$$$E$F$Y$$$20240828$$HP$US$US
242599551$24259955$1$I$20240819$20240819$20240828$20240828$EXP$$US-MALLINCKRODT-MNK202405232$MALLINCKRODT$$58$YR$A$F$Y$$$20240828$$CN$US$US
242599572$24259957$2$F$20220312$20240904$20240828$20240912$EXP$$JP-AstraZeneca-2024A155278$ASTRAZENECA$$61$YR$$F$Y$66$KG$20240912$$MD$JP$
242599581$24259958$1$I$20240101$20240816$20240828$20240828$PER$$US-SA-2024SA248797$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240828$$MD$US$US
242599591$24259959$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA247770$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240828$$MD$US$US
242599601$24259960$1$I$20240101$20240816$20240828$20240828$PER$$US-SA-2024SA248184$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240828$$MD$US$US
242599611$24259961$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248692$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240828$$MD$US$US
242599621$24259962$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA245799$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240828$$CN$US$US
242599631$24259963$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248962$SANOFI AVENTIS$$$$A$F$Y$58.05$KG$20240828$$MD$US$US
242599641$24259964$1$I$20240815$20240816$20240828$20240828$PER$$US-SA-2024SA247110$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240828$$MD$US$US
242599651$24259965$1$I$20240101$20240816$20240828$20240828$PER$$US-SA-2024SA248636$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240828$$MD$US$US
242599661$24259966$1$I$$20240816$20240828$20240828$PER$$US-SA-2023SA145464$SANOFI AVENTIS$$62$YR$A$F$Y$54$KG$20240828$$MD$US$US
242599671$24259967$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA247111$SANOFI AVENTIS$$$$C$F$Y$$$20240828$$MD$US$US
242599681$24259968$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248664$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240828$$MD$US$US
242599691$24259969$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248113$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240828$$MD$US$US
242599702$24259970$2$F$20240101$20240905$20240828$20240914$PER$$US-SA-2024SA245955$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240914$$MD$US$US
242599711$24259971$1$I$20240825$20240826$20240828$20240828$EXP$$US-AstraZeneca-2024A194686$ASTRAZENECA$$33413$DY$$M$Y$$$20240828$$CN$US$
242599721$24259972$1$I$20240801$20240816$20240828$20240828$PER$$US-SA-2024SA246864$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240828$$CN$US$US
242599731$24259973$1$I$20240101$20240816$20240828$20240828$PER$$US-SA-2024SA248240$SANOFI AVENTIS$$$$E$M$Y$$$20240828$$MD$US$US
242599741$24259974$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA249051$SANOFI AVENTIS$$9$YR$C$F$Y$77.11$KG$20240828$$MD$US$US
242599751$24259975$1$I$20240801$20240816$20240828$20240828$PER$$US-SA-2024SA247937$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240828$$CN$US$US
242599761$24259976$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248679$SANOFI AVENTIS$$4$YR$C$F$Y$15.87$KG$20240828$$MD$US$US
242599771$24259977$1$I$20240101$20240816$20240828$20240828$PER$$US-SA-2024SA247102$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240828$$MD$US$US
242599781$24259978$1$I$20240801$20240816$20240828$20240828$PER$$US-SA-2024SA248458$SANOFI AVENTIS$$56$YR$A$M$Y$123.19$KG$20240828$$MD$US$US
242599791$24259979$1$I$20231101$20240816$20240828$20240828$PER$$US-SA-2024SA248755$SANOFI AVENTIS$$65$YR$E$F$Y$63.5$KG$20240828$$MD$US$US
242599801$24259980$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA247708$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240828$$MD$US$US
242599811$24259981$1$I$20240101$20240816$20240828$20240828$PER$$US-SA-2024SA247733$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240828$$MD$US$US
242599821$24259982$1$I$20240731$20240816$20240828$20240828$PER$$US-SA-2024SA247894$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240828$$MD$US$US
242599831$24259983$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA246743$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240828$$CN$US$US
242599841$24259984$1$I$20240101$20240816$20240828$20240828$PER$$US-SA-2024SA247985$SANOFI AVENTIS$$$$E$F$Y$$$20240828$$MD$US$US
242599851$24259985$1$I$20240625$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59132$$FDA-CTU$$84$YR$$F$N$69.1$KG$20240827$N$$US$
242599861$24259986$1$I$20230301$20240816$20240828$20240828$PER$$US-SA-2024SA248552$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240828$$MD$US$US
242599871$24259987$1$I$20240821$20240827$20240827$20240827$DIR$716176$$FDA-CTU$$66$YR$$M$N$88.7$KG$20240827$N$HP$US$
242599881$24259988$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248857$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$HP$US$US
242599891$24259989$1$I$20240101$20240816$20240828$20240828$PER$$US-SA-2024SA248843$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240828$$MD$US$US
242599901$24259990$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248175$SANOFI AVENTIS$$$$E$F$Y$$$20240828$$MD$US$US
242599911$24259991$1$I$20240101$20240816$20240828$20240828$PER$$US-SA-2024SA248725$SANOFI AVENTIS$$62$YR$A$F$Y$99.773$KG$20240828$$MD$US$US
242599921$24259992$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248008$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240828$$MD$US$US
242599931$24259993$1$I$20240501$20240816$20240828$20240828$PER$$US-SA-2024SA229214$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240828$$CN$US$US
242599941$24259994$1$I$20240101$20240816$20240828$20240828$PER$$US-SA-2024SA248247$SANOFI AVENTIS$$42$YR$A$M$Y$109.7$KG$20240828$$MD$US$US
242599951$24259995$1$I$$20240821$20240828$20240828$EXP$$CA-PERRIGO-24CA007838$PERRIGO$$$$$F$Y$$$20240828$$HP$CA$CA
242599961$24259996$1$I$20240601$20240820$20240828$20240828$EXP$FR-AFSSAPS-SE2024000637$FR-TEVA-VS-3235476$TEVA$$64$YR$$F$Y$$$20240828$$MD$FR$FR
242599971$24259997$1$I$20240301$20240821$20240828$20240828$PER$$US-ABBVIE-5891645$ABBVIE$$80$YR$$F$Y$$$20240828$$CN$US$US
242599981$24259998$1$I$$20240814$20240828$20240828$EXP$$US-HLS-202400905$HLS THERAPEUTICS$$$$A$$Y$$$20240828$$MD$US$US
242599991$24259999$1$I$$20240813$20240828$20240828$EXP$$CA-HLS-202401818$HLS THERAPEUTICS$$47$YR$A$F$Y$$$20240828$$MD$CA$CA
242600001$24260000$1$I$$20240817$20240828$20240828$PER$$US-SA-2024SA248665$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240828$$MD$US$US
242600011$24260001$1$I$20240701$20240817$20240828$20240828$PER$$US-SA-2024SA247818$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240828$$MD$US$US
242600021$24260002$1$I$20240818$20240819$20240828$20240828$PER$$US-SA-2024SA249737$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240828$$CN$US$US
242600031$24260003$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA246046$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240828$$CN$US$US
242600041$24260004$1$I$20240501$20240817$20240828$20240828$PER$$US-SA-2024SA248669$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240828$$MD$US$US
242600051$24260005$1$I$20240801$20240816$20240828$20240828$PER$$US-SA-2024SA248492$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240828$$MD$US$US
242600061$24260006$1$I$20240101$20240817$20240828$20240828$PER$$US-SA-2024SA248203$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240828$$MD$US$US
242600071$24260007$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248740$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240828$$MD$US$US
242600081$24260008$1$I$20240701$20240816$20240828$20240828$PER$$US-SA-2024SA246725$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240828$$MD$US$US
242600091$24260009$1$I$20240101$20240817$20240828$20240828$PER$$US-SA-2024SA248193$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240828$$MD$US$US
242600101$24260010$1$I$$20240817$20240828$20240828$PER$$US-SA-2024SA248802$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242600111$24260011$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248583$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242600121$24260012$1$I$$20240817$20240828$20240828$PER$$US-SA-2024SA246867$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240828$$MD$US$US
242600132$24260013$2$F$20240801$20240919$20240828$20240930$PER$$US-SA-2024SA248562$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240930$$MD$US$US
242600141$24260014$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248213$SANOFI AVENTIS$$$$A$M$Y$$$20240828$$MD$US$US
242600151$24260015$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248212$SANOFI AVENTIS$$$$A$F$Y$58$KG$20240828$$MD$US$US
242600161$24260016$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248634$SANOFI AVENTIS$$98$YR$E$F$Y$$$20240828$$MD$US$US
242600171$24260017$1$I$20240819$20240820$20240828$20240828$PER$$US-SA-2024SA249897$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240828$$CN$US$US
242600181$24260018$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249275$SANOFI AVENTIS$$$$A$F$Y$129$KG$20240828$$MD$US$US
242600191$24260019$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA249478$SANOFI AVENTIS$$98$YR$E$M$Y$54$KG$20240828$$MD$US$US
242600201$24260020$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249448$SANOFI AVENTIS$$$$E$F$Y$$$20240828$$MD$US$US
242600211$24260021$1$I$20240801$20240819$20240828$20240828$PER$$US-SA-2024SA248542$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240828$$CN$US$US
242600222$24260022$2$F$20240101$20240821$20240828$20240830$PER$$US-SA-2024SA248228$SANOFI AVENTIS$$$$$M$Y$$$20240830$$HP$US$US
242600231$24260023$1$I$20240817$20240819$20240828$20240828$PER$$US-SA-2024SA247951$SANOFI AVENTIS$$25$YR$A$$Y$$$20240828$$MD$US$US
242600241$24260024$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248277$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240828$$MD$US$US
242600251$24260025$1$I$20240101$20240820$20240828$20240828$PER$$US-SA-2024SA249580$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240828$$MD$US$US
242600261$24260026$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA250429$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240828$$HP$US$US
242600271$24260027$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249633$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240828$$MD$US$US
242600281$24260028$1$I$$20240819$20240828$20240828$EXP$$JP-009507513-2408JPN002285J$MERCK$ARATAKE J, SHIBUTANI T, NARITA M, HAMASAKI K, YAMAMOTO K, KITAI M, et al.. [ORIGINAL] Impact of the number of prior systemic treatment lines on lenvatinib and pembrolizumab combination therapy for advanced or recurrent endometrial cancer : Experience from a single institution in Japan with 21 cases. Advances in Obstetrics and Gynecology. 2024;76(3):222-8$$$$F$Y$$$20240828$$MD$JP$JP
242600291$24260029$1$I$20220101$20240823$20240828$20240828$EXP$$US-ABBVIE-5893980$ABBVIE$$46$YR$$F$Y$$$20240828$$CN$US$US
242600301$24260030$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA250201$SANOFI AVENTIS$$$$E$M$Y$97.5$KG$20240828$$MD$US$US
242600311$24260031$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248364$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240828$$MD$US$US
242600321$24260032$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249553$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240828$$MD$US$US
242600331$24260033$1$I$20240801$20240821$20240828$20240828$PER$$US-SA-2024SA249685$SANOFI AVENTIS$$31$YR$A$$Y$$$20240828$$HP$US$US
242600351$24260035$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248758$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240828$$MD$US$US
242600361$24260036$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249742$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240828$$MD$US$US
242600371$24260037$1$I$20240816$20240819$20240828$20240828$PER$$US-FreseniusKabi-FK202412732$FRESENIUS KABI$$$$$$Y$$$20240828$$PH$US$US
242600381$24260038$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249582$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240828$$MD$US$US
242600391$24260039$1$I$20240827$20240827$20240827$20240827$DIR$716160$$FDA-CTU$$60$YR$$F$N$74.1$KG$20240827$N$PH$US$
242600401$24260040$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249938$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240828$$CN$US$US
242600411$24260041$1$I$$20240827$20240827$20240827$DIR$716127$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242600421$24260042$1$I$20240803$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59201$$FDA-CTU$$12$YR$$M$N$$$20240827$N$HP$US$
242600431$24260043$1$I$20240818$20240820$20240828$20240828$PER$$US-SA-2024SA250494$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240828$$MD$US$US
242600441$24260044$1$I$20240817$20240820$20240828$20240828$PER$$US-SA-2024SA250395$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240828$$MD$US$US
242600452$24260045$2$F$$20240819$20240828$20240917$PER$$US-SA-2024SA248075$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240918$$MD$US$US
242600461$24260046$1$I$20240701$20240819$20240828$20240828$PER$$US-SA-2024SA248156$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240828$$MD$US$US
242600471$24260047$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA222953$SANOFI AVENTIS$$$$A$M$Y$$$20240828$$MD$US$US
242600481$24260048$1$I$20240801$20240819$20240828$20240828$PER$$US-SA-2024SA247781$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240828$$MD$US$US
242600492$24260049$2$F$$20240819$20240828$20240830$PER$$US-SA-2024SA248660$SANOFI AVENTIS$$$$A$F$Y$$$20240830$$CN$US$US
242600501$24260050$1$I$20240818$20240819$20240828$20240828$PER$$US-SA-2024SA248219$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240828$$CN$US$US
242600511$24260051$1$I$20240801$20240819$20240828$20240828$PER$$US-SA-2024SA248494$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240828$$MD$US$US
242600522$24260052$2$F$$20240822$20240828$20240910$PER$$US-SA-2024SA249496$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240910$$CN$US$US
242600531$24260053$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248744$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240828$$MD$US$US
242600541$24260054$1$I$$20240814$20240828$20240828$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007351$AEGERION$$$$$F$Y$$$20240828$$CN$US$US
242600552$24260055$2$F$20240101$20240917$20240828$20240923$PER$$US-ABBVIE-5891368$ABBVIE$$$$$$Y$64$KG$20240923$$CN$US$US
242600561$24260056$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248773$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240828$$HP$US$US
242600571$24260057$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248677$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240828$$MD$US$US
242600581$24260058$1$I$20240801$20240820$20240828$20240828$PER$$US-SA-2024SA249786$SANOFI AVENTIS$$$$A$$Y$$$20240828$$CN$US$US
242600591$24260059$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249249$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240828$$CN$US$US
242600601$24260060$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249852$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240828$$MD$US$US
242600611$24260061$1$I$20240101$20240820$20240828$20240828$PER$$US-SA-2024SA250433$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240828$$MD$US$US
242600621$24260062$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA215153$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240828$$MD$US$US
242600631$24260063$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA133378$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240828$$MD$US$US
242600641$24260064$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA250030$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240828$$MD$US$US
242600651$24260065$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA249147$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240828$$MD$US$US
242600662$24260066$2$F$20240801$20240904$20240828$20240912$EXP$$US-ABBVIE-5894119$ABBVIE$$74$YR$$F$Y$$$20240912$$CN$US$US
242600671$24260067$1$I$20240818$20240820$20240828$20240828$EXP$$CN-TAKEDA-2024TUS086143$TAKEDA$$71$YR$$F$Y$51$KG$20240828$$HP$CN$CN
242600681$24260068$1$I$$20240821$20240828$20240828$PER$$US-RDY-SPO/USA/24/0012445$DR REDDYS$$$$$$Y$$$20240828$$CN$US$US
242600691$24260069$1$I$20240817$20240827$20240827$20240827$DIR$716038$$FDA-CTU$$62$YR$$M$N$103.5$KG$20240827$N$CN$US$
242600701$24260070$1$I$20240821$20240827$20240827$20240827$DIR$716036$$FDA-CTU$$53$YR$$F$N$65.25$KG$20240827$N$CN$US$
242600741$24260074$1$I$20240702$20240827$20240827$20240827$DIR$716211$$FDA-CTU$$67$YR$$F$N$51.75$KG$20240827$N$CN$US$
242600751$24260075$1$I$20240819$20240827$20240827$20240827$DIR$716167$$FDA-CTU$$77$YR$$M$N$72.45$KG$20240827$N$CN$US$
242600761$24260076$1$I$$20240827$20240827$20240827$DIR$716132$$FDA-CTU$$$$$UNK$N$$$20240827$$CN$US$
242600771$24260077$1$I$$20240827$20240827$20240827$DIR$716050$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242600781$24260078$1$I$20240822$20240827$20240827$20240827$DIR$716206$$FDA-CTU$$58$YR$$M$N$82.8$KG$20240827$N$PH$US$
242600791$24260079$1$I$20240416$20240827$20240827$20240827$DIR$716030$$FDA-CTU$$66$YR$$F$N$$$20240827$N$CN$CH$
242600801$24260080$1$I$20240824$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59330$$FDA-CTU$$56$YR$$F$N$2.5$KG$20240827$Y$CN$US$
242600811$24260081$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249733$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240828$$MD$US$US
242600822$24260082$2$F$20240730$20240912$20240828$20240926$PER$$US-SA-2024SA250040$SANOFI AVENTIS$$56$YR$A$F$Y$120.66$KG$20240926$$MD$US$US
242600831$24260083$1$I$20240701$20240820$20240828$20240828$PER$$US-SA-2024SA250238$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240828$$MD$US$US
242600841$24260084$1$I$20240820$20240820$20240828$20240828$PER$$US-SA-2024SA250204$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240828$$HP$US$US
242600852$24260085$2$F$$20240905$20240828$20240919$PER$$US-SA-2024SA217482$SANOFI AVENTIS$$$$E$F$Y$76$KG$20240919$$MD$US$US
242600862$24260086$2$F$20240101$20240909$20240828$20240917$PER$$US-SA-2024SA248427$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240918$$MD$US$US
242600871$24260087$1$I$20240101$20240820$20240828$20240828$PER$$US-SA-2024SA249703$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242600881$24260088$1$I$20200101$20240819$20240828$20240828$PER$$US-SA-2024SA249534$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240828$$MD$US$US
242600891$24260089$1$I$20240401$20240819$20240828$20240828$PER$$US-SA-2024SA249569$SANOFI AVENTIS$$51$YR$A$F$Y$83.915$KG$20240828$$MD$US$US
242600901$24260090$1$I$20240801$20240819$20240828$20240828$PER$$US-SA-2024SA247838$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240828$$MD$US$US
242600911$24260091$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA247472$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240828$$CN$US$US
242600921$24260092$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249905$SANOFI AVENTIS$$$$C$F$Y$$$20240828$$MD$US$US
242600932$24260093$2$F$20240809$20240820$20240828$20240911$PER$$US-SA-2024SA248515$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240911$$MD$US$US
242600941$24260094$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA250350$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240828$$MD$US$US
242600951$24260095$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248471$SANOFI AVENTIS$$$$E$F$Y$$$20240828$$MD$US$US
242600961$24260096$1$I$20240818$20240819$20240828$20240828$PER$$US-SA-2024SA249613$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242600971$24260097$1$I$20240701$20240822$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134289$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$$$20240828$$HP$US$US
242600981$24260098$1$I$20240807$20240820$20240828$20240828$EXP$$GB-TEVA-VS-3235709$TEVA$$85$YR$$F$Y$49$KG$20240828$$HP$GB$GB
242600991$24260099$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249450$SANOFI AVENTIS$$$$A$F$Y$89$KG$20240828$$MD$US$US
242601001$24260100$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249688$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240828$$CN$US$US
242601011$24260101$1$I$20240801$20240819$20240828$20240828$PER$$US-SA-2024SA248225$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240828$$MD$US$US
242601021$24260102$1$I$20240101$20240820$20240828$20240828$PER$$US-SA-2024SA249468$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240828$$MD$US$US
242601031$24260103$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249780$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240828$$MD$US$US
242601041$24260104$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249925$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240828$$MD$US$US
242601051$24260105$1$I$20240818$20240819$20240828$20240828$PER$$US-SA-2024SA249361$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240828$$MD$US$US
242601062$24260106$2$F$$20240819$20240828$20240909$PER$$US-SA-2024SA249692$SANOFI AVENTIS$$$$E$M$Y$$$20240909$$MD$US$US
242601081$24260108$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249759$SANOFI AVENTIS$$$$A$F$Y$77.11$KG$20240828$$MD$US$US
242601091$24260109$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249919$SANOFI AVENTIS$$$$A$F$Y$108$KG$20240828$$MD$US$US
242601101$24260110$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA248968$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240828$$MD$US$US
242601111$24260111$1$I$20240101$20240820$20240828$20240828$PER$$US-SA-2024SA249961$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240828$$MD$US$US
242601121$24260112$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248762$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240828$$HP$US$US
242601131$24260113$1$I$20240301$20240823$20240828$20240828$EXP$$US-ABBVIE-5722713$ABBVIE$$33$YR$$F$Y$$$20240828$$CN$US$US
242601151$24260115$1$I$$20240827$20240828$20240828$EXP$GB-ROCHE-10000067637$GB-ROCHE-10000067637$ROCHE$$56$YR$A$$Y$$$20240828$$PH$GB$GB
242601161$24260116$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA250134$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240828$$MD$US$US
242601171$24260117$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248742$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240828$$MD$US$US
242601181$24260118$1$I$$20240819$20240828$20240828$EXP$$CA-JNJFOC-20230110809$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240828$$HP$CA$CA
242601191$24260119$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248840$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242601201$24260120$1$I$20240101$20240820$20240828$20240828$PER$$US-SA-2024SA249484$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240828$$MD$US$US
242601211$24260121$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249457$SANOFI AVENTIS$$$$E$M$Y$76.2$KG$20240828$$MD$US$US
242601221$24260122$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA000290$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240828$$MD$US$US
242601231$24260123$1$I$20230101$20240819$20240828$20240828$PER$$US-SA-2024SA249775$SANOFI AVENTIS$$6$YR$C$M$Y$28.571$KG$20240828$$MD$US$US
242601241$24260124$1$I$20240801$20240819$20240828$20240828$PER$$US-SA-2024SA250186$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240828$$MD$US$US
242601251$24260125$1$I$20240801$20240820$20240828$20240828$PER$$US-SA-2024SA249909$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240828$$MD$US$US
242601261$24260126$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248024$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240828$$MD$US$US
242601271$24260127$1$I$$20240821$20240828$20240828$PER$$US-SA-2024SA249946$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240828$$CN$US$US
242601281$24260128$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA249281$SANOFI AVENTIS$$62$YR$A$F$Y$68.038$KG$20240828$$MD$US$US
242601291$24260129$1$I$20240815$20240819$20240828$20240828$PER$$US-SA-2024SA248176$SANOFI AVENTIS$$26$YR$A$F$Y$63.5$KG$20240828$$CN$US$US
242601301$24260130$1$I$20240701$20240820$20240828$20240828$PER$$US-SA-2024SA250260$SANOFI AVENTIS$$1$YR$I$M$Y$11$KG$20240828$$HP$US$US
242601311$24260131$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA249267$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240828$$MD$US$US
242601322$24260132$2$F$20240819$20240822$20240828$20240829$PER$$US-SA-2024SA248146$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240829$$CN$US$US
242601331$24260133$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249015$SANOFI AVENTIS$$$$$$Y$$$20240828$$MD$US$US
242601341$24260134$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249745$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240828$$MD$US$US
242601351$24260135$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249060$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240828$$MD$US$US
242601361$24260136$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA249753$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240828$$MD$US$US
242601371$24260137$1$I$20240813$20240820$20240828$20240828$PER$$US-SA-2024SA248123$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240828$$HP$US$US
242601382$24260138$2$F$20240101$20240826$20240828$20240830$EXP$$ES-ABBVIE-5847330$ABBVIE$$$$$F$Y$$$20240830$$CN$ES$ES
242601391$24260139$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA248647$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240828$$MD$US$US
242601401$24260140$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248039$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240828$$MD$US$US
242601411$24260141$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248483$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240828$$MD$US$US
242601421$24260142$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248817$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240828$$MD$US$US
242601431$24260143$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA250315$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240828$$CN$US$US
242601441$24260144$1$I$20240601$20240819$20240828$20240828$PER$$US-SA-2024SA248369$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240828$$MD$US$US
242601451$24260145$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248208$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240828$$MD$US$US
242601461$24260146$1$I$20240801$20240821$20240828$20240828$EXP$$US-ABBVIE-5888749$ABBVIE$$57$YR$$F$Y$$$20240828$$CN$US$US
242601471$24260147$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248202$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240828$$MD$US$US
242601481$24260148$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248223$SANOFI AVENTIS$$$$E$F$Y$$$20240828$$MD$US$US
242601491$24260149$1$I$$20240821$20240828$20240828$EXP$$US-PERRIGO-24US007910$PERRIGO$Patel R, Elghawy O, Gibbs A, Gupta S, Kaur V. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer Reports. 2024;7(7):e2110. DOI:10.1002/cnr2.2110.$84$YR$$M$Y$$$20240828$$MD$US$US
242601501$24260150$1$I$20240819$20240820$20240828$20240828$PER$$US-SA-2024SA248507$SANOFI AVENTIS$$$$$F$Y$$$20240828$$CN$US$US
242601511$24260151$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248793$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240828$$CN$US$US
242601521$24260152$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248440$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240828$$MD$US$US
242601531$24260153$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249629$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240828$$MD$US$US
242601541$24260154$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA250023$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240828$$HP$US$US
242601551$24260155$1$I$20240827$20240827$20240827$20240827$DIR$716187$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242601561$24260156$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA250323$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240828$$CN$US$US
242601571$24260157$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249463$SANOFI AVENTIS$$$$A$M$Y$$$20240828$$MD$US$US
242601581$24260158$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA248919$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242601591$24260159$1$I$20240819$20240820$20240828$20240828$PER$$US-SA-2024SA248147$SANOFI AVENTIS$$$$$$Y$$$20240828$$HP$US$US
242601611$24260161$1$I$$20240827$20240827$20240827$DIR$716150$$FDA-CTU$$$$$UNK$N$$$20240827$$CN$US$
242601621$24260162$1$I$20240826$20240827$20240827$20240827$DIR$716046$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242601631$24260163$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA169350$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240828$$MD$US$US
242601641$24260164$1$I$20240819$20240820$20240828$20240828$PER$$US-SA-2024SA248323$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240828$$CN$US$US
242601651$24260165$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249773$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240828$$MD$US$US
242601661$24260166$1$I$20240826$20240827$20240827$20240827$DIR$716144$$FDA-CTU$$70$YR$$M$N$81$KG$20240827$N$CN$US$
242601671$24260167$1$I$20240827$20240827$20240827$20240827$DIR$716049$$FDA-CTU$$45$YR$$M$N$85.5$KG$20240827$N$CN$US$
242601681$24260168$1$I$20240826$20240827$20240827$20240827$DIR$716047$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242601691$24260169$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249320$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240828$$MD$US$US
242601701$24260170$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248670$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240828$$MD$US$US
242601711$24260171$1$I$20240501$20240820$20240828$20240828$PER$$US-SA-2024SA249466$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242601721$24260172$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249573$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240828$$MD$US$US
242601731$24260173$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248767$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240828$$HP$US$US
242601741$24260174$1$I$20240820$20240820$20240828$20240828$PER$$US-SA-2024SA249365$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240828$$MD$US$US
242601751$24260175$1$I$$20240827$20240827$20240827$DIR$716131$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242601761$24260176$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249837$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240828$$MD$US$US
242601771$24260177$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248757$SANOFI AVENTIS$$60$YR$A$F$Y$87$KG$20240828$$MD$US$US
242601781$24260178$1$I$20240817$20240819$20240828$20240828$PER$$US-SA-2024SA247932$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240828$$PH$US$US
242601791$24260179$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249792$SANOFI AVENTIS$$$$T$F$Y$$$20240828$$MD$US$US
242601801$24260180$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA250250$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240828$$MD$US$US
242601812$24260181$2$F$$20240821$20240828$20240903$EXP$$NVSC2024US170207$NOVARTIS$$$$$$Y$$$20240903$$PH$US$US
242601821$24260182$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248142$SANOFI AVENTIS$$$$E$F$Y$$$20240828$$MD$US$US
242601831$24260183$1$I$20240101$20240820$20240828$20240828$PER$$US-SA-2024SA249966$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240828$$MD$US$US
242601841$24260184$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA249073$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240828$$MD$US$US
242601851$24260185$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248800$SANOFI AVENTIS$$$$A$F$Y$49$KG$20240828$$MD$US$US
242601861$24260186$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249418$SANOFI AVENTIS$$$$E$M$Y$$$20240828$$MD$US$US
242601871$24260187$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249435$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240828$$MD$US$US
242601882$24260188$2$F$20240818$20240819$20240828$20240830$PER$$US-SA-2024SA247679$SANOFI AVENTIS$$37$YR$A$M$Y$83.46$KG$20240830$$MD$US$US
242601891$24260189$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248765$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242601901$24260190$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA249476$SANOFI AVENTIS$$$$$F$Y$$$20240828$$MD$US$US
242601911$24260191$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA247596$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242601921$24260192$1$I$20240801$20240819$20240828$20240828$PER$$US-SA-2024SA248668$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240828$$MD$US$US
242601931$24260193$1$I$20240705$20240819$20240828$20240828$PER$$US-SA-2024SA249533$SANOFI AVENTIS$$25$YR$A$F$Y$47.619$KG$20240828$$MD$US$US
242601941$24260194$1$I$$20240822$20240828$20240828$PER$$US-SA-2024SA250933$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240828$$CN$US$US
242601951$24260195$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249515$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240828$$CN$US$US
242601962$24260196$2$F$$20240822$20240828$20240913$PER$$US-SA-2024SA248355$SANOFI AVENTIS$$69$YR$E$F$Y$83$KG$20240913$$MD$US$US
242601972$24260197$2$F$$20240822$20240828$20240906$PER$$US-SA-2021SA216929$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$MD$US$US
242601981$24260198$1$I$20240825$20240826$20240828$20240828$PER$$US-SA-2024SA250802$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240828$$HP$US$US
242601991$24260199$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA249920$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240828$$MD$US$US
242602001$24260200$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248605$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240828$$MD$US$US
242602011$24260201$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248414$SANOFI AVENTIS$$$$C$$Y$$$20240828$$CN$US$US
242602021$24260202$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA034746$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240828$$MD$US$US
242602031$24260203$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249868$SANOFI AVENTIS$$12$YR$T$F$Y$46$KG$20240828$$MD$US$US
242602041$24260204$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248444$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240828$$MD$US$US
242602051$24260205$1$I$$20240825$20240828$20240828$EXP$$GB-ABBVIE-5897456$ABBVIE$$$$E$M$Y$$$20240828$$HP$GB$GB
242602061$24260206$1$I$20240601$20240826$20240828$20240828$EXP$$AU-ABBVIE-5897567$ABBVIE$$75$YR$$M$Y$$$20240828$$CN$AU$AU
242602071$24260207$1$I$$20240819$20240828$20240828$EXP$$US-SA-2024SA249352$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242602081$24260208$1$I$20200524$20240822$20240828$20240828$EXP$PL-URPL-1-1665-2020$PL-MYLANLABS-2024M1078209$MYLAN$$75$YR$$M$Y$100$KG$20240828$$MD$PL$PL
242602091$24260209$1$I$$20240824$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135447$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$102.06$KG$20240828$$CN$US$US
242602101$24260210$1$I$20240305$20240822$20240828$20240828$EXP$$US-APELLIS-2024-APL-0000442$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$US$US
242602111$24260211$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249707$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242602121$24260212$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249518$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240828$$MD$US$US
242602131$24260213$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA248125$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240828$$MD$US$US
242602141$24260214$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248675$SANOFI AVENTIS$$$$A$F$Y$58.9$KG$20240828$$MD$US$US
242602151$24260215$1$I$20240801$20240819$20240828$20240828$PER$$US-SA-2024SA248761$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240828$$MD$US$US
242602161$24260216$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248770$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240828$$MD$US$US
242602171$24260217$1$I$20240101$20240820$20240828$20240828$PER$$US-SA-2024SA249795$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240828$$MD$US$US
242602181$24260218$1$I$20240801$20240819$20240828$20240828$PER$$US-SA-2024SA249128$SANOFI AVENTIS$$69$YR$E$M$Y$86.18$KG$20240828$$CN$US$US
242602191$24260219$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249195$SANOFI AVENTIS$$$$C$M$Y$$$20240828$$MD$US$US
242602202$24260220$2$F$$20240826$20240828$20240912$PER$$US-SA-2024SA249814$SANOFI AVENTIS$$$$C$M$Y$28.118$KG$20240912$$MD$US$US
242602211$24260221$1$I$$20240822$20240828$20240828$PER$$US-PFIZER INC-PV202400110276$PFIZER$$25$YR$$F$Y$$$20240828$$HP$US$US
242602221$24260222$1$I$$20240827$20240828$20240828$EXP$$CA-ORGANON-O2408CAN002007$ORGANON$$40$YR$$F$Y$$$20240828$$HP$CA$CA
242602231$24260223$1$I$20240801$20240820$20240828$20240828$EXP$IT-MINISAL02-998884$IT-TEVA-VS-3235396$TEVA$$57$YR$$F$Y$56$KG$20240828$$MD$IT$IT
242602241$24260224$1$I$20240416$20240823$20240828$20240828$EXP$$DE-ABBVIE-5897544$ABBVIE$$60$YR$$F$Y$$$20240828$$CN$DE$DE
242602251$24260225$1$I$$20240813$20240828$20240828$EXP$$US-HLS-202400875$HLS THERAPEUTICS$$$$A$$Y$$$20240828$$HP$US$US
242602261$24260226$1$I$$20240819$20240828$20240828$EXP$$AR-GSK-AR2024AMR103722$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$CN$AR$AR
242602271$24260227$1$I$20240702$20240828$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048316$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$$$20240828$$CN$US$US
242602282$24260228$2$F$$20240903$20240828$20240912$EXP$$PT-SA-2024SA251187$SANOFI AVENTIS$$$$E$$Y$$$20240912$$CN$PT$PT
242602291$24260229$1$I$20240101$20240827$20240828$20240828$PER$$US-Eisai-EC-2024-173085$EISAI$$56$YR$A$F$Y$$$20240828$$CN$US$US
242602301$24260230$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170894$AMGEN$$63$YR$A$F$Y$$$20240828$$CN$US$US
242602311$24260231$1$I$$20240819$20240828$20240828$PER$$US-FreseniusKabi-FK202412735$FRESENIUS KABI$$$$$$Y$$$20240828$$PH$US$US
242602321$24260232$1$I$$20240819$20240828$20240828$PER$$US-FreseniusKabi-FK202412734$FRESENIUS KABI$$$$$$Y$$$20240828$$PH$US$US
242602331$24260233$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136585$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240828$$HP$US$US
242602341$24260234$1$I$20240802$20240808$20240828$20240828$EXP$$US-PHARMING-PHAUS2024000681$PHARMING GROUP$$$$$$Y$$$20240814$$CN$US$US
242602351$24260235$1$I$$20240808$20240828$20240828$PER$$US-PHARMING-PHAUS2024000683$PHARMING GROUP$$$$$$Y$$$20240815$$CN$US$US
242602363$24260236$3$F$$20240906$20240828$20240916$EXP$$US-PHARMING-PHAUS2024000685$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
242602371$24260237$1$I$20230101$20240805$20240828$20240828$EXP$$US-PHARMING-PHAUS2024000676$PHARMING GROUP$$$$$$Y$$$20240812$$CN$US$US
242602381$24260238$1$I$$20240805$20240828$20240828$EXP$$US-PHARMING-PHAUS2024000674$PHARMING GROUP$$$$$$Y$$$20240812$$CN$US$US
242602401$24260240$1$I$$20240827$20240827$20240827$DIR$716092$$FDA-CTU$$$$$UNK$N$$$20240827$$CN$US$
242602411$24260241$1$I$$20240806$20240828$20240828$PER$$US-PHARMING-PHAUS2024000679$PHARMING GROUP$$$$$$Y$$$20240812$$CN$US$US
242602421$24260242$1$I$$20240806$20240828$20240828$PER$$US-PHARMING-PHAUS2024000680$PHARMING GROUP$$$$$$Y$$$20240812$$CN$US$US
242602431$24260243$1$I$$20240815$20240828$20240828$PER$$US-AstraZeneca-2024A186969$ASTRAZENECA$$$$A$M$Y$$$20240828$$HP$US$
242602441$24260244$1$I$$20240823$20240828$20240828$EXP$$IT-PFIZER INC-202400244763$PFIZER$Neirotti, A.. Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients. Frontiers in Pediatrics. 2024;12:10.3389/fped.2024.1434493$164$MON$$F$Y$$$20240828$$HP$IT$IT
242602451$24260245$1$I$20240825$20240827$20240827$20240827$DIR$716080$$FDA-CTU$$25$YR$$F$N$$$20240827$N$CN$IN$
242602461$24260246$1$I$$20240827$20240827$20240827$DIR$716192$$FDA-CTU$$$$$F$N$$$20240827$N$CN$US$
242602481$24260248$1$I$$20240827$20240827$20240827$DIR$716034$$FDA-CTU$$29$YR$$F$N$69.75$KG$20240827$N$CN$US$
242602491$24260249$1$I$20210110$20240822$20240828$20240828$EXP$$US-TAKEDA-2024TUS086311$TAKEDA$$0$YR$$F$Y$$$20240828$$MD$US$US
242602501$24260250$1$I$20240730$20240822$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110023$PFIZER$$66$YR$$M$Y$72$KG$20240828$$HP$CN$CN
242602511$24260251$1$I$$20240822$20240828$20240828$EXP$$SA-PFIZER INC-202400242659$PFIZER$$$$A$F$Y$$$20240828$$MD$SA$SA
242602521$24260252$1$I$$20240823$20240828$20240828$EXP$$IT-PFIZER INC-202400244777$PFIZER$Neirotti, A.. Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients. Frontiers in Pediatrics. 2024;12:10.3389/fped.2024.1434493$32$MON$$M$Y$$$20240828$$HP$IT$IT
242602531$24260253$1$I$$20240822$20240828$20240828$EXP$$CN-PFIZER INC-PV202400109700$PFIZER$$$$A$F$Y$$$20240828$$CN$CN$CN
242602541$24260254$1$I$$20240823$20240828$20240828$EXP$$IT-PFIZER INC-202400244779$PFIZER$Neirotti, A.. Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients. Frontiers in Pediatrics. 2024;12:10.3389/fped.2024.1434493$231$MON$$F$Y$$$20240828$$HP$IT$IT
242602561$24260256$1$I$$20240820$20240828$20240828$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007323$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240828$$MD$DE$DE
242602571$24260257$1$I$20240701$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016046$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240828$$CN$US$US
242602582$24260258$2$F$20240826$20240828$20240828$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016367$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240829$$CN$US$US
242602592$24260259$2$F$$20240903$20240828$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408017328$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240904$$CN$US$US
242602601$24260260$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248455$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240828$$MD$US$US
242602611$24260261$1$I$20210101$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016282$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240828$$CN$US$US
242602621$24260262$1$I$$20240822$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136155$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$62.6$KG$20240828$$CN$US$US
242602632$24260263$2$F$$20240904$20240828$20240911$EXP$$US-TAKEDA-2024TUS083749$TAKEDA$$$$$$Y$$$20240911$$CN$US$US
242602641$24260264$1$I$20240121$20240826$20240828$20240828$EXP$FR-AFSSAPS-PV2024000795$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-135372$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$57$KG$20240828$$MD$FR$FR
242602661$24260266$1$I$$20240814$20240828$20240828$EXP$$US-HLS-202400904$HLS THERAPEUTICS$$$$A$$Y$$$20240828$$HP$US$US
242602671$24260267$1$I$$20240827$20240828$20240828$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048323$BOEHRINGER INGELHEIM$$$$$$Y$$$20240828$$CN$US$US
242602681$24260268$1$I$20240701$20240826$20240828$20240828$PER$$US-PFIZER INC-202400244120$PFIZER$$64$YR$$M$Y$$$20240828$$HP$US$US
242602691$24260269$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-PV202400111527$PFIZER$$76$YR$$F$Y$$$20240828$$CN$US$US
242602701$24260270$1$I$$20240826$20240828$20240828$PER$$US-PFIZER INC-PV202400111202$PFIZER$$75$YR$$F$Y$$$20240828$$MD$US$US
242602711$24260271$1$I$$20240823$20240828$20240828$PER$$US-PFIZER INC-PV202400089782$PFIZER$$44$YR$$F$Y$$$20240828$$MD$US$US
242602721$24260272$1$I$20240821$20240827$20240828$20240828$EXP$$US-BAUSCH-BL-2024-012967$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240828$$CN$US$US
242602731$24260273$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA248163$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240828$$CN$US$US
242602741$24260274$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA247395$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240828$$CN$US$US
242602751$24260275$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA248969$SANOFI AVENTIS$$$$A$M$Y$77$KG$20240828$$MD$US$US
242602761$24260276$1$I$20240722$20240813$20240828$20240828$EXP$$CA-HLS-202402065$HLS THERAPEUTICS$$61$YR$A$M$Y$$$20240828$$HP$CA$CA
242602781$24260278$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136777$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$50.35$KG$20240828$$CN$US$US
242602791$24260279$1$I$20150101$20240822$20240828$20240828$EXP$IE-HPRA-2024-114991$IE-BAUSCH-BL-2024-012812$BAUSCH AND LOMB$$2$DEC$$M$Y$$$20240828$$CN$IE$IE
242602801$24260280$1$I$20240817$20240827$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136489$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240828$$HP$US$US
242602811$24260281$1$I$$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136253$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240828$$CN$US$US
242602821$24260282$1$I$20240101$20240816$20240828$20240828$PER$$US-SA-2024SA249125$SANOFI AVENTIS$$69$YR$E$F$Y$80.7$KG$20240828$$MD$US$US
242602831$24260283$1$I$20240826$20240827$20240827$20240827$DIR$716109$$FDA-CTU$$51$YR$$M$N$111.6$KG$20240827$Y$CN$US$
242602841$24260284$1$I$$20240827$20240828$20240828$EXP$$US-BAUSCH-BL-2024-012961$BAUSCH AND LOMB$$69$YR$$M$Y$$$20240828$$CN$US$US
242602861$24260286$1$I$20240817$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169384$AMGEN$$49$YR$A$F$Y$$$20240828$$CN$US$US
242602882$24260288$2$F$$20240904$20240828$20240909$EXP$$NVSC2024CN173657$NOVARTIS$$7$YR$$M$Y$26$KG$20240909$$CN$CN$CN
242602891$24260289$1$I$20240824$20240827$20240827$20240827$DIR$716043$$FDA-CTU$$67$YR$$M$N$$$20240827$N$HP$US$
242602901$24260290$1$I$$20240828$20240828$20240828$PER$$NVSC2024US173816$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242602911$24260291$1$I$20240814$20240826$20240828$20240828$EXP$$CN-ROCHE-10000066704$ROCHE$$53$YR$A$F$Y$70$KG$20240828$$HP$CN$CN
242602921$24260292$1$I$20240801$20240809$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008404$INCYTE$$$$$$Y$$$20240828$$PH$US$US
242602931$24260293$1$I$$20240826$20240828$20240828$EXP$$US-ABBVIE-5897341$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242602941$24260294$1$I$$20240820$20240828$20240828$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007328$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240828$$MD$DE$DE
242602951$24260295$1$I$$20240429$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001602$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242602961$24260296$1$I$$20240516$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001892$AMERICAN REGENT$$$$$F$Y$$$20240828$$HP$US$US
242602971$24260297$1$I$$20240501$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001692$AMERICAN REGENT$$$$$$Y$$$20240828$$HP$US$US
242602981$24260298$1$I$20240424$20240429$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001607$AMERICAN REGENT$$$$A$F$Y$$$20240828$$HP$US$US
242602991$24260299$1$I$20240301$20240507$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001746$AMERICAN REGENT$$64$YR$$F$Y$$$20240828$$HP$US$US
242603001$24260300$1$I$20240101$20240505$20240828$20240828$PER$$US-AMERICAN REGENT INC-2024001716$AMERICAN REGENT$$$$$$Y$$$20240828$$CN$US$US
242603031$24260303$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170230$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242603041$24260304$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000260$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603061$24260306$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000682$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603071$24260307$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000609$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603081$24260308$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000786$SUNOVION$$$$$$Y$$$20240828$$HP$US$US
242603091$24260309$1$I$$20240806$20240828$20240828$PER$$US-SMPA-2024SPA001026$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603101$24260310$1$I$$20240814$20240828$20240828$PER$$US-SMPA-2024SPA001399$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603113$24260311$3$F$$20240830$20240828$20240923$PER$$US-SMPA-2024SPA000652$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242603121$24260312$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000659$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603131$24260313$1$I$$20240816$20240828$20240828$PER$$US-SMPA-2024SPA001587$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603142$24260314$2$F$20240101$20240815$20240828$20240910$PER$$US-SMPA-2024SPA000664$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
242603151$24260315$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000667$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603161$24260316$1$I$$20240822$20240828$20240828$PER$$US-SMPA-2024SPA001829$SUNOVION$$$$$$Y$$$20240828$$HP$US$US
242603171$24260317$1$I$$20240805$20240828$20240828$PER$$US-SMPA-2024SPA000856$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603181$24260318$1$I$$20240807$20240828$20240828$PER$$US-SMPA-2024SPA001060$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603211$24260321$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000841$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603221$24260322$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000552$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603231$24260323$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000671$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603252$24260325$2$F$$20240923$20240828$20240930$EXP$$US-TAKEDA-2024TUS085088$TAKEDA$$$$$F$Y$$$20240930$$PH$US$US
242603261$24260326$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000716$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603271$24260327$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000630$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603281$24260328$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000480$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603292$24260329$2$F$$20240813$20240828$20240910$PER$$US-SMPA-2024SPA000678$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
242603301$24260330$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000639$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603311$24260331$1$I$$20240823$20240828$20240828$PER$$US-SMPA-2024SPA001934$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603321$24260332$1$I$$20240806$20240828$20240828$PER$$US-SMPA-2024SPA000987$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603331$24260333$1$I$$20240802$20240828$20240828$PER$$US-SMPA-2024SPA000824$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603341$24260334$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000708$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603352$24260335$2$F$$20240822$20240828$20240918$PER$$US-SMPA-2024SPA000715$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
242603361$24260336$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59320$$FDA-CTU$$$$$F$N$101.6$KG$20240827$Y$$US$
242603372$24260337$2$F$$20240828$20240828$20240927$PER$$US-SMPA-2024SPA000662$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242603381$24260338$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000744$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603391$24260339$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000670$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603401$24260340$1$I$$20240822$20240828$20240828$PER$$US-SMPA-2024SPA001852$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603411$24260341$1$I$$20240821$20240828$20240828$PER$$US-SMPA-2024SPA001763$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603421$24260342$1$I$$20240807$20240828$20240828$PER$$US-SMPA-2024SPA001081$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603442$24260344$2$F$20230710$20240912$20240828$20240927$PER$$US-SMPA-2024SPA000970$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242603462$24260346$2$F$$20240828$20240828$20240927$PER$$US-SMPA-2024SPA000737$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242603491$24260349$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000647$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603512$24260351$2$F$20240101$20240830$20240828$20240923$PER$$US-SMPA-2024SPA000692$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242603521$24260352$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000747$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603531$24260353$1$I$$20240823$20240828$20240828$PER$$US-SMPA-2024SPA001833$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603542$24260354$2$F$$20240809$20240828$20240904$PER$$US-SMPA-2024SPA000723$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242603551$24260355$1$I$$20240804$20240828$20240828$PER$$US-SMPA-2024SPA000798$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603561$24260356$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000840$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603571$24260357$1$I$$20240806$20240828$20240828$PER$$US-SMPA-2024SPA000901$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603582$24260358$2$F$$20240904$20240828$20240925$PER$$US-SMPA-2024SPA000379$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242603591$24260359$1$I$$20240813$20240828$20240828$PER$$US-SMPA-2024SPA001376$SUNOVION$$$$$$Y$$$20240828$$PH$US$US
242603601$24260360$1$I$$20240822$20240828$20240828$PER$$US-SMPA-2024SPA001873$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603612$24260361$2$F$20240601$20240923$20240828$20240927$PER$$US-SMPA-2024SPA001789$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242603622$24260362$2$F$$20240905$20240828$20240927$PER$$US-SMPA-2024SPA000820$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242603631$24260363$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000684$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603641$24260364$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000806$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603651$24260365$1$I$$20240814$20240828$20240828$PER$$US-SMPA-2024SPA001396$SUNOVION$$$$$$Y$$$20240828$$MD$US$US
242603661$24260366$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000700$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603671$24260367$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000707$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603681$24260368$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000782$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603692$24260369$2$F$20240801$20240826$20240828$20240915$PER$$US-SMPA-2024SPA000900$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
242603701$24260370$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000683$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603712$24260371$2$F$$20240904$20240828$20240925$PER$$US-SMPA-2024SPA001073$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242603722$24260372$2$F$$20240920$20240828$20240930$PER$$US-SMPA-2024SPA001781$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242603731$24260373$1$I$20240701$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000634$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603741$24260374$1$I$$20240730$20240828$20240828$PER$$US-SMPA-2024SPA000581$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603751$24260375$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000709$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603761$24260376$1$I$$20240823$20240828$20240828$PER$$US-SMPA-2024SPA001882$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603772$24260377$2$F$$20240814$20240828$20240910$PER$$US-SMPA-2024SPA000711$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
242603782$24260378$2$F$20240730$20240904$20240828$20240911$PER$$US-SMPA-2024SPA000694$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
242603801$24260380$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000653$SUNOVION$$$$$$Y$$$20240828$$PH$US$US
242603811$24260381$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000698$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603831$24260383$1$I$$20240806$20240828$20240828$PER$$US-SMPA-2024SPA000979$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603841$24260384$1$I$$20240809$20240828$20240828$PER$$US-SMPA-2024SPA001435$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603851$24260385$1$I$$20240730$20240828$20240828$PER$$US-SMPA-2024SPA000548$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603861$24260386$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000701$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603871$24260387$1$I$$20240730$20240828$20240828$PER$$US-SMPA-2024SPA000484$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603882$24260388$2$F$$20240902$20240828$20240917$PER$$US-SMPA-2024SPA000920$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
242603891$24260389$1$I$$20240730$20240828$20240828$PER$$US-SMPA-2024SPA000591$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603902$24260390$2$F$$20240904$20240828$20240924$PER$$US-SMPA-2024SPA000426$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242603911$24260391$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000679$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603921$24260392$1$I$$20240820$20240828$20240828$PER$$US-SMPA-2024SPA001717$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603941$24260394$1$I$$20240801$20240828$20240828$PER$$US-SMPA-2024SPA000705$SUNOVION$$$$$$Y$$$20240828$$HP$US$US
242603961$24260396$1$I$$20240806$20240828$20240828$PER$$US-SMPA-2024SPA000917$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603971$24260397$1$I$$20240806$20240828$20240828$PER$$US-SMPA-2024SPA000958$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242603982$24260398$2$F$$20240919$20240828$20240930$PER$$US-SMPA-2024SPA000802$SUNOVION$$$$$$Y$$$20240929$$CN$US$US
242603991$24260399$1$I$$20240802$20240828$20240828$PER$$US-SMPA-2024SPA000570$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242604001$24260400$1$I$20240801$20240821$20240828$20240828$PER$$US-SMPA-2024SPA001751$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242604011$24260401$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000583$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242604021$24260402$1$I$$20240828$20240828$20240828$PER$$NVSC2024US173818$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242604031$24260403$1$I$$20240823$20240828$20240828$EXP$$NVSC2024GB173162$NOVARTIS$$$$$M$Y$$$20240828$$CN$GB$GB
242604051$24260405$1$I$$20240731$20240828$20240828$PER$$US-SMPA-2024SPA000603$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242604061$24260406$1$I$20221201$20240812$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008455$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242604071$24260407$1$I$$20240822$20240828$20240828$PER$$US-ABBVIE-5895181$ABBVIE$$$$A$$Y$$$20240828$$PH$US$US
242604081$24260408$1$I$20240701$20240820$20240828$20240828$EXP$$IT-ABBVIE-5890844$ABBVIE$$73$YR$$F$Y$$$20240828$$CN$IT$IT
242604091$24260409$1$I$$20240821$20240828$20240828$EXP$$CA-TEVA-VS-3235912$TEVA$$3$YR$$M$Y$$$20240828$$HP$CA$CA
242604101$24260410$1$I$$20240812$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008451$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242604111$24260411$1$I$$20240820$20240828$20240828$EXP$$AU-AstraZeneca-2024A188676$ASTRAZENECA$Kao Y.H.;  Falzone N.;  Pearson M.;  Pook D.;  Sivaratnam D.. 177 Lu-PSMA With Olaparib Radiosensitization Potentiates Response and Toxicity in Extensive Castration-Resistant Metastatic Prostate cancer. Clinical Nuclear Medicine 2024;$58$YR$$M$Y$$$20240828$$HP$AU$
242604121$24260412$1$I$$20240821$20240828$20240828$EXP$$CA-TEVA-VS-3235914$TEVA$$45$YR$$F$Y$$$20240828$$HP$CA$CA
242604131$24260413$1$I$20240807$20240826$20240828$20240828$EXP$$US-TAKEDA-2024TUS086628$TAKEDA$$13$YR$$F$Y$$$20240828$$CN$US$US
242604141$24260414$1$I$$20240824$20240828$20240828$EXP$$GB-AstraZeneca-2024A193174$ASTRAZENECA$$69$YR$$F$Y$69$KG$20240828$$MD$GB$
242604151$24260415$1$I$20240816$20240822$20240828$20240828$EXP$$US-ABBVIE-5892137$ABBVIE$$52$YR$$F$Y$$$20240828$$CN$US$US
242604171$24260417$1$I$$20240828$20240828$20240828$PER$$NVSC2024US173820$NOVARTIS$$$$$$Y$$$20240828$$HP$US$US
242604182$24260418$2$F$20160101$20240903$20240828$20240924$EXP$$EG-SA-2018SA184291$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240924$$CN$EG$EG
242604191$24260419$1$I$20240302$20240823$20240828$20240828$EXP$$US-ABBVIE-5894265$ABBVIE$$66$YR$$F$Y$$$20240828$$CN$US$US
242604203$24260420$3$F$20240720$20240925$20240828$20240928$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-010067$JAZZ$$14$YR$$M$Y$$$20240928$$MD$US$US
242604211$24260421$1$I$$20240816$20240828$20240828$EXP$$US-FARMAPROD-202407-2618$DOMPE FARMACEUTICI$$$$E$F$Y$99.79$KG$20240828$$CN$US$US
242604221$24260422$1$I$$20240821$20240828$20240828$EXP$$JP-ARDELYX-2024ARDX006360$ARDELYX$$$$$F$Y$$$20240828$$MD$JP$JP
242604231$24260423$1$I$$20240729$20240828$20240828$PER$$US-SMPA-2024SPA000510$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242604252$24260425$2$F$20240501$20240911$20240828$20240921$EXP$$JP-ARDELYX-2024ARDX006388$ARDELYX$$8$DEC$$M$Y$$$20240921$$MD$JP$JP
242604261$24260426$1$I$$20240821$20240828$20240828$EXP$$JP-ARDELYX-2024ARDX006369$ARDELYX$$81$YR$$F$Y$$$20240828$$MD$JP$JP
242604271$24260427$1$I$20240817$20240820$20240828$20240828$PER$$US-SA-2024SA249689$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240828$$MD$US$US
242604281$24260428$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA149260$SANOFI AVENTIS$$$$A$M$Y$$$20240828$$MD$US$US
242604301$24260430$1$I$$20240815$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008579$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242604311$24260431$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136849$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240828$$PH$US$US
242604321$24260432$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136614$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240828$$HP$US$US
242604331$24260433$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135916$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$50.8$KG$20240828$$CN$US$US
242604341$24260434$1$I$$20240815$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008578$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242604351$24260435$1$I$20240714$20240822$20240828$20240828$EXP$$JP-009507513-2408JPN002706J$MERCK$$81$YR$$M$Y$71$KG$20240828$$PH$JP$JP
242604371$24260437$1$I$20240101$20240822$20240828$20240828$PER$$US-PFIZER INC-202400242981$PFIZER$$84$YR$$F$Y$$$20240828$$HP$US$US
242604381$24260438$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015993$ELI LILLY AND CO$$$$$M$Y$$$20240828$$CN$US$US
242604391$24260439$1$I$20240824$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016152$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240828$$PH$US$US
242604401$24260440$1$I$$20240816$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408010583$ELI LILLY AND CO$$56$YR$A$$Y$$$20240828$$LW$US$US
242604411$24260441$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017410$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240828$$CN$US$US
242604421$24260442$1$I$20240301$20240820$20240828$20240828$EXP$$US-SA-2024SA249977$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240828$$CN$US$US
242604431$24260443$1$I$20231101$20240820$20240828$20240828$EXP$GB-MHRA-MED-202408201001008310-PTDKG$GB-TEVA-VS-3235847$TEVA$$70$YR$$M$Y$89$KG$20240828$$MD$GB$GB
242604441$24260444$1$I$$20240827$20240828$20240828$PER$$US-TAKEDA-2024TUS086462$TAKEDA$$$$$F$Y$$$20240828$$HP$US$US
242604463$24260446$3$F$20240801$20240828$20240828$20240902$EXP$$AU-ABBVIE-5897621$ABBVIE$$82$YR$$F$Y$$$20240902$$CN$AU$AU
242604472$24260447$2$F$20240101$20240906$20240828$20240909$EXP$$US-KYOWAKIRIN-2024KK020083$KYOWA$$$$$$Y$$$20240909$$HP$US$US
242604481$24260448$1$I$$20240823$20240828$20240828$EXP$$ES-SANDOZ INC.-SDZ2024ES075705$SANDOZ$$$$$F$Y$$$20240828$$CN$ES$ES
242604491$24260449$1$I$$20240816$20240828$20240828$PER$$US-SA-2024SA070372$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240828$$MD$US$US
242604502$24260450$2$F$$20240822$20240828$20240830$PER$$US-SA-2024SA248290$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240830$$CN$US$US
242604511$24260451$1$I$20240401$20240816$20240828$20240828$PER$$US-SA-2024SA248701$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240828$$MD$US$US
242604523$24260452$3$F$$20240917$20240828$20240919$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013556$JAZZ$$$$$F$Y$$$20240919$$CN$US$US
242604532$24260453$2$F$$20240823$20240828$20240828$EXP$$US-ROCHE-10000065626$ROCHE$$$$$F$Y$$$20240828$$MD$US$US
242604551$24260455$1$I$20240726$20240821$20240828$20240828$EXP$ES-AEMPS-1561229$ES-TEVA-VS-3236410$TEVA$$72$YR$$F$Y$$$20240828$$MD$ES$ES
242604562$24260456$2$F$20240810$20240902$20240828$20240904$EXP$$US-INCYTE CORPORATION-2024IN008448$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242604571$24260457$1$I$$20240826$20240828$20240828$PER$$NVSC2024US173337$NOVARTIS$$$$$F$Y$$$20240828$$MD$US$US
242604601$24260460$1$I$$20240827$20240828$20240828$EXP$$PT-SA-2024SA251233$SANOFI AVENTIS$Ghiletchi A, Pinto AR, Maltez F.. ADEUS, RIM: REACCAPARADOXAL AO TRATAMENTO DA TUBERCULOSE DISSEMINADA / FAREWELL, KIDNEY: PARADOXICAL REACTION IN TREATMENT FOR DISSEMINATED TUBERCULOSIS.. Medicina Interna - Congressos Nacionais, 30CNMI.. 2024;05:654$27$YR$A$F$Y$$$20240828$$HP$PT$PT
242604611$24260461$1$I$20240803$20240821$20240828$20240828$EXP$$CO-AMGEN-COLSL2024169789$AMGEN$$56$YR$A$F$Y$$$20240828$$CN$CO$CO
242604622$24260462$2$F$$20240822$20240828$20240903$EXP$$JP-Eisai-EC-2024-172749$EISAI$$$$A$M$Y$$$20240903$$MD$JP$JP
242604631$24260463$1$I$$20240823$20240828$20240828$PER$$US-ALXN-202408USA001663US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240828$$CN$US$US
242604641$24260464$1$I$$20240207$20240828$20240828$PER$$US-KOWA-24US000154$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604651$24260465$1$I$$20231222$20240828$20240828$PER$$US-KOWA-23US002491$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604661$24260466$1$I$20231213$20231219$20240828$20240828$PER$$US-KOWA-23US002434$KOWA PHARM$$73$YR$$F$Y$$$20240828$$CN$US$US
242604671$24260467$1$I$20240112$20240206$20240828$20240828$PER$$US-KOWA-24US000153$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604681$24260468$1$I$$20240117$20240828$20240828$PER$$US-KOWA-24US000052$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604691$24260469$1$I$$20231215$20240828$20240828$PER$$US-KOWA-23US002393$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604701$24260470$1$I$$20240301$20240828$20240828$PER$$US-KOWA-24US000259$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604711$24260471$1$I$$20240212$20240828$20240828$PER$$US-KOWA-24US000181$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604721$24260472$1$I$$20231228$20240828$20240828$PER$$US-KOWA-23US002494$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604731$24260473$1$I$20231226$20240109$20240828$20240828$PER$$US-KOWA-24US000008$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604741$24260474$1$I$$20240129$20240828$20240828$PER$$US-KOWA-24US000041$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604751$24260475$1$I$20231101$20240129$20240828$20240828$PER$$US-KOWA-24US000042$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604761$24260476$1$I$20231229$20240228$20240828$20240828$PER$$US-KOWA-24US000073$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604771$24260477$1$I$$20231219$20240828$20240828$PER$$US-KOWA-23US002433$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604781$24260478$1$I$$20231213$20240828$20240828$PER$$US-KOWA-23US002375$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604791$24260479$1$I$20240101$20240227$20240828$20240828$PER$$US-KOWA-24US000243$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604801$24260480$1$I$20231128$20231219$20240828$20240828$PER$$US-KOWA-23US002435$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604811$24260481$1$I$$20240301$20240828$20240828$PER$$US-KOWA-24US000260$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604821$24260482$1$I$20240103$20240212$20240828$20240828$PER$$US-KOWA-24US000043$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604831$24260483$1$I$$20240125$20240828$20240828$PER$$US-KOWA-24US000021$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604841$24260484$1$I$20231115$20240208$20240828$20240828$PER$$US-KOWA-24US000166$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604851$24260485$1$I$$20240119$20240828$20240828$PER$$US-KOWA-24US000062$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604861$24260486$1$I$20240322$20240408$20240828$20240828$PER$$US-KOWA-24US000367$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604871$24260487$1$I$$20240205$20240828$20240828$PER$$US-KOWA-24US000145$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604881$24260488$1$I$$20240306$20240828$20240828$PER$$US-KOWA-24US000126$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604891$24260489$1$I$20240128$20240205$20240828$20240828$PER$$US-KOWA-24US000144$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604901$24260490$1$I$20231101$20240226$20240828$20240828$PER$$US-KOWA-24US000063$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604921$24260492$1$I$20240126$20240130$20240828$20240828$PER$$US-KOWA-24US000121$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604931$24260493$1$I$20231206$20231228$20240828$20240828$PER$$US-KOWA-23US002492$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242604941$24260494$1$I$20240813$20240826$20240828$20240828$PER$$CN-Eisai-EC-2024-172964$EISAI$$55$YR$A$F$Y$60$KG$20240828$$HP$CN$CN
242604951$24260495$1$I$$20240822$20240828$20240828$PER$$US-Eisai-EC-2024-172875$EISAI$$$$$F$Y$$$20240828$$MD$US$US
242604962$24260496$2$F$20240823$20240905$20240828$20240909$EXP$$JP-Eisai-EC-2024-172816$EISAI$$82$YR$E$F$Y$$$20240909$$PH$JP$JP
242604971$24260497$1$I$$20240821$20240828$20240828$EXP$$DE-TAKEDA-2024TUS084034$TAKEDA$$18$YR$$M$Y$$$20240828$$CN$DE$DE
242604981$24260498$1$I$20240817$20240827$20240828$20240828$EXP$FR-AFSSAPS-MA2024001415$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-136081$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240828$$MD$FR$FR
242604991$24260499$1$I$$20240822$20240828$20240828$EXP$$JP-ABBVIE-5897951$ABBVIE$$95$YR$$F$Y$$$20240828$$PH$JP$JP
242605001$24260500$1$I$20230601$20240823$20240828$20240828$EXP$DE-CADRBFARM-2024329316$DE-ABBVIE-5897249$ABBVIE$$32$YR$$M$Y$$$20240828$$CN$DE$DE
242605012$24260501$2$F$$20240903$20240828$20240913$PER$$US-VERTEX PHARMACEUTICALS-2024-013528$VERTEX$$27$YR$$F$Y$$$20240913$$CN$US$US
242605021$24260502$1$I$$20240822$20240828$20240828$PER$$US-VERTEX PHARMACEUTICALS-2024-013573$VERTEX$$25$YR$$M$Y$$$20240828$$CN$US$US
242605041$24260504$1$I$$20240822$20240828$20240828$EXP$$BR-BIOMARINAP-BR-2024-160114$BIOMARIN$$$$$$Y$$$20240828$$CN$BR$BR
242605051$24260505$1$I$20240820$20240827$20240828$20240828$PER$$US-ABBVIE-5897920$ABBVIE$$18$YR$$F$Y$56$KG$20240828$$CN$US$US
242605061$24260506$1$I$20240101$20240815$20240828$20240828$PER$$US-SA-2024SA248787$SANOFI AVENTIS$$62$YR$A$F$Y$81$KG$20240828$$MD$US$US
242605071$24260507$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA247892$SANOFI AVENTIS$$$$A$F$Y$$$20240828$$MD$US$US
242605081$24260508$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170227$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242605091$24260509$1$I$$20240522$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00280$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$US$US
242605101$24260510$1$I$$20240820$20240828$20240828$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007329$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240828$$MD$DE$DE
242605111$24260511$1$I$$20240827$20240828$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA075689$SANDOZ$$51$YR$$M$Y$102$KG$20240828$$PH$CA$CA
242605121$24260512$1$I$$20240718$20240828$20240828$PER$$US-LUNDBECK-DKLU4002307$LUNDBECK$$$$$$Y$$$20240828$$CN$US$US
242605131$24260513$1$I$$20240826$20240828$20240828$PER$$US-ABBVIE-5896420$ABBVIE$$$$$F$Y$$$20240828$$MD$US$US
242605151$24260515$1$I$20211203$20240821$20240828$20240828$EXP$$ES-PFIZER INC-2021SGN06356$PFIZER$$31$YR$$F$Y$87$KG$20240828$$MD$ES$ES
242605161$24260516$1$I$$20240818$20240828$20240828$EXP$$PH-PFIZER INC-2024SGN05091$PFIZER$$28$YR$$M$Y$$$20240828$$CN$PH$PH
242605191$24260519$1$I$20240820$20240821$20240828$20240828$EXP$$CN-PFIZER INC-PV202400109371$PFIZER$$48$YR$$F$Y$70$KG$20240828$$HP$CN$CN
242605221$24260522$1$I$$20240805$20240828$20240828$PER$$US-GILEAD-2024-0684672$GILEAD$$$$A$M$Y$$$20240828$$MD$US$US
242605231$24260523$1$I$$20240825$20240828$20240828$EXP$$US-ABBVIE-5895650$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242605241$24260524$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173782$NOVARTIS$$$$$M$Y$$$20240828$$MD$US$US
242605251$24260525$1$I$20240101$20240823$20240828$20240828$PER$$US-009507513-2408USA008668$MERCK$$$$$F$Y$79.5$KG$20240828$$HP$US$US
242605261$24260526$1$I$$20240827$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075911$SANDOZ$$$$$M$Y$$$20240828$$MD$US$US
242605281$24260528$1$I$$20240820$20240828$20240828$PER$$US-JNJFOC-20240855330$JOHNSON AND JOHNSON$$$$$M$Y$$$20240828$$CN$US$US
242605291$24260529$1$I$$20240823$20240828$20240828$EXP$$HN-MYLANLABS-2024M1079077$MYLAN$$$$$M$Y$61.23$KG$20240828$$CN$HN$HN
242605301$24260530$1$I$$20240823$20240828$20240828$EXP$GB-MHRA-MED-202408232131548640-DRQGW$GB-MYLANLABS-2024M1078514$MYLAN$$9$YR$$F$Y$$$20240828$$CN$GB$GB
242605322$24260532$2$F$20240819$20240924$20240828$20240930$EXP$$HN-MYLANLABS-2024M1079104$MYLAN$$83$YR$$F$Y$60.32$KG$20240930$$CN$HN$HN
242605331$24260533$1$I$$20240823$20240828$20240828$EXP$$GB-MYLANLABS-2024M1032359$MYLAN$$75$YR$$F$Y$$$20240828$$CN$GB$GB
242605341$24260534$1$I$$20240821$20240828$20240828$EXP$NO-NOMAADVRE-PASRAPP-2024-Vewrjd-2$NO-TEVA-VS-3236362$TEVA$$52$YR$$F$Y$56$KG$20240828$$CN$NO$NO
242605351$24260535$1$I$$20240827$20240828$20240828$EXP$$NVSC2024CN173502$NOVARTIS$$73$YR$$F$Y$$$20240828$$CN$CN$CN
242605361$24260536$1$I$20231201$20240813$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008491$INCYTE$$$$$$Y$$$20240828$$CN$US$US
242605371$24260537$1$I$$20240821$20240828$20240828$EXP$$NVSC2024VN170208$NOVARTIS$$$$A$M$Y$$$20240828$$MD$VN$VN
242605381$24260538$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016661$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240828$$CN$US$US
242605391$24260539$1$I$$20240826$20240828$20240828$EXP$$US-ABBVIE-5896557$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242605401$24260540$1$I$$20240828$20240828$20240828$EXP$$IN-SANDOZ INC.-SDZ2024IN075874$SANDOZ$$11$YR$$M$Y$$$20240828$$MD$IN$IN
242605411$24260541$1$I$$20240819$20240828$20240828$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-136873$BRISTOL MYERS SQUIBB$Dentoni M, Florean I, Farina A, Joubert B, Do L, Honnorat J, et al. Immune checkpoint inhibitor-related cerebellar toxicity: clinical features and comparison with paraneoplastic cerebellar ataxia. The Cerebellum. 2024 Aug 17;doi:10.1007/s12311-024-01727-5.$32$YR$A$M$Y$$$20240828$$HP$IT$IT
242605421$24260542$1$I$$20240819$20240828$20240828$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-136871$BRISTOL MYERS SQUIBB$Dentoni M, Florean I, Farina A, Joubert B, Do L, Honnorat J, et al. Immune checkpoint inhibitor-related cerebellar toxicity: clinical features and comparison with paraneoplastic cerebellar ataxia. The Cerebellum. 2024 Aug 17;doi:10.1007/s12311-024-01727-5.$66$YR$E$M$Y$$$20240828$$HP$IT$IT
242605432$24260543$2$F$20240101$20240823$20240828$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135204$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$61.68$KG$20240906$$MD$US$US
242605441$24260544$1$I$$20240821$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133438$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240828$$HP$US$US
242605451$24260545$1$I$$20240827$20240828$20240828$PER$$US-ABBVIE-5898027$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242605461$24260546$1$I$20240101$20240823$20240828$20240828$EXP$$US-ABBVIE-5896471$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242605471$24260547$1$I$20240101$20240823$20240828$20240828$PER$$US-AMGEN-USASP2024169583$AMGEN$$72$YR$E$F$Y$$$20240828$$HP$US$US
242605481$24260548$1$I$$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A193466$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242605491$24260549$1$I$20240501$20240823$20240828$20240828$EXP$$US-PFIZER INC-202400243910$PFIZER$$53$YR$$F$Y$$$20240828$$HP$US$US
242605501$24260550$1$I$$20240822$20240828$20240828$EXP$$EG-PFIZER INC-2023SGN11269$PFIZER$$19$YR$$M$Y$$$20240828$$CN$EG$EG
242605511$24260551$1$I$$20240827$20240828$20240828$EXP$$PH-PFIZER INC-PV202400112334$PFIZER$$$$$M$Y$$$20240828$$CN$PH$PH
242605521$24260552$1$I$20240601$20240827$20240828$20240828$EXP$$CL-PFIZER INC-202400244921$PFIZER$$$$$F$Y$$$20240828$$MD$CL$CL
242605531$24260553$1$I$20240205$20240823$20240828$20240828$EXP$$CN-PFIZER INC-PV202400110629$PFIZER$$66$YR$$F$Y$59.6$KG$20240828$$HP$CN$CN
242605541$24260554$1$I$$20240812$20240828$20240828$PER$$US-AstraZeneca-2024A184673$ASTRAZENECA$$$$$$Y$$$20240828$$HP$US$
242605561$24260556$1$I$$20240828$20240828$20240828$EXP$$MY-PFIZER INC-PV202400112229$PFIZER$$67$YR$$M$Y$$$20240828$$CN$MY$MY
242605571$24260557$1$I$$20240827$20240828$20240828$EXP$$CA-PFIZER INC-202400244874$PFIZER$$49$YR$$F$Y$$$20240828$$HP$CA$CA
242605591$24260559$1$I$20231001$20240820$20240828$20240828$PER$$US-SA-2024SA249458$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240828$$MD$US$US
242605601$24260560$1$I$$20240823$20240828$20240828$EXP$$US-AMGEN-USASP2024169346$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242605611$24260561$1$I$$20240814$20240828$20240828$EXP$$BR-IMP-2024000657$Harrow Health$$67$YR$E$M$Y$$$20240828$$CN$BR$BR
242605621$24260562$1$I$$20240820$20240828$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134716$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240828$$CN$JP$JP
242605631$24260563$1$I$20240605$20240827$20240828$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-136693$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$57$KG$20240828$$PH$JP$JP
242605641$24260564$1$I$$20240819$20240828$20240828$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-136874$BRISTOL MYERS SQUIBB$Dentoni M, Florean I, Farina A, Joubert B, Do L, Honnorat J, et al. Immune checkpoint inhibitor-related cerebellar toxicity: clinical features and comparison with paraneoplastic cerebellar ataxia. The Cerebellum. 2024 Aug 17;doi:10.1007/s12311-024-01727-5.$72$YR$E$M$Y$$$20240828$$HP$IT$IT
242605651$24260565$1$I$$20240826$20240828$20240828$PER$$US-ABBVIE-5897392$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242605661$24260566$1$I$$20240823$20240828$20240828$PER$$US-ALXN-202408USA001661US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240828$$CN$US$US
242605671$24260567$1$I$$20240819$20240828$20240828$PER$$US-ABBVIE-5886062$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242605681$24260568$1$I$20240731$20240809$20240828$20240828$PER$$US-PHARMING-PHAUS2024000691$PHARMING GROUP$$$$$$Y$$$20240819$$CN$US$US
242605691$24260569$1$I$20191201$20240827$20240828$20240828$EXP$$CA-SANDOZ INC.-PHHY2019CA161408$SANDOZ$$47$YR$$F$Y$$$20240828$$MD$CA$CA
242605701$24260570$1$I$$20240820$20240828$20240828$EXP$$GB-TEVA-2023-GB-2903988$TEVA$$83$YR$$M$Y$$$20240828$$CN$GB$GB
242605713$24260571$3$F$20240719$20240903$20240828$20240906$EXP$$US-PHARMING-PHAUS2024000634$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242605721$24260572$1$I$$20240802$20240828$20240828$PER$$US-PHARMING-PHAUS2024000682$PHARMING GROUP$$$$$$Y$$$20240815$$CN$US$US
242605731$24260573$1$I$20240628$20240809$20240828$20240828$EXP$$US-PHARMING-PHAUS2024000689$PHARMING GROUP$$$$$$Y$$$20240815$$CN$US$US
242605741$24260574$1$I$20240820$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59340$$FDA-CTU$$46$YR$$$N$$$20240827$N$PH$US$
242605751$24260575$1$I$$20240809$20240828$20240828$PER$$US-PHARMING-PHAUS2024000688$PHARMING GROUP$$$$$$Y$$$20240815$$CN$US$US
242605761$24260576$1$I$20240822$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59339$$FDA-CTU$$65$YR$$F$N$$$20240827$N$PH$US$
242605771$24260577$1$I$$20240809$20240828$20240828$PER$$US-PHARMING-PHAUS2024000684$PHARMING GROUP$$$$$$Y$$$20240815$$CN$US$US
242605781$24260578$1$I$$20240827$20240828$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA075798$SANDOZ$$48$YR$$F$Y$$$20240828$$PH$CA$CA
242605791$24260579$1$I$20240821$20240822$20240828$20240828$EXP$$AU-MYLANLABS-2024M1078931$MYLAN$$47$YR$$F$Y$$$20240828$$PH$AU$AU
242605811$24260581$1$I$20240801$20240823$20240828$20240828$EXP$$US-AMERICAN REGENT INC-2024003274$AMERICAN REGENT$$4$DEC$$F$Y$$$20240828$$HP$US$US
242605821$24260582$1$I$20240301$20240827$20240828$20240828$EXP$IT-MINISAL02-999947$IT-ABBVIE-5897895$ABBVIE$$52$YR$$F$Y$62$KG$20240828$$MD$IT$IT
242605831$24260583$1$I$20240701$20240809$20240828$20240828$PER$$US-JNJFOC-20240827809$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240828$$CN$US$US
242605842$24260584$2$F$$20240916$20240828$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135287$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$70.76$KG$20240918$$CN$US$US
242605851$24260585$1$I$$20240827$20240828$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-136734$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240828$$PH$JP$JP
242605862$24260586$2$F$20240812$20240903$20240828$20240905$EXP$$ES-AMERICAN REGENT INC-2024003289$AMERICAN REGENT$$49$YR$$F$Y$$$20240905$$PH$ES$ES
242605871$24260587$1$I$20240817$20240821$20240828$20240828$EXP$GB-MHRA-MED-202408211240167380-GFQHZ$GB-TEVA-VS-3236219$TEVA$$50$YR$$F$Y$$$20240828$$CN$GB$GB
242605881$24260588$1$I$$20240825$20240828$20240828$PER$$US-JNJFOC-20240867586$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240828$$HP$US$US
242605891$24260589$1$I$$20240823$20240828$20240828$PER$$US-ABBVIE-5895399$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242605901$24260590$1$I$20090101$20240816$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408012699$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240828$$CN$US$US
242605921$24260592$1$I$$20240823$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408015677$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240828$$CN$US$US
242605931$24260593$1$I$20240629$20240826$20240828$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013577$JAZZ$$81$YR$$M$Y$$$20240828$$CN$US$US
242605951$24260595$1$I$$20240717$20240828$20240828$PER$$US-Merz Pharmaceuticals GmbH-2024070000038$MERZ$$$$A$F$Y$$$20240828$$CN$US$US
242605961$24260596$1$I$$20240808$20240828$20240828$PER$$US-TEVA-VS-3231697$TEVA$$76$YR$$M$Y$$$20240828$$CN$US$US
242605971$24260597$1$I$$20240823$20240828$20240828$EXP$$US-ABBVIE-5895095$ABBVIE$Konda SM, Deaner JD, Proia AD, Jaffe GJ. Primary vitreoretinal lymphoma masquerading as postoperative endophthalmitis in a pregnant patient with long-standing idiopathic panuveitis. Retin Cases Brief Rep. 2024;18(4):468-472.$$$$F$Y$$$20240828$$HP$US$US
242605981$24260598$1$I$$20240828$20240828$20240828$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048332$BOEHRINGER INGELHEIM$$$$$$Y$$$20240828$$CN$US$US
242605991$24260599$1$I$20240703$20240703$20240828$20240828$PER$$US-MRZWEB-2024070000065$MERZ$$$$$F$Y$$$20240828$$HP$US$US
242606001$24260600$1$I$20190814$20240819$20240828$20240828$EXP$$DE-IMP-2023000440$Harrow Health$$51$YR$A$M$Y$$$20240828$$CN$DE$DE
242606011$24260601$1$I$$20240819$20240828$20240828$PER$$JP-Eisai-EC-2024-172490$EISAI$$$$A$$Y$$$20240828$$MD$JP$JP
242606021$24260602$1$I$20240501$20240822$20240828$20240828$EXP$$DE-MYLANLABS-2024M1078309$MYLAN$$74$YR$$M$Y$$$20240828$$MD$DE$DE
242606031$24260603$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137049$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$45.81$KG$20240828$$PH$US$US
242606041$24260604$1$I$$20240822$20240828$20240828$PER$$US-JNJFOC-20240872487$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$PH$US$US
242606051$24260605$1$I$$20240820$20240828$20240828$PER$$US-JNJFOC-20240872057$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240828$$MD$US$US
242606082$24260608$2$F$20240717$20240916$20240828$20240924$EXP$IT-MINISAL02-998960$IT-TEVA-VS-3234908$TEVA$$63$YR$$F$Y$95$KG$20240924$$PH$IT$IT
242606091$24260609$1$I$20190101$20240823$20240828$20240828$EXP$$US-009507513-2408USA008618$MERCK$Soliman A, Hassan R, Codreanu I, Plaxe SC, Dasanu CA.. Sjogren^s syndrome due to immune checkpoint inhibitors (ICIs): Insights from a single-institution series and systematic review of the literature. Journal of Oncology Pharmacy Practice. 2024$78$YR$$M$Y$$$20240828$$HP$US$US
242606101$24260610$1$I$$20240821$20240828$20240828$PER$$US-009507513-2408USA008596$MERCK$$$$$F$Y$$$20240828$$HP$US$US
242606111$24260611$1$I$$20240820$20240828$20240828$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007335$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240828$$MD$DE$DE
242606132$24260613$2$F$20240101$20240808$20240828$20240910$PER$$US-TEVA-VS-3231709$TEVA$$$$$M$Y$$$20240910$$HP$US$US
242606141$24260614$1$I$$20240819$20240828$20240828$PER$$US-JNJFOC-20240873060$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$HP$US$US
242606151$24260615$1$I$$20240820$20240828$20240828$PER$$JP-Eisai-EC-2024-172635$EISAI$Kosuke Ueda. Renal Cell Carcinoma Web Lecture.$$$E$M$Y$$$20240828$$MD$JP$JP
242606161$24260616$1$I$$20240821$20240828$20240828$PER$$AU-Eisai-EC-2024-172645$EISAI$$$$$F$Y$$$20240828$$MD$AU$AU
242606172$24260617$2$F$20240801$20240918$20240828$20240925$PER$$JP-Eisai-EC-2024-172710$EISAI$$70$YR$E$M$Y$$$20240925$$MD$JP$JP
242606181$24260618$1$I$20210801$20240816$20240828$20240828$PER$$US-INCYTE CORPORATION-2024IN008642$INCYTE$$$$$$Y$$$20240828$$PH$US$US
242606191$24260619$1$I$$20240819$20240828$20240828$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-136875$BRISTOL MYERS SQUIBB$Dentoni M, Florean I, Farina A, Joubert B, Do L, Honnorat J, et al. Immune checkpoint inhibitor-related cerebellar toxicity: clinical features and comparison with paraneoplastic cerebellar ataxia. The Cerebellum. 2024 Aug 17;doi:10.1007/s12311-024-01727-5.$62$YR$A$M$Y$$$20240828$$HP$IT$IT
242606202$24260620$2$F$20240730$20240822$20240828$20240829$EXP$$CN-009507513-2408CHN009085$MERCK$$60$YR$$F$Y$$$20240829$$HP$CN$CN
242606211$24260621$1$I$20230731$20240827$20240828$20240828$EXP$FR-AFSSAPS-PO2024000872$FR-SANDOZ INC.-SDZ2024FR075574$SANDOZ$$1$DY$$M$Y$2.26$KG$20240828$$HP$FR$FR
242606221$24260622$1$I$$20240828$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048326$BOEHRINGER INGELHEIM$$$$$$Y$$$20240828$$CN$US$US
242606241$24260624$1$I$$20240819$20240828$20240828$PER$$US-MYLANLABS-2024M1077548$MYLAN$$$$$F$Y$$$20240828$$CN$US$US
242606251$24260625$1$I$20240811$20240814$20240828$20240828$EXP$$US-PHARMING-PHAUS2024000702$PHARMING GROUP$$$$$$Y$$$20240822$$CN$US$US
242606261$24260626$1$I$$20240814$20240828$20240828$PER$$US-PHARMING-PHAUS2024000706$PHARMING GROUP$$$$$$Y$$$20240822$$CN$US$US
242606272$24260627$2$F$$20240903$20240828$20240906$PER$$US-PHARMING-PHAUS2024000704$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242606281$24260628$1$I$$20240814$20240828$20240828$EXP$$US-PHARMING-PHAUS2024000705$PHARMING GROUP$$$$$$Y$$$20240822$$CN$US$US
242606291$24260629$1$I$$20240815$20240828$20240828$EXP$$US-PHARMING-PHAUS2024000708$PHARMING GROUP$$$$$$Y$$$20240822$$CN$US$US
242606301$24260630$1$I$$20240812$20240828$20240828$PER$$US-PHARMING-PHAUS2024000695$PHARMING GROUP$$$$$$Y$$$20240819$$CN$US$US
242606311$24260631$1$I$$20240826$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408016500$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240828$$CN$US$US
242606321$24260632$1$I$$20240814$20240828$20240828$PER$$US-PHARMING-PHAUS2024000703$PHARMING GROUP$$$$$$Y$$$20240822$$CN$US$US
242606341$24260634$1$I$$20240822$20240828$20240828$EXP$$TW-INCYTE CORPORATION-2024IN008879$INCYTE$$$$$$Y$$$20240828$$MD$TW$TW
242606351$24260635$1$I$20240701$20240816$20240828$20240828$EXP$CH-SM-2024-15219$CH-ELI_LILLY_AND_COMPANY-CH202408012979$ELI LILLY AND CO$$82$YR$E$M$Y$85.8$KG$20240828$$HP$CH$CH
242606361$24260636$1$I$$20240806$20240828$20240828$30DAY$$EG-SANDOZ INC.-SDZ2024EG075898$SANDOZ$$$$$M$Y$$$20240828$$CN$EG$EG
242606371$24260637$1$I$$20240813$20240828$20240828$PER$$US-PHARMING-PHAUS2024000696$PHARMING GROUP$$$$$$Y$$$20240819$$CN$US$US
242606381$24260638$1$I$$20240826$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075283$SANDOZ$$$$$F$Y$$$20240828$$CN$US$US
242606392$24260639$2$F$$20240825$20240828$20240830$EXP$$NVSC2024GB172250$NOVARTIS$$$$$F$Y$$$20240830$$CN$GB$GB
242606401$24260640$1$I$$20240827$20240828$20240828$EXP$$PT-SANDOZ INC.-SDZ2024PT075856$SANDOZ$$63$YR$$F$Y$$$20240828$$MD$PT$PT
242606411$24260641$1$I$$20240822$20240828$20240828$PER$$US-ABBVIE-5895773$ABBVIE$$$$A$$Y$$$20240828$$PH$US$US
242606421$24260642$1$I$$20240820$20240828$20240828$EXP$$FR-INCYTE CORPORATION-2024IN009009$INCYTE$Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon Pennamen MD, Rivet J, et al. Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024;38:e32-4$$$$$Y$$$20240828$$HP$FR$FR
242606431$24260643$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA250427$SANOFI AVENTIS$$$$A$F$Y$74$KG$20240828$$MD$US$US
242606452$24260645$2$F$20240821$20240917$20240828$20240924$PER$$US-Eisai-EC-2024-172771$EISAI$$81$YR$E$F$Y$$$20240924$$CN$US$US
242606461$24260646$1$I$$20240823$20240828$20240828$EXP$$US-AstraZeneca-2024A193536$ASTRAZENECA$$$$$$Y$$$20240828$$MD$US$
242606471$24260647$1$I$$20240822$20240828$20240828$EXP$$CA-PFIZER INC-202400244926$PFIZER$$67$YR$$F$Y$$$20240828$$CN$CA$CA
242606481$24260648$1$I$20240618$20240827$20240828$20240828$EXP$FR-AFSSAPS-BS2024000573$FR-PFIZER INC-202400244450$PFIZER$$66$YR$$M$Y$70$KG$20240828$$MD$FR$FR
242606491$24260649$1$I$20240422$20240816$20240828$20240828$EXP$$US-ASTELLAS-2024-AER-002500$ASTELLAS$$61$YR$A$M$Y$66.68$KG$20240828$$CN$US$US
242606501$24260650$1$I$$20240703$20240828$20240828$PER$$US-Merz Pharmaceuticals GmbH-2024070000071$MERZ$$$$$F$Y$$$20240828$$HP$US$US
242606513$24260651$3$F$20240801$20240829$20240828$20240830$PER$$US-PURDUE PHARMA-USA-2024-0311626$PURDUE$$57$YR$$M$Y$136.08$KG$20240830$$CN$US$US
242606521$24260652$1$I$$20240827$20240828$20240828$PER$$US-PURDUE PHARMA-USA-2024-0311627$PURDUE$$$$$M$Y$$$20240828$$CN$US$US
242606531$24260653$1$I$$20240827$20240828$20240828$PER$$US-PURDUE PHARMA-USA-2024-0311625$PURDUE$$59$YR$$M$Y$$$20240828$$CN$US$US
242606542$24260654$2$F$20110519$20240911$20240828$20240916$EXP$$US-PURDUE PHARMA-USA-2024-0311640$PURDUE$$$$A$M$Y$$$20240917$$CN$US$US
242606552$24260655$2$F$20240611$20240831$20240828$20240904$PER$$US-PURDUE PHARMA-USA-2024-0311600$PURDUE$$26$YR$$F$Y$$$20240904$$CN$US$US
242606561$24260656$1$I$$20240827$20240828$20240828$PER$$US-PURDUE PHARMA-USA-2024-0311637$PURDUE$$$$$$Y$$$20240828$$CN$US$US
242606571$24260657$1$I$20240822$20240823$20240828$20240828$PER$$US-ABBVIE-5896189$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242606581$24260658$1$I$20240801$20240812$20240828$20240828$EXP$$US-RADIUS HEALTH INC.-2024US006394$RADIUS PHARM$$$$$$Y$$$20240828$$CN$US$US
242606591$24260659$1$I$$20240826$20240828$20240828$EXP$$US-BAUSCH-BL-2024-012944$BAUSCH AND LOMB$$59$YR$$F$Y$$$20240828$$LW$US$US
242606601$24260660$1$I$20240429$20240716$20240828$20240828$EXP$CH-SM-2024-12957$2024-035526$SK LIFE SCIENCE$$$$$$Y$$$20240828$$HP$CH$CH
242606611$24260661$1$I$20240801$20240826$20240828$20240828$PER$$US-BAUSCH-BL-2024-012896$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240828$$MD$US$US
242606621$24260662$1$I$$20240822$20240828$20240828$EXP$$CN-JNJFOC-20240864862$JOHNSON AND JOHNSON$$$$$$Y$$$20240828$$HP$CN$CN
242606631$24260663$1$I$$20240827$20240828$20240828$EXP$$NVSC2024US173428$NOVARTIS$$$$$F$Y$$$20240828$$CN$US$US
242606641$24260664$1$I$$20240712$20240828$20240828$PER$$US-MRZWEB-2024070000018$MERZ$$$$$M$Y$$$20240828$$MD$US$US
242606661$24260666$1$I$$20240715$20240828$20240828$DIR$FDA-CDER-CTU-2024-59377$$FDA-CTU$$$$$$N$$$20240715$N$PH$US$
242606672$24260667$2$F$$20240828$20240828$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048346$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240829$$CN$US$US
242606681$24260668$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136170$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240828$$HP$US$US
242606701$24260670$1$I$$20240820$20240828$20240828$PER$$US-ABBVIE-5889032$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242606712$24260671$2$F$$20240920$20240828$20240927$EXP$AU-TGA-0000816089$NVSC2024AU169923$NOVARTIS$$73$YR$$M$Y$$$20240927$$HP$AU$AU
242606721$24260672$1$I$$20240819$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134749$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240828$$HP$US$US
242606731$24260673$1$I$20240701$20240717$20240828$20240828$PER$$US-Merz Pharmaceuticals GmbH-2024070000014$MERZ$$$$A$F$Y$$$20240828$$HP$US$US
242606742$24260674$2$F$$20240903$20240828$20240913$PER$$US-PHARMING-PHAUS2024000690$PHARMING GROUP$$$$$$Y$$$20240913$$CN$US$US
242606751$24260675$1$I$$20240827$20240828$20240828$EXP$$US-AstraZeneca-2024A195329$ASTRAZENECA$$$$$M$Y$$$20240828$$CN$US$
242606763$24260676$3$F$20240621$20240917$20240828$20240926$EXP$$JP-Eisai-EC-2024-172719$EISAI$$76$YR$E$F$Y$48.5$KG$20240926$$MD$JP$JP
242606771$24260677$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136563$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240828$$CN$US$US
242606781$24260678$1$I$$20240819$20240828$20240828$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-136869$BRISTOL MYERS SQUIBB$Dentoni M, Florean I, Farina A, Joubert B, Do L, Honnorat J, et al. Immune checkpoint inhibitor-related cerebellar toxicity: clinical features and comparison with paraneoplastic cerebellar ataxia. The Cerebellum. 2024 Aug 17;doi:10.1007/s12311-024-01727-5.$79$YR$E$M$Y$$$20240828$$HP$IT$IT
242606792$24260679$2$F$$20240828$20240828$20240902$EXP$$CA-AstraZeneca-2024A091311$ASTRAZENECA$$66$YR$$M$Y$$$20240902$$MD$CA$
242606812$24260681$2$F$$20240902$20240828$20240911$EXP$$IL-TEVA-VS-3236051$TEVA$Shaklai S, Marcus-Perlman Y, Klein A, Stern N, Greenman Y. De-Novo Graves Ophthalmopathy After Total Thyroidectomy With Exacerbation Following Rifampicin Therapy for Latent Tuberculosis: A Call for Attention to Disease Modifying Interventions. J-Endocr-Soc 2020; 4 (Suppl. 1) A1125 abstr. SUN-LB87.; Shaklai S, Marcus-Perlman Y, Klein A, Stern N, Greenman Y. De-Novo Graves Ophthalmopathy After Total Thyroidectomy With Exacerbation Following Rifampicin Therapy for Latent Tuberculosis: A Call for...$46$YR$$F$Y$$$20240911$$MD$IL$IL
242606821$24260682$1$I$$20240820$20240828$20240828$PER$$US-ABBVIE-5889859$ABBVIE$$$$$$Y$$$20240828$$CN$US$US
242606841$24260684$1$I$20240811$20240813$20240828$20240828$EXP$$NL-ASTELLAS-AER-2024-020625$ASTELLAS$$$$$M$Y$$$20240822$$CN$NL$NL
242606851$24260685$1$I$20240201$20240813$20240828$20240828$EXP$$GB-ASTELLAS-AER-2024-020624$ASTELLAS$$$$$F$Y$$$20240827$$HP$GB$GB
242606861$24260686$1$I$20240807$20240813$20240828$20240828$EXP$GB-MHRA-MED-202408120655222520-DNFRV$GB-ASTELLAS-2024-AER-000614$ASTELLAS$$74$YR$E$M$Y$77$KG$20240823$$CN$GB$GB
242606881$24260688$1$I$20240101$20240815$20240828$20240828$PER$$US-SA-2024SA247358$SANOFI AVENTIS$$62$YR$A$F$Y$66.1$KG$20240828$$MD$US$US
242606892$24260689$2$F$$20240904$20240828$20240930$PER$$US-SA-2024SA250112$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
242606902$24260690$2$F$$20240917$20240828$20240918$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048289$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240918$$CN$US$US
242606911$24260691$1$I$$20240828$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048351$BOEHRINGER INGELHEIM$$$$$$Y$$$20240828$$CN$US$US
242606921$24260692$1$I$20240801$20240820$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132446$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240828$$HP$US$US
242606932$24260693$2$F$20240101$20240924$20240828$20240927$PER$$US-009507513-2408USA004065$MERCK$$$$$F$Y$$$20240927$$MD$US$US
242606941$24260694$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017744$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240828$$CN$US$US
242606951$24260695$1$I$$20240828$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048350$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240828$$CN$US$US
242606961$24260696$1$I$20240101$20240819$20240828$20240828$PER$$US-SA-2024SA249095$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240828$$MD$US$US
242606971$24260697$1$I$$20240828$20240828$20240828$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048347$BOEHRINGER INGELHEIM$$$$$$Y$$$20240828$$CN$US$US
242606981$24260698$1$I$20240705$20240823$20240828$20240828$EXP$$US-OTSUKA-2024_023384$OTSUKA$$81$YR$$F$Y$$$20240828$$CN$US$US
242607001$24260700$1$I$$20240819$20240828$20240828$PER$$US-SA-2024SA245524$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240828$$MD$US$US
242607011$24260701$1$I$$20240821$20240828$20240828$EXP$$US-SA-2024SA249639$SANOFI AVENTIS$$$$C$F$Y$$$20240828$$HP$US$US
242607031$24260703$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249385$SANOFI AVENTIS$$$$A$M$Y$$$20240828$$MD$US$US
242607042$24260704$2$F$$20240925$20240828$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136979$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240927$$CN$US$US
242607051$24260705$1$I$$20240820$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133000$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240828$$CN$US$US
242607061$24260706$1$I$$20240820$20240828$20240828$EXP$$TW-EMD Serono-2024044922$EMD SERONO INC$$46$YR$A$M$Y$$$20240828$$MD$TW$TW
242607071$24260707$1$I$$20240820$20240828$20240828$PER$$US-SA-2024SA249436$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240828$$MD$US$US
242607081$24260708$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173851$NOVARTIS$$$$$M$Y$$$20240828$$HP$US$US
242607101$24260710$1$I$$20240821$20240828$20240828$EXP$$US-MALLINCKRODT-MNK202405290$MALLINCKRODT$$$$$M$Y$$$20240828$$CN$US$US
242607111$24260711$1$I$$20240820$20240828$20240828$EXP$$US-MALLINCKRODT-MNK202405284$MALLINCKRODT$$$$$F$Y$$$20240828$$HP$US$US
242607122$24260712$2$F$20240101$20240823$20240828$20240829$EXP$$US-BIOGEN-2024BI01279831$BIOGEN$$$$$F$Y$$$20240829$$HP$US$US
242607131$24260713$1$I$$20240822$20240828$20240828$EXP$DE-Eisai-EC-2024-171614$DE-009507513-2408DEU008237$MERCK$$$$$F$Y$$$20240828$$MD$DE$DE
242607141$24260714$1$I$$20240821$20240828$20240828$EXP$$US-BIOGEN-2024BI01279081$BIOGEN$$$$$F$Y$$$20240828$$CN$US$US
242607151$24260715$1$I$$20240820$20240828$20240828$PER$$US-BIOMARINAP-US-2024-160029$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
242607161$24260716$1$I$$20240821$20240828$20240828$PER$$US-BIOMARINAP-US-2024-160034$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
242607171$24260717$1$I$$20230302$20240828$20240828$EXP$$CA-DSJP-DSJ-2023-109553$DAIICHI$$$$$F$Y$$$20240828$$CN$CA$CA
242607181$24260718$1$I$20240711$20240717$20240828$20240828$PER$$US-LUNDBECK-DKLU4001846$LUNDBECK$$$$$$Y$$$20240828$$CN$US$US
242607191$24260719$1$I$$20240815$20240828$20240828$PER$$US-JNJFOC-20240847300$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242607201$24260720$1$I$$20240822$20240828$20240828$EXP$$CA-BIOGEN-2024BI01279889$BIOGEN$$$$$F$Y$$$20240828$$CN$CA$CA
242607211$24260721$1$I$20230101$20240819$20240828$20240828$PER$$US-BIOGEN-2024BI01245161$BIOGEN$$$$$M$Y$85.779$KG$20240828$$CN$US$US
242607221$24260722$1$I$20240508$20240510$20240828$20240828$PER$$US-KOWA-24US001089$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607231$24260723$1$I$20230827$20240614$20240828$20240828$PER$$US-KOWA-24US001312$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607241$24260724$1$I$$20240503$20240828$20240828$PER$$US-KOWA-24US000966$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607251$24260725$1$I$20240511$20240518$20240828$20240828$PER$$US-KOWA-24US001167$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607261$24260726$1$I$$20240731$20240828$20240828$PER$$US-KOWA-24US001774$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607271$24260727$1$I$20240218$20240411$20240828$20240828$PER$$US-KOWA-24US000635$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607281$24260728$1$I$20240402$20240415$20240828$20240828$PER$$US-KOWA-24US000704$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607291$24260729$1$I$$20240422$20240828$20240828$PER$$US-KOWA-24US000837$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607301$24260730$1$I$20240301$20240410$20240828$20240828$PER$$US-KOWA-24US000589$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607311$24260731$1$I$20230101$20240603$20240828$20240828$PER$$US-KOWA-24US000902$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607321$24260732$1$I$20240401$20240425$20240828$20240828$PER$$US-KOWA-24US000889$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607331$24260733$1$I$20240211$20240615$20240828$20240828$PER$$US-KOWA-24US001699$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607341$24260734$1$I$$20240528$20240828$20240828$PER$$US-KOWA-24US000903$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607351$24260735$1$I$$20240411$20240828$20240828$PER$$US-KOWA-24US000660$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607361$24260736$1$I$20240101$20240416$20240828$20240828$PER$$US-KOWA-24US000726$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607371$24260737$1$I$$20240520$20240828$20240828$PER$$US-KOWA-24US001168$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607381$24260738$1$I$20240216$20240617$20240828$20240828$PER$$US-KOWA-24US001700$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607391$24260739$1$I$20240410$20240717$20240828$20240828$PER$$US-KOWA-24US001398$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607401$24260740$1$I$$20240604$20240828$20240828$PER$$US-KOWA-24US001440$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607411$24260741$1$I$$20240530$20240828$20240828$PER$$US-KOWA-24US001371$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607421$24260742$1$I$20240501$20240503$20240828$20240828$PER$$US-KOWA-24US000965$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607431$24260743$1$I$$20240417$20240828$20240828$PER$$US-KOWA-24US000779$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607441$24260744$1$I$20231207$20240508$20240828$20240828$PER$$US-KOWA-24US001018$KOWA PHARM$$63$YR$$F$Y$$$20240828$$CN$US$US
242607451$24260745$1$I$$20240824$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135495$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240828$$HP$US$US
242607461$24260746$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136527$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240828$$HP$US$US
242607471$24260747$1$I$20240416$20240516$20240828$20240828$PER$$US-KOWA-24US001166$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607481$24260748$1$I$20240223$20240321$20240828$20240828$PER$$US-KOWA-24US000379$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607491$24260749$1$I$20240621$20240715$20240828$20240828$PER$$US-KOWA-24US001897$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607501$24260750$1$I$20240326$20240402$20240828$20240828$PER$$US-KOWA-24US000446$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607511$24260751$1$I$$20240508$20240828$20240828$PER$$US-KOWA-24US001017$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607521$24260752$1$I$20240701$20240820$20240828$20240828$EXP$NO-NOMAADVRE-PASRAPP-2024-V6enzn$NO-DUCHESNAY-2024NO000333$DUCHESNAY$$$$$$Y$$$20240828$$CN$NO$NO
242607531$24260753$1$I$$20240424$20240828$20240828$PER$$US-KOWA-24US000888$KOWA PHARM$$$$$$Y$$$20240828$$CN$US$US
242607542$24260754$2$F$$20240905$20240828$20240910$PER$$US-Taiho Oncology Inc-2024-008047$TAIHO ONCOLOGY INC$$82$YR$E$F$Y$$$20240910$$CN$US$US
242607552$24260755$2$F$20240826$20240918$20240828$20240921$PER$$US-JNJFOC-20240867616$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240921$$CN$US$US
242607561$24260756$1$I$$20240820$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133612$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240828$$HP$US$US
242607571$24260757$1$I$20240818$20240823$20240828$20240828$PER$$US-UNITED THERAPEUTICS-UNT-2024-026664$UNITED THERAPEUTICS$$78$YR$$F$Y$120.18$KG$20240828$$$US$US
242607581$24260758$1$I$$20240718$20240828$20240828$DIR$FDA-CDER-CTU-2024-59389$$FDA-CTU$$$$$$N$$$20240718$N$PH$US$
242607591$24260759$1$I$$20240716$20240828$20240828$DIR$FDA-CDER-CTU-2024-59385$$FDA-CTU$$$$$$N$$$20240716$N$PH$US$
242607601$24260760$1$I$$20240713$20240828$20240828$DIR$FDA-CDER-CTU-2024-59378$$FDA-CTU$$$$$$N$$$20240713$N$PH$US$
242607611$24260761$1$I$$20240711$20240828$20240828$DIR$FDA-CDER-CTU-2024-59379$$FDA-CTU$$$$$$N$$$20240711$N$PH$US$
242607631$24260763$1$I$20231101$20240822$20240828$20240828$EXP$$US-ABBVIE-5891478$ABBVIE$$82$YR$$M$Y$$$20240828$$CN$US$US
242607641$24260764$1$I$20240822$20240826$20240828$20240828$EXP$$CN-PFIZER INC-PV202400111307$PFIZER$$39$YR$$M$Y$110$KG$20240828$$HP$CN$CN
242607651$24260765$1$I$$20240308$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00131$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$PH$US$US
242607661$24260766$1$I$$20230921$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00613$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$MD$US$US
242607671$24260767$1$I$$20240202$20240828$20240828$PER$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00056$VELOXIS PHARMACEUTICALS$$$$$$Y$$$20240828$$HP$US$US
242607682$24260768$2$F$$20240819$20240828$20240914$EXP$$US-TEVA-VS-3235516$TEVA$Robinson CL, Wahab S, Cai V. Delayed Hypersensitivity Reaction to Iodinated-Contrast Following Lumbar Epidural Steroid Injection: Case Report. Pain-Med-Case-Rep 2023; 7 (1): 11-14.; Robinson CL, Wahab S, Cai V. Delayed Hypersensitivity Reaction to Iodinated-Contrast Following Lumbar Epidural Steroid Injection: Case Report. Pain-Med-Case-Rep 2023; 7 (1): 11-14.; Robinson CL, Wahab S, Cai V. Delayed Hypersensitivity Reaction to Iodinated-Contrast Following Lumbar Epidural Steroid Injection: Cas...$54$YR$$F$Y$$$20240914$$MD$US$US
242607692$24260769$2$F$$20240902$20240828$20240910$EXP$$US-TEVA-VS-3235524$TEVA$Ergando T. Successful Recovery After Immune Checkpoint Inhibitor Induced Myocarditis And Cariogenic ShockIn A Patient With Urothelial Cancer:A Case Report. J-Card-Fail 2024; 30 (1): 177 abstr. 138.; Ergando T. Successful Recovery After Immune Checkpoint Inhibitor Induced Myocarditis And Cariogenic ShockIn A Patient With Urothelial Cancer:A Case Report. J-Card-Fail 2024; 30 (1): 177 abstr. 138.$69$YR$$F$Y$$$20240910$$HP$US$US
242607702$24260770$2$F$$20240902$20240828$20240910$EXP$$US-TEVA-VS-3235517$TEVA$Gondal MUR, Rovenstine L, Ansari F, Kiyani Z, Nair DPJR, Khan T, et al. NAVIGATING A COMPLEX CASE OF MYCOBACTERIUM XENOPI IN A PATIENT WITH BLUE RUBBER BLEB NEVUS SYNDROME. Eur-J-Case-Rep-Intern-Med 2024; 11 (6):.; Gondal MUR, Rovenstine L, Ansari F, Kiyani Z, Nair DPJR, Khan T, et al. NAVIGATING A COMPLEX CASE OF MYCOBACTERIUM XENOPI IN A PATIENT WITH BLUE RUBBER BLEB NEVUS SYNDROME. Eur-J-Case-Rep-Intern-Med 2024; 11 (6):.$40$YR$$F$Y$$$20240910$$HP$US$US
242607712$24260771$2$F$$20240902$20240828$20240911$EXP$$BE-TEVA-VS-3236061$TEVA$Boogers A, Van Bogaert T, Peeters J, Kilic U, Sunaert S, Vandenberghe W, et al. Aligning Dentato-Rubro-Thalamic Tract and Subthalamic Nucleus Targets in a Patient with Comorbid Essential Tremor and Parkinson^s Disease: Case Report. Stereotac-Funct-Neurosurg 2023; 100 (5-6): 340-345.; Boogers A, Van Bogaert T, Peeters J, Kilic U, Sunaert S, Vandenberghe W, et al. Aligning Dentato-Rubro-Thalamic Tract and Subthalamic Nucleus Targets in a Patient with Comorbid Essential Tremor and Parkinson^s Di...$70$YR$$M$Y$$$20240911$$HP$BE$BE
242607721$24260772$1$I$$20240819$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132183$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240828$$HP$US$US
242607731$24260773$1$I$20240823$20240823$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136677$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240828$$CN$US$US
242607744$24260774$4$F$20240101$20240914$20240828$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-026181$UNITED THERAPEUTICS$$$$$F$Y$51.701$KG$20240921$$$US$US
242607761$24260776$1$I$20240701$20240819$20240828$20240828$PER$$US-009507513-2408USA006625$MERCK$$$$$F$Y$$$20240828$$CN$US$US
242607791$24260779$1$I$$20240821$20240828$20240828$EXP$$NVSC2024US173492$NOVARTIS$$$$$M$Y$$$20240828$$CN$US$US
242607832$24260783$2$F$$20240826$20240828$20240829$PER$$US-ABBVIE-5897670$ABBVIE$$$$$F$Y$$$20240829$$MD$US$US
242607841$24260784$1$I$$20240820$20240828$20240828$PER$$JP-Eisai-EC-2024-163902$EISAI$Eri Takagi. A case in which it was difficult to distinguish between central hypothyroidism and hypothyroidism due to irAE. The 252nd Tokai Regional Meeting of the Japanese Society of Internal Medicine (Abstracts). 2024: 28-28.$55$YR$A$F$Y$$$20240828$$MD$JP$JP
242607851$24260785$1$I$$20240822$20240828$20240828$PER$$US-009507513-2408USA008191$MERCK$Kiernan DF. Sustained-release low-dose fluocinolone acetonide intravitreal implant for chronic postoperative cystoid macular edema: Two case reports. Retinal Cases and Brief Reports. 2024;18 (4):421-7$75$YR$$F$Y$$$20240828$$MD$US$US
242607861$24260786$1$I$$20240827$20240828$20240828$PER$$US-AMGEN-USASP2024171661$AMGEN$$$$A$F$Y$$$20240828$$CN$US$US
242607891$24260789$1$I$20240801$20240819$20240828$20240828$EXP$$JP-Eisai-EC-2024-159573$EISAI$Yamamoto Nao. Experiences of pembrolizumab plus lenvatinib therapy and introduction of oral medication support in our hospital. Lecture; -; .$52$YR$A$F$Y$$$20240828$$MD$JP$JP
242607901$24260790$1$I$$20240821$20240828$20240828$EXP$$US-VIVUS LLC-2024V1001040$VIVUS$$$$A$F$Y$$$20240828$$CN$US$US
242607911$24260791$1$I$$20240823$20240828$20240828$EXP$$ES-ANIPHARMA-2024-ES-000088$ANI$Soto-Moreno A, Diaz-Calvillo P, Arias-Santiago S.Kounis syndrome, mast cells beyond the skin..Actas Dermo-Sifiliograficas.2024;.$51$YR$$M$Y$$$20240828$$HP$ES$ES
242607921$24260792$1$I$$20240819$20240828$20240828$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS002237$BLUEPRINT MEDICINES$Dimou A, Lo YC, Merrell K, Halling K, and Mansfield A. EP08.02-037 Small Cell Transformation in a Patient with RET Fusion Positive Lung Adenocarcinoma on Pralsetinib. Journal of Thoracic Oncology. 2022;6:1-4$$$$$Y$$$20240827$$MD$US$US
242607932$24260793$2$F$$20240830$20240828$20240907$EXP$$CA-HLS-202402083$HLS THERAPEUTICS$$$$A$F$Y$$$20240907$$HP$CA$CA
242607942$24260794$2$F$20221104$20240830$20240828$20240905$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS002037$Unknown Manufacturer$$$$$$Y$$$20240904$$MD$FR$FR
242607951$24260795$1$I$$20240827$20240828$20240828$PER$$US-ABBVIE-5899017$ABBVIE$$$$$$Y$$$20240828$$CN$US$US
242607961$24260796$1$I$$20240820$20240828$20240828$PER$$US-009507513-2408USA006588$MERCK$$$$$F$Y$57.1$KG$20240828$$HP$US$US
242607972$24260797$2$F$20240101$20240816$20240828$20240916$PER$$US-SA-2024SA248671$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240916$$CN$US$US
242607981$24260798$1$I$$20240822$20240828$20240828$EXP$$BR-BIOMARINAP-BR-2024-160157$BIOMARIN$$$$$$Y$$$20240828$$CN$BR$BR
242607991$24260799$1$I$$20240822$20240828$20240828$EXP$$BR-BIOMARINAP-BR-2024-160159$BIOMARIN$$$$$$Y$$$20240828$$CN$BR$BR
242608001$24260800$1$I$$20240815$20240828$20240828$EXP$$CA-HLS-202402080$HLS THERAPEUTICS$$$$A$F$Y$$$20240828$$HP$CA$CA
242608011$24260801$1$I$$20240819$20240828$20240828$EXP$$JP-AMGEN-JPNSP2024169812$AMGEN$Yoshida, S.. A case of IgA vasculitis developed during long-term treatment of etanercept for rheumatoid arthritis. The Nishinihon Journal of Dermatology, Journal of the Western Japan Division of. 2024;86(4):429$28$YR$A$F$Y$$$20240828$$HP$JP$JP
242608021$24260802$1$I$$20240827$20240828$20240828$PER$$US-ELI_LILLY_AND_COMPANY-US202408017431$ELI LILLY AND CO$$66$YR$E$$Y$$$20240828$$CN$US$US
242608031$24260803$1$I$20240801$20240826$20240828$20240828$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013629$JAZZ$$12$YR$$M$Y$$$20240828$$CN$US$US
242608061$24260806$1$I$$20240816$20240828$20240828$EXP$$US-HLS-202400940$HLS THERAPEUTICS$$51$YR$A$M$Y$$$20240828$$MD$US$US
242608071$24260807$1$I$20240824$20240825$20240828$20240828$EXP$GB-MHRA-MED-202408250908130170-TVYHK$GB-GE HEALTHCARE-2024CSU009677$GE HEALTHCARE$$64$YR$$M$Y$112$KG$20240829$$HP$GB$GB
242608081$24260808$1$I$20200509$20240824$20240828$20240828$EXP$PL-URPL-2-1168-2020$PL-GE HEALTHCARE-2024CSU009682$GE HEALTHCARE$$42$YR$$M$Y$73$KG$20240829$$HP$PL$PL
242608111$24260811$1$I$20240822$20240823$20240828$20240828$PER$$US-ALXN-202408USA001687US$ALEXION PHARMACEUTICALS$$83$YR$$F$Y$$$20240828$$CN$US$US
242608121$24260812$1$I$$20240822$20240828$20240828$EXP$$JP-ASTELLAS-2024US022984$ASTELLAS$Fumiya, K.. Initial experience with enfortumab vedotin for advanced urothelial carcinoma. The 74th Annual Meeting of the West Japan Urological Association 2022:197.$$$E$$Y$$$20240828$$HP$JP$JP
242608142$24260814$2$F$$20240815$20240828$20240901$PER$$US-JNJFOC-20240841732$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242608161$24260816$1$I$$20240827$20240828$20240828$PER$$US-JNJFOC-20240871136$JOHNSON AND JOHNSON$$$$$F$Y$$$20240828$$CN$US$US
242608171$24260817$1$I$$20240822$20240828$20240828$EXP$$US-BIOMARINAP-US-2024-160060$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
242608182$24260818$2$F$20240825$20240827$20240828$20240906$EXP$$DE-BIOMARINAP-DE-2024-160125$BIOMARIN$$$$$$Y$$$20240906$$CN$DE$DE
242608191$24260819$1$I$$20240826$20240828$20240828$PER$$US-ROCHE-10000067063$ROCHE$$67$YR$E$F$Y$$$20240828$$CN$US$US
242608201$24260820$1$I$$20240820$20240828$20240828$PER$$US-BIOMARINAP-US-2024-160017$BIOMARIN$$$$$$Y$$$20240828$$CN$US$US
242608211$24260821$1$I$$20240826$20240828$20240828$EXP$$JP-ORGANON-O2408JPN001838$ORGANON$$74$YR$$M$Y$$$20240828$$PH$JP$JP
242608221$24260822$1$I$$20240823$20240828$20240828$EXP$$GB-AMGEN-GBRSP2024171488$AMGEN$$$$$F$Y$$$20240828$$MD$GB$GB
242608242$24260824$2$F$$20240924$20240828$20240925$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047949$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240926$$CN$US$US
242608252$24260825$2$F$20240818$20240918$20240828$20240925$EXP$$CA-HLS-202402096$HLS THERAPEUTICS$$34$YR$A$M$Y$$$20240925$$HP$CA$CA
242608261$24260826$1$I$$20240730$20240828$20240828$PER$$US-LEX-000412$LEXICON PHARMACEUTICALS$$78$YR$$F$Y$70.5$KG$20240828$$CN$US$US
242608271$24260827$1$I$$20240826$20240828$20240828$PER$$US-AstraZeneca-2024A195204$ASTRAZENECA$$$$$$Y$$$20240829$$CN$US$
242608281$24260828$1$I$20240726$20240730$20240828$20240828$PER$$US-LEX-000413$LEXICON PHARMACEUTICALS$$82$YR$$F$Y$$$20240828$$CN$US$US
242608291$24260829$1$I$20240723$20240816$20240828$20240828$EXP$$US-SMPA-2024SPA001495$SUNOVION$$$$$$Y$$$20240828$$CN$US$US
242608301$24260830$1$I$20240820$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170062$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242608311$24260831$1$I$$20240822$20240828$20240828$EXP$$US-JNJFOC-20240857864$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242608321$24260832$1$I$$20240828$20240828$20240828$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048381$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240829$$CN$US$US
242608332$24260833$2$F$$20240906$20240828$20240919$EXP$$AU-SMPA-2024SMP012178$SUNOVION$$$$$$Y$$$20240919$$CN$AU$AU
242608342$24260834$2$F$20240809$20240903$20240828$20240910$PER$$US-AMGEN-USASP2024166263$AMGEN$$62$YR$A$F$Y$$$20240910$$CN$US$US
242608351$24260835$1$I$$20201106$20240828$20240828$EXP$$GB-AstraZeneca-2020SF48549$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$GB$
242608361$24260836$1$I$$20210629$20240828$20240828$EXP$$GB-AstraZeneca-2021A345957$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$GB$
242608372$24260837$2$F$20230808$20240828$20240828$20240902$EXP$$US-ORGANON-O2408USA001942$ORGANON$$34$YR$$F$Y$$$20240902$$MD$US$US
242608381$24260838$1$I$$20240826$20240828$20240828$EXP$$US-Bion-013743$BIONPHARMA$$51$YR$A$F$Y$$$20240829$$HP$US$US
242608393$24260839$3$F$$20240923$20240828$20240924$PER$$NVSC2024US173780$NOVARTIS$$$$$F$Y$$$20240924$$HP$US$US
242608411$24260841$1$I$$20240826$20240828$20240828$EXP$$NVSJ2024JP010023$NOVARTIS$$81$YR$$F$Y$$$20240829$$CN$JP$JP
242608421$24260842$1$I$$20240819$20240828$20240828$EXP$$BR-JNJFOC-20240851158$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$MD$BR$BR
242608432$24260843$2$F$$20240910$20240828$20240924$EXP$$CA-HLS-202402047$HLS THERAPEUTICS$$33$YR$A$M$Y$$$20240924$$HP$CA$CA
242608441$24260844$1$I$$20240825$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075216$SANDOZ$$$$$$Y$$$20240828$$CN$US$US
242608451$24260845$1$I$$20240813$20240828$20240828$PER$$CA-HLS-202402038$HLS THERAPEUTICS$$$$A$M$Y$$$20240828$$HP$CA$CA
242608461$24260846$1$I$$20240823$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075181$SANDOZ$$$$$$Y$$$20240828$$CN$US$US
242608471$24260847$1$I$20240826$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170529$AMGEN$$$$$$Y$$$20240828$$PH$US$US
242608481$24260848$1$I$20240201$20240826$20240828$20240828$PER$$US-ORGANON-O2408USA001968$ORGANON$$16$YR$$F$Y$$$20240828$$CN$US$US
242608491$24260849$1$I$$20240827$20240828$20240828$EXP$$CA-SANDOZ INC.-SDZ2024CA075683$SANDOZ$$55$YR$$F$Y$$$20240828$$CN$CA$CA
242608502$24260850$2$F$$20240821$20240828$20240830$EXP$$US-JNJFOC-20240848907$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$CN$US$US
242608511$24260851$1$I$$20240820$20240828$20240828$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134461$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240829$$MD$JP$JP
242608521$24260852$1$I$20240801$20240819$20240828$20240828$PER$$US-SA-2024SA249801$SANOFI AVENTIS$$59$YR$A$F$Y$55.3$KG$20240829$$MD$US$US
242608541$24260854$1$I$20240808$20240808$20240828$20240828$30DAY$$CO-JNJFOC-20240826408$JOHNSON AND JOHNSON$$38$YR$A$F$Y$68$KG$20240829$$HP$CO$CO
242608551$24260855$1$I$20240828$20240828$20240828$20240828$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048310$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240829$$CN$US$US
242608561$24260856$1$I$$20240813$20240828$20240828$EXP$$CA-HLS-202402045$HLS THERAPEUTICS$$82$YR$E$M$Y$$$20240828$$HP$CA$CA
242608571$24260857$1$I$20240807$20240822$20240828$20240828$PER$$US-ABBVIE-5891381$ABBVIE$$68$YR$$F$Y$$$20240828$$CN$US$US
242608581$24260858$1$I$$20240827$20240828$20240828$EXP$$US-TAKEDA-2024TUS086677$TAKEDA$$$$$F$Y$57.78$KG$20240828$$MD$US$US
242608592$24260859$2$F$$20240913$20240828$20240920$EXP$$US-TAKEDA-2022TUS036835$TAKEDA$$$$$F$Y$$$20240920$$CN$US$US
242608601$24260860$1$I$$20240826$20240828$20240828$PER$$US-ABBVIE-5896298$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242608611$24260861$1$I$20240801$20240820$20240828$20240828$EXP$$US-JNJFOC-20240851887$JOHNSON AND JOHNSON$$49$YR$$F$Y$$$20240829$$HP$US$US
242608631$24260863$1$I$20240802$20240827$20240828$20240828$PER$$US-ORGANON-O2408USA002074$ORGANON$$$$$F$Y$$$20240828$$MD$US$US
242608642$24260864$2$F$20240806$20240816$20240828$20240829$30DAY$$CA-JNJFOC-20240826056$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240829$$HP$CA$CA
242608651$24260865$1$I$$20240813$20240828$20240828$EXP$$CA-HLS-202402044$HLS THERAPEUTICS$$77$YR$E$M$Y$$$20240828$$HP$CA$CA
242608661$24260866$1$I$$20240828$20240828$20240828$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048324$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240829$$CN$US$US
242608671$24260867$1$I$$20240828$20240828$20240828$PER$$NVSC2024US173850$NOVARTIS$$47$YR$$F$Y$50.8$KG$20240829$$CN$US$US
242608682$24260868$2$F$$20240827$20240828$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136806$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$72.57$KG$20240904$$MD$US$US
242608692$24260869$2$F$$20240829$20240828$20240902$PER$$US-AMGEN-USASP2024170167$AMGEN$$$$$F$Y$$$20240901$$CN$US$US
242608701$24260870$1$I$$20240813$20240828$20240828$PER$$CA-HLS-202402043$HLS THERAPEUTICS$$$$$F$Y$$$20240828$$HP$CA$CA
242608711$24260871$1$I$$20240827$20240828$20240828$EXP$$US-TAKEDA-2024TUS083842$TAKEDA$$$$$F$Y$$$20240828$$CN$US$US
242608721$24260872$1$I$$20240823$20240828$20240828$EXP$$US-JNJFOC-20240868041$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$HP$US$US
242608732$24260873$2$F$20240101$20240923$20240828$20240924$PER$$US-ORGANON-O2408USA002078$ORGANON$$28$YR$$F$Y$$$20240924$$HP$US$US
242608741$24260874$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5894347$ABBVIE$$28$YR$$F$Y$$$20240828$$HP$US$US
242608751$24260875$1$I$$20240826$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137001$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240829$$CN$US$US
242608761$24260876$1$I$$20240827$20240828$20240828$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136723$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240829$$CN$US$US
242608772$24260877$2$F$$20240820$20240828$20240919$PER$$US-BIOGEN-2024BI01279286$BIOGEN$$32$YR$$$Y$$$20240919$$MD$US$US
242608781$24260878$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5894350$ABBVIE$$25$YR$$F$Y$$$20240828$$HP$US$US
242608792$24260879$2$F$20240824$20240826$20240828$20240902$PER$$US-AMGEN-USASP2024170120$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242608802$24260880$2$F$20240913$20240913$20240828$20240919$EXP$$CA-TAKEDA-2024TUS086088$TAKEDA$$32$YR$$M$Y$$$20240919$$CN$CA$CA
242608821$24260882$1$I$20240823$20240823$20240828$20240828$EXP$$CA-TAKEDA-2024TUS066719$TAKEDA$$39$YR$$M$Y$$$20240828$$CN$CA$CA
242608831$24260883$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5894100$ABBVIE$$27$YR$$M$Y$$$20240828$$HP$US$US
242608841$24260884$1$I$$20240819$20240828$20240828$EXP$$ZA-TAKEDA-2024TUS083832$TAKEDA$$$$$F$Y$$$20240828$$PH$ZA$ZA
242608852$24260885$2$F$20240701$20240903$20240828$20240905$EXP$$JP-SAKK-2024SA250608AA$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240905$$MD$JP$JP
242608861$24260886$1$I$20240823$20240823$20240828$20240828$EXP$$US-TAKEDA-2024TUS085910$TAKEDA$$57$YR$$M$Y$$$20240828$$MD$US$US
242608871$24260887$1$I$$20240824$20240828$20240828$EXP$$JP-SA-2024SA250605$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240829$$CN$JP$JP
242608881$24260888$1$I$$20240813$20240828$20240828$EXP$$CA-HLS-202402042$HLS THERAPEUTICS$$$$$M$Y$$$20240828$$HP$CA$CA
242608891$24260889$1$I$20240501$20240822$20240828$20240828$EXP$$US-ABBVIE-5892375$ABBVIE$$61$YR$$M$Y$$$20240828$$CN$US$US
242608902$24260890$2$F$20240101$20240807$20240828$20240905$PER$$US-JNJFOC-20240873192$JOHNSON AND JOHNSON$$51$YR$A$F$Y$78.912$KG$20240905$$CN$US$US
242608911$24260891$1$I$$20240813$20240828$20240828$EXP$$CA-HLS-202402041$HLS THERAPEUTICS$$$$A$$Y$$$20240828$$HP$CA$CA
242608921$24260892$1$I$$20240828$20240828$20240828$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-042705$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240829$$CN$CA$CA
242608931$24260893$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5893831$ABBVIE$$24$YR$$F$Y$$$20240828$$HP$US$US
242608942$24260894$2$F$20230320$20240819$20240828$20240831$EXP$$US-ABBVIE-5887157$ABBVIE$$33$YR$$F$Y$$$20240831$$CN$US$US
242608951$24260895$1$I$$20240827$20240828$20240828$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136704$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240829$$HP$US$US
242608961$24260896$1$I$$20240813$20240828$20240828$EXP$$CA-HLS-202402040$HLS THERAPEUTICS$$$$$F$Y$$$20240828$$HP$CA$CA
242608971$24260897$1$I$20230321$20240816$20240828$20240828$EXP$$DE-UCBSA-2024031426$UCB$$$$A$M$Y$$$20240829$$HP$DE$DE
242608981$24260898$1$I$$20240821$20240828$20240828$EXP$$GB-ABBVIE-5891179$ABBVIE$$$$A$M$Y$$$20240828$$CN$GB$GB
242608991$24260899$1$I$20240801$20240826$20240828$20240828$EXP$$US-ABBVIE-5896284$ABBVIE$$69$YR$$M$Y$$$20240828$$CN$US$US
242609001$24260900$1$I$$20240826$20240828$20240828$EXP$$US-ABBVIE-5897387$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242609011$24260901$1$I$$20240814$20240828$20240828$PER$$US-ABBVIE-5894810$ABBVIE$$56$YR$$F$Y$$$20240828$$HP$US$US
242609021$24260902$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5894308$ABBVIE$$42$YR$$F$Y$$$20240828$$HP$US$US
242609031$24260903$1$I$$20240813$20240828$20240828$EXP$$CA-HLS-202402039$HLS THERAPEUTICS$$$$A$$Y$$$20240828$$HP$CA$CA
242609042$24260904$2$F$20240826$20240909$20240828$20240910$30DAY$$US-SANDOZ INC.-SDZ2024US075818$SANDOZ$$39$YR$$M$Y$$$20240910$$HP$US$US
242609051$24260905$1$I$$20240826$20240828$20240828$EXP$$US-ABBVIE-5896650$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242609071$24260907$1$I$$20240826$20240828$20240828$EXP$$CA-ORGANON-O2408CAN002050$ORGANON$Unknown. Unknown. Unknown$4$YR$$M$Y$$$20240828$$HP$CA$CA
242609085$24260908$5$F$20210127$20240919$20240828$20240925$EXP$$US-009507513-2408USA005314$MERCK$$$$A$F$Y$$$20240925$$MD$US$US
242609091$24260909$1$I$$20240827$20240828$20240828$EXP$$US-ABBVIE-5898524$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242609101$24260910$1$I$$20240823$20240828$20240828$EXP$$US-SANDOZ INC.-SDZ2024US075188$SANDOZ$$$$$F$Y$$$20240828$$CN$US$US
242609111$24260911$1$I$$20240827$20240828$20240828$PER$$NVSC2024US173776$NOVARTIS$$$$$$Y$$$20240829$$MD$US$US
242609121$24260912$1$I$20240728$20240821$20240828$20240828$EXP$$CA-UCBSA-2024038347$UCB$$61$YR$$M$Y$$$20240829$$CN$CA$CA
242609141$24260914$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5894821$ABBVIE$$33$YR$$F$Y$$$20240828$$HP$US$US
242609152$24260915$2$F$$20240921$20240828$20240930$EXP$$US-JNJFOC-20240866472$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240930$$CN$US$US
242609171$24260917$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5894526$ABBVIE$$55$YR$$F$Y$$$20240828$$HP$US$US
242609181$24260918$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5894568$ABBVIE$$33$YR$$F$Y$$$20240828$$HP$US$US
242609201$24260920$1$I$$20240826$20240828$20240828$EXP$$US-ABBVIE-5896362$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242609211$24260921$1$I$$20240823$20240828$20240828$EXP$$CA-ORGANON-O2408CAN001806$ORGANON$Unknown. Unknown. Unknown$52$YR$$F$Y$$$20240828$$HP$CA$CA
242609221$24260922$1$I$20240627$20240826$20240828$20240828$EXP$$CA-ABBVIE-5896321$ABBVIE$$33$YR$$M$Y$$$20240828$$CN$CA$CA
242609231$24260923$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5893965$ABBVIE$$28$YR$$F$Y$$$20240828$$HP$US$US
242609242$24260924$2$F$20240801$20240904$20240828$20240911$EXP$$US-ABBVIE-5896732$ABBVIE$$47$YR$$F$Y$$$20240911$$CN$US$US
242609251$24260925$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5893949$ABBVIE$$58$YR$$F$Y$$$20240828$$HP$US$US
242609261$24260926$1$I$20240822$20240823$20240828$20240828$EXP$$FR-ABBVIE-5897017$ABBVIE$$88$YR$$F$Y$$$20240828$$HP$FR$FR
242609281$24260928$1$I$$20240826$20240828$20240828$PER$$US-AMGEN-USASP2024170022$AMGEN$$61$YR$A$M$Y$$$20240828$$CN$US$US
242609301$24260930$1$I$20240819$20240826$20240828$20240828$EXP$$DE-ABBVIE-5897313$ABBVIE$$83$YR$$M$Y$$$20240828$$CN$DE$DE
242609311$24260931$1$I$20230101$20240814$20240828$20240828$PER$$US-ABBVIE-5893973$ABBVIE$$75$YR$$F$Y$$$20240828$$HP$US$US
242609321$24260932$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249839$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240829$$MD$US$US
242609331$24260933$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249295$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240829$$MD$US$US
242609342$24260934$2$F$20240101$20240906$20240829$20240917$PER$$US-SA-2024SA249433$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240918$$MD$US$US
242609351$24260935$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249170$SANOFI AVENTIS$$16$YR$T$M$Y$58$KG$20240829$$MD$US$US
242609361$24260936$1$I$$20240821$20240829$20240829$EXP$$AU-SANDOZ INC.-SDZ2024AU075830$SANDOZ$$$$$F$Y$$$20240829$$HP$AU$AU
242609371$24260937$1$I$$20240813$20240829$20240829$PER$$US-ASTELLAS-2024-AER-001064$ASTELLAS$$$$A$F$Y$$$20240829$$MD$US$US
242609381$24260938$1$I$20240801$20240821$20240829$20240829$EXP$$US-GSK-US2024104510$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240829$$CN$US$US
242609392$24260939$2$F$$20240827$20240829$20240902$PER$$US-AMGEN-USASP2024169679$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242609401$24260940$1$I$$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171097$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242609412$24260941$2$F$20240221$20240903$20240829$20240906$PER$$US-AMGEN-USASP2024167712$AMGEN$$68$YR$E$F$Y$77$KG$20240906$$HP$US$US
242609421$24260942$1$I$20200925$20240825$20240829$20240829$EXP$$CA-TAKEDA-2024TUS086298$TAKEDA$$62$YR$$F$Y$$$20240829$$CN$CA$CA
242609431$24260943$1$I$$20240822$20240829$20240829$EXP$$RU-STRIDES ARCOLAB LIMITED-2024SP010667$STRIDES$Malyshev SM, Popov KD, Simakov KV, Marichev AO, Topuzova MP, Smirnova AY, et al.. [Status epilepticus in a pregnant patient with a previously unrecognized POLG-associated disease]. [Russian].. Zh-Nevropatol-Psikhiatr-Im-S-S-Korsakova. 2023;123 (10):129-135$33$YR$$F$Y$$$20240829$$HP$RU$RU
242609441$24260944$1$I$20231017$20240817$20240829$20240829$EXP$$PT-AUROBINDO-AUR-APL-2024-042350$AUROBINDO$$78$YR$$M$Y$$$20240829$$MD$PT$PT
242609451$24260945$1$I$$20240816$20240829$20240829$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-08416$LUPIN$$$$$$Y$$$20240829$$CN$AU$AU
242609462$24260946$2$F$20240101$20240918$20240829$20240927$EXP$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000734$DECIPHERA PHARMACEUTICALS$$75$YR$E$F$Y$$$20240927$$CN$US$US
242609472$24260947$2$F$20230925$20240905$20240829$20240913$30DAY$$US-AMGEN-USASP2024162944$AMGEN$$$$$$Y$$$20240912$$HP$US$US
242609482$24260948$2$F$20240823$20240830$20240829$20240902$PER$$US-AMGEN-USASP2024170619$AMGEN$$74$YR$E$F$Y$$$20240902$$HP$US$US
242609491$24260949$1$I$20240823$20240823$20240829$20240829$EXP$$CA-BIOGEN-2024BI01279912$BIOGEN$$58$YR$$F$Y$$$20240829$$CN$CA$CA
242609501$24260950$1$I$20240815$20240820$20240829$20240829$PER$$US-BIOGEN-2024BI01279296$BIOGEN$$13$YR$$M$Y$$$20240829$$CN$US$US
242609511$24260951$1$I$$20240822$20240829$20240829$EXP$$DE-BIOGEN-2024BI01279887$BIOGEN$$$$$F$Y$$$20240829$$MD$DE$DE
242609521$24260952$1$I$$20240823$20240829$20240829$EXP$$US-BIOGEN-2024BI01279899$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
242609531$24260953$1$I$$20240827$20240829$20240829$PER$$NVSC2024US174055$NOVARTIS$$3$YR$$M$Y$$$20240829$$CN$US$US
242609541$24260954$1$I$20240101$20240822$20240829$20240829$EXP$$US-SA-2024SA251006$SANOFI AVENTIS$$90$YR$E$M$Y$$$20240829$$MD$US$US
242609552$24260955$2$F$20240810$20240824$20240829$20240904$EXP$$NVSC2024CN173663$NOVARTIS$$82$YR$$M$Y$60$KG$20240904$$HP$CN$CN
242609563$24260956$3$F$20240820$20240906$20240829$20240910$PER$$US-AMGEN-USASP2024171701$AMGEN$$75$YR$E$M$Y$$$20240909$$PH$US$US
242609571$24260957$1$I$$20240823$20240829$20240829$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010794$STRIDES$Tang J, Lu P, Yang H, Qian H, Xi J, Shen J.. Death due to severe hypoglycemia caused by diclofenac sodium and lidocaine injection. [Chinese].. Advers-Drug-React-J. 2021;23 (6):324-325$53$YR$$M$Y$$$20240829$$HP$CN$CN
242609581$24260958$1$I$20240825$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170305$AMGEN$$74$YR$E$M$Y$$$20240828$$CN$US$US
242609591$24260959$1$I$$20240816$20240829$20240829$EXP$$US-INSMED, INC.-2024-03357-US$INSMED$$$$$F$Y$$$20240829$$CN$US$US
242609621$24260962$1$I$$20240826$20240829$20240829$PER$$NVSC2024US173021$NOVARTIS$$$$$$Y$$$20240829$$MD$US$US
242609631$24260963$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137050$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240829$$CN$US$US
242609641$24260964$1$I$20170301$20240820$20240829$20240829$EXP$BR-MLMSERVICE-20240812-PI160454-00059-1$BR-STRIDES ARCOLAB LIMITED-2024SP010565$STRIDES$Dutra RM, Pinto FPJ, Craveiro MMS, Baima JP, Saad-Hossne R, Romeiro FG, et al.. Risks and benefits of anti-TNF therapy for ulcerative colitis in a patient with autoimmune hepatitis-related cirrhosis: Case report.. Medicine. 2024;103(31):e39095$28$YR$$F$Y$$$20240829$$MD$BR$BR
242609651$24260965$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170178$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242609661$24260966$1$I$20240206$20240822$20240829$20240829$EXP$$DE-AMGEN-DEUNI2024043930$AMGEN$$79$YR$E$F$Y$57.2$KG$20240828$$MD$DE$DE
242609671$24260967$1$I$20240825$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171523$AMGEN$$79$YR$E$F$Y$$$20240828$$CN$US$US
242609681$24260968$1$I$20240101$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017034$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240829$$CN$US$US
242609691$24260969$1$I$$20240821$20240829$20240829$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000738$DECIPHERA PHARMACEUTICALS$$64$YR$A$M$Y$$$20240829$$CN$US$US
242609702$24260970$2$F$$20240917$20240829$20240927$PER$$US-GSK-US2024104410$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$HP$US$US
242609711$24260971$1$I$20240825$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024171599$AMGEN$$74$YR$E$F$Y$$$20240828$$PH$US$US
242609731$24260973$1$I$$20240821$20240829$20240829$EXP$$ZA-AstraZeneca-2024A193114$ASTRAZENECA$$85$YR$$M$Y$$$20240829$$CN$ZA$
242609741$24260974$1$I$$20240812$20240829$20240829$PER$$US-AstraZeneca-2024A183734$ASTRAZENECA$$70$YR$$M$Y$$$20240829$$CN$US$
242609751$24260975$1$I$20240810$20240820$20240829$20240829$EXP$$US-009507513-2408USA007246$MERCK$$29$YR$$$Y$$$20240829$$PH$US$US
242609761$24260976$1$I$20240819$20240823$20240829$20240829$EXP$$CN-AstraZeneca-2024A192962$ASTRAZENECA$$48$YR$$M$Y$100$KG$20240829$$MD$CN$
242609771$24260977$1$I$$20240822$20240829$20240829$EXP$$US-AstraZeneca-2024A192509$ASTRAZENECA$$$$$F$Y$$$20240829$$MD$US$
242609781$24260978$1$I$$20240817$20240829$20240829$PER$$US-AstraZeneca-2024A189806$ASTRAZENECA$$$$$$Y$$$20240829$$CN$US$
242609792$24260979$2$F$$20240821$20240829$20240913$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010767$STRIDES$Thurston L, Todd G, Parsapour S, Kong WM.. The complexities of managing neuropathic pain.. Br-J-Diabetes. 2024;24 (1):114$75$YR$$M$Y$$$20240913$$HP$GB$GB
242609801$24260980$1$I$$20240823$20240829$20240829$EXP$$US-JNJFOC-20240865759$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$HP$US$US
242609811$24260981$1$I$$20240816$20240829$20240829$PER$$US-AstraZeneca-2024A188049$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242609821$24260982$1$I$$20240826$20240829$20240829$EXP$$US-JNJFOC-20240868713$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240829$$HP$US$US
242609831$24260983$1$I$20240821$20240822$20240829$20240829$PER$$US-AstraZeneca-2024A192419$ASTRAZENECA$$60$YR$$F$Y$$$20240829$$CN$US$
242609841$24260984$1$I$20240801$20240820$20240829$20240829$EXP$$IE-JNJFOC-20240856796$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240829$$HP$IE$IE
242609851$24260985$1$I$20240803$20240826$20240829$20240829$EXP$$DE-JNJFOC-20240873269$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240829$$MD$DE$DE
242609861$24260986$1$I$$20240826$20240829$20240829$EXP$$AR-AstraZeneca-2024A194209$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$AR$
242609871$24260987$1$I$$20240826$20240829$20240829$EXP$$US-JNJFOC-20240868605$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240829$$PH$US$US
242609881$24260988$1$I$$20240813$20240829$20240829$PER$$US-AstraZeneca-2024A184816$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242609891$24260989$1$I$20240717$20240826$20240829$20240829$EXP$FR-AFSSAPS-LL2024001496$FR-JNJFOC-20240873802$JOHNSON AND JOHNSON$$78$YR$E$F$Y$80$KG$20240829$$PH$FR$FR
242609901$24260990$1$I$$20240826$20240829$20240829$EXP$$US-JNJFOC-20240869451$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242609911$24260991$1$I$20240815$20240816$20240829$20240829$PER$$US-AstraZeneca-2024A188120$ASTRAZENECA$$27504$DY$$M$Y$$$20240829$$CN$US$
242609921$24260992$1$I$$20240814$20240829$20240829$PER$$US-AstraZeneca-2024A186136$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242609931$24260993$1$I$$20240826$20240829$20240829$PER$$US-AstraZeneca-2024A194720$ASTRAZENECA$$13$YR$$F$Y$$$20240829$$MD$US$
242609941$24260994$1$I$$20240828$20240829$20240829$PER$$NVSC2024US173928$NOVARTIS$$31$YR$$M$Y$$$20240829$$CN$US$US
242609951$24260995$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174080$NOVARTIS$$64$YR$$F$Y$$$20240829$$CN$US$US
242609971$24260997$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174077$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242609983$24260998$3$F$$20240911$20240829$20240923$EXP$$AU-ROCHE-10000065727$ROCHE$$53$YR$A$F$Y$$$20240923$$MD$AU$AU
242609991$24260999$1$I$20240620$20240814$20240829$20240829$EXP$IT-MINISAL02-998909$IT-SERVIER-S24010290$SERVIER$$$$$$Y$$$20240829$$MD$IT$IT
242610001$24261000$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170168$AMGEN$$$$$$Y$$$20240828$$CN$US$US
242610011$24261001$1$I$$20240823$20240829$20240829$PER$$US-AMGEN-USASP2024169452$AMGEN$$$$E$F$Y$$$20240828$$MD$US$US
242610023$24261002$3$F$20240801$20240919$20240829$20240923$PER$$US-BIOGEN-2024BI01279797$BIOGEN$$30$YR$$F$Y$$$20240923$$CN$US$US
242610032$24261003$2$F$20230815$20240906$20240829$20240919$EXP$$DE-AUROBINDO-AUR-APL-2024-042281$AUROBINDO$$55$YR$$M$Y$$$20240919$$MD$DE$DE
242610041$24261004$1$I$$20240822$20240829$20240829$PER$$US-ROCHE-10000064810$ROCHE$$28$YR$A$F$Y$$$20240829$$CN$US$US
242610051$24261005$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017760$ELI LILLY AND CO$$$$$M$Y$$$20240829$$CN$US$US
242610061$24261006$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017384$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240829$$CN$US$US
242610071$24261007$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017593$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240829$$CN$US$US
242610082$24261008$2$F$20240826$20240911$20240829$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202408017272$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240912$$CN$US$US
242610091$24261009$1$I$20240701$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017037$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240829$$CN$US$US
242610101$24261010$1$I$$20240813$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017084$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240829$$CN$US$US
242610121$24261012$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017026$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240829$$CN$US$US
242610131$24261013$1$I$20230901$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017219$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240829$$CN$US$US
242610141$24261014$1$I$20240801$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136455$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240829$$CN$US$US
242610151$24261015$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136990$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240829$$CN$US$US
242610171$24261017$1$I$$20240822$20240829$20240829$EXP$$GB-ABBVIE-5898789$ABBVIE$$$$E$M$Y$$$20240829$$CN$GB$GB
242610181$24261018$1$I$$20240820$20240829$20240829$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000733$DECIPHERA PHARMACEUTICALS$$75$YR$E$M$Y$$$20240829$$HP$US$US
242610191$24261019$1$I$$20240822$20240829$20240829$PER$$US-AMGEN-USASP2024168207$AMGEN$$81$YR$E$F$Y$$$20240828$$CN$US$US
242610201$24261020$1$I$$20240820$20240829$20240829$EXP$$US-LUOXIN-LUX-2024-US-LIT-00047$LUOXIN AUROVITAS PHARMA(CHENGDU)$Chetana Shanmukhappa S, Kumar A, Dey A, JVS J, Lokeshwaran S, Kumar K S, et al. .Omalizumab rescue therapy in refractory status asthmaticus. .J-Asthma.2023;60 (12):2243-2247$39$YR$A$M$Y$58$KG$20240829$$MD$US$US
242610211$24261021$1$I$$20240820$20240829$20240829$EXP$$CA-Umedica-000100$UMEDICA LABS$ameron-Coffill KM, Ondiveeran HK, Walsh LD. A Case of Delayed and Persistent Carbamazepine Overdose Treated With Hemodialysis, Plasmapheresis, and Neostigmine. J Pharm Pract. 2024 Aug 14:8971900241273234. doi: 10.1177/08971900241273234.$61$YR$$F$Y$$$20240827$$HP$CA$
242610231$24261023$1$I$20240101$20240819$20240829$20240829$EXP$$US-JNJFOC-20240849214$JOHNSON AND JOHNSON$$$$A$F$Y$45.4$KG$20240829$$CN$US$US
242610241$24261024$1$I$$20240821$20240829$20240829$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP010761$STRIDES$Ribeiro R, Teixeira A, Lopes T, et al.. A Case of Acute Eosinophilic Pneumonia Associated With Non-steroidal Anti-inflammatory Drugs.. Cureus. 2024;16(1):e52159$77$YR$$F$Y$$$20240829$$HP$PT$PT
242610252$24261025$2$F$20240820$20240828$20240829$20240905$EXP$$TW-JNJFOC-20240854794$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$TW$TW
242610261$24261026$1$I$20240501$20240821$20240829$20240829$EXP$$CO-JNJFOC-20240861302$JOHNSON AND JOHNSON$$74$YR$E$F$Y$62$KG$20240829$$HP$CO$CO
242610271$24261027$1$I$$20240814$20240829$20240829$EXP$$US-ENDO USA, INC.-2024-003225$ENDO$$$$$$Y$$$20240829$$HP$US$US
242610281$24261028$1$I$20240820$20240827$20240829$20240829$EXP$$US-JNJFOC-20240870723$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$HP$US$US
242610291$24261029$1$I$20240101$20240815$20240829$20240829$EXP$$US-UCBSA-2024004039$UCB$$$$$F$Y$$$20240829$$CN$US$US
242610301$24261030$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017644$ELI LILLY AND CO$$$$A$F$Y$$$20240829$$CN$US$US
242610311$24261031$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016271$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240829$$CN$US$US
242610321$24261032$1$I$20240825$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016976$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240829$$CN$US$US
242610331$24261033$1$I$20240801$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017157$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240829$$CN$US$US
242610342$24261034$2$F$$20240821$20240829$20240903$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010785$STRIDES$Otero-Lobato M, Adeyemo A, Higley M, Lomax KG, Geldhof A, Esslinger S.. Exposure to golimumab during pregnancy: Results from the Company^s global safety database.. Pharmacol-Res-Perspect. 2024;12 (4)$$$$$Y$$$20240903$$HP$NL$NL
242610352$24261035$2$F$20240802$20240816$20240829$20240830$EXP$$US-FARMAPROD-202408-2811$DOMPE FARMACEUTICI$$79$YR$E$F$Y$53.07$KG$20240830$$CN$US$US
242610361$24261036$1$I$20240826$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171713$AMGEN$$35$YR$A$M$Y$$$20240829$$PH$US$US
242610371$24261037$1$I$$20240823$20240829$20240829$PER$$US-ROCHE-10000065885$ROCHE$$35$YR$A$M$Y$$$20240829$$CN$US$US
242610382$24261038$2$F$$20240821$20240829$20240903$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010783$STRIDES$Otero-Lobato M, Adeyemo A, Higley M, Lomax KG, Geldhof A, Esslinger S.. Exposure to golimumab during pregnancy: Results from the Company^s global safety database.. Pharmacol-Res-Perspect. 2024;12 (4)$$$$$Y$$$20240903$$HP$NL$NL
242610392$24261039$2$F$20210201$20240904$20240829$20240912$EXP$$US-JNJFOC-20240854698$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
242610401$24261040$1$I$$20240816$20240829$20240829$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-08417$LUPIN$$$$$$Y$$$20240829$$CN$AU$AU
242610411$24261041$1$I$$20240814$20240829$20240829$EXP$$US-ENDO USA, INC.-2024-003224$ENDO$$$$$$Y$$$20240829$$HP$US$US
242610421$24261042$1$I$20240821$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170176$AMGEN$$59$YR$A$F$Y$$$20240828$$PH$US$US
242610431$24261043$1$I$20240801$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170411$AMGEN$$29$YR$A$M$Y$$$20240828$$HP$US$US
242610441$24261044$1$I$20240824$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170742$AMGEN$$76$YR$E$F$Y$$$20240828$$CN$US$US
242610451$24261045$1$I$20240826$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171656$AMGEN$$65$YR$E$F$Y$$$20240829$$PH$US$US
242610461$24261046$1$I$$20240819$20240829$20240829$PER$$US-ROCHE-10000061882$ROCHE$Rashidi A, Wanchoo R, Izzedine H. How I Manage Hypertension and Proteinuria Associated with VEGF Inhibitor. Clinical Journal of the American Society of Nephrology. 2023-Jan;18 (1):121-3. doi:10.2215/CJN.05610522.$64$YR$A$F$Y$$$20240829$$MD$US$US
242610471$24261047$1$I$20240801$20240820$20240829$20240829$EXP$$US-ABBVIE-5894398$ABBVIE$$89$YR$$M$Y$$$20240829$$MD$US$US
242610481$24261048$1$I$$20240818$20240829$20240829$EXP$$VN-ROCHE-10000065361$ROCHE$$40$YR$A$F$Y$$$20240829$$MD$VN$VN
242610492$24261049$2$F$$20240909$20240829$20240917$EXP$$SG-ROCHE-10000060973$ROCHE$$75$YR$E$F$Y$44$KG$20240917$$CN$SG$SG
242610501$24261050$1$I$$20240824$20240829$20240829$EXP$$IN-ROCHE-10000067324$ROCHE$$74$YR$E$M$Y$$$20240829$$CN$IN$IN
242610511$24261051$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000068298$ROCHE$$58$YR$A$M$Y$$$20240829$$MD$US$US
242610533$24261053$3$F$$20240909$20240829$20240913$EXP$$US-GSK-US2024AMR104943$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
242610541$24261054$1$I$20230801$20240821$20240829$20240829$EXP$$MX-ROCHE-10000065053$ROCHE$$65$YR$E$F$Y$70$KG$20240829$$CN$MX$MX
242610551$24261055$1$I$$20240827$20240829$20240829$PER$$US-GILEAD-2024-0685483$GILEAD$$$$$M$Y$$$20240828$$MD$US$US
242610573$24261057$3$F$$20240821$20240829$20240905$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP010791$STRIDES$Otero-Lobato M, Adeyemo A, Higley M, Lomax KG, Geldhof A, Esslinger S.. Exposure to golimumab during pregnancy: Results from the Company^s global safety database.. Pharmacol-Res-Perspect. 2024;12 (4)$$$$$Y$$$20240905$$HP$NL$NL
242610581$24261058$1$I$20240812$20240816$20240829$20240829$EXP$$US-FARMAPROD-202407-2647$DOMPE FARMACEUTICI$$82$YR$E$F$Y$73.07$KG$20240829$$CN$US$US
242610591$24261059$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170939$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242610601$24261060$1$I$20240301$20240823$20240829$20240829$EXP$$AR-AMGEN-ARGSP2024171436$AMGEN$$68$YR$E$F$Y$$$20240828$$CN$AR$AR
242610611$24261061$1$I$$20240822$20240829$20240829$EXP$GB-MLMSERVICE-20240814-PI162489-00097-1$GB-STRIDES ARCOLAB LIMITED-2024SP010704$STRIDES$Edwards GM, Alejmi AA.. Pure red cell aplasia secondary to erythropoietin therapy.. Clinical Medicine, Journal of the Royal College of Physicians of London. 2024;24 (4):100229$$$$$Y$$$20240829$$MD$GB$GB
242610632$24261063$2$F$20240101$20240912$20240829$20240923$EXP$$CZ-NOVOPROD-1272231$NOVO NORDISK$$70$YR$$M$Y$91.5$KG$20240923$$MD$CZ$CZ
242610641$24261064$1$I$20240728$20240820$20240829$20240829$EXP$$GB-NOVOPROD-1271725$NOVO NORDISK$$44$YR$$F$Y$90$KG$20240829$$HP$GB$GB
242610651$24261065$1$I$20240809$20240820$20240829$20240829$EXP$BE-FAMHP-DHH-N2024-122509$BE-NOVOPROD-1272859$NOVO NORDISK$$56$YR$$F$Y$86$KG$20240829$$CN$BE$BE
242610661$24261066$1$I$20240615$20240820$20240829$20240829$EXP$FR-AFSSAPS-PV2024000760$FR-NOVOPROD-1272860$NOVO NORDISK$$44$YR$$F$Y$96.9$KG$20240829$$MD$FR$FR
242610671$24261067$1$I$20080101$20240820$20240829$20240829$EXP$$CO-NOVOPROD-1273823$NOVO NORDISK$$74$YR$$M$Y$75$KG$20240829$$CN$CO$CO
242610681$24261068$1$I$$20240820$20240829$20240829$EXP$$DE-NOVOPROD-1272902$NOVO NORDISK$$$$$M$Y$$$20240829$$PH$DE$DE
242610692$24261069$2$F$20240101$20240904$20240829$20240913$EXP$DE-CADRBFARM-2024329967$DE-NOVOPROD-1272853$NOVO NORDISK$$61$YR$$F$Y$86$KG$20240913$$MD$DE$DE
242610702$24261070$2$F$20160101$20240911$20240829$20240923$EXP$$EG-NOVOPROD-1272643$NOVO NORDISK$$856$MON$$F$Y$84$KG$20240923$$CN$EG$EG
242610721$24261072$1$I$20160101$20240819$20240829$20240829$EXP$$US-NOVOPROD-1274181$NOVO NORDISK$$62$YR$$F$Y$$$20240829$$CN$US$US
242610731$24261073$1$I$$20240819$20240829$20240829$EXP$$US-NOVOPROD-1272907$NOVO NORDISK$$52$YR$$$Y$$$20240829$$CN$US$US
242610741$24261074$1$I$20231026$20240819$20240829$20240829$EXP$$US-NOVOPROD-1273454$NOVO NORDISK$$56$YR$$F$Y$119.27$KG$20240829$$HP$US$US
242610751$24261075$1$I$20240507$20240816$20240829$20240829$EXP$$US-NOVOPROD-1273168$NOVO NORDISK$$$$$M$Y$$$20240829$$CN$US$US
242610761$24261076$1$I$20240601$20240819$20240829$20240829$EXP$$US-NOVOPROD-1273926$NOVO NORDISK$$48$YR$$F$Y$$$20240829$$CN$US$US
242610771$24261077$1$I$$20240819$20240829$20240829$EXP$$US-NOVOPROD-1272789$NOVO NORDISK$$$$A$F$Y$$$20240829$$CN$US$US
242610781$24261078$1$I$20231001$20240819$20240829$20240829$EXP$$CN-NOVOPROD-1271780$NOVO NORDISK$$66$YR$$M$Y$83$KG$20240829$$CN$CN$CN
242610791$24261079$1$I$$20240819$20240829$20240829$EXP$$GB-NOVOPROD-1272283$NOVO NORDISK$$$$A$F$Y$$$20240829$$HP$GB$GB
242610801$24261080$1$I$$20240819$20240829$20240829$EXP$$US-NOVOPROD-1272685$NOVO NORDISK$$$$$M$Y$$$20240829$$CN$US$US
242610811$24261081$1$I$20240819$20240819$20240829$20240829$EXP$$CN-NOVOPROD-1272418$NOVO NORDISK$$70$YR$$M$Y$90$KG$20240829$$CN$CN$CN
242610831$24261083$1$I$$20240815$20240829$20240829$EXP$$CO-NOVOPROD-1274891$NOVO NORDISK$$$$E$F$Y$$$20240829$$CN$CO$CO
242610841$24261084$1$I$$20240819$20240829$20240829$EXP$GB-MHRA-MED-202408192055433250-WRHCM$GB-NOVOPROD-1271381$NOVO NORDISK$$43$YR$$F$Y$100$KG$20240829$$CN$GB$GB
242610851$24261085$1$I$20240604$20240819$20240829$20240829$EXP$$US-NOVOPROD-1273167$NOVO NORDISK$$70$YR$$M$Y$$$20240829$$CN$US$US
242610862$24261086$2$F$20240705$20240828$20240829$20240909$EXP$$US-NOVOPROD-1273023$NOVO NORDISK$$59$YR$$F$Y$$$20240909$$CN$US$US
242610871$24261087$1$I$20100101$20240819$20240829$20240829$EXP$$US-NOVOPROD-1273043$NOVO NORDISK$$65$YR$$F$Y$$$20240829$$CN$US$US
242610881$24261088$1$I$20190101$20240819$20240829$20240829$EXP$$US-NOVOPROD-1273875$NOVO NORDISK$$65$YR$$F$Y$$$20240829$$CN$US$US
242610892$24261089$2$F$$20240905$20240829$20240916$EXP$$JP-AMGEN-JPNSP2024157214$AMGEN$$$$$$Y$$$20240915$$PH$JP$JP
242610901$24261090$1$I$$20240821$20240829$20240829$EXP$$US-SPECGX-T202401766$SPECGX$Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85$52$YR$$M$Y$$$20240829$$HP$US$US
242610921$24261092$1$I$$20240819$20240829$20240829$PER$$US-AMGEN-USASP2024168480$AMGEN$Arnold S. E.; Hendrix S.; Johnson J. N. et al.. Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer^s disease. Alzheimer^s and Dementia: Translational Research and Clinical Interventions. 2024;10 (3):1-13$$$$$Y$$$20240828$$HP$US$US
242610931$24261093$1$I$$20240816$20240829$20240829$EXP$816439$AU-LUPIN PHARMACEUTICALS INC.-2024-08380$LUPIN$$$$$$Y$$$20240829$$CN$AU$AU
242610941$24261094$1$I$$20240827$20240829$20240829$EXP$$IN-ROCHE-10000064069$ROCHE$$62$YR$A$M$Y$40$KG$20240829$$MD$IN$IN
242610951$24261095$1$I$20230808$20240814$20240829$20240829$EXP$$BR-SERVIER DO BRASIL-S24010435$SERVIER$$$$$$Y$$$20240829$$MD$BR$BR
242610961$24261096$1$I$$20240820$20240829$20240829$EXP$$US-JNJFOC-20240854277$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$MD$US$US
242610971$24261097$1$I$20240101$20240823$20240829$20240829$EXP$$US-JNJFOC-20240865822$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240829$$HP$US$US
242610981$24261098$1$I$20240622$20240826$20240829$20240829$EXP$$US-TAKEDA-2024TUS065779$TAKEDA$$1$YR$$F$Y$$$20240829$$MD$US$US
242610991$24261099$1$I$20240501$20240821$20240829$20240829$EXP$$DE-TAKEDA-2024TUS085812$TAKEDA$$74$YR$$M$Y$$$20240829$$HP$DE$DE
242611001$24261100$1$I$20240815$20240826$20240829$20240829$EXP$FR-AFSSAPS-RS2024000821$FR-JNJFOC-20240872043$JOHNSON AND JOHNSON$$64$YR$A$M$Y$76$KG$20240829$$MD$FR$FR
242611011$24261101$1$I$20230101$20240813$20240829$20240829$PER$$US-JNJFOC-20240834609$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240829$$CN$US$US
242611021$24261102$1$I$20240810$20240819$20240829$20240829$EXP$$CN-ROCHE-10000061442$ROCHE$$44$YR$A$F$Y$64.7$KG$20240829$$HP$CN$CN
242611031$24261103$1$I$$20240823$20240829$20240829$EXP$$IN-ROCHE-10000065410$ROCHE$$56$YR$A$F$Y$$$20240829$$CN$IN$IN
242611042$24261104$2$F$$20240828$20240829$20240903$PER$$US-CHATTEMPRD-2024OHG027214$CHATTEM$$$$E$M$Y$$$20240903$$HP$US$US
242611051$24261105$1$I$20240401$20240816$20240829$20240829$PER$$US-JNJFOC-20240849086$JOHNSON AND JOHNSON$$49$YR$A$F$Y$88$KG$20240829$$CN$US$US
242611061$24261106$1$I$$20240826$20240829$20240829$PER$$US-ROCHE-10000066894$ROCHE$$52$YR$A$F$Y$$$20240829$$CN$US$US
242611071$24261107$1$I$$20240828$20240829$20240829$PER$$US-ROCHE-10000068404$ROCHE$$$$C$M$Y$$$20240829$$CN$US$US
242611081$24261108$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000067888$ROCHE$$$$$M$Y$$$20240829$$CN$US$US
242611101$24261110$1$I$20240101$20240820$20240829$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009179$UNITED THERAPEUTICS$$$$$F$Y$81.633$KG$20240829$$$US$US
242611112$24261111$2$F$20240823$20240911$20240829$20240912$PER$$US-ROCHE-10000068027$ROCHE$$39$YR$A$M$Y$$$20240912$$CN$US$US
242611121$24261112$1$I$20240706$20240823$20240829$20240829$EXP$$CN-ROCHE-10000064621$ROCHE$$61$YR$A$M$Y$$$20240829$$HP$CN$CN
242611131$24261113$1$I$$20240826$20240829$20240829$PER$$US-ROCHE-10000067150$ROCHE$$3$MON$I$M$Y$$$20240829$$CN$US$US
242611141$24261114$1$I$20240817$20240827$20240829$20240829$PER$$US-ROCHE-10000067677$ROCHE$$2$YR$C$M$Y$$$20240829$$CN$US$US
242611154$24261115$4$F$20240827$20240829$20240829$20240902$EXP$$CA-ROCHE-10000068563$ROCHE$$36$YR$A$F$Y$$$20240902$$CN$CA$CA
242611161$24261116$1$I$$20240821$20240829$20240829$EXP$$TR-ROCHE-10000066515$ROCHE$$$$$$Y$$$20240829$$PH$TR$TR
242611171$24261117$1$I$20240216$20240821$20240829$20240829$EXP$$DE-ROCHE-10000064074$ROCHE$$46$YR$A$F$Y$60$KG$20240829$$MD$DE$DE
242611182$24261118$2$F$20240824$20240826$20240829$20240903$EXP$$US-ROCHE-10000066493$ROCHE$$89$YR$E$F$Y$$$20240903$$CN$US$US
242611192$24261119$2$F$$20240827$20240829$20240829$EXP$$CA-ROCHE-10000067644$ROCHE$$$$A$F$Y$$$20240829$$CN$CA$CA
242611201$24261120$1$I$$20240823$20240829$20240829$PER$$US-ROCHE-10000065689$ROCHE$$$$A$F$Y$$$20240829$$CN$US$US
242611211$24261121$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000068062$ROCHE$$31$YR$A$M$Y$$$20240829$$CN$US$US
242611242$24261124$2$F$$20240918$20240829$20240919$PER$$US-ROCHE-10000066860$ROCHE$$$$A$M$Y$$$20240919$$CN$US$US
242611251$24261125$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170121$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242611261$24261126$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024171670$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242611271$24261127$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170751$AMGEN$Kamel I. R.; Mohseni A.; Baghdadi A. et al.. Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy-an evaluation of volumetric imaging parameters. Abdominal Radiology. 2024;49(8):2595-2605$$$$$Y$$$20240828$$HP$US$US
242611281$24261128$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170786$AMGEN$Kamel I. R.; Mohseni A.; Baghdadi A. et al.. Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy-an evaluation of volumetric imaging parameters. Abdominal Radiology. 2024;49(8):2595-2605$$$$$Y$$$20240828$$HP$US$US
242611292$24261129$2$F$$20240826$20240829$20240902$PER$$US-ROCHE-10000067258$ROCHE$$$$$$Y$$$20240902$$CN$US$US
242611302$24261130$2$F$20240816$20240906$20240829$20240911$PER$$US-ROCHE-10000061515$ROCHE$$$$$F$Y$$$20240911$$CN$US$US
242611311$24261131$1$I$$20240822$20240829$20240829$EXP$$CA-ROCHE-10000063967$ROCHE$$42$YR$A$F$Y$$$20240829$$CN$CA$CA
242611321$24261132$1$I$$20240827$20240829$20240829$EXP$$US-ROCHE-10000067958$ROCHE$$38$YR$A$F$Y$$$20240829$$CN$US$US
242611331$24261133$1$I$20240818$20240827$20240829$20240829$PER$$US-ROCHE-10000067272$ROCHE$$19$YR$A$M$Y$$$20240829$$CN$US$US
242611341$24261134$1$I$$20240822$20240829$20240829$PER$$US-ROCHE-10000064687$ROCHE$$$$T$M$Y$$$20240829$$CN$US$US
242611351$24261135$1$I$$20240820$20240829$20240829$PER$$US-ROCHE-10000066113$ROCHE$$$$$M$Y$$$20240829$$CN$US$US
242611361$24261136$1$I$$20240826$20240829$20240829$PER$$US-ROCHE-10000067292$ROCHE$$$$$$Y$$$20240829$$CN$US$US
242611371$24261137$1$I$$20240826$20240829$20240829$PER$$US-ROCHE-10000066457$ROCHE$$$$E$F$Y$$$20240829$$CN$US$US
242611381$24261138$1$I$$20240825$20240829$20240829$EXP$$CA-ROCHE-10000066359$ROCHE$$$$A$M$Y$$$20240829$$CN$CA$CA
242611394$24261139$4$F$$20240903$20240829$20240915$PER$$US-ROCHE-10000064211$ROCHE$$$$E$F$Y$61.23$KG$20240916$$CN$US$US
242611401$24261140$1$I$$20240819$20240829$20240829$EXP$$US-ROCHE-10000061139$ROCHE$$89$YR$E$F$Y$$$20240829$$CN$US$US
242611412$24261141$2$F$$20240924$20240829$20240927$EXP$$BA-ROCHE-10000062726$ROCHE$$70$YR$E$F$Y$$$20240927$$MD$BA$BA
242611422$24261142$2$F$20240801$20240828$20240829$20240830$EXP$$US-ROCHE-10000067008$ROCHE$$62$YR$A$M$Y$$$20240830$$CN$US$US
242611431$24261143$1$I$$20240826$20240829$20240829$EXP$$IE-ROCHE-10000067408$ROCHE$$$$$F$Y$$$20240829$$CN$IE$IE
242611441$24261144$1$I$$20240826$20240829$20240829$EXP$$US-ROCHE-10000067065$ROCHE$$$$A$F$Y$$$20240829$$CN$US$US
242611451$24261145$1$I$$20240823$20240829$20240829$EXP$$US-ROCHE-10000023165$ROCHE$$41$YR$A$F$Y$$$20240829$$CN$US$US
242611461$24261146$1$I$20230630$20240819$20240829$20240829$EXP$$PT-AUROBINDO-AUR-APL-2024-042104$AUROBINDO$$3$YR$$M$Y$$$20240829$$MD$PT$PT
242611471$24261147$1$I$$20240825$20240829$20240829$PER$$US-LEO Pharma-373052$LEO PHARM$$68$YR$$F$Y$$$20240829$$CN$US$US
242611481$24261148$1$I$$20240819$20240829$20240829$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR103502$VIIV$$$$$M$Y$$$20240829$$MD$US$US
242611491$24261149$1$I$20220701$20240820$20240829$20240829$EXP$$JP-009507513-2404JPN002975J$MERCK$Fujita K, Yamada Y, Nishikimi S, Ogawa C, Kanao S, Sakou T, et al.. Lenvatinib and pembrolizumab combination therapy in 11 cases of recurrent endometrial cancer at our hospital. The Tokai journal of obstetrics and gynecology. 2024;60:269-77$71$YR$$F$Y$$$20240829$$MD$JP$JP
242611502$24261150$2$F$$20240826$20240829$20240902$EXP$$US-GSK-US2024AMR105360$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
242611511$24261151$1$I$20240811$20240821$20240829$20240829$EXP$$GB-AMGEN-GBRSP2024167420$AMGEN$$$$$F$Y$$$20240828$$MD$GB$GB
242611522$24261152$2$F$20240801$20240911$20240829$20240917$PER$$US-AMGEN-USASP2024167922$AMGEN$$72$YR$E$F$Y$$$20240917$$MD$US$US
242611531$24261153$1$I$20231001$20240823$20240829$20240829$EXP$$BR-ROCHE-10000066353$ROCHE$$55$YR$A$F$Y$$$20240829$$MD$BR$BR
242611541$24261154$1$I$$20240828$20240829$20240829$PER$$US-HALEON-2194154$Haleon PLC$$$$$$Y$$$20240829$$CN$US$US
242611551$24261155$1$I$20240821$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171715$AMGEN$$23$YR$A$F$Y$$$20240828$$CN$US$US
242611561$24261156$1$I$$20240824$20240829$20240829$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001734$BLUEPRINT MEDICINES$$$$$F$Y$$$20240829$$CN$US$US
242611571$24261157$1$I$20200615$20240819$20240829$20240829$EXP$$PL-AUROBINDO-AUR-APL-2024-042114$AUROBINDO$$44$YR$$F$Y$75$KG$20240829$$MD$PL$PL
242611581$24261158$1$I$20240801$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171577$AMGEN$$61$YR$A$M$Y$$$20240828$$CN$US$US
242611591$24261159$1$I$$20240821$20240829$20240829$EXP$$CA-ASTELLAS-2024-AER-002269$ASTELLAS$$61$YR$A$M$Y$$$20240829$$MD$CA$CA
242611611$24261161$1$I$$20240820$20240829$20240829$EXP$$AT-AMGEN-AUTSP2024171197$AMGEN$$$$E$F$Y$$$20240828$$MD$AT$AT
242611621$24261162$1$I$20240825$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024171222$AMGEN$$$$$M$Y$$$20240828$$CN$US$US
242611631$24261163$1$I$$20240819$20240829$20240829$EXP$$ES-MSNLABS-2024MSNLIT01853$MSN LABORATORIES$Posado-Dominguez L, Figuero-Perez L, Olivares-Hernandez A, Chinchilla-Tabora L, Antunez-Plaza P, Rivas-Hernandez R, Martin-Galache M, Redondo Gonzalez JC, Fonseca Sanchez E.Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review.Chinese Clinical Oncology.2024;13(3):1-7$$$$$Y$$$20240829$$MD$ES$ES
242611641$24261164$1$I$20240101$20240816$20240829$20240829$EXP$$NL-AUROBINDO-AUR-APL-2024-041901$AUROBINDO$$55$YR$$F$Y$52.1$KG$20240829$$MD$NL$NL
242611651$24261165$1$I$$20240819$20240829$20240829$EXP$$PL-AUROBINDO-AUR-APL-2024-042130$AUROBINDO$$20$YR$$M$Y$$$20240829$$MD$PL$PL
242611661$24261166$1$I$20080101$20240822$20240829$20240829$EXP$$FI-AMGEN-FINSP2024168672$AMGEN$Kaarniranta K.; Helotera H.; Siintamo L. et al.. Analysis of prognostic and predictive factors in neovascular age-related macular degeneration Kuopio cohort. Acta Ophthalmologica. 2024;102 (6):703-713$$$$$Y$$$20240828$$HP$FI$FI
242611671$24261167$1$I$$20240820$20240829$20240829$EXP$US-MLMSERVICE-20240813-PI161238-00204-1$US-STRIDES PHARMA UK LTD.-2024SP010610$STRIDES$Bhandari B, Siddique S, Tahir S, Link MG.. Loperamide-Induced Torsades de Pointes. Cureus. 2024;16(7):e64427$27$YR$$F$Y$$$20240829$$MD$US$US
242611682$24261168$2$F$20240101$20240904$20240829$20240909$PER$$US-AMGEN-USASP2024170655$AMGEN$$81$YR$E$F$Y$$$20240909$$CN$US$US
242611691$24261169$1$I$20231031$20240820$20240829$20240829$EXP$$BR-TAKEDA-2024TUS086491$TAKEDA$$$$$M$Y$$$20240829$$PH$BR$BR
242611701$24261170$1$I$20240801$20240819$20240829$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022010$UNITED THERAPEUTICS$$66$YR$$F$Y$49.66$KG$20240829$$$US$US
242611721$24261172$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170966$AMGEN$$$$$$Y$$$20240829$$CN$US$US
242611732$24261173$2$F$20240801$20240910$20240829$20240917$EXP$$MX-ROCHE-10000066176$ROCHE$$33$YR$A$M$Y$70$KG$20240917$$MD$MX$MX
242611741$24261174$1$I$20240401$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017486$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240829$$CN$US$US
242611751$24261175$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017149$ELI LILLY AND CO$$$$$M$Y$$$20240829$$CN$US$US
242611761$24261176$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017067$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240829$$CN$US$US
242611771$24261177$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016885$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240829$$CN$US$US
242611781$24261178$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042430$AUROBINDO$$67$YR$$F$Y$$$20240829$$HP$CA$CA
242611791$24261179$1$I$$20240820$20240829$20240829$EXP$$US-AMGEN-USASP2024167693$AMGEN$Alkabie S.; Diamond E. L.. Erdheim-Chester Disease Masquerading as CLIPPERS. Neurology Neuroimmunology + Neuroinflammation. 2024;11 (5):e200294 (1-4)$65$YR$E$M$Y$$$20240828$$MD$US$US
242611802$24261180$2$F$$20240911$20240829$20240912$PER$$NVSC2024US173902$NOVARTIS$$$$$$Y$$$20240912$$MD$US$US
242611811$24261181$1$I$$20240822$20240829$20240829$PER$$US-BIOGEN-2024BI01279714$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
242611821$24261182$1$I$$20240822$20240829$20240829$PER$$US-ROCHE-10000065205$ROCHE$$$$$$Y$$$20240829$$HP$US$US
242611831$24261183$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170780$AMGEN$Kamel I. R.; Mohseni A.; Baghdadi A. et al.. Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy-an evaluation of volumetric imaging parameters. Abdominal Radiology. 2024;49(8):2595-2605$$$$$Y$$$20240828$$HP$US$US
242611861$24261186$1$I$$20240823$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137042$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240829$$CN$US$US
242611871$24261187$1$I$20240813$20240823$20240829$20240829$EXP$$CN-JNJFOC-20240868437$JOHNSON AND JOHNSON$$7$YR$C$M$Y$25$KG$20240829$$HP$CN$CN
242611881$24261188$1$I$$20240823$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-135568$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240829$$HP$CA$CA
242611891$24261189$1$I$20240819$20240819$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132606$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$72.03$KG$20240829$$HP$US$US
242611902$24261190$2$F$$20240916$20240829$20240925$EXP$$US-INSMED, INC.-2024-03356-US$INSMED$$$$$$Y$$$20240925$$CN$US$US
242611922$24261192$2$F$20240601$20240903$20240829$20240906$EXP$$CN-TAKEDA-2024TUS084639$TAKEDA$$13$YR$$M$Y$$$20240906$$CN$CN$CN
242611931$24261193$1$I$$20240817$20240829$20240829$PER$$US-AstraZeneca-2024A189610$ASTRAZENECA$$$$$$Y$$$20240829$$CN$US$
242611943$24261194$3$F$20240811$20240903$20240829$20240909$30DAY$$US-AMGEN-USASP2024168845$AMGEN$$62$YR$A$M$Y$65.77$KG$20240909$$HP$US$US
242611951$24261195$1$I$20240101$20240826$20240829$20240829$EXP$$US-AMGEN-USASP2024170642$AMGEN$$$$A$F$Y$$$20240828$$HP$US$US
242611961$24261196$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042487$AUROBINDO$$54$YR$$F$Y$$$20240829$$HP$CA$CA
242611971$24261197$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042472$AUROBINDO$$61$YR$$M$Y$$$20240829$$HP$CA$CA
242611981$24261198$1$I$$20240826$20240829$20240829$EXP$$US-TAKEDA-2024TUS004476$TAKEDA$$$$$M$Y$$$20240829$$CN$US$US
242611991$24261199$1$I$20240822$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170371$AMGEN$$81$YR$E$M$Y$$$20240829$$CN$US$US
242612002$24261200$2$F$20240801$20240827$20240829$20240902$EXP$$US-ABBVIE-5892168$ABBVIE$$81$YR$$M$Y$$$20240902$$CN$US$US
242612011$24261201$1$I$$20240816$20240829$20240829$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-08419$LUPIN$$$$$$Y$$$20240829$$CN$AU$AU
242612021$24261202$1$I$20240101$20240828$20240829$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048392$BOEHRINGER INGELHEIM$$5$DEC$A$M$Y$$$20240829$$HP$US$US
242612031$24261203$1$I$20240706$20240819$20240829$20240829$EXP$$IT-AUROBINDO-AUR-APL-2024-042088$AUROBINDO$$73$YR$$M$Y$$$20240829$$MD$IT$IT
242612041$24261204$1$I$$20240823$20240829$20240829$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013631$JAZZ$$$$$F$Y$$$20240829$$MD$US$US
242612051$24261205$1$I$20240821$20240823$20240829$20240829$30DAY$$US-AMGEN-USASP2024169141$AMGEN$$49$YR$A$F$Y$67.1$KG$20240828$$PH$US$US
242612061$24261206$1$I$$20240817$20240829$20240829$PER$$US-JNJFOC-20240849188$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242612071$24261207$1$I$$20240816$20240829$20240829$EXP$$PT-AUROBINDO-AUR-APL-2024-041993$AUROBINDO$Correia I, E?a R, Barbosa MJ, Soares L, Monteiro M, Caixas U.. S?NDROME DE DRESS: UMA RESPOSTA SECUND?RIA RARA. 30?. (DRESS SYNDROME: A RARE SECONDARY RESPONSE. 30th). Congresso Nacional de Medicina Interna. 2024;846$30$YR$$M$Y$$$20240829$$MD$PT$PT
242612081$24261208$1$I$$20240813$20240829$20240829$PER$$US-ASTELLAS-2024-AER-001607$ASTELLAS$$7$DEC$E$M$Y$$$20240829$$MD$US$US
242612091$24261209$1$I$$20240828$20240829$20240829$PER$$NVSC2024US173898$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242612101$24261210$1$I$$20240818$20240829$20240829$PER$$US-AstraZeneca-2024A189608$ASTRAZENECA$$$$$$Y$$$20240829$$CN$US$
242612111$24261211$1$I$$20240823$20240829$20240829$PER$$US-ALXN-202408USA001703US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242612121$24261212$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170777$AMGEN$Kamel I. R.; Mohseni A.; Baghdadi A. et al.. Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy-an evaluation of volumetric imaging parameters. Abdominal Radiology. 2024;49(8):2595-2605$$$$$Y$$$20240828$$HP$US$US
242612131$24261213$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170772$AMGEN$Kamel I. R.; Mohseni A.; Baghdadi A. et al.. Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy-an evaluation of volumetric imaging parameters. Abdominal Radiology. 2024;49(8):2595-2605$$$$$Y$$$20240828$$HP$US$US
242612141$24261214$1$I$20240101$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171801$AMGEN$$58$YR$A$F$Y$$$20240828$$HP$US$US
242612151$24261215$1$I$20240601$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170018$AMGEN$$71$YR$E$M$Y$$$20240828$$CN$US$US
242612161$24261216$1$I$$20240823$20240829$20240829$PER$$US-GILEAD-2024-0685255$GILEAD$$$$$F$Y$$$20240829$$MD$US$US
242612171$24261217$1$I$20240724$20240827$20240829$20240829$EXP$$CN-BEIGENE-BGN-2024-013528$BEIGENE$$$$$$Y$$$20240829$$HP$CN$CN
242612181$24261218$1$I$$20240822$20240829$20240829$EXP$$BR-ROCHE-10000067394$ROCHE$Prestes-Carneiro L, Carrilho P, Torelli D, Bressa J, Parizi A, Vieira P. Infectious Diseases and Secondary Antibody Deficiency in Patients from a Mesoregion of Sao Paulo State, Brazil. Tropicalmedicine and infectious disease. 2024-May;9 (5):1-13. doi:10.3390/tropicalmed9050104.$$$$$Y$$$20240829$$HP$BR$BR
242612191$24261219$1$I$$20240822$20240829$20240829$EXP$$US-AMGEN-USASP2024169112$AMGEN$Caldera F.; Smith R. A.; Desai A. et al.. Patients with Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus. The American Journal of Gastroenterology. 2024;119 (8):1545-1554$$$$$Y$$$20240828$$MD$US$US
242612201$24261220$1$I$20240101$20240820$20240829$20240829$PER$$US-AstraZeneca-2024A190580$ASTRAZENECA$$76$YR$$F$Y$$$20240829$$CN$US$
242612211$24261221$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137111$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240829$$CN$US$US
242612221$24261222$1$I$20230310$20240826$20240829$20240829$EXP$$CO-UCBSA-2024043786$UCB$$65$YR$$F$Y$$$20240829$$CN$CO$CO
242612231$24261223$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042437$AUROBINDO$$40$YR$$M$Y$$$20240829$$MD$CA$CA
242612241$24261224$1$I$20240817$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170151$AMGEN$$60$YR$A$F$Y$$$20240828$$CN$US$US
242612261$24261226$1$I$$20240816$20240829$20240829$PER$$US-AstraZeneca-2024A189808$ASTRAZENECA$$$$$$Y$$$20240829$$CN$US$
242612271$24261227$1$I$20240815$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016269$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240829$$CN$US$US
242612282$24261228$2$F$$20240828$20240829$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-041151$AUROBINDO$Perry RM, Casey SD, Lee AQ, Bowditch SP, Rasmussen MA, Sethi V, et al.. SARS-CoV-2-Triggered Hemophagocytic Lymphohistiocytosis with Complications of Posterior Reversible Encephalopathy Syndrome. Case reports in pediatrics. 2024;2024:8829060$6$YR$$F$Y$$$20240910$$MD$US$US
242612292$24261229$2$F$$20240919$20240829$20240924$PER$$US-JAZZ PHARMACEUTICALS-2024-US-013527$JAZZ$$$$$F$Y$42.1$KG$20240923$$HP$US$US
242612301$24261230$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170944$AMGEN$$$$$$Y$$$20240829$$CN$US$US
242612312$24261231$2$F$20240823$20240828$20240829$20240904$PER$$US-AMGEN-USASP2024170308$AMGEN$$60$YR$A$F$Y$$$20240904$$CN$US$US
242612321$24261232$1$I$20230201$20240819$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041938$AUROBINDO$$32$YR$$F$Y$144$KG$20240829$$PH$GB$GB
242612331$24261233$1$I$20240810$20240817$20240829$20240829$PER$$US-AstraZeneca-2024A188632$ASTRAZENECA$$24710$DY$$F$Y$$$20240829$$CN$US$
242612341$24261234$1$I$20240501$20240821$20240829$20240829$EXP$$US-PFIZER INC-202400242218$PFIZER$$65$YR$$F$Y$$$20240829$$HP$US$US
242612351$24261235$1$I$20240808$20240823$20240829$20240829$EXP$$CN-PFIZER INC-PV202400110654$PFIZER$$85$YR$$M$Y$80$KG$20240829$$HP$CN$CN
242612361$24261236$1$I$$20240826$20240829$20240829$EXP$$TR-PFIZER INC-PV202400112066$PFIZER$$79$YR$$M$Y$$$20240829$$MD$TR$TR
242612372$24261237$2$F$$20240925$20240829$20240930$30DAY$$AT-UCBSA-2024043731$UCB$$$$$$Y$$$20240930$$CN$AT$AT
242612381$24261238$1$I$$20240816$20240829$20240829$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-08384$LUPIN$$65$YR$$M$Y$$$20240829$$CN$AU$AU
242612391$24261239$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017008$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240829$$CN$US$US
242612401$24261240$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016910$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242612411$24261241$1$I$$20240821$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202303010593$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240829$$CN$US$US
242612421$24261242$1$I$20240823$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016178$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240829$$CN$US$US
242612431$24261243$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017208$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242612441$24261244$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016873$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240829$$CN$US$US
242612451$24261245$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017226$ELI LILLY AND CO$$64$YR$A$$Y$$$20240829$$CN$US$US
242612461$24261246$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016896$ELI LILLY AND CO$$28$YR$A$M$Y$$$20240829$$CN$US$US
242612471$24261247$1$I$20240825$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016239$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240829$$CN$US$US
242612481$24261248$1$I$20240825$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016624$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240829$$CN$US$US
242612491$24261249$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017829$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242612502$24261250$2$F$$20240918$20240829$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202408016829$ELI LILLY AND CO$$59$YR$A$F$Y$81.466$KG$20240926$$MD$US$US
242612511$24261251$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016423$ELI LILLY AND CO$$57$YR$A$$Y$$$20240829$$CN$US$US
242612522$24261252$2$F$20240827$20240828$20240829$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016949$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240909$$CN$US$US
242612531$24261253$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017225$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240829$$CN$US$US
242612541$24261254$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017068$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242612551$24261255$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016788$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240829$$CN$US$US
242612561$24261256$1$I$20240801$20240822$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015944$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240829$$CN$US$US
242612571$24261257$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174027$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242612581$24261258$1$I$$20240827$20240829$20240829$PER$$NVSC2024US173695$NOVARTIS$$$$$M$Y$$$20240829$$HP$US$US
242612592$24261259$2$F$$20240828$20240829$20240830$PER$$NVSC2024US174014$NOVARTIS$$72$YR$$F$Y$$$20240830$$MD$US$US
242612601$24261260$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170763$AMGEN$Kamel I. R.; Mohseni A.; Baghdadi A. et al.. Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy-an evaluation of volumetric imaging parameters. Abdominal Radiology. 2024;49(8):2595-2605$$$$$Y$$$20240828$$HP$US$US
242612612$24261261$2$F$$20240827$20240829$20240829$PER$$NVSC2024US173849$NOVARTIS$$$$$M$Y$$$20240829$$HP$US$US
242612621$24261262$1$I$$20240827$20240829$20240829$PER$$NVSC2024US173692$NOVARTIS$$39$YR$$F$Y$$$20240829$$HP$US$US
242612631$24261263$1$I$$20240828$20240829$20240829$PER$$NVSC2024US173807$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242612651$24261265$1$I$20240601$20240827$20240829$20240829$EXP$$NVSJ2024JP010072$NOVARTIS$$56$YR$$M$Y$$$20240829$$MD$JP$JP
242612662$24261266$2$F$$20240828$20240829$20240829$PER$$NVSC2024US173783$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
242612671$24261267$1$I$$20240826$20240829$20240829$EXP$$NVSC2024US087975$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
242612682$24261268$2$F$$20240828$20240829$20240829$PER$$NVSC2024US173808$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
242612692$24261269$2$F$$20240829$20240829$20240906$EXP$$NVSJ2024JP009897$NOVARTIS$Fukuhara K, Tanaka Y, Saeki A, Kuroda R, Nishimura T, Ito T, et al.. Two cases of inoperable recurrent granulosa cell tumor responding to combination therapy with an aromatase inhibitor and a GnRH agonist. The journal of the Japan Society of Gynecologic Oncology. 2024;42(1):22-28$84$YR$$F$Y$$$20240906$$HP$JP$JP
242612701$24261270$1$I$$20240828$20240829$20240829$PER$$NVSC2024US173913$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242612711$24261271$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174021$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
242612721$24261272$1$I$$20240821$20240829$20240829$EXP$$US-SPECGX-T202401285$SPECGX$Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report. J Clin Oncol. 2003;21:4439-43$$$$$Y$$$20240829$$MD$US$US
242612731$24261273$1$I$$20240821$20240829$20240829$PER$$US-CHATTEMPRD-2024OHG028973$CHATTEM$$$$$F$Y$$$20240829$$CN$US$US
242612741$24261274$1$I$20240801$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171460$AMGEN$$16$YR$T$F$Y$$$20240829$$CN$US$US
242612761$24261276$1$I$20240127$20240814$20240829$20240829$EXP$$CN-UCBSA-2024041569$UCB$$0$YR$$F$Y$3.21$KG$20240829$$CN$CN$CN
242612771$24261277$1$I$20240109$20240814$20240829$20240829$EXP$$CN-UCBSA-2024041595$UCB$$$$N$F$Y$2.5$KG$20240829$$CN$CN$CN
242612781$24261278$1$I$20240701$20240815$20240829$20240829$EXP$GB-MHRA-MED-202408151146388200-FQHTC$GB-UCBSA-2024041571$UCB$$43$YR$$M$Y$$$20240829$$PH$GB$GB
242612791$24261279$1$I$20240101$20240817$20240829$20240829$EXP$$CA-UCBSA-2024042075$UCB$$$$$M$Y$$$20240829$$CN$CA$CA
242612801$24261280$1$I$20240101$20240819$20240829$20240829$EXP$$CA-UCBSA-2024019792$UCB$$$$$F$Y$$$20240829$$CN$CA$CA
242612812$24261281$2$F$20240821$20240913$20240829$20240919$EXP$$JP-JNJFOC-20240875075$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240919$$HP$JP$JP
242612821$24261282$1$I$$20240827$20240829$20240829$EXP$$NVSC2024CA173587$NOVARTIS$$$$$F$Y$$$20240829$$MD$CA$CA
242612831$24261283$1$I$$20240823$20240829$20240829$PER$$US-AMGEN-USASP2024169885$AMGEN$$$$$$Y$$$20240828$$MD$US$US
242612842$24261284$2$F$$20240827$20240829$20240830$EXP$$CA-HLS-202402164$HLS THERAPEUTICS$$$$A$M$Y$$$20240830$$PH$CA$CA
242612851$24261285$1$I$20240804$20240814$20240829$20240829$EXP$$CA-HLS-202402069$HLS THERAPEUTICS$$70$YR$E$F$Y$$$20240828$$HP$CA$CA
242612862$24261286$2$F$20240801$20240902$20240829$20240910$EXP$$IL-UNITED THERAPEUTICS-UNT-2024-026239$UNITED THERAPEUTICS$$68$YR$$F$Y$$$20240910$$MD$IL$IL
242612871$24261287$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170596$AMGEN$$$$A$F$Y$$$20240828$$MD$US$US
242612891$24261289$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017047$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240829$$CN$US$US
242612901$24261290$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017619$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240829$$HP$US$US
242612911$24261291$1$I$20240826$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017252$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240829$$PH$US$US
242612921$24261292$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016968$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240829$$CN$US$US
242612932$24261293$2$F$$20240920$20240829$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202408017120$ELI LILLY AND CO$$56$YR$A$F$Y$65.76$KG$20240925$$CN$US$US
242612941$24261294$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017539$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242612951$24261295$1$I$20240824$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016985$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240829$$CN$US$US
242612961$24261296$1$I$$20240822$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202404008625$ELI LILLY AND CO$$84$YR$E$$Y$$$20240829$$CN$US$US
242612971$24261297$1$I$20240801$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017229$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240829$$CN$US$US
242612981$24261298$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017057$ELI LILLY AND CO$$$$$$Y$$$20240829$$CN$US$US
242612991$24261299$1$I$$20240819$20240829$20240829$EXP$$AU-ASTELLAS-2024-AER-000597$ASTELLAS$$$$A$F$Y$$$20240829$$MD$AU$AU
242613001$24261300$1$I$$20240821$20240829$20240829$EXP$$US-SPECGX-T202401773$SPECGX$Crosby MM, Truver MT, Chronister CW, Hoyer JL, Kinsey AM, Brogan SC et al. Identification of 11-nor-delta8-tetrahydrocannabinol-9-carboxylic acid in postmortem urine. Journal of Analytical Toxicology. 2023;47(5):481-7$23$YR$$M$Y$$$20240829$$HP$US$US
242613011$24261301$1$I$20240816$20240820$20240829$20240829$PER$$US-SA-2024SA249806$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240829$$MD$US$US
242613021$24261302$1$I$20240101$20240819$20240829$20240829$PER$$US-SA-2024SA249474$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240829$$MD$US$US
242613031$24261303$1$I$20240101$20240819$20240829$20240829$PER$$US-SA-2023SA280912$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240829$$MD$US$US
242613051$24261305$1$I$20240101$20240820$20240829$20240829$PER$$US-SA-2024SA249751$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240829$$CN$US$US
242613061$24261306$1$I$$20240826$20240829$20240829$PER$$US-SA-2024SA251236$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240829$$CN$US$US
242613071$24261307$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA250304$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240829$$MD$US$US
242613081$24261308$1$I$20240101$20240820$20240829$20240829$PER$$US-SA-2024SA249380$SANOFI AVENTIS$$$$A$F$Y$$$20240829$$MD$US$US
242613091$24261309$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170769$AMGEN$Kamel I. R.; Mohseni A.; Baghdadi A. et al.. Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy-an evaluation of volumetric imaging parameters. Abdominal Radiology. 2024;49(8):2595-2605$$$$$Y$$$20240828$$HP$US$US
242613101$24261310$1$I$20240819$20240823$20240829$20240829$PER$$US-AMGEN-USASP2024169361$AMGEN$$86$YR$E$F$Y$$$20240828$$CN$US$US
242613111$24261311$1$I$20240801$20240822$20240829$20240829$EXP$$US-AMGEN-USASP2024169429$AMGEN$$$$$$Y$$$20240828$$HP$US$US
242613121$24261312$1$I$$20240821$20240829$20240829$PER$$US-CHATTEMPRD-2024OHG029058$CHATTEM$$8$YR$C$M$Y$$$20240829$$CN$US$US
242613131$24261313$1$I$$20240821$20240829$20240829$PER$$US-CHATTEMPRD-2024OHG029174$CHATTEM$Rodriguez R, Rodriguez PS, Rinaldi R, Galera A, Olivieri CL, Perez F, et al. A YOUNG WOMAN WITH POST-PRANDIAL ABDOMINAL PAIN. JACC. 2019;73(9)$36$YR$A$F$Y$$$20240829$$HP$US$US
242613141$24261314$1$I$20240825$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170494$AMGEN$$75$YR$E$M$Y$$$20240829$$CN$US$US
242613151$24261315$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024171259$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242613161$24261316$1$I$$20240819$20240829$20240829$EXP$$US-JNJFOC-20240846896$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$CN$US$US
242613171$24261317$1$I$$20240819$20240829$20240829$30DAY$$US-GSK-US2024AMR104086$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$US$US
242613181$24261318$1$I$$20240821$20240829$20240829$PER$$US-AMGEN-USASP2024168082$AMGEN$$$$$F$Y$$$20240828$$CN$US$US
242613192$24261319$2$F$20220101$20240917$20240829$20240927$EXP$$US-JUBILANT PHARMA LTD-2024US001230$JUBILANT$Gwynn N, Lindenmayer JP, Boes T, Pitalo C. Late Recognition of Cholinergic Delirium in Patient on Donepezil Combination Treatment.. Journal of clinical psychopharmacology. 2024$70$YR$$M$Y$$$20240927$$HP$US$US
242613211$24261321$1$I$20240818$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170558$AMGEN$$90$YR$E$M$Y$$$20240829$$CN$US$US
242613222$24261322$2$F$20240201$20240924$20240829$20240930$30DAY$$US-AMGEN-USASP2024167943$AMGEN$$60$YR$A$F$Y$65$KG$20240930$$HP$US$US
242613232$24261323$2$F$20240813$20240910$20240829$20240913$30DAY$$US-AMGEN-USASP2024168261$AMGEN$$85$YR$E$M$Y$71.655$KG$20240913$$HP$US$US
242613242$24261324$2$F$20240821$20240904$20240829$20240905$PER$$US-AMGEN-USASP2024170605$AMGEN$$39$YR$A$M$Y$$$20240905$$HP$US$US
242613251$24261325$1$I$$20240823$20240829$20240829$PER$$US-ROCHE-10000067573$ROCHE$$$$A$F$Y$$$20240829$$CN$US$US
242613262$24261326$2$F$20240401$20240829$20240829$20240901$PER$$US-AMGEN-USASP2024172062$AMGEN$$28$YR$A$$Y$$$20240901$$CN$US$US
242613271$24261327$1$I$$20240821$20240829$20240829$PER$$US-ROCHE-10000062945$ROCHE$$42$YR$A$F$Y$$$20240829$$CN$US$US
242613281$24261328$1$I$20240513$20240819$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041770$AUROBINDO$$$$$F$Y$$$20240829$$CN$GB$GB
242613291$24261329$1$I$20240821$20240821$20240829$20240829$EXP$$US-JNJFOC-20240860742$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240829$$MD$US$US
242613301$24261330$1$I$20080901$20240823$20240829$20240829$PER$$US-JNJFOC-20240868964$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240829$$LW$US$US
242613314$24261331$4$F$$20240909$20240829$20240920$EXP$$PL-AUROBINDO-AUR-APL-2024-042289$AUROBINDO$Nizinska I, Gattner K.. Zatrucie litem w przebiegu stosowania antagonistow receptora angiotensyny II oraz hydrochlorotiazydu. Opis dwoch przypadkow/Lithium intoxication in patients using angiotensin II receptor antagonists and hydrochlorothiazide: two case reports.. Farmakoterapia w Psychiatrii i Neurologii.. 2024;40(1):53-60$72$YR$$F$Y$$$20240920$$MD$PL$PL
242613321$24261332$1$I$$20240827$20240829$20240829$PER$$US-ABBVIE-5898075$ABBVIE$$$$$$Y$$$20240829$$CN$US$US
242613341$24261334$1$I$$20240826$20240829$20240829$PER$$US-ROCHE-10000067542$ROCHE$$$$E$F$Y$$$20240829$$CN$US$US
242613351$24261335$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000067572$ROCHE$$20$YR$A$F$Y$$$20240829$$HP$US$US
242613361$24261336$1$I$20240101$20240825$20240829$20240829$EXP$$IL-UCBSA-2024043754$UCB$$$$$F$Y$$$20240829$$MD$IL$IL
242613372$24261337$2$F$$20240822$20240829$20240829$EXP$$JP-SA-2024SA250521$SANOFI AVENTIS$$$$$$Y$$$20240829$$PH$JP$JP
242613382$24261338$2$F$$20240826$20240829$20240902$PER$$US-ALXN-202408USA001705US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240902$$CN$US$US
242613401$24261340$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136271$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$42.64$KG$20240829$$CN$US$US
242613412$24261341$2$F$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004419$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242613421$24261342$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137031$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240829$$CN$US$US
242613431$24261343$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136532$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$61.23$KG$20240829$$CN$US$US
242613441$24261344$1$I$20230101$20240826$20240829$20240829$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013590$JAZZ$$$$$M$Y$$$20240829$$CN$US$US
242613451$24261345$1$I$$20240817$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041677$AUROBINDO$$$$$F$Y$$$20240829$$CN$GB$GB
242613461$24261346$1$I$$20240824$20240829$20240829$EXP$$VN-AstraZeneca-2024A194091$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$VN$
242613471$24261347$1$I$20240814$20240821$20240829$20240829$EXP$$GB-AstraZeneca-2024A190700$ASTRAZENECA$$55$YR$$F$Y$$$20240829$$MD$GB$
242613481$24261348$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004426$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242613491$24261349$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004459$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242613501$24261350$1$I$$20240701$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005074$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613511$24261351$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004448$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$HP$US$US
242613521$24261352$1$I$20240219$20240806$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004428$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240829$$CN$US$US
242613531$24261353$1$I$20240805$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004429$ACADIA PHARMACEUTICALS$$56$YR$$M$Y$$$20240829$$CN$US$US
242613542$24261354$2$F$$20240831$20240829$20240925$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004461$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240925$$CN$US$US
242613551$24261355$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003704$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613561$24261356$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004457$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242613571$24261357$1$I$$20240806$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004430$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613581$24261358$1$I$20240703$20240806$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004401$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240829$$CN$US$US
242613591$24261359$1$I$20240803$20240806$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004395$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240829$$CN$US$US
242613602$24261360$2$F$$20240830$20240829$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004391$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
242613611$24261361$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004404$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613621$24261362$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5893880$ABBVIE$$67$YR$$F$Y$$$20240829$$HP$US$US
242613631$24261363$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004449$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613641$24261364$1$I$20240710$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004424$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240829$$CN$US$US
242613661$24261366$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004421$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240829$$CN$US$US
242613681$24261368$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004452$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242613691$24261369$1$I$20240728$20240806$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004403$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240829$$CN$US$US
242613702$24261370$2$F$20240526$20240905$20240829$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004397$ACADIA PHARMACEUTICALS$$37$YR$$F$Y$$$20240916$$CN$US$US
242613711$24261371$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004438$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613722$24261372$2$F$$20240912$20240829$20240920$PER$$US-HALEON-2194043$Haleon PLC$$$$$F$Y$$$20240920$$CN$US$US
242613731$24261373$1$I$$20240807$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004441$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613741$24261374$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004445$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613751$24261375$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004443$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242613761$24261376$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004446$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613771$24261377$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004456$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613791$24261379$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004394$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$HP$US$US
242613801$24261380$1$I$$20240806$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004422$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$HP$US$US
242613822$24261382$2$F$$20240909$20240829$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004454$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$CN$US$US
242613831$24261383$1$I$$20240813$20240829$20240829$PER$$US-ASTELLAS-2024-AER-001289$ASTELLAS$$$$E$F$Y$$$20240829$$HP$US$US
242613842$24261384$2$F$20240603$20240918$20240829$20240923$EXP$$JP-TAKEDA-2024TJP012618$TAKEDA$$9$DEC$$F$Y$$$20240923$$MD$JP$JP
242613851$24261385$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004451$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613862$24261386$2$F$20240701$20240910$20240829$20240912$EXP$$NVSC2024US172958$NOVARTIS$$49$YR$$F$Y$$$20240912$$CN$US$US
242613871$24261387$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004357$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613881$24261388$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004444$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613891$24261389$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004360$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613901$24261390$1$I$20231220$20240816$20240829$20240829$EXP$AU-TGA-0000808102$AU-COLLEGIUM PHARMACEUTICAL, INC.-20240800633$COLLEGIUM PHARMACEUTICAL$$$$$F$Y$$$20240828$$CN$AU$AU
242613912$24261391$2$F$$20240903$20240829$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004361$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242613921$24261392$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004358$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242613941$24261394$1$I$$20240823$20240829$20240829$PER$$US-ROCHE-10000066375$ROCHE$$$$$$Y$$$20240829$$PH$US$US
242613951$24261395$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004442$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242613961$24261396$1$I$20240501$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016240$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240829$$CN$US$US
242613974$24261397$4$F$$20240923$20240829$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202408017871$ELI LILLY AND CO$$75$YR$E$F$Y$57.17$KG$20240925$$CN$US$US
242613981$24261398$1$I$20240822$20240823$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016209$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240829$$CN$US$US
242613991$24261399$1$I$20240819$20240822$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015343$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240829$$CN$US$US
242614001$24261400$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016131$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240829$$CN$US$US
242614011$24261401$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016945$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240829$$CN$US$US
242614021$24261402$1$I$20240807$20240826$20240829$20240829$EXP$$NVSC2024US172372$NOVARTIS$$59$YR$$M$Y$$$20240829$$CN$US$US
242614032$24261403$2$F$$20240920$20240829$20240924$PER$$NVSC2024US173934$NOVARTIS$$$$$$Y$$$20240924$$HP$US$US
242614041$24261404$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004423$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242614051$24261405$1$I$20240708$20240827$20240829$20240829$EXP$$JP-TAKEDA-2024TJP012659$TAKEDA$$4$DEC$$F$Y$$$20240829$$MD$JP$JP
242614061$24261406$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004440$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242614071$24261407$1$I$$20240820$20240829$20240829$PER$$US-ABBVIE-5890960$ABBVIE$$$$$$Y$$$20240829$$MD$US$US
242614081$24261408$1$I$$20240826$20240829$20240829$PER$$US-ALXN-202408USA001683US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240829$$CN$US$US
242614091$24261409$1$I$$20240820$20240829$20240829$30DAY$$BR-SA-2024SA250794$SANOFI AVENTIS$$$$$$Y$$$20240829$$CN$BR$BR
242614102$24261410$2$F$20240703$20240904$20240829$20240913$EXP$$IT-AUROBINDO-AUR-APL-2024-042302$AUROBINDO$$91$YR$$M$Y$$$20240913$$PH$IT$IT
242614111$24261411$1$I$$20240819$20240829$20240829$PER$$US-SA-2024SA249838$SANOFI AVENTIS$$$$A$F$Y$102.95$KG$20240829$$MD$US$US
242614121$24261412$1$I$$20240823$20240829$20240829$PER$$US-ROCHE-10000065230$ROCHE$$46$YR$A$F$Y$$$20240829$$CN$US$US
242614131$24261413$1$I$20240820$20240820$20240829$20240829$PER$$US-SA-2024SA249489$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240829$$HP$US$US
242614141$24261414$1$I$20240801$20240820$20240829$20240829$PER$$US-SA-2024SA250349$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240829$$MD$US$US
242614151$24261415$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249299$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240829$$CN$US$US
242614161$24261416$1$I$20240625$20240821$20240829$20240829$EXP$$BE-JNJFOC-20240859361$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240829$$MD$BE$BE
242614171$24261417$1$I$20230101$20240819$20240829$20240829$PER$$US-SA-2024SA249858$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240829$$MD$US$US
242614181$24261418$1$I$20240801$20240820$20240829$20240829$PER$$US-SA-2024SA248894$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240829$$MD$US$US
242614191$24261419$1$I$$20240820$20240829$20240829$PER$$US-SA-2022SA082025$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240829$$CN$US$US
242614201$24261420$1$I$20240801$20240820$20240829$20240829$PER$$US-SA-2024SA249886$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240829$$CN$US$US
242614212$24261421$2$F$20240801$20240830$20240829$20240924$PER$$US-SA-2024SA234257$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240924$$MD$US$US
242614221$24261422$1$I$20240729$20240820$20240829$20240829$PER$$US-SA-2024SA249500$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240829$$PH$US$US
242614231$24261423$1$I$20240801$20240820$20240829$20240829$PER$$US-SA-2024SA249289$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240829$$CN$US$US
242614241$24261424$1$I$20240101$20240820$20240829$20240829$PER$$US-SA-2024SA249083$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240829$$MD$US$US
242614261$24261426$1$I$$20240822$20240829$20240829$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024105075$VIIV$$$$$$Y$$$20240829$$HP$US$US
242614271$24261427$1$I$$20240823$20240829$20240829$PER$$US-ROCHE-10000065535$ROCHE$$$$A$F$Y$$$20240829$$CN$US$US
242614281$24261428$1$I$$20240819$20240829$20240829$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000293$EMCURE$$$$$$Y$$$20240829$$HP$US$US
242614291$24261429$1$I$20240201$20240821$20240829$20240829$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000296$EMCURE$$$$$$Y$$$20240829$$CN$US$US
242614301$24261430$1$I$$20240820$20240829$20240829$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000297$EMCURE$Cunningham BW, Shah S, Biswas S.. Vancomycin Anaphylaxis and Kounis Syndrome Case Report. Cureus. 2024;16(7):e64740$67$YR$$M$Y$112$KG$20240829$$HP$US$US
242614312$24261431$2$F$$20240824$20240829$20240829$EXP$$JP-SA-2024SA250594$SANOFI AVENTIS$$$$$$Y$$$20240829$$MD$JP$JP
242614321$24261432$1$I$$20240820$20240829$20240829$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000299$EMCURE$Rechdan M, Svoboda S, Mojica R, Chung M, Motaparthi K, Saikaly SK.. Acute vesiculobullous eruption in lupus patient on trimethoprim-sulfamethoxazole. JAAD Case Reports. 2024;50:126-128$48$YR$$F$Y$$$20240829$$MD$US$US
242614331$24261433$1$I$$20240820$20240829$20240829$EXP$$US-GSK-US2024100812$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242614341$24261434$1$I$20240821$20240821$20240829$20240829$PER$$US-GE HEALTHCARE-2024CSU009617$GE HEALTHCARE$$25$YR$$F$Y$$$20240829$$HP$US$US
242614351$24261435$1$I$$20240822$20240829$20240829$EXP$$CA-ROCHE-10000063480$ROCHE$$71$YR$E$M$Y$$$20240829$$HP$CA$CA
242614361$24261436$1$I$20240705$20240822$20240829$20240829$EXP$$CN-SA-2024SA251437$SANOFI AVENTIS$$62$YR$A$M$Y$75$KG$20240829$$HP$CN$CN
242614371$24261437$1$I$$20240821$20240829$20240829$PER$$US-ROCHE-10000066043$ROCHE$$$$$M$Y$$$20240829$$CN$US$US
242614381$24261438$1$I$20240515$20240817$20240829$20240829$EXP$$FR-AUROBINDO-AUR-APL-2024-037761$AUROBINDO$$64$YR$$M$Y$82$KG$20240829$$MD$FR$FR
242614391$24261439$1$I$20240725$20240813$20240829$20240829$PER$$US-JNJFOC-20240833509$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240829$$HP$US$US
242614401$24261440$1$I$20240803$20240808$20240829$20240829$PER$$US-JNJFOC-20240827808$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$HP$US$US
242614411$24261441$1$I$$20240826$20240829$20240829$EXP$$JP-JNJFOC-20240872334$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$MD$JP$JP
242614421$24261442$1$I$$20240826$20240829$20240829$EXP$$JP-JNJFOC-20240874775$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240829$$PH$JP$JP
242614431$24261443$1$I$$20240827$20240829$20240829$EXP$$CN-JNJFOC-20240875786$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240829$$HP$CN$CN
242614441$24261444$1$I$$20240824$20240829$20240829$EXP$$US-JNJFOC-20240864629$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242614451$24261445$1$I$$20240820$20240829$20240829$PER$$US-ABBVIE-5890074$ABBVIE$$$$$$Y$$$20240829$$CN$US$US
242614461$24261446$1$I$20200614$20240819$20240829$20240829$EXP$$PL-AUROBINDO-AUR-APL-2024-042112$AUROBINDO$$53$YR$$F$Y$56$KG$20240829$$MD$PL$PL
242614472$24261447$2$F$$20240905$20240829$20240913$EXP$$CA-TOLMAR, INC.-24CA052015$TOLMAR$$$$$M$Y$$$20240913$$PH$CA$CA
242614481$24261448$1$I$$20240821$20240829$20240829$EXP$$CA-TOLMAR, INC.-24CA052016$TOLMAR$$$$$M$Y$$$20240829$$CN$CA$CA
242614491$24261449$1$I$$20240821$20240829$20240829$EXP$$CA-TOLMAR, INC.-24CA052021$TOLMAR$$$$$M$Y$$$20240829$$PH$CA$CA
242614501$24261450$1$I$$20240822$20240829$20240829$EXP$$CA-TOLMAR, INC.-24CA052083$TOLMAR$$$$$M$Y$$$20240829$$CN$CA$CA
242614511$24261451$1$I$$20240822$20240829$20240829$EXP$$CA-TOLMAR, INC.-24CA052084$TOLMAR$$$$$M$Y$$$20240829$$CN$CA$CA
242614521$24261452$1$I$$20240822$20240829$20240829$EXP$$CA-TOLMAR, INC.-24CA052085$TOLMAR$$$$$M$Y$$$20240829$$CN$CA$CA
242614531$24261453$1$I$$20240822$20240829$20240829$PER$$CA-TOLMAR, INC.-24CA052086$TOLMAR$$$$$M$Y$$$20240829$$CN$CA$CA
242614541$24261454$1$I$20240827$20240827$20240829$20240829$PER$$US-GILEAD-2024-0685525$GILEAD$$61$YR$A$M$Y$$$20240829$$CN$US$US
242614551$24261455$1$I$$20240822$20240829$20240829$EXP$$JP-AMGEN-JPNSP2024169984$AMGEN$$7$DEC$E$$Y$$$20240829$$MD$JP$JP
242614561$24261456$1$I$$20240802$20240829$20240829$PER$$US-UniquePharma-US-2024UPLSPO00027$UNIQUE PHARMACEUTICALS$$82$YR$E$F$Y$210$KG$20240829$$CN$US$US
242614581$24261458$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174127$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242614592$24261459$2$F$$20240906$20240829$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004363$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242614603$24261460$3$F$20240829$20240909$20240829$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136899$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$100.7$KG$20240912$$CN$US$US
242614611$24261461$1$I$$20240823$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135462$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240829$$HP$US$US
242614621$24261462$1$I$$20240819$20240829$20240829$EXP$$JP-ROCHE-10000065986$ROCHE$Yoshimatsu G, Ezaki A, Yamada T, Sakata N, Kodama S. 3 A case of pancreatic islet transplant in which immunosuppressives were discontinued due to function kidney decreased. Journal of Japanese Society of Tissue Transplantation / The 22nd Japanese Societ. 2024;22(1):72-73$48$YR$A$M$Y$$$20240829$$MD$JP$JP
242614632$24261463$2$F$20240101$20240904$20240829$20240913$EXP$$US-INSMED, INC.-2024-03030-US$INSMED$$$$$M$Y$$$20240913$$CN$US$US
242614641$24261464$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004389$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240829$$CN$US$US
242614652$24261465$2$F$$20240910$20240829$20240917$PER$$US-AMGEN-USASP2024169761$AMGEN$Zahner, S.. Recalcitrant cutaneous sarcoidosis treated with upadacitinib: Case report. JAAD Case Reports. 2024;51:7-9$56$YR$A$M$Y$$$20240916$$MD$US$US
242614661$24261466$1$I$20240728$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004372$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240829$$CN$US$US
242614672$24261467$2$F$$20240904$20240829$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004479$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242614682$24261468$2$F$$20240911$20240829$20240911$PER$$US-ALXN-202405USA000540US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
242614691$24261469$1$I$20200612$20240819$20240829$20240829$EXP$$PL-AUROBINDO-AUR-APL-2024-042119$AUROBINDO$$64$YR$$F$Y$60$KG$20240829$$MD$PL$PL
242614701$24261470$1$I$$20240815$20240829$20240829$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00406$MELINTA THERAPEUTICS$$$$$$Y$$$20240829$$CN$CN$CN
242614721$24261472$1$I$20240701$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004487$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240829$$CN$US$US
242614732$24261473$2$F$$20240919$20240829$20240925$PER$$US-ROCHE-10000067192$ROCHE$$43$YR$A$F$Y$$$20240925$$CN$US$US
242614741$24261474$1$I$20240818$20240826$20240829$20240829$EXP$$CO-UCBSA-2024043609$UCB$$13$YR$$F$Y$$$20240829$$CN$CO$CO
242614751$24261475$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042503$AUROBINDO$$66$YR$$M$Y$$$20240829$$HP$CA$CA
242614761$24261476$1$I$$20240828$20240829$20240829$EXP$$US-UCBSA-2024043773$UCB$$$$$M$Y$$$20240829$$CN$US$US
242614772$24261477$2$F$20240717$20240916$20240829$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137018$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240925$$CN$US$US
242614781$24261478$1$I$20240801$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004492$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240829$$CN$US$US
242614791$24261479$1$I$20240301$20240820$20240829$20240829$EXP$$DK-BAUSCH-BL-2024-012872$BAUSCH AND LOMB$$77$YR$$F$Y$72$KG$20240829$$MD$DK$DK
242614802$24261480$2$F$20240818$20240906$20240829$20240906$EXP$$JP-ABBVIE-5898503$ABBVIE$$62$YR$$F$Y$$$20240906$$PH$JP$JP
242614811$24261481$1$I$$20240821$20240829$20240829$EXP$$US-CHATTEMPRD-2024OHG029166$CHATTEM$$43$YR$A$M$Y$$$20240829$$LW$US$US
242614822$24261482$2$F$20230307$20240802$20240829$20240829$EXP$$US-ROCHE-10000067849$ROCHE$$62$YR$A$F$Y$$$20240829$$HP$US$US
242614831$24261483$1$I$$20240319$20240829$20240829$EXP$$CA-ROCHE-10000060857$ROCHE$$43$YR$A$F$Y$$$20240829$$CN$CA$CA
242614841$24261484$1$I$20240716$20240822$20240829$20240829$EXP$$PK-ROCHE-10000063935$ROCHE$$56$YR$A$M$Y$$$20240829$$CN$PK$PK
242614852$24261485$2$F$20240714$20240830$20240829$20240905$PER$$US-ROCHE-10000033393$ROCHE$$58$YR$A$F$Y$$$20240905$$CN$US$US
242614861$24261486$1$I$$20240816$20240829$20240829$EXP$$RU-MELINTA THERAPEUTICS, LLC-RU-MLNT-24-00400$MELINTA THERAPEUTICS$$$$$$Y$$$20240829$$MD$RU$RU
242614871$24261487$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017437$ELI LILLY AND CO$$65$YR$E$$Y$$$20240829$$CN$US$US
242614881$24261488$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016786$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240829$$CN$US$US
242614891$24261489$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016769$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240829$$CN$US$US
242614901$24261490$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016991$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240829$$CN$US$US
242614911$24261491$1$I$20240820$20240822$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408014606$ELI LILLY AND CO$$39$YR$A$$Y$$$20240829$$CN$US$US
242614921$24261492$1$I$$20240823$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015387$ELI LILLY AND CO$$65$YR$E$$Y$$$20240829$$CN$US$US
242614931$24261493$1$I$20240825$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016115$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240829$$CN$US$US
242614941$24261494$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042501$AUROBINDO$$71$YR$$M$Y$$$20240829$$HP$CA$CA
242614952$24261495$2$F$20240801$20240829$20240829$20240830$PER$$US-AMGEN-USASP2024170603$AMGEN$$77$YR$E$F$Y$$$20240830$$CN$US$US
242614961$24261496$1$I$$20240819$20240829$20240829$EXP$$US-GSK-US2024103373$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242614971$24261497$1$I$20231006$20240823$20240829$20240829$EXP$$US-CHATTEMPRD-2024OHG029597$CHATTEM$$70$YR$E$M$Y$$$20240829$$LW$US$US
242614981$24261498$1$I$$20240822$20240829$20240829$EXP$$US-CHATTEMPRD-2021SA003624$CHATTEM$$$$E$M$Y$$$20240829$$LW$US$US
242614992$24261499$2$F$$20240924$20240829$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136044$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$95.71$KG$20240926$$CN$US$US
242615001$24261500$1$I$20240818$20240821$20240829$20240829$EXP$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00404$MELINTA THERAPEUTICS$$$$$$Y$$$20240829$$CN$US$US
242615011$24261501$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136443$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240829$$CN$US$US
242615021$24261502$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136150$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240829$$HP$US$US
242615031$24261503$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136781$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240829$$HP$US$US
242615041$24261504$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135934$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240829$$CN$US$US
242615051$24261505$1$I$20240701$20240820$20240829$20240829$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-021403$UNITED THERAPEUTICS$$60$YR$$M$Y$$$20240829$$MD$JP$JP
242615061$24261506$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136176$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240829$$HP$US$US
242615071$24261507$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136605$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$87.09$KG$20240829$$CN$US$US
242615082$24261508$2$F$20240806$20240918$20240829$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024797$UNITED THERAPEUTICS$$59$YR$$M$Y$104.76$KG$20240927$$$US$US
242615092$24261509$2$F$20240201$20240905$20240829$20240913$EXP$$NL-ALK-ABELLO A/S-2024AA003272$ALK-ABELLO$$$$$$Y$$$20240913$$HP$NL$NL
242615101$24261510$1$I$$20240826$20240829$20240829$EXP$$US-CHATTEMPRD-2024OHG029588$CHATTEM$$$$$F$Y$$$20240829$$LW$US$US
242615111$24261511$1$I$20240508$20240826$20240829$20240829$EXP$$US-CHATTEMPRD-2024OHG029595$CHATTEM$$77$YR$E$M$Y$$$20240829$$LW$US$US
242615121$24261512$1$I$$20240822$20240829$20240829$PER$$US-ROCHE-10000065212$ROCHE$$$$A$F$Y$$$20240829$$CN$US$US
242615141$24261514$1$I$20240701$20240826$20240829$20240829$PER$$US-ABBVIE-5896034$ABBVIE$$34$YR$$M$Y$$$20240829$$CN$US$US
242615151$24261515$1$I$$20240819$20240829$20240829$EXP$$DE-JNJFOC-20240871375$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240829$$HP$DE$DE
242615161$24261516$1$I$$20240822$20240829$20240829$PER$$US-ROCHE-10000064768$ROCHE$$18$YR$A$F$Y$$$20240829$$CN$US$US
242615171$24261517$1$I$$20240806$20240829$20240829$PER$$AU-TOLMAR, INC.-24AU051730$TOLMAR$$$$$M$Y$$$20240829$$CN$AU$AU
242615181$24261518$1$I$20240101$20240806$20240829$20240829$PER$$BR-TOLMAR, INC.-24BR051725$TOLMAR$$12$YR$$F$Y$$$20240829$$MD$BR$BR
242615201$24261520$1$I$20240806$20240806$20240829$20240829$PER$$CA-TOLMAR, INC.-24CA051689$TOLMAR$$79$YR$$M$Y$$$20240829$$CN$CA$CA
242615211$24261521$1$I$20240805$20240808$20240829$20240829$PER$$CA-TOLMAR, INC.-24CA051802$TOLMAR$$76$YR$$M$Y$$$20240829$$CN$CA$CA
242615221$24261522$1$I$$20240806$20240829$20240829$PER$$CA-TOLMAR, INC.-24CA051641$TOLMAR$$$$$M$Y$$$20240829$$CN$CA$CA
242615232$24261523$2$F$$20240829$20240829$20240918$PER$$CA-TOLMAR, INC.-24CA051803$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
242615241$24261524$1$I$20240809$20240809$20240829$20240829$PER$$CA-TOLMAR, INC.-24CA051807$TOLMAR$$52$YR$$M$Y$$$20240829$$CN$CA$CA
242615251$24261525$1$I$20240809$20240809$20240829$20240829$PER$$CA-TOLMAR, INC.-24CA051827$TOLMAR$$90$YR$$M$Y$$$20240829$$CN$CA$CA
242615261$24261526$1$I$20240807$20240807$20240829$20240829$PER$$CA-TOLMAR, INC.-24CA052014$TOLMAR$$82$YR$$M$Y$$$20240829$$CN$CA$CA
242615271$24261527$1$I$20240809$20240809$20240829$20240829$PER$$CA-TOLMAR, INC.-24CA051830$TOLMAR$$70$YR$$M$Y$$$20240829$$CN$CA$CA
242615281$24261528$1$I$$20240809$20240829$20240829$PER$$DE-TOLMAR, INC.-24DE051567$TOLMAR$$$$$$Y$$$20240829$$PH$DE$DE
242615291$24261529$1$I$20240805$20240806$20240829$20240829$PER$$FR-TOLMAR, INC.-24FR051715$TOLMAR$$90$YR$$M$Y$$$20240829$$PH$FR$FR
242615311$24261531$1$I$20240805$20240809$20240829$20240829$PER$$FR-TOLMAR, INC.-24FR051717$TOLMAR$$81$YR$$M$Y$$$20240829$$PH$FR$FR
242615321$24261532$1$I$$20240826$20240829$20240829$PER$$US-ALXN-202408USA001673US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242615341$24261534$1$I$20240809$20240809$20240829$20240829$PER$$FR-TOLMAR, INC.-24FR051798$TOLMAR$$78$YR$$M$Y$$$20240829$$PH$FR$FR
242615351$24261535$1$I$$20240809$20240829$20240829$PER$$FR-TOLMAR, INC.-24FR051796$TOLMAR$$$$$M$Y$$$20240829$$PH$FR$FR
242615361$24261536$1$I$20240806$20240806$20240829$20240829$PER$$TR-TOLMAR, INC.-24TR051756$TOLMAR$$88$YR$$M$Y$$$20240829$$PH$TR$TR
242615371$24261537$1$I$$20240807$20240829$20240829$PER$$NL-TOLMAR, INC.-24NL051531$TOLMAR$$$$$M$Y$$$20240829$$HP$NL$NL
242615381$24261538$1$I$20240806$20240806$20240829$20240829$PER$$TR-TOLMAR, INC.-24TR051721$TOLMAR$$76$YR$$M$Y$$$20240829$$MD$TR$TR
242615391$24261539$1$I$$20240823$20240829$20240829$PER$$US-ROCHE-10000066282$ROCHE$$32$YR$A$M$Y$$$20240829$$CN$US$US
242615401$24261540$1$I$$20240823$20240829$20240829$PER$$US-ROCHE-10000065516$ROCHE$$$$A$F$Y$$$20240829$$CN$US$US
242615412$24261541$2$F$$20240902$20240829$20240903$PER$$NVSC2024US173721$NOVARTIS$$$$$$Y$$$20240903$$CN$US$US
242615421$24261542$1$I$20110415$20240823$20240829$20240829$EXP$$DE-BIOGEN-2024BI01280109$BIOGEN$$41$YR$$F$Y$$$20240829$$CN$DE$DE
242615432$24261543$2$F$20240822$20240910$20240829$20240918$EXP$$PE-ABBVIE-5897959$ABBVIE$$33$YR$$F$Y$$$20240918$$MD$PE$PE
242615442$24261544$2$F$20240822$20240823$20240829$20240919$PER$$US-ROCHE-10000065917$ROCHE$$29$YR$A$F$Y$68.04$KG$20240919$$CN$US$US
242615451$24261545$1$I$$20240823$20240829$20240829$PER$$US-ROCHE-10000065749$ROCHE$$$$E$M$Y$$$20240829$$CN$US$US
242615461$24261546$1$I$$20240826$20240829$20240829$PER$$US-ROCHE-10000067210$ROCHE$$67$YR$E$M$Y$$$20240829$$MD$US$US
242615471$24261547$1$I$20220308$20230329$20240829$20240829$EXP$$CA-CELLTRION INC.-2021CA019657$CELLTRION$$$$$$Y$$$20240829$$CN$CA$CA
242615481$24261548$1$I$$20240823$20240829$20240829$EXP$$JP-AMGEN-JPNSP2024171403$AMGEN$$8$DEC$E$M$Y$$$20240829$$MD$JP$JP
242615491$24261549$1$I$$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136992$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240829$$CN$US$US
242615501$24261550$1$I$$20240822$20240829$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-135695$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240829$$PH$JP$JP
242615511$24261551$1$I$$20240826$20240829$20240829$PER$$US-ROCHE-10000066608$ROCHE$$$$A$F$Y$$$20240829$$CN$US$US
242615521$24261552$1$I$$20240823$20240829$20240829$EXP$$CA-TAKEDA-2024TUS086029$TAKEDA$$$$$M$Y$$$20240829$$CN$CA$CA
242615531$24261553$1$I$$20240826$20240829$20240829$EXP$$HR-JNJFOC-20240872040$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$MD$HR$HR
242615541$24261554$1$I$20230705$20240826$20240829$20240829$EXP$$BE-AMGEN-BELSP2024170112$AMGEN$$51$YR$A$F$Y$54.1$KG$20240829$$MD$BE$BE
242615552$24261555$2$F$20240823$20240903$20240829$20240904$PER$$US-AMGEN-USASP2024170607$AMGEN$$57$YR$A$F$Y$$$20240904$$MD$US$US
242615561$24261556$1$I$$20240822$20240829$20240829$EXP$$CO-SANDOZ INC.-SDZ2024CO075680$SANDOZ$$$$$M$Y$61.8$KG$20240829$$CN$CO$CO
242615571$24261557$1$I$$20240819$20240829$20240829$EXP$$DE-AUROBINDO-AUR-APL-2024-042099$AUROBINDO$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$67$YR$$M$Y$$$20240829$$HP$DE$DE
242615581$24261558$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004488$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242615601$24261560$1$I$$20240823$20240829$20240829$PER$$US-ABBVIE-5893943$ABBVIE$$$$$$Y$$$20240829$$HP$US$US
242615611$24261561$1$I$20230601$20240820$20240829$20240829$EXP$$US-ROCHE-10000061992$ROCHE$$77$YR$E$M$Y$85.28$KG$20240829$$CN$US$US
242615621$24261562$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-001010$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242615631$24261563$1$I$$20240821$20240829$20240829$PER$$US-AstraZeneca-2024A191956$ASTRAZENECA$$67$YR$$M$Y$$$20240829$$MD$US$
242615651$24261565$1$I$$20240826$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US075772$SANDOZ$$$$$F$Y$54.55$KG$20240829$$CN$US$US
242615662$24261566$2$F$$20240911$20240829$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA056249$SANDOZ$$$$$M$Y$$$20240916$$MD$CA$CA
242615671$24261567$1$I$20240825$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016319$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240829$$CN$US$US
242615681$24261568$1$I$$20240821$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017322$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242615691$24261569$1$I$20240816$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016720$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242615701$24261570$1$I$20240826$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016561$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240829$$CN$US$US
242615711$24261571$1$I$$20240820$20240829$20240829$EXP$$US-009507513-2408USA007376$MERCK$$$$$M$Y$$$20240829$$PH$US$US
242615721$24261572$1$I$20230101$20240821$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408013742$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240829$$CN$US$US
242615731$24261573$1$I$20240822$20240822$20240829$20240829$EXP$$US-BIOGEN-2024BI01279743$BIOGEN$$24$YR$$F$Y$$$20240829$$CN$US$US
242615751$24261575$1$I$20151106$20240821$20240829$20240829$EXP$$CA-SANDOZ INC.-PHHY2015CA147774$SANDOZ$$56$YR$$F$Y$$$20240829$$CN$CA$CA
242615763$24261576$3$F$20240822$20240904$20240829$20240912$EXP$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00408$MELINTA THERAPEUTICS$$$$$$Y$$$20240912$$PH$US$US
242615771$24261577$1$I$$20240802$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07878$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242615781$24261578$1$I$$20240823$20240829$20240829$EXP$$CA-TAKEDA-2024TUS086115$TAKEDA$$$$$F$Y$$$20240829$$CN$CA$CA
242615791$24261579$1$I$20240825$20240826$20240829$20240829$EXP$$US-ABBVIE-5897333$ABBVIE$$52$YR$$M$Y$$$20240829$$CN$US$US
242615811$24261581$1$I$$20240823$20240829$20240829$EXP$$CA-TAKEDA-2024TUS086079$TAKEDA$$$$$F$Y$$$20240829$$CN$CA$CA
242615821$24261582$1$I$20240805$20240819$20240829$20240829$30DAY$$US-GSK-US2024103300$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240829$$CN$US$US
242615831$24261583$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5894541$ABBVIE$$30$YR$$F$Y$$$20240829$$HP$US$US
242615851$24261585$1$I$20240729$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004491$ACADIA PHARMACEUTICALS$$65$YR$$F$Y$$$20240829$$CN$US$US
242615861$24261586$1$I$$20240424$20240829$20240829$EXP$$CA-ROCHE-10000060839$ROCHE$$28$YR$A$F$Y$$$20240829$$HP$CA$CA
242615871$24261587$1$I$20240101$20240827$20240829$20240829$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012546$JAZZ$$$$$M$Y$$$20240829$$HP$US$US
242615881$24261588$1$I$$20240824$20240829$20240829$EXP$$CA-TAKEDA-2024TUS086386$TAKEDA$$$$$F$Y$$$20240829$$MD$CA$CA
242615891$24261589$1$I$$20240819$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041908$AUROBINDO$$52$YR$$M$Y$101$KG$20240829$$CN$GB$GB
242615902$24261590$2$F$$20240823$20240829$20240830$EXP$$US-CHATTEMPRD-2024OHG029473$CHATTEM$$80$YR$E$M$Y$$$20240830$$CN$US$US
242615921$24261592$1$I$20240727$20240807$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004490$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240829$$CN$US$US
242615931$24261593$1$I$20240101$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171528$AMGEN$$60$YR$A$M$Y$$$20240829$$HP$US$US
242615943$24261594$3$F$$20240917$20240829$20240919$EXP$$JP-GILEAD-2024-0685126$GILEAD$$77$YR$E$M$Y$$$20240919$$PH$JP$JP
242615951$24261595$1$I$$20240827$20240829$20240829$EXP$$NVSC2024US173526$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
242615963$24261596$3$F$20230901$20240920$20240829$20240925$EXP$$CA-TAKEDA-2024TUS086394$TAKEDA$$5$YR$$F$Y$$$20240925$$CN$CA$CA
242615971$24261597$1$I$$20240820$20240829$20240829$PER$$US-JNJFOC-20240867870$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242615981$24261598$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004494$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242615991$24261599$1$I$$20240807$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004473$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242616001$24261600$1$I$$20240828$20240829$20240829$EXP$$CA-HALEON-2193991$Haleon PLC$$$$$$Y$$$20240829$$CN$CA$CA
242616011$24261601$1$I$$20240821$20240829$20240829$EXP$$DE-BIOGEN-2024BI01279710$BIOGEN$$$$A$F$Y$$$20240829$$MD$DE$DE
242616032$24261603$2$F$$20240916$20240829$20240920$EXP$$US-BIOGEN-2024BI01279732$BIOGEN$$$$$M$Y$$$20240920$$CN$US$US
242616041$24261604$1$I$20240528$20240822$20240829$20240829$EXP$$NL-BIOGEN-2024BI01279886$BIOGEN$$51$YR$$F$Y$$$20240829$$CN$NL$NL
242616052$24261605$2$F$20240801$20240826$20240829$20240830$PER$$US-BIOGEN-2024BI01279983$BIOGEN$$81$YR$$F$Y$$$20240830$$CN$US$US
242616061$24261606$1$I$$20240822$20240829$20240829$EXP$$US-BIOGEN-2024BI01279740$BIOGEN$$$$$F$Y$$$20240829$$HP$US$US
242616072$24261607$2$F$$20240904$20240829$20240906$PER$$US-BIOGEN-2023BI01216531$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242616081$24261608$1$I$20231201$20240821$20240829$20240829$EXP$$DE-BIOGEN-2024BI01279437$BIOGEN$$$$$F$Y$$$20240828$$CN$DE$DE
242616092$24261609$2$F$$20240827$20240829$20240903$EXP$$US-BIOGEN-2024BI01279509$BIOGEN$$$$$F$Y$$$20240903$$HP$US$US
242616101$24261610$1$I$20240701$20240821$20240829$20240829$EXP$$US-BIOGEN-2024BI01263103$BIOGEN$$41$YR$$F$Y$$$20240828$$CN$US$US
242616111$24261611$1$I$$20240819$20240829$20240829$30DAY$$US-GSK-US2024103415$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242616121$24261612$1$I$$20240819$20240829$20240829$30DAY$$US-GSK-US2024103292$GLAXOSMITHKLINE$$$$$M$Y$$$20240829$$CN$US$US
242616132$24261613$2$F$$20240920$20240829$20240923$EXP$$DE-SANDOZ INC.-SDZ2024DE075548$SANDOZ$$80$YR$$M$Y$69$KG$20240923$$HP$DE$DE
242616142$24261614$2$F$$20240819$20240829$20240903$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-131900$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$97$KG$20240903$$HP$CA$CA
242616161$24261616$1$I$20240804$20240823$20240829$20240829$EXP$DE-BFARM-24005829$DE-AMGEN-DEUSP2024169181$AMGEN$$84$YR$E$M$Y$90$KG$20240829$$MD$DE$DE
242616171$24261617$1$I$$20240805$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07932$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242616181$24261618$1$I$20240826$20240826$20240829$20240829$EXP$GB-MHRA-MED-202408261025433370-CNBJH$GB-ABBVIE-5898146$ABBVIE$$50$YR$$M$Y$$$20240829$$MD$GB$GB
242616191$24261619$1$I$$20240822$20240829$20240829$EXP$$US-AstraZeneca-2024A192340$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242616201$24261620$1$I$20240720$20240821$20240829$20240829$EXP$$US-EMD Serono-2024045166$EMD SERONO INC$$$$$F$Y$$$20240829$$HP$US$US
242616211$24261621$1$I$$20240822$20240829$20240829$PER$$US-HALEON-2193636$Haleon PLC$$36$YR$$F$Y$$$20240829$$HP$US$US
242616221$24261622$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004499$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242616231$24261623$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004496$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242616241$24261624$1$I$20240101$20240826$20240829$20240829$EXP$$US-ABBVIE-5896582$ABBVIE$$53$YR$$F$Y$$$20240829$$CN$US$US
242616251$24261625$1$I$20240628$20240822$20240829$20240829$EXP$$US-SA-2024SA251011$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240829$$MD$US$US
242616261$24261626$1$I$$20240816$20240829$20240829$PER$$US-SA-2024SA246467$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240829$$MD$US$US
242616271$24261627$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249118$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240829$$MD$US$US
242616281$24261628$1$I$20240808$20240820$20240829$20240829$PER$$US-SA-2024SA249062$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240829$$MD$US$US
242616291$24261629$1$I$20240401$20240821$20240829$20240829$EXP$$US-SA-2024SA249989$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240829$$CN$US$US
242616301$24261630$1$I$$20240819$20240829$20240829$PER$$US-SA-2024SA248186$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240829$$MD$US$US
242616311$24261631$1$I$20240101$20240816$20240829$20240829$PER$$US-SA-2024SA246283$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240829$$MD$US$US
242616321$24261632$1$I$$20240812$20240829$20240829$30DAY$$ES-SA-2024SA251081$SANOFI AVENTIS$$$$$$Y$$$20240829$$PH$ES$ES
242616331$24261633$1$I$20240101$20240826$20240829$20240829$EXP$$US-ABBVIE-5896911$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242616341$24261634$1$I$$20240819$20240829$20240829$EXP$$US-SA-2024SA249915$SANOFI AVENTIS$$$$E$M$Y$116.5$KG$20240829$$MD$US$US
242616351$24261635$1$I$20240819$20240827$20240829$20240829$EXP$$CN-ROCHE-10000068008$ROCHE$$63$YR$A$F$Y$86$KG$20240829$$HP$CN$CN
242616361$24261636$1$I$$20240828$20240829$20240829$EXP$$GB-GILEAD-2024-0685575$GILEAD$$$$$M$Y$$$20240829$$CN$GB$GB
242616372$24261637$2$F$20240812$20240820$20240829$20240925$PER$$US-SA-2024SA248753$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240925$$MD$US$US
242616381$24261638$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA250253$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240829$$MD$US$US
242616391$24261639$1$I$20240101$20240819$20240829$20240829$PER$$US-SA-2024SA249348$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240829$$CN$US$US
242616401$24261640$1$I$20240101$20240815$20240829$20240829$PER$$US-SA-2024SA247852$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240829$$MD$US$US
242616412$24261641$2$F$$20240913$20240829$20240917$EXP$$JP-SA-2024SA247188$SANOFI AVENTIS$$$$$$Y$$$20240918$$MD$JP$JP
242616421$24261642$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA248623$SANOFI AVENTIS$$$$A$$Y$$$20240829$$HP$US$US
242616431$24261643$1$I$20240101$20240819$20240829$20240829$PER$$US-SA-2024SA248778$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240829$$MD$US$US
242616441$24261644$1$I$20240101$20240816$20240829$20240829$PER$$US-SA-2024SA248389$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240829$$MD$US$US
242616451$24261645$1$I$$20240816$20240829$20240829$PER$$US-SA-2024SA245925$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240829$$MD$US$US
242616461$24261646$1$I$20240501$20240820$20240829$20240829$PER$$US-SA-2024SA249881$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240829$$MD$US$US
242616472$24261647$2$F$20240101$20240830$20240829$20240904$EXP$$US-ABBVIE-5897014$ABBVIE$$$$$M$Y$70.76$KG$20240904$$CN$US$US
242616481$24261648$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA248666$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240829$$MD$US$US
242616491$24261649$1$I$20240801$20240820$20240829$20240829$PER$$US-SA-2024SA249972$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240829$$MD$US$US
242616501$24261650$1$I$$20240819$20240829$20240829$PER$$US-SA-2024SA248794$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240829$$MD$US$US
242616511$24261651$1$I$$20240819$20240829$20240829$PER$$US-SA-2024SA249098$SANOFI AVENTIS$$$$A$F$Y$62.5$KG$20240829$$MD$US$US
242616521$24261652$1$I$20240601$20240819$20240829$20240829$PER$$US-SA-2024SA248686$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240829$$MD$US$US
242616531$24261653$1$I$20240101$20240820$20240829$20240829$PER$$US-SA-2024SA249895$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240829$$MD$US$US
242616541$24261654$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA250055$SANOFI AVENTIS$$$$A$M$Y$70.7$KG$20240829$$MD$US$US
242616561$24261656$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004489$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242616571$24261657$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004425$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242616581$24261658$1$I$$20240825$20240829$20240829$EXP$$EG-AMGEN-EGYSP2024042850$AMGEN$$57$YR$A$F$Y$$$20240829$$CN$EG$EG
242616591$24261659$1$I$$20240820$20240829$20240829$PER$$US-RDY-SPO/USA/24/0012311$DR REDDYS$$$$$$Y$$$20240829$$MD$US$US
242616601$24261660$1$I$20240601$20240826$20240829$20240829$EXP$$US-ABBVIE-5896657$ABBVIE$$87$YR$$M$Y$$$20240829$$CN$US$US
242616611$24261661$1$I$20240714$20240819$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041926$AUROBINDO$$$$$F$Y$$$20240829$$CN$GB$GB
242616622$24261662$2$F$$20240904$20240829$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004427$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242616642$24261664$2$F$$20240910$20240829$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004434$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
242616651$24261665$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004432$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242616661$24261666$1$I$20240805$20240807$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004411$ACADIA PHARMACEUTICALS$$84$YR$$F$Y$$$20240829$$CN$US$US
242616671$24261667$1$I$$20240807$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004418$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242616681$24261668$1$I$20240601$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004431$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240829$$CN$US$US
242616701$24261670$1$I$20240820$20240826$20240829$20240829$EXP$$US-ABBVIE-5896859$ABBVIE$$54$YR$$F$Y$$$20240829$$CN$US$US
242616711$24261671$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004530$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242616721$24261672$1$I$20190101$20240826$20240829$20240829$EXP$$AU-ABBVIE-5895185$ABBVIE$$$$$F$Y$$$20240829$$CN$AU$AU
242616731$24261673$1$I$$20240807$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004433$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242616742$24261674$2$F$$20240924$20240829$20240927$EXP$$CA-TAKEDA-2024TUS086390$TAKEDA$$$$$F$Y$$$20240927$$MD$CA$CA
242616751$24261675$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170659$AMGEN$$$$$$Y$$$20240829$$CN$US$US
242616761$24261676$1$I$20240826$20240826$20240829$20240829$EXP$$US-ABBVIE-5897229$ABBVIE$$68$YR$$F$Y$$$20240829$$CN$US$US
242616771$24261677$1$I$$20240827$20240829$20240829$EXP$FR-AFSSAPS-PB2024000897$FR-ORGANON-O2408FRA001982$ORGANON$$63$YR$$M$Y$$$20240829$$PH$FR$FR
242616781$24261678$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017321$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240829$$CN$US$US
242616791$24261679$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016934$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240829$$CN$US$US
242616801$24261680$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016953$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242616811$24261681$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017049$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240829$$CN$US$US
242616821$24261682$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017426$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242616831$24261683$1$I$$20240821$20240829$20240829$EXP$$DE-JNJFOC-20240857098$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$MD$DE$DE
242616841$24261684$1$I$20200101$20240823$20240829$20240829$EXP$GB-MHRA-MED-202408221012549690-PRGVD$GB-CHEPLA-2024010955$CHEPLAPHARM$$63$YR$$F$Y$80$KG$20240829$$CN$COUNTRY NOT SPECIFIED$GB
242616851$24261685$1$I$$20240822$20240829$20240829$EXP$$US-CHEPLA-2024011018$CHEPLAPHARM$$$$$F$Y$$$20240829$$HP$COUNTRY NOT SPECIFIED$US
242616861$24261686$1$I$$20240826$20240829$20240829$EXP$$US-JNJFOC-20240869841$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240829$$HP$US$US
242616871$24261687$1$I$$20240823$20240829$20240829$EXP$$GR-CHEPLA-2024010981$CHEPLAPHARM$Kofopoulos Lymperis E. RARE GASTROINTESTINAL ANASTOMOTIC LEAKAGE COMPLICATION AFTER RECEIVING CHEMOTHERAPY. 33rd PANHELLENIC SURGICAL CONGRESS AND INTERNATIONAL SURGICAL FORUM.2023:470.$67$YR$$F$Y$$$20240829$$MD$COUNTRY NOT SPECIFIED$GR
242616881$24261688$1$I$$20240823$20240829$20240829$EXP$$US-CHEPLA-2024011053$CHEPLAPHARM$$$$E$M$Y$123.8$KG$20240829$$HP$COUNTRY NOT SPECIFIED$US
242616891$24261689$1$I$$20240823$20240829$20240829$EXP$$CA-CHEPLA-2024010888$CHEPLAPHARM$$65$YR$$F$Y$34$KG$20240829$$HP$COUNTRY NOT SPECIFIED$CA
242616901$24261690$1$I$$20240806$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004405$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242616911$24261691$1$I$$20240826$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US075807$SANDOZ$$$$$F$Y$69.55$KG$20240829$$CN$US$US
242616921$24261692$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004406$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242616931$24261693$1$I$$20240828$20240829$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US076138$SANDOZ$$$$$M$Y$$$20240829$$HP$US$US
242616941$24261694$1$I$20240701$20240826$20240829$20240829$EXP$$CA-ABBVIE-5896423$ABBVIE$$44$YR$$F$Y$$$20240829$$CN$CA$PK
242616951$24261695$1$I$$20240814$20240829$20240829$PER$$US-GLANDPHARMA-US-2024GLNSPO00703$GLAND PHARMA$$$$$$Y$$$20240829$$CN$US$US
242616961$24261696$1$I$$20240816$20240829$20240829$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-08423$LUPIN$$$$$$Y$$$20240829$$CN$AU$AU
242616972$24261697$2$F$$20240829$20240829$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004531$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
242616981$24261698$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5894511$ABBVIE$$29$YR$$F$Y$$$20240829$$HP$US$US
242616991$24261699$1$I$$20240827$20240829$20240829$PER$$NVSC2024US173731$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242617011$24261701$1$I$$20240826$20240829$20240829$EXP$$US-ABBVIE-5896815$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242617021$24261702$1$I$$20240828$20240829$20240829$PER$$US-ROCHE-10000068878$ROCHE$$31$YR$A$F$Y$$$20240829$$HP$US$US
242617031$24261703$1$I$$20240814$20240829$20240829$PER$$US-GLANDPHARMA-US-2024GLNSPO00682$GLAND PHARMA$$$$$$Y$$$20240829$$CN$US$US
242617041$24261704$1$I$$20240819$20240829$20240829$EXP$$CA-APOTEX-2024AP009522$APOTEX$$75$YR$$F$Y$$$20240829$$HP$CA$CA
242617051$24261705$1$I$20240712$20240819$20240829$20240829$EXP$$US-BAXTER-2024BAX023436$BAXTER$$$$$$Y$$$20240829$$HP$US$US
242617061$24261706$1$I$$20240819$20240829$20240829$EXP$$US-BAXTER-2024BAX023556$BAXTER$$52$YR$$M$Y$$$20240829$$MD$US$US
242617071$24261707$1$I$20240723$20240819$20240829$20240829$EXP$$BR-BAXTER-2024BAX023156$BAXTER$$26$YR$$F$Y$$$20240829$$PH$BR$BR
242617081$24261708$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004407$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242617092$24261709$2$F$20240815$20240913$20240829$20240920$30DAY$$US-AMGEN-USASP2024166688$AMGEN$$68$YR$E$F$Y$77.7$KG$20240919$$HP$US$US
242617101$24261710$1$I$$20240828$20240829$20240829$PER$$US-PROD-AS2-212756134-RB-103939-2023$RECKITT BENCKISER$$$$$M$Y$$$20240829$$CN$US$US
242617121$24261712$1$I$$20240823$20240829$20240829$EXP$$CA-AMGEN-CANSL2024170418$AMGEN$$66$YR$E$M$Y$$$20240829$$CN$CA$CA
242617141$24261714$1$I$20240701$20240824$20240829$20240829$EXP$$CA-ABBVIE-5899058$ABBVIE$$61$YR$$M$Y$$$20240829$$CN$CA$CA
242617151$24261715$1$I$$20240826$20240829$20240829$EXP$$CA-ABBVIE-5897505$ABBVIE$$32$YR$$F$Y$$$20240829$$CN$CA$CA
242617161$24261716$1$I$$20240821$20240829$20240829$EXP$$US-ROCHE-10000020843$ROCHE$$54$YR$A$F$Y$$$20240829$$MD$US$US
242617171$24261717$1$I$20240701$20240823$20240829$20240829$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001728$BLUEPRINT MEDICINES$$68$YR$E$M$Y$$$20240829$$CN$US$US
242617182$24261718$2$F$$20240826$20240829$20240916$PER$$US-CHATTEMPRD-2024OHG029667$CHATTEM$$69$YR$E$F$Y$$$20240916$$CN$US$US
242617191$24261719$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A190795$ASTRAZENECA$$$$$M$Y$$$20240829$$PH$US$
242617202$24261720$2$F$$20240912$20240829$20240912$PER$$US-ALXN-202408USA001637US$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240912$$HP$US$US
242617211$24261721$1$I$20240626$20240806$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004408$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240829$$CN$US$US
242617222$24261722$2$F$20240825$20240828$20240829$20240830$PER$$US-AMGEN-USASP2024171580$AMGEN$$38$YR$A$F$Y$$$20240830$$CN$US$US
242617231$24261723$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170919$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242617241$24261724$1$I$$20240821$20240829$20240829$EXP$$DE-JNJFOC-20240857128$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$MD$DE$DE
242617251$24261725$1$I$20240807$20240821$20240829$20240829$EXP$$CN-ABBVIE-5899046$ABBVIE$$53$YR$$M$Y$74$KG$20240829$$HP$CN$CN
242617261$24261726$1$I$$20240826$20240829$20240829$PER$$US-ALXN-202408USA001780US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242617271$24261727$1$I$$20240823$20240829$20240829$PER$$US-CHATTEMPRD-2024OHG029664$CHATTEM$$$$$$Y$$$20240829$$CN$US$US
242617281$24261728$1$I$20240701$20240819$20240829$20240829$EXP$CH-SM-2024-14741$CH-TEVA-VS-3235300$TEVA$$69$YR$$M$Y$$$20240829$$PH$CH$CH
242617291$24261729$1$I$$20240827$20240829$20240829$PER$$US-HALEON-2193979$Haleon PLC$$$$$$Y$$$20240829$$CN$US$US
242617301$24261730$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000068164$ROCHE$$63$YR$A$F$Y$$$20240829$$CN$US$US
242617311$24261731$1$I$$20240817$20240829$20240829$PER$$US-TAKEDA-2024TUS083751$TAKEDA$$$$$$Y$$$20240829$$PH$US$US
242617321$24261732$1$I$20240101$20240827$20240829$20240829$EXP$$CA-ABBVIE-5899043$ABBVIE$$78$YR$$M$Y$$$20240829$$MD$CA$CA
242617331$24261733$1$I$$20240825$20240829$20240829$PER$$US-CHATTEMPRD-2024OHG029431$CHATTEM$$$$$$Y$$$20240829$$CN$US$US
242617341$24261734$1$I$$20240827$20240829$20240829$EXP$$NVSC2024CA173774$NOVARTIS$$$$$$Y$$$20240829$$MD$CA$CA
242617351$24261735$1$I$20240827$20240828$20240829$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US076102$SANDOZ$$72$YR$$M$Y$$$20240829$$HP$US$US
242617361$24261736$1$I$20230101$20240827$20240829$20240829$EXP$$US-ABBVIE-5898364$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242617372$24261737$2$F$20240725$20240903$20240829$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004409$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240926$$CN$US$US
242617381$24261738$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004537$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242617391$24261739$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004410$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242617401$24261740$1$I$$20240821$20240829$20240829$EXP$$AU-JNJFOC-20240855659$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240829$$CN$AU$AU
242617411$24261741$1$I$20240201$20240821$20240829$20240829$EXP$$CA-JNJFOC-20231137048$JOHNSON AND JOHNSON$$67$YR$E$F$Y$110$KG$20240829$$HP$CA$CA
242617421$24261742$1$I$$20240817$20240829$20240829$EXP$$PT-AUROBINDO-AUR-APL-2024-030336$AUROBINDO$Costa L, Morgado C, Carvalho C, Amorim I, et al.. A disfun??o cerebelosa no doente com epilepsia (Cerebellar dysfunction in patients with epilepsy). Sinapse. 2023;23(Suppl1):83,$60$YR$$F$Y$$$20240829$$HP$PT$PT
242617432$24261743$2$F$20240819$20240826$20240829$20240905$EXP$$US-INSMED, INC.-2024-03376-US$INSMED$$80$YR$$F$Y$$$20240905$$CN$US$US
242617441$24261744$1$I$$20240820$20240829$20240829$EXP$$CA-ROCHE-2812790$ROCHE$$50$YR$A$F$Y$$$20240829$$MD$CA$CA
242617451$24261745$1$I$$20240808$20240829$20240829$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093225$GLENMARK$$$$$$Y$$$20240829$$CN$US$US
242617461$24261746$1$I$$20240823$20240829$20240829$EXP$$CZ-AMGEN-CZESP2024168809$AMGEN$Bartakova,H. Endobronchial involvement as an extremely rare manifestation of the Waldenstrom^s disease. Clin Respir J. 2018;12:816-819$66$YR$E$M$Y$$$20240829$$HP$CZ$CZ
242617472$24261747$2$F$20240820$20240903$20240829$20240906$30DAY$$US-AMGEN-USASP2024168086$AMGEN$$$$$F$Y$93.8$KG$20240906$$HP$US$US
242617481$24261748$1$I$$20240821$20240829$20240829$EXP$$CA-TEVA-VS-3235870$TEVA$$$$$$Y$$$20240829$$HP$CA$CA
242617494$24261749$4$F$20240821$20240828$20240829$20240910$30DAY$$US-AMGEN-USASP2024167725$AMGEN$$54$YR$A$F$Y$158.1$KG$20240910$$PH$US$US
242617501$24261750$1$I$20240826$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017090$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240829$$CN$US$US
242617511$24261751$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017016$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240829$$CN$US$US
242617521$24261752$1$I$20240822$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017359$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240829$$CN$US$US
242617531$24261753$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018122$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240829$$CN$US$US
242617542$24261754$2$F$20240702$20240905$20240829$20240912$EXP$$NVSC2024CN173708$NOVARTIS$$$$$M$Y$$$20240912$$CN$CN$CN
242617551$24261755$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174115$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242617571$24261757$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004462$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242617582$24261758$2$F$$20240919$20240829$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004469$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242617591$24261759$1$I$20240701$20240820$20240829$20240829$EXP$$CL-JNJFOC-20240857788$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240829$$CN$CL$CL
242617601$24261760$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004467$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242617611$24261761$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004412$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242617622$24261762$2$F$$20240905$20240829$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004463$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242617631$24261763$1$I$20230701$20240820$20240829$20240829$EXP$FR-AFSSAPS-PO2024000917$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111420$ZYDUS PHARM$$$$$$Y$$$20240829$$MD$FR$FR
242617641$24261764$1$I$20240726$20240808$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004474$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240829$$CN$US$US
242617651$24261765$1$I$20240626$20240816$20240829$20240829$EXP$GB-MHRA-MED-202408151421501400-KNLRT$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-111478$ZYDUS PHARM$$$$$$Y$$$20240829$$MD$GB$GB
242617661$24261766$1$I$20240101$20240826$20240829$20240829$EXP$$US-ABBVIE-5897340$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242617681$24261768$1$I$$20240822$20240829$20240829$EXP$$US-MTPC-MTDA2024-0018079$MITSUBISHI TANABE PHARMA$$$$A$$Y$$$20240829$$HP$US$US
242617691$24261769$1$I$$20240808$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004475$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242617701$24261770$1$I$20240304$20240826$20240829$20240829$EXP$$US-ABBVIE-5896788$ABBVIE$$70$YR$$F$Y$$$20240829$$CN$US$US
242617721$24261772$1$I$20231101$20240822$20240829$20240829$PER$$US-009507513-2408USA008380$MERCK$$81$YR$$F$Y$$$20240829$$CN$US$US
242617733$24261773$3$F$20240507$20240910$20240829$20240918$EXP$$CA-CELLTRION INC.-2024CA020421$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
242617741$24261774$1$I$20210101$20231217$20240829$20240829$EXP$$CA-CELLTRION INC.-2020CA035379$CELLTRION$$$$$$Y$$$20240829$$CN$CA$CA
242617751$24261775$1$I$$20240822$20240829$20240829$EXP$$US-ROCHE-10000000715$ROCHE$$89$YR$E$M$Y$$$20240829$$CN$US$US
242617761$24261776$1$I$$20240821$20240829$20240829$EXP$$ZA-AstraZeneca-2024A191876$ASTRAZENECA$$63$YR$$M$Y$$$20240829$$CN$ZA$
242617771$24261777$1$I$$20240821$20240829$20240829$EXP$$ZA-AstraZeneca-2024A191864$ASTRAZENECA$$70$YR$$M$Y$$$20240829$$CN$ZA$
242617781$24261778$1$I$$20240821$20240829$20240829$EXP$$ZA-AstraZeneca-2024A192076$ASTRAZENECA$$57$YR$$M$Y$$$20240829$$CN$ZA$
242617792$24261779$2$F$$20240902$20240829$20240911$EXP$$US-TEVA-VS-3236242$TEVA$Chetana Shanmukhappa S, Kumar A, Dey A, JVS J, Lokeshwaran S, Kumar K S, et al. Omalizumab rescue therapy in refractory status asthmaticus. J-Asthma 2023; 60 (12): 2243-2247.; Chetana Shanmukhappa S, Kumar A, Dey A, JVS J, Lokeshwaran S, Kumar K S, et al. Omalizumab rescue therapy in refractory status asthmaticus. J-Asthma 2023; 60 (12): 2243-2247.$39$YR$$M$Y$$$20240911$$MD$US$US
242617801$24261780$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A191779$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242617811$24261781$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A193901$ASTRAZENECA$$79$YR$$F$Y$$$20240829$$HP$US$
242617822$24261782$2$F$20240101$20240826$20240829$20240905$PER$$US-AstraZeneca-2024A194526$ASTRAZENECA$$74$YR$$F$Y$$$20240905$$CN$US$
242617831$24261783$1$I$20240817$20240827$20240829$20240829$EXP$$CA-ABBVIE-5899069$ABBVIE$$76$YR$$F$Y$$$20240829$$MD$CA$CA
242617841$24261784$1$I$$20240815$20240829$20240829$EXP$$US-ENDO USA, INC.-2024-003229$ENDO$$$$$M$Y$$$20240829$$HP$US$US
242617851$24261785$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5893721$ABBVIE$$37$YR$$F$Y$$$20240829$$HP$US$US
242617862$24261786$2$F$20240507$20240904$20240829$20240911$EXP$$NVSC2024ZA171956$NOVARTIS$$78$YR$$F$Y$$$20240911$$HP$ZA$ZA
242617871$24261787$1$I$$20240604$20240829$20240829$PER$$US-ENDO USA, INC.-2024-002513$ENDO$$$$$F$Y$$$20240829$$CN$US$US
242617881$24261788$1$I$20240409$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004539$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240829$$CN$US$US
242617891$24261789$1$I$$20240725$20240829$20240829$PER$$US-ENDO USA, INC.-2024-003056$ENDO$$$$$F$Y$$$20240829$$CN$US$US
242617901$24261790$1$I$$20240723$20240829$20240829$PER$$US-ENDO USA, INC.-2024-002583$ENDO$$$$$M$Y$$$20240829$$CN$US$US
242617911$24261791$1$I$$20240521$20240829$20240829$PER$$US-ENDO USA, INC.-2024-002272$ENDO$$$$$F$Y$$$20240829$$CN$US$US
242617921$24261792$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004413$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242617932$24261793$2$F$$20240829$20240829$20240830$PER$$US-JNJFOC-20240875998$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242617941$24261794$1$I$20231231$20240817$20240829$20240829$EXP$$DE-AUROBINDO-AUR-APL-2024-041964$AUROBINDO$$70$YR$$M$Y$68$KG$20240829$$MD$DE$DE
242617951$24261795$1$I$$20240820$20240829$20240829$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR106256$VIIV$$$$$$Y$$$20240829$$HP$US$US
242617961$24261796$1$I$$20240819$20240829$20240829$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR106242$VIIV$$$$$$Y$$$20240829$$HP$US$US
242617971$24261797$1$I$$20240819$20240829$20240829$30DAY$$US-GSK-US2024103424$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242617981$24261798$1$I$$20240819$20240829$20240829$30DAY$$US-GSK-US2024103458$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242617991$24261799$1$I$$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171819$AMGEN$$70$YR$E$M$Y$$$20240829$$CN$US$US
242618003$24261800$3$F$20240820$20240827$20240829$20240903$EXP$$US-GSK-US2024AMR105469$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
242618011$24261801$1$I$$20240819$20240829$20240829$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006197$BIOCON$$$$$$Y$$$20240829$$HP$CA$CA
242618021$24261802$1$I$20200901$20240820$20240829$20240829$EXP$$CA-CELLTRION INC.-2020CA027553$CELLTRION$$$$$$Y$$$20240829$$HP$CA$CA
242618031$24261803$1$I$$20240822$20240829$20240829$PER$$US-AMGEN-USASP2024169740$AMGEN$$45$YR$A$M$Y$$$20240829$$PH$US$US
242618041$24261804$1$I$20200602$20240819$20240829$20240829$EXP$$PL-AUROBINDO-AUR-APL-2024-042109$AUROBINDO$$14$YR$$M$Y$63$KG$20240829$$MD$PL$PL
242618051$24261805$1$I$$20240815$20240829$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-041198$AUROBINDO$Preskorn SH, Masolak DD. Life-threatening Rash Due to Lamotrigine and a Failure to Understand Its Pharmacology: How Forensic Detective Work Uses Medical Knowledge and Clinical Pharmacology to Solve Cases. Journal of Psychiatric Practice. 2024;30 (4):273-8$13$YR$$M$Y$$$20240829$$MD$US$US
242618062$24261806$2$F$$20240828$20240829$20240906$EXP$$US-AUROBINDO-AUR-APL-2024-042273$AUROBINDO$$$$$M$Y$$$20240906$$CN$US$US
242618071$24261807$1$I$$20240816$20240829$20240829$EXP$816212$AU-LUPIN PHARMACEUTICALS INC.-2024-08391$LUPIN$$$$$$Y$$$20240829$$CN$AU$AU
242618081$24261808$1$I$20200101$20240821$20240829$20240829$PER$$US-009507513-2408USA007229$MERCK$$$$$M$Y$$$20240829$$MD$US$US
242618091$24261809$1$I$$20240815$20240829$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-041149$AUROBINDO$Jha V, Jha SK, Aryal B, Dhungel S, Jha S, Brock M. A Report of a Rare Case of Kounis Syndrome in a Patient With HIV/AIDS and Mpox. Cureus. 2024;16(7):e63957$45$YR$$M$Y$$$20240829$$MD$US$US
242618101$24261810$1$I$20240603$20240826$20240829$20240829$EXP$$US-ROCHE-10000067240$ROCHE$$65$YR$E$F$Y$86.18$KG$20240829$$CN$US$US
242618111$24261811$1$I$$20240816$20240829$20240829$EXP$$IN-QUAGEN-2024QUALIT00248$QUAGEN PHARMACEUTICALS$Avadhesh Oli.Unusual clinical features and histopathological findings in a case of Pseudo-endophthalmitis in neovascular glaucoma.Romanian Journal of Ophthalmology.2024;68 (2):182-186$56$YR$A$M$Y$$$20240829$$MD$IN$IN
242618121$24261812$1$I$$20240822$20240829$20240829$EXP$$CA-JNJFOC-20240862812$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240829$$CN$CA$CA
242618131$24261813$1$I$$20240820$20240829$20240829$EXP$$CA-ROCHE-3503739$ROCHE$$24$YR$A$F$Y$79$KG$20240829$$HP$CA$CA
242618141$24261814$1$I$$20240815$20240829$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-041217$AUROBINDO$Enstrom C, Gast S, Church L, Heflin MK, Moore C, Cook C, et al. Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy. US-Cardiol. 2024$29$YR$$M$Y$$$20240829$$HP$US$US
242618151$24261815$1$I$$20240829$20240829$20240829$PER$$US-PROD-AS2-212756134-RB-103832-2023$RECKITT BENCKISER$$$$$F$Y$$$20240829$$CN$US$US
242618161$24261816$1$I$$20240816$20240829$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-041517$AUROBINDO$Lum EL, Datta N, Beaird O, Zuckerman J, Bunnapradist S, Schaenman J. Cutaneous Fungal Masses From Prior Environmental Injury Following Kidney Transplant: A Case Report. Transplantation Proceedings. 2019;51(9):3087-3091$72$YR$$F$Y$$$20240829$$MD$US$US
242618181$24261818$1$I$20240808$20240821$20240829$20240829$EXP$$US-VIIV HEALTHCARE LIMITED-US2024104559$VIIV$$52$YR$$M$Y$$$20240829$$CN$US$US
242618191$24261819$1$I$$20240821$20240829$20240829$30DAY$$US-GSK-US2024104592$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242618202$24261820$2$F$20231101$20240917$20240829$20240923$30DAY$$US-AMGEN-USASP2024168267$AMGEN$$68$YR$E$F$Y$63$KG$20240923$$HP$US$US
242618221$24261822$1$I$20240804$20240822$20240829$20240829$EXP$$PK-ROCHE-10000063924$ROCHE$$51$YR$A$M$Y$$$20240829$$CN$PK$PK
242618231$24261823$1$I$20240816$20240816$20240829$20240829$EXP$$CA-INTERCEPT-PM2024001686$INTERCEPT PHARMACEUTICALS$$71$YR$$M$Y$$$20240829$$CN$CA$CA
242618241$24261824$1$I$20200601$20240820$20240829$20240829$EXP$DE-MODERNATX-MOC20240802000041$DE-ROCHE-10000062272$ROCHE$$48$YR$A$F$Y$$$20240829$$CN$DE$DE
242618251$24261825$1$I$20240228$20240816$20240829$20240829$EXP$$FR-AUROBINDO-AUR-APL-2024-041584$AUROBINDO$$82$YR$$M$Y$78$KG$20240829$$MD$FR$FR
242618261$24261826$1$I$20240101$20240820$20240829$20240829$EXP$$US-INTERCEPT-PM2024001662$INTERCEPT PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242618271$24261827$1$I$20240819$20240826$20240829$20240829$PER$$US-ALXN-202408USA001764US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242618282$24261828$2$F$20240811$20240909$20240829$20240919$EXP$$DE-AUROBINDO-AUR-APL-2024-042416$AUROBINDO$$82$YR$$F$Y$60$KG$20240919$$MD$DE$DE
242618291$24261829$1$I$$20240820$20240829$20240829$EXP$$US-PCCINC-2024-PPL-000634$PIRAMAL$$$$$$Y$$$20240829$$HP$US$US
242618301$24261830$1$I$20240820$20240823$20240829$20240829$EXP$$US-ALXN-202408USA001715US$ALEXION PHARMACEUTICALS$$87$YR$$M$Y$77.098$KG$20240829$$HP$US$US
242618311$24261831$1$I$$20240816$20240829$20240829$EXP$$DE-QUAGEN-2024QUALIT00250$QUAGEN PHARMACEUTICALS$Veit Rothhammer.Case report: Cerebrospinal fluid neutrophilic pleocytosis upon intrathecal triamcinolone injection.Frontiers in Neurology.23-APR-2024;15:01-05$76$YR$E$F$Y$$$20240829$$HP$DE$DE
242618322$24261832$2$F$$20240905$20240829$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004476$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
242618332$24261833$2$F$20240821$20240909$20240829$20240913$PER$$US-AMGEN-USASP2024169420$AMGEN$$81$YR$E$F$Y$99.1$KG$20240912$$MD$US$US
242618341$24261834$1$I$$20240822$20240829$20240829$EXP$$US-TAKEDA-2024TUS075344$TAKEDA$$$$$F$Y$$$20240829$$CN$US$US
242618352$24261835$2$F$$20240919$20240829$20240925$EXP$$US-TAKEDA-2024TUS084665$TAKEDA$$$$$M$Y$$$20240925$$CN$US$US
242618361$24261836$1$I$$20240822$20240829$20240829$EXP$$CA-TAKEDA-2024TUS085737$TAKEDA$$$$$F$Y$$$20240829$$MD$CA$CA
242618371$24261837$1$I$$20240826$20240829$20240829$PER$$US-JNJFOC-20240872252$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$CN$US$US
242618382$24261838$2$F$20211207$20240827$20240829$20240903$EXP$$CA-TAKEDA-2018TUS016568$TAKEDA$$45$YR$$F$Y$$$20240903$$CN$CA$CA
242618391$24261839$1$I$20200612$20240819$20240829$20240829$EXP$$PL-AUROBINDO-AUR-APL-2024-042118$AUROBINDO$$42$YR$$F$Y$55$KG$20240829$$MD$PL$PL
242618401$24261840$1$I$$20240815$20240829$20240829$PER$$US-QUAGEN-2024QUASPO00249$QUAGEN PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242618411$24261841$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5894555$ABBVIE$$27$YR$$F$Y$$$20240829$$HP$US$US
242618421$24261842$1$I$$20240821$20240829$20240829$EXP$$US-GSK-US2024104501$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$MD$US$US
242618431$24261843$1$I$20240101$20240829$20240829$20240829$EXP$SE-SEMPA-2024-006282$SE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048463$BOEHRINGER INGELHEIM$$88$YR$E$M$Y$$$20240829$$MD$SE$SE
242618441$24261844$1$I$$20240816$20240829$20240829$EXP$815795$AU-LUPIN PHARMACEUTICALS INC.-2024-08435$LUPIN$$$$$$Y$$$20240829$$CN$AU$AU
242618451$24261845$1$I$$20240827$20240829$20240829$EXP$$US-AstraZeneca-2024A195476$ASTRAZENECA$$$$$M$Y$84.8$KG$20240829$$CN$US$
242618461$24261846$1$I$20240621$20240826$20240829$20240829$EXP$$US-AstraZeneca-2024A194120$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
242618471$24261847$1$I$20240623$20240817$20240829$20240829$EXP$$SE-AUROBINDO-AUR-APL-2024-042249$AUROBINDO$$85$YR$$F$Y$$$20240829$$MD$SE$SE
242618481$24261848$1$I$$20240815$20240829$20240829$PER$$US-AstraZeneca-2024A186970$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
242618491$24261849$1$I$20240601$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171289$AMGEN$$82$YR$E$F$Y$$$20240829$$CN$US$US
242618501$24261850$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000067819$ROCHE$$$$$$Y$$$20240829$$CN$US$US
242618513$24261851$3$F$20240813$20240913$20240829$20240923$PER$$US-AMGEN-USASP2024167635$AMGEN$$35$YR$A$F$Y$65$KG$20240923$$HP$US$US
242618521$24261852$1$I$20240601$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017281$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240829$$CN$US$US
242618531$24261853$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017417$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240829$$CN$US$US
242618541$24261854$1$I$20240823$20240823$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016444$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240829$$CN$US$US
242618561$24261856$1$I$20240821$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017413$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240829$$CN$US$US
242618571$24261857$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017283$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240829$$CN$US$US
242618581$24261858$1$I$20240827$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017246$ELI LILLY AND CO$$43$YR$A$$Y$$$20240829$$CN$US$US
242618591$24261859$1$I$20240801$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016981$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240829$$CN$US$US
242618601$24261860$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004477$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242618611$24261861$1$I$20240812$20240819$20240829$20240829$EXP$$CN-EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD.-EVI-CN-2024-000028$Evive Biotechnology$$45$YR$$F$Y$52$KG$20240829$$MD$CN$CN
242618621$24261862$1$I$$20240826$20240829$20240829$EXP$$US-JNJFOC-20240868886$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240829$$HP$US$US
242618631$24261863$1$I$$20240816$20240829$20240829$PER$$US-QUAGEN-2024QUASPO00247$QUAGEN PHARMACEUTICALS$$3$YR$C$F$Y$$$20240829$$CN$US$US
242618642$24261864$2$F$20171108$20240925$20240829$20240930$EXP$$CA-TAKEDA-2022TUS061051$TAKEDA$$66$YR$$M$Y$$$20240930$$CN$CA$CA
242618651$24261865$1$I$20240801$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170304$AMGEN$$86$YR$E$F$Y$$$20240829$$CN$US$US
242618661$24261866$1$I$20240501$20240819$20240829$20240829$EXP$$DE-AUROBINDO-AUR-APL-2024-042123$AUROBINDO$$74$YR$$M$Y$$$20240829$$MD$DE$DE
242618671$24261867$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170934$AMGEN$$$$$$Y$$$20240829$$CN$US$US
242618681$24261868$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000068520$ROCHE$$40$YR$A$F$Y$$$20240829$$CN$US$US
242618691$24261869$1$I$$20240819$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041753$AUROBINDO$$$$$F$Y$$$20240829$$MD$GB$GB
242618701$24261870$1$I$20240730$20240817$20240829$20240829$EXP$$PT-AUROBINDO-AUR-APL-2024-041858$AUROBINDO$$64$YR$$F$Y$67$KG$20240829$$PH$PT$PT
242618711$24261871$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004478$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242618721$24261872$1$I$20240826$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171343$AMGEN$$61$YR$A$M$Y$$$20240829$$CN$US$US
242618741$24261874$1$I$$20240823$20240829$20240829$PER$$US-HALEON-2193628$Haleon PLC$$30$YR$$F$Y$$$20240829$$MD$US$US
242618751$24261875$1$I$$20240823$20240829$20240829$EXP$$JP-JNJFOC-20240875847$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$CN$JP$JP
242618761$24261876$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042583$AUROBINDO$Weil T, Bebawi E.. Insuffisance r?nale aigue fonctionnelle sous furos?mide.. Qu?bec Pharmacie. 2023;70:5:11-16$65$YR$$F$Y$$$20240829$$HP$CA$CA
242618771$24261877$1$I$$20240828$20240829$20240829$EXP$JP-MLMSERVICE-20240807-PI154586-00082-1$JP-SANDOZ INC.-SDZ2024JP075878$SANDOZ$$66$YR$$M$Y$$$20240829$$MD$JP$JP
242618781$24261878$1$I$20220801$20240822$20240829$20240829$EXP$$GB-CELLTRION INC.-2024GB020475$CELLTRION$$$$$$Y$$$20240829$$CN$GB$GB
242618791$24261879$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004481$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242618801$24261880$1$I$20240624$20240827$20240829$20240829$EXP$FR-AFSSAPS-AVPO2024000159$FR-SANDOZ INC.-SDZ2024FR075554$SANDOZ$$59$YR$$F$Y$$$20240829$$PH$FR$FR
242618811$24261881$1$I$20240101$20240823$20240829$20240829$EXP$DK-DKMA-30735196$DK-ABBVIE-5897010$ABBVIE$$55$YR$$F$Y$$$20240829$$MD$DK$DK
242618821$24261882$1$I$$20240827$20240829$20240829$EXP$$CA-ORGANON-O2408CAN001938$ORGANON$$40$YR$$F$Y$$$20240829$$HP$CA$CA
242618831$24261883$1$I$$20240826$20240829$20240829$EXP$$US-TAKEDA-2023TUS035864$TAKEDA$$$$$M$Y$$$20240829$$HP$US$US
242618841$24261884$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004482$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242618861$24261886$1$I$20240112$20240826$20240829$20240829$EXP$FR-AFSSAPS-LL2024001576$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08057$HIKMA$$$$$$Y$$$20240829$$PH$FR$FR
242618881$24261888$1$I$$20240826$20240829$20240829$PER$$US-JNJFOC-20240870089$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242618912$24261891$2$F$20240801$20240923$20240829$20240925$EXP$$US-TAKEDA-2024TUS078162$TAKEDA$$51$YR$$F$Y$$$20240925$$CN$US$US
242618931$24261893$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042542$AUROBINDO$$43$YR$$F$Y$93.8$KG$20240829$$CN$CA$CA
242618942$24261894$2$F$$20240902$20240829$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-041969$AUROBINDO$$59$YR$$F$Y$$$20240910$$HP$FR$FR
242618952$24261895$2$F$$20240827$20240829$20240902$PER$$US-HALEON-2194030$Haleon PLC$$$$$F$Y$$$20240902$$CN$US$US
242618961$24261896$1$I$$20240820$20240829$20240829$EXP$$US-BAUSCHBL-2024BNL032064$BAUSCH AND LOMB$$88$YR$$M$Y$$$20240829$$CN$US$US
242618972$24261897$2$F$20240801$20240909$20240829$20240915$PER$$US-AMGEN-USASP2024169892$AMGEN$$71$YR$E$F$Y$$$20240915$$HP$US$US
242618981$24261898$1$I$$20240827$20240829$20240829$EXP$$US-SA-2024SA251588$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240829$$MD$US$US
242618991$24261899$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5894532$ABBVIE$$54$YR$$F$Y$$$20240829$$HP$US$US
242619002$24261900$2$F$$20240826$20240829$20240905$EXP$$CA-GALDERMA-CA2024013077$GALDERMA$$$$$$Y$$$20240905$$HP$CA$CA
242619011$24261901$1$I$$20240823$20240829$20240829$EXP$$GB-AstraZeneca-2024A193272$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$GB$
242619021$24261902$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A191406$ASTRAZENECA$$$$$F$Y$$$20240829$$HP$US$
242619031$24261903$1$I$$20240822$20240829$20240829$PER$$US-AstraZeneca-2024A172393$ASTRAZENECA$$83$YR$$M$Y$$$20240829$$CN$US$
242619041$24261904$1$I$20240525$20240827$20240829$20240829$EXP$$US-TAKEDA-2024TUS060081$TAKEDA$$76$YR$$F$Y$$$20240829$$MD$US$US
242619051$24261905$1$I$$20230812$20240829$20240829$PER$$PR-BSC-2023000045$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$MD$PR$PR
242619061$24261906$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042588$AUROBINDO$$44$YR$$M$Y$$$20240829$$PH$CA$CA
242619071$24261907$1$I$20230802$20230809$20240829$20240829$PER$$US-BSC-2023000043$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$HP$US$US
242619081$24261908$1$I$$20240823$20240829$20240829$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001729$BLUEPRINT MEDICINES$$$$$F$Y$$$20240829$$CN$US$US
242619091$24261909$1$I$$20240819$20240829$20240829$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004066$PAREXEL$$$$$$Y$$$20240829$$CN$US$US
242619101$24261910$1$I$$20240820$20240829$20240829$EXP$$CA-GALDERMA-CA2024013078$GALDERMA$$$$$$Y$$$20240829$$HP$CA$CA
242619111$24261911$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174160$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
242619121$24261912$1$I$20231231$20240815$20240829$20240829$EXP$$US-UCBSA-2024041578$UCB$$51$YR$$M$Y$$$20240829$$HP$US$US
242619131$24261913$1$I$$20240817$20240829$20240829$EXP$$FR-AUROBINDO-AUR-APL-2024-042139$AUROBINDO$$$$$M$Y$$$20240829$$CN$FR$FR
242619141$24261914$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042585$AUROBINDO$$65$YR$$F$Y$$$20240829$$HP$CA$CA
242619151$24261915$1$I$20240809$20240829$20240829$20240829$EXP$NO-NOMAADVRE-RELISV-2024-Vbkmwx$NO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048472$BOEHRINGER INGELHEIM$$49$YR$A$F$Y$$$20240829$$MD$NO$NO
242619163$24261916$3$F$$20240829$20240829$20240901$PER$$US-JNJFOC-20240867201$JOHNSON AND JOHNSON$$$$$$Y$$$20240901$$PH$US$US
242619171$24261917$1$I$$20240819$20240829$20240829$EXP$$CA-ORPHANEU-2024006426$RECORDATI$$$$$$Y$$$20240829$$HP$CA$CA
242619181$24261918$1$I$20240820$20240820$20240829$20240829$30DAY$$US-GSK-US2024103985$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240829$$CN$US$US
242619191$24261919$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004483$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242619202$24261920$2$F$$20240828$20240829$20240830$PER$$US-AMGEN-USASP2024171709$AMGEN$$$$$F$Y$$$20240830$$CN$US$US
242619211$24261921$1$I$$20240825$20240829$20240829$EXP$$US-TAKEDA-2024TUS086220$TAKEDA$$$$$F$Y$$$20240829$$MD$US$US
242619221$24261922$1$I$$20240820$20240829$20240829$EXP$E2B_06331112$CA-GALDERMA-CA2024013083$GALDERMA$$$$$$Y$$$20240829$$HP$CA$CA
242619231$24261923$1$I$$20240820$20240829$20240829$EXP$E2B_06336163$CA-GALDERMA-CA2024013081$GALDERMA$$$$$$Y$$$20240829$$HP$CA$CA
242619241$24261924$1$I$$20240820$20240829$20240829$PER$$US-ASTELLAS-2024-AER-002141$ASTELLAS$$$$$F$Y$$$20240829$$CN$US$US
242619251$24261925$1$I$20240826$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017184$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240829$$CN$US$US
242619261$24261926$1$I$$20240821$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408014638$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240829$$CN$US$US
242619271$24261927$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016662$ELI LILLY AND CO$$62$YR$A$$Y$$$20240829$$CN$US$US
242619281$24261928$1$I$20240301$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016530$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240829$$CN$US$US
242619292$24261929$2$F$$20240823$20240829$20240904$EXP$$PT-AUROBINDO-AUR-APL-2024-041182$AUROBINDO$Direito J, Neves FC, Almeida I, Aveiro A, Ribeiro JC. DE REA??O ADVERSA A NEOPLASIA: QUANDO A ICTER?CIA ? O PRIMEIRO SINAL PARA O DIAGN?STICO (RELATO DE CASO)[ OC (oral communications) 123| from adverse reaction to neoplasia: when jaundice is the first sign for diagnosis (case report)]. (OF ADVERSE REACTION TO NEOPLASM: WHEN JAUNCE IS THE FIRST SIGN FOR DIAGNOSIS (CASE REPORT)[ OC (oral communications) 123| from adverse reaction to neoplasia: when jaundice is the first sign for diagnosis (case r$63$YR$$M$Y$$$20240904$$HP$PT$PT
242619301$24261930$1$I$$20240822$20240829$20240829$EXP$$US-BAUSCHBL-2024BNL032329$BAUSCH AND LOMB$$78$YR$$F$Y$$$20240829$$MD$US$US
242619311$24261931$1$I$20240707$20240827$20240829$20240829$EXP$$CL-UCBSA-2024043869$UCB$$77$YR$$M$Y$$$20240829$$CN$CL$CL
242619321$24261932$1$I$20240127$20240814$20240829$20240829$EXP$$CN-UCBSA-2024005137$UCB$$30$YR$$F$Y$68$KG$20240829$$MD$CN$CN
242619331$24261933$1$I$$20240826$20240829$20240829$EXP$$CA-TAKEDA-2024TUS086448$TAKEDA$$$$$M$Y$$$20240829$$MD$CA$CA
242619341$24261934$1$I$20230815$20230815$20240829$20240829$EXP$$US-BSC-2023000049$BOSTON SCIENTIFIC$$$$$M$Y$$$20240829$$HP$US$US
242619351$24261935$1$I$20240806$20240816$20240829$20240829$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00909$CATALYST PHARMA$$70$YR$$F$Y$$$20240829$$CN$US$US
242619361$24261936$1$I$20230816$20231019$20240829$20240829$PER$$US-BSC-2023000050$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$HP$US$US
242619372$24261937$2$F$20090101$20240910$20240829$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-042237$AUROBINDO$$59$YR$$M$Y$59$KG$20240920$$MD$FR$FR
242619381$24261938$1$I$20230816$20231019$20240829$20240829$PER$$US-BSC-2023000053$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$HP$US$US
242619391$24261939$1$I$20230816$20231019$20240829$20240829$PER$$US-BSC-2023000052$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$HP$US$US
242619401$24261940$1$I$20230823$20230823$20240829$20240829$PER$$US-BSC-2023000055$BOSTON SCIENTIFIC$$$$A$F$Y$$$20240829$$HP$US$US
242619411$24261941$1$I$20230823$20230823$20240829$20240829$PER$$US-BSC-2023000056$BOSTON SCIENTIFIC$$$$A$F$Y$$$20240829$$HP$US$US
242619421$24261942$1$I$$20230830$20240829$20240829$EXP$$US-BSC-2023000058$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$MD$US$US
242619431$24261943$1$I$$20240510$20240829$20240829$EXP$$CA-ROCHE-10000060843$ROCHE$$65$YR$E$F$Y$34$KG$20240829$$HP$CA$CA
242619441$24261944$1$I$20230816$20231019$20240829$20240829$PER$$US-BSC-2023000054$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$HP$US$US
242619451$24261945$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5895105$ABBVIE$$70$YR$$F$Y$$$20240829$$HP$US$US
242619461$24261946$1$I$$20240821$20240829$20240829$EXP$$JP-EMD Serono-2024046036$EMD SERONO INC$$7$DEC$E$F$Y$$$20240829$$PH$JP$JP
242619472$24261947$2$F$$20240812$20240829$20240902$PER$$US-ASTELLAS-2024US013900$ASTELLAS$$$$A$M$Y$$$20240830$$CN$US$US
242619481$24261948$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136775$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$62.6$KG$20240829$$CN$US$US
242619491$24261949$1$I$$20240823$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135322$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$101.15$KG$20240829$$CN$US$US
242619501$24261950$1$I$20240727$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004485$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240829$$CN$US$US
242619511$24261951$1$I$20240625$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137034$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240829$$CN$US$US
242619521$24261952$1$I$20240813$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136792$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$68.9$KG$20240829$$PH$US$US
242619531$24261953$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136480$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240829$$CN$US$US
242619541$24261954$1$I$$20240820$20240829$20240829$EXP$$GB-AMICUS THERAPEUTICS, INC.-AMI_3333$AMICUS THERAPEUTICS$$$$$$Y$$$20240829$$HP$GB$GB
242619552$24261955$2$F$20240812$20240927$20240829$20240930$PER$$US-JNJFOC-20240867239$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240930$$PH$US$US
242619561$24261956$1$I$20240122$20240822$20240829$20240829$EXP$$CO-EMD Serono-2024045673$EMD SERONO INC$$74$YR$E$F$Y$65$KG$20240829$$HP$CO$CO
242619571$24261957$1$I$$20240819$20240829$20240829$EXP$$JP-AMGEN-JPNSP2024170945$AMGEN$$$$$$Y$$$20240829$$PH$JP$JP
242619581$24261958$1$I$$20240819$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041771$AUROBINDO$$84$YR$$F$Y$62$KG$20240829$$MD$GB$GB
242619591$24261959$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136685$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$76.66$KG$20240829$$CN$US$US
242619601$24261960$1$I$$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136973$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240829$$CN$US$US
242619611$24261961$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137163$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240829$$CN$US$US
242619621$24261962$1$I$20240601$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135818$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240829$$HP$US$US
242619633$24261963$3$F$20240730$20240909$20240829$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135274$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$58.97$KG$20240916$$HP$US$US
242619641$24261964$1$I$20240814$20240826$20240829$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134648$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240829$$PH$JP$JP
242619651$24261965$1$I$$20240822$20240829$20240829$EXP$PL-URPL-1-1905-2020$PL-EMD Serono-2024045311$EMD SERONO INC$$46$YR$A$M$Y$98$KG$20240829$$MD$PL$PL
242619661$24261966$1$I$$20240822$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-137327$BRISTOL MYERS SQUIBB$Literature citation unavailable$15$YR$T$M$Y$$$20240829$$HP$CA$CA
242619671$24261967$1$I$20240824$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170662$AMGEN$$53$YR$A$F$Y$$$20240829$$CN$US$US
242619681$24261968$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004486$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242619691$24261969$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5894550$ABBVIE$$60$YR$$F$Y$$$20240829$$HP$US$US
242619701$24261970$1$I$$20240822$20240829$20240829$EXP$$JP-JNJFOC-20240874693$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240829$$MD$JP$JP
242619711$24261971$1$I$20240809$20240828$20240829$20240829$EXP$FR-AFSSAPS-MP2024001334$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-136632$BRISTOL MYERS SQUIBB$$31$YR$A$M$Y$53$KG$20240829$$MD$FR$FR
242619721$24261972$1$I$20240825$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136505$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$90.72$KG$20240829$$PH$US$US
242619732$24261973$2$F$$20240916$20240829$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134628$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240923$$CN$US$US
242619741$24261974$1$I$20240816$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136952$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240829$$CN$US$US
242619752$24261975$2$F$$20240829$20240829$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07785$LUPIN$$$$$$Y$$$20240919$$CN$US$US
242619761$24261976$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174235$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
242619771$24261977$1$I$$20240827$20240829$20240829$PER$$NVSC2024US173894$NOVARTIS$$$$$M$Y$$$20240829$$MD$US$US
242619781$24261978$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174177$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
242619791$24261979$1$I$20240825$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171376$AMGEN$$76$YR$E$M$Y$$$20240829$$CN$US$US
242619801$24261980$1$I$$20240827$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US075888$SANDOZ$$68$YR$$M$Y$$$20240829$$MD$US$US
242619811$24261981$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042459$AUROBINDO$$55$YR$$F$Y$120$KG$20240829$$HP$CA$CA
242619821$24261982$1$I$$20230830$20240829$20240829$PER$$US-BSC-2023000059$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242619831$24261983$1$I$20240819$20240827$20240829$20240829$PER$$NVSC2024US174150$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
242619841$24261984$1$I$20230901$20231018$20240829$20240829$PER$$US-BSC-2023000060$BOSTON SCIENTIFIC$$57$YR$$F$Y$$$20240829$$HP$US$US
242619851$24261985$1$I$20230901$20231018$20240829$20240829$PER$$US-BSC-2023000061$BOSTON SCIENTIFIC$$65$YR$$M$Y$$$20240829$$HP$US$US
242619861$24261986$1$I$20240820$20240826$20240829$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023415$UNITED THERAPEUTICS$$64$YR$$F$Y$49.433$KG$20240829$$$US$US
242619871$24261987$1$I$20240205$20240827$20240829$20240829$EXP$GB-MHRA-MED-202408272236429120-LYCFW$GB-TEVA-VS-3237892$TEVA$$19$YR$$F$Y$$$20240829$$CN$GB$GB
242619881$24261988$1$I$20230910$20230915$20240829$20240829$PER$$US-BSC-2023000062$BOSTON SCIENTIFIC$$$$E$F$Y$$$20240829$$MD$US$US
242619891$24261989$1$I$20230905$20231018$20240829$20240829$PER$$US-BSC-2023000067$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242619901$24261990$1$I$20230905$20240104$20240829$20240829$PER$$US-BSC-2023000065$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242619911$24261991$1$I$20230831$20231018$20240829$20240829$PER$$US-BSC-2023000066$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242619921$24261992$1$I$20230830$20231018$20240829$20240829$PER$$US-BSC-2023000064$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242619931$24261993$1$I$20230905$20231018$20240829$20240829$PER$$US-BSC-2023000068$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242619941$24261994$1$I$$20240809$20240829$20240829$PER$$US-TEVA-VS-3233181$TEVA$$$$$$Y$$$20240829$$HP$US$US
242619962$24261996$2$F$$20240904$20240829$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001733$BLUEPRINT MEDICINES$$$$$F$Y$$$20240911$$CN$US$US
242619971$24261997$1$I$$20240821$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133948$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$66.2$KG$20240829$$HP$US$US
242619982$24261998$2$F$20220827$20240917$20240829$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133165$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$88.9$KG$20240924$$CN$US$US
242619991$24261999$1$I$20240817$20240823$20240829$20240829$EXP$$CN-JNJFOC-20240863408$JOHNSON AND JOHNSON$$61$YR$A$F$Y$60$KG$20240829$$HP$CN$CN
242620002$24262000$2$F$$20240916$20240829$20240926$EXP$$US-ROCHE-10000060859$ROCHE$$64$YR$A$M$Y$$$20240926$$CN$US$US
242620021$24262002$1$I$$20240802$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07826$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242620051$24262005$1$I$$20240826$20240829$20240829$EXP$$US-TAKEDA-2024TUS086329$TAKEDA$$$$$M$Y$92$KG$20240829$$HP$US$US
242620071$24262007$1$I$$20240816$20240829$20240829$PER$$US-TAKEDA-2024TUS082987$TAKEDA$$$$$$Y$45$KG$20240829$$MD$US$US
242620081$24262008$1$I$20240809$20240826$20240829$20240829$EXP$$US-TAKEDA-2024TUS076554$TAKEDA$$55$YR$$F$Y$$$20240829$$HP$US$US
242620092$24262009$2$F$20240719$20240829$20240829$20240905$EXP$$CA-TAKEDA-2024TUS077116$TAKEDA$$17$YR$$M$Y$$$20240905$$CN$CA$CA
242620101$24262010$1$I$$20240823$20240829$20240829$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001740$BLUEPRINT MEDICINES$$$$$F$Y$$$20240829$$CN$US$US
242620111$24262011$1$I$$20240827$20240829$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048246$BOEHRINGER INGELHEIM$$$$$$Y$$$20240829$$CN$US$US
242620122$24262012$2$F$20240821$20240924$20240829$20240928$EXP$$CA-ABBVIE-5897622$ABBVIE$$58$YR$$M$Y$$$20240928$$CN$CA$CA
242620131$24262013$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004501$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242620141$24262014$1$I$$20240821$20240829$20240829$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001707$BLUEPRINT MEDICINES$$$$$F$Y$$$20240829$$CN$US$US
242620171$24262017$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000067878$ROCHE$$59$YR$A$F$Y$$$20240829$$MD$US$US
242620181$24262018$1$I$$20240826$20240829$20240829$EXP$$CA-ABBVIE-5899053$ABBVIE$$$$A$M$Y$$$20240829$$MD$CA$CA
242620191$24262019$1$I$$20240802$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07875$LUPIN$$$$$$Y$$$20240829$$PH$US$US
242620201$24262020$1$I$$20240821$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408013792$ELI LILLY AND CO$$$$$M$Y$$$20240829$$CN$US$US
242620211$24262021$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016955$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240829$$CN$US$US
242620221$24262022$1$I$20240826$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016583$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240829$$CN$US$US
242620231$24262023$1$I$$20240821$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015129$ELI LILLY AND CO$$$$$$Y$$$20240829$$CN$US$US
242620242$24262024$2$F$20240801$20240906$20240829$20240920$EXP$$US-UCBSA-2024043769$UCB$$44$YR$$F$Y$$$20240920$$CN$US$US
242620251$24262025$1$I$$20240822$20240829$20240829$EXP$$JP-CHEPLA-2024010956$CHEPLAPHARM$$$$$$Y$$$20240829$$PH$COUNTRY NOT SPECIFIED$JP
242620263$24262026$3$F$$20240920$20240829$20240930$PER$$US-ROCHE-10000059911$ROCHE$$85$YR$E$M$Y$$$20240930$$CN$US$US
242620271$24262027$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004414$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242620281$24262028$1$I$20210101$20240823$20240829$20240829$EXP$$NVSC2024RU173225$NOVARTIS$$12$YR$$M$Y$57$KG$20240829$$HP$RU$RU
242620291$24262029$1$I$$20240814$20240829$20240829$PER$$US-ABBVIE-5894516$ABBVIE$$44$YR$$F$Y$$$20240829$$HP$US$US
242620301$24262030$1$I$$20240814$20240829$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-041097$AUROBINDO$St. George Teaford H. Psychotherapeutic Approach to the Treatment of a Youth with Schizophrenia and OCD: A Case Report. Journal of Indian Association for Child and Adolescent Mental Health. 2024;20(2):181-3$13$YR$$M$Y$$$20240829$$MD$US$US
242620311$24262031$1$I$$20240814$20240829$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-041045$AUROBINDO$Walterscheid B, Batchinsky M, Tarbox M. Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Preceding Toxic Epidermal Necrolysis Secondary to Sildenafil: A Case Report. Cureus. 2024;16(7):e63922$66$YR$$F$Y$$$20240829$$MD$US$US
242620322$24262032$2$F$20240725$20240822$20240829$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-042199$AUROBINDO$$56$YR$$F$Y$$$20240902$$MD$FR$FR
242620331$24262033$1$I$20240202$20240816$20240829$20240829$EXP$$ES-AUROBINDO-AUR-APL-2024-042077$AUROBINDO$$86$YR$$M$Y$68.2$KG$20240829$$MD$ES$ES
242620341$24262034$1$I$20230905$20231018$20240829$20240829$PER$$US-BSC-2023000069$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242620351$24262035$1$I$20230906$20231018$20240829$20240829$PER$$US-BSC-2023000070$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242620361$24262036$1$I$20240815$20240817$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041669$AUROBINDO$$$$$$Y$$$20240829$$CN$GB$GB
242620371$24262037$1$I$20230911$20231018$20240829$20240829$PER$$US-BSC-2023000072$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242620381$24262038$1$I$20230911$20231018$20240829$20240829$PER$$US-BSC-2023000071$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242620391$24262039$1$I$$20231129$20240829$20240829$PER$$US-BSC-2023000077$BOSTON SCIENTIFIC$$61$YR$$F$Y$$$20240829$$HP$US$US
242620401$24262040$1$I$20230912$20231018$20240829$20240829$PER$$US-BSC-2023000074$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242620411$24262041$1$I$20230912$20231018$20240829$20240829$PER$$US-BSC-2023000073$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242620421$24262042$1$I$20230701$20231009$20240829$20240829$PER$$US-BSC-2023000078$BOSTON SCIENTIFIC$$$$A$F$Y$$$20240829$$HP$US$US
242620431$24262043$1$I$20230101$20231204$20240829$20240829$PER$$US-BSC-2023000080$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242620441$24262044$1$I$$20240827$20240829$20240829$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-116718$REGENERON$$$$$F$Y$$$20240829$$HP$CA$CA
242620452$24262045$2$F$$20240820$20240829$20240903$30DAY$$AT-SA-2024SA251428$SANOFI AVENTIS$$$$A$$Y$$$20240903$$MD$AT$AT
242620461$24262046$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004502$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242620481$24262048$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136682$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240829$$CN$US$US
242620491$24262049$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136909$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240829$$CN$US$US
242620501$24262050$1$I$$20240805$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07886$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242620511$24262051$1$I$$20240816$20240829$20240829$PER$$US-JNJFOC-20240849446$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242620521$24262052$1$I$$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136907$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240829$$CN$US$US
242620531$24262053$1$I$$20240822$20240829$20240829$EXP$$CA-JNJFOC-20240861658$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$CA$CA
242620541$24262054$1$I$$20240822$20240829$20240829$PER$$US-AstraZeneca-2024A193350$ASTRAZENECA$$$$$$Y$$$20240829$$MD$US$
242620551$24262055$1$I$$20240827$20240829$20240829$PER$$US-AstraZeneca-2024A195589$ASTRAZENECA$$$$$$Y$$$20240829$$HP$US$
242620561$24262056$1$I$$20240813$20240829$20240829$PER$$US-AstraZeneca-2024A184599$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242620571$24262057$1$I$$20240819$20240829$20240829$EXP$$GB-UCBSA-2024042539$UCB$$$$$F$Y$$$20240829$$HP$GB$GB
242620581$24262058$1$I$20240803$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A193902$ASTRAZENECA$$869$MON$$F$Y$75.2$KG$20240829$$HP$US$
242620591$24262059$1$I$20240801$20240816$20240829$20240829$PER$$US-SA-2024SA248698$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240829$$MD$US$US
242620601$24262060$1$I$20240101$20240815$20240829$20240829$PER$$US-SA-2024SA247896$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240829$$MD$US$US
242620611$24262061$1$I$20240101$20240816$20240829$20240829$PER$$US-SA-2024SA246789$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240829$$MD$US$US
242620622$24262062$2$F$20240801$20240903$20240829$20240911$PER$$US-SA-2024SA121557$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240911$$MD$US$US
242620631$24262063$1$I$20240801$20240820$20240829$20240829$PER$$US-SA-2024SA250421$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240829$$MD$US$US
242620641$24262064$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249396$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240829$$MD$US$US
242620651$24262065$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249504$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240829$$HP$US$US
242620661$24262066$1$I$20240101$20240819$20240829$20240829$PER$$US-SA-2024SA249106$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240829$$MD$US$US
242620671$24262067$1$I$20240101$20240819$20240829$20240829$PER$$US-SA-2024SA250247$SANOFI AVENTIS$$77$YR$E$M$Y$80.73$KG$20240829$$MD$US$US
242620681$24262068$1$I$$20240809$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08163$LUPIN$$$$$$Y$$$20240829$$MD$US$US
242620691$24262069$1$I$20231101$20240824$20240829$20240829$EXP$$US-ABBVIE-5896158$ABBVIE$$65$YR$$F$Y$$$20240829$$CN$US$US
242620701$24262070$1$I$20240101$20240820$20240829$20240829$PER$$US-SA-2024SA249093$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240829$$MD$US$US
242620711$24262071$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA248599$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240829$$CN$US$US
242620721$24262072$1$I$20240101$20240819$20240829$20240829$PER$$US-SA-2024SA249122$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240829$$MD$US$US
242620731$24262073$1$I$$20240805$20240829$20240829$EXP$$JP-SA-2024SA251140$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240829$$PH$JP$JP
242620741$24262074$1$I$20240803$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004503$ACADIA PHARMACEUTICALS$$62$YR$$M$Y$$$20240829$$CN$US$US
242620751$24262075$1$I$$20240820$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133945$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240829$$CN$US$US
242620761$24262076$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136488$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$86.18$KG$20240829$$CN$US$US
242620772$24262077$2$F$$20240827$20240829$20240910$EXP$$FR-JNJFOC-20240872094$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240910$$PH$FR$FR
242620781$24262078$1$I$20231026$20231026$20240829$20240829$PER$$US-BSC-2023000088$BOSTON SCIENTIFIC$$67$YR$E$F$Y$$$20240829$$HP$US$US
242620792$24262079$2$F$$20240812$20240829$20240910$30DAY$$ES-SA-2024SA250930$SANOFI AVENTIS$$$$$$Y$$$20240910$$HP$ES$ES
242620811$24262081$1$I$20240101$20240815$20240829$20240829$EXP$$CA-UCBSA-2024029485$UCB$$$$$F$Y$$$20240829$$MD$CA$CA
242620821$24262082$1$I$20230101$20231204$20240829$20240829$PER$$US-BSC-2023000081$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242620831$24262083$1$I$20240801$20240822$20240829$20240829$EXP$$AR-ROCHE-10000065223$ROCHE$$53$YR$A$F$Y$$$20240829$$MD$AR$AR
242620841$24262084$1$I$20240721$20240819$20240829$20240829$EXP$$IT-AUROBINDO-AUR-APL-2024-042092$AUROBINDO$$94$YR$$F$Y$$$20240829$$MD$IT$IT
242620851$24262085$1$I$$20231013$20240829$20240829$PER$$US-BSC-2023000083$BOSTON SCIENTIFIC$$$$$M$Y$$$20240829$$CN$US$US
242620861$24262086$1$I$$20240822$20240829$20240829$EXP$$US-GSK-US2024104954$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$MD$US$US
242620871$24262087$1$I$20231016$20240220$20240829$20240829$PER$$US-BSC-2023000085$BOSTON SCIENTIFIC$$$$A$M$Y$$$20240829$$HP$US$US
242620881$24262088$1$I$20230101$20231204$20240829$20240829$PER$$US-BSC-2023000082$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242620891$24262089$1$I$$20231016$20240829$20240829$PER$$US-BSC-2023000084$BOSTON SCIENTIFIC$$$$A$M$Y$$$20240829$$HP$US$US
242620901$24262090$1$I$$20231103$20240829$20240829$PER$$US-BSC-2023000090$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$CN$US$US
242620911$24262091$1$I$$20231020$20240829$20240829$PER$$US-BSC-2023000086$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242620921$24262092$1$I$20231023$20231212$20240829$20240829$PER$$US-BSC-2023000087$BOSTON SCIENTIFIC$$$$A$M$Y$$$20240829$$HP$US$US
242620931$24262093$1$I$20231005$20231026$20240829$20240829$PER$$US-BSC-2023000089$BOSTON SCIENTIFIC$$$$$M$Y$$$20240829$$HP$US$US
242620951$24262095$1$I$20240401$20240820$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-026315$UNITED THERAPEUTICS$$65$YR$$F$Y$$$20240829$$$US$US
242620962$24262096$2$F$20240825$20240904$20240829$20240908$PER$$US-ALXN-202408USA001669US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$CN$US$US
242620971$24262097$1$I$20240823$20240826$20240829$20240829$EXP$$US-ABBVIE-5896182$ABBVIE$$78$YR$$M$Y$$$20240829$$CN$US$US
242620991$24262099$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249430$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240829$$MD$US$US
242621001$24262100$1$I$20240101$20240819$20240829$20240829$PER$$US-SA-2024SA220491$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240829$$CN$US$US
242621012$24262101$2$F$20240713$20240905$20240829$20240906$EXP$$DE-SANDOZ INC.-SDZ2024DE075666$SANDOZ$$89$YR$$F$Y$53$KG$20240906$$HP$DE$DE
242621021$24262102$1$I$20240820$20240827$20240829$20240829$EXP$$US-TAKEDA-2024TUS086581$TAKEDA$$28$YR$$M$Y$$$20240829$$CN$US$US
242621031$24262103$1$I$20240703$20240827$20240829$20240829$EXP$FR-AFSSAPS-BX2024001695$FR-SANDOZ INC.-SDZ2024FR075594$SANDOZ$$55$YR$$F$Y$55$KG$20240829$$PH$FR$FR
242621041$24262104$1$I$20240816$20240816$20240829$20240829$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002170$Alvotech$$78$YR$$F$Y$54.422$KG$20240829$$HP$CA$CA
242621051$24262105$1$I$20240101$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136049$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240829$$HP$US$US
242621061$24262106$1$I$20230501$20240822$20240829$20240829$EXP$$DE-CELLTRION INC.-2024DE008591$CELLTRION$$$$$$Y$$$20240829$$MD$DE$DE
242621073$24262107$3$F$$20240828$20240829$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-135482$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240903$$HP$JP$JP
242621081$24262108$1$I$$20240820$20240829$20240829$EXP$$JP-ROCHE-10000066137$ROCHE$$6$DEC$A$$Y$$$20240829$$MD$JP$JP
242621092$24262109$2$F$20240823$20240906$20240829$20240911$PER$$US-AMGEN-USASP2024171592$AMGEN$$61$YR$A$F$Y$$$20240911$$MD$US$US
242621111$24262111$1$I$$20240815$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08318$LUPIN$$$$$$Y$$$20240829$$MD$US$US
242621121$24262112$1$I$20170101$20240105$20240829$20240829$PER$$US-BSC-2023000094$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621131$24262113$1$I$20160601$20240110$20240829$20240829$PER$$US-BSC-2023000093$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621141$24262114$1$I$20200101$20231109$20240829$20240829$PER$$US-BSC-2023000096$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621151$24262115$1$I$20240816$20240821$20240829$20240829$EXP$$CN-SANDOZ INC.-SDZ2024CN074426$SANDOZ$$77$YR$$F$Y$49$KG$20240829$$HP$CN$CN
242621161$24262116$1$I$20200101$20231109$20240829$20240829$PER$$US-BSC-2023000095$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621171$24262117$1$I$$20231109$20240829$20240829$PER$$US-BSC-2023000099$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621181$24262118$1$I$$20231109$20240829$20240829$PER$$US-BSC-2023000100$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621191$24262119$1$I$20210101$20231109$20240829$20240829$PER$$US-BSC-2023000098$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621201$24262120$1$I$20210101$20231109$20240829$20240829$PER$$US-BSC-2023000101$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621211$24262121$1$I$$20231109$20240829$20240829$PER$$US-BSC-2023000097$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621221$24262122$1$I$$20231109$20240829$20240829$PER$$US-BSC-2023000102$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621231$24262123$1$I$$20240826$20240829$20240829$EXP$$CA-GSK-CA2024106069$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$CA$CA
242621241$24262124$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000067998$ROCHE$$$$A$F$Y$$$20240829$$CN$US$US
242621251$24262125$1$I$$20240820$20240829$20240829$EXP$$US-PCCINC-2024-PPL-000637$PIRAMAL$$$$$$Y$$$20240829$$HP$US$US
242621261$24262126$1$I$$20240805$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07930$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242621271$24262127$1$I$$20240823$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135009$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240829$$HP$US$US
242621281$24262128$1$I$$20240823$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135480$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240829$$HP$US$US
242621291$24262129$1$I$20240821$20240822$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134761$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240829$$CN$US$US
242621301$24262130$1$I$20240616$20240826$20240829$20240829$EXP$$US-JNJFOC-20240869300$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240829$$HP$US$US
242621312$24262131$2$F$$20240516$20240829$20240918$EXP$$AU-UCBSA-2024043434$UCB$$$$$F$Y$$$20240918$$CN$AU$AU
242621331$24262133$1$I$20240101$20240821$20240829$20240829$EXP$$CA-CELLTRION INC.-2024CA000908$CELLTRION$$$$$$Y$$$20240829$$CN$CA$CA
242621341$24262134$1$I$20240816$20240820$20240829$20240829$PER$$US-ABBVIE-5887959$ABBVIE$$17$YR$$M$Y$$$20240829$$CN$US$US
242621351$24262135$1$I$20240722$20240806$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004415$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240829$$CN$US$US
242621361$24262136$1$I$$20240820$20240829$20240829$EXP$$US-GSK-US2024103988$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$HP$US$US
242621371$24262137$1$I$$20240819$20240829$20240829$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR107150$VIIV$$$$$$Y$$$20240829$$HP$US$US
242621381$24262138$1$I$$20240827$20240829$20240829$EXP$$US-AstraZeneca-2024A195505$ASTRAZENECA$$$$$$Y$$$20240829$$MD$US$
242621391$24262139$1$I$$20240821$20240829$20240829$EXP$$VN-AstraZeneca-2024A194093$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$VN$
242621401$24262140$1$I$$20240822$20240829$20240829$EXP$$US-AstraZeneca-2024A192184$ASTRAZENECA$$$$$F$Y$$$20240829$$MD$US$
242621411$24262141$1$I$20210101$20231109$20240829$20240829$PER$$US-BSC-2023000103$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621421$24262142$1$I$$20240105$20240829$20240829$PER$$US-BSC-2023000104$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621431$24262143$1$I$$20240821$20240829$20240829$EXP$$CA-AstraZeneca-2024A188956$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$CA$
242621441$24262144$1$I$$20231109$20240829$20240829$PER$$US-BSC-2023000105$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621451$24262145$1$I$$20240822$20240829$20240829$EXP$$CA-AstraZeneca-2024A193645$ASTRAZENECA$$31$YR$$F$Y$71$KG$20240829$$MD$CA$
242621461$24262146$1$I$20240821$20240822$20240829$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026508$UNITED THERAPEUTICS$$83$YR$$F$Y$51.701$KG$20240829$$$US$US
242621471$24262147$1$I$$20231122$20240829$20240829$PER$$US-BSC-2023000112$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$MD$US$US
242621481$24262148$1$I$$20240103$20240829$20240829$PER$$US-BSC-2023000107$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242621501$24262150$1$I$20230301$20231212$20240829$20240829$PER$$US-BSC-2023000108$BOSTON SCIENTIFIC$$70$YR$$$Y$$$20240829$$CN$US$US
242621511$24262151$1$I$20231117$20240201$20240829$20240829$PER$$US-BSC-2023000109$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$HP$US$US
242621521$24262152$1$I$$20231122$20240829$20240829$PER$$US-BSC-2023000113$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242621531$24262153$1$I$$20231122$20240829$20240829$PER$$US-BSC-2023000114$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242621541$24262154$1$I$20240818$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017009$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240829$$CN$US$US
242621551$24262155$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018305$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240829$$CN$US$US
242621561$24262156$1$I$20240401$20240822$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015970$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240829$$CN$US$US
242621571$24262157$1$I$20240826$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017041$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240829$$CN$US$US
242621601$24262160$1$I$20240501$20240823$20240829$20240829$EXP$$US-ABBVIE-5897436$ABBVIE$$33$YR$$M$Y$$$20240829$$CN$US$US
242621611$24262161$1$I$$20240820$20240829$20240829$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP010664$STRIDES$Styczynski T, Sadlok J, Richert-Przygonska M, Debski R, Zalas-Wiecek P, Czyzewski K, et al.. Infection With Saprochaete Clavata in Children After Hematopoietic Cell Transplantation.. J-Pediatr-Hematol-Oncol. 2023;45 (8):e976-e979$14$YR$$F$Y$$$20240829$$MD$PL$PL
242621621$24262162$1$I$$20240806$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07892$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242621631$24262163$1$I$$20240822$20240829$20240829$EXP$$JP-009507513-2408JPN002856J$MERCK$$$$E$$Y$$$20240829$$HP$JP$JP
242621651$24262165$1$I$$20240826$20240829$20240829$PER$$US-ALXN-202408USA001727US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242621661$24262166$1$I$$20240802$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07839$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242621671$24262167$1$I$$20240823$20240829$20240829$EXP$$CO-ASTELLAS-2024-AER-002208$ASTELLAS$$72$YR$E$M$Y$$$20240829$$CN$CO$CO
242621681$24262168$1$I$$20240826$20240829$20240829$EXP$$US-ABBVIE-5895723$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242621691$24262169$1$I$$20240820$20240829$20240829$EXP$$US-PADAGIS-2024PAD01373$PADAGIS$$$$$$Y$$$20240829$$PH$US$US
242621701$24262170$1$I$$20240819$20240829$20240829$PER$$US-ROCHE-10000062397$ROCHE$Wing S, Jafri S. EP08.01-079 Long Term Use of Immune Checkpoint Inhibitors in Patients with Non-Small Cell Lung Cancer (NSCLC) and Abnormal Marrow Pathology: A Case Series. Journal of Thoracic Oncology. 2022-Sep;17 (9):S379. doi:10.1016/j.jtho.2022.07.651.$62$YR$A$F$Y$$$20240829$$HP$US$US
242621711$24262171$1$I$20210930$20240815$20240829$20240829$EXP$$US-COOPERSURGICAL, INC.-2024CPS002517$COOPERSURGICAL$$$$$F$Y$$$20240829$$LW$US$US
242621721$24262172$1$I$20210716$20240815$20240829$20240829$EXP$$US-COOPERSURGICAL, INC.-2024CPS002518$COOPERSURGICAL$$$$$F$Y$$$20240829$$LW$US$US
242621731$24262173$1$I$20220728$20240815$20240829$20240829$EXP$$US-COOPERSURGICAL, INC.-2024CPS002553$COOPERSURGICAL$$$$$F$Y$$$20240829$$LW$US$US
242621741$24262174$1$I$20210702$20240815$20240829$20240829$EXP$$US-COOPERSURGICAL, INC.-2024CPS002524$COOPERSURGICAL$$$$$F$Y$$$20240829$$LW$US$US
242621751$24262175$1$I$20220718$20240815$20240829$20240829$EXP$$US-COOPERSURGICAL, INC.-2024CPS002529$COOPERSURGICAL$$$$$F$Y$$$20240829$$LW$US$US
242621761$24262176$1$I$20210503$20240815$20240829$20240829$EXP$$US-COOPERSURGICAL, INC.-2024CPS002522$COOPERSURGICAL$$$$$F$Y$$$20240829$$LW$US$US
242621771$24262177$1$I$20210715$20240815$20240829$20240829$EXP$$US-COOPERSURGICAL, INC.-2024CPS002542$COOPERSURGICAL$$$$$F$Y$$$20240829$$LW$US$US
242621781$24262178$1$I$$20240821$20240829$20240829$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010782$STRIDES$Takamiya R, Fukuda K, Katsurada N, Kawa Y, Satouchi M, Kaneshiro K, et al.. EP14.05-022 The Drug Induced Interstitial Lung Disease in Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer.. J-Thorac-Oncol. 2022;17 (Suppl.) (9):S553 abstr. EP14.05-022.$$$$$Y$$$20240829$$HP$JP$JP
242621791$24262179$1$I$$20240821$20240829$20240829$PER$$US-JNJFOC-20240859456$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$HP$US$US
242621802$24262180$2$F$20231013$20240904$20240829$20240912$EXP$$CA-CELLTRION INC.-2024CA001452$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
242621811$24262181$1$I$$20240822$20240829$20240829$EXP$$US-GSK-US2024105037$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$MD$US$US
242621821$24262182$1$I$$20240823$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US075246$SANDOZ$$$$$F$Y$$$20240829$$CN$US$US
242621832$24262183$2$F$$20240913$20240829$20240920$EXP$$CA-GSK-CA2024094231$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CA$CA
242621841$24262184$1$I$20221101$20240826$20240829$20240829$EXP$$US-ABBVIE-5643796$ABBVIE$$70$YR$$F$Y$86.182$KG$20240829$$CN$US$US
242621852$24262185$2$F$$20240906$20240829$20240910$EXP$$US-AMGEN-USASP2024168182$AMGEN$$51$YR$A$F$Y$$$20240910$$CN$US$US
242621863$24262186$3$F$20240824$20240828$20240829$20240909$PER$$US-AMGEN-USASP2024171401$AMGEN$$78$YR$E$F$Y$$$20240909$$CN$US$US
242621871$24262187$1$I$$20240813$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08241$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242621881$24262188$1$I$20240801$20240826$20240829$20240829$EXP$$CA-ABBVIE-5897677$ABBVIE$$44$YR$$F$Y$$$20240829$$CN$CA$CA
242621891$24262189$1$I$$20240827$20240829$20240829$EXP$$CA-ROCHE-10000068569$ROCHE$$$$A$F$Y$$$20240829$$CN$CA$CA
242621901$24262190$1$I$$20240814$20240829$20240829$EXP$$BD-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464676$RANBAXY$Hossain MS, Azad MAK, Rahaman MFU, Aftab KA, Rahman IB, Monira S. A Case of Milk Alkali Syndrome: The Forgotten Diagnosis of Generalized Weakness and Altered Consciousness. J Med Bang. 2024;25 (2):184-186$76$YR$$$Y$$$20240829$$HP$BD$BD
242621911$24262191$1$I$20150601$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-361471$RANBAXY$$73$YR$$M$Y$78$KG$20240829$$MD$FR$FR
242621921$24262192$1$I$$20240814$20240829$20240829$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464393$RANBAXY$$$$$F$Y$$$20240829$$MD$US$US
242621932$24262193$2$F$$20240820$20240829$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464692$RANBAXY$Fling C, Granados L, Coruh B. An Ophtha-MALA-gic Anomaly:Metformin Associated Lactic Acidosis Causing Transient Blindness. Am J Respir Crit Care Med. 2023;May;207:A3498;B48$62$YR$$M$Y$$$20240904$$HP$US$US
242621941$24262194$1$I$$20240814$20240829$20240829$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464792$RANBAXY$Ruano-Zaragoza M, Torrent-Rodriguez A, AraujoSanchez G, Ribo P, Loli-Ausejo D, Solis K, et al. Successful Desensitization to Oral Dasatinib in Immediate Hypersensitivity Reaction. J Investig Allergol Clin Immunol. 2024;34 (4):274-276$53$YR$$F$Y$$$20240829$$HP$ES$ES
242621951$24262195$1$I$$20240814$20240829$20240829$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464687$RANBAXY$Lee SH, Lee S, Kim H, Kim G-H. Pseudo-Gitelman Syndrome Presenting with Hypokalemic Metabolic Alkalosis and Hypocalciuria. Electroly Blood Press. 2023;21:72-76$20$YR$$F$Y$$$20240829$$HP$KR$KR
242621961$24262196$1$I$$20240814$20240829$20240829$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464827$RANBAXY$Zou Q, Jiang C, Lin P, Yu Y, Li J, Zhao F, et al. Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period. Front Cardiovasc Med. 2024;11 (0):1388024/1-17$59$YR$$M$Y$50$KG$20240829$$HP$CN$CN
242621971$24262197$1$I$$20240821$20240829$20240829$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010789$STRIDES$Kotamarti V.. Disentangling the Diagnoses of Psychotic Depression, Catatonia, Neurocognitive Disorders, and Delirium: A Multidisciplinary Approach.. Am-J-Geriatr-Psychiatry. 2024;32 (Suppl.) (4):S35-S36$77$YR$$M$Y$$$20240829$$MD$US$US
242621981$24262198$1$I$$20240814$20240829$20240829$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464724$RANBAXY$Esposito P, Cappadona F, Sangregorio F, Costa E, Mallia L, Zanetti V, et al. Combined extracorporeal CO2 removal and renal replacement therapy in a pregnant patient with COVID-19: a case report.. G Ital Nefrol. 2023;40 (2):1-10$34$YR$$F$Y$$$20240829$$HP$IT$IT
242621991$24262199$1$I$$20240814$20240829$20240829$EXP$$SY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464791$RANBAXY$Alaswad M, Hamsho S, Sultan E, Al-Ibrahim M, Merza A, Al-Baroudi Y.. Sulfasalazine^s potential in managing rheumatoid nodules. Medicine. 2024;103 (31):e39209$52$YR$$M$Y$$$20240829$$MD$SY$SY
242622001$24262200$1$I$$20240814$20240829$20240829$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464942$RANBAXY$LeSaint KT, Kendric KJ, Logan AA.. Successful administration of extended-release buprenorphine in the emergency department. Am J Emerg Med. 2024$38$YR$$M$Y$$$20240829$$MD$US$US
242622011$24262201$1$I$20240604$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464536$RANBAXY$$73$YR$$F$Y$62.5$KG$20240829$$MD$FR$FR
242622021$24262202$1$I$$20240814$20240829$20240829$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464740$RANBAXY$Plans-Galvan O, Daniel X, Rosich S, Blazquez-Alcaide V, Gil-Castillejos D, Bodi M. Use of isoflurane as treatment for super-refractory status epilepticus. Rev Neurol. 2023;76 (9):309-312$58$YR$$M$Y$$$20240829$$HP$ES$ES
242622031$24262203$1$I$$20240814$20240829$20240829$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464957$RANBAXY$Zou Q, Jiang C, Lin P, Yu Y, Li J, Zhao F, et al. Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period. Front Cardiovasc Med. 2024;11 (0):1388024/1-17$72$YR$$F$Y$70$KG$20240829$$HP$CN$CN
242622041$24262204$1$I$$20240814$20240829$20240829$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464973$RANBAXY$SHARMA V, MONFASANI A, JSTEIGER D, BECKER CD, NWAOHA N. Symptomatic Presentation of Mycobacterium Xenopi In A Patient with Schamberg Disease. Chest. 2023;164 (Suppl.)4:A1411$20$YR$$F$Y$$$20240829$$HP$US$US
242622051$24262205$1$I$$20240814$20240829$20240829$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464727$RANBAXY$$49$YR$$F$Y$61$KG$20240829$$CN$DE$DE
242622061$24262206$1$I$20230826$20240814$20240829$20240829$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464474$RANBAXY$$84$YR$$F$Y$$$20240829$$MD$IT$IT
242622071$24262207$1$I$$20240814$20240829$20240829$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464955$RANBAXY$Zou Q, Jiang C, Lin P, Yu Y, Li J, Zhao F, et al. Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period. Front Cardiovasc Med. 2024;11 (0):1388024/1-17$45$YR$$F$Y$55$KG$20240829$$HP$CN$CN
242622081$24262208$1$I$$20240814$20240829$20240829$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464825$RANBAXY$Rodriguez-Cuadrado FJ, Roustan-Gullon G, Suarez- Massa D, Hospital-Gil M. Multirefractory bullous pemphigoid, psoriasis and psoriatic arthritis successfully treated with guselkumab. Anais Brasil Dermatol. 2024;99 (5):783-785$48$YR$$M$Y$$$20240829$$HP$ES$ES
242622091$24262209$1$I$$20240814$20240829$20240829$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464338$RANBAXY$$80$YR$$$Y$$$20240829$$PH$GB$GB
242622101$24262210$1$I$20231101$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464278$RANBAXY$$54$YR$$M$Y$96$KG$20240829$$MD$FR$FR
242622111$24262211$1$I$$20240814$20240829$20240829$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464951$RANBAXY$Zou Q, Jiang C, Lin P, Yu Y, Li J, Zhao F, et al. Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period. Front Cardiovasc Med. 2024;11 (0):1388024/1-17$59$YR$$M$Y$72$KG$20240829$$HP$CN$CN
242622121$24262212$1$I$$20240814$20240829$20240829$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464839$RANBAXY$$$$$F$Y$$$20240829$$CN$GB$GB
242622131$24262213$1$I$20230907$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464772$RANBAXY$$46$YR$$F$Y$$$20240829$$MD$FR$FR
242622141$24262214$1$I$$20240814$20240829$20240829$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464906$RANBAXY$Shahab MH, Prasad S, Kalli S, Usmani SS, Liaqat S, Umer M, et al. Treatment of a resistant case of schizoaffective disorder with lumateperone: A case report. SAGE Open Med Case Rep. 2024;12 (0):1-4$27$YR$$F$Y$$$20240829$$HP$US$US
242622151$24262215$1$I$$20240814$20240829$20240829$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464857$RANBAXY$Ramakrishnan R, Munir F, Quesada AE, Tewari SO, Cuglievan B. Down Syndrome with Acute Myeloid Leukemia in an Adolescent Male Successfully Treated with Low Dose Ara-C in Combination with Hypomethylating Agent. Blood. 2023;Nov 2;142(S1):5943-5944;615$25$YR$$M$Y$$$20240829$$MD$US$US
242622161$24262216$1$I$20240312$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464886$RANBAXY$$54$YR$$M$Y$$$20240829$$PH$FR$FR
242622171$24262217$1$I$$20240814$20240829$20240829$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464959$RANBAXY$Zou Q, Jiang C, Lin P, Yu Y, Li J, Zhao F, et al. Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period. Front Cardiovasc Med. 2024;11 (0):1388024/1-17$75$YR$$F$Y$60$KG$20240829$$HP$CN$CN
242622181$24262218$1$I$$20240814$20240829$20240829$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464760$RANBAXY$Peters MG, Apte N, Kalra DK. Wide Complex Tachycardia in a Middle Aged Woman With Diarrhea. JAMA Cardiol. 2024;May;9 (6):582-583$$$$F$Y$$$20240829$$MD$US$US
242622191$24262219$1$I$20240528$20240814$20240829$20240829$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464289$RANBAXY$$77$YR$$M$Y$68$KG$20240829$$MD$IT$IT
242622201$24262220$1$I$$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464648$RANBAXY$Mercier L, Delaye M, Fuerea A, Ducreux M, Boileve A. Oral ADAGRASIB associated with cetuximab unblocks obstructed colorectal cancer. Eur J Cancer. 2024;208 (0):1-3$42$YR$$$Y$$$20240829$$HP$FR$FR
242622212$24262221$2$F$$20240820$20240829$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464680$RANBAXY$Odigwe C.. Suicide Left Ventricle Post -TAVR. South Med J. 2022;115 55:55$80$YR$$F$Y$$$20240904$$MD$US$US
242622221$24262222$1$I$20230604$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465016$RANBAXY$$70$YR$$F$Y$58$KG$20240829$$CN$FR$FR
242622231$24262223$1$I$20230801$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464485$RANBAXY$$67$YR$$F$Y$58$KG$20240829$$PH$FR$FR
242622241$24262224$1$I$$20240814$20240829$20240829$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464928$RANBAXY$Davis P, Evans D. Emergency Department Buprenorphine and Naloxone Prescribing Disparities Among Racial and Ethnic Minorities Presenting With an Opioid Overdose. Advan Emerg Nurs J. 2024;46 (3):187-194$50$YR$$M$Y$$$20240829$$HP$US$US
242622251$24262225$1$I$20240530$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464798$RANBAXY$$48$YR$$M$Y$65.8$KG$20240829$$MD$FR$FR
242622261$24262226$1$I$$20240814$20240829$20240829$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464497$RANBAXY$Hata T, Hara T, Tanizaki K, Okano M, Takayama O, Kim Y, et al. Two Cases of Trousseau Syndrome during Chemotherapy. Gan to Kagaku Ryoho. 2022;49 (13):1628-1630$86$YR$$M$Y$$$20240829$$HP$JP$JP
242622271$24262227$1$I$20240401$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464537$RANBAXY$$84$YR$$M$Y$72$KG$20240829$$MD$FR$FR
242622281$24262228$1$I$$20240814$20240829$20240829$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464963$RANBAXY$Zou Q, Jiang C, Lin P, Yu Y, Li J, Zhao F, et al. Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period. Front Cardiovasc Med. 2024;11 (0):1388024/1-17$68$YR$$F$Y$$$20240829$$HP$CN$CN
242622291$24262229$1$I$20240219$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464285$RANBAXY$$76$YR$$F$Y$108$KG$20240829$$MD$FR$FR
242622301$24262230$1$I$20240511$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464633$RANBAXY$$64$YR$$F$Y$50$KG$20240829$$MD$FR$FR
242622312$24262231$2$F$$20240821$20240829$20240905$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464674$RANBAXY$Goyal A, Jakulla RS, Alarfaj M, Tayeb T, Barker S, Bhyan P, et al.. Myasthenia Crisis Complicated with Takotsubo Cardiomyopathy. US Cardiol. 2024;18 (Suppl.1):7-8/18$77$YR$$F$Y$$$20240905$$HP$US$US
242622321$24262232$1$I$20240506$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464481$RANBAXY$$81$YR$$M$Y$90$KG$20240829$$PH$FR$FR
242622331$24262233$1$I$$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464539$RANBAXY$$38$YR$$M$Y$$$20240829$$CN$FR$FR
242622341$24262234$1$I$20240525$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464936$RANBAXY$$24$YR$$M$Y$$$20240829$$MD$FR$FR
242622351$24262235$1$I$$20240814$20240829$20240829$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464960$RANBAXY$Zou Q, Jiang C, Lin P, Yu Y, Li J, Zhao F, et al. Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period. Front Cardiovasc Med. 2024;11 (0):1388024/1-17$69$YR$$F$Y$69$KG$20240829$$HP$CN$CN
242622361$24262236$1$I$$20240814$20240829$20240829$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464736$RANBAXY$Esposito P, Cappadona F, Sangregorio F, Costa E, Mallia L, Zanetti V, et al. Combined extracorporeal CO2 removal and renal replacement therapy in a pregnant patient with COVID-19: a case report.. G Ital Nefrol. 2023;40 (2):1-10$$$N$F$Y$$$20240829$$HP$IT$IT
242622372$24262237$2$F$20230227$20240829$20240829$20240913$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464863$RANBAXY$$85$YR$$M$Y$$$20240913$$MD$BE$BE
242622381$24262238$1$I$$20240814$20240829$20240829$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464784$RANBAXY$AlNassir B, AlOtaibi H. Aldosterone synthase deficiency associated with a CYP11B2 variant of uncertain significance: Case report and literature review. J Clin Transl Endocrinol Case Rep. 2024;32 (0):100164;1-4$10$MON$$M$Y$5.9$KG$20240829$$HP$SA$SA
242622391$24262239$1$I$$20240814$20240829$20240829$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464677$RANBAXY$Ogawa T, Kawamoto S, Yamamoto K, Atarashi M, Terashima T, Kurogi N. Two Cases of Transfusion-Free Hepatectomy Following Chemotherapy for H3 Grade of Simultaneous Liver Metastases. Gan To Kagaku Ryoho. 2023;50 (2):236-238$72$YR$$F$Y$$$20240829$$HP$JP$JP
242622401$24262240$1$I$$20240814$20240829$20240829$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464755$RANBAXY$$77$YR$$F$Y$$$20240829$$MD$IT$IT
242622411$24262241$1$I$$20240814$20240829$20240829$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464658$RANBAXY$$71$YR$$M$Y$$$20240829$$CN$PL$PL
242622421$24262242$1$I$20240402$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464779$RANBAXY$$17$YR$$F$Y$$$20240829$$MD$FR$FR
242622431$24262243$1$I$$20240814$20240829$20240829$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463625$RANBAXY$Kaur J, Modesto-Lowe V, Leon-Barriera R. Do Not Overlook Bupropion Misuse. Prim Care Companion CNS Disord. 2024;26(2):23lr03685;1-2$$$$M$Y$$$20240829$$MD$US$US
242622441$24262244$1$I$20240524$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464523$RANBAXY$$66$YR$$F$Y$$$20240829$$MD$FR$FR
242622451$24262245$1$I$20161002$20240814$20240829$20240829$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464782$RANBAXY$$92$YR$$F$Y$$$20240829$$PH$FR$FR
242622461$24262246$1$I$$20240814$20240829$20240829$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464684$RANBAXY$Dalivand MM, Abdolazimi R, Alikhani M. Hypokalemic quadriplegia in Sjogren^s syndrome: A case report. Clinical case reports. 2024;12 (8):e9227 (1-5)$38$YR$$F$Y$$$20240829$$HP$IR$IR
242622481$24262248$1$I$20240301$20240827$20240829$20240829$EXP$$CA-ROCHE-10000068633$ROCHE$$33$YR$A$F$Y$$$20240829$$CN$CA$CA
242622491$24262249$1$I$20240101$20240821$20240829$20240829$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034422$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240829$$CN$US$US
242622511$24262251$1$I$$20240827$20240829$20240829$EXP$$US-SANDOZ INC.-NVSC2019US053745$SANDOZ$$16$YR$$M$Y$$$20240829$$MD$US$US
242622521$24262252$1$I$$20240821$20240829$20240829$EXP$$US-TAKEDA-2024TUS064829$TAKEDA$$$$$F$Y$$$20240829$$MD$US$US
242622541$24262254$1$I$20240813$20240820$20240829$20240829$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-116966$REGENERON$$63$YR$$F$Y$$$20240829$$HP$CO$CO
242622551$24262255$1$I$$20240826$20240829$20240829$EXP$$US-ABBVIE-5896059$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242622562$24262256$2$F$20240822$20240919$20240829$20240927$EXP$$US-ABBVIE-5897510$ABBVIE$$72$YR$$F$Y$$$20240927$$CN$US$US
242622571$24262257$1$I$$20240814$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08271$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242622581$24262258$1$I$$20240820$20240829$20240829$EXP$$US-JNJFOC-20240851897$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242622591$24262259$1$I$20240701$20240826$20240829$20240829$EXP$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-114012$GB-STRIDES ARCOLAB LIMITED-2024SP010774$STRIDES$$70$YR$$M$Y$$$20240829$$MD$GB$GB
242622601$24262260$1$I$$20240805$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07887$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242622611$24262261$1$I$$20240814$20240829$20240829$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464961$RANBAXY$Zou Q, Jiang C, Lin P, Yu Y, Li J, Zhao F, et al. Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period. Front Cardiovasc Med. 2024;11 (0):1388024/1-17$76$YR$$M$Y$55$KG$20240829$$HP$CN$CN
242622621$24262262$1$I$$20240823$20240829$20240829$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP010793$STRIDES$Juliao M, Ulrich J, Calaveiras P, Costa E, Lucas I, Faria de SousaP.. Ketamine subcutaneous continuous infusion for non-cancer neuropathic pain at home: a case report.. BMJ-Support-Palliat-Care. 2023;13 (3):e902-e907$94$YR$$F$Y$$$20240829$$HP$PT$PT
242622641$24262264$1$I$20240602$20240814$20240829$20240829$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464704$RANBAXY$$3$YR$$M$Y$20$KG$20240829$$PH$ES$ES
242622651$24262265$1$I$$20240821$20240829$20240829$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP010749$STRIDES$Garcia M, Albizua Madariaga I, Sainz-Gil M, Lertxundi U.. Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database.. Br-J-Clin-Pharmacol. 2024;90 (7):1751-1755$$$$$Y$$$20240829$$HP$ES$ES
242622661$24262266$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170206$AMGEN$$$$$F$Y$$$20240829$$CN$US$US
242622671$24262267$1$I$$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024172197$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242622681$24262268$1$I$$20240821$20240829$20240829$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP010750$STRIDES$Garcia M, Albizua Madariaga I, Sainz-Gil M, Lertxundi U.. Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database.. Br-J-Clin-Pharmacol. 2024;90 (7):1751-1755$$$$$Y$$$20240829$$HP$ES$ES
242622691$24262269$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136562$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$83.46$KG$20240829$$CN$US$US
242622701$24262270$1$I$$20240822$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134739$BRISTOL MYERS SQUIBB$$27$YR$A$M$Y$$$20240829$$CN$US$US
242622711$24262271$1$I$20240101$20240816$20240829$20240829$PER$$US-SA-2024SA247507$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240829$$MD$US$US
242622721$24262272$1$I$$20240821$20240829$20240829$30DAY$$US-SA-2024SA250108$SANOFI AVENTIS$$$$$$Y$$$20240829$$CN$US$US
242622731$24262273$1$I$20240826$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136669$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240829$$HP$US$US
242622741$24262274$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249955$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240829$$CN$US$US
242622751$24262275$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249576$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240829$$MD$US$US
242622771$24262277$1$I$20240819$20240820$20240829$20240829$PER$$US-SA-2024SA249317$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240829$$CN$US$US
242622782$24262278$2$F$$20240906$20240829$20240912$EXP$$JP-JNJFOC-20240875871$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240912$$MD$JP$JP
242622791$24262279$1$I$$20240819$20240829$20240829$EXP$$DE-JNJFOC-20240852392$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240829$$HP$DE$DE
242622801$24262280$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A195578$ASTRAZENECA$$41$YR$$F$Y$$$20240829$$CN$US$
242622811$24262281$1$I$20240823$20240826$20240829$20240829$EXP$$US-AstraZeneca-2024A194226$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242622821$24262282$1$I$$20240814$20240829$20240829$PER$$US-ALIMERA SCIENCES INC.-US-A16013-24-000529$ALIMERA$$$$$M$Y$$$20240829$$CN$US$US
242622831$24262283$1$I$20231127$20231127$20240829$20240829$PER$$US-BSC-2023000115$BOSTON SCIENTIFIC$$50$YR$A$M$Y$$$20240829$$MD$US$US
242622841$24262284$1$I$20231130$20231130$20240829$20240829$PER$$US-BSC-2023000116$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242622851$24262285$1$I$20211103$20231214$20240829$20240829$PER$$US-BSC-2023000119$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$75$YR$$F$Y$$$20240829$$MD$US$US
242622861$24262286$1$I$20231130$20231130$20240829$20240829$PER$$US-BSC-2023000117$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$MD$US$US
242622871$24262287$1$I$20211007$20231214$20240829$20240829$PER$$US-BSC-2023000118$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$64$YR$$M$Y$$$20240829$$MD$US$US
242622881$24262288$1$I$20220411$20231214$20240829$20240829$PER$$US-BSC-2023000120$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$51$YR$$M$Y$$$20240829$$MD$US$US
242622891$24262289$1$I$20240827$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171647$AMGEN$$41$YR$A$F$Y$$$20240829$$CN$US$US
242622911$24262291$1$I$20190507$20231214$20240829$20240829$PER$$US-BSC-2023000121$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$68$YR$$M$Y$$$20240829$$MD$US$US
242622921$24262292$1$I$20240101$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171307$AMGEN$$76$YR$E$F$Y$$$20240829$$CN$US$US
242622931$24262293$1$I$20240826$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171344$AMGEN$$80$YR$E$M$Y$$$20240829$$CN$US$US
242622941$24262294$1$I$$20240823$20240829$20240829$EXP$$CN-AMGEN-CHNSP2024169421$AMGEN$$$$$$Y$$$20240829$$PH$CN$CN
242622951$24262295$1$I$$20240816$20240829$20240829$PER$$US-AstraZeneca-2024A188005$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
242622961$24262296$1$I$20210616$20231214$20240829$20240829$PER$$US-BSC-2023000124$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$41$YR$$F$Y$$$20240829$$MD$US$US
242622971$24262297$1$I$20200113$20231214$20240829$20240829$PER$$US-BSC-2023000123$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$47$YR$$F$Y$$$20240829$$MD$US$US
242622981$24262298$1$I$20190325$20231214$20240829$20240829$PER$$US-BSC-2023000122$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$65$YR$$F$Y$$$20240829$$MD$US$US
242622991$24262299$1$I$20240810$20240826$20240829$20240829$EXP$$US-AstraZeneca-2024A194208$ASTRAZENECA$$32715$DY$$F$Y$$$20240829$$HP$US$
242623001$24262300$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A190911$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
242623011$24262301$1$I$20240621$20240826$20240829$20240829$EXP$$US-AstraZeneca-2024A194243$ASTRAZENECA$$27778$DY$$M$Y$$$20240829$$CN$US$
242623031$24262303$1$I$20240412$20240826$20240829$20240829$EXP$$US-AstraZeneca-2024A194389$ASTRAZENECA$$26368$DY$$F$Y$$$20240829$$HP$US$
242623041$24262304$1$I$$20240821$20240829$20240829$EXP$$BG-AstraZeneca-2024A192956$ASTRAZENECA$$$$A$F$Y$$$20240829$$HP$BG$
242623052$24262305$2$F$20240805$20240827$20240829$20240919$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000506$BECTON DICKINSON$$$$$$Y$$$20240919$$CN$GB$GB
242623062$24262306$2$F$20240805$20240827$20240829$20240919$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000507$BECTON DICKINSON$$$$$$Y$$$20240919$$CN$GB$GB
242623071$24262307$1$I$$20240822$20240829$20240829$PER$$US-TAKEDA-2024TUS085347$TAKEDA$$$$$M$Y$$$20240829$$CN$US$US
242623081$24262308$1$I$$20240806$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004417$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242623091$24262309$1$I$$20240826$20240829$20240829$PER$$US-BIOGEN-2024BI01279885$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
242623102$24262310$2$F$$20240829$20240829$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07902$LUPIN$$$$$$Y$$$20240913$$CN$US$US
242623111$24262311$1$I$20200825$20231214$20240829$20240829$PER$$US-BSC-2023000127$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$59$YR$$M$Y$$$20240829$$MD$US$US
242623121$24262312$1$I$20180627$20231214$20240829$20240829$PER$$US-BSC-2023000125$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$73$YR$$F$Y$$$20240829$$MD$US$US
242623131$24262313$1$I$20180627$20231214$20240829$20240829$PER$$US-BSC-2023000126$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$73$YR$$F$Y$$$20240829$$MD$US$US
242623141$24262314$1$I$20240809$20240821$20240829$20240829$EXP$FR-AFSSAPS-MA2024001376$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08002$HIKMA$$60$YR$$M$Y$$$20240829$$MD$FR$FR
242623151$24262315$1$I$20191114$20231214$20240829$20240829$PER$$US-BSC-2023000129$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$69$YR$$M$Y$$$20240829$$MD$US$US
242623161$24262316$1$I$20231129$20231213$20240829$20240829$PER$$US-BSC-2023000131$BOSTON SCIENTIFIC$$$$A$F$Y$$$20240829$$MD$US$US
242623171$24262317$1$I$20211028$20231214$20240829$20240829$PER$$US-BSC-2023000128$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$49$YR$$F$Y$$$20240829$$MD$US$US
242623181$24262318$1$I$$20240828$20240829$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA075949$SANDOZ$$11$YR$$F$Y$$$20240829$$HP$CA$CA
242623191$24262319$1$I$20230928$20240827$20240829$20240829$EXP$GB-MHRA-MED-202408270745395860-NYMJH$GB-SANDOZ INC.-SDZ2024GB075825$SANDOZ$$67$YR$$F$Y$52$KG$20240829$$CN$GB$GB
242623201$24262320$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017256$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240829$$CN$US$US
242623211$24262321$1$I$$20240820$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015871$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242623221$24262322$1$I$$20240823$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016002$ELI LILLY AND CO$$53$YR$A$$Y$$$20240829$$LW$US$US
242623241$24262324$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016476$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240829$$CN$US$US
242623262$24262326$2$F$20240628$20240905$20240829$20240914$EXP$$US-ABBVIE-5889702$ABBVIE$$58$YR$$F$Y$$$20240914$$CN$US$US
242623271$24262327$1$I$20240708$20240822$20240829$20240829$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047268$BOEHRINGER INGELHEIM$$58$YR$A$M$Y$$$20240829$$CN$US$US
242623291$24262329$1$I$$20240815$20240829$20240829$EXP$GB-MHRA-MED-202408151507220520-MFNJD$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-07920$HIKMA$$51$YR$$F$Y$$$20240829$$HP$GB$GB
242623301$24262330$1$I$$20240820$20240829$20240829$EXP$$US-ROCHE-10000062411$ROCHE$$77$YR$E$F$Y$$$20240829$$CN$US$US
242623311$24262331$1$I$20240810$20240820$20240829$20240829$EXP$FR-AFSSAPS-PA2024001472$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111412$ZYDUS PHARM$$$$$$Y$$$20240829$$MD$FR$FR
242623322$24262332$2$F$$20240823$20240829$20240829$EXP$$US-AMGEN-USASP2024169366$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242623351$24262335$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137032$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240829$$CN$US$US
242623361$24262336$1$I$$20240827$20240829$20240829$EXP$$CA-ORGANON-O2408CAN001996$ORGANON$$$$$F$Y$$$20240829$$HP$CA$CA
242623371$24262337$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174314$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242623381$24262338$1$I$$20240827$20240829$20240829$EXP$$NVSC2024US173753$NOVARTIS$$$$A$M$Y$$$20240829$$MD$US$US
242623401$24262340$1$I$$20240823$20240829$20240829$EXP$$IT-AMGEN-ITASP2024168820$AMGEN$Petti, M.C.. High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias. Annals of Hematology. 2003;82(8):476-480$64$YR$A$M$Y$$$20240829$$HP$IT$IT
242623411$24262341$1$I$$20240828$20240829$20240829$PER$$US-JNJFOC-20240874572$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$HP$US$US
242623421$24262342$1$I$$20240819$20240829$20240829$30DAY$$US-GSK-US2024AMR104070$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242623431$24262343$1$I$$20240820$20240829$20240829$EXP$$CA-GSK-CA2024103902$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$MD$CA$CA
242623442$24262344$2$F$$20240830$20240829$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08115$LUPIN$$$$$$Y$$$20240920$$CN$US$US
242623451$24262345$1$I$20230825$20240103$20240829$20240829$PER$$US-BSC-2024000002$BOSTON SCIENTIFIC$$53$YR$$F$Y$77.1$KG$20240829$$HP$US$US
242623461$24262346$1$I$$20240112$20240829$20240829$PER$$US-BSC-2024000003$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$CN$US$US
242623471$24262347$1$I$20231201$20240118$20240829$20240829$PER$$US-BSC-2024000004$BOSTON SCIENTIFIC$$$$A$F$Y$$$20240829$$MD$US$US
242623481$24262348$1$I$$20240123$20240829$20240829$PER$$US-BSC-2024000009$BOSTON SCIENTIFIC$Amanda L. Chin, Stephanie D. Talutis, Peter F. Lawrence, Karen Woo, David A. Rigberg, Johnathon C. Rollo, Juan Carlos Jimenez Factors Associated with Ablation Related Thrombus Extension (ARTE) Following Microfoam Versus Radiofrequency Saphenous Vein Closure$$$$$Y$$$20240829$$MD$US$US
242623491$24262349$1$I$20240112$20240118$20240829$20240829$PER$$US-BSC-2024000005$BOSTON SCIENTIFIC$$$$A$F$Y$$$20240829$$HP$US$US
242623501$24262350$1$I$$20240123$20240829$20240829$PER$$US-BSC-2024000008$BOSTON SCIENTIFIC$Amanda L. Chin, Stephanie D. Talutis, Peter F. Lawrence, Karen Woo, David A. Rigberg, Johnathon C. Rollo, Juan Carlos Jimenez. Factors Associated with Ablation Related Thrombus Extension (ARTE) Following Microfoam Versus Radiofrequency Saphenous Vein Closure.$$$$$Y$$$20240829$$MD$US$US
242623511$24262351$1$I$$20240123$20240829$20240829$PER$$US-BSC-2024000007$BOSTON SCIENTIFIC$Amanda L. Chin, Stephanie D. Talutis, Peter F. Lawrence, Karen Woo, David A. Rigberg, Johnathon C. Rollo, Juan Carlos Jimenez. Factors Associated with Ablation Related Thrombus Extension (ARTE) Following Microfoam Versus Radiofrequency Saphenous Vein Closure.$$$$$Y$$$20240829$$MD$US$US
242623521$24262352$1$I$$20240123$20240829$20240829$PER$$US-BSC-2024000006$BOSTON SCIENTIFIC$Amanda L. Chin, Stephanie D. Talutis, Peter F. Lawrence, Karen Woo, David A. Rigberg, Johnathon C. Rollo, Juan Carlos Jimenez. Factors Associated with Ablation Related Thrombus Extension (ARTE) Following Microfoam Versus Radiofrequency Saphenous Vein Closure.$$$$$Y$$$20240829$$MD$US$US
242623531$24262353$1$I$$20240123$20240829$20240829$PER$$US-BSC-2024000010$BOSTON SCIENTIFIC$Amanda L. Chin, Stephanie D. Talutis, Peter F. Lawrence, Karen Woo, David A. Rigberg, Johnathon C. Rollo, Juan Carlos Jimenez Factors Associated with Ablation Related Thrombus Extension (ARTE) Following Microfoam Versus Radiofrequency Saphenous Vein Closure$$$$$Y$$$20240829$$MD$US$US
242623541$24262354$1$I$20231204$20240126$20240829$20240829$PER$$US-BSC-2024000015$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242623551$24262355$1$I$20231204$20240126$20240829$20240829$PER$$US-BSC-2024000013$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242623561$24262356$1$I$20240216$20240216$20240829$20240829$PER$$US-BSC-2024000019$BOSTON SCIENTIFIC$$68$YR$E$F$Y$$$20240829$$HP$US$US
242623571$24262357$1$I$20231227$20240126$20240829$20240829$PER$$US-BSC-2024000016$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242623581$24262358$1$I$20240201$20240408$20240829$20240829$PER$$US-BSC-2024000020$BOSTON SCIENTIFIC$$88$YR$E$F$Y$$$20240829$$HP$US$US
242623591$24262359$1$I$$20240123$20240829$20240829$PER$$US-BSC-2024000012$BOSTON SCIENTIFIC$Amanda L. Chin, Stephanie D. Talutis, Peter F. Lawrence, Karen Woo, David A. Rigberg, Johnathon C. Rollo, Juan Carlos Jimenez Factors Associated with Ablation Related Thrombus Extension (ARTE) Following Microfoam Versus Radiofrequency Saphenous Vein Closure$$$$$Y$$$20240829$$MD$US$US
242623601$24262360$1$I$$20240123$20240829$20240829$PER$$US-BSC-2024000011$BOSTON SCIENTIFIC$Amanda L. Chin, Stephanie D. Talutis, Peter F. Lawrence, Karen Woo, David A. Rigberg, Johnathon C. Rollo, Juan Carlos Jimenez Factors Associated with Ablation Related Thrombus Extension (ARTE) Following Microfoam Versus Radiofrequency Saphenous Vein Closure$$$$$Y$$$20240829$$MD$US$US
242623621$24262362$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004455$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242623632$24262363$2$F$20240813$20240909$20240829$20240916$EXP$$DE-SANDOZ INC.-SDZ2024DE075532$SANDOZ$$76$YR$$M$Y$$$20240916$$MD$DE$DE
242623641$24262364$1$I$20240617$20240827$20240829$20240829$EXP$ES-MEN-2024-108215$ES-MEN-2024-108215$MENARINI$$78$YR$$M$Y$$$20240829$$MD$ES$ES
242623651$24262365$1$I$$20240823$20240829$20240829$EXP$$US-AMGEN-USASP2024169855$AMGEN$$72$YR$E$M$Y$$$20240829$$CN$US$US
242623661$24262366$1$I$20240808$20240827$20240829$20240829$EXP$$DE-ROCHE-10000068261$ROCHE$$58$YR$A$F$Y$$$20240829$$MD$DE$DE
242623671$24262367$1$I$$20240820$20240829$20240829$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-115744$REGENERON$$78$YR$$M$Y$$$20240829$$MD$JP$JP
242623681$24262368$1$I$$20240823$20240829$20240829$PER$$US-GRUNENTHAL-2024-124477$AVERITAS$$$$E$M$Y$$$20240827$$HP$US$US
242623691$24262369$1$I$20240824$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170374$AMGEN$$61$YR$A$F$Y$$$20240829$$CN$US$US
242623711$24262371$1$I$$20240823$20240829$20240829$PER$$US-BIOGEN-2024BI01279895$BIOGEN$$$$$M$Y$$$20240829$$CN$US$US
242623731$24262373$1$I$20240101$20240823$20240829$20240829$PER$$US-BIOGEN-2024BI01279854$BIOGEN$$$$$M$Y$$$20240829$$CN$US$US
242623742$24262374$2$F$$20240901$20240829$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134114$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240905$$HP$US$US
242623751$24262375$1$I$$20240827$20240829$20240829$EXP$$NVSC2024US173735$NOVARTIS$$$$$M$Y$140.61$KG$20240829$$CN$US$US
242623771$24262377$1$I$$20240827$20240829$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA037174$SANDOZ$$3$MON$$M$Y$$$20240829$$CN$CA$CA
242623781$24262378$1$I$$20240821$20240829$20240829$EXP$$CN-AstraZeneca-2024A191960$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$CN$
242623791$24262379$1$I$$20240814$20240829$20240829$EXP$$CA-GRANULES-CA-2024GRALIT00377$GRANULES INDIA$Stephen A. Hoption Cann.Acetaminophen as a cause of  ^^non-acetaminophen-related  acute liver failure^^.CMAJ: Canadian Medical Association Journal .15-JUL-2024;196 (25):E883$18$YR$T$M$Y$$$20240829$$HP$CA$CA
242623801$24262380$1$I$$20240822$20240829$20240829$EXP$$US-AstraZeneca-2024A193457$ASTRAZENECA$$$$$M$Y$95$KG$20240829$$CN$US$
242623812$24262381$2$F$$20240826$20240829$20240904$PER$$US-AMGEN-USASP2024170184$AMGEN$$$$$F$Y$$$20240904$$PH$US$US
242623821$24262382$1$I$$20240813$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08122$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242623831$24262383$1$I$$20240819$20240829$20240829$EXP$$JP-ROCHE-3551320$ROCHE$Kawano T, Atsukawa M, Iwakiri K. A case of successful Lenvatinib for bone metastases from HCC complicated by psoriasiform dermatitis [Abstract number: P-0802]. Hepatology International. 2024-Mar;18 (SUP 1):S711.$7$DEC$E$M$Y$$$20240829$$MD$JP$JP
242623841$24262384$1$I$20220101$20240814$20240829$20240829$EXP$$IN-GRANULES-IN-2024GRALIT00373$GRANULES INDIA$PRATIK CHABHADIYA.Acetaminophen-Induced Toxic Epidermal Necrolysis In Pediatric Patients-A Case Series.International Journal of Pharmacy and Pharmaceutical Science.2024;16 (7):50-53$16$YR$T$M$Y$$$20240829$$HP$IN$IN
242623851$24262385$1$I$20240812$20240819$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041757$AUROBINDO$$74$YR$$M$Y$84$KG$20240829$$HP$GB$GB
242623861$24262386$1$I$$20240228$20240829$20240829$PER$$US-BSC-2024000021$BOSTON SCIENTIFIC$$$$A$M$Y$$$20240829$$CN$US$US
242623871$24262387$1$I$$20240308$20240829$20240829$PER$$US-BSC-2024000023$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$MD$US$US
242623881$24262388$1$I$$20240321$20240829$20240829$PER$$US-BSC-2024000027$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$CN$US$US
242623891$24262389$1$I$$20240312$20240829$20240829$PER$$US-BSC-2024000024$BOSTON SCIENTIFIC$$$$A$F$Y$$$20240829$$MD$US$US
242623901$24262390$1$I$$20240322$20240829$20240829$PER$$US-BSC-2024000028$BOSTON SCIENTIFIC$$31$YR$$F$Y$$$20240829$$CN$US$US
242623911$24262391$1$I$20240301$20240313$20240829$20240829$PER$$US-BSC-2024000025$BOSTON SCIENTIFIC$$$$$M$Y$$$20240829$$MD$US$US
242623921$24262392$1$I$$20240322$20240829$20240829$PER$$US-BSC-2024000030$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242623931$24262393$1$I$$20240322$20240829$20240829$PER$$US-BSC-2024000029$BOSTON SCIENTIFIC$$75$YR$$F$Y$$$20240829$$CN$US$US
242623941$24262394$1$I$$20240401$20240829$20240829$PER$$US-BSC-2024000031$BOSTON SCIENTIFIC$$82$YR$$F$Y$$$20240829$$MD$US$US
242623951$24262395$1$I$$20240401$20240829$20240829$PER$$US-BSC-2024000032$BOSTON SCIENTIFIC$$$$$M$Y$$$20240829$$MD$US$US
242623961$24262396$1$I$20240405$20240408$20240829$20240829$PER$$US-BSC-2024000034$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$MD$US$
242623981$24262398$1$I$$20240417$20240829$20240829$EXP$$US-BSC-2024000036$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$HP$US$US
242623991$24262399$1$I$20240409$20240419$20240829$20240829$PER$$US-BSC-2024000039$BOSTON SCIENTIFIC$$71$YR$E$F$Y$97$KG$20240829$$HP$US$US
242624001$24262400$1$I$20240305$20240419$20240829$20240829$PER$$US-BSC-2024000037$BOSTON SCIENTIFIC$$52$YR$$F$Y$54$KG$20240829$$HP$US$US
242624011$24262401$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000040$BOSTON SCIENTIFIC$Mariam Mesa, Francisco Melesio, Jailenne Qui?ones-Rodr?guez, Rafael Demarchi Malgor, Limael Rodr?guez. Early Experience Managing Intravascular Coagulum Using Polidocanol Endovenous Foam: Risk Factor Analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders. Volume 12, Number 3:37.$$$$$Y$$$20240829$$HP$US$US
242624021$24262402$1$I$20240419$20240419$20240829$20240829$PER$$US-BSC-2024000038$BOSTON SCIENTIFIC$$62$YR$A$F$Y$82$KG$20240829$$HP$US$US
242624031$24262403$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000042$BOSTON SCIENTIFIC$Mariam Mesa, Francisco Melesio, Jailenne Qui?ones-Rodr?guez, Rafael Demarchi Malgor, Limael Rodr?guez. Early Experience Managing Intravascular Coagulum Using Polidocanol Endovenous Foam: Risk Factor Analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders. Volume 12, Number 3:37.$$$$$Y$$$20240829$$HP$US$US
242624041$24262404$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000041$BOSTON SCIENTIFIC$Mariam Mesa, Francisco Melesio, Jailenne Qui?ones-Rodr?guez, Rafael Demarchi Malgor, Limael Rodr?guez. . Early Experience Managing Intravascular Coagulum Using Polidocanol Endovenous Foam: Risk Factor Analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders. Volume 12, Number 3:37.$$$$$Y$$$20240829$$HP$US$US
242624051$24262405$1$I$$20240814$20240829$20240829$EXP$$US-GRANULES-US-2024GRALIT00371$GRANULES INDIA$Cohen Phillip.Repeated Hemodialysis After Extended-Release Acetaminophen Ingestion.Critical Care Medicine.JAN-2024;52 (1):S301 abstr. 657$15$YR$T$M$Y$$$20240829$$HP$US$US
242624061$24262406$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5893547$ABBVIE$$32$YR$$F$Y$$$20240829$$HP$US$US
242624071$24262407$1$I$20240815$20240815$20240829$20240829$PER$$US-GRANULES-US-2024GRASPO00380$GRANULES INDIA$$$$$$Y$$$20240829$$CN$US$US
242624081$24262408$1$I$20240101$20240823$20240829$20240829$EXP$$NVSC2024BR067587$NOVARTIS$$51$YR$$F$Y$$$20240829$$CN$BR$BR
242624091$24262409$1$I$$20240819$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041782$AUROBINDO$$70$YR$$F$Y$64$KG$20240829$$MD$GB$GB
242624101$24262410$1$I$$20240823$20240829$20240829$EXP$$US-EMD Serono-2024045607$EMD SERONO INC$$$$A$M$Y$$$20240829$$CN$US$US
242624111$24262411$1$I$20240816$20240819$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041897$AUROBINDO$$67$YR$$F$Y$75$KG$20240829$$MD$GB$GB
242624121$24262412$1$I$$20240822$20240829$20240829$EXP$$CA-BEH-2024177658$CSL BEHRING$$72$YR$E$M$Y$105$KG$20240829$$CN$CA$CA
242624141$24262414$1$I$$20240827$20240829$20240829$EXP$$CA-ROCHE-10000068592$ROCHE$$$$A$F$Y$$$20240829$$CN$CA$CA
242624151$24262415$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042549$AUROBINDO$$75$YR$$M$Y$$$20240829$$CN$CA$CA
242624161$24262416$1$I$$20240828$20240829$20240829$PER$$US-ROCHE-10000069007$ROCHE$$$$A$F$Y$$$20240829$$CN$US$US
242624171$24262417$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000043$BOSTON SCIENTIFIC$Mariam Mesa, Francisco Melesio, Jailenne Qui?ones-Rodr?guez, Rafael Demarchi Malgor, Limael Rodr?guez. Early Experience Managing Intravascular Coagulum Using Polidocanol Endovenous Foam: Risk Factor Analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders.  Volume 12, Number 3:37.$$$$$Y$$$20240829$$HP$US$US
242624181$24262418$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000044$BOSTON SCIENTIFIC$Mariam Mesa, Francisco Melesio, Jailenne Qui?ones-Rodr?guez, Rafael Demarchi Malgor, Limael Rodr?guez. Early Experience Managing Intravascular Coagulum Using Polidocanol Endovenous Foam: Risk Factor Analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders.  Volume 12, Number 3:37.$$$$$Y$$$20240829$$HP$US$US
242624191$24262419$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000047$BOSTON SCIENTIFIC$Mariam Mesa, Francisco Melesio, Jailenne Qui?ones-Rodr?guez, Rafael Demarchi Malgor, Limael Rodr?guez. Early Experience Managing Intravascular Coagulum Using Polidocanol Endovenous Foam: Risk Factor Analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders. Volume 12, Number 3:37.$$$$$Y$$$20240829$$HP$US$US
242624201$24262420$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000046$BOSTON SCIENTIFIC$Mariam Mesa, Francisco Melesio, Jailenne Qui?ones-Rodr?guez, Rafael Demarchi Malgor, Limael Rodr?guez. Early Experience Managing Intravascular Coagulum Using Polidocanol Endovenous Foam: Risk Factor Analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders. Volume 12, Number 3:37.$$$$$Y$$$20240829$$HP$US$US
242624211$24262421$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000045$BOSTON SCIENTIFIC$Mariam Mesa, Francisco Melesio, Jailenne Qui?ones-Rodr?guez, Rafael Demarchi Malgor, Limael Rodr?guez. . Early Experience Managing Intravascular Coagulum Using Polidocanol Endovenous Foam: Risk Factor Analysis. . Journal of Vascular Surgery: Venous and Lymphatic Disorders. . Volume 12, Number 3:37.$$$$$Y$$$20240829$$HP$US$US
242624221$24262422$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000048$BOSTON SCIENTIFIC$Mariam Mesa, Francisco Melesio, Jailenne Qui?ones-Rodr?guez, Rafael Demarchi Malgor, Limael Rodr?guez. Early Experience Managing Intravascular Coagulum Using Polidocanol Endovenous Foam: Risk Factor Analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders. Volume 12, Number 3:37.$$$$$Y$$$20240829$$HP$US$US
242624231$24262423$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000049$BOSTON SCIENTIFIC$Mariam Mesa, Francisco Melesio, Jailenne Qui?ones-Rodr?guez, Rafael Demarchi Malgor, Limael Rodr?guez. Early Experience Managing Intravascular Coagulum Using Polidocanol Endovenous Foam: Risk Factor Analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders. Volume 12, Number 3:37.$$$$$Y$$$20240829$$HP$US$US
242624241$24262424$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000051$BOSTON SCIENTIFIC$Mariam Mesa, Francisco Melesio, Jailenne Qui?ones-Rodr?guez, Rafael Demarchi Malgor, Limael Rodr?guez. Early Experience Managing Intravascular Coagulum Using Polidocanol Endovenous Foam: Risk Factor Analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders. Volume 12, Number 3:$$$$$Y$$$20240829$$HP$US$US
242624251$24262425$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000050$BOSTON SCIENTIFIC$Mariam Mesa, Francisco Melesio, Jailenne Qui?ones-Rodr?guez, Rafael Demarchi Malgor, Limael Rodr?guez. Early Experience Managing Intravascular Coagulum Using Polidocanol Endovenous Foam: Risk Factor Analysis. Journal of Vascular Surgery: Venous and Lymphatic Disorders. Volume 12, Number 3:37.$$$$$Y$$$20240829$$HP$US$US
242624261$24262426$1$I$$20240620$20240829$20240829$PER$$US-BSC-2024000052$BOSTON SCIENTIFIC$$$$A$F$Y$$$20240829$$MD$US$US
242624271$24262427$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000056$BOSTON SCIENTIFIC$Fang J, Fang C, Moyal A, Ascher E, Hingorani A, Marks N. Factors Associated with Recanalization and Reintervention Following Below Knee Polidocanol Endovenous Microfoam Ablation for Great Saphenous and Small Saphenous Veins. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2024 Apr 3;101886:$$$$$Y$$$20240829$$HP$US$US
242624282$24262428$2$F$$20240829$20240829$20240903$EXP$$CA-BEH-2024177610$CSL BEHRING$$58$YR$A$F$Y$75$KG$20240903$$CN$CA$CA
242624291$24262429$1$I$$20240423$20240829$20240829$PER$$US-BSC-2024000054$BOSTON SCIENTIFIC$Fang J, Fang C, Moyal A, Ascher E, Hingorani A, Marks N. Factors Associated with Recanalization and Reintervention Following Below Knee Polidocanol Endovenous Microfoam Ablation for Great Saphenous and Small Saphenous Veins . Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2024 Apr 3;101886:$$$$$Y$$$20240829$$HP$US$US
242624301$24262430$1$I$$20240424$20240829$20240829$PER$$US-BSC-2024000055$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$HP$US$US
242624311$24262431$1$I$20240422$20240423$20240829$20240829$PER$$US-BSC-2024000053$BOSTON SCIENTIFIC$$49$YR$A$F$Y$$$20240829$$MD$US$US
242624321$24262432$1$I$$20240430$20240829$20240829$PER$$US-BSC-2024000059$BOSTON SCIENTIFIC$$33$YR$$F$Y$$$20240829$$CN$US$US
242624331$24262433$1$I$20240508$20240509$20240829$20240829$PER$$US-BSC-2024000061$BOSTON SCIENTIFIC$$87$YR$E$F$Y$$$20240829$$HP$US$US
242624341$24262434$1$I$$20240820$20240829$20240829$PER$$US-ABBVIE-5890563$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242624351$24262435$1$I$20240426$20240509$20240829$20240829$PER$$US-BSC-2024000063$BOSTON SCIENTIFIC$$41$YR$A$F$Y$$$20240829$$CN$US$US
242624361$24262436$1$I$$20240621$20240829$20240829$PER$$US-BSC-2024000062$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242624371$24262437$1$I$20240408$20240408$20240829$20240829$PER$$US-BSC-2024000065$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$CN$US$US
242624381$24262438$1$I$20240522$20240522$20240829$20240829$PER$$US-BSC-2024000066$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$MD$US$US
242624391$24262439$1$I$20240101$20240816$20240829$20240829$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004449$PAREXEL$$$$$$Y$$$20240829$$CN$US$US
242624402$24262440$2$F$20240201$20240905$20240829$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-041721$AUROBINDO$$6$YR$$F$Y$20$KG$20240918$$CN$GB$GB
242624411$24262441$1$I$$20240813$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08121$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242624421$24262442$1$I$$20240731$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07860$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242624431$24262443$1$I$$20240822$20240829$20240829$EXP$$CO-VANTIVE-2024VAN019180$Vantive US Healthcare$$$$$M$Y$76$KG$20240829$$HP$CO$CO
242624442$24262444$2$F$$20240906$20240829$20240913$EXP$$IN-VANTIVE-2024VAN019301$Vantive US Healthcare$$49$YR$$M$Y$$$20240913$$CN$IN$IN
242624452$24262445$2$F$$20240829$20240829$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004458$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
242624461$24262446$1$I$20240818$20240822$20240829$20240829$EXP$$CO-VANTIVE-2024VAN019179$Vantive US Healthcare$$83$YR$$F$Y$52$KG$20240829$$HP$CO$CO
242624472$24262447$2$F$$20240906$20240829$20240913$EXP$$IN-VANTIVE-2024VAN019300$Vantive US Healthcare$$62$YR$$M$Y$$$20240913$$CN$IN$IN
242624482$24262448$2$F$$20240902$20240829$20240911$EXP$$NL-TEVA-VS-3237026$TEVA$Van Der Arend BWH, Van Veelen N, De Ruijter JET, Olsen MH, Maassen Van Den Brink A and Terwindt GM. Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine. Front. Neurol. 2024, 15:1387044.$43$YR$$F$Y$$$20240911$$HP$NL$NL
242624491$24262449$1$I$20240416$20240801$20240829$20240829$PER$$IE-TOLMAR, INC.-24IE051137$TOLMAR$$74$YR$$M$Y$$$20240829$$MD$IE$IE
242624501$24262450$1$I$20240402$20240731$20240829$20240829$PER$$NL-TOLMAR, INC.-24NL051497$TOLMAR$$77$YR$$M$Y$$$20240829$$CN$NL$NL
242624511$24262451$1$I$20240222$20240801$20240829$20240829$PER$$NL-TOLMAR, INC.-24NL051571$TOLMAR$$74$YR$$M$Y$$$20240829$$CN$NL$NL
242624521$24262452$1$I$20240801$20240802$20240829$20240829$PER$$PA-TOLMAR, INC.-24PA051675$TOLMAR$$91$YR$$M$Y$$$20240829$$CN$PA$PA
242624531$24262453$1$I$20240701$20240802$20240829$20240829$PER$$NL-TOLMAR, INC.-24NL051658$TOLMAR$$72$YR$$M$Y$$$20240829$$HP$NL$NL
242624541$24262454$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249898$SANOFI AVENTIS$$$$E$M$Y$$$20240829$$MD$US$US
242624551$24262455$1$I$20240101$20240827$20240829$20240829$PER$$US-ABBVIE-5898121$ABBVIE$$$$$F$Y$$$20240829$$HP$US$US
242624561$24262456$1$I$20240814$20240828$20240829$20240829$EXP$$CN-ROCHE-10000068701$ROCHE$$59$YR$A$F$Y$54$KG$20240829$$HP$CN$CN
242624572$24262457$2$F$20240815$20240829$20240829$20240902$PER$$US-ROCHE-10000068885$ROCHE$$41$YR$A$F$Y$72.57$KG$20240902$$CN$US$US
242624581$24262458$1$I$$20240819$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131132$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240829$$HP$US$US
242624591$24262459$1$I$$20240819$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131506$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240829$$HP$US$US
242624611$24262461$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137081$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240829$$CN$US$US
242624621$24262462$1$I$20240802$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136745$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240829$$HP$US$US
242624632$24262463$2$F$$20240917$20240829$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136783$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$88.45$KG$20240919$$CN$US$US
242624641$24262464$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042450$AUROBINDO$$82$YR$$F$Y$$$20240829$$HP$CA$CA
242624652$24262465$2$F$20240730$20240831$20240829$20240905$EXP$DE-DCGMA-24203765$DE-TORRENT-00027231$TORRENT$$66$YR$E$M$Y$$$20240905$$MD$DE$DE
242624662$24262466$2$F$20240803$20240831$20240829$20240904$EXP$DE-DCGMA-24203758$DE-TORRENT-00027229$TORRENT$$$$$F$Y$57$KG$20240904$$MD$DE$DE
242624671$24262467$1$I$$20240805$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07938$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242624681$24262468$1$I$20240805$20240826$20240829$20240829$EXP$DE-AMK-279444$DE-TORRENT-00027234$TORRENT$$67$YR$E$F$Y$$$20240829$$PH$DE$DE
242624691$24262469$1$I$$20240823$20240829$20240829$EXP$GB-MHRA-MED-202408231918201240-SFTWV$GB-TORRENT-00037713$TORRENT$$4$YR$C$F$Y$16$KG$20240829$$CN$GB$GB
242624701$24262470$1$I$20240701$20240823$20240829$20240829$EXP$GB-MHRA-MED-202408231439294480-JKGRB$GB-TORRENT-00037715$TORRENT$$32$YR$A$F$Y$$$20240829$$MD$GB$GB
242624721$24262472$1$I$20240501$20240827$20240829$20240829$EXP$GB-MHRA-MED-202408271819015540-YDQLC$GB-SANDOZ INC.-SDZ2024GB075981$SANDOZ$$86$YR$$F$Y$66$KG$20240829$$CN$GB$GB
242624731$24262473$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042494$AUROBINDO$$78$YR$$M$Y$$$20240829$$HP$CA$CA
242624742$24262474$2$F$$20240911$20240829$20240923$EXP$$GB-TAKEDA-2024TUS083052$TAKEDA$$$$$F$Y$$$20240923$$CN$GB$GB
242624751$24262475$1$I$$20240528$20240829$20240829$PER$$US-BSC-2024000067$BOSTON SCIENTIFIC$$$$$M$Y$$$20240829$$CN$US$US
242624761$24262476$1$I$$20240531$20240829$20240829$PER$$US-BSC-2024000070$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242624771$24262477$1$I$$20240528$20240829$20240829$PER$$US-BSC-2024000068$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242624781$24262478$1$I$$20240606$20240829$20240829$PER$$US-BSC-2024000071$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$MD$US$US
242624791$24262479$1$I$20240517$20240607$20240829$20240829$PER$$US-BSC-2024000072$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242624801$24262480$1$I$$20240614$20240829$20240829$PER$$US-BSC-2024000074$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$CN$US$US
242624811$24262481$1$I$20240522$20240607$20240829$20240829$PER$$US-BSC-2024000073$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242624821$24262482$1$I$$20240621$20240829$20240829$PER$$US-BSC-2024000075$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$CN$US$US
242624831$24262483$1$I$20240222$20240710$20240829$20240829$PER$$US-BSC-2024000076$BOSTON SCIENTIFIC$$73$YR$$F$Y$$$20240829$$CN$US$US
242624841$24262484$1$I$20240809$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017890$ELI LILLY AND CO$$$$A$F$Y$$$20240829$$CN$US$US
242624851$24262485$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017320$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242624862$24262486$2$F$$20240829$20240829$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408018143$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240904$$CN$US$US
242624871$24262487$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017887$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240829$$CN$US$US
242624891$24262489$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017991$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240829$$CN$US$US
242624901$24262490$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017020$ELI LILLY AND CO$$45$YR$A$$Y$$$20240829$$CN$US$US
242624911$24262491$1$I$20240701$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017066$ELI LILLY AND CO$$70$YR$E$$Y$$$20240829$$CN$US$US
242624921$24262492$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018084$ELI LILLY AND CO$$11$YR$C$M$Y$$$20240829$$CN$US$US
242624931$24262493$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016994$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240829$$CN$US$US
242624951$24262495$1$I$20240821$20240821$20240829$20240829$PER$$US-AMGEN-USASP2024172311$AMGEN$$60$YR$A$M$Y$$$20240829$$PH$US$US
242624961$24262496$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016977$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240829$$CN$US$US
242624991$24262499$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042442$AUROBINDO$$74$YR$$F$Y$$$20240829$$HP$CA$CA
242625002$24262500$2$F$20240101$20240829$20240829$20240906$EXP$$JP-ALK-ABELLO A/S-2024AA003270$ALK-ABELLO$$$$$$Y$$$20240906$$HP$JP$JP
242625012$24262501$2$F$$20240827$20240829$20240830$30DAY$$FR-UCBSA-2024043591$UCB$$78$YR$$M$Y$$$20240830$$PH$FR$FR
242625021$24262502$1$I$20240513$20240821$20240829$20240829$EXP$PL-URPL-DML-MLP.4401.1.172.2024$PL-TEVA-VS-3235951$TEVA$$66$YR$$F$Y$59$KG$20240829$$HP$PL$PL
242625031$24262503$1$I$$20240530$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02015$AMNEAL$$$$$F$Y$$$20240829$$CN$US$US
242625041$24262504$1$I$$20231121$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04189$AMNEAL$$$$$F$Y$$$20240829$$CN$US$US
242625052$24262505$2$F$$20240819$20240829$20240930$EXP$$US-ROCHE-3565229$ROCHE$$31$YR$A$F$Y$79.83$KG$20240930$$MD$US$US
242625061$24262506$1$I$$20231109$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04014$AMNEAL$$$$$F$Y$$$20240829$$CN$US$US
242625071$24262507$1$I$$20231108$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03960$AMNEAL$$$$$F$Y$$$20240829$$CN$US$US
242625081$24262508$1$I$20240101$20240130$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00321$AMNEAL$$54$YR$$F$Y$$$20240829$$HP$US$US
242625091$24262509$1$I$$20240522$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01911$AMNEAL$$$$$F$Y$$$20240829$$MD$US$US
242625101$24262510$1$I$$20240327$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01069$AMNEAL$$$$$F$Y$$$20240829$$CN$US$US
242625111$24262511$1$I$$20231004$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03516$AMNEAL$$$$$M$Y$$$20240829$$CN$US$US
242625121$24262512$1$I$$20240510$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01732$AMNEAL$$$$$F$Y$$$20240829$$MD$US$US
242625131$24262513$1$I$$20231002$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03473$AMNEAL$$$$$F$Y$$$20240829$$MD$US$US
242625141$24262514$1$I$$20240117$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00161$AMNEAL$$$$$F$Y$$$20240829$$MD$US$US
242625151$24262515$1$I$$20240116$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00164$AMNEAL$$$$$F$Y$$$20240829$$CN$US$US
242625161$24262516$1$I$$20240403$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01109$AMNEAL$$$$$F$Y$$$20240829$$MD$US$US
242625171$24262517$1$I$$20231026$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03887$AMNEAL$$$$$F$Y$$$20240829$$MD$US$US
242625181$24262518$1$I$$20231220$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04484$AMNEAL$$$$$F$Y$$$20240829$$CN$US$US
242625191$24262519$1$I$$20240520$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01941$AMNEAL$$$$$$Y$$$20240829$$CN$US$US
242625201$24262520$1$I$$20231215$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04388$AMNEAL$$$$$F$Y$$$20240829$$HP$US$US
242625211$24262521$1$I$$20240506$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01594$AMNEAL$$$$$F$Y$$$20240829$$CN$US$US
242625221$24262522$1$I$$20240129$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00371$AMNEAL$$$$$F$Y$$$20240829$$CN$US$US
242625231$24262523$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249601$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240829$$HP$US$US
242625241$24262524$1$I$$20240819$20240829$20240829$EXP$$CA-AUROBINDO-AUR-APL-2024-042590$AUROBINDO$$77$YR$$M$Y$103$KG$20240829$$HP$CA$CA
242625251$24262525$1$I$$20240312$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00847$AMNEAL$$$$$F$Y$$$20240829$$HP$US$US
242625261$24262526$1$I$20240701$20240816$20240829$20240829$PER$$US-SA-2024SA216655$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240829$$MD$US$US
242625271$24262527$1$I$$20240817$20240829$20240829$PER$$US-SA-2024SA204674$SANOFI AVENTIS$$$$A$F$Y$$$20240829$$MD$US$US
242625281$24262528$1$I$$20240815$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130014$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240829$$HP$US$US
242625291$24262529$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004460$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242625301$24262530$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5895112$ABBVIE$$31$YR$$F$Y$$$20240829$$HP$US$US
242625311$24262531$1$I$$20240607$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02163$AMNEAL$$$$$M$Y$$$20240829$$HP$US$US
242625321$24262532$1$I$$20240603$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02111$AMNEAL$$$$$M$Y$$$20240829$$MD$US$US
242625331$24262533$1$I$20240401$20240826$20240829$20240829$EXP$FR-AFSSAPS-LY2024001253$FR-JNJFOC-20240872015$JOHNSON AND JOHNSON$$52$YR$A$F$Y$60$KG$20240829$$CN$FR$FR
242625341$24262534$1$I$20240804$20240821$20240829$20240829$EXP$$CA-JNJFOC-20240856611$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240829$$CN$CA$CA
242625351$24262535$1$I$20240408$20240828$20240829$20240829$EXP$$US-UCBSA-2024025752$UCB$$49$YR$$F$Y$$$20240829$$CN$US$US
242625362$24262536$2$F$20240815$20240815$20240829$20240830$EXP$$US-BAXTER-2024BAX023299$BAXTER$$$$$$Y$$$20240830$$PH$US$US
242625371$24262537$1$I$20240601$20240819$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041790$AUROBINDO$$70$YR$$M$Y$$$20240829$$PH$GB$GB
242625381$24262538$1$I$$20240819$20240829$20240829$PER$$US-ROCHE-10000061270$ROCHE$$$$E$M$Y$$$20240829$$CN$US$US
242625392$24262539$2$F$$20240917$20240829$20240926$EXP$PL-EMA-DD-20240814-7482661-093405$PL-BAXTER-2024BAX023656$BAXTER$$22$YR$$F$Y$$$20240926$$HP$PL$PL
242625401$24262540$1$I$20200618$20240819$20240829$20240829$EXP$$PL-AUROBINDO-AUR-APL-2024-042134$AUROBINDO$$$$$F$Y$52$KG$20240829$$MD$PL$PL
242625431$24262543$1$I$20240805$20240822$20240829$20240829$EXP$$CN-AMGEN-CHNSP2024171243$AMGEN$$45$YR$A$F$Y$$$20240829$$HP$CN$CN
242625441$24262544$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249785$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240829$$CN$US$US
242625451$24262545$1$I$$20240820$20240829$20240829$EXP$$PL-MYLANLABS-2024M1078646$MYLAN$Styczynski T, Sadlok J, Richert-Przygonska M, Debski R, Zalas-Wiecek P, Czyzewski K, et al. Infection With Saprochaete Clavata in Children After Hematopoietic Cell Transplantation. J-Pediatr-Hematol-Oncol 2023; 45 (8): e976-e979.$14$YR$$F$Y$$$20240829$$MD$PL$PL
242625461$24262546$1$I$$20240807$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004464$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242625471$24262547$1$I$$20240821$20240829$20240829$EXP$$US-MYLANLABS-2024M1078930$MYLAN$Burton A, DeBona DJ, Handzel M, Kelly-Pisciotti S, Qiao M, Rojek D, et al. Surgical removal of extended-release buprenorphine depot due to adverse reactions. Am-J-Emerg-Med 2024; 81 127-128.$26$YR$$M$Y$$$20240829$$PH$US$US
242625491$24262549$1$I$$20240819$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-137180$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$97$KG$20240829$$HP$CA$CA
242625502$24262550$2$F$20240801$20240923$20240829$20240925$EXP$$DE-ROCHE-10000068497$ROCHE$$48$YR$A$F$Y$69$KG$20240925$$MD$DE$DE
242625511$24262551$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004466$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242625521$24262552$1$I$20200618$20240819$20240829$20240829$EXP$$PL-AUROBINDO-AUR-APL-2024-042131$AUROBINDO$$20$YR$$M$Y$120$KG$20240829$$MD$PL$PL
242625532$24262553$2$F$20200105$20240909$20240829$20240916$EXP$$JP-AMGEN-JPNSP2024171416$AMGEN$$58$YR$A$F$Y$$$20240915$$MD$JP$JP
242625541$24262554$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024171684$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242625551$24262555$1$I$$20240205$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04608$AMNEAL$$$$$M$Y$$$20240829$$CN$US$US
242625561$24262556$1$I$20231215$20231220$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04578$AMNEAL$$79$YR$$F$Y$$$20240829$$CN$US$US
242625571$24262557$1$I$$20231026$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03893$AMNEAL$$$$$F$Y$$$20240829$$CN$US$US
242625581$24262558$1$I$20240509$20240513$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01717$AMNEAL$$76$YR$$F$Y$93.424$KG$20240829$$CN$US$US
242625591$24262559$1$I$20240801$20240820$20240829$20240829$PER$$US-SA-2024SA249460$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240829$$MD$US$US
242625601$24262560$1$I$20220825$20240814$20240829$20240829$EXP$$US-ARGENX-2024-ARGX-JP006757$ARGENX BVBA$$$$$$Y$$$20240828$$HP$US$JP
242625612$24262561$2$F$$20240829$20240829$20240909$EXP$$JP-BAXTERJP-2024BAX023431AA$BAXTER$$75$YR$$F$Y$$$20240909$$HP$JP$JP
242625621$24262562$1$I$$20240827$20240829$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US075756$SANDOZ$$$$$M$Y$$$20240829$$CN$US$US
242625632$24262563$2$F$$20240827$20240829$20240903$EXP$$BG-SANDOZ INC.-SDZ2024BG075857$SANDOZ$$66$YR$$F$Y$$$20240903$$HP$BG$BG
242625641$24262564$1$I$$20240827$20240829$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US075821$SANDOZ$$$$$F$Y$$$20240829$$CN$US$US
242625651$24262565$1$I$$20240828$20240829$20240829$EXP$$PK-SANDOZ INC.-SDZ2024PK075875$SANDOZ$$27$DY$$M$Y$4$KG$20240829$$MD$PK$PK
242625661$24262566$1$I$$20240819$20240829$20240829$EXP$$NL-TEVA-VS-3237016$TEVA$Van Der Arend BWH, Van Veelen N, De Ruijter JET, Olsen MH, Maassen Van Den Brink A and Terwindt GM. Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine. Front. Neurol. 2024, 15:1387044.$42$YR$$F$Y$$$20240829$$HP$NL$NL
242625671$24262567$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136868$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240829$$CN$US$US
242625681$24262568$1$I$20240512$20240819$20240829$20240829$EXP$$GB-AUROBINDO-AUR-APL-2024-041943$AUROBINDO$$69$YR$$M$Y$98$KG$20240829$$PH$GB$GB
242625692$24262569$2$F$$20240906$20240829$20240916$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024103270$VIIV$$$$$F$Y$97.9$KG$20240916$$PH$US$US
242625701$24262570$1$I$$20240815$20240829$20240829$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463762$RANBAXY$$$$E$$Y$$$20240829$$CN$US$US
242625712$24262571$2$F$20240604$20240826$20240829$20240909$EXP$$US-SUNPHARMA-2024R1-464311AA$RANBAXY$$55$YR$A$M$Y$$$20240909$$MD$US$US
242625721$24262572$1$I$$20240821$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03066$AMNEAL$$$$$$Y$$$20240829$$CN$US$US
242625731$24262573$1$I$20240805$20240820$20240829$20240829$EXP$$FR-AUROBINDO-AUR-APL-2024-042049$AUROBINDO$$67$YR$$M$Y$75$KG$20240829$$PH$FR$FR
242625741$24262574$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174367$NOVARTIS$$$$$$Y$$$20240829$$MD$US$US
242625751$24262575$1$I$$20240822$20240829$20240829$EXP$GB-MHRA-MIDB-f2e310a8-9d28-4c5b-ba9e-7896d2e17bbf$GB-RDY-SPO/GBR/24/0012379$DR REDDYS$$79$YR$E$F$Y$$$20240829$$HP$GB$GB
242625761$24262576$1$I$20240827$20240827$20240829$20240829$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-136508$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$64.86$KG$20240829$$CN$PR$PR
242625771$24262577$1$I$20230501$20240826$20240829$20240829$PER$$US-ALXN-A202309289$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240829$$CN$US$US
242625781$24262578$1$I$$20240822$20240829$20240829$EXP$$US-ALXN-202408USA001714US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240829$$MD$US$US
242625791$24262579$1$I$$20240823$20240829$20240829$EXP$$US-ALXN-202408USA001733US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$MD$US$US
242625801$24262580$1$I$$20240829$20240829$20240829$PER$$US-PROD-AS2-212756134-RB-100973-2023$RECKITT BENCKISER$$$$$M$Y$$$20240829$$CN$US$US
242625811$24262581$1$I$20240701$20240822$20240829$20240829$EXP$$US-AMGEN-USASP2024169721$AMGEN$$66$YR$E$F$Y$$$20240829$$HP$US$US
242625823$24262582$3$F$20240301$20240903$20240829$20240910$EXP$$US-ROCHE-10000068318$ROCHE$$$$E$M$Y$$$20240910$$MD$US$US
242625831$24262583$1$I$20170131$20240826$20240829$20240829$PER$$US-JNJFOC-20240868488$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242625841$24262584$1$I$20240826$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017363$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240829$$CN$US$US
242625851$24262585$1$I$20240828$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017988$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240829$$CN$US$US
242625861$24262586$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017967$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240829$$CN$US$US
242625872$24262587$2$F$$20240827$20240829$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016957$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240830$$CN$US$US
242625881$24262588$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018093$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240829$$CN$US$US
242625891$24262589$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017227$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240829$$CN$US$US
242625901$24262590$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017462$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240829$$CN$US$US
242625911$24262591$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000068134$ROCHE$$56$YR$A$F$Y$$$20240829$$HP$US$US
242625921$24262592$1$I$$20240827$20240829$20240829$EXP$$CA-ORGANON-O2408CAN002023$ORGANON$$40$YR$$F$Y$$$20240829$$HP$CA$CA
242625931$24262593$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004468$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242625941$24262594$1$I$$20240821$20240829$20240829$EXP$$CA-ROCHE-10000059658$ROCHE$$$$A$F$Y$$$20240829$$CN$CA$CA
242625951$24262595$1$I$$20240814$20240829$20240829$PER$$US-ABBVIE-5894314$ABBVIE$$65$YR$$F$Y$$$20240829$$HP$US$US
242625961$24262596$1$I$$20240819$20240829$20240829$EXP$$CN-TEYRO-2024-TY-000523$Teyro Labs$Yu J, Jiang L, Zhao L, Yang X, Wang X, Yang D, et al..High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial.Lancet Respir Med.2024;S2213-2600(24)00189-9$$$$$Y$$$20240829$$HP$CN$CN
242625971$24262597$1$I$$20240820$20240829$20240829$EXP$$CA-APOTEX-2024AP009621$APOTEX$$57$YR$$M$Y$$$20240829$$HP$CA$CA
242625982$24262598$2$F$20240601$20240830$20240829$20240905$EXP$$CA-ROCHE-10000068653$ROCHE$$64$YR$A$M$Y$$$20240905$$CN$CA$CA
242625991$24262599$1$I$20140901$20240820$20240829$20240829$EXP$$PL-BAXTER-20190838519$BAXTER$$52$YR$$F$Y$$$20240829$$HP$PL$PL
242626001$24262600$1$I$$20240816$20240829$20240829$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08220$LUPIN$Bulleit C, Rho J, Fleisch SB, Radhakrishnan NS. Treating malignant catatonia with liquid amantadine: A case report and literature review. Journal of Psychiatric Practice. 2024;30:308-310$51$YR$$F$Y$$$20240829$$MD$US$US
242626012$24262601$2$F$20240802$20240904$20240829$20240914$EXP$$AU-BAXTER-2024BAX023576$BAXTER$$82$YR$$M$Y$$$20240914$$MD$AU$AU
242626021$24262602$1$I$20240715$20240821$20240829$20240829$EXP$CN-NMPACDR-1305011517137202400167$CN-BAXTER-2024BAX023697$BAXTER$$16$YR$$F$Y$16$KG$20240829$$MD$CN$CN
242626031$24262603$1$I$$20240826$20240829$20240829$EXP$$US-CURRAX PHARMACEUTICALS LLC-US-2024CUR003957$CURRAX PHARMACEUTICALS$$33$YR$$F$Y$$$20240829$$HP$US$US
242626042$24262604$2$F$$20240828$20240829$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004465$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
242626061$24262606$1$I$20240826$20240826$20240829$20240829$EXP$$US-GSK-US2024105950$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240829$$HP$US$US
242626081$24262608$1$I$$20240822$20240829$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026490$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240829$$$US$US
242626092$24262609$2$F$$20240821$20240829$20240902$EXP$AU-MLMSERVICE-20240812-PI159359-00306-1$AU-STRIDES ARCOLAB LIMITED-2024SP010564$STRIDES$Montarello NL, Irvine I, Warner V, Hare J, Kaye D, Cloud GC.. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report.. BMC neurology. 2024;24(1):277$51$YR$$F$Y$$$20240902$$MD$AU$AU
242626101$24262610$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137224$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$72.57$KG$20240829$$CN$US$US
242626111$24262611$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004471$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242626121$24262612$1$I$$20240405$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01224$AMNEAL$$$$$M$Y$$$20240829$$CN$US$US
242626131$24262613$1$I$$20240822$20240829$20240829$EXP$$US-JNJFOC-20240865692$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$HP$US$US
242626141$24262614$1$I$20231009$20231229$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04412$AMNEAL$$38$YR$$F$Y$64.3$KG$20240829$$PH$US$US
242626151$24262615$1$I$$20240807$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004470$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242626161$24262616$1$I$20230501$20240823$20240829$20240829$EXP$DE-PFIZER INC-PV202400106352$DE-ROCHE-10000064727$ROCHE$$$$$F$Y$$$20240829$$MD$DE$DE
242626171$24262617$1$I$$20240819$20240829$20240829$30DAY$$US-GSK-US2024103427$GLAXOSMITHKLINE$$$$$M$Y$$$20240829$$CN$US$US
242626181$24262618$1$I$$20240819$20240829$20240829$EXP$$US-ROCHE-10000061236$ROCHE$$79$YR$E$F$Y$$$20240829$$CN$US$US
242626191$24262619$1$I$$20240827$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US075864$SANDOZ$$58$YR$$F$Y$$$20240829$$MD$US$US
242626201$24262620$1$I$$20240828$20240829$20240829$EXP$GB-MHRA-MED-202408272155149930-PBJNH$GB-ORGANON-O2408GBR002035$ORGANON$$36$YR$$F$Y$$$20240829$$CN$GB$GB
242626211$24262621$1$I$$20240625$20240829$20240829$EXP$$CA-SANDOZ INC.-NVSC2021CA274520$SANDOZ$$77$YR$$F$Y$$$20240829$$HP$CA$CA
242626221$24262622$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59327$$FDA-CTU$$$$$$N$$$20240827$$CN$US$
242626231$24262623$1$I$20240101$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136799$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240829$$CN$US$US
242626241$24262624$1$I$20240502$20240814$20240829$20240829$EXP$GB-MHRA-31436577$GB-SHIELD THERAPEUTICS-GB-STX-24-00220$IRON THERAPEUTICS$$78$YR$$F$Y$$$20240829$$HP$GB$GB
242626251$24262625$1$I$$20240816$20240829$20240829$PER$$US-AstraZeneca-2024A187877$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
242626261$24262626$1$I$$20240821$20240829$20240829$EXP$$ZA-AstraZeneca-2024A191967$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$ZA$
242626271$24262627$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A195741$ASTRAZENECA$$27648$DY$$F$Y$$$20240829$$CN$US$
242626281$24262628$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A191462$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242626291$24262629$1$I$20240815$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A191034$ASTRAZENECA$$34283$DY$$M$Y$78.9$KG$20240829$$CN$US$
242626301$24262630$1$I$$20240814$20240829$20240829$EXP$$HU-ALVOGEN-2024095349$ALVOGEN$M?hes G, Mok?nszki A, Ujfalusi A, Hevessy Z, Milt?nyi Z, Gergely L, Bedekovics J. Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: Tracing the Paths to Leukemic Transformation. International Journal of  Molecular Sciences. 2024 Jul 22;25:8003. doi:https://doi.org/ 10.3390/ijms25148003$$$A$M$Y$$$20240829$$HP$HU$HU
242626314$24262631$4$F$$20240921$20240829$20240924$30DAY$$DO-PFIZER INC-PV202400052663$PFIZER$$14$YR$$F$Y$$$20240924$$CN$DO$DO
242626321$24262632$1$I$20240721$20240723$20240829$20240829$30DAY$$KR-PFIZER INC-202400222392$PFIZER$$14$YR$$M$Y$$$20240829$$CN$KR$KR
242626332$24262633$2$F$20240712$20240928$20240829$20240930$30DAY$$US-PFIZER INC-202400215899$PFIZER$$15$YR$$M$Y$$$20240930$$CN$US$US
242626341$24262634$1$I$20220801$20240814$20240829$20240829$EXP$$HU-ALVOGEN-2024095348$ALVOGEN$M?hes G, Mok?nszki A, Ujfalusi A, Hevessy Z, Milt?nyi Z, Gergely L, Bedekovics J. Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: Tracing the Paths to Leukemic Transformation. International Journal of  Molecular Sciences. 2024 Jul 22;25:8003. doi:https://doi.org/ 10.3390/ijms25148003$$$E$M$Y$$$20240829$$HP$HU$HU
242626351$24262635$1$I$$20240822$20240829$20240829$PER$$US-JNJFOC-20240860592$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$HP$US$US
242626361$24262636$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A191128$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242626371$24262637$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5893594$ABBVIE$$47$YR$$F$Y$$$20240829$$HP$US$US
242626381$24262638$1$I$20240813$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171586$AMGEN$$74$YR$E$M$Y$$$20240829$$CN$US$US
242626391$24262639$1$I$20240822$20240823$20240829$20240829$PER$$US-AMGEN-USASP2024172173$AMGEN$$74$YR$E$M$Y$$$20240829$$CN$US$US
242626401$24262640$1$I$$20240823$20240829$20240829$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024851$UNITED THERAPEUTICS$$$$$F$Y$92.063$KG$20240829$$MD$US$US
242626411$24262641$1$I$20220801$20240822$20240829$20240829$EXP$GB-MHRA-MED-202408221511599270-QZSRF$GB-AMGEN-GBRSP2024168319$AMGEN$$$$$M$Y$92$KG$20240829$$CN$GB$GB
242626421$24262642$1$I$20240701$20240809$20240829$20240829$PER$$US-009507513-2408USA003982$MERCK$$69$YR$$F$Y$$$20240829$$CN$US$US
242626431$24262643$1$I$$20240819$20240829$20240829$EXP$$IT-AMGEN-ITASP2024167654$AMGEN$Cozzolino M.. Subcutaneous G-CSF administration improves IVF outcomes in patierits with recurrent implantation failure presenting a KIR/HLA-C mismatch. Journal of Reproductive Immunology. 2024;165:1-7$$$A$F$Y$$$20240829$$HP$IT$IT
242626441$24262644$1$I$$20240822$20240829$20240829$EXP$$US-TAKEDA-2024TUS013616$TAKEDA$$$$$F$Y$$$20240829$$CN$US$US
242626451$24262645$1$I$20240825$20240825$20240829$20240829$EXP$$CN-ABBVIE-5899580$ABBVIE$$$$$$Y$$$20240829$$MD$CN$CN
242626461$24262646$1$I$20240101$20240828$20240829$20240829$EXP$$US-UCBSA-2024043813$UCB$$$$$F$Y$$$20240829$$CN$US$US
242626481$24262648$1$I$$20240524$20240829$20240829$PER$US-MLMSERVICE-20240513-PI058057-00233-1$US-STRIDES ARCOLAB LIMITED-2024SP005918$STRIDES$Burbank K, Hansell M, Nelson C.. Running into Rash Decisions.. Clinical Journal of Sport Medicine. 2024;34 (2):e7-e8$31$YR$$F$Y$$$20240829$$MD$US$US
242626491$24262649$1$I$$20240403$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01136$AMNEAL$$$$$$Y$$$20240829$$CN$US$US
242626501$24262650$1$I$$20231116$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04060$AMNEAL$$$$$$Y$$$20240829$$CN$US$US
242626511$24262651$1$I$$20240812$20240829$20240829$30DAY$$ES-SA-2024SA251079$SANOFI AVENTIS$$$$A$$Y$$$20240829$$HP$ES$ES
242626521$24262652$1$I$20231203$20240111$20240829$20240829$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00127$AMNEAL$$77$YR$$F$Y$$$20240829$$CN$US$US
242626531$24262653$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249973$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240829$$MD$US$US
242626541$24262654$1$I$20240801$20240816$20240829$20240829$PER$$US-SA-2024SA231990$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240829$$MD$US$US
242626551$24262655$1$I$20240101$20240816$20240829$20240829$PER$$US-SA-2024SA247811$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240829$$MD$US$US
242626561$24262656$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249168$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240829$$MD$US$US
242626571$24262657$1$I$20240607$20240607$20240829$20240829$30DAY$$PA-PFIZER INC-202400190539$PFIZER$$13$YR$$M$Y$$$20240829$$CN$PA$PA
242626581$24262658$1$I$$20240822$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015378$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240829$$CN$US$US
242626591$24262659$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017292$ELI LILLY AND CO$$$$A$M$Y$$$20240829$$CN$US$US
242626601$24262660$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017100$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240829$$CN$US$US
242626611$24262661$1$I$20240820$20240821$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015987$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240829$$CN$US$US
242626621$24262662$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016828$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242626631$24262663$1$I$20240827$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018085$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240829$$CN$US$US
242626641$24262664$1$I$20240813$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017397$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240829$$CN$US$US
242626651$24262665$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017881$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240829$$CN$US$US
242626661$24262666$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018206$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242626671$24262667$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017998$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240829$$CN$US$US
242626681$24262668$1$I$20240825$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017402$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240829$$CN$US$US
242626691$24262669$1$I$20240806$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018057$ELI LILLY AND CO$$16$YR$T$F$Y$$$20240829$$CN$US$US
242626701$24262670$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018218$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240829$$CN$US$US
242626711$24262671$1$I$$20240806$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07894$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242626721$24262672$1$I$$20240819$20240829$20240829$30DAY$$US-GSK-US2024AMR104659$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242626731$24262673$1$I$20240101$20240819$20240829$20240829$PER$$US-ABBVIE-5888247$ABBVIE$$48$YR$$M$Y$$$20240829$$HP$US$US
242626742$24262674$2$F$$20240917$20240829$20240925$PER$$US-ASTELLAS-2024-AER-002920$ASTELLAS$$56$YR$A$F$Y$$$20240925$$CN$US$US
242626751$24262675$1$I$20240726$20240816$20240829$20240829$EXP$$GB-CIPLA LTD.-2024GB09152$CIPLA$$$$$$Y$$$20240829$$PH$GB$GB
242626761$24262676$1$I$$20240822$20240829$20240829$EXP$$CA-ROCHE-10000065178$ROCHE$$$$A$F$Y$$$20240829$$CN$CA$CA
242626771$24262677$1$I$$20240812$20240829$20240829$PER$$US-ASTELLAS-2024-AER-002952$ASTELLAS$$54$YR$A$M$Y$$$20240829$$HP$US$US
242626781$24262678$1$I$$20240823$20240829$20240829$EXP$$US-MYLANLABS-2024M1079355$MYLAN$Finn R, Jex B, Singh A. Resolution of Brachial Plexus Neuritis from Post-Herpetic Neuralgia by Serial Brachial Plexus Blocks with Steroid. J-Pain 2019; 20 (Suppl.) (4): S47.$92$YR$$F$Y$$$20240829$$HP$US$US
242626792$24262679$2$F$$20240925$20240829$20240927$EXP$$CA-TAKEDA-2024TUS061768$TAKEDA$$$$$M$Y$$$20240927$$CN$CA$CA
242626802$24262680$2$F$$20240911$20240829$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004504$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
242626812$24262681$2$F$20240729$20240913$20240829$20240923$EXP$$US-TEVA-VS-3237166$TEVA$$16$YR$$F$Y$$$20240923$$HP$US$US
242626831$24262683$1$I$$20240823$20240829$20240829$EXP$$US-TAKEDA-2024TUS085985$TAKEDA$$$$$F$Y$$$20240829$$HP$US$US
242626841$24262684$1$I$20240813$20240816$20240829$20240829$EXP$$US-CIPLA LTD.-2024US09155$CIPLA$$$$$$Y$$$20240829$$CN$US$US
242626851$24262685$1$I$$20240819$20240829$20240829$EXP$$IT-AMGEN-ITASP2024167655$AMGEN$Cozzolino M.. Subcutaneous G-CSF administration improves IVF outcomes in patierits with recurrent implantation failure presenting a KIR/HLA-C mismatch. Journal of Reproductive Immunology. 2024;165:1-7$$$A$F$Y$$$20240829$$HP$IT$IT
242626861$24262686$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59328$$FDA-CTU$$$$$$N$$$20240827$$CN$US$
242626871$24262687$1$I$$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59337$$FDA-CTU$$$$$$N$$$20240827$$CN$US$
242626881$24262688$1$I$20230824$20231013$20240829$20240829$EXP$$CN-MYLANLABS-2023M1110715$MYLAN$$52$YR$$F$Y$$$20240829$$HP$CN$CN
242626902$24262690$2$F$$20240920$20240829$20240923$EXP$$DE-SANDOZ INC.-SDZ2024DE075549$SANDOZ$$80$YR$$M$Y$69$KG$20240923$$HP$DE$DE
242626911$24262691$1$I$$20240828$20240829$20240829$EXP$$US-UCBSA-2024043934$UCB$$$$$F$Y$$$20240829$$CN$US$US
242626921$24262692$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004506$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242626931$24262693$1$I$$20240827$20240829$20240829$EXP$$US-AMERICAN REGENT INC-2024003293$AMERICAN REGENT$Kotamarti V.. Disentangling the Diagnoses of Psychotic Depression, Catatonia, Neurocognitive Disorders, and Delirium: A Multidisciplinary Approach. American Journal of Geriatric Psychiatry. 2024;32(Suppl. 4):S35-S36$77$YR$$M$Y$$$20240829$$MD$US$US
242626941$24262694$1$I$$20240827$20240829$20240829$30DAY$$US-GSK-US2024106688$GLAXOSMITHKLINE$$$$$M$Y$$$20240829$$CN$US$US
242626951$24262695$1$I$20230804$20240822$20240829$20240829$EXP$$CA-GSK-CA2023AMR109921$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$HP$CA$CA
242626961$24262696$1$I$$20240820$20240829$20240829$EXP$$JP-TEVA-VS-3237184$TEVA$$$$E$$Y$$$20240829$$MD$JP$JP
242626971$24262697$1$I$20240826$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170616$AMGEN$$48$YR$A$F$Y$$$20240829$$HP$US$US
242626982$24262698$2$F$$20240904$20240829$20240911$EXP$$CA-AMGEN-CANNI2024171419$AMGEN$$$$A$F$Y$$$20240910$$CN$CA$CA
242626991$24262699$1$I$20240723$20240819$20240829$20240829$EXP$IT-MINISAL02-999180$IT-STERISCIENCE B.V.-2024-ST-001237$Steriscience PTE$$89$YR$$F$Y$60$KG$20240829$$MD$IT$IT
242627001$24262700$1$I$20240101$20240816$20240829$20240829$PER$$US-SA-2024SA245962$SANOFI AVENTIS$$33$WK$I$F$Y$$$20240829$$MD$US$US
242627011$24262701$1$I$20220101$20240819$20240829$20240829$30DAY$$US-GSK-US2022041346$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240829$$CN$US$US
242627021$24262702$1$I$20240808$20240809$20240829$20240829$PER$$US-TEVA-VS-3232212$TEVA$$84$YR$$M$Y$73.94$KG$20240829$$PH$US$US
242627031$24262703$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004518$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242627042$24262704$2$F$20240808$20240820$20240829$20240909$PER$$US-SA-2024SA250220$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240909$$HP$US$US
242627051$24262705$1$I$$20240823$20240829$20240829$EXP$$LB-MYLANLABS-2024M1078959$MYLAN$Keyrouz E, Rizk M, Fouani MI, Mashlab H, Sadaka A, Avery R, et al. Novel Cases of Invasive Rhino-Orbital-Cerebral Mucormycosis in 2 Patients Who had Recently Recovered From Coronavirus Disease 2019. J-Neuroophthalmol 2023; 43 (3): E74-E75.$62$YR$$M$Y$$$20240829$$MD$LB$LB
242627061$24262706$1$I$$20240823$20240829$20240829$EXP$$US-MYLANLABS-2024M1078924$MYLAN$Balashova O, Rosoph S, Buryk Y. Multiple Pneumothoraces Due to COVID-19 Related Interstitial Lung Disease in a Middle-aged Female with AIDS. South-Med-J 2022; 116.$59$YR$$F$Y$$$20240829$$HP$US$US
242627071$24262707$1$I$$20240805$20240829$20240829$PER$$US-AMGEN-USASP2024171807$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242627081$24262708$1$I$$20240823$20240829$20240829$EXP$$IE-BRISTOL-MYERS SQUIBB COMPANY-2024-136188$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240829$$MD$IE$IE
242627091$24262709$1$I$20240813$20240827$20240827$20240827$DIR$FDA-CDER-CTU-2024-59360$$FDA-CTU$$85$YR$$M$N$72.6$KG$20240827$N$$US$
242627101$24262710$1$I$$20240809$20240829$20240829$PER$$US-TEVA-VS-3233738$TEVA$$21$YR$$F$Y$$$20240829$$HP$US$US
242627121$24262712$1$I$$20240814$20240829$20240829$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000422$AZURITY PHARMACEUTICALS$Liao A., Fajoles-Vasseneix C, Rali A, Ward L, Fernandes A, Y Steven et al.. Visual morbidity and outcomes of scleritis associated with intraocular inflammation compared to isolated scleritis. Ocular immunology and inflammation. 2024;32(6):947-54$$$$F$Y$$$20240829$$MD$US$US
242627131$24262713$1$I$$20240827$20240829$20240829$EXP$$NVSC2024US173929$NOVARTIS$$$$$F$Y$$$20240829$$HP$US$US
242627141$24262714$1$I$$20240826$20240829$20240829$EXP$$NVSC2024DE173973$NOVARTIS$$$$$F$Y$$$20240829$$MD$DE$DE
242627151$24262715$1$I$$20240808$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004509$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242627161$24262716$1$I$$20240826$20240829$20240829$PER$$US-JNJFOC-20240869971$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$LW$US$US
242627171$24262717$1$I$$20240821$20240829$20240829$EXP$$CA-APOTEX-2024AP009668$APOTEX$$54$YR$$M$Y$$$20240829$$PH$CA$CA
242627181$24262718$1$I$$20240823$20240829$20240829$EXP$$US-JNJFOC-20240865601$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242627191$24262719$1$I$$20240815$20240829$20240829$PER$$US-AstraZeneca-2024A186682$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
242627201$24262720$1$I$$20240820$20240829$20240829$PER$$US-AstraZeneca-2024A190396$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242627211$24262721$1$I$$20240817$20240829$20240829$PER$$US-AstraZeneca-2024A189753$ASTRAZENECA$$$$$$Y$$$20240829$$CN$US$
242627221$24262722$1$I$20240803$20240826$20240829$20240829$EXP$$US-AstraZeneca-2024A194769$ASTRAZENECA$$25004$DY$$M$Y$$$20240829$$CN$US$
242627231$24262723$1$I$$20240821$20240829$20240829$EXP$$JP-AstraZeneca-2024A191330$ASTRAZENECA$$$$E$M$Y$$$20240829$$MD$JP$
242627241$24262724$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A191087$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242627251$24262725$1$I$$20240822$20240829$20240829$PER$$US-009507513-2408USA008096$MERCK$$$$$F$Y$$$20240829$$CN$US$US
242627261$24262726$1$I$$20240816$20240829$20240829$EXP$$US-NAPO PHARMACEUTICALS-2024US002696$PAREXEL$$$$$$Y$$$20240829$$CN$US$US
242627271$24262727$1$I$20240814$20240823$20240829$20240829$PER$$US-009507513-2408USA008448$MERCK$$35$YR$$F$Y$$$20240829$$CN$US$US
242627302$24262730$2$F$$20240820$20240829$20240830$EXP$$JP-ASTELLAS-2024-AER-000561$ASTELLAS$$82$YR$E$M$Y$$$20240830$$MD$JP$JP
242627321$24262732$1$I$$20240815$20240829$20240829$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01352$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240829$$MD$US$US
242627331$24262733$1$I$$20240806$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07986$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242627341$24262734$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004520$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$HP$US$US
242627352$24262735$2$F$$20240902$20240829$20240911$EXP$$PT-TEVA-VS-3236371$TEVA$Literature Reference: Brito-Santana L, Medinas RL, Neves A, Gago J. Steroid-induced psychosis: a spectrum of neuropsychiatric glucocorticoid side effects. BMJ-Case-Rep 2024; 17 (7):.; Brito-Santana L, Medinas RL, Neves A, Gago J. Steroid-induced psychosis: a spectrum of neuropsychiatric glucocorticoid side effects. BMJ-Case-Rep 2024; 17 (7):.$$$A$M$Y$$$20240911$$MD$PT$PT
242627362$24262736$2$F$20240809$20240913$20240829$20240919$PER$$US-AMGEN-USASP2024169360$AMGEN$$47$YR$A$F$Y$66.6$KG$20240919$$PH$US$US
242627373$24262737$3$F$20240812$20240924$20240829$20240928$30DAY$$US-AMGEN-USASP2024169296$AMGEN$$57$YR$A$F$Y$96$KG$20240927$$HP$US$US
242627381$24262738$1$I$$20240606$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00437$IMMUNOGEN$$$$$F$Y$$$20240829$$PH$US$US
242627391$24262739$1$I$$20240531$20240829$20240829$PER$$GB-IMMUNOGEN, INC.-GB-IMGN-24-00463$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$GB$US
242627401$24262740$1$I$$20240531$20240829$20240829$PER$$GB-IMMUNOGEN, INC.-GB-IMGN-24-00467$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$GB$US
242627411$24262741$1$I$$20240531$20240829$20240829$PER$$GB-IMMUNOGEN, INC.-GB-IMGN-24-00466$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$GB$US
242627421$24262742$1$I$$20240515$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00432$IMMUNOGEN$$$$E$F$Y$$$20240829$$HP$US$US
242627431$24262743$1$I$$20240531$20240829$20240829$PER$$GB-IMMUNOGEN, INC.-GB-IMGN-24-00465$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$GB$US
242627451$24262745$1$I$$20240516$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00435$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$US$US
242627461$24262746$1$I$$20240516$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00436$IMMUNOGEN$$$$$F$Y$$$20240829$$HP$US$US
242627471$24262747$1$I$$20240531$20240829$20240829$PER$$GB-IMMUNOGEN, INC.-GB-IMGN-24-00464$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$GB$US
242627481$24262748$1$I$$20240515$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00433$IMMUNOGEN$$$$E$F$Y$$$20240829$$HP$US$US
242627494$24262749$4$F$$20240906$20240829$20240918$PER$$US-ROCHE-10000067303$ROCHE$$34$YR$A$F$Y$$$20240918$$CN$US$US
242627501$24262750$1$I$20240522$20240522$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00453$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$US$US
242627511$24262751$1$I$20240523$20240607$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00470$IMMUNOGEN$$80$YR$$F$Y$$$20240829$$HP$US$US
242627521$24262752$1$I$$20240528$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00476$IMMUNOGEN$$$$$F$Y$$$20240829$$MD$US$US
242627531$24262753$1$I$$20240523$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00460$IMMUNOGEN$$$$$F$Y$$$20240829$$HP$US$US
242627541$24262754$1$I$$20240520$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00440$IMMUNOGEN$$40$YR$$F$Y$$$20240829$$CN$US$US
242627551$24262755$1$I$$20240523$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00457$IMMUNOGEN$$$$$F$Y$$$20240829$$MD$US$US
242627561$24262756$1$I$20240219$20240624$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00479$IMMUNOGEN$$68$YR$$F$Y$$$20240829$$PH$US$US
242627571$24262757$1$I$$20240528$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00469$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$US$US
242627581$24262758$1$I$$20240522$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00461$IMMUNOGEN$$$$$M$Y$98.3$KG$20240829$$CN$US$US
242627591$24262759$1$I$20240501$20240523$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00455$IMMUNOGEN$$64$YR$$F$Y$$$20240829$$CN$US$US
242627621$24262762$1$I$$20240817$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008628$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242627631$24262763$1$I$$20240819$20240829$20240829$EXP$$JP-009507513-2408JPN002286J$MERCK$ARATAKE J, SHIBUTANI T, NARITA M, HAMASAKI K, YAMAMOTO K, KITAI M, et al.. [ORIGINAL] Impact of the number of prior systemic treatment lines on lenvatinib and pembrolizumab combination therapy for advanced or recurrent endometrial cancer : Experience from a single institution in Japan with 21 cases. Advances in Obstetrics and Gynecology. 2024;76(3):222-8$$$$F$Y$$$20240829$$MD$JP$JP
242627641$24262764$1$I$20101112$20240816$20240829$20240829$EXP$$NZ-ASTELLAS-2024-AER-000133$ASTELLAS$$45$YR$A$M$Y$52$KG$20240821$$HP$NZ$NZ
242627661$24262766$1$I$20240509$20240816$20240829$20240829$EXP$$TH-ASTELLAS-2024-AER-000015$ASTELLAS$$70$YR$E$F$Y$$$20240821$$MD$TH$TH
242627671$24262767$1$I$$20240820$20240829$20240829$EXP$$US-RDY-SPO/USA/24/0012348$DR REDDYS$Pechacek J, Schmitt MM, Ferre EM, Webb T, Goldberg J, Pathan S, et al. Successful Treatment of Refractory Cutaneous Protothecosis With MAT2203, an Oral Lipid Nanocrystal Formulation of Amphotericin B. Open Forum Infectious Diseases. 2024 Aug;11(8): doi:10.1093/ofid/ofae428.$71$YR$E$M$Y$$$20240829$$HP$US$US
242627681$24262768$1$I$20240522$20240711$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00506$IMMUNOGEN$$73$YR$$F$Y$$$20240829$$MD$US$US
242627691$24262769$1$I$20240601$20240703$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00490$IMMUNOGEN$$68$YR$$F$Y$$$20240829$$CN$US$US
242627701$24262770$1$I$20240530$20240620$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00522$IMMUNOGEN$$75$YR$$F$Y$$$20240829$$PH$US$US
242627711$24262771$1$I$20240306$20240624$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00480$IMMUNOGEN$$79$YR$$F$Y$$$20240829$$PH$US$US
242627721$24262772$1$I$$20240607$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00497$IMMUNOGEN$$$$$$Y$$$20240829$$MD$US$US
242627731$24262773$1$I$20200101$20240822$20240829$20240829$EXP$GB-MHRA-MED-202408221012549690-PRGVD$GB-RDY-SPO/GBR/24/0012394$DR REDDYS$$63$YR$A$F$Y$80$KG$20240829$$CN$GB$GB
242627741$24262774$1$I$$20240610$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00503$IMMUNOGEN$$$$$F$Y$$$20240829$$HP$US$US
242627751$24262775$1$I$$20240817$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008620$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242627761$24262776$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249879$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240829$$CN$US$US
242627772$24262777$2$F$20240825$20240918$20240829$20240919$PER$$US-AMGEN-USASP2024171320$AMGEN$$62$YR$A$M$Y$$$20240919$$CN$US$US
242627781$24262778$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136901$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240829$$CN$US$US
242627791$24262779$1$I$$20240819$20240829$20240829$PER$$US-AMGEN-USASP2024168462$AMGEN$Arnold S. E.; Hendrix S.; Johnson J. N. et al.. Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer^s disease. Alzheimer^s and Dementia: Translational Research and Clinical Interventions. 2024;10 (3):1-13$$$$$Y$$$20240829$$HP$US$US
242627801$24262780$1$I$20240718$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136981$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240829$$HP$US$US
242627811$24262781$1$I$$20240822$20240829$20240829$PER$$NVSC2024US173848$NOVARTIS$$58$YR$$F$Y$$$20240829$$CN$US$US
242627821$24262782$1$I$$20240711$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00568$IMMUNOGEN$$$$$$Y$$$20240829$$HP$US$US
242627831$24262783$1$I$$20240708$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00560$IMMUNOGEN$$$$$F$Y$$$20240829$$HP$US$US
242627841$24262784$1$I$$20240705$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00546$IMMUNOGEN$$$$$F$Y$$$20240829$$HP$US$US
242627851$24262785$1$I$$20240708$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00551$IMMUNOGEN$$$$A$F$Y$$$20240829$$HP$US$US
242627861$24262786$1$I$$20240729$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00600$IMMUNOGEN$$$$$F$Y$$$20240829$$MD$US$US
242627871$24262787$1$I$$20240708$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00553$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$US$US
242627881$24262788$1$I$$20240802$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00608$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$US$US
242627891$24262789$1$I$$20240710$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00541$IMMUNOGEN$$$$A$F$Y$$$20240829$$HP$US$US
242627901$24262790$1$I$20240709$20240710$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00558$IMMUNOGEN$$$$$F$Y$$$20240829$$HP$US$US
242627911$24262791$1$I$$20240628$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00535$IMMUNOGEN$$$$$$Y$$$20240829$$HP$US$US
242627921$24262792$1$I$$20240701$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00544$IMMUNOGEN$$$$A$F$Y$$$20240829$$CN$US$US
242627931$24262793$1$I$$20240702$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00542$IMMUNOGEN$$$$$$Y$$$20240829$$MD$US$US
242627942$24262794$2$F$$20240730$20240829$20240924$PER$$US-INCYTE CORPORATION-2024IN007984$INCYTE$$$$$$Y$$$20240924$$CN$US$US
242627951$24262795$1$I$$20240822$20240829$20240829$EXP$$US-MYLANLABS-2024M1079003$MYLAN$Ashinne B, Zablah G, Colombo R. The use of impella for right ventricle decompression: a life saver. J-Am-Coll-Cardiol 2019; 73 (Suppl. 1) (9): 2505.$49$YR$$M$Y$$$20240829$$HP$US$US
242627961$24262796$1$I$20240101$20240822$20240829$20240829$EXP$IT-MINISAL02-999440$IT-MYLANLABS-2024M1078051$MYLAN$$83$YR$$F$Y$$$20240829$$MD$IT$IT
242627971$24262797$1$I$$20240822$20240829$20240829$EXP$$US-MYLANLABS-2024M1078997$MYLAN$Shah T, Aboumerhi H. Are New Diagnostic Criteria Needed? Diffuse Idiopathic Skeletal Hyperostosis Concealed by Cervical Radiculopathy: A Case Report. Pain-Med-Case-Rep 2023; 7 (3): 139-142.$52$YR$$M$Y$$$20240829$$MD$US$US
242627981$24262798$1$I$$20240819$20240829$20240829$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07976$HIKMA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.. Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024;/:/$39$WK$$$Y$$$20240829$$MD$US$US
242627991$24262799$1$I$$20240822$20240829$20240829$EXP$$NL-MYLANLABS-2024M1078621$MYLAN$Brakenhoff SM, Chi H, Friederich P, Doukas M, Den Hoed C, Flink HJ, et al. A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report. Case-Rep-Gastroenterol 2024; 18 (1): 252-259.$64$YR$$M$Y$$$20240829$$HP$NL$NL
242628001$24262800$1$I$$20240822$20240829$20240829$EXP$$GB-MYLANLABS-2024M1074234$MYLAN$$$$$M$Y$$$20240829$$HP$GB$GB
242628011$24262801$1$I$$20240821$20240829$20240829$EXP$$NL-MYLANLABS-2024M1078909$MYLAN$Otero-Lobato M, Adeyemo A, Higley M, Lomax KG, Geldhof A, Esslinger S. Exposure to golimumab during pregnancy: Results from the Company^s global safety database. Pharmacol-Res-Perspect 2024; 12 (4):.$$$$$Y$$$20240829$$HP$NL$NL
242628021$24262802$1$I$20240531$20240822$20240829$20240829$EXP$SE-SEMPA-2024-006130$SE-MYLANLABS-2024M1078296$MYLAN$$79$YR$$F$Y$$$20240829$$MD$SE$SE
242628031$24262803$1$I$$20240822$20240829$20240829$EXP$$US-MYLANLABS-2024M1079005$MYLAN$Wathen C, Yang AI, Hitti FL, Henry L, Chaibainou H, Baltuch GH. Feasibility of Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Essential Tremor in the Setting of Prior Craniotomy. Oper-Neurosurg 2022; 22 (2): 61-65.$55$YR$$M$Y$$$20240829$$MD$US$US
242628041$24262804$1$I$$20240822$20240829$20240829$EXP$$IN-MYLANLABS-2024M1078999$MYLAN$Mukherjee D, Nair RK, Sharma S, Datt B, Rao A. An Unusual Cure for Resistant Renovascular Hypertension: Cutting the Gordian Knot: A Case Report. SriLanka-J-Med 2024; 33 (2):.$34$YR$$M$Y$$$20240829$$HP$IN$IN
242628051$24262805$1$I$$20240823$20240829$20240829$EXP$$US-JNJFOC-20240865374$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242628061$24262806$1$I$20230530$20240822$20240829$20240829$EXP$$AU-MYLANLABS-2024M1078936$MYLAN$$79$YR$$M$Y$128$KG$20240829$$HP$AU$AU
242628071$24262807$1$I$$20240822$20240829$20240829$EXP$$AT-MYLANLABS-2024M1079321$MYLAN$Habenbacher M, Andrianakis A, Gellner V, Braun H, Szkandera J, Liegl-Atzwanger B, et al. Aggressive EWSR1::POU2AF3(COLCA2) spindle/round cell sarcoma of the sinonasal tract. Histopathology 2024; 0 (0).$32$YR$$M$Y$$$20240829$$HP$AT$AT
242628081$24262808$1$I$$20240812$20240829$20240829$EXP$$US-MACLEODS PHARMA-MAC2024048879$MACLEODS$$$$$$Y$$$20240829$$CN$US$US
242628091$24262809$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018054$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240829$$CN$US$US
242628101$24262810$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018047$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240829$$CN$US$US
242628111$24262811$1$I$20240401$20240822$20240829$20240829$EXP$$CO-JNJFOC-20240862883$JOHNSON AND JOHNSON$$35$YR$A$F$Y$72$KG$20240829$$HP$CO$CO
242628131$24262813$1$I$20240515$20240822$20240829$20240829$EXP$FR-AFSSAPS-TS2024000856$FR-MYLANLABS-2024M1078045$MYLAN$$64$YR$$M$Y$82$KG$20240829$$MD$FR$FR
242628141$24262814$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017940$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240829$$CN$US$US
242628151$24262815$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018160$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242628161$24262816$1$I$$20240827$20240829$20240829$PER$$US-GILEAD-2024-0685542$GILEAD$$$$$$Y$$$20240829$$CN$US$US
242628171$24262817$1$I$20240825$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016263$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240829$$CN$US$US
242628191$24262819$1$I$20240702$20240827$20240829$20240829$EXP$$US-GILEAD-2024-0685630$GILEAD$$79$YR$E$F$Y$$$20240829$$CN$US$US
242628201$24262820$1$I$20240628$20240808$20240829$20240829$PER$$US-009507513-2408USA002948$MERCK$$46$YR$$$Y$$$20240829$$HP$US$US
242628212$24262821$2$F$$20240913$20240829$20240923$PER$$US-GSK-US2024AMR104712$GLAXOSMITHKLINE$$$$$M$Y$$$20240923$$CN$US$US
242628231$24262823$1$I$20240822$20240828$20240829$20240829$EXP$$US-INCYTE CORPORATION-2024IN009107$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242628241$24262824$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA250292$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240829$$MD$US$US
242628261$24262826$1$I$$20240820$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133644$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240829$$PH$US$US
242628271$24262827$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004484$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$HP$US$US
242628281$24262828$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004517$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242628291$24262829$1$I$$20240822$20240829$20240829$PER$$US-ALXN-202408USA001615US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242628302$24262830$2$F$$20240827$20240829$20240830$EXP$GB-MHRA-MED-202408271235370900-VDRPM$GB-ABBVIE-5898001$ABBVIE$$61$YR$$M$Y$60$KG$20240830$$PH$GB$GB
242628311$24262831$1$I$20240717$20240821$20240829$20240829$EXP$FR-AFSSAPS-RE2024000817$FR-TEVA-VS-3235935$TEVA$$93$YR$$F$Y$76$KG$20240829$$PH$FR$FR
242628322$24262832$2$F$$20240830$20240829$20240904$EXP$$US-TAKEDA-2024TUS086524$TAKEDA$$$$$M$Y$$$20240904$$CN$US$US
242628331$24262833$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170960$AMGEN$$$$$M$Y$$$20240829$$MD$US$US
242628351$24262835$1$I$20240808$20240816$20240829$20240829$PER$$US-AstraZeneca-2024A187846$ASTRAZENECA$$31089$DY$$F$Y$$$20240829$$CN$US$
242628361$24262836$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A191231$ASTRAZENECA$$$$$F$Y$$$20240829$$MD$US$
242628371$24262837$1$I$20240821$20240827$20240827$20240827$DIR$716072$$FDA-CTU$$32$YR$$F$N$$$20240827$N$PH$US$
242628381$24262838$1$I$$20240820$20240829$20240829$30DAY$$US-GSK-US2024103987$GLAXOSMITHKLINE$$$$A$F$Y$$$20240829$$CN$US$US
242628391$24262839$1$I$20240803$20240817$20240829$20240829$EXP$$US-Accord-443010$ACCORD$$28$YR$A$F$Y$$$20240829$$PH$US$US
242628402$24262840$2$F$20240715$20240817$20240829$20240829$EXP$$FR-Accord-440089$ACCORD$$2$YR$C$F$Y$18$KG$20240829$$PH$FR$FR
242628411$24262841$1$I$$20240817$20240829$20240829$EXP$NL-LRB-00995888$NL-Accord-442689$ACCORD$$74$YR$E$M$Y$93.2$KG$20240829$$MD$NL$NL
242628421$24262842$1$I$20240724$20240819$20240829$20240829$EXP$CN-HENLIUS-24CN016507$CN-Accord-443545$ACCORD$$67$YR$E$F$Y$57.8$KG$20240829$$MD$CN$CN
242628441$24262844$1$I$20240802$20240827$20240827$20240827$DIR$716041$$FDA-CTU$$64$YR$$F$N$69.3$KG$20240827$N$CN$US$
242628451$24262845$1$I$$20240827$20240827$20240827$DIR$716128$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242628461$24262846$1$I$20240104$20240827$20240827$20240827$DIR$716125$$FDA-CTU$$75$YR$$F$N$59.4$KG$20240827$N$CN$US$
242628482$24262848$2$F$$20240908$20240829$20240913$EXP$$NL-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00446$VELOXIS PHARMACEUTICALS$Ghambari K, de Jong DM, Bruno MJ, Polak WG, van Driel LMJW, den Hoed CM.. Risks of post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation. Clinical Transplantation. 2024;38(7):1-9$24$YR$$M$Y$$$20240913$$HP$NL$NL
242628491$24262849$1$I$$20240821$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137159$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240829$$HP$US$US
242628501$24262850$1$I$$20240827$20240829$20240829$EXP$$US-INCYTE CORPORATION-2024IN009010$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242628511$24262851$1$I$$20240819$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-134179$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240829$$HP$CA$CA
242628551$24262855$1$I$$20240827$20240827$20240827$DIR$716139$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242628562$24262856$2$F$$20240902$20240829$20240911$EXP$$GB-TEVA-VS-3236099$TEVA$Mukhtar S, Rashid S, Hawari R. Nicolau syndrome (embolia cutis medicamentosa) due to glatiramer acetate (Copaxone) injection: a case report. Br-J-Dermatol 2024; 192 (Suppl.) i114.; Mukhtar S, Rashid S, Hawari R. Nicolau syndrome (embolia cutis medicamentosa) due to glatiramer acetate (Copaxone) injection: a case report. Br-J-Dermatol 2024; 192 (Suppl.) i114.$50$YR$$F$Y$$$20240911$$HP$GB$GB
242628571$24262857$1$I$20240821$20240822$20240829$20240829$PER$$US-BEH-2024177664$CSL BEHRING$$61$YR$A$M$Y$$$20240829$$CN$US$US
242628581$24262858$1$I$20210101$20240827$20240829$20240829$EXP$$US-GILEAD-2024-0685522$GILEAD$$$$A$M$Y$$$20240829$$CN$US$US
242628592$24262859$2$F$$20240917$20240829$20240925$EXP$$BA-ROCHE-10000065098$ROCHE$$$$$F$Y$$$20240925$$MD$BA$BA
242628601$24262860$1$I$$20240828$20240829$20240829$30DAY$$CA-SANDOZ INC.-SDZ2024CA076222$SANDOZ$$$$$M$Y$$$20240829$$CN$CA$CA
242628611$24262861$1$I$20240801$20240820$20240829$20240829$EXP$$US-VIIV HEALTHCARE LIMITED-US2024103909$VIIV$$37$YR$$M$Y$$$20240829$$HP$US$US
242628621$24262862$1$I$$20240819$20240829$20240829$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR103663$VIIV$$$$A$M$Y$$$20240829$$CN$US$US
242628631$24262863$1$I$$20240821$20240829$20240829$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024104561$VIIV$$57$YR$$M$Y$$$20240829$$HP$US$US
242628642$24262864$2$F$20240814$20240823$20240829$20240902$EXP$GB-MHRA-MED-202408191022437500-CHPVR$GB-BAXTER-2024BAX023508$BAXTER$$71$YR$$M$Y$$$20240902$$MD$GB$GB
242628651$24262865$1$I$20220425$20240724$20240829$20240829$EXP$$US-BAXTER-2024BAX022333$BAXTER$$2$YR$$F$Y$$$20240829$$LW$US$US
242628661$24262866$1$I$$20240821$20240829$20240829$EXP$$CA-BAXTER-2024BAX023571$BAXTER$$8$YR$$F$Y$$$20240829$$HP$CA$CA
242628671$24262867$1$I$20240808$20240820$20240829$20240829$EXP$$EG-BAXTER-2024BAX023439$BAXTER$$8$YR$$F$Y$$$20240829$$MD$EG$EG
242628691$24262869$1$I$$20240821$20240829$20240829$EXP$NL-EMA-20170119-psevhumanwtdd-134344020$NL-JUBILANT CADISTA PHARMACEUTICALS-2024NL001214$JUBILANT$Timmerman L, v.d. Hoek-Mensink A.. Opiates and SSRI^s: risk for serotonin syndrome. Eur Neuropsychopharmacol. 2009;19 Suppl 3:S252$89$YR$$F$Y$$$20240829$$HP$NL$NL
242628701$24262870$1$I$$20240821$20240829$20240829$EXP$GB-MHRA-MED-202408211331256540-HZWRL$GB-JUBILANT PHARMA LTD-2024GB001228$JUBILANT$$82$YR$$F$Y$$$20240829$$HP$GB$GB
242628711$24262871$1$I$$20240822$20240829$20240829$EXP$NL-LRB-00999119$NL-JUBILANT PHARMA LTD-2024NL001222$JUBILANT$$43$YR$$F$Y$$$20240829$$MD$NL$NL
242628731$24262873$1$I$20240601$20240823$20240829$20240829$EXP$$US-INCYTE CORPORATION-2024IN008901$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242628761$24262876$1$I$20240801$20240816$20240829$20240829$PER$$US-SA-2024SA247864$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240829$$MD$US$US
242628771$24262877$1$I$20240620$20240716$20240829$20240829$EXP$$GB-APCER-AZR202407-000436$AZURITY PHARMACEUTICALS$$60$YR$$$Y$75$KG$20240829$$CN$GB$GB
242628781$24262878$1$I$$20240823$20240829$20240829$EXP$$US-AMGEN-USASP2024169514$AMGEN$$$$A$F$Y$$$20240829$$HP$US$US
242628801$24262880$1$I$20240125$20240820$20240829$20240829$EXP$FR-AFSSAPS-RE2024000820$FR-TEVA-VS-3235286$TEVA$$72$YR$$F$Y$52.5$KG$20240829$$MD$FR$FR
242628811$24262881$1$I$$20240827$20240829$20240829$EXP$$NVSC2024CA173397$NOVARTIS$$59$YR$$F$Y$$$20240829$$CN$CA$CA
242628821$24262882$1$I$20240819$20240826$20240829$20240829$EXP$$US-INCYTE CORPORATION-2024IN008949$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242628831$24262883$1$I$$20240705$20240829$20240829$EXP$$SE-AZURITY PHARMACEUTICALS, INC.-AZR202407-000440$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240829$$MD$SE$SE
242628841$24262884$1$I$20240701$20240820$20240829$20240829$PER$$US-SA-2024SA249985$SANOFI AVENTIS$$4$YR$C$F$Y$17$KG$20240829$$MD$US$US
242628851$24262885$1$I$$20240819$20240829$20240829$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07977$HIKMA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.. Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024;/:/$34$WK$$$Y$$$20240829$$MD$US$US
242628861$24262886$1$I$$20240814$20240829$20240829$EXP$$CN-AZURITY PHARMACEUTICALS, INC.-AZR202408-000388$AZURITY PHARMACEUTICALS$Wang Z, Li D, Lu L, Xu Z, Ouyang G, Sun Y.. Identification of Anncaliia algerae in Ascites in an Immunosuppressed Patient, China.. Open Forum Infect. Dis. 2024;11(8):393$63$YR$$F$Y$$$20240829$$MD$CN$CN
242628871$24262887$1$I$20240722$20240816$20240829$20240829$PER$$US-ABBVIE-5887508$ABBVIE$$39$YR$$F$Y$$$20240829$$CN$US$US
242628881$24262888$1$I$$20240814$20240829$20240829$EXP$$DE-ASTELLAS-2024-AER-000447$ASTELLAS$Rauber C. Exacerbation of Myopathy in Glycogen Debrancher Deficiency After Liver Transplantation: Case Report and Review of the Literature. Transplantation Proceedings. 2024;5(56): 1153-1156. doi:10.1016/j.transproceed.2024.02.020.$27$YR$A$M$Y$$$20240822$$HP$DE$DE
242628892$24262889$2$F$20240624$20240827$20240829$20240905$EXP$$JP-ASTELLAS-2024JP005882$ASTELLAS$$8$DEC$E$M$Y$$$20240905$$MD$JP$JP
242628901$24262890$1$I$20240827$20240827$20240827$20240827$DIR$716199$$FDA-CTU$$38$YR$$M$N$$$20240827$N$$US$
242628911$24262891$1$I$$20240828$20240829$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA068433$SANDOZ$$68$YR$$M$Y$$$20240829$$PH$CA$CA
242628921$24262892$1$I$$20240818$20240829$20240829$EXP$$AU-ASTELLAS-2024-AER-000830$ASTELLAS$$$$$F$Y$$$20240822$$MD$AU$AU
242628931$24262893$1$I$$20240731$20240829$20240829$PER$$US-LUNDBECK-DKLU4002461$LUNDBECK$$$$$$Y$$$20240829$$CN$US$US
242628941$24262894$1$I$20240718$20240819$20240829$20240829$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160973$JIANGSU HENGRUI MEDICINE$$70$YR$$F$Y$65$KG$20240829$$MD$CN$CN
242628951$24262895$1$I$$20240820$20240829$20240829$EXP$CA-NEBO-667053$CA-NEBO-667053$PHARMACOSMOS$$41$YR$$F$Y$72$KG$20240829$$HP$CA$CA
242628961$24262896$1$I$$20240816$20240829$20240829$EXP$$US-AUROBINDO-AUR-APL-2024-041507$AUROBINDO$Quan Soon KL, Shah S, Ibrahim R, Alzwahereh K. A Case Report on Iatrogenic Methotrexate Toxicity. Cureus. 2024;16(7):e64081$54$YR$$F$Y$$$20240829$$MD$US$US
242628981$24262898$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174181$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242628991$24262899$1$I$$20240827$20240827$20240827$DIR$716179$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242629001$24262900$1$I$20240822$20240822$20240829$20240829$EXP$$NVSC2024RU172404$NOVARTIS$$$$A$F$Y$$$20240829$$MD$RU$RU
242629011$24262901$1$I$$20240823$20240829$20240829$EXP$$NVSC2024GB076445$NOVARTIS$$75$YR$$F$Y$$$20240829$$CN$GB$GB
242629021$24262902$1$I$20220527$20240826$20240829$20240829$EXP$$NVSC2024KR171933$NOVARTIS$$$$A$F$Y$$$20240829$$HP$KR$KR
242629031$24262903$1$I$20240725$20240819$20240829$20240829$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160972$JIANGSU HENGRUI MEDICINE$$52$YR$$F$Y$55$KG$20240829$$MD$CN$CN
242629041$24262904$1$I$20240804$20240826$20240829$20240829$EXP$$NVSC2024US173113$NOVARTIS$$62$YR$$F$Y$90.7$KG$20240829$$CN$US$US
242629051$24262905$1$I$$20240814$20240829$20240829$EXP$$NL-AZURITY PHARMACEUTICALS, INC.-AZR202408-000394$AZURITY PHARMACEUTICALS$Simoons M, Naipal KAT, de Jong H, den Hoed CM, de Winter BCM, Mulder MB.. Oral antibiotics lower mycophenolate mofetil drug exposure, possibly by interfering with the enterohepatic recirculation: A case series. Pharmacol Res Perspect. 2023;11(3):1-6$53$YR$$M$Y$$$20240829$$HP$NL$NL
242629061$24262906$1$I$$20240814$20240829$20240829$EXP$$NL-AZURITY PHARMACEUTICALS, INC.-AZR202408-000395$AZURITY PHARMACEUTICALS$Simoons M, Naipal KAT, de Jong H, den Hoed CM, de Winter BCM, Mulder MB.. Oral antibiotics lower mycophenolate mofetil drug exposure, possibly by interfering with the enterohepatic recirculation: A case series. Pharmacol Res Perspect. 2023;11(3):1-6$13$YR$$M$Y$$$20240829$$HP$NL$NL
242629071$24262907$1$I$$20240820$20240829$20240829$EXP$$IR-NOVITIUMPHARMA-2024IRNVP01694$NOVITIUM PHARMA$Elahe Sasani.Concomitant tuberculosis and aspergillosis in patients with COVID-19: a case report.Iranian Journal of Microbiology.21-JUN-2024;16(3):428-433$51$YR$A$F$Y$$$20240829$$HP$IR$IR
242629081$24262908$1$I$$20240819$20240829$20240829$EXP$$CN-B.Braun Medical Inc.-2160977$B BRAUN$$47$YR$$F$Y$$$20240829$$$CN$CN
242629091$24262909$1$I$20240301$20240819$20240829$20240829$PER$$US-Appco Pharma LLC-2160971$APPCO PHARMA$$29$YR$$F$Y$$$20240829$$$US$US
242629101$24262910$1$I$$20240814$20240829$20240829$EXP$$NL-AZURITY PHARMACEUTICALS, INC.-AZR202408-000396$AZURITY PHARMACEUTICALS$Simoons M, Naipal KAT, de Jong H,  den Hoed CM, de Winter BCM, Mulder MB. Oral antibiotics lower mycophenolate mofetil drug exposure, possibly by interfering with the enterohepatic recirculation: A case series. Pharmacol Res Perspect. 2023;11 (3):1-6$13$YR$$F$Y$$$20240829$$HP$NL$NL
242629131$24262913$1$I$$20240821$20240829$20240829$PER$$US-RDY-SPO/USA/24/0012542$DR REDDYS$Shah J, Devalaraju S, Baerman E, Jeong-Ah Lee I, Takigawa K, Machado AP, et al. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024 Jul 05;150(7): doi:10.1007/s00432-024-05716-3.$$$$$Y$$$20240829$$HP$US$US
242629141$24262914$1$I$$20240823$20240829$20240829$PER$$US-RDY-SPO/USA/24/0012443$DR REDDYS$$$$$F$Y$$$20240829$$CN$US$US
242629151$24262915$1$I$$20240610$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00502$IMMUNOGEN$$$$$$Y$$$20240829$$HP$US$US
242629161$24262916$1$I$$20240601$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00483$IMMUNOGEN$$$$$F$Y$$$20240829$$MD$US$US
242629171$24262917$1$I$20240311$20240608$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00500$IMMUNOGEN$$$$$$Y$$$20240829$$CN$US$US
242629181$24262918$1$I$20240501$20240613$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00495$IMMUNOGEN$$$$$F$Y$$$20240829$$PH$US$US
242629191$24262919$1$I$20240501$20240530$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00482$IMMUNOGEN$$$$$F$Y$$$20240829$$HP$US$US
242629201$24262920$1$I$20240801$20240827$20240829$20240829$30DAY$$US-GSK-US2024106631$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240829$$CN$US$US
242629211$24262921$1$I$20240817$20240827$20240827$20240827$DIR$716133$$FDA-CTU$$65$YR$$M$N$102$KG$20240827$N$PH$US$
242629221$24262922$1$I$$20240827$20240827$20240827$DIR$716057$$FDA-CTU$$$$$UNK$N$$$20240827$$CN$US$
242629241$24262924$1$I$$20240827$20240827$20240827$DIR$716058$$FDA-CTU$$$$$UNK$N$$$20240827$$CN$US$
242629261$24262926$1$I$20231120$20240826$20240829$20240829$EXP$ES-AEMPS-1483486$ES-GSK-ES2024105909$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$MD$ES$ES
242629271$24262927$1$I$$20240819$20240829$20240829$EXP$$US-NOVITIUMPHARMA-2024USNVP01689$NOVITIUM PHARMA$Seohyeon Im.Latent melioidosis activation presenting with urinary tract infection and bacteremia.IDCases.07-JUN-2024;36:e02007$68$YR$A$F$Y$$$20240829$$HP$US$US
242629281$24262928$1$I$$20240819$20240829$20240829$EXP$$JP-ROCHE-10000066065$ROCHE$Sugahara S, Maruyama Y, Shimizu A, Matsuyama M, Tsuchiya N, Tachibana T et al.. 16 A case of therapy-related myelodysplastic syndrome which developed during chemotherapy for ovarian cancer. The Journal of the Kanagawa Medical Association / The 441st Annual Meeting of Ka. 2024;51(2):74$75$YR$E$F$Y$$$20240829$$MD$JP$JP
242629291$24262929$1$I$$20240822$20240829$20240829$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160968$JIANGSU HENGRUI MEDICINE$Application of method of pungent dispersing and bitter descending in diarrhoea related to chemotherapy for colorectal carcinoma$62$YR$$M$Y$$$20240829$$MD$CN$CN
242629301$24262930$1$I$$20240801$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07786$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242629311$24262931$1$I$20240716$20240816$20240829$20240829$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160969$JIANGSU HENGRUI MEDICINE$$4$YR$$F$Y$18$KG$20240829$$MD$CN$CN
242629321$24262932$1$I$20240807$20240820$20240829$20240829$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2160970$JIANGSU HANSOH PHARMACEUTICAL$$57$YR$$F$Y$47$KG$20240829$$MD$CN$CN
242629331$24262933$1$I$20240727$20240821$20240829$20240829$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16753$IPSEN$$51$YR$A$F$Y$$$20240829$$HP$US$US
242629341$24262934$1$I$$20230719$20240829$20240829$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083715$GLENMARK$$$$$$Y$$$20240829$$HP$US$US
242629351$24262935$1$I$20240715$20240817$20240829$20240829$EXP$FR-AFSSAPS-CF2024000417$FR-Accord-442701$ACCORD$$64$YR$A$M$Y$57$KG$20240829$$PH$FR$FR
242629361$24262936$1$I$20240720$20240817$20240829$20240829$EXP$ES-AEMPS-1558327$ES-Accord-442696$ACCORD$$64$YR$A$F$Y$54$KG$20240829$$MD$ES$ES
242629371$24262937$1$I$20240626$20240806$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00533$IMMUNOGEN$$66$YR$$F$Y$$$20240829$$PH$US$US
242629381$24262938$1$I$$20240807$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00571$IMMUNOGEN$$$$$$Y$$$20240829$$PH$US$US
242629391$24262939$1$I$$20240711$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00563$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$US$US
242629401$24262940$1$I$20240627$20240627$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00532$IMMUNOGEN$$$$$F$Y$$$20240829$$HP$US$US
242629411$24262941$1$I$$20240613$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00512$IMMUNOGEN$$$$$F$Y$$$20240829$$HP$US$US
242629421$24262942$1$I$$20240715$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00574$IMMUNOGEN$$$$$$Y$$$20240829$$HP$US$US
242629431$24262943$1$I$$20240624$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00523$IMMUNOGEN$$$$$$Y$$$20240829$$MD$US$US
242629441$24262944$1$I$$20240716$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00539$IMMUNOGEN$$$$A$F$Y$$$20240829$$CN$US$US
242629451$24262945$1$I$$20240715$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00569$IMMUNOGEN$$$$A$F$Y$$$20240829$$MD$US$US
242629461$24262946$1$I$$20240712$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00531$IMMUNOGEN$$64$YR$$F$Y$$$20240829$$HP$US$US
242629471$24262947$1$I$20240813$20240821$20240829$20240829$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2160974$JIANGSU HENGRUI MEDICINE$$71$YR$$M$Y$73.4$KG$20240829$$MD$CN$CN
242629481$24262948$1$I$$20240820$20240829$20240829$EXP$$US-NOVITIUMPHARMA-2024USNVP01696$NOVITIUM PHARMA$N. Alsaati.REFRACTORY EARLY ONSET SYSTEMIC LUPUS ERYTHEMATOSUS DUE C1Q DEFICIENCY.Annals of Allergy, Asthma + Immunology.2023;131(5):S160$$$I$M$Y$$$20240829$$HP$US$US
242629493$24262949$3$F$$20240905$20240829$20240906$PER$$NVSC2024US174173$NOVARTIS$$40$YR$$M$Y$$$20240906$$CN$US$US
242629501$24262950$1$I$$20240820$20240829$20240829$EXP$$US-NOVITIUMPHARMA-2024USNVP01699$NOVITIUM PHARMA$Mohamed Salah Mohamed.The Missed Culprit For A Complex Case Of Non-ischemic Cardiomyopathy.Journal of Cardiac Failure.09-JAN-2024;30(1):157-158$60$YR$A$F$Y$$$20240829$$HP$US$US
242629511$24262951$1$I$$20240813$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00618$IMMUNOGEN$$$$$F$Y$$$20240829$$CN$US$US
242629521$24262952$1$I$$20240814$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00619$IMMUNOGEN$$72$YR$$F$Y$$$20240829$$HP$US$US
242629531$24262953$1$I$$20240726$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00596$IMMUNOGEN$$$$$F$Y$$$20240829$$MD$US$US
242629541$24262954$1$I$$20240730$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00601$IMMUNOGEN$$$$$$Y$$$20240829$$HP$US$US
242629551$24262955$1$I$$20240722$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00585$IMMUNOGEN$$$$$$Y$$$20240829$$HP$US$US
242629561$24262956$1$I$$20240724$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00589$IMMUNOGEN$$$$$F$Y$$$20240829$$MD$US$US
242629571$24262957$1$I$$20240731$20240829$20240829$PER$$US-IMMUNOGEN, INC.-US-IMGN-24-00607$IMMUNOGEN$$$$$F$Y$$$20240829$$MD$US$US
242629581$24262958$1$I$20240306$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A193448$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$US$
242629591$24262959$1$I$$20240823$20240829$20240829$PER$$US-PFIZER INC-PV202400110718$PFIZER$$40$YR$$M$Y$$$20240829$$CN$US$US
242629602$24262960$2$F$20240101$20240829$20240829$20240903$PER$$US-PFIZER INC-202400242782$PFIZER$$$$$F$Y$$$20240903$$CN$US$US
242629611$24262961$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-PV202400111498$PFIZER$$49$YR$$M$Y$80$KG$20240829$$HP$US$US
242629621$24262962$1$I$$20240821$20240829$20240829$EXP$$CA-AstraZeneca-2024A192222$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$CA$
242629635$24262963$5$F$$20240917$20240829$20240917$PER$$US-PFIZER INC-202400243248$PFIZER$$49$YR$$M$Y$$$20240917$$CN$US$US
242629641$24262964$1$I$$20240823$20240829$20240829$PER$$US-PFIZER INC-PV202400111222$PFIZER$$14$YR$$M$Y$$$20240829$$CN$US$US
242629651$24262965$1$I$$20240822$20240829$20240829$PER$$US-PFIZER INC-202400242998$PFIZER$$32$YR$$M$Y$$$20240829$$HP$US$US
242629661$24262966$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018019$ELI LILLY AND CO$$$$A$F$Y$$$20240829$$CN$US$US
242629671$24262967$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018049$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240829$$CN$US$US
242629681$24262968$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017079$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240829$$CN$US$US
242629692$24262969$2$F$$20240928$20240829$20240930$PER$$US-PFIZER INC-202400244025$PFIZER$$31$YR$$M$Y$92.99$KG$20240930$$CN$US$US
242629701$24262970$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018179$ELI LILLY AND CO$$83$YR$E$$Y$$$20240829$$CN$US$US
242629711$24262971$1$I$20240827$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017099$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240829$$CN$US$US
242629731$24262973$1$I$20240501$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018013$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240829$$CN$US$US
242629741$24262974$1$I$20240304$20240821$20240829$20240829$EXP$$US-BAYER-2024A121840$BAYER$$42$YR$A$M$Y$$$20240829$$CN$US$US
242629751$24262975$1$I$$20240829$20240829$20240829$PER$$US-PROD-AS2-212756134-RB-084201-2024$RECKITT BENCKISER$$$$$M$Y$$$20240829$$CN$US$US
242629761$24262976$1$I$$20240801$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07851$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242629771$24262977$1$I$20240820$20240827$20240827$20240827$DIR$716066$$FDA-CTU$$31$YR$$F$N$58.5$KG$20240827$N$CN$US$
242629781$24262978$1$I$$20240827$20240827$20240827$DIR$716181$$FDA-CTU$$$$$UNK$N$$$20240827$N$CN$US$
242629791$24262979$1$I$20240826$20240827$20240827$20240827$DIR$716070$$FDA-CTU$$32$YR$$F$N$65.25$KG$20240827$N$CN$US$
242629801$24262980$1$I$$20240826$20240829$20240829$PER$$US-JNJFOC-20240870177$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$LW$US$US
242629812$24262981$2$F$20240404$20240910$20240829$20240920$EXP$FR-AFSSAPS-PV2024000765$FR-JNJFOC-20240871981$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$MD$FR$FR
242629821$24262982$1$I$$20240822$20240829$20240829$EXP$$ES-JNJFOC-20240867975$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240829$$CN$ES$ES
242629831$24262983$1$I$20230101$20240823$20240829$20240829$PER$$US-BAYER-2024A122742$BAYER$$32$YR$A$F$Y$$$20240829$$HP$US$US
242629841$24262984$1$I$20220801$20240822$20240829$20240829$30DAY$$US-GSK-US2024104995$GLAXOSMITHKLINE$$61$YR$$M$Y$$$20240829$$CN$US$US
242629851$24262985$1$I$20240101$20240820$20240829$20240829$PER$$US-SA-2024SA249908$SANOFI AVENTIS$$1$YR$I$M$Y$11.7$KG$20240829$$MD$US$US
242629863$24262986$3$F$$20240820$20240829$20240912$PER$$US-SA-2024SA249997$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240912$$CN$US$US
242629871$24262987$1$I$20240501$20240820$20240829$20240829$PER$$US-SA-2023SA068296$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240829$$MD$US$US
242629881$24262988$1$I$20160401$20240822$20240829$20240829$EXP$$ES-AMGEN-ESPSP2024168758$AMGEN$Rullan J. D.. Radiotherapy for isolated granulocytic sarcoma: Case report and review of literature. Clinical and Translational Radiation Oncology. 2018;8:1-3$71$YR$E$M$Y$$$20240829$$HP$ES$ES
242629891$24262989$1$I$$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024172096$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242629901$24262990$1$I$20240817$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170216$AMGEN$$69$YR$E$F$Y$$$20240829$$CN$US$US
242629911$24262991$1$I$20240820$20240823$20240829$20240829$EXP$$TH-BAYER-2024A123490$BAYER$$$$$F$Y$$$20240829$$CN$TH$TH
242629921$24262992$1$I$20230920$20240820$20240829$20240829$EXP$$CA-GSK-CA2023AMR071155$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$CA$CA
242629932$24262993$2$F$20240610$20240916$20240829$20240919$EXP$$AR-MYLANLABS-2024M1053991$MYLAN$$37$YR$$F$Y$$$20240919$$CN$AR$AR
242629941$24262994$1$I$20230801$20240827$20240829$20240829$EXP$$US-ROCHE-10000068204$ROCHE$$17$YR$T$M$Y$26.3$KG$20240829$$CN$US$US
242629951$24262995$1$I$$20240827$20240829$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA075758$SANDOZ$$$$$M$Y$$$20240829$$HP$CA$CA
242629961$24262996$1$I$$20240802$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07836$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242629971$24262997$1$I$20240815$20240826$20240829$20240829$EXP$$CN-ROCHE-10000066867$ROCHE$$50$YR$A$F$Y$59$KG$20240829$$HP$CN$CN
242629981$24262998$1$I$$20240815$20240829$20240829$EXP$$US-ROCHE-3159885$ROCHE$$85$YR$E$M$Y$$$20240829$$CN$US$US
242629991$24262999$1$I$$20240819$20240829$20240829$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-07978$HIKMA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.. Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024;/:/$38$WK$$$Y$$$20240829$$MD$US$US
242630002$24263000$2$F$20240812$20240928$20240829$20240930$PER$$US-PFIZER INC-202400244092$PFIZER$$62$YR$$M$Y$$$20240930$$CN$US$US
242630011$24263001$1$I$20240822$20240825$20240829$20240829$PER$$US-PFIZER INC-202400243448$PFIZER$$34$YR$$F$Y$$$20240829$$CN$US$US
242630022$24263002$2$F$$20240829$20240829$20240904$PER$$US-PFIZER INC-202400244543$PFIZER$$$$A$F$Y$$$20240904$$CN$US$US
242630031$24263003$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-PV202400111412$PFIZER$$$$$F$Y$$$20240829$$CN$US$US
242630041$24263004$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-PV202400111618$PFIZER$$$$$F$Y$$$20240829$$CN$US$US
242630051$24263005$1$I$20240823$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244627$PFIZER$$50$YR$$F$Y$$$20240829$$CN$US$US
242630061$24263006$1$I$20240601$20240821$20240829$20240829$PER$$US-PFIZER INC-202400244199$PFIZER$$76$YR$$F$Y$79.38$KG$20240829$$CN$US$US
242630071$24263007$1$I$$20240812$20240829$20240829$30DAY$$US-PFIZER INC-PV202400105934$PFIZER$$$$$$Y$$$20240829$$CN$US$US
242630082$24263008$2$F$$20240826$20240829$20240829$EXP$$CA-PFIZER INC-202201017435$PFIZER$$65$YR$$M$Y$$$20240829$$HP$CA$CA
242630091$24263009$1$I$20240823$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244621$PFIZER$$57$YR$$F$Y$$$20240829$$CN$US$US
242630101$24263010$1$I$20240824$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244643$PFIZER$$25$YR$$M$Y$$$20240829$$CN$US$US
242630112$24263011$2$F$20240824$20240826$20240829$20240905$PER$$US-PFIZER INC-202400244541$PFIZER$$64$YR$$F$Y$$$20240905$$CN$US$US
242630121$24263012$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-PV202400111851$PFIZER$$$$$F$Y$$$20240829$$CN$US$US
242630132$24263013$2$F$$20240910$20240829$20240913$30DAY$$US-PFIZER INC-PV202400106469$PFIZER$$7$YR$$F$Y$$$20240913$$MD$US$US
242630141$24263014$1$I$$20240823$20240829$20240829$PER$$US-PFIZER INC-202400243508$PFIZER$$55$YR$$$Y$$$20240829$$CN$US$US
242630152$24263015$2$F$$20240829$20240829$20240904$PER$$US-PFIZER INC-PV202400025090$PFIZER$$63$YR$$F$Y$77.11$KG$20240904$$HP$US$US
242630161$24263016$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-PV202400111523$PFIZER$$$$$$Y$$$20240829$$CN$US$US
242630172$24263017$2$F$$20240928$20240829$20240930$30DAY$$US-PFIZER INC-202400242418$PFIZER$$7$YR$$M$Y$33.4$KG$20240930$$CN$US$US
242630191$24263019$1$I$20240101$20240821$20240829$20240829$PER$$US-BIOMARINAP-US-2024-160063$BIOMARIN$$$$$$Y$$$20240829$$CN$US$US
242630201$24263020$1$I$$20240826$20240829$20240829$EXP$$US-JNJFOC-20240869082$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242630211$24263021$1$I$$20240826$20240829$20240829$PER$$US-JNJFOC-20240867865$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242630221$24263022$1$I$$20240823$20240829$20240829$PER$$US-LEO Pharma-373049$LEO PHARM$$56$YR$$F$Y$$$20240828$$CN$US$US
242630231$24263023$1$I$$20240821$20240829$20240829$PER$$US-BIOMARINAP-US-2024-160062$BIOMARIN$$$$$$Y$$$20240829$$CN$US$US
242630241$24263024$1$I$$20240805$20240829$20240829$30DAY$$CA-ABBVIE-5895879$ABBVIE$$$$$$Y$$$20240829$$CN$CA$CA
242630251$24263025$1$I$$20240814$20240829$20240829$PER$$US-ABBVIE-5893920$ABBVIE$$68$YR$$F$Y$$$20240829$$HP$US$US
242630261$24263026$1$I$20240620$20240823$20240829$20240829$EXP$$US-INCYTE CORPORATION-2024IN008897$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242630271$24263027$1$I$20240116$20240827$20240827$20240827$DIR$716087$$FDA-CTU$$80$YR$$F$N$50.35$KG$20240827$N$PH$US$
242630281$24263028$1$I$20240816$20240827$20240827$20240827$DIR$716202$$FDA-CTU$$9$YR$$M$N$41.4$KG$20240827$N$$US$
242630291$24263029$1$I$20240827$20240827$20240827$20240827$DIR$716112$$FDA-CTU$$76$YR$$F$N$$$20240827$N$$US$
242630301$24263030$1$I$20240827$20240827$20240827$20240827$DIR$716116$$FDA-CTU$$75$YR$$F$N$$$20240827$N$$US$
242630311$24263031$1$I$20240805$20240827$20240827$20240827$DIR$716158$$FDA-CTU$$59$YR$$M$N$109.8$KG$20240827$N$CN$US$
242630321$24263032$1$I$$20240827$20240827$20240827$DIR$716172$$FDA-CTU$$$$$UNK$N$$$20240827$$CN$US$
242630341$24263034$1$I$20240814$20240827$20240827$20240827$DIR$716151$$FDA-CTU$$87$YR$$F$N$25.25$KG$20240827$N$$US$
242630361$24263036$1$I$$20240816$20240829$20240829$EXP$$US-ALVOGEN-2024095350$ALVOGEN$Green KD, Bianco LM, McCleskey BC, Scott KS. The Emergence of Bromazolam in Jefferson County AL. A Case Series. 2024; doi:10.1093/jat/bkae067/7725379$25$YR$$M$Y$$$20240829$$MD$US$US
242630371$24263037$1$I$20240701$20240822$20240829$20240829$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07603$VIFOR$$76$YR$$F$Y$$$20240829$$HP$ZA$ZA
242630391$24263039$1$I$$20240823$20240829$20240829$EXP$$US-INCYTE CORPORATION-2024IN008895$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242630402$24263040$2$F$20240801$20240830$20240829$20240909$EXP$GB-MYLANLABS-2024M1075316$GB-PERRIGO-24GB007770$PERRIGO$$$$$M$Y$$$20240909$$HP$GB$GB
242630411$24263041$1$I$$20240827$20240829$20240829$EXP$$AU-MYLANLABS-2024M1079268$MYLAN$$$$$F$Y$$$20240829$$PH$AU$AU
242630421$24263042$1$I$20190601$20240827$20240829$20240829$EXP$GB-MHRA-MED-202408271901515760-QRSHP$GB-MYLANLABS-2024M1079289$MYLAN$$61$YR$$M$Y$$$20240829$$CN$GB$GB
242630432$24263043$2$F$$20240929$20240829$20240930$30DAY$$US-PFIZER INC-202400242281$PFIZER$$15$YR$$M$Y$63.5$KG$20240930$$CN$US$US
242630442$24263044$2$F$20240826$20240830$20240829$20240902$PER$$US-AMGEN-USASP2024171324$AMGEN$$77$YR$E$F$Y$$$20240902$$HP$US$US
242630451$24263045$1$I$$20240823$20240829$20240829$30DAY$$US-PFIZER INC-202400243291$PFIZER$$$$$$Y$$$20240829$$HP$US$US
242630471$24263047$1$I$20240825$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244481$PFIZER$$60$YR$$F$Y$$$20240829$$CN$US$US
242630491$24263049$1$I$20230101$20240826$20240829$20240829$EXP$$CA-PFIZER INC-202300071759$PFIZER$$53$YR$$F$Y$$$20240829$$MD$CA$CA
242630501$24263050$1$I$20220101$20240826$20240829$20240829$EXP$$CA-PFIZER INC-202201391301$PFIZER$$31$YR$$M$Y$$$20240829$$HP$CA$CA
242630511$24263051$1$I$$20240822$20240829$20240829$30DAY$$GR-PFIZER INC-PV202400110366$PFIZER$$15$YR$$M$Y$40$KG$20240829$$CN$GR$GR
242630522$24263052$2$F$$20240929$20240829$20240930$30DAY$$US-PFIZER INC-202400239723$PFIZER$$11$YR$$M$Y$$$20240930$$CN$US$US
242630532$24263053$2$F$$20240928$20240829$20240930$30DAY$$US-PFIZER INC-202400243343$PFIZER$$1$YR$$M$Y$$$20240930$$CN$US$US
242630541$24263054$1$I$$20240823$20240829$20240829$PER$$US-PFIZER INC-202400242967$PFIZER$$39$YR$$F$Y$75.75$KG$20240829$$CN$US$US
242630552$24263055$2$F$$20240901$20240829$20240911$PER$$US-PFIZER INC-PV202400111524$PFIZER$$71$YR$$$Y$$$20240911$$CN$US$US
242630562$24263056$2$F$$20240916$20240829$20240918$EXP$$US-PFIZER INC-PV202400090313$PFIZER$$63$YR$$F$Y$$$20240918$$CN$US$US
242630581$24263058$1$I$$20240823$20240829$20240829$30DAY$$US-PFIZER INC-202400243293$PFIZER$$$$$$Y$$$20240829$$HP$US$US
242630601$24263060$1$I$$20240823$20240829$20240829$PER$$PR-PFIZER INC-202400243938$PFIZER$$85$YR$$M$Y$$$20240829$$CN$PR$PR
242630621$24263062$1$I$20240823$20240823$20240829$20240829$30DAY$$US-PFIZER INC-202400243200$PFIZER$$20$YR$$F$Y$$$20240829$$HP$US$US
242630652$24263065$2$F$20240101$20240920$20240829$20240923$EXP$$CA-PFIZER INC-202400231294$PFIZER$$33$YR$$F$Y$$$20240923$$HP$CA$CA
242630661$24263066$1$I$$20240823$20240829$20240829$30DAY$$US-PFIZER INC-202400243292$PFIZER$$$$$$Y$$$20240829$$HP$US$US
242630672$24263067$2$F$20240101$20240829$20240829$20240904$PER$$US-PFIZER INC-202400246217$PFIZER$$52$YR$$F$Y$$$20240904$$HP$US$US
242630703$24263070$3$F$$20240918$20240829$20240920$30DAY$$CA-PFIZER INC-202400245677$PFIZER$$$$$$Y$$$20240920$$CN$CA$CA
242630712$24263071$2$F$20240820$20240928$20240829$20240930$30DAY$$US-PFIZER INC-202400242255$PFIZER$$13$YR$$M$Y$29.48$KG$20240930$$CN$US$US
242630721$24263072$1$I$20240807$20240827$20240829$20240829$EXP$GB-MHRA-MED-202408261731134380-MGSZV$GB-PFIZER INC-202400244685$PFIZER$$63$YR$$F$Y$100$KG$20240829$$CN$GB$GB
242630741$24263074$1$I$$20240823$20240829$20240829$PER$$US-PFIZER INC-202400243127$PFIZER$$62$YR$$F$Y$$$20240829$$CN$US$US
242630752$24263075$2$F$$20240929$20240829$20240930$30DAY$$US-PFIZER INC-202400240619$PFIZER$$13$YR$$M$Y$$$20240930$$CN$US$US
242630773$24263077$3$F$20240825$20240922$20240829$20240923$PER$$US-PFIZER INC-202400244608$PFIZER$$67$YR$$F$Y$68.027$KG$20240923$$CN$US$US
242630782$24263078$2$F$20240821$20240919$20240829$20240925$30DAY$$US-PFIZER INC-202400242295$PFIZER$$9$YR$$F$Y$28.7$KG$20240925$$HP$US$US
242630791$24263079$1$I$20201228$20240826$20240829$20240829$EXP$$CO-UCBSA-2024043757$UCB$$53$YR$$M$Y$$$20240829$$CN$CO$CO
242630801$24263080$1$I$$20240823$20240829$20240829$EXP$$US-INCYTE CORPORATION-2024IN008890$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242630811$24263081$1$I$20240724$20240818$20240829$20240829$EXP$GB-MHRA-MED-202408181025517650-FYNHK$GB-Accord-442310$ACCORD$$53$YR$A$F$Y$$$20240829$$CN$GB$GB
242630821$24263082$1$I$20240619$20240817$20240829$20240829$EXP$$BR-Accord-436223$ACCORD$$62$YR$A$F$Y$82$KG$20240829$$PH$BR$BR
242630831$24263083$1$I$20240801$20240817$20240829$20240829$EXP$$US-Accord-443069$ACCORD$$25$YR$A$F$Y$$$20240829$$PH$US$US
242630841$24263084$1$I$$20240817$20240829$20240829$EXP$GB-MHRA-MED-202408171703580750-MPZDK$GB-Accord-442500$ACCORD$$$$$F$Y$$$20240829$$CN$GB$GB
242630851$24263085$1$I$$20240826$20240829$20240829$30DAY$$US-GSK-US2024106151$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242630862$24263086$2$F$$20240916$20240829$20240917$PER$$US-JNJFOC-20240867526$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$US$US
242630871$24263087$1$I$$20240813$20240829$20240829$PER$$US-ASTELLAS-2024-AER-001674$ASTELLAS$$$$A$F$Y$$$20240829$$HP$US$US
242630881$24263088$1$I$$20240806$20240829$20240829$EXP$$US-Vifor (International) Inc.-VIT-2024-07138$VIFOR$$$$E$F$Y$$$20240829$$CN$US$US
242630891$24263089$1$I$20240101$20240822$20240829$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US075175$SANDOZ$$$$$F$Y$72.18$KG$20240829$$CN$US$US
242630901$24263090$1$I$$20240822$20240829$20240829$EXP$$US-MYLANLABS-2024M1079233$MYLAN$Zahran NA, Zeller WP, Charnogursky GA. Hyperglycemia and multiple organ failure in a male adolescent. J-Clin-Transl-Endocrinol-Case-Rep 2023; 28 1-5.$14$YR$$M$Y$$$20240829$$HP$US$US
242630911$24263091$1$I$$20240823$20240829$20240829$PER$$US-BIOGEN-2023BI01186166$BIOGEN$$$$$M$Y$$$20240829$$CN$US$US
242630921$24263092$1$I$$20240821$20240829$20240829$EXP$$JP-ASTELLAS-2024-AER-000795$ASTELLAS$$$$$$Y$$$20240829$$PH$JP$JP
242630931$24263093$1$I$20240823$20240826$20240829$20240829$EXP$$CO-UCBSA-2024043783$UCB$$41$YR$$F$Y$$$20240829$$CN$CO$CO
242630942$24263094$2$F$$20240911$20240829$20240919$PER$$US-INCYTE CORPORATION-2024IN008748$INCYTE$$$$$$Y$$$20240919$$CN$US$US
242630951$24263095$1$I$20200630$20240819$20240829$20240829$EXP$$PL-AUROBINDO-AUR-APL-2024-042136$AUROBINDO$$26$YR$$M$Y$80$KG$20240829$$MD$PL$PL
242630961$24263096$1$I$$20240826$20240829$20240829$EXP$$US-AMGEN-USASL2024171667$AMGEN$$96$YR$E$F$Y$$$20240829$$CN$US$US
242630981$24263098$1$I$20240823$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171113$AMGEN$$71$YR$E$F$Y$$$20240829$$CN$US$US
242630991$24263099$1$I$20240717$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171125$AMGEN$$75$YR$E$F$Y$$$20240829$$CN$US$US
242631001$24263100$1$I$20240816$20240823$20240829$20240829$EXP$$US-BAYER-2024A122713$BAYER$$69$YR$E$F$Y$$$20240829$$HP$US$US
242631011$24263101$1$I$$20240820$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008747$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242631031$24263103$1$I$$20240816$20240829$20240829$EXP$$HK-ASTELLAS-2024-AER-000010$ASTELLAS$$$$T$$Y$$$20240823$$MD$HK$HK
242631041$24263104$1$I$$20240814$20240829$20240829$EXP$$CO-ASTELLAS-2024-AER-000443$ASTELLAS$$59$YR$A$F$Y$68$KG$20240823$$CN$CO$CO
242631052$24263105$2$F$$20240818$20240829$20240903$EXP$$AU-ASTELLAS-2024-AER-001033$ASTELLAS$$80$YR$E$M$Y$$$20240903$$HP$AU$AU
242631092$24263109$2$F$$20240928$20240829$20240930$30DAY$$US-PFIZER INC-PV202400087796$PFIZER$$9$YR$$M$Y$$$20240930$$HP$US$US
242631111$24263111$1$I$$20240826$20240829$20240829$EXP$$CN-PFIZER INC-PV202400111057$PFIZER$$$$E$M$Y$$$20240829$$CN$CN$CN
242631141$24263114$1$I$20240206$20240820$20240829$20240829$EXP$FR-AFSSAPS-PO2024000314$FR-TEVA-VS-3188054$TEVA$$52$YR$$M$Y$$$20240829$$MD$FR$FR
242631152$24263115$2$F$$20240909$20240829$20240919$PER$$US-INCYTE CORPORATION-2024IN008746$INCYTE$$$$$$Y$$$20240919$$CN$US$US
242631161$24263116$1$I$$20240827$20240829$20240829$EXP$$CA-ORGANON-O2408CAN001934$ORGANON$$43$YR$$F$Y$96$KG$20240829$$HP$CA$CA
242631171$24263117$1$I$$20240824$20240829$20240829$EXP$$US-ABBVIE-5898145$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242631191$24263119$1$I$$20240814$20240829$20240829$PER$$US-ABBVIE-5894041$ABBVIE$$54$YR$$F$Y$$$20240829$$HP$US$US
242631201$24263120$1$I$$20240828$20240829$20240829$EXP$$CA-BAUSCH-BL-2024-013032$BAUSCH AND LOMB$HC. Unspecified Article. Unspecified Journal.$$$$$Y$$$20240829$$HP$CA$CA
242631211$24263121$1$I$$20240828$20240829$20240829$EXP$GB-MHRA-MED-202408281425375760-GHMRZ$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048455$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$$$20240829$$CN$GB$GB
242631222$24263122$2$F$$20240916$20240829$20240923$EXP$$AR-GSK-AR2024AMR072519$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$AR$AR
242631231$24263123$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174187$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
242631241$24263124$1$I$$20240828$20240829$20240829$EXP$$CA-BAUSCH-BL-2024-013030$BAUSCH AND LOMB$HC. Unspecified Article. Unspecified Journal.$$$$$Y$$$20240829$$HP$CA$CA
242631252$24263125$2$F$20240101$20240821$20240829$20240831$EXP$$US-TEVA-VS-3235572$TEVA$$69$YR$$F$Y$$$20240831$$CN$US$US
242631261$24263126$1$I$20240801$20240820$20240829$20240829$PER$$US-SA-2024SA250130$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240829$$MD$US$US
242631271$24263127$1$I$20240109$20240814$20240829$20240829$EXP$$CN-UCBSA-2024005136$UCB$$36$YR$$F$Y$60$KG$20240829$$MD$CN$CN
242631281$24263128$1$I$$20240826$20240829$20240829$EXP$$PE-ROCHE-10000068514$ROCHE$$$$$$Y$$$20240829$$MD$PE$PE
242631291$24263129$1$I$$20240819$20240829$20240829$PER$$US-SA-2024SA249441$SANOFI AVENTIS$$$$A$M$Y$95.2$KG$20240829$$MD$US$US
242631301$24263130$1$I$20220101$20240826$20240829$20240829$EXP$$NO-BAYER-2024A107438$BAYER$$30$YR$A$F$Y$$$20240829$$CN$NO$NO
242631311$24263131$1$I$20240701$20240820$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015111$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240829$$CN$US$US
242631321$24263132$1$I$20100101$20240814$20240829$20240829$EXP$$TR-ASTELLAS-2024-AER-000486$ASTELLAS$Koylu NY, Koc NS. Everolimus-Related Chylothorax: A Rare Case Report. Experimental and Clinical Transplantation. 2024;22(6): 471-4. doi:10.6002/ect.2023.0252.$27$YR$A$M$Y$$$20240824$$HP$TR$TR
242631332$24263133$2$F$$20240830$20240829$20240906$EXP$$GB-TAKEDA-2024TUS086743$TAKEDA$$57$YR$$M$Y$$$20240906$$CN$SE$GB
242631341$24263134$1$I$$20240814$20240829$20240829$PER$$US-MYLANLABS-2024M1077166$MYLAN$$$$$F$Y$$$20240829$$CN$US$US
242631351$24263135$1$I$$20240814$20240829$20240829$PER$$US-MYLANLABS-2024M1077161$MYLAN$$$$$F$Y$$$20240829$$CN$US$US
242631361$24263136$1$I$$20240829$20240829$20240829$PER$$US-PROD-AS2-212756134-RB-082153-2024$RECKITT BENCKISER$$$$$F$Y$$$20240829$$CN$US$US
242631372$24263137$2$F$$20240916$20240829$20240925$30DAY$$AU-JNJFOC-20240859566$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$PH$AU$AU
242631382$24263138$2$F$20240809$20240926$20240829$20240928$PER$$US-JNJFOC-20240849523$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240928$$CN$US$US
242631401$24263140$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA188561$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240829$$MD$US$US
242631411$24263141$1$I$20240819$20240820$20240829$20240829$PER$$US-SA-2024SA249747$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240829$$MD$US$US
242631421$24263142$1$I$20240814$20240824$20240829$20240829$EXP$$PA-BAYER-2024A124132$BAYER$$$$$F$Y$$$20240829$$MD$PA$PA
242631431$24263143$1$I$$20240828$20240829$20240829$PER$$US-HALEON-2194135$Haleon PLC$$55$YR$$F$Y$$$20240829$$CN$US$US
242631441$24263144$1$I$20240101$20240822$20240829$20240829$EXP$$JP-JNJFOC-20240865932$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240829$$MD$JP$JP
242631461$24263146$1$I$$20240826$20240829$20240829$PER$$US-HALEON-2193721$Haleon PLC$$$$$F$Y$$$20240829$$CN$US$US
242631471$24263147$1$I$20230731$20231002$20240829$20240829$PER$$US-BSC-2023000046$BOSTON SCIENTIFIC$$66$YR$E$F$Y$$$20240829$$MD$US$US
242631481$24263148$1$I$20230717$20231116$20240829$20240829$PER$$US-BSC-2023000047$BOSTON SCIENTIFIC$$52$YR$A$F$Y$$$20240829$$MD$US$US
242631501$24263150$1$I$20191218$20231214$20240829$20240829$PER$$US-BSC-2023000079$BOSTON SCIENTIFIC$Stephanie D. Talutis, Amanda L. Chin, Peter F. Lawrence, Karen Woo, Steven M. Farley, William Duong, Juan Carlos Jimenez. Increased Body Mass Index and Vein Diameter are Associated with Incomplete Target Vein Closure following Microfoam Ablation of Incompetent Saphenous Veins.$72$YR$$F$Y$$$20240829$$MD$US$US
242631511$24263151$1$I$$20240110$20240829$20240829$PER$$US-BSC-2023000130$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$MD$US$US
242631521$24263152$1$I$$20240715$20240829$20240829$PER$$US-BSC-2024000077$BOSTON SCIENTIFIC$$$$$F$Y$$$20240829$$HP$US$US
242631531$24263153$1$I$20240821$20240822$20240829$20240829$PER$$US-BEH-2024177672$CSL BEHRING$$40$YR$A$F$Y$$$20240829$$HP$US$US
242631541$24263154$1$I$$20240729$20240829$20240829$PER$$US-BSC-2024000080$BOSTON SCIENTIFIC$$$$$$Y$$$20240829$$CN$US$US
242631551$24263155$1$I$20240801$20240828$20240829$20240829$PER$$US-BAUSCH-BL-2024-013004$BAUSCH AND LOMB$$65$YR$$F$Y$71.732$KG$20240829$$CN$US$US
242631561$24263156$1$I$20240122$20240430$20240829$20240829$PER$$US-BSC-2024000014$BOSTON SCIENTIFIC$$65$YR$$M$Y$$$20240829$$MD$US$US
242631572$24263157$2$F$$20240829$20240829$20240903$PER$$US-MYLANLABS-2024M1078381$MYLAN$$67$YR$$F$Y$$$20240903$$MD$US$US
242631581$24263158$1$I$$20240827$20240829$20240829$EXP$$US-BAUSCH-BL-2024-012995$BAUSCH AND LOMB$Rink D, Abramson R, Johnson N, Lee R. Diagnostic Confounders in Brain Death A Woman with Unexplained Coma and Brainstem Areflexia. Annals of the American Thoracic Society. 2024;21(8):1204-1208. doi:10.1513/AnnalsATS.202403-232CC.$60$YR$$F$Y$$$20240829$$MD$US$US
242631591$24263159$1$I$20240818$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170177$AMGEN$$73$YR$E$M$Y$$$20240829$$CN$US$US
242631601$24263160$1$I$$20240821$20240829$20240829$EXP$$US-AMGEN-USASP2024167429$AMGEN$$$$A$F$Y$$$20240829$$CN$US$US
242631611$24263161$1$I$$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245296$PFIZER$$23$YR$$M$Y$$$20240829$$HP$US$US
242631621$24263162$1$I$20230101$20240820$20240829$20240829$EXP$$PL-PFIZER INC-202400234666$PFIZER$Czarnecki, L.. Pembrolizumab plus chemotherapy in a patient with lung cancer (adenocarcinoma) and below 1% PD-L1 expression. Oncology in Clinical Practise-Education. 2024;10(C):10-4$56$YR$$M$Y$$$20240829$$MD$PL$PL
242631631$24263163$1$I$$20240823$20240829$20240829$EXP$$PL-PFIZER INC-PV202400110385$PFIZER$Stryjkowska-Gora, A.. Treatment of a non-small cell lung cancer patient with low PD-L1 expression using chemotherapy in combination with pembrolizumab. ONKOLOGIA W PRAKTYCE KLINICZNEJ - EDUKACJA. 2024;10(Supl. C):C40-C43$74$YR$$M$Y$$$20240829$$MD$PL$PL
242631651$24263165$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-PV202400111473$PFIZER$$$$$$Y$$$20240829$$CN$US$US
242631661$24263166$1$I$20240101$20240827$20240829$20240829$EXP$$US-BAUSCH-BL-2024-012956$BAUSCH AND LOMB$$3$YR$$F$Y$$$20240829$$CN$US$US
242631671$24263167$1$I$20240801$20240825$20240829$20240829$EXP$$CA-BAYER-2024A122214$BAYER$$59$YR$A$F$Y$$$20240829$$CN$CA$CA
242631681$24263168$1$I$$20240819$20240829$20240829$EXP$$US-APOTEX-2024AP009652$APOTEX$Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D.. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report.. Frontiers in Psychiatry. 2024;14:1332999 (01-04)$$$A$F$Y$$$20240829$$HP$US$US
242631691$24263169$1$I$20240710$20240821$20240829$20240829$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR105696$VIIV$$35$YR$$M$Y$$$20240829$$HP$US$US
242631701$24263170$1$I$$20240820$20240829$20240829$EXP$$JP-TEVA-VS-3237233$TEVA$$$$E$$Y$$$20240829$$MD$JP$JP
242631711$24263171$1$I$$20240822$20240829$20240829$EXP$$GB-TAKEDA-2024TUS086742$TAKEDA$$$$$$Y$$$20240829$$CN$GB$GB
242631721$24263172$1$I$$20240806$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07893$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242631731$24263173$1$I$20240813$20240819$20240829$20240829$PER$$US-SA-2024SA249805$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240829$$MD$US$US
242631741$24263174$1$I$20240101$20240820$20240829$20240829$PER$$US-SA-2024SA249606$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240829$$MD$US$US
242631751$24263175$1$I$$20240820$20240829$20240829$EXP$$JP-TEVA-VS-3237300$TEVA$$$$$$Y$$$20240829$$MD$JP$JP
242631761$24263176$1$I$20240818$20240826$20240829$20240829$EXP$$NVSC2024CN173474$NOVARTIS$$73$YR$$M$Y$60$KG$20240829$$HP$CN$CN
242631771$24263177$1$I$$20240822$20240829$20240829$PER$$US-ROCHE-10000065381$ROCHE$$$$N$M$Y$3.17$KG$20240829$$CN$US$US
242631791$24263179$1$I$$20240825$20240829$20240829$PER$$US-ROCHE-10000065616$ROCHE$$$$C$M$Y$$$20240829$$MD$US$US
242631801$24263180$1$I$$20240819$20240829$20240829$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07979$HIKMA$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J.. Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024;/:/$35$WK$$$Y$$$20240829$$MD$US$US
242631811$24263181$1$I$$20240826$20240829$20240829$PER$$US-ALXN-202408USA001810US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242631821$24263182$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244227$PFIZER$$63$YR$$M$Y$$$20240829$$CN$US$US
242631831$24263183$1$I$$20240827$20240829$20240829$EXP$$CA-PFIZER INC-202400244891$PFIZER$$$$$$Y$$$20240829$$HP$CA$CA
242631843$24263184$3$F$20240705$20240920$20240829$20240920$EXP$$US-PFIZER INC-202400243941$PFIZER$$73$YR$$F$Y$72.57$KG$20240920$$CN$US$US
242631851$24263185$1$I$20240824$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244654$PFIZER$$53$YR$$F$Y$$$20240829$$CN$US$US
242631861$24263186$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244973$PFIZER$$70$YR$$F$Y$$$20240829$$CN$US$US
242631871$24263187$1$I$20240731$20240826$20240829$20240829$PER$$US-PFIZER INC-PV202400111884$PFIZER$$46$YR$$F$Y$80.272$KG$20240829$$CN$US$US
242631881$24263188$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244544$PFIZER$$60$YR$$M$Y$$$20240829$$CN$US$US
242631892$24263189$2$F$$20240901$20240829$20240904$PER$$US-PFIZER INC-202400244350$PFIZER$$72$YR$$F$Y$$$20240904$$PH$US$US
242631901$24263190$1$I$20240826$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244527$PFIZER$$30$YR$$F$Y$$$20240829$$CN$US$US
242631911$24263191$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-202400243948$PFIZER$$$$$$Y$$$20240829$$PH$US$US
242631921$24263192$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-202400243956$PFIZER$$$$$M$Y$$$20240829$$CN$US$US
242631931$24263193$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-PV202300205876$PFIZER$$85$YR$$M$Y$76.19$KG$20240829$$CN$US$US
242631941$24263194$1$I$20240819$20240826$20240829$20240829$PER$$US-PFIZER INC-202400243904$PFIZER$$$$E$F$Y$$$20240829$$CN$US$US
242631951$24263195$1$I$$20240826$20240829$20240829$PER$$KR-PFIZER INC-PV202400110968$PFIZER$$$$$F$Y$$$20240829$$CN$KR$KR
242631961$24263196$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244068$PFIZER$$69$YR$$M$Y$$$20240829$$HP$US$US
242631971$24263197$1$I$20240816$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244602$PFIZER$$66$YR$$F$Y$$$20240829$$CN$US$US
242631991$24263199$1$I$20240825$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244582$PFIZER$$50$YR$$F$Y$$$20240829$$HP$US$US
242632002$24263200$2$F$$20240830$20240829$20240904$PER$$US-PFIZER INC-202400244005$PFIZER$$57$YR$$F$Y$$$20240904$$PH$US$US
242632012$24263201$2$F$20230101$20240903$20240829$20240905$PER$$US-PFIZER INC-PV202400111536$PFIZER$$71$YR$$F$Y$118.1$KG$20240905$$HP$US$US
242632021$24263202$1$I$$20240820$20240829$20240829$EXP$$CA-APOTEX-2022AP002341$APOTEX$$23$YR$$F$Y$$$20240829$$HP$CA$CA
242632031$24263203$1$I$20240717$20240821$20240829$20240829$EXP$$CN-BEIGENE-BGN-2024-013207$BEIGENE$$$$$$Y$$$20240829$$HP$CN$CN
242632051$24263205$1$I$$20240823$20240829$20240829$EXP$$US-AstraZeneca-2024A193413$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
242632062$24263206$2$F$20240826$20240827$20240829$20240830$PER$$US-ROCHE-10000067954$ROCHE$$60$YR$A$M$Y$66.22$KG$20240830$$CN$US$US
242632071$24263207$1$I$20240606$20240827$20240829$20240829$EXP$$DE-GSK-DE2024106913$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$DE$DE
242632081$24263208$1$I$20240826$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170228$AMGEN$$58$YR$A$F$Y$$$20240829$$CN$US$US
242632093$24263209$3$F$20240101$20240912$20240829$20240913$PER$$US-AMGEN-USASP2024171133$AMGEN$$76$YR$E$F$Y$$$20240913$$CN$US$US
242632102$24263210$2$F$20240821$20240828$20240829$20240902$EXP$$US-AMGEN-USASP2024171236$AMGEN$$71$YR$E$F$Y$$$20240902$$CN$US$US
242632111$24263211$1$I$20240826$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170257$AMGEN$$71$YR$E$F$Y$$$20240829$$CN$US$US
242632121$24263212$1$I$$20240826$20240829$20240829$EXP$$US-LUNDBECK-DKLU4003502$LUNDBECK$$$$$$Y$$$20240829$$HP$US$US
242632131$24263213$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004521$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242632141$24263214$1$I$$20240826$20240829$20240829$EXP$$DE-SANDOZ INC.-NVSC2020DE070840$SANDOZ$$74$YR$$F$Y$$$20240829$$MD$DE$DE
242632151$24263215$1$I$20230613$20240828$20240829$20240829$EXP$$FR-AMERICAN REGENT INC-2024003313$AMERICAN REGENT$$22$YR$$F$Y$72$KG$20240829$$MD$FR$FR
242632161$24263216$1$I$20240827$20240827$20240829$20240829$EXP$GB-MHRA-WEBRADR-202408272252547000-WFVHT$GB-SANDOZ INC.-SDZ2024GB075991$SANDOZ$$21$YR$$M$Y$74$KG$20240829$$CN$GB$GB
242632171$24263217$1$I$$20240824$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US075211$SANDOZ$$$$$M$Y$$$20240829$$CN$US$US
242632191$24263219$1$I$20240101$20240822$20240829$20240829$EXP$$JP-GENMAB-2024-02350AA$GENMAB$$75$YR$$F$Y$$$20240829$$HP$JP$JP
242632244$24263224$4$F$20240101$20240911$20240829$20240918$EXP$$JP-009507513-2407JPN003226J$MERCK$$75$YR$$F$Y$$$20240918$$MD$JP$JP
242632251$24263225$1$I$$20240819$20240829$20240829$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104710$VIIV$$$$$M$Y$$$20240829$$CN$US$US
242632262$24263226$2$F$$20240820$20240829$20240904$EXP$$PT-BEH-2024177687$CSL BEHRING$$$$$F$Y$$$20240904$$HP$PT$PT
242632281$24263228$1$I$20240813$20240821$20240829$20240829$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004487$Unknown Manufacturer$$$$$$Y$$$20240828$$CN$US$US
242632291$24263229$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000068621$ROCHE$$6$YR$C$F$Y$$$20240829$$HP$US$US
242632301$24263230$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249912$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240829$$CN$US$US
242632312$24263231$2$F$20240701$20240828$20240829$20240906$EXP$$DE-Rhythm Pharmaceuticals, Inc.-2024RHM000472$RHYTHM PHARMACEUTICALS$$52$YR$A$M$Y$$$20240906$$HP$DE$DE
242632321$24263232$1$I$20100101$20240826$20240829$20240829$EXP$$CO-UCBSA-2024043756$UCB$$50$YR$$F$Y$$$20240829$$CN$CO$CO
242632331$24263233$1$I$20240825$20240826$20240829$20240829$EXP$$US-BAYER-2024A122617$BAYER$$74$YR$E$F$Y$$$20240829$$CN$US$US
242632342$24263234$2$F$20240823$20240904$20240829$20240910$PER$$US-AMGEN-USASP2024169414$AMGEN$$$$$$Y$$$20240909$$PH$US$US
242632352$24263235$2$F$20240809$20240919$20240829$20240924$EXP$$CA-LUNDBECK-DKLU4003501$LUNDBECK$$$$$$Y$$$20240924$$HP$CA$CA
242632361$24263236$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174163$NOVARTIS$$$$$M$Y$$$20240829$$MD$US$US
242632372$24263237$2$F$20230827$20240830$20240829$20240906$EXP$$DE-Rhythm Pharmaceuticals, Inc.-2023RHM000431$RHYTHM PHARMACEUTICALS$$31$YR$A$F$Y$$$20240906$$HP$DE$DE
242632381$24263238$1$I$$20240819$20240829$20240829$EXP$JP-MLMSERVICE-20240813-PI156937-00328-1$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP001206$JUBILANT$Takahashi K, Kobayashi R, Morikawa K, Maeda M, Samura O, Okamoto A.. Overdose of angiotensin II receptor blocker in the third trimester of pregnancy: A case report.. Journal of Obstetrics and Gynaecology Research.. 2024;50(8):1425-8.$$$N$$Y$$$20240829$$MD$JP$JP
242632392$24263239$2$F$20240807$20240912$20240829$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024611$UNITED THERAPEUTICS$$57$YR$$M$Y$141.95$KG$20240920$$$US$US
242632401$24263240$1$I$20240112$20240823$20240829$20240829$PER$$US-ALXN-202408USA001593US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240829$$HP$US$US
242632411$24263241$1$I$$20240828$20240829$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US076024$SANDOZ$$43$YR$$M$Y$$$20240829$$CN$US$US
242632421$24263242$1$I$$20240821$20240829$20240829$PER$$US-ALXN-202408USA001509US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242632431$24263243$1$I$20240701$20240820$20240829$20240829$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408013931$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240829$$MD$DE$DE
242632441$24263244$1$I$20240722$20240819$20240829$20240829$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408015561$ELI LILLY AND CO$$60$YR$A$M$Y$57$KG$20240829$$CN$DE$CN
242632451$24263245$1$I$20240826$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017196$ELI LILLY AND CO$$90$YR$E$F$Y$$$20240829$$CN$US$US
242632462$24263246$2$F$$20240909$20240829$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408011863$ELI LILLY AND CO$$$$$$Y$$$20240920$$PH$JP$JP
242632471$24263247$1$I$20240816$20240826$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016958$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240829$$CN$US$US
242632481$24263248$1$I$20240807$20240821$20240829$20240829$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408016490$ELI LILLY AND CO$$61$YR$A$F$Y$54$KG$20240829$$CN$DE$CN
242632492$24263249$2$F$$20240828$20240829$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408017362$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240902$$CN$US$US
242632501$24263250$1$I$20240728$20240820$20240829$20240829$EXP$FR-AFSSAPS-LM2024000470$FR-ELI_LILLY_AND_COMPANY-FR202408013093$ELI LILLY AND CO$$68$YR$E$M$Y$59.7$KG$20240829$$CN$FR$FR
242632511$24263251$1$I$20240815$20240820$20240829$20240829$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408012063$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240829$$MD$DE$DE
242632521$24263252$1$I$$20240818$20240829$20240829$EXP$$TH-ELI_LILLY_AND_COMPANY-TH202408011905$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240829$$CN$TH$TH
242632532$24263253$2$F$20240820$20240906$20240829$20240913$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408015665$ELI LILLY AND CO$$28$YR$A$M$Y$60$KG$20240913$$CN$FR$FR
242632541$24263254$1$I$$20240821$20240829$20240829$EXP$GB-MHRA-MED-202408211138445520-TWVMY$GB-ELI_LILLY_AND_COMPANY-GB202408014181$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$GB$GB
242632551$24263255$1$I$$20240820$20240829$20240829$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408012772$ELI LILLY AND CO$$75$YR$E$$Y$$$20240829$$CN$JP$JP
242632561$24263256$1$I$20240301$20240819$20240829$20240829$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408012712$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240829$$CN$JP$JP
242632571$24263257$1$I$20240619$20240817$20240829$20240829$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408012176$ELI LILLY AND CO$$55$YR$A$F$Y$31.4$KG$20240829$$CN$CN$CN
242632581$24263258$1$I$20240801$20240823$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016755$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240829$$CN$US$US
242632591$24263259$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018306$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240829$$CN$US$US
242632601$24263260$1$I$20240201$20240823$20240829$20240829$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202404001704$ELI LILLY AND CO$$83$YR$E$F$Y$37$KG$20240829$$MD$JP$JP
242632611$24263261$1$I$$20240820$20240829$20240829$EXP$$JP-ASTELLAS-2024-AER-001099$ASTELLAS$$64$YR$A$F$Y$$$20240826$$MD$JP$JP
242632621$24263262$1$I$$20240814$20240829$20240829$EXP$$IN-ASTELLAS-2024-AER-000073$ASTELLAS$Nimi G, Kirubakaran K, John J, Kumar P. Disseminated protozoa zopfii infection in liver transplant recipient. Journal of Clinical and Experimental Hepatology. 01-Jan-2024, 14(1)$62$YR$A$M$Y$$$20240826$$HP$IN$IN
242632631$24263263$1$I$$20240814$20240829$20240829$EXP$$JP-ASTELLAS-2024-AER-000112$ASTELLAS$Shoji R, Fukuda K, Mizobuchi T, Arakawa Y, Yamashiro K. Reactivation of herpes simplex virus 2 presenting as recurrent acute retinal necrosis following COVID-19 vaccination. International Journal of Infectious Diseases. 2024;147: 1-3. doi:10.1016/j.ijid.2024.107170.$58$YR$A$F$Y$$$20240826$$MD$JP$JP
242632641$24263264$1$I$20231031$20240815$20240829$20240829$EXP$FR-AFSSAPS-TO2024001571$FR-ASTELLAS-2024-AER-001532$ASTELLAS$$75$YR$E$F$Y$$$20240826$$MD$FR$FR
242632651$24263265$1$I$20210101$20240814$20240829$20240829$EXP$$ES-ASTELLAS-2024-AER-000418$ASTELLAS$Garrido-Marin M, Boixadera A. Multiresistant Candida Endophthalmitis Treated with Intravitreal Caspofungin: A Case Report. Ocular Immunology and Inflammation. 2024;32(6): 858-62. doi:10.1080/09273948.2023.2168701.$24$YR$A$M$Y$$$20240826$$MD$ES$ES
242632661$24263266$1$I$$20240816$20240829$20240829$EXP$$CA-ASTELLAS-2024-AER-000322$ASTELLAS$$$$A$M$Y$$$20240826$$CN$CA$CA
242632671$24263267$1$I$$20240820$20240829$20240829$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-103620$REGENERON$$82$YR$$M$Y$$$20240829$$MD$JP$JP
242632682$24263268$2$F$$20240829$20240829$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07303$LUPIN$$$$$$Y$$$20240919$$CN$US$US
242632691$24263269$1$I$$20240826$20240829$20240829$PER$$US-ABBVIE-5898833$ABBVIE$$$$A$F$Y$$$20240829$$MD$US$US
242632701$24263270$1$I$$20240822$20240829$20240829$EXP$$US-ROCHE-10000065304$ROCHE$$$$$$Y$$$20240829$$CN$US$US
242632711$24263271$1$I$$20240829$20240829$20240829$PER$$US-ROCHE-10000069058$ROCHE$$26$YR$A$F$Y$$$20240829$$HP$US$US
242632721$24263272$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA250233$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240829$$MD$US$US
242632731$24263273$1$I$$20240827$20240829$20240829$EXP$$CA-JNJFOC-20240873198$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$CN$CA$CA
242632741$24263274$1$I$$20240827$20240829$20240829$PER$$NVSC2024US173773$NOVARTIS$$82$YR$$M$Y$$$20240829$$MD$US$US
242632751$24263275$1$I$20240807$20240826$20240829$20240829$EXP$FR-AFSSAPS-BS2024000558$FR-BAYER-2024A122828$BAYER$$82$YR$E$M$Y$$$20240829$$MD$FR$FR
242632761$24263276$1$I$$20240823$20240829$20240829$EXP$$US-MYLANLABS-2024M1079598$MYLAN$Kuo C, Carlini SV, Tiwari S. (012) Parkinsonism is a Red Herring: Broad Differential Diagnoses in a Case of Catatonia Secondary to Clozapine Withdrawal. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S6-S7 abstr. 012.$56$YR$$F$Y$$$20240829$$HP$US$US
242632781$24263278$1$I$20240701$20240827$20240829$20240829$EXP$$GB-SANDOZ INC.-SDZ2024GB076020$SANDOZ$$57$YR$$M$Y$$$20240829$$CN$GB$GB
242632792$24263279$2$F$$20240910$20240829$20240913$EXP$$JP-OTSUKA-2024_022015$OTSUKA$$$$$$Y$$$20240913$$PH$JP$JP
242632801$24263280$1$I$20220727$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59343$$FDA-CTU$$29$YR$$F$N$53.52$KG$20240828$N$CN$US$
242632821$24263282$1$I$$20240823$20240829$20240829$EXP$$IR-MYLANLABS-2024M1079667$MYLAN$Sadeghi A, Bahrami Hezaveh E, Ali Asgari A. Ulcerative colitis in a transgender woman with a sigmoid neovagina: a case report. Int-J-Colorectal-Dis 2024; 39 1-4.$$$A$M$Y$$$20240829$$HP$IR$IR
242632831$24263283$1$I$$20240821$20240829$20240829$EXP$$ID-AstraZeneca-2024A193081$ASTRAZENECA$$$$$$Y$$$20240829$$MD$ID$
242632841$24263284$1$I$$20240827$20240829$20240829$PER$$NVSC2024US173767$NOVARTIS$$$$$F$Y$$$20240829$$HP$US$US
242632851$24263285$1$I$$20240808$20240829$20240829$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004522$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242632861$24263286$1$I$20240827$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59365$$FDA-CTU$$18$YR$$M$N$103.1$KG$20240828$N$PH$US$
242632871$24263287$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59335$$FDA-CTU$$17$YR$$M$N$$$20240828$N$$US$
242632881$24263288$1$I$$20240828$20240829$20240829$EXP$ES-MLMSERVICE-20230614-4351512-1$ES-SANDOZ INC.-SDZ2024ES076027$SANDOZ$$53$YR$$F$Y$$$20240829$$MD$ES$ES
242632891$24263289$1$I$$20240822$20240829$20240829$EXP$$DE-AMGEN-DEUSP2024168769$AMGEN$$73$YR$E$F$Y$$$20240829$$MD$DE$DE
242632901$24263290$1$I$20211214$20240820$20240829$20240829$EXP$$US-TEVA-VS-3235641$TEVA$$56$YR$$F$Y$$$20240829$$CN$US$US
242632911$24263291$1$I$20240101$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171162$AMGEN$$75$YR$E$F$Y$$$20240829$$CN$US$US
242632921$24263292$1$I$20240816$20240820$20240829$20240829$PER$$FR-IGSA-BIG0030414$GRIFOLS$$27$YR$$M$Y$$$20240829$$HP$FR$FR
242632931$24263293$1$I$20240101$20240827$20240829$20240829$EXP$$US-JNJFOC-20240874145$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240829$$HP$US$US
242632941$24263294$1$I$$20240814$20240829$20240829$PER$$US-ABBVIE-5893886$ABBVIE$$46$YR$$M$Y$$$20240829$$HP$US$US
242632951$24263295$1$I$$20240820$20240829$20240829$EXP$$BR-JNJFOC-20240854978$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$MD$BR$BR
242632961$24263296$1$I$20240101$20240817$20240829$20240829$EXP$$US-BAYER-2024A119385$BAYER$$78$YR$E$M$Y$64.9$KG$20240829$$CN$US$US
242632971$24263297$1$I$20240818$20240818$20240829$20240829$EXP$GB-MHRA-MED-202408181451589020-KBYNH$GB-GUERBET / LLC-GB-20240107$GUERBET$$68$YR$E$M$Y$69$KG$20240829$$HP$GB$GB
242632981$24263298$1$I$$20240809$20240829$20240829$PER$$US-TEVA-VS-3234087$TEVA$$80$YR$$F$Y$$$20240829$$HP$US$US
242632991$24263299$1$I$$20240826$20240829$20240829$PER$$US-MYLANLABS-2024M1079050$MYLAN$$$$$M$Y$$$20240829$$CN$US$US
242633001$24263300$1$I$$20240822$20240829$20240829$EXP$$US-MYLANLABS-2024M1078995$MYLAN$Jones H, Bhakta A, Jia L, Wojciechowski D, Torrealba J. An Unusual Presentation of Metastatic BK Virus-Associated Urothelial Carcinoma Arising in the Allograft, Persisting After Transplant Nephrectomy. Int-J-Surg-Pathol 2023; 31 (8): 1586-1592.$32$YR$$M$Y$$$20240829$$MD$US$US
242633011$24263301$1$I$$20240828$20240828$20240828$DIR$716272$$FDA-CTU$$$$$UNK$N$$$20240828$N$CN$US$
242633021$24263302$1$I$$20240828$20240828$20240828$DIR$716244$$FDA-CTU$$$$$UNK$N$$$20240828$N$CN$US$
242633031$24263303$1$I$$20240828$20240828$20240828$DIR$716323$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
242633041$24263304$1$I$$20240828$20240828$20240828$DIR$716241$$FDA-CTU$$$$$UNK$N$$$20240828$N$CN$US$
242633051$24263305$1$I$$20240827$20240829$20240829$EXP$$US-DSJP-DSU-2024-142430$DAIICHI$$$$$M$Y$$$20240829$$HP$US$US
242633071$24263307$1$I$20240824$20240826$20240829$20240829$PER$$NVSC2024US173271$NOVARTIS$$56$YR$$F$Y$$$20240829$$CN$US$US
242633081$24263308$1$I$$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004527$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242633092$24263309$2$F$$20240826$20240829$20240904$PER$$US-AMGEN-USASP2024171505$AMGEN$$$$$M$Y$$$20240904$$MD$US$US
242633101$24263310$1$I$20240822$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171156$AMGEN$$37$YR$A$F$Y$$$20240829$$CN$US$US
242633111$24263311$1$I$$20240827$20240829$20240829$EXP$$US-ALXN-202408USA001831US$ALEXION PHARMACEUTICALS$$$$C$F$Y$$$20240829$$CN$US$US
242633121$24263312$1$I$$20240814$20240829$20240829$PER$$US-ABBVIE-5893567$ABBVIE$$44$YR$$F$Y$$$20240829$$HP$US$US
242633131$24263313$1$I$$20240819$20240829$20240829$EXP$$US-UCBSA-2024042084$UCB$Peterson BL, Midthun KM.. Prevalence of fentanyl in the pediatric postmortem population from 2019 to 2023.. Journal of forensic sciences. 2024;1-9$$$$$Y$$$20240829$$HP$US$US
242633141$24263314$1$I$20240819$20240822$20240829$20240829$EXP$$US-HBP-2024US031128$HELSINN HEALTHCARE$$71$YR$$F$Y$$$20240829$$CN$US$US
242633153$24263315$3$F$20240724$20240914$20240829$20240924$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004526$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240924$$CN$US$US
242633162$24263316$2$F$$20240823$20240829$20240903$EXP$$CA-ROCHE-3467444$ROCHE$$$$A$F$Y$$$20240903$$CN$CA$CA
242633173$24263317$3$F$$20240904$20240829$20240910$PER$$US-SA-2024SA252040$SANOFI AVENTIS$$$$A$M$Y$$$20240910$$MD$US$US
242633181$24263318$1$I$$20240819$20240829$20240829$30DAY$$US-GSK-US2024103453$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242633201$24263320$1$I$$20240827$20240829$20240829$PER$$US-JNJFOC-20240874397$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$MD$US$US
242633211$24263321$1$I$20240827$20240827$20240829$20240829$PER$$US-SA-2024SA251483$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240829$$CN$US$US
242633221$24263322$1$I$20240818$20240827$20240829$20240829$EXP$$CN-BAYER-2024A123379$BAYER$$71$YR$E$F$Y$56.1$KG$20240829$$HP$CN$CN
242633231$24263323$1$I$$20240815$20240829$20240829$EXP$$US-UCBSA-2024041768$UCB$$$$$F$Y$77.098$KG$20240829$$HP$US$US
242633241$24263324$1$I$20240721$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004528$ACADIA PHARMACEUTICALS$$89$YR$$M$Y$$$20240829$$CN$US$US
242633251$24263325$1$I$20191021$20240826$20240829$20240829$EXP$$CO-UCBSA-2024040699$UCB$$47$YR$$F$Y$$$20240829$$CN$CO$CO
242633261$24263326$1$I$$20240828$20240829$20240829$PER$$US-HALEON-2194208$Haleon PLC$$$$$$Y$$$20240829$$CN$US$US
242633272$24263327$2$F$$20240819$20240829$20240902$EXP$$CA-DSJP-DSJ-2024-142118$DAIICHI$$$$$F$Y$$$20240902$$MD$CA$CA
242633291$24263329$1$I$20240801$20240826$20240829$20240829$EXP$$US-JNJFOC-20240872935$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240829$$CN$US$US
242633302$24263330$2$F$$20240906$20240829$20240912$EXP$$JP-JNJFOC-20240872397$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240913$$MD$JP$JP
242633311$24263331$1$I$$20240829$20240829$20240829$PER$$US-PROD-AS2-212756134-RB-083669-2024$RECKITT BENCKISER$$$$$F$Y$$$20240829$$CN$US$US
242633331$24263333$1$I$$20240821$20240829$20240829$EXP$US-drreddys-LIT/USA/21/0138501$US-RDY-LIT/USA/21/0138501$DR REDDYS$Winegarden JA, Carr DB, Bradshaw YS. Topical Ketamine with Other Adjuvants: Underutilized for Refractory Cancer Pain? A Case Series and Suggested Revision of the World Health Organization Stepladder for Cancer Pain. Journal of Palliative Medicine. 2020;23(9): 1167-1171. doi:10.1089/jpm.2019.0618.$72$YR$E$F$Y$$$20240829$$MD$US$US
242633341$24263334$1$I$20240804$20240808$20240829$20240829$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004529$ACADIA PHARMACEUTICALS$$90$YR$$M$Y$$$20240829$$CN$US$US
242633351$24263335$1$I$$20240820$20240829$20240829$EXP$$CA-APOTEX-2024AP009633$APOTEX$$62$YR$$F$Y$$$20240829$$HP$CA$CA
242633361$24263336$1$I$$20240820$20240829$20240829$EXP$$US-ELITEPHARMA-2024ELLIT00222$ELITE$Lee IJ, et al.MULTIPLE ORGAN DYSFUNCTION SYNDROME and DISSEMINATED INTRAVASCULAR COAGULATION CAUSING EXTENSIVE MULTIPLE AMALRIC TRIANGULAR CHOROIDAL INFARCTIONS.Retinal Cases and Brief Reports.Mar-2024;18 (2):251-4$49$YR$A$F$Y$$$20240829$$MD$US$US
242633371$24263337$1$I$$20240812$20240829$20240829$5DAY$$US-ASTELLAS-2024US023023$ASTELLAS$$$$$$Y$$$20240829$$MD$US$US
242633381$24263338$1$I$$20240823$20240829$20240829$EXP$$JP-ROCHE-10000067919$ROCHE$$9$DEC$E$$Y$$$20240829$$MD$JP$JP
242633391$24263339$1$I$$20240531$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002107$AMERICAN REGENT$$$$$$Y$$$20240829$$CN$US$US
242633401$24263340$1$I$20240601$20240607$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002188$AMERICAN REGENT$$$$$F$Y$$$20240829$$HP$US$US
242633411$24263341$1$I$$20240605$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002156$AMERICAN REGENT$$$$$M$Y$$$20240829$$PH$US$US
242633421$24263342$1$I$$20240522$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024001977$AMERICAN REGENT$$$$$F$Y$$$20240829$$MD$US$US
242633431$24263343$1$I$$20240603$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002114$AMERICAN REGENT$$$$$F$Y$$$20240829$$MD$US$US
242633441$24263344$1$I$20240617$20240627$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002109$AMERICAN REGENT$$43$YR$$F$Y$$$20240829$$HP$US$US
242633471$24263347$1$I$20240706$20240827$20240829$20240829$EXP$$SG-VANTIVE-2024VAN019332$Vantive US Healthcare$$77$YR$$M$Y$$$20240829$$CN$SG$SG
242633481$24263348$1$I$20240822$20240822$20240829$20240829$EXP$$US-VANTIVE-2024VAN019288$Vantive US Healthcare$$$$$$Y$$$20240829$$CN$US$US
242633491$24263349$1$I$$20240429$20240829$20240829$EXP$$CA-ROCHE-10000060278$ROCHE$$32$YR$A$F$Y$$$20240829$$CN$CA$CA
242633501$24263350$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174497$NOVARTIS$$$$$$Y$$$20240829$$HP$US$US
242633512$24263351$2$F$$20240829$20240829$20240903$EXP$$CO-TAKEDA-2024TUS086760$TAKEDA$$$$$M$Y$72$KG$20240903$$CN$CO$CO
242633521$24263352$1$I$20240809$20240817$20240829$20240829$EXP$$US-Accord-443068$ACCORD$$33$YR$A$M$Y$$$20240829$$PH$US$US
242633531$24263353$1$I$20240815$20240817$20240829$20240829$EXP$GB-MHRA-MED-202408172356121370-JKCPY$GB-Accord-442501$ACCORD$$$$$$Y$$$20240829$$CN$GB$GB
242633541$24263354$1$I$20240808$20240821$20240829$20240829$EXP$$CN-AstraZeneca-2024A192922$ASTRAZENECA$$18787$DY$$F$Y$60$KG$20240829$$MD$CN$
242633552$24263355$2$F$20240601$20240903$20240829$20240906$EXP$$US-AMGEN-USASP2024168124$AMGEN$$82$YR$E$M$Y$$$20240906$$CN$US$US
242633561$24263356$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59520$$FDA-CTU$$61$YR$$F$N$$$20240828$N$$US$
242633571$24263357$1$I$20240628$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59399$$FDA-CTU$$36$YR$$F$N$$$20240828$N$PH$US$
242633581$24263358$1$I$$20240823$20240829$20240829$EXP$$CN-PFIZER INC-202400243721$PFIZER$Zhu, R.. Linezolid-induced fatal lactic acidosis: an adverse reaction easily confused with septic shock. Chinese Journal of Infection Control. 2024;23(7):897-900$48$YR$$M$Y$$$20240829$$HP$CN$CN
242633591$24263359$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59495$$FDA-CTU$$56$YR$$M$N$$$20240828$N$$US$
242633601$24263360$1$I$20240809$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59524$$FDA-CTU$$34$YR$$M$N$102.51$KG$20240828$N$CN$US$
242633622$24263362$2$F$$20240828$20240829$20240903$EXP$$AU-PFIZER INC-202400244694$PFIZER$Soma, M.. Mediastinal Nontuberculous Mycobacterial Infection in Children A Multidisciplinary Approach. Pediatric Infectious Disease Journal. 2024;43(7):e225-e230$14$MON$$F$Y$$$20240903$$MD$AU$AU
242633632$24263363$2$F$$20240905$20240829$20240906$EXP$DE-SANDOZ-SDZ2024DE072920$DE-UCBSA-2024043234$UCB$$67$YR$$M$Y$$$20240906$$MD$DE$DE
242633671$24263367$1$I$20230523$20240827$20240829$20240829$EXP$$KR-009507513-2408KOR008903$MERCK$$$$A$F$Y$$$20240829$$PH$KR$KR
242633681$24263368$1$I$$20240822$20240829$20240829$EXP$$IN-MYLANLABS-2024M1079224$MYLAN$Mahajan S, Karishetti MSK. Cardinal sin of soft tissue sarcoma in a renal transplant patient. Indian-J-Nephrol 2023; 33 (Suppl.) S119.$37$YR$$M$Y$$$20240829$$HP$IN$IN
242633701$24263370$1$I$$20240827$20240829$20240829$PER$$US-BIOVITRUM-2024-US-011428$BIOVITRUM$$69$YR$$M$Y$$$20240829$$HP$US$US
242633711$24263371$1$I$$20240822$20240829$20240829$EXP$$CH-AMGEN-CHESP2024169274$AMGEN$Pabst T.. Determinants of Interpatient Variability in Treosulfan Pharmacokinetics in AML Patients Undergoing Autologous Stem Cell Transplantation. International Journal of Molecular Sciences. 2024;25 (15):1 to 18$$$$$Y$$$20240829$$HP$CH$CH
242633721$24263372$1$I$$20240819$20240829$20240829$EXP$$CA-APOTEX-2024AP009529$APOTEX$$62$YR$$M$Y$$$20240829$$CN$CA$CA
242633731$24263373$1$I$20240624$20240821$20240829$20240829$EXP$$CN-BEIGENE-BGN-2024-013208$BEIGENE$$$$$$Y$$$20240829$$HP$CN$CN
242633741$24263374$1$I$$20240814$20240829$20240829$EXP$$US-Innogenix, LLC-2160980$INNOGENIX$Full text$58$YR$$M$Y$$$20240829$$$US$US
242633751$24263375$1$I$$20240828$20240829$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048497$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240829$$CN$US$US
242633761$24263376$1$I$20240617$20240820$20240829$20240829$EXP$$FR-GSK-FR2024GSK097446$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$MD$FR$FR
242633771$24263377$1$I$$20240819$20240829$20240829$30DAY$US-MMM-XEGVWJN1$US-GSK-US2024103317$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242633781$24263378$1$I$20240101$20240821$20240829$20240829$EXP$$CA-APOTEX-2024AP009728$APOTEX$$$$A$M$Y$$$20240829$$HP$CA$CA
242633801$24263380$1$I$$20240821$20240829$20240829$EXP$$CA-TEVA-VS-3235769$TEVA$$69$YR$$M$Y$$$20240829$$PH$CA$CA
242633811$24263381$1$I$$20240823$20240829$20240829$EXP$$IN-MYLANLABS-2024M1079583$MYLAN$Rupakumar T, Sankar A, Vijayasekharan K, VarikkattuRajendran P, ChellapanSojamani G, Rajeswari B, et al. Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India. Br-J-Haematol 2024; 220-228.$$$C$$Y$$$20240829$$HP$IN$IN
242633841$24263384$1$I$20240715$20240823$20240829$20240829$EXP$FR-AFSSAPS-LM2024000463$FR-MYLANLABS-2024M1078356$MYLAN$$78$YR$$M$Y$60$KG$20240829$$MD$FR$FR
242633851$24263385$1$I$$20240827$20240829$20240829$EXP$$US-BAYER-2024A123909$BAYER$$$$$$Y$$$20240829$$CN$US$US
242633861$24263386$1$I$$20240821$20240829$20240829$EXP$$AU-Waylis Therapeutics LLC-ATNAHS20240802439$Waylis$$$$$F$Y$$$20240829$$HP$AU$AU
242633871$24263387$1$I$$20240816$20240829$20240829$PER$$US-Calliditas-2024CAL01614$CALLIDITAS THERAPEUTICS$$50$YR$A$M$Y$83$KG$20240829$$CN$US$US
242633881$24263388$1$I$20240718$20240821$20240829$20240829$EXP$$CN-BEIGENE-BGN-2024-013209$BEIGENE$$$$$$Y$$$20240829$$HP$CN$CN
242633891$24263389$1$I$20240301$20240820$20240829$20240829$PER$$JP-Eisai-EC-2024-172493$EISAI$$$$E$F$Y$$$20240829$$MD$JP$JP
242633901$24263390$1$I$20240516$20240827$20240829$20240829$EXP$FR-AFSSAPS-LL2024001593$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-08072$HIKMA$$$$$$Y$$$20240829$$MD$FR$FR
242633911$24263391$1$I$20240814$20240819$20240829$20240829$PER$$CN-Eisai-EC-2024-172395$EISAI$$67$YR$E$F$Y$$$20240829$$HP$CN$CN
242633921$24263392$1$I$$20240819$20240829$20240829$EXP$$AU-B.Braun Medical Inc.-2160981$B BRAUN$$64$YR$$M$Y$$$20240829$$MD$AU$AU
242633931$24263393$1$I$$20240815$20240829$20240829$EXP$$BR-UCBSA-2024042277$UCB$$$$$F$Y$$$20240829$$CN$BR$BR
242633941$24263394$1$I$$20240821$20240829$20240829$EXP$$AU-Atnahs Limited-ATNAHS20240802443$Atnahs Healthcare$$$$$$Y$$$20240829$$HP$AU$AU
242633951$24263395$1$I$20240801$20240823$20240829$20240829$EXP$$US-AMGEN-USASP2024169959$AMGEN$$$$A$M$Y$$$20240829$$MD$US$US
242633961$24263396$1$I$$20240822$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-026429$UNITED THERAPEUTICS$$$$$F$Y$65.76$KG$20240829$$$US$US
242633971$24263397$1$I$$20240814$20240829$20240829$PER$$US-AMGEN-USASP2024171940$AMGEN$$$$$F$Y$$$20240829$$CN$US$US
242633981$24263398$1$I$$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171136$AMGEN$$$$$F$Y$$$20240829$$CN$US$US
242633991$24263399$1$I$$20240823$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-015128$UNITED THERAPEUTICS$$$$$F$Y$$$20240829$$$US$US
242634001$24263400$1$I$$20240827$20240829$20240829$EXP$$CA-ORGANON-O2408CAN002010$ORGANON$$43$YR$$F$Y$$$20240829$$HP$CA$CA
242634011$24263401$1$I$$20240821$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134892$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240829$$CN$US$US
242634021$24263402$1$I$20231009$20240816$20240829$20240829$EXP$CH-SM-2024-14945$CH-SA-2024SA251182$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240829$$PH$CH$CH
242634031$24263403$1$I$$20240820$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133577$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$95.71$KG$20240829$$HP$US$US
242634041$24263404$1$I$20240806$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136962$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240829$$CN$US$US
242634051$24263405$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137010$BRISTOL MYERS SQUIBB$$71$YR$A$F$Y$$$20240829$$HP$US$US
242634071$24263407$1$I$$20240716$20240828$20240828$DIR$FDA-CDER-CTU-2024-59384$$FDA-CTU$$$$$$N$$$20240716$N$PH$US$
242634091$24263409$1$I$20240201$20240820$20240828$20240828$DIR$FDA-CDER-CTU-2024-59370$$FDA-CTU$$68$YR$$F$N$56.25$KG$20240820$N$CN$US$
242634101$24263410$1$I$20240801$20240822$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134188$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240829$$CN$US$US
242634111$24263411$1$I$$20240814$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129180$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$66.68$KG$20240829$$CN$US$US
242634121$24263412$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135858$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240829$$CN$US$US
242634131$24263413$1$I$20240101$20240819$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137278$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$74.84$KG$20240829$$CN$US$US
242634152$24263415$2$F$$20240911$20240829$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135814$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240913$$CN$US$US
242634161$24263416$1$I$$20240820$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132562$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240829$$HP$US$US
242634172$24263417$2$F$$20240925$20240829$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135174$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240929$$HP$US$US
242634181$24263418$1$I$$20240823$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-137306$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240829$$HP$CA$CA
242634191$24263419$1$I$$20240823$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135335$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240829$$CN$US$US
242634201$24263420$1$I$$20240823$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-135689$BRISTOL MYERS SQUIBB$Literature Citation unavailable$85$YR$E$F$Y$$$20240829$$PH$CA$CA
242634212$24263421$2$F$20240528$20240906$20240829$20240912$EXP$$NVSC2024FR166514$NOVARTIS$$81$YR$$F$Y$$$20240912$$MD$FR$FR
242634223$24263422$3$F$20240610$20240917$20240829$20240919$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-136415$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240919$$HP$NL$NL
242634231$24263423$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135900$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240829$$CN$US$US
242634241$24263424$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5894517$ABBVIE$$55$YR$$F$Y$$$20240829$$HP$US$US
242634251$24263425$1$I$20240820$20240821$20240829$20240829$EXP$$CN-BEIGENE-BGN-2024-013210$BEIGENE$$$$$$Y$$$20240829$$HP$CN$CN
242634261$24263426$1$I$$20240821$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-025974$UNITED THERAPEUTICS$$$$$F$Y$$$20240829$$$US$US
242634271$24263427$1$I$$20240821$20240829$20240829$EXP$$AU-Waylis Therapeutics LLC-ATNAHS20240802450$Waylis$$$$$F$Y$$$20240829$$HP$AU$AU
242634281$24263428$1$I$20240817$20240823$20240829$20240829$EXP$$GR-TAKEDA-2024TUS086837$TAKEDA$$65$YR$$F$Y$$$20240829$$CN$GR$GR
242634291$24263429$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5894058$ABBVIE$$31$YR$$F$Y$$$20240829$$HP$US$US
242634302$24263430$2$F$20240821$20240919$20240829$20240920$PER$$US-AMGEN-USASP2024170412$AMGEN$$55$YR$A$F$Y$$$20240920$$PH$US$US
242634311$24263431$1$I$20240623$20240823$20240829$20240829$PER$$US-009507513-2408USA008677$MERCK$$73$YR$$M$Y$$$20240829$$CN$US$US
242634321$24263432$1$I$$20240814$20240829$20240829$EXP$$US-Eywa Pharma Inc.-2160982$EYWA PHARMA$Full text$58$YR$$M$Y$$$20240829$$$US$US
242634331$24263433$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5893919$ABBVIE$$70$YR$$F$Y$$$20240829$$HP$US$US
242634341$24263434$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5894622$ABBVIE$$25$YR$$F$Y$$$20240829$$HP$US$US
242634351$24263435$1$I$$20240822$20240829$20240829$EXP$$US-Waylis Therapeutics LLC-ATNAHS20240802445$Waylis$$69$YR$E$F$Y$$$20240829$$CN$US$US
242634361$24263436$1$I$$20240821$20240829$20240829$EXP$$CA-TEVA-VS-3235745$TEVA$$77$YR$$F$Y$73$KG$20240829$$HP$CA$CA
242634371$24263437$1$I$20240822$20240826$20240829$20240829$PER$$US-SA-2024SA251530$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240829$$CN$US$US
242634381$24263438$1$I$20240101$20240820$20240829$20240829$PER$$US-SA-2024SA252118$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240829$$HP$US$US
242634391$24263439$1$I$20240101$20240820$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-025061$UNITED THERAPEUTICS$$$$$F$Y$$$20240829$$$US$US
242634411$24263441$1$I$$20240321$20240829$20240829$EXP$$CA-ROCHE-10000060896$ROCHE$$43$YR$A$F$Y$$$20240829$$MD$CA$CA
242634432$24263443$2$F$$20240925$20240829$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136634$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240927$$CN$US$US
242634441$24263444$1$I$20240101$20240820$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-009258$UNITED THERAPEUTICS$$$$$M$Y$68.481$KG$20240829$$$US$US
242634451$24263445$1$I$20240801$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136960$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240829$$CN$US$US
242634461$24263446$1$I$20240302$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136674$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240829$$HP$US$US
242634471$24263447$1$I$20231001$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136608$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$98.1$KG$20240829$$PH$US$US
242634482$24263448$2$F$20240809$20240828$20240829$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136422$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$45.81$KG$20240903$$PH$US$US
242634491$24263449$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5893964$ABBVIE$$33$YR$$F$Y$$$20240829$$HP$US$US
242634501$24263450$1$I$$20240822$20240829$20240829$PER$$US-AMGEN-USASP2024168728$AMGEN$Adomi M.; Mcelrath T.F.; Hernandez-Diaz S. et al.. TNF-a inhibitor use during pregnancy and the risk of preeclampsia: population-based cohort study. Journal of Hypertension. 2024;42 (9):1529-1537$$$$F$Y$$$20240829$$MD$US$US
242634521$24263452$1$I$$20240809$20240829$20240829$PER$$US-TEVA-VS-3232075$TEVA$$$$$$Y$$$20240829$$CN$US$US
242634531$24263453$1$I$$20240821$20240829$20240829$EXP$$GB-AstraZeneca-2024A191088$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$GB$
242634541$24263454$1$I$$20240823$20240829$20240829$EXP$$CN-PFIZER INC-PV202400110131$PFIZER$Zhu, R.. Linezolid-induced fatal lactic acidosiss: an adverse reaction easily confused with septic shock. Chinese Journal of Infection Control. 2024;23(7):897-900$28$YR$$F$Y$$$20240829$$HP$CN$CN
242634551$24263455$1$I$$20240823$20240829$20240829$EXP$$CN-PFIZER INC-202400243722$PFIZER$Zhu, R.. Linezolid-induced fatal lactic acidosiss: an adverse reaction easily confused with septic shock. Chinese Journal of Infection Control. 2024;23(7):897-900$16$YR$$M$Y$$$20240829$$HP$CN$CN
242634561$24263456$1$I$20240701$20240815$20240829$20240829$EXP$$US-UCBSA-2024042425$UCB$$60$YR$$F$Y$$$20240829$$HP$US$US
242634573$24263457$3$F$20240101$20240923$20240829$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-026723$UNITED THERAPEUTICS$$$$$F$Y$96.145$KG$20240927$$$US$US
242634581$24263458$1$I$$20240717$20240828$20240828$DIR$FDA-CDER-CTU-2024-59386$$FDA-CTU$$$$$$N$$$20240717$N$PH$US$
242634592$24263459$2$F$$20240822$20240829$20240902$PER$$US-ASTELLAS-2024US022669$ASTELLAS$$63$YR$A$M$Y$$$20240830$$MD$US$US
242634601$24263460$1$I$$20240814$20240829$20240829$PER$$US-ABBVIE-5894315$ABBVIE$$39$YR$$F$Y$$$20240829$$HP$US$US
242634612$24263461$2$F$$20240909$20240829$20240913$EXP$$JP-Eisai-EC-2024-172724$EISAI$$75$YR$E$F$Y$54.1$KG$20240913$$MD$JP$JP
242634621$24263462$1$I$20240813$20240828$20240829$20240829$EXP$$JP-BAYER-2024A123668$BAYER$$63$YR$A$M$Y$$$20240829$$MD$JP$JP
242634631$24263463$1$I$$20240816$20240829$20240829$PER$$US-SA-2024SA248596$SANOFI AVENTIS$$$$E$M$Y$$$20240829$$MD$US$US
242634641$24263464$1$I$$20240823$20240829$20240829$EXP$AT-TEVA-VS-3221828$AT-RDY-SPO/AUT/24/0012389$DR REDDYS$Spanberger T., Therapeutic success in the relapse of multiple myeloma. Spectrum Oncology; 2024 (No. 3): p. 99.$66$YR$E$F$Y$$$20240829$$MD$AT$AT
242634651$24263465$1$I$$20240820$20240829$20240829$EXP$$CA-APOTEX-2024AP009602$APOTEX$$$$$F$Y$$$20240829$$HP$CA$CA
242634661$24263466$1$I$20240812$20240821$20240829$20240829$PER$$CN-Eisai-EC-2024-172622$EISAI$$49$YR$A$M$Y$68$KG$20240829$$HP$CN$CN
242634671$24263467$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137257$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240829$$CN$US$US
242634691$24263469$1$I$$20240819$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131500$BRISTOL MYERS SQUIBB$Kumar A, Lee M, Azemi T. Immune check point inhibitor myocarditis mimicking acs. Journal of the American College of Cardiology. 2019 Mar 12;73(9):2681.$71$YR$E$M$Y$$$20240829$$HP$US$US
242634702$24263470$2$F$$20240902$20240829$20240911$EXP$$US-TEVA-VS-3236226$TEVA$Lee DH, Donkor R, Parvus MN, Dannenbaum MJ, Schefler AC. Incidence and Risk Factors for Neutropenia after Intra-Arterial Chemotherapy for Retinoblastoma. JAMA-Ophthalmol 2023; 141 (12): 1133-1138; Lee DH, Donkor R, Parvus MN, Dannenbaum MJ, Schefler AC. Incidence and Risk Factors for Neutropenia after Intra-Arterial Chemotherapy for Retinoblastoma. JAMA-Ophthalmol 2023; 141 (12): 1133-1138.; Lee DH, Donkor R, Parvus MN, Dannenbaum MJ, Schefler AC. Incidence and Risk Factors for Neutropenia af...$$$$$Y$$$20240911$$MD$US$US
242634711$24263471$1$I$20240101$20240827$20240829$20240829$EXP$$PT-JNJFOC-20240871937$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240829$$MD$PT$PT
242634731$24263473$1$I$$20240823$20240829$20240829$EXP$$US-JNJFOC-20240861566$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242634741$24263474$1$I$20240824$20240826$20240829$20240829$EXP$$CR-BAYER-2024A124207$BAYER$$31$YR$A$F$Y$67$KG$20240829$$MD$CR$CR
242634761$24263476$1$I$$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136986$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240829$$HP$US$US
242634771$24263477$1$I$$20240821$20240829$20240829$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-134068$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$63.5$KG$20240829$$CN$PR$PR
242634781$24263478$1$I$$20240821$20240829$20240829$PER$$UM-JNJFOC-20240855171$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$UM$UM
242634791$24263479$1$I$$20240821$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134030$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240829$$HP$US$US
242634801$24263480$1$I$$20240823$20240829$20240829$EXP$$FR-ROCHE-3377212$ROCHE$Pinana M, Rapoport C, Champtiaux N, Lescaille G, Allenbach Y, Rochefort J. Cytomegalovirus-induced oral ulcers: A case report and literature review.. Clinical Case Reports. 2023 Jun 07;11(6):E7459-.$62$YR$A$F$Y$$$20240829$$HP$FR$FR
242634811$24263481$1$I$20240805$20240822$20240829$20240829$PER$$CN-Eisai-EC-2024-172712$EISAI$$35$YR$A$M$Y$$$20240829$$HP$CN$CN
242634821$24263482$1$I$$20240823$20240829$20240829$EXP$$CN-RDY-SPO/CHN/24/0012545$DR REDDYS$Tang J, Lu P, Yang H, Qian H, Xi J, Shen J. Death due to severe hypoglycemia caused by diclofenac sodium and lidocaine injection. Adverse drug reactions journal. 2021 Jun 28;23(6): 324-325. doi:10.3760/cma.j.cn114015-20201120-01163.$53$YR$A$M$Y$$$20240829$$HP$CN$CN
242634831$24263483$1$I$20240701$20240803$20240829$20240829$PER$$EG-Eisai-EC-2024-171840$EISAI$$$$$F$Y$$$20240829$$CN$EG$EG
242634841$24263484$1$I$$20240820$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134199$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240829$$CN$US$US
242634851$24263485$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136748$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240829$$CN$US$US
242634861$24263486$1$I$20240627$20240627$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002505$AMERICAN REGENT$$31$YR$$F$Y$$$20240829$$HP$US$US
242634871$24263487$1$I$20240601$20240617$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002339$AMERICAN REGENT$$46$YR$$F$Y$$$20240829$$HP$US$US
242634881$24263488$1$I$$20240624$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002425$AMERICAN REGENT$$$$$$Y$$$20240829$$CN$US$US
242634891$24263489$1$I$20240617$20240617$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002340$AMERICAN REGENT$$$$A$F$Y$$$20240829$$HP$US$US
242634901$24263490$1$I$20240624$20240624$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002427$AMERICAN REGENT$$$$A$F$Y$$$20240829$$PH$US$US
242634911$24263491$1$I$$20240612$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002289$AMERICAN REGENT$$$$$F$Y$$$20240829$$HP$US$US
242634921$24263492$1$I$20240617$20240621$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002415$AMERICAN REGENT$$5$DEC$$F$Y$$$20240829$$HP$US$US
242634931$24263493$1$I$20230101$20240625$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002430$AMERICAN REGENT$$$$$F$Y$$$20240829$$CN$US$US
242634941$24263494$1$I$$20240821$20240829$20240829$EXP$$GB-EMD Serono-2024027866$EMD SERONO INC$$$$A$F$Y$$$20240829$$HP$GB$GB
242634951$24263495$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017215$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240829$$CN$US$US
242634961$24263496$1$I$20240826$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017326$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240829$$CN$US$US
242634971$24263497$1$I$$20240819$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008692$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242634981$24263498$1$I$20240612$20240822$20240829$20240829$EXP$$CO-EMD Serono-2024045613$EMD SERONO INC$$74$YR$E$F$Y$65$KG$20240829$$HP$CO$CO
242634992$24263499$2$F$$20240828$20240829$20240903$EXP$$CN-PFIZER INC-202400244695$PFIZER$Yao, J.. Pneumomediastinum and pneumoretroperitoneum after COVID-19: concealed intestinal perforation. BMC Infectious Diseases. 2024;24(1):801$74$YR$$F$Y$$$20240903$$MD$CN$CN
242635001$24263500$1$I$$20240822$20240829$20240829$PER$$US-AMGEN-USASP2024168741$AMGEN$Adomi M.; Mcelrath T.F.; Hernandez-Diaz S. et al.. TNF-a inhibitor use during pregnancy and the risk of preeclampsia: population-based cohort study. Journal of Hypertension. 2024;42 (9):1529-1537$$$$$Y$$$20240829$$MD$US$US
242635011$24263501$1$I$$20240814$20240829$20240829$PER$$US-GLANDPHARMA-US-2024GLNSPO00700$GLAND PHARMA$$$$$$Y$$$20240829$$CN$US$US
242635021$24263502$1$I$20240701$20240821$20240829$20240829$EXP$$CN-BEIGENE-BGN-2024-013213$BEIGENE$$$$$$Y$$$20240829$$HP$CN$CN
242635031$24263503$1$I$20240708$20240823$20240829$20240829$EXP$$JP-GENMAB-2024-02486$GENMAB$$73$YR$$F$Y$$$20240829$$MD$JP$JP
242635041$24263504$1$I$20240822$20240823$20240829$20240829$EXP$$NVSC2024RU173173$NOVARTIS$$60$YR$$F$Y$$$20240829$$CN$RU$RU
242635051$24263505$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249845$SANOFI AVENTIS$$$$A$F$Y$$$20240829$$MD$US$US
242635061$24263506$1$I$20231101$20240829$20240829$20240829$EXP$FR-AFSSAPS-TS2024000941$NVSC2024FR174157$NOVARTIS$$80$YR$$M$Y$68$KG$20240829$$MD$FR$FR
242635072$24263507$2$F$20240301$20240826$20240829$20240904$EXP$$AT-HIKMA PHARMACEUTICALS-AT-H14001-24-08000$HIKMA$$38$YR$$M$Y$$$20240904$$CN$AT$AT
242635081$24263508$1$I$20240101$20240823$20240829$20240829$EXP$$US-SA-2024SA250988$SANOFI AVENTIS$$$$A$M$Y$$$20240829$$MD$US$US
242635091$24263509$1$I$$20240823$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-135536$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240829$$HP$CA$CA
242635101$24263510$1$I$$20240814$20240829$20240829$PER$$US-ABBVIE-5895094$ABBVIE$$29$YR$$F$Y$$$20240829$$HP$US$US
242635111$24263511$1$I$$20240819$20240829$20240829$EXP$$CA-APOTEX-2022AP002439$APOTEX$$34$YR$$F$Y$$$20240829$$HP$CA$CA
242635121$24263512$1$I$$20240718$20240828$20240828$DIR$FDA-CDER-CTU-2024-59390$$FDA-CTU$$$$$$N$$$20240718$N$PH$US$
242635131$24263513$1$I$$20240814$20240829$20240829$PER$$US-GLANDPHARMA-US-2024GLNSPO00685$GLAND PHARMA$$$$$F$Y$$$20240829$$CN$US$US
242635141$24263514$1$I$20240301$20240821$20240829$20240829$EXP$$US-ARGENX-2024-ARGX-US007044$ARGENX BVBA$$$$$$Y$$$20240829$$MD$US$US
242635151$24263515$1$I$$20240822$20240829$20240829$EXP$$KR-009507513-2408KOR008913$MERCK$$$$$F$Y$$$20240829$$CN$KR$KR
242635161$24263516$1$I$$20231012$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1109088$BIOCON$$42$YR$$M$Y$88.43$KG$20240829$$$US$US
242635171$24263517$1$I$$20231023$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1113033$BIOCON$$$$$M$Y$$$20240829$$$US$US
242635181$24263518$1$I$20231213$20231227$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2023001912$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635191$24263519$1$I$$20240123$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000535$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635201$24263520$1$I$$20231106$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1119008$BIOCON$$$$$M$Y$$$20240829$$$US$US
242635211$24263521$1$I$$20240118$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000403$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635221$24263522$1$I$$20240131$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000679$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635231$24263523$1$I$$20240826$20240829$20240829$PER$$US-LEO Pharma-373058$LEO PHARM$$42$YR$$F$Y$$$20240829$$PH$US$US
242635241$24263524$1$I$20240730$20240823$20240829$20240829$PER$$CN-Eisai-EC-2024-172867$EISAI$$55$YR$A$F$Y$59$KG$20240829$$HP$CN$CN
242635251$24263525$1$I$$20240817$20240829$20240829$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08309$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242635261$24263526$1$I$$20240828$20240829$20240829$PER$$US-GILEAD-2024-0685608$GILEAD$$65$YR$E$M$Y$$$20240829$$HP$US$US
242635271$24263527$1$I$20240101$20240815$20240829$20240829$PER$$US-SA-2024SA243216$SANOFI AVENTIS$$$$T$F$Y$$$20240829$$CN$US$US
242635281$24263528$1$I$$20240131$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000688$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635291$24263529$1$I$20240101$20240306$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024000834$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635301$24263530$1$I$$20240213$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001005$BIOCON$$$$$$Y$$$20240829$$MD$US$US
242635311$24263531$1$I$$20240220$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001144$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635321$24263532$1$I$$20240220$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001147$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635331$24263533$1$I$$20240301$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001188$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635341$24263534$1$I$$20240305$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001535$BIOCON$$$$$$Y$$$20240829$$HP$US$US
242635351$24263535$1$I$$20240411$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024002483$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635361$24263536$1$I$$20240513$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024003400$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635371$24263537$1$I$20240305$20240305$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024001515$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635381$24263538$1$I$$20240816$20240829$20240829$PER$$US-SA-2024SA248855$SANOFI AVENTIS$$$$A$M$Y$$$20240829$$MD$US$US
242635391$24263539$1$I$$20240822$20240829$20240829$EXP$$CA-GSK-CA2023162624$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$CA$CA
242635401$24263540$1$I$$20240814$20240829$20240829$PER$$US-GLANDPHARMA-US-2024GLNSPO00701$GLAND PHARMA$$$$$$Y$$$20240829$$CN$US$US
242635411$24263541$1$I$$20240815$20240829$20240829$EXP$$US-FMCRTG-FMC-2408-001021$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240829$$HP$US$US
242635421$24263542$1$I$$20240815$20240829$20240829$EXP$$US-FMCRTG-FMC-2408-001006$FRESENIUS MEDICAL CARE$$59$YR$A$M$Y$$$20240829$$HP$US$US
242635431$24263543$1$I$$20240816$20240829$20240829$EXP$$US-FMCRTG-FMC-2408-001008$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240829$$HP$US$US
242635441$24263544$1$I$$20240820$20240829$20240829$EXP$$AU-RDY-SPO/AUS/24/0012252$DR REDDYS$$32$YR$A$M$Y$$$20240829$$CN$AU$AU
242635451$24263545$1$I$$20240823$20240829$20240829$EXP$DE-MLMSERVICE-20240816-PI165226-00196-1$DE-RDY-SPO/DEU/24/0012483$DR REDDYS$Nagele H, Rosenkranz M, Nagele MP. Hyponatremia-Induced Epileptic Seizure Provoked by Levetiracetam and Pain Medication Intake in a Patient with Central Diabetes Insipidus. Case reports in neurology. 2024;16(1):204-7. DOI:10.1159/000540320.$67$YR$E$M$Y$$$20240829$$MD$DE$DE
242635461$24263546$1$I$$20240702$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024004951$BIOCON$$$$$$Y$$$20240829$$HP$US$US
242635471$24263547$1$I$$20240705$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-BBL2024005048$BIOCON$$$$$$Y$$$20240829$$CN$US$US
242635481$24263548$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137279$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$58.51$KG$20240829$$HP$US$US
242635491$24263549$1$I$$20240824$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135690$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240829$$CN$US$US
242635511$24263551$1$I$$20240823$20240829$20240829$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013645$VERTEX$$$$$F$Y$$$20240829$$CN$GB$GB
242635532$24263553$2$F$$20240905$20240829$20240911$PER$$US-VERTEX PHARMACEUTICALS-2024-013431$VERTEX$$24$YR$$F$Y$$$20240911$$CN$US$US
242635541$24263554$1$I$$20240821$20240829$20240829$EXP$$US-VERTEX PHARMACEUTICALS-2024-013520$VERTEX$$$$$F$Y$$$20240829$$CN$US$US
242635561$24263556$1$I$20240101$20240819$20240829$20240829$PER$$US-VERTEX PHARMACEUTICALS-2024-013422$VERTEX$$$$$$Y$$$20240829$$CN$US$US
242635571$24263557$1$I$$20240822$20240829$20240829$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013669$VERTEX$$36$YR$$$Y$$$20240829$$CN$GB$GB
242635581$24263558$1$I$20240101$20240823$20240829$20240829$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013676$VERTEX$$$$A$F$Y$$$20240829$$CN$GB$GB
242635591$24263559$1$I$20240101$20240823$20240829$20240829$EXP$$US-VERTEX PHARMACEUTICALS-2024-012855$VERTEX$$$$$F$Y$$$20240829$$CN$US$US
242635601$24263560$1$I$$20240822$20240829$20240829$PER$$US-VERTEX PHARMACEUTICALS-2024-013623$VERTEX$$$$$$Y$$$20240829$$CN$US$US
242635611$24263561$1$I$20230101$20240822$20240829$20240829$EXP$$US-VERTEX PHARMACEUTICALS-2024-013666$VERTEX$$$$$$Y$$$20240829$$CN$US$US
242635621$24263562$1$I$$20240826$20240829$20240829$PER$$US-LEO Pharma-373071$LEO PHARM$$72$YR$$F$Y$$$20240829$$CN$US$US
242635636$24263563$6$F$20240813$20240905$20240829$20240913$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16782$IPSEN$$91$YR$E$F$Y$56.1$KG$20240913$$CN$US$US
242635641$24263564$1$I$$20240821$20240829$20240829$EXP$$AU-AstraZeneca-2024A193000$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$AU$
242635651$24263565$1$I$20240101$20240822$20240829$20240829$EXP$FR-AFSSAPS-AM2024000628$FR-PFIZER INC-202400241695$PFIZER$$64$YR$$M$Y$$$20240829$$PH$FR$FR
242635663$24263566$3$F$20221227$20240919$20240829$20240924$EXP$$PT-PFIZER INC-PV202400111165$PFIZER$Soares, M.. Cytotoxic lesions of the corpus callosum due to FOLFIRINOX chemotherapy. Brain Disorders. 2024;15:10.1016/j.dscb.2024.100157$47$YR$$F$Y$$$20240924$$HP$PT$PT
242635671$24263567$1$I$$20240823$20240829$20240829$EXP$$CN-PFIZER INC-PV202400110572$PFIZER$$$$A$M$Y$$$20240829$$CN$CN$CN
242635681$24263568$1$I$20240803$20240823$20240829$20240829$EXP$$CN-PFIZER INC-PV202400110601$PFIZER$$50$YR$$F$Y$52$KG$20240829$$HP$CN$CN
242635701$24263570$1$I$20240726$20240823$20240829$20240829$EXP$$JP-PFIZER INC-202400244360$PFIZER$$7$DEC$$M$Y$$$20240829$$MD$JP$JP
242635713$24263571$3$F$20240615$20240906$20240829$20240910$EXP$$JP-PFIZER INC-PV202400072265$PFIZER$$80$YR$$M$Y$48.9$KG$20240910$$MD$JP$JP
242635721$24263572$1$I$20231201$20240822$20240829$20240829$EXP$$CA-PFIZER INC-202400243842$PFIZER$$49$YR$$F$Y$$$20240829$$HP$CA$CA
242635731$24263573$1$I$20240815$20240824$20240829$20240829$EXP$$VN-AstraZeneca-2024A194089$ASTRAZENECA$$24567$DY$$F$Y$$$20240829$$CN$VN$
242635741$24263574$1$I$$20240826$20240829$20240829$EXP$$JP-PFIZER INC-PV202400030571$PFIZER$Uragami, T.. A case of methotrexate-associated intravascular lymphoma. The 502th Osaka Regional Meeting of the Japanese Dermatological Association. 2024;502nd$55$YR$$F$Y$$$20240829$$HP$JP$JP
242635751$24263575$1$I$20230101$20240823$20240829$20240829$EXP$$US-PFIZER INC-202400244058$PFIZER$$67$YR$$F$Y$$$20240829$$HP$US$US
242635772$24263577$2$F$20240801$20240830$20240829$20240904$EXP$$CA-PFIZER INC-202400242800$PFIZER$$74$YR$$F$Y$$$20240904$$HP$CA$CA
242635781$24263578$1$I$$20240822$20240829$20240829$PER$$US-VERTEX PHARMACEUTICALS-2024-013597$VERTEX$$29$YR$$$Y$$$20240829$$CN$US$US
242635791$24263579$1$I$$20240822$20240829$20240829$PER$$US-VERTEX PHARMACEUTICALS-2024-013620$VERTEX$$$$$$Y$$$20240829$$CN$US$US
242635801$24263580$1$I$$20240822$20240829$20240829$PER$$US-VERTEX PHARMACEUTICALS-2024-013656$VERTEX$$$$$$Y$$$20240829$$CN$US$US
242635821$24263582$1$I$$20240822$20240829$20240829$PER$$US-VERTEX PHARMACEUTICALS-2024-013687$VERTEX$$$$$$Y$$$20240829$$CN$US$US
242635831$24263583$1$I$20230501$20240821$20240829$20240829$EXP$$US-BEH-2023162058$CSL BEHRING$$61$YR$A$F$Y$$$20240829$$CN$US$US
242635841$24263584$1$I$$20240815$20240829$20240829$EXP$$US-UCBSA-2024043194$UCB$$$$$$Y$$$20240829$$CN$US$US
242635851$24263585$1$I$20240704$20240828$20240829$20240829$EXP$FR-AFSSAPS-MA2024001249$FR-TAKEDA-2024TUS086959$TAKEDA$$35$YR$$F$Y$$$20240829$$HP$FR$FR
242635861$24263586$1$I$20220501$20240824$20240829$20240829$EXP$$IT-ANIPHARMA-2024-IT-000124$ANI$Puppo G, Novelli F, Pinelli V, et al.Valproic acid-induced pleural effusion..Rassegna di Patologia dell^Apparato Respiratorio.2023;38(1):53-56.$53$YR$$M$Y$$$20240829$$HP$IT$IT
242635871$24263587$1$I$$20240827$20240829$20240829$EXP$$GT-BAYER-2024A123853$BAYER$$44$YR$A$F$Y$$$20240829$$CN$GT$GT
242635881$24263588$1$I$$20240820$20240829$20240829$EXP$$JP-BEH-2024177839$CSL BEHRING$$8$YR$C$M$Y$$$20240829$$HP$JP$JP
242635891$24263589$1$I$$20240826$20240829$20240829$PER$$US-GRUNENTHAL-2024-124492$AVERITAS$$$$E$M$Y$$$20240828$$CN$US$US
242635902$24263590$2$F$20240730$20240829$20240829$20240902$EXP$FR-AFSSAPS-TO2024001633$NVSC2024FR174159$NOVARTIS$$66$YR$$M$Y$74$KG$20240902$$MD$FR$FR
242635911$24263591$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137587$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240829$$CN$US$US
242635922$24263592$2$F$$20240924$20240829$20240925$PER$$US-GILEAD-2024-0684254$GILEAD$$73$YR$E$M$Y$$$20240925$$HP$US$US
242635931$24263593$1$I$$20240827$20240829$20240829$PER$$US-JNJFOC-20240870692$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$CN$US$US
242635941$24263594$1$I$$20240826$20240829$20240829$EXP$$US-AMGEN-USASP2024170302$AMGEN$$51$YR$A$M$Y$$$20240829$$HP$US$US
242635951$24263595$1$I$20240811$20240819$20240829$20240829$30DAY$$GB-PFIZER INC-PV202400107817$PFIZER$$9$YR$$M$Y$$$20240829$$CN$GB$GB
242635961$24263596$1$I$20240813$20240819$20240829$20240829$EXP$$GB-TEVA-VS-3235343$TEVA$$78$YR$$F$Y$68$KG$20240829$$HP$GB$GB
242635971$24263597$1$I$$20240828$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US076032$SANDOZ$$62$YR$$F$Y$$$20240829$$MD$US$US
242635981$24263598$1$I$$20240823$20240829$20240829$EXP$$GB-SANDOZ INC.-NVSC2020GB215488$SANDOZ$$$$$F$Y$$$20240829$$CN$GB$GB
242635991$24263599$1$I$$20240827$20240829$20240829$EXP$$GB-MYLANLABS-2024M1079221$MYLAN$$21$YR$$F$Y$80$KG$20240829$$PH$GB$GB
242636001$24263600$1$I$$20240815$20240829$20240829$EXP$$US-UCBSA-2024043445$UCB$$$$$$Y$$$20240829$$CN$US$US
242636011$24263601$1$I$20240822$20240823$20240829$20240829$PER$$US-BEH-2024177642$CSL BEHRING$$53$YR$A$F$Y$$$20240829$$CN$US$US
242636032$24263603$2$F$$20240829$20240829$20240906$30DAY$$US-GSK-US2024AMR104665$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242636041$24263604$1$I$$20240820$20240829$20240829$EXP$CA-NEBO-667233$CA-NEBO-667233$PHARMACOSMOS$$55$YR$$F$Y$95$KG$20240829$$HP$CA$CA
242636051$24263605$1$I$$20240810$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128052$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240829$$CN$US$US
242636061$24263606$1$I$$20240822$20240829$20240829$PER$$US-JNJFOC-20240861571$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$MD$US$US
242636071$24263607$1$I$20240101$20240826$20240829$20240829$EXP$$US-JNJFOC-20240869538$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240829$$HP$US$US
242636081$24263608$1$I$$20240820$20240829$20240829$PER$$US-ROCHE-10000062516$ROCHE$$$$$$Y$$$20240829$$HP$US$US
242636091$24263609$1$I$20240827$20240827$20240829$20240829$EXP$GB-MHRA-MED-202408270736420740-DNTKJ$GB-ABBVIE-5898805$ABBVIE$$$$$$Y$$$20240829$$CN$GB$GB
242636101$24263610$1$I$$20240827$20240829$20240829$EXP$$US-KYOWAKIRIN-2024KK020036$KYOWA$$$$$$Y$$$20240829$$HP$US$US
242636111$24263611$1$I$$20240718$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002814$AMERICAN REGENT$$34$YR$$F$Y$$$20240829$$HP$US$US
242636121$24263612$1$I$$20240822$20240829$20240829$EXP$$CA-TAKEDA-2024TUS087059$TAKEDA$$91$YR$$M$Y$$$20240829$$HP$CA$CA
242636131$24263613$1$I$20240601$20240712$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002708$AMERICAN REGENT$$$$A$F$Y$$$20240829$$HP$US$US
242636141$24263614$1$I$$20240702$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002567$AMERICAN REGENT$$$$$$Y$$$20240829$$MD$US$US
242636151$24263615$1$I$$20240820$20240829$20240829$EXP$$BR-SANDOZ INC.-SDZ2024BR076225$SANDOZ$$$$$F$Y$$$20240829$$CN$BR$BR
242636162$24263616$2$F$$20240911$20240829$20240913$PER$$US-PFIZER INC-202400245475$PFIZER$$70$YR$$F$Y$$$20240913$$CN$US$US
242636182$24263618$2$F$$20240828$20240829$20240830$PER$$US-PFIZER INC-202400245938$PFIZER$$48$YR$$F$Y$$$20240830$$MD$US$US
242636191$24263619$1$I$$20240828$20240829$20240829$PER$$US-PFIZER INC-202400245976$PFIZER$$69$YR$$F$Y$$$20240829$$CN$US$US
242636201$24263620$1$I$$20240828$20240829$20240829$PER$$US-PFIZER INC-202400246056$PFIZER$$$$$$Y$$$20240829$$CN$US$US
242636211$24263621$1$I$$20240827$20240829$20240829$PER$$US-PFIZER INC-PV202400111882$PFIZER$$21$YR$$M$Y$$$20240829$$HP$US$US
242636222$24263622$2$F$20240828$20240828$20240829$20240830$PER$$US-PFIZER INC-202400246049$PFIZER$$31$YR$$F$Y$$$20240830$$HP$US$US
242636232$24263623$2$F$$20240830$20240829$20240830$PER$$US-PFIZER INC-PV202400112291$PFIZER$$75$YR$$$Y$$$20240830$$CN$US$US
242636241$24263624$1$I$20240827$20240827$20240829$20240829$PER$$US-PFIZER INC-202400244809$PFIZER$$61$YR$$M$Y$$$20240829$$CN$US$US
242636251$24263625$1$I$20240801$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245826$PFIZER$$28$YR$$M$Y$$$20240829$$CN$US$US
242636261$24263626$1$I$20240824$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245147$PFIZER$$49$YR$$F$Y$$$20240829$$CN$US$US
242636271$24263627$1$I$20240824$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245109$PFIZER$$69$YR$$M$Y$$$20240829$$CN$US$US
242636281$24263628$1$I$20240827$20240828$20240829$20240829$PER$$US-PFIZER INC-202400245866$PFIZER$$51$YR$$F$Y$$$20240829$$CN$US$US
242636291$24263629$1$I$20240828$20240828$20240829$20240829$PER$$US-PFIZER INC-202400245920$PFIZER$$$$$$Y$$$20240829$$CN$US$US
242636301$24263630$1$I$20240826$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245092$PFIZER$$61$YR$$F$Y$$$20240829$$CN$US$US
242636311$24263631$1$I$20240820$20240827$20240829$20240829$PER$$US-PFIZER INC-202400244893$PFIZER$$53$YR$$F$Y$$$20240829$$HP$US$US
242636321$24263632$1$I$20240827$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245562$PFIZER$$54$YR$$M$Y$$$20240829$$CN$US$US
242636331$24263633$1$I$20240826$20240827$20240829$20240829$PER$$US-PFIZER INC-202400244900$PFIZER$$52$YR$$M$Y$$$20240829$$CN$US$US
242636341$24263634$1$I$20240824$20240827$20240829$20240829$PER$$US-PFIZER INC-202400244916$PFIZER$$74$YR$$M$Y$$$20240829$$CN$US$US
242636352$24263635$2$F$$20240827$20240829$20240830$PER$$US-PFIZER INC-PV202400112002$PFIZER$$15$YR$$M$Y$$$20240830$$CN$US$US
242636361$24263636$1$I$20240509$20240510$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202405006174$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240829$$CN$US$US
242636371$24263637$1$I$20240226$20240828$20240829$20240829$EXP$FR-AFSSAPS-TO2024001437$FR-BAYER-2024A113292$BAYER$$27$YR$A$F$Y$62$KG$20240829$$CN$FR$FR
242636381$24263638$1$I$20240819$20240820$20240829$20240829$EXP$$GB-TEVA-VS-3236415$TEVA$$53$YR$$F$Y$$$20240829$$CN$GB$GB
242636391$24263639$1$I$$20240819$20240829$20240829$EXP$$US-SMPA-2024SPA001672$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242636401$24263640$1$I$$20240823$20240829$20240829$EXP$$US-SMPA-2024SPA001936$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242636411$24263641$1$I$20240611$20240827$20240829$20240829$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004777$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240829$$HP$US$US
242636422$24263642$2$F$$20240829$20240829$20240904$EXP$$NVSC2024US174151$NOVARTIS$$$$$M$Y$$$20240904$$CN$US$US
242636432$24263643$2$F$$20240913$20240829$20240920$EXP$$IE-SANDOZ INC.-SDZ2024IE075230$SANDOZ$$62$YR$$F$Y$$$20240920$$MD$IE$IE
242636441$24263644$1$I$$20240819$20240829$20240829$PER$$US-TAKEDA-2024TUS083706$TAKEDA$$40$YR$$F$Y$61$KG$20240829$$CN$US$US
242636451$24263645$1$I$$20240821$20240829$20240829$EXP$$US-GSK-US2024AMR104704$GLAXOSMITHKLINE$$82$YR$$$Y$$$20240829$$CN$US$US
242636462$24263646$2$F$20170101$20240913$20240829$20240917$EXP$$US-009507513-2408USA008510$MERCK$$57$YR$$M$Y$$$20240917$$CN$US$US
242636471$24263647$1$I$$20240821$20240829$20240829$PER$$US-JNJFOC-20240859290$JOHNSON AND JOHNSON$$4$YR$C$F$Y$$$20240829$$CN$US$US
242636481$24263648$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137098$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$94.35$KG$20240829$$CN$US$US
242636493$24263649$3$F$20240701$20240909$20240829$20240913$PER$$US-BAYER-2024A123980$BAYER$$30$YR$A$F$Y$92.971$KG$20240913$$MD$US$US
242636501$24263650$1$I$$20240826$20240829$20240829$EXP$$CN-MYLANLABS-2024M1078722$MYLAN$$$$$M$Y$$$20240829$$CN$CN$CN
242636511$24263651$1$I$20070301$20240823$20240829$20240829$EXP$$SE-CHEPLA-1200030884$CHEPLAPHARM$$45$YR$$F$Y$$$20240829$$MD$COUNTRY NOT SPECIFIED$SE
242636521$24263652$1$I$$20240808$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07973$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242636531$24263653$1$I$20051110$20240823$20240829$20240829$EXP$FR-EMA-DD-20240816-7482677-114420$FR-CHEPLA-1200027084$CHEPLAPHARM$$51$YR$$F$Y$80$KG$20240829$$MD$COUNTRY NOT SPECIFIED$FR
242636551$24263655$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A191373$ASTRAZENECA$$$$$M$Y$79.4$KG$20240829$$CN$US$
242636561$24263656$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A192051$ASTRAZENECA$$$$$$Y$$$20240829$$CN$US$
242636571$24263657$1$I$20240311$20240816$20240829$20240829$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000827$PAREXEL$$$$$$Y$$$20240829$$HP$CN$CN
242636582$24263658$2$F$$20240826$20240829$20240904$EXP$$US-AstraZeneca-2024A193975$ASTRAZENECA$$$$$M$Y$70.3$KG$20240905$$CN$US$
242636592$24263659$2$F$$20240902$20240829$20240910$PER$$US-AstraZeneca-2024A163722$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
242636611$24263661$1$I$$20240821$20240829$20240829$EXP$$GB-AstraZeneca-2024A190652$ASTRAZENECA$$73$YR$$F$Y$76$KG$20240829$$MD$GB$
242636621$24263662$1$I$20240801$20240821$20240829$20240829$PER$$JP-Eisai-EC-2024-172716$EISAI$$$$$$Y$$$20240829$$MD$JP$JP
242636631$24263663$1$I$20240617$20240827$20240829$20240829$EXP$FR-AFSSAPS-PO2024000928$FR-Eisai-EC-2024-172951$EISAI$$63$YR$A$M$Y$71$KG$20240829$$MD$FR$FR
242636641$24263664$1$I$$20240823$20240829$20240829$EXP$$JP-Eisai-EC-2024-172841$EISAI$Yoshikazu Ichikawa. Gynecologic Cancer Seminar from Shizuoka; -; .$$$$F$Y$$$20240829$$MD$JP$JP
242636651$24263665$1$I$$20240822$20240829$20240829$EXP$$BR-ROCHE-10000064130$ROCHE$$30$YR$A$$Y$$$20240829$$MD$BR$BR
242636661$24263666$1$I$$20240819$20240829$20240829$EXP$$US-GSK-US2024103379$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242636681$24263668$1$I$$20240820$20240829$20240829$PER$$US-ASTELLAS-2024-AER-002100$ASTELLAS$$$$$M$Y$$$20240829$$PH$US$US
242636691$24263669$1$I$20200101$20240823$20240829$20240829$PER$$US-Millicent Holdings Ltd.-MILL20241116$MILLICENT HOLDINGS$$56$YR$A$F$Y$$$20240829$$CN$US$US
242636711$24263671$1$I$$20240719$20240828$20240828$DIR$FDA-CDER-CTU-2024-59391$$FDA-CTU$$$$$$N$$$20240719$N$PH$US$
242636721$24263672$1$I$$20240823$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-135641$BRISTOL MYERS SQUIBB$Literature Citation unavailable$$$$$Y$$$20240829$$HP$CA$CA
242636731$24263673$1$I$20230101$20240820$20240829$20240829$EXP$$US-ROCHE-3498948$ROCHE$$76$YR$E$F$Y$73.48$KG$20240829$$CN$US$US
242636741$24263674$1$I$$20240828$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US076192$SANDOZ$$$$$F$Y$$$20240829$$CN$US$US
242636751$24263675$1$I$20240101$20240820$20240829$20240829$PER$$US-SA-2024SA196729$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240829$$MD$US$US
242636761$24263676$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA250019$SANOFI AVENTIS$$$$$M$Y$$$20240829$$PH$US$US
242636771$24263677$1$I$$20240821$20240829$20240829$EXP$$CA-TEVA-VS-3235841$TEVA$$63$YR$$M$Y$$$20240829$$MD$CA$CA
242636792$24263679$2$F$$20240906$20240829$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07853$LUPIN$$$$$$Y$$$20240920$$CN$US$US
242636801$24263680$1$I$$20240808$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08038$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242636811$24263681$1$I$$20240821$20240829$20240829$EXP$$US-JNJFOC-20240865670$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$HP$US$US
242636831$24263683$1$I$20240528$20240821$20240829$20240829$EXP$$JP-TAKEDA-2024TUS058328$TAKEDA$$4$DEC$$F$Y$$$20240829$$PH$JP$JP
242636841$24263684$1$I$20240817$20240827$20240829$20240829$EXP$$US-BEH-2024177824$CSL BEHRING$$70$YR$E$F$Y$$$20240829$$HP$US$US
242636851$24263685$1$I$$20240819$20240829$20240829$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07942$HIKMA$Ajami G, Connors JM, Nabzdyk CG, Zenati MA.. Gikandi A, Connors JM, Nabzdyk CG, Zenati MA. Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest. Perfusion. 2024;0(0):1-4$67$YR$$M$Y$$$20240829$$MD$US$US
242636861$24263686$1$I$20240730$20240816$20240829$20240829$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000828$PAREXEL$$$$$$Y$$$20240829$$HP$CN$CN
242636872$24263687$2$F$$20240822$20240829$20240905$EXP$$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-07953$HIKMA$Mira AR, Brincat MR, Zalawadia S, Sideris M, Dilley J.. Mira AR, Brincat MR, Zalawadia S, Sideris M, Dilley J. Immature ovarian teratoma with gliomatosis peritonei, paraneoplastic hyponatremia and growing teratoma syndrome: a case report and literature review.. Annals of Medicine and Surgery. 2024;86(8):4907-4912$26$YR$$F$Y$$$20240905$$MD$GB$GB
242636881$24263688$1$I$20240816$20240826$20240829$20240829$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024106152$VIIV$$$$A$M$Y$$$20240829$$HP$US$US
242636891$24263689$1$I$$20240820$20240829$20240829$30DAY$$US-GSK-US2024103968$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242636901$24263690$1$I$20240205$20240826$20240829$20240829$EXP$FR-AFSSAPS-ST2024001338$FR-GSK-FR2024105958$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$PH$FR$FR
242636911$24263691$1$I$20201015$20240823$20240829$20240829$EXP$$JP-GSK-JP2024JPN081264$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$MD$JP$JP
242636921$24263692$1$I$$20240821$20240829$20240829$EXP$$GB-EMD Serono-2024045490$EMD SERONO INC$$$$A$M$Y$$$20240829$$CN$GB$GB
242636932$24263693$2$F$20240701$20240828$20240829$20240830$PER$$US-AMGEN-USASP2024171089$AMGEN$$68$YR$E$F$Y$$$20240830$$CN$US$US
242636941$24263694$1$I$$20240826$20240829$20240829$EXP$BE-FAMHP-DHH-N2024-122534$BE-GSK-BE2024105919$GLAXOSMITHKLINE$$$$$$Y$$$20240828$$HP$BE$BE
242636951$24263695$1$I$$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171641$AMGEN$$$$$M$Y$$$20240829$$HP$US$US
242636962$24263696$2$F$20240814$20240906$20240829$20240916$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024103272$VIIV$$54$YR$$M$Y$120$KG$20240916$$PH$US$US
242636971$24263697$1$I$$20240825$20240829$20240829$EXP$$NL-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00451$VELOXIS PHARMACEUTICALS$Ghambari K, de Jong DM, Bruno MJ, Polak WG, van Driel LMJW, den Hoed CM. Risks of post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation.. Clinical Transplantation. 2024;38(7):1-9$60$YR$$F$Y$$$20240829$$HP$NL$NL
242636991$24263699$1$I$$20240826$20240829$20240829$EXP$$US-SA-2024SA252100$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240829$$CN$US$US
242637001$24263700$1$I$$20240805$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07911$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242637011$24263701$1$I$20240801$20240815$20240829$20240829$EXP$$AU-Orion Corporation ORION PHARMA-24_00031465$ORION$$25$YR$A$F$Y$116$KG$20240829$$MD$AU$
242637021$24263702$1$I$$20240828$20240829$20240829$EXP$$US-SANDOZ INC.-PHHY2016US168164$SANDOZ$$53$YR$$F$Y$$$20240829$$MD$US$US
242637031$24263703$1$I$20181101$20240513$20240829$20240829$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06832$HIKMA$Chinello M, Arnone OC, Artusa S, Mazzuca G, Bonetti E, Vitale V, Zaccaron A, Raniero D, Cesaro S.. Chinello M, Arnone OC, Artusa S, Mazzuca G, Bonetti E, Vitale V, Zaccaron A, Raniero D, Cesaro S. Pneumatosis Cystoides Intestinalis with Fatal Air Embolism after Minor Blunt Abdominal Trauma in a 6-Year-Old Girl Undergoing Hematopoietic Stem Cell Trasplant: Case Report and Review of Literature. Mediterranean Journal of Hematology and Infectious Diseases. 2024;16(1):e2024028:1-4$7$YR$$F$Y$$$20240829$$MD$IT$IT
242637042$24263704$2$F$20240530$20240906$20240829$20240917$PER$$IT-IGSA-BIG0030360$GRIFOLS$$57$YR$$F$Y$70$KG$20240917$$HP$IT$IT
242637051$24263705$1$I$$20240430$20240829$20240829$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06599$HIKMA$Villa NA, Pausescu DG, Espiridion ED.. Villa NA, Pausescu DG, Espiridion ED. Agranulocytosis Associated With Psychiatric Polypharmacy: Lessons Learned From a Clinical Case.. Cureus. 2024;16(3):e56701:1-5$20$YR$$F$Y$$$20240829$$MD$US$US
242637061$24263706$1$I$$20240828$20240829$20240829$PER$$US-HALEON-2194163$Haleon PLC$$$$$F$Y$$$20240829$$CN$US$US
242637071$24263707$1$I$20230701$20240822$20240829$20240829$PER$$US-SA-2024SA252030$SANOFI AVENTIS$$$$A$F$Y$$$20240829$$HP$US$US
242637081$24263708$1$I$20200111$20240819$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008690$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242637091$24263709$1$I$20240801$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171114$AMGEN$$85$YR$E$F$Y$$$20240829$$CN$US$US
242637101$24263710$1$I$20240101$20240826$20240829$20240829$EXP$$US-AMGEN-USASL2024170633$AMGEN$$64$YR$A$F$Y$$$20240829$$CN$US$US
242637111$24263711$1$I$20240726$20240823$20240829$20240829$PER$$US-BIOGEN-2024BI01279832$BIOGEN$$56$YR$$F$Y$$$20240829$$HP$US$US
242637121$24263712$1$I$20240101$20240719$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002818$AMERICAN REGENT$$$$$$Y$$$20240829$$PH$US$US
242637131$24263713$1$I$20240717$20240724$20240829$20240829$PER$$US-AMERICAN REGENT INC-2024002865$AMERICAN REGENT$$41$YR$$F$Y$$$20240829$$HP$US$US
242637141$24263714$1$I$20220503$20240813$20240829$20240829$EXP$$CA-CELLTRION INC.-2021CA019692$CELLTRION$$$$$$Y$$$20240829$$CN$CA$CA
242637152$24263715$2$F$$20240909$20240829$20240911$PER$$US-BAYER-2024A120630$BAYER$$$$$$Y$$$20240911$$CN$US$US
242637161$24263716$1$I$20190901$20240819$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008685$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242637171$24263717$1$I$$20240823$20240829$20240829$EXP$$DE-JNJFOC-20240869414$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$MD$DE$DE
242637181$24263718$1$I$20240731$20240816$20240829$20240829$EXP$$CH-SK LIFE SCIENCE, INC-SKPVG-2024-001994$SK LIFE SCIENCE$$$$$$Y$$$20240829$$HP$CH$CH
242637191$24263719$1$I$20231214$20240808$20240829$20240829$PER$$US-JNJFOC-20240874009$JOHNSON AND JOHNSON$$7$DEC$$M$Y$$$20240829$$CN$US$US
242637201$24263720$1$I$$20240823$20240829$20240829$PER$$US-JNJFOC-20240869651$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$LW$US$US
242637211$24263721$1$I$$20240826$20240829$20240829$EXP$$US-JNJFOC-20240873491$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242637221$24263722$1$I$20240828$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018168$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240829$$CN$US$US
242637231$24263723$1$I$20240824$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018061$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240829$$CN$US$US
242637241$24263724$1$I$20240731$20240823$20240829$20240829$EXP$FR-AFSSAPS-TS2024000921$FR-MYLANLABS-2024M1078460$MYLAN$$51$YR$$F$Y$68$KG$20240829$$MD$FR$FR
242637251$24263725$1$I$20240312$20240823$20240829$20240829$EXP$FR-AFSSAPS-PB2024000317$FR-VIATRISJAPAN-2024M1030616AA$MYLAN$$34$YR$$F$Y$$$20240829$$PH$FR$FR
242637261$24263726$1$I$$20240823$20240829$20240829$EXP$$US-MYLANLABS-2024M1079372$MYLAN$Benson D, Thorsen T, Kirchen G. Lumbar Radiculopathy in the Pregnant Patient. J-Pain 2019; 20 (Suppl.) (4): S47.$35$YR$$F$Y$$$20240829$$HP$US$US
242637271$24263727$1$I$$20240821$20240829$20240829$PER$$US-JNJFOC-20240856315$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$CN$US$US
242637281$24263728$1$I$20240601$20240826$20240829$20240829$EXP$$US-SA-2024SA252080$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240829$$MD$US$US
242637291$24263729$1$I$$20240819$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008681$INCYTE$$$$$$Y$$$20240829$$HP$US$US
242637321$24263732$1$I$$20240820$20240829$20240829$PER$$US-AstraZeneca-2024A190114$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
242637331$24263733$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137106$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240829$$HP$US$US
242637341$24263734$1$I$$20240821$20240829$20240829$EXP$NO-NOMAADVRE-PASRAPP-2024-V49336$NO-TEVA-VS-3235953$TEVA$$40$YR$$F$Y$86$KG$20240829$$CN$NO$NO
242637361$24263736$1$I$20240814$20240826$20240829$20240829$EXP$$CN-PFIZER INC-PV202400111366$PFIZER$$67$YR$$F$Y$50$KG$20240829$$HP$CN$CN
242637371$24263737$1$I$20230223$20240826$20240829$20240829$EXP$FR-AFSSAPS-LY2023000951$FR-PFIZER INC-202400243600$PFIZER$$60$YR$$F$Y$71$KG$20240829$$PH$FR$FR
242637381$24263738$1$I$$20240827$20240829$20240829$EXP$$RU-PFIZER INC-PV202400111662$PFIZER$$29$YR$$F$Y$$$20240829$$CN$RU$RU
242637391$24263739$1$I$$20240826$20240829$20240829$EXP$$US-PFIZER INC-PV202300179436$PFIZER$$84$YR$$M$Y$$$20240829$$CN$US$US
242637401$24263740$1$I$20240719$20240826$20240829$20240829$EXP$FR-AFSSAPS-AM2024000681$FR-PFIZER INC-202400243571$PFIZER$$86$YR$$F$Y$$$20240829$$PH$FR$FR
242637411$24263741$1$I$20240701$20240826$20240829$20240829$EXP$IT-MINISAL02-999649$IT-PFIZER INC-202400243466$PFIZER$$36$YR$$F$Y$58$KG$20240829$$CN$IT$IT
242637421$24263742$1$I$20240317$20240826$20240829$20240829$EXP$FR-AFSSAPS-DJ2024000930$FR-PFIZER INC-202400243613$PFIZER$$73$YR$$M$Y$75$KG$20240829$$MD$FR$FR
242637431$24263743$1$I$$20240826$20240829$20240829$EXP$$JP-PFIZER INC-202400243659$PFIZER$$$$$$Y$$$20240829$$PH$JP$JP
242637441$24263744$1$I$$20240826$20240829$20240829$EXP$$TW-PFIZER INC-PV202400111481$PFIZER$Wu, W.. Incorporating Tumor Genomic Profiling and Circulating Tumor Cell-derived Organoids into Clinical Practice for Gastrointestinal Cancers. Anticancer Research. 2024;44(8):3481-3491$69$YR$$F$Y$$$20240829$$HP$TW$TW
242637451$24263745$1$I$$20240828$20240829$20240829$EXP$$CA-PFIZER INC-202400245767$PFIZER$$81$YR$$F$Y$$$20240829$$HP$CA$CA
242637461$24263746$1$I$20240820$20240826$20240829$20240829$EXP$$CN-PFIZER INC-PV202400111335$PFIZER$$62$YR$$F$Y$52.1$KG$20240829$$HP$CN$CN
242637471$24263747$1$I$20240101$20240826$20240829$20240829$EXP$$US-PFIZER INC-PV202400111508$PFIZER$$59$YR$$F$Y$$$20240829$$HP$US$US
242637491$24263749$1$I$20240730$20240826$20240829$20240829$EXP$$CN-PFIZER INC-PV202400111293$PFIZER$$18$YR$$F$Y$63$KG$20240829$$HP$CN$CN
242637501$24263750$1$I$$20240826$20240829$20240829$EXP$CZ-CZSUKL-24002355$CZ-PFIZER INC-202400243476$PFIZER$$67$YR$$$Y$$$20240829$$MD$CZ$CZ
242637511$24263751$1$I$20240701$20240827$20240829$20240829$EXP$$US-PFIZER INC-PV202400112095$PFIZER$$75$YR$$M$Y$$$20240829$$HP$US$US
242637521$24263752$1$I$$20240827$20240829$20240829$EXP$$CA-PFIZER INC-202400244925$PFIZER$$$$$F$Y$$$20240829$$HP$CA$CA
242637531$24263753$1$I$20240101$20240826$20240829$20240829$EXP$$CA-PFIZER INC-202400052251$PFIZER$$84$YR$$F$Y$64$KG$20240829$$HP$CA$CA
242637541$24263754$1$I$$20240826$20240829$20240829$EXP$$CA-PFIZER INC-202400244971$PFIZER$$82$YR$$M$Y$$$20240829$$MD$CA$CA
242637551$24263755$1$I$20240701$20240827$20240829$20240829$EXP$FR-AFSSAPS-RS2024000826$FR-PFIZER INC-202400244448$PFIZER$$60$YR$$F$Y$$$20240829$$MD$FR$FR
242637561$24263756$1$I$20240116$20240826$20240829$20240829$EXP$FR-AFSSAPS-ST2024001325$FR-PFIZER INC-202400243490$PFIZER$$77$YR$$F$Y$44$KG$20240829$$HP$FR$FR
242637571$24263757$1$I$20240812$20240826$20240829$20240829$EXP$$CN-PFIZER INC-PV202400111324$PFIZER$$30$YR$$M$Y$$$20240829$$HP$CN$CN
242637581$24263758$1$I$20220827$20240827$20240829$20240829$EXP$$IN-PFIZER INC-2020113230$PFIZER$$72$YR$$F$Y$85$KG$20240829$$CN$IN$IN
242637591$24263759$1$I$20230807$20240826$20240829$20240829$EXP$FR-AFSSAPS-ST2024001333$FR-PFIZER INC-202400243594$PFIZER$$66$YR$$M$Y$69.9$KG$20240829$$HP$FR$FR
242637601$24263760$1$I$20240724$20240826$20240829$20240829$EXP$FR-AFSSAPS-AM2024000685$FR-PFIZER INC-202400243611$PFIZER$$74$YR$$M$Y$85$KG$20240829$$MD$FR$FR
242637612$24263761$2$F$$20240912$20240829$20240918$EXP$$CA-PFIZER INC-202400245303$PFIZER$$55$YR$$F$Y$$$20240918$$HP$CA$CA
242637623$24263762$3$F$$20240911$20240829$20240913$EXP$$US-PFIZER INC-PV202400111539$PFIZER$$75$YR$$F$Y$$$20240913$$CN$US$US
242637631$24263763$1$I$20240101$20240826$20240829$20240829$EXP$$CN-PFIZER INC-PV202400111374$PFIZER$$58$YR$$F$Y$48.5$KG$20240829$$HP$CN$CN
242637642$24263764$2$F$20240311$20240902$20240829$20240904$EXP$FR-AFSSAPS-TO2024001604$FR-PFIZER INC-202400243481$PFIZER$$66$YR$$M$Y$$$20240904$$PH$FR$FR
242637651$24263765$1$I$20240817$20240826$20240829$20240829$EXP$DE-CADRBFARM-2024330004$DE-PFIZER INC-202400243642$PFIZER$$16$YR$$M$Y$50$KG$20240829$$CN$DE$DE
242637661$24263766$1$I$$20240821$20240829$20240829$EXP$$US-PFIZER INC-PV202400109450$PFIZER$$74$YR$$F$Y$71.927$KG$20240829$$MD$US$US
242637671$24263767$1$I$20240101$20240827$20240829$20240829$EXP$DE-BFARM-24005937$DE-PFIZER INC-202400244441$PFIZER$$69$YR$$M$Y$$$20240829$$MD$DE$DE
242637682$24263768$2$F$$20240919$20240829$20240924$EXP$$CA-PFIZER INC-202300107395$PFIZER$$50$YR$$F$Y$94$KG$20240924$$MD$CA$CA
242637691$24263769$1$I$20240406$20240826$20240829$20240829$EXP$FR-AFSSAPS-RE2024000850$FR-PFIZER INC-202400243593$PFIZER$$53$YR$$M$Y$77.5$KG$20240829$$MD$FR$FR
242637701$24263770$1$I$20240801$20240826$20240829$20240829$EXP$$CA-PFIZER INC-202400239175$PFIZER$$37$YR$$M$Y$$$20240829$$PH$CA$CA
242637711$24263771$1$I$20240720$20240826$20240829$20240829$EXP$$CN-PFIZER INC-PV202400111305$PFIZER$$61$YR$$M$Y$70$KG$20240829$$HP$CN$CN
242637721$24263772$1$I$$20240826$20240829$20240829$EXP$$US-PFIZER INC-202400244381$PFIZER$$$$$F$Y$$$20240829$$CN$US$US
242637731$24263773$1$I$20240805$20240826$20240829$20240829$EXP$FR-AFSSAPS-RN2024000890$FR-PFIZER INC-202400243488$PFIZER$$64$YR$$M$Y$$$20240829$$PH$FR$FR
242637741$24263774$1$I$$20240823$20240829$20240829$PER$$US-BAYER-2024A122782$BAYER$$$$$$Y$$$20240829$$CN$US$US
242637751$24263775$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170348$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242637761$24263776$1$I$20200101$20240820$20240829$20240829$EXP$$JP-Eisai-EC-2024-172626$EISAI$Seiichi Yoshikawa. Treatment experience of hepatocellular carcinoma at our hospital.$70$YR$E$M$Y$$$20240829$$MD$JP$JP
242637774$24263777$4$F$20240816$20240918$20240829$20240927$PER$$US-Calliditas-2024CAL01621$CALLIDITAS THERAPEUTICS$$54$YR$A$F$Y$$$20240927$$CN$US$US
242637781$24263778$1$I$20230413$20240827$20240829$20240829$EXP$$NVSC2023CA088314$NOVARTIS$$40$YR$$M$Y$$$20240829$$CN$CA$CA
242637791$24263779$1$I$$20240820$20240829$20240829$EXP$$PT-FreseniusKabi-FK202412767$FRESENIUS KABI$$48$YR$A$F$Y$$$20240829$$HP$PT$PT
242637801$24263780$1$I$$20240819$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008679$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242637811$24263781$1$I$$20240820$20240829$20240829$EXP$CA-drreddys-USA/CAN/19/0116270$CA-RDY-USA/CAN/19/0116270$DR REDDYS$$65$YR$E$F$Y$69$KG$20240829$$HP$CA$CA
242637831$24263783$1$I$$20240717$20240828$20240828$DIR$FDA-CDER-CTU-2024-59387$$FDA-CTU$$$$$$N$$$20240717$N$PH$US$
242637841$24263784$1$I$20240802$20240826$20240829$20240829$EXP$FR-AFSSAPS-NY2024000965$FR-FreseniusKabi-FK202412920$FRESENIUS KABI$$71$YR$E$F$Y$$$20240829$$PH$FR$FR
242637921$24263792$1$I$$20240806$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07936$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242637931$24263793$1$I$20240801$20240815$20240829$20240829$EXP$$GB-AMGEN-GBRSL2024171547$AMGEN$$59$YR$A$M$Y$$$20240829$$CN$GB$GB
242637942$24263794$2$F$$20240830$20240829$20240903$PER$$US-JNJFOC-20240857046$JOHNSON AND JOHNSON$$$$$M$Y$86.4$KG$20240903$$CN$US$US
242637951$24263795$1$I$$20240821$20240829$20240829$EXP$$US-JNJFOC-20240854940$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$MD$US$US
242637961$24263796$1$I$$20240826$20240829$20240829$PER$$US-JNJFOC-20240873035$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242637992$24263799$2$F$20240101$20240827$20240829$20240903$EXP$$CO-UCBSA-2024039850$UCB$$$$$M$Y$$$20240903$$CN$CO$CO
242638001$24263800$1$I$$20240816$20240829$20240829$PER$$US-SA-2024SA248510$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240829$$MD$US$US
242638011$24263801$1$I$20240826$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170614$AMGEN$$$$$$Y$$$20240829$$HP$US$US
242638022$24263802$2$F$$20240827$20240829$20240904$PER$$US-AMGEN-USASP2024171050$AMGEN$$$$$M$Y$$$20240904$$CN$US$US
242638031$24263803$1$I$20240810$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024172362$AMGEN$$66$YR$E$M$Y$$$20240829$$CN$US$US
242638041$24263804$1$I$20240810$20240823$20240829$20240829$EXP$FR-AFSSAPS-PA2024001472$FR-MYLANLABS-2024M1078403$MYLAN$$59$YR$$M$Y$79$KG$20240829$$MD$FR$FR
242638051$24263805$1$I$20240808$20240823$20240829$20240829$EXP$FR-AFSSAPS-AN2024001153$FR-AMGEN-FRASP2024169124$AMGEN$$60$YR$A$F$Y$$$20240829$$MD$FR$FR
242638061$24263806$1$I$20240701$20240817$20240829$20240829$PER$$US-SA-2024SA248269$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240829$$MD$US$US
242638071$24263807$1$I$$20240816$20240829$20240829$PER$$US-SA-2024SA248019$SANOFI AVENTIS$$$$A$M$Y$$$20240829$$MD$US$US
242638081$24263808$1$I$20240805$20240820$20240829$20240829$EXP$$CN-009507513-2408CHN007964$MERCK$$66$YR$$M$Y$70$KG$20240829$$HP$CN$CN
242638091$24263809$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249914$SANOFI AVENTIS$$$$A$M$Y$$$20240829$$MD$US$US
242638101$24263810$1$I$20240822$20240822$20240829$20240829$EXP$$FR-DSJP-DSE-2024-142176$DAIICHI$$$$E$F$Y$41$KG$20240829$$MD$FR$FR
242638111$24263811$1$I$20240719$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136815$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240829$$CN$US$US
242638121$24263812$1$I$20231201$20240820$20240829$20240829$EXP$$JP-TAKEDA-2024TUS086736$TAKEDA$$67$YR$$F$Y$$$20240829$$MD$JP$JP
242638131$24263813$1$I$$20240802$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07825$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242638141$24263814$1$I$20240801$20240815$20240829$20240829$PER$$US-JNJFOC-20240846321$JOHNSON AND JOHNSON$$82$YR$E$F$Y$63.6$KG$20240829$$CN$US$US
242638151$24263815$1$I$$20240826$20240829$20240829$PER$$US-HALEON-2193770$Haleon PLC$$$$$$Y$$$20240829$$CN$US$US
242638161$24263816$1$I$20240717$20240819$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008674$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242638172$24263817$2$F$20240601$20240916$20240829$20240918$EXP$SE-SEMPA-2024-006143$SE-FreseniusKabi-FK202412837$FRESENIUS KABI$$75$YR$E$F$Y$$$20240918$$MD$SE$SE
242638181$24263818$1$I$20240726$20240826$20240829$20240829$EXP$FR-AFSSAPS-PB2024000913$FR-FreseniusKabi-FK202412987$FRESENIUS KABI$$41$YR$A$M$Y$60$KG$20240829$$PH$FR$FR
242638191$24263819$1$I$20240516$20240826$20240829$20240829$EXP$FR-AFSSAPS-LL2024001593$FR-FreseniusKabi-FK202412968$FRESENIUS KABI$$60$YR$A$F$Y$50.6$KG$20240829$$MD$FR$FR
242638201$24263820$1$I$20240123$20240826$20240829$20240829$EXP$FR-AFSSAPS-BS2024000531$FR-FreseniusKabi-FK202412955$FRESENIUS KABI$$62$YR$A$F$Y$55$KG$20240829$$HP$FR$FR
242638211$24263821$1$I$$20240826$20240829$20240829$EXP$DE-AUROBINDO-AUR-APL-2024-039781$DE-UCBSA-2024043227$UCB$$$$A$F$Y$$$20240829$$HP$DE$DE
242638222$24263822$2$F$20240717$20240826$20240829$20240829$EXP$$US-ROCHE-10000067377$ROCHE$$$$$$Y$$$20240829$$HP$US$US
242638231$24263823$1$I$$20240819$20240829$20240829$PER$$US-APOTEX-2024AP009584$APOTEX$$$$$$Y$$$20240829$$CN$US$US
242638241$24263824$1$I$$20240816$20240829$20240829$PER$$US-APOTEX-2024AP009735$APOTEX$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, Block MS. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. Journal of Clinical Oncology. 2024;42 (16)$$$E$$Y$$$20240829$$HP$US$US
242638251$24263825$1$I$20240801$20240821$20240829$20240829$EXP$$CA-ABBVIE-5865858$ABBVIE$$$$A$F$Y$$$20240829$$CN$CA$CA
242638261$24263826$1$I$$20240804$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07899$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242638271$24263827$1$I$$20240816$20240829$20240829$PER$$US-APOTEX-2024AP009734$APOTEX$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, Block MS. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. Journal of Clinical Oncology. 2024;42 (16)$$$E$$Y$$$20240829$$HP$US$US
242638281$24263828$1$I$20240816$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137026$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$122.83$KG$20240829$$HP$US$US
242638292$24263829$2$F$$20240903$20240829$20240905$EXP$FR-EMA-DD-20240814-7482661-163817$FR-SA-2024SA251767$SANOFI AVENTIS$Vidil F, Ranqueb B, Nili R, Lillo-Le Louet A.. Myositis case during chemotherapy with docetaxel.. Societe Francaise de Pharmacologie et de Therapeutique.. 2017;31(SUPPL.1):21-5$43$YR$A$M$Y$$$20240905$$HP$FR$FR
242638301$24263830$1$I$$20240816$20240829$20240829$PER$$US-APOTEX-2024AP009733$APOTEX$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, Block MS. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. Journal of Clinical Oncology. 2024;42 (16)$$$E$$Y$$$20240829$$HP$US$US
242638311$24263831$1$I$20240812$20240826$20240829$20240829$PER$$US-BIOGEN-2024BI01278435$BIOGEN$$37$YR$$M$Y$$$20240829$$CN$US$US
242638321$24263832$1$I$20240101$20240826$20240829$20240829$PER$$US-ABBVIE-5896893$ABBVIE$$$$$M$Y$$$20240829$$MD$US$US
242638331$24263833$1$I$$20240816$20240829$20240829$PER$$US-APOTEX-2024AP009732$APOTEX$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, Block MS. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. Journal of Clinical Oncology. 2024;42 (16)$$$E$$Y$$$20240829$$HP$US$US
242638341$24263834$1$I$$20240816$20240829$20240829$PER$$US-APOTEX-2024AP009731$APOTEX$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, Block MS. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. Journal of Clinical Oncology. 2024;42 (16)$$$E$$Y$$$20240829$$HP$US$US
242638351$24263835$1$I$$20240816$20240829$20240829$PER$$US-APOTEX-2024AP009549$APOTEX$$$$$F$Y$$$20240829$$CN$US$US
242638361$24263836$1$I$$20240815$20240829$20240829$PER$$US-APOTEX-2024AP009472$APOTEX$$$$C$$Y$$$20240829$$HP$US$US
242638372$24263837$2$F$20240821$20240902$20240829$20240910$EXP$$CA-CELLTRION INC.-2024CA020564$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
242638391$24263839$1$I$20240819$20240820$20240829$20240829$EXP$$GB-TEVA-VS-3236017$TEVA$$70$YR$$F$Y$66$KG$20240829$$MD$GB$GB
242638401$24263840$1$I$20240814$20240816$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408011089$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240829$$CN$US$US
242638411$24263841$1$I$20240824$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017367$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240829$$CN$US$US
242638421$24263842$1$I$$20240814$20240829$20240829$PER$$US-APOTEX-2024AP009597$APOTEX$Shahab MH, Prasad S, Kalli S, Usmani SS, Liaqat S, Umer M. Treatment of a resistant case of schizoaffective disorder with lumateperone: A case report. SAGE Open Medical Case Reports. 2024;12:1-4$27$YR$$F$Y$$$20240828$$HP$US$US
242638431$24263843$1$I$20240821$20240821$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408013959$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240829$$CN$US$US
242638441$24263844$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017583$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240829$$CN$US$US
242638451$24263845$1$I$20240826$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018042$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240829$$CN$US$US
242638461$24263846$1$I$$20240824$20240829$20240829$EXP$$IN-SANDOZ INC.-SDZ2024IN075922$SANDOZ$$$$$M$Y$$$20240829$$CN$IN$IN
242638471$24263847$1$I$20240101$20240819$20240829$20240829$EXP$$US-ABBVIE-5887436$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242638491$24263849$1$I$$20240829$20240829$20240829$PER$$US-PROD-AS2-212756134-RB-083588-2024$RECKITT BENCKISER$$$$$F$Y$$$20240829$$CN$US$US
242638501$24263850$1$I$20240501$20240820$20240829$20240829$EXP$$US-UCBSA-2024032227$UCB$$27$YR$$F$Y$$$20240829$$HP$US$US
242638511$24263851$1$I$$20240805$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07921$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242638521$24263852$1$I$$20240827$20240829$20240829$EXP$$US-TAKEDA-2024TUS086994$TAKEDA$$$$$M$Y$$$20240829$$CN$US$US
242638532$24263853$2$F$$20240822$20240829$20240830$EXP$$CA-009507513-2408CAN008747$MERCK$$$$$$Y$$$20240830$$PH$CA$CA
242638541$24263854$1$I$20240701$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136549$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$$$20240829$$HP$US$US
242638551$24263855$1$I$20220101$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170344$AMGEN$$46$YR$A$M$Y$$$20240829$$CN$US$US
242638562$24263856$2$F$20220701$20240913$20240829$20240920$EXP$$US-GSK-US2024AMR105232$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
242638571$24263857$1$I$$20240822$20240829$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA051407$SANDOZ$$$$$F$Y$$$20240829$$MD$CA$CA
242638581$24263858$1$I$$20240814$20240829$20240829$EXP$$US-HLS-202400900$HLS THERAPEUTICS$$$$A$$Y$$$20240829$$MD$US$US
242638591$24263859$1$I$$20240819$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008670$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242638601$24263860$1$I$$20240821$20240829$20240829$PER$$US-009507513-2408USA008241$MERCK$$$$$F$Y$$$20240829$$CN$US$US
242638612$24263861$2$F$20240819$20240904$20240829$20240911$EXP$$TR-009507513-2408USA009517$MERCK$$62$YR$$M$Y$95.6$KG$20240911$$CN$TR$TR
242638621$24263862$1$I$20191101$20240819$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008668$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242638641$24263864$1$I$20240726$20240819$20240829$20240829$EXP$$CN-ROCHE-10000060764$ROCHE$$60$YR$A$F$Y$77.5$KG$20240829$$HP$CN$CN
242638651$24263865$1$I$$20240805$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07901$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242638671$24263867$1$I$$20240823$20240829$20240829$PER$$US-ROCHE-10000065697$ROCHE$$54$YR$A$M$Y$$$20240829$$CN$US$US
242638691$24263869$1$I$20240731$20240812$20240829$20240829$PER$$US-009507513-2408USA004313$MERCK$$79$YR$$M$Y$$$20240829$$CN$US$US
242638701$24263870$1$I$$20240820$20240829$20240829$EXP$NL-LRB-00994793$NL-TEVA-VS-3235392$TEVA$$71$YR$$M$Y$80$KG$20240829$$MD$NL$NL
242638711$24263871$1$I$$20240822$20240829$20240829$PER$$US-RDY-SPO/USA/24/0012438$DR REDDYS$$16$YR$T$M$Y$$$20240829$$MD$US$US
242638721$24263872$1$I$$20240827$20240829$20240829$EXP$$CA-FreseniusKabi-FK202413033$FRESENIUS KABI$$68$YR$E$M$Y$$$20240829$$HP$CA$CA
242638731$24263873$1$I$$20240822$20240829$20240829$PER$$US-FreseniusKabi-FK202412862$FRESENIUS KABI$$$$$$Y$$$20240829$$HP$US$US
242638741$24263874$1$I$20240822$20240827$20240829$20240829$EXP$$NVSC2024CN174336$NOVARTIS$$36$YR$$M$Y$89$KG$20240829$$HP$CN$CN
242638751$24263875$1$I$$20240819$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008666$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242638761$24263876$1$I$$20240827$20240829$20240829$EXP$$CA-FreseniusKabi-FK202413010$FRESENIUS KABI$$50$YR$A$M$Y$83$KG$20240829$$HP$CA$CA
242638771$24263877$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000068260$ROCHE$$63$YR$A$M$Y$$$20240829$$CN$US$US
242638802$24263880$2$F$20240801$20240829$20240829$20240905$EXP$$US-ABBVIE-5896257$ABBVIE$$54$YR$$F$Y$$$20240905$$CN$US$US
242638811$24263881$1$I$$20240814$20240829$20240829$EXP$$CA-HLS-202402074$HLS THERAPEUTICS$$$$E$M$Y$$$20240829$$HP$CA$CA
242638821$24263882$1$I$20240710$20240816$20240829$20240829$EXP$$JP-ROCHE-10000066873$ROCHE$$6$DEC$A$$Y$$$20240829$$MD$JP$JP
242638831$24263883$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59371$$FDA-CTU$$$$$F$N$$$20240828$N$$US$
242638841$24263884$1$I$$20240827$20240829$20240829$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048393$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240829$$CN$US$US
242638851$24263885$1$I$$20240820$20240829$20240829$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006517$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242638861$24263886$1$I$20240719$20240821$20240829$20240829$PER$$US-BAYER-2024A121964$BAYER$$25$YR$A$F$Y$$$20240829$$CN$US$US
242638881$24263888$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A192025$ASTRAZENECA$$$$$F$Y$44.5$KG$20240829$$HP$US$
242638891$24263889$1$I$$20240826$20240829$20240829$EXP$$DK-AstraZeneca-2024A196576$ASTRAZENECA$$$$$$Y$$$20240829$$HP$DK$
242638901$24263890$1$I$$20240821$20240829$20240829$EXP$$US-SMPA-2024SPA001759$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242638912$24263891$2$F$$20240910$20240829$20240919$EXP$$JP-OTSUKA-2024_023216$OTSUKA$$61$YR$$F$Y$$$20240919$$HP$JP$JP
242638921$24263892$1$I$20240801$20240820$20240829$20240829$PER$$US-SA-2024SA249618$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240829$$MD$US$US
242638931$24263893$1$I$20240801$20240820$20240829$20240829$PER$$US-SA-2024SA250187$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240829$$CN$US$US
242638951$24263895$1$I$20240821$20240809$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127150$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$69.4$KG$20240829$$HP$US$US
242638971$24263897$1$I$$20240818$20240829$20240829$EXP$$US-JNJFOC-20240850278$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242638981$24263898$1$I$20240101$20240821$20240829$20240829$EXP$$MX-AMGEN-MEXSL2024167794$AMGEN$$74$YR$E$F$Y$65$KG$20240829$$CN$MX$MX
242638992$24263899$2$F$20240807$20240916$20240829$20240926$30DAY$$US-JNJFOC-20240824794$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240926$$CN$US$US
242639002$24263900$2$F$$20240826$20240829$20240903$PER$$US-AMGEN-USASP2024170534$AMGEN$$$$$F$Y$$$20240903$$PH$US$US
242639011$24263901$1$I$$20240820$20240829$20240829$EXP$$US-UCBSA-2024042686$UCB$$$$$M$Y$120.18$KG$20240829$$HP$US$US
242639021$24263902$1$I$$20240825$20240829$20240829$PER$$US-ABBVIE-5899885$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242639032$24263903$2$F$$20240827$20240829$20240904$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007352$AEGERION$$$$$M$Y$$$20240904$$CN$US$US
242639041$24263904$1$I$$20240827$20240829$20240829$EXP$$CA-ORGANON-O2408CAN002006$ORGANON$$65$YR$$F$Y$$$20240829$$HP$CA$CA
242639051$24263905$1$I$$20240819$20240829$20240829$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006133$BIOCON$$$$$$Y$$$20240829$$HP$CA$CA
242639071$24263907$1$I$$20240722$20240828$20240828$DIR$FDA-CDER-CTU-2024-59394$$FDA-CTU$$$$$$N$$$20240722$N$PH$US$
242639081$24263908$1$I$$20240720$20240828$20240828$DIR$FDA-CDER-CTU-2024-59393$$FDA-CTU$$$$$$N$$$20240720$N$HP$US$
242639101$24263910$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59498$$FDA-CTU$$70$YR$$F$N$108.86$KG$20240828$N$$US$
242639111$24263911$1$I$$20240828$20240828$20240828$DIR$716234$$FDA-CTU$$$$$UNK$N$$$20240828$N$CN$US$
242639121$24263912$1$I$20230322$20240823$20240829$20240829$PER$$US-ALXN-202408USA001658US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$HP$US$US
242639141$24263914$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59466$$FDA-CTU$$68$YR$$F$N$$$20240828$N$$US$
242639161$24263916$1$I$$20240828$20240828$20240828$DIR$716235$$FDA-CTU$$$$$UNK$N$$$20240828$N$CN$US$
242639171$24263917$1$I$20240820$20240828$20240828$20240828$DIR$716221$$FDA-CTU$$40$YR$$F$N$106.65$KG$20240828$N$CN$US$
242639181$24263918$1$I$20231219$20240828$20240828$20240828$DIR$716223$$FDA-CTU$$71$YR$$F$N$$$20240828$Y$CN$US$
242639191$24263919$1$I$$20240814$20240829$20240829$EXP$$CN-ASTELLAS-2024-AER-000852$ASTELLAS$Jianping Z, Zhongxia Y, Rongrong Z, Boxia L. Efficacy and safety of sodium stibogluconate and liposomal amphotericin B in the treatment of Kala-azar: A retrospective analysis. Adverse Drug Reactions Journal. 2024;26(7):399-404. doi:UNK$5$YR$C$$Y$17$KG$20240827$$HP$CN$CN
242639201$24263920$1$I$$20240819$20240829$20240829$EXP$GB-MHRA-TPP14848343C9685860YC1723551108802$GB-ASTELLAS-2024-AER-000251$ASTELLAS$$58$YR$A$F$Y$64$KG$20240827$$PH$GB$GB
242639211$24263921$1$I$20240716$20240816$20240829$20240829$EXP$$CN-ASTELLAS-2024-AER-000106$ASTELLAS$$55$YR$A$M$Y$65$KG$20240827$$HP$CN$CN
242639221$24263922$1$I$$20240813$20240829$20240829$PER$$US-ASTELLAS-2024-AER-000290$ASTELLAS$$$$E$M$Y$$$20240827$$HP$US$US
242639241$24263924$1$I$$20240816$20240829$20240829$EXP$$JP-ASTELLAS-2024-AER-000044$ASTELLAS$$5$DEC$A$M$Y$$$20240827$$MD$JP$JP
242639253$24263925$3$F$$20240902$20240829$20240919$EXP$$GB-ASTELLAS-2024-AER-001437$ASTELLAS$$38$YR$A$M$Y$$$20240919$$HP$GB$GB
242639261$24263926$1$I$$20240815$20240829$20240829$EXP$$US-ASTELLAS-2024US019679$ASTELLAS$$72$YR$E$F$Y$$$20240827$$CN$US$US
242639271$24263927$1$I$$20240818$20240829$20240829$EXP$$AU-ASTELLAS-2024-AER-000812$ASTELLAS$$$$E$F$Y$$$20240827$$MD$AU$AU
242639281$24263928$1$I$20240730$20240822$20240829$20240829$EXP$$CN-ASTELLAS-2024-AER-001497$ASTELLAS$$48$YR$A$M$Y$$$20240827$$HP$CN$CN
242639291$24263929$1$I$$20240816$20240829$20240829$EXP$$GB-ASTELLAS-2024-AER-001599$ASTELLAS$$51$YR$A$F$Y$$$20240827$$HP$GB$GB
242639301$24263930$1$I$20240601$20240826$20240829$20240829$EXP$FR-AFSSAPS-DJ2024000920$FR-FreseniusKabi-FK202412983$FRESENIUS KABI$$52$YR$A$F$Y$40$KG$20240829$$MD$FR$FR
242639311$24263931$1$I$20240822$20240826$20240829$20240829$EXP$$CN-FreseniusKabi-FK202413018$FRESENIUS KABI$$36$YR$A$M$Y$43$KG$20240829$$HP$CN$CN
242639321$24263932$1$I$20240809$20240827$20240829$20240829$EXP$PT-INFARMED-T202408-451$PT-FreseniusKabi-FK202413051$FRESENIUS KABI$$60$YR$A$M$Y$55$KG$20240829$$HP$PT$PT
242639331$24263933$1$I$20240819$20240822$20240829$20240829$PER$$US-BAYER-2024A124124$BAYER$$66$YR$E$F$Y$$$20240829$$CN$US$US
242639341$24263934$1$I$$20240819$20240829$20240829$PER$$US-ROCHE-10000061502$ROCHE$Yu J, Ballouz D, Paulus Y. Bevacizumab and External Beam Radiation Therapy for Diffuse Choroidal Hemangioma in Sturge-Weber Syndrome: A Case Report. Case reports in ophthalmology. 2024-Aug-05;15 (1):590-594. doi:10.1159/000539655.$37$YR$A$M$Y$$$20240829$$HP$US$US
242639351$24263935$1$I$$20240814$20240829$20240829$EXP$$CA-HLS-202402072$HLS THERAPEUTICS$$$$A$M$Y$$$20240829$$HP$CA$CA
242639361$24263936$1$I$$20240821$20240829$20240829$PER$$US-TAKEDA-2024TUS084805$TAKEDA$$$$$F$Y$67$KG$20240829$$MD$US$US
242639372$24263937$2$F$$20240829$20240829$20240830$PER$$US-JNJFOC-20240876599$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242639381$24263938$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000751$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242639392$24263939$2$F$$20240911$20240829$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07904$LUPIN$$$$$$Y$$$20240926$$CN$US$US
242639401$24263940$1$I$$20240820$20240829$20240829$EXP$$US-TEVA-VS-3236744$TEVA$$69$YR$$F$Y$$$20240829$$CN$US$US
242639411$24263941$1$I$$20240820$20240829$20240829$EXP$$GB-TEVA-VS-3235772$TEVA$$48$YR$$F$Y$154$KG$20240829$$HP$GB$GB
242639421$24263942$1$I$20240822$20240823$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015472$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240829$$CN$US$US
242639431$24263943$1$I$20240820$20240822$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408014536$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240829$$CN$US$US
242639451$24263945$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000755$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242639461$24263946$1$I$20240201$20240822$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015403$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240829$$CN$US$US
242639471$24263947$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000733$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242639481$24263948$1$I$$20240819$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-136534$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240829$$HP$CA$CA
242639491$24263949$1$I$$20240827$20240829$20240829$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-137090$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$110.22$KG$20240829$$CN$PR$PR
242639501$24263950$1$I$$20240821$20240829$20240829$EXP$$CA-BAYER-2024A121566$BAYER$$$$$$Y$$$20240829$$HP$CA$CA
242639532$24263953$2$F$$20240826$20240829$20240904$PER$$US-AMGEN-USASP2024170185$AMGEN$$$$$M$Y$$$20240904$$PH$US$US
242639551$24263955$1$I$$20240826$20240829$20240829$PER$$US-BAYER-2024A123660$BAYER$$45$YR$A$F$Y$$$20240829$$MD$US$US
242639561$24263956$1$I$$20240823$20240829$20240829$EXP$$US-ALXN-202408USA001679US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242639571$24263957$1$I$20240101$20240826$20240829$20240829$PER$$JP-Eisai-EC-2024-173020$EISAI$$$$E$M$Y$$$20240829$$MD$JP$JP
242639581$24263958$1$I$$20240827$20240829$20240829$EXP$$NVSC2024US173115$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
242639591$24263959$1$I$$20240828$20240829$20240829$PER$$US-ROCHE-10000068958$ROCHE$$33$YR$A$F$Y$$$20240829$$MD$US$US
242639601$24263960$1$I$20240430$20240820$20240829$20240829$EXP$FR-AFSSAPS-TO2024001570$FR-TEVA-VS-3235352$TEVA$$73$YR$$M$Y$$$20240829$$PH$FR$FR
242639621$24263962$1$I$20240801$20240821$20240829$20240829$EXP$$US-ABBVIE-5839657$ABBVIE$$69$YR$$F$Y$$$20240829$$CN$US$US
242639631$24263963$1$I$20240101$20240821$20240829$20240829$EXP$$AR-ABBVIE-5890671$ABBVIE$$$$$F$Y$$$20240829$$CN$AR$AR
242639641$24263964$1$I$$20240816$20240829$20240829$EXP$$US-UCBSA-2024042056$UCB$$$$$$Y$$$20240829$$CN$US$US
242639651$24263965$1$I$$20240827$20240829$20240829$EXP$$CA-FreseniusKabi-FK202413008$FRESENIUS KABI$$57$YR$A$M$Y$76$KG$20240829$$HP$CA$CA
242639661$24263966$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59396$$FDA-CTU$$68$YR$$F$N$135$LBS$20240828$N$$US$
242639671$24263967$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59519$$FDA-CTU$$63$YR$$F$N$$$20240828$N$$US$
242639681$24263968$1$I$20240809$20240828$20240828$20240828$DIR$716228$$FDA-CTU$$39$YR$$UNK$N$85.5$KG$20240828$N$CN$US$
242639691$24263969$1$I$$20240828$20240828$20240828$DIR$716242$$FDA-CTU$$$$$UNK$N$$$20240828$N$CN$US$
242639711$24263971$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59427$$FDA-CTU$$47$YR$$F$N$$$20240828$N$$US$
242639721$24263972$1$I$20240802$20240827$20240829$20240829$PER$$US-BAYER-2024A123235$BAYER$$38$YR$A$F$Y$$$20240829$$MD$US$US
242639732$24263973$2$F$20240827$20240919$20240829$20240920$PER$$US-AMGEN-USASP2024171716$AMGEN$$76$YR$E$M$Y$$$20240920$$CN$US$US
242639743$24263974$3$F$20240711$20240915$20240829$20240919$EXP$$US-ABBVIE-5898862$ABBVIE$$23$YR$$F$Y$91$KG$20240919$$HP$US$US
242639751$24263975$1$I$20240801$20240823$20240829$20240829$EXP$$JP-009507513-2408JPN003113J$MERCK$$7$DEC$$F$Y$$$20240829$$MD$JP$JP
242639761$24263976$1$I$20240612$20240822$20240829$20240829$EXP$ES-AEMPS-1560503$ES-ROCHE-10000067820$ROCHE$$59$YR$A$M$Y$$$20240829$$MD$ES$ES
242639771$24263977$1$I$$20180810$20240829$20240829$EXP$$PK-SA-2018SA221529$SANOFI AVENTIS$$$$A$F$Y$$$20240829$$CN$PK$PK
242639781$24263978$1$I$$20240827$20240829$20240829$PER$$US-BAYER-2024A123819$BAYER$$37$YR$A$F$Y$$$20240829$$MD$US$US
242639803$24263980$3$F$20240801$20240823$20240829$20240903$PER$$US-JNJFOC-20240861535$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240903$$CN$US$US
242639812$24263981$2$F$$20240904$20240829$20240909$EXP$$US-JNJFOC-20240217591$JOHNSON AND JOHNSON$$$$$F$Y$90.9$KG$20240910$$HP$US$US
242639821$24263982$1$I$20240728$20240827$20240829$20240829$EXP$$NVSC2024EG173627$NOVARTIS$$69$YR$$F$Y$$$20240829$$CN$EG$EG
242639841$24263984$1$I$$20240826$20240829$20240829$PER$$US-BAYER-2024A122816$BAYER$$80$YR$E$M$Y$$$20240829$$CN$US$US
242639851$24263985$1$I$$20240827$20240829$20240829$PER$$US-BAYER-2024A123507$BAYER$$41$YR$A$F$Y$$$20240829$$CN$US$US
242639861$24263986$1$I$20240827$20240827$20240829$20240829$PER$$US-BAYER-2024A123906$BAYER$$77$YR$E$F$Y$$$20240829$$CN$US$US
242639871$24263987$1$I$$20240827$20240829$20240829$PER$$US-BAYER-2024A123568$BAYER$$46$YR$A$M$Y$$$20240829$$HP$US$US
242639881$24263988$1$I$20240825$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170420$AMGEN$$64$YR$A$F$Y$$$20240829$$CN$US$US
242639891$24263989$1$I$20240819$20240821$20240829$20240829$EXP$$CN-ORPHANEU-2024006533$RECORDATI$$$$$$Y$$$20240829$$MD$CN$CN
242639901$24263990$1$I$20240813$20240823$20240829$20240829$EXP$$CN-ROCHE-10000068021$ROCHE$$34$YR$A$M$Y$73.5$KG$20240829$$HP$CN$CN
242639921$24263992$1$I$20240822$20240827$20240829$20240829$EXP$$US-SA-2024SA251718$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240829$$HP$US$US
242639931$24263993$1$I$20240821$20240827$20240829$20240829$PER$$US-BAYER-2024A123785$BAYER$$44$YR$A$M$Y$$$20240829$$HP$US$US
242639941$24263994$1$I$$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136996$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240829$$CN$US$US
242639951$24263995$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59523$$FDA-CTU$$72$YR$$F$N$$$20240828$N$$US$
242639971$24263997$1$I$$20240827$20240829$20240829$EXP$$CA-TAKEDA-2024TUS086925$TAKEDA$$$$$M$Y$$$20240829$$CN$CA$CA
242639981$24263998$1$I$$20240829$20240829$20240829$PER$$US-PROD-AS2-212756134-RB-083580-2024$RECKITT BENCKISER$$$$$M$Y$$$20240829$$CN$US$US
242639991$24263999$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59529$$FDA-CTU$$60$YR$$F$N$$$20240828$N$$US$
242640001$24264000$1$I$20210422$20240827$20240829$20240829$EXP$$CA-TAKEDA-2024TUS086970$TAKEDA$$28$YR$$$Y$$$20240829$$CN$CA$CA
242640011$24264001$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59401$$FDA-CTU$$48$YR$$M$N$$$20240828$N$$US$
242640021$24264002$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59452$$FDA-CTU$$80$YR$$F$N$138$LBS$20240828$N$$US$
242640031$24264003$1$I$20240813$20240828$20240829$20240829$EXP$$CH-GILEAD-2024-0685154$GILEAD$$29$YR$A$F$Y$$$20240829$$MD$CH$CH
242640041$24264004$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59400$$FDA-CTU$$52$YR$$F$N$$$20240828$N$$US$
242640051$24264005$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59502$$FDA-CTU$$61$YR$$F$N$155$LBS$20240828$N$$US$
242640061$24264006$1$I$20240806$20240827$20240829$20240829$EXP$$US-PFIZER INC-202400245863$PFIZER$$63$YR$$F$Y$$$20240829$$HP$US$US
242640072$24264007$2$F$20200101$20240826$20240829$20240830$EXP$$CA-PFIZER INC-202400244923$PFIZER$$38$YR$$M$Y$$$20240830$$HP$CA$CA
242640081$24264008$1$I$$20240827$20240829$20240829$EXP$$ZA-PFIZER INC-PV202200111141$PFIZER$$68$YR$$F$Y$80$KG$20240829$$MD$ZA$ZA
242640091$24264009$1$I$$20240827$20240829$20240829$EXP$$CA-PFIZER INC-202400244922$PFIZER$$$$$F$Y$$$20240829$$MD$CA$CA
242640111$24264011$1$I$20240811$20240827$20240829$20240829$EXP$$DK-PFIZER INC-202400244486$PFIZER$$50$YR$$F$Y$86.5$KG$20240829$$MD$DK$DK
242640121$24264012$1$I$$20240827$20240829$20240829$EXP$$CA-PFIZER INC-202400244968$PFIZER$$56$YR$$M$Y$76$KG$20240829$$HP$CA$CA
242640131$24264013$1$I$$20240827$20240829$20240829$EXP$$US-PFIZER INC-202400244964$PFIZER$$85$YR$$F$Y$58.97$KG$20240829$$CN$US$US
242640141$24264014$1$I$$20240828$20240829$20240829$EXP$$US-PFIZER INC-PV202400112674$PFIZER$$70$YR$$F$Y$$$20240829$$CN$US$US
242640152$24264015$2$F$$20240828$20240829$20240902$PER$$US-PFIZER INC-PV202400063599$PFIZER$$46$YR$$F$Y$$$20240902$$HP$US$US
242640161$24264016$1$I$20240710$20240827$20240829$20240829$EXP$SE-SEMPA-2024-006201$SE-PFIZER INC-202400244458$PFIZER$$55$YR$$F$Y$$$20240829$$MD$SE$SE
242640171$24264017$1$I$$20240828$20240829$20240829$EXP$$CN-PFIZER INC-PV202400112227$PFIZER$$$$A$M$Y$$$20240829$$CN$CN$CN
242640191$24264019$1$I$$20240827$20240829$20240829$EXP$$AM-PFIZER INC-PV202400112054$PFIZER$$52$YR$$M$Y$$$20240829$$MD$AM$AM
242640201$24264020$1$I$$20240828$20240829$20240829$EXP$$CN-PFIZER INC-PV202400112028$PFIZER$$$$A$F$Y$$$20240829$$CN$CN$CN
242640211$24264021$1$I$20240827$20240828$20240829$20240829$EXP$$CA-PFIZER INC-202400245750$PFIZER$$78$YR$$M$Y$$$20240829$$HP$CA$CA
242640221$24264022$1$I$$20240827$20240829$20240829$EXP$$CA-PFIZER INC-202400244939$PFIZER$$67$YR$$M$Y$$$20240829$$MD$CA$CA
242640231$24264023$1$I$20240408$20240827$20240829$20240829$EXP$$US-AstraZeneca-2024A195446$ASTRAZENECA$$26254$DY$$$Y$$$20240829$$MD$US$
242640241$24264024$1$I$$20240827$20240829$20240829$EXP$$CA-PFIZER INC-202400244910$PFIZER$$61$YR$$F$Y$$$20240829$$MD$CA$CA
242640252$24264025$2$F$20240817$20240827$20240829$20240830$EXP$$US-PFIZER INC-202300193734$PFIZER$$85$YR$$M$Y$99.79$KG$20240830$$HP$US$US
242640262$24264026$2$F$20240811$20240917$20240829$20240925$30DAY$$CA-JNJFOC-20240832405$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240925$$HP$CA$CA
242640271$24264027$1$I$20240125$20240827$20240829$20240829$EXP$$US-PFIZER INC-202400244966$PFIZER$$2$YR$$M$Y$$$20240829$$CN$US$US
242640281$24264028$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59415$$FDA-CTU$$38$YR$$F$N$$$20240828$N$$US$
242640291$24264029$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59503$$FDA-CTU$$46$YR$$F$N$$$20240828$N$$US$
242640301$24264030$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018063$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240829$$CN$US$US
242640312$24264031$2$F$20240801$20240822$20240829$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408013550$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240830$$CN$US$US
242640321$24264032$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59424$$FDA-CTU$$86$YR$$F$N$$$20240828$N$$US$
242640341$24264034$1$I$$20240828$20240828$20240828$DIR$716229$$FDA-CTU$$63$YR$$F$N$75.6$KG$20240828$N$CN$US$
242640351$24264035$1$I$$20240807$20240829$20240829$EXP$$US-GILEAD-2024-0683576$GILEAD$$$$A$M$Y$$$20240829$$CN$US$US
242640361$24264036$1$I$20240801$20240827$20240829$20240829$EXP$$GB-BAUSCH-BL-2024-012998$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240829$$HP$GB$GB
242640371$24264037$1$I$20220224$20240821$20240829$20240829$EXP$FR-AFSSAPS-SE2024000271$FR-TEVA-VS-3236329$TEVA$$61$YR$$M$Y$96$KG$20240829$$MD$FR$FR
242640381$24264038$1$I$$20240828$20240829$20240829$EXP$$CA-BAUSCH-BL-2024-013034$BAUSCH AND LOMB$UNKNOWN. Unspecified Article. Unspecified Journal.$$$$$Y$$$20240829$$HP$CA$CA
242640391$24264039$1$I$20240819$20240821$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134523$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$113.4$KG$20240829$$CN$US$US
242640401$24264040$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135501$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240829$$HP$US$US
242640411$24264041$1$I$$20240823$20240829$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-136620$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240829$$PH$JP$JP
242640421$24264042$1$I$$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136976$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240829$$CN$US$US
242640431$24264043$1$I$20240716$20240826$20240829$20240829$EXP$$US-GILEAD-2024-0685469$GILEAD$$13$YR$T$M$Y$$$20240829$$CN$US$US
242640441$24264044$1$I$$20240828$20240829$20240829$EXP$$US-JNJFOC-20240873940$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242640451$24264045$1$I$20240601$20240823$20240829$20240829$EXP$$US-JNJFOC-20240866332$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240829$$CN$US$US
242640461$24264046$1$I$$20240827$20240829$20240829$PER$$US-JNJFOC-20240875525$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240829$$CN$US$US
242640473$24264047$3$F$$20240904$20240829$20240910$EXP$$CL-JNJFOC-20240870647$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240910$$CN$CL$CL
242640481$24264048$1$I$$20240823$20240829$20240829$PER$$US-ALXN-202408USA001704US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242640492$24264049$2$F$20240901$20240905$20240829$20240909$EXP$$US-BAYER-2024A123022$BAYER$$54$YR$A$F$Y$$$20240909$$CN$US$US
242640501$24264050$1$I$$20240801$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07800$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242640511$24264051$1$I$20240728$20240826$20240829$20240829$EXP$$CA-ABBVIE-5898032$ABBVIE$$$$$F$Y$$$20240829$$CN$CA$CA
242640521$24264052$1$I$20240101$20240809$20240829$20240829$PER$$US-AVS-000014$AAVIS PHARMACEUTICALS$$$$$F$Y$$$20240828$$CN$US$US
242640531$24264053$1$I$20240711$20240829$20240829$20240829$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048540$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$60$KG$20240829$$HP$CN$CN
242640541$24264054$1$I$20210801$20240820$20240829$20240829$PER$$US-INCYTE CORPORATION-2021IN008933$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242640551$24264055$1$I$$20240819$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132419$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240829$$HP$US$US
242640561$24264056$1$I$20180101$20240824$20240829$20240829$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00450$VELOXIS PHARMACEUTICALS$Chowdhury RB, Shah SI, Milford E, Tullius SG, Rennke H, Bianchi G.. Extramedullary plasmacytoma exclusively localized in transplanted kidney: Post-transplant lymphoproliferative disorder or monoclonal gammopathy of renal significance?. Journal of Onco-Nephrology.. 2024;8(2):70-4$44$YR$$F$Y$$$20240829$$MD$US$US
242640571$24264057$1$I$$20240824$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135673$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$68.49$KG$20240829$$CN$US$US
242640581$24264058$1$I$20240801$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136113$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$127.01$KG$20240829$$CN$US$US
242640591$24264059$1$I$$20240819$20240829$20240829$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006135$BIOCON$$$$$$Y$$$20240829$$HP$CA$CA
242640602$24264060$2$F$20240820$20240918$20240829$20240923$EXP$$US-AMGEN-USASP2024169161$AMGEN$$67$YR$E$F$Y$$$20240923$$CN$US$US
242640611$24264061$1$I$$20240827$20240829$20240829$PER$$US-BAYER-2024A123933$BAYER$$8$YR$C$F$Y$$$20240829$$CN$US$US
242640631$24264063$1$I$$20240827$20240829$20240829$EXP$$CA-ABBVIE-5897429$ABBVIE$$27$YR$$F$Y$$$20240829$$HP$CA$CA
242640641$24264064$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170402$AMGEN$$$$$F$Y$$$20240829$$CN$US$US
242640651$24264065$1$I$$20240827$20240829$20240829$PER$$US-BAYER-2024A123914$BAYER$$33$YR$A$F$Y$$$20240829$$HP$US$US
242640661$24264066$1$I$$20240828$20240828$20240828$DIR$716238$$FDA-CTU$$55$YR$$F$N$66.15$KG$20240828$N$$US$
242640681$24264068$1$I$20240804$20240828$20240828$20240828$DIR$716231$$FDA-CTU$$69$YR$$M$N$98.1$KG$20240828$N$CN$US$
242640691$24264069$1$I$20240716$20240828$20240828$20240828$DIR$716237$$FDA-CTU$$38$YR$$F$N$108.9$KG$20240828$N$CN$US$
242640711$24264071$1$I$20221126$20240828$20240828$20240828$DIR$716247$$FDA-CTU$$46$YR$$M$N$85.5$KG$20240828$N$CN$US$
242640731$24264073$1$I$20240813$20240828$20240828$20240828$DIR$716250$$FDA-CTU$$53$YR$$F$N$61.65$KG$20240828$N$$US$
242640741$24264074$1$I$$20240826$20240828$20240828$DIR$FDA-CDER-CTU-2024-59494$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242640771$24264077$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59412$$FDA-CTU$$61$YR$$F$N$$$20240828$N$$US$
242640781$24264078$1$I$20240828$20240828$20240828$20240828$DIR$716246$$FDA-CTU$$44$YR$$F$N$117.9$KG$20240828$N$CN$US$
242640791$24264079$1$I$$20240827$20240829$20240829$PER$$US-BAYER-2024A123928$BAYER$$29$YR$A$F$Y$$$20240829$$MD$US$US
242640801$24264080$1$I$20240405$20240826$20240829$20240829$EXP$GB-MHRA-MED-202408260710274140-NYRSF$GB-MYLANLABS-2024M1078755$MYLAN$$63$YR$$F$Y$74$KG$20240829$$CN$GB$GB
242640811$24264081$1$I$20240801$20240821$20240829$20240829$EXP$$US-SA-2024SA251945$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240829$$CN$US$US
242640821$24264082$1$I$20240801$20240821$20240829$20240829$EXP$$US-SA-2024SA250959$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240829$$MD$US$US
242640831$24264083$1$I$$20240828$20240829$20240829$PER$$US-BAYER-2024A123910$BAYER$$71$YR$E$F$Y$$$20240829$$CN$US$US
242640841$24264084$1$I$$20240809$20240829$20240829$PER$$US-TEVA-VS-3232628$TEVA$$$$$$Y$$$20240829$$HP$US$US
242640851$24264085$1$I$$20240828$20240829$20240829$EXP$$PT-SA-2024SA251929$SANOFI AVENTIS$Sousa MR, Simoes F, Lopes D, Andrade J, Martins FA, Goncalves I et al.. CO-0022 -(2385)-Acquired thrombotic thrombocytopenic purpura: diagnostic and therapeutic challenges of a complex clinical case.. Medicina Interna - Congressos Nacionais, 30CNMI. 2024;05:122$58$YR$A$F$Y$$$20240829$$HP$PT$PT
242640862$24264086$2$F$$20240821$20240829$20240830$EXP$$US-JNJFOC-20240858952$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242640871$24264087$1$I$$20240828$20240829$20240829$PER$$US-BAYER-2024A123915$BAYER$$85$YR$E$F$Y$$$20240829$$CN$US$US
242640881$24264088$1$I$$20240828$20240829$20240829$EXP$$JP-ALXN-202408JPN001895JP$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$MD$JP$JP
242640891$24264089$1$I$$20240828$20240829$20240829$PER$$US-BAYER-2024A123943$BAYER$$$$$$Y$$$20240829$$CN$US$US
242640901$24264090$1$I$$20240827$20240829$20240829$EXP$$UA-TAKEDA-2024TUS086943$TAKEDA$$$$$F$Y$$$20240829$$CN$UA$UA
242640912$24264091$2$F$20230101$20240822$20240829$20240830$EXP$$JP-AstraZeneca-2024A193861$ASTRAZENECA$$68$YR$$M$Y$$$20240830$$MD$JP$
242640921$24264092$1$I$20240805$20240821$20240829$20240829$EXP$$CN-AstraZeneca-2024A194056$ASTRAZENECA$$2798$WK$$M$Y$$$20240829$$MD$CN$
242640931$24264093$1$I$20230101$20240814$20240829$20240829$PER$$US-ABBVIE-5894009$ABBVIE$$24$YR$$F$Y$$$20240829$$HP$US$US
242640941$24264094$1$I$$20240827$20240829$20240829$EXP$$NVSC2024US173892$NOVARTIS$$$$$$Y$$$20240829$$CN$US$US
242640951$24264095$1$I$20240520$20240822$20240829$20240829$EXP$$BR-BAYER-2024A122382$BAYER$$$$$M$Y$$$20240829$$CN$BR$BR
242640961$24264096$1$I$20170201$20240823$20240829$20240829$EXP$$CA-TAKEDA-2017TUS005213$TAKEDA$$38$YR$$F$Y$$$20240829$$MD$CA$CA
242640971$24264097$1$I$20240801$20240828$20240829$20240829$PER$$US-BAYER-2024A123989$BAYER$$$$$$Y$$$20240829$$CN$US$US
242640982$24264098$2$F$$20240822$20240829$20240911$EXP$$US-Vifor (International) Inc.-VIT-2024-07617$VIFOR$$$$$F$Y$$$20240911$$MD$US$US
242640991$24264099$1$I$$20240821$20240829$20240829$EXP$$US-SA-2024SA244349$SANOFI AVENTIS$$$$A$F$Y$$$20240829$$MD$US$US
242641001$24264100$1$I$20240101$20240820$20240829$20240829$EXP$$CA-ABBVIE-5889505$ABBVIE$$43$YR$$F$Y$$$20240829$$CN$CA$CA
242641011$24264101$1$I$$20240828$20240829$20240829$PER$$US-BAYER-2024A124202$BAYER$$9$YR$C$F$Y$$$20240829$$CN$US$US
242641021$24264102$1$I$20240828$20240828$20240829$20240829$PER$$US-BAYER-2024A124214$BAYER$$$$$F$Y$$$20240829$$CN$US$US
242641031$24264103$1$I$20231018$20231024$20240829$20240829$EXP$$US-VIATRISJAPAN-2023M1119494AA$MYLAN$$14$YR$$F$Y$30$KG$20240829$$CN$US$US
242641041$24264104$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136831$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240829$$CN$US$US
242641051$24264105$1$I$20240101$20240820$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133096$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240829$$HP$US$US
242641061$24264106$1$I$20240826$20240827$20240829$20240829$EXP$$US-GILEAD-2024-0685600$GILEAD$$75$YR$E$M$Y$$$20240829$$CN$US$US
242641071$24264107$1$I$20240801$20240822$20240829$20240829$EXP$$CN-ABBVIE-5891479$ABBVIE$$60$YR$$F$Y$44$KG$20240829$$MD$CN$CN
242641081$24264108$1$I$$20240822$20240829$20240829$EXP$$AR-TAKEDA-2024TUS086738$TAKEDA$$63$YR$$M$Y$$$20240829$$MD$AR$AR
242641091$24264109$1$I$20221123$20240827$20240829$20240829$EXP$$CA-TAKEDA-2024TUS086862$TAKEDA$$65$YR$$M$Y$$$20240829$$CN$CA$CA
242641101$24264110$1$I$$20240828$20240829$20240829$PER$$US-BAYER-2024A124236$BAYER$$$$$F$Y$$$20240829$$HP$US$US
242641111$24264111$1$I$20240704$20240826$20240829$20240829$EXP$FR-AFSSAPS-AN2024001144$FR-TAKEDA-2024TUS085693$TAKEDA$$67$YR$$M$Y$$$20240829$$HP$FR$FR
242641131$24264113$1$I$$20240815$20240829$20240829$EXP$$US-HLS-202400938$HLS THERAPEUTICS$$48$YR$A$M$Y$$$20240829$$HP$US$US
242641141$24264114$1$I$20240811$20240826$20240829$20240829$EXP$$US-009507513-2408USA008952$MERCK$$71$YR$$M$Y$$$20240829$$CN$US$US
242641151$24264115$1$I$$20240827$20240829$20240829$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004794$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240829$$MD$IT$IT
242641161$24264116$1$I$$20240826$20240829$20240829$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004769$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240829$$MD$US$US
242641171$24264117$1$I$20240801$20240826$20240829$20240829$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004763$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240829$$CN$US$US
242641181$24264118$1$I$$20240722$20240829$20240829$EXP$$IL-DEXCEL-BBL2024006293$BIOCON$$$$$$Y$$$20240829$$HP$IL$IL
242641191$24264119$1$I$$20240827$20240829$20240829$PER$$US-TAKEDA-2024TUS086723$TAKEDA$$$$$F$Y$101$KG$20240829$$HP$US$US
242641201$24264120$1$I$$20240816$20240829$20240829$EXP$$US-BAYER-2024A122475$BAYER$Mejia E.; Cole J.; Soszyn N.; Auerbach S.; Morgan G.J.. Percutaneous Stenting of a Stenotic Berlin Heart Outflow Cannula Graft in a 2-Year-Old Child. ASAIO Journal. 2024;70:8:e110-e112$2$YR$C$F$Y$$$20240829$$HP$US$US
242641221$24264122$1$I$20240201$20240820$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133465$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$58.51$KG$20240829$$CN$US$US
242641231$24264123$1$I$$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136784$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240829$$CN$US$US
242641241$24264124$1$I$20230701$20240823$20240829$20240829$EXP$FR-AFSSAPS-PO2024000917$FR-MYLANLABS-2024M1078461$MYLAN$$44$YR$$F$Y$$$20240829$$MD$FR$FR
242641251$24264125$1$I$$20240820$20240829$20240829$EXP$$US-AMGEN-USASP2024167747$AMGEN$Alkabie S.; Diamond E. L.. Erdheim-Chester Disease Masquerading as CLIPPERS. Neurology Neuroimmunology + Neuroinflammation. 2024;11 (5):e200294 (1-4)$27$YR$A$F$Y$$$20240829$$MD$US$US
242641271$24264127$1$I$20240827$20240828$20240828$20240828$DIR$716252$$FDA-CTU$$64$YR$$M$N$$$20240828$N$CN$US$
242641281$24264128$1$I$$20240828$20240828$20240828$DIR$716257$$FDA-CTU$$$$$UNK$N$$$20240828$$CN$US$
242641291$24264129$1$I$$20240828$20240828$20240828$DIR$716267$$FDA-CTU$$68$YR$$F$N$$$20240828$N$PH$US$
242641301$24264130$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59509$$FDA-CTU$$60$YR$$M$N$$$20240828$N$$US$
242641311$24264131$1$I$$20240828$20240828$20240828$DIR$716269$$FDA-CTU$$81$YR$$M$N$$$20240828$N$PH$US$
242641331$24264133$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59440$$FDA-CTU$$85$YR$$M$N$$$20240828$N$CN$US$
242641351$24264135$1$I$20240621$20240828$20240828$20240828$DIR$716266$$FDA-CTU$$66$YR$$M$N$63$KG$20240828$N$CN$US$
242641381$24264138$1$I$20240828$20240828$20240828$20240828$DIR$716271$$FDA-CTU$$21$YR$$F$N$114.75$KG$20240828$N$$US$
242641391$24264139$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59407$$FDA-CTU$$86$YR$$F$N$$$20240828$N$$US$
242641401$24264140$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59521$$FDA-CTU$$84$YR$$M$N$$$20240828$N$$US$
242641411$24264141$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59508$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
242641421$24264142$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59397$$FDA-CTU$$71$YR$$M$N$$$20240828$N$$US$
242641431$24264143$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59480$$FDA-CTU$$$$$M$N$$$20240828$N$PH$US$
242641451$24264145$1$I$20240416$20240827$20240829$20240829$EXP$$DE-PFIZER INC-202400244564$PFIZER$$50$YR$$M$Y$87$KG$20240829$$MD$DE$DE
242641461$24264146$1$I$$20240826$20240829$20240829$EXP$$IN-PFIZER INC-PV202400087786$PFIZER$$58$YR$$F$Y$$$20240829$$CN$IN$IN
242641482$24264148$2$F$$20240924$20240829$20240927$EXP$$US-PFIZER INC-202400244178$PFIZER$$82$YR$$M$Y$59.42$KG$20240927$$CN$US$US
242641501$24264150$1$I$$20240828$20240829$20240829$EXP$$CA-PFIZER INC-202400245728$PFIZER$$72$YR$$F$Y$$$20240829$$HP$CA$CA
242641512$24264151$2$F$$20240923$20240829$20240924$EXP$$CA-PFIZER INC-202400245763$PFIZER$$80$YR$$M$Y$$$20240924$$HP$CA$CA
242641521$24264152$1$I$$20240827$20240829$20240829$PER$$US-JNJFOC-20240871467$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242641531$24264153$1$I$20240823$20240823$20240829$20240829$EXP$$US-JNJFOC-20240869062$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240829$$HP$US$US
242641541$24264154$1$I$$20240828$20240829$20240829$PER$$PR-JNJFOC-20240874659$JOHNSON AND JOHNSON$$$$$M$Y$54.026$KG$20240829$$CN$PR$PR
242641551$24264155$1$I$$20240827$20240829$20240829$EXP$$US-JNJFOC-20240871176$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$HP$US$US
242641562$24264156$2$F$20231127$20240827$20240829$20240902$EXP$$CA-ABBVIE-5897232$ABBVIE$$57$YR$$F$Y$$$20240902$$CN$CA$CA
242641571$24264157$1$I$20240427$20240823$20240829$20240829$EXP$$UZ-AMERICAN REGENT INC-2024003270$AMERICAN REGENT$$0$YR$$M$Y$4.068$KG$20240829$$MD$UZ$UZ
242641581$24264158$1$I$20240101$20240813$20240829$20240829$EXP$$DE-AMGEN-DEUSP2024165214$AMGEN$$$$A$F$Y$$$20240829$$MD$DE$DE
242641592$24264159$2$F$20240422$20240917$20240829$20240926$EXP$$US-ABBVIE-5888080$ABBVIE$$57$YR$$F$Y$72$KG$20240926$$CN$US$US
242641601$24264160$1$I$$20240822$20240829$20240829$PER$$US-AMGEN-USASP2024168380$AMGEN$Salgia R.; Muddasani R.; Talwar Neel. et.al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73 (10):1-9$60$YR$A$F$Y$$$20240829$$HP$US$US
242641611$24264161$1$I$$20240822$20240829$20240829$PER$$US-AMGEN-USASP2024168355$AMGEN$Salgia R.; Muddasani R.; Talwar Neel. et.al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73 (10):1-9$71$YR$E$F$Y$$$20240829$$HP$US$US
242641621$24264162$1$I$$20240821$20240829$20240829$PER$$US-AMGEN-USASP2024167853$AMGEN$Fisher K.S.; Yarimi J.M.; Sandweiss A.J. et al.. IT-DEX and B cell depletion in a child with anti-GAD 65 autoimmune encephalitis presenting as NORSE: A case report. Journal of Neuroimmunology. 2024;395:1-4$11$YR$C$F$Y$$$20240829$$HP$US$US
242641631$24264163$1$I$20240701$20240823$20240829$20240829$EXP$$US-OTSUKA-2024_023445$OTSUKA$$49$YR$$F$Y$$$20240829$$CN$US$US
242641641$24264164$1$I$20210901$20240821$20240829$20240829$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-134388$BRISTOL MYERS SQUIBB$Yan Z, Jianbin Y, Yanmei M. Dasatinib monotherapy for intramedullary T-lymphocyte blast crisis in chronic myeloid leukemia: a case report. Chin J Hematol. 2024 Jun 14;45(6):608-9. doi:10.3760/cma.j.cn121090-20240110-00016.$20$YR$A$M$Y$$$20240829$$HP$CN$CN
242641651$24264165$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59499$$FDA-CTU$$13$YR$$M$N$$$20240828$N$$US$
242641661$24264166$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59501$$FDA-CTU$$16$YR$$M$N$$$20240828$N$$US$
242641681$24264168$1$I$$20240812$20240829$20240829$PER$$AU-TOLMAR, INC.-24AU051812$TOLMAR$$$$$M$Y$$$20240829$$CN$AU$AU
242641691$24264169$1$I$$20240812$20240829$20240829$PER$$AU-TOLMAR, INC.-24AU051849$TOLMAR$$$$$M$Y$$$20240829$$CN$AU$AU
242641701$24264170$1$I$20240315$20240812$20240829$20240829$PER$$BR-TOLMAR, INC.-24BR051753$TOLMAR$$8$YR$$F$Y$$$20240829$$CN$BR$BR
242641711$24264171$1$I$$20240812$20240829$20240829$PER$$BR-TOLMAR, INC.-24BR051859$TOLMAR$$$$$F$Y$$$20240829$$CN$BR$BR
242641721$24264172$1$I$20240801$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245187$PFIZER$$82$YR$$F$Y$60.78$KG$20240829$$CN$US$US
242641731$24264173$1$I$$20240828$20240829$20240829$PER$$US-PFIZER INC-PV202400112749$PFIZER$$65$YR$$F$Y$$$20240829$$HP$US$US
242641741$24264174$1$I$20240801$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245211$PFIZER$$68$YR$$F$Y$$$20240829$$PH$US$US
242641751$24264175$1$I$20240801$20240823$20240829$20240829$PER$$US-PFIZER INC-202400244184$PFIZER$$75$YR$$M$Y$$$20240829$$HP$US$US
242641761$24264176$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-PV202400111505$PFIZER$$77$YR$$$Y$$$20240829$$CN$US$US
242641771$24264177$1$I$20240629$20240819$20240829$20240829$EXP$$US-BAYER-2024A100915$BAYER$$78$YR$E$M$Y$101.59$KG$20240829$$CN$US$US
242641781$24264178$1$I$$20240820$20240829$20240829$EXP$$GB-TEVA-VS-3235785$TEVA$$87$YR$$F$Y$76$KG$20240829$$HP$GB$GB
242641791$24264179$1$I$$20240827$20240829$20240829$PER$$US-PFIZER INC-202400244984$PFIZER$$$$$F$Y$$$20240829$$CN$US$US
242641801$24264180$1$I$$20240827$20240829$20240829$PER$$US-PFIZER INC-PV202400111880$PFIZER$$59$YR$$F$Y$$$20240829$$HP$US$US
242641814$24264181$4$F$20240424$20240910$20240829$20240912$PER$$US-PFIZER INC-PV202400063651$PFIZER$$77$YR$$F$Y$$$20240912$$CN$US$US
242641821$24264182$1$I$20240101$20240823$20240829$20240829$PER$$US-PFIZER INC-202400244071$PFIZER$$64$YR$$M$Y$$$20240829$$HP$US$US
242641831$24264183$1$I$$20240828$20240829$20240829$PER$$US-PFIZER INC-202400246195$PFIZER$$$$$$Y$$$20240829$$HP$US$US
242641841$24264184$1$I$$20240828$20240829$20240829$PER$$US-PFIZER INC-PV202400113028$PFIZER$$75$YR$$F$Y$$$20240829$$CN$US$US
242641852$24264185$2$F$20240818$20240827$20240829$20240830$PER$$US-PFIZER INC-202400243794$PFIZER$$75$YR$$M$Y$78.47$KG$20240830$$CN$US$US
242641861$24264186$1$I$20240826$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245169$PFIZER$$47$YR$$F$Y$$$20240829$$CN$US$US
242641872$24264187$2$F$$20240903$20240829$20240903$PER$$US-PFIZER INC-PV202400111845$PFIZER$$16$YR$$M$Y$49.8$KG$20240903$$MD$US$US
242641881$24264188$1$I$20240824$20240828$20240829$20240829$PER$$US-PFIZER INC-202400246280$PFIZER$$40$YR$$F$Y$$$20240829$$CN$US$US
242641902$24264190$2$F$$20240901$20240829$20240904$PER$$US-PFIZER INC-PV202400111872$PFIZER$$57$YR$$F$Y$$$20240904$$HP$US$US
242641911$24264191$1$I$20240825$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245173$PFIZER$$52$YR$$M$Y$$$20240829$$CN$US$US
242641921$24264192$1$I$$20240827$20240829$20240829$PER$$US-PFIZER INC-2020187726$PFIZER$$52$YR$$F$Y$$$20240829$$HP$US$US
242641931$24264193$1$I$$20240827$20240829$20240829$PER$$US-PFIZER INC-PV202300049694$PFIZER$$73$YR$$F$Y$$$20240829$$MD$US$US
242641941$24264194$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-202400245318$PFIZER$$46$YR$$F$Y$$$20240829$$HP$US$US
242641951$24264195$1$I$$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245129$PFIZER$$$$$$Y$$$20240829$$CN$US$US
242641961$24264196$1$I$20240101$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244617$PFIZER$$7$YR$$F$Y$29.025$KG$20240829$$CN$US$US
242641971$24264197$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244473$PFIZER$$71$YR$$F$Y$54.43$KG$20240829$$CN$US$US
242641981$24264198$1$I$$20240820$20240829$20240829$EXP$$US-AMGEN-USASP2024169295$AMGEN$Kimball A.B.; Gibson R.S.; Snyder C.L. et al.. Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study. International Journal of  Women^s Dermatology. 2024;10 (3):1-4$$$$F$Y$$$20240829$$MD$US$US
242641991$24264199$1$I$20240817$20240822$20240829$20240829$EXP$$US-JNJFOC-20240860329$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240829$$CN$US$US
242642002$24264200$2$F$20240828$20240829$20240829$20240831$PER$$US-AMGEN-USASP2024172630$AMGEN$$73$YR$E$F$Y$$$20240831$$CN$US$US
242642011$24264201$1$I$20240814$20240821$20240829$20240829$EXP$$MX-009507513-2408MEX008768$MERCK$$$$$M$Y$$$20240829$$MD$MX$MX
242642021$24264202$1$I$$20240822$20240829$20240829$PER$$US-AMGEN-USASP2024168383$AMGEN$Salgia R.; Muddasani R.; Talwar Neel. et.al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73 (10):1-9$61$YR$A$F$Y$$$20240829$$HP$US$US
242642031$24264203$1$I$$20240829$20240829$20240829$EXP$$TH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048487$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240829$$HP$TH$TH
242642041$24264204$1$I$$20240821$20240829$20240829$EXP$$US-AMGEN-USASP2024169129$AMGEN$Hasbun R.; Mann I.; Morado-aramburo O. et. al.. Emerging shadows: HHV-8-associated encephalitis unveiled in a solid organ transplant recipient. Transplant Infectious disease. 2024;26 (4):1-3$73$YR$E$F$Y$$$20240829$$HP$US$US
242642051$24264205$1$I$$20240822$20240829$20240829$EXP$$US-AMGEN-USASP2024168662$AMGEN$Marks C.R; Durand C.M; Bowring M.G. et. al. Influence of induction therapy and antiretroviral regimen on outcomes in kidney transplant recipients living with human immunodeficiency. Transplant Infectious Disease. 2024;26 (4):1-8$$$$$Y$$$20240829$$HP$US$US
242642061$24264206$1$I$$20240822$20240829$20240829$PER$$US-AMGEN-USASP2024168381$AMGEN$Salgia R.; Muddasani R.; Talwar Neel. et.al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73 (10):1-9$55$YR$A$F$Y$$$20240829$$HP$US$US
242642071$24264207$1$I$$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136741$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240829$$MD$US$US
242642081$24264208$1$I$$20240822$20240829$20240829$EXP$$US-AMGEN-USASP2024168382$AMGEN$Salgia R.; Muddasani R.; Talwar Neel. et.al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73 (10):1-9$69$YR$E$M$Y$$$20240829$$HP$US$US
242642092$24264209$2$F$20240822$20240909$20240829$20240911$EXP$$JP-ALXN-202408JPN001412JP$ALEXION PHARMACEUTICALS$$8$DEC$$M$Y$$$20240912$$MD$JP$JP
242642102$24264210$2$F$$20240912$20240829$20240918$EXP$$US-GILEAD-2024-0685603$GILEAD$$64$YR$A$F$Y$$$20240918$$MD$US$US
242642121$24264212$1$I$20240312$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59496$$FDA-CTU$$55$YR$$M$N$$$20240827$N$HP$US$
242642152$24264215$2$F$$20240816$20240829$20240829$EXP$$US-ASTELLAS-2024-AER-001878$ASTELLAS$$8$DEC$E$M$Y$$$20240829$$MD$US$US
242642161$24264216$1$I$$20230622$20240829$20240829$PER$$US-MYLANLABS-2023M1067021$BIOCON$$$$$$Y$$$20240829$$MD$US$US
242642171$24264217$1$I$20231012$20231012$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1109092$BIOCON$$42$YR$$M$Y$88$KG$20240829$$$US$US
242642181$24264218$1$I$$20231108$20240829$20240829$PER$$US-BIOCON BIOLOGICS LIMITED-2023M1120917$BIOCON$$$$$M$Y$$$20240829$$PH$US$US
242642191$24264219$1$I$20240822$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137562$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240829$$CN$US$US
242642201$24264220$1$I$20240101$20240824$20240829$20240829$PER$$US-SA-2024SA252002$SANOFI AVENTIS$$$$A$F$Y$$$20240829$$MD$US$US
242642221$24264222$1$I$20240726$20240826$20240829$20240829$EXP$$RU-BAYER-2024A123259$BAYER$$20$YR$A$F$Y$53$KG$20240829$$MD$RU$RU
242642232$24264223$2$F$$20240909$20240829$20240918$EXP$$NVSC2024IT042954$NOVARTIS$Conti EA, Chironi F, Petaccia A, Lanni S, Minoia F, Filocamo G. Safety and efficacy of concomitant use of anti IL17 and anti IL6 agents in a case of severe refractory systemic JIA: Report of the first 18 months of treatment. PEDIATRIC RHEUMATOLOGY. 2023;21(2):P307$4$YR$$F$Y$$$20240918$$HP$IT$IT
242642241$24264224$1$I$20240724$20240829$20240829$20240829$EXP$FR-AFSSAPS-PV2024000793$NVSC2024FR174155$NOVARTIS$$84$YR$$M$Y$73.9$KG$20240829$$MD$FR$FR
242642251$24264225$1$I$$20240822$20240829$20240829$PER$$US-JNJFOC-20240864912$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240829$$PH$US$US
242642262$24264226$2$F$$20240916$20240829$20240924$PER$$US-GSK-US2024103463$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
242642271$24264227$1$I$$20240819$20240829$20240829$30DAY$$US-GSK-US2024103464$GLAXOSMITHKLINE$$$$$M$Y$$$20240829$$CN$US$US
242642291$24264229$1$I$$20240822$20240829$20240829$EXP$$CA-TEVA-VS-3236682$TEVA$$18$YR$$F$Y$90$KG$20240829$$HP$CA$CA
242642301$24264230$1$I$$20240815$20240829$20240829$EXP$$US-HLS-202400928$HLS THERAPEUTICS$$$$A$M$Y$$$20240829$$CN$US$US
242642312$24264231$2$F$20180101$20240909$20240829$20240910$PER$$US-BAYER-2024A124245$BAYER$$27$YR$A$F$Y$$$20240910$$CN$US$US
242642321$24264232$1$I$20240825$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171734$AMGEN$$81$YR$E$F$Y$$$20240829$$CN$US$US
242642331$24264233$1$I$$20240826$20240829$20240829$EXP$$JP-BAYER-2024A122618$BAYER$$$$$M$Y$$$20240829$$MD$JP$JP
242642341$24264234$1$I$20240802$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136801$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240829$$CN$US$US
242642352$24264235$2$F$20240101$20240820$20240829$20240902$EXP$$JP-009507513-2408JPN007968$MERCK$$$$$$Y$$$20240902$$HP$JP$JP
242642361$24264236$1$I$20240813$20240828$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137648$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240829$$HP$US$US
242642371$24264237$1$I$20240729$20240826$20240829$20240829$PER$IT-MINISAL02-998186$IT-BRACCO-2024IT05217$BRACCO$$49$YR$$M$Y$$$20240829$$PH$IT$IT
242642381$24264238$1$I$$20240822$20240829$20240829$EXP$$CA-GILEAD-2024-0685209$GILEAD$Maheswaran J, Rafiee MJ, Cordes s, Lefebvre B, Chetrit M. Multimodality Imaging of Acute Myocarditis in Cytokine Release Syndrome (CRS) Following CAR-T Therapy. CJC Open. 2024;6(8):973-977. doi:https://doi.org/10.1016/j.cjco.2024.04.004$74$YR$E$F$Y$$$20240829$$MD$CA$CA
242642391$24264239$1$I$$20240826$20240829$20240829$PER$$US-ABBVIE-5897529$ABBVIE$$$$$F$Y$$$20240829$$HP$US$US
242642411$24264241$1$I$$20240822$20240829$20240829$EXP$$US-ANIPHARMA-2024-US-045465$ANI$$$$$M$Y$$$20240829$$HP$US$US
242642421$24264242$1$I$$20240828$20240829$20240829$PER$$US-BAYER-2024A123916$BAYER$$$$$$Y$$$20240829$$CN$US$US
242642431$24264243$1$I$20240827$20240828$20240829$20240829$PER$$US-JNJFOC-20240873865$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242642442$24264244$2$F$$20240926$20240829$20240930$PER$$US-ALXN-202408USA000873US$ALEXION PHARMACEUTICALS$$$$A$$Y$$$20240930$$$US$US
242642453$24264245$3$F$20240101$20240906$20240829$20240920$30DAY$$CA-JNJFOC-20240834974$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240920$$PH$CA$CA
242642461$24264246$1$I$20240827$20240827$20240829$20240829$PER$$US-JNJFOC-20240875292$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242642471$24264247$1$I$20240820$20240827$20240829$20240829$PER$$US-JNJFOC-20240874092$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240829$$CN$US$US
242642481$24264248$1$I$20240101$20240731$20240829$20240829$PER$$US-009507513-2408USA000206$MERCK$$75$YR$$F$Y$$$20240829$$CN$US$US
242642491$24264249$1$I$20240627$20240826$20240829$20240829$EXP$IT-MINISAL02-997812$IT-FreseniusKabi-FK202412906$FRESENIUS KABI$$60$YR$A$M$Y$141$KG$20240829$$MD$IT$IT
242642501$24264250$1$I$$20240819$20240829$20240829$30DAY$$US-GSK-US2024103429$GLAXOSMITHKLINE$$$$$M$Y$$$20240829$$CN$US$US
242642511$24264251$1$I$$20240822$20240829$20240829$EXP$$US-GSK-US2024AMR105316$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$US$US
242642541$24264254$1$I$20240820$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59486$$FDA-CTU$$44$YR$$F$N$$$20240827$N$HP$US$
242642572$24264257$2$F$20240101$20240920$20240829$20240926$EXP$$US-BIOGEN-2024BI01280408$BIOGEN$$$$$M$Y$$$20240926$$CN$US$US
242642581$24264258$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59492$$FDA-CTU$$96$YR$$F$N$$$20240828$N$$US$
242642591$24264259$1$I$$20240821$20240829$20240829$PER$$US-BAYER-2024A121231$BAYER$$$$$$Y$$$20240829$$CN$US$US
242642601$24264260$1$I$$20240826$20240829$20240829$EXP$$CA-ABBVIE-5897984$ABBVIE$$39$YR$$F$Y$$$20240829$$CN$CA$CA
242642612$24264261$2$F$20200618$20240822$20240829$20240904$EXP$PL-URPL-1-1874-2020$PL-JNJFOC-20240855635$JOHNSON AND JOHNSON$$20$YR$A$M$Y$120$KG$20240904$$MD$PL$PL
242642621$24264262$1$I$$20240819$20240829$20240829$EXP$$US-GSK-US2024103460$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242642631$24264263$1$I$$20240821$20240829$20240829$PER$$US-ABBVIE-5891069$ABBVIE$$$$$$Y$$$20240829$$HP$US$US
242642641$24264264$1$I$$20240827$20240829$20240829$EXP$$NVSC2024US054151$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
242642651$24264265$1$I$$20240827$20240829$20240829$EXP$$NVSC2024US173893$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
242642661$24264266$1$I$$20240823$20240829$20240829$EXP$$US-TORRENT-00013729$TORRENT$$$$$M$Y$$$20240829$$PH$US$US
242642671$24264267$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137023$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240829$$CN$US$US
242642681$24264268$1$I$$20240811$20240829$20240829$PER$$US-AMGEN-USASP2024163191$AMGEN$Sadek J.; Valter I.; Desouza A. et al.. A randomized, double-blind, study to evaluate the efficacy, pharmacodynamics, safety and immunogenicity of FKS518 proposed biosimilar to denosumab with the originator in postmenopausal women with osteoporosis (LUMIADE-3 study). Journal of Clinical Oncology. 2024;42 (16):3155$$$$$Y$$$20240829$$HP$US$US
242642691$24264269$1$I$$20240826$20240829$20240829$PER$$US-BAYER-2024A123514$BAYER$$$$$F$Y$$$20240829$$CN$US$US
242642701$24264270$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136045$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240829$$CN$US$US
242642711$24264271$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136846$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240829$$CN$US$US
242642721$24264272$1$I$20240812$20240819$20240829$20240829$EXP$$GB-TEVA-VS-3235451$TEVA$$74$YR$$M$Y$84$KG$20240829$$HP$GB$GB
242642731$24264273$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137041$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240829$$CN$US$US
242642741$24264274$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59463$$FDA-CTU$$72$YR$$F$N$$$20240828$N$$US$
242642751$24264275$1$I$$20240828$20240828$20240828$DIR$716256$$FDA-CTU$$$$$UNK$N$$$20240828$$CN$US$
242642761$24264276$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137305$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240829$$HP$US$US
242642772$24264277$2$F$$20240827$20240829$20240904$EXP$$IN-VANTIVE-2024VAN019351$Vantive US Healthcare$$68$YR$$M$Y$$$20240904$$CN$IN$IN
242642782$24264278$2$F$$20240910$20240829$20240917$EXP$$IN-VANTIVE-2024VAN019313$Vantive US Healthcare$$56$YR$$M$Y$$$20240917$$CN$IN$IN
242642791$24264279$1$I$20240625$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59500$$FDA-CTU$$74$YR$$F$N$$$20240828$N$PH$US$
242642801$24264280$1$I$$20240821$20240829$20240829$EXP$$CA-BAXTER-2024BAX023627$BAXTER$$5$YR$$F$Y$$$20240829$$HP$CA$CA
242642811$24264281$1$I$20240205$20240828$20240828$20240828$DIR$716273$$FDA-CTU$$33$YR$$F$N$$$20240828$N$MD$US$
242642822$24264282$2$F$20240822$20240912$20240829$20240919$EXP$$DE-BAXTER-2024BAX023714$BAXTER$$88$YR$$M$Y$$$20240919$$HP$DE$DE
242642831$24264283$1$I$20240806$20240828$20240828$20240828$DIR$716275$$FDA-CTU$$78$YR$$M$N$$$20240828$Y$HP$US$
242642841$24264284$1$I$20240810$20240821$20240829$20240829$EXP$CN-NMPACDR-4403061004846202400189$CN-BAXTER-2024BAX023687$BAXTER$$43$YR$$F$Y$64$KG$20240829$$MD$CN$CN
242642851$24264285$1$I$20240818$20240819$20240829$20240829$EXP$$IE-BAXTER-2024BAX023502$BAXTER$$52$YR$$F$Y$$$20240829$$CN$IE$IE
242642861$24264286$1$I$$20240829$20240829$20240829$PER$$US-PROD-AS2-212756134-RB-083571-2024$RECKITT BENCKISER$$$$$F$Y$$$20240829$$CN$US$US
242642881$24264288$1$I$$20240813$20240829$20240829$PER$$US-ASTELLAS-2024-AER-001100$ASTELLAS$$83$YR$E$M$Y$$$20240828$$PH$US$US
242642892$24264289$2$F$20240701$20240913$20240829$20240916$EXP$$BR-JNJFOC-20240851665$JOHNSON AND JOHNSON$$40$YR$A$F$Y$66$KG$20240916$$CN$BR$BR
242642901$24264290$1$I$$20240826$20240829$20240829$PER$$US-JNJFOC-20240868980$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242642911$24264291$1$I$$20240826$20240829$20240829$EXP$$US-JNJFOC-20240867101$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$HP$US$US
242642921$24264292$1$I$$20240819$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-132048$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240829$$HP$CA$CA
242642931$24264293$1$I$20220801$20240822$20240829$20240829$EXP$GB-MHRA-MED-202408221511599270-QZSRF$GB-FreseniusKabi-FK202412846$FRESENIUS KABI$$$$$M$Y$92$KG$20240829$$CN$GB$GB
242642941$24264294$1$I$20220715$20240826$20240829$20240829$EXP$$NVSC2024KR172204$NOVARTIS$$$$A$F$Y$$$20240829$$PH$KR$KR
242642951$24264295$1$I$$20240819$20240829$20240829$EXP$GB-MHRA-MED-202408191528579690-FHGPQ$GB-TEVA-VS-3235466$TEVA$$$$$F$Y$$$20240829$$PH$GB$GB
242642961$24264296$1$I$$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135707$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240829$$CN$US$US
242642971$24264297$1$I$20240731$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136854$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240829$$CN$US$US
242642982$24264298$2$F$$20240924$20240829$20240925$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048510$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240926$$CN$US$US
242642991$24264299$1$I$20240101$20240819$20240829$20240829$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000173$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240829$$CN$US$US
242643001$24264300$1$I$20240101$20240813$20240829$20240829$PER$$US-ASTELLAS-2024-AER-001023$ASTELLAS$$82$YR$E$F$Y$$$20240828$$CN$US$US
242643011$24264301$1$I$$20240822$20240829$20240829$PER$US-MLMSERVICE-20240815-PI163802-00030-1$US-RDY-SPO/USA/24/0012383$DR REDDYS$Parikh SV, Madhavan S, Shapiro J, Knight R, Rosenberg AZ, Parikh CR, et al. Characterization of Glomerular and Tubulointerstitial Proteomes in a Case of Nonsteroidal Anti-Inflammatory Drug-Attributed Acute Kidney Injury A Clinical Pathologic Molecular Correlation. Clinical Journal of the American Society of Nephrology. 2023;18(3):402-10. DOI:10.2215/CJN.09260822.$38$YR$A$F$Y$$$20240829$$MD$US$US
242643021$24264302$1$I$20240801$20240820$20240829$20240829$EXP$$JP-ASTELLAS-2024-AER-000725$ASTELLAS$$6$DEC$A$F$Y$$$20240828$$MD$JP$JP
242643031$24264303$1$I$$20240819$20240829$20240829$EXP$$GB-TEVA-VS-3236033$TEVA$$$$$F$Y$$$20240829$$MD$GB$GB
242643041$24264304$1$I$20240101$20240819$20240829$20240829$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000175$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240829$$CN$US$US
242643051$24264305$1$I$20240701$20240822$20240829$20240829$EXP$$NVSC2024MX172426$NOVARTIS$$58$YR$$M$Y$78$KG$20240829$$CN$MX$MX
242643062$24264306$2$F$$20240909$20240829$20240920$30DAY$$ES-JNJFOC-20240854449$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$ES$ES
242643071$24264307$1$I$$20240816$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010558$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240829$$CN$US$US
242643081$24264308$1$I$$20240820$20240829$20240829$EXP$GB-MHRA-MED-202408201705546700-GNDVQ$GB-ELI_LILLY_AND_COMPANY-GB202408013303$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240829$$CN$GB$GB
242643091$24264309$1$I$$20240820$20240829$20240829$EXP$GB-MHRA-MED-202408201412263640-SWFHN$GB-ELI_LILLY_AND_COMPANY-GB202408013112$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$GB$GB
242643101$24264310$1$I$$20240820$20240829$20240829$EXP$GB-MHRA-MED-202408201419481070-TVJCD$GB-ELI_LILLY_AND_COMPANY-GB202408013103$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$GB$GB
242643111$24264311$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018098$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240829$$CN$US$US
242643121$24264312$1$I$20240810$20240821$20240829$20240829$EXP$GB-MHRA-MED-202408211711245940-BPRDY$GB-ELI_LILLY_AND_COMPANY-GB202408014070$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240829$$CN$GB$GB
242643132$24264313$2$F$20231001$20240913$20240829$20240919$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408011168$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240919$$CN$DE$DE
242643141$24264314$1$I$20240719$20240820$20240829$20240829$EXP$GB-MHRA-MED-202408201342314610-FJYCR$GB-ELI_LILLY_AND_COMPANY-GB202408013155$ELI LILLY AND CO$$77$YR$E$M$Y$114$KG$20240829$$CN$GB$GB
242643151$24264315$1$I$$20240820$20240829$20240829$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408013416$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240829$$CN$JP$JP
242643161$24264316$1$I$$20240820$20240829$20240829$EXP$GB-MHRA-MED-202408201117398700-YFGTH$GB-ELI_LILLY_AND_COMPANY-GB202408013027$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$GB$GB
242643171$24264317$1$I$$20240816$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012679$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240829$$HP$US$US
242643181$24264318$1$I$$20240816$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010559$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240829$$CN$US$US
242643191$24264319$1$I$$20240820$20240829$20240829$EXP$GB-MHRA-MED-202408201217001710-VGLJK$GB-ELI_LILLY_AND_COMPANY-GB202408013164$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240829$$CN$GB$GB
242643201$24264320$1$I$20240401$20240819$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012872$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240829$$CN$US$US
242643211$24264321$1$I$$20240823$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016250$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240829$$CN$US$US
242643221$24264322$1$I$20240815$20240820$20240829$20240829$EXP$GB-MHRA-MED-202408201112364930-KMBRW$GB-ELI_LILLY_AND_COMPANY-GB202408013021$ELI LILLY AND CO$$46$YR$A$F$Y$87$KG$20240829$$CN$GB$GB
242643231$24264323$1$I$$20240820$20240829$20240829$EXP$GB-MHRA-MED-202408201120431040-NSRMF$GB-ELI_LILLY_AND_COMPANY-GB202408013031$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$GB$GB
242643241$24264324$1$I$$20240820$20240829$20240829$EXP$GB-MHRA-MED-202408201530038350-MPLHD$GB-ELI_LILLY_AND_COMPANY-GB202408013276$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240829$$CN$GB$GB
242643251$24264325$1$I$$20240820$20240829$20240829$EXP$GB-MHRA-MED-202408201522478090-VPDFH$GB-ELI_LILLY_AND_COMPANY-GB202408013274$ELI LILLY AND CO$$30$YR$A$F$Y$76$KG$20240829$$CN$GB$GB
242643261$24264326$1$I$$20240820$20240829$20240829$EXP$GB-MHRA-MED-202408201115116240-SYGCK$GB-ELI_LILLY_AND_COMPANY-GB202408013023$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$GB$GB
242643271$24264327$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018100$ELI LILLY AND CO$$$$$M$Y$$$20240829$$CN$US$US
242643282$24264328$2$F$20240810$20240827$20240829$20240830$EXP$PT-INFARMED-F202408-450$PT-ELI_LILLY_AND_COMPANY-PT202408015002$ELI LILLY AND CO$$45$YR$A$F$Y$61$KG$20240830$$CN$PT$PT
242643291$24264329$1$I$$20240816$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202404017809$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240829$$CN$US$US
242643301$24264330$1$I$20240805$20240821$20240829$20240829$EXP$GB-MHRA-MED-202408210805419350-VMZKR$GB-ELI_LILLY_AND_COMPANY-GB202408014125$ELI LILLY AND CO$$61$YR$A$F$Y$19$KG$20240829$$CN$GB$GB
242643311$24264331$1$I$20240822$20240826$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016201$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240829$$HP$US$US
242643321$24264332$1$I$20240724$20240820$20240829$20240829$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006513$AURINIA PHARMACEUTICALS$$34$YR$$F$Y$$$20240829$$HP$US$US
242643332$24264333$2$F$20240801$20240905$20240829$20240910$EXP$$JP-ASTELLAS-2024-AER-001373$ASTELLAS$$7$DEC$E$M$Y$$$20240910$$MD$JP$JP
242643341$24264334$1$I$$20240730$20240829$20240829$30DAY$$ES-SA-2024SA251887$SANOFI AVENTIS$$$$A$$Y$$$20240829$$PH$ES$ES
242643361$24264336$1$I$$20240820$20240829$20240829$EXP$$GR-BAYER-2024A121090$BAYER$Karachalios X., Panagiotouni M., Pliakou E., Kalyva V., Visvikis A., Sgouros I, et. al.. Pneumonitis in a patient with metastatic castration-sensitive prostate cancer (prca) under darolutamide treatment.. Hellenic oncology congress 7th edition; 24-27 APRIL 2024.$67$YR$E$M$Y$$$20240829$$MD$GR$GR
242643371$24264337$1$I$20230514$20240822$20240829$20240829$EXP$$FR-AstraZeneca-2024A195749$ASTRAZENECA$$$$N$M$Y$3.5$KG$20240829$$MD$FR$
242643381$24264338$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A195527$ASTRAZENECA$$59$YR$$M$Y$$$20240829$$CN$US$
242643391$24264339$1$I$20240828$20240828$20240829$20240829$PER$$US-AstraZeneca-2024A196858$ASTRAZENECA$$20104$DY$$F$Y$$$20240829$$CN$US$
242643401$24264340$1$I$20230311$20240821$20240829$20240829$EXP$$JP-AstraZeneca-2024A121745$ASTRAZENECA$$74$YR$$M$Y$50$KG$20240829$$MD$JP$
242643411$24264341$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249202$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240829$$MD$US$US
242643422$24264342$2$F$$20240919$20240829$20240925$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006544$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
242643431$24264343$1$I$20240501$20240826$20240829$20240829$PER$$US-DSJP-DSU-2024-142624$DAIICHI$$$$$F$Y$$$20240829$$PH$US$US
242643441$24264344$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135938$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240829$$CN$US$US
242643451$24264345$1$I$20240101$20240820$20240829$20240829$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000177$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240829$$CN$US$US
242643462$24264346$2$F$20240101$20240918$20240829$20240923$EXP$$US-AMGEN-USASP2024170745$AMGEN$$66$YR$E$M$Y$$$20240923$$HP$US$US
242643471$24264347$1$I$$20240819$20240829$20240829$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR107153$VIIV$$$$$$Y$$$20240829$$HP$US$US
242643481$24264348$1$I$$20240719$20240829$20240829$PER$$US-LUNDBECK-DKLU4002033$LUNDBECK$$$$$$Y$$$20240829$$CN$US$US
242643491$24264349$1$I$20240611$20240826$20240829$20240829$EXP$FR-AFSSAPS-GR2024000936$FR-ABBVIE-5898147$ABBVIE$$73$YR$$F$Y$$$20240829$$PH$FR$FR
242643501$24264350$1$I$20240315$20240826$20240829$20240829$EXP$$NVSC2024SE144586$NOVARTIS$$55$YR$$F$Y$$$20240829$$CN$SE$SE
242643511$24264351$1$I$$20240825$20240829$20240829$EXP$$US-INCYTE CORPORATION-2024IN008904$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242643531$24264353$1$I$20230928$20240827$20240829$20240829$EXP$GB-MHRA-MED-202408270745395860-NYMJH$GB-MYLANLABS-2024M1079287$MYLAN$$67$YR$$F$Y$52$KG$20240829$$CN$GB$GB
242643541$24264354$1$I$$20240826$20240829$20240829$EXP$$CA-JNJFOC-20240875751$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240829$$HP$CA$CA
242643551$24264355$1$I$$20240820$20240829$20240829$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000176$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240829$$CN$US$US
242643561$24264356$1$I$$20240827$20240829$20240829$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-142638$DAIICHI$$$$$F$Y$$$20240829$$MD$US$US
242643572$24264357$2$F$$20240814$20240829$20240829$PER$$US-ASTELLAS-2024-AER-000727$ASTELLAS$$67$YR$E$M$Y$$$20240828$$CN$US$US
242643581$24264358$1$I$$20240826$20240829$20240829$EXP$$US-INCYTE CORPORATION-2024IN008954$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242643591$24264359$1$I$$20240826$20240829$20240829$EXP$$US-INCYTE CORPORATION-2024IN008959$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242643601$24264360$1$I$20240823$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171694$AMGEN$$68$YR$E$M$Y$$$20240829$$CN$US$US
242643611$24264361$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137328$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240829$$CN$US$US
242643621$24264362$1$I$20240501$20240819$20240829$20240829$EXP$SE-SEMPA-2024-005998$SE-TEVA-VS-3235452$TEVA$$67$YR$$F$Y$$$20240829$$MD$SE$SE
242643631$24264363$1$I$20240101$20240829$20240829$20240829$EXP$SE-SEMPA-2024-006279$SE-BAYER-2024A124248$BAYER$$29$YR$A$M$Y$$$20240829$$MD$SE$SE
242643642$24264364$2$F$$20240816$20240829$20240829$PER$$US-ASTELLAS-2024-AER-001717$ASTELLAS$$$$$M$Y$$$20240828$$MD$US$US
242643651$24264365$1$I$20240701$20240826$20240829$20240829$EXP$$US-INCYTE CORPORATION-2024IN008952$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242643661$24264366$1$I$$20240822$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-014841$UNITED THERAPEUTICS$$$$$M$Y$117.91$KG$20240829$$$US$US
242643671$24264367$1$I$$20240827$20240829$20240829$PER$$US-ROCHE-10000068038$ROCHE$$36$YR$A$M$Y$$$20240829$$HP$US$US
242643691$24264369$1$I$$20240817$20240829$20240829$PER$$US-JNJFOC-20240849862$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242643701$24264370$1$I$$20240828$20240829$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA075962$SANDOZ$$62$YR$$F$Y$$$20240829$$CN$CA$CA
242643711$24264371$1$I$20240101$20240828$20240829$20240829$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-142640$DAIICHI$$47$YR$$F$Y$$$20240829$$CN$US$US
242643721$24264372$1$I$20230703$20240822$20240829$20240829$EXP$$AR-GSK-AR2023AMR098942$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$AR$AR
242643731$24264373$1$I$20240816$20240828$20240829$20240829$EXP$$US-TAKEDA-2024TUS086972$TAKEDA$$65$YR$$F$Y$$$20240829$$CN$US$US
242643741$24264374$1$I$20240101$20240824$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-024816$UNITED THERAPEUTICS$$$$$M$Y$75.737$KG$20240829$$$US$US
242643751$24264375$1$I$$20240828$20240829$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA075998$SANDOZ$$76$YR$$M$Y$$$20240829$$CN$CA$CA
242643761$24264376$1$I$20240101$20240822$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-026547$UNITED THERAPEUTICS$$$$$M$Y$107.03$KG$20240829$$$US$US
242643771$24264377$1$I$$20240825$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135528$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$92.08$KG$20240829$$CN$US$US
242643781$24264378$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135869$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$73.48$KG$20240829$$CN$US$US
242643791$24264379$1$I$20240823$20240826$20240829$20240829$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-142448$DAIICHI$$65$YR$$M$Y$$$20240829$$CN$US$US
242643801$24264380$1$I$20240101$20240816$20240829$20240829$EXP$$US-SA-2024SA249917$SANOFI AVENTIS$$51$YR$A$F$Y$59$KG$20240829$$MD$US$US
242643811$24264381$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A191067$ASTRAZENECA$$$$$F$Y$74$KG$20240829$$CN$US$
242643821$24264382$1$I$20240807$20240821$20240829$20240829$EXP$IT-MINISAL02-999051$IT-TEVA-VS-3235980$TEVA$$60$YR$$F$Y$$$20240829$$MD$IT$IT
242643831$24264383$1$I$20240826$20240826$20240829$20240829$EXP$$US-AstraZeneca-2024A194228$ASTRAZENECA$$$$$M$Y$$$20240829$$MD$US$
242643841$24264384$1$I$$20240828$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US076181$SANDOZ$$49$YR$$F$Y$$$20240829$$HP$US$US
242643861$24264386$1$I$$20240821$20240829$20240829$EXP$$ZA-AstraZeneca-2024A194309$ASTRAZENECA$$$$$F$Y$$$20240829$$MD$ZA$
242643871$24264387$1$I$20240101$20240827$20240829$20240829$EXP$FI-FIMEA-202403014$FI-ORGANON-O2408FIN001975$ORGANON$$61$YR$$F$Y$$$20240829$$MD$FI$FI
242643881$24264388$1$I$20180605$20240823$20240829$20240829$EXP$$AU-TAKEDA-2024TUS086420$TAKEDA$$63$YR$$F$Y$$$20240829$$MD$AU$AU
242643891$24264389$1$I$$20240822$20240829$20240829$EXP$$GB-TAKEDA-2024TUS086747$TAKEDA$$$$$$Y$$$20240829$$CN$GB$GB
242643901$24264390$1$I$$20240822$20240829$20240829$EXP$$US-AstraZeneca-2024A195791$ASTRAZENECA$$$$$F$Y$$$20240829$$MD$US$
242643911$24264391$1$I$20240821$20240826$20240829$20240829$EXP$$CN-AstraZeneca-2024A195239$ASTRAZENECA$$88$YR$$F$Y$$$20240829$$MD$CN$
242643921$24264392$1$I$$20240828$20240829$20240829$EXP$$US-AstraZeneca-2024A197079$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
242643931$24264393$1$I$20240630$20240827$20240829$20240829$EXP$FR-AFSSAPS-MA2024001009$FR-ABBVIE-5896339$ABBVIE$$50$YR$$M$Y$$$20240829$$MD$FR$FR
242643941$24264394$1$I$$20240826$20240829$20240829$EXP$$US-AstraZeneca-2024A194932$ASTRAZENECA$$81$YR$$M$Y$$$20240829$$MD$US$
242643951$24264395$1$I$20240820$20240822$20240829$20240829$EXP$$US-AstraZeneca-2024A192455$ASTRAZENECA$$25157$DY$$F$Y$$$20240829$$CN$US$
242643961$24264396$1$I$$20240826$20240829$20240829$EXP$$ES-ANIPHARMA-2024-ES-000092$ANI$$46$YR$$M$Y$$$20240829$$MD$ES$ES
242643971$24264397$1$I$20240101$20240821$20240829$20240829$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00389$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242643981$24264398$1$I$$20240821$20240829$20240829$EXP$$GB-AstraZeneca-2024A190653$ASTRAZENECA$$82$YR$$M$Y$83$KG$20240829$$MD$GB$
242643991$24264399$1$I$$20240820$20240829$20240829$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007334$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240829$$MD$DE$DE
242644001$24264400$1$I$20220201$20240822$20240829$20240829$EXP$$CH-SANDOZ INC.-NVSC2022CH210768$SANDOZ$$54$YR$$F$Y$$$20240829$$MD$CH$CH
242644011$24264401$1$I$20240101$20240823$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-026635$UNITED THERAPEUTICS$$$$$M$Y$63.492$KG$20240829$$$US$US
242644021$24264402$1$I$20240531$20240824$20240829$20240829$EXP$$CA-TAKEDA-2024TUS060721$TAKEDA$$45$YR$$F$Y$$$20240829$$CN$CA$CA
242644031$24264403$1$I$20211018$20240827$20240829$20240829$EXP$$CA-TAKEDA-2024TUS020656$TAKEDA$$55$YR$$F$Y$$$20240829$$MD$CA$CA
242644041$24264404$1$I$$20240809$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08059$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242644051$24264405$1$I$$20240820$20240829$20240829$PER$$US-ROCHE-10000064464$ROCHE$$$$$$Y$$$20240829$$CN$US$US
242644061$24264406$1$I$$20240827$20240829$20240829$30DAY$$IT-SANDOZ INC.-SDZ2024IT032634$SANDOZ$$13$YR$$F$Y$$$20240829$$CN$IT$IT
242644071$24264407$1$I$$20240814$20240829$20240829$EXP$$US-ASTELLAS-2024-AER-000819$ASTELLAS$Attieh RM, Oring J. Case Report: Early-Onset Adenovirus Nephritis Without Hemorrhagic Cystitis Following Kidney Transplantation. Transplantation Proceedings. 2024;56(5): 1196-9. doi:10.1016/j.transproceed.2024.05.018.$35$YR$A$M$Y$$$20240828$$HP$US$US
242644082$24264408$2$F$$20240923$20240829$20240925$EXP$$NVSC2024US173568$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
242644091$24264409$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142313$DAIICHI$$$$$F$Y$$$20240829$$MD$CA$CA
242644101$24264410$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142319$DAIICHI$$$$$F$Y$79$KG$20240829$$CN$CA$CA
242644111$24264411$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142302$DAIICHI$$$$$F$Y$$$20240829$$MD$CA$CA
242644121$24264412$1$I$$20240827$20240829$20240829$PER$$US-HALEON-2194220$Haleon PLC$$$$$$Y$$$20240829$$CN$US$US
242644131$24264413$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142322$DAIICHI$$$$$F$Y$$$20240829$$MD$CA$CA
242644141$24264414$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142285$DAIICHI$$$$$F$Y$$$20240829$$CN$CA$CA
242644151$24264415$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142296$DAIICHI$$$$$F$Y$$$20240829$$CN$CA$CA
242644161$24264416$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142289$DAIICHI$$$$$F$Y$58$KG$20240829$$MD$CA$CA
242644171$24264417$1$I$$20240828$20240829$20240829$EXP$$ZA-SANDOZ INC.-PHHY2018ZA005899$SANDOZ$$30$YR$$F$Y$$$20240829$$MD$ZA$ZA
242644182$24264418$2$F$$20240902$20240829$20240913$EXP$$JP-ASTELLAS-2024-AER-000527$ASTELLAS$$77$YR$E$M$Y$$$20240913$$PH$JP$JP
242644192$24264419$2$F$$20240903$20240829$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408017061$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240905$$CN$US$US
242644201$24264420$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59433$$FDA-CTU$$51$YR$$F$N$187$LBS$20240828$N$$US$
242644212$24264421$2$F$20240101$20240829$20240829$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-023003$UNITED THERAPEUTICS$$$$$F$Y$65.76$KG$20240903$$$US$US
242644221$24264422$1$I$$20240823$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-026675$UNITED THERAPEUTICS$$$$$M$Y$92.971$KG$20240829$$$US$US
242644231$24264423$1$I$$20240828$20240829$20240829$PER$$US-JNJFOC-20240873593$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$PH$US$US
242644241$24264424$1$I$20240516$20240827$20240829$20240829$EXP$FR-AFSSAPS-DJ2024000890$FR-JNJFOC-20240875608$JOHNSON AND JOHNSON$$15$YR$T$M$Y$61$KG$20240829$$MD$FR$FR
242644251$24264425$1$I$20240827$20240828$20240828$20240828$DIR$716284$$FDA-CTU$$69$YR$$M$N$$$20240828$N$$US$
242644261$24264426$1$I$$20240828$20240828$20240828$DIR$716278$$FDA-CTU$$$$$UNK$N$$$20240828$N$CN$US$
242644281$24264428$1$I$$20240816$20240829$20240829$EXP$NL-LRB-00990443$NL-ASTELLAS-2024-AER-001730$ASTELLAS$$82$YR$E$F$Y$70$KG$20240828$$CN$NL$NL
242644291$24264429$1$I$$20240823$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-026654$UNITED THERAPEUTICS$$$$$F$Y$60.317$KG$20240829$$$US$US
242644301$24264430$1$I$$20240828$20240829$20240829$PER$$US-ROCHE-10000068389$ROCHE$$$$C$M$Y$$$20240829$$CN$US$US
242644311$24264431$1$I$20240812$20240828$20240829$20240829$PER$$US-ROCHE-10000068755$ROCHE$$29$YR$A$M$Y$62.14$KG$20240829$$CN$US$US
242644321$24264432$1$I$$20240828$20240828$20240828$DIR$716283$$FDA-CTU$$44$YR$$F$N$$$20240828$Y$$US$
242644331$24264433$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59506$$FDA-CTU$$56$YR$$F$N$152$LBS$20240828$N$$US$
242644341$24264434$1$I$$20240828$20240828$20240828$DIR$716302$$FDA-CTU$$$$$UNK$N$$$20240828$$CN$US$
242644361$24264436$1$I$20240813$20240823$20240829$20240829$EXP$FR-AFSSAPS-BX2024001672$FR-MYLANLABS-2024M1078372$MYLAN$$54$YR$$M$Y$$$20240829$$MD$FR$FR
242644371$24264437$1$I$$20240722$20240829$20240829$30DAY$$ES-SA-2024SA251881$SANOFI AVENTIS$$$$A$$Y$$$20240829$$HP$ES$ES
242644381$24264438$1$I$$20240820$20240829$20240829$EXP$$JP-ASTELLAS-2024-AER-001080$ASTELLAS$$83$YR$E$M$Y$$$20240828$$MD$JP$JP
242644391$24264439$1$I$$20240828$20240828$20240828$DIR$716268$$FDA-CTU$$7$YR$$M$N$$$20240828$N$PH$US$
242644401$24264440$1$I$20240705$20240822$20240829$20240829$EXP$$CN-GSK-CN2024APC105148$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$HP$CN$CN
242644421$24264442$1$I$$20240828$20240829$20240829$EXP$$TR-SANDOZ INC.-SDZ2024TR075906$SANDOZ$$60$YR$$M$Y$$$20240829$$MD$TR$TR
242644431$24264443$1$I$$20240822$20240829$20240829$EXP$$US-TAKEDA-2024TUS085259$TAKEDA$$$$$M$Y$$$20240829$$MD$US$US
242644441$24264444$1$I$20150701$20240828$20240829$20240829$EXP$PL-MLMSERVICE-20160804-0380260-1$PL-SANDOZ INC.-SDZ2024PL076124$SANDOZ$$65$YR$$M$Y$$$20240829$$MD$PL$PL
242644452$24264445$2$F$$20240903$20240829$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07920$LUPIN$$$$$$Y$$$20240920$$CN$US$US
242644461$24264446$1$I$$20240828$20240829$20240829$PER$$US-ROCHE-10000068799$ROCHE$$$$C$M$Y$$$20240829$$CN$US$US
242644471$24264447$1$I$20240814$20240823$20240829$20240829$EXP$$CN-PURDUE-USA-2024-0311653$PURDUE$$67$YR$$F$Y$50$KG$20240829$$HP$CN$CN
242644481$24264448$1$I$20231201$20240828$20240829$20240829$EXP$$US-PURDUE PHARMA-USA-2024-0311642$PURDUE$$17$YR$$M$Y$$$20240829$$CN$US$US
242644491$24264449$1$I$20240812$20240823$20240829$20240829$EXP$$CN-PURDUE-USA-2024-0311662$PURDUE$$76$YR$$M$Y$50$KG$20240829$$HP$CN$CN
242644511$24264451$1$I$$20240819$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-132125$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240829$$HP$CA$CA
242644531$24264453$1$I$$20240828$20240829$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA075921$SANDOZ$$6$DEC$$M$Y$$$20240829$$MD$CA$CA
242644541$24264454$1$I$$20240828$20240829$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA076223$SANDOZ$$$$$F$Y$$$20240829$$CN$CA$CA
242644552$24264455$2$F$$20240821$20240829$20240916$PER$$US-SA-2024SA250064$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240916$$HP$US$US
242644561$24264456$1$I$$20240828$20240828$20240828$DIR$716286$$FDA-CTU$$$$$UNK$N$$$20240828$N$CN$US$
242644571$24264457$1$I$20240826$20240828$20240828$20240828$DIR$716287$$FDA-CTU$$35$YR$$F$N$83.25$KG$20240828$$CN$US$
242644581$24264458$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59436$$FDA-CTU$$37$YR$$F$N$307$LBS$20240828$N$$US$
242644591$24264459$1$I$20240828$20240828$20240828$20240828$DIR$716285$$FDA-CTU$$78$YR$$F$N$76.5$KG$20240828$Y$CN$US$
242644601$24264460$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59518$$FDA-CTU$$48$YR$$F$N$195$LBS$20240828$N$$US$
242644621$24264462$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59422$$FDA-CTU$$43$YR$$F$N$87.09$KG$20240828$N$$US$
242644631$24264463$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59514$$FDA-CTU$$51$YR$$F$N$$$20240828$N$$US$
242644642$24264464$2$F$20171110$20240913$20240829$20240925$EXP$$JP-ASTELLAS-2024-AER-000287$ASTELLAS$$24$YR$A$F$Y$$$20240925$$MD$JP$JP
242644652$24264465$2$F$20240101$20240829$20240829$20240903$EXP$$US-ABBVIE-5893325$ABBVIE$$$$$F$Y$132$KG$20240903$$CN$US$US
242644662$24264466$2$F$$20240903$20240829$20240906$EXP$$DE-MFDS-2021000061-2408DEU009369$MERCK$Groth O, Roider G, Graw M. Drug-induced deaths in renal impairment. Munchener Medizinische Wochenschrift - Fortschritte der Medizin. 2024;166 (13):48-51$67$YR$$M$Y$$$20240906$$HP$DE$DE
242644671$24264467$1$I$$20240731$20240829$20240829$PER$$US-009507513-2408USA000281$MERCK$Estes W, Latt LD, Robishaw-Denton J, Repp ML, Suri Y, Chadaz T, et al.. Musculoskeletal manifestations of lower-extremity coccidioidomycosis: a case series. Journal of Bone and Joint Infection. 2024;9(4):197-205$41$YR$$M$Y$$$20240829$$HP$US$US
242644683$24264468$3$F$20240802$20240905$20240829$20240917$PER$$US-ASTELLAS-2024US023030$ASTELLAS$$69$YR$E$F$Y$$$20240917$$MD$US$US
242644691$24264469$1$I$20240801$20240822$20240829$20240829$EXP$$US-ABBVIE-5892246$ABBVIE$$73$YR$$M$Y$$$20240829$$CN$US$US
242644701$24264470$1$I$20240101$20240826$20240829$20240829$PER$$US-UNITED THERAPEUTICS-UNT-2024-026809$UNITED THERAPEUTICS$$$$$F$Y$55.329$KG$20240829$$$US$US
242644711$24264471$1$I$20230101$20240823$20240829$20240829$EXP$$US-ABBVIE-5342963$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242644721$24264472$1$I$20240823$20240826$20240829$20240829$PER$$US-TEVA-VS-3237561$TEVA$$76$YR$$F$Y$$$20240829$$CN$US$US
242644741$24264474$1$I$$20240826$20240829$20240829$EXP$$US-ABBVIE-5896637$ABBVIE$$$$$$Y$$$20240829$$CN$US$US
242644751$24264475$1$I$$20240819$20240829$20240829$EXP$$CA-JNJFOC-20230310443$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240829$$HP$CA$CA
242644771$24264477$1$I$$20240818$20240829$20240829$EXP$$KR-JNJFOC-20240850087$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$MD$KR$US
242644791$24264479$1$I$20240501$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137694$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240829$$CN$US$US
242644801$24264480$1$I$20240601$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136843$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$66.22$KG$20240829$$CN$US$US
242644811$24264481$1$I$20240415$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137707$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240829$$CN$US$US
242644821$24264482$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59510$$FDA-CTU$$69$YR$$F$N$$$20240828$N$$US$
242644831$24264483$1$I$20070101$20240827$20240829$20240829$EXP$$SK-SANDOZ INC.-PHHY2018SK080314$SANDOZ$$29$YR$$M$Y$$$20240829$$MD$SK$SK
242644841$24264484$1$I$20240101$20240826$20240829$20240829$EXP$$US-ABBVIE-5898220$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242644851$24264485$1$I$20240708$20240828$20240828$20240828$DIR$716294$$FDA-CTU$$49$YR$$F$N$103.5$KG$20240828$N$CN$US$
242644861$24264486$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59458$$FDA-CTU$$82$YR$$F$N$54.43$KG$20240828$N$$US$
242644871$24264487$1$I$20191201$20240829$20240829$20240829$EXP$BG-EMA-DD-20240826-7482827-083236$NVSC2024BG174169$NOVARTIS$$53$YR$$F$Y$54$KG$20240829$$MD$BG$BG
242644881$24264488$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59469$$FDA-CTU$$41$YR$$F$N$$$20240828$N$$US$
242644891$24264489$1$I$20240826$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59477$$FDA-CTU$$79$YR$$M$N$$$20240828$N$PH$US$
242644901$24264490$1$I$20240813$20240824$20240829$20240829$PER$$US-TAKEDA-2024TUS085624$TAKEDA$$57$YR$$F$Y$98.87$KG$20240829$$PH$US$US
242644911$24264491$1$I$20240807$20240820$20240829$20240829$EXP$$GB-ASTELLAS-2024-AER-000600$ASTELLAS$$85$YR$E$F$Y$49$KG$20240828$$HP$GB$GB
242644921$24264492$1$I$20240826$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171568$AMGEN$$$$$$Y$$$20240829$$HP$US$US
242644931$24264493$1$I$$20240827$20240829$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US075771$SANDOZ$$$$$M$Y$$$20240829$$HP$US$US
242644942$24264494$2$F$$20240827$20240829$20240917$EXP$$CA-ORGANON-O2408CAN002022$ORGANON$$43$YR$$F$Y$$$20240917$$HP$CA$CA
242644951$24264495$1$I$20240701$20240814$20240829$20240829$EXP$CH-SM-2024-14889$CH-UCBSA-2024041687$UCB$$59$YR$$F$Y$75.75$KG$20240829$$PH$CH$CH
242644961$24264496$1$I$20240301$20240823$20240829$20240829$EXP$$CA-JNJFOC-20240864854$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240829$$HP$CA$CA
242644971$24264497$1$I$$20240826$20240829$20240829$PER$$US-JNJFOC-20240869033$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242644981$24264498$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142250$DAIICHI$$42$YR$$$Y$102$KG$20240829$$MD$CA$CA
242644991$24264499$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142230$DAIICHI$$$$$F$Y$$$20240829$$MD$CA$CA
242645001$24264500$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142266$DAIICHI$$$$$F$Y$$$20240829$$CN$CA$CA
242645011$24264501$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142240$DAIICHI$$51$YR$$F$Y$$$20240829$$MD$CA$CA
242645021$24264502$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142259$DAIICHI$$$$$F$Y$84$KG$20240829$$MD$CA$CA
242645031$24264503$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142263$DAIICHI$$$$$F$Y$$$20240829$$CN$CA$CA
242645041$24264504$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142227$DAIICHI$$$$$F$Y$65$KG$20240829$$MD$CA$CA
242645051$24264505$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142262$DAIICHI$$$$$F$Y$70$KG$20240829$$MD$CA$CA
242645061$24264506$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142278$DAIICHI$$56$YR$$F$Y$$$20240829$$CN$CA$CA
242645071$24264507$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142270$DAIICHI$$77$YR$$F$Y$$$20240829$$CN$CA$CA
242645081$24264508$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142231$DAIICHI$$$$$F$Y$$$20240829$$MD$CA$CA
242645091$24264509$1$I$$20240822$20240829$20240829$EXP$$US-GSK-US2024105098$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$US$US
242645101$24264510$1$I$$20240820$20240829$20240829$EXP$$JP-TERSERA THERAPEUTICS LLC-2024TRS004358$TERSERA THERAPEUTICS$$$$$$Y$$$20240829$$PH$JP$JP
242645111$24264511$1$I$20240711$20240826$20240829$20240829$EXP$$US-AstraZeneca-2024A194187$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
242645121$24264512$1$I$$20240826$20240829$20240829$EXP$$US-AstraZeneca-2024A195123$ASTRAZENECA$$78$YR$$F$Y$84.6$KG$20240829$$CN$US$
242645131$24264513$1$I$$20240821$20240829$20240829$EXP$$ZA-AstraZeneca-2024A191884$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$ZA$
242645141$24264514$1$I$$20240826$20240829$20240829$EXP$$BR-AstraZeneca-2024A196831$ASTRAZENECA$$$$$F$Y$$$20240829$$CN$BR$
242645152$24264515$2$F$$20240918$20240829$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135812$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240920$$CN$US$US
242645161$24264516$1$I$20240801$20240821$20240829$20240829$EXP$$IE-AstraZeneca-2024A194736$ASTRAZENECA$$25457$DY$$F$Y$$$20240829$$HP$IE$
242645172$24264517$2$F$20240827$20240909$20240829$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137000$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240912$$CN$US$US
242645191$24264519$1$I$$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135544$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240829$$HP$US$US
242645201$24264520$1$I$$20240814$20240829$20240829$PER$$US-ASTELLAS-2024-AER-000769$ASTELLAS$$55$YR$A$M$Y$$$20240828$$HP$US$US
242645211$24264521$1$I$20240709$20240820$20240829$20240829$EXP$FR-AFSSAPS-NT2024001050$FR-TEVA-VS-3235243$TEVA$$70$YR$$F$Y$52$KG$20240829$$PH$FR$FR
242645221$24264522$1$I$20240801$20240826$20240829$20240829$PER$$US-BIOGEN-2024BI01279998$BIOGEN$$35$YR$$F$Y$$$20240829$$CN$US$US
242645232$24264523$2$F$$20240904$20240829$20240910$EXP$$CA-INCYTE CORPORATION-2024IN009012$INCYTE$$$$$$Y$$$20240910$$MD$CA$CA
242645241$24264524$1$I$20240825$20240826$20240829$20240829$PER$$US-BIOGEN-2024BI01280031$BIOGEN$$64$YR$$F$Y$$$20240829$$CN$US$US
242645253$24264525$3$F$20240703$20240911$20240829$20240918$EXP$$US-BIOGEN-2024BI01280041$BIOGEN$$62$YR$$F$Y$$$20240918$$CN$US$US
242645261$24264526$1$I$$20240826$20240829$20240829$PER$$US-BIOGEN-2024BI01280021$BIOGEN$$$$$M$Y$$$20240829$$CN$US$US
242645281$24264528$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59446$$FDA-CTU$$68$YR$$M$N$$$20240828$N$$US$
242645301$24264530$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59517$$FDA-CTU$$40$YR$$F$N$$$20240828$N$$US$
242645311$24264531$1$I$20240610$20240828$20240829$20240829$EXP$$AU-ABBVIE-5844300$ABBVIE$$15$YR$$$Y$$$20240829$$MD$AU$AU
242645321$24264532$1$I$20240727$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59522$$FDA-CTU$$57$YR$$M$N$86$KG$20240828$N$PH$US$
242645331$24264533$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59493$$FDA-CTU$$43$YR$$M$N$$$20240828$N$$US$
242645341$24264534$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59515$$FDA-CTU$$46$YR$$F$N$$$20240828$N$$US$
242645361$24264536$1$I$20240818$20240828$20240828$20240828$DIR$716299$$FDA-CTU$$55$YR$$F$N$71.3$KG$20240828$N$PH$US$
242645371$24264537$1$I$$20240828$20240828$20240828$DIR$716308$$FDA-CTU$$$$$UNK$N$$$20240828$N$CN$US$
242645381$24264538$1$I$$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59511$$FDA-CTU$$$$$F$N$$$20240827$N$HP$US$
242645391$24264539$1$I$20240530$20240826$20240829$20240829$EXP$$SK-ABBVIE-5897952$ABBVIE$$43$YR$$F$Y$$$20240829$$MD$SK$SK
242645401$24264540$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59528$$FDA-CTU$$77$YR$$M$N$$$20240828$N$$US$
242645421$24264542$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59512$$FDA-CTU$$79$YR$$M$N$$$20240828$N$$US$
242645431$24264543$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59395$$FDA-CTU$$78$YR$$F$N$$$20240828$N$$US$
242645441$24264544$1$I$20240822$20240828$20240828$20240828$DIR$716277$$FDA-CTU$$71$YR$$F$N$90$KG$20240828$N$CN$US$
242645451$24264545$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59455$$FDA-CTU$$81$YR$$M$N$$$20240828$N$$US$
242645461$24264546$1$I$20240805$20240820$20240829$20240829$EXP$$CN-JNJFOC-20240860003$JOHNSON AND JOHNSON$$67$YR$E$F$Y$43$KG$20240829$$HP$CN$CN
242645471$24264547$1$I$$20240828$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US075955$SANDOZ$$28$YR$$F$Y$$$20240829$$HP$US$US
242645481$24264548$1$I$$20240826$20240829$20240829$EXP$$CA-OTSUKA-2024_023676$OTSUKA$$51$YR$$F$Y$$$20240829$$PH$CA$CA
242645491$24264549$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59489$$FDA-CTU$$68$YR$$F$N$$$20240828$N$$US$
242645501$24264550$1$I$20240806$20240822$20240829$20240829$EXP$$CN-009507513-2408CHN009109$MERCK$$40$YR$$F$Y$$$20240829$$HP$CN$CN
242645511$24264551$1$I$20240828$20240828$20240828$20240828$DIR$716279$$FDA-CTU$$50$YR$$F$N$$$20240828$Y$$US$
242645521$24264552$1$I$$20240828$20240828$20240828$DIR$716301$$FDA-CTU$$$$$UNK$N$$$20240828$$CN$US$
242645531$24264553$1$I$20240708$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171676$AMGEN$$$$$F$Y$$$20240829$$PH$US$US
242645541$24264554$1$I$$20240826$20240829$20240829$EXP$$IT-SANDOZ INC.-SDZ2024IT075259$SANDOZ$$$$$F$Y$$$20240829$$HP$IT$IT
242645551$24264555$1$I$$20240820$20240829$20240829$PER$$US-ROCHE-2764278$ROCHE$Puing A, Couture-Cossette A, Wang A, Zygourakis C, Cheng X, Stevens B, Banaei N, Novoa R, Ho D and Subramanian A Simultaneous coccidioidomycosis and phaeohyphomycosis in a kidney transplant recipient: A case report and literature review. Transplant Infectious Disease 2020 Dec;22 (6):1-5.$64$YR$A$M$Y$$$20240829$$HP$US$US
242645561$24264556$1$I$$20240827$20240829$20240829$EXP$$NVSC2024US173751$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
242645571$24264557$1$I$$20240814$20240829$20240829$EXP$$IN-AZURITY PHARMACEUTICALS, INC.-AZR202408-000424$AZURITY PHARMACEUTICALS$Princy R, Neethu R.. Methotrexate-Induced Mucositis Due to Accidental Overdose; a Case Report. Afr. J. Biol. Sci.. 2024;6:3:700-3$71$YR$$F$Y$$$20240829$$HP$IN$IN
242645581$24264558$1$I$$20240820$20240829$20240829$EXP$$BE-INCYTE CORPORATION-2024IN009023$INCYTE$Kik AE, Kuylen MV, Bailly B, Fallas J, Bondue B. Unusual cause of dyspnea in patient with Myelofibrosis: The Ruxolitinib lung. RESPIRATORY MEDICINE CASE REPORTS. 2024;51:1-4$$$$$Y$$$20240829$$HP$BE$BE
242645591$24264559$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142206$DAIICHI$$$$$F$Y$63$KG$20240829$$CN$CA$CA
242645601$24264560$1$I$$20240816$20240829$20240829$EXP$$US-ASTELLAS-2024-AER-001786$ASTELLAS$Fasanya-Maku H. A case of metastatic HPV-related cervical small cell neuroendocrine carcinoma with varying cytomorphology found in cytological specimens of a solid organ transplant recipient. Diagnostic Cytopathology. 2024;9(52): E202-7. doi:10.1002/dc.25361.$53$YR$A$F$Y$$$20240829$$MD$US$US
242645611$24264561$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142226$DAIICHI$$$$$F$Y$$$20240829$$CN$CA$CA
242645621$24264562$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142210$DAIICHI$$$$$F$Y$$$20240829$$CN$CA$CA
242645631$24264563$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142224AA$DAIICHI$$66$YR$$F$Y$$$20240829$$CN$CA$CA
242645641$24264564$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142215$DAIICHI$$45$YR$$F$Y$$$20240829$$CN$CA$CA
242645651$24264565$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142208$DAIICHI$$$$$F$Y$46$KG$20240829$$HP$CA$CA
242645661$24264566$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142202$DAIICHI$$52$YR$$F$Y$77$KG$20240829$$CN$CA$CA
242645671$24264567$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142204$DAIICHI$$$$$F$Y$$$20240829$$MD$CA$CA
242645681$24264568$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142220$DAIICHI$$75$YR$$F$Y$$$20240829$$MD$CA$CA
242645691$24264569$1$I$$20240819$20240829$20240829$EXP$$CA-DSJP-DSJ-2024-142218$DAIICHI$$$$$F$Y$$$20240829$$MD$CA$CA
242645702$24264570$2$F$20240101$20240828$20240829$20240904$EXP$$GB-ABBVIE-5899415$ABBVIE$$73$YR$$M$Y$$$20240904$$CN$GB$GB
242645713$24264571$3$F$$20240924$20240829$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA075924$SANDOZ$$60$YR$$F$Y$$$20240925$$CN$CA$CA
242645721$24264572$1$I$$20240819$20240829$20240829$30DAY$$US-GSK-US2024AMR103698$GLAXOSMITHKLINE$$$$$F$Y$$$20240829$$CN$US$US
242645732$24264573$2$F$$20240909$20240829$20240916$EXP$$US-GSK-US2024AMR105341$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
242645741$24264574$1$I$$20240805$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07933$LUPIN$$$$$$Y$$$20240829$$PH$US$US
242645751$24264575$1$I$$20240813$20240829$20240829$PER$$US-ASTELLAS-2024-AER-001118$ASTELLAS$$82$YR$E$F$Y$$$20240829$$CN$US$US
242645771$24264577$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136861$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$64.86$KG$20240829$$CN$US$US
242645782$24264578$2$F$$20240912$20240829$20240912$PER$$US-ALXN-202408USA001544US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240912$$MD$US$US
242645791$24264579$1$I$20200201$20240822$20240829$20240829$EXP$$PL-AMGEN-POLSP2024168109$AMGEN$$43$YR$A$M$Y$$$20240829$$HP$PL$PL
242645801$24264580$1$I$20240826$20240826$20240829$20240829$EXP$$US-OTSUKA-2024_023535$OTSUKA$$$$$F$Y$$$20240829$$CN$US$US
242645811$24264581$1$I$20240815$20240829$20240829$20240829$EXP$$RU-SANDOZ INC.-SDZ2024RU076260$SANDOZ$$$$$F$Y$78$KG$20240829$$MD$RU$RU
242645821$24264582$1$I$20240701$20240823$20240829$20240829$EXP$$CO-ABBVIE-5898744$ABBVIE$$75$YR$$M$Y$62$KG$20240829$$HP$CO$CO
242645831$24264583$1$I$20240404$20240826$20240829$20240829$EXP$PT-INFARMED-B202404-607$PT-DAIICHI SANKYO, INC.-DSE-2024-119301$DAIICHI$$29$YR$$F$Y$$$20240829$$MD$PT$PT
242645842$24264584$2$F$20230717$20240823$20240829$20240906$EXP$FR-AFSSAPS-BX2024001677$FR-ASTELLAS-2024-AER-002155$ASTELLAS$$68$YR$E$M$Y$75$KG$20240906$$PH$FR$FR
242645851$24264585$1$I$20240701$20240816$20240829$20240829$EXP$$JP-ASTELLAS-2024-AER-000045$ASTELLAS$$$$$F$Y$$$20240827$$CN$JP$JP
242645862$24264586$2$F$$20240820$20240829$20240829$PER$$US-ASTELLAS-2024-AER-002214$ASTELLAS$$$$$F$Y$$$20240827$$MD$US$US
242645871$24264587$1$I$$20240819$20240829$20240829$EXP$$JP-ASTELLAS-2024JP002112$ASTELLAS$$9$DEC$E$M$Y$$$20240827$$MD$JP$JP
242645891$24264589$1$I$$20240814$20240829$20240829$EXP$$CN-ASTELLAS-2024-AER-001787$ASTELLAS$$$$$$Y$$$20240828$$MD$CN$CN
242645902$24264590$2$F$$20240822$20240829$20240909$PER$$US-ASTELLAS-2024-AER-000382$ASTELLAS$$$$A$F$Y$$$20240909$$MD$US$US
242645911$24264591$1$I$20240603$20240827$20240829$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US076013$SANDOZ$$68$YR$$M$Y$$$20240829$$HP$US$US
242645921$24264592$1$I$$20240819$20240829$20240829$PER$$US-MYLANLABS-2024M1077344$MYLAN$$$$$F$Y$68.04$KG$20240829$$CN$US$US
242645932$24264593$2$F$20240426$20240813$20240829$20240903$PER$$US-ASTELLAS-2024US013037$ASTELLAS$$81$YR$E$M$Y$$$20240830$$CN$US$US
242645941$24264594$1$I$$20240820$20240829$20240829$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00919$CATALYST PHARMA$$$$$F$Y$52.154$KG$20240829$$CN$US$US
242645951$24264595$1$I$20240301$20240823$20240829$20240829$EXP$$JP-DSJP-DSJ-2024-126499$DAIICHI$$72$YR$$$Y$$$20240829$$MD$JP$JP
242645961$24264596$1$I$20240814$20240825$20240829$20240829$EXP$$CN-DSJP-DSJ-2024-142003$DAIICHI$$49$YR$$F$Y$59$KG$20240829$$HP$CN$CN
242645972$24264597$2$F$$20240909$20240829$20240912$PER$$US-BAYER-2024A124008$BAYER$$$$$F$Y$$$20240912$$CN$US$US
242645983$24264598$3$F$$20240911$20240829$20240917$EXP$$CN-AstraZeneca-2024A194256$ASTRAZENECA$$77$YR$$F$Y$$$20240917$$CN$CN$
242645992$24264599$2$F$20220101$20240909$20240829$20240917$EXP$$JP-AstraZeneca-2024A193926$ASTRAZENECA$$49$YR$$M$Y$107$KG$20240917$$MD$JP$
242646002$24264600$2$F$20240624$20240910$20240829$20240913$EXP$$BE-AstraZeneca-2024A193821$ASTRAZENECA$$85$YR$$M$Y$$$20240913$$MD$BE$
242646011$24264601$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137045$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240829$$PH$US$US
242646021$24264602$1$I$20240729$20240828$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137755$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240829$$CN$US$US
242646031$24264603$1$I$20240824$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136190$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$80.74$KG$20240829$$CN$US$US
242646042$24264604$2$F$20240810$20240829$20240829$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137231$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240903$$CN$US$US
242646051$24264605$1$I$$20240819$20240829$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-136932$BRISTOL MYERS SQUIBB$Nakamura S, et al. A case of bone marrow fibrosis during treatment of AML-MR with a single deletion of 5q. The 25th Annual Meeting of the Japanese Society of Laboratory Hematology.$5$DEC$A$M$Y$$$20240829$$HP$JP$JP
242646061$24264606$1$I$$20240828$20240828$20240828$DIR$716313$$FDA-CTU$$$$$UNK$N$$$20240828$N$CN$US$
242646071$24264607$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59505$$FDA-CTU$$60$YR$$F$N$$$20240828$N$$US$
242646091$24264609$1$I$20240802$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59461$$FDA-CTU$$80$YR$$M$N$$$20240828$N$HP$US$
242646101$24264610$1$I$$20240828$20240828$20240828$DIR$716317$$FDA-CTU$$$$$UNK$N$$$20240828$N$CN$US$
242646111$24264611$1$I$20240828$20240828$20240828$20240828$DIR$716315$$FDA-CTU$$19$YR$$F$N$$$20240828$N$PH$US$
242646131$24264613$1$I$20240716$20240828$20240828$20240828$DIR$716318$$FDA-CTU$$62$YR$$M$N$92.25$KG$20240828$N$PH$US$
242646141$24264614$1$I$$20240828$20240828$20240828$DIR$716319$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
242646171$24264617$1$I$20240828$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59483$$FDA-CTU$$76$YR$$F$N$$$20240828$N$CN$US$
242646181$24264618$1$I$20240815$20240828$20240828$20240828$DIR$716322$$FDA-CTU$$64$YR$$F$N$76.5$KG$20240828$Y$CN$US$
242646191$24264619$1$I$20170630$20240828$20240828$20240828$DIR$716324$$FDA-CTU$$39$YR$$F$N$85.5$KG$20240828$N$CN$US$
242646201$24264620$1$I$$20240828$20240828$20240828$DIR$716333$$FDA-CTU$$$$$M$N$75.6$KG$20240828$N$$US$
242646211$24264621$1$I$20121004$20240828$20240828$20240828$DIR$716327$$FDA-CTU$$$$$UNK$N$$$20240828$N$CN$US$
242646222$24264622$2$F$20240809$20240902$20240829$20240905$EXP$$JP-AstraZeneca-2024A195249$ASTRAZENECA$$80$YR$$M$Y$$$20240905$$MD$JP$
242646231$24264623$1$I$20240101$20240822$20240829$20240829$EXP$GB-MHRA-MED-202408221136012750-FZHCR$GB-TEVA-VS-3236564$TEVA$$$$$M$Y$$$20240829$$PH$GB$GB
242646241$24264624$1$I$$20240821$20240829$20240829$EXP$$IT-AstraZeneca-2024A190487$ASTRAZENECA$Frezzini S., Tasca G., Borgato L., Sartor L., Ferrero A., Artioli G., Modena A., Baldoni A.. PARP INHIBITORS IN BRAIN METASTASES FROM EPITHELIAL OVARIAN CANCER THROUGH A MULTIMODAL PATIENT JOURNEY: CASE REPORTS AND LITERATURE REVIEW. International Journal of Molecular Sciences 2024;25(14):$52$YR$$F$Y$$$20240829$$HP$IT$
242646251$24264625$1$I$$20240826$20240829$20240829$EXP$$JP-AstraZeneca-2024A195840$ASTRAZENECA$$$$$$Y$$$20240829$$MD$JP$
242646261$24264626$1$I$$20240816$20240829$20240829$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16481$IPSEN$$$$$$Y$87.86$KG$20240829$$HP$US$US
242646271$24264627$1$I$$20240805$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07940$LUPIN$$$$$$Y$$$20240829$$PH$US$US
242646281$24264628$1$I$20240401$20240819$20240829$20240829$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048571$BOEHRINGER INGELHEIM$$44$YR$A$F$Y$$$20240829$$CN$US$US
242646291$24264629$1$I$20240101$20240827$20240829$20240829$EXP$$US-ABBVIE-5898907$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242646302$24264630$2$F$$20240912$20240829$20240923$EXP$$JP-FERRINGPH-2024FE04849$FERRING$$$$$$Y$$$20240923$$HP$JP$JP
242646311$24264631$1$I$20210101$20240820$20240829$20240829$EXP$$US-CATALYST PHARMACEUTICALS, INC-EC-2022-118843$CATALYST PHARMA$$$$$F$Y$72.109$KG$20240829$$CN$US$US
242646321$24264632$1$I$20230916$20240822$20240829$20240829$EXP$$JP-FERRINGPH-2024FE04808$FERRING$$$$$$Y$$$20240829$$MD$JP$JP
242646331$24264633$1$I$$20240819$20240829$20240829$EXP$$CN-FERRINGPH-2024FE04860$FERRING$$$$$$Y$$$20240829$$CN$CN$CN
242646341$24264634$1$I$$20240827$20240829$20240829$EXP$$CN-FERRINGPH-2024FE04863$FERRING$$$$$$Y$$$20240829$$CN$CN$CN
242646362$24264636$2$F$20240701$20240905$20240829$20240913$EXP$$JP-FERRINGPH-2024FE04270$FERRING$$$$$$Y$$$20240913$$PH$JP$JP
242646372$24264637$2$F$20240827$20240828$20240829$20240903$PER$$US-AMGEN-USASP2024171342$AMGEN$$54$YR$A$F$Y$$$20240902$$CN$US$US
242646381$24264638$1$I$$20240828$20240829$20240829$EXP$PH-MLMSERVICE-20230213-4100142-1$PH-SANDOZ INC.-SDZ2024PH076175$SANDOZ$$63$YR$$F$Y$$$20240829$$HP$PH$PH
242646391$24264639$1$I$20240801$20240821$20240829$20240829$EXP$$JP-AMGEN-JPNSP2024169935$AMGEN$$$$$$Y$$$20240829$$MD$JP$JP
242646401$24264640$1$I$$20240829$20240829$20240829$PER$$US-PROD-AS2-212756134-RB-082198-2024$RECKITT BENCKISER$$$$$F$Y$$$20240829$$CN$US$US
242646411$24264641$1$I$$20240828$20240829$20240829$PER$$US-BIOVITRUM-2024-US-010225$BIOVITRUM$$82$YR$$M$Y$$$20240829$$CN$US$US
242646421$24264642$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137737$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240829$$CN$US$US
242646431$24264643$1$I$20240814$20240820$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132527$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$68.1$KG$20240829$$PH$US$US
242646441$24264644$1$I$20240801$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136256$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$127.01$KG$20240829$$CN$US$US
242646451$24264645$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135563$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240829$$HP$US$US
242646461$24264646$1$I$$20240823$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135277$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240829$$CN$US$US
242646471$24264647$1$I$20230201$20240822$20240829$20240829$EXP$FR-AFSSAPS-MP2024001295$FR-009507513-2408FRA008199$MERCK$$67$YR$$M$Y$93$KG$20240829$$MD$FR$FR
242646481$24264648$1$I$$20240805$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07941$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242646491$24264649$1$I$20240720$20240822$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133879$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240829$$PH$US$US
242646501$24264650$1$I$$20240828$20240829$20240829$EXP$$NVSC2024US173876$NOVARTIS$$$$$M$Y$$$20240829$$CN$US$US
242646512$24264651$2$F$$20240912$20240829$20240912$PER$$US-ALXN-202408USA001559US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$MD$US$US
242646521$24264652$1$I$20240814$20240815$20240829$20240829$EXP$$CA-HLS-202402078$HLS THERAPEUTICS$$37$YR$A$M$Y$$$20240829$$CN$CA$CA
242646541$24264654$1$I$$20240823$20240829$20240829$EXP$$IT-MYLANLABS-2024M1078385$MYLAN$$36$YR$$M$Y$105$KG$20240829$$MD$IT$IT
242646551$24264655$1$I$20240722$20240820$20240829$20240829$EXP$$US-BAYER-2024A111228$BAYER$$63$YR$A$M$Y$$$20240829$$CN$US$US
242646561$24264656$1$I$20240801$20240819$20240829$20240829$EXP$$US-LEX-000446$LEXICON PHARMACEUTICALS$$97$YR$$M$Y$$$20240829$$CN$US$US
242646571$24264657$1$I$$20240827$20240829$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US075884$SANDOZ$$$$$M$Y$$$20240829$$CN$US$US
242646581$24264658$1$I$20210601$20240827$20240829$20240829$EXP$$DE-SANDOZ INC.-NVSC2022DE083187$SANDOZ$$55$YR$$F$Y$$$20240829$$MD$DE$DE
242646591$24264659$1$I$$20240823$20240829$20240829$EXP$GB-MHRA-MED-202408231918201240-SFTWV$GB-RDY-SPO/GBR/24/0012486$DR REDDYS$$4$YR$C$F$Y$16$KG$20240829$$CN$GB$GB
242646601$24264660$1$I$20240821$20240826$20240829$20240829$PER$$US-TAKEDA-2024TUS086620$TAKEDA$$31$YR$$F$Y$$$20240829$$CN$US$US
242646611$24264661$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135649$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240829$$CN$US$US
242646621$24264662$1$I$20240810$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137166$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$42.18$KG$20240829$$CN$US$US
242646631$24264663$1$I$20240827$20240828$20240828$20240828$DIR$716310$$FDA-CTU$$74$YR$$F$N$62.1$KG$20240828$N$PH$US$
242646641$24264664$1$I$20240828$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59527$$FDA-CTU$$55$YR$$M$N$$$20240828$Y$PH$US$
242646651$24264665$1$I$$20240820$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132731$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240829$$CN$US$US
242646662$24264666$2$F$$20240829$20240829$20240830$PER$$US-JNJFOC-20240876462$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242646671$24264667$1$I$20240824$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59513$$FDA-CTU$$64$YR$$F$N$$$20240828$Y$PH$US$
242646681$24264668$1$I$$20240826$20240829$20240829$PER$$US-JNJFOC-20240869557$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242646691$24264669$1$I$$20240828$20240829$20240829$PER$$US-HALEON-2194151$Haleon PLC$$$$$$Y$$$20240829$$CN$US$US
242646701$24264670$1$I$$20240805$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07942$LUPIN$$$$$$Y$$$20240829$$PH$US$US
242646711$24264671$1$I$$20240828$20240829$20240829$PER$$US-HALEON-2194201$Haleon PLC$$$$$$Y$$$20240829$$CN$US$US
242646722$24264672$2$F$20240101$20240828$20240829$20240910$PER$$US-BAYER-2024A123931$BAYER$$27$YR$A$F$Y$$$20240910$$MD$US$US
242646741$24264674$1$I$20240825$20240828$20240828$20240828$DIR$716331$$FDA-CTU$$27$YR$$F$N$117$KG$20240828$N$PH$US$
242646751$24264675$1$I$$20240819$20240829$20240829$PER$$US-AstraZeneca-2024A188978$ASTRAZENECA$$$$$$Y$$$20240829$$CN$US$
242646761$24264676$1$I$$20240826$20240829$20240829$EXP$$JP-AstraZeneca-2024A195836$ASTRAZENECA$$$$$$Y$$$20240829$$MD$JP$
242646771$24264677$1$I$$20240826$20240829$20240829$EXP$$JP-AstraZeneca-2024A195689$ASTRAZENECA$$$$$$Y$$$20240829$$MD$JP$
242646781$24264678$1$I$20240819$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017138$ELI LILLY AND CO$$64$YR$A$$Y$$$20240829$$CN$US$US
242646791$24264679$1$I$20210101$20240820$20240829$20240829$EXP$$US-CATALYST PHARMACEUTICALS, INC-EC-2022-112812$CATALYST PHARMA$$$$$F$Y$$$20240829$$CN$US$US
242646801$24264680$1$I$$20240824$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US075289$SANDOZ$$$$$$Y$$$20240829$$CN$US$US
242646811$24264681$1$I$$20240821$20240829$20240829$EXP$$US-PHARMING-PHAUS2024000724$PHARMING GROUP$$$$$$Y$$$20240829$$CN$US$US
242646822$24264682$2$F$$20240906$20240829$20240912$EXP$$US-PHARMING-PHAUS2024000731$PHARMING GROUP$$$$$$Y$$$20240912$$CN$US$US
242646831$24264683$1$I$$20240822$20240829$20240829$EXP$$CA-TEVA-VS-3236783$TEVA$$$$A$F$Y$$$20240829$$HP$CA$CA
242646841$24264684$1$I$$20240821$20240829$20240829$PER$$US-SA-2024SA249772$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240829$$CN$US$US
242646861$24264686$1$I$20240705$20240828$20240828$20240828$DIR$716336$$FDA-CTU$$76$YR$$F$N$99$KG$20240828$N$CN$US$
242646871$24264687$1$I$20240828$20240828$20240828$20240828$DIR$716311$$FDA-CTU$$66$YR$$M$N$69.75$KG$20240828$N$CN$US$
242646881$24264688$1$I$$20240809$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08097$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242646892$24264689$2$F$$20240902$20240829$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07982$LUPIN$$$$$$Y$$$20240919$$CN$US$US
242646901$24264690$1$I$20240430$20240828$20240828$20240828$DIR$716335$$FDA-CTU$$35$YR$$F$N$67.5$KG$20240828$N$CN$US$
242646911$24264691$1$I$20240701$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59410$$FDA-CTU$$48$YR$$M$N$$$20240828$N$HP$US$
242646921$24264692$1$I$$20240817$20240829$20240829$EXP$$DE-Accord-442732$ACCORD$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023,1-28.$$$$$Y$$$20240829$$MD$DE$DE
242646931$24264693$1$I$20240617$20240817$20240829$20240829$EXP$ES-AEMPS-1558386$ES-Accord-442681$ACCORD$$50$YR$A$M$Y$84$KG$20240829$$MD$ES$ES
242646941$24264694$1$I$20240727$20240817$20240829$20240829$EXP$FR-AFSSAPS-RS2024000793$FR-Accord-442685$ACCORD$$19$YR$A$M$Y$54$KG$20240829$$MD$FR$FR
242646951$24264695$1$I$$20240817$20240829$20240829$EXP$$DE-Accord-443858$ACCORD$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023,1-28.$$$N$$Y$$$20240829$$MD$DE$DE
242646961$24264696$1$I$20240810$20240817$20240829$20240829$EXP$GB-MHRA-MED-202408171121569570-KMTRW$GB-Accord-442494$ACCORD$$39$YR$A$F$Y$$$20240829$$CN$GB$GB
242646971$24264697$1$I$$20240817$20240829$20240829$EXP$$PT-Accord-442852$ACCORD$Dias F, E Silva AS, Alvarenga L, Sobral S, Lopes JG, Nzwalo H. PO-0658 - (4754)- ATRAS DO DRAGAO, A ENCEFALOPATIA -RELATO DE CASO CLINICO (PO-0658 - (4754) - BEHIND THE DRAGON, ENCEPHALOPATHY - CLINICAL CASE REPORT). Doencas cerebrovasculares e eurologicas / Caso clinico (Cerebrovascular and ne). 1003$33$YR$A$M$Y$$$20240829$$MD$PT$PT
242646982$24264698$2$F$$20240830$20240829$20240911$EXP$$DE-Accord-443857$ACCORD$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023,1-28.$3$DY$N$$Y$$$20240911$$MD$DE$DE
242646991$24264699$1$I$20230917$20240817$20240829$20240829$EXP$FR-AFSSAPS-PP2024000887$FR-Accord-442687$ACCORD$$23$YR$A$F$Y$60$KG$20240829$$PH$FR$FR
242647002$24264700$2$F$$20240827$20240829$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08171$LUPIN$$$$$$Y$$$20240918$$CN$US$US
242647011$24264701$1$I$$20240826$20240829$20240829$EXP$$GB-GSK-GB2024GSK106277$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$MD$GB$GB
242647021$24264702$1$I$$20240826$20240829$20240829$EXP$$GB-GSK-GB2024GSK106985$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$MD$GB$GB
242647032$24264703$2$F$$20240904$20240829$20240906$PER$$US-AMGEN-USASP2024170023$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242647041$24264704$1$I$$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171905$AMGEN$$$$$$Y$$$20240829$$CN$US$US
242647051$24264705$1$I$20240814$20240816$20240829$20240829$EXP$$CN-OTSUKA-2024_022805$OTSUKA$$14$YR$$F$Y$55$KG$20240829$$HP$CN$CN
242647061$24264706$1$I$$20240827$20240829$20240829$EXP$$JP-KYOWAKIRIN-2024KK020050$KYOWA$$$$$$Y$$$20240829$$HP$JP$JP
242647072$24264707$2$F$$20240827$20240829$20240904$30DAY$$US-GSK-US2024AMR106848$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$US$US
242647082$24264708$2$F$$20240927$20240829$20240930$EXP$$AR-PFIZER INC-202400245851$PFIZER$$66$YR$$M$Y$$$20240930$$CN$AR$AR
242647091$24264709$1$I$$20240828$20240829$20240829$EXP$$US-PFIZER INC-PV202400112507$PFIZER$$87$YR$$M$Y$$$20240829$$CN$US$US
242647111$24264711$1$I$20240827$20240828$20240829$20240829$EXP$$IN-PFIZER INC-PV202400110786$PFIZER$$54$YR$$$Y$$$20240829$$CN$IN$IN
242647121$24264712$1$I$$20240828$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US076120$SANDOZ$$63$YR$$M$Y$$$20240829$$MD$US$US
242647132$24264713$2$F$20200101$20240916$20240829$20240918$EXP$ES-ASTELLAS-2022US026364$ES-SANDOZ INC.-SDZ2024ES075452$SANDOZ$$62$YR$$F$Y$$$20240918$$HP$ES$ES
242647141$24264714$1$I$20240817$20240822$20240829$20240829$EXP$$US-GSK-US2024AMR105977$GLAXOSMITHKLINE$$57$YR$$F$Y$58.96$KG$20240829$$CN$US$US
242647151$24264715$1$I$$20240821$20240829$20240829$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-00917$CATALYST PHARMA$$$$$M$Y$$$20240829$$CN$US$US
242647161$24264716$1$I$20240824$20240828$20240828$20240828$DIR$716329$$FDA-CTU$$68$YR$$M$N$$$20240828$N$CN$US$
242647171$24264717$1$I$$20240819$20240829$20240829$PER$$US-SA-2024SA247831$SANOFI AVENTIS$$74$YR$E$M$Y$87$KG$20240829$$MD$US$US
242647181$24264718$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249162$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240829$$CN$US$US
242647191$24264719$1$I$$20240827$20240829$20240829$PER$$US-ABBVIE-5898011$ABBVIE$$$$$$Y$$$20240829$$HP$US$US
242647211$24264721$1$I$$20240809$20240829$20240829$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08320$LUPIN$$$$$$Y$$$20240829$$CN$US$US
242647231$24264723$1$I$20220901$20240828$20240829$20240829$EXP$$CO-SANDOZ INC.-SDZ2024CO076019$SANDOZ$$67$YR$$M$Y$$$20240829$$MD$CO$CO
242647242$24264724$2$F$$20240920$20240829$20240923$EXP$$DE-SANDOZ INC.-SDZ2024DE075550$SANDOZ$$80$YR$$M$Y$69$KG$20240923$$HP$DE$DE
242647251$24264725$1$I$20240101$20240813$20240829$20240829$PER$$US-009507513-2408USA004648$MERCK$$$$$F$Y$$$20240829$$CN$US$US
242647261$24264726$1$I$$20240815$20240829$20240829$EXP$$US-HLS-202400920$HLS THERAPEUTICS$$47$YR$A$M$Y$$$20240829$$MD$US$US
242647292$24264729$2$F$$20240929$20240829$20240930$30DAY$$US-PFIZER INC-202400240561$PFIZER$$15$YR$$M$Y$$$20240930$$CN$US$US
242647311$24264731$1$I$20240815$20240826$20240829$20240829$EXP$$US-PFIZER INC-202400233475$PFIZER$$72$YR$$F$Y$92.517$KG$20240829$$CN$US$US
242647322$24264732$2$F$20240101$20240828$20240829$20240903$EXP$$CA-PFIZER INC-202400242836$PFIZER$$17$YR$$M$Y$$$20240903$$MD$CA$CA
242647331$24264733$1$I$$20240823$20240829$20240829$EXP$$ZA-PFIZER INC-PV202400110899$PFIZER$$4$DEC$$F$Y$75.6$KG$20240829$$MD$ZA$ZA
242647341$24264734$1$I$$20240827$20240829$20240829$EXP$$US-PFIZER INC-202400244239$PFIZER$$67$YR$$F$Y$$$20240829$$CN$US$US
242647351$24264735$1$I$20240826$20240826$20240829$20240829$EXP$$SA-PFIZER INC-202400243926$PFIZER$$$$A$M$Y$$$20240829$$MD$SA$SA
242647363$24264736$3$F$20240827$20240917$20240829$20240920$EXP$$CA-PFIZER INC-PV202400111803$PFIZER$$54$YR$$F$Y$$$20240920$$CN$CA$CA
242647371$24264737$1$I$$20240827$20240829$20240829$EXP$$US-PFIZER INC-202400244935$PFIZER$$5$YR$$M$Y$$$20240829$$MD$US$US
242647381$24264738$1$I$20220101$20240823$20240829$20240829$EXP$FR-AFSSAPS-AVLY2024000136$FR-MYLANLABS-2024M1078513$MYLAN$$18$YR$$F$Y$83$KG$20240829$$MD$FR$FR
242647391$24264739$1$I$20240627$20240823$20240829$20240829$EXP$FR-AFSSAPS-AVLY2024000135$FR-MYLANLABS-2024M1078409$MYLAN$$18$YR$$F$Y$83$KG$20240829$$MD$FR$FR
242647401$24264740$1$I$20231001$20240823$20240829$20240829$EXP$FR-AFSSAPS-PA2024001440$FR-MYLANLABS-2024M1078362$MYLAN$$66$YR$$M$Y$$$20240829$$MD$FR$FR
242647411$24264741$1$I$20240628$20240823$20240829$20240829$EXP$FR-AFSSAPS-CN2024000724$FR-MYLANLABS-2024M1078376$MYLAN$$72$YR$$F$Y$73$KG$20240829$$MD$FR$FR
242647421$24264742$1$I$$20240820$20240829$20240829$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-107447$REGENERON$$79$YR$$F$Y$$$20240829$$MD$JP$JP
242647431$24264743$1$I$20240612$20240626$20240829$20240829$PER$$US-3MMEDICAL-2024-US-045572$3M$$$$$UNK$Y$$$20240829$$CN$US$US
242647442$24264744$2$F$20240822$20240912$20240829$20240917$PER$$JP-Eisai-EC-2024-172720$EISAI$$$$E$F$Y$$$20240917$$MD$JP$JP
242647451$24264745$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249158$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240829$$CN$US$US
242647461$24264746$1$I$20240819$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170859$AMGEN$$81$YR$E$F$Y$$$20240829$$PH$US$US
242647471$24264747$1$I$20240101$20240822$20240829$20240829$PER$$AU-Eisai-EC-2024-172866$EISAI$$74$YR$E$M$Y$$$20240829$$MD$AU$AU
242647491$24264749$1$I$20240813$20240827$20240829$20240829$EXP$$GB-MYLANLABS-2024M1079291$MYLAN$$65$YR$$M$Y$83$KG$20240829$$MD$GB$GB
242647501$24264750$1$I$20240823$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170005$AMGEN$$$$$M$Y$$$20240829$$CN$US$US
242647512$24264751$2$F$20240101$20240822$20240829$20240903$EXP$$JP-AstraZeneca-2024A193857$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$JP$
242647522$24264752$2$F$$20240910$20240829$20240913$EXP$$JP-AstraZeneca-2024A195687$ASTRAZENECA$$50$YR$$F$Y$$$20240913$$MD$JP$
242647531$24264753$1$I$20240203$20240816$20240829$20240829$EXP$FR-AFSSAPS-BR2024000384$FR-ABBVIE-5899085$ABBVIE$$72$YR$$M$Y$$$20240829$$MD$FR$FR
242647541$24264754$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00252$MEITHEAL PHARMACEUTICALS$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, ET.AL.Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9(7):1-8$40$YR$A$M$Y$$$20240829$$HP$NL$NL
242647551$24264755$1$I$$20240823$20240829$20240829$EXP$$ID-INCYTE CORPORATION-2024IN008944$INCYTE$$$$$$Y$$$20240829$$MD$ID$ID
242647561$24264756$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00253$MEITHEAL PHARMACEUTICALS$A. T. Meuleman et al..Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9 (7):1-8$45$YR$A$M$Y$$$20240829$$HP$NL$NL
242647571$24264757$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00255$MEITHEAL PHARMACEUTICALS$A. T. Meuleman et al..Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9 (7):1-8$39$YR$A$M$Y$$$20240829$$HP$NL$NL
242647581$24264758$1$I$$20240822$20240829$20240829$EXP$GB-MHRA-MED-202408221100121110-QHFBM$GB-TEVA-VS-3236790$TEVA$$77$YR$$M$Y$$$20240829$$PH$GB$GB
242647592$24264759$2$F$$20240830$20240829$20240902$PER$$US-AMGEN-USASP2024171161$AMGEN$$$$$F$Y$$$20240901$$CN$US$US
242647601$24264760$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00257$MEITHEAL PHARMACEUTICALS$A. T. Meuleman et al..Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9(7):1-8$42$YR$A$M$Y$$$20240829$$HP$NL$NL
242647611$24264761$1$I$$20240828$20240829$20240829$PER$$US-GILEAD-2024-0685649$GILEAD$$86$YR$E$F$Y$$$20240829$$PH$US$US
242647621$24264762$1$I$$20240821$20240829$20240829$PER$$US-ABBVIE-5891408$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242647631$24264763$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00254$MEITHEAL PHARMACEUTICALS$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, ET.AL.Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9(7):1-8$50$YR$A$M$Y$$$20240829$$HP$NL$NL
242647641$24264764$1$I$20240820$20240823$20240829$20240829$PER$$US-EMD Serono-2024045623$EMD SERONO INC$$58$YR$A$F$Y$$$20240829$$HP$US$US
242647651$24264765$1$I$$20240828$20240829$20240829$PER$$US-JNJFOC-20240875207$JOHNSON AND JOHNSON$$$$E$$Y$$$20240829$$HP$US$US
242647661$24264766$1$I$$20240819$20240829$20240829$EXP$$US-HLS-202400982$HLS THERAPEUTICS$$$$A$M$Y$$$20240829$$HP$US$US
242647672$24264767$2$F$20221102$20240909$20240829$20240913$PER$$US-009507513-2408USA009553$MERCK$$$$$M$Y$$$20240913$$CN$US$US
242647691$24264769$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174598$NOVARTIS$$$$$F$Y$$$20240829$$CN$US$US
242647701$24264770$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00251$MEITHEAL PHARMACEUTICALS$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, ET.AL.Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9(7):1-8$47$YR$A$M$Y$$$20240829$$HP$NL$NL
242647711$24264771$1$I$20240301$20240827$20240829$20240829$EXP$$US-TAKEDA-2024TUS078570$TAKEDA$$20$YR$$M$Y$$$20240829$$CN$US$US
242647721$24264772$1$I$20211102$20240822$20240829$20240829$EXP$$CA-TAKEDA-2021TUS018307$TAKEDA$$60$YR$$F$Y$$$20240829$$CN$CA$CA
242647731$24264773$1$I$20240819$20240826$20240829$20240829$EXP$$US-BAYER-2024A122861$BAYER$$33$YR$A$M$Y$$$20240829$$HP$US$US
242647751$24264775$1$I$$20240828$20240829$20240829$PER$$US-GILEAD-2024-0685676$GILEAD$$$$$F$Y$$$20240829$$HP$US$US
242647771$24264777$1$I$20240827$20240829$20240829$20240829$PER$$US-BAYER-2024A124423$BAYER$$40$YR$A$F$Y$$$20240829$$MD$US$US
242647781$24264778$1$I$20240101$20240827$20240829$20240829$EXP$$CA-BAUSCH-BL-2024-012986$BAUSCH AND LOMB$$45$YR$$F$Y$$$20240829$$PH$CA$CA
242647791$24264779$1$I$20240701$20240815$20240829$20240829$EXP$$US-UCBSA-2024041788$UCB$$42$YR$$M$Y$$$20240829$$HP$US$US
242647802$24264780$2$F$$20240826$20240829$20240830$EXP$$US-AMGEN-USASP2024170670$AMGEN$$$$$F$Y$$$20240830$$MD$US$US
242647811$24264781$1$I$20220101$20240820$20240829$20240829$EXP$$US-Eisai-EC-2022-130760$EISAI$$45$YR$A$M$Y$88$KG$20240829$$CN$US$US
242647821$24264782$1$I$20240722$20240819$20240829$20240829$EXP$$BR-BAXTER-2024BAX023158$BAXTER$$21$YR$$F$Y$$$20240829$$PH$BR$BR
242647831$24264783$1$I$$20240828$20240829$20240829$PER$$US-JNJFOC-20240875286$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$HP$US$US
242647841$24264784$1$I$$20240828$20240829$20240829$PER$$US-JNJFOC-20240875253$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$HP$US$US
242647851$24264785$1$I$20190918$20240823$20240829$20240829$EXP$$PL-BAUSCH-BL-2021-012148$BAUSCH AND LOMB$$62$YR$$M$Y$98$KG$20240829$$MD$PL$PL
242647861$24264786$1$I$$20240828$20240829$20240829$EXP$$CA-BAUSCH-BL-2024-013029$BAUSCH AND LOMB$$63$YR$$M$Y$86$KG$20240829$$HP$CA$CA
242647871$24264787$1$I$20240801$20240824$20240829$20240829$EXP$$CA-JNJFOC-20240865694$JOHNSON AND JOHNSON$$15$YR$T$F$Y$58$KG$20240829$$HP$CA$CA
242647881$24264788$1$I$20080701$20240826$20240829$20240829$EXP$$IT-PFIZER INC-PV202400112356$PFIZER$Condorelli, A.. Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over. Acta Haematologica. 2024;147(4):493-498$69$YR$$F$Y$$$20240829$$HP$IT$IT
242647891$24264789$1$I$$20240822$20240829$20240829$EXP$$CA-PFIZER INC-202400245529$PFIZER$$75$YR$$F$Y$76$KG$20240829$$PH$CA$CA
242647902$24264790$2$F$20240509$20240830$20240829$20240905$EXP$$CN-PFIZER INC-2024SGN04553$PFIZER$$35$YR$$F$Y$55$KG$20240905$$MD$CN$CN
242647911$24264791$1$I$$20240828$20240829$20240829$EXP$$US-PFIZER INC-202400245741$PFIZER$$$$$$Y$$$20240829$$HP$US$US
242647921$24264792$1$I$$20240827$20240829$20240829$EXP$$CN-PFIZER INC-PV202400111625$PFIZER$$$$A$M$Y$$$20240829$$CN$CN$CN
242647941$24264794$1$I$20200501$20240819$20240829$20240829$EXP$$JP-TAKEDA-2024TUS086080$TAKEDA$$5$DEC$$M$Y$$$20240829$$MD$JP$JP
242647952$24264795$2$F$20240611$20240910$20240829$20240925$30DAY$$BE-BAXTER-2024BAX022593$BAXTER$$$$$$Y$$$20240925$$MD$BE$BE
242647961$24264796$1$I$20240811$20240821$20240829$20240829$EXP$$US-Amarin Pharma, Inc-2024AMR000439$AMARIN$$67$YR$E$M$Y$$$20240829$$CN$US$US
242647971$24264797$1$I$$20240820$20240829$20240829$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007330$AEGERION$Michelle Krienke, Michael Stumvoll, Konstanze Miehle. Longterm course of metabolic parameters in lipodystrophy patients treated with metreleptin$$$$$Y$$$20240829$$MD$DE$DE
242647982$24264798$2$F$20240124$20240819$20240829$20240901$EXP$$RS-BRISTOL-MYERS SQUIBB COMPANY-2024-133024$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240902$$MD$RS$RS
242647991$24264799$1$I$$20240821$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US075963$SANDOZ$$$$$$Y$$$20240829$$PH$US$US
242648001$24264800$1$I$$20240821$20240829$20240829$EXP$$US-AstraZeneca-2024A191955$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
242648011$24264801$1$I$$20240822$20240829$20240829$PER$$US-BAYER-2024A121495$BAYER$$$$$M$Y$$$20240829$$CN$US$US
242648021$24264802$1$I$20240501$20240827$20240829$20240829$PER$$US-ORGANON-O2408USA002049$ORGANON$$$$$F$Y$$$20240829$$CN$US$US
242648031$24264803$1$I$$20240806$20240829$20240829$EXP$$CO-NOVOPROD-1261701$NOVO NORDISK$$82$YR$$M$Y$67$KG$20240829$$CN$CO$CO
242648042$24264804$2$F$$20240828$20240829$20240902$EXP$$CA-AstraZeneca-2021A526581$ASTRAZENECA$$65$YR$$F$Y$69$KG$20240902$$MD$CA$
242648051$24264805$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59550$$FDA-CTU$$48$YR$$F$N$$$20240829$N$$US$
242648071$24264807$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170790$AMGEN$Kamel I. R.; Mohseni A.; Baghdadi A. et al.. Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy-an evaluation of volumetric imaging parameters. Abdominal Radiology. 2024;49(8):2595-2605$$$$$Y$$$20240829$$HP$US$US
242648081$24264808$1$I$$20240828$20240829$20240829$PER$$US-AMGEN-USASP2024172158$AMGEN$$$$$F$Y$$$20240829$$HP$US$US
242648091$24264809$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59532$$FDA-CTU$$29$YR$$M$N$77.56$KG$20240829$N$$US$
242648101$24264810$1$I$20240824$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59530$$FDA-CTU$$70$YR$$F$N$42.5$KG$20240828$N$$US$
242648111$24264811$1$I$$20240828$20240829$20240829$EXP$$IT-SANDOZ INC.-SDZ2024IT076139$SANDOZ$$59$YR$$F$Y$$$20240829$$MD$IT$IT
242648121$24264812$1$I$20240828$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59559$$FDA-CTU$$72$YR$$F$N$$$20240829$N$PH$US$
242648131$24264813$1$I$20240101$20240820$20240829$20240829$EXP$$US-LEX-000451$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242648141$24264814$1$I$20240827$20240828$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137772$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240829$$CN$US$US
242648151$24264815$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59556$$FDA-CTU$$69$YR$$F$N$$$20240829$N$PH$US$
242648161$24264816$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59575$$FDA-CTU$$67$YR$$M$N$71.67$KG$20240829$N$$US$
242648171$24264817$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59551$$FDA-CTU$$53$YR$$F$N$82.55$KG$20240829$N$$US$
242648181$24264818$1$I$$20240823$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015716$ELI LILLY AND CO$$$$A$M$Y$$$20240829$$CN$US$US
242648191$24264819$1$I$$20240820$20240829$20240829$EXP$$US-LEX-000450$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242648201$24264820$1$I$20240201$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245868$PFIZER$$56$YR$$F$Y$$$20240829$$HP$US$US
242648222$24264822$2$F$$20240905$20240829$20240909$PER$$US-PFIZER INC-202400245964$PFIZER$$56$YR$$$Y$$$20240909$$CN$US$US
242648231$24264823$1$I$$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245042$PFIZER$$$$$F$Y$$$20240829$$MD$US$US
242648241$24264824$1$I$$20240828$20240829$20240829$PER$$US-PFIZER INC-PV202400112798$PFIZER$$89$YR$$F$Y$$$20240829$$HP$US$US
242648251$24264825$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244018$PFIZER$$57$YR$$F$Y$$$20240829$$PH$US$US
242648261$24264826$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-PV202400111520$PFIZER$$$$$F$Y$$$20240829$$CN$US$US
242648271$24264827$1$I$$20240826$20240829$20240829$PER$$US-PFIZER INC-202400244489$PFIZER$$80$YR$$M$Y$$$20240829$$CN$US$US
242648281$24264828$1$I$20240801$20240828$20240829$20240829$PER$$US-PFIZER INC-202400246096$PFIZER$$24$YR$$M$Y$$$20240829$$HP$US$US
242648291$24264829$1$I$20240824$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245935$PFIZER$$66$YR$$F$Y$$$20240829$$HP$US$US
242648301$24264830$1$I$20240815$20240827$20240829$20240829$EXP$$US-BAUSCH-BL-2024-013003$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240829$$CN$US$US
242648311$24264831$1$I$20240101$20240826$20240829$20240829$EXP$$US-ABBVIE-5896890$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242648321$24264832$1$I$$20240826$20240829$20240829$EXP$$US-AMGEN-USASP2024170841$AMGEN$$57$YR$A$F$Y$$$20240829$$MD$US$US
242648331$24264833$1$I$$20240827$20240829$20240829$EXP$$DE-ROCHE-10000068279$ROCHE$$$$$$Y$$$20240829$$CN$DE$DE
242648342$24264834$2$F$$20240829$20240829$20240904$PER$$US-PFIZER INC-202400245432$PFIZER$$$$$F$Y$$$20240904$$HP$US$US
242648351$24264835$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137361$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240829$$MD$US$US
242648361$24264836$1$I$$20240821$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133882$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240829$$HP$US$US
242648371$24264837$1$I$$20240828$20240829$20240829$EXP$$PL-GILEAD-2024-0685598$GILEAD$$$$$F$Y$$$20240829$$MD$PL$PL
242648381$24264838$1$I$$20240827$20240829$20240829$EXP$$GB-PFIZER INC-PV202400112357$PFIZER$Malik, M.. Inflammatory myopathy and metabolic disorders causing myopathies. Rheumatology (United Kingdom). 2021;60(SUPPL 1):i30$37$YR$$F$Y$$$20240829$$HP$GB$GB
242648391$24264839$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00262$MEITHEAL PHARMACEUTICALS$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, ET.AL.Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9(7):1-8$24$YR$A$M$Y$$$20240829$$HP$NL$NL
242648401$24264840$1$I$$20240826$20240829$20240829$EXP$$IT-PFIZER INC-202400245674$PFIZER$Condorelli, A.. Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over. Acta Haematologica. 2024;147(4):493-498$69$YR$$F$Y$$$20240829$$HP$IT$IT
242648411$24264841$1$I$20020101$20240823$20240829$20240829$EXP$$JP-PFIZER INC-PV202400110468$PFIZER$Sakamoto, N.. Nonspecific interstitial pneumonia with poor prognosis associated with amyopathic dermatomyositis. Internal Medicine. 2004;43(9):838-842$49$YR$$M$Y$$$20240829$$HP$JP$JP
242648422$24264842$2$F$20240601$20240912$20240829$20240916$PER$$US-ORGANON-O2408USA001599$ORGANON$$25$YR$$F$Y$$$20240916$$MD$US$US
242648431$24264843$1$I$$20240826$20240829$20240829$EXP$$US-ABBVIE-5897128$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242648441$24264844$1$I$$20240819$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-132104$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$73$KG$20240829$$MD$CA$CA
242648451$24264845$1$I$$20240819$20240829$20240829$EXP$$CA-ROCHE-10000061035$ROCHE$$$$A$F$Y$$$20240829$$HP$CA$CA
242648461$24264846$1$I$20240816$20240819$20240829$20240829$PER$$US-AstraZeneca-2024A188857$ASTRAZENECA$$20914$DY$$M$Y$$$20240829$$CN$US$
242648471$24264847$1$I$$20240821$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133240$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240829$$HP$US$US
242648481$24264848$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136594$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$51.71$KG$20240829$$CN$US$US
242648491$24264849$1$I$20240809$20240822$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137429$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240829$$CN$US$US
242648502$24264850$2$F$20240724$20240916$20240829$20240925$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093448$GLENMARK$$$$$$Y$$$20240925$$PH$US$US
242648511$24264851$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-083556$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240829$$CN$US$US
242648521$24264852$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00263$MEITHEAL PHARMACEUTICALS$A. T. Meuleman et al..Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9 (7):1-8$45$YR$A$M$Y$$$20240829$$HP$NL$NL
242648551$24264855$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59555$$FDA-CTU$$59$YR$$M$N$$$20240829$N$$US$
242648591$24264859$1$I$20240813$20240828$20240828$20240828$DIR$716339$$FDA-CTU$$65$YR$$F$N$101.25$KG$20240828$N$CN$US$
242648611$24264861$1$I$$20240824$20240829$20240829$PER$$US-ABBVIE-5896109$ABBVIE$$$$$$Y$$$20240829$$CN$US$US
242648621$24264862$1$I$20240426$20240827$20240829$20240829$EXP$$IT-ROCHE-10000068353$ROCHE$$56$YR$A$M$Y$$$20240829$$MD$IT$IT
242648631$24264863$1$I$20240822$20240826$20240829$20240829$EXP$$US-LEX-000460$LEXICON PHARMACEUTICALS$$64$YR$$F$Y$$$20240829$$HP$US$US
242648642$24264864$2$F$20240901$20240920$20240829$20240927$EXP$$US-ABBVIE-5895763$ABBVIE$$83$YR$$M$Y$$$20240927$$CN$US$US
242648651$24264865$1$I$20240101$20240820$20240829$20240829$PER$$US-SA-2024SA165053$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240829$$MD$US$US
242648661$24264866$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00264$MEITHEAL PHARMACEUTICALS$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, ET.AL.Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9(7):1-8$38$YR$A$M$Y$$$20240829$$HP$NL$NL
242648671$24264867$1$I$20240704$20240826$20240829$20240829$EXP$FR-AFSSAPS-AN2024001144$FR-MYLANLABS-2024M1078710$MYLAN$$67$YR$$M$Y$$$20240829$$PH$FR$FR
242648681$24264868$1$I$$20240814$20240829$20240829$EXP$$US-HLS-202400898$HLS THERAPEUTICS$$$$A$M$Y$$$20240829$$HP$US$US
242648691$24264869$1$I$20240401$20240822$20240829$20240829$EXP$$US-009507513-2408USA007991$MERCK$$85$YR$$M$Y$$$20240829$$CN$US$US
242648702$24264870$2$F$20240803$20240829$20240829$20240902$PER$$US-AMGEN-USASP2024170427$AMGEN$$73$YR$E$M$Y$$$20240902$$CN$US$US
242648711$24264871$1$I$$20240820$20240829$20240829$EXP$$CA-TEVA-VS-3237440$TEVA$$50$YR$$F$Y$68$KG$20240829$$HP$CA$CA
242648721$24264872$1$I$$20240828$20240829$20240829$EXP$$CA-PFIZER INC-202400245738$PFIZER$$47$YR$$F$Y$$$20240829$$HP$CA$CA
242648731$24264873$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00265$MEITHEAL PHARMACEUTICALS$A. T. Meuleman et al..Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9 (7):1-8$38$YR$A$M$Y$$$20240829$$HP$NL$NL
242648741$24264874$1$I$$20240827$20240829$20240829$PER$$US-HALEON-2193960$Haleon PLC$$$$$$Y$$$20240829$$CN$US$US
242648752$24264875$2$F$20240824$20240902$20240829$20240903$EXP$$IT-GILEAD-2024-0685727$GILEAD$$54$YR$A$M$Y$$$20240903$$CN$IT$IT
242648781$24264878$1$I$20240101$20240730$20240829$20240829$PER$$US-009507513-2407USA015862$MERCK$$$$$F$Y$$$20240829$$CN$US$US
242648791$24264879$1$I$20240817$20240822$20240829$20240829$EXP$CN-91110000556821568D-2024DRL001592$CN-RDY-SPO/CHN/24/0012455$DR REDDYS$$76$YR$E$M$Y$$$20240829$$HP$CN$CN
242648801$24264880$1$I$$20240828$20240829$20240829$PER$$US-HALEON-2194143$Haleon PLC$$44$YR$$F$Y$$$20240829$$CN$US$US
242648811$24264881$1$I$$20240819$20240829$20240829$EXP$$AU-TEVA-VS-3236321$TEVA$$45$YR$$F$Y$$$20240829$$HP$AU$AU
242648822$24264882$2$F$$20240926$20240829$20240930$PER$$US-ROCHE-10000064849$ROCHE$$$$$$Y$$$20240930$$PH$US$US
242648831$24264883$1$I$$20240826$20240829$20240829$EXP$$US-Taiho Oncology Inc-2024-008227$TAIHO ONCOLOGY INC$$$$E$M$Y$$$20240829$$CN$US$US
242648861$24264886$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59586$$FDA-CTU$$52$YR$$M$N$153.31$KG$20240829$N$$US$
242648871$24264887$1$I$20240701$20240823$20240829$20240829$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202408017251$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240829$$CN$CO$CO
242648891$24264889$1$I$20240801$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016609$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240829$$HP$US$US
242648901$24264890$1$I$20240602$20240817$20240829$20240829$EXP$GB-MHRA-MED-202408171003289520-SVGFK$GB-ELI_LILLY_AND_COMPANY-GB202408011219$ELI LILLY AND CO$$32$YR$A$F$Y$122$KG$20240829$$CN$GB$GB
242648931$24264893$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59536$$FDA-CTU$$60$YR$$F$N$$$20240829$N$$US$
242648951$24264895$1$I$20240811$20240826$20240829$20240829$EXP$$CN-PFIZER INC-PV202400111308$PFIZER$$79$YR$$F$Y$58$KG$20240829$$HP$CN$CN
242648971$24264897$1$I$$20240829$20240829$20240829$EXP$$TW-PFIZER INC-202400246335$PFIZER$$40$YR$$M$Y$$$20240829$$CN$TW$TW
242648981$24264898$1$I$20240719$20240826$20240829$20240829$EXP$FR-AFSSAPS-CN2024000814$FR-PFIZER INC-202400243595$PFIZER$$70$YR$$F$Y$89$KG$20240829$$PH$FR$FR
242648991$24264899$1$I$20240622$20240826$20240829$20240829$EXP$ES-AEMPS-1562975$ES-PFIZER INC-202400243619$PFIZER$$77$YR$$M$Y$$$20240829$$MD$ES$ES
242649002$24264900$2$F$20240805$20240830$20240829$20240904$EXP$$JP-GILEAD-2024-0682999$GILEAD$$$$E$M$Y$$$20240904$$PH$JP$JP
242649012$24264901$2$F$20240814$20240906$20240829$20240910$EXP$GB-MHRA-MED-202408240949589110-FRWHK$GB-MYLANLABS-2024M1078666$MYLAN$$55$YR$$M$Y$89$KG$20240910$$CN$GB$GB
242649031$24264903$1$I$20240701$20240715$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000008$MERZ$$$$$F$Y$$$20240829$$HP$US$US
242649041$24264904$1$I$$20240702$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000009$MERZ$$$$A$M$Y$$$20240829$$CN$US$US
242649051$24264905$1$I$$20240819$20240829$20240829$EXP$$AU-TEVA-VS-3236372$TEVA$$78$YR$$F$Y$$$20240829$$HP$AU$AU
242649073$24264907$3$F$20230114$20240830$20240829$20240905$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000994$Unknown Manufacturer$$$$$$Y$$$20240904$$MD$FR$FR
242649082$24264908$2$F$20240818$20240829$20240829$20240905$EXP$$DE-BIOMARINAP-DE-2024-160074$BIOMARIN$$$$$$Y$$$20240905$$HP$DE$DE
242649091$24264909$1$I$20240827$20240828$20240829$20240829$EXP$$US-BIOMARINAP-US-2024-160188$BIOMARIN$$$$$$Y$$$20240829$$CN$US$US
242649101$24264910$1$I$$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136334$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240829$$HP$US$US
242649111$24264911$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137475$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240829$$HP$US$US
242649141$24264914$1$I$20240812$20240826$20240829$20240829$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-137238$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$76$KG$20240829$$CN$CN$CN
242649151$24264915$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00256$MEITHEAL PHARMACEUTICALS$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, ET.AL.Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9(7):1-8$22$YR$A$M$Y$$$20240829$$HP$NL$NL
242649161$24264916$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00258$MEITHEAL PHARMACEUTICALS$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, ET.AL.Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9(7):1-8$43$YR$A$M$Y$$$20240829$$HP$NL$NL
242649171$24264917$1$I$$20240716$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000010$MERZ$$48$YR$$F$Y$$$20240829$$MD$US$US
242649182$24264918$2$F$20240101$20240906$20240829$20240913$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047482$BOEHRINGER INGELHEIM$$3$YR$C$M$Y$17$KG$20240913$$CN$BR$BR
242649191$24264919$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00259$MEITHEAL PHARMACEUTICALS$A. T. Meuleman et al..Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9 (7):1-8$49$YR$A$M$Y$$$20240829$$HP$NL$NL
242649201$24264920$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00260$MEITHEAL PHARMACEUTICALS$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, ET.AL.Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9(7):1-8$25$YR$A$M$Y$$$20240829$$HP$NL$NL
242649211$24264921$1$I$20240101$20240826$20240829$20240829$EXP$$US-ABBVIE-5897623$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242649221$24264922$1$I$$20240821$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133735$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$54.88$KG$20240829$$HP$US$US
242649231$24264923$1$I$$20240819$20240829$20240829$EXP$$NL-MEITHEAL-2024MPLIT00261$MEITHEAL PHARMACEUTICALS$A. T. Meuleman et al..Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.ESMO Open.13-JUL-2024;9(7):1-8$24$YR$A$M$Y$$$20240829$$HP$NL$NL
242649251$24264925$1$I$20240709$20240826$20240829$20240829$EXP$$ES-MYLANLABS-2024M1078698$MYLAN$$32$YR$$F$Y$$$20240829$$HP$ES$ES
242649261$24264926$1$I$20240827$20240827$20240829$20240829$PER$$US-PFIZER INC-202400245133$PFIZER$$87$YR$$M$Y$$$20240829$$MD$US$US
242649271$24264927$1$I$$20240822$20240829$20240829$EXP$$CA-TEVA-VS-3236627$TEVA$$76$YR$$F$Y$$$20240829$$HP$CA$CA
242649281$24264928$1$I$$20240822$20240829$20240829$EXP$$CA-TEVA-VS-3236596$TEVA$$47$YR$$F$Y$$$20240829$$HP$CA$CA
242649291$24264929$1$I$$20240822$20240829$20240829$EXP$$CA-TEVA-VS-3236788$TEVA$$14$YR$$M$Y$$$20240829$$HP$CA$CA
242649311$24264931$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59552$$FDA-CTU$$61$YR$$F$N$$$20240829$N$$US$
242649361$24264936$1$I$20240101$20240828$20240828$20240828$DIR$716352$$FDA-CTU$$39$YR$$F$N$$$20240828$N$CN$US$
242649371$24264937$1$I$20200731$20240828$20240829$20240829$EXP$PL-URPL-1-1719-2020$PL-ABBVIE-5900356$ABBVIE$$21$YR$$F$Y$$$20240829$$MD$PL$PL
242649381$24264938$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136642$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$78.93$KG$20240829$$CN$US$US
242649391$24264939$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136666$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240829$$HP$US$US
242649403$24264940$3$F$20240201$20240902$20240829$20240906$EXP$$CO-TAKEDA-2024TUS030535$TAKEDA$$54$YR$$F$Y$62$KG$20240906$$CN$CO$CO
242649411$24264941$1$I$$20240820$20240829$20240829$PER$$US-ABBVIE-5891423$ABBVIE$$$$$$Y$$$20240829$$HP$US$US
242649422$24264942$2$F$$20240829$20240829$20240830$EXP$$GB-AstraZeneca-2024A196774$ASTRAZENECA$Adeoye F.W.; Jaffar N.; Surandran S.; Begum G.; Islam M.R.. DURVALUMAB-INDUCED TRIPLE-M SYNDROME. European Journal of Case Reports in Internal Medicine 2024;11(8):$69$YR$$F$Y$$$20240830$$HP$GB$
242649431$24264943$1$I$20240807$20240821$20240829$20240829$EXP$$US-AMGEN-USASP2024167647$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242649441$24264944$1$I$$20240819$20240829$20240829$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI07958$NEUROCRINE BIOSCIENCES$$60$YR$$F$Y$$$20240829$$PH$JP$JP
242649451$24264945$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137513$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240829$$CN$US$US
242649461$24264946$1$I$$20240808$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126695$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240829$$MD$US$US
242649471$24264947$1$I$20240812$20240821$20240829$20240829$EXP$$CN-ABBVIE-5899048$ABBVIE$$59$YR$$F$Y$62$KG$20240829$$HP$CN$CN
242649481$24264948$1$I$20240818$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016389$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240829$$CN$US$US
242649491$24264949$1$I$20240818$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017213$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240829$$CN$US$US
242649501$24264950$1$I$$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017336$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240829$$CN$US$US
242649511$24264951$1$I$20240827$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017112$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240829$$PH$US$US
242649521$24264952$1$I$20240701$20240827$20240829$20240829$EXP$$US-PFIZER INC-202400245867$PFIZER$$74$YR$$M$Y$$$20240829$$HP$US$US
242649531$24264953$1$I$20230101$20240828$20240829$20240829$EXP$$US-PFIZER INC-202400245987$PFIZER$$61$YR$$F$Y$$$20240829$$CN$US$US
242649541$24264954$1$I$$20240827$20240829$20240829$EXP$$IN-PFIZER INC-PV202400112759$PFIZER$$23$YR$$F$Y$$$20240829$$MD$IN$IN
242649552$24264955$2$F$$20240906$20240829$20240915$EXP$GB-MHRA-MED-202408191528579690-FHGPQ$GB-GLENMARK PHARMACEUTICALS-2024GMK093537$GLENMARK$$$$$$Y$$$20240915$$PH$GB$GB
242649562$24264956$2$F$20231004$20240919$20240829$20240925$EXP$$US-TAKEDA-2024TUS084452$TAKEDA$$44$YR$$F$Y$57$KG$20240925$$MD$US$US
242649581$24264958$1$I$$20240828$20240829$20240829$EXP$$CA-BAUSCH-BL-2024-013031$BAUSCH AND LOMB$$67$YR$$F$Y$74$KG$20240829$$HP$CA$CA
242649591$24264959$1$I$$20240823$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-137820$BRISTOL MYERS SQUIBB$Literature Citation unavailable$86$YR$E$M$Y$$$20240829$$HP$CA$CA
242649602$24264960$2$F$20240101$20240905$20240829$20240911$EXP$$JP-ABBVIE-5815040$ABBVIE$$80$YR$$M$Y$$$20240911$$MD$JP$JP
242649612$24264961$2$F$$20240823$20240829$20240903$EXP$$US-ABBVIE-5898691$ABBVIE$Karl TA, Johnson M, Scott FI. Unanticipated findings with upadacitinib therapy. Gastroenterology. 2024.$45$YR$$M$Y$$$20240903$$MD$US$US
242649621$24264962$1$I$$20240823$20240829$20240829$EXP$$GB-TAKEDA-2024TUS086740$TAKEDA$$$$$$Y$$$20240829$$CN$GB$GB
242649633$24264963$3$F$$20240919$20240829$20240923$EXP$$PT-MYLANLABS-2024M1078944$MYLAN$$$$$F$Y$$$20240923$$MD$PT$PT
242649651$24264965$1$I$20240802$20240828$20240828$20240828$DIR$716337$$FDA-CTU$$$$$UNK$N$$$20240828$Y$PH$US$
242649661$24264966$1$I$20240828$20240828$20240828$20240828$DIR$716353$$FDA-CTU$$51$YR$$F$N$52.2$KG$20240828$Y$CN$US$
242649671$24264967$1$I$20240520$20240828$20240828$20240828$DIR$716346$$FDA-CTU$$69$YR$$F$N$65.25$KG$20240828$N$CN$US$
242649681$24264968$1$I$20240826$20240828$20240828$20240828$DIR$716348$$FDA-CTU$$66$YR$$F$N$65.25$KG$20240828$N$CN$US$
242649691$24264969$1$I$20240824$20240828$20240828$20240828$DIR$716338$$FDA-CTU$$69$YR$$F$N$$$20240828$Y$PH$US$
242649701$24264970$1$I$$20230919$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2023IS002277$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649711$24264971$1$I$$20240109$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS001060$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649721$24264972$1$I$$20240212$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS001509$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242649731$24264973$1$I$20200915$20240212$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS001510$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242649741$24264974$1$I$$20240212$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS001511$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242649751$24264975$1$I$$20240212$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS001512$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242649761$24264976$1$I$$20240212$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS001513$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242649771$24264977$1$I$$20240212$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS001514$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242649781$24264978$1$I$20200820$20240311$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002507$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242649791$24264979$1$I$$20240311$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002508$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649801$24264980$1$I$$20240311$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002510$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242649811$24264981$1$I$$20240311$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002540$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242649821$24264982$1$I$$20240311$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002545$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242649831$24264983$1$I$$20240216$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS001591$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649841$24264984$1$I$$20230921$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2023IS002303$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649851$24264985$1$I$$20231027$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2023IS002549$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649861$24264986$1$I$$20231218$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2023IS002914$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649871$24264987$1$I$$20231117$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2023IS002663$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649881$24264988$1$I$20200130$20240312$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002663$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649891$24264989$1$I$20230301$20231218$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS001089$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649901$24264990$1$I$20230101$20240213$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2023IS002984$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649911$24264991$1$I$$20240313$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002616$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649921$24264992$1$I$20190903$20240308$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002751$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242649931$24264993$1$I$20200901$20240315$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002795$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242649941$24264994$1$I$$20240313$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002617$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649951$24264995$1$I$20210803$20240315$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002796$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242649961$24264996$1$I$$20240312$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002665$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649971$24264997$1$I$$20240312$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002666$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242649981$24264998$1$I$20200229$20240308$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002752$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242649991$24264999$1$I$20200304$20240308$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002753$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650001$24265000$1$I$20200301$20240308$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS002754$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650011$24265001$1$I$$20240820$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008732$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242650022$24265002$2$F$$20240823$20240829$20240830$EXP$$DE-009507513-2408DEU009004$MERCK$$$$$F$Y$$$20240830$$MD$DE$DE
242650031$24265003$1$I$20240826$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171546$AMGEN$$79$YR$E$M$Y$$$20240829$$CN$US$US
242650042$24265004$2$F$$20240917$20240829$20240925$PER$$US-INCYTE CORPORATION-2024IN008727$INCYTE$$$$$$Y$$$20240925$$CN$US$US
242650051$24265005$1$I$20231201$20240711$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS001112$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242650061$24265006$1$I$20231001$20231019$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2023IS002499$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650071$24265007$1$I$$20240117$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2023IS002678$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650081$24265008$1$I$20200830$20240321$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003032$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650091$24265009$1$I$$20230822$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2023IS002136$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650101$24265010$1$I$20240109$20240112$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS001070$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650111$24265011$1$I$$20240214$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS001202$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650121$24265012$1$I$20190219$20240322$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003057$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242650131$24265013$1$I$20240101$20240819$20240829$20240829$EXP$$US-TEVA-VS-3204351$TEVA$$58$YR$$F$Y$$$20240829$$CN$US$US
242650141$24265014$1$I$20200624$20240321$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003030$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650151$24265015$1$I$20210311$20240329$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003203$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650161$24265016$1$I$$20240403$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003362$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650171$24265017$1$I$$20240403$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003363$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242650181$24265018$1$I$20191101$20240417$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003904$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650191$24265019$1$I$20200624$20240417$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003905$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650201$24265020$1$I$$20240417$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003907$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242650211$24265021$1$I$$20240412$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003611$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650221$24265022$1$I$$20240412$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003745$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650231$24265023$1$I$$20240419$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003925$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650241$24265024$1$I$20200903$20240412$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003612$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650251$24265025$1$I$$20240418$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003935$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650261$24265026$1$I$$20240418$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003936$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650271$24265027$1$I$20200501$20240418$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003933$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650281$24265028$1$I$20200901$20240418$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003934$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650291$24265029$1$I$$20240329$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003231$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650301$24265030$1$I$$20240417$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003956$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650311$24265031$1$I$$20240412$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003608$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650321$24265032$1$I$$20240416$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003727$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650331$24265033$1$I$$20240416$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003728$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650341$24265034$1$I$20211001$20240418$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003931$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650351$24265035$1$I$$20240430$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004337$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650361$24265036$1$I$$20240430$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004338$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650371$24265037$1$I$$20240418$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003932$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650381$24265038$1$I$$20240424$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004120$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650391$24265039$1$I$$20240424$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004121$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650401$24265040$1$I$$20240503$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004439$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650411$24265041$1$I$20210115$20240503$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004440$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650421$24265042$1$I$$20240417$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003955$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650431$24265043$1$I$20210305$20240417$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003957$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650441$24265044$1$I$20190606$20240429$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004248$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650451$24265045$1$I$20210827$20240506$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004531$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650461$24265046$1$I$20211017$20240506$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004532$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650471$24265047$1$I$$20240506$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004550$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650491$24265049$1$I$$20240821$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133845$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240829$$HP$US$US
242650502$24265050$2$F$20240825$20240919$20240829$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137170$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240920$$CN$US$US
242650511$24265051$1$I$20240801$20240821$20240829$20240829$PER$$US-ABBVIE-5891386$ABBVIE$$$$$F$Y$$$20240829$$MD$US$US
242650521$24265052$1$I$$20240826$20240829$20240829$EXP$$CA-ABBVIE-5895673$ABBVIE$$80$YR$$F$Y$$$20240829$$PH$CA$CA
242650531$24265053$1$I$$20240527$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005367$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242650541$24265054$1$I$20191104$20240527$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005368$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242650551$24265055$1$I$$20240417$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003958$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650561$24265056$1$I$20210305$20240417$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003959$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650571$24265057$1$I$$20240417$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS003960$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650581$24265058$1$I$$20240429$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004249$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650601$24265060$1$I$20200817$20240520$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005384$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650611$24265061$1$I$20210108$20240603$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005468$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650631$24265063$1$I$$20240603$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005469$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650641$24265064$1$I$20191001$20240604$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005491$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650651$24265065$1$I$$20240604$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005508$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650661$24265066$1$I$20210301$20240604$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005509$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650671$24265067$1$I$20200115$20240604$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005516$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650681$24265068$1$I$$20240606$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005594$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650691$24265069$1$I$$20240606$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005597$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650701$24265070$1$I$20190322$20240606$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005598$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650711$24265071$1$I$20181120$20240607$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005634$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650721$24265072$1$I$$20240607$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005637$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650731$24265073$1$I$20200502$20240607$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005642$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242650741$24265074$1$I$$20240822$20240829$20240829$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16916$IPSEN$$$$$$Y$$$20240829$$HP$US$US
242650751$24265075$1$I$$20240506$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004551$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650761$24265076$1$I$$20240815$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004604$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650771$24265077$1$I$$20240508$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004646$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242650781$24265078$1$I$20200815$20240510$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004688$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650791$24265079$1$I$$20240506$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004458$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650801$24265080$1$I$20200818$20240506$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004599$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650811$24265081$1$I$$20240510$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004752$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650821$24265082$1$I$$20240513$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004797$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650831$24265083$1$I$20201006$20240513$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004811$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650841$24265084$1$I$20210205$20240514$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004817$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650851$24265085$1$I$20210325$20240514$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004818$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650861$24265086$1$I$20190101$20240510$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004687$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650871$24265087$1$I$20210115$20240514$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004846$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650881$24265088$1$I$$20240514$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004847$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650891$24265089$1$I$$20240515$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004906$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650901$24265090$1$I$$20240515$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004908$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650911$24265091$1$I$20200101$20240510$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004689$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650921$24265092$1$I$$20240510$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004751$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650931$24265093$1$I$$20240516$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004942$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650941$24265094$1$I$$20240516$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004943$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650951$24265095$1$I$$20240516$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004950$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242650961$24265096$1$I$20190101$20240517$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005108$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242650971$24265097$1$I$$20240517$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005109$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242650981$24265098$1$I$$20240517$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005112$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242650991$24265099$1$I$20190904$20240521$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005113$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242651001$24265100$1$I$$20240513$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004814$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242651011$24265101$1$I$20191101$20240521$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005114$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242651021$24265102$1$I$$20240521$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005116$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242651031$24265103$1$I$20190724$20240517$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005144$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242651041$24265104$1$I$$20240517$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005145$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242651051$24265105$1$I$$20240517$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005146$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242651061$24265106$1$I$20200101$20240604$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005507$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242651071$24265107$1$I$20200801$20240521$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005155$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242651081$24265108$1$I$$20240521$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005156$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242651091$24265109$1$I$20190104$20240522$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005227$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242651101$24265110$1$I$$20240522$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005228$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242651111$24265111$1$I$$20240522$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005229$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242651121$24265112$1$I$$20240522$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005230$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242651131$24265113$1$I$$20240523$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005280$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$MD$US$US
242651141$24265114$1$I$$20240520$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005302$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242651151$24265115$1$I$20210101$20240826$20240829$20240829$PER$$US-JNJFOC-20240866646$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242651161$24265116$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174276$NOVARTIS$$$$$F$Y$$$20240829$$HP$US$US
242651171$24265117$1$I$$20240827$20240829$20240829$EXP$$CA-MYLANLABS-2024M1079505$MYLAN$$77$YR$$F$Y$$$20240829$$PH$CA$CA
242651181$24265118$1$I$$20240604$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005492$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242651191$24265119$1$I$$20240520$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005386$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242651201$24265120$1$I$$20240430$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004339$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242651211$24265121$1$I$$20240430$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004340$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242651221$24265122$1$I$$20240520$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS005387$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242651231$24265123$1$I$20201101$20240515$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004907$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$HP$US$US
242651241$24265124$1$I$$20240516$20240829$20240829$EXP$$US-AKCEA THERAPEUTICS, INC.-2024IS004949$AKCEA THERAPEUTICS$$$$$$Y$$$20240828$$CN$US$US
242651271$24265127$1$I$20240822$20240823$20240829$20240829$EXP$$US-KYOWAKIRIN-2024KK020017$KYOWA$$$$$$Y$$$20240829$$HP$US$US
242651282$24265128$2$F$20240101$20240906$20240829$20240911$EXP$$US-TG THERAPEUTICS INC.-TGT003925$TG THERAPEUTICS$$$$$$Y$$$20240911$$HP$US$US
242651291$24265129$1$I$20240419$20240827$20240829$20240829$EXP$$US-APELLIS-2024-APL-0000864$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240829$$CN$US$US
242651302$24265130$2$F$20220904$20240829$20240829$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048575$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240829$$CN$US$US
242651311$24265131$1$I$$20240715$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000016$MERZ$$$$$$Y$$$20240829$$HP$US$US
242651321$24265132$1$I$$20240715$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000015$MERZ$$$$$F$Y$$$20240829$$HP$US$US
242651331$24265133$1$I$$20240828$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408018592$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240829$$HP$US$US
242651341$24265134$1$I$20240729$20240801$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017947$ELI LILLY AND CO$$$$$$Y$$$20240829$$CN$US$US
242651351$24265135$1$I$20240827$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017194$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240829$$CN$US$US
242651361$24265136$1$I$20240823$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408017154$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240829$$CN$US$US
242651371$24265137$1$I$20240101$20240816$20240829$20240829$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407004459$ELI LILLY AND CO$$38$YR$A$F$Y$57.5$KG$20240829$$CN$CN$CN
242651381$24265138$1$I$$20240828$20240829$20240829$EXP$US-MLMSERVICE-20230801-4451176-1$US-SANDOZ INC.-SDZ2024US075966$SANDOZ$$74$YR$$F$Y$$$20240829$$MD$US$US
242651391$24265139$1$I$$20240716$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000017$MERZ$$67$YR$$F$Y$$$20240829$$HP$US$US
242651401$24265140$1$I$$20240823$20240829$20240829$EXP$$DE-ROCHE-10000066191$ROCHE$$$$E$F$Y$$$20240829$$HP$DE$DE
242651411$24265141$1$I$$20240822$20240829$20240829$EXP$$GB-MYLANLABS-2024M1078627$MYLAN$Edwards GM, Alejmi AA. Pure red cell aplasia secondary to erythropoietin therapy. Clin-Med-London 2024; 24 (4):.$65$YR$$F$Y$$$20240829$$HP$GB$GB
242651421$24265142$1$I$20240828$20240828$20240829$20240829$EXP$$US-KYOWAKIRIN-2024KK020195$KYOWA$$$$$$Y$$$20240829$$HP$US$US
242651431$24265143$1$I$$20240712$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000019$MERZ$$$$$$Y$$$20240829$$HP$US$US
242651442$24265144$2$F$$20240827$20240829$20240905$EXP$$US-OTSUKA-2024_023724$OTSUKA$$$$$M$Y$$$20240905$$CN$US$US
242651451$24265145$1$I$$20240603$20240829$20240829$PER$$US-TEVA-VS-3207585$TEVA$$65$YR$$F$Y$$$20240829$$HP$US$US
242651471$24265147$1$I$20240822$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137274$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$77.11$KG$20240829$$CN$US$US
242651481$24265148$1$I$$20240823$20240829$20240829$EXP$$GB-MYLANLABS-2024M1079627$MYLAN$Soldera J. Navigating treatment resistance: Janus kinase inhibitors for ulcerative colitis. World-J-Clin-Cases 2024; 12 (24): 5468-5472.$57$YR$$M$Y$$$20240829$$MD$GB$GB
242651491$24265149$1$I$$20240823$20240829$20240829$EXP$$IN-MYLANLABS-2024M1079625$MYLAN$Rupakumar T, Sankar A, Vijayasekharan K, VarikkattuRajendran P, ChellapanSojamani G, Rajeswari B, et al. Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India. Br-J-Haematol 2024; 220-228.$$$C$$Y$$$20240829$$HP$IN$IN
242651502$24265150$2$F$20240924$20240924$20240829$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137311$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240927$$CN$US$US
242651511$24265151$1$I$20240813$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137336$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$51.26$KG$20240829$$CN$US$US
242651522$24265152$2$F$20240301$20240829$20240829$20240905$EXP$$NL-ABBVIE-5891634$ABBVIE$$66$YR$$M$Y$99$KG$20240905$$MD$NL$NL
242651531$24265153$1$I$$20240712$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000025$MERZ$$$$$$Y$$$20240829$$HP$US$US
242651542$24265154$2$F$20240801$20240828$20240829$20240910$PER$$US-SA-2024SA248939$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240910$$CN$US$US
242651551$24265155$1$I$$20240709$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000020$MERZ$$$$$F$Y$$$20240829$$HP$US$US
242651581$24265158$1$I$20240101$20240820$20240829$20240829$EXP$$ZA-ABBVIE-5889692$ABBVIE$$43$YR$$M$Y$$$20240829$$CN$ZA$ZA
242651601$24265160$1$I$20240701$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137243$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240829$$HP$US$US
242651611$24265161$1$I$20240828$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59526$$FDA-CTU$$65$YR$$M$N$$$20240828$Y$PH$US$
242651621$24265162$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59507$$FDA-CTU$$55$YR$$F$N$$$20240828$N$$US$
242651632$24265163$2$F$$20240828$20240829$20240909$PER$$US-Prasco Laboratories-PRAS20241122$PRASCO$$$$E$F$Y$$$20240909$$CN$US$US
242651642$24265164$2$F$20240809$20240902$20240829$20240904$EXP$$US-SANDOZ INC.-SDZ2024US074603$SANDOZ$$66$YR$$F$Y$68.18$KG$20240904$$CN$US$US
242651651$24265165$1$I$20240731$20240823$20240829$20240829$EXP$FR-AFSSAPS-LM2024000455$FR-MYLANLABS-2024M1078361$MYLAN$$88$YR$$F$Y$45$KG$20240829$$PH$FR$FR
242651661$24265166$1$I$$20240820$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008718$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242651671$24265167$1$I$$20240820$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008722$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242651681$24265168$1$I$20240101$20240821$20240829$20240829$PER$$US-INSUD PHARMA-2408US06671$INSUD PHARMA$$$$$$Y$$$20240829$$CN$US$US
242651691$24265169$1$I$$20240815$20240829$20240829$PER$$US-INSUD PHARMA-2407US06444$INSUD PHARMA$$$$$$Y$$$20240829$$MD$US$US
242651701$24265170$1$I$$20240822$20240829$20240829$EXP$$US-INSUD PHARMA-2408US06725$INSUD PHARMA$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, Yue A, Rizvi A, Salgia R. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73:200:1-9$$$$$Y$$$20240829$$HP$US$US
242651711$24265171$1$I$$20240712$20240829$20240829$PER$$US-MRZWEB-2024070000026$MERZ$$$$$F$Y$$$20240829$$HP$US$US
242651741$24265174$1$I$20240801$20240820$20240829$20240829$30DAY$$UY-PFIZER INC-202400240905$PFIZER$$15$YR$$M$Y$$$20240829$$CN$UY$UY
242651781$24265178$1$I$$20240820$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008725$INCYTE$$$$$$Y$$$20240829$$HP$US$US
242651791$24265179$1$I$$20240822$20240829$20240829$EXP$$GB-TAKEDA-2024TUS086748$TAKEDA$$$$$$Y$$$20240829$$MD$GB$GB
242651801$24265180$1$I$20240801$20240820$20240829$20240829$PER$$US-INCYTE CORPORATION-2024IN008717$INCYTE$$$$$$Y$$$20240829$$CN$US$US
242651812$24265181$2$F$20240601$20240903$20240829$20240905$EXP$$US-ABBVIE-5898915$ABBVIE$$62$YR$$F$Y$83.46$KG$20240905$$CN$US$US
242651821$24265182$1$I$20240826$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136392$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240829$$HP$US$US
242651831$24265183$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137678$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240829$$HP$US$US
242651841$24265184$1$I$20240101$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137192$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240829$$HP$US$US
242651861$24265186$1$I$20240809$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59516$$FDA-CTU$$71$YR$$M$N$$$20240828$Y$PH$US$
242651872$24265187$2$F$$20240826$20240829$20240905$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202408015817$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240905$$CN$MX$MX
242651881$24265188$1$I$$20240828$20240829$20240829$EXP$$CA-SANDOZ INC.-SDZ2024CA076112$SANDOZ$$$$$$Y$$$20240829$$MD$CA$CA
242651891$24265189$1$I$$20240826$20240829$20240829$EXP$$US-MYLANLABS-2024M1079497$MYLAN$$$$$F$Y$$$20240829$$CN$US$US
242651901$24265190$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174600$NOVARTIS$$$$$$Y$$$20240829$$MD$US$US
242651911$24265191$1$I$20180101$20240828$20240829$20240829$EXP$US-MLMSERVICE-20240816-PI161771-00232-1$US-SANDOZ INC.-SDZ2024US076187$SANDOZ$$44$YR$$F$Y$$$20240829$$MD$US$US
242651921$24265192$1$I$$20240821$20240829$20240829$EXP$$GB-TEVA-VS-3236073$TEVA$$52$YR$$M$Y$146$KG$20240829$$MD$GB$GB
242651931$24265193$1$I$20180924$20240827$20240829$20240829$EXP$$CA-TAKEDA-2024TUS086834$TAKEDA$$38$YR$$F$Y$$$20240829$$MD$CA$CA
242651941$24265194$1$I$20240711$20240821$20240829$20240829$EXP$$KZ-BIOMARIN PHARMACEUTICAL INC.-AE-2024-160202$BIOMARIN$$$$$$Y$$$20240829$$CN$KZ$AE
242651951$24265195$1$I$$20240821$20240829$20240829$EXP$GB-MHRA-MED-202408211331256540-HZWRL$GB-TEVA-VS-3236302$TEVA$$82$YR$$F$Y$$$20240829$$HP$GB$GB
242651961$24265196$1$I$$20240827$20240829$20240829$PER$$JP-Eisai-EC-2024-173165$EISAI$$$$$F$Y$$$20240829$$MD$JP$JP
242651971$24265197$1$I$20240429$20240823$20240829$20240829$PER$$JP-Eisai-EC-2024-172811$EISAI$$$$E$M$Y$$$20240829$$MD$JP$JP
242651981$24265198$1$I$$20240828$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US076062$SANDOZ$$55$YR$$M$Y$$$20240829$$MD$US$US
242651991$24265199$1$I$20240716$20240820$20240829$20240829$EXP$FR-AFSSAPS-GR2024001011$FR-TEVA-VS-3235432$TEVA$$27$YR$$F$Y$$$20240829$$PH$FR$FR
242652001$24265200$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137927$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240829$$CN$US$US
242652011$24265201$1$I$$20240822$20240829$20240829$EXP$$US-MYLANLABS-2024M1079006$MYLAN$Mangini P, Serdenes R, Ortiz N. (101) Hyperactive Delirium in Heroin Toxic Leukoencephalopathy Complicated by Atypical NMS. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S50 abstr. 101.$52$YR$$M$Y$$$20240829$$HP$US$US
242652022$24265202$2$F$$20240819$20240829$20240906$EXP$$JP-009507513-2408JPN002294J$MERCK$Kono M, Takahashi K, Shimazaki M, Tomita K, Tabata J, Noguchi D, et al.. ORIGINAL ARTICLE: A retrospective study of the management of immune-related adverse events in patients with immune checkpoint inhibitors. Tokyo Journal of Obstetrics and Gynecology. 2024;73(3):475-9$49$YR$$F$Y$$$20240906$$HP$JP$JP
242652031$24265203$1$I$20240826$20240826$20240829$20240829$PER$$US-JNJFOC-20240870783$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$MD$US$US
242652041$24265204$1$I$$20240823$20240829$20240829$EXP$$NVSC2024HU173569$NOVARTIS$Siegler Z. Az Aicardi-szindromarol ot betegunk kapcsan [About Aicardi syndrome in five of our patients]. GYERMEKGYOGYASZAT. 2024;4:282-9$6$MON$$F$Y$$$20240829$$HP$HU$HU
242652051$24265205$1$I$20240424$20240820$20240829$20240829$EXP$FR-AFSSAPS-RE2024000826$FR-TEVA-VS-3234804$TEVA$$37$YR$$M$Y$85$KG$20240829$$MD$FR$FR
242652061$24265206$1$I$20240611$20240820$20240829$20240829$EXP$IT-MINISAL02-998854$IT-TEVA-VS-3234825$TEVA$$68$YR$$F$Y$$$20240829$$MD$IT$IT
242652072$24265207$2$F$20240801$20240910$20240829$20240918$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US002765$PAREXEL$$$$$$Y$$$20240918$$HP$US$US
242652081$24265208$1$I$20240507$20240820$20240829$20240829$EXP$FR-AFSSAPS-AN2024001088$FR-TEVA-VS-3235133$TEVA$$77$YR$$M$Y$65$KG$20240829$$MD$FR$FR
242652091$24265209$1$I$$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59448$$FDA-CTU$$$$$F$N$$$20240827$N$HP$US$
242652101$24265210$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59404$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
242652111$24265211$1$I$$20240822$20240828$20240828$DIR$FDA-CDER-CTU-2024-59474$$FDA-CTU$$$$$F$N$$$20240822$N$CN$US$
242652121$24265212$1$I$$20240819$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137599$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$96.62$KG$20240829$$CN$US$US
242652131$24265213$1$I$$20240827$20240829$20240829$EXP$$IN-SANDOZ INC.-SDZ2024IN075958$SANDOZ$$$$$M$Y$$$20240829$$CN$IN$IN
242652141$24265214$1$I$20220518$20240822$20240829$20240829$EXP$$JP-DSJP-DSJ-2022-146151$DAIICHI$Hirose N, Tachibana T, Izumi A, Sato S, Tadera N, Tamai Y, et al.. Bridging to transplant and post-transplant maintenance therapy with FLT3 inhibitors in patients with relapsed or refractory FLT3 mutated acute myeloid leukemia. Hematology. 2023;28(1):2220518$22$YR$$M$Y$$$20240829$$MD$JP$JP
242652151$24265215$1$I$20240718$20240820$20240829$20240829$EXP$FR-AFSSAPS-GR2024001017$FR-TEVA-VS-3235330$TEVA$$94$YR$$M$Y$$$20240829$$PH$FR$FR
242652161$24265216$1$I$20240629$20240823$20240829$20240829$EXP$FR-AFSSAPS-AVLY2024000134$FR-MYLANLABS-2024M1078364$MYLAN$$36$YR$$F$Y$$$20240829$$MD$FR$FR
242652174$24265217$4$F$20240722$20240911$20240829$20240919$EXP$FR-AFSSAPS-CN2024000792$FR-MYLANLABS-2024M1078373$MYLAN$$64$YR$$M$Y$86.85$KG$20240919$$MD$FR$FR
242652181$24265218$1$I$20240321$20240823$20240829$20240829$EXP$FR-AFSSAPS-AM2024000648$FR-MYLANLABS-2024M1078384$MYLAN$$17$YR$$M$Y$$$20240829$$MD$FR$FR
242652192$24265219$2$F$$20240924$20240829$20240930$EXP$$PT-MYLANLABS-2024M1078537$MYLAN$Caldeira E, Moniz E, Loja J, Almada S, Gomes S, Henriques CF, Capelo M, Brazao ML, Faria T, Silva S.. PO-0400 ? (3976) A rare case of tetany in the emergency department.. Medicina Interna - Congressos Nacionais. 2024;30(Sup 1):762$41$YR$$F$Y$$$20240930$$MD$PT$PT
242652201$24265220$1$I$$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137461$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240829$$CN$US$US
242652211$24265221$1$I$$20240821$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134934$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240829$$CN$US$US
242652221$24265222$1$I$20240724$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137792$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240829$$CN$US$US
242652241$24265224$1$I$20240731$20240820$20240829$20240829$EXP$FR-AFSSAPS-MP2024001277$FR-TEVA-VS-3235543$TEVA$$70$YR$$F$Y$75.6$KG$20240829$$MD$FR$FR
242652251$24265225$1$I$20231001$20240826$20240829$20240829$EXP$$TH-ELI_LILLY_AND_COMPANY-TH202408016294$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240829$$CN$TH$TH
242652261$24265226$1$I$$20240820$20240829$20240829$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408014256$ELI LILLY AND CO$Yoshida K, et al..Case Report: A case of contralateral vertebral artery dissection after initiation of Ramucirumab + nab-paclitaxel combination therapy in a patient with postoperative recurrence of gastric cancer with a history of vertebral artery dissection.Japanese Journal of Stroke 2024;4:305-308.$52$YR$A$M$Y$$$20240829$$MD$JP$JP
242652271$24265227$1$I$20240522$20240823$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408015688$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240829$$CN$US$US
242652281$24265228$1$I$20240701$20240820$20240829$20240829$EXP$ES-AEMPS-1560624$ES-TEVA-VS-3235606$TEVA$$54$YR$$F$Y$$$20240829$$MD$ES$ES
242652291$24265229$1$I$20240808$20240820$20240829$20240829$EXP$IT-MINISAL02-998880$IT-TEVA-VS-3235793$TEVA$$10$YR$$M$Y$38$KG$20240829$$MD$IT$IT
242652302$24265230$2$F$20240828$20240829$20240829$20240830$PER$$US-JAZZ PHARMACEUTICALS-2024-US-013737$JAZZ$$10$YR$$M$Y$$$20240830$$CN$US$US
242652311$24265231$1$I$20240101$20240821$20240829$20240829$EXP$NO-NOMAADVRE-PASRAPP-2024-Vxe7ee$NO-TEVA-VS-3235963$TEVA$$32$YR$$F$Y$$$20240829$$CN$NO$NO
242652321$24265232$1$I$$20240823$20240829$20240829$EXP$$GB-ABBVIE-5766129$ABBVIE$$$$E$M$Y$$$20240829$$CN$GB$GB
242652331$24265233$1$I$20240801$20240820$20240829$20240829$PER$$US-ABBVIE-5890362$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242652341$24265234$1$I$20240101$20240826$20240829$20240829$PER$$US-ABBVIE-5897142$ABBVIE$$$$$$Y$$$20240829$$CN$US$US
242652352$24265235$2$F$$20240911$20240829$20240917$EXP$$US-ABBVIE-5894386$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
242652371$24265237$1$I$20240101$20240821$20240829$20240829$EXP$DE-CADRBFARM-2024329864$DE-TEVA-VS-3236399$TEVA$$55$YR$$M$Y$78$KG$20240829$$CN$DE$DE
242652382$24265238$2$F$20240701$20240903$20240829$20240904$PER$$US-PURDUE PHARMA-USA-2024-0311670$PURDUE$$65$YR$$$Y$$$20240904$$CN$US$US
242652391$24265239$1$I$$20240828$20240829$20240829$PER$$US-PURDUE-USA-2024-0311645$PURDUE$$$$$F$Y$$$20240829$$CN$US$US
242652401$24265240$1$I$$20240827$20240829$20240829$PER$$US-PURDUE PHARMA-USA-2024-0311659$PURDUE$$$$A$M$Y$$$20240829$$CN$US$US
242652412$24265241$2$F$$20240829$20240829$20240830$PER$$US-PURDUE PHARMA-USA-2024-0311644$PURDUE$$$$$F$Y$$$20240830$$CN$US$US
242652421$24265242$1$I$$20240828$20240829$20240829$PER$$US-PURDUE PHARMA-USA-2024-0311643$PURDUE$$$$$M$Y$$$20240829$$PH$US$US
242652431$24265243$1$I$20240823$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137615$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240829$$HP$US$US
242652441$24265244$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137381$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240829$$HP$US$US
242652451$24265245$1$I$$20240820$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131904$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240829$$CN$US$US
242652461$24265246$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137016$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240829$$CN$US$US
242652471$24265247$1$I$20240825$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170196$AMGEN$$77$YR$E$F$Y$$$20240829$$CN$US$US
242652481$24265248$1$I$$20240828$20240829$20240829$EXP$$US-PFIZER INC-202400245842$PFIZER$$19$YR$$M$Y$$$20240829$$HP$US$US
242652491$24265249$1$I$20240719$20240820$20240829$20240829$EXP$FR-AFSSAPS-GR2024001015$FR-TEVA-VS-3235434$TEVA$$53$YR$$F$Y$$$20240829$$PH$FR$FR
242652502$24265250$2$F$$20240909$20240829$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137210$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240911$$CN$US$US
242652511$24265251$1$I$$20240823$20240829$20240829$EXP$$JP-PFIZER INC-202400245871$PFIZER$$37$YR$$$Y$$$20240829$$MD$JP$JP
242652532$24265253$2$F$20240502$20240919$20240829$20240923$EXP$$US-PFIZER INC-202400099252$PFIZER$$61$YR$$F$Y$$$20240923$$CN$US$US
242652551$24265255$1$I$20240801$20240820$20240829$20240829$PER$$US-SA-2024SA249665$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240829$$MD$US$US
242652561$24265256$1$I$$20240822$20240829$20240829$PER$$US-VERTEX PHARMACEUTICALS-2023-005461$VERTEX$$$$$$Y$$$20240829$$CN$US$US
242652572$24265257$2$F$$20240905$20240829$20240911$PER$$US-VERTEX PHARMACEUTICALS-2024-013661$VERTEX$$5$YR$$F$Y$$$20240911$$CN$US$US
242652591$24265259$1$I$20220101$20240821$20240829$20240829$EXP$$ES-VERTEX PHARMACEUTICALS-2023-017972$VERTEX$Mir-Ihara P, De Las Vecillas L, Heredia R, Fiandor A, Gonzalez-Munoz M, Zamarron E, et al.. Successful desensitization protocol to ivacaftor and a compound of elexacaftor/tezacaftor/ivacaftor in a delayed hypersensitivity reaction confirmed by lymphocyte transformation test. J Investig Allergol Clin Immunol. 2023$40$YR$$M$Y$$$20240829$$MD$ES$ES
242652601$24265260$1$I$20240820$20240827$20240828$20240828$DIR$FDA-CDER-CTU-2024-59491$$FDA-CTU$$44$YR$$F$N$$$20240827$N$$US$
242652611$24265261$1$I$20240101$20240828$20240829$20240829$EXP$$US-PFIZER INC-PV202400000817$PFIZER$$90$YR$$M$Y$$$20240829$$CN$US$US
242652622$24265262$2$F$$20240829$20240829$20240904$EXP$$CA-AstraZeneca-2024A196862$ASTRAZENECA$$65$YR$$F$Y$$$20240905$$MD$CA$
242652631$24265263$1$I$20240101$20240823$20240829$20240829$EXP$$US-VERTEX PHARMACEUTICALS-2024-011863$VERTEX$$$$$F$Y$$$20240829$$CN$US$US
242652641$24265264$1$I$20240720$20240821$20240829$20240829$EXP$PT-INFARMED-B202408-104$PT-TEVA-VS-3235762$TEVA$$19$YR$$M$Y$$$20240829$$MD$PT$PT
242652651$24265265$1$I$$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170229$AMGEN$$$$$M$Y$$$20240829$$CN$US$US
242652661$24265266$1$I$20231201$20240826$20240829$20240829$EXP$IE-HPRA-2024-114894$IE-MYLANLABS-2024M1078939$MYLAN$$$$$F$Y$$$20240829$$HP$IE$IE
242652681$24265268$1$I$20240817$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59576$$FDA-CTU$$57$YR$$F$N$$$20240829$N$HP$US$
242652691$24265269$1$I$$20240822$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014763$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240829$$CN$US$US
242652701$24265270$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59557$$FDA-CTU$$64$YR$$F$N$$$20240829$N$$US$
242652721$24265272$1$I$20240101$20240816$20240829$20240829$PER$$US-SA-2024SA196621$SANOFI AVENTIS$$$$A$F$Y$$$20240829$$MD$US$US
242652731$24265273$1$I$$20240718$20240829$20240829$PER$$US-LUNDBECK-DKLU4003121$LUNDBECK$$$$$$Y$$$20240829$$HP$US$US
242652751$24265275$1$I$20240816$20240821$20240829$20240829$DIR$FDA-CDER-CTU-2024-59531$$FDA-CTU$$62$YR$$F$N$57.9$KG$20240821$N$$US$
242652771$24265277$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59558$$FDA-CTU$$78$YR$$F$N$66.22$KG$20240829$N$$US$
242652781$24265278$1$I$$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59535$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
242652791$24265279$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59563$$FDA-CTU$$81$YR$$M$N$0$KG$20240829$N$$US$
242652801$24265280$1$I$20240804$20240809$20240829$20240829$PER$$US-TEVA-VS-3234428$TEVA$$34$YR$$M$Y$$$20240829$$CN$US$US
242652811$24265281$1$I$20240821$20240823$20240829$20240829$EXP$$CN-009507513-2408CHN009664$MERCK$$52$YR$$M$Y$62$KG$20240829$$HP$CN$CN
242652821$24265282$1$I$20240801$20240820$20240829$20240829$PER$$US-SA-2024SA249762$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240829$$CN$US$US
242652831$24265283$1$I$20230101$20240820$20240829$20240829$PER$$US-SA-2024SA249563$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240829$$MD$US$US
242652841$24265284$1$I$20240806$20240812$20240829$20240829$PER$$US-009507513-2408USA004067$MERCK$$$$$$Y$$$20240829$$CN$US$US
242652851$24265285$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137804$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240829$$CN$US$US
242652861$24265286$1$I$20220301$20240821$20240829$20240829$PER$$US-009507513-2408USA007472$MERCK$$64$YR$$M$Y$$$20240829$$CN$US$US
242652871$24265287$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137298$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240829$$HP$US$US
242652881$24265288$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137973$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$94.71$KG$20240829$$CN$US$US
242652891$24265289$1$I$20240714$20240719$20240829$20240829$PER$$US-LUNDBECK-DKLU4002238$LUNDBECK$$$$$$Y$$$20240829$$CN$US$US
242652901$24265290$1$I$20240814$20240823$20240829$20240829$EXP$$US-LANTHEUS-LMI-2024-01020$LANTHEUS MEDICAL IMAGING$$24$YR$$F$Y$81$KG$20240829$$CN$US$US
242652912$24265291$2$F$$20240909$20240829$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134466$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240912$$CN$US$US
242652921$24265292$1$I$20240101$20240803$20240829$20240829$PER$$US-009507513-2408USA001824$MERCK$$$$$F$Y$77.6$KG$20240829$$CN$US$US
242652931$24265293$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59553$$FDA-CTU$$59$YR$$M$N$$$20240829$N$$US$
242652941$24265294$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59577$$FDA-CTU$$65$YR$$M$N$$$20240829$N$$US$
242652951$24265295$1$I$$20240827$20240829$20240829$EXP$$PL-ELI_LILLY_AND_COMPANY-PL202408017523$ELI LILLY AND CO$$$$$F$Y$$$20240829$$MD$PL$PL
242652961$24265296$1$I$20240725$20240827$20240829$20240829$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407008202$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$BR$BR
242652971$24265297$1$I$$20240821$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013446$ELI LILLY AND CO$$$$$F$Y$$$20240829$$CN$US$US
242652981$24265298$1$I$20230309$20240821$20240829$20240829$EXP$$PL-ELI_LILLY_AND_COMPANY-PL202408014079$ELI LILLY AND CO$$60$YR$A$M$Y$90.6$KG$20240829$$CN$PL$PL
242652991$24265299$1$I$$20240821$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408017681$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240829$$CN$US$US
242653001$24265300$1$I$20240717$20240821$20240829$20240829$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408018186$ELI LILLY AND CO$$71$YR$E$M$Y$77$KG$20240829$$CN$DE$CN
242653011$24265301$1$I$$20240820$20240829$20240829$PER$$US-ABBVIE-5889810$ABBVIE$$$$$$Y$$$20240829$$CN$US$US
242653021$24265302$1$I$20240616$20240820$20240829$20240829$EXP$FR-AFSSAPS-LY2024001221$FR-009507513-2408FRA006800$MERCK$$60$YR$$M$Y$50.5$KG$20240829$$PH$FR$FR
242653041$24265304$1$I$$20240823$20240829$20240829$EXP$$US-ELI_LILLY_AND_COMPANY-US202408017851$ELI LILLY AND CO$$84$YR$E$F$Y$86.168$KG$20240829$$CN$US$US
242653051$24265305$1$I$$20240828$20240829$20240829$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048422$BOEHRINGER INGELHEIM$$$$$$Y$$$20240829$$CN$US$US
242653071$24265307$1$I$$20240828$20240829$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US076128$SANDOZ$$$$$M$Y$$$20240829$$CN$US$US
242653081$24265308$1$I$$20240719$20240829$20240829$PER$$US-LUNDBECK-DKLU4002039$LUNDBECK$$$$$$Y$$$20240829$$HP$US$US
242653091$24265309$1$I$$20240815$20240829$20240829$PER$$US-BIOMARINAP-US-2024-160120$BIOMARIN$$$$$$Y$$$20240829$$CN$US$US
242653101$24265310$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59584$$FDA-CTU$$31$YR$$F$N$$$20240829$N$$US$
242653112$24265311$2$F$20240816$20240830$20240829$20240911$EXP$$ES-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000026$IOVANCE BIOTHERAPEUTICS$$68$YR$$M$Y$$$20240910$$MD$ES$ES
242653121$24265312$1$I$20240701$20240710$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000039$MERZ$$$$$F$Y$$$20240829$$HP$US$US
242653131$24265313$1$I$20240701$20240710$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000041$MERZ$$$$$F$Y$$$20240829$$HP$US$US
242653141$24265314$1$I$20230808$20230809$20240829$20240829$PER$$US-GALDERMA-US2023012019$GALDERMA$$$$$$Y$$$20240829$$CN$US$US
242653151$24265315$1$I$20240701$20240710$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000040$MERZ$$$$$F$Y$$$20240829$$HP$US$US
242653161$24265316$1$I$$20240126$20240829$20240829$PER$$US-GALDERMA-US2024001474$GALDERMA$$$$$M$Y$$$20240829$$HP$US$US
242653171$24265317$1$I$$20240123$20240829$20240829$PER$$US-GALDERMA-US2024001289$GALDERMA$$$$$F$Y$$$20240829$$MD$US$US
242653181$24265318$1$I$$20240130$20240829$20240829$PER$$US-GALDERMA-US2024001742$GALDERMA$$$$$$Y$$$20240829$$MD$US$US
242653191$24265319$1$I$$20240111$20240829$20240829$PER$$US-GALDERMA-US2024000466$GALDERMA$$$$$$Y$$$20240829$$HP$US$US
242653201$24265320$1$I$$20240129$20240829$20240829$PER$$US-GALDERMA-US2024001643$GALDERMA$$$$$$Y$$$20240829$$HP$US$US
242653211$24265321$1$I$$20240201$20240829$20240829$PER$$US-GALDERMA-US2024001847$GALDERMA$$$$$F$Y$$$20240829$$HP$US$US
242653221$24265322$1$I$$20240307$20240829$20240829$PER$$US-GALDERMA-US2024004301$GALDERMA$$$$$$Y$$$20240829$$MD$US$US
242653231$24265323$1$I$$20240110$20240829$20240829$PER$$US-GALDERMA-US2024000425$GALDERMA$$$$$$Y$$$20240829$$HP$US$US
242653241$24265324$1$I$$20240131$20240829$20240829$PER$$US-GALDERMA-US2024001774$GALDERMA$$$$$$Y$$$20240829$$MD$US$US
242653251$24265325$1$I$$20240314$20240829$20240829$PER$$US-GALDERMA-US2024004746$GALDERMA$$$$$$Y$$$20240829$$MD$US$US
242653261$24265326$1$I$$20240314$20240829$20240829$PER$$US-GALDERMA-US2024004738$GALDERMA$$$$$$Y$$$20240829$$MD$US$US
242653271$24265327$1$I$$20240322$20240829$20240829$PER$$US-GALDERMA-US2024005275$GALDERMA$$$$$F$Y$$$20240829$$HP$US$US
242653281$24265328$1$I$$20240314$20240829$20240829$PER$$US-GALDERMA-US2024004743$GALDERMA$$$$$$Y$$$20240829$$MD$US$US
242653291$24265329$1$I$$20240328$20240829$20240829$PER$$US-GALDERMA-US2024005633$GALDERMA$$$$$$Y$$$20240829$$MD$US$US
242653301$24265330$1$I$$20240429$20240829$20240829$PER$$US-GALDERMA-US2024007463$GALDERMA$$$$$$Y$$$20240829$$CN$US$US
242653311$24265331$1$I$$20240515$20240829$20240829$PER$$US-GALDERMA-US2024008449$GALDERMA$$$$$F$Y$$$20240829$$CN$US$US
242653321$24265332$1$I$$20240312$20240829$20240829$PER$$US-GALDERMA-US2024004547$GALDERMA$$$$$$Y$$$20240829$$CN$US$US
242653331$24265333$1$I$$20240411$20240829$20240829$PER$$US-GALDERMA-US2024006307$GALDERMA$$$$$$Y$$$20240829$$HP$US$US
242653341$24265334$1$I$$20240521$20240829$20240829$PER$$US-GALDERMA-US2024008764$GALDERMA$$$$$$Y$$$20240829$$MD$US$US
242653351$24265335$1$I$$20240624$20240829$20240829$PER$$US-GALDERMA-US2024010482$GALDERMA$$$$$$Y$$$20240829$$MD$US$US
242653361$24265336$1$I$$20240307$20240829$20240829$PER$$US-GALDERMA-US2024004308$GALDERMA$$$$$$Y$$$20240829$$MD$US$US
242653373$24265337$3$F$$20240920$20240829$20240930$EXP$$JP-Eisai-EC-2024-172940$EISAI$$$$$M$Y$$$20240930$$MD$JP$JP
242653381$24265338$1$I$20240701$20240710$20240829$20240829$PER$$US-MRZWEB-2024070000043$MERZ$$49$YR$$F$Y$$$20240829$$HP$US$US
242653391$24265339$1$I$$20240710$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000044$MERZ$$$$A$F$Y$$$20240829$$HP$US$US
242653411$24265341$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59562$$FDA-CTU$$66$YR$$F$N$$$20240829$N$$US$
242653431$24265343$1$I$$20240709$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000045$MERZ$$$$$F$Y$$$20240829$$MD$US$US
242653441$24265344$1$I$$20240816$20240829$20240829$EXP$$SE-VER-202400001$VERITY PHARMACEUTICALS$$$$$M$Y$$$20240829$$MD$SE$SE
242653451$24265345$1$I$$20240703$20240829$20240829$PER$$US-Merz Pharmaceuticals GmbH-2024070000063$MERZ$$61$YR$$M$Y$$$20240829$$HP$US$US
242653461$24265346$1$I$20220101$20240827$20240829$20240829$EXP$$NVSC2024EG164104$NOVARTIS$$$$$F$Y$49.5$KG$20240829$$CN$EG$EG
242653472$24265347$2$F$$20240910$20240829$20240920$PER$$US-BAUSCHBL-2024BNL032149$BAUSCH AND LOMB$$$$$F$Y$$$20240920$$CN$US$US
242653481$24265348$1$I$$20240823$20240829$20240829$PER$$US-BAUSCHBL-2024BNL032292$BAUSCH AND LOMB$$$$$F$Y$$$20240829$$CN$US$US
242653492$24265349$2$F$20240713$20240904$20240829$20240910$EXP$$EU-BAUSCHBL-2024BNL032270$BAUSCH AND LOMB$$89$YR$$F$Y$53$KG$20240910$$MD$EU$EU
242653502$24265350$2$F$20231201$20240904$20240829$20240910$EXP$$US-ABBVIE-5891353$ABBVIE$$68$YR$$F$Y$57$KG$20240910$$CN$US$US
242653511$24265351$1$I$$20240828$20240829$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048524$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240829$$CN$US$US
242653521$24265352$1$I$$20240828$20240829$20240829$PER$$US-JNJFOC-20240874006$JOHNSON AND JOHNSON$$$$$M$Y$$$20240829$$CN$US$US
242653531$24265353$1$I$20240801$20240827$20240829$20240829$EXP$$US-ABBVIE-5899297$ABBVIE$$76$YR$$M$Y$$$20240829$$CN$US$US
242653541$24265354$1$I$$20240827$20240829$20240829$PER$$US-ALXN-202408USA001826US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242653551$24265355$1$I$$20240827$20240829$20240829$PER$$US-JNJFOC-20240871035$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$CN$US$US
242653561$24265356$1$I$$20240828$20240829$20240829$EXP$$ES-PAIPHARMA-2024-ES-000093$PHARMACEUTICAL ASSOC$Soto-Moreno A, Diaz-Calvillo P, Arias-Santiago S.Kounis syndrome, mast cells beyond the skin..Actas Dermo-Sifiliograficas.2024;.$51$YR$$M$Y$$$20240829$$HP$ES$ES
242653571$24265357$1$I$20220501$20240828$20240829$20240829$EXP$$IT-PAIPHARMA-2024-IT-000125$PHARMACEUTICAL ASSOC$Puppo G, Novelli F, Pinelli V, et al.Valproic acid-induced pleural effusion..Rassegna di Patologia dell^Apparato Respiratorio.2023;38(1):53-56.$53$YR$$M$Y$$$20240829$$HP$IT$IT
242653581$24265358$1$I$$20240705$20240829$20240829$PER$$US-MRZWEB-2024070000074$MERZ$$50$YR$$M$Y$$$20240829$$HP$US$US
242653591$24265359$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136561$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240829$$HP$US$US
242653611$24265361$1$I$20220101$20240813$20240829$20240829$PER$$US-INSUD PHARMA-2408US06445$INSUD PHARMA$$$$$$Y$$$20240829$$CN$US$US
242653621$24265362$1$I$20240823$20240827$20240829$20240829$EXP$$US-ABBVIE-5898776$ABBVIE$$42$YR$$F$Y$$$20240829$$CN$US$US
242653642$24265364$2$F$$20240828$20240829$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136795$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240903$$CN$US$US
242653652$24265365$2$F$20240803$20240827$20240829$20240905$PER$$US-BIOGEN-2024BI01279730$BIOGEN$$33$YR$$F$Y$$$20240905$$CN$US$US
242653661$24265366$1$I$20240101$20240821$20240829$20240829$PER$$US-ABBVIE-5890015$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242653671$24265367$1$I$$20240808$20240829$20240829$PER$$US-009507513-2408USA003001$MERCK$$$$$M$Y$$$20240829$$CN$US$US
242653691$24265369$1$I$20240808$20240822$20240829$20240829$EXP$$US-009507513-2408USA008217$MERCK$$66$YR$$F$Y$103$KG$20240829$$HP$US$US
242653701$24265370$1$I$20240816$20240826$20240829$20240829$PER$$US-JNJFOC-20240875694$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240829$$HP$US$US
242653712$24265371$2$F$20230101$20240905$20240829$20240912$EXP$$US-009507513-2408USA008395$MERCK$$$$$F$Y$55.3$KG$20240912$$HP$US$US
242653721$24265372$1$I$20240702$20240820$20240829$20240829$EXP$FR-AFSSAPS-CF2024000390$FR-TEVA-VS-3235358$TEVA$$53$YR$$M$Y$$$20240829$$MD$FR$FR
242653731$24265373$1$I$$20240819$20240829$20240829$PER$$US-JNJFOC-20240877025$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240829$$CN$US$US
242653741$24265374$1$I$20240101$20240829$20240829$20240829$PER$$US-JNJFOC-20240878052$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$CN$US$US
242653752$24265375$2$F$$20240906$20240829$20240921$PER$$US-JNJFOC-20240876845$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240921$$PH$US$US
242653761$24265376$1$I$20240710$20240821$20240829$20240829$PER$$US-JNJFOC-20240877056$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240829$$HP$US$US
242653772$24265377$2$F$20240814$20240906$20240829$20240921$PER$$US-JNJFOC-20240875788$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240921$$PH$US$US
242653791$24265379$1$I$$20240828$20240829$20240829$PER$$US-009507513-2408USA010112$MERCK$$$$$M$Y$$$20240829$$PH$US$US
242653802$24265380$2$F$20240523$20240905$20240829$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024070000075$MERZ$$$$$$Y$$$20240925$$HP$US$US
242653811$24265381$1$I$$20240806$20240829$20240829$PER$$US-JNJFOC-20240816410$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240829$$CN$US$US
242653821$24265382$1$I$$20240827$20240829$20240829$PER$$US-ALXN-202408USA001768US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$HP$US$US
242653831$24265383$1$I$$20240823$20240829$20240829$PER$$US-ALXN-202408USA001668US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242653851$24265385$1$I$$20240626$20240829$20240829$30DAY$$BR-PFIZER INC-202400244929$PFIZER$$$$$$Y$$$20240829$$CN$BR$BR
242653861$24265386$1$I$20240829$20240829$20240829$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048623$BOEHRINGER INGELHEIM$$75$YR$E$$Y$$$20240829$$CN$US$US
242653871$24265387$1$I$20180101$20240819$20240829$20240829$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-133975$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240829$$MD$DE$DE
242653881$24265388$1$I$20240101$20240823$20240829$20240829$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005005$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240829$$MD$US$US
242653891$24265389$1$I$20240101$20240820$20240829$20240829$EXP$FR-AFSSAPS-BR2024000672$FR-TEVA-VS-3235319$TEVA$$82$YR$$F$Y$61$KG$20240829$$MD$FR$FR
242653901$24265390$1$I$20240101$20240819$20240829$20240829$PER$$US-JNJFOC-20240849628$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240829$$CN$US$US
242653912$24265391$2$F$$20240905$20240829$20240912$PER$$US-AstraZeneca-2024A179055$ASTRAZENECA$$$$$$Y$$$20240912$$CN$US$
242653922$24265392$2$F$$20240827$20240829$20240904$EXP$$CA-BIOGEN-2024BI01279712$BIOGEN$$$$$F$Y$$$20240904$$CN$CA$CA
242653942$24265394$2$F$20240820$20240917$20240829$20240926$PER$$US-BIOGEN-2024BI01279297$BIOGEN$$19$YR$$M$Y$$$20240926$$CN$US$US
242653951$24265395$1$I$$20240814$20240829$20240829$PER$$US-BIOMARINAP-US-2024-160118$BIOMARIN$$$$$$Y$$$20240829$$CN$US$US
242653961$24265396$1$I$$20240822$20240829$20240829$EXP$$FR-009507513-2408FRA010193$MERCK$Bottosso M, Verret B, Caron O, Hamzaoui N, Pasmant E, Danlos FX, et al. Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome. JCO Precision Oncology. 2024;8():1-6$$$A$F$Y$$$20240829$$MD$FR$FR
242653981$24265398$1$I$$20240826$20240829$20240829$EXP$$CA-009507513-2408CAN009595$MERCK$$81$YR$$$Y$$$20240829$$PH$CA$CA
242653993$24265399$3$F$20240101$20240906$20240829$20240919$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1110$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240919$$HP$US$US
242654011$24265401$1$I$$20240826$20240829$20240829$EXP$$CZ-GILEAD-2024-0685444$GILEAD$$65$YR$E$M$Y$$$20240829$$MD$CZ$CZ
242654021$24265402$1$I$$20240814$20240829$20240829$PER$$US-ASTELLAS-2024-AER-000847$ASTELLAS$$59$YR$A$F$Y$$$20240829$$CN$US$US
242654033$24265403$3$F$20240822$20240906$20240829$20240920$EXP$$CA-HLS-202402171$HLS THERAPEUTICS$$45$YR$A$M$Y$104$KG$20240920$$PH$CA$CA
242654041$24265404$1$I$$20240829$20240829$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048626$BOEHRINGER INGELHEIM$$$$$$Y$$$20240829$$CN$US$US
242654051$24265405$1$I$$20240814$20240829$20240829$EXP$$US-IOVANCE BIOTHERAPEUTICS, INC-2024IOV000059$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240829$$HP$US$US
242654061$24265406$1$I$20240320$20240606$20240829$20240829$EXP$$US-BIOMARINAP-US-2024-160208$BIOMARIN$$$$$$Y$$$20240829$$CN$US$US
242654073$24265407$3$F$$20240904$20240829$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-137440$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240910$$MD$JP$JP
242654081$24265408$1$I$$20240821$20240829$20240829$PER$$US-AstraZeneca-2024A191048$ASTRAZENECA$$$$$M$Y$$$20240829$$CN$US$
242654091$24265409$1$I$$20240815$20240829$20240829$EXP$$US-HLS-202400937$HLS THERAPEUTICS$$$$A$F$Y$$$20240829$$HP$US$US
242654102$24265410$2$F$$20240911$20240829$20240920$EXP$$CA-TAKEDA-2021TUS022093$TAKEDA$$65$YR$$M$Y$96$KG$20240920$$MD$CA$CA
242654111$24265411$1$I$20230509$20240822$20240829$20240829$EXP$$JP-009507513-2408JPN003141J$MERCK$$77$YR$$F$Y$$$20240829$$MD$JP$JP
242654131$24265413$1$I$$20240820$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132528$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240829$$CN$US$US
242654141$24265414$1$I$20240827$20240822$20240829$20240829$EXP$$US-TAKEDA-2024TUS085753$TAKEDA$$77$YR$$M$Y$$$20240829$$CN$US$US
242654151$24265415$1$I$20240301$20240828$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137611$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240829$$CN$US$US
242654161$24265416$1$I$$20240822$20240829$20240829$PER$$US-JNJFOC-20240873028$JOHNSON AND JOHNSON$$$$$F$Y$$$20240829$$HP$US$US
242654171$24265417$1$I$20240101$20240821$20240829$20240829$PER$$US-SA-2024SA249311$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240830$$PH$US$US
242654181$24265418$1$I$$20240821$20240829$20240829$PER$$US-SA-2024SA249800$SANOFI AVENTIS$$$$$$Y$$$20240830$$PH$US$US
242654191$24265419$1$I$20240623$20240826$20240829$20240829$EXP$$CO-AMGEN-COLSP2024171876$AMGEN$$$$$F$Y$$$20240829$$CN$CO$CO
242654202$24265420$2$F$$20240822$20240829$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-136329$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240905$$CN$JP$JP
242654211$24265421$1$I$$20240827$20240829$20240829$PER$$US-JNJFOC-20240869825$JOHNSON AND JOHNSON$$$$$$Y$$$20240829$$MD$US$US
242654221$24265422$1$I$20230101$20240826$20240829$20240829$EXP$$CO-AMGEN-COLSP2024171878$AMGEN$$$$$F$Y$$$20240829$$CN$CO$CO
242654231$24265423$1$I$20240808$20240827$20240829$20240829$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013725$JAZZ$$38$YR$$F$Y$$$20240829$$CN$US$US
242654241$24265424$1$I$20230101$20240827$20240829$20240829$EXP$$CO-AMGEN-COLSP2024172440$AMGEN$$$$$F$Y$$$20240829$$CN$CO$CO
242654251$24265425$1$I$$20240820$20240829$20240829$PER$$US-BIOMARINAP-US-2024-160003$BIOMARIN$$$$$$Y$$$20240829$$CN$US$US
242654261$24265426$1$I$20240709$20240821$20240829$20240829$EXP$$JP-AMGEN-JPNSP2024154331$AMGEN$$$$$$Y$$$20240829$$PH$JP$JP
242654271$24265427$1$I$$20240827$20240829$20240829$EXP$$NVSJ2024JP010095$NOVARTIS$$$$$M$Y$$$20240830$$MD$JP$JP
242654281$24265428$1$I$$20240826$20240829$20240829$EXP$$JP-TAKEDA-2024TJP012499$TAKEDA$$$$A$$Y$$$20240829$$MD$JP$JP
242654291$24265429$1$I$$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171939$AMGEN$$$$$$Y$$$20240829$$HP$US$US
242654301$24265430$1$I$$20240818$20240829$20240829$EXP$$US-JNJFOC-20240849111$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240830$$MD$US$US
242654311$24265431$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000881$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654332$24265433$2$F$$20240831$20240829$20240924$PER$$US-SMPA-2024SPA000718$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242654341$24265434$1$I$$20240804$20240829$20240829$PER$$US-SMPA-2024SPA000796$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654351$24265435$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000842$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654361$24265436$1$I$$20240803$20240829$20240829$PER$$US-SMPA-2024SPA000831$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654371$24265437$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000761$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654381$24265438$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000882$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654391$24265439$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000823$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654401$24265440$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000871$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654413$24265441$3$F$$20240913$20240829$20240927$PER$$US-SMPA-2024SPA000778$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242654421$24265442$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000748$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654433$24265443$3$F$20240801$20240919$20240829$20240930$PER$$US-SMPA-2024SPA000896$SUNOVION$$$$$$Y$$$20240929$$CN$US$US
242654441$24265444$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000955$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654454$24265445$4$F$$20240911$20240829$20240925$PER$$US-SMPA-2024SPA000904$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242654461$24265446$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000764$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654471$24265447$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000810$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654481$24265448$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000919$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654492$24265449$2$F$$20240901$20240829$20240924$PER$$US-SMPA-2024SPA000804$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242654501$24265450$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000762$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654512$24265451$2$F$$20240802$20240829$20240919$PER$$US-SMPA-2024SPA000777$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
242654521$24265452$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000923$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654531$24265453$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000760$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654551$24265455$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000863$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654561$24265456$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000956$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654572$24265457$2$F$$20240910$20240829$20240927$PER$$US-SMPA-2024SPA000779$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242654581$24265458$1$I$$20240803$20240829$20240829$PER$$US-SMPA-2024SPA000799$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654592$24265459$2$F$$20240913$20240829$20240927$PER$$US-SMPA-2024SPA000887$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242654601$24265460$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000790$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654611$24265461$1$I$$20240803$20240829$20240829$PER$$US-SMPA-2024SPA000895$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654621$24265462$1$I$$20240803$20240829$20240829$PER$$US-SMPA-2024SPA000812$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654631$24265463$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000792$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654642$24265464$2$F$$20240904$20240829$20240924$PER$$US-SMPA-2024SPA000908$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242654651$24265465$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000977$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654661$24265466$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000939$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654681$24265468$1$I$20240101$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000844$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654691$24265469$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000833$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654702$24265470$2$F$$20240904$20240829$20240924$PER$$US-SMPA-2024SPA000834$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242654712$24265471$2$F$$20240904$20240829$20240924$PER$$US-SMPA-2024SPA000800$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242654731$24265473$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA001106$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654741$24265474$1$I$20240701$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000787$SUNOVION$$$$$$Y$$$20240829$$PH$US$US
242654752$24265475$2$F$$20240906$20240829$20240927$PER$$US-SMPA-2024SPA000811$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242654761$24265476$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000965$SUNOVION$$$$$$Y$$$20240829$$MD$US$US
242654772$24265477$2$F$20240710$20240829$20240829$20240923$PER$$US-SMPA-2024SPA000825$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242654781$24265478$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000756$SUNOVION$$$$$$Y$$$20240829$$HP$US$US
242654791$24265479$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000758$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654801$24265480$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000853$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654811$24265481$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000914$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654821$24265482$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000861$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654831$24265483$1$I$$20240805$20240829$20240829$PER$$US-SMPA-2024SPA000902$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654841$24265484$1$I$$20240802$20240829$20240829$PER$$US-SMPA-2024SPA000874$SUNOVION$$$$$$Y$$$20240829$$CN$US$US
242654852$24265485$2$F$$20240830$20240829$20240923$PER$$US-SMPA-2024SPA000190$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242654861$24265486$1$I$20240701$20240815$20240829$20240829$EXP$$US-MDD US Operations-MDD202407-002583$MDD OPERATIONS$$57$YR$$F$Y$$$20240829$$HP$US$
242654871$24265487$1$I$$20240820$20240829$20240829$EXP$$IT-JNJFOC-20240855618$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$HP$IT$IT
242654881$24265488$1$I$$20240828$20240829$20240829$EXP$$AU-SANDOZ INC.-SDZ2024AU075964$SANDOZ$$55$YR$$M$Y$$$20240829$$MD$AU$AU
242654893$24265489$3$F$20240813$20240924$20240829$20240926$EXP$$JP-TAKEDA-2024TJP012611$TAKEDA$$19$YR$$M$Y$$$20240926$$HP$JP$JP
242654901$24265490$1$I$$20240822$20240829$20240829$PER$$US-BIOGEN-2024BI01279870$BIOGEN$$$$$M$Y$$$20240829$$CN$US$US
242654911$24265491$1$I$$20240828$20240829$20240829$EXP$$JP-SANDOZ INC.-SDZ2024JP056119$SANDOZ$$48$YR$$F$Y$$$20240829$$MD$JP$JP
242654922$24265492$2$F$20240822$20240905$20240829$20240909$EXP$$JP-TAKEDA-2024TJP012507$TAKEDA$$3$DEC$$F$Y$$$20240909$$MD$JP$JP
242654932$24265493$2$F$20240825$20240910$20240829$20240911$PER$$US-AMGEN-USASP2024171742$AMGEN$$58$YR$A$M$Y$$$20240911$$CN$US$US
242654941$24265494$1$I$$20240829$20240829$20240829$PER$$NVSC2024US174642$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
242654951$24265495$1$I$$20240828$20240829$20240829$EXP$$IE-SANDOZ INC.-SDZ2024IE075947$SANDOZ$$63$YR$$F$Y$$$20240829$$MD$IE$IE
242654963$24265496$3$F$$20240913$20240829$20240925$30DAY$$CA-JNJFOC-20240842156$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$PH$CA$CA
242654971$24265497$1$I$$20240829$20240829$20240829$PER$$NVSC2024US174644$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
242654981$24265498$1$I$20240816$20240819$20240829$20240829$30DAY$$MX-AMGEN-MEXSP2024166851$AMGEN$$64$YR$A$F$Y$$$20240829$$CN$MX$MX
242655001$24265500$1$I$$20240829$20240829$20240829$PER$$NVSC2024US174646$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
242655011$24265501$1$I$20240802$20240822$20240829$20240829$EXP$$CN-BEIGENE-BGN-2024-013260$BEIGENE$$$$$$Y$$$20240829$$HP$CN$CN
242655021$24265502$1$I$$20240829$20240829$20240829$PER$$NVSC2024US174645$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
242655042$24265504$2$F$20231226$20240903$20240829$20240911$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001684$BLUEPRINT MEDICINES$$47$YR$A$M$Y$161.8$KG$20240911$$MD$US$US
242655052$24265505$2$F$20240701$20240910$20240829$20240918$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001708$BLUEPRINT MEDICINES$$61$YR$A$F$Y$$$20240918$$CN$US$US
242655062$24265506$2$F$20240813$20240828$20240829$20240905$PER$$US-AMGEN-USASP2024168759$AMGEN$$35$YR$A$F$Y$65$KG$20240904$$HP$US$US
242655071$24265507$1$I$$20240822$20240829$20240829$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001727$BLUEPRINT MEDICINES$$$$$$Y$$$20240830$$MD$US$US
242655081$24265508$1$I$$20240820$20240829$20240829$PER$$US-ABBVIE-5890953$ABBVIE$$$$A$F$Y$$$20240829$$MD$US$US
242655092$24265509$2$F$20240801$20240823$20240829$20240908$PER$$US-BAUSCHBL-2024BNL032217$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240909$$PH$US$US
242655101$24265510$1$I$20240404$20240828$20240829$20240829$EXP$$JP-TAKEDA-2024TJP012624$TAKEDA$$85$YR$$F$Y$40.5$KG$20240829$$PH$JP$JP
242655111$24265511$1$I$20240528$20240827$20240829$20240829$EXP$$CA-TAKEDA-2024TUS087133$TAKEDA$$73$YR$$F$Y$$$20240829$$CN$CA$CA
242655121$24265512$1$I$$20240821$20240829$20240829$EXP$$US-JNJFOC-20240870247$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240830$$HP$US$US
242655131$24265513$1$I$$20240826$20240829$20240829$EXP$$US-TAKEDA-2024TUS060243$TAKEDA$$$$$F$Y$$$20240829$$MD$US$US
242655142$24265514$2$F$20240828$20240829$20240829$20240902$PER$$US-AMGEN-USASP2024172380$AMGEN$$55$YR$A$F$Y$$$20240902$$CN$US$US
242655151$24265515$1$I$20220101$20240827$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016967$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240829$$CN$US$US
242655162$24265516$2$F$20240609$20240912$20240829$20240915$EXP$$US-ORGANON-O2408USA002208$ORGANON$$23$YR$$F$Y$104.31$KG$20240915$$MD$US$US
242655171$24265517$1$I$20231020$20240826$20240829$20240829$EXP$$JP-TAKEDA-2024TJP012488$TAKEDA$$84$YR$$F$Y$$$20240829$$MD$JP$JP
242655181$24265518$1$I$20240621$20240828$20240829$20240829$EXP$$NVSJ2024JP006914$NOVARTIS$$94$YR$$F$Y$$$20240830$$PH$JP$JP
242655191$24265519$1$I$20240101$20240829$20240829$20240829$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048631$BOEHRINGER INGELHEIM$$$$$$Y$$$20240830$$HP$US$US
242655201$24265520$1$I$20240827$20240828$20240829$20240829$EXP$$CL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048539$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240830$$MD$CL$CL
242655211$24265521$1$I$20230501$20240822$20240829$20240829$EXP$$CA-ABBVIE-5892700$ABBVIE$$$$A$F$Y$$$20240829$$CN$CA$CA
242655222$24265522$2$F$$20240830$20240829$20240904$EXP$$TW-009507513-2408TWN008898$MERCK$Chu C, Liang H, Lien M, Wu H.. Immune Checkpoint Inhibitor-Related Myocarditis: A Case Series and Literature Review. Acta Cardiologica Sinica. 2024;40 (4)::445-50$63$YR$$F$Y$$$20240904$$HP$TW$TW
242655231$24265523$1$I$20240701$20240823$20240829$20240829$EXP$$US-JNJFOC-20240707349$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240830$$HP$US$US
242655241$24265524$1$I$20240801$20240823$20240829$20240829$EXP$$US-MTPC-MTDA2024-0018108$MITSUBISHI TANABE PHARMA$$81$YR$$M$Y$$$20240829$$CN$US$US
242655252$24265525$2$F$20240822$20240905$20240829$20240908$30DAY$$US-SANDOZ INC.-SDZ2024US076214$SANDOZ$$81$YR$$M$Y$$$20240908$$CN$US$US
242655261$24265526$1$I$20221001$20240822$20240829$20240829$EXP$$US-ABBVIE-5892361$ABBVIE$$43$YR$$M$Y$$$20240829$$CN$US$US
242655271$24265527$1$I$$20240823$20240829$20240829$EXP$$US-MTPC-MTDA2024-0018212$MITSUBISHI TANABE PHARMA$$$$A$$Y$$$20240829$$CN$US$US
242655281$24265528$1$I$$20240823$20240829$20240829$EXP$$JP-MTPC-MTPC2024-0016305$MITSUBISHI TANABE PHARMA$$69$YR$$F$Y$$$20240829$$PH$JP$JP
242655301$24265530$1$I$$20240822$20240829$20240829$EXP$$GR-AMGEN-GRCSP2024168940$AMGEN$$$$$F$Y$$$20240829$$MD$GR$GR
242655311$24265531$1$I$$20240819$20240829$20240829$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001241$ALEMBIC$Hui J, Zhan X, Bashir A, Policeni F, KimHsieh S. Epithelial-myoepithelial carcinoma occurrence in the site of previously treated ductal carcinoma in??situ of the breast: Imaging features with histopathologic correlation, a case report and review of the literature. Clinical Case Reports. 2024;12 (8) e9270:1-6$$$$$Y$$$20240829$$HP$US$US
242655321$24265532$1$I$$20240819$20240829$20240829$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001253$ALEMBIC$Glahn J.Z, Almeidaazaz M.N, Kochen A, Noel O, Stogner V, Hsia H.C et.al.. Lamotrigine Emerging as a Driver of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An 8-Year Retrospective Study. Burns. 2024;1-10$$$$$Y$$$20240829$$HP$US$US
242655332$24265533$2$F$20231001$20240903$20240829$20240905$EXP$$US-ABBVIE-5896801$ABBVIE$$82$YR$$M$Y$68$KG$20240905$$CN$US$US
242655341$24265534$1$I$$20240823$20240829$20240829$PER$$US-ABBVIE-5895816$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242655351$24265535$1$I$$20240823$20240829$20240829$EXP$$US-CHATTEMPRD-2024OHG029320$CHATTEM$$$$$M$Y$$$20240829$$LW$US$US
242655361$24265536$1$I$$20240821$20240829$20240829$EXP$$US-CHATTEMPRD-2024OHG028924$CHATTEM$$$$A$M$Y$$$20240829$$LW$US$US
242655382$24265538$2$F$$20240920$20240829$20240924$EXP$$NVSJ2024JP010011$NOVARTIS$$50$YR$$M$Y$130$KG$20240925$$MD$JP$JP
242655391$24265539$1$I$$20240821$20240829$20240829$EXP$$US-CHATTEMPRD-2024OHG029184$CHATTEM$$$$$F$Y$$$20240829$$CN$US$US
242655401$24265540$1$I$20240828$20240828$20240829$20240829$EXP$$NVSJ2024JP010141$NOVARTIS$$$$$$Y$$$20240830$$MD$JP$JP
242655411$24265541$1$I$$20240820$20240829$20240829$EXP$$US-CHATTEMPRD-2024OHG028556$CHATTEM$$$$T$F$Y$$$20240829$$LW$US$US
242655421$24265542$1$I$20240529$20240821$20240829$20240829$EXP$GB-MHRA-MED-202408212149061270-PWTSD$GB-CHATTEMPRD-2024OHG028864$CHATTEM$$39$YR$A$F$Y$73$KG$20240829$$CN$GB$GB
242655431$24265543$1$I$$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137894$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240830$$CN$US$US
242655441$24265544$1$I$20240819$20240822$20240829$20240829$EXP$$CN-BEIGENE-BGN-2024-013254$BEIGENE$$$$$$Y$$$20240829$$HP$CN$CN
242655451$24265545$1$I$$20240828$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137244$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$70.31$KG$20240830$$CN$US$US
242655461$24265546$1$I$$20240827$20240829$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048470$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240830$$CN$US$US
242655472$24265547$2$F$20240315$20240903$20240829$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137898$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240911$$CN$US$US
242655481$24265548$1$I$20240318$20240822$20240829$20240829$EXP$$CN-BEIGENE-BGN-2024-013258$BEIGENE$$$$$$Y$$$20240829$$HP$CN$CN
242655491$24265549$1$I$$20240828$20240829$20240829$EXP$$US-TAKEDA-2024TUS086996$TAKEDA$$$$$M$Y$$$20240829$$CN$US$US
242655501$24265550$1$I$$20240828$20240829$20240829$EXP$GB-MHRA-MED-202408280906441100-ZYGRK$GB-ORGANON-O2408GBR002136$ORGANON$$$$$M$Y$$$20240829$$PH$GB$GB
242655511$24265551$1$I$$20240826$20240829$20240829$EXP$$US-BIOGEN-2024BI01279939$BIOGEN$$$$$M$Y$$$20240829$$CN$US$US
242655521$24265552$1$I$$20240823$20240829$20240829$EXP$$JP-JNJFOC-20240876078$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240830$$PH$JP$JP
242655531$24265553$1$I$20240726$20240822$20240829$20240829$EXP$$CN-BEIGENE-BGN-2024-013248$BEIGENE$$$$$$Y$$$20240829$$HP$CN$CN
242655542$24265554$2$F$20240724$20240909$20240829$20240913$EXP$$US-ABBVIE-5896533$ABBVIE$$69$YR$$F$Y$$$20240913$$CN$US$US
242655552$24265555$2$F$20240801$20240826$20240829$20240903$EXP$$US-TEVA-VS-3234012$TEVA$$74$YR$$M$Y$$$20240903$$HP$US$US
242655562$24265556$2$F$$20240827$20240829$20240902$EXP$$GB-ABBVIE-5887481$ABBVIE$$$$A$M$Y$$$20240902$$HP$GB$GB
242655571$24265557$1$I$20240725$20240820$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133023$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$77.11$KG$20240830$$PH$US$US
242655581$24265558$1$I$20240824$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137886$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240830$$CN$US$US
242655594$24265559$4$F$20240101$20240830$20240829$20240905$EXP$$IE-ABBVIE-5898310$ABBVIE$$51$YR$$M$Y$$$20240905$$CN$IE$IE
242655602$24265560$2$F$20240116$20240827$20240829$20240904$EXP$$CA-TAKEDA-2024TUS007560$TAKEDA$$80$YR$$F$Y$$$20240904$$CN$CA$CA
242655611$24265561$1$I$$20240823$20240829$20240829$PER$$US-ALXN-202408USA001693US$ALEXION PHARMACEUTICALS$$$$$F$Y$108$KG$20240830$$CN$US$US
242655621$24265562$1$I$20240101$20240826$20240829$20240829$EXP$$US-ABBVIE-5896115$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242655631$24265563$1$I$20240817$20240822$20240829$20240829$EXP$$CN-BEIGENE-BGN-2024-013253$BEIGENE$$$$$$Y$$$20240829$$HP$CN$CN
242655641$24265564$1$I$$20240826$20240829$20240829$EXP$$US-ABBVIE-5896400$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242655651$24265565$1$I$20240101$20240827$20240829$20240829$EXP$$US-ABBVIE-5898657$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242655661$24265566$1$I$20240807$20240823$20240829$20240829$EXP$$JP-009507513-2408JPN000949J$MERCK$$85$YR$$M$Y$$$20240829$$PH$JP$JP
242655671$24265567$1$I$$20240823$20240829$20240829$PER$$US-BIOGEN-2024BI01279973$BIOGEN$$$$$M$Y$$$20240829$$CN$US$US
242655681$24265568$1$I$$20240823$20240829$20240829$EXP$$US-BIOGEN-2023BI01202515$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
242655691$24265569$1$I$20240801$20240821$20240829$20240829$PER$$US-ABBVIE-5891496$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242655701$24265570$1$I$20240813$20240826$20240829$20240829$EXP$$US-ABBVIE-5885947$ABBVIE$$27$YR$$F$Y$$$20240829$$CN$US$US
242655711$24265571$1$I$$20240828$20240829$20240829$EXP$$AE-ABBVIE-5899480$ABBVIE$$$$$M$Y$$$20240829$$CN$AE$AE
242655721$24265572$1$I$$20240821$20240829$20240829$EXP$$US-BIOGEN-2024BI01279736$BIOGEN$$$$$F$Y$$$20240829$$HP$US$US
242655731$24265573$1$I$$20240827$20240829$20240829$EXP$$UY-BIOGEN-2024BI01280290$BIOGEN$$$$$F$Y$$$20240829$$CN$UY$UY
242655741$24265574$1$I$20240829$20240829$20240829$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048635$BOEHRINGER INGELHEIM$$$$$$Y$$$20240830$$CN$US$US
242655751$24265575$1$I$$20240827$20240829$20240829$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048475$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240830$$HP$US$US
242655761$24265576$1$I$$20240826$20240829$20240829$EXP$$US-ABBVIE-5896089$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242655771$24265577$1$I$20240401$20240823$20240829$20240829$EXP$$US-BIOGEN-2024BI01279903$BIOGEN$$43$YR$$F$Y$$$20240829$$CN$US$US
242655781$24265578$1$I$$20240823$20240829$20240829$PER$$US-BIOGEN-2024BI01279825$BIOGEN$$$$$M$Y$$$20240829$$CN$US$US
242655791$24265579$1$I$$20240821$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133332$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240830$$CN$US$US
242655801$24265580$1$I$$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137764$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240830$$CN$US$US
242655811$24265581$1$I$$20240829$20240829$20240829$PER$$NVSC2024US174707$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
242655821$24265582$1$I$$20240823$20240829$20240829$PER$$US-JNJFOC-20240870324$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$LW$US$US
242655831$24265583$1$I$$20240814$20240829$20240829$PER$$US-AstraZeneca-2024A186055$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242655851$24265585$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174384$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
242655861$24265586$1$I$$20240827$20240829$20240829$30DAY$$IT-SANDOZ INC.-SDZ2024IT049016$SANDOZ$$14$YR$$M$Y$$$20240829$$CN$IT$IT
242655871$24265587$1$I$$20240822$20240829$20240829$EXP$$US-BIOGEN-2024BI01279826$BIOGEN$$$$$F$Y$$$20240829$$CN$US$US
242655881$24265588$1$I$20240801$20240823$20240829$20240829$EXP$$US-BIOGEN-2024BI01280093$BIOGEN$$40$YR$$F$Y$$$20240829$$CN$US$US
242655892$24265589$2$F$$20240903$20240829$20240912$PER$$US-ABBVIE-5888047$ABBVIE$$$$$F$Y$65.77$KG$20240912$$CN$US$US
242655911$24265591$1$I$20240701$20240826$20240829$20240829$EXP$$US-ABBVIE-5897065$ABBVIE$$58$YR$$F$Y$$$20240829$$CN$US$US
242655921$24265592$1$I$20221201$20240819$20240829$20240829$EXP$$DE-ESPERIONTHERAPEUTICS-2023DEU00734$ESPERION THERAPEUTICS$$79$YR$$F$Y$75$KG$20240830$$MD$DE$DE
242655931$24265593$1$I$$20240827$20240829$20240829$EXP$$NVSJ2024JP010075$NOVARTIS$$$$$M$Y$$$20240830$$CN$JP$JP
242655941$24265594$1$I$$20200710$20240829$20240829$EXP$$JP-TAKEDA-JP202022518$TAKEDA$$$$$$Y$$$20240829$$MD$JP$JP
242655951$24265595$1$I$20240820$20240827$20240829$20240829$30DAY$$US-SANDOZ INC.-SDZ2024US075765$SANDOZ$$12$YR$$M$Y$$$20240829$$CN$US$US
242655961$24265596$1$I$20240822$20240827$20240829$20240829$EXP$$US-ABBVIE-5898192$ABBVIE$$52$YR$$M$Y$$$20240829$$CN$US$US
242655971$24265597$1$I$20240630$20240829$20240829$20240829$EXP$FR-AFSSAPS-GR2024001032$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-137812$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$70$KG$20240830$$MD$FR$FR
242655981$24265598$1$I$$20240823$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135168$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240830$$CN$US$US
242655991$24265599$1$I$$20240824$20240829$20240829$EXP$$NVSJ2024JP010040$NOVARTIS$Komori Y, Hijioka S, Okamoto K, Yamashige D, Agarie D, Morizane C et al.. Outcome of PRRT Retreatment for Unresectable Neuroendocrine Tumors in our hospital. 2024$$$A$$Y$$$20240830$$HP$JP$JP
242656001$24265600$1$I$$20240823$20240829$20240829$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-227547$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$$$20240829$$CN$CA$CA
242656011$24265601$1$I$20240805$20240822$20240829$20240829$PER$$US-ABBVIE-5893635$ABBVIE$$23$YR$$F$Y$$$20240829$$HP$US$US
242656021$24265602$1$I$$20240828$20240829$20240829$EXP$$US-PFIZER INC-202400246376$PFIZER$$49$YR$$M$Y$$$20240829$$CN$US$US
242656031$24265603$1$I$$20240826$20240829$20240829$EXP$$CA-PFIZER INC-202400244816$PFIZER$$68$YR$$F$Y$$$20240829$$HP$CA$CA
242656043$24265604$3$F$$20240903$20240829$20240904$EXP$$US-PFIZER INC-202400245172$PFIZER$$80$YR$$F$Y$$$20240904$$CN$US$US
242656051$24265605$1$I$$20240828$20240829$20240829$EXP$$CN-PFIZER INC-PV202400112108$PFIZER$$$$A$M$Y$$$20240829$$CN$CN$CN
242656061$24265606$1$I$$20240828$20240829$20240829$EXP$$CA-ABBVIE-5899027$ABBVIE$Rankin BD, Sood S, Park Y, Rimke A, Abduelmula A, Georgakopoulos JR, et.al. Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an interim analysis of week 20-32 data from a real-world multicenter retrospective review. British Journal of Dermatology. 2024;191(Supplement 2);ii24-ii25.$$$$$Y$$$20240829$$MD$CA$CA
242656071$24265607$1$I$20120101$20240827$20240829$20240829$EXP$$ZA-PFIZER INC-2021464856$PFIZER$$57$YR$$F$Y$66$KG$20240829$$MD$ZA$ZA
242656081$24265608$1$I$$20240823$20240829$20240829$EXP$$US-ABBVIE-5892896$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242656091$24265609$1$I$$20240826$20240829$20240829$EXP$$US-ABBVIE-5897603$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242656101$24265610$1$I$20240701$20240822$20240829$20240829$EXP$$RS-JNJFOC-20240860247$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$MD$RS$RS
242656111$24265611$1$I$$20240823$20240829$20240829$EXP$$JP-009507513-2402JPN003418J$MERCK$$62$YR$$F$Y$$$20240829$$MD$JP$JP
242656121$24265612$1$I$$20240822$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US076293$SANDOZ$$$$$$Y$$$20240829$$CN$US$US
242656131$24265613$1$I$20240711$20240826$20240829$20240829$EXP$$US-ABBVIE-5838140$ABBVIE$$63$YR$$F$Y$54.885$KG$20240829$$CN$US$US
242656141$24265614$1$I$20240601$20240826$20240829$20240829$EXP$$US-ABBVIE-5897264$ABBVIE$$59$YR$$M$Y$$$20240829$$CN$US$US
242656151$24265615$1$I$$20240821$20240829$20240829$PER$$US-AstraZeneca-2024A190825$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242656161$24265616$1$I$20240826$20240826$20240829$20240829$EXP$$US-ABBVIE-5896091$ABBVIE$$54$YR$$F$Y$$$20240829$$CN$US$US
242656171$24265617$1$I$$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137921$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240830$$CN$US$US
242656181$24265618$1$I$20240801$20240826$20240829$20240829$EXP$$US-ABBVIE-5897560$ABBVIE$$41$YR$$F$Y$$$20240829$$CN$US$US
242656201$24265620$1$I$20240101$20240826$20240829$20240829$EXP$$US-ABBVIE-5864744$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242656212$24265621$2$F$20240814$20240828$20240829$20240831$EXP$GB-MHRA-MED-202408281556131720-DCJVW$GB-ABBVIE-5899424$ABBVIE$$$$$$Y$$$20240831$$CN$GB$GB
242656221$24265622$1$I$20240821$20240822$20240829$20240829$EXP$$US-JNJFOC-20240859711$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$PH$US$US
242656231$24265623$1$I$20240820$20240820$20240829$20240829$EXP$$CA-JNJFOC-20240834728$JOHNSON AND JOHNSON$$84$YR$E$M$Y$61$KG$20240830$$PH$CA$CA
242656241$24265624$1$I$20211201$20240827$20240829$20240829$EXP$GB-MHRA-MED-202408272110503530-NGYPZ$GB-JNJFOC-20240877498$JOHNSON AND JOHNSON$$3$YR$C$F$Y$$$20240830$$CN$GB$GB
242656251$24265625$1$I$$20240822$20240829$20240829$EXP$$US-TAKEDA-2024TUS064405$TAKEDA$$$$$F$Y$62.132$KG$20240829$$CN$US$US
242656261$24265626$1$I$20240727$20240827$20240829$20240829$EXP$$US-ABBVIE-5897923$ABBVIE$$38$YR$$M$Y$$$20240829$$CN$US$US
242656271$24265627$1$I$$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136987$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240830$$CN$US$US
242656281$24265628$1$I$$20240828$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137989$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240830$$CN$US$US
242656291$24265629$1$I$$20240828$20240829$20240829$PER$$NVSC2024US174564$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
242656302$24265630$2$F$20240801$20240918$20240829$20240926$EXP$$CA-ABBVIE-5898021$ABBVIE$$17$YR$$F$Y$$$20240926$$MD$CA$CA
242656311$24265631$1$I$$20240822$20240829$20240829$EXP$$US-ABBVIE-5819367$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242656321$24265632$1$I$20240101$20240826$20240829$20240829$EXP$$CA-ABBVIE-5898200$ABBVIE$$57$YR$$F$Y$$$20240829$$CN$CA$CA
242656331$24265633$1$I$$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024171769$AMGEN$$$$$F$Y$$$20240829$$CN$US$US
242656342$24265634$2$F$$20240911$20240829$20240915$EXP$$US-ABBVIE-5898415$ABBVIE$$$$$M$Y$$$20240915$$CN$US$US
242656351$24265635$1$I$20240501$20240821$20240829$20240829$PER$$US-ABBVIE-5889695$ABBVIE$$81$YR$$M$Y$$$20240829$$HP$US$US
242656361$24265636$1$I$20240426$20240828$20240829$20240829$EXP$$US-ABBVIE-5899743$ABBVIE$$66$YR$$F$Y$$$20240829$$CN$US$US
242656381$24265638$1$I$$20240829$20240829$20240829$PER$$NVSC2024US174741$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
242656391$24265639$1$I$$20240826$20240829$20240829$EXP$$CA-CELLTRION INC.-2024CA020459$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
242656401$24265640$1$I$20240703$20240829$20240829$20240829$EXP$ES-AEMPS-1562656$ES-JNJFOC-20240876762$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240830$$MD$ES$ES
242656411$24265641$1$I$$20240826$20240829$20240829$PER$$US-AstraZeneca-2024A194704$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242656421$24265642$1$I$20240827$20240827$20240829$20240829$EXP$$US-ABBVIE-5898850$ABBVIE$$82$YR$$M$Y$$$20240829$$CN$US$US
242656431$24265643$1$I$$20240820$20240829$20240829$PER$$US-SA-2024SA249455$SANOFI AVENTIS$$$$A$F$Y$$$20240830$$MD$US$US
242656442$24265644$2$F$20210101$20240909$20240829$20240913$EXP$$CO-ABBVIE-5897905$ABBVIE$$$$$M$Y$100$KG$20240913$$CN$CO$CO
242656451$24265645$1$I$20240804$20240827$20240829$20240829$EXP$$CO-ABBVIE-5899483$ABBVIE$$65$YR$$F$Y$$$20240829$$CN$CO$CO
242656461$24265646$1$I$20240301$20240826$20240829$20240829$EXP$$NVSC2024US172642$NOVARTIS$$45$YR$$F$Y$$$20240830$$CN$US$US
242656472$24265647$2$F$$20240917$20240829$20240919$EXP$$US-ABBVIE-5898668$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
242656481$24265648$1$I$$20240828$20240829$20240829$PER$$US-HALEON-2194224$Haleon PLC$$$$$M$Y$86.18$KG$20240829$$HP$US$US
242656501$24265650$1$I$20240806$20240820$20240829$20240829$PER$$US-JNJFOC-20240851658$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$MD$US$US
242656511$24265651$1$I$$20240821$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134250$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240829$$CN$US$US
242656521$24265652$1$I$20240819$20240826$20240829$20240829$EXP$$US-ABBVIE-5897647$ABBVIE$$75$YR$$F$Y$$$20240829$$CN$US$US
242656531$24265653$1$I$20240825$20240826$20240829$20240829$PER$$US-AMGEN-USASP2024170364$AMGEN$$56$YR$A$M$Y$$$20240829$$CN$US$US
242656541$24265654$1$I$$20240826$20240829$20240829$EXP$$CA-JNJFOC-20240876766$JOHNSON AND JOHNSON$$72$YR$E$F$Y$99$KG$20240830$$PH$CA$CA
242656561$24265656$1$I$$20240829$20240829$20240829$PER$$NVSC2024US174709$NOVARTIS$$$$$$Y$$$20240830$$CN$US$US
242656572$24265657$2$F$20240101$20240830$20240829$20240905$EXP$$GB-ABBVIE-5898057$ABBVIE$$$$A$F$Y$$$20240905$$CN$GB$GB
242656581$24265658$1$I$20240828$20240828$20240829$20240829$PER$$NVSC2024US174711$NOVARTIS$$31$YR$$F$Y$$$20240830$$CN$US$US
242656591$24265659$1$I$20240826$20240826$20240829$20240829$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-136558$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$152.86$KG$20240829$$CN$PR$PR
242656602$24265660$2$F$$20240903$20240829$20240906$PER$$US-ABBVIE-5898901$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242656611$24265661$1$I$$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137871$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240830$$CN$US$US
242656621$24265662$1$I$$20240823$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-135614$BRISTOL MYERS SQUIBB$Literature citation unavailable.$$$$$Y$$$20240829$$HP$CA$CA
242656631$24265663$1$I$20240821$20240821$20240829$20240829$PER$$US-AstraZeneca-2024A191540$ASTRAZENECA$$76$YR$$F$Y$$$20240830$$CN$US$
242656641$24265664$1$I$$20240826$20240829$20240829$PER$$US-AstraZeneca-2024A194662$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242656651$24265665$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136914$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$48.99$KG$20240829$$CN$US$US
242656661$24265666$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136955$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$104.33$KG$20240829$$CN$US$US
242656671$24265667$1$I$20240815$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136026$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240829$$HP$US$US
242656682$24265668$2$F$$20240821$20240829$20240902$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012345$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240902$$CN$US$US
242656691$24265669$1$I$$20240826$20240829$20240829$PER$$US-ELI_LILLY_AND_COMPANY-US202408016483$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240829$$CN$US$US
242656702$24265670$2$F$20240424$20240904$20240829$20240906$EXP$$JP-SA-2024SA245389$SANOFI AVENTIS$$29$YR$A$F$Y$61.5$KG$20240906$$PH$JP$JP
242656711$24265671$1$I$$20240826$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136920$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240829$$CN$US$US
242656721$24265672$1$I$20240701$20240821$20240829$20240829$EXP$$CA-JNJFOC-20240729599$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240830$$HP$CA$CA
242656731$24265673$1$I$20240820$20240821$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133962$BRISTOL MYERS SQUIBB$$$$$M$Y$86$KG$20240829$$PH$US$US
242656751$24265675$1$I$$20240823$20240829$20240829$EXP$$US-ABBVIE-5886256$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242656761$24265676$1$I$20240401$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136905$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240829$$CN$US$US
242656771$24265677$1$I$$20240823$20240829$20240829$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-135494$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$49$KG$20240829$$PH$CA$CA
242656782$24265678$2$F$20240806$20240828$20240829$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136850$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240905$$PH$US$US
242656801$24265680$1$I$20150101$20171109$20240829$20240829$EXP$$JP-TAKEDA-JP201708460$TAKEDA$$$$$F$Y$$$20240829$$CN$JP$JP
242656811$24265681$1$I$$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136767$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240829$$CN$US$US
242656821$24265682$1$I$20240826$20240826$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136982$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240829$$MD$US$US
242656831$24265683$1$I$$20240820$20240829$20240829$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134462$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240829$$MD$JP$JP
242656842$24265684$2$F$20240101$20240918$20240829$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135565$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240924$$HP$US$US
242656851$24265685$1$I$$20240827$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136710$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240829$$HP$US$US
242656861$24265686$1$I$$20240820$20240829$20240829$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132983$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240829$$CN$US$US
242656872$24265687$2$F$20240820$20240823$20240829$20240830$PER$$US-SA-2024SA250290$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240830$$CN$US$US
242656881$24265688$1$I$$20240827$20240829$20240829$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136821$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240829$$CN$US$US
242656903$24265690$3$F$20240914$20240914$20240829$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136972$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240918$$CN$US$US
242656911$24265691$1$I$$20240827$20240829$20240829$EXP$$US-SANDOZ INC.-SDZ2024US075762$SANDOZ$$$$$F$Y$$$20240829$$CN$US$US
242656921$24265692$1$I$20240819$20240826$20240829$20240829$EXP$$US-GSK-US2024106004$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$CN$US$US
242656932$24265693$2$F$$20240828$20240829$20240917$EXP$$GB-GSK-GB2024094763$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$GB$GB
242656941$24265694$1$I$20240624$20240828$20240829$20240829$EXP$FR-AFSSAPS-AVPO2024000159$FR-GSK-FR2024107076$GLAXOSMITHKLINE$$$$$$Y$$$20240829$$PH$FR$FR
242656961$24265696$1$I$$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024172302$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242656971$24265697$1$I$$20240823$20240829$20240829$PER$$US-AMGEN-USASP2024169764$AMGEN$$$$$$Y$$$20240829$$CN$US$US
242656981$24265698$1$I$$20240827$20240829$20240829$PER$$US-AMGEN-USASP2024172091$AMGEN$$$$$$Y$$$20240829$$PH$US$US
242656991$24265699$1$I$$20240821$20240829$20240829$EXP$$GB-AMGEN-GBRSL2024168572$AMGEN$$$$$F$Y$$$20240829$$CN$GB$GB
242657001$24265700$1$I$20240101$20240820$20240829$20240829$PER$$US-SA-2024SA249866$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240830$$CN$US$US
242657012$24265701$2$F$$20240830$20240829$20240903$EXP$$US-ABBVIE-5899013$ABBVIE$$28$YR$$M$Y$$$20240903$$CN$US$US
242657021$24265702$1$I$$20240822$20240829$20240829$EXP$$IE-STRIDES ARCOLAB LIMITED-2024SP010839$STRIDES$Moollan N, Durcan L.. A tale of two pregnancies.. Pol-Arch-Med-Wewn. 2022;132 (Suppl.):11-12$$$$$Y$$$20240830$$HP$IE$IE
242657031$24265703$1$I$$20240822$20240829$20240829$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010834$STRIDES$Zhang Y, Bangert M, Chun M, Mattingly T, Zheng C.. ACUTE AND CHRONIC INFECTIOUS COMPLICATIONS FOLLOWING GUNSHOT INJURIES: A CASE COMPARISON.. South-Med-J. 2022;115:561$26$YR$$M$Y$$$20240830$$HP$US$US
242657041$24265704$1$I$$20240827$20240830$20240830$PER$$US-ABBVIE-5898824$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242657051$24265705$1$I$20240528$20240827$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137805$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240830$$CN$US$US
242657061$24265706$1$I$20240801$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137249$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240830$$HP$US$US
242657072$24265707$2$F$20240706$20240829$20240830$20240904$EXP$$IT-ABBVIE-5898787$ABBVIE$$72$YR$$M$Y$$$20240904$$MD$IT$IT
242657081$24265708$1$I$$20240823$20240830$20240830$EXP$$US-TAKEDA-2024TUS032879$TAKEDA$$$$$M$Y$$$20240830$$CN$US$US
242657091$24265709$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5898785$ABBVIE$$63$YR$$F$Y$$$20240830$$CN$US$US
242657101$24265710$1$I$20240821$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171756$AMGEN$$84$YR$E$M$Y$$$20240829$$CN$US$US
242657111$24265711$1$I$$20240820$20240830$20240830$EXP$$CN-AMGEN-CHNNI2024170995$AMGEN$Hu X., Li J., Zhu Y., He G.. Efficacy and safety of early Ivabradine in the treatment of acute decompensated heart failure. Shanxi Med J. 2024;53(9)$$$$$Y$$$20240829$$MD$CN$CN
242657121$24265712$1$I$20240807$20240828$20240830$20240830$EXP$$US-ABBVIE-5900083$ABBVIE$$77$YR$$M$Y$$$20240830$$CN$US$US
242657131$24265713$1$I$20240826$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016922$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240829$$CN$US$US
242657142$24265714$2$F$20240101$20240914$20240830$20240919$EXP$$US-SANDOZ INC.-SDZ2024US076324$SANDOZ$$$$$F$Y$$$20240919$$CN$US$US
242657151$24265715$1$I$$20240826$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137007$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240830$$CN$US$US
242657161$24265716$1$I$20230213$20240821$20240830$20240830$EXP$IT-MINISAL02-994755$IT-ABBVIE-5890409$ABBVIE$$61$YR$$F$Y$$$20240830$$MD$IT$IT
242657171$24265717$1$I$$20240822$20240830$20240830$EXP$$US-ABBVIE-5892597$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242657181$24265718$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA204764$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240830$$MD$US$US
242657192$24265719$2$F$$20240820$20240830$20240913$PER$$US-SA-2024SA250037$SANOFI AVENTIS$$73$YR$E$M$Y$71.36$KG$20240913$$MD$US$US
242657201$24265720$1$I$20230101$20240826$20240830$20240830$EXP$$CO-ABBVIE-5899151$ABBVIE$$$$$F$Y$55$KG$20240830$$HP$CO$CO
242657211$24265721$1$I$$20240814$20240830$20240830$PER$$US-ABBVIE-5895881$ABBVIE$$59$YR$$F$Y$$$20240830$$HP$US$US
242657222$24265722$2$F$20210817$20240917$20240830$20240919$EXP$$JP-TAKEDA-SH202114076$TAKEDA$$14$YR$$F$Y$$$20240919$$MD$JP$JP
242657231$24265723$1$I$20240801$20240826$20240830$20240830$EXP$$CA-ABBVIE-5899561$ABBVIE$$66$YR$$M$Y$$$20240830$$CN$CA$CA
242657241$24265724$1$I$20240809$20240821$20240830$20240830$EXP$$US-VIIV HEALTHCARE LIMITED-US2024104470$VIIV$$31$YR$$M$Y$$$20240830$$CN$US$US
242657251$24265725$1$I$20240501$20240826$20240830$20240830$EXP$$JP-GSK-JP2024JPN090189$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$JP$JP
242657261$24265726$1$I$20240101$20240826$20240830$20240830$EXP$$US-ABBVIE-5896566$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242657272$24265727$2$F$20240820$20240830$20240830$20240906$EXP$GB-MHRA-MED-202408261304047330-GPYBV$GB-GSK-GB2024105935$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$PH$GB$GB
242657281$24265728$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137174$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$70.31$KG$20240830$$CN$US$US
242657291$24265729$1$I$$20240827$20240830$20240830$EXP$$IT-TAKEDA-2024TUS037850$TAKEDA$Cecchi N, et al. Efficacy of thrombopoietin receptor agonists in evans syndrome: a single center series. Haematologica. 2021;106(S3):37$54$YR$$M$Y$$$20240830$$MD$IT$IT
242657301$24265730$1$I$20240812$20240827$20240830$20240830$EXP$$US-ABBVIE-5898628$ABBVIE$$57$YR$$M$Y$$$20240830$$CN$US$US
242657311$24265731$1$I$20240101$20240828$20240830$20240830$EXP$$AU-ABBVIE-5898819$ABBVIE$$$$$M$Y$$$20240830$$CN$AU$AU
242657321$24265732$1$I$20240801$20240827$20240830$20240830$EXP$$US-ABBVIE-5898953$ABBVIE$$55$YR$$F$Y$$$20240830$$CN$US$US
242657331$24265733$1$I$20240817$20240819$20240830$20240830$EXP$$BR-EMD Serono-2024044780$EMD SERONO INC$$43$YR$A$M$Y$$$20240829$$CN$BR$BR
242657341$24265734$1$I$20240801$20240820$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133596$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240829$$PH$US$US
242657351$24265735$1$I$$20240821$20240830$20240830$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000298$EMCURE$$$$$$Y$$$20240830$$CN$US$US
242657361$24265736$1$I$$20240618$20240830$20240830$EXP$$BG-BRISTOL-MYERS SQUIBB COMPANY-2024-136238$BRISTOL MYERS SQUIBB$Tsakov A, Krachunov I. Immunotherapy-induced pneumonitis - case report. Cardiology and Cardiac Surgery. 2024 Feb;7(2):38-49.$54$YR$A$M$Y$$$20240829$$MD$BG$BG
242657371$24265737$1$I$20240801$20240820$20240830$20240830$PER$$US-SA-2024SA249888$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240830$$MD$US$US
242657381$24265738$1$I$20240628$20240822$20240830$20240830$EXP$$CA-ABBVIE-5892852$ABBVIE$$35$YR$$F$Y$$$20240830$$CN$CA$CA
242657391$24265739$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA250026$SANOFI AVENTIS$$$$A$F$Y$$$20240830$$MD$US$US
242657401$24265740$1$I$$20240821$20240830$20240830$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000295$EMCURE$Gwynn N, Lindenmayer JP, Boes T, Pitalo C. Late Recognition of Cholinergic Delirium in Patient on Donepezil Combination Treatment. Journal of Clinical Psychopharmacology. 2024$69$YR$$M$Y$$$20240830$$MD$US$US
242657413$24265741$3$F$20240801$20240905$20240830$20240910$EXP$$US-ABBVIE-5872781$ABBVIE$$77$YR$$M$Y$$$20240910$$CN$US$US
242657421$24265742$1$I$$20240826$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135817$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$102.97$KG$20240829$$HP$US$US
242657431$24265743$1$I$$20240823$20240830$20240830$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-137082$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$49$KG$20240829$$PH$CA$CA
242657443$24265744$3$F$$20240920$20240830$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136013$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240923$$CN$US$US
242657451$24265745$1$I$$20240827$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136273$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$70.76$KG$20240830$$CN$US$US
242657461$24265746$1$I$$20240826$20240830$20240830$PER$$US-LEO Pharma-373061$LEO PHARM$$$$$M$Y$$$20240830$$CN$US$US
242657471$24265747$1$I$20240101$20240822$20240830$20240830$EXP$$GB-ABBVIE-5892805$ABBVIE$$69$YR$$M$Y$$$20240830$$CN$GB$GB
242657481$24265748$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5898958$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242657491$24265749$1$I$$20240823$20240830$20240830$EXP$$US-ABBVIE-5894429$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242657501$24265750$1$I$20240825$20240827$20240830$20240830$EXP$$ZA-ABBVIE-5899486$ABBVIE$$63$YR$$M$Y$$$20240830$$CN$ZA$ZA
242657511$24265751$1$I$$20240814$20240830$20240830$PER$$US-ABBVIE-5894349$ABBVIE$$44$YR$$F$Y$$$20240830$$HP$US$US
242657521$24265752$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024172839$AMGEN$$$$$F$Y$$$20240829$$PH$US$US
242657531$24265753$1$I$$20240827$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136922$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$72.57$KG$20240829$$MD$US$US
242657541$24265754$1$I$20240730$20240827$20240830$20240830$EXP$FR-AFSSAPS-AVCN2024000652$FR-GSK-FR2024106544$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$FR$FR
242657551$24265755$1$I$$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195209$ASTRAZENECA$$$$$F$Y$$$20240830$$MD$US$
242657561$24265756$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA249589$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240830$$MD$US$US
242657571$24265757$1$I$20240501$20240823$20240830$20240830$EXP$$US-GSK-US2024105497$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$US$US
242657582$24265758$2$F$20240801$20240920$20240830$20240927$EXP$$US-ABBVIE-5893568$ABBVIE$$53$YR$$F$Y$$$20240927$$CN$US$US
242657591$24265759$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA249968$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240830$$MD$US$US
242657601$24265760$1$I$$20240820$20240830$20240830$PER$$US-JNJFOC-20240855329$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$CN$US$US
242657621$24265762$1$I$$20240822$20240830$20240830$EXP$$US-ABBVIE-5896224$ABBVIE$Himed S, Tawfik H, Kaffenberger BH. Treatment of pyoderma gangrenosum with vilobelimab. JAMA Dermatol. 2024;160(8):898.$20$YR$$M$Y$$$20240830$$MD$US$US
242657631$24265763$1$I$20240817$20240823$20240830$20240830$EXP$$PL-ROCHE-10000065926$ROCHE$$49$YR$A$F$Y$$$20240830$$MD$PL$PL
242657641$24265764$1$I$20240401$20240820$20240830$20240830$EXP$$BR-NALPROPION PHARMACEUTICALS INC.-BR-2024CUR004003$CURRAX PHARMACEUTICALS$$$$$$Y$$$20240830$$CN$BR$BR
242657651$24265765$1$I$20240818$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024170434$AMGEN$$65$YR$E$F$Y$$$20240829$$PH$US$US
242657661$24265766$1$I$20240801$20240823$20240830$20240830$EXP$$US-ABBVIE-5894367$ABBVIE$$78$YR$$F$Y$$$20240830$$CN$US$US
242657671$24265767$1$I$20240701$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137937$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240830$$CN$US$US
242657681$24265768$1$I$20240701$20240820$20240830$20240830$EXP$FR-AFSSAPS-TO2024001250$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111453$ZYDUS PHARM$$$$$$Y$$$20240829$$PH$FR$FR
242657692$24265769$2$F$20230403$20240827$20240830$20240902$EXP$$CO-TAKEDA-2023TUS035513$TAKEDA$$13$YR$$M$Y$53$KG$20240902$$CN$CO$CO
242657701$24265770$1$I$$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137732$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240830$$CN$US$US
242657711$24265771$1$I$$20240819$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131950$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240830$$CN$US$US
242657721$24265772$1$I$20230301$20240822$20240830$20240830$EXP$$US-ABBVIE-5892787$ABBVIE$$58$YR$$F$Y$$$20240830$$CN$US$US
242657731$24265773$1$I$20240827$20240827$20240830$20240830$EXP$GB-MHRA-TPP54531347C10389046YC1724772553387$GB-GSK-GB2024106618$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$GB$GB
242657741$24265774$1$I$20240703$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A194258$ASTRAZENECA$$31166$DY$$F$Y$$$20240830$$CN$US$
242657751$24265775$1$I$$20240827$20240830$20240830$PER$$US-ABBVIE-5898538$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242657761$24265776$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017985$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240830$$CN$US$US
242657771$24265777$1$I$20240815$20240816$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408013181$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240830$$CN$US$US
242657781$24265778$1$I$$20240821$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408013722$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240830$$MD$US$US
242657791$24265779$1$I$$20240823$20240830$20240830$EXP$$US-ABBVIE-5892906$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242657801$24265780$1$I$20231109$20240826$20240830$20240830$EXP$$SE-ABBVIE-5894724$ABBVIE$$54$YR$$M$Y$88$KG$20240830$$MD$SE$SE
242657811$24265781$1$I$$20240826$20240830$20240830$EXP$$US-CHATTEMPRD-2024OHG029649$CHATTEM$$$$$M$Y$$$20240830$$CN$US$US
242657823$24265782$3$F$20240101$20240903$20240830$20240911$PER$$US-TEVA-VS-3236419$TEVA$$46$YR$$F$Y$$$20240911$$CN$US$US
242657831$24265783$1$I$20240101$20240826$20240830$20240830$EXP$$US-ABBVIE-5897384$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242657842$24265784$2$F$$20240816$20240830$20240924$PER$$US-ROCHE-10000062022$ROCHE$$$$$$Y$$$20240924$$CN$US$US
242657851$24265785$1$I$$20240827$20240830$20240830$PER$$US-ROCHE-10000068125$ROCHE$$22$YR$A$F$Y$$$20240830$$MD$US$US
242657862$24265786$2$F$20240821$20240904$20240830$20240909$EXP$$US-ABBVIE-5898821$ABBVIE$$59$YR$$M$Y$81.646$KG$20240909$$CN$US$US
242657871$24265787$1$I$20240101$20240829$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-083315-2024$RECKITT BENCKISER$$$$$F$Y$$$20240829$$CN$US$US
242657881$24265788$1$I$$20240829$20240830$20240830$PER$$NVSC2024US174770$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
242657901$24265790$1$I$$20240828$20240830$20240830$EXP$$US-SANDOZ INC.-SDZ2024US076336$SANDOZ$$$$$M$Y$$$20240830$$CN$US$US
242657911$24265791$1$I$20240801$20240822$20240830$20240830$EXP$$DE-JNJFOC-20240861563$JOHNSON AND JOHNSON$$84$YR$E$$Y$$$20240830$$MD$DE$DE
242657921$24265792$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171794$AMGEN$$$$$$Y$$$20240829$$CN$US$US
242657932$24265793$2$F$$20240915$20240830$20240921$EXP$$JP-TEVA-VS-3235267$TEVA$Kawashima S, Kinoshita H, Kawashima W, Nakajima Y. Electroencephalogram inability to detect intraoperative awakening in a patient with remimazolam tolerance. Minerv-Anestesiol 2023; 89 (5): 482-483.; Kawashima S, Kinoshita H, Kawashima W, Nakajima Y. Electroencephalogram inability to detect intraoperative awakening in a patient with remimazolam tolerance. Minerv-Anestesiol 2023; 89 (5): 482-483.$57$YR$$M$Y$$$20240921$$HP$JP$JP
242657942$24265794$2$F$20240101$20240827$20240830$20240904$PER$$US-AMGEN-USASP2024171252$AMGEN$$79$YR$E$F$Y$$$20240904$$CN$US$US
242657951$24265795$1$I$$20240808$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001221$AXSOME THERAPEUTICS$$37$YR$A$$Y$$$20240829$$MD$US$
242657961$24265796$1$I$$20240816$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001251$AXSOME THERAPEUTICS$$62$YR$A$M$Y$$$20240829$$CN$US$
242657971$24265797$1$I$$20240809$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001198$AXSOME THERAPEUTICS$$$$A$$Y$$$20240829$$MD$US$
242657981$24265798$1$I$$20240806$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001167$AXSOME THERAPEUTICS$$50$YR$A$F$Y$$$20240829$$MD$US$
242657991$24265799$1$I$$20240730$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001144$AXSOME THERAPEUTICS$$$$A$F$Y$$$20240829$$MD$US$
242658001$24265800$1$I$$20240805$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001157$AXSOME THERAPEUTICS$$64$YR$A$F$Y$$$20240829$$CN$US$
242658011$24265801$1$I$$20240820$20240830$20240830$PER$$US-ROCHE-10000062762$ROCHE$$$$$$Y$$$20240830$$HP$US$US
242658021$24265802$1$I$$20240730$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001121$AXSOME THERAPEUTICS$$$$$F$Y$$$20240829$$$US$
242658031$24265803$1$I$$20240729$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001111$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$$US$
242658042$24265804$2$F$$20240913$20240830$20240921$EXP$$IT-TEVA-VS-3236320$TEVA$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series. J-Clin-Med 2023; 12 (1):.; Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series. J-Clin-Med 2023; 12 (1):.; Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with ...$29$YR$$M$Y$$$20240921$$HP$IT$IT
242658051$24265805$1$I$$20240718$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001050$AXSOME THERAPEUTICS$$53$YR$A$F$Y$$$20240829$$CN$US$
242658061$24265806$1$I$20240101$20240718$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000962$AXSOME THERAPEUTICS$$69$YR$E$F$Y$$$20240829$$CN$US$
242658071$24265807$1$I$20240101$20240726$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001003$AXSOME THERAPEUTICS$$62$YR$A$F$Y$$$20240829$$CN$US$
242658081$24265808$1$I$20240101$20240717$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001047$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$CN$US$
242658091$24265809$1$I$$20240708$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000970$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$CN$US$
242658101$24265810$1$I$20240101$20240708$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000969$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$CN$US$
242658111$24265811$1$I$20240101$20240705$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000963$AXSOME THERAPEUTICS$$44$YR$A$F$Y$$$20240829$$$US$
242658121$24265812$1$I$$20240702$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000947$AXSOME THERAPEUTICS$$43$YR$A$M$Y$$$20240829$$CN$US$
242658131$24265813$1$I$$20240705$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000904$AXSOME THERAPEUTICS$$$$A$M$Y$$$20240829$$$US$
242658141$24265814$1$I$20240101$20240620$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000891$AXSOME THERAPEUTICS$$38$YR$A$M$Y$$$20240829$$CN$US$
242658151$24265815$1$I$$20240611$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000725$AXSOME THERAPEUTICS$$41$YR$A$M$Y$$$20240829$$CN$US$
242658161$24265816$1$I$20240601$20240611$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000829$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$CN$US$
242658171$24265817$1$I$$20240827$20240830$20240830$EXP$$BE-ABBVIE-5899481$ABBVIE$$$$$M$Y$$$20240830$$MD$BE$BE
242658181$24265818$1$I$20240601$20240610$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000815$AXSOME THERAPEUTICS$$$$$F$Y$$$20240829$$$US$
242658191$24265819$1$I$20231001$20240826$20240830$20240830$EXP$FR-AFSSAPS-MP2024001303$FR-BIOGEN-2024BI01279946$BIOGEN$$30$YR$$M$Y$54$KG$20240830$$MD$FR$FR
242658201$24265820$1$I$20240501$20240528$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000730$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$CN$US$
242658211$24265821$1$I$$20240528$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000734$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$$US$
242658221$24265822$1$I$$20240521$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000687$AXSOME THERAPEUTICS$$$$$F$Y$$$20240829$$$US$
242658231$24265823$1$I$20240601$20240823$20240830$20240830$EXP$$TR-ABBVIE-5845665$ABBVIE$$60$YR$$M$Y$90$KG$20240830$$CN$TR$TR
242658241$24265824$1$I$20231201$20240827$20240830$20240830$EXP$$US-ABBVIE-5898498$ABBVIE$$68$YR$$F$Y$$$20240830$$CN$US$US
242658251$24265825$1$I$20210412$20240822$20240830$20240830$EXP$$IL-ABBVIE-4144384$ABBVIE$$68$YR$$F$Y$91$KG$20240830$$MD$IL$IL
242658261$24265826$1$I$$20240827$20240830$20240830$PER$$US-ABBVIE-5898168$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242658271$24265827$1$I$20120101$20240823$20240830$20240830$PER$$US-JNJFOC-20240868485$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240830$$HP$US$US
242658281$24265828$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137880$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240830$$CN$US$US
242658291$24265829$1$I$20240821$20240823$20240830$20240830$EXP$$CO-ABBVIE-5900516$ABBVIE$$81$YR$$F$Y$67$KG$20240830$$HP$CO$CO
242658301$24265830$1$I$$20240821$20240830$20240830$EXP$$US-ABBVIE-5891784$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242658311$24265831$1$I$20240827$20240827$20240830$20240830$EXP$$BE-ABBVIE-5900804$ABBVIE$$86$YR$$F$Y$$$20240830$$HP$BE$BE
242658321$24265832$1$I$$20240818$20240830$20240830$PER$$US-AstraZeneca-2024A189957$ASTRAZENECA$$$$$$Y$$$20240830$$CN$US$
242658331$24265833$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA249226$SANOFI AVENTIS$$$$A$F$Y$58.967$KG$20240830$$MD$US$US
242658341$24265834$1$I$$20240827$20240830$20240830$PER$$US-ROCHE-10000068252$ROCHE$$48$YR$A$F$Y$$$20240830$$CN$US$US
242658351$24265835$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137655$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240830$$HP$US$US
242658361$24265836$1$I$$20240823$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135442$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240829$$HP$US$US
242658371$24265837$1$I$$20240819$20240830$20240830$EXP$$IT-TEVA-VS-3236393$TEVA$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series. J-Clin-Med 2023; 12 (1):.; Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series. J-Clin-Med 2023; 12 (1):.$27$YR$$M$Y$$$20240829$$HP$IT$IT
242658381$24265838$1$I$20230501$20240821$20240830$20240830$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-235769$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240829$$CN$US$US
242658391$24265839$1$I$$20240818$20240830$20240830$PER$$US-JNJFOC-20240849877$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242658411$24265841$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000069135$ROCHE$$6$YR$C$M$Y$$$20240830$$MD$US$US
242658421$24265842$1$I$20240822$20240823$20240830$20240830$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03122$AMNEAL$$$$$$Y$$$20240830$$CN$US$US
242658431$24265843$1$I$20231101$20240826$20240830$20240830$EXP$$US-ABBVIE-5852183$ABBVIE$$74$YR$$F$Y$82$KG$20240830$$CN$US$US
242658442$24265844$2$F$20240101$20240910$20240830$20240917$EXP$$US-ABBVIE-5826952$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
242658451$24265845$1$I$20240401$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137882$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240830$$CN$US$US
242658462$24265846$2$F$20240721$20240822$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013255$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242658471$24265847$1$I$20240701$20240809$20240830$20240830$PER$$US-TEVA-VS-3232163$TEVA$$29$YR$$F$Y$$$20240829$$CN$US$US
242658481$24265848$1$I$$20240821$20240830$20240830$PER$$US-ABBVIE-5891077$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242658491$24265849$1$I$20240801$20240824$20240830$20240830$EXP$$CN-GSK-CN2024APC105749$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$CN$CN
242658502$24265850$2$F$$20240829$20240830$20240902$EXP$$US-ABBVIE-5897365$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242658511$24265851$1$I$$20240827$20240830$20240830$EXP$$US-JNJFOC-20240871628$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242658521$24265852$1$I$20240821$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137503$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240830$$PH$US$US
242658531$24265853$1$I$$20240823$20240830$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001724$BLUEPRINT MEDICINES$$$$$F$Y$$$20240830$$CN$US$US
242658541$24265854$1$I$$20240822$20240830$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001725$BLUEPRINT MEDICINES$$$$$F$Y$$$20240830$$CN$US$US
242658551$24265855$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137863$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240830$$CN$US$US
242658562$24265856$2$F$20240806$20240904$20240830$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001715$BLUEPRINT MEDICINES$$78$YR$E$M$Y$$$20240911$$CN$US$US
242658571$24265857$1$I$20240724$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195332$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242658581$24265858$1$I$$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195340$ASTRAZENECA$$$$$M$Y$$$20240830$$MD$US$
242658591$24265859$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136853$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$81.19$KG$20240829$$CN$US$US
242658601$24265860$1$I$$20240821$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133542$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240829$$CN$US$US
242658611$24265861$1$I$$20240822$20240830$20240830$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-134325$BRISTOL MYERS SQUIBB$$32$YR$A$M$Y$$$20240829$$MD$FR$FR
242658621$24265862$1$I$20240817$20240823$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013357$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242658632$24265863$2$F$20240801$20240822$20240830$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026265$UNITED THERAPEUTICS$$86$YR$$M$Y$79.365$KG$20240831$$$US$US
242658641$24265864$1$I$$20240829$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-082349-2024$RECKITT BENCKISER$$$$$F$Y$$$20240830$$CN$US$US
242658651$24265865$1$I$$20240826$20240830$20240830$EXP$$FR-JAZZ PHARMACEUTICALS-2024-FR-013669$JAZZ$$$$$$Y$$$20240829$$HP$FR$FR
242658661$24265866$1$I$20240816$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024171407$AMGEN$$67$YR$E$F$Y$$$20240829$$CN$US$US
242658673$24265867$3$F$$20240927$20240830$20240930$EXP$$CA-JNJFOC-20240776045$JOHNSON AND JOHNSON$$$$$F$Y$73$KG$20240930$$HP$CA$CA
242658681$24265868$1$I$$20240823$20240830$20240830$30DAY$$US-GSK-US2024105562$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242658691$24265869$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5898210$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242658701$24265870$1$I$$20240823$20240830$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-026706$UNITED THERAPEUTICS$$$$$F$Y$$$20240830$$$US$US
242658711$24265871$1$I$$20240821$20240830$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-026206$UNITED THERAPEUTICS$$$$$F$Y$75.737$KG$20240830$$$US$US
242658721$24265872$1$I$20240827$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017512$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240830$$CN$US$US
242658731$24265873$1$I$$20240821$20240830$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-026290$UNITED THERAPEUTICS$$$$$F$Y$50.34$KG$20240830$$$US$US
242658741$24265874$1$I$$20240820$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408013043$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240830$$CN$US$US
242658751$24265875$1$I$$20240826$20240830$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013623$JAZZ$$$$$M$Y$$$20240829$$CN$US$US
242658761$24265876$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA250212$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240830$$MD$US$US
242658771$24265877$1$I$$20240826$20240830$20240830$EXP$$MX-JNJFOC-20240878171$JOHNSON AND JOHNSON$$66$YR$E$F$Y$72$KG$20240830$$CN$MX$MX
242658781$24265878$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137850$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240830$$CN$US$US
242658791$24265879$1$I$20240724$20240822$20240830$20240830$EXP$$US-ALK-ABELLO A/S-2024AA003278$ALK-ABELLO$$$$$$Y$$$20240830$$CN$US$US
242658801$24265880$1$I$$20240809$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001222$AXSOME THERAPEUTICS$$$$A$F$Y$$$20240829$$MD$US$
242658811$24265881$1$I$$20240816$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001145$AXSOME THERAPEUTICS$$50$YR$A$M$Y$$$20240829$$HP$US$
242658821$24265882$1$I$$20240806$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001169$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$MD$US$
242658831$24265883$1$I$$20240808$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001188$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$$US$
242658841$24265884$1$I$20240101$20240805$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001164$AXSOME THERAPEUTICS$$68$YR$E$F$Y$$$20240829$$MD$US$
242658851$24265885$1$I$20240101$20240809$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000972$AXSOME THERAPEUTICS$$58$YR$A$F$Y$97$KG$20240829$$CN$US$
242658861$24265886$1$I$$20240725$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001087$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$CN$US$
242658871$24265887$1$I$$20240725$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001090$AXSOME THERAPEUTICS$$$$$F$Y$$$20240829$$MD$US$
242658881$24265888$1$I$$20240729$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001113$AXSOME THERAPEUTICS$$$$A$$Y$$$20240829$$CN$US$
242658891$24265889$1$I$$20240724$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001078$AXSOME THERAPEUTICS$$49$YR$A$F$Y$$$20240829$$CN$US$
242658901$24265890$1$I$20231101$20240731$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000992$AXSOME THERAPEUTICS$$35$YR$A$F$Y$$$20240829$$$US$
242658911$24265891$1$I$20240601$20240731$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001018$AXSOME THERAPEUTICS$$22$YR$A$M$Y$$$20240829$$CN$US$
242658921$24265892$1$I$20240401$20240802$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001058$AXSOME THERAPEUTICS$$32$YR$A$F$Y$$$20240829$$HP$US$
242658931$24265893$1$I$20240719$20240722$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001070$AXSOME THERAPEUTICS$$40$YR$A$F$Y$$$20240829$$MD$US$
242658941$24265894$1$I$20240701$20240722$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001068$AXSOME THERAPEUTICS$$$$$M$Y$$$20240829$$PH$US$
242658951$24265895$1$I$$20240719$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000884$AXSOME THERAPEUTICS$$19$YR$A$F$Y$$$20240829$$$US$
242658961$24265896$1$I$$20240716$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001026$AXSOME THERAPEUTICS$$$$$M$Y$$$20240829$$$US$
242658971$24265897$1$I$20240101$20240716$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000954$AXSOME THERAPEUTICS$$49$YR$A$F$Y$$$20240829$$CN$US$
242658981$24265898$1$I$$20240711$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001006$AXSOME THERAPEUTICS$$60$YR$A$F$Y$$$20240829$$MD$US$
242658991$24265899$1$I$20230101$20240710$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000999$AXSOME THERAPEUTICS$$53$YR$A$F$Y$$$20240829$$MD$US$
242659001$24265900$1$I$$20240712$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001012$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$MD$US$
242659011$24265901$1$I$20240101$20240708$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000717$AXSOME THERAPEUTICS$$63$YR$A$M$Y$$$20240829$$CN$US$
242659021$24265902$1$I$20240601$20240705$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000886$AXSOME THERAPEUTICS$$23$YR$A$M$Y$$$20240829$$CN$US$
242659031$24265903$1$I$20240101$20240628$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000756$AXSOME THERAPEUTICS$$47$YR$A$M$Y$$$20240829$$CN$US$
242659041$24265904$1$I$$20240826$20240830$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013644$JAZZ$$$$$M$Y$$$20240829$$CN$US$US
242659051$24265905$1$I$$20240628$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000934$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$MD$US$
242659061$24265906$1$I$20240101$20240625$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000828$AXSOME THERAPEUTICS$$61$YR$A$F$Y$$$20240829$$CN$US$
242659071$24265907$1$I$20240530$20240618$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000855$AXSOME THERAPEUTICS$$61$YR$A$M$Y$94.8$KG$20240829$$$US$
242659081$24265908$1$I$$20240620$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000892$AXSOME THERAPEUTICS$$21$YR$A$F$Y$$$20240829$$$US$
242659091$24265909$1$I$$20240605$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000796$AXSOME THERAPEUTICS$$57$YR$A$M$Y$$$20240829$$$US$
242659101$24265910$1$I$$20240530$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000770$AXSOME THERAPEUTICS$$$$A$M$Y$$$20240829$$$US$
242659111$24265911$1$I$$20240528$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000733$AXSOME THERAPEUTICS$$$$$F$Y$$$20240829$$$US$
242659121$24265912$1$I$20240601$20240705$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000778$AXSOME THERAPEUTICS$$72$YR$E$F$Y$$$20240829$$CN$US$
242659131$24265913$1$I$$20240819$20240830$20240830$PER$$US-AstraZeneca-2024A197143$ASTRAZENECA$$71$YR$$F$Y$$$20240830$$CN$US$
242659141$24265914$1$I$$20240523$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000709$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$CN$US$
242659151$24265915$1$I$$20240828$20240830$20240830$EXP$$CN-TAKEDA-2024TUS087177$TAKEDA$$$$$F$Y$$$20240830$$CN$CN$CN
242659161$24265916$1$I$20230724$20230809$20240830$20240830$PER$$US-Accord-373588$ACCORD$$73$YR$E$M$Y$79.38$KG$20240830$$CN$US$US
242659171$24265917$1$I$$20240821$20240830$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-136276$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240829$$PH$JP$JP
242659181$24265918$1$I$$20240820$20240830$20240830$EXP$$US-NOVOPROD-1273744$NOVO NORDISK$$63$YR$$M$Y$$$20240830$$CN$US$US
242659191$24265919$1$I$20230501$20240819$20240830$20240830$EXP$$US-NOVOPROD-1273379$NOVO NORDISK$$50$YR$$M$Y$$$20240830$$CN$US$US
242659201$24265920$1$I$$20240820$20240830$20240830$EXP$RU-RZN-2521644$RU-NOVOPROD-1273833$NOVO NORDISK$$45$YR$$F$Y$$$20240830$$HP$RU$RU
242659221$24265922$1$I$$20240819$20240830$20240830$EXP$$US-NOVOPROD-1272598$NOVO NORDISK$$51$YR$$$Y$$$20240830$$CN$US$US
242659231$24265923$1$I$$20240819$20240830$20240830$EXP$$US-NOVOPROD-1274183$NOVO NORDISK$$56$YR$$F$Y$$$20240830$$CN$US$US
242659242$24265924$2$F$20140101$20240829$20240830$20240912$EXP$$US-NOVOPROD-1273376$NOVO NORDISK$$74$YR$$M$Y$$$20240912$$CN$US$US
242659252$24265925$2$F$20230728$20240901$20240830$20240911$EXP$$US-NOVOPROD-1272950$NOVO NORDISK$$52$YR$$F$Y$$$20240911$$CN$US$US
242659271$24265927$1$I$20100101$20240819$20240830$20240830$EXP$$US-NOVOPROD-1274182$NOVO NORDISK$$56$YR$$F$Y$$$20240830$$CN$US$US
242659281$24265928$1$I$$20240819$20240830$20240830$EXP$$US-NOVOPROD-1274193$NOVO NORDISK$$56$YR$$F$Y$$$20240830$$CN$US$US
242659292$24265929$2$F$20240612$20240829$20240830$20240910$EXP$$CO-NOVOPROD-1273751$NOVO NORDISK$$84$YR$$F$Y$75$KG$20240910$$CN$CO$CO
242659301$24265930$1$I$$20240819$20240830$20240830$EXP$$US-NOVOPROD-1272836$NOVO NORDISK$$$$$F$Y$$$20240830$$MD$US$US
242659311$24265931$1$I$$20240820$20240830$20240830$EXP$$TR-NOVOPROD-1273990$NOVO NORDISK$$$$$M$Y$$$20240830$$CN$TR$TR
242659321$24265932$1$I$$20240827$20240830$20240830$EXP$$BR-EMD Serono-2024046100$EMD SERONO INC$$$$A$F$Y$$$20240830$$CN$BR$BR
242659331$24265933$1$I$20240826$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024172224$AMGEN$$$$$$Y$$$20240829$$CN$US$US
242659341$24265934$1$I$20240801$20240823$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013348$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242659351$24265935$1$I$$20240821$20240830$20240830$PER$$US-ABBVIE-5890872$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242659361$24265936$1$I$$20240821$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134986$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240829$$CN$US$US
242659371$24265937$1$I$20240801$20240820$20240830$20240830$EXP$GB-MHRA-MED-202408200950062680-VGCKT$GB-NOVOPROD-1271735$NOVO NORDISK$$$$$F$Y$$$20240830$$HP$GB$GB
242659381$24265938$1$I$20240810$20240826$20240830$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013636$JAZZ$$32$YR$$M$Y$67$KG$20240829$$CN$US$US
242659391$24265939$1$I$$20240820$20240830$20240830$EXP$$EG-NOVOPROD-1272236$NOVO NORDISK$$$$$M$Y$$$20240830$$CN$EG$EG
242659401$24265940$1$I$$20240820$20240830$20240830$EXP$$DE-NOVOPROD-1272287$NOVO NORDISK$$240$MON$$F$Y$$$20240830$$PH$DE$DE
242659411$24265941$1$I$20240701$20240820$20240830$20240830$EXP$$US-NOVOPROD-1268704$NOVO NORDISK$$$$$F$Y$$$20240830$$CN$US$US
242659421$24265942$1$I$20240807$20240820$20240830$20240830$EXP$$GB-NOVOPROD-1255457$NOVO NORDISK$$67$YR$$F$Y$$$20240830$$PH$GB$GB
242659431$24265943$1$I$20211201$20240820$20240830$20240830$EXP$$US-NOVOPROD-1274027$NOVO NORDISK$$73$YR$$F$Y$$$20240830$$CN$US$US
242659441$24265944$1$I$20240531$20240820$20240830$20240830$EXP$$JP-NOVOPROD-1233714$NOVO NORDISK$$74$YR$$M$Y$68$KG$20240830$$MD$JP$JP
242659451$24265945$1$I$20220101$20240820$20240830$20240830$EXP$$US-NOVOPROD-1273352$NOVO NORDISK$$71$YR$$F$Y$$$20240830$$CN$US$US
242659461$24265946$1$I$$20240820$20240830$20240830$EXP$$US-NOVOPROD-1273370$NOVO NORDISK$$$$$M$Y$$$20240830$$CN$US$US
242659471$24265947$1$I$20230903$20240820$20240830$20240830$EXP$$US-NOVOPROD-1271786$NOVO NORDISK$$32$YR$$F$Y$$$20240830$$CN$US$US
242659482$24265948$2$F$$20240918$20240830$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136584$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240919$$CN$US$US
242659491$24265949$1$I$20211206$20240821$20240830$20240830$EXP$$DE-JNJFOC-20240863726$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$MD$DE$DE
242659512$24265951$2$F$$20240925$20240830$20240927$EXP$$JP-JNJFOC-20240875645$JOHNSON AND JOHNSON$Maki KAKU, et al.; Department of Oncology/Hematology/Infection, Fukuoka University. Ganciclovir-resistant CMV infection developed in patient with multiple myeloma. International Journal of Myeloma. Proceedings of the 49th Annual Meeting of the Japanese Society of Myeloma; 2024.5.31,6.1,2;Fukuoka -shi Fukuoka:2024; 14(3)114$67$YR$E$F$Y$$$20240927$$MD$JP$JP
242659521$24265952$1$I$20240712$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137776$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240830$$CN$US$US
242659532$24265953$2$F$$20240906$20240830$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136647$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240913$$HP$US$US
242659541$24265954$1$I$20240101$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137345$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240830$$CN$US$US
242659551$24265955$1$I$20240801$20240828$20240830$20240830$EXP$$AU-AMGEN-AUSSP2024159848$AMGEN$$$$$F$Y$$$20240829$$PH$AU$AU
242659562$24265956$2$F$$20240826$20240830$20240910$PER$$US-SA-2024SA251864$SANOFI AVENTIS$$25$YR$A$$Y$$$20240910$$CN$US$US
242659571$24265957$1$I$$20240816$20240830$20240830$PER$$US-SA-2024SA250057$SANOFI AVENTIS$$$$A$F$Y$61.1$KG$20240830$$MD$US$US
242659581$24265958$1$I$$20240822$20240830$20240830$EXP$$US-AMGEN-USASP2024168658$AMGEN$Hahn N. M.. Neoadjuvant Cisplatin, Gemeitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis. Bladder Cancer. 2024;10 (2):133-143$$$$$Y$$$20240829$$MD$US$US
242659601$24265960$1$I$$20240820$20240830$20240830$EXP$$US-GSK-US2024103995$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242659612$24265961$2$F$$20240828$20240830$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137027$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240902$$CN$US$US
242659621$24265962$1$I$$20240826$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137011$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240829$$CN$US$US
242659631$24265963$1$I$20240101$20240822$20240830$20240830$EXP$$CA-TAKEDA-2024TUS085604$TAKEDA$$$$$M$Y$$$20240830$$MD$CA$CA
242659641$24265964$1$I$20240101$20240815$20240830$20240830$EXP$$US-UCBSA-2024041084$UCB$$$$$F$Y$95.29$KG$20240830$$HP$US$US
242659651$24265965$1$I$20240101$20240820$20240830$20240830$PER$$US-SA-2024SA249411$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240830$$MD$US$US
242659661$24265966$1$I$$20240819$20240830$20240830$PER$$US-JNJFOC-20240848539$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$HP$US$US
242659681$24265968$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136294$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240829$$CN$US$US
242659691$24265969$1$I$$20240814$20240830$20240830$PER$$US-TEVA-VS-3235134$TEVA$$65$YR$$F$Y$$$20240830$$CN$US$US
242659701$24265970$1$I$20230101$20240808$20240830$20240830$PER$$US-JNJFOC-20240846009$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240830$$CN$US$US
242659722$24265972$2$F$$20240919$20240830$20240925$EXP$$JP-EMD Serono-2024045798$EMD SERONO INC$$6$DEC$A$M$Y$$$20240925$$MD$JP$JP
242659731$24265973$1$I$20240401$20240819$20240830$20240830$EXP$$SG-ROCHE-10000061375$ROCHE$$83$YR$E$F$Y$$$20240830$$CN$SG$SG
242659741$24265974$1$I$$20240829$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-082334-2024$RECKITT BENCKISER$$$$$F$Y$$$20240830$$CN$US$US
242659751$24265975$1$I$$20240826$20240830$20240830$PER$$US-BIOVITRUM-2024-US-011374$BIOVITRUM$$81$YR$$F$Y$$$20240829$$CN$US$US
242659771$24265977$1$I$$20240826$20240830$20240830$PER$$US-ROCHE-10000068355$ROCHE$$$$$$Y$$$20240830$$CN$US$US
242659781$24265978$1$I$$20240819$20240830$20240830$EXP$$US-INSMED, INC.-2024-03404-US$INSMED$$$$$$Y$$$20240830$$CN$US$US
242659791$24265979$1$I$$20240821$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408013593$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240830$$CN$US$US
242659801$24265980$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018273$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240830$$CN$US$US
242659811$24265981$1$I$$20240819$20240830$20240830$EXP$$CA-AUROBINDO-AUR-APL-2024-042502$AUROBINDO$$91$YR$$F$Y$114$KG$20240830$$PH$CA$CA
242659821$24265982$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018018$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240830$$CN$US$US
242659831$24265983$1$I$$20240823$20240830$20240830$PER$$US-AMGEN-USASP2024170424$AMGEN$$$$$$Y$$$20240829$$HP$US$US
242659841$24265984$1$I$20240823$20240826$20240830$20240830$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-115987$REGENERON$$$$$F$Y$$$20240830$$CN$US$US
242659851$24265985$1$I$20240801$20240826$20240830$20240830$EXP$$US-ABBVIE-5897654$ABBVIE$$34$YR$$F$Y$$$20240830$$CN$US$US
242659861$24265986$1$I$$20240828$20240830$20240830$EXP$$JP-SANDOZ INC.-SDZ2024JP076184$SANDOZ$$61$YR$$M$Y$$$20240830$$MD$JP$JP
242659871$24265987$1$I$20240701$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137355$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240830$$HP$US$US
242659881$24265988$1$I$$20240821$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133537$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240830$$CN$US$US
242659891$24265989$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004567$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242659901$24265990$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004568$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242659911$24265991$1$I$20190501$20240819$20240830$20240830$EXP$$DE-AUROBINDO-AUR-APL-2024-042128$AUROBINDO$Mispelbaum R, Hattenhauer T, Bauernfeind F, Lau J, Brossart P, Heine A.. Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden. Frontiers in Oncology. 2024;14$68$YR$$F$Y$$$20240830$$HP$DE$DE
242659921$24265992$1$I$$20240826$20240830$20240830$EXP$$CA-BIOGEN-2024BI01280254$BIOGEN$$$$$M$Y$$$20240830$$CN$CA$CA
242659931$24265993$1$I$20230402$20240821$20240830$20240830$EXP$$US-ROCHE-10000063284$ROCHE$$59$YR$A$M$Y$97.06$KG$20240830$$CN$US$US
242659951$24265995$1$I$20240813$20240822$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013257$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242659961$24265996$1$I$$20240824$20240830$20240830$EXP$$PK-GSK-PK2024APC106832$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$PK$PK
242659972$24265997$2$F$20240815$20240827$20240830$20240904$PER$$US-AMGEN-USASP2024171056$AMGEN$$81$YR$E$F$Y$$$20240904$$PH$US$US
242659982$24265998$2$F$20240830$20240830$20240830$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004435$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240909$$CN$US$US
242659991$24265999$1$I$20240808$20240823$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013330$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242660001$24266000$1$I$$20240816$20240830$20240830$PER$$US-SA-2024SA245344$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240830$$MD$US$US
242660011$24266001$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA158886$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240830$$MD$US$US
242660021$24266002$1$I$$20240820$20240830$20240830$PER$$US-BIOVITRUM-2024-US-011472$BIOVITRUM$$60$YR$$F$Y$$$20240830$$CN$US$US
242660031$24266003$1$I$$20240826$20240830$20240830$EXP$$JP-JNJFOC-20240876031$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$MD$JP$JP
242660041$24266004$1$I$20240730$20240823$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013352$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242660051$24266005$1$I$20240310$20240819$20240830$20240830$EXP$$GB-AUROBINDO-AUR-APL-2024-041923$AUROBINDO$$41$YR$$F$Y$127$KG$20240830$$CN$GB$GB
242660061$24266006$1$I$$20240823$20240830$20240830$EXP$$US-ABBVIE-5893960$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242660071$24266007$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137591$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$84.37$KG$20240830$$CN$US$US
242660081$24266008$1$I$20240701$20240828$20240830$20240830$EXP$$US-ABBVIE-5900155$ABBVIE$$70$YR$$F$Y$$$20240830$$CN$US$US
242660091$24266009$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5897586$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242660101$24266010$1$I$20240808$20240823$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013331$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242660111$24266011$1$I$$20240827$20240830$20240830$PER$$US-ROCHE-10000068399$ROCHE$$60$YR$A$M$Y$$$20240830$$HP$US$US
242660141$24266014$1$I$$20240829$20240830$20240830$EXP$CA-002147023-NVSC2021CA038268$CA-SANDOZ INC.-NVSC2021CA038268$SANDOZ$$80$YR$$M$Y$69$KG$20240830$$HP$CA$CA
242660151$24266015$1$I$$20240826$20240830$20240830$EXP$$JP-JNJFOC-20240875535$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240830$$PH$JP$JP
242660161$24266016$1$I$20240712$20240823$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013275$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242660171$24266017$1$I$20240614$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195770$ASTRAZENECA$$28214$DY$$M$Y$$$20240830$$HP$US$
242660181$24266018$1$I$$20240820$20240830$20240830$PER$$US-AstraZeneca-2024A190243$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242660191$24266019$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A193941$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242660211$24266021$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004569$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242660221$24266022$1$I$20240401$20240820$20240830$20240830$EXP$$US-NOVOPROD-1274117$NOVO NORDISK$$57$YR$$M$Y$$$20240830$$CN$US$US
242660231$24266023$1$I$$20240821$20240830$20240830$EXP$$JP-NOVOPROD-1234304$NOVO NORDISK$J. Shinoda et al.. A patient with type A insulin resistance syndrome who repeated midtrimester abortions, required different amounts of insulin, and had a recurrence of post-abortion transient hypoglycaemia. The 67th Annual Meeting of the Japan Diabetes Society. 2024;67$26$YR$$F$Y$$$20240830$$MD$JP$JP
242660241$24266024$1$I$$20240820$20240830$20240830$EXP$$US-NOVOPROD-1274490$NOVO NORDISK$$$$A$F$Y$$$20240830$$CN$US$US
242660251$24266025$1$I$$20240821$20240830$20240830$EXP$$JP-NOVOPROD-1236708$NOVO NORDISK$J. Shinoda et al.. A patient with type A insulin resistance syndrome who repeated midtrimester abortions, required different amounts of insulin, and had a recurrence of post-abortion transient hypoglycaemia. The 67th Annual Meeting of the Japan Diabetes Society. 2024;67$27$YR$$F$Y$$$20240830$$MD$JP$JP
242660261$24266026$1$I$$20240820$20240830$20240830$EXP$$US-NOVOPROD-1274627$NOVO NORDISK$$$$$$Y$$$20240830$$CN$US$US
242660271$24266027$1$I$20240826$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171355$AMGEN$$74$YR$E$M$Y$$$20240829$$CN$US$US
242660281$24266028$1$I$20240805$20240809$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004512$ACADIA PHARMACEUTICALS$$68$YR$$F$Y$$$20240830$$CN$US$US
242660291$24266029$1$I$20240729$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137533$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240830$$CN$US$US
242660302$24266030$2$F$$20240918$20240830$20240927$EXP$$BR-NOVOPROD-1274218$NOVO NORDISK$$$$$F$Y$$$20240927$$MD$BR$BR
242660311$24266031$1$I$$20240821$20240830$20240830$EXP$GB-MHRA-MED-202408211513100510-ZLNDJ$GB-NOVOPROD-1272407$NOVO NORDISK$$$$$M$Y$$$20240830$$CN$GB$GB
242660321$24266032$1$I$20240501$20240822$20240830$20240830$EXP$GB-MHRA-MED-202408221532009020-TPLDR$GB-NOVOPROD-1273777$NOVO NORDISK$$73$YR$$F$Y$$$20240830$$HP$GB$GB
242660331$24266033$1$I$20240101$20240821$20240830$20240830$EXP$$US-NOVOPROD-1274287$NOVO NORDISK$$$$A$M$Y$$$20240830$$MD$US$US
242660344$24266034$4$F$20240101$20240911$20240830$20240923$EXP$$US-UCBSA-2024020600$UCB$$$$$M$Y$55$KG$20240923$$CN$US$US
242660351$24266035$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA249479$SANOFI AVENTIS$$$$A$$Y$$$20240830$$HP$US$US
242660361$24266036$1$I$20240823$20240717$20240830$20240830$PER$$US-SA-2024SA251565$SANOFI AVENTIS$$$$$F$Y$$$20240830$$CN$US$US
242660371$24266037$1$I$$20240821$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408013859$ELI LILLY AND CO$$47$YR$A$$Y$$$20240830$$LW$US$US
242660381$24266038$1$I$$20240819$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408011428$ELI LILLY AND CO$$$$$$Y$$$20240830$$CN$US$US
242660391$24266039$1$I$$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016558$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240830$$CN$US$US
242660401$24266040$1$I$20240828$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018112$ELI LILLY AND CO$$32$YR$A$$Y$$$20240830$$CN$US$US
242660411$24266041$1$I$20240101$20240817$20240830$20240830$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019369$VALIDUS$$$$$$Y$$$20240830$$CN$US$US
242660421$24266042$1$I$20240819$20240827$20240830$20240830$EXP$$US-ABBVIE-5898262$ABBVIE$$61$YR$$F$Y$$$20240830$$CN$US$US
242660431$24266043$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5898573$ABBVIE$$$$$F$Y$$$20240830$$HP$US$US
242660442$24266044$2$F$$20240826$20240830$20240903$EXP$$CN-AMGEN-CHNSP2024170970$AMGEN$Zhai H, Li Y, Li R, Chu Q.. A case of recurrent torsade de pointes induced by IVABRADINE combined with Amiodarone after emergency percutaneous coronary intervention for acute myocardial infarction. Chinese Journal of Cardiac Pacing and Electrophysiology$65$YR$E$M$Y$$$20240902$$MD$CN$CN
242660451$24266045$1$I$$20240822$20240830$20240830$EXP$$US-JNJFOC-20240859654$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240830$$CN$US$US
242660461$24266046$1$I$20240621$20240823$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013327$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242660472$24266047$2$F$$20240830$20240830$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004574$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
242660481$24266048$1$I$20240101$20240815$20240830$20240830$EXP$$AU-IMP-2024000655$Harrow Health$$$$E$M$Y$$$20240830$$CN$AU$AU
242660491$24266049$1$I$$20240815$20240830$20240830$EXP$$TR-NOVOPROD-1272922$NOVO NORDISK$$$$$$Y$$$20240830$$CN$TR$TR
242660501$24266050$1$I$20240813$20240814$20240830$20240830$30DAY$$US-NOVOPROD-1274051$NOVO NORDISK$$47$YR$$F$Y$$$20240830$$PH$US$US
242660511$24266051$1$I$20240520$20240822$20240830$20240830$EXP$GB-MHRA-MED-202408211529232520-KPHYT$GB-NOVOPROD-1273816$NOVO NORDISK$$54$YR$$F$Y$150$KG$20240830$$MD$GB$GB
242660541$24266054$1$I$$20240819$20240830$20240830$EXP$$JP-ROCHE-10000065839$ROCHE$$89$YR$E$F$Y$$$20240830$$MD$JP$JP
242660551$24266055$1$I$20240811$20240816$20240830$20240830$PER$$US-SA-2024SA247870$SANOFI AVENTIS$$60$YR$A$F$Y$86.9$KG$20240830$$MD$US$US
242660562$24266056$2$F$20240827$20240906$20240830$20240913$PER$$US-AMGEN-USASP2024172598$AMGEN$$80$YR$E$F$Y$$$20240913$$CN$US$US
242660571$24266057$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172703$AMGEN$$$$E$F$Y$$$20240829$$HP$US$US
242660581$24266058$1$I$$20240829$20240830$20240830$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048679$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240830$$CN$US$US
242660591$24266059$1$I$20240819$20240819$20240830$20240830$PER$$US-ABBVIE-5887144$ABBVIE$$43$YR$$F$Y$$$20240830$$CN$US$US
242660601$24266060$1$I$$20240823$20240830$20240830$EXP$$TW-ROCHE-10000068288$ROCHE$Li P, Tai S. Persistent Visual Loss in a 1-Eyed Patient After Intravenous Thrombolytic Therapy for Acute Ischemic Stroke. Journal of Neuro-Ophthalmology. 2024;44:3: e309-e310.$87$YR$E$F$Y$$$20240830$$MD$TW$TW
242660611$24266061$1$I$20240818$20240823$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013329$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242660621$24266062$1$I$$20240823$20240830$20240830$PER$$US-AMGEN-USASP2024169852$AMGEN$$$$$F$Y$$$20240829$$PH$US$US
242660631$24266063$1$I$20230427$20240805$20240830$20240830$EXP$KR-KAERS-2023000667390$KR-AMGEN-KORSP2024159195$AMGEN$$78$YR$E$M$Y$$$20240829$$HP$KR$KR
242660641$24266064$1$I$$20240520$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000690$AXSOME THERAPEUTICS$$$$E$$Y$$$20240830$$$US$
242660651$24266065$1$I$20240501$20240521$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000695$AXSOME THERAPEUTICS$$$$$M$Y$$$20240830$$$US$
242660661$24266066$1$I$$20240521$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000700$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$$US$
242660671$24266067$1$I$$20240521$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000698$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$HP$US$
242660681$24266068$1$I$20240501$20240521$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000682$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242660691$24266069$1$I$20240501$20240521$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000697$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$HP$US$
242660701$24266070$1$I$20240501$20240522$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000703$AXSOME THERAPEUTICS$$30$YR$A$F$Y$$$20240830$$CN$US$
242660711$24266071$1$I$20240101$20240522$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000704$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242660721$24266072$1$I$20240101$20240522$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000708$AXSOME THERAPEUTICS$$52$YR$A$F$Y$$$20240830$$$US$
242660731$24266073$1$I$20240101$20240523$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000714$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242660741$24266074$1$I$$20240524$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000728$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$MD$US$
242660751$24266075$1$I$$20240528$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000731$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242660761$24266076$1$I$$20240531$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000763$AXSOME THERAPEUTICS$$$$A$F$Y$$$20240830$$MD$US$
242660771$24266077$1$I$20240101$20240524$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000727$AXSOME THERAPEUTICS$$82$YR$E$M$Y$$$20240830$$MD$US$
242660781$24266078$1$I$20240529$20240529$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000735$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242660791$24266079$1$I$20220101$20240528$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000739$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242660801$24266080$1$I$$20240530$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000750$AXSOME THERAPEUTICS$$67$YR$E$M$Y$$$20240830$$$US$
242660811$24266081$1$I$$20240528$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000740$AXSOME THERAPEUTICS$$39$YR$A$M$Y$$$20240830$$CN$US$
242660821$24266082$1$I$20240501$20240530$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000646$AXSOME THERAPEUTICS$$53$YR$A$M$Y$74$KG$20240830$$CN$US$
242660831$24266083$1$I$20240101$20240529$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000753$AXSOME THERAPEUTICS$$24$YR$A$F$Y$$$20240830$$CN$US$
242660841$24266084$1$I$20240501$20240531$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000757$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242660851$24266085$1$I$$20240531$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000760$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242660861$24266086$1$I$20240501$20240531$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000761$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242660872$24266087$2$F$20180101$20240828$20240830$20240906$EXP$$ES-AUROBINDO-AUR-APL-2024-042026$AUROBINDO$Sneyers Closa M, Perez Requena A, Sanchez Garcia S, Sistac Ballarin J.. Anaesthetic management of thyroid storm in a patient with Friederich^s ataxia. A case report.. Rev-EspanolAnestes-Reanim. 2023;70(6):362-365$26$YR$$M$Y$$$20240906$$HP$ES$ES
242660881$24266088$1$I$$20240822$20240830$20240830$PER$$US-BEH-2024177666$CSL BEHRING$$$$A$M$Y$$$20240830$$HP$US$US
242660891$24266089$1$I$20240827$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171778$AMGEN$$75$YR$E$F$Y$$$20240829$$CN$US$US
242660921$24266092$1$I$20240101$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171829$AMGEN$$67$YR$E$F$Y$$$20240829$$CN$US$US
242660931$24266093$1$I$$20240827$20240830$20240830$PER$$US-TAKEDA-2024TUS086732$TAKEDA$$$$$M$Y$$$20240830$$CN$US$US
242660941$24266094$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004498$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242660952$24266095$2$F$$20240904$20240830$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004497$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242660961$24266096$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137716$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240830$$HP$US$US
242660971$24266097$1$I$$20240819$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131310$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240830$$HP$US$US
242660981$24266098$1$I$20240601$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137160$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$84.82$KG$20240830$$CN$US$US
242660991$24266099$1$I$20240822$20240825$20240830$20240830$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-17048$IPSEN$$83$YR$E$M$Y$$$20240830$$CN$GB$GB
242661001$24266100$1$I$$20240819$20240830$20240830$PER$$US-JNJFOC-20240856061$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$CN$US$US
242661011$24266101$1$I$$20240824$20240830$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001732$BLUEPRINT MEDICINES$$$$$M$Y$$$20240830$$CN$US$US
242661021$24266102$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA251974$SANOFI AVENTIS$$$$T$M$Y$$$20240830$$HP$US$US
242661031$24266103$1$I$$20240827$20240830$20240830$PER$$US-GILEAD-2024-0685707$GILEAD$$35$YR$A$M$Y$$$20240829$$CN$US$US
242661041$24266104$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018027$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240830$$CN$US$US
242661051$24266105$1$I$$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018795$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240830$$HP$US$US
242661061$24266106$1$I$$20240828$20240830$20240830$EXP$$US-SANDOZ INC.-SDZ2024US076290$SANDOZ$$$$$F$Y$$$20240830$$CN$US$US
242661071$24266107$1$I$$20240823$20240830$20240830$PER$$US-ROCHE-1723514$ROCHE$Simmons S, Smith M, Chang-Miller A and Keddis M. Antinuclear Antibody-Negative Lupus Nephritis with Full House Nephropathy: A Case Report and Review of the Literature. American Journal of Nephrology 2015 Dec 01;42(6):451-459.$49$YR$A$F$Y$71.5$KG$20240830$$MD$US$US
242661081$24266108$1$I$$20240822$20240830$20240830$PER$$US-ROCHE-2484241$ROCHE$Lum E, Datta N, Beaird O, Zuckerman J, Bunnapradist S and Schaenman J Cutaneous Fungal Masses From Prior Environmental Injury Following Kidney Transplant: A Case Report. Transplantation Proceedings 2019 Nov;51.9:3087-91.$72$YR$E$F$Y$$$20240830$$MD$US$US
242661091$24266109$1$I$$20240821$20240830$20240830$EXP$$IE-ROCHE-10000063845$ROCHE$$62$YR$A$$Y$$$20240830$$CN$IE$IE
242661101$24266110$1$I$$20240822$20240830$20240830$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010811$STRIDES$Jones H, Bhakta A, Jia L, Wojciechowski D, Torrealba J.. An Unusual Presentation of Metastatic BK Virus-Associated Urothelial Carcinoma Arising in the Allograft, Persisting After Transplant Nephrectomy.. Int-J-Surg-Pathol. 2023;31 (8):1586-1592$$$$$Y$$$20240830$$MD$US$US
242661121$24266112$1$I$20240808$20240809$20240830$20240830$PER$$US-AstraZeneca-2024A182393$ASTRAZENECA$$30586$DY$$F$Y$$$20240830$$CN$US$
242661141$24266114$1$I$$20240828$20240830$20240830$EXP$$JP-SANDOZ INC.-SDZ2024JP076135$SANDOZ$$59$YR$$M$Y$$$20240830$$MD$JP$JP
242661151$24266115$1$I$$20240826$20240830$20240830$PER$$US-ROCHE-10000066876$ROCHE$$67$YR$E$F$Y$$$20240830$$CN$US$US
242661161$24266116$1$I$20240718$20240820$20240830$20240830$EXP$FR-AFSSAPS-GR2024001016$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111348$ZYDUS PHARM$$$$$$Y$$$20240830$$PH$FR$FR
242661171$24266117$1$I$20240716$20240820$20240830$20240830$EXP$FR-AFSSAPS-AVLL2024000198$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111359$ZYDUS PHARM$$$$$$Y$$$20240830$$MD$FR$FR
242661181$24266118$1$I$20240726$20240820$20240830$20240830$EXP$ES-AEMPS-1561229$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111467$ZYDUS PHARM$$$$$$Y$$$20240830$$MD$ES$ES
242661191$24266119$1$I$$20240814$20240830$20240830$PER$$US-TEVA-VS-3235151$TEVA$$54$YR$$F$Y$$$20240830$$CN$US$US
242661201$24266120$1$I$$20240822$20240830$20240830$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000745$DECIPHERA PHARMACEUTICALS$$73$YR$E$M$Y$$$20240830$$CN$US$US
242661211$24266121$1$I$20240628$20240820$20240830$20240830$EXP$FR-AFSSAPS-CN2024000724$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111410$ZYDUS PHARM$$$$$$Y$$$20240830$$MD$FR$FR
242661221$24266122$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004573$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242661231$24266123$1$I$$20240820$20240830$20240830$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP010503$STRIDES$De Rose DU, Landolfo F, Flaminia P, Giliberti P, Santisi A, Columbo C et al.. Use of N-Acetylcysteine in Preterm Neonates with Enteral Feeding Intolerance and Intestinal Obstruction: A Case Series and Review of the Literature.. Children. 2024;11:873$23$WK$$M$Y$0.7$KG$20240830$$HP$IT$IT
242661261$24266126$1$I$20240101$20240813$20240830$20240830$30DAY$$US-ABBVIE-5897606$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242661271$24266127$1$I$20240729$20240823$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013356$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242661281$24266128$1$I$20240601$20240809$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004549$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240830$$CN$US$US
242661291$24266129$1$I$20240801$20240826$20240830$20240830$EXP$$US-AMGEN-USASP2024170676$AMGEN$$$$$M$Y$$$20240829$$MD$US$US
242661301$24266130$1$I$20240101$20240823$20240830$20240830$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000603$DECIPHERA PHARMACEUTICALS$$79$YR$E$F$Y$$$20240830$$MD$US$US
242661321$24266132$1$I$20240421$20240819$20240830$20240830$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003153$PAREXEL$$76$YR$$F$Y$$$20240830$$CN$US$US
242661331$24266133$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004575$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242661341$24266134$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004550$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$HP$US$US
242661352$24266135$2$F$20240828$20240828$20240830$20240903$PER$$US-AMGEN-USASP2024172333$AMGEN$$50$YR$A$F$Y$$$20240903$$CN$US$US
242661362$24266136$2$F$20240101$20240906$20240830$20240912$EXP$$US-ABBVIE-5898306$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
242661371$24266137$1$I$20240418$20240828$20240830$20240830$EXP$$IN-SANDOZ INC.-SDZ2024IN076328$SANDOZ$$21$YR$$M$Y$$$20240830$$CN$IN$IN
242661382$24266138$2$F$$20240906$20240830$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004519$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242661392$24266139$2$F$$20240829$20240830$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004554$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
242661401$24266140$1$I$$20240827$20240830$20240830$EXP$$JP-TAKEDA-2024TJP012617$TAKEDA$$7$DEC$$M$Y$$$20240830$$MD$JP$JP
242661412$24266141$2$F$$20240902$20240830$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004556$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
242661421$24266142$1$I$20240803$20240809$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004561$ACADIA PHARMACEUTICALS$$63$YR$$F$Y$$$20240830$$CN$US$US
242661431$24266143$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004505$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242661452$24266145$2$F$$20240902$20240830$20240911$EXP$$PT-IPCA LABORATORIES LIMITED-IPC-2024-PT-002113$IPCA$Ines Correia, Rosario Eca, Maria Joao Barbosa, et al. Dress syndrome: A rare secondary response.. Congress of the Portuguese society of internal medicine. 30th national congress. 2024;846$$$$$Y$$$20240911$$MD$PT$PT
242661461$24266146$1$I$$20240827$20240830$20240830$EXP$$CA-HALEON-2193874$Haleon PLC$$60$YR$$F$Y$$$20240830$$HP$CA$CA
242661471$24266147$1$I$20240827$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018119$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240830$$CN$US$US
242661481$24266148$1$I$20240601$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018339$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240830$$CN$US$US
242661491$24266149$1$I$20240825$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018249$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240830$$CN$US$US
242661501$24266150$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004560$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242661511$24266151$1$I$20240730$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004507$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240830$$CN$US$US
242661521$24266152$1$I$$20240823$20240830$20240830$EXP$$US-CELLTRION INC.-2024US020492$CELLTRION$$$$$$Y$$$20240830$$CN$US$US
242661531$24266153$1$I$20240825$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024170314$AMGEN$$64$YR$A$F$Y$$$20240829$$CN$US$US
242661551$24266155$1$I$20240819$20240823$20240830$20240830$EXP$$CN-ALCON LABORATORIES-ALC2024CN003951$ALCON$$86$YR$$M$Y$49$KG$20240830$$HP$CN$CN
242661561$24266156$1$I$$20240820$20240830$20240830$PER$$US-EMD Serono-2024044899$EMD SERONO INC$$$$A$M$Y$$$20240830$$CN$US$US
242661571$24266157$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004577$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242661581$24266158$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004564$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242661591$24266159$1$I$20240810$20240810$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004508$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240830$$CN$US$US
242661601$24266160$1$I$20240101$20240816$20240830$20240830$PER$$US-SA-2024SA245511$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240830$$MD$US$US
242661611$24266161$1$I$$20240828$20240830$20240830$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048406$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240829$$CN$US$US
242661621$24266162$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004565$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$MD$US$US
242661632$24266163$2$F$$20240812$20240830$20240906$PER$$US-TEVA-VS-3232837$TEVA$$$$$M$Y$$$20240906$$CN$US$US
242661641$24266164$1$I$20240701$20240802$20240830$20240830$PER$$US-AMGEN-USASP2024172005$AMGEN$$61$YR$A$F$Y$$$20240829$$CN$US$US
242661651$24266165$1$I$$20240819$20240830$20240830$PER$$US-JNJFOC-20240853013$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240830$$CN$US$US
242661672$24266167$2$F$$20240913$20240830$20240919$EXP$$JP-JNJFOC-20240875107$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$PH$JP$JP
242661691$24266169$1$I$20240801$20240814$20240830$20240830$PER$$US-JNJFOC-20240841844$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240830$$CN$US$US
242661701$24266170$1$I$$20240826$20240830$20240830$EXP$$US-JNJFOC-20240870117$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$CN$US$US
242661711$24266171$1$I$$20240809$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004582$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242661721$24266172$1$I$20240812$20240829$20240830$20240830$PER$$US-ROCHE-10000069449$ROCHE$$30$YR$A$M$Y$86.18$KG$20240830$$CN$US$US
242661731$24266173$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000068870$ROCHE$$$$C$M$Y$$$20240830$$CN$US$US
242661751$24266175$1$I$$20240619$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000881$AXSOME THERAPEUTICS$$$$$M$Y$$$20240830$$CN$US$
242661761$24266176$1$I$$20240619$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000878$AXSOME THERAPEUTICS$$44$YR$A$F$Y$$$20240830$$MD$AE$
242661771$24266177$1$I$$20240621$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000894$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$$US$
242661781$24266178$1$I$20240601$20240618$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000871$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242661791$24266179$1$I$$20240624$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000899$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242661801$24266180$1$I$20240101$20240618$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000748$AXSOME THERAPEUTICS$$$$A$M$Y$83.91$KG$20240830$$CN$US$
242661811$24266181$1$I$$20240621$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000893$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$CN$US$
242661821$24266182$1$I$20240601$20240621$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000898$AXSOME THERAPEUTICS$$47$YR$A$F$Y$$$20240830$$MD$US$
242661831$24266183$1$I$20240101$20240625$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000834$AXSOME THERAPEUTICS$$42$YR$A$F$Y$$$20240830$$CN$US$
242661841$24266184$1$I$$20240624$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000905$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$MD$US$
242661851$24266185$1$I$20240501$20240625$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000831$AXSOME THERAPEUTICS$$63$YR$A$F$Y$$$20240830$$CN$US$
242661861$24266186$1$I$$20240624$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000906$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$MD$US$
242661871$24266187$1$I$$20240624$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000907$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$MD$US$
242661881$24266188$1$I$$20240625$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000909$AXSOME THERAPEUTICS$$$$$M$Y$$$20240830$$HP$US$
242661891$24266189$1$I$20240623$20240626$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000913$AXSOME THERAPEUTICS$$18$YR$A$F$Y$$$20240830$$CN$US$
242661901$24266190$1$I$20240101$20240626$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000786$AXSOME THERAPEUTICS$$74$YR$E$F$Y$$$20240830$$CN$US$
242661911$24266191$1$I$20240101$20240624$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000908$AXSOME THERAPEUTICS$$67$YR$E$M$Y$$$20240830$$CN$US$
242661921$24266192$1$I$$20240626$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000914$AXSOME THERAPEUTICS$$47$YR$A$F$Y$$$20240830$$CN$US$
242661931$24266193$1$I$20240101$20240626$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000920$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242661941$24266194$1$I$20240624$20240627$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000925$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242661951$24266195$1$I$20240805$20240820$20240830$20240830$EXP$$US-GSK-US2024104546$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240830$$CN$US$US
242661961$24266196$1$I$$20240628$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000932$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242661971$24266197$1$I$$20240702$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000945$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242661982$24266198$2$F$$20240912$20240830$20240918$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104349$VIIV$$$$$M$Y$$$20240918$$HP$US$US
242661991$24266199$1$I$20230701$20240628$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000841$AXSOME THERAPEUTICS$$23$YR$A$F$Y$$$20240830$$CN$US$
242662001$24266200$1$I$20240101$20240701$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000842$AXSOME THERAPEUTICS$$60$YR$A$F$Y$$$20240830$$CN$US$
242662011$24266201$1$I$$20240820$20240830$20240830$PER$$US-APOTEX-2024AP009647$APOTEX$$51$YR$$M$Y$$$20240830$$HP$US$US
242662021$24266202$1$I$$20240819$20240830$20240830$EXP$CA-MHPD-001090131$CA-Accord-442524$ACCORD$$45$YR$A$F$Y$$$20240830$$CN$CA$CA
242662031$24266203$1$I$$20240820$20240830$20240830$EXP$$CA-GALDERMA-CA2024013082$GALDERMA$$$$$$Y$$$20240830$$HP$CA$CA
242662041$24266204$1$I$$20240827$20240830$20240830$EXP$$CA-HALEON-2193737$Haleon PLC$$43$YR$$F$Y$$$20240829$$HP$CA$CA
242662051$24266205$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000069307$ROCHE$$$$A$M$Y$$$20240830$$CN$US$US
242662061$24266206$1$I$$20240810$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004541$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242662072$24266207$2$F$20240816$20240826$20240830$20240904$EXP$$US-HALEON-2193855$Haleon PLC$$1$YR$$M$Y$10.433$KG$20240904$$HP$US$US
242662081$24266208$1$I$$20240826$20240830$20240830$PER$$US-AstraZeneca-2024A194779$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242662091$24266209$1$I$$20240823$20240830$20240830$EXP$$US-VIIV HEALTHCARE LIMITED-US2024105612$VIIV$$$$$$Y$$$20240830$$PH$US$US
242662101$24266210$1$I$20240101$20240717$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001052$AXSOME THERAPEUTICS$$$$$M$Y$$$20240829$$MD$US$
242662111$24266211$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-083641-2024$RECKITT BENCKISER$$$$$$Y$$$20240830$$CN$US$US
242662121$24266212$1$I$$20240717$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001045$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$CN$US$
242662131$24266213$1$I$$20240719$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001056$AXSOME THERAPEUTICS$$49$YR$A$M$Y$$$20240829$$CN$US$
242662141$24266214$1$I$$20240717$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001051$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$MD$US$
242662151$24266215$1$I$20240701$20240722$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001062$AXSOME THERAPEUTICS$$$$$$Y$$$20240829$$CN$US$
242662161$24266216$1$I$$20240722$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001065$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$CN$US$
242662171$24266217$1$I$$20240722$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001066$AXSOME THERAPEUTICS$$61$YR$A$F$Y$$$20240830$$CN$US$
242662181$24266218$1$I$$20240722$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001064$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242662191$24266219$1$I$20240725$20240826$20240830$20240830$EXP$$CN-HALEON-2193810$Haleon PLC$$54$YR$$M$Y$$$20240830$$HP$CN$CN
242662201$24266220$1$I$$20240722$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001038$AXSOME THERAPEUTICS$$47$YR$A$F$Y$$$20240830$$CN$US$
242662211$24266221$1$I$20240101$20240722$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001067$AXSOME THERAPEUTICS$$69$YR$E$F$Y$$$20240830$$CN$US$
242662221$24266222$1$I$20240701$20240725$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001085$AXSOME THERAPEUTICS$$$$A$F$Y$$$20240830$$$US$
242662231$24266223$1$I$$20240725$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001098$AXSOME THERAPEUTICS$$75$YR$E$F$Y$$$20240830$$CN$US$
242662241$24266224$1$I$20240101$20240723$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000991$AXSOME THERAPEUTICS$$70$YR$E$F$Y$$$20240830$$CN$US$
242662251$24266225$1$I$20240101$20240726$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001104$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$CN$US$
242662261$24266226$1$I$$20240729$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001109$AXSOME THERAPEUTICS$$35$YR$A$F$Y$$$20240830$$HP$US$
242662271$24266227$1$I$20240618$20240726$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000879$AXSOME THERAPEUTICS$$76$YR$E$F$Y$$$20240830$$CN$US$
242662281$24266228$1$I$$20240822$20240830$20240830$EXP$$CA-GALDERMA-CA2024013197$GALDERMA$$$$$$Y$$$20240830$$HP$CA$CA
242662291$24266229$1$I$20240701$20240726$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001005$AXSOME THERAPEUTICS$$65$YR$E$F$Y$$$20240830$$CN$US$
242662301$24266230$1$I$20230101$20240729$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202404-000522$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242662311$24266231$1$I$$20240729$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001115$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242662321$24266232$1$I$$20240724$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001116$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$HP$US$
242662331$24266233$1$I$$20240724$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001117$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$HP$US$
242662341$24266234$1$I$$20240729$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001118$AXSOME THERAPEUTICS$$32$YR$A$F$Y$$$20240830$$$US$
242662351$24266235$1$I$$20240730$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001128$AXSOME THERAPEUTICS$$40$YR$A$F$Y$$$20240830$$CN$US$
242662361$24266236$1$I$20240701$20240730$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001129$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242662371$24266237$1$I$$20240730$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001136$AXSOME THERAPEUTICS$$56$YR$A$M$Y$$$20240830$$MD$US$
242662381$24266238$1$I$$20240731$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001139$AXSOME THERAPEUTICS$$50$YR$A$F$Y$$$20240830$$$US$
242662391$24266239$1$I$20240814$20240826$20240830$20240830$PER$$US-ABBVIE-5895924$ABBVIE$$25$YR$$F$Y$92.5$KG$20240830$$HP$US$US
242662401$24266240$1$I$20240701$20240801$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001035$AXSOME THERAPEUTICS$$39$YR$A$M$Y$$$20240830$$$US$
242662411$24266241$1$I$$20240801$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001148$AXSOME THERAPEUTICS$$50$YR$A$F$Y$$$20240830$$CN$US$
242662421$24266242$1$I$20240101$20240801$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001146$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$CN$US$
242662431$24266243$1$I$20240101$20240730$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001024$AXSOME THERAPEUTICS$$55$YR$A$M$Y$$$20240830$$CN$US$
242662441$24266244$1$I$$20240801$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001141$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$HP$US$
242662451$24266245$1$I$20240101$20240801$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001151$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$CN$US$
242662461$24266246$1$I$20240101$20240802$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001152$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$CN$US$
242662471$24266247$1$I$$20240806$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001165$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$MD$US$
242662481$24266248$1$I$$20240827$20240830$20240830$EXP$$CA-HALEON-2193719$Haleon PLC$$60$YR$$F$Y$$$20240829$$MD$CA$CA
242662491$24266249$1$I$$20240806$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001168$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$$US$
242662501$24266250$1$I$$20240806$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001170$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$CN$US$
242662511$24266251$1$I$20240101$20240807$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001180$AXSOME THERAPEUTICS$$65$YR$E$M$Y$$$20240830$$CN$US$
242662521$24266252$1$I$20240301$20240807$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001073$AXSOME THERAPEUTICS$$65$YR$E$F$Y$117$KG$20240830$$CN$US$
242662531$24266253$1$I$$20240807$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001181$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$CN$US$
242662541$24266254$1$I$20240101$20240807$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001182$AXSOME THERAPEUTICS$$$$$M$Y$$$20240830$$CN$US$
242662551$24266255$1$I$$20240807$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001183$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$CN$US$
242662561$24266256$1$I$20240301$20240808$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001187$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$CN$US$
242662571$24266257$1$I$20240809$20240809$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001190$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$CN$US$
242662581$24266258$1$I$20240701$20240809$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001191$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$CN$US$
242662591$24266259$1$I$20240801$20240809$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001192$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$CN$US$
242662601$24266260$1$I$$20240812$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001215$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$CN$US$
242662611$24266261$1$I$20240101$20240812$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001216$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$CN$US$
242662621$24266262$1$I$20240101$20240812$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001217$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$CN$US$
242662631$24266263$1$I$$20240813$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001228$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$HP$US$
242662641$24266264$1$I$20231102$20240813$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001048$AXSOME THERAPEUTICS$$61$YR$A$F$Y$$$20240830$$$US$
242662651$24266265$1$I$20240101$20240814$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001126$AXSOME THERAPEUTICS$$50$YR$A$F$Y$$$20240830$$MD$US$
242662661$24266266$1$I$20240101$20240814$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000685$AXSOME THERAPEUTICS$$60$YR$A$F$Y$$$20240830$$CN$US$
242662671$24266267$1$I$$20240810$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001095$AXSOME THERAPEUTICS$$19$YR$A$F$Y$$$20240830$$CN$US$
242662681$24266268$1$I$$20240814$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001235$AXSOME THERAPEUTICS$$$$A$$Y$$$20240830$$CN$US$
242662691$24266269$1$I$$20240816$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001158$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$$US$
242662701$24266270$1$I$$20240816$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001253$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$$US$
242662711$24266271$1$I$$20240816$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202408-001254$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$$US$
242662721$24266272$1$I$$20240725$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001099$AXSOME THERAPEUTICS$$$$$M$Y$$$20240830$$$US$
242662731$24266273$1$I$$20240823$20240830$20240830$EXP$$US-ABBVIE-5894373$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242662741$24266274$1$I$$20240822$20240830$20240830$EXP$$PT-IPCA LABORATORIES LIMITED-IPC-2024-PT-002127$IPCA$Carolina Roias, Catarina La Cueva Couto, Bruna Bolas Cardoso et al.. Sindrome de DRESS na doenca renal cronica. Congressos da Sociedade Portuguesa Medicina Interna: 30.? Congresso Nacional de. 2024;1207$$$$$Y$$$20240830$$MD$PT$PT
242662751$24266275$1$I$$20240822$20240830$20240830$EXP$001056363$CA-GALDERMA-CA2024013228$GALDERMA$$$$$$Y$$$20240830$$HP$CA$CA
242662761$24266276$1$I$$20240703$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005098$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242662771$24266277$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018037$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240830$$CN$US$US
242662781$24266278$1$I$20240826$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016620$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240830$$CN$US$US
242662791$24266279$1$I$$20240821$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408014669$ELI LILLY AND CO$$43$YR$A$$Y$$$20240830$$LW$US$US
242662801$24266280$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018419$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240830$$CN$US$US
242662811$24266281$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018016$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240830$$CN$US$US
242662821$24266282$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137876$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240830$$CN$US$US
242662833$24266283$3$F$$20240913$20240830$20240925$PER$$US-ROCHE-10000067111$ROCHE$$78$YR$E$M$Y$$$20240925$$CN$US$US
242662841$24266284$1$I$20240801$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136331$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240830$$HP$US$US
242662862$24266286$2$F$$20240819$20240830$20240904$EXP$$CA-HALEON-2192913$Haleon PLC$$43$YR$$F$Y$96$KG$20240904$$HP$CA$CA
242662871$24266287$1$I$$20240823$20240830$20240830$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001731$BLUEPRINT MEDICINES$$$$$M$Y$$$20240830$$CN$US$US
242662881$24266288$1$I$$20240813$20240830$20240830$PER$$US-Encube-001292$ENCUBE ETHICALS$$$$$F$Y$$$20240828$$CN$US$
242662891$24266289$1$I$$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137918$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240830$$CN$US$US
242662901$24266290$1$I$$20240824$20240830$20240830$PER$$US-ABBVIE-5895542$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242662912$24266291$2$F$$20240829$20240830$20240906$PER$$US-HALEON-2194312$Haleon PLC$$$$$$Y$$$20240906$$CN$US$US
242662921$24266292$1$I$20240103$20240822$20240830$20240830$EXP$$CA-JNJFOC-20231215968$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240830$$HP$CA$CA
242662931$24266293$1$I$$20240826$20240830$20240830$PER$$PR-JNJFOC-20240875499$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$MD$PR$PR
242662942$24266294$2$F$$20240910$20240830$20240927$EXP$$CA-HALEON-2193863$Haleon PLC$$43$YR$$F$Y$97$KG$20240927$$HP$CA$CA
242662951$24266295$1$I$$20240828$20240830$20240830$EXP$$US-SANDOZ INC.-SDZ2024US075914$SANDOZ$$62$YR$$F$Y$$$20240830$$MD$US$US
242662961$24266296$1$I$$20240821$20240830$20240830$30DAY$$US-GSK-US2024104439$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$CN$US$US
242662972$24266297$2$F$$20240913$20240830$20240917$EXP$$GB-SANDOZ INC.-SDZ2024GB076047$SANDOZ$$71$YR$$F$Y$$$20240917$$MD$GB$GB
242662981$24266298$1$I$$20240823$20240830$20240830$PER$$US-AstraZeneca-2024A194730$ASTRAZENECA$$47$YR$$F$Y$$$20240830$$CN$US$
242662991$24266299$1$I$20240101$20240829$20240830$20240830$EXP$$US-UCBSA-2024030264$UCB$$$$$F$Y$$$20240830$$CN$US$US
242663001$24266300$1$I$$20240826$20240830$20240830$EXP$$CA-HALEON-2193516$Haleon PLC$$65$YR$$F$Y$$$20240829$$CN$CA$CA
242663011$24266301$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024172504$AMGEN$$$$$$Y$$$20240830$$CN$US$US
242663021$24266302$1$I$20170901$20240827$20240830$20240830$EXP$$JP-ABBVIE-5898483$ABBVIE$$27$YR$$F$Y$$$20240830$$MD$JP$JP
242663031$24266303$1$I$20240801$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024170733$AMGEN$$$$$M$Y$$$20240830$$PH$US$US
242663041$24266304$1$I$$20240827$20240830$20240830$EXP$$JP-ORGANON-O2408JPN002028$ORGANON$Fujiwara Y, Ikenoyama Y, Hamada Y, Nakagawa H, Matsui K. P12-6 A case of oesophageal carcinoma thought to have developed against the background of drug-induced esophagitis caused by alendronate. The 78th Annual Meeting of The Japan Esophageal Society. 2024;226$75$YR$$F$Y$$$20240830$$MD$JP$JP
242663051$24266305$1$I$$20240826$20240830$20240830$EXP$$CA-JNJFOC-20240877083$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240830$$HP$CA$CA
242663061$24266306$1$I$20240807$20240823$20240830$20240830$EXP$$JP-AMGEN-JPNSP2024171551$AMGEN$$7$DEC$E$M$Y$$$20240830$$MD$JP$JP
242663072$24266307$2$F$20240801$20240823$20240830$20240919$PER$$US-SMPA-2024SPA000858$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
242663101$24266310$1$I$$20240802$20240830$20240830$PER$$US-SMPA-2024SPA000869$SUNOVION$$$$$$Y$$$20240830$$CN$US$US
242663111$24266311$1$I$$20240802$20240830$20240830$PER$$US-SMPA-2024SPA000839$SUNOVION$$$$$$Y$$$20240830$$CN$US$US
242663131$24266313$1$I$$20240822$20240830$20240830$EXP$$CN-ROCHE-10000064072$ROCHE$Zhang L, Yang X, Zhang Y, Wen Y, Huang M, An J. Cervical metastasis of breast cancer: A case report and literature review. Medicine (United States).103 (32):1-5. doi:10.1097/MD.0000000000039275.$64$YR$A$F$Y$$$20240830$$MD$CN$CN
242663141$24266314$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017306$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240830$$CN$US$US
242663153$24266315$3$F$$20240924$20240830$20240926$EXP$$DE-JNJFOC-20240873154$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240927$$HP$DE$DE
242663161$24266316$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017801$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240830$$CN$US$US
242663171$24266317$1$I$$20240822$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408015018$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240830$$CN$US$US
242663181$24266318$1$I$$20230317$20240830$20240830$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00413$Unknown Manufacturer$$$$$$Y$$$20240830$$CN$BR$BR
242663191$24266319$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137552$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$76.2$KG$20240830$$CN$US$US
242663202$24266320$2$F$20240101$20240902$20240830$20240910$EXP$$JP-GENMAB-2024-03047$GENMAB$$62$YR$$M$Y$62.7$KG$20240910$$MD$JP$JP
242663221$24266322$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A192128$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242663231$24266323$1$I$20240710$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A195700$ASTRAZENECA$$25883$DY$$F$Y$72.8$KG$20240830$$CN$US$
242663241$24266324$1$I$$20240815$20240830$20240830$PER$$US-AstraZeneca-2024A188263$ASTRAZENECA$$$$$$Y$$$20240830$$HP$US$
242663251$24266325$1$I$20240818$20240818$20240830$20240830$PER$$US-JNJFOC-20240855536$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$CN$US$US
242663261$24266326$1$I$$20240828$20240830$20240830$EXP$$FR-SANDOZ INC.-SDZ2024FR076159$SANDOZ$$58$YR$$M$Y$$$20240830$$MD$FR$FR
242663271$24266327$1$I$$20240819$20240830$20240830$EXP$$US-AUROBINDO-AUR-APL-2024-042067$AUROBINDO$Pillai A, Badr M, Mai X, Bell J.. One Pump For Two Hearts - A Single-center Experience With An Impella 5.5 Micro-axial Pump In A Peripartum Patient With Cardiogenic Shock. J-Card-Fail. 2024;30:138$27$YR$$F$Y$$$20240830$$HP$US$US
242663282$24266328$2$F$20240820$20240903$20240830$20240909$EXP$$JP-009507513-2408JPN002477J$MERCK$$88$YR$$F$Y$$$20240909$$PH$JP$JP
242663291$24266329$1$I$$20240820$20240830$20240830$30DAY$$US-GSK-US2024AMR104611$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$HP$US$US
242663301$24266330$1$I$20240101$20240826$20240830$20240830$EXP$$US-ABBVIE-5897440$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242663311$24266331$1$I$$20240822$20240830$20240830$EXP$$US-AMGEN-USASP2024168732$AMGEN$Leeaphorn N.; Attieh R.M.; Wadei H.M. et al.. The impact of induction therapy on the risk of posttransplant lymphoproliferative disorder in adult kidney transplant recipients with donor-recipient serological Epstein-Barr virus mismatch. American Journal of Transplantation. 2024;24 (8):1486-1494$$$$$Y$$$20240830$$HP$US$US
242663321$24266332$1$I$$20240822$20240830$20240830$PER$$US-AMGEN-USASP2024168414$AMGEN$Taha M.; Sirmans B.; Haines K. et. al. Next-Generation Sequencing Testing Can Save Generations of Lives. JCO Precision Oncology. 2024;8:1-4$85$YR$E$M$Y$$$20240830$$HP$US$US
242663331$24266333$1$I$20240822$20240822$20240830$20240830$EXP$$CN-ROCHE-10000063635$ROCHE$$69$YR$E$M$Y$$$20240830$$MD$CN$CN
242663343$24266334$3$F$$20240909$20240830$20240917$EXP$$PT-ROCHE-10000067630$ROCHE$Costa A, Faustino C, Correia F, Chave V, Almeida J. haemophagocytic syndrome - when should we think about this condition? a case report [Abstract Number: PO-0184-(2479)]. Oncological Diseases. 2024;9:552.$50$YR$A$F$Y$$$20240917$$MD$PT$PT
242663351$24266335$1$I$20240101$20240705$20240830$20240830$PER$$US-CIPLA LTD.-2024US01628$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242663361$24266336$1$I$20240101$20240111$20240830$20240830$PER$$US-CIPLA LTD.-2024US00649$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242663371$24266337$1$I$20230101$20231228$20240830$20240830$PER$$US-CIPLA LTD.-2024US00013$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242663381$24266338$1$I$20240101$20240129$20240830$20240830$PER$$US-CIPLA LTD.-2024US00836$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242663391$24266339$1$I$$20240127$20240830$20240830$PER$$US-CIPLA LTD.-2024US00551$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242663401$24266340$1$I$$20231219$20240830$20240830$PER$$US-CIPLA LTD.-2023US08375$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242663411$24266341$1$I$20230101$20231221$20240830$20240830$PER$$US-CIPLA LTD.-2023US08579$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242663421$24266342$1$I$$20240112$20240830$20240830$PER$$US-CIPLA LTD.-2023US08580$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242663431$24266343$1$I$$20240124$20240830$20240830$PER$$US-CIPLA LTD.-2024US00679$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242663441$24266344$1$I$$20231227$20240830$20240830$PER$$US-CIPLA LTD.-2023US08708$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242663451$24266345$1$I$20240101$20240809$20240830$20240830$PER$$US-CIPLA LTD.-2024US01801$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242663461$24266346$1$I$$20240823$20240830$20240830$PER$$US-JNJFOC-20240861947$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$HP$US$US
242663472$24266347$2$F$$20240829$20240830$20240903$EXP$$US-ABBVIE-5896910$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242663482$24266348$2$F$$20240925$20240830$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137100$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240926$$CN$US$US
242663491$24266349$1$I$$20240829$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-089447-2024$RECKITT BENCKISER$$$$$M$Y$$$20240830$$CN$US$US
242663501$24266350$1$I$20240819$20240820$20240830$20240830$30DAY$$US-GSK-US2024103962$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240830$$CN$US$US
242663531$24266353$1$I$20240811$20240819$20240830$20240830$EXP$$CN-GE HEALTHCARE-2024CSU009553$GE HEALTHCARE$$44$YR$$M$Y$70$KG$20240830$$HP$CN$CN
242663541$24266354$1$I$20240814$20240820$20240830$20240830$EXP$GB-MHRA-MED-202408191022437500-CHPVR$GB-GE HEALTHCARE-2024CSU009533$GE HEALTHCARE$$71$YR$$M$Y$$$20240830$$MD$GB$GB
242663551$24266355$1$I$20240321$20240824$20240830$20240830$EXP$FR-AFSSAPS-AM2024000648$FR-GE HEALTHCARE-2024CSU009681$GE HEALTHCARE$$17$YR$$M$Y$$$20240830$$HP$FR$FR
242663562$24266356$2$F$$20240827$20240830$20240910$EXP$$US-SMPA-2024SPA001638$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
242663571$24266357$1$I$$20240824$20240830$20240830$EXP$$IN-TAKEDA-2024TUS086139$TAKEDA$$14$YR$$$Y$$$20240830$$CN$US$IN
242663581$24266358$1$I$20240101$20240822$20240830$20240830$EXP$$CA-CELLTRION INC.-2024CA020650$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
242663591$24266359$1$I$$20240821$20240830$20240830$PER$$US-ABBVIE-5897205$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242663602$24266360$2$F$20240817$20240912$20240830$20240919$EXP$$JP-ASTELLAS-2024-AER-001265$ASTELLAS$$7$DEC$E$$Y$$$20240919$$MD$JP$JP
242663611$24266361$1$I$20220901$20240823$20240830$20240830$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047579$BOEHRINGER INGELHEIM$Zhang C, Zhang W, Deng R, Lv J, Wang F, Chen Y. Afatinib as first-line treatment for advanced lung squamous cell carcinoma harboring uncommon EGFR G719C and S7681 co-mutation: A case report and literature review. Heliyon. 2024;10:15: e35304. doi:10.1016/j.heliyon.2024.e35304.$66$YR$E$M$Y$$$20240830$$HP$CN$CN
242663621$24266362$1$I$20201105$20240820$20240830$20240830$EXP$$PL-AUROBINDO-AUR-APL-2024-042220$AUROBINDO$$72$YR$$M$Y$71$KG$20240830$$MD$PL$PL
242663631$24266363$1$I$$20240827$20240830$20240830$PER$$US-ABBVIE-5898831$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242663641$24266364$1$I$$20240819$20240830$20240830$EXP$$JP-ROCHE-10000066015$ROCHE$Tanigawa T, Goto I, Sugiura S, Sato Y, Iwata M. Two cases of patients with breast cancer in whom chronological changes of left ventricular diastolic function allowed prediction of the onset of cardiac failure. [Abstract number: PS1-3]. The 7th Annual Meeting of the Japanese Onco-cardiology Society. 2024;106.$8$DEC$E$F$Y$$$20240830$$MD$JP$JP
242663651$24266365$1$I$20240828$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017984$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240830$$CN$US$US
242663661$24266366$1$I$20240701$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018159$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240830$$CN$US$US
242663671$24266367$1$I$20240801$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018110$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$US$US
242663681$24266368$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018147$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240830$$CN$US$US
242663691$24266369$1$I$$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016438$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240830$$CN$US$US
242663701$24266370$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017910$ELI LILLY AND CO$$$$$$Y$$$20240830$$MD$US$US
242663711$24266371$1$I$20240701$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018052$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240830$$CN$US$US
242663721$24266372$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018187$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240830$$CN$US$US
242663731$24266373$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018326$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240830$$CN$US$US
242663751$24266375$1$I$$20240822$20240830$20240830$30DAY$$US-GSK-US2024105073$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$CN$US$US
242663761$24266376$1$I$$20240828$20240830$20240830$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-117117$REGENERON$$$$$F$Y$$$20240830$$MD$US$US
242663771$24266377$1$I$20240101$20240826$20240830$20240830$EXP$$JP-GENMAB-2024-01712AA$GENMAB$$72$YR$$M$Y$$$20240830$$MD$JP$JP
242663781$24266378$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172691$AMGEN$$65$YR$E$F$Y$$$20240830$$CN$US$US
242663791$24266379$1$I$$20240730$20240830$20240830$PER$$US-GLK-002374$GLAUKOS$$$$$$Y$$$20240830$$MD$US$US
242663801$24266380$1$I$20240724$20240820$20240830$20240830$EXP$$US-AMGEN-USASP2024167491$AMGEN$$71$YR$E$F$Y$$$20240830$$MD$US$US
242663811$24266381$1$I$$20240823$20240830$20240830$EXP$$AR-Orion Corporation ORION PHARMA-ENT 2024-0041$ORION$$75$YR$E$F$Y$$$20240830$$CN$AR$
242663822$24266382$2$F$$20240916$20240830$20240926$EXP$$CA-TEVA-VS-3234326$TEVA$$$$C$M$Y$$$20240926$$HP$CA$CA
242663831$24266383$1$I$20240701$20240827$20240830$20240830$EXP$$US-ABBVIE-5897982$ABBVIE$$58$YR$$M$Y$$$20240830$$CN$US$US
242663841$24266384$1$I$20240701$20240822$20240830$20240830$PER$$US-SA-2024SA252057$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240830$$HP$US$US
242663851$24266385$1$I$$20240821$20240830$20240830$PER$$US-SA-2024SA252083$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240830$$CN$US$US
242663861$24266386$1$I$20240101$20240822$20240830$20240830$PER$$US-SA-2024SA252000$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240830$$MD$US$US
242663871$24266387$1$I$20240827$20240828$20240830$20240830$EXP$$US-ABBVIE-5900065$ABBVIE$$77$YR$$M$Y$$$20240830$$HP$US$US
242663882$24266388$2$F$20240601$20240923$20240830$20240927$EXP$$CA-ABBVIE-5897672$ABBVIE$$57$YR$$F$Y$$$20240927$$CN$CA$CA
242663891$24266389$1$I$20230701$20240826$20240830$20240830$EXP$$US-ABBVIE-5897580$ABBVIE$$73$YR$$F$Y$$$20240830$$CN$US$US
242663911$24266391$1$I$$20240821$20240830$20240830$EXP$$JP-ASTELLAS-2024-AER-000797$ASTELLAS$$74$YR$E$F$Y$$$20240830$$PH$JP$JP
242663921$24266392$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137702$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240830$$CN$US$US
242663931$24266393$1$I$$20240819$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136569$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$72.03$KG$20240830$$HP$US$US
242663943$24266394$3$F$$20240918$20240830$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137649$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240919$$HP$US$US
242663951$24266395$1$I$$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137864$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240830$$CN$US$US
242663961$24266396$1$I$$20240820$20240830$20240830$30DAY$$US-GSK-US2024AMR104877$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$CN$US$US
242663981$24266398$1$I$20240813$20240827$20240830$20240830$EXP$$US-ABBVIE-5898835$ABBVIE$$45$YR$$F$Y$$$20240830$$CN$US$US
242663991$24266399$1$I$20240817$20240823$20240830$20240830$EXP$$CN-TAKEDA-2024TUS087120$TAKEDA$$61$YR$$F$Y$60$KG$20240830$$HP$CN$CN
242664001$24266400$1$I$$20240828$20240830$20240830$EXP$$US-ABBVIE-5899343$ABBVIE$$$$$M$Y$$$20240830$$HP$US$US
242664011$24266401$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898859$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242664021$24266402$1$I$20240805$20240823$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013351$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242664031$24266403$1$I$$20240425$20240830$20240830$EXP$$CA-ABBVIE-5900935$ABBVIE$$$$A$F$Y$$$20240830$$CN$CA$CA
242664051$24266405$1$I$20240609$20240828$20240830$20240830$EXP$$US-ABBVIE-5900459$ABBVIE$$82$YR$$M$Y$$$20240830$$CN$US$US
242664061$24266406$1$I$20240618$20240826$20240830$20240830$EXP$$PK-ROCHE-10000066135$ROCHE$$58$YR$A$F$Y$$$20240830$$CN$PK$PK
242664071$24266407$1$I$$20240822$20240830$20240830$EXP$$ZA-ROCHE-10000067599$ROCHE$$$$$F$Y$$$20240830$$MD$ZA$ZA
242664081$24266408$1$I$20240821$20240826$20240830$20240830$PER$$US-ABBVIE-5898046$ABBVIE$$35$YR$$$Y$$$20240830$$HP$US$US
242664092$24266409$2$F$20240820$20240830$20240830$20240913$EXP$$AT-MELINTA THERAPEUTICS, LLC-AT-MLNT-24-00409$MELINTA THERAPEUTICS$$$$$$Y$$$20240913$$PH$AT$AT
242664101$24266410$1$I$20230101$20240814$20240830$20240830$PER$$US-ABBVIE-5893957$ABBVIE$$65$YR$$F$Y$$$20240830$$HP$US$US
242664112$24266411$2$F$20240111$20240912$20240830$20240924$EXP$$GB-AMGEN-GBRNI2024130476$AMGEN$$46$YR$A$F$Y$70.75$KG$20240923$$HP$GB$GB
242664121$24266412$1$I$$20240823$20240830$20240830$EXP$$US-CHATTEMPRD-2024OHG029423$CHATTEM$$$$$M$Y$$$20240830$$LW$US$US
242664131$24266413$1$I$20240819$20240819$20240830$20240830$EXP$$PK-ROCHE-10000060660$ROCHE$$74$YR$E$M$Y$$$20240830$$CN$PK$PK
242664141$24266414$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017342$ELI LILLY AND CO$$48$YR$A$$Y$$$20240830$$CN$US$US
242664151$24266415$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018506$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240830$$CN$US$US
242664161$24266416$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018297$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240830$$CN$US$US
242664171$24266417$1$I$20240401$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018398$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240830$$CN$US$US
242664181$24266418$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018029$ELI LILLY AND CO$$$$$$Y$$$20240830$$CN$US$US
242664191$24266419$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137807$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240830$$CN$US$US
242664201$24266420$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137727$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240830$$CN$US$US
242664211$24266421$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137567$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240830$$HP$US$US
242664221$24266422$1$I$20240820$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138062$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$73.48$KG$20240830$$CN$US$US
242664231$24266423$1$I$20240801$20240821$20240830$20240830$EXP$$JP-ASTELLAS-2024-AER-001156$ASTELLAS$$80$YR$E$M$Y$$$20240830$$MD$JP$JP
242664241$24266424$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5899099$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242664251$24266425$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898620$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240830$$HP$CN$CN
242664261$24266426$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137140$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$62.6$KG$20240830$$CN$US$US
242664271$24266427$1$I$20240801$20240823$20240830$20240830$EXP$$US-ABBVIE-5893793$ABBVIE$$60$YR$$F$Y$$$20240830$$CN$US$US
242664281$24266428$1$I$$20240819$20240830$20240830$EXP$$US-SMPA-2024SPA001624$SUNOVION$$$$$$Y$$$20240830$$CN$US$US
242664291$24266429$1$I$$20240613$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000849$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$$US$
242664301$24266430$1$I$$20240613$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000857$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$MD$US$
242664311$24266431$1$I$$20240614$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000858$AXSOME THERAPEUTICS$$$$$M$Y$$$20240830$$MD$US$
242664321$24266432$1$I$20240601$20240614$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000859$AXSOME THERAPEUTICS$$21$YR$A$M$Y$$$20240830$$CN$US$
242664331$24266433$1$I$$20240614$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000860$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$MD$US$
242664341$24266434$1$I$$20240617$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000864$AXSOME THERAPEUTICS$$61$YR$A$M$Y$$$20240830$$CN$US$
242664351$24266435$1$I$20230101$20240617$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000869$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$CN$US$
242664361$24266436$1$I$20240501$20240611$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202405-000715$AXSOME THERAPEUTICS$$52$YR$A$F$Y$$$20240830$$$US$
242664371$24266437$1$I$$20240820$20240830$20240830$EXP$$JP-AMGEN-JPNSP2024170211$AMGEN$$$$$$Y$$$20240830$$HP$JP$JP
242664381$24266438$1$I$$20240602$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000768$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$HP$US$
242664391$24266439$1$I$20240604$20240604$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000779$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242664401$24266440$1$I$$20240602$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000769$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$HP$US$
242664411$24266441$1$I$20230101$20240604$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000780$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242664421$24266442$1$I$$20240603$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000784$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$$US$
242664431$24266443$1$I$$20240603$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000788$AXSOME THERAPEUTICS$$$$A$F$Y$$$20240830$$$US$
242664441$24266444$1$I$$20240603$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000790$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$$US$
242664451$24266445$1$I$$20240603$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000794$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242664461$24266446$1$I$$20240602$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000793$AXSOME THERAPEUTICS$$32$YR$A$F$Y$$$20240830$$CN$US$
242664471$24266447$1$I$20240101$20240606$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000799$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242664481$24266448$1$I$20240101$20240606$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000808$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$HP$US$
242664491$24266449$1$I$$20240606$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000809$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242664501$24266450$1$I$20240501$20240607$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000810$AXSOME THERAPEUTICS$$20$YR$A$F$Y$$$20240830$$CN$US$
242664511$24266451$1$I$$20240610$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000814$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242664521$24266452$1$I$$20240607$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000820$AXSOME THERAPEUTICS$$35$YR$A$F$Y$$$20240830$$CN$US$
242664531$24266453$1$I$$20240607$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000822$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242664541$24266454$1$I$$20240611$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000838$AXSOME THERAPEUTICS$$$$$M$Y$$$20240830$$$US$
242664551$24266455$1$I$20240720$20240826$20240830$20240830$EXP$$CN-ABBVIE-5896112$ABBVIE$$61$YR$$M$Y$70$KG$20240830$$MD$CN$CN
242664561$24266456$1$I$$20240819$20240830$20240830$EXP$$US-SMPA-2024SPA001678$SUNOVION$$$$$$Y$$$20240830$$CN$US$US
242664571$24266457$1$I$$20240816$20240830$20240830$PER$$US-CHATTEMPRD-2024OHG029273$CHATTEM$$$$$$Y$$$20240830$$CN$US$US
242664581$24266458$1$I$$20240814$20240830$20240830$EXP$$DK-ASTELLAS-2024-AER-000603$ASTELLAS$$17$YR$T$F$Y$$$20240830$$HP$DK$DK
242664592$24266459$2$F$20240826$20240830$20240830$20240904$PER$$US-AMGEN-USASP2024171152$AMGEN$$51$YR$A$F$Y$$$20240904$$CN$US$US
242664601$24266460$1$I$$20240819$20240830$20240830$EXP$$US-SMPA-2024SPA001685$SUNOVION$$$$$$Y$$$20240830$$CN$US$US
242664611$24266461$1$I$$20240820$20240830$20240830$EXP$$US-GSK-US2024103855$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242664621$24266462$1$I$20240818$20240820$20240830$20240830$30DAY$$US-GSK-US2024103994$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240830$$CN$US$US
242664631$24266463$1$I$20240207$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171664$AMGEN$$84$YR$E$F$Y$$$20240830$$CN$US$US
242664641$24266464$1$I$$20240819$20240830$20240830$EXP$$US-SMPA-2024SPA001686$SUNOVION$$$$$$Y$$$20240830$$CN$US$US
242664651$24266465$1$I$$20240827$20240830$20240830$PER$$US-ALXN-202408USA001823US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242664663$24266466$3$F$20240626$20240910$20240830$20240916$EXP$$CO-TAKEDA-2024TUS071514$TAKEDA$$66$YR$$F$Y$64$KG$20240916$$HP$CO$CO
242664681$24266468$1$I$20240314$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195713$ASTRAZENECA$$31077$DY$$M$Y$$$20240830$$CN$US$
242664691$24266469$1$I$20240201$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042081$AUROBINDO$$66$YR$$M$Y$68$KG$20240830$$MD$FR$FR
242664711$24266471$1$I$20240719$20240822$20240830$20240830$EXP$$CA-JNJFOC-20240860564$JOHNSON AND JOHNSON$$69$YR$E$M$Y$107$KG$20240830$$HP$CA$CA
242664721$24266472$1$I$20240819$20240820$20240830$20240830$EXP$$GB-AUROBINDO-AUR-APL-2024-042065$AUROBINDO$$70$YR$$F$Y$66$KG$20240830$$MD$GB$GB
242664731$24266473$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137733$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$83.46$KG$20240830$$CN$US$US
242664741$24266474$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137116$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240830$$PH$US$US
242664751$24266475$1$I$$20190718$20240830$20240830$EXP$$JP-TAKEDA-SH201915868$TAKEDA$$$$$$Y$$$20240830$$MD$JP$JP
242664761$24266476$1$I$$20200206$20240830$20240830$EXP$$JP-TAKEDA-SH201808426$TAKEDA$$$$$$Y$$$20240830$$MD$JP$JP
242664771$24266477$1$I$20240101$20240820$20240830$20240830$PER$$US-AMGEN-USASP2024168562$AMGEN$$75$YR$E$F$Y$$$20240830$$CN$US$US
242664781$24266478$1$I$20240829$20240829$20240830$20240830$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048710$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240830$$CN$US$US
242664791$24266479$1$I$20240724$20240829$20240830$20240830$EXP$$JP-TAKEDA-2024TJP012738$TAKEDA$$6$DEC$$F$Y$$$20240830$$MD$JP$JP
242664801$24266480$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137604$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240830$$CN$US$US
242664812$24266481$2$F$20240814$20240926$20240830$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137630$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$70$KG$20240930$$PH$US$US
242664821$24266482$1$I$20240814$20240816$20240830$20240830$PER$$US-RDY-CLI/USA/24/0012025$DR REDDYS$$41$YR$A$M$Y$$$20240830$$CN$US$US
242664831$24266483$1$I$20230501$20240826$20240830$20240830$EXP$$SG-ROCHE-10000066140$ROCHE$Chua C, Chai G, Lim X, Manghani M, Leung B, Koh L. Successful rescue treatment of refractory anti-MDA5 autoantibody positive dermatomyositis with rapidly progressive interstitial lung disease using daratumumab. Clinical and Experimental Rheumatology. 2024-Feb;42 (2):460-61. doi:10.55563/clinexprheumatol/monpb6.$30$YR$A$M$Y$$$20240830$$HP$SG$SG
242664841$24266484$1$I$20150701$20240827$20240830$20240830$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-137576$BRISTOL MYERS SQUIBB$$63$YR$A$$Y$$$20240830$$MD$DE$DE
242664851$24266485$1$I$20240601$20240823$20240830$20240830$PER$$US-SA-2024SA251490$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240830$$MD$US$US
242664861$24266486$1$I$20240101$20240823$20240830$20240830$EXP$$US-Rigel Pharmaceuticals, Inc.-20240700120$RIGEL PHARMACEUTICALS$$$$$F$Y$103.42$KG$20240830$$CN$US$US
242664871$24266487$1$I$20240821$20240821$20240830$20240830$EXP$$JP-ROCHE-10000066955$ROCHE$$7$DEC$E$$Y$$$20240830$$MD$JP$JP
242664881$24266488$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018010$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240830$$CN$US$US
242664891$24266489$1$I$20240401$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018630$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240830$$CN$US$US
242664901$24266490$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018515$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240830$$CN$US$US
242664911$24266491$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018331$ELI LILLY AND CO$$$$$M$Y$$$20240830$$CN$US$US
242664921$24266492$1$I$$20240820$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408012684$ELI LILLY AND CO$$$$$$Y$$$20240830$$CN$US$US
242664932$24266493$2$F$20240101$20240827$20240830$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023151$UNITED THERAPEUTICS$$$$$F$Y$75.283$KG$20240905$$$US$US
242664942$24266494$2$F$$20240903$20240830$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408018006$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240904$$CN$US$US
242664951$24266495$1$I$20240814$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016539$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240830$$CN$US$US
242664961$24266496$1$I$20240505$20240710$20240830$20240830$PER$$US-CIPLA LTD.-2024US04907$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242664971$24266497$1$I$20240510$20240510$20240830$20240830$PER$$US-CIPLA LTD.-2024US04862$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242664981$24266498$1$I$$20240524$20240830$20240830$PER$$US-CIPLA LTD.-2024US05014$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242664991$24266499$1$I$20240101$20240508$20240830$20240830$PER$$US-CIPLA LTD.-2024US03871$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242665001$24266500$1$I$20240514$20240521$20240830$20240830$PER$$US-CIPLA LTD.-2024US05057$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242665011$24266501$1$I$20240101$20240516$20240830$20240830$PER$$US-CIPLA LTD.-2024US04263$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242665021$24266502$1$I$20240401$20240515$20240830$20240830$PER$$US-CIPLA LTD.-2024US05084$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242665031$24266503$1$I$20240501$20240509$20240830$20240830$PER$$US-CIPLA LTD.-2024US04861$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242665041$24266504$1$I$$20240418$20240830$20240830$PER$$US-CIPLA LTD.-2024US04049$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242665051$24266505$1$I$$20240319$20240830$20240830$PER$$US-CIPLA LTD.-2024US02916$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242665061$24266506$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137955$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240830$$HP$US$US
242665071$24266507$1$I$20240101$20240531$20240830$20240830$PER$$US-CIPLA LTD.-2024US03109$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242665083$24266508$3$F$$20240920$20240830$20240924$PER$$US-GSK-US2024104570$GLAXOSMITHKLINE$$$$$M$Y$$$20240924$$CN$US$US
242665091$24266509$1$I$$20240702$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06141$HIKMA$$$$$$Y$$$20240829$$CN$US$US
242665101$24266510$1$I$$20240416$20240830$20240830$PER$$US-CIPLA LTD.-2024US03632$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242665111$24266511$1$I$$20240829$20240830$20240830$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-137950$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$43$KG$20240830$$MD$IT$IT
242665121$24266512$1$I$20240529$20240619$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05672$HIKMA$$16$YR$$M$Y$93.1$KG$20240829$$HP$US$US
242665131$24266513$1$I$20240101$20240820$20240830$20240830$PER$$US-SA-2024SA249740$SANOFI AVENTIS$$46$YR$A$F$Y$81.64$KG$20240830$$MD$US$US
242665141$24266514$1$I$$20240603$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05436$HIKMA$$$$$F$Y$$$20240829$$CN$US$US
242665152$24266515$2$F$$20240909$20240830$20240916$PER$$US-SA-2024SA139987$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240916$$CN$US$US
242665161$24266516$1$I$$20240529$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-05137$HIKMA$$$$$F$Y$$$20240829$$CN$US$US
242665171$24266517$1$I$$20240430$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03780$HIKMA$$$$$M$Y$$$20240829$$CN$US$US
242665181$24266518$1$I$$20240417$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-03486$HIKMA$$$$$F$Y$$$20240829$$CN$US$US
242665191$24266519$1$I$$20240301$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-01932$HIKMA$$$$$F$Y$$$20240829$$CN$US$US
242665201$24266520$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171826$AMGEN$$$$$M$Y$$$20240830$$CN$US$US
242665211$24266521$1$I$$20240101$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00087$HIKMA$$$$$$Y$$$20240829$$CN$US$US
242665221$24266522$1$I$$20231201$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67918$HIKMA$$$$$F$Y$$$20240829$$CN$US$US
242665231$24266523$1$I$20231201$20240823$20240830$20240830$EXP$$US-ABBVIE-5880767$ABBVIE$$54$YR$$F$Y$85$KG$20240830$$CN$US$US
242665241$24266524$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A194252$ASTRAZENECA$$$$$M$Y$86.2$KG$20240830$$CN$US$
242665251$24266525$1$I$20240826$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024172132$AMGEN$$40$YR$A$F$Y$$$20240830$$HP$US$US
242665264$24266526$4$F$$20240912$20240830$20240920$EXP$$CA-TEVA-VS-3237472$TEVA$$21$YR$$F$Y$$$20240920$$HP$CA$CA
242665271$24266527$1$I$$20231101$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-66815$HIKMA$$$$$M$Y$$$20240829$$CN$US$US
242665281$24266528$1$I$$20230918$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65452$HIKMA$$61$YR$$F$Y$$$20240829$$HP$US$US
242665291$24266529$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-084780-2024$RECKITT BENCKISER$$$$$M$Y$$$20240830$$CN$US$US
242665301$24266530$1$I$$20230808$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64291$HIKMA$$$$$$Y$$$20240829$$MD$US$US
242665311$24266531$1$I$20240123$20240301$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-01052$HIKMA$$$$$$Y$$$20240829$$CN$US$US
242665321$24266532$1$I$20240701$20240822$20240830$20240830$EXP$$DE-EMD Serono-2024045329$EMD SERONO INC$$64$YR$A$F$Y$69$KG$20240830$$MD$DE$DE
242665331$24266533$1$I$$20240826$20240830$20240830$EXP$$US-TAKEDA-2024TUS086714$TAKEDA$$$$$M$Y$$$20240830$$CN$US$US
242665341$24266534$1$I$$20230807$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64241$HIKMA$$$$$$Y$$$20240829$$CN$US$US
242665351$24266535$1$I$20210930$20230802$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-64083$HIKMA$$$$$$Y$$$20240829$$HP$US$US
242665361$24266536$1$I$20180101$20240821$20240830$20240830$EXP$$RO-ROCHE-2729234$ROCHE$$78$YR$E$F$Y$68$KG$20240830$$CN$RO$RO
242665371$24266537$1$I$$20230911$20240830$20240830$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-65293$HIKMA$$$$$$Y$$$20240829$$CN$US$US
242665381$24266538$1$I$20240801$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172375$AMGEN$$31$YR$A$F$Y$$$20240830$$HP$US$US
242665401$24266540$1$I$20240101$20240826$20240830$20240830$EXP$FR-AFSSAPS-BX2024001593$FR-CHEPLA-2024011014$CHEPLAPHARM$$85$YR$$M$Y$81$KG$20240830$$MD$COUNTRY NOT SPECIFIED$FR
242665411$24266541$1$I$20220409$20230127$20240830$20240830$EXP$$CA-CELLTRION INC.-2021CA019679$CELLTRION$$$$$$Y$$$20240830$$CN$CA$CA
242665422$24266542$2$F$20240702$20240830$20240830$20240905$EXP$FR-AFSSAPS-LL2024001628$FR-JNJFOC-20240879790$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240905$$MD$FR$FR
242665432$24266543$2$F$$20240918$20240830$20240924$EXP$$JP-JNJFOC-20240879060$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240924$$MD$JP$JP
242665442$24266544$2$F$20240820$20240828$20240830$20240902$PER$$US-ABBVIE-5899063$ABBVIE$$41$YR$$F$Y$$$20240902$$MD$US$US
242665451$24266545$1$I$$20240820$20240830$20240830$EXP$$IN-ROCHE-10000062494$ROCHE$$$$$F$Y$$$20240830$$MD$IN$IN
242665461$24266546$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000069579$ROCHE$$$$$$Y$$$20240830$$MD$US$US
242665471$24266547$1$I$$20240826$20240830$20240830$EXP$$CA-JNJFOC-20240872786$JOHNSON AND JOHNSON$$40$YR$A$F$Y$73$KG$20240830$$MD$CA$CA
242665481$24266548$1$I$20240201$20240822$20240830$20240830$EXP$$US-LEO Pharma-373027$LEO PHARM$$53$YR$$F$Y$77$KG$20240830$$CN$US$US
242665492$24266549$2$F$$20240919$20240830$20240923$30DAY$$DE-UCBSA-2024044002$UCB$$$$$$Y$$$20240923$$PH$DE$DE
242665511$24266551$1$I$$20240823$20240830$20240830$PER$$US-ABBVIE-5894985$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242665521$24266552$1$I$$20240821$20240830$20240830$EXP$$US-APOTEX-2024AP009750$APOTEX$Sterina E. Cognitive Decline in Older Adults with Schizophrenia-Bipolar Spectrum Disorder. American Journal of Geriatric Psychiatry. 2024;32(4):S36-S37$67$YR$$M$Y$$$20240830$$HP$US$US
242665541$24266554$1$I$$20240827$20240830$20240830$EXP$$US-TAKEDA-2024TUS053771$TAKEDA$$$$$F$Y$$$20240830$$CN$US$US
242665551$24266555$1$I$20160101$20240822$20240830$20240830$EXP$$CA-TAKEDA-2016TUS019248$TAKEDA$$$$$F$Y$$$20240830$$MD$CA$CA
242665561$24266556$1$I$20240101$20240826$20240830$20240830$EXP$$CA-ABBVIE-5898199$ABBVIE$$$$E$M$Y$$$20240830$$MD$CA$CA
242665571$24266557$1$I$20240823$20240827$20240830$20240830$EXP$$US-AMGEN-USASP2024171140$AMGEN$$85$YR$E$F$Y$$$20240830$$CN$US$US
242665581$24266558$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5890221$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242665591$24266559$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898444$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242665601$24266560$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898654$ABBVIE$$$$$M$Y$$$20240830$$HP$US$US
242665611$24266561$1$I$$20240823$20240830$20240830$EXP$$US-AMGEN-USASP2024169244$AMGEN$$$$$F$Y$$$20240830$$HP$US$US
242665621$24266562$1$I$20231001$20240802$20240830$20240830$PER$$US-JNJFOC-20240873167$JOHNSON AND JOHNSON$$87$YR$E$M$Y$$$20240830$$CN$US$US
242665651$24266565$1$I$$20240822$20240830$20240830$EXP$$JP-ROCHE-10000066889$ROCHE$$49$YR$A$F$Y$$$20240830$$MD$JP$JP
242665661$24266566$1$I$$20240816$20240830$20240830$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-08396$LUPIN$$$$$$Y$$$20240830$$CN$AU$AU
242665671$24266567$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A192495$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242665681$24266568$1$I$$20240820$20240830$20240830$EXP$$CA-TEVA-VS-3235076$TEVA$$43$YR$$F$Y$$$20240830$$HP$CA$CA
242665691$24266569$1$I$20240826$20240826$20240830$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001745$BLUEPRINT MEDICINES$$$$$F$Y$$$20240830$$CN$US$US
242665701$24266570$1$I$$20240827$20240830$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001746$BLUEPRINT MEDICINES$$$$$M$Y$$$20240830$$CN$US$US
242665711$24266571$1$I$$20240826$20240830$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001739$BLUEPRINT MEDICINES$$$$$F$Y$$$20240830$$CN$US$US
242665721$24266572$1$I$20240805$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018205$ELI LILLY AND CO$$$$$$Y$$$20240830$$CN$US$US
242665731$24266573$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017995$ELI LILLY AND CO$$$$A$F$Y$$$20240830$$CN$US$US
242665741$24266574$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018440$ELI LILLY AND CO$$68$YR$E$$Y$$$20240830$$CN$US$US
242665751$24266575$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018065$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240830$$CN$US$US
242665761$24266576$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017064$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240830$$CN$US$US
242665771$24266577$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017868$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$US$US
242665781$24266578$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018294$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240830$$CN$US$US
242665791$24266579$1$I$20240828$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018139$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240830$$CN$US$US
242665801$24266580$1$I$20231001$20240823$20240830$20240830$EXP$$GB-CELLTRION INC.-2024GB020542$CELLTRION$$$$$$Y$$$20240830$$PH$GB$GB
242665811$24266581$1$I$20240823$20240826$20240830$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001738$BLUEPRINT MEDICINES$$74$YR$E$M$Y$$$20240830$$CN$US$US
242665821$24266582$1$I$$20240827$20240830$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001757$BLUEPRINT MEDICINES$$$$$F$Y$$$20240830$$CN$US$US
242665831$24266583$1$I$$20240822$20240830$20240830$PER$$US-JNJFOC-20240857745$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240830$$CN$US$US
242665841$24266584$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5898358$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242665851$24266585$1$I$20240701$20240826$20240830$20240830$EXP$$US-ABBVIE-5899029$ABBVIE$$89$YR$$M$Y$$$20240830$$CN$US$US
242665861$24266586$1$I$20240801$20240823$20240830$20240830$EXP$$US-ABBVIE-5894131$ABBVIE$$65$YR$$F$Y$$$20240830$$CN$US$US
242665871$24266587$1$I$20240826$20240826$20240830$20240830$EXP$$FR-ABBVIE-5897775$ABBVIE$$74$YR$$M$Y$$$20240830$$CN$FR$FR
242665881$24266588$1$I$$20240819$20240830$20240830$EXP$$IL-IMMUNOCORE, LTD.-2024-IMC-003011$IMMUNOCORE$$$$$$Y$$$20240830$$HP$IL$IL
242665891$24266589$1$I$$20240816$20240830$20240830$EXP$$US-ALVOGEN-2024095353$ALVOGEN$Green KD, Bianco LM, McCleskey BC, Scott KS. The Emergence of Bromazolam in Jefferson County AL. A Case Series. 2024; doi:10.1093/jat/bkae067/7725379$20$YR$$M$Y$$$20240830$$MD$US$US
242665901$24266590$1$I$$20240816$20240830$20240830$EXP$$US-ALVOGEN-2024095354$ALVOGEN$Green KD, Bianco LM, McCleskey BC, Scott KS. The Emergence of Bromazolam in Jefferson County AL. A Case Series. Journal of Analytical Toxicology. 2024  Aug 01;bkae067. doi:https://doi.org/10.1093/jat/bkae067$41$YR$$F$Y$$$20240830$$MD$US$US
242665911$24266591$1$I$20240722$20240823$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013350$BEIGENE$$$$$$Y$$$20240830$$HP$CN$CN
242665921$24266592$1$I$$20240816$20240830$20240830$EXP$$US-ALVOGEN-2024095352$ALVOGEN$Green KD, Bianco LM, McCleskey BC, Scott KS. The Emergence of Bromazolam in Jefferson County AL. A Case Series. Journal of Analytical Toxicology. 2024  Aug 01;bkae067. doi:https://doi.org/10.1093/jat/bkae067$35$YR$$F$Y$$$20240830$$MD$US$US
242665931$24266593$1$I$20240801$20240826$20240830$20240830$EXP$$US-ABBVIE-5896572$ABBVIE$$70$YR$$F$Y$$$20240830$$CN$US$US
242665941$24266594$1$I$20240808$20240823$20240830$20240830$PER$$US-SA-2024SA250982$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240830$$MD$US$US
242665951$24266595$1$I$$20240816$20240830$20240830$EXP$$US-ALVOGEN-2024095351$ALVOGEN$Green KD, Bianco LM, McCleskey BC, Scott KS. The Emergence of Bromazolam in Jefferson County AL. A Case Series. 2024; doi:10.1093/jat/bkae067/7725379$20$YR$$M$Y$$$20240830$$MD$US$US
242665961$24266596$1$I$$20240828$20240830$20240830$EXP$$US-ABBVIE-5899603$ABBVIE$$$$$F$Y$$$20240830$$HP$US$US
242665971$24266597$1$I$$20240828$20240830$20240830$EXP$$CN-BEIGENE-BGN-2024-013636$BEIGENE$Liao Yin, Cheng Sheng, Li Xingang. Clinical characteristics analysis of immune-related myocarditis induced by PD-1 inhibitor. Clinical Medication Journal. 2024;22:64-68$$$$$Y$$$20240830$$PH$CN$CN
242665981$24266598$1$I$20240801$20240827$20240830$20240830$EXP$$US-ABBVIE-5899068$ABBVIE$$24$YR$$F$Y$$$20240830$$CN$US$US
242665991$24266599$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5898902$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242666002$24266600$2$F$20240503$20240912$20240830$20240925$EXP$$US-INSMED, INC.-2024-01903-US$INSMED$$69$YR$$F$Y$$$20240925$$CN$US$US
242666022$24266602$2$F$20240827$20240923$20240830$20240925$PER$$US-AMGEN-USASP2024171968$AMGEN$$74$YR$E$M$Y$$$20240924$$CN$US$US
242666032$24266603$2$F$$20240826$20240830$20240905$EXP$$CA-JNJFOC-20240879781$JOHNSON AND JOHNSON$$68$YR$E$F$Y$68$KG$20240905$$PH$CA$CA
242666051$24266605$1$I$20240710$20240820$20240830$20240830$EXP$FR-AFSSAPS-AN2024001095$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111360$ZYDUS PHARM$$$$$$Y$$$20240830$$MD$FR$FR
242666062$24266606$2$F$20240716$20240909$20240830$20240919$EXP$FR-AFSSAPS-AN2024001132$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111343$ZYDUS PHARM$$$$$$Y$$$20240919$$MD$FR$FR
242666071$24266607$1$I$20240731$20240820$20240830$20240830$EXP$FR-AFSSAPS-TS2024000921$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111419$ZYDUS PHARM$$$$$$Y$$$20240830$$MD$FR$FR
242666084$24266608$4$F$20240601$20240923$20240830$20240927$EXP$FR-AFSSAPS-AN2024001042$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111370$ZYDUS PHARM$$$$$$Y$$$20240927$$MD$FR$FR
242666091$24266609$1$I$20240706$20240820$20240830$20240830$EXP$FR-AFSSAPS-NY2024000953$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111341$ZYDUS PHARM$$$$$$Y$$$20240830$$MD$FR$FR
242666101$24266610$1$I$20240728$20240816$20240830$20240830$EXP$$US-UCBSA-2024042349$UCB$$30$YR$$F$Y$$$20240830$$HP$US$US
242666111$24266611$1$I$20240101$20240827$20240830$20240830$EXP$$US-BEH-2024177889$CSL BEHRING$$$$T$M$Y$$$20240830$$CN$US$US
242666121$24266612$1$I$$20240805$20240830$20240830$EXP$$JP-AMGEN-JPNSP2024158604$AMGEN$Maho Inoue, Takayuki Minoji, Ken Konishi, Yuiko Fukumoto, Takahiko Nishigaki, Keiji Sugimoto, et al.. Complete response in a case of rectal cancer with liver metastases achieved through FOLFOX6 plus panitumumab combination therapy. The 79th General Meeting of the Japanese Society of Gastroenterological Surgery. 2024;1$65$YR$E$M$Y$$$20240830$$MD$JP$JP
242666131$24266613$1$I$20240818$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172477$AMGEN$$56$YR$A$M$Y$$$20240830$$CN$US$US
242666141$24266614$1$I$$20240828$20240830$20240830$EXP$$ES-ADIENNEP-2024AD000694$ADIENNE PHARMA + BIOTECH$Quintero V, Bueno-Sanchez D, Mozo-Del-Castillo Y, Urtasun-Erburu A, Sisinni L, Lopez-Duarte M et al. Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow Failure. Transplant Cell Ther. 2023;29(10):621.e1-6. DOI: 10.1016/j.jtct.2023.07.011.$11$YR$$F$Y$$$20240829$$MD$ES$ES
242666151$24266615$1$I$20240817$20240826$20240830$20240830$EXP$$CO-ABBVIE-5900142$ABBVIE$$79$YR$$M$Y$62$KG$20240830$$HP$CO$CO
242666161$24266616$1$I$$20240827$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137052$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240830$$CN$US$US
242666171$24266617$1$I$20240601$20240827$20240830$20240830$EXP$$US-ABBVIE-5898541$ABBVIE$$63$YR$$M$Y$$$20240830$$CN$US$US
242666181$24266618$1$I$$20240820$20240830$20240830$EXP$$US-GSK-US2024008971$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242666192$24266619$2$F$20240801$20240917$20240830$20240924$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-117368$REGENERON$$65$YR$$F$Y$$$20240924$$HP$CO$CO
242666201$24266620$1$I$20240828$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172343$AMGEN$$61$YR$A$F$Y$$$20240830$$PH$US$US
242666211$24266621$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5474614$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242666221$24266622$1$I$$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A194961$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242666231$24266623$1$I$$20240820$20240830$20240830$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001698$BLUEPRINT MEDICINES$$$$$F$Y$$$20240830$$MD$US$US
242666241$24266624$1$I$$20240820$20240830$20240830$EXP$$CN-ROCHE-10000027556$ROCHE$$61$YR$A$F$Y$$$20240830$$CN$CN$CN
242666251$24266625$1$I$20240801$20240830$20240830$20240830$EXP$FR-AFSSAPS-BR2024000695$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048696$BOEHRINGER INGELHEIM$$90$YR$E$M$Y$65$KG$20240830$$MD$FR$FR
242666261$24266626$1$I$$20240820$20240830$20240830$PER$$US-JNJFOC-20240856174$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242666271$24266627$1$I$20240825$20240827$20240830$20240830$EXP$$US-ABBVIE-5899402$ABBVIE$$74$YR$$F$Y$$$20240830$$CN$US$US
242666291$24266629$1$I$$20240805$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07980$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242666301$24266630$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898314$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242666311$24266631$1$I$$20240827$20240830$20240830$EXP$$GB-ABBVIE-5899589$ABBVIE$$$$E$F$Y$$$20240830$$CN$GB$GB
242666321$24266632$1$I$$20240828$20240830$20240830$EXP$$US-ABBVIE-5900031$ABBVIE$$$$$M$Y$$$20240830$$HP$US$US
242666331$24266633$1$I$$20240819$20240830$20240830$EXP$$US-ALVOGEN-2024095287$ALVOGEN$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024 Jul 23; doi:https://dx.doi.org/10.3233/NPM-230165$1$DY$$F$Y$$$20240830$$MD$US$US
242666341$24266634$1$I$20240820$20240827$20240830$20240830$EXP$$US-ABBVIE-5898651$ABBVIE$$71$YR$$F$Y$$$20240830$$CN$US$US
242666352$24266635$2$F$20240807$20240821$20240830$20240905$EXP$$CN-BEH-2024177668$CSL BEHRING$$50$YR$A$M$Y$$$20240905$$HP$CN$CN
242666361$24266636$1$I$$20240829$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408019003$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240830$$CN$US$US
242666371$24266637$1$I$$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018312$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$US$US
242666381$24266638$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018429$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240830$$CN$US$US
242666391$24266639$1$I$20240701$20240823$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017494$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240830$$CN$US$US
242666401$24266640$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018265$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240830$$CN$US$US
242666411$24266641$1$I$20240507$20240827$20240830$20240830$EXP$$JP-SANDOZ INC.-SDZ2024JP075715$SANDOZ$$$$$F$Y$$$20240830$$CN$JP$JP
242666421$24266642$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898542$ABBVIE$$80$YR$$M$Y$$$20240830$$HP$US$US
242666431$24266643$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017972$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240830$$CN$US$US
242666442$24266644$2$F$20240101$20240904$20240830$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202408018285$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240906$$MD$US$US
242666451$24266645$1$I$$20240827$20240830$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA052864$SANDOZ$$6$DEC$$M$Y$$$20240830$$CN$CA$CA
242666462$24266646$2$F$$20240827$20240830$20240906$EXP$$CH-TAKEDA-2022TUS062299$TAKEDA$$64$YR$$F$Y$$$20240906$$CN$CH$CH
242666471$24266647$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-083566-2024$RECKITT BENCKISER$$$$$F$Y$$$20240830$$CN$US$US
242666482$24266648$2$F$20240719$20240827$20240830$20240908$EXP$$FR-JNJFOC-20240870277$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240908$$MD$FR$FR
242666491$24266649$1$I$$20240827$20240830$20240830$PER$$US-JNJFOC-20240872884$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240830$$CN$US$US
242666503$24266650$3$F$$20240823$20240830$20240902$EXP$$GB-CELLTRION INC.-2024GB020555$CELLTRION$$$$$$Y$$$20240902$$CN$GB$GB
242666512$24266651$2$F$$20240913$20240830$20240920$EXP$$AR-TAKEDA-2024TUS082050$TAKEDA$$80$YR$$M$Y$$$20240920$$CN$AR$AR
242666521$24266652$1$I$$20240828$20240830$20240830$EXP$$US-ABBVIE-5899510$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242666532$24266653$2$F$$20240905$20240830$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US076445$SANDOZ$$$$$F$Y$$$20240909$$HP$US$US
242666541$24266654$1$I$20240821$20240821$20240830$20240830$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-026327$UNITED THERAPEUTICS$$56$YR$$F$Y$$$20240830$$$CA$CA
242666561$24266656$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172688$AMGEN$$$$$$Y$$$20240830$$HP$US$US
242666571$24266657$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172592$AMGEN$$$$$$Y$$$20240830$$HP$US$US
242666581$24266658$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172589$AMGEN$$$$$$Y$$$20240830$$HP$US$US
242666591$24266659$1$I$$20240822$20240830$20240830$EXP$PT-EMA-DD-20240820-7482705-073453$PT-IPCA LABORATORIES LIMITED-IPC-2024-PT-002129$IPCA$Sara Campos, Vanda Conceicao, Nuno Vieira et al.. Sindrome de Lyell - um efeito adverso relevante. 30 Congresso Nacional de Medicina Interna. 2024;30(Sup 1):637$$$$$Y$$$20240830$$MD$PT$PT
242666602$24266660$2$F$20240322$20240826$20240830$20240904$EXP$$IT-AUROBINDO-AUR-APL-2024-042530$AUROBINDO$$56$YR$$M$Y$72$KG$20240904$$CN$IT$IT
242666611$24266661$1$I$$20240823$20240830$20240830$EXP$$US-GSK-US2024105457$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$US$US
242666621$24266662$1$I$20240505$20240820$20240830$20240830$30DAY$$US-GSK-US2024105029$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240830$$CN$US$US
242666631$24266663$1$I$$20240821$20240830$20240830$30DAY$$US-GSK-US2024AMR105420$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$CN$US$US
242666642$24266664$2$F$$20240830$20240830$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076351$SANDOZ$$$$$$Y$$$20240902$$HP$US$US
242666651$24266665$1$I$20240725$20240819$20240830$20240830$EXP$$JP-AMGEN-JPNSP2024170077$AMGEN$$81$YR$E$F$Y$$$20240830$$MD$JP$JP
242666663$24266666$3$F$20240822$20240829$20240830$20240905$PER$$US-AMGEN-USASP2024172043$AMGEN$$66$YR$E$M$Y$$$20240904$$CN$US$US
242666672$24266667$2$F$$20240913$20240830$20240927$EXP$$US-PHARMAAND GMBH-2024PHR00488$pharmaAND$$$$$F$Y$$$20240927$$CN$US$US
242666681$24266668$1$I$20240513$20240815$20240830$20240830$EXP$$AU-PHARMAAND GMBH-2024PHR00482$pharmaAND$$83$YR$$M$Y$80$KG$20240830$$CN$AU$AU
242666691$24266669$1$I$$20240826$20240830$20240830$EXP$$US-SANDOZ INC.-SDZ2024US075597$SANDOZ$Cunningham BW, Shah S, Biswas S, Biswas S. Vancomycin Anaphylaxis and Kounis SyndromeCase Report. Cureus. 2024;16(7)$67$YR$$M$Y$112$KG$20240830$$HP$US$US
242666701$24266670$1$I$20240802$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004533$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240830$$CN$US$US
242666711$24266671$1$I$20240731$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042162$AUROBINDO$$88$YR$$F$Y$45$KG$20240830$$PH$FR$FR
242666721$24266672$1$I$20240711$20240827$20240830$20240830$EXP$$DE-EMD Serono-2024046044$EMD SERONO INC$$81$YR$E$F$Y$75$KG$20240830$$MD$DE$DE
242666732$24266673$2$F$20240501$20240910$20240830$20240926$30DAY$$CA-BECTON DICKINSON-CA-BD-24-000509$BECTON DICKINSON$$$$$$Y$$$20240926$$CN$CA$CA
242666741$24266674$1$I$$20240820$20240830$20240830$PER$$US-RDY-CLI/USA/24/0012325$DR REDDYS$$24$YR$A$F$Y$63.05$KG$20240830$$CN$US$US
242666751$24266675$1$I$20240709$20240806$20240830$20240830$30DAY$$CA-BECTON DICKINSON-CA-BD-24-000510$BECTON DICKINSON$$$$$$Y$$$20240830$$CN$CA$CA
242666762$24266676$2$F$$20240826$20240830$20240906$EXP$$AU-ROCHE-10000065675$ROCHE$$$$A$M$Y$$$20240906$$MD$AU$AU
242666781$24266678$1$I$20240801$20240826$20240830$20240830$EXP$$US-ABBVIE-5897573$ABBVIE$$52$YR$$F$Y$$$20240830$$CN$US$US
242666791$24266679$1$I$20240621$20240823$20240830$20240830$EXP$AT-BASGAGES-2024-006219$AT-TAKEDA-2024TUS085111$TAKEDA$$69$YR$$F$Y$47$KG$20240830$$HP$AT$AT
242666801$24266680$1$I$$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195325$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242666811$24266681$1$I$$20240821$20240830$20240830$PER$$US-AstraZeneca-2024A194654$ASTRAZENECA$$$$$F$Y$$$20240830$$MD$US$
242666822$24266682$2$F$20240801$20240902$20240830$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004538$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240926$$CN$US$US
242666831$24266683$1$I$20240801$20240822$20240830$20240830$EXP$$JP-ROCHE-10000069168$ROCHE$$6$DEC$A$F$Y$$$20240830$$MD$JP$JP
242666841$24266684$1$I$$20240812$20240830$20240830$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001234$ALEMBIC$Sheth K, Lee C, Srinivas N, Hasan Y, Myat K.et.al. Hydrochlorothiazide-Induced Exfoliative Rash and Sepsis. Cureus. 2024;16(7):e63655.$$$$$Y$$$20240830$$MD$US$US
242666861$24266686$1$I$$20240816$20240830$20240830$PER$$US-JNJFOC-20240843566$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$MD$US$US
242666872$24266687$2$F$$20240829$20240830$20240830$PER$$US-JNJFOC-20240876357$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242666881$24266688$1$I$$20240820$20240830$20240830$PER$$US-JNJFOC-20240854843$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$HP$US$US
242666891$24266689$1$I$20230502$20240822$20240830$20240830$EXP$$BE-JNJFOC-20240260245$JOHNSON AND JOHNSON$$$$A$F$Y$63$KG$20240830$$MD$BE$BE
242666901$24266690$1$I$$20240818$20240830$20240830$EXP$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000198-2024$QILU PHARMACEUTICAL$Raval DM Pagan RJ Butt S Rueda Prada L.A Case of Hepatocellular Carcinoma after Treatment for Chronic Myeloid Leukemia in a Patient without Liver Disease.Case Reports in Oncology.25-JUL-2024;17(1):788-796$80$YR$E$F$Y$$$20240827$$HP$US$US
242666931$24266693$1$I$$20240731$20240830$20240830$30DAY$$US-VEROBIOTECH-2024USVEROSPO00191$VERO BIOTECH$$$$$$Y$$$20240830$$HP$US$US
242666941$24266694$1$I$$20240812$20240830$20240830$PER$$US-TOLMAR, INC.-24US051821$TOLMAR$$$$$M$Y$$$20240830$$MD$US$US
242666951$24266695$1$I$$20240819$20240830$20240830$EXP$CA-MHPD-E2B_07117237$CA-Accord-442621$ACCORD$$70$YR$E$F$Y$66$KG$20240830$$MD$CA$CA
242666961$24266696$1$I$$20240828$20240830$20240830$EXP$$US-SANDOZ INC.-PHHY2018US076534$SANDOZ$$69$YR$$F$Y$$$20240830$$MD$US$US
242666971$24266697$1$I$$20240823$20240830$20240830$PER$$US-009507513-2408USA009447$MERCK$$$$$F$Y$$$20240830$$CN$US$US
242666981$24266698$1$I$$20240823$20240830$20240830$EXP$$CN-009507513-2408CHN009321$MERCK$$$$$M$Y$$$20240830$$CN$CN$CN
242666991$24266699$1$I$$20240826$20240830$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013585$JAZZ$$$$$F$Y$$$20240830$$HP$US$US
242667001$24266700$1$I$$20240821$20240830$20240830$30DAY$$US-GSK-US2024AMR105435$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$US$US
242667011$24266701$1$I$20230801$20240826$20240830$20240830$EXP$$US-ABBVIE-5632535$ABBVIE$$72$YR$$F$Y$$$20240830$$CN$US$US
242667022$24266702$2$F$20240725$20240911$20240830$20240919$EXP$$CA-CELLTRION INC.-2024CA019292$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
242667031$24266703$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5896146$ABBVIE$$86$YR$$F$Y$$$20240830$$HP$US$US
242667041$24266704$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5898324$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242667052$24266705$2$F$$20240909$20240830$20240917$EXP$$US-BIOGEN-2024BI01280303$BIOGEN$$$$$M$Y$$$20240917$$CN$US$US
242667061$24266706$1$I$$20240806$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07985$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242667071$24266707$1$I$20240816$20240823$20240830$20240830$EXP$$KR-TAKEDA-2024TUS085240$TAKEDA$$81$YR$$F$Y$$$20240830$$CN$KR$KR
242667081$24266708$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898933$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242667091$24266709$1$I$20240101$20240823$20240830$20240830$EXP$FR-AFSSAPS-NC2024000865$FR-ABBVIE-5896932$ABBVIE$$60$YR$$M$Y$$$20240830$$MD$FR$FR
242667101$24266710$1$I$$20240827$20240830$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA075885$SANDOZ$$64$YR$$F$Y$$$20240830$$HP$CA$CA
242667111$24266711$1$I$$20240822$20240830$20240830$EXP$$AU-SANDOZ INC.-SDZ2024AU075817$SANDOZ$$$$$F$Y$$$20240830$$PH$AU$AU
242667121$24266712$1$I$20240101$20240828$20240830$20240830$EXP$$US-ABBVIE-5899727$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242667131$24266713$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004540$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242667141$24266714$1$I$20240624$20240820$20240830$20240830$EXP$SE-SEMPA-2024-006098$SE-BAXTER-2024BAX023536$BAXTER$$26$YR$$F$Y$$$20240830$$MD$SE$SE
242667151$24266715$1$I$20240814$20240826$20240830$20240830$EXP$$CN-SANDOZ INC.-SDZ2024CN076201$SANDOZ$$65$YR$$F$Y$54$KG$20240830$$HP$CN$CN
242667162$24266716$2$F$20240722$20240904$20240830$20240915$EXP$$FR-AUROBINDO-AUR-APL-2024-042290$AUROBINDO$$64$YR$$M$Y$86.85$KG$20240915$$MD$FR$FR
242667171$24266717$1$I$$20240701$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000902$AXSOME THERAPEUTICS$$63$YR$A$M$Y$$$20240830$$CN$US$
242667181$24266718$1$I$$20240702$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000951$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$$US$
242667191$24266719$1$I$$20240628$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000953$AXSOME THERAPEUTICS$$$$A$M$Y$$$20240830$$MD$US$
242667201$24266720$1$I$20240601$20240701$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000872$AXSOME THERAPEUTICS$$64$YR$A$F$Y$$$20240830$$CN$US$
242667211$24266721$1$I$20240601$20240703$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000874$AXSOME THERAPEUTICS$$37$YR$A$F$Y$77$KG$20240830$$CN$US$
242667221$24266722$1$I$20240601$20240703$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000956$AXSOME THERAPEUTICS$$$$$M$Y$$$20240830$$CN$US$
242667231$24266723$1$I$20240701$20240820$20240830$20240830$EXP$FR-AFSSAPS-CN2024000703$FR-BAXTER-2024BAX023516$BAXTER$$31$YR$$F$Y$$$20240830$$MD$FR$FR
242667241$24266724$1$I$$20240708$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000968$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242667251$24266725$1$I$20240101$20240703$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000958$AXSOME THERAPEUTICS$$$$A$F$Y$$$20240830$$CN$US$
242667261$24266726$1$I$$20240708$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000973$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$$US$
242667271$24266727$1$I$$20240709$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000978$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242667281$24266728$1$I$$20240708$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000986$AXSOME THERAPEUTICS$$$$$M$Y$$$20240830$$CN$US$
242667291$24266729$1$I$$20240710$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000989$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242667301$24266730$1$I$$20240710$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-000990$AXSOME THERAPEUTICS$$36$YR$A$F$Y$$$20240830$$$US$
242667311$24266731$1$I$20231201$20240710$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202406-000917$AXSOME THERAPEUTICS$$27$YR$A$F$Y$$$20240830$$CN$US$
242667321$24266732$1$I$$20240712$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001013$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$CN$US$
242667331$24266733$1$I$$20240715$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001017$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242667341$24266734$1$I$$20240712$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001007$AXSOME THERAPEUTICS$$62$YR$A$F$Y$$$20240830$$$US$
242667351$24266735$1$I$$20240712$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001022$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242667361$24266736$1$I$$20240716$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001029$AXSOME THERAPEUTICS$$$$$F$Y$$$20240830$$CN$US$
242667371$24266737$1$I$20240701$20240716$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001030$AXSOME THERAPEUTICS$$68$YR$E$F$Y$$$20240830$$MD$US$
242667381$24266738$1$I$20240701$20240716$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001032$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242667391$24266739$1$I$20240711$20240712$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001004$AXSOME THERAPEUTICS$$71$YR$E$F$Y$$$20240830$$CN$US$
242667401$24266740$1$I$20240601$20240716$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001033$AXSOME THERAPEUTICS$$35$YR$A$M$Y$$$20240830$$MD$US$
242667411$24266741$1$I$$20240717$20240830$20240830$PER$$US-Axsome Therapeutics, Inc.-AXS202407-001037$AXSOME THERAPEUTICS$$$$$$Y$$$20240830$$CN$US$
242667421$24266742$1$I$20240530$20240711$20240830$20240830$PER$US-Food and Drug Administration-AXS202406-000912$US-Food and Drug Administration-AXS202406-000912$FOOD AND DRUG ADMINISTRATION$$64$YR$A$F$Y$$$20240830$$CN$US$
242667431$24266743$1$I$20240401$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003385$ACADIA PHARMACEUTICALS$$23$YR$$F$Y$$$20240830$$CN$US$US
242667442$24266744$2$F$20240819$20240909$20240830$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003955$ACADIA PHARMACEUTICALS$$11$YR$$F$Y$$$20240919$$CN$US$US
242667452$24266745$2$F$20240803$20240912$20240830$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003094$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240923$$MD$US$US
242667461$24266746$1$I$$20231031$20240830$20240830$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016642$STRIDES$Kalla P, Namerow LB, Walker SA, Ruano G, Malik S.. Contrasting ABCB1 pharmacogenetics and psychotropic responses in child and adolescent psychiatry: a case comparison.. Pharmacogenomics. 2023;24(3):131-139.$11$YR$$F$Y$$$20240830$$HP$US$US
242667471$24266747$1$I$$20240329$20240830$20240830$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003950$STRIDES$Mohammed D, Verma S.. Methylphenidate for neurological improvement post-TBI. Journal of Family Medicine and Primary Care. 2023;12(11):2987-2989$51$YR$$M$Y$$$20240830$$HP$US$US
242667481$24266748$1$I$20240701$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018422$ELI LILLY AND CO$$86$YR$E$F$Y$$$20240830$$CN$US$US
242667491$24266749$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018330$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240830$$CN$US$US
242667501$24266750$1$I$20240721$20240812$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004544$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240830$$CN$US$US
242667511$24266751$1$I$$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018304$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240830$$CN$US$US
242667521$24266752$1$I$$20240620$20240830$20240830$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007650$STRIDES$Adegoke T, Subramanian S, Daunis D, Bick S, Ward HB. A Case of Treatment-Resistant Depression Complicated by Traumatic Brain Injury and Seizure: Implications for Interventional Treatment and Psychiatric Training.. Harv-Rev-Psychiatry. 2024;32 (3):117-125$45$YR$$M$Y$$$20240830$$HP$US$US
242667531$24266753$1$I$$20240812$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004552$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240830$$CN$US$US
242667541$24266754$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018729$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$US$US
242667552$24266755$2$F$$20240924$20240830$20240927$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013639$JAZZ$$$$$M$Y$$$20240927$$CN$US$US
242667561$24266756$1$I$$20240828$20240830$20240830$PER$$NVSC2024US174836$NOVARTIS$$$$$$Y$$$20240830$$MD$US$US
242667571$24266757$1$I$20240807$20240820$20240830$20240830$EXP$$GB-AUROBINDO-AUR-APL-2024-041982$AUROBINDO$$85$YR$$F$Y$49$KG$20240830$$HP$GB$GB
242667583$24266758$3$F$20240818$20240910$20240830$20240912$EXP$$NVSJ2024JP010321$NOVARTIS$$$$A$F$Y$$$20240913$$MD$JP$JP
242667591$24266759$1$I$$20240710$20240830$20240830$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008729$STRIDES$Meeder R, Peterson A, Reynard H, Andersen L.. Dyadic Work in Conjunction With Electroconvulsive Therapy in a 12-Year-Old Female With Autism Spectrum Disorder and Catatonia.. Ochsner-J. 2024;24(2):141-146$$$$F$Y$$$20240830$$HP$US$US
242667601$24266760$1$I$$20240710$20240830$20240830$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008753$STRIDES$Garman JC, Mahgoub Y, Pathare A.. Psychogenic Hyperphagia: Excessive Eating as Stereotypy in a Patient with Catatonia.. J-Psychiatr-Pract. 2024;30 (3):242-244$30$YR$$M$Y$$$20240830$$MD$US$US
242667611$24266761$1$I$$20240829$20240830$20240830$PER$$NVSC2024US174949$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
242667621$24266762$1$I$20230101$20240826$20240830$20240830$EXP$$JP-SANDOZ INC.-SDZ2024JP076230$SANDOZ$$88$YR$$M$Y$$$20240830$$CN$JP$JP
242667631$24266763$1$I$$20240828$20240830$20240830$PER$$NVSC2024US174839$NOVARTIS$$$$$F$Y$$$20240830$$MD$US$US
242667641$24266764$1$I$$20240821$20240830$20240830$EXP$$CA-TEVA-VS-3235622$TEVA$$40$YR$$F$Y$73$KG$20240830$$MD$CA$CA
242667655$24266765$5$F$$20240905$20240830$20240906$PER$$NVSC2024US173904$NOVARTIS$$$$$M$Y$$$20240906$$CN$US$US
242667661$24266766$1$I$$20240823$20240830$20240830$EXP$$NVSC2024AT173984$NOVARTIS$$$$A$M$Y$$$20240830$$MD$AT$AT
242667672$24266767$2$F$$20240925$20240830$20240930$EXP$$NVSJ2024JP010239$NOVARTIS$$$$$$Y$$$20240930$$MD$JP$JP
242667681$24266768$1$I$20240801$20240827$20240830$20240830$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03136$AMNEAL$$$$$F$Y$$$20240830$$MD$US$US
242667691$24266769$1$I$$20240829$20240830$20240830$PER$$NVSC2024US174946$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
242667701$24266770$1$I$$20240828$20240830$20240830$EXP$$US-GILEAD-2024-0685711$GILEAD$$$$$M$Y$$$20240830$$CN$US$US
242667711$24266771$1$I$20240817$20240827$20240830$20240830$EXP$$TH-ROCHE-10000068443$ROCHE$$55$YR$A$F$Y$$$20240830$$CN$TH$TH
242667721$24266772$1$I$20240809$20240821$20240830$20240830$EXP$$NVSC2024ZA174328$NOVARTIS$$35$YR$$M$Y$64.9$KG$20240830$$HP$ZA$ZA
242667731$24266773$1$I$$20240828$20240830$20240830$PER$$NVSC2024US174835$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
242667751$24266775$1$I$$20240829$20240830$20240830$PER$$NVSC2024US174820$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
242667761$24266776$1$I$$20240829$20240830$20240830$PER$$NVSC2024US174968$NOVARTIS$$$$$M$Y$$$20240830$$MD$US$US
242667771$24266777$1$I$$20240828$20240830$20240830$EXP$$NVSC2024US174658$NOVARTIS$$$$$M$Y$$$20240830$$MD$US$US
242667821$24266782$1$I$20231001$20240826$20240830$20240830$EXP$$US-ABBVIE-5896550$ABBVIE$$55$YR$$M$Y$$$20240830$$CN$US$US
242667831$24266783$1$I$$20240821$20240830$20240830$PER$$US-JNJFOC-20240860649$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$HP$US$US
242667842$24266784$2$F$$20240830$20240830$20240902$PER$$US-JNJFOC-20240876023$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242667852$24266785$2$F$$20240917$20240830$20240926$PER$$US-GSK-US2024103991$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
242667861$24266786$1$I$$20240809$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004542$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242667871$24266787$1$I$$20240820$20240830$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR103845$VIIV$$$$A$M$Y$$$20240830$$CN$US$US
242667881$24266788$1$I$$20240823$20240830$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001737$BLUEPRINT MEDICINES$$$$$F$Y$$$20240830$$CN$US$US
242667892$24266789$2$F$$20240906$20240830$20240910$PER$$US-ABBVIE-5898988$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
242667901$24266790$1$I$$20240821$20240830$20240830$PER$$US-AstraZeneca-2024A191365$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242667911$24266791$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5899050$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242667921$24266792$1$I$$20240822$20240830$20240830$EXP$$JP-AstraZeneca-2024A193838$ASTRAZENECA$$77$YR$$M$Y$$$20240830$$MD$JP$
242667931$24266793$1$I$$20240809$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004545$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242667941$24266794$1$I$20240101$20240827$20240830$20240830$PER$$US-ABBVIE-5898365$ABBVIE$$$$$M$Y$79$KG$20240830$$CN$US$US
242667951$24266795$1$I$20240101$20240816$20240830$20240830$EXP$$US-UCBSA-2024041963$UCB$$$$$F$Y$56.689$KG$20240830$$HP$US$US
242667961$24266796$1$I$20240806$20240809$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004548$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240830$$CN$US$US
242667971$24266797$1$I$$20240820$20240830$20240830$EXP$$DE-AMGEN-DEUSP2024168772$AMGEN$$$$$$Y$$$20240830$$MD$DE$DE
242667981$24266798$1$I$20240101$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172069$AMGEN$$83$YR$E$M$Y$$$20240830$$PH$US$US
242667991$24266799$1$I$$20240827$20240830$20240830$30DAY$$US-SANDOZ INC.-SDZ2024US076089$SANDOZ$$$$$F$Y$$$20240830$$CN$US$US
242668002$24266800$2$F$$20240827$20240830$20240906$EXP$$DE-GILEAD-2024-0685466$GILEAD$$$$$F$Y$$$20240906$$MD$DE$DE
242668011$24266801$1$I$$20240828$20240830$20240830$EXP$$US-SANDOZ INC.-SDZ2024US076246$SANDOZ$$$$$F$Y$$$20240830$$CN$US$US
242668022$24266802$2$F$20240822$20240829$20240830$20240905$EXP$$BR-CELLTRION INC.-2024BR020376$CELLTRION$$$$$$Y$$$20240905$$CN$BR$BR
242668031$24266803$1$I$$20240810$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004543$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242668051$24266805$1$I$20240808$20240816$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004771$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240830$$CN$US$US
242668061$24266806$1$I$$20240821$20240830$20240830$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01725$NOVITIUM PHARMA$Ying Shang.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Haematology.2023;40:275-304$61$YR$A$F$Y$$$20240830$$HP$CN$CN
242668071$24266807$1$I$$20240823$20240830$20240830$EXP$$US-GILEAD-2024-0685435$GILEAD$$$$A$M$Y$$$20240830$$CN$US$US
242668081$24266808$1$I$$20240827$20240830$20240830$EXP$$GB-ROCHE-10000009804$ROCHE$$$$A$F$Y$$$20240830$$CN$GB$GB
242668091$24266809$1$I$$20240827$20240830$20240830$EXP$$JP-AMGEN-JPNSP2024173040$AMGEN$$7$DEC$E$M$Y$$$20240830$$MD$JP$JP
242668101$24266810$1$I$$20240815$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004765$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242668111$24266811$1$I$$20240810$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004571$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242668121$24266812$1$I$20240401$20240822$20240830$20240830$EXP$$US-IMMUNOGEN, INC.-US-IMGN-24-00647$IMMUNOGEN$$$$A$F$Y$71$KG$20240830$$HP$US$US
242668131$24266813$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5898984$ABBVIE$$$$$M$Y$$$20240830$$HP$US$US
242668141$24266814$1$I$20240819$20240820$20240830$20240830$EXP$GB-MHRA-TPP17761064C9489811YC1724084081235$GB-Accord-442635$ACCORD$$70$YR$E$F$Y$66$KG$20240830$$MD$GB$GB
242668151$24266815$1$I$20240507$20240822$20240830$20240830$EXP$$TW-AMGEN-TWNSP2024172266$AMGEN$$82$YR$E$F$Y$$$20240830$$MD$TW$TW
242668161$24266816$1$I$20240101$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171368$AMGEN$$69$YR$E$F$Y$$$20240830$$CN$US$US
242668171$24266817$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172088$AMGEN$$$$$M$Y$$$20240830$$CN$US$US
242668181$24266818$1$I$$20240820$20240830$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-133832$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240830$$PH$JP$JP
242668191$24266819$1$I$20240709$20240726$20240830$20240830$EXP$$US-GILEAD-2024-0685758$GILEAD$$98$YR$E$F$Y$$$20240830$$CN$US$US
242668201$24266820$1$I$$20240826$20240830$20240830$EXP$$CA-ROCHE-10000066112$ROCHE$$66$YR$E$M$Y$$$20240830$$CN$CA$CA
242668231$24266823$1$I$$20240823$20240830$20240830$PER$$US-RDY-SPO/USA/24/0012467$DR REDDYS$$79$YR$E$M$Y$$$20240830$$CN$US$US
242668241$24266824$1$I$20240808$20240812$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004576$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240830$$CN$US$US
242668251$24266825$1$I$20240601$20240822$20240830$20240830$EXP$$CA-CELLTRION INC.-2024CA017130$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
242668262$24266826$2$F$20240827$20240911$20240830$20240916$EXP$$JP-JNJFOC-20240879982$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240916$$PH$JP$JP
242668271$24266827$1$I$$20240821$20240830$20240830$PER$$US-JNJFOC-20240858968$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242668281$24266828$1$I$$20240823$20240830$20240830$EXP$$CL-JNJFOC-20240867059$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240830$$CN$CL$CL
242668291$24266829$1$I$$20240820$20240830$20240830$30DAY$$US-GSK-US2024103996$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242668301$24266830$1$I$$20240822$20240830$20240830$EXP$$US-ROCHE-3329221$ROCHE$$81$YR$E$M$Y$$$20240830$$CN$US$US
242668311$24266831$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898621$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240830$$HP$CN$CN
242668321$24266832$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898897$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240830$$HP$CN$CN
242668331$24266833$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898898$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240830$$HP$CN$CN
242668351$24266835$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A192951$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242668361$24266836$1$I$20240504$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195286$ASTRAZENECA$$28156$DY$$M$Y$$$20240830$$CN$US$
242668371$24266837$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898899$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240830$$HP$CN$CN
242668381$24266838$1$I$20240101$20240822$20240830$20240830$EXP$ES-AEMPS-1526657$ES-INTERCEPT-PM2024001709$INTERCEPT PHARMACEUTICALS$$55$YR$$M$Y$$$20240830$$MD$ES$ES
242668391$24266839$1$I$20240809$20240826$20240830$20240830$EXP$$US-INTERCEPT-PM2024001698$INTERCEPT PHARMACEUTICALS$$80$YR$$F$Y$$$20240830$$CN$US$US
242668401$24266840$1$I$20240710$20240827$20240830$20240830$EXP$$US-ABBVIE-5898570$ABBVIE$$67$YR$$M$Y$$$20240830$$CN$US$US
242668411$24266841$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018335$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240830$$CN$US$US
242668421$24266842$1$I$$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016162$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240830$$CN$US$US
242668431$24266843$1$I$$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016479$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240830$$CN$US$US
242668441$24266844$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018074$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240830$$CN$US$US
242668451$24266845$1$I$20240824$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018241$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240830$$CN$US$US
242668461$24266846$1$I$20240821$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018067$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240830$$CN$US$US
242668471$24266847$1$I$$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016382$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240830$$CN$US$US
242668482$24266848$2$F$20240701$20240917$20240830$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202408018556$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240918$$CN$US$US
242668494$24266849$4$F$$20240920$20240830$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137835$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240924$$CN$US$US
242668501$24266850$1$I$20240828$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172482$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242668512$24266851$2$F$$20240903$20240830$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137427$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240904$$CN$US$US
242668521$24266852$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137788$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240830$$CN$US$US
242668531$24266853$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137376$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240830$$CN$US$US
242668541$24266854$1$I$20240801$20240821$20240830$20240830$EXP$$CA-APOTEX-2024AP009749$APOTEX$$60$YR$A$M$Y$$$20240830$$PH$CA$CA
242668561$24266856$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137986$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240830$$CN$US$US
242668571$24266857$1$I$$20240826$20240830$20240830$EXP$$US-JNJFOC-20240866377$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$HP$US$US
242668581$24266858$1$I$20230101$20240827$20240830$20240830$EXP$$GB-ABBVIE-5899528$ABBVIE$$64$YR$$M$Y$$$20240830$$MD$GB$GB
242668591$24266859$1$I$20240801$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898126$ABBVIE$$60$YR$$M$Y$42$KG$20240830$$MD$CN$CN
242668602$24266860$2$F$20240806$20240906$20240830$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004730$ACADIA PHARMACEUTICALS$$90$YR$$M$Y$$$20240916$$CN$US$US
242668611$24266861$1$I$20240801$20240819$20240830$20240830$PER$$US-JNJFOC-20240849123$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240830$$CN$US$US
242668622$24266862$2$F$20240101$20240903$20240830$20240906$EXP$$US-ABBVIE-5898317$ABBVIE$$$$$F$Y$62.595$KG$20240906$$CN$US$US
242668632$24266863$2$F$20240101$20240903$20240830$20240909$EXP$$US-ABBVIE-5898773$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242668641$24266864$1$I$$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024171325$AMGEN$Charrow A.. High-Dose Upadacitinib Therapy for Refractory Metastatic Crohn Disease. JAMA Dermatology. 2024;160 (7):782-783$$$A$F$Y$$$20240830$$MD$US$US
242668662$24266866$2$F$20240822$20240905$20240830$20240912$EXP$$IL-TAKEDA-2023TUS097153$TAKEDA$$58$YR$$M$Y$$$20240912$$CN$IL$IL
242668671$24266867$1$I$$20240823$20240830$20240830$PER$$US-TAKEDA-2024TUS086275$TAKEDA$$$$$F$Y$$$20240830$$CN$US$US
242668681$24266868$1$I$20240812$20240815$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004732$ACADIA PHARMACEUTICALS$$86$YR$$F$Y$$$20240830$$CN$US$US
242668691$24266869$1$I$$20240812$20240830$20240830$PER$$US-TEVA-VS-3232787$TEVA$$87$YR$$F$Y$$$20240830$$CN$US$US
242668701$24266870$1$I$20240723$20240820$20240830$20240830$PER$$US-ABBVIE-5900468$ABBVIE$$19$YR$$F$Y$$$20240830$$HP$US$US
242668711$24266871$1$I$$20240813$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004647$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242668721$24266872$1$I$20240801$20240820$20240830$20240830$PER$$US-SA-2024SA250196$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240830$$MD$US$US
242668731$24266873$1$I$$20240823$20240830$20240830$EXP$US-MLMSERVICE-20240822-PI163394-00175-3$US-RDY-SPO/USA/24/0012484$DR REDDYS$Kim K, Llanos D, Ramos C, Shahnavaz N, Adhyaru BB. Finding the Balance: Venous Thromboembolism Prophylaxis during Hematochezia in Crohn^s Disease. Case Reports in Gastroenterology. 2024;18(1):367-72.DOI:10.1159/000540128.$39$YR$A$F$Y$$$20240830$$MD$US$US
242668741$24266874$1$I$20231004$20240820$20240830$20240830$EXP$FR-AFSSAPS-LY2024001267$FR-TEVA-VS-3235538$TEVA$$82$YR$$F$Y$74.5$KG$20240830$$PH$FR$FR
242668753$24266875$3$F$$20240924$20240830$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07812$LUPIN$$$$$$Y$$$20240925$$CN$US$US
242668761$24266876$1$I$20240825$20240828$20240830$20240830$EXP$$US-GILEAD-2024-0685656$GILEAD$$67$YR$E$F$Y$$$20240830$$CN$US$US
242668771$24266877$1$I$20240722$20240820$20240830$20240830$EXP$$US-RDY-CLI/USA/24/0012431$DR REDDYS$$29$YR$A$F$Y$$$20240830$$MD$US$US
242668781$24266878$1$I$$20240822$20240830$20240830$PER$$US-JNJFOC-20240864783$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$HP$US$US
242668791$24266879$1$I$$20240820$20240830$20240830$EXP$$CA-RDY-CLI/CAN/24/0012520$DR REDDYS$$78$YR$E$F$Y$$$20240830$$CN$CA$CA
242668801$24266880$1$I$$20240828$20240830$20240830$PER$$US-JNJFOC-20240876537$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242668811$24266881$1$I$20240101$20240822$20240830$20240830$PER$$US-AMGEN-USASP2024169040$AMGEN$$75$YR$E$F$Y$$$20240830$$CN$US$US
242668822$24266882$2$F$20240727$20240830$20240830$20240902$PER$$US-AMGEN-USASP2024171472$AMGEN$$70$YR$E$F$Y$$$20240902$$CN$US$US
242668831$24266883$1$I$20240828$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172566$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242668841$24266884$1$I$20240826$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171739$AMGEN$$70$YR$E$M$Y$$$20240830$$CN$US$US
242668852$24266885$2$F$20240909$20240910$20240830$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004680$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240920$$CN$US$US
242668871$24266887$1$I$$20240816$20240830$20240830$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-08455$LUPIN$$52$YR$$F$Y$$$20240830$$CN$AU$AU
242668881$24266888$1$I$20240801$20240823$20240830$20240830$PER$$US-BEH-2024177654$CSL BEHRING$$33$YR$A$$Y$$$20240830$$HP$US$US
242668891$24266889$1$I$20220920$20240820$20240830$20240830$EXP$GB-MHRA-MED-202301311544413690-CZJHB$GB-JUBILANT CADISTA PHARMACEUTICALS-2024GB001209$JUBILANT$$83$YR$$F$Y$$$20240830$$CN$GB$GB
242668901$24266890$1$I$20240804$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042052$AUROBINDO$$78$YR$$F$Y$55$KG$20240830$$MD$FR$FR
242668911$24266891$1$I$$20240821$20240830$20240830$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01714$NOVITIUM PHARMA$Ying Shang.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Haematology.2023;40:275-304$68$YR$A$M$Y$$$20240830$$HP$CN$CN
242668921$24266892$1$I$20240516$20240822$20240830$20240830$EXP$$DE-ROCHE-10000065073$ROCHE$$47$YR$A$F$Y$$$20240830$$MD$DE$DE
242668932$24266893$2$F$20240101$20240910$20240830$20240919$EXP$$US-SA-2024SA251774$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240919$$CN$US$US
242668941$24266894$1$I$20240701$20240813$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004650$ACADIA PHARMACEUTICALS$$91$YR$$F$Y$$$20240830$$CN$US$US
242668951$24266895$1$I$$20240823$20240830$20240830$PER$$US-BEH-2024177649$CSL BEHRING$$$$E$M$Y$$$20240830$$HP$US$US
242668961$24266896$1$I$$20240821$20240830$20240830$PER$$US-ROCHE-10000063818$ROCHE$$69$YR$E$F$Y$$$20240830$$CN$US$US
242668971$24266897$1$I$20240129$20240820$20240830$20240830$EXP$$DK-AUROBINDO-AUR-APL-2024-042164$AUROBINDO$$49$YR$$F$Y$71$KG$20240830$$MD$DK$DK
242668982$24266898$2$F$20240826$20240909$20240830$20240910$PER$$US-JNJFOC-20240869482$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
242668991$24266899$1$I$20240809$20240822$20240830$20240830$EXP$$US-JNJFOC-20240867270$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240830$$MD$US$US
242669001$24266900$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A193560$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242669021$24266902$1$I$20240722$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042239$AUROBINDO$$66$YR$$F$Y$79$KG$20240830$$CN$FR$FR
242669031$24266903$1$I$$20240822$20240830$20240830$30DAY$$US-GSK-US2024105091$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242669041$24266904$1$I$$20240819$20240830$20240830$PER$$US-ABBVIE-5898191$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242669051$24266905$1$I$$20240820$20240830$20240830$30DAY$$US-GSK-US2024104010$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242669061$24266906$1$I$$20240826$20240830$20240830$EXP$$GB-TAKEDA-2024TUS087093$TAKEDA$$$$$M$Y$$$20240830$$CN$GB$GB
242669071$24266907$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-087357-2024$RECKITT BENCKISER$$$$$F$Y$$$20240830$$CN$US$US
242669081$24266908$1$I$$20240826$20240830$20240830$PER$$US-TAKEDA-2024TUS086644$TAKEDA$$$$A$F$Y$$$20240830$$CN$US$US
242669091$24266909$1$I$$20240823$20240830$20240830$EXP$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-432520$GB-RDY-SPO/GBR/24/0005731$DR REDDYS$$75$YR$E$F$Y$$$20240830$$CN$GB$GB
242669101$24266910$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000069587$ROCHE$$73$YR$E$M$Y$$$20240830$$HP$US$US
242669122$24266912$2$F$20240819$20240829$20240830$20240906$EXP$$US-EMD Serono-2024045129$EMD SERONO INC$$81$YR$E$M$Y$$$20240906$$CN$US$US
242669131$24266913$1$I$20240112$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042093$AUROBINDO$$57$YR$$M$Y$$$20240830$$PH$FR$FR
242669142$24266914$2$F$20240611$20240911$20240830$20240918$EXP$$JP-BEH-2024177892$CSL BEHRING$$55$YR$A$F$Y$66.2$KG$20240918$$CN$JP$JP
242669163$24266916$3$F$$20240919$20240830$20240920$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048709$BOEHRINGER INGELHEIM$$$$$$Y$$$20240920$$MD$US$US
242669171$24266917$1$I$20240801$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172577$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242669181$24266918$1$I$$20240828$20240830$20240830$EXP$$NVSC2024US174655$NOVARTIS$$$$$M$Y$$$20240830$$MD$US$US
242669192$24266919$2$F$$20240905$20240830$20240913$PER$$US-ROCHE-10000068072$ROCHE$$$$$$Y$$$20240913$$HP$US$US
242669201$24266920$1$I$20220101$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042167$AUROBINDO$$18$YR$$F$Y$83$KG$20240830$$MD$FR$FR
242669211$24266921$1$I$$20240826$20240830$20240830$PER$$US-ROCHE-10000068336$ROCHE$File B, Hari A. Discrepancy in PD-L1 expression between primary and metastatic tumors in two patients with recurrent cervical cancer. Gynecologic Oncology Reports. 2024;55:1-4. doi:10.1016/j.gore.2024.101484.$42$YR$A$F$Y$$$20240830$$HP$US$US
242669221$24266922$1$I$20230701$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042216$AUROBINDO$$44$YR$$F$Y$$$20240830$$MD$FR$FR
242669231$24266923$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018460$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240830$$CN$US$US
242669241$24266924$1$I$$20240820$20240830$20240830$EXP$$DE-AUROBINDO-AUR-APL-2024-042361$AUROBINDO$Groth, Olwen; Roider, Gabriele; Graw, Matthias.. Drug-induced deaths in renal insufficiency. Munich Medical Weekly. Advances in Medicine. 2024;166 (13):48-51$89$YR$$M$Y$$$20240830$$HP$DE$DE
242669251$24266925$1$I$$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016834$ELI LILLY AND CO$$$$$M$Y$$$20240830$$CN$US$US
242669261$24266926$1$I$20240801$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017893$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240830$$CN$US$US
242669271$24266927$1$I$$20240827$20240830$20240830$EXP$$KR-ROCHE-10000068270$ROCHE$$$$$F$Y$$$20240830$$MD$KR$KR
242669282$24266928$2$F$$20240828$20240830$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08078$LUPIN$$$$$$Y$$$20240919$$PH$US$US
242669292$24266929$2$F$20240825$20240829$20240830$20240911$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240800083$UPSHER SMITH LABORATORIES$$18$YR$$F$Y$$$20240911$$MD$US$US
242669311$24266931$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898544$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242669321$24266932$1$I$20240501$20240822$20240830$20240830$EXP$$CA-CELLTRION INC.-2024CA011868$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
242669332$24266933$2$F$20240801$20240830$20240830$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-042060$AUROBINDO$$$$$M$Y$$$20240910$$MD$GB$GB
242669341$24266934$1$I$20240731$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042107$AUROBINDO$$51$YR$$F$Y$68$KG$20240830$$MD$FR$FR
242669351$24266935$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5898158$ABBVIE$$$$$F$Y$$$20240830$$MD$US$US
242669361$24266936$1$I$$20240827$20240830$20240830$PER$$IQ-REGENERON PHARMACEUTICALS, INC.-2024-117504$REGENERON$$66$YR$$M$Y$$$20240830$$CN$IQ$IQ
242669371$24266937$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5898869$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242669381$24266938$1$I$20240214$20240215$20240830$20240830$PER$$US-CIPLA LTD.-2024US02136$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242669391$24266939$1$I$$20240812$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08116$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242669401$24266940$1$I$20221228$20240731$20240830$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR097837$VIIV$$63$YR$$M$Y$$$20240830$$MD$US$US
242669411$24266941$1$I$20240701$20240812$20240830$20240830$EXP$$US-VIIV HEALTHCARE LIMITED-US2024100225$VIIV$$31$YR$$F$Y$$$20240830$$CN$US$US
242669421$24266942$1$I$$20240624$20240830$20240830$PER$$US-CIPLA LTD.-2024US02132$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242669431$24266943$1$I$20231001$20240826$20240830$20240830$EXP$$BR-ORGANON-O2408BRA002056$ORGANON$$$$$F$Y$$$20240830$$CN$BR$BR
242669441$24266944$1$I$$20240315$20240830$20240830$PER$$US-CIPLA LTD.-2024US02255$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242669451$24266945$1$I$20240222$20240301$20240830$20240830$PER$$US-CIPLA LTD.-2024US02306$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242669461$24266946$1$I$$20240820$20240830$20240830$EXP$$DE-AUROBINDO-AUR-APL-2024-042154$AUROBINDO$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz (Drug-induced deaths in renal failure). M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$80$YR$$M$Y$$$20240830$$HP$DE$DE
242669481$24266948$1$I$$20240821$20240830$20240830$EXP$$PL-ABBVIE-5896011$ABBVIE$$72$YR$$$Y$$$20240830$$MD$PL$PL
242669491$24266949$1$I$20240222$20240226$20240830$20240830$PER$$US-CIPLA LTD.-2024US02386$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242669501$24266950$1$I$$20240227$20240830$20240830$PER$$US-CIPLA LTD.-2024US02418$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242669511$24266951$1$I$20240801$20240814$20240830$20240830$PER$$US-TEVA-VS-3233725$TEVA$$94$YR$$M$Y$$$20240830$$CN$US$US
242669521$24266952$1$I$20240802$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042214$AUROBINDO$$92$YR$$F$Y$57$KG$20240830$$MD$FR$FR
242669531$24266953$1$I$$20240314$20240830$20240830$PER$$US-CIPLA LTD.-2024US02496$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242669541$24266954$1$I$$20240613$20240830$20240830$PER$$US-CIPLA LTD.-2024US02671$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242669551$24266955$1$I$20240616$20240820$20240830$20240830$EXP$$GB-AUROBINDO-AUR-APL-2024-042080$AUROBINDO$$78$YR$$F$Y$$$20240830$$HP$GB$GB
242669562$24266956$2$F$$20240820$20240830$20240902$EXP$$IT-AUROBINDO-AUR-APL-2024-042434$AUROBINDO$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series. A Case Series. J-Clin-Med. 2023;12 (1):129$27$YR$$M$Y$$$20240902$$HP$IT$IT
242669572$24266957$2$F$$20240827$20240830$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08134$LUPIN$$$$$$Y$$$20240919$$CN$US$US
242669581$24266958$1$I$$20240815$20240830$20240830$EXP$$US-UCBSA-2024041837$UCB$$$$$M$Y$$$20240830$$HP$US$US
242669591$24266959$1$I$$20240304$20240830$20240830$PER$$US-CIPLA LTD.-2024US02710$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242669601$24266960$1$I$$20240821$20240830$20240830$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01726$NOVITIUM PHARMA$Ying Shang.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Haematology.2023;40:275-304$75$YR$E$F$Y$$$20240830$$HP$CN$CN
242669621$24266962$1$I$20240304$20240703$20240830$20240830$PER$$US-CIPLA LTD.-2024US02827$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242669631$24266963$1$I$$20240820$20240830$20240830$30DAY$$US-GSK-US2024103970$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242669641$24266964$1$I$$20240822$20240830$20240830$30DAY$$US-GSK-US2024105042$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$MD$US$US
242669651$24266965$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A194601$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242669661$24266966$1$I$$20240826$20240830$20240830$EXP$$CA-GILEAD-2024-0685152$GILEAD$$$$A$M$Y$$$20240830$$HP$CA$CA
242669671$24266967$1$I$20240817$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171486$AMGEN$$65$YR$E$F$Y$$$20240830$$CN$US$US
242669681$24266968$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A194883$ASTRAZENECA$$78$YR$$M$Y$$$20240830$$CN$US$
242669691$24266969$1$I$20240101$20240829$20240830$20240830$EXP$$US-UCBSA-2024044019$UCB$$$$$F$Y$$$20240830$$CN$US$US
242669701$24266970$1$I$$20240823$20240830$20240830$EXP$$GB-TAKEDA-2024TUS087220$TAKEDA$$$$$$Y$$$20240830$$MD$GB$GB
242669712$24266971$2$F$$20240920$20240830$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138078$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$73.028$KG$20240927$$CN$US$US
242669721$24266972$1$I$$20240824$20240830$20240830$PER$$US-ABBVIE-5895983$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242669731$24266973$1$I$$20240829$20240830$20240830$PER$$US-ROCHE-10000069866$ROCHE$$$$A$F$Y$$$20240830$$CN$US$US
242669741$24266974$1$I$$20240820$20240830$20240830$EXP$$JP-BEH-2024177840$CSL BEHRING$$10$YR$C$M$Y$$$20240830$$HP$JP$JP
242669751$24266975$1$I$$20240824$20240830$20240830$PER$$NVSC2024US174727$NOVARTIS$$$$$$Y$$$20240830$$CN$US$US
242669761$24266976$1$I$20240202$20240820$20240830$20240830$EXP$ES-AEMPS-1561249$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111468$ZYDUS PHARM$$$$$$Y$$$20240830$$MD$ES$ES
242669771$24266977$1$I$20240810$20240815$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004726$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240830$$CN$US$US
242669781$24266978$1$I$20240717$20240820$20240830$20240830$EXP$FR-AFSSAPS-GR2024001019$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111385$ZYDUS PHARM$$$$$$Y$$$20240830$$PH$FR$FR
242669791$24266979$1$I$20240729$20240820$20240830$20240830$EXP$FR-AFSSAPS-BX2024001674$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111401$ZYDUS PHARM$$$$$$Y$$$20240830$$MD$FR$FR
242669801$24266980$1$I$20240802$20240820$20240830$20240830$EXP$FR-AFSSAPS-TS2024000920$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111418$ZYDUS PHARM$$$$$$Y$$$20240830$$MD$FR$FR
242669812$24266981$2$F$20240722$20240909$20240830$20240916$EXP$FR-AFSSAPS-CN2024000792$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111407$ZYDUS PHARM$$$$$$Y$$$20240916$$MD$FR$FR
242669821$24266982$1$I$20210628$20240823$20240830$20240830$EXP$$BR-TAKEDA-2021TUS041666$TAKEDA$$6$YR$$M$Y$$$20240830$$CN$BR$BR
242669831$24266983$1$I$20240818$20240826$20240830$20240830$EXP$$US-ARGENX-2024-ARGX-US007113$ARGENX BVBA$$$$$$Y$$$20240830$$CN$US$US
242669841$24266984$1$I$$20240820$20240830$20240830$PER$$US-JNJFOC-20240855624$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242669851$24266985$1$I$$20240826$20240830$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013544$JAZZ$$$$$F$Y$$$20240830$$CN$US$US
242669861$24266986$1$I$$20240827$20240830$20240830$EXP$$IT-UCBSA-2024043781$UCB$Biondo T, Baldino G, Burrascano G, Tarzia P, Indelicato M, Asmundo A et al. Sudden Unexpected Death in Epilepsy (SUDEP). Full forensic approach in two cases and review of literature. Clinica Terapeutica. 2024;175(4):97-108$13$YR$$F$Y$$$20240830$$HP$IT$IT
242669872$24266987$2$F$20240711$20240924$20240830$20240930$EXP$$US-ABBVIE-5898904$ABBVIE$$53$YR$$M$Y$$$20240930$$CN$US$US
242669882$24266988$2$F$$20240909$20240830$20240913$EXP$$JP-GSK-JP2024JPN105655$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$PH$JP$JP
242669892$24266989$2$F$$20240926$20240830$20240927$EXP$$NVSC2024CA128586$NOVARTIS$$49$YR$$F$Y$$$20240927$$CN$CA$CA
242669901$24266990$1$I$$20240828$20240830$20240830$EXP$$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-002135$IPCA$$$$$$Y$$$20240830$$MD$GB$GB
242669911$24266991$1$I$$20240823$20240830$20240830$PER$$US-ROCHE-10000065650$ROCHE$$35$YR$A$F$Y$$$20240830$$CN$US$US
242669932$24266993$2$F$$20240820$20240830$20240905$EXP$$JP-BEH-2024177904$CSL BEHRING$$89$YR$E$M$Y$$$20240905$$HP$JP$JP
242669942$24266994$2$F$20240728$20240911$20240830$20240912$PER$$US-AMGEN-USASP2024172833$AMGEN$$50$YR$A$F$Y$$$20240912$$CN$US$US
242669951$24266995$1$I$20240827$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171611$AMGEN$$18$YR$A$F$Y$$$20240830$$CN$US$US
242669961$24266996$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898303$ABBVIE$$$$$M$Y$$$20240830$$HP$US$US
242669972$24266997$2$F$20230504$20240920$20240830$20240930$EXP$FR-AFSSAPS-PO2024000870$FR-TEVA-VS-3235426$TEVA$$1$DY$$M$Y$3.415$KG$20240930$$HP$FR$FR
242669981$24266998$1$I$20240822$20240823$20240830$20240830$PER$$US-ROCHE-10000066318$ROCHE$$$$$F$Y$$$20240830$$CN$US$US
242670001$24267000$1$I$20240801$20240826$20240830$20240830$EXP$$CA-ABBVIE-5898035$ABBVIE$$38$YR$$F$Y$$$20240830$$CN$CA$CA
242670021$24267002$1$I$20240826$20240826$20240830$20240830$PER$$US-ROCHE-10000066571$ROCHE$$49$YR$A$F$Y$74.84$KG$20240830$$CN$US$US
242670031$24267003$1$I$$20240821$20240830$20240830$EXP$$CA-TEVA-VS-3235909$TEVA$$70$YR$$F$Y$$$20240830$$HP$CA$CA
242670041$24267004$1$I$$20240823$20240830$20240830$EXP$$CA-TAKEDA-2022TUS086258$TAKEDA$$$$$F$Y$$$20240830$$CN$CA$CA
242670051$24267005$1$I$$20240815$20240830$20240830$PER$$US-SIMILASAN-2024USSIMSPO00140$SIMILASAN$$$$$$Y$$$20240830$$CN$US$US
242670063$24267006$3$F$20240812$20240916$20240830$20240919$EXP$$US-ABBVIE-5896114$ABBVIE$$47$YR$$F$Y$$$20240919$$CN$US$US
242670071$24267007$1$I$$20240805$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07924$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242670081$24267008$1$I$20240601$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018071$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240830$$CN$US$US
242670092$24267009$2$F$$20240906$20240830$20240911$EXP$$CA-JNJFOC-20240879040$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240911$$HP$CA$CA
242670101$24267010$1$I$$20240819$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408011680$ELI LILLY AND CO$$54$YR$A$$Y$$$20240830$$LW$US$US
242670111$24267011$1$I$20240801$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018124$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$US$US
242670122$24267012$2$F$$20240917$20240830$20240927$PER$$US-GSK-US2024104986$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
242670131$24267013$1$I$$20240814$20240830$20240830$PER$$US-ABBVIE-5894341$ABBVIE$$55$YR$$F$Y$$$20240830$$HP$US$US
242670141$24267014$1$I$20240708$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042236$AUROBINDO$$68$YR$$M$Y$59.7$KG$20240830$$MD$FR$FR
242670151$24267015$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137569$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240830$$CN$US$US
242670161$24267016$1$I$20181001$20240820$20240830$20240830$EXP$$US-ROCHE-10000062343$ROCHE$$48$YR$A$F$Y$97.06$KG$20240830$$CN$US$US
242670171$24267017$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137922$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240830$$CN$US$US
242670181$24267018$1$I$20240101$20240826$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137911$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240830$$PH$US$US
242670192$24267019$2$F$20240820$20240829$20240830$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004943$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240923$$CN$US$US
242670201$24267020$1$I$$20240826$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135971$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240830$$CN$US$US
242670211$24267021$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137819$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240830$$HP$US$US
242670221$24267022$1$I$20240823$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137665$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$63.5$KG$20240830$$CN$US$US
242670231$24267023$1$I$$20240821$20240830$20240830$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01730$NOVITIUM PHARMA$Ying Shang.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Haematology.2023;40:275-304$72$YR$E$M$Y$$$20240830$$HP$CN$CN
242670241$24267024$1$I$20210203$20240829$20240830$20240830$EXP$FR-AFSSAPS-ST2024001356$NVSC2024FR174179$NOVARTIS$$45$YR$$F$Y$74$KG$20240830$$MD$FR$FR
242670251$24267025$1$I$$20240829$20240830$20240830$PER$$NVSC2024US174744$NOVARTIS$$$$$$Y$148.32$KG$20240830$$CN$US$US
242670262$24267026$2$F$20240501$20240823$20240830$20240902$EXP$GB-MHRA-MED-202408231308355820-THCRM$GB-ABBVIE-5893120$ABBVIE$$35$YR$$M$Y$$$20240902$$PH$GB$GB
242670272$24267027$2$F$20240825$20240920$20240830$20240924$PER$$US-ROCHE-10000066578$ROCHE$$46$YR$A$F$Y$$$20240924$$CN$US$US
242670283$24267028$3$F$20240815$20240920$20240830$20240923$PER$$US-ROCHE-10000065594$ROCHE$$66$YR$E$F$Y$64.86$KG$20240923$$CN$US$US
242670291$24267029$1$I$20210101$20240824$20240830$20240830$EXP$$IN-SANDOZ INC.-SDZ2024IN076375$SANDOZ$$$$$M$Y$$$20240830$$CN$IN$IN
242670301$24267030$1$I$20240805$20240822$20240830$20240830$EXP$$CL-AstraZeneca-2024A194976$ASTRAZENECA$$14007$DY$$F$Y$$$20240830$$CN$CL$
242670311$24267031$1$I$$20240805$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07922$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242670332$24267033$2$F$20240810$20240906$20240830$20240913$EXP$$US-AstraZeneca-2024A191871$ASTRAZENECA$$24963$DY$$M$Y$$$20240913$$CN$US$
242670341$24267034$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A192594$ASTRAZENECA$$$$$F$Y$73$KG$20240830$$HP$US$
242670351$24267035$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A193585$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242670361$24267036$1$I$20240512$20240826$20240830$20240830$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00030$AMNEAL$$64$YR$$M$Y$$$20240830$$CN$US$US
242670372$24267037$2$F$$20240827$20240830$20240905$EXP$$NL-AUROBINDO-AUR-APL-2024-042772$AUROBINDO$$33$YR$$M$Y$85$KG$20240905$$CN$NL$NL
242670381$24267038$1$I$20240101$20240826$20240830$20240830$EXP$$GB-ABBVIE-5899590$ABBVIE$$37$YR$$F$Y$$$20240830$$CN$GB$GB
242670391$24267039$1$I$20240118$20240826$20240830$20240830$EXP$$FR-EXELIXIS-CABO-24080956$EXELIXIS$$72$YR$$M$Y$64.3$KG$20240830$$PH$FR$FR
242670403$24267040$3$F$20240816$20240823$20240830$20240917$PER$$US-SA-2024SA252642$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240918$$CN$US$US
242670411$24267041$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA249761$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240830$$MD$US$US
242670421$24267042$1$I$20240725$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042182$AUROBINDO$$84$YR$$F$Y$53$KG$20240830$$PH$FR$FR
242670431$24267043$1$I$$20240807$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08033$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242670441$24267044$1$I$20240724$20240826$20240830$20240830$PER$$US-TAKEDA-2024TUS086230$TAKEDA$$48$YR$$F$Y$52$KG$20240830$$MD$US$US
242670451$24267045$1$I$20240716$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042621$AUROBINDO$$$$A$M$Y$$$20240830$$MD$FR$FR
242670462$24267046$2$F$$20240828$20240830$20240905$PER$$US-AMGEN-USASP2024172387$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242670471$24267047$1$I$20240827$20240829$20240830$20240830$EXP$$CZ-GILEAD-2024-0685530$GILEAD$$$$$F$Y$$$20240830$$PH$CZ$CZ
242670482$24267048$2$F$20231123$20240823$20240830$20240903$EXP$$NVSC2024BR173267$NOVARTIS$$70$YR$$F$Y$59$KG$20240903$$HP$BR$BR
242670491$24267049$1$I$$20240826$20240830$20240830$EXP$$NVSC2024NL174728$NOVARTIS$$$$$M$Y$$$20240830$$MD$NL$NL
242670501$24267050$1$I$$20240829$20240830$20240830$PER$$NVSC2024US175091$NOVARTIS$$$$$F$Y$$$20240830$$PH$US$US
242670511$24267051$1$I$$20240829$20240830$20240830$PER$$US-ROCHE-3492331$ROCHE$$63$YR$A$F$Y$$$20240830$$HP$US$US
242670521$24267052$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898412$ABBVIE$$27$YR$$M$Y$$$20240830$$MD$US$US
242670542$24267054$2$F$$20240902$20240830$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-041976$AUROBINDO$$$$$F$Y$$$20240910$$CN$GB$GB
242670552$24267055$2$F$20240101$20240828$20240830$20240830$EXP$$US-BAUSCH-BL-2024-013043$BAUSCH AND LOMB$$69$YR$$M$Y$$$20240830$$CN$US$US
242670561$24267056$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137363$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$81.19$KG$20240830$$CN$US$US
242670572$24267057$2$F$$20240918$20240830$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138002$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$86.64$KG$20240920$$CN$US$US
242670581$24267058$1$I$20240507$20240521$20240830$20240830$PER$$US-CIPLA LTD.-2024US05377$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242670591$24267059$1$I$20240101$20240823$20240830$20240830$EXP$$JP-GENMAB-2024-01393AA$GENMAB$$$$$M$Y$59$KG$20240830$$PH$JP$JP
242670601$24267060$1$I$$20240826$20240830$20240830$PER$$US-TAKEDA-2024TUS087123$TAKEDA$$$$A$F$Y$$$20240830$$CN$US$US
242670612$24267061$2$F$$20240827$20240830$20240905$EXP$$CA-TEVA-VS-3235739$TEVA$$12$MON$$M$Y$$$20240905$$HP$CA$CA
242670621$24267062$1$I$$20240524$20240830$20240830$PER$$US-CIPLA LTD.-2024US05555$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242670631$24267063$1$I$$20240828$20240830$20240830$EXP$US-MLMSERVICE-20230525-4305439-1$US-SANDOZ INC.-SDZ2024US076244$SANDOZ$$78$YR$$M$Y$$$20240830$$MD$US$US
242670641$24267064$1$I$20240826$20240827$20240830$20240830$PER$$US-SA-2024SA251537$SANOFI AVENTIS$$101$YR$E$M$Y$$$20240830$$CN$US$US
242670651$24267065$1$I$$20240821$20240830$20240830$PER$$US-SA-2024SA249631$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240830$$CN$US$US
242670661$24267066$1$I$$20240827$20240830$20240830$PER$$US-ROCHE-10000067955$ROCHE$$$$A$F$Y$$$20240830$$CN$US$US
242670671$24267067$1$I$20220810$20240814$20240830$20240830$EXP$$CH-ABBVIE-5885831$ABBVIE$$54$YR$$F$Y$$$20240829$$MD$CH$CH
242670682$24267068$2$F$20230101$20240911$20240830$20240912$PER$$US-AMGEN-USASP2024171608$AMGEN$$$$$M$Y$$$20240912$$CN$US$US
242670691$24267069$1$I$20240101$20240802$20240830$20240830$PER$$US-CIPLA LTD.-2024US05813$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242670701$24267070$1$I$$20240820$20240830$20240830$30DAY$$US-GSK-US2024103958$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240830$$CN$US$US
242670721$24267072$1$I$$20240529$20240830$20240830$PER$$US-CIPLA LTD.-2024US05823$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242670731$24267073$1$I$$20240827$20240830$20240830$PER$$US-ROCHE-10000068013$ROCHE$$$$E$F$Y$$$20240830$$CN$US$US
242670741$24267074$1$I$20240501$20240612$20240830$20240830$PER$$US-CIPLA LTD.-2024US05890$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242670751$24267075$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000069288$ROCHE$$$$A$F$Y$$$20240830$$MD$US$US
242670762$24267076$2$F$$20240912$20240830$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08035$LUPIN$$$$$$Y$$$20240927$$CN$US$US
242670771$24267077$1$I$20231109$20240823$20240830$20240830$PER$$US-009507513-2408USA010039$MERCK$$$$$F$Y$$$20240830$$HP$US$US
242670781$24267078$1$I$20240601$20240603$20240830$20240830$PER$$US-CIPLA LTD.-2024US05958$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242670791$24267079$1$I$$20240826$20240830$20240830$EXP$$CN-ROCHE-10000066944$ROCHE$Zhang J, Guan X, Zhao S, Ge X, Li H. Clinical Analysis of Autoimmune Encephalitis with Different Antineurotic Antibodies. Henan Medical Research. 2024-Jul;33 (13):2323-28. doi:10.3969/j.issn.1004-437X.2024.13.005.$21$YR$A$F$Y$$$20240830$$HP$CN$CN
242670802$24267080$2$F$20240522$20240925$20240830$20240926$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-030475$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240926$$CN$JP$JP
242670811$24267081$1$I$20240101$20240731$20240830$20240830$PER$$US-CIPLA LTD.-2024US06668$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242670821$24267082$1$I$$20240820$20240830$20240830$EXP$$DE-AUROBINDO-AUR-APL-2024-042411$AUROBINDO$Groth O, Roider G, Graw M.. Drug-induced deaths in renal insufficiency. Munich Medical Weekly. Advances in Medicine.. 2024;166 (13):48-51$80$YR$$F$Y$$$20240830$$HP$DE$DE
242670831$24267083$1$I$20200513$20240824$20240830$20240830$EXP$$BR-TAKEDA-BR202016753$TAKEDA$$15$YR$$M$Y$28$KG$20240830$$CN$BR$BR
242670841$24267084$1$I$20240620$20240710$20240830$20240830$PER$$US-CIPLA LTD.-2024US06795$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242670851$24267085$1$I$20240620$20240620$20240830$20240830$PER$$US-CIPLA LTD.-2024US06785$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242670861$24267086$1$I$$20240811$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08154$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242670871$24267087$1$I$20240101$20240625$20240830$20240830$PER$$US-CIPLA LTD.-2024US06900$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242670891$24267089$1$I$$20240821$20240830$20240830$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01729$NOVITIUM PHARMA$Ying Shang.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Haematology.2023;40:275-304$76$YR$E$F$Y$$$20240830$$HP$CN$CN
242670901$24267090$1$I$20240827$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171765$AMGEN$$$$$$Y$$$20240830$$CN$US$US
242670911$24267091$1$I$20240819$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172259$AMGEN$$$$$$Y$$$20240830$$HP$US$US
242670921$24267092$1$I$$20240627$20240830$20240830$PER$$US-CIPLA LTD.-2024US06927$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242670932$24267093$2$F$$20240902$20240830$20240911$EXP$$JP-CELLTRION INC.-2024JP020641$CELLTRION$Shimizu A, Tsuboi N, Haruhara K, Shirai I, Ogawa K, Miura A, et al.. CASE REPORT Active flare of IgA nephropathy during long - term therapy with anti- tumor necrosis factor - a antibody drugs for Crohn^s disease: three case reports and literature review.. CEN Case Reports. 2024;13(4):249-257$$$$$Y$$$20240911$$MD$JP$JP
242670951$24267095$1$I$20240701$20240702$20240830$20240830$PER$$US-CIPLA LTD.-2024US07249$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242670961$24267096$1$I$20240827$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171570$AMGEN$$76$YR$E$F$Y$$$20240830$$CN$US$US
242670971$24267097$1$I$$20240823$20240830$20240830$EXP$$US-AMGEN-USASL2024165545$AMGEN$$69$YR$E$M$Y$$$20240830$$MD$US$US
242670981$24267098$1$I$$20240829$20240830$20240830$PER$$NVSC2024US174896$NOVARTIS$$$$$F$Y$$$20240830$$HP$US$US
242670991$24267099$1$I$$20240822$20240830$20240830$PER$$US-TAKEDA-2024TUS085732$TAKEDA$$$$$M$Y$$$20240830$$CN$US$US
242671001$24267100$1$I$20230101$20231012$20240830$20240830$PER$$US-CIPLA LTD.-2023US05784$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242671011$24267101$1$I$$20240819$20240830$20240830$EXP$$CA-CELLTRION INC.-2021CA017461$CELLTRION$$$$$$Y$$$20240830$$MD$CA$CA
242671022$24267102$2$F$20240101$20240830$20240830$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-017082$UNITED THERAPEUTICS$$$$$F$Y$103.86$KG$20240906$$$US$US
242671031$24267103$1$I$20240101$20240823$20240830$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-014028$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240830$$$US$US
242671041$24267104$1$I$$20240826$20240830$20240830$PER$$US-AstraZeneca-2024A194646$ASTRAZENECA$$$$$F$Y$$$20240830$$PH$US$
242671051$24267105$1$I$$20240823$20240830$20240830$EXP$$JP-AstraZeneca-2024A194708$ASTRAZENECA$$$$E$F$Y$$$20240830$$MD$JP$
242671061$24267106$1$I$$20240827$20240830$20240830$EXP$$DE-AstraZeneca-2024A195646$ASTRAZENECA$$$$$F$Y$$$20240830$$MD$DE$
242671071$24267107$1$I$20240101$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A193500$ASTRAZENECA$$29065$DY$$F$Y$$$20240830$$CN$US$
242671081$24267108$1$I$$20240822$20240830$20240830$EXP$$ZA-AstraZeneca-2024A194296$ASTRAZENECA$$74$YR$$F$Y$$$20240830$$CN$ZA$
242671091$24267109$1$I$20240801$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018289$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240830$$CN$US$US
242671101$24267110$1$I$20240823$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018770$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240830$$CN$US$US
242671111$24267111$1$I$20240701$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018009$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240830$$CN$US$US
242671121$24267112$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017936$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240830$$CN$US$US
242671131$24267113$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018390$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240830$$CN$US$US
242671142$24267114$2$F$$20240923$20240830$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202408018789$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240926$$CN$US$US
242671151$24267115$1$I$$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018269$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240830$$CN$US$US
242671161$24267116$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018817$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240830$$CN$US$US
242671171$24267117$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017610$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240830$$CN$US$US
242671181$24267118$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A194139$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242671191$24267119$1$I$20240827$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018344$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240830$$CN$US$US
242671201$24267120$1$I$$20240827$20240830$20240830$EXP$$US-JNJFOC-20240870498$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240830$$HP$US$US
242671211$24267121$1$I$20240730$20240821$20240830$20240830$PER$$US-AstraZeneca-2024A177782$ASTRAZENECA$$75$YR$$F$Y$$$20240830$$CN$US$
242671221$24267122$1$I$$20240823$20240830$20240830$PER$$US-AstraZeneca-2024A193778$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242671231$24267123$1$I$20240401$20240822$20240830$20240830$EXP$$CA-ROCHE-10000061837$ROCHE$$70$YR$E$F$Y$$$20240830$$CN$CA$CA
242671241$24267124$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000068859$ROCHE$$$$E$F$Y$$$20240830$$CN$US$US
242671251$24267125$1$I$$20240813$20240830$20240830$PER$$GB-LUPIN PHARMACEUTICALS INC.-2024-08153$LUPIN$$$$$$Y$$$20240830$$CN$GB$US
242671261$24267126$1$I$20240824$20240826$20240830$20240830$EXP$$US-GSK-US2024105942$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$US$US
242671281$24267128$1$I$20240825$20240828$20240830$20240830$PER$$US-BAUSCH-BL-2024-013020$BAUSCH AND LOMB$$$$$M$Y$$$20240830$$CN$US$US
242671291$24267129$1$I$$20240828$20240830$20240830$EXP$$CA-BAUSCH-BL-2024-013015$BAUSCH AND LOMB$$$$$M$Y$$$20240830$$CN$CA$CA
242671301$24267130$1$I$20230901$20230929$20240830$20240830$PER$$US-CIPLA LTD.-2023US05802$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242671311$24267131$1$I$$20240828$20240830$20240830$PER$$US-BAUSCH-BL-2024-013045$BAUSCH AND LOMB$$$$$F$Y$$$20240830$$CN$US$US
242671322$24267132$2$F$$20240827$20240830$20240903$PER$$US-BAUSCH-BL-2024-013017$BAUSCH AND LOMB$$$$$F$Y$$$20240903$$CN$US$US
242671331$24267133$1$I$$20240828$20240830$20240830$PER$$US-BAUSCH-BL-2024-013061$BAUSCH AND LOMB$$$$$M$Y$$$20240830$$CN$US$US
242671341$24267134$1$I$20240715$20240819$20240830$20240830$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08040$HIKMA$$54$YR$$F$Y$56.69$KG$20240830$$CN$US$US
242671351$24267135$1$I$$20240826$20240830$20240830$EXP$$AU-ROCHE-10000066547$ROCHE$Hii R, Bennett A. Acute haemostasis with bevacizumab for upper gastrointestinal bleeding secondary to lymphoma. Internal Medicine Journal. 2024-Aug;54 (8):1418-9. doi:10.1111/imj.16481.$48$YR$A$F$Y$$$20240830$$HP$AU$AU
242671361$24267136$1$I$$20231027$20240830$20240830$PER$$US-CIPLA LTD.-2023US06878$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242671371$24267137$1$I$$20240819$20240830$20240830$EXP$$US-FARMAPROD-202408-2985$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240830$$CN$US$US
242671382$24267138$2$F$$20240919$20240830$20240925$EXP$$JP-ASTELLAS-2024-AER-001240$ASTELLAS$$7$DEC$E$$Y$$$20240925$$MD$JP$JP
242671391$24267139$1$I$$20240712$20240830$20240830$PER$$US-CIPLA LTD.-2024US04364$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242671401$24267140$1$I$20240101$20240529$20240830$20240830$PER$$US-CIPLA LTD.-2024US05770$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242671411$24267141$1$I$$20240529$20240830$20240830$PER$$US-CIPLA LTD.-2024US05818$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242671421$24267142$1$I$$20240819$20240830$20240830$EXP$$US-FARMAPROD-202408-2992$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240830$$CN$US$US
242671431$24267143$1$I$$20240827$20240830$20240830$EXP$$US-TAKEDA-2021TUS006973$TAKEDA$$$$$M$Y$$$20240830$$CN$US$US
242671441$24267144$1$I$$20240808$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08077$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242671451$24267145$1$I$$20230130$20240830$20240830$EXP$$SG-UCBSA-2024040362$UCB$Wong SW, Pang RY. Bradycardia in a Woman Presenting with Altered Behaviour. Acta Cardiologica Sinica. 2023;39(1):177-180$29$YR$$F$Y$$$20240830$$MD$SG$SG
242671461$24267146$1$I$$20240824$20240830$20240830$EXP$$US-GSK-US2024AMR106347$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$MD$US$US
242671471$24267147$1$I$$20240820$20240830$20240830$30DAY$$US-GSK-US2024104008$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242671481$24267148$1$I$$20240823$20240830$20240830$EXP$$AR-AMGEN-ARGSP2024171869$AMGEN$$58$YR$A$F$Y$$$20240830$$CN$AR$AR
242671491$24267149$1$I$$20240821$20240830$20240830$EXP$$US-NOVITIUMPHARMA-2024USNVP01710$NOVITIUM PHARMA$Goyal A.Myasthenia Crisis Complicated with Takotsubo Cardiomyopathy.US-Cardiology.2024;18:7-8$77$YR$E$F$Y$$$20240830$$HP$US$US
242671501$24267150$1$I$20211001$20240826$20240830$20240830$EXP$$CA-TAKEDA-2021TUS061593$TAKEDA$$71$YR$$F$Y$$$20240830$$CN$CA$CA
242671511$24267151$1$I$20240701$20240820$20240830$20240830$PER$$US-TAKEDA-2024TUS083970$TAKEDA$$27$YR$$F$Y$$$20240830$$CN$US$US
242671522$24267152$2$F$$20240923$20240830$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137833$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240924$$CN$US$US
242671531$24267153$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137914$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240830$$HP$US$US
242671541$24267154$1$I$$20240808$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08075$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242671551$24267155$1$I$$20240826$20240830$20240830$EXP$$CA-ABBVIE-5898028$ABBVIE$$$$A$F$Y$$$20240830$$CN$CA$CA
242671562$24267156$2$F$20240809$20240918$20240830$20240920$EXP$$US-GILEAD-2024-0685618$GILEAD$$17$YR$T$F$Y$72.6$KG$20240920$$HP$US$US
242671572$24267157$2$F$20230801$20240919$20240830$20240927$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001718$BLUEPRINT MEDICINES$$84$YR$E$F$Y$$$20240927$$CN$US$US
242671581$24267158$1$I$$20240829$20240830$20240830$PER$$US-ROCHE-10000070167$ROCHE$$$$A$F$Y$$$20240830$$CN$US$US
242671591$24267159$1$I$$20240829$20240830$20240830$PER$$US-ROCHE-10000070135$ROCHE$$$$A$F$Y$$$20240830$$CN$US$US
242671601$24267160$1$I$20240801$20240826$20240830$20240830$PER$$US-ABBVIE-5896498$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242671611$24267161$1$I$$20240830$20240830$20240830$PER$$NVSC2024US175131$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
242671621$24267162$1$I$20240627$20240826$20240830$20240830$EXP$FR-AFSSAPS-MP2024001318$FR-AMGEN-FRASP2024170149$AMGEN$$77$YR$E$M$Y$62$KG$20240830$$MD$FR$FR
242671631$24267163$1$I$20240828$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172455$AMGEN$$70$YR$E$F$Y$$$20240830$$CN$US$US
242671641$24267164$1$I$$20240829$20240830$20240830$PER$$US-ROCHE-10000070029$ROCHE$$57$YR$A$M$Y$$$20240830$$CN$US$US
242671651$24267165$1$I$20240801$20240826$20240830$20240830$EXP$$FR-ABBVIE-5900225$ABBVIE$$$$$F$Y$$$20240830$$MD$FR$FR
242671671$24267167$1$I$$20240820$20240830$20240830$EXP$$DE-AUROBINDO-AUR-APL-2024-042186$AUROBINDO$$$$E$F$Y$$$20240830$$CN$DE$DE
242671681$24267168$1$I$$20240809$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08067$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242671691$24267169$1$I$$20240828$20240830$20240830$EXP$$JP-GSK-JP2024JPN107341$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$JP$JP
242671701$24267170$1$I$$20240820$20240830$20240830$30DAY$$US-GSK-US2024103960$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242671711$24267171$1$I$20240712$20240712$20240830$20240830$PER$$US-CIPLA LTD.-2024US07707$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242671721$24267172$1$I$20240101$20240709$20240830$20240830$PER$$US-CIPLA LTD.-2024US07520$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242671731$24267173$1$I$20060701$20240827$20240830$20240830$EXP$$SK-SANDOZ INC.-SDZ2024SK075438$SANDOZ$$29$YR$$M$Y$$$20240830$$HP$SK$SK
242671741$24267174$1$I$$20240826$20240830$20240830$EXP$$CA-TAKEDA-2024TUS086403$TAKEDA$$$$$F$Y$$$20240830$$CN$CA$CA
242671751$24267175$1$I$$20240821$20240830$20240830$EXP$$CA-TEVA-VS-3235815$TEVA$$68$YR$$F$Y$$$20240830$$HP$CA$CA
242671762$24267176$2$F$20240826$20240911$20240830$20240917$PER$$US-AstraZeneca-2024A194842$ASTRAZENECA$$27736$DY$$F$Y$$$20240917$$CN$US$
242671772$24267177$2$F$$20240826$20240830$20240830$EXP$$US-ROCHE-10000068209$ROCHE$$$$$M$Y$$$20240830$$CN$US$US
242671781$24267178$1$I$$20240821$20240830$20240830$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01731$NOVITIUM PHARMA$Ying Shang.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Haematology.2023;40:275-304$71$YR$E$F$Y$$$20240830$$HP$CN$CN
242671791$24267179$1$I$$20240809$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08071$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242671801$24267180$1$I$$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A195322$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242671811$24267181$1$I$20240718$20240827$20240830$20240830$EXP$$ZA-AstraZeneca-2024A195729$ASTRAZENECA$$73$YR$$M$Y$$$20240830$$CN$ZA$
242671821$24267182$1$I$$20240819$20240830$20240830$PER$$US-AstraZeneca-2024A192475$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242671831$24267183$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000069103$ROCHE$$$$$$Y$$$20240830$$MD$US$US
242671841$24267184$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000069804$ROCHE$$$$$F$Y$$$20240830$$HP$US$US
242671851$24267185$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137616$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$58.06$KG$20240830$$CN$US$US
242671862$24267186$2$F$20240821$20240917$20240830$20240923$EXP$$US-JNJFOC-20240865824$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240924$$MD$US$US
242671872$24267187$2$F$$20240925$20240830$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137488$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$72.12$KG$20240927$$CN$US$US
242671881$24267188$1$I$$20240820$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132793$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240830$$CN$US$US
242671892$24267189$2$F$$20240909$20240830$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138093$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240911$$HP$US$US
242671911$24267191$1$I$$20240822$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135282$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240830$$CN$US$US
242671921$24267192$1$I$$20240820$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132796$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240830$$CN$US$US
242671931$24267193$1$I$20240818$20240819$20240830$20240830$EXP$$US-Accord-443648$ACCORD$$34$YR$A$F$Y$$$20240830$$HP$US$US
242671941$24267194$1$I$20240824$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024172394$AMGEN$$75$YR$E$F$Y$$$20240830$$CN$US$US
242671951$24267195$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000069669$ROCHE$$$$$$Y$$$20240830$$CN$US$US
242671961$24267196$1$I$$20240816$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004786$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242671971$24267197$1$I$20240216$20240820$20240830$20240830$EXP$$JP-Merz Pharmaceuticals GmbH-24-02187$MERZ$$81$YR$$M$Y$$$20240830$$MD$JP$JP
242671981$24267198$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000070100$ROCHE$$$$$F$Y$$$20240830$$HP$US$US
242671991$24267199$1$I$$20240820$20240830$20240830$EXP$$BR-TAKEDA-2024TUS087221$TAKEDA$$$$$$Y$$$20240830$$MD$BR$BR
242672001$24267200$1$I$$20240820$20240830$20240830$PER$$US-009507513-2408USA007398$MERCK$$$$$F$Y$$$20240830$$CN$US$US
242672011$24267201$1$I$20240827$20240829$20240830$20240830$EXP$GB-MHRA-MED-202408281601191460-VRTND$GB-JNJFOC-20240878285$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240830$$HP$GB$GB
242672041$24267204$1$I$$20240823$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408015319$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240830$$CN$US$US
242672051$24267205$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018995$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240830$$CN$US$US
242672061$24267206$1$I$$20240829$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018855$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240830$$CN$US$US
242672071$24267207$1$I$$20240822$20240830$20240830$EXP$$GB-AMGEN-GBRSP2024169754$AMGEN$$$$$F$Y$$$20240830$$CN$GB$GB
242672081$24267208$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000068863$ROCHE$$$$A$M$Y$$$20240830$$MD$US$US
242672091$24267209$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018239$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240830$$CN$US$US
242672103$24267210$3$F$20240822$20240910$20240830$20240919$PER$$US-ROCHE-10000065187$ROCHE$$$$$M$Y$$$20240919$$CN$US$US
242672121$24267212$1$I$$20240822$20240830$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-137685$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240830$$PH$JP$JP
242672131$24267213$1$I$20240801$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137216$BRISTOL MYERS SQUIBB$$53$YR$A$$Y$$$20240830$$PH$US$US
242672141$24267214$1$I$$20240829$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138123$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240830$$CN$US$US
242672152$24267215$2$F$$20240826$20240830$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136794$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240903$$MD$US$US
242672161$24267216$1$I$20240807$20240820$20240830$20240830$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00747$PARATEK PHARMACEUTICALS$$72$YR$$M$Y$70$KG$20240830$$HP$CN$CN
242672181$24267218$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000068949$ROCHE$$$$E$F$Y$$$20240830$$CN$US$US
242672192$24267219$2$F$$20240827$20240830$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137824$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240904$$HP$US$US
242672201$24267220$1$I$$20240827$20240830$20240830$EXP$$IE-MYLANLABS-2024M1079212$MYLAN$$54$YR$$F$Y$$$20240830$$CN$IE$IE
242672212$24267221$2$F$$20240920$20240830$20240925$EXP$$JP-GILEAD-2024-0685412$GILEAD$Migita K, Soyama A, Hara T, Matsushima H, Yamashita M, Imamura H, et al.. O1-6 A case of semi-emergent ABO-incompatible living donor liver transplant in a patient with ACLF who registered for the waiting list for liver transplant from a brain-dead donor. The 50th Meeting of the Japan Acute Liver Failure Society. 2024;unk:44$4$DEC$A$F$Y$$$20240925$$MD$JP$JP
242672221$24267222$1$I$$20240821$20240830$20240830$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01733$NOVITIUM PHARMA$Ying Shang.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Haematology.2023;40:275-304$69$YR$E$F$Y$$$20240830$$HP$CN$CN
242672231$24267223$1$I$20240101$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171946$AMGEN$$$$$$Y$$$20240830$$CN$US$US
242672244$24267224$4$F$20240803$20240916$20240830$20240926$EXP$$IT-AUROBINDO-AUR-APL-2024-041319$AUROBINDO$$80$YR$$F$Y$$$20240926$$MD$IT$IT
242672251$24267225$1$I$20240812$20240823$20240830$20240830$PER$$US-ROCHE-10000065824$ROCHE$$68$YR$E$F$Y$$$20240830$$CN$US$US
242672261$24267226$1$I$20240829$20240829$20240830$20240830$PER$$NVSC2024US174943$NOVARTIS$$65$YR$$$Y$$$20240830$$MD$US$US
242672271$24267227$1$I$20240820$20240821$20240830$20240830$EXP$$PK-ROCHE-10000063077$ROCHE$$29$YR$A$F$Y$$$20240830$$CN$PK$PK
242672281$24267228$1$I$$20240828$20240830$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA076183$SANDOZ$$53$YR$$F$Y$$$20240830$$CN$CA$CA
242672292$24267229$2$F$$20240912$20240830$20240924$EXP$$DE-Accord-443587$ACCORD$Nagele H, Rosenkranz M, Nagele MP. Hyponatremia-Induced Epileptic Seizure Provoked by Levetiracetam and Pain Medication Intake in a Patient with Central Diabetes Insipidus. Case reports in neurology. 2024;16(1):204-7.$67$YR$E$M$Y$$$20240924$$HP$DE$DE
242672301$24267230$1$I$20240822$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136818$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240830$$HP$US$US
242672321$24267232$1$I$$20240820$20240830$20240830$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-133915$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240830$$MD$AU$AU
242672331$24267233$1$I$20240818$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137102$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240830$$HP$US$US
242672341$24267234$1$I$$20240821$20240830$20240830$EXP$$US-JNJFOC-20240856463$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$HP$US$US
242672351$24267235$1$I$20240501$20240827$20240830$20240830$EXP$$IL-ABBVIE-5898914$ABBVIE$$74$YR$$F$Y$$$20240830$$CN$IL$IL
242672361$24267236$1$I$20240814$20240819$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004881$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240830$$CN$US$US
242672371$24267237$1$I$$20240821$20240830$20240830$EXP$$US-NOVITIUMPHARMA-2024USNVP01711$NOVITIUM PHARMA$VENUS SHARMA.SYMPTOMATIC PRESENTATION OF MYCOBACTERIUM XENOPI IN A PATIENT WITH SCHAMBERG DISEASE.CHEST 2023.11-OCT-2023;164(4):1411A$20$YR$A$F$Y$$$20240830$$HP$US$US
242672381$24267238$1$I$20240803$20240816$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004739$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240830$$CN$US$US
242672391$24267239$1$I$20240812$20240821$20240830$20240830$EXP$$CA-ROCHE-10000064205$ROCHE$$64$YR$A$F$Y$$$20240830$$CN$CA$CA
242672401$24267240$1$I$$20240827$20240830$20240830$PER$$US-ROCHE-10000068190$ROCHE$$61$YR$A$F$Y$$$20240830$$CN$US$US
242672411$24267241$1$I$$20240827$20240830$20240830$PER$$US-ROCHE-10000068120$ROCHE$$$$A$M$Y$$$20240830$$CN$US$US
242672431$24267243$1$I$20240101$20240826$20240830$20240830$EXP$$JP-JNJFOC-20240879061$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240830$$MD$JP$JP
242672441$24267244$1$I$20240822$20240826$20240830$20240830$EXP$$CO-ABBVIE-5898040$ABBVIE$$62$YR$$F$Y$60$KG$20240830$$CN$CO$CO
242672451$24267245$1$I$$20240807$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004493$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242672461$24267246$1$I$$20240821$20240830$20240830$EXP$$US-SCIEGENP-2024SCLIT00357$SCIEGEN$Lee IJ, et al.MULTIPLE ORGAN DYSFUNCTION SYNDROME AND DISSEMINATED INTRAVASCULAR COAGULATION CAUSING EXTENSIVE MULTIPLE AMALRIC TRIANGULAR CHOROIDAL INFARCTIONS.Retinal Cases and Brief Reports.mar-2024;18 (2):251-4$49$YR$A$F$Y$$$20240830$$MD$US$US
242672471$24267247$1$I$20240802$20240815$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004759$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240830$$CN$US$US
242672481$24267248$1$I$$20240821$20240830$20240830$EXP$$JP-SCIEGENP-2024SCLIT00359$SCIEGEN$Morisaki Y, et al..Intraoperative monitoring of trigeminal neuralgia: a technical note.Acta Neurochirurgica.30-MAY-2024;166 (1):1-5$8$DEC$E$F$Y$$$20240830$$HP$JP$JP
242672491$24267249$1$I$$20240821$20240830$20240830$EXP$$US-SCIEGENP-2024SCLIT00358$SCIEGEN$Srivastava A, et al..Cardiogenic Shock: An Unusual Presentation Of Hydralazine-induced Anca-associated Vasculitis. Journal of Cardiac Failure.JAN-2024;30 (1):149-50$68$YR$A$F$Y$$$20240830$$HP$US$US
242672502$24267250$2$F$20240801$20240916$20240830$20240925$EXP$$CA-CELLTRION INC.-2024CA019661$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
242672511$24267251$1$I$$20240823$20240830$20240830$EXP$$CA-ROCHE-10000064885$ROCHE$$$$$F$Y$$$20240830$$HP$CA$CA
242672521$24267252$1$I$$20240828$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-086195-2024$RECKITT BENCKISER$$$$$F$Y$$$20240830$$CN$US$US
242672531$24267253$1$I$$20240821$20240830$20240830$EXP$$TR-SCIEGENP-2024SCLIT00360$SCIEGEN$Ceylan ME, et al..A Bell^s Palsy Case Probably Related to Sertraline Use.Psychopharmacology Bulletin.APR-2024;54(2):51-2$53$YR$A$M$Y$$$20240830$$HP$TR$TR
242672541$24267254$1$I$$20240819$20240830$20240830$EXP$$JP-ROCHE-10000066405$ROCHE$Yamazaki M, Yamazaki M, Kaneda T, Yatabe M, Et al.. An investigation into cases of prolongation and reactivation of novel coronavirus (COVID-19) infection. The 39th Annual Meeting of Japanese Society for Infection Prevention and Control. 2024;314:$$$$$Y$$$20240830$$MD$JP$JP
242672561$24267256$1$I$20240805$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172802$AMGEN$$77$YR$E$M$Y$$$20240830$$CN$US$US
242672571$24267257$1$I$$20240821$20240830$20240830$30DAY$$US-GSK-US2024AMR105153$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242672581$24267258$1$I$$20240815$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464858$RANBAXY$$51$YR$$F$Y$$$20240830$$HP$GB$GB
242672591$24267259$1$I$$20240815$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464670$RANBAXY$$81$YR$$F$Y$65$KG$20240830$$PH$GB$GB
242672602$24267260$2$F$$20240912$20240830$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464069$RANBAXY$$$$A$M$Y$$$20240927$$CN$US$US
242672612$24267261$2$F$$20240909$20240830$20240917$PER$$US-ABBVIE-5891061$ABBVIE$$$$$$Y$$$20240917$$MD$US$US
242672621$24267262$1$I$20240806$20240821$20240830$20240830$EXP$$AU-BEH-2024177881$CSL BEHRING$$82$YR$E$M$Y$$$20240830$$CN$AU$AU
242672631$24267263$1$I$20181012$20240815$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464939$RANBAXY$$53$YR$$F$Y$83$KG$20240830$$CN$GB$GB
242672641$24267264$1$I$20231207$20240815$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464868$RANBAXY$$36$YR$$M$Y$80$KG$20240830$$CN$GB$GB
242672651$24267265$1$I$$20240814$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004714$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242672661$24267266$1$I$$20240826$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135906$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$64$KG$20240830$$PH$US$US
242672672$24267267$2$F$$20240830$20240830$20240902$PER$$US-JNJFOC-20240880227$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242672681$24267268$1$I$20231225$20240815$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464820$RANBAXY$$79$YR$$F$Y$65$KG$20240830$$MD$GB$GB
242672691$24267269$1$I$$20240816$20240830$20240830$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465069$RANBAXY$Tully S, Domit ND, Carr T. Desensitization to IVIG in a patient with a complex allergy history. Ann Allergy Asthma Immunol. 2023;131(Suppl)(5):S119(M072)$28$YR$$F$Y$$$20240830$$HP$US$US
242672701$24267270$1$I$$20240815$20240830$20240830$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464739$RANBAXY$Klimaszyk D, Klimaszyk S.. Fentanyl and other opioid poisoning. Medycyna Praktyczna. 2024;(7-8):81-85, 110$60$YR$$M$Y$$$20240830$$HP$PL$PL
242672711$24267271$1$I$$20240816$20240830$20240830$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464833$RANBAXY$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, et al. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. J Clin Oncol. 2024;42 (Suppl.)(16):e23269$$$E$$Y$$$20240830$$HP$US$US
242672731$24267273$1$I$20240603$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465033$RANBAXY$$22$YR$$F$Y$114.5$KG$20240830$$PH$FR$FR
242672742$24267274$2$F$$20240822$20240830$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464966$RANBAXY$Bulleit C, Rho J, Fleisch SB, Radhakrishnan NS. Treating Malignant Catatonia With Liquid Amantadine:A Case Report and Literature Review. [Review].. J Psychiatr Pract. 2024;JUL; 30 (4):308-310$51$YR$$F$Y$$$20240906$$MD$US$US
242672751$24267275$1$I$20240519$20240816$20240830$20240830$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465213$RANBAXY$$76$YR$$F$Y$44.2$KG$20240830$$MD$ES$ES
242672761$24267276$1$I$$20240816$20240830$20240830$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465246$RANBAXY$Backhouse B, Scully T, Rajakariar K, Jin D, Chandrasekhar J, Freeman M. Coronary artery vasospasm in patients with eosinophilia. JACC Case Rep. 2023;19:1-7$53$YR$$M$Y$$$20240830$$HP$AU$AU
242672771$24267277$1$I$20240603$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465051$RANBAXY$$74$YR$$M$Y$90$KG$20240830$$PH$FR$FR
242672782$24267278$2$F$$20240826$20240830$20240909$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465071$RANBAXY$Sopena B, Araujo O, Freire M, Barrera-Lopez L, Hernandez-Rodriguez J. Efficacy of canakinumab in a patient with adult-onset glucocorticoid-resistant periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome. Mod Rheumatol Case Rep. 2023;7 (1):276-279$42$YR$$F$Y$65$KG$20240909$$HP$ES$ES
242672791$24267279$1$I$20230731$20240816$20240830$20240830$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464941$RANBAXY$$59$YR$$F$Y$58$KG$20240830$$MD$IT$IT
242672801$24267280$1$I$20240204$20240816$20240830$20240830$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465173$RANBAXY$$80$YR$$M$Y$$$20240830$$HP$IT$IT
242672811$24267281$1$I$20240421$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464990$RANBAXY$$14$YR$$M$Y$48$KG$20240830$$CN$FR$FR
242672821$24267282$1$I$20240229$20240816$20240830$20240830$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465119$RANBAXY$$71$YR$$M$Y$59.5$KG$20240830$$MD$ES$ES
242672831$24267283$1$I$20240414$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465058$RANBAXY$$63$YR$$M$Y$100$KG$20240830$$MD$FR$FR
242672841$24267284$1$I$$20240815$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464841$RANBAXY$$66$YR$$F$Y$$$20240830$$PH$GB$GB
242672851$24267285$1$I$$20240816$20240830$20240830$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465283$RANBAXY$Nguyen JK, Holmes Z, Kelly RI. Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum. Australas J Dermatol. 2023;64(2):221-228$76$YR$$M$Y$$$20240830$$MD$AU$AU
242672861$24267286$1$I$20240527$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465125$RANBAXY$$15$YR$$F$Y$48$KG$20240830$$MD$FR$FR
242672871$24267287$1$I$20240610$20240816$20240830$20240830$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465182$RANBAXY$$66$YR$$F$Y$$$20240830$$MD$ES$ES
242672881$24267288$1$I$$20240816$20240830$20240830$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464344$RANBAXY$$$$$F$Y$$$20240830$$CN$US$US
242672891$24267289$1$I$20240815$20240816$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465312$RANBAXY$$60$YR$$F$Y$$$20240830$$PH$GB$GB
242672901$24267290$1$I$20240505$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465543$RANBAXY$$63$YR$$F$Y$50$KG$20240830$$PH$FR$FR
242672911$24267291$1$I$$20240816$20240830$20240830$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465243$RANBAXY$Nguyen JK, Holmes Z, Kelly RI. Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum. Australas J Dermatol. 2023;64(2):221-228$31$YR$$F$Y$$$20240830$$MD$AU$AU
242672921$24267292$1$I$20231201$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464877$RANBAXY$$24$YR$$M$Y$$$20240830$$MD$FR$FR
242672931$24267293$1$I$$20240816$20240830$20240830$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465275$RANBAXY$Nguyen JK, Holmes Z, Kelly RI. Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum. Australas J Dermatol. 2023;64(2):221-228$65$YR$$F$Y$$$20240830$$MD$AU$AU
242672941$24267294$1$I$$20240816$20240830$20240830$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465270$RANBAXY$Backhouse B, Scully T, Rajakariar K, Jin D, Chandrasekhar J, Freeman M. Coronary artery vasospasm in patients with eosinophilia. JACC Case Rep. 2023;19:1-7$59$YR$$F$Y$$$20240830$$HP$AU$AU
242672951$24267295$1$I$$20240816$20240830$20240830$EXP$$MA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465039$RANBAXY$Chamsi FZ, El Ammouri A. Resistant schizophrenia due to underdiagnosed epilepsy (about a case). JNeurol Sci. 2023;455 (Suppl.):no pagination$20$YR$$M$Y$$$20240830$$HP$MA$MA
242672962$24267296$2$F$$20240826$20240830$20240909$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465007$RANBAXY$Sladowska-Zwolinska A, Zwolinski J. Peripartum care of pregnancy complicated by sjogren syndrome. Eur J Obstet Gynecol Reprod Biol. 2024;Feb;293:P129$32$YR$$F$Y$$$20240909$$HP$PL$PL
242672971$24267297$1$I$20240522$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465136$RANBAXY$$50$YR$$F$Y$49.5$KG$20240830$$PH$FR$FR
242672981$24267298$1$I$$20240816$20240830$20240830$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452420$RANBAXY$Mocikova H. Treatment of peripheral T-cell lymphoma with hemophagocytic lymphohistiocytosis. kaczynski/klinicka praxis. 2024;20 (S6):1-36$41$YR$$F$Y$$$20240830$$HP$CZ$CZ
242672991$24267299$1$I$20240201$20240816$20240830$20240830$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464968$RANBAXY$$89$YR$$F$Y$$$20240830$$MD$IT$IT
242673001$24267300$1$I$20240612$20240816$20240830$20240830$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464835$RANBAXY$$39$YR$$F$Y$$$20240830$$MD$DE$DE
242673011$24267301$1$I$20200222$20240816$20240830$20240830$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464896$RANBAXY$$80$YR$$M$Y$80$KG$20240830$$MD$PL$PL
242673021$24267302$1$I$20221125$20240816$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465023$RANBAXY$$32$YR$$F$Y$72$KG$20240830$$MD$GB$GB
242673031$24267303$1$I$$20240816$20240830$20240830$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465251$RANBAXY$Nguyen JK, Holmes Z, Kelly RI. Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum. Australas J Dermatol. 2023;64(2):221-228$35$YR$$F$Y$$$20240830$$MD$AU$AU
242673041$24267304$1$I$20240414$20240816$20240830$20240830$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464925$RANBAXY$$63$YR$$F$Y$$$20240830$$MD$ES$ES
242673051$24267305$1$I$20240423$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465532$RANBAXY$$68$YR$$F$Y$$$20240830$$PH$FR$FR
242673061$24267306$1$I$$20240816$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464888$RANBAXY$Noushad MA. VZV infection causing multiple cranial neuropathies. J Neurol Sci. 2023;455 (Suppl.):121339$44$YR$$F$Y$$$20240830$$HP$GB$GB
242673071$24267307$1$I$$20240816$20240830$20240830$EXP$$SG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464917$RANBAXY$Huang W, Tan MG, Tan YE. Cerebral mucormycosis secondary to traumatic implantation. Pathology. 2024;56 (Suppl.):S33$60$YR$$$Y$$$20240830$$HP$SG$SG
242673081$24267308$1$I$$20240816$20240830$20240830$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465263$RANBAXY$Nguyen JK, Holmes Z, Kelly RI. Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum. Australas J Dermatol. 2023;64(2):221-228$74$YR$$F$Y$$$20240830$$MD$AU$AU
242673091$24267309$1$I$$20240816$20240830$20240830$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465269$RANBAXY$Nguyen JK, Holmes Z, Kelly RI. Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum. Australas J Dermatol. 2023;64(2):221-228$64$YR$$F$Y$$$20240830$$MD$AU$AU
242673101$24267310$1$I$$20240816$20240830$20240830$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465010$RANBAXY$Ling G, Wenyi B, Jian Q. Severe allergic reaction and acute respiratory failure due to dyclonine hydrochloride mucilage. ADRJ. 2021;Feb; 23 (2):108-109$87$YR$$M$Y$$$20240830$$HP$CN$CN
242673111$24267311$1$I$20240424$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464882$RANBAXY$$53$YR$$F$Y$72$KG$20240830$$MD$FR$FR
242673121$24267312$1$I$20210906$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464895$RANBAXY$$52$YR$$F$Y$80$KG$20240830$$MD$FR$FR
242673131$24267313$1$I$$20240816$20240830$20240830$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465001$RANBAXY$Sasani E, Khodavaisy S, Salehi M, Bagheri-Josheghani S, Abdorahimi M, Manshadi SAD, et al. Concomitant tuberculosis and aspergillosis in patients with COVID-19: a case report. Iranian JMicrobio. 2024;16 (3):428-433$51$YR$$F$Y$$$20240830$$HP$IR$IR
242673141$24267314$1$I$20240409$20240816$20240830$20240830$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464994$RANBAXY$$55$YR$$M$Y$$$20240830$$MD$ES$ES
242673152$24267315$2$F$$20240829$20240830$20240912$EXP$$MA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465083$RANBAXY$Belharti K, El Yamani L, Benkaraache M, Dikhaye S, Zizi N. Lenalidomide-induced drug hypersensitvity syndrome: a case report. Rev Fr Allergol. 2024;64 (Suppl.):1-4$58$YR$$M$Y$$$20240912$$HP$MA$MA
242673161$24267316$1$I$$20240826$20240830$20240830$EXP$$US-ARGENX-2024-ARGX-US007090$ARGENX BVBA$$$$$$Y$$$20240830$$CN$US$US
242673171$24267317$1$I$20200224$20240816$20240830$20240830$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464901$RANBAXY$$19$YR$$M$Y$67$KG$20240830$$MD$PL$PL
242673181$24267318$1$I$$20240816$20240830$20240830$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464983$RANBAXY$Acar IH, Guvenc B. Richter Syndrome Transformation Under Venetoclax Treatment: A Case Report Of A 51-Year-Old Female With CLL. Hematol Transfus Cell Ther. 2023;45 (Suppl.):S33-S34$51$YR$$F$Y$$$20240830$$HP$TR$TR
242673191$24267319$1$I$20050303$20240816$20240830$20240830$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465009$RANBAXY$$21$YR$$F$Y$50$KG$20240830$$MD$ES$ES
242673201$24267320$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA250441$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240830$$MD$US$US
242673211$24267321$1$I$20240723$20240827$20240830$20240830$PER$$US-SA-2024SA251683$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240830$$CN$US$US
242673223$24267322$3$F$20240815$20240831$20240830$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US076516$SANDOZ$$21$YR$$F$Y$$$20240903$$HP$US$US
242673241$24267324$1$I$20240722$20240812$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004642$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240830$$CN$US$US
242673251$24267325$1$I$$20240828$20240830$20240830$EXP$US-MLMSERVICE-20240815-PI162002-00031-2$US-SANDOZ INC.-SDZ2024US076016$SANDOZ$$84$YR$$M$Y$$$20240830$$MD$US$US
242673261$24267326$1$I$20240808$20240826$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042946$AUROBINDO$$20$YR$$M$Y$$$20240830$$MD$FR$FR
242673271$24267327$1$I$$20240829$20240830$20240830$PER$$US-HALEON-2194315$Haleon PLC$$$$$$Y$$$20240830$$CN$US$US
242673291$24267329$1$I$20240801$20240826$20240830$20240830$PER$$US-BIOGEN-2024BI01280105$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
242673301$24267330$1$I$$20240821$20240830$20240830$EXP$$US-ROCHE-2043102$ROCHE$$$$A$F$Y$$$20240830$$MD$US$US
242673311$24267331$1$I$20240101$20240826$20240830$20240830$PER$$US-BIOGEN-2024BI01280132$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
242673321$24267332$1$I$$20240812$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004645$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242673331$24267333$1$I$$20240822$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016729$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240830$$CN$US$US
242673341$24267334$1$I$$20240822$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408014918$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240830$$CN$US$US
242673351$24267335$1$I$20240827$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018332$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240830$$CN$US$US
242673361$24267336$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018407$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240830$$CN$US$US
242673371$24267337$1$I$20240820$20240821$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408013636$ELI LILLY AND CO$$31$YR$A$M$Y$$$20240830$$CN$US$US
242673381$24267338$1$I$$20240201$20240830$20240830$EXP$$NVSC2024ES174685$NOVARTIS$$$$$M$Y$$$20240830$$MD$ES$ES
242673391$24267339$1$I$$20220603$20240830$20240830$EXP$$NVSC2022BR131136$NOVARTIS$$$$$F$Y$$$20240830$$HP$BR$BR
242673401$24267340$1$I$$20240822$20240830$20240830$PER$$US-ROCHE-10000064616$ROCHE$$$$$F$Y$$$20240830$$MD$US$US
242673411$24267341$1$I$20240725$20240821$20240830$20240830$PER$$US-ABBVIE-5892359$ABBVIE$$78$YR$$F$Y$$$20240830$$HP$US$US
242673424$24267342$4$F$$20240918$20240830$20240921$PER$$US-ROCHE-10000066847$ROCHE$$$$A$F$Y$$$20240921$$CN$US$US
242673431$24267343$1$I$$20240826$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138238$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240830$$CN$US$US
242673441$24267344$1$I$$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59534$$FDA-CTU$$$$$M$N$$$20240828$N$HP$US$
242673461$24267346$1$I$20240817$20240819$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004794$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240830$$CN$US$US
242673471$24267347$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-086058-2024$RECKITT BENCKISER$$$$$M$Y$$$20240830$$CN$US$US
242673481$24267348$1$I$$20240819$20240830$20240830$EXP$$JP-SLATERUN-2024SRLIT00142$SLATE RUN$Maruyama T, Maruyama T, Kondo S, Nomura H.Case series of bradycardia, renal failure, atrioventricular nodal blockers, shock and hyperkalemia syndrome in patients with dementia.Geriatrics and Gerontology International.2024;24(7):737-8$94$YR$E$M$Y$$$20240830$$HP$JP$JP
242673501$24267350$1$I$20240827$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172884$AMGEN$$34$YR$A$F$Y$$$20240830$$CN$US$US
242673511$24267351$1$I$20240605$20240816$20240830$20240830$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465099$RANBAXY$$70$YR$$M$Y$80$KG$20240830$$MD$IT$IT
242673521$24267352$1$I$20240816$20240828$20240830$20240830$PER$$US-ABBVIE-5900340$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242673531$24267353$1$I$20171001$20240816$20240830$20240830$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465212$RANBAXY$$48$YR$$M$Y$110$KG$20240830$$CN$DE$DE
242673541$24267354$1$I$$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465055$RANBAXY$$57$YR$$F$Y$$$20240830$$MD$FR$FR
242673551$24267355$1$I$$20240816$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465413$RANBAXY$$66$YR$$F$Y$81$KG$20240830$$MD$GB$GB
242673561$24267356$1$I$$20240817$20240830$20240830$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465013$RANBAXY$Alshaya M, Almutairi N, Alrasheed A, Albanaqi I, Laxer RM, Alhammad A. Reactive Arthritis in Children: Case Report, Narrative Review and Proposed Therapy. Curr-Pediatr-Rev. 2024;20 (4):444-452$13$YR$$M$Y$$$20240830$$HP$SA$SA
242673571$24267357$1$I$20030101$20240816$20240830$20240830$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464915$RANBAXY$$20$YR$$M$Y$72$KG$20240830$$CN$IT$IT
242673581$24267358$1$I$$20240816$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465027$RANBAXY$$79$YR$$F$Y$68$KG$20240830$$MD$GB$GB
242673591$24267359$1$I$$20240816$20240830$20240830$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465278$RANBAXY$Nguyen JK, Holmes Z, Kelly RI. Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum. Australas J Dermatol. 2023;64(2):221-228$48$YR$$M$Y$$$20240830$$MD$AU$AU
242673601$24267360$1$I$$20240816$20240830$20240830$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465237$RANBAXY$Nguyen JK, Holmes Z, Kelly RI. Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum. Australas J Dermatol. 2023;64(2):221-228$79$YR$$F$Y$$$20240830$$MD$AU$AU
242673611$24267361$1$I$20240609$20240815$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464679$RANBAXY$$85$YR$$F$Y$80$KG$20240830$$PH$GB$GB
242673621$24267362$1$I$20230801$20240816$20240830$20240830$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465049$RANBAXY$$61$YR$$M$Y$$$20240830$$MD$FR$FR
242673631$24267363$1$I$$20240823$20240830$20240830$EXP$$US-LEO Pharma-373020$LEO PHARM$$65$YR$$F$Y$$$20240830$$CN$US$US
242673641$24267364$1$I$$20240816$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004804$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242673651$24267365$1$I$$20240827$20240830$20240830$EXP$$US-GILEAD-2024-0685637$GILEAD$$25$YR$A$F$Y$$$20240830$$HP$US$US
242673662$24267366$2$F$20240813$20240904$20240830$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004801$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240916$$CN$US$US
242673671$24267367$1$I$20240101$20240821$20240830$20240830$EXP$$US-TEVA-VS-3236683$TEVA$$53$YR$$F$Y$$$20240830$$CN$US$US
242673681$24267368$1$I$$20240125$20240830$20240830$PER$$US-CIPLA LTD.-2023US04087$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242673692$24267369$2$F$20240101$20240906$20240830$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-026572$UNITED THERAPEUTICS$$$$$F$Y$82.086$KG$20240912$$$US$US
242673701$24267370$1$I$$20240816$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004814$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242673711$24267371$1$I$20230101$20240422$20240830$20240830$PER$$US-CIPLA LTD.-2023US04897$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242673722$24267372$2$F$$20240924$20240830$20240926$EXP$$CA-SANDOZ INC.-SDZ2024CA076228$SANDOZ$$$$$F$Y$$$20240926$$CN$CA$CA
242673731$24267373$1$I$$20231123$20240830$20240830$PER$$US-CIPLA LTD.-2023US04198$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242673741$24267374$1$I$$20240826$20240830$20240830$EXP$$TW-AstraZeneca-2024A195581$ASTRAZENECA$$$$$M$Y$$$20240830$$HP$TW$
242673751$24267375$1$I$20240824$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195930$ASTRAZENECA$$32496$DY$$M$Y$$$20240830$$CN$US$
242673761$24267376$1$I$20230101$20231218$20240830$20240830$PER$$US-CIPLA LTD.-2023US04644$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242673771$24267377$1$I$$20240823$20240830$20240830$EXP$$ZA-AstraZeneca-2024A194415$ASTRAZENECA$$83$YR$$F$Y$$$20240830$$CN$ZA$
242673781$24267378$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024172495$AMGEN$$$$$$Y$$$20240830$$CN$US$US
242673791$24267379$1$I$20230812$20230815$20240830$20240830$PER$$US-CIPLA LTD.-2023US05033$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242673801$24267380$1$I$$20240509$20240830$20240830$PER$$US-CIPLA LTD.-2023US05032$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242673811$24267381$1$I$20230101$20230824$20240830$20240830$PER$$US-CIPLA LTD.-2023US05008$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242673831$24267383$1$I$$20230901$20240830$20240830$PER$$US-CIPLA LTD.-2023US05453$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242673841$24267384$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5899100$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242673851$24267385$1$I$20231015$20240320$20240830$20240830$PER$$US-CIPLA LTD.-2023US05177$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242673861$24267386$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5899101$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242673871$24267387$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5899102$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242673881$24267388$1$I$$20240823$20240830$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-026862$UNITED THERAPEUTICS$$$$$M$Y$81.633$KG$20240830$$$US$US
242673892$24267389$2$F$20240731$20240830$20240830$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004816$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240909$$CN$US$US
242673901$24267390$1$I$20240825$20240826$20240830$20240830$EXP$$JP-MALLINCKRODT-MNK202405355$MALLINCKRODT$$80$YR$E$F$Y$$$20240830$$MD$JP$JP
242673911$24267391$1$I$20240803$20240819$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004818$ACADIA PHARMACEUTICALS$$90$YR$$M$Y$$$20240830$$CN$US$US
242673921$24267392$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5899103$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242673931$24267393$1$I$$20240821$20240830$20240830$EXP$$US-ABBVIE-5890128$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242673941$24267394$1$I$20230101$20240710$20240830$20240830$PER$$US-CIPLA LTD.-2023US05042$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242673961$24267396$1$I$$20240820$20240830$20240830$EXP$$US-TEVA-VS-3236869$TEVA$$$$$F$Y$$$20240830$$CN$US$US
242673972$24267397$2$F$20240707$20240913$20240830$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004669$ACADIA PHARMACEUTICALS$$94$YR$$M$Y$$$20240923$$HP$US$US
242673981$24267398$1$I$$20240617$20240830$20240830$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451197$RANBAXY$$20$YR$$F$Y$$$20240830$$HP$US$US
242673991$24267399$1$I$20240728$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042235$AUROBINDO$$68$YR$$M$Y$59.7$KG$20240830$$MD$FR$FR
242674001$24267400$1$I$20220307$20240828$20240830$20240830$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-137472$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$44$KG$20240830$$CN$DE$DE
242674011$24267401$1$I$20240610$20240822$20240830$20240830$EXP$$BR-EMD Serono-2024045420$EMD SERONO INC$$81$YR$E$M$Y$$$20240830$$CN$BR$BR
242674021$24267402$1$I$20240720$20240822$20240830$20240830$EXP$$JP-VANTIVE-2024VAN018662$Vantive US Healthcare$$8$DEC$$M$Y$$$20240830$$MD$JP$JP
242674031$24267403$1$I$$20240822$20240830$20240830$EXP$$JP-VANTIVE-2024VAN019183$Vantive US Healthcare$$$$$M$Y$$$20240830$$MD$JP$JP
242674041$24267404$1$I$20240822$20240822$20240830$20240830$EXP$$CN-VANTIVE-2024VAN019291$Vantive US Healthcare$$$$$$Y$$$20240830$$HP$CN$CN
242674052$24267405$2$F$$20240905$20240830$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004677$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
242674071$24267407$1$I$$20240829$20240830$20240830$PER$$NVSC2024US174764$NOVARTIS$$$$$$Y$$$20240830$$CN$US$US
242674082$24267408$2$F$$20240906$20240830$20240910$EXP$$CA-TAKEDA-2024TUS085768$TAKEDA$$14$YR$$M$Y$41$KG$20240910$$HP$CA$CA
242674091$24267409$1$I$20240101$20240827$20240830$20240830$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004770$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240830$$CN$US$US
242674101$24267410$1$I$20230101$20240815$20240830$20240830$PER$$US-SA-2024SA244860$SANOFI AVENTIS$$$$$F$Y$$$20240830$$HP$US$US
242674111$24267411$1$I$20231130$20240827$20240830$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026954$UNITED THERAPEUTICS$$87$YR$$M$Y$58.957$KG$20240830$$$US$US
242674121$24267412$1$I$20240801$20240827$20240830$20240830$PER$$US-DSJP-DSU-2024-142648$DAIICHI$$7$DEC$$F$Y$$$20240830$$HP$US$US
242674132$24267413$2$F$$20240903$20240830$20240911$EXP$JP-MLMSERVICE-20240815-PI163592-00139-1$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP001227$JUBILANT$Adachi K, Murata M, Inada A, Morimoto T, Shimizu M, Beppu S, et al. Interaction of a caffeine overdose with clinical doses of contraceptive ethinyl estradiol in a young woman. Acute medicine + surgery. 2024;11(1)$23$YR$$F$Y$67$KG$20240911$$MD$JP$JP
242674141$24267414$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898880$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242674171$24267417$1$I$20240807$20240829$20240830$20240830$EXP$$US-UCBSA-2024043999$UCB$$60$YR$$M$Y$$$20240830$$CN$US$US
242674181$24267418$1$I$20240805$20240812$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004593$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240830$$CN$US$US
242674191$24267419$1$I$$20240814$20240830$20240830$PER$$US-ABBVIE-5895581$ABBVIE$$50$YR$$F$Y$$$20240830$$HP$US$US
242674201$24267420$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5898683$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242674211$24267421$1$I$20240804$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59598$$FDA-CTU$$80$YR$$M$N$69$KG$20240828$N$PH$US$
242674231$24267423$1$I$20240101$20240829$20240830$20240830$EXP$$US-UCBSA-2024044044$UCB$$$$$F$Y$$$20240830$$CN$US$US
242674241$24267424$1$I$$20240822$20240830$20240830$PER$$US-ROCHE-10000064945$ROCHE$$$$$$Y$$$20240830$$PH$US$US
242674251$24267425$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5899309$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242674281$24267428$1$I$$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59606$$FDA-CTU$$$$$$N$$$20240828$N$CN$US$
242674294$24267429$4$F$20240816$20240920$20240830$20240927$EXP$$IE-MYLANLABS-2024M1076784$MYLAN$$$$$F$Y$$$20240927$$MD$IE$IE
242674301$24267430$1$I$$20240827$20240830$20240830$EXP$GB-MHRA-MED-202408272155149930-PBJNH$GB-MYLANLABS-2024M1079360$MYLAN$$36$YR$$F$Y$$$20240830$$CN$GB$GB
242674311$24267431$1$I$$20240827$20240830$20240830$EXP$GB-MHRA-MED-202408271153381770-VWZMY$GB-MYLANLABS-2024M1079333$MYLAN$$55$YR$$M$Y$$$20240830$$CN$GB$GB
242674321$24267432$1$I$$20240820$20240830$20240830$EXP$$CA-TEVA-VS-3235070$TEVA$$43$YR$$F$Y$$$20240830$$HP$CA$CA
242674331$24267433$1$I$$20240827$20240830$20240830$EXP$GB-MHRA-MED-202408260754075230-QCTSY$GB-MYLANLABS-2024M1079142$MYLAN$$46$YR$$F$Y$60$KG$20240830$$CN$GB$GB
242674342$24267434$2$F$20240701$20240917$20240830$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004601$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240927$$CN$US$US
242674351$24267435$1$I$20240801$20240814$20240830$20240830$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000302$EMCURE$$$$$$Y$$$20240830$$PH$US$US
242674362$24267436$2$F$$20240830$20240830$20240902$PER$$US-AMGEN-USASP2024173080$AMGEN$$$$$$Y$$$20240901$$CN$US$US
242674382$24267438$2$F$20240822$20240826$20240830$20240912$EXP$$JP-AMGEN-JPNSP2024169290$AMGEN$$$$E$F$Y$$$20240912$$PH$JP$JP
242674391$24267439$1$I$$20240822$20240830$20240830$EXP$$IN-ROCHE-10000064815$ROCHE$$34$YR$A$F$Y$$$20240830$$CN$IN$IN
242674401$24267440$1$I$$20240820$20240830$20240830$EXP$$US-TEVA-VS-3235329$TEVA$$42$YR$$M$Y$$$20240830$$PH$US$US
242674411$24267441$1$I$20231001$20240820$20240830$20240830$PER$$US-ABBVIE-5887802$ABBVIE$$41$YR$$F$Y$72.121$KG$20240830$$CN$US$US
242674421$24267442$1$I$$20240828$20240830$20240830$EXP$$CA-BAUSCH-BL-2024-013027$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240830$$MD$CA$CA
242674431$24267443$1$I$$20240828$20240830$20240830$EXP$$CA-BAUSCH-BL-2024-013022$BAUSCH AND LOMB$$48$YR$$M$Y$$$20240830$$HP$CA$CA
242674441$24267444$1$I$$20240828$20240830$20240830$EXP$$CA-BAUSCH-BL-2024-013019$BAUSCH AND LOMB$$45$YR$$F$Y$$$20240830$$CN$CA$CA
242674451$24267445$1$I$$20240828$20240830$20240830$EXP$$CA-BAUSCH-BL-2024-013028$BAUSCH AND LOMB$$51$YR$$F$Y$54$KG$20240830$$HP$CA$CA
242674461$24267446$1$I$20240101$20240822$20240830$20240830$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2023001750$BIOCON$$$$$$Y$$$20240830$$HP$CA$CA
242674471$24267447$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-081950-2024$RECKITT BENCKISER$$$$$F$Y$$$20240830$$CN$US$US
242674481$24267448$1$I$20240810$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042095$AUROBINDO$$59$YR$$M$Y$79$KG$20240830$$MD$FR$FR
242674501$24267450$1$I$$20240827$20240830$20240830$EXP$$JP-AstraZeneca-2024A194703$ASTRAZENECA$$$$$$Y$$$20240830$$MD$JP$
242674511$24267451$1$I$20240701$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195993$ASTRAZENECA$$52$YR$$M$Y$117.9$KG$20240830$$CN$US$
242674521$24267452$1$I$$20240802$20240830$20240830$PER$$US-AMGEN-USASP2024173402$AMGEN$$$$$$Y$$$20240830$$CN$US$US
242674531$24267453$1$I$$20240822$20240830$20240830$EXP$$CA-AstraZeneca-2024A194336$ASTRAZENECA$$76$YR$$M$Y$$$20240830$$MD$CA$
242674542$24267454$2$F$$20240904$20240830$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004480$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
242674551$24267455$1$I$$20240829$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018791$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240830$$CN$US$US
242674561$24267456$1$I$20240815$20240818$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464953$RANBAXY$$$$$$Y$$$20240830$$CN$GB$GB
242674571$24267457$1$I$20240804$20240812$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004603$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240830$$CN$US$US
242674581$24267458$1$I$$20240828$20240830$20240830$EXP$$US-BAUSCH-BL-2024-013024$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240830$$LW$US$US
242674591$24267459$1$I$$20240829$20240830$20240830$EXP$$US-BAUSCH-BL-2024-013059$BAUSCH AND LOMB$$55$YR$$M$Y$$$20240830$$CN$US$US
242674601$24267460$1$I$20240514$20240828$20240828$20240828$DIR$FDA-CDER-CTU-2024-59608$$FDA-CTU$$31$YR$$$N$57.61$KG$20240828$N$$US$
242674611$24267461$1$I$$20240828$20240830$20240830$PER$$US-BAUSCH-BL-2024-013033$BAUSCH AND LOMB$$91$YR$$F$Y$$$20240830$$CN$US$US
242674621$24267462$1$I$20240529$20240822$20240830$20240830$EXP$$CA-CELLTRION INC.-2024CA014276$CELLTRION$$$$$$Y$$$20240830$$HP$CA$CA
242674631$24267463$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137539$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240830$$CN$US$US
242674641$24267464$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137176$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240830$$CN$US$US
242674651$24267465$1$I$20240727$20240816$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132075$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240830$$CN$US$US
242674661$24267466$1$I$$20240829$20240830$20240830$PER$$NVSC2024US175042$NOVARTIS$$$$$F$Y$$$20240830$$HP$US$US
242674671$24267467$1$I$20240701$20240814$20240830$20240830$PER$$US-TEVA-VS-3233708$TEVA$$59$YR$$F$Y$$$20240830$$CN$US$US
242674681$24267468$1$I$$20240814$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004701$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242674701$24267470$1$I$20240827$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024171931$AMGEN$$66$YR$E$F$Y$$$20240830$$CN$US$US
242674711$24267471$1$I$20240101$20240826$20240830$20240830$EXP$$JP-ABBVIE-5896242$ABBVIE$$$$$M$Y$$$20240830$$CN$JP$JP
242674721$24267472$1$I$20240101$20240821$20240830$20240830$PER$$US-SA-2024SA252352$SANOFI AVENTIS$$$$E$F$Y$$$20240830$$HP$US$US
242674731$24267473$1$I$20221031$20240828$20240830$20240830$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-142646$DAIICHI$$73$YR$$M$Y$$$20240830$$HP$US$US
242674741$24267474$1$I$$20240826$20240830$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013627$JAZZ$$$$$F$Y$$$20240830$$CN$US$US
242674751$24267475$1$I$$20240821$20240830$20240830$EXP$$AT-AMGEN-AUTSP2024168648$AMGEN$Finsterer J.; Scorza C.A.; Scorza F.A.. Takotsubo syndrome is triggered by hypoactive delirium and recognized by increased catecholamine requirement in the ICU. Clinics. 2024;79:1-2$60$YR$A$F$Y$75$KG$20240830$$HP$AT$AT
242674761$24267476$1$I$$20240829$20240830$20240830$EXP$$NVSC2024US174856$NOVARTIS$$$$$F$Y$$$20240830$$HP$US$US
242674772$24267477$2$F$$20240828$20240830$20240904$EXP$$AU-ROCHE-10000064294$ROCHE$$$$$$Y$$$20240904$$CN$AU$AU
242674781$24267478$1$I$20240807$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042125$AUROBINDO$$82$YR$$M$Y$$$20240830$$MD$FR$FR
242674791$24267479$1$I$20240710$20240822$20240830$20240830$EXP$FR-AFSSAPS-AN2024001095$FR-TEVA-VS-3236752$TEVA$$79$YR$$M$Y$98.5$KG$20240830$$MD$FR$FR
242674801$24267480$1$I$$20240821$20240830$20240830$EXP$$US-GSK-US2024AMR105292$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$HP$US$US
242674811$24267481$1$I$20240815$20240819$20240830$20240830$EXP$$US-Accord-443070$ACCORD$$33$YR$A$M$Y$$$20240830$$HP$US$US
242674821$24267482$1$I$$20240812$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004613$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242674831$24267483$1$I$20240801$20240814$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004703$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240830$$CN$US$US
242674842$24267484$2$F$20240824$20240917$20240830$20240918$PER$$US-AMGEN-USASP2024171072$AMGEN$$74$YR$E$F$Y$$$20240918$$CN$US$US
242674851$24267485$1$I$$20240826$20240830$20240830$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-031855$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240830$$CN$US$US
242674862$24267486$2$F$20240225$20240829$20240830$20240903$EXP$$US-ROCHE-10000060290$ROCHE$$42$YR$A$M$Y$64.23$KG$20240903$$MD$US$US
242674871$24267487$1$I$$20240829$20240829$20240829$DIR$716362$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242674881$24267488$1$I$20240828$20240829$20240829$20240829$DIR$716355$$FDA-CTU$$77$YR$$M$N$83.25$KG$20240829$N$CN$US$
242674891$24267489$1$I$$20240829$20240829$20240829$DIR$716361$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242674901$24267490$1$I$$20240829$20240829$20240829$DIR$716363$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242674911$24267491$1$I$20240101$20240829$20240829$20240829$DIR$716357$$FDA-CTU$$44$YR$$F$N$85.5$KG$20240829$N$CN$US$
242674921$24267492$1$I$20200206$20240827$20240830$20240830$EXP$$US-SANDOZ INC.-NVSC2020US062882$SANDOZ$$69$YR$$F$Y$56.689$KG$20240830$$CN$US$US
242674931$24267493$1$I$$20240430$20240830$20240830$PER$$US-ROCHE-10000070362$ROCHE$$$$$$Y$$$20240830$$PH$US$US
242674941$24267494$1$I$$20240829$20240829$20240829$DIR$716360$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242674952$24267495$2$F$20240815$20240913$20240830$20240914$PER$$US-AMGEN-USASP2024170941$AMGEN$$49$YR$A$M$Y$$$20240914$$CN$US$US
242674961$24267496$1$I$20240818$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172402$AMGEN$$62$YR$A$F$Y$$$20240830$$CN$US$US
242674971$24267497$1$I$$20240821$20240830$20240830$EXP$$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-08006$HIKMA$N?gele H, Rosenkranz M, N?gele MP.. N?gele H, Rosenkranz M, N?gele MP. Hyponatremia-induced epileptic seizure provoked by Levetiracetam and pain medication intake in a patient with central diabetes insipidus. Case Reports in Neurology. 2024;16(1):204-207$67$YR$$M$Y$$$20240830$$MD$DE$DE
242674981$24267498$1$I$$20240823$20240830$20240830$EXP$$US-ZENPEP LLC-2024AIMT01286$AIMMUNE$$$$$$Y$$$20240830$$HP$US$US
242674991$24267499$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137396$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240830$$CN$US$US
242675001$24267500$1$I$20240827$20240829$20240830$20240830$PER$$US-HALEON-2194309$Haleon PLC$$$$$$Y$$$20240830$$CN$US$US
242675011$24267501$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137385$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$63.5$KG$20240830$$CN$US$US
242675021$24267502$1$I$20240723$20240819$20240830$20240830$PER$$US-009507513-2408USA006855$MERCK$$69$YR$$M$Y$$$20240830$$CN$US$US
242675031$24267503$1$I$$20240823$20240830$20240830$EXP$$US-JNJFOC-20240861861$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$HP$US$US
242675041$24267504$1$I$$20240823$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004616$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$HP$US$US
242675051$24267505$1$I$$20240826$20240830$20240830$EXP$$US-JNJFOC-20240869582$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$CN$US$US
242675061$24267506$1$I$$20240206$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138466$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$73.39$KG$20240830$$CN$US$US
242675071$24267507$1$I$$20240814$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004708$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242675081$24267508$1$I$$20231127$20240830$20240830$EXP$$TN-UCBSA-2024040245$UCB$Charfi O, Lakhoua G, Sahnoun R, Aidli SE, Daghfous R, Kastalli S, et al.. Multiple drug intolerance syndrome in an epileptic woman. Therapie. 2023;78(5):S85-S86$50$YR$$F$Y$$$20240830$$HP$TN$TN
242675091$24267509$1$I$20240801$20240815$20240830$20240830$EXP$$US-BRAINTREE LABORATORIES, INC.-2024BTE00532$BRAINTREE$$$$A$M$Y$$$20240830$$CN$US$US
242675101$24267510$1$I$$20240820$20240830$20240830$EXP$$GB-AUROBINDO-AUR-APL-2024-041985$AUROBINDO$$$$$$Y$$$20240830$$CN$GB$GB
242675111$24267511$1$I$$20240814$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004699$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242675122$24267512$2$F$$20240904$20240830$20240910$EXP$$US-ABBVIE-5898708$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
242675131$24267513$1$I$$20240822$20240830$20240830$PER$$US-AstraZeneca-2024A193511$ASTRAZENECA$$$$$$Y$$$20240830$$MD$US$
242675141$24267514$1$I$20240701$20240827$20240830$20240830$EXP$$US-ABBVIE-5898580$ABBVIE$$63$YR$$M$Y$$$20240830$$CN$US$US
242675152$24267515$2$F$$20240827$20240830$20240903$EXP$$CA-ROCHE-10000068819$ROCHE$$$$$F$Y$$$20240903$$CN$CA$CA
242675161$24267516$1$I$$20240219$20240830$20240830$EXP$$OM-UCBSA-2024040570$UCB$Al Futaisi A, Uraba WB, Al Dhawi N, Al Ajmi E, Al Kindi M, Al Shukaili J, et al. N-Methyl-D-Aspartate Receptor Encephalitis, Post Herpes Encephalitis in Two Pediatric Cases. Oman Medical Journal. 2023;38(6):e578$8$MON$$F$Y$$$20240830$$HP$OM$OM
242675171$24267517$1$I$$20240828$20240830$20240830$PER$$US-JNJFOC-20240877013$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$HP$US$US
242675181$24267518$1$I$20240801$20240826$20240830$20240830$PER$$US-ALXN-202408USA001805US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242675191$24267519$1$I$20240821$20240823$20240830$20240830$EXP$$CN-JNJFOC-20240864073$JOHNSON AND JOHNSON$$53$YR$A$F$Y$56$KG$20240830$$HP$CN$CN
242675201$24267520$1$I$20240710$20240813$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004632$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240830$$CN$US$US
242675211$24267521$1$I$$20240826$20240830$20240830$PER$$US-JNJFOC-20240869709$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240830$$CN$US$US
242675222$24267522$2$F$20240824$20240830$20240830$20240902$PER$$NVSC2024US174753$NOVARTIS$$29$YR$$M$Y$$$20240902$$CN$US$US
242675231$24267523$1$I$20240523$20240816$20240830$20240830$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465493$RANBAXY$$17$YR$$F$Y$$$20240830$$PH$ES$ES
242675241$24267524$1$I$20240322$20240820$20240830$20240830$EXP$FR-AFSSAPS-BX2024001655$FR-TEVA-VS-3235366$TEVA$$59$YR$$M$Y$$$20240830$$MD$FR$FR
242675252$24267525$2$F$20240401$20240925$20240830$20240927$30DAY$$AU-UCBSA-2024043965$UCB$$83$YR$$F$Y$75$KG$20240927$$CN$AU$AU
242675261$24267526$1$I$$20240827$20240830$20240830$EXP$$JP-ROCHE-10000069842$ROCHE$$8$DEC$E$F$Y$$$20240830$$MD$JP$JP
242675271$24267527$1$I$20240820$20240822$20240830$20240830$PER$$US-SA-2024SA252193$SANOFI AVENTIS$$$$$F$Y$$$20240830$$CN$US$US
242675281$24267528$1$I$20220518$20240820$20240830$20240830$EXP$$PL-AUROBINDO-AUR-APL-2024-042213$AUROBINDO$$$$A$M$Y$$$20240830$$HP$PL$PL
242675291$24267529$1$I$20240524$20240816$20240830$20240830$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465488$RANBAXY$$37$YR$$M$Y$$$20240830$$MD$ES$ES
242675301$24267530$1$I$$20240824$20240830$20240830$PER$$US-RDY-SPO/USA/24/0012503$DR REDDYS$$18$YR$A$$Y$$$20240830$$CN$US$US
242675311$24267531$1$I$20240826$20240827$20240830$20240830$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-116676$REGENERON$$$$$F$Y$$$20240830$$CN$US$US
242675321$24267532$1$I$$20240823$20240830$20240830$EXP$$TR-SANDOZ INC.-SDZ2024TR076398$SANDOZ$$84$YR$$F$Y$$$20240830$$CN$TR$TR
242675331$24267533$1$I$20240430$20240814$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004698$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240830$$CN$US$US
242675341$24267534$1$I$20240729$20240812$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004633$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240830$$CN$US$US
242675351$24267535$1$I$20240102$20240828$20240830$20240830$EXP$$CA-ABBVIE-5900640$ABBVIE$$51$YR$$M$Y$$$20240830$$MD$CA$CA
242675361$24267536$1$I$20240601$20240820$20240830$20240830$EXP$$FR-AUROBINDO-AUR-APL-2024-042206$AUROBINDO$$71$YR$$M$Y$98$KG$20240830$$PH$FR$FR
242675371$24267537$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-085993-2024$RECKITT BENCKISER$$$$$M$Y$$$20240830$$CN$US$US
242675381$24267538$1$I$$20240821$20240830$20240830$EXP$$US-MSNLABS-2024MSNLIT01869$MSN LABORATORIES$Kim M, Graham C, Stevens RW, Shah A.A Rare Case of Bacterial Meningitis Caused by Hematogenous Spread of Vancomycin-Resistant Enterococcus faecium in an Immunocompromised Patient.Case reports in infectious diseases.2024;2193650$$$$$Y$$$20240830$$MD$US$US
242675391$24267539$1$I$$20240821$20240830$20240830$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01732$NOVITIUM PHARMA$Ying Shang.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Haematology.2023;40:275-304$66$YR$E$M$Y$$$20240830$$HP$CN$CN
242675401$24267540$1$I$20240810$20240812$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004634$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240830$$CN$US$US
242675411$24267541$1$I$$20240821$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408013919$ELI LILLY AND CO$$61$YR$A$$Y$$$20240830$$LW$US$US
242675421$24267542$1$I$20240827$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018073$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240830$$CN$US$US
242675431$24267543$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018090$ELI LILLY AND CO$$86$YR$E$M$Y$$$20240830$$CN$US$US
242675441$24267544$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018601$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$US$US
242675451$24267545$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018202$ELI LILLY AND CO$$$$$$Y$$$20240830$$CN$US$US
242675461$24267546$1$I$20240618$20240812$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004636$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240830$$CN$US$US
242675471$24267547$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018060$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240830$$CN$US$US
242675481$24267548$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137370$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$71.21$KG$20240830$$CN$US$US
242675491$24267549$1$I$$20240822$20240830$20240830$EXP$$MT-STRIDES ARCOLAB LIMITED-2024SP010814$STRIDES$Vassallo C, Saliba J, Bardon MP.. Leptospirosis: a clinical and diagnostic challenge.. BMJ-Case-Rep. 2024;17$6$DEC$$M$Y$$$20240830$$MD$MT$MT
242675501$24267550$1$I$$20240822$20240830$20240830$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010817$STRIDES$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.. Cancer-Immunol-Immunother. 2024;73$55$YR$$F$Y$$$20240830$$HP$US$US
242675512$24267551$2$F$20240824$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024170385$AMGEN$$63$YR$A$F$Y$$$20240830$$CN$US$US
242675521$24267552$1$I$$20240822$20240830$20240830$EXP$$US-ZENPEP LLC-2024AIMT01287$AIMMUNE$$$$$$Y$$$20240830$$CN$US$US
242675531$24267553$1$I$$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59659$$FDA-CTU$$$$$M$N$$$20240828$N$HP$US$
242675541$24267554$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59639$$FDA-CTU$$73$YR$$F$N$108.86$KG$20240829$N$$US$
242675551$24267555$1$I$20240826$20240829$20240829$20240829$DIR$716356$$FDA-CTU$$33$YR$$F$N$67.5$KG$20240829$N$CN$US$
242675561$24267556$1$I$$20240813$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004638$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242675571$24267557$1$I$$20240820$20240830$20240830$EXP$$CA-GSK-CA2024062407$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$CA$CA
242675581$24267558$1$I$20230918$20240826$20240830$20240830$EXP$$AU-MYLANLABS-2024M1078970$MYLAN$$17$YR$$F$Y$$$20240830$$HP$AU$AU
242675591$24267559$1$I$$20240826$20240830$20240830$EXP$$GT-MYLANLABS-2024M1079354$MYLAN$$$$$F$Y$57.15$KG$20240830$$CN$GT$GT
242675601$24267560$1$I$$20240822$20240830$20240830$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP010812$STRIDES$Fiorani C, Tchawa C, Cadoni A, Moro M, Porzio G, Giusti R.. Letter to the Editor: Chlorpromazine as a Viable Alternative to Midazolam for Palliative Sedation in a Liver Transplant Recipient with HCC: A Brief Communication.. J-Palliat-Med. 2024;27 (7)$51$YR$$F$Y$$$20240830$$MD$IT$IT
242675611$24267561$1$I$$20240829$20240829$20240829$DIR$716364$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242675621$24267562$1$I$$20240820$20240830$20240830$EXP$$IN-ROCHE-10000062638$ROCHE$$50$YR$A$F$Y$$$20240830$$CN$IN$IN
242675631$24267563$1$I$$20240822$20240830$20240830$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010819$STRIDES$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.. Cancer-Immunol-Immunother. 2024;73$75$YR$$F$Y$$$20240830$$HP$US$US
242675641$24267564$1$I$$20240829$20240829$20240829$DIR$716377$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242675651$24267565$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59656$$FDA-CTU$$61$YR$$M$N$99.34$KG$20240829$N$$US$
242675661$24267566$1$I$$20240829$20240829$20240829$DIR$716378$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242675671$24267567$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59636$$FDA-CTU$$62$YR$$M$N$102.06$KG$20240829$N$$US$
242675681$24267568$1$I$20240828$20240829$20240829$20240829$DIR$716367$$FDA-CTU$$67$YR$$M$N$64.8$KG$20240829$N$HP$US$
242675691$24267569$1$I$$20240829$20240829$20240829$DIR$716374$$FDA-CTU$$$$$UNK$N$$$20240829$$CN$US$
242675701$24267570$1$I$20240825$20240829$20240829$20240829$DIR$716376$$FDA-CTU$$58$YR$$F$N$75.6$KG$20240829$N$CN$US$
242675731$24267573$1$I$20240828$20240829$20240829$20240829$DIR$716384$$FDA-CTU$$65$YR$$M$N$76$KG$20240829$N$PH$US$
242675741$24267574$1$I$$20240829$20240829$20240829$DIR$716387$$FDA-CTU$$51$YR$$F$N$$$20240829$N$$US$
242675751$24267575$1$I$20240814$20240819$20240830$20240830$EXP$$FR-AMICUS THERAPEUTICS, INC.-AMI_3339$AMICUS THERAPEUTICS$$47$YR$$M$Y$$$20240830$$PH$FR$FR
242675761$24267576$1$I$$20240829$20240830$20240830$PER$$US-ROCHE-10000070308$ROCHE$$75$YR$E$F$Y$$$20240830$$MD$US$US
242675771$24267577$1$I$$20240822$20240830$20240830$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010832$STRIDES$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.. Cancer-Immunol-Immunother. 2024;73$71$YR$$F$Y$$$20240830$$HP$US$US
242675781$24267578$1$I$$20240819$20240830$20240830$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-132222$BRISTOL MYERS SQUIBB$Dentoni M, Florean I, Farina A, Joubert B, Do L, Honnorat J, et al. Immune checkpoint inhibitor-related cerebellar toxicity: clinical features and comparison with paraneoplastic cerebellar ataxia. The Cerebellum. 2024 Aug 17;doi:10.1007/s12311-024-01727-5.$66$YR$E$F$Y$$$20240830$$HP$IT$IT
242675791$24267579$1$I$20240703$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138314$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240830$$CN$US$US
242675801$24267580$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137754$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240830$$CN$US$US
242675812$24267581$2$F$$20240923$20240830$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138115$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240924$$CN$US$US
242675822$24267582$2$F$20240827$20240909$20240830$20240909$EXP$$CL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048587$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240910$$MD$CL$CL
242675831$24267583$1$I$$20240805$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07935$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242675842$24267584$2$F$20230913$20240731$20240830$20240830$30DAY$$US-AMGEN-USASL2024153137$AMGEN$$53$YR$A$M$Y$$$20240830$$MD$US$US
242675851$24267585$1$I$$20240821$20240830$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024104518$VIIV$$$$$M$Y$$$20240830$$HP$US$US
242675863$24267586$3$F$$20240924$20240830$20240927$30DAY$$US-UCBSA-2024043878$UCB$$$$$F$Y$$$20240927$$PH$US$US
242675871$24267587$1$I$20240223$20240819$20240830$20240830$EXP$$US-BAYER-2024A046709$BAYER$$78$YR$E$F$Y$51.701$KG$20240830$$CN$US$US
242675892$24267589$2$F$20240827$20240910$20240830$20240912$EXP$$NVSJ2024JP010066$NOVARTIS$$13$YR$$M$Y$$$20240912$$PH$JP$JP
242675901$24267590$1$I$$20240827$20240830$20240830$EXP$$NVSJ2024JP010089$NOVARTIS$$$$E$$Y$$$20240830$$MD$JP$JP
242675911$24267591$1$I$20240810$20240829$20240829$20240829$DIR$716392$$FDA-CTU$$60$YR$$F$N$84.6$KG$20240829$N$CN$US$
242675921$24267592$1$I$$20240829$20240829$20240829$DIR$716389$$FDA-CTU$$$$$UNK$N$$$20240829$$CN$US$
242675961$24267596$1$I$20240823$20240829$20240829$20240829$DIR$716369$$FDA-CTU$$62$YR$$M$N$$$20240829$N$PH$US$
242675971$24267597$1$I$20240606$20240829$20240829$20240829$DIR$716394$$FDA-CTU$$16$YR$$F$N$85.6$KG$20240829$N$MD$US$
242675981$24267598$1$I$20240828$20240829$20240829$20240829$DIR$716399$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242676001$24267600$1$I$$20240820$20240830$20240830$EXP$$ES-AMGEN-ESPSP2024169326$AMGEN$Ibanez B. M.; Ramirez A. G.; Gonzalez M. et al.. SECONDARY PREVENTION OF OSTEOPOROSIS CLINICAL AND FUNCTIONAL PROFILE OF ELDERLY PATIENTS WITH HIP FRACTURE. Annals of the Rheumatic Diseases. 2024;1399-1400$$$$$Y$$$20240830$$HP$ES$ES
242676011$24267601$1$I$20240401$20240820$20240830$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012796$UNITED THERAPEUTICS$$34$YR$$M$Y$69.388$KG$20240830$$$US$US
242676021$24267602$1$I$$20240826$20240830$20240830$EXP$GB-MHRA-MED-202408261547572090-RHSJP$GB-MYLANLABS-2024M1078844$MYLAN$$50$YR$$M$Y$$$20240830$$PH$GB$GB
242676032$24267603$2$F$$20240827$20240830$20240902$EXP$$NVSC2024PT174377$NOVARTIS$Freitas JG, Ribeiro T, Moreira C, Moreira I, Mariz JM. When ^Myeloma^ is not a Myeloma: a case report of malignant bone lymphoma. PORTO BIOMEDICAL JOURNAL. 2024;9(4):e261$63$YR$$F$Y$$$20240902$$HP$PT$PT
242676041$24267604$1$I$$20240826$20240830$20240830$EXP$FR-AFSSAPS-AVLL2024000213$FR-MYLANLABS-2024M1078881$MYLAN$$21$YR$$M$Y$$$20240830$$HP$FR$FR
242676051$24267605$1$I$$20240823$20240830$20240830$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010796$STRIDES$Fahad M, Goindoo R.. Hypoglycaemia in a Patient Taking Tetracyclines. Cureus. 2023;15(9):e45406$$$T$M$Y$$$20240830$$HP$GB$GB
242676061$24267606$1$I$$20240822$20240830$20240830$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010823$STRIDES$Sasidharan A, Iftikhar M, Kyaw NK, Sighakoli S, Shah SS.. First presentation of gestational diabetes mellitus with impending DKA and hypertriglyceridemia.. Br-J-Diabetes. 2024;24 (1):10-11 abstr. 34$$$$$Y$$$20240830$$HP$GB$GB
242676072$24267607$2$F$$20240827$20240830$20240905$PER$$US-TAKEDA-2023TUS101825$TAKEDA$$24$YR$$F$Y$$$20240905$$CN$US$US
242676081$24267608$1$I$20240101$20240822$20240830$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026430$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240830$$$US$US
242676091$24267609$1$I$20240825$20240827$20240830$20240830$EXP$GB-MHRA-MED-202408251635551540-YPRZL$GB-STRIDES ARCOLAB LIMITED-2024SP010837$STRIDES$$46$YR$$F$Y$$$20240830$$CN$GB$GB
242676101$24267610$1$I$$20240821$20240830$20240830$EXP$$DE-MSNLABS-2024MSNLIT01866$MSN LABORATORIES$Gruhn B et al.Continuous complete molecular remission using three different monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with chemotherapy-refractory acute lymphoblastic leukemia.Bone marrow transplantation.2019;54:543-544$$$$$Y$$$20240830$$HP$DE$DE
242676111$24267611$1$I$20230101$20240826$20240830$20240830$PER$$US-BIOGEN-2024BI01280116$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
242676121$24267612$1$I$$20240826$20240830$20240830$PER$$US-BIOGEN-2024BI01280052$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
242676131$24267613$1$I$20240601$20240827$20240830$20240830$PER$$US-BIOGEN-2024BI01271032$BIOGEN$$44$YR$$F$Y$$$20240830$$CN$US$US
242676141$24267614$1$I$$20240820$20240830$20240830$EXP$$US-Vifor (International) Inc.-VIT-2024-07605$VIFOR$$$$$$Y$$$20240830$$MD$US$US
242676161$24267616$1$I$20240817$20240820$20240830$20240830$EXP$CN-HENLIUS-24CN016521$CN-Accord-443999$ACCORD$$77$YR$E$F$Y$56$KG$20240830$$MD$CN$CN
242676171$24267617$1$I$$20240822$20240830$20240830$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08047$HIKMA$$$$A$F$Y$$$20240830$$MD$US$US
242676181$24267618$1$I$$20240819$20240830$20240830$EXP$CA-MHPD-001088239$CA-Accord-442617$ACCORD$$59$YR$A$M$Y$69$KG$20240830$$PH$CA$CA
242676191$24267619$1$I$$20240819$20240830$20240830$EXP$CA-MHPD-E2B_07151094$CA-Accord-442535$ACCORD$$8$YR$C$F$Y$28$KG$20240830$$MD$CA$CA
242676201$24267620$1$I$$20240822$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134693$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240830$$HP$US$US
242676211$24267621$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137961$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240830$$HP$US$US
242676221$24267622$1$I$$20240819$20240830$20240830$EXP$$US-Accord-442917$ACCORD$Schwartz W, Christiansen AC, Patel SS. Intraorbital amphotericin B for mucormycosis in an Allo-HSCT recipient. Bone Marrow Transplantation. 2024;59(8):1176-7.$68$YR$$M$Y$$$20240830$$MD$US$US
242676231$24267623$1$I$$20240819$20240830$20240830$EXP$GB-MHRA-MED-202408191141120190-NVSHL$GB-Accord-442550$ACCORD$$52$YR$A$M$Y$101$KG$20240830$$CN$GB$GB
242676241$24267624$1$I$20240708$20240828$20240830$20240830$EXP$NO-NOMAADVRE-RELISN-2024-Vp3bwn$NO-BRISTOL-MYERS SQUIBB COMPANY-2024-136790$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240830$$MD$NO$NO
242676251$24267625$1$I$$20240822$20240830$20240830$30DAY$$US-GSK-US2024AMR105652$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$US$US
242676261$24267626$1$I$$20240828$20240830$20240830$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-142647$DAIICHI$$$$$M$Y$$$20240830$$CN$US$US
242676272$24267627$2$F$$20240819$20240830$20240830$PER$$US-ROCHE-10000067341$ROCHE$Rios IP, Nguyen CHL, Misra SS, Ryan MS, Nair SS, Khamash HA. Foscarnet-induced nephropathy in a kidney transplant recipient. Kidney International. 2024;106(1):156. doi: 10.1016/j.kint.2024.02.017.$53$YR$A$M$Y$$$20240830$$MD$US$US
242676281$24267628$1$I$20240703$20240821$20240830$20240830$EXP$$DE-JNJFOC-20240713570$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$MD$DE$DE
242676291$24267629$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-085955-2024$RECKITT BENCKISER$$$$$F$Y$$$20240830$$CN$US$US
242676301$24267630$1$I$20240823$20240826$20240830$20240830$PER$$US-BIOGEN-2024BI01280103$BIOGEN$$36$YR$$F$Y$$$20240830$$CN$US$US
242676312$24267631$2$F$$20240901$20240830$20240903$PER$$US-PFIZER INC-PV202400111844$PFIZER$$42$YR$$F$Y$$$20240903$$CN$US$US
242676321$24267632$1$I$20240101$20240826$20240830$20240830$PER$$US-PFIZER INC-202400245095$PFIZER$$$$$F$Y$$$20240830$$MD$US$US
242676331$24267633$1$I$$20240822$20240830$20240830$EXP$$CA-APOTEX-2024AP009708$APOTEX$$80$YR$$M$Y$86$KG$20240830$$HP$CA$CA
242676341$24267634$1$I$20240820$20240826$20240830$20240830$EXP$GB-MHRA-MED-202408261304047330-GPYBV$GB-MYLANLABS-2024M1078943$MYLAN$$45$YR$$F$Y$85$KG$20240830$$PH$GB$GB
242676351$24267635$1$I$$20240826$20240830$20240830$PER$$US-PFIZER INC-PV202400111448$PFIZER$$$$$$Y$$$20240830$$HP$US$US
242676361$24267636$1$I$20240701$20240806$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07944$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242676371$24267637$1$I$20240625$20240813$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004689$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240830$$CN$US$US
242676381$24267638$1$I$20240828$20240829$20240829$20240829$DIR$716403$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242676401$24267640$1$I$20240628$20240829$20240829$20240829$DIR$716358$$FDA-CTU$$63$YR$$F$N$90$KG$20240829$N$CN$US$
242676411$24267641$1$I$20240813$20240829$20240829$20240829$DIR$716406$$FDA-CTU$$16$YR$$F$N$108$KG$20240829$N$$US$
242676421$24267642$1$I$20240828$20240829$20240829$20240829$DIR$716407$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242676431$24267643$1$I$20240709$20240829$20240829$20240829$DIR$716410$$FDA-CTU$$80$YR$$F$N$77.4$KG$20240829$N$PH$US$
242676441$24267644$1$I$20240822$20240829$20240829$20240829$DIR$716401$$FDA-CTU$$32$YR$$F$N$70.2$KG$20240829$N$MD$US$
242676451$24267645$1$I$$20240822$20240830$20240830$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP010824$STRIDES$Sasidharan A, Iftikhar M, Kyaw NK, Sighakoli S, Shah SS.. First presentation of gestational diabetes mellitus with impending DKA and hypertriglyceridemia.. Br-J-Diabetes. 2024;24 (1):10-11 abstr. 34$$$$$Y$$$20240830$$HP$GB$GB
242676461$24267646$1$I$$20240817$20240830$20240830$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465172$RANBAXY$$$$$F$Y$$$20240830$$CN$GB$GB
242676471$24267647$1$I$$20240829$20240829$20240829$DIR$716408$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242676481$24267648$1$I$$20240829$20240829$20240829$DIR$716411$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242676491$24267649$1$I$20240825$20240829$20240830$20240830$EXP$GB-MHRA-MED-202408281754313550-NTMKR$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048731$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$90$KG$20240830$$CN$GB$GB
242676501$24267650$1$I$$20240820$20240830$20240830$EXP$$TN-NOVITIUMPHARMA-2024TNNVP01701$NOVITIUM PHARMA$Becem Trabelsi.Epstein-Barr virus-associated encephalitis during pregnancy: a diagnostic and therapeutic challenge.Acta Neurologica Belgica.02-JUN-2022;123(4):1533-1535$24$YR$A$F$Y$$$20240830$$HP$TN$TN
242676511$24267651$1$I$$20240822$20240830$20240830$EXP$$PL-RDY-SPO/POL/24/0012557$DR REDDYS$Salomon-Perzynski A, Budziszewska BK. How do I manage the myelotoxicity of venetoclax and azacitidine in patients with newly diagnosed acute myeloid leukemia. Hematology in Clinical Practice. 2023;14: 6-10. doi:10.5603/HCP.2023.0002.$68$YR$E$F$Y$$$20240830$$HP$PL$PL
242676521$24267652$1$I$20240829$20240829$20240829$20240829$DIR$716412$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242676531$24267653$1$I$20240829$20240829$20240829$20240829$DIR$716414$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242676541$24267654$1$I$20240828$20240829$20240829$20240829$DIR$716416$$FDA-CTU$$37$YR$$F$N$89.4$KG$20240829$N$PH$US$
242676551$24267655$1$I$20240801$20240823$20240830$20240830$EXP$$US-GSK-US2024105494$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$US$US
242676564$24267656$4$F$20240801$20240912$20240830$20240922$PER$$US-GSK-US2024AMR104774$GLAXOSMITHKLINE$$39$YR$$F$Y$56.689$KG$20240922$$CN$US$US
242676571$24267657$1$I$$20240822$20240830$20240830$EXP$$US-GSK-US2024105542$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240830$$MD$US$US
242676602$24267660$2$F$20240801$20240911$20240830$20240913$EXP$$PE-JNJFOC-20240870196$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240913$$CN$PE$PE
242676611$24267661$1$I$20240101$20240828$20240830$20240830$EXP$$US-ABBVIE-5900814$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242676621$24267662$1$I$20240824$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024170146$AMGEN$$78$YR$E$M$Y$$$20240830$$CN$US$US
242676631$24267663$1$I$20240729$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59653$$FDA-CTU$$70$YR$$F$N$53.52$KG$20240829$N$HP$US$
242676641$24267664$1$I$20240706$20240819$20240830$20240830$EXP$IT-MINISAL02-999382$IT-MACLEODS PHARMA-MAC2024048984$MACLEODS$$$$$$Y$$$20240830$$MD$IT$IT
242676651$24267665$1$I$$20240819$20240830$20240830$EXP$$US-MACLEODS PHARMA-MAC2024048991$MACLEODS$Woods HB, Bharathidasan K, Yang M, Nichols J, Nugent K..Delayed onset Graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency  virus: A case series.American Journal of the Medical Sciences.2024;367(Suppl 1):S9-10$$$$$Y$$$20240830$$MD$US$US
242676661$24267666$1$I$$20240822$20240830$20240830$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010818$STRIDES$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.. Cancer-Immunol-Immunother. 2024;73$$$$$Y$$$20240830$$HP$US$US
242676671$24267667$1$I$$20240819$20240830$20240830$EXP$$ZA-MACLEODS PHARMA-MAC2024048983$MACLEODS$$$$$$Y$$$20240830$$CN$ZA$ZA
242676681$24267668$1$I$$20240819$20240830$20240830$EXP$$NO-MACLEODS PHARMA-MAC2024048992$MACLEODS$Janeras L, Breivik H, Lundeland B, Ringstad GA, Stubhaug A.Long-term intrathecal infusion of low-dose morphine effectively relieves symptoms of severe restless legs syndrome/Willis-Ekbom disease without inducing opioid tolerance.Pain.2024;1-5$$$$F$Y$$$20240830$$MD$NO$NO
242676691$24267669$1$I$20240823$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018382$ELI LILLY AND CO$$$$A$M$Y$$$20240830$$CN$US$US
242676701$24267670$1$I$20240310$20240819$20240830$20240830$EXP$GB-MHRA-MED-202408190134368090-SQLMH$GB-MACLEODS PHARMA-MAC2024048995$MACLEODS$$$$$$Y$$$20240830$$CN$GB$GB
242676712$24267671$2$F$$20240911$20240830$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202408016368$ELI LILLY AND CO$$57$YR$A$$Y$$$20240917$$CN$US$US
242676722$24267672$2$F$$20240925$20240830$20240930$EXP$$NL-PFIZER INC-202400245613$PFIZER$$$$$$Y$$$20240930$$HP$NL$NL
242676731$24267673$1$I$$20240826$20240830$20240830$PER$$US-PFIZER INC-202400243967$PFIZER$$64$YR$$M$Y$111.13$KG$20240830$$CN$US$US
242676741$24267674$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245939$PFIZER$$44$YR$$F$Y$$$20240830$$HP$US$US
242676751$24267675$1$I$$20240826$20240830$20240830$PER$$US-PFIZER INC-202400243971$PFIZER$$71$YR$$F$Y$$$20240830$$PH$US$US
242676761$24267676$1$I$20160101$20240821$20240830$20240830$PER$$US-PFIZER INC-202400243547$PFIZER$$72$YR$$F$Y$$$20240830$$MD$US$US
242676771$24267677$1$I$20240826$20240826$20240830$20240830$PER$$US-PFIZER INC-PV202400111567$PFIZER$$63$YR$$F$Y$$$20240830$$CN$US$US
242676783$24267678$3$F$20240830$20240904$20240830$20240909$PER$$US-PFIZER INC-202400245441$PFIZER$$79$YR$$F$Y$$$20240909$$PH$US$US
242676791$24267679$1$I$$20240822$20240830$20240830$PER$$US-PFIZER INC-PV202400110492$PFIZER$$59$YR$$F$Y$$$20240830$$HP$US$US
242676802$24267680$2$F$$20240903$20240830$20240906$PER$$US-PFIZER INC-PV202400111812$PFIZER$$72$YR$$F$Y$118.09$KG$20240906$$HP$US$US
242676813$24267681$3$F$$20240922$20240830$20240926$PER$$US-PFIZER INC-202400245130$PFIZER$$57$YR$$F$Y$$$20240926$$HP$US$US
242676821$24267682$1$I$20240101$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245328$PFIZER$$61$YR$$F$Y$$$20240830$$HP$US$US
242676831$24267683$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-PV202400112027$PFIZER$$77$YR$$F$Y$$$20240830$$HP$US$US
242676841$24267684$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245909$PFIZER$$47$YR$$F$Y$$$20240830$$HP$US$US
242676851$24267685$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400244983$PFIZER$$$$A$F$Y$$$20240830$$CN$US$US
242676861$24267686$1$I$$20240826$20240830$20240830$PER$$US-PFIZER INC-PV202400111545$PFIZER$$28$YR$$F$Y$$$20240830$$HP$US$US
242676871$24267687$1$I$$20240826$20240830$20240830$PER$$US-PFIZER INC-PV202400111823$PFIZER$$67$YR$$F$Y$$$20240830$$CN$US$US
242676882$24267688$2$F$20240701$20240830$20240830$20240830$PER$$US-PFIZER INC-202400245918$PFIZER$$65$YR$$F$Y$$$20240830$$HP$US$US
242676891$24267689$1$I$20231001$20231028$20240830$20240830$EXP$$CN-PFIZER INC-PV202400112084$PFIZER$$37$YR$$M$Y$$$20240830$$CN$CN$CN
242676901$24267690$1$I$20240101$20240827$20240830$20240830$PER$$US-PFIZER INC-PV202400112199$PFIZER$$42$YR$$M$Y$$$20240830$$HP$US$US
242676911$24267691$1$I$$20240826$20240830$20240830$PER$$US-PFIZER INC-202400245058$PFIZER$$67$YR$$M$Y$$$20240830$$HP$US$US
242676924$24267692$4$F$20240825$20240912$20240830$20240913$EXP$$EG-SANDOZ INC.-SDZ2024EG075967$SANDOZ$$5$YR$$M$Y$$$20240913$$PH$EG$EG
242676933$24267693$3$F$20240424$20240828$20240830$20240924$EXP$$AU-BEH-2024177287$CSL BEHRING$$71$YR$E$F$Y$79$KG$20240924$$MD$AU$AU
242676941$24267694$1$I$$20240806$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07948$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242676951$24267695$1$I$20240818$20240822$20240830$20240830$EXP$$US-BAYER-2024A122487$BAYER$$69$YR$E$F$Y$46.259$KG$20240830$$HP$US$US
242676961$24267696$1$I$$20240823$20240830$20240830$EXP$$US-BAYER-2024A122281$BAYER$$$$$F$Y$$$20240830$$HP$US$US
242676971$24267697$1$I$$20240821$20240830$20240830$30DAY$$US-GSK-US2024AMR105979$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242676981$24267698$1$I$$20240822$20240830$20240830$EXP$$US-GSK-US2024105119$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$US$US
242676991$24267699$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024172581$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242677001$24267700$1$I$20240701$20240822$20240830$20240830$PER$$US-ASTELLAS-2024-AER-002644$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242677014$24267701$4$F$$20240819$20240830$20240909$PER$$US-ROCHE-10000062101$ROCHE$$17$YR$T$F$Y$68.89$KG$20240909$$CN$US$US
242677022$24267702$2$F$$20240829$20240830$20240902$PER$$NVSC2024US174934$NOVARTIS$$$$$$Y$$$20240902$$CN$US$US
242677031$24267703$1$I$20240301$20240820$20240830$20240830$EXP$$US-TEVA-VS-3174700$TEVA$$45$YR$$M$Y$77.27$KG$20240830$$PH$US$US
242677041$24267704$1$I$$20240827$20240830$20240830$EXP$$US-AMERICAN REGENT INC-2024003318$AMERICAN REGENT$Credo R, Kesey J, Bharadia D, Griswold J, Pang A. Acute Intermittent Porphyria in a Burn Patient: Case Study and Review of the Literature. Journal of Burn Care + Research. 2024;45(3):790-795$60$YR$$M$Y$$$20240830$$HP$US$US
242677051$24267705$1$I$20240808$20240808$20240830$20240830$PER$$US-UniquePharma-US-2024UPLSPO00030$UNIQUE PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242677071$24267707$1$I$20240713$20240822$20240830$20240830$EXP$$CN-AstraZeneca-2024A194768$ASTRAZENECA$$21702$DY$$F$Y$48$KG$20240830$$MD$CN$
242677082$24267708$2$F$$20240902$20240830$20240903$EXP$$IT-UCBSA-2023026102$UCB$Falcicchio G, Lattanzi S, Negri F, De Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox?Gastaut Syndrome: A Case Series. Journal of Clinical Medicine. 2023;12(1):129$27$YR$$M$Y$$$20240903$$HP$IT$IT
242677091$24267709$1$I$$20240819$20240830$20240830$PER$$US-AstraZeneca-2024A189226$ASTRAZENECA$$$$$$Y$$$20240830$$CN$US$
242677101$24267710$1$I$20240819$20240821$20240830$20240830$EXP$$US-ZENPEP LLC-2024AIMT01279$AIMMUNE$$$$$$Y$$$20240830$$CN$US$US
242677111$24267711$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A194185$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242677121$24267712$1$I$20240801$20240827$20240830$20240830$PER$$US-PFIZER INC-PV202400112672$PFIZER$$76$YR$$$Y$$$20240830$$CN$US$US
242677131$24267713$1$I$20220101$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245135$PFIZER$$30$YR$$M$Y$77.11$KG$20240830$$CN$US$US
242677141$24267714$1$I$$20240829$20240829$20240829$DIR$716429$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242677171$24267717$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-PV202400112502$PFIZER$$36$YR$$F$Y$$$20240830$$HP$US$US
242677182$24267718$2$F$20240801$20240830$20240830$20240904$PER$$US-PFIZER INC-202400245205$PFIZER$$91$YR$$M$Y$72.57$KG$20240904$$HP$US$US
242677201$24267720$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-PV202400112418$PFIZER$$77$YR$$$Y$$$20240830$$CN$US$US
242677211$24267721$1$I$20240827$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245563$PFIZER$$63$YR$$F$Y$$$20240830$$CN$US$US
242677221$24267722$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245009$PFIZER$$5$DEC$$F$Y$$$20240830$$PH$US$US
242677231$24267723$1$I$20240801$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245160$PFIZER$$84$YR$$M$Y$77.11$KG$20240830$$CN$US$US
242677241$24267724$1$I$20240808$20240829$20240829$20240829$DIR$716422$$FDA-CTU$$63$YR$$F$N$67.6$KG$20240829$N$MD$US$
242677251$24267725$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245136$PFIZER$$$$$F$Y$48.99$KG$20240830$$CN$US$US
242677271$24267727$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245322$PFIZER$$69$YR$$F$Y$79.83$KG$20240830$$CN$US$US
242677281$24267728$1$I$20240801$20240827$20240830$20240830$PER$$US-PFIZER INC-PV202400112453$PFIZER$$38$YR$$F$Y$$$20240830$$HP$US$US
242677291$24267729$1$I$20240701$20240827$20240830$20240830$PER$$US-PFIZER INC-202400239994$PFIZER$$74$YR$$F$Y$58.06$KG$20240830$$MD$US$US
242677311$24267731$1$I$20240826$20240829$20240829$20240829$DIR$716417$$FDA-CTU$$61$YR$$M$N$$$20240829$N$CN$US$
242677321$24267732$1$I$$20240829$20240829$20240829$DIR$716420$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242677331$24267733$1$I$20240821$20240829$20240829$20240829$DIR$716418$$FDA-CTU$$58$YR$$F$N$$$20240829$N$PH$US$
242677341$24267734$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59748$$FDA-CTU$$30$YR$$F$N$$$20240829$N$$US$
242677351$24267735$1$I$20240827$20240829$20240829$20240829$DIR$716421$$FDA-CTU$$55$YR$$F$N$65.25$KG$20240829$Y$CN$US$
242677361$24267736$1$I$20240824$20240829$20240829$20240829$DIR$716396$$FDA-CTU$$73$YR$$F$N$$$20240829$N$$US$
242677371$24267737$1$I$20240827$20240829$20240829$20240829$DIR$716372$$FDA-CTU$$60$YR$$F$N$70.65$KG$20240829$N$CN$US$
242677381$24267738$1$I$20240809$20240828$20240830$20240830$EXP$FR-AFSSAPS-BX2024001704$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-136961$BRISTOL MYERS SQUIBB$$14$YR$T$F$Y$56.2$KG$20240830$$MD$FR$FR
242677391$24267739$1$I$20240807$20240829$20240829$20240829$DIR$716425$$FDA-CTU$$66$YR$$F$N$67.5$KG$20240829$Y$CN$US$
242677401$24267740$1$I$$20240822$20240830$20240830$EXP$$US-MYLANLABS-2024M1079010$MYLAN$Fatima R, Altorok N. Secukinumab-Induced Bullous Pemphigoid in a Patient with Psoriatic Arthritis. Am-J-Ther 2024; 31 (4): e434-e435.$62$YR$$M$Y$$$20240830$$MD$US$US
242677411$24267741$1$I$$20240822$20240830$20240830$EXP$$US-MYLANLABS-2024M1079263$MYLAN$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.$75$YR$$F$Y$$$20240830$$HP$US$US
242677421$24267742$1$I$$20240822$20240830$20240830$EXP$$US-MYLANLABS-2024M1079267$MYLAN$Smith S, Grove D. Distal toxic acral erythema and mucositis secondary to 6-mercaptopurine in a thiopurine methyltransferase ^super shunter^. Pediatr-Dermatol 2024; 41 (4): 722-725.$4$YR$$F$Y$$$20240830$$MD$US$US
242677431$24267743$1$I$$20240822$20240830$20240830$EXP$$US-MYLANLABS-2024M1079227$MYLAN$Dana IN, Austin E, Asrani F. Mucocutaneous ulcers in an immunocompromised patient. JAAD-Case-Rep 2024; 51 48-50.$49$YR$$F$Y$$$20240830$$HP$US$US
242677441$24267744$1$I$$20240820$20240830$20240830$EXP$$CA-TEVA-VS-3235048$TEVA$$$$$F$Y$$$20240830$$HP$CA$CA
242677451$24267745$1$I$$20240522$20240830$20240830$EXP$$JP-ASTELLAS-2024-AER-003318$ASTELLAS$$70$YR$E$M$Y$$$20240830$$MD$JP$JP
242677461$24267746$1$I$20240117$20240829$20240829$20240829$DIR$716437$$FDA-CTU$$69$YR$$M$N$$$20240829$N$$US$
242677471$24267747$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59684$$FDA-CTU$$77$YR$$F$N$78.47$KG$20240829$N$$US$
242677481$24267748$1$I$20240616$20240820$20240830$20240830$EXP$$US-VIIV HEALTHCARE LIMITED-US2024103886$VIIV$$65$YR$$F$Y$$$20240830$$CN$US$US
242677491$24267749$1$I$$20240822$20240830$20240830$EXP$$US-GSK-US2024104960$GLAXOSMITHKLINE$$3$DEC$$M$Y$$$20240830$$HP$US$US
242677501$24267750$1$I$20240517$20240829$20240829$20240829$DIR$716430$$FDA-CTU$$68$YR$$M$N$$$20240829$Y$HP$US$
242677511$24267751$1$I$20240327$20240829$20240829$20240829$DIR$716438$$FDA-CTU$$81$YR$$M$N$$$20240829$N$$US$
242677522$24267752$2$F$$20240830$20240830$20240903$EXP$$US-GSK-US2024107233$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
242677531$24267753$1$I$20240820$20240827$20240830$20240830$EXP$$US-GSK-US2024106673$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$US$US
242677541$24267754$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-085157-2024$RECKITT BENCKISER$$43$YR$$F$Y$$$20240830$$CN$US$US
242677561$24267756$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59610$$FDA-CTU$$76$YR$$F$N$98.88$KG$20240829$N$$US$
242677571$24267757$1$I$$20240702$20240830$20240830$PER$$FR-SIGA Technologies, Inc.-2161012$SIGA TECHNOLOGIES$$$$$$Y$$$20240830$$$FR$FR
242677601$24267760$1$I$20240716$20240820$20240830$20240830$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161019$JIANGSU HENGRUI MEDICINE$$26$YR$$F$Y$72$KG$20240830$$MD$CN$CN
242677611$24267761$1$I$$20240702$20240830$20240830$PER$$FR-SIGA Technologies, Inc.-2161010$SIGA TECHNOLOGIES$$$$$$Y$$$20240830$$$FR$FR
242677621$24267762$1$I$$20240821$20240830$20240830$PER$$US-APOTEX-2024AP009847$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242677641$24267764$1$I$$20240829$20240830$20240830$PER$$NVSC2024US175000$NOVARTIS$$$$$F$Y$$$20240830$$MD$US$US
242677653$24267765$3$F$$20240925$20240830$20240928$EXP$$PT-Karo Pharma-2160996$Karo Pharma$$81$YR$$M$Y$$$20240928$$MD$PT$PT
242677671$24267767$1$I$$20240807$20240830$20240830$EXP$$GB-Karo Pharma-2160998$Karo Pharma$$$$$F$Y$$$20240830$$$GB$GB
242677681$24267768$1$I$20240826$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024173045$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242677693$24267769$3$F$20240820$20240905$20240830$20240918$30DAY$$US-AMGEN-USASP2024168307$AMGEN$$62$YR$A$F$Y$58.503$KG$20240918$$HP$US$US
242677711$24267771$1$I$$20240814$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004693$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242677721$24267772$1$I$20240101$20240822$20240830$20240830$EXP$$HU-ABBVIE-5900739$ABBVIE$$39$YR$$F$Y$$$20240830$$MD$HU$HU
242677731$24267773$1$I$20240801$20240826$20240830$20240830$EXP$$US-BAYER-2024A122502$BAYER$$48$YR$A$F$Y$$$20240830$$CN$US$US
242677741$24267774$1$I$$20231110$20240830$20240830$PER$$US-STERISCIENCE B.V.-2023-ST-002198$Steriscience PTE$Kong C, Bubic IJ, Tran AA, Tan G, Medak AJ, Oswald J.. Genicular nerve block for emergency department patient: A successful management of subacute osteoarthritic knee pain.. Pain-Management. 2023;13(7):373-378$72$YR$$F$Y$$$20240830$$HP$US$US
242677751$24267775$1$I$$20240702$20240830$20240830$EXP$$US-Jiangsu Hengrui Medicine Co., Ltd.-2161023$JIANGSU HENGRUI MEDICINE$Cytomegalovirus Retinitis in an Eye with Unilateral Retinoblastoma: A Case Report. Case Reports in Ophthalmology.$24$MON$$M$Y$$$20240830$$MD$US$US
242677761$24267776$1$I$$20230921$20240830$20240830$PER$$US-STERISCIENCE B.V.-2023-ST-001967$Steriscience PTE$Bromberg H, Guastella A, Haas M, Akel R, Craig D.. Two Patients Experience Same-Day Analgesic Effect of Methadone on Trigeminal Neuralgia Secondary to Malignancy: A Case Report.. J-Palliat-Med. 2023;26(7):1024-1026$45$YR$$M$Y$$$20240830$$MD$US$US
242677771$24267777$1$I$20240501$20240829$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137984$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240830$$CN$US$US
242677781$24267778$1$I$$20240829$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138138$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240830$$CN$US$US
242677791$24267779$1$I$$20240709$20240830$20240830$PER$$US-STERISCIENCE B.V.-2024-ST-001047$Steriscience PTE$Mittal S, Eftekharzadeh S, Weinstein C, Fombona A, Hyacinthe N, Shah YB, et al. Does ketorolac administration at the time of hypospadias surgery increase unplanned encounters in the immediate postoperative period?. J-Pediatr-Urol. 2023;19 (3):289.e1-289.e6$$$$$Y$$$20240830$$HP$US$US
242677801$24267780$1$I$20230501$20240822$20240830$20240830$EXP$$JP-009507513-2406JPN001635J$MERCK$$52$YR$$F$Y$$$20240830$$MD$JP$JP
242677811$24267781$1$I$$20240814$20240830$20240830$EXP$$US-Nostrum Laboratories, Inc.-2161016$NOSTRUM$$$$$F$Y$$$20240830$$$US$US
242677822$24267782$2$F$$20240820$20240830$20240912$PER$$US-SMPA-2024SPA001108$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
242677841$24267784$1$I$20230101$20240816$20240830$20240830$EXP$$GB-Ascend Therapeutics US, LLC-2160997$ASCEND$$$$$M$Y$$$20240830$$$GB$GB
242677851$24267785$1$I$20200601$20240820$20240830$20240830$EXP$$US-ROCHE-10000014751$ROCHE$$81$YR$E$F$Y$$$20240830$$CN$US$US
242677861$24267786$1$I$20240723$20240816$20240830$20240830$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161020$JIANGSU HANSOH PHARMACEUTICAL$$59$YR$$M$Y$69$KG$20240830$$MD$CN$CN
242677871$24267787$1$I$$20240828$20240830$20240830$EXP$US-MLMSERVICE-20240815-PI164305-00123-1$US-SANDOZ INC.-SDZ2024US076141$SANDOZ$$75$YR$$F$Y$$$20240830$$MD$US$US
242677881$24267788$1$I$$20240702$20240830$20240830$PER$$FR-SIGA Technologies, Inc.-2161013$SIGA TECHNOLOGIES$$$$$$Y$$$20240830$$$FR$FR
242677891$24267789$1$I$$20240826$20240830$20240830$PER$$US-Mission Pharmacal Company-2161004$MISSION$$47$YR$$F$Y$$$20240830$$$US$US
242677902$24267790$2$F$$20240906$20240830$20240917$PER$$KR-SIGA Technologies, Inc.-2161014$SIGA TECHNOLOGIES$$23$YR$$M$Y$$$20240917$$MD$KR$KR
242677911$24267791$1$I$$20240828$20240830$20240830$EXP$$US-AVA, Inc.-2161005$AVA$$$$$F$Y$$$20240830$$$US$US
242677921$24267792$1$I$20240719$20240819$20240830$20240830$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161024$JIANGSU HENGRUI MEDICINE$$47$YR$$F$Y$61$KG$20240830$$MD$CN$CN
242677931$24267793$1$I$$20240814$20240830$20240830$EXP$$CN-ASTELLAS-2024-AER-001839$ASTELLAS$Shen C, Dou Y. An efficient and successful outcome after haematopoietic stem cell transplantation in a patient with an LPS-responsive beige-like anchor gene mutation. Frontiers in Pediatrics. 2024 Jul 23;12(Unknown): 1-10. doi:10.3389/fped.2024.1420118.$$$C$M$Y$$$20240830$$HP$CN$CN
242677941$24267794$1$I$20230101$20231212$20240830$20240830$PER$US-MLMSERVICE-20231123-4684119-1$US-STERISCIENCE B.V.-2023-ST-002333$Steriscience PTE$Koenig NI, Mcguire JA, Shackleford VP, Bauer K.. Reactivation of Herpes Simplex Virus Following Sphenopalatine Ganglion Nerve Block: Case Report and Review of the Literature. A-A-Pract. 2023;17 (10)$36$YR$$F$Y$$$20240830$$HP$US$US
242677951$24267795$1$I$20240101$20240814$20240830$20240830$EXP$$GB-Ascend Therapeutics US, LLC-2161000$ASCEND$$49$YR$$F$Y$$$20240830$$$GB$GB
242677961$24267796$1$I$$20240819$20240830$20240830$PER$$US-P+L Developments of Newyork Corporation-2161031$PL DEVELOPMENTS$$$$$$Y$$$20240830$$$US$US
242677971$24267797$1$I$20240107$20240820$20240830$20240830$EXP$CH-SM-2024-10508$CH-TEVA-VS-3235316$TEVA$$54$YR$$M$Y$89.7$KG$20240830$$MD$CH$CH
242677981$24267798$1$I$20240813$20240818$20240830$20240830$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161030$JIANGSU HANSOH PHARMACEUTICAL$$60$YR$$M$Y$$$20240830$$MD$CN$CN
242677991$24267799$1$I$20240719$20240829$20240829$20240829$DIR$716451$$FDA-CTU$$71$YR$$M$N$89.55$KG$20240829$N$PH$US$
242678001$24267800$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898940$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242678011$24267801$1$I$$20240827$20240830$20240830$PER$$US-GILEAD-2024-0685655$GILEAD$$$$$$Y$$$20240830$$CN$US$US
242678021$24267802$1$I$20240809$20240820$20240830$20240830$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161026$JIANGSU HENGRUI MEDICINE$$73$YR$$M$Y$54$KG$20240830$$MD$CN$CN
242678031$24267803$1$I$20240628$20240702$20240830$20240830$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161032$JIANGSU HANSOH PHARMACEUTICAL$$35$YR$$M$Y$60$KG$20240830$$MD$CN$CN
242678041$24267804$1$I$20240629$20240829$20240829$20240829$DIR$716427$$FDA-CTU$$63$YR$$M$N$$$20240829$N$$US$
242678051$24267805$1$I$$20240820$20240830$20240830$EXP$$GB-AUROBINDO-AUR-APL-2023-038981$AUROBINDO$$83$YR$$M$Y$$$20240830$$HP$GB$GB
242678061$24267806$1$I$20240811$20240820$20240830$20240830$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161025$JIANGSU HENGRUI MEDICINE$$14$YR$$F$Y$36.8$KG$20240830$$MD$CN$CN
242678071$24267807$1$I$20240623$20240829$20240829$20240829$DIR$716428$$FDA-CTU$$62$YR$$F$N$$$20240829$N$$US$
242678082$24267808$2$F$$20240901$20240830$20240904$EXP$$US-ROCHE-10000066696$ROCHE$$$$$M$Y$$$20240904$$CN$US$US
242678091$24267809$1$I$20240808$20240819$20240830$20240830$PER$$US-P+L Developments of Newyork Corporation-2161029$PL DEVELOPMENTS$$$$$F$Y$$$20240830$$$US$US
242678111$24267811$1$I$20240826$20240829$20240829$20240829$DIR$716461$$FDA-CTU$$68$YR$$F$N$$$20240829$N$$US$
242678121$24267812$1$I$$20240826$20240830$20240830$EXP$$MY-BAYER-2024A123665$BAYER$$$$$M$Y$$$20240830$$HP$MY$MY
242678131$24267813$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59768$$FDA-CTU$$59$YR$$F$N$$$20240829$N$$US$
242678141$24267814$1$I$$20240821$20240830$20240830$PER$$US-APOTEX-2024AP009848$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242678151$24267815$1$I$$20240819$20240830$20240830$EXP$$US-Accord-443006$ACCORD$$$$$M$Y$83.46$KG$20240830$$HP$US$US
242678161$24267816$1$I$20240812$20240819$20240830$20240830$EXP$$US-Accord-443384$ACCORD$$64$YR$A$M$Y$$$20240830$$HP$US$US
242678172$24267817$2$F$$20240906$20240830$20240918$EXP$GB-MHRA-MED-202408191528579690-FHGPQ$GB-Accord-442686$ACCORD$$$$$F$Y$$$20240918$$PH$GB$GB
242678181$24267818$1$I$20210101$20240819$20240830$20240830$EXP$GB-MHRA-MED-202408192109260830-YVNKD$GB-Accord-442601$ACCORD$$74$YR$E$M$Y$77$KG$20240830$$CN$GB$GB
242678191$24267819$1$I$$20240819$20240830$20240830$EXP$$US-Accord-443650$ACCORD$$25$YR$A$M$Y$$$20240830$$HP$US$US
242678201$24267820$1$I$20240815$20240819$20240830$20240830$EXP$$US-Accord-443072$ACCORD$$53$YR$A$F$Y$$$20240830$$PH$US$US
242678211$24267821$1$I$20200901$20240818$20240830$20240830$EXP$$ES-Accord-442871$ACCORD$Erquicia Peralt J, Fernandez Gonzalez L, Garcia San Roman K, Astorga Burgo JC, Acin Labarta A. An acute coronary syndrome in an unusual patient: analysing cisplatin toxicity-a case report and review of the literature. Eur Heart J Case Rep. 2024 Aug 2;8(8):ytae365. doi: 10.1093/ehjcr/ytae365.$23$YR$A$M$Y$$$20240830$$MD$ES$ES
242678221$24267822$1$I$$20240823$20240830$20240830$EXP$$US-COLGATE PALMOLIVE COMPANY-20240801316$COLGATE$$24$YR$$F$Y$$$20240830$$CN$US$US
242678231$24267823$1$I$$20240826$20240830$20240830$EXP$$AU-ROCHE-10000065894$ROCHE$Tatarczuch M, Lewis K, Gunjur A, Shaw B, Poon L, Paul E, et al. Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance. eJHaem. 2024-Aug;5 (4):709-20. doi:10.1002/jha2.951.$$$$$Y$$$20240830$$HP$AU$AU
242678241$24267824$1$I$$20240827$20240830$20240830$EXP$$US-SANDOZ INC.-SDZ2024US075915$SANDOZ$$$$$$Y$$$20240830$$CN$US$US
242678251$24267825$1$I$$20240821$20240830$20240830$EXP$$US-BAXTER-2024BAX023662$BAXTER$$50$YR$$F$Y$54.4$KG$20240830$$HP$US$US
242678261$24267826$1$I$20240701$20240820$20240830$20240830$EXP$$US-GSK-US2024103969$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240830$$CN$US$US
242678271$24267827$1$I$$20240820$20240830$20240830$EXP$$JP-BAXTER-2024BAX023773$BAXTER$$$$A$F$Y$$$20240830$$CN$JP$JP
242678281$24267828$1$I$20240801$20240820$20240830$20240830$30DAY$$US-GSK-US2024103907$GLAXOSMITHKLINE$$43$YR$$F$Y$$$20240830$$CN$US$US
242678291$24267829$1$I$$20240826$20240830$20240830$EXP$$DE-SA-2024SA252122$SANOFI AVENTIS$Shamseldin M, Heers H, Steiner T, Puls R.. Anatomic locations of ureterovascular fistulae: a review of 532 patients in the literature and a new series of 8 patients. CVIR Endovascular. 2024;7(1):63$84$YR$E$M$Y$$$20240830$$HP$DE$DE
242678301$24267830$1$I$20240701$20240826$20240830$20240830$EXP$$US-JNJFOC-20240877072$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240830$$HP$US$US
242678311$24267831$1$I$20170608$20240827$20240830$20240830$EXP$PL-URPL-2-423-2019$PL-ORGANON-O2408POL001972$ORGANON$$$$$M$Y$$$20240830$$CN$PL$PL
242678331$24267833$1$I$20240813$20240814$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004719$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240830$$CN$US$US
242678341$24267834$1$I$$20240822$20240830$20240830$EXP$$JP-AstraZeneca-2024A193725$ASTRAZENECA$$$$$F$Y$$$20240830$$PH$JP$
242678351$24267835$1$I$$20240821$20240830$20240830$EXP$$CA-TEVA-VS-3235826$TEVA$$$$$M$Y$$$20240830$$HP$CA$CA
242678361$24267836$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A193231$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242678371$24267837$1$I$$20240822$20240830$20240830$EXP$$US-ABBVIE-5891713$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242678382$24267838$2$F$20240827$20240828$20240830$20240904$PER$$US-AMGEN-USASP2024172656$AMGEN$$66$YR$E$M$Y$$$20240904$$PH$US$US
242678391$24267839$1$I$$20240821$20240830$20240830$EXP$$US-PROCTER+GAMBLE-PH24006806$PROCTER AND GAMBLE$Green KD, Bianco LM, McCleskey BC, Scott KS. The Emergence of Bromazolam in Jefferson County AL. A Case Series. J Anal Toxicol. 2024;1$34$YR$$F$Y$$$20240830$$HP$US$US
242678401$24267840$1$I$20240801$20240823$20240830$20240830$PER$$US-ALXN-202408USA001951US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242678421$24267842$1$I$$20240816$20240830$20240830$EXP$$US-UCBSA-2024041922$UCB$$$$$F$Y$$$20240830$$HP$US$US
242678431$24267843$1$I$20240824$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59765$$FDA-CTU$$79$YR$$F$N$$$20240829$Y$PH$US$
242678443$24267844$3$F$20240511$20240905$20240830$20240911$PER$$US-AMGEN-USASP2024171019$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
242678451$24267845$1$I$20240803$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024170476$AMGEN$$80$YR$E$M$Y$$$20240830$$CN$US$US
242678471$24267847$1$I$$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024170719$AMGEN$$$$$$Y$$$20240830$$HP$US$US
242678491$24267849$1$I$20230101$20240816$20240830$20240830$PER$$US-009507513-2408USA006400$MERCK$$$$$F$Y$$$20240830$$CN$US$US
242678502$24267850$2$F$$20240826$20240830$20240910$PER$$US-BAYER-2024A122536$BAYER$$33$YR$A$F$Y$$$20240910$$MD$US$US
242678521$24267852$1$I$20240512$20240819$20240830$20240830$EXP$GB-MHRA-MED-202408191143490880-GTNKD$GB-Accord-442474$ACCORD$$69$YR$E$M$Y$98$KG$20240830$$PH$GB$GB
242678531$24267853$1$I$$20240819$20240830$20240830$EXP$CA-MHPD-E2B_07179024$CA-Accord-442618$ACCORD$$$$A$$Y$$$20240830$$HP$CA$CA
242678541$24267854$1$I$20240719$20240819$20240830$20240830$EXP$CN-HENLIUS-24CN016492$CN-Accord-443536$ACCORD$$37$YR$A$F$Y$61$KG$20240830$$MD$CN$CN
242678551$24267855$1$I$$20240827$20240830$20240830$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001756$BLUEPRINT MEDICINES$$$$$F$Y$$$20240830$$CN$US$US
242678561$24267856$1$I$20220601$20240822$20240830$20240830$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08035$HIKMA$$$$A$F$Y$$$20240830$$MD$US$US
242678571$24267857$1$I$$20240828$20240830$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA076014$SANDOZ$$4$DEC$$F$Y$$$20240830$$MD$CA$CA
242678581$24267858$1$I$$20240822$20240830$20240830$EXP$$CA-APOTEX-2024AP009711$APOTEX$$67$YR$$F$Y$$$20240830$$HP$CA$CA
242678591$24267859$1$I$$20240819$20240830$20240830$PER$$US-SA-2024SA217852$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240830$$MD$US$US
242678601$24267860$1$I$20240101$20240824$20240830$20240830$EXP$$US-SA-2024SA251975$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240830$$MD$US$US
242678611$24267861$1$I$20240531$20240813$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002654$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240830$$CN$US$US
242678621$24267862$1$I$$20240805$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08091$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242678631$24267863$1$I$20240810$20240827$20240830$20240830$EXP$$NL-AMGEN-NLDSL2024171792$AMGEN$$69$YR$E$M$Y$$$20240830$$CN$NL$NL
242678641$24267864$1$I$$20240816$20240830$20240830$EXP$$AU-LUPIN EUROPE GMBH-2024-08388$LUPIN$$$$$M$Y$$$20240830$$CN$AU$AU
242678651$24267865$1$I$20240815$20240820$20240830$20240830$EXP$$GB-AUROBINDO-AUR-APL-2024-041999$AUROBINDO$$23$YR$$F$Y$50$KG$20240830$$CN$GB$GB
242678681$24267868$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137497$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240830$$HP$US$US
242678691$24267869$1$I$20240801$20240815$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004762$ACADIA PHARMACEUTICALS$$66$YR$$F$Y$$$20240830$$CN$US$US
242678701$24267870$1$I$20240701$20240826$20240830$20240830$EXP$$PL-BAYER-2024A124086$BAYER$$74$YR$E$F$Y$$$20240830$$HP$PL$PL
242678711$24267871$1$I$20240321$20240820$20240830$20240830$EXP$$GB-AUROBINDO-AUR-APL-2024-041995$AUROBINDO$$38$YR$$$Y$$$20240830$$CN$GB$GB
242678721$24267872$1$I$$20240818$20240830$20240830$EXP$$DE-Nexus Pharma-000305$NEXUS PHARMACEUTICALS$Nagele H, Rosenkranz M, Nagele MP. Hyponatremia-Induced Epileptic Seizure Provoked by Levetiracetam and Pain Medication Intake in a Patient with Central Diabetes Insipidus.$67$YR$E$M$Y$$$20240830$$HP$DE$DE
242678731$24267873$1$I$$20240814$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004736$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242678741$24267874$1$I$$20240823$20240830$20240830$PER$$US-AMGEN-USASP2024170460$AMGEN$$$$$$Y$$$20240830$$CN$US$US
242678751$24267875$1$I$$20240819$20240830$20240830$EXP$GB-MHRA-TPP10700375C9943625YC1723816014249$GB-Accord-442580$ACCORD$$71$YR$E$F$Y$60$KG$20240830$$MD$GB$GB
242678761$24267876$1$I$20240310$20240819$20240830$20240830$EXP$$GB-LUPIN PHARMACEUTICALS INC.-2024-08195$LUPIN$$$$$$Y$$$20240830$$CN$GB$GB
242678771$24267877$1$I$20240824$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59666$$FDA-CTU$$70$YR$$F$N$$$20240829$Y$HP$US$
242678781$24267878$1$I$20240826$20240829$20240829$20240829$DIR$716373$$FDA-CTU$$96$YR$$F$N$51$KG$20240829$N$PH$US$
242678791$24267879$1$I$20240804$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59786$$FDA-CTU$$59$YR$$F$N$$$20240829$N$$US$
242678811$24267881$1$I$$20240821$20240830$20240830$EXP$$US-APOTEX-2024AP009963$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242678821$24267882$1$I$20240823$20240829$20240830$20240830$PER$$US-JNJFOC-20240878256$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$CN$US$US
242678841$24267884$1$I$$20240825$20240830$20240830$PER$$US-009507513-2408USA009221$MERCK$$$$$M$Y$$$20240830$$CN$US$US
242678851$24267885$1$I$$20240828$20240830$20240830$EXP$$US-GILEAD-2024-0685755$GILEAD$$$$E$F$Y$$$20240830$$CN$US$US
242678881$24267888$1$I$20230101$20240826$20240830$20240830$EXP$$US-PFIZER INC-PV202300127864$PFIZER$$66$YR$$F$Y$$$20240830$$HP$US$US
242678891$24267889$1$I$$20240821$20240830$20240830$PER$$US-ABBVIE-5892307$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242678901$24267890$1$I$$20240828$20240830$20240830$PER$$NVSC2024US175192$NOVARTIS$$$$$$Y$$$20240830$$MD$US$US
242678921$24267892$1$I$$20240826$20240830$20240830$PER$$US-BAYER-2024A122835$BAYER$$57$YR$A$F$Y$$$20240830$$CN$US$US
242678931$24267893$1$I$$20240820$20240830$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR107154$VIIV$$$$$$Y$$$20240830$$HP$US$US
242678941$24267894$1$I$$20240825$20240830$20240830$EXP$$TH-ROCHE-10000066001$ROCHE$$93$YR$E$F$Y$$$20240830$$CN$TH$TH
242678961$24267896$1$I$$20240829$20240830$20240830$EXP$$US-ROCHE-10000070370$ROCHE$$$$A$F$Y$$$20240830$$CN$US$US
242678971$24267897$1$I$$20240824$20240830$20240830$EXP$$US-JNJFOC-20240865805$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$CN$US$US
242678991$24267899$1$I$$20240828$20240830$20240830$EXP$$US-JNJFOC-20240874624$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$HP$US$US
242679002$24267900$2$F$20240821$20240916$20240830$20240918$PER$$US-ALXN-202408USA001656US$ALEXION PHARMACEUTICALS$$38$YR$$F$Y$$$20240918$$CN$US$US
242679011$24267901$1$I$20240101$20240826$20240830$20240830$EXP$$US-JNJFOC-20240870185$JOHNSON AND JOHNSON$$$$I$F$Y$$$20240830$$HP$US$US
242679021$24267902$1$I$$20240820$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008744$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242679031$24267903$1$I$20240821$20240822$20240830$20240830$EXP$$FI-VANTIVE-2024VAN019366$Vantive US Healthcare$$$$$$Y$$$20240830$$MD$FI$FI
242679042$24267904$2$F$$20240829$20240830$20240912$EXP$$ZA-LUPIN PHARMACEUTICALS INC.-2024-08530$LUPIN$$$$$$Y$$$20240912$$CN$ZA$ZA
242679052$24267905$2$F$20240301$20240906$20240830$20240913$EXP$$US-BAYER-2024A107573$BAYER$$90$YR$E$M$Y$$$20240913$$CN$US$US
242679072$24267907$2$F$20231101$20240820$20240830$20240830$PER$$US-ROCHE-10000062587$ROCHE$$76$YR$E$M$Y$97.52$KG$20240830$$MD$US$US
242679082$24267908$2$F$20190101$20240910$20240830$20240918$EXP$$US-ZENPEP LLC-2024AIMT01294$AIMMUNE$$$$$$Y$$$20240918$$HP$US$US
242679091$24267909$1$I$$20240826$20240830$20240830$EXP$$US-AMGEN-USASP2024170366$AMGEN$$$$$F$Y$$$20240830$$CN$US$US
242679121$24267912$1$I$$20240805$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07937$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242679132$24267913$2$F$$20240828$20240830$20240903$EXP$$US-PFIZER INC-202400245829$PFIZER$$12$YR$$F$Y$25.714$KG$20240903$$PH$US$US
242679141$24267914$1$I$$20240820$20240830$20240830$EXP$$CN-009507513-2408CHN008769$MERCK$Xu C, Sha Y, Pan J, Pan T, Zhou Xi, Wang H, et al.. COVID-19 related acute necrotizing encephalopathy and acute myocarditis in an adult female: a novel case report of brain injury and myocarditis. BMC Neurology. 2024;24 (1):274$27$YR$$F$Y$44.5$KG$20240830$$HP$CN$CN
242679151$24267915$1$I$20240601$20240820$20240830$20240830$EXP$FR-AFSSAPS-NY2024000943$FR-TEVA-VS-3235233$TEVA$$63$YR$$F$Y$$$20240830$$CN$FR$FR
242679161$24267916$1$I$$20240816$20240830$20240830$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07966$HIKMA$Quan Soon KL, Shah S, Ibrahim R, Alzwahereh K.. Quan Soon KL, Shah S, Ibrahim R, Alzwahereh K. A Case Report on Iatrogenic Methotrexate Toxicity.. Cureus. 2024;16(7):e64081$54$YR$$F$Y$$$20240830$$MD$US$US
242679172$24267917$2$F$$20240909$20240830$20240919$PER$$US-INCYTE CORPORATION-2024IN008743$INCYTE$$$$$$Y$$$20240919$$CN$US$US
242679182$24267918$2$F$$20240923$20240830$20240925$EXP$$US-PFIZER INC-202400242040$PFIZER$$71$YR$$F$Y$67.13$KG$20240925$$CN$US$US
242679191$24267919$1$I$20240101$20240826$20240830$20240830$EXP$$US-PFIZER INC-PV202400111811$PFIZER$$18$YR$$M$Y$67.6$KG$20240830$$MD$US$US
242679201$24267920$1$I$20240311$20240826$20240830$20240830$EXP$IT-MINISAL02-999543$IT-ROCHE-10000065925$ROCHE$$5$MON$I$F$Y$2$KG$20240830$$MD$IT$IT
242679211$24267921$1$I$20230627$20240819$20240830$20240830$EXP$FR-AFSSAPS-PO2024000860$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-07931$HIKMA$$52$YR$$F$Y$$$20240830$$MD$FR$FR
242679221$24267922$1$I$20240402$20240828$20240830$20240830$EXP$$CN-HALEON-2194106$Haleon PLC$$71$YR$$M$Y$$$20240830$$HP$CN$CN
242679231$24267923$1$I$$20240830$20240830$20240830$EXP$$FI-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048747$BOEHRINGER INGELHEIM$$$$$$Y$$$20240830$$MD$FI$FI
242679241$24267924$1$I$$20240816$20240830$20240830$EXP$$AU-LUPIN EUROPE GMBH-2024-08368$LUPIN$$$$$$Y$$$20240830$$CN$AU$AU
242679252$24267925$2$F$$20240917$20240830$20240927$30DAY$$JP-JNJFOC-20240873034$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$JP$JP
242679261$24267926$1$I$$20240827$20240830$20240830$EXP$$LT-BAYER-2024A123653$BAYER$$$$$F$Y$$$20240830$$CN$LT$LT
242679271$24267927$1$I$20240731$20240822$20240830$20240830$EXP$$FR-Valinor Pharma, LLC-VLR202408-000101$Valinor Pharma$$88$YR$E$F$Y$45$KG$20240830$$PH$FR$
242679282$24267928$2$F$$20240829$20240830$20240830$EXP$$US-ROCHE-10000070115$ROCHE$$$$A$F$Y$$$20240830$$CN$US$US
242679291$24267929$1$I$20231215$20240819$20240830$20240830$EXP$FR-AFSSAPS-PO2024000878$FR-ROCHE-10000066049$ROCHE$$31$YR$A$F$Y$$$20240830$$MD$FR$FR
242679312$24267931$2$F$$20240906$20240830$20240910$EXP$$US-AMGEN-USASP2024169166$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
242679321$24267932$1$I$$20240823$20240830$20240830$EXP$$SG-ROCHE-10000065724$ROCHE$$61$YR$A$F$Y$$$20240830$$CN$SG$SG
242679331$24267933$1$I$$20240823$20240830$20240830$EXP$$US-MYLANLABS-2024M1041543$MYLAN$$$$$M$Y$$$20240830$$CN$US$US
242679341$24267934$1$I$$20240823$20240830$20240830$EXP$$IN-MYLANLABS-2024M1079582$MYLAN$Rupakumar T, Sankar A, Vijayasekharan K, VarikkattuRajendran P, ChellapanSojamani G, Rajeswari B, et al. Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India. Br-J-Haematol 2024; 220-228.$$$C$$Y$$$20240830$$HP$IN$IN
242679351$24267935$1$I$$20240823$20240830$20240830$EXP$$IN-MYLANLABS-2024M1079580$MYLAN$Rupakumar T, Sankar A, Vijayasekharan K, VarikkattuRajendran P, ChellapanSojamani G, Rajeswari B, et al. Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India. Br-J-Haematol 2024; 220-228.$$$C$$Y$$$20240830$$HP$IN$IN
242679361$24267936$1$I$$20240814$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004084$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242679371$24267937$1$I$20240101$20240823$20240830$20240830$EXP$$BR-SANDOZ INC.-SDZ2024BR076300$SANDOZ$$51$YR$$F$Y$$$20240830$$CN$BR$BR
242679381$24267938$1$I$20240818$20240828$20240830$20240830$EXP$$NVSC2024US174180$NOVARTIS$$87$YR$$F$Y$$$20240830$$MD$US$US
242679391$24267939$1$I$$20240820$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008737$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242679401$24267940$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018219$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240830$$CN$US$US
242679411$24267941$1$I$$20240823$20240830$20240830$EXP$$US-MYLANLABS-2024M1079595$MYLAN$Kistler EA, Clinebell K, Gannon JM, Nathaniel VI, Lupu AM, Chengappa KNR. Applying Shared Decision Making to the Process of Medication Deprescribing in Schizophrenia. Clin-Ther 2023; 45 (10): 1008-1011.$42$YR$$M$Y$$$20240830$$MD$US$US
242679423$24267942$3$F$20240101$20240906$20240830$20240912$PER$$CA-PFIZER INC-202400227891$PFIZER$$59$YR$$F$Y$$$20240912$$HP$CA$CA
242679431$24267943$1$I$20240820$20240828$20240830$20240830$EXP$GB-MHRA-MED-202408281629303290-NCTYL$GB-PFIZER INC-202400245769$PFIZER$$39$YR$$F$Y$59$KG$20240830$$CN$GB$GB
242679441$24267944$1$I$$20240821$20240830$20240830$EXP$$US-APOTEX-2024AP009964$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242679461$24267946$1$I$$20240822$20240830$20240830$EXP$$US-Calliditas-2024CAL01645$CALLIDITAS THERAPEUTICS$$74$YR$E$M$Y$96.6$KG$20240830$$CN$US$US
242679471$24267947$1$I$$20240827$20240830$20240830$EXP$$GB-TAKEDA-2024TUS087301$TAKEDA$$$$$F$Y$$$20240830$$CN$GB$GB
242679481$24267948$1$I$20240601$20240823$20240830$20240830$EXP$$LB-ROCHE-10000065915$ROCHE$$$$$$Y$$$20240830$$MD$LB$LB
242679491$24267949$1$I$20240801$20240825$20240830$20240830$EXP$GB-MHRA-MED-202408252145352040-GFPCD$GB-ALCON LABORATORIES-ALC2024GB003949$ALCON$$58$YR$$F$Y$102$KG$20240830$$HP$GB$GB
242679501$24267950$1$I$20240826$20240826$20240830$20240830$EXP$$US-BAYER-2024A124899$BAYER$$50$YR$A$F$Y$74.83$KG$20240830$$HP$US$US
242679511$24267951$1$I$20240101$20240820$20240830$20240830$PER$$US-JNJFOC-20240859478$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$CN$US$US
242679521$24267952$1$I$20240601$20240820$20240830$20240830$EXP$CH-SM-2024-14333$CH-TEVA-VS-3235322$TEVA$$73$YR$$M$Y$90$KG$20240830$$MD$CH$CH
242679531$24267953$1$I$$20240819$20240830$20240830$EXP$GB-MHRA-MED-202408191904114260-DJKGQ$GB-Accord-442376$ACCORD$$70$YR$E$M$Y$$$20240830$$CN$GB$GB
242679541$24267954$1$I$$20240819$20240830$20240830$EXP$CA-MHPD-001090158$CA-Accord-442531$ACCORD$$5$YR$C$M$Y$$$20240830$$CN$CA$CA
242679551$24267955$1$I$20240818$20240820$20240830$20240830$EXP$GB-MHRA-MED-202408191739164600-CKLBQ$GB-Accord-442807$ACCORD$$60$YR$A$F$Y$$$20240830$$PH$GB$GB
242679561$24267956$1$I$20230201$20240822$20240830$20240830$EXP$$ZA-JNJFOC-20240864046$JOHNSON AND JOHNSON$$12$YR$T$M$Y$51$KG$20240830$$HP$ZA$ZA
242679571$24267957$1$I$$20240820$20240830$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR107151$VIIV$$$$$$Y$$$20240830$$HP$US$US
242679581$24267958$1$I$20240816$20240819$20240830$20240830$EXP$GB-MHRA-MED-202408180153570310-BLZKV$GB-Accord-442464$ACCORD$$58$YR$A$F$Y$96$KG$20240830$$MD$GB$GB
242679591$24267959$1$I$20240824$20240828$20240830$20240830$EXP$$US-BAYER-2024A124714$BAYER$$60$YR$A$M$Y$104.76$KG$20240830$$CN$US$US
242679601$24267960$1$I$$20240829$20240830$20240830$PER$$US-HALEON-2194402$Haleon PLC$$$$$F$Y$$$20240830$$CN$US$US
242679613$24267961$3$F$$20240912$20240830$20240916$EXP$$CA-BAYER-2024A124625$BAYER$$49$YR$A$F$Y$$$20240916$$MD$CA$CA
242679621$24267962$1$I$20240814$20240819$20240830$20240830$EXP$$US-BAYER-2024A119813$BAYER$$39$YR$A$F$Y$$$20240830$$CN$US$US
242679641$24267964$1$I$$20240827$20240830$20240830$EXP$$US-TAKEDA-2024TUS086643$TAKEDA$$$$$F$Y$$$20240830$$CN$US$US
242679651$24267965$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-082301-2024$RECKITT BENCKISER$$$$$M$Y$$$20240830$$CN$US$US
242679671$24267967$1$I$$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59647$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
242679681$24267968$1$I$20240801$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59645$$FDA-CTU$$67$YR$$M$N$$$20240828$N$HP$US$
242679691$24267969$1$I$20240829$20240829$20240829$20240829$DIR$716471$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242679701$24267970$1$I$$20240829$20240829$20240829$DIR$716477$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242679712$24267971$2$F$$20240929$20240830$20240930$30DAY$$US-PFIZER INC-202400242407$PFIZER$$14$YR$$M$Y$$$20240930$$CN$US$US
242679722$24267972$2$F$$20240929$20240830$20240930$30DAY$$US-PFIZER INC-PV202400110699$PFIZER$$16$YR$$M$Y$$$20240930$$CN$US$US
242679734$24267973$4$F$20240801$20240929$20240830$20240930$30DAY$$US-PFIZER INC-202400243509$PFIZER$$14$YR$$F$Y$$$20240930$$CN$US$US
242679752$24267975$2$F$$20240916$20240830$20240920$EXP$$US-PFIZER INC-PV202400110560$PFIZER$$58$YR$$F$Y$70.31$KG$20240920$$CN$US$US
242679761$24267976$1$I$$20240820$20240830$20240830$30DAY$$US-PFIZER INC-202400246403$PFIZER$$$$$$Y$$$20240830$$HP$US$US
242679772$24267977$2$F$$20240903$20240830$20240906$30DAY$$GB-PFIZER INC-202400241774$PFIZER$$10$YR$$F$Y$$$20240906$$CN$GB$GB
242679812$24267981$2$F$$20240917$20240830$20240919$30DAY$$JP-PFIZER INC-202400240296$PFIZER$$$$$$Y$$$20240919$$PH$JP$JP
242679831$24267983$1$I$$20240125$20240830$20240830$PER$$US-CIPLA LTD.-2023US06882$CIPLA$$$$$$Y$$$20240830$$MD$US$US
242679841$24267984$1$I$$20231025$20240830$20240830$PER$$US-CIPLA LTD.-2023US06825$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242679851$24267985$1$I$$20240822$20240830$20240830$EXP$$BE-LEO Pharma-373042$LEO PHARM$$$$$F$Y$$$20240830$$MD$BE$BE
242679861$24267986$1$I$$20231114$20240830$20240830$PER$$US-CIPLA LTD.-2023US06936$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242679871$24267987$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59623$$FDA-CTU$$44$YR$$F$N$$$20240829$N$$US$
242679881$24267988$1$I$$20231019$20240830$20240830$PER$$US-CIPLA LTD.-2023US06493$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242679891$24267989$1$I$20230101$20240125$20240830$20240830$PER$$US-CIPLA LTD.-2023US07168$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242679901$24267990$1$I$$20240829$20240829$20240829$DIR$716472$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242679911$24267991$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59625$$FDA-CTU$$78$YR$$F$N$$$20240829$N$$US$
242679921$24267992$1$I$20240828$20240829$20240829$20240829$DIR$716379$$FDA-CTU$$63$YR$$M$N$$$20240829$N$$US$
242679931$24267993$1$I$20240829$20240829$20240829$20240829$DIR$716482$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242679941$24267994$1$I$20231001$20231106$20240830$20240830$PER$$US-CIPLA LTD.-2023US06789$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242679951$24267995$1$I$20230101$20231101$20240830$20240830$PER$$US-CIPLA LTD.-2023US06808$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242679961$24267996$1$I$$20240422$20240830$20240830$PER$$US-CIPLA LTD.-2023US06498$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242679971$24267997$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59664$$FDA-CTU$$69$YR$$F$N$$$20240829$N$$US$
242679981$24267998$1$I$$20240829$20240829$20240829$DIR$716483$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242679991$24267999$1$I$20230101$20231214$20240830$20240830$PER$$US-CIPLA LTD.-2023US06764$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242680001$24268000$1$I$20240801$20240826$20240830$20240830$PER$$US-Eisai-EC-2024-173103$EISAI$$60$YR$A$F$Y$$$20240830$$CN$US$US
242680011$24268001$1$I$20240819$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172074$AMGEN$$70$YR$E$M$Y$$$20240830$$CN$US$US
242680021$24268002$1$I$20240805$20240810$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004536$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240830$$CN$US$US
242680031$24268003$1$I$20230101$20240424$20240830$20240830$PER$$US-CIPLA LTD.-2023US07422$CIPLA$$$$$$Y$$$20240830$$MD$US$US
242680052$24268005$2$F$$20240911$20240830$20240921$PER$$US-ROCHE-10000061074$ROCHE$$$$$$Y$$$20240921$$PH$US$US
242680061$24268006$1$I$$20240826$20240830$20240830$PER$$US-LEO Pharma-373090$LEO PHARM$$37$YR$$F$Y$$$20240830$$CN$US$US
242680071$24268007$1$I$20240701$20240828$20240830$20240830$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048394$BOEHRINGER INGELHEIM$$90$YR$E$F$Y$$$20240830$$PH$JP$JP
242680082$24268008$2$F$20180101$20240911$20240830$20240918$EXP$$CZ-SA-2024SA252723$SANOFI AVENTIS$Novakova M, Kotolova H, Ustohal L.. Experience with the administration of clozapine and long-term paliperidone palmitate in combination in a patient with paranoid schizophrenia and marijuana abuse. Czech and Psychiat.. 2024;120(3):151-6$45$YR$A$M$Y$$$20240918$$PH$CZ$CZ
242680091$24268009$1$I$$20240829$20240830$20240830$PER$$US-ROCHE-10000069910$ROCHE$$26$YR$A$F$Y$$$20240830$$CN$US$US
242680101$24268010$1$I$$20240830$20240830$20240830$PER$$US-ROCHE-10000070163$ROCHE$$$$A$M$Y$$$20240830$$CN$US$US
242680111$24268011$1$I$$20240826$20240830$20240830$EXP$$CA-ROCHE-10000065681$ROCHE$$54$YR$A$M$Y$112$KG$20240830$$HP$CA$CA
242680121$24268012$1$I$$20240829$20240830$20240830$PER$$US-HALEON-2194310$Haleon PLC$$$$$M$Y$$$20240830$$CN$US$US
242680131$24268013$1$I$$20240820$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008734$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242680141$24268014$1$I$$20240829$20240830$20240830$30DAY$$DE-UCBSA-2024044018$UCB$$75$YR$$M$Y$$$20240830$$PH$DE$DE
242680151$24268015$1$I$$20240822$20240830$20240830$EXP$$CA-APOTEX-2024AP009709$APOTEX$$81$YR$$F$Y$$$20240830$$PH$CA$CA
242680161$24268016$1$I$$20240827$20240830$20240830$EXP$$US-TAKEDA-2024TUS086552$TAKEDA$$$$$F$Y$$$20240830$$HP$US$US
242680171$24268017$1$I$$20240823$20240830$20240830$EXP$$GB-TAKEDA-2024TUS028995$TAKEDA$$$$$F$Y$$$20240830$$CN$GB$GB
242680181$24268018$1$I$$20240823$20240830$20240830$PER$$US-AMGEN-USASP2024169528$AMGEN$$$$$F$Y$$$20240830$$CN$US$US
242680191$24268019$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024172726$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242680201$24268020$1$I$$20240820$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008733$INCYTE$$$$$$Y$$$20240830$$HP$US$US
242680211$24268021$1$I$$20240829$20240830$20240830$EXP$$JP-BAYER-2024A124669$BAYER$$$$$$Y$$$20240830$$PH$JP$JP
242680222$24268022$2$F$$20240929$20240830$20240930$30DAY$$US-PFIZER INC-202400244037$PFIZER$$14$YR$$M$Y$61.23$KG$20240930$$CN$US$US
242680232$24268023$2$F$$20240929$20240830$20240930$30DAY$$US-PFIZER INC-202400244152$PFIZER$$15$YR$$M$Y$$$20240930$$CN$US$US
242680262$24268026$2$F$$20240924$20240830$20240927$30DAY$$US-PFIZER INC-202400237786$PFIZER$$50$YR$$F$Y$$$20240927$$CN$US$US
242680281$24268028$1$I$$20240823$20240830$20240830$30DAY$$US-PFIZER INC-PV202400110544$PFIZER$$$$$$Y$$$20240830$$CN$US$US
242680292$24268029$2$F$$20240830$20240830$20240903$30DAY$$US-PFIZER INC-202400243837$PFIZER$$$$$M$Y$$$20240903$$CN$US$US
242680322$24268032$2$F$$20240923$20240830$20240927$30DAY$$US-PFIZER INC-202400244612$PFIZER$$8$YR$$F$Y$22.68$KG$20240927$$CN$US$US
242680331$24268033$1$I$20240822$20240826$20240830$20240830$30DAY$$CA-PFIZER INC-202400245006$PFIZER$$29$YR$$F$Y$$$20240830$$HP$CA$CA
242680341$24268034$1$I$$20240827$20240830$20240830$30DAY$$GB-PFIZER INC-PV202400111726$PFIZER$$59$YR$$F$Y$$$20240830$$CN$GB$GB
242680352$24268035$2$F$$20240929$20240830$20240930$30DAY$$US-PFIZER INC-202400244464$PFIZER$$13$YR$$F$Y$$$20240930$$CN$US$US
242680391$24268039$1$I$$20240822$20240830$20240830$EXP$$US-AGIOS-2408US03868$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242680401$24268040$1$I$$20240827$20240830$20240830$EXP$$US-GILEAD-2024-0678279$GILEAD$$$$E$F$Y$$$20240830$$CN$US$US
242680411$24268041$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024172735$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242680421$24268042$1$I$$20240815$20240830$20240830$PER$$US-LEADINGPHARMA-US-2024LEASPO00363$LEADING PHARMA$$$$$F$Y$$$20240830$$CN$US$US
242680431$24268043$1$I$$20240816$20240830$20240830$EXP$$AU-LUPIN EUROPE GMBH-2024-08425$LUPIN$$$$$$Y$$$20240830$$CN$AU$AU
242680441$24268044$1$I$20240801$20240826$20240830$20240830$EXP$FR-AFSSAPS-AVLL2024000211$FR-MYLANLABS-2024M1078794$MYLAN$$18$YR$$F$Y$$$20240830$$HP$FR$FR
242680452$24268045$2$F$$20240826$20240830$20240904$EXP$$US-SA-2024SA251304$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240904$$CN$US$US
242680461$24268046$1$I$$20240821$20240830$20240830$PER$$US-SA-2024SA251992$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240830$$CN$US$US
242680471$24268047$1$I$20240801$20240819$20240830$20240830$PER$$US-SA-2024SA249178$SANOFI AVENTIS$$7$YR$C$F$Y$23.583$KG$20240830$$MD$US$US
242680493$24268049$3$F$20240714$20240913$20240830$20240924$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07943$HIKMA$$68$YR$$M$Y$111.65$KG$20240924$$HP$US$US
242680502$24268050$2$F$20170115$20240917$20240830$20240924$EXP$$CA-TAKEDA-2017TUS001963$TAKEDA$$19$YR$$F$Y$$$20240924$$CN$CA$CA
242680511$24268051$1$I$$20240801$20240830$20240830$30DAY$$US-VEROBIOTECH-2024USVEROSPO00192$VERO BIOTECH$$$$$$Y$$$20240830$$HP$US$US
242680531$24268053$1$I$$20240805$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07939$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242680541$24268054$1$I$$20240825$20240830$20240830$EXP$$US-JNJFOC-20240865672$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242680551$24268055$1$I$$20240820$20240830$20240830$EXP$$US-EXELIXIS-CABO-24080945$EXELIXIS$Kathuria-Prakash N, Lopez LP, Raman S, Ye H, Anaokar J, Sisk A, et al.. ALK inhibition with alectinib for refractory metastatic renal cell carcinoma with alk rearrangement: a rare case report and literature review.. JCO Precision Oncology. 2024;8:1-6$64$YR$$M$Y$$$20240830$$MD$US$US
242680571$24268057$1$I$20190822$20240825$20240830$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013553$JAZZ$$63$YR$$F$Y$$$20240830$$MD$US$US
242680583$24268058$3$F$20240101$20240919$20240830$20240927$EXP$$AT-SERVIER-S24009919$SERVIER$$$$$$Y$$$20240927$$MD$AT$AT
242680591$24268059$1$I$$20240828$20240830$20240830$EXP$$US-009507513-2408USA010333$MERCK$$$$$M$Y$$$20240830$$MD$US$US
242680601$24268060$1$I$$20240826$20240830$20240830$30DAY$$US-PFIZER INC-202400244354$PFIZER$$12$YR$$F$Y$$$20240830$$CN$US$US
242680611$24268061$1$I$20240825$20240827$20240830$20240830$30DAY$$GB-PFIZER INC-PV202400111652$PFIZER$$13$YR$$M$Y$$$20240830$$CN$GB$GB
242680621$24268062$1$I$$20240803$20240830$20240830$30DAY$$US-VEROBIOTECH-2024USVEROSPO00193$VERO BIOTECH$$$$$$Y$$$20240830$$HP$US$US
242680631$24268063$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137384$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240830$$CN$US$US
242680641$24268064$1$I$$20240824$20240830$20240830$EXP$$NVSC2024IN174688$NOVARTIS$$$$$M$Y$$$20240830$$CN$IN$IN
242680652$24268065$2$F$$20240905$20240830$20240911$EXP$$NVSC2024ZA171566$NOVARTIS$$45$YR$$F$Y$$$20240911$$HP$ZA$ZA
242680671$24268067$1$I$20220101$20240828$20240830$20240830$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00453$VELOXIS PHARMACEUTICALS$Mann I, Morado-Aramburo O, Hasbun R.. Emerging shadows: HHV-8-associated encephalitis unveiled in a solid organ transplant recipient.. Transplant Infectious Disease.. 2024;26(4):e14343$73$YR$$F$Y$$$20240830$$MD$US$US
242680701$24268070$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59654$$FDA-CTU$$78$YR$$F$N$$$20240829$N$$US$
242680711$24268071$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59756$$FDA-CTU$$53$YR$$F$N$82.1$KG$20240829$N$$US$
242680721$24268072$1$I$20240701$20240826$20240830$20240830$EXP$$US-ABBVIE-5898141$ABBVIE$$0$YR$$M$Y$3.86$KG$20240830$$CN$US$US
242680732$24268073$2$F$20240101$20240822$20240830$20240904$PER$$US-SA-2024SA251716$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240904$$CN$US$US
242680741$24268074$1$I$$20240821$20240830$20240830$PER$$US-SA-2024SA249741$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240830$$CN$US$US
242680751$24268075$1$I$20240821$20240821$20240830$20240830$EXP$GB-MHRA-MED-202408210939190530-CYFWG$GB-GUERBET / LLC-GB-20240109$GUERBET$$66$YR$E$F$Y$80$KG$20240830$$HP$GB$GB
242680761$24268076$1$I$20231221$20240821$20240830$20240830$EXP$$JP-CHEPLA-2024011046$CHEPLAPHARM$$82$YR$$M$Y$55$KG$20240830$$PH$COUNTRY NOT SPECIFIED$JP
242680781$24268078$1$I$$20240827$20240830$20240830$EXP$$CA-CHEPLA-2024011087$CHEPLAPHARM$$$$$M$Y$$$20240830$$MD$COUNTRY NOT SPECIFIED$CA
242680791$24268079$1$I$$20240820$20240830$20240830$EXP$$JP-ROCHE-10000016948$ROCHE$$9$DEC$E$F$Y$$$20240830$$MD$JP$JP
242680801$24268080$1$I$20240801$20240820$20240830$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024104472$VIIV$$29$YR$$M$Y$$$20240830$$PH$US$US
242680811$24268081$1$I$$20240825$20240830$20240830$EXP$$US-JNJFOC-20240865555$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242680822$24268082$2$F$20240814$20240912$20240830$20240924$30DAY$$CA-JNJFOC-20240849400$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240924$$HP$CA$CA
242680832$24268083$2$F$$20240903$20240830$20240906$EXP$$CA-BAYER-2024A124699$BAYER$$$$$F$Y$$$20240906$$HP$CA$CA
242680841$24268084$1$I$20240820$20240826$20240830$20240830$PER$$US-ABBVIE-5899433$ABBVIE$$$$A$F$Y$$$20240830$$CN$US$US
242680852$24268085$2$F$$20240827$20240830$20240910$PER$$US-ABBVIE-5899551$ABBVIE$$$$$$Y$$$20240910$$CN$US$US
242680862$24268086$2$F$20240827$20240830$20240830$20240902$PER$$US-AMGEN-USASP2024173340$AMGEN$$22$YR$A$F$Y$$$20240901$$CN$US$US
242680871$24268087$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018279$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240830$$CN$US$US
242680881$24268088$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018080$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$US$US
242680891$24268089$1$I$20240822$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171292$AMGEN$$74$YR$E$F$Y$$$20240830$$CN$US$US
242680901$24268090$1$I$$20240828$20240830$20240830$EXP$$US-BAYER-2024A124244$BAYER$$72$YR$E$M$Y$$$20240830$$CN$US$US
242680911$24268091$1$I$$20240822$20240830$20240830$PER$$US-ROCHE-10000064108$ROCHE$Boyinepally K, Marellapudi A, Nawras Y, Fatima R, Altorok N. Therapeutic Management of Transverse Myelitis Secondary to Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. American Journal of Therapeutics. 2024;31 (4):e505-e508. doi:10.1097/MJT.0000000000001706.$35$YR$A$F$Y$$$20240830$$HP$US$US
242680921$24268092$1$I$20240823$20240823$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136207$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240830$$CN$US$US
242680931$24268093$1$I$$20240827$20240830$20240830$PER$$US-009507513-2408USA009491$MERCK$Feinaj A, Fox E, Sinibaldi V, Kleinberg L, Ged Y. Abscopal effect following checkpoint inhibitor therapy and localized radiotherapy for metastatic clear cell renal cell carcinoma. Urology Case Reports. 2024;56 ()::102824$64$YR$$M$Y$$$20240830$$HP$US$US
242680951$24268095$1$I$20240818$20240829$20240830$20240830$EXP$$NVSC2024US175059$NOVARTIS$$70$YR$$M$Y$$$20240830$$MD$US$US
242680962$24268096$2$F$20240101$20240925$20240830$20240930$EXP$$US-ABBVIE-5898921$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
242680981$24268098$1$I$$20240826$20240830$20240830$EXP$$DE-MYLANLABS-2024M1078674$MYLAN$Groth, Olwen; Roider, Gabriele; Graw, Matthias.. Drug-induced deaths in renal insufficiency. Munich Medical Weekly ? Advances in Medicine. 2024;166 (13):48-51$72$YR$$F$Y$$$20240830$$HP$DE$DE
242680992$24268099$2$F$20240823$20240902$20240830$20240908$EXP$$CO-JNJFOC-20240874513$JOHNSON AND JOHNSON$$34$YR$A$M$Y$60$KG$20240908$$HP$CO$CO
242681001$24268100$1$I$$20240826$20240830$20240830$EXP$$PE-MYLANLABS-2024M1080017$MYLAN$Viru-Loza MA, Alvarado-Gamarra G, Zapata-Sequeiros RI, Flores-Nakandakare HF. Life-threatening hypercalcemia in a child with vitamin D intoxication due to parental self-medication: A case report. SAGE-Open-Med-Case-Rep 2024; 12.$4$YR$$M$Y$$$20240830$$HP$PE$PE
242681012$24268101$2$F$20240601$20240920$20240830$20240930$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00218$OPKO HEALTH$$57$YR$$F$Y$66$KG$20240927$$PH$US$US
242681021$24268102$1$I$$20240820$20240830$20240830$EXP$$US-TAKEDA-2024TUS087101$TAKEDA$$$$N$$Y$$$20240830$$MD$US$US
242681031$24268103$1$I$$20240816$20240830$20240830$EXP$$US-Renata Limited-2161033$RENATA LIMITED$Abstract$24$YR$$M$Y$$$20240830$$$US$US
242681041$24268104$1$I$$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A194165$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242681051$24268105$1$I$$20240823$20240830$20240830$EXP$$US-ALXN-202408USA001748US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$HP$US$US
242681061$24268106$1$I$20240612$20240826$20240830$20240830$EXP$$AU-ASTELLAS-2024-AER-002685$ASTELLAS$$68$YR$E$F$Y$$$20240830$$HP$AU$AU
242681071$24268107$1$I$$20240826$20240830$20240830$PER$$US-HALEON-2193971$Haleon PLC$$37$YR$$M$Y$$$20240830$$HP$US$US
242681081$24268108$1$I$20240813$20240819$20240830$20240830$EXP$$US-IOVANCE BIOTHERAPEUTICS, INC-2024IOV000061$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240830$$CN$US$US
242681092$24268109$2$F$20240827$20240828$20240830$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137783$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$PH$US$US
242681101$24268110$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59670$$FDA-CTU$$48$YR$$M$N$$$20240829$N$$US$
242681111$24268111$1$I$20240615$20240829$20240829$20240829$DIR$716488$$FDA-CTU$$$$$UNK$N$$$20240829$Y$CN$US$
242681121$24268112$1$I$$20240821$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137172$BRISTOL MYERS SQUIBB$Ali Z, Zafar M, Wolfe Z, Akbar F, Lash B. Thrombotic thrombocytopenic purpura induced by immune checkpoint inhibitiors: a case report and review of the literature. Cureus. 2020 Oct 29;12(10):1-3. doi:10.7759/cureus.11246.$46$YR$A$M$Y$$$20240830$$HP$US$US
242681131$24268113$1$I$20240809$20240826$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136672$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240830$$CN$US$US
242681141$24268114$1$I$$20240822$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134385$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$109$KG$20240830$$PH$US$US
242681151$24268115$1$I$$20240801$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122660$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240830$$CN$US$US
242681171$24268117$1$I$20240825$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A194483$ASTRAZENECA$$$$$F$Y$$$20240830$$MD$US$
242681181$24268118$1$I$$20240823$20240830$20240830$EXP$$BR-AstraZeneca-2024A196492$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$BR$
242681191$24268119$1$I$$20240822$20240830$20240830$EXP$$CA-APOTEX-2024AP009710$APOTEX$$82$YR$$M$Y$$$20240830$$PH$CA$CA
242681201$24268120$1$I$20240812$20240829$20240829$20240829$DIR$716459$$FDA-CTU$$75$YR$$F$N$$$20240829$N$MD$US$
242681212$24268121$2$F$20160101$20240830$20240830$20240831$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048133$BOEHRINGER INGELHEIM$$50$YR$A$F$Y$$$20240831$$CN$US$US
242681221$24268122$1$I$20240821$20240822$20240830$20240830$EXP$GB-MHRA-MED-202408221624042960-LPFHY$GB-RDY-SPO/GBR/24/0012367$DR REDDYS$$45$YR$A$F$Y$68$KG$20240830$$MD$GB$GB
242681261$24268126$1$I$$20240829$20240829$20240829$DIR$716431$$FDA-CTU$$$$$UNK$N$$$20240829$$CN$US$
242681271$24268127$1$I$20240713$20240805$20240829$20240829$DIR$FDA-CDER-CTU-2024-59618$$FDA-CTU$$64$YR$$M$N$$$20240805$N$HP$US$
242681281$24268128$1$I$20240722$20240829$20240829$20240829$DIR$716474$$FDA-CTU$$75$YR$$F$N$65.25$KG$20240829$N$CN$US$
242681292$24268129$2$F$20240710$20240913$20240830$20240924$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00220$OPKO HEALTH$$74$YR$$F$Y$$$20240921$$PH$US$US
242681301$24268130$1$I$$20240821$20240830$20240830$PER$$US-APOTEX-2024AP009844$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242681311$24268131$1$I$$20240828$20240830$20240830$EXP$$CA-ROCHE-10000069759$ROCHE$$$$E$F$Y$$$20240830$$HP$CA$CA
242681321$24268132$1$I$$20240820$20240830$20240830$EXP$$JP-009507513-2408JPN002495J$MERCK$$66$YR$$F$Y$$$20240830$$MD$JP$JP
242681333$24268133$3$F$$20240909$20240830$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005085$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$CN$US$US
242681342$24268134$2$F$$20240913$20240830$20240924$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00221$OPKO HEALTH$$$$$F$Y$60.862$KG$20240921$$PH$US$US
242681361$24268136$1$I$$20231128$20240830$20240830$PER$$US-CIPLA LTD.-2023US07802$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242681371$24268137$1$I$$20240222$20240830$20240830$PER$$US-CIPLA LTD.-2023US07924$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242681381$24268138$1$I$$20231127$20240830$20240830$PER$$US-CIPLA LTD.-2023US07621$CIPLA$$$$$$Y$$$20240830$$HP$US$US
242681391$24268139$1$I$$20240821$20240830$20240830$EXP$$JP-ROCHE-10000067320$ROCHE$$82$YR$E$F$Y$$$20240830$$PH$JP$JP
242681401$24268140$1$I$$20240801$20240830$20240830$PER$$US-009507513-2408USA000524$MERCK$$$$$F$Y$61.224$KG$20240830$$CN$US$US
242681411$24268141$1$I$20230101$20240219$20240830$20240830$PER$$US-CIPLA LTD.-2023US08102$CIPLA$$$$$$Y$$$20240830$$CN$US$US
242681421$24268142$1$I$$20240829$20240830$20240830$PER$$NVSC2024US174827$NOVARTIS$$$$$F$Y$$$20240830$$HP$US$US
242681431$24268143$1$I$20231123$20240826$20240830$20240830$EXP$$DE-MYLANLABS-2024M1078711$MYLAN$$62$YR$$M$Y$$$20240830$$MD$DE$DE
242681441$24268144$1$I$20240824$20240826$20240830$20240830$PER$$US-REGENERON PHARMACEUTICALS, INC.-2024-115781$REGENERON$$$$$F$Y$$$20240830$$CN$US$US
242681452$24268145$2$F$$20240830$20240830$20240907$EXP$$FR-AMGEN-FRASP2024170489$AMGEN$$$$$$Y$$$20240907$$MD$FR$FR
242681461$24268146$1$I$20240829$20240829$20240829$20240829$DIR$716489$$FDA-CTU$$55$YR$$F$N$$$20240829$N$$US$
242681471$24268147$1$I$20240829$20240829$20240829$20240829$DIR$716478$$FDA-CTU$$$$$UNK$N$$$20240829$N$CN$US$
242681481$24268148$1$I$$20240826$20240829$20240829$DIR$FDA-CDER-CTU-2024-59709$$FDA-CTU$$$$$M$N$$$20240826$N$HP$US$
242681492$24268149$2$F$$20240909$20240830$20240911$PER$$US-BIOGEN-2023BI01191763$BIOGEN$$$$$M$Y$$$20240911$$CN$US$US
242681501$24268150$1$I$20240801$20240821$20240830$20240830$PER$$US-TEVA-VS-3236999$TEVA$$$$$F$Y$$$20240830$$HP$US$US
242681512$24268151$2$F$$20240911$20240830$20240924$EXP$$FR-Merck Healthcare KGaA-2024045574$MERCK KGAA$$$$$F$Y$$$20240918$$CN$FR$FR
242681521$24268152$1$I$$20240821$20240830$20240830$PER$$US-MYLANLABS-2024M1078041$MYLAN$$$$$F$Y$111.58$KG$20240830$$CN$US$US
242681531$24268153$1$I$20240815$20240829$20240830$20240830$EXP$$US-UCBSA-2024044197$UCB$$60$YR$$M$Y$$$20240830$$CN$US$US
242681541$24268154$1$I$20240101$20240827$20240830$20240830$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-116616$REGENERON$$$$$F$Y$$$20240830$$HP$US$US
242681551$24268155$1$I$20240824$20240823$20240830$20240830$EXP$$US-GILEAD-2024-0682659$GILEAD$$68$YR$E$F$Y$$$20240830$$CN$US$US
242681561$24268156$1$I$$20240821$20240830$20240830$EXP$$CA-ASTELLAS-2024-AER-003204$ASTELLAS$$39$YR$A$F$Y$$$20240830$$HP$CA$CA
242681571$24268157$1$I$20240805$20240821$20240830$20240830$EXP$$CN-SA-2024SA252271$SANOFI AVENTIS$$94$YR$E$M$Y$$$20240830$$HP$CN$CN
242681581$24268158$1$I$$20240826$20240830$20240830$PER$US-ELI_LILLY_AND_COMPANY-US202408005327$US-RDY-SPO/USA/24/0012514$DR REDDYS$Karakus KE, Shah VN, Akturk HK. Tirzepatide-Induced Rapid Weight Loss-Related Thyrotoxicosis. JAMA Internal Medicine. 2024. DOI:10.1001/jamainternmed.2024.2919.$62$YR$A$M$Y$93$KG$20240830$$MD$US$US
242681592$24268159$2$F$20240401$20240824$20240830$20240913$EXP$$GB-SA-2024SA252665$SANOFI AVENTIS$$41$YR$A$M$Y$70$KG$20240913$$CN$GB$GB
242681601$24268160$1$I$$20240821$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008806$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242681611$24268161$1$I$20240401$20240828$20240830$20240830$EXP$$DE-ROCHE-10000068972$ROCHE$$38$YR$A$F$Y$$$20240830$$HP$DE$DE
242681621$24268162$1$I$20240101$20240820$20240830$20240830$PER$$US-SA-2024SA204510$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240830$$CN$US$US
242681631$24268163$1$I$$20240821$20240830$20240830$PER$$US-SA-2024SA252951$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240830$$CN$US$US
242681641$24268164$1$I$20240801$20240820$20240830$20240830$PER$$US-SA-2024SA252154$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240830$$HP$US$US
242681651$24268165$1$I$$20240820$20240830$20240830$EXP$$TH-ENDO USA, INC.-2024-003279$ENDO$Lortrakul J, Pattanaseri K. A Case Report of Ketamine-induced Hypoglycemia in Treatment Resistance Depression. Clinical Psychopharmacology and Neuroscience. 2024;22(3):541-543$36$YR$$M$Y$$$20240830$$HP$TH$TH
242681661$24268166$1$I$20240514$20240827$20240830$20240830$EXP$FR-AFSSAPS-CN2024000729$FR-ASTELLAS-2024-AER-002965$ASTELLAS$$79$YR$E$F$Y$60$KG$20240830$$MD$FR$FR
242681672$24268167$2$F$$20240916$20240830$20240924$30DAY$$GB-JNJFOC-20240844761$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240924$$CN$GB$GB
242681681$24268168$1$I$$20240828$20240830$20240830$PER$$US-JNJFOC-20240876533$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$CN$US$US
242681701$24268170$1$I$$20240827$20240830$20240830$EXP$$CA-JNJFOC-20240876592$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$HP$CA$CA
242681711$24268171$1$I$$20240827$20240830$20240830$PER$$US-JNJFOC-20240874090$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$HP$US$US
242681721$24268172$1$I$20240802$20240829$20240830$20240830$EXP$$US-INCYTE CORPORATION-2024IN009123$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242681731$24268173$1$I$$20240822$20240830$20240830$EXP$$US-APOTEX-2024AP009784$APOTEX$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73 (200):1-9$71$YR$$F$Y$$$20240830$$HP$US$US
242681741$24268174$1$I$$20240814$20240830$20240830$PER$$US-ASTELLAS-2024-AER-000405$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
242681751$24268175$1$I$$20240829$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018850$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240830$$CN$US$US
242681761$24268176$1$I$$20240820$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408012672$ELI LILLY AND CO$$35$YR$A$$Y$$$20240830$$LW$US$US
242681771$24268177$1$I$$20240819$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408013246$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240830$$CN$US$US
242681781$24268178$1$I$20240828$20240829$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018842$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240830$$CN$US$US
242681792$24268179$2$F$$20240828$20240830$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202408018413$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240913$$CN$US$US
242681811$24268181$1$I$$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59727$$FDA-CTU$$$$$M$N$$$20240828$N$HP$US$
242681821$24268182$1$I$$20240829$20240829$20240829$DIR$716480$$FDA-CTU$$$$$UNK$N$$$20240829$$CN$US$
242681841$24268184$1$I$$20240806$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07946$LUPIN$$$$$$Y$$$20240830$$PH$US$US
242681851$24268185$1$I$$20231211$20240830$20240830$PER$$US-AMERICAN REGENT INC-2023002869$AMERICAN REGENT$$$$$F$Y$$$20240830$$MD$US$US
242681861$24268186$1$I$$20240823$20240830$20240830$EXP$$BE-AstraZeneca-2024A165656$ASTRAZENECA$$$$$$Y$$$20240830$$HP$BE$
242681871$24268187$1$I$$20240828$20240830$20240830$EXP$$NVSC2024AU023030$NOVARTIS$$$$$M$Y$$$20240830$$CN$AU$AU
242681901$24268190$1$I$$20240827$20240830$20240830$EXP$$US-MYLANLABS-2024M1079653$MYLAN$$$$$F$Y$$$20240830$$HP$US$US
242681912$24268191$2$F$20240713$20240829$20240830$20240910$EXP$FR-AFSSAPS-AVLL2024000216$FR-MYLANLABS-2024M1079717$MYLAN$$12$YR$$M$Y$$$20240910$$MD$FR$FR
242681921$24268192$1$I$$20240827$20240830$20240830$EXP$GB-MHRA-MIDB- 2b0bc0bf-eacd-42a5-8939-2c98373e7af3$GB-MYLANLABS-2024M1079259$MYLAN$$80$YR$$$Y$$$20240830$$HP$GB$GB
242681931$24268193$1$I$$20240827$20240830$20240830$EXP$$NL-MYLANLABS-2024M1078980$MYLAN$Ghambari K, de Jong DM, Bruno MJ, Polak WG, van Driel LMJW, den Hoed CM. Risks of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis After Liver Transplantation. Clinical Transplantation. 2024;38(7):1-9$72$YR$$M$Y$$$20240830$$HP$NL$NL
242681951$24268195$1$I$$20240816$20240830$20240830$PER$$US-Apozeal Pharmaceuticals-2161034$Apozeal Pharmaceuticals$$$$$M$Y$$$20240830$$$US$US
242681961$24268196$1$I$$20240821$20240830$20240830$PER$$US-APOTEX-2024AP009849$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242681971$24268197$1$I$20240305$20240823$20240830$20240830$EXP$$AR-GSK-AR2024AMR030407$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$AR$AR
242681981$24268198$1$I$20240801$20240822$20240830$20240830$30DAY$$US-GSK-US2024101725$GLAXOSMITHKLINE$$37$YR$$M$Y$$$20240830$$PH$US$US
242681991$24268199$1$I$$20240821$20240830$20240830$30DAY$$US-GSK-US2024104590$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242682001$24268200$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A193754$ASTRAZENECA$$$$$$Y$$$20240830$$MD$US$
242682011$24268201$1$I$$20240828$20240830$20240830$EXP$$HK-SANDOZ INC.-SDZ2024HK075989$SANDOZ$$45$YR$$M$Y$$$20240830$$MD$HK$HK
242682021$24268202$1$I$$20240821$20240830$20240830$EXP$$CA-TEVA-VS-3235812$TEVA$$62$YR$$M$Y$$$20240830$$HP$CA$CA
242682031$24268203$1$I$20240813$20240830$20240830$20240830$EXP$$GB-JNJFOC-20240879173$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240830$$HP$GB$GB
242682041$24268204$1$I$20240824$20240824$20240830$20240830$EXP$$AT-AstraZeneca-2024A196689$ASTRAZENECA$$33108$DY$$M$Y$$$20240830$$CN$AT$
242682051$24268205$1$I$20240824$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024172559$AMGEN$$67$YR$E$F$Y$$$20240830$$CN$US$US
242682061$24268206$1$I$20240827$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172538$AMGEN$$55$YR$A$F$Y$$$20240830$$CN$US$US
242682071$24268207$1$I$20230101$20240822$20240830$20240830$EXP$$CA-ROCHE-3429257$ROCHE$$65$YR$E$F$Y$$$20240830$$CN$CA$CA
242682081$24268208$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A193942$ASTRAZENECA$$$$$M$Y$115.9$KG$20240830$$CN$US$
242682091$24268209$1$I$$20240822$20240830$20240830$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-08022$HIKMA$$2$DEC$$F$Y$$$20240830$$MD$GB$GB
242682102$24268210$2$F$20240214$20240915$20240830$20240924$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08122$HIKMA$$$$$F$Y$$$20240924$$CN$CA$CA
242682111$24268211$1$I$$20240827$20240830$20240830$PER$$US-BIOGEN-2021BI01063786$BIOGEN$$$$$F$Y$76.726$KG$20240830$$CN$US$US
242682122$24268212$2$F$20240801$20240913$20240830$20240923$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00754$PARATEK PHARMACEUTICALS$$35$YR$$F$Y$108.84$KG$20240923$$MD$US$US
242682131$24268213$1$I$20240813$20240823$20240830$20240830$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00772$PARATEK PHARMACEUTICALS$$50$YR$$M$Y$57$KG$20240830$$HP$CN$CN
242682142$24268214$2$F$20240312$20240828$20240830$20240830$PER$$US-ROCHE-10000069001$ROCHE$$55$YR$A$M$Y$$$20240830$$HP$US$US
242682151$24268215$1$I$$20240826$20240830$20240830$EXP$$SG-ROCHE-10000066546$ROCHE$$61$YR$A$F$Y$$$20240830$$CN$SG$SG
242682162$24268216$2$F$$20240910$20240830$20240918$EXP$$US-AMGEN-USASL2024169610$AMGEN$$65$YR$E$M$Y$$$20240917$$CN$US$US
242682181$24268218$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171261$AMGEN$$$$$M$Y$$$20240830$$CN$US$US
242682191$24268219$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137579$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240830$$MD$US$US
242682201$24268220$1$I$$20240827$20240830$20240830$EXP$$US-TAKEDA-2024TUS086548$TAKEDA$$$$$F$Y$$$20240830$$CN$US$US
242682211$24268221$1$I$$20240829$20240829$20240829$DIR$716481$$FDA-CTU$$$$$UNK$N$$$20240829$$CN$US$
242682221$24268222$1$I$$20240822$20240830$20240830$PER$$JP-Eisai-EC-2024-172723$EISAI$Yosuke Ito. Considerations from treatment experience with pembrolizumab + lenvatinib combination therapy. Disclosure of Conflict of Interest.$59$YR$A$F$Y$$$20240830$$MD$JP$JP
242682231$24268223$1$I$20240101$20240820$20240830$20240830$PER$$US-SA-2024SA252206$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240830$$MD$US$US
242682241$24268224$1$I$20240824$20240829$20240829$20240829$DIR$716498$$FDA-CTU$$32$YR$$F$N$103.95$KG$20240829$N$CN$US$
242682261$24268226$1$I$20240827$20240829$20240829$20240829$DIR$716496$$FDA-CTU$$$$$M$N$106.65$KG$20240829$N$$US$
242682271$24268227$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-085017-2024$RECKITT BENCKISER$$$$$F$Y$$$20240830$$CN$US$US
242682281$24268228$1$I$$20240820$20240830$20240830$PER$$US-ABBVIE-5889101$ABBVIE$$$$$F$Y$$$20240830$$HP$US$US
242682302$24268230$2$F$$20240903$20240830$20240909$PER$$US-JNJFOC-20240873635$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242682321$24268232$1$I$$20240826$20240830$20240830$PER$$US-ROCHE-10000067528$ROCHE$$$$$$Y$$$20240830$$HP$US$US
242682331$24268233$1$I$$20240829$20240830$20240830$PER$$US-ROCHE-10000070217$ROCHE$$$$E$M$Y$$$20240830$$CN$US$US
242682341$24268234$1$I$$20240816$20240830$20240830$EXP$$US-Apozeal Pharmaceuticals-2161035$Apozeal Pharmaceuticals$Abstract$24$YR$$M$Y$$$20240830$$$US$US
242682352$24268235$2$F$$20240828$20240830$20240830$EXP$$US-ROCHE-10000068912$ROCHE$$$$A$F$Y$104.69$KG$20240830$$PH$US$US
242682361$24268236$1$I$$20240822$20240830$20240830$PER$$US-ABBVIE-5893006$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242682371$24268237$1$I$20240422$20240826$20240830$20240830$EXP$$FR-ABBVIE-5861309$ABBVIE$$76$YR$$M$Y$60$KG$20240830$$MD$FR$FR
242682381$24268238$1$I$$20240823$20240830$20240830$EXP$$GB-TAKEDA-2024TUS086510$TAKEDA$$$$$M$Y$$$20240830$$CN$GB$GB
242682391$24268239$1$I$$20240822$20240830$20240830$EXP$$BR-TAKEDA-2023TUS113011$TAKEDA$$$$$F$Y$$$20240830$$CN$BR$BR
242682401$24268240$1$I$$20240826$20240830$20240830$EXP$$US-MYLANLABS-2024M1079687$MYLAN$$$$$F$Y$96.62$KG$20240830$$CN$US$US
242682411$24268241$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-135167-2023$RECKITT BENCKISER$$$$$F$Y$$$20240830$$CN$US$US
242682421$24268242$1$I$20240101$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137553$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240830$$PH$US$US
242682431$24268243$1$I$20240101$20240826$20240830$20240830$EXP$$US-ABBVIE-5897597$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242682441$24268244$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5627855$ABBVIE$$69$YR$$F$Y$$$20240830$$CN$US$US
242682451$24268245$1$I$$20240825$20240830$20240830$EXP$GB-MHRA-MED-202408251533267900-SPNVQ$GB-MYLANLABS-2024M1078659$MYLAN$$68$YR$$F$Y$56$KG$20240830$$MD$GB$GB
242682462$24268246$2$F$$20240913$20240830$20240921$EXP$$FR-TEVA-VS-3230073$TEVA$Gigante E, Bouattour M, Bedoya JU, Regnault H, Ziol M, Assenat E, et al. Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: a multicentric retrospective study. J-Hepatol 2023; 78 (Suppl.) S577.; Gigante E, Bouattour M, Bedoya JU, Regnault H, Ziol M, Assenat E, et al. Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: a multicentric retrospective study. J-Hepatol 2023; 78 (Suppl.) S577...$66$YR$$M$Y$$$20240921$$HP$FR$FR
242682471$24268247$1$I$$20240818$20240830$20240830$EXP$$GD-JNJFOC-20240850105$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240830$$HP$US$US
242682491$24268249$1$I$$20240819$20240830$20240830$EXP$$JP-ROCHE-10000064879$ROCHE$Nakamura T, Yoshida T, Masuda K, Shinno Y, Okuma Y, Goto Y et al.. 17 A case of small cell lung cancer extensive stage in which immune-related retinopathy due to atezolizumab occurred. The 199th Kanto Branch Scientific Meeting of the Japan Lung Cancer Society. 2024;13$75$YR$E$M$Y$$$20240830$$MD$JP$JP
242682502$24268250$2$F$20240601$20240910$20240830$20240918$PER$$US-JAZZ PHARMACEUTICALS-2024-US-009305$JAZZ$$72$YR$$F$Y$$$20240918$$CN$US$US
242682511$24268251$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A194804$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242682521$24268252$1$I$$20240823$20240830$20240830$EXP$$GB-TAKEDA-2024TUS086489$TAKEDA$$$$$F$Y$$$20240830$$CN$GB$GB
242682532$24268253$2$F$20161205$20240904$20240830$20240911$EXP$$CA-TAKEDA-2024TUS083565$TAKEDA$$61$YR$$M$Y$$$20240911$$CN$CA$CA
242682541$24268254$1$I$20240619$20240827$20240830$20240830$EXP$$TW-AstraZeneca-2024A197673$ASTRAZENECA$$21599$DY$$M$Y$$$20240830$$CN$TW$
242682551$24268255$1$I$20240614$20240816$20240830$20240830$EXP$$FR-BRAINTREE LABORATORIES, INC.-2024BTE00554$BRAINTREE$$55$YR$$F$Y$$$20240830$$MD$FR$FR
242682561$24268256$1$I$$20240827$20240830$20240830$EXP$$JP-AstraZeneca-2024A196239$ASTRAZENECA$Goto E, et al.. Salvage extended surgery after immune-checkpoint inhibitor treatment for advanced non-small cell lung cancer. Surgery Today 2024;54(8):917-926.$59$YR$$M$Y$$$20240830$$MD$JP$
242682571$24268257$1$I$20240101$20240821$20240830$20240830$EXP$$GB-TEVA-VS-3237263$TEVA$$72$YR$$F$Y$$$20240830$$CN$GB$GB
242682591$24268259$1$I$$20240816$20240830$20240830$PER$$US-Apozeal Pharmaceuticals-2161036$Apozeal Pharmaceuticals$$$$$$Y$$$20240830$$$US$US
242682601$24268260$1$I$$20240820$20240830$20240830$EXP$$JP-BIOCON BIOLOGICS LIMITED-BBL2024006347$BIOCON$Kumagai A, Oshima N, Hirayama Y, Iwagaki A, Hoshino M, Sugimura Y et al.. Septic shock caused by ovarian abscess arisen in ovarian endometrioma in a patient complicated with rheumatoid arthritis. The Journal of Japan Society for Menopause and Women^s Health. 2024;31(4):682-687$$$$$Y$$$20240830$$HP$JP$JP
242682611$24268261$1$I$20240701$20240819$20240830$20240830$EXP$$FR-Valinor Pharma, LLC-VLR202408-000099$Valinor Pharma$$31$YR$A$F$Y$$$20240830$$MD$FR$
242682623$24268262$3$F$20240801$20240911$20240830$20240913$PER$$US-AMGEN-USASP2024173054$AMGEN$$15$YR$T$F$Y$$$20240913$$CN$US$US
242682631$24268263$1$I$$20240828$20240830$20240830$EXP$$US-ABBVIE-5899485$ABBVIE$$$$$M$Y$$$20240830$$MD$US$US
242682641$24268264$1$I$20240823$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024170143$AMGEN$$59$YR$A$M$Y$$$20240830$$CN$US$US
242682651$24268265$1$I$$20240822$20240830$20240830$PER$$US-BAYER-2024A124238$BAYER$$$$$F$Y$$$20240830$$CN$US$US
242682661$24268266$1$I$20240501$20240819$20240830$20240830$EXP$$CN-009507513-2408CHN007940$MERCK$$44$YR$$F$Y$$$20240830$$MD$CN$CN
242682671$24268267$1$I$$20240821$20240830$20240830$EXP$$JP-TEVA-VS-3237435$TEVA$$64$YR$$F$Y$$$20240830$$MD$JP$JP
242682681$24268268$1$I$$20240825$20240830$20240830$EXP$$DE-MYLANLABS-2023M1075431$MYLAN$Kaulen LD, Gumbinger C, Hinz F, Kessler T, Winkler F, Bendszus M, Sahm F and Wick W.. Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma. Neuro-Oncology Advances. 2022;4 (1):1-4$77$YR$$F$Y$$$20240830$$MD$DE$DE
242682691$24268269$1$I$20240705$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59747$$FDA-CTU$$68$YR$$M$N$$$20240828$N$HP$US$
242682701$24268270$1$I$$20240827$20240829$20240829$DIR$FDA-CDER-CTU-2024-59681$$FDA-CTU$$$$$M$N$$$20240827$N$HP$US$
242682711$24268271$1$I$$20240822$20240830$20240830$EXP$$AR-JNJFOC-20240861668$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240830$$MD$AR$AR
242682721$24268272$1$I$20240815$20240826$20240830$20240830$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000873$PAREXEL$$$$$$Y$$$20240830$$HP$CN$CN
242682731$24268273$1$I$$20240819$20240830$20240830$EXP$$US-JNJFOC-20240854484$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242682741$24268274$1$I$20240810$20240826$20240830$20240830$EXP$$CN-JNJFOC-20240868876$JOHNSON AND JOHNSON$$77$YR$E$M$Y$44.5$KG$20240830$$HP$CN$CN
242682751$24268275$1$I$$20240826$20240829$20240829$DIR$FDA-CDER-CTU-2024-59723$$FDA-CTU$$$$$M$N$$$20240826$N$HP$US$
242682761$24268276$1$I$$20240822$20240830$20240830$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08061$HIKMA$Hui J, Zhan X, Bashir A, Policeni F, Kim Hsieh SU. Hui J, Zhan X, Bashir A, Policeni F, Kim Hsieh SU. Epithelial-myoepithelial carcinoma occurrence in the site of previously treated ductal carcinoma in situ of the breast: Imaging features with histopathologic correlation, a case report and review of the literature. Clinical Case Reports. 2024;12(8):e9270$75$YR$$F$Y$$$20240830$$MD$US$US
242682771$24268277$1$I$20240301$20240820$20240830$20240830$PER$$US-SA-2024SA252153$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240830$$HP$US$US
242682781$24268278$1$I$20240101$20240826$20240830$20240830$PER$$US-ABBVIE-5899842$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242682791$24268279$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246058$PFIZER$$77$YR$$F$Y$$$20240830$$CN$US$US
242682802$24268280$2$F$20240817$20240827$20240830$20240918$PER$$US-PFIZER INC-202400245225$PFIZER$$78$YR$$F$Y$70.31$KG$20240918$$CN$US$US
242682812$24268281$2$F$$20240821$20240830$20240904$EXP$$CA-ASTELLAS-2024-AER-003170$ASTELLAS$UNKNOWN U. No information. No information. Unk(Unk): Unk-Unk.$49$YR$A$F$Y$$$20240904$$HP$CA$CA
242682821$24268282$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246282$PFIZER$$$$$$Y$$$20240830$$CN$US$US
242682831$24268283$1$I$20240828$20240828$20240830$20240830$PER$$US-PFIZER INC-202400245561$PFIZER$$$$E$M$Y$$$20240830$$CN$US$US
242682841$24268284$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-PV202400112397$PFIZER$$63$YR$$F$Y$$$20240830$$CN$US$US
242682851$24268285$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245802$PFIZER$$53$YR$$F$Y$123$KG$20240830$$MD$US$US
242682861$24268286$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400242382$PFIZER$$56$YR$$F$Y$$$20240830$$HP$US$US
242682871$24268287$1$I$$20240829$20240830$20240830$PER$$US-PFIZER INC-202400246892$PFIZER$$64$YR$$F$Y$$$20240830$$CN$US$US
242682882$24268288$2$F$$20240830$20240830$20240904$PER$$US-PFIZER INC-PV202400113223$PFIZER$$59$YR$$F$Y$$$20240904$$MD$US$US
242682891$24268289$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246055$PFIZER$$66$YR$$F$Y$$$20240830$$CN$US$US
242682901$24268290$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246738$PFIZER$$60$YR$$F$Y$$$20240830$$HP$US$US
242682912$24268291$2$F$20240826$20240924$20240830$20240926$PER$$US-PFIZER INC-202400245647$PFIZER$$74$YR$$M$Y$75.283$KG$20240926$$CN$US$US
242682921$24268292$1$I$20240826$20240829$20240830$20240830$PER$$US-PFIZER INC-202400246724$PFIZER$$41$YR$$M$Y$$$20240830$$CN$US$US
242682931$24268293$1$I$20240806$20240827$20240830$20240830$PER$$US-PFIZER INC-202400244940$PFIZER$$$$$F$Y$$$20240830$$MD$US$US
242682941$24268294$1$I$20240828$20240829$20240830$20240830$PER$$US-PFIZER INC-202400246921$PFIZER$$39$YR$$M$Y$$$20240830$$CN$US$US
242682952$24268295$2$F$20240108$20240902$20240830$20240909$EXP$$AU-009507513-2408AUS010409$MERCK$$53$YR$$F$Y$96.85$KG$20240909$$MD$AU$AU
242682961$24268296$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-PV202400112513$PFIZER$$24$YR$$F$Y$$$20240830$$HP$US$US
242682972$24268297$2$F$$20240926$20240830$20240930$PER$$US-PFIZER INC-PV202400112745$PFIZER$$70$YR$$F$Y$$$20240930$$HP$US$US
242682981$24268298$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246209$PFIZER$$70$YR$$F$Y$$$20240830$$CN$US$US
242682991$24268299$1$I$20240826$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246223$PFIZER$$82$YR$$M$Y$$$20240830$$CN$US$US
242683002$24268300$2$F$$20240902$20240830$20240904$PER$$US-PFIZER INC-PV202400112871$PFIZER$$$$$F$Y$$$20240904$$CN$US$US
242683011$24268301$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245485$PFIZER$$$$$M$Y$80.7$KG$20240830$$HP$US$US
242683021$24268302$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246622$PFIZER$$6$YR$$M$Y$$$20240830$$CN$US$US
242683031$24268303$1$I$$20240829$20240830$20240830$PER$$US-PFIZER INC-202400246989$PFIZER$$$$$$Y$$$20240830$$CN$US$US
242683044$24268304$4$F$$20240918$20240830$20240923$PER$$US-PFIZER INC-PV202400112664$PFIZER$$79$YR$$F$Y$58.97$KG$20240923$$CN$US$US
242683051$24268305$1$I$$20240829$20240830$20240830$PER$$US-PFIZER INC-PV202400104001$PFIZER$$45$YR$$F$Y$$$20240830$$HP$US$US
242683061$24268306$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245121$PFIZER$$$$$M$Y$$$20240830$$MD$US$US
242683072$24268307$2$F$20240825$20240918$20240830$20240920$PER$$US-PFIZER INC-202400245957$PFIZER$$75$YR$$F$Y$85.28$KG$20240920$$CN$US$US
242683091$24268309$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-PV202400112974$PFIZER$$44$YR$$F$Y$$$20240830$$MD$US$US
242683101$24268310$1$I$20240701$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246788$PFIZER$$32$YR$$F$Y$$$20240830$$HP$US$US
242683111$24268311$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246090$PFIZER$$41$YR$$F$Y$$$20240830$$CN$US$US
242683121$24268312$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-PV202400112782$PFIZER$$69$YR$$F$Y$$$20240830$$CN$US$US
242683131$24268313$1$I$20240826$20240828$20240830$20240830$PER$$US-PFIZER INC-202400245693$PFIZER$$36$YR$$M$Y$$$20240830$$CN$US$US
242683141$24268314$1$I$20200101$20240819$20240830$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2020-US-018471$JAZZ$$$$$F$Y$$$20240830$$CN$US$US
242683151$24268315$1$I$20240828$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246252$PFIZER$$62$YR$$F$Y$$$20240830$$CN$US$US
242683162$24268316$2$F$20240827$20240923$20240830$20240926$PER$$US-PFIZER INC-202400245665$PFIZER$$77$YR$$F$Y$58.957$KG$20240926$$CN$US$US
242683171$24268317$1$I$20240828$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246051$PFIZER$$40$YR$$F$Y$$$20240830$$CN$US$US
242683182$24268318$2$F$20240828$20240829$20240830$20240904$PER$$US-PFIZER INC-PV202400112875$PFIZER$$63$YR$$M$Y$$$20240904$$CN$US$US
242683192$24268319$2$F$20240827$20240924$20240830$20240925$PER$$US-PFIZER INC-202400245875$PFIZER$$61$YR$$F$Y$61.224$KG$20240925$$CN$US$US
242683201$24268320$1$I$20240828$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246271$PFIZER$$62$YR$$M$Y$$$20240830$$CN$US$US
242683211$24268321$1$I$20240101$20240828$20240830$20240830$PER$$US-PFIZER INC-PV202400112506$PFIZER$$40$YR$$F$Y$$$20240830$$HP$US$US
242683222$24268322$2$F$20240101$20240924$20240830$20240926$PER$$US-PFIZER INC-202400246336$PFIZER$$71$YR$$F$Y$$$20240926$$CN$US$US
242683231$24268323$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245192$PFIZER$$56$YR$$F$Y$$$20240830$$CN$US$US
242683241$24268324$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245023$PFIZER$$$$$$Y$$$20240830$$CN$US$US
242683252$24268325$2$F$$20240913$20240830$20240923$PER$$US-PFIZER INC-202400245104$PFIZER$$25$YR$$M$Y$$$20240923$$MD$US$US
242683261$24268326$1$I$20240723$20240826$20240830$20240830$EXP$$NVSC2024CN173650$NOVARTIS$$83$YR$$M$Y$$$20240830$$HP$CN$CN
242683271$24268327$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018760$ELI LILLY AND CO$$$$A$F$Y$$$20240830$$CN$US$US
242683291$24268329$1$I$20240731$20240820$20240830$20240830$EXP$FR-AFSSAPS-BR2024000666$FR-TEVA-VS-3234812$TEVA$$82$YR$$M$Y$70.7$KG$20240830$$HP$FR$FR
242683302$24268330$2$F$$20240903$20240830$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408018079$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240909$$CN$US$US
242683321$24268332$1$I$20240729$20240815$20240830$20240830$EXP$$BR-SERVIER-S24010485$SERVIER$$$$$$Y$$$20240830$$PH$BR$BR
242683331$24268333$1$I$20181116$20240827$20240830$20240830$EXP$$US-ROCHE-3017706$ROCHE$$60$YR$A$F$Y$46$KG$20240830$$CN$US$US
242683341$24268334$1$I$20240801$20240822$20240830$20240830$PER$$US-SERVIER-S24010748$SERVIER$$$$$$Y$$$20240830$$MD$US$US
242683351$24268335$1$I$$20240829$20240830$20240830$PER$$NVSC2024US175281$NOVARTIS$$$$$$Y$$$20240830$$HP$US$US
242683362$24268336$2$F$20240701$20240916$20240830$20240921$PER$$US-ROCHE-10000067879$ROCHE$$$$$F$Y$72.57$KG$20240921$$CN$US$US
242683371$24268337$1$I$$20240819$20240830$20240830$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16532$IPSEN$$$$$F$Y$74.8$KG$20240830$$CN$US$US
242683381$24268338$1$I$$20240820$20240829$20240829$DIR$FDA-CDER-CTU-2024-59651$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242683391$24268339$1$I$$20240807$20240829$20240829$DIR$FDA-CDER-CTU-2024-59655$$FDA-CTU$$$$$M$N$$$20240807$N$HP$US$
242683411$24268341$1$I$20240821$20240826$20240830$20240830$EXP$$CA-JNJFOC-20240869789$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240830$$HP$CA$CA
242683421$24268342$1$I$$20240821$20240830$20240830$PER$$US-APOTEX-2024AP009850$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242683432$24268343$2$F$$20240910$20240830$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003937$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
242683442$24268344$2$F$$20240903$20240830$20240905$EXP$$CA-SANDOZ INC.-SDZ2023CA040444$SANDOZ$$$$$M$Y$$$20240905$$HP$CA$CA
242683452$24268345$2$F$20240826$20240826$20240830$20240903$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023146$UNITED THERAPEUTICS$$50$YR$$F$Y$70.748$KG$20240903$$$US$US
242683461$24268346$1$I$$20240826$20240830$20240830$EXP$$PE-AMGEN-PERSL2024171695$AMGEN$$46$YR$A$F$Y$$$20240830$$CN$PE$PE
242683471$24268347$1$I$$20240821$20240830$20240830$EXP$$CA-TEVA-VS-3237224$TEVA$$35$YR$$M$Y$$$20240830$$PH$CA$CA
242683481$24268348$1$I$$20240822$20240830$20240830$EXP$$JP-AMGEN-JPNSP2024172033$AMGEN$Hirabayashi M, Koizumi T, Nakajima D, Azegami S, Midorikawa H, Kitagawa N, et al. Parathyroid Hormone-Related Protein-Producing Adenocarcinoma Suspicious of Lung Cancer: A Case Report. Case Reports in Oncology. 2024;17:900-5$69$YR$E$M$Y$$$20240830$$MD$JP$JP
242683491$24268349$1$I$20240815$20240823$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135576$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240830$$HP$US$US
242683511$24268351$1$I$20240818$20240829$20240830$20240830$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048647$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$52.5$KG$20240830$$HP$CN$CN
242683521$24268352$1$I$$20240830$20240830$20240830$EXP$$FI-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048750$BOEHRINGER INGELHEIM$$$$$$Y$$$20240830$$MD$FI$FI
242683531$24268353$1$I$20240821$20240821$20240830$20240830$EXP$GB-MHRA-MED-202408211817071280-BKVTM$GB-GUERBET / LLC-GB-20240110$GUERBET$$50$YR$A$F$Y$55$KG$20240830$$HP$GB$GB
242683541$24268354$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-087374-2024$RECKITT BENCKISER$$69$YR$$F$Y$97.73$KG$20240830$$CN$US$US
242683551$24268355$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59620$$FDA-CTU$$57$YR$$F$N$$$20240829$N$$US$
242683561$24268356$1$I$$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59671$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
242683571$24268357$1$I$20240813$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59662$$FDA-CTU$$59$YR$$F$N$$$20240828$N$HP$US$
242683581$24268358$1$I$20240825$20240826$20240829$20240829$DIR$FDA-CDER-CTU-2024-59751$$FDA-CTU$$79$YR$$F$N$$$20240826$N$HP$US$
242683591$24268359$1$I$20240827$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59622$$FDA-CTU$$72$YR$$F$N$$$20240828$N$HP$US$
242683601$24268360$1$I$20240611$20240820$20240830$20240830$EXP$ES-AEMPS-1561569$ES-BAXTER-2024BAX023542$BAXTER$$76$YR$$M$Y$$$20240830$$MD$ES$ES
242683621$24268362$1$I$20240304$20240820$20240830$20240830$EXP$DK-DKMA-30737660$DK-BAXTER-2024BAX023515$BAXTER$$17$YR$$F$Y$109$KG$20240830$$MD$DK$DK
242683631$24268363$1$I$$20240821$20240830$20240830$PER$$US-APOTEX-2024AP009810$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242683641$24268364$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172807$AMGEN$$$$$M$Y$$$20240830$$CN$US$US
242683651$24268365$1$I$20240816$20240829$20240830$20240830$EXP$$CN-BAYER-2024A124680$BAYER$$74$YR$E$M$Y$$$20240830$$HP$CN$CN
242683661$24268366$1$I$$20240819$20240830$20240830$EXP$$CA-AMGEN-CANSP2024170123$AMGEN$$$$N$$Y$$$20240830$$HP$CA$CA
242683681$24268368$1$I$$20240826$20240830$20240830$EXP$$US-BAYER-2024A123150$BAYER$$65$YR$E$M$Y$$$20240830$$CN$US$US
242683691$24268369$1$I$20240801$20240822$20240830$20240830$PER$$US-MYLANLABS-2024M1078365$MYLAN$$41$YR$$M$Y$$$20240830$$CN$US$US
242683701$24268370$1$I$$20240826$20240830$20240830$EXP$$US-OTSUKA-2024_023564$OTSUKA$$$$$F$Y$$$20240830$$HP$US$US
242683711$24268371$1$I$$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A194094$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242683721$24268372$1$I$$20240827$20240830$20240830$EXP$$JP-AstraZeneca-2024A196635$ASTRAZENECA$$$$$$Y$$$20240830$$HP$JP$
242683731$24268373$1$I$20240415$20240822$20240830$20240830$EXP$$IT-AstraZeneca-2024A194403$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$IT$
242683741$24268374$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A193352$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242683751$24268375$1$I$$20240822$20240830$20240830$EXP$$CA-AstraZeneca-2024A091660$ASTRAZENECA$$76$YR$$M$Y$105$KG$20240830$$MD$CA$
242683761$24268376$1$I$20231201$20240827$20240830$20240830$EXP$CH-SM-2024-14462$CH-Waylis Therapeutics LLC-ATNAHS20240802465$Waylis$$22$YR$A$M$Y$80$KG$20240830$$MD$CH$CH
242683781$24268378$1$I$$20240823$20240830$20240830$PER$$US-AstraZeneca-2024A193140$ASTRAZENECA$$$$$$Y$$$20240830$$CN$US$
242683791$24268379$1$I$20240808$20240814$20240830$20240830$PER$$US-TEVA-VS-3233671$TEVA$$26$YR$$F$Y$$$20240830$$CN$US$US
242683812$24268381$2$F$20240101$20240918$20240830$20240923$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-115782$REGENERON$$$$$F$Y$$$20240923$$CN$US$US
242683822$24268382$2$F$$20240828$20240830$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137489$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240903$$CN$US$US
242683833$24268383$3$F$20240823$20240912$20240830$20240912$PER$$US-ALXN-202408USA001836US$ALEXION PHARMACEUTICALS$$$$$M$Y$132$KG$20240912$$CN$US$US
242683843$24268384$3$F$$20240927$20240830$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137388$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240930$$HP$US$US
242683851$24268385$1$I$20240819$20240829$20240830$20240830$EXP$$US-ROCHE-10000069865$ROCHE$$71$YR$E$F$Y$92.98$KG$20240830$$CN$US$US
242683861$24268386$1$I$$20240828$20240830$20240830$EXP$$JP-EMD Serono-2024046175$EMD SERONO INC$$76$YR$E$M$Y$$$20240830$$MD$JP$JP
242683871$24268387$1$I$20240723$20240820$20240830$20240830$EXP$FR-AFSSAPS-LM2024000447$FR-TEVA-VS-3235421$TEVA$$66$YR$$M$Y$49.9$KG$20240830$$MD$FR$FR
242683881$24268388$1$I$$20240825$20240830$20240830$PER$$US-BAYER-2024A122732$BAYER$$$$$F$Y$$$20240830$$CN$US$US
242683891$24268389$1$I$20240202$20240819$20240830$20240830$EXP$ES-AEMPS-1561249$ES-GLENMARK PHARMACEUTICALS-2024GMK093516$GLENMARK$$$$$$Y$$$20240830$$MD$ES$ES
242683911$24268391$1$I$$20240531$20240830$20240830$PER$$US-PERRIGO-24US005369$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242683921$24268392$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59687$$FDA-CTU$$45$YR$$F$N$125.19$KG$20240829$N$$US$
242683931$24268393$1$I$20240101$20240829$20240830$20240830$EXP$$US-UCBSA-2024044074$UCB$$$$$M$Y$$$20240830$$CN$US$US
242683941$24268394$1$I$$20240821$20240830$20240830$EXP$$AU-Atnahs Limited-ATNAHS20240802452$Atnahs Healthcare$$$$$$Y$$$20240830$$HP$AU$AU
242683951$24268395$1$I$$20240821$20240830$20240830$PER$$US-APOTEX-2024AP009843$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242683962$24268396$2$F$20240801$20240829$20240830$20240917$PER$$US-KARYOPHARM-2024KPT001466$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240917$$CN$US$US
242683971$24268397$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59704$$FDA-CTU$$86$YR$$F$N$59.87$KG$20240829$N$$US$
242683991$24268399$1$I$$20240826$20240830$20240830$PER$$US-ABBVIE-5897751$ABBVIE$$$$$F$Y$$$20240830$$HP$US$US
242684003$24268400$3$F$$20240913$20240830$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004245$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
242684011$24268401$1$I$20231031$20240820$20240830$20240830$EXP$FR-AFSSAPS-TO2024001571$FR-TEVA-VS-3235252$TEVA$$75$YR$$F$Y$$$20240830$$MD$FR$FR
242684021$24268402$1$I$$20240806$20240829$20240829$DIR$FDA-CDER-CTU-2024-59640$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
242684031$24268403$1$I$20240820$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59616$$FDA-CTU$$79$YR$$M$N$$$20240829$N$$US$
242684051$24268405$1$I$$20240819$20240830$20240830$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16536$IPSEN$$$$$M$Y$$$20240830$$CN$US$US
242684061$24268406$1$I$$20240820$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132689$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240830$$CN$US$US
242684071$24268407$1$I$$20240821$20240830$20240830$PER$$US-SA-2024SA252305$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240830$$MD$US$US
242684081$24268408$1$I$20240801$20240820$20240830$20240830$PER$$US-SA-2024SA252145$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240830$$HP$US$US
242684091$24268409$1$I$20240828$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172780$AMGEN$$60$YR$A$M$Y$$$20240830$$CN$US$US
242684101$24268410$1$I$20240822$20240823$20240830$20240830$PER$$US-BAYER-2024A122856$BAYER$$$$$$Y$$$20240830$$CN$US$US
242684111$24268411$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-086175-2024$RECKITT BENCKISER$$81$YR$$F$Y$$$20240830$$CN$US$US
242684121$24268412$1$I$$20240826$20240830$20240830$EXP$$BR-MYLANLABS-2024M1079145$MYLAN$$$$$F$Y$52$KG$20240830$$CN$BR$BR
242684131$24268413$1$I$20240828$20240828$20240830$20240830$EXP$$IN-REGENERON PHARMACEUTICALS, INC.-2024-117494$REGENERON$$74$YR$$F$Y$$$20240830$$MD$IN$IN
242684141$24268414$1$I$$20240826$20240830$20240830$PER$$US-BAYER-2024A122535$BAYER$$53$YR$A$F$Y$$$20240830$$MD$US$US
242684152$24268415$2$F$$20240902$20240830$20240909$PER$$US-LEO Pharma-373107$LEO PHARM$$51$YR$$M$Y$$$20240909$$CN$US$US
242684161$24268416$1$I$$20240816$20240830$20240830$EXP$$AU-LUPIN HEALTHCARE (UK) LIMITED-2024-08432$LUPIN$$$$$$Y$$$20240830$$CN$AU$AU
242684191$24268419$1$I$$20240821$20240830$20240830$EXP$$US-APOTEX-2024AP009956$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242684201$24268420$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172919$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242684211$24268421$1$I$$20240826$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016718$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240830$$CN$US$US
242684221$24268422$1$I$$20240821$20240830$20240830$EXP$$AU-Waylis Therapeutics LLC-ATNAHS20240802451$Waylis$$$$$$Y$$$20240829$$HP$AU$AU
242684231$24268423$1$I$$20240826$20240830$20240830$PER$$US-MYLANLABS-2024M1079430$MYLAN$$$$$F$Y$$$20240830$$CN$US$US
242684252$24268425$2$F$$20240828$20240830$20240905$EXP$$NVSC2024BE154655$NOVARTIS$Meganck S, Raevens S, Ferdinande K, Verhelst X, Hoorens A, Degroote H et al. Recurrent rejections after liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient. ACTA CLINICA BELGICA: INTERNATIONAL JOURNAL OF CLINICAL AND LABORATORY MEDICINE. 2024;1-8$32$YR$$F$Y$$$20240905$$HP$BE$BE
242684261$24268426$1$I$$20240821$20240830$20240830$EXP$$CA-ASTELLAS-2024-AER-003009$ASTELLAS$$35$YR$A$F$Y$$$20240830$$HP$CA$CA
242684272$24268427$2$F$$20240829$20240830$20240903$EXP$$NVSC2024US019137$NOVARTIS$$$$$M$Y$$$20240903$$CN$US$US
242684281$24268428$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137217$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240830$$CN$US$US
242684291$24268429$1$I$20240701$20240819$20240830$20240830$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08315$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242684301$24268430$1$I$20240101$20240821$20240830$20240830$EXP$$US-TEVA-VS-3237374$TEVA$$23$YR$$F$Y$$$20240830$$HP$US$US
242684311$24268431$1$I$20240730$20240819$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131954$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240830$$CN$US$US
242684321$24268432$1$I$$20240826$20240830$20240830$EXP$$US-SA-2024SA252288$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240830$$MD$US$US
242684331$24268433$1$I$20240826$20240826$20240830$20240830$PER$$US-BAYER-2024A122769$BAYER$$49$YR$A$F$Y$$$20240830$$CN$US$US
242684341$24268434$1$I$20240101$20240816$20240830$20240830$EXP$$US-UCBSA-2024041936$UCB$$$$$F$Y$$$20240830$$HP$US$US
242684354$24268435$4$F$20240826$20240925$20240830$20240930$PER$$US-ROCHE-10000066995$ROCHE$$$$$$Y$$$20240930$$PH$US$US
242684361$24268436$1$I$$20240827$20240830$20240830$PER$$US-ROCHE-10000067996$ROCHE$$$$E$F$Y$$$20240830$$MD$US$US
242684371$24268437$1$I$20231026$20240823$20240830$20240830$EXP$ES-AEMPS-1473928$ES-GSK-ES2024105408$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$ES$ES
242684381$24268438$1$I$$20240821$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008803$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242684391$24268439$1$I$$20240821$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008802$INCYTE$$$$$$Y$$$20240830$$HP$US$US
242684402$24268440$2$F$20240820$20240828$20240830$20240902$EXP$$JP-AstraZeneca-2024A193404$ASTRAZENECA$$$$E$F$Y$$$20240902$$MD$JP$
242684411$24268441$1$I$$20240827$20240830$20240830$PER$$US-BAYER-2024A123173$BAYER$$$$$$Y$$$20240830$$CN$US$US
242684421$24268442$1$I$20240829$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59780$$FDA-CTU$$71$YR$$M$N$$$20240829$Y$PH$US$
242684432$24268443$2$F$$20240830$20240830$20240905$PER$$US-LEO Pharma-373072$LEO PHARM$$42$YR$$F$Y$$$20240905$$HP$US$US
242684441$24268444$1$I$$20240821$20240830$20240830$EXP$$CA-ASTELLAS-2024-AER-002982$ASTELLAS$No information. No information. (Unknown): Unknown-Unknown.$$$$$Y$$$20240830$$CN$CA$CA
242684451$24268445$1$I$$20240826$20240830$20240830$PER$$US-JNJFOC-20240869529$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$CN$US$US
242684461$24268446$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137352$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240830$$HP$US$US
242684472$24268447$2$F$20240814$20240909$20240830$20240912$PER$$US-BAYER-2024A122700$BAYER$$77$YR$E$$Y$$$20240912$$CN$US$US
242684481$24268448$1$I$20240308$20240822$20240830$20240830$EXP$FR-AFSSAPS-AVMA2024000349$FR-Waylis Therapeutics LLC-ATNAHS20240802424$Waylis$$32$YR$A$M$Y$$$20240829$$PH$FR$FR
242684491$24268449$1$I$$20240827$20240830$20240830$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048190$BOEHRINGER INGELHEIM$$$$$$Y$$$20240830$$MD$US$US
242684501$24268450$1$I$$20240826$20240830$20240830$EXP$$IN-MYLANLABS-2024M1080010$MYLAN$Somasundaram A, Gupta A, Sathishkumar D, Mathew L, George A, Thomas M. Rapid recovery in a child with febrile ulceronecrotic Mucha-Habermann disease following intravenous immunoglobulin administration. Pediatr-Dermatol 2024; 41 (3): 518-522.$5$YR$$M$Y$$$20240830$$MD$IN$IN
242684511$24268451$1$I$20240717$20240821$20240830$20240830$EXP$$CN-AMGEN-CHNSP2024169541$AMGEN$$71$YR$E$M$Y$77$KG$20240830$$HP$CN$CN
242684521$24268452$1$I$$20240829$20240830$20240830$30DAY$$US-SANDOZ INC.-SDZ2024US076413$SANDOZ$$$$$F$Y$$$20240830$$CN$US$US
242684541$24268454$1$I$$20240822$20240830$20240830$EXP$$CA-TEVA-VS-3236807$TEVA$$36$YR$$F$Y$$$20240830$$HP$CA$CA
242684551$24268455$1$I$20240803$20240808$20240830$20240830$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000781$PAREXEL$$$$$$Y$$$20240830$$PH$US$US
242684561$24268456$1$I$$20240821$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008796$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242684571$24268457$1$I$$20240821$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008800$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242684591$24268459$1$I$20180101$20240829$20240829$20240829$DIR$716499$$FDA-CTU$$47$YR$$F$N$108$KG$20240829$N$CN$US$
242684601$24268460$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59699$$FDA-CTU$$$$$M$N$$$20240829$N$HP$US$
242684611$24268461$1$I$20240601$20240827$20240829$20240829$DIR$FDA-CDER-CTU-2024-59650$$FDA-CTU$$66$YR$$F$N$$$20240827$N$HP$US$
242684621$24268462$1$I$20240829$20240829$20240829$20240829$DIR$716494$$FDA-CTU$$82$YR$$F$N$$$20240829$N$PH$US$
242684631$24268463$1$I$20240822$20240826$20240829$20240829$DIR$FDA-CDER-CTU-2024-59703$$FDA-CTU$$56$YR$$F$N$$$20240826$N$HP$US$
242684641$24268464$1$I$$20240815$20240829$20240829$DIR$FDA-CDER-CTU-2024-59652$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242684651$24268465$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59663$$FDA-CTU$$39$YR$$M$N$$$20240829$N$$US$
242684671$24268467$1$I$$20240815$20240830$20240830$PER$$US-RISINGPHARMA-US-2024RISSPO00298$RISING PHARMACEUTICALS$$$$$M$Y$$$20240830$$HP$US$US
242684681$24268468$1$I$$20240820$20240830$20240830$30DAY$$US-GSK-US2024AMR103716$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$CN$US$US
242684691$24268469$1$I$$20240821$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008791$INCYTE$$$$$$Y$$$20240830$$HP$US$US
242684701$24268470$1$I$20240827$20240827$20240830$20240830$PER$$US-BAYER-2024A123965$BAYER$$41$YR$A$F$Y$$$20240830$$MD$US$US
242684711$24268471$1$I$20240801$20240828$20240830$20240830$EXP$$CA-PFIZER INC-202400245672$PFIZER$$68$YR$$M$Y$$$20240830$$CN$CA$CA
242684731$24268473$1$I$$20240822$20240830$20240830$EXP$$CA-PFIZER INC-202400246008$PFIZER$$48$YR$$F$Y$$$20240830$$PH$CA$CA
242684752$24268475$2$F$$20240902$20240830$20240903$EXP$GB-MHRA-MED-202408281340588810-PTCLH$GB-PFIZER INC-202400245691$PFIZER$$36$YR$$F$Y$75$KG$20240903$$CN$GB$GB
242684762$24268476$2$F$20240820$20240904$20240830$20240909$PER$$FR-PFIZER INC-202400244815$PFIZER$$73$YR$$M$Y$$$20240909$$PH$FR$FR
242684771$24268477$1$I$$20240826$20240830$20240830$EXP$$US-PFIZER INC-PV202400111855$PFIZER$$81$YR$$$Y$$$20240830$$CN$US$US
242684781$24268478$1$I$$20240819$20240830$20240830$30DAY$$CL-PFIZER INC-202400246492$PFIZER$$$$$$Y$$$20240830$$CN$CL$CL
242684791$24268479$1$I$$20240822$20240830$20240830$PER$$US-JNJFOC-20240860954$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$PH$US$US
242684801$24268480$1$I$20240812$20240812$20240830$20240830$PER$$US-TEVA-VS-3232833$TEVA$$$$$F$Y$$$20240830$$CN$US$US
242684811$24268481$1$I$$20240821$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008789$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242684821$24268482$1$I$20240701$20240821$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008787$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242684831$24268483$1$I$$20240820$20240830$20240830$EXP$$EG-JNJFOC-20240877575$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240830$$MD$EG$EG
242684842$24268484$2$F$20240101$20240829$20240830$20240905$EXP$$US-INDIVIOR US-INDV-156206-2024$RECKITT BENCKISER$$$$$$Y$$$20240905$$HP$US$US
242684851$24268485$1$I$20240810$20240815$20240829$20240829$DIR$FDA-CDER-CTU-2024-59660$$FDA-CTU$$80$YR$$F$N$$$20240815$N$HP$US$
242684861$24268486$1$I$$20240827$20240830$20240830$PER$$US-ROCHE-10000068384$ROCHE$$$$$$Y$$$20240830$$CN$US$US
242684871$24268487$1$I$20240101$20240822$20240830$20240830$EXP$$US-SA-2024SA251863$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240830$$MD$US$US
242684881$24268488$1$I$20240813$20240813$20240830$20240830$PER$$CA-TOLMAR, INC.-24CA051911$TOLMAR$$75$YR$$M$Y$$$20240829$$CN$CA$CA
242684891$24268489$1$I$20240812$20240813$20240830$20240830$PER$$CA-TOLMAR, INC.-24CA051886$TOLMAR$$89$YR$$M$Y$$$20240829$$CN$CA$CA
242684901$24268490$1$I$20240813$20240813$20240830$20240830$PER$$CA-TOLMAR, INC.-24CA051912$TOLMAR$$44$YR$$M$Y$$$20240829$$CN$CA$CA
242684911$24268491$1$I$20240813$20240813$20240830$20240830$PER$$TR-TOLMAR, INC.-24TR051885$TOLMAR$$63$YR$$M$Y$$$20240829$$MD$TR$TR
242684921$24268492$1$I$20240710$20240813$20240830$20240830$PER$$US-TOLMAR, INC.-24US051639$TOLMAR$$72$YR$$M$Y$$$20240829$$HP$US$US
242684931$24268493$1$I$20230616$20240813$20240830$20240830$PER$$SV-TOLMAR, INC.-24SV051216$TOLMAR$$81$YR$$M$Y$$$20240829$$CN$SV$SV
242684941$24268494$1$I$20240813$20240813$20240830$20240830$PER$$US-TOLMAR, INC.-24US051860$TOLMAR$$42$YR$$F$Y$$$20240829$$HP$US$US
242684962$24268496$2$F$20240402$20240913$20240830$20240930$PER$$US-TOLMAR, INC.-24US051657$TOLMAR$$$$$$Y$$$20240927$$PH$US$US
242684972$24268497$2$F$20240801$20240830$20240830$20240905$EXP$$CA-ROCHE-10000068646$ROCHE$$29$YR$A$M$Y$$$20240905$$CN$CA$CA
242684981$24268498$1$I$$20240827$20240830$20240830$PER$$US-BAYER-2024A124032$BAYER$$33$YR$A$F$Y$$$20240830$$HP$US$US
242684991$24268499$1$I$20240716$20240807$20240830$20240830$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000775$PAREXEL$$$$$$Y$$$20240830$$PH$US$US
242685001$24268500$1$I$$20240823$20240830$20240830$EXP$$US-ALXN-202408USA001734US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$MD$US$US
242685021$24268502$1$I$$20240827$20240830$20240830$EXP$$US-BAUSCH-BL-2022-017069$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240830$$CN$US$US
242685031$24268503$1$I$20231001$20240827$20240830$20240830$EXP$$US-BAUSCH-BL-2024-012975$BAUSCH AND LOMB$$69$YR$$M$Y$$$20240830$$CN$US$US
242685041$24268504$1$I$$20240827$20240830$20240830$PER$$US-BAYER-2024A124312$BAYER$$50$YR$A$F$Y$$$20240830$$HP$US$US
242685051$24268505$1$I$$20240816$20240830$20240830$EXP$$AU-LUPIN EUROPE GMBH-2024-08394$LUPIN$$42$YR$$M$Y$$$20240830$$CN$AU$AU
242685062$24268506$2$F$20240427$20240829$20240830$20240903$EXP$DE-AMK-278930$DE-REGENERON PHARMACEUTICALS, INC.-2024-117512$REGENERON$$80$YR$$F$Y$$$20240903$$PH$DE$DE
242685071$24268507$1$I$20240829$20240829$20240830$20240830$EXP$$AU-MYLANLABS-2024M1079887$MYLAN$$73$YR$$F$Y$$$20240830$$HP$AU$AU
242685081$24268508$1$I$20240101$20240823$20240830$20240830$PER$$US-ABBVIE-5894849$ABBVIE$$$$$F$Y$$$20240830$$HP$US$US
242685091$24268509$1$I$$20240821$20240830$20240830$EXP$$AU-AMGEN-AUSSP2024167838$AMGEN$$$$$M$Y$$$20240830$$CN$AU$AU
242685101$24268510$1$I$20210101$20240819$20240830$20240830$EXP$$JP-JNJFOC-20240160824$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240830$$MD$JP$JP
242685111$24268511$1$I$20240809$20240816$20240830$20240830$PER$$US-SA-2024SA240869$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240830$$CN$US$US
242685122$24268512$2$F$$20240911$20240830$20240913$EXP$$CA-SANDOZ INC.-NVSC2022CA155071$SANDOZ$$$$$F$Y$$$20240913$$CN$CA$CA
242685151$24268515$1$I$20240718$20240807$20240830$20240830$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000768$PAREXEL$$$$$$Y$$$20240830$$HP$US$US
242685161$24268516$1$I$$20240828$20240830$20240830$EXP$$US-SANDOZ INC.-PHHY2016US080381$SANDOZ$$55$YR$$M$Y$$$20240830$$MD$US$US
242685171$24268517$1$I$$20240808$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08037$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242685181$24268518$1$I$20240701$20240820$20240830$20240830$30DAY$$US-GSK-US2024AMR104153$GLAXOSMITHKLINE$$38$YR$$F$Y$$$20240830$$CN$US$US
242685192$24268519$2$F$20231101$20240920$20240830$20240924$PER$$US-ROCHE-10000068997$ROCHE$$54$YR$A$M$Y$99.79$KG$20240924$$CN$US$US
242685201$24268520$1$I$$20240824$20240830$20240830$EXP$$US-GSK-US2024AMR106499$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$US$US
242685211$24268521$1$I$20240823$20240823$20240830$20240830$EXP$$CO-AstraZeneca-2024A195159$ASTRAZENECA$$14832$DY$$F$Y$$$20240830$$CN$CO$
242685221$24268522$1$I$$20240828$20240830$20240830$PER$$US-BAYER-2024A123871$BAYER$$$$$$Y$$$20240830$$CN$US$US
242685231$24268523$1$I$$20240828$20240830$20240830$PER$$US-BAYER-2024A124212$BAYER$$$$$F$Y$$$20240830$$HP$US$US
242685241$24268524$1$I$20240816$20240822$20240830$20240830$EXP$$CN-AstraZeneca-2024A195170$ASTRAZENECA$$18193$DY$$F$Y$$$20240830$$MD$CN$
242685251$24268525$1$I$20240704$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195499$ASTRAZENECA$$$$$M$Y$$$20240830$$HP$US$
242685261$24268526$1$I$$20240828$20240830$20240830$EXP$$US-ROCHE-10000069022$ROCHE$$34$YR$A$F$Y$58.06$KG$20240830$$CN$US$US
242685271$24268527$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59772$$FDA-CTU$$23$YR$$F$N$$$20240829$N$$US$
242685281$24268528$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59644$$FDA-CTU$$41$YR$$F$N$46.72$KG$20240829$N$$US$
242685291$24268529$1$I$20240817$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59648$$FDA-CTU$$77$YR$$M$N$$$20240829$N$PH$US$
242685301$24268530$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59729$$FDA-CTU$$56$YR$$M$N$$$20240829$N$$US$
242685311$24268531$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017354$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$US$US
242685321$24268532$1$I$$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018185$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240830$$CN$US$US
242685331$24268533$1$I$20231201$20240822$20240830$20240830$EXP$$GB-CELLTRION INC.-2024GB020474$CELLTRION$$$$$$Y$$$20240830$$HP$GB$GB
242685341$24268534$1$I$$20240826$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137410$BRISTOL MYERS SQUIBB$$8$YR$C$M$Y$$$20240830$$CN$US$US
242685351$24268535$1$I$$20240829$20240830$20240830$PER$$US-BAYER-2024A124513$BAYER$$$$$$Y$$$20240830$$CN$US$US
242685361$24268536$1$I$$20240828$20240830$20240830$PER$$US-BAYER-2024A124222$BAYER$$$$$F$Y$$$20240830$$CN$US$US
242685371$24268537$1$I$$20240821$20240830$20240830$PER$$US-ABBVIE-5892836$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242685381$24268538$1$I$20231101$20240820$20240830$20240830$EXP$$US-TAKEDA-2024TUS087095$TAKEDA$$$$N$$Y$$$20240830$$MD$US$US
242685392$24268539$2$F$20240826$20240828$20240830$20240905$PER$$US-AMGEN-USASP2024172647$AMGEN$$80$YR$E$M$Y$$$20240904$$CN$US$US
242685401$24268540$1$I$20240101$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171135$AMGEN$$71$YR$E$M$Y$$$20240830$$CN$US$US
242685411$24268541$1$I$20240803$20240807$20240830$20240830$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000767$PAREXEL$$$$$$Y$$$20240830$$PH$US$US
242685421$24268542$1$I$20240731$20240805$20240830$20240830$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000752$PAREXEL$$$$$$Y$$$20240830$$PH$US$US
242685432$24268543$2$F$20240510$20240830$20240830$20240905$EXP$FR-AFSSAPS-TS2024000944$NVSC2024FR175097$NOVARTIS$$80$YR$$F$Y$65$KG$20240905$$MD$FR$FR
242685441$24268544$1$I$20240826$20240828$20240830$20240830$PER$$US-BAYER-2024A124258$BAYER$$$$$F$Y$$$20240830$$HP$US$US
242685451$24268545$1$I$$20240801$20240830$20240830$PER$$US-LEX-000418$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242685461$24268546$1$I$20240718$20240828$20240830$20240830$PER$$US-BAYER-2024A124431$BAYER$$46$YR$A$F$Y$$$20240830$$MD$US$US
242685471$24268547$1$I$20240401$20240827$20240830$20240830$PER$$US-ABBVIE-5899166$ABBVIE$$64$YR$$$Y$$$20240830$$CN$US$US
242685481$24268548$1$I$20240506$20240821$20240830$20240830$EXP$FR-AFSSAPS-DJ2024000906$FR-TEVA-VS-3235742$TEVA$$93$YR$$F$Y$97$KG$20240830$$MD$FR$FR
242685491$24268549$1$I$$20240821$20240830$20240830$PER$$US-JNJFOC-20240857076$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242685501$24268550$1$I$$20240821$20240830$20240830$EXP$$US-APOTEX-2024AP009755$APOTEX$Kotamarti V. Disentangling the Diagnoses of Psychotic Depression, Catatonia, Neurocognitive Disorders, and Delirium: A Multidisciplinary Approach. American Journal of Geriatric Psychiatry. 2024;32 (Suppl. 4):S35-S36$77$YR$$M$Y$$$20240830$$HP$US$US
242685511$24268551$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5898711$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242685521$24268552$1$I$20240805$20240829$20240830$20240830$EXP$PT-INFARMED-J202408-560$PT-Eisai-EC-2024-173187$EISAI$$66$YR$E$F$Y$$$20240830$$PH$PT$PT
242685531$24268553$1$I$20240416$20240827$20240830$20240830$EXP$$JP-AMGEN-JPNSP2024172403$AMGEN$$5$DEC$A$F$Y$$$20240830$$MD$JP$JP
242685541$24268554$1$I$20200101$20240826$20240830$20240830$EXP$$JP-Eisai-EC-2021-095291$EISAI$$78$YR$E$M$Y$39$KG$20240830$$MD$JP$JP
242685551$24268555$1$I$20240701$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136351$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240830$$HP$US$US
242685565$24268556$5$F$20240119$20240909$20240830$20240911$EXP$$NVSC2024DK174613$NOVARTIS$$37$YR$$M$Y$$$20240911$$MD$DK$DK
242685571$24268557$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898319$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242685581$24268558$1$I$20231214$20240830$20240830$20240830$EXP$IT-MINISAL02-1000255$NVSC2024IT175076$NOVARTIS$$47$YR$$M$Y$$$20240830$$MD$IT$IT
242685592$24268559$2$F$20240821$20240821$20240830$20240917$PER$$US-SA-2024SA250763$SANOFI AVENTIS$$67$YR$E$F$Y$62.73$KG$20240918$$MD$US$US
242685601$24268560$1$I$20240812$20240822$20240830$20240830$PER$$US-RDY-SPO/USA/24/0012434$DR REDDYS$$$$$F$Y$$$20240830$$CN$US$US
242685611$24268561$1$I$$20240822$20240830$20240830$30DAY$$US-GSK-US2024AMR106211$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$US$US
242685621$24268562$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59617$$FDA-CTU$$74$YR$$F$N$$$20240829$N$$US$
242685631$24268563$1$I$20240820$20240821$20240830$20240830$PER$$US-ABBVIE-5891589$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242685641$24268564$1$I$$20240829$20240830$20240830$PER$$US-BAYER-2024A124575$BAYER$$$$$$Y$$$20240830$$CN$US$US
242685651$24268565$1$I$20240804$20240805$20240829$20240829$DIR$FDA-CDER-CTU-2024-59638$$FDA-CTU$$33$YR$$M$N$$$20240805$N$HP$US$
242685661$24268566$1$I$20240724$20240826$20240830$20240830$EXP$FR-AFSSAPS-AM2024000685$FR-FreseniusKabi-FK202413080$FRESENIUS KABI$$74$YR$A$M$Y$85$KG$20240830$$MD$FR$FR
242685681$24268568$1$I$$20240806$20240829$20240829$DIR$FDA-CDER-CTU-2024-59637$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
242685691$24268569$1$I$20240815$20240816$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004774$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240830$$CN$US$US
242685701$24268570$1$I$20240524$20240829$20240829$20240829$DIR$716514$$FDA-CTU$$31$YR$$F$N$60.75$KG$20240829$Y$CN$US$
242685711$24268571$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59697$$FDA-CTU$$69$YR$$M$N$$$20240829$N$$US$
242685721$24268572$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59674$$FDA-CTU$$79$YR$$M$N$$$20240829$N$$US$
242685731$24268573$1$I$$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59693$$FDA-CTU$$$$$F$N$68.49$KG$20240828$N$$US$
242685741$24268574$1$I$20240829$20240829$20240829$20240829$DIR$716398$$FDA-CTU$$72$YR$$M$N$92.25$KG$20240829$N$CN$US$
242685761$24268576$1$I$$20240827$20240829$20240829$DIR$FDA-CDER-CTU-2024-59658$$FDA-CTU$$$$$F$N$$$20240827$N$$US$
242685781$24268578$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59613$$FDA-CTU$$16$YR$$M$N$$$20240829$N$$US$
242685791$24268579$1$I$20240801$20240805$20240830$20240830$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000750$PAREXEL$$$$$$Y$$$20240830$$PH$US$US
242685801$24268580$1$I$20240622$20240829$20240830$20240830$PER$$US-ROCHE-10000070372$ROCHE$$16$YR$T$M$Y$$$20240830$$CN$US$US
242685811$24268581$1$I$$20240829$20240830$20240830$EXP$$BR-ASTELLAS-2024-AER-003380$ASTELLAS$$$$$F$Y$$$20240830$$MD$BR$BR
242685821$24268582$1$I$20230101$20240814$20240830$20240830$PER$$US-ABBVIE-5894003$ABBVIE$$47$YR$$F$Y$$$20240830$$HP$US$US
242685831$24268583$1$I$$20240828$20240830$20240830$PER$$US-BAYER-2024A124436$BAYER$$41$YR$A$F$Y$$$20240830$$MD$US$US
242685841$24268584$1$I$20240801$20240821$20240830$20240830$PER$$US-ABBVIE-5891571$ABBVIE$$17$YR$$F$Y$$$20240830$$CN$US$US
242685851$24268585$1$I$20240821$20240822$20240830$20240830$30DAY$$US-GSK-US2024105074$GLAXOSMITHKLINE$$48$YR$$F$Y$$$20240830$$CN$US$US
242685861$24268586$1$I$20231221$20240318$20240830$20240830$PER$$US-MAYNE PHARMA-2024MYN000076$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242685871$24268587$1$I$$20240607$20240830$20240830$PER$$US-MAYNE PHARMA-2024MYN000194$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242685881$24268588$1$I$$20230828$20240830$20240830$PER$$US-MAYNE PHARMA-2023MYN000533$MAYNE$$$$$$Y$$$20240830$$PH$US$US
242685891$24268589$1$I$$20240425$20240830$20240830$PER$$US-MAYNE PHARMA-2024MYN000122$MAYNE$$$$$$Y$$$20240830$$HP$US$US
242685901$24268590$1$I$20240701$20240716$20240830$20240830$PER$$US-MAYNE PHARMA-2024MYN000315$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242685911$24268591$1$I$20240101$20240725$20240830$20240830$PER$$US-MAYNE PHARMA-2024MYN000322$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242685921$24268592$1$I$20240401$20240730$20240830$20240830$PER$$US-MAYNE PHARMA-2024MYN000330$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242685931$24268593$1$I$20240806$20240806$20240830$20240830$PER$$US-MAYNE PHARMA-2024MYN000343$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242685941$24268594$1$I$$20230831$20240830$20240830$PER$$US-MAYNE PHARMA-2023MYN000537$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242685951$24268595$1$I$$20230919$20240830$20240830$PER$$US-MAYNE PHARMA-2023MYN000578$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242685961$24268596$1$I$$20230926$20240830$20240830$PER$$US-MAYNE PHARMA-2023MYN000589$MAYNE$$$$$$Y$$$20240830$$MD$US$US
242685971$24268597$1$I$20230907$20230928$20240830$20240830$PER$$US-MAYNE PHARMA-2023MYN000597$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242685981$24268598$1$I$$20231005$20240830$20240830$PER$$US-MAYNE PHARMA-2023MYN000610$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242685991$24268599$1$I$$20231023$20240830$20240830$PER$$US-MAYNE PHARMA-2023MYN000629$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242686001$24268600$1$I$$20240102$20240830$20240830$PER$$US-MAYNE PHARMA-2024MYN000001$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242686011$24268601$1$I$20240125$20240131$20240830$20240830$PER$$US-MAYNE PHARMA-2024MYN000031$MAYNE$$$$$$Y$$$20240830$$CN$US$US
242686021$24268602$1$I$$20240220$20240830$20240830$PER$$US-MAYNE PHARMA-2024MYN000053$MAYNE$$$$$$Y$$$20240830$$MD$US$US
242686041$24268604$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137786$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240830$$CN$US$US
242686051$24268605$1$I$20240823$20240826$20240830$20240830$PER$$US-ROCHE-10000066598$ROCHE$$55$YR$A$F$Y$78.47$KG$20240830$$CN$US$US
242686061$24268606$1$I$$20240818$20240830$20240830$EXP$$US-JNJFOC-20240875854$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$HP$US$US
242686071$24268607$1$I$$20240826$20240830$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-026801$UNITED THERAPEUTICS$$$$$F$Y$83.9$KG$20240830$$$US$US
242686081$24268608$1$I$$20240829$20240830$20240830$PER$$US-ROCHE-10000070013$ROCHE$$$$A$M$Y$$$20240830$$CN$US$US
242686091$24268609$1$I$$20240822$20240830$20240830$EXP$$US-JNJFOC-20240859303$JOHNSON AND JOHNSON$$13$YR$T$F$Y$$$20240830$$HP$US$US
242686101$24268610$1$I$$20240826$20240830$20240830$PER$$US-HALEON-2194055$Haleon PLC$$$$$$Y$$$20240830$$CN$US$US
242686121$24268612$1$I$20240828$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024173456$AMGEN$$85$YR$E$M$Y$$$20240830$$PH$US$US
242686131$24268613$1$I$20240827$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172824$AMGEN$$70$YR$E$M$Y$$$20240830$$CN$US$US
242686142$24268614$2$F$20240719$20240806$20240830$20240905$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000748$PAREXEL$$$$$$Y$$$20240905$$PH$US$US
242686151$24268615$1$I$$20240822$20240830$20240830$EXP$$US-APOTEX-2024AP010050$APOTEX$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73 (200):1-9$55$YR$$F$Y$$$20240830$$HP$US$US
242686162$24268616$2$F$20240101$20240902$20240830$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-026827$UNITED THERAPEUTICS$$$$$M$Y$78.458$KG$20240905$$$US$US
242686171$24268617$1$I$20240101$20240823$20240830$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-026759$UNITED THERAPEUTICS$$$$$M$Y$88.435$KG$20240830$$$US$US
242686181$24268618$1$I$20240101$20240829$20240830$20240830$PER$$US-BAYER-2024A124460$BAYER$$21$YR$A$F$Y$$$20240830$$MD$US$US
242686191$24268619$1$I$$20240826$20240830$20240830$EXP$$US-ORG100016242-2024000552$PACIRA$$$$$F$Y$$$20240830$$HP$US$US
242686201$24268620$1$I$$20240821$20240830$20240830$EXP$$GB-CELLTRION INC.-2024GB020584$CELLTRION$$$$$$Y$$$20240830$$CN$GB$GB
242686211$24268621$1$I$20240818$20240820$20240830$20240830$EXP$GB-MHRA-MED-202408191739164600-CKLBQ$GB-LUPIN PHARMACEUTICALS INC.-2024-08274$LUPIN$$60$YR$$F$Y$$$20240830$$PH$GB$GB
242686221$24268622$1$I$$20240823$20240830$20240830$EXP$$IT-AstraZeneca-2024A195157$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$IT$
242686231$24268623$1$I$$20240814$20240830$20240830$PER$$US-AstraZeneca-2024A185809$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242686241$24268624$1$I$20240818$20240822$20240830$20240830$EXP$$CN-AstraZeneca-2024A193982$ASTRAZENECA$$717$DY$$M$Y$13$KG$20240830$$MD$CN$
242686251$24268625$1$I$$20240825$20240830$20240830$EXP$$NVSC2024US172420$NOVARTIS$$$$$$Y$$$20240830$$CN$US$US
242686261$24268626$1$I$20240805$20240829$20240830$20240830$EXP$IT-MINISAL02-1000189$IT-SANDOZ INC.-SDZ2024IT076251$SANDOZ$$71$YR$$F$Y$$$20240830$$MD$IT$IT
242686281$24268628$1$I$20240821$20240823$20240830$20240830$EXP$$BR-GSK-BR2024AMR106177$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$BR$BR
242686291$24268629$1$I$20240818$20240827$20240830$20240830$PER$$US-Eisai-EC-2024-173258$EISAI$$66$YR$E$M$Y$83.6$KG$20240830$$MD$US$US
242686301$24268630$1$I$$20240822$20240830$20240830$PER$$US-ALXN-202408USA001681US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242686311$24268631$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA249464$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240830$$MD$US$US
242686321$24268632$1$I$$20240819$20240830$20240830$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08284$LUPIN$Maresch KJ. Arytenoid dislocation and vocal cord immobility after emergent fiberoptic intubation: A case report. American Association of Nurse Anesthesiology. 2020;88 (6):459-463$53$YR$$M$Y$82$KG$20240830$$MD$US$US
242686331$24268633$1$I$$20240821$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134307$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240830$$CN$US$US
242686341$24268634$1$I$20240823$20240823$20240830$20240830$PER$$US-RDY-SPO/USA/24/0012526$DR REDDYS$$18$YR$A$F$Y$$$20240830$$MD$US$US
242686351$24268635$1$I$20240824$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172846$AMGEN$$80$YR$E$F$Y$$$20240830$$CN$US$US
242686361$24268636$1$I$$20240826$20240830$20240830$EXP$$IT-SANDOZ INC.-SDZ2024IT076168$SANDOZ$$$$$F$Y$$$20240830$$HP$IT$IT
242686371$24268637$1$I$$20240826$20240830$20240830$EXP$$US-TAKEDA-2023TUS074043$TAKEDA$$$$$F$Y$$$20240830$$CN$US$US
242686382$24268638$2$F$$20240919$20240830$20240925$PER$US-MLMSERVICE-20240819-PI166584-00071-1$US-RDY-SPO/USA/24/0012513$DR REDDYS$Cheung D, Ebach D, Davis B. Pediatric eosinophilic gastritis treated with benralizumab: A case report. JPGN reports. 2024;5(3):394-7. DOI: 10.1002/jpr3.12088.$8$YR$C$M$Y$27.5$KG$20240925$$MD$US$US
242686391$24268639$1$I$$20240719$20240830$20240830$PER$$US-ASCENT-2024ASSPO00015$ASCENT$$37$YR$A$$Y$$$20240830$$CN$US$US
242686401$24268640$1$I$$20240821$20240830$20240830$PER$$US-ABBVIE-5890990$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242686411$24268641$1$I$20240624$20240826$20240830$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-020299$UNITED THERAPEUTICS$$83$YR$$M$Y$73.016$KG$20240830$$$US$US
242686421$24268642$1$I$$20240822$20240830$20240830$30DAY$$US-GSK-US2024105102$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242686431$24268643$1$I$$20240823$20240830$20240830$EXP$$US-GSK-US2024105486$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$US$US
242686441$24268644$1$I$$20240829$20240830$20240830$EXP$$DE-GILEAD-2024-0685454$GILEAD$$$$$F$Y$$$20240830$$MD$DE$DE
242686451$24268645$1$I$$20240819$20240830$20240830$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408012261$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$BR$BR
242686461$24268646$1$I$$20240823$20240830$20240830$PER$$US-APOTEX-2024AP009832$APOTEX$Benson D, Thorsen T, Kirchen G. Lumbar Radiculopathy in the Pregnant Patient. Journal of Pain. 2019;20: 4:(S47)$35$YR$$F$Y$$$20240830$$HP$US$US
242686471$24268647$1$I$20240101$20240827$20240830$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-026939$UNITED THERAPEUTICS$$$$$F$Y$81.633$KG$20240830$$$US$US
242686482$24268648$2$F$20240801$20240904$20240830$20240912$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014500$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
242686491$24268649$1$I$20240618$20240829$20240829$20240829$DIR$716475$$FDA-CTU$$64$YR$$F$N$68.4$KG$20240829$N$CN$US$
242686501$24268650$1$I$$20240805$20240829$20240829$DIR$FDA-CDER-CTU-2024-59633$$FDA-CTU$$$$$F$N$$$20240805$N$HP$US$
242686511$24268651$1$I$$20240819$20240830$20240830$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408012139$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$BR$BR
242686521$24268652$1$I$20240818$20240819$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013077$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$US$US
242686531$24268653$1$I$$20240819$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012452$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240830$$CN$US$US
242686541$24268654$1$I$$20240820$20240830$20240830$EXP$GB-MHRA-MED-202408201043133080-LHCKM$GB-ELI_LILLY_AND_COMPANY-GB202408013013$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$GB$GB
242686551$24268655$1$I$$20240826$20240830$20240830$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408015844$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240830$$PH$JP$JP
242686561$24268656$1$I$$20240821$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013532$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240830$$CN$US$US
242686571$24268657$1$I$$20240821$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013744$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240830$$CN$US$US
242686581$24268658$1$I$$20240819$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012045$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240830$$CN$US$US
242686591$24268659$1$I$$20240819$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011508$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240830$$CN$US$US
242686601$24268660$1$I$20240820$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013574$ELI LILLY AND CO$$$$$$Y$$$20240830$$CN$US$US
242686611$24268661$1$I$20240701$20240827$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408017087$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240830$$CN$US$US
242686621$24268662$1$I$20220101$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012527$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$US$US
242686632$24268663$2$F$$20240827$20240830$20240905$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408014779$ELI LILLY AND CO$$79$YR$E$F$Y$70$KG$20240905$$CN$CN$CN
242686641$24268664$1$I$$20240819$20240830$20240830$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202408011497$ELI LILLY AND CO$$$$$M$Y$$$20240830$$CN$CA$CA
242686651$24268665$1$I$20240730$20240820$20240830$20240830$EXP$SE-SEMPA-2024-006157$SE-ELI_LILLY_AND_COMPANY-SE202408013248$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240830$$CN$SE$SE
242686661$24268666$1$I$$20240821$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013729$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240830$$CN$US$US
242686671$24268667$1$I$$20240822$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014665$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240830$$CN$US$US
242686681$24268668$1$I$$20240821$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016582$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240830$$CN$US$US
242686691$24268669$1$I$$20240821$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408015019$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240830$$CN$US$US
242686701$24268670$1$I$20240801$20240819$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014411$ELI LILLY AND CO$$43$YR$A$F$Y$56$KG$20240830$$CN$US$US
242686711$24268671$1$I$20240820$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013501$ELI LILLY AND CO$$$$A$F$Y$$$20240830$$CN$US$US
242686721$24268672$1$I$$20240820$20240830$20240830$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408013037$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240830$$CN$DE$DE
242686731$24268673$1$I$$20240821$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014281$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240830$$CN$US$US
242686741$24268674$1$I$20240820$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014898$ELI LILLY AND CO$$$$A$M$Y$$$20240830$$CN$US$US
242686751$24268675$1$I$$20240822$20240830$20240830$EXP$$JP-ROCHE-10000007858$ROCHE$Otsuji N, Sugiyama K, Owada T, Arifuku H, Koyama K, Hirata H, et al. Safety of Tocilizumab on Rheumatoid Arthritis in Patients with Interstitial Lung Disease. Open access rheumatology : research and reviews. 2024-Jun-11;16:127-35. doi:10.2147/OARRR.S462662.$$$$$Y$$$20240830$$HP$JP$JP
242686761$24268676$1$I$20240601$20240820$20240830$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026312$UNITED THERAPEUTICS$$76$YR$$F$Y$$$20240830$$$US$US
242686771$24268677$1$I$$20240816$20240830$20240830$PER$$US-Apozeal Pharmaceuticals-2161040$Apozeal Pharmaceuticals$$$$$$Y$$$20240830$$$US$US
242686782$24268678$2$F$20130201$20240902$20240830$20240911$EXP$GB-MHRA-MED-202408271105123500-BTHWR$GB-ABBVIE-5900353$ABBVIE$$41$YR$$M$Y$$$20240911$$CN$GB$GB
242686791$24268679$1$I$$20240816$20240830$20240830$PER$$US-Apozeal Pharmaceuticals-2161041$Apozeal Pharmaceuticals$$8$MON$$F$Y$$$20240830$$$US$US
242686801$24268680$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137855$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240830$$CN$US$US
242686811$24268681$1$I$20240823$20240823$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135724$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240830$$PH$US$US
242686821$24268682$1$I$$20240826$20240830$20240830$PER$$US-ROCHE-10000067472$ROCHE$$$$$$Y$$$20240830$$CN$US$US
242686832$24268683$2$F$$20240830$20240830$20240903$EXP$$US-ROCHE-10000070355$ROCHE$$83$YR$E$M$Y$$$20240903$$CN$US$US
242686841$24268684$1$I$$20240820$20240830$20240830$EXP$$JP-JNJFOC-20240873864$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240830$$PH$JP$JP
242686861$24268686$1$I$$20240826$20240830$20240830$EXP$$US-EMD Serono-2024046085$EMD SERONO INC$$$$E$F$Y$$$20240830$$CN$US$US
242686872$24268687$2$F$20240826$20240827$20240830$20240926$EXP$$CA-SA-2024SA252627$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240926$$CN$CA$CA
242686881$24268688$1$I$20240812$20240828$20240830$20240830$EXP$$US-ABBVIE-5900408$ABBVIE$$51$YR$$M$Y$$$20240830$$CN$US$US
242686891$24268689$1$I$$20240829$20240830$20240830$PER$$US-BAYER-2024A124464$BAYER$$34$YR$A$F$Y$$$20240830$$MD$US$US
242686901$24268690$1$I$$20240802$20240830$20240830$PER$$US-LEX-000417$LEXICON PHARMACEUTICALS$$82$YR$$F$Y$$$20240830$$CN$US$US
242686911$24268691$1$I$$20240821$20240830$20240830$PER$$US-APOTEX-2024AP009851$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242686921$24268692$1$I$$20240826$20240830$20240830$EXP$$US-MYLANLABS-2024M1079894$MYLAN$Palmer JP, Suriawinata AA, Yan S, Kerr DA, Afzal MZ, Shirai K. Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series. Am-J-Case-Rep 2023; 24.$51$YR$$M$Y$$$20240830$$HP$US$US
242686931$24268693$1$I$20240101$20240830$20240830$20240830$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048768$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$$$20240830$$MD$US$US
242686941$24268694$1$I$20240101$20240828$20240830$20240830$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048749$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240830$$CN$US$US
242686951$24268695$1$I$$20240827$20240830$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-026993$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240830$$$US$US
242686961$24268696$1$I$$20240827$20240830$20240830$EXP$$CA-FreseniusKabi-FK202413031$FRESENIUS KABI$$55$YR$A$F$Y$63$KG$20240830$$HP$CA$CA
242686971$24268697$1$I$$20240827$20240830$20240830$EXP$$CA-FreseniusKabi-FK202413030$FRESENIUS KABI$$54$YR$A$M$Y$74$KG$20240830$$HP$CA$CA
242686981$24268698$1$I$20240718$20240807$20240830$20240830$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000747$PAREXEL$$$$$$Y$$$20240830$$PH$US$US
242686992$24268699$2$F$20240801$20240806$20240830$20240905$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000738$PAREXEL$$$$$$Y$$$20240905$$HP$US$US
242687001$24268700$1$I$$20240805$20240830$20240830$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000730$PAREXEL$$$$$$Y$$$20240830$$HP$US$US
242687011$24268701$1$I$20240801$20240822$20240830$20240830$EXP$$JP-009507513-2408JPN002841J$MERCK$$87$YR$$M$Y$$$20240830$$MD$JP$JP
242687021$24268702$1$I$$20240826$20240830$20240830$EXP$$CA-TAKEDA-2024TUS086525$TAKEDA$$$$$M$Y$$$20240830$$MD$CA$CA
242687051$24268705$1$I$$20240827$20240829$20240829$DIR$FDA-CDER-CTU-2024-59746$$FDA-CTU$$$$$F$N$$$20240827$N$HP$US$
242687061$24268706$1$I$20240501$20240829$20240829$20240829$DIR$716534$$FDA-CTU$$58$YR$$F$N$$$20240829$Y$CN$US$
242687071$24268707$1$I$20240821$20240829$20240829$20240829$DIR$716462$$FDA-CTU$$63$YR$$F$N$65.25$KG$20240829$N$CN$US$
242687081$24268708$1$I$20240815$20240829$20240829$20240829$DIR$716508$$FDA-CTU$$47$YR$$F$N$97$KG$20240829$N$PH$US$
242687091$24268709$1$I$20240827$20240827$20240827$20240827$DIR$716214$$FDA-CTU$$50$YR$$M$N$$$20240827$N$$US$
242687101$24268710$1$I$$20240827$20240830$20240830$EXP$$MX-AMGEN-MEXSP2024172320$AMGEN$$$$$M$Y$$$20240830$$MD$MX$MX
242687111$24268711$1$I$$20240828$20240830$20240830$PER$$US-BAYER-2024A124517$BAYER$$39$YR$A$F$Y$$$20240830$$MD$US$US
242687121$24268712$1$I$20221222$20240821$20240830$20240830$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001267$AKEBIA THERAPEUTICS$$68$YR$$M$Y$59.3$KG$20240830$$MD$JP$JP
242687131$24268713$1$I$$20240821$20240830$20240830$EXP$$DE-TAKEDA-2024TUS084645$TAKEDA$$$$$$Y$$$20240830$$HP$DE$DE
242687141$24268714$1$I$20240725$20240827$20240830$20240830$EXP$IE-HPRA-2024-114853$IE-TAKEDA-2024TUS086370$TAKEDA$$70$YR$$M$Y$87.8$KG$20240830$$HP$IE$IE
242687151$24268715$1$I$20240801$20240821$20240830$20240830$EXP$$JP-Eisai-EC-2024-172711$EISAI$$36$YR$A$F$Y$$$20240830$$MD$JP$JP
242687162$24268716$2$F$$20240902$20240830$20240916$EXP$$PT-COSETTE-CP2024PT000184$COSETTE PHARMACEUTICALS$$72$YR$E$F$Y$$$20240916$$MD$PT$PT
242687171$24268717$1$I$$20240823$20240830$20240830$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006549$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242687181$24268718$1$I$20240716$20240829$20240830$20240830$PER$$US-BAYER-2024A124529$BAYER$$36$YR$A$F$Y$$$20240830$$MD$US$US
242687201$24268720$1$I$20240827$20240829$20240829$20240829$DIR$716500$$FDA-CTU$$58$YR$$F$N$86.85$KG$20240829$N$$US$
242687211$24268721$1$I$20240101$20240822$20240830$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-026470$UNITED THERAPEUTICS$$$$$M$Y$85.714$KG$20240830$$$US$US
242687221$24268722$1$I$20240829$20240829$20240829$20240829$DIR$716501$$FDA-CTU$$77$YR$$M$N$80.1$KG$20240829$N$CN$US$
242687231$24268723$1$I$$20240806$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07950$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242687241$24268724$1$I$20240601$20240821$20240830$20240830$PER$$US-SA-2024SA252176$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240830$$HP$US$US
242687261$24268726$1$I$$20240826$20240830$20240830$PER$US-MLMSERVICE-20240820-PI146989-00117-3$US-RDY-SPO/USA/24/0012528$DR REDDYS$Peshin S, Modi SK, Burwick N. Lenalidomide and Dexamethasone in Scleromyxedema: A Case Report of Long-Term Efficacy and Challenges in a 54-Year-Old Patient. Cureus. 2024;16(6):e63181. DOI:10.7759/cureus.63181.$6$DEC$A$M$Y$$$20240830$$MD$US$US
242687271$24268727$1$I$$20240815$20240830$20240830$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01528$AVADEL CNS PHARMA$$$$$F$Y$$$20240830$$CN$US$US
242687281$24268728$1$I$$20240829$20240830$20240830$PER$$US-BAYER-2024A124532$BAYER$$19$YR$A$F$Y$$$20240830$$MD$US$US
242687291$24268729$1$I$20240801$20240822$20240830$20240830$PER$$US-ABBVIE-5896489$ABBVIE$$44$YR$$M$Y$$$20240830$$CN$US$US
242687302$24268730$2$F$20090101$20240826$20240830$20240904$EXP$FR-EMA-20130725-mmevhumanwt-101400683$FR-TEVA-VS-3236265$TEVA$$59$YR$$M$Y$59$KG$20240904$$PH$FR$FR
242687311$24268731$1$I$20231211$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-081167-2024$RECKITT BENCKISER$$92$YR$$F$Y$$$20240830$$CN$US$US
242687322$24268732$2$F$20240801$20240826$20240830$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-026744$UNITED THERAPEUTICS$$63$YR$$F$Y$57.596$KG$20240904$$$US$US
242687331$24268733$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172788$AMGEN$$$$$F$Y$$$20240830$$CN$US$US
242687341$24268734$1$I$20240820$20240823$20240830$20240830$EXP$$US-AMGEN-USASP2024169377$AMGEN$$45$YR$A$F$Y$67.574$KG$20240830$$HP$US$US
242687351$24268735$1$I$20240728$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A194406$ASTRAZENECA$$27863$DY$$M$Y$$$20240830$$CN$US$
242687361$24268736$1$I$20240722$20240826$20240830$20240830$EXP$$JP-PFIZER INC-PV202400098673$PFIZER$$73$YR$$M$Y$72.9$KG$20240830$$PH$JP$JP
242687371$24268737$1$I$$20240822$20240830$20240830$EXP$$CA-PFIZER INC-202400244762$PFIZER$$59$YR$$F$Y$72.562$KG$20240830$$PH$CA$CA
242687382$24268738$2$F$$20240902$20240830$20240903$EXP$$IN-PFIZER INC-202400246410$PFIZER$Prasad, M.. PRE-IRRADIATION CHEMOTHERAPY AND DELAYED RADIATION THERAPY IN INFANTS AND YOUNG CHILDREN WITH WITH CENTRAL NERVOUS SYSTEM EMBRYONAL TUMOURS. Neuro-Oncology. 2024;26(Suppl 4):iv209$$$C$$Y$$$20240903$$HP$IN$IN
242687391$24268739$1$I$$20240827$20240830$20240830$EXP$$JP-PFIZER INC-PV202400112069$PFIZER$$$$$$Y$$$20240830$$MD$JP$JP
242687401$24268740$1$I$$20240827$20240830$20240830$EXP$$CL-PFIZER INC-PV202400112447$PFIZER$$58$YR$$F$Y$$$20240830$$CN$CL$CL
242687411$24268741$1$I$20240809$20240827$20240830$20240830$EXP$$CN-PFIZER INC-PV202400111928$PFIZER$$57$YR$$M$Y$65$KG$20240830$$HP$CN$CN
242687423$24268742$3$F$20240627$20240918$20240830$20240920$EXP$$US-PFIZER INC-202400231861$PFIZER$$64$YR$$F$Y$$$20240920$$PH$US$US
242687433$24268743$3$F$20240819$20240912$20240830$20240916$EXP$$BR-PFIZER INC-202400245016$PFIZER$$63$YR$$F$Y$59.8$KG$20240916$$HP$BR$BR
242687441$24268744$1$I$20240708$20240826$20240830$20240830$EXP$$DE-PFIZER INC-202400243527$PFIZER$$$$$M$Y$70$KG$20240830$$MD$DE$DE
242687453$24268745$3$F$20240608$20240917$20240830$20240920$EXP$$IN-PFIZER INC-2020351701$PFIZER$$76$YR$$F$Y$44$KG$20240920$$CN$IN$IN
242687461$24268746$1$I$20240627$20240826$20240830$20240830$EXP$FR-AFSSAPS-MP2024001318$FR-PFIZER INC-202400243573$PFIZER$$77$YR$$M$Y$62$KG$20240830$$MD$FR$FR
242687472$24268747$2$F$20210101$20240905$20240830$20240909$EXP$$US-PFIZER INC-202400243955$PFIZER$$75$YR$$F$Y$88.889$KG$20240909$$CN$US$US
242687482$24268748$2$F$20240101$20240830$20240830$20240904$EXP$$CA-PFIZER INC-202400244965$PFIZER$$67$YR$$F$Y$$$20240904$$HP$CA$CA
242687492$24268749$2$F$$20240902$20240830$20240905$EXP$$US-PFIZER INC-202400245449$PFIZER$Cunningham, B.. Vancomycin Anaphylaxis and Kounis Syndrome Case Report. Cureus. 2024;16(7):e64740$67$YR$$M$Y$112$KG$20240905$$MD$US$US
242687502$24268750$2$F$$20240902$20240830$20240903$EXP$$IN-PFIZER INC-PV202400112901$PFIZER$Prasad, M.. PRE-IRRADIATION CHEMOTHERAPY AND DELAYED RADIATION THERAPY IN INFANTS AND YOUNG CHILDREN WITH WITH CENTRAL NERVOUS SYSTEM EMBRYONAL TUMOURS. Neuro-Oncology. 2024;26(Suppl 4):iv209$$$C$$Y$$$20240903$$HP$IN$IN
242687511$24268751$1$I$$20240826$20240830$20240830$EXP$$ES-PFIZER INC-202400245805$PFIZER$Galindo-Rodriguez, D.. Multidrug-resistant Mycobacterium abscessus infection in an anophthalmic socket treated with bedaquiline on a compassionate use basis: A case report. American Journal of Ophthalmology Case Reports. 2024;36:10.1016/j.ajoc.2024.102139$60$YR$$F$Y$$$20240830$$HP$ES$ES
242687521$24268752$1$I$$20240827$20240830$20240830$EXP$$CA-ORGANON-O2408CAN002142$ORGANON$$43$YR$$F$Y$$$20240830$$HP$CA$CA
242687531$24268753$1$I$$20240821$20240830$20240830$EXP$$PH-PFIZER INC-202400242271$PFIZER$Luceno, V.. Severe COVID-19 Infection in a Lupus Nephritis Patient on Treatment for Multidrug-Resistant Disseminated Tuberculosis. Phillippine Journal of Internal Medicine. 2024;62(2):106-109$24$YR$$F$Y$$$20240830$$MD$PH$PH
242687541$24268754$1$I$$20240826$20240830$20240830$EXP$$JP-PFIZER INC-PV202400111383$PFIZER$Gotoh, T.. A case of residual sodium zirconium cyclosilicate hydrate in the stomach after administration via a nasogastric tube. Journal of Japanese Society of Hospital Pharmacists. 2024;60(8):883-887$7$DEC$$F$Y$58.7$KG$20240830$$HP$JP$JP
242687551$24268755$1$I$20240101$20240826$20240830$20240830$EXP$$CA-PFIZER INC-PV202400056512$PFIZER$$33$YR$$M$Y$$$20240830$$HP$CA$CA
242687561$24268756$1$I$20240801$20240827$20240830$20240830$EXP$$US-PFIZER INC-PV202400112312$PFIZER$$$$$M$Y$$$20240830$$CN$US$US
242687571$24268757$1$I$20240522$20240827$20240830$20240830$EXP$ES-AEMPS-1563835$ES-PFIZER INC-202400244442$PFIZER$$6$YR$$M$Y$$$20240830$$MD$ES$ES
242687581$24268758$1$I$20240801$20240827$20240830$20240830$EXP$FR-AFSSAPS-PB2024000914$FR-PFIZER INC-202400244449$PFIZER$$81$YR$$M$Y$48$KG$20240830$$PH$FR$FR
242687591$24268759$1$I$$20240827$20240830$20240830$EXP$$PT-PFIZER INC-202400245520$PFIZER$Moura, Mariana. PO-0118 - (4088) - Intoxicacao aguda por metotrexato. Congresso Nacional de Medicina Interna. 2024;488$85$YR$$F$Y$$$20240830$$MD$PT$PT
242687602$24268760$2$F$20240501$20240918$20240830$20240920$EXP$$US-PFIZER INC-202400244901$PFIZER$$73$YR$$F$Y$85.261$KG$20240920$$CN$US$US
242687612$24268761$2$F$20230220$20240902$20240830$20240904$EXP$$FR-PFIZER INC-PV202300207638$PFIZER$$46$YR$$F$Y$55$KG$20240904$$MD$FR$FR
242687621$24268762$1$I$20240719$20240827$20240830$20240830$EXP$FR-AFSSAPS-TS2024000935$FR-PFIZER INC-202400244435$PFIZER$$83$YR$$M$Y$$$20240830$$MD$FR$FR
242687631$24268763$1$I$$20240823$20240830$20240830$EXP$$CA-PFIZER INC-202400246713$PFIZER$$84$YR$$M$Y$49$KG$20240830$$PH$CA$CA
242687641$24268764$1$I$$20240828$20240830$20240830$PER$$NVSC2024US174944$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
242687651$24268765$1$I$20240806$20240827$20240830$20240830$PER$$US-ABBVIE-5898489$ABBVIE$$$$$F$Y$$$20240830$$MD$US$US
242687661$24268766$1$I$$20240820$20240830$20240830$30DAY$$US-GSK-US2024104014$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$CN$US$US
242687681$24268768$1$I$20240826$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138266$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240830$$CN$US$US
242687692$24268769$2$F$$20240911$20240830$20240926$PER$$US-GLANDPHARMA-US-2024GLNSPO00704$GLAND PHARMA$$$$$$Y$$$20240926$$HP$US$US
242687701$24268770$1$I$$20240823$20240830$20240830$PER$$US-UNITED THERAPEUTICS-UNT-2024-026704$UNITED THERAPEUTICS$$$$$F$Y$73.469$KG$20240830$$$US$US
242687711$24268771$1$I$20240101$20240816$20240830$20240830$EXP$$US-UCBSA-2024041928$UCB$$$$$F$Y$$$20240830$$HP$US$US
242687721$24268772$1$I$$20240821$20240830$20240830$PER$$US-APOTEX-2024AP009852$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242687731$24268773$1$I$20220827$20240815$20240830$20240830$EXP$$PT-SEBELA IRELAND LIMITED-2024SEB00059$SEBELA$$27$YR$$F$Y$56$KG$20240830$$CN$PT$PT
242687751$24268775$1$I$$20240822$20240830$20240830$EXP$$CO-ROCHE-10000070026$ROCHE$$$$$M$Y$61.8$KG$20240830$$CN$CO$CO
242687761$24268776$1$I$$20240828$20240830$20240830$PER$$NVSC2024US174597$NOVARTIS$$$$$M$Y$$$20240830$$CN$US$US
242687771$24268777$1$I$$20240820$20240830$20240830$PER$$US-SA-2024SA230246$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240830$$MD$US$US
242687781$24268778$1$I$20240425$20240829$20240830$20240830$PER$$US-BAYER-2024A124538$BAYER$$22$YR$A$F$Y$$$20240830$$MD$US$US
242687791$24268779$1$I$20240820$20240829$20240829$20240829$DIR$716502$$FDA-CTU$$42$YR$$F$N$78.75$KG$20240829$N$CN$US$
242687801$24268780$1$I$$20240820$20240830$20240830$EXP$$CA-APOTEX-2024AP009625$APOTEX$$60$YR$$F$Y$$$20240830$$MD$CA$CA
242687811$24268781$1$I$20210715$20240826$20240830$20240830$EXP$$KR-AMGEN-KORSP2024172411$AMGEN$$58$YR$A$F$Y$$$20240830$$PH$KR$KR
242687821$24268782$1$I$$20240807$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07928$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242687831$24268783$1$I$$20240828$20240830$20240830$EXP$$US-SANDOZ INC.-SDZ2024US076045$SANDOZ$$70$YR$$M$Y$$$20240830$$MD$US$US
242687841$24268784$1$I$$20240829$20240830$20240830$EXP$$GB-SANDOZ INC.-SDZ2023GB070321$SANDOZ$$$$E$F$Y$$$20240830$$CN$GB$GB
242687851$24268785$1$I$20240618$20240823$20240830$20240830$EXP$$FR-Integrated Therapeutic Solutions Inc.-2161047$Integrated Therapeutic Solutions$$62$YR$$M$Y$$$20240830$$$FR$FR
242687861$24268786$1$I$20240710$20240829$20240829$20240829$DIR$716497$$FDA-CTU$$72$YR$$F$N$63$KG$20240829$N$CN$US$
242687871$24268787$1$I$$20240825$20240830$20240830$PER$$US-JNJFOC-20240865536$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$CN$US$US
242687881$24268788$1$I$20210701$20240828$20240830$20240830$EXP$$BA-SANDOZ INC.-SDZ2024BA076182$SANDOZ$$38$YR$$F$Y$$$20240830$$MD$BA$BA
242687901$24268790$1$I$20240720$20240829$20240829$20240829$DIR$716493$$FDA-CTU$$51$YR$$M$N$112.1$KG$20240829$N$PH$US$
242687921$24268792$1$I$$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59646$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
242687931$24268793$1$I$20240815$20240829$20240829$20240829$DIR$716503$$FDA-CTU$$26$YR$$F$N$$$20240829$Y$PH$US$
242687941$24268794$1$I$20240828$20240829$20240829$20240829$DIR$716509$$FDA-CTU$$30$YR$$F$N$$$20240829$Y$PH$US$
242687951$24268795$1$I$$20240820$20240830$20240830$EXP$$US-IMMUNOGEN, INC.-US-IMGN-24-00651$IMMUNOGEN$$$$$$Y$$$20240830$$MD$US$US
242687961$24268796$1$I$$20240816$20240830$20240830$EXP$$US-UCBSA-2024041548$UCB$$$$$F$Y$$$20240830$$HP$US$US
242687971$24268797$1$I$$20240809$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08076$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242687981$24268798$1$I$20240810$20240826$20240830$20240830$EXP$$CA-TAKEDA-2024TUS086457$TAKEDA$$41$YR$$M$Y$$$20240830$$MD$CA$CA
242687991$24268799$1$I$20240812$20240827$20240830$20240830$EXP$PT-INFARMED-B202408-396$PT-FreseniusKabi-FK202413052$FRESENIUS KABI$$63$YR$A$M$Y$$$20240830$$HP$PT$PT
242688001$24268800$1$I$20240614$20240827$20240830$20240830$EXP$BE-FAMHP-DHH-N2024-122537$BE-FreseniusKabi-FK202412963$FRESENIUS KABI$$18$YR$A$F$Y$$$20240830$$HP$BE$BE
242688021$24268802$1$I$$20240826$20240830$20240830$30DAY$$SE-MYLANLABS-2024M1079244$MYLAN$$$$$$Y$$$20240830$$CN$SE$SE
242688033$24268803$3$F$$20240903$20240830$20240913$30DAY$$US-MYLANLABS-2024M1079176$MYLAN$$$$$$Y$$$20240913$$CN$US$US
242688041$24268804$1$I$$20240826$20240830$20240830$30DAY$$FI-MYLANLABS-2024M1078968$MYLAN$$$$$$Y$$$20240830$$CN$FI$FI
242688052$24268805$2$F$$20240924$20240830$20240927$30DAY$$AU-MYLANLABS-2024M1079565$MYLAN$$$$$$Y$$$20240927$$CN$AU$AU
242688061$24268806$1$I$20240101$20240821$20240830$20240830$EXP$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000686$Day One Biopharmaceuticals$$9$YR$$F$Y$$$20240828$$HP$US$US
242688071$24268807$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5897359$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242688081$24268808$1$I$20190809$20240826$20240830$20240830$EXP$PL-URPL-1-2248-2019$PL-ABBVIE-5894977$ABBVIE$$60$YR$$F$Y$68$KG$20240829$$MD$PL$PL
242688092$24268809$2$F$$20240827$20240830$20240902$EXP$$US-ABBVIE-5896456$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242688101$24268810$1$I$20240823$20240826$20240830$20240830$EXP$$US-ABBVIE-5896335$ABBVIE$$49$YR$$M$Y$$$20240829$$CN$US$US
242688111$24268811$1$I$20240101$20240826$20240830$20240830$EXP$$US-ABBVIE-5896411$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242688121$24268812$1$I$20240501$20240826$20240830$20240830$EXP$$US-ABBVIE-5896575$ABBVIE$$32$YR$$F$Y$$$20240828$$CN$US$US
242688132$24268813$2$F$20240101$20240905$20240830$20240911$EXP$$NVSC2024CN174487$NOVARTIS$$51$YR$$M$Y$$$20240911$$CN$CN$CN
242688151$24268815$1$I$$20240829$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018815$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240830$$CN$US$US
242688171$24268817$1$I$$20240827$20240830$20240830$PER$$US-ABBVIE-5899175$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242688181$24268818$1$I$20210326$20240821$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008774$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242688191$24268819$1$I$$20240821$20240830$20240830$PER$$US-INCYTE CORPORATION-2024IN008772$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242688201$24268820$1$I$$20240822$20240830$20240830$EXP$$CA-TEVA-VS-3236699$TEVA$$$$$$Y$$$20240830$$MD$CA$CA
242688211$24268821$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137258$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240830$$CN$US$US
242688221$24268822$1$I$$20240827$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137943$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240830$$CN$US$US
242688231$24268823$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-089497-2024$RECKITT BENCKISER$$56$YR$$F$Y$$$20240830$$CN$US$US
242688241$24268824$1$I$20240101$20240826$20240830$20240830$EXP$$US-ABBVIE-5896866$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242688251$24268825$1$I$$20240807$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07974$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242688262$24268826$2$F$$20240819$20240830$20240830$PER$$US-ROCHE-10000062524$ROCHE$$$$$$Y$$$20240830$$CN$US$US
242688271$24268827$1$I$20240819$20240821$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133890$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$68.95$KG$20240830$$HP$US$US
242688281$24268828$1$I$20210901$20230406$20240830$20240830$EXP$$BR-BIOVITRUM-2023-BR-009280$BIOVITRUM$$4$MON$$M$Y$12$KG$20240830$$CN$BR$BR
242688291$24268829$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5896688$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242688301$24268830$1$I$$20240819$20240830$20240830$EXP$$JP-JNJFOC-20240880005$JOHNSON AND JOHNSON$1 A case of acute renal failure requiring hemodiafiltration which developed after status epilepticus. The 16th Tokai-Hokuriku Regional Meeting of The Japan Epilepsy Society (03 AUG 2024). 2024;11.$20$YR$A$M$Y$99.8$KG$20240830$$HP$JP$JP
242688311$24268831$1$I$20240711$20240826$20240830$20240830$EXP$$US-ABBVIE-5896787$ABBVIE$$94$YR$$F$Y$$$20240829$$CN$US$US
242688321$24268832$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5896417$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242688331$24268833$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5896390$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242688341$24268834$1$I$20240101$20240826$20240830$20240830$EXP$$US-ABBVIE-5896369$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242688351$24268835$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5897692$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242688361$24268836$1$I$20240819$20240826$20240830$20240830$EXP$$CN-ABBVIE-5896123$ABBVIE$$62$YR$$F$Y$$$20240828$$MD$CN$CN
242688371$24268837$1$I$20240829$20240829$20240830$20240830$PER$$US-BAYER-2024A124681$BAYER$$33$YR$A$F$Y$$$20240830$$MD$US$US
242688381$24268838$1$I$$20240826$20240830$20240830$PER$$US-ROCHE-10000067102$ROCHE$$$$E$$Y$$$20240830$$CN$US$US
242688392$24268839$2$F$$20240913$20240830$20240921$EXP$$US-TEVA-VS-3232674$TEVA$Perkit NR, Sekar A, Geetha HS, Abraham GM. AD-DRESS-ING AN UNUSUAL PRESENTATION OF VANCOMYCIN-INDUCED DRESS SYNDROME. Crit-Care-Med 2024; 52 (Suppl.) (1): S731.; Perkit NR, Sekar A, Geetha HS, Abraham GM. AD-DRESS-ING AN UNUSUAL PRESENTATION OF VANCOMYCIN-INDUCED DRESS SYNDROME. Crit-Care-Med 2024; 52 (Suppl.) (1): S731.$70$YR$$M$Y$$$20240921$$HP$US$US
242688402$24268840$2$F$$20240917$20240830$20240923$PER$$DE-IDORSIA-008396-2024-DE$IDORSIA PHARMACEUTICALS$$67$YR$$M$Y$58$KG$20240923$$PH$DE$DE
242688411$24268841$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A194088$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242688422$24268842$2$F$20240822$20240912$20240830$20240918$EXP$$US-ABBVIE-5897651$ABBVIE$$71$YR$$F$Y$73$KG$20240918$$CN$US$US
242688431$24268843$1$I$$20240821$20240830$20240830$PER$$US-APOTEX-2024AP009853$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242688441$24268844$1$I$20240823$20240829$20240829$20240829$DIR$716504$$FDA-CTU$$27$YR$$F$N$$$20240829$Y$PH$US$
242688451$24268845$1$I$20240819$20240829$20240829$20240829$DIR$716487$$FDA-CTU$$55$YR$$F$N$$$20240829$Y$CN$US$
242688461$24268846$1$I$20240401$20240826$20240830$20240830$EXP$$US-ABBVIE-5897443$ABBVIE$$59$YR$$F$Y$$$20240828$$CN$US$US
242688471$24268847$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5897208$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242688481$24268848$1$I$20240801$20240826$20240830$20240830$EXP$$US-ABBVIE-5896583$ABBVIE$$47$YR$$M$Y$$$20240829$$CN$US$US
242688491$24268849$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5897576$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242688502$24268850$2$F$20240826$20240918$20240830$20240922$EXP$$AT-ABBVIE-5897618$ABBVIE$$84$YR$$F$Y$$$20240922$$HP$AT$AT
242688511$24268851$1$I$$20240826$20240830$20240830$EXP$$AU-ABBVIE-5895520$ABBVIE$$$$$F$Y$$$20240829$$CN$AU$AU
242688521$24268852$1$I$$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59649$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
242688531$24268853$1$I$20240815$20240829$20240829$20240829$DIR$716531$$FDA-CTU$$32$YR$$F$N$65.25$KG$20240829$N$CN$US$
242688551$24268855$1$I$20240827$20240829$20240829$20240829$DIR$716523$$FDA-CTU$$24$YR$$F$N$$$20240829$N$$US$
242688561$24268856$1$I$$20240822$20240830$20240830$EXP$$CA-TEVA-VS-3236687$TEVA$$44$YR$$F$Y$97$KG$20240830$$HP$CA$CA
242688571$24268857$1$I$20240710$20240826$20240830$20240830$EXP$$US-ABBVIE-5896870$ABBVIE$$65$YR$$F$Y$$$20240829$$CN$US$US
242688581$24268858$1$I$20240825$20240826$20240830$20240830$EXP$$US-ABBVIE-5896607$ABBVIE$$64$YR$$F$Y$$$20240829$$CN$US$US
242688591$24268859$1$I$20240826$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024170187$AMGEN$$$$$F$Y$$$20240830$$CN$US$US
242688601$24268860$1$I$20240828$20240829$20240829$20240829$DIR$716517$$FDA-CTU$$2$MON$$F$N$$$20240829$N$PH$US$
242688611$24268861$1$I$$20240826$20240830$20240830$EXP$$FR-ABBVIE-5897691$ABBVIE$$76$YR$$F$Y$$$20240829$$MD$FR$FR
242688621$24268862$1$I$20240802$20240828$20240830$20240830$PER$$US-BAYER-2024A124796$BAYER$$$$$F$Y$$$20240830$$CN$US$US
242688632$24268863$2$F$20240702$20240909$20240830$20240910$PER$$US-AMGEN-USASP2024172811$AMGEN$$77$YR$E$F$Y$$$20240910$$HP$US$US
242688651$24268865$1$I$20240422$20240821$20240830$20240830$PER$$US-Eisai-EC-2024-172704$EISAI$$75$YR$E$F$Y$$$20240830$$MD$US$US
242688662$24268866$2$F$$20240827$20240830$20240904$PER$$US-MYLANLABS-2024M1079461$MYLAN$$60$YR$$$Y$$$20240904$$CN$US$US
242688671$24268867$1$I$20230213$20240822$20240830$20240830$EXP$$BR-TAKEDA-2023TUS017181$TAKEDA$$58$YR$$M$Y$$$20240830$$CN$BR$BR
242688681$24268868$1$I$$20240827$20240830$20240830$EXP$$CA-FreseniusKabi-FK202413066$FRESENIUS KABI$$64$YR$A$M$Y$$$20240830$$CN$CA$CA
242688702$24268870$2$F$20240821$20240827$20240830$20240906$EXP$BE-FAMHP-DHH-N2024-122540$BE-ABBVIE-5896401$ABBVIE$$$$$F$Y$$$20240906$$CN$BE$BE
242688711$24268871$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898288$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242688721$24268872$1$I$20240701$20240827$20240830$20240830$EXP$$US-ABBVIE-5898550$ABBVIE$$85$YR$$M$Y$$$20240829$$CN$US$US
242688731$24268873$1$I$$20240827$20240830$20240830$EXP$$CA-FreseniusKabi-FK202413065$FRESENIUS KABI$$63$YR$A$M$Y$86$KG$20240830$$HP$CA$CA
242688741$24268874$1$I$$20240822$20240830$20240830$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006543$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$MD$US$US
242688752$24268875$2$F$20240101$20240903$20240830$20240911$PER$$US-UNITED THERAPEUTICS-UNT-2024-024463$UNITED THERAPEUTICS$$$$$F$Y$52.608$KG$20240911$$$US$US
242688761$24268876$1$I$20240813$20240827$20240830$20240830$EXP$$US-ABBVIE-5897764$ABBVIE$$54$YR$$F$Y$$$20240829$$CN$US$US
242688771$24268877$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898511$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242688782$24268878$2$F$20231103$20240913$20240830$20240916$EXP$$CA-ABBVIE-5898527$ABBVIE$$$$A$F$Y$$$20240916$$CN$CA$CA
242688791$24268879$1$I$20240726$20240823$20240830$20240830$EXP$$US-BAYER-2024A123198$BAYER$$46$YR$A$F$Y$59$KG$20240830$$CN$US$US
242688821$24268882$1$I$20240829$20240829$20240829$20240829$DIR$716518$$FDA-CTU$$76$YR$$F$N$65.25$KG$20240829$N$CN$US$
242688831$24268883$1$I$$20240829$20240829$20240829$DIR$716491$$FDA-CTU$$29$YR$$F$N$90$KG$20240829$Y$CN$US$
242688841$24268884$1$I$20240823$20240829$20240829$20240829$DIR$716533$$FDA-CTU$$77$YR$$F$N$72$KG$20240829$N$CN$US$
242688851$24268885$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898599$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242688861$24268886$1$I$20240801$20240809$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08083$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242688871$24268887$1$I$$20240822$20240830$20240830$PER$$US-ROCHE-3579853$ROCHE$Collet D, Canestraro J A. MEK Inhibitor Associated Ocular Hypertension.. Ocular Oncology and Pathology. 2024;10:98-102. doi:10.1159/000535427.$46$YR$A$M$Y$$$20240830$$HP$US$US
242688881$24268888$1$I$20240712$20240826$20240830$20240830$EXP$$FR-ORGANON-O2408FRA002234$ORGANON$$22$YR$$F$Y$$$20240830$$HP$FR$FR
242688891$24268889$1$I$$20240808$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07975$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242688901$24268890$1$I$$20240801$20240830$20240830$PER$$US-009507513-2408USA001001$MERCK$$58$YR$$M$Y$$$20240830$$MD$US$US
242688911$24268891$1$I$20240101$20240828$20240830$20240830$EXP$$US-PFIZER INC-202400230960$PFIZER$$45$YR$$M$Y$$$20240830$$CN$US$US
242688921$24268892$1$I$$20240828$20240830$20240830$EXP$$AR-PFIZER INC-202400245839$PFIZER$$81$YR$$M$Y$$$20240830$$MD$AR$AR
242688933$24268893$3$F$$20240910$20240830$20240912$EXP$$US-PFIZER INC-PV202300152724$PFIZER$$52$YR$$F$Y$$$20240912$$HP$US$US
242688941$24268894$1$I$$20240827$20240830$20240830$EXP$$US-PFIZER INC-PV202400112174$PFIZER$Sangam, S.. A CASE OF LEGIONELLA PNEUMONIA WITH RHABDOMYOLYSIS, WITH EXTREMELY HIGH CREATININE KINASE WITHOUT ACUTE KIDNEY INJURY IN AN ADULT. European Journal of Case Reports in Internal Medicine. 2024;11(8):10.12890/2024_004539$38$YR$$M$Y$$$20240830$$HP$US$US
242688951$24268895$1$I$20240307$20240828$20240830$20240830$EXP$ES-AEMPS-1535412$ES-PFIZER INC-202400245343$PFIZER$$54$YR$$F$Y$$$20240830$$PH$ES$ES
242688962$24268896$2$F$20240504$20240906$20240830$20240912$PER$$US-AMGEN-USASP2024169363$AMGEN$$44$YR$A$M$Y$85.4$KG$20240912$$PH$US$US
242688973$24268897$3$F$20240822$20240916$20240830$20240920$30DAY$$US-AMGEN-USASP2024169259$AMGEN$$62$YR$A$F$Y$72.6$KG$20240920$$PH$US$US
242688981$24268898$1$I$20240827$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172295$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242688991$24268899$1$I$$20240822$20240830$20240830$EXP$$US-AMGEN-USASP2024168636$AMGEN$Hahn NM.. Neoadjuvant Cisplatin, Gemeitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis. Bladder Cancer. 2024;10 (2):133-143$$$$$Y$$$20240830$$MD$US$US
242689001$24268900$1$I$$20240823$20240830$20240830$EXP$$JP-AMGEN-JPNSP2024169982$AMGEN$$$$E$F$Y$$$20240830$$PH$JP$JP
242689011$24268901$1$I$20240820$20240821$20240830$20240830$PER$$US-AMGEN-USASP2024171988$AMGEN$$$$A$M$Y$$$20240830$$HP$US$US
242689022$24268902$2$F$20240827$20240927$20240830$20240930$PER$$US-AMGEN-USASP2024172633$AMGEN$$72$YR$E$M$Y$$$20240928$$CN$US$US
242689031$24268903$1$I$20240826$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024170331$AMGEN$$58$YR$A$F$Y$$$20240830$$CN$US$US
242689041$24268904$1$I$$20240826$20240830$20240830$EXP$$US-MYLANLABS-2024M1080084$MYLAN$Pace JL, Hopstone MD, Conti PS, Tom C, Mohamed P, Gong Y, et al. Unresectable Metastatic Solid Pseudopapillary Pancreatic Neoplasm Treated with Liver Transplantation. ACG-Case-Rep-J 2024; 11 (8):.$49$YR$$F$Y$$$20240830$$MD$US$US
242689051$24268905$1$I$$20240826$20240830$20240830$EXP$$US-MYLANLABS-2024M1080034$MYLAN$Nakasone ES, Bustillos HC, Gui X, Konnick EQ, Sham JG, Cohen SA. Multidisciplinary Approach for the Management of Metastatic Poorly Differentiated Neuroendocrine Carcinoma of the Pancreas A Case Report of an Exceptional Responder. Pancreas 2024; 53 (6): e487-e491.$51$YR$$M$Y$$$20240830$$MD$US$US
242689061$24268906$1$I$$20240827$20240830$20240830$EXP$$IN-MYLANLABS-2024M1080097$MYLAN$Princy R, Neethu R. Methotrexate-Induced Mucositis Due to Accidental Overdose; a Case Report. Afr-J-Biol-Sci 2024; 6 (3): 700-703.$71$YR$$F$Y$$$20240830$$HP$IN$IN
242689072$24268907$2$F$20240101$20240925$20240830$20240927$EXP$$CA-ABBVIE-5899098$ABBVIE$$26$YR$$M$Y$$$20240927$$CN$CA$CA
242689081$24268908$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5897607$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242689091$24268909$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898582$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242689101$24268910$1$I$20230101$20240814$20240830$20240830$PER$$US-ABBVIE-5894342$ABBVIE$$50$YR$$F$Y$$$20240829$$HP$US$US
242689111$24268911$1$I$20230101$20240814$20240830$20240830$PER$$US-ABBVIE-5894340$ABBVIE$$71$YR$$F$Y$$$20240829$$HP$US$US
242689121$24268912$1$I$20230101$20240814$20240830$20240830$PER$$US-ABBVIE-5894348$ABBVIE$$39$YR$$F$Y$$$20240829$$HP$US$US
242689131$24268913$1$I$20230101$20240814$20240830$20240830$PER$$US-ABBVIE-5894346$ABBVIE$$61$YR$$M$Y$$$20240828$$HP$US$US
242689141$24268914$1$I$20230101$20240814$20240830$20240830$PER$$US-ABBVIE-5894536$ABBVIE$$50$YR$$M$Y$$$20240829$$HP$US$US
242689151$24268915$1$I$20240809$20240829$20240830$20240830$EXP$GB-MHRA-MED-202408291101421820-CDWQY$GB-BIOVITRUM-2024-GB-011480$BIOVITRUM$$29$YR$$M$Y$$$20240830$$CN$GB$GB
242689161$24268916$1$I$20230101$20240814$20240830$20240830$PER$$US-ABBVIE-5894512$ABBVIE$$41$YR$$F$Y$$$20240829$$HP$US$US
242689181$24268918$1$I$20240829$20240829$20240829$20240829$DIR$716490$$FDA-CTU$$74$YR$$F$N$$$20240829$N$$US$
242689191$24268919$1$I$$20240810$20240830$20240830$PER$$US-TEVA-VS-3232562$TEVA$$$$$$Y$$$20240830$$CN$US$US
242689201$24268920$1$I$20240829$20240829$20240829$20240829$DIR$716512$$FDA-CTU$$37$YR$$F$N$$$20240829$Y$PH$US$
242689221$24268922$1$I$20240813$20240829$20240829$20240829$DIR$716511$$FDA-CTU$$77$YR$$F$N$61.2$KG$20240829$N$PH$US$
242689231$24268923$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-088148-2024$RECKITT BENCKISER$$$$$M$Y$$$20240830$$CN$US$US
242689242$24268924$2$F$20240827$20240828$20240830$20240904$PER$$US-AMGEN-USASP2024172810$AMGEN$$90$YR$E$M$Y$$$20240904$$CN$US$US
242689251$24268925$1$I$20240731$20240816$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004282$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240830$$CN$US$US
242689261$24268926$1$I$20240821$20240822$20240830$20240830$EXP$$JP-ROCHE-10000069061$ROCHE$$$$E$F$Y$$$20240830$$MD$JP$JP
242689271$24268927$1$I$$20240809$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08086$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242689281$24268928$1$I$20240820$20240826$20240830$20240830$EXP$GB-MHRA-MED-202408261304047330-GPYBV$GB-TEVA-VS-3237344$TEVA$$45$YR$$F$Y$85$KG$20240830$$PH$GB$GB
242689291$24268929$1$I$20230101$20240814$20240830$20240830$PER$$US-ABBVIE-5893777$ABBVIE$$47$YR$$M$Y$$$20240829$$HP$US$US
242689301$24268930$1$I$20230101$20240814$20240830$20240830$PER$$US-ABBVIE-5894033$ABBVIE$$46$YR$$F$Y$$$20240829$$HP$US$US
242689311$24268931$1$I$$20240821$20240830$20240830$PER$$US-ABBVIE-5893682$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242689321$24268932$1$I$$20240823$20240830$20240830$PER$$US-ABBVIE-5897525$ABBVIE$$$$$$Y$$$20240828$$HP$US$US
242689331$24268933$1$I$$20240826$20240830$20240830$PER$$US-ABBVIE-5896330$ABBVIE$$$$$$Y$$$20240829$$CN$US$US
242689341$24268934$1$I$$20240826$20240830$20240830$PER$$US-ABBVIE-5897725$ABBVIE$$$$$M$Y$$$20240829$$MD$US$US
242689351$24268935$1$I$$20240826$20240830$20240830$PER$$US-ABBVIE-5897846$ABBVIE$$$$$$Y$$$20240829$$HP$US$US
242689362$24268936$2$F$20240801$20240827$20240830$20240902$PER$$US-ABBVIE-5898386$ABBVIE$$$$A$M$Y$$$20240902$$HP$US$US
242689371$24268937$1$I$20240103$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-083034-2024$RECKITT BENCKISER$$21$YR$$M$Y$75$KG$20240830$$CN$US$US
242689381$24268938$1$I$$20240827$20240830$20240830$EXP$$NVSC2024FR174705$NOVARTIS$$$$$$Y$$$20240830$$PH$FR$FR
242689391$24268939$1$I$$20240826$20240830$20240830$EXP$$NVSC2024BR164945$NOVARTIS$$$$$F$Y$$$20240830$$HP$BR$BR
242689401$24268940$1$I$$20240828$20240830$20240830$PER$$US-BAYER-2024A124924$BAYER$$$$$F$Y$$$20240830$$CN$US$US
242689411$24268941$1$I$20240101$20240827$20240830$20240830$PER$$US-Eisai-EC-2024-173112$EISAI$$73$YR$E$F$Y$$$20240830$$CN$US$US
242689422$24268942$2$F$20240803$20240910$20240830$20240918$30DAY$$US-JNJFOC-20240814942$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240918$$CN$US$US
242689431$24268943$1$I$$20240823$20240830$20240830$EXP$$US-JNJFOC-20240879669$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$PH$US$US
242689442$24268944$2$F$20240820$20240903$20240830$20240911$PER$$US-Eisai-EC-2024-172785$EISAI$$73$YR$E$M$Y$78.9$KG$20240911$$HP$US$US
242689451$24268945$1$I$$20240827$20240830$20240830$PER$$US-BIOGEN-2024BI01280260$BIOGEN$$$$$F$Y$91$KG$20240830$$MD$US$US
242689461$24268946$1$I$20240801$20240823$20240830$20240830$PER$$US-BIOGEN-2024BI01280079$BIOGEN$$62$YR$$F$Y$$$20240830$$CN$US$US
242689471$24268947$1$I$$20240826$20240830$20240830$PER$$US-BIOGEN-2023BI01239065$BIOGEN$$$$$F$Y$$$20240830$$MD$US$US
242689481$24268948$1$I$$20240821$20240830$20240830$EXP$$US-CHIESI USA, INC.-2024CHF05350$CHIESI$$$$$M$Y$$$20240830$$CN$US$US
242689491$24268949$1$I$$20240827$20240830$20240830$EXP$$CA-FreseniusKabi-FK202413182$FRESENIUS KABI$$1$YR$I$F$Y$9$KG$20240830$$HP$CA$CA
242689501$24268950$1$I$$20240827$20240830$20240830$EXP$$CA-FreseniusKabi-FK202413194$FRESENIUS KABI$$16$YR$T$F$Y$$$20240830$$HP$CA$CA
242689512$24268951$2$F$20240829$20240829$20240830$20240903$PER$$NVSC2024US175310$NOVARTIS$$53$YR$$M$Y$$$20240903$$CN$US$US
242689521$24268952$1$I$20240708$20240827$20240830$20240830$EXP$$DE-FreseniusKabi-FK202413016$FRESENIUS KABI$$$$$M$Y$70$KG$20240830$$MD$DE$DE
242689531$24268953$1$I$$20240812$20240830$20240830$PER$$US-TEVA-VS-3234714$TEVA$$$$A$M$Y$$$20240830$$CN$US$US
242689541$24268954$1$I$$20240809$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08074$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242689551$24268955$1$I$$20240822$20240830$20240830$EXP$$US-VERTEX PHARMACEUTICALS-2024-013590$VERTEX$$$$A$$Y$$$20240830$$CN$US$US
242689561$24268956$1$I$$20240826$20240830$20240830$PER$$US-VERTEX PHARMACEUTICALS-2024-013753$VERTEX$$$$T$M$Y$$$20240830$$HP$US$US
242689571$24268957$1$I$20240823$20240823$20240830$20240830$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013678$VERTEX$$$$E$F$Y$$$20240830$$CN$GB$GB
242689581$24268958$1$I$$20240827$20240830$20240830$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013762$VERTEX$$$$C$M$Y$$$20240830$$CN$GB$GB
242689591$24268959$1$I$$20240827$20240830$20240830$EXP$$NL-ORGANON-O2408NLD002131$ORGANON$Hutten EM, Roeloffzen WW, Lambeck AJ, van den Born-Bondt T, Oude Elberink HN, van de VenAAJ.. Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization.. J-Investig-Allergol-Clin-Immunol. 2024;34 (3):214-6.$52$YR$$F$Y$$$20240830$$HP$NL$NL
242689601$24268960$1$I$$20240826$20240830$20240830$PER$$US-VERTEX PHARMACEUTICALS-2024-013720$VERTEX$$$$$$Y$$$20240830$$CN$US$US
242689611$24268961$1$I$20220928$20240823$20240830$20240830$EXP$GB-MHRA-MED-202408231257272330-HZQSM$GB-VERTEX PHARMACEUTICALS-2024-013700$VERTEX$$14$YR$$F$Y$42$KG$20240830$$CN$GB$GB
242689621$24268962$1$I$20240101$20240827$20240830$20240830$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013764$VERTEX$$$$A$M$Y$$$20240830$$CN$GB$GB
242689631$24268963$1$I$$20240826$20240830$20240830$EXP$$US-VERTEX PHARMACEUTICALS-2024-013750$VERTEX$$$$$F$Y$$$20240830$$MD$US$US
242689641$24268964$1$I$$20240823$20240830$20240830$PER$$US-VERTEX PHARMACEUTICALS-2024-013667$VERTEX$$6$YR$$F$Y$$$20240830$$CN$US$US
242689651$24268965$1$I$20240424$20240827$20240830$20240830$EXP$FR-AFSSAPS-MP2024000901$FR-MYLANLABS-2024M1078967$MYLAN$$38$YR$$M$Y$$$20240830$$CN$FR$FR
242689662$24268966$2$F$20240701$20240905$20240830$20240913$PER$$US-ROCHE-10000020259$ROCHE$$12$YR$T$M$Y$45.36$KG$20240914$$CN$US$US
242689671$24268967$1$I$$20240814$20240830$20240830$PER$$US-AstraZeneca-2024A186544$ASTRAZENECA$$$$$F$Y$$$20240830$$HP$US$
242689681$24268968$1$I$$20240822$20240830$20240830$PER$$DE-AstraZeneca-2024A198146$ASTRAZENECA$$$$$$Y$$$20240830$$HP$US$
242689691$24268969$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-084432-2024$RECKITT BENCKISER$$65$YR$$F$Y$$$20240830$$CN$US$US
242689701$24268970$1$I$$20240822$20240830$20240830$EXP$$ZA-AstraZeneca-2024A194233$ASTRAZENECA$$55$YR$$F$Y$$$20240830$$CN$ZA$
242689711$24268971$1$I$$20240814$20240830$20240830$PER$$US-AstraZeneca-2024A186189$ASTRAZENECA$$$$$F$Y$$$20240830$$HP$US$
242689721$24268972$1$I$$20240829$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018825$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240830$$CN$US$US
242689732$24268973$2$F$20240825$20240829$20240830$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018378$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240903$$CN$US$US
242689741$24268974$1$I$$20240822$20240830$20240830$EXP$$CA-AstraZeneca-2024A194408$ASTRAZENECA$$76$YR$$M$Y$$$20240830$$MD$CA$
242689761$24268976$1$I$$20240826$20240830$20240830$EXP$$US-AMGEN-USASP2024170336$AMGEN$Nowak R.J.; Coffey C.S.; Goldstein J.M. et.al.. Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis The BeatMG Study. Neurology. 2022;98 (4):e377-e389$$$$$Y$$$20240830$$MD$US$US
242689771$24268977$1$I$$20240823$20240830$20240830$EXP$$US-AMGEN-USASP2024169752$AMGEN$Fischer M.D.; Green M.L.; Selke S. et.al.. Evaluation of oral herpes simplex virus shedding among solid organ transplant recipients: A pilot study. Transplant Infectious Disease. 2024;26 (4):1 to 7$$$A$F$Y$$$20240830$$HP$US$US
242689781$24268978$1$I$$20240826$20240830$20240830$EXP$$CA-AstraZeneca-2024A196660$ASTRAZENECA$$65$YR$$F$Y$$$20240830$$MD$CA$
242689791$24268979$1$I$$20240828$20240830$20240830$PER$$NVSC2024US174929$NOVARTIS$$$$$F$Y$99.7$KG$20240830$$HP$US$US
242689802$24268980$2$F$$20240909$20240830$20240917$EXP$$CA-BAUSCH-BL-2024-012955$BAUSCH AND LOMB$$26$YR$$M$Y$$$20240917$$CN$CA$CA
242689811$24268981$1$I$$20240828$20240830$20240830$PER$$US-BAUSCH-BL-2024-012999$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240830$$CN$US$US
242689821$24268982$1$I$$20240822$20240830$20240830$EXP$$US-AMGEN-USASP2024169090$AMGEN$Mokhtari S.; Verma N.; Jaffer M. et al.. Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis. Cureus. 2021;13 (7):1-5$70$YR$E$F$Y$$$20240830$$HP$US$US
242689831$24268983$1$I$$20240821$20240830$20240830$EXP$$GB-AMGEN-GBRSL2024169409$AMGEN$$$$$F$Y$$$20240830$$CN$GB$GB
242689841$24268984$1$I$$20240823$20240830$20240830$EXP$$US-AMGEN-USASP2024169742$AMGEN$Fischer M.D.; Green M.L.; Selke S. et.al.. Evaluation of oral herpes simplex virus shedding among solid organ transplant recipients: A pilot study. Transplant Infectious Disease. 2024;26 (4):1 to 7$$$$F$Y$$$20240830$$HP$US$US
242689851$24268985$1$I$20240701$20240812$20240830$20240830$PER$$US-TEVA-VS-3232848$TEVA$$$$E$F$Y$$$20240830$$CN$US$US
242689862$24268986$2$F$$20240904$20240830$20240906$PER$$US-BAUSCH-BL-2024-013021$BAUSCH AND LOMB$$$$$F$Y$$$20240906$$CN$US$US
242689871$24268987$1$I$20240706$20240821$20240830$20240830$EXP$FR-AFSSAPS-NY2024000953$FR-TEVA-VS-3235946$TEVA$$79$YR$$F$Y$$$20240830$$MD$FR$FR
242689882$24268988$2$F$20240712$20240829$20240830$20240905$EXP$$TW-009507513-2408TWN009943$MERCK$$87$YR$$F$Y$46.8$KG$20240905$$HP$TW$TW
242689894$24268989$4$F$20240817$20240909$20240830$20240917$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03090$AMNEAL$$20$YR$$M$Y$83.9$KG$20240917$$PH$US$US
242689901$24268990$1$I$$20240809$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08066$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242689921$24268992$1$I$20240101$20240822$20240830$20240830$PER$$US-SA-2024SA252199$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240830$$MD$US$US
242689931$24268993$1$I$$20240829$20240830$20240830$PER$$US-BAYER-2024A124533$BAYER$$47$YR$A$F$Y$$$20240830$$MD$US$US
242689942$24268994$2$F$20240101$20240912$20240830$20240921$EXP$$JP-ROCHE-10000066583$ROCHE$$8$DEC$E$M$Y$$$20240921$$MD$JP$JP
242689951$24268995$1$I$$20240827$20240830$20240830$PER$$US-ROCHE-10000067797$ROCHE$$$$$F$Y$45.36$KG$20240830$$CN$US$US
242689962$24268996$2$F$20240624$20240828$20240830$20240910$PER$$US-ROCHE-10000069415$ROCHE$$81$YR$E$M$Y$$$20240910$$CN$US$US
242689971$24268997$1$I$$20240822$20240830$20240830$EXP$$AT-ROCHE-10000066085$ROCHE$$$$$M$Y$$$20240830$$MD$AT$AT
242689981$24268998$1$I$$20240809$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08064$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242689991$24268999$1$I$$20240828$20240830$20240830$EXP$$NVSC2024US174200$NOVARTIS$$$$$F$Y$$$20240830$$CN$US$US
242690002$24269000$2$F$$20240903$20240830$20240904$PER$$US-AMGEN-USASP2024169113$AMGEN$$72$YR$E$F$Y$$$20240904$$CN$US$US
242690011$24269001$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024173614$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242690021$24269002$1$I$20240607$20240820$20240830$20240830$EXP$IT-MINISAL02-998792$IT-TEVA-VS-3234919$TEVA$$66$YR$$F$Y$75$KG$20240830$$MD$IT$IT
242690032$24269003$2$F$20240822$20240905$20240830$20240909$EXP$$US-BAYER-2024A123494$BAYER$$32$YR$A$F$Y$$$20240909$$CN$US$US
242690051$24269005$1$I$20240119$20240823$20240830$20240830$EXP$$CN-ROCHE-3577981$ROCHE$$77$YR$E$F$Y$$$20240830$$MD$CN$CN
242690062$24269006$2$F$20240101$20240826$20240830$20240910$EXP$$US-Eisai-EC-2024-171542$EISAI$$67$YR$E$M$Y$$$20240910$$CN$US$US
242690071$24269007$1$I$$20240828$20240830$20240830$PER$$US-ROCHE-10000068961$ROCHE$$28$YR$A$F$Y$$$20240830$$PH$US$US
242690082$24269008$2$F$20240816$20240904$20240830$20240906$EXP$$NVSC2024ZA173887$NOVARTIS$$68$YR$$F$Y$$$20240906$$HP$ZA$ZA
242690092$24269009$2$F$$20240826$20240830$20240904$EXP$$PT-ROCHE-10000067503$ROCHE$Vasconcelos C, Magalhaes R, Relvas R, Monteiro N. Severe Iatrogenic Neutropenia - An Unlikely Culprit. Infectious and Parasitic Diseases.394.$81$YR$E$M$Y$$$20240904$$MD$PT$PT
242690101$24269010$1$I$20240101$20240826$20240830$20240830$EXP$$US-INCYTE CORPORATION-2024IN009033$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242690111$24269011$1$I$20230807$20240826$20240830$20240830$EXP$FR-AFSSAPS-ST2024001333$FR-FreseniusKabi-FK202413061$FRESENIUS KABI$$66$YR$E$M$Y$69.9$KG$20240830$$HP$FR$FR
242690123$24269012$3$F$20240815$20240923$20240830$20240928$PER$$US-ROCHE-10000070197$ROCHE$$80$YR$E$M$Y$85.28$KG$20240928$$CN$US$US
242690131$24269013$1$I$$20240809$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08054$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242690142$24269014$2$F$$20240918$20240830$20240927$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US000172$PAREXEL$$$$$$Y$$$20240927$$CN$US$US
242690151$24269015$1$I$$20240822$20240830$20240830$EXP$$CA-TEVA-VS-3236781$TEVA$$68$YR$$F$Y$$$20240830$$HP$CA$CA
242690171$24269017$1$I$$20240823$20240830$20240830$EXP$$US-ORGANON-O2408USA001830$ORGANON$$23$YR$$F$Y$$$20240830$$CN$US$US
242690182$24269018$2$F$20240822$20240918$20240830$20240926$EXP$$US-BAYER-2024A123533$BAYER$$16$YR$T$M$Y$$$20240926$$CN$US$US
242690191$24269019$1$I$20240601$20240830$20240830$20240830$EXP$$MY-PFIZER INC-PV202400113684$PFIZER$$53$YR$$F$Y$$$20240830$$CN$MY$MY
242690201$24269020$1$I$$20240829$20240830$20240830$EXP$$US-PFIZER INC-202400246630$PFIZER$$60$YR$$F$Y$$$20240830$$MD$US$US
242690222$24269022$2$F$20240801$20240830$20240830$20240904$EXP$$US-PFIZER INC-202400246950$PFIZER$$68$YR$$F$Y$$$20240904$$CN$US$US
242690231$24269023$1$I$20240227$20240828$20240830$20240830$EXP$IT-MINISAL02-1000125$IT-PFIZER INC-202400245454$PFIZER$$56$YR$$M$Y$$$20240830$$MD$IT$IT
242690251$24269025$1$I$$20240829$20240830$20240830$EXP$$CA-PFIZER INC-202400246612$PFIZER$$64$YR$$F$Y$$$20240830$$MD$CA$CA
242690261$24269026$1$I$20240808$20240828$20240830$20240830$EXP$$CN-PFIZER INC-PV202400112564$PFIZER$$28$YR$$F$Y$59$KG$20240830$$HP$CN$CN
242690271$24269027$1$I$$20240828$20240830$20240830$EXP$$GB-PFIZER INC-202400245573$PFIZER$$$$$M$Y$$$20240830$$PH$GB$GB
242690281$24269028$1$I$20240501$20240829$20240830$20240830$EXP$$MA-PFIZER INC-PV202400113643$PFIZER$$$$$F$Y$$$20240830$$CN$MA$MA
242690291$24269029$1$I$20240601$20240829$20240830$20240830$EXP$$US-PFIZER INC-202400246806$PFIZER$$72$YR$$F$Y$$$20240830$$CN$US$US
242690301$24269030$1$I$20240701$20240828$20240830$20240830$EXP$$US-PFIZER INC-202400246602$PFIZER$$59$YR$$F$Y$$$20240830$$HP$US$US
242690311$24269031$1$I$20240101$20240826$20240830$20240830$EXP$$IE-PFIZER INC-PV202400111749$PFIZER$Tomkins, E.. Neurology. Module 368, Clinical Focus: Chronic migraine - layering treatment. Hospital Doctor of Ireland. 2024;30:26$50$YR$$F$Y$$$20240830$$HP$IE$IE
242690321$24269032$1$I$$20240829$20240830$20240830$EXP$$CA-PFIZER INC-202400246631$PFIZER$$68$YR$$M$Y$$$20240830$$MD$CA$CA
242690331$24269033$1$I$$20240829$20240830$20240830$EXP$$CA-PFIZER INC-202400246614$PFIZER$$32$YR$$F$Y$$$20240830$$MD$CA$CA
242690341$24269034$1$I$$20240829$20240830$20240830$EXP$$CA-PFIZER INC-202400246634$PFIZER$$59$YR$$F$Y$$$20240830$$MD$CA$CA
242690351$24269035$1$I$$20240829$20240830$20240830$EXP$$US-PFIZER INC-202400246685$PFIZER$$$$$F$Y$$$20240830$$CN$US$US
242690361$24269036$1$I$20240801$20240828$20240830$20240830$EXP$$CN-PFIZER INC-202400245151$PFIZER$$$$$F$Y$$$20240830$$MD$CN$CN
242690372$24269037$2$F$$20240917$20240830$20240919$EXP$$JP-PFIZER INC-PV202400112090$PFIZER$$8$DEC$$F$Y$$$20240919$$MD$JP$JP
242690381$24269038$1$I$20240822$20240823$20240830$20240830$PER$$US-ROCHE-10000065555$ROCHE$$66$YR$E$F$Y$$$20240830$$CN$US$US
242690392$24269039$2$F$$20240826$20240830$20240903$EXP$$JP-PFIZER INC-202400245038$PFIZER$Matsui, T.. Variceal bleeding following treatment with atezolizumab plus bevacizumab in two patients with unresectable hepatocellular carcinoma. Clinical Journal of Gastroenterology. 2024;10.1007/s12328-024-02031-9$8$DEC$$M$Y$$$20240903$$HP$JP$JP
242690402$24269040$2$F$$20240826$20240830$20240903$EXP$$JP-PFIZER INC-PV202400111841$PFIZER$Matsui, T.. Variceal bleeding following treatment with atezolizumab plus bevacizumab in two patients with unresectable hepatocellular carcinoma. Clinical Journal of Gastroenterology. 2024;1-9$7$DEC$$M$Y$$$20240903$$HP$JP$JP
242690411$24269041$1$I$20240201$20240826$20240830$20240830$EXP$$CA-LUNDBECK-DKLU4003566$LUNDBECK$$$$$$Y$$$20240830$$HP$CA$CA
242690421$24269042$1$I$$20240809$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08082$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242690431$24269043$1$I$$20240826$20240830$20240830$EXP$$US-INCYTE CORPORATION-2024IN009037$INCYTE$$$$$$Y$$$20240830$$MD$US$US
242690441$24269044$1$I$20240826$20240829$20240830$20240830$EXP$$US-KARYOPHARM-2024KPT001490$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240830$$HP$US$US
242690451$24269045$1$I$20240101$20240820$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133571$BRISTOL MYERS SQUIBB$$63$YR$A$$Y$49.9$KG$20240830$$CN$US$US
242690461$24269046$1$I$$20240816$20240830$20240830$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-133731$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240830$$MD$GB$GB
242690471$24269047$1$I$$20240827$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137290$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240830$$CN$US$US
242690482$24269048$2$F$20240828$20240828$20240830$20240905$PER$$US-AMGEN-USASP2024172524$AMGEN$$72$YR$E$F$Y$$$20240904$$CN$US$US
242690501$24269050$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024173626$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242690531$24269053$1$I$$20240822$20240830$20240830$PER$$US-ROCHE-10000064835$ROCHE$$53$YR$A$F$Y$74.4$KG$20240830$$CN$US$US
242690541$24269054$1$I$$20240824$20240830$20240830$PER$$US-BAYER-2024A122744$BAYER$$$$$F$Y$$$20240830$$CN$US$US
242690551$24269055$1$I$20240823$20240826$20240830$20240830$PER$$US-ROCHE-10000067867$ROCHE$$77$YR$E$F$Y$$$20240830$$CN$US$US
242690561$24269056$1$I$$20240815$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08255$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242690581$24269058$1$I$20240813$20240820$20240830$20240830$EXP$$US-JNJFOC-20240869525$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240830$$MD$US$US
242690591$24269059$1$I$$20240822$20240830$20240830$PER$$US-BAYER-2024A121433$BAYER$$59$YR$A$F$Y$$$20240830$$CN$US$US
242690601$24269060$1$I$20231010$20240828$20240830$20240830$EXP$PT-INFARMED-T202408-281$PT-BAYER-2024A123605$BAYER$$22$YR$A$F$Y$60$KG$20240830$$PH$PT$PT
242690611$24269061$1$I$$20240826$20240830$20240830$EXP$$BR-TAKEDA-2024TUS086893$TAKEDA$$45$YR$$$Y$$$20240830$$CN$BR$BR
242690622$24269062$2$F$20240816$20240912$20240830$20240913$PER$$US-ALXN-202408USA001730US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240913$$HP$US$US
242690632$24269063$2$F$$20240911$20240830$20240913$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006548$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
242690642$24269064$2$F$20240618$20240830$20240830$20240903$EXP$$CO-AstraZeneca-2024A197610$ASTRAZENECA$$30597$DY$$F$Y$83$KG$20240903$$HP$CO$
242690651$24269065$1$I$$20240822$20240830$20240830$EXP$$CA-TEVA-VS-3236763$TEVA$$14$YR$$M$Y$41$KG$20240830$$HP$CA$CA
242690661$24269066$1$I$$20240823$20240830$20240830$EXP$$US-TAKEDA-2024TUS086657$TAKEDA$$$$$F$Y$$$20240830$$MD$US$US
242690671$24269067$1$I$20240724$20240826$20240830$20240830$EXP$$US-TAKEDA-2024TUS080218$TAKEDA$$61$YR$$F$Y$$$20240830$$CN$US$US
242690681$24269068$1$I$$20240829$20240830$20240830$PER$$US-ROCHE-10000069733$ROCHE$$$$A$F$Y$$$20240830$$CN$US$US
242690691$24269069$1$I$20240820$20240824$20240830$20240830$EXP$$CO-GSK-CO2024AMR107156$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$CO$CO
242690701$24269070$1$I$20240601$20240822$20240830$20240830$EXP$$FR-AstraZeneca-2024A196701$ASTRAZENECA$$79$YR$$F$Y$$$20240830$$MD$FR$
242690711$24269071$1$I$20230804$20240823$20240830$20240830$PER$$VN-Eisai-EC-2024-173322$EISAI$$$$$F$Y$$$20240830$$MD$VN$VN
242690722$24269072$2$F$$20240903$20240830$20240909$PER$$US-ROCHE-10000069603$ROCHE$$$$A$F$Y$$$20240909$$CN$US$US
242690734$24269073$4$F$20240731$20240911$20240830$20240913$PER$$JP-Eisai-EC-2024-173331$EISAI$$75$YR$E$F$Y$$$20240913$$MD$JP$JP
242690741$24269074$1$I$20240724$20240827$20240830$20240830$PER$$US-BAYER-2024A123821$BAYER$$46$YR$A$F$Y$$$20240830$$MD$US$US
242690751$24269075$1$I$$20240823$20240830$20240830$EXP$$US-TAKEDA-2024TUS085678$TAKEDA$$$$$M$Y$$$20240830$$CN$US$US
242690761$24269076$1$I$$20240823$20240830$20240830$EXP$$CA-TAKEDA-2024TUS007220$TAKEDA$$$$$M$Y$$$20240830$$CN$CA$CA
242690772$24269077$2$F$$20240913$20240830$20240918$EXP$$US-ABBVIE-5815307$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
242690782$24269078$2$F$20240818$20240820$20240830$20240908$EXP$$US-ABBVIE-5889374$ABBVIE$$83$YR$$F$Y$$$20240908$$CN$US$US
242690792$24269079$2$F$20240715$20240830$20240830$20240904$EXP$$US-ABBVIE-5890923$ABBVIE$$75$YR$$F$Y$$$20240904$$CN$US$US
242690801$24269080$1$I$$20240821$20240830$20240830$EXP$$US-ABBVIE-5891268$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242690811$24269081$1$I$20240101$20240821$20240830$20240830$EXP$$US-ABBVIE-5891282$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242690821$24269082$1$I$$20240828$20240830$20240830$PER$$US-JNJFOC-20240874982$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$HP$US$US
242690841$24269084$1$I$20240814$20240815$20240830$20240830$EXP$$CN-EAGLE PHARMACEUTICALS, INC.-CN-2024EAG000202$EAGLE$$45$YR$$F$Y$53.97$KG$20240830$$HP$CN$CN
242690861$24269086$1$I$$20240822$20240830$20240830$EXP$$US-RDY-SPO/USA/24/0012433$DR REDDYS$$59$YR$A$F$Y$$$20240830$$HP$US$US
242690871$24269087$1$I$20240101$20240821$20240830$20240830$EXP$$US-TEVA-VS-3236691$TEVA$$64$YR$$F$Y$$$20240830$$CN$US$US
242690881$24269088$1$I$20230101$20240827$20240830$20240830$PER$$US-BAYER-2024A123934$BAYER$$32$YR$A$F$Y$$$20240830$$MD$US$US
242690901$24269090$1$I$20240703$20240821$20240830$20240830$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408013846$ELI LILLY AND CO$$50$YR$A$F$Y$65$KG$20240830$$CN$CN$CN
242690911$24269091$1$I$20240708$20240820$20240830$20240830$EXP$FR-AFSSAPS-LM2024000468$FR-ELI_LILLY_AND_COMPANY-FR202408013256$ELI LILLY AND CO$$68$YR$E$M$Y$59.7$KG$20240830$$CN$FR$FR
242690922$24269092$2$F$20240716$20240906$20240830$20240920$EXP$FR-AFSSAPS-AN2024001132$FR-BAXTER-2024BAX023519$BAXTER$$75$YR$$M$Y$66$KG$20240920$$MD$FR$FR
242690931$24269093$1$I$20240808$20240820$20240830$20240830$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408018349$ELI LILLY AND CO$$60$YR$A$M$Y$60$KG$20240830$$CN$DE$CN
242690941$24269094$1$I$$20240821$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013844$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240830$$MD$US$US
242690951$24269095$1$I$20230101$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012606$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240830$$CN$US$US
242690961$24269096$1$I$20240731$20240827$20240830$20240830$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408017370$ELI LILLY AND CO$$56$YR$A$F$Y$49$KG$20240830$$CN$CN$CN
242690971$24269097$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59776$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242690981$24269098$1$I$20240701$20240821$20240830$20240830$EXP$GR-GREOF-202400911$GR-ELI_LILLY_AND_COMPANY-GR202408014122$ELI LILLY AND CO$$78$YR$E$F$Y$85$KG$20240830$$CN$GR$GR
242690991$24269099$1$I$$20240821$20240830$20240830$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202408016190$ELI LILLY AND CO$$$$$M$Y$$$20240830$$MD$AE$AE
242691001$24269100$1$I$$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012884$ELI LILLY AND CO$$$$$$Y$$$20240830$$CN$US$US
242691011$24269101$1$I$20240108$20240819$20240830$20240830$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408012668$ELI LILLY AND CO$$60$YR$A$F$Y$61$KG$20240830$$CN$CN$CN
242691021$24269102$1$I$20240127$20240822$20240830$20240830$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202408018593$ELI LILLY AND CO$$$$$M$Y$52$KG$20240830$$CN$DE$CO
242691031$24269103$1$I$$20240820$20240830$20240830$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408013342$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240830$$CN$JP$JP
242691041$24269104$1$I$$20240816$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011022$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240830$$CN$US$US
242691062$24269106$2$F$$20240821$20240830$20240903$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408014746$ELI LILLY AND CO$$$$$$Y$$$20240903$$CN$CN$CN
242691081$24269108$1$I$20240806$20240822$20240830$20240830$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408018589$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240830$$CN$DE$CN
242691091$24269109$1$I$20240528$20240820$20240830$20240830$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408018128$ELI LILLY AND CO$$68$YR$E$M$Y$68$KG$20240830$$CN$DE$CN
242691101$24269110$1$I$$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013754$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240830$$CN$US$US
242691111$24269111$1$I$$20240820$20240830$20240830$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202408012957$ELI LILLY AND CO$$$$$$Y$$$20240830$$CN$BE$BE
242691121$24269112$1$I$$20240819$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012701$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$US$US
242691131$24269113$1$I$$20240822$20240830$20240830$EXP$$US-ABBVIE-5892374$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242691142$24269114$2$F$20240101$20240826$20240830$20240831$EXP$$ES-ABBVIE-5893138$ABBVIE$$$$$F$Y$54$KG$20240831$$CN$ES$ES
242691151$24269115$1$I$20230101$20240822$20240830$20240830$EXP$$US-ABBVIE-5658369$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242691161$24269116$1$I$$20240829$20240830$20240830$PER$$US-ROCHE-10000069949$ROCHE$$74$YR$E$F$Y$$$20240830$$CN$US$US
242691171$24269117$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137632$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$115.21$KG$20240830$$CN$US$US
242691181$24269118$1$I$20240828$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024173417$AMGEN$$$$$$Y$$$20240830$$HP$US$US
242691201$24269120$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171562$AMGEN$Alhassan E.; Quismorio Jr F. P.. The Unique Fusion: Systemic Sclerosis and Ankylosing Spondylitis Overlap. American Journal of Medicine. 2024;137(9):e171-e172$56$YR$A$M$Y$$$20240830$$MD$US$US
242691211$24269121$1$I$$20240829$20240830$20240830$PER$$US-BAYER-2024A124468$BAYER$$41$YR$A$F$Y$$$20240830$$MD$US$US
242691221$24269122$1$I$$20240823$20240830$20240830$PER$$US-BEH-2024177691$CSL BEHRING$$$$$$Y$$$20240830$$CN$US$US
242691231$24269123$1$I$$20240829$20240830$20240830$EXP$$JP-ABBVIE-5901370$ABBVIE$$$$$$Y$$$20240830$$MD$JP$JP
242691241$24269124$1$I$20240826$20240828$20240830$20240830$PER$$PR-JNJFOC-20240878137$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$MD$PR$PR
242691251$24269125$1$I$$20240822$20240830$20240830$EXP$$US-ABBVIE-5892895$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242691261$24269126$1$I$$20240829$20240830$20240830$EXP$GB-MHRA-MED-202408291531588130-WZQJS$GB-BAYER-2024A124638$BAYER$$$$$M$Y$$$20240830$$CN$GB$GB
242691271$24269127$1$I$20240201$20240822$20240830$20240830$EXP$$US-ABBVIE-5879159$ABBVIE$$57$YR$$F$Y$75$KG$20240828$$CN$US$US
242691282$24269128$2$F$20240101$20240917$20240830$20240921$EXP$$US-ABBVIE-5892685$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
242691291$24269129$1$I$$20240823$20240830$20240830$EXP$$US-ABBVIE-5894096$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242691301$24269130$1$I$20240726$20240822$20240830$20240830$EXP$$CN-ABBVIE-5890905$ABBVIE$$69$YR$$F$Y$$$20240829$$MD$CN$CN
242691311$24269131$1$I$20220401$20240823$20240830$20240830$EXP$$JP-009507513-2408JPN003186J$MERCK$$$$$F$Y$$$20240830$$MD$JP$JP
242691321$24269132$1$I$20240101$20240823$20240830$20240830$EXP$$US-ABBVIE-5894379$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242691331$24269133$1$I$20240731$20240823$20240830$20240830$EXP$$JP-009507513-2408JPN002906J$MERCK$$73$YR$$M$Y$$$20240830$$MD$JP$JP
242691351$24269135$1$I$20240826$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171791$AMGEN$$54$YR$A$F$Y$$$20240830$$CN$US$US
242691371$24269137$1$I$$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137951$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240830$$CN$US$US
242691381$24269138$1$I$20240801$20240828$20240830$20240830$PER$$US-BAYER-2024A124916$BAYER$$$$$F$Y$$$20240830$$MD$US$US
242691391$24269139$1$I$20240620$20240807$20240830$20240830$PER$$AR-TOLMAR, INC.-24AR051707$TOLMAR$$87$YR$$M$Y$$$20240830$$CN$AR$AR
242691401$24269140$1$I$20240806$20240807$20240830$20240830$PER$$AR-TOLMAR, INC.-24AR051754$TOLMAR$$8$YR$$F$Y$$$20240830$$HP$AR$AR
242691411$24269141$1$I$$20240807$20240830$20240830$PER$$AU-TOLMAR, INC.-24AU051700$TOLMAR$$$$$M$Y$$$20240830$$CN$AU$AU
242691421$24269142$1$I$$20240807$20240830$20240830$PER$$AU-TOLMAR, INC.-24AU051731$TOLMAR$$$$$M$Y$$$20240830$$CN$AU$AU
242691431$24269143$1$I$$20240807$20240830$20240830$PER$$AU-TOLMAR, INC.-24AU051760$TOLMAR$$$$$M$Y$$$20240830$$CN$AU$AU
242691441$24269144$1$I$20240815$20240820$20240830$20240830$EXP$$BR-FreseniusKabi-FK202412727$FRESENIUS KABI$$48$YR$A$F$Y$70$KG$20240830$$CN$BR$BR
242691451$24269145$1$I$$20240823$20240830$20240830$PER$$US-JNJFOC-20240862590$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$MD$US$US
242691461$24269146$1$I$$20240822$20240830$20240830$EXP$$US-JNJFOC-20240869340$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240830$$HP$US$US
242691471$24269147$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-135256-2023$RECKITT BENCKISER$$$$$F$Y$$$20240830$$CN$US$US
242691481$24269148$1$I$$20240830$20240830$20240830$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048808$BOEHRINGER INGELHEIM$$$$$$Y$$$20240830$$CN$US$US
242691491$24269149$1$I$20240401$20240823$20240830$20240830$EXP$$US-ABBVIE-5894370$ABBVIE$$76$YR$$F$Y$$$20240829$$CN$US$US
242691501$24269150$1$I$20240703$20240823$20240830$20240830$EXP$$US-ABBVIE-5894366$ABBVIE$$23$YR$$F$Y$$$20240829$$CN$US$US
242691513$24269151$3$F$20221101$20240920$20240830$20240925$EXP$$US-ABBVIE-5894177$ABBVIE$$50$YR$$F$Y$$$20240925$$CN$US$US
242691521$24269152$1$I$$20240823$20240830$20240830$EXP$$US-ABBVIE-5893988$ABBVIE$$$$$M$Y$$$20240829$$CN$US$US
242691531$24269153$1$I$$20240823$20240830$20240830$EXP$$US-ABBVIE-5894217$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242691541$24269154$1$I$20240101$20240816$20240830$20240830$EXP$$IT-UCBSA-2024042287$UCB$$$$$F$Y$$$20240830$$CN$IT$IT
242691551$24269155$1$I$$20240827$20240830$20240830$EXP$$AU-AMGEN-AUSSP2024172323$AMGEN$Hii R.; Bennett A.. Acute haemostasis with bevacizumab for upper gastrointestinal bleeding secondary to lymphoma. Internal Medicine Journal. 2024;54 (8):1418-1419$48$YR$A$F$Y$$$20240830$$HP$AU$AU
242691561$24269156$1$I$$20240809$20240830$20240830$EXP$$US-SMPA-2024SPA001965$SUNOVION$$$$$$Y$$$20240830$$CN$US$US
242691571$24269157$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A193341$ASTRAZENECA$$70$YR$$M$Y$78.9$KG$20240830$$CN$US$
242691582$24269158$2$F$20240812$20240830$20240830$20240905$EXP$IT-MINISAL02-999907$IT-BAYER-2024A124813$BAYER$$22$YR$A$M$Y$77$KG$20240905$$CN$IT$IT
242691591$24269159$1$I$$20240823$20240830$20240830$EXP$$IN-AstraZeneca-2024A196113$ASTRAZENECA$$74$YR$$M$Y$64$KG$20240830$$CN$IN$
242691601$24269160$1$I$$20240823$20240830$20240830$EXP$$ZA-AstraZeneca-2024A194196$ASTRAZENECA$$77$YR$$M$Y$$$20240830$$CN$ZA$
242691611$24269161$1$I$$20240826$20240830$20240830$EXP$$JP-PFIZER INC-PV202400113272$PFIZER$Mizutani, F.. A Case of Pulmonary Coriolus Hirsutus Infection with Intractable Course. 2024;26$80$YR$$M$Y$$$20240830$$HP$JP$JP
242691624$24269162$4$F$$20240909$20240830$20240911$EXP$$CN-PFIZER INC-202400245319$PFIZER$Hu, M.. Clinical analysis of 18 cases of listeriosis during pregnancy. Chin J Infect Control. 2024;23 (6):706-711$$$N$$Y$2.155$KG$20240911$$HP$CN$CN
242691631$24269163$1$I$$20240826$20240830$20240830$EXP$$JP-PFIZER INC-PV202400111528$PFIZER$Nakabori, T.. Abscopal effect in a patient with advanced hepatocellular carcinoma upon resuming bevacizumab in combination with atezolizumab after radiotherapy. Clinical Journal of Gastroenterology. 2024;10.1007/s12328-024-02030-w$7$DEC$$M$Y$$$20240830$$HP$JP$JP
242691641$24269164$1$I$$20240819$20240830$20240830$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007369$AEGERION$$24$YR$$M$Y$$$20240830$$CN$US$US
242691651$24269165$1$I$20240810$20240827$20240830$20240830$EXP$ES-AEMPS-1562974$ES-MYLANLABS-2024M1079181$MYLAN$$92$YR$$M$Y$$$20240830$$MD$ES$ES
242691661$24269166$1$I$$20240823$20240830$20240830$PER$$US-MYLANLABS-2024M1079448$MYLAN$$$$$M$Y$140.61$KG$20240830$$CN$US$US
242691673$24269167$3$F$20240801$20240903$20240830$20240910$EXP$$US-ABBVIE-5894155$ABBVIE$$77$YR$$F$Y$79$KG$20240910$$CN$US$US
242691681$24269168$1$I$20240821$20240823$20240830$20240830$EXP$$CN-ABBVIE-5894787$ABBVIE$$67$YR$$M$Y$55$KG$20240829$$MD$CN$CN
242691691$24269169$1$I$$20240823$20240830$20240830$EXP$$CO-ABBVIE-5897926$ABBVIE$$$$$M$Y$60$KG$20240828$$HP$CO$CO
242691701$24269170$1$I$20240228$20240830$20240830$20240830$DIR$716537$$FDA-CTU$$38$YR$$F$N$85.5$KG$20240830$N$CN$US$
242691711$24269171$1$I$$20240830$20240830$20240830$DIR$716547$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242691721$24269172$1$I$20240401$20240823$20240830$20240830$EXP$$AR-ABBVIE-5730597$ABBVIE$$61$YR$$F$Y$$$20240829$$CN$AR$AR
242691731$24269173$1$I$$20240823$20240830$20240830$EXP$$US-ABBVIE-5895461$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242691741$24269174$1$I$$20240824$20240830$20240830$EXP$$IN-VANTIVE-2024VAN019369$Vantive US Healthcare$$58$YR$$M$Y$$$20240830$$CN$IN$IN
242691751$24269175$1$I$$20240830$20240830$20240830$DIR$716551$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242691761$24269176$1$I$20240610$20240830$20240830$20240830$DIR$716539$$FDA-CTU$$71$YR$$M$N$62$KG$20240830$N$CN$KR$
242691771$24269177$1$I$$20240830$20240830$20240830$DIR$716556$$FDA-CTU$$$$$UNK$N$$$20240830$$CN$US$
242691781$24269178$1$I$20240719$20240823$20240830$20240830$EXP$$IN-VANTIVE-2024VAN018531$Vantive US Healthcare$$59$YR$$F$Y$$$20240830$$CN$IN$IN
242691791$24269179$1$I$20240819$20240823$20240830$20240830$EXP$$IN-VANTIVE-2024VAN017703$Vantive US Healthcare$$58$YR$$F$Y$$$20240830$$CN$IN$IN
242691802$24269180$2$F$$20240829$20240830$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08080$LUPIN$$$$$$Y$$$20240919$$CN$US$US
242691821$24269182$1$I$$20240821$20240830$20240830$EXP$$JP-ROCHE-10000067009$ROCHE$$8$DEC$E$M$Y$$$20240830$$MD$JP$JP
242691831$24269183$1$I$20240830$20240830$20240830$20240830$DIR$716554$$FDA-CTU$$71$YR$$F$N$$$20240830$Y$$US$
242691841$24269184$1$I$20240829$20240830$20240830$20240830$DIR$716558$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242691851$24269185$1$I$$20231020$20240830$20240830$EXP$$NVSC2023TR281039$NOVARTIS$$$$$M$Y$65$KG$20240830$$MD$TR$TR
242691861$24269186$1$I$20240829$20240830$20240830$20240830$DIR$716559$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242691871$24269187$1$I$20240829$20240830$20240830$20240830$DIR$716563$$FDA-CTU$$$$$UNK$N$$$20240830$$CN$US$
242691881$24269188$1$I$20240829$20240829$20240830$20240830$PER$$US-BAYER-2024A124941$BAYER$$37$YR$A$F$Y$$$20240830$$CN$US$US
242691891$24269189$1$I$$20240823$20240830$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013531$JAZZ$$$$$F$Y$$$20240830$$CN$US$US
242691901$24269190$1$I$$20240807$20240830$20240830$PER$$US-Vifor (International) Inc.-VIT-2024-07178$VIFOR$$$$E$F$Y$$$20240830$$HP$US$US
242691913$24269191$3$F$20240812$20240916$20240830$20240923$EXP$$CO-ABBVIE-5898746$ABBVIE$$65$YR$$M$Y$78$KG$20240923$$HP$CO$CO
242691921$24269192$1$I$$20240820$20240830$20240830$EXP$NL-LRB-00996332$NL-TEVA-VS-3235369$TEVA$$70$YR$$M$Y$92$KG$20240830$$CN$NL$NL
242691931$24269193$1$I$$20240822$20240830$20240830$EXP$$CA-AstraZeneca-2024A194305$ASTRAZENECA$$$$$F$Y$$$20240830$$MD$CA$
242691941$24269194$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024172207$AMGEN$$$$$M$Y$$$20240830$$CN$US$US
242691951$24269195$1$I$$20240823$20240830$20240830$EXP$$US-ABBVIE-5894271$ABBVIE$$$$$F$Y$$$20240829$$CN$US$US
242691961$24269196$1$I$$20240827$20240830$20240830$PER$$US-BIOVITRUM-2024-US-011385$BIOVITRUM$$67$YR$$F$Y$$$20240830$$CN$US$US
242691971$24269197$1$I$$20240828$20240830$20240830$EXP$$RO-ALXN-202408EEA001803RO$ALEXION PHARMACEUTICALS$$$$I$M$Y$7$KG$20240830$$MD$RO$RO
242691981$24269198$1$I$$20240828$20240830$20240830$PER$$US-TAKEDA-2024TUS087158$TAKEDA$$$$$M$Y$71$KG$20240830$$HP$US$US
242691991$24269199$1$I$$20240812$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08079$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242692001$24269200$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138474$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240830$$CN$US$US
242692011$24269201$1$I$$20240829$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138624$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$147$KG$20240830$$PH$US$US
242692021$24269202$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137703$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240830$$HP$US$US
242692031$24269203$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137635$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240830$$HP$US$US
242692042$24269204$2$F$$20240829$20240830$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138673$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240904$$CN$US$US
242692051$24269205$1$I$20240801$20240826$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136264$BRISTOL MYERS SQUIBB$$88$YR$E$$Y$$$20240830$$PH$US$US
242692061$24269206$1$I$$20240829$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-089350-2024$RECKITT BENCKISER$$$$$M$Y$$$20240830$$CN$US$US
242692071$24269207$1$I$20240829$20240830$20240830$20240830$DIR$716564$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242692081$24269208$1$I$$20240827$20240830$20240830$PER$$US-ROCHE-10000068296$ROCHE$$78$YR$E$F$Y$$$20240830$$CN$US$US
242692092$24269209$2$F$20240101$20240829$20240830$20240904$EXP$$CA-ABBVIE-5897762$ABBVIE$$53$YR$$F$Y$$$20240904$$CN$CA$CA
242692101$24269210$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5896398$ABBVIE$$$$$M$Y$$$20240828$$CN$US$US
242692111$24269211$1$I$$20240826$20240830$20240830$EXP$$BE-ABBVIE-5897610$ABBVIE$$$$$$Y$$$20240828$$MD$BE$BE
242692131$24269213$1$I$20240829$20240830$20240830$20240830$DIR$716568$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242692141$24269214$1$I$20240101$20240826$20240830$20240830$EXP$$US-ABBVIE-5897470$ABBVIE$$$$$F$Y$$$20240828$$CN$US$US
242692151$24269215$1$I$$20240822$20240830$20240830$EXP$$FR-FreseniusKabi-FK202413063$FRESENIUS KABI$Julien M, Gilles DD, Allou N. Pink urine syndrome in an anuric patient during continuous renal replacement therapy. Medicine (United States). 2024;103(31): 1-3. doi:https://dx.doi.org/10.1097/MD.0000000000038986.$61$YR$A$F$Y$$$20240830$$MD$FR$FR
242692161$24269216$1$I$20240815$20240830$20240830$20240830$DIR$716562$$FDA-CTU$$37$YR$$F$N$$$20240830$Y$HP$US$
242692171$24269217$1$I$$20240830$20240830$20240830$DIR$716555$$FDA-CTU$$$$$UNK$N$$$20240830$$CN$US$
242692181$24269218$1$I$$20240830$20240830$20240830$DIR$716548$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242692191$24269219$1$I$20240729$20240824$20240830$20240830$EXP$$CN-FreseniusKabi-FK202412883$FRESENIUS KABI$$66$YR$E$F$Y$38$KG$20240830$$HP$CN$CN
242692231$24269223$1$I$20240821$20240821$20240830$20240830$PER$$US-JNJFOC-20240859465$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242692241$24269224$1$I$20230101$20240827$20240830$20240830$EXP$GB-MHRA-MED-202408271457432090-BHSFG$GB-ORGANON-O2408GBR002064$ORGANON$$33$YR$$M$Y$65$KG$20240830$$CN$GB$GB
242692251$24269225$1$I$20240801$20240820$20240830$20240830$EXP$$US-TEVA-VS-3236894$TEVA$$59$YR$$F$Y$$$20240830$$CN$US$US
242692281$24269228$1$I$$20240822$20240830$20240830$EXP$$AU-ROCHE-10000063784$ROCHE$$10$YR$C$$Y$$$20240830$$HP$AU$AU
242692291$24269229$1$I$20240725$20240826$20240830$20240830$EXP$$US-ORGANON-O2408USA002014$ORGANON$$$$$F$Y$$$20240830$$CN$US$US
242692301$24269230$1$I$20240712$20240828$20240830$20240830$PER$$US-HALEON-2194199$Haleon PLC$$0$YR$$M$Y$$$20240830$$HP$US$US
242692331$24269233$1$I$20240601$20240821$20240830$20240830$EXP$$JP-RADIUS HEALTH INC.-2024JP004568$RADIUS PHARM$$63$YR$$F$Y$$$20240830$$CN$JP$JP
242692341$24269234$1$I$$20240823$20240830$20240830$PER$$US-APOTEX-2024AP009838$APOTEX$Gaston FN, Chatterjee T. Spontaneous Iliac Artery Dissection in a 66-Year Old Male Complicated By Hemorrhage, GI Bleeding, and Bilateral DVT/PE. Blood. 2023;142 (Suppl. 1):5416-5417$66$YR$$M$Y$$$20240830$$MD$US$US
242692351$24269235$1$I$$20240822$20240830$20240830$EXP$$RU-BAYER-2024A121956$BAYER$$49$YR$A$F$Y$$$20240830$$MD$RU$RU
242692361$24269236$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137856$BRISTOL MYERS SQUIBB$$22$YR$A$M$Y$$$20240830$$HP$US$US
242692371$24269237$1$I$20240801$20240823$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135656$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240830$$CN$US$US
242692391$24269239$1$I$20240514$20240820$20240830$20240830$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000011$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240829$$MD$US$US
242692401$24269240$1$I$$20240823$20240830$20240830$PER$$US-BAYER-2024A122837$BAYER$$44$YR$A$M$Y$$$20240830$$HP$US$US
242692421$24269242$1$I$20240201$20240827$20240830$20240830$EXP$$CR-BAYER-2024A124042$BAYER$$37$YR$A$F$Y$$$20240830$$CN$CR$CR
242692431$24269243$1$I$20240101$20240822$20240830$20240830$EXP$$JP-AstraZeneca-2024A193394$ASTRAZENECA$$$$$$Y$$$20240830$$MD$JP$
242692441$24269244$1$I$$20240824$20240830$20240830$EXP$$MX-AstraZeneca-2024A195902$ASTRAZENECA$$$$$$Y$$$20240830$$MD$MX$
242692451$24269245$1$I$20240809$20240822$20240830$20240830$EXP$$CN-AstraZeneca-2024A194495$ASTRAZENECA$$$$$M$Y$65.3$KG$20240830$$MD$CN$
242692461$24269246$1$I$$20240820$20240830$20240830$EXP$$US-SEPTODONT-2024018933$SEPTODONT$Dolphin T, Fowler S, Drum M, Nusstein J, Reader A, Draper J. Efficacy of the TuttleNumbNow Intraosseous Method for Pulpal Anesthesia in the Mandibular First Molar: A Prospective,  Randomized, Crossover Study. JOE. 2024 Apr ;50 (4):406-413. doi:https://doi.org/10.1016/ j.joen.2024.01.003$$$$$Y$$$20240830$$CN$US$US
242692471$24269247$1$I$20240829$20240830$20240830$20240830$DIR$716571$$FDA-CTU$$93$YR$$F$N$$$20240830$N$HP$US$
242692481$24269248$1$I$20240829$20240830$20240830$20240830$DIR$716577$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242692491$24269249$1$I$$20240828$20240830$20240830$EXP$$US-SANDOZ INC.-NVSC2019US051904$SANDOZ$$72$YR$$F$Y$$$20240830$$MD$US$US
242692501$24269250$1$I$$20211126$20240830$20240830$EXP$$NL-BIOVITRUM-2021NL11873$BIOVITRUM$$$$I$M$Y$5.6$KG$20240830$$CN$NL$NL
242692511$24269251$1$I$$20240827$20240830$20240830$PER$$US-BIOGEN-2024BI01280155$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
242692521$24269252$1$I$$20240822$20240830$20240830$30DAY$$US-GSK-US2024104931$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$CN$US$US
242692531$24269253$1$I$$20240812$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08105$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242692541$24269254$1$I$20240829$20240830$20240830$20240830$DIR$716572$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242692561$24269256$1$I$20240829$20240830$20240830$20240830$DIR$716575$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242692571$24269257$1$I$$20240830$20240830$20240830$DIR$716565$$FDA-CTU$$$$$UNK$N$$$20240830$$CN$US$
242692581$24269258$1$I$$20240826$20240830$20240830$EXP$$US-TAKEDA-2024TUS086213$TAKEDA$$$$A$M$Y$$$20240830$$CN$US$US
242692611$24269261$1$I$20240826$20240830$20240830$20240830$DIR$716549$$FDA-CTU$$59$YR$$F$N$$$20240830$N$HP$US$
242692621$24269262$1$I$20240824$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-59816$$FDA-CTU$$$$$F$N$97.5$KG$20240829$N$$US$
242692631$24269263$1$I$$20240820$20240830$20240830$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-133775$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240830$$PH$AU$AU
242692641$24269264$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137021$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240830$$PH$US$US
242692651$24269265$1$I$$20240822$20240830$20240830$PER$$US-SA-2024SA252267$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240830$$CN$US$US
242692662$24269266$2$F$20240201$20240912$20240830$20240913$PER$$US-ALXN-202408USA001732US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240913$$HP$US$US
242692671$24269267$1$I$20240809$20240827$20240830$20240830$EXP$IT-MINISAL02-999683$IT-MYLANLABS-2024M1078966$MYLAN$$75$YR$$F$Y$$$20240830$$MD$IT$IT
242692691$24269269$1$I$$20240826$20240830$20240830$PER$$US-ALXN-202408USA001884US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242692702$24269270$2$F$20240703$20240829$20240830$20240906$EXP$$BE-ORGANON-O2408BEL002268$ORGANON$$$$$F$Y$$$20240906$$MD$BE$BE
242692711$24269271$1$I$20240826$20240830$20240830$20240830$DIR$716586$$FDA-CTU$$66$YR$$M$N$$$20240830$N$HP$US$
242692721$24269272$1$I$$20240816$20240830$20240830$DIR$FDA-CDER-CTU-2024-59824$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242692741$24269274$1$I$20240806$20240830$20240830$20240830$DIR$716587$$FDA-CTU$$76$YR$$F$N$93.7$KG$20240830$N$PH$US$
242692751$24269275$1$I$20240828$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59839$$FDA-CTU$$68$YR$$F$N$$$20240830$N$$US$
242692761$24269276$1$I$20240827$20240830$20240830$20240830$DIR$716589$$FDA-CTU$$19$YR$$M$N$55$KG$20240830$Y$PH$US$
242692771$24269277$1$I$20240808$20240830$20240830$20240830$DIR$716593$$FDA-CTU$$76$YR$$M$N$$$20240830$Y$HP$US$
242692781$24269278$1$I$$20240830$20240830$20240830$DIR$716594$$FDA-CTU$$77$YR$$M$N$$$20240830$Y$HP$US$
242692811$24269281$1$I$$20240830$20240830$20240830$DIR$716567$$FDA-CTU$$$$$UNK$N$$$20240830$$CN$US$
242692822$24269282$2$F$20220101$20240820$20240830$20240907$PER$$US-ZENPEP LLC-2024AIMT01265$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242692831$24269283$1$I$$20240826$20240830$20240830$PER$$US-ROCHE-10000068294$ROCHE$$67$YR$E$M$Y$$$20240830$$CN$US$US
242692841$24269284$1$I$$20240827$20240830$20240830$PER$$US-ROCHE-10000068016$ROCHE$$21$YR$A$M$Y$$$20240830$$CN$US$US
242692851$24269285$1$I$20230724$20240826$20240830$20240830$EXP$$KR-AMGEN-KORSP2024171753$AMGEN$$72$YR$E$F$Y$52$KG$20240830$$MD$KR$KR
242692861$24269286$1$I$20240815$20240820$20240830$20240830$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002172$Alvotech$$48$YR$$M$Y$$$20240830$$CN$CA$CA
242692881$24269288$1$I$$20240820$20240830$20240830$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-137452$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240830$$PH$AU$AU
242692891$24269289$1$I$$20240829$20240830$20240830$PER$$US-ROCHE-10000070412$ROCHE$$$$A$F$Y$$$20240830$$CN$US$US
242692901$24269290$1$I$$20240822$20240830$20240830$PER$$US-009507513-2408USA008178$MERCK$$$$$F$Y$$$20240830$$CN$US$US
242692911$24269291$1$I$$20240826$20240830$20240830$PER$$US-BEH-2024177903$CSL BEHRING$$$$$M$Y$$$20240830$$CN$US$US
242692921$24269292$1$I$$20240812$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08158$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242692931$24269293$1$I$20240814$20240823$20240830$20240830$PER$$CO-Eisai-EC-2024-173029$EISAI$$61$YR$A$F$Y$91$KG$20240830$$CN$CO$CO
242692941$24269294$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138467$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240830$$CN$US$US
242692951$24269295$1$I$$20240830$20240830$20240830$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048793$BOEHRINGER INGELHEIM$$63$YR$A$F$Y$$$20240830$$CN$US$US
242692961$24269296$1$I$20240807$20240822$20240830$20240830$EXP$$CN-Merck Healthcare KGaA-2024045541$MERCK KGAA$$53$YR$A$F$Y$59$KG$20240828$$HP$CN$CN
242692971$24269297$1$I$20240716$20240828$20240830$20240830$EXP$$CO-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00885$BIOCRYST PHARMACEUTICALS$$12$YR$$M$Y$44$KG$20240830$$CN$CO$CO
242692982$24269298$2$F$20240820$20240902$20240830$20240904$PER$$US-AMGEN-USASP2024172229$AMGEN$$57$YR$A$M$Y$$$20240904$$CN$US$US
242692991$24269299$1$I$20240827$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172721$AMGEN$$71$YR$E$F$Y$$$20240830$$CN$US$US
242693001$24269300$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172886$AMGEN$$$$A$F$Y$$$20240830$$HP$US$US
242693011$24269301$1$I$20240330$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A194217$ASTRAZENECA$$$$$$Y$$$20240830$$CN$US$
242693021$24269302$1$I$$20240829$20240830$20240830$EXP$$JP-AstraZeneca-2024A197224$ASTRAZENECA$Inoue F., Okazaki Y., Huh K., Ichiba T., Chiba T., Namera A.. Pharmacobezoar Associated Prolonged Clinical Course in a Patient with Immediate Release Quetiapine Overdose. Journal of Medical Toxicology 2024;$57$YR$$F$Y$$$20240830$$HP$JP$
242693031$24269303$1$I$$20240828$20240830$20240830$EXP$$US-ABBVIE-5900828$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242693042$24269304$2$F$20240808$20240828$20240830$20240906$EXP$$US-TEVA-VS-3237136$TEVA$$75$YR$$F$Y$59$KG$20240906$$MD$US$US
242693051$24269305$1$I$20230101$20240824$20240830$20240830$EXP$$MX-ABBVIE-5898745$ABBVIE$$$$E$F$Y$90$KG$20240830$$CN$MX$MX
242693061$24269306$1$I$20240813$20240822$20240830$20240830$EXP$$US-GSK-US2024105090$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240830$$CN$US$US
242693071$24269307$1$I$$20240829$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138376$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240830$$CN$US$US
242693084$24269308$4$F$20230908$20240906$20240830$20240913$EXP$$CA-GSK-CA2023114002$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$CA$CA
242693091$24269309$1$I$20240802$20240815$20240830$20240830$EXP$$GB-AZURITY PHARMACEUTICALS, INC.-AZR202408-000505$AZURITY PHARMACEUTICALS$$42$YR$$F$Y$103$KG$20240830$$CN$GB$GB
242693101$24269310$1$I$$20240820$20240830$20240830$EXP$$RU-AMGEN-RUSSP2024168876$AMGEN$Kim E.; Kalinchenko N.; Eremkina A. et al.. Combination approach for CDC73-related parathyroid carcinoma in an adolescent female patient: a case report and literature review. Therapeutic Advances in Medical Oncology. 2024;16:1-14$17$YR$T$F$Y$$$20240830$$HP$RU$RU
242693111$24269311$1$I$$20240822$20240830$20240830$PER$$US-ABBVIE-5892980$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242693121$24269312$1$I$$20240828$20240830$20240830$PER$$US-TAKEDA-2024TUS087175$TAKEDA$$55$YR$$M$Y$$$20240830$$CN$US$US
242693131$24269313$1$I$$20240816$20240830$20240830$EXP$$EG-AZURITY PHARMACEUTICALS, INC.-AZR202408-000433$AZURITY PHARMACEUTICALS$Elgendy SA, Shoeib O, Elgharbawy D, Abo El-Noor MM, Kabbash A.. Assessment of B-type natriuretic peptide as an early predictor of mortality in acutely poisoned patients with cardiotoxicities. Toxicol. Res.. 2024;13 (4):1-8$$$A$$Y$$$20240830$$HP$EG$EG
242693141$24269314$1$I$20240601$20240827$20240830$20240830$EXP$$NVSC2024GB140689$NOVARTIS$$$$$M$Y$$$20240830$$CN$GB$GB
242693151$24269315$1$I$$20240821$20240830$20240830$EXP$$JP-ROCHE-10000067924$ROCHE$$8$DEC$E$M$Y$$$20240830$$MD$JP$JP
242693161$24269316$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172730$AMGEN$$$$$F$Y$15$KG$20240830$$HP$US$US
242693171$24269317$1$I$20240701$20240820$20240830$20240830$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00375$XERIS PHARMACEUTICALS$$67$YR$$M$Y$86.168$KG$20240829$$CN$US$US
242693181$24269318$1$I$$20240816$20240830$20240830$EXP$$AU-AZURITY PHARMACEUTICALS, INC.-AZR202408-000412$AZURITY PHARMACEUTICALS$Montarello NL, Irvine I, Warner V, Hare J, Kaye D, Cloud GC.. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report. BMC Neurol. 2024;24:1$51$YR$$F$Y$$$20240830$$HP$AU$AU
242693193$24269319$3$F$20240101$20240923$20240830$20240926$EXP$$US-BAUSCH-BL-2023-014548$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240926$$CN$US$US
242693202$24269320$2$F$20200101$20240830$20240830$20240913$EXP$$CN-AZURITY PHARMACEUTICALS, INC.-AZR202408-000411$AZURITY PHARMACEUTICALS$Sun L, Mu J, Wang Y, He H.. Perioperative dexmedetomidine-induced delirium in a patient with schizophrenia: a case report. BMC Anesthesiol. 2024;24(1)$81$YR$$M$Y$$$20240913$$HP$CN$CN
242693211$24269321$1$I$20240826$20240829$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138155$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240830$$HP$US$US
242693221$24269322$1$I$$20240827$20240830$20240830$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013658$JAZZ$$$$I$F$Y$$$20240830$$HP$US$US
242693231$24269323$1$I$20221228$20240731$20240830$20240830$PER$$US-JNJFOC-20240880309$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240830$$MD$US$US
242693241$24269324$1$I$$20240821$20240830$20240830$EXP$GB-MHRA-MED-202408211420572470-ZKQSC$GB-TEVA-VS-3236365$TEVA$$82$YR$$F$Y$$$20240830$$HP$GB$GB
242693251$24269325$1$I$$20240826$20240830$20240830$PER$$US-JNJFOC-20240865890$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240830$$HP$US$US
242693262$24269326$2$F$$20240912$20240830$20240925$PER$$US-JNJFOC-20240879657$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$HP$US$US
242693271$24269327$1$I$$20240816$20240830$20240830$EXP$$US-JNJFOC-20240846897$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240830$$MD$US$US
242693283$24269328$3$F$20240815$20240821$20240830$20240911$EXP$$MX-JNJFOC-20240843948$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240911$$CN$MX$MX
242693291$24269329$1$I$20240809$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024173675$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242693301$24269330$1$I$$20240822$20240830$20240830$EXP$$US-JNJFOC-20240860409$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$MD$US$US
242693311$24269331$1$I$20240701$20240826$20240830$20240830$EXP$$US-ABBVIE-5897867$ABBVIE$$62$YR$$F$Y$$$20240830$$CN$US$US
242693322$24269332$2$F$20240822$20240826$20240830$20240902$EXP$$BS-BIOVITRUM-2024-BS-011492$BIOVITRUM$$27$WK$$F$Y$$$20240902$$CN$BS$BS
242693332$24269333$2$F$20240823$20240912$20240830$20240915$EXP$$IL-ALXN-202408ISR001603IL$ALEXION PHARMACEUTICALS$$62$YR$$M$Y$78$KG$20240915$$CN$IL$IL
242693341$24269334$1$I$$20240822$20240830$20240830$PER$$US-MYLANLABS-2024M1078343$MYLAN$$$$$F$Y$$$20240830$$CN$US$US
242693351$24269335$1$I$20240821$20240821$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133891$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$89.81$KG$20240830$$PH$US$US
242693361$24269336$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59896$$FDA-CTU$$64$YR$$F$N$85.28$KG$20240830$N$$US$
242693371$24269337$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59889$$FDA-CTU$$59$YR$$F$N$$$20240830$N$$US$
242693381$24269338$1$I$20240829$20240830$20240830$20240830$DIR$716590$$FDA-CTU$$55$YR$$F$N$$$20240830$N$$US$
242693391$24269339$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59890$$FDA-CTU$$56$YR$$F$N$72.12$KG$20240830$N$$US$
242693401$24269340$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59894$$FDA-CTU$$58$YR$$F$N$65.77$KG$20240830$N$$US$
242693411$24269341$1$I$20240822$20240830$20240830$20240830$DIR$716592$$FDA-CTU$$64$YR$$F$N$$$20240830$N$PH$US$
242693441$24269344$1$I$20240827$20240830$20240830$20240830$DIR$716581$$FDA-CTU$$65$YR$$F$N$83.7$KG$20240830$N$HP$US$
242693461$24269346$1$I$$20240830$20240830$20240830$DIR$716561$$FDA-CTU$$$$$UNK$N$$$20240830$$CN$US$
242693501$24269350$1$I$$20240830$20240830$20240830$DIR$716582$$FDA-CTU$$$$$UNK$N$$$20240830$$CN$US$
242693511$24269351$1$I$$20240830$20240830$20240830$DIR$716569$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242693521$24269352$1$I$20240828$20240830$20240830$20240830$DIR$716570$$FDA-CTU$$58$YR$$M$N$94.5$KG$20240830$N$CN$US$
242693531$24269353$1$I$$20240827$20240830$20240830$DIR$FDA-CDER-CTU-2024-59855$$FDA-CTU$$$$$F$N$$$20240827$N$HP$US$
242693541$24269354$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59902$$FDA-CTU$$45$YR$$F$N$77.11$KG$20240830$N$$US$
242693551$24269355$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59892$$FDA-CTU$$74$YR$$F$N$$$20240830$N$$US$
242693561$24269356$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59829$$FDA-CTU$$63$YR$$F$N$$$20240830$N$$US$
242693581$24269358$1$I$$20240815$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08413$LUPIN$$$$$$Y$$$20240830$$MD$US$US
242693601$24269360$1$I$20230331$20230510$20240830$20240830$EXP$$BR-BIOVITRUM-2023-BR-009284$BIOVITRUM$$686$DY$$M$Y$12$KG$20240830$$CN$BR$BR
242693611$24269361$1$I$$20240827$20240830$20240830$PER$$US-SA-2024SA251573$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240830$$CN$US$US
242693621$24269362$1$I$20240613$20240827$20240830$20240830$EXP$FR-AFSSAPS-RN2024000892$FR-GSK-FR2024106543$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$FR$FR
242693641$24269364$1$I$$20240820$20240830$20240830$PER$$US-JNJFOC-20240880130$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240830$$CN$US$US
242693651$24269365$1$I$$20240821$20240830$20240830$PER$$US-JNJFOC-20240880648$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240830$$HP$US$US
242693663$24269366$3$F$20240206$20240912$20240830$20240927$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464812$RANBAXY$$83$YR$$M$Y$66$KG$20240927$$HP$CN$CN
242693671$24269367$1$I$$20240821$20240830$20240830$EXP$$US-ROCHE-10000063716$ROCHE$$$$A$M$Y$$$20240830$$CN$US$US
242693682$24269368$2$F$20240821$20240911$20240830$20240924$EXP$$FR-Merck Healthcare KGaA-2024045343$MERCK KGAA$$$$$F$Y$$$20240919$$CN$FR$FR
242693691$24269369$1$I$$20240827$20240830$20240830$EXP$$ES-AstraZeneca-2024A197146$ASTRAZENECA$Lendinez-Sanchez G, Diaz-Redondo T, Iglesias-Campos M, Garrido-Almazan L, Alba-Conejo E, Rueda-Dominguez A, Sanchez-Munoz A.. Role of poly-ADP-ribose polymerase inhibitors after brain progression in platinum-sensitive ovarian cancer: a case report and review of the literature. Frontiers in Oncology 2024;14:1423992..$54$YR$$F$Y$$$20240830$$HP$ES$
242693701$24269370$1$I$$20240824$20240830$20240830$EXP$$BR-AstraZeneca-2024A196851$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$BR$
242693711$24269371$1$I$$20240827$20240830$20240830$EXP$$JP-AstraZeneca-2024A196220$ASTRAZENECA$Goto E, et al.. Salvage extended surgery after immune-checkpoint inhibitor treatment for advanced non-small cell lung cancer. Surgery Today 2024;54(8):917-926.$72$YR$$M$Y$$$20240830$$MD$JP$
242693721$24269372$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A192684$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242693731$24269373$1$I$20240815$20240816$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08466$LUPIN$$$$$$Y$$$20240830$$PH$US$US
242693741$24269374$1$I$$20240827$20240830$20240830$EXP$$JP-AstraZeneca-2024A196329$ASTRAZENECA$$$$$$Y$$$20240830$$MD$JP$
242693751$24269375$1$I$$20240823$20240830$20240830$EXP$$JP-AstraZeneca-2024A194628$ASTRAZENECA$$$$$$Y$$$20240830$$MD$JP$
242693762$24269376$2$F$$20240823$20240830$20240912$EXP$$JP-AstraZeneca-2024A178538$ASTRAZENECA$$$$$$Y$$$20240912$$PH$JP$
242693772$24269377$2$F$$20240903$20240830$20240911$EXP$$GB-ROCHE-10000068588$ROCHE$$$$$M$Y$$$20240911$$CN$GB$GB
242693781$24269378$1$I$20240601$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A194291$ASTRAZENECA$$751$MON$$F$Y$$$20240830$$CN$US$
242693792$24269379$2$F$$20240912$20240830$20240920$EXP$$US-UROGEN PHARMA LTD.-2024-UGN-000126$UROGEN PHARMA$$$$$$Y$$$20240920$$CN$US$US
242693801$24269380$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A194753$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242693811$24269381$1$I$20240801$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024173678$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242693821$24269382$1$I$20210501$20240826$20240830$20240830$EXP$$FR-ANIPHARMA-2024-FR-000146$ANI$$71$YR$$M$Y$$$20240830$$HP$FR$FR
242693833$24269383$3$F$$20240905$20240830$20240913$EXP$$JP-FERRINGPH-2024FE04877$FERRING$$$$$$Y$$$20240913$$PH$JP$JP
242693841$24269384$1$I$20240401$20240826$20240830$20240830$EXP$DE-EMBRYOTOX-202403143$DE-RDY-SPO/DEU/24/0012479$DR REDDYS$$$$$M$Y$2.44$KG$20240830$$MD$DE$DE
242693851$24269385$1$I$20181201$20240823$20240830$20240830$EXP$GB-MLMSERVICE-20240806-PI154095-00057-1$GB-RDY-SPO/GBR/24/0011856$DR REDDYS$Ibrahim A, Prasad G, Kilpatrick ES, Morris TJ. A case of autoimmune hepatitis associated with the PCSK9 inhibitor alirocumab. Annals of clinical biochemistry. 2024;00(00):45632241269657. DOI: 10.1177/000456322412696$61$YR$A$F$Y$$$20240830$$MD$GB$GB
242693861$24269386$1$I$$20240826$20240830$20240830$EXP$DE-EMBRYOTOX-202307169$DE-RDY-SPO/DEU/24/0012494$DR REDDYS$$$$$$Y$$$20240830$$MD$DE$DE
242693871$24269387$1$I$20240101$20240823$20240830$20240830$EXP$$JP-RADIUS HEALTH INC.-2024JP006466$RADIUS PHARM$$6$DEC$$F$Y$$$20240830$$HP$JP$JP
242693881$24269388$1$I$$20240816$20240830$20240830$EXP$$RU-RDY-SPO/RUS/24/0012213$DR REDDYS$Chaplygin AV, Chaplygina NV, Shperling NV, Shperling MI. Neurodermatitis ? a forgotten past or an objective reality. RMJ. 2024;7: 56-60.$45$YR$A$M$Y$$$20240830$$HP$RU$RU
242693891$24269389$1$I$$20240829$20240830$20240830$PER$$NVSC2024US175212$NOVARTIS$$$$$M$Y$$$20240830$$HP$US$US
242693901$24269390$1$I$$20240828$20240830$20240830$PER$$US-JNJFOC-20240874672$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$HP$US$US
242693911$24269391$1$I$20240822$20240822$20240830$20240830$EXP$$US-JNJFOC-20240859928$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$HP$US$US
242693921$24269392$1$I$20150101$20240826$20240830$20240830$PER$$US-JNJFOC-20240873103$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20240830$$LW$US$US
242693931$24269393$1$I$$20240829$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018856$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240830$$CN$US$US
242693941$24269394$1$I$20240301$20240827$20240830$20240830$EXP$FR-AFSSAPS-PA2024001297$FR-MYLANLABS-2024M1079063$MYLAN$$40$YR$$F$Y$$$20240830$$PH$FR$FR
242693951$24269395$1$I$$20240820$20240830$20240830$EXP$$JP-ROCHE-10000061194$ROCHE$Nakayasu S, Tanji M, Uto M, Takeuchi Y, Makino Y, Yamamoto E. Hypofractionated radiotherapy combined with bevacizumab plus low-dose ifosfamide, carboplatin, and etoposide as second-line chemoradiotherapy for progressing spinal diffuse midline glioma, H3K27-altered: illustrative case. Journal of neurosurgery Case lessons. 2024-Aug-12;8 (7):1-6. doi:10.3171/CASE2464.$45$YR$A$M$Y$$$20240830$$MD$JP$JP
242693961$24269396$1$I$20240705$20240826$20240830$20240830$EXP$ES-AEMPS-1562316$ES-MYLANLABS-2024M1078772$MYLAN$$77$YR$$M$Y$$$20240830$$MD$ES$ES
242693973$24269397$3$F$20240826$20240904$20240830$20240912$EXP$$IE-TAKEDA-2024TUS086992$TAKEDA$$27$YR$$F$Y$$$20240912$$CN$IE$IE
242693981$24269398$1$I$$20240830$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-084881-2024$RECKITT BENCKISER$$$$$F$Y$$$20240830$$CN$US$US
242693992$24269399$2$F$20230405$20240903$20240830$20240907$EXP$$KR-TAKEDA-2024TUS085956$TAKEDA$$$$E$F$Y$$$20240907$$MD$KR$KR
242694001$24269400$1$I$20240101$20240820$20240830$20240830$PER$$US-TEVA-VS-3235944$TEVA$$64$YR$$M$Y$$$20240830$$CN$US$US
242694011$24269401$1$I$$20240827$20240830$20240830$EXP$$US-SANDOZ INC.-SDZ2024US076018$SANDOZ$Bell Jr AP, Custer MK, Presley S. Pyoderma Gangrenosum in a 75-Year-Old MaleWith Follicular Diffuse Large B-cell Lymphoma. Cureus. 2024;16(8):e67234$75$YR$$M$Y$$$20240830$$HP$US$US
242694021$24269402$1$I$20240627$20240825$20240830$20240830$EXP$$CN-JNJFOC-20240875902$JOHNSON AND JOHNSON$$17$YR$T$M$Y$46$KG$20240830$$HP$CN$CN
242694031$24269403$1$I$20230630$20240816$20240830$20240830$EXP$$DE-UCBSA-2024028919$UCB$$$$A$F$Y$$$20240830$$MD$DE$DE
242694042$24269404$2$F$20231101$20240830$20240830$20240906$EXP$$CA-GSK-CA2023164072$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$HP$CA$CA
242694051$24269405$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171731$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242694061$24269406$1$I$20240826$20240827$20240830$20240830$30DAY$$IT-SANDOZ INC.-SDZ2024IT075951$SANDOZ$$15$YR$$M$Y$47$KG$20240830$$CN$IT$IT
242694071$24269407$1$I$20231101$20240829$20240830$20240830$EXP$FR-AFSSAPS-TS2024000941$FR-SANDOZ INC.-SDZ2024FR076364$SANDOZ$$80$YR$$M$Y$68$KG$20240830$$MD$FR$FR
242694082$24269408$2$F$$20240906$20240830$20240909$EXP$$DE-SANDOZ INC.-SDZ2024DE076143$SANDOZ$$67$YR$$M$Y$$$20240909$$MD$DE$DE
242694091$24269409$1$I$$20240822$20240830$20240830$EXP$$CN-ROCHE-10000063547$ROCHE$$$$A$F$Y$50$KG$20240830$$CN$CN$CN
242694113$24269411$3$F$20240801$20240926$20240830$20240930$PER$$US-BIOGEN-2024BI01280043$BIOGEN$$51$YR$$F$Y$$$20240930$$CN$US$US
242694121$24269412$1$I$$20240820$20240830$20240830$30DAY$$US-GSK-US2024103840$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242694132$24269413$2$F$$20240827$20240830$20240830$30DAY$$US-SANDOZ INC.-SDZ2024US075345$SANDOZ$$$$$M$Y$$$20240830$$CN$US$US
242694141$24269414$1$I$$20240821$20240830$20240830$EXP$$JP-ASTELLAS-2024-AER-000984$ASTELLAS$$$$$M$Y$$$20240830$$MD$JP$JP
242694151$24269415$1$I$20240708$20240826$20240830$20240830$EXP$FR-AFSSAPS-LM2024000468$FR-FreseniusKabi-FK202412958$FRESENIUS KABI$$68$YR$E$M$Y$59.7$KG$20240830$$MD$FR$FR
242694161$24269416$1$I$$20240826$20240830$20240830$EXP$$CA-BAUSCH-BL-2024-012965$BAUSCH AND LOMB$$78$YR$$F$Y$$$20240830$$HP$CA$CA
242694171$24269417$1$I$20240705$20240826$20240830$20240830$EXP$FR-AFSSAPS-LM2024000469$FR-FreseniusKabi-FK202412957$FRESENIUS KABI$$68$YR$E$M$Y$59.7$KG$20240830$$MD$FR$FR
242694181$24269418$1$I$$20240826$20240830$20240830$EXP$$US-JNJFOC-20240869661$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$CN$US$US
242694191$24269419$1$I$$20240826$20240830$20240830$PER$$US-JNJFOC-20240873159$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$LW$US$US
242694201$24269420$1$I$$20240823$20240830$20240830$EXP$$US-SANDOZ INC.-NVSC2022US201870$SANDOZ$$$$$F$Y$$$20240830$$CN$US$US
242694211$24269421$1$I$20240819$20240827$20240830$20240830$EXP$IT-MINISAL02-999712$IT-ORGANON-O2408ITA001990$ORGANON$$60$YR$$F$Y$$$20240830$$MD$IT$IT
242694221$24269422$1$I$$20240824$20240830$20240830$EXP$$GB-ABBVIE-5895966$ABBVIE$$$$A$M$Y$$$20240830$$CN$GB$GB
242694232$24269423$2$F$20240101$20240904$20240830$20240912$EXP$$NL-ABBVIE-5895687$ABBVIE$$78$YR$$F$Y$$$20240912$$CN$NL$NL
242694241$24269424$1$I$20240701$20240823$20240830$20240830$EXP$$BR-AstraZeneca-2024A196397$ASTRAZENECA$$3178$WK$$M$Y$111$KG$20240830$$CN$BR$
242694251$24269425$1$I$$20240821$20240830$20240830$EXP$$CA-TEVA-VS-3235819$TEVA$$3$YR$$F$Y$$$20240830$$HP$CA$CA
242694271$24269427$1$I$$20240828$20240830$20240830$EXP$$US-AstraZeneca-2024A196314$ASTRAZENECA$$$$$F$Y$$$20240830$$PH$US$
242694281$24269428$1$I$$20240822$20240830$20240830$EXP$$ZA-AstraZeneca-2024A194627$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$ZA$
242694291$24269429$1$I$20240824$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195693$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242694301$24269430$1$I$$20240827$20240830$20240830$EXP$$CA-ABBVIE-5900827$ABBVIE$$$$A$M$Y$$$20240830$$CN$CA$CA
242694311$24269431$1$I$$20240827$20240830$20240830$EXP$$JP-AstraZeneca-2024A196216$ASTRAZENECA$$$$$$Y$$$20240830$$MD$JP$
242694321$24269432$1$I$$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A194565$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242694332$24269433$2$F$20240616$20240829$20240830$20240905$EXP$$FR-AstraZeneca-2024A197748$ASTRAZENECA$$45$YR$$M$Y$85.6$KG$20240905$$MD$FR$
242694341$24269434$1$I$$20240823$20240830$20240830$EXP$$CA-AstraZeneca-2024A194631$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$CA$
242694352$24269435$2$F$20240801$20240905$20240830$20240911$EXP$$JP-AstraZeneca-2024A193406$ASTRAZENECA$$$$E$M$Y$$$20240911$$MD$JP$
242694361$24269436$1$I$$20240823$20240830$20240830$EXP$$RU-AstraZeneca-2024A194327$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$RU$
242694371$24269437$1$I$20240730$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A195937$ASTRAZENECA$$18237$DY$$F$Y$$$20240830$$CN$US$
242694381$24269438$1$I$20240701$20240822$20240830$20240830$EXP$$MX-AstraZeneca-2024A165975$ASTRAZENECA$$28944$DY$$M$Y$55$KG$20240830$$CN$MX$
242694392$24269439$2$F$$20240828$20240830$20240905$EXP$$JP-AstraZeneca-2024A193836$ASTRAZENECA$$$$$F$Y$$$20240905$$PH$JP$
242694401$24269440$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A193423$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242694411$24269441$1$I$$20240822$20240830$20240830$EXP$$JP-AstraZeneca-2024A190821$ASTRAZENECA$$9$YR$$F$Y$$$20240830$$PH$JP$
242694422$24269442$2$F$20240901$20240910$20240830$20240918$PER$$US-AstraZeneca-2024A193903$ASTRAZENECA$$964$MON$$F$Y$$$20240918$$HP$US$
242694431$24269443$1$I$$20240823$20240830$20240830$EXP$$JP-AstraZeneca-2024A187941$ASTRAZENECA$$$$$$Y$$$20240830$$PH$JP$
242694452$24269445$2$F$20240817$20240826$20240830$20240904$EXP$$IN-VANTIVE-2024VAN019336$Vantive US Healthcare$$8$MON$$F$Y$$$20240904$$CN$IN$IN
242694461$24269446$1$I$20240720$20240826$20240830$20240830$EXP$$GR-GSK-GR2024EME106315$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$GR$GR
242694472$24269447$2$F$$20240904$20240830$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132654$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240911$$CN$US$US
242694481$24269448$1$I$$20240829$20240830$20240830$EXP$$TN-SANDOZ INC.-SDZ2024TN076542$SANDOZ$$24$YR$$M$Y$$$20240830$$MD$TN$TN
242694492$24269449$2$F$$20240827$20240830$20240904$EXP$$CA-AstraZeneca-2024A194584$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$CA$
242694501$24269450$1$I$$20240828$20240830$20240830$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-138139$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240830$$MD$JP$JP
242694511$24269451$1$I$$20240827$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137933$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$$$20240830$$MD$US$US
242694521$24269452$1$I$$20240828$20240830$20240830$EXP$$US-SANDOZ INC.-SDZ2024US076563$SANDOZ$$$$$F$Y$92.27$KG$20240830$$CN$US$US
242694531$24269453$1$I$$20240827$20240830$20240830$PER$$US-GILEAD-2024-0685650$GILEAD$$$$$$Y$$$20240830$$CN$US$US
242694552$24269455$2$F$$20240820$20240830$20240830$EXP$US-MLMSERVICE-20240807-PI154441-00232-1$US-ROCHE-10000062961$ROCHE$Farkouh EK, Michel IM, Harrison DJ, Issa N. Dual Donor-Derived Renal Allograft Mucormycosis From a Single Deceased Donor. Mayo Clinic Proceedings. 2024;99(8):1341-42. DOI: 10.1016/j.mayocp.2024.04.001.$$$$F$Y$$$20240830$$MD$US$US
242694561$24269456$1$I$$20231128$20240830$20240830$PER$$US-APOTEX-2023AP017529$APOTEX$Baroud E, Chaudhary N, Georgiopoulos AM. Management of neuropsychiatric symptoms in adults treated with elexacaftor/tezacaftor/ivacaftor. Pediatric Pulmonology. 2023;58(7):1920-1930$62$YR$$F$Y$$$20240830$$MD$US$US
242694571$24269457$1$I$$20240830$20240830$20240830$EXP$FR-EMA-DD-20240826-7482647-151112$FR-SANDOZ INC.-SDZ2024FR076475$SANDOZ$$71$YR$$M$Y$$$20240830$$HP$FR$FR
242694581$24269458$1$I$$20230818$20240830$20240830$PER$$US-APOTEX-2023AP012948$APOTEX$Duarte A, Teive HAG.. Lingual dystonia secondary to medication use: a review of case reports. Neurology. 2023;100(17)(Suppl2)$$$$$Y$$$20240830$$HP$US$US
242694591$24269459$1$I$$20240125$20240830$20240830$PER$$US-APOTEX-2024AP001791$APOTEX$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series.. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY. 2023;33 (Number 10):433-438$17$YR$$F$Y$$$20240830$$PH$US$US
242694601$24269460$1$I$$20231027$20240830$20240830$PER$$US-APOTEX-2023AP016250$APOTEX$Tomlinson MG, Velez L, Rodriguez-Roman L.. Psychotic Mania Secondary to Chronic Hypercalcemia. The Primary Care Companion for CNS Disorders. 2023;25(4):22cr03463$58$YR$$F$Y$$$20240830$$HP$US$US
242694621$24269462$1$I$20240618$20240830$20240830$20240830$DIR$716599$$FDA-CTU$$62$YR$$M$N$122.6$KG$20240830$Y$HP$US$
242694631$24269463$1$I$$20240125$20240830$20240830$PER$$US-APOTEX-2024AP001800$APOTEX$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series.. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY. 2023;33 (Number 10):433-438$17$YR$$M$Y$$$20240830$$PH$US$US
242694641$24269464$1$I$$20240125$20240830$20240830$PER$$US-APOTEX-2024AP001793$APOTEX$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series.. Journal of Child and Adolescent Psychopharmacology. 2023;33(10):433-438$15$YR$$F$Y$$$20240830$$PH$US$US
242694651$24269465$1$I$$20240125$20240830$20240830$PER$$US-APOTEX-2024AP001792$APOTEX$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series.. Journal of Child and Adolescent Psychopharmacology. 2023;33(10):433-438$15$YR$$M$Y$$$20240830$$PH$US$US
242694661$24269466$1$I$$20240125$20240830$20240830$PER$$US-APOTEX-2024AP001797$APOTEX$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series.. Journal of Child and Adolescent Psychopharmacology. 2023;33(10):433-438$17$YR$$F$Y$$$20240830$$PH$US$US
242694671$24269467$1$I$$20240125$20240830$20240830$PER$$US-APOTEX-2024AP001795$APOTEX$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series.. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY. 2023;33 (Number 10):433-438$15$YR$$F$Y$$$20240830$$PH$US$US
242694681$24269468$1$I$20240828$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024173507$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242694691$24269469$1$I$$20231121$20240830$20240830$PER$$US-APOTEX-2023AP017139$APOTEX$Kalla P, Namerow LB, Walker SA, Ruano G, Malik S.. Contrasting ABCB1 pharmacogenetics and psychotropic responses in child and adolescent psychiatry: a case comparison. Pharmacogenomics. 2023;24(3):131-139$9$YR$$M$Y$$$20240830$$HP$US$US
242694701$24269470$1$I$$20240125$20240830$20240830$PER$$US-APOTEX-2024AP001798$APOTEX$Moon E, Kim E, Williams A.. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series.. Journal of Child and Adolescent Psychopharmacology. 2023;33(10):433-438$16$YR$$M$Y$$$20240830$$PH$US$US
242694711$24269471$1$I$$20240830$20240830$20240830$DIR$716600$$FDA-CTU$$28$YR$$M$N$$$20240830$N$$US$
242694721$24269472$1$I$20240801$20240827$20240830$20240830$EXP$$US-ABBVIE-5898420$ABBVIE$$62$YR$$M$Y$$$20240830$$CN$US$US
242694731$24269473$1$I$20240101$20240826$20240830$20240830$EXP$$US-ABBVIE-5899760$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242694741$24269474$1$I$$20240827$20240830$20240830$EXP$GB-MHRA-MIDB-fb1746f4-4d84-4ca2-a812-3855472d4954$GB-MYLANLABS-2024M1079141$MYLAN$$90$YR$$M$Y$$$20240830$$PH$GB$GB
242694751$24269475$1$I$20240702$20240826$20240830$20240830$EXP$$GB-MYLANLABS-2024M1062206$MYLAN$$75$YR$$M$Y$$$20240830$$CN$GB$GB
242694761$24269476$1$I$$20240828$20240830$20240830$EXP$$US-SANDOZ INC.-NVSC2019US037705$SANDOZ$$69$YR$$M$Y$$$20240830$$MD$US$US
242694771$24269477$1$I$$20240821$20240830$20240830$EXP$$CA-TEVA-VS-3235908$TEVA$$$$$F$Y$$$20240830$$HP$CA$CA
242694791$24269479$1$I$$20240823$20240830$20240830$EXP$$CA-GSK-CA2023174554$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$CN$CA$CA
242694801$24269480$1$I$20240820$20240828$20240830$20240830$EXP$$CN-TAKEDA-2024TUS087187$TAKEDA$$82$YR$$M$Y$70$KG$20240830$$HP$CN$CN
242694811$24269481$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138556$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$65.9$KG$20240830$$MD$US$US
242694831$24269483$1$I$$20240822$20240830$20240830$EXP$$US-SANDOZ INC.-SDZ2024US076295$SANDOZ$$$$$$Y$$$20240830$$HP$US$US
242694841$24269484$1$I$$20240827$20240830$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA076278$SANDOZ$$$$$M$Y$$$20240830$$MD$CA$CA
242694851$24269485$1$I$$20240828$20240830$20240830$EXP$$CN-GSK-CN2024GSK108076$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$CN$CN
242694861$24269486$1$I$20240101$20240819$20240830$20240830$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001238$ALEMBIC$$$$$$Y$$$20240830$$CN$US$US
242694882$24269488$2$F$$20240912$20240830$20240920$EXP$$NVSC2024HU173556$NOVARTIS$Siegler Z, Maka E, Kormos E, Hegyi M, Ambrus B, Cservenyak J et al.. Az Aicardi-szindromarol ot betegunk kapcsan [About Aicardi syndrome in relation to five of our patient]. PEDIATRICS (GYERMEKGYOGYASZAT). 2024;75(4):282-9$2$MON$$$Y$$$20240920$$HP$HU$HU
242694891$24269489$1$I$$20240819$20240830$20240830$EXP$$FR-PERRIGO-24FR007809$PERRIGO$$67$YR$$M$Y$$$20240830$$MD$FR$FR
242694901$24269490$1$I$$20240826$20240830$20240830$EXP$$QA-JNJFOC-20240868007$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240830$$CN$QA$QA
242694911$24269491$1$I$20240821$20240826$20240830$20240830$DIR$FDA-CDER-CTU-2024-59805$$FDA-CTU$$$$$F$N$97.1$KG$20240826$N$$US$
242694921$24269492$1$I$$20240829$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018963$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240830$$CN$US$US
242694931$24269493$1$I$$20240828$20240830$20240830$EXP$$US-ABBVIE-5901070$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242694941$24269494$1$I$$20240822$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408014808$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240830$$CN$US$US
242694953$24269495$3$F$20240101$20240910$20240830$20240917$EXP$$JP-RADIUS HEALTH, INC.-2024JP005831$RADIUS PHARM$$$$$F$Y$$$20240917$$MD$JP$JP
242694961$24269496$1$I$20240823$20240823$20240830$20240830$EXP$GB-MHRA-MED-202408231939005540-ZPTFY$GB-BAUSCH-BL-2024-013107$BAUSCH AND LOMB$$40$YR$$M$Y$98$KG$20240830$$CN$GB$GB
242694971$24269497$1$I$20230101$20240826$20240830$20240830$EXP$$US-INCYTE CORPORATION-2024IN008998$INCYTE$$$$$$Y$$$20240830$$HP$US$US
242694981$24269498$1$I$$20240821$20240830$20240830$EXP$$DE-TAKEDA-2024TUS084722$TAKEDA$$$$$$Y$$$20240830$$CN$DE$DE
242694991$24269499$1$I$20240701$20240815$20240830$20240830$EXP$$US-MOBIUS THERAPEUTICS-2024MB000004$MOBIUS THERAPEUTICS$$$$$$Y$$$20240830$$HP$US$US
242695001$24269500$1$I$$20240821$20240830$20240830$EXP$$US-ADMA BIOLOGICS INC.-US-2024ADM000111$ADMA BIOLOGICS$Fogel LA, Bigley TM, Cole JJ, Estabrook MM, Kitcharoensakkul M.. Aicardi-Gouti?res syndrome presenting with pneumocystis jirovecii pneumonia. Pediatric Allergy and Immunology. 2023;34:e13968$1$DY$$M$Y$2.76$KG$20240830$$HP$US$US
242695011$24269501$1$I$$20240829$20240830$20240830$PER$$US-HALEON-2194394$Haleon PLC$$$$$$Y$$$20240830$$CN$US$US
242695021$24269502$1$I$$20240821$20240830$20240830$EXP$$US-ADMA BIOLOGICS INC.-US-2024ADM000110$ADMA BIOLOGICS$Fogel LA, Bigley TM, Cole JJ, Estabrook MM, Kitcharoensakkul M.. Aicardi-Gouti?res syndrome presenting with pneumocystis  jirovecii pneumonia. Pediatric Allergy and Immunology. 2023;34:e13968$1$DY$$M$Y$2.76$KG$20240830$$HP$US$US
242695031$24269503$1$I$$20240828$20240830$20240830$EXP$$US-ABBVIE-5901292$ABBVIE$$23$YR$$M$Y$$$20240830$$MD$US$US
242695042$24269504$2$F$$20240830$20240830$20240903$PER$$US-JNJFOC-20240880443$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242695052$24269505$2$F$$20240830$20240830$20240902$PER$$US-JNJFOC-20240880568$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242695061$24269506$1$I$$20240819$20240830$20240830$PER$$US-JNJFOC-20240872047$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$MD$US$US
242695081$24269508$1$I$20240623$20240822$20240830$20240830$EXP$FR-AFSSAPS-LL2024001588$FR-AMGEN-FRASP2024168214$AMGEN$$59$YR$A$F$Y$$$20240830$$MD$FR$FR
242695091$24269509$1$I$$20240826$20240830$20240830$EXP$$AU-ABBVIE-5897704$ABBVIE$$$$$M$Y$$$20240830$$HP$AU$AU
242695101$24269510$1$I$20240516$20240827$20240830$20240830$EXP$$US-JNJFOC-20240869812$JOHNSON AND JOHNSON$$45$YR$A$M$Y$96$KG$20240830$$HP$US$US
242695111$24269511$1$I$20240816$20240820$20240830$20240830$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001930$SK LIFE SCIENCE$$$$$$Y$$$20240830$$CN$US$US
242695121$24269512$1$I$$20240822$20240830$20240830$EXP$$ZA-AstraZeneca-2024A193185$ASTRAZENECA$$64$YR$$M$Y$$$20240830$$CN$ZA$
242695141$24269514$1$I$20240220$20240828$20240830$20240830$EXP$$US-AstraZeneca-2024A197039$ASTRAZENECA$$22386$DY$$M$Y$$$20240830$$HP$US$
242695151$24269515$1$I$20230101$20240819$20240830$20240830$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2024-001915$SK LIFE SCIENCE$$$$$$Y$$$20240830$$CN$US$US
242695161$24269516$1$I$20240821$20240822$20240830$20240830$EXP$$ZA-AstraZeneca-2024A194294$ASTRAZENECA$$74$YR$$F$Y$$$20240830$$CN$ZA$
242695211$24269521$1$I$20240713$20240829$20240830$20240830$EXP$$FR-AstraZeneca-2024A196857$ASTRAZENECA$$87$YR$$M$Y$82$KG$20240830$$MD$FR$
242695221$24269522$1$I$20230601$20240822$20240830$20240830$EXP$FR-AFSSAPS-PA2024001449$FR-TEVA-VS-3236798$TEVA$$76$YR$$M$Y$88$KG$20240830$$CN$FR$FR
242695231$24269523$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A191966$ASTRAZENECA$$$$$$Y$$$20240830$$CN$US$
242695241$24269524$1$I$$20240828$20240830$20240830$EXP$$FR-AstraZeneca-2024A196196$ASTRAZENECA$$$$$F$Y$$$20240830$$MD$FR$
242695261$24269526$1$I$20240614$20240823$20240830$20240830$EXP$$JP-AstraZeneca-2024A194692$ASTRAZENECA$$85$YR$$M$Y$$$20240830$$MD$JP$
242695271$24269527$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A192636$ASTRAZENECA$$$$$F$Y$81$KG$20240830$$CN$US$
242695281$24269528$1$I$$20240827$20240830$20240830$EXP$$JP-AstraZeneca-2024A196217$ASTRAZENECA$$$$$$Y$$$20240830$$MD$JP$
242695291$24269529$1$I$20201101$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A193349$ASTRAZENECA$$23484$DY$$F$Y$$$20240830$$CN$US$
242695301$24269530$1$I$20240826$20240827$20240830$20240830$EXP$$PL-AstraZeneca-2024A197530$ASTRAZENECA$$28489$DY$$F$Y$$$20240830$$HP$PL$
242695311$24269531$1$I$20240812$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A192162$ASTRAZENECA$$25945$DY$$F$Y$$$20240830$$CN$US$
242695321$24269532$1$I$$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195220$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242695331$24269533$1$I$20240813$20240822$20240830$20240830$EXP$$DO-AstraZeneca-2024A194221$ASTRAZENECA$$$$$F$Y$$$20240830$$MD$DO$
242695341$24269534$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A193506$ASTRAZENECA$$$$$M$Y$$$20240830$$HP$US$
242695351$24269535$1$I$20240729$20240822$20240830$20240830$EXP$$GB-AstraZeneca-2024A191557$ASTRAZENECA$$12$YR$$M$Y$92$KG$20240830$$MD$GB$
242695371$24269537$1$I$$20240826$20240830$20240830$PER$$US-ABBVIE-5896038$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242695381$24269538$1$I$20240814$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137899$BRISTOL MYERS SQUIBB$$26$YR$A$M$Y$$$20240830$$HP$US$US
242695391$24269539$1$I$$20240823$20240830$20240830$EXP$$CA-TAKEDA-2024TUS085681$TAKEDA$$$$$M$Y$$$20240830$$CN$CA$CA
242695401$24269540$1$I$$20240830$20240830$20240830$EXP$$DE-SANDOZ INC.-SDZ2024DE076559$SANDOZ$$$$$$Y$$$20240830$$MD$DE$DE
242695411$24269541$1$I$$20240827$20240830$20240830$EXP$$CA-MYLANLABS-2024M1079703$MYLAN$$3$DEC$$M$Y$$$20240830$$HP$CA$CA
242695421$24269542$1$I$20231202$20240820$20240830$20240830$DIR$FDA-CDER-CTU-2024-59812$$FDA-CTU$$$$$M$N$121.6$KG$20240820$N$$US$
242695431$24269543$1$I$20240818$20240827$20240830$20240830$DIR$FDA-CDER-CTU-2024-59809$$FDA-CTU$$$$$F$N$89.4$KG$20240827$N$$US$
242695442$24269544$2$F$$20240821$20240830$20240830$EXP$$US-ROCHE-10000064528$ROCHE$$$$$$Y$$$20240830$$HP$US$US
242695451$24269545$1$I$20240726$20240820$20240830$20240830$DIR$FDA-CDER-CTU-2024-59819$$FDA-CTU$$$$$M$N$66.3$KG$20240820$N$$US$
242695461$24269546$1$I$20240625$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-59822$$FDA-CTU$$84$YR$$F$N$69.1$KG$20240829$N$$US$
242695471$24269547$1$I$$20240821$20240830$20240830$PER$$US-ABBVIE-5891567$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242695481$24269548$1$I$20240101$20240823$20240830$20240830$EXP$$US-JNJFOC-20240862466$JOHNSON AND JOHNSON$$83$YR$E$F$Y$56.75$KG$20240830$$CN$US$US
242695491$24269549$1$I$20240801$20240821$20240830$20240830$PER$$US-JNJFOC-20240859382$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240830$$CN$US$US
242695501$24269550$1$I$$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137844$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240830$$CN$US$US
242695511$24269551$1$I$$20240821$20240830$20240830$EXP$GB-MHRA-MED-202408211344193490-JDYTS$GB-BAXTER-2024BAX023594$BAXTER$$82$YR$$F$Y$$$20240830$$HP$GB$GB
242695521$24269552$1$I$$20240827$20240830$20240830$EXP$$GB-ABBVIE-5899414$ABBVIE$$$$A$F$Y$$$20240830$$CN$GB$GB
242695531$24269553$1$I$20240725$20240820$20240830$20240830$EXP$$GB-AMRYT PHARMACEUTICALS DAC-AEGR007362$AEGERION$$$$$$Y$$$20240830$$HP$GB$GB
242695541$24269554$1$I$$20240828$20240830$20240830$EXP$$GB-ABBVIE-5900372$ABBVIE$$$$$$Y$$$20240830$$CN$GB$GB
242695551$24269555$1$I$$20230807$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004616$ENDO$$$$$$Y$$$20240830$$CN$US$US
242695561$24269556$1$I$$20230721$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004430$ENDO$$$$$$Y$$$20240830$$CN$US$US
242695571$24269557$1$I$$20240103$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2024-000134$ENDO$$35$YR$$F$Y$$$20240830$$CN$US$US
242695581$24269558$1$I$20231006$20231013$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005410$ENDO$$$$$M$Y$$$20240830$$CN$US$US
242695591$24269559$1$I$$20230829$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004902$ENDO$$$$$$Y$$$20240830$$CN$US$US
242695601$24269560$1$I$$20240312$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2024-001343$ENDO$$$$$$Y$$$20240830$$CN$US$US
242695611$24269561$1$I$$20231128$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005993$ENDO$$$$$$Y$$$20240830$$CN$US$US
242695621$24269562$1$I$$20230928$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005203$ENDO$$$$$$Y$$$20240830$$CN$US$US
242695631$24269563$1$I$$20231031$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005664$ENDO$$20$YR$$F$Y$$$20240830$$CN$US$US
242695641$24269564$1$I$20200101$20240422$20240830$20240830$PER$$US-ENDO USA, INC.-2024-001913$ENDO$$$$$$Y$$$20240830$$CN$US$US
242695651$24269565$1$I$$20240823$20240830$20240830$PER$$US-JNJFOC-20240861062$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$PH$US$US
242695662$24269566$2$F$20221001$20240923$20240830$20240926$EXP$$LT-REGENERON PHARMACEUTICALS, INC.-2024-117411$REGENERON$$58$YR$$M$Y$$$20240926$$MD$LT$LT
242695671$24269567$1$I$20230101$20240828$20240830$20240830$EXP$$US-ABBVIE-5900424$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242695682$24269568$2$F$$20240828$20240830$20240905$EXP$$US-ASTELLAS-2024-AER-003680$ASTELLAS$$82$YR$E$M$Y$$$20240905$$MD$US$US
242695691$24269569$1$I$$20240814$20240830$20240830$PER$$US-TEVA-VS-3236234$TEVA$$64$YR$$F$Y$$$20240830$$MD$US$US
242695701$24269570$1$I$20240801$20240820$20240830$20240830$EXP$$US-ABBVIE-5890568$ABBVIE$$42$YR$$F$Y$$$20240830$$CN$US$US
242695711$24269571$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138684$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240830$$CN$US$US
242695721$24269572$1$I$20240717$20240830$20240830$20240830$EXP$IT-MINISAL02-1000586$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-138429$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$51$KG$20240830$$MD$IT$IT
242695731$24269573$1$I$20240801$20240825$20240830$20240830$PER$$US-ABBVIE-5895663$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242695741$24269574$1$I$$20240816$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132035$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240830$$HP$US$US
242695751$24269575$1$I$$20240827$20240830$20240830$EXP$$LT-REGENERON PHARMACEUTICALS, INC.-2024-117410$REGENERON$$79$YR$$M$Y$$$20240830$$MD$LT$LT
242695761$24269576$1$I$20240101$20240821$20240830$20240830$PER$$US-SA-2023SA355124$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240830$$HP$US$US
242695771$24269577$1$I$$20240826$20240830$20240830$EXP$$DE-SA-2024SA252117$SANOFI AVENTIS$Shamseldin M, Heers H, Steiner T, Puls R.. Anatomic locations of ureterovascular fistulae: a review of 532 patients in the literature and a new series of 8 patients.. CVIR Endovascular.. 2024;7(1):1-15$80$YR$E$F$Y$$$20240830$$HP$DE$DE
242695781$24269578$1$I$20231201$20240826$20240830$20240830$EXP$DE-EMBRYOTOX-202310245$DE-RDY-SPO/DEU/24/0012480$DR REDDYS$$$$$F$Y$2.6$KG$20240830$$MD$DE$DE
242695791$24269579$1$I$$20240823$20240830$20240830$EXP$$JP-009507513-2408JPN002863J$MERCK$$66$YR$$F$Y$$$20240830$$PH$JP$JP
242695801$24269580$1$I$$20240822$20240830$20240830$EXP$GB-MHRA-MIDB-f2e310a8-9d28-4c5b-ba9e-7896d2e17bbf$GB-TEVA-VS-3236650$TEVA$$79$YR$$F$Y$$$20240830$$HP$GB$GB
242695811$24269581$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5897015$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242695821$24269582$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5897500$ABBVIE$$$$$M$Y$$$20240830$$HP$US$US
242695831$24269583$1$I$20240701$20240823$20240830$20240830$EXP$$FR-ABBVIE-5895867$ABBVIE$$74$YR$$M$Y$$$20240830$$HP$FR$FR
242695841$24269584$1$I$$20240822$20240830$20240830$EXP$$US-AMGEN-USASP2024168657$AMGEN$Hahn N.. Neoadjuvant Cisplatin, Gemeitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis. Bladder Cancer. 2024;10 (2):133-143$$$$$Y$$$20240830$$MD$US$US
242695851$24269585$1$I$$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A195722$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242695861$24269586$1$I$$20240823$20240830$20240830$EXP$$ZA-AstraZeneca-2024A195013$ASTRAZENECA$$90$YR$$M$Y$$$20240830$$CN$ZA$
242695871$24269587$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A192218$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242695881$24269588$1$I$20231001$20240826$20240830$20240830$EXP$$US-ABBVIE-5896666$ABBVIE$$40$YR$$M$Y$$$20240830$$CN$US$US
242695891$24269589$1$I$$20240823$20240830$20240830$EXP$$ZA-AstraZeneca-2024A194527$ASTRAZENECA$$76$YR$$F$Y$$$20240830$$CN$ZA$
242695901$24269590$1$I$20240805$20240826$20240830$20240830$EXP$$ZA-AstraZeneca-2024A195353$ASTRAZENECA$$88$YR$$F$Y$$$20240830$$CN$ZA$
242695911$24269591$1$I$$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A194257$ASTRAZENECA$$$$$F$Y$85.7$KG$20240830$$CN$US$
242695922$24269592$2$F$20240710$20240829$20240830$20240906$EXP$GB-MHRA-MED-202408221347087970-JSZRY$GB-TEVA-VS-3236870$TEVA$$74$YR$$F$Y$90$KG$20240906$$MD$GB$GB
242695931$24269593$1$I$20240709$20240823$20240830$20240830$EXP$$CN-AstraZeneca-2024A193060$ASTRAZENECA$$63$YR$$F$Y$70$KG$20240830$$MD$CN$
242695941$24269594$1$I$$20240829$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018892$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240830$$CN$US$US
242695951$24269595$1$I$$20240826$20240830$20240830$EXP$$US-JNJFOC-20240869518$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242695961$24269596$1$I$$20240823$20240830$20240830$EXP$$JP-AstraZeneca-2024A187938$ASTRAZENECA$$$$$M$Y$$$20240830$$MD$JP$
242695971$24269597$1$I$$20240827$20240830$20240830$EXP$$JP-AstraZeneca-2024A196901$ASTRAZENECA$Kakimoto D, et al. DP65-1 A case of widespread postoperative cerebral infarction. The 29th Annual meeting of Japanese Society of Cardiovascular Anesthesiologists 2024;295.$77$YR$$F$Y$70$KG$20240830$$MD$JP$
242695981$24269598$1$I$20240607$20240823$20240830$20240830$EXP$$AR-JNJFOC-20240646227$JOHNSON AND JOHNSON$$77$YR$E$F$Y$68$KG$20240830$$CN$AR$AR
242695991$24269599$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59828$$FDA-CTU$$70$YR$$M$N$$$20240830$N$$US$
242696001$24269600$1$I$20240801$20240823$20240830$20240830$DIR$FDA-CDER-CTU-2024-59823$$FDA-CTU$$84$YR$$F$N$$$20240823$N$HP$US$
242696011$24269601$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A193446$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242696021$24269602$1$I$20240826$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-59813$$FDA-CTU$$$$$M$N$68.6$KG$20240829$N$$US$
242696031$24269603$1$I$$20240822$20240830$20240830$EXP$GB-MHRA-MIDB-e67ea340-cc12-45d5-a6fd-8e42fe8a1b35$GB-TEVA-VS-3236848$TEVA$$59$YR$$F$Y$$$20240830$$PH$GB$GB
242696041$24269604$1$I$$20240829$20240830$20240830$PER$$US-PROD-AS2-212756134-RB-103757-2023$RECKITT BENCKISER$$88$YR$$F$Y$$$20240830$$CN$US$US
242696052$24269605$2$F$$20240829$20240830$20240904$EXP$$IN-VANTIVE-2024VAN019404$Vantive US Healthcare$$54$YR$$M$Y$$$20240904$$CN$IN$IN
242696062$24269606$2$F$$20240830$20240830$20240904$EXP$$IT-SANDOZ INC.-SDZ2024IT076579$SANDOZ$$$$$$Y$$$20240904$$HP$IT$IT
242696072$24269607$2$F$20230401$20240828$20240830$20240903$EXP$$NVSC2024EG174648$NOVARTIS$$69$YR$$F$Y$70$KG$20240903$$CN$EG$EG
242696081$24269608$1$I$20240101$20240823$20240830$20240830$EXP$$JP-009507513-2405JPN000532J$MERCK$$81$YR$$M$Y$$$20240830$$MD$JP$JP
242696101$24269610$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137843$BRISTOL MYERS SQUIBB$$$$A$F$Y$$$20240830$$MD$US$US
242696112$24269611$2$F$$20240816$20240830$20240830$EXP$$AU-SANDOZ INC.-SDZ2024AU073235$SANDOZ$$$$$$Y$$$20240830$$HP$AU$AU
242696121$24269612$1$I$20240825$20240826$20240830$20240830$DIR$FDA-CDER-CTU-2024-59827$$FDA-CTU$$90$YR$$F$N$$$20240826$N$HP$US$
242696131$24269613$1$I$$20240823$20240830$20240830$EXP$$GB-EMD Serono-2024046001$EMD SERONO INC$$$$A$F$Y$$$20240830$$CN$GB$GB
242696141$24269614$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59901$$FDA-CTU$$66$YR$$F$N$64.41$KG$20240830$N$$US$
242696151$24269615$1$I$$20240822$20240830$20240830$PER$$US-EMD Serono-2024045667$EMD SERONO INC$$$$A$F$Y$$$20240830$$CN$US$US
242696161$24269616$1$I$20240828$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59888$$FDA-CTU$$43$YR$$F$N$$$20240830$N$HP$US$
242696171$24269617$1$I$$20240826$20240830$20240830$DIR$FDA-CDER-CTU-2024-59826$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242696182$24269618$2$F$$20240909$20240830$20240912$EXP$$GB-EMD Serono-2024045975$EMD SERONO INC$$$$A$F$Y$$$20240912$$CN$GB$GB
242696191$24269619$1$I$$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-59840$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242696201$24269620$1$I$20240817$20240821$20240830$20240830$EXP$$DE-EMD Serono-2024045114$EMD SERONO INC$$25$YR$A$M$Y$$$20240830$$MD$DE$DE
242696211$24269621$1$I$$20240822$20240830$20240830$EXP$$US-NOVOPROD-1275036$NOVO NORDISK$$$$$F$Y$$$20240830$$MD$US$US
242696221$24269622$1$I$$20240827$20240830$20240830$EXP$$DE-AMGEN-DEUSP2024171559$AMGEN$Kalthoff S.; Wolniak C.; Lutz P. et al.. Only repeatedly elevated IgG4 levels in primary sclerosing cholangitis may distinguish a particular patient phenotype. BMC Gastroenterology. 2024;24(1):1-8$$$$$Y$$$20240830$$HP$DE$DE
242696231$24269623$1$I$$20240817$20240830$20240830$EXP$$US-HLS-202400958$HLS THERAPEUTICS$$45$YR$A$F$Y$$$20240830$$PH$US$US
242696241$24269624$1$I$$20240827$20240830$20240830$EXP$$US-JNJFOC-20240872928$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242696251$24269625$1$I$$20240827$20240830$20240830$EXP$$US-JNJFOC-20240873555$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240830$$PH$US$US
242696271$24269627$1$I$$20230823$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004832$ENDO$$$$$$Y$$$20240830$$CN$US$US
242696281$24269628$1$I$$20231030$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005633$ENDO$$$$$$Y$$$20240830$$CN$US$US
242696291$24269629$1$I$$20240520$20240830$20240830$PER$$US-ENDO USA, INC.-2024-002271$ENDO$$$$$$Y$$$20240830$$CN$US$US
242696301$24269630$1$I$$20230724$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004454$ENDO$$$$$M$Y$$$20240830$$CN$US$US
242696311$24269631$1$I$$20240220$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2024-001090$ENDO$$$$$$Y$$$20240830$$CN$US$US
242696321$24269632$1$I$20230101$20231109$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005766$ENDO$$$$$$Y$$$20240830$$CN$US$US
242696331$24269633$1$I$$20231003$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005265$ENDO$$$$$$Y$$$20240830$$CN$US$US
242696341$24269634$1$I$$20240828$20240830$20240830$PER$$US-BIOVITRUM-2024-US-011435$BIOVITRUM$$72$YR$$F$Y$$$20240830$$CN$US$US
242696352$24269635$2$F$20240801$20240909$20240830$20240916$EXP$$CA-ABBVIE-5896654$ABBVIE$$16$YR$$M$Y$$$20240916$$HP$CA$CA
242696361$24269636$1$I$20240823$20240813$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004663$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240830$$CN$US$US
242696371$24269637$1$I$$20230830$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004911$ENDO$$$$$F$Y$$$20240830$$CN$US$US
242696381$24269638$1$I$20230101$20231214$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-006178$ENDO$$$$$M$Y$$$20240830$$CN$US$US
242696393$24269639$3$F$$20240925$20240830$20240927$PER$$US-BIOVITRUM-2024-US-011469$BIOVITRUM$$75$YR$$F$Y$$$20240927$$CN$US$US
242696403$24269640$3$F$20240801$20240912$20240830$20240920$PER$$US-Eisai-EC-2024-172846$EISAI$$72$YR$E$F$Y$$$20240920$$HP$US$US
242696413$24269641$3$F$20240814$20240926$20240830$20240930$EXP$$US-BIOVITRUM-2024-US-011439$BIOVITRUM$$87$YR$$M$Y$$$20240930$$CN$US$US
242696421$24269642$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5898173$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242696431$24269643$1$I$20240101$20240410$20240830$20240830$PER$$US-ENDO USA, INC.-2024-001742$ENDO$$$$$M$Y$$$20240830$$CN$US$US
242696441$24269644$1$I$20240101$20240826$20240830$20240830$EXP$$US-SA-2024SA251244$SANOFI AVENTIS$$$$$F$Y$$$20240830$$MD$US$US
242696461$24269646$1$I$20240820$20240823$20240830$20240830$EXP$$NVSC2024RU173147$NOVARTIS$$73$YR$$F$Y$$$20240830$$CN$RU$RU
242696471$24269647$1$I$$20240823$20240830$20240830$EXP$$US-AMGEN-USASP2024169303$AMGEN$Aldoss I.; Othman T.; Koller P. et al.. Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia. British Journal of Haematology. 2024;205 (2):711-715$34$YR$A$M$Y$$$20240830$$HP$US$US
242696481$24269648$1$I$20240801$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138543$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240830$$HP$US$US
242696492$24269649$2$F$$20240924$20240830$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137847$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240925$$CN$US$US
242696502$24269650$2$F$$20240830$20240830$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137459$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$120.66$KG$20240902$$HP$US$US
242696511$24269651$1$I$20240820$20240826$20240830$20240830$EXP$GB-MHRA-MED-202408261304047330-GPYBV$GB-RDY-SPO/GBR/24/0012509$DR REDDYS$$45$YR$A$F$Y$85$KG$20240830$$PH$GB$GB
242696521$24269652$1$I$$20240820$20240830$20240830$EXP$$DE-RDY-LIT/DEU/24/0012403$DR REDDYS$Ritter M, Yomade O, Holtz B, Deinhardt-Emmer S, McLean AL, Hartinger S, et al. Chronic hepatitis E virus-induced spinal cord atrophy in a patient with chronic lymphatic leukemia: a case report and interdisciplinary management proposal. Frontiers in Immunology. 2024;15: 1-8. doi:10.3389/fimmu.2024.1445944.$61$YR$A$M$Y$$$20240830$$HP$DE$DE
242696531$24269653$1$I$20240101$20240816$20240830$20240830$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002382$CORCEPT$$$$$$Y$$$20240830$$HP$US$US
242696541$24269654$1$I$$20240823$20240830$20240830$EXP$$BR-GSK-BR2023AMR118950$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$HP$BR$BR
242696552$24269655$2$F$$20240830$20240830$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024103853$VIIV$$$$$M$Y$$$20240905$$HP$US$US
242696562$24269656$2$F$20240101$20240917$20240830$20240920$EXP$$US-ABBVIE-5895057$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
242696571$24269657$1$I$$20240827$20240830$20240830$PER$$US-BIOVITRUM-2024-US-011404$BIOVITRUM$$$$I$M$Y$$$20240830$$CN$US$US
242696611$24269661$1$I$20240501$20240806$20240830$20240830$DIR$FDA-CDER-CTU-2024-59798$$FDA-CTU$$24$YR$$F$N$$$20240806$N$HP$US$
242696621$24269662$1$I$20240731$20240828$20240830$20240830$DIR$FDA-CDER-CTU-2024-59878$$FDA-CTU$$51$YR$$M$N$95.25$KG$20240828$N$$US$
242696631$24269663$1$I$$20240813$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004664$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242696641$24269664$1$I$20240801$20240827$20240830$20240830$EXP$$US-ABBVIE-5898381$ABBVIE$$68$YR$$M$Y$$$20240830$$CN$US$US
242696651$24269665$1$I$$20240826$20240830$20240830$PER$$US-ABBVIE-5896709$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242696661$24269666$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172246$AMGEN$$$$$M$Y$$$20240830$$CN$US$US
242696671$24269667$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59859$$FDA-CTU$$63$YR$$F$N$72.12$KG$20240830$N$$US$
242696681$24269668$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59860$$FDA-CTU$$43$YR$$F$N$$$20240830$N$$US$
242696691$24269669$1$I$$20240823$20240830$20240830$EXP$$US-AMGEN-USASP2024169306$AMGEN$Aldoss I.; Othman T.; Koller P. et al.. Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia. British Journal of Haematology. 2024;205 (2):711-715$51$YR$A$F$Y$$$20240830$$HP$US$US
242696702$24269670$2$F$20240101$20240828$20240830$20240903$EXP$$US-ABBVIE-5832880$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242696714$24269671$4$F$20240828$20240905$20240830$20240910$EXP$$CN-JNJFOC-20240877547$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$MD$CN$CN
242696721$24269672$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59867$$FDA-CTU$$78$YR$$F$N$$$20240830$N$$US$
242696731$24269673$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59886$$FDA-CTU$$67$YR$$F$N$$$20240830$N$$US$
242696741$24269674$1$I$$20240829$20240830$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA076461$SANDOZ$$64$YR$$M$Y$$$20240830$$CN$CA$CA
242696751$24269675$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137338$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240830$$PH$US$US
242696761$24269676$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5835312$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242696772$24269677$2$F$20240626$20240910$20240830$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004665$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240920$$CN$US$US
242696781$24269678$1$I$$20240828$20240830$20240830$EXP$$US-ABBVIE-5900088$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242696791$24269679$1$I$20240828$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172428$AMGEN$$75$YR$E$F$Y$$$20240830$$CN$US$US
242696801$24269680$1$I$$20240827$20240830$20240830$EXP$$KR-AMGEN-KORSP2024170935$AMGEN$$86$YR$E$F$Y$$$20240830$$MD$KR$KR
242696811$24269681$1$I$$20240820$20240830$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024105508$VIIV$$3$DEC$$M$Y$$$20240830$$MD$US$US
242696821$24269682$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172674$AMGEN$$$$$F$Y$$$20240830$$CN$US$US
242696831$24269683$1$I$$20240827$20240830$20240830$EXP$$ZA-AstraZeneca-2024A195983$ASTRAZENECA$$61$YR$$F$Y$$$20240830$$CN$ZA$
242696841$24269684$1$I$$20240827$20240830$20240830$EXP$$JP-AstraZeneca-2024A196219$ASTRAZENECA$$$$$$Y$$$20240830$$MD$JP$
242696851$24269685$1$I$$20240822$20240830$20240830$EXP$$JP-AstraZeneca-2024A193859$ASTRAZENECA$$$$A$F$Y$$$20240830$$MD$JP$
242696861$24269686$1$I$$20240823$20240830$20240830$PER$$US-ABBVIE-5895787$ABBVIE$$$$$F$Y$$$20240830$$HP$US$US
242696871$24269687$1$I$$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195350$ASTRAZENECA$$$$$$Y$$$20240830$$CN$US$
242696881$24269688$1$I$20240101$20240828$20240830$20240830$EXP$$FI-AstraZeneca-2024A196194$ASTRAZENECA$$61$YR$$F$Y$$$20240830$$MD$FI$
242696891$24269689$1$I$$20240828$20240830$20240830$EXP$$CN-AstraZeneca-2024A197573$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$CN$
242696901$24269690$1$I$20240701$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A195803$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242696912$24269691$2$F$20240608$20240909$20240830$20240916$EXP$$JP-AstraZeneca-2024A194629$ASTRAZENECA$$87$YR$$M$Y$$$20240916$$PH$JP$
242696921$24269692$1$I$$20240822$20240830$20240830$EXP$$CA-AstraZeneca-2024A194261$ASTRAZENECA$$18$YR$$F$Y$72$KG$20240830$$MD$CA$
242696932$24269693$2$F$20240716$20240910$20240830$20240920$EXP$FR-AFSSAPS-AN2024001132$FR-TEVA-VS-3236764$TEVA$$75$YR$$M$Y$66$KG$20240920$$MD$FR$FR
242696951$24269695$1$I$20240722$20240823$20240830$20240830$PER$$CN-Eisai-EC-2024-172880$EISAI$$31$YR$A$F$Y$69$KG$20240830$$MD$CN$CN
242696962$24269696$2$F$$20240830$20240830$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004653$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242696971$24269697$1$I$$20240819$20240830$20240830$EXP$$CA-DSJP-DSJ-2024-142271$DAIICHI$$62$YR$$F$Y$$$20240830$$MD$CA$CA
242696981$24269698$1$I$$20240819$20240830$20240830$EXP$$CA-DSJP-DSJ-2024-142257$DAIICHI$$$$$F$Y$$$20240830$$CN$CA$CA
242696991$24269699$1$I$$20240819$20240830$20240830$EXP$$CA-DSJP-DSJ-2024-142280$DAIICHI$$76$YR$$F$Y$$$20240830$$CN$CA$CA
242697001$24269700$1$I$$20240819$20240830$20240830$EXP$$CA-DSJP-DSJ-2024-142279$DAIICHI$$$$$F$Y$$$20240830$$CN$CA$CA
242697011$24269701$1$I$20240731$20240827$20240830$20240830$EXP$$CN-DSJP-DSJ-2024-142503$DAIICHI$$59$YR$$F$Y$$$20240830$$HP$CN$CN
242697021$24269702$1$I$20230110$20240823$20240830$20240830$EXP$$US-BIOGEN-2024BI01280167$BIOGEN$$30$YR$$F$Y$87.09$KG$20240830$$MD$US$US
242697031$24269703$1$I$$20240825$20240830$20240830$EXP$$DE-DSJP-DSE-2023-145665$DAIICHI$$61$YR$$F$Y$$$20240830$$MD$DE$DE
242697041$24269704$1$I$$20240827$20240830$20240830$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-142834$DAIICHI$$$$$F$Y$$$20240830$$MD$US$US
242697051$24269705$1$I$$20240827$20240830$20240830$EXP$$BR-DSJP-DSE-2024-142582$DAIICHI$$36$YR$$F$Y$$$20240830$$MD$BR$BR
242697061$24269706$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5898592$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242697071$24269707$1$I$20231001$20240829$20240830$20240830$EXP$$US-PURDUE PHARMA-USA-2024-0311675$PURDUE$$31$YR$$M$Y$$$20240830$$CN$US$US
242697081$24269708$1$I$$20240829$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138175$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$90.4$KG$20240830$$HP$US$US
242697091$24269709$1$I$20240703$20240826$20240830$20240830$EXP$$CN-PURDUE-USA-2024-0311697$PURDUE$$60$YR$$M$Y$60$KG$20240830$$HP$CN$CN
242697101$24269710$1$I$$20240828$20240830$20240830$EXP$CA-HEALTHCANVIG-001094597$CA-PURDUE-USA-2024-0311680$PURDUE$$$$$M$Y$$$20240830$$CN$CA$CA
242697111$24269711$1$I$$20240828$20240830$20240830$EXP$$DE-PURDUE-USA-2024-0311698$PURDUE$Groth O, Roider G, Graw M.. Fatalities associated with failure to adjust drug dose in patients with renal insufficiency: A retrospective study at the Institute of Forensic Medicine in Munich (2019-2023).. MMW Fortschritte der Medizin. 2024;166 (13):48-51$89$YR$$M$Y$$$20240830$$HP$DE$DE
242697121$24269712$1$I$20210101$20240430$20240830$20240830$PER$$US-PERRIGO-24US004253$PERRIGO$$$$$F$Y$97.959$KG$20240830$$CN$US$US
242697131$24269713$1$I$20240407$20240418$20240830$20240830$PER$$US-PERRIGO-24US003949$PERRIGO$$69$YR$$M$Y$97.052$KG$20240830$$CN$US$US
242697141$24269714$1$I$$20240715$20240830$20240830$PER$$US-PERRIGO-24US006774$PERRIGO$$$$$M$Y$$$20240830$$CN$US$US
242697151$24269715$1$I$$20240624$20240830$20240830$PER$$US-PERRIGO-24US006077$PERRIGO$$$$$F$Y$$$20240830$$CN$US$US
242697161$24269716$1$I$20231101$20240808$20240830$20240830$PER$$US-PERRIGO-24US007524$PERRIGO$$20$YR$$F$Y$81.633$KG$20240830$$CN$US$US
242697171$24269717$1$I$20170901$20231212$20240830$20240830$PER$$US-PERRIGO-23US014263$PERRIGO$$71$YR$$F$Y$90.703$KG$20240830$$CN$US$US
242697181$24269718$1$I$20240521$20240605$20240830$20240830$PER$$US-PERRIGO-24US005495$PERRIGO$$68$YR$$F$Y$108.84$KG$20240830$$CN$US$US
242697191$24269719$1$I$20220101$20240122$20240830$20240830$PER$$US-PERRIGO-24US000758$PERRIGO$$$$$F$Y$48.526$KG$20240830$$CN$US$US
242697201$24269720$1$I$$20240318$20240830$20240830$PER$$US-PERRIGO-24US003060$PERRIGO$$$$$F$Y$$$20240830$$CN$US$US
242697211$24269721$1$I$$20231128$20240830$20240830$PER$$US-PERRIGO-23US013758$PERRIGO$$$$$$Y$$$20240830$$CN$US$US
242697221$24269722$1$I$$20231227$20240830$20240830$PER$$US-PERRIGO-23US014999$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242697231$24269723$1$I$20170818$20240430$20240830$20240830$PER$$US-PERRIGO-24US004251$PERRIGO$$31$YR$$F$Y$72.562$KG$20240830$$CN$US$US
242697241$24269724$1$I$20240103$20240103$20240830$20240830$PER$$US-PERRIGO-24US000070$PERRIGO$$74$YR$$F$Y$58.957$KG$20240830$$CN$US$US
242697251$24269725$1$I$20220101$20240812$20240830$20240830$PER$$US-PERRIGO-24US007617$PERRIGO$$$$$M$Y$77.098$KG$20240830$$CN$US$US
242697261$24269726$1$I$20170901$20231020$20240830$20240830$PER$$US-PERRIGO-23US012251$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242697271$24269727$1$I$20221001$20231020$20240830$20240830$PER$$US-PERRIGO-23US012253$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242697281$24269728$1$I$$20240828$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018379$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240830$$CN$US$US
242697291$24269729$1$I$20231001$20231018$20240830$20240830$PER$$US-PERRIGO-23US012129$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242697301$24269730$1$I$20230101$20240124$20240830$20240830$PER$$US-PERRIGO-24US000874$PERRIGO$$$$$M$Y$86.168$KG$20240830$$CN$US$US
242697311$24269731$1$I$20240101$20240826$20240830$20240830$EXP$$US-ABBVIE-5897520$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242697323$24269732$3$F$20240828$20240903$20240830$20240930$PER$$US-JNJFOC-20240877245$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240930$$PH$US$US
242697331$24269733$1$I$20240626$20240827$20240830$20240830$EXP$FR-AFSSAPS-AM2024000689$FR-ORGANON-O2408FRA001980$ORGANON$$61$YR$$F$Y$44$KG$20240830$$MD$FR$FR
242697351$24269735$1$I$$20240814$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08294$LUPIN$$$$$$Y$$$20240830$$PH$US$US
242697362$24269736$2$F$$20240902$20240830$20240905$EXP$$US-AMGEN-USASP2024171748$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242697382$24269738$2$F$20240601$20240826$20240830$20240906$EXP$$NVSC2024DE174605$NOVARTIS$$$$A$F$Y$$$20240906$$CN$DE$DE
242697391$24269739$1$I$20231101$20231121$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005902$ENDO$$$$$M$Y$$$20240830$$CN$US$US
242697401$24269740$1$I$$20240308$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2024-001314$ENDO$$$$$$Y$$$20240830$$CN$US$US
242697421$24269742$1$I$$20231219$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-006238$ENDO$$$$$F$Y$$$20240830$$CN$US$US
242697431$24269743$1$I$$20231011$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005382$ENDO$$$$$$Y$$$20240830$$CN$US$US
242697441$24269744$1$I$$20240703$20240830$20240830$PER$$US-ENDO USA, INC.-2024-002864$ENDO$$$$$F$Y$$$20240830$$CN$US$US
242697451$24269745$1$I$$20240415$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2024-001811$ENDO$$$$$M$Y$$$20240830$$CN$US$US
242697461$24269746$1$I$$20240618$20240830$20240830$PER$$US-ENDO USA, INC.-2024-002700$ENDO$$$$$F$Y$$$20240830$$CN$US$US
242697471$24269747$1$I$$20230928$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005218$ENDO$$$$$$Y$$$20240830$$CN$US$US
242697481$24269748$1$I$$20240827$20240830$20240830$PER$$US-ABBVIE-5900816$ABBVIE$$$$$$Y$$$20240830$$HP$US$US
242697491$24269749$1$I$$20231031$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005663$ENDO$$$$$$Y$$$20240830$$CN$US$US
242697501$24269750$1$I$$20231103$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005716$ENDO$$$$$$Y$$$20240830$$CN$US$US
242697511$24269751$1$I$$20231227$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-006376$ENDO$$60$YR$$F$Y$$$20240830$$CN$US$US
242697521$24269752$1$I$$20231110$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005787$ENDO$$$$$$Y$$$20240830$$CN$US$US
242697531$24269753$1$I$$20240508$20240830$20240830$PER$$US-ENDO USA, INC.-2024-002126$ENDO$$$$$$Y$$$20240830$$CN$US$US
242697541$24269754$1$I$$20230823$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004831$ENDO$$$$$F$Y$$$20240830$$CN$US$US
242697551$24269755$1$I$$20240426$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2022-001839$ENDO$$$$$$Y$$$20240830$$CN$US$US
242697561$24269756$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59882$$FDA-CTU$$62$YR$$F$N$$$20240830$N$$US$
242697571$24269757$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59875$$FDA-CTU$$72$YR$$F$N$73.48$KG$20240830$N$$US$
242697581$24269758$1$I$20230401$20230926$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005160$ENDO$$$$$$Y$$$20240830$$CN$US$US
242697591$24269759$1$I$$20240202$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2024-000881$ENDO$$$$$$Y$$$20240830$$CN$US$US
242697601$24269760$1$I$$20231211$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-006140$ENDO$$$$$F$Y$$$20240830$$CN$US$US
242697631$24269763$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59881$$FDA-CTU$$68$YR$$F$N$$$20240830$N$$US$
242697641$24269764$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59884$$FDA-CTU$$37$YR$$F$N$$$20240830$N$$US$
242697651$24269765$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59887$$FDA-CTU$$34$YR$$F$N$90.72$KG$20240830$N$$US$
242697661$24269766$1$I$$20240521$20240830$20240830$PER$$US-ENDO USA, INC.-2024-002275$ENDO$$$$$$Y$$$20240830$$CN$US$US
242697681$24269768$1$I$$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-59853$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242697691$24269769$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59898$$FDA-CTU$$36$YR$$M$N$$$20240830$N$$US$
242697701$24269770$1$I$20240826$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-59857$$FDA-CTU$$75$YR$$F$N$$$20240829$Y$PH$US$
242697711$24269771$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59885$$FDA-CTU$$61$YR$$F$N$94$KG$20240830$N$HP$US$
242697731$24269773$1$I$20240101$20240827$20240830$20240830$EXP$$FR-ABBVIE-5859127$ABBVIE$$43$YR$$M$Y$105$KG$20240830$$MD$FR$FR
242697741$24269774$1$I$$20240828$20240830$20240830$EXP$$TW-SANDOZ INC.-SDZ2024TW076086$SANDOZ$$39$YR$$M$Y$112.8$KG$20240830$$MD$TW$TW
242697751$24269775$1$I$20240828$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172801$AMGEN$$59$YR$A$F$Y$$$20240830$$CN$US$US
242697761$24269776$1$I$20240825$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171415$AMGEN$$41$YR$A$F$Y$$$20240830$$CN$US$US
242697771$24269777$1$I$$20240822$20240830$20240830$EXP$$IN-AMGEN-INDSP2024169258$AMGEN$Karmore S.; Mude G. S.. Idiopathic Thrombocytopenic Purpura (ITP) Complicated by a Hemorrhagic Ovarian Cyst and Hemoperitoneum: A Case Report. Cureus. 2024;16 (7):1-5$27$YR$A$F$Y$$$20240830$$HP$IN$IN
242697781$24269778$1$I$$20240822$20240830$20240830$EXP$$DE-TAKEDA-2024TUS085351$TAKEDA$$$$C$F$Y$$$20240830$$MD$DE$DE
242697801$24269780$1$I$$20240822$20240830$20240830$EXP$$JP-Eisai-EC-2024-172725$EISAI$Kazuhiko Yoshida. Postoperative adjuvant therapy at Tokyo Women^s Medical University. Renal cell cancer treatment Web Live Seminar.$$$A$M$Y$$$20240830$$MD$JP$JP
242697811$24269781$1$I$$20240827$20240830$20240830$EXP$$US-TAKEDA-2023TUS058105$TAKEDA$$$$$F$Y$70$KG$20240830$$HP$US$US
242697821$24269782$1$I$20240201$20240826$20240830$20240830$EXP$$US-OTSUKA-2024_018818$OTSUKA$$72$YR$$M$Y$125.19$KG$20240830$$CN$US$US
242697831$24269783$1$I$$20240822$20240830$20240830$PER$$US-RDY-SPO/USA/24/0012436$DR REDDYS$$16$YR$T$$Y$$$20240830$$MD$US$US
242697841$24269784$1$I$$20240821$20240830$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR105236$VIIV$$$$$F$Y$$$20240830$$CN$US$US
242697851$24269785$1$I$$20240820$20240830$20240830$30DAY$$US-GSK-US2024103998$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$PH$US$US
242697861$24269786$1$I$20240802$20240826$20240830$20240830$EXP$SE-SEMPA-2024-006182$SE-MYLANLABS-2024M1078783$MYLAN$$35$YR$$F$Y$56$KG$20240830$$CN$SE$SE
242697871$24269787$1$I$$20240826$20240830$20240830$PER$$US-ABBVIE-5897632$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242697881$24269788$1$I$20240401$20240829$20240830$20240830$PER$$US-JNJFOC-20240878408$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$MD$US$US
242697892$24269789$2$F$20240708$20240905$20240830$20240913$EXP$$JP-AstraZeneca-2024A171568$ASTRAZENECA$$23718$DY$$M$Y$62$KG$20240913$$MD$JP$
242697911$24269791$1$I$$20240819$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004850$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242697921$24269792$1$I$$20240822$20240830$20240830$EXP$$ZA-AstraZeneca-2024A194144$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$ZA$
242697931$24269793$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A192456$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242697941$24269794$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A193109$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242697951$24269795$1$I$20240712$20240829$20240830$20240830$EXP$$CN-AstraZeneca-2024A197273$ASTRAZENECA$$838$MON$$M$Y$$$20240830$$MD$CN$
242697961$24269796$1$I$$20240823$20240830$20240830$EXP$$ZA-AstraZeneca-2024A194462$ASTRAZENECA$$86$YR$$M$Y$$$20240830$$CN$ZA$
242697971$24269797$1$I$$20240820$20240830$20240830$PER$$US-ABBVIE-5890459$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242697981$24269798$1$I$20240801$20240826$20240830$20240830$EXP$$NVSC2024BR174848$NOVARTIS$$34$YR$$F$Y$$$20240830$$CN$BR$BR
242697991$24269799$1$I$20240101$20240815$20240830$20240830$PER$$US-009507513-2408USA005560$MERCK$$$$$F$Y$$$20240830$$HP$US$US
242698002$24269800$2$F$$20240906$20240830$20240912$EXP$$NVSC2021US318462$NOVARTIS$Currier R, Puck JM. SCID newborn screening: What we^ve learned. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2021;147:417-26$$$N$$Y$$$20240912$$HP$US$US
242698011$24269801$1$I$$20240819$20240830$20240830$EXP$$US-HLS-202400990$HLS THERAPEUTICS$$$$A$$Y$$$20240830$$MD$US$US
242698023$24269802$3$F$20240401$20240909$20240830$20240913$EXP$$JP-AstraZeneca-2024A196899$ASTRAZENECA$$97$YR$$F$Y$$$20240913$$MD$JP$
242698031$24269803$1$I$$20231127$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005965$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698041$24269804$1$I$$20240412$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2024-001784$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698051$24269805$1$I$$20231219$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-006239$ENDO$$$$$M$Y$$$20240830$$CN$US$US
242698061$24269806$1$I$$20240521$20240830$20240830$PER$$US-ENDO USA, INC.-2024-002284$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698071$24269807$1$I$$20240404$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2024-001641$ENDO$$$$$M$Y$$$20240830$$CN$US$US
242698081$24269808$1$I$$20231101$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005671$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698091$24269809$1$I$$20230911$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004999$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698101$24269810$1$I$$20230712$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004300$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698111$24269811$1$I$$20240711$20240830$20240830$PER$$US-ENDO USA, INC.-2024-002949$ENDO$$$$$M$Y$$$20240830$$CN$US$US
242698121$24269812$1$I$$20240821$20240830$20240830$PER$$US-ABBVIE-5892008$ABBVIE$$$$A$F$Y$$$20240830$$CN$US$US
242698141$24269814$1$I$20240819$20240819$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004856$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240830$$CN$US$US
242698151$24269815$1$I$$20230809$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004641$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698162$24269816$2$F$20240723$20240912$20240830$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004836$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240923$$CN$US$US
242698171$24269817$1$I$$20240822$20240830$20240830$EXP$$CA-TEVA-VS-3236648$TEVA$$81$YR$$M$Y$$$20240830$$MD$CA$CA
242698181$24269818$1$I$20240701$20240823$20240830$20240830$EXP$$JP-009507513-2408JPN003109J$MERCK$$7$DEC$$F$Y$$$20240830$$MD$JP$JP
242698191$24269819$1$I$20240101$20240826$20240830$20240830$EXP$$US-ABBVIE-5897043$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242698202$24269820$2$F$20221101$20240827$20240830$20240903$EXP$$SG-PFIZER INC-PV202400111507$PFIZER$Chua, C.. Successful rescue treatment of refractory anti-MDA5 autoantibody positive dermatomyositis with rapidly progressive interstitial lung disease using daratumumab. Clinical and Experimental Rheumatology. 2024;42(2):460-461$30$YR$$M$Y$$$20240903$$MD$SG$SG
242698211$24269821$1$I$$20240827$20240830$20240830$EXP$$ES-PFIZER INC-202400244566$PFIZER$Lobo-Antuna, V.. Rituximab-induced cystoid macular edema in a patient with systemic lupus erythematosus: A case report and literature review. Autoimmunity reviews. 2024;103588$61$YR$$F$Y$$$20240830$$HP$ES$ES
242698223$24269822$3$F$$20240902$20240830$20240910$EXP$$JP-PFIZER INC-202400246203$PFIZER$Sobue, S.. De novo hepatitis B in a patient with negative hepatitis B core antibody and high normal range hepatitis B surface antibody treated with R-CHOP therapy for Diffuse large B-cell lymphoma. Kanzo/Acta Hepatologica Japonica. 2024;65(7):336-342$8$DEC$$F$Y$51.5$KG$20240910$$MD$JP$JP
242698231$24269823$1$I$$20240826$20240830$20240830$EXP$$US-PFIZER INC-PV202400111408$PFIZER$$59$YR$$F$Y$$$20240830$$CN$US$US
242698241$24269824$1$I$20221108$20240823$20240830$20240830$EXP$$CN-PFIZER INC-PV202400110173$PFIZER$Sun, H.. Interstitial pneumonia caused by epirubicin and cyclophosphamide: a case report. Shanghai Medical + Pharmaceutical Journal. 2024;45(13):69-71$44$YR$$F$Y$$$20240830$$PH$CN$CN
242698251$24269825$1$I$20240819$20240829$20240830$20240830$PER$$US-AMGEN-USASP2024173192$AMGEN$$63$YR$A$F$Y$$$20240830$$CN$US$US
242698261$24269826$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5897432$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242698271$24269827$1$I$$20240826$20240830$20240830$EXP$$CA-ABBVIE-5895698$ABBVIE$$59$YR$$$Y$62$KG$20240830$$CN$CA$CA
242698281$24269828$1$I$$20240815$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08316$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242698291$24269829$1$I$$20240819$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004866$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240830$$CN$US$US
242698301$24269830$1$I$$20240827$20240830$20240830$PER$$US-BAYER-2024A123219$BAYER$$$$$$Y$$$20240830$$CN$US$US
242698311$24269831$1$I$$20231024$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005013$ENDO$$$$$F$Y$$$20240830$$CN$US$US
242698321$24269832$1$I$$20230803$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004572$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698331$24269833$1$I$$20240822$20240830$20240830$EXP$$CA-TEVA-VS-3236633$TEVA$$81$YR$$F$Y$$$20240830$$HP$CA$CA
242698341$24269834$1$I$20240101$20240827$20240830$20240830$PER$$US-Eisai-EC-2024-173086$EISAI$$55$YR$A$M$Y$$$20240830$$CN$US$US
242698352$24269835$2$F$$20240827$20240830$20240905$EXP$$JP-Eisai-EC-2024-173137$EISAI$$$$$M$Y$$$20240905$$MD$JP$JP
242698361$24269836$1$I$$20230829$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004901$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698371$24269837$1$I$$20230929$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005223$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698381$24269838$1$I$20230101$20240827$20240830$20240830$EXP$FR-AFSSAPS-ST2024001346$FR-Eisai-EC-2024-172960$EISAI$$77$YR$E$F$Y$44$KG$20240830$$PH$FR$FR
242698391$24269839$1$I$$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-59838$$FDA-CTU$$$$$M$N$$$20240829$N$HP$US$
242698401$24269840$1$I$20240614$20240822$20240830$20240830$EXP$$US-BAYER-2024A121409$BAYER$$66$YR$E$F$Y$$$20240830$$HP$US$US
242698411$24269841$1$I$20240801$20240827$20240830$20240830$EXP$$US-ABBVIE-5898844$ABBVIE$$35$YR$$M$Y$$$20240830$$CN$US$US
242698421$24269842$1$I$$20240827$20240830$20240830$PER$$US-BIOGEN-2024BI01278880$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
242698431$24269843$1$I$$20231019$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005521$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698441$24269844$1$I$20220101$20240827$20240830$20240830$PER$$US-BIOGEN-2024BI01266730$BIOGEN$$$$$F$Y$$$20240830$$CN$US$US
242698451$24269845$1$I$$20240516$20240830$20240830$PER$$US-ENDO USA, INC.-2024-002250$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698461$24269846$1$I$$20231110$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005794$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698471$24269847$1$I$20230101$20230823$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004840$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698481$24269848$1$I$$20231221$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-006277$ENDO$$$$$F$Y$$$20240830$$CN$US$US
242698491$24269849$1$I$20240101$20240612$20240830$20240830$PER$$US-ENDO USA, INC.-2024-002636$ENDO$$$$$F$Y$$$20240830$$CN$US$US
242698501$24269850$1$I$$20240409$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2024-001706$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698511$24269851$1$I$20230101$20231121$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-006116$ENDO$$$$$M$Y$$$20240830$$CN$US$US
242698521$24269852$1$I$$20240809$20240830$20240830$PER$$US-MYLANLABS-2024M1075060$MYLAN$$$$$F$Y$$$20240830$$CN$US$US
242698531$24269853$1$I$20240819$20240823$20240830$20240830$DIR$FDA-CDER-CTU-2024-59856$$FDA-CTU$$6$YR$$M$N$$$20240823$N$HP$US$
242698541$24269854$1$I$$20230731$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-004428$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698551$24269855$1$I$$20231117$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-005862$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698561$24269856$1$I$$20240823$20240830$20240830$EXP$$GB-MYLANLABS-2024M1079476$MYLAN$Munisamy N, Price H. Everolimus-induced diabetes. Br-J-Diabetes 2024; 24 (1): 4-5 abstr. 11.$19$YR$$M$Y$$$20240830$$HP$GB$GB
242698571$24269857$1$I$$20240816$20240830$20240830$DIR$FDA-CDER-CTU-2024-59825$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242698582$24269858$2$F$20230626$20240830$20240830$20240905$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000784$Unknown Manufacturer$$$$$$Y$$$20240904$$MD$FR$FR
242698591$24269859$1$I$$20240826$20240830$20240830$EXP$$CA-JAZZ PHARMACEUTICALS-2024-CA-013626$JAZZ$$$$$M$Y$$$20240830$$HP$CA$CA
242698601$24269860$1$I$$20240819$20240830$20240830$EXP$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01323$TARO$Schwartz AH, Sieminski S. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event. Am J Ophthalmol Case Rep. 2023;30:1-4$$$$$Y$$$20240830$$HP$US$US
242698611$24269861$1$I$20231019$20240829$20240830$20240830$EXP$$US-TAKEDA-2024TUS087245$TAKEDA$$43$YR$$F$Y$$$20240830$$HP$US$US
242698621$24269862$1$I$20230801$20240827$20240830$20240830$EXP$$CO-ABBVIE-5899410$ABBVIE$$46$YR$$F$Y$68$KG$20240830$$CN$CO$CO
242698631$24269863$1$I$$20240819$20240830$20240830$EXP$$US-HLS-202400983$HLS THERAPEUTICS$$$$A$$Y$$$20240830$$$COUNTRY NOT SPECIFIED$US
242698641$24269864$1$I$$20240828$20240830$20240830$EXP$$TW-ROCHE-10000067771$ROCHE$Tai S, Li P. Persistent Visual Loss in a 1-Eyed Patient AfterIntravenous Thrombolytic Therapy for Acute Ischemic Stroke. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024;44 (3):1-2. doi:10.1097/WNO.0000000000001891.$87$YR$E$F$Y$$$20240830$$MD$TW$TW
242698651$24269865$1$I$20240624$20240823$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408016732$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240830$$CN$US$US
242698662$24269866$2$F$$20240830$20240830$20240903$PER$$US-JNJFOC-20240878118$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242698671$24269867$1$I$$20240815$20240830$20240830$PER$$US-JNJFOC-20240842509$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240830$$CN$US$US
242698681$24269868$1$I$$20240809$20240830$20240830$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08085$LUPIN$$$$$$Y$$$20240830$$CN$US$US
242698691$24269869$1$I$$20240825$20240830$20240830$EXP$$TW-JNJFOC-20240868635$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$HP$TW$TW
242698701$24269870$1$I$20240722$20240827$20240830$20240830$EXP$FR-AFSSAPS-PB2024000879$FR-009507513-2408FRA009331$MERCK$$41$YR$$F$Y$$$20240830$$MD$FR$FR
242698711$24269871$1$I$20240727$20240819$20240830$20240830$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004870$ACADIA PHARMACEUTICALS$$95$YR$$M$Y$$$20240830$$CN$US$US
242698721$24269872$1$I$20240813$20240823$20240830$20240830$EXP$$US-BIOGEN-2024BI01280577$BIOGEN$$$$$$Y$$$20240830$$CN$US$US
242698731$24269873$1$I$$20240520$20240830$20240830$PER$$US-ENDO USA, INC.-2024-002270$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698741$24269874$1$I$$20240409$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2024-001709$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698751$24269875$1$I$$20240226$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2024-001172$ENDO$$$$$F$Y$$$20240830$$CN$US$US
242698761$24269876$1$I$20230101$20240409$20240830$20240830$PER$$US-ENDO PHARMACEUTICALS INC-2023-006136$ENDO$$$$$$Y$$$20240830$$CN$US$US
242698771$24269877$1$I$20240801$20240819$20240830$20240830$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004849$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240830$$CN$US$US
242698781$24269878$1$I$20240824$20240826$20240830$20240830$PER$$NVSC2024US173398$NOVARTIS$$30$YR$$F$Y$$$20240830$$CN$US$US
242698791$24269879$1$I$$20240823$20240830$20240830$EXP$$CA-AstraZeneca-2024A194193$ASTRAZENECA$$$$$F$Y$$$20240830$$MD$CA$
242698801$24269880$1$I$20240801$20240823$20240830$20240830$EXP$$JP-AstraZeneca-2024A194508$ASTRAZENECA$$50$YR$$F$Y$$$20240830$$MD$JP$
242698811$24269881$1$I$20240101$20240822$20240830$20240830$EXP$$JP-AstraZeneca-2024A193392$ASTRAZENECA$$$$$$Y$$$20240830$$MD$JP$
242698821$24269882$1$I$20240713$20240823$20240830$20240830$EXP$$SE-AstraZeneca-2024A198144$ASTRAZENECA$$85$YR$$F$Y$$$20240830$$HP$SE$
242698831$24269883$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A193588$ASTRAZENECA$$$$$F$Y$60.2$KG$20240830$$CN$US$
242698841$24269884$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A192528$ASTRAZENECA$$$$$M$Y$$$20240830$$HP$US$
242698851$24269885$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A194505$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242698861$24269886$1$I$$20240823$20240830$20240830$EXP$$RU-AstraZeneca-2024A192930$ASTRAZENECA$$71$YR$$F$Y$$$20240830$$CN$RU$
242698871$24269887$1$I$$20240826$20240830$20240830$EXP$$US-AstraZeneca-2024A194140$ASTRAZENECA$$$$$$Y$$$20240830$$CN$US$
242698881$24269888$1$I$$20240827$20240830$20240830$PER$$US-MYLANLABS-2024M1079510$MYLAN$$$$$F$Y$$$20240830$$HP$US$US
242698892$24269889$2$F$20240101$20240909$20240830$20240912$EXP$$US-ABBVIE-5866748$ABBVIE$$$$$M$Y$93$KG$20240912$$CN$US$US
242698901$24269890$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171609$AMGEN$$$$$F$Y$$$20240830$$MD$US$US
242698921$24269892$1$I$$20240826$20240830$20240830$EXP$$CZ-ABBVIE-5898671$ABBVIE$$$$$$Y$$$20240830$$MD$CZ$CZ
242698931$24269893$1$I$$20240828$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138513$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240830$$CN$US$US
242698941$24269894$1$I$$20240821$20240830$20240830$PER$$US-ROCHE-10000067337$ROCHE$Babette N, Newman B, Poremba M. Angioedema secondary to tenecteplase use in a patient with acute ischemic stroke: a case report. Clinical Practice and Cases in Emergency Meidcine. 2024-Aug-03;3 (8):264-7. doi:10.5881/cpcem.7190.$65$YR$E$M$Y$$$20240830$$HP$US$US
242698952$24269895$2$F$20240730$20240829$20240830$20240910$EXP$FR-AFSSAPS-TS2024000938$FR-MYLANLABS-2024M1079682$MYLAN$$61$YR$$M$Y$$$20240910$$MD$FR$FR
242698961$24269896$1$I$$20191202$20240830$20240830$EXP$$CA-Covis Pharma GmbH-2021COV22167$COVIS PHARMA$$45$YR$A$M$Y$$$20240830$$MD$CA$CA
242698971$24269897$1$I$20240813$20240814$20240830$20240830$PER$$US-Covis Pharma GmbH-2024COV01010$COVIS PHARMA$$91$YR$E$F$Y$$$20240830$$CN$US$US
242698981$24269898$1$I$$20240717$20240830$20240830$EXP$$DE-Covis Pharma GmbH-2024COV00890$COVIS PHARMA$$68$YR$E$F$Y$50$KG$20240830$$CN$DE$DE
242698992$24269899$2$F$20240819$20240830$20240830$20240903$EXP$$CO-BAYER-2024A122017$BAYER$$73$YR$E$M$Y$$$20240903$$CN$CO$CO
242699001$24269900$1$I$20240822$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-59801$$FDA-CTU$$$$$F$N$55.2$KG$20240829$N$$US$
242699011$24269901$1$I$$20240821$20240830$20240830$EXP$$CA-TEVA-VS-3237442$TEVA$$44$YR$$F$Y$70$KG$20240830$$HP$CA$CA
242699021$24269902$1$I$20240819$20240821$20240830$20240830$EXP$$US-VIIV HEALTHCARE LIMITED-US2024104433$VIIV$$69$YR$$M$Y$$$20240830$$CN$US$US
242699031$24269903$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172282$AMGEN$$$$$F$Y$$$20240830$$HP$US$US
242699041$24269904$1$I$$20240821$20240830$20240830$30DAY$$US-GSK-US2024104575$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242699051$24269905$1$I$$20240821$20240830$20240830$30DAY$$US-GSK-US2024104565$GLAXOSMITHKLINE$$$$$M$Y$$$20240830$$CN$US$US
242699061$24269906$1$I$$20240820$20240830$20240830$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024103873$VIIV$$$$$$Y$$$20240830$$MD$US$US
242699072$24269907$2$F$20240301$20240909$20240830$20240917$EXP$$US-BAYER-2024A122752$BAYER$$78$YR$E$M$Y$$$20240917$$CN$US$US
242699081$24269908$1$I$20240731$20240829$20240830$20240830$EXP$DE-AMK-279236$DE-REGENERON PHARMACEUTICALS, INC.-2024-117475$REGENERON$$78$YR$$F$Y$$$20240830$$PH$DE$DE
242699091$24269909$1$I$20240821$20240822$20240830$20240830$EXP$$PT-SMPA-2024SPA001908$SUNOVION$$$$$$Y$$$20240830$$MD$DE$DE
242699101$24269910$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5897139$ABBVIE$$$$$M$Y$$$20240830$$HP$US$US
242699111$24269911$1$I$20240101$20240823$20240830$20240830$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-013899$JAZZ$$$$$$Y$$$20240830$$MD$JP$JP
242699131$24269913$1$I$$20240822$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134610$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$147.2$KG$20240830$$CN$US$US
242699151$24269915$1$I$20230201$20240820$20240830$20240830$PER$$US-SA-2024SA252155$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240830$$$US$US
242699161$24269916$1$I$20240101$20240816$20240830$20240830$PER$$US-SA-2024SA215285$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240830$$MD$US$US
242699171$24269917$1$I$20240813$20240821$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133659$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240830$$HP$US$US
242699181$24269918$1$I$$20240827$20240830$20240830$PER$$US-ABBVIE-5899475$ABBVIE$$$$$$Y$$$20240830$$HP$US$US
242699191$24269919$1$I$$20240823$20240830$20240830$EXP$$KR-009507513-2408KOR007978$MERCK$$68$YR$$F$Y$$$20240830$$MD$KR$KR
242699202$24269920$2$F$$20240828$20240830$20240912$EXP$$JP-BAYER-2024A123902$BAYER$$69$YR$E$M$Y$$$20240912$$MD$JP$JP
242699211$24269921$1$I$$20240819$20240830$20240830$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-134521$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$96$KG$20240830$$HP$CA$CA
242699241$24269924$1$I$$20240827$20240830$20240830$PER$$US-JNJFOC-20240875125$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$MD$US$US
242699251$24269925$1$I$20240601$20240828$20240830$20240830$PER$$US-JNJFOC-20240874387$JOHNSON AND JOHNSON$$$$$M$Y$$$20240830$$HP$US$US
242699262$24269926$2$F$20240815$20240919$20240830$20240926$EXP$$JP-Eisai-EC-2024-172935$EISAI$$77$YR$E$M$Y$53.7$KG$20240926$$MD$JP$JP
242699271$24269927$1$I$$20240827$20240830$20240830$EXP$$RU-ABBVIE-5898597$ABBVIE$$51$YR$$F$Y$$$20240830$$MD$RU$RU
242699282$24269928$2$F$$20240923$20240830$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134623$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240926$$CN$US$US
242699292$24269929$2$F$$20240913$20240830$20240918$EXP$$US-AstraZeneca-2024A192614$ASTRAZENECA$$7$YR$$F$Y$$$20240918$$PH$US$
242699301$24269930$1$I$20240827$20240827$20240830$20240830$EXP$$US-AstraZeneca-2024A195352$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242699311$24269931$1$I$$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A192453$ASTRAZENECA$$$$$M$Y$$$20240830$$HP$US$
242699321$24269932$1$I$$20240828$20240830$20240830$EXP$$CA-SANDOZ INC.-SDZ2024CA076092$SANDOZ$$$$$M$Y$$$20240830$$CN$CA$CA
242699331$24269933$1$I$20240715$20240827$20240830$20240830$EXP$$US-ABBVIE-5898236$ABBVIE$$60$YR$$F$Y$$$20240830$$CN$US$US
242699341$24269934$1$I$$20240822$20240830$20240830$EXP$$PL-RDY-SPO/POL/24/0012546$DR REDDYS$Stawarz K, Galazka A, Gorzelnik A, Durzynska M, Bienkowska-Pluta K, Zwolinski J. Case report: An uncommon presentation of extramedullary plasmacytoma without a concurrent diagnosis of multiple myeloma. Frontiers in Oncology. 2024;14: 1-7. doi:10.3389/fonc.2024.1353943.$72$YR$E$M$Y$$$20240830$$HP$PL$PL
242699351$24269935$1$I$20160601$20240828$20240830$20240830$EXP$$GB-SANDOZ INC.-NVSC2020GB220229$SANDOZ$$58$YR$$M$Y$$$20240830$$MD$GB$GB
242699362$24269936$2$F$20240801$20240910$20240830$20240917$PER$$US-TAKEDA-2024TUS087374$TAKEDA$$47$YR$$M$Y$$$20240917$$MD$US$US
242699372$24269937$2$F$20240804$20240903$20240830$20240906$EXP$$EG-AstraZeneca-2024A195814$ASTRAZENECA$$26800$DY$$F$Y$$$20240906$$CN$EG$
242699381$24269938$1$I$20240822$20240826$20240830$20240830$PER$$US-BAYER-2024A122409$BAYER$$25$YR$A$F$Y$$$20240830$$MD$US$US
242699391$24269939$1$I$20210401$20240826$20240830$20240830$EXP$$CA-TAKEDA-2024TUS087407$TAKEDA$$60$YR$$F$Y$$$20240830$$HP$CA$CA
242699402$24269940$2$F$$20240902$20240830$20240903$EXP$$GR-PFIZER INC-202400246275$PFIZER$Verrou, E.. Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.. Hematological Oncology. 2024;45(5):1-7$96$YR$$F$Y$$$20240903$$MD$GR$GR
242699421$24269942$1$I$$20240829$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408018870$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240830$$CN$US$US
242699441$24269944$1$I$$20240823$20240830$20240830$EXP$$US-AstraZeneca-2024A197825$ASTRAZENECA$$$$$F$Y$$$20240830$$MD$US$
242699454$24269945$4$F$$20240909$20240830$20240912$EXP$$IN-PFIZER INC-202400246269$PFIZER$Anandan, S.. A very rare side effect of a very commonly used drug: pantoprazole-induced seizure. The Journal of the Association of Physicians of India. 2024;72(8):89$69$YR$$F$Y$$$20240912$$HP$IN$IN
242699461$24269946$1$I$$20240823$20240830$20240830$DIR$FDA-CDER-CTU-2024-59858$$FDA-CTU$$$$$M$N$$$20240823$N$HP$US$
242699472$24269947$2$F$$20240829$20240830$20240903$EXP$$CA-PFIZER INC-PV202400111530$PFIZER$Briard, J.. Refractory Status Epilepticus in a Patient With Aducanumab-Induced Amyloid-Related Imaging Abnormalities. Neurology. 2024;103(5):e209582(1)-e209582(5)$75$YR$$F$Y$$$20240903$$MD$CA$CA
242699481$24269948$1$I$$20240822$20240830$20240830$EXP$$CA-AstraZeneca-2024A193583$ASTRAZENECA$$65$YR$$F$Y$$$20240830$$MD$CA$
242699501$24269950$1$I$$20240624$20240830$20240830$EXP$$CA-PFIZER INC-202400245349$PFIZER$$40$YR$$F$Y$$$20240830$$HP$CA$CA
242699511$24269951$1$I$$20240828$20240830$20240830$EXP$$PL-GILEAD-2024-0685326$GILEAD$$64$YR$A$F$Y$$$20240830$$MD$PL$PL
242699521$24269952$1$I$20240401$20240824$20240830$20240830$EXP$GB-MHRA-MED-202408241631166090-PDJYF$GB-TEVA-VS-3237248$TEVA$$41$YR$$M$Y$70$KG$20240830$$CN$GB$GB
242699531$24269953$1$I$$20240828$20240830$20240830$EXP$$GB-SANDOZ INC.-NVSC2021GB089243$SANDOZ$$$$$F$Y$$$20240830$$CN$GB$GB
242699541$24269954$1$I$$20240820$20240830$20240830$EXP$$US-BAYER-2024A123698$BAYER$Muddasani R.; Talwar N.; Mambetsariev I.; Fricke J.; Lin M.; Schmolze D.; Yue A.; Rizvi A.; Salgia R.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73:10:Article Number: 200$49$YR$A$F$Y$$$20240830$$HP$US$US
242699551$24269955$1$I$$20240826$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137558$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240830$$MD$US$US
242699561$24269956$1$I$$20240828$20240830$20240830$PER$$US-JNJFOC-20240873596$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$PH$US$US
242699571$24269957$1$I$$20240826$20240830$20240830$EXP$$CA-TAKEDA-2024TUS086535$TAKEDA$$$$$M$Y$$$20240830$$CN$CA$CA
242699581$24269958$1$I$20240701$20240827$20240830$20240830$EXP$$US-INCYTE CORPORATION-2024IN009019$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242699591$24269959$1$I$$20240819$20240830$20240830$EXP$$CA-IMP-2024000677$Harrow Health$$12$MON$I$M$Y$$$20240830$$CN$CA$CA
242699602$24269960$2$F$20180803$20240924$20240830$20240927$EXP$$US-INCYTE CORPORATION-2024IN009024$INCYTE$$$$$$Y$$$20240927$$CN$US$US
242699611$24269961$1$I$20240801$20240823$20240830$20240830$EXP$$US-ABBVIE-5895306$ABBVIE$$63$YR$$F$Y$$$20240830$$CN$US$US
242699621$24269962$1$I$20240614$20240827$20240830$20240830$EXP$$NVSC2024US126662$NOVARTIS$$50$YR$$M$Y$$$20240830$$CN$US$US
242699631$24269963$1$I$20240801$20240826$20240830$20240830$EXP$$US-ABBVIE-5897002$ABBVIE$$54$YR$$F$Y$$$20240830$$CN$US$US
242699641$24269964$1$I$$20240828$20240830$20240830$EXP$$CN-TAKEDA-2024TUS087166$TAKEDA$$$$$M$Y$$$20240830$$CN$CN$CN
242699651$24269965$1$I$20240601$20240823$20240830$20240830$PER$$US-Eisai-EC-2024-170003$EISAI$$63$YR$A$F$Y$$$20240830$$CN$US$US
242699661$24269966$1$I$20240826$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024170094$AMGEN$$54$YR$A$M$Y$$$20240830$$CN$US$US
242699671$24269967$1$I$20220901$20240828$20240830$20240830$EXP$$JP-FreseniusKabi-FK202413126$FRESENIUS KABI$$5$DEC$A$F$Y$46$KG$20240830$$MD$JP$JP
242699681$24269968$1$I$$20240828$20240830$20240830$EXP$$KR-INCYTE CORPORATION-2024IN009178$INCYTE$$$$$$Y$$$20240830$$CN$KR$KR
242699691$24269969$1$I$$20240828$20240830$20240830$EXP$$EG-TAKEDA-2024TUS087088$TAKEDA$$$$$F$Y$$$20240830$$MD$EG$EG
242699722$24269972$2$F$20240801$20240910$20240830$20240918$EXP$$JP-TEVA-VS-3237204$TEVA$$57$YR$$F$Y$$$20240918$$CN$JP$JP
242699731$24269973$1$I$$20240826$20240830$20240830$EXP$$IE-ABBVIE-5901225$ABBVIE$$$$E$F$Y$$$20240830$$CN$IE$IE
242699741$24269974$1$I$$20240827$20240830$20240830$EXP$$NVSC2023CA250381$NOVARTIS$$60$YR$$M$Y$$$20240830$$HP$CA$CA
242699751$24269975$1$I$20240820$20240821$20240830$20240830$PER$$US-ABBVIE-5891659$ABBVIE$$43$YR$$F$Y$$$20240830$$CN$US$US
242699761$24269976$1$I$20240731$20240815$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130244$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240830$$PH$US$US
242699771$24269977$1$I$20240601$20240819$20240830$20240830$EXP$$US-BAYER-2024A097774$BAYER$$32$YR$A$M$Y$$$20240830$$CN$US$US
242699782$24269978$2$F$$20240824$20240830$20240903$EXP$$AU-ABBVIE-5899071$ABBVIE$$$$$F$Y$$$20240903$$CN$AU$AU
242699791$24269979$1$I$$20240819$20240830$20240830$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-132660$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240830$$HP$CA$CA
242699801$24269980$1$I$20240828$20240828$20240830$20240830$EXP$$AE-ABBVIE-5898725$ABBVIE$$59$YR$$F$Y$$$20240830$$HP$AE$AE
242699822$24269982$2$F$$20240909$20240830$20240910$EXP$$US-TAKEDA-2024TUS086988$TAKEDA$$$$$F$Y$$$20240910$$CN$US$US
242699832$24269983$2$F$$20240822$20240830$20240909$EXP$$AT-BAYER-2024A122299$BAYER$$73$YR$E$$Y$$$20240909$$HP$AT$AT
242699841$24269984$1$I$20240829$20240829$20240830$20240830$EXP$$US-DSJP-DSU-2024-142836$DAIICHI$$52$YR$$F$Y$$$20240830$$HP$US$US
242699851$24269985$1$I$$20240828$20240830$20240830$EXP$$CA-AstraZeneca-2024A163676$ASTRAZENECA$$$$$F$Y$67.7$KG$20240830$$MD$CA$
242699862$24269986$2$F$$20240828$20240830$20240830$PER$$US-GILEAD-2024-0685672$GILEAD$$$$$$Y$$$20240830$$CN$US$US
242699871$24269987$1$I$20240816$20240828$20240830$20240830$EXP$$US-ABBVIE-5900098$ABBVIE$$84$YR$$M$Y$$$20240830$$CN$US$US
242699891$24269989$1$I$20240618$20240823$20240830$20240830$EXP$$CA-OTSUKA-2024_019057$OTSUKA$$$$$$Y$$$20240830$$HP$CA$CA
242699901$24269990$1$I$$20240823$20240830$20240830$EXP$$US-FreseniusKabi-FK202413161$FRESENIUS KABI$Cheney A, Krieger E, Dardas T, Vincent L. FROM MULTIPLE MYELOMA TO MYOCARDITIS. Journal of the American College of Cardiology. 2019 Mar 12;73(9): doi:https://doi.org/10.1016/S0735-1097(19)33203-6.$53$YR$A$M$Y$$$20240830$$HP$US$US
242699911$24269991$1$I$20240601$20240826$20240830$20240830$PER$$US-ABBVIE-5897860$ABBVIE$$70$YR$$M$Y$$$20240830$$CN$US$US
242699921$24269992$1$I$$20240827$20240830$20240830$EXP$$CA-FreseniusKabi-FK202413184$FRESENIUS KABI$$3$YR$C$F$Y$15$KG$20240830$$HP$CA$CA
242699931$24269993$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5901144$ABBVIE$$$$$F$Y$$$20240830$$MD$US$US
242699941$24269994$1$I$$20240823$20240830$20240830$EXP$$PT-AMGEN-ESPSP2024169467$AMGEN$$$$$F$Y$$$20240830$$MD$PT$PT
242699951$24269995$1$I$20240101$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172254$AMGEN$$63$YR$A$M$Y$$$20240830$$CN$US$US
242699961$24269996$1$I$$20240827$20240830$20240830$PER$$US-ABBVIE-5899344$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242699971$24269997$1$I$20240822$20240822$20240830$20240830$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-013897$JAZZ$$44$YR$$F$Y$$$20240830$$HP$JP$JP
242699981$24269998$1$I$20240814$20240828$20240830$20240830$EXP$$US-KYOWAKIRIN-2024KK020315$KYOWA$$$$$$Y$$$20240830$$HP$US$US
242699992$24269999$2$F$$20240907$20240830$20240911$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018728$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240911$$CN$US$US
242700001$24270000$1$I$20240112$20240820$20240830$20240830$EXP$FR-AFSSAPS-LL2024001576$FR-ELI_LILLY_AND_COMPANY-FR202408013255$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240830$$CN$FR$FR
242700011$24270001$1$I$20240803$20240820$20240830$20240830$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408017391$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240830$$CN$DE$CN
242700021$24270002$1$I$$20240820$20240830$20240830$EXP$$ZA-ELI_LILLY_AND_COMPANY-ZA202408012893$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240830$$CN$ZA$ZA
242700031$24270003$1$I$$20240820$20240830$20240830$EXP$$AR-ELI_LILLY_AND_COMPANY-AR202408019019$ELI LILLY AND CO$$55$YR$A$$Y$$$20240830$$CN$DE$AR
242700041$24270004$1$I$20240703$20240819$20240830$20240830$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202408012116$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240830$$CN$IT$IT
242700051$24270005$1$I$$20240820$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408013238$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240830$$CN$US$US
242700061$24270006$1$I$$20240821$20240830$20240830$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202408017082$ELI LILLY AND CO$$21$YR$A$M$Y$$$20240830$$MD$IN$IN
242700071$24270007$1$I$20230401$20240825$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408017648$ELI LILLY AND CO$Burrows JT, Lantz R..Chronic Use of Abemaciclib Leading to Breathlessness and Demise: A Case Report.Cureus 2024;16(7):e64774.DOI:https://dx.doi.org/10.7759/cureus.64774$85$YR$E$F$Y$$$20240830$$MD$US$US
242700081$24270008$1$I$20240726$20240819$20240830$20240830$EXP$IT-MINISAL02-999386$IT-ELI_LILLY_AND_COMPANY-IT202408012120$ELI LILLY AND CO$$76$YR$E$F$Y$55$KG$20240830$$CN$IT$IT
242700091$24270009$1$I$20240806$20240821$20240830$20240830$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408013814$ELI LILLY AND CO$$57$YR$A$M$Y$54$KG$20240830$$CN$CN$CN
242700101$24270010$1$I$20240701$20240819$20240830$20240830$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408013177$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$FR$FR
242700111$24270011$1$I$20230808$20240819$20240830$20240830$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408012273$ELI LILLY AND CO$$$$A$M$Y$$$20240830$$CN$DE$DE
242700121$24270012$1$I$20240525$20240829$20240830$20240830$EXP$$CH-GILEAD-2024-0685788$GILEAD$$65$YR$E$F$Y$$$20240830$$MD$CH$CH
242700132$24270013$2$F$20240101$20240829$20240830$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138462$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240902$$CN$US$US
242700141$24270014$1$I$$20240820$20240830$20240830$EXP$$KR-JNJFOC-20240855651$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240830$$HP$KR$KR
242700151$24270015$1$I$20240801$20240826$20240830$20240830$EXP$$DE-MYLANLABS-2024M1078808$MYLAN$$$$$$Y$$$20240830$$CN$DE$DE
242700164$24270016$4$F$20231227$20240923$20240830$20240926$EXP$$AR-MYLANLABS-2024M1000621$MYLAN$$26$YR$$M$Y$$$20240926$$CN$AR$AR
242700171$24270017$1$I$20240101$20240826$20240830$20240830$EXP$$FR-MYLANLABS-2024M1078781$MYLAN$$76$YR$$F$Y$$$20240830$$CN$FR$FR
242700181$24270018$1$I$20240701$20240826$20240830$20240830$EXP$$FR-MYLANLABS-2024M1078675$MYLAN$$67$YR$$M$Y$$$20240830$$MD$FR$FR
242700192$24270019$2$F$$20240905$20240830$20240910$PER$$US-AMGEN-USASP2024171428$AMGEN$$$$$F$Y$$$20240910$$MD$US$US
242700202$24270020$2$F$$20240829$20240830$20240902$PER$$NVSC2024US175415$NOVARTIS$$$$$F$Y$66.667$KG$20240902$$CN$US$US
242700211$24270021$1$I$$20240829$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138362$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240830$$CN$US$US
242700221$24270022$1$I$20240527$20240828$20240830$20240830$EXP$FR-AFSSAPS-DJ2024000892$FR-MYLANLABS-2024M1079410$MYLAN$$65$YR$$M$Y$66$KG$20240830$$MD$FR$FR
242700231$24270023$1$I$$20240819$20240830$20240830$EXP$CA-IMP-2024000668$CA-IMP-2024000668$Harrow Health$$14$YR$T$M$Y$$$20240830$$PH$CA$CA
242700241$24270024$1$I$$20240827$20240830$20240830$EXP$GB-MHRA-MED-202408271052594920-GHCNB$GB-RDY-SPO/GBR/24/0012599$DR REDDYS$$25$YR$A$M$Y$$$20240830$$MD$GB$GB
242700251$24270025$1$I$$20240827$20240830$20240830$EXP$$US-INCYTE CORPORATION-2024IN007434$INCYTE$$$$$$Y$$$20240830$$CN$US$US
242700261$24270026$1$I$$20240829$20240830$20240830$EXP$$US-GILEAD-2024-0685794$GILEAD$$31$YR$A$M$Y$$$20240830$$CN$US$US
242700271$24270027$1$I$$20240823$20240830$20240830$EXP$$US-KYOWA KIRIN , INC.-2024KK019827$KYOWA$Paloian NJ, Boyke-Lohmann LR, Steiner RD. X-linked hypophosphatemic rickets and nephrocalcinosis: clinical characteristics of a single-center pediatric cohort in North America before and after burosumab. Frontiers in Pediatrics. 2024;12:01-07$$$$$Y$$$20240830$$HP$US$US
242700282$24270028$2$F$20240716$20240910$20240830$20240913$EXP$$BR-009507513-2408BRA010081$MERCK$$30$YR$$M$Y$75.6$KG$20240913$$PH$BR$BR
242700302$24270030$2$F$$20240911$20240830$20240918$EXP$$CA-TEVA-VS-3236658$TEVA$$31$MON$$$Y$$$20240918$$HP$CA$CA
242700311$24270031$1$I$$20240822$20240830$20240830$PER$$US-JNJFOC-20240865379$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242700321$24270032$1$I$$20240816$20240830$20240830$EXP$$US-HLS-202400943$HLS THERAPEUTICS$$$$A$$Y$$$20240830$$PH$US$US
242700331$24270033$1$I$$20240829$20240830$20240830$PER$$US-HALEON-2194316$Haleon PLC$$48$YR$$F$Y$$$20240830$$CN$US$US
242700341$24270034$1$I$$20240823$20240830$20240830$EXP$$US-APELLIS-2024-APL-0000783$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240830$$MD$US$US
242700351$24270035$1$I$$20240822$20240830$20240830$EXP$$CA-TEVA-VS-3236802$TEVA$$65$YR$$F$Y$$$20240830$$HP$CA$CA
242700361$24270036$1$I$$20240822$20240830$20240830$EXP$$CA-TEVA-VS-3236599$TEVA$$43$YR$$F$Y$70$KG$20240830$$HP$CA$CA
242700371$24270037$1$I$20240801$20240822$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133986$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$104.33$KG$20240830$$CN$US$US
242700391$24270039$1$I$$20240822$20240830$20240830$EXP$$CA-TEVA-VS-3236794$TEVA$$30$YR$$M$Y$$$20240830$$HP$CA$CA
242700421$24270042$1$I$20240822$20240827$20240830$20240830$PER$$CN-Eisai-EC-2024-173044$EISAI$$58$YR$A$F$Y$50$KG$20240830$$HP$CN$CN
242700431$24270043$1$I$20240101$20240826$20240830$20240830$PER$$JP-Eisai-EC-2024-171365$EISAI$$$$E$M$Y$$$20240830$$MD$JP$JP
242700441$24270044$1$I$20240101$20240827$20240830$20240830$EXP$$US-ALKERMES INC.-ALK-2024-002237$ALKERMES$$$$$F$Y$$$20240830$$HP$US$US
242700451$24270045$1$I$$20240821$20240830$20240830$PER$$US-JNJFOC-20240856614$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242700462$24270046$2$F$20240802$20240902$20240830$20240902$EXP$PT-INFARMED-B202408-115$PT-009507513-2408PRT007629$MERCK$$15$YR$$M$Y$37$KG$20240902$$MD$PT$PT
242700472$24270047$2$F$20200101$20240828$20240830$20240904$EXP$$US-ABBVIE-5857871$ABBVIE$$$$$F$Y$113$KG$20240904$$CN$US$US
242700481$24270048$1$I$20231226$20240828$20240830$20240830$EXP$$US-KYOWAKIRIN-2024KK020285$KYOWA$$$$$$Y$$$20240830$$HP$US$US
242700491$24270049$1$I$20240801$20240827$20240830$20240830$EXP$FR-AFSSAPS-AVLL2024000215$FR-MYLANLABS-2024M1079193$MYLAN$$21$YR$$F$Y$$$20240830$$CN$FR$FR
242700501$24270050$1$I$20140101$20240827$20240830$20240830$EXP$$NL-SANDOZ INC.-NVSC2016NL006689$SANDOZ$$67$YR$$F$Y$$$20240830$$HP$NL$NL
242700512$24270051$2$F$20240828$20240914$20240830$20240915$PER$$US-ALXN-202408USA001988US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$MD$US$US
242700521$24270052$1$I$20240808$20240823$20240830$20240830$PER$$US-ALKERMES INC.-ALK-2024-002222$ALKERMES$$63$YR$$M$Y$$$20240830$$CN$US$US
242700531$24270053$1$I$$20240821$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408014119$ELI LILLY AND CO$$$$$$Y$$$20240830$$CN$US$US
242700541$24270054$1$I$20230101$20240804$20240830$20240830$EXP$$US-APELLIS-2024-APL-0000636$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240830$$CN$US$US
242700561$24270056$1$I$20240822$20240822$20240830$20240830$PER$$US-SA-2024SA252219$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240830$$CN$US$US
242700571$24270057$1$I$20200816$20240821$20240830$20240830$EXP$DE-CADRBFARM-2022291021$DE-TEVA-2022-DE-2031667$TEVA$$28$YR$$M$Y$83$KG$20240830$$CN$DE$DE
242700581$24270058$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136708$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$107.05$KG$20240830$$CN$US$US
242700591$24270059$1$I$20240101$20240807$20240830$20240830$PER$$US-Eisai-EC-2024-171728$EISAI$$$$$F$Y$$$20240830$$CN$US$US
242700601$24270060$1$I$$20240824$20240830$20240830$EXP$$US-JNJFOC-20240865883$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242700611$24270061$1$I$20240501$20240828$20240830$20240830$PER$$CN-Eisai-EC-2024-173311$EISAI$$62$YR$A$F$Y$55.4$KG$20240830$$HP$CN$CN
242700622$24270062$2$F$20240101$20240924$20240830$20240930$PER$$US-Eisai-EC-2024-171816$EISAI$$77$YR$E$M$Y$$$20240930$$CN$US$US
242700633$24270063$3$F$$20240913$20240830$20240923$EXP$$IT-TEVA-VS-3238005$TEVA$Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports. Journal of pediatric hematology/oncology. 2024. DOI:10.1097/MPH.0000000000002904.; Muggeo P, Sinisi C, Angarano R, Daniele RM, Grassi M, Ingravallo G, et al. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and C...$13$YR$$M$Y$$$20240923$$MD$IT$IT
242700641$24270064$1$I$20240724$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59635$$FDA-CTU$$74$YR$$M$N$$$20240829$Y$PH$US$
242700651$24270065$1$I$$20240821$20240830$20240830$PER$$US-SA-2024SA252308$SANOFI AVENTIS$$$$C$M$Y$$$20240830$$HP$US$US
242700661$24270066$1$I$$20240827$20240830$20240830$PER$$US-ABBVIE-5899039$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242700671$24270067$1$I$20240808$20240830$20240829$20240829$DIR$FDA-CDER-CTU-2024-59728$$FDA-CTU$$27$YR$$F$N$68$KG$20240830$N$$US$
242700681$24270068$1$I$20240826$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59730$$FDA-CTU$$75$YR$$F$N$$$20240829$Y$PH$US$
242700701$24270070$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59933$$FDA-CTU$$56$YR$$F$N$$$20240829$N$$US$
242700711$24270071$1$I$$20240826$20240830$20240830$PER$$US-ABBVIE-5896523$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242700721$24270072$1$I$$20240821$20240830$20240830$EXP$$CA-TEVA-VS-3235874$TEVA$$69$YR$$F$Y$$$20240830$$HP$CA$CA
242700731$24270073$1$I$20231028$20231030$20240830$20240830$PER$$US-PERRIGO-23US012576$PERRIGO$$87$YR$$F$Y$52.154$KG$20240830$$CN$US$US
242700741$24270074$1$I$20230901$20231001$20240830$20240830$PER$$US-PERRIGO-23US011642$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700751$24270075$1$I$20230801$20230823$20240830$20240830$PER$$US-PERRIGO-23US009446$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700761$24270076$1$I$20230901$20230907$20240830$20240830$PER$$US-PERRIGO-23US010814$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700771$24270077$1$I$20230821$20230823$20240830$20240830$PER$$US-PERRIGO-23US009504$PERRIGO$$$$E$F$Y$68.027$KG$20240830$$CN$US$US
242700781$24270078$1$I$20230901$20230919$20240830$20240830$PER$$US-PERRIGO-23US011161$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700791$24270079$1$I$20231106$20231109$20240830$20240830$PER$$US-PERRIGO-23US012945$PERRIGO$$78$YR$$M$Y$81.633$KG$20240830$$CN$US$US
242700801$24270080$1$I$20231020$20231011$20240830$20240830$PER$$US-PERRIGO-23US012149$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700811$24270081$1$I$$20240828$20240830$20240830$PER$$US-ALXN-202408USA002030US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$HP$US$US
242700822$24270082$2$F$20230301$20240903$20240830$20240909$EXP$$FR-009507513-2408FRA009472$MERCK$Roussot N, Thibaudin M, Fumet JD, Daumoine S, Hampe L, Rebe C, et al. Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC. Frontiers in Immunology. 2024;15$$$A$F$Y$$$20240909$$HP$FR$FR
242700831$24270083$1$I$20240202$20240202$20240830$20240830$PER$$US-PERRIGO-24US001292$PERRIGO$$82$YR$$F$Y$103.4$KG$20240830$$CN$US$US
242700841$24270084$1$I$20240402$20240401$20240830$20240830$PER$$US-PERRIGO-24US003391$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700851$24270085$1$I$$20240303$20240830$20240830$PER$$US-PERRIGO-24US002366$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700861$24270086$1$I$$20231109$20240830$20240830$PER$$US-PERRIGO-23US013048$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700871$24270087$1$I$20240101$20240411$20240830$20240830$PER$$US-PERRIGO-24US003598$PERRIGO$$$$$$Y$54.422$KG$20240830$$CN$US$US
242700881$24270088$1$I$$20240614$20240830$20240830$PER$$US-PERRIGO-24US005866$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700891$24270089$1$I$$20231205$20240830$20240830$PER$$US-PERRIGO-23US013960$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700901$24270090$1$I$$20240303$20240830$20240830$PER$$US-PERRIGO-24US002376$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700911$24270091$1$I$$20240506$20240830$20240830$PER$$US-PERRIGO-24US004474$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700921$24270092$1$I$$20231204$20240830$20240830$PER$$US-PERRIGO-23US013931$PERRIGO$$$$$F$Y$$$20240830$$CN$US$US
242700931$24270093$1$I$$20240422$20240830$20240830$PER$$US-PERRIGO-24US003999$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700941$24270094$1$I$20240212$20240212$20240830$20240830$PER$$US-PERRIGO-24US001593$PERRIGO$$$$$$Y$$$20240830$$CN$US$US
242700951$24270095$1$I$$20240210$20240830$20240830$PER$$US-PERRIGO-24US001613$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700961$24270096$1$I$$20231231$20240830$20240830$PER$$US-PERRIGO-23US015050$PERRIGO$$$$A$$Y$$$20240830$$CN$US$US
242700971$24270097$1$I$20240415$20240415$20240830$20240830$PER$$US-PERRIGO-24US003729$PERRIGO$$85$YR$$M$Y$86.621$KG$20240830$$CN$US$US
242700981$24270098$1$I$20240218$20240221$20240830$20240830$PER$$US-PERRIGO-24US001904$PERRIGO$$74$YR$$F$Y$75.283$KG$20240830$$CN$US$US
242700991$24270099$1$I$20240119$20240126$20240830$20240830$PER$$US-PERRIGO-24US000970$PERRIGO$$66$YR$$M$Y$88.435$KG$20240830$$CN$US$US
242701001$24270100$1$I$20240519$20240522$20240830$20240830$PER$$US-PERRIGO-24US005040$PERRIGO$$92$YR$$F$Y$71.655$KG$20240830$$CN$US$US
242701012$24270101$2$F$$20240910$20240830$20240916$EXP$$NVSC2024CA173932$NOVARTIS$$$$$M$Y$$$20240916$$HP$CA$CA
242701021$24270102$1$I$$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137409$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240830$$MD$US$US
242701031$24270103$1$I$20240827$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137836$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$67.59$KG$20240830$$HP$US$US
242701041$24270104$1$I$20231101$20240821$20240830$20240830$EXP$FR-AFSSAPS-LY2024001220$FR-TEVA-VS-3236001$TEVA$$28$YR$$M$Y$$$20240830$$MD$FR$FR
242701051$24270105$1$I$20240703$20240703$20240830$20240830$PER$$US-PERRIGO-24US006338$PERRIGO$$66$YR$$M$Y$77.098$KG$20240830$$CN$US$US
242701061$24270106$1$I$$20240821$20240830$20240830$PER$$US-ABBVIE-5892102$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242701071$24270107$1$I$20240806$20240822$20240830$20240830$EXP$ES-AEMPS-1561852$ES-HIKMA PHARMACEUTICALS USA INC.-ES-H14001-24-08020$HIKMA$$$$$$Y$$$20240830$$PH$ES$ES
242701081$24270108$1$I$20240101$20240816$20240830$20240830$PER$$US-SA-2024SA184367$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240830$$CN$US$US
242701091$24270109$1$I$20240822$20240827$20240830$20240830$PER$$US-PFIZER INC-202400246264$PFIZER$$65$YR$$F$Y$$$20240830$$HP$US$US
242701101$24270110$1$I$20240801$20240828$20240830$20240830$PER$$US-BAUSCH-BL-2024-013090$BAUSCH AND LOMB$$80$YR$$M$Y$$$20240830$$CN$US$US
242701111$24270111$1$I$20230801$20240829$20240830$20240830$EXP$$DE-BAUSCH-BL-2024-013102$BAUSCH AND LOMB$$$$$M$Y$2.535$KG$20240830$$MD$DE$DE
242701121$24270112$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245071$PFIZER$$70$YR$$F$Y$$$20240830$$MD$US$US
242701131$24270113$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245873$PFIZER$$12$YR$$F$Y$$$20240830$$HP$US$US
242701141$24270114$1$I$20240828$20240828$20240830$20240830$PER$$US-PFIZER INC-202400245910$PFIZER$$75$YR$$F$Y$$$20240830$$MD$US$US
242701151$24270115$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-202400245934$PFIZER$$52$YR$$F$Y$$$20240830$$MD$US$US
242701171$24270117$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245806$PFIZER$$65$YR$$M$Y$$$20240830$$MD$US$US
242701181$24270118$1$I$20240829$20240829$20240830$20240830$PER$$US-PFIZER INC-202400246830$PFIZER$$75$YR$$F$Y$$$20240830$$CN$US$US
242701193$24270119$3$F$20230101$20240919$20240830$20240924$PER$$US-PFIZER INC-PV202300150159$PFIZER$$59$YR$$F$Y$63.5$KG$20240924$$CN$US$US
242701201$24270120$1$I$$20240829$20240830$20240830$PER$$US-PFIZER INC-202400246880$PFIZER$$57$YR$$M$Y$$$20240830$$MD$US$US
242701211$24270121$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-202400245917$PFIZER$$41$YR$$F$Y$$$20240830$$MD$US$US
242701222$24270122$2$F$$20240830$20240830$20240904$PER$$US-PFIZER INC-PV202400113462$PFIZER$$74$YR$$F$Y$$$20240904$$HP$US$US
242701231$24270123$1$I$20240827$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245134$PFIZER$$29$YR$$M$Y$$$20240830$$CN$US$US
242701241$24270124$1$I$$20240827$20240830$20240830$PER$$US-PFIZER INC-202400246864$PFIZER$$78$YR$$F$Y$$$20240830$$CN$US$US
242701251$24270125$1$I$$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246529$PFIZER$$14$YR$$F$Y$$$20240830$$HP$US$US
242701261$24270126$1$I$20240801$20240828$20240830$20240830$PER$$US-PFIZER INC-202400245988$PFIZER$$51$YR$$F$Y$$$20240830$$PH$US$US
242701271$24270127$1$I$20240827$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246272$PFIZER$$58$YR$$M$Y$$$20240830$$HP$US$US
242701281$24270128$1$I$20240828$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246004$PFIZER$$63$YR$$F$Y$$$20240830$$CN$US$US
242701291$24270129$1$I$20240826$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246011$PFIZER$$72$YR$$$Y$$$20240830$$CN$US$US
242701301$24270130$1$I$$20240829$20240830$20240830$PER$$US-PFIZER INC-202400247262$PFIZER$$37$YR$$F$Y$$$20240830$$CN$US$US
242701311$24270131$1$I$20240801$20240826$20240830$20240830$PER$$US-PFIZER INC-202400243865$PFIZER$$70$YR$$F$Y$81.65$KG$20240830$$CN$US$US
242701321$24270132$1$I$20240801$20240827$20240830$20240830$PER$$US-PFIZER INC-202400245178$PFIZER$$52$YR$$F$Y$$$20240830$$HP$US$US
242701331$24270133$1$I$20240827$20240829$20240830$20240830$PER$$US-PFIZER INC-202400247120$PFIZER$$68$YR$$F$Y$$$20240830$$CN$US$US
242701351$24270135$1$I$20240829$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59957$$FDA-CTU$$45$YR$$F$N$$$20240829$N$PH$US$
242701362$24270136$2$F$$20240924$20240830$20240926$PER$$US-PFIZER INC-202400245176$PFIZER$$42$YR$$F$Y$$$20240926$$MD$US$US
242701371$24270137$1$I$20240801$20240828$20240830$20240830$PER$$US-PFIZER INC-202400246860$PFIZER$$16$YR$$F$Y$$$20240830$$CN$US$US
242701381$24270138$1$I$$20240829$20240830$20240830$PER$$US-PFIZER INC-PV202400113477$PFIZER$$69$YR$$F$Y$$$20240830$$HP$US$US
242701391$24270139$1$I$$20240828$20240830$20240830$PER$$JP-Eisai-EC-2024-173296$EISAI$Arisa Kodama ,et al.. Experience and considerations of Lenvatinib and Pembrolizumab therapy. Endometrial Cancer Seminar in Wakayama.$$$$F$Y$$$20240830$$MD$JP$JP
242701401$24270140$1$I$20180101$20240827$20240830$20240830$EXP$$US-ABBVIE-5898829$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242701412$24270141$2$F$$20240823$20240830$20240912$PER$$JP-APELLIS-2024-APL-0000526$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240912$$MD$JP$JP
242701422$24270142$2$F$$20240926$20240830$20240927$EXP$$CA-PFIZER INC-202400244919$PFIZER$$62$YR$$M$Y$$$20240927$$MD$CA$CA
242701431$24270143$1$I$20240828$20240828$20240830$20240830$EXP$GB-MHRA-MED-202408282214043250-QDBWC$GB-PFIZER INC-202400245848$PFIZER$$48$YR$$F$Y$90$KG$20240830$$CN$GB$GB
242701441$24270144$1$I$20240801$20240827$20240830$20240830$EXP$$CN-PFIZER INC-PV202400111940$PFIZER$$39$YR$$M$Y$68.5$KG$20240830$$HP$CN$CN
242701461$24270146$1$I$$20240828$20240830$20240830$EXP$$US-PFIZER INC-202400245914$PFIZER$$41$YR$$F$Y$$$20240830$$CN$US$US
242701471$24270147$1$I$20220101$20240822$20240830$20240830$PER$$US-ABBVIE-5893827$ABBVIE$$$$$M$Y$$$20240830$$MD$US$US
242701481$24270148$1$I$20240828$20240829$20240830$20240830$PER$$US-ELI_LILLY_AND_COMPANY-US202408019149$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240830$$CN$US$US
242701502$24270150$2$F$$20240919$20240830$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134344$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240925$$CN$US$US
242701511$24270151$1$I$20221215$20240829$20240830$20240830$EXP$FR-AFSSAPS-MP2024001335$FR-BAUSCH-BL-2024-013112$BAUSCH AND LOMB$$0$DY$$F$Y$2.92$KG$20240830$$MD$FR$PF
242701522$24270152$2$F$20221123$20240906$20240830$20240910$EXP$$JP-TEVA-VS-3237894$TEVA$$17$YR$$M$Y$$$20240910$$MD$JP$JP
242701531$24270153$1$I$$20240803$20240830$20240830$PER$$US-JNJFOC-20240880643$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$CN$US$US
242701541$24270154$1$I$$20240826$20240830$20240830$EXP$$ES-PFIZER INC-202400245804$PFIZER$Galindo-Rodriguez, D.. Multidrug-resistant Mycobacterium abscessus infection in an anophthalmic socket treated with bedaquiline on a compassionate use basis: A case report. American Journal of Ophthalmology Case Reports. 2024;36:10.1016/j.ajoc.2024.102139$60$YR$$F$Y$$$20240830$$HP$ES$ES
242701562$24270156$2$F$$20240911$20240830$20240920$EXP$$CA-TEVA-VS-3237436$TEVA$$40$YR$$F$Y$$$20240920$$HP$CA$CA
242701572$24270157$2$F$$20240903$20240830$20240909$EXP$$US-OTSUKA-2024_023602$OTSUKA$$$$$F$Y$$$20240909$$PH$US$US
242701581$24270158$1$I$$20240823$20240830$20240830$PER$$US-MYLANLABS-2024M1079024$MYLAN$$$$$F$Y$53.07$KG$20240830$$CN$US$US
242701591$24270159$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59952$$FDA-CTU$$47$YR$$F$N$$$20240829$N$$US$
242701601$24270160$1$I$$20240826$20240830$20240830$PER$$US-MYLANLABS-2024M1079337$MYLAN$$$$$F$Y$57.15$KG$20240830$$CN$US$US
242701611$24270161$1$I$$20240828$20240830$20240830$EXP$$US-KYOWAKIRIN-2024KK020235$KYOWA$$$$$$Y$$$20240830$$HP$US$US
242701621$24270162$1$I$20240809$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59955$$FDA-CTU$$5$YR$$F$N$$$20240829$N$$US$
242701632$24270163$2$F$$20240911$20240830$20240918$EXP$$CA-TEVA-VS-3236911$TEVA$$40$YR$$F$Y$$$20240918$$HP$CA$CA
242701651$24270165$1$I$$20240820$20240830$20240830$EXP$$US-MYLANLABS-2024M1078035$MYLAN$$$$$F$Y$86.65$KG$20240830$$CN$US$US
242701661$24270166$1$I$$20240826$20240830$20240830$PER$$US-AstraZeneca-2024A194670$ASTRAZENECA$$$$$M$Y$$$20240830$$CN$US$
242701671$24270167$1$I$00010101$20230329$20231020$20231020$DIR$FDA-CDER-CTU-2023-77782$$FDA-CTU$$79$YR$$M$N$$$20230329$N$PH$US$
242701681$24270168$1$I$$20240819$20240830$20240830$EXP$$CA-AMRYT PHARMACEUTICALS DAC-AEGR007361$AEGERION$$$$$$Y$$$20240830$$HP$CA$CA
242701691$24270169$1$I$20240809$20240822$20240830$20240830$EXP$FR-AFSSAPS-PO2024000909$FR-TEVA-VS-3236677$TEVA$$78$YR$$M$Y$102$KG$20240830$$MD$FR$FR
242701701$24270170$1$I$$20240823$20240830$20240830$PER$$JP-Eisai-EC-2024-163897$EISAI$$81$YR$E$F$Y$$$20240830$$PH$JP$JP
242701731$24270173$1$I$$20240827$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138494$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240830$$CN$US$US
242701741$24270174$1$I$20240822$20240822$20240830$20240830$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-16800$IPSEN$$61$YR$A$M$Y$$$20240830$$HP$CA$CA
242701751$24270175$1$I$$20240820$20240830$20240830$EXP$$AR-ELI_LILLY_AND_COMPANY-AR202408019015$ELI LILLY AND CO$$55$YR$A$$Y$$$20240830$$CN$DE$AR
242701761$24270176$1$I$$20240822$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408015443$ELI LILLY AND CO$$$$$$Y$$$20240830$$CN$US$US
242701771$24270177$1$I$20240311$20240819$20240830$20240830$EXP$IT-MINISAL02-999387$IT-ELI_LILLY_AND_COMPANY-IT202408012122$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240830$$CN$IT$IT
242701781$24270178$1$I$20230209$20240823$20240830$20240830$EXP$FR-AFSSAPS-RN2024000880$FR-ELI_LILLY_AND_COMPANY-FR202408015681$ELI LILLY AND CO$$74$YR$E$M$Y$65$KG$20240830$$CN$FR$FR
242701792$24270179$2$F$20240801$20240823$20240830$20240903$EXP$$CN-009507513-2408CHN009457$MERCK$$69$YR$$M$Y$45.5$KG$20240903$$HP$CN$CN
242701801$24270180$1$I$20240814$20240827$20240830$20240830$EXP$$NVSC2024CN175207$NOVARTIS$$77$YR$$M$Y$75$KG$20240830$$HP$CN$CN
242701811$24270181$1$I$20240101$20240808$20240830$20240830$PER$$US-JNJFOC-20240822857$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240830$$CN$US$US
242701821$24270182$1$I$20240826$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024170570$AMGEN$$60$YR$A$M$Y$$$20240830$$CN$US$US
242701832$24270183$2$F$20240729$20240903$20240830$20240905$EXP$$US-ALXN-202408USA001883US$ALEXION PHARMACEUTICALS$$41$YR$$F$Y$$$20240906$$CN$US$US
242701841$24270184$1$I$$20240820$20240830$20240830$EXP$$CA-VER-202400389$VERITY PHARMACEUTICALS$$84$YR$E$M$Y$$$20240830$$CN$CA$CA
242701861$24270186$1$I$$20240131$20240201$20240201$DIR$FDA-CDER-CTU-2024-8971$$FDA-CTU$$$$$M$N$$$20240131$N$HP$US$
242701871$24270187$1$I$$20240819$20240819$20240819$DIR$FDA-CDER-CTU-2024-56823$$FDA-CTU$$66$YR$$F$N$$$20240819$N$$US$
242701881$24270188$1$I$$20230921$20230921$20230921$DIR$FDA-CDER-CTU-2023-70015$$FDA-CTU$$71$YR$$F$N$$$20230921$N$$US$
242701891$24270189$1$I$$20240102$20240103$20240103$DIR$FDA-CDER-CTU-2024-987$$FDA-CTU$$$$$M$N$$$20240102$N$HP$US$
242701901$24270190$1$I$20240826$20240828$20240830$20240830$EXP$$CN-PFIZER INC-PV202400112630$PFIZER$$6$YR$$F$Y$20$KG$20240830$$HP$CN$CN
242701921$24270192$1$I$20230701$20240826$20240830$20240830$EXP$$IN-PFIZER INC-PV202300195039$PFIZER$$55$YR$$F$Y$$$20240830$$CN$IN$IN
242701932$24270193$2$F$20240701$20240829$20240830$20240904$EXP$$US-PFIZER INC-202400246815$PFIZER$$$$$F$Y$48.98$KG$20240904$$CN$US$US
242701942$24270194$2$F$$20240924$20240830$20240925$EXP$$CA-PFIZER INC-202400246632$PFIZER$$79$YR$$F$Y$$$20240925$$MD$CA$CA
242701951$24270195$1$I$20240814$20240829$20240830$20240830$EXP$NO-NOMAADVRE-RELISSO-2024-V493gn$NO-PFIZER INC-202400246175$PFIZER$$59$YR$$F$Y$$$20240830$$MD$NO$NO
242701961$24270196$1$I$$20240829$20240830$20240830$EXP$$MA-PFIZER INC-PV202400113666$PFIZER$$$$$F$Y$$$20240830$$HP$MA$MA
242701971$24270197$1$I$$20240828$20240830$20240830$EXP$$CA-PFIZER INC-202400245726$PFIZER$$49$YR$$F$Y$$$20240830$$CN$CA$CA
242701982$24270198$2$F$20240301$20240902$20240830$20240904$EXP$$US-PFIZER INC-202400246897$PFIZER$$81$YR$$F$Y$$$20240904$$HP$US$US
242701991$24270199$1$I$20240826$20240828$20240830$20240830$EXP$$CN-PFIZER INC-PV202400112629$PFIZER$$31$YR$$F$Y$60$KG$20240830$$HP$CN$CN
242702001$24270200$1$I$$20240828$20240830$20240830$EXP$$CA-PFIZER INC-202400245731$PFIZER$$61$YR$$F$Y$$$20240830$$HP$CA$CA
242702011$24270201$1$I$20240820$20240828$20240830$20240830$EXP$$CA-PFIZER INC-202400026281$PFIZER$$65$YR$$F$Y$$$20240830$$HP$CA$CA
242702021$24270202$1$I$20240101$20240829$20240830$20240830$EXP$$US-PFIZER INC-202400247043$PFIZER$$16$YR$$M$Y$$$20240830$$HP$US$US
242702031$24270203$1$I$$20240829$20240830$20240830$EXP$$CN-PFIZER INC-PV202400112914$PFIZER$$$$A$F$Y$$$20240830$$CN$CN$CN
242702051$24270205$1$I$$20240528$20240830$20240830$EXP$$US-009507513-2408USA010570$MERCK$$$$$F$Y$$$20240830$$MD$US$US
242702061$24270206$1$I$20240726$20240828$20240830$20240830$EXP$$CN-PFIZER INC-PV202400112590$PFIZER$$51$YR$$M$Y$$$20240830$$HP$CN$CN
242702071$24270207$1$I$$20240801$20240830$20240830$PER$$US-009507513-2408USA000775$MERCK$$$$$F$Y$76.4$KG$20240830$$HP$US$US
242702091$24270209$1$I$$20240829$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138402$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240830$$CN$US$US
242702101$24270210$1$I$$20240829$20240830$20240830$PER$$NVSC2024US175290$NOVARTIS$$$$$F$Y$$$20240830$$MD$US$US
242702111$24270211$1$I$20240823$20240828$20240830$20240830$PER$$NVSC2024US174745$NOVARTIS$$64$YR$$F$Y$$$20240830$$CN$US$US
242702121$24270212$1$I$$20240822$20240830$20240830$EXP$$GB-TEVA-VS-3236710$TEVA$$66$YR$$F$Y$60$KG$20240830$$MD$GB$GB
242702131$24270213$1$I$20231222$20240822$20240830$20240830$EXP$IT-MINISAL02-999159$IT-TEVA-VS-3236096$TEVA$$19$YR$$M$Y$$$20240830$$PH$IT$IT
242702141$24270214$1$I$$20240823$20240830$20240830$EXP$$US-SMPA-2024SPA001937$SUNOVION$$$$$$Y$$$20240830$$CN$US$US
242702151$24270215$1$I$$20240819$20240830$20240830$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007366$AEGERION$$$$$F$Y$$$20240830$$CN$US$US
242702162$24270216$2$F$20240802$20240909$20240830$20240910$EXP$FR-AFSSAPS-TO2024001662$FR-ABBVIE-5899857$ABBVIE$$66$YR$$M$Y$$$20240910$$MD$FR$FR
242702172$24270217$2$F$20240819$20240829$20240830$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131426$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240910$$CN$US$US
242702191$24270219$1$I$20240701$20240827$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137185$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240830$$CN$US$US
242702202$24270220$2$F$20210720$20240917$20240830$20240925$PER$$JP-Eisai-EC-2024-173161$EISAI$Masashi Ninomiya. Verification of the usefulness of combination/sequential therapy of ATZ+BV and TACE. The 30th Japan Association of Systemic Therapy of HCC Program and Abstracts. 2024: OS2-1-.$70$YR$E$M$Y$52$KG$20240925$$MD$JP$JP
242702212$24270221$2$F$$20240824$20240830$20240906$PER$$US-SA-2024SA242861$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240906$$MD$US$US
242702221$24270222$1$I$$20240824$20240830$20240830$EXP$$US-CBFLEET-202408-US-002871$CB FLEET$$2$YR$C$F$Y$14.97$KG$20240830$$CN$US$US
242702231$24270223$1$I$20240715$20240826$20240830$20240830$EXP$FR-AFSSAPS-LM2024000463$FR-009507513-2408FRA009687$MERCK$$78$YR$$M$Y$60$KG$20240830$$MD$FR$FR
242702241$24270224$1$I$$20240822$20240830$20240830$EXP$NL-LRB-00996068$NL-TEVA-VS-3236490$TEVA$$40$MON$$M$Y$15$KG$20240830$$PH$NL$NL
242702251$24270225$1$I$20240822$20240828$20240830$20240830$EXP$$CN-PFIZER INC-PV202400112557$PFIZER$$55$YR$$M$Y$67$KG$20240830$$HP$CN$CN
242702263$24270226$3$F$20230601$20240826$20240830$20240918$EXP$$BR-009507513-2408BRA010100$MERCK$$43$YR$$M$Y$$$20240918$$MD$BR$BR
242702271$24270227$1$I$$20240829$20240830$20240830$PER$$NVSC2024US175329$NOVARTIS$$$$$F$Y$57$KG$20240830$$CN$US$US
242702281$24270228$1$I$20240517$20240604$20240830$20240830$PER$$US-GE HEALTHCARE-2024CSU006212$GE HEALTHCARE$$77$YR$$F$Y$74.8$KG$20240830$$HP$US$US
242702291$24270229$1$I$20240101$20240826$20240830$20240830$EXP$DK-DKMA-30729454$DK-INCYTE CORPORATION-2024IN008940$INCYTE$$$$$$Y$$$20240830$$MD$DK$DK
242702302$24270230$2$F$20240701$20240821$20240830$20240916$EXP$$US-BEH-2024177552$CSL BEHRING$$70$YR$E$M$Y$82.812$KG$20240916$$HP$US$US
242702321$24270232$1$I$20231201$20240828$20240830$20240830$EXP$$CA-PFIZER INC-202400043028$PFIZER$$11$YR$$M$Y$$$20240830$$HP$CA$CA
242702331$24270233$1$I$20240604$20240604$20240830$20240830$PER$$US-GE HEALTHCARE-2024CSU006213$GE HEALTHCARE$$56$YR$$F$Y$84.4$KG$20240830$$HP$US$US
242702361$24270236$1$I$$20240805$20240830$20240830$PER$$US-FMCRTG-FMC-2408-000948$FRESENIUS MEDICAL CARE$$78$YR$E$F$Y$90$KG$20240830$$HP$US$US
242702371$24270237$1$I$20240701$20240827$20240830$20240830$EXP$$CN-PFIZER INC-PV202400112246$PFIZER$$39$YR$$M$Y$$$20240830$$CN$CN$CN
242702381$24270238$1$I$$20240827$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137954$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240830$$CN$US$US
242702391$24270239$1$I$$20240816$20240830$20240830$EXP$$US-FMCRTG-FMC-2408-001027$FRESENIUS MEDICAL CARE$$71$YR$E$F$Y$87$KG$20240830$$HP$US$US
242702401$24270240$1$I$20240730$20240802$20240830$20240830$PER$$US-FMCRTG-FMC-2408-000942$FRESENIUS MEDICAL CARE$$53$YR$A$F$Y$$$20240830$$HP$US$US
242702411$24270241$1$I$$20240821$20240830$20240830$EXP$$CA-TEVA-VS-3235610$TEVA$$43$YR$$F$Y$97$KG$20240830$$HP$CA$CA
242702421$24270242$1$I$20190502$20240826$20240830$20240830$EXP$$US-JAZZ-2019-US-006317$JAZZ$$39$YR$$F$Y$$$20240830$$CN$US$US
242702431$24270243$1$I$20240801$20240822$20240830$20240830$EXP$$CN-009507513-2408CHN009169$MERCK$$38$YR$$F$Y$50.4$KG$20240830$$HP$CN$CN
242702442$24270244$2$F$$20240917$20240830$20240920$PER$$US-HALEON-2194332$Haleon PLC$$72$YR$$$Y$$$20240920$$CN$US$US
242702452$24270245$2$F$20240822$20240902$20240830$20240906$EXP$$GB-ABBVIE-5899600$ABBVIE$$74$YR$$M$Y$$$20240906$$HP$GB$GB
242702461$24270246$1$I$20240819$20240821$20240830$20240830$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000027$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240830$$CN$US$US
242702471$24270247$1$I$20240514$20240822$20240830$20240830$EXP$FR-AFSSAPS-CN2024000729$FR-TEVA-VS-3236504$TEVA$$79$YR$$F$Y$60$KG$20240830$$MD$FR$FR
242702481$24270248$1$I$$20240820$20240830$20240830$EXP$$US-FMCRTG-FMC-2408-001041$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240830$$HP$US$US
242702501$24270250$1$I$$20240822$20240830$20240830$EXP$FR-AFSSAPS-AVMA2024000346$FR-TEVA-VS-3236502$TEVA$$$$$$Y$$$20240830$$CN$FR$FR
242702511$24270251$1$I$20240701$20240821$20240830$20240830$EXP$$US-BAUSCHBL-2024BNL032151$BAUSCH AND LOMB$$83$YR$$F$Y$$$20240830$$CN$US$US
242702521$24270252$1$I$$20240828$20240830$20240830$EXP$$AU-GILEAD-2024-0685830$GILEAD$$77$YR$E$F$Y$$$20240830$$HP$AU$AU
242702541$24270254$1$I$20231231$20240822$20240830$20240830$EXP$$BE-TEVA-VS-3236487$TEVA$$85$YR$$M$Y$$$20240830$$HP$BE$BE
242702552$24270255$2$F$$20240905$20240830$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-137949$BRISTOL MYERS SQUIBB$$8$DEC$E$$Y$$$20240910$$MD$JP$JP
242702561$24270256$1$I$20230601$20240830$20240830$20240830$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048824$BOEHRINGER INGELHEIM$$63$YR$A$$Y$$$20240830$$MD$BR$BR
242702571$24270257$1$I$$20240822$20240830$20240830$EXP$$US-BAUSCHBL-2024BNL032597$BAUSCH AND LOMB$$$$$M$Y$$$20240830$$CN$US$US
242702591$24270259$1$I$$20240821$20240830$20240830$PER$$US-JNJFOC-20240856386$JOHNSON AND JOHNSON$$$$$F$Y$$$20240830$$CN$US$US
242702601$24270260$1$I$$20240827$20240830$20240830$EXP$$US-SANDOZ INC.-SDZ2024US075990$SANDOZ$$$$$$Y$$$20240830$$CN$US$US
242702611$24270261$1$I$20240810$20240823$20240830$20240830$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026610$UNITED THERAPEUTICS$$85$YR$$M$Y$87.528$KG$20240830$$$US$US
242702621$24270262$1$I$$20240826$20240830$20240830$EXP$$CA-009507513-2408CAN009258$MERCK$Unknown. Unknown. Unknown$74$YR$$F$Y$$$20240830$$HP$CA$CA
242702631$24270263$1$I$20230724$20240717$20240830$20240830$PER$$DE-Eisai-EC-2024-169611$EISAI$$76$YR$E$$Y$$$20240830$$MD$DE$DE
242702641$24270264$1$I$20240624$20240822$20240830$20240830$EXP$PT-INFARMED-T202408-201$PT-TEVA-VS-3236500$TEVA$$65$YR$$M$Y$$$20240830$$PH$PT$PT
242702651$24270265$1$I$$20240829$20240830$20240830$EXP$$AU-JAZZ PHARMACEUTICALS-2024-AU-013868$JAZZ$$$$$F$Y$$$20240830$$MD$AU$AU
242702662$24270266$2$F$20240717$20240902$20240830$20240903$EXP$PT-INFARMED-F202407-487$PT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048753$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$$$20240903$$PH$PT$PT
242702672$24270267$2$F$$20240827$20240830$20240901$PER$$US-ABBVIE-5899079$ABBVIE$$$$$F$Y$$$20240901$$HP$US$US
242702702$24270270$2$F$$20240926$20240830$20240927$EXP$$CA-PFIZER INC-202400245759$PFIZER$$64$YR$$M$Y$$$20240927$$HP$CA$CA
242702712$24270271$2$F$20240630$20240911$20240830$20240911$EXP$$MY-PFIZER INC-PV202400113529$PFIZER$$74$YR$$M$Y$40$KG$20240911$$MD$MY$MY
242702731$24270273$1$I$$20240828$20240830$20240830$EXP$$CA-PFIZER INC-202300269163$PFIZER$$63$YR$$M$Y$$$20240830$$HP$CA$CA
242702741$24270274$1$I$$20240819$20240830$20240830$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08354$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240830$$MD$US$US
242702751$24270275$1$I$$20240823$20240830$20240830$EXP$$TR-ANIPHARMA-2024-TR-000098$ANI$Bozca BC, Alpsoy A, Bilgic A, et al.Clinicopathological analysis of patients diagnosed with DRESS..Turkderm - Turkish Archives of Dermatology and Venereology.2023;57101-107.$$$$UNK$Y$$$20240830$$HP$TR$TR
242702763$24270276$3$F$20231001$20240904$20240830$20240906$EXP$$BE-PFIZER INC-PV202300186211$PFIZER$$85$YR$$M$Y$$$20240906$$HP$BE$BE
242702771$24270277$1$I$$20240827$20240830$20240830$EXP$$CA-PFIZER INC-202300102017$PFIZER$$63$YR$$F$Y$$$20240830$$HP$CA$CA
242702781$24270278$1$I$$20240827$20240830$20240830$EXP$$CA-PFIZER INC-202400244931$PFIZER$$45$YR$$F$Y$$$20240830$$HP$CA$CA
242702791$24270279$1$I$20240723$20240822$20240830$20240830$EXP$FR-AFSSAPS-AN2024001092$FR-TEVA-VS-3236735$TEVA$$82$YR$$M$Y$80.1$KG$20240830$$MD$FR$FR
242702801$24270280$1$I$20240101$20240828$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137858$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240830$$CN$US$US
242702821$24270282$1$I$20210801$20240829$20240830$20240830$EXP$$US-PURDUE PHARMA-USA-2024-0311673$PURDUE$$20$YR$$F$Y$$$20240830$$CN$US$US
242702831$24270283$1$I$$20240828$20240830$20240830$EXP$$CA-PURDUE-USA-2024-0311694$PURDUE$$75$YR$$M$Y$125$KG$20240830$$HP$CA$CA
242702841$24270284$1$I$$20240819$20240830$20240830$EXP$$JP-PURDUE-USA-2024-0311400$PURDUE$$$$E$$Y$$$20240830$$HP$JP$JP
242702851$24270285$1$I$$20240829$20240830$20240830$PER$$US-PURDUE PHARMA-USA-2024-0311682$PURDUE$$$$$$Y$$$20240830$$CN$US$US
242702861$24270286$1$I$$20240829$20240830$20240830$PER$$US-PURDUE PHARMA-USA-2024-0311681$PURDUE$$$$$F$Y$$$20240830$$CN$US$US
242702872$24270287$2$F$19990101$20240906$20240830$20240909$PER$$US-PURDUE PHARMA-USA-2024-0311672$PURDUE$$$$$M$Y$$$20240909$$CN$US$US
242702881$24270288$1$I$20210801$20240829$20240830$20240830$PER$$US-PURDUE PHARMA-USA-2024-0311674$PURDUE$$35$YR$$M$Y$$$20240830$$CN$US$US
242702891$24270289$1$I$$20240829$20240830$20240830$PER$$US-PURDUE PHARMA-USA-2024-0311671$PURDUE$$$$A$M$Y$$$20240830$$CN$US$US
242702931$24270293$1$I$$20240827$20240830$20240830$EXP$$JP-AstraZeneca-2024A196256$ASTRAZENECA$$$$$$Y$$$20240830$$MD$JP$
242702941$24270294$1$I$20240826$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172389$AMGEN$$57$YR$A$M$Y$$$20240830$$CN$US$US
242702951$24270295$1$I$$20240823$20240830$20240830$EXP$$GB-009507513-2401GBR016594$MERCK$$76$YR$$M$Y$$$20240830$$HP$GB$GB
242702961$24270296$1$I$$20240823$20240830$20240830$EXP$PL-AMGEN-POLSP2024161676$PL-Taiho Oncology Inc-2024-008327$TAIHO ONCOLOGY INC$Adamczuk-nurzynska A.. Electrolyte disturbances in an elderly patient with colon cancer. Unknown. 2024;1-3. 2024;1-3$73$YR$E$M$Y$$$20240830$$MD$PL$PL
242702973$24270297$3$F$20240812$20240819$20240830$20240920$PER$$US-JNJFOC-20240850022$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240920$$CN$US$US
242702981$24270298$1$I$20240101$20240826$20240830$20240830$EXP$$US-JNJFOC-20240873633$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240830$$HP$US$US
242702991$24270299$1$I$$20240819$20240830$20240830$PER$$US-IMP-2024000653$Harrow Health$$77$YR$E$F$Y$$$20240830$$CN$US$US
242703002$24270300$2$F$$20240829$20240830$20240912$PER$$US-IMP-2024000659$Harrow Health$$$$A$F$Y$$$20240912$$CN$US$US
242703011$24270301$1$I$$20240827$20240830$20240830$PER$$US-IDORSIA-008026-2024-US$IDORSIA PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242703021$24270302$1$I$20240626$20240822$20240830$20240830$EXP$ES-AEMPS-1561567$ES-TEVA-VS-3236956$TEVA$$52$YR$$M$Y$$$20240830$$MD$ES$ES
242703031$24270303$1$I$$20240830$20240830$20240830$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048879$BOEHRINGER INGELHEIM$$$$$$Y$$$20240830$$CN$US$US
242703041$24270304$1$I$20240604$20240604$20240830$20240830$PER$$US-GE HEALTHCARE-2024CSU006263$GE HEALTHCARE$$37$YR$$$Y$$$20240830$$HP$US$US
242703051$24270305$1$I$20210101$20240604$20240830$20240830$PER$$US-GE HEALTHCARE-2024CSU009960$GE HEALTHCARE$$$$A$$Y$$$20240830$$HP$US$US
242703062$24270306$2$F$20240701$20240824$20240830$20240902$EXP$$AU-AstraZeneca-2024A166733$ASTRAZENECA$$50$YR$$F$Y$$$20240902$$PH$AU$
242703071$24270307$1$I$20240830$20240830$20240830$20240830$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048867$BOEHRINGER INGELHEIM$$73$YR$E$$Y$$$20240830$$CN$US$US
242703081$24270308$1$I$$20240822$20240830$20240830$PER$$US-JNJFOC-20240859912$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242703101$24270310$1$I$$20240827$20240830$20240830$EXP$$BE-GILEAD-2024-0685740$GILEAD$$79$YR$E$M$Y$$$20240830$$MD$BE$BE
242703112$24270311$2$F$$20240830$20240830$20240909$EXP$NL-LRB-00994154$NL-TEVA-VS-3236861$TEVA$$42$YR$$F$Y$57$KG$20240909$$CN$NL$NL
242703121$24270312$1$I$20240801$20240819$20240830$20240830$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004987$SAREPTA THERAPEUTICS$$12$YR$$M$Y$$$20240830$$CN$US$US
242703141$24270314$1$I$$20240826$20240830$20240830$EXP$$US-ABBVIE-5896540$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242703161$24270316$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5898917$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242703171$24270317$1$I$$20240801$20240830$20240830$PER$$US-009507513-2408USA000737$MERCK$$$$$M$Y$$$20240830$$CN$US$US
242703181$24270318$1$I$$20240826$20240830$20240830$PER$$US-AstraZeneca-2024A194570$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242703191$24270319$1$I$20150101$20240826$20240830$20240830$EXP$$HU-ABBVIE-5899477$ABBVIE$$$$$F$Y$$$20240830$$CN$HU$HU
242703202$24270320$2$F$$20240905$20240830$20240908$EXP$$US-ABBVIE-5900808$ABBVIE$$$$$M$Y$$$20240908$$CN$US$US
242703213$24270321$3$F$20240101$20240916$20240830$20240928$EXP$$BR-ABBVIE-5900143$ABBVIE$$62$YR$$M$Y$78.7$KG$20240928$$MD$BR$BR
242703221$24270322$1$I$20240101$20240822$20240830$20240830$EXP$$US-AstraZeneca-2024A062073$ASTRAZENECA$$804$MON$$F$Y$$$20240830$$CN$US$
242703231$24270323$1$I$20240101$20240815$20240830$20240830$EXP$$US-RADIUS HEALTH INC.-2024US003939$RADIUS PHARM$$$$$$Y$$$20240830$$CN$US$US
242703241$24270324$1$I$$20240819$20240830$20240830$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08374$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240830$$MD$US$US
242703251$24270325$1$I$$20240827$20240830$20240830$PER$$US-ALXN-202408USA001892US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242703261$24270326$1$I$$20240827$20240830$20240830$EXP$$US-ABBVIE-5860417$ABBVIE$$$$$M$Y$$$20240830$$CN$US$US
242703271$24270327$1$I$20201021$20240821$20240830$20240830$EXP$PL-URPL-1-2523-2020$PL-TEVA-VS-3235760$TEVA$$69$YR$$F$Y$58$KG$20240830$$HP$PL$PL
242703291$24270329$1$I$$20240830$20240830$20240830$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048887$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240830$$CN$US$US
242703302$24270330$2$F$$20240904$20240830$20240906$EXP$$CA-PFIZER INC-202400245594$PFIZER$$40$YR$$F$Y$96$KG$20240906$$HP$CA$CA
242703311$24270331$1$I$20240711$20240821$20240830$20240830$EXP$FR-AFSSAPS-AVMP2024000230$FR-TEVA-VS-3235998$TEVA$$21$YR$$M$Y$$$20240830$$MD$FR$FR
242703321$24270332$1$I$20240804$20240822$20240830$20240830$EXP$IT-MINISAL02-999206$IT-TEVA-VS-3236132$TEVA$$50$YR$$F$Y$$$20240830$$MD$IT$IT
242703331$24270333$1$I$20240701$20240822$20240830$20240830$EXP$DE-BFARM-24005694$DE-TEVA-VS-3236092$TEVA$$55$YR$$F$Y$76$KG$20240830$$CN$DE$DE
242703341$24270334$1$I$20240713$20240822$20240830$20240830$EXP$FR-AFSSAPS-BR2024000681$FR-TEVA-VS-3236503$TEVA$$75$YR$$F$Y$$$20240830$$MD$FR$FR
242703362$24270336$2$F$20240810$20240919$20240830$20240925$EXP$FR-AFSSAPS-CN2024000794$FR-TEVA-VS-3236506$TEVA$$53$YR$$M$Y$130$KG$20240925$$PH$FR$FR
242703371$24270337$1$I$$20240815$20240830$20240830$EXP$$US-ASTELLAS-2024-AER-001773$ASTELLAS$$59$YR$A$M$Y$$$20240830$$CN$US$US
242703381$24270338$1$I$$20240821$20240830$20240830$EXP$$DE-TAKEDA-2024TUS087408$TAKEDA$$$$$$Y$$$20240830$$CN$DE$DE
242703391$24270339$1$I$$20240822$20240830$20240830$EXP$DE-BFARM-24005696$DE-TEVA-VS-3236854$TEVA$$$$$F$Y$$$20240830$$CN$DE$DE
242703411$24270341$1$I$20230101$20240822$20240830$20240830$EXP$FI-FIMEA-202402920$FI-TEVA-VS-3236867$TEVA$$46$YR$$F$Y$$$20240830$$HP$FI$FI
242703431$24270343$1$I$20240701$20240822$20240830$20240830$EXP$FR-AFSSAPS-CN2024000703$FR-TEVA-VS-3236515$TEVA$$31$YR$$F$Y$$$20240830$$MD$FR$FR
242703441$24270344$1$I$$20240827$20240830$20240830$PER$$US-ALXN-202408USA001894US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242703451$24270345$1$I$20220101$20240821$20240830$20240830$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132610$BRISTOL MYERS SQUIBB$Desai D, Nohria A, Alhanshali L, Buontempo M, Lo Sicco KI, Fern C, et al. Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: report of two cases. JAAD Case Reports. 2024;51:86-91. doi:10.1016/j.jdcr.2024.06.034.$39$YR$A$M$Y$$$20240830$$HP$US$US
242703462$24270346$2$F$$20240817$20240830$20240830$PER$$US-ASTELLAS-2024-AER-001927$ASTELLAS$$72$YR$E$F$Y$$$20240830$$CN$US$US
242703471$24270347$1$I$$20240823$20240830$20240830$EXP$$US-SMPA-2024SPA001911$SUNOVION$$$$$$Y$$$20240830$$CN$US$US
242703481$24270348$1$I$$20240827$20240830$20240830$PER$$US-ALXN-202408USA001897US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240830$$CN$US$US
242703501$24270350$1$I$$20240823$20240830$20240830$EXP$DE-PEI-202300005017$DE-009507513-2408DEU009027$MERCK$$76$YR$$M$Y$$$20240830$$MD$DE$DE
242703511$24270351$1$I$$20240814$20240830$20240830$PER$$US-AstraZeneca-2024A185902$ASTRAZENECA$$$$$F$Y$$$20240830$$CN$US$
242703531$24270353$1$I$20231110$20240819$20240830$20240830$EXP$$DE-AstraZeneca-2024A008905$ASTRAZENECA$$$$A$F$Y$65.4$KG$20240830$$MD$DE$
242703542$24270354$2$F$$20240826$20240830$20240913$EXP$$JP-009507513-2405JPN003390J$MERCK$Sanami T, Hiruma K, Shirono Y, Ikeda M, Anraku T, Tasaki M, et al. 6 A case of right renal tumor with cT3c inferior vena cava thrombosis in which radical resection achieved after pembrolizumab-lenvatinib combination therapy. The Ko-Shin-Etsu Joint Regional Meeting of the  Japan Urological Association[The. 5$56$YR$$M$Y$$$20240913$$MD$JP$JP
242703551$24270355$1$I$$20240830$20240830$20240830$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048896$BOEHRINGER INGELHEIM$$$$$$Y$$$20240830$$HP$US$US
242703561$24270356$1$I$20240624$20240822$20240830$20240830$EXP$$ES-AstraZeneca-2024A196388$ASTRAZENECA$$$$A$M$Y$$$20240831$$MD$ES$
242703571$24270357$1$I$20240801$20240821$20240830$20240830$EXP$PT-INFARMED-B202408-58$PT-TEVA-VS-3236417$TEVA$$61$YR$$M$Y$79$KG$20240830$$MD$PT$PT
242703581$24270358$1$I$$20240822$20240830$20240830$PER$$US-JNJFOC-20240859363$JOHNSON AND JOHNSON$$$$$$Y$$$20240830$$CN$US$US
242703592$24270359$2$F$20240409$20240903$20240830$20240910$EXP$FR-AFSSAPS-TO2024001273$FR-TEVA-VS-3236953$TEVA$$77$YR$$M$Y$81.9$KG$20240910$$PH$FR$FR
242703601$24270360$1$I$20240708$20240822$20240830$20240830$EXP$$FR-TAKEDA-2024TUS087375$TAKEDA$$81$YR$$M$Y$83$KG$20240830$$MD$FR$FR
242703611$24270361$1$I$20240828$20240829$20240830$20240830$PER$$US-009507513-2408USA010624$MERCK$$$$$F$Y$$$20240830$$CN$US$US
242703621$24270362$1$I$20230522$20240822$20240830$20240830$EXP$$US-BIOGEN-2024BI01279891$BIOGEN$$56$YR$$M$Y$$$20240830$$HP$US$US
242703641$24270364$1$I$$20240820$20240830$20240830$EXP$$NVSC2024FR171056$NOVARTIS$IL?4R? Inhibition for Severe ?Eosinophilic Gastroenteritis, Allergy, and Anaphylaxis? Syndrome due to a Gain?of?Function Variant in STAT6. Faguer S, Delabesse E, Paul C, Pasquet M. JOURNAL OF CLINICAL IMMUNOLOGY. 2024;44 (29):1-3$$$$F$Y$$$20240831$$HP$FR$FR
242703651$24270365$1$I$$20240825$20240830$20240830$EXP$$JP-009507513-2408JPN003629J$MERCK$$7$DEC$$M$Y$$$20240830$$MD$JP$JP
242703661$24270366$1$I$20240817$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171396$AMGEN$$$$$M$Y$$$20240830$$CN$US$US
242703992$24270399$2$F$20240101$20240828$20240830$20240913$PER$$US-AMGEN-USASP2024173209$AMGEN$$70$YR$E$M$Y$$$20240913$$HP$US$US
242704001$24270400$1$I$$20240725$20240830$20240830$PER$$US-AMGEN-USASP2024172908$AMGEN$$70$YR$E$$Y$$$20240830$$CN$US$US
242704031$24270403$1$I$$20240819$20240830$20240830$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202408013834$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240830$$MD$SA$SA
242704041$24270404$1$I$20240601$20240820$20240830$20240830$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408012608$ELI LILLY AND CO$$70$YR$E$M$Y$73$KG$20240830$$CN$DE$DE
242704061$24270406$1$I$20240715$20240821$20240830$20240830$EXP$DE-AMK-279319$DE-ELI_LILLY_AND_COMPANY-DE202408013990$ELI LILLY AND CO$$73$YR$E$M$Y$110$KG$20240830$$CN$DE$DE
242704071$24270407$1$I$20220930$20240819$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011550$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240830$$CN$US$US
242704081$24270408$1$I$$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012930$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240830$$CN$US$US
242704091$24270409$1$I$20240702$20240821$20240830$20240830$EXP$GB-MHRA-MED-202408211155405520-PVFQY$GB-ELI_LILLY_AND_COMPANY-GB202408014202$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240830$$CN$GB$GB
242704101$24270410$1$I$$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012609$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240830$$CN$US$US
242704111$24270411$1$I$$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012617$ELI LILLY AND CO$$68$YR$E$$Y$$$20240830$$CN$US$US
242704121$24270412$1$I$20221201$20240821$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013751$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240830$$CN$US$US
242704131$24270413$1$I$20240801$20240820$20240830$20240830$EXP$DE-CADRBFARM-2024329973$DE-ELI_LILLY_AND_COMPANY-DE202408013015$ELI LILLY AND CO$$64$YR$A$F$Y$92$KG$20240830$$CN$DE$DE
242704141$24270414$1$I$20240201$20240821$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013496$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240830$$CN$US$US
242704152$24270415$2$F$20240720$20240819$20240830$20240902$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408013409$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240902$$CN$JP$JP
242704161$24270416$1$I$$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013056$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240830$$CN$US$US
242704171$24270417$1$I$20240820$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013228$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240830$$CN$US$US
242704181$24270418$1$I$20240721$20240820$20240830$20240830$EXP$GB-MHRA-MED-202408191951415080-WMLPN$GB-ELI_LILLY_AND_COMPANY-GB202408012237$ELI LILLY AND CO$$$$$F$Y$74$KG$20240830$$CN$GB$GB
242704191$24270419$1$I$20240618$20240821$20240830$20240830$EXP$GB-MHRA-MED-202408211703316310-JFLZG$GB-ELI_LILLY_AND_COMPANY-GB202408014065$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240830$$CN$GB$GB
242704202$24270420$2$F$$20240905$20240830$20240917$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408011931$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240917$$PH$FR$FR
242704211$24270421$1$I$$20240821$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014377$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240830$$CN$US$US
242704221$24270422$1$I$$20240819$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012047$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240830$$CN$US$US
242704231$24270423$1$I$20240806$20240821$20240830$20240830$EXP$GB-MHRA-MED-202408210818053000-JMNYP$GB-ELI_LILLY_AND_COMPANY-GB202408014131$ELI LILLY AND CO$$61$YR$A$F$Y$19$KG$20240830$$CN$GB$GB
242704241$24270424$1$I$$20240819$20240830$20240830$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408012101$ELI LILLY AND CO$$64$YR$A$M$Y$201$KG$20240830$$CN$GB$GB
242704252$24270425$2$F$20240805$20240828$20240830$20240909$EXP$$HN-ELI_LILLY_AND_COMPANY-HN202408017987$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240909$$CN$GT$HN
242704261$24270426$1$I$$20240820$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012870$ELI LILLY AND CO$$$$$M$Y$$$20240830$$CN$US$US
242704271$24270427$1$I$$20240819$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011777$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$US$US
242704291$24270429$1$I$$20240820$20240830$20240830$EXP$GB-MHRA-MED-202408201645345610-KQGHF$GB-ELI_LILLY_AND_COMPANY-GB202408013301$ELI LILLY AND CO$$$$$F$Y$$$20240830$$CN$GB$GB
242704301$24270430$1$I$20240701$20240821$20240830$20240830$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013715$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240830$$CN$US$US
242704311$24270431$1$I$$20240821$20240830$20240830$EXP$GB-MHRA-MED-202408210927342550-TNZYV$GB-ELI_LILLY_AND_COMPANY-GB202408014145$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240830$$CN$GB$GB
242704323$24270432$3$F$$20240920$20240830$20240925$EXP$$IN-ABBVIE-5900841$ABBVIE$$57$YR$$F$Y$$$20240925$$CN$IN$IN
242704331$24270433$1$I$$20240605$20240830$20240830$PER$$DE-SIGA Technologies, Inc.-2161065$SIGA TECHNOLOGIES$Literature source$40$YR$$M$Y$$$20240830$$MD$DE$DE
242704341$24270434$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898613$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240830$$HP$CN$CN
242704351$24270435$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898891$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242704361$24270436$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898612$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240830$$HP$CN$CN
242704371$24270437$1$I$20220607$20230914$20240830$20240830$EXP$$CA-CELLTRION INC.-2021CA019658$CELLTRION$$$$$$Y$$$20240831$$CN$CA$CA
242704381$24270438$1$I$$20240820$20240830$20240830$EXP$$GB-B.Braun Medical Inc.-2161061$B BRAUN$$$$$M$Y$$$20240830$$$GB$GB
242704391$24270439$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898892$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242704401$24270440$1$I$$20240820$20240830$20240830$EXP$$GB-B.Braun Medical Inc.-2161060$B BRAUN$$$$$$Y$$$20240830$$$GB$GB
242704411$24270441$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898893$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242704422$24270442$2$F$$20240827$20240830$20240904$EXP$$CN-ABBVIE-5898614$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240904$$HP$CN$CN
242704431$24270443$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898894$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242704441$24270444$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898895$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242704451$24270445$1$I$$20240814$20240830$20240830$PER$$US-LGM Pharma Solutions, LLC-2161058$LGM PHARMA$$6$YR$$M$Y$$$20240830$$$US$US
242704461$24270446$1$I$$20240605$20240830$20240830$PER$$DE-SIGA Technologies, Inc.-2161066$SIGA TECHNOLOGIES$Literature source$40$YR$$M$Y$$$20240830$$MD$DE$DE
242704471$24270447$1$I$$20240815$20240830$20240830$EXP$$US-Stallergenes SAS-2161059$STALLERGENES$$33$YR$$F$Y$$$20240830$$$US$US
242704482$24270448$2$F$20240201$20240828$20240830$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016458$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240909$$CN$US$US
242704491$24270449$1$I$20240616$20240826$20240830$20240830$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202408015698$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240830$$CN$CA$CA
242704501$24270450$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898896$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242704511$24270451$1$I$$20240827$20240830$20240830$PER$$US-ABBVIE-5900230$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242704521$24270452$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898618$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240830$$HP$CN$CN
242704531$24270453$1$I$20240817$20240819$20240830$20240830$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08340$NEUROCRINE BIOSCIENCES$$61$YR$$F$Y$$$20240831$$CN$US$US
242704541$24270454$1$I$20240717$20240827$20240830$20240830$EXP$$KR-ASTELLAS-2024-AER-002312$ASTELLAS$$58$YR$A$M$Y$$$20240831$$CN$KR$KR
242704551$24270455$1$I$20230907$20240826$20240830$20240830$EXP$FR-AFSSAPS-GR2024001028$FR-ABBVIE-5895312$ABBVIE$$74$YR$$M$Y$98$KG$20240830$$PH$FR$FR
242704561$24270456$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898619$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240830$$HP$CN$CN
242704571$24270457$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5898617$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240830$$HP$CN$CN
242704581$24270458$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5899105$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242704591$24270459$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5899107$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242704601$24270460$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5899106$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242704611$24270461$1$I$$20240821$20240830$20240830$PER$$US-009507513-2408USA007719$MERCK$Shah PJ, Blair JE.. Voriconazole-induced periostitis: A Mimicker of Skeletal Coccidioidomycosis.. American Journal of Case Reports. 2024;25:e944102$50$YR$$F$Y$62$KG$20240830$$HP$US$US
242704622$24270462$2$F$20240801$20240913$20240830$20240927$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08385$NEUROCRINE BIOSCIENCES$$70$YR$$F$Y$$$20240927$$CN$US$US
242704631$24270463$1$I$$20240827$20240830$20240830$EXP$$CN-ABBVIE-5899108$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240830$$HP$CN$CN
242704641$24270464$1$I$$20240822$20240830$20240830$PER$$US-009507513-2408USA009000$MERCK$Hansen L, Lindahl AC, Eller EB, Day CS.. Cutibacterium acnes Infection as a Cause of Nonunion After Ulnar-Shortening Osteotomy. Orthopedics. 2024;47(4):e211-3$$$$M$Y$$$20240830$$HP$US$US
242704653$24270465$3$F$20240101$20240923$20240830$20240925$EXP$$US-ABBVIE-5901364$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
242704661$24270466$1$I$20240825$20240829$20240830$20240830$EXP$$US-ABBVIE-5901778$ABBVIE$$76$YR$$F$Y$$$20240830$$CN$US$US
242704671$24270467$1$I$20240714$20240822$20240830$20240830$EXP$$CA-ABBVIE-5899558$ABBVIE$$40$YR$$M$Y$$$20240830$$PH$CA$CA
242704681$24270468$1$I$$20240821$20240830$20240830$PER$$US-ABBVIE-5891818$ABBVIE$$$$$$Y$$$20240830$$CN$US$US
242704691$24270469$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5899796$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242704701$24270470$1$I$$20240826$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136092$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240831$$HP$US$US
242704711$24270471$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024173602$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242704721$24270472$1$I$$20240821$20240830$20240830$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133370$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$78.47$KG$20240831$$CN$US$US
242704731$24270473$1$I$$20240821$20240830$20240830$EXP$$US-GSK-US2024104479$GLAXOSMITHKLINE$$$$$F$Y$$$20240830$$CN$US$US
242704741$24270474$1$I$20240101$20240828$20240830$20240830$EXP$$HR-009507513-2408HRV010172$MERCK$$75$YR$$F$Y$$$20240830$$MD$HR$HR
242704751$24270475$1$I$20240801$20240820$20240830$20240830$EXP$$US-ABBVIE-5889932$ABBVIE$$66$YR$$F$Y$$$20240830$$CN$US$US
242704761$24270476$1$I$20240823$20240829$20240830$20240830$EXP$$AU-ABBVIE-5900836$ABBVIE$$86$YR$$M$Y$$$20240830$$HP$AU$AU
242704771$24270477$1$I$$20240731$20240830$20240830$PER$$US-SMPA-2024SPA000655$SUNOVION$$$$$$Y$$$20240830$$CN$US$US
242704781$24270478$1$I$$20240823$20240830$20240830$EXP$$US-NOVITIUMPHARMA-2024USNVP01746$NOVITIUM PHARMA$$76$YR$E$F$Y$$$20240831$$CN$US$US
242704791$24270479$1$I$$20240821$20240830$20240830$EXP$GB-MHRA-MED-202408211359586690-GSZLK$GB-TEVA-VS-3236420$TEVA$$82$YR$$$Y$$$20240830$$HP$GB$GB
242704801$24270480$1$I$20240820$20240826$20240830$20240830$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000254$DENDREON$$$$$$Y$$$20240830$$HP$US$US
242704811$24270481$1$I$$20240828$20240830$20240830$EXP$$HR-ABBVIE-5899660$ABBVIE$Krecak I, Supe M, Markov B, Skelin M, Lucijanic M. Fatal heart tamponade during induction treatment with azacitidine and venetoclax. Ann Hematol. 2024.$62$YR$$M$Y$$$20240830$$HP$HR$HR
242704821$24270482$1$I$20240627$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024173664$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242704831$24270483$1$I$20240614$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024173669$AMGEN$$$$$$Y$$$20240830$$PH$US$US
242704841$24270484$1$I$$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172067$AMGEN$$$$$$Y$$$20240830$$CN$US$US
242704851$24270485$1$I$20240101$20240826$20240830$20240830$EXP$$US-ABBVIE-5897372$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242704861$24270486$1$I$20240101$20240820$20240830$20240830$EXP$$GB-ABBVIE-5891600$ABBVIE$$65$YR$$F$Y$$$20240830$$MD$GB$GB
242704881$24270488$1$I$20240820$20240823$20240830$20240830$EXP$$CN-ABBVIE-5895038$ABBVIE$$58$YR$$F$Y$55$KG$20240830$$MD$CN$CN
242704891$24270489$1$I$20240820$20240821$20240830$20240830$EXP$GB-MHRA-MED-202408211223360470-YQBGF$GB-TEVA-VS-3236249$TEVA$$43$YR$$M$Y$$$20240830$$CN$GB$GB
242704901$24270490$1$I$$20240828$20240830$20240830$EXP$$US-ABBVIE-5901834$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242704911$24270491$1$I$$20240722$20240830$20240830$PER$$US-AMGEN-USASP2024171877$AMGEN$$$$$M$Y$$$20240830$$PH$US$US
242704921$24270492$1$I$20240820$20240821$20240830$20240830$EXP$$US-GSK-US2024104588$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240830$$CN$US$US
242704931$24270493$1$I$$20240821$20240830$20240830$PER$$US-APOTEX-2024AP009845$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242704941$24270494$1$I$20240101$20240821$20240830$20240830$EXP$GB-MHRA-MED-202408202027029230-NVSPL$GB-TEVA-VS-3236095$TEVA$$40$YR$$F$Y$89$KG$20240830$$CN$GB$GB
242704951$24270495$1$I$20240801$20240828$20240830$20240830$PER$$US-AMGEN-USASP2024172660$AMGEN$$70$YR$E$F$Y$$$20240830$$CN$US$US
242704961$24270496$1$I$20240824$20240826$20240830$20240830$PER$$US-AMGEN-USASP2024170490$AMGEN$$81$YR$E$F$Y$$$20240830$$CN$US$US
242704971$24270497$1$I$$20240821$20240830$20240830$EXP$$US-APOTEX-2024AP009957$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242704981$24270498$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024172555$AMGEN$$$$$$Y$$$20240830$$CN$US$US
242704991$24270499$1$I$$20240821$20240830$20240830$EXP$$US-APOTEX-2024AP009958$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242705001$24270500$1$I$$20240827$20240830$20240830$PER$$US-ABBVIE-5900864$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242705011$24270501$1$I$$20240821$20240830$20240830$30DAY$$US-GSK-US2024104591$GLAXOSMITHKLINE$$$$$$Y$$$20240830$$MD$US$US
242705021$24270502$1$I$20240101$20240827$20240830$20240830$EXP$$US-ABBVIE-5898957$ABBVIE$$$$$F$Y$$$20240830$$CN$US$US
242705031$24270503$1$I$$20240821$20240830$20240830$EXP$$US-APOTEX-2024AP009959$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240830$$HP$US$US
242705041$24270504$1$I$$20240828$20240830$20240830$EXP$$CA-ABBVIE-5900632$ABBVIE$$$$E$M$Y$$$20240830$$HP$CA$CA
242705061$24270506$1$I$$20240827$20240830$20240830$PER$$US-AMGEN-USASP2024171348$AMGEN$$$$$M$Y$$$20240830$$CN$US$US
242705071$24270507$1$I$20240801$20240826$20240831$20240831$EXP$$US-ABBVIE-5896647$ABBVIE$$70$YR$$F$Y$$$20240830$$CN$US$US
242705081$24270508$1$I$$20240815$20240831$20240831$PER$$US-NOVITIUMPHARMA-2024USNVP01737$NOVITIUM PHARMA$$$$$M$Y$$$20240831$$CN$US$US
242705091$24270509$1$I$20240812$20240830$20240831$20240831$EXP$$CN-ROCHE-10000070331$ROCHE$$34$YR$A$F$Y$69$KG$20240831$$HP$CN$CN
242705101$24270510$1$I$$20240827$20240831$20240831$EXP$$US-ABBVIE-5898778$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242705111$24270511$1$I$$20240826$20240831$20240831$PER$$US-ABBVIE-5896706$ABBVIE$$$$$$Y$$$20240831$$CN$US$US
242705121$24270512$1$I$20240828$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172396$AMGEN$$$$$$Y$$$20240830$$CN$US$US
242705131$24270513$1$I$$20240825$20240831$20240831$EXP$$US-GSK-US2024AMR105800$GLAXOSMITHKLINE$$$$$$Y$$$20240831$$CN$US$US
242705141$24270514$1$I$20240701$20240829$20240831$20240831$EXP$$MM-ROCHE-10000070348$ROCHE$$36$YR$A$F$Y$$$20240831$$CN$MM$MM
242705151$24270515$1$I$20240101$20240826$20240831$20240831$EXP$$CA-ABBVIE-5898197$ABBVIE$$64$YR$$F$Y$$$20240831$$CN$CA$CA
242705161$24270516$1$I$20230101$20240829$20240831$20240831$EXP$$CA-ABBVIE-5343938$ABBVIE$$$$$F$Y$$$20240831$$CN$CA$CA
242705181$24270518$1$I$$20240822$20240831$20240831$PER$$US-NOVITIUMPHARMA-2024USNVP01738$NOVITIUM PHARMA$$$$$F$Y$$$20240831$$CN$US$US
242705191$24270519$1$I$$20240822$20240831$20240831$30DAY$$US-GSK-US2024105079$GLAXOSMITHKLINE$$$$$M$Y$$$20240831$$CN$US$US
242705201$24270520$1$I$$20240827$20240831$20240831$PER$$US-ABBVIE-5898325$ABBVIE$$$$$$Y$$$20240831$$CN$US$US
242705221$24270522$1$I$20240201$20240828$20240831$20240831$EXP$$US-ABBVIE-5892737$ABBVIE$$11$YR$$M$Y$49.895$KG$20240831$$CN$US$US
242705251$24270525$1$I$20240101$20240826$20240831$20240831$EXP$$US-ABBVIE-5679724$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242705261$24270526$1$I$$20240820$20240831$20240831$EXP$$US-862174955-ML2024-04638$Unknown Manufacturer$Sorabella RA, Gray WH, Dabal RJ, Padilla LA, Hock K, Clark MG, et al. Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal. 2023 Nov;70(7): e92-e96. doi:10.1097/MAT.0000000000002102.$17$YR$T$M$Y$85$KG$20240831$$HP$US$US
242705271$24270527$1$I$$20240827$20240831$20240831$PER$$US-AMGEN-USASP2024171973$AMGEN$$$$A$M$Y$$$20240830$$MD$US$US
242705291$24270529$1$I$$20240826$20240831$20240831$EXP$$JP-ABBVIE-5901670$ABBVIE$Maho Minai, Kazutaka Kitayama, Noritomo Narita, Manabu Yonekura, Yuichi Sotoyama, Chisato Kato, et al. Cardiac arrest resulting from long QT syndrome (LQTS) triggered by sudden change in patient^s father - a case report. The 177th Tohoku Regional Meeting of the Japanese Circulation Society. 2023;47$43$YR$$F$Y$$$20240831$$MD$JP$JP
242705301$24270530$1$I$20240801$20240828$20240831$20240831$EXP$$US-ABBVIE-5901321$ABBVIE$$80$YR$$M$Y$$$20240831$$CN$US$US
242705311$24270531$1$I$20240715$20240823$20240831$20240831$EXP$$CN-ABBVIE-5894566$ABBVIE$$65$YR$$F$Y$40$KG$20240831$$MD$CN$CN
242705321$24270532$1$I$$20240821$20240831$20240831$EXP$$CA-MEDLEY-000023$MEDLEY PHARMACEUTICALS$$16$YR$T$M$Y$$$20240823$$MD$CA$CA
242705331$24270533$1$I$20240814$20240828$20240831$20240831$EXP$$CN-ROCHE-10000068684$ROCHE$$71$YR$E$F$Y$55$KG$20240831$$HP$CN$CN
242705341$24270534$1$I$20230101$20240827$20240831$20240831$EXP$$US-ABBVIE-5898755$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242705351$24270535$1$I$20240101$20240829$20240831$20240831$EXP$$US-ABBVIE-5901762$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242705361$24270536$1$I$20240826$20240827$20240831$20240831$PER$$US-AMGEN-USASP2024171497$AMGEN$$80$YR$E$F$Y$$$20240830$$CN$US$US
242705371$24270537$1$I$$20240822$20240831$20240831$PER$$US-ABBVIE-5891366$ABBVIE$$$$$M$Y$$$20240831$$MD$US$US
242705401$24270540$1$I$$20240821$20240831$20240831$EXP$GB-MHRA-MED-202408211733525570-ZVMKT$GB-TEVA-VS-3236344$TEVA$$$$$F$Y$$$20240831$$HP$GB$GB
242705412$24270541$2$F$20240716$20240920$20240831$20240930$PER$$US-GSK-US2024104942$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240930$$HP$US$US
242705421$24270542$1$I$20240811$20240823$20240831$20240831$EXP$$CN-AMGEN-CHNSP2024170475$AMGEN$$61$YR$A$F$Y$$$20240830$$HP$CN$CN
242705431$24270543$1$I$$20240823$20240831$20240831$EXP$$AU-CELLTRION INC.-2024AU020733$CELLTRION$$$$$$Y$$$20240831$$MD$AU$AU
242705441$24270544$1$I$$20240816$20240831$20240831$EXP$$FR-Nuvo Pharmaceuticals Inc-2161073$NUVO PHARMACEUTICALS$Source document (Abstract).$40$YR$$M$Y$$$20240831$$$FR$FR
242705451$24270545$1$I$$20240828$20240831$20240831$EXP$$JP-ABBVIE-5901330$ABBVIE$$51$YR$$M$Y$$$20240831$$HP$JP$JP
242705461$24270546$1$I$$20240821$20240831$20240831$PER$$US-ABBVIE-5893047$ABBVIE$$$$$M$Y$$$20240831$$HP$US$US
242705471$24270547$1$I$$20240826$20240831$20240831$EXP$$KR-AMGEN-KORSP2024171702$AMGEN$$22$YR$A$F$Y$$$20240830$$PH$KR$KR
242705481$24270548$1$I$20240601$20240821$20240831$20240831$30DAY$$US-GSK-US2024104491$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240831$$CN$US$US
242705491$24270549$1$I$20240701$20240822$20240831$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR105789$VIIV$$27$YR$$M$Y$$$20240831$$PH$US$US
242705501$24270550$1$I$$20240830$20240831$20240831$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048898$BOEHRINGER INGELHEIM$$$$$$Y$$$20240831$$CN$US$US
242705511$24270551$1$I$$20240822$20240831$20240831$30DAY$$US-GSK-US2024105087$GLAXOSMITHKLINE$$$$$F$Y$$$20240831$$CN$US$US
242705521$24270552$1$I$$20240820$20240831$20240831$EXP$GB-MHRA-MED-202406200035020410-NFZCY$GB-Accord-431930$ACCORD$$$$$M$Y$$$20240831$$CN$GB$GB
242705532$24270553$2$F$20240310$20240819$20240831$20240831$EXP$GB-MHRA-MED-202408190134368090-SQLMH$GB-Accord-442462$ACCORD$$41$YR$A$F$Y$127$KG$20240831$$CN$GB$GB
242705541$24270554$1$I$$20240827$20240831$20240831$PER$$US-AMGEN-USASP2024172371$AMGEN$$$$$$Y$$$20240830$$CN$US$US
242705552$24270555$2$F$20240723$20240904$20240831$20240906$PER$$US-ABBVIE-5901348$ABBVIE$$19$YR$$F$Y$$$20240906$$MD$US$US
242705562$24270556$2$F$$20240821$20240831$20240904$PER$$US-ABBVIE-5895441$ABBVIE$$$$$M$Y$$$20240904$$HP$US$US
242705591$24270559$1$I$$20240822$20240831$20240831$PER$$US-ABBVIE-5893285$ABBVIE$$$$$F$Y$$$20240831$$MD$US$US
242705601$24270560$1$I$$20240820$20240831$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR107152$VIIV$$$$$$Y$$$20240831$$HP$US$US
242705612$24270561$2$F$20240101$20240826$20240831$20240905$PER$$US-AMGEN-USASP2024170798$AMGEN$$80$YR$E$F$Y$$$20240905$$CN$US$US
242705621$24270562$1$I$$20240824$20240831$20240831$EXP$$GB-ABBVIE-5900153$ABBVIE$$$$$M$Y$$$20240831$$CN$GB$GB
242705631$24270563$1$I$20240101$20240821$20240831$20240831$PER$$US-ABBVIE-5893076$ABBVIE$$24$YR$$F$Y$$$20240831$$MD$US$US
242705641$24270564$1$I$$20240828$20240831$20240831$PER$$US-ABBVIE-5900769$ABBVIE$$$$$$Y$$$20240831$$CN$US$US
242705651$24270565$1$I$20240503$20240819$20240831$20240831$EXP$$US-UCBSA-2024022423$UCB$$32$YR$$F$Y$$$20240831$$CN$US$US
242705661$24270566$1$I$20240101$20240822$20240831$20240831$PER$$US-SA-2024SA252333$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240831$$CN$US$US
242705672$24270567$2$F$$20240823$20240831$20240904$EXP$$NVSJ2022JP095180$NOVARTIS$Saito K, Matsuura R, Daida A, Hirata Y, Koichihara R, Kikuchi K et al.. A case of pediatric multiple sclerosis treated with fingolimod hydrochloride. OFFICIAL JOURNAL OF THE JAPANESE SOCIETY OF CHILD NEUROLOGY. 2022;54:S267$14$YR$$F$Y$$$20240904$$HP$JP$JP
242705681$24270568$1$I$20240801$20240827$20240831$20240831$EXP$$US-ABBVIE-5898419$ABBVIE$$74$YR$$M$Y$$$20240831$$CN$US$US
242705691$24270569$1$I$$20240821$20240831$20240831$PER$$US-ABBVIE-5892062$ABBVIE$$$$$$Y$$$20240831$$MD$US$US
242705711$24270571$1$I$$20240827$20240831$20240831$EXP$$CA-ABBVIE-5899564$ABBVIE$$$$A$M$Y$$$20240831$$MD$CA$CA
242705721$24270572$1$I$20240824$20240826$20240831$20240831$EXP$$CO-ABBVIE-5901367$ABBVIE$$62$YR$$M$Y$73$KG$20240831$$HP$CO$CO
242705731$24270573$1$I$$20240823$20240831$20240831$PER$$US-AstraZeneca-2024A193481$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$US$
242705741$24270574$1$I$$20240822$20240831$20240831$PER$$US-SA-2024SA252214$SANOFI AVENTIS$$14$YR$T$F$Y$44$KG$20240831$$CN$US$US
242705751$24270575$1$I$20240301$20240821$20240831$20240831$PER$$US-ABBVIE-5894303$ABBVIE$$80$YR$$F$Y$$$20240831$$CN$US$US
242705761$24270576$1$I$20240830$20240830$20240831$20240831$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048890$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240831$$CN$US$US
242705771$24270577$1$I$$20240823$20240831$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-026963$UNITED THERAPEUTICS$$$$$F$Y$55.782$KG$20240831$$$US$US
242705782$24270578$2$F$$20240925$20240831$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138261$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$88.9$KG$20240926$$CN$US$US
242705791$24270579$1$I$20240801$20240826$20240831$20240831$EXP$$US-ABBVIE-5897507$ABBVIE$$49$YR$$F$Y$$$20240831$$CN$US$US
242705801$24270580$1$I$$20240827$20240831$20240831$EXP$$NVSC2024US175441$NOVARTIS$Edelbach BM, Gospodarev V, Raghavan R, Dye J. Primary intracranial sarcoma, DICER-1 mutant, with hemorrhagic presentation: A case report. SURGICAL NEUROLOGY INTERNATIONAL. 2024;15:253$26$YR$$M$Y$$$20240831$$HP$US$US
242705811$24270581$1$I$$20240827$20240831$20240831$PER$$US-ABBVIE-5899393$ABBVIE$$$$$F$Y$$$20240831$$HP$US$US
242705821$24270582$1$I$$20240822$20240831$20240831$PER$$US-ABBVIE-5893022$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242705832$24270583$2$F$20240821$20240906$20240831$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-026660$UNITED THERAPEUTICS$$79$YR$$F$Y$69.841$KG$20240914$$$US$US
242705842$24270584$2$F$20240101$20240830$20240831$20240906$EXP$$US-ABBVIE-5897569$ABBVIE$$$$$M$Y$84.368$KG$20240906$$CN$US$US
242705851$24270585$1$I$$20240826$20240831$20240831$EXP$$US-ABBVIE-5896053$ABBVIE$$$$$F$Y$54.431$KG$20240831$$CN$US$US
242705861$24270586$1$I$$20240822$20240831$20240831$EXP$$CA-AstraZeneca-2024A194819$ASTRAZENECA$$36$YR$$F$Y$$$20240831$$MD$CA$
242705872$24270587$2$F$20230418$20240903$20240831$20240910$EXP$$US-ABBVIE-5897155$ABBVIE$$76$YR$$M$Y$$$20240910$$CN$US$US
242705881$24270588$1$I$$20240820$20240831$20240831$EXP$$US-CPL-004549$CADILA$Acuff KN, Villatoro GA, Baxter SL. Acute Bilateral Periorbital Edema in a Psychiatric Patient. JAMA Ophthalmol. 2024 Aug 1.$$$$M$Y$$$20240831$$HP$US$US
242705891$24270589$1$I$20240801$20240826$20240831$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-026790$UNITED THERAPEUTICS$$55$YR$$F$Y$45.351$KG$20240831$$$US$US
242705901$24270590$1$I$$20240826$20240831$20240831$PER$$US-ABBVIE-5895987$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242705912$24270591$2$F$20240730$20240830$20240831$20240906$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048778$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240906$$HP$CN$CN
242705921$24270592$1$I$$20240826$20240831$20240831$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138773$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240831$$CN$US$US
242705931$24270593$1$I$20240809$20240829$20240831$20240831$EXP$$CA-ABBVIE-5901836$ABBVIE$$77$YR$$$Y$$$20240831$$CN$CA$CA
242705941$24270594$1$I$20240820$20240821$20240831$20240831$30DAY$$US-GSK-US2024104563$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240831$$CN$US$US
242705951$24270595$1$I$$20240822$20240831$20240831$PER$$US-SA-2024SA252616$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240831$$CN$US$US
242705961$24270596$1$I$$20240820$20240831$20240831$PER$$US-AstraZeneca-2024A189972$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$US$
242705971$24270597$1$I$20240701$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173035$AMGEN$$$$A$M$Y$$$20240830$$CN$US$US
242705981$24270598$1$I$20190227$20240829$20240831$20240831$EXP$$JP-ABBVIE-18S-087-2525577-00$ABBVIE$$79$YR$$M$Y$$$20240831$$MD$JP$JP
242705991$24270599$1$I$$20240821$20240831$20240831$EXP$$US-ASTELLAS-2024-AER-003348$ASTELLAS$$80$YR$E$M$Y$$$20240831$$CN$US$US
242706001$24270600$1$I$20240825$20240827$20240831$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202408017257$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240831$$CN$US$US
242706011$24270601$1$I$20230101$20240827$20240831$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-026941$UNITED THERAPEUTICS$$$$$M$Y$75.193$KG$20240831$$$US$US
242706021$24270602$1$I$$20240828$20240831$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-017475$UNITED THERAPEUTICS$$$$$F$Y$88.435$KG$20240831$$$US$US
242706032$24270603$2$F$$20240906$20240831$20240916$30DAY$$US-GSK-US2024AMR105231$GLAXOSMITHKLINE$$$$$M$Y$$$20240916$$CN$US$US
242706041$24270604$1$I$$20240821$20240831$20240831$30DAY$$US-GSK-US2024AMR105167$GLAXOSMITHKLINE$$$$$M$Y$$$20240831$$CN$US$US
242706051$24270605$1$I$$20240531$20240831$20240831$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450355$RANBAXY$$$$E$$Y$$$20240831$$PH$US$US
242706061$24270606$1$I$$20240723$20240831$20240831$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459524$RANBAXY$$$$$M$Y$$$20240831$$CN$US$US
242706071$24270607$1$I$$20240711$20240831$20240831$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458262$RANBAXY$$74$YR$$M$Y$105.67$KG$20240831$$CN$US$US
242706081$24270608$1$I$$20240625$20240831$20240831$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455142$RANBAXY$$$$E$M$Y$$$20240831$$HP$US$US
242706091$24270609$1$I$$20240517$20240831$20240831$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-448549$RANBAXY$$73$YR$$M$Y$$$20240831$$HP$US$US
242706101$24270610$1$I$$20240827$20240831$20240831$EXP$$US-ABBVIE-5898553$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242706111$24270611$1$I$$20240716$20240831$20240831$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458839$RANBAXY$$$$A$M$Y$$$20240831$$HP$US$US
242706121$24270612$1$I$$20240627$20240831$20240831$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455704$RANBAXY$$$$E$F$Y$$$20240831$$CN$US$US
242706131$24270613$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5899567$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242706141$24270614$1$I$$20240807$20240831$20240831$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458261$RANBAXY$$$$E$M$Y$$$20240831$$HP$US$US
242706151$24270615$1$I$$20240827$20240831$20240831$EXP$$NO-ABBVIE-5902703$ABBVIE$$$$$$Y$$$20240831$$HP$NO$NO
242706171$24270617$1$I$$20240827$20240831$20240831$PER$$US-ABBVIE-5899207$ABBVIE$$$$$$Y$$$20240831$$CN$US$US
242706181$24270618$1$I$20240731$20240827$20240831$20240831$EXP$$US-ABBVIE-5899348$ABBVIE$$73$YR$$F$Y$$$20240831$$CN$US$US
242706192$24270619$2$F$20240919$20240920$20240831$20240930$EXP$$CA-CELLTRION INC.-2024CA020732$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
242706201$24270620$1$I$$20240826$20240831$20240831$PER$$US-AstraZeneca-2024A194949$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242706211$24270621$1$I$$20240827$20240831$20240831$EXP$$BD-Bion-013748$BIONPHARMA$$76$YR$E$M$Y$$$20240831$$HP$BD$BD
242706221$24270622$1$I$20240820$20240820$20240831$20240831$PER$$US-SA-2024SA252202$SANOFI AVENTIS$$$$$$Y$$$20240831$$HP$US$US
242706231$24270623$1$I$$20240827$20240831$20240831$EXP$$IT-Bion-013747$BIONPHARMA$$53$YR$A$M$Y$$$20240831$$HP$IT$IT
242706241$24270624$1$I$$20240822$20240831$20240831$PER$$US-AMGEN-USASP2024172223$AMGEN$$$$$M$Y$$$20240831$$CN$US$US
242706261$24270626$1$I$$20240822$20240831$20240831$30DAY$$US-GSK-US2024105083$GLAXOSMITHKLINE$$$$E$F$Y$$$20240831$$CN$US$US
242706271$24270627$1$I$$20240822$20240831$20240831$30DAY$$US-GSK-US2024105097$GLAXOSMITHKLINE$$$$$F$Y$$$20240831$$CN$US$US
242706282$24270628$2$F$20230101$20240911$20240831$20240916$PER$$US-ABBVIE-5892011$ABBVIE$$$$$M$Y$68.038$KG$20240916$$CN$US$US
242706291$24270629$1$I$$20240822$20240831$20240831$EXP$$GB-TEVA-VS-3236877$TEVA$$2$DEC$$F$Y$$$20240831$$MD$GB$GB
242706301$24270630$1$I$$20240822$20240831$20240831$EXP$$US-AMGEN-USASP2024173906$AMGEN$$$$$$Y$$$20240831$$MD$US$US
242706311$24270631$1$I$$20240822$20240831$20240831$PER$$US-AstraZeneca-2024A192728$ASTRAZENECA$$$$$$Y$$$20240831$$CN$US$
242706321$24270632$1$I$20240819$20240822$20240831$20240831$PER$$US-AMGEN-USASP2024173262$AMGEN$$$$$M$Y$$$20240831$$HP$US$US
242706331$24270633$1$I$20240510$20240821$20240831$20240831$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-015006$UNITED THERAPEUTICS$$73$YR$$M$Y$$$20240831$$PH$JP$JP
242706341$24270634$1$I$20240605$20240822$20240831$20240831$EXP$GB-MHRA-MIDB-eeb7c531-1a52-4db5-bfc8-62a59572d727$GB-TEVA-VS-3236922$TEVA$$73$YR$$F$Y$$$20240831$$PH$GB$GB
242706351$24270635$1$I$20240823$20240827$20240831$20240831$EXP$$JP-ABBVIE-5898196$ABBVIE$$21$YR$$M$Y$52.8$KG$20240831$$MD$JP$JP
242706361$24270636$1$I$$20240822$20240831$20240831$PER$$US-SA-2024SA252889$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240831$$MD$US$US
242706371$24270637$1$I$$20240826$20240831$20240831$PER$$US-AMGEN-USASP2024171659$AMGEN$$$$$M$Y$$$20240831$$CN$US$US
242706382$24270638$2$F$20240101$20240902$20240831$20240906$EXP$IT-MINISAL02-989023$IT-ABBVIE-5900231$ABBVIE$$68$YR$$F$Y$$$20240906$$MD$IT$IT
242706392$24270639$2$F$$20240828$20240831$20240905$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03120$AMNEAL$$$$$F$Y$$$20240905$$CN$US$US
242706401$24270640$1$I$20240828$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172894$AMGEN$$70$YR$E$F$Y$$$20240831$$CN$US$US
242706411$24270641$1$I$20240101$20240827$20240831$20240831$EXP$$US-ABBVIE-5353412$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242706421$24270642$1$I$$20240821$20240831$20240831$EXP$$US-GSK-US2024GSK105865$GLAXOSMITHKLINE$$$$$$Y$$$20240831$$MD$US$US
242706431$24270643$1$I$$20240826$20240831$20240831$EXP$$RU-AUROBINDO-AUR-APL-2024-043044$AUROBINDO$Malyshev SM, Popov KD, Simakov KV, Marichev AO, Topuzova MP, Smirnova AY, et al. [Status epilepticus in a pregnant patient with a previously unrecognized POLG-associated disease]. [Russian]. Zh-Nevropatol-Psikhiatr-Im-S-S-Korsakova (J-Neuropathy-Psychiatrist-Im-S-S-Korsa. 2023;123(10):129-135$33$YR$$F$Y$$$20240831$$HP$RU$RU
242706441$24270644$1$I$20240101$20240826$20240831$20240831$EXP$$DE-ABBVIE-5898581$ABBVIE$$67$YR$$$Y$$$20240831$$CN$DE$DE
242706451$24270645$1$I$20240101$20240827$20240831$20240831$EXP$$US-ABBVIE-5898876$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242706461$24270646$1$I$$20240827$20240831$20240831$PER$$US-ABBVIE-5899795$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242706471$24270647$1$I$$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172417$AMGEN$$$$$$Y$$$20240831$$CN$US$US
242706491$24270649$1$I$$20240822$20240831$20240831$EXP$$US-AMGEN-USASP2024168704$AMGEN$Kong B. L.; Stommel J. M.; Keck J. M. et al.. Exceptional Response to Trastuzumab Deruxtecan in a Patient with Recurrent Ovarian Clear Cell Carcinoma with Human Epidermal Growth Factor Receptor 2 Expression. JCO Precision Oncology. 2024;1-7$67$YR$E$F$Y$$$20240831$$HP$US$US
242706501$24270650$1$I$$20240823$20240831$20240831$EXP$$AU-AMGEN-AUSSP2024169279$AMGEN$Rosettenstein K.; Parasyn A.; Neville K. et al.. Neonatal Severe Hyperparathyroidism Causing Life-Threatening Hypercalcemia Treated With Medical and Surgical Management. JCEM case reports. 2024;2 (8):1-6$3$DY$N$M$Y$$$20240831$$MD$AU$AU
242706511$24270651$1$I$$20240822$20240831$20240831$EXP$$US-RDY-SPO/USA/24/0012548$DR REDDYS$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 06;73: doi:10.1007/s00262-024-03775-6.$71$YR$E$F$Y$$$20240831$$HP$US$US
242706521$24270652$1$I$$20240828$20240831$20240831$PER$$US-AstraZeneca-2024A196331$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242706531$24270653$1$I$$20240827$20240831$20240831$PER$$US-AstraZeneca-2024A195541$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242706541$24270654$1$I$20240101$20240828$20240831$20240831$EXP$SI-JAZMP-NCPHV-2024SI0845_0845$SI-ABBVIE-5898271$ABBVIE$$$$$F$Y$$$20240831$$CN$SI$SI
242706552$24270655$2$F$$20240819$20240831$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-042117$AUROBINDO$Gallagher K, Ortenberg R, Toprak D. A Rare Pediatric Case of Anti-melanoma Differentiationassociated Gene 5 Rapidly Progressive Interstitial Lung Disease. Am-J-Respir-Crit-Care-Med. 2023;207:A5475$6$YR$$M$Y$$$20240902$$HP$US$US
242706561$24270656$1$I$20240815$20240823$20240831$20240831$EXP$$CN-ABBVIE-5901898$ABBVIE$$65$YR$$F$Y$53$KG$20240831$$MD$CN$CN
242706571$24270657$1$I$$20240822$20240831$20240831$EXP$$IN-NOVITIUMPHARMA-2024INNVP01719$NOVITIUM PHARMA$Prabhjot Kaur.Carbamazepine-Triggered Hemophagocytic Lymphohistiocytosis: A Case Report and Review of Literature.Pediatric Neurology.23-MAR-2023;144:69-71$4$YR$C$F$Y$$$20240831$$HP$IN$IN
242706581$24270658$1$I$20240101$20240814$20240831$20240831$EXP$$ZA-ABBVIE-5902527$ABBVIE$$$$$M$Y$$$20240831$$MD$ZA$ZA
242706591$24270659$1$I$$20240826$20240831$20240831$PER$$US-AMGEN-USASP2024173046$AMGEN$$$$$M$Y$$$20240831$$CN$US$US
242706601$24270660$1$I$$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024173769$AMGEN$$$$A$F$Y$$$20240831$$HP$US$US
242706612$24270661$2$F$$20240819$20240831$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-042038$AUROBINDO$Alagha Z, Crow S, Abdeen AMZ, Alastal M, Alastal A. Cefepime Neurotoxicity in Patients With Normal Renal Function: An Overlooked Cause of Encephalopathy in the Intensive Care Unit. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-5$69$YR$$F$Y$$$20240902$$MD$US$US
242706622$24270662$2$F$20240815$20240820$20240831$20240902$EXP$$GB-AUROBINDO-AUR-APL-2024-042102$AUROBINDO$$51$YR$$F$Y$$$20240902$$CN$GB$GB
242706632$24270663$2$F$$20240903$20240831$20240917$EXP$$US-AUROBINDO-AUR-APL-2024-041694$AUROBINDO$Schwartz W, Christiansen AC, Patel SS.. Intraorbital amphotericin B for mucormycosis in an Allo-HSCT recipient. Bone Marrow Transplantation. 2024;59(8):176-7$68$YR$$M$Y$$$20240917$$MD$US$US
242706642$24270664$2$F$$20240903$20240831$20240904$EXP$$US-SA-2024SA252343$SANOFI AVENTIS$Hui J, Zhan X, Bashir A, Policeni F,  Hsieh Kim SU.. Epithelial-myoepithelial carcinoma occurrence in the site of previously treated ductal carcinoma in situ of the breast: Imaging features with histopathologic correlation, a case report and review of the literature.. Clin Case Rep.. 2024;12(8):1-6$75$YR$E$F$Y$$$20240904$$MD$US$US
242706652$24270665$2$F$$20240819$20240831$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-042161$AUROBINDO$Sidhu SK, Ciancarelli J, Alviar C, Greco A. Case of Severe Cardiopulmonary Sarcoidosis and Sub-massive Pulmonary Embolism. US-Cardiol. 2024;18 (Suppl. 1):25-26$68$YR$$M$Y$$$20240902$$HP$US$US
242706661$24270666$1$I$$20240820$20240831$20240831$EXP$$DE-AUROBINDO-AUR-APL-2024-042364$AUROBINDO$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift. Fortschritte der Medizin. 2024;166 (13):48-51$79$YR$$M$Y$$$20240831$$HP$DE$DE
242706671$24270667$1$I$$20240827$20240831$20240831$EXP$$US-ABBVIE-5899701$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242706682$24270668$2$F$20240723$20240820$20240831$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-042221$AUROBINDO$$78$YR$$M$Y$$$20240902$$MD$FR$FR
242706691$24270669$1$I$$20240822$20240831$20240831$EXP$$US-RDY-SPO/USA/24/0012549$DR REDDYS$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 06;73: doi:10.1007/s00262-024-03775-6.$60$YR$A$F$Y$$$20240831$$HP$US$US
242706701$24270670$1$I$20240101$20240828$20240831$20240831$EXP$$US-ABBVIE-5899866$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242706712$24270671$2$F$$20240819$20240831$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-042012$AUROBINDO$Difiore E, Pittman J.. A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting. Case-Rep-Psychiatry. 2024;Arti ID 8824770:1-4$54$YR$$M$Y$$$20240902$$HP$US$US
242706721$24270672$1$I$$20240827$20240831$20240831$EXP$$US-ABBVIE-5898848$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242706731$24270673$1$I$20240821$20240829$20240831$20240831$EXP$$US-AstraZeneca-2024A197751$ASTRAZENECA$$27566$DY$$F$Y$$$20240831$$CN$US$
242706742$24270674$2$F$$20240916$20240831$20240918$EXP$$US-AstraZeneca-2024A196311$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
242706751$24270675$1$I$$20240821$20240831$20240831$EXP$$US-GSK-US2024AMR105628$GLAXOSMITHKLINE$$$$$F$Y$111$KG$20240831$$CN$US$US
242706761$24270676$1$I$$20240829$20240831$20240831$EXP$$US-AstraZeneca-2024A197629$ASTRAZENECA$$$$$$Y$$$20240831$$CN$US$
242706771$24270677$1$I$20240819$20240829$20240831$20240831$EXP$$US-AstraZeneca-2024A197561$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$US$
242706781$24270678$1$I$$20240827$20240831$20240831$EXP$$US-AstraZeneca-2024A196010$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$US$
242706791$24270679$1$I$20240617$20240827$20240831$20240831$PER$$US-AMGEN-USASP2024171827$AMGEN$$$$$M$Y$$$20240831$$CN$US$US
242706801$24270680$1$I$$20240827$20240831$20240831$PER$$US-ABBVIE-5899542$ABBVIE$$$$$F$Y$49$KG$20240831$$CN$US$US
242706812$24270681$2$F$$20240917$20240831$20240926$EXP$$PT-AUROBINDO-AUR-APL-2024-042504$AUROBINDO$Caldeira E, Moniz E, Loja J, Almada S, Gomes S, Henriques CF, et al. Um caso raro de tetania no servi?o de urg?ncia (A rare case of tetany in the emergency department.). Medicina Interna (Internal Medicine). 2024;30 (Sup 1):762$41$YR$$F$Y$$$20240926$$MD$PT$PT
242706821$24270682$1$I$$20240826$20240831$20240831$EXP$$US-ABBVIE-5896606$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242706832$24270683$2$F$$20240917$20240831$20240927$PER$$US-GSK-US2024AMR105425$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
242706841$24270684$1$I$20240101$20240822$20240831$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026410$UNITED THERAPEUTICS$$$$$F$Y$58.05$KG$20240831$$$US$US
242706851$24270685$1$I$20240601$20240827$20240831$20240831$EXP$$CA-ABBVIE-5898198$ABBVIE$$80$YR$$M$Y$$$20240831$$HP$CA$CA
242706861$24270686$1$I$20240729$20240820$20240831$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-042248$AUROBINDO$$68$YR$$M$Y$$$20240831$$MD$FR$FR
242706871$24270687$1$I$$20240823$20240831$20240831$EXP$$DE-NOVITIUMPHARMA-2024DENVP01735$NOVITIUM PHARMA$Noelle Dyballa.A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting - clinical, toxicological and forensic aspects.Forensic Science, Medicine and Pathology.01-AUG-2024;NA:NA$12$WK$I$M$Y$$$20240831$$HP$DE$DE
242706881$24270688$1$I$$20240820$20240831$20240831$EXP$$DE-AUROBINDO-AUR-APL-2024-042415$AUROBINDO$Groth O, Roider G, Graw M.. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift. Fortschritte der Medizin. 2024;166 (13):48-51$84$YR$$F$Y$$$20240831$$HP$DE$DE
242706892$24270689$2$F$20240821$20240904$20240831$20240906$PER$$US-AMGEN-USASP2024172597$AMGEN$$69$YR$E$F$Y$$$20240906$$CN$US$US
242706901$24270690$1$I$$20240826$20240831$20240831$PER$$US-AstraZeneca-2024A195675$ASTRAZENECA$$$$$F$Y$$$20240831$$HP$US$
242706911$24270691$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5899473$ABBVIE$$$$$F$Y$$$20240831$$HP$US$US
242706921$24270692$1$I$$20240830$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-139563-2023$RECKITT BENCKISER$$95$YR$$M$Y$65.91$KG$20240831$$CN$US$US
242706931$24270693$1$I$20240828$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024171959$AMGEN$$77$YR$E$F$Y$$$20240831$$CN$US$US
242706941$24270694$1$I$20240323$20240830$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-087548-2024$RECKITT BENCKISER$$70$YR$$M$Y$73.64$KG$20240831$$CN$US$US
242706951$24270695$1$I$20240715$20240820$20240831$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-042238$AUROBINDO$$78$YR$$M$Y$60$KG$20240831$$MD$FR$FR
242706972$24270697$2$F$20240701$20240903$20240831$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135933$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240904$$HP$US$US
242706981$24270698$1$I$20240101$20240827$20240831$20240831$EXP$$US-ABBVIE-5898906$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242706991$24270699$1$I$20240611$20240821$20240831$20240831$EXP$IT-MINISAL02-998854$IT-Accord-442889$ACCORD$$68$YR$E$F$Y$$$20240831$$MD$IT$IT
242707001$24270700$1$I$$20240822$20240831$20240831$EXP$GB-MHRA-MIDB-0b987871-d6c4-4d3e-955e-e973ea10c63d$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-111563$ZYDUS PHARM$$$$$$Y$$$20240831$$PH$GB$GB
242707011$24270701$1$I$20230514$20240820$20240831$20240831$EXP$FR-AFSSAPS-PO2024000903$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111344$ZYDUS PHARM$$$$$$Y$$$20240831$$HP$FR$FR
242707021$24270702$1$I$$20240827$20240831$20240831$EXP$$US-ABBVIE-5899758$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242707031$24270703$1$I$20240101$20240827$20240831$20240831$EXP$$US-ABBVIE-5867234$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242707041$24270704$1$I$$20240821$20240831$20240831$EXP$$CN-Merck Healthcare KGaA-2024045147$MERCK KGAA$$$$$F$Y$$$20240830$$CN$CN$CN
242707052$24270705$2$F$$20240829$20240831$20240912$EXP$NL-LRB-00997028$NL-Merck Healthcare KGaA-2024045746$MERCK KGAA$$56$YR$A$F$Y$90$KG$20240906$$CN$NL$NL
242707061$24270706$1$I$20150101$20240821$20240831$20240831$PER$$US-ABBVIE-5893669$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242707071$24270707$1$I$$20240830$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-082202-2024$RECKITT BENCKISER$$$$$F$Y$$$20240831$$CN$US$US
242707081$24270708$1$I$$20240827$20240831$20240831$PER$$US-AMGEN-USASP2024171087$AMGEN$$$$$F$Y$$$20240831$$HP$US$US
242707101$24270710$1$I$20240703$20240820$20240831$20240831$EXP$ES-AEMPS-1561072$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111464$ZYDUS PHARM$$$$$$Y$$$20240831$$MD$ES$ES
242707112$24270711$2$F$20240101$20240829$20240831$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-026760$UNITED THERAPEUTICS$$$$$F$Y$52.608$KG$20240906$$$US$US
242707121$24270712$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5899843$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242707131$24270713$1$I$$20240828$20240831$20240831$EXP$$TW-ASTELLAS-2024-AER-002797$ASTELLAS$$$$$M$Y$$$20240831$$MD$TW$TW
242707141$24270714$1$I$20240813$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172544$AMGEN$$$$$$Y$$$20240831$$HP$US$US
242707151$24270715$1$I$20240212$20240831$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-085219-2024$RECKITT BENCKISER$$$$$F$Y$$$20240831$$CN$US$US
242707164$24270716$4$F$20240101$20240919$20240831$20240922$PER$$US-AMGEN-USASP2024173379$AMGEN$$71$YR$E$F$Y$$$20240922$$CN$US$US
242707171$24270717$1$I$20240820$20240821$20240831$20240831$PER$$US-ABBVIE-5893929$ABBVIE$$15$YR$$F$Y$$$20240831$$HP$US$US
242707181$24270718$1$I$$20240821$20240831$20240831$EXP$$CA-ASTELLAS-2024-AER-002957$ASTELLAS$UNKNOWN U.$$$$$Y$$$20240831$$HP$CA$CA
242707201$24270720$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5899540$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242707211$24270721$1$I$$20240828$20240831$20240831$PER$$US-AstraZeneca-2024A196938$ASTRAZENECA$$$$$F$Y$$$20240831$$HP$US$
242707221$24270722$1$I$$20240819$20240831$20240831$PER$$US-AstraZeneca-2024A189171$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$US$
242707231$24270723$1$I$$20240830$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-085300-2024$RECKITT BENCKISER$$$$$F$Y$$$20240831$$CN$US$US
242707242$24270724$2$F$20240101$20240917$20240831$20240921$EXP$$US-ABBVIE-5899805$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
242707251$24270725$1$I$$20240819$20240831$20240831$PER$$US-AMGEN-USASP2024168481$AMGEN$Arnold S. E.; Hendrix S.; Johnson J. N. et al.. Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer^s disease. Alzheimer^s and Dementia: Translational Research and Clinical Interventions. 2024;10 (3):1-13$$$$$Y$$$20240831$$HP$US$US
242707262$24270726$2$F$20220701$20240830$20240831$20240913$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-183865$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240913$$CN$CA$CA
242707271$24270727$1$I$$20240822$20240831$20240831$PER$$US-TEVA-VS-3238238$TEVA$$$$A$M$Y$$$20240831$$HP$US$US
242707281$24270728$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5900332$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242707291$24270729$1$I$20240801$20240817$20240831$20240831$PER$$US-LEADINGPHARMA-US-2024LEASPO00364$LEADING PHARMA$$29$YR$A$M$Y$$$20240831$$CN$US$US
242707301$24270730$1$I$$20240828$20240831$20240831$PER$$US-ABBVIE-5901028$ABBVIE$$$$$$Y$$$20240831$$CN$US$US
242707311$24270731$1$I$20240821$20240822$20240831$20240831$30DAY$$US-GSK-US2024105081$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240831$$CN$US$US
242707322$24270732$2$F$20240827$20240829$20240831$20240903$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027056$UNITED THERAPEUTICS$$68$YR$$M$Y$62.132$KG$20240903$$MD$US$US
242707331$24270733$1$I$20240819$20240823$20240831$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026234$UNITED THERAPEUTICS$$60$YR$$M$Y$61.224$KG$20240831$$$US$US
242707341$24270734$1$I$20240816$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172604$AMGEN$$73$YR$E$M$Y$$$20240831$$CN$US$US
242707351$24270735$1$I$$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024171904$AMGEN$$$$$F$Y$$$20240831$$CN$US$US
242707361$24270736$1$I$20240701$20240827$20240831$20240831$PER$$US-ABBVIE-5898159$ABBVIE$$76$YR$$F$Y$62$KG$20240831$$CN$US$US
242707371$24270737$1$I$$20240822$20240831$20240831$PER$$US-TEVA-VS-3237142$TEVA$$26$YR$$F$Y$$$20240831$$CN$US$US
242707381$24270738$1$I$$20240814$20240831$20240831$PER$$US-AstraZeneca-2024A185959$ASTRAZENECA$$$$$M$Y$$$20240831$$HP$US$
242707391$24270739$1$I$$20240830$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-135516-2023$RECKITT BENCKISER$$$$$F$Y$$$20240831$$CN$US$US
242707401$24270740$1$I$$20240822$20240831$20240831$PER$$US-RDY-SPO/USA/24/0012442$DR REDDYS$$26$YR$A$M$Y$$$20240831$$MD$US$US
242707411$24270741$1$I$$20240820$20240831$20240831$EXP$$US-KOANAAP-SML-US-2024-00877$Unknown Manufacturer$Ali ST, VanderWeele DJ. Prolonged Response to Osimertinib in EGFR-Mutated Metastatic Urothelial Carcinoma, a Case Report. Current oncology. 2024 Jul 14;4015-4021. doi:10.3390/curroncol31070298.$48$YR$A$F$Y$$$20240831$$MD$US$US
242707421$24270742$1$I$$20240824$20240831$20240831$PER$$US-RDY-SPO/USA/24/0012502$DR REDDYS$$15$YR$T$F$Y$$$20240831$$HP$US$US
242707431$24270743$1$I$20240801$20240823$20240831$20240831$PER$$US-RDY-SPO/USA/24/0012508$DR REDDYS$$23$YR$A$F$Y$$$20240831$$MD$US$US
242707441$24270744$1$I$$20240823$20240831$20240831$PER$$US-RDY-SPO/USA/24/0012501$DR REDDYS$$17$YR$T$$Y$$$20240831$$CN$US$US
242707451$24270745$1$I$20240601$20240822$20240831$20240831$PER$$US-RDY-SPO/USA/24/0012450$DR REDDYS$$19$YR$A$F$Y$$$20240831$$HP$US$US
242707461$24270746$1$I$20240409$20240820$20240831$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-042053$AUROBINDO$$24$YR$$F$Y$$$20240831$$PH$FR$FR
242707471$24270747$1$I$$20240821$20240831$20240831$EXP$$US-AUROBINDO-AUR-APL-2022-014793$AUROBINDO$Svoboda SA, Bisbee EL, Bender N, Motaparthi K. Acute generalized exanthematous pustulosis sine pustules. A case series. JAAD Case Reports. 2022;23:24-6$38$YR$$F$Y$$$20240831$$MD$US$US
242707482$24270748$2$F$20240628$20240820$20240831$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-042055$AUROBINDO$$72$YR$$F$Y$73$KG$20240902$$MD$FR$FR
242707491$24270749$1$I$$20231213$20240831$20240831$PER$$US-AUROBINDO-AUR-APL-2023-079665$AUROBINDO$$$$$F$Y$$$20240831$$HP$US$US
242707501$24270750$1$I$$20240826$20240831$20240831$PER$$US-ABBVIE-5900790$ABBVIE$$$$$$Y$$$20240831$$CN$US$US
242707511$24270751$1$I$$20240827$20240831$20240831$EXP$$JP-AMGEN-JPNSP2024172312$AMGEN$$$$$$Y$$$20240831$$MD$JP$JP
242707522$24270752$2$F$20240804$20240906$20240831$20240919$EXP$$IT-AUROBINDO-AUR-APL-2024-042441$AUROBINDO$$83$YR$$F$Y$$$20240919$$HP$IT$IT
242707531$24270753$1$I$20240722$20240820$20240831$20240831$EXP$FR-AFSSAPS-LM2024000459$FR-KOANAAP-SML-FR-2024-00875$Unknown Manufacturer$$66$YR$E$F$Y$79$KG$20240831$$CN$FR$FR
242707541$24270754$1$I$$20240820$20240831$20240831$EXP$$IN-KOANAAP-SML-IN-2024-00878$Unknown Manufacturer$Jaspreet K, Ajaykumar S, Minit S, Pratik C, Anuradha C, Omshree S. Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy. Cancer Research, Statistics, and Treatment. 2023;288-295. doi:10.4103/crst.crst_176_23.$77$YR$E$M$Y$$$20240831$$MD$IN$IN
242707551$24270755$1$I$20230401$20240826$20240831$20240831$EXP$$BR-ABBVIE-5902083$ABBVIE$$$$$M$Y$90$KG$20240831$$CN$BR$BR
242707561$24270756$1$I$$20240826$20240831$20240831$EXP$DE-EMA-DD-20210405-jain_h1-134426$DE-RDY-GER/GER/21/0134424$DR REDDYS$Paul LD, Welter-Luedeke J, Penzel S, Zangl A, Graw M. Alpha-Pyrrolidinopentiothiophenone (-PVT): A forensic case study including plasma concentrations. Forensic Sci Int 2021; 321: 110721. DOI: 10.1016/j.forsciint.2021.110721.$41$YR$A$M$Y$$$20240831$$MD$DE$DE
242707571$24270757$1$I$$20240820$20240831$20240831$EXP$$US-KOANAAP-SML-US-2024-00876$Unknown Manufacturer$Mark C, Minasyan A, Ebia MI, Abbas A, Ghosh A, Watson R. Painful tongue lesion as an initial presentation of metastatic pancreatic ductal adenocarcinoma: a case report and review of the literature. Ann-Pancreat-Cancer. 2023 Nov 02;doi:10.21037/apc-23-10.$91$YR$E$M$Y$$$20240831$$MD$US$US
242707581$24270758$1$I$$20240821$20240831$20240831$PER$$US-ABBVIE-5894428$ABBVIE$$$$$M$Y$$$20240831$$MD$US$US
242707591$24270759$1$I$$20240827$20240831$20240831$EXP$$CA-SANDOZ INC.-SDZ2024CA076116$SANDOZ$$$$$M$Y$$$20240831$$CN$CA$CA
242707602$24270760$2$F$$20240904$20240831$20240906$EXP$$US-ABBVIE-5899621$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242707613$24270761$3$F$20240101$20240920$20240831$20240926$EXP$$US-ABBVIE-5898932$ABBVIE$$$$$F$Y$91$KG$20240926$$CN$US$US
242707622$24270762$2$F$20240801$20240830$20240831$20240909$EXP$$CA-CELLTRION INC.-2024CA020206$CELLTRION$$$$$$Y$$$20240909$$CN$CA$CA
242707631$24270763$1$I$$20240821$20240831$20240831$EXP$$NL-AUROBINDO-AUR-APL-2015-08961$AUROBINDO$DongyanWu, Roland D. Thijs. Anticonvulsant-induced downbeat nystagmus in epilepsy. Epilepsy + Behavior Case Reports. 2015;4:74-75$30$YR$$M$Y$$$20240831$$HP$NL$NL
242707641$24270764$1$I$20240101$20240823$20240831$20240831$EXP$$JP-GENMAB-2024-01726$GENMAB$$75$YR$$M$Y$49.8$KG$20240831$$MD$JP$JP
242707651$24270765$1$I$$20240826$20240831$20240831$PER$$US-AMGEN-USASP2024173682$AMGEN$$$$$M$Y$$$20240831$$CN$US$US
242707662$24270766$2$F$20240101$20240913$20240831$20240923$EXP$$GB-TEVA-VS-3237505$TEVA$$37$YR$$F$Y$$$20240923$$HP$GB$GB
242707671$24270767$1$I$$20240822$20240831$20240831$EXP$$US-TEVA-VS-3237549$TEVA$$72$YR$$F$Y$$$20240831$$CN$US$US
242707691$24270769$1$I$$20240821$20240831$20240831$EXP$$CA-AUROBINDO-AUR-APL-2024-042797$AUROBINDO$$$$$F$Y$$$20240831$$CN$CA$CA
242707701$24270770$1$I$$20240821$20240831$20240831$EXP$$CA-AUROBINDO-AUR-APL-2024-042776$AUROBINDO$$$$$F$Y$$$20240831$$HP$CA$CA
242707711$24270771$1$I$20240801$20240821$20240831$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-042534$AUROBINDO$$18$YR$$F$Y$$$20240831$$HP$FR$FR
242707721$24270772$1$I$$20240827$20240831$20240831$PER$$US-AstraZeneca-2024A195413$ASTRAZENECA$$$$$F$Y$$$20240831$$MD$US$
242707731$24270773$1$I$$20240828$20240831$20240831$EXP$$CA-AstraZeneca-2024A196760$ASTRAZENECA$$$$$F$Y$$$20240831$$HP$CA$
242707741$24270774$1$I$$20240829$20240831$20240831$EXP$$US-AstraZeneca-2024A197722$ASTRAZENECA$$$$C$F$Y$35$KG$20240831$$MD$US$
242707751$24270775$1$I$20240726$20240821$20240831$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-042518$AUROBINDO$$47$YR$$F$Y$130$KG$20240831$$MD$FR$FR
242707761$24270776$1$I$$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024173172$AMGEN$$$$$$Y$$$20240831$$HP$US$US
242707771$24270777$1$I$$20240831$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-087158-2024$RECKITT BENCKISER$$$$$F$Y$$$20240831$$CN$US$US
242707781$24270778$1$I$20181003$20240821$20240831$20240831$EXP$$ES-AUROBINDO-AUR-APL-2018-056264$AUROBINDO$$87$YR$$F$Y$$$20240831$$MD$ES$ES
242707791$24270779$1$I$20240627$20240828$20240831$20240831$EXP$$US-ABBVIE-5899893$ABBVIE$$42$YR$$F$Y$$$20240831$$CN$US$US
242707801$24270780$1$I$$20240827$20240831$20240831$EXP$$US-ABBVIE-5898315$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242707811$24270781$1$I$$20240821$20240831$20240831$EXP$$GB-AUROBINDO-AUR-APL-2024-042366$AUROBINDO$$22$YR$$F$Y$$$20240831$$CN$GB$GB
242707821$24270782$1$I$20240808$20240821$20240831$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-042454$AUROBINDO$$72$YR$$$Y$88$KG$20240831$$PH$FR$FR
242707831$24270783$1$I$$20240821$20240831$20240831$EXP$$US-TEVA-VS-3237113$TEVA$$64$YR$$F$Y$$$20240831$$CN$US$US
242707842$24270784$2$F$$20240905$20240831$20240912$EXP$$US-ABBVIE-5896323$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
242707851$24270785$1$I$$20240820$20240831$20240831$EXP$$DE-AUROBINDO-AUR-APL-2024-042417$AUROBINDO$Groth.O, Roider.G, Graw.M. Drug-induced deaths in renal insufficiency (Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz). M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$59$YR$$F$Y$$$20240831$$HP$DE$DE
242707862$24270786$2$F$20240426$20240913$20240831$20240917$EXP$$JP-ABBVIE-5863028$ABBVIE$$81$YR$$F$Y$40$KG$20240917$$MD$JP$JP
242707872$24270787$2$F$20240101$20240827$20240831$20240906$EXP$$US-ABBVIE-5899630$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242707891$24270789$1$I$20240801$20240827$20240831$20240831$EXP$$US-ABBVIE-5898698$ABBVIE$$76$YR$$F$Y$$$20240831$$CN$US$US
242707901$24270790$1$I$$20240821$20240831$20240831$EXP$$GB-AUROBINDO-AUR-APL-2024-042196$AUROBINDO$$59$YR$$M$Y$101$KG$20240831$$PH$GB$GB
242707911$24270791$1$I$$20240827$20240831$20240831$PER$$US-ABBVIE-5899620$ABBVIE$$$$$$Y$$$20240831$$HP$US$US
242707921$24270792$1$I$$20240827$20240831$20240831$EXP$$US-ABBVIE-5898780$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242707931$24270793$1$I$$20240827$20240831$20240831$EXP$$US-ABBVIE-5899623$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242707951$24270795$1$I$$20240820$20240831$20240831$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0332$GRAVITI PHARMACEUTICALS$Odigwe C.Suicide Left Ventricle Post -TAVR.South-Med-J .2022;115(1):55$80$YR$E$F$Y$$$20240831$$HP$US$US
242707961$24270796$1$I$$20240827$20240831$20240831$EXP$$BE-ABBVIE-5899601$ABBVIE$$$$E$F$Y$60$KG$20240831$$HP$BE$BE
242707971$24270797$1$I$$20240831$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-135201-2023$RECKITT BENCKISER$$$$$F$Y$$$20240831$$CN$US$US
242707981$24270798$1$I$$20240819$20240831$20240831$EXP$$PT-Accord-443108$ACCORD$Moura RD, Miranda J, Rocha M, Barros P, Gregorio T, Costa H, et al. IMI-245- (4930) - UM AVC CARDIOEMBOLICO APESAR DO DOAC. Cerebrovascular and neurological diseases/ Imaging in Internal Medicine.$54$YR$A$M$Y$$$20240831$$HP$PT$PT
242707991$24270799$1$I$$20240708$20240831$20240831$PER$$US-ABBVIE-5902168$ABBVIE$$$$$$Y$$$20240831$$CN$US$US
242708001$24270800$1$I$$20240826$20240831$20240831$PER$$US-ABBVIE-5898065$ABBVIE$$$$$$Y$$$20240831$$CN$US$US
242708011$24270801$1$I$20201028$20210412$20240831$20240831$EXP$$CA-CELLTRION INC.-2020CA035400$CELLTRION$$$$$$Y$$$20240831$$CN$CA$CA
242708021$24270802$1$I$$20240822$20240831$20240831$EXP$$JP-ROCHE-10000068024$ROCHE$$7$DEC$E$M$Y$$$20240831$$PH$JP$JP
242708032$24270803$2$F$$20240917$20240831$20240927$PER$$US-GSK-US2024105567$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
242708041$24270804$1$I$$20240819$20240831$20240831$EXP$$CN-PBT-009659$PANACEA BIOTEC$Wang Q, Lin L, Zhen J, Jiang B, Liu G. Case report: Effective treatment of rituximab-resistant minimal change disease with obinutuzumab in an adult. Front Immunol. 2024 Jul 29;15:1407461. doi: 10.3389/fimmu.2024.1407461.$37$YR$A$F$Y$$$20240831$$HP$CN$CN
242708052$24270805$2$F$20240101$20240831$20240831$20240910$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026651$UNITED THERAPEUTICS$$$$$M$Y$57.596$KG$20240910$$$US$US
242708062$24270806$2$F$20240813$20240823$20240831$20240902$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026657$UNITED THERAPEUTICS$$38$YR$$F$Y$64.853$KG$20240902$$$US$US
242708071$24270807$1$I$$20240821$20240831$20240831$EXP$$US-AUROBINDO-AUR-APL-2014-07332$AUROBINDO$Shelton G, Lakhera N, Yarra P, Woodard LD. Known enemy to the kidney....also a hepatic foe. Journal of General Internal Medicine. 2014;29(1):S378$41$YR$$M$Y$$$20240831$$HP$US$US
242708081$24270808$1$I$$20240830$20240831$20240831$EXP$$CA-ROCHE-10000070270$ROCHE$$69$YR$E$M$Y$$$20240831$$HP$CA$CA
242708091$24270809$1$I$$20240821$20240831$20240831$EXP$$GB-AUROBINDO-AUR-APL-2024-042354$AUROBINDO$$$$$M$Y$$$20240831$$CN$GB$GB
242708102$24270810$2$F$20240822$20240916$20240831$20240918$PER$$US-AMGEN-USASP2024171941$AMGEN$$78$YR$E$F$Y$$$20240918$$CN$US$US
242708112$24270811$2$F$$20240912$20240831$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013723$JAZZ$$$$$F$Y$65$KG$20240917$$CN$US$US
242708121$24270812$1$I$20240620$20240826$20240831$20240831$EXP$FR-AFSSAPS-PB2024000797$FR-ABBVIE-5901338$ABBVIE$$65$YR$$F$Y$$$20240831$$MD$FR$FR
242708131$24270813$1$I$$20240821$20240831$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-042562$AUROBINDO$$63$YR$$M$Y$$$20240831$$PH$FR$FR
242708141$24270814$1$I$$20240831$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-134180-2023$RECKITT BENCKISER$$$$$F$Y$$$20240831$$CN$US$US
242708151$24270815$1$I$20240820$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024171999$AMGEN$$$$$F$Y$$$20240831$$CN$US$US
242708161$24270816$1$I$20240827$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172382$AMGEN$$55$YR$A$F$Y$$$20240831$$CN$US$US
242708171$24270817$1$I$$20240828$20240831$20240831$PER$$US-ABBVIE-5900820$ABBVIE$$$$$F$Y$$$20240831$$HP$US$US
242708181$24270818$1$I$20240704$20240824$20240831$20240831$EXP$$CA-CELLTRION INC.-2024CA020590$CELLTRION$$$$$$Y$$$20240831$$MD$CA$CA
242708192$24270819$2$F$$20240913$20240831$20240924$EXP$$PT-AUROBINDO-AUR-APL-2024-037177$AUROBINDO$Le?o A, Correia J, Broa AL, Grilo VL, Trabucho I.. PO-0405 - (4907) - Uma hiponatremia grave por insufici?ncia suprarenal. 30?. Congresso Nacional de Medicina Interna. 2024;23-26$70$YR$$M$Y$$$20240924$$MD$PT$PT
242708201$24270820$1$I$$20240822$20240831$20240831$PER$$US-AstraZeneca-2024A192471$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242708212$24270821$2$F$20240101$20240924$20240831$20240927$EXP$$US-ABBVIE-5898230$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
242708222$24270822$2$F$$20240913$20240831$20240917$PER$$US-JAZZ PHARMACEUTICALS-2024-US-013844$JAZZ$$$$$M$Y$$$20240917$$HP$US$US
242708233$24270823$3$F$20240804$20240902$20240831$20240910$EXP$$US-ROCHE-10000070337$ROCHE$$66$YR$E$F$Y$$$20240910$$CN$US$US
242708241$24270824$1$I$20240101$20240828$20240831$20240831$EXP$$GT-ABBVIE-5901441$ABBVIE$$$$$M$Y$$$20240831$$MD$GT$GT
242708252$24270825$2$F$20240801$20240903$20240831$20240906$EXP$$US-ABBVIE-5901107$ABBVIE$$77$YR$$F$Y$$$20240906$$CN$US$US
242708261$24270826$1$I$20240516$20240821$20240831$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-042471$AUROBINDO$$60$YR$$F$Y$50.6$KG$20240831$$MD$FR$FR
242708271$24270827$1$I$20240823$20240827$20240831$20240831$PER$$US-AMGEN-USASP2024171492$AMGEN$$83$YR$E$F$Y$$$20240831$$CN$US$US
242708281$24270828$1$I$20240827$20240827$20240831$20240831$PER$$US-AMGEN-USASP2024171233$AMGEN$$64$YR$A$F$Y$$$20240831$$CN$US$US
242708291$24270829$1$I$20240827$20240828$20240831$20240831$PER$$US-ABBVIE-5900541$ABBVIE$$40$YR$$$Y$$$20240831$$HP$US$US
242708302$24270830$2$F$$20240923$20240831$20240930$PER$$US-GSK-US2024AMR105890$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
242708321$24270832$1$I$$20240828$20240831$20240831$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137680$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240831$$HP$US$US
242708331$24270833$1$I$20240802$20240828$20240831$20240831$PER$$US-ABBVIE-5899890$ABBVIE$$76$YR$$F$Y$$$20240831$$CN$US$US
242708341$24270834$1$I$20240318$20240828$20240831$20240831$EXP$$US-ABBVIE-5901068$ABBVIE$$63$YR$$F$Y$$$20240831$$CN$US$US
242708351$24270835$1$I$$20240821$20240831$20240831$EXP$$IT-AUROBINDO-AUR-APL-2022-014065$AUROBINDO$Gianfranco C, Maurizio C, Eustachio N, Luigi M, Caterina F, Angelo V. Hypersensitivity to febuxostat in a patient with a previous allopurinol-induced Steven-Johnson syndrome: a case report of treatment with a slow desensitization protocol. Endocr Metab Immune Disord Drug Targets. 2022;22:895-899$43$YR$$M$Y$$$20240831$$MD$IT$IT
242708361$24270836$1$I$20180101$20240821$20240831$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-042270$AUROBINDO$$31$YR$$F$Y$59$KG$20240831$$CN$FR$FR
242708371$24270837$1$I$$20240819$20240831$20240831$EXP$$PT-Accord-443104$ACCORD$Vicente B, Rodrigues C, Serrao C, Baptista M, Carvalho V, Antunes AP. Headache secondary to Zoledronic acidinduced inflammatory orbitopathy: A rare complication of a frequent treatment. Sinapse. Supp 1. Vol 23. Dec 2023.$57$YR$A$F$Y$$$20240831$$HP$PT$PT
242708381$24270838$1$I$20240101$20240821$20240831$20240831$EXP$$US-TEVA-VS-3237161$TEVA$$56$YR$$F$Y$$$20240831$$CN$US$US
242708392$24270839$2$F$$20240912$20240831$20240916$EXP$$US-ABBVIE-5900409$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
242708402$24270840$2$F$20240816$20240827$20240831$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-026500$UNITED THERAPEUTICS$$32$YR$$F$Y$86.168$KG$20240905$$$US$US
242708411$24270841$1$I$20240101$20240819$20240831$20240831$EXP$$BR-UCBSA-2024029048$UCB$$$$$F$Y$54$KG$20240831$$CN$BR$BR
242708421$24270842$1$I$$20240822$20240831$20240831$EXP$$US-AMGEN-USASP2024168838$AMGEN$Kim K.; Llanos D.; Ramos C. et. al. Finding the Balance: Venous Thromboembolism Prophylaxis during Hematochezia in Crohn^s Disease. Case Reports in Gastroenterology. 2024;18 (1):367-372$39$YR$A$F$Y$$$20240831$$HP$US$US
242708431$24270843$1$I$$20240821$20240831$20240831$EXP$$GB-AUROBINDO-AUR-APL-2024-042183$AUROBINDO$$$$$F$Y$$$20240831$$HP$GB$GB
242708441$24270844$1$I$$20240826$20240831$20240831$PER$$US-AMGEN-USASP2024171398$AMGEN$$$$$$Y$$$20240831$$CN$US$US
242708451$24270845$1$I$20240820$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172038$AMGEN$$69$YR$E$F$Y$$$20240831$$CN$US$US
242708461$24270846$1$I$20240101$20240827$20240831$20240831$EXP$$US-ABBVIE-5898139$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242708471$24270847$1$I$20240101$20240821$20240831$20240831$EXP$$CA-ABBVIE-5895281$ABBVIE$$58$YR$$F$Y$$$20240831$$CN$CA$CA
242708483$24270848$3$F$20240101$20240920$20240831$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-026973$UNITED THERAPEUTICS$$$$$M$Y$77.098$KG$20240927$$$US$US
242708491$24270849$1$I$$20240827$20240831$20240831$EXP$$GB-ABBVIE-5899426$ABBVIE$$$$A$M$Y$$$20240831$$CN$GB$GB
242708501$24270850$1$I$$20240829$20240831$20240831$PER$$US-ABBVIE-5902217$ABBVIE$$$$$$Y$$$20240831$$HP$US$US
242708511$24270851$1$I$20240401$20240827$20240831$20240831$EXP$$US-ABBVIE-5859865$ABBVIE$$49$YR$$F$Y$$$20240831$$CN$US$US
242708521$24270852$1$I$20240827$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172168$AMGEN$$$$$$Y$$$20240831$$CN$US$US
242708531$24270853$1$I$20240828$20240828$20240831$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202408018474$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240831$$CN$US$US
242708541$24270854$1$I$$20240819$20240831$20240831$EXP$$PT-AUROBINDO-AUR-APL-2024-042203$AUROBINDO$Ferreira I, Pires SX, Santos FV, Goncalves L, Goncalves G, Pereira C, et al. LUDWIG^S ANGINA - AN EMERGENCY NOT TO FORGET. Eur-J-Case-Rep-Intern-Med. 2019;6 (Suppl. 1):218$32$YR$$F$Y$$$20240831$$HP$PT$PT
242708551$24270855$1$I$20240805$20240828$20240831$20240831$EXP$$US-ABBVIE-5899749$ABBVIE$$62$YR$$F$Y$$$20240831$$CN$US$US
242708561$24270856$1$I$20240801$20240827$20240831$20240831$EXP$$US-ABBVIE-5898479$ABBVIE$$29$YR$$F$Y$$$20240831$$CN$US$US
242708572$24270857$2$F$20180101$20240905$20240831$20240911$EXP$$US-ABBVIE-5899663$ABBVIE$$62$YR$$F$Y$$$20240911$$CN$US$US
242708584$24270858$4$F$20210316$20240920$20240831$20240926$EXP$$KR-TAKEDA-2021TUS023770$TAKEDA$$54$YR$$M$Y$74$KG$20240926$$CN$KR$KR
242708591$24270859$1$I$$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172854$AMGEN$$$$$F$Y$$$20240831$$CN$US$US
242708601$24270860$1$I$$20240819$20240831$20240831$EXP$$CA-UCBSA-2024042340$UCB$$$$$F$Y$$$20240831$$CN$CA$CA
242708611$24270861$1$I$$20240828$20240831$20240831$EXP$$JP-ABBVIE-5899645$ABBVIE$$$$$$Y$$$20240831$$MD$JP$JP
242708621$24270862$1$I$$20240819$20240831$20240831$EXP$$JP-UCBSA-2024042360$UCB$$$$C$$Y$$$20240831$$CN$JP$JP
242708631$24270863$1$I$20240101$20240828$20240831$20240831$EXP$$US-ABBVIE-5900396$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242708641$24270864$1$I$$20240827$20240831$20240831$EXP$$CA-ABBVIE-5899090$ABBVIE$$$$E$M$Y$$$20240831$$HP$CA$CA
242708651$24270865$1$I$20240702$20240821$20240831$20240831$EXP$$GB-AUROBINDO-AUR-APL-2024-042153$AUROBINDO$$35$YR$$F$Y$89$KG$20240831$$PH$GB$GB
242708661$24270866$1$I$$20240827$20240831$20240831$EXP$$US-AstraZeneca-2024A196496$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$US$
242708671$24270867$1$I$20240331$20240829$20240831$20240831$EXP$$US-AstraZeneca-2024A197536$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242708682$24270868$2$F$20240301$20240906$20240831$20240912$EXP$$US-ABBVIE-5900277$ABBVIE$$67$YR$$F$Y$84$KG$20240912$$CN$US$US
242708691$24270869$1$I$20240101$20240828$20240831$20240831$EXP$$CA-ABBVIE-5900789$ABBVIE$$42$YR$$M$Y$$$20240831$$CN$CA$CA
242708701$24270870$1$I$$20240821$20240831$20240831$EXP$$DE-AUROBINDO-AUR-APL-2024-042423$AUROBINDO$Groth, Olwen; Roider, Gabriele; Graw, Matthias. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift. Fortschritte der Medizin. 2024;166 (13):48-51$72$YR$$F$Y$$$20240831$$HP$DE$DE
242708711$24270871$1$I$20240101$20240828$20240831$20240831$EXP$$US-ABBVIE-5900968$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242708721$24270872$1$I$$20240829$20240831$20240831$EXP$$SI-ABBVIE-5902662$ABBVIE$$86$YR$$F$Y$$$20240831$$HP$SI$SI
242708731$24270873$1$I$20240819$20240820$20240831$20240831$EXP$$US-Accord-443387$ACCORD$$41$YR$A$$Y$$$20240831$$HP$US$US
242708741$24270874$1$I$$20240821$20240831$20240831$EXP$GB-MHRA-MED-202408211939013530-PSVHC$GB-Accord-442963$ACCORD$$$$$M$Y$$$20240831$$CN$GB$GB
242708752$24270875$2$F$$20240826$20240831$20240906$EXP$$AU-Accord-442828$ACCORD$$79$YR$E$F$Y$$$20240906$$CN$AU$AU
242708761$24270876$1$I$$20240820$20240831$20240831$EXP$$JP-Accord-388505$ACCORD$Ogawa K, Honjo M, Sakamoto K, Funamizu N, Tamura K, Shine M, et al. Epstein-Barr Virus-Associated Latent Malignant Lymphoma With Acute Exacerbation After Living Donor Liver Transplantation: Case Report. Transplantation Proceedings. 2023;55(8):1959-63. DOI: 10.1016/j.transproceed.2023.07.008.$69$YR$E$M$Y$43$KG$20240831$$MD$JP$JP
242708771$24270877$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5900430$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242708781$24270878$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5900434$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242708791$24270879$1$I$$20240822$20240831$20240831$PER$$US-ABBVIE-5892877$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242708801$24270880$1$I$20240101$20240828$20240831$20240831$EXP$$US-ABBVIE-5900467$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242708821$24270882$1$I$20240101$20240828$20240831$20240831$EXP$$US-ABBVIE-5900489$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242708831$24270883$1$I$$20240828$20240831$20240831$30DAY$$US-SANDOZ INC.-SDZ2024US020960$SANDOZ$$12$YR$$F$Y$$$20240831$$HP$US$US
242708841$24270884$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5901015$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242708851$24270885$1$I$20240512$20240819$20240831$20240831$EXP$GB-MHRA-MED-202408191143490880-GTNKD$GB-MACLEODS PHARMA-MAC2024049003$MACLEODS$$$$$$Y$$$20240831$$PH$GB$GB
242708861$24270886$1$I$$20240823$20240831$20240831$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP010898$STRIDES$dos SantosSilva RP, Lopes AJM, Bezerra RB, Andrade RA, Andrade RG, da Costa LMF, et al.. Persistent hypotension and other complications of celiac plexus neurolysis: A case report and literature review.. Clin-Case-Rep. 2023;11 (6):01-04$41$YR$$F$Y$$$20240831$$HP$BR$BR
242708871$24270887$1$I$$20240819$20240831$20240831$EXP$$JP-MACLEODS PHARMA-MAC2024049001$MACLEODS$Takahashi K, Kobayashi R, Morikawa K, Maeda M, Samura O, Okamoto A..Overdose of angiotensin II receptor blocker in the third trimester of pregnancy: A case report.Journal of Obstetrics and Gynaecology Research.2024;50(8):1425-8$$$$$Y$$$20240831$$MD$JP$JP
242708882$24270888$2$F$20220101$20240917$20240831$20240926$EXP$$US-MACLEODS PHARMA-MAC2024049046$MACLEODS$Gwynn N, Lindenmayer JP, Boes T, Pitalo C.Late Recognition of Cholinergic Delirium in Patient on Donepezil Combination Treatment..Journal of Clinical Psychopharmacology.2024$$$$$Y$$$20240926$$MD$US$US
242708891$24270889$1$I$$20240823$20240831$20240831$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010863$STRIDES$Belal AA, Slater A, Clapp WL, Ibrahim H, Santos A, Mehta RV.. Tacrolimus-Induced Thrombotic Microangiopathy After Kidney Transplant.. J-Am-Soc-Nephrol. 2023;34:613 abstr. FR-PO758.$73$YR$$F$Y$$$20240831$$HP$US$US
242708901$24270890$1$I$$20240819$20240831$20240831$EXP$$GB-MACLEODS PHARMA-MAC2024049005$MACLEODS$$$$$$Y$$$20240831$$MD$GB$GB
242708911$24270891$1$I$$20240820$20240831$20240831$EXP$$IN-MACLEODS PHARMA-MAC2024049058$MACLEODS$Malwade S, Dharmagadda A, Premkumar V..Neonatal Abstinence Syndrome: A Case Series..Cureus.2024;16(7):e64372$$$$$Y$$$20240831$$MD$IN$IN
242708921$24270892$1$I$20240101$20240821$20240831$20240831$EXP$$US-TEVA-VS-3237150$TEVA$$54$YR$$F$Y$$$20240831$$CN$US$US
242708931$24270893$1$I$$20240820$20240831$20240831$EXP$$US-MACLEODS PHARMA-MAC2024049055$MACLEODS$Boolani H, Shanberg D, Chikkam V, Lakkireddy D..Metformin associated Atrial Fibrillation - A Case Report.Journal of Atrial Fibrillation..30-SEP-2011;4(3):411$$$$$Y$$$20240831$$HP$US$US
242708941$24270894$1$I$20240531$20240819$20240831$20240831$EXP$$GB-MACLEODS PHARMA-MAC2024049039$MACLEODS$$$$$$Y$$$20240831$$MD$GB$GB
242708952$24270895$2$F$20230101$20240830$20240831$20240912$EXP$$ES-MACLEODS PHARMA-MAC2024049040$MACLEODS$Blundell DB, Mousavi H.Dose adjustment according to renal function in a polymedicated patient included in the medication reconditioning service using medication compliance aids (MCA).Community Farm.19 MAR 2024;16(2):37-42.$$$$$Y$$$20240912$$PH$ES$ES
242708961$24270896$1$I$$20240828$20240831$20240831$30DAY$$US-SANDOZ INC.-SDZ2024US050029$SANDOZ$$$$$M$Y$$$20240831$$CN$US$US
242708971$24270897$1$I$$20240829$20240831$20240831$EXP$$US-ABBVIE-5902416$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242708981$24270898$1$I$20210504$20240826$20240831$20240831$EXP$$KR-AMGEN-KORSP2024171802$AMGEN$$52$YR$A$F$Y$$$20240831$$MD$KR$KR
242708991$24270899$1$I$$20240825$20240831$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202408016543$ELI LILLY AND CO$$$$$$Y$$$20240831$$CN$US$US
242709001$24270900$1$I$$20240819$20240831$20240831$EXP$$JP-MACLEODS PHARMA-MAC2024049013$MACLEODS$Takahashi K, Kobayashi R, Morikawa K, Maeda M, Samura O, Okamoto A..Overdose of angiotensin II receptor blocker in the third trimester of pregnancy: A case report..Journal of Obstetrics and Gynaecology Research..204;50(8):1425-8$$$$$Y$$$20240831$$MD$JP$JP
242709021$24270902$1$I$$20240823$20240831$20240831$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP010881$STRIDES$Peralt JE, Gonzalez LF, San Roman KG, Astorga Burgo JC, Labarta AA.. An acute coronary syndrome in an unusual patient: analysing cisplatin toxicity-a case report and review of the literature.. Eur-Heart-J-Case-Rep. 2024;8 (8):ytae365$23$YR$$M$Y$$$20240831$$HP$ES$ES
242709031$24270903$1$I$20240101$20240822$20240831$20240831$EXP$$US-TEVA-VS-3237409$TEVA$$64$YR$$F$Y$$$20240831$$CN$US$US
242709043$24270904$3$F$20240701$20240925$20240831$20240930$EXP$$US-ABBVIE-5900210$ABBVIE$$78$YR$$M$Y$97.522$KG$20240930$$CN$US$US
242709051$24270905$1$I$20200916$20240826$20240831$20240831$EXP$$KR-AMGEN-KORSP2024172287$AMGEN$$62$YR$A$F$Y$$$20240831$$PH$KR$KR
242709061$24270906$1$I$20240101$20240828$20240831$20240831$EXP$$US-ABBVIE-5899855$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242709071$24270907$1$I$20201027$20240826$20240831$20240831$EXP$$KR-AMGEN-KORSP2024172326$AMGEN$$61$YR$A$F$Y$$$20240831$$PH$KR$KR
242709081$24270908$1$I$20240825$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172381$AMGEN$$84$YR$E$M$Y$$$20240831$$CN$US$US
242709091$24270909$1$I$20240101$20240828$20240831$20240831$EXP$$CN-ABBVIE-5899792$ABBVIE$$53$YR$$F$Y$75$KG$20240831$$MD$CN$CN
242709101$24270910$1$I$$20240823$20240831$20240831$PER$$US-ABBVIE-5895416$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242709111$24270911$1$I$$20240828$20240831$20240831$EXP$$CA-ABBVIE-5900669$ABBVIE$$46$YR$$F$Y$$$20240831$$CN$CA$CA
242709121$24270912$1$I$$20240828$20240831$20240831$EXP$$AU-ABBVIE-5900890$ABBVIE$$$$$F$Y$$$20240831$$CN$AU$AU
242709131$24270913$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5900191$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242709141$24270914$1$I$$20240830$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-104669-2023$RECKITT BENCKISER$$$$$F$Y$$$20240831$$CN$US$US
242709151$24270915$1$I$$20240821$20240831$20240831$EXP$$CA-AUROBINDO-AUR-APL-2024-042676$AUROBINDO$$$$$M$Y$$$20240831$$HP$CA$CA
242709161$24270916$1$I$$20240820$20240831$20240831$EXP$$DE-AUROBINDO-AUR-APL-2024-043542$AUROBINDO$Dyballa N, Hartel JA, Prangenberg J, Andresen-Streichert H. A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting - clinical, toxicological and forensic aspects. Forensic-Sci-Med-Pathol. 2024$12$WK$$M$Y$$$20240831$$HP$DE$DE
242709172$24270917$2$F$20240101$20240906$20240831$20240911$EXP$$US-ABBVIE-5898025$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
242709181$24270918$1$I$20240824$20240826$20240831$20240831$PER$$US-AMGEN-USASP2024170512$AMGEN$$$$$$Y$$$20240831$$PH$US$US
242709191$24270919$1$I$20220101$20240827$20240831$20240831$EXP$$US-ABBVIE-5899018$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242709201$24270920$1$I$$20240821$20240831$20240831$EXP$$DE-AUROBINDO-AUR-APL-2024-042399$AUROBINDO$Groth O, Roider G, Graw M. Fatalities associated with failure to adjust drug dose in patients with renal insufficiency: A retrospective study at the Institute of Forensic Medicine in Munich (2019-2023). MMW Fortschritte der Medizin. 2024;166 (13):48-51$89$YR$$M$Y$$$20240831$$HP$DE$DE
242709212$24270921$2$F$20240802$20240830$20240831$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-042414$AUROBINDO$$61$YR$$M$Y$$$20240910$$MD$DE$DE
242709221$24270922$1$I$20220101$20240826$20240831$20240831$EXP$$US-ABBVIE-5896888$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242709231$24270923$1$I$$20240821$20240831$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024104576$VIIV$$$$$F$Y$$$20240831$$HP$US$US
242709251$24270925$1$I$20240229$20240821$20240831$20240831$EXP$$DE-AUROBINDO-AUR-APL-2024-016814$AUROBINDO$$67$YR$$F$Y$61$KG$20240831$$MD$DE$DE
242709261$24270926$1$I$20200221$20240822$20240831$20240831$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03116$AMNEAL$$39$YR$$F$Y$93.515$KG$20240831$$MD$US$US
242709271$24270927$1$I$$20240821$20240831$20240831$EXP$GB-MHRA-MED-202408211435335820-FBLQZ$GB-TEVA-VS-3236412$TEVA$$82$YR$$F$Y$$$20240831$$HP$GB$GB
242709281$24270928$1$I$$20240827$20240831$20240831$PER$$US-ABBVIE-5899685$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242709293$24270929$3$F$20240101$20240917$20240831$20240920$EXP$$DE-ABBVIE-5889272$ABBVIE$$$$E$M$Y$$$20240920$$MD$DE$DE
242709301$24270930$1$I$$20240827$20240831$20240831$EXP$$US-ABBVIE-5899484$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242709311$24270931$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5899595$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242709321$24270932$1$I$$20240821$20240831$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024104493$VIIV$$$$$F$Y$$$20240831$$CN$US$US
242709341$24270934$1$I$$20240821$20240831$20240831$EXP$$GB-AUROBINDO-AUR-APL-2024-042363$AUROBINDO$$82$YR$$F$Y$$$20240831$$HP$GB$GB
242709351$24270935$1$I$20240829$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173470$AMGEN$$69$YR$E$F$Y$$$20240831$$CN$US$US
242709362$24270936$2$F$20240829$20240830$20240831$20240902$PER$$US-AMGEN-USASP2024173605$AMGEN$$69$YR$E$F$Y$$$20240902$$CN$US$US
242709371$24270937$1$I$20240701$20240828$20240831$20240831$EXP$$US-ABBVIE-5900892$ABBVIE$$38$YR$$F$Y$$$20240831$$CN$US$US
242709381$24270938$1$I$$20240821$20240831$20240831$EXP$$CA-AUROBINDO-AUR-APL-2024-042689$AUROBINDO$$86$YR$$M$Y$$$20240831$$MD$CA$CA
242709392$24270939$2$F$20240826$20240912$20240831$20240921$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-027220$UNITED THERAPEUTICS$$51$YR$$M$Y$$$20240921$$PH$JP$JP
242709401$24270940$1$I$20240522$20240821$20240831$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-042500$AUROBINDO$$2$MON$$M$Y$2.23$KG$20240831$$PH$FR$FR
242709412$24270941$2$F$$20240830$20240831$20240905$PER$$US-AMGEN-USASP2024173743$AMGEN$$$$A$F$Y$$$20240904$$HP$US$US
242709421$24270942$1$I$$20240826$20240831$20240831$EXP$$CA-ROCHE-10000065874$ROCHE$$$$$F$Y$$$20240831$$HP$CA$CA
242709441$24270944$1$I$$20240822$20240831$20240831$PER$$US-TEVA-VS-3237252$TEVA$$58$YR$$M$Y$$$20240831$$CN$US$US
242709461$24270946$1$I$$20240826$20240831$20240831$EXP$$US-AMGEN-USASP2024170318$AMGEN$Liaquat H.; Shupp B.; Rollins S. et. al. Comparison of the impact of chronic corticosterold therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease. Scientific reports. 2021;11 (1):1- 11$$$$$Y$$$20240831$$HP$US$US
242709481$24270948$1$I$20130101$20240826$20240831$20240831$EXP$$US-ABBVIE-5897605$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242709491$24270949$1$I$20240626$20240827$20240831$20240831$PER$$US-AMGEN-USASP2024171226$AMGEN$$$$$$Y$$$20240831$$HP$US$US
242709501$24270950$1$I$$20240822$20240831$20240831$PER$$US-ABBVIE-5893154$ABBVIE$$$$$$Y$$$20240831$$CN$US$US
242709511$24270951$1$I$$20240820$20240831$20240831$EXP$CA-MHPD-E2B_001086837$CA-Accord-442804$ACCORD$$70$YR$E$F$Y$$$20240831$$MD$CA$CA
242709521$24270952$1$I$20240101$20240820$20240831$20240831$PER$$US-SA-2024SA251963$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240831$$MD$US$US
242709531$24270953$1$I$$20240821$20240831$20240831$EXP$$GB-AUROBINDO-AUR-APL-2024-042225$AUROBINDO$$82$YR$$F$Y$$$20240831$$HP$GB$GB
242709541$24270954$1$I$20240708$20240821$20240831$20240831$EXP$FR-AFSSAPS-SE2024000571$FR-TEVA-VS-3225144$TEVA$$61$YR$$F$Y$$$20240831$$MD$FR$FR
242709551$24270955$1$I$20240826$20240827$20240831$20240831$EXP$$IE-ABBVIE-5901235$ABBVIE$$74$YR$$M$Y$$$20240831$$HP$IE$IE
242709561$24270956$1$I$$20240831$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-088493-2024$RECKITT BENCKISER$$78$YR$$F$Y$$$20240831$$CN$US$US
242709571$24270957$1$I$$20240820$20240831$20240831$EXP$$CA-AUROBINDO-AUR-APL-2024-042955$AUROBINDO$$81$YR$$F$Y$$$20240831$$HP$CA$CA
242709581$24270958$1$I$$20240821$20240831$20240831$EXP$$CA-AUROBINDO-AUR-APL-2024-042718$AUROBINDO$$66$YR$$F$Y$$$20240831$$HP$CA$CA
242709591$24270959$1$I$20240422$20240826$20240831$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2024-002810$UNITED THERAPEUTICS$$84$YR$$M$Y$$$20240831$$$US$US
242709601$24270960$1$I$$20240821$20240831$20240831$EXP$$GB-ROCHE-10000062905$ROCHE$$$$$$Y$$$20240831$$MD$GB$GB
242709611$24270961$1$I$20240725$20240823$20240831$20240831$EXP$$CA-TAKEDA-2024TUS086119$TAKEDA$$92$YR$$M$Y$71$KG$20240831$$HP$CA$CA
242709622$24270962$2$F$20240813$20240904$20240831$20240911$EXP$$PT-AUROBINDO-AUR-APL-2024-042257$AUROBINDO$$81$YR$$F$Y$$$20240911$$PH$PT$PT
242709631$24270963$1$I$$20240821$20240831$20240831$EXP$$US-ROCHE-10000064722$ROCHE$$$$$$Y$$$20240831$$MD$US$US
242709641$24270964$1$I$$20240819$20240831$20240831$EXP$$FR-AUROBINDO-AUR-APL-2016-02459$AUROBINDO$Berger P, Ferlay C, Poiron L, Chillet P.. High anion gap metabolic acidosis secondary to chronic paracetamol (acetaminophen) poisoning. Toxicologie Analytique et Clinique. 2015;27(4):255-261$40$YR$$F$Y$$$20240831$$MD$FR$FR
242709651$24270965$1$I$20240815$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173220$AMGEN$$72$YR$E$$Y$$$20240831$$CN$US$US
242709661$24270966$1$I$$20240828$20240831$20240831$EXP$$US-AstraZeneca-2024A196346$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$US$
242709671$24270967$1$I$20231201$20240821$20240831$20240831$EXP$$FR-AUROBINDO-AUR-APL-2024-042453$AUROBINDO$$2$MON$$F$Y$$$20240831$$MD$FR$FR
242709681$24270968$1$I$$20240821$20240831$20240831$EXP$$GB-AUROBINDO-AUR-APL-2024-042340$AUROBINDO$$82$YR$$F$Y$$$20240831$$HP$GB$GB
242709691$24270969$1$I$$20240819$20240831$20240831$EXP$$AU-AUROBINDO-AUR-APL-2024-042165$AUROBINDO$Kwok L, Mahmood A, Kumar S, Chang A.. Case Report: Macula Structural and Functional Assessment in Nab-Paclitaxel-Related Cystoid Macular Edema. Ophthalmic-Surg-Lasers-Imaging Retina. 2024;55(7):408-411$54$YR$$F$Y$$$20240831$$HP$AU$AU
242709701$24270970$1$I$20230514$20240821$20240831$20240831$EXP$FR-AFSSAPS-PO2024000903$FR-TEVA-VS-3235938$TEVA$$1$DY$$M$Y$3.5$KG$20240831$$HP$FR$FR
242709711$24270971$1$I$20240718$20240821$20240831$20240831$EXP$FR-AFSSAPS-LY2024001211$FR-TEVA-VS-3236434$TEVA$$75$YR$$M$Y$79.1$KG$20240831$$PH$FR$FR
242709733$24270973$3$F$20240701$20240919$20240831$20240926$EXP$$KR-UNITED THERAPEUTICS-UNT-2024-026838$UNITED THERAPEUTICS$$32$YR$$F$Y$32$KG$20240926$$$KR$KR
242709741$24270974$1$I$20240823$20240823$20240831$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-027028$UNITED THERAPEUTICS$$43$YR$$M$Y$$$20240831$$$US$US
242709751$24270975$1$I$$20240821$20240831$20240831$30DAY$$US-GSK-US2024AMR105386$GLAXOSMITHKLINE$$$$$F$Y$$$20240831$$CN$US$US
242709761$24270976$1$I$20240101$20240824$20240831$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-026632$UNITED THERAPEUTICS$$$$$M$Y$85.261$KG$20240831$$$US$US
242709774$24270977$4$F$20240725$20240917$20240831$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-042524$AUROBINDO$$67$YR$$M$Y$125$KG$20240926$$MD$FR$FR
242709781$24270978$1$I$$20240829$20240831$20240831$EXP$$BR-ROCHE-10000069657$ROCHE$$$$$$Y$$$20240831$$MD$BR$BR
242709791$24270979$1$I$20240701$20240820$20240831$20240831$EXP$$US-Accord-443672$ACCORD$$41$YR$A$F$Y$$$20240831$$PH$US$US
242709801$24270980$1$I$$20240819$20240831$20240831$EXP$$US-Accord-443073$ACCORD$$26$YR$$M$Y$$$20240831$$HP$US$US
242709811$24270981$1$I$20240810$20240819$20240831$20240831$EXP$$US-Accord-443074$ACCORD$$77$YR$E$M$Y$$$20240831$$HP$US$US
242709821$24270982$1$I$20200416$20240819$20240831$20240831$EXP$$US-Accord-182604$ACCORD$$31$YR$A$F$Y$$$20240831$$MD$US$US
242709831$24270983$1$I$20240419$20240821$20240831$20240831$EXP$FR-AFSSAPS-MA2024001364$FR-Accord-442855$ACCORD$$85$YR$E$F$Y$46$KG$20240831$$PH$FR$FR
242709841$24270984$1$I$20240816$20240820$20240831$20240831$EXP$$US-Accord-443388$ACCORD$$19$YR$A$M$Y$$$20240831$$HP$US$US
242709851$24270985$1$I$20240531$20240821$20240831$20240831$EXP$ES-AEMPS-1559445$ES-Accord-442892$ACCORD$$80$YR$E$F$Y$86$KG$20240831$$MD$ES$ES
242709861$24270986$1$I$20240101$20240827$20240831$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-026201$UNITED THERAPEUTICS$$$$$F$Y$87.982$KG$20240831$$$US$US
242709871$24270987$1$I$20240828$20240828$20240831$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-027120$UNITED THERAPEUTICS$$57$YR$$F$Y$56.689$KG$20240831$$$US$US
242709881$24270988$1$I$20240622$20240820$20240831$20240831$EXP$CN-HENLIUS-24CN016519$CN-Accord-443995$ACCORD$$65$YR$E$F$Y$65$KG$20240831$$MD$CN$CN
242709891$24270989$1$I$$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173630$AMGEN$$$$$$Y$$$20240831$$HP$US$US
242709901$24270990$1$I$20240829$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173426$AMGEN$$$$$$Y$$$20240831$$PH$US$US
242709912$24270991$2$F$$20240916$20240831$20240918$PER$$US-AstraZeneca-2024A197052$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
242709921$24270992$1$I$20230701$20240821$20240831$20240831$PER$$US-AstraZeneca-2024A191367$ASTRAZENECA$$844$MON$$F$Y$52.6$KG$20240831$$CN$US$
242709942$24270994$2$F$20240812$20240830$20240831$20240913$EXP$$US-Accord-443651$ACCORD$$26$YR$A$M$Y$$$20240913$$PH$US$US
242709951$24270995$1$I$20230101$20240826$20240831$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2023-025250$UNITED THERAPEUTICS$$$$$M$Y$98.866$KG$20240831$$$US$US
242709961$24270996$1$I$20240717$20240821$20240831$20240831$30DAY$$US-GSK-US2024104484$GLAXOSMITHKLINE$$44$YR$$M$Y$$$20240831$$CN$US$US
242709982$24270998$2$F$20240731$20240903$20240831$20240913$EXP$$US-TEVA-VS-3237291$TEVA$$67$YR$$F$Y$80.2$KG$20240913$$MD$US$US
242709991$24270999$1$I$$20240821$20240831$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR104756$VIIV$$$$T$F$Y$$$20240831$$CN$US$US
242710001$24271000$1$I$20220630$20240821$20240831$20240831$EXP$$PL-AUROBINDO-AUR-APL-2024-042486$AUROBINDO$$67$YR$$F$Y$55$KG$20240831$$MD$PL$PL
242710011$24271001$1$I$$20240822$20240831$20240831$EXP$$US-ROCHE-10000064709$ROCHE$$74$YR$E$F$Y$$$20240831$$CN$US$US
242710021$24271002$1$I$20240825$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173195$AMGEN$$40$YR$A$M$Y$$$20240831$$CN$US$US
242710031$24271003$1$I$20240730$20240823$20240831$20240831$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026630$UNITED THERAPEUTICS$$39$YR$$F$Y$56.236$KG$20240831$$$US$US
242710042$24271004$2$F$20240829$20240926$20240831$20240927$PER$$US-AMGEN-USASP2024173454$AMGEN$$74$YR$E$F$Y$$$20240927$$CN$US$US
242710051$24271005$1$I$20240828$20240828$20240831$20240831$PER$$US-AstraZeneca-2024A197048$ASTRAZENECA$$20927$DY$$F$Y$$$20240831$$CN$US$
242710061$24271006$1$I$$20240826$20240831$20240831$EXP$$ZA-AstraZeneca-2024A194550$ASTRAZENECA$$58$YR$$F$Y$$$20240831$$CN$ZA$
242710071$24271007$1$I$$20240819$20240831$20240831$EXP$GB-MHRA-MED-202408191141120190-NVSHL$GB-GLENMARK PHARMACEUTICALS-2024GMK093532$GLENMARK$$$$$$Y$$$20240831$$CN$GB$GB
242710083$24271008$3$F$20240825$20240919$20240831$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-026811$UNITED THERAPEUTICS$$47$YR$$F$Y$70.748$KG$20240921$$$US$US
242710091$24271009$1$I$$20240821$20240831$20240831$EXP$$DE-AUROBINDO-AUR-APL-2024-042391$AUROBINDO$Groth O, Roider G, Graw M. Medikamenteninduzierte Todesf?lle bei Niereninsuffizienz. M?nchener Medizinische Wochenschrift ? Fortschritte der Medizin. 2024;166 (13):48-51$52$YR$$F$Y$$$20240831$$HP$DE$DE
242710101$24271010$1$I$20240701$20240823$20240831$20240831$30DAY$$US-GSK-US2024105484$GLAXOSMITHKLINE$$$$$$Y$$$20240831$$CN$US$US
242710112$24271011$2$F$20240601$20240916$20240831$20240918$PER$$US-AMGEN-USASP2024173358$AMGEN$$85$YR$E$F$Y$$$20240918$$CN$US$US
242710121$24271012$1$I$$20240831$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-088419-2024$RECKITT BENCKISER$$$$$F$Y$$$20240831$$CN$US$US
242710131$24271013$1$I$20170608$20240821$20240831$20240831$EXP$$PL-AUROBINDO-AUR-APL-2024-042473$AUROBINDO$$$$$M$Y$$$20240831$$CN$PL$PL
242710142$24271014$2$F$$20240903$20240831$20240906$PER$$US-AMGEN-USASP2024173215$AMGEN$$$$$$Y$$$20240906$$CN$US$US
242710151$24271015$1$I$$20240817$20240831$20240831$EXP$$ES-Accord-443095$ACCORD$Quintero V, Bueno-Sanchez D, Mozo-Del-Castillo Y, Urtasun-Erburu A, Sisinni L, Lopez-Duarte M et al. Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow Failure. Transplantation and Cellular Therapy. 2023;29(10):1-5$9$YR$C$M$Y$$$20240831$$HP$ES$ES
242710161$24271016$1$I$20231101$20240820$20240831$20240831$EXP$GB-MHRA-MED-202408201001008310-PTDKG$GB-Accord-442648$ACCORD$$70$YR$E$M$Y$89$KG$20240831$$MD$GB$GB
242710171$24271017$1$I$20240809$20240821$20240831$20240831$EXP$PT-INFARMED-R202408-253$PT-Accord-442904$ACCORD$$39$YR$A$F$Y$$$20240831$$MD$PT$PT
242710181$24271018$1$I$$20240821$20240831$20240831$EXP$GB-MHRA-MED-202408211022345950-CSDPH$GB-Accord-442796$ACCORD$$$$$M$Y$$$20240831$$PH$GB$GB
242710191$24271019$1$I$20240702$20240821$20240831$20240831$EXP$GB-MHRA-TPP60357783C18085649YC1724151055904$GB-Accord-442769$ACCORD$$35$YR$A$F$Y$89$KG$20240831$$PH$GB$GB
242710201$24271020$1$I$$20240819$20240831$20240831$EXP$$IN-Accord-441993$ACCORD$Sebastian A, Bhaskar E, Moorthy S, M L. Reversible Second-Degree Heart Block Attributed to Ondansetron: A Rare Side Effect. Cureus. 2024 Jul 8;16(7):e64109.$26$YR$A$F$Y$$$20240831$$MD$IN$IN
242710211$24271021$1$I$$20240820$20240831$20240831$EXP$CA-MHPD-E2B_07127746$CA-Accord-442803$ACCORD$$73$YR$E$F$Y$88$KG$20240831$$HP$CA$CA
242710221$24271022$1$I$20240819$20240820$20240831$20240831$EXP$$US-Accord-443386$ACCORD$$47$YR$$M$Y$$$20240831$$HP$US$US
242710231$24271023$1$I$20240808$20240819$20240831$20240831$EXP$$US-Accord-443002$ACCORD$$49$YR$A$M$Y$$$20240831$$HP$US$US
242710241$24271024$1$I$$20240821$20240831$20240831$EXP$GB-MHRA-MED-202408211435335820-FBLQZ$GB-Accord-442929$ACCORD$$82$YR$E$F$Y$$$20240831$$HP$GB$GB
242710251$24271025$1$I$20240821$20240821$20240831$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024104499$VIIV$$43$YR$$M$Y$$$20240831$$HP$US$US
242710261$24271026$1$I$$20240821$20240831$20240831$EXP$$CA-AUROBINDO-AUR-APL-2024-042769$AUROBINDO$$38$YR$$F$Y$$$20240831$$MD$CA$CA
242710271$24271027$1$I$$20240829$20240831$20240831$PER$$US-AstraZeneca-2024A197887$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$US$
242710281$24271028$1$I$$20240831$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-087887-2024$RECKITT BENCKISER$$$$$F$Y$$$20240831$$CN$US$US
242710291$24271029$1$I$$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173493$AMGEN$$70$YR$E$F$Y$$$20240831$$HP$US$US
242710301$24271030$1$I$20240828$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173498$AMGEN$$68$YR$E$F$Y$$$20240831$$CN$US$US
242710321$24271032$1$I$$20240822$20240831$20240831$EXP$GB-MHRA-MIDB-f2e310a8-9d28-4c5b-ba9e-7896d2e17bbf$GB-KOANAAP-SML-GB-2024-00884$Unknown Manufacturer$$79$YR$E$F$Y$$$20240831$$HP$GB$GB
242710331$24271033$1$I$20240624$20240823$20240831$20240831$EXP$FR-AFSSAPS-NT2024001064$FR-KOANAAP-SML-FR-2024-00886$Unknown Manufacturer$$60$YR$A$M$Y$82$KG$20240831$$PH$FR$FR
242710341$24271034$1$I$20240815$20240822$20240831$20240831$EXP$FR-AFSSAPS-RS2024000821$FR-KOANAAP-SML-FR-2024-00882$Unknown Manufacturer$$64$YR$A$M$Y$76$KG$20240831$$MD$FR$FR
242710352$24271035$2$F$20200101$20240911$20240831$20240920$EXP$ES-ASTELLAS-2022US026364$ES-KOANAAP-SML-ES-2024-00888$SHILPA MEDICARE$$62$YR$A$F$Y$$$20240920$$HP$ES$ES
242710361$24271036$1$I$20240801$20240827$20240831$20240831$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-005090$JAZZ$$37$YR$$F$Y$$$20240831$$HP$US$US
242710382$24271038$2$F$20240813$20240917$20240831$20240926$EXP$$US-UROGEN PHARMA LTD.-2024-UGN-000115$UROGEN PHARMA$$$$$$Y$$$20240926$$CN$US$US
242710392$24271039$2$F$$20240913$20240831$20240924$EXP$$CA-APOTEX-2024AP009672$APOTEX$$70$YR$$F$Y$$$20240924$$HP$CA$CA
242710401$24271040$1$I$$20240822$20240831$20240831$EXP$$JP-TAKEDA-2024TUS087432$TAKEDA$$76$YR$$F$Y$$$20240831$$MD$JP$JP
242710411$24271041$1$I$20240826$20240829$20240831$20240831$EXP$$GB-ABBVIE-5901221$ABBVIE$$$$E$M$Y$$$20240831$$CN$GB$GB
242710422$24271042$2$F$$20240903$20240831$20240906$EXP$$CA-ABBVIE-5889651$ABBVIE$$$$A$M$Y$$$20240906$$CN$CA$CA
242710431$24271043$1$I$20240816$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173694$AMGEN$$65$YR$E$F$Y$$$20240831$$CN$US$US
242710441$24271044$1$I$20240827$20240829$20240831$20240831$EXP$GB-MHRA-MED-202408291728596080-RQGZC$GB-ROCHE-10000069993$ROCHE$$70$YR$E$M$Y$$$20240831$$HP$GB$GB
242710451$24271045$1$I$20240101$20240827$20240831$20240831$PER$$US-ABBVIE-5899682$ABBVIE$$$$$M$Y$65$KG$20240831$$HP$US$US
242710461$24271046$1$I$$20240828$20240831$20240831$PER$$US-BAYER-2024A124408$BAYER$$$$$$Y$$$20240831$$CN$US$US
242710472$24271047$2$F$$20240924$20240831$20240926$EXP$$CA-ROCHE-10000065797$ROCHE$$40$YR$A$F$Y$$$20240926$$HP$CA$CA
242710481$24271048$1$I$20240826$20240830$20240831$20240831$PER$$US-BAYER-2024A125092$BAYER$$26$YR$A$F$Y$$$20240831$$MD$US$US
242710491$24271049$1$I$20240821$20240821$20240831$20240831$PER$$US-ABBVIE-5891385$ABBVIE$$50$YR$$M$Y$$$20240831$$CN$US$US
242710501$24271050$1$I$$20240831$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-087574-2024$RECKITT BENCKISER$$$$$F$Y$$$20240831$$CN$US$US
242710511$24271051$1$I$20240827$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173401$AMGEN$$78$YR$E$F$Y$$$20240831$$CN$US$US
242710522$24271052$2$F$20240809$20240917$20240831$20240924$EXP$$JP-GENMAB-2024-02911$GENMAB$$69$YR$$M$Y$65.8$KG$20240924$$MD$JP$JP
242710531$24271053$1$I$20240101$20240822$20240831$20240831$PER$$US-SA-2024SA200279$SANOFI AVENTIS$$$$A$F$Y$$$20240831$$MD$US$US
242710541$24271054$1$I$20240803$20240827$20240831$20240831$PER$$US-BAYER-2024A123411$BAYER$$42$YR$A$F$Y$$$20240831$$MD$US$US
242710551$24271055$1$I$$20240831$20240831$20240831$PER$$US-PROD-AS2-212756134-RB-081370-2024$RECKITT BENCKISER$$$$$F$Y$$$20240831$$CN$US$US
242710562$24271056$2$F$$20240917$20240831$20240927$PER$$US-GSK-US2024105084$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
242710571$24271057$1$I$20240101$20240822$20240831$20240831$PER$$US-SA-2024SA248392$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240831$$CN$US$US
242710581$24271058$1$I$20240801$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173061$AMGEN$$50$YR$A$F$Y$$$20240831$$CN$US$US
242710591$24271059$1$I$20240818$20240829$20240831$20240831$EXP$$CN-ROCHE-10000069795$ROCHE$$62$YR$A$F$Y$$$20240831$$HP$CN$CN
242710601$24271060$1$I$20240820$20240829$20240831$20240831$EXP$$CN-ROCHE-10000069229$ROCHE$$54$YR$A$F$Y$58$KG$20240831$$HP$CN$CN
242710611$24271061$1$I$20240819$20240821$20240831$20240831$30DAY$$US-GSK-US2024104578$GLAXOSMITHKLINE$$17$YR$$M$Y$$$20240831$$CN$US$US
242710621$24271062$1$I$20240827$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173408$AMGEN$$71$YR$E$F$Y$$$20240831$$CN$US$US
242710631$24271063$1$I$$20240822$20240831$20240831$EXP$$GB-BAXTER-2024BAX023650$BAXTER$$2$DEC$$F$Y$$$20240831$$MD$GB$GB
242710641$24271064$1$I$$20240822$20240831$20240831$EXP$$US-BAXTER-2024BAX023638$BAXTER$$$$$$Y$$$20240831$$MD$US$US
242710651$24271065$1$I$20240730$20240822$20240831$20240831$EXP$CN-NMPACDR-1301081003139202400270$CN-BAXTER-2024BAX023741$BAXTER$$61$YR$$F$Y$70$KG$20240831$$MD$CN$CN
242710661$24271066$1$I$$20240823$20240831$20240831$30DAY$$US-GSK-US2024105518$GLAXOSMITHKLINE$$$$$M$Y$$$20240831$$MD$US$US
242710671$24271067$1$I$20240823$20240828$20240831$20240831$PER$$US-SA-2024SA252544$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240831$$CN$US$US
242710681$24271068$1$I$20240101$20240813$20240831$20240831$PER$$US-TEVA-VS-3233618$TEVA$$$$A$F$Y$$$20240831$$CN$US$US
242710692$24271069$2$F$$20240827$20240831$20240906$EXP$$BR-TEVA-VS-3232372$TEVA$$$$$$Y$$$20240906$$PH$BR$BR
242710701$24271070$1$I$20240822$20240822$20240831$20240831$EXP$$BR-TAKEDA-2024TUS086191$TAKEDA$$34$YR$$M$Y$98$KG$20240831$$MD$BR$BR
242710711$24271071$1$I$20221031$20240821$20240831$20240831$EXP$$US-BAXTER-2024BAX023578$BAXTER$$15$YR$$M$Y$46.4$KG$20240831$$HP$US$US
242710721$24271072$1$I$$20240822$20240831$20240831$EXP$GB-MHRA-MIDB-a8eb119e-06d5-4eb2-bb18-b3cc85e02e58$GB-BAXTER-2024BAX023599$BAXTER$$45$YR$$$Y$$$20240831$$PH$GB$GB
242710732$24271073$2$F$20231101$20240820$20240831$20240909$PER$$US-SA-2024SA252945$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240909$$MD$US$US
242710741$24271074$1$I$$20240819$20240831$20240831$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK093552$GLENMARK$Poyekar S, Nagral A.. Plasma cell rich rejection following liver transplant for wilsons disease: a case series. Journal of Clinical and Experimental Hepatology. 2024;14 Supplement 1:102185$$$$$Y$$$20240831$$HP$IN$IN
242710751$24271075$1$I$$20240822$20240831$20240831$30DAY$$US-GSK-US2024105085$GLAXOSMITHKLINE$$$$$F$Y$$$20240831$$CN$US$US
242710762$24271076$2$F$$20240819$20240831$20240831$EXP$$CN-AZURITY PHARMACEUTICALS, INC.-AZR202408-000441$AZURITY PHARMACEUTICALS$Shen J, Shen X, Zhao F, Yao J.. Pneumomediastinum and pneumoretroperitoneum after COVID-19: concealed intestinal perforation. BMC Infect. Dis. 2024;24:801$74$YR$$F$Y$$$20240831$$HP$CN$CN
242710771$24271077$1$I$$20240819$20240831$20240831$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK093553$GLENMARK$Poyekar S, Nagral A.. Plasma cell rich rejection following liver transplant for wilsons disease: a case series. Journal of Clinical and Experimental Hepatology. 2024;14 Supplement 1:102185$$$$$Y$$$20240831$$HP$IN$IN
242710781$24271078$1$I$20231124$20240828$20240831$20240831$EXP$FR-AFSSAPS-LY2023001904$FR-ROCHE-10000068156$ROCHE$$47$YR$A$F$Y$$$20240831$$MD$FR$FR
242710791$24271079$1$I$20220101$20240822$20240831$20240831$PER$$US-ABBVIE-5893998$ABBVIE$$$$$F$Y$56$KG$20240831$$CN$US$US
242710801$24271080$1$I$$20240819$20240831$20240831$EXP$$IT-AZURITY PHARMACEUTICALS, INC.-AZR202408-000418$AZURITY PHARMACEUTICALS$Tarda L, Sacco MA, Tarzia P, Verrina MC, Calafiore J, Aquila I. Analysis of toxicological findings related to immunofluorescence investigations. Clin Ter. 2024;2(4):183-6$54$YR$$M$Y$$$20240831$$HP$IT$IT
242710811$24271081$1$I$$20240819$20240831$20240831$EXP$$IT-AZURITY PHARMACEUTICALS, INC.-AZR202408-000419$AZURITY PHARMACEUTICALS$Tarda L, Sacco MA, Tarzia P, Verrina MC, Calafiore J, Aquila I. Analysis of toxicological findings related to immunofluorescence investigations. Clin Ter. 2024;2(4):183-6$56$YR$$F$Y$$$20240831$$HP$IT$IT
242710821$24271082$1$I$20240724$20240827$20240831$20240831$PER$$US-AMGEN-USASP2024171727$AMGEN$$$$$$Y$$$20240831$$HP$US$US
242710831$24271083$1$I$20210501$20240819$20240831$20240831$EXP$$GB-AZURITY PHARMACEUTICALS, INC.-AZR202408-000482$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240831$$CN$GB$GB
242710841$24271084$1$I$20240829$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173697$AMGEN$$75$YR$E$F$Y$$$20240831$$CN$US$US
242710851$24271085$1$I$$20240820$20240831$20240831$EXP$$MX-AZURITY PHARMACEUTICALS, INC.-AZR202408-000417$AZURITY PHARMACEUTICALS$Campa MG, Cisneros MR, Hinojosa MD, Carrilo JC, Avila RA, Mendoza APF. et al.. Gastrointestinal Cytomegalovirus Infection in a Transplantation Recipient With a Negative Serum Viral Load: Case Report. Transplant. Proc. 2024;56(5):1188-91$49$YR$$M$Y$$$20240831$$HP$MX$MX
242710861$24271086$1$I$$20240822$20240831$20240831$EXP$$US-GSK-US2024AMR105732$GLAXOSMITHKLINE$$$$$F$Y$$$20240831$$CN$US$US
242710872$24271087$2$F$$20240911$20240831$20240920$EXP$$FI-UNITED THERAPEUTICS-UNT-2024-027042$UNITED THERAPEUTICS$$$$$$Y$$$20240920$$$FI$FI
242710882$24271088$2$F$20240826$20240903$20240831$20240910$EXP$$CO-ABBVIE-5902325$ABBVIE$$66$YR$$M$Y$72$KG$20240910$$HP$CO$CO
242710891$24271089$1$I$$20240819$20240831$20240831$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK093554$GLENMARK$Poyekar S, Nagral A.. Plasma cell rich rejection following liver transplant for wilsons disease: a case series. Journal of Clinical and Experimental Hepatology. 2024;14 Supplement 1:102185$$$$$Y$$$20240831$$HP$IN$IN
242710901$24271090$1$I$$20240826$20240831$20240831$PER$US-MLMSERVICE-20240826-PI146989-00043-4$US-RDY-SPO/USA/24/0012538$DR REDDYS$Peshin S, Modi SK, Burwick N. Lenalidomide and Dexamethasone in Scleromyxedema: A Case Report of Long-Term Efficacy and Challenges in a 54-Year-Old Patient. Cureus. 2024;16(6):e63181. DOI:10.7759/cureus.63181.$54$YR$A$M$Y$$$20240831$$MD$US$US
242710912$24271091$2$F$20240829$20240902$20240831$20240904$PER$$US-AMGEN-USASP2024174025$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242710922$24271092$2$F$20240801$20240904$20240831$20240911$EXP$$US-ABBVIE-5898512$ABBVIE$$45$YR$$F$Y$$$20240911$$CN$US$US
242710931$24271093$1$I$20240801$20240823$20240831$20240831$PER$$US-UNITED THERAPEUTICS-UNT-2024-026345$UNITED THERAPEUTICS$$71$YR$$F$Y$49.887$KG$20240831$$$US$US
242710941$24271094$1$I$$20240821$20240831$20240831$EXP$GB-MHRA-MED-202408211118557790-TFKZR$GB-TEVA-VS-3236173$TEVA$$59$YR$$M$Y$101$KG$20240831$$PH$GB$GB
242710951$24271095$1$I$$20240827$20240831$20240831$EXP$$US-ABBVIE-5898825$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242710961$24271096$1$I$20240801$20240828$20240831$20240831$EXP$$US-ABBVIE-5899676$ABBVIE$$47$YR$$M$Y$$$20240831$$CN$US$US
242710971$24271097$1$I$20240801$20240828$20240831$20240831$EXP$$US-ABBVIE-5899920$ABBVIE$$63$YR$$F$Y$$$20240831$$CN$US$US
242710981$24271098$1$I$$20240822$20240831$20240831$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134639$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240831$$MD$US$US
242710991$24271099$1$I$$20240828$20240831$20240831$PER$$US-ABBVIE-5900381$ABBVIE$$$$$M$Y$113$KG$20240831$$CN$US$US
242711001$24271100$1$I$20240819$20240828$20240831$20240831$EXP$$CN-ROCHE-10000068233$ROCHE$$55$YR$A$M$Y$48$KG$20240831$$HP$CN$CN
242711011$24271101$1$I$20240830$20240830$20240831$20240831$PER$$US-AMGEN-USASP2024174002$AMGEN$$78$YR$E$F$Y$$$20240831$$HP$US$US
242711021$24271102$1$I$20230101$20240828$20240831$20240831$EXP$$US-ABBVIE-5899631$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242711031$24271103$1$I$20240827$20240828$20240831$20240831$EXP$$US-ABBVIE-5900437$ABBVIE$$41$YR$$F$Y$$$20240831$$CN$US$US
242711041$24271104$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5900910$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242711051$24271105$1$I$20240814$20240821$20240831$20240831$EXP$GB-MHRA-MED-202408211641176620-NZYFW$GB-TEVA-VS-3236343$TEVA$$55$YR$$F$Y$$$20240831$$PH$GB$GB
242711061$24271106$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5900466$ABBVIE$$$$$F$Y$$$20240831$$CN$US$US
242711072$24271107$2$F$$20240924$20240831$20240930$EXP$$DE-ABBVIE-5901096$ABBVIE$$77$YR$$F$Y$$$20240930$$MD$DE$DE
242711081$24271108$1$I$20240823$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173600$AMGEN$$83$YR$E$F$Y$$$20240831$$CN$US$US
242711091$24271109$1$I$$20240828$20240831$20240831$EXP$$US-ABBVIE-5900441$ABBVIE$$$$$$Y$$$20240831$$MD$US$US
242711101$24271110$1$I$20240501$20240820$20240831$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202408018238$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240831$$CN$US$US
242711111$24271111$1$I$20240826$20240827$20240831$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202408016965$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240831$$CN$US$US
242711121$24271112$1$I$$20240812$20240831$20240831$PER$$US-RDY-SPO/USA/24/0012539$DR REDDYS$$$$$$Y$$$20240831$$CN$US$US
242711152$24271115$2$F$20240826$20240827$20240831$20240905$PER$$US-AMGEN-USASP2024171455$AMGEN$$$$A$F$Y$$$20240905$$HP$US$US
242711162$24271116$2$F$$20240909$20240831$20240916$EXP$$GB-TAKEDA-2024TUS086044$TAKEDA$$$$$M$Y$$$20240916$$CN$GB$GB
242711171$24271117$1$I$20240819$20240822$20240831$20240831$PER$$US-SA-2024SA252868$SANOFI AVENTIS$$71$YR$E$F$Y$68.03$KG$20240831$$MD$US$US
242711181$24271118$1$I$20240829$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173565$AMGEN$$81$YR$E$F$Y$$$20240831$$CN$US$US
242711192$24271119$2$F$20240801$20240911$20240831$20240926$PER$$US-SA-2024SA252256$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240926$$MD$US$US
242711201$24271120$1$I$$20240821$20240831$20240831$PER$$US-RDY-SPO/USA/24/0012537$DR REDDYS$$16$YR$T$$Y$$$20240831$$MD$US$US
242711211$24271121$1$I$$20240822$20240831$20240831$PER$$US-RDY-SPO/USA/24/0012534$DR REDDYS$$17$YR$T$$Y$$$20240831$$MD$US$US
242711221$24271122$1$I$$20240822$20240831$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024105586$VIIV$$$$$M$Y$$$20240831$$MD$US$US
242711231$24271123$1$I$20240828$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173301$AMGEN$$72$YR$E$F$Y$$$20240831$$CN$US$US
242711241$24271124$1$I$20240819$20240822$20240831$20240831$PER$$US-SA-2024SA252730$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240831$$CN$US$US
242711261$24271126$1$I$$20240826$20240831$20240831$EXP$$NVSC2024CO174277$NOVARTIS$$$$$M$Y$61$KG$20240831$$CN$CO$CO
242711271$24271127$1$I$20240828$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173543$AMGEN$$75$YR$E$M$Y$$$20240831$$CN$US$US
242711281$24271128$1$I$20240829$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173571$AMGEN$$75$YR$E$F$Y$$$20240831$$CN$US$US
242711301$24271130$1$I$20240829$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173530$AMGEN$$$$$$Y$$$20240831$$PH$US$US
242711313$24271131$3$F$$20240914$20240831$20240925$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093501$GLENMARK$$$$$$Y$$$20240925$$CN$US$US
242711321$24271132$1$I$20230201$20240820$20240831$20240831$PER$$US-SA-2024SA252335$SANOFI AVENTIS$$$$$M$Y$$$20240831$$CN$US$US
242711331$24271133$1$I$$20240821$20240831$20240831$EXP$$US-RDY-SPO/USA/24/0012524$DR REDDYS$Patel N, Madi P, Monteiro I, Shah SP. The anesthetic management of a child with ohtahara syndrome and severe stridor: a case report. BMC Pediatrics. 2024 Jul 25;24(1): doi:10.1186/s12887-024-04907-8.$$$I$M$Y$$$20240831$$HP$US$US
242711341$24271134$1$I$20240101$20240828$20240831$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202408018227$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240831$$CN$US$US
242711351$24271135$1$I$20211207$20240827$20240831$20240831$EXP$$US-TAKEDA-US201937580$TAKEDA$$40$YR$$F$Y$$$20240831$$CN$US$US
242711361$24271136$1$I$20240828$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024172912$AMGEN$$62$YR$A$F$Y$$$20240831$$CN$US$US
242711372$24271137$2$F$20240817$20240902$20240831$20240903$PER$$US-AMGEN-USASP2024174024$AMGEN$$58$YR$A$M$Y$$$20240903$$CN$US$US
242711381$24271138$1$I$20230101$20240822$20240831$20240831$PER$$US-SA-2024SA252834$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240831$$CN$US$US
242711391$24271139$1$I$$20240822$20240831$20240831$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-143007$DAIICHI$$$$$F$Y$$$20240831$$MD$US$US
242711402$24271140$2$F$20240823$20240829$20240831$20240903$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-17112$IPSEN$$53$YR$A$F$Y$$$20240903$$HP$US$US
242711411$24271141$1$I$$20240822$20240831$20240831$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR105871$VIIV$$$$$M$Y$$$20240831$$PH$US$US
242711421$24271142$1$I$20240828$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024172976$AMGEN$$63$YR$A$F$Y$$$20240831$$CN$US$US
242711431$24271143$1$I$$20240819$20240831$20240831$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093550$GLENMARK$Estes W, Latt LD, Robishaw-Denton J, Repp ML, Suri Y, Chadaz T, et al. Musculoskeletal manifestations of lower-extremity coccidioidomycosis: a case series. Journal of Bone and Joint Infection. 2024;9:197-205$$$$$Y$$$20240831$$HP$US$US
242711441$24271144$1$I$20240827$20240828$20240831$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202408018082$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240831$$CN$US$US
242711451$24271145$1$I$$20240822$20240831$20240831$EXP$$IT-AMGEN-ITASP2024168466$AMGEN$Mauro,F. Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial. LEUKEMIA + LYMPHOMA. 2017;58 (7):1640-1647$$$$$Y$$$20240831$$HP$IT$IT
242711473$24271147$3$F$20240826$20240912$20240831$20240923$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-004282$UNITED THERAPEUTICS$$64$YR$$M$Y$$$20240923$$$JP$JP
242711481$24271148$1$I$20240819$20240823$20240831$20240831$EXP$$CN-Ipsen Biopharmaceuticals, Inc.-2024-17304$IPSEN$$41$YR$A$M$Y$$$20240831$$MD$CN$CN
242711491$24271149$1$I$$20240820$20240831$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR106251$VIIV$$$$$$Y$$$20240831$$MD$US$US
242711502$24271150$2$F$$20240826$20240831$20240904$EXP$$FR-TAKEDA-2024TUS086939$TAKEDA$$$$A$M$Y$$$20240904$$CN$FR$FR
242711511$24271151$1$I$20240126$20240828$20240831$20240831$EXP$$US-TAKEDA-2024TUS055955$TAKEDA$$77$YR$$M$Y$$$20240831$$CN$US$US
242711521$24271152$1$I$20240801$20240827$20240831$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202408017674$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240831$$CN$US$US
242711531$24271153$1$I$20240325$20240822$20240831$20240831$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16883$IPSEN$$41$YR$A$F$Y$$$20240831$$HP$US$US
242711542$24271154$2$F$20230106$20240829$20240831$20240905$EXP$$CA-TAKEDA-2023TUS039071$TAKEDA$$14$YR$$M$Y$$$20240905$$MD$CA$CA
242711552$24271155$2$F$$20240911$20240831$20240920$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-16977$IPSEN$Shiraishi K, Kobayashi S, Enomoto M, Hamaguchi T, Asai Y, Tozuka Y, et al.. A Case of Diverticular Perforation in the Sigmoid Colon during Drug Therapy for Unresectable Pancreatic Cancer. The 68th Meeting of Kanagawa Society of Gastroenterology. 2024$$$A$F$Y$$$20240920$$MD$JP$JP
242711561$24271156$1$I$20240501$20240822$20240831$20240831$PER$$US-SA-2024SA252321$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240831$$MD$US$US
242711571$24271157$1$I$20240813$20240823$20240831$20240831$EXP$CN-NMPA-2201041020783202400611$CN-Ipsen Biopharmaceuticals, Inc.-2024-17303$IPSEN$$55$YR$A$M$Y$71$KG$20240831$$HP$CN$CN
242711581$24271158$1$I$20240826$20240827$20240831$20240831$PER$$US-AMGEN-USASP2024171298$AMGEN$$72$YR$E$M$Y$$$20240831$$CN$US$US
242711591$24271159$1$I$$20240822$20240831$20240831$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR105701$VIIV$$$$$M$Y$$$20240831$$CN$US$US
242711601$24271160$1$I$$20240826$20240831$20240831$EXP$$CN-AstraZeneca-2024A197973$ASTRAZENECA$Liu Zhong?an, Li Guiling, et al.. Pneumocystis jirovecii Infection During Immune Checkpoint Inhibitor Therapy: A Report of Two Cases and Literature Review. Anti-tumor Pharmacy 2023;13(1):$46$YR$$M$Y$$$20240831$$HP$CN$
242711611$24271161$1$I$$20240825$20240831$20240831$EXP$$TR-AMGEN-TURSP2024171487$AMGEN$Ozturk K.; Koru L.; Esen F. et al.. Clinical characteristics of pediatric noninfectious uveitis and risk factors for severe disease: a single-center study. Clinical Rheumatology. 2024;43 (9):2933-2942$$$$$Y$$$20240831$$HP$TR$TR
242711621$24271162$1$I$$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172018$AMGEN$$$$$F$Y$$$20240831$$CN$US$US
242711631$24271163$1$I$20240818$20240830$20240831$20240831$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048777$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$56$KG$20240831$$HP$CN$CN
242711641$24271164$1$I$20240101$20240822$20240831$20240831$PER$$US-SA-2024SA252718$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240831$$CN$US$US
242711651$24271165$1$I$20240829$20240829$20240831$20240831$PER$$US-AMGEN-USASP2024173208$AMGEN$$60$YR$A$F$Y$$$20240831$$CN$US$US
242711661$24271166$1$I$$20240829$20240831$20240831$EXP$$ZA-AstraZeneca-2024A197738$ASTRAZENECA$$57$YR$$M$Y$$$20240831$$CN$ZA$
242711671$24271167$1$I$$20240828$20240831$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202408018517$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240831$$CN$US$US
242711681$24271168$1$I$$20240829$20240831$20240831$EXP$$US-AstraZeneca-2024A197832$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242711691$24271169$1$I$$20240826$20240831$20240831$EXP$$BR-AstraZeneca-2024A197612$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$BR$
242711701$24271170$1$I$$20240828$20240831$20240831$EXP$$US-AstraZeneca-2024A196803$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$US$
242711711$24271171$1$I$$20240826$20240831$20240831$EXP$$US-AstraZeneca-2024A194890$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242711721$24271172$1$I$20240603$20240823$20240831$20240831$EXP$$JP-ABBVIE-5902699$ABBVIE$$76$YR$$M$Y$$$20240831$$PH$JP$JP
242711731$24271173$1$I$$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024173368$AMGEN$$$$$$Y$$$20240831$$CN$US$US
242711751$24271175$1$I$$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024173141$AMGEN$$$$$$Y$$$20240831$$PH$US$US
242711761$24271176$1$I$$20240825$20240831$20240831$EXP$$TW-JNJFOC-20240868625$JOHNSON AND JOHNSON$$90$YR$E$M$Y$$$20240831$$HP$TW$FR
242711771$24271177$1$I$$20240821$20240831$20240831$PER$$US-AstraZeneca-2024A191225$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242711781$24271178$1$I$$20240826$20240831$20240831$PER$$US-AstraZeneca-2024A194385$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242711792$24271179$2$F$20240701$20240828$20240831$20240906$EXP$GB-MHRA-MIDB-d00395d1-a34b-452f-afca-1ba11a5483ea$GB-ABBVIE-5899070$ABBVIE$$61$YR$$$Y$$$20240906$$PH$GB$GB
242711811$24271181$1$I$20240717$20240826$20240831$20240831$EXP$FR-AFSSAPS-AM2024000663$FR-ALCON LABORATORIES-ALC2024FR003956$ALCON$$$$$$Y$$$20240831$$HP$FR$FR
242711821$24271182$1$I$$20240827$20240831$20240831$PER$$US-AstraZeneca-2024A195975$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242711831$24271183$1$I$20230101$20240822$20240831$20240831$PER$$US-SA-2024SA252327$SANOFI AVENTIS$$$$A$F$Y$$$20240831$$MD$US$US
242711841$24271184$1$I$20220101$20240823$20240831$20240831$EXP$$BR-AMGEN-BRASL2023082667$AMGEN$$69$YR$E$M$Y$$$20240831$$CN$BR$BR
242711861$24271186$1$I$20240101$20240827$20240831$20240831$PER$$US-AstraZeneca-2024A195562$ASTRAZENECA$$30869$DY$$F$Y$$$20240831$$CN$US$
242711871$24271187$1$I$20240827$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172433$AMGEN$$61$YR$A$F$Y$$$20240831$$CN$US$US
242711882$24271188$2$F$20240401$20240910$20240831$20240913$PER$$US-AMGEN-USASP2024171949$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
242711891$24271189$1$I$20240726$20240828$20240831$20240831$PER$$US-AMGEN-USASP2024172435$AMGEN$$58$YR$A$F$Y$$$20240831$$HP$US$US
242711911$24271191$1$I$$20240822$20240831$20240831$PER$$US-AstraZeneca-2024A191778$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242711923$24271192$3$F$20240827$20240904$20240831$20240906$PER$$US-AMGEN-USASP2024173813$AMGEN$$$$$F$Y$$$20240906$$PH$US$US
242711931$24271193$1$I$$20240815$20240831$20240831$PER$$US-AstraZeneca-2024A186701$ASTRAZENECA$$$$$M$Y$$$20240831$$CN$US$
242711951$24271195$1$I$$20240814$20240831$20240831$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130389$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$106.59$KG$20240831$$CN$US$US
242711961$24271196$1$I$$20240827$20240831$20240831$PER$$US-AstraZeneca-2024A195277$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242711971$24271197$1$I$20230201$20240828$20240831$20240831$EXP$$NVSC2023GB065115$NOVARTIS$$$$$F$Y$$$20240831$$CN$GB$GB
242711981$24271198$1$I$20240824$20240826$20240831$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202408017622$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240831$$CN$US$US
242711991$24271199$1$I$$20240822$20240831$20240831$PER$$US-JNJFOC-20240859537$JOHNSON AND JOHNSON$$$$$$Y$$$20240831$$CN$US$US
242712001$24271200$1$I$$20240829$20240831$20240831$PER$$US-AstraZeneca-2024A197818$ASTRAZENECA$$$$$F$Y$$$20240831$$CN$US$
242712011$24271201$1$I$$20240820$20240831$20240831$PER$$US-JNJFOC-20240855485$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240831$$CN$US$US
242712021$24271202$1$I$20240821$20240821$20240831$20240831$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01284$AIMMUNE$$$$$$Y$$$20240831$$CN$US$US
242712032$24271203$2$F$$20240904$20240831$20240916$EXP$$US-ZENPEP LLC-2024AIMT01275$AIMMUNE$$$$$$Y$$$20240916$$CN$US$US
242712041$24271204$1$I$$20240822$20240831$20240831$EXP$$US-VIIV HEALTHCARE LIMITED-US2024105526$VIIV$$$$$M$Y$$$20240831$$PH$US$US
242712051$24271205$1$I$20240801$20240828$20240831$20240831$PER$$US-ABBVIE-5900728$ABBVIE$$$$$M$Y$$$20240831$$CN$US$US
242712061$24271206$1$I$$20240827$20240831$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202408018166$ELI LILLY AND CO$$$$$$Y$$$20240831$$CN$US$US
242712071$24271207$1$I$20240828$20240828$20240831$20240831$PER$$US-ELI_LILLY_AND_COMPANY-US202408018176$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240831$$CN$US$US
242712081$24271208$1$I$$20240822$20240831$20240831$EXP$$US-GSK-US2024104975$GLAXOSMITHKLINE$$$$$F$Y$$$20240831$$CN$US$US
242712101$24271210$1$I$$20240822$20240831$20240831$30DAY$$US-GSK-US2024105067$GLAXOSMITHKLINE$$$$$F$Y$$$20240831$$PH$US$US
242712111$24271211$1$I$$20240823$20240831$20240831$PER$$US-AstraZeneca-2024A193086$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
242712121$24271212$1$I$$20240829$20240901$20240901$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048743$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240901$$MD$US$US
242712131$24271213$1$I$$20240822$20240901$20240901$PER$$US-AstraZeneca-2024A195908$ASTRAZENECA$$58$YR$$F$Y$$$20240901$$CN$US$
242712141$24271214$1$I$$20240819$20240901$20240901$PER$$US-AstraZeneca-2024A191688$ASTRAZENECA$$$$$$Y$$$20240901$$CN$US$
242712151$24271215$1$I$$20240827$20240901$20240901$EXP$$US-JNJFOC-20240876877$JOHNSON AND JOHNSON$$$$$F$Y$$$20240901$$HP$US$US
242712161$24271216$1$I$20240625$20240823$20240901$20240901$EXP$$US-JNJFOC-20240878930$JOHNSON AND JOHNSON$$77$YR$E$$Y$$$20240901$$CN$US$US
242712171$24271217$1$I$$20240822$20240901$20240901$PER$$US-JNJFOC-20240856917$JOHNSON AND JOHNSON$$$$$F$Y$$$20240901$$CN$US$US
242712181$24271218$1$I$$20240826$20240901$20240901$EXP$$US-AstraZeneca-2024A198002$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
242712192$24271219$2$F$20240701$20240828$20240901$20240909$PER$$US-JNJFOC-20240873977$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240909$$CN$US$US
242712212$24271221$2$F$$20240913$20240901$20240916$PER$$US-JNJFOC-20240865573$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$HP$US$US
242712221$24271222$1$I$20240801$20240823$20240901$20240901$PER$$US-SA-2024SA252510$SANOFI AVENTIS$$$$A$F$Y$$$20240901$$HP$US$US
242712231$24271223$1$I$$20240803$20240901$20240901$30DAY$$US-VEROBIOTECH-2024USVEROSPO00194$VERO BIOTECH$$$$$F$Y$$$20240901$$HP$US$US
242712241$24271224$1$I$$20240821$20240901$20240901$PER$$US-JNJFOC-20240856362$JOHNSON AND JOHNSON$$$$$F$Y$$$20240901$$CN$US$US
242712251$24271225$1$I$$20240828$20240901$20240901$PER$$US-AstraZeneca-2024A196716$ASTRAZENECA$$$$$M$Y$$$20240901$$CN$US$
242712261$24271226$1$I$20240101$20240812$20240901$20240901$PER$$US-TEVA-VS-3234401$TEVA$$23$YR$$M$Y$$$20240901$$CN$US$US
242712271$24271227$1$I$$20240829$20240901$20240901$PER$$US-AstraZeneca-2024A197803$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
242712291$24271229$1$I$$20240829$20240901$20240901$PER$$US-ELI_LILLY_AND_COMPANY-US202408019142$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240901$$CN$US$US
242712301$24271230$1$I$20240601$20240821$20240901$20240901$PER$$US-SA-2024SA252361$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240901$$MD$US$US
242712311$24271231$1$I$$20240828$20240901$20240901$PER$$US-AstraZeneca-2024A197097$ASTRAZENECA$$$$$$Y$$$20240901$$CN$US$
242712321$24271232$1$I$$20240821$20240901$20240901$EXP$$BR-JNJFOC-20240860693$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240901$$CN$BR$BR
242712331$24271233$1$I$$20240820$20240901$20240901$PER$$US-SA-2024SA252341$SANOFI AVENTIS$$$$E$F$Y$$$20240901$$MD$US$US
242712341$24271234$1$I$$20240822$20240901$20240901$PER$$US-JNJFOC-20240858164$JOHNSON AND JOHNSON$$$$$$Y$$$20240901$$HP$US$US
242712351$24271235$1$I$$20240823$20240901$20240901$EXP$$US-JNJFOC-20240862464$JOHNSON AND JOHNSON$$$$$F$Y$$$20240901$$CN$US$US
242712361$24271236$1$I$$20240822$20240901$20240901$EXP$$US-GSK-US2024AMR105597$GLAXOSMITHKLINE$$$$$M$Y$$$20240901$$HP$US$US
242712371$24271237$1$I$20240801$20240826$20240901$20240901$EXP$$BE-JNJFOC-20240869264$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240901$$MD$BE$BE
242712381$24271238$1$I$20240101$20240819$20240901$20240901$EXP$$GB-UCBSA-2024042245$UCB$$$$$F$Y$$$20240901$$CN$GB$GB
242712391$24271239$1$I$$20240821$20240901$20240901$PER$$US-SA-2024SA252339$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240901$$HP$US$US
242712401$24271240$1$I$$20240821$20240901$20240901$PER$$US-SA-2024SA252484$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240901$$CN$US$US
242712421$24271242$1$I$20240819$20240822$20240901$20240901$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024106585$VIIV$$37$YR$$M$Y$$$20240901$$HP$US$US
242712431$24271243$1$I$$20240819$20240901$20240901$EXP$$CA-UCBSA-2024042260$UCB$$$$$F$Y$$$20240901$$CN$CA$CA
242712441$24271244$1$I$20240807$20240829$20240901$20240901$EXP$$US-AstraZeneca-2024A197897$ASTRAZENECA$$27510$DY$$M$Y$$$20240901$$CN$US$
242712451$24271245$1$I$$20240829$20240901$20240901$PER$$US-ELI_LILLY_AND_COMPANY-US202408019150$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240901$$CN$US$US
242712462$24271246$2$F$20240101$20240913$20240901$20240927$EXP$$CA-UCBSA-2024042284$UCB$$$$$F$Y$$$20240927$$HP$CA$CA
242712471$24271247$1$I$$20240827$20240901$20240901$PER$$US-JNJFOC-20240873345$JOHNSON AND JOHNSON$$$$$$Y$$$20240901$$HP$US$US
242712481$24271248$1$I$$20240805$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08032$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242712501$24271250$1$I$$20240812$20240901$20240901$PER$$US-AstraZeneca-2024A183341$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
242712511$24271251$1$I$$20240827$20240901$20240901$EXP$$US-AstraZeneca-2024A195407$ASTRAZENECA$$$$$M$Y$$$20240901$$CN$US$
242712521$24271252$1$I$$20240816$20240901$20240901$PER$$US-JNJFOC-20240844459$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240901$$CN$US$US
242712531$24271253$1$I$$20240831$20240901$20240901$PER$$US-PROD-AS2-212756134-RB-087262-2024$RECKITT BENCKISER$$42$YR$$F$Y$$$20240901$$CN$US$US
242712541$24271254$1$I$20240807$20240807$20240901$20240901$PER$$US-CSL-2024-007596$CSL Plasma$$18$YR$$F$Y$$$20240901$$HP$US$US
242712551$24271255$1$I$$20240828$20240901$20240901$EXP$$US-AstraZeneca-2024A196273$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
242712561$24271256$1$I$$20240831$20240901$20240901$PER$$US-PROD-AS2-212756134-RB-086403-2024$RECKITT BENCKISER$$$$$M$Y$$$20240901$$CN$US$US
242712571$24271257$1$I$$20240828$20240901$20240901$PER$$US-ELI_LILLY_AND_COMPANY-US202408018354$ELI LILLY AND CO$$$$$$Y$$$20240901$$CN$US$US
242712581$24271258$1$I$$20240828$20240901$20240901$PER$$US-ELI_LILLY_AND_COMPANY-US202408018372$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240901$$CN$US$US
242712591$24271259$1$I$$20240826$20240901$20240901$30DAY$$US-GSK-US2024106037$GLAXOSMITHKLINE$$$$$M$Y$$$20240901$$MD$US$US
242712601$24271260$1$I$20240701$20240819$20240901$20240901$EXP$$US-UCBSA-2024042318$UCB$$38$YR$$F$Y$$$20240901$$HP$US$US
242712611$24271261$1$I$20240801$20240819$20240901$20240901$EXP$$US-UCBSA-2024042327$UCB$$67$YR$$F$Y$56.372$KG$20240901$$HP$US$US
242712621$24271262$1$I$$20240831$20240901$20240901$PER$$US-PROD-AS2-212756134-RB-085250-2024$RECKITT BENCKISER$$$$$F$Y$$$20240901$$CN$US$US
242712631$24271263$1$I$$20240826$20240901$20240901$EXP$$US-JNJFOC-20240869422$JOHNSON AND JOHNSON$$$$$M$Y$$$20240901$$CN$US$US
242712641$24271264$1$I$$20240824$20240901$20240901$PER$$US-JNJFOC-20240869878$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240901$$CN$US$US
242712651$24271265$1$I$$20240826$20240901$20240901$PER$$US-AstraZeneca-2024A194234$ASTRAZENECA$$$$$F$Y$$$20240901$$MD$US$
242712662$24271266$2$F$$20240910$20240901$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08281$LUPIN$$$$$$Y$$$20240926$$CN$US$US
242712671$24271267$1$I$$20240823$20240901$20240901$PER$$US-SA-2024SA252720$SANOFI AVENTIS$$$$A$$Y$$$20240901$$HP$US$US
242712681$24271268$1$I$20240803$20240823$20240901$20240901$EXP$$CN-JNJFOC-20240863176$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240901$$HP$CN$CN
242712691$24271269$1$I$$20240814$20240901$20240901$PER$$US-JNJFOC-20240837173$JOHNSON AND JOHNSON$$$$$F$Y$$$20240901$$CN$US$US
242712701$24271270$1$I$$20240815$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08291$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242712711$24271271$1$I$$20240820$20240901$20240901$PER$$US-SA-2024SA249607$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240901$$MD$US$US
242712722$24271272$2$F$20240101$20240909$20240901$20240913$PER$$US-AMGEN-USASP2024172228$AMGEN$$50$YR$A$M$Y$$$20240913$$CN$US$US
242712731$24271273$1$I$$20240816$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08461$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242712741$24271274$1$I$$20240822$20240901$20240901$PER$$US-AstraZeneca-2024A191953$ASTRAZENECA$$52$YR$$M$Y$$$20240901$$HP$US$
242712751$24271275$1$I$20230101$20240807$20240901$20240901$PER$$US-AstraZeneca-2024A180135$ASTRAZENECA$$24111$DY$$F$Y$$$20240901$$CN$US$
242712761$24271276$1$I$20240101$20240828$20240901$20240901$EXP$$US-JNJFOC-20240877215$JOHNSON AND JOHNSON$$$$$M$Y$$$20240901$$CN$US$US
242712771$24271277$1$I$$20240821$20240901$20240901$PER$$US-JNJFOC-20240881564$JOHNSON AND JOHNSON$$$$$F$Y$$$20240901$$CN$US$US
242712782$24271278$2$F$$20240830$20240901$20240905$PER$$US-JNJFOC-20240881467$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240905$$HP$US$US
242712791$24271279$1$I$$20240815$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08289$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242712801$24271280$1$I$$20240820$20240901$20240901$PER$$US-JNJFOC-20240881956$JOHNSON AND JOHNSON$$$$$$Y$$$20240901$$MD$US$US
242712811$24271281$1$I$20240101$20240829$20240901$20240901$PER$$US-JNJFOC-20240878438$JOHNSON AND JOHNSON$$$$$F$Y$$$20240901$$CN$US$US
242712821$24271282$1$I$$20240820$20240901$20240901$PER$$US-JNJFOC-20240881483$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240901$$MD$US$US
242712832$24271283$2$F$20240521$20240827$20240901$20240906$PER$$US-JNJFOC-20240880494$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240906$$MD$US$US
242712841$24271284$1$I$$20240828$20240901$20240901$EXP$$US-JNJFOC-20240877389$JOHNSON AND JOHNSON$$$$$M$Y$$$20240901$$CN$US$US
242712851$24271285$1$I$20240801$20240823$20240901$20240901$PER$$US-SA-2024SA252588$SANOFI AVENTIS$$$$A$M$Y$$$20240901$$HP$US$US
242712861$24271286$1$I$$20240826$20240901$20240901$30DAY$$US-GSK-US2024AMR106434$GLAXOSMITHKLINE$$$$$F$Y$$$20240901$$CN$US$US
242712871$24271287$1$I$$20240823$20240901$20240901$EXP$$SE-JNJFOC-20240867917$JOHNSON AND JOHNSON$$$$$$Y$$$20240901$$MD$SE$SE
242712881$24271288$1$I$20240801$20240828$20240901$20240901$PER$$US-AMGEN-USASP2024172291$AMGEN$$65$YR$E$M$Y$$$20240901$$CN$US$US
242712891$24271289$1$I$$20240822$20240901$20240901$PER$$US-AstraZeneca-2024A192228$ASTRAZENECA$$$$$M$Y$$$20240901$$CN$US$
242712911$24271291$1$I$20240501$20240828$20240901$20240901$EXP$$US-AMGEN-USASP2024171958$AMGEN$$62$YR$A$M$Y$$$20240901$$CN$US$US
242712921$24271292$1$I$$20240821$20240901$20240901$PER$$US-SA-2024SA252596$SANOFI AVENTIS$$$$A$$Y$$$20240901$$MD$US$US
242712931$24271293$1$I$20240201$20240827$20240901$20240901$PER$$US-ROCHE-10000068239$ROCHE$$30$YR$A$F$Y$74.39$KG$20240901$$CN$US$US
242712941$24271294$1$I$$20240828$20240901$20240901$PER$$US-ROCHE-10000068919$ROCHE$$$$A$F$Y$$$20240901$$CN$US$US
242712951$24271295$1$I$$20240829$20240901$20240901$PER$$US-ROCHE-10000070171$ROCHE$$$$A$F$Y$$$20240901$$CN$US$US
242712961$24271296$1$I$$20240828$20240901$20240901$PER$$US-JNJFOC-20240874457$JOHNSON AND JOHNSON$$$$$$Y$$$20240901$$HP$US$US
242712971$24271297$1$I$$20240820$20240901$20240901$PER$$US-SA-2024SA252443$SANOFI AVENTIS$$$$E$M$Y$$$20240901$$MD$US$US
242712981$24271298$1$I$$20240829$20240901$20240901$PER$$US-ELI_LILLY_AND_COMPANY-US202408019057$ELI LILLY AND CO$$$$$$Y$$$20240901$$CN$US$US
242712992$24271299$2$F$$20240905$20240901$20240915$EXP$$US-ARDELYX-2024ARDX006336$ARDELYX$$$$$M$Y$$$20240916$$HP$US$US
242713001$24271300$1$I$20240424$20240822$20240901$20240901$EXP$$US-ARDELYX-2024ARDX006359$ARDELYX$$75$YR$$F$Y$$$20240901$$HP$US$US
242713011$24271301$1$I$20240809$20240809$20240901$20240901$PER$$US-CSL-2024-007694$CSL Plasma$$30$YR$$M$Y$$$20240901$$HP$US$US
242713021$24271302$1$I$$20240827$20240901$20240901$PER$$US-AstraZeneca-2024A195557$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
242713032$24271303$2$F$20240818$20240910$20240901$20240917$PER$$US-AstraZeneca-2024A189315$ASTRAZENECA$$25645$DY$$M$Y$$$20240917$$CN$US$
242713041$24271304$1$I$$20240809$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08060$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242713071$24271307$1$I$$20240816$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08453$LUPIN$$$$$$Y$$$20240901$$MD$US$US
242713081$24271308$1$I$$20240816$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08312$LUPIN$$$$$$Y$$$20240901$$MD$US$US
242713091$24271309$1$I$$20240827$20240901$20240901$PER$$US-AstraZeneca-2024A197006$ASTRAZENECA$$$$$F$Y$$$20240901$$HP$US$
242713101$24271310$1$I$$20240819$20240901$20240901$PER$$US-AstraZeneca-2024A197152$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
242713111$24271311$1$I$20240821$20240822$20240901$20240901$30DAY$$US-GSK-US2024105094$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240901$$CN$US$US
242713121$24271312$1$I$$20240813$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08151$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242713131$24271313$1$I$$20240815$20240901$20240901$PER$$US-AstraZeneca-2024A189877$ASTRAZENECA$$76$YR$$M$Y$68.9$KG$20240901$$HP$US$
242713141$24271314$1$I$$20240813$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08155$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242713151$24271315$1$I$$20240814$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08279$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242713161$24271316$1$I$$20240814$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08265$LUPIN$$$$$$Y$$$20240901$$PH$US$US
242713171$24271317$1$I$$20240813$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08152$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242713181$24271318$1$I$$20240821$20240901$20240901$PER$$US-JNJFOC-20240858588$JOHNSON AND JOHNSON$$$$$$Y$$$20240901$$HP$US$US
242713191$24271319$1$I$$20240814$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08252$LUPIN$$$$$$Y$$$20240901$$HP$US$US
242713201$24271320$1$I$20240703$20240829$20240901$20240901$EXP$AT-BASGAGES-2024-006379$AT-ROCHE-10000069434$ROCHE$$65$YR$E$M$Y$$$20240901$$MD$AT$AT
242713211$24271321$1$I$$20240808$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07971$LUPIN$$$$$$Y$$$20240901$$PH$US$US
242713221$24271322$1$I$$20240822$20240901$20240901$EXP$$US-RDY-SPO/USA/24/0012553$DR REDDYS$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 06;73: doi:10.1007/s00262-024-03775-6.$75$YR$E$F$Y$$$20240901$$HP$US$US
242713231$24271323$1$I$$20240828$20240901$20240901$PER$$US-ROCHE-10000069092$ROCHE$$$$$F$Y$$$20240901$$HP$US$US
242713241$24271324$1$I$$20240822$20240901$20240901$PER$$US-JNJFOC-20240857506$JOHNSON AND JOHNSON$$$$$M$Y$$$20240901$$CN$US$US
242713251$24271325$1$I$20240809$20240810$20240901$20240901$PER$$US-CSL-2024-007597$CSL Plasma$$22$YR$$F$Y$$$20240901$$HP$US$US
242713261$24271326$1$I$$20240809$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08058$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242713271$24271327$1$I$$20240811$20240901$20240901$EXP$$BO-JNJFOC-20240874642$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240901$$CN$BO$BO
242713281$24271328$1$I$20240813$20240813$20240901$20240901$PER$$US-CSL-2024-007671$CSL Plasma$$42$YR$$F$Y$$$20240901$$HP$US$US
242713291$24271329$1$I$20240826$20240830$20240901$20240901$PER$$US-JNJFOC-20240881437$JOHNSON AND JOHNSON$$$$$F$Y$$$20240901$$CN$US$US
242713301$24271330$1$I$20231121$20240828$20240901$20240901$PER$$US-ELI_LILLY_AND_COMPANY-US202408018106$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240901$$CN$US$US
242713311$24271331$1$I$$20240812$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08199$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242713332$24271333$2$F$20240101$20240917$20240901$20240926$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000752$DECIPHERA PHARMACEUTICALS$$70$YR$E$M$Y$$$20240926$$CN$US$US
242713341$24271334$1$I$$20240812$20240901$20240901$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06954$LUPIN$$$$$$Y$$$20240901$$CN$US$US
242713351$24271335$1$I$$20240831$20240901$20240901$PER$$US-BAYER-2024A125135$BAYER$$$$$$Y$$$20240901$$CN$US$US
242713362$24271336$2$F$20230327$20240919$20240901$20240930$EXP$$JP-AMGEN-JPNSP2024172875$AMGEN$$$$$$Y$$$20240930$$MD$JP$JP
242713371$24271337$1$I$$20240829$20240901$20240901$PER$$US-JNJFOC-20240881138$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240901$$CN$US$US
242713381$24271338$1$I$$20240827$20240901$20240901$PER$$US-JNJFOC-20240871115$JOHNSON AND JOHNSON$$$$$$Y$$$20240901$$CN$US$US
242713391$24271339$1$I$$20240827$20240901$20240901$PER$$US-JNJFOC-20240873302$JOHNSON AND JOHNSON$$$$$F$Y$$$20240901$$CN$US$US
242713401$24271340$1$I$$20240830$20240901$20240901$PER$$US-JNJFOC-20240882177$JOHNSON AND JOHNSON$$$$$F$Y$$$20240901$$HP$US$US
242713412$24271341$2$F$20231010$20240909$20240901$20240919$EXP$$US-JNJFOC-20240878056$JOHNSON AND JOHNSON$$27$YR$A$M$Y$122.58$KG$20240919$$HP$US$US
242713421$24271342$1$I$20240814$20240829$20240901$20240901$PER$$US-JNJFOC-20240878393$JOHNSON AND JOHNSON$$$$$F$Y$$$20240901$$CN$US$US
242713433$24271343$3$F$$20240904$20240901$20240914$EXP$$US-JNJFOC-20240882172$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240914$$HP$US$US
242713442$24271344$2$F$20240709$20240904$20240901$20240911$EXP$$US-GSK-US2024AMR102780$GLAXOSMITHKLINE$$37$YR$$M$Y$$$20240911$$CN$US$US
242713461$24271346$1$I$$20230201$20240901$20240901$PER$$US-HALEON-2194417$Haleon PLC$$$$E$M$Y$$$20240901$$CN$US$US
242713472$24271347$2$F$20240709$20240904$20240901$20240911$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR102780$VIIV$$37$YR$$M$Y$$$20240911$$CN$US$US
242713511$24271351$1$I$$20240819$20240901$20240901$EXP$$CA-UCBSA-2024042408$UCB$$$$$F$Y$$$20240901$$CN$CA$CA
242713521$24271352$1$I$$20240829$20240901$20240901$PER$$US-JNJFOC-20240878598$JOHNSON AND JOHNSON$$$$$$Y$$$20240901$$MD$US$US
242713531$24271353$1$I$$20230717$20240901$20240901$PER$$US-HALEON-2194424$Haleon PLC$$$$$F$Y$$$20240901$$MD$US$US
242713541$24271354$1$I$20240701$20240819$20240901$20240901$EXP$$US-UCBSA-2024042353$UCB$$52$YR$$F$Y$$$20240901$$HP$US$US
242713551$24271355$1$I$20240101$20240819$20240901$20240901$EXP$$US-UCBSA-2024019513$UCB$$$$$F$Y$92.1$KG$20240901$$HP$US$US
242713562$24271356$2$F$20240530$20240913$20240901$20240926$EXP$$US-UCBSA-2024027942$UCB$$1$YR$$F$Y$$$20240926$$MD$US$US
242713571$24271357$1$I$$20240826$20240901$20240901$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137917$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240901$$CN$US$US
242713581$24271358$1$I$20240101$20240819$20240901$20240901$EXP$$CA-UCBSA-2024005528$UCB$$44$YR$$F$Y$$$20240901$$CN$CA$CA
242713591$24271359$1$I$$20240828$20240901$20240901$PER$$US-JNJFOC-20240879490$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240901$$CN$US$US
242713601$24271360$1$I$20240811$20240819$20240901$20240901$EXP$$GB-UCBSA-2024042361$UCB$$73$YR$$F$Y$$$20240901$$CN$GB$GB
242713611$24271361$1$I$$20240807$20240901$20240901$PER$$US-AstraZeneca-2024A179936$ASTRAZENECA$$$$$F$Y$$$20240901$$CN$US$
242713621$24271362$1$I$20240826$20240826$20240901$20240901$PER$$US-JNJFOC-20240869560$JOHNSON AND JOHNSON$$$$$M$Y$$$20240901$$PH$US$US
242713632$24271363$2$F$20240624$20240906$20240901$20240911$EXP$IT-MINISAL02-999632$IT-REGENERON PHARMACEUTICALS, INC.-2024-116449$REGENERON$$64$YR$$M$Y$$$20240911$$PH$IT$IT
242713642$24271364$2$F$20240827$20240830$20240901$20240904$PER$$US-AMGEN-USASP2024173206$AMGEN$$70$YR$E$F$Y$$$20240904$$MD$US$US
242713651$24271365$1$I$$20240827$20240901$20240901$PER$$US-ELI_LILLY_AND_COMPANY-US202408017267$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240901$$CN$US$US
242713662$24271366$2$F$20240830$20240830$20240901$20240904$PER$$US-JNJFOC-20240881937$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242713671$24271367$1$I$20230101$20230906$20240901$20240901$PER$$US-CIPLA LTD.-2023US05506$CIPLA$$$$$$Y$$$20240901$$HP$US$US
242713681$24271368$1$I$20230905$20230905$20240901$20240901$PER$$US-CIPLA LTD.-2023US05481$CIPLA$$$$$$Y$$$20240901$$HP$US$US
242713691$24271369$1$I$$20240807$20240901$20240901$PER$$US-AstraZeneca-2024A182844$ASTRAZENECA$$$$$F$Y$108.2$KG$20240901$$HP$US$
242713701$24271370$1$I$$20240521$20240901$20240901$PER$$US-CIPLA LTD.-2023US05697$CIPLA$$$$$$Y$$$20240901$$HP$US$US
242713711$24271371$1$I$20231006$20231226$20240901$20240901$PER$$US-CIPLA LTD.-2023US06382$CIPLA$$$$$$Y$$$20240901$$HP$US$US
242713721$24271372$1$I$20231003$20231026$20240901$20240901$PER$$US-CIPLA LTD.-2023US06171$CIPLA$$$$$$Y$$$20240901$$CN$US$US
242713731$24271373$1$I$20230101$20231003$20240901$20240901$PER$$US-CIPLA LTD.-2023US05886$CIPLA$$$$$$Y$$$20240901$$HP$US$US
242713741$24271374$1$I$$20240819$20240901$20240901$EXP$$US-STERISCIENCE B.V.-2024-ST-001241$Steriscience PTE$Osama M, Pendela VS, Mohamed M, Parikh V.. Trigger-Point Bupivacaine Injection Causing A ^Heart-Break^.. J-Card-Fail. 2024;30 (1):276-277 abstr. 369.$59$YR$$F$Y$$$20240901$$HP$US$US
242713751$24271375$1$I$20231010$20231020$20240901$20240901$PER$$US-CIPLA LTD.-2023US06489$CIPLA$$$$$$Y$$$20240901$$HP$US$US
242713761$24271376$1$I$$20240819$20240901$20240901$EXP$$KR-STERISCIENCE B.V.-2024-ST-001242$Steriscience PTE$Kim HJ, Jung YJ, Lee JH, Lee HJ, Maeng CH, Baek SK, et al.. Severe acquired hemophilia A associated with COVID-19 vaccination: A case report and literature review. [Review].. Medicine. 2024;103 (31):e39166$56$YR$$M$Y$$$20240901$$HP$KR$KR
242713771$24271377$1$I$$20240819$20240901$20240901$EXP$$RU-STERISCIENCE B.V.-2024-ST-001244$Steriscience PTE$Ilieva K, Karnaukhova EYu, Pobegalova OE, Lioznov DA.. Clinical cases of pneumocystis pneumonia in patients with HIV infection and underlying COVID-19. [Russian].. J-Infektol. 2022;14 (4):126-131$35$YR$$M$Y$$$20240901$$HP$RU$RU
242713781$24271378$1$I$$20240821$20240901$20240901$EXP$US-MMM-XEY8GO7Q$US-GSK-US2024104553$GLAXOSMITHKLINE$$$$$F$Y$$$20240901$$HP$US$US
242713791$24271379$1$I$$20240829$20240901$20240901$PER$$US-ELI_LILLY_AND_COMPANY-US202408019006$ELI LILLY AND CO$$72$YR$E$$Y$$$20240901$$CN$US$US
242713801$24271380$1$I$$20240826$20240901$20240901$PER$$US-AstraZeneca-2024A194280$ASTRAZENECA$$$$$$Y$$$20240901$$CN$US$
242713811$24271381$1$I$20240814$20240819$20240901$20240901$EXP$$IN-CIPLA LTD.-2024IN09296$CIPLA$$$$$$Y$$$20240901$$CN$IN$IN
242713821$24271382$1$I$20240801$20240828$20240901$20240901$EXP$$US-AstraZeneca-2024A197596$ASTRAZENECA$$20480$DY$$F$Y$$$20240901$$CN$US$
242713831$24271383$1$I$$20240827$20240901$20240901$PER$$US-ELI_LILLY_AND_COMPANY-US202408017115$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240901$$CN$US$US
242713841$24271384$1$I$$20240829$20240901$20240901$PER$$US-AMGEN-USASP2024173808$AMGEN$$$$$F$Y$$$20240901$$CN$US$US
242713861$24271386$1$I$20240709$20240828$20240901$20240901$PER$$US-AMGEN-USASP2024173750$AMGEN$$67$YR$E$M$Y$$$20240901$$PH$US$US
242713871$24271387$1$I$$20240829$20240901$20240901$EXP$$ZA-AstraZeneca-2024A197686$ASTRAZENECA$$66$YR$$M$Y$$$20240901$$CN$ZA$
242713881$24271388$1$I$20240703$20240828$20240901$20240901$EXP$$US-AstraZeneca-2024A196598$ASTRAZENECA$$27637$DY$$F$Y$$$20240901$$CN$US$
242713901$24271390$1$I$$20240826$20240901$20240901$EXP$$US-AMGEN-USASP2024170618$AMGEN$$75$YR$E$M$Y$$$20240901$$CN$US$US
242713961$24271396$1$I$$20240827$20240901$20240901$PER$$US-009507513-2408USA010150$MERCK$$$$A$F$Y$138.2$KG$20240901$$CN$US$US
242713971$24271397$1$I$20240101$20240826$20240901$20240901$PER$$US-AMGEN-USASP2024171593$AMGEN$$$$$F$Y$$$20240901$$CN$US$US
242713981$24271398$1$I$$20240822$20240901$20240901$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01283$AIMMUNE$$$$$$Y$$$20240901$$CN$US$US
242713991$24271399$1$I$20231101$20240827$20240901$20240901$EXP$$NVSC2024MX174969$NOVARTIS$$50$YR$$F$Y$$$20240902$$CN$MX$MX
242714021$24271402$1$I$$20240825$20240901$20240901$EXP$$US-MTPC-MTDA2024-0018223$Unknown Manufacturer$$$$A$M$Y$$$20240901$$CN$US$US
242714091$24271409$1$I$$20240830$20240901$20240901$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048925$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240902$$CN$US$US
242714101$24271410$1$I$$20240828$20240901$20240901$PER$$US-ABBVIE-5900857$ABBVIE$$$$$F$Y$$$20240901$$CN$US$US
242714111$24271411$1$I$$20240822$20240901$20240901$PER$$US-ABBVIE-5893888$ABBVIE$$$$$M$Y$$$20240901$$CN$US$US
242714121$24271412$1$I$$20240830$20240901$20240901$PER$$NVSC2024US175615$NOVARTIS$$$$$$Y$$$20240902$$HP$US$US
242714131$24271413$1$I$$20240830$20240901$20240901$PER$$NVSC2024US175616$NOVARTIS$$$$$$Y$$$20240902$$HP$US$US
242714171$24271417$1$I$20240809$20240812$20240901$20240901$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127317$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240902$$HP$US$US
242714201$24271420$1$I$$20240821$20240901$20240901$PER$$US-RDY-SPO/USA/24/0012466$DR REDDYS$Cooper J, Soneji D, Rieger K, Narala S, Kim Y. Primary Cutaneous CD30+ Large T Cell Lymphoproliferative Disorder Associated With Prolonged Exposure to Fingolimod. Multiple Sclerosis Journal. 2023 Oct;29(3): 969. doi:10.1177/1352458523.$67$YR$E$F$Y$$$20240902$$HP$US$US
242714211$24271421$1$I$$20240830$20240901$20240901$PER$$NVSC2024US175617$NOVARTIS$$$$$$Y$$$20240902$$HP$US$US
242714222$24271422$2$F$20240909$20240920$20240901$20240927$PER$$US-AMGEN-USASP2024172021$AMGEN$$78$YR$E$F$Y$$$20240927$$MD$US$US
242714231$24271423$1$I$$20240823$20240901$20240901$EXP$$US-ARGENX-2024-ARGX-US005456$ARGENX BVBA$$$$$$Y$$$20240901$$CN$US$US
242714242$24271424$2$F$20240101$20240828$20240901$20240905$EXP$$DE-JNJFOC-20240880376$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20240905$$CN$DE$DE
242714251$24271425$1$I$20240801$20240829$20240901$20240901$EXP$$GB-ABBVIE-5902637$ABBVIE$$84$YR$$M$Y$$$20240901$$CN$GB$GB
242714261$24271426$1$I$20240821$20240826$20240901$20240901$PER$$US-AMGEN-USASP2024170811$AMGEN$$31$YR$A$F$Y$$$20240901$$CN$US$US
242714271$24271427$1$I$$20240820$20240901$20240901$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-134463$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$MD$JP$JP
242714291$24271429$1$I$20240813$20240828$20240901$20240901$EXP$$CN-ABBVIE-5899973$ABBVIE$$61$YR$$M$Y$74$KG$20240901$$MD$CN$CN
242714301$24271430$1$I$$20240829$20240901$20240901$30DAY$$US-SANDOZ INC.-SDZ2024US076481$SANDOZ$$$$$$Y$$$20240901$$CN$US$US
242714311$24271431$1$I$$20240826$20240901$20240901$EXP$$US-SHIRE-US201842222AA$TAKEDA$$$$$M$Y$88.435$KG$20240901$$HP$US$US
242714332$24271433$2$F$20240809$20240904$20240901$20240908$EXP$$US-ABBVIE-5900417$ABBVIE$$67$YR$$F$Y$65$KG$20240908$$CN$US$US
242714341$24271434$1$I$$20240826$20240901$20240901$EXP$$US-TAKEDA-2024TUS083908$TAKEDA$$$$$M$Y$$$20240901$$CN$US$US
242714351$24271435$1$I$20230801$20240830$20240901$20240901$EXP$GB-MHRA-MED-202408291513231100-LJWGN$GB-ORGANON-O2408GBR002253$ORGANON$$$$$F$Y$$$20240901$$CN$GB$GB
242714371$24271437$1$I$$20240829$20240901$20240901$EXP$$GB-ABBVIE-5902672$ABBVIE$$$$A$M$Y$$$20240901$$HP$GB$GB
242714382$24271438$2$F$20240501$20240830$20240901$20240905$EXP$$US-ABBVIE-5898555$ABBVIE$$48$YR$$F$Y$146$KG$20240905$$CN$US$US
242714432$24271443$2$F$20160101$20240905$20240901$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-135430$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$PH$JP$JP
242714441$24271444$1$I$$20240830$20240901$20240901$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138656$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$119.75$KG$20240902$$CN$US$US
242714451$24271445$1$I$20240801$20240830$20240901$20240901$EXP$$HR-ABBVIE-5902592$ABBVIE$$81$YR$$F$Y$$$20240901$$CN$HR$HR
242714461$24271446$1$I$$20240828$20240901$20240901$EXP$$CA-TAKEDA-2021TUS070259$TAKEDA$$$$$M$Y$$$20240901$$CN$CA$CA
242714471$24271447$1$I$20240522$20240821$20240901$20240901$EXP$$US-ABBVIE-5804181$ABBVIE$$57$YR$$F$Y$58$KG$20240901$$CN$US$US
242714482$24271448$2$F$20240101$20240923$20240901$20240927$EXP$$US-ABBVIE-5762096$ABBVIE$$$$$F$Y$70$KG$20240927$$CN$US$US
242714491$24271449$1$I$$20240827$20240901$20240901$EXP$$US-ABBVIE-5900384$ABBVIE$$$$$F$Y$$$20240901$$CN$US$US
242714501$24271450$1$I$$20240826$20240901$20240901$EXP$$CN-ORGANON-O2408CHN002237$ORGANON$$66$YR$$M$Y$$$20240901$$CN$CN$CN
242714511$24271451$1$I$$20240828$20240901$20240901$EXP$$US-ABBVIE-5899868$ABBVIE$$$$$F$Y$$$20240901$$CN$US$US
242714532$24271453$2$F$20240812$20240903$20240901$20240907$EXP$$TR-JNJFOC-20240863501$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240907$$MD$TR$TR
242714544$24271454$4$F$20240829$20240919$20240901$20240925$EXP$$US-ABBVIE-5902481$ABBVIE$$75$YR$$M$Y$$$20240925$$CN$US$US
242714552$24271455$2$F$20240625$20240919$20240901$20240919$EXP$$JP-TAKEDA-2024TJP012776$TAKEDA$$87$YR$$M$Y$$$20240919$$MD$JP$JP
242714561$24271456$1$I$20230101$20240827$20240901$20240901$EXP$$US-ABBVIE-5898166$ABBVIE$$$$$F$Y$$$20240901$$CN$US$US
242714581$24271458$1$I$$20240813$20240901$20240901$PER$$US-JNJFOC-20240832791$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240902$$CN$US$US
242714591$24271459$1$I$$20240826$20240901$20240901$PER$$US-AMGEN-USASP2024171195$AMGEN$$$$$F$Y$$$20240901$$CN$US$US
242714601$24271460$1$I$$20240824$20240901$20240901$EXP$$US-BIOGEN-2024BI01280145$BIOGEN$$$$$F$Y$$$20240901$$CN$US$US
242714611$24271461$1$I$$20240829$20240901$20240901$EXP$$US-ABBVIE-5901476$ABBVIE$$38$YR$$M$Y$$$20240901$$HP$US$US
242714621$24271462$1$I$$20240827$20240901$20240901$EXP$$US-ABBVIE-5898990$ABBVIE$$$$$M$Y$$$20240901$$CN$US$US
242714631$24271463$1$I$$20240827$20240901$20240901$EXP$$CA-ABBVIE-5899052$ABBVIE$$$$E$M$Y$$$20240901$$HP$CA$CA
242714642$24271464$2$F$20240828$20240911$20240901$20240917$EXP$$US-ABBVIE-5900354$ABBVIE$$72$YR$$F$Y$$$20240917$$CN$US$US
242714661$24271466$1$I$20240801$20240828$20240901$20240901$EXP$$US-ABBVIE-5900946$ABBVIE$$85$YR$$F$Y$$$20240901$$CN$US$US
242714671$24271467$1$I$$20240829$20240901$20240901$PER$$NVSC2024US175652$NOVARTIS$$$$$$Y$$$20240902$$MD$US$US
242714681$24271468$1$I$20240819$20240823$20240901$20240901$PER$$US-ABBVIE-5894916$ABBVIE$$38$YR$$F$Y$$$20240901$$MD$US$US
242714691$24271469$1$I$20240829$20240829$20240901$20240901$EXP$$RO-ABBVIE-5902664$ABBVIE$$85$YR$$M$Y$$$20240901$$CN$RO$RO
242714701$24271470$1$I$$20240829$20240901$20240901$EXP$$GB-ABBVIE-5902705$ABBVIE$$$$E$M$Y$$$20240901$$HP$GB$GB
242714711$24271471$1$I$20240807$20240824$20240901$20240901$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161078$JIANGSU HANSOH PHARMACEUTICAL$$17$YR$$M$Y$70$KG$20240901$$MD$CN$CN
242714731$24271473$1$I$$20240829$20240901$20240901$30DAY$$US-SANDOZ INC.-SDZ2024US022466$SANDOZ$$$$$M$Y$$$20240901$$CN$US$US
242714741$24271474$1$I$$20240827$20240901$20240901$EXP$$AU-009507513-2408AUS010404$MERCK$$71$YR$$F$Y$$$20240901$$MD$AU$AU
242714751$24271475$1$I$$20240823$20240901$20240901$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135002$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240902$$CN$US$US
242714781$24271478$1$I$$20240823$20240901$20240901$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135176$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240902$$CN$US$US
242714791$24271479$1$I$$20240828$20240901$20240901$PER$$US-JNJFOC-20240874248$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$PH$US$US
242714802$24271480$2$F$$20240827$20240901$20240905$EXP$$JP-JNJFOC-20230460565$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$MD$JP$JP
242714811$24271481$1$I$$20240826$20240901$20240901$EXP$$CA-JNJFOC-20240877254$JOHNSON AND JOHNSON$$48$YR$A$M$Y$144$KG$20240902$$PH$CA$CA
242714821$24271482$1$I$20240109$20240827$20240901$20240901$EXP$$US-ABBVIE-5706393$ABBVIE$$52$YR$$F$Y$73$KG$20240901$$CN$US$US
242714841$24271484$1$I$$20240829$20240901$20240901$EXP$$NVSC2024US175512$NOVARTIS$$$$$$Y$$$20240902$$HP$US$US
242714852$24271485$2$F$20240304$20240827$20240901$20240909$EXP$$US-ABBVIE-5439805$ABBVIE$$35$YR$$F$Y$56.699$KG$20240909$$CN$US$US
242714863$24271486$3$F$20240824$20240903$20240901$20240905$EXP$$NVSJ2024JP010378$NOVARTIS$$73$YR$$M$Y$65.3$KG$20240906$$MD$JP$JP
242714871$24271487$1$I$$20240821$20240901$20240901$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134850$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$85.28$KG$20240902$$HP$US$US
242714881$24271488$1$I$$20240826$20240901$20240901$EXP$$CA-JNJFOC-20240876820$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240902$$PH$CA$CA
242714891$24271489$1$I$20240809$20240828$20240901$20240901$EXP$FR-AFSSAPS-RE2024000851$FR-JNJFOC-20240880536$JOHNSON AND JOHNSON$$38$YR$A$F$Y$42$KG$20240902$$MD$FR$FR
242714901$24271490$1$I$20240828$20240829$20240901$20240901$EXP$$US-ABBVIE-5902690$ABBVIE$$75$YR$$M$Y$$$20240901$$CN$US$US
242714911$24271491$1$I$20240822$20240822$20240901$20240901$PER$$US-ABBVIE-5892519$ABBVIE$$76$YR$$F$Y$$$20240901$$CN$US$US
242714921$24271492$1$I$20240416$20240823$20240901$20240901$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-069469$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$72$KG$20240902$$MD$DE$DE
242714931$24271493$1$I$20240811$20240830$20240901$20240901$EXP$FR-AFSSAPS-PB2024000935$FR-JNJFOC-20240880445$JOHNSON AND JOHNSON$$88$YR$E$M$Y$$$20240902$$PH$FR$FR
242714942$24271494$2$F$20240701$20240903$20240901$20240912$EXP$$US-ABBVIE-5897056$ABBVIE$$67$YR$$M$Y$$$20240912$$CN$US$US
242714951$24271495$1$I$20240101$20240828$20240901$20240901$EXP$$US-ABBVIE-5901114$ABBVIE$$$$$M$Y$$$20240901$$CN$US$US
242714991$24271499$1$I$20240604$20240827$20240901$20240901$EXP$$US-ABBVIE-5900345$ABBVIE$$81$YR$$M$Y$$$20240901$$CN$US$US
242715001$24271500$1$I$$20240821$20240901$20240901$PER$$US-BAUSCHBL-2024BNL032115$BAUSCH AND LOMB$$$$$F$Y$$$20240902$$CN$US$US
242715011$24271501$1$I$$20240820$20240901$20240901$PER$$US-BAUSCHBL-2024BNL032054$BAUSCH AND LOMB$$$$$F$Y$$$20240902$$CN$US$US
242715021$24271502$1$I$$20240828$20240901$20240901$EXP$$US-ABBVIE-5899440$ABBVIE$$$$$M$Y$$$20240901$$HP$US$US
242715031$24271503$1$I$$20240820$20240901$20240901$PER$$US-BAUSCHBL-2024BNL032132$BAUSCH AND LOMB$$$$$F$Y$$$20240902$$CN$US$US
242715041$24271504$1$I$$20240829$20240901$20240901$EXP$$US-SANDOZ INC.-SDZ2024US076582$SANDOZ$$$$$F$Y$$$20240901$$CN$US$US
242715051$24271505$1$I$$20240820$20240901$20240901$PER$$US-BAUSCHBL-2024BNL032111$BAUSCH AND LOMB$$$$$M$Y$$$20240902$$CN$US$US
242715061$24271506$1$I$$20240826$20240901$20240901$EXP$$CA-BIOGEN-2020BI00933233$BIOGEN$$$$$M$Y$$$20240901$$CN$CA$CA
242715071$24271507$1$I$$20240822$20240901$20240901$PER$$US-BAUSCHBL-2024BNL032198$BAUSCH AND LOMB$$12$YR$$F$Y$$$20240902$$CN$US$US
242715081$24271508$1$I$20240822$20240828$20240901$20240901$EXP$$US-ABBVIE-5899526$ABBVIE$$84$YR$$F$Y$$$20240901$$CN$US$US
242715091$24271509$1$I$20240814$20240828$20240901$20240901$EXP$$US-ABBVIE-5900958$ABBVIE$$75$YR$$F$Y$$$20240901$$CN$US$US
242715101$24271510$1$I$$20240828$20240901$20240901$PER$$US-JNJFOC-20240880311$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240902$$CN$US$US
242715111$24271511$1$I$$20240829$20240901$20240901$PER$$US-ELI_LILLY_AND_COMPANY-US202408019136$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240901$$CN$US$US
242715121$24271512$1$I$$20240826$20240901$20240901$EXP$$US-PFIZER INC-202400245128$PFIZER$$76$YR$$M$Y$$$20240901$$HP$US$US
242715131$24271513$1$I$$20240830$20240901$20240901$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048934$BOEHRINGER INGELHEIM$$$$$$Y$$$20240902$$CN$US$US
242715141$24271514$1$I$$20240829$20240901$20240901$EXP$$AU-ABBVIE-5901278$ABBVIE$$$$$M$Y$$$20240901$$HP$AU$AU
242715151$24271515$1$I$$20240827$20240901$20240901$EXP$$NL-SANDOZ INC.-SDZ2024NL075677$SANDOZ$$52$YR$$F$Y$$$20240901$$HP$NL$NL
242715161$24271516$1$I$20240101$20240828$20240901$20240901$EXP$$CA-ABBVIE-5901861$ABBVIE$$44$YR$$F$Y$$$20240901$$HP$CA$CA
242715171$24271517$1$I$$20240828$20240901$20240901$EXP$$CO-AMGEN-COLSP2024173640$AMGEN$$$$$$Y$$$20240901$$MD$CO$CO
242715181$24271518$1$I$$20240822$20240901$20240901$PER$$US-ABBVIE-5894259$ABBVIE$$$$$$Y$$$20240901$$HP$US$US
242715211$24271521$1$I$20240730$20240822$20240901$20240901$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161079$JIANGSU HENGRUI MEDICINE$$51$YR$$F$Y$56$KG$20240901$$MD$CN$CN
242715222$24271522$2$F$20240815$20240903$20240901$20240905$30DAY$$US-AMGEN-USASP2024169267$AMGEN$$66$YR$E$M$Y$82.1$KG$20240905$$PH$US$US
242715233$24271523$3$F$20240101$20240917$20240901$20240923$PER$$US-BAUSCHBL-2024BNL032164$BAUSCH AND LOMB$$$$$F$Y$$$20240924$$CN$US$US
242715241$24271524$1$I$$20240821$20240901$20240901$PER$$US-BAUSCHBL-2024BNL032148$BAUSCH AND LOMB$$$$$F$Y$$$20240902$$CN$US$US
242715251$24271525$1$I$$20240827$20240901$20240901$PER$$US-ROCHE-10000068091$ROCHE$$27$YR$A$F$Y$$$20240902$$HP$US$US
242715262$24271526$2$F$20240101$20240905$20240901$20240911$EXP$$US-ABBVIE-5899400$ABBVIE$$$$$M$Y$129.27$KG$20240911$$CN$US$US
242715271$24271527$1$I$$20240823$20240901$20240901$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135426$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$40.82$KG$20240902$$CN$US$US
242715283$24271528$3$F$20240101$20240916$20240901$20240921$EXP$$GB-ABBVIE-5901233$ABBVIE$$61$YR$$M$Y$$$20240921$$CN$GB$GB
242715291$24271529$1$I$20240101$20240828$20240901$20240901$EXP$$US-ABBVIE-5900854$ABBVIE$$$$$M$Y$$$20240901$$CN$US$US
242715303$24271530$3$F$$20240913$20240901$20240919$EXP$$JP-GSK-JP2024JPN106222$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$PH$JP$JP
242715311$24271531$1$I$20240101$20240826$20240901$20240901$EXP$$AR-AMGEN-ARGSP2024172508$AMGEN$$$$$F$Y$$$20240901$$MD$AR$AR
242715321$24271532$1$I$$20240827$20240901$20240901$EXP$$US-JNJFOC-20240870965$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$HP$US$US
242715332$24271533$2$F$20240101$20240910$20240901$20240920$PER$$US-BAUSCHBL-2024BNL032059$BAUSCH AND LOMB$$68$YR$$F$Y$$$20240920$$CN$US$US
242715342$24271534$2$F$20240827$20240906$20240901$20240916$EXP$$AE-JNJFOC-20240869676$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240916$$CN$AE$AE
242715351$24271535$1$I$$20240820$20240901$20240901$PER$$US-BAUSCHBL-2024BNL032052$BAUSCH AND LOMB$$$$$F$Y$$$20240829$$HP$US$US
242715362$24271536$2$F$$20240924$20240901$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138097$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240925$$HP$US$US
242715372$24271537$2$F$20240801$20240904$20240901$20240910$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-138539$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240910$$MD$FR$FR
242715381$24271538$1$I$$20240822$20240901$20240901$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161080$JIANGSU HENGRUI MEDICINE$Literature title: Clinical analysis of a patient with postoperative docetaxel extravasation in ovarian cancer.?Literature publication journal: Electronic Journal of Practical Gynecological Endocrinology 2024; 11 (15) :126-128.?Author: Xiaoshan Kang.$45$YR$$F$Y$49$KG$20240901$$MD$CN$CN
242715392$24271539$2$F$$20240827$20240901$20240917$EXP$$DE-JNJFOC-20240872062$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240917$$MD$DE$DE
242715401$24271540$1$I$20240827$20240830$20240901$20240901$EXP$$RO-ABBVIE-5902680$ABBVIE$$83$YR$$M$Y$$$20240901$$CN$RO$RO
242715411$24271541$1$I$20240601$20240826$20240901$20240901$EXP$$US-ABBVIE-5896370$ABBVIE$$38$YR$$F$Y$$$20240901$$CN$US$US
242715421$24271542$1$I$$20240829$20240901$20240901$PER$$NVSC2024US175684$NOVARTIS$$$$$$Y$$$20240902$$MD$US$US
242715431$24271543$1$I$$20240826$20240901$20240901$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-136903$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$72.12$KG$20240902$$CN$PR$PR
242715451$24271545$1$I$20240822$20240828$20240901$20240901$EXP$$US-ABBVIE-5901013$ABBVIE$$82$YR$$M$Y$$$20240901$$CN$US$US
242715461$24271546$1$I$20240401$20240829$20240901$20240901$EXP$$CA-ABBVIE-5902542$ABBVIE$$75$YR$$M$Y$$$20240901$$CN$CA$CA
242715471$24271547$1$I$$20240827$20240901$20240901$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137103$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240902$$HP$US$US
242715481$24271548$1$I$$20240828$20240901$20240901$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138144$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240902$$CN$US$US
242715492$24271549$2$F$20240504$20240923$20240901$20240927$EXP$$ES-TAKEDA-2024TUS086410$TAKEDA$$74$YR$$M$Y$$$20240927$$HP$ES$ES
242715501$24271550$1$I$20240802$20240826$20240901$20240901$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137008$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$83.91$KG$20240902$$HP$US$US
242715511$24271551$1$I$$20240827$20240901$20240901$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137745$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$MD$US$US
242715521$24271552$1$I$$20240823$20240901$20240901$EXP$$US-TAKEDA-2024TUS086228$TAKEDA$$$$C$M$Y$$$20240901$$HP$US$US
242715531$24271553$1$I$20240825$20240829$20240901$20240901$EXP$$SG-AstraZeneca-2024A197483$ASTRAZENECA$$29764$DY$$F$Y$$$20240902$$CN$SG$
242715541$24271554$1$I$$20240823$20240901$20240901$EXP$$US-JNJFOC-20240867686$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240902$$CN$US$US
242715551$24271555$1$I$$20240827$20240901$20240901$PER$$US-ROCHE-10000067949$ROCHE$$91$YR$E$M$Y$$$20240902$$HP$US$US
242715562$24271556$2$F$$20240903$20240901$20240904$PER$$NVSC2024US175690$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242715572$24271557$2$F$20240710$20240916$20240901$20240926$PER$$US-JNJFOC-20240833183$JOHNSON AND JOHNSON$$53$YR$A$F$Y$78.996$KG$20240926$$HP$US$US
242715581$24271558$1$I$$20240829$20240901$20240901$EXP$$US-TAKEDA-2024TUS087384$TAKEDA$$$$$F$Y$$$20240901$$CN$US$US
242715592$24271559$2$F$20240101$20240909$20240901$20240913$EXP$$JP-009507513-2403JPN001993J$MERCK$$6$DEC$$F$Y$$$20240913$$MD$JP$JP
242715603$24271560$3$F$20230101$20240918$20240901$20240923$EXP$$US-ABBVIE-5900921$ABBVIE$$$$$M$Y$68.038$KG$20240923$$CN$US$US
242715611$24271561$1$I$20240101$20240827$20240901$20240901$PER$$US-ROCHE-10000067846$ROCHE$$$$$M$Y$$$20240902$$MD$US$US
242715631$24271563$1$I$$20240829$20240901$20240901$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048726$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240902$$CN$US$US
242715641$24271564$1$I$20240101$20240827$20240901$20240901$EXP$$US-AMGEN-USASP2024171356$AMGEN$$70$YR$E$F$Y$$$20240901$$CN$US$US
242715651$24271565$1$I$$20240822$20240901$20240901$EXP$$US-TAKEDA-2024TUS085019$TAKEDA$$$$$F$Y$$$20240901$$CN$US$US
242715661$24271566$1$I$20240807$20240822$20240901$20240901$EXP$$CN-ROCHE-10000064166$ROCHE$$69$YR$E$M$Y$$$20240902$$HP$CN$CN
242715671$24271567$1$I$$20240828$20240901$20240901$PER$$US-ROCHE-10000068821$ROCHE$$$$$F$Y$$$20240902$$MD$US$US
242715681$24271568$1$I$$20240827$20240901$20240901$PER$$US-ROCHE-10000068523$ROCHE$$$$A$F$Y$$$20240902$$CN$US$US
242715691$24271569$1$I$$20240828$20240901$20240901$EXP$$US-JNJFOC-20240877005$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240902$$HP$US$US
242715702$24271570$2$F$20240819$20240905$20240901$20240911$EXP$$US-JNJFOC-20240877029$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240912$$HP$US$US
242715711$24271571$1$I$$20240829$20240901$20240901$PER$$US-ROCHE-10000070285$ROCHE$$$$$$Y$$$20240902$$CN$US$US
242715751$24271575$1$I$20221201$20240827$20240901$20240901$EXP$$CN-009507513-2408CHN010741$MERCK$HUANG S, WANG W, ZHU D, SHEN J, CAO Q.. Treatment and reflection of infective endocarditis caused by methicillin-resistant Staphylococcus aureus in children after complex congenital heart disease.. J Clin Pediatr. 2024;42(8):728-36$6$YR$$M$Y$$$20240901$$HP$CN$CN
242715761$24271576$1$I$$20240828$20240902$20240902$EXP$$US-TAKEDA-2024TUS087099$TAKEDA$$$$$F$Y$$$20240902$$CN$US$US
242715771$24271577$1$I$20240528$20240830$20240902$20240902$EXP$$CN-ROCHE-10000070316$ROCHE$$66$YR$E$M$Y$70$KG$20240902$$HP$CN$CN
242715781$24271578$1$I$$20240827$20240902$20240902$EXP$$BR-RDY-SPO/BRA/24/0012543$DR REDDYS$$$$$M$Y$$$20240902$$CN$BR$BR
242715792$24271579$2$F$20231213$20240925$20240902$20240926$PER$$US-AMGEN-USASP2024170362$AMGEN$$72$YR$E$F$Y$$$20240926$$CN$US$US
242715801$24271580$1$I$20240721$20240826$20240902$20240902$EXP$IT-MINISAL02-999535$IT-TAKEDA-2024TUS085975$TAKEDA$$43$YR$$F$Y$$$20240902$$HP$IT$IT
242715811$24271581$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018879$ELI LILLY AND CO$$$$$F$Y$$$20240901$$CN$US$US
242715821$24271582$1$I$$20240828$20240902$20240902$EXP$$JP-TAKEDA-2024TJP012753$TAKEDA$Yugo Takagi, Hideki Ban, Yoshihiko Sugino, Akio Furuse. Successful dual biologic therapy for VEO-CD accompanied by IgA nephropathy and severe atopic dermatitis. 62$12$YR$$M$Y$$$20240902$$MD$JP$JP
242715832$24271583$2$F$20240801$20240828$20240902$20240905$EXP$$CA-JNJFOC-20240880535$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$CA$CA
242715841$24271584$1$I$$20240826$20240902$20240902$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000480$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240831$$CN$US$US
242715851$24271585$1$I$20240811$20240815$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131762$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240902$$CN$US$US
242715861$24271586$1$I$$20240827$20240902$20240902$EXP$$AU-TAKEDA-2024TUS087266$TAKEDA$$$$$M$Y$$$20240902$$CN$AU$AU
242715871$24271587$1$I$20240801$20240828$20240902$20240902$EXP$$US-ABBVIE-5899952$ABBVIE$$80$YR$$M$Y$$$20240902$$CN$US$US
242715881$24271588$1$I$$20240830$20240902$20240902$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048956$BOEHRINGER INGELHEIM$$$$$$Y$$$20240902$$CN$US$US
242715891$24271589$1$I$$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137757$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240902$$CN$US$US
242715901$24271590$1$I$$20240826$20240902$20240902$EXP$$US-ABBVIE-5897104$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242715911$24271591$1$I$20170307$20240827$20240902$20240902$EXP$$US-ABBVIE-5703355$ABBVIE$$83$YR$$F$Y$54$KG$20240902$$CN$US$US
242715921$24271592$1$I$20220812$20240827$20240902$20240902$EXP$$AU-TAKEDA-2022TUS001410$TAKEDA$$39$YR$$M$Y$$$20240902$$CN$AU$AU
242715942$24271594$2$F$$20240826$20240902$20240905$EXP$$BR-JNJFOC-20240880557$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$BR$BR
242715952$24271595$2$F$20240701$20240902$20240902$20240903$PER$$US-AMGEN-USASP2024174634$AMGEN$$56$YR$A$F$Y$$$20240902$$CN$US$US
242715961$24271596$1$I$$20240808$20240902$20240902$PER$$TR-TOLMAR, INC.-24TR051192$TOLMAR$$$$$$Y$$$20240902$$PH$TR$TR
242715971$24271597$1$I$$20240820$20240902$20240902$EXP$$BR-ABBVIE-5899793$ABBVIE$Nunes RAB, Avezum A, Marques MdO, Baiocchi OCCG, Bachour P. Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabrutinib or ibrutinib: a real-world analysis. Ann Hematol. 2024.$$$$$Y$$$20240902$$HP$BR$BR
242715981$24271598$1$I$20231128$20240809$20240902$20240902$PER$$NL-TOLMAR, INC.-24NL051746$TOLMAR$$76$YR$$M$Y$$$20240902$$CN$NL$NL
242715991$24271599$1$I$$20240808$20240902$20240902$PER$$TR-TOLMAR, INC.-24TR051303$TOLMAR$$$$$F$Y$$$20240902$$PH$TR$TR
242716001$24271600$1$I$20240809$20240809$20240902$20240902$PER$$TR-TOLMAR, INC.-24TR051792$TOLMAR$$80$YR$$M$Y$$$20240902$$PH$TR$TR
242716011$24271601$1$I$$20240827$20240902$20240902$EXP$$US-ABBVIE-5899397$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242716022$24271602$2$F$20240101$20240903$20240902$20240906$EXP$$CA-ABBVIE-5893350$ABBVIE$$66$YR$$M$Y$$$20240906$$HP$CA$CA
242716041$24271604$1$I$20240826$20240827$20240902$20240902$EXP$$US-JNJFOC-20240876942$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240902$$HP$US$US
242716051$24271605$1$I$$20240818$20240902$20240902$EXP$$US-Indicus Pharma-001034$INDICUS$Gwynn N, Lindenmayer JP, Boes T, Pitalo C. Late Recognition of Cholinergic Delirium in Patient on Donepezil Combination Treatment. J Clin Psychopharmacol. 2024 Aug 16$69$YR$E$M$Y$$$20240831$$MD$US$US
242716071$24271607$1$I$$20240829$20240902$20240902$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048589$BOEHRINGER INGELHEIM$Hirokawa H, Hirata H, Azuma H, Sugitate K, Soda S, Matsushima J. Case report of a patient with stage IV lung adenocarcinoma and uncommon/compound EGFR mutations who responded to afatinib. Respiratory medicine case reports. 2024;51: 102094. doi:10.1016/j.rmcr.2024.102094.$73$YR$E$M$Y$$$20240902$$HP$JP$JP
242716081$24271608$1$I$$20240821$20240902$20240902$EXP$IR-MLMSERVICE-20240814-PI162134-00059-1$IR-STRIDES ARCOLAB LIMITED-2024SP010724$STRIDES$Soufi GJ, Tooyserkani SH, Hekmatnia A, Norouzi A, Sadeghian A, Riahi F.. Co-occurrence of anti-phospholipid syndrome and posterior reversible encephalopathy syndrome in a patient with Autoimmune hepatitis: A case report.. Radiology Case Reports. 2024;19(10):4346-53$36$YR$$F$Y$$$20240902$$MD$IR$IR
242716091$24271609$1$I$20240609$20240826$20240902$20240902$EXP$$CO-JNJFOC-20240878489$JOHNSON AND JOHNSON$$72$YR$E$M$Y$93$KG$20240902$$HP$CO$CO
242716111$24271611$1$I$$20240827$20240902$20240902$EXP$$CA-TAKEDA-2020TUS016225$TAKEDA$$$$$M$Y$$$20240902$$CN$CA$CA
242716122$24271612$2$F$20240801$20240905$20240902$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134536$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240912$$CN$US$US
242716131$24271613$1$I$$20240821$20240902$20240902$EXP$$CA-APOTEX-2024AP009664$APOTEX$$91$YR$$M$Y$$$20240902$$HP$CA$CA
242716141$24271614$1$I$$20240821$20240902$20240902$PER$$US-APOTEX-2024AP009846$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240902$$HP$US$US
242716151$24271615$1$I$$20240829$20240902$20240902$PER$$US-AstraZeneca-2024A198065$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$US$
242716161$24271616$1$I$20240101$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024171160$AMGEN$$87$YR$E$F$Y$$$20240901$$CN$US$US
242716171$24271617$1$I$20240820$20240821$20240902$20240902$EXP$$JP-009507513-2408JPN002482J$MERCK$$$$$F$Y$$$20240902$$CN$JP$JP
242716181$24271618$1$I$20240829$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173477$AMGEN$$36$YR$A$F$Y$$$20240901$$CN$US$US
242716191$24271619$1$I$20240822$20240823$20240902$20240902$PER$$US-AMGEN-USASP2024169488$AMGEN$$34$YR$A$F$Y$$$20240901$$CN$US$US
242716203$24271620$3$F$20240716$20240913$20240902$20240918$EXP$$CO-JNJFOC-20240866784$JOHNSON AND JOHNSON$$21$YR$A$M$Y$60$KG$20240918$$HP$CO$CO
242716211$24271621$1$I$20240825$20240826$20240902$20240902$EXP$$IT-ABBVIE-5897514$ABBVIE$$74$YR$$M$Y$$$20240902$$HP$IT$IT
242716221$24271622$1$I$20240821$20240828$20240902$20240902$EXP$$CA-ABBVIE-5899995$ABBVIE$$61$YR$$M$Y$$$20240902$$CN$CA$CA
242716231$24271623$1$I$$20240529$20240902$20240902$EXP$$EG-AMGEN-EGYSP2024171992$AMGEN$Rashed EM. Pharmacokinetic and pharmacodynamic changes of Ivabradine induced by hypoalbuminemia: A case report.. Journal of Advanced Pharmaceutical Sciences. 2024$62$YR$A$M$Y$$$20240901$$MD$EG$EG
242716243$24271624$3$F$20240801$20240917$20240902$20240926$EXP$$JP-NOVOPROD-1269724$NOVO NORDISK$$6$DEC$$F$Y$$$20240926$$PH$JP$JP
242716251$24271625$1$I$$20240819$20240902$20240902$EXP$$GB-NOVOPROD-1275991$NOVO NORDISK$Muhammad Athar Iqbal khan. Diabetes management challenges and end-of-life considerations in a complex case of dementia. Br J Diabetes. 2024;24(1):114$75$YR$$M$Y$$$20240902$$HP$GB$GB
242716261$24271626$1$I$$20240829$20240902$20240902$EXP$$JP-JNJFOC-20240811567$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$MD$JP$JP
242716271$24271627$1$I$$20240828$20240902$20240902$EXP$$US-ABBVIE-5900442$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242716293$24271629$3$F$20240910$20240919$20240902$20240924$EXP$$CA-TAKEDA-2024TUS087345$TAKEDA$$72$YR$$F$Y$$$20240924$$CN$CA$CA
242716311$24271631$1$I$$20240821$20240902$20240902$EXP$$US-APOTEX-2024AP009960$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240902$$HP$US$US
242716321$24271632$1$I$$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137875$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240902$$CN$US$US
242716333$24271633$3$F$20240212$20240919$20240902$20240930$EXP$$CA-TAKEDA-2024TUS014056$TAKEDA$$36$YR$$M$Y$$$20240930$$MD$CA$CA
242716341$24271634$1$I$$20240821$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133887$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240902$$CN$US$US
242716351$24271635$1$I$$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024172489$AMGEN$$$$E$M$Y$$$20240901$$HP$US$US
242716361$24271636$1$I$$20240820$20240902$20240902$EXP$$JP-NOVOPROD-1272876$NOVO NORDISK$$62$YR$$F$Y$$$20240902$$PH$JP$JP
242716371$24271637$1$I$20240701$20240820$20240902$20240902$EXP$DK-DKMA-30737539$DK-NOVOPROD-1272854$NOVO NORDISK$$58$YR$$M$Y$$$20240902$$MD$DK$DK
242716381$24271638$1$I$20220301$20240821$20240902$20240902$EXP$PK-MLMSERVICE-20240814-PI162487-00270-1$PK-STRIDES ARCOLAB LIMITED-2024SP010721$STRIDES$Sethi SM, Arshad A.. An immunocompetent lady with invasive aspergillosis presenting as disseminated lesions: a case report.. Journal of Medical Case Reports.. 2024;18(1):354$29$YR$$F$Y$$$20240902$$MD$PK$PK
242716393$24271639$3$F$20220426$20240913$20240902$20240919$EXP$$NO-NALPROPION PHARMACEUTICALS INC.-NO-2024CUR003928$CURRAX PHARMACEUTICALS$$56$YR$$M$Y$$$20240919$$CN$NO$NO
242716402$24271640$2$F$$20240920$20240902$20240930$EXP$TR-MLMSERVICE-20240814-PI162244-00097-1$TR-STRIDES ARCOLAB LIMITED-2024SP010722$STRIDES$Kaynar K, Alizade L, Uyar ?, Mungan S, Rashidzade K.. To screen or not to screen renal cell cancer in a kidney transplant patient.. Hippokratia. 2023;27(2):69-71$55$YR$$M$Y$$$20240930$$MD$TR$TR
242716411$24271641$1$I$20240705$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196703$ASTRAZENECA$$31557$DY$$F$Y$$$20240902$$HP$US$
242716422$24271642$2$F$20240101$20240829$20240902$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03109$AMNEAL$$$$$F$Y$36.508$KG$20240905$$CN$US$US
242716432$24271643$2$F$$20240913$20240902$20240919$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001754$BLUEPRINT MEDICINES$$$$$F$Y$$$20240919$$CN$US$US
242716441$24271644$1$I$$20240830$20240902$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA076661$SANDOZ$$61$YR$$M$Y$$$20240902$$MD$CA$CA
242716451$24271645$1$I$$20240820$20240902$20240902$PER$$US-NATCOUSA-2024-NATCOUSA-000222$NATCO PHARMA$$79$YR$$F$Y$63.5$KG$20240902$$CN$US$
242716461$24271646$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018126$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240902$$CN$US$US
242716471$24271647$1$I$20240525$20240820$20240902$20240902$EXP$CN-NMPA-51012211030856202400225$CN-NOVOPROD-1272965$NOVO NORDISK$$34$YR$$M$Y$122.8$KG$20240902$$HP$CN$CN
242716481$24271648$1$I$$20240820$20240902$20240902$EXP$$US-NOVOPROD-1273374$NOVO NORDISK$$$$$F$Y$$$20240902$$PH$US$US
242716491$24271649$1$I$20240813$20240828$20240902$20240902$EXP$$GB-JNJFOC-20240882364$JOHNSON AND JOHNSON$$78$YR$E$M$Y$65$KG$20240902$$MD$GB$GB
242716501$24271650$1$I$$20240821$20240902$20240902$EXP$$US-APOTEX-2024AP009961$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240902$$HP$US$US
242716511$24271651$1$I$20180101$20240826$20240902$20240902$EXP$$US-ABBVIE-5798194$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242716521$24271652$1$I$20240713$20240827$20240902$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-043083$AUROBINDO$$87$YR$$M$Y$82$KG$20240902$$MD$FR$FR
242716532$24271653$2$F$$20240919$20240902$20240925$PER$$US-LEO Pharma-373069$LEO PHARM$$56$YR$$M$Y$$$20240926$$PH$US$US
242716542$24271654$2$F$20240701$20240918$20240902$20240924$EXP$$CO-JNJFOC-20240871054$JOHNSON AND JOHNSON$$63$YR$A$M$Y$69$KG$20240925$$HP$CO$CO
242716551$24271655$1$I$20240101$20240826$20240902$20240902$EXP$$US-AMGEN-USASP2024170672$AMGEN$$67$YR$E$F$Y$$$20240901$$CN$US$US
242716562$24271656$2$F$20240101$20240910$20240902$20240916$EXP$$US-AMGEN-USASP2024171385$AMGEN$$59$YR$A$F$Y$$$20240916$$HP$US$US
242716571$24271657$1$I$$20240827$20240902$20240902$EXP$$US-AMGEN-USASP2024171535$AMGEN$$$$$M$Y$$$20240901$$CN$US$US
242716581$24271658$1$I$20220101$20240828$20240902$20240902$EXP$$US-ABBVIE-5889432$ABBVIE$$$$$F$Y$113$KG$20240902$$CN$US$US
242716591$24271659$1$I$$20240821$20240902$20240902$EXP$$US-APOTEX-2024AP009962$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240902$$HP$US$US
242716601$24271660$1$I$$20240820$20240902$20240902$EXP$$US-NATCOUSA-2024-NATCOUSA-000223$NATCO PHARMA$Raval DM, Pagan RJ, Butt S, Rueda Prada L. A Case of Hepatocellular Carcinoma after Treatment for Chronic Myeloid Leukemia in a Patient without Liver Disease. Case Rep Oncol. 2024 Jul 25;17(1):788-796. doi: 10.1159/000540260.$80$YR$$F$Y$$$20240902$$HP$US$
242716612$24271661$2$F$20240821$20240904$20240902$20240911$EXP$$US-ABBVIE-5900853$ABBVIE$$55$YR$$M$Y$97$KG$20240911$$CN$US$US
242716621$24271662$1$I$20240713$20240821$20240902$20240902$EXP$$CA-AMGEN-CANNI2024174067$AMGEN$$81$YR$E$F$Y$$$20240901$$CN$CA$CA
242716631$24271663$1$I$$20240829$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-103669-2023$RECKITT BENCKISER$$$$$F$Y$$$20240901$$CN$US$US
242716641$24271664$1$I$20080806$20240823$20240902$20240902$PER$$US-JNJFOC-20240868245$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240902$$HP$US$US
242716651$24271665$1$I$20240827$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172379$AMGEN$$81$YR$E$F$Y$$$20240901$$CN$US$US
242716661$24271666$1$I$20240807$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024171502$AMGEN$$80$YR$E$F$Y$$$20240901$$CN$US$US
242716671$24271667$1$I$$20240823$20240902$20240902$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03135$AMNEAL$Desai D, Nohria A, Alhanshali L, Buontempo M, Lo Sicco K.I, et al.. Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections. JAAD Case Reports. 2024;51:86-91$58$YR$$F$Y$$$20240902$$HP$US$US
242716682$24271668$2$F$$20240902$20240902$20240909$PER$$US-LEO Pharma-373091$LEO PHARM$$50$YR$$F$Y$$$20240909$$PH$US$US
242716691$24271669$1$I$20240721$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196574$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242716702$24271670$2$F$$20240916$20240902$20240920$EXP$$US-ABBVIE-5900444$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
242716711$24271671$1$I$$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196550$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$US$
242716721$24271672$1$I$$20240828$20240902$20240902$EXP$$TR-SANDOZ INC.-SDZ2024TR075960$SANDOZ$$6$YR$$M$Y$26$KG$20240902$$MD$TR$TR
242716731$24271673$1$I$$20240606$20240902$20240902$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006828$STRIDES$Aziz Q-U-A, Champion A.. Massive Adrenomyelolipomas Due To Longstanding CAH. J-Endocr-Soc. 2023;7 (Suppl. 1):A181$47$YR$$F$Y$$$20240902$$MD$US$US
242716741$24271674$1$I$$20240618$20240902$20240902$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007399$STRIDES$Eid JJ, Stelzer JW, Rodner CM.. Severe Carpal Tunnel Syndrome in a Pediatric Patient With a History of Congenital Adrenal Hyperplasia.. J-Hand-Surg-Glob-Online. 2024;6 (3):430-432$17$YR$$F$Y$$$20240902$$HP$US$US
242716751$24271675$1$I$$20240822$20240902$20240902$PER$$US-TAKEDA-2024TUS085707$TAKEDA$$$$$F$Y$$$20240902$$CN$US$US
242716761$24271676$1$I$$20240823$20240902$20240902$PER$$US-AMGEN-USASP2024169577$AMGEN$$$$$F$Y$$$20240901$$MD$US$US
242716771$24271677$1$I$$20240529$20240902$20240902$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006482$STRIDES$Sittol R, Jang JH, Chaudhary R, Bryan C, Chokshi A, Adrian M, et al.. Panhypopituitarism Causing a Life Threatening Prolonged QT Interval Which Can Be Reversible with Treatment of Underlying Endocrine Disorders.. J-Endocr-Soc. 2019;13 (Suppl. 1).$38$YR$$F$Y$$$20240902$$MD$US$US
242716782$24271678$2$F$20240101$20240902$20240902$20240903$PER$$US-AMGEN-USASP2024172013$AMGEN$$54$YR$A$M$Y$$$20240903$$CN$US$US
242716791$24271679$1$I$$20240607$20240902$20240902$PER$US-MLMSERVICE-20240603-PI083042-00177-1$US-STRIDES ARCOLAB LIMITED-2024SP006817$STRIDES$Song L, Sue LY, Heaney AP.. Low Cortisol in a Cushingoid Patient. Clinical Chemistry. 2023;69(6):558-61$52$YR$$F$Y$$$20240902$$MD$US$US
242716801$24271680$1$I$$20240827$20240902$20240902$PER$$US-TAKEDA-2024TUS087201$TAKEDA$$13$YR$$F$Y$$$20240902$$CN$US$US
242716811$24271681$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018261$ELI LILLY AND CO$$38$YR$A$$Y$$$20240902$$LW$US$US
242716821$24271682$1$I$$20240822$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408014505$ELI LILLY AND CO$$41$YR$A$$Y$$$20240902$$LW$US$US
242716831$24271683$1$I$$20240828$20240902$20240902$PER$$US-TAKEDA-2024TUS087212$TAKEDA$$37$YR$$M$Y$73$KG$20240902$$MD$US$US
242716841$24271684$1$I$20240413$20240819$20240902$20240902$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002171$Alvotech$$69$YR$$F$Y$$$20240902$$CN$CA$CA
242716861$24271686$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173185$AMGEN$$$$$F$Y$$$20240901$$CN$US$US
242716871$24271687$1$I$20240823$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024171967$AMGEN$$78$YR$E$F$Y$$$20240901$$MD$US$US
242716881$24271688$1$I$$20240823$20240902$20240902$EXP$$CA-TOLMAR, INC.-24CA050160$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242716891$24271689$1$I$20240701$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138477$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240902$$CN$US$US
242716901$24271690$1$I$$20240823$20240902$20240902$EXP$$CA-TOLMAR, INC.-24CA052105$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242716911$24271691$1$I$20240201$20240823$20240902$20240902$EXP$FR-AFSSAPS-BX2024001668$FR-TOLMAR, INC.-24FR052077$TOLMAR$$66$YR$$M$Y$68$KG$20240902$$MD$FR$FR
242716921$24271692$1$I$$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137047$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$68.04$KG$20240902$$CN$US$US
242716931$24271693$1$I$20240409$20240828$20240902$20240902$EXP$ES-AEMPS-1563198$ES-ABBVIE-5898097$ABBVIE$$47$YR$$M$Y$$$20240902$$MD$ES$ES
242716941$24271694$1$I$20230810$20240828$20240902$20240902$EXP$PL-URPL-DML-MLP.4401.1.836.2023$PL-ORGANON-O2408POL002236$ORGANON$$34$YR$$F$Y$76$KG$20240902$$MD$PL$PL
242716952$24271695$2$F$20240101$20240919$20240902$20240926$EXP$$US-ABBVIE-5805783$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
242716961$24271696$1$I$20240101$20240823$20240902$20240902$EXP$$US-009507513-2408USA008977$MERCK$$$$E$F$Y$$$20240902$$MD$US$US
242716971$24271697$1$I$20240701$20240827$20240902$20240902$EXP$$US-ABBVIE-5898595$ABBVIE$$75$YR$$F$Y$$$20240902$$CN$US$US
242716984$24271698$4$F$$20240909$20240902$20240910$PER$$US-JNJFOC-20240862370$JOHNSON AND JOHNSON$$$$$M$Y$167.98$KG$20240910$$CN$US$US
242716991$24271699$1$I$20220101$20240823$20240902$20240902$EXP$$CA-CELLTRION INC.-2024CA020734$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
242717001$24271700$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137596$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$61.69$KG$20240902$$CN$US$US
242717011$24271701$1$I$20240701$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137709$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240902$$HP$US$US
242717021$24271702$1$I$20231013$20240826$20240902$20240902$EXP$$CO-ABBVIE-5902427$ABBVIE$$76$YR$$F$Y$53$KG$20240902$$HP$CO$CO
242717031$24271703$1$I$20240516$20240807$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051735$TOLMAR$$77$YR$$M$Y$$$20240902$$CN$CA$CA
242717041$24271704$1$I$$20240807$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051706$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242717051$24271705$1$I$20240807$20240807$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051736$TOLMAR$$69$YR$$M$Y$$$20240902$$CN$CA$CA
242717061$24271706$1$I$$20240808$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051739$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242717071$24271707$1$I$20240807$20240807$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051748$TOLMAR$$81$YR$$M$Y$$$20240902$$CN$CA$CA
242717081$24271708$1$I$20240808$20240809$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051773$TOLMAR$$70$YR$$M$Y$$$20240902$$CN$CA$CA
242717091$24271709$1$I$20240804$20240807$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051745$TOLMAR$$67$YR$$M$Y$$$20240902$$CN$CA$CA
242717101$24271710$1$I$20240809$20240809$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051769$TOLMAR$$80$YR$$M$Y$$$20240902$$CN$CA$CA
242717111$24271711$1$I$$20240809$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051774$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242717122$24271712$2$F$$20240913$20240902$20240917$EXP$$US-ROCHE-10000069308$ROCHE$$$$$$Y$$$20240917$$CN$US$US
242717131$24271713$1$I$$20240809$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051775$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242717141$24271714$1$I$20240807$20240807$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051779$TOLMAR$$76$YR$$M$Y$$$20240902$$CN$CA$CA
242717151$24271715$1$I$$20240807$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051780$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242717161$24271716$1$I$20240807$20240807$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051781$TOLMAR$$80$YR$$M$Y$$$20240902$$CN$CA$CA
242717171$24271717$1$I$20240808$20240808$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051782$TOLMAR$$62$YR$$M$Y$$$20240902$$CN$CA$CA
242717181$24271718$1$I$20240808$20240808$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051790$TOLMAR$$56$YR$$M$Y$$$20240902$$CN$CA$CA
242717191$24271719$1$I$$20240822$20240902$20240902$EXP$$US-APOTEX-2024AP010052$APOTEX$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73 (200):1-9$61$YR$$F$Y$$$20240902$$HP$US$US
242717201$24271720$1$I$$20240828$20240902$20240902$EXP$$US-JNJFOC-20240874529$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$HP$US$US
242717211$24271721$1$I$$20240821$20240902$20240902$EXP$$JP-AMGEN-JPNSP2024172840$AMGEN$$$$$$Y$$$20240901$$PH$JP$JP
242717221$24271722$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137020$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240902$$CN$US$US
242717231$24271723$1$I$20240701$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138628$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240902$$CN$US$US
242717241$24271724$1$I$$20240827$20240902$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA051831$SANDOZ$$$$$F$Y$$$20240902$$CN$CA$CA
242717251$24271725$1$I$$20240826$20240902$20240902$PER$$US-ROCHE-10000068463$ROCHE$$82$YR$E$M$Y$$$20240902$$CN$US$US
242717261$24271726$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137318$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240902$$PH$US$US
242717271$24271727$1$I$$20240826$20240902$20240902$EXP$$CA-JNJFOC-20240876773$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240902$$PH$CA$CA
242717281$24271728$1$I$$20230925$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2023-055435$AUROBINDO$$44$YR$$M$Y$74$KG$20240902$$CN$US$US
242717291$24271729$1$I$$20240828$20240902$20240902$PER$$US-ROCHE-10000069108$ROCHE$$$$$$Y$$$20240902$$CN$US$US
242717302$24271730$2$F$20220101$20240905$20240902$20240910$EXP$$CA-TAKEDA-CA201825190$TAKEDA$$$$$F$Y$62$KG$20240910$$CN$CA$CA
242717311$24271731$1$I$20230801$20231004$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2023-063930$AUROBINDO$$83$YR$$F$Y$63.5$KG$20240902$$CN$US$US
242717321$24271732$1$I$$20230718$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2023-050395$AUROBINDO$$63$YR$$F$Y$109$KG$20240902$$CN$US$US
242717331$24271733$1$I$$20231128$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2023-064760$AUROBINDO$$$$$F$Y$$$20240902$$CN$US$US
242717341$24271734$1$I$$20240305$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2024-011912$AUROBINDO$$65$YR$$M$Y$79.83$KG$20240902$$CN$US$US
242717351$24271735$1$I$$20230810$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2023-054592$AUROBINDO$$$$$F$Y$$$20240902$$CN$US$US
242717361$24271736$1$I$20230801$20231006$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2023-063333$AUROBINDO$$83$YR$$F$Y$63.492$KG$20240902$$CN$US$US
242717371$24271737$1$I$$20240411$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2024-016547$AUROBINDO$$$$$F$Y$$$20240902$$HP$US$US
242717381$24271738$1$I$20240219$20240516$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2024-012355$AUROBINDO$$64$YR$$F$Y$$$20240902$$PH$US$US
242717391$24271739$1$I$$20231207$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2023-078761$AUROBINDO$$60$YR$$M$Y$75$KG$20240902$$CN$US$US
242717401$24271740$1$I$$20240724$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2024-029597$AUROBINDO$$$$$M$Y$$$20240902$$CN$US$US
242717411$24271741$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018979$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$US$US
242717421$24271742$1$I$20240827$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137768$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$HP$US$US
242717431$24271743$1$I$$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137982$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240902$$CN$US$US
242717441$24271744$1$I$20240129$20240820$20240902$20240902$EXP$$US-NOVOPROD-1273792$NOVO NORDISK$$59$YR$$M$Y$$$20240902$$CN$US$US
242717461$24271746$1$I$$20240821$20240902$20240902$EXP$$US-NOVOPROD-1275314$NOVO NORDISK$$$$A$M$Y$$$20240902$$HP$US$US
242717471$24271747$1$I$$20240820$20240902$20240902$EXP$$AU-NOVOPROD-1274195$NOVO NORDISK$$$$$M$Y$$$20240902$$CN$AU$AU
242717481$24271748$1$I$$20240820$20240902$20240902$EXP$$US-NOVOPROD-1274118$NOVO NORDISK$$71$YR$$F$Y$$$20240902$$CN$US$US
242717491$24271749$1$I$$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A197127$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242717501$24271750$1$I$$20240819$20240902$20240902$PER$$US-AstraZeneca-2024A192219$ASTRAZENECA$$63$YR$$M$Y$$$20240902$$CN$US$
242717511$24271751$1$I$20240701$20240821$20240902$20240902$EXP$GB-MHRA-MED-202408211137472150-SDMWZ$GB-NOVOPROD-1272527$NOVO NORDISK$$46$YR$$M$Y$170$KG$20240902$$CN$GB$GB
242717521$24271752$1$I$$20240821$20240902$20240902$EXP$GB-MHRA-MED-202408211641193720-LBQVZ$GB-NOVOPROD-1272364$NOVO NORDISK$$$$$M$Y$$$20240902$$CN$GB$GB
242717531$24271753$1$I$20240817$20240821$20240902$20240902$EXP$CN-NMPA-42011811006740202400250$CN-NOVOPROD-1273254$NOVO NORDISK$$27$YR$$F$Y$$$20240902$$HP$CN$CN
242717541$24271754$1$I$20240709$20240821$20240902$20240902$EXP$GB-MHRA-MED-202408210923460880-YKHSM$GB-NOVOPROD-1272531$NOVO NORDISK$$48$YR$$M$Y$$$20240902$$PH$GB$GB
242717552$24271755$2$F$$20240830$20240902$20240913$EXP$$JP-AMGEN-JPNSP2024174102$AMGEN$Fukui S, Uchida T, Iwamoto N, Umetsu A, Okamoto M, Fujikawa K. Absence of Glucocorticoids Concomitant With Avacopan and Subsequent Liver Injury in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. The Journal of Rheumatology 2024. 2024;1-3. doi:10.3899/jrheum.2024-0340$$$E$F$Y$$$20240913$$MD$JP$JP
242717563$24271756$3$F$20240821$20240926$20240902$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134001$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240926$$CN$US$US
242717571$24271757$1$I$$20240828$20240902$20240902$EXP$$US-JNJFOC-20240874845$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$HP$US$US
242717581$24271758$1$I$$20240813$20240902$20240902$PER$$US-TEVA-VS-3233595$TEVA$$52$YR$$M$Y$$$20240902$$CN$US$US
242717591$24271759$1$I$$20240824$20240902$20240902$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000300$EMCURE$$$$$$Y$$$20240902$$CN$US$US
242717601$24271760$1$I$$20240823$20240902$20240902$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000301$EMCURE$$$$$$Y$$$20240902$$CN$US$US
242717611$24271761$1$I$$20240826$20240902$20240902$EXP$$US-UCBSA-2024043883$UCB$$$$$$Y$$$20240902$$CN$US$US
242717621$24271762$1$I$$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138437$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240902$$CN$US$US
242717632$24271763$2$F$20240101$20240827$20240902$20240913$EXP$$CA-AMGEN-CANSP2024173383$AMGEN$$61$YR$A$F$Y$$$20240912$$PH$CA$CA
242717641$24271764$1$I$20240101$20240828$20240902$20240902$EXP$$US-RIGEL-20240800117$RIGEL PHARMACEUTICALS$$81$YR$$M$Y$$$20240902$$CN$US$US
242717652$24271765$2$F$$20240830$20240902$20240913$EXP$$JP-AMGEN-JPNSP2024174219$AMGEN$Fukui S, Uchida T, Iwamoto N, Umetsu A, Okamoto M, Fujikawa K. Absence of Glucocorticoids Concomitant With Avacopan and Subsequent Liver Injury in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. The Journal of Rheumatology 2024. 2024;1-3. doi:10.3899/jrheum.2024-0340$$$E$F$Y$$$20240912$$MD$JP$JP
242717661$24271766$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024172982$AMGEN$$$$$F$Y$$$20240901$$CN$US$US
242717671$24271767$1$I$20240801$20240820$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132693$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240902$$CN$US$US
242717682$24271768$2$F$20230101$20240905$20240902$20240910$EXP$$ES-ORGANON-O2405ESP001061$ORGANON$Barris DB, Mousavi H. Dose adjustment according to renal function in a polymedicated patient included included in the medication reconditioning service using medication compliance aids (MCA).. Community pharmacists. 2024;16(2):37-42$78$YR$$F$Y$$$20240910$$PH$ES$ES
242717691$24271769$1$I$$20240829$20240902$20240902$PER$$US-ABBVIE-5902519$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242717701$24271770$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137802$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240902$$CN$US$US
242717711$24271771$1$I$$20240828$20240902$20240902$PER$$US-ABBVIE-5900928$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242717721$24271772$1$I$$20240828$20240902$20240902$EXP$$CN-HALEON-2194117$Haleon PLC$Mei Yongsheng; Zhang Yiwen; Mou Zepeng; Wang Yangang; Xu Lili. A case of refractory gout accompanied by gastrointestinal bleeding treated with integrated Chinese and Western medicine. Journal of Precision Medicine. #PY#;39(05):469-470. 10.13362/j.jpmed.202405023.; Mei Yongsheng; Zhang Yiwen; Mou Zepeng; Wang Yangang; Xu Lili. A case of refractory gout accompanied by gastrointestinal bleeding treated with integrated Chinese and Western medicine. Journal of Precision Medicine. #PY#;39(05):469-4...$35$YR$$M$Y$$$20240830$$HP$CN$CN
242717731$24271773$1$I$$20240827$20240902$20240902$EXP$$CA-ABBVIE-5900875$ABBVIE$$$$A$F$Y$$$20240902$$CN$CA$CA
242717741$24271774$1$I$20240701$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018396$ELI LILLY AND CO$$$$$M$Y$$$20240902$$CN$US$US
242717751$24271775$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019177$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240902$$CN$US$US
242717761$24271776$1$I$$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408017371$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240902$$CN$US$US
242717771$24271777$1$I$$20240827$20240902$20240902$EXP$$JP-GSK-JP2024107987$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$JP$JP
242717781$24271778$1$I$$20240828$20240902$20240902$PER$$US-HALEON-2194188$Haleon PLC$$$$$$Y$$$20240902$$CN$US$US
242717791$24271779$1$I$$20240828$20240902$20240902$EXP$$CN-Bion-013750$BIONPHARMA$$53$YR$A$M$Y$$$20240902$$HP$CN$CN
242717801$24271780$1$I$$20240828$20240902$20240902$EXP$$GB-Bion-013757$BIONPHARMA$$97$YR$E$M$Y$$$20240902$$HP$GB$GB
242717811$24271781$1$I$$20240828$20240902$20240902$EXP$$IR-Bion-013755$BIONPHARMA$$51$YR$A$M$Y$$$20240902$$HP$IR$IR
242717822$24271782$2$F$$20240830$20240902$20240913$EXP$$JP-AMGEN-JPNSP2024174220$AMGEN$Fukui S, Uchida T, Iwamoto N, Umetsu A, Okamoto M, Fujikawa K. Absence of Glucocorticoids Concomitant With Avacopan and Subsequent Liver Injury in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. The Journal of Rheumatology. 2024;1-3. doi:10.3899/jrheum.2024-0340$$$E$F$Y$$$20240912$$MD$JP$JP
242717831$24271783$1$I$$20240827$20240902$20240902$EXP$$PT-Bion-013744$BIONPHARMA$$94$YR$E$F$Y$$$20240902$$HP$PT$PT
242717841$24271784$1$I$$20240827$20240902$20240902$EXP$$RU-Bion-013745$BIONPHARMA$$33$YR$A$F$Y$$$20240902$$HP$RU$RU
242717851$24271785$1$I$$20240828$20240902$20240902$EXP$$US-Bion-013760$BIONPHARMA$$87$YR$E$$Y$$$20240902$$HP$US$US
242717861$24271786$1$I$20240827$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138726$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240902$$CN$US$US
242717871$24271787$1$I$$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138540$BRISTOL MYERS SQUIBB$$102$YR$E$F$Y$$$20240902$$CN$US$US
242717881$24271788$1$I$20240501$20240828$20240902$20240902$EXP$$US-ABBVIE-5900111$ABBVIE$$60$YR$$F$Y$$$20240902$$CN$US$US
242717891$24271789$1$I$$20240828$20240902$20240902$EXP$$US-Bion-013758$BIONPHARMA$$86$YR$E$$Y$$$20240902$$HP$US$US
242717901$24271790$1$I$$20240829$20240902$20240902$EXP$$NZ-ROCHE-10000069021$ROCHE$$$$A$M$Y$$$20240902$$MD$NZ$NZ
242717911$24271791$1$I$20240823$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024171255$AMGEN$$68$YR$E$F$Y$$$20240901$$CN$US$US
242717921$24271792$1$I$20220402$20220610$20240902$20240902$EXP$$IT-SANDOZ INC.-NVSC2022IT133949$SANDOZ$$16$YR$$F$Y$$$20240902$$PH$IT$IT
242717931$24271793$1$I$$20240827$20240902$20240902$PER$$US-JNJFOC-20240879912$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$HP$US$US
242717941$24271794$1$I$$20240829$20240902$20240902$EXP$$US-AMGEN-USASP2024173557$AMGEN$Gottiparthy A.; Lam K.; Kundu S. et al.. Neurofilament light chain in serum of cancer patients with acute neurological complications. CNS Oncology. 2024;13 (1):1-18$78$YR$E$F$Y$$$20240901$$HP$US$US
242717951$24271795$1$I$20240814$20240827$20240902$20240902$EXP$$NVSC2024CN175011$NOVARTIS$$68$YR$$F$Y$65$KG$20240902$$HP$CN$CN
242717961$24271796$1$I$20240121$20240830$20240902$20240902$EXP$FR-AFSSAPS-PV2024000795$FR-SANDOZ INC.-SDZ2024FR076567$SANDOZ$$87$YR$$F$Y$57$KG$20240902$$MD$FR$FR
242717971$24271797$1$I$$20240820$20240902$20240902$EXP$GB-MHRA-MED-202408200146400480-CYRZJ$GB-UCBSA-2024041906$UCB$$28$YR$$F$Y$68$KG$20240902$$CN$GB$GB
242717981$24271798$1$I$20240823$20240823$20240902$20240902$30DAY$$US-GSK-US2024105492$GLAXOSMITHKLINE$$66$YR$$M$Y$$$20240902$$CN$US$US
242717991$24271799$1$I$20240101$20240827$20240902$20240902$PER$$US-ABBVIE-5903308$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242718001$24271800$1$I$20240822$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137066$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240902$$HP$US$US
242718022$24271802$2$F$$20240829$20240902$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004661$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
242718031$24271803$1$I$$20240901$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-082213-2024$RECKITT BENCKISER$$$$$M$Y$$$20240902$$CN$US$US
242718042$24271804$2$F$$20240902$20240902$20240904$EXP$$IT-SANDOZ INC.-SDZ2024IT076726$SANDOZ$$$$$$Y$$$20240904$$HP$IT$IT
242718052$24271805$2$F$$20240829$20240902$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004195$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
242718061$24271806$1$I$20100101$20240821$20240902$20240902$EXP$$JP-NOVOPROD-1273783$NOVO NORDISK$$$$$F$Y$48.8$KG$20240902$$PH$JP$JP
242718071$24271807$1$I$$20240821$20240902$20240902$EXP$$US-NOVOPROD-1274474$NOVO NORDISK$$$$$$Y$$$20240902$$CN$US$US
242718081$24271808$1$I$$20240821$20240902$20240902$EXP$$US-NOVOPROD-1274276$NOVO NORDISK$$41$YR$$M$Y$$$20240902$$MD$US$US
242718091$24271809$1$I$$20240821$20240902$20240902$EXP$$US-NOVOPROD-1274250$NOVO NORDISK$$$$A$M$Y$$$20240902$$MD$US$US
242718101$24271810$1$I$$20240821$20240902$20240902$EXP$$US-NOVOPROD-1274346$NOVO NORDISK$$$$$F$Y$$$20240902$$HP$US$US
242718111$24271811$1$I$$20240821$20240902$20240902$EXP$$US-NOVOPROD-1273282$NOVO NORDISK$$61$YR$$$Y$$$20240902$$CN$US$US
242718121$24271812$1$I$20240519$20240821$20240902$20240902$EXP$$US-NOVOPROD-1274338$NOVO NORDISK$$$$$F$Y$$$20240902$$CN$US$US
242718131$24271813$1$I$$20240821$20240902$20240902$EXP$$US-NOVOPROD-1274254$NOVO NORDISK$$74$YR$$$Y$$$20240902$$CN$US$US
242718141$24271814$1$I$$20240821$20240902$20240902$EXP$$DE-NOVOPROD-1273835$NOVO NORDISK$$$$$M$Y$$$20240902$$MD$DE$DE
242718151$24271815$1$I$20240601$20240821$20240902$20240902$EXP$$US-NOVOPROD-1274297$NOVO NORDISK$$61$YR$$F$Y$$$20240902$$CN$US$US
242718161$24271816$1$I$20240814$20240821$20240902$20240902$EXP$$US-NOVOPROD-1274261$NOVO NORDISK$$57$YR$$$Y$$$20240902$$CN$US$US
242718172$24271817$2$F$20240801$20240826$20240902$20240903$EXP$$CA-JNJFOC-20240808219$JOHNSON AND JOHNSON$$21$YR$A$M$Y$67$KG$20240903$$HP$CA$CA
242718181$24271818$1$I$20080318$20240823$20240902$20240902$PER$$US-JNJFOC-20240869502$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20240902$$HP$US$US
242718191$24271819$1$I$$20240819$20240902$20240902$EXP$$DE-UCBSA-2024042534$UCB$$7$MON$$F$Y$$$20240902$$MD$DE$DE
242718201$24271820$1$I$20240706$20240901$20240902$20240902$EXP$GB-MHRA-MED-202409011111404480-SKBRY$GB-JNJFOC-20240900206$JOHNSON AND JOHNSON$$73$YR$E$M$Y$79$KG$20240902$$CN$GB$GB
242718211$24271821$1$I$$20240828$20240902$20240902$EXP$$US-JNJFOC-20240881193$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$MD$US$US
242718221$24271822$1$I$$20240822$20240902$20240902$EXP$$JP-ROCHE-3578483$ROCHE$$8$DEC$E$F$Y$$$20240902$$MD$JP$JP
242718231$24271823$1$I$$20240822$20240902$20240902$EXP$NL-LRB-00996976$NL-NOVOPROD-1272869$NOVO NORDISK$$41$YR$$M$Y$180$KG$20240902$$CN$NL$NL
242718241$24271824$1$I$20240819$20240821$20240902$20240902$EXP$$US-NOVOPROD-1275193$NOVO NORDISK$$72$YR$$M$Y$$$20240902$$CN$US$US
242718251$24271825$1$I$$20240822$20240902$20240902$EXP$$JP-NOVOPROD-1274224$NOVO NORDISK$$8$DEC$$M$Y$$$20240902$$MD$JP$JP
242718261$24271826$1$I$$20240821$20240902$20240902$EXP$$US-NOVOPROD-1274657$NOVO NORDISK$$$$$F$Y$$$20240902$$CN$US$US
242718271$24271827$1$I$$20240821$20240902$20240902$EXP$$US-NOVOPROD-1274907$NOVO NORDISK$$$$$F$Y$$$20240902$$MD$US$US
242718281$24271828$1$I$$20240821$20240902$20240902$EXP$$US-NOVOPROD-1274564$NOVO NORDISK$$55$YR$$M$Y$$$20240902$$CN$US$US
242718291$24271829$1$I$20170101$20240821$20240902$20240902$EXP$$US-NOVOPROD-1274849$NOVO NORDISK$$55$YR$$M$Y$$$20240902$$CN$US$US
242718301$24271830$1$I$$20240822$20240902$20240902$EXP$$DE-NOVOPROD-1275045$NOVO NORDISK$$31$YR$$M$Y$$$20240902$$CN$DE$DE
242718311$24271831$1$I$20230618$20240821$20240902$20240902$EXP$$US-NOVOPROD-1275184$NOVO NORDISK$$70$YR$$M$Y$$$20240902$$CN$US$US
242718321$24271832$1$I$20240730$20240822$20240902$20240902$EXP$$GT-SANDOZ INC.-SDZ2024GT076673$SANDOZ$$62$YR$$F$Y$$$20240902$$MD$GT$GT
242718331$24271833$1$I$20240101$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024173219$AMGEN$$36$YR$A$F$Y$$$20240901$$PH$US$US
242718341$24271834$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018767$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240902$$CN$US$US
242718351$24271835$1$I$20230101$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018286$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240902$$CN$US$US
242718361$24271836$1$I$20240823$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174071$AMGEN$$$$$F$Y$$$20240901$$CN$US$US
242718371$24271837$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138575$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240902$$CN$US$US
242718381$24271838$1$I$20240826$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408017263$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240902$$CN$US$US
242718391$24271839$1$I$20240821$20240822$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408014764$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240902$$CN$US$US
242718412$24271841$2$F$$20240829$20240902$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004855$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
242718421$24271842$1$I$$20240827$20240902$20240902$EXP$$ID-ROCHE-10000068467$ROCHE$$52$YR$A$M$Y$$$20240902$$MD$ID$ID
242718441$24271844$1$I$20240704$20240813$20240902$20240902$PER$$US-CSL-2024-007778$CSL Plasma$$54$YR$$F$Y$$$20240902$$HP$US$US
242718461$24271846$1$I$$20240830$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US076809$SANDOZ$$$$$F$Y$$$20240902$$CN$US$US
242718471$24271847$1$I$$20240827$20240902$20240902$PER$$US-ABBVIE-5899238$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242718481$24271848$1$I$$20240826$20240902$20240902$EXP$$US-TAKEDA-2024TUS086224$TAKEDA$$$$$M$Y$$$20240902$$HP$US$US
242718491$24271849$1$I$$20240827$20240902$20240902$EXP$$CA-BIOGEN-2024BI01280308$BIOGEN$$$$$M$Y$$$20240902$$PH$CA$CA
242718501$24271850$1$I$20230601$20240827$20240902$20240902$EXP$$CA-BIOGEN-2024BI01279784$BIOGEN$$67$YR$$F$Y$$$20240902$$MD$CA$CA
242718511$24271851$1$I$$20240826$20240902$20240902$PER$$US-AstraZeneca-2024A194682$ASTRAZENECA$$$$$F$Y$$$20240902$$HP$US$
242718521$24271852$1$I$20230830$20240828$20240902$20240902$EXP$$AU-TAKEDA-2021TUS007903$TAKEDA$$24$YR$$M$Y$$$20240902$$CN$AU$AU
242718532$24271853$2$F$20240701$20240910$20240902$20240916$PER$$US-AstraZeneca-2024A195907$ASTRAZENECA$$756$MON$$F$Y$$$20240916$$CN$US$
242718541$24271854$1$I$20240726$20240819$20240902$20240902$EXP$$US-BEH-2024177473$CSL BEHRING$$55$YR$A$M$Y$$$20240902$$HP$US$US
242718551$24271855$1$I$20240824$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172636$AMGEN$$54$YR$A$F$Y$$$20240901$$CN$US$US
242718561$24271856$1$I$$20240823$20240902$20240902$EXP$$GB-CELLTRION INC.-2024GB020514$CELLTRION$$$$$$Y$$$20240902$$CN$GB$GB
242718571$24271857$1$I$20221221$20240823$20240902$20240902$EXP$$IE-TAKEDA-2023TUS013315$TAKEDA$$40$YR$$M$Y$$$20240902$$CN$IE$IE
242718581$24271858$1$I$20221126$20240827$20240902$20240902$EXP$$JP-ROCHE-10000014791$ROCHE$$82$YR$E$M$Y$$$20240902$$MD$JP$JP
242718591$24271859$1$I$$20240829$20240902$20240902$EXP$$US-ROCHE-10000070424$ROCHE$$$$$$Y$$$20240902$$CN$US$US
242718601$24271860$1$I$$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138591$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240902$$CN$US$US
242718611$24271861$1$I$$20240822$20240902$20240902$EXP$$CA-APOTEX-2024AP009715$APOTEX$$$$$M$Y$$$20240902$$HP$CA$CA
242718621$24271862$1$I$20240815$20240820$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133141$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240902$$CN$US$US
242718641$24271864$1$I$$20240829$20240902$20240902$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048834$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240902$$CN$US$US
242718651$24271865$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000070015$ROCHE$$$$$$Y$$$20240902$$PH$US$US
242718661$24271866$1$I$$20240819$20240902$20240902$EXP$$US-BEH-2024177470$CSL BEHRING$$80$YR$E$F$Y$$$20240902$$CN$US$US
242718672$24271867$2$F$20240101$20240925$20240902$20240930$PER$$US-AMGEN-USASP2024174470$AMGEN$$41$YR$A$F$Y$$$20240930$$HP$US$US
242718691$24271869$1$I$$20240827$20240902$20240902$PER$$US-ROCHE-10000067957$ROCHE$$$$$M$Y$$$20240902$$HP$US$US
242718702$24271870$2$F$20240814$20240821$20240902$20240916$PER$$US-SA-2024SA249793$SANOFI AVENTIS$$14$YR$T$F$Y$41.09$KG$20240916$$MD$US$US
242718711$24271871$1$I$$20240826$20240902$20240902$EXP$$US-BIOGEN-2023BI01236722$BIOGEN$$$$$F$Y$$$20240902$$CN$US$US
242718721$24271872$1$I$20240827$20240828$20240902$20240902$EXP$$US-ABBVIE-5900500$ABBVIE$$45$YR$$F$Y$$$20240902$$CN$US$US
242718731$24271873$1$I$20240101$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172147$AMGEN$$75$YR$E$F$Y$$$20240901$$CN$US$US
242718741$24271874$1$I$20190807$20240827$20240902$20240902$EXP$$CA-TAKEDA-2024TUS086820$TAKEDA$$62$YR$$M$Y$$$20240902$$MD$CA$CA
242718751$24271875$1$I$$20240823$20240902$20240902$EXP$$JP-Merz Pharmaceuticals GmbH-2024080000262$MERZ$$$$$$Y$$$20240902$$MD$JP$JP
242718761$24271876$1$I$$20240901$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-084308-2024$RECKITT BENCKISER$$$$$F$Y$$$20240902$$CN$US$US
242718771$24271877$1$I$$20240823$20240902$20240902$EXP$$US-GSK-US2024105570$GLAXOSMITHKLINE$$$$$M$Y$$$20240902$$HP$US$US
242718781$24271878$1$I$$20240826$20240902$20240902$EXP$$CA-TAKEDA-2024TUS086514$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
242718791$24271879$1$I$20240801$20240827$20240902$20240902$EXP$$NVSC2024DE175538$NOVARTIS$$$$E$M$Y$$$20240902$$CN$DE$DE
242718802$24271880$2$F$20240828$20240912$20240902$20240918$EXP$$JP-JNJFOC-20240900417$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240918$$PH$JP$JP
242718812$24271881$2$F$20240101$20240918$20240902$20240924$EXP$$US-KYOWAKIRIN-2024KK020092$KYOWA$$$$$$Y$$$20240924$$CN$US$US
242718824$24271882$4$F$20240830$20240910$20240902$20240913$PER$$US-AMGEN-USASP2024174099$AMGEN$$89$YR$E$M$Y$$$20240913$$CN$US$US
242718831$24271883$1$I$20240829$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018950$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240902$$CN$US$US
242718841$24271884$1$I$20240817$20240823$20240902$20240902$EXP$$JP-VANTIVE-2024VAN019115$Vantive US Healthcare$$$$$$Y$$$20240902$$MD$JP$JP
242718851$24271885$1$I$20240815$20240826$20240902$20240902$EXP$$US-VANTIVE-2024VAN019321$Vantive US Healthcare$$65$YR$$M$Y$$$20240902$$HP$US$US
242718861$24271886$1$I$$20240827$20240902$20240902$EXP$$JP-VANTIVE-2024VAN019144$Vantive US Healthcare$$87$YR$$M$Y$$$20240902$$HP$JP$JP
242718871$24271887$1$I$$20240827$20240902$20240902$PER$$US-ALXN-202408USA001925US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240902$$CN$US$US
242718881$24271888$1$I$$20240827$20240902$20240902$PER$$US-ALXN-202408USA001921US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242718891$24271889$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138715$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240902$$HP$US$US
242718901$24271890$1$I$$20240827$20240902$20240902$EXP$$US-JNJFOC-20240870439$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$MD$US$US
242718911$24271891$1$I$$20240823$20240902$20240902$EXP$$US-TAKEDA-2024TUS086293$TAKEDA$$57$YR$$F$Y$$$20240902$$CN$US$US
242718921$24271892$1$I$$20240826$20240902$20240902$EXP$$US-BIOGEN-2024BI01279919$BIOGEN$$$$$F$Y$$$20240902$$CN$US$US
242718931$24271893$1$I$20240101$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174214$AMGEN$$62$YR$A$F$Y$$$20240901$$CN$US$US
242718941$24271894$1$I$$20240830$20240902$20240902$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048891$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240902$$CN$US$US
242718952$24271895$2$F$$20240829$20240902$20240903$PER$$US-ABBVIE-5900766$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242718961$24271896$1$I$20240801$20240823$20240902$20240902$EXP$$CN-TAKEDA-2024TUS087347$TAKEDA$$68$YR$$F$Y$67$KG$20240902$$HP$CN$CN
242718971$24271897$1$I$20240801$20240802$20240902$20240902$EXP$JP-ONO-2024JP016227$JP-AMGEN-JPNSP2024163567$AMGEN$$35$YR$A$M$Y$66.4$KG$20240901$$PH$JP$JP
242718981$24271898$1$I$20240805$20240819$20240902$20240902$EXP$$CN-OCTA-ALB13824$OCTAPHARMA$$75$YR$E$M$Y$66$KG$20240830$$HP$CN$CN
242718991$24271899$1$I$$20240820$20240902$20240902$EXP$$US-862174955-ML2024-04634$Unknown Manufacturer$DiFiore E, Pittman J. A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting. Case Reports in Psychiatry. 2024 Jun 18;1-4. doi:10.1155/2024/8824770.$54$YR$A$M$Y$$$20240902$$HP$US$US
242719001$24271900$1$I$20240822$20240828$20240902$20240902$EXP$$US-JNJFOC-20240880409$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240902$$HP$US$US
242719012$24271901$2$F$$20240902$20240902$20240905$EXP$$NVSC2024GB174756$NOVARTIS$$$$C$M$Y$$$20240905$$PH$GB$GB
242719021$24271902$1$I$$20240823$20240902$20240902$30DAY$$US-GSK-US2024105473$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$MD$US$US
242719041$24271904$1$I$$20240408$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2024-012882$AUROBINDO$$47$YR$$M$Y$$$20240902$$PH$US$US
242719051$24271905$1$I$$20240509$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2024-023970$AUROBINDO$$80$YR$$F$Y$$$20240902$$PH$US$US
242719061$24271906$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138522$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240902$$CN$US$US
242719071$24271907$1$I$$20240826$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136718$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240902$$CN$US$US
242719081$24271908$1$I$$20240823$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135697$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240902$$HP$US$US
242719101$24271910$1$I$20230801$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137834$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240902$$CN$US$US
242719111$24271911$1$I$20240816$20240823$20240902$20240902$EXP$$CO-BIOVITRUM-2024-CO-011520$BIOVITRUM$$16$WK$$M$Y$5.2$KG$20240902$$CN$CO$CO
242719121$24271912$1$I$$20240829$20240902$20240902$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048965$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240902$$CN$US$US
242719131$24271913$1$I$$20240829$20240902$20240902$PER$$NVSC2024US175811$NOVARTIS$$$$$F$Y$$$20240902$$MD$US$US
242719141$24271914$1$I$20240101$20240826$20240902$20240902$PER$$US-ABBVIE-5896291$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242719152$24271915$2$F$20240828$20240829$20240902$20240907$PER$$US-AMGEN-USASP2024173251$AMGEN$$$$$F$Y$$$20240907$$CN$US$US
242719161$24271916$1$I$20240822$20240822$20240902$20240902$EXP$$CA-APOTEX-2024AP009752$APOTEX$$80$YR$E$F$Y$$$20240902$$CN$CA$CA
242719171$24271917$1$I$20240101$20240828$20240902$20240902$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048495$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240902$$CN$US$US
242719181$24271918$1$I$$20240814$20240902$20240902$PER$$AR-TOLMAR, INC.-24AR051870$TOLMAR$$$$$M$Y$$$20240902$$CN$AR$AR
242719201$24271920$1$I$$20240814$20240902$20240902$PER$$AU-TOLMAR, INC.-24AU051663$TOLMAR$$$$$M$Y$$$20240902$$HP$AU$AU
242719211$24271921$1$I$$20240814$20240902$20240902$PER$$AU-TOLMAR, INC.-24AU051679$TOLMAR$$$$$M$Y$$$20240902$$CN$AU$AU
242719221$24271922$1$I$$20240814$20240902$20240902$PER$$AU-TOLMAR, INC.-24AU051869$TOLMAR$$$$$M$Y$$$20240902$$CN$AU$AU
242719231$24271923$1$I$$20240814$20240902$20240902$PER$$AU-TOLMAR, INC.-24AU051878$TOLMAR$$$$$M$Y$$$20240902$$CN$AU$AU
242719241$24271924$1$I$20240501$20240814$20240902$20240902$PER$$AU-TOLMAR, INC.-24AU051881$TOLMAR$$75$YR$$M$Y$$$20240902$$CN$AU$AU
242719251$24271925$1$I$$20240827$20240902$20240902$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048527$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240902$$CN$US$US
242719261$24271926$1$I$$20240828$20240902$20240902$PER$$US-JNJFOC-20240877867$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$MD$US$US
242719271$24271927$1$I$$20240820$20240902$20240902$PER$$US-SA-2024SA250312$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240902$$MD$US$US
242719281$24271928$1$I$$20240829$20240902$20240902$PER$$US-ABBVIE-5902910$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242719291$24271929$1$I$20240828$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172704$AMGEN$$93$YR$E$F$Y$$$20240901$$CN$US$US
242719301$24271930$1$I$20240101$20240821$20240902$20240902$PER$$US-SA-2024SA252431$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240902$$MD$US$US
242719311$24271931$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000070632$ROCHE$$93$YR$E$F$Y$$$20240902$$HP$US$US
242719321$24271932$1$I$20240701$20240823$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408015822$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240902$$CN$US$US
242719331$24271933$1$I$$20240823$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408016285$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240902$$CN$US$US
242719341$24271934$1$I$$20240819$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131986$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$89.36$KG$20240902$$CN$US$US
242719351$24271935$1$I$$20240817$20240902$20240902$PER$$US-ASTELLAS-2024-AER-001933$ASTELLAS$$79$YR$E$M$Y$$$20240902$$CN$US$US
242719371$24271937$1$I$$20240828$20240902$20240902$PER$$US-ABBVIE-5902233$ABBVIE$$$$$$Y$$$20240902$$HP$US$US
242719381$24271938$1$I$$20240823$20240902$20240902$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019371$VALIDUS$$$$$$Y$$$20240902$$MD$US$US
242719392$24271939$2$F$20240830$20240902$20240902$20240903$PER$$US-AMGEN-USASP2024174047$AMGEN$$$$$F$Y$$$20240903$$CN$US$US
242719402$24271940$2$F$$20240909$20240902$20240912$PER$$US-ABBVIE-5901065$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
242719411$24271941$1$I$$20240813$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129504$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240902$$CN$US$US
242719422$24271942$2$F$$20240830$20240902$20240904$EXP$$NVSC2024ET175486$NOVARTIS$$$$$F$Y$$$20240904$$MD$ET$ET
242719431$24271943$1$I$20240801$20240827$20240902$20240902$EXP$$JP-009507513-2408JPN003379J$MERCK$$79$YR$$M$Y$$$20240902$$MD$JP$JP
242719442$24271944$2$F$20240730$20240826$20240902$20240905$EXP$$CN-HALEON-2193917$Haleon PLC$$82$YR$$M$Y$60$KG$20240905$$HP$CN$CN
242719461$24271946$1$I$20240722$20240823$20240902$20240902$EXP$$AU-EMD Serono-2024039882$EMD SERONO INC$$55$YR$A$F$Y$$$20240902$$CN$AU$AU
242719471$24271947$1$I$$20240820$20240902$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-042332$AUROBINDO$Bedi R, Das D, Ahmad A, Atallah I, Smart SC, Verma D, et al. MECHANICAL SUPPORT AS A RESCUE BRIDGE TO TAVR IN A PATIENT WITH CARDIOGENIC SHOCK (CS) DUE TO SEVERE AS AND AR. J-Am-Coll-Cardiol. 2024;83 (Suppl.13):3856$71$YR$$F$Y$$$20240902$$HP$US$US
242719481$24271948$1$I$$20240827$20240902$20240902$EXP$$US-TAKEDA-2024TUS087114$TAKEDA$$$$$M$Y$$$20240902$$CN$US$US
242719491$24271949$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-085225-2024$RECKITT BENCKISER$$$$$F$Y$$$20240902$$CN$US$US
242719511$24271951$1$I$$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138718$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240902$$HP$US$US
242719521$24271952$1$I$$20240828$20240902$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-138381$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240902$$MD$JP$JP
242719531$24271953$1$I$$20240821$20240902$20240902$EXP$$FR-AUROBINDO-AUR-APL-2023-063912$AUROBINDO$Naim G, Malissin I, Megarbane B. Cerebral microbleeds in the poisoned patient - an observational magnetic resonance imaging study. Basic + Clinical Pharmacology + Toxicology. 2023$40$YR$$M$Y$$$20240902$$MD$FR$FR
242719541$24271954$1$I$20240814$20240814$20240902$20240902$PER$$US-CSL-2024-007932$CSL Plasma$$28$YR$$M$Y$$$20240902$$HP$US$US
242719552$24271955$2$F$$20240911$20240902$20240913$EXP$$US-INTERCEPT-PM2024001715$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240913$$HP$US$US
242719561$24271956$1$I$$20240821$20240902$20240902$EXP$$GB-AUROBINDO-AUR-APL-2024-042211$AUROBINDO$$$$$M$Y$$$20240902$$CN$GB$GB
242719572$24271957$2$F$20240101$20240912$20240902$20240920$EXP$$US-INTERCEPT-PM2024001293$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
242719581$24271958$1$I$$20240823$20240902$20240902$EXP$$US-INTERCEPT-PM2024001682$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242719601$24271960$1$I$$20240827$20240902$20240902$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048622$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240902$$CN$US$US
242719611$24271961$1$I$20240808$20240821$20240902$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-042497$AUROBINDO$$84$YR$$M$Y$85$KG$20240902$$PH$FR$FR
242719622$24271962$2$F$$20240909$20240902$20240912$EXP$$JP-AMGEN-JPNSP2024172131$AMGEN$$8$DEC$E$F$Y$$$20240912$$HP$JP$JP
242719631$24271963$1$I$$20240826$20240902$20240902$PER$$US-ALXN-202408USA001774US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242719641$24271964$1$I$20231101$20240827$20240902$20240902$PER$$US-ALXN-202408USA001909US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$HP$US$US
242719651$24271965$1$I$20240701$20240820$20240902$20240902$PER$$US-SA-2024SA252356$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240902$$MD$US$US
242719661$24271966$1$I$20240101$20240826$20240902$20240902$PER$$US-SA-2024SA252346$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240902$$MD$US$US
242719671$24271967$1$I$20240818$20240827$20240902$20240902$PER$$US-SA-2024SA251541$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240902$$CN$US$US
242719682$24271968$2$F$$20240823$20240902$20240906$30DAY$$US-SA-2024SA251798$SANOFI AVENTIS$$$$A$$Y$$$20240906$$PH$US$US
242719691$24271969$1$I$20240501$20240827$20240902$20240902$EXP$$US-SA-2024SA252320$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240902$$MD$US$US
242719702$24271970$2$F$20200819$20240905$20240902$20240905$EXP$$CO-UCBSA-2024044321$UCB$$37$YR$$M$Y$$$20240905$$CN$CO$CO
242719711$24271971$1$I$$20240821$20240902$20240902$EXP$$GB-AUROBINDO-AUR-APL-2024-042144$AUROBINDO$$52$YR$$M$Y$146$KG$20240902$$MD$GB$GB
242719721$24271972$1$I$20240701$20240821$20240902$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-042531$AUROBINDO$$41$YR$$F$Y$$$20240902$$CN$FR$FR
242719731$24271973$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076704$SANDOZ$$66$YR$$M$Y$$$20240902$$MD$US$US
242719742$24271974$2$F$$20240821$20240902$20240904$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK093551$GLENMARK$Nimi G, Kirubakaran KR, John J, Kumar P.. Disseminated Protozoa Zopfii Infection in Liver transplant Recipient.. Journal of Clinical and Experimental Hepatology.. 2024;14 Supplement 1$$$$$Y$$$20240904$$MD$IN$IN
242719751$24271975$1$I$20240724$20240724$20240902$20240902$PER$$US-AMGEN-USASP2024171103$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242719761$24271976$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018602$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240902$$CN$US$US
242719771$24271977$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000136$ELI LILLY AND CO$$$$$M$Y$$$20240902$$CN$US$US
242719782$24271978$2$F$20240823$20240823$20240902$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408015355$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240903$$CN$US$US
242719791$24271979$1$I$20240301$20240826$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408016597$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240902$$CN$US$US
242719802$24271980$2$F$20240827$20240924$20240902$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202408019179$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
242719812$24271981$2$F$$20240830$20240902$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408019001$ELI LILLY AND CO$$$$$$Y$$$20240904$$CN$US$US
242719821$24271982$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018878$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240902$$CN$US$US
242719831$24271983$1$I$20240818$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019453$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240902$$CN$US$US
242719841$24271984$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000076$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240902$$CN$US$US
242719851$24271985$1$I$20240827$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018931$ELI LILLY AND CO$$$$$M$Y$$$20240902$$CN$US$US
242719861$24271986$1$I$$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018175$ELI LILLY AND CO$$$$$$Y$$$20240902$$CN$US$US
242719871$24271987$1$I$20240101$20240828$20240902$20240902$EXP$$US-ABBVIE-5901136$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242719881$24271988$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019449$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240902$$CN$US$US
242719891$24271989$1$I$$20240821$20240902$20240902$EXP$$PT-AUROBINDO-AUR-APL-2024-042513$AUROBINDO$Teixeira S, Rodrigues PS.. Do dep?sito ao dano: angiopatia amil?ide cerebral. Congressos Da Sociedade Portuguesa De Medicina Interna: 30. o Congresso Nacional. 2024;30:453$78$YR$$M$Y$$$20240902$$MD$PT$PT
242719902$24271990$2$F$$20240829$20240902$20240909$PER$$US-AMGEN-USASP2024173335$AMGEN$$$$$F$Y$$$20240909$$MD$US$US
242719912$24271991$2$F$20240821$20240829$20240902$20240903$PER$$US-AMGEN-USASP2024174514$AMGEN$$74$YR$E$F$Y$$$20240902$$CN$US$US
242719921$24271992$1$I$$20240821$20240902$20240902$EXP$$US-APOTEX-2024AP009753$APOTEX$Cooper J, Soneji D, Rieger K, Narala S, Kim Y.. Primary Cutaneous CD30+ Large T Cell Lymphoproliferative Disorder Associated With Prolonged Exposure to Fingolimod. Multiple Sclerosis Journal. 2023;29(Suppl 3):969$67$YR$$F$Y$$$20240902$$HP$US$US
242719931$24271993$1$I$20200101$20240820$20240902$20240902$PER$$US-JNJFOC-20240855452$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242719941$24271994$1$I$20230829$20240823$20240902$20240902$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240800119$RIGEL PHARMACEUTICALS$$77$YR$$F$Y$64$KG$20240902$$MD$JP$JP
242719961$24271996$1$I$20240801$20240826$20240902$20240902$EXP$$JP-ARGENX-2024-ARGX-JP007076$ARGENX BVBA$$$$$$Y$$$20240902$$MD$JP$JP
242719971$24271997$1$I$20240827$20240829$20240902$20240902$EXP$$CA-ROCHE-10000070861$ROCHE$$26$YR$A$F$Y$$$20240902$$CN$CA$CA
242719991$24271999$1$I$$20240826$20240902$20240902$EXP$PL-URPL-2-1354-2019$PL-STRIDES ARCOLAB LIMITED-2024SP010723$STRIDES$$70$YR$$M$Y$$$20240902$$CN$PL$PL
242720001$24272000$1$I$$20240827$20240902$20240902$EXP$$US-TAKEDA-2024TUS058799$TAKEDA$$$$$F$Y$$$20240902$$CN$US$US
242720012$24272001$2$F$20240830$20240902$20240902$20240903$PER$$US-AMGEN-USASP2024174354$AMGEN$$33$YR$A$F$Y$$$20240902$$CN$US$US
242720021$24272002$1$I$$20240819$20240902$20240902$EXP$$DE-SANDOZ INC.-SDZ2024DE073432$SANDOZ$$$$$$Y$$$20240902$$HP$DE$DE
242720031$24272003$1$I$$20240829$20240902$20240902$EXP$$CA-ROCHE-3292861$ROCHE$$$$A$F$Y$$$20240902$$CN$CA$CA
242720041$24272004$1$I$20240807$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024173754$AMGEN$$77$YR$E$F$Y$$$20240902$$PH$US$US
242720051$24272005$1$I$20240601$20240815$20240902$20240902$PER$$US-AstraZeneca-2024A186762$ASTRAZENECA$$792$MON$$M$Y$$$20240902$$CN$US$
242720061$24272006$1$I$20240818$20240823$20240902$20240902$EXP$$CN-SPECGX-T202401765$SPECGX$$70$YR$$F$Y$60$KG$20240902$$CN$CN$CN
242720081$24272008$1$I$$20240819$20240902$20240902$EXP$$DE-SANDOZ INC.-SDZ2024DE073446$SANDOZ$$$$$$Y$$$20240902$$HP$DE$DE
242720091$24272009$1$I$$20240822$20240902$20240902$EXP$$CA-APOTEX-2024AP009738$APOTEX$$67$YR$$M$Y$81$KG$20240902$$MD$CA$CA
242720101$24272010$1$I$$20240819$20240902$20240902$EXP$$DE-SANDOZ INC.-SDZ2024DE073450$SANDOZ$$$$$$Y$$$20240902$$HP$DE$DE
242720112$24272011$2$F$20240917$20240917$20240902$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136142$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240925$$HP$US$US
242720121$24272012$1$I$$20240827$20240902$20240902$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-138515$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240902$$CN$PR$PR
242720131$24272013$1$I$$20240816$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130843$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240902$$CN$US$US
242720141$24272014$1$I$20240101$20240826$20240902$20240902$EXP$$JP-009507513-2408JPN003344J$MERCK$$74$YR$$F$Y$$$20240902$$MD$JP$JP
242720161$24272016$1$I$$20240823$20240902$20240902$EXP$$US-VIIV HEALTHCARE LIMITED-US2024105563$VIIV$$$$$$Y$$$20240902$$HP$US$US
242720182$24272018$2$F$20240101$20240918$20240902$20240924$EXP$$US-ROCHE-10000063949$ROCHE$$55$YR$A$F$Y$154.22$KG$20240924$$CN$US$US
242720191$24272019$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173481$AMGEN$$$$$M$Y$$$20240902$$HP$US$US
242720201$24272020$1$I$$20240821$20240902$20240902$EXP$$US-SPECGX-T202401778$SPECGX$Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85$31$YR$$M$Y$$$20240902$$HP$US$US
242720231$24272023$1$I$20240401$20240827$20240902$20240902$PER$$US-BIOGEN-2024BI01280258$BIOGEN$$47$YR$$F$Y$$$20240902$$HP$US$US
242720242$24272024$2$F$$20240909$20240902$20240913$PER$$US-BIOGEN-2024BI01269744$BIOGEN$$$$$F$Y$$$20240913$$CN$US$US
242720251$24272025$1$I$20240808$20240828$20240902$20240902$EXP$$CO-UCBSA-2024044326$UCB$$5$YR$$M$Y$$$20240902$$CN$CO$CO
242720261$24272026$1$I$20240101$20240826$20240902$20240902$EXP$$PL-UCBSA-2024043884$UCB$Czaplicka A, Szymanska E, Walecka I. The use of a combination of calcipotriol and betamethasone gel in the local treatment of scalp psoriasis ? a case report. THE WORLD OF PHARMACY AND MEDICINE. 2024;8-12$19$YR$$M$Y$$$20240902$$MD$PL$PL
242720271$24272027$1$I$20240820$20240820$20240902$20240902$EXP$$US-HALEON-2193949$Haleon PLC$$$$$$Y$$$20240830$$CN$US$US
242720282$24272028$2$F$$20240829$20240902$20240909$PER$$US-AMGEN-USASP2024173338$AMGEN$$$$$F$Y$$$20240909$$MD$US$US
242720291$24272029$1$I$20240820$20240822$20240902$20240902$PER$$IT-IGSA-BIG0030426$GRIFOLS$$55$YR$$M$Y$$$20240902$$HP$IT$IT
242720301$24272030$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018432$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240902$$CN$US$US
242720311$24272031$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019221$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240902$$CN$US$US
242720321$24272032$1$I$20240828$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019450$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240902$$CN$US$US
242720331$24272033$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019087$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240902$$CN$US$US
242720341$24272034$1$I$$20240820$20240902$20240902$EXP$$US-NAARI PTE LIMITED-2024NP000084$NAARI PHARMA$Yu R.. Exaggerated Increases in the Serum Cortisol Level in a Woman Following Oral Contraceptive Treatment.. AACE-Clin-Case-Rep. 2024$50$YR$$F$Y$$$20240902$$MD$US$US
242720351$24272035$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000070719$ROCHE$$$$$$Y$$$20240902$$CN$US$US
242720361$24272036$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000070210$ROCHE$$$$$$Y$$$20240902$$CN$US$US
242720371$24272037$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000070481$ROCHE$$$$E$M$Y$$$20240902$$CN$US$US
242720381$24272038$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-103567-2023$RECKITT BENCKISER$$$$$F$Y$$$20240902$$CN$US$US
242720391$24272039$1$I$$20240822$20240902$20240902$PER$$US-SA-2024SA252476$SANOFI AVENTIS$$$$A$$Y$$$20240902$$HP$US$US
242720401$24272040$1$I$$20240821$20240902$20240902$PER$$US-SA-2024SA253182$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240902$$MD$US$US
242720421$24272042$1$I$20240828$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174098$AMGEN$$68$YR$E$M$Y$$$20240902$$PH$US$US
242720431$24272043$1$I$20231101$20240829$20240902$20240902$EXP$GB-MHRA-MED-202408300017290670-NRMZL$GB-ABBVIE-5902133$ABBVIE$$47$YR$$F$Y$$$20240902$$CN$GB$GB
242720441$24272044$1$I$20230111$20240831$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US076820$SANDOZ$$56$YR$$F$Y$95.238$KG$20240902$$HP$US$US
242720452$24272045$2$F$$20240905$20240902$20240919$EXP$$US-UCBSA-2024044307$UCB$$$$$M$Y$$$20240919$$CN$US$US
242720461$24272046$1$I$20240818$20240823$20240902$20240902$PER$$US-BEH-2024177660$CSL BEHRING$$70$YR$E$F$Y$$$20240902$$HP$US$US
242720472$24272047$2$F$20240801$20240909$20240902$20240917$PER$$US-TRIS PHARMA, INC.-24US011602$TRIS PHARM$$$$$$Y$$$20240917$$CN$US$US
242720483$24272048$3$F$20240801$20240911$20240902$20240919$PER$$US-TRIS PHARMA, INC.-24US011597$TRIS PHARM$$$$$$Y$$$20240919$$CN$US$US
242720491$24272049$1$I$$20240827$20240902$20240902$EXP$$JP-ALXN-202408JPN001640JP$ALEXION PHARMACEUTICALS$$27$YR$$M$Y$$$20240902$$MD$JP$JP
242720501$24272050$1$I$20240728$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173593$AMGEN$$83$YR$E$F$Y$$$20240902$$CN$US$US
242720512$24272051$2$F$20240828$20240830$20240902$20240904$PER$$US-AMGEN-USASP2024173560$AMGEN$$72$YR$E$F$Y$$$20240904$$CN$US$US
242720521$24272052$1$I$$20240827$20240902$20240902$EXP$$US-JNJFOC-20240877875$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$CN$US$US
242720531$24272053$1$I$$20240819$20240902$20240902$EXP$$GB-AUROBINDO-AUR-APL-2024-041701$AUROBINDO$Babra D, Youn S, Devendra S. Postural orthostatic tachycardia syndrome (POTS) occurring during treatment for breast cancer. BMJ Case Reports. 2021;14(8):1-5$58$YR$$F$Y$$$20240902$$MD$GB$GB
242720541$24272054$1$I$$20240821$20240902$20240902$EXP$$DE-DEXPHARM-2024-2937$DEXCEL$Bingert R, Kolbe V, Boy D, B?ttner A. Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock. Rechtsmedizin. 2023 Jun 30;33(5):396?402. doi:10.1007/s00194-023-00633-0$17$YR$T$M$Y$$$20240902$$HP$DE$DE
242720551$24272055$1$I$$20240809$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051118$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242720561$24272056$1$I$$20240807$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051444$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242720571$24272057$1$I$20240101$20240809$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051378$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242720581$24272058$1$I$20240401$20240808$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051306$TOLMAR$$72$YR$$M$Y$$$20240902$$CN$CA$CA
242720591$24272059$1$I$20240730$20240808$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051607$TOLMAR$$62$YR$$M$Y$$$20240902$$CN$CA$CA
242720601$24272060$1$I$$20240809$20240902$20240902$PER$$CA-TOLMAR, INC.-24CA051519$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242720611$24272061$1$I$20240731$20240731$20240902$20240902$PER$$TR-TOLMAR, INC.-24TR051462$TOLMAR$$79$YR$$M$Y$$$20240902$$MD$TR$TR
242720621$24272062$1$I$20240729$20240731$20240902$20240902$PER$$TR-TOLMAR, INC.-24TR051406$TOLMAR$$77$YR$$M$Y$$$20240902$$PH$TR$TR
242720631$24272063$1$I$20240701$20240828$20240902$20240902$EXP$$US-KYOWAKIRIN-2024KK020227$KYOWA$$$$$$Y$$$20240902$$CN$US$US
242720641$24272064$1$I$$20240826$20240902$20240902$EXP$$CA-CELLTRION INC.-2024CA020438$CELLTRION$$$$$$Y$$$20240902$$MD$CA$CA
242720651$24272065$1$I$$20240812$20240902$20240902$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004547$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242720661$24272066$1$I$$20240812$20240902$20240902$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004559$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242720671$24272067$1$I$$20240812$20240902$20240902$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004553$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240902$$CN$US$US
242720681$24272068$1$I$$20240812$20240902$20240902$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004546$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242720692$24272069$2$F$20240824$20240824$20240902$20240904$EXP$$US-CSL-2024-008053$CSL Plasma$$26$YR$$F$Y$$$20240904$$HP$US$US
242720711$24272071$1$I$20240625$20240812$20240902$20240902$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004558$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240902$$CN$US$US
242720721$24272072$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018903$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240902$$CN$US$US
242720731$24272073$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018716$ELI LILLY AND CO$$94$YR$E$F$Y$$$20240902$$CN$US$US
242720741$24272074$1$I$$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408017414$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240902$$CN$US$US
242720751$24272075$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018887$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240902$$CN$US$US
242720761$24272076$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019135$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$US$US
242720771$24272077$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018149$ELI LILLY AND CO$$$$$$Y$$$20240902$$CN$US$US
242720781$24272078$1$I$$20240826$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408016632$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240902$$CN$US$US
242720791$24272079$1$I$20240828$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018938$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240902$$CN$US$US
242720801$24272080$1$I$20230101$20240826$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408016324$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240902$$CN$US$US
242720821$24272082$1$I$20240819$20240828$20240902$20240902$EXP$GB-MHRA-MED-202408281511121410-CVZMW$GB-CHATTEMPRD-2024OHG030003$CHATTEM$$68$YR$E$F$Y$$$20240902$$PH$GB$GB
242720831$24272083$1$I$$20240821$20240902$20240902$EXP$$CA-AUROBINDO-AUR-APL-2024-042717$AUROBINDO$$$$$F$Y$$$20240902$$CN$CA$CA
242720871$24272087$1$I$20240101$20240821$20240902$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-042617$AUROBINDO$$76$YR$$F$Y$$$20240902$$PH$FR$FR
242720881$24272088$1$I$$20240827$20240902$20240902$EXP$$PT-CHATTEMPRD-2024OHG029968$CHATTEM$$$$E$$Y$$$20240902$$HP$PT$PT
242720892$24272089$2$F$20240803$20240912$20240902$20240918$EXP$$TR-TAKEDA-2024TUS085335$TAKEDA$$16$YR$$M$Y$$$20240918$$CN$TR$TR
242720902$24272090$2$F$$20240828$20240902$20240912$EXP$US-MLMSERVICE-20240812-PI155406-00306-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19633$ALKEM$Fasanya-Maku H, Petty D, Knapik J, Leon M, Gonsalves C.. A case of metastatic HPV-related cervical small cell neuroendocrine carcinoma with varying cytomorphology found in cytological specimens of a solid organ transplant recipient. Diagnostic Cytopathology. 2024;52(9):E202-7$53$YR$$F$Y$$$20240912$$MD$US$US
242720912$24272091$2$F$$20240828$20240902$20240912$EXP$US-MLMSERVICE-20240812-PI156101-00306-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19635$ALKEM$Trabzonlu L, McDermott S, Pitman MB, Chebib I.. Pulmonary Kaposi sarcoma in a patient with bilateral lung transplant: An unexpected diagnosis on transbronchial fine needle aspiration and core biopsy. Diagnostic Cytopathology. 2024;52(9):E215-E221$70$YR$$F$Y$$$20240912$$MD$US$US
242720931$24272093$1$I$$20240819$20240902$20240902$EXP$CO-MLMSERVICE-20171018-0925569-1$CO-ALKEM LABORATORIES LIMITED-CO-ALKEM-2017-02101$ALKEM$Nieto-R?os JF, Ram?rez I, Zuluaga-Quintero M, Serna-Higuita LM, Gaviria-Gil F, Velez-Hoyos A.. Malakoplakia after kidney transplantation: Case report and literature review. Transplant Infectious Disease. 2017;19(5):e12731$45$YR$$F$Y$$$20240902$$HP$CO$CO
242720941$24272094$1$I$20240310$20240819$20240902$20240902$EXP$GB-MHRA-MED-202408190134368090-SQLMH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19603$ALKEM$$41$YR$$F$Y$127$KG$20240902$$CN$GB$GB
242720951$24272095$1$I$20230101$20240828$20240902$20240902$EXP$$US-ABBVIE-5656401$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242720961$24272096$1$I$$20240823$20240902$20240902$EXP$$US-ARGENX-2024-ARGX-US007057$ARGENX BVBA$$$$$$Y$$$20240902$$HP$US$US
242720971$24272097$1$I$20240705$20240821$20240902$20240902$EXP$$ES-AUROBINDO-AUR-APL-2024-042433$AUROBINDO$$77$YR$$M$Y$$$20240902$$MD$ES$ES
242720981$24272098$1$I$$20240828$20240902$20240902$EXP$$CA-TAKEDA-2024TUS087287$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
242720991$24272099$1$I$20231101$20240827$20240902$20240902$EXP$FR-AFSSAPS-TS2024000941$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111673$ZYDUS PHARM$$$$$$Y$$$20240902$$MD$FR$FR
242721001$24272100$1$I$20240601$20240829$20240902$20240902$EXP$$US-JNJFOC-20240877540$JOHNSON AND JOHNSON$$6$DEC$A$$Y$$$20240902$$CN$US$US
242721011$24272101$1$I$20240823$20240826$20240902$20240902$PER$$US-ABBVIE-5895919$ABBVIE$$67$YR$$F$Y$$$20240902$$CN$US$US
242721021$24272102$1$I$$20240820$20240902$20240902$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111470$ZYDUS PHARM$Fling C, Granados L, Coruh B.. An Ophtha-MALA-gic Anomaly: Metformin Associated Lactic Acidosis Causing Transient Blindness.. Am-J-Respir-Crit-Care-Med. 2023;207:A3498 abstr. B48$$$$$Y$$$20240902$$HP$US$US
242721031$24272103$1$I$20240828$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173563$AMGEN$$$$$$Y$$$20240902$$HP$US$US
242721041$24272104$1$I$$20240821$20240902$20240902$EXP$$CA-TAKEDA-2024TUS068096$TAKEDA$$$$$M$Y$80.5$KG$20240902$$MD$CA$CA
242721051$24272105$1$I$20240507$20240823$20240902$20240902$EXP$DE-EMA-DD-20240610-7482707-112836$DE-ALKABELLO A/S-2024AA002131$ALK-ABELLO$$$$$$Y$$$20240902$$MD$DE$DE
242721061$24272106$1$I$$20240822$20240902$20240902$EXP$$US-RDY-SPO/USA/24/0012555$DR REDDYS$Reinfeld S, Gill P. Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: A case series. CNS Spectrums. 2023 Oct;28(5): 587-591. doi:10.1017/S1092852922001158.$12$YR$T$F$Y$$$20240902$$HP$US$US
242721071$24272107$1$I$$20240821$20240902$20240902$PER$$US-ROCHE-10000067763$ROCHE$$$$$F$Y$$$20240902$$CN$US$US
242721081$24272108$1$I$$20240827$20240902$20240902$EXP$$CN-ABBVIE-5899104$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$M$Y$$$20240902$$HP$CN$CN
242721091$24272109$1$I$$20240829$20240902$20240902$EXP$$CA-TAKEDA-2024TUS087680$TAKEDA$$$$$M$Y$$$20240902$$MD$CA$CA
242721102$24272110$2$F$$20240830$20240902$20240904$EXP$$NVSC2024NL175488$NOVARTIS$$$$$M$Y$$$20240904$$CN$NL$NL
242721121$24272112$1$I$20240823$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138500$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240902$$CN$US$US
242721161$24272116$1$I$20160301$20240828$20240902$20240902$EXP$$US-TAKEDA-2016BLT001284$TAKEDA$$60$YR$$F$Y$$$20240902$$CN$US$US
242721171$24272117$1$I$$20240819$20240902$20240902$EXP$$US-UCBSA-2024042402$UCB$$$$$M$Y$92.063$KG$20240902$$HP$US$US
242721181$24272118$1$I$20110101$20240820$20240902$20240902$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00414$Unknown Manufacturer$$$$$$Y$$$20240902$$CN$BR$BR
242721191$24272119$1$I$20240501$20240827$20240902$20240902$PER$$US-ALXN-202408USA001934US$ALEXION PHARMACEUTICALS$$40$YR$$F$Y$$$20240902$$PH$US$US
242721201$24272120$1$I$20240823$20240823$20240902$20240902$PER$$US-ABBVIE-5896107$ABBVIE$$40$YR$$F$Y$$$20240902$$MD$US$US
242721212$24272121$2$F$$20240829$20240902$20240909$EXP$$US-ASTELLAS-2024-AER-002940$ASTELLAS$$75$YR$E$M$Y$$$20240909$$CN$US$US
242721221$24272122$1$I$20240616$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196201$ASTRAZENECA$$31441$DY$$M$Y$$$20240902$$CN$US$
242721231$24272123$1$I$$20240827$20240902$20240902$PER$$US-BIOGEN-2024BI01280250$BIOGEN$$$$$F$Y$$$20240902$$MD$US$US
242721241$24272124$1$I$$20240827$20240902$20240902$PER$$US-BIOGEN-2024BI01280238$BIOGEN$$$$$F$Y$$$20240902$$CN$US$US
242721251$24272125$1$I$20240813$20240813$20240902$20240902$PER$$US-TEVA-VS-3233696$TEVA$$69$YR$$M$Y$$$20240902$$PH$US$US
242721261$24272126$1$I$20171117$20240828$20240902$20240902$EXP$$CA-TAKEDA-2018TUS001383$TAKEDA$$23$YR$$M$Y$$$20240902$$CN$CA$CA
242721271$24272127$1$I$20231116$20231128$20240902$20240902$EXP$$CA-CELLTRION INC.-2021CA019697$CELLTRION$$$$$$Y$$$20240902$$MD$CA$CA
242721281$24272128$1$I$$20240823$20240902$20240902$PER$$US-JNJFOC-20240867404$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$MD$US$US
242721291$24272129$1$I$$20240823$20240902$20240902$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-138723$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240902$$MD$FR$FR
242721301$24272130$1$I$$20240813$20240902$20240902$PER$$US-TEVA-VS-3233848$TEVA$$$$$$Y$$$20240902$$CN$US$US
242721311$24272131$1$I$$20240819$20240902$20240902$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07957$HIKMA$$$$A$$Y$$$20240902$$HP$US$US
242721321$24272132$1$I$$20240828$20240902$20240902$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048500$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240902$$CN$US$US
242721331$24272133$1$I$$20240829$20240902$20240902$EXP$$JP-TAKEDA-2024TJP012775$TAKEDA$Ikuto Maita, Reo Kondo, Hiroshi Hashimoto, Yutaka Shirai, Kazuyo Hosomi, Osamu Shirakawa. A case of sudden deterioration of thyroid function during the clinical course of depression that led to a suicide attempt. Psychoneurology Magazine. 2024;S421$4$DEC$$F$Y$$$20240902$$MD$JP$JP
242721341$24272134$1$I$20240701$20240827$20240902$20240902$PER$$US-BIOGEN-2024BI01280469$BIOGEN$$56$YR$$F$Y$$$20240902$$CN$US$US
242721351$24272135$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173328$AMGEN$$68$YR$E$F$Y$$$20240902$$HP$US$US
242721362$24272136$2$F$$20240830$20240902$20240905$PER$$US-AMGEN-USASP2024171997$AMGEN$$69$YR$E$M$Y$$$20240904$$HP$US$US
242721371$24272137$1$I$$20240823$20240902$20240902$PER$$US-GILEAD-2024-0685246$GILEAD$$81$YR$E$F$Y$$$20240902$$CN$US$US
242721382$24272138$2$F$$20240829$20240902$20240903$EXP$$CA-SANDOZ INC.-SDZ2024CA076497$SANDOZ$$55$YR$$M$Y$$$20240903$$CN$CA$CA
242721392$24272139$2$F$20240829$20240903$20240902$20240906$PER$$US-AMGEN-USASP2024174475$AMGEN$$87$YR$E$M$Y$$$20240906$$HP$US$US
242721401$24272140$1$I$$20240821$20240902$20240902$EXP$$US-SPECGX-T202401779$SPECGX$Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85$42$YR$$F$Y$$$20240902$$HP$US$US
242721411$24272141$1$I$$20240821$20240902$20240902$EXP$$US-SPECGX-T202401780$SPECGX$Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85$38$YR$$M$Y$$$20240902$$HP$US$US
242721421$24272142$1$I$20240812$20240826$20240902$20240902$EXP$$CN-ROCHE-10000066454$ROCHE$$66$YR$E$M$Y$80$KG$20240902$$HP$CN$CN
242721431$24272143$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000006$ELI LILLY AND CO$$$$A$F$Y$$$20240902$$CN$US$US
242721441$24272144$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018788$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$US$US
242721451$24272145$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018801$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240902$$CN$US$US
242721461$24272146$1$I$20240801$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018195$ELI LILLY AND CO$$28$YR$A$M$Y$$$20240902$$CN$US$US
242721472$24272147$2$F$$20240829$20240902$20240912$PER$$US-GILEAD-2024-0685853$GILEAD$$$$$F$Y$$$20240912$$CN$US$US
242721481$24272148$1$I$20240101$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137742$BRISTOL MYERS SQUIBB$$4$DEC$A$M$Y$$$20240902$$MD$US$US
242721491$24272149$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137968$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240902$$CN$US$US
242721501$24272150$1$I$$20240821$20240902$20240902$EXP$$US-SPECGX-T202401781$SPECGX$Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85$51$YR$$M$Y$$$20240902$$HP$US$US
242721511$24272151$1$I$$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024173820$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242721522$24272152$2$F$$20240910$20240902$20240915$EXP$$CA-JNJFOC-20240873853$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240916$$HP$CA$CA
242721531$24272153$1$I$20240828$20240828$20240902$20240902$PER$$US-JNJFOC-20240880446$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240902$$HP$US$US
242721541$24272154$1$I$$20240821$20240902$20240902$EXP$$US-SPECGX-T202401782$SPECGX$Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85$21$YR$$M$Y$$$20240902$$HP$US$US
242721553$24272155$3$F$20240801$20240912$20240902$20240915$EXP$$JP-JNJFOC-20240900752$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240916$$PH$JP$JP
242721561$24272156$1$I$20200101$20240823$20240902$20240902$EXP$NO-NOMAADVRE-RELISSO-2024-V37448$NO-TEVA-VS-3237070$TEVA$$$$$F$Y$$$20240902$$MD$NO$NO
242721571$24272157$1$I$$20240829$20240902$20240902$EXP$$NVSC2024BO175631$NOVARTIS$$$$$F$Y$$$20240902$$MD$BO$BO
242721581$24272158$1$I$$20240829$20240902$20240902$PER$$NVSC2024US175560$NOVARTIS$$$$$$Y$$$20240902$$CN$US$US
242721591$24272159$1$I$20240621$20240827$20240902$20240902$EXP$BE-FAMHP-DHH-N2024-122555$BE-CURRAX PHARMACEUTICALS LLC-BE-2024CUR003970$CURRAX PHARMACEUTICALS$$57$YR$$F$Y$86$KG$20240902$$CN$BE$BE
242721611$24272161$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-087341-2024$RECKITT BENCKISER$$76$YR$$F$Y$55.45$KG$20240902$$CN$US$US
242721621$24272162$1$I$20240829$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024172922$AMGEN$$65$YR$E$M$Y$$$20240902$$HP$US$US
242721631$24272163$1$I$$20240823$20240902$20240902$EXP$$CA-APOTEX-2024AP009765$APOTEX$$$$$F$Y$$$20240902$$HP$CA$CA
242721641$24272164$1$I$$20240829$20240902$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA076534$SANDOZ$$67$YR$$F$Y$$$20240902$$HP$CA$CA
242721652$24272165$2$F$$20240828$20240902$20240911$PER$$US-AstraZeneca-2024A196535$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
242721661$24272166$1$I$$20240823$20240902$20240902$EXP$$CA-TAKEDA-2024TUS086007$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
242721671$24272167$1$I$20240101$20240826$20240902$20240902$EXP$$CA-JNJFOC-20240734922$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240902$$HP$CA$CA
242721681$24272168$1$I$$20240828$20240902$20240902$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS004399$TERSERA THERAPEUTICS$$$$$$Y$$$20240902$$MD$AU$AU
242721691$24272169$1$I$20240824$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173580$AMGEN$$64$YR$A$F$Y$$$20240902$$CN$US$US
242721701$24272170$1$I$$20240823$20240902$20240902$EXP$$CA-APOTEX-2024AP009767$APOTEX$$30$YR$$F$Y$$$20240902$$HP$CA$CA
242721711$24272171$1$I$$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172243$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242721721$24272172$1$I$20240801$20240822$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134637$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240902$$HP$US$US
242721731$24272173$1$I$$20240828$20240902$20240902$EXP$$CA-HALEON-2194073$Haleon PLC$$65$YR$$F$Y$$$20240902$$HP$CA$CA
242721742$24272174$2$F$$20240919$20240902$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136196$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240920$$CN$US$US
242721751$24272175$1$I$20230628$20231013$20240902$20240902$EXP$$CA-CELLTRION INC.-2021CA019706$CELLTRION$$$$$$Y$$$20240902$$MD$CA$CA
242721761$24272176$1$I$$20240820$20240902$20240902$EXP$$CA-UCBSA-2024042499$UCB$$$$$F$Y$$$20240902$$CN$CA$CA
242721771$24272177$1$I$20240823$20240823$20240902$20240902$30DAY$$US-GSK-US2024106121$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240902$$CN$US$US
242721781$24272178$1$I$$20240819$20240902$20240902$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07958$HIKMA$$$$A$$Y$$$20240902$$HP$US$US
242721791$24272179$1$I$20240411$20240823$20240902$20240902$EXP$SE-SEMPA-2024-006079$SE-TEVA-VS-3237081$TEVA$$71$YR$$F$Y$$$20240902$$MD$SE$SE
242721801$24272180$1$I$20240821$20240822$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134358$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$125.6$KG$20240902$$PH$US$US
242721811$24272181$1$I$$20240830$20240902$20240902$PER$$US-HALEON-2194582$Haleon PLC$$$$$M$Y$$$20240902$$CN$US$US
242721821$24272182$1$I$$20240822$20240902$20240902$EXP$$JP-ROCHE-10000069867$ROCHE$$79$YR$E$F$Y$$$20240902$$MD$JP$JP
242721831$24272183$1$I$$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138411$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$90.72$KG$20240902$$CN$US$US
242721851$24272185$1$I$$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138347$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240902$$CN$US$US
242721871$24272187$1$I$$20240821$20240902$20240902$EXP$$ZA-AUROBINDO-AUR-APL-2021-011260$AUROBINDO$Mouton JP, Jobanputra N, Njuguna C, Gunter H, Stewart A, Mehta U, et al.. Adult medical emergency unit presentations due to adverse drug reactions in a setting of high HIV prevalence.. African Journal of Emergency Medicine. 2021;11(1):46-52$39$YR$$M$Y$$$20240902$$HP$ZA$ZA
242721882$24272188$2$F$$20240829$20240902$20240905$PER$$US-AMGEN-USASP2024173730$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242721902$24272190$2$F$20240828$20240910$20240902$20240912$PER$$US-AMGEN-USASP2024174543$AMGEN$$60$YR$A$F$Y$$$20240912$$HP$US$US
242721911$24272191$1$I$20191103$20240830$20240902$20240902$EXP$$DE-SANDOZ INC.-SDZ2024DE076583$SANDOZ$$39$YR$$F$Y$$$20240902$$MD$DE$DE
242721921$24272192$1$I$20240828$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018069$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240902$$CN$US$US
242721931$24272193$1$I$20240401$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408017776$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240902$$CN$US$US
242721941$24272194$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018014$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240902$$CN$US$US
242721951$24272195$1$I$20240826$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408017045$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240902$$MD$US$US
242721961$24272196$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019035$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240902$$CN$US$US
242721971$24272197$1$I$20240823$20240823$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408015873$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240902$$CN$US$US
242721981$24272198$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018983$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240902$$CN$US$US
242721991$24272199$1$I$20240823$20240823$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019223$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240902$$CN$US$US
242722001$24272200$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018992$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$US$US
242722011$24272201$1$I$20240801$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138436$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240902$$HP$US$US
242722024$24272202$4$F$$20240905$20240902$20240906$PER$$US-AMGEN-USASP2024172935$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242722032$24272203$2$F$$20240828$20240902$20240905$PER$$US-AMGEN-USASP2024173741$AMGEN$$$$$M$Y$$$20240905$$PH$US$US
242722061$24272206$1$I$$20240813$20240902$20240902$PER$$US-TEVA-VS-3233568$TEVA$$43$YR$$F$Y$$$20240902$$HP$US$US
242722071$24272207$1$I$20240824$20240829$20240902$20240902$EXP$$CN-SANDOZ INC.-SDZ2024CN076454$SANDOZ$$60$YR$$F$Y$55$KG$20240902$$HP$CN$CN
242722081$24272208$1$I$20240801$20240828$20240902$20240902$EXP$$US-AMGEN-USASP2024172536$AMGEN$$43$YR$A$F$Y$$$20240902$$PH$US$US
242722101$24272210$1$I$$20240823$20240902$20240902$PER$$US-TAKEDA-2024TUS085909$TAKEDA$$$$$F$Y$$$20240902$$HP$US$US
242722111$24272211$1$I$$20240809$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08073$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242722121$24272212$1$I$20240601$20240830$20240902$20240902$EXP$$JP-TAKEDA-2024TJP012880$TAKEDA$$$$$F$Y$$$20240902$$PH$JP$JP
242722131$24272213$1$I$$20240829$20240902$20240902$EXP$$DE-SANDOZ INC.-SDZ2024DE076584$SANDOZ$$46$YR$$F$Y$$$20240902$$MD$DE$DE
242722141$24272214$1$I$$20240828$20240902$20240902$PER$$US-ALXN-202408USA002011US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242722151$24272215$1$I$20240821$20240822$20240902$20240902$PER$$US-ROCHE-10000065155$ROCHE$$$$$F$Y$$$20240902$$CN$US$US
242722171$24272217$1$I$$20240822$20240902$20240902$EXP$$US-RDY-SPO/USA/24/0012550$DR REDDYS$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 06;73: doi:10.1007/s00262-024-03775-6.$49$YR$A$F$Y$$$20240902$$HP$US$US
242722192$24272219$2$F$20240801$20240916$20240902$20240919$EXP$$US-ABBVIE-5899011$ABBVIE$$29$YR$$M$Y$61$KG$20240919$$MD$US$US
242722201$24272220$1$I$20240626$20240829$20240902$20240902$EXP$$US-ABBVIE-5903432$ABBVIE$$78$YR$$M$Y$$$20240902$$CN$US$US
242722211$24272221$1$I$20240521$20240822$20240902$20240902$EXP$CN-NMPACDR-3301051028618202400187$CN-BAXTER-2024BAX023748$BAXTER$$6$YR$$F$Y$20.7$KG$20240902$$MD$CN$CN
242722221$24272222$1$I$20240722$20240823$20240902$20240902$EXP$FR-AFSSAPS-PB2024000879$FR-BAXTER-2024BAX023671$BAXTER$$41$YR$$F$Y$$$20240902$$MD$FR$FR
242722231$24272223$1$I$$20240829$20240902$20240902$EXP$$CN-ROCHE-10000069799$ROCHE$SHAN H, WANG Y, JI P, XU Y, WANG Y, CHEN J, et al. A single-center observational study of reduced-dose rituximab in the treatment of ANCA-associated vasculitis. Chinese Journal of Hospital Pharmacy. 2024-Jul;44 (14):1669-74. doi:10.13286/j.1001-5213.2024.14.10.$$$$$Y$$$20240902$$PH$CN$CN
242722243$24272224$3$F$$20240918$20240902$20240925$30DAY$$GB-JNJFOC-20240849183$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$GB$GB
242722261$24272226$1$I$$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137006$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$PH$US$US
242722282$24272228$2$F$20190620$20240919$20240902$20240930$EXP$$MX-ROCHE-10000066088$ROCHE$$41$YR$A$F$Y$52.5$KG$20240930$$CN$MX$MX
242722291$24272229$1$I$$20240830$20240902$20240902$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048957$BOEHRINGER INGELHEIM$$$$$$Y$$$20240902$$MD$JP$JP
242722302$24272230$2$F$20240312$20240906$20240902$20240910$EXP$$NVSC2024DE157988$NOVARTIS$$$$E$F$Y$71$KG$20240910$$HP$DE$DE
242722311$24272231$1$I$$20240829$20240902$20240902$PER$$US-TAKEDA-2024TUS087545$TAKEDA$$$$$F$Y$$$20240902$$CN$US$US
242722321$24272232$1$I$$20240826$20240902$20240902$EXP$$US-GSK-US2024106001$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
242722331$24272233$1$I$$20240826$20240902$20240902$PER$$US-ROCHE-10000066992$ROCHE$$$$$F$Y$$$20240902$$PH$US$US
242722341$24272234$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173445$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242722361$24272236$1$I$20240829$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018942$ELI LILLY AND CO$$$$$M$Y$$$20240902$$MD$US$US
242722371$24272237$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018854$ELI LILLY AND CO$$$$$$Y$$$20240902$$CN$US$US
242722382$24272238$2$F$20240801$20240911$20240902$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202408018936$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240916$$CN$US$US
242722391$24272239$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018989$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240902$$CN$US$US
242722401$24272240$1$I$20240828$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018538$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240902$$CN$US$US
242722411$24272241$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018857$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240902$$CN$US$US
242722421$24272242$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019175$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240902$$CN$US$US
242722431$24272243$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019037$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240902$$MD$US$US
242722441$24272244$1$I$$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138282$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$84.37$KG$20240902$$CN$US$US
242722451$24272245$1$I$$20240826$20240902$20240902$PER$$US-TAKEDA-2024TUS086206$TAKEDA$$$$$$Y$$$20240902$$CN$US$US
242722463$24272246$3$F$20240201$20240924$20240902$20240926$PER$$US-SA-2024SA252713$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240926$$CN$US$US
242722471$24272247$1$I$20230601$20240821$20240902$20240902$PER$$US-SA-2024SA252468$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240902$$MD$US$US
242722481$24272248$1$I$$20240822$20240902$20240902$PER$$US-SA-2024SA252917$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240902$$MD$US$US
242722491$24272249$1$I$$20240823$20240902$20240902$PER$$US-APOTEX-2024AP010053$APOTEX$Kistler EA, Clinebell K, Gannon JM, Nathaniel VI, Lupu AM, Chengappa KN. Applying Shared Decision Making to the Process of Medication Deprescribing in Schizophrenia. Clinical Therapeutics. 2023;45:1008-1011$42$YR$$M$Y$$$20240902$$MD$US$US
242722501$24272250$1$I$$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024174271$AMGEN$$$$$$Y$$$20240902$$HP$US$US
242722511$24272251$1$I$20221201$20240826$20240902$20240902$EXP$JP-MLMSERVICE-20240814-PI162200-00077-2$JP-CHEPLA-2024011093$CHEPLAPHARM$Asazuma K, Shimomura A, Kawamura Y, Taniyama T, Shimizu C. Case Report of Complete Response to Olaparib in a Patient with Breast Cancer Brain Metastases. Case Reports in Oncology. 2024;17(1):773-8. DOI: 10.1159/000540257.$3$DEC$$F$Y$$$20240902$$MD$COUNTRY NOT SPECIFIED$JP
242722521$24272252$1$I$20171001$20240826$20240902$20240902$EXP$$CA-CHEPLA-2024011055$CHEPLAPHARM$Yang XY, Le-Nguyen A, Alvarez F, Rong ZX, Borsuk D, Piche N, et al. Pediatric living donor liver transplant for Budd-Chiari syndrome using a cryopreserved pulmonary vein graft for retro-hepatic vena cava reconstruction: A case report. Pediatric Transplantation.2024;28(1):e14674. doi: 10.1111/petr.14674.$8$YR$$F$Y$$$20240902$$MD$COUNTRY NOT SPECIFIED$CA
242722531$24272253$1$I$$20240826$20240902$20240902$EXP$$JP-CHEPLA-2024011107$CHEPLAPHARM$Kato T, Hiyama S, Sano M, et al. Transient Arginine Vasopressin Deficiency Induced by Valproic Acid Intoxication: A Case Report. Cureus. 2024;16(7):e65165. doi: 10.7759/cureus.65165.$42$YR$$F$Y$$$20240902$$HP$COUNTRY NOT SPECIFIED$JP
242722541$24272254$1$I$$20240826$20240902$20240902$EXP$$US-CHEPLA-2024011079$CHEPLAPHARM$Corcione S, Lupia T, Vita D, Sidoti F, Zanotto E, Solidoro P et al. Maribavir treatment for resistant cytomegalovirus disseminated disease in kidney transplant recipients: A case-based scoping review of real life data in literature. Transplantation Reviews.2024;38(4):100873. doi: 10.1016/j.trre.2024.100873.$54$YR$$F$Y$$$20240902$$HP$COUNTRY NOT SPECIFIED$US
242722551$24272255$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138649$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240902$$CN$US$US
242722561$24272256$1$I$$20240829$20240902$20240902$EXP$$US-ABBVIE-5902401$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242722571$24272257$1$I$20240810$20240822$20240902$20240902$PER$$US-JNJFOC-20240860040$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242722581$24272258$1$I$$20240827$20240902$20240902$PER$$US-GILEAD-2024-0685698$GILEAD$$$$$$Y$$$20240902$$CN$US$US
242722591$24272259$1$I$20240501$20240828$20240902$20240902$EXP$$US-ABBVIE-5900241$ABBVIE$$48$YR$$F$Y$$$20240902$$CN$US$US
242722601$24272260$1$I$20240710$20240829$20240902$20240902$EXP$SE-SEMPA-2024-006201$SE-009507513-2408SWE010334$MERCK$$55$YR$$F$Y$$$20240902$$MD$SE$SE
242722611$24272261$1$I$$20240818$20240902$20240902$PER$$US-JNJFOC-20240875861$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242722621$24272262$1$I$20240712$20240812$20240902$20240902$PER$$US-APOTEX-2024AP009259$APOTEX$$78$YR$$F$Y$$$20240902$$CN$US$US
242722631$24272263$1$I$$20240828$20240902$20240902$EXP$$US-ABBVIE-5899553$ABBVIE$$$$$F$Y$$$20240902$$HP$US$US
242722641$24272264$1$I$$20240827$20240902$20240902$PER$$US-JNJFOC-20240871747$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240902$$HP$US$US
242722652$24272265$2$F$20240827$20240829$20240902$20240902$PER$$US-JNJFOC-20240871758$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242722661$24272266$1$I$$20240822$20240902$20240902$PER$$US-JNJFOC-20240878858$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240902$$CN$US$US
242722671$24272267$1$I$20240801$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138747$BRISTOL MYERS SQUIBB$$27$YR$A$F$Y$65.77$KG$20240902$$CN$US$US
242722681$24272268$1$I$$20240823$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135228$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240902$$CN$US$US
242722691$24272269$1$I$$20240612$20240902$20240902$30DAY$$FR-GSK-FR2024075666$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$PH$FR$FR
242722701$24272270$1$I$$20240810$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08212$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242722711$24272271$1$I$$20240821$20240902$20240902$EXP$$NL-AUROBINDO-AUR-APL-2019-083582$AUROBINDO$TIMMERMAN L, VD HOEK-MENSINK A.. OPIATES AND SSRI^S: RISK FOR SEROTONIN SYNDROME. 22ND ANNUAL CONGRESS OF THE EUROPEAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY: 2009 SEP 12;ABSTR:P.1.C.003. 2009;ABSTR:P.1.C.003. 22nd Annual Congress of the European College of Neuropsychopharmacology. 2009;19 (Suppl.3):S252$89$YR$$F$Y$$$20240902$$MD$NL$NL
242722721$24272272$1$I$$20240828$20240902$20240902$PER$$US-ABBVIE-5900978$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242722731$24272273$1$I$$20240821$20240902$20240902$EXP$$PT-IPCA LABORATORIES LIMITED-IPC-2024-PT-002105$IPCA$Novais C, Cruz AM. Co 55 unexpected challenges: recognizing the serious adverse effects of oral antidiabetics. Rev Port Med Geral Fam. 2024;40(13):S21$$$$$Y$$$20240902$$HP$PT$PT
242722741$24272274$1$I$$20240822$20240902$20240902$EXP$$CA-APOTEX-2024AP009718$APOTEX$$54$YR$$F$Y$$$20240902$$HP$CA$CA
242722751$24272275$1$I$$20240821$20240902$20240902$EXP$$DE-AUROBINDO-AUR-APL-2024-042573$AUROBINDO$Wildermann T, Becker F, Jesse S, Baier H, Wagner J.. Successful use of Fenfluramine in super-refractory status epilepticus in a patient with tuberous sclerosis complex and Lennox-Gastaut syndrome.. Epilepsy and Behavior Reports.. 2024;27:1-5$24$YR$$F$Y$$$20240902$$HP$DE$DE
242722762$24272276$2$F$$20240827$20240902$20240904$PER$$US-CHATTEMPRD-2024OHG029861$CHATTEM$$$$$F$Y$$$20240904$$CN$US$US
242722771$24272277$1$I$$20240827$20240902$20240902$PER$$US-CHATTEMPRD-2024OHG029895$CHATTEM$$$$$F$Y$$$20240902$$CN$US$US
242722781$24272278$1$I$20240801$20240828$20240902$20240902$EXP$$US-ABBVIE-5899482$ABBVIE$$77$YR$$F$Y$$$20240902$$CN$US$US
242722791$24272279$1$I$$20240827$20240902$20240902$EXP$$US-ABBVIE-5898931$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242722801$24272280$1$I$20220101$20240828$20240902$20240902$EXP$$US-ABBVIE-5899935$ABBVIE$$60$YR$$F$Y$$$20240902$$CN$US$US
242722811$24272281$1$I$$20240825$20240902$20240902$EXP$$SI-AMGEN-SVNSP2024171306$AMGEN$Marovt M.; Marko P.B.. Denosumab-induced Acute Generalized Exanthematous Pustulosis. Acta dermato-venereologica. 2024;104:1-2$72$YR$E$F$Y$$$20240902$$HP$SI$SI
242722821$24272282$1$I$20240501$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024171394$AMGEN$$58$YR$A$M$Y$$$20240902$$CN$US$US
242722842$24272284$2$F$$20240829$20240902$20240906$EXP$$CA-ROCHE-10000069023$ROCHE$$$$A$M$Y$$$20240906$$CN$CA$CA
242722851$24272285$1$I$20240811$20240829$20240902$20240902$EXP$$BG-ABBVIE-5902748$ABBVIE$$76$YR$$F$Y$$$20240902$$CN$BG$BG
242722862$24272286$2$F$20240729$20240823$20240902$20240910$EXP$$CA-CELLTRION INC.-2024CA019316$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
242722871$24272287$1$I$20230101$20240828$20240902$20240902$EXP$$US-ABBVIE-5710424$ABBVIE$$43$YR$$F$Y$$$20240902$$CN$US$US
242722881$24272288$1$I$$20240827$20240902$20240902$PER$$US-CHATTEMPRD-2024OHG029979$CHATTEM$$$$$$Y$$$20240902$$CN$US$US
242722891$24272289$1$I$$20240828$20240902$20240902$EXP$$US-ABBVIE-5900972$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242722901$24272290$1$I$$20240828$20240902$20240902$EXP$$US-ABBVIE-5901047$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242722911$24272291$1$I$$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174361$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242722922$24272292$2$F$20240827$20240829$20240902$20240909$PER$$US-AMGEN-USASP2024173598$AMGEN$$65$YR$E$F$Y$$$20240909$$CN$US$US
242722932$24272293$2$F$$20240831$20240902$20240910$EXP$$PT-AUROBINDO-AUR-APL-2024-037257$AUROBINDO$BS Ferreira; I Andrade; M Presume; F D?maso; AM Ribeiro; FF De Liz, et,al.. A PROP?SITO DO DIAGN?STICO  DIFERENCIAL DA HEPATITE AGUDA (FOR THE PURPOSE OF THE DIFFERENTIAL DIAGNOSIS OF ACUTE HEPATITIS). Gastroenterological diseases and liver diseases; clinical case. 30:616$65$YR$$F$Y$$$20240910$$MD$PT$PT
242722942$24272294$2$F$20230701$20240905$20240902$20240909$EXP$$US-ABBVIE-5901069$ABBVIE$$59$YR$$M$Y$$$20240909$$CN$US$US
242722952$24272295$2$F$20240311$20240923$20240902$20240926$30DAY$$US-AMGEN-USASP2024172342$AMGEN$$$$$$Y$$$20240926$$HP$US$US
242722961$24272296$1$I$$20240827$20240902$20240902$PER$$US-GILEAD-2024-0685682$GILEAD$$$$$$Y$$$20240902$$CN$US$US
242722972$24272297$2$F$20240804$20240903$20240902$20240910$EXP$$US-EMD Serono-2024043035$EMD SERONO INC$$69$YR$E$F$Y$58$KG$20240910$$CN$US$US
242722981$24272298$1$I$$20240822$20240902$20240902$PER$$US-CHATTEMPRD-2024OHG029932$CHATTEM$$$$E$F$Y$$$20240902$$HP$US$US
242722992$24272299$2$F$20211201$20240924$20240902$20240930$EXP$$JP-GSK-JP2024JPN105801$GLAXOSMITHKLINE$Murayama A, Kan Y, Takami T, Matsuura K, Ueda C, Kashu-Uozumi N, et al. Case report A case of refeeding syndrome in a patient with malnutrition due to Stevens-Johnson syndrome. Journal of Japanese Society for Parenteral and Enteral Nutrition Therapy. 2024;6:143-148$$$$$Y$$$20240930$$MD$JP$JP
242723011$24272301$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018831$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240902$$CN$US$US
242723021$24272302$1$I$20240829$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018941$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240902$$CN$US$US
242723031$24272303$1$I$20240829$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000205$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240902$$CN$US$US
242723042$24272304$2$F$20240510$20240905$20240902$20240905$EXP$$CO-UCBSA-2024044260$UCB$$60$YR$$M$Y$$$20240905$$CN$CO$CO
242723051$24272305$1$I$$20240828$20240902$20240902$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14590$DE-GSK-DE2024086967$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$HP$DE$DE
242723061$24272306$1$I$$20240827$20240902$20240902$PER$$US-ALXN-202408USA001893US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242723082$24272308$2$F$20240101$20240917$20240902$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138699$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$129.27$KG$20240919$$CN$US$US
242723091$24272309$1$I$20220101$20240829$20240902$20240902$EXP$$US-ABBVIE-5901648$ABBVIE$$47$YR$$M$Y$$$20240902$$CN$US$US
242723101$24272310$1$I$20240801$20240828$20240902$20240902$EXP$$DE-ABBVIE-5901158$ABBVIE$$60$YR$$F$Y$$$20240902$$CN$DE$DE
242723111$24272311$1$I$$20240828$20240902$20240902$PER$$US-CHATTEMPRD-2024OHG030169$CHATTEM$$$$$$Y$$$20240902$$CN$US$US
242723121$24272312$1$I$$20240822$20240902$20240902$PER$$US-BAUSCHBL-2024BNL031388$BAUSCH AND LOMB$$$$$$Y$$$20240902$$CN$US$US
242723131$24272313$1$I$20240801$20240823$20240902$20240902$30DAY$$US-GSK-US2024105528$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$CN$US$US
242723142$24272314$2$F$$20240823$20240902$20240906$EXP$$CA-UCBSA-2024042517$UCB$$$$$M$Y$$$20240906$$CN$CA$CA
242723151$24272315$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-080328-2024$RECKITT BENCKISER$$$$$F$Y$$$20240902$$CN$US$US
242723161$24272316$1$I$$20240813$20240902$20240902$PER$$US-TEVA-VS-3234302$TEVA$$40$YR$$F$Y$$$20240902$$CN$US$US
242723171$24272317$1$I$$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024171617$AMGEN$$$$$M$Y$130.16$KG$20240902$$CN$US$US
242723181$24272318$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173310$AMGEN$$$$$F$Y$$$20240902$$PH$US$US
242723201$24272320$1$I$$20240826$20240902$20240902$EXP$$JP-ROCHE-10000066605$ROCHE$Imamura Y, Kato T, Nomata Y, Okado S, Watanabe H, Kawasumi Y, et al. Efficacy of Immune Checkpoint Inhibitors in Postoperative Recurrence of Wild-type EGFR Non-Small Cell Lung Cancer. Anticancer Research. 2024-Aug;44 (8):3451-3461. doi:10.21873/anticanres.17165.$$$$$Y$$$20240902$$HP$JP$JP
242723211$24272321$1$I$20190101$20240828$20240902$20240902$EXP$$US-ABBVIE-5900966$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242723221$24272322$1$I$$20240823$20240902$20240902$EXP$$GB-MSNLABS-2024MSNSPO01874$MSN LABORATORIES$$$$$$Y$$$20240902$$MD$GB$GB
242723231$24272323$1$I$$20240821$20240902$20240902$EXP$$JP-NOVOPROD-1235500$NOVO NORDISK$S.Hirano et.al. A patient with type II diabetes mellitus testing positive for insulin antibodies with high binding capacity and low affinity, who improved hypoglycaemia and the characteristics of the antibodies through treatment with steroid. Diabetes/The 67th Annual Scientific Meeting of the Japanese Diabetes Association. 2024$79$YR$$F$Y$$$20240902$$MD$JP$JP
242723241$24272324$1$I$$20240822$20240902$20240902$EXP$$CA-APOTEX-2024AP009724$APOTEX$$57$YR$$F$Y$$$20240902$$HP$CA$CA
242723251$24272325$1$I$20230801$20240827$20240902$20240902$EXP$$NVSC2024CN175191$NOVARTIS$$53$YR$$F$Y$53$KG$20240902$$HP$CN$CN
242723261$24272326$1$I$$20240827$20240902$20240902$EXP$$GB-AMGEN-GBRSP2024173044$AMGEN$$70$YR$E$M$Y$$$20240902$$CN$GB$GB
242723281$24272328$1$I$$20240827$20240902$20240902$PER$$US-CHATTEMPRD-2024OHG029970$CHATTEM$$$$$$Y$$$20240902$$CN$US$US
242723291$24272329$1$I$$20240826$20240902$20240902$EXP$$FR-GSK-FR2024106062$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$FR$FR
242723301$24272330$1$I$$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196561$ASTRAZENECA$$$$$$Y$$$20240902$$MD$US$
242723312$24272331$2$F$$20240826$20240902$20240917$PER$$US-AstraZeneca-2024A194698$ASTRAZENECA$$56$YR$$F$Y$$$20240918$$CN$US$
242723321$24272332$1$I$$20240829$20240902$20240902$EXP$$US-AstraZeneca-2024A197940$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242723342$24272334$2$F$20240813$20240917$20240902$20240923$EXP$$CO-JNJFOC-20240866457$JOHNSON AND JOHNSON$$32$YR$A$M$Y$57$KG$20240923$$HP$CO$CO
242723351$24272335$1$I$$20240829$20240902$20240902$EXP$$US-JNJFOC-20240877635$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242723361$24272336$1$I$$20240828$20240902$20240902$EXP$$CN-ABBVIE-5902877$ABBVIE$$$$$$Y$$$20240902$$MD$CN$CN
242723371$24272337$1$I$20240816$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138507$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240902$$CN$US$US
242723381$24272338$1$I$20230101$20240823$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135606$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240902$$CN$US$US
242723391$24272339$1$I$$20240828$20240902$20240902$PER$$US-MSNLABS-2024MSNSPO01897$MSN LABORATORIES$$$$$$Y$$$20240902$$CN$US$US
242723401$24272340$1$I$20240801$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138548$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240902$$HP$US$US
242723411$24272341$1$I$$20240828$20240902$20240902$EXP$$US-ALXN-202408USA002075US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240902$$CN$US$US
242723421$24272342$1$I$20070301$20240823$20240902$20240902$EXP$$SE-ROCHE-10000070017$ROCHE$$45$YR$A$F$Y$$$20240902$$MD$SE$SE
242723431$24272343$1$I$20240705$20240826$20240902$20240902$EXP$FR-AFSSAPS-LM2024000469$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08048$HIKMA$$$$$$Y$$$20240902$$MD$FR$FR
242723441$24272344$1$I$$20240821$20240902$20240902$PER$$US-SA-2024SA253107$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240902$$MD$US$US
242723451$24272345$1$I$20240814$20240821$20240902$20240902$PER$$US-SA-2024SA253201$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240902$$MD$US$US
242723461$24272346$1$I$$20240829$20240902$20240902$PER$$US-ABBVIE-5902143$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242723471$24272347$1$I$20240501$20240820$20240902$20240902$PER$$US-SA-2024SA250443$SANOFI AVENTIS$$34$YR$A$F$Y$66.22$KG$20240902$$MD$US$US
242723481$24272348$1$I$20240818$20240826$20240902$20240902$EXP$SE-SEMPA-2024-006283$SE-STRIDES ARCOLAB LIMITED-2024SP010855$STRIDES$$88$YR$$F$Y$$$20240902$$MD$SE$SE
242723491$24272349$1$I$$20240827$20240902$20240902$PER$$US-SA-2024SA251926$SANOFI AVENTIS$$$$A$F$Y$$$20240902$$CN$US$US
242723501$24272350$1$I$20240101$20240823$20240902$20240902$PER$$US-SA-2024SA253383$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240902$$CN$US$US
242723511$24272351$1$I$20240801$20240827$20240902$20240902$PER$$PR-SA-2024SA252215$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240902$$CN$US$PR
242723522$24272352$2$F$$20240916$20240902$20240930$PER$$US-SA-2024SA253164$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240930$$HP$US$US
242723531$24272353$1$I$$20240829$20240902$20240902$PER$$US-SA-2024SA253501$SANOFI AVENTIS$$3$YR$C$F$Y$15$KG$20240902$$CN$US$US
242723541$24272354$1$I$$20240822$20240902$20240902$PER$$US-SA-2024SA251224$SANOFI AVENTIS$$$$$$Y$$$20240902$$HP$US$US
242723551$24272355$1$I$20240829$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174040$AMGEN$$45$YR$A$M$Y$$$20240902$$HP$US$US
242723571$24272357$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-080423-2024$RECKITT BENCKISER$$$$$F$Y$$$20240902$$CN$US$US
242723581$24272358$1$I$$20240805$20240902$20240902$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004388$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242723603$24272360$3$F$20240820$20240905$20240902$20240910$30DAY$$US-AMGEN-USASP2024166835$AMGEN$$49$YR$A$M$Y$104.31$KG$20240910$$HP$US$US
242723612$24272361$2$F$20240829$20240902$20240902$20240903$PER$$US-AMGEN-USASP2024174496$AMGEN$$35$YR$A$F$Y$$$20240902$$CN$US$US
242723621$24272362$1$I$20240826$20240826$20240902$20240902$PER$$US-AMGEN-USASP2024171000$AMGEN$$$$$$Y$$$20240902$$PH$US$US
242723631$24272363$1$I$20240101$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018824$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$US$US
242723641$24272364$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000112$ELI LILLY AND CO$$$$$$Y$$$20240902$$CN$US$US
242723651$24272365$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018959$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240902$$CN$US$US
242723661$24272366$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019007$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240902$$CN$US$US
242723671$24272367$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018993$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240902$$CN$US$US
242723681$24272368$1$I$20240701$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018952$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240902$$CN$US$US
242723691$24272369$1$I$20240829$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018974$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240902$$CN$US$US
242723701$24272370$1$I$$20240821$20240902$20240902$PER$$US-JNJFOC-20240858998$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242723711$24272371$1$I$$20240820$20240902$20240902$EXP$$MX-TAKEDA-2024TUS087619$TAKEDA$$63$YR$$F$Y$58$KG$20240902$$CN$MX$MX
242723731$24272373$1$I$20240825$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138662$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240902$$CN$US$US
242723741$24272374$1$I$20240101$20240822$20240902$20240902$PER$$US-ABBVIE-5893173$ABBVIE$$$$$F$Y$$$20240902$$HP$US$US
242723751$24272375$1$I$20240101$20240813$20240902$20240902$PER$$US-TEVA-VS-3231989$TEVA$$73$YR$$F$Y$$$20240902$$PH$US$US
242723761$24272376$1$I$$20240823$20240902$20240902$EXP$$US-ROCHE-3292210$ROCHE$$54$YR$A$F$Y$$$20240902$$CN$US$US
242723771$24272377$1$I$20240810$20240822$20240902$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-042755$AUROBINDO$$14$YR$$M$Y$42$KG$20240902$$MD$FR$FR
242723781$24272378$1$I$20240811$20240821$20240902$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-042470$AUROBINDO$$67$YR$$M$Y$$$20240902$$MD$FR$FR
242723792$24272379$2$F$20240826$20240903$20240902$20240906$PER$$US-AMGEN-USASP2024170711$AMGEN$$$$$F$Y$$$20240906$$PH$US$US
242723801$24272380$1$I$20240828$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173263$AMGEN$$$$$$Y$$$20240902$$HP$US$US
242723821$24272382$1$I$$20240822$20240902$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-042707$AUROBINDO$Beurier P, Dallevet CA, Brissot E, Cholet C, Santin A, Lionnet F, et al.. Hematopoietic stem cell allograft remission of periarteritis nodosa associated with azacytidine-refractory myelodysplastic syndrome. The Review of Internal Medicine. 2024;45:512-515$32$YR$$M$Y$$$20240902$$HP$FR$FR
242723831$24272383$1$I$20211118$20240621$20240902$20240902$EXP$$CA-CELLTRION INC.-2021CA019691$CELLTRION$$$$$$Y$$$20240902$$CN$CA$CA
242723851$24272385$1$I$$20240827$20240902$20240902$EXP$$US-AstraZeneca-2024A195551$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$US$
242723861$24272386$1$I$20240819$20240822$20240902$20240902$EXP$$IT-AUROBINDO-AUR-APL-2024-042603$AUROBINDO$$60$YR$$F$Y$$$20240902$$MD$IT$IT
242723871$24272387$1$I$20240815$20240821$20240902$20240902$EXP$$IT-AUROBINDO-AUR-APL-2024-042462$AUROBINDO$$82$YR$$M$Y$$$20240902$$MD$IT$IT
242723881$24272388$1$I$20240816$20240822$20240902$20240902$EXP$CN-NMPACDR-4403051004695202400761$CN-BAXTER-2024BAX023738$BAXTER$$42$YR$$F$Y$59.4$KG$20240902$$MD$CN$CN
242723892$24272389$2$F$20240101$20240909$20240902$20240910$PER$$US-JNJFOC-20240860005$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240910$$CN$US$US
242723901$24272390$1$I$20240731$20240826$20240902$20240902$EXP$$CN-JNJFOC-20240875976$JOHNSON AND JOHNSON$$3$YR$C$M$Y$15.2$KG$20240902$$HP$CN$CN
242723911$24272391$1$I$$20240822$20240902$20240902$EXP$$DE-AUROBINDO-AUR-APL-2024-042886$AUROBINDO$STRATMANN J, GUNDERMANN S, GEISEN C, ALEXANDRA D, MIESBACH W.. LONG-TERM REMISSION OF ACQUIRED VON-WILLEBRAND^S DISEASE AND PLATELET DYSFUNCTION AFTER HIGH-DOSE MELPHALAN IN A PATIENT WITH MULTIPLE MYELOMA.. INTERNATIONAL JOURNAL OF HEMATOLOGY-ONCOLOGY AND STEM CELL RESEARCH.. 2019;13(1):7-11$62$YR$$M$Y$65$KG$20240902$$HP$DE$DE
242723921$24272392$1$I$$20240821$20240902$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-042876$AUROBINDO$$$$$M$Y$$$20240902$$CN$US$US
242723931$24272393$1$I$20240828$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172739$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242723951$24272395$1$I$$20231005$20240902$20240902$PER$$CA-AUROBINDO-AUR-APL-2023-063055$AUROBINDO$$76$YR$$F$Y$$$20240902$$CN$CA$US
242723961$24272396$1$I$20230401$20230810$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2023-054231$AUROBINDO$$$$$F$Y$$$20240902$$CN$US$US
242723971$24272397$1$I$$20231102$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2023-058901$AUROBINDO$$57$YR$$F$Y$$$20240902$$CN$US$US
242723981$24272398$1$I$$20230828$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2023-056945$AUROBINDO$$73$YR$$F$Y$$$20240902$$MD$US$US
242723992$24272399$2$F$20240807$20240828$20240902$20240906$EXP$$DE-AUROBINDO-AUR-APL-2024-042669$AUROBINDO$$67$YR$$M$Y$$$20240906$$MD$DE$DE
242724001$24272400$1$I$$20240108$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2024-001755$AUROBINDO$$$$$F$Y$127$KG$20240902$$CN$US$US
242724011$24272401$1$I$$20240829$20240902$20240902$EXP$$US-ABBVIE-5902661$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242724021$24272402$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138004$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240902$$CN$US$US
242724031$24272403$1$I$$20240821$20240902$20240902$PER$$US-P+L Developments of Newyork Corporation-2161083$PL DEVELOPMENTS$$$$$F$Y$$$20240902$$$US$US
242724041$24272404$1$I$$20240830$20240902$20240902$EXP$$CA-GILEAD-2024-0685885$GILEAD$$51$YR$A$F$Y$$$20240902$$PH$CA$CA
242724052$24272405$2$F$$20240916$20240902$20240921$EXP$$US-ROCHE-10000068255$ROCHE$$$$$$Y$$$20240921$$CN$US$US
242724061$24272406$1$I$$20240326$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2024-015486$AUROBINDO$$$$$M$Y$$$20240902$$CN$US$US
242724072$24272407$2$F$20240101$20240903$20240902$20240916$EXP$$GB-UCBSA-2024042250$UCB$$$$$M$Y$$$20240916$$CN$GB$GB
242724081$24272408$1$I$$20240227$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2024-010750$AUROBINDO$$75$YR$$M$Y$$$20240902$$CN$US$US
242724101$24272410$1$I$$20240511$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2024-017304$AUROBINDO$$$$$M$Y$$$20240902$$CN$US$US
242724112$24272411$2$F$20220624$20240828$20240902$20240906$EXP$$DE-AUROBINDO-AUR-APL-2024-042758$AUROBINDO$$$$A$F$Y$73$KG$20240906$$CN$DE$DE
242724121$24272412$1$I$20180101$20240811$20240902$20240902$PER$$US-AMGEN-USASP2024164909$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240902$$MD$US$US
242724132$24272413$2$F$$20240905$20240902$20240917$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001258$ALEMBIC$$$$$$Y$$$20240917$$CN$US$US
242724141$24272414$1$I$$20240828$20240902$20240902$PER$$US-HALEON-2194243$Haleon PLC$$$$$$Y$$$20240902$$CN$US$US
242724151$24272415$1$I$20240628$20240704$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2024-034238$AUROBINDO$$$$$F$Y$76.6$KG$20240902$$CN$US$US
242724162$24272416$2$F$20240601$20240905$20240902$20240917$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001259$ALEMBIC$$$$$$Y$$$20240917$$CN$US$US
242724191$24272419$1$I$20240808$20240826$20240902$20240902$EXP$$CN-ROCHE-10000066399$ROCHE$$59$YR$A$F$Y$85$KG$20240902$$HP$CN$CN
242724201$24272420$1$I$20240101$20240828$20240902$20240902$EXP$$US-ABBVIE-5899794$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242724211$24272421$1$I$$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135973$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240902$$CN$US$US
242724221$24272422$1$I$$20240820$20240902$20240902$PER$$US-JNJFOC-20240860248$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$CN$US$US
242724231$24272423$1$I$20240805$20240826$20240902$20240902$EXP$$CN-ROCHE-10000066636$ROCHE$$47$YR$A$F$Y$66$KG$20240902$$HP$CN$CN
242724242$24272424$2$F$$20240903$20240902$20240904$PER$$US-JNJFOC-20240900923$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242724252$24272425$2$F$20171012$20240912$20240902$20240918$EXP$$CA-TAKEDA-2017TUS020812$TAKEDA$$42$YR$$F$Y$$$20240918$$MD$CA$CA
242724261$24272426$1$I$20191101$20240822$20240902$20240902$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-136888$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240902$$MD$DE$DE
242724271$24272427$1$I$20221201$20240828$20240902$20240902$EXP$$US-ABBVIE-5899574$ABBVIE$$75$YR$$M$Y$$$20240902$$CN$US$US
242724281$24272428$1$I$$20240829$20240902$20240902$PER$$NVSC2024US175526$NOVARTIS$$$$$$Y$$$20240902$$CN$US$US
242724302$24272430$2$F$20240101$20240911$20240902$20240916$EXP$$AR-PUMA BIOTECHNOLOGY, INC.-2024-PUM-AR001162$PUMA$$$$$$Y$$$20240916$$CN$AR$AR
242724311$24272431$1$I$20191129$20240822$20240902$20240902$EXP$$US-TEVA-2020-US-1805129$TEVA$$75$YR$$M$Y$$$20240902$$LW$US$US
242724322$24272432$2$F$$20240910$20240902$20240917$EXP$$JP-GSK-JP2024106448$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$JP$JP
242724332$24272433$2$F$$20240830$20240902$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004833$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
242724341$24272434$1$I$20240101$20240829$20240902$20240902$EXP$$US-ABBVIE-5901858$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242724351$24272435$1$I$$20240822$20240902$20240902$EXP$$US-GILEAD-2024-0685044$GILEAD$$$$I$F$Y$2.5$KG$20240902$$HP$US$US
242724361$24272436$1$I$$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196717$ASTRAZENECA$$$$$$Y$$$20240902$$HP$US$
242724371$24272437$1$I$20240101$20240813$20240902$20240902$PER$$US-TEVA-VS-3235167$TEVA$$$$$M$Y$$$20240902$$CN$US$US
242724381$24272438$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000314$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240902$$CN$US$US
242724391$24272439$1$I$20240829$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000012$ELI LILLY AND CO$$51$YR$A$$Y$$$20240902$$CN$US$US
242724401$24272440$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018994$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240902$$HP$US$US
242724421$24272442$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000101$ELI LILLY AND CO$$$$$$Y$$$20240902$$CN$US$US
242724431$24272443$1$I$$20240826$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408016454$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240902$$CN$US$US
242724441$24272444$1$I$20240829$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018964$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240902$$CN$US$US
242724451$24272445$1$I$$20240823$20240902$20240902$EXP$$DE-JNJFOC-20240880827$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$HP$DE$DE
242724462$24272446$2$F$20240816$20240902$20240902$20240904$PER$$US-AMGEN-USASP2024173980$AMGEN$$71$YR$E$F$Y$$$20240904$$CN$US$US
242724471$24272447$1$I$$20240830$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138947$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240902$$CN$US$US
242724481$24272448$1$I$$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138642$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240902$$HP$US$US
242724492$24272449$2$F$20240601$20240909$20240902$20240913$EXP$$JP-TAKEDA-2024TJP011039$TAKEDA$$3$DEC$$F$Y$$$20240913$$MD$JP$JP
242724501$24272450$1$I$$20240822$20240902$20240902$EXP$$US-SPRINGWORKS THERAPEUTICS-SW-001955$SPRINGWORKS THERAPEUTIC$$60$YR$$F$Y$$$20240902$$MD$US$US
242724511$24272451$1$I$$20240829$20240902$20240902$EXP$$NVSC2024US175435$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
242724522$24272452$2$F$20231227$20240904$20240902$20240905$EXP$$IN-SANDOZ INC.-SDZ2024IN076795$SANDOZ$$$$$$Y$$$20240905$$CN$IN$IN
242724531$24272453$1$I$$20240829$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076640$SANDOZ$$$$$$Y$$$20240902$$CN$US$US
242724541$24272454$1$I$$20240827$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US075824$SANDOZ$$$$$$Y$$$20240902$$CN$US$US
242724552$24272455$2$F$20240601$20240828$20240902$20240906$EXP$$ES-AUROBINDO-AUR-APL-2024-042741$AUROBINDO$$39$YR$$F$Y$$$20240906$$CN$ES$ES
242724571$24272457$1$I$$20240830$20240902$20240902$PER$$US-BAUSCH-BL-2024-013119$BAUSCH AND LOMB$$42$YR$$F$Y$$$20240902$$CN$US$US
242724581$24272458$1$I$20240801$20240827$20240902$20240902$PER$$US-BAUSCH-BL-2024-012976$BAUSCH AND LOMB$$$$$F$Y$$$20240902$$CN$US$US
242724591$24272459$1$I$$20240829$20240902$20240902$EXP$$PK-BAUSCH-BL-2024-013030$BAUSCH AND LOMB$Waheed A, Wong C, Zhu X, Yip E, Powell K, Tankel K, Paulson K, Heikal A, Murland S, Ghosh S, Elangovan A, Abraham A, Severin D, Usmani N, Joseph K. Sharing Mono-Institutional Experience of Treating Pancreatic Cancer With Stereotactic Body Radiation Therapy (SBRT) as an Adjuvant Therapy for Non operative Patients or Salvaging Local Failure. Cureus. 2023 SEP 19;15(9):1-2.$$$$$Y$$$20240902$$MD$PK$PK
242724601$24272460$1$I$$20240831$20240902$20240902$EXP$$DE-BAUSCH-BL-2024-013142$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240902$$MD$DE$DE
242724611$24272461$1$I$$20240826$20240902$20240902$EXP$$AT-BAUSCH-BL-2024-013048$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240902$$HP$AT$AT
242724621$24272462$1$I$$20240822$20240902$20240902$EXP$$US-APOTEX-2024AP010049$APOTEX$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73 (200):1-9$60$YR$$F$Y$$$20240902$$HP$US$US
242724632$24272463$2$F$20220902$20240926$20240902$20240930$EXP$$JP-TAKEDA-2024TJP012710$TAKEDA$$14$YR$$M$Y$36.2$KG$20240929$$MD$JP$JP
242724641$24272464$1$I$20240101$20240820$20240902$20240902$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004492$PAREXEL$$$$$$Y$$$20240902$$CN$US$US
242724652$24272465$2$F$$20240909$20240902$20240917$EXP$$JP-UCBSA-2024042613$UCB$Nakata C, et al. A case of CACNA1A missense mutation with intractable epilepsy, behavior disorder and severe intellectual disability. Psychiatria et Neurologia Japonica. 2024;3:P40-6$3$DEC$$M$Y$$$20240917$$MD$JP$JP
242724661$24272466$1$I$$20240821$20240902$20240902$PER$$US-P+L Developments of Newyork Corporation-2161084$PL DEVELOPMENTS$$$$$F$Y$$$20240902$$$US$US
242724671$24272467$1$I$$20240823$20240902$20240902$EXP$$US-APOTEX-2024AP010012$APOTEX$Reinfeld S, Gill P. Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: a case series. CNS Spectrums. 2022;28:587-591$15$YR$$M$Y$$$20240902$$HP$US$US
242724681$24272468$1$I$$20240828$20240902$20240902$EXP$$US-AMGEN-USASP2024172671$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242724691$24272469$1$I$$20240827$20240902$20240902$EXP$$US-ROCHE-10000067890$ROCHE$$61$YR$A$F$Y$$$20240902$$HP$US$US
242724701$24272470$1$I$20240815$20240829$20240902$20240902$EXP$$US-ABBVIE-5901718$ABBVIE$$72$YR$$F$Y$$$20240902$$CN$US$US
242724711$24272471$1$I$20240808$20240826$20240902$20240902$EXP$$IT-AUROBINDO-AUR-APL-2024-043080$AUROBINDO$$80$YR$$F$Y$63$KG$20240902$$MD$IT$IT
242724721$24272472$1$I$20240819$20240826$20240902$20240902$PER$$US-JNJFOC-20240867296$JOHNSON AND JOHNSON$$78$YR$E$$Y$$$20240902$$HP$US$US
242724732$24272473$2$F$20240101$20240826$20240902$20240916$PER$$US-JNJFOC-20240873626$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$US$US
242724741$24272474$1$I$$20240826$20240902$20240902$PER$$US-ABBVIE-5898749$ABBVIE$$$$$$Y$$$20240902$$HP$US$US
242724751$24272475$1$I$$20240808$20240902$20240902$PER$$US-BEIGENE-BGN-2024-012543$BEIGENE$$$$$$Y$$$20240902$$CN$US$US
242724761$24272476$1$I$$20240807$20240902$20240902$PER$$US-BEIGENE-BGN-2024-012458$BEIGENE$$$$$$Y$$$20240902$$CN$US$US
242724771$24272477$1$I$20240801$20240829$20240902$20240902$EXP$$NVSC2024IE174872$NOVARTIS$$$$$F$Y$$$20240902$$HP$IE$IE
242724791$24272479$1$I$$20240821$20240902$20240902$PER$$US-ROCHE-10000063270$ROCHE$$$$E$F$Y$$$20240902$$CN$US$US
242724801$24272480$1$I$$20240820$20240902$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-042309$AUROBINDO$Wynn CW, Burg G, George A, Sawnani H. Persistent Air Leak Treated With Endobronchial Valve in an Adolescent With Hyper-IgE Syndrome. Am-J-Respir-Crit-Care-Med. 2023;207:A2639$15$YR$$F$Y$$$20240902$$HP$US$US
242724811$24272481$1$I$20240827$20240830$20240902$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA076826$SANDOZ$$82$YR$$F$Y$$$20240902$$HP$CA$CA
242724821$24272482$1$I$20240728$20240828$20240902$20240902$EXP$$CN-ABBVIE-5902128$ABBVIE$$28$YR$$F$Y$42$KG$20240902$$HP$CN$CN
242724832$24272483$2$F$$20240920$20240902$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137437$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240923$$CN$US$US
242724841$24272484$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138813$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240902$$CN$US$US
242724851$24272485$1$I$$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138612$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240902$$CN$US$US
242724861$24272486$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138675$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240902$$CN$US$US
242724871$24272487$1$I$$20240827$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137952$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240902$$CN$US$US
242724891$24272489$1$I$$20240820$20240902$20240902$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-111492$ZYDUS PHARM$Gupta D, Singh L, Kumar S, Singh K, Mendonca S, Chatterjee T.. Rare complications of heart transplant: Autopsy findings.. Indian Journal of Pathology and Microbiology. 2024;67(3):624-627$$$$$Y$$$20240902$$HP$IN$IN
242724911$24272491$1$I$20200601$20240827$20240902$20240902$EXP$$JP-AMGEN-JPNSP2024172893$AMGEN$$88$YR$E$F$Y$$$20240902$$MD$JP$JP
242724921$24272492$1$I$$20240824$20240902$20240902$EXP$$GB-TAKEDA-2024TUS073266$TAKEDA$$$$$M$Y$$$20240902$$CN$GB$GB
242724931$24272493$1$I$20240826$20240829$20240902$20240902$EXP$$CN-SANDOZ INC.-SDZ2024CN076480$SANDOZ$$79$YR$$F$Y$42$KG$20240902$$HP$CN$CN
242724941$24272494$1$I$20240812$20240813$20240902$20240902$PER$$US-UniquePharma-US-2024UPLSPO00031$UNIQUE PHARMACEUTICALS$$94$YR$E$F$Y$120$KG$20240902$$CN$US$US
242724951$24272495$1$I$$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196495$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$US$
242724961$24272496$1$I$$20240829$20240902$20240902$EXP$$US-AstraZeneca-2024A197585$ASTRAZENECA$$$$$M$Y$$$20240902$$MD$US$
242724971$24272497$1$I$20240820$20240828$20240902$20240902$EXP$$ZA-AstraZeneca-2024A196595$ASTRAZENECA$$54$YR$$M$Y$$$20240902$$CN$ZA$
242724981$24272498$1$I$20240827$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024174479$AMGEN$$65$YR$E$F$Y$$$20240902$$PH$US$US
242724991$24272499$1$I$20240812$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173806$AMGEN$$63$YR$A$F$Y$$$20240902$$CN$US$US
242725001$24272500$1$I$20240801$20240827$20240902$20240902$PER$$US-ABBVIE-5900382$ABBVIE$$$$A$M$Y$$$20240902$$HP$US$US
242725011$24272501$1$I$$20240827$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076097$SANDOZ$$$$$$Y$$$20240902$$CN$US$US
242725021$24272502$1$I$$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174279$AMGEN$$$$$$Y$$$20240902$$HP$US$US
242725031$24272503$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173861$AMGEN$$66$YR$E$M$Y$$$20240902$$PH$US$US
242725041$24272504$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173254$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242725051$24272505$1$I$20240820$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173877$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242725061$24272506$1$I$20240405$20240823$20240902$20240902$EXP$$US-ROCHE-10000065327$ROCHE$$79$YR$E$M$Y$$$20240902$$CN$US$US
242725071$24272507$1$I$20240807$20240826$20240902$20240902$EXP$$CN-AMGEN-CHNSP2024171842$AMGEN$$60$YR$A$M$Y$59$KG$20240902$$HP$CN$CN
242725082$24272508$2$F$20200101$20240904$20240902$20240916$EXP$$JP-TAKEDA-2024TUS087121$TAKEDA$$64$YR$$M$Y$$$20240916$$HP$JP$JP
242725092$24272509$2$F$20221201$20240902$20240902$20240909$EXP$$KR-ABBVIE-5901086$ABBVIE$$37$YR$$M$Y$88$KG$20240909$$MD$KR$KR
242725101$24272510$1$I$20231001$20240827$20240902$20240902$EXP$$IL-EMD Serono-2024046197$EMD SERONO INC$$71$YR$E$F$Y$$$20240902$$CN$IL$IL
242725111$24272511$1$I$$20240828$20240902$20240902$PER$$US-ABBVIE-5901195$ABBVIE$$$$$$Y$$$20240902$$HP$US$US
242725121$24272512$1$I$$20240822$20240902$20240902$EXP$$CA-APOTEX-2024AP009727$APOTEX$$$$$$Y$$$20240902$$CN$CA$CA
242725131$24272513$1$I$20240823$20240823$20240902$20240902$EXP$$US-GSK-US2024105477$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240902$$CN$US$US
242725142$24272514$2$F$$20240830$20240902$20240904$PER$$US-HALEON-2194615$Haleon PLC$$81$YR$$F$Y$$$20240904$$CN$US$US
242725152$24272515$2$F$20240815$20240903$20240902$20240910$PER$$US-AMGEN-USASP2024171124$AMGEN$$81$YR$E$M$Y$$$20240910$$HP$US$US
242725161$24272516$1$I$20240523$20240826$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408016233$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240902$$MD$US$US
242725171$24272517$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018822$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$US$US
242725181$24272518$1$I$$20240826$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408017030$ELI LILLY AND CO$$$$$M$Y$$$20240902$$CN$US$US
242725191$24272519$1$I$20240828$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018973$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240902$$CN$US$US
242725201$24272520$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019111$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240902$$HP$US$US
242725211$24272521$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019145$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240902$$PH$US$US
242725221$24272522$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019041$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240902$$CN$US$US
242725231$24272523$1$I$20240826$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018738$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240902$$CN$US$US
242725241$24272524$1$I$$20240816$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408011695$ELI LILLY AND CO$$$$A$F$Y$$$20240902$$CN$US$US
242725251$24272525$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019089$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240902$$CN$US$US
242725261$24272526$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000139$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240902$$CN$US$US
242725271$24272527$1$I$20240828$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018971$ELI LILLY AND CO$$40$YR$A$$Y$$$20240902$$CN$US$US
242725291$24272529$1$I$$20240827$20240902$20240902$EXP$$JP-ABBVIE-5903573$ABBVIE$$11$YR$$M$Y$$$20240902$$CN$JP$JP
242725301$24272530$1$I$$20240823$20240902$20240902$EXP$$AE-NOVAST LABORATORIES INC.-2024NOV000292$NOVAST$Jumani A, Ibrahim H, Purra H, Alkhazraji AK, AlNajjar MS. Metformin-Induced Hemolysis in a Glucose-6- Phosphate Dehydrogenase-Deficient Patient: A Case Report. Cureus. 2024;16(7)$40$YR$$M$Y$$$20240902$$HP$AE$AE
242725311$24272531$1$I$$20240823$20240902$20240902$PER$$US-ABBVIE-5896076$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242725321$24272532$1$I$20240801$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138648$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240902$$CN$US$US
242725331$24272533$1$I$20240817$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138687$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240902$$CN$US$US
242725341$24272534$1$I$$20240731$20240902$20240902$EXP$$CA-AUROBINDO-AUR-APL-2024-013530$AUROBINDO$Albanese I, Nicolas N, Wing SS, Mitmaker E, Vautour L. A Curious Case Of Severe Reversible PTH-mediated Hypercalcemia Of Pregnancy. J-Endocr-Soc. 2023;7 (Suppl. 1):A265-A266$35$YR$$F$Y$$$20240902$$MD$CA$CA
242725352$24272535$2$F$20240101$20240904$20240902$20240905$PER$$US-JNJFOC-20240860310$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240905$$CN$US$US
242725362$24272536$2$F$20240731$20240913$20240902$20240919$30DAY$$US-AMGEN-USASP2024171267$AMGEN$$90$YR$E$M$Y$$$20240919$$HP$US$US
242725371$24272537$1$I$$20240820$20240902$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-042311$AUROBINDO$Barnes A, Restrepo VJ, Hansra B, Levenson J.. Immune Checkpoint Inhibitor Use Leading to Fulminant Myocarditis with Cardiogenic Shock: A Case Series.. US-Cardiol. 2024;18 (Suppl.)4:abstr. 12$62$YR$$F$Y$$$20240902$$HP$US$US
242725381$24272538$1$I$$20240821$20240902$20240902$EXP$$US-INSMED, INC.-2024-03402-US$INSMED$$$$$$Y$$$20240902$$CN$US$US
242725391$24272539$1$I$$20240822$20240902$20240902$EXP$$GB-AUROBINDO-AUR-APL-2024-042410$AUROBINDO$$45$YR$$$Y$$$20240902$$PH$GB$GB
242725402$24272540$2$F$$20240830$20240902$20240925$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004792$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
242725411$24272541$1$I$20240801$20240827$20240902$20240902$PER$$US-ABBVIE-5900556$ABBVIE$$$$A$M$Y$$$20240902$$HP$US$US
242725421$24272542$1$I$20240108$20240821$20240902$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-042268$AUROBINDO$$53$YR$$M$Y$64.7$KG$20240902$$MD$FR$FR
242725432$24272543$2$F$20240618$20240903$20240902$20240906$EXP$$AU-SANDOZ INC.-SDZ2024AU076305$SANDOZ$$8$YR$$F$Y$31$KG$20240906$$CN$AU$AU
242725441$24272544$1$I$$20240828$20240902$20240902$EXP$$NVSJ2024JP010161$NOVARTIS$$$$$$Y$$$20240902$$PH$JP$JP
242725451$24272545$1$I$$20240827$20240902$20240902$EXP$$CA-TAKEDA-2024TUS086342$TAKEDA$$$$$F$Y$$$20240902$$HP$CA$CA
242725461$24272546$1$I$20240101$20240826$20240902$20240902$EXP$$US-ABBVIE-5901477$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242725472$24272547$2$F$20240101$20240903$20240902$20240905$EXP$$ES-ABBVIE-5888059$ABBVIE$$$$$F$Y$$$20240905$$CN$ES$ES
242725481$24272548$1$I$20240101$20240827$20240902$20240902$EXP$$US-ABBVIE-5901048$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242725491$24272549$1$I$20230601$20240823$20240902$20240902$EXP$$US-ABBVIE-5898349$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242725501$24272550$1$I$$20240824$20240902$20240902$EXP$$US-JNJFOC-20240865677$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242725511$24272551$1$I$$20240828$20240902$20240902$EXP$$US-JNJFOC-20240880118$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$CN$US$US
242725521$24272552$1$I$$20240829$20240902$20240902$EXP$$CA-TAKEDA-2024TUS087684$TAKEDA$$$$$M$Y$$$20240902$$CN$CA$CA
242725531$24272553$1$I$$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174522$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242725542$24272554$2$F$$20240911$20240902$20240912$PER$$US-AMGEN-USASP2024174035$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
242725551$24272555$1$I$20240401$20240826$20240902$20240902$EXP$$CO-AMGEN-COLSL2024171893$AMGEN$$67$YR$E$F$Y$$$20240902$$CN$CO$CO
242725561$24272556$1$I$20180101$20240822$20240902$20240902$EXP$$DE-AUROBINDO-AUR-APL-2018-023503$AUROBINDO$$$$$F$Y$$$20240902$$CN$DE$DE
242725571$24272557$1$I$20210830$20240828$20240902$20240902$EXP$$US-ABBVIE-5900957$ABBVIE$$68$YR$$F$Y$$$20240902$$CN$US$US
242725583$24272558$3$F$20240822$20240916$20240902$20240923$30DAY$$US-AMGEN-USASL2024169167$AMGEN$$50$YR$A$F$Y$$$20240923$$PH$US$US
242725591$24272559$1$I$$20240822$20240902$20240902$EXP$GB-MHRA-MIDB-e67ea340-cc12-45d5-a6fd-8e42fe8a1b35$GB-RDY-SPO/GBR/24/0012397$DR REDDYS$$59$YR$A$F$Y$$$20240902$$PH$GB$GB
242725601$24272560$1$I$$20240822$20240902$20240902$EXP$$CA-APOTEX-2024AP009713$APOTEX$$69$YR$$F$Y$$$20240902$$PH$CA$CA
242725611$24272561$1$I$$20240828$20240902$20240902$PER$$US-ALXN-202408USA001937US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242725621$24272562$1$I$$20240828$20240902$20240902$EXP$$US-ABBVIE-5901108$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242725631$24272563$1$I$20240818$20240822$20240902$20240902$EXP$$IT-AUROBINDO-AUR-APL-2024-042614$AUROBINDO$$58$YR$$F$Y$$$20240902$$MD$IT$IT
242725641$24272564$1$I$20240101$20240828$20240902$20240902$EXP$$US-ABBVIE-5901058$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242725651$24272565$1$I$$20240827$20240902$20240902$EXP$$CA-TAKEDA-2024TUS086858$TAKEDA$$$$$F$Y$$$20240902$$MD$CA$CA
242725661$24272566$1$I$$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196254$ASTRAZENECA$$$$$$Y$$$20240902$$HP$US$
242725671$24272567$1$I$20240422$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196387$ASTRAZENECA$$29420$DY$$F$Y$$$20240902$$CN$US$
242725691$24272569$1$I$20240723$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196264$ASTRAZENECA$$27365$DY$$F$Y$$$20240902$$HP$US$
242725701$24272570$1$I$20240825$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196382$ASTRAZENECA$$30704$DY$$M$Y$$$20240902$$CN$US$
242725711$24272571$1$I$$20240826$20240902$20240902$EXP$$US-GSK-US2024AMR107976$GLAXOSMITHKLINE$$$$$M$Y$$$20240902$$CN$US$US
242725731$24272573$1$I$$20240828$20240902$20240902$PER$$US-ABBVIE-5899977$ABBVIE$$$$A$F$Y$$$20240902$$CN$US$US
242725741$24272574$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138705$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240902$$CN$US$US
242725761$24272576$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138356$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$72.12$KG$20240902$$HP$US$US
242725783$24272578$3$F$$20240923$20240902$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134291$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240925$$CN$US$US
242725791$24272579$1$I$20211111$20240806$20240902$20240902$EXP$$CA-CELLTRION INC.-2021CA019690$CELLTRION$$$$$$Y$$$20240902$$CN$CA$CA
242725812$24272581$2$F$$20240919$20240902$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134969$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240924$$CN$US$US
242725821$24272582$1$I$20240801$20240827$20240902$20240902$PER$$US-BIOGEN-2024BI01280234$BIOGEN$$37$YR$$F$Y$$$20240902$$CN$US$US
242725831$24272583$1$I$$20240718$20240902$20240902$PER$$US-AUROBINDO-AUR-APL-2024-037378$AUROBINDO$$63$YR$$M$Y$$$20240902$$CN$US$US
242725841$24272584$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-139180-2023$RECKITT BENCKISER$$$$$M$Y$$$20240902$$CN$US$US
242725851$24272585$1$I$20240809$20240820$20240902$20240902$EXP$$CA-CELLTRION INC.-2024CA020648$CELLTRION$$$$$$Y$$$20240902$$MD$CA$CA
242725861$24272586$1$I$$20240823$20240902$20240902$PER$$US-JNJFOC-20240861726$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$MD$US$US
242725871$24272587$1$I$$20240806$20240902$20240902$PER$$US-JNJFOC-20240817256$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240902$$CN$US$US
242725881$24272588$1$I$20240520$20240825$20240902$20240902$PER$$US-JNJFOC-20240868904$JOHNSON AND JOHNSON$$53$YR$A$$Y$$$20240902$$CN$US$US
242725891$24272589$1$I$$20240821$20240902$20240902$EXP$$CA-APOTEX-2024AP009306$APOTEX$$76$YR$$M$Y$$$20240902$$HP$CA$CA
242725901$24272590$1$I$$20240823$20240902$20240902$EXP$$FR-UNITED THERAPEUTICS-UNT-2024-018048$UNITED THERAPEUTICS$$71$YR$$$Y$75$KG$20240902$$MD$FR$FR
242725921$24272592$1$I$20240730$20240820$20240902$20240902$EXP$$US-UCBSA-2024042644$UCB$$70$YR$$F$Y$$$20240902$$HP$US$US
242725931$24272593$1$I$$20240829$20240902$20240902$EXP$$ZA-GILEAD-2024-0685798$GILEAD$$15$YR$T$F$Y$$$20240902$$HP$ZA$ZA
242725941$24272594$1$I$$20240329$20240902$20240902$EXP$$JP-TEVA-790217ROM$TEVA$Kano K, Sato T, Maezawa Y, Segami K, Nakajima T, Ikeda K, et al. [A Case of Synchronous Esophageal and Gastric Cancer Successfully Treated Using Multimodal Therapy]. Gan-To-Kagaku-Ryoho 2016;43(10):1262-1264.; Kano K, Sato T, Maezawa Y, Segami K, Nakajima T, Ikeda K, et al. [A Case of Synchronous Esophageal and Gastric Cancer Successfully Treated Using Multimodal Therapy]. Gan-To-Kagaku-Ryoho 2016;43(10):1262-1264.$65$YR$$M$Y$54$KG$20240902$$HP$JP$JP
242725952$24272595$2$F$$20240826$20240902$20240909$EXP$$PL-AUROBINDO-AUR-APL-2024-042509$AUROBINDO$$70$YR$$M$Y$$$20240909$$CN$PL$PL
242725961$24272596$1$I$$20240828$20240902$20240902$EXP$$US-AMGEN-USASP2024172476$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242725971$24272597$1$I$$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024171286$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242725981$24272598$1$I$20240826$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173435$AMGEN$$60$YR$A$F$Y$$$20240902$$CN$US$US
242725991$24272599$1$I$20240601$20240829$20240902$20240902$EXP$$US-ABBVIE-5901673$ABBVIE$$75$YR$$F$Y$$$20240902$$CN$US$US
242726001$24272600$1$I$20240826$20240827$20240902$20240902$EXP$$CO-UCBSA-2024044273$UCB$$87$YR$$M$Y$$$20240902$$CN$CO$CO
242726021$24272602$1$I$20240830$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000242$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240902$$CN$US$US
242726031$24272603$1$I$20240829$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018991$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240902$$CN$US$US
242726041$24272604$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018847$ELI LILLY AND CO$$62$YR$A$$Y$$$20240902$$CN$US$US
242726052$24272605$2$F$20240826$20240903$20240902$20240905$PER$$US-ALXN-202408USA002005US$ALEXION PHARMACEUTICALS$$77$YR$$F$Y$$$20240905$$CN$US$US
242726061$24272606$1$I$$20240828$20240902$20240902$EXP$$US-ABBVIE-5900021$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242726071$24272607$1$I$20240708$20240829$20240902$20240902$EXP$$US-ABBVIE-5902734$ABBVIE$$76$YR$$F$Y$$$20240902$$CN$US$US
242726081$24272608$1$I$20240518$20240829$20240902$20240902$EXP$$CA-ABBVIE-5882617$ABBVIE$$67$YR$$M$Y$81.1$KG$20240902$$MD$CA$CA
242726091$24272609$1$I$$20240822$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134538$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240902$$PH$US$US
242726102$24272610$2$F$20240813$20240920$20240902$20240925$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001730$BLUEPRINT MEDICINES$$55$YR$A$F$Y$$$20240925$$CN$US$US
242726121$24272612$1$I$$20240828$20240902$20240902$EXP$$US-JNJFOC-20240874550$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$HP$US$US
242726132$24272613$2$F$20240801$20240830$20240902$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004841$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240909$$CN$US$US
242726141$24272614$1$I$$20240808$20240902$20240902$PER$$US-JNJFOC-20240822938$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240902$$CN$US$US
242726153$24272615$3$F$20240825$20240919$20240902$20240925$EXP$$CA-ABBVIE-5901726$ABBVIE$$65$YR$$F$Y$$$20240925$$HP$CA$CA
242726161$24272616$1$I$$20240826$20240902$20240902$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024106067$VIIV$$$$$$Y$$$20240902$$CN$US$US
242726171$24272617$1$I$20240819$20240819$20240902$20240902$PER$$US-CSL-2024-007830$CSL Plasma$$24$YR$$M$Y$$$20240902$$HP$US$US
242726181$24272618$1$I$$20240829$20240902$20240902$EXP$$ZA-AstraZeneca-2024A197473$ASTRAZENECA$$23010$DY$$F$Y$$$20240902$$CN$ZA$
242726191$24272619$1$I$20240804$20240828$20240902$20240902$EXP$$CA-AstraZeneca-2024A197977$ASTRAZENECA$$23955$DY$$M$Y$$$20240902$$HP$CA$
242726201$24272620$1$I$20240528$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196763$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242726211$24272621$1$I$20240827$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A198454$ASTRAZENECA$$23470$DY$$M$Y$$$20240902$$CN$US$
242726221$24272622$1$I$$20240830$20240902$20240902$EXP$$VN-AstraZeneca-2024A198509$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$VN$
242726231$24272623$1$I$$20240829$20240902$20240902$EXP$$US-AstraZeneca-2024A197920$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$US$
242726241$24272624$1$I$$20240830$20240902$20240902$EXP$$US-AstraZeneca-2024A198399$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242726252$24272625$2$F$$20240919$20240902$20240920$EXP$DE-AUROBINDO-AUR-APL-2024-039772$DE-UCBSA-2024043220$UCB$$$$$$Y$$$20240920$$HP$DE$DE
242726262$24272626$2$F$$20240918$20240902$20240927$EXP$$US-TEVA-VS-3202783$TEVA$Siddiqui A, Agrawal S, Sekhri N. Fentanyl-Induced Serotonin Syndrome 5 Days after Cessation of Serotonergic Agents: A Case Report. A-A-Pract 2023; 17 (11): 1-; Siddiqui A, Agrawal S, Sekhri N. Fentanyl-Induced Serotonin Syndrome 5 Days after Cessation of Serotonergic Agents: A Case Report. A-A-Pract 2023; 17 (11): 1-3.; Siddiqui A, Agrawal S, Sekhri N. Fentanyl-Induced Serotonin Syndrome 5 Days after Cessation of Serotonergic Agents: A Case Report. A-A-Pract 2023; 17 (11): 1-3.$21$YR$$F$Y$$$20240927$$MD$US$US
242726271$24272627$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137613$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240902$$CN$US$US
242726281$24272628$1$I$$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138386$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240902$$CN$US$US
242726291$24272629$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139063$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240902$$CN$US$US
242726301$24272630$1$I$20240101$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138413$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$80$KG$20240902$$PH$US$US
242726311$24272631$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138677$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240902$$CN$US$US
242726321$24272632$1$I$$20240819$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132836$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$68.04$KG$20240902$$CN$US$US
242726331$24272633$1$I$20211101$20240826$20240902$20240902$EXP$$US-TAKEDA-2023TUS054563$TAKEDA$$33$YR$$M$Y$$$20240902$$CN$US$US
242726342$24272634$2$F$$20240902$20240902$20240905$EXP$$US-ABBVIE-5901206$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242726351$24272635$1$I$$20240822$20240902$20240902$EXP$$US-RDY-SPO/USA/24/0012556$DR REDDYS$Smith S, Grove D. Distal toxic acral erythema and mucositis secondary to 6-mercaptopurine in a thiopurine methyltransferase ^super shunter^. Pediatric Dermatology 41: 722-725, No. 4, 2024. doi:10.1111/pde.15589$4$YR$C$F$Y$$$20240902$$HP$US$US
242726361$24272636$1$I$$20240812$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08081$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242726371$24272637$1$I$$20240830$20240902$20240902$EXP$GB-MHRA-MED-202408292033091690-TLCWP$GB-ORGANON-O2408GBR002281$ORGANON$$76$YR$$F$Y$76$KG$20240902$$CN$GB$GB
242726381$24272638$1$I$20240807$20240822$20240902$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-042740$AUROBINDO$$91$YR$$M$Y$59$KG$20240902$$PH$FR$FR
242726391$24272639$1$I$20240101$20240828$20240902$20240902$EXP$$CA-ABBVIE-5900967$ABBVIE$$48$YR$$M$Y$$$20240902$$CN$CA$CA
242726401$24272640$1$I$$20240814$20240902$20240902$PER$$US-TEVA-VS-3234123$TEVA$$41$YR$$F$Y$$$20240902$$PH$US$US
242726411$24272641$1$I$20240625$20240827$20240902$20240902$EXP$$NVSC2024CN175205$NOVARTIS$$35$YR$$M$Y$96.2$KG$20240902$$HP$CN$CN
242726431$24272643$1$I$$20240819$20240902$20240902$EXP$$US-CIPLA (EU) LIMITED-2024US03894$CIPLA$Woods HB, Bharathdasan K, Yang M, Nichols J, Nugent K.. Delayed onset graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency virus: A case series.. The American Journal of the Medical Sciences.. 2024;367 (S1):S9 to S10$$$$$Y$$$20240902$$MD$US$US
242726441$24272644$1$I$$20240827$20240902$20240902$EXP$FI-FIMEA-202403033$FI-AMGEN-FINSP2024171060$AMGEN$$$$$$Y$$$20240902$$CN$FI$FI
242726451$24272645$1$I$20240708$20240827$20240902$20240902$EXP$$DE-AMGEN-DEUSP2024171054$AMGEN$$$$$M$Y$70$KG$20240902$$MD$DE$DE
242726461$24272646$1$I$20230831$20240830$20240902$20240902$EXP$$CA-ABBVIE-5903550$ABBVIE$$50$YR$$F$Y$$$20240902$$CN$CA$CA
242726471$24272647$1$I$20220504$20240821$20240902$20240902$EXP$$ES-AUROBINDO-AUR-APL-2024-042627$AUROBINDO$$$$E$M$Y$$$20240902$$MD$ES$ES
242726482$24272648$2$F$20210922$20240902$20240902$20240906$EXP$$NL-AMGEN-NLDSP2024169099$AMGEN$$75$YR$E$F$Y$98$KG$20240906$$HP$NL$NL
242726491$24272649$1$I$20240101$20240827$20240902$20240902$EXP$$US-ABBVIE-5709874$ABBVIE$$$$$M$Y$111$KG$20240902$$CN$US$US
242726501$24272650$1$I$$20240828$20240902$20240902$EXP$$DE-ROCHE-10000069170$ROCHE$$$$$F$Y$$$20240902$$CN$DE$DE
242726511$24272651$1$I$$20240827$20240902$20240902$EXP$$US-ROCHE-10000067909$ROCHE$$71$YR$E$$Y$$$20240902$$CN$US$US
242726521$24272652$1$I$20240824$20240829$20240902$20240902$EXP$$CN-ROCHE-10000069770$ROCHE$$54$YR$A$M$Y$65$KG$20240902$$HP$CN$CN
242726531$24272653$1$I$$20240823$20240902$20240902$EXP$$JP-ROCHE-10000069112$ROCHE$$67$YR$E$F$Y$$$20240902$$PH$JP$JP
242726541$24272654$1$I$20240619$20240822$20240902$20240902$EXP$$FR-AUROBINDO-AUR-APL-2024-042753$AUROBINDO$$45$YR$$M$Y$85.6$KG$20240902$$MD$FR$FR
242726551$24272655$1$I$$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136880$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$56.7$KG$20240902$$HP$US$US
242726561$24272656$1$I$$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137848$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240902$$CN$US$US
242726582$24272658$2$F$$20240909$20240902$20240917$EXP$$JP-AMGEN-JPNSP2024173689$AMGEN$$$$E$M$Y$$$20240917$$MD$JP$JP
242726603$24272660$3$F$$20240917$20240902$20240926$EXP$$JP-ROCHE-10000059872$ROCHE$$8$DEC$E$M$Y$$$20240926$$MD$JP$JP
242726621$24272662$1$I$$20240828$20240902$20240902$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001762$BLUEPRINT MEDICINES$$$$$M$Y$$$20240902$$CN$US$US
242726632$24272663$2$F$20240828$20240903$20240902$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001753$BLUEPRINT MEDICINES$$75$YR$E$F$Y$$$20240911$$CN$US$US
242726641$24272664$1$I$$20240826$20240902$20240902$PER$$US-JNJFOC-20240867250$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$MD$US$US
242726661$24272666$1$I$$20240812$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08104$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242726671$24272667$1$I$$20240821$20240902$20240902$EXP$$IN-DEXPHARM-2024-2953$DEXCEL$Anandan S, Rajendran SS, Somarajan SA, Udayan A. A Very Rare Side Effect of a Very Commonly Used Drug: Pantoprazole-induced Seizure. J Assoc Physicians India. 2024 Aug;72(8):89. doi: 10.59556/japi.72.0579.$69$YR$E$F$Y$$$20240902$$HP$IN$IN
242726681$24272668$1$I$$20240826$20240902$20240902$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024105999$VIIV$$$$$F$Y$$$20240902$$PH$US$US
242726691$24272669$1$I$20210615$20240823$20240902$20240902$EXP$PL-URPL-DML-MLP.4401.1.5017.2021$PL-ROCHE-10000064788$ROCHE$$62$YR$A$F$Y$79$KG$20240902$$MD$PL$PL
242726701$24272670$1$I$20240805$20240828$20240902$20240902$EXP$FR-AFSSAPS-LM2024000471$FR-ROCHE-10000068085$ROCHE$$15$YR$T$F$Y$49$KG$20240902$$MD$FR$FR
242726711$24272671$1$I$$20240821$20240902$20240902$EXP$$AU-ROCHE-10000063395$ROCHE$$20$YR$A$M$Y$$$20240902$$CN$AU$AU
242726721$24272672$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138431$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240902$$HP$US$US
242726731$24272673$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138559$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240902$$CN$US$US
242726741$24272674$1$I$$20240829$20240902$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA076556$SANDOZ$$33$YR$$M$Y$$$20240902$$CN$CA$CA
242726751$24272675$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138491$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240902$$CN$US$US
242726761$24272676$1$I$20240807$20240822$20240902$20240902$PER$$US-JNJFOC-20240859724$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240902$$CN$US$US
242726772$24272677$2$F$$20240829$20240902$20240912$EXP$$FR-JNJFOC-20240880729$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$MD$FR$FR
242726781$24272678$1$I$$20240823$20240902$20240902$EXP$$AE-ROCHE-10000065420$ROCHE$$48$YR$A$F$Y$$$20240902$$CN$AE$AE
242726791$24272679$1$I$$20240825$20240902$20240902$EXP$$GB-CELLTRION INC.-2024GB020639$CELLTRION$$$$$$Y$$$20240902$$CN$GB$GB
242726801$24272680$1$I$$20240830$20240902$20240902$30DAY$$US-UCBSA-2024029901$UCB$$$$$M$Y$240$KG$20240902$$CN$US$US
242726811$24272681$1$I$$20240826$20240902$20240902$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14652$DE-RDY-SPO/DEU/24/0012447$DR REDDYS$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. Alpha -Pyrrolidinohexanophenone (-PHP) vs. Alpha -pyrrolidinoisohexanophenone (-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313. doi:10.1093/jat/bkae011$39$YR$A$F$Y$$$20240902$$HP$DE$DE
242726821$24272682$1$I$$20240812$20240902$20240902$PER$$US-UniquePharma-US-2024UPLSPO00032$UNIQUE PHARMACEUTICALS$$28$YR$A$F$Y$190$KG$20240902$$CN$US$US
242726832$24272683$2$F$$20240828$20240902$20240905$PER$$US-AMGEN-USASP2024173114$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242726841$24272684$1$I$20240119$20240826$20240902$20240902$EXP$FR-AFSSAPS-RE2024000187$FR-RDY-SPO/FRA/24/0003579$DR REDDYS$$50$YR$A$F$Y$62$KG$20240902$$MD$FR$FR
242726851$24272685$1$I$$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174003$AMGEN$$71$YR$E$F$Y$$$20240902$$PH$US$US
242726861$24272686$1$I$$20240823$20240902$20240902$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010910$STRIDES$Kistler EA, Clinebell K, Gannon JM, Nathaniel VI, Lupu AM, Chengappa KNR.. Applying Shared Decision Making to the Process of Medication Deprescribing in Schizophrenia.. Clin-Ther. 2023;45 (10):1008-1011$$$$$Y$$$20240902$$MD$US$US
242726871$24272687$1$I$$20240823$20240902$20240902$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001736$BLUEPRINT MEDICINES$$$$$F$Y$$$20240902$$CN$US$US
242726881$24272688$1$I$$20240808$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08096$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242726891$24272689$1$I$$20240826$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018328$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240902$$CN$US$US
242726901$24272690$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000333$ELI LILLY AND CO$$$$$$Y$$$20240902$$CN$US$US
242726911$24272691$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018998$ELI LILLY AND CO$$86$YR$E$M$Y$$$20240902$$CN$US$US
242726921$24272692$1$I$20240828$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019020$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240902$$MD$US$US
242726931$24272693$1$I$20240506$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408017244$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240902$$CN$US$US
242726941$24272694$1$I$20240822$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000159$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240902$$CN$US$US
242726961$24272696$1$I$20240819$20240828$20240902$20240902$EXP$$IN-ROCHE-10000069534$ROCHE$$72$YR$E$M$Y$$$20240902$$CN$IN$IN
242726971$24272697$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138799$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240902$$CN$US$US
242726981$24272698$1$I$$20240823$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135209$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$136.98$KG$20240902$$CN$US$US
242726991$24272699$1$I$20240808$20240826$20240902$20240902$EXP$FR-AFSSAPS-TS2024000925$FR-BIOGEN-2024BI01280335$BIOGEN$$1$DY$$F$Y$$$20240902$$MD$FR$FR
242727001$24272700$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138512$BRISTOL MYERS SQUIBB$$15$YR$T$F$Y$$$20240902$$HP$US$US
242727011$24272701$1$I$$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137830$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240902$$MD$US$US
242727023$24272702$3$F$$20240921$20240902$20240930$EXP$$US-PADAGIS-2024PAD01402$PADAGIS$$$$$$Y$$$20240930$$CN$US$US
242727031$24272703$1$I$$20240829$20240902$20240902$EXP$GB-MHRA-MED-202408291332522860-HJTFM$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-138268$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$HP$GB$GB
242727041$24272704$1$I$20240821$20240822$20240902$20240902$EXP$$US-PADAGIS-2024PAD01398$PADAGIS$$$$$$Y$$$20240902$$CN$US$US
242727051$24272705$1$I$$20240821$20240902$20240902$EXP$$US-PADAGIS-2024PAD01384$PADAGIS$$$$$$Y$$$20240902$$MD$US$US
242727061$24272706$1$I$$20240822$20240902$20240902$EXP$$US-PADAGIS-2024PAD01396$PADAGIS$$$$$$Y$$$20240902$$MD$US$US
242727071$24272707$1$I$20240823$20240823$20240902$20240902$EXP$$US-PADAGIS-2024PAD01400$PADAGIS$$$$$$Y$$$20240902$$CN$US$US
242727081$24272708$1$I$20240827$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172008$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242727091$24272709$1$I$20240813$20240822$20240902$20240902$EXP$$US-PADAGIS-2024PAD01395$PADAGIS$$$$$$Y$$$20240902$$CN$US$US
242727121$24272712$1$I$$20240821$20240902$20240902$EXP$$US-PADAGIS-2024PAD01376$PADAGIS$Liao A., Fajoles-Vasseneix C., Rali A., Ward L., Fernandes A., Patel P.S et.al. Visual Morbidity and Outcomes of Scleritis Associated with Intraocular Inflammation Compared to Isolated Scleritis. Ocular Immunology and Inflammation. 2024;32(6):947-954$$$$$Y$$$20240902$$MD$US$US
242727131$24272713$1$I$$20240822$20240902$20240902$EXP$$CA-APOTEX-2024AP007466$APOTEX$$34$YR$$F$Y$$$20240902$$HP$CA$CA
242727142$24272714$2$F$$20240827$20240902$20240918$PER$$US-SA-2024SA253460$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240918$$CN$US$US
242727161$24272716$1$I$20240825$20240827$20240902$20240902$EXP$$PK-ROCHE-10000063218$ROCHE$$74$YR$E$$Y$$$20240902$$CN$PK$PK
242727171$24272717$1$I$20180626$20240827$20240902$20240902$EXP$$CA-TAKEDA-2019TUS005310$TAKEDA$$53$YR$$F$Y$$$20240902$$MD$CA$CA
242727181$24272718$1$I$$20240821$20240902$20240902$PER$$US-APOTEX-2024AP009756$APOTEX$Sunagawa SW, Havens JP, Podany A, Walker B, Scarsi KK, Bares SH.. Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case Report. Open Forum Infectious Diseases. 2023;10:1-3$49$YR$$M$Y$66.1$KG$20240902$$PH$US$US
242727191$24272719$1$I$$20240824$20240902$20240902$EXP$$IN-VANTIVE-2024VAN019365$Vantive US Healthcare$$13$YR$$F$Y$$$20240902$$CN$IN$IN
242727201$24272720$1$I$$20240827$20240902$20240902$EXP$$US-TAKEDA-2024TUS087460$TAKEDA$$$$$F$Y$$$20240902$$CN$US$US
242727221$24272722$1$I$20240816$20240823$20240902$20240902$EXP$$CN-REGENERON PHARMACEUTICALS, INC.-2024-117627$REGENERON$$43$YR$$M$Y$$$20240902$$HP$CN$CN
242727251$24272725$1$I$$20240822$20240902$20240902$EXP$$GB-SA-2024SA251231$SANOFI AVENTIS$$68$YR$E$M$Y$90$KG$20240902$$MD$GB$GB
242727272$24272727$2$F$$20240906$20240902$20240923$30DAY$$IE-BECTON DICKINSON-IE-BD-24-000511$BECTON DICKINSON$$$$$$Y$$$20240923$$PH$IE$IE
242727281$24272728$1$I$$20240827$20240902$20240902$EXP$$US-SHIRE-US201724906$TAKEDA$$$$$F$Y$$$20240902$$MD$US$US
242727291$24272729$1$I$$20240823$20240902$20240902$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010923$STRIDES$Wang L, CAI M, Huang Y, Xu P, Chen S, Zhao W.. Selinexor in Combination with Salvage Regimen for Refractory Peripheral T-Cell Lymphoma (PTCL) Patients.. Blood. 2023;142 (Suppl. 1):6211-6212$$$$$Y$$$20240902$$HP$CN$CN
242727301$24272730$1$I$20180523$20240819$20240902$20240902$EXP$DE-ROCHE-2669047$DE-DEXPHARM-2021-0401$DEXCEL$$52$YR$A$F$Y$62$KG$20240902$$HP$DE$DE
242727311$24272731$1$I$20240801$20240814$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08342$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242727322$24272732$2$F$$20240920$20240902$20240925$EXP$$DE-EXELIXIS-CABO-24081052$EXELIXIS$$$$$M$Y$$$20240925$$CN$DE$DE
242727331$24272733$1$I$$20240823$20240902$20240902$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP010925$STRIDES$Rupakumar T, Sankar A, Vijayasekharan K, VarikkattuRajendran P, ChellapanSojamani G, Rajeswari B, et al.. Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India.. Br-J-Haematol. 2024;220-228$$$C$$Y$$$20240902$$HP$IN$IN
242727342$24272734$2$F$20240807$20240910$20240902$20240925$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000512$BECTON DICKINSON$$$$$$Y$$$20240925$$CN$GB$GB
242727352$24272735$2$F$20240807$20240910$20240902$20240925$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000513$BECTON DICKINSON$$$$$$Y$$$20240925$$CN$GB$GB
242727361$24272736$1$I$20240326$20240608$20240902$20240902$PER$$US-ASTELLAS-2024US009997$ASTELLAS$$77$YR$E$M$Y$$$20240830$$CN$US$US
242727371$24272737$1$I$$20240822$20240902$20240902$PER$$US-AMGEN-USASP2024170835$AMGEN$$$$$$Y$$$20240902$$PH$US$US
242727381$24272738$1$I$$20240823$20240902$20240902$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP010926$STRIDES$Rupakumar T, Sankar A, Vijayasekharan K, VarikkattuRajendran P, ChellapanSojamani G, Rajeswari B, et al.. Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India.. Br-J-Haematol. 2024;220-228$$$C$$Y$$$20240902$$HP$IN$IN
242727391$24272739$1$I$20240810$20240822$20240902$20240902$EXP$$CN-SA-2024SA252740$SANOFI AVENTIS$$53$YR$A$F$Y$61$KG$20240902$$HP$CN$CN
242727401$24272740$1$I$20240101$20240829$20240902$20240902$EXP$$US-ABBVIE-5901894$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242727411$24272741$1$I$$20240823$20240902$20240902$EXP$$US-VIIV HEALTHCARE LIMITED-US2024105555$VIIV$$$$$M$Y$$$20240902$$CN$US$US
242727421$24272742$1$I$$20240828$20240902$20240902$EXP$$ZA-STRIDES ARCOLAB LIMITED-2024SP010882$STRIDES$$$$$$Y$$$20240902$$HP$ZA$ZA
242727431$24272743$1$I$$20240824$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135412$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$98.88$KG$20240902$$CN$US$US
242727441$24272744$1$I$$20240815$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130000$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240902$$CN$US$US
242727451$24272745$1$I$$20240826$20240902$20240902$EXP$$US-BIOGEN-2024BI01280242$BIOGEN$$$$$M$Y$$$20240902$$MD$US$US
242727461$24272746$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138896$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240902$$CN$US$US
242727471$24272747$1$I$20240723$20240823$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136122$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$63.5$KG$20240902$$HP$US$US
242727481$24272748$1$I$20210701$20240822$20240902$20240902$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-136052$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240902$$MD$DE$DE
242727491$24272749$1$I$$20240830$20240902$20240902$EXP$$US-ROCHE-10000071201$ROCHE$$66$YR$E$F$Y$$$20240902$$CN$US$US
242727501$24272750$1$I$$20240827$20240902$20240902$EXP$$VN-ROCHE-10000068926$ROCHE$$67$YR$E$F$Y$$$20240902$$MD$VN$VN
242727511$24272751$1$I$20240801$20240828$20240902$20240902$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001758$BLUEPRINT MEDICINES$$69$YR$E$M$Y$$$20240902$$CN$US$US
242727521$24272752$1$I$$20240819$20240902$20240902$PER$$US-SA-2024SA248356$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240902$$CN$US$US
242727531$24272753$1$I$20240801$20240820$20240902$20240902$PER$$US-SA-2024SA251932$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240902$$MD$US$US
242727541$24272754$1$I$20240801$20240820$20240902$20240902$PER$$US-SA-2024SA249706$SANOFI AVENTIS$$50$YR$A$F$Y$74.3$KG$20240902$$MD$US$US
242727561$24272756$1$I$$20240829$20240902$20240902$EXP$$CA-TAKEDA-2024TUS087729$TAKEDA$$$$$M$Y$$$20240902$$MD$CA$CA
242727571$24272757$1$I$$20240827$20240902$20240902$EXP$$CA-TAKEDA-2024TUS086888$TAKEDA$$$$C$$Y$$$20240902$$MD$CA$CA
242727581$24272758$1$I$$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A197159$ASTRAZENECA$$$$A$F$Y$65.8$KG$20240902$$CN$US$
242727591$24272759$1$I$$20240826$20240902$20240902$EXP$$ZA-AstraZeneca-2024A194585$ASTRAZENECA$$58$YR$$F$Y$$$20240902$$CN$ZA$
242727601$24272760$1$I$$20240829$20240902$20240902$PER$$US-SA-2024SA253153$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240902$$MD$US$US
242727612$24272761$2$F$20240101$20240903$20240902$20240924$PER$$US-SA-2024SA253145$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240924$$MD$US$US
242727621$24272762$1$I$$20240823$20240902$20240902$PER$$US-SA-2024SA253038$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240902$$MD$US$US
242727631$24272763$1$I$20240826$20240827$20240902$20240902$PER$$US-SA-2024SA251559$SANOFI AVENTIS$$76$YR$E$M$Y$71$KG$20240902$$CN$US$US
242727641$24272764$1$I$20240823$20240827$20240902$20240902$PER$$US-SA-2024SA253552$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240902$$CN$US$US
242727651$24272765$1$I$$20240826$20240902$20240902$EXP$$US-VIIV HEALTHCARE LIMITED-US2024106063$VIIV$$$$$$Y$$$20240902$$CN$US$US
242727672$24272767$2$F$20240601$20240906$20240902$20240912$30DAY$$US-AMGEN-USASP2024169368$AMGEN$$63$YR$A$F$Y$115$KG$20240911$$PH$US$US
242727682$24272768$2$F$20240807$20240910$20240902$20240925$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000514$BECTON DICKINSON$$$$$$Y$$$20240925$$CN$GB$GB
242727691$24272769$1$I$$20240820$20240902$20240902$EXP$$CN-TENSHI KAIZEN PRIVATE LIMITED-2024TK000075$TENSHI KAIZEN PRIVATE LIMITED$Xin H, Xiaoyun C, Yaping L, Xingkun L, Guiying Z, Ying Z, et al.. Efficacy and safety of dupilumab in the treatment of 123 cases of atopic dermatitis.. Chinese Journal of Dermatology. 2022;55 (6):486-493$4$YR$$F$Y$$$20240902$$HP$CN$CN
242727703$24272770$3$F$20240801$20240905$20240902$20240912$EXP$$JP-SANDOZ INC.-SDZ2024JP076298$SANDOZ$$$$$F$Y$$$20240912$$CN$JP$JP
242727711$24272771$1$I$$20240828$20240902$20240902$EXP$$IE-ROCHE-10000068549$ROCHE$$$$$F$Y$$$20240902$$CN$IE$IE
242727721$24272772$1$I$$20240830$20240902$20240902$PER$$US-ROCHE-10000071360$ROCHE$$74$YR$E$F$Y$$$20240902$$MD$US$US
242727731$24272773$1$I$$20240826$20240902$20240902$EXP$$CA-ROCHE-10000065847$ROCHE$$55$YR$A$M$Y$$$20240902$$HP$CA$CA
242727741$24272774$1$I$20240819$20240822$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408014439$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240902$$HP$US$US
242727751$24272775$1$I$20240201$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018927$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240902$$CN$US$US
242727761$24272776$1$I$20240801$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019178$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240902$$HP$US$US
242727771$24272777$1$I$20240501$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018679$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240902$$CN$US$US
242727782$24272778$2$F$$20240903$20240902$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408010609$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240905$$CN$US$US
242727791$24272779$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019039$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240902$$CN$US$US
242727801$24272780$1$I$$20240822$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408014689$ELI LILLY AND CO$$35$YR$A$$Y$$$20240902$$LW$US$US
242727811$24272781$1$I$20240701$20240827$20240902$20240902$EXP$ES-AEMPS-1562658$ES-REGENERON PHARMACEUTICALS, INC.-2024-116890$REGENERON$$72$YR$$M$Y$$$20240902$$MD$ES$ES
242727821$24272782$1$I$20240816$20240826$20240902$20240902$30DAY$$US-GSK-US2024106143$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240902$$CN$US$US
242727831$24272783$1$I$20240806$20240821$20240902$20240902$PER$$US-Nobelpharma America, LLC-NPA-2024-01458$NOBELPHARMA$$10$YR$C$M$Y$$$20240902$$PH$US$US
242727841$24272784$1$I$$20240819$20240902$20240902$PER$$US-Nobelpharma America, LLC-NPA-2024-01435$NOBELPHARMA$$$$$M$Y$$$20240902$$HP$US$US
242727862$24272786$2$F$20240713$20240829$20240902$20240903$PER$$US-BIOGEN-2024BI01273876$BIOGEN$$64$YR$$F$Y$$$20240903$$CN$US$US
242727871$24272787$1$I$$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-106233$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240902$$CN$US$US
242727881$24272788$1$I$$20240823$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135503$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240902$$MD$US$US
242727891$24272789$1$I$$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137874$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240902$$CN$US$US
242727901$24272790$1$I$20240820$20240820$20240902$20240902$PER$$US-CSL-2024-007769$CSL Plasma$$42$YR$$F$Y$$$20240902$$HP$US$US
242727912$24272791$2$F$$20240903$20240902$20240904$PER$$US-JNJFOC-20240900702$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242727921$24272792$1$I$20240121$20240829$20240902$20240902$EXP$FR-AFSSAPS-PV2024000795$FR-JNJFOC-20240881180$JOHNSON AND JOHNSON$$87$YR$E$F$Y$57$KG$20240902$$MD$FR$FR
242727931$24272793$1$I$$20240821$20240902$20240902$EXP$$DE-PDX-000387$PHARMADAX$Nagele H, Rosenkranz M, Nagele MP. Hyponatremia-Induced Epileptic Seizure Provoked by Levetiracetam and Pain Medication Intake in a Patient with Central Diabetes Insipidus. Case Rep Neurol. 2024 Jul 22;16(1):204-207. doi: 10.1159/000540320.$67$YR$E$M$Y$$$20240902$$HP$DE$DE
242727941$24272794$1$I$$20240825$20240902$20240902$EXP$$US-AMGEN-USASP2024171585$AMGEN$Garza-ramos C. D.; Silver C. R.; Stauffer J. A. et al.. lpilimumab and nivolumab plus radioembolization as salvage therapy for atezolizumab and bevacizumab refractory hepatocellular carcinoma resulting in complete pathologic response. Radiology Case Reports. 2024;19 (11):5024-5028$55$YR$A$F$Y$$$20240902$$MD$US$US
242727951$24272795$1$I$$20240502$20240902$20240902$PER$$US-ASTELLAS-2024US004246$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242727961$24272796$1$I$$20240828$20240902$20240902$EXP$$TH-SA-2024SA252678$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240902$$HP$TH$TH
242727972$24272797$2$F$$20240917$20240902$20240927$PER$$US-GSK-US2024AMR105808$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
242727981$24272798$1$I$$20240830$20240902$20240902$PER$$US-TAKEDA-2024TUS087583$TAKEDA$$$$$M$Y$$$20240902$$CN$US$US
242727991$24272799$1$I$20230101$20240813$20240902$20240902$30DAY$$CH-UCBSA-2024042623$UCB$$60$YR$$F$Y$$$20240902$$PH$CH$CH
242728003$24272800$3$F$$20240904$20240902$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138352$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240906$$CN$US$US
242728012$24272801$2$F$$20240911$20240902$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-042520$AUROBINDO$$67$YR$$M$Y$$$20240921$$MD$FR$FR
242728021$24272802$1$I$$20240830$20240902$20240902$EXP$$CA-GILEAD-2024-0685886$GILEAD$$68$YR$E$F$Y$44$KG$20240902$$PH$CA$CA
242728032$24272803$2$F$20220801$20240904$20240902$20240906$EXP$PT-INFARMED-T202408-622$PT-GILEAD-2024-0685882$GILEAD$$26$YR$A$M$Y$96$KG$20240906$$PH$PT$PT
242728041$24272804$1$I$$20240307$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089098$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728051$24272805$1$I$$20240125$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088680$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728061$24272806$1$I$20240116$20240329$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088949$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728071$24272807$1$I$20240219$20240315$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089101$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728081$24272808$1$I$$20240719$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092014$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728091$24272809$1$I$$20240605$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091449$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728101$24272810$1$I$$20240124$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088704$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728111$24272811$1$I$$20240606$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090521$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728121$24272812$1$I$$20240514$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090448$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728131$24272813$1$I$$20240416$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090312$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728141$24272814$1$I$$20240507$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090757$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728151$24272815$1$I$$20240220$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089064$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728161$24272816$1$I$20240725$20240821$20240902$20240902$EXP$$DE-AUROBINDO-AUR-APL-2024-042466$AUROBINDO$$67$YR$$F$Y$$$20240902$$MD$DE$DE
242728171$24272817$1$I$$20240618$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091071$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242728183$24272818$3$F$20240809$20240903$20240902$20240909$EXP$$NVSC2024AT175547$NOVARTIS$$$$A$F$Y$61$KG$20240909$$MD$AT$AT
242728191$24272819$1$I$$20240830$20240902$20240902$PER$$NVSC2024US175988$NOVARTIS$$$$$F$Y$$$20240902$$HP$US$US
242728201$24272820$1$I$20230712$20240829$20240902$20240902$EXP$FR-AFSSAPS-PA2023001726$FR-JNJFOC-20240882575$JOHNSON AND JOHNSON$$40$YR$A$M$Y$87$KG$20240902$$CN$FR$FR
242728211$24272821$1$I$$20240828$20240902$20240902$EXP$$ZA-AstraZeneca-2024A197586$ASTRAZENECA$$52$YR$$M$Y$$$20240902$$CN$ZA$
242728221$24272822$1$I$$20240825$20240902$20240902$EXP$$JP-GENMAB-2024-03095$GENMAB$$76$YR$$F$Y$$$20240902$$MD$JP$JP
242728231$24272823$1$I$20240827$20240829$20240902$20240902$PER$$US-AstraZeneca-2024A197967$ASTRAZENECA$$85$YR$$F$Y$$$20240902$$CN$US$
242728242$24272824$2$F$20240101$20240910$20240902$20240917$EXP$$JP-GENMAB-2024-03093$GENMAB$$62$YR$$M$Y$$$20240917$$MD$JP$JP
242728251$24272825$1$I$$20240827$20240902$20240902$PER$$US-AstraZeneca-2024A195905$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242728261$24272826$1$I$$20240821$20240902$20240902$PER$$US-AstraZeneca-2024A191555$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242728271$24272827$1$I$20240101$20240823$20240902$20240902$EXP$$US-SA-2024SA251906$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240902$$CN$US$US
242728281$24272828$1$I$20240819$20240820$20240902$20240902$EXP$$AU-BEH-2024177575$CSL BEHRING$$68$YR$E$F$Y$$$20240902$$MD$AU$AU
242728301$24272830$1$I$$20240819$20240902$20240902$EXP$$GB-UCBSA-2024042289$UCB$$$$$M$Y$$$20240902$$CN$GB$GB
242728311$24272831$1$I$20170701$20240829$20240902$20240902$PER$$US-SA-2024SA254458$SANOFI AVENTIS$$28$YR$A$M$Y$88.64$KG$20240902$$HP$US$US
242728322$24272832$2$F$20240801$20240914$20240902$20240918$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048452$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240918$$CN$US$US
242728331$24272833$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138829$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240902$$CN$US$US
242728341$24272834$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138389$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240902$$CN$US$US
242728361$24272836$1$I$20240819$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138231$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240902$$HP$US$US
242728372$24272837$2$F$$20240905$20240902$20240918$EXP$$NL-AUROBINDO-AUR-APL-2024-042780$AUROBINDO$Ghambari K, de Jong DM, Bruno MJ, Polak WG, van Driel LMJW, den Hoed CM. Risks of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis After Liver Transplantation. Clinical Transplantation. 2024;38(7):1-9$24$YR$$M$Y$$$20240918$$HP$NL$NL
242728381$24272838$1$I$$20240426$20240902$20240902$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445167$RANBAXY$$58$YR$$F$Y$$$20240902$$HP$US$US
242728401$24272840$1$I$20231201$20240829$20240902$20240902$EXP$$US-ROCHE-10000070341$ROCHE$$65$YR$E$M$Y$$$20240902$$CN$US$US
242728411$24272841$1$I$$20240827$20240902$20240902$EXP$$CA-JNJFOC-20240873413$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$CN$CA$CA
242728431$24272843$1$I$20240725$20240827$20240902$20240902$EXP$$JP-ROCHE-10000069848$ROCHE$$8$DEC$E$F$Y$$$20240902$$MD$JP$JP
242728441$24272844$1$I$$20240822$20240902$20240902$EXP$$GB-AUROBINDO-AUR-APL-2024-042408$AUROBINDO$$66$YR$$F$Y$60$KG$20240902$$MD$GB$GB
242728451$24272845$1$I$20240818$20240823$20240902$20240902$PER$$US-JNJFOC-20240865458$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242728461$24272846$1$I$20240829$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174095$AMGEN$$40$YR$A$F$Y$$$20240902$$CN$US$US
242728471$24272847$1$I$$20240822$20240902$20240902$EXP$$PT-ASPEN-GLO2024PT005844$ASPEN$Olimpia Varela, Bruna Malheiro, Ana Paula Castro, Jose Antonio Carvalho, Eliana Costa. Leucemia de plasmocitos - caso clinico (plasmocyte leukemia - clinical case). XIII CONGRESSO NACIONAL DE PATOLOGIA CLINICA (XIII NATIONAL CONGRESS OF CLINICAL$$$$$Y$$$20240902$$HP$PT$PT
242728481$24272848$1$I$$20240826$20240902$20240902$PER$$US-SA-2024SA253426$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240902$$CN$US$US
242728491$24272849$1$I$$20240829$20240902$20240902$EXP$$NVSC2024US175206$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
242728522$24272852$2$F$$20240917$20240902$20240927$PER$$US-GSK-US2024AMR106343$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
242728541$24272854$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076700$SANDOZ$$43$YR$$M$Y$$$20240902$$MD$US$US
242728551$24272855$1$I$20240205$20240827$20240902$20240902$EXP$GB-MHRA-MED-202408272236429120-LYCFW$GB-862174955-ML2024-04678$Unknown Manufacturer$$19$YR$A$F$Y$$$20240902$$CN$GB$GB
242728561$24272856$1$I$$20240827$20240902$20240902$EXP$US-MLMSERVICE-20240821-PI166205-00275-1$US-RDY-SPO/USA/24/0012593$DR REDDYS$Rink DE, Abramson RH, Johnson NJ, Lee RY. Diagnostic Confounders in Brain Death A Woman with Unexplained Coma and Brainstem Areflexia. Annals of the American Thoracic Society. 2024;21(8):1204-8. DOI: 10.1513/AnnalsATS.202403-232CC.$60$YR$A$F$Y$$$20240902$$MD$US$US
242728571$24272857$1$I$$20240828$20240902$20240902$EXP$GB-MHRA-MED-202408280906441100-ZYGRK$GB-862174955-ML2024-04689$Unknown Manufacturer$$$$$M$Y$$$20240902$$PH$GB$GB
242728591$24272859$1$I$20221227$20240826$20240902$20240902$EXP$$KR-AMGEN-KORSP2024173150$AMGEN$$86$YR$E$F$Y$56$KG$20240902$$HP$KR$KR
242728601$24272860$1$I$$20240829$20240902$20240902$EXP$$NVSC2024US175252$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
242728611$24272861$1$I$$20240827$20240902$20240902$EXP$$JP-009507513-2408JPN003636J$MERCK$$7$DEC$$M$Y$$$20240902$$PH$JP$JP
242728621$24272862$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000193$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240902$$CN$US$US
242728641$24272864$1$I$20240828$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000011$ELI LILLY AND CO$$25$YR$A$$Y$$$20240902$$CN$US$US
242728651$24272865$1$I$20240830$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000436$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240902$$CN$US$US
242728661$24272866$1$I$$20240823$20240902$20240902$EXP$$NL-AUROBINDO-AUR-APL-2024-042656$AUROBINDO$$82$YR$$M$Y$78$KG$20240902$$CN$NL$NL
242728681$24272868$1$I$20240717$20240830$20240902$20240902$EXP$$CN-ROCHE-10000070296$ROCHE$$72$YR$E$F$Y$$$20240902$$HP$CN$CN
242728691$24272869$1$I$20240101$20240819$20240902$20240902$EXP$$US-UCBSA-2024027678$UCB$$$$$F$Y$$$20240902$$HP$US$US
242728701$24272870$1$I$$20240820$20240902$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-042310$AUROBINDO$Khurshid A, Paranji S, Kapur R, Weber A, Cohen M, Vegunta R, et al. Outcomes of R-MPV followed by ara-c in primary central nervous system lymphoma: A single-center retrospective analysis. J-Clin-Oncol. 2024;42 (Suppl.):16$$$$$Y$$$20240902$$HP$US$US
242728711$24272871$1$I$20200706$20240828$20240902$20240902$EXP$$CO-UCBSA-2024044319$UCB$$71$YR$$F$Y$$$20240902$$CN$CO$CO
242728721$24272872$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138869$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240902$$CN$US$US
242728741$24272874$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138357$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240902$$CN$US$US
242728751$24272875$1$I$$20240829$20240902$20240902$EXP$$NVSC2024US175497$NOVARTIS$$$$$F$Y$$$20240902$$HP$US$US
242728762$24272876$2$F$$20240918$20240902$20240927$EXP$$US-TEVA-VS-3238221$TEVA$Acosta A, Venkatesh S, Elfessi Z. Spontaneous tumor lysis syndrome in the setting of Candida albicans Fungemia. Am-J-Emerg-Med 2023; 67 195.e5-195.e6.; Acosta A, Venkatesh S, Elfessi Z. Spontaneous tumor lysis syndrome in the setting of Candida albicans Fungemia. Am-J-Emerg-Med 2023; 67 195.e5-195.e6.$75$YR$$M$Y$$$20240927$$HP$US$US
242728771$24272877$1$I$20240101$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172768$AMGEN$$30$YR$A$F$Y$$$20240902$$CN$US$US
242728782$24272878$2$F$20240101$20240831$20240902$20240906$EXP$$CA-Orion Corporation ORION PHARMA-24_00031507$ORION$$67$YR$E$F$Y$$$20240906$$HP$CA$
242728791$24272879$1$I$20240819$20240820$20240902$20240902$EXP$$US-SERVIER-S24010650$SERVIER$$$$$$Y$$$20240902$$MD$US$US
242728801$24272880$1$I$$20240819$20240902$20240902$EXP$$JP-UCBSA-2024042358$UCB$$32$YR$$M$Y$$$20240902$$MD$JP$JP
242728811$24272881$1$I$$20240829$20240902$20240902$EXP$$US-JNJFOC-20240877319$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$HP$US$US
242728821$24272882$1$I$20240829$20240829$20240902$20240902$EXP$$IL-ABBVIE-5903524$ABBVIE$$62$YR$$M$Y$$$20240902$$MD$IL$IL
242728831$24272883$1$I$20240703$20240820$20240902$20240902$PER$$US-AstraZeneca-2024A153332$ASTRAZENECA$$27706$DY$$F$Y$$$20240902$$CN$US$
242728851$24272885$1$I$20230717$20240830$20240902$20240902$EXP$FR-AFSSAPS-NY2024000976$FR-ROCHE-10000070403$ROCHE$$74$YR$E$M$Y$86$KG$20240902$$PH$FR$FR
242728861$24272886$1$I$$20240822$20240902$20240902$EXP$$US-APOTEX-2024AP010051$APOTEX$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73 (200):1-9$69$YR$$M$Y$$$20240902$$HP$US$US
242728881$24272888$1$I$$20240823$20240902$20240902$EXP$$US-TEVA-VS-3236968$TEVA$$15$YR$$M$Y$70.17$KG$20240902$$PH$US$US
242728891$24272889$1$I$$20240826$20240902$20240902$EXP$$US-GSK-US2024105992$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
242728903$24272890$3$F$20240327$20240830$20240902$20240906$EXP$$CA-SA-2024SA125106$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240906$$HP$CA$CA
242728911$24272891$1$I$$20240823$20240902$20240902$EXP$$US-GSK-US2024105544$GLAXOSMITHKLINE$$$$$M$Y$$$20240902$$CN$US$US
242728922$24272892$2$F$20240804$20240820$20240902$20240913$PER$$US-RDY-CLI/USA/24/0012377$DR REDDYS$$20$YR$A$F$Y$$$20240913$$CN$US$US
242728931$24272893$1$I$20240809$20240827$20240902$20240902$EXP$FR-AFSSAPS-ST2024001355$FR-RDY-SPO/FRA/24/0012529$DR REDDYS$$84$YR$E$F$Y$60$KG$20240902$$MD$FR$FR
242728951$24272895$1$I$$20240821$20240902$20240902$PER$$US-RDY-CLI/USA/24/0012519$DR REDDYS$$$$$F$Y$14$KG$20240902$$CN$US$US
242728961$24272896$1$I$$20240827$20240902$20240902$EXP$US-MLMSERVICE-20240820-PI167714-00145-1$US-RDY-SPO/USA/24/0012600$DR REDDYS$Cowan M, Kumar P, McManus J, Bilodeau S, Beck A. A Case Report of Delayed Opioid Toxidrome After Administration of Naloxone. Clinical practice and cases in emergency medicine. 2024;8(3):222-5. DOI: 10.5811/cpcem.6622.$30$YR$A$M$Y$$$20240902$$MD$US$US
242728971$24272897$1$I$$20240821$20240902$20240902$EXP$$CA-AUROBINDO-AUR-APL-2024-042785$AUROBINDO$$38$YR$$F$Y$$$20240902$$CN$CA$CA
242728981$24272898$1$I$20240101$20240809$20240902$20240902$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004516$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240902$$CN$US$US
242728991$24272899$1$I$$20240828$20240902$20240902$PER$$US-ALXN-202408USA002028US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240902$$CN$US$US
242729001$24272900$1$I$$20240828$20240902$20240902$EXP$$FR-TAKEDA-2024TUS086778$TAKEDA$$$$N$M$Y$3.4$KG$20240902$$HP$FR$FR
242729011$24272901$1$I$20230811$20240821$20240902$20240902$EXP$$US-MPL-000057$MLV PHARMA$$87$YR$E$M$Y$$$20240823$$MD$US$US
242729021$24272902$1$I$$20240826$20240902$20240902$EXP$$TR-ROCHE-10000071291$ROCHE$$65$YR$E$F$Y$$$20240902$$CN$TR$TR
242729031$24272903$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000070205$ROCHE$$13$YR$T$F$Y$$$20240902$$CN$US$US
242729041$24272904$1$I$$20240814$20240902$20240902$EXP$$VN-ROCHE-10000070557$ROCHE$$40$YR$A$M$Y$$$20240902$$HP$VN$VN
242729051$24272905$1$I$20240808$20240826$20240902$20240902$EXP$$IE-JNJFOC-20240873109$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240902$$HP$IE$IE
242729062$24272906$2$F$20240809$20240926$20240902$20240928$PER$$US-JNJFOC-20240841519$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240928$$CN$US$US
242729071$24272907$1$I$20230101$20240827$20240902$20240902$PER$$US-SA-2024SA253654$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240902$$MD$US$US
242729081$24272908$1$I$20240820$20240820$20240902$20240902$PER$$US-CSL-2024-008020$CSL Plasma$$46$YR$$F$Y$$$20240902$$HP$US$US
242729091$24272909$1$I$$20240828$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076118$SANDOZ$$68$YR$$F$Y$$$20240902$$MD$US$US
242729101$24272910$1$I$20240829$20240830$20240902$20240902$PER$$US-ROCHE-10000071371$ROCHE$$53$YR$A$M$Y$109$KG$20240902$$HP$US$US
242729111$24272911$1$I$20230101$20240822$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134689$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240902$$CN$US$US
242729132$24272913$2$F$$20240827$20240902$20240909$EXP$$JP-UCBSA-2024030672$UCB$$41$YR$$$Y$$$20240909$$MD$JP$JP
242729141$24272914$1$I$$20240823$20240902$20240902$30DAY$$US-GSK-US2024AMR105803$GLAXOSMITHKLINE$$$$$M$Y$$$20240902$$CN$US$US
242729151$24272915$1$I$$20240827$20240902$20240902$EXP$$FR-AMGEN-FRASP2024172458$AMGEN$Vandenbos,F. Sarcoidosis-like disease probably induced by apremilast- A case report. Revue de Pneumologie Clinique. 2024;86:1-2$56$YR$A$M$Y$$$20240902$$HP$FR$FR
242729161$24272916$1$I$20240627$20240902$20240902$20240902$EXP$DK-DKMA-30737898$NVSC2024DK175966$NOVARTIS$$50$YR$$F$Y$70$KG$20240902$$MD$DK$DK
242729181$24272918$1$I$$20240827$20240902$20240902$EXP$$CN-ABBVIE-5898615$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240902$$HP$CN$CN
242729191$24272919$1$I$$20240827$20240902$20240902$EXP$$CN-ABBVIE-5898616$ABBVIE$Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, et al. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia. Leukemia Research. 2024;145:107564.$$$A$F$Y$$$20240902$$HP$CN$CN
242729211$24272921$1$I$20240818$20240902$20240902$20240902$EXP$IT-MINISAL02-1000599$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049012$BOEHRINGER INGELHEIM$$54$YR$A$M$Y$67$KG$20240902$$MD$IT$IT
242729221$24272922$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-082508-2024$RECKITT BENCKISER$$$$$F$Y$$$20240902$$CN$US$US
242729231$24272923$1$I$$20240822$20240902$20240902$EXP$$ES-ROCHE-10000064558$ROCHE$Esquirol A, Pascual M, Montoro J, Pinana J, Ferra C, Herruzo B, et al. Comparison of three strategies of GVHD prophylaxis after T-cell replete haploidentical hematopoietic transplantation: Tacrolimus vs. Calcineurin inhibitors-MMF Vs Sirolimus-MMF. Transplantation and cellular therapy. 2024; doi:10.1016/j.jtct.2024.07.027.$$$$$Y$$$20240902$$HP$ES$ES
242729241$24272924$1$I$$20240821$20240902$20240902$EXP$$US-DEXPHARM-2024-2952$DEXCEL$Patel, R.; Elghawy, O.; Gibbs, A.; Gupta, S.; Kaur, V.  A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer Reports 2024, V7, Pe2110$84$YR$E$M$Y$$$20240902$$HP$US$US
242729251$24272925$1$I$20230801$20240826$20240902$20240902$EXP$$JP-CHEPLA-2024011072$CHEPLAPHARM$Asaga S, et al. Rhabdomyolysis during postoperative chemotherapy for breast cancer-a case report. Journal of the Japanese Society of Clinical Surgery. 2024;85(7):979-983.$50$YR$$F$Y$$$20240902$$MD$COUNTRY NOT SPECIFIED$JP
242729261$24272926$1$I$$20240822$20240902$20240902$PER$$US-SA-2024SA252728$SANOFI AVENTIS$$$$$M$Y$$$20240902$$HP$US$US
242729272$24272927$2$F$$20240819$20240902$20240902$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0330$GRAVITI PHARMACEUTICALS$$54$YR$A$M$Y$$$20240902$$HP$US$US
242729281$24272928$1$I$20240626$20240827$20240902$20240902$EXP$FR-AFSSAPS-CF2024000402$FR-ABBVIE-5901328$ABBVIE$$77$YR$$M$Y$86$KG$20240902$$PH$FR$FR
242729291$24272929$1$I$20240811$20240823$20240902$20240902$EXP$$US-ROCHE-10000065298$ROCHE$$68$YR$E$F$Y$$$20240902$$CN$US$US
242729301$24272930$1$I$$20240823$20240902$20240902$EXP$$US-APOTEX-2024AP010011$APOTEX$Reinfeld S, Gill P. Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: a case series. CNS Spectrums. 2022;28:587-591$12$YR$$F$Y$$$20240902$$HP$US$US
242729321$24272932$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076699$SANDOZ$$71$YR$$M$Y$$$20240902$$MD$US$US
242729341$24272934$1$I$$20240826$20240902$20240902$EXP$$CA-CHEPLA-2022007895$CHEPLAPHARM$Kobylianskii J, Austin E, Kumachev A, Wu PE. A 53-year-old woman with a suspected drug overdose. CMAJ.2022;194:E163-6. doi: 10.1503/cmaj.211620.$53$YR$$F$Y$$$20240902$$MD$COUNTRY NOT SPECIFIED$CA
242729351$24272935$1$I$$20240827$20240902$20240902$EXP$$US-ABBVIE-5899398$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242729362$24272936$2$F$20240101$20240912$20240902$20240919$EXP$$JP-AMGEN-JPNSP2024171699$AMGEN$$$$$$Y$$$20240919$$HP$JP$JP
242729371$24272937$1$I$20240830$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000290$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240902$$CN$US$US
242729381$24272938$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018799$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240902$$CN$US$US
242729391$24272939$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018966$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240902$$CN$US$US
242729401$24272940$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000198$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240902$$CN$US$US
242729411$24272941$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019208$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240902$$MD$US$US
242729431$24272943$1$I$$20240830$20240902$20240902$PER$$NVSC2024US175783$NOVARTIS$$60$MON$$F$Y$$$20240902$$HP$US$US
242729441$24272944$1$I$$20240823$20240902$20240902$PER$$US-ROCHE-10000066268$ROCHE$$7$YR$C$F$Y$$$20240902$$CN$US$US
242729451$24272945$1$I$$20240819$20240902$20240902$PER$$US-SA-2024SA249612$SANOFI AVENTIS$$$$A$F$Y$104$KG$20240902$$MD$US$US
242729461$24272946$1$I$$20240826$20240902$20240902$EXP$$US-GSK-US2024106010$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$HP$US$US
242729471$24272947$1$I$20090901$20240819$20240902$20240902$EXP$$FR-CIPLA LTD.-2024FR09201$CIPLA$$$$$$Y$$$20240902$$MD$FR$FR
242729482$24272948$2$F$$20240830$20240902$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138036$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240905$$CN$US$US
242729491$24272949$1$I$20240725$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024171450$AMGEN$$14$YR$T$M$Y$$$20240902$$CN$US$US
242729501$24272950$1$I$$20240828$20240902$20240902$EXP$$NVSC2024US174469$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
242729511$24272951$1$I$$20240828$20240902$20240902$EXP$$US-SANDOZ INC.-NVSC2020US341780$SANDOZ$$64$YR$$F$Y$$$20240902$$MD$US$US
242729531$24272953$1$I$20230801$20240826$20240902$20240902$EXP$$CN-ROCHE-10000065969$ROCHE$Luo S, Jiang Q, Zeng W, Wang Q, Zou Z, Yu Y, et al. Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China. Annals of Clinical and Translational Neurology. 2024-Aug;11 (8):2212-21. doi:10.1002/acn3.52142.$46$YR$A$F$Y$$$20240902$$HP$CN$CN
242729541$24272954$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-083376-2024$RECKITT BENCKISER$$$$$F$Y$$$20240902$$CN$US$US
242729551$24272955$1$I$$20240826$20240902$20240902$EXP$$JP-ROCHE-10000067361$ROCHE$Matsui T, Nagai H, Mukozu T, Wakui N, Matsuda T, Igarashi Y. Variceal bleeding following treatment with atezolizumab plus bevacizumab in two patients with unresectable hepatocellular carcinoma. Clinical Journal of Gastroenterology. 2024-Jan;1-9. doi:10.1007/s12328-024-02031-9.$6$DEC$A$M$Y$$$20240902$$HP$JP$JP
242729561$24272956$1$I$20240828$20240828$20240902$20240902$EXP$$TW-TAKEDA-2024TUS087080$TAKEDA$$31$YR$$M$Y$$$20240902$$CN$TW$TW
242729571$24272957$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138475$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240902$$CN$US$US
242729581$24272958$1$I$$20240819$20240902$20240902$EXP$$US-INSMED, INC.-2024-03386-US$INSMED$$$$$F$Y$$$20240902$$CN$US$US
242729591$24272959$1$I$$20240823$20240902$20240902$30DAY$$US-GSK-US2024105561$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$PH$US$US
242729601$24272960$1$I$$20240823$20240902$20240902$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024105535$VIIV$$$$$$Y$$$20240902$$HP$US$US
242729611$24272961$1$I$$20240820$20240902$20240902$EXP$$IT-862174955-ML2024-04642$Unknown Manufacturer$Piovani E, Barison C, Bizioli P, Martinelli R, Bazzani C, Franceschini F. CLINICAL FEATURES OF RHEUMATOID ARTHRITIS PATIENTS ELIGIBLE FOR JAK-INHIBITOR THERAPY: AN ASSESSMENT BEFORE VERSUS AFTER EMA RECOMMENDATIONS TO MINIMIZE CARDIOVASCULAR, THROMBOEMBOLIC, AND NEOPLASTIC RISKS. Ann-Rheum-Dis. 2024;83(1): 1645-1646. doi:10.1136/annrheumdis-2024-eular.5445.$73$YR$E$F$Y$$$20240902$$HP$IT$IT
242729621$24272962$1$I$$20240820$20240902$20240902$EXP$$IT-862174955-ML2024-04645$Unknown Manufacturer$Piovani E, Barison C, Bizioli P, Martinelli R, Bazzani C, Franceschini F. CLINICAL FEATURES OF RHEUMATOID ARTHRITIS PATIENTS ELIGIBLE FOR JAK-INHIBITOR THERAPY: AN ASSESSMENT BEFORE VERSUS AFTER EMA RECOMMENDATIONS TO MINIMIZE CARDIOVASCULAR, THROMBOEMBOLIC, AND NEOPLASTIC RISKS. Ann-Rheum-Dis. 2024;83(1): 1645-1646. doi:10.1136/annrheumdis-2024-eular.5445.$63$YR$A$M$Y$$$20240902$$HP$IT$IT
242729631$24272963$1$I$$20240820$20240902$20240902$EXP$$IT-862174955-ML2024-04644$Unknown Manufacturer$Piovani E, Barison C, Bizioli P, Martinelli R, Bazzani C, Franceschini F. CLINICAL FEATURES OF RHEUMATOID ARTHRITIS PATIENTS ELIGIBLE FOR JAK-INHIBITOR THERAPY: AN ASSESSMENT BEFORE VERSUS AFTER EMA RECOMMENDATIONS TO MINIMIZE CARDIOVASCULAR, THROMBOEMBOLIC, AND NEOPLASTIC RISKS. Ann-Rheum-Dis. 2024;83(Suppl. 1): 1645-1646. doi:10.1136/annrheumdis-2024-eular.5445.$58$YR$A$F$Y$$$20240902$$HP$IT$IT
242729641$24272964$1$I$$20240826$20240902$20240902$EXP$DE-UCBINNMED-20240020$DE-RDY-SPO/DEU/24/0012492$DR REDDYS$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313. doi:https://doi.org/10.1093/jat/bkae011$32$YR$A$M$Y$$$20240902$$HP$DE$DE
242729651$24272965$1$I$$20240827$20240902$20240902$EXP$$CA-TAKEDA-2020TUS050502$TAKEDA$$$$$M$Y$$$20240902$$CN$CA$CA
242729661$24272966$1$I$$20240820$20240902$20240902$EXP$$JP-BELUSA-2024BELLIT0098$BIOLOGICAL E.$Yamamoto H, Ogawa M, Murata T, Ishikawa J, Harada K.A case of deep vein thrombosis in elderly patients in the latter stages of life whose blood clots improved after catheter-based thrombolytic therapy.Journal of the Japan Geriatrics Society.2023;60(3):275-282$$$$$Y$$$20240902$$HP$JP$JP
242729671$24272967$1$I$$20240612$20240902$20240902$PER$$US-CIPLA LTD.-2024US06598$CIPLA$$$$$$Y$$$20240902$$HP$US$US
242729682$24272968$2$F$20240801$20240829$20240902$20240905$PER$$US-AMGEN-USASP2024173529$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242729701$24272970$1$I$$20240831$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-087493-2024$RECKITT BENCKISER$$$$$F$Y$$$20240902$$CN$US$US
242729711$24272971$1$I$20240515$20240829$20240902$20240902$PER$$US-ALXN-202408USA002034US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240902$$HP$US$US
242729721$24272972$1$I$$20240227$20240902$20240902$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089207$GLENMARK$$$$$$Y$$$20240902$$CN$US$US
242729731$24272973$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138390$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240902$$CN$US$US
242729741$24272974$1$I$20220101$20240702$20240902$20240902$PER$$US-CIPLA LTD.-2024US06602$CIPLA$$$$$$Y$$$20240902$$HP$US$US
242729751$24272975$1$I$$20240829$20240902$20240902$EXP$$GB-TAKEDA-2024TUS087352$TAKEDA$$43$YR$$F$Y$$$20240902$$HP$GB$GB
242729761$24272976$1$I$$20240822$20240902$20240902$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-135981$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240902$$CN$CN$CN
242729771$24272977$1$I$20240801$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138605$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240902$$CN$US$US
242729783$24272978$3$F$$20240920$20240902$20240925$PER$$NVSC2024US175890$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
242729792$24272979$2$F$20180101$20240906$20240902$20240910$EXP$$NVSC2024DE175645$NOVARTIS$$51$YR$$M$Y$$$20240910$$CN$DE$DE
242729821$24272982$1$I$20240411$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-087589-2024$RECKITT BENCKISER$$93$YR$$M$Y$56.82$KG$20240902$$CN$US$US
242729831$24272983$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-140207-2023$RECKITT BENCKISER$$$$$M$Y$$$20240902$$CN$US$US
242729841$24272984$1$I$$20240828$20240902$20240902$PER$$US-LEO Pharma-373138$LEO PHARM$$36$YR$$M$Y$$$20240902$$PH$US$US
242729851$24272985$1$I$20240808$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A197577$ASTRAZENECA$$12725$DY$$F$Y$$$20240902$$HP$US$
242729861$24272986$1$I$$20240826$20240902$20240902$EXP$$US-AstraZeneca-2024A194097$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242729871$24272987$1$I$$20240827$20240902$20240902$EXP$$US-AstraZeneca-2024A195487$ASTRAZENECA$$$$$F$Y$122.5$KG$20240902$$CN$US$
242729891$24272989$1$I$20240828$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174464$AMGEN$$54$YR$A$F$Y$$$20240902$$CN$US$US
242729901$24272990$1$I$$20240827$20240902$20240902$EXP$$ZA-AstraZeneca-2024A195558$ASTRAZENECA$$82$YR$$M$Y$$$20240902$$CN$ZA$
242729911$24272991$1$I$$20240826$20240902$20240902$EXP$$US-AstraZeneca-2024A195796$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$US$
242729921$24272992$1$I$$20240821$20240902$20240902$30DAY$$US-JNJFOC-20240876917$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242729931$24272993$1$I$$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136832$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240902$$CN$US$US
242729941$24272994$1$I$$20240827$20240902$20240902$EXP$$CA-TEVA-VS-3238037$TEVA$$76$YR$$M$Y$$$20240902$$CN$CA$CA
242729951$24272995$1$I$$20240823$20240902$20240902$EXP$$US-GSK-US2024105552$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$PH$US$US
242729961$24272996$1$I$$20240827$20240902$20240902$EXP$$JP-009507513-2408JPN003638J$MERCK$$8$DEC$$F$Y$$$20240902$$PH$JP$JP
242729971$24272997$1$I$20231130$20240829$20240902$20240902$EXP$FR-AFSSAPS-LY2023001956$FR-SERVIER-S23015225$SERVIER$$$$$$Y$$$20240902$$MD$FR$FR
242729981$24272998$1$I$$20240819$20240902$20240902$EXP$$JP-ROCHE-10000065991$ROCHE$So S, Shiomi C, Kurokawa K, Murakami K, Imai M, Tsuboi M et al.. 30 A case of post-heart transplant de novo IBD that successfully responded to risankizumab. The 380th Kanto Branch Regular Meeting of the Japanese Society of Gastroenterolo. 2024;31$38$YR$A$F$Y$$$20240902$$MD$JP$JP
242729991$24272999$1$I$20220923$20240826$20240902$20240902$EXP$$JP-ROCHE-10000030526$ROCHE$$66$YR$E$F$Y$56.1$KG$20240902$$MD$JP$JP
242730001$24273000$1$I$$20240827$20240902$20240902$EXP$US-MLMSERVICE-20240823-PI166205-00163-2$US-RDY-SPO/USA/24/0012598$DR REDDYS$Rink DE, Abramson RH, Johnson NJ, Lee RY. Diagnostic Confounders in Brain Death A Woman with Unexplained Coma and Brainstem Areflexia. Annals of the American Thoracic Society. 2024;21(8):1204-8. DOI: 10.1513/AnnalsATS.202403-232CC.$60$YR$A$F$Y$$$20240902$$MD$US$US
242730011$24273001$1$I$20240824$20240826$20240902$20240902$30DAY$$US-GSK-US2024106068$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240902$$CN$US$US
242730021$24273002$1$I$20240812$20240829$20240902$20240902$EXP$$US-TAKEDA-2023TUS089686$TAKEDA$$76$YR$$F$Y$$$20240902$$CN$US$US
242730031$24273003$1$I$$20240501$20240902$20240902$PER$$US-ASTELLAS-2024US004403$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
242730041$24273004$1$I$20240430$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-088571-2024$RECKITT BENCKISER$$53$YR$$F$Y$$$20240902$$CN$US$US
242730052$24273005$2$F$$20240910$20240902$20240913$PER$$US-SA-2024SA250953$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240913$$MD$US$US
242730061$24273006$1$I$20240801$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018355$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240902$$CN$US$US
242730072$24273007$2$F$$20240903$20240902$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408019190$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240905$$CN$US$US
242730081$24273008$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000207$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240902$$CN$US$US
242730091$24273009$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000469$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240902$$CN$US$US
242730101$24273010$1$I$$20240828$20240902$20240902$PER$$US-ABBVIE-5901745$ABBVIE$$$$A$M$Y$$$20240902$$MD$US$US
242730111$24273011$1$I$20230101$20240830$20240902$20240902$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048716$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240902$$CN$AU$AU
242730121$24273012$1$I$20230612$20240826$20240902$20240902$EXP$$KR-AMGEN-KORSP2024173282$AMGEN$$68$YR$E$F$Y$$$20240902$$PH$KR$KR
242730131$24273013$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139013$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240902$$CN$US$US
242730141$24273014$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138974$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240902$$HP$US$US
242730151$24273015$1$I$20240817$20240823$20240902$20240902$EXP$$US-VIIV HEALTHCARE LIMITED-US2024105481$VIIV$$54$YR$$F$Y$$$20240902$$MD$US$US
242730161$24273016$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138354$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240902$$HP$US$US
242730181$24273018$1$I$$20240823$20240902$20240902$30DAY$$US-GSK-US2024105448$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$CN$US$US
242730191$24273019$1$I$$20240828$20240902$20240902$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048436$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240902$$CN$US$US
242730211$24273021$1$I$20221104$20240828$20240902$20240902$PER$$NVSC2024US174754$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
242730221$24273022$1$I$20240403$20240826$20240902$20240902$EXP$$CA-CELLTRION INC.-2024CA009613$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
242730231$24273023$1$I$$20240826$20240902$20240902$EXP$PL-URPL-1-1872-2020$PL-CHEPLA-2024011010$CHEPLAPHARM$$20$YR$$M$Y$$$20240902$$MD$COUNTRY NOT SPECIFIED$PL
242730241$24273024$1$I$20240828$20240828$20240902$20240902$EXP$$US-SA-2024SA253726$SANOFI AVENTIS$$43$YR$A$F$Y$65$KG$20240902$$PH$US$US
242730251$24273025$1$I$20221101$20240823$20240902$20240902$EXP$$US-JNJFOC-20240868726$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$LW$US$US
242730261$24273026$1$I$$20240820$20240902$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-041968$AUROBINDO$Bhandari B, Siddique S, Tahir S, Link MG.. Loperamide-Induced Torsades de Pointes. Cureus. 2024;16(7):e64427$27$YR$$F$Y$$$20240902$$MD$US$US
242730272$24273027$2$F$$20240830$20240902$20240913$EXP$$JP-CHATTEMPRD-2024OHG030040$CHATTEM$$8$YR$C$M$Y$$$20240913$$HP$JP$JP
242730281$24273028$1$I$20171117$20240826$20240902$20240902$EXP$$BR-GSK-BR2017GSK173980$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$PH$BR$BR
242730291$24273029$1$I$$20240826$20240902$20240902$EXP$$PT-ROCHE-10000067469$ROCHE$Araujo P, Parente A, Fernandes A, Silva D, Ferreira A, Barreiros C, et al. PO-0153 - (2746) - ORIGEM IMPREVISIVEL DE FASCEITE NECROTIZANTE EM DOENTE IMUNOSSUPRIMIDA.521-521.$78$YR$E$F$Y$$$20240902$$MD$PT$PT
242730301$24273030$1$I$$20240820$20240902$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-042312$AUROBINDO$Barnes A, Restrepo VJ, Hansra B, Levenson J. Immune Checkpoint Inhibitor Use Leading to Fulminant Myocarditis with Cardiogenic Shock: A Case Series. US-Cardiol. 2024;18 (Suppl.4):12$72$YR$$F$Y$$$20240902$$HP$US$US
242730311$24273031$1$I$$20240820$20240902$20240902$EXP$$CA-APOTEX-2022AP002362$APOTEX$$60$YR$$M$Y$$$20240902$$HP$CA$CA
242730321$24273032$1$I$20240805$20240825$20240902$20240902$EXP$$CN-BEIGENE-BGN-2024-013361$BEIGENE$$$$$$Y$$$20240902$$HP$CN$CN
242730342$24273034$2$F$20240731$20240827$20240902$20240904$EXP$FR-AFSSAPS-PB2024000882$FR-BAXTER-2024BAX023669$BAXTER$$58$YR$$F$Y$$$20240904$$MD$FR$FR
242730351$24273035$1$I$$20240829$20240902$20240902$EXP$$ZA-AstraZeneca-2024A197434$ASTRAZENECA$$18993$DY$$F$Y$$$20240902$$CN$ZA$
242730361$24273036$1$I$$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196516$ASTRAZENECA$$$$$M$Y$$$20240902$$PH$US$
242730371$24273037$1$I$$20240820$20240902$20240902$EXP$$GB-AUROBINDO-AUR-APL-2024-042362$AUROBINDO$Katis G, Srinivasan S, Eleftheriou P, Walker M, Demetriades P. Characterizing left ventricular systolic dysfunction in sickle cell disease: three contrasting case reports. European Heart Journal - Case Reports. 2024;8:ytae383$52$YR$$M$Y$$$20240902$$MD$GB$GB
242730381$24273038$1$I$$20240820$20240902$20240902$EXP$$US-AUROBINDO-AUR-APL-2024-042333$AUROBINDO$Odigwe C. Suicide Left Ventricle Post -TAVR. South-Med-J. 2022;115(1):55$80$YR$$F$Y$$$20240902$$MD$US$US
242730391$24273039$1$I$$20240819$20240902$20240902$30DAY$$GB-JNJFOC-20240875609$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$GB$GB
242730401$24273040$1$I$20240515$20240819$20240902$20240902$PER$$US-JNJFOC-20240850383$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240902$$CN$US$US
242730411$24273041$1$I$20240821$20240822$20240902$20240902$EXP$$US-Rigel Pharmaceuticals, Inc.-20240800097$RIGEL PHARMACEUTICALS$$36$YR$$F$Y$55.338$KG$20240902$$PH$US$US
242730421$24273042$1$I$20231101$20240822$20240902$20240902$EXP$$US-ROCHE-10000065478$ROCHE$$41$YR$A$F$Y$63.8$KG$20240902$$MD$US$US
242730431$24273043$1$I$$20240820$20240902$20240902$EXP$$IT-AUROBINDO-AUR-APL-2024-043020$AUROBINDO$Falcicchio G, Lattanzi S, Negri F, de Tommaso M, La Neve A, Specchio N. Treatment with Cenobamate in Adult Patients with Lennox-Gastaut Syndrome: A Case Series. J-Clin-Med. 2023;12No. 1$36$YR$$M$Y$$$20240902$$HP$IT$IT
242730451$24273045$1$I$$20240822$20240902$20240902$PER$$US-ABBVIE-5893908$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242730462$24273046$2$F$20240919$20240919$20240902$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136108$BRISTOL MYERS SQUIBB$$20$YR$A$F$Y$$$20240922$$CN$US$US
242730471$24273047$1$I$$20240828$20240902$20240902$EXP$$HK-AMGEN-HKGSP2024173399$AMGEN$Yu S.. Targeted Therapy for the Management of Pancreatic Cancer. Journal of the Society of Physicians of Hong Kong. 2024;67-69$59$YR$A$M$Y$$$20240902$$MD$HK$HK
242730481$24273048$1$I$$20240827$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138180$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240902$$HP$US$US
242730492$24273049$2$F$$20240820$20240902$20240906$EXP$$ES-AUROBINDO-AUR-APL-2024-042308$AUROBINDO$Ayen-Rodriguez A, Gil-Villalba A, Ruiz-Villaverde R, Navarro-Trivino FJ. Methotrexate Toxicity in Dermatological Patients. Actas-Dermosifiliogr. 2024;115(7):741-743$86$YR$$M$Y$$$20240906$$HP$ES$ES
242730501$24273050$1$I$$20240823$20240902$20240902$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024105541$VIIV$$$$$M$Y$$$20240902$$CN$US$US
242730511$24273051$1$I$$20240823$20240902$20240902$30DAY$$US-GSK-US2024AMR106265$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$CN$US$US
242730521$24273052$1$I$$20240823$20240902$20240902$EXP$$US-GSK-US2024AMR106443$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$CN$US$US
242730533$24273053$3$F$20240830$20240923$20240902$20240925$PER$$US-AMGEN-USASP2024174033$AMGEN$$75$YR$E$M$Y$$$20240925$$CN$US$US
242730541$24273054$1$I$$20240826$20240902$20240902$PER$$US-AMGEN-USASP2024171614$AMGEN$$$$$$Y$$$20240902$$HP$US$US
242730551$24273055$1$I$$20240828$20240902$20240902$EXP$$NVSC2024US106072$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
242730561$24273056$1$I$$20240827$20240902$20240902$PER$$US-ALXN-202408USA001957US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242730571$24273057$1$I$$20240821$20240902$20240902$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08009$HIKMA$Gabbay JM, Place AE, Ilowite M, Zhu J.. Gabbay JM, Place AE, Ilowite M, Zhu J. Use of the osmolal gap in diagnosing mixed physiology hyponatremia in a child with B-cell acute lymphoblastic leukemia.. Clinical Case Reports. 2023;11(6):1-4 pgs$12$YR$$M$Y$$$20240902$$MD$US$US
242730581$24273058$1$I$20240819$20240821$20240902$20240902$EXP$$US-Accord-443550$ACCORD$$64$YR$A$M$Y$$$20240902$$HP$US$US
242730591$24273059$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000070138$ROCHE$Chen L, Keating C, Leb J, Saqi A, Shu C. Unusual presentation of ROS1 rearranged metastatic non-small cell lung cancer. Respiratory Medicine Case Reports. 2024-Jan;51:1-6. doi:10.1016/j.rmcr.2024.102091.$75$YR$E$F$Y$$$20240902$$HP$US$US
242730601$24273060$1$I$20240724$20240828$20240902$20240902$EXP$FR-AFSSAPS-LY2024001325$FR-ROCHE-10000068052$ROCHE$$59$YR$A$M$Y$128$KG$20240902$$PH$FR$FR
242730611$24273061$1$I$20240703$20240722$20240902$20240902$EXP$$US-CURIUM-2024000492$CURIUM PHARMACEUTICALS$$72$YR$$F$Y$$$20240902$$HP$US$US
242730621$24273062$1$I$20240826$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173850$AMGEN$$$$$$Y$$$20240902$$HP$US$US
242730671$24273067$1$I$20240828$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137715$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240902$$CN$US$US
242730681$24273068$1$I$$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138493$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$39.46$KG$20240902$$CN$US$US
242730691$24273069$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138815$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$101.6$KG$20240902$$HP$US$US
242730702$24273070$2$F$$20240923$20240902$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138818$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240927$$HP$US$US
242730722$24273072$2$F$20240801$20240912$20240902$20240921$EXP$$US-GSK-US2024AMR106497$GLAXOSMITHKLINE$$60$YR$$F$Y$75.283$KG$20240921$$CN$US$US
242730731$24273073$1$I$$20240822$20240902$20240902$EXP$$JP-ASTELLAS-2024-AER-001393$ASTELLAS$$8$DEC$E$M$Y$$$20240902$$MD$JP$JP
242730741$24273074$1$I$20240717$20240827$20240902$20240902$EXP$FR-AFSSAPS-AM2024000696$FR-RDY-SPO/FRA/24/0012533$DR REDDYS$$64$YR$A$M$Y$140$KG$20240902$$PH$FR$FR
242730751$24273075$1$I$$20240820$20240902$20240902$EXP$$GB-AUROBINDO-AUR-APL-2024-042360$AUROBINDO$Katis G, Srinivasan S, Eleftheriou P, Walker M, Demetriades P. Characterizing left ventricular systolic dysfunction in sickle cell disease: three contrasting case reports. European Heart Journal - Case Reports. 2024;8:ytae383$42$YR$$M$Y$$$20240902$$MD$GB$GB
242730761$24273076$1$I$$20240822$20240902$20240902$EXP$$PT-AUROBINDO-AUR-APL-2024-042806$AUROBINDO$Mendes ML, Cam?es S, Da Silva CR, Apar?cio D, Costa BS, Marques M, et al.. Meningite dissimulada.. Congressos da Sociedade Portuguesa de Medicina Interna: 30.o Congresso Nacional. 2024;30:810$74$YR$$M$Y$$$20240902$$MD$PT$PT
242730781$24273078$1$I$$20240828$20240902$20240902$EXP$$NVSC2024TR174755$NOVARTIS$$14$YR$$M$Y$$$20240902$$CN$TR$TR
242730792$24273079$2$F$20240709$20240920$20240902$20240930$EXP$$CA-CELLTRION INC.-2024CA017973$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
242730811$24273081$1$I$20240609$20240827$20240902$20240902$EXP$$CA-AMGEN-CANSP2024171194$AMGEN$$78$YR$E$F$Y$$$20240902$$HP$CA$CA
242730822$24273082$2$F$$20240910$20240902$20240925$30DAY$$TW-JNJFOC-20240869261$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$TW$TW
242730831$24273083$1$I$$20240820$20240902$20240902$EXP$$PL-AUROBINDO-AUR-APL-2024-042577$AUROBINDO$Czarnecki ?.. Pembrolizumab plus chemotherapy in a patient with lung cancer (adenocarcinoma) and below 1% PD-L1 expression (Pembrolizumab plus chemotherapy in a patient with lung cancer (adenocarcinoma) and below 1% PD-L1 expression). ONKOLOGIA W PRAKTYCE KLINICZNEJ - EDUKACJA. 2024;10(Supl. C):C10-C14$56$YR$$M$Y$$$20240902$$HP$PL$PL
242730851$24273085$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018834$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240902$$CN$US$US
242730861$24273086$1$I$20240829$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000163$ELI LILLY AND CO$$50$YR$A$$Y$$$20240902$$CN$US$US
242730871$24273087$1$I$20240601$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000232$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240902$$CN$US$US
242730881$24273088$1$I$$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019363$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240902$$CN$US$US
242730891$24273089$1$I$20240805$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408010018$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240902$$CN$US$US
242730901$24273090$1$I$$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408017465$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240902$$CN$US$US
242730912$24273091$2$F$20240801$20240828$20240902$20240906$EXP$$US-INSMED, INC.-2024-03426-US$INSMED$$58$YR$$F$Y$$$20240906$$CN$US$US
242730921$24273092$1$I$20240819$20240821$20240902$20240902$EXP$GB-MHRA-MED-202408211229036410-ZWTHB$GB-ADVANZ PHARMA-202408006995$ADVANZ PHARMA$$$$$$Y$$$20240902$$HP$GB$GB
242730931$24273093$1$I$$20240821$20240902$20240902$EXP$$CA-APOTEX-2024AP009654$APOTEX$$61$YR$$F$Y$35$KG$20240902$$CN$CA$CA
242730942$24273094$2$F$$20240821$20240902$20240924$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16819$IPSEN$$$$$F$Y$$$20240924$$HP$US$US
242730951$24273095$1$I$$20240825$20240902$20240902$EXP$$KE-UCBSA-2024044316$UCB$$$$$$Y$$$20240902$$PH$KE$KE
242730961$24273096$1$I$20240701$20240820$20240902$20240902$EXP$$US-UCBSA-2024042570$UCB$$30$YR$$F$Y$$$20240902$$HP$US$US
242730971$24273097$1$I$$20240402$20240902$20240902$PER$$US-ASTELLAS-2024US008827$ASTELLAS$$78$YR$E$M$Y$$$20240830$$CN$US$US
242730982$24273098$2$F$$20240920$20240902$20240926$EXP$$IN-VANTIVE-2024VAN019398$Vantive US Healthcare$$60$YR$$F$Y$$$20240926$$CN$IN$IN
242730991$24273099$1$I$$20240826$20240902$20240902$EXP$$IN-VANTIVE-2024VAN019403$Vantive US Healthcare$$38$YR$$F$Y$$$20240902$$CN$IN$IN
242731001$24273100$1$I$20240101$20240823$20240902$20240902$EXP$$CA-CELLTRION INC.-2024CA017228$CELLTRION$$$$$$Y$$$20240902$$HP$CA$CA
242731011$24273101$1$I$$20240820$20240902$20240902$EXP$$US-APOTEX-2024AP009706$APOTEX$Heering G, Lin Z, Rosman M, Hara N, Shakil F, Georgostathis D.. Side Effects of Stem Cell Transplant Mimicking Symptoms of Known Amyloidosis. Case Reports in Gastroenterology. 2024;18 (1):273-278$67$YR$$F$Y$$$20240902$$HP$US$US
242731021$24273102$1$I$$20240829$20240902$20240902$EXP$$CA-AstraZeneca-2024A198288$ASTRAZENECA$$74$YR$$M$Y$$$20240902$$MD$CA$
242731031$24273103$1$I$$20240829$20240902$20240902$PER$$NVSC2024US175232$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
242731041$24273104$1$I$$20240405$20240902$20240902$PER$$US-ASTELLAS-2024US010754$ASTELLAS$$$$$M$Y$$$20240830$$PH$US$US
242731051$24273105$1$I$$20240826$20240902$20240902$EXP$$US-SA-2024SA252621$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240902$$CN$US$US
242731061$24273106$1$I$$20240827$20240902$20240902$EXP$$CA-AMGEN-CANSL2024171471$AMGEN$$17$YR$T$M$Y$$$20240902$$MD$CA$CA
242731071$24273107$1$I$$20240828$20240902$20240902$PER$$US-BIOGEN-2024BI01280374$BIOGEN$$$$$M$Y$$$20240902$$CN$US$US
242731081$24273108$1$I$$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138645$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240902$$CN$US$US
242731091$24273109$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138445$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240902$$CN$US$US
242731103$24273110$3$F$$20240911$20240902$20240913$PER$$US-BIOGEN-2024BI01280214$BIOGEN$$$$$F$Y$$$20240913$$CN$US$US
242731111$24273111$1$I$$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172400$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242731121$24273112$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173846$AMGEN$$70$YR$E$F$Y$$$20240902$$HP$US$US
242731141$24273114$1$I$$20240821$20240902$20240902$EXP$$US-LA JOLLA PHARMA, LLC-2024-INNO-US000067$PAREXEL$Adam Horblitt, Diwakar Jain, Nitin Kabra, George Jolly, Shashvat Gupta, Kartik Dhaduk. SYNTHETIC ANGIOTENSIN II EXACERBATION OF SEPTIC MYOCARDITIS, CAUTIOUS UTILIZATION OF NOVEL VASOPRESSOR PHARMACEUTICALS. Journal of the American college of cardiology. 2019;73:2600$$$$$Y$$$20240902$$HP$US$US
242731161$24273116$1$I$$20240826$20240902$20240902$EXP$$US-GSK-US2024106099$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
242731171$24273117$1$I$20240820$20240823$20240902$20240902$EXP$$CA-GSK-CA2022AMR124880$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$PH$CA$CA
242731181$24273118$1$I$$20240823$20240902$20240902$30DAY$$US-GSK-US2024105536$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$CN$US$US
242731191$24273119$1$I$20230928$20240827$20240902$20240902$EXP$GB-MHRA-MED-202408270745395860-NYMJH$GB-RDY-SPO/GBR/24/0012596$DR REDDYS$$67$YR$E$F$Y$52$KG$20240902$$CN$GB$GB
242731201$24273120$1$I$$20240829$20240902$20240902$PER$$US-ABBVIE-5903312$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242731211$24273121$1$I$20240823$20240823$20240902$20240902$EXP$GB-MHRA-MED-202408231135595490-CSTNM$GB-TEVA-VS-3236895$TEVA$$25$YR$$M$Y$105$KG$20240902$$CN$GB$GB
242731221$24273122$1$I$$20240821$20240902$20240902$EXP$$CA-ROCHE-10000063280$ROCHE$$77$YR$E$M$Y$$$20240902$$HP$CA$CA
242731231$24273123$1$I$$20240823$20240902$20240902$PER$$US-ABBVIE-5895427$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242731241$24273124$1$I$20240821$20240821$20240902$20240902$PER$$US-AMGEN-USASP2024168275$AMGEN$$$$$$Y$$$20240902$$HP$US$US
242731251$24273125$1$I$20240101$20240819$20240902$20240902$PER$$US-SA-2024SA249728$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240902$$MD$US$US
242731262$24273126$2$F$20240821$20240904$20240902$20240910$PER$$US-SA-2024SA252721$SANOFI AVENTIS$$$$$F$Y$$$20240910$$HP$US$US
242731271$24273127$1$I$20240420$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-088091-2024$RECKITT BENCKISER$$60$YR$$F$Y$$$20240902$$CN$US$US
242731291$24273129$1$I$$20240828$20240902$20240902$EXP$$US-ABBVIE-5901918$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242731301$24273130$1$I$$20240822$20240902$20240902$EXP$$ES-AUROBINDO-AUR-APL-2024-042711$AUROBINDO$$43$YR$$F$Y$62$KG$20240902$$MD$ES$ES
242731311$24273131$1$I$$20240821$20240902$20240902$EXP$$CA-APOTEX-2024AP009667$APOTEX$$50$YR$$M$Y$$$20240902$$MD$CA$CA
242731321$24273132$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138626$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240902$$CN$US$US
242731331$24273133$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138608$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240902$$HP$US$US
242731341$24273134$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138574$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240902$$PH$US$US
242731351$24273135$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138193$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240902$$HP$US$US
242731361$24273136$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138235$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240902$$HP$US$US
242731371$24273137$1$I$$20240823$20240902$20240902$EXP$NL-LRB-00996801$NL-TEVA-VS-3237036$TEVA$$69$YR$$M$Y$90$KG$20240902$$CN$NL$NL
242731381$24273138$1$I$$20240830$20240902$20240902$PER$$US-ROCHE-10000071668$ROCHE$$60$YR$A$M$Y$$$20240902$$MD$US$US
242731391$24273139$1$I$$20240830$20240902$20240902$PER$$US-ROCHE-10000071609$ROCHE$$80$YR$E$F$Y$$$20240902$$MD$US$US
242731401$24273140$1$I$$20240827$20240902$20240902$EXP$$NVSC2024DE174734$NOVARTIS$$$$A$M$Y$$$20240902$$HP$DE$DE
242731411$24273141$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-084570-2024$RECKITT BENCKISER$$80$YR$$M$Y$$$20240902$$CN$US$US
242731421$24273142$1$I$$20240825$20240902$20240902$EXP$$US-GSK-US2024AMR106415$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
242731431$24273143$1$I$20230718$20240829$20240902$20240902$EXP$$US-ALXN-202408USA002062US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242731441$24273144$1$I$20230702$20240827$20240902$20240902$EXP$$US-CHEPLA-2024011081$CHEPLAPHARM$$51$YR$$F$Y$87.089$KG$20240902$$CN$COUNTRY NOT SPECIFIED$US
242731451$24273145$1$I$20240101$20240826$20240902$20240902$EXP$$JP-ABBVIE-5901361$ABBVIE$$90$YR$$F$Y$$$20240902$$MD$JP$JP
242731472$24273147$2$F$20080101$20240822$20240902$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-042763$AUROBINDO$Krengel, S et al. Azathioprine/prednisolone: Kaposi^s sarcoma in an elderly patient: case report. Reactions weekly issue 1422. 2012;12-13$80$YR$$M$Y$$$20240903$$MD$DE$DE
242731481$24273148$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138805$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240902$$PH$US$US
242731491$24273149$1$I$20240828$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173495$AMGEN$$35$YR$A$F$Y$$$20240902$$CN$US$US
242731501$24273150$1$I$20240815$20240829$20240902$20240902$EXP$$CN-HALEON-2194370$Haleon PLC$$32$YR$$M$Y$90$KG$20240902$$HP$CN$CN
242731512$24273151$2$F$$20240829$20240902$20240907$30DAY$$US-GSK-US2024106055$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$CN$US$US
242731531$24273153$1$I$$20240827$20240902$20240902$PER$$US-TAKEDA-2024TUS086727$TAKEDA$$$$$$Y$$$20240902$$MD$US$US
242731541$24273154$1$I$$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196212$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242731551$24273155$1$I$20240823$20240829$20240902$20240902$EXP$$JP-AstraZeneca-2024A197766$ASTRAZENECA$$69$YR$$M$Y$$$20240902$$MD$JP$
242731563$24273156$3$F$20230101$20240909$20240902$20240919$EXP$$US-INSMED, INC.-2023-00498-US$INSMED$$$$$M$Y$$$20240919$$CN$US$US
242731571$24273157$1$I$$20240822$20240902$20240902$PER$$US-SA-2024SA252377$SANOFI AVENTIS$$$$A$M$Y$$$20240902$$MD$US$US
242731581$24273158$1$I$20240101$20240820$20240902$20240902$PER$$US-SA-2024SA252739$SANOFI AVENTIS$$$$A$F$Y$$$20240902$$CN$US$US
242731591$24273159$1$I$20240828$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018230$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240902$$CN$US$US
242731601$24273160$1$I$20240828$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018922$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240902$$PH$US$US
242731611$24273161$1$I$20240801$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000268$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240902$$CN$US$US
242731621$24273162$1$I$$20240821$20240902$20240902$EXP$$CA-APOTEX-2024AP009669$APOTEX$$$$$F$Y$$$20240902$$HP$CA$CA
242731641$24273164$1$I$$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172831$AMGEN$$$$$$Y$$$20240902$$HP$US$US
242731651$24273165$1$I$20240829$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138857$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240902$$CN$US$US
242731661$24273166$1$I$20240106$20240902$20240902$20240902$EXP$$US-PROD-AS2-212756134-RB-081302-2024$RECKITT BENCKISER$$55$YR$$F$Y$$$20240902$$CN$US$US
242731671$24273167$1$I$$20240823$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135214$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$88.45$KG$20240902$$CN$US$US
242731681$24273168$1$I$20230501$20240821$20240902$20240902$EXP$$IN-Accord-443301$ACCORD$Mavoor PP, George S, Chetambath R, Poornima MV. A Rare Parasitic Infection from the Common Cockroach: A Case of Lophomonas Blattarum from a Tertiary Center in Kerala. Indian Journal of Nephrology. 2024;34(4):387-9.$40$YR$A$M$Y$$$20240902$$MD$IN$IN
242731691$24273169$1$I$$20240827$20240902$20240902$PER$$US-ALXN-202408USA001965US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242731701$24273170$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-087857-2024$RECKITT BENCKISER$$$$$$Y$$$20240902$$CN$US$US
242731711$24273171$1$I$20231113$20240821$20240902$20240902$EXP$PL-URPL-DML-MLP.4401.1.819.2023$PL-Accord-442901$ACCORD$$69$YR$E$F$Y$80$KG$20240902$$MD$PL$PL
242731721$24273172$1$I$$20240821$20240902$20240902$EXP$$DE-Accord-442878$ACCORD$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann JE et al. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;-:1-28. doi:10.1016/j.seizure.2023.02.015$$$$F$Y$$$20240902$$MD$DE$DE
242731731$24273173$1$I$20240801$20240821$20240902$20240902$EXP$ES-AEMPS-1559706$ES-Accord-443137$ACCORD$$79$YR$E$M$Y$$$20240902$$MD$ES$ES
242731741$24273174$1$I$20240528$20240821$20240902$20240902$EXP$FR-AFSSAPS-BS2024000547$FR-Accord-443153$ACCORD$$52$YR$A$F$Y$69$KG$20240902$$MD$FR$FR
242731751$24273175$1$I$20160101$20221206$20240902$20240902$EXP$$MX-SANDOZ INC.-NVSC2022MX275350$SANDOZ$$$$$F$Y$45$KG$20240902$$CN$MX$MX
242731761$24273176$1$I$20240730$20240822$20240902$20240902$EXP$ES-AEMPS-1560664$ES-Accord-443524$ACCORD$$88$YR$E$M$Y$59.3$KG$20240902$$MD$ES$ES
242731771$24273177$1$I$20240806$20240821$20240902$20240902$EXP$ES-AEMPS-1558862$ES-Accord-442982$ACCORD$$68$YR$E$F$Y$50$KG$20240902$$PH$ES$ES
242731781$24273178$1$I$20240818$20240819$20240902$20240902$EXP$$US-Accord-444505$ACCORD$$65$YR$E$M$Y$$$20240902$$HP$US$US
242731791$24273179$1$I$20240815$20240821$20240902$20240902$EXP$$US-Accord-443535$ACCORD$$66$YR$E$M$Y$$$20240902$$HP$US$US
242731801$24273180$1$I$20240711$20240821$20240902$20240902$EXP$ES-AEMPS-1560026$ES-Accord-443164$ACCORD$$58$YR$A$F$Y$$$20240902$$HP$ES$ES
242731811$24273181$1$I$20240705$20240821$20240902$20240902$EXP$$BR-Accord-443701$ACCORD$$59$YR$A$M$Y$108.4$KG$20240902$$PH$BR$BR
242731821$24273182$1$I$20220401$20240821$20240902$20240902$EXP$$PT-Accord-443202$ACCORD$Henriques C, Melo J, Vasconcelos S, Ramos R, Costa MM. PO-0552 - (4842) - Respiratory infections: when appearances are deceiving. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. 2024;905.$60$YR$A$F$Y$$$20240902$$HP$PT$PT
242731831$24273183$1$I$20240201$20240821$20240902$20240902$EXP$FR-AFSSAPS-PP2024000869$FR-Accord-442856$ACCORD$$80$YR$E$F$Y$$$20240902$$MD$FR$FR
242731841$24273184$1$I$$20240821$20240902$20240902$EXP$$PT-Accord-443082$ACCORD$Marques M, Vilar da Mota R, Salgueiro D, Ferreira I, Gouveia M, . PO-0679 - (4269) - ^Carcinomatose e hipofosfatemia: a etiologia multifatorial do delirium^. Congress da Sociedade Portuguesa de Medicina Interna: 30. CNMI. 2024;1024$65$YR$E$M$Y$$$20240902$$HP$PT$PT
242731851$24273185$1$I$20220709$20240821$20240902$20240902$EXP$ES-AEMPS-1560363$ES-Accord-442893$ACCORD$$64$YR$A$M$Y$$$20240902$$PH$ES$ES
242731861$24273186$1$I$$20240821$20240902$20240902$EXP$$TR-Accord-443314$ACCORD$Kaynar K, Alizade L, Uyar O, Mungan S, Rashidzade K. To screen or not to screen renal cell cancer in a kidney transplant patient. Hippokratia. 2023;27(2):69-71.$55$YR$A$M$Y$$$20240902$$MD$TR$TR
242731871$24273187$1$I$20240815$20240821$20240902$20240902$EXP$$US-Accord-443543$ACCORD$$38$YR$A$F$Y$$$20240902$$HP$US$US
242731881$24273188$1$I$20180910$20240821$20240902$20240902$EXP$$US-Accord-073751$ACCORD$$62$YR$A$F$Y$$$20240902$$HP$US$US
242731891$24273189$1$I$$20240821$20240902$20240902$EXP$$US-Axsome Therapeutics, Inc.-AXS202408-001271$AXSOME THERAPEUTICS$$$$A$$Y$$$20240902$$CN$US$
242731901$24273190$1$I$$20240821$20240902$20240902$EXP$$US-Accord-443315$ACCORD$Dana IN, Austin E, Asrani F. Mucocutaneous ulcers in an immunocompromised patient.  JAAD Case Reports. 2024;51:48-50.$49$YR$A$F$Y$$$20240902$$HP$US$US
242731911$24273191$1$I$$20240823$20240902$20240902$PER$$US-009507513-2408USA008699$MERCK$$70$YR$$M$Y$$$20240902$$HP$US$US
242731921$24273192$1$I$20240826$20240826$20240902$20240902$PER$$US-SA-2024SA251118$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240902$$CN$US$US
242731943$24273194$3$F$20240826$20240911$20240902$20240917$EXP$$FR-JNJFOC-20240868159$JOHNSON AND JOHNSON$$$$E$M$Y$82$KG$20240917$$MD$FR$FR
242731951$24273195$1$I$$20240827$20240902$20240902$EXP$$CA-JNJFOC-20240900575$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$CA$CA
242731961$24273196$1$I$20240101$20240819$20240902$20240902$EXP$$CA-UCBSA-2024000683$UCB$$$$$F$Y$$$20240902$$HP$CA$CA
242731971$24273197$1$I$$20240820$20240902$20240902$EXP$$US-CELLTRION INC.-2024US020284$CELLTRION$Huda T, Hussain F. ,Mani H., Gheith S., and Skandan S.. Rituximab-Associated Liver Toxicity Without Known Viral Reactivation. Cureus. 2024;16(7)$$$$$Y$$$20240902$$MD$US$US
242731981$24273198$1$I$$20240826$20240902$20240902$EXP$$US-VIIV HEALTHCARE LIMITED-US2024106016$VIIV$$$$$M$Y$$$20240902$$CN$US$US
242731991$24273199$1$I$$20240829$20240902$20240902$EXP$$US-VIIV HEALTHCARE LIMITED-US2024107831$VIIV$$$$$M$Y$$$20240902$$HP$US$US
242732011$24273201$1$I$$20240823$20240902$20240902$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024105559$VIIV$$$$$F$Y$$$20240902$$HP$US$US
242732021$24273202$1$I$$20240828$20240902$20240902$EXP$$JP-ORGANON-O2408JPN002077$ORGANON$$90$YR$$F$Y$$$20240902$$CN$JP$JP
242732032$24273203$2$F$20240828$20240903$20240902$20240904$PER$$US-AMGEN-USASP2024174351$AMGEN$$80$YR$E$F$Y$$$20240904$$CN$US$US
242732041$24273204$1$I$$20240828$20240902$20240902$EXP$$US-ROCHE-10000069305$ROCHE$$71$YR$E$F$Y$$$20240902$$CN$US$US
242732051$24273205$1$I$$20240829$20240902$20240902$PER$$US-ABBVIE-5903946$ABBVIE$$$$$F$Y$$$20240902$$HP$US$US
242732061$24273206$1$I$20240822$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173352$AMGEN$$67$YR$E$F$Y$$$20240902$$CN$US$US
242732082$24273208$2$F$20240123$20240912$20240902$20240916$EXP$$CO-UCBSA-2024044320$UCB$$43$YR$$F$Y$79$KG$20240916$$CN$CO$CO
242732091$24273209$1$I$20221125$20240823$20240902$20240902$EXP$$MX-TAKEDA-2022TUS092162$TAKEDA$$76$YR$$F$Y$$$20240902$$CN$MX$MX
242732102$24273210$2$F$20240304$20240911$20240902$20240918$EXP$$CA-TAKEDA-2024TUS020755$TAKEDA$$61$YR$$F$Y$$$20240918$$CN$CA$CA
242732112$24273211$2$F$20200309$20240905$20240902$20240911$EXP$$CA-TAKEDA-2019TUS073692$TAKEDA$$41$YR$$F$Y$$$20240911$$HP$CA$CA
242732121$24273212$1$I$20240402$20240830$20240902$20240902$EXP$$TW-GILEAD-2024-0685881$GILEAD$$58$YR$A$F$Y$$$20240902$$CN$TW$TW
242732131$24273213$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139389$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240902$$CN$US$US
242732141$24273214$1$I$$20240826$20240902$20240902$EXP$$GB-ROCHE-10000066070$ROCHE$Kothari J, Eyre T, Rismani A, Ediriwickrema K, Edwards D, Galani S, et al. PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenstrom^s Macroglobulinaemia. British Journal of Haematology. 2024-Jan;1-9. doi:10.1111/bjh.19706.$$$$$Y$$$20240902$$HP$GB$GB
242732152$24273215$2$F$$20240905$20240902$20240917$EXP$$PL-JNJFOC-20240900250$JOHNSON AND JOHNSON$Moydyey K. Stan padaczkowy u pacjentek w ciy  opis dw ch przypadk w i przegld literatury,. Polski Przegld Neurologiczny.$$$N$M$Y$2.48$KG$20240917$$HP$PL$PL
242732161$24273216$1$I$$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172683$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242732171$24273217$1$I$20240812$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024172989$AMGEN$$66$YR$E$M$Y$$$20240902$$CN$US$US
242732211$24273221$1$I$$20240823$20240902$20240902$EXP$$DE-TEVA-VS-3236978$TEVA$$$$A$M$Y$$$20240902$$MD$DE$DE
242732221$24273222$1$I$20240301$20240827$20240902$20240902$EXP$AT-BASGAGES-2024-006205$AT-TEVA-VS-3237522$TEVA$$38$YR$$M$Y$$$20240902$$CN$AT$AT
242732232$24273223$2$F$20230404$20240904$20240902$20240913$EXP$$GB-ROCHE-3326534$ROCHE$$68$YR$E$F$Y$140$KG$20240913$$CN$GB$GB
242732242$24273224$2$F$20170101$20240917$20240902$20240927$EXP$$IE-UCBSA-2024044000$UCB$$$$$F$Y$$$20240927$$CN$IE$IE
242732253$24273225$3$F$20240819$20240904$20240902$20240920$EXP$$CA-CELLTRION INC.-2021CA019717$CELLTRION$$$$$$Y$$$20240920$$CN$CA$CA
242732271$24273227$1$I$$20240826$20240902$20240902$EXP$$BR-TAKEDA-2024TUS077320$TAKEDA$$$$$M$Y$$$20240902$$CN$BR$BR
242732281$24273228$1$I$$20240819$20240902$20240902$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001257$ALEMBIC$Koh S, Wu C, Cypro A, Castellanos L. HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-ASSOCIATED TAKOTSUBO CARDIOMYOPATHY AND SURVIVAL AFTER VENTRICULAR FIBRILLATION ARREST. Journal of the American College of Cardiology. 2019;73 (9):2599$$$$$Y$$$20240902$$HP$US$US
242732291$24273229$1$I$20240815$20240822$20240902$20240902$EXP$$US-RECORDATI RARE DISEASE INC.-2024006516$RECORDATI$$$$$$Y$$$20240902$$CN$US$US
242732302$24273230$2$F$20240823$20240830$20240902$20240906$EXP$$LB-ROCHE-10000069317$ROCHE$$45$YR$A$F$Y$$$20240906$$MD$LB$LB
242732311$24273231$1$I$$20240821$20240902$20240902$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001702$BLUEPRINT MEDICINES$$$$$M$Y$$$20240829$$CN$US$US
242732322$24273232$2$F$$20240913$20240902$20240919$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001709$BLUEPRINT MEDICINES$$$$$F$Y$$$20240919$$CN$US$US
242732331$24273233$1$I$$20240820$20240902$20240902$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001695$BLUEPRINT MEDICINES$$$$$F$Y$$$20240829$$CN$US$US
242732341$24273234$1$I$$20240820$20240902$20240902$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001688$BLUEPRINT MEDICINES$$$$$F$Y$$$20240829$$CN$US$US
242732351$24273235$1$I$20240610$20240822$20240902$20240902$EXP$$JP-TAKEDA-2024TUS087663$TAKEDA$$71$YR$$M$Y$69$KG$20240902$$PH$JP$JP
242732361$24273236$1$I$$20240820$20240902$20240902$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001704$BLUEPRINT MEDICINES$$$$$M$Y$$$20240829$$CN$US$US
242732371$24273237$1$I$$20240820$20240902$20240902$PER$$DE-Blueprint Medicines Corporation-SP-DE-2024-001699$BLUEPRINT MEDICINES$$$$$$Y$$$20240829$$MD$DE$DE
242732391$24273239$1$I$$20240820$20240902$20240902$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001697$BLUEPRINT MEDICINES$$$$$M$Y$$$20240829$$CN$US$US
242732401$24273240$1$I$$20240821$20240902$20240902$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001713$BLUEPRINT MEDICINES$$$$$M$Y$$$20240829$$CN$US$US
242732411$24273241$1$I$$20240829$20240902$20240902$EXP$$NVSC2024BO175635$NOVARTIS$$$$$F$Y$$$20240902$$MD$BO$BO
242732431$24273243$1$I$20240807$20240823$20240902$20240902$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07664$VIFOR$$59$YR$$M$Y$$$20240902$$HP$ZA$ZA
242732442$24273244$2$F$$20240911$20240902$20240923$EXP$$JP-SMPA-2024SMP012425$SUNOVION$$$$$$Y$$$20240923$$CN$JP$JP
242732451$24273245$1$I$$20240821$20240902$20240902$EXP$$CA-APOTEX-2024AP009674$APOTEX$$$$$M$Y$$$20240902$$MD$CA$CA
242732461$24273246$1$I$$20240819$20240902$20240902$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08317$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242732471$24273247$1$I$20240701$20240828$20240902$20240902$EXP$$FI-ROCHE-10000060681$ROCHE$$$$A$F$Y$$$20240902$$CN$FI$FI
242732481$24273248$1$I$$20240823$20240902$20240902$EXP$NL-LRB-00996723$NL-TEVA-VS-3237004$TEVA$$61$YR$$F$Y$83.4$KG$20240902$$MD$NL$NL
242732491$24273249$1$I$$20240828$20240902$20240902$EXP$$US-AMGEN-USASP2024172863$AMGEN$$64$YR$A$M$Y$$$20240902$$HP$US$US
242732501$24273250$1$I$20240828$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174074$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242732511$24273251$1$I$$20240828$20240902$20240902$EXP$$BR-AMGEN-BRASP2024172199$AMGEN$$55$YR$A$F$Y$$$20240902$$CN$BR$BR
242732521$24273252$1$I$$20240821$20240902$20240902$PER$$US-SA-2021SA107010$SANOFI AVENTIS$$18$YR$A$M$Y$58.05$KG$20240902$$CN$US$US
242732531$24273253$1$I$$20240822$20240902$20240902$PER$$US-SA-2024SA164664$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240902$$MD$US$US
242732541$24273254$1$I$20240401$20240823$20240902$20240902$PER$$US-SA-2024SA251451$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240902$$CN$US$US
242732551$24273255$1$I$20240827$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018362$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$US$US
242732561$24273256$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000171$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240902$$CN$US$US
242732571$24273257$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019045$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240902$$CN$US$US
242732581$24273258$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018806$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240902$$CN$US$US
242732601$24273260$1$I$$20240823$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135221$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$120.66$KG$20240902$$CN$US$US
242732611$24273261$1$I$20240701$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138696$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240902$$PH$US$US
242732621$24273262$1$I$$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024172542$AMGEN$$$$$M$Y$$$20240902$$CN$US$US
242732631$24273263$1$I$20240816$20240828$20240902$20240902$PER$$US-ABBVIE-5900184$ABBVIE$$23$YR$$F$Y$$$20240902$$HP$US$US
242732641$24273264$1$I$20240609$20240823$20240902$20240902$EXP$ES-AEMPS-1561634$ES-TEVA-VS-3237023$TEVA$$73$YR$$F$Y$$$20240902$$MD$ES$ES
242732651$24273265$1$I$$20240828$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076949$SANDOZ$$$$$M$Y$$$20240902$$HP$US$US
242732662$24273266$2$F$20190101$20240829$20240902$20240910$EXP$$IN-MACLEODS PHARMA-MAC2024049060$MACLEODS$Gouru G, Durga Prasad T..Topical Corticosteroid Induced Osteoporotic Vertebral Fractures ? A Case Report.Research Journal of Pharmacy and Technology.2024;17(6):2658-60$$$$$Y$$$20240910$$PH$IN$IN
242732671$24273267$1$I$$20240821$20240902$20240902$EXP$$GB-MACLEODS PHARMA-MAC2024049056$MACLEODS$$$$$$Y$$$20240902$$HP$GB$GB
242732681$24273268$1$I$$20240821$20240902$20240902$EXP$$CN-MACLEODS PHARMA-MAC2024049084$MACLEODS$Zeng QL, Chen RY, Lv XY, Huang S, Li WZ, Pan YJ, Wang FS, Yu ZJ..Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study..BMC Infectious Diseases.15-AUG-2024;24(1):830$$$$$Y$$$20240902$$HP$CN$CN
242732691$24273269$1$I$$20240821$20240902$20240902$EXP$$PK-MACLEODS PHARMA-MAC2024049079$MACLEODS$Muhammad ZA, Ahmad T, Rashid H.Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-a cohort study.Expert Opinion on Drug Safety.19-AUG-2024;1-8$$$$$Y$$$20240902$$MD$PK$PK
242732701$24273270$1$I$$20240821$20240902$20240902$EXP$$RO-MACLEODS PHARMA-MAC2024049070$MACLEODS$Vangeison CT, Roys JP, Catalanotto MN, Kupperman WI, Kovacs AR, Dirzu DS, et al..Medication-induced mood disorders following epidural steroid injections in patients with pain: A case series.Clinical Case Reports.2023;11(6):e7415$$$$$Y$$$20240902$$MD$RO$RO
242732711$24273271$1$I$$20240821$20240902$20240902$EXP$$PK-MACLEODS PHARMA-MAC2024049080$MACLEODS$Muhammad ZA, Ahmad T, Rashid H..Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-A cohort study.Expert Opinion on Drug Safety.19-AUG-2024;1-8$$$$$Y$$$20240902$$MD$PK$PK
242732721$24273272$1$I$$20240821$20240902$20240902$EXP$GB-MHRA-MED-202408211331256540-HZWRL$GB-MACLEODS PHARMA-MAC2024049064$MACLEODS$$$$$$Y$$$20240902$$HP$GB$GB
242732731$24273273$1$I$$20240821$20240902$20240902$EXP$$CN-MACLEODS PHARMA-MAC2024049086$MACLEODS$Zeng QL, Chen RY, Lv XY, Huang S, Li WZ, Pan YJ, et.al.Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study.BMC Infectious Diseases.15 AUG 2024;24(1):830$$$$$Y$$$20240902$$HP$CN$CN
242732741$24273274$1$I$$20240821$20240902$20240902$EXP$$ID-MACLEODS PHARMA-MAC2024049067$MACLEODS$Permatasanti A, Sufiawati I..Case Series of HIV-Associated Oral Lesions Across Different Clinical Stages in People Living with HIV..HIV/AIDS - Research and Palliative Care.2024;16:289-99$$$$$Y$$$20240902$$MD$ID$ID
242732751$24273275$1$I$$20240821$20240902$20240902$EXP$$RO-MACLEODS PHARMA-MAC2024049071$MACLEODS$Vangeison CT, Roys JP, Catalanotto MN, Kupperman WI, Kovacs AR, Dirzu DS, et al..Medication-induced mood disorders following epidural steroid injections in patients with  pain: A case series.Clinical Case Reports.2023;11(6):e7415$$$$$Y$$$20240902$$MD$RO$RO
242732761$24273276$1$I$$20240821$20240902$20240902$EXP$$CN-MACLEODS PHARMA-MAC2024049085$MACLEODS$Zeng QL, Chen RY, Lv XY, Huang S, Li WZ, Pan YJ,et.al.Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study..BMC Infectious Diseases..15-AUG-2024;24(1):830$$$$$Y$$$20240902$$HP$CN$CN
242732771$24273277$1$I$$20240821$20240902$20240902$EXP$$RO-MACLEODS PHARMA-MAC2024049072$MACLEODS$Vangeison CT, Roys JP, Catalanotto MN, Kupperman WI, Kovacs AR, Dirzu DS, et al..Medication-induced mood disorders following epidural steroid injections in patients with pain: A case series..Clinical Case Reports..2023;11(6):e7415$$$$$Y$$$20240902$$MD$RO$RO
242732781$24273278$1$I$$20240821$20240902$20240902$EXP$$CN-MACLEODS PHARMA-MAC2024049092$MACLEODS$Zeng QL, Chen RY, Lv XY, Huang S, Li WZ, Pan YJ, et. al.Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study.BMC Infectious Diseases.15 AUG 2024;24(1):830$$$$$Y$$$20240902$$HP$CN$CN
242732791$24273279$1$I$$20240821$20240902$20240902$EXP$$TR-MACLEODS PHARMA-MAC2024049068$MACLEODS$Yilmaz C, Gurbuz H, Ata F, Gamli M..A rare complication of lumbar plexus block: Tadpole pupil and Edinger Westphal nucleus involvement due to possible subdural spread of local anesthetic.Minerva Anestesiologica.2024;90(7-8):711-2$$$$$Y$$$20240902$$MD$TR$TR
242732802$24273280$2$F$20230528$20240906$20240902$20240918$EXP$$PK-MACLEODS PHARMA-MAC2024049081$MACLEODS$$$$$$Y$$$20240918$$MD$PK$PK
242732812$24273281$2$F$$20240906$20240902$20240918$EXP$$PK-MACLEODS PHARMA-MAC2024049077$MACLEODS$Muhammad ZA, Ahmad T, Rashid H..Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-a cohort study.Expert Opinion on Drug Safety.19-AUG-2024;1-8$$$$$Y$$$20240918$$HP$PK$PK
242732821$24273282$1$I$20240815$20240821$20240902$20240902$EXP$IT-MINISAL02-999575$IT-MACLEODS PHARMA-MAC2024049074$MACLEODS$$$$$$Y$$$20240902$$MD$IT$IT
242732831$24273283$1$I$$20240821$20240902$20240902$EXP$$CN-MACLEODS PHARMA-MAC2024049087$MACLEODS$Zeng QL, Chen RY, Lv XY, Huang S, Li WZ, Pan YJ. et.al..Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study.BMC Infectious Diseases.15-AUG-2024;24(1):830:1-11$$$$$Y$$$20240902$$HP$CN$CN
242732841$24273284$1$I$$20240821$20240902$20240902$EXP$$CN-MACLEODS PHARMA-MAC2024049090$MACLEODS$Zeng QL, Chen RY, Lv XY, Huang S, Li WZ, Pan YJ, et.al..Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study..BMC Infectious Diseases.15-AUG-2024;24(1):830$$$$$Y$$$20240902$$HP$CN$CN
242732851$24273285$1$I$$20240821$20240902$20240902$EXP$$CN-MACLEODS PHARMA-MAC2024049091$MACLEODS$Zeng QL, Chen RY, Lv XY, Huang S, Li WZ, Pan YJ, Wang FS, Yu ZJ..Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study.BMC Infectious Diseases.15-AUG-2024;24(1):830$$$$$Y$$$20240902$$HP$CN$CN
242732861$24273286$1$I$$20240821$20240902$20240902$EXP$$CN-MACLEODS PHARMA-MAC2024049089$MACLEODS$Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study.BMC Infect Dis$$$$$Y$$$20240902$$HP$CN$CN
242732871$24273287$1$I$$20240821$20240902$20240902$EXP$$CN-MACLEODS PHARMA-MAC2024049088$MACLEODS$Zeng QL, Chen RY, Lv XY, Huang S, Li WZ, Pan YJ, et.al.Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study.BMC Infectious Diseases.2024;24(1):830:1-11.$$$$$Y$$$20240902$$HP$CN$CN
242732881$24273288$1$I$$20240821$20240902$20240902$EXP$$CN-MACLEODS PHARMA-MAC2024049093$MACLEODS$Zeng QL, Chen RY, Lv XY, Huang S, Li WZ, Pan YJ, Wang FS, Yu ZJ..Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study.BMC Infectious Diseases..15-AUG-2024;24(1):830$$$$$Y$$$20240902$$HP$CN$CN
242732891$24273289$1$I$$20240826$20240902$20240902$PER$$US-VERTEX PHARMACEUTICALS-2024-013711$VERTEX$$$$$$Y$$$20240902$$CN$US$US
242732901$24273290$1$I$$20240828$20240902$20240902$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013886$VERTEX$$$$$F$Y$$$20240902$$CN$GB$GB
242732911$24273291$1$I$20240601$20240826$20240902$20240902$EXP$$US-ROCHE-10000066417$ROCHE$$78$YR$E$F$Y$$$20240902$$CN$US$US
242732921$24273292$1$I$$20240830$20240902$20240902$EXP$$CA-SANDOZ INC.-NVSC2019CA094573$SANDOZ$$43$YR$$F$Y$68$KG$20240902$$HP$CA$CA
242732941$24273294$1$I$20240601$20240827$20240902$20240902$EXP$$NVSJ2024JP007554$NOVARTIS$$$$A$F$Y$$$20240902$$PH$JP$JP
242732951$24273295$1$I$20240729$20240829$20240902$20240902$EXP$DE-CADRBFARM-2024329804$NVSC2024DE175535$NOVARTIS$$89$YR$$M$Y$90$KG$20240902$$CN$DE$DE
242732961$24273296$1$I$$20240826$20240902$20240902$EXP$$NVSC2024IT172120$NOVARTIS$Fontana G, Gozzoli G, Lini D, Nalli C, Andreoli L, Tincani A. Exploring the safety and effectiveness of biosimilars biological disease modifying anti-rheumatic drugs during pregnancy.. ANNALS OF THE RHEUMATIC DISEASES.. 2024;83 (Suppl. 1):2133$$$N$$Y$1.9$KG$20240902$$HP$IT$IT
242732971$24273297$1$I$$20240823$20240902$20240902$EXP$$NVSC2024DE172935$NOVARTIS$Wildermann T, Becker F, Jesse S, Baier H, Wagner J. Successful use of Fenfluramine in super-refractory status epilepticus in a patient with tuberous sclerosis complex and Lennox-Gastaut syndrome. EPILEPSY AND BEHAVIOR REPORTS. 2024;27:1-5$24$YR$$F$Y$$$20240902$$HP$DE$DE
242732981$24273298$1$I$$20240829$20240902$20240902$PER$$US-BIOVITRUM-2024-US-011524$BIOVITRUM$$94$YR$$M$Y$$$20240902$$CN$US$US
242732991$24273299$1$I$20200101$20240827$20240902$20240902$EXP$$NVSC2024SK174302$NOVARTIS$Suchanova K. pemphigus vulgaris. DERMATOVENEROLOGIA. 2024;5(1):16-9$$$$M$Y$$$20240902$$HP$SK$SK
242733011$24273301$1$I$$20240828$20240902$20240902$EXP$$NVSC2024CA175229$NOVARTIS$Paczkowski F, Raphael J, Browne C. Durable Response to Atezolizumab in Extensive-Stage Small-Cell Lung Cancer Leading to 60 Months Overall Survival. A Case Report. CURRENT ONCOLOGY (TORONTO, ONT). 2024;31(7):3682-9$6$DEC$$M$Y$$$20240902$$HP$CA$CA
242733021$24273302$1$I$$20240829$20240902$20240902$EXP$$US-JNJFOC-20240882481$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$CN$US$US
242733031$24273303$1$I$20240822$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173204$AMGEN$$69$YR$E$F$Y$$$20240902$$CN$US$US
242733041$24273304$1$I$$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024171490$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242733051$24273305$1$I$20240626$20240824$20240902$20240902$EXP$FR-AFSSAPS-LL2024001626$FR-KOANAAP-SML-FR-2024-00889$Unknown Manufacturer$$35$YR$A$F$Y$$$20240902$$MD$FR$FR
242733071$24273307$1$I$20240509$20240821$20240902$20240902$EXP$ES-AEMPS-1561636$ES-ROCHE-10000062204$ROCHE$$78$YR$E$M$Y$$$20240902$$MD$ES$ES
242733081$24273308$1$I$20240817$20240828$20240902$20240902$PER$$PR-BIOGEN-2024BI01280499$BIOGEN$$38$YR$$F$Y$42.222$KG$20240902$$CN$PR$PR
242733091$24273309$1$I$20240808$20240823$20240902$20240902$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000879$PAREXEL$$$$$$Y$$$20240902$$HP$CN$CN
242733101$24273310$1$I$$20240827$20240902$20240902$PER$$US-EMD Serono-2024046331$EMD SERONO INC$$31$YR$A$F$Y$$$20240902$$CN$US$US
242733111$24273311$1$I$20240820$20240827$20240902$20240902$EXP$$DE-ROCHE-10000067552$ROCHE$$38$YR$A$F$Y$$$20240902$$MD$DE$DE
242733121$24273312$1$I$$20240823$20240902$20240902$EXP$$PT-TEVA-VS-3237357$TEVA$Caldeira E, Moniz E, Loja J, Almada S, Gomes S, Henriques CF, et al. Um caso raro de tetania no servico de urgencia. Medicina Interna. 2024;30(1):762$41$YR$$F$Y$$$20240902$$MD$PT$PT
242733131$24273313$1$I$$20240808$20240902$20240902$PER$$US-009507513-2408USA003536$MERCK$Ra OH, Tan JC, Zhao CW, Burns SL. Transient recurrence of chemotherapy-induced peripheral neuropathy in the immediate postoperative period following gynaecological surgery under general anaesthesia. Anaesthesia Reports. 2024;12:e12315$57$YR$$F$Y$$$20240902$$MD$US$US
242733141$24273314$1$I$$20240813$20240902$20240902$PER$$US-TEVA-VS-3233206$TEVA$$61$YR$$M$Y$$$20240902$$CN$US$US
242733151$24273315$1$I$20240202$20240823$20240902$20240902$EXP$ES-AEMPS-1561249$ES-TEVA-VS-3237010$TEVA$$86$YR$$M$Y$68.2$KG$20240902$$MD$ES$ES
242733161$24273316$1$I$$20240813$20240902$20240902$PER$$US-TEVA-VS-3233572$TEVA$$$$$$Y$$$20240902$$CN$US$US
242733172$24273317$2$F$$20240902$20240902$20240905$EXP$$NVSC2024CH174656$NOVARTIS$$$$A$F$Y$$$20240905$$MD$CH$CH
242733182$24273318$2$F$20240807$20240911$20240902$20240916$EXP$$NVSC2024US174444$NOVARTIS$$60$YR$$F$Y$$$20240916$$CN$US$US
242733191$24273319$1$I$$20240827$20240902$20240902$EXP$$US-JNJFOC-20240877109$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242733202$24273320$2$F$20240808$20240916$20240902$20240925$EXP$FR-AFSSAPS-MP2024001325$FR-JNJFOC-20240900270$JOHNSON AND JOHNSON$$53$YR$A$F$Y$62$KG$20240925$$PH$FR$FR
242733211$24273321$1$I$20160513$20240829$20240902$20240902$EXP$$PHHY2016CO072042$NOVARTIS$$46$YR$$F$Y$73$KG$20240902$$CN$CO$CO
242733222$24273322$2$F$$20240910$20240902$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08293$LUPIN$$$$$$Y$$$20240925$$CN$US$US
242733241$24273324$1$I$$20240805$20240902$20240902$PER$$US-AstraZeneca-2024A197183$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242733251$24273325$1$I$20221101$20240829$20240902$20240902$EXP$$PE-UCBSA-2024044322$UCB$$63$YR$$F$Y$$$20240902$$CN$PE$PE
242733261$24273326$1$I$$20240823$20240902$20240902$PER$$US-ALXN-202408USA001595US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242733271$24273327$1$I$20240728$20240822$20240902$20240902$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000877$PAREXEL$$$$$$Y$$$20240902$$HP$CN$CN
242733281$24273328$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173512$AMGEN$$$$$$Y$$$20240902$$PH$US$US
242733291$24273329$1$I$$20220420$20240902$20240902$EXP$$NVSC2022AU094448$NOVARTIS$$$$$M$Y$$$20240902$$PH$AU$AU
242733301$24273330$1$I$$20230926$20240902$20240902$EXP$$NVSC2023FR281025$NOVARTIS$$10$YR$$M$Y$32$KG$20240902$$MD$FR$FR
242733311$24273331$1$I$$20240826$20240902$20240902$PER$$US-ABBVIE-5896710$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242733321$24273332$1$I$$20240824$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135461$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$92.53$KG$20240902$$CN$US$US
242733351$24273335$1$I$$20240823$20240902$20240902$EXP$$US-JNJFOC-20240862880$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$MD$US$US
242733363$24273336$3$F$20240820$20240916$20240902$20240930$30DAY$$CA-JNJFOC-20240853292$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240930$$PH$CA$CA
242733371$24273337$1$I$$20240827$20240902$20240902$PER$$US-JNJFOC-20240877171$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242733381$24273338$1$I$$20240820$20240902$20240902$EXP$$JP-UCBSA-2024042908$UCB$$26$YR$$M$Y$$$20240902$$MD$JP$JP
242733391$24273339$1$I$$20240805$20240902$20240902$PER$$US-TOLMAR, INC.-24US051683$TOLMAR$$$$$$Y$$$20240902$$MD$US$US
242733401$24273340$1$I$$20240809$20240902$20240902$PER$$US-TOLMAR, INC.-24US051825$TOLMAR$$$$$M$Y$$$20240902$$HP$US$US
242733411$24273341$1$I$$20240809$20240902$20240902$PER$$US-TOLMAR, INC.-24US051759$TOLMAR$$$$A$M$Y$$$20240902$$MD$US$US
242733421$24273342$1$I$20240313$20240422$20240902$20240902$PER$$US-ASTELLAS-2024US012011$ASTELLAS$$55$YR$A$M$Y$$$20240830$$CN$US$US
242733431$24273343$1$I$20240629$20240822$20240902$20240902$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000875$PAREXEL$$$$$$Y$$$20240902$$HP$CN$CN
242733441$24273344$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000070654$ROCHE$$$$E$M$Y$$$20240902$$MD$US$US
242733451$24273345$1$I$20240801$20240826$20240902$20240902$EXP$$US-ABBVIE-5900810$ABBVIE$$0$YR$$F$Y$0.9$KG$20240902$$CN$US$US
242733462$24273346$2$F$20240808$20240826$20240902$20240905$EXP$$NVSC2024CN175195$NOVARTIS$$54$YR$$F$Y$48$KG$20240905$$HP$CN$CN
242733471$24273347$1$I$$20240819$20240902$20240902$EXP$$DE-UCBSA-2024042530$UCB$$10$YR$$F$Y$$$20240902$$MD$DE$DE
242733481$24273348$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000082$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240902$$CN$US$US
242733491$24273349$1$I$$20240823$20240902$20240902$EXP$CZ-CZSUKL-24002331$CZ-TEVA-VS-3237091$TEVA$$45$YR$$F$Y$$$20240902$$CN$CZ$CZ
242733501$24273350$1$I$20240101$20240902$20240902$20240902$EXP$$US-PROD-AS2-212756134-RB-082570-2024$RECKITT BENCKISER$$$$$M$Y$$$20240902$$CN$US$US
242733511$24273351$1$I$$20240821$20240902$20240902$PER$$US-JNJFOC-20240860611$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$CN$US$US
242733521$24273352$1$I$$20240828$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US076103$SANDOZ$$$$$F$Y$$$20240902$$CN$US$US
242733531$24273353$1$I$20240303$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-087041-2024$RECKITT BENCKISER$$89$YR$$F$Y$60$KG$20240902$$CN$US$US
242733541$24273354$1$I$20240101$20240821$20240902$20240902$PER$$US-SA-2024SA252309$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240902$$HP$US$US
242733551$24273355$1$I$$20240826$20240902$20240902$EXP$$JP-TEVA-VS-3237422$TEVA$Nakura M, Nojima K, Yamazaki H, Takenaka S, Watanabe T, Takeshita M, et al. [Cases of Advanced Colorectal Cancer with Nephrotic Syndrome after FOLFIRI plus Ramucirumab Administration]. [Japanese]. Gan-To-Kagaku-Ryoho 2022; 49 (13): 1745-1747.$54$YR$$F$Y$$$20240902$$HP$JP$JP
242733561$24273356$1$I$20230101$20240821$20240902$20240902$EXP$$US-ROCHE-10000063498$ROCHE$$59$YR$A$F$Y$61.23$KG$20240902$$CN$US$US
242733581$24273358$1$I$20240701$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137300$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240902$$CN$US$US
242733591$24273359$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138366$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$130.63$KG$20240902$$CN$US$US
242733601$24273360$1$I$20240305$20240819$20240902$20240902$EXP$GB-MHRA-MED-202408131609536260-DYWZV$GB-USV-002847$USV PRIVATE$$84$YR$E$F$Y$44$KG$20240902$$MD$GB$GB
242733612$24273361$2$F$20240829$20240911$20240902$20240912$PER$$US-AMGEN-USASP2024172987$AMGEN$$73$YR$E$M$Y$$$20240912$$CN$US$US
242733621$24273362$1$I$20240702$20240826$20240902$20240902$EXP$$US-ARGENX-2024-ARGX-US007131$ARGENX BVBA$$$$$$Y$$$20240902$$MD$US$US
242733631$24273363$1$I$$20240829$20240902$20240902$EXP$$US-ABBVIE-5901838$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242733641$24273364$1$I$$20240830$20240902$20240902$PER$$US-AstraZeneca-2024A199269$ASTRAZENECA$$$$$F$Y$$$20240902$$HP$US$
242733651$24273365$1$I$20240201$20240821$20240902$20240902$EXP$ES-AEMPS-1559997$ES-Accord-443162$ACCORD$$82$YR$E$F$Y$$$20240902$$MD$ES$ES
242733661$24273366$1$I$$20240821$20240902$20240902$EXP$$CA-Accord-443692$ACCORD$$67$YR$E$F$Y$70$KG$20240902$$HP$CA$CA
242733671$24273367$1$I$20220902$20240826$20240902$20240902$EXP$$NZ-TEVA-VS-3237467$TEVA$$$$$$Y$$$20240902$$PH$NZ$NZ
242733681$24273368$1$I$$20240821$20240902$20240902$EXP$$BE-Accord-443603$ACCORD$$$$$$Y$$$20240902$$PH$BE$BE
242733691$24273369$1$I$20240820$20240821$20240902$20240902$EXP$$US-Accord-443594$ACCORD$$29$YR$A$M$Y$$$20240902$$HP$US$US
242733701$24273370$1$I$$20240828$20240902$20240902$PER$$US-BEH-2024177977$CSL BEHRING$$$$$F$Y$$$20240902$$HP$US$US
242733711$24273371$1$I$$20240821$20240902$20240902$EXP$$BE-Accord-443605$ACCORD$$$$$$Y$$$20240902$$PH$BE$BE
242733721$24273372$1$I$20240801$20240821$20240902$20240902$EXP$IT-MINISAL02-998878$IT-Accord-443012$ACCORD$$37$YR$A$F$Y$$$20240902$$MD$IT$IT
242733731$24273373$1$I$20240820$20240821$20240902$20240902$EXP$$US-Accord-443693$ACCORD$$63$YR$A$M$Y$$$20240902$$HP$US$US
242733741$24273374$1$I$20240507$20240821$20240902$20240902$EXP$FR-AFSSAPS-AN2024001088$FR-Accord-443091$ACCORD$$77$YR$E$M$Y$65$KG$20240902$$MD$FR$FR
242733751$24273375$1$I$$20240825$20240902$20240902$EXP$$DE-AstraZeneca-2024A197727$ASTRAZENECA$$61$YR$$F$Y$$$20240902$$MD$DE$
242733761$24273376$1$I$20230814$20240821$20240902$20240902$EXP$$RU-Accord-444076$ACCORD$Shalaeva DD, Pereverzeva KG, Fomina OA, Yakushin SS. BRASH syndrome: a clinical case. Rational Pharmacotherapy in Cardiology. 2024;20(3):367-73.$85$YR$E$F$Y$$$20240902$$MD$RU$RU
242733772$24273377$2$F$$20240830$20240902$20240903$EXP$$CA-SANDOZ INC.-SDZ2021CA000511$SANDOZ$$44$YR$$F$Y$97$KG$20240903$$HP$CA$CA
242733782$24273378$2$F$$20240910$20240902$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08329$LUPIN$$$$$$Y$$$20240926$$CN$US$US
242733791$24273379$1$I$$20240830$20240902$20240902$EXP$$CA-SANDOZ INC.-SDZ2021CA000510$SANDOZ$$44$YR$$F$Y$97$KG$20240902$$HP$CA$CA
242733801$24273380$1$I$20240405$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-087444-2024$RECKITT BENCKISER$$65$YR$$F$Y$$$20240902$$CN$US$US
242733821$24273382$1$I$$20240823$20240902$20240902$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS004402$TERSERA THERAPEUTICS$$$$$$Y$$$20240902$$MD$CN$CN
242733831$24273383$1$I$$20240822$20240902$20240902$PER$$US-SA-2024SA252227$SANOFI AVENTIS$$$$A$F$Y$$$20240902$$MD$US$US
242733841$24273384$1$I$$20240828$20240902$20240902$EXP$$NVSC2024US175203$NOVARTIS$$60$YR$$M$Y$$$20240902$$CN$US$US
242733851$24273385$1$I$$20240821$20240902$20240902$PER$$US-JNJFOC-20240882465$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$HP$US$US
242733863$24273386$3$F$20240801$20240911$20240902$20240914$EXP$$JP-ALXN-202408JPN001670JP$ALEXION PHARMACEUTICALS$$30$YR$$F$Y$$$20240914$$MD$JP$JP
242733881$24273388$1$I$20230913$20240823$20240902$20240902$EXP$$DE-TERSERA THERAPEUTICS LLC-2024TRS004403$TERSERA THERAPEUTICS$$$$$$Y$$$20240902$$MD$DE$DE
242733902$24273390$2$F$$20240828$20240902$20240904$PER$$US-ROCHE-10000066679$ROCHE$$$$E$F$Y$53.07$KG$20240904$$CN$US$US
242733911$24273391$1$I$20240101$20240826$20240902$20240902$PER$$US-ROCHE-10000066606$ROCHE$$$$$M$Y$71.21$KG$20240902$$CN$US$US
242733921$24273392$1$I$$20240823$20240902$20240902$EXP$DE-BFARM-24005734$DE-TEVA-VS-3237095$TEVA$$$$$F$Y$$$20240902$$CN$DE$DE
242733931$24273393$1$I$20240101$20240826$20240902$20240902$EXP$$JP-GENMAB-2024-01713AA$GENMAB$$63$YR$$F$Y$$$20240902$$MD$JP$JP
242733941$24273394$1$I$$20240822$20240902$20240902$EXP$$JP-ROCHE-10000067989$ROCHE$$8$DEC$E$$Y$$$20240902$$MD$JP$JP
242733951$24273395$1$I$20231101$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174072$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242733962$24273396$2$F$20240820$20240904$20240902$20240909$30DAY$$US-AMGEN-USASP2024167599$AMGEN$$80$YR$E$F$Y$75.4$KG$20240908$$PH$US$US
242733972$24273397$2$F$20240801$20240904$20240902$20240910$30DAY$$US-AMGEN-USASP2024171257$AMGEN$$58$YR$A$F$Y$$$20240910$$PH$US$US
242733981$24273398$1$I$$20240826$20240902$20240902$EXP$$CA-ROCHE-10000066148$ROCHE$$43$YR$A$M$Y$$$20240902$$HP$CA$CA
242733991$24273399$1$I$20240101$20240826$20240902$20240902$PER$$US-ABBVIE-5897790$ABBVIE$$25$YR$$F$Y$70$KG$20240902$$CN$US$US
242734001$24273400$1$I$$20240821$20240902$20240902$PER$$US-JNJFOC-20240882476$JOHNSON AND JOHNSON$$$$T$F$Y$$$20240902$$CN$US$US
242734011$24273401$1$I$20240821$20240821$20240902$20240902$PER$$US-JNJFOC-20240882473$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240902$$HP$US$US
242734021$24273402$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-082227-2024$RECKITT BENCKISER$$$$$$Y$$$20240902$$CN$US$US
242734031$24273403$1$I$$20240820$20240902$20240902$EXP$$JP-BEH-2024177878$CSL BEHRING$$$$$$Y$$$20240902$$HP$JP$JP
242734043$24273404$3$F$20240101$20240916$20240902$20240925$EXP$$CA-CELLTRION INC.-2024CA013256$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
242734051$24273405$1$I$20240815$20240821$20240902$20240902$EXP$$US-Accord-443527$ACCORD$$32$YR$A$M$Y$$$20240902$$HP$US$US
242734061$24273406$1$I$20220624$20240821$20240902$20240902$EXP$ES-AEMPS-1534603$ES-Accord-442986$ACCORD$$65$YR$E$M$Y$$$20240902$$PH$ES$ES
242734074$24273407$4$F$$20240925$20240902$20240930$EXP$$US-UCBSA-2024042627$UCB$$$$$F$Y$$$20240930$$CN$US$US
242734081$24273408$1$I$20240817$20240821$20240902$20240902$EXP$GB-MHRA-MED-202408211240167380-GFQHZ$GB-Accord-442880$ACCORD$$50$YR$A$F$Y$$$20240902$$CN$GB$GB
242734091$24273409$1$I$20240815$20240821$20240902$20240902$EXP$$US-Accord-443593$ACCORD$$56$YR$A$M$Y$$$20240902$$HP$US$US
242734101$24273410$1$I$$20240821$20240902$20240902$EXP$$PT-Accord-443195$ACCORD$Damaso F, Ribeiro AM, Oliveira JC, Anastacio M, Duarte J, Eliseu A et al. PO 0331 - (4887)- syndrome hemolitico uremico alipico. Congressos da sociedade portuguesa de medicina interna: 30 th congress nacional. 2024; 695.$58$YR$A$M$Y$$$20240902$$HP$PT$PT
242734111$24273411$1$I$$20240821$20240902$20240902$EXP$$DE-Accord-443364$ACCORD$Pottharst A, Schaumann F, Tritschler J, Bruder C, Brucker R, Hengstler H, et al. Specialized Palliative Care in a 54 y/o pat with RAS G12Cmutated NSCLC in need of high-flow oxygen at dischargement: An ethical and logistic dilemma. Oncology Research and Treatment. 2023;46 (Suppl 5):332.$54$YR$A$$Y$$$20240902$$HP$DE$DE
242734121$24273412$1$I$$20240821$20240902$20240902$EXP$$DE-Accord-443079$ACCORD$Scheiermann J, Kunkele A, von Stackelberg A, Eggert A, Lang P, Zirngibl F et?al. Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous disease. Front Immunol. 2023;14:1042650$14$MON$$M$Y$$$20240902$$MD$DE$DE
242734131$24273413$1$I$$20240821$20240902$20240902$EXP$$PT-Accord-443205$ACCORD$Pereira I, Ferreira IM, Barbosa FR, Pereira D, Gabriel DF. CARBAMAZEPINE POISONING: CAUSE AND/OR CONSEQUENCE. Congresses of the Portuguese Society of Internal Medicine: 30th National Congress of Internal Medicine - Book of abstracts. May 2024: 1199.$66$YR$E$M$Y$$$20240902$$MD$PT$PT
242734141$24273414$1$I$20240807$20240821$20240902$20240902$EXP$$US-Accord-443686$ACCORD$$19$YR$$M$Y$$$20240902$$HP$US$US
242734151$24273415$1$I$$20240821$20240902$20240902$PER$$US-SA-2024SA253170$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240902$$MD$US$US
242734171$24273417$1$I$20240527$20240823$20240902$20240902$EXP$$CN-SA-2024SA253119$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240902$$HP$CN$CN
242734182$24273418$2$F$$20240918$20240902$20240926$EXP$$JP-ROCHE-10000067884$ROCHE$$7$DEC$E$M$Y$63$KG$20240926$$MD$JP$JP
242734191$24273419$1$I$$20240821$20240902$20240902$EXP$$CN-Accord-443295$ACCORD$Wang Z, Li D, Lu L, Xu Z, Ouyang G, Sun Y. Identification of Anncaliia algerae in Ascites in an Immunosuppressed Patient, China. Open Forum Infectious Diseases. 2024;11(8).$63$YR$A$F$Y$$$20240902$$MD$CN$CN
242734202$24273420$2$F$$20240923$20240902$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202408018836$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240925$$CN$US$US
242734211$24273421$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-087174-2024$RECKITT BENCKISER$$$$$$Y$$$20240902$$CN$US$US
242734221$24273422$1$I$$20240822$20240902$20240902$PER$$US-ABBVIE-5893642$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242734231$24273423$1$I$$20240828$20240902$20240902$PER$$US-ABBVIE-5901668$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242734252$24273425$2$F$20240202$20240904$20240902$20240906$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-136970$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240906$$MD$IT$IT
242734261$24273426$1$I$$20240826$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135943$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240902$$HP$US$US
242734271$24273427$1$I$20240501$20240829$20240902$20240902$EXP$$TN-UCBSA-2024044412$UCB$$35$YR$$F$Y$$$20240902$$MD$TN$TN
242734282$24273428$2$F$20240808$20240808$20240902$20240906$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000817$PAREXEL$$$$$$Y$$$20240906$$CN$US$US
242734301$24273430$1$I$$20240725$20240902$20240902$EXP$$ES-SANDOZ INC.-SDZ2024ES068000$SANDOZ$$$$$$Y$$$20240902$$MD$ES$ES
242734312$24273431$2$F$$20240902$20240902$20240910$EXP$$PT-Waylis Therapeutics LLC-ATNAHS20240802245$Waylis$BS Ferreira; I Andrade; M Presume; F Damaso; AM Ribeiro; FF De Liz, et,al.. A PROPOSITO DO DIAGNOSTICO  DIFERENCIAL DA HEPATITE AGUDA (FOR THE PURPOSE OF THE DIFFERENTIAL DIAGNOSIS OF ACUTE HEPATITIS). Gastroenterological diseases and liver diseases; clinical case. 616$65$YR$E$F$Y$$$20240909$$HP$PT$PT
242734321$24273432$1$I$$20240830$20240902$20240902$EXP$$CA-SANDOZ INC.-SDZ2024CA076802$SANDOZ$$$$$$Y$$$20240902$$CN$CA$CA
242734331$24273433$1$I$$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172070$AMGEN$$$$$M$Y$$$20240902$$CN$US$US
242734341$24273434$1$I$$20240822$20240902$20240902$EXP$$JP-AMGEN-JPNSP2024172896$AMGEN$$$$$$Y$$$20240902$$MD$JP$JP
242734351$24273435$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173210$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242734371$24273437$1$I$20240519$20240829$20240902$20240902$EXP$$TN-UCBSA-2024044339$UCB$$37$YR$$F$Y$$$20240902$$MD$TN$TN
242734381$24273438$1$I$$20240827$20240902$20240902$PER$$US-SA-2024SA252609$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240902$$MD$US$US
242734391$24273439$1$I$$20240822$20240902$20240902$PER$$US-SA-2024SA253347$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240902$$MD$US$US
242734401$24273440$1$I$20230301$20240830$20240902$20240902$EXP$$US-SA-2024SA253573$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240902$$MD$US$US
242734411$24273441$1$I$20240725$20240819$20240902$20240902$EXP$$US-UCBSA-2024038879$UCB$$63$YR$$M$Y$116.57$KG$20240902$$CN$US$US
242734421$24273442$1$I$$20240828$20240902$20240902$EXP$$JP-SANDOZ INC.-SDZ2024JP076233$SANDOZ$Yada T, Kaneda M, Komura Y, Okumura A, Okamoto K, Matsumoto T, et al.. A case of carboplatin-induced immune hemolytic anemia with thrombotic microangiopathy developed rapidly after treatment for recurrent uterine body cancer. Journal of the Japanese Society of Gynecologic Oncology. 2024;42(3):OS-163$82$YR$$F$Y$$$20240902$$MD$JP$JP
242734431$24273443$1$I$$20240826$20240902$20240902$EXP$$NVSC2024NL175534$NOVARTIS$Van der SarIG, Wijsenbeek MS, Dumoulin DW, Jager A, van der VeldtAAM, Rossius MJP, et al.. Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis. ANNALS OF THE AMERICAN THORACIC SOCIETY. 2024;21 (6):989-92$$$$$Y$$$20240902$$HP$NL$NL
242734442$24273444$2$F$$20240916$20240902$20240927$PER$$US-ROCHE-10000070798$ROCHE$$38$YR$A$F$Y$$$20240927$$CN$US$US
242734462$24273446$2$F$20240809$20240809$20240902$20240906$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000804$PAREXEL$$$$$$Y$$$20240906$$HP$US$US
242734471$24273447$1$I$20240814$20240822$20240902$20240902$EXP$$US-BEH-2024177635$CSL BEHRING$$57$YR$A$M$Y$$$20240902$$CN$US$US
242734481$24273448$1$I$20170101$20240829$20240902$20240902$EXP$$IT-SANDOZ INC.-NVSC2019IT103865$SANDOZ$$26$YR$$F$Y$$$20240902$$HP$IT$IT
242734491$24273449$1$I$$20240827$20240902$20240902$EXP$$US-Alcon Laboratories-ALC2024US003977$ALCON$$$$$F$Y$$$20240902$$HP$US$US
242734502$24273450$2$F$$20240829$20240902$20240907$PER$$US-AMGEN-USASP2024173060$AMGEN$$$$$F$Y$$$20240907$$PH$US$US
242734511$24273451$1$I$$20240820$20240902$20240902$PER$$US-009507513-2408USA007442$MERCK$Ataei, Y, Welak, SR., Telega, GW., Khammar, AJ.. A rare case of spontaneous hyphema secondary to gestational alloimmune liver disease. Journal of AAPOS. 2024;28(28):1-3$$$N$F$Y$$$20240902$$MD$US$US
242734522$24273452$2$F$$20240824$20240902$20240908$EXP$$US-GSK-US2024106123$GLAXOSMITHKLINE$$$$$M$Y$$$20240908$$CN$US$US
242734541$24273454$1$I$$20240830$20240902$20240902$PER$$US-ROCHE-10000071284$ROCHE$$$$A$F$Y$$$20240902$$MD$US$US
242734551$24273455$1$I$$20240830$20240902$20240902$PER$$US-ROCHE-10000071513$ROCHE$$$$A$F$Y$$$20240902$$MD$US$US
242734561$24273456$1$I$$20240827$20240902$20240902$EXP$$US-AMGEN-USASP2024171645$AMGEN$Frank SM. Gastrointestinal Bleeding and Survival after a Nadir Hemoglobin +lt;3.0 g/dL in 2 Jehovah^s Witness Patients: A Case Report. A + A Practice. 2024;18 (8):1-4$64$YR$A$F$Y$$$20240902$$MD$US$US
242734571$24273457$1$I$$20240819$20240902$20240902$PER$$US-SA-2024SA253266$SANOFI AVENTIS$$3$YR$C$F$Y$15$KG$20240902$$MD$US$US
242734581$24273458$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076670$SANDOZ$$12$YR$$F$Y$$$20240902$$MD$US$US
242734593$24273459$3$F$$20240830$20240902$20240905$EXP$$US-ALXN-202408USA002010US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242734601$24273460$1$I$$20240829$20240902$20240902$EXP$$GB-TAKEDA-2024TUS087733$TAKEDA$$$$$M$Y$$$20240902$$HP$GB$GB
242734611$24273461$1$I$20240627$20240829$20240902$20240902$EXP$FR-AFSSAPS-MA2024001414$FR-JNJFOC-20240900273$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240902$$MD$FR$FR
242734621$24273462$1$I$$20240830$20240902$20240902$EXP$$CA-SANDOZ INC.-SDZ2023CA076661$SANDOZ$$44$YR$$F$Y$97$KG$20240902$$HP$CA$CA
242734631$24273463$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138633$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240902$$CN$US$US
242734641$24273464$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138273$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240902$$CN$US$US
242734651$24273465$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000070652$ROCHE$$18$YR$A$F$Y$$$20240902$$MD$US$US
242734661$24273466$1$I$20240619$20240823$20240902$20240902$EXP$FR-AFSSAPS-AVCN2024000653$FR-Waylis Therapeutics LLC-ATNAHS20240802430$Waylis$$45$YR$A$F$Y$$$20240830$$MD$FR$FR
242734671$24273467$1$I$$20240830$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US076865$SANDOZ$$$$$F$Y$$$20240902$$CN$US$US
242734682$24273468$2$F$$20240913$20240902$20240921$PER$$US-ROCHE-10000070610$ROCHE$$$$A$F$Y$$$20240921$$CN$US$US
242734692$24273469$2$F$20240802$20240923$20240902$20240930$PER$$US-ROCHE-10000070616$ROCHE$$21$YR$A$M$Y$$$20240930$$CN$US$US
242734701$24273470$1$I$$20240829$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076565$SANDOZ$$3$DEC$$F$Y$$$20240902$$MD$US$US
242734721$24273472$1$I$$20240828$20240902$20240902$EXP$$US-BEH-2024178014$CSL BEHRING$$45$YR$A$F$Y$$$20240902$$CN$US$US
242734731$24273473$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-3513924$ROCHE$$$$A$F$Y$$$20240902$$CN$US$US
242734741$24273474$1$I$$20240626$20240902$20240902$PER$$US-ASTELLAS-2024US018464$ASTELLAS$$45$YR$A$F$Y$$$20240830$$PH$US$US
242734751$24273475$1$I$$20240830$20240902$20240902$PER$$US-SA-2024SA253323$SANOFI AVENTIS$$$$$F$Y$$$20240902$$CN$US$US
242734761$24273476$1$I$$20240819$20240902$20240902$EXP$$US-UCBSA-2024042320$UCB$$$$$$Y$$$20240902$$CN$US$US
242734771$24273477$1$I$20240502$20240827$20240902$20240902$EXP$$CA-TAKEDA-2023TUS099311$TAKEDA$$39$YR$$F$Y$$$20240902$$CN$CA$CA
242734781$24273478$1$I$$20240819$20240902$20240902$EXP$$GB-UCBSA-2024042756$UCB$$$$$F$Y$$$20240902$$HP$GB$GB
242734791$24273479$1$I$$20240830$20240902$20240902$PER$$US-ROCHE-10000071324$ROCHE$$$$A$F$Y$$$20240902$$CN$US$US
242734801$24273480$1$I$$20240528$20240902$20240902$PER$$US-ASTELLAS-2024US015591$ASTELLAS$$$$A$M$Y$$$20240830$$HP$US$US
242734811$24273481$1$I$20230731$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-103692-2023$RECKITT BENCKISER$$89$YR$$F$Y$$$20240902$$CN$US$US
242734821$24273482$1$I$$20240820$20240902$20240902$EXP$$JP-UCBSA-2024042905$UCB$$5$YR$$M$Y$$$20240902$$PH$JP$JP
242734831$24273483$1$I$$20240819$20240902$20240902$EXP$$BR-UCBSA-2024042323$UCB$$$$$F$Y$$$20240902$$CN$BR$BR
242734851$24273485$1$I$20240709$20240827$20240902$20240902$EXP$FR-AFSSAPS-MA2024001203$FR-Waylis Therapeutics LLC-ATNAHS20240802454$Waylis$$3$YR$C$M$Y$$$20240902$$MD$FR$FR
242734861$24273486$1$I$$20240828$20240902$20240902$EXP$$US-AMGEN-USASP2024172615$AMGEN$$$$$$Y$$$20240902$$PH$US$US
242734871$24273487$1$I$20240801$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174528$AMGEN$$37$YR$A$F$Y$$$20240902$$HP$US$US
242734882$24273488$2$F$20240829$20240829$20240902$20240904$PER$$US-AMGEN-USASP2024173130$AMGEN$$65$YR$E$F$Y$$$20240904$$CN$US$US
242734891$24273489$1$I$$20240827$20240902$20240902$PER$$US-SA-2024SA251840$SANOFI AVENTIS$$63$YR$A$F$Y$17$KG$20240902$$CN$US$US
242734901$24273490$1$I$20240212$20240826$20240902$20240902$EXP$$CA-PFIZER INC-202300360324$PFIZER$$82$YR$$F$Y$59$KG$20240902$$HP$CA$CA
242734911$24273491$1$I$20240830$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000244$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$US$US
242734921$24273492$1$I$20240813$20240828$20240902$20240902$EXP$FR-AFSSAPS-PA2024001494$FR-Atnahs Limited-ATNAHS20240802462$Atnahs Healthcare$$59$YR$A$F$Y$$$20240902$$MD$FR$FR
242734933$24273493$3$F$$20240917$20240902$20240924$EXP$$US-OTSUKA-2024_023613$OTSUKA$$24$YR$$M$Y$$$20240924$$CN$US$US
242734941$24273494$1$I$20240101$20240815$20240902$20240902$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000730$DECIPHERA PHARMACEUTICALS$$74$YR$E$F$Y$$$20240902$$CN$US$US
242734951$24273495$1$I$20190109$20240827$20240902$20240902$EXP$$CA-TAKEDA-2024TUS086761$TAKEDA$$62$YR$$F$Y$$$20240902$$CN$CA$CA
242734961$24273496$1$I$20240101$20240828$20240902$20240902$EXP$$US-PFIZER INC-202400246355$PFIZER$$52$YR$$M$Y$88.435$KG$20240902$$CN$US$US
242734972$24273497$2$F$20240510$20240917$20240902$20240918$EXP$$JP-PFIZER INC-PV202400113326$PFIZER$$87$YR$$M$Y$58.9$KG$20240918$$MD$JP$JP
242734981$24273498$1$I$$20240827$20240902$20240902$EXP$$FR-PFIZER INC-202400244591$PFIZER$$$$$M$Y$$$20240902$$CN$FR$FR
242734991$24273499$1$I$20240101$20240828$20240902$20240902$EXP$$US-PFIZER INC-202400245968$PFIZER$$$$$$Y$$$20240902$$CN$US$US
242735001$24273500$1$I$$20240829$20240902$20240902$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-138691$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240902$$CN$PR$PR
242735011$24273501$1$I$20240828$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138385$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240902$$PH$US$US
242735021$24273502$1$I$$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137083$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240902$$HP$US$US
242735031$24273503$1$I$20240801$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138157$BRISTOL MYERS SQUIBB$$9$DEC$E$$Y$$$20240902$$CN$US$US
242735041$24273504$1$I$$20240826$20240902$20240902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-137358$BRISTOL MYERS SQUIBB$Utoyama H, et al. A case of irAE fulminant type 1 diabetes mellitus after nivolumab use for gastric cancer with peritoneal dissemination. The Journal of the Kyoto Medical Association. 2024;71(1):119-21.$59$YR$A$M$Y$$$20240902$$MD$JP$JP
242735071$24273507$1$I$20240819$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136130$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$38.56$KG$20240902$$PH$US$US
242735082$24273508$2$F$$20240828$20240902$20240904$EXP$FR-AFSSAPS-LL2024001543$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08059$HIKMA$$56$YR$$F$Y$$$20240904$$MD$FR$FR
242735091$24273509$1$I$$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172023$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242735101$24273510$1$I$$20240824$20240902$20240902$PER$$US-ABBVIE-5897186$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242735111$24273511$1$I$$20240826$20240902$20240902$PER$$US-TEVA-VS-3238148$TEVA$Wynn CW, Burg G, George A, Sawnani H. Persistent Air Leak Treated With Endobronchial Valve in an Adolescent With Hyper-IgE Syndrome. Am-J-Respir-Crit-Care-Med 2023; 207 A2639.$15$YR$$F$Y$$$20240902$$HP$US$US
242735121$24273512$1$I$20220101$20240827$20240902$20240902$EXP$$RO-AMGEN-ROUSP2024171569$AMGEN$$69$YR$E$M$Y$$$20240902$$MD$RO$RO
242735132$24273513$2$F$$20240904$20240902$20240905$EXP$$US-PFIZER INC-202400244852$PFIZER$$41$YR$$F$Y$$$20240905$$CN$US$US
242735141$24273514$1$I$$20240828$20240902$20240902$EXP$$CN-PFIZER INC-202400245536$PFIZER$$$$$F$Y$$$20240902$$MD$CN$CN
242735152$24273515$2$F$20231020$20240924$20240902$20240927$EXP$FR-AFSSAPS-RE2024000187$FR-PFIZER INC-202400051664$PFIZER$$50$YR$$F$Y$62$KG$20240927$$MD$FR$FR
242735161$24273516$1$I$20230307$20240828$20240902$20240902$EXP$$CA-PFIZER INC-202300127013$PFIZER$$34$YR$$F$Y$$$20240902$$MD$CA$CA
242735171$24273517$1$I$20240625$20240827$20240902$20240902$EXP$$JP-PFIZER INC-PV202400091624$PFIZER$$69$YR$$M$Y$50$KG$20240902$$MD$JP$JP
242735181$24273518$1$I$20230807$20240828$20240902$20240902$EXP$$CN-PFIZER INC-PV202400112534$PFIZER$$23$YR$$F$Y$55$KG$20240902$$HP$CN$CN
242735192$24273519$2$F$20240430$20240909$20240902$20240909$EXP$$DE-PFIZER INC-202400246182$PFIZER$$51$YR$$M$Y$$$20240909$$CN$DE$DE
242735201$24273520$1$I$20240818$20240827$20240902$20240902$EXP$$CN-PFIZER INC-PV202400111936$PFIZER$$28$YR$$F$Y$52.5$KG$20240902$$HP$CN$CN
242735211$24273521$1$I$20240528$20240826$20240902$20240902$EXP$$CA-PFIZER INC-202400100138$PFIZER$$62$YR$$F$Y$$$20240902$$MD$CA$CA
242735221$24273522$1$I$$20240827$20240902$20240902$EXP$$US-PFIZER INC-202400245782$PFIZER$$76$YR$$F$Y$$$20240902$$HP$US$US
242735232$24273523$2$F$20240301$20240925$20240902$20240930$EXP$$IN-PFIZER INC-PV202400054605$PFIZER$$44$YR$$F$Y$$$20240930$$CN$IN$IN
242735242$24273524$2$F$$20240909$20240902$20240911$EXP$$IN-PFIZER INC-PV202400112301$PFIZER$$44$YR$$F$Y$$$20240911$$CN$IN$IN
242735251$24273525$1$I$20240101$20240827$20240902$20240902$EXP$$CA-PFIZER INC-202400238004$PFIZER$$72$YR$$M$Y$$$20240902$$PH$CA$CA
242735261$24273526$1$I$20230101$20240828$20240902$20240902$EXP$$CA-PFIZER INC-202300159875$PFIZER$$29$YR$$F$Y$100$KG$20240902$$MD$CA$CA
242735272$24273527$2$F$20240816$20240917$20240902$20240920$EXP$$BE-PFIZER INC-202400244538$PFIZER$$69$YR$$M$Y$58.9$KG$20240920$$MD$BE$BE
242735281$24273528$1$I$20240822$20240827$20240902$20240902$EXP$$CN-PFIZER INC-PV202400111990$PFIZER$$49$YR$$F$Y$$$20240902$$HP$CN$CN
242735291$24273529$1$I$$20240827$20240902$20240902$EXP$$CA-PFIZER INC-202400244906$PFIZER$$$$$$Y$$$20240902$$HP$CA$CA
242735301$24273530$1$I$$20240829$20240902$20240902$EXP$$CA-PFIZER INC-202400246525$PFIZER$$73$YR$$F$Y$$$20240902$$HP$CA$CA
242735321$24273532$1$I$20240819$20240827$20240902$20240902$EXP$$CN-PFIZER INC-PV202400111935$PFIZER$$59$YR$$F$Y$61.9$KG$20240902$$HP$CN$CN
242735334$24273533$4$F$$20240904$20240902$20240910$30DAY$$US-SANDOZ INC.-SDZ2024US076126$SANDOZ$$$$$F$Y$$$20240910$$CN$US$US
242735341$24273534$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138338$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240902$$HP$US$US
242735351$24273535$1$I$20240111$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-084192-2024$RECKITT BENCKISER$$$$$F$Y$$$20240902$$CN$US$US
242735361$24273536$1$I$20240824$20240826$20240902$20240902$PER$$US-ROCHE-10000068361$ROCHE$$74$YR$E$F$Y$53.07$KG$20240902$$CN$US$US
242735371$24273537$1$I$$20240826$20240902$20240902$EXP$$NVSC2024IT174523$NOVARTIS$Costa A, Abruzzese E, Latagliata R, Mulas O, Carmosino I, Scalzulli E, et al.. Safety and Efficacy of TKIs in very Elderly Patients (?75 Years) with Chronic Myeloid Leukemia. JOURNAL OF CLINICAL MEDICINE. 2024;13:273$$$E$$Y$$$20240902$$HP$IT$IT
242735381$24273538$1$I$20240718$20240828$20240902$20240902$EXP$$CN-ABBVIE-5901396$ABBVIE$$$$A$F$Y$$$20240902$$CN$CN$CN
242735394$24273539$4$F$20240901$20240923$20240902$20240930$EXP$$NVSC2024AR107598$NOVARTIS$$78$YR$$F$Y$$$20240930$$CN$AR$AR
242735401$24273540$1$I$20240429$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-089470-2024$RECKITT BENCKISER$$$$$F$Y$$$20240902$$CN$US$US
242735421$24273542$1$I$$20240830$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139169$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240902$$CN$US$US
242735431$24273543$1$I$$20240829$20240902$20240902$EXP$$JP-SANDOZ INC.-SDZ2024JP076580$SANDOZ$$$$A$F$Y$$$20240902$$MD$JP$JP
242735441$24273544$1$I$$20240819$20240902$20240902$EXP$$DE-UCBSA-2024042556$UCB$$9$YR$$M$Y$$$20240902$$MD$DE$DE
242735451$24273545$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138405$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240902$$CN$US$US
242735462$24273546$2$F$20230101$20240904$20240902$20240910$EXP$$ES-AUROBINDO-AUR-APL-2024-022723$AUROBINDO$Barris D, Mousavi H. Dose adjustment according to renal function in a polymedicated patient included in the drug reconditioning service using personalized dosing systems (PDS). Community Farms. 2024;16(2):37-42$78$YR$$F$Y$$$20240910$$PH$ES$ES
242735471$24273547$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076605$SANDOZ$$38$YR$$M$Y$$$20240902$$MD$US$US
242735481$24273548$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138300$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$91.63$KG$20240902$$CN$US$US
242735492$24273549$2$F$20240101$20240830$20240902$20240913$EXP$$CA-UCBSA-2024042524$UCB$$$$$F$Y$$$20240913$$CN$CA$CA
242735502$24273550$2$F$$20240918$20240902$20240927$EXP$$US-TEVA-VS-3238149$TEVA$Carr KA, Sokolow AG, O^Connor MG, Austin ED. An Atypical Cause of an Acute Exacerbation of Bronchopulmonary Dysplasia Associated Pulmonary Hypertension. Am-J-Respir-Crit-Care-Med 2023; 207.; Carr KA, Sokolow AG, O^Connor MG, Austin ED. An Atypical Cause of an Acute Exacerbation of Bronchopulmonary Dysplasia Associated Pulmonary Hypertension. Am-J-Respir-Crit-Care-Med 2023; 207.; Carr KA, Sokolow AG, O^Connor MG, Austin ED. An Atypical Cause of an Acute Exacerbation of Bronchopulmonary Dysplas...$4$MON$$F$Y$$$20240927$$HP$US$US
242735511$24273551$1$I$$20240830$20240902$20240902$EXP$$NVSC2024US175880$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
242735521$24273552$1$I$20211006$20240826$20240902$20240902$EXP$$US-ABBVIE-5897278$ABBVIE$$64$YR$$M$Y$$$20240902$$CN$US$US
242735531$24273553$1$I$20240809$20240828$20240902$20240902$EXP$$CO-ABBVIE-5902811$ABBVIE$$67$YR$$M$Y$80$KG$20240902$$HP$CO$CO
242735541$24273554$1$I$$20240212$20240902$20240902$PER$$US-ASTELLAS-2024US004668$ASTELLAS$$$$E$F$Y$58.7$KG$20240830$$MD$US$US
242735551$24273555$1$I$$20231003$20240902$20240902$PER$$US-ASTELLAS-2023US029832$ASTELLAS$$$$$$Y$$$20240830$$CN$US$US
242735561$24273556$1$I$$20240408$20240902$20240902$PER$$US-ASTELLAS-2024US010543$ASTELLAS$$$$$F$Y$$$20240830$$PH$US$US
242735571$24273557$1$I$20210101$20240514$20240902$20240902$PER$$US-ASTELLAS-2024US005271$ASTELLAS$$$$E$F$Y$$$20240830$$CN$US$US
242735581$24273558$1$I$$20240129$20240902$20240902$PER$$US-ASTELLAS-2024US003057$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
242735591$24273559$1$I$$20240726$20240902$20240902$PER$$US-ASTELLAS-2024US021600$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242735601$24273560$1$I$$20240813$20240902$20240902$PER$$US-ASTELLAS-2024US017971$ASTELLAS$$76$YR$E$M$Y$92$KG$20240830$$PH$US$US
242735611$24273561$1$I$$20240610$20240902$20240902$PER$$US-ASTELLAS-2024US016792$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242735621$24273562$1$I$20231023$20231024$20240902$20240902$PER$$US-ASTELLAS-2023US032219$ASTELLAS$$15$YR$T$$Y$$$20240830$$HP$US$US
242735631$24273563$1$I$$20240725$20240902$20240902$PER$$US-ASTELLAS-2024US012377$ASTELLAS$$$$E$M$Y$$$20240830$$MD$US$US
242735641$24273564$1$I$$20240405$20240902$20240902$PER$$US-ASTELLAS-2024US007865$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242735651$24273565$1$I$$20240724$20240902$20240902$PER$$US-ASTELLAS-2024US019987$ASTELLAS$$68$YR$E$M$Y$70.3$KG$20240830$$CN$US$US
242735661$24273566$1$I$20240515$20240627$20240902$20240902$PER$$US-ASTELLAS-2024US014551$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
242735671$24273567$1$I$$20240306$20240902$20240902$PER$$US-ASTELLAS-2024US007283$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242735681$24273568$1$I$$20240507$20240902$20240902$PER$$US-ASTELLAS-2024US013766$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242735691$24273569$1$I$20240501$20240605$20240902$20240902$PER$$US-ASTELLAS-2024US016439$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242735701$24273570$1$I$$20240808$20240902$20240902$PER$$US-ASTELLAS-2024US014308$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242735711$24273571$1$I$$20240715$20240902$20240902$PER$$US-ASTELLAS-2024US019405$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
242735721$24273572$1$I$$20240725$20240902$20240902$PER$$US-ASTELLAS-2024US021516$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242735731$24273573$1$I$$20240718$20240902$20240902$PER$$US-ASTELLAS-2024US020787$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242735741$24273574$1$I$$20240812$20240902$20240902$PER$$US-ASTELLAS-2024US022122$ASTELLAS$$74$YR$E$M$Y$$$20240830$$MD$US$US
242735751$24273575$1$I$20240201$20240715$20240902$20240902$PER$$US-ASTELLAS-2024US006920$ASTELLAS$$5$DEC$A$M$Y$$$20240830$$HP$US$US
242735761$24273576$1$I$$20240725$20240902$20240902$PER$$GT-ASTELLAS-2024US021711$ASTELLAS$$$$$M$Y$$$20240830$$MD$GT$GT
242735771$24273577$1$I$$20240607$20240902$20240902$PER$$US-ASTELLAS-2024US016592$ASTELLAS$$$$$M$Y$$$20240830$$PH$US$US
242735781$24273578$1$I$$20240220$20240902$20240902$PER$$US-ASTELLAS-2024US005705$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242735791$24273579$1$I$$20240425$20240902$20240902$PER$$US-ASTELLAS-2024US012226$ASTELLAS$$89$YR$E$M$Y$$$20240830$$HP$US$US
242735801$24273580$1$I$20240605$20240621$20240902$20240902$PER$$US-ASTELLAS-2024US017160$ASTELLAS$$$$$M$Y$$$20240830$$PH$US$US
242735812$24273581$2$F$$20240913$20240902$20240918$PER$$US-ASTELLAS-2024US017219$ASTELLAS$$$$$M$Y$$$20240918$$MD$US$US
242735821$24273582$1$I$20240401$20240607$20240902$20240902$PER$$US-ASTELLAS-2024US015617$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242735831$24273583$1$I$$20240718$20240902$20240902$PER$$US-ASTELLAS-2024US020778$ASTELLAS$$64$YR$A$M$Y$$$20240830$$MD$US$US
242735841$24273584$1$I$$20240531$20240902$20240902$PER$$US-ASTELLAS-2024US016102$ASTELLAS$$61$YR$A$M$Y$$$20240830$$MD$US$US
242735852$24273585$2$F$20240110$20240912$20240902$20240918$PER$$US-ASTELLAS-2024US021474$ASTELLAS$$68$YR$E$M$Y$$$20240918$$MD$US$US
242735861$24273586$1$I$$20240702$20240902$20240902$PER$$US-ASTELLAS-2024US019946$ASTELLAS$$$$E$M$Y$94.4$KG$20240830$$MD$US$US
242735871$24273587$1$I$20231213$20240806$20240902$20240902$PER$$US-ASTELLAS-2024US013648$ASTELLAS$$56$YR$A$M$Y$$$20240830$$HP$US$US
242735881$24273588$1$I$$20240716$20240902$20240902$PER$$US-ASTELLAS-2024US020695$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242735891$24273589$1$I$$20240722$20240902$20240902$PER$$US-ASTELLAS-2024US021192$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242735901$24273590$1$I$20240304$20240418$20240902$20240902$PER$$US-ASTELLAS-2024US006865$ASTELLAS$$55$YR$A$M$Y$$$20240830$$PH$US$US
242735911$24273591$1$I$$20240624$20240902$20240902$PER$$US-ASTELLAS-2024US006210$ASTELLAS$$$$$$Y$$$20240830$$MD$US$US
242735932$24273593$2$F$$20240903$20240902$20240913$30DAY$$US-GSK-US2024AMR107440$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
242735941$24273594$1$I$$20240613$20240902$20240902$PER$$US-ASTELLAS-2024US016934$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242735951$24273595$1$I$$20240708$20240902$20240902$PER$$US-ASTELLAS-2024US019554$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242735961$24273596$1$I$$20240725$20240902$20240902$PER$$US-ASTELLAS-2024US018343$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242735971$24273597$1$I$20240722$20240730$20240902$20240902$PER$$US-ASTELLAS-2024US021858$ASTELLAS$$70$YR$E$M$Y$$$20240830$$MD$US$US
242735981$24273598$1$I$20230712$20240209$20240902$20240902$PER$$US-ASTELLAS-2024US005031$ASTELLAS$$84$YR$E$M$Y$$$20240830$$CN$US$US
242735991$24273599$1$I$$20240213$20240902$20240902$PER$$US-ASTELLAS-2024US002697$ASTELLAS$$$$$$Y$$$20240830$$HP$US$US
242736001$24273600$1$I$$20240722$20240902$20240902$PER$$US-ASTELLAS-2024US016995$ASTELLAS$$84$YR$E$M$Y$$$20240830$$HP$US$US
242736011$24273601$1$I$$20240410$20240902$20240902$PER$$US-ASTELLAS-2024US010963$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242736021$24273602$1$I$$20240503$20240902$20240902$PER$$US-ASTELLAS-2024US011057$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242736031$24273603$1$I$$20240207$20240902$20240902$PER$$US-ASTELLAS-2024US004380$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242736041$24273604$1$I$$20240404$20240902$20240902$PER$$US-ASTELLAS-2024US010444$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242736051$24273605$1$I$20240501$20240604$20240902$20240902$PER$$US-ASTELLAS-2024US014219$ASTELLAS$$75$YR$E$M$Y$$$20240830$$CN$US$US
242736061$24273606$1$I$$20240624$20240902$20240902$PER$$US-ASTELLAS-2024US013130$ASTELLAS$$$$E$M$Y$$$20240830$$PH$US$US
242736071$24273607$1$I$$20240716$20240902$20240902$PER$$US-ASTELLAS-2024US020755$ASTELLAS$$$$A$M$Y$$$20240830$$HP$US$US
242736081$24273608$1$I$20240401$20240402$20240902$20240902$PER$$US-ASTELLAS-2024US010713$ASTELLAS$$74$YR$E$M$Y$$$20240830$$HP$US$US
242736091$24273609$1$I$$20240406$20240902$20240902$PER$$US-ASTELLAS-2024US010889$ASTELLAS$$$$E$M$Y$$$20240830$$MD$US$US
242736101$24273610$1$I$$20240624$20240902$20240902$PER$$US-ASTELLAS-2024US016970$ASTELLAS$$$$E$M$Y$$$20240830$$CN$US$US
242736111$24273611$1$I$$20240711$20240902$20240902$PER$$US-ASTELLAS-2024US020134$ASTELLAS$$59$YR$A$M$Y$$$20240830$$CN$US$US
242736121$24273612$1$I$20240220$20240801$20240902$20240902$PER$$US-ASTELLAS-2024US011965$ASTELLAS$$69$YR$E$M$Y$$$20240830$$MD$US$US
242736131$24273613$1$I$20240101$20240513$20240902$20240902$PER$$US-ASTELLAS-2024US014057$ASTELLAS$$89$YR$E$M$Y$$$20240830$$PH$US$US
242736141$24273614$1$I$20240625$20240627$20240902$20240902$PER$$US-ASTELLAS-2024US018486$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242736151$24273615$1$I$$20240613$20240902$20240902$PER$$US-ASTELLAS-2024US017357$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242736161$24273616$1$I$$20240807$20240902$20240902$PER$$US-ASTELLAS-2024US021921$ASTELLAS$$$$$M$Y$$$20240830$$PH$US$US
242736171$24273617$1$I$20240101$20240822$20240902$20240902$PER$$US-ABBVIE-5894063$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242736181$24273618$1$I$$20240213$20240902$20240902$PER$$US-ASTELLAS-2024US004804$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242736191$24273619$1$I$20240101$20240418$20240902$20240902$PER$$US-ASTELLAS-2024US004979$ASTELLAS$$84$YR$E$M$Y$$$20240830$$MD$US$US
242736201$24273620$1$I$$20240404$20240902$20240902$PER$$US-ASTELLAS-2024US010590$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242736211$24273621$1$I$$20240319$20240902$20240902$PER$$US-ASTELLAS-2024US008455$ASTELLAS$$$$E$F$Y$$$20240830$$CN$US$US
242736221$24273622$1$I$$20231129$20240902$20240902$PER$$US-ASTELLAS-2023US036308$ASTELLAS$$77$YR$E$M$Y$$$20240830$$CN$US$US
242736231$24273623$1$I$$20240709$20240902$20240902$PER$$US-ASTELLAS-2024US019580$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242736241$24273624$1$I$$20240610$20240902$20240902$PER$$US-ASTELLAS-2024US016856$ASTELLAS$$84$YR$E$M$Y$$$20240830$$CN$US$US
242736251$24273625$1$I$$20240604$20240902$20240902$PER$$US-ASTELLAS-2024US012695$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242736261$24273626$1$I$$20240627$20240902$20240902$PER$$US-ASTELLAS-2024US018566$ASTELLAS$$95$YR$E$M$Y$$$20240830$$HP$US$US
242736271$24273627$1$I$$20240219$20240902$20240902$PER$$US-ASTELLAS-2024US005740$ASTELLAS$$80$YR$E$M$Y$$$20240830$$MD$US$US
242736281$24273628$1$I$$20231013$20240902$20240902$PER$$US-ASTELLAS-2023US031238$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242736291$24273629$1$I$$20240419$20240902$20240902$PER$$US-ASTELLAS-2024US011907$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242736301$24273630$1$I$$20240604$20240902$20240902$PER$$US-ASTELLAS-2024US007307$ASTELLAS$$8$DEC$E$M$Y$$$20240830$$MD$US$US
242736311$24273631$1$I$20240314$20240611$20240902$20240902$PER$$US-ASTELLAS-2024US013194$ASTELLAS$$74$YR$E$F$Y$$$20240830$$PH$US$US
242736321$24273632$1$I$20240701$20240729$20240902$20240902$PER$$US-ASTELLAS-2024US021701$ASTELLAS$$90$YR$E$M$Y$$$20240830$$CN$US$US
242736331$24273633$1$I$$20240604$20240902$20240902$PER$$US-ASTELLAS-2024US015605$ASTELLAS$$$$E$M$Y$97.6$KG$20240830$$MD$US$US
242736341$24273634$1$I$$20240726$20240902$20240902$PER$$US-ASTELLAS-2024US017908$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242736351$24273635$1$I$$20231213$20240902$20240902$PER$$US-ASTELLAS-2023US037890$ASTELLAS$$82$YR$E$M$Y$$$20240830$$CN$US$US
242736361$24273636$1$I$20231222$20240226$20240902$20240902$PER$$US-ASTELLAS-2024US002269$ASTELLAS$$96$YR$E$M$Y$$$20240830$$PH$US$US
242736371$24273637$1$I$20231001$20240109$20240902$20240902$PER$$US-ASTELLAS-2023US032654$ASTELLAS$$84$YR$E$M$Y$$$20240830$$MD$US$US
242736381$24273638$1$I$$20240726$20240902$20240902$PER$$US-ASTELLAS-2024US021535$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
242736391$24273639$1$I$$20240422$20240902$20240902$PER$$US-ASTELLAS-2024US002578$ASTELLAS$$80$YR$E$$Y$$$20240830$$MD$US$US
242736401$24273640$1$I$$20240617$20240902$20240902$PER$$US-ASTELLAS-2024US017703$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242736411$24273641$1$I$$20240319$20240902$20240902$PER$$US-ASTELLAS-2024US003036$ASTELLAS$$$$$$Y$$$20240830$$MD$US$US
242736421$24273642$1$I$$20240123$20240902$20240902$PER$$US-ASTELLAS-2024US002561$ASTELLAS$$72$YR$E$M$Y$$$20240830$$HP$US$US
242736431$24273643$1$I$20240605$20240606$20240902$20240902$PER$$US-ASTELLAS-2024US016662$ASTELLAS$$86$YR$E$M$Y$$$20240830$$CN$US$US
242736441$24273644$1$I$$20240411$20240902$20240902$PER$$US-ASTELLAS-2024US011095$ASTELLAS$$80$YR$E$F$Y$$$20240830$$MD$US$US
242736451$24273645$1$I$20240201$20240704$20240902$20240902$PER$$US-ASTELLAS-2024US012657$ASTELLAS$$68$YR$E$M$Y$$$20240830$$CN$US$US
242736462$24273646$2$F$$20240903$20240902$20240911$PER$$US-ASTELLAS-2024US016240$ASTELLAS$$$$$M$Y$$$20240911$$MD$US$US
242736471$24273647$1$I$20240212$20240722$20240902$20240902$PER$$US-ASTELLAS-2024US021159$ASTELLAS$$$$E$M$Y$$$20240830$$CN$US$US
242736481$24273648$1$I$$20240627$20240902$20240902$PER$$US-ASTELLAS-2024US017436$ASTELLAS$$$$A$M$Y$$$20240830$$PH$US$US
242736491$24273649$1$I$$20240325$20240902$20240902$PER$$US-ASTELLAS-2024US009490$ASTELLAS$$65$YR$E$M$Y$$$20240830$$CN$US$US
242736502$24273650$2$F$$20240919$20240902$20240927$PER$$US-ASTELLAS-2024US006519$ASTELLAS$$60$YR$A$M$Y$$$20240927$$CN$US$US
242736511$24273651$1$I$20240601$20240710$20240902$20240902$PER$$US-ASTELLAS-2024US018168$ASTELLAS$$83$YR$E$F$Y$$$20240830$$CN$US$US
242736521$24273652$1$I$20240514$20240611$20240902$20240902$PER$$US-ASTELLAS-2024US014860$ASTELLAS$$8$DEC$E$F$Y$$$20240830$$HP$US$US
242736531$24273653$1$I$$20240326$20240902$20240902$PER$$US-ASTELLAS-2024US009618$ASTELLAS$$60$YR$A$M$Y$$$20240830$$CN$US$US
242736541$24273654$1$I$$20240308$20240902$20240902$PER$$US-ASTELLAS-2024US007810$ASTELLAS$$75$YR$E$M$Y$53.5$KG$20240830$$CN$US$US
242736551$24273655$1$I$20220601$20240603$20240902$20240902$PER$$US-ASTELLAS-2024US008349$ASTELLAS$$73$YR$E$M$Y$81.6$KG$20240830$$CN$US$US
242736561$24273656$1$I$$20240422$20240902$20240902$PER$$US-ASTELLAS-2024US011954$ASTELLAS$$75$YR$E$M$Y$$$20240830$$MD$US$US
242736571$24273657$1$I$$20240326$20240902$20240902$PER$$GT-ASTELLAS-2024US010130$ASTELLAS$$70$YR$E$M$Y$$$20240830$$MD$GT$GT
242736581$24273658$1$I$$20240718$20240902$20240902$PER$$US-ASTELLAS-2024US019645$ASTELLAS$$71$YR$E$M$Y$$$20240830$$PH$US$US
242736591$24273659$1$I$$20240208$20240902$20240902$PER$$US-ASTELLAS-2024US003540$ASTELLAS$$62$YR$A$M$Y$$$20240830$$CN$US$US
242736601$24273660$1$I$$20240311$20240902$20240902$PER$$US-ASTELLAS-2024US006804$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242736611$24273661$1$I$$20240820$20240902$20240902$EXP$$JP-UCBSA-2024042910$UCB$$16$YR$$F$Y$$$20240902$$MD$JP$JP
242736621$24273662$1$I$$20240820$20240902$20240902$EXP$$JP-UCBSA-2024043988$UCB$$13$YR$$M$Y$$$20240902$$MD$JP$JP
242736631$24273663$1$I$$20240422$20240902$20240902$PER$$US-ASTELLAS-2024US003129$ASTELLAS$$$$$$Y$$$20240830$$MD$US$US
242736641$24273664$1$I$$20240118$20240902$20240902$PER$$US-ASTELLAS-2024US002817$ASTELLAS$$86$YR$E$M$Y$$$20240830$$CN$US$US
242736651$24273665$1$I$20231016$20231017$20240902$20240902$PER$$US-ASTELLAS-2023US031345$ASTELLAS$$$$$M$Y$$$20240830$$PH$US$US
242736661$24273666$1$I$20240410$20240430$20240902$20240902$PER$$US-ASTELLAS-2024US011761$ASTELLAS$$$$A$M$Y$$$20240830$$HP$US$US
242736671$24273667$1$I$$20240718$20240902$20240902$PER$$US-ASTELLAS-2024US019768$ASTELLAS$$88$YR$E$M$Y$$$20240830$$PH$US$US
242736681$24273668$1$I$$20240216$20240902$20240902$PER$$US-ASTELLAS-2024US005553$ASTELLAS$$$$$$Y$$$20240830$$CN$US$US
242736691$24273669$1$I$$20240213$20240902$20240902$PER$$US-ASTELLAS-2023US028867$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242736701$24273670$1$I$$20240422$20240902$20240902$PER$$US-ASTELLAS-2024US002630$ASTELLAS$$$$A$$Y$$$20240830$$MD$US$US
242736711$24273671$1$I$$20240508$20240902$20240902$PER$$US-ASTELLAS-2024US013501$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
242736721$24273672$1$I$$20240328$20240902$20240902$PER$$US-ASTELLAS-2023US038453$ASTELLAS$$$$$$Y$$$20240830$$CN$US$US
242736731$24273673$1$I$20240415$20240416$20240902$20240902$PER$$US-ASTELLAS-2024US011475$ASTELLAS$$81$YR$E$M$Y$$$20240830$$PH$US$US
242736741$24273674$1$I$$20240523$20240902$20240902$PER$$US-ASTELLAS-2024US008844$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
242736751$24273675$1$I$$20240123$20240902$20240902$PER$$US-ASTELLAS-2024US002943$ASTELLAS$$$$$M$Y$$$20240830$$PH$US$US
242736761$24273676$1$I$$20240102$20240902$20240902$PER$$US-ASTELLAS-2024US000288$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242736771$24273677$1$I$$20240326$20240902$20240902$PER$$US-ASTELLAS-2023US036521$ASTELLAS$$68$YR$E$M$Y$90.7$KG$20240830$$CN$US$US
242736781$24273678$1$I$20230101$20240406$20240902$20240902$PER$$US-ASTELLAS-2024US009644$ASTELLAS$$80$YR$E$M$Y$90.7$KG$20240830$$CN$US$US
242736791$24273679$1$I$$20240311$20240902$20240902$PER$$US-ASTELLAS-2024US007679$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242736801$24273680$1$I$$20231012$20240902$20240902$PER$$US-ASTELLAS-2023US030739$ASTELLAS$$7$DEC$E$M$Y$$$20240830$$MD$US$US
242736811$24273681$1$I$$20240517$20240902$20240902$PER$$US-ASTELLAS-2024US014705$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242736821$24273682$1$I$20230610$20240215$20240902$20240902$PER$$US-ASTELLAS-2024US001724$ASTELLAS$$82$YR$E$M$Y$79.4$KG$20240830$$CN$US$US
242736831$24273683$1$I$$20231019$20240902$20240902$PER$$US-ASTELLAS-2023US031731$ASTELLAS$$79$YR$E$M$Y$$$20240830$$HP$US$US
242736841$24273684$1$I$20231003$20240326$20240902$20240902$PER$$US-ASTELLAS-2024US006562$ASTELLAS$$60$YR$A$M$Y$$$20240830$$HP$US$US
242736851$24273685$1$I$$20240329$20240902$20240902$PER$$US-ASTELLAS-2024US008630$ASTELLAS$$71$YR$E$M$Y$$$20240830$$PH$US$US
242736861$24273686$1$I$$20240207$20240902$20240902$PER$$US-ASTELLAS-2024US004381$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242736871$24273687$1$I$$20240624$20240902$20240902$PER$$US-ASTELLAS-2024US018134$ASTELLAS$$71$YR$E$M$Y$$$20240830$$CN$US$US
242736881$24273688$1$I$$20231019$20240902$20240902$PER$$US-ASTELLAS-2023US031144$ASTELLAS$$$$E$M$Y$$$20240830$$MD$US$US
242736891$24273689$1$I$$20240205$20240902$20240902$PER$$US-ASTELLAS-2024US003963$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242736901$24273690$1$I$$20231215$20240902$20240902$PER$$US-ASTELLAS-2023US037576$ASTELLAS$$58$YR$A$M$Y$$$20240830$$CN$US$US
242736911$24273691$1$I$$20230920$20240902$20240902$PER$$US-ASTELLAS-2023US028441$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242736921$24273692$1$I$$20230919$20240902$20240902$PER$$US-ASTELLAS-2023US028304$ASTELLAS$$65$YR$E$M$Y$$$20240830$$MD$US$US
242736931$24273693$1$I$20231101$20240306$20240902$20240902$PER$$US-ASTELLAS-2024US007290$ASTELLAS$$72$YR$E$M$Y$$$20240830$$CN$US$US
242736941$24273694$1$I$20240301$20240624$20240902$20240902$PER$$US-ASTELLAS-2024US008960$ASTELLAS$$65$YR$E$M$Y$$$20240830$$MD$US$US
242736951$24273695$1$I$$20231214$20240902$20240902$PER$$US-ASTELLAS-2023US037492$ASTELLAS$$83$YR$E$M$Y$$$20240830$$PH$US$US
242736961$24273696$1$I$20200101$20240102$20240902$20240902$PER$$US-ASTELLAS-2023US037634$ASTELLAS$$59$YR$A$M$Y$$$20240830$$CN$US$US
242736971$24273697$1$I$20240319$20240424$20240902$20240902$PER$$US-ASTELLAS-2024US009551$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
242736981$24273698$1$I$20231120$20231127$20240902$20240902$PER$$US-ASTELLAS-2023US035832$ASTELLAS$$66$YR$E$M$Y$$$20240830$$HP$US$US
242736991$24273699$1$I$$20240603$20240902$20240902$PER$$US-ASTELLAS-2024US012026$ASTELLAS$$$$E$M$Y$$$20240830$$CN$US$US
242737001$24273700$1$I$$20240319$20240902$20240902$PER$$US-ASTELLAS-2024US007300$ASTELLAS$$90$YR$E$M$Y$$$20240830$$MD$US$US
242737011$24273701$1$I$$20240410$20240902$20240902$PER$$US-ASTELLAS-2024US011223$ASTELLAS$$66$YR$E$M$Y$$$20240830$$CN$US$US
242737021$24273702$1$I$$20240702$20240902$20240902$PER$$US-ASTELLAS-2024US018930$ASTELLAS$$66$YR$E$M$Y$$$20240830$$CN$US$US
242737031$24273703$1$I$$20240305$20240902$20240902$PER$$US-ASTELLAS-2024US007153$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737041$24273704$1$I$$20240425$20240902$20240902$PER$$US-ASTELLAS-2024US008411$ASTELLAS$$$$E$M$Y$$$20240830$$CN$US$US
242737051$24273705$1$I$$20240806$20240902$20240902$PER$$US-ASTELLAS-2024US013594$ASTELLAS$$67$YR$E$F$Y$$$20240830$$HP$US$US
242737061$24273706$1$I$$20231115$20240902$20240902$PER$$US-ASTELLAS-2023US034674$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242737071$24273707$1$I$$20240223$20240902$20240902$PER$$US-ASTELLAS-2024US000676$ASTELLAS$$72$YR$E$M$Y$$$20240830$$PH$US$US
242737081$24273708$1$I$$20231017$20240902$20240902$PER$$US-ASTELLAS-2023US031278$ASTELLAS$$75$YR$E$M$Y$$$20240830$$CN$US$US
242737091$24273709$1$I$$20231211$20240902$20240902$PER$$US-ASTELLAS-2023US037630$ASTELLAS$$55$YR$A$M$Y$$$20240830$$CN$US$US
242737101$24273710$1$I$$20231222$20240902$20240902$PER$$US-ASTELLAS-2023US036291$ASTELLAS$$$$$F$Y$$$20240830$$PH$US$US
242737111$24273711$1$I$20230901$20230918$20240902$20240902$PER$$US-ASTELLAS-2023US027067$ASTELLAS$$83$YR$E$M$Y$$$20240830$$CN$US$US
242737121$24273712$1$I$$20240727$20240902$20240902$PER$$US-ASTELLAS-2024US021512$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737131$24273713$1$I$$20231128$20240902$20240902$PER$$US-ASTELLAS-2023US036042$ASTELLAS$$66$YR$E$M$Y$$$20240830$$CN$US$US
242737141$24273714$1$I$$20231229$20240902$20240902$PER$$US-ASTELLAS-2024US000079$ASTELLAS$$67$YR$E$M$Y$$$20240830$$CN$US$US
242737151$24273715$1$I$$20240808$20240902$20240902$PER$$US-ASTELLAS-2024US015828$ASTELLAS$$70$YR$E$F$Y$$$20240830$$MD$US$US
242737161$24273716$1$I$$20240522$20240902$20240902$PER$$US-ASTELLAS-2024US012468$ASTELLAS$$72$YR$E$M$Y$$$20240830$$CN$US$US
242737171$24273717$1$I$20231001$20231110$20240902$20240902$PER$$US-ASTELLAS-2023US034249$ASTELLAS$$$$A$M$Y$$$20240830$$CN$US$US
242737181$24273718$1$I$$20240118$20240902$20240902$PER$$US-ASTELLAS-2024US002418$ASTELLAS$$58$YR$A$M$Y$$$20240830$$MD$US$US
242737191$24273719$1$I$$20231106$20240902$20240902$PER$$US-ASTELLAS-2023US033521$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242737201$24273720$1$I$$20240514$20240902$20240902$PER$$US-ASTELLAS-2024US012090$ASTELLAS$$71$YR$E$M$Y$$$20240830$$CN$US$US
242737211$24273721$1$I$20231201$20240116$20240902$20240902$PER$$US-ASTELLAS-2024US001701$ASTELLAS$$$$$M$Y$$$20240830$$PH$US$US
242737221$24273722$1$I$20230101$20240411$20240902$20240902$PER$$US-ASTELLAS-2024US001243$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737231$24273723$1$I$$20240429$20240902$20240902$PER$$US-ASTELLAS-2024US008822$ASTELLAS$$68$YR$E$M$Y$$$20240830$$CN$US$US
242737241$24273724$1$I$$20230912$20240902$20240902$PER$$US-ASTELLAS-2023US027728$ASTELLAS$$79$YR$E$M$Y$76.2$KG$20240830$$CN$US$US
242737251$24273725$1$I$20230904$20230922$20240902$20240902$PER$$US-ASTELLAS-2023US027533$ASTELLAS$$74$YR$E$M$Y$$$20240830$$CN$US$US
242737261$24273726$1$I$$20240604$20240902$20240902$PER$$US-ASTELLAS-2024US015750$ASTELLAS$$88$YR$E$M$Y$$$20240830$$MD$US$US
242737271$24273727$1$I$$20231214$20240902$20240902$PER$$US-ASTELLAS-2023US037887$ASTELLAS$$51$YR$A$M$Y$$$20240830$$CN$US$US
242737281$24273728$1$I$$20240214$20240902$20240902$PER$$US-ASTELLAS-2024US005319$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737291$24273729$1$I$$20231024$20240902$20240902$PER$$US-ASTELLAS-2023US032155$ASTELLAS$$$$$$Y$$$20240830$$CN$US$US
242737301$24273730$1$I$$20240604$20240902$20240902$PER$$US-ASTELLAS-2024US016386$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737311$24273731$1$I$$20231011$20240902$20240902$PER$$US-ASTELLAS-2023US028220$ASTELLAS$$77$YR$E$M$Y$$$20240830$$MD$US$US
242737321$24273732$1$I$$20240725$20240902$20240902$PER$$US-ASTELLAS-2024US021672$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242737331$24273733$1$I$$20240321$20240902$20240902$PER$$US-ASTELLAS-2024US007757$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242737341$24273734$1$I$$20231117$20240902$20240902$PER$$US-ASTELLAS-2023US035266$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737351$24273735$1$I$$20240116$20240902$20240902$PER$$US-ASTELLAS-2024US001512$ASTELLAS$$$$A$M$Y$$$20240830$$CN$US$US
242737361$24273736$1$I$$20240507$20240902$20240902$PER$$US-ASTELLAS-2024US013521$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737371$24273737$1$I$$20240111$20240902$20240902$PER$$US-ASTELLAS-2024US001420$ASTELLAS$$$$E$M$Y$$$20240830$$MD$US$US
242737381$24273738$1$I$$20230905$20240902$20240902$PER$$US-ASTELLAS-2023US026848$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242737391$24273739$1$I$$20230925$20240902$20240902$PER$$US-ASTELLAS-2023US028943$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242737401$24273740$1$I$$20240610$20240902$20240902$PER$$US-ASTELLAS-2024US016805$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
242737411$24273741$1$I$$20240604$20240902$20240902$PER$$US-ASTELLAS-2024US016484$ASTELLAS$$86$YR$E$M$Y$$$20240830$$CN$US$US
242737421$24273742$1$I$$20231129$20240902$20240902$PER$$US-ASTELLAS-2023US035934$ASTELLAS$$$$$$Y$$$20240830$$CN$US$US
242737431$24273743$1$I$$20240806$20240902$20240902$PER$$US-ASTELLAS-2024US013645$ASTELLAS$$74$YR$E$F$Y$$$20240830$$HP$US$US
242737441$24273744$1$I$$20240605$20240902$20240902$PER$$US-ASTELLAS-2024US016671$ASTELLAS$$71$YR$E$M$Y$$$20240830$$PH$US$US
242737451$24273745$1$I$$20240103$20240902$20240902$PER$$US-ASTELLAS-2024US000452$ASTELLAS$$81$YR$E$M$Y$$$20240830$$MD$US$US
242737461$24273746$1$I$$20231226$20240902$20240902$PER$$US-ASTELLAS-2023US038799$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242737471$24273747$1$I$$20240513$20240902$20240902$PER$$US-ASTELLAS-2024US014153$ASTELLAS$$67$YR$E$M$Y$$$20240830$$CN$US$US
242737481$24273748$1$I$$20231129$20240902$20240902$PER$$US-ASTELLAS-2023US035941$ASTELLAS$$$$$$Y$$$20240830$$CN$US$US
242737491$24273749$1$I$$20231026$20240902$20240902$PER$$US-ASTELLAS-2023US031865$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242737501$24273750$1$I$$20240202$20240902$20240902$PER$$US-ASTELLAS-2024US003971$ASTELLAS$$$$$M$Y$$$20240830$$PH$US$US
242737511$24273751$1$I$$20231205$20240902$20240902$PER$$US-ASTELLAS-2023US036544$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737521$24273752$1$I$20230711$20231006$20240902$20240902$PER$$US-ASTELLAS-2023US030751$ASTELLAS$$85$YR$E$M$Y$73.9$KG$20240830$$CN$US$US
242737531$24273753$1$I$$20231013$20240902$20240902$PER$$US-ASTELLAS-2023US029826$ASTELLAS$$$$A$M$Y$$$20240830$$HP$US$US
242737541$24273754$1$I$20230807$20231218$20240902$20240902$PER$$US-ASTELLAS-2023US038070$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242737551$24273755$1$I$$20230914$20240902$20240902$PER$$US-ASTELLAS-2023US027948$ASTELLAS$$65$YR$E$M$Y$$$20240830$$MD$US$US
242737561$24273756$1$I$$20231206$20240902$20240902$PER$$US-ASTELLAS-2023US036953$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737571$24273757$1$I$$20240422$20240902$20240902$PER$$US-ASTELLAS-2024US012028$ASTELLAS$$83$YR$E$M$Y$$$20240830$$CN$US$US
242737581$24273758$1$I$20240701$20240708$20240902$20240902$PER$$US-ASTELLAS-2024US019425$ASTELLAS$$55$YR$A$F$Y$$$20240830$$MD$US$US
242737591$24273759$1$I$$20240429$20240902$20240902$PER$$US-ASTELLAS-2024US012860$ASTELLAS$$68$YR$E$M$Y$$$20240830$$CN$US$US
242737601$24273760$1$I$$20240125$20240902$20240902$PER$$US-ASTELLAS-2024US001491$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242737611$24273761$1$I$$20231219$20240902$20240902$PER$$US-ASTELLAS-2023US038457$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242737621$24273762$1$I$$20230920$20240902$20240902$PER$$US-ASTELLAS-2023US028431$ASTELLAS$$86$YR$E$M$Y$$$20240830$$HP$US$US
242737631$24273763$1$I$$20240213$20240902$20240902$PER$$US-ASTELLAS-2024US004577$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242737641$24273764$1$I$$20240321$20240902$20240902$PER$$US-ASTELLAS-2024US009266$ASTELLAS$$82$YR$E$M$Y$$$20240830$$CN$US$US
242737651$24273765$1$I$$20240501$20240902$20240902$PER$$US-ASTELLAS-2024US003914$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737661$24273766$1$I$$20240222$20240902$20240902$PER$$US-ASTELLAS-2024US001457$ASTELLAS$$$$E$M$Y$$$20240830$$CN$US$US
242737671$24273767$1$I$20230501$20231010$20240902$20240902$PER$$US-ASTELLAS-2023US029683$ASTELLAS$$77$YR$E$M$Y$$$20240830$$HP$US$US
242737681$24273768$1$I$$20240523$20240902$20240902$PER$$US-ASTELLAS-2024US015166$ASTELLAS$$64$YR$A$M$Y$$$20240830$$CN$US$US
242737691$24273769$1$I$20240314$20240507$20240902$20240902$PER$$US-ASTELLAS-2024US008972$ASTELLAS$$69$YR$E$F$Y$$$20240830$$CN$US$US
242737701$24273770$1$I$$20230907$20240902$20240902$PER$$US-ASTELLAS-2023US027368$ASTELLAS$$95$YR$E$M$Y$$$20240830$$CN$US$US
242737711$24273771$1$I$$20240617$20240902$20240902$PER$$US-ASTELLAS-2024US017648$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737721$24273772$1$I$$20230912$20240902$20240902$PER$$US-ASTELLAS-2023US027535$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737731$24273773$1$I$$20240516$20240902$20240902$PER$$US-ASTELLAS-2024US014414$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242737741$24273774$1$I$$20231219$20240902$20240902$PER$$US-ASTELLAS-2023US038138$ASTELLAS$$84$YR$E$M$Y$$$20240830$$PH$US$US
242737751$24273775$1$I$$20231021$20240902$20240902$PER$$US-ASTELLAS-2023US031807$ASTELLAS$$9$DEC$E$M$Y$$$20240830$$MD$US$US
242737761$24273776$1$I$$20230927$20240902$20240902$PER$$US-ASTELLAS-2023US029052$ASTELLAS$$90$YR$E$M$Y$$$20240830$$MD$US$US
242737771$24273777$1$I$$20240807$20240902$20240902$PER$$US-ASTELLAS-2024US021911$ASTELLAS$$$$$M$Y$$$20240830$$PH$US$US
242737781$24273778$1$I$$20240514$20240902$20240902$PER$$US-ASTELLAS-2024US005152$ASTELLAS$$$$E$F$Y$$$20240830$$HP$US$US
242737791$24273779$1$I$$20231219$20240902$20240902$PER$$US-ASTELLAS-2023US038456$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242737801$24273780$1$I$$20230919$20240902$20240902$PER$$US-ASTELLAS-2023US028300$ASTELLAS$$8$DEC$E$M$Y$$$20240830$$MD$US$US
242737811$24273781$1$I$$20240718$20240902$20240902$PER$$US-ASTELLAS-2024US020736$ASTELLAS$$80$YR$E$M$Y$$$20240830$$HP$US$US
242737821$24273782$1$I$$20240612$20240902$20240902$PER$$US-ASTELLAS-2024US017361$ASTELLAS$$68$YR$E$M$Y$$$20240830$$CN$US$US
242737831$24273783$1$I$$20240321$20240902$20240902$PER$$US-ASTELLAS-2024US002354$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737841$24273784$1$I$$20240531$20240902$20240902$PER$$US-ASTELLAS-2024US014372$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242737851$24273785$1$I$$20240305$20240902$20240902$PER$$US-ASTELLAS-2024US006963$ASTELLAS$$90$YR$E$M$Y$$$20240830$$CN$US$US
242737861$24273786$1$I$20240304$20240402$20240902$20240902$PER$$US-ASTELLAS-2024US010398$ASTELLAS$$75$YR$E$M$Y$$$20240830$$HP$US$US
242737871$24273787$1$I$20231015$20240419$20240902$20240902$PER$$US-ASTELLAS-2024US002920$ASTELLAS$$66$YR$E$M$Y$$$20240830$$MD$US$US
242737881$24273788$1$I$$20240606$20240902$20240902$PER$$US-ASTELLAS-2024US016552$ASTELLAS$$79$YR$E$M$Y$$$20240830$$CN$US$US
242737891$24273789$1$I$$20240408$20240902$20240902$PER$$US-ASTELLAS-2024US010962$ASTELLAS$$$$E$$Y$$$20240830$$MD$US$US
242737901$24273790$1$I$$20231130$20240902$20240902$PER$$US-ASTELLAS-2023US036094$ASTELLAS$$84$YR$E$M$Y$$$20240830$$MD$US$US
242737911$24273791$1$I$20231025$20240627$20240902$20240902$PER$$US-ASTELLAS-2024US008220$ASTELLAS$$62$YR$A$M$Y$$$20240830$$PH$US$US
242737921$24273792$1$I$$20240607$20240902$20240902$PER$$US-ASTELLAS-2024EU005029$ASTELLAS$$63$YR$A$M$Y$$$20240830$$CN$US$US
242737931$24273793$1$I$$20231206$20240902$20240902$PER$$US-ASTELLAS-2023US036980$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242737941$24273794$1$I$$20240111$20240902$20240902$PER$$US-ASTELLAS-2024US001259$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242737951$24273795$1$I$$20240522$20240902$20240902$PER$$US-ASTELLAS-2024US015007$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737961$24273796$1$I$20240605$20240605$20240902$20240902$PER$$US-ASTELLAS-2024US016482$ASTELLAS$$74$YR$E$M$Y$$$20240830$$CN$US$US
242737971$24273797$1$I$20230830$20240202$20240902$20240902$PER$$US-ASTELLAS-2024US000821$ASTELLAS$$65$YR$E$M$Y$$$20240830$$MD$US$US
242737981$24273798$1$I$$20240516$20240902$20240902$PER$$US-ASTELLAS-2024US013050$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242737991$24273799$1$I$20230201$20240112$20240902$20240902$PER$$US-ASTELLAS-2023US037518$ASTELLAS$$69$YR$E$M$Y$$$20240830$$CN$US$US
242738001$24273800$1$I$$20240322$20240902$20240902$PER$$US-ASTELLAS-2024US009220$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242738011$24273801$1$I$$20240305$20240902$20240902$PER$$US-ASTELLAS-2024US007539$ASTELLAS$$$$$$Y$$$20240830$$MD$US$US
242738021$24273802$1$I$$20240220$20240902$20240902$PER$$US-ASTELLAS-2024US005702$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242738031$24273803$1$I$$20240215$20240902$20240902$PER$$US-ASTELLAS-2024US005147$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242738041$24273804$1$I$$20240603$20240902$20240902$PER$$US-ASTELLAS-2024US016141$ASTELLAS$$65$YR$E$M$Y$$$20240830$$CN$US$US
242738051$24273805$1$I$$20231127$20240902$20240902$PER$$US-ASTELLAS-2023US035970$ASTELLAS$$51$YR$A$M$Y$$$20240830$$MD$US$US
242738061$24273806$1$I$$20240426$20240902$20240902$PER$$US-ASTELLAS-2024US003210$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
242738071$24273807$1$I$$20240401$20240902$20240902$PER$$US-ASTELLAS-2024US010143$ASTELLAS$$68$YR$E$M$Y$$$20240830$$HP$US$US
242738081$24273808$1$I$20240801$20240822$20240902$20240902$PER$$US-ABBVIE-5893867$ABBVIE$$31$YR$$M$Y$$$20240902$$MD$US$US
242738091$24273809$1$I$$20240105$20240902$20240902$PER$$US-ASTELLAS-2024US000798$ASTELLAS$$83$YR$E$M$Y$$$20240830$$CN$US$US
242738101$24273810$1$I$20240102$20240411$20240902$20240902$PER$$US-ASTELLAS-2024US001232$ASTELLAS$$9$DEC$E$F$Y$$$20240830$$MD$US$US
242738111$24273811$1$I$$20240808$20240902$20240902$PER$$US-ASTELLAS-2024US013682$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
242738121$24273812$1$I$20180101$20240522$20240902$20240902$PER$$US-ASTELLAS-2024US015566$ASTELLAS$$73$YR$E$M$Y$$$20240830$$CN$US$US
242738131$24273813$1$I$$20240530$20240902$20240902$PER$$US-ASTELLAS-2024US005878$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242738141$24273814$1$I$$20231205$20240902$20240902$PER$$US-ASTELLAS-2023US036813$ASTELLAS$$9$DEC$E$M$Y$$$20240830$$HP$US$US
242738151$24273815$1$I$$20230920$20240902$20240902$PER$$US-ASTELLAS-2023US028489$ASTELLAS$$87$YR$E$M$Y$$$20240830$$CN$US$US
242738161$24273816$1$I$$20231006$20240902$20240902$PER$$US-ASTELLAS-2023US030008$ASTELLAS$$72$YR$E$M$Y$$$20240830$$MD$US$US
242738171$24273817$1$I$$20240102$20240902$20240902$PER$$US-ASTELLAS-2023US037842$ASTELLAS$$$$$M$Y$$$20240830$$PH$US$US
242738181$24273818$1$I$20231101$20231206$20240902$20240902$PER$$US-ASTELLAS-2023US036920$ASTELLAS$$71$YR$E$M$Y$$$20240830$$CN$US$US
242738191$24273819$1$I$$20240717$20240902$20240902$PER$$US-ASTELLAS-2024US020702$ASTELLAS$$$$$M$Y$$$20240830$$PH$US$US
242738201$24273820$1$I$$20240521$20240902$20240902$PER$$US-ASTELLAS-2024US015113$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242738211$24273821$1$I$$20240514$20240902$20240902$PER$$US-ASTELLAS-2024US014371$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242738221$24273822$1$I$20220101$20240406$20240902$20240902$PER$$US-ASTELLAS-2024US010908$ASTELLAS$$80$YR$E$M$Y$$$20240830$$CN$US$US
242738231$24273823$1$I$$20240604$20240902$20240902$PER$$US-ASTELLAS-2024US016253$ASTELLAS$$78$YR$E$M$Y$$$20240830$$CN$US$US
242738241$24273824$1$I$$20240514$20240902$20240902$PER$$US-ASTELLAS-2024US014373$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242738251$24273825$1$I$$20240314$20240902$20240902$PER$$US-ASTELLAS-2024US008510$ASTELLAS$$78$YR$E$M$Y$$$20240830$$PH$US$US
242738261$24273826$1$I$20240507$20240607$20240902$20240902$PER$$US-ASTELLAS-2024US016848$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242738271$24273827$1$I$$20231110$20240902$20240902$PER$$US-ASTELLAS-2023US034079$ASTELLAS$$67$YR$E$M$Y$$$20240830$$HP$US$US
242738281$24273828$1$I$20240501$20240524$20240902$20240902$PER$$US-ASTELLAS-2024US014680$ASTELLAS$$80$YR$E$F$Y$$$20240830$$MD$US$US
242738291$24273829$1$I$20231004$20240411$20240902$20240902$PER$$US-ASTELLAS-2024US011246$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242738301$24273830$1$I$$20240521$20240902$20240902$PER$$US-ASTELLAS-2024US014681$ASTELLAS$$$$E$M$Y$$$20240830$$PH$US$US
242738311$24273831$1$I$$20231016$20240902$20240902$PER$$US-ASTELLAS-2023US030918$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242738321$24273832$1$I$$20240215$20240902$20240902$PER$$US-ASTELLAS-2024US005309$ASTELLAS$$84$YR$E$M$Y$$$20240830$$HP$US$US
242738331$24273833$1$I$$20240329$20240902$20240902$PER$$US-ASTELLAS-2024US009967$ASTELLAS$$66$YR$E$M$Y$$$20240830$$CN$US$US
242738341$24273834$1$I$20230501$20240118$20240902$20240902$PER$$US-ASTELLAS-2024US000646$ASTELLAS$$62$YR$A$M$Y$$$20240830$$HP$US$US
242738351$24273835$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-089385-2024$RECKITT BENCKISER$$$$$$Y$$$20240902$$CN$US$US
242738361$24273836$1$I$20240805$20240830$20240902$20240902$EXP$FR-AFSSAPS-PB2024000936$FR-SANDOZ INC.-SDZ2024FR076564$SANDOZ$$84$YR$$F$Y$$$20240902$$PH$FR$FR
242738371$24273837$1$I$20240824$20240825$20240902$20240902$EXP$GB-MHRA-MED-202408250908130170-TVYHK$GB-GUERBET / LLC-GB-20240113$GUERBET$$64$YR$A$M$Y$112$KG$20240902$$HP$GB$GB
242738381$24273838$1$I$$20240829$20240902$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013903$JAZZ$$$$$F$Y$$$20240902$$CN$US$US
242738391$24273839$1$I$20240727$20240821$20240902$20240902$PER$$US-JNJFOC-20240881718$JOHNSON AND JOHNSON$$63$YR$A$M$Y$81$KG$20240902$$MD$US$US
242738401$24273840$1$I$$20240819$20240902$20240902$EXP$$US-UCBSA-2024042286$UCB$$$$$F$Y$72.8$KG$20240902$$HP$US$US
242738412$24273841$2$F$$20240826$20240902$20240905$EXP$AU-TGA-0000816815$AU-JNJFOC-20240879176$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240905$$MD$AU$AU
242738421$24273842$1$I$$20240823$20240902$20240902$EXP$GB-MHRA-MIDB-222191ba-f6bf-4a90-93ce-9ba0b3e1c4dc$GB-TEVA-VS-3236889$TEVA$$59$YR$$F$Y$$$20240902$$PH$GB$GB
242738431$24273843$1$I$20240829$20240829$20240902$20240902$PER$$US-ALXN-202408USA002057US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240902$$CN$US$US
242738441$24273844$1$I$20240825$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019196$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240902$$MD$US$US
242738451$24273845$1$I$20240521$20240823$20240902$20240902$EXP$GB-MHRA-MED-202408231519288800-WHGZV$GB-TEVA-VS-3237202$TEVA$$57$YR$$M$Y$83$KG$20240902$$PH$GB$GB
242738462$24273846$2$F$$20240924$20240902$20240927$EXP$$CA-PFIZER INC-202400247404$PFIZER$$$$N$$Y$$$20240927$$HP$CA$CA
242738471$24273847$1$I$$20240827$20240902$20240902$EXP$$ES-ABBVIE-5901049$ABBVIE$$$$$M$Y$$$20240902$$CN$ES$ES
242738481$24273848$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-087151-2024$RECKITT BENCKISER$$74$YR$$F$Y$97.73$KG$20240902$$CN$US$US
242738492$24273849$2$F$$20240827$20240902$20240909$EXP$$US-SA-2024SA252749$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240909$$CN$US$US
242738501$24273850$1$I$$20240821$20240902$20240902$PER$$US-SA-2024SA253916$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240902$$MD$US$US
242738511$24273851$1$I$$20240820$20240902$20240902$PER$$US-AMGEN-USASP2024174887$AMGEN$$$$$$Y$$$20240902$$MD$US$US
242738522$24273852$2$F$$20240904$20240902$20240916$EXP$$CA-AMGEN-CANSP2024170867$AMGEN$$43$YR$A$F$Y$96$KG$20240916$$HP$CA$CA
242738531$24273853$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173863$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242738541$24273854$1$I$20240827$20240828$20240902$20240902$EXP$$KR-PFIZER INC-202400245636$PFIZER$$66$YR$$F$Y$$$20240902$$CN$KR$KR
242738551$24273855$1$I$$20240131$20240902$20240902$PER$$US-ASTELLAS-2024US003539$ASTELLAS$$83$YR$E$M$Y$$$20240830$$HP$US$US
242738561$24273856$1$I$$20240827$20240902$20240902$EXP$$NVSC2024US175182$NOVARTIS$Boozel T, Moran J, Godil S, Lenivy C, Musco K, Lustgarten DS. What about the rash? a case of disseminated varicella zoster virus leading to ards.. CHEST. 2020;158(4):A2047-8$58$YR$$F$Y$$$20240902$$HP$US$US
242738571$24273857$1$I$$20240826$20240902$20240902$EXP$$CA-ABBVIE-5902111$ABBVIE$$81$YR$$F$Y$$$20240902$$HP$CA$CA
242738581$24273858$1$I$20240212$20240612$20240902$20240902$PER$$US-ASTELLAS-2024US006418$ASTELLAS$$74$YR$E$M$Y$$$20240830$$HP$US$US
242738592$24273859$2$F$20240601$20240903$20240902$20240904$EXP$$US-ABBVIE-5899784$ABBVIE$$54$YR$$F$Y$$$20240904$$CN$US$US
242738601$24273860$1$I$$20240821$20240902$20240902$EXP$GB-MHRA-MED-202408211344193490-JDYTS$GB-Accord-442927$ACCORD$$82$YR$E$F$Y$$$20240902$$HP$GB$GB
242738611$24273861$1$I$$20240828$20240902$20240902$EXP$$US-PFIZER INC-PV202400113258$PFIZER$$73$YR$$M$Y$$$20240902$$CN$US$US
242738621$24273862$1$I$20240828$20240828$20240902$20240902$EXP$$CA-PFIZER INC-202400247473$PFIZER$$30$YR$$F$Y$$$20240902$$HP$CA$CA
242738631$24273863$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-085620-2024$RECKITT BENCKISER$$$$$M$Y$$$20240902$$CN$US$US
242738641$24273864$1$I$20240820$20240821$20240902$20240902$EXP$$US-SA-2024SA254263$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240902$$MD$US$US
242738651$24273865$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138639$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240902$$CN$US$US
242738662$24273866$2$F$20240815$20240904$20240902$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139186$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240906$$CN$US$US
242738671$24273867$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138492$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240902$$CN$US$US
242738682$24273868$2$F$$20240823$20240902$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-136316$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240905$$MD$JP$JP
242738691$24273869$1$I$$20240630$20240902$20240902$PER$$US-ASTELLAS-2024US018720$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242738701$24273870$1$I$$20240725$20240902$20240902$PER$$US-ASTELLAS-2024US021508$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242738711$24273871$1$I$20240612$20240612$20240902$20240902$PER$$US-ASTELLAS-2024US017039$ASTELLAS$$66$YR$E$M$Y$$$20240830$$CN$US$US
242738721$24273872$1$I$$20240327$20240902$20240902$PER$$US-ASTELLAS-2024US009664$ASTELLAS$$$$$F$Y$$$20240830$$CN$US$US
242738731$24273873$1$I$$20240109$20240902$20240902$PER$$US-ASTELLAS-2024US001140$ASTELLAS$$78$YR$E$M$Y$$$20240830$$CN$US$US
242738741$24273874$1$I$$20240411$20240902$20240902$PER$$US-ASTELLAS-2024US011125$ASTELLAS$$90$YR$E$M$Y$$$20240830$$HP$US$US
242738751$24273875$1$I$$20240528$20240902$20240902$PER$$US-ASTELLAS-2024US015734$ASTELLAS$$81$YR$E$M$Y$$$20240830$$CN$US$US
242738761$24273876$1$I$$20240123$20240902$20240902$PER$$US-ASTELLAS-2024US001707$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
242738771$24273877$1$I$$20240405$20240902$20240902$PER$$US-ASTELLAS-2024US011054$ASTELLAS$$77$YR$E$M$Y$107.9$KG$20240830$$MD$US$US
242738781$24273878$1$I$$20240307$20240902$20240902$PER$$US-ASTELLAS-2024US007744$ASTELLAS$$77$YR$E$M$Y$$$20240830$$CN$US$US
242738791$24273879$1$I$20240701$20240718$20240902$20240902$PER$$US-ASTELLAS-2024US020140$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242738801$24273880$1$I$$20231009$20240902$20240902$PER$$US-ASTELLAS-2023US030405$ASTELLAS$$94$YR$E$M$Y$$$20240830$$HP$US$US
242738811$24273881$1$I$$20240213$20240902$20240902$PER$$US-ASTELLAS-2023US034483$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242738821$24273882$1$I$$20231121$20240902$20240902$PER$$US-ASTELLAS-2023US035372$ASTELLAS$$$$E$M$Y$$$20240830$$HP$US$US
242738831$24273883$1$I$20240130$20240412$20240902$20240902$PER$$US-ASTELLAS-2024US009774$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242738841$24273884$1$I$$20231012$20240902$20240902$PER$$US-ASTELLAS-2023US030913$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242738851$24273885$1$I$$20240206$20240902$20240902$PER$$US-ASTELLAS-2024US004312$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242738861$24273886$1$I$$20240411$20240902$20240902$PER$$US-ASTELLAS-2024US010909$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242738871$24273887$1$I$20231026$20231110$20240902$20240902$PER$$US-ASTELLAS-2023US034462$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242738881$24273888$1$I$20240401$20240405$20240902$20240902$PER$$US-ASTELLAS-2024US010750$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242738891$24273889$1$I$$20231116$20240902$20240902$PER$$US-ASTELLAS-2023US033690$ASTELLAS$$78$YR$E$M$Y$$$20240830$$PH$US$US
242738901$24273890$1$I$$20230831$20240902$20240902$PER$$US-ASTELLAS-2023US026750$ASTELLAS$$$$A$M$Y$$$20240830$$MD$US$US
242738911$24273891$1$I$$20240215$20240902$20240902$PER$$US-ASTELLAS-2024US005149$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242738921$24273892$1$I$$20240106$20240902$20240902$PER$$US-ASTELLAS-2023US034114$ASTELLAS$$75$YR$E$M$Y$$$20240830$$MD$US$US
242738931$24273893$1$I$$20231012$20240902$20240902$PER$$US-ASTELLAS-2023US030741$ASTELLAS$$7$DEC$E$M$Y$$$20240830$$MD$US$US
242738941$24273894$1$I$$20230928$20240902$20240902$PER$$US-ASTELLAS-2023US029413$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242738951$24273895$1$I$20240709$20240731$20240902$20240902$PER$$US-ASTELLAS-2024US020202$ASTELLAS$$$$$M$Y$$$20240830$$PH$US$US
242738961$24273896$1$I$$20240508$20240902$20240902$PER$$US-ASTELLAS-2024US007280$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242738971$24273897$1$I$$20240507$20240902$20240902$PER$$US-ASTELLAS-2024US013615$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242738981$24273898$1$I$20240301$20240326$20240902$20240902$PER$$US-ASTELLAS-2024US009721$ASTELLAS$$79$YR$E$M$Y$$$20240830$$CN$US$US
242738991$24273899$1$I$$20240709$20240902$20240902$PER$$US-ASTELLAS-2024US016203$ASTELLAS$$75$YR$E$M$Y$$$20240830$$MD$US$US
242739001$24273900$1$I$20240201$20240524$20240902$20240902$PER$$US-ASTELLAS-2024US006205$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242739011$24273901$1$I$20230101$20231107$20240902$20240902$PER$$US-ASTELLAS-2023US033752$ASTELLAS$$$$A$M$Y$$$20240830$$CN$US$US
242739021$24273902$1$I$20230101$20240716$20240902$20240902$PER$$US-ASTELLAS-2024US018158$ASTELLAS$$89$YR$E$M$Y$$$20240830$$CN$US$US
242739031$24273903$1$I$$20240416$20240902$20240902$PER$$US-ASTELLAS-2024US011703$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242739041$24273904$1$I$$20240219$20240902$20240902$PER$$US-ASTELLAS-2024US005456$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242739051$24273905$1$I$$20231205$20240902$20240902$PER$$US-ASTELLAS-2023US036562$ASTELLAS$$82$YR$E$M$Y$$$20240830$$CN$US$US
242739061$24273906$1$I$20240101$20240125$20240902$20240902$PER$$US-ASTELLAS-2024US002687$ASTELLAS$$90$YR$E$M$Y$$$20240830$$HP$US$US
242739071$24273907$1$I$$20240403$20240902$20240902$PER$$US-ASTELLAS-2024US006613$ASTELLAS$$68$YR$E$M$Y$$$20240830$$HP$US$US
242739081$24273908$1$I$$20240222$20240902$20240902$PER$$US-ASTELLAS-2024US006192$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242739091$24273909$1$I$$20231010$20240902$20240902$PER$$US-ASTELLAS-2023US030483$ASTELLAS$$$$$F$Y$$$20240830$$CN$US$US
242739101$24273910$1$I$$20240531$20240902$20240902$PER$$US-ASTELLAS-2024US016114$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242739111$24273911$1$I$$20231212$20240902$20240902$PER$$US-ASTELLAS-2023US035953$ASTELLAS$$82$YR$E$M$Y$$$20240830$$CN$US$US
242739121$24273912$1$I$$20240109$20240902$20240902$PER$$US-ASTELLAS-2024US000891$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242739131$24273913$1$I$$20240618$20240902$20240902$PER$$US-ASTELLAS-2024US018053$ASTELLAS$$$$E$M$Y$67.2$KG$20240830$$MD$US$US
242739141$24273914$1$I$$20240612$20240902$20240902$PER$$US-ASTELLAS-2024US017143$ASTELLAS$$85$YR$E$M$Y$$$20240830$$HP$US$US
242739151$24273915$1$I$$20231204$20240902$20240902$PER$$US-ASTELLAS-2023US036519$ASTELLAS$$68$YR$E$M$Y$$$20240830$$MD$US$US
242739161$24273916$1$I$$20240628$20240902$20240902$PER$$US-ASTELLAS-2024US018520$ASTELLAS$$$$A$M$Y$$$20240830$$PH$US$US
242739171$24273917$1$I$$20240702$20240902$20240902$PER$$US-ASTELLAS-2024US018879$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
242739181$24273918$1$I$$20240805$20240902$20240902$PER$$US-ASTELLAS-2024US022357$ASTELLAS$$76$YR$E$M$Y$$$20240830$$CN$US$US
242739191$24273919$1$I$$20231205$20240902$20240902$PER$$US-ASTELLAS-2023US036770$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242739201$24273920$1$I$$20240213$20240902$20240902$PER$$US-ASTELLAS-2024US004819$ASTELLAS$$80$YR$E$M$Y$$$20240830$$CN$US$US
242739211$24273921$1$I$$20231214$20240902$20240902$PER$$US-ASTELLAS-2023US037885$ASTELLAS$$74$YR$E$M$Y$$$20240830$$CN$US$US
242739221$24273922$1$I$20240826$20240826$20240902$20240902$EXP$$AT-ROCHE-10000067577$ROCHE$$56$YR$A$F$Y$$$20240902$$HP$AT$AT
242739231$24273923$1$I$20230101$20240703$20240902$20240902$PER$$US-ASTELLAS-2024US018841$ASTELLAS$$84$YR$E$M$Y$$$20240830$$CN$US$US
242739241$24273924$1$I$20240301$20240429$20240902$20240902$PER$$US-ASTELLAS-2024US010736$ASTELLAS$$84$YR$E$M$Y$$$20240830$$CN$US$US
242739251$24273925$1$I$20240101$20240821$20240902$20240902$PER$$US-JNJFOC-20240859507$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$CN$US$US
242739262$24273926$2$F$$20240918$20240902$20240927$EXP$$JP-TEVA-VS-3237429$TEVA$Hara M, Mandai S, Mori T, Maejima Y, Uchida S. Takayasu arteritis manifesting as acute kidney injury and congestion due to renal artery stenosis and myocarditis: a case report. Eur-Heart-J-Case-Rep 2024; 8 (8); Hara M, Mandai S, Mori T, Maejima Y, Uchida S. Takayasu arteritis manifesting as acute kidney injury and congestion due to renal artery stenosis and myocarditis: a case report. Eur-Heart-J-Case-Rep 2024; 8 (8):.; Hara M, Mandai S, Mori T, Maejima Y, Uchida S. Takayasu arteritis manifes...$18$YR$$F$Y$$$20240927$$HP$JP$JP
242739271$24273927$1$I$$20240822$20240902$20240902$EXP$$JP-ASTELLAS-2024-AER-001414$ASTELLAS$$$$$$Y$$$20240902$$MD$JP$JP
242739281$24273928$1$I$$20240826$20240902$20240902$EXP$$JP-ROCHE-10000068049$ROCHE$Ito T, Kamimura T, Kiguchi T, Kato K, Takenaka R, Kobayashi M. Venetoclax treatment for chronic lymphocytic leukemia/small lymphocytic leukemia in Japan: post-marketing surveillance. International Journal of Hematology. 2024; doi:10.1007/s12185-024-03832-x.$$$$$Y$$$20240902$$HP$JP$JP
242739291$24273929$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-085312-2024$RECKITT BENCKISER$$$$$$Y$$$20240902$$CN$US$US
242739301$24273930$1$I$20230401$20240828$20240902$20240902$EXP$$US-ABBVIE-5900969$ABBVIE$$67$YR$$F$Y$$$20240902$$CN$US$US
242739311$24273931$1$I$$20240829$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076778$SANDOZ$$7$DEC$$F$Y$$$20240902$$MD$US$US
242739321$24273932$1$I$$20240820$20240902$20240902$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08446$LUPIN$Winston DJ, Young PA, Schlamm HT, Schiller GJ. Fosmanogepix therapy of disseminated Fusarium Infection. Clinical Infectious Diseases. 2023;77:848-850$26$YR$$F$Y$$$20240902$$HP$US$US
242739332$24273933$2$F$$20240910$20240902$20240917$EXP$$US-SA-2024SA252772$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240917$$HP$US$US
242739341$24273934$1$I$$20240828$20240902$20240902$EXP$$US-ABBVIE-5901192$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242739351$24273935$1$I$20240801$20240828$20240902$20240902$EXP$$US-ABBVIE-5901149$ABBVIE$$52$YR$$F$Y$$$20240902$$CN$US$US
242739362$24273936$2$F$$20240823$20240902$20240906$EXP$$CA-009507513-2408CAN009474$MERCK$$57$YR$$M$Y$90$KG$20240906$$PH$CA$CA
242739371$24273937$1$I$20240807$20240828$20240902$20240902$EXP$$US-SA-2024SA252464$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240902$$CN$US$US
242739402$24273940$2$F$$20240826$20240902$20240904$EXP$$US-JNJFOC-20240868669$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242739411$24273941$1$I$$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024171304$AMGEN$$$$$F$Y$$$20240902$$HP$US$US
242739421$24273942$1$I$20230921$20240827$20240902$20240902$EXP$$NVSC2023DE236976$NOVARTIS$$$$E$F$Y$105$KG$20240902$$MD$DE$DE
242739441$24273944$1$I$$20240828$20240902$20240902$EXP$$AT-ABBVIE-5901228$ABBVIE$$34$YR$$M$Y$$$20240902$$CN$AT$AT
242739451$24273945$1$I$20240710$20240826$20240902$20240902$EXP$IT-MINISAL02-1000086$IT-ABBVIE-5895014$ABBVIE$$52$YR$$M$Y$72$KG$20240902$$CN$IT$IT
242739461$24273946$1$I$20240524$20240826$20240902$20240902$EXP$ES-AEMPS-1561670$ES-TEVA-VS-3237288$TEVA$$88$YR$$M$Y$$$20240902$$MD$ES$ES
242739472$24273947$2$F$20240101$20240830$20240902$20240904$PER$$US-JNJFOC-20240874373$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240904$$CN$US$US
242739481$24273948$1$I$20240820$20240823$20240902$20240902$PER$$US-ABBVIE-5893779$ABBVIE$$56$YR$$F$Y$81.647$KG$20240902$$CN$US$US
242739492$24273949$2$F$$20240918$20240902$20240927$EXP$$US-TEVA-VS-3238154$TEVA$Goyal A, Jakulla RS, Alarfaj M, Tayeb T, Barker S, Bhyan P, et al. Myasthenia Crisis Complicated with Takotsubo Cardiomyopathy. US-Cardiol 2024; 18 (Suppl.) 7-8.; Goyal A, Jakulla RS, Alarfaj M, Tayeb T, Barker S, Bhyan P, et al. Myasthenia Crisis Complicated with Takotsubo Cardiomyopathy. US-Cardiol 2024; 18 (Suppl.) 7-8.$77$YR$$F$Y$$$20240927$$HP$US$US
242739501$24273950$1$I$$20240826$20240902$20240902$EXP$$US-AstraZeneca-2024A194687$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242739511$24273951$1$I$$20240830$20240902$20240902$PER$$US-HALEON-2194688$Haleon PLC$$$$$$Y$$$20240902$$CN$US$US
242739521$24273952$1$I$20240101$20240823$20240902$20240902$PER$$US-AstraZeneca-2024A193071$ASTRAZENECA$$75$YR$$F$Y$$$20240902$$CN$US$
242739531$24273953$1$I$20240823$20240829$20240902$20240902$EXP$$EG-AstraZeneca-2024A199020$ASTRAZENECA$$63$YR$$F$Y$$$20240902$$CN$EG$
242739581$24273958$1$I$$20240829$20240902$20240902$EXP$GB-MHRA-MED-202408291257256700-VTFZW$GB-PFIZER INC-202400246489$PFIZER$$$$$F$Y$$$20240902$$HP$GB$GB
242739591$24273959$1$I$20240719$20240828$20240902$20240902$EXP$$CN-PFIZER INC-PV202400112544$PFIZER$$84$YR$$M$Y$50$KG$20240902$$HP$CN$CN
242739612$24273961$2$F$20240820$20240920$20240902$20240930$PER$$US-GSK-US2024106719$GLAXOSMITHKLINE$$88$YR$$F$Y$$$20240930$$CN$US$US
242739661$24273966$1$I$20230101$20240828$20240902$20240902$EXP$$CA-PFIZER INC-202300450161$PFIZER$$59$YR$$M$Y$$$20240902$$HP$CA$CA
242739672$24273967$2$F$20240101$20240828$20240902$20240902$EXP$$CA-PFIZER INC-202400210031$PFIZER$$62$YR$$F$Y$$$20240902$$PH$CA$CA
242739681$24273968$1$I$$20240828$20240902$20240902$EXP$$US-PFIZER INC-202400191458$PFIZER$$70$YR$$F$Y$$$20240902$$HP$US$US
242739691$24273969$1$I$20240816$20240828$20240902$20240902$EXP$$CN-PFIZER INC-PV202400112539$PFIZER$$24$YR$$F$Y$58$KG$20240902$$HP$CN$CN
242739711$24273971$1$I$20240602$20240827$20240902$20240902$EXP$CH-SM-2024-13874$CH-PFIZER INC-202400244785$PFIZER$$93$YR$$F$Y$49$KG$20240902$$PH$CH$CH
242739721$24273972$1$I$$20240829$20240902$20240902$EXP$$CA-PFIZER INC-202400246643$PFIZER$$76$YR$$F$Y$$$20240902$$MD$CA$CA
242739732$24273973$2$F$20240629$20240903$20240902$20240910$EXP$$DE-BAXTER-2024BAX021023$BAXTER$$52$YR$$M$Y$$$20240910$$HP$DE$DE
242739741$24273974$1$I$$20240823$20240902$20240902$EXP$$CA-BAXTER-2024BAX023804$BAXTER$$38$YR$$M$Y$$$20240902$$HP$CA$CA
242739751$24273975$1$I$20240802$20240823$20240902$20240902$EXP$CN-NMPACDR-3208011027682202400289$CN-BAXTER-2024BAX023831$BAXTER$$63$YR$$F$Y$55$KG$20240902$$MD$CN$CN
242739761$24273976$1$I$$20240823$20240902$20240902$EXP$GB-MHRA-MED-202408231847181010-MVGWS$GB-BAXTER-2024BAX023787$BAXTER$$$$$F$Y$$$20240902$$CN$GB$GB
242739771$24273977$1$I$$20240823$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139301$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240902$$HP$US$US
242739781$24273978$1$I$20240801$20240828$20240902$20240902$EXP$$US-ABBVIE-5900279$ABBVIE$$59$YR$$F$Y$$$20240902$$CN$US$US
242739791$24273979$1$I$$20240311$20240902$20240902$PER$$US-ASTELLAS-2024US008093$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242739801$24273980$1$I$$20240827$20240902$20240902$30DAY$$US-GSK-US2024106722$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
242739811$24273981$1$I$$20240630$20240902$20240902$PER$$US-ASTELLAS-2024US018799$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
242739821$24273982$1$I$$20240823$20240902$20240902$30DAY$$US-GSK-US2024105538$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$CN$US$US
242739831$24273983$1$I$$20240823$20240902$20240902$EXP$$JP-ASTELLAS-2024-AER-001458$ASTELLAS$$6$DEC$A$M$Y$$$20240902$$HP$JP$JP
242739841$24273984$1$I$20240813$20240826$20240902$20240902$EXP$$NVSC2024CN175184$NOVARTIS$$87$YR$$M$Y$60$KG$20240902$$HP$CN$CN
242739852$24273985$2$F$20240817$20240827$20240902$20240906$EXP$$FR-ROCHE-10000065042$ROCHE$$76$YR$E$M$Y$70$KG$20240906$$HP$FR$FR
242739861$24273986$1$I$$20240828$20240902$20240902$EXP$$GB-JNJFOC-20240900755$JOHNSON AND JOHNSON$$79$YR$E$F$Y$95$KG$20240902$$CN$GB$GB
242739871$24273987$1$I$$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024172575$AMGEN$Mammen A. L.; Torres-ruiz J.; Pinal-fernandez I. et al.. Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology. 2024;42:367-376$$$$$Y$$$20240902$$HP$US$US
242739881$24273988$1$I$$20240828$20240902$20240902$EXP$$CA-JNJFOC-20240876151$JOHNSON AND JOHNSON$$31$YR$A$M$Y$80$KG$20240902$$HP$CA$CA
242739891$24273989$1$I$20240617$20240815$20240902$20240902$PER$$US-ASTELLAS-2024US017897$ASTELLAS$$70$YR$E$M$Y$$$20240902$$CN$US$US
242739901$24273990$1$I$$20240827$20240902$20240902$30DAY$$US-GSK-US2024106711$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$CN$US$US
242739911$24273991$1$I$$20240827$20240902$20240902$30DAY$$US-GSK-US2024AMR106928$GLAXOSMITHKLINE$$$$$F$Y$$$20240902$$CN$US$US
242739921$24273992$1$I$$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172321$AMGEN$$87$YR$E$F$Y$$$20240902$$CN$US$US
242739932$24273993$2$F$20240829$20240903$20240902$20240904$PER$$US-AMGEN-USASP2024173386$AMGEN$$43$YR$A$F$Y$$$20240904$$PH$US$US
242739951$24273995$1$I$$20240828$20240902$20240902$EXP$$DE-SA-2024SA253557$SANOFI AVENTIS$$$$A$M$Y$$$20240902$$MD$DE$DE
242739961$24273996$1$I$$20240827$20240902$20240902$EXP$$US-TAKEDA-2024TUS087110$TAKEDA$$$$$F$Y$65$KG$20240902$$HP$US$US
242739971$24273997$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138657$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240902$$CN$US$US
242739981$24273998$1$I$$20240604$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-05054$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242739992$24273999$2$F$20240822$20240828$20240902$20240904$EXP$$IN-VANTIVE-2024VAN019411$Vantive US Healthcare$$53$YR$$F$Y$$$20240904$$CN$IN$IN
242740001$24274000$1$I$20051110$20240829$20240902$20240902$EXP$FR-EMA-DD-20240816-7482677-114420$NVSC2024FR175517$NOVARTIS$$51$YR$$F$Y$80$KG$20240902$$CN$FR$FR
242740011$24274001$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138816$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$66.8$KG$20240902$$PH$US$US
242740021$24274002$1$I$20240823$20240823$20240902$20240902$EXP$$CN-VANTIVE-2024VAN019322$Vantive US Healthcare$$61$YR$$M$Y$75$KG$20240902$$CN$CN$CN
242740052$24274005$2$F$20240826$20240905$20240902$20240909$EXP$$JP-AstraZeneca-2024A198016$ASTRAZENECA$$90$YR$$M$Y$$$20240909$$MD$JP$
242740061$24274006$1$I$$20240830$20240902$20240902$EXP$GB-MHRA-TPP18978005C7016075YC1724924261304$GB-SANDOZ INC.-SDZ2024GB076756$SANDOZ$$60$YR$$F$Y$88$KG$20240902$$MD$GB$GB
242740072$24274007$2$F$20240728$20240904$20240902$20240905$EXP$$IT-AUROBINDO-AUR-APL-2024-043218$AUROBINDO$$85$YR$$F$Y$$$20240905$$MD$IT$IT
242740091$24274009$1$I$20210101$20240820$20240902$20240902$EXP$$JP-EMD Serono-9244476$EMD SERONO INC$$59$YR$A$M$Y$74$KG$20240902$$CN$JP$JP
242740121$24274012$1$I$$20240829$20240902$20240902$EXP$$JP-PFIZER INC-PV202400113639$PFIZER$$$$$$Y$$$20240902$$MD$JP$JP
242740131$24274013$1$I$20240206$20240829$20240902$20240902$EXP$FR-AFSSAPS-PA2024001439$FR-PFIZER INC-202400246161$PFIZER$$86$YR$$F$Y$49$KG$20240902$$PH$FR$FR
242740141$24274014$1$I$$20240829$20240902$20240902$EXP$$RU-PFIZER INC-PV202400113088$PFIZER$$73$YR$$F$Y$$$20240902$$MD$RU$RU
242740151$24274015$1$I$20240726$20240829$20240902$20240902$EXP$FR-AFSSAPS-PV2024000782$FR-PFIZER INC-202400246298$PFIZER$$15$YR$$F$Y$48$KG$20240902$$MD$FR$FR
242740162$24274016$2$F$$20240901$20240902$20240904$EXP$$US-PFIZER INC-202400247419$PFIZER$$67$YR$$M$Y$$$20240904$$MD$US$US
242740171$24274017$1$I$$20240830$20240902$20240902$EXP$$US-PFIZER INC-PV202400072907$PFIZER$$67$YR$$M$Y$$$20240902$$HP$US$US
242740181$24274018$1$I$20240801$20240830$20240902$20240902$EXP$$MA-PFIZER INC-PV202400113847$PFIZER$$$$$F$Y$$$20240902$$CN$MA$MA
242740191$24274019$1$I$20240301$20240829$20240902$20240902$EXP$$CL-PFIZER INC-PV202400113270$PFIZER$$41$YR$$F$Y$$$20240902$$CN$CL$CL
242740202$24274020$2$F$20240811$20240924$20240902$20240926$EXP$FR-AFSSAPS-2024072444$FR-SA-2024SA252750$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240926$$MD$FR$FR
242740211$24274021$1$I$$20240827$20240902$20240902$EXP$$CA-TAKEDA-2024TUS064575$TAKEDA$$$$$F$Y$$$20240902$$CN$CA$CA
242740221$24274022$1$I$$20240823$20240902$20240902$EXP$$DE-GSK-DE2024EME108503$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$PH$DE$DE
242740231$24274023$1$I$$20240823$20240902$20240902$EXP$$CA-RDY-CLI/CAN/24/0012609$DR REDDYS$$82$YR$E$F$Y$$$20240902$$CN$CA$CA
242740241$24274024$1$I$$20240822$20240902$20240902$EXP$$US-RDY-SPO/USA/24/0012562$DR REDDYS$Fatima R, Altorok N. Secukinumab-Induced Bullous Pemphigoid in a Patient Psoriatic Arthritis. American Journal of Therapeutics. 2024 Jul;31(4): e434-e435. doi:10.1097/MJT.0000000000001642.$62$YR$A$M$Y$$$20240902$$MD$US$US
242740261$24274026$1$I$20240830$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174206$AMGEN$$81$YR$E$F$Y$$$20240902$$CN$US$US
242740302$24274030$2$F$20240618$20240925$20240902$20240930$EXP$$DE-JNJFOC-20240651553$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240930$$HP$DE$DE
242740311$24274031$1$I$$20240827$20240902$20240902$EXP$$CA-JNJFOC-20240879143$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240902$$CN$CA$CA
242740321$24274032$1$I$20240814$20240821$20240902$20240902$EXP$$US-BEH-2024177673$CSL BEHRING$$48$YR$A$M$Y$177$KG$20240902$$CN$US$US
242740341$24274034$1$I$$20240826$20240902$20240902$EXP$$US-ROCHE-10000066719$ROCHE$$66$YR$E$M$Y$$$20240902$$CN$US$US
242740351$24274035$1$I$$20240819$20240902$20240902$EXP$$US-PADAGIS-2024PAD01363$PADAGIS$$$$$$Y$$$20240829$$CN$US$US
242740371$24274037$1$I$$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174559$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242740381$24274038$1$I$$20240805$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07923$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242740391$24274039$1$I$$20240828$20240902$20240902$PER$$NVSC2024US175886$NOVARTIS$$$$$$Y$$$20240902$$MD$US$US
242740402$24274040$2$F$$20240918$20240902$20240923$EXP$$FI-ABBVIE-5899346$ABBVIE$$$$$M$Y$$$20240923$$HP$FI$FI
242740411$24274041$1$I$$20240819$20240902$20240902$EXP$$US-UCBSA-2024042314$UCB$$$$$F$Y$$$20240902$$HP$US$US
242740421$24274042$1$I$20110727$20240827$20240902$20240902$EXP$$CZ-SANDOZ INC.-NVSC2021CZ062855$SANDOZ$$8$YR$$M$Y$18$KG$20240902$$MD$CZ$CZ
242740441$24274044$1$I$$20240828$20240902$20240902$EXP$DE-SANOFI-02181439$DE-GSK-DE2024107045$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$DE$DE
242740451$24274045$1$I$20240828$20240829$20240902$20240902$EXP$$GB-ABBVIE-5902655$ABBVIE$$72$YR$$M$Y$$$20240902$$CN$GB$GB
242740471$24274047$1$I$$20240828$20240902$20240902$PER$$US-ABBVIE-5901653$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242740491$24274049$1$I$$20240828$20240902$20240902$PER$$US-BIOGEN-2024BI01280251$BIOGEN$$$$$F$Y$$$20240902$$CN$US$US
242740501$24274050$1$I$20240719$20240902$20240902$20240902$EXP$IT-MINISAL02-1000441$NVSC2024IT175947$NOVARTIS$$1$YR$$M$Y$$$20240902$$MD$IT$IT
242740512$24274051$2$F$$20240903$20240902$20240905$PER$$US-JNJFOC-20240900928$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242740521$24274052$1$I$$20240829$20240902$20240902$EXP$$US-AstraZeneca-2024A198561$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$US$
242740541$24274054$1$I$20240717$20240826$20240902$20240902$EXP$$CO-AstraZeneca-2024A197090$ASTRAZENECA$$3191$WK$$M$Y$$$20240902$$CN$CO$
242740551$24274055$1$I$20240101$20240822$20240902$20240902$EXP$$JP-GENMAB-2024-00693AA$GENMAB$$65$YR$$M$Y$$$20240902$$PH$JP$JP
242740561$24274056$1$I$$20240829$20240902$20240902$EXP$$US-AstraZeneca-2024A197965$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242740571$24274057$1$I$20220601$20240829$20240902$20240902$EXP$$CA-SA-2023SA041914$SANOFI AVENTIS$$9$YR$C$M$Y$24.5$KG$20240902$$MD$CA$CA
242740581$24274058$1$I$$20240828$20240902$20240902$PER$$US-TAKEDA-2024TUS087142$TAKEDA$$17$YR$$$Y$$$20240902$$CN$US$US
242740592$24274059$2$F$20240705$20240920$20240902$20240930$EXP$$JP-TEVA-VS-3238377$TEVA$$82$YR$$M$Y$$$20240930$$MD$JP$JP
242740602$24274060$2$F$20240710$20240911$20240902$20240920$EXP$$US-BEH-2024168862$CSL BEHRING$$46$YR$A$F$Y$88$KG$20240920$$CN$US$US
242740611$24274061$1$I$$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136553$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240902$$CN$US$US
242740621$24274062$1$I$20240801$20240823$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135192$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$69.4$KG$20240902$$PH$US$US
242740631$24274063$1$I$20240801$20240827$20240902$20240902$EXP$$CN-DSJP-DSJ-2024-142495$DAIICHI$$68$YR$$F$Y$$$20240902$$HP$CN$CN
242740641$24274064$1$I$20240101$20240830$20240902$20240902$EXP$$US-AMGEN-USASP2024174643$AMGEN$$$$$M$Y$$$20240902$$CN$US$US
242740651$24274065$1$I$20240815$20240828$20240902$20240902$EXP$SE-SEMPA-2024-006249$SE-TAKEDA-2024TUS086546$TAKEDA$$9$YR$$M$Y$33$KG$20240902$$HP$SE$SE
242740661$24274066$1$I$20240801$20240823$20240902$20240902$EXP$GB-MHRA-MED-202408231918201240-SFTWV$GB-TEVA-VS-3237286$TEVA$$4$YR$$F$Y$16$KG$20240902$$CN$GB$GB
242740671$24274067$1$I$$20240829$20240902$20240902$PER$$US-TAKEDA-2024TUS087469$TAKEDA$$$$$M$Y$$$20240902$$CN$US$US
242740681$24274068$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-083317-2024$RECKITT BENCKISER$$$$$$Y$$$20240902$$CN$US$US
242740692$24274069$2$F$$20240902$20240902$20240909$EXP$$IN-TAKEDA-2024TUS086265$TAKEDA$$25$YR$$M$Y$$$20240909$$CN$IN$IN
242740701$24274070$1$I$20240801$20240822$20240902$20240902$PER$$US-ABBVIE-5894185$ABBVIE$$82$YR$$F$Y$$$20240902$$CN$US$US
242740712$24274071$2$F$20240601$20240919$20240902$20240930$EXP$$US-JNJFOC-20240858111$JOHNSON AND JOHNSON$$67$YR$E$M$Y$51.756$KG$20240930$$HP$US$US
242740723$24274072$3$F$20240501$20240910$20240902$20240930$PER$$US-SMPA-2024MYSCI0500535$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242740732$24274073$2$F$$20240903$20240902$20240905$PER$$US-JNJFOC-20240900655$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242740742$24274074$2$F$$20240903$20240902$20240904$PER$$US-JNJFOC-20240900938$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242740751$24274075$1$I$$20240826$20240902$20240902$PER$$US-ROCHE-10000067064$ROCHE$Silver C, De la Garza-Ramos C, Stauffer J, Majeed U, Wang J, Toskich B. Ipilimumab and nivolumab plus radioembolization as salvage therapy for atezolizumab and bevacizumab refractory hepatocellular carcinoma resulting in complete pathologic response. Radiology Case Reports. 2024-Nov;19 (11):5024-5028. doi:10.1016/j.radcr.2024.07.157.$55$YR$A$M$Y$$$20240902$$HP$US$US
242740762$24274076$2$F$$20240901$20240902$20240906$PER$$US-ROCHE-10000066820$ROCHE$$$$$$Y$$$20240906$$CN$US$US
242740781$24274078$1$I$20240725$20240823$20240902$20240902$EXP$$JP-TEVA-VS-3238303$TEVA$$$$E$F$Y$$$20240902$$MD$JP$JP
242740791$24274079$1$I$20240826$20240826$20240902$20240902$EXP$$US-TAKEDA-US202004047$TAKEDA$$62$YR$$F$Y$$$20240902$$MD$US$US
242740801$24274080$1$I$$20240827$20240902$20240902$PER$$US-SA-2024SA251821$SANOFI AVENTIS$$$$A$F$Y$$$20240902$$CN$US$US
242740811$24274081$1$I$$20240827$20240902$20240902$PER$$US-SA-2024SA251874$SANOFI AVENTIS$$$$A$F$Y$$$20240902$$CN$US$US
242740821$24274082$1$I$$20240902$20240902$20240902$EXP$$DE-SANDOZ INC.-SDZ2024DE076912$SANDOZ$$67$YR$$M$Y$$$20240902$$HP$DE$DE
242740832$24274083$2$F$20240826$20240906$20240902$20240910$EXP$$NVSC2024ZA174342$NOVARTIS$$81$YR$$F$Y$$$20240910$$HP$ZA$ZA
242740841$24274084$1$I$20080101$20240826$20240902$20240902$EXP$$JP-TEVA-VS-3237430$TEVA$Waseda Y, Hirano K, Inagaki S, Goto Y, Yamada S, Miwa K, et al. Chronic hepatitis C with autoimmune phenomenon complicated with Pneumocystis pneumonia: A rare case that developed following steroid treatment and finally responded to PEG-IFNalpha-2b plus ribavirin combination therapy. [Japanese]. Kanzo 2010; 51 (12): 722-729.$50$YR$$F$Y$$$20240902$$HP$JP$JP
242740851$24274085$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018144$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240902$$CN$US$US
242740861$24274086$1$I$20240801$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000352$ELI LILLY AND CO$$67$YR$E$$Y$$$20240902$$CN$US$US
242740871$24274087$1$I$20240826$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000363$ELI LILLY AND CO$$50$YR$A$$Y$$$20240902$$CN$US$US
242740881$24274088$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138619$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$104.78$KG$20240902$$CN$US$US
242740891$24274089$1$I$20240522$20240828$20240902$20240902$EXP$$NVSC2024US174882$NOVARTIS$$22$MON$$M$Y$$$20240902$$MD$US$US
242740901$24274090$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137948$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240902$$PH$US$US
242740911$24274091$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076863$SANDOZ$$$$$F$Y$$$20240902$$CN$US$US
242740921$24274092$1$I$20240701$20240830$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139319$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240902$$CN$US$US
242740931$24274093$1$I$$20240827$20240902$20240902$PER$$US-ROCHE-10000067336$ROCHE$$$$A$F$Y$$$20240902$$CN$US$US
242740941$24274094$1$I$20240801$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174092$AMGEN$$71$YR$$$Y$$$20240902$$CN$US$US
242740952$24274095$2$F$$20240828$20240902$20240905$PER$$US-JNJFOC-20240877091$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$HP$US$US
242740961$24274096$1$I$$20240827$20240902$20240902$PER$$US-JNJFOC-20240876299$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242740971$24274097$1$I$20240101$20240827$20240902$20240902$EXP$$JP-AMGEN-JPNSP2024172310$AMGEN$$$$$$Y$$$20240902$$MD$JP$JP
242740981$24274098$1$I$20230401$20240827$20240902$20240902$EXP$$US-ABBVIE-5899406$ABBVIE$$63$YR$$F$Y$$$20240902$$CN$US$US
242741001$24274100$1$I$$20240826$20240902$20240902$PER$$US-JNJFOC-20240867375$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242741011$24274101$1$I$20240811$20240828$20240902$20240902$EXP$$CO-AstraZeneca-2024A197300$ASTRAZENECA$$26249$DY$$M$Y$$$20240902$$CN$CO$
242741031$24274103$1$I$20240807$20240822$20240902$20240902$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161086$JIANGSU HANSOH PHARMACEUTICAL$$45$YR$$F$Y$54.3$KG$20240902$$MD$CN$CN
242741041$24274104$1$I$20240815$20240822$20240902$20240902$PER$$US-BEH-2024177768$CSL BEHRING$$47$YR$A$M$Y$$$20240902$$HP$US$US
242741052$24274105$2$F$20240517$20240919$20240902$20240923$EXP$$DE-SANDOZ INC.-SDZ2024DE056699$SANDOZ$$67$YR$$F$Y$$$20240923$$MD$DE$DE
242741073$24274107$3$F$20240815$20240903$20240902$20240905$PER$$US-AMGEN-USASP2024173931$AMGEN$$87$YR$E$F$Y$$$20240905$$CN$US$US
242741081$24274108$1$I$20221201$20240827$20240902$20240902$EXP$$DE-ALXN-202408EEA001708DE$ALEXION PHARMACEUTICALS$$73$YR$$F$Y$$$20240902$$MD$DE$DE
242741091$24274109$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139507$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240902$$CN$US$US
242741101$24274110$1$I$20240507$20240829$20240902$20240902$EXP$FR-AFSSAPS-DJ2024000979$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-137774$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$48$KG$20240902$$MD$FR$FR
242741111$24274111$1$I$$20240829$20240902$20240902$PER$$US-ALXN-202408USA002041US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$HP$US$US
242741121$24274112$1$I$20240101$20240823$20240902$20240902$EXP$$US-TEVA-VS-3236778$TEVA$$54$YR$$F$Y$$$20240902$$MD$US$US
242741131$24274113$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076665$SANDOZ$$$$$$Y$$$20240902$$CN$US$US
242741141$24274114$1$I$20240601$20240821$20240902$20240902$EXP$$MY-EXELIXIS-CABO-24076644$EXELIXIS$$67$YR$$F$Y$36$KG$20240902$$CN$MY$MY
242741151$24274115$1$I$20220101$20240821$20240902$20240902$EXP$$AU-EXELIXIS-CABO-24081074$EXELIXIS$$52$YR$$M$Y$$$20240902$$HP$AU$AU
242741171$24274117$1$I$$20240829$20240902$20240902$PER$$NVSC2024US175529$NOVARTIS$$$$$$Y$$$20240902$$CN$US$US
242741192$24274119$2$F$20240101$20240903$20240902$20240912$EXP$$ES-TEVA-VS-3237620$TEVA$$50$YR$$F$Y$$$20240912$$CN$ES$ES
242741201$24274120$1$I$$20240828$20240902$20240902$PER$$US-ROCHE-10000068841$ROCHE$$$$E$F$Y$$$20240902$$CN$US$US
242741211$24274121$1$I$$20240809$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08084$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242741221$24274122$1$I$20240809$20240814$20240902$20240902$30DAY$$US-AMGEN-USASL2024162204$AMGEN$$61$YR$A$F$Y$$$20240902$$PH$US$US
242741231$24274123$1$I$20231227$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-082172-2024$RECKITT BENCKISER$$$$$F$Y$$$20240902$$CN$US$US
242741241$24274124$1$I$$20240828$20240902$20240902$PER$$US-LEO Pharma-373145$LEO PHARM$$22$YR$$F$Y$$$20240902$$CN$US$US
242741252$24274125$2$F$$20240918$20240902$20240927$EXP$$US-TEVA-VS-3238436$TEVA$Kline K, Chen W, Kallen ME, Koka R, Omili D, Fan X, et al. Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD). Hum-Vaccin-Immunother 2023; 19 (2):.; Kline K, Chen W, Kallen ME, Koka R, Omili D, Fan X, et al. Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD). Hum-Vaccin-Immunother 2023; 19 (2):.; Kline K, ...$55$YR$$F$Y$$$20240927$$HP$US$US
242741262$24274126$2$F$20240806$20240919$20240902$20240926$30DAY$$JP-JNJFOC-20240837565$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$JP$JP
242741271$24274127$1$I$$20240812$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08088$LUPIN$$$$$$Y$$$20240902$$PH$US$US
242741281$24274128$1$I$$20240511$20240902$20240902$PER$$US-ASTELLAS-2024US014060$ASTELLAS$$64$YR$A$F$Y$$$20240830$$MD$US$US
242741291$24274129$1$I$20240101$20240827$20240902$20240902$PER$$US-SA-2024SA253332$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240902$$MD$US$US
242741301$24274130$1$I$20230204$20240826$20240902$20240902$EXP$$CO-GSK-CO2023AMR031036$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$PH$CO$CO
242741321$24274132$1$I$20240721$20240822$20240902$20240902$EXP$$US-BEH-2024177665$CSL BEHRING$$25$YR$A$F$Y$$$20240902$$CN$US$US
242741331$24274133$1$I$20240826$20240829$20240902$20240902$EXP$$US-ABBVIE-5903505$ABBVIE$$72$YR$$M$Y$$$20240902$$CN$US$US
242741353$24274135$3$F$20240814$20240902$20240902$20240924$EXP$$JP-GUERBET / LLC-JP-20240121$GUERBET$$78$YR$E$M$Y$$$20240924$$HP$JP$JP
242741361$24274136$1$I$20240605$20240823$20240902$20240902$EXP$ES-AEMPS-1561855$ES-TEVA-VS-3237020$TEVA$$80$YR$$M$Y$$$20240902$$MD$ES$ES
242741371$24274137$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024174531$AMGEN$$82$YR$E$F$Y$$$20240902$$CN$US$US
242741381$24274138$1$I$20240723$20240829$20240902$20240902$EXP$$NVSC2024CN176197$NOVARTIS$$58$YR$$F$Y$41$KG$20240902$$HP$CN$CN
242741391$24274139$1$I$$20240821$20240902$20240902$EXP$$JP-ASTELLAS-2023JP002431$ASTELLAS$Nakako S, Koh H, Sogabe N, Kuno M, Makuuchi Y, Takakuwa T, et al. Successful treatment with mesenchymal stem cells for steroid-refractory late-onset idiopathic pneumonia syndrome following allogeneic hematopoietic cell transplantation. Transplant Immunology. 2024;86: 1-4. doi:10.1016/j.trim.2024.102107.$55$YR$A$M$Y$$$20240902$$MD$JP$JP
242741401$24274140$1$I$20240801$20240829$20240902$20240902$PER$$US-ROCHE-10000070146$ROCHE$$$$$F$Y$$$20240902$$MD$US$US
242741411$24274141$1$I$$20240820$20240902$20240902$PER$$US-AstraZeneca-2024A190113$ASTRAZENECA$$$$$F$Y$$$20240902$$MD$US$
242741432$24274143$2$F$$20240828$20240902$20240903$EXP$$CA-AstraZeneca-2024A196171$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$CA$
242741451$24274145$1$I$$20240826$20240902$20240902$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408016155$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240902$$CN$JP$JP
242741461$24274146$1$I$20240406$20240821$20240902$20240902$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202404004804$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$BR$BR
242741471$24274147$1$I$20240814$20240828$20240902$20240902$EXP$GB-MHRA-MED-202408281459081240-JKPCL$GB-SA-2024SA252491$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240902$$PH$GB$GB
242741491$24274149$1$I$20240101$20240821$20240902$20240902$EXP$FR-AFSSAPS-TS2024000925$FR-ELI_LILLY_AND_COMPANY-FR202408014093$ELI LILLY AND CO$$1$DY$N$F$Y$$$20240902$$CN$FR$FR
242741501$24274150$1$I$20200101$20240820$20240902$20240902$EXP$$US-ELI_LILLY_AND_COMPANY-US202408012978$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240902$$CN$US$US
242741511$24274151$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000175$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240902$$CN$US$US
242741521$24274152$1$I$20240701$20240821$20240902$20240902$EXP$$US-ELI_LILLY_AND_COMPANY-US202408013734$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240902$$CN$US$US
242741551$24274155$1$I$20240407$20240827$20240902$20240902$EXP$GB-MHRA-MED-202408271558560080-GCFNW$GB-ELI_LILLY_AND_COMPANY-GB202408017730$ELI LILLY AND CO$$60$YR$A$M$Y$85$KG$20240902$$CN$GB$GB
242741561$24274156$1$I$$20240827$20240902$20240902$EXP$$NL-ELI_LILLY_AND_COMPANY-NL202408016754$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240902$$CN$NL$NL
242741571$24274157$1$I$20240805$20240826$20240902$20240902$EXP$$US-VIIV HEALTHCARE LIMITED-US2024106588$VIIV$$$$$$Y$$$20240902$$MD$US$US
242741581$24274158$1$I$20240822$20240826$20240902$20240902$EXP$$CN-GSK-CN2024APC106365$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$HP$CN$CN
242741591$24274159$1$I$$20240821$20240902$20240902$PER$$NVSC2024US176168$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
242741611$24274161$1$I$20240812$20240830$20240902$20240902$EXP$$US-JNJFOC-20240881832$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242741621$24274162$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-084300-2024$RECKITT BENCKISER$$$$$M$Y$$$20240902$$CN$US$US
242741631$24274163$1$I$20240801$20240827$20240902$20240902$EXP$$JP-JNJFOC-20240900810$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240902$$MD$JP$JP
242741641$24274164$1$I$20240801$20240823$20240902$20240902$EXP$$US-TEVA-VS-3237754$TEVA$$77$YR$$F$Y$$$20240902$$CN$US$US
242741651$24274165$1$I$$20240827$20240902$20240902$PER$$US-TAKEDA-2024TUS086566$TAKEDA$$$$$$Y$$$20240902$$PH$US$US
242741661$24274166$1$I$20240807$20240827$20240902$20240902$EXP$$US-TAKEDA-2024TUS070126$TAKEDA$$79$YR$$M$Y$$$20240902$$MD$US$US
242741681$24274168$1$I$20240827$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173542$AMGEN$$74$YR$E$F$Y$$$20240902$$CN$US$US
242741701$24274170$1$I$20240101$20240829$20240902$20240902$PER$$US-ORGANON-O2408USA002266$ORGANON$$$$$F$Y$$$20240902$$CN$US$US
242741711$24274171$1$I$20240817$20240829$20240902$20240902$EXP$$CA-JNJFOC-20240881291$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240902$$HP$CA$CA
242741721$24274172$1$I$20240802$20240822$20240902$20240902$EXP$$US-JNJFOC-20240861129$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240902$$CN$US$US
242741732$24274173$2$F$$20240912$20240902$20240920$EXP$$CA-TEVA-VS-3238749$TEVA$$74$YR$$M$Y$$$20240920$$HP$CA$CA
242741741$24274174$1$I$20200225$20240827$20240902$20240902$EXP$$DE-SANDOZ INC.-NVSC2020DE086657$SANDOZ$$$$E$F$Y$94$KG$20240902$$HP$DE$DE
242741751$24274175$1$I$$20240829$20240902$20240902$EXP$$CA-TAKEDA-2024TUS087749$TAKEDA$$$$$F$Y$$$20240902$$MD$CA$CA
242741761$24274176$1$I$20240303$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-087131-2024$RECKITT BENCKISER$$$$$M$Y$$$20240902$$CN$US$US
242741771$24274177$1$I$$20240830$20240902$20240902$PER$$US-ABBVIE-5903381$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242741781$24274178$1$I$$20240305$20240902$20240902$PER$$US-ASTELLAS-2024US005591$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
242741791$24274179$1$I$20240622$20240830$20240902$20240902$EXP$$US-TAKEDA-2024TUS087764$TAKEDA$$89$YR$$F$Y$$$20240902$$HP$US$US
242741802$24274180$2$F$20240724$20240916$20240902$20240917$PER$$US-AMGEN-USASP2024174694$AMGEN$$77$YR$E$F$Y$$$20240916$$CN$US$US
242741813$24274181$3$F$20240829$20240903$20240902$20240905$PER$$US-AMGEN-USASP2024174093$AMGEN$$74$YR$E$F$Y$$$20240904$$CN$US$US
242741823$24274182$3$F$20240825$20240912$20240902$20240921$EXP$$JP-DSJP-DSJ-2024-142306$DAIICHI$$54$YR$$F$Y$42.1$KG$20240921$$MD$JP$JP
242741831$24274183$1$I$$20240828$20240902$20240902$PER$$US-ABBVIE-5901784$ABBVIE$$66$YR$$F$Y$$$20240902$$CN$US$US
242741841$24274184$1$I$$20240827$20240902$20240902$EXP$$CA-TAKEDA-2024TUS086892$TAKEDA$$$$$F$Y$$$20240902$$MD$CA$CA
242741851$24274185$1$I$$20240901$20240902$20240902$EXP$$DE-BAUSCH-BL-2024-013147$BAUSCH AND LOMB$$$$$$Y$$$20240902$$MD$DE$DE
242741861$24274186$1$I$20240730$20240829$20240902$20240902$EXP$FR-AFSSAPS-TO2024001518$FR-BAUSCH-BL-2024-013110$BAUSCH AND LOMB$$69$YR$$M$Y$49$KG$20240902$$MD$FR$FR
242741882$24274188$2$F$$20240918$20240902$20240930$PER$$US-ALXN-202408USA002086US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
242741893$24274189$3$F$$20240912$20240902$20240912$PER$$US-ALXN-202408USA001882US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
242741901$24274190$1$I$$20240826$20240902$20240902$EXP$$IR-BAUSCH-BL-2024-012972$BAUSCH AND LOMB$Roshanzamiri S, Mousavizadeh S, Razazzadeh S, Ziaie S. Acyclovir-induced psychiatric and renal adverse effects in a diabetic patient: A case report. Clinical Case Reports. 2024;12:1-4. doi:10.1002/ccr3.9310$52$YR$$F$Y$$$20240902$$PH$IR$IR
242741911$24274191$1$I$$20240815$20240902$20240902$PER$$US-TEVA-VS-3235563$TEVA$$$$A$M$Y$$$20240902$$CN$US$US
242741922$24274192$2$F$$20240826$20240902$20240925$EXP$$US-GSK-US2024106135$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
242741931$24274193$1$I$20240830$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139111$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240902$$CN$US$US
242741951$24274195$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138836$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$56.45$KG$20240902$$PH$US$US
242741961$24274196$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-081808-2024$RECKITT BENCKISER$$$$$$Y$$$20240902$$CN$US$US
242741971$24274197$1$I$$20240827$20240902$20240902$EXP$$CA-BIOVITRUM-2021CA5077$BIOVITRUM$$3$YR$$F$Y$$$20240902$$HP$CA$CA
242741981$24274198$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024174608$AMGEN$$$$$$Y$$$20240902$$PH$US$US
242741991$24274199$1$I$$20240828$20240902$20240902$PER$$NVSC2024US175527$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
242742001$24274200$1$I$20240827$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018401$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$US$US
242742012$24274201$2$F$$20240905$20240902$20240909$PER$$US-BIOVITRUM-2024-US-011384$BIOVITRUM$$78$YR$$F$Y$$$20240909$$CN$US$US
242742021$24274202$1$I$$20240826$20240902$20240902$EXP$$CA-JNJFOC-20240880152$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$MD$CA$CA
242742031$24274203$1$I$20000101$20240827$20240902$20240902$EXP$$US-ABBVIE-5818989$ABBVIE$$$$$F$Y$80$KG$20240902$$CN$US$US
242742041$24274204$1$I$$20240823$20240902$20240902$EXP$$US-SA-2024SA253029$SANOFI AVENTIS$$$$C$F$Y$$$20240902$$MD$US$US
242742061$24274206$1$I$$20240826$20240902$20240902$EXP$$NVSC2024DO052540$NOVARTIS$$$$$F$Y$$$20240902$$CN$DO$DO
242742081$24274208$1$I$20240101$20240827$20240902$20240902$EXP$$US-ABBVIE-5900971$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242742101$24274210$1$I$20230501$20240820$20240902$20240902$PER$$US-SA-2024SA253338$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240902$$CN$US$US
242742111$24274211$1$I$20240801$20240827$20240902$20240902$EXP$$AR-SANDOZ INC.-SDZ2024AR076392$SANDOZ$$13$YR$$M$Y$42$KG$20240902$$CN$AR$AR
242742121$24274212$1$I$20240601$20240823$20240902$20240902$EXP$$CO-ABBVIE-5902765$ABBVIE$$59$YR$$M$Y$72$KG$20240902$$CN$CO$CO
242742131$24274213$1$I$$20240828$20240902$20240902$EXP$$US-ABBVIE-5900161$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242742141$24274214$1$I$$20240829$20240902$20240902$EXP$$US-ABBVIE-5901603$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242742151$24274215$1$I$$20240826$20240902$20240902$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006349$BIOCON$$$$$$Y$$$20240902$$HP$CA$CA
242742161$24274216$1$I$20230807$20240826$20240902$20240902$EXP$$KR-AMGEN-KORSP2024173413$AMGEN$$68$YR$E$F$Y$$$20240902$$PH$KR$KR
242742171$24274217$1$I$20240701$20240826$20240902$20240902$EXP$$CO-ABBVIE-5805380$ABBVIE$$38$YR$$F$Y$70$KG$20240902$$CN$CO$CO
242742181$24274218$1$I$20200308$20240822$20240902$20240902$EXP$$GR-TAKEDA-GR202009190$TAKEDA$$61$YR$$F$Y$$$20240902$$CN$IE$GR
242742191$24274219$1$I$20230519$20240826$20240902$20240902$EXP$$KR-AMGEN-KORSP2024173249$AMGEN$$51$YR$A$F$Y$61$KG$20240902$$PH$KR$KR
242742201$24274220$1$I$20240730$20240812$20240902$20240902$EXP$$CA-ABBVIE-5903569$ABBVIE$$67$YR$$F$Y$$$20240902$$CN$CA$CA
242742211$24274221$1$I$20170215$20240827$20240902$20240902$EXP$$US-TAKEDA-2017BLT002209$TAKEDA$$47$YR$$F$Y$$$20240902$$HP$US$US
242742221$24274222$1$I$$20240826$20240902$20240902$PER$$US-JNJFOC-20240873969$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$HP$US$US
242742232$24274223$2$F$20240813$20240822$20240902$20240903$EXP$$GR-ARGENX-2024-ARGX-GR007008$ARGENX BVBA$$$$$$Y$$$20240903$$MD$GR$GR
242742241$24274224$1$I$$20240829$20240902$20240902$EXP$$US-TAKEDA-2024TUS087493$TAKEDA$$$$$F$Y$$$20240902$$HP$US$US
242742252$24274225$2$F$20240823$20240904$20240902$20240911$EXP$$GB-ABBVIE-5899914$ABBVIE$$51$YR$$F$Y$48.2$KG$20240911$$PH$GB$GB
242742261$24274226$1$I$20240723$20240826$20240902$20240902$EXP$FR-AFSSAPS-AN2024001092$FR-SA-2024SA254830$SANOFI AVENTIS$$82$YR$E$M$Y$80.1$KG$20240902$$MD$FR$FR
242742271$24274227$1$I$$20240825$20240902$20240902$PER$$US-ROCHE-10000067836$ROCHE$$$$$M$Y$$$20240902$$CN$US$US
242742281$24274228$1$I$20240301$20240826$20240902$20240902$EXP$$CA-GSK-CA2023146615$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$CA$CA
242742291$24274229$1$I$$20240815$20240902$20240902$PER$$US-TEVA-VS-3235337$TEVA$$60$YR$$$Y$$$20240902$$CN$US$US
242742311$24274231$1$I$20240829$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024174545$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242742321$24274232$1$I$$20240815$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08341$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242742332$24274233$2$F$20240811$20240824$20240902$20240910$EXP$$CN-009507513-2408CHN009975$MERCK$$57$YR$$M$Y$65$KG$20240910$$HP$CN$CN
242742341$24274234$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000070246$ROCHE$$$$A$M$Y$$$20240902$$CN$US$US
242742351$24274235$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000069774$ROCHE$$$$$F$Y$$$20240902$$CN$US$US
242742361$24274236$1$I$20230801$20240830$20240902$20240902$EXP$$DE-SANDOZ INC.-SDZ2024DE076816$SANDOZ$$$$$M$Y$2.535$KG$20240902$$MD$DE$DE
242742371$24274237$1$I$$20240826$20240902$20240902$EXP$$US-GSK-US2024105946$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
242742381$24274238$1$I$$20240212$20240902$20240902$PER$$US-ASTELLAS-2024US004855$ASTELLAS$$$$$F$Y$$$20240830$$HP$US$US
242742391$24274239$1$I$20240823$20240826$20240902$20240902$EXP$$DE-BAXTER-2024BAX023895$BAXTER$$66$YR$$M$Y$$$20240902$$HP$DE$DE
242742401$24274240$1$I$20240801$20240829$20240902$20240902$EXP$$US-GILEAD-2024-0685819$GILEAD$$60$YR$A$M$Y$$$20240902$$CN$US$US
242742411$24274241$1$I$$20240827$20240902$20240902$EXP$$GB-TAKEDA-2024TUS022505$TAKEDA$$$$$F$Y$$$20240902$$CN$GB$GB
242742431$24274243$1$I$$20240830$20240902$20240902$PER$$US-ROCHE-10000070703$ROCHE$$$$A$M$Y$$$20240902$$CN$US$US
242742441$24274244$1$I$20240701$20240820$20240902$20240902$PER$$US-SA-2024SA252393$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240902$$MD$US$US
242742451$24274245$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-087190-2024$RECKITT BENCKISER$$$$$M$Y$$$20240902$$CN$US$US
242742463$24274246$3$F$20240830$20240904$20240902$20240905$PER$$US-AMGEN-USASP2024174800$AMGEN$$88$YR$E$F$Y$$$20240905$$CN$US$US
242742471$24274247$1$I$20240829$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024173895$AMGEN$$62$YR$A$F$Y$$$20240902$$CN$US$US
242742491$24274249$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018681$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240902$$CN$US$US
242742501$24274250$1$I$$20240829$20240902$20240902$EXP$$US-GSK-US2024107913$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$MD$US$US
242742511$24274251$1$I$20240823$20240830$20240902$20240902$PER$$US-ROCHE-10000071582$ROCHE$$12$YR$T$M$Y$$$20240902$$CN$US$US
242742521$24274252$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138471$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240902$$CN$US$US
242742531$24274253$1$I$$20240828$20240902$20240902$EXP$$CA-SANDOZ INC.-SDZ2024US076341$SANDOZ$$$$$$Y$$$20240902$$CN$CA$US
242742541$24274254$1$I$$20240830$20240902$20240902$PER$$US-ROCHE-10000071375$ROCHE$$$$T$M$Y$$$20240902$$CN$US$US
242742551$24274255$1$I$20240814$20240830$20240902$20240902$PER$$US-ROCHE-10000071330$ROCHE$$24$YR$A$M$Y$$$20240902$$CN$US$US
242742562$24274256$2$F$$20240912$20240902$20240916$PER$$US-ROCHE-10000071467$ROCHE$$$$A$M$Y$$$20240916$$CN$US$US
242742571$24274257$1$I$$20240830$20240902$20240902$PER$$US-ROCHE-10000071199$ROCHE$$$$$M$Y$$$20240902$$CN$US$US
242742591$24274259$1$I$$20240831$20240902$20240902$EXP$$NVSC2024US176039$NOVARTIS$$21$YR$$F$Y$$$20240902$$MD$US$US
242742601$24274260$1$I$$20240815$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08263$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242742611$24274261$1$I$$20240826$20240902$20240902$PER$$US-AMGEN-USASP2024172921$AMGEN$$$$$$Y$$$20240902$$PH$US$US
242742621$24274262$1$I$$20240830$20240902$20240902$PER$$US-ROCHE-10000071202$ROCHE$$$$A$M$Y$$$20240902$$CN$US$US
242742643$24274264$3$F$20240830$20240916$20240902$20240918$PER$$US-ROCHE-10000071489$ROCHE$$3$YR$C$M$Y$$$20240918$$CN$US$US
242742652$24274265$2$F$$20240903$20240902$20240904$PER$$US-JNJFOC-20240901282$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242742661$24274266$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076828$SANDOZ$$62$YR$$M$Y$$$20240902$$MD$US$US
242742671$24274267$1$I$$20240826$20240902$20240902$PER$$US-JNJFOC-20240875047$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$HP$US$US
242742681$24274268$1$I$$20240829$20240902$20240902$PER$$US-HALEON-2194450$Haleon PLC$$$$$$Y$$$20240902$$CN$US$US
242742691$24274269$1$I$$20240827$20240902$20240902$PER$$US-ABBVIE-5901704$ABBVIE$$$$$$Y$$$20240902$$MD$US$US
242742701$24274270$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-136617-2023$RECKITT BENCKISER$$90$YR$$F$Y$$$20240902$$CN$US$US
242742711$24274271$1$I$20200615$20240826$20240902$20240902$EXP$PL-URPL-1-1867-2020$PL-TEVA-VS-3237212$TEVA$$44$YR$$F$Y$75$KG$20240902$$MD$PL$PL
242742721$24274272$1$I$$20240822$20240902$20240902$PER$$US-ABBVIE-5892457$ABBVIE$$$$$F$Y$$$20240902$$MD$US$US
242742731$24274273$1$I$$20240826$20240902$20240902$EXP$DE-UCBINNMED-20240022$DE-RDY-SPO/DEU/24/0012446$DR REDDYS$Isabel Brueckner, JessicaWelter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313.?doi:https://doi.org/10.1093/jat/bkae011$28$YR$A$M$Y$$$20240902$$HP$DE$DE
242742751$24274275$1$I$$20240425$20240902$20240902$PER$$US-ASTELLAS-2024US008491$ASTELLAS$$$$E$M$Y$$$20240830$$CN$US$US
242742761$24274276$1$I$$20240301$20240902$20240902$PER$$US-ASTELLAS-2024US006869$ASTELLAS$$86$YR$E$M$Y$$$20240830$$CN$US$US
242742771$24274277$1$I$20240818$20240824$20240902$20240902$PER$$US-SA-2024SA253053$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240902$$MD$US$US
242742781$24274278$1$I$$20240822$20240902$20240902$PER$$US-SA-2024SA252707$SANOFI AVENTIS$$$$A$$Y$$$20240902$$PH$US$US
242742791$24274279$1$I$20240206$20240826$20240902$20240902$EXP$$US-GSK-US2024AMR106974$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
242742801$24274280$1$I$$20240820$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133578$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240902$$CN$US$US
242742821$24274282$1$I$20240112$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-082709-2024$RECKITT BENCKISER$$43$YR$$F$Y$$$20240902$$CN$US$US
242742831$24274283$1$I$$20240228$20240902$20240902$PER$$US-ASTELLAS-2024US006571$ASTELLAS$$81$YR$E$F$Y$$$20240830$$CN$US$US
242742841$24274284$1$I$20240830$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174045$AMGEN$$79$YR$E$F$Y$$$20240902$$CN$US$US
242742851$24274285$1$I$$20240826$20240902$20240902$EXP$$US-ROCHE-10000068586$ROCHE$Webb L, Campian J, Caron S, Roh M, Sener U. A Rare Case of Glioblastoma with Osseous Metastases. Canadian Journal of Neurological Sciences. 2024-May-01;51 (3):425-6. doi:10.1017/cjn.2023.256.$83$YR$E$M$Y$$$20240902$$HP$US$US
242742863$24274286$3$F$20240829$20240916$20240902$20240918$PER$$US-AMGEN-USASP2024174340$AMGEN$$85$YR$E$F$Y$$$20240917$$CN$US$US
242742872$24274287$2$F$$20240918$20240902$20240927$EXP$$GB-TEVA-VS-3238324$TEVA$Maung AC, Brain H, Ballav C, Sihota S. Severe bradycardia at acute medical take - Think about myxoedema coma. J-R-Coll-Physicians-Edinb 2024; 54 (2): 133-137.; Maung AC, Brain H, Ballav C, Sihota S. Severe bradycardia at acute medical take - Think about myxoedema coma. J-R-Coll-Physicians-Edinb 2024; 54 (2): 133-137.$97$YR$$M$Y$$$20240927$$HP$GB$GB
242742882$24274288$2$F$$20240907$20240902$20240910$PER$$US-AMGEN-USASP2024169843$AMGEN$$$$A$F$Y$$$20240910$$CN$US$US
242742891$24274289$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138665$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$102.51$KG$20240902$$PH$US$US
242742901$24274290$1$I$$20240830$20240902$20240902$PER$$US-HALEON-2194434$Haleon PLC$$$$$$Y$$$20240902$$CN$US$US
242742912$24274291$2$F$$20240918$20240902$20240927$EXP$$TR-TEVA-VS-3238750$TEVA$Yildirim HC, Guven DC, Ismayilov R, Chalabiyev E, Dizdar O. Deficient Mismatch Repair Jejunal Cancer Hyperprogression with Pembrolizumab. J-Oncol-Sci 2024; 10 (2): 122-124; Yildirim HC, Guven DC, Ismayilov R, Chalabiyev E, Dizdar O. Deficient Mismatch Repair Jejunal Cancer Hyperprogression with Pembrolizumab. J-Oncol-Sci 2024; 10 (2): 122-124.; Yildirim HC, Guven DC, Ismayilov R, Chalabiyev E, Dizdar O. Deficient Mismatch Repair Jejunal Cancer Hyperprogression with Pembrolizumab. J-Oncol-Sci ...$58$YR$$M$Y$$$20240927$$HP$TR$TR
242742932$24274293$2$F$$20240902$20240902$20240903$PER$$NVSC2024US176274$NOVARTIS$$$$$M$Y$$$20240903$$CN$US$US
242742941$24274294$1$I$20240814$20240826$20240902$20240902$EXP$FR-AFSSAPS-MP2024001312$FR-GUERBET / LLC-FR-20240320$GUERBET$$59$YR$A$M$Y$95$KG$20240902$$HP$FR$FR
242742951$24274295$1$I$$20240618$20240902$20240902$PER$$US-ASTELLAS-2024US017780$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242742961$24274296$1$I$$20240802$20240902$20240902$PER$$US-SMPA-2024SPA002103$SUNOVION$$$$$$Y$$$20240902$$CN$US$US
242742971$24274297$1$I$20230101$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018655$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$US$US
242742981$24274298$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019025$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240902$$CN$US$US
242742991$24274299$1$I$20240824$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019186$ELI LILLY AND CO$$39$YR$A$$Y$$$20240902$$CN$US$US
242743001$24274300$1$I$$20240825$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136698$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$55.34$KG$20240902$$CN$US$US
242743011$24274301$1$I$20200612$20240826$20240902$20240902$EXP$PL-URPL-1-1870-2020$PL-TEVA-VS-3237234$TEVA$$64$YR$$F$Y$60$KG$20240902$$MD$PL$PL
242743021$24274302$1$I$20200801$20240829$20240902$20240902$PER$$US-009507513-2408USA010088$MERCK$$$$$F$Y$$$20240902$$MD$US$US
242743043$24274304$3$F$$20240920$20240902$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138925$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240927$$CN$US$US
242743051$24274305$1$I$$20240828$20240902$20240902$EXP$$GB-BIOVITRUM-2024-GB-011424$BIOVITRUM$$$$$$Y$$$20240902$$CN$GB$GB
242743061$24274306$1$I$$20240830$20240902$20240902$EXP$$US-009507513-2409USA000397$MERCK$$$$$M$Y$$$20240902$$HP$US$US
242743073$24274307$3$F$20240802$20240919$20240902$20240924$PER$$US-ROCHE-10000070194$ROCHE$$10$YR$C$M$Y$71.8$KG$20240924$$CN$US$US
242743082$24274308$2$F$20240101$20240909$20240902$20240920$EXP$$US-ARDELYX-2024ARDX006379$ARDELYX$$$$$F$Y$$$20240920$$CN$US$US
242743091$24274309$1$I$$20240827$20240902$20240902$PER$$US-ABBVIE-5901595$ABBVIE$$$$$$Y$$$20240902$$MD$US$US
242743101$24274310$1$I$$20240813$20240902$20240902$PER$$US-TEVA-VS-3236151$TEVA$$$$$$Y$$$20240902$$CN$US$US
242743112$24274311$2$F$$20240919$20240902$20240926$EXP$$NVSC2024GB174480$NOVARTIS$$$$$F$Y$$$20240926$$CN$GB$GB
242743121$24274312$1$I$20240731$20240826$20240902$20240902$EXP$$CO-ABBVIE-5902810$ABBVIE$$83$YR$$F$Y$62$KG$20240902$$HP$CO$CO
242743132$24274313$2$F$$20240904$20240902$20240906$PER$$US-BIOVITRUM-2024-US-009297$BIOVITRUM$$84$YR$$F$Y$$$20240906$$CN$US$US
242743141$24274314$1$I$20240722$20240819$20240902$20240902$EXP$$FR-ASTELLAS-2024-AER-002288$ASTELLAS$$61$YR$A$F$Y$$$20240902$$MD$FR$FR
242743151$24274315$1$I$20240601$20240829$20240902$20240902$PER$$US-BIOVITRUM-2024-US-011490$BIOVITRUM$$67$YR$$M$Y$$$20240902$$CN$US$US
242743171$24274317$1$I$$20240815$20240902$20240902$PER$$US-JNJFOC-20240849790$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242743182$24274318$2$F$20240824$20240915$20240902$20240923$EXP$$GB-JNJFOC-20240879110$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240923$$CN$GB$GB
242743191$24274319$1$I$$20240826$20240902$20240902$EXP$$US-GSK-US2024AMR106853$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
242743201$24274320$1$I$$20240826$20240902$20240902$PER$$US-JNJFOC-20240866538$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20240902$$CN$US$US
242743221$24274322$1$I$20240711$20240826$20240902$20240902$EXP$HU-OGYI-0103624$HU-TEVA-VS-3237331$TEVA$$25$YR$$M$Y$58$KG$20240902$$CN$HU$HU
242743231$24274323$1$I$$20240828$20240902$20240902$EXP$$FR-AstraZeneca-2024A197880$ASTRAZENECA$Sanchis-Borja M., Guisier F., Swalduz A., Curcio H., Basse V., Maritaz C., Chouaid C., Auliac J. B.. Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France.. OncoTargets and therapy 2024;17:439-448.$50$YR$$F$Y$$$20240902$$HP$FR$
242743241$24274324$1$I$$20240829$20240902$20240902$EXP$$JP-AstraZeneca-2024A197969$ASTRAZENECA$$$$E$F$Y$$$20240902$$MD$JP$
242743251$24274325$1$I$$20240813$20240902$20240902$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08123$LUPIN$$$$$$Y$$$20240902$$CN$US$US
242743271$24274327$1$I$$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196978$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242743281$24274328$1$I$20240725$20240829$20240902$20240902$EXP$$KR-AstraZeneca-2024A199004$ASTRAZENECA$$26991$DY$$M$Y$$$20240902$$CN$KR$
242743291$24274329$1$I$20240808$20240825$20240902$20240902$EXP$$US-AstraZeneca-2024A194951$ASTRAZENECA$$27652$DY$$F$Y$65.4$KG$20240902$$CN$US$
242743301$24274330$1$I$$20240902$20240902$20240902$EXP$$NL-Air Products and Chemicals-2161088$AIR PRODUCTS$$3$YR$$M$Y$$$20240902$$$NL$NL
242743311$24274331$1$I$20240701$20240823$20240902$20240902$PER$$US-JNJFOC-20240865865$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240902$$CN$US$US
242743321$24274332$1$I$$20240828$20240902$20240902$PER$$US-JNJFOC-20240873517$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$HP$US$US
242743331$24274333$1$I$$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135969$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240902$$CN$US$US
242743341$24274334$1$I$$20240822$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135234$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$101.6$KG$20240902$$CN$US$US
242743351$24274335$1$I$$20240824$20240902$20240902$EXP$$US-JNJFOC-20240867325$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240902$$HP$US$US
242743363$24274336$3$F$$20240917$20240902$20240920$EXP$$US-BIOVITRUM-2024-US-011546$BIOVITRUM$$61$YR$$F$Y$$$20240920$$CN$US$US
242743371$24274337$1$I$$20240611$20240902$20240902$PER$$US-ASTELLAS-2024US016966$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242743381$24274338$1$I$20240824$20240827$20240902$20240902$EXP$$CO-BIOVITRUM-2024-CO-011554$BIOVITRUM$$71$DY$$F$Y$$$20240902$$CN$CO$CO
242743391$24274339$1$I$20240824$20240829$20240902$20240902$EXP$$NVSC2024CN176343$NOVARTIS$$40$YR$$F$Y$48$KG$20240902$$HP$CN$CN
242743401$24274340$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000070595$ROCHE$$$$E$F$Y$$$20240902$$CN$US$US
242743411$24274341$1$I$$20240902$20240902$20240902$PER$$US-PROD-AS2-212756134-RB-140521-2023$RECKITT BENCKISER$$$$$F$Y$$$20240902$$CN$US$US
242743421$24274342$1$I$$20240826$20240902$20240902$EXP$$US-GSK-US2024AMR106865$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
242743431$24274343$1$I$$20240821$20240902$20240902$EXP$$US-ABBVIE-5889870$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242743441$24274344$1$I$$20240828$20240902$20240902$EXP$$US-ABBVIE-5899996$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242743451$24274345$1$I$20211104$20240826$20240902$20240902$EXP$$CH-SANDOZ INC.-NVSC2021CH266916$SANDOZ$$67$YR$$F$Y$78$KG$20240902$$MD$CH$CH
242743461$24274346$1$I$$20240829$20240902$20240902$EXP$$JP-SANDOZ INC.-PHHY2018JP101438$SANDOZ$$46$YR$$F$Y$58.1$KG$20240902$$MD$JP$JP
242743472$24274347$2$F$20240830$20240830$20240902$20240909$PER$$US-HALEON-2194587$Haleon PLC$$82$YR$$F$Y$$$20240909$$CN$US$US
242743481$24274348$1$I$$20240826$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408017736$ELI LILLY AND CO$$$$A$M$Y$$$20240902$$CN$US$US
242743501$24274350$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018614$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240902$$CN$US$US
242743511$24274351$1$I$$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137907$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240902$$CN$US$US
242743531$24274353$1$I$$20240823$20240902$20240902$PER$$US-JNJFOC-20240865203$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242743541$24274354$1$I$$20240829$20240902$20240902$EXP$$US-JNJFOC-20240880734$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$CN$US$US
242743551$24274355$1$I$$20240902$20240902$20240902$EXP$$NVSC2024AM176379$NOVARTIS$$$$$F$Y$$$20240902$$MD$AM$AM
242743561$24274356$1$I$20240701$20240827$20240902$20240902$PER$$US-ALXN-202408USA001835US$ALEXION PHARMACEUTICALS$$$$A$M$Y$$$20240902$$MD$US$US
242743571$24274357$1$I$20240501$20240826$20240902$20240902$EXP$$US-ABBVIE-5840420$ABBVIE$$63$YR$$F$Y$$$20240902$$CN$US$US
242743591$24274359$1$I$20240701$20240828$20240902$20240902$EXP$$US-ABBVIE-5848529$ABBVIE$$85$YR$$M$Y$$$20240902$$CN$US$US
242743602$24274360$2$F$$20240907$20240902$20240913$EXP$$IN-VANTIVE-2024VAN019450$Vantive US Healthcare$$76$YR$$F$Y$$$20240913$$CN$IN$IN
242743621$24274362$1$I$20230201$20240902$20240902$20240902$EXP$FR-AFSSAPS-DJ2024000904$NVSC2024FR175995$NOVARTIS$$79$YR$$M$Y$65$KG$20240902$$MD$FR$FR
242743631$24274363$1$I$$20240830$20240902$20240902$PER$$US-ABBVIE-5903335$ABBVIE$$$$$F$Y$$$20240902$$HP$US$US
242743641$24274364$1$I$$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136751$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240902$$CN$US$US
242743651$24274365$1$I$$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024172573$AMGEN$Mammen A. L.; Torres-ruiz J.; Pinal-fernandez I. et al.. Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology. 2024;42:367-376$$$$$Y$$$20240902$$HP$US$US
242743661$24274366$1$I$$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024172564$AMGEN$Mammen A. L.; Torres-ruiz J.; Pinal-fernandez I. et al.. Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology. 2024;42:367-376$$$$$Y$$$20240902$$MD$US$US
242743671$24274367$1$I$$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024172576$AMGEN$Mammen A. L.; Torres-ruiz J.; Pinal-fernandez I. et al.. Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology. 2024;42:367-376$$$$$Y$$$20240902$$HP$US$US
242743682$24274368$2$F$$20240913$20240902$20240917$EXP$$RU-AstraZeneca-2024A198411$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$RU$
242743691$24274369$1$I$20191225$20240827$20240902$20240902$EXP$DE-ADRED-04592-01$DE-RDY-GER/GER/20/0126381$DR REDDYS$$71$YR$E$M$Y$74$KG$20240902$$PH$DE$DE
242743701$24274370$1$I$$20240828$20240902$20240902$EXP$$FR-AstraZeneca-2024A197730$ASTRAZENECA$Sanchis-Borja M., Guisier F., Swalduz A., Curcio H., Basse V., Maritaz C., Chouaid C., Auliac J. B.. Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France.. OncoTargets and therapy 2024;17:439-448.$77$YR$$M$Y$$$20240902$$HP$FR$
242743711$24274371$1$I$20240627$20240828$20240902$20240902$EXP$$CN-AstraZeneca-2024A198436$ASTRAZENECA$$75$YR$$M$Y$74$KG$20240902$$MD$CN$
242743721$24274372$1$I$$20240825$20240902$20240902$EXP$$US-AstraZeneca-2024A193683$ASTRAZENECA$$$$$M$Y$87.1$KG$20240902$$CN$US$
242743731$24274373$1$I$$20240828$20240902$20240902$PER$$US-AstraZeneca-2024A197150$ASTRAZENECA$$$$$M$Y$$$20240902$$HP$US$
242743741$24274374$1$I$20240101$20240829$20240902$20240902$EXP$$JP-AstraZeneca-2024A197307$ASTRAZENECA$$75$YR$$F$Y$$$20240902$$MD$JP$
242743762$24274376$2$F$$20240904$20240902$20240911$EXP$SE-SEMPA-2022-017817$SE-TAKEDA-2024TUS086518$TAKEDA$$37$YR$$F$Y$$$20240911$$HP$SE$SE
242743771$24274377$1$I$$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024172574$AMGEN$Mammen A. L.; Torres-ruiz J.; Pinal-fernandez I. et al.. Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology. 2024;42:367-376$$$$$Y$$$20240902$$HP$US$US
242743782$24274378$2$F$20240824$20240904$20240902$20240911$PER$$US-AMGEN-USASP2024174886$AMGEN$$74$YR$E$F$Y$$$20240910$$CN$US$US
242743791$24274379$1$I$20210101$20240821$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134072$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$54.43$KG$20240902$$CN$US$US
242743801$24274380$1$I$$20240827$20240902$20240902$PER$$US-JNJFOC-20240877124$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$CN$US$US
242743811$24274381$1$I$20240401$20240823$20240902$20240902$EXP$$US-JNJFOC-20240531664$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20240902$$HP$US$US
242743822$24274382$2$F$$20240914$20240902$20240915$PER$$US-ALXN-202408USA001992US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240915$$MD$US$US
242743841$24274384$1$I$20240821$20240821$20240902$20240902$EXP$$US-Accord-443592$ACCORD$$44$YR$A$F$Y$$$20240902$$HP$US$US
242743851$24274385$1$I$20210627$20240821$20240902$20240902$EXP$SE-SEMPA-2024-006020$SE-Accord-442905$ACCORD$$16$YR$T$F$Y$$$20240902$$CN$SE$SE
242743861$24274386$1$I$$20240821$20240902$20240902$EXP$$IN-Accord-443306$ACCORD$Nimi G, Kirubakaran K, John J, Kumar P. Disseminated Protozoa Zopfii Infection in Liver transplant Recipient. Journal of Clinical and Experimental Hepatology. 2024;14(Supplement 1).$62$YR$A$M$Y$$$20240902$$MD$IN$IN
242743871$24274387$1$I$$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139422$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240902$$CN$US$US
242743921$24274392$1$I$20240101$20240821$20240902$20240902$EXP$GB-MHRA-MED-202408202027029230-NVSPL$GB-Accord-442782$ACCORD$$40$YR$A$F$Y$89$KG$20240902$$CN$GB$GB
242743941$24274394$1$I$20210101$20240821$20240902$20240902$EXP$$MT-Accord-443311$ACCORD$Gauci L, Scerri C, Mifsud M, Gauci J. Interstitial lung disease secondary to oxaliplatin-raltitrexed based chemotherapy. Malta Medical Journal. 2024;36(3):73-7.$72$YR$E$M$Y$$$20240902$$MD$MT$MT
242743951$24274395$1$I$$20240821$20240902$20240902$EXP$$JP-Accord-443355$ACCORD$Fukuda K, Ohno T. Successful monotherapy with autologous formalin-fixed tumor vaccine for a Stage IV uterine cancer patient who rejected rational chemotherapy and immune checkpoint inhibitor treatment. Clinical Case Reports. 2023;11(6): e7513.$57$YR$A$F$Y$$$20240902$$MD$JP$JP
242743961$24274396$1$I$20240826$20240826$20240902$20240902$PER$$US-SA-2024SA253257$SANOFI AVENTIS$$$$$F$Y$$$20240902$$HP$US$US
242743972$24274397$2$F$20210528$20240918$20240902$20240930$EXP$$NL-Accord-443312$ACCORD$Geerts PA, Hart N, Visser O, Ortiz-Maldonado V, Chamuleau ME. Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR-T cell infusion. Clinical Case Reports. 2023;11(6):e7361$36$YR$A$M$Y$$$20240930$$MD$NL$NL
242743981$24274398$1$I$$20240821$20240902$20240902$EXP$$ES-Accord-443204$ACCORD$Hernani R, Sancho A, Amat P, Hernandez-Boluda J, Perez A, Pinana J, Carretero  C, Goterris R, Gozmez M, Saus A, Ferrer B, Teruel A, Terol M and Solano C. CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review. Current Research in Translational Medicine 2021 Oct;69 (4):1-5. doi:10.1016/j.retram.2021.103304$56$YR$A$M$Y$$$20240902$$HP$ES$ES
242743991$24274399$1$I$20240515$20240611$20240902$20240902$PER$$US-ASTELLAS-2024US014226$ASTELLAS$$$$A$M$Y$$$20240830$$HP$US$US
242744001$24274400$1$I$$20240826$20240902$20240902$PER$$US-JNJFOC-20240866777$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$CN$US$US
242744021$24274402$1$I$$20240826$20240902$20240902$EXP$$BR-JNJFOC-20240870978$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$MD$BR$BR
242744051$24274405$1$I$$20240827$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018095$ELI LILLY AND CO$$$$$M$Y$$$20240902$$CN$US$US
242744071$24274407$1$I$20240821$20240821$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408017835$ELI LILLY AND CO$$$$A$F$Y$$$20240902$$CN$US$US
242744081$24274408$1$I$20240829$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018688$ELI LILLY AND CO$$$$$$Y$$$20240902$$CN$US$US
242744091$24274409$1$I$20240801$20240815$20240902$20240902$EXP$$AU-ASTELLAS-2024-AER-001262$ASTELLAS$$41$YR$A$F$Y$$$20240902$$MD$AU$AU
242744101$24274410$1$I$20240801$20240822$20240902$20240902$PER$$US-SA-2024SA253828$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240902$$CN$US$US
242744111$24274411$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139425$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240902$$CN$US$US
242744121$24274412$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138463$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$102.51$KG$20240902$$CN$US$US
242744131$24274413$1$I$$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138758$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240902$$CN$US$US
242744141$24274414$1$I$$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135957$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240902$$CN$US$US
242744151$24274415$1$I$$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138830$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240902$$CN$US$US
242744161$24274416$1$I$$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172892$AMGEN$$$$A$F$Y$$$20240902$$CN$US$US
242744171$24274417$1$I$$20240823$20240902$20240902$EXP$$US-TEVA-VS-3237724$TEVA$$71$YR$$F$Y$$$20240902$$CN$US$US
242744181$24274418$1$I$20130901$20240828$20240902$20240902$PER$$US-BIOGEN-2024BI01280369$BIOGEN$$29$YR$$M$Y$$$20240902$$CN$US$US
242744191$24274419$1$I$20180901$20240828$20240902$20240902$PER$$US-BIOGEN-2018BI00632510$BIOGEN$$57$YR$$F$Y$$$20240902$$CN$US$US
242744201$24274420$1$I$20240320$20240829$20240902$20240902$EXP$$JP-AstraZeneca-2024A169202$ASTRAZENECA$$77$YR$$F$Y$$$20240902$$MD$JP$
242744211$24274421$1$I$20240816$20240823$20240902$20240902$EXP$$MX-AstraZeneca-2024A194420$ASTRAZENECA$$20283$DY$$M$Y$103$KG$20240902$$CN$MX$
242744221$24274422$1$I$$20240830$20240902$20240902$EXP$$US-AstraZeneca-2024A198497$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$US$
242744231$24274423$1$I$20240531$20240830$20240902$20240902$EXP$$US-AstraZeneca-2024A198407$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$US$
242744241$24274424$1$I$$20240826$20240902$20240902$EXP$$US-AstraZeneca-2024A195033$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242744251$24274425$1$I$20230611$20240830$20240902$20240902$EXP$$JP-AstraZeneca-2023A282656$ASTRAZENECA$$73$YR$$M$Y$71$KG$20240902$$MD$JP$
242744261$24274426$1$I$20240103$20240830$20240902$20240902$EXP$$US-AstraZeneca-2024A198503$ASTRAZENECA$$26745$DY$$M$Y$$$20240902$$PH$US$
242744271$24274427$1$I$20210101$20240827$20240902$20240902$EXP$$JP-009507513-2408JPN003425J$MERCK$$7$DEC$$M$Y$$$20240902$$PH$JP$JP
242744281$24274428$1$I$$20240827$20240902$20240902$EXP$$CA-AMGEN-CANSP2024171327$AMGEN$Mainville L.; MacHaalany J.; Veillette H.. Hidradenitis suppurativa patient requiring cardiac procedure with inguinal access: Case management with ertapenem. SAGE Open Medical Case Reports. 2024;12:1-3$59$YR$A$F$Y$$$20240902$$HP$CA$CA
242744291$24274429$1$I$$20240823$20240902$20240902$EXP$$GB-TEVA-VS-3181634$TEVA$$75$YR$$F$Y$$$20240902$$CN$GB$GB
242744302$24274430$2$F$$20240918$20240902$20240927$EXP$$US-TEVA-VS-3238409$TEVA$Odigwe C. Suicide Left Ventricle Post -TAVR. South-Med-J 2022; 115 (1): 55.; Odigwe C. Suicide Left Ventricle Post -TAVR. South-Med-J 2022; 115 (1): 55.$80$YR$$F$Y$$$20240927$$MD$US$US
242744341$24274434$1$I$$20240829$20240902$20240902$EXP$$US-GSK-US2024107823$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
242744351$24274435$1$I$20240701$20240823$20240902$20240902$30DAY$$US-GSK-US2024105582$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240902$$CN$US$US
242744361$24274436$1$I$$20240826$20240902$20240902$EXP$$US-GSK-US2024AMR107375$GLAXOSMITHKLINE$$$$$M$Y$$$20240902$$HP$US$US
242744372$24274437$2$F$$20240903$20240902$20240904$PER$$US-JNJFOC-20240871703$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$PH$US$US
242744381$24274438$1$I$20240822$20240827$20240902$20240902$EXP$$AR-JNJFOC-20240874219$JOHNSON AND JOHNSON$$34$YR$A$F$Y$45$KG$20240902$$CN$AR$AR
242744395$24274439$5$F$20180101$20240918$20240902$20240927$EXP$$GB-TEVA-VS-3238686$TEVA$Ibrahim A, Prasad G, Kilpatrick ES, Morris TJ. ^A case of autoimmune hepatitis associated with the PCSK9 inhibitor alirocumab^. Ann-Clin-Biochem 2024;.; Ibrahim A, Prasad G, Kilpatrick ES, Morris TJ. A case of autoimmune hepatitis associated with the PCSK9 inhibitor alirocumab. Annals of clinical biochemistry. 2024;doi_10.1177_000456322412696.; Ibrahim A, Prasad G, Kilpatrick ES, Morris TJ. A case of autoimmune hepatitis associated with the PCSK9 inhibitor alirocumab. Annals of Clinical Bioch...$61$YR$$F$Y$$$20240927$$HP$GB$GB
242744402$24274440$2$F$$20240918$20240902$20240927$EXP$$US-TEVA-VS-3238412$TEVA$SHARMA V, MONFASANI A, JSTEIGER D, BECKER CD, NWAOHA N. SYMPTOMATIC PRESENTATION OF MYCOBACTERIUM XENOPI IN A PATIENT WITH SCHAMBERG DISEASE. Chest 2023; 164 (Suppl.) (4): A1411 (plus Poster).; SHARMA V, MONFASANI A, JSTEIGER D, BECKER CD, NWAOHA N. SYMPTOMATIC PRESENTATION OF MYCOBACTERIUM XENOPI IN A PATIENT WITH SCHAMBERG DISEASE. Chest 2023; 164 (Suppl.) (4): A1411 (plus Poster).$20$YR$$F$Y$$$20240927$$HP$US$US
242744422$24274442$2$F$$20240903$20240902$20240904$EXP$$US-ABBVIE-5898382$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242744431$24274443$1$I$$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136347$BRISTOL MYERS SQUIBB$Kendel N, Wilson Y, Wright EN. HGG-45. High grade glioma presenting as a synchronous cancer in a patient with diffuse large b cell lymphoma: a unique treatment dilemma. Neuro-Oncology. 2024 Jun 01;26(Suppl_4):iv98.$7$YR$C$M$Y$$$20240902$$HP$US$US
242744441$24274444$1$I$20240828$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139172$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240902$$CN$US$US
242744451$24274445$1$I$20240805$20240823$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135506$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$76.2$KG$20240902$$CN$US$US
242744461$24274446$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138320$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$PH$US$US
242744471$24274447$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024174302$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242744481$24274448$1$I$20240512$20240829$20240902$20240902$EXP$$NL-BAUSCH-BL-2024-013098$BAUSCH AND LOMB$$78$YR$$F$Y$$$20240902$$HP$NL$NL
242744491$24274449$1$I$20240717$20240829$20240902$20240902$EXP$$FR-BAUSCH-BL-2024-013094$BAUSCH AND LOMB$$48$YR$$F$Y$$$20240902$$PH$FR$FR
242744501$24274450$1$I$$20240829$20240902$20240902$EXP$$PK-BAUSCH-BL-2024-013034$BAUSCH AND LOMB$Waheed A, Wong C, Zhu X, Yip E, Powell K, Tankel K, Paulson K, Heikal A, Murland S, Ghosh S, Elangovan A, Abraham A, Severin D, Usmani N, Joseph K. Sharing Mono-Institutional Experience of Treating Pancreatic Cancer With Stereotactic Body Radiation Therapy (SBRT) as an Adjuvant Therapy for Non operative Patients or Salvaging Local Failure. Cureus. 2023 SEP 19;15(9):1-2.$$$$$Y$$$20240902$$MD$PK$PK
242744511$24274451$1$I$20191103$20240829$20240902$20240902$EXP$$DE-BAUSCH-BL-2024-013104$BAUSCH AND LOMB$$39$YR$$F$Y$$$20240902$$MD$DE$DE
242744521$24274452$1$I$$20240829$20240902$20240902$EXP$$PK-BAUSCH-BL-2024-013032$BAUSCH AND LOMB$Waheed A, Wong C, Zhu X, Yip E, Tankel K, Paulson K, Heikal A, Murland S, Powell K, Ghosh S, Elangovan A, Abraham A, Severin D, Usmani N, Joseph K. Sharing Mono-Institutional Experience of Treating Pancreatic Cancer With Stereotactic Body Radiation Therapy (SBRT) as an Adjuvant Therapy for Non operative Patients or Salvaging Local Failure. Cureus. 2023 SEP 19;15(9):.$$$$$Y$$$20240902$$MD$PK$PK
242744531$24274453$1$I$$20231118$20240902$20240902$EXP$$CH-PFIZER INC-202400247344$PFIZER$$$$$F$Y$61$KG$20240902$$HP$CH$CH
242744541$24274454$1$I$20240801$20240828$20240902$20240902$EXP$$US-ABBVIE-5899870$ABBVIE$$47$YR$$M$Y$$$20240902$$CN$US$US
242744551$24274455$1$I$$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172568$AMGEN$$$$$M$Y$$$20240902$$HP$US$US
242744562$24274456$2$F$$20240828$20240902$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136858$BRISTOL MYERS SQUIBB$Lukin R, Ciner A. Fulminant immune-related?colitis after dual checkpoint inhibitor therapy: case report. Immunotherapy. 2024 Aug 19;1-6. doi:10.1080/1750743X.2024.2386234.$69$YR$E$M$Y$$$20240905$$HP$US$US
242744571$24274457$1$I$$20240826$20240902$20240902$EXP$$US-GSK-US2024GSK106834$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$HP$US$US
242744581$24274458$1$I$20240804$20240902$20240902$20240902$EXP$FR-AFSSAPS-NC2024001032$NVSC2024FR175975$NOVARTIS$$53$YR$$M$Y$60$KG$20240902$$MD$FR$FR
242744591$24274459$1$I$20240826$20240827$20240902$20240902$PER$$US-AMGEN-USASP2024171073$AMGEN$$67$YR$E$F$Y$$$20240902$$CN$US$US
242744601$24274460$1$I$$20240823$20240902$20240902$PER$$US-JNJFOC-20240865200$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242744612$24274461$2$F$20240727$20240919$20240902$20240923$PER$$US-AMGEN-USASP2024171479$AMGEN$$39$YR$A$F$Y$$$20240923$$CN$US$US
242744621$24274462$1$I$$20240823$20240902$20240902$EXP$$CA-GALDERMA-CA2024013256$GALDERMA$$$$$$Y$$$20240902$$HP$CA$CA
242744631$24274463$1$I$$20240829$20240902$20240902$PER$$PR-JNJFOC-20240877713$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$MD$PR$PR
242744641$24274464$1$I$$20240830$20240902$20240902$EXP$$US-BAUSCH-BL-2024-013130$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240902$$CN$US$US
242744651$24274465$1$I$$20240823$20240902$20240902$EXP$$CA-GALDERMA-CA2024013303$GALDERMA$$$$$$Y$$$20240902$$HP$CA$CA
242744661$24274466$1$I$$20240901$20240902$20240902$EXP$$NVSC2024US176229$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
242744671$24274467$1$I$$20240830$20240902$20240902$EXP$$CN-AstraZeneca-2024A198168$ASTRAZENECA$Jiao Y, Liu M, Luo N, Guo H, Li J. Novel MRPL13-ALK and PPP1CB-ALK double fusion as a potential mechanism of acquired resistance to first-line osimertinib in EGFR-mutant high-grade neuroendocrine tumor of the lung. JTO Clin Res Rep 2020;1(4):1-5.$80$YR$$M$Y$$$20240902$$HP$CN$
242744681$24274468$1$I$$20240823$20240902$20240902$EXP$$CA-GALDERMA-CA2024013304$GALDERMA$$$$$$Y$$$20240902$$HP$CA$CA
242744691$24274469$1$I$$20240830$20240902$20240902$EXP$$CN-AstraZeneca-2024A198343$ASTRAZENECA$Gong S., Zhang S., Ye Y., Wu M.. Dapagliflozin-induced abnormal uterine bleeding in a patient with dilated cardiomyopathy and chronic heart failure: a case report. Journal of International Medical Research 2024;52(8):$75$YR$$F$Y$$$20240902$$HP$CN$
242744701$24274470$1$I$20240101$20240828$20240902$20240902$EXP$$JP-AstraZeneca-2024A197359$ASTRAZENECA$$$$E$F$Y$$$20240902$$MD$JP$
242744711$24274471$1$I$$20240828$20240902$20240902$EXP$$PL-AstraZeneca-2024A187112$ASTRAZENECA$Olkowski A. Tools for optimizing pharmacotherapy?the FORTA (Fit for The Aged) list. Geriatria 2024;2:75-82.$76$YR$$F$Y$$$20240902$$MD$PL$
242744721$24274472$1$I$20240101$20240902$20240902$20240902$EXP$$TH-PFIZER INC-PV202400114636$PFIZER$$$$$F$Y$$$20240902$$CN$TH$TH
242744731$24274473$1$I$20231201$20240827$20240902$20240902$EXP$DE-EMBRYOTOX-202310245$DE-TORRENT-00027235$TORRENT$$$$$F$Y$2$KG$20240902$$MD$DE$DE
242744741$24274474$1$I$$20240827$20240902$20240902$EXP$DE-UCBSA-2023017628$DE-TORRENT-00027163$TORRENT$$3$DY$N$$Y$$$20240902$$MD$DE$DE
242744751$24274475$1$I$$20240902$20240902$20240902$EXP$$MY-PFIZER INC-PV202400114390$PFIZER$$32$YR$$F$Y$$$20240902$$MD$MY$MY
242744761$24274476$1$I$20240101$20240902$20240902$20240902$EXP$$NP-PFIZER INC-PV202400114434$PFIZER$$57$YR$$F$Y$$$20240902$$MD$NP$NP
242744771$24274477$1$I$20240821$20240822$20240902$20240902$EXP$GB-MHRA-MED-202408221624042960-LPFHY$GB-TORRENT-00037730$TORRENT$$45$YR$A$F$Y$68$KG$20240902$$MD$GB$GB
242744782$24274478$2$F$20240515$20240902$20240902$20240911$EXP$DE-CADRBFARM-2024330079$DE-TORRENT-00027242$TORRENT$$35$YR$A$M$Y$66$KG$20240911$$CN$DE$DE
242744791$24274479$1$I$20240827$20240827$20240902$20240902$EXP$GB-MHRA-MED-202408270736420740-DNTKJ$GB-TORRENT-00037724$TORRENT$$45$YR$A$M$Y$78$KG$20240902$$CN$GB$GB
242744801$24274480$1$I$20240816$20240828$20240902$20240902$EXP$$CN-PFIZER INC-PV202400112553$PFIZER$$72$YR$$M$Y$64$KG$20240902$$HP$CN$CN
242744812$24274481$2$F$$20240831$20240902$20240905$EXP$$BG-PFIZER INC-PV202400114539$PFIZER$$51$YR$$F$Y$$$20240905$$MD$BG$BG
242744821$24274482$1$I$$20240830$20240902$20240902$EXP$$CN-PFIZER INC-PV202400113600$PFIZER$$$$A$M$Y$$$20240902$$CN$CN$CN
242744831$24274483$1$I$$20240827$20240902$20240902$EXP$$US-PFIZER INC-202400245210$PFIZER$$74$YR$$M$Y$$$20240902$$CN$US$US
242744841$24274484$1$I$$20240828$20240902$20240902$EXP$$CN-PFIZER INC-PV202400112155$PFIZER$$$$A$M$Y$$$20240902$$CN$CN$CN
242744851$24274485$1$I$20240518$20240830$20240902$20240902$EXP$$IN-PFIZER INC-PV202400114731$PFIZER$$44$YR$$F$Y$$$20240902$$CN$IN$IN
242744861$24274486$1$I$$20240830$20240902$20240902$EXP$$US-PFIZER INC-202400247757$PFIZER$$50$YR$$$Y$$$20240902$$CN$US$US
242744871$24274487$1$I$20240801$20240829$20240902$20240902$EXP$GB-MHRA-MED-202408291728596080-RQGZC$GB-PFIZER INC-202400246767$PFIZER$$70$YR$$M$Y$$$20240902$$HP$GB$GB
242744881$24274488$1$I$20240815$20240827$20240902$20240902$EXP$$US-TORRENT-00013732$TORRENT$$56$YR$A$F$Y$$$20240902$$CN$US$US
242744891$24274489$1$I$20240426$20240902$20240902$20240902$EXP$$TH-PFIZER INC-PV202400114506$PFIZER$$39$YR$$M$Y$$$20240902$$CN$TH$TH
242744901$24274490$1$I$20240820$20240828$20240902$20240902$EXP$$JP-PFIZER INC-PV202400112521$PFIZER$$$$$M$Y$$$20240902$$PH$JP$JP
242744911$24274491$1$I$$20240830$20240902$20240902$EXP$$US-PFIZER INC-202400247778$PFIZER$$43$YR$$F$Y$$$20240902$$CN$US$US
242744921$24274492$1$I$20220101$20240828$20240902$20240902$EXP$$US-PFIZER INC-PV202400112509$PFIZER$$52$YR$$F$Y$66.22$KG$20240902$$CN$US$US
242744932$24274493$2$F$20240821$20240828$20240902$20240904$PER$$US-SA-2024SA253017$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240904$$CN$US$US
242744941$24274494$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018779$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240902$$CN$US$US
242744951$24274495$1$I$20240828$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018843$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240902$$CN$US$US
242744961$24274496$1$I$20140101$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202409000223$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240902$$CN$US$US
242744971$24274497$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139357$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240902$$CN$US$US
242744981$24274498$1$I$20240828$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018409$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240902$$CN$US$US
242744991$24274499$1$I$20240814$20240823$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135141$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240902$$PH$US$US
242745002$24274500$2$F$$20240914$20240902$20240915$PER$$US-ALXN-202408USA001962US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$MD$US$US
242745021$24274502$1$I$$20240902$20240902$20240902$EXP$$NVSC2024NP176386$NOVARTIS$$$$$M$Y$$$20240902$$MD$NP$NP
242745031$24274503$1$I$20070301$20240829$20240902$20240902$EXP$SE-EMA-DD-20240816-7482711-121902$NVSC2024SE175545$NOVARTIS$$45$YR$$F$Y$$$20240902$$CN$SE$SE
242745041$24274504$1$I$20240826$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172086$AMGEN$$40$YR$A$F$Y$$$20240902$$HP$US$US
242745051$24274505$1$I$$20240830$20240902$20240902$PER$$US-HALEON-2194576$Haleon PLC$$$$$$Y$$$20240902$$CN$US$US
242745071$24274507$1$I$20240816$20240830$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US076821$SANDOZ$$$$$M$Y$$$20240902$$CN$US$US
242745081$24274508$1$I$20240416$20240815$20240902$20240902$PER$$US-Vifor (International) Inc.-VIT-2024-07440$VIFOR$$63$YR$$F$Y$60.5$KG$20240902$$HP$US$US
242745091$24274509$1$I$20240706$20240826$20240902$20240902$EXP$IT-MINISAL02-999382$IT-TEVA-VS-3237250$TEVA$$73$YR$$M$Y$$$20240902$$MD$IT$IT
242745101$24274510$1$I$20240830$20240830$20240902$20240902$EXP$GB-MHRA-TPP20689955C8778330YC1725017667149$GB-SANDOZ INC.-SDZ2024GB076755$SANDOZ$$65$YR$$F$Y$89$KG$20240902$$MD$GB$GB
242745112$24274511$2$F$$20240905$20240902$20240906$EXP$$US-SANDOZ INC.-SDZ2024US076123$SANDOZ$$86$YR$$F$Y$$$20240906$$MD$US$US
242745122$24274512$2$F$20240829$20240902$20240902$20240903$PER$$US-AMGEN-USASP2024174806$AMGEN$$76$YR$E$F$Y$$$20240903$$CN$US$US
242745131$24274513$1$I$20240704$20240815$20240902$20240902$PER$$US-Vifor (International) Inc.-VIT-2024-07458$VIFOR$$41$YR$$M$Y$155$KG$20240902$$HP$US$US
242745141$24274514$1$I$$20240827$20240902$20240902$EXP$$GB-TAKEDA-2024TUS087380$TAKEDA$$$$$M$Y$$$20240902$$CN$GB$GB
242745161$24274516$1$I$$20240822$20240902$20240902$EXP$$US-RDY-SPO/USA/24/0012554$DR REDDYS$Wathen C, Yang AI, Hitti FL, Henry L, Chaibainou H, Baltuch GH. Feasibility of Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Essential Tremor in the Setting of Prior Craniotomy. Operative Neurosurgery. 2022 Feb;22(2): 61-65. doi:10.1227/ONS.0000000000000012.$55$YR$A$M$Y$$$20240902$$MD$US$US
242745191$24274519$1$I$$20240823$20240902$20240902$PER$$US-BIOGEN-2024BI01279984$BIOGEN$$$$$$Y$$$20240902$$CN$US$US
242745202$24274520$2$F$20240701$20240823$20240902$20240920$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16978$IPSEN$$77$YR$E$F$Y$$$20240920$$HP$US$US
242745211$24274521$1$I$$20240827$20240902$20240902$EXP$$US-TAKEDA-2024TUS086698$TAKEDA$$$$$M$Y$$$20240902$$CN$US$US
242745221$24274522$1$I$$20240827$20240902$20240902$EXP$$US-ABBVIE-5898518$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242745231$24274523$1$I$$20240829$20240902$20240902$EXP$$GB-SANDOZ INC.-SDZ2024GB042321$SANDOZ$$$$T$M$Y$$$20240902$$CN$GB$GB
242745241$24274524$1$I$20230101$20240711$20240902$20240902$EXP$$CA-SA-2023SA240093$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240902$$MD$CA$CA
242745251$24274525$1$I$20240101$20240823$20240902$20240902$EXP$$BR-TEVA-VS-3222250$TEVA$$28$YR$$F$Y$$$20240902$$CN$BR$BR
242745261$24274526$1$I$$20240826$20240902$20240902$EXP$$US-TAKEDA-US202026209$TAKEDA$$$$$F$Y$$$20240902$$CN$US$US
242745271$24274527$1$I$$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136590$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240902$$CN$US$US
242745281$24274528$1$I$20240830$20240830$20240902$20240902$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-139232$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$73.94$KG$20240902$$CN$PR$PR
242745291$24274529$1$I$20240101$20240821$20240902$20240902$PER$$US-JNJFOC-20240856348$JOHNSON AND JOHNSON$$51$YR$A$$Y$$$20240902$$CN$US$US
242745301$24274530$1$I$$20240822$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135587$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240902$$MD$US$US
242745311$24274531$1$I$$20240826$20240902$20240902$EXP$$US-GSK-US2024106137$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$US$US
242745331$24274533$1$I$20240724$20240828$20240902$20240902$PER$$US-ALXN-202408USA002020US$ALEXION PHARMACEUTICALS$$68$YR$$M$Y$113.38$KG$20240902$$HP$US$US
242745341$24274534$1$I$20200101$20240827$20240902$20240902$EXP$$US-ABBVIE-5898507$ABBVIE$$61$YR$$M$Y$$$20240902$$CN$US$US
242745381$24274538$1$I$20240803$20240813$20240902$20240902$EXP$$CN-BEIGENE-BGN-2024-012681$BEIGENE$$$$$$Y$$$20240902$$HP$CN$CN
242745391$24274539$1$I$$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024174300$AMGEN$$$$$$Y$$$20240902$$HP$US$US
242745401$24274540$1$I$$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196501$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242745411$24274541$1$I$$20240821$20240902$20240902$PER$$US-AstraZeneca-2024A192820$ASTRAZENECA$$$$$$Y$$$20240902$$CN$US$
242745423$24274542$3$F$$20240829$20240902$20240906$EXP$$CA-AstraZeneca-2024A197055$ASTRAZENECA$$78$YR$$M$Y$$$20240906$$CN$CA$
242745431$24274543$1$I$20240706$20240815$20240902$20240902$PER$$US-Vifor (International) Inc.-VIT-2024-07445$VIFOR$$57$YR$$M$Y$77$KG$20240902$$HP$US$US
242745441$24274544$1$I$20240723$20240815$20240902$20240902$EXP$$US-Vifor (International) Inc.-VIT-2024-07442$VIFOR$$57$YR$$M$Y$91$KG$20240902$$HP$US$US
242745451$24274545$1$I$20240723$20240815$20240902$20240902$PER$$US-Vifor (International) Inc.-VIT-2024-07454$VIFOR$$34$YR$$M$Y$64.8$KG$20240902$$HP$US$US
242745461$24274546$1$I$20240101$20240808$20240902$20240902$EXP$$US-Vifor (International) Inc.-VIT-2024-07199$VIFOR$$$$$M$Y$$$20240902$$CN$US$US
242745471$24274547$1$I$20240720$20240815$20240902$20240902$PER$$US-Vifor (International) Inc.-VIT-2024-07435$VIFOR$$65$YR$$F$Y$63.5$KG$20240902$$HP$US$US
242745481$24274548$1$I$20240422$20240815$20240902$20240902$PER$$US-Vifor (International) Inc.-VIT-2024-07449$VIFOR$$69$YR$$M$Y$111$KG$20240902$$HP$US$US
242745491$24274549$1$I$20240727$20240815$20240902$20240902$PER$$US-Vifor (International) Inc.-VIT-2024-07446$VIFOR$$20$YR$$F$Y$59$KG$20240902$$HP$US$US
242745501$24274550$1$I$20240427$20240827$20240902$20240902$EXP$$CA-Vifor (International) Inc.-VIT-2024-07794$VIFOR$$44$YR$$M$Y$$$20240902$$CN$CA$CA
242745511$24274551$1$I$$20240717$20240902$20240902$PER$$US-ASTELLAS-2024US020771$ASTELLAS$$73$YR$E$M$Y$$$20240830$$MD$US$US
242745525$24274552$5$F$20240822$20240919$20240902$20240923$PER$$US-AMGEN-USASP2024174046$AMGEN$$41$YR$A$F$Y$$$20240923$$PH$US$US
242745531$24274553$1$I$$20240829$20240902$20240902$EXP$$CH-AMGEN-CHENI2024174262$AMGEN$$$$E$M$Y$$$20240902$$MD$CH$CH
242745542$24274554$2$F$$20240905$20240902$20240913$EXP$$US-ASTELLAS-2024US017085$ASTELLAS$$73$YR$E$M$Y$$$20240913$$CN$US$US
242745552$24274555$2$F$$20240912$20240902$20240917$30DAY$$GB-SANDOZ INC.-SDZ2023GB034270$SANDOZ$$$$$M$Y$$$20240916$$CN$GB$GB
242745561$24274556$1$I$$20240829$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US076659$SANDOZ$$$$$M$Y$$$20240902$$CN$US$US
242745571$24274557$1$I$$20240829$20240902$20240902$EXP$$US-ABBVIE-5901893$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242745581$24274558$1$I$$20240816$20240902$20240902$PER$$US-ASTELLAS-2024-AER-001856$ASTELLAS$$86$YR$E$M$Y$$$20240902$$CN$US$US
242745591$24274559$1$I$20240301$20240827$20240902$20240902$EXP$$US-PFIZER INC-PV202200081937$PFIZER$$65$YR$$F$Y$$$20240902$$CN$US$US
242745601$24274560$1$I$$20240830$20240902$20240902$EXP$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-23-00553$US-SANDOZ INC.-SDZ2024US076740$SANDOZ$$67$YR$$M$Y$$$20240902$$MD$US$US
242745611$24274561$1$I$$20240827$20240902$20240902$EXP$$US-PFIZER INC-PV202400112641$PFIZER$$14$YR$$M$Y$$$20240902$$HP$US$US
242745621$24274562$1$I$$20240826$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408016315$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240902$$CN$US$US
242745631$24274563$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138887$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240902$$MD$US$US
242745641$24274564$1$I$$20240826$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139072$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$MD$US$US
242745651$24274565$1$I$$20240901$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139385$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240902$$HP$US$US
242745661$24274566$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139347$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$95.25$KG$20240902$$CN$US$US
242745671$24274567$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139332$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$72.12$KG$20240902$$CN$US$US
242745681$24274568$1$I$20240101$20240822$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134732$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240902$$HP$US$US
242745691$24274569$1$I$20240829$20240829$20240902$20240902$PER$$US-JNJFOC-20240877780$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240902$$CN$US$US
242745703$24274570$3$F$20220322$20240924$20240902$20240930$EXP$$CA-AMGEN-CANSL2024108124$AMGEN$$65$YR$E$M$Y$$$20240930$$HP$CA$CA
242745712$24274571$2$F$20240830$20240902$20240902$20240905$PER$$US-AMGEN-USASP2024174451$AMGEN$$58$YR$A$M$Y$$$20240904$$CN$US$US
242745721$24274572$1$I$20240817$20240830$20240902$20240902$EXP$GB-MHRA-MED-202408301238146220-CLDQT$GB-ORGANON-O2409GBR000017$ORGANON$$65$YR$$F$Y$62$KG$20240902$$PH$GB$GB
242745731$24274573$1$I$$20240827$20240902$20240902$EXP$$BR-GSK-BR2024AMR107953$GLAXOSMITHKLINE$$$$$$Y$$$20240902$$CN$BR$BR
242745751$24274575$1$I$20240801$20240830$20240902$20240902$EXP$$CN-ROCHE-10000071219$ROCHE$$71$YR$E$M$Y$72$KG$20240902$$HP$CN$CN
242745782$24274578$2$F$20240229$20240905$20240902$20240913$EXP$$JP-ASTELLAS-2024JP001652$ASTELLAS$$76$YR$E$M$Y$$$20240913$$MD$JP$JP
242745791$24274579$1$I$20240828$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173280$AMGEN$$65$YR$E$F$Y$$$20240902$$CN$US$US
242745801$24274580$1$I$20240830$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174869$AMGEN$$71$YR$E$F$Y$$$20240902$$HP$US$US
242745811$24274581$1$I$20240817$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024173047$AMGEN$$85$YR$E$F$Y$$$20240902$$CN$US$US
242745821$24274582$1$I$$20240823$20240902$20240902$PER$$US-AMGEN-USASP2024169753$AMGEN$Fischer M.D.; Green M.L.; Selke S. et.al.. Evaluation of oral herpes simplex virus shedding among solid organ transplant recipients: A pilot study. Transplant Infectious Disease. 2024;26 (4):1 to 7$$$A$F$Y$$$20240902$$HP$US$US
242745831$24274583$1$I$$20240828$20240902$20240902$PER$$US-JNJFOC-20240876841$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$HP$US$US
242745841$24274584$1$I$$20240828$20240902$20240902$EXP$$BR-DAIICHI SANKYO, INC.-DSE-2024-142639$DAIICHI$$75$YR$$F$Y$$$20240902$$MD$BR$BR
242745851$24274585$1$I$$20240827$20240902$20240902$EXP$$AT-JAZZ PHARMACEUTICALS-2024-AT-013640$JAZZ$$$$$$Y$$$20240902$$MD$AT$AT
242745861$24274586$1$I$20240827$20240829$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US076453$SANDOZ$$46$YR$$M$Y$$$20240902$$CN$US$US
242745871$24274587$1$I$$20240829$20240902$20240902$EXP$$JP-SANDOZ INC.-SDZ2024JP076614$SANDOZ$$71$YR$$F$Y$$$20240902$$MD$JP$JP
242745881$24274588$1$I$$20240828$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US076119$SANDOZ$$$$$F$Y$$$20240902$$CN$US$US
242745891$24274589$1$I$20240830$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174857$AMGEN$$57$YR$A$F$Y$76.19$KG$20240902$$CN$US$US
242745901$24274590$1$I$20240814$20240815$20240902$20240902$PER$$US-AMGEN-USASP2024163232$AMGEN$$37$YR$A$F$Y$$$20240902$$PH$US$US
242745911$24274591$1$I$20240716$20240819$20240902$20240902$30DAY$$US-AMGEN-USASP2024165199$AMGEN$$$$$$Y$$$20240902$$PH$US$US
242745922$24274592$2$F$20240601$20240902$20240902$20240904$PER$$US-AMGEN-USASP2024174344$AMGEN$$76$YR$E$F$Y$$$20240903$$CN$US$US
242745942$24274594$2$F$20240828$20240905$20240902$20240906$EXP$$CN-ROCHE-10000069951$ROCHE$$86$YR$E$F$Y$$$20240906$$MD$CN$CN
242745951$24274595$1$I$20240813$20240814$20240902$20240902$PER$$US-AstraZeneca-2024A199101$ASTRAZENECA$$91$YR$$F$Y$$$20240902$$CN$US$
242745961$24274596$1$I$$20240828$20240902$20240902$EXP$$DE-AstraZeneca-2024A198292$ASTRAZENECA$$63$YR$$F$Y$90$KG$20240902$$CN$DE$
242745971$24274597$1$I$$20240826$20240902$20240902$EXP$$NVSC2024CN173504$NOVARTIS$$$$$M$Y$$$20240902$$MD$CN$CN
242745981$24274598$1$I$$20240830$20240902$20240902$EXP$$GB-SANDOZ INC.-SDZ2024GB076768$SANDOZ$$16$YR$$M$Y$$$20240902$$CN$GB$GB
242745991$24274599$1$I$$20240826$20240902$20240902$PER$$US-ALXN-202408USA001759US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$CN$US$US
242746002$24274600$2$F$$20240831$20240902$20240910$EXP$$US-SANDOZ INC.-SDZ2024US076578$SANDOZ$$$$$$Y$$$20240910$$CN$US$US
242746021$24274602$1$I$$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136884$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$60.78$KG$20240902$$HP$US$US
242746031$24274603$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139119$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240902$$CN$US$US
242746042$24274604$2$F$$20240926$20240902$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138422$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240930$$CN$US$US
242746051$24274605$1$I$$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137767$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240902$$PH$US$US
242746061$24274606$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138344$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240902$$HP$US$US
242746072$24274607$2$F$$20240911$20240902$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139197$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$70.76$KG$20240913$$CN$US$US
242746082$24274608$2$F$20240801$20240904$20240902$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-138022$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240913$$PH$JP$JP
242746091$24274609$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138641$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240902$$CN$US$US
242746101$24274610$1$I$$20240823$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135380$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240902$$CN$US$US
242746111$24274611$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138631$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240902$$CN$US$US
242746121$24274612$1$I$$20240822$20240902$20240902$EXP$$BE-BRISTOL-MYERS SQUIBB COMPANY-2024-139043$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240902$$HP$BE$BE
242746131$24274613$1$I$20230301$20240830$20240902$20240902$PER$$US-TAKEDA-2024TUS087815$TAKEDA$$73$YR$$F$Y$86$KG$20240902$$MD$US$US
242746141$24274614$1$I$$20240831$20240902$20240902$PER$$US-AMGEN-USASP2024174728$AMGEN$$$$A$F$Y$$$20240902$$CN$US$US
242746151$24274615$1$I$$20240829$20240902$20240902$PER$$US-ORGANON-O2408USA002307$ORGANON$$$$$F$Y$$$20240902$$MD$US$US
242746161$24274616$1$I$$20240819$20240902$20240902$EXP$$CN-ASTELLAS-2024-AER-002279$ASTELLAS$$$$E$$Y$$$20240902$$MD$CN$CN
242746171$24274617$1$I$20240826$20240826$20240902$20240902$EXP$$US-JNJFOC-20240875213$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240902$$MD$US$US
242746181$24274618$1$I$$20240826$20240902$20240902$EXP$$US-JNJFOC-20240873152$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242746191$24274619$1$I$$20240830$20240902$20240902$EXP$PL-URPL-1-2183-2020$PL-ROCHE-10000071410$ROCHE$$59$YR$A$F$Y$$$20240902$$MD$PL$PL
242746201$24274620$1$I$$20240829$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US076437$SANDOZ$$$$$F$Y$$$20240902$$HP$US$US
242746221$24274622$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076636$SANDOZ$$30$YR$$F$Y$42$KG$20240902$$MD$US$US
242746231$24274623$1$I$$20240823$20240902$20240902$EXP$$CA-GALDERMA-CA2024013427$GALDERMA$$$$$$Y$$$20240902$$HP$CA$CA
242746251$24274625$1$I$20220104$20230220$20240902$20240902$EXP$$CN-SANDOZ INC.-NVSC2023CN040924$SANDOZ$$68$YR$$F$Y$60$KG$20240902$$HP$CN$CN
242746281$24274628$1$I$$20240822$20240902$20240902$EXP$$JP-TAKEDA-2024TUS087486$TAKEDA$$17$YR$$F$Y$$$20240902$$MD$JP$JP
242746291$24274629$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076972$SANDOZ$$$$$M$Y$$$20240902$$MD$US$US
242746301$24274630$1$I$20240311$20240826$20240902$20240902$EXP$IT-MINISAL02-999387$IT-TEVA-VS-3237323$TEVA$$75$YR$$F$Y$$$20240902$$MD$IT$IT
242746311$24274631$1$I$20230101$20240711$20240902$20240902$PER$$US-ASTELLAS-2024US010918$ASTELLAS$$56$YR$A$F$Y$$$20240830$$CN$US$US
242746332$24274633$2$F$$20240910$20240902$20240920$EXP$$CA-SANDOZ INC.-SDZ2024CA075073$SANDOZ$$13$YR$$M$Y$$$20240920$$HP$CA$CA
242746341$24274634$1$I$$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174885$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242746352$24274635$2$F$$20240822$20240902$20240902$EXP$$US-ROCHE-10000064843$ROCHE$$$$A$M$Y$$$20240902$$CN$US$US
242746361$24274636$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018691$ELI LILLY AND CO$$$$$$Y$$$20240902$$CN$US$US
242746371$24274637$1$I$20240729$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136998$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$74.84$KG$20240902$$PH$US$US
242746381$24274638$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139481$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240902$$HP$US$US
242746391$24274639$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139348$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$52.62$KG$20240902$$HP$US$US
242746401$24274640$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139484$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240902$$CN$US$US
242746421$24274642$1$I$$20240829$20240902$20240902$EXP$$JP-SANDOZ INC.-SDZ2024JP076811$SANDOZ$$75$YR$$F$Y$$$20240902$$MD$JP$JP
242746431$24274643$1$I$20240315$20240820$20240902$20240902$EXP$$DK-CIPLA LTD.-2024DK09226$CIPLA$$$$$$Y$$$20240902$$MD$DK$DK
242746441$24274644$1$I$$20240830$20240902$20240902$EXP$US-MLMSERVICE-20240809-PI157958-00218-1$US-SANDOZ INC.-SDZ2024US076732$SANDOZ$$54$YR$$F$Y$$$20240902$$MD$US$US
242746451$24274645$1$I$$20240829$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076641$SANDOZ$$$$$M$Y$$$20240902$$CN$US$US
242746461$24274646$1$I$$20240830$20240902$20240902$PER$$NVSC2024US176476$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
242746481$24274648$1$I$$20240828$20240902$20240902$EXP$$US-AstraZeneca-2024A196303$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$US$
242746491$24274649$1$I$20240822$20240830$20240902$20240902$EXP$$CN-AstraZeneca-2024A198369$ASTRAZENECA$$88$YR$$F$Y$75$KG$20240902$$MD$CN$
242746501$24274650$1$I$$20240829$20240902$20240902$EXP$$US-AstraZeneca-2024A197468$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242746511$24274651$1$I$$20240830$20240902$20240902$EXP$$BR-AstraZeneca-2024A198913$ASTRAZENECA$$$$$M$Y$$$20240902$$CN$BR$
242746521$24274652$1$I$20240801$20240827$20240902$20240902$EXP$$CN-ABBVIE-5898375$ABBVIE$$60$YR$$F$Y$42$KG$20240902$$MD$CN$CN
242746531$24274653$1$I$$20240823$20240902$20240902$EXP$$CA-GALDERMA-CA2024013429$GALDERMA$$$$$$Y$$$20240902$$HP$CA$CA
242746551$24274655$1$I$$20240826$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US075867$SANDOZ$Defayette A, Anibaldi E PA, Abad A, Ibegbu C, Silvestri N, Doobay R et.al.. A case report of elevated bromide levels from pyridostigmine bromide for treatment of myasthenia gravis.. American journal of health-system pharmacy : AJHP : official journal of the Amer. 2024$37$YR$$M$Y$70$KG$20240902$$HP$US$US
242746561$24274656$1$I$20240412$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138993$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240902$$CN$US$US
242746573$24274657$3$F$$20240920$20240902$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137572$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240924$$HP$US$US
242746581$24274658$1$I$20240801$20240830$20240902$20240902$PER$$US-JNJFOC-20240881628$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240902$$CN$US$US
242746591$24274659$1$I$$20240822$20240902$20240902$PER$$US-RDY-SPO/USA/24/0012547$DR REDDYS$Jones AA, Martin JS, Giangiacomo AL, Costakos DM. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024;36: doi:10.1016/j.ajoc.2024.102131.$$$I$M$Y$$$20240902$$HP$US$US
242746601$24274660$1$I$20240501$20240827$20240902$20240902$30DAY$$GB-PFIZER INC-PV202400111748$PFIZER$$12$YR$$F$Y$$$20240902$$CN$GB$GB
242746652$24274665$2$F$$20240827$20240902$20240903$30DAY$$US-PFIZER INC-202400243148$PFIZER$$15$YR$$M$Y$$$20240903$$CN$US$US
242746673$24274667$3$F$20240801$20240918$20240902$20240923$30DAY$$US-PFIZER INC-202400245001$PFIZER$$14$YR$$M$Y$$$20240923$$CN$US$US
242746684$24274668$4$F$$20240918$20240902$20240924$30DAY$$US-PFIZER INC-202400245153$PFIZER$$14$YR$$M$Y$$$20240924$$HP$US$US
242746731$24274673$1$I$20240801$20240827$20240902$20240902$30DAY$$US-PFIZER INC-202400245204$PFIZER$$2$YR$$F$Y$11.1$KG$20240902$$CN$US$US
242746751$24274675$1$I$$20240821$20240902$20240902$30DAY$$US-PFIZER INC-PV202400109392$PFIZER$$$$$M$Y$$$20240902$$CN$US$US
242746784$24274678$4$F$20240101$20240913$20240902$20240920$30DAY$$US-PFIZER INC-202400242345$PFIZER$$33$YR$$F$Y$154.2$KG$20240920$$CN$US$US
242746801$24274680$1$I$20240101$20240826$20240902$20240902$30DAY$$US-PFIZER INC-202400244110$PFIZER$$16$YR$$M$Y$$$20240902$$CN$US$US
242746811$24274681$1$I$20240802$20240823$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136031$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$55.57$KG$20240902$$HP$US$US
242746821$24274682$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139441$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240902$$CN$US$US
242746831$24274683$1$I$$20240830$20240902$20240902$EXP$US-MLMSERVICE-20240801-PI149556-00218-1$US-SANDOZ INC.-SDZ2024US076701$SANDOZ$$71$YR$$M$Y$$$20240902$$MD$US$US
242746841$24274684$1$I$20220123$20220128$20240902$20240902$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-138748$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$74.4$KG$20240902$$MD$TR$TR
242746851$24274685$1$I$20240324$20240829$20240902$20240902$EXP$$NVSC2024CN176352$NOVARTIS$$38$YR$$F$Y$72.5$KG$20240902$$HP$CN$CN
242746861$24274686$1$I$20240701$20240715$20240902$20240902$PER$$US-ASTELLAS-2024US020411$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242746871$24274687$1$I$20150421$20240830$20240902$20240902$EXP$$US-GILEAD-2024-0685992$GILEAD$$31$YR$A$F$Y$$$20240902$$LW$US$US
242746881$24274688$1$I$$20240828$20240902$20240902$EXP$$BR-PFIZER INC-202400245610$PFIZER$$36$YR$$F$Y$$$20240902$$CN$BR$BR
242746901$24274690$1$I$20240801$20240827$20240902$20240902$30DAY$$GB-PFIZER INC-PV202400112317$PFIZER$$10$YR$$F$Y$$$20240902$$CN$GB$GB
242746931$24274693$1$I$20180718$20240821$20240902$20240902$EXP$AU-TGA-0000815669$AU-ORGANON-O2408AUS002279$ORGANON$$52$YR$$F$Y$$$20240902$$MD$AU$AU
242746944$24274694$4$F$20240801$20240917$20240902$20240923$EXP$$CA-PFIZER INC-202400247325$PFIZER$$76$YR$$M$Y$$$20240923$$HP$CA$CA
242746952$24274695$2$F$$20240830$20240902$20240906$30DAY$$JP-PFIZER INC-202400245508$PFIZER$$$$$$Y$$$20240906$$PH$JP$JP
242746983$24274698$3$F$$20240918$20240902$20240923$EXP$$CN-PFIZER INC-PV202400112316$PFIZER$$37$YR$$M$Y$$$20240923$$CN$CN$CN
242747011$24274701$1$I$20240601$20240820$20240902$20240902$EXP$$CN-SA-2024SA253609$SANOFI AVENTIS$$52$YR$A$M$Y$78$KG$20240902$$HP$CN$CN
242747042$24274704$2$F$20230121$20240903$20240902$20240906$PER$$CA-PFIZER INC-202201360528$PFIZER$$38$YR$$M$Y$104$KG$20240906$$HP$CA$CA
242747051$24274705$1$I$$20240829$20240902$20240902$EXP$$GB-TAKEDA-2024TUS087556$TAKEDA$$$$$F$Y$$$20240902$$PH$GB$GB
242747061$24274706$1$I$$20240828$20240902$20240902$EXP$$PH-TAKEDA-2023TUS056379$TAKEDA$$$$$F$Y$$$20240902$$MD$PH$PH
242747071$24274707$1$I$20231101$20240829$20240902$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019272$JAZZ$$62$YR$$M$Y$$$20240902$$CN$US$US
242747081$24274708$1$I$20240501$20240822$20240902$20240902$PER$$US-ABBVIE-5893299$ABBVIE$$35$YR$$M$Y$$$20240902$$HP$US$US
242747091$24274709$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139203$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$70.31$KG$20240902$$CN$US$US
242747101$24274710$1$I$20240828$20240828$20240902$20240902$PER$$US-SA-2024SA253055$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240902$$MD$US$US
242747111$24274711$1$I$20240801$20240826$20240902$20240902$EXP$$US-SA-2024SA252533$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240902$$MD$US$US
242747121$24274712$1$I$20240101$20240828$20240902$20240902$PER$$US-009507513-2408USA010278$MERCK$$12$YR$$$Y$$$20240902$$HP$US$US
242747131$24274713$1$I$$20240830$20240902$20240902$PER$$US-JNJFOC-20240882023$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242747141$24274714$1$I$$20240829$20240902$20240902$PER$$US-JNJFOC-20240880836$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242747151$24274715$1$I$$20240828$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018132$ELI LILLY AND CO$$90$YR$E$F$Y$$$20240902$$CN$US$US
242747161$24274716$1$I$$20240828$20240902$20240902$EXP$$US-SA-2024SA253278$SANOFI AVENTIS$$$$E$F$Y$$$20240902$$MD$US$US
242747171$24274717$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019380$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240902$$CN$US$US
242747181$24274718$1$I$$20240826$20240902$20240902$PER$$US-ABBVIE-5896613$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242747191$24274719$1$I$20240830$20240831$20240902$20240902$EXP$GB-MHRA-MED-202408301434208730-KHWLD$GB-ORGANON-O2409GBR000020$ORGANON$$87$YR$$F$Y$$$20240902$$MD$GB$GB
242747211$24274721$1$I$20190625$20240830$20240902$20240902$EXP$$NVSC2024GB175873$NOVARTIS$$$$A$M$Y$89.4$KG$20240902$$HP$GB$GB
242747222$24274722$2$F$20240825$20240902$20240902$20240903$PER$$NVSC2024US176444$NOVARTIS$$69$YR$$F$Y$$$20240903$$CN$US$US
242747242$24274724$2$F$$20240829$20240902$20240903$PER$$NVSC2024US175431$NOVARTIS$$$$$F$Y$$$20240903$$CN$US$US
242747251$24274725$1$I$$20240820$20240902$20240902$EXP$$IT-CIPLA LTD.-2024IT09238$CIPLA$Castelli M, Betelli M, Valenti A, Merelli B, Loglio A, Vigan? M, Benetti A. A Case of Polyserositis, Chylous Ascites and Hepatitis Induced by Immune Checkpoint Inhibitors.. Eur J Case Rep Intern Med. 2024;11(7):004237$$$$$Y$$$20240902$$HP$IT$IT
242747261$24274726$1$I$$20240820$20240902$20240902$PER$$US-JNJFOC-20240860332$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242747271$24274727$1$I$20240701$20240823$20240902$20240902$EXP$$GB-TEVA-VS-3237347$TEVA$$70$YR$$M$Y$$$20240902$$MD$GB$GB
242747282$24274728$2$F$20191224$20240920$20240902$20240925$EXP$$US-TAKEDA-US202000259$TAKEDA$$36$YR$$M$Y$$$20240925$$HP$US$US
242747291$24274729$1$I$20240101$20240823$20240902$20240902$EXP$GB-MHRA-MED-202408231849259030-YDKNM$GB-TEVA-VS-3237258$TEVA$$65$YR$$F$Y$81$KG$20240902$$CN$GB$GB
242747301$24274730$1$I$20240823$20240823$20240902$20240902$EXP$$GB-TEVA-VS-3236979$TEVA$$66$YR$$M$Y$83$KG$20240902$$MD$GB$GB
242747321$24274732$1$I$$20240829$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076919$SANDOZ$$$$$F$Y$52.27$KG$20240902$$CN$US$US
242747331$24274733$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076980$SANDOZ$$$$$F$Y$$$20240902$$CN$US$US
242747341$24274734$1$I$20240801$20240829$20240902$20240902$EXP$$US-KYOWAKIRIN-2024KK020299$KYOWA$$$$$$Y$$$20240902$$HP$US$US
242747351$24274735$1$I$$20240221$20240902$20240902$PER$$US-ASTELLAS-2024US003929$ASTELLAS$$$$$F$Y$$$20240830$$CN$US$US
242747361$24274736$1$I$20240101$20240827$20240902$20240902$EXP$$US-IMMUNOGEN, INC.-US-IMGN-24-00612$IMMUNOGEN$$$$A$F$Y$$$20240902$$CN$US$US
242747371$24274737$1$I$$20240827$20240902$20240902$EXP$$US-IMMUNOGEN, INC.-US-IMGN-24-00626$IMMUNOGEN$$48$YR$$F$Y$$$20240902$$MD$US$US
242747382$24274738$2$F$$20240904$20240902$20240909$EXP$$EG-TAKEDA-2024TUS087889$TAKEDA$$$$$F$Y$$$20240909$$MD$EG$EG
242747391$24274739$1$I$$20240813$20240902$20240902$PER$$US-TEVA-VS-3234176$TEVA$$60$YR$$F$Y$$$20240902$$CN$US$US
242747402$24274740$2$F$$20240830$20240902$20240903$EXP$$CA-SANDOZ INC.-SDZ2023CA076659$SANDOZ$$44$YR$$F$Y$97$KG$20240903$$HP$CA$CA
242747431$24274743$1$I$$20240830$20240902$20240902$EXP$$US-ABBVIE-5903527$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242747441$24274744$1$I$$20240830$20240902$20240902$PER$$NVSC2024US176550$NOVARTIS$$$$$$Y$$$20240902$$MD$US$US
242747451$24274745$1$I$$20240829$20240902$20240902$EXP$$US-ORGANON-O2409USA000031$ORGANON$$$$$F$Y$$$20240902$$MD$US$US
242747461$24274746$1$I$$20240830$20240902$20240902$PER$$US-JNJFOC-20240880838$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$HP$US$US
242747471$24274747$1$I$$20240829$20240902$20240902$PER$$US-JNJFOC-20240880558$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242747481$24274748$1$I$$20240826$20240902$20240902$EXP$PL-URPL-1-4204-2020$PL-TEVA-VS-3237433$TEVA$$64$YR$$F$Y$$$20240902$$MD$PL$PL
242747491$24274749$1$I$20240827$20240827$20240902$20240902$EXP$$JP-AMGEN-JPNSP2024171651$AMGEN$$75$YR$E$F$Y$$$20240902$$PH$JP$JP
242747501$24274750$1$I$$20240827$20240902$20240902$EXP$$JP-AMGEN-JPNSP2024171773$AMGEN$$$$E$$Y$$$20240902$$MD$JP$JP
242747511$24274751$1$I$$20240828$20240902$20240902$EXP$$US-TAKEDA-2024TUS086842$TAKEDA$$$$$F$Y$$$20240902$$CN$US$US
242747521$24274752$1$I$$20240823$20240902$20240902$EXP$$JP-TAKEDA-2024TUS087702$TAKEDA$$27$YR$$F$Y$$$20240902$$MD$JP$JP
242747531$24274753$1$I$$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024172582$AMGEN$$$$E$F$Y$$$20240902$$HP$US$US
242747541$24274754$1$I$$20240829$20240902$20240902$PER$$US-ABBVIE-5903217$ABBVIE$$$$$F$Y$$$20240902$$HP$US$US
242747551$24274755$1$I$$20240829$20240902$20240902$PER$$NVSC2024US175810$NOVARTIS$$$$$$Y$$$20240902$$CN$US$US
242747571$24274757$1$I$20230601$20240830$20240902$20240902$EXP$$US-PURDUE PHARMA-USA-2024-0311707$PURDUE$$$$$M$Y$$$20240902$$CN$US$US
242747581$24274758$1$I$$20240829$20240902$20240902$EXP$$CA-PURDUE-USA-2024-0311716$PURDUE$$$$$$Y$$$20240902$$PH$CA$CA
242747604$24274760$4$F$20231101$20240916$20240902$20240924$EXP$$CA-TAKEDA-2024TUS086882$TAKEDA$$20$YR$$M$Y$$$20240924$$CN$CA$CA
242747611$24274761$1$I$$20240826$20240902$20240902$EXP$NL-LRB-00996930$NL-TEVA-VS-3237338$TEVA$$62$YR$$F$Y$94$KG$20240902$$CN$NL$NL
242747621$24274762$1$I$$20240828$20240902$20240902$PER$$NVSC2024US174762$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
242747641$24274764$1$I$20240101$20240823$20240902$20240902$EXP$$CA-TEVA-VS-3238861$TEVA$$34$YR$$F$Y$$$20240902$$CN$CA$CA
242747651$24274765$1$I$20230801$20240828$20240902$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013786$JAZZ$$27$YR$$F$Y$$$20240902$$CN$US$US
242747661$24274766$1$I$$20240719$20240902$20240902$PER$$US-ASTELLAS-2024US011754$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242747681$24274768$1$I$$20240828$20240902$20240902$PER$$US-EMD Serono-2024046614$EMD SERONO INC$$37$YR$A$F$Y$$$20240902$$CN$US$US
242747691$24274769$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139279$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240902$$HP$US$US
242747702$24274770$2$F$20240801$20240904$20240902$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139222$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240905$$CN$US$US
242747711$24274771$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139224$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240902$$CN$US$US
242747721$24274772$1$I$20240820$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137896$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240902$$HP$US$US
242747731$24274773$1$I$$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136516$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$52.16$KG$20240902$$CN$US$US
242747741$24274774$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137690$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240902$$CN$US$US
242747752$24274775$2$F$20240919$20240920$20240902$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134879$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$74.84$KG$20240930$$CN$US$US
242747761$24274776$1$I$$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139354$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240902$$CN$US$US
242747771$24274777$1$I$$20240828$20240902$20240902$EXP$$IT-TAKEDA-2024TUS087446$TAKEDA$$$$$F$Y$$$20240902$$CN$IT$IT
242747781$24274778$1$I$$20240828$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US076455$SANDOZ$$$$$F$Y$$$20240902$$CN$US$US
242747791$24274779$1$I$20240101$20240823$20240902$20240902$PER$$US-MYLANLABS-2024M1078847$MYLAN$$$$$F$Y$$$20240902$$CN$US$US
242747801$24274780$1$I$$20240819$20240902$20240902$PER$$US-JNJFOC-20240850581$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242747811$24274781$1$I$$20240830$20240902$20240902$PER$$US-JNJFOC-20240880865$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$HP$US$US
242747821$24274782$1$I$20240730$20240820$20240902$20240902$EXP$$FR-CIPLA LTD.-2024FR09218$CIPLA$$$$$$Y$$$20240902$$PH$FR$FR
242747831$24274783$1$I$$20240820$20240902$20240902$EXP$$IN-CIPLA LTD.-2024IN09323$CIPLA$Malwade S, Dharmagadda A, Premkumar V.. Neonatal abstinence syndrome: A case series.. Cureus.. 2024;16 (7):e64372$$$$$Y$$$20240902$$HP$IN$IN
242747841$24274784$1$I$$20240830$20240902$20240902$PER$$NVSC2024US176513$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
242747851$24274785$1$I$20240723$20240820$20240902$20240902$EXP$$FR-CIPLA LTD.-2024FR09216$CIPLA$$$$$$Y$$$20240902$$MD$FR$FR
242747861$24274786$1$I$20240830$20240830$20240902$20240902$PER$$US-JNJFOC-20240881934$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240902$$CN$US$US
242747871$24274787$1$I$$20240822$20240902$20240902$PER$$US-JNJFOC-20240882603$JOHNSON AND JOHNSON$$$$$M$Y$$$20240902$$MD$US$US
242747881$24274788$1$I$20240112$20240827$20240902$20240902$EXP$FR-AFSSAPS-LL2024001576$FR-009507513-2408FRA009475$MERCK$$57$YR$$M$Y$$$20240902$$PH$FR$FR
242747892$24274789$2$F$$20240830$20240902$20240909$EXP$$PT-MYLANLABS-2024M1067280$MYLAN$Carolina Roias, Catarina la Cueva Couto, Bruna Bolas Cardoso, Vera Oom, Ricardo Paquete Oliveira.. POSA-133-(4410) - DRESS syndrome in chronic kidney disease. Abstract Book. Congresses of the Portuguese Society of Internal Medicine. 2024;1207$47$YR$$M$Y$$$20240909$$MD$PT$PT
242747911$24274791$1$I$$20240827$20240902$20240902$PER$$US-ALXN-202408USA001781US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240902$$HP$US$US
242747921$24274792$1$I$$20240822$20240902$20240902$EXP$$AT-RDY-SPO/AUT/24/0012559$DR REDDYS$Habenbacher M, Andrianakis A, Gellner V, Braun H, Szkandera J, Liegl-Atzwanger B, et al. Aggressive EWSR1::POU2AF3(COLCA2) spindle/round cell sarcoma of the sinonasal tract. Histopathology. 2024;0(0): doi:10.1111/his.15216.$32$YR$A$M$Y$$$20240902$$HP$AT$AT
242747931$24274793$1$I$20221101$20240830$20240902$20240902$EXP$$IT-KYOWAKIRIN-2024KK020340$KYOWA$Pavone P, Arletti L, Ilariucci F, Albano T, Lusetti D, Corsini R, Merli F, Mezzadri S.. Atypical Presentation of Invasive Aspergillosis during Treatment with Mogamulizumab. Journal of fungi (Basel, Switzerland). 2024;10(8):1-6$$$$$Y$$$20240902$$HP$IT$IT
242747961$24274796$1$I$$20240826$20240902$20240902$PER$$US-009507513-2408USA009254$MERCK$$$$$M$Y$$$20240902$$HP$US$US
242747971$24274797$1$I$20240827$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024174114$AMGEN$$$$$$Y$$$20240902$$HP$US$US
242747981$24274798$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138932$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240902$$CN$US$US
242747991$24274799$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139239$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240902$$CN$US$US
242748001$24274800$1$I$20240826$20240829$20240902$20240902$EXP$$NVSC2024CN176375$NOVARTIS$$50$YR$$M$Y$53$KG$20240902$$HP$CN$CN
242748011$24274801$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139446$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240902$$CN$US$US
242748021$24274802$1$I$20240827$20240827$20240902$20240902$EXP$$US-AMGEN-USASL2024171209$AMGEN$$82$YR$E$F$Y$$$20240902$$CN$US$US
242748031$24274803$1$I$20230101$20240827$20240902$20240902$EXP$$RO-009507513-2408ROU010117$MERCK$$57$YR$$M$Y$$$20240902$$MD$RO$RO
242748041$24274804$1$I$$20240829$20240902$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013839$JAZZ$$$$$F$Y$$$20240902$$CN$US$US
242748051$24274805$1$I$20190101$20240826$20240902$20240902$EXP$$CN-JNJFOC-20240876860$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240902$$HP$CN$CN
242748061$24274806$1$I$20240719$20240826$20240902$20240902$EXP$IT-MINISAL02-999439$IT-TEVA-VS-3237508$TEVA$$81$YR$$M$Y$$$20240902$$MD$IT$IT
242748071$24274807$1$I$20240805$20240823$20240902$20240902$EXP$$ES-TEVA-VS-3237817$TEVA$$62$YR$$F$Y$$$20240902$$CN$ES$ES
242748081$24274808$1$I$20240418$20240830$20240902$20240902$EXP$$CA-ABBVIE-5903485$ABBVIE$$50$YR$$M$Y$$$20240902$$CN$CA$CA
242748091$24274809$1$I$$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139667$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240902$$MD$US$US
242748102$24274810$2$F$20221229$20240909$20240902$20240922$PER$$US-009507513-2408USA005322$MERCK$$$$$M$Y$$$20240922$$MD$US$US
242748111$24274811$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139281$BRISTOL MYERS SQUIBB$$73$YR$A$F$Y$73.94$KG$20240902$$CN$US$US
242748121$24274812$1$I$$20240823$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135687$BRISTOL MYERS SQUIBB$$76$YR$E$$Y$$$20240902$$MD$US$US
242748141$24274814$1$I$20240801$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138714$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240902$$PH$US$US
242748151$24274815$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139663$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240902$$CN$US$US
242748161$24274816$1$I$$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139523$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240902$$CN$US$US
242748171$24274817$1$I$$20240828$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138939$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240902$$CN$US$US
242748181$24274818$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139115$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240902$$HP$US$US
242748191$24274819$1$I$$20240826$20240902$20240902$EXP$$US-ABBVIE-5897431$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242748201$24274820$1$I$20240801$20240828$20240902$20240902$EXP$$CA-ABBVIE-5902445$ABBVIE$$$$E$F$Y$$$20240902$$CN$CA$CA
242748211$24274821$1$I$20240101$20240829$20240902$20240902$EXP$$US-ABBVIE-5901567$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242748221$24274822$1$I$$20240820$20240902$20240902$PER$$US-JNJFOC-20240855283$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242748231$24274823$1$I$$20240829$20240902$20240902$PER$$US-JNJFOC-20240881635$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242748241$24274824$1$I$20240313$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138425$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$72.57$KG$20240902$$HP$US$US
242748251$24274825$1$I$$20240823$20240902$20240902$EXP$$GB-TEVA-VS-3237105$TEVA$$84$YR$$F$Y$59$KG$20240902$$MD$GB$GB
242748261$24274826$1$I$20240705$20240829$20240902$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013879$JAZZ$$42$YR$$M$Y$$$20240902$$HP$US$US
242748281$24274828$1$I$$20240826$20240902$20240902$EXP$PL-URPL-1-1872-2020$PL-TEVA-VS-3237477$TEVA$$20$YR$$M$Y$$$20240902$$MD$PL$PL
242748291$24274829$1$I$20230101$20240827$20240902$20240902$PER$$US-ASTELLAS-2024-AER-003729$ASTELLAS$$7$DEC$E$F$Y$$$20240902$$MD$US$US
242748301$24274830$1$I$$20240823$20240902$20240902$EXP$$AU-ASTELLAS-2024-AER-001411$ASTELLAS$$63$YR$A$F$Y$$$20240902$$CN$AU$AU
242748311$24274831$1$I$20240719$20240827$20240902$20240902$EXP$$ES-SANDOZ INC.-SDZ2024ES076705$SANDOZ$$47$YR$$F$Y$59.1$KG$20240902$$MD$ES$ES
242748341$24274834$1$I$$20240821$20240902$20240902$PER$$US-SA-2024SA252695$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240902$$CN$US$US
242748361$24274836$1$I$$20240826$20240902$20240902$EXP$DE-UCBINNMED-20240023$DE-RDY-SPO/DEU/24/0012472$DR REDDYS$Isabel Brueckner, Jessica Welter-Luedeke, Anna Zangl, Matthias Graw, Liane D. Paul. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313. doi:https://doi.org/10.1093/jat/bkae011$30$YR$A$M$Y$$$20240902$$HP$DE$DE
242748382$24274838$2$F$$20240914$20240902$20240916$PER$$NVSC2024US176578$NOVARTIS$$$$$$Y$$$20240916$$CN$US$US
242748391$24274839$1$I$$20240823$20240902$20240902$EXP$$BR-TEVA-VS-3238924$TEVA$$34$YR$$M$Y$$$20240902$$CN$BR$BR
242748401$24274840$1$I$20240829$20240830$20240902$20240902$PER$$US-AstraZeneca-2024A199263$ASTRAZENECA$$$$$F$Y$$$20240902$$HP$US$
242748411$24274841$1$I$$20240822$20240902$20240902$EXP$$AR-TAKEDA-2024TUS087592$TAKEDA$$63$YR$$M$Y$$$20240902$$MD$AR$AR
242748421$24274842$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138531$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240902$$CN$US$US
242748432$24274843$2$F$20240627$20240830$20240902$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138452$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$73.03$KG$20240906$$CN$US$US
242748441$24274844$1$I$$20240826$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138859$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$102.04$KG$20240902$$CN$US$US
242748451$24274845$1$I$$20240829$20240902$20240902$EXP$$BR-ABBVIE-5902443$ABBVIE$$$$$F$Y$$$20240902$$MD$BR$BR
242748461$24274846$1$I$$20240821$20240902$20240902$PER$$US-JNJFOC-20240857095$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242748471$24274847$1$I$20240829$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018690$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240902$$CN$US$US
242748481$24274848$1$I$$20240828$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US076447$SANDOZ$$$$$F$Y$$$20240902$$CN$US$US
242748491$24274849$1$I$$20240826$20240902$20240902$EXP$$US-TAKEDA-2024TUS086262$TAKEDA$$$$$M$Y$$$20240902$$MD$US$US
242748511$24274851$1$I$$20240830$20240902$20240902$PER$$NVSC2024US176211$NOVARTIS$$$$$M$Y$$$20240902$$HP$US$US
242748521$24274852$1$I$20240827$20240827$20240902$20240902$PER$$US-ALXN-202408USA001985US$ALEXION PHARMACEUTICALS$$75$YR$$F$Y$$$20240902$$CN$US$US
242748531$24274853$1$I$20240601$20240731$20240902$20240902$PER$$US-ASTELLAS-2024US019588$ASTELLAS$$76$YR$E$M$Y$$$20240830$$PH$US$US
242748541$24274854$1$I$$20240829$20240902$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013913$JAZZ$$$$$$Y$$$20240902$$CN$US$US
242748551$24274855$1$I$$20240821$20240902$20240902$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16740$IPSEN$$$$$F$Y$$$20240902$$CN$US$US
242748563$24274856$3$F$$20240830$20240902$20240905$PER$$US-JNJFOC-20240878085$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242748571$24274857$1$I$20240827$20240829$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138917$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240902$$HP$US$US
242748581$24274858$1$I$$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138812$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240902$$CN$US$US
242748591$24274859$1$I$20240827$20240827$20240902$20240902$PER$$US-RDY-SPO/USA/24/0012636$DR REDDYS$$13$YR$T$$Y$$$20240902$$MD$US$US
242748601$24274860$1$I$20240101$20240822$20240902$20240902$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08485$NEUROCRINE BIOSCIENCES$$5$DEC$$M$Y$$$20240902$$MD$US$US
242748612$24274861$2$F$$20240821$20240902$20240912$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049105$BOEHRINGER INGELHEIM$$53$YR$A$M$Y$$$20240912$$CN$US$US
242748621$24274862$1$I$20220601$20240823$20240902$20240902$EXP$$BR-TEVA-VS-3238072$TEVA$$32$YR$$M$Y$$$20240902$$CN$BR$BR
242748631$24274863$1$I$20240101$20240820$20240902$20240902$PER$$US-JNJFOC-20240858914$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242748641$24274864$1$I$$20240823$20240902$20240902$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016180$ELI LILLY AND CO$$$$E$$Y$$$20240902$$CN$US$US
242748651$24274865$1$I$$20240823$20240902$20240902$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202408016287$ELI LILLY AND CO$$$$$$Y$$$20240902$$CN$MX$MX
242748661$24274866$1$I$$20240822$20240902$20240902$EXP$GB-MHRA-MED-202408222012341230-QZMDS$GB-ELI_LILLY_AND_COMPANY-GB202408014978$ELI LILLY AND CO$$$$$F$Y$$$20240902$$CN$GB$GB
242748671$24274867$1$I$$20240822$20240902$20240902$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202408015226$ELI LILLY AND CO$$$$$$Y$$$20240902$$CN$BE$BE
242748681$24274868$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018689$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240902$$CN$US$US
242748691$24274869$1$I$$20240827$20240902$20240902$EXP$$GR-TAKEDA-2024TUS087274$TAKEDA$Chatzis G, Vlachopoulou. Metabolic acidosis in dyslipidemia with acute renal failure in pioglitazone/metformin treatment a case report. Atherosclerosis. 395$50$YR$$F$Y$$$20240902$$HP$GR$GR
242748701$24274870$1$I$$20240829$20240902$20240902$PER$$US-ALXN-202408USA002060US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240902$$HP$US$US
242748713$24274871$3$F$20230823$20240919$20240902$20240923$PER$$US-009507513-2408USA009170$MERCK$$$$$F$Y$$$20240923$$MD$US$US
242748722$24274872$2$F$$20240910$20240902$20240920$EXP$$FR-TEVA-VS-3237201$TEVA$$59$YR$$F$Y$$$20240920$$HP$FR$FR
242748731$24274873$1$I$20240806$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136807$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$59.87$KG$20240902$$PH$US$US
242748741$24274874$1$I$20240101$20240827$20240902$20240902$EXP$$BE-009507513-2408BEL010671$MERCK$$$$E$F$Y$$$20240902$$MD$BE$BE
242748751$24274875$1$I$20200818$20240826$20240902$20240902$EXP$PL-URPL-1-1532-2020$PL-TEVA-VS-3237211$TEVA$$54$YR$$M$Y$76$KG$20240902$$MD$PL$PL
242748762$24274876$2$F$20240822$20240909$20240902$20240920$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-136019$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$77.11$KG$20240920$$CN$PR$PR
242748781$24274878$1$I$20200630$20240826$20240902$20240902$EXP$PL-URPL-1-1906-2020$PL-TEVA-VS-3237216$TEVA$$26$YR$$M$Y$80$KG$20240902$$MD$PL$PL
242748791$24274879$1$I$$20240902$20240902$20240902$EXP$$HR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049054$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240902$$CN$HR$HR
242748801$24274880$1$I$20240821$20240822$20240902$20240902$PER$$US-ABBVIE-5893785$ABBVIE$$48$YR$$M$Y$$$20240902$$CN$US$US
242748811$24274881$1$I$20240101$20240829$20240902$20240902$PER$$US-AMGEN-USASP2024174561$AMGEN$$$$$M$Y$$$20240902$$CN$US$US
242748821$24274882$1$I$20240623$20240826$20240902$20240902$EXP$SE-SEMPA-2024-006131$SE-TEVA-VS-3237229$TEVA$$85$YR$$F$Y$$$20240902$$MD$SE$SE
242748831$24274883$1$I$$20240828$20240902$20240902$PER$$US-ALXN-202408USA002080US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240902$$CN$US$US
242748851$24274885$1$I$$20240826$20240902$20240902$EXP$PL-URPL-1-1905-2020$PL-TEVA-VS-3237432$TEVA$$46$YR$$M$Y$98$KG$20240902$$MD$PL$PL
242748861$24274886$1$I$$20240829$20240902$20240902$EXP$$JP-AstraZeneca-2024A197405$ASTRAZENECA$$$$$M$Y$$$20240902$$MD$JP$
242748871$24274887$1$I$$20240826$20240902$20240902$EXP$PL-URPL-1-1863-2020$PL-TEVA-VS-3237481$TEVA$$42$MON$$M$Y$82$KG$20240902$$MD$PL$PL
242748881$24274888$1$I$20240129$20240827$20240902$20240902$EXP$DK-DKMA-30729627$DK-TEVA-VS-3237744$TEVA$$49$YR$$F$Y$71$KG$20240902$$MD$DK$DK
242748891$24274889$1$I$$20240809$20240902$20240902$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049103$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240902$$CN$US$US
242748901$24274890$1$I$20240731$20240814$20240902$20240902$PER$$US-009507513-2408USA005136$MERCK$$$$$$Y$$$20240902$$CN$US$US
242748911$24274891$1$I$$20240828$20240902$20240902$EXP$PL-URPL-2-1354-2019$PL-TEVA-VS-3238137$TEVA$$70$YR$$M$Y$$$20240902$$CN$PL$PL
242748921$24274892$1$I$$20240829$20240902$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013935$JAZZ$$$$$M$Y$$$20240902$$CN$US$US
242748931$24274893$1$I$$20240830$20240902$20240902$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049078$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240902$$MD$BR$BR
242748941$24274894$1$I$20220101$20240827$20240902$20240902$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048267$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$63$KG$20240902$$CN$BR$BR
242748952$24274895$2$F$20240101$20240912$20240902$20240919$EXP$$US-PFIZER INC-202400245958$PFIZER$$65$YR$$M$Y$$$20240919$$HP$US$US
242748961$24274896$1$I$$20240828$20240902$20240902$EXP$$CA-PFIZER INC-202300283421$PFIZER$$69$YR$$F$Y$$$20240902$$HP$CA$CA
242748971$24274897$1$I$20240827$20240828$20240902$20240902$EXP$$US-PFIZER INC-202400246666$PFIZER$$78$YR$$M$Y$$$20240902$$HP$US$US
242748981$24274898$1$I$20231117$20240826$20240902$20240902$EXP$$CN-PFIZER INC-2023SGN13035$PFIZER$$72$YR$$M$Y$85$KG$20240902$$MD$CN$CN
242748991$24274899$1$I$20240830$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174808$AMGEN$$65$YR$E$F$Y$$$20240902$$PH$US$US
242749001$24274900$1$I$$20240828$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137320$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240902$$HP$US$US
242749011$24274901$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139477$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$CN$US$US
242749021$24274902$1$I$$20240830$20240902$20240902$PER$$NVSC2024US176293$NOVARTIS$$$$$$Y$$$20240902$$CN$US$US
242749031$24274903$1$I$20240701$20240822$20240902$20240902$PER$$US-JNJFOC-20240882569$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240902$$PH$US$US
242749041$24274904$1$I$$20240823$20240902$20240902$PER$$US-JNJFOC-20240901540$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$HP$US$US
242749051$24274905$1$I$$20240826$20240902$20240902$PER$$US-JNJFOC-20240901115$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$CN$US$US
242749061$24274906$1$I$20240819$20240822$20240902$20240902$PER$$US-JNJFOC-20240900127$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240902$$HP$US$US
242749071$24274907$1$I$$20240826$20240902$20240902$PER$$US-JNJFOC-20240901188$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$PH$US$US
242749082$24274908$2$F$$20240916$20240902$20240919$PER$$US-JNJFOC-20240901228$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$CN$US$US
242749091$24274909$1$I$$20240828$20240902$20240902$PER$$US-JNJFOC-20240875115$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242749101$24274910$1$I$$20240830$20240902$20240902$EXP$$US-ALXN-202408USA002125US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240902$$HP$US$US
242749111$24274911$1$I$$20240823$20240902$20240902$PER$$US-JNJFOC-20240901351$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$HP$US$US
242749121$24274912$1$I$$20240827$20240902$20240902$PER$$US-JNJFOC-20240874628$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$PH$US$US
242749131$24274913$1$I$$20240901$20240902$20240902$PER$$NVSC2024US176283$NOVARTIS$$$$$M$Y$$$20240902$$CN$US$US
242749141$24274914$1$I$20230901$20240828$20240902$20240902$EXP$$US-PFIZER INC-PV202300175389$PFIZER$$58$YR$$F$Y$$$20240902$$HP$US$US
242749152$24274915$2$F$$20240830$20240902$20240903$EXP$$US-PFIZER INC-PV202400072969$PFIZER$$50$YR$$M$Y$90.7$KG$20240903$$HP$US$US
242749161$24274916$1$I$$20240828$20240902$20240902$EXP$$NVSC2024GB175546$NOVARTIS$Reisz Z, Pereira R, Nevis S, Mackay A, Bhaw L, Grabovska Y et al.. An exceptionally rare case of a diffuse midline glioma with concomitant H3.1 K27M and G34R mutations in the HIST1H3C (H3C3) gene. NEURO-ONCOLOGY. 2024;26 (Suppl) iv30$2$YR$$F$Y$$$20240902$$HP$GB$GB
242749171$24274917$1$I$$20240829$20240902$20240902$EXP$$CA-PFIZER INC-202101595976$PFIZER$$46$YR$$M$Y$$$20240902$$HP$CA$CA
242749181$24274918$1$I$20240516$20240827$20240902$20240902$EXP$FR-AFSSAPS-LL2024001593$FR-009507513-2408FRA009505$MERCK$$60$YR$$F$Y$50.6$KG$20240902$$MD$FR$FR
242749191$24274919$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138802$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240902$$PH$US$US
242749202$24274920$2$F$$20240830$20240902$20240903$EXP$$CA-SANDOZ INC.-SDZ2021CA000509$SANDOZ$$44$YR$$F$Y$97$KG$20240903$$HP$CA$CA
242749211$24274921$1$I$$20240820$20240902$20240902$PER$$US-JNJFOC-20240882650$JOHNSON AND JOHNSON$$$$$$Y$$$20240902$$MD$US$US
242749221$24274922$1$I$20240731$20240822$20240902$20240902$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08501$NEUROCRINE BIOSCIENCES$$30$YR$$M$Y$$$20240902$$CN$US$US
242749233$24274923$3$F$20231201$20240912$20240902$20240913$PER$$US-PURDUE PHARMA-USA-2024-0311703$PURDUE$$84$YR$$F$Y$43.09$KG$20240913$$PH$US$US
242749241$24274924$1$I$$20240830$20240902$20240902$PER$$US-PURDUE PHARMA-USA-2024-0311704$PURDUE$$53$YR$$M$Y$$$20240902$$CN$US$US
242749251$24274925$1$I$$20240830$20240902$20240902$PER$$US-PURDUE PHARMA-USA-2024-0311722$PURDUE$$42$YR$$M$Y$$$20240902$$CN$US$US
242749261$24274926$1$I$$20240830$20240902$20240902$PER$$US-PURDUE PHARMA-USA-2024-0311723$PURDUE$$43$YR$$M$Y$$$20240902$$CN$US$US
242749271$24274927$1$I$$20240830$20240902$20240902$PER$$US-PURDUE PHARMA-USA-2024-0311701$PURDUE$$$$$M$Y$$$20240902$$CN$US$US
242749281$24274928$1$I$$20240830$20240902$20240902$PER$$US-PURDUE PHARMA-USA-2024-0311724$PURDUE$$32$YR$$M$Y$$$20240902$$CN$US$US
242749291$24274929$1$I$20240301$20240902$20240902$20240902$PER$$US-PURDUE PHARMA-USA-2024-0311708$PURDUE$$42$YR$$F$Y$$$20240902$$CN$US$US
242749301$24274930$1$I$$20240830$20240902$20240902$PER$$NVSC2024US176581$NOVARTIS$$$$$F$Y$$$20240902$$CN$US$US
242749312$24274931$2$F$$20240830$20240902$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409000755$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240912$$CN$US$US
242749331$24274933$1$I$$20240821$20240902$20240902$EXP$$US-FARMAPROD-202408-3016$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240902$$CN$US$US
242749341$24274934$1$I$$20240829$20240902$20240902$PER$$US-AstraZeneca-2024A197878$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242749352$24274935$2$F$20240830$20240927$20240902$20240930$PER$$US-JNJFOC-20240881230$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20241001$$CN$US$US
242749361$24274936$1$I$20240101$20240827$20240902$20240902$PER$$US-SA-2024SA253005$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240902$$MD$US$US
242749371$24274937$1$I$$20240828$20240902$20240902$PER$$US-ABBVIE-5901625$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242749381$24274938$1$I$$20240524$20240902$20240902$PER$$US-ASTELLAS-2024US015127$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242749391$24274939$1$I$20240301$20240823$20240902$20240902$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409000307$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240902$$CN$DE$BR
242749401$24274940$1$I$$20240815$20240902$20240902$EXP$$US-ALXN-202408USA002161US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240902$$HP$US$US
242749411$24274941$1$I$20240801$20240826$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136894$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$57.61$KG$20240902$$CN$US$US
242749421$24274942$1$I$20240401$20240522$20240902$20240902$PER$$US-ASTELLAS-2024US013621$ASTELLAS$$70$YR$E$M$Y$$$20240830$$CN$US$US
242749431$24274943$1$I$$20240822$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408014914$ELI LILLY AND CO$$22$YR$A$$Y$$$20240902$$CN$US$US
242749441$24274944$1$I$$20240823$20240902$20240902$EXP$DE-TAKEDA-2024TUS081688$DE-RDY-SPO/DEU/24/0012396$DR REDDYS$Holzer MT, Kotter I, Xiong T, Ruffer N, Feindt FC, Melderis S, et al. Daratumumab for refractory systemic rheumatic diseases: a single center experience. Annals of the Rheumatic Diseases. 83:2133-4. doi:10.1136/annrheumdis-2024-eular.3090$31$YR$A$F$Y$$$20240902$$HP$DE$DE
242749451$24274945$1$I$$20240826$20240902$20240902$PER$$US-ALXN-202408USA001788US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240902$$CN$US$US
242749461$24274946$1$I$20240827$20240828$20240902$20240902$EXP$$JP-009507513-2408JPN003830J$MERCK$$94$YR$$M$Y$$$20240902$$MD$JP$JP
242749471$24274947$1$I$20240730$20240830$20240902$20240902$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013972$JAZZ$$6$YR$$M$Y$$$20240902$$CN$US$US
242749481$24274948$1$I$20240601$20240830$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139191$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240902$$CN$US$US
242749501$24274950$1$I$20240320$20240827$20240902$20240902$EXP$$AU-009507513-2408AUS010179$MERCK$$44$YR$$M$Y$$$20240902$$MD$AU$AU
242749511$24274951$1$I$20240724$20240828$20240902$20240902$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-048241$REGENERON$$$$$F$Y$$$20240902$$CN$US$US
242749521$24274952$1$I$$20240822$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134593$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240902$$HP$US$US
242749531$24274953$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139655$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240902$$CN$US$US
242749541$24274954$1$I$$20240829$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US076424$SANDOZ$$$$$M$Y$$$20240902$$CN$US$US
242749561$24274956$1$I$20240618$20240624$20240902$20240902$PER$$NZ-PFIZER INC-202400199153$PFIZER$$83$YR$$F$Y$92$KG$20240902$$HP$NZ$US
242749571$24274957$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139093$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240902$$CN$US$US
242749581$24274958$1$I$$20240826$20240902$20240902$PER$$US-RDY-SPO/USA/24/0012602$DR REDDYS$$40$YR$A$$Y$$$20240902$$CN$US$US
242749591$24274959$1$I$20231201$20240827$20240902$20240902$PER$$US-ASTELLAS-2024-AER-003617$ASTELLAS$$90$YR$E$M$Y$$$20240902$$MD$US$US
242749611$24274961$1$I$$20240830$20240902$20240902$PER$$US-AstraZeneca-2024A198512$ASTRAZENECA$$$$$F$Y$$$20240902$$CN$US$
242749622$24274962$2$F$20240823$20240917$20240902$20240919$EXP$$JP-ABBVIE-5898249$ABBVIE$$40$YR$$M$Y$$$20240919$$MD$JP$JP
242749631$24274963$1$I$20240823$20240823$20240902$20240902$PER$$US-JNJFOC-20240865260$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242749641$24274964$1$I$$20240830$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019418$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240902$$CN$US$US
242749651$24274965$1$I$$20240822$20240902$20240902$EXP$$US-RDY-SPO/USA/24/0012561$DR REDDYS$Majid M, Yaker ZS, Brands C, Unai S, Klein AL. Not So Transient Effusive-Constrictive Pericarditis. JACC: Case Reports. 2023 Dec 20;28: doi:10.1016/j.jaccas.2023.102088.$63$YR$A$M$Y$$$20240902$$MD$US$US
242749711$24274971$1$I$20240330$20240830$20240902$20240902$EXP$$US-APELLIS-2024-APL-0000906$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240902$$CN$US$US
242749721$24274972$1$I$$20240826$20240902$20240902$PER$$US-AstraZeneca-2024A194672$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242749752$24274975$2$F$$20240924$20240902$20240924$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049037$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240925$$CN$US$US
242749761$24274976$1$I$20240805$20240808$20240902$20240902$PER$$MX-ASTELLAS-2024US022471$ASTELLAS$$37$YR$A$F$Y$$$20240830$$HP$US$US
242749771$24274977$1$I$$20240827$20240902$20240902$EXP$$DE-SANDOZ INC.-SDZ2024DE065200$SANDOZ$$44$YR$$M$Y$$$20240902$$HP$DE$DE
242749801$24274980$1$I$$20240822$20240902$20240902$EXP$$JP-ASTELLAS-2024JP003197$ASTELLAS$$9$DEC$E$M$Y$$$20240902$$MD$JP$JP
242749811$24274981$1$I$$20240814$20240902$20240902$PER$$US-ASTELLAS-2024-AER-001513$ASTELLAS$$75$YR$E$M$Y$$$20240902$$CN$US$US
242749821$24274982$1$I$20231127$20240827$20240902$20240902$EXP$FR-AFSSAPS-LY2023001956$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-135793$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$102$KG$20240902$$MD$FR$FR
242749831$24274983$1$I$20240821$20240829$20240902$20240902$EXP$$BR-ASTELLAS-2024-AER-003740$ASTELLAS$$75$YR$E$M$Y$$$20240902$$CN$BR$BR
242749881$24274988$1$I$$20240816$20240902$20240902$PER$$US-JNJFOC-20240846826$JOHNSON AND JOHNSON$$$$$F$Y$$$20240902$$CN$US$US
242749891$24274989$1$I$$20240827$20240902$20240902$EXP$$NVSC2024SA174568$NOVARTIS$$$$$M$Y$$$20240903$$MD$SA$SA
242749901$24274990$1$I$$20240829$20240902$20240902$EXP$$JP-ORGANON-O2408JPN002175$ORGANON$$$$$F$Y$$$20240902$$CN$JP$JP
242749911$24274991$1$I$$20240819$20240902$20240902$EXP$$FR-Marksans Pharma Limited-2161089$MARKSANS$Eid R, Zamparini E, Ouchrif Y, Snanoudj R, Ottolenghi C, Zaidan M. A case report of Paracetamol related pyroglutamic acidosis: mind the gap in a malnourished patient. BMC Nephrol. 2024 Aug 13;25(1):260. doi: 10.1186/s12882-024-03678-9. PMID: 39138387.$67$YR$$M$Y$$$20240902$$$FR$FR
242749922$24274992$2$F$20240828$20240919$20240902$20240923$EXP$$US-JNJFOC-20240880327$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240923$$MD$US$US
242749931$24274993$1$I$$20240826$20240902$20240902$EXP$$CA-JNJFOC-20240877326$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240903$$MD$CA$CA
242749981$24274998$1$I$$20240827$20240902$20240902$PER$$US-MTPC-MTDA2024-0018355$Unknown Manufacturer$$$$A$F$Y$$$20240902$$CN$US$US
242749991$24274999$1$I$20240701$20240827$20240902$20240902$EXP$$JP-MTPC-MTPC2024-0018372$Unknown Manufacturer$$8$DEC$$M$Y$$$20240902$$MD$JP$JP
242750001$24275000$1$I$20240825$20240826$20240902$20240902$EXP$$US-MTPC-MTDA2024-0018226$Unknown Manufacturer$$80$YR$$F$Y$$$20240902$$CN$US$US
242750041$24275004$1$I$$20240826$20240902$20240902$PER$$US-AMGEN-USASP2024170620$AMGEN$$$$$F$Y$$$20240902$$MD$US$US
242750051$24275005$1$I$$20240830$20240902$20240902$PER$$NVSC2024US176608$NOVARTIS$$$$$$Y$$$20240903$$HP$US$US
242750131$24275013$1$I$$20240814$20240902$20240902$PER$$US-AstraZeneca-2024A186095$ASTRAZENECA$$$$$$Y$$$20240903$$MD$US$
242750141$24275014$1$I$$20240826$20240902$20240902$PER$$US-BIOGEN-2024BI01279915$BIOGEN$$$$$F$Y$$$20240902$$CN$US$US
242750151$24275015$1$I$$20240826$20240902$20240902$PER$$US-BIOGEN-2024BI01280207$BIOGEN$$$$$$Y$$$20240902$$HP$US$US
242750162$24275016$2$F$20240827$20240906$20240902$20240911$EXP$$NVSJ2024JP010194$NOVARTIS$$104$YR$$F$Y$$$20240912$$PH$JP$JP
242750171$24275017$1$I$$20240830$20240902$20240902$PER$$NVSC2024US176609$NOVARTIS$$$$$$Y$$$20240903$$HP$US$US
242750251$24275025$1$I$20240815$20240823$20240902$20240902$EXP$$CO-JNJFOC-20240866794$JOHNSON AND JOHNSON$$69$YR$E$F$Y$55$KG$20240903$$HP$CO$CO
242750261$24275026$1$I$20240101$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408019033$ELI LILLY AND CO$$63$YR$A$$Y$$$20240902$$CN$US$US
242750311$24275031$1$I$20240826$20240830$20240902$20240902$EXP$$CN-BEIGENE-BGN-2024-013719$BEIGENE$$$$$$Y$$$20240902$$HP$CN$CN
242750331$24275033$1$I$20240201$20240812$20240902$20240902$PER$$US-ABBVIE-5901493$ABBVIE$$38$YR$$F$Y$47$KG$20240902$$CN$US$US
242750341$24275034$1$I$$20240821$20240902$20240902$PER$$US-SA-2024SA254712$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240903$$MD$US$US
242750351$24275035$1$I$$20240823$20240902$20240902$EXP$$US-JNJFOC-20240865854$JOHNSON AND JOHNSON$$77$YR$E$F$Y$80.3$KG$20240903$$CN$US$US
242750361$24275036$1$I$$20240830$20240902$20240902$PER$$NVSC2024US176548$NOVARTIS$$$$$F$Y$$$20240903$$HP$US$US
242750371$24275037$1$I$$20240828$20240902$20240902$EXP$$BR-ABBVIE-5903595$ABBVIE$$$$$F$Y$$$20240902$$CN$BR$BR
242750381$24275038$1$I$$20240821$20240902$20240902$EXP$$EG-BEH-2024177685$CSL BEHRING$$$$$F$Y$$$20240902$$CN$EG$EG
242750391$24275039$1$I$20240801$20240827$20240902$20240902$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-136243$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240903$$CN$DE$DE
242750411$24275041$1$I$$20240830$20240902$20240902$EXP$$NVSJ2024JP010381$NOVARTIS$$$$A$F$Y$$$20240903$$MD$JP$JP
242750431$24275043$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138464$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240903$$HP$US$US
242750441$24275044$1$I$20230625$20240824$20240902$20240902$EXP$$CN-BEIGENE-BGN-2024-013367$BEIGENE$$$$$$Y$$$20240902$$HP$CN$CN
242750451$24275045$1$I$20240619$20240828$20240902$20240902$EXP$IT-MINISAL02-999613$IT-COLLEGIUM PHARMACEUTICAL, INC.-20240800663$COLLEGIUM PHARMACEUTICAL$$54$YR$$M$Y$$$20240902$$PH$IT$IT
242750461$24275046$1$I$20240101$20240822$20240902$20240902$EXP$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240800661$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240902$$CN$US$US
242750471$24275047$1$I$20240816$20240821$20240902$20240902$EXP$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240800659$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240902$$HP$US$US
242750481$24275048$1$I$$20240820$20240902$20240902$EXP$$AU-COLLEGIUM PHARMACEUTICAL, INC.-20240800643$COLLEGIUM PHARMACEUTICAL$$$$$F$Y$$$20240902$$CN$AU$AU
242750491$24275049$1$I$$20240826$20240902$20240902$30DAY$$US-SANDOZ INC.-SDZ2024US075558$SANDOZ$$$$$M$Y$$$20240902$$MD$US$US
242750501$24275050$1$I$$20240819$20240902$20240902$EXP$$GB-COLLEGIUM PHARMACEUTICAL, INC.-20240800654$COLLEGIUM PHARMACEUTICAL$Thurston L.; Todd G.; Parsapour S.; Kong W.M.. The complexities of managing neuropathic pain. The British Journal of Diabetes. 2024;24:1:114$$$$$Y$$$20240902$$HP$GB$GB
242750511$24275051$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076808$SANDOZ$$$$$M$Y$$$20240902$$MD$US$US
242750521$24275052$1$I$20240812$20240829$20240902$20240902$PER$$US-ABBVIE-5901741$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242750531$24275053$1$I$20220101$20240829$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076626$SANDOZ$$69$YR$$F$Y$$$20240902$$MD$US$US
242750541$24275054$1$I$$20240827$20240902$20240902$EXP$$US-BIOGEN-2024BI01280295$BIOGEN$$$$$M$Y$$$20240902$$CN$US$US
242750551$24275055$1$I$$20240826$20240902$20240902$EXP$$US-BIOGEN-2024BI01280122$BIOGEN$$$$$F$Y$$$20240902$$CN$US$US
242750561$24275056$1$I$$20231223$20240902$20240902$EXP$$US-Jiangsu Hengrui Medicine Co., Ltd.-2161091$JIANGSU HENGRUI MEDICINE$A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis$15$YR$$$Y$$$20240902$$MD$US$US
242750581$24275058$1$I$20240828$20240829$20240902$20240902$PER$$US-ABBVIE-5903273$ABBVIE$$15$YR$$M$Y$$$20240902$$HP$US$US
242750592$24275059$2$F$20231127$20240915$20240902$20240924$30DAY$$US-AMGEN-USASP2024167816$AMGEN$$96$YR$E$M$Y$68$KG$20240924$$HP$US$US
242750602$24275060$2$F$$20240905$20240902$20240909$EXP$$JP-ABBVIE-5901608$ABBVIE$$$$$$Y$$$20240909$$PH$JP$JP
242750611$24275061$1$I$20240717$20240829$20240902$20240902$EXP$FR-AFSSAPS-AM2024000696$NVSC2024FR174205$NOVARTIS$$64$YR$$M$Y$140$KG$20240903$$PH$FR$FR
242750621$24275062$1$I$$20240830$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139358$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240903$$HP$US$US
242750642$24275064$2$F$20240703$20240910$20240902$20240916$30DAY$$US-AMGEN-USASP2024171281$AMGEN$$63$YR$A$F$Y$145$KG$20240916$$PH$US$US
242750651$24275065$1$I$$20240829$20240902$20240902$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-138826$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240903$$CN$CH$CH
242750661$24275066$1$I$20240829$20240830$20240902$20240902$EXP$$CA-ABBVIE-5903490$ABBVIE$$67$YR$$M$Y$$$20240902$$CN$CA$CA
242750671$24275067$1$I$20240730$20240829$20240902$20240902$EXP$$CA-ABBVIE-5903917$ABBVIE$$79$YR$$M$Y$$$20240902$$HP$CA$CA
242750681$24275068$1$I$20240101$20240830$20240902$20240902$EXP$$US-ABBVIE-5903506$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242750691$24275069$1$I$20240701$20240827$20240902$20240902$EXP$$US-BIOGEN-2024BI01280310$BIOGEN$$26$YR$$F$Y$$$20240902$$HP$US$US
242750701$24275070$1$I$$20240829$20240902$20240902$EXP$$US-ABBVIE-5902191$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242750711$24275071$1$I$$20240828$20240902$20240902$EXP$$US-SANDOZ INC.-NVSC2019US051908$SANDOZ$$63$YR$$M$Y$$$20240902$$MD$US$US
242750721$24275072$1$I$$20240826$20240902$20240902$EXP$$US-BIOGEN-2024BI01280296$BIOGEN$$$$$M$Y$$$20240902$$CN$US$US
242750732$24275073$2$F$$20240917$20240902$20240920$EXP$$JP-SA-2024SA251232$SANOFI AVENTIS$$$$$F$Y$$$20240920$$MD$JP$JP
242750741$24275074$1$I$$20240825$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135792$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$83.91$KG$20240903$$CN$US$US
242750751$24275075$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139077$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240903$$HP$US$US
242750761$24275076$1$I$20240824$20240830$20240902$20240902$EXP$$CN-ABBVIE-5904004$ABBVIE$$52$YR$$M$Y$65$KG$20240902$$MD$CN$CN
242750772$24275077$2$F$$20240909$20240902$20240916$EXP$$US-BIOGEN-2024BI01280631$BIOGEN$$$$$M$Y$$$20240916$$CN$US$US
242750793$24275079$3$F$20240810$20240918$20240902$20240927$30DAY$$AR-JNJFOC-20240842816$JOHNSON AND JOHNSON$$53$YR$A$F$Y$61$KG$20240927$$CN$AR$AR
242750801$24275080$1$I$$20240829$20240902$20240902$EXP$$AU-ABBVIE-5902121$ABBVIE$$$$$$Y$$$20240902$$MD$AU$AU
242750811$24275081$1$I$$20240828$20240902$20240902$EXP$$CA-SANDOZ INC.-NVSC2022CA202286$SANDOZ$$$$$M$Y$77.098$KG$20240902$$CN$CA$CA
242750821$24275082$1$I$$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024173707$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242750831$24275083$1$I$$20240830$20240902$20240902$EXP$$NVSJ2024JP010384$NOVARTIS$$$$$$Y$$$20240903$$MD$JP$JP
242750841$24275084$1$I$20240101$20240827$20240902$20240902$EXP$$US-ABBVIE-5884223$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242750851$24275085$1$I$$20240828$20240902$20240902$EXP$$US-ABBVIE-5899461$ABBVIE$$$$$F$Y$$$20240902$$HP$US$US
242750861$24275086$1$I$20240826$20240830$20240902$20240902$EXP$$US-ABBVIE-5903465$ABBVIE$$82$YR$$F$Y$$$20240902$$CN$US$US
242750871$24275087$1$I$$20240831$20240902$20240902$PER$$NVSC2024US176545$NOVARTIS$$$$$F$Y$$$20240903$$CN$US$US
242750883$24275088$3$F$20240827$20240913$20240902$20240917$PER$$US-AMGEN-USASP2024174781$AMGEN$$54$YR$A$M$Y$$$20240917$$CN$US$US
242750891$24275089$1$I$20240811$20240830$20240902$20240902$EXP$$CN-BEIGENE-BGN-2024-013773$BEIGENE$$$$$$Y$$$20240902$$HP$CN$CN
242750901$24275090$1$I$$20240830$20240902$20240902$EXP$GB-MHRA-MIDB-e3ffbe2f-4c0f-47ec-9c6b-f968b73335b6$GB-SANDOZ INC.-SDZ2024GB076762$SANDOZ$$81$YR$$F$Y$$$20240902$$PH$GB$GB
242750911$24275091$1$I$20240801$20240829$20240902$20240902$PER$$US-ABBVIE-5903236$ABBVIE$$$$A$F$Y$$$20240902$$HP$US$US
242750921$24275092$1$I$$20240828$20240902$20240902$PER$$US-JNJFOC-20240874561$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$MD$US$US
242750931$24275093$1$I$20240101$20240825$20240902$20240902$EXP$$US-JNJFOC-20240869379$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240903$$CN$US$US
242750941$24275094$1$I$$20240828$20240902$20240902$EXP$$GB-ABBVIE-5902400$ABBVIE$$$$A$F$Y$$$20240902$$CN$GB$GB
242750951$24275095$1$I$20240707$20240830$20240902$20240902$EXP$$US-ABBVIE-5903488$ABBVIE$$53$YR$$F$Y$$$20240902$$CN$US$US
242750961$24275096$1$I$20240809$20240828$20240902$20240902$EXP$$CA-ABBVIE-5901908$ABBVIE$$51$YR$$F$Y$$$20240902$$CN$CA$CA
242750971$24275097$1$I$20240101$20240829$20240902$20240902$EXP$$US-ABBVIE-5901739$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242750981$24275098$1$I$20240825$20240829$20240902$20240902$EXP$$US-ABBVIE-5901940$ABBVIE$$65$YR$$F$Y$$$20240902$$CN$US$US
242750991$24275099$1$I$20240301$20240830$20240902$20240902$PER$$NVSC2024US176363$NOVARTIS$$65$YR$$M$Y$$$20240903$$HP$US$US
242751001$24275100$1$I$20240101$20240827$20240902$20240902$EXP$$NVSC2024CN106006$NOVARTIS$$47$YR$$M$Y$$$20240903$$CN$CN$CN
242751011$24275101$1$I$$20240813$20240902$20240902$PER$$US-AstraZeneca-2024A184801$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242751021$24275102$1$I$20240624$20240827$20240902$20240902$EXP$$AR-AMGEN-ARGSP2024129429$AMGEN$$71$YR$E$F$Y$$$20240902$$CN$AR$AR
242751031$24275103$1$I$20240101$20240828$20240902$20240902$EXP$$US-ABBVIE-5878085$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242751041$24275104$1$I$20240801$20240828$20240902$20240902$EXP$$US-ABBVIE-5900840$ABBVIE$$62$YR$$F$Y$$$20240902$$CN$US$US
242751051$24275105$1$I$$20240826$20240902$20240902$EXP$$US-JNJFOC-20240901198$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242751062$24275106$2$F$20240101$20240918$20240902$20240924$EXP$$US-ABBVIE-5901951$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
242751071$24275107$1$I$20240829$20240829$20240902$20240902$EXP$$US-ABBVIE-5903484$ABBVIE$$75$YR$$F$Y$$$20240902$$CN$US$US
242751081$24275108$1$I$20240703$20240828$20240902$20240902$EXP$$US-ABBVIE-5899768$ABBVIE$$60$YR$$M$Y$$$20240902$$CN$US$US
242751091$24275109$1$I$20240808$20240830$20240902$20240902$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-044875$BOEHRINGER INGELHEIM$$56$YR$A$M$Y$$$20240903$$CN$US$US
242751102$24275110$2$F$20231201$20240906$20240902$20240911$EXP$$JP-SA-2024SA251098$SANOFI AVENTIS$$$$$F$Y$$$20240912$$MD$JP$JP
242751111$24275111$1$I$20240801$20240822$20240902$20240902$PER$$US-BAUSCHBL-2024BNL032227$BAUSCH AND LOMB$$$$$F$Y$$$20240903$$CN$US$US
242751121$24275112$1$I$$20240816$20240902$20240902$PER$$US-AstraZeneca-2024A187833$ASTRAZENECA$$$$$$Y$$$20240903$$CN$US$
242751131$24275113$1$I$20240101$20240829$20240902$20240902$EXP$$US-ABBVIE-5901326$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242751141$24275114$1$I$20240101$20240830$20240902$20240902$PER$$US-AMGEN-USASP2024174602$AMGEN$$73$YR$E$F$Y$$$20240902$$MD$US$US
242751151$24275115$1$I$$20240826$20240902$20240902$EXP$$BR-ABBVIE-5899399$ABBVIE$$$$$$Y$$$20240902$$MD$BR$BR
242751161$24275116$1$I$20240501$20240828$20240902$20240902$PER$$US-AMGEN-USASP2024174537$AMGEN$$$$$F$Y$$$20240902$$HP$US$US
242751171$24275117$1$I$20240826$20240826$20240902$20240902$PER$$US-ALXN-202408USA001802US$ALEXION PHARMACEUTICALS$$91$YR$$M$Y$$$20240903$$CN$US$US
242751181$24275118$1$I$$20240830$20240902$20240902$EXP$$NVSJ2024JP010398$NOVARTIS$$71$YR$$F$Y$$$20240903$$MD$JP$JP
242751191$24275119$1$I$20230801$20240819$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408011356$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240902$$HP$US$US
242751201$24275120$1$I$20240801$20240822$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408015078$ELI LILLY AND CO$$$$A$M$Y$$$20240902$$CN$US$US
242751211$24275121$1$I$20240101$20240827$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137033$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240903$$CN$US$US
242751221$24275122$1$I$$20240829$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408018827$ELI LILLY AND CO$$52$YR$A$$Y$$$20240902$$CN$US$US
242751232$24275123$2$F$$20240903$20240902$20240910$EXP$$ET-BRISTOL-MYERS SQUIBB COMPANY-2024-136902$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$$$20240910$$CN$ET$ET
242751241$24275124$1$I$20240701$20240821$20240902$20240902$EXP$$US-ETON PHARMACEUTICALS, INC-2024ETO000206$ETON PHARMACEUTICALS$$$$$$Y$$$20240902$$CN$US$US
242751261$24275126$1$I$$20240826$20240902$20240902$EXP$$IN-NOVITIUMPHARMA-2024INNVP01742$NOVITIUM PHARMA$Shivangi Negi.Case Report - Role of Low Volume Plasmapheresis in Acute Liver Failure.Journal of Clinical and Experimental Hepatology.2024;14 (1):S2-S3$29$YR$A$F$Y$$$20240903$$HP$IN$IN
242751272$24275127$2$F$$20240920$20240902$20240926$EXP$$NVSJ2024JP009519$NOVARTIS$$$$A$M$Y$$$20240926$$PH$JP$JP
242751281$24275128$1$I$20240828$20240830$20240902$20240902$EXP$$CA-ABBVIE-5903562$ABBVIE$$$$A$F$Y$$$20240902$$CN$CA$CA
242751291$24275129$1$I$$20240830$20240902$20240902$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139582$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240903$$CN$US$US
242751301$24275130$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139267$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240903$$HP$US$US
242751311$24275131$1$I$$20240828$20240902$20240902$EXP$$US-ABBVIE-5902255$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242751321$24275132$1$I$20240101$20240829$20240902$20240902$EXP$$BG-ABBVIE-5902757$ABBVIE$$55$YR$$F$Y$$$20240902$$CN$BG$BG
242751331$24275133$1$I$20240801$20240829$20240902$20240902$EXP$$CA-ABBVIE-5902603$ABBVIE$$66$YR$$F$Y$$$20240902$$CN$CA$CA
242751341$24275134$1$I$20240701$20240829$20240902$20240902$EXP$$US-ABBVIE-5901702$ABBVIE$$62$YR$$F$Y$$$20240902$$CN$US$US
242751351$24275135$1$I$20230101$20240829$20240902$20240902$EXP$$US-ABBVIE-5901747$ABBVIE$$$$$F$Y$$$20240902$$CN$US$US
242751361$24275136$1$I$20230101$20240829$20240902$20240902$EXP$$US-ABBVIE-5901319$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242751371$24275137$1$I$20240821$20240830$20240902$20240902$EXP$$RO-ABBVIE-5902550$ABBVIE$$68$YR$$M$Y$$$20240902$$CN$RO$RO
242751381$24275138$1$I$$20240831$20240902$20240902$EXP$$US-ABBVIE-5904634$ABBVIE$$$$$M$Y$$$20240902$$CN$US$US
242751391$24275139$1$I$20230601$20240830$20240902$20240902$EXP$$CA-ABBVIE-5903483$ABBVIE$$42$YR$$M$Y$$$20240902$$CN$CA$CA
242751401$24275140$1$I$20240701$20240826$20240902$20240902$EXP$$CO-ABBVIE-5885275$ABBVIE$$84$YR$$M$Y$$$20240902$$HP$CO$CO
242751411$24275141$1$I$20240831$20240902$20240902$20240902$EXP$$JP-ABBVIE-5904541$ABBVIE$$75$YR$$F$Y$$$20240902$$MD$JP$JP
242751421$24275142$1$I$20240820$20240821$20240902$20240902$PER$$US-ELI_LILLY_AND_COMPANY-US202408014007$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240902$$CN$US$US
242751441$24275144$1$I$$20240829$20240902$20240902$PER$$US-ROCHE-10000071400$ROCHE$$$$$$Y$$$20240903$$CN$US$US
242751451$24275145$1$I$$20240819$20240902$20240902$EXP$$IT-Noden Pharma DAC-NOD202408-000112$NODEN PHARMA$$50$YR$A$M$Y$$$20240903$$$COUNTRY NOT SPECIFIED$
242751461$24275146$1$I$20240829$20240829$20240902$20240902$PER$$US-ABBVIE-5902895$ABBVIE$$$$A$$Y$$$20240902$$HP$US$US
242751471$24275147$1$I$$20240827$20240902$20240902$EXP$$US-TAKEDA-2024TUS058732$TAKEDA$$$$$F$Y$$$20240902$$CN$US$US
242751482$24275148$2$F$$20240904$20240902$20240911$EXP$GB-002147023-NVSC2024GB173100$GB-GSK-GB2024107198$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$MD$GB$GB
242751491$24275149$1$I$$20240826$20240902$20240902$EXP$$US-NOVITIUMPHARMA-2024USNVP01743$NOVITIUM PHARMA$Andrew H. Schwartz.Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event.American Journal of Ophthalmology Case Reports.28-MAR-2023;30:1-4$59$YR$A$F$Y$$$20240903$$HP$US$US
242751501$24275150$1$I$20240823$20240827$20240902$20240902$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-137692$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240903$$CN$TW$TW
242751512$24275151$2$F$$20240909$20240902$20240917$PER$$US-AstraZeneca-2024A186613$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
242751521$24275152$1$I$$20240819$20240902$20240902$EXP$$US-APCER-AGP202408-000014$Agepha Pharmaceuticals$$76$YR$$M$Y$$$20240902$$CN$US$US
242751531$24275153$1$I$$20240822$20240902$20240902$PER$$US-ABBVIE-5894258$ABBVIE$$$$$$Y$$$20240902$$CN$US$US
242751542$24275154$2$F$20240301$20240903$20240902$20240906$EXP$$CR-BIOGEN-2024BI01259957$BIOGEN$$47$YR$$F$Y$110$KG$20240906$$CN$CR$CR
242751551$24275155$1$I$$20240830$20240902$20240902$PER$$NVSC2024US176514$NOVARTIS$$$$$$Y$$$20240903$$PH$US$US
242751561$24275156$1$I$$20240828$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076169$SANDOZ$$7$DEC$$F$Y$$$20240902$$MD$US$US
242751571$24275157$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139287$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240903$$CN$US$US
242751581$24275158$1$I$$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137962$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$74.39$KG$20240903$$CN$US$US
242751591$24275159$1$I$$20240825$20240902$20240902$EXP$$CN-JNJFOC-20240877122$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240903$$HP$CN$CN
242751603$24275160$3$F$$20240920$20240902$20240925$EXP$$BE-JNJFOC-20240874970$JOHNSON AND JOHNSON$$$$E$$Y$$$20240925$$MD$BE$BE
242751612$24275161$2$F$$20240910$20240902$20240924$30DAY$$TW-JNJFOC-20240869258$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$HP$TW$TW
242751622$24275162$2$F$20240514$20240902$20240902$20240906$EXP$$JP-JNJFOC-20240900607$JOHNSON AND JOHNSON$$56$YR$A$F$Y$44.1$KG$20240906$$MD$JP$JP
242751631$24275163$1$I$$20230804$20240902$20240902$PER$$US-HALEON-2194653$Haleon PLC$$$$A$$Y$$$20240902$$HP$US$US
242751641$24275164$1$I$$20240830$20240902$20240902$EXP$$US-SANDOZ INC.-SDZ2024US076825$SANDOZ$$73$YR$$$Y$$$20240902$$MD$US$US
242751651$24275165$1$I$$20240827$20240902$20240902$EXP$$ES-ARGENX-2024-ARGX-ES007172$ARGENX BVBA$$$$$$Y$$$20240902$$MD$ES$ES
242751661$24275166$1$I$$20240821$20240902$20240902$PER$$US-SA-2024SA252662$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240903$$HP$US$US
242751671$24275167$1$I$$20240831$20240902$20240902$PER$$US-AMGEN-USASP2024174911$AMGEN$$$$$$Y$$$20240902$$PH$US$US
242751681$24275168$1$I$20240826$20240829$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139656$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240903$$CN$US$US
242751701$24275170$1$I$$20240830$20240902$20240902$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139073$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240903$$CN$US$US
242751711$24275171$1$I$20240801$20240829$20240903$20240903$EXP$PT-INFARMED-F202408-212$PT-VIIV HEALTHCARE LIMITED-PT2024107663$VIIV$$$$$$Y$$$20240902$$PH$PT$PT
242751721$24275172$1$I$$20240826$20240903$20240903$PER$$US-AMGEN-USASP2024170355$AMGEN$$$$$M$Y$$$20240902$$MD$US$US
242751731$24275173$1$I$$20240902$20240903$20240903$EXP$$IT-SANDOZ INC.-SDZ2024IT077034$SANDOZ$$$$$$Y$$$20240902$$HP$IT$IT
242751741$24275174$1$I$$20240827$20240903$20240903$EXP$$JP-009507513-2408JPN003858J$MERCK$$60$YR$$M$Y$$$20240903$$MD$JP$JP
242751751$24275175$1$I$$20240617$20240903$20240903$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-13868$ALKEM$Zhao L, Wu F, Wang J, Wang Y, Peng W, Chen Y.. Efficacy of transcutaneous electrical nerve stimulation combined with mirabegron therapy compared with mirabegron monotherapy for overactive bladder: a prospective randomized controlled study. World Journal of Urology. 2024;42:370$$$$F$Y$$$20240903$$HP$CN$CN
242751761$24275176$1$I$20240801$20240829$20240903$20240903$EXP$SE-SEMPA-2024-006126$SE-GSK-SE2024107659$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$MD$SE$SE
242751771$24275177$1$I$20210104$20240828$20240903$20240903$EXP$IT-MINISAL02-1000037$IT-PFIZER INC-202400245455$PFIZER$$82$YR$$F$Y$$$20240902$$MD$IT$IT
242751781$24275178$1$I$20240801$20240828$20240903$20240903$EXP$$AR-PFIZER INC-202400247466$PFIZER$$58$YR$$F$Y$$$20240902$$CN$AR$AR
242751791$24275179$1$I$20240101$20240823$20240903$20240903$EXP$FR-AFSSAPS-PB2024000911$FR-PFIZER INC-202400246245$PFIZER$$28$YR$$M$Y$96$KG$20240902$$PH$FR$FR
242751801$24275180$1$I$$20240814$20240903$20240903$PER$$US-JNJFOC-20240837742$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$MD$US$US
242751811$24275181$1$I$$20240821$20240903$20240903$PER$$US-JNJFOC-20240867651$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240903$$HP$US$US
242751831$24275183$1$I$$20240831$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US077018$SANDOZ$$$$$$Y$$$20240903$$CN$US$US
242751841$24275184$1$I$20240826$20240830$20240903$20240903$EXP$GB-MHRA-MED-202408291058495620-HKSVB$GB-TAKEDA-2024TUS087599$TAKEDA$$35$YR$$F$Y$75$KG$20240903$$HP$GB$GB
242751851$24275185$1$I$$20240828$20240903$20240903$EXP$$US-ABBVIE-5899693$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242751862$24275186$2$F$$20240906$20240903$20240909$EXP$$JP-TAKEDA-2024TJP012890$TAKEDA$$7$DEC$$F$Y$$$20240909$$MD$JP$JP
242751871$24275187$1$I$20240101$20240826$20240903$20240903$EXP$$JP-GENMAB-2024-02680$GENMAB$$7$DEC$$F$Y$$$20240903$$MD$JP$JP
242751881$24275188$1$I$20240101$20240827$20240903$20240903$EXP$$US-ABBVIE-5798162$ABBVIE$$74$YR$$F$Y$$$20240903$$CN$US$US
242751891$24275189$1$I$20240101$20240827$20240903$20240903$EXP$$US-ABBVIE-5900515$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242751901$24275190$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194347$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242751911$24275191$1$I$20220830$20240828$20240903$20240903$EXP$$US-ABBVIE-5892817$ABBVIE$$56$YR$$F$Y$73.481$KG$20240903$$CN$US$US
242751931$24275193$1$I$$20240831$20240903$20240903$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049119$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240903$$HP$CO$CO
242751941$24275194$1$I$$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024172944$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242751952$24275195$2$F$$20240924$20240903$20240927$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013856$JAZZ$$$$$F$Y$$$20240927$$HP$US$US
242751961$24275196$1$I$20240401$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174674$AMGEN$$$$A$F$Y$$$20240902$$HP$US$US
242751971$24275197$1$I$20231001$20240902$20240903$20240903$EXP$$US-ROCHE-10000071716$ROCHE$$$$$$Y$$$20240903$$CN$US$US
242751981$24275198$1$I$$20240827$20240903$20240903$PER$$US-AMGEN-USASP2024172572$AMGEN$Mammen A. L.; Torres-ruiz J.; Pinal-fernandez I. et al.. Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology. 2024;42:367-376$$$A$$Y$$$20240902$$HP$US$US
242751992$24275199$2$F$20240101$20240827$20240903$20240904$EXP$$US-009507513-2408USA010699$MERCK$$$$$F$Y$$$20240904$$CN$US$US
242752002$24275200$2$F$20150707$20240910$20240903$20240917$EXP$$FR-SANDOZ INC.-PHHY2017FR189018$SANDOZ$$44$YR$$M$Y$$$20240917$$MD$FR$FR
242752011$24275201$1$I$20230101$20240819$20240903$20240903$EXP$$JP-CHATTEMPRD-2024OHG029552$CHATTEM$Matsuda S, Saito Y, Hayashi K, Shiraya S, Suzuki R, Zama S, et al.. Picture in Clinical Hematology No. 164: Aggressive T-LGL leukemia occurring during the course of B-cell malignant lymphoma.. The Japanese journal of clinical hematology.. 2024;65 (7):613$56$YR$A$F$Y$$$20240903$$MD$JP$JP
242752021$24275202$1$I$$20240828$20240903$20240903$PER$$US-ROCHE-10000070247$ROCHE$$$$$$Y$$$20240903$$CN$US$US
242752031$24275203$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5902533$ABBVIE$$$$$$Y$$$20240903$$MD$US$US
242752041$24275204$1$I$$20240829$20240903$20240903$EXP$$FR-TAKEDA-2024TUS087781$TAKEDA$$86$YR$$F$Y$$$20240903$$HP$FR$FR
242752052$24275205$2$F$$20240910$20240903$20240916$EXP$$PT-CHATTEMPRD-2024OHG029965$CHATTEM$$$$E$$Y$$$20240916$$HP$PT$PT
242752061$24275206$1$I$$20240819$20240903$20240903$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25742$SAMSUNG BIOEPIS$$20$YR$A$F$Y$$$20240903$$CN$CA$CA
242752071$24275207$1$I$$20240827$20240903$20240903$EXP$$US-BIOGEN-2024BI01280377$BIOGEN$$$$$F$Y$$$20240903$$CN$US$US
242752081$24275208$1$I$$20240830$20240903$20240903$PER$$US-ROCHE-10000071529$ROCHE$$$$E$F$Y$$$20240903$$CN$US$US
242752091$24275209$1$I$20240529$20240830$20240903$20240903$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049115$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240903$$HP$CO$CO
242752102$24275210$2$F$20240401$20240906$20240903$20240910$PER$$US-ABBVIE-5903101$ABBVIE$$29$YR$$F$Y$86$KG$20240910$$CN$US$US
242752111$24275211$1$I$20240801$20240829$20240903$20240903$PER$$US-ABBVIE-5902826$ABBVIE$$54$YR$$$Y$$$20240903$$CN$US$US
242752121$24275212$1$I$20240821$20240826$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408015884$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240903$$CN$US$US
242752131$24275213$1$I$20230101$20240826$20240903$20240903$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03147$AMNEAL$$$$$M$Y$14.512$KG$20240903$$CN$US$US
242752141$24275214$1$I$$20240821$20240903$20240903$EXP$$US-NOVOPROD-1276589$NOVO NORDISK$$$$$F$Y$$$20240903$$CN$US$US
242752151$24275215$1$I$$20240822$20240903$20240903$EXP$$US-NOVOPROD-1274960$NOVO NORDISK$$$$A$F$Y$$$20240903$$CN$US$US
242752161$24275216$1$I$20240719$20240822$20240903$20240903$EXP$$TR-NOVOPROD-1274190$NOVO NORDISK$$547$MON$$M$Y$83$KG$20240903$$CN$TR$TR
242752171$24275217$1$I$20230301$20240822$20240903$20240903$EXP$$US-NOVOPROD-1275009$NOVO NORDISK$$48$YR$$$Y$$$20240903$$CN$US$US
242752181$24275218$1$I$$20240822$20240903$20240903$EXP$$US-NOVOPROD-1274941$NOVO NORDISK$$$$$F$Y$$$20240903$$HP$US$US
242752191$24275219$1$I$20230901$20240822$20240903$20240903$EXP$$US-NOVOPROD-1274936$NOVO NORDISK$$62$YR$$F$Y$$$20240903$$CN$US$US
242752201$24275220$1$I$20230301$20240822$20240903$20240903$EXP$$US-NOVOPROD-1274948$NOVO NORDISK$$$$$M$Y$$$20240903$$CN$US$US
242752212$24275221$2$F$$20240828$20240903$20240906$PER$$US-AMGEN-USASP2024173712$AMGEN$$$$A$F$Y$$$20240905$$MD$US$US
242752221$24275222$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5902729$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242752232$24275223$2$F$$20240916$20240903$20240923$EXP$$CA-ABBVIE-5902504$ABBVIE$$$$A$F$Y$$$20240923$$CN$CA$CA
242752241$24275224$1$I$$20240826$20240903$20240903$EXP$$CN-AstraZeneca-2024A195582$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$CN$
242752251$24275225$1$I$20240820$20240822$20240903$20240903$EXP$$US-NOVOPROD-1275150$NOVO NORDISK$$43$YR$$F$Y$$$20240903$$CN$US$US
242752261$24275226$1$I$20240101$20240822$20240903$20240903$EXP$$US-NOVOPROD-1276563$NOVO NORDISK$$$$E$F$Y$$$20240903$$CN$US$US
242752271$24275227$1$I$$20240822$20240903$20240903$EXP$$US-NOVOPROD-1275515$NOVO NORDISK$$$$$F$Y$$$20240903$$CN$US$US
242752281$24275228$1$I$$20240830$20240903$20240903$PER$$NVSC2024US176279$NOVARTIS$$$$$M$Y$3.17$KG$20240903$$MD$US$US
242752291$24275229$1$I$$20240829$20240903$20240903$EXP$$NVSJ2024JP009178$NOVARTIS$$$$$$Y$$$20240903$$PH$JP$JP
242752301$24275230$1$I$20100101$20240828$20240903$20240903$PER$$US-JNJFOC-20240875814$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240903$$HP$US$US
242752311$24275231$1$I$$20240822$20240903$20240903$EXP$$US-RDY-SPO/USA/24/0012552$DR REDDYS$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 06;73: doi:10.1007/s00262-024-03775-6.$61$YR$A$F$Y$$$20240903$$HP$US$US
242752324$24275232$4$F$$20240911$20240903$20240912$PER$$US-AMGEN-USASP2024174369$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
242752331$24275233$1$I$$20240819$20240903$20240903$EXP$$US-RK PHARMA, INC-20240800050$RK PHARMA$Ali M. Hassan. Potential anaphylactoid reaction to nicardipine. Journal of the American College of Emergency Physicians Open. 2024;5(4):e13271$$$$$Y$$$20240902$$MD$US$US
242752342$24275234$2$F$$20240920$20240903$20240924$EXP$$CA-ABBVIE-5902770$ABBVIE$$82$YR$$M$Y$$$20240924$$MD$CA$CA
242752361$24275236$1$I$$20240828$20240903$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US076177$SANDOZ$$$$$F$Y$$$20240903$$CN$US$US
242752372$24275237$2$F$$20240916$20240903$20240921$EXP$$US-ABBVIE-5723891$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
242752381$24275238$1$I$20240801$20240830$20240903$20240903$EXP$GB-MHRA-MED-202408290929206990-WZKJV$GB-ABBVIE-5902425$ABBVIE$$60$YR$$F$Y$$$20240903$$CN$GB$GB
242752391$24275239$1$I$20220101$20240826$20240903$20240903$EXP$$US-ABBVIE-5896287$ABBVIE$$71$YR$$F$Y$56$KG$20240903$$CN$US$US
242752401$24275240$1$I$$20240829$20240903$20240903$EXP$$US-JNJFOC-20240900252$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242752411$24275241$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5902213$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242752421$24275242$1$I$20240806$20240830$20240903$20240903$EXP$$CA-ABBVIE-5903860$ABBVIE$$61$YR$$F$Y$$$20240903$$CN$CA$CA
242752431$24275243$1$I$20240812$20240830$20240903$20240903$EXP$$DE-ABBVIE-5904583$ABBVIE$$72$YR$$M$Y$88$KG$20240903$$MD$DE$DE
242752441$24275244$1$I$$20240827$20240903$20240903$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001747$BLUEPRINT MEDICINES$$$$$F$Y$$$20240903$$CN$US$US
242752451$24275245$1$I$$20240823$20240903$20240903$EXP$$CO-NOVOPROD-1275542$NOVO NORDISK$$66$YR$$M$Y$110$KG$20240903$$CN$CO$CO
242752461$24275246$1$I$$20240823$20240903$20240903$EXP$$CN-NOVOPROD-1274217$NOVO NORDISK$$70$YR$$F$Y$70$KG$20240903$$CN$CN$CN
242752471$24275247$1$I$$20240823$20240903$20240903$EXP$$US-NOVOPROD-1275431$NOVO NORDISK$$$$$F$Y$$$20240903$$CN$US$US
242752481$24275248$1$I$$20240823$20240903$20240903$EXP$$US-NOVOPROD-1275068$NOVO NORDISK$$$$$M$Y$$$20240903$$CN$US$US
242752491$24275249$1$I$$20240823$20240903$20240903$EXP$$US-NOVOPROD-1275016$NOVO NORDISK$$$$$M$Y$$$20240903$$CN$US$US
242752501$24275250$1$I$20240408$20240823$20240903$20240903$EXP$$GB-NOVOPROD-1273910$NOVO NORDISK$$46$YR$$F$Y$130$KG$20240903$$HP$GB$GB
242752512$24275251$2$F$20230101$20240920$20240903$20240925$EXP$$US-PFIZER INC-202400244889$PFIZER$$75$YR$$F$Y$47.63$KG$20240925$$CN$US$US
242752522$24275252$2$F$$20240830$20240903$20240912$EXP$$US-ADVANZ PHARMA-202408007119$ADVANZ PHARMA$$$$$$Y$$$20240912$$HP$US$US
242752531$24275253$1$I$20240701$20240823$20240903$20240903$EXP$$SE-NOVOPROD-1273733$NOVO NORDISK$$64$YR$$F$Y$83$KG$20240903$$HP$SE$SE
242752541$24275254$1$I$$20240823$20240903$20240903$EXP$RU-RZN-2526853$RU-NOVOPROD-1274944$NOVO NORDISK$$27$YR$$M$Y$$$20240903$$HP$RU$RU
242752551$24275255$1$I$$20240823$20240903$20240903$EXP$$US-NOVOPROD-1275087$NOVO NORDISK$$$$A$F$Y$$$20240903$$CN$US$US
242752561$24275256$1$I$$20240823$20240903$20240903$EXP$$ZA-NOVOPROD-1274231$NOVO NORDISK$$$$$F$Y$$$20240903$$HP$ZA$ZA
242752571$24275257$1$I$$20240823$20240903$20240903$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP010947$STRIDES$Haoyu C, Fan Y, Yixin Y, Shuqin Z, Yongping Z, Weijie Z, et al.. Application of quantitative detection of multiple-source cytomegalovirus DNA in diagnosis of cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation.. Organ-Transplant. 2021;12 (1):96-102$$$$M$Y$$$20240903$$HP$CN$CN
242752582$24275258$2$F$$20240904$20240903$20240906$PER$$US-AMGEN-USASP2024174397$AMGEN$$$$$M$Y$$$20240906$$HP$US$US
242752591$24275259$1$I$$20240810$20240903$20240903$EXP$$TW-AMGEN-TWNSP2024174128$AMGEN$$$$$$Y$$$20240902$$MD$TW$TW
242752601$24275260$1$I$$20240826$20240903$20240903$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010942$STRIDES$Cecchini A, Stephenson E, Sill JM.. An Uncommon Cause of Immunosuppression: Fatal Pneumocystis Jiroveci Pneumonia in a Patient With Cushing^s Syndrome.. Am-J-Respir-Crit-Care-Med. 2023;207:A1341$61$YR$$F$Y$$$20240903$$HP$US$US
242752611$24275261$1$I$20240827$20240827$20240903$20240903$EXP$$US-JNJFOC-20240877034$JOHNSON AND JOHNSON$$24$YR$A$F$Y$$$20240903$$HP$US$US
242752621$24275262$1$I$$20240829$20240903$20240903$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP010944$STRIDES$Campos ID, Moreira H, Portal F, Paiva JA.. Unusual presentation of benzodiazepine withdrawal with Takotsubo syndrome: a case report.. Eur-Heart-J-Case-Rep. 2024;8 (4)$58$YR$$F$Y$$$20240903$$HP$PT$PT
242752631$24275263$1$I$20240828$20240829$20240903$20240903$EXP$$CA-ABBVIE-5903903$ABBVIE$$88$YR$$M$Y$$$20240903$$CN$CA$CA
242752642$24275264$2$F$$20240903$20240903$20240909$PER$$US-ABBVIE-5899875$ABBVIE$$$$$$Y$$$20240909$$CN$US$US
242752651$24275265$1$I$$20240824$20240903$20240903$EXP$$GB-AMGEN-GBRSP2024172466$AMGEN$$$$$M$Y$$$20240902$$HP$GB$GB
242752661$24275266$1$I$$20240828$20240903$20240903$PER$$US-AMGEN-USASP2024172490$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242752671$24275267$1$I$20240601$20240828$20240903$20240903$EXP$$CA-ABBVIE-5902534$ABBVIE$$89$YR$$F$Y$$$20240903$$CN$CA$CA
242752681$24275268$1$I$20240101$20240826$20240903$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-026910$UNITED THERAPEUTICS$$$$$F$Y$137.87$KG$20240903$$$US$US
242752691$24275269$1$I$$20240829$20240903$20240903$PER$$US-JNJFOC-20240880672$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$HP$US$US
242752702$24275270$2$F$20240817$20240915$20240903$20240921$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03129$AMNEAL$$59$YR$$M$Y$104.31$KG$20240921$$CN$US$US
242752711$24275271$1$I$20240508$20240830$20240903$20240903$EXP$FR-AFSSAPS-AN2024000998$FR-ABBVIE-5904565$ABBVIE$$$$$$Y$$$20240903$$MD$FR$FR
242752721$24275272$1$I$20240818$20240826$20240903$20240903$EXP$$US-ABBVIE-5896031$ABBVIE$$76$YR$$M$Y$$$20240903$$CN$US$US
242752731$24275273$1$I$20240101$20240828$20240903$20240903$EXP$$US-ABBVIE-5900909$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242752741$24275274$1$I$$20240902$20240903$20240903$PER$$NVSC2024US176757$NOVARTIS$$$$$$Y$$$20240903$$HP$US$US
242752752$24275275$2$F$20240816$20240902$20240903$20240904$PER$$US-AMGEN-USASP2024174847$AMGEN$$79$YR$E$M$Y$$$20240903$$CN$US$US
242752761$24275276$1$I$20240101$20240826$20240903$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-024157$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240903$$$US$US
242752771$24275277$1$I$$20240827$20240903$20240903$PER$$US-ABBVIE-5903180$ABBVIE$$$$$$Y$$$20240903$$CN$US$US
242752782$24275278$2$F$$20240829$20240903$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139012$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240906$$CN$US$US
242752791$24275279$1$I$20240830$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174403$AMGEN$$82$YR$E$F$Y$$$20240902$$CN$US$US
242752801$24275280$1$I$20240625$20240827$20240903$20240903$EXP$$US-ABBVIE-5898629$ABBVIE$$45$YR$$M$Y$79$KG$20240903$$CN$US$US
242752811$24275281$1$I$$20240830$20240903$20240903$EXP$$JP-TAKEDA-2024TJP012894$TAKEDA$$8$DEC$$F$Y$$$20240903$$MD$JP$JP
242752821$24275282$1$I$$20240901$20240903$20240903$PER$$NVSC2024US176503$NOVARTIS$$$$$F$Y$$$20240903$$CN$US$US
242752831$24275283$1$I$$20240830$20240903$20240903$PER$$NVSC2024US176552$NOVARTIS$$40$YR$$F$Y$$$20240903$$HP$US$US
242752851$24275285$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5901776$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242752861$24275286$1$I$$20240830$20240903$20240903$EXP$$US-AstraZeneca-2024A198425$ASTRAZENECA$$$$$$Y$$$20240903$$HP$US$
242752871$24275287$1$I$20240815$20240830$20240903$20240903$EXP$$US-AstraZeneca-2024A198389$ASTRAZENECA$$31985$DY$$F$Y$$$20240903$$CN$US$
242752881$24275288$1$I$$20240826$20240903$20240903$PER$$US-AstraZeneca-2024A194953$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242752891$24275289$1$I$20240101$20240827$20240903$20240903$EXP$$US-ABBVIE-5781446$ABBVIE$$$$$F$Y$52$KG$20240903$$CN$US$US
242752901$24275290$1$I$20240101$20240828$20240903$20240903$EXP$$CA-ABBVIE-5901717$ABBVIE$$58$YR$$F$Y$$$20240903$$CN$CA$CA
242752911$24275291$1$I$$20240829$20240903$20240903$PER$$US-ABBVIE-5902639$ABBVIE$$$$$$Y$$$20240903$$CN$US$US
242752921$24275292$1$I$20240701$20240828$20240903$20240903$EXP$$US-ABBVIE-5900949$ABBVIE$$88$YR$$F$Y$$$20240903$$CN$US$US
242752931$24275293$1$I$$20240827$20240903$20240903$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001752$BLUEPRINT MEDICINES$$$$$M$Y$$$20240903$$CN$US$US
242752941$24275294$1$I$20240825$20240826$20240903$20240903$PER$$US-ROCHE-10000067353$ROCHE$$$$$F$Y$$$20240903$$CN$US$US
242752952$24275295$2$F$$20240905$20240903$20240910$EXP$$CA-TAKEDA-2024TUS087477$TAKEDA$$$$$M$Y$$$20240910$$CN$CA$CA
242752962$24275296$2$F$$20240903$20240903$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139295$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240905$$HP$US$US
242752971$24275297$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5901879$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242752981$24275298$1$I$20240801$20240826$20240903$20240903$PER$$US-ABBVIE-5898134$ABBVIE$$$$$M$Y$$$20240903$$MD$US$US
242752993$24275299$3$F$$20240925$20240903$20240930$PER$$US-ROCHE-10000068110$ROCHE$$$$A$F$Y$$$20240930$$CN$US$US
242753011$24275301$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000272$ELI LILLY AND CO$$$$$M$Y$$$20240903$$CN$US$US
242753022$24275302$2$F$20240712$20240827$20240903$20240906$EXP$$JP-UCBSA-2024042907$UCB$$57$YR$$M$Y$$$20240906$$CN$JP$JP
242753031$24275303$1$I$20240101$20240829$20240903$20240903$EXP$$US-ABBVIE-5902176$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242753041$24275304$1$I$$20240829$20240903$20240903$EXP$$TW-SANDOZ INC.-SDZ2024TW076462$SANDOZ$$$$$M$Y$125$KG$20240903$$PH$TW$TW
242753051$24275305$1$I$$20240830$20240903$20240903$EXP$$US-ABBVIE-5903504$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242753061$24275306$1$I$20240801$20240829$20240903$20240903$PER$$US-ABBVIE-5901773$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242753081$24275308$1$I$20060201$20240828$20240903$20240903$EXP$$US-JNJFOC-20240877077$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240903$$LW$US$US
242753091$24275309$1$I$$20240828$20240903$20240903$EXP$$BR-JNJFOC-20240882702$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$MD$BR$BR
242753101$24275310$1$I$$20240829$20240903$20240903$PER$$US-ROCHE-10000071262$ROCHE$$$$$$Y$$$20240903$$CN$US$US
242753112$24275311$2$F$20240828$20240829$20240903$20240906$EXP$$US-JNJFOC-20240881121$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240906$$MD$US$US
242753131$24275313$1$I$$20240828$20240903$20240903$EXP$$CA-ABBVIE-5902448$ABBVIE$$$$$F$Y$$$20240903$$CN$CA$CA
242753141$24275314$1$I$$20240828$20240903$20240903$EXP$$US-ABBVIE-5900484$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242753152$24275315$2$F$20240719$20240904$20240903$20240906$EXP$$US-ABBVIE-5903821$ABBVIE$$85$YR$$F$Y$61$KG$20240906$$CN$US$US
242753161$24275316$1$I$$20240829$20240903$20240903$EXP$$US-AstraZeneca-2024A197408$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242753171$24275317$1$I$$20240829$20240903$20240903$EXP$$US-AstraZeneca-2024A197516$ASTRAZENECA$$$$$M$Y$$$20240903$$HP$US$
242753181$24275318$1$I$20240531$20240822$20240903$20240903$EXP$CN-HENLIUS-24CN016569$CN-Accord-443539$ACCORD$$53$YR$A$F$Y$64.3$KG$20240903$$MD$CN$CN
242753191$24275319$1$I$$20240820$20240903$20240903$EXP$$US-AUROBINDO-AUR-APL-2024-042330$AUROBINDO$Chetana Shanmukhappa S, Kumar A, Dey A, JVS J, Lokeshwaran S et al. Omalizumab rescue therapy in refractory status asthmaticus. J-Asthma. 2023;60(12):2243-2247$39$YR$$M$Y$$$20240903$$HP$US$US
242753201$24275320$1$I$$20240829$20240903$20240903$EXP$$ZA-AstraZeneca-2024A198492$ASTRAZENECA$$56$YR$$F$Y$$$20240903$$CN$ZA$
242753211$24275321$1$I$$20240827$20240903$20240903$PER$$US-ABBVIE-5904110$ABBVIE$$$$$$Y$$$20240903$$CN$US$US
242753222$24275322$2$F$20240101$20240921$20240903$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016595$UNITED THERAPEUTICS$$$$$F$Y$$$20240927$$$US$US
242753231$24275323$1$I$20240828$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138856$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240903$$CN$US$US
242753241$24275324$1$I$$20240820$20240903$20240903$EXP$$US-AUROBINDO-AUR-APL-2024-042325$AUROBINDO$Juneja P, Swor D. An Evidence-Based Approach to Diagnosis and Prognosis in a Young Woman with New-Onset Super-Refractory Status Epilepticus: A Case Report. Case-Rep-Neurol. 2022;14(1):5-11$24$YR$$F$Y$$$20240903$$HP$US$US
242753251$24275325$1$I$20240701$20240817$20240903$20240903$PER$$US-TEVA-VS-3234838$TEVA$$$$$$Y$$$20240903$$CN$US$US
242753261$24275326$1$I$$20240827$20240903$20240903$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001755$BLUEPRINT MEDICINES$$$$$M$Y$$$20240903$$CN$US$US
242753272$24275327$2$F$$20240917$20240903$20240918$EXP$$NVSJ2024JP010351$NOVARTIS$$$$$$Y$$$20240919$$MD$JP$JP
242753281$24275328$1$I$$20240820$20240903$20240903$EXP$$CA-AUROBINDO-AUR-APL-2024-042321$AUROBINDO$Alawneh I, Amburgey K, Gonorazky H, Gorodetsky C.. CAMK4-related Case of Hyperkinetic Movement Disorder. Mov-Disord-Clin-Pract. 2023;10(4):707-709$16$YR$$M$Y$$$20240903$$MD$CA$CA
242753291$24275329$1$I$20230101$20240829$20240903$20240903$PER$$US-ROCHE-10000070168$ROCHE$$76$YR$E$F$Y$$$20240903$$CN$US$US
242753301$24275330$1$I$$20240820$20240903$20240903$EXP$$BR-GLENMARK PHARMACEUTICALS-2024GMK093493$GLENMARK$Lima VACC, Gouvea ALF, Menezes P, Santos JDF, Rochael MC, Carvalho FR, et, al.. Hemophagocytic lymphohistiocytosis, a rare condition in renal transplant - a case report.. Jornal brasileiro de nefrologia : ^orgao oficial de Sociedades Brasileira e Lati. 2018;40 (4):423-427$$$$$Y$$$20240903$$HP$BR$BR
242753311$24275331$1$I$20240101$20240824$20240903$20240903$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023375$UNITED THERAPEUTICS$$$$$F$Y$113.38$KG$20240903$$$US$US
242753321$24275332$1$I$$20240820$20240903$20240903$PER$$US-SA-2024SA252061$SANOFI AVENTIS$$$$C$M$Y$$$20240903$$MD$US$US
242753332$24275333$2$F$$20240829$20240903$20240904$PER$$NVSC2024US176312$NOVARTIS$$$$$F$Y$$$20240904$$HP$US$US
242753341$24275334$1$I$$20240823$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408016005$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240903$$CN$US$US
242753351$24275335$1$I$20240819$20240826$20240903$20240903$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026873$UNITED THERAPEUTICS$$63$YR$$F$Y$79.819$KG$20240903$$$US$US
242753371$24275337$1$I$20240101$20240820$20240903$20240903$EXP$$US-UCBSA-2024042569$UCB$$$$$F$Y$$$20240903$$HP$US$US
242753382$24275338$2$F$20240801$20240904$20240903$20240913$EXP$$CA-CELLTRION INC.-2024CA020862$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
242753391$24275339$1$I$$20240822$20240903$20240903$EXP$$US-RDY-SPO/USA/24/0012551$DR REDDYS$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 06;73: doi:10.1007/s00262-024-03775-6.$69$YR$E$M$Y$$$20240903$$HP$US$US
242753401$24275340$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA251371$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240903$$MD$US$US
242753411$24275341$1$I$$20240822$20240903$20240903$PER$$US-SA-2024SA252950$SANOFI AVENTIS$$$$A$$Y$$$20240903$$MD$US$US
242753422$24275342$2$F$20240801$20240917$20240903$20240924$PER$$US-CHATTEMPRD-2024OHG029907$CHATTEM$$76$YR$E$M$Y$$$20240924$$CN$US$US
242753432$24275343$2$F$$20240905$20240903$20240918$EXP$$GB-ADVANZ PHARMA-202408006998$ADVANZ PHARMA$$$$$$Y$$$20240918$$MD$GB$GB
242753441$24275344$1$I$$20240829$20240903$20240903$EXP$$US-AstraZeneca-2024A198136$ASTRAZENECA$$$$$F$Y$59.9$KG$20240903$$CN$US$
242753462$24275346$2$F$$20240912$20240903$20240923$EXP$$JP-UCBSA-2024043507$UCB$$6$YR$$M$Y$$$20240923$$MD$JP$JP
242753471$24275347$1$I$$20240824$20240903$20240903$EXP$$US-NOVOPROD-1275985$NOVO NORDISK$$$$$$Y$$$20240903$$CN$US$US
242753482$24275348$2$F$20220101$20240910$20240903$20240923$EXP$DE-BFARM-24005879$DE-NOVOPROD-1275673$NOVO NORDISK$$83$YR$$F$Y$105.4$KG$20240923$$CN$DE$DE
242753491$24275349$1$I$$20240823$20240903$20240903$30DAY$$FR-NOVOPROD-1274910$NOVO NORDISK$$$$$F$Y$$$20240903$$PH$FR$FR
242753501$24275350$1$I$20230101$20240823$20240903$20240903$EXP$SE-SEMPA-2024-006269$SE-NOVOPROD-1275891$NOVO NORDISK$$50$YR$$F$Y$85$KG$20240903$$CN$SE$SE
242753512$24275351$2$F$$20240916$20240903$20240925$EXP$$US-NOVOPROD-1275910$NOVO NORDISK$$$$$F$Y$$$20240925$$CN$US$US
242753521$24275352$1$I$20240624$20240823$20240903$20240903$EXP$$US-NOVOPROD-1275706$NOVO NORDISK$$65$YR$$F$Y$$$20240903$$MD$US$US
242753531$24275353$1$I$20240812$20240823$20240903$20240903$EXP$SE-SEMPA-2024-006166$SE-NOVOPROD-1275657$NOVO NORDISK$$47$YR$$F$Y$90$KG$20240903$$CN$SE$SE
242753541$24275354$1$I$$20240826$20240903$20240903$EXP$$US-NOVOPROD-1276315$NOVO NORDISK$$$$$F$Y$$$20240903$$MD$US$US
242753551$24275355$1$I$20240823$20240823$20240903$20240903$EXP$$US-NOVOPROD-1275881$NOVO NORDISK$$69$YR$$F$Y$$$20240903$$CN$US$US
242753561$24275356$1$I$20240823$20240823$20240903$20240903$EXP$$CN-NOVOPROD-1275607$NOVO NORDISK$$85$YR$$M$Y$55$KG$20240903$$CN$CN$CN
242753571$24275357$1$I$$20240824$20240903$20240903$EXP$$TR-NOVOPROD-1275636$NOVO NORDISK$$872$MON$$F$Y$67$KG$20240903$$CN$TR$TR
242753581$24275358$1$I$$20240823$20240903$20240903$EXP$$US-NOVOPROD-1275846$NOVO NORDISK$$$$$F$Y$$$20240903$$CN$US$US
242753591$24275359$1$I$$20240828$20240903$20240903$EXP$$JP-SANDOZ INC.-SDZ2024JP076405$SANDOZ$Yukinori K, Doki Y, Kitabayashi R, Takaki Y, Nomura T, Tsuji K, et.al. Short?term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S?1 for gastric cancer with extensive lymph node metastasis (JCOG1704). Gastric Cancer. 2024;27(2):366-374$$$$$Y$$$20240903$$MD$JP$JP
242753601$24275360$1$I$20240601$20240830$20240903$20240903$EXP$$CL-UCBSA-2024044659$UCB$$78$YR$$M$Y$$$20240903$$CN$CL$CL
242753612$24275361$2$F$$20240909$20240903$20240910$EXP$$US-SANDOZ INC.-SDZ2024US076804$SANDOZ$$71$YR$$M$Y$$$20240910$$HP$US$US
242753621$24275362$1$I$$20240827$20240903$20240903$PER$$US-PCCINC-2024-PPL-000642$PIRAMAL$$$$$$Y$$$20240903$$HP$US$US
242753631$24275363$1$I$$20240830$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139653$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240903$$CN$US$US
242753651$24275365$1$I$$20240827$20240903$20240903$PER$$US-JNJFOC-20240875320$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$HP$US$US
242753662$24275366$2$F$$20240913$20240903$20240926$EXP$$US-AUROBINDO-AUR-APL-2024-042582$AUROBINDO$Liang J, Bhat ZY, Alrawi O. Rare Case of Exogenous Vasopressin-Induced Hyponatremia. American Journal of Therapeutics. 2023;31(4):e431$33$YR$$F$Y$$$20240926$$MD$US$US
242753671$24275367$1$I$20240829$20240830$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139615$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240903$$CN$US$US
242753681$24275368$1$I$$20240821$20240903$20240903$EXP$$US-AUROBINDO-AUR-APL-2021-034030$AUROBINDO$Winegarden JA, Carr DB, Bradshaw YS. Topical Ketamine with Other Adjuvants: Underutilized for Refractory Cancer Pain? A Case Series and Suggested Revision of the World Health Organization Stepladder for Cancer Pain. JOURNAL OF PALLIATIVE MEDICINE. 2020;23 (9):1167-1171$72$YR$$F$Y$$$20240903$$MD$US$US
242753692$24275369$2$F$20240601$20240902$20240903$20240905$EXP$$US-AMGEN-USASP2024173959$AMGEN$$66$YR$E$F$Y$$$20240905$$CN$US$US
242753701$24275370$1$I$$20240828$20240903$20240903$PER$$US-ROCHE-10000069933$ROCHE$$$$$$Y$$$20240903$$CN$US$US
242753712$24275371$2$F$$20240916$20240903$20240925$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000304$EMCURE$$$$$$Y$$$20240925$$CN$US$US
242753721$24275372$1$I$$20240825$20240903$20240903$PER$$US-ABBVIE-5897194$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242753741$24275374$1$I$$20240830$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US076833$SANDOZ$$16$YR$$M$Y$$$20240903$$MD$US$US
242753751$24275375$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-140436-2023$RECKITT BENCKISER$$$$$F$Y$$$20240903$$CN$US$US
242753761$24275376$1$I$20200606$20240822$20240903$20240903$EXP$PL-URPL-1-2140-2020$PL-Accord-443628$ACCORD$$60$YR$A$F$Y$56$KG$20240903$$MD$PL$PL
242753771$24275377$1$I$$20240829$20240903$20240903$PER$$US-ROCHE-10000071066$ROCHE$$$$E$F$Y$$$20240903$$CN$US$US
242753782$24275378$2$F$20211110$20240919$20240903$20240927$EXP$$US-AMGEN-USASP2024171603$AMGEN$$64$YR$A$M$Y$$$20240927$$LW$US$US
242753791$24275379$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A198077$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242753802$24275380$2$F$$20240905$20240903$20240909$EXP$$US-ABBVIE-5897219$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242753811$24275381$1$I$20240101$20240829$20240903$20240903$EXP$$US-ABBVIE-5902269$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242753821$24275382$1$I$20240801$20240822$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408014696$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240903$$CN$US$US
242753831$24275383$1$I$$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018719$ELI LILLY AND CO$$61$YR$A$$Y$$$20240903$$CN$US$US
242753841$24275384$1$I$20230511$20240826$20240903$20240903$EXP$$CA-CELLTRION INC.-2023CA008482$CELLTRION$$$$$$Y$$$20240903$$MD$CA$CA
242753852$24275385$2$F$20240101$20240910$20240903$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-026255$UNITED THERAPEUTICS$$$$$F$Y$84.807$KG$20240919$$$US$US
242753861$24275386$1$I$$20240829$20240903$20240903$PER$$NVSC2024US176598$NOVARTIS$$$$$F$Y$$$20240903$$CN$US$US
242753872$24275387$2$F$20240830$20240902$20240903$20240918$PER$$US-AMGEN-USASP2024174379$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
242753881$24275388$1$I$$20240827$20240903$20240903$30DAY$$US-GSK-US2024106728$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$CN$US$US
242753891$24275389$1$I$20240824$20240827$20240903$20240903$30DAY$$US-GSK-US2024106605$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240903$$CN$US$US
242753901$24275390$1$I$$20240828$20240903$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-026997$UNITED THERAPEUTICS$$$$$M$Y$$$20240903$$$US$US
242753911$24275391$1$I$$20240901$20240903$20240903$EXP$$IL-ALXN-202407ISR002135IL$ALEXION PHARMACEUTICALS$$60$YR$$M$Y$$$20240903$$MD$IL$IL
242753922$24275392$2$F$20240325$20240916$20240903$20240917$EXP$DE-CADRBFARM-2024328098$DE-SANDOZ INC.-SDZ2024DE077009$SANDOZ$$41$YR$$F$Y$75$KG$20240917$$MD$DE$DE
242753941$24275394$1$I$20240821$20240829$20240903$20240903$EXP$$CN-ABBVIE-5901932$ABBVIE$$71$YR$$M$Y$61$KG$20240903$$MD$CN$CN
242753951$24275395$1$I$20240401$20240831$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-087886-2024$RECKITT BENCKISER$$$$$F$Y$$$20240903$$CN$US$US
242753961$24275396$1$I$20240825$20240901$20240903$20240903$PER$$US-ROCHE-10000071406$ROCHE$$23$YR$A$M$Y$$$20240903$$CN$US$US
242753971$24275397$1$I$$20240830$20240903$20240903$PER$$US-ROCHE-10000071346$ROCHE$$$$A$M$Y$$$20240903$$CN$US$US
242753982$24275398$2$F$20240601$20240912$20240903$20240920$EXP$$DE-AMGEN-DEUSP2024174711$AMGEN$$$$A$F$Y$70$KG$20240919$$MD$DE$DE
242753991$24275399$1$I$20240101$20240829$20240903$20240903$EXP$$CA-ABBVIE-5901911$ABBVIE$$$$A$F$Y$$$20240903$$CN$CA$CA
242754001$24275400$1$I$20240101$20240827$20240903$20240903$EXP$$US-AMGEN-USASL2024127401$AMGEN$$$$E$M$Y$$$20240902$$CN$US$US
242754011$24275401$1$I$$20240829$20240903$20240903$PER$$US-ABBVIE-5902413$ABBVIE$$$$$$Y$$$20240903$$HP$US$US
242754022$24275402$2$F$20240825$20240912$20240903$20240918$PER$$US-ROCHE-10000072127$ROCHE$$47$YR$A$F$Y$$$20240918$$CN$US$US
242754031$24275403$1$I$$20240830$20240903$20240903$PER$$US-ROCHE-10000071310$ROCHE$$$$C$M$Y$$$20240903$$CN$US$US
242754041$24275404$1$I$20240822$20240824$20240903$20240903$30DAY$$US-GSK-US2024106035$GLAXOSMITHKLINE$$63$YR$$F$Y$72.57$KG$20240903$$CN$US$US
242754051$24275405$1$I$20240101$20240829$20240903$20240903$EXP$SE-SEMPA-2024-006327$SE-JNJFOC-20240901105$JOHNSON AND JOHNSON$$42$YR$A$M$Y$85$KG$20240903$$CN$SE$SE
242754062$24275406$2$F$$20240912$20240903$20240918$EXP$$US-ABBVIE-5901880$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
242754071$24275407$1$I$$20240826$20240903$20240903$EXP$FR-AFSSAPS-LL2023000412$FR-CELLTRION INC.-2024FR020623$CELLTRION$$$$$$Y$$$20240903$$MD$FR$FR
242754081$24275408$1$I$$20240826$20240903$20240903$EXP$$CL-CHEPLA-2024011264$CHEPLAPHARM$Zavadzki G, Robles JI, Mart?n MFS, Torres WG, Ramos-Rojas JT, Gauna-Cordero J, Bigossi Aguiar N. Case report of superwarfarin intoxication: a therapeutic challenge. Rev Med Chile 2023; 151: 797-800. Spanish. doi: 10.4067/s0034-98872023000600797. PMID: 38801389.$42$YR$$M$Y$$$20240902$$HP$COUNTRY NOT SPECIFIED$CL
242754091$24275409$1$I$$20240826$20240903$20240903$EXP$$US-TAKEDA-2024TUS071558$TAKEDA$$$$$M$Y$$$20240903$$CN$US$US
242754103$24275410$3$F$20230617$20240906$20240903$20240917$EXP$$US-TAKEDA-2023TUS069864$TAKEDA$$71$YR$$F$Y$$$20240917$$CN$US$US
242754111$24275411$1$I$$20240829$20240903$20240903$PER$$NVSC2024US176599$NOVARTIS$$$$$$Y$$$20240903$$CN$US$US
242754121$24275412$1$I$20240809$20240829$20240903$20240903$EXP$$US-ABBVIE-5902254$ABBVIE$$70$YR$$M$Y$$$20240903$$CN$US$US
242754132$24275413$2$F$20240603$20240906$20240903$20240912$EXP$$US-ABBVIE-5902289$ABBVIE$$76$YR$$F$Y$$$20240912$$CN$US$US
242754141$24275414$1$I$20231101$20240829$20240903$20240903$EXP$$US-ABBVIE-5902451$ABBVIE$$71$YR$$F$Y$$$20240903$$CN$US$US
242754152$24275415$2$F$20220101$20240919$20240903$20240928$EXP$$US-AMGEN-USASP2024172590$AMGEN$$$$$M$Y$100$KG$20240928$$LW$US$US
242754161$24275416$1$I$20240827$20240829$20240903$20240903$PER$$US-ROCHE-10000068838$ROCHE$$47$YR$A$M$Y$$$20240903$$CN$US$US
242754171$24275417$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139401$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240903$$CN$US$US
242754181$24275418$1$I$$20240823$20240903$20240903$PER$$US-ABBVIE-5894301$ABBVIE$$$$$F$Y$$$20240903$$MD$US$US
242754191$24275419$1$I$$20240826$20240903$20240903$PER$$US-ROCHE-10000071207$ROCHE$$11$MON$I$M$Y$$$20240903$$CN$US$US
242754201$24275420$1$I$$20240826$20240903$20240903$PER$$US-CHATTEMPRD-2024OHG029960$CHATTEM$Pico MJ, Badri M, Michalak N, Siefferman JW. Systemic allergic reaction to galcanezumab (emgality): a case report. Cephalalgia. 2024;44(1): 1-4. doi:10.1177/03331024231222914.$50$YR$A$F$Y$$$20240903$$HP$US$US
242754211$24275421$1$I$$20240829$20240903$20240903$EXP$$US-AstraZeneca-2024A197994$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242754221$24275422$1$I$20240819$20240827$20240903$20240903$PER$$US-ABBVIE-5897856$ABBVIE$$71$YR$$F$Y$58$KG$20240903$$CN$US$US
242754231$24275423$1$I$$20240830$20240903$20240903$EXP$$ES-ARGENX-2024-ARGX-ES007318$ARGENX BVBA$$$$$$Y$$$20240903$$MD$ES$ES
242754242$24275424$2$F$20240101$20240905$20240903$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136065$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$88.45$KG$20240912$$HP$US$US
242754251$24275425$1$I$$20240829$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138808$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240903$$CN$US$US
242754261$24275426$1$I$20240829$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173608$AMGEN$$$$$$Y$$$20240902$$PH$US$US
242754271$24275427$1$I$20240830$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174454$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242754281$24275428$1$I$20240725$20240821$20240903$20240903$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161092$JIANGSU HENGRUI MEDICINE$$81$YR$$F$Y$60$KG$20240903$$MD$CN$CN
242754291$24275429$1$I$$20240902$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-082979-2024$RECKITT BENCKISER$$$$$F$Y$$$20240903$$CN$US$US
242754301$24275430$1$I$$20240830$20240903$20240903$EXP$$IT-SANDOZ INC.-NVSC2021IT128378$SANDOZ$$55$YR$$F$Y$$$20240903$$MD$IT$IT
242754311$24275431$1$I$20240710$20240829$20240903$20240903$EXP$$AU-ROCHE-10000069161$ROCHE$$60$YR$A$F$Y$91.4$KG$20240903$$HP$AU$AU
242754321$24275432$1$I$$20240825$20240903$20240903$EXP$$CN-JNJFOC-20240877166$JOHNSON AND JOHNSON$$50$YR$A$$Y$$$20240903$$HP$CN$CN
242754331$24275433$1$I$$20240825$20240903$20240903$EXP$$CN-JNJFOC-20240877183$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240903$$HP$CN$CN
242754341$24275434$1$I$20240813$20240820$20240903$20240903$EXP$$US-JNJFOC-20240881205$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$HP$US$US
242754352$24275435$2$F$20240101$20240911$20240903$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026724$UNITED THERAPEUTICS$$$$$F$Y$50.794$KG$20240920$$$US$US
242754361$24275436$1$I$$20240820$20240903$20240903$EXP$$US-AUROBINDO-AUR-APL-2024-043856$AUROBINDO$Bulleit C, Rho J, Fleisch SB, Radhakrishnan NS.. Treating malignant catatonia with liquid amantadine: A case report and literature review. Journal of psychiatric practice. 2024;30(4):308-10$51$YR$$F$Y$$$20240903$$HP$US$US
242754371$24275437$1$I$$20240826$20240903$20240903$EXP$$BD-SSPHARMA-2024BDSSP00076$SS PHARMA$Sabbir Hossain.A Case of Milk Alkali Syndrome: The Forgotten Diagnosis of Generalized Weakness and Altered Consciousness.Journal of Medicine Bangladesh.16-JUL-2024;25(2):184-186$76$YR$E$M$Y$$$20240903$$HP$BD$BD
242754381$24275438$1$I$$20240813$20240903$20240903$PER$$AU-TOLMAR, INC.-24AU051848$TOLMAR$$$$$M$Y$$$20240903$$CN$AU$AU
242754391$24275439$1$I$$20240813$20240903$20240903$PER$$AU-TOLMAR, INC.-24AU051873$TOLMAR$$74$YR$$M$Y$$$20240903$$HP$AU$AU
242754401$24275440$1$I$$20240813$20240903$20240903$PER$$AU-TOLMAR, INC.-24AU051841$TOLMAR$$$$$M$Y$$$20240903$$CN$AU$AU
242754411$24275441$1$I$$20240813$20240903$20240903$PER$$AU-TOLMAR, INC.-24AU051874$TOLMAR$$$$$M$Y$$$20240903$$CN$AU$AU
242754421$24275442$1$I$20240828$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000415$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240903$$CN$US$US
242754431$24275443$1$I$$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018105$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240903$$CN$US$US
242754441$24275444$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139275$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240903$$CN$US$US
242754451$24275445$1$I$$20240830$20240903$20240903$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-138900$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240903$$HP$PR$PR
242754461$24275446$1$I$$20240829$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138803$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240903$$CN$US$US
242754471$24275447$1$I$20240101$20240829$20240903$20240903$EXP$$ZA-ABBVIE-5901526$ABBVIE$$30$YR$$F$Y$$$20240903$$CN$ZA$ZA
242754481$24275448$1$I$$20240820$20240903$20240903$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002196$Alvotech$$62$YR$$F$Y$$$20240903$$CN$CA$CA
242754491$24275449$1$I$$20240828$20240903$20240903$PER$$US-BIOGEN-2024BI01272861$BIOGEN$$$$$F$Y$$$20240903$$CN$US$US
242754501$24275450$1$I$$20240826$20240903$20240903$EXP$$US-GSK-US2024105943$GLAXOSMITHKLINE$$$$$M$Y$$$20240903$$CN$US$US
242754511$24275451$1$I$$20240830$20240903$20240903$EXP$$US-ALXN-202408USA002114US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$MD$US$US
242754521$24275452$1$I$20240821$20240902$20240903$20240903$EXP$GB-MHRA-MED-202408301236218330-GVHRN$GB-ABBVIE-5904768$ABBVIE$$79$YR$$M$Y$$$20240903$$MD$GB$GB
242754531$24275453$1$I$20240815$20240902$20240903$20240903$EXP$FR-AFSSAPS-LY2024001352$NVSC2024FR176484$NOVARTIS$$48$YR$$F$Y$62$KG$20240903$$PH$FR$FR
242754551$24275455$1$I$$20240827$20240903$20240903$EXP$$NO-AMGEN-NORSP2024173618$AMGEN$$5$DEC$A$F$Y$$$20240902$$MD$NO$NO
242754561$24275456$1$I$20240101$20240828$20240903$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-027195$UNITED THERAPEUTICS$$$$$F$Y$97.506$KG$20240903$$$US$US
242754571$24275457$1$I$20240827$20240828$20240903$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-027180$UNITED THERAPEUTICS$$84$YR$$F$Y$47.166$KG$20240903$$$US$US
242754583$24275458$3$F$20240101$20240909$20240903$20240919$EXP$$US-AMGEN-USASP2024173464$AMGEN$$64$YR$A$F$Y$75.3$KG$20240919$$HP$US$US
242754591$24275459$1$I$$20240828$20240903$20240903$EXP$$IT-AMGEN-ITASP2024173180$AMGEN$Pilotto C.; Coassin E.; Borsatti E. et al.. USING [18F]FET-PET/CT SCAN TO DIFFERENTIATE RADIONECROSIS FROM RECURRENCE/NEW TUMOURS: THE CASE OF A CNS SARCOMA. Neuro-Oncology. 2024;26 (SUPPL_4):iv107$$$$F$Y$$$20240902$$HP$IT$IT
242754601$24275460$1$I$$20240829$20240903$20240903$30DAY$$US-GSK-US2024107922$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$CN$US$US
242754611$24275461$1$I$$20240829$20240903$20240903$EXP$$GB-ABBVIE-5902569$ABBVIE$$$$A$F$Y$$$20240903$$CN$GB$GB
242754621$24275462$1$I$$20240830$20240903$20240903$EXP$$JP-ABBVIE-5831381$ABBVIE$$85$YR$$M$Y$$$20240903$$CN$JP$JP
242754631$24275463$1$I$20240701$20240829$20240903$20240903$EXP$$US-ABBVIE-5902657$ABBVIE$$65$YR$$F$Y$$$20240903$$CN$US$US
242754641$24275464$1$I$20240829$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174339$AMGEN$$62$YR$A$F$Y$$$20240902$$CN$US$US
242754651$24275465$1$I$$20240828$20240903$20240903$PER$$US-JNJFOC-20240874464$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242754662$24275466$2$F$$20240903$20240903$20240904$PER$$US-JNJFOC-20240854118$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$CN$US$US
242754671$24275467$1$I$$20240830$20240903$20240903$EXP$GB-MHRA-MIDB-4035c570-4526-4c0b-a68b-35af2137afec$GB-ORGANON-O2409GBR000075$ORGANON$$78$YR$$M$Y$$$20240903$$PH$GB$GB
242754681$24275468$1$I$20240401$20240429$20240903$20240903$PER$$US-CIPLA LTD.-2023US06771$CIPLA$$$$$$Y$$$20240903$$HP$US$US
242754691$24275469$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-082315-2024$RECKITT BENCKISER$$76$YR$$M$Y$39.55$KG$20240903$$CN$US$US
242754702$24275470$2$F$20240101$20240914$20240903$20240923$PER$$US-SA-2024SA252563$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240923$$MD$US$US
242754711$24275471$1$I$20230914$20240826$20240903$20240903$EXP$$IT-CELLTRION INC.-2024IT020573$CELLTRION$$$$$$Y$$$20240903$$MD$IT$IT
242754721$24275472$1$I$$20240826$20240903$20240903$PER$$US-JNJFOC-20240875380$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$HP$US$US
242754731$24275473$1$I$$20240829$20240903$20240903$PER$$US-ROCHE-10000070728$ROCHE$$$$$$Y$$$20240903$$CN$US$US
242754741$24275474$1$I$$20240827$20240903$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-026272$UNITED THERAPEUTICS$$$$$F$Y$58.05$KG$20240903$$$US$US
242754752$24275475$2$F$20240827$20240910$20240903$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-027282$UNITED THERAPEUTICS$$75$YR$$F$Y$92.517$KG$20240919$$$US$US
242754771$24275477$1$I$20240101$20240829$20240903$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-004992$UNITED THERAPEUTICS$$$$$M$Y$74.83$KG$20240903$$$US$US
242754783$24275478$3$F$$20240919$20240903$20240925$EXP$$JP-ABBVIE-5873510$ABBVIE$$85$YR$$M$Y$$$20240925$$PH$JP$JP
242754801$24275480$1$I$$20240826$20240903$20240903$EXP$$NL-CELLTRION INC.-2024NL020622$CELLTRION$$$$$$Y$$$20240903$$MD$NL$NL
242754811$24275481$1$I$$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024172978$AMGEN$$$$$$Y$$$20240902$$CN$US$US
242754821$24275482$1$I$$20240826$20240903$20240903$EXP$$JP-AMGEN-JPNSP2024173589$AMGEN$$76$YR$E$M$Y$$$20240902$$HP$JP$JP
242754831$24275483$1$I$20240301$20240826$20240903$20240903$EXP$$DE-SANDOZ INC.-SDZ2024DE076365$SANDOZ$$$$$$Y$$$20240903$$CN$DE$DE
242754841$24275484$1$I$$20240829$20240903$20240903$PER$$US-ABBVIE-5902337$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242754852$24275485$2$F$$20240831$20240903$20240904$EXP$$MX-UNITED THERAPEUTICS-UNT-2024-013612$UNITED THERAPEUTICS$$69$YR$$$Y$40$KG$20240904$$$MX$MX
242754861$24275486$1$I$$20240819$20240903$20240903$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US001242$PAREXEL$$$$$$Y$$$20240903$$CN$US$US
242754871$24275487$1$I$20240830$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000480$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240903$$CN$US$US
242754881$24275488$1$I$20240829$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000604$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240903$$CN$US$US
242754893$24275489$3$F$20240801$20240904$20240903$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409000190$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240906$$CN$US$US
242754901$24275490$1$I$20240828$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018653$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240903$$CN$US$US
242754911$24275491$1$I$20240824$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408019227$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240903$$CN$US$US
242754921$24275492$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000257$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240903$$CN$US$US
242754931$24275493$1$I$20240701$20240830$20240903$20240903$EXP$FR-ABBVIE-5891153$FR-ROCHE-10000070447$ROCHE$$$$E$M$Y$$$20240903$$MD$FR$FR
242754951$24275495$1$I$20240810$20240822$20240903$20240903$EXP$$PT-AUROBINDO-AUR-APL-2024-042747$AUROBINDO$$36$YR$$M$Y$$$20240903$$MD$PT$PT
242754961$24275496$1$I$$20240830$20240903$20240903$EXP$$FR-ABBVIE-5904799$ABBVIE$$88$YR$$F$Y$$$20240903$$CN$FR$FR
242754972$24275497$2$F$$20240909$20240903$20240919$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161093$JIANGSU HENGRUI MEDICINE$$$$$$Y$$$20240919$$$CN$CN
242754981$24275498$1$I$$20240827$20240903$20240903$EXP$$JP-009507513-2407JPN001850J$MERCK$Furusako R, Suwa K, Kikuchi M, Miyabe R, Mastushima H, Kobayashi J, et al.. EP-1157 Four cases of breast cancer in which secondary adrenal insufficiency developed after preoperative chemotherapy with pembrolizumab. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 467$57$YR$$F$Y$$$20240903$$MD$JP$JP
242755001$24275500$1$I$$20240827$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US076645$SANDOZ$$30$YR$$F$Y$$$20240903$$HP$US$US
242755013$24275501$3$F$20221001$20240918$20240903$20240928$EXP$$CA-CELLTRION INC.-2021CA019676$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
242755021$24275502$1$I$$20240813$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08148$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242755031$24275503$1$I$$20240828$20240903$20240903$EXP$$US-ROCHE-10000069413$ROCHE$$$$A$F$Y$$$20240903$$CN$US$US
242755041$24275504$1$I$$20240828$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137093$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240903$$PH$US$US
242755052$24275505$2$F$$20240909$20240903$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135744$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240917$$CN$US$US
242755061$24275506$1$I$$20240816$20240903$20240903$PER$$US-ASTELLAS-2024-AER-001859$ASTELLAS$$5$DEC$A$F$Y$$$20240903$$HP$US$US
242755071$24275507$1$I$$20240829$20240903$20240903$EXP$$US-GSK-US2024107752$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$MD$US$US
242755081$24275508$1$I$$20240830$20240903$20240903$PER$$US-HALEON-2194573$Haleon PLC$$$$$$Y$$$20240903$$CN$US$US
242755091$24275509$1$I$20210701$20240822$20240903$20240903$EXP$$PT-TERSERA THERAPEUTICS LLC-2024TRS004047$TERSERA THERAPEUTICS$Oliveira C, Queiroz L, Almeida M, Fernandes R, Caeiro C.. Hepatoxicidade grave com ribociclib, a proposito de um caso desafiante [Challenging case of severe hepatotoxicity with ribociclib]. REVISTA PORTUGUESA DE ONCOLOGIA. 2024;7((N1-2)):46-8$$$$$Y$$$20240903$$MD$PT$PT
242755101$24275510$1$I$20240826$20240901$20240903$20240903$EXP$GB-MHRA-MED-202408301212566200-GVZQK$GB-DEXPHARM-2024-2955$DEXCEL$$$$$F$Y$$$20240903$$HP$GB$
242755112$24275511$2$F$20240101$20240910$20240903$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027171$UNITED THERAPEUTICS$$$$$F$Y$66.667$KG$20240919$$$US$US
242755121$24275512$1$I$$20240819$20240903$20240903$EXP$$US-CorePharma LLC-2161094$COREPHARMA$Source documents (Abstract).$14$YR$$F$Y$129$KG$20240903$$$US$US
242755131$24275513$1$I$20240820$20240829$20240903$20240903$EXP$$CN-ROCHE-10000069810$ROCHE$$53$YR$A$M$Y$71.8$KG$20240903$$HP$CN$CN
242755141$24275514$1$I$20240806$20240827$20240903$20240903$PER$$US-ROCHE-10000067834$ROCHE$$39$YR$A$F$Y$$$20240903$$CN$US$US
242755151$24275515$1$I$$20240826$20240903$20240903$EXP$$US-JNJFOC-20240877158$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240903$$HP$US$US
242755161$24275516$1$I$$20240828$20240903$20240903$EXP$$JP-JNJFOC-20240880375$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$MD$JP$JP
242755171$24275517$1$I$$20240828$20240903$20240903$EXP$$CA-ROCHE-10000068469$ROCHE$$$$$F$Y$$$20240903$$HP$CA$CA
242755182$24275518$2$F$20190805$20240829$20240903$20240907$EXP$$DE-AUROBINDO-AUR-APL-2024-042660$AUROBINDO$$$$A$F$Y$114$KG$20240907$$MD$DE$DE
242755191$24275519$1$I$$20240823$20240903$20240903$EXP$$US-ROCHE-10000065339$ROCHE$$79$YR$E$M$Y$$$20240903$$CN$US$US
242755201$24275520$1$I$$20240822$20240903$20240903$EXP$$GB-AUROBINDO-AUR-APL-2024-042396$AUROBINDO$$85$YR$$F$Y$$$20240903$$PH$GB$GB
242755211$24275521$1$I$20240815$20240822$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042749$AUROBINDO$$64$YR$$M$Y$76$KG$20240903$$MD$FR$FR
242755221$24275522$1$I$20240805$20240805$20240903$20240903$EXP$$US-NEBO-665967$PHARMACOSMOS$$80$YR$$F$Y$61.2$KG$20240903$$HP$US$US
242755231$24275523$1$I$20230101$20240822$20240903$20240903$EXP$FI-FIMEA-202402920$FI-Accord-443353$ACCORD$$46$YR$A$F$Y$$$20240903$$HP$FI$FI
242755241$24275524$1$I$$20240826$20240903$20240903$EXP$$CA-TAKEDA-2024TUS086606$TAKEDA$$$$$F$Y$$$20240903$$MD$CA$CA
242755251$24275525$1$I$20240501$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174084$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242755261$24275526$1$I$20240822$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174032$AMGEN$$87$YR$E$M$Y$$$20240902$$CN$US$US
242755271$24275527$1$I$$20240828$20240903$20240903$PER$$US-ABBVIE-5900829$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242755281$24275528$1$I$$20240822$20240903$20240903$EXP$$NL-AUROBINDO-AUR-APL-2024-042783$AUROBINDO$$43$YR$$F$Y$$$20240903$$MD$NL$NL
242755291$24275529$1$I$$20240830$20240903$20240903$PER$$NVSC2024US176781$NOVARTIS$$$$$M$Y$68$KG$20240903$$HP$US$US
242755301$24275530$1$I$$20240814$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08286$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242755311$24275531$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138881$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240903$$HP$US$US
242755321$24275532$1$I$$20240819$20240903$20240903$EXP$$US-CorePharma LLC-2161095$COREPHARMA$Source document (Abstract).$12$YR$$F$Y$63$KG$20240903$$$US$US
242755331$24275533$1$I$20240821$20240822$20240903$20240903$EXP$$GB-AUROBINDO-AUR-APL-2024-042559$AUROBINDO$$45$YR$$F$Y$68$KG$20240903$$MD$GB$GB
242755351$24275535$1$I$$20240820$20240903$20240903$EXP$$US-UCBSA-2024042572$UCB$$$$$F$Y$$$20240903$$MD$US$US
242755361$24275536$1$I$20240827$20240827$20240903$20240903$EXP$$US-AMGEN-USASP2024171530$AMGEN$$72$YR$E$F$Y$$$20240902$$CN$US$US
242755372$24275537$2$F$20240831$20240924$20240903$20240926$PER$$US-AMGEN-USASP2024175109$AMGEN$$22$YR$A$F$Y$$$20240926$$MD$US$US
242755382$24275538$2$F$20240301$20240913$20240903$20240918$EXP$$CA-SANDOZ INC.-SDZ2024CA034463$SANDOZ$$76$YR$$M$Y$$$20240918$$MD$CA$CA
242755392$24275539$2$F$20180101$20240904$20240903$20240909$EXP$GB-MLMSERVICE-20240806-PI154095-00057-1$GB-SANDOZ INC.-SDZ2024GB076765$SANDOZ$$61$YR$$F$Y$$$20240909$$MD$GB$GB
242755401$24275540$1$I$20240825$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018816$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240903$$CN$US$US
242755411$24275541$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000225$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240903$$CN$US$US
242755421$24275542$1$I$$20240829$20240903$20240903$PER$$US-ALXN-202408USA002077US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242755431$24275543$1$I$20240712$20240822$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042738$AUROBINDO$$76$YR$$M$Y$71$KG$20240903$$PH$FR$FR
242755441$24275544$1$I$20240622$20240822$20240903$20240903$EXP$$ES-AUROBINDO-AUR-APL-2024-042612$AUROBINDO$$77$YR$$M$Y$$$20240903$$MD$ES$ES
242755451$24275545$1$I$$20240826$20240903$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-026920$UNITED THERAPEUTICS$$$$$M$Y$126.08$KG$20240903$$$US$US
242755462$24275546$2$F$20240101$20240917$20240903$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-022381$UNITED THERAPEUTICS$$$$$F$Y$61.678$KG$20240924$$$US$US
242755471$24275547$1$I$20240101$20240321$20240903$20240903$PER$$US-ASTELLAS-2024US009283$ASTELLAS$$82$YR$E$M$Y$$$20240830$$PH$US$US
242755481$24275548$1$I$$20240213$20240903$20240903$PER$$US-ASTELLAS-2024US005332$ASTELLAS$$88$YR$E$M$Y$$$20240830$$PH$US$US
242755491$24275549$1$I$$20240826$20240903$20240903$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000755$DECIPHERA PHARMACEUTICALS$$76$YR$E$F$Y$68.6$KG$20240903$$CN$US$US
242755501$24275550$1$I$$20240814$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08339$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242755521$24275552$1$I$20240824$20240826$20240903$20240903$PER$$US-ABBVIE-5899689$ABBVIE$$$$$$Y$$$20240903$$CN$US$US
242755532$24275553$2$F$$20240909$20240903$20240911$EXP$$DE-SANDOZ INC.-NVSC2020DE173517$SANDOZ$$72$YR$$M$Y$57.8$KG$20240911$$MD$DE$DE
242755541$24275554$1$I$$20240318$20240903$20240903$PER$$US-ASTELLAS-2024US008811$ASTELLAS$$81$YR$E$M$Y$$$20240830$$HP$US$US
242755551$24275555$1$I$$20240516$20240903$20240903$PER$$US-ASTELLAS-2024US008227$ASTELLAS$$$$$F$Y$$$20240830$$MD$US$US
242755561$24275556$1$I$20240501$20240606$20240903$20240903$PER$$US-ASTELLAS-2024US016544$ASTELLAS$$96$YR$E$M$Y$$$20240830$$HP$US$US
242755571$24275557$1$I$20240101$20240820$20240903$20240903$PER$$US-SA-2024SA252515$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240903$$MD$US$US
242755581$24275558$1$I$$20240830$20240903$20240903$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048889$BOEHRINGER INGELHEIM$$$$$$Y$$$20240903$$MD$US$US
242755591$24275559$1$I$20240721$20240823$20240903$20240903$EXP$$CN-ROCHE-10000064715$ROCHE$$46$YR$A$F$Y$65$KG$20240903$$HP$CN$CN
242755601$24275560$1$I$$20240719$20240903$20240903$PER$$US-ASTELLAS-2024US020897$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242755611$24275561$1$I$$20240725$20240903$20240903$PER$$US-ASTELLAS-2024US021598$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242755621$24275562$1$I$$20240730$20240903$20240903$PER$$US-ASTELLAS-2024US021861$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242755631$24275563$1$I$$20240624$20240903$20240903$PER$$US-ASTELLAS-2024US018019$ASTELLAS$$67$YR$E$M$Y$$$20240830$$CN$US$US
242755641$24275564$1$I$$20240822$20240903$20240903$EXP$GB-MHRA-MIDB-a8eb119e-06d5-4eb2-bb18-b3cc85e02e58$GB-Accord-442991$ACCORD$$45$YR$A$$Y$$$20240903$$PH$GB$GB
242755652$24275565$2$F$20240308$20240904$20240903$20240916$EXP$$FR-AUROBINDO-AUR-APL-2024-042985$AUROBINDO$$32$YR$$M$Y$$$20240916$$PH$FR$FR
242755661$24275566$1$I$$20240820$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133513$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$PH$US$US
242755671$24275567$1$I$$20240806$20240903$20240903$PER$$US-ASTELLAS-2024US022422$ASTELLAS$$71$YR$E$M$Y$$$20240830$$CN$US$US
242755681$24275568$1$I$$20240815$20240903$20240903$PER$$US-ASTELLAS-2024-AER-001640$ASTELLAS$$$$$F$Y$$$20240903$$MD$US$US
242755701$24275570$1$I$$20240820$20240903$20240903$EXP$$US-UCBSA-2024042654$UCB$$$$$M$Y$105.68$KG$20240903$$HP$US$US
242755711$24275571$1$I$20210601$20240826$20240903$20240903$EXP$$BR-BIOGEN-2024BI01280233$BIOGEN$$27$YR$$F$Y$49$KG$20240903$$CN$BR$BR
242755722$24275572$2$F$20240730$20240912$20240903$20240930$PER$$US-TOLMAR, INC.-24US051502$TOLMAR$$58$YR$$M$Y$$$20240927$$HP$US$US
242755731$24275573$1$I$$20240809$20240903$20240903$PER$$US-TOLMAR, INC.-24US051241$TOLMAR$$$$$M$Y$$$20240903$$PH$US$US
242755741$24275574$1$I$20240713$20240827$20240903$20240903$PER$$US-TOLMAR, INC.-24US051055$TOLMAR$$75$YR$$M$Y$$$20240903$$HP$US$US
242755752$24275575$2$F$20240101$20240912$20240903$20240930$PER$$US-TOLMAR, INC.-24US051515$TOLMAR$$$$$M$Y$$$20240927$$HP$US$US
242755762$24275576$2$F$20240726$20240913$20240903$20240930$PER$$US-TOLMAR, INC.-24US051556$TOLMAR$$$$$$Y$$$20240927$$HP$US$US
242755772$24275577$2$F$20240101$20240912$20240903$20240930$PER$$US-TOLMAR, INC.-24US051516$TOLMAR$$$$$M$Y$$$20240927$$HP$US$US
242755781$24275578$1$I$$20240827$20240903$20240903$30DAY$$US-GSK-US2024106723$GLAXOSMITHKLINE$$$$$M$Y$$$20240903$$CN$US$US
242755791$24275579$1$I$$20240820$20240903$20240903$EXP$$JP-UCBSA-2024042912$UCB$$17$YR$$M$Y$$$20240903$$MD$JP$JP
242755801$24275580$1$I$20240801$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024173099$AMGEN$$$$$F$Y$$$20240902$$CN$US$US
242755811$24275581$1$I$20230101$20240827$20240903$20240903$PER$$US-ASTELLAS-2024-AER-003727$ASTELLAS$$90$YR$E$M$Y$$$20240902$$MD$US$US
242755831$24275583$1$I$20220701$20240829$20240903$20240903$PER$$US-BIOVITRUM-2024-US-011548$BIOVITRUM$$81$YR$$F$Y$$$20240903$$CN$US$US
242755841$24275584$1$I$20240220$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-086019-2024$RECKITT BENCKISER$$69$YR$$F$Y$$$20240903$$CN$US$US
242755852$24275585$2$F$20240601$20240910$20240903$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-020895$UNITED THERAPEUTICS$$49$YR$$F$Y$126.98$KG$20240917$$$US$US
242755862$24275586$2$F$$20240830$20240903$20240905$EXP$$US-AMGEN-USASP2024172988$AMGEN$$9$YR$C$F$Y$$$20240904$$MD$US$US
242755871$24275587$1$I$20240101$20240828$20240903$20240903$PER$$US-AMGEN-USASP2024172546$AMGEN$$61$YR$A$F$Y$$$20240902$$HP$US$US
242755884$24275588$4$F$20240101$20240913$20240903$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026604$UNITED THERAPEUTICS$$$$$F$Y$80.272$KG$20240921$$$US$US
242755891$24275589$1$I$20240829$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174430$AMGEN$$60$YR$A$M$Y$$$20240902$$CN$US$US
242755901$24275590$1$I$$20240825$20240903$20240903$EXP$$CN-JNJFOC-20240869960$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240903$$HP$CN$CN
242755911$24275591$1$I$20240820$20240823$20240903$20240903$PER$$US-JNJFOC-20240865111$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240903$$CN$US$US
242755922$24275592$2$F$$20240822$20240903$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137821$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$96.16$KG$20240910$$HP$US$US
242755931$24275593$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138481$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240903$$CN$US$US
242755941$24275594$1$I$$20240815$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08253$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242755951$24275595$1$I$20240730$20240808$20240903$20240903$PER$$US-ALK-ABELLO A/S-2024AA003157$ALK-ABELLO$$$$$$Y$$$20240903$$MD$US$US
242755961$24275596$1$I$$20240827$20240903$20240903$EXP$$KR-SA-2024SA252420$SANOFI AVENTIS$$$$$$Y$$$20240903$$CN$KR$KR
242755971$24275597$1$I$$20240819$20240903$20240903$EXP$$US-CorePharma LLC-2161096$COREPHARMA$Source document (FTA).$15$YR$$F$Y$49$KG$20240903$$$US$US
242755991$24275599$1$I$20240701$20240821$20240903$20240903$EXP$$US-UCBSA-2024042795$UCB$$52$YR$$F$Y$$$20240903$$HP$US$US
242756021$24275602$1$I$$20240828$20240903$20240903$PER$$US-JNJFOC-20240874230$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$CN$US$US
242756041$24275604$1$I$20240801$20240815$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08337$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242756051$24275605$1$I$$20240807$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408013047$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240903$$MD$US$US
242756061$24275606$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000203$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240903$$CN$US$US
242756071$24275607$1$I$$20240830$20240903$20240903$PER$$US-ROCHE-10000071491$ROCHE$$43$YR$A$F$Y$$$20240903$$CN$US$US
242756081$24275608$1$I$20230614$20240822$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042446$AUROBINDO$$67$YR$$M$Y$69$KG$20240903$$MD$FR$FR
242756091$24275609$1$I$$20240823$20240903$20240903$EXP$$JP-ROCHE-10000067782$ROCHE$$$$A$F$Y$$$20240903$$PH$JP$JP
242756101$24275610$1$I$20240101$20240828$20240903$20240903$EXP$$ZA-ABBVIE-5900908$ABBVIE$$67$YR$$F$Y$$$20240903$$CN$ZA$ZA
242756114$24275611$4$F$20240101$20240910$20240903$20240911$PER$$US-AMGEN-USASP2024171151$AMGEN$$62$YR$A$F$Y$$$20240911$$CN$US$US
242756121$24275612$1$I$20240801$20240830$20240903$20240903$PER$$US-AMGEN-USASL2024172686$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242756131$24275613$1$I$$20240828$20240903$20240903$EXP$$GB-SANDOZ INC.-SDZ2024GB005862$SANDOZ$$$$$F$Y$$$20240903$$CN$GB$GB
242756161$24275616$1$I$$20240808$20240903$20240903$PER$$US-JNJFOC-20240827787$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240903$$CN$US$US
242756171$24275617$1$I$20231201$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-080901-2024$RECKITT BENCKISER$$71$YR$$F$Y$$$20240903$$CN$US$US
242756181$24275618$1$I$$20240827$20240903$20240903$PER$$US-AMGEN-USASP2024172571$AMGEN$Mammen A. L.; Torres-ruiz J.; Pinal-fernandez I. et al.. Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology. 2024;42:367-376$$$$$Y$$$20240903$$HP$US$US
242756191$24275619$1$I$$20240820$20240903$20240903$PER$$US-009507513-2408USA006740$MERCK$$$$$F$Y$73.5$KG$20240903$$CN$US$US
242756201$24275620$1$I$$20240822$20240903$20240903$EXP$$JP-AMGEN-JPNSP2024173409$AMGEN$$75$YR$E$M$Y$$$20240903$$PH$JP$JP
242756211$24275621$1$I$$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173273$AMGEN$Patrizi S.T.; Tandel M.D.; Boothroyd D. et al.. Prognostic Value of the 2019 EULAR/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria to Renal Response One Year After Treatment in a Cohort With Childhood-Onset Lupus Nephritis. ACR open rheumatology. 2024;6 (8):454-462$$$$$Y$$$20240903$$HP$US$US
242756222$24275622$2$F$$20240830$20240903$20240905$PER$$US-GILEAD-2024-0685892$GILEAD$$36$YR$A$M$Y$$$20240904$$CN$US$US
242756231$24275623$1$I$$20240819$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08502$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242756241$24275624$1$I$20030101$20240826$20240903$20240903$PER$$US-JNJFOC-20150924312$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240903$$LW$US$US
242756251$24275625$1$I$20240723$20240822$20240903$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-042687$AUROBINDO$$$$E$M$Y$80$KG$20240903$$MD$DE$DE
242756262$24275626$2$F$20240722$20240912$20240903$20240925$EXP$$JP-AMGEN-JPNSP2024174078$AMGEN$$70$YR$E$F$Y$54.3$KG$20240925$$MD$JP$JP
242756271$24275627$1$I$$20240827$20240903$20240903$PER$$US-AMGEN-USASP2024171679$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242756281$24275628$1$I$$20240826$20240903$20240903$PER$$US-AMGEN-USASP2024171363$AMGEN$Charrow A.; Ebriani J.; Yoon J. et al.. High-Dose Upadacitinib Therapy for Refractory Metastatic Crohn Disease. JAMA Dermatology. 2024;160 (7):782-783$$$A$F$Y$$$20240903$$MD$US$US
242756291$24275629$1$I$20240601$20240829$20240903$20240903$PER$$US-JNJFOC-20240878202$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242756301$24275630$1$I$20240101$20240829$20240903$20240903$EXP$$CA-JNJFOC-20240637170$JOHNSON AND JOHNSON$$30$YR$A$F$Y$79$KG$20240903$$HP$CA$CA
242756311$24275631$1$I$$20240820$20240903$20240903$PER$$US-JNJFOC-20240856319$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242756331$24275633$1$I$$20240821$20240903$20240903$EXP$$PL-ASTELLAS-2024-AER-000713$ASTELLAS$$64$YR$A$M$Y$$$20240903$$PH$PL$PL
242756341$24275634$1$I$$20240902$20240903$20240903$EXP$$PT-SANDOZ INC.-SDZ2022PT000453$SANDOZ$$$$E$$Y$$$20240903$$HP$PT$PT
242756361$24275636$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-088042-2024$RECKITT BENCKISER$$$$$$Y$$$20240903$$CN$US$US
242756371$24275637$1$I$$20240821$20240903$20240903$EXP$$PL-AUROBINDO-AUR-APL-2024-042715$AUROBINDO$Nizinska I, Gattner K. Lithium intoxication in  patients using angiotensin II receptor  antagonists and hydrochlorothiazide:  two case reports.. FARMAKOTERAPIA W PSYCHIATRII I NEUROLOGII. 2024;40 (1):53-60$69$YR$$F$Y$$$20240903$$MD$PL$PL
242756381$24275638$1$I$$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408019216$ELI LILLY AND CO$$74$YR$E$$Y$$$20240903$$LW$US$US
242756392$24275639$2$F$20240815$20240910$20240903$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409000129$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240912$$CN$US$US
242756401$24275640$1$I$20240601$20240827$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408017315$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240903$$CN$US$US
242756411$24275641$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000212$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240903$$CN$US$US
242756431$24275643$1$I$$20240827$20240903$20240903$30DAY$$US-GSK-US2024106720$GLAXOSMITHKLINE$$$$$M$Y$$$20240903$$CN$US$US
242756441$24275644$1$I$20240815$20240827$20240903$20240903$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024106656$VIIV$$35$YR$$M$Y$$$20240903$$HP$US$US
242756451$24275645$1$I$$20240821$20240903$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-042584$AUROBINDO$Holzer MT, Kotter I, Xiong T, Ruffer N, Feindt FC, Melderis S, et al. Daratumumab for refractory systemic rheumatic diseases: a single center experience. Annals of the Rheumatic Diseases. 83:2133-4$31$YR$$F$Y$$$20240903$$HP$DE$DE
242756461$24275646$1$I$$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000121$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240903$$CN$US$US
242756472$24275647$2$F$$20240906$20240903$20240916$EXP$$US-TEVA-VS-3238219$TEVA$Schmalz L, Bloomer C, Zhang W, Petty W. Durable response to amivantamab in treatment refractory NSCLC harboring EGFR and complex MET mutations: A case report. Lung-Cancer 2023; 186.; Schmalz L, Bloomer C, Zhang W, Petty W. Durable response to amivantamab in treatment refractory NSCLC harboring EGFR and complex MET mutations: A case report. Lung-Cancer 2023; 186.$47$YR$$F$Y$$$20240916$$HP$US$US
242756481$24275648$1$I$20240827$20240827$20240903$20240903$PER$$US-SA-2024SA251936$SANOFI AVENTIS$$19$YR$A$M$Y$49.44$KG$20240903$$CN$US$US
242756491$24275649$1$I$20240101$20240901$20240903$20240903$PER$$US-SA-2024SA254048$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240903$$MD$US$US
242756501$24275650$1$I$20231101$20240826$20240903$20240903$PER$$US-SA-2024SA252490$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240903$$MD$US$US
242756512$24275651$2$F$20221228$20240828$20240903$20240909$EXP$$US-UCBSA-2023000172$UCB$$3$YR$$M$Y$$$20240909$$CN$US$US
242756521$24275652$1$I$$20240826$20240903$20240903$EXP$$CN-AstraZeneca-2024A196167$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$CN$
242756531$24275653$1$I$20240817$20240826$20240903$20240903$EXP$$CN-AstraZeneca-2024A196104$ASTRAZENECA$$59$YR$$F$Y$60$KG$20240903$$MD$CN$
242756541$24275654$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A195177$ASTRAZENECA$$$$$$Y$$$20240903$$CN$US$
242756561$24275656$1$I$20180625$20240821$20240903$20240903$EXP$$BE-AUROBINDO-AUR-APL-2024-042386$AUROBINDO$Sharra I;Lhoir M;Des Grottes JM;Vaes M;Guerisse F. Recurrent Fanconi Syndrome Induced by Lenalidomide. A Case Report Cureus Cureus. 2024;16 (8):e66118$59$YR$$F$Y$$$20240903$$MD$BE$BE
242756571$24275657$1$I$$20240829$20240903$20240903$PER$$US-BIOGEN-2023BI01206522$BIOGEN$$$$$F$Y$$$20240903$$CN$US$US
242756581$24275658$1$I$$20240821$20240903$20240903$EXP$$GB-AUROBINDO-AUR-APL-2024-042180$AUROBINDO$$82$YR$$F$Y$$$20240903$$HP$GB$GB
242756591$24275659$1$I$20240704$20240821$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042495$AUROBINDO$$67$YR$$M$Y$$$20240903$$PH$FR$FR
242756601$24275660$1$I$$20240826$20240903$20240903$PER$$US-BEH-2024177841$CSL BEHRING$$$$$$Y$$$20240903$$PH$US$US
242756611$24275661$1$I$$20240819$20240903$20240903$PER$$US-ASTELLAS-2024-AER-001852$ASTELLAS$$$$$M$Y$$$20240903$$HP$US$US
242756621$24275662$1$I$20170101$20240828$20240903$20240903$PER$$US-BIOGEN-2017BI00352400$BIOGEN$$49$YR$$F$Y$$$20240903$$CN$US$US
242756641$24275664$1$I$$20240829$20240903$20240903$PER$$US-ABBVIE-5901916$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242756671$24275667$1$I$20240730$20240827$20240903$20240903$EXP$$DE-EMD Serono-2024046024$EMD SERONO INC$$66$YR$E$M$Y$$$20240903$$MD$DE$DE
242756681$24275668$1$I$$20240821$20240903$20240903$EXP$$CA-AUROBINDO-AUR-APL-2024-042720$AUROBINDO$$75$YR$$M$Y$$$20240903$$CN$CA$CA
242756692$24275669$2$F$$20240928$20240903$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139534$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$83.46$KG$20240930$$CN$US$US
242756701$24275670$1$I$20240812$20240822$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042771$AUROBINDO$$31$YR$$F$Y$$$20240903$$MD$FR$FR
242756711$24275671$1$I$20240819$20240829$20240903$20240903$EXP$$CO-UCBSA-2024044701$UCB$$39$YR$$F$Y$$$20240903$$CN$CO$CO
242756721$24275672$1$I$$20240828$20240903$20240903$PER$$US-ROCHE-10000069691$ROCHE$$28$YR$A$F$Y$$$20240903$$CN$US$US
242756741$24275674$1$I$$20240901$20240903$20240903$EXP$$NVSC2024US176537$NOVARTIS$$$$$M$Y$$$20240903$$CN$US$US
242756751$24275675$1$I$$20240830$20240903$20240903$PER$$NVSC2024US176573$NOVARTIS$$$$$$Y$$$20240903$$MD$US$US
242756761$24275676$1$I$$20240819$20240903$20240903$PER$$US-JNJFOC-20240847096$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$CN$US$US
242756772$24275677$2$F$$20240909$20240903$20240916$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048493$BOEHRINGER INGELHEIM$$63$YR$A$F$Y$$$20240916$$CN$US$US
242756782$24275678$2$F$20140627$20240903$20240903$20240906$EXP$$DE-SANDOZ INC.-GXKR2014DE002631$SANDOZ$$28$YR$$M$Y$$$20240906$$MD$DE$DE
242756791$24275679$1$I$20200403$20240830$20240903$20240903$EXP$PL-URPL-1-1480-2020$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-138528$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$77$KG$20240903$$PH$PL$PL
242756801$24275680$1$I$20240830$20240830$20240903$20240903$PER$$NVSC2024US176546$NOVARTIS$$$$$M$Y$$$20240903$$CN$US$US
242756811$24275681$1$I$20240801$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174150$AMGEN$$69$YR$E$M$Y$$$20240903$$CN$US$US
242756831$24275683$1$I$20240814$20240829$20240903$20240903$EXP$$MX-ROCHE-10000070991$ROCHE$$54$YR$A$F$Y$54$KG$20240903$$CN$MX$MX
242756841$24275684$1$I$20240101$20240829$20240903$20240903$EXP$$US-ABBVIE-5901983$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242756851$24275685$1$I$$20240828$20240903$20240903$EXP$$US-AstraZeneca-2024A196261$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242756861$24275686$1$I$$20240804$20240903$20240903$PER$$US-AstraZeneca-2024A179546$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242756872$24275687$2$F$20240802$20240905$20240903$20240909$PER$$US-AMGEN-USASP2024174443$AMGEN$$77$YR$E$F$Y$$$20240909$$CN$US$US
242756881$24275688$1$I$20240829$20240829$20240903$20240903$PER$$US-AMGEN-USASL2024175149$AMGEN$$$$$M$Y$$$20240903$$CN$US$US
242756892$24275689$2$F$$20240902$20240903$20240903$EXP$$DK-SANDOZ INC.-SDZ2024DK044219$SANDOZ$$49$YR$$M$Y$$$20240903$$HP$DK$DK
242756901$24275690$1$I$20240101$20240826$20240903$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-026869$UNITED THERAPEUTICS$$$$$F$Y$58.503$KG$20240903$$$US$US
242756911$24275691$1$I$20240823$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408019022$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240903$$CN$US$US
242756921$24275692$1$I$$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000070$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240903$$CN$US$US
242756931$24275693$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000401$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240903$$CN$US$US
242756941$24275694$1$I$$20240821$20240903$20240903$EXP$$DE-AUROBINDO-AUR-APL-2022-026384$AUROBINDO$Stomper J, Richter-Pechanska P, Pfeifer D, Andolfo I, Iolascon A, Muckenthaler MU et al... Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the TRIB2 and ABCB6 genes.. BLOOD ADVANCES.. 2022;6 (1):3551-5$55$YR$$F$Y$$$20240903$$HP$DE$DE
242756951$24275695$1$I$20240726$20240827$20240903$20240903$EXP$$CN-JNJFOC-20240873952$JOHNSON AND JOHNSON$$53$YR$A$M$Y$56$KG$20240903$$HP$CN$CN
242756961$24275696$1$I$$20240829$20240903$20240903$PER$$US-JNJFOC-20240878642$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$HP$US$US
242756971$24275697$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174284$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242756981$24275698$1$I$$20240819$20240903$20240903$EXP$$FR-EPICPHARMA-FR-2024EPCLIT01048$EPIC PHARM$$40$YR$A$M$Y$$$20240903$$HP$FR$FR
242757001$24275700$1$I$20240826$20240827$20240903$20240903$EXP$$CA-JNJFOC-20240879824$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240903$$HP$CA$CA
242757011$24275701$1$I$20240215$20240826$20240903$20240903$EXP$$CA-TAKEDA-2024TUS004787$TAKEDA$$57$YR$$M$Y$$$20240903$$CN$CA$CA
242757022$24275702$2$F$20240730$20240903$20240903$20240906$EXP$$US-KYOWAKIRIN-2024KK020421$KYOWA$$$$$$Y$$$20240906$$HP$US$US
242757031$24275703$1$I$20240402$20240825$20240903$20240903$EXP$GB-MHRA-MED-202408251224011680-VNDWT$GB-THEA-2024001876$Thea Pharma$$70$YR$$M$Y$73$KG$20240903$$CN$GB$GB
242757041$24275704$1$I$20240807$20240827$20240903$20240903$EXP$FR-AFSSAPS-LM2024000467$FR-TEVA-VS-3237704$TEVA$$85$YR$$F$Y$$$20240903$$MD$FR$FR
242757051$24275705$1$I$$20240819$20240903$20240903$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25662$SAMSUNG BIOEPIS$$21$YR$A$F$Y$$$20240903$$PH$CA$CA
242757061$24275706$1$I$$20240902$20240903$20240903$EXP$$DE-SANDOZ INC.-SDZ2024DE064352$SANDOZ$$36$YR$$M$Y$$$20240903$$HP$DE$DE
242757081$24275708$1$I$$20240819$20240903$20240903$EXP$$IE-EPICPHARMA-IE-2024EPCLIT01037$EPIC PHARM$John Kelliher.Severe atypical iliac wing fracture associated with long-term bisphosphonate use.Skeletal Radiology.20-JUL-2024$63$YR$A$F$Y$$$20240903$$HP$IE$IE
242757091$24275709$1$I$20240810$20240820$20240903$20240903$EXP$$US-MDD US Operations-MDD202408-003140$MDD OPERATIONS$$58$YR$$F$Y$$$20240903$$CN$US$
242757111$24275711$1$I$20240617$20240822$20240903$20240903$EXP$SE-SEMPA-2024-006034$SE-Accord-443414$ACCORD$$70$YR$E$F$Y$48$KG$20240903$$MD$SE$SE
242757122$24275712$2$F$20240801$20240829$20240903$20240909$EXP$$US-INSMED, INC.-2024-03420-US$INSMED$$72$YR$$F$Y$$$20240909$$CN$US$US
242757131$24275713$1$I$$20240828$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138810$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240903$$CN$US$US
242757141$24275714$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139309$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$CN$US$US
242757151$24275715$1$I$20240803$20240821$20240903$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-042420$AUROBINDO$$$$$F$Y$57$KG$20240903$$MD$DE$DE
242757162$24275716$2$F$$20240828$20240903$20240905$PER$$US-CHATTEMPRD-2024OHG030105$CHATTEM$$$$$F$Y$$$20240905$$CN$US$US
242757171$24275717$1$I$$20240830$20240903$20240903$EXP$$US-TAKEDA-2023TUS052783$TAKEDA$$$$$M$Y$$$20240903$$CN$US$US
242757181$24275718$1$I$$20240827$20240903$20240903$EXP$$US-JNJFOC-20240805117$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240903$$CN$US$US
242757191$24275719$1$I$$20240820$20240903$20240903$EXP$GB-MYLANLABS-2024M1048983$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19621$ALKEM$$$$$F$Y$$$20240903$$MD$GB$GB
242757202$24275720$2$F$20240801$20240827$20240903$20240910$EXP$$GB-UCBSA-2024042666$UCB$$80$YR$$F$Y$$$20240910$$CN$GB$GB
242757211$24275721$1$I$20230301$20240827$20240903$20240903$EXP$$CA-JNJFOC-20230120770$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240903$$HP$CA$CA
242757221$24275722$1$I$20190612$20240829$20240903$20240903$EXP$$CO-UCBSA-2024044691$UCB$$72$YR$$M$Y$$$20240903$$CN$CO$CO
242757251$24275725$1$I$20230505$20240830$20240903$20240903$EXP$$CA-GSK-CA2023067471$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$HP$CA$CA
242757261$24275726$1$I$20240113$20240827$20240903$20240903$EXP$$AU-TAKEDA-2024TUS004270$TAKEDA$$89$YR$$M$Y$$$20240903$$CN$AU$AU
242757271$24275727$1$I$$20240828$20240903$20240903$EXP$$CA-APOTEX-2024AP010078$APOTEX$$77$YR$$M$Y$$$20240903$$CN$CA$CA
242757281$24275728$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA050447$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240903$$MD$US$US
242757291$24275729$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000520$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240903$$CN$US$US
242757301$24275730$1$I$20240803$20240826$20240903$20240903$EXP$$DE-EMD Serono-2024045779$EMD SERONO INC$$$$$F$Y$57$KG$20240903$$MD$DE$DE
242757311$24275731$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000285$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240903$$CN$US$US
242757321$24275732$1$I$20240701$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000297$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240903$$CN$US$US
242757331$24275733$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000740$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240903$$CN$US$US
242757341$24275734$1$I$$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000131$ELI LILLY AND CO$$$$$$Y$$$20240903$$HP$US$US
242757351$24275735$1$I$20240829$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000187$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240903$$CN$US$US
242757361$24275736$1$I$20240830$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000110$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240903$$CN$US$US
242757371$24275737$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000252$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240903$$CN$US$US
242757382$24275738$2$F$20230821$20240905$20240903$20240912$EXP$$DE-SA-2024SA254473$SANOFI AVENTIS$$18$YR$A$F$Y$53$KG$20240912$$CN$DE$DE
242757401$24275740$1$I$$20240819$20240903$20240903$EXP$$JP-EPICPHARMA-JP-2024EPCLIT01043$EPIC PHARM$Morisaki Y.Intraoperative monitoring of trigeminal neuralgia.Acta Neurochirurgica.DEC-2024;166 (1):1-5$7$DEC$E$F$Y$$$20240903$$HP$JP$JP
242757413$24275741$3$F$$20240912$20240903$20240918$EXP$$JP-SA-2024SA253651$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240918$$MD$JP$JP
242757421$24275742$1$I$$20240828$20240903$20240903$EXP$$HR-AMGEN-HRVSP2024172623$AMGEN$$$$$M$Y$$$20240903$$MD$HR$HR
242757431$24275743$1$I$20240609$20240826$20240903$20240903$EXP$$SG-UCBSA-2024044681$UCB$$38$YR$$M$Y$$$20240903$$HP$SG$SG
242757441$24275744$1$I$20240101$20240820$20240903$20240903$PER$$US-SA-2024SA251895$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240903$$MD$US$US
242757451$24275745$1$I$20240101$20240821$20240903$20240903$PER$$US-SA-2024SA252231$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240903$$MD$US$US
242757462$24275746$2$F$$20240924$20240903$20240930$EXP$$AR-ROCHE-10000068658$ROCHE$$50$YR$A$F$Y$$$20240929$$MD$AR$AR
242757482$24275748$2$F$20240101$20240905$20240903$20240917$EXP$$US-INSMED, INC.-2024-00601-US$INSMED$$$$$M$Y$$$20240917$$HP$US$US
242757491$24275749$1$I$20240821$20240827$20240903$20240903$EXP$$US-ABBVIE-5898318$ABBVIE$$49$YR$$M$Y$$$20240903$$CN$US$US
242757501$24275750$1$I$$20240829$20240903$20240903$EXP$NL-LRB-00999247$NL-TEVA-VS-3238564$TEVA$$74$YR$$M$Y$84$KG$20240903$$CN$NL$NL
242757521$24275752$1$I$20240205$20240826$20240903$20240903$EXP$$FR-AstraZeneca-2024A193711$ASTRAZENECA$$62$YR$$F$Y$61$KG$20240903$$MD$FR$
242757531$24275753$1$I$20230616$20240829$20240903$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-138823$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240903$$MD$JP$JP
242757541$24275754$1$I$$20240826$20240903$20240903$EXP$$NVSC2024KR174418$NOVARTIS$$59$YR$$F$Y$$$20240903$$MD$KR$KR
242757551$24275755$1$I$$20240828$20240903$20240903$EXP$$CA-ROCHE-10000069524$ROCHE$$27$YR$A$M$Y$$$20240903$$HP$CA$CA
242757561$24275756$1$I$20240809$20240827$20240903$20240903$EXP$$JP-ASTELLAS-2024-AER-002745$ASTELLAS$$78$YR$E$$Y$$$20240903$$PH$JP$JP
242757571$24275757$1$I$$20240821$20240903$20240903$EXP$$IL-ASTELLAS-2024-AER-001111$ASTELLAS$$81$YR$E$M$Y$$$20240903$$MD$IL$IL
242757581$24275758$1$I$$20240826$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US077086$SANDOZ$$$$$$Y$$$20240903$$CN$US$US
242757592$24275759$2$F$$20240827$20240903$20240906$EXP$$US-GSK-US2024106570$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242757603$24275760$3$F$20240822$20240902$20240903$20240909$EXP$$JP-009507513-2408JPN003342J$MERCK$$70$YR$$M$Y$$$20240909$$MD$JP$JP
242757611$24275761$1$I$20240830$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174380$AMGEN$$61$YR$A$F$Y$$$20240903$$CN$US$US
242757621$24275762$1$I$20240830$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174824$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242757631$24275763$1$I$20240830$20240901$20240903$20240903$PER$$US-AMGEN-USASP2024174754$AMGEN$$66$YR$E$M$Y$$$20240903$$CN$US$US
242757641$24275764$1$I$$20240829$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139579$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240903$$CN$US$US
242757651$24275765$1$I$$20240830$20240903$20240903$EXP$$JP-GSK-JP2024108735$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$MD$JP$JP
242757681$24275768$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000450$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240903$$CN$US$US
242757691$24275769$1$I$$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018397$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240903$$CN$US$US
242757701$24275770$1$I$$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000008$ELI LILLY AND CO$$$$$$Y$$$20240903$$CN$US$US
242757711$24275771$1$I$20240816$20240820$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408013695$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240903$$CN$US$US
242757721$24275772$1$I$20240830$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000384$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240903$$CN$US$US
242757731$24275773$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000229$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240903$$CN$US$US
242757741$24275774$1$I$$20240830$20240903$20240903$PER$$US-JNJFOC-20240881077$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$MD$US$US
242757751$24275775$1$I$20240701$20240826$20240903$20240903$EXP$$CA-SA-2024SA252602$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240903$$CN$CA$CA
242757761$24275776$1$I$$20240822$20240903$20240903$EXP$$PT-AUROBINDO-AUR-APL-2024-042805$AUROBINDO$Marques D. et al.. CO-0096 - (4705) - HIPOTENS?O ORTOST?TICA REFRAT?RIA - ABORDAGEM E TRATAMENTO.. Congressos da Sociedade Portuguesa de Medicina Interna: 30.o Congresso Nacional.. 2024;30:197$83$YR$$F$Y$$$20240903$$MD$PT$PT
242757771$24275777$1$I$$20240819$20240903$20240903$EXP$$IN-EPICPHARMA-IN-2024EPCLIT01038$EPIC PHARM$Avadhesh Oli.Unusual clinical features and histopathological findings in a case of  Pseudo-endophthalmitis in neovascular glaucoma.Romanian Journal of Ophthalmology.APR-2024;68(2):182-186$56$YR$A$M$Y$$$20240903$$MD$IN$IN
242757781$24275778$1$I$$20240819$20240903$20240903$PER$$US-ASTELLAS-2024-AER-002044$ASTELLAS$$72$YR$E$M$Y$$$20240903$$CN$US$US
242757791$24275779$1$I$$20240830$20240903$20240903$PER$$NVSC2024US175379$NOVARTIS$$$$$F$Y$$$20240903$$MD$US$US
242757801$24275780$1$I$20240826$20240828$20240903$20240903$PER$$US-009507513-2408USA009751$MERCK$$72$YR$$F$Y$$$20240903$$CN$US$US
242757812$24275781$2$F$20240806$20240920$20240903$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024106695$VIIV$$55$YR$$M$Y$97.778$KG$20240930$$MD$US$US
242757821$24275782$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194182$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242757831$24275783$1$I$20240824$20240902$20240903$20240903$EXP$FR-AFSSAPS-TO2024001663$FR-SANDOZ INC.-SDZ2024FR076924$SANDOZ$$24$YR$$M$Y$$$20240903$$PH$FR$FR
242757841$24275784$1$I$20240825$20240901$20240903$20240903$EXP$$EG-SANDOZ INC.-SDZ2024EG076927$SANDOZ$$5$YR$$M$Y$$$20240903$$CN$EG$EG
242757851$24275785$1$I$$20240416$20240903$20240903$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-08854$ALKEM$$$$$F$Y$$$20240903$$CN$US$US
242757861$24275786$1$I$$20240521$20240903$20240903$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-11506$ALKEM$$$$$M$Y$$$20240903$$CN$US$US
242757871$24275787$1$I$20230721$20231031$20240903$20240903$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-08824$ALKEM$$$$$M$Y$$$20240903$$CN$US$US
242757881$24275788$1$I$$20240821$20240903$20240903$EXP$$FR-WOCKHARDT BIO AG-2024WBA000018$WOCKHARDT BIO AG$Eid R, Zamparini E, Ouchrif Y, Snanoudj R, Ottolenghi C, Zaidan M.. A case report of Paracetamol related pyroglutamic acidosis: mind the gap in a malnourished patient.. BMC Nephrol.. 2024;25(1):260$67$YR$$M$Y$$$20240830$$HP$FR$FR
242757891$24275789$1$I$$20240828$20240903$20240903$PER$$US-AMGEN-USASP2024173759$AMGEN$Cheung A.Y.; Mansur S.. Treatment of Corneal Neovascularization Before Deep Anterior Lamellar Keratoplasty. Cornea. 2024;1-6$71$YR$E$F$Y$$$20240903$$MD$US$US
242757901$24275790$1$I$$20240828$20240903$20240903$PER$$US-AMGEN-USASP2024173621$AMGEN$Cheung A.Y.; Mansur S.. Treatment of Corneal Neovascularization Before Deep Anterior Lamellar Keratoplasty. Cornea. 2024;1-6$57$YR$A$F$Y$$$20240903$$MD$US$US
242757911$24275791$1$I$$20240828$20240903$20240903$EXP$$US-JNJFOC-20240876785$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240903$$HP$US$US
242757921$24275792$1$I$20240807$20240828$20240903$20240903$EXP$$CA-JNJFOC-20240880161$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240903$$HP$CA$CA
242757931$24275793$1$I$$20240828$20240903$20240903$EXP$$ZA-JNJFOC-20240877656$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$MD$ZA$ZA
242757941$24275794$1$I$$20240826$20240903$20240903$EXP$US-MLMSERVICE-20240820-PI146989-00117-2$US-RDY-SPO/USA/24/0012521$DR REDDYS$Peshin S, Modi SK, Burwick N. Lenalidomide and Dexamethasone in Scleromyxedema: A Case Report of Long-Term Efficacy and Challenges in a 54-Year-Old Patient. Cureus. 2024;16(6):e63181. DOI:10.7759/cureus.63181.$$$A$M$Y$$$20240903$$MD$US$US
242757951$24275795$1$I$$20240826$20240903$20240903$EXP$$FR-CELLTRION INC.-2024FR020624$CELLTRION$$$$$$Y$$$20240903$$HP$FR$FR
242757963$24275796$3$F$20240823$20240911$20240903$20240913$PER$$US-AMGEN-USASP2024174566$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
242757971$24275797$1$I$$20240819$20240903$20240903$EXP$$DE-EPICPHARMA-DE-2024EPCLIT01039$EPIC PHARM$Veit Rothhammer.Case report: Cerebrospinal fluid neutrophilic pleocytosis upon intrathecal triamcinolone injection.Frontiers in Neurology.23-APR-2024;15:1-5$76$YR$E$F$Y$$$20240903$$HP$DE$DE
242757982$24275798$2$F$$20240904$20240903$20240913$EXP$$US-TAKEDA-2024TUS086156$TAKEDA$$$$$M$Y$$$20240913$$CN$US$US
242757991$24275799$1$I$$20240828$20240903$20240903$EXP$$GB-AMGEN-GBRSP2024173971$AMGEN$$90$YR$E$F$Y$$$20240903$$CN$GB$GB
242758001$24275800$1$I$20240830$20240830$20240903$20240903$PER$$US-ALXN-202408USA002153US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242758011$24275801$1$I$20240812$20240829$20240903$20240903$PER$$US-ABBVIE-5901795$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242758021$24275802$1$I$20240819$20240828$20240903$20240903$EXP$$CN-ROCHE-10000068981$ROCHE$$59$YR$A$M$Y$$$20240903$$CN$CN$CN
242758031$24275803$1$I$$20240828$20240903$20240903$EXP$$JP-SA-2024SA251430$SANOFI AVENTIS$$$$$M$Y$$$20240903$$CN$JP$JP
242758041$24275804$1$I$20240819$20240826$20240903$20240903$EXP$$US-SA-2024SA253046$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240903$$MD$US$US
242758051$24275805$1$I$20240101$20240829$20240903$20240903$PER$$US-ABBVIE-5902697$ABBVIE$$$$$$Y$$$20240903$$CN$US$US
242758061$24275806$1$I$20240805$20240829$20240903$20240903$EXP$IT-MINISAL02-999895$IT-009507513-2408ITA010470$MERCK$$69$YR$$F$Y$75$KG$20240903$$MD$IT$IT
242758071$24275807$1$I$$20240829$20240903$20240903$PER$$US-ABBVIE-5902122$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242758081$24275808$1$I$$20240902$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US076973$SANDOZ$$75$YR$$M$Y$$$20240903$$MD$US$US
242758091$24275809$1$I$$20240828$20240903$20240903$EXP$$US-CHEPLA-2024011178$CHEPLAPHARM$$$$$F$Y$$$20240903$$CN$COUNTRY NOT SPECIFIED$US
242758101$24275810$1$I$$20240823$20240903$20240903$30DAY$$US-GSK-US2024105574$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$CN$US$US
242758111$24275811$1$I$$20240828$20240903$20240903$EXP$$BR-CHEPLA-2024011165$CHEPLAPHARM$$$$$F$Y$$$20240903$$CN$COUNTRY NOT SPECIFIED$BR
242758122$24275812$2$F$20090101$20240911$20240903$20240918$EXP$$MX-CHEPLA-2024011120$CHEPLAPHARM$$52$YR$$F$Y$101.4$KG$20240918$$CN$COUNTRY NOT SPECIFIED$MX
242758131$24275813$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174913$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242758141$24275814$1$I$$20240823$20240903$20240903$EXP$$AU-AMGEN-AUSSP2024174975$AMGEN$$$$$M$Y$$$20240903$$MD$AU$AU
242758151$24275815$1$I$$20240821$20240903$20240903$EXP$$DE-AMNEAL PHARMACEUTICALS-2024-AMRX-03191$AMNEAL$$$$$$Y$$$20240903$$MD$DE$DE
242758161$24275816$1$I$$20240828$20240903$20240903$EXP$$TH-ROCHE-10000068309$ROCHE$$$$$F$Y$$$20240903$$CN$TH$TH
242758171$24275817$1$I$$20240710$20240903$20240903$PER$$US-ABBVIE-5896635$ABBVIE$$$$$$Y$$$20240903$$CN$US$US
242758181$24275818$1$I$$20240830$20240903$20240903$EXP$$US-ROCHE-10000064720$ROCHE$$81$YR$E$M$Y$$$20240903$$MD$US$US
242758191$24275819$1$I$$20240819$20240903$20240903$EXP$$US-EPICPHARMA-US-2024EPCLIT01045$EPIC PHARM$Priyanka M. Mathias.Iatrogenic Cushing^s Syndrome following Epidural Steroid Injections in an HIV-Infected Patient on Treatment with Genvoya.Journal of the Endocrine Society.15-APR-2020;6(No. 5):1-4$76$YR$E$F$Y$$$20240903$$MD$US$US
242758201$24275820$1$I$$20240826$20240903$20240903$EXP$$JP-ADVANZ PHARMA-202408007127$ADVANZ PHARMA$$$$$$Y$$$20240903$$HP$JP$JP
242758211$24275821$1$I$$20240821$20240903$20240903$EXP$$US-FARMAPROD-202407-2575$DOMPE FARMACEUTICI$$$$A$F$Y$62.6$KG$20240902$$CN$US$US
242758221$24275822$1$I$20240801$20240828$20240903$20240903$PER$$US-AMGEN-USASP2024173354$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242758241$24275824$1$I$$20240829$20240903$20240903$PER$$US-LEO Pharma-373186$LEO PHARM$$70$YR$$F$Y$$$20240903$$PH$US$US
242758251$24275825$1$I$20210210$20240826$20240903$20240903$EXP$$KR-AMGEN-KORSP2024172393$AMGEN$$71$YR$E$M$Y$$$20240903$$HP$KR$KR
242758261$24275826$1$I$20240826$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174063$AMGEN$$73$YR$E$F$Y$$$20240903$$CN$US$US
242758271$24275827$1$I$$20240826$20240903$20240903$PER$$US-ABBVIE-5900709$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242758282$24275828$2$F$$20240822$20240903$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465021$RANBAXY$Aiello M, Roy S, Chitty L, Johnson B, Warrick M. Prolonged administration of intrathecal baclofen in a patient with generalized grade 4 tetanus. Region Anesth Pain Med. 2024;49 (7):540-542$62$YR$$F$Y$$$20240906$$HP$US$US
242758291$24275829$1$I$$20240830$20240903$20240903$PER$$US-AstraZeneca-2024A198357$ASTRAZENECA$$65$YR$$$Y$$$20240903$$CN$US$
242758301$24275830$1$I$20240823$20240827$20240903$20240903$EXP$$US-VIIV HEALTHCARE LIMITED-US2024107359$VIIV$$$$$$Y$$$20240903$$PH$US$US
242758311$24275831$1$I$$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000117$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240903$$CN$US$US
242758321$24275832$1$I$20240829$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000533$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240903$$CN$US$US
242758332$24275833$2$F$$20240830$20240903$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408019101$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240905$$CN$US$US
242758341$24275834$1$I$$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000454$ELI LILLY AND CO$$$$$F$Y$$$20240903$$CN$US$US
242758361$24275836$1$I$20180101$20240811$20240903$20240903$PER$$US-AMGEN-USASP2024164918$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$F$Y$$$20240903$$MD$US$US
242758371$24275837$1$I$20240827$20240829$20240903$20240903$PER$$US-ALXN-202408USA002048US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242758381$24275838$1$I$$20240830$20240903$20240903$PER$$US-ALXN-202408USA002133US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242758391$24275839$1$I$$20240828$20240903$20240903$EXP$$US-ALXN-202408USA002033US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242758401$24275840$1$I$$20240819$20240903$20240903$EXP$$CN-EPICPHARMA-CN-2024EPCLIT01047$EPIC PHARM$Xiaolan Ye.The culprit of uncontrolled hypertension: A case of monoamine oxidase inhibitor and clonidine interaction.Revista Portuguesa de Cardiologia.2024;43:223-224$64$YR$A$M$Y$$$20240903$$HP$CN$CN
242758411$24275841$1$I$20160101$20240827$20240903$20240903$EXP$$DE-SANDOZ INC.-SDZ2024DE076284$SANDOZ$$80$YR$$F$Y$$$20240903$$CN$DE$DE
242758421$24275842$1$I$20240301$20240829$20240903$20240903$EXP$$SG-ROCHE-10000070342$ROCHE$$33$YR$A$F$Y$$$20240903$$CN$SG$SG
242758431$24275843$1$I$$20240826$20240903$20240903$EXP$$JP-MSNLABS-2024MSNLIT01883$MSN LABORATORIES$Yamada K, Ida-Ichikawa M, Fujimoto N, Ishida M, Dohi K.Takotsubo syndrome in a cancer patient treated with a combination of anti-cancer drugs including immune checkpoint inhibitors: a case report.European Heart Journal-Case Reports.2024;8(8):1-5$$$$$Y$$$20240903$$HP$JP$JP
242758441$24275844$1$I$20240701$20240821$20240903$20240903$EXP$$US-UCBSA-2024042881$UCB$$37$YR$$F$Y$$$20240903$$HP$US$US
242758451$24275845$1$I$20240723$20240829$20240903$20240903$EXP$DK-DKMA-30737845$DK-CHEPLA-2024011219$CHEPLAPHARM$$25$YR$$M$Y$$$20240903$$MD$COUNTRY NOT SPECIFIED$DK
242758471$24275847$1$I$20240626$20240829$20240903$20240903$EXP$FR-AFSSAPS-AM2024000689$FR-CHEPLA-2024011183$CHEPLAPHARM$$61$YR$$F$Y$44$KG$20240903$$MD$COUNTRY NOT SPECIFIED$FR
242758481$24275848$1$I$20240101$20240829$20240903$20240903$EXP$FR-AFSSAPS-MP2024001310$FR-CHEPLA-2024011220$CHEPLAPHARM$$31$YR$$F$Y$$$20240903$$MD$COUNTRY NOT SPECIFIED$FR
242758491$24275849$1$I$20240816$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139571$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240903$$CN$US$US
242758501$24275850$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139127$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240903$$CN$US$US
242758511$24275851$1$I$$20240828$20240903$20240903$PER$$US-HALEON-2194138$Haleon PLC$$$$$F$Y$$$20240903$$CN$US$US
242758531$24275853$1$I$$20240821$20240903$20240903$EXP$$JP-SA-2016SA181352$SANOFI AVENTIS$Hirai I, Funakoshi T.. Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget^s disease.. Journal of Dermatology. 2017;44(10):1148-51$65$YR$E$M$Y$$$20240903$$MD$JP$JP
242758541$24275854$1$I$20240819$20240828$20240903$20240903$EXP$GB-MHRA-MED-202408282331429150-DRMKB$GB-TAKEDA-2024TUS087258$TAKEDA$$41$YR$$F$Y$$$20240903$$HP$GB$GB
242758552$24275855$2$F$20240829$20240905$20240903$20240909$PER$$US-AMGEN-USASP2024174334$AMGEN$$87$YR$E$M$Y$$$20240909$$CN$US$US
242758562$24275856$2$F$$20240906$20240903$20240916$EXP$$IT-TEVA-VS-3238681$TEVA$Frattari A, De Angelis MV, Battilana M, Polilli E, Ferrieri A, Onofrillo D, et al. High viral load VZV encephalitis complicated by super refractory status epilepticus in a vaccinated child with in Acute Lymphocytic Leukemia: Case report and review of the literature. Neuroimmunol-Rep 2024; 6 (0): no pagination.; Frattari A, De Angelis MV, Battilana M, Polilli E, Ferrieri A, Onofrillo D, et al. High viral load VZV encephalitis complicated by super refractory status epilepticus in a vaccinated c...$6$YR$$M$Y$$$20240916$$HP$IT$IT
242758571$24275857$1$I$20180101$20240811$20240903$20240903$PER$$US-AMGEN-USASP2024164919$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$F$Y$$$20240903$$MD$US$US
242758581$24275858$1$I$$20240828$20240903$20240903$PER$$US-AMGEN-USASP2024174782$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242758591$24275859$1$I$$20240814$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08250$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242758601$24275860$1$I$20240101$20240827$20240903$20240903$EXP$$NVSC2024DE175552$NOVARTIS$$51$YR$$F$Y$$$20240903$$HP$DE$DE
242758611$24275861$1$I$20240821$20240822$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136091$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$95.25$KG$20240903$$CN$US$US
242758621$24275862$1$I$$20240826$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135433$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240903$$CN$US$US
242758631$24275863$1$I$20240807$20240820$20240903$20240903$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK093562$GLENMARK$$$$$$Y$$$20240903$$HP$GB$GB
242758641$24275864$1$I$$20240829$20240903$20240903$PER$$US-JNJFOC-20240877475$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$HP$US$US
242758661$24275866$1$I$$20231221$20240903$20240903$EXP$$US-TEVA-VS-3232738$TEVA$$78$YR$$F$Y$$$20240903$$CN$US$US
242758691$24275869$1$I$20240719$20240829$20240903$20240903$EXP$NO-NOMAADVRE-PASRAPP-2024-V37rdd$NO-TAKEDA-2024TUS087092$TAKEDA$$31$YR$$F$Y$57$KG$20240903$$HP$NO$NO
242758702$24275870$2$F$20240717$20240906$20240903$20240916$EXP$$JP-AMGEN-JPNSP2024174838$AMGEN$$68$YR$E$F$Y$$$20240916$$HP$JP$JP
242758711$24275871$1$I$$20240822$20240903$20240903$EXP$$US-Accord-443878$ACCORD$$49$YR$A$M$Y$$$20240903$$HP$US$US
242758721$24275872$1$I$20240101$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174576$AMGEN$$85$YR$E$F$Y$$$20240903$$CN$US$US
242758731$24275873$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194247$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242758741$24275874$1$I$$20240829$20240903$20240903$EXP$$US-TAKEDA-2024TUS087500$TAKEDA$$$$$F$Y$$$20240903$$CN$US$US
242758751$24275875$1$I$20240201$20240808$20240903$20240903$PER$$US-BEIGENE-BGN-2024-012544$BEIGENE$$$$$$Y$$$20240903$$CN$US$US
242758761$24275876$1$I$20240801$20240828$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US077081$SANDOZ$$63$YR$$F$Y$$$20240903$$CN$US$US
242758771$24275877$1$I$$20240814$20240903$20240903$PER$$US-TEVA-VS-3235131$TEVA$$34$YR$$M$Y$$$20240903$$CN$US$US
242758781$24275878$1$I$20240818$20240830$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139510$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240903$$HP$US$US
242758791$24275879$1$I$20240723$20240823$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136046$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$65.32$KG$20240903$$HP$US$US
242758811$24275881$1$I$$20240827$20240903$20240903$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-137012$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$PH$DE$DE
242758821$24275882$1$I$$20240829$20240903$20240903$EXP$$CA-JNJFOC-20240879970$JOHNSON AND JOHNSON$$17$YR$T$F$Y$48$KG$20240903$$HP$CA$CA
242758831$24275883$1$I$20240101$20240829$20240903$20240903$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-138874$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$68.04$KG$20240903$$CN$PR$PR
242758841$24275884$1$I$20240821$20240823$20240903$20240903$EXP$$JP-TERSERA THERAPEUTICS LLC-2024TRS004406$TERSERA THERAPEUTICS$$$$$$Y$$$20240903$$CN$JP$JP
242758851$24275885$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174954$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242758861$24275886$1$I$20240826$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173388$AMGEN$$$$$M$Y$$$20240903$$CN$US$US
242758871$24275887$1$I$20240820$20240822$20240903$20240903$EXP$$US-Accord-443597$ACCORD$$30$YR$A$F$Y$$$20240903$$HP$US$US
242758881$24275888$1$I$20240614$20240823$20240903$20240903$EXP$$ES-AUROBINDO-AUR-APL-2024-042908$AUROBINDO$$91$YR$$F$Y$$$20240903$$MD$ES$ES
242758891$24275889$1$I$$20240829$20240903$20240903$EXP$$IT-TAKEDA-2024TUS087168$TAKEDA$$$$N$$Y$1.9$KG$20240903$$HP$IT$IT
242758901$24275890$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000393$ELI LILLY AND CO$$$$$F$Y$$$20240903$$CN$US$US
242758911$24275891$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5901689$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242758921$24275892$1$I$20240829$20240829$20240903$20240903$EXP$$US-ABBVIE-5904014$ABBVIE$$69$YR$$M$Y$$$20240903$$CN$US$US
242758932$24275893$2$F$20230701$20240903$20240903$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-042931$AUROBINDO$$32$YR$$M$Y$78$KG$20240913$$CN$FR$FR
242758941$24275894$1$I$20240810$20240822$20240903$20240903$EXP$$ES-AUROBINDO-AUR-APL-2024-042625$AUROBINDO$$92$YR$$M$Y$$$20240903$$MD$ES$ES
242758952$24275895$2$F$$20240923$20240903$20240927$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001759$BLUEPRINT MEDICINES$$$$$M$Y$$$20240927$$MD$US$US
242758961$24275896$1$I$$20240822$20240903$20240903$EXP$$IT-AUROBINDO-AUR-APL-2024-042792$AUROBINDO$D^Angelo E. R., Tauriello A., Magagnoli M., Tabo G., Scarzella M, Morabito B. et al... The active role of the caregiver in managing the drug therapy of a schizophrenic patient. Evidence Based -. Italian Journal of Psychiatry. 2024;10 (3)$57$YR$$M$Y$$$20240903$$MD$IT$IT
242758982$24275898$2$F$20240801$20240904$20240903$20240913$EXP$$CA-CELLTRION INC.-2024CA004116$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
242758991$24275899$1$I$$20240830$20240903$20240903$EXP$$US-GILEAD-2024-0685962$GILEAD$$$$E$M$Y$$$20240903$$CN$US$US
242759011$24275901$1$I$$20240825$20240903$20240903$PER$$US-ABBVIE-5895107$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242759021$24275902$1$I$20240805$20240826$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136152$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240903$$HP$US$US
242759031$24275903$1$I$20240822$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138638$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$88.18$KG$20240903$$PH$US$US
242759041$24275904$1$I$20240319$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-087280-2024$RECKITT BENCKISER$$$$$M$Y$$$20240903$$CN$US$US
242759051$24275905$1$I$20240830$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024175110$AMGEN$$23$YR$A$M$Y$$$20240903$$CN$US$US
242759061$24275906$1$I$$20240828$20240903$20240903$EXP$$JP-009507513-2408JPN004081J$MERCK$$6$DEC$$F$Y$$$20240903$$MD$JP$JP
242759071$24275907$1$I$$20240828$20240903$20240903$PER$$US-009507513-2408USA010391$MERCK$$$$C$$Y$$$20240903$$HP$US$US
242759081$24275908$1$I$$20240830$20240903$20240903$EXP$$CA-GILEAD-2024-0685936$GILEAD$$5$MON$I$F$Y$$$20240903$$HP$CA$CA
242759091$24275909$1$I$$20240826$20240903$20240903$PER$$US-ALXN-202408USA001770US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242759111$24275911$1$I$$20240826$20240903$20240903$PER$$US-ALXN-202408USA001720US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242759121$24275912$1$I$$20240826$20240903$20240903$PER$$US-ALXN-202408USA001688US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242759131$24275913$1$I$$20240823$20240903$20240903$PER$$US-ALXN-202408USA001671US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242759141$24275914$1$I$$20240823$20240903$20240903$PER$$US-ALXN-202408USA001692US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242759151$24275915$1$I$$20240821$20240903$20240903$PER$$US-ALXN-202408USA001579US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240829$$CN$US$US
242759161$24275916$1$I$$20240823$20240903$20240903$PER$$US-ALXN-202408USA001672US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242759171$24275917$1$I$20240823$20240823$20240903$20240903$PER$$US-ALXN-202408USA001644US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240829$$CN$US$US
242759191$24275919$1$I$20240512$20240829$20240903$20240903$EXP$$CO-UCBSA-2024044675$UCB$$66$YR$$M$Y$$$20240903$$CN$CO$CO
242759201$24275920$1$I$$20240828$20240903$20240903$PER$$US-JNJFOC-20240877821$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240903$$CN$US$US
242759211$24275921$1$I$$20240129$20240903$20240903$PER$$US-AUROBINDO-AUR-APL-2024-005543$AUROBINDO$$$$$F$Y$$$20240903$$CN$US$US
242759222$24275922$2$F$20240201$20240912$20240903$20240918$PER$$US-AMGEN-USASP2024174449$AMGEN$$77$YR$E$F$Y$$$20240918$$PH$US$US
242759232$24275923$2$F$20240101$20240904$20240903$20240916$EXP$$US-INSMED-2024-02936-USAA$INSMED$$$$$M$Y$$$20240916$$CN$US$US
242759242$24275924$2$F$$20240905$20240903$20240915$EXP$$NL-AUROBINDO-AUR-APL-2024-042708$AUROBINDO$$32$YR$$F$Y$58$KG$20240915$$CN$NL$NL
242759251$24275925$1$I$20210601$20230802$20240903$20240903$PER$$US-AUROBINDO-AUR-APL-2023-052402$AUROBINDO$$71$YR$$F$Y$70.3$KG$20240903$$CN$US$US
242759261$24275926$1$I$$20240422$20240903$20240903$PER$$US-AUROBINDO-AUR-APL-2024-021139$AUROBINDO$$$$E$F$Y$72.574$KG$20240903$$CN$US$US
242759271$24275927$1$I$$20240827$20240903$20240903$EXP$$NVSC2024BG175603$NOVARTIS$Drenovska K, Valeva E, Shahid M, Vassileva S. Case report: Coexistence of bullous pemphigoid and psoriasis: Therapeutic challenge and IL17A-targeted parallel treatment strategy. FRONTIERS IN MEDICINE. 2023;1-7$71$YR$$F$Y$$$20240903$$HP$BG$BG
242759281$24275928$1$I$20240817$20240824$20240903$20240903$EXP$GB-MHRA-MED-202408241725483310-JZPSM$GB-TEVA-VS-3237253$TEVA$$71$YR$$M$Y$73$KG$20240903$$CN$GB$GB
242759301$24275930$1$I$$20240823$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042923$AUROBINDO$$$DY$$M$Y$3.378$KG$20240903$$HP$FR$FR
242759311$24275931$1$I$20240824$20240824$20240903$20240903$EXP$GB-MHRA-MED-202408241712263180-RYDCL$GB-TEVA-VS-3237376$TEVA$$80$YR$$F$Y$$$20240903$$CN$GB$GB
242759321$24275932$1$I$$20240827$20240903$20240903$EXP$$JP-AMGEN-JPNSP2024173584$AMGEN$$$$E$$Y$$$20240903$$MD$JP$JP
242759331$24275933$1$I$$20240829$20240903$20240903$PER$$US-AstraZeneca-2024A198081$ASTRAZENECA$$$$$$Y$$$20240903$$CN$US$
242759341$24275934$1$I$$20240819$20240903$20240903$EXP$$CN-Techdow-2024Techdow000184$SHENZHEN TECHDOW PHARMACEUTICAL$Zou Q, Jiang C, Lin P, Yu Y, Li J, Zhao F, et al. Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period. Frontiers in Cardiovascular Medicine. 2024 Jul 23;11.$59$YR$A$M$Y$50$KG$20240903$$MD$CN$CN
242759351$24275935$1$I$$20240826$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137200$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240903$$HP$US$US
242759361$24275936$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138215$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$57.61$KG$20240903$$CN$US$US
242759372$24275937$2$F$20240101$20240906$20240903$20240912$PER$$US-AMGEN-USASP2024173437$AMGEN$$56$YR$A$F$Y$$$20240912$$HP$US$US
242759391$24275939$1$I$20240730$20240822$20240903$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-042685$AUROBINDO$$66$YR$$M$Y$$$20240903$$MD$DE$DE
242759401$24275940$1$I$20240806$20240823$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042925$AUROBINDO$$72$YR$$M$Y$$$20240903$$MD$FR$FR
242759411$24275941$1$I$20240801$20240823$20240903$20240903$EXP$$BE-AUROBINDO-AUR-APL-2024-042820$AUROBINDO$$$$$F$Y$$$20240903$$PH$BE$BE
242759422$24275942$2$F$20240101$20240913$20240903$20240917$PER$$US-BIOGEN-2024BI01277656$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
242759432$24275943$2$F$20240111$20240827$20240903$20240909$EXP$$DE-ROCHE-10000068225$ROCHE$$42$YR$A$M$Y$174$KG$20240909$$MD$DE$DE
242759441$24275944$1$I$20240827$20240829$20240903$20240903$EXP$$CZ-GILEAD-2024-0685459$GILEAD$$$$$F$Y$$$20240903$$MD$CZ$CZ
242759462$24275946$2$F$20240828$20240903$20240903$20240904$PER$$US-AMGEN-USASP2024174603$AMGEN$$60$YR$A$M$Y$$$20240904$$CN$US$US
242759472$24275947$2$F$20240827$20240905$20240903$20240907$PER$$US-AMGEN-USASP2024174320$AMGEN$$69$YR$E$F$Y$$$20240907$$CN$US$US
242759481$24275948$1$I$$20240823$20240903$20240903$EXP$$GB-AUROBINDO-AUR-APL-2024-042649$AUROBINDO$$4$YR$$F$Y$16$KG$20240903$$CN$GB$GB
242759501$24275950$1$I$$20240826$20240903$20240903$PER$$US-ROCHE-10000066562$ROCHE$$$$E$M$Y$$$20240903$$CN$US$US
242759511$24275951$1$I$$20240826$20240903$20240903$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006374$BIOCON$$$$$$Y$$$20240903$$CN$CA$CA
242759521$24275952$1$I$20221228$20240827$20240903$20240903$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2022197678$VIIV$$$$$$Y$$$20240903$$HP$CA$CA
242759531$24275953$1$I$$20240830$20240903$20240903$PER$$US-ALXN-202408USA002143US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242759541$24275954$1$I$$20240830$20240903$20240903$EXP$$US-JNJFOC-20240901991$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242759551$24275955$1$I$20240817$20240822$20240903$20240903$EXP$CN-HENLIUS-24CN016570$CN-Accord-443733$ACCORD$$54$YR$A$F$Y$60$KG$20240903$$MD$CN$CN
242759561$24275956$1$I$20230701$20240828$20240903$20240903$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001761$BLUEPRINT MEDICINES$$$$$F$Y$$$20240903$$CN$US$US
242759571$24275957$1$I$20240817$20240902$20240903$20240903$EXP$FR-AFSSAPS-NC2024001033$NVSC2024FR176059$NOVARTIS$$50$YR$$M$Y$110$KG$20240903$$MD$FR$FR
242759581$24275958$1$I$$20240826$20240903$20240903$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006356$BIOCON$$$$$$Y$$$20240903$$MD$CA$CA
242759591$24275959$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174953$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242759601$24275960$1$I$20240728$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174820$AMGEN$$66$YR$E$F$Y$$$20240903$$CN$US$US
242759611$24275961$1$I$$20240827$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408017125$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240903$$CN$US$US
242759621$24275962$1$I$20240829$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000557$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240903$$CN$US$US
242759631$24275963$1$I$20240801$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000527$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240903$$CN$US$US
242759641$24275964$1$I$$20240827$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000567$ELI LILLY AND CO$$$$$M$Y$$$20240903$$CN$US$US
242759651$24275965$1$I$20230101$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408019210$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240903$$CN$US$US
242759661$24275966$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000349$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240903$$CN$US$US
242759671$24275967$1$I$$20240823$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408015865$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240903$$CN$US$US
242759681$24275968$1$I$20240801$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000321$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240903$$CN$US$US
242759691$24275969$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000375$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240903$$CN$US$US
242759701$24275970$1$I$20240827$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408019462$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240903$$CN$US$US
242759721$24275972$1$I$20240701$20240821$20240903$20240903$EXP$$US-UCBSA-2024042777$UCB$$29$YR$$M$Y$$$20240903$$HP$US$US
242759731$24275973$1$I$$20240830$20240903$20240903$PER$$NVSC2024US176601$NOVARTIS$$$$$F$Y$$$20240903$$MD$US$US
242759741$24275974$1$I$20231206$20240828$20240903$20240903$EXP$$SG-ROCHE-10000068991$ROCHE$$74$YR$E$F$Y$$$20240903$$CN$SG$SG
242759751$24275975$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138181$BRISTOL MYERS SQUIBB$$37$YR$A$M$Y$$$20240903$$HP$US$US
242759761$24275976$1$I$$20240821$20240903$20240903$EXP$$CA-ASTELLAS-2024-AER-003195$ASTELLAS$$58$YR$A$M$Y$$$20240903$$HP$CA$CA
242759771$24275977$1$I$$20240821$20240903$20240903$EXP$$CA-ASTELLAS-2024-AER-003269$ASTELLAS$Unknown U. No Information. No Information. Unknown: Unknown-Unknown.$51$YR$A$M$Y$$$20240903$$CN$CA$CA
242759781$24275978$1$I$$20240828$20240903$20240903$EXP$$US-BIOGEN-2024BI01280463$BIOGEN$$$$$F$Y$$$20240903$$HP$US$US
242759791$24275979$1$I$20240601$20240829$20240903$20240903$PER$$US-BIOGEN-2024BI01280629$BIOGEN$$30$YR$$F$Y$$$20240903$$CN$US$US
242759801$24275980$1$I$20231202$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-081104-2024$RECKITT BENCKISER$$73$YR$$M$Y$$$20240903$$CN$US$US
242759811$24275981$1$I$$20240826$20240903$20240903$EXP$$FR-CELLTRION INC.-2024FR020686$CELLTRION$Longo R, Thiebaut V, Legros P, Campitiello M, Plastino F, Goetz C. Is the TCH-P regimen active in early or locally advanced HER2-positive breast cancer results of a retrospective study. Acta Oncologica. 2022;61 (11):1394-1399$$$$$Y$$$20240903$$MD$FR$FR
242759822$24275982$2$F$20240309$20240906$20240903$20240910$EXP$$NVSC2024AU012245$NOVARTIS$$51$YR$$F$Y$$$20240910$$CN$AU$AU
242759831$24275983$1$I$20210506$20240826$20240903$20240903$EXP$$CA-CELLTRION INC.-2021CA017360$CELLTRION$$$$$$Y$$$20240903$$MD$CA$CA
242759841$24275984$1$I$$20240826$20240903$20240903$EXP$$US-ROCHE-10000067080$ROCHE$$16$YR$T$M$Y$$$20240903$$CN$US$US
242759851$24275985$1$I$20240524$20240819$20240903$20240903$EXP$$US-ASTELLAS-2024US019233$ASTELLAS$$78$YR$E$M$Y$$$20240903$$CN$US$US
242759861$24275986$1$I$$20240826$20240903$20240903$EXP$$CA-CELLTRION INC.-2024CA020729$CELLTRION$$$$$$Y$$$20240903$$CN$CA$CA
242759881$24275988$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174935$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242759891$24275989$1$I$20240801$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174895$AMGEN$$79$YR$E$F$Y$$$20240903$$CN$US$US
242759901$24275990$1$I$20240814$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174365$AMGEN$$83$YR$E$F$Y$$$20240903$$CN$US$US
242759911$24275991$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174950$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242759921$24275992$1$I$$20240829$20240903$20240903$EXP$$US-AMGEN-USASP2024173761$AMGEN$$$$A$F$Y$$$20240903$$HP$US$US
242759931$24275993$1$I$$20240822$20240903$20240903$PER$$US-AMGEN-USASP2024174897$AMGEN$$$$$F$Y$$$20240903$$CN$US$US
242759941$24275994$1$I$$20240826$20240903$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-138149$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$PH$JP$JP
242759951$24275995$1$I$$20240827$20240903$20240903$EXP$$CA-BIOGEN-2024BI01280309$BIOGEN$$$$$F$Y$$$20240903$$CN$CA$CA
242759962$24275996$2$F$20240816$20240827$20240903$20240910$EXP$$US-BIOGEN-2024BI01280130$BIOGEN$$60$YR$$F$Y$$$20240910$$HP$US$US
242759971$24275997$1$I$20240830$20240830$20240903$20240903$EXP$$US-ABBVIE-5903555$ABBVIE$$23$YR$$F$Y$$$20240903$$CN$US$US
242759981$24275998$1$I$20240827$20240829$20240903$20240903$EXP$GB-MHRA-MED-202408281601191460-VRTND$GB-RDY-SPO/GBR/24/0012671$DR REDDYS$$83$YR$E$M$Y$$$20240903$$HP$GB$GB
242759991$24275999$1$I$$20240822$20240903$20240903$EXP$$BE-AUROBINDO-AUR-APL-2024-042698$AUROBINDO$$$$A$F$Y$$$20240903$$HP$BE$BE
242760011$24276001$1$I$20240101$20240828$20240903$20240903$EXP$$MX-AMGEN-MEXSP2024172354$AMGEN$$$$$M$Y$$$20240903$$MD$MX$MX
242760021$24276002$1$I$$20240819$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08483$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242760032$24276003$2$F$20240101$20240904$20240903$20240909$EXP$$US-009507513-2408USA010005$MERCK$$64$YR$$M$Y$$$20240909$$CN$US$US
242760041$24276004$1$I$20240720$20240822$20240903$20240903$EXP$$US-Accord-443600$ACCORD$$15$YR$T$M$Y$$$20240903$$HP$US$US
242760061$24276006$1$I$20240601$20240826$20240903$20240903$EXP$CZ-CZSUKL-24002325$CZ-TEVA-VS-3237219$TEVA$$82$YR$$F$Y$$$20240903$$MD$CZ$CZ
242760071$24276007$1$I$$20240902$20240903$20240903$EXP$$CA-ORGANON-O2409CAN000061$ORGANON$$44$YR$$F$Y$97$KG$20240903$$HP$CA$CA
242760081$24276008$1$I$$20240827$20240903$20240903$EXP$$JP-ASTELLAS-2024-AER-002692$ASTELLAS$$76$YR$E$M$Y$$$20240903$$PH$JP$JP
242760091$24276009$1$I$20210706$20240830$20240903$20240903$EXP$$US-TAKEDA-2021TUS042716$TAKEDA$$67$YR$$F$Y$49$KG$20240903$$HP$US$US
242760101$24276010$1$I$$20240829$20240903$20240903$PER$$US-ABBVIE-5903249$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242760111$24276011$1$I$20240807$20240827$20240903$20240903$EXP$FR-AFSSAPS-BS2024000558$FR-TEVA-VS-3237755$TEVA$$82$YR$$M$Y$$$20240903$$MD$FR$FR
242760121$24276012$1$I$$20240826$20240903$20240903$EXP$$NL-TOLMAR, INC.-24NL052109$TOLMAR$$$$$M$Y$$$20240903$$CN$NL$NL
242760131$24276013$1$I$$20240826$20240903$20240903$EXP$$NL-TOLMAR, INC.-24NL052108$TOLMAR$$$$$M$Y$$$20240903$$CN$NL$NL
242760141$24276014$1$I$$20240826$20240903$20240903$EXP$$NL-TOLMAR, INC.-24NL052143$TOLMAR$$$$$M$Y$$$20240903$$HP$NL$NL
242760151$24276015$1$I$$20240826$20240903$20240903$EXP$$US-TOLMAR, INC.-24US052176$TOLMAR$Hamadi R, Karam I, Khan S, Luhrs C.. Tumour-to-tumour metastasis: a rare case of prostate cancer metastasising to primary lung adenocarcinoma. EJCRIM. 2024;11$80$YR$$M$Y$$$20240903$$MD$US$US
242760161$24276016$1$I$$20240820$20240903$20240903$EXP$$US-INSMED, INC.-2024-00925-US$INSMED$$$$$M$Y$$$20240903$$CN$US$US
242760171$24276017$1$I$$20240826$20240903$20240903$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024106061$VIIV$$$$$$Y$$$20240903$$CN$US$US
242760181$24276018$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174933$AMGEN$$$$$$Y$$$20240903$$MD$US$US
242760191$24276019$1$I$20240520$20240903$20240903$20240903$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049139$BOEHRINGER INGELHEIM$$44$YR$A$M$Y$$$20240903$$HP$AU$AU
242760201$24276020$1$I$$20240828$20240903$20240903$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001765$BLUEPRINT MEDICINES$$$$$F$Y$$$20240903$$CN$US$US
242760211$24276021$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-085795-2024$RECKITT BENCKISER$$$$$M$Y$$$20240903$$CN$US$US
242760221$24276022$1$I$20240115$20240827$20240903$20240903$EXP$$CO-ORPHANEU-2024005884$RECORDATI$$$$$$Y$$$20240903$$CN$CO$CO
242760231$24276023$1$I$$20240824$20240903$20240903$PER$$US-ABBVIE-5895350$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242760241$24276024$1$I$20240729$20240830$20240903$20240903$EXP$DE-PEI-202400018661$DE-ROCHE-10000070151$ROCHE$$67$YR$E$F$Y$$$20240903$$MD$DE$DE
242760252$24276025$2$F$$20240918$20240903$20240924$EXP$$JP-GILEAD-2024-0685820$GILEAD$$85$YR$E$M$Y$$$20240924$$PH$JP$JP
242760261$24276026$1$I$$20240821$20240903$20240903$EXP$$US-WOCKHARDT LIMITED-2024WLD000028$WOCKHARDT$Hassan AM, Hill H, Donley C, Leonelli C.. Potential anaphylactoid reaction to nicardipine. J Am Coll Emerg Physicians Open.. 2024;5(4):13271$52$YR$$M$Y$$$20240830$$MD$US$US
242760271$24276027$1$I$$20240821$20240903$20240903$EXP$$IN-WOCKHARDT BIO AG-2024WBA000019$WOCKHARDT BIO AG$Anandan S, Rajendran SS, Somarajan SA, Udayan A.. A Very Rare Side Effect of a Very Commonly Used Drug: Pantoprazole-induced Seizure.. J Assoc Physicians India.. 2024;72(8):89-89.$69$YR$$F$Y$$$20240830$$HP$IN$IN
242760281$24276028$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174810$AMGEN$$$$$M$Y$$$20240903$$CN$US$US
242760292$24276029$2$F$20240823$20240911$20240903$20240913$PER$$US-TAKEDA-2024TUS087939$TAKEDA$$23$YR$$F$Y$$$20240913$$CN$US$US
242760301$24276030$1$I$$20240829$20240903$20240903$PER$$US-ALXN-202408USA002058US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240903$$CN$US$US
242760311$24276031$1$I$$20240827$20240903$20240903$EXP$$GB-JNJFOC-20240900934$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240903$$HP$GB$GB
242760321$24276032$1$I$$20240822$20240903$20240903$EXP$$NL-AUROBINDO-AUR-APL-2024-042767$AUROBINDO$$74$YR$$M$Y$84$KG$20240903$$CN$NL$NL
242760331$24276033$1$I$20231204$20240822$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042737$AUROBINDO$$62$YR$$M$Y$$$20240903$$MD$FR$FR
242760341$24276034$1$I$$20240821$20240903$20240903$EXP$$US-ASTELLAS-2024-AER-002101$ASTELLAS$$$$E$M$Y$$$20240903$$CN$US$US
242760351$24276035$1$I$20240716$20240820$20240903$20240903$EXP$$US-INSMED, INC.-2024-03393-US$INSMED$$84$YR$$M$Y$$$20240903$$CN$US$US
242760361$24276036$1$I$$20240821$20240903$20240903$PER$$US-ALXN-202408USA001396US$ALEXION PHARMACEUTICALS$$$$$M$Y$145.13$KG$20240903$$MD$US$US
242760371$24276037$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174550$AMGEN$$$$$$Y$$$20240903$$HP$US$US
242760381$24276038$1$I$20240101$20240826$20240903$20240903$EXP$$JP-AstraZeneca-2024A196769$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$JP$
242760391$24276039$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A195811$ASTRAZENECA$$$$$F$Y$$$20240903$$MD$US$
242760401$24276040$1$I$20231101$20240829$20240903$20240903$EXP$$FR-AstraZeneca-2024A196941$ASTRAZENECA$$80$YR$$M$Y$68$KG$20240903$$MD$FR$
242760411$24276041$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000452$ELI LILLY AND CO$$59$YR$A$$Y$$$20240903$$LW$US$US
242760421$24276042$1$I$20240726$20240827$20240903$20240903$EXP$$US-AMGEN-USASP2024171284$AMGEN$$75$YR$E$F$Y$$$20240903$$CN$US$US
242760431$24276043$1$I$$20240822$20240903$20240903$EXP$$NL-AUROBINDO-AUR-APL-2024-042782$AUROBINDO$Ghambari K, de Jong DM, Bruno MJ, Polak WG, van Driel LMJW, den Hoed CM.. Risks of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis After Liver Transplantation. Clinical Transplantation. 2024;38(7):1-9$60$YR$$F$Y$$$20240903$$HP$NL$NL
242760441$24276044$1$I$20240801$20240826$20240903$20240903$PER$$US-ABBVIE-5896159$ABBVIE$$$$$$Y$$$20240903$$CN$US$US
242760451$24276045$1$I$$20240824$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137884$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$CN$US$US
242760462$24276046$2$F$20240830$20240918$20240903$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139690$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240920$$CN$US$US
242760471$24276047$1$I$$20240830$20240903$20240903$EXP$$NVSC2024US176174$NOVARTIS$$$$$M$Y$$$20240903$$CN$US$US
242760481$24276048$1$I$$20240826$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136090$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240903$$HP$US$US
242760501$24276050$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-088067-2024$RECKITT BENCKISER$$$$$$Y$$$20240903$$CN$US$US
242760511$24276051$1$I$20240817$20240829$20240903$20240903$EXP$DE-CADRBFARM-2024330004$DE-TEVA-VS-3238588$TEVA$$16$YR$$M$Y$50$KG$20240903$$CN$DE$DE
242760522$24276052$2$F$20240814$20240906$20240903$20240916$EXP$GB-MHRA-MED-202408240949589110-FRWHK$GB-TEVA-VS-3237397$TEVA$$55$DY$$M$Y$89$KG$20240916$$CN$GB$GB
242760531$24276053$1$I$$20240829$20240903$20240903$EXP$$CA-TAKEDA-2024TUS087682$TAKEDA$$$$$F$Y$$$20240903$$MD$CA$CA
242760541$24276054$1$I$$20240829$20240903$20240903$EXP$$US-TAKEDA-2024TUS062982$TAKEDA$$$$$M$Y$$$20240903$$CN$US$US
242760551$24276055$1$I$20230101$20240828$20240903$20240903$EXP$$SG-ROCHE-10000069230$ROCHE$$66$YR$E$F$Y$$$20240903$$CN$SG$SG
242760561$24276056$1$I$$20240822$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042730$AUROBINDO$$72$YR$$F$Y$$$20240903$$MD$FR$FR
242760571$24276057$1$I$$20240823$20240903$20240903$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03131$AMNEAL$Desai D, Nohria A, Alhanshali L, Buontempo M, Lo Sicco K.I, et al.. Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases. JAAD Case Reports. 2024;51:86-91$34$YR$$M$Y$$$20240903$$HP$US$US
242760581$24276058$1$I$$20240809$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08114$LUPIN$$$$$$Y$$$20240903$$PH$US$US
242760592$24276059$2$F$$20240829$20240903$20240904$PER$$NVSC2024US174973$NOVARTIS$$48$YR$$M$Y$$$20240904$$CN$US$US
242760602$24276060$2$F$$20240831$20240903$20240904$PER$$NVSC2024US176699$NOVARTIS$$$$$$Y$$$20240904$$CN$US$US
242760611$24276061$1$I$$20240901$20240903$20240903$PER$$US-AMGEN-USASP2024175180$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242760622$24276062$2$F$20240725$20240906$20240903$20240918$EXP$$US-INSMED, INC.-2024-03031-US$INSMED$$74$YR$$F$Y$$$20240918$$MD$US$US
242760661$24276066$1$I$20240720$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174864$AMGEN$$76$YR$E$F$Y$$$20240903$$CN$US$US
242760672$24276067$2$F$20240801$20240910$20240903$20240925$30DAY$$US-AMGEN-USASL2024171943$AMGEN$$76$YR$E$F$Y$$$20240925$$PH$US$US
242760682$24276068$2$F$$20240904$20240903$20240905$PER$$US-JNJFOC-20240867931$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242760702$24276070$2$F$$20240909$20240903$20240920$EXP$$NL-AUROBINDO-AUR-APL-2024-042610$AUROBINDO$Ghambari K, de Jong DM, Bruno MJ, Polak WG, van Driel LMJW, den Hoed CM. Endoscopic Retrograde Cholangiopancreatography Pancreatitis After Liver Transplantation. Clinical Transplantation. 2024;38(7):1-9$72$YR$$M$Y$$$20240920$$HP$NL$NL
242760721$24276072$1$I$$20240827$20240903$20240903$EXP$$US-TAKEDA-2024TUS086274$TAKEDA$$$$A$M$Y$91$KG$20240903$$MD$US$US
242760731$24276073$1$I$20240612$20240828$20240903$20240903$EXP$SE-SEMPA-2024-006205$SE-TEVA-VS-3238041$TEVA$$76$YR$$F$Y$$$20240903$$MD$SE$SE
242760751$24276075$1$I$$20240828$20240903$20240903$PER$$US-AMGEN-USASP2024173436$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242760762$24276076$2$F$20240808$20240905$20240903$20240909$30DAY$$US-AMGEN-USASP2024171176$AMGEN$$69$YR$E$F$Y$72.4$KG$20240909$$PH$US$US
242760774$24276077$4$F$$20240909$20240903$20240911$PER$$US-ALXN-202408USA001723US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
242760792$24276079$2$F$20240815$20240902$20240903$20240910$EXP$$AR-ABBVIE-5904657$ABBVIE$$47$YR$$M$Y$$$20240910$$CN$AR$AR
242760801$24276080$1$I$$20240811$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08145$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242760811$24276081$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139687$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240903$$HP$US$US
242760821$24276082$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139696$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240903$$CN$US$US
242760842$24276084$2$F$$20240917$20240903$20240923$EXP$$GB-TAKEDA-2024TUS087441$TAKEDA$$$$$M$Y$$$20240923$$CN$GB$GB
242760854$24276085$4$F$20240828$20240924$20240903$20240930$PER$$US-AMGEN-USASP2024173397$AMGEN$$73$YR$E$M$Y$72.7$KG$20240930$$HP$US$US
242760861$24276086$1$I$20160101$20240828$20240903$20240903$PER$$US-JNJFOC-20170510371$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240903$$LW$US$US
242760871$24276087$1$I$$20240827$20240903$20240903$EXP$$JP-ASTELLAS-2024-AER-002376$ASTELLAS$$$$E$M$Y$$$20240903$$PH$JP$JP
242760891$24276089$1$I$20240810$20240829$20240903$20240903$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-17187$IPSEN$$62$YR$A$M$Y$$$20240903$$HP$GB$GB
242760902$24276090$2$F$20240801$20240911$20240903$20240923$PER$$US-ASTELLAS-2024-AER-002056$ASTELLAS$$51$YR$A$F$Y$$$20240923$$CN$US$US
242760911$24276091$1$I$20240821$20240829$20240903$20240903$EXP$$ZA-AstraZeneca-2024A198480$ASTRAZENECA$$63$YR$$F$Y$$$20240903$$CN$ZA$
242760921$24276092$1$I$$20240829$20240903$20240903$EXP$$NL-AstraZeneca-2024A198133$ASTRAZENECA$$$$$F$Y$$$20240903$$HP$NL$
242760931$24276093$1$I$20240807$20240829$20240903$20240903$EXP$$DE-AstraZeneca-2024A197688$ASTRAZENECA$$29478$DY$$F$Y$78$KG$20240903$$MD$DE$
242760941$24276094$1$I$$20240828$20240903$20240903$EXP$$CA-APOTEX-2024AP010060$APOTEX$$30$YR$$M$Y$$$20240903$$HP$CA$CA
242760951$24276095$1$I$$20240819$20240903$20240903$EXP$$US-EPICPHARMA-US-2024EPCLIT01041$EPIC PHARM$Monique Leys.Multiple organ dysfunction syndrome and disseminated intravascular coagulation causing extensive multiple amalric triangular choroidal infarctions .Retinal Cases and Brief Reports.2024;18:251-254$49$YR$A$F$Y$$$20240903$$MD$US$US
242760962$24276096$2$F$20231201$20240905$20240903$20240906$EXP$$SG-ROCHE-10000067948$ROCHE$$74$YR$E$M$Y$$$20240906$$CN$SG$SG
242760973$24276097$3$F$20240813$20240918$20240903$20240927$30DAY$$US-AMGEN-USASP2024172322$AMGEN$$$$$$Y$$$20240926$$HP$US$US
242760991$24276099$1$I$20240101$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174424$AMGEN$$76$YR$E$F$Y$$$20240903$$CN$US$US
242761003$24276100$3$F$20240827$20240923$20240903$20240930$30DAY$$US-AMGEN-USASP2024171473$AMGEN$$66$YR$E$F$Y$97.52$KG$20240930$$HP$US$US
242761011$24276101$1$I$$20240828$20240903$20240903$EXP$$CA-TAKEDA-2024TUS087509$TAKEDA$$$$$M$Y$$$20240903$$MD$CA$CA
242761021$24276102$1$I$$20240826$20240903$20240903$PER$$US-ABBVIE-5896135$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242761031$24276103$1$I$$20240828$20240903$20240903$EXP$$PL-GILEAD-2024-0685607$GILEAD$$64$YR$A$F$Y$$$20240903$$HP$PL$PL
242761042$24276104$2$F$20240719$20240903$20240903$20240911$EXP$$BR-CELLTRION INC.-2023BR003235$CELLTRION$$$$$$Y$$$20240911$$CN$BR$BR
242761052$24276105$2$F$20220101$20240910$20240903$20240917$PER$$US-ABBVIE-5896735$ABBVIE$$$$$F$Y$34$KG$20240917$$CN$US$US
242761061$24276106$1$I$20240828$20240828$20240903$20240903$PER$$US-ABBVIE-5901106$ABBVIE$$62$YR$$F$Y$$$20240903$$MD$US$US
242761071$24276107$1$I$$20240827$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US076101$SANDOZ$$$$$$Y$$$20240903$$CN$US$US
242761081$24276108$1$I$$20240826$20240903$20240903$EXP$$CA-CELLTRION INC.-2024CA017957$CELLTRION$$$$$$Y$$$20240903$$PH$CA$CA
242761092$24276109$2$F$$20240910$20240903$20240916$EXP$PT-EMA-DD-20240726-7482655-085920$PT-SANDOZ INC.-SDZ2024PT077003$SANDOZ$$79$YR$$F$Y$$$20240916$$MD$PT$PT
242761101$24276110$1$I$20240809$20240822$20240903$20240903$EXP$$IT-AUROBINDO-AUR-APL-2024-042604$AUROBINDO$$75$YR$$F$Y$$$20240903$$MD$IT$IT
242761111$24276111$1$I$20240827$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000202$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240903$$CN$US$US
242761121$24276112$1$I$$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408019319$ELI LILLY AND CO$$59$YR$A$$Y$$$20240903$$LW$US$US
242761141$24276114$1$I$$20240827$20240903$20240903$EXP$$IT-CELLTRION INC.-2024IT020700$CELLTRION$$$$$$Y$$$20240903$$MD$IT$IT
242761153$24276115$3$F$20231006$20240906$20240903$20240916$EXP$$CA-TAKEDA-2024TUS087155$TAKEDA$$68$YR$$F$Y$$$20240916$$CN$CA$CA
242761161$24276116$1$I$$20240902$20240903$20240903$EXP$$IN-TAKEDA-2024TUS087928$TAKEDA$Kumar NM, Bhargava R. ALL-766 Asciminib as a bridge to allogenic transplant in 3 patients with relapsed/refractory philadelphia chromosome-positive ALL or CML lymphoid blast crisis refractory/intolerant to ponatinib. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(supp 1):S283-S284$$$$F$Y$$$20240903$$MD$IN$IN
242761171$24276117$1$I$$20240829$20240903$20240903$EXP$$US-TAKEDA-2024TUS087485$TAKEDA$$$$$F$Y$$$20240903$$CN$US$US
242761191$24276119$1$I$$20240901$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139589$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$59.42$KG$20240903$$CN$US$US
242761201$24276120$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139556$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$68.49$KG$20240903$$HP$US$US
242761221$24276122$1$I$$20240829$20240903$20240903$PER$$US-ALXN-202408USA002109US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
242761241$24276124$1$I$$20240830$20240903$20240903$EXP$$JP-ROCHE-10000072174$ROCHE$$8$DEC$E$$Y$$$20240903$$MD$JP$JP
242761251$24276125$1$I$20240829$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174472$AMGEN$$65$YR$E$M$Y$$$20240903$$CN$US$US
242761261$24276126$1$I$20240829$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174613$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242761271$24276127$1$I$$20240827$20240903$20240903$EXP$$CA-TAKEDA-2024TUS087533$TAKEDA$$$$$M$Y$$$20240903$$HP$CA$CA
242761281$24276128$1$I$$20240827$20240903$20240903$EXP$$SG-ROCHE-10000067933$ROCHE$$$$$F$Y$$$20240903$$CN$SG$SG
242761311$24276131$1$I$$20240819$20240903$20240903$EXP$$DE-EPICPHARMA-DE-2024EPCLIT01044$EPIC PHARM$Dr. Raw Bingart.Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock.Rechtsmedizin.30-JUN-2023;33:396-402$17$YR$T$M$Y$$$20240903$$HP$DE$DE
242761322$24276132$2$F$20240801$20240827$20240903$20240904$EXP$GB-MHRA-MED-202408271647286320-LBQKP$GB-ABBVIE-5897921$ABBVIE$$37$YR$$F$Y$$$20240904$$MD$GB$GB
242761331$24276133$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138616$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$CN$US$US
242761341$24276134$1$I$20240829$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139554$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240903$$CN$US$US
242761351$24276135$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138547$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240903$$CN$US$US
242761361$24276136$1$I$20240531$20240829$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138537$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$83.91$KG$20240903$$CN$US$US
242761372$24276137$2$F$$20240828$20240903$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137723$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240910$$PH$US$US
242761384$24276138$4$F$$20240902$20240903$20240909$PER$$NVSC2024US176602$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
242761401$24276140$1$I$20240827$20240828$20240903$20240903$EXP$$US-ABBVIE-5902505$ABBVIE$$51$YR$$F$Y$$$20240903$$CN$US$US
242761411$24276141$1$I$20240801$20240814$20240903$20240903$EXP$$US-862174955-ML2024-04495$Unknown Manufacturer$$89$YR$E$M$Y$70$KG$20240903$$CN$US$US
242761421$24276142$1$I$$20240829$20240903$20240903$PER$$US-BIOGEN-2024BI01280592$BIOGEN$$60$YR$$F$Y$$$20240903$$HP$US$US
242761432$24276143$2$F$20240301$20240909$20240903$20240912$EXP$$US-ABBVIE-5902934$ABBVIE$$73$YR$$F$Y$$$20240912$$CN$US$US
242761452$24276145$2$F$20240625$20240904$20240903$20240906$EXP$$US-ABBVIE-5901798$ABBVIE$$25$YR$$F$Y$86$KG$20240906$$CN$US$US
242761461$24276146$1$I$20240801$20240826$20240903$20240903$EXP$$CA-JNJFOC-20240869128$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240903$$HP$CA$CA
242761471$24276147$1$I$20240116$20240829$20240903$20240903$EXP$$CO-UCBSA-2024032340$UCB$$69$YR$$F$Y$58$KG$20240903$$CN$CO$CO
242761481$24276148$1$I$20210101$20240830$20240903$20240903$EXP$DE-AMK-279338$DE-ABBVIE-5902714$ABBVIE$$18$YR$$F$Y$$$20240903$$PH$DE$DE
242761492$24276149$2$F$$20240925$20240903$20240930$30DAY$$AT-UCBSA-2024044672$UCB$$$$$F$Y$$$20240930$$PH$AT$AT
242761511$24276151$1$I$$20240819$20240903$20240903$EXP$$JP-PURACAP-JP-2024EPCLIT01042$PURACAP$M Shimomura.Successful treatment of erythema nodosum with salazosulfapyridine in a 9-year-old patient with chronic non-bacterial osteomyelitis..Modern Rheumatology Case Reports.JUL-2024;8:394-397$9$YR$C$F$Y$$$20240903$$HP$JP$JP
242761521$24276152$1$I$20240701$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174490$AMGEN$$80$YR$E$F$Y$$$20240903$$CN$US$US
242761531$24276153$1$I$20240829$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174598$AMGEN$$74$YR$E$M$Y$$$20240903$$CN$US$US
242761541$24276154$1$I$$20240816$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08479$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242761551$24276155$1$I$20230326$20240823$20240903$20240903$EXP$$US-BAXTER-2023BAX025145$BAXTER$$12$YR$$F$Y$38.9$KG$20240903$$HP$US$US
242761561$24276156$1$I$20240709$20240823$20240903$20240903$EXP$$US-BAXTER-2024BAX023704$BAXTER$$69$YR$$M$Y$94.9$KG$20240903$$PH$US$US
242761571$24276157$1$I$20240327$20240902$20240903$20240903$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-013634$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240903$$CN$JP$JP
242761591$24276159$1$I$20240225$20240829$20240903$20240903$EXP$$SG-ROCHE-10000068509$ROCHE$$54$YR$A$F$Y$$$20240903$$CN$SG$SG
242761602$24276160$2$F$20240822$20240918$20240903$20240923$PER$$US-GILEAD-2024-0685997$GILEAD$$30$YR$A$M$Y$74.83$KG$20240922$$HP$US$US
242761611$24276161$1$I$$20240826$20240903$20240903$EXP$$FR-CELLTRION INC.-2024FR020688$CELLTRION$Longo R, Thiebaut V, Legros P, Campitiello M, Plastino F, Goetz C. Is the TCH-P regimen active in early or locally advanced HER2-positive breast cancer results of a retrospective study. Acta Oncologica. 2022;61 (11):1394-1399$$$$$Y$$$20240903$$MD$FR$FR
242761622$24276162$2$F$$20240828$20240903$20240909$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-231141$BOEHRINGER INGELHEIM$Hiromasa Ohno, Mari Yamamoto, Yukari Murai, Yoshio Fujita; 2-1. A case of a patient with type 2 diabetes mellitus with ketoacidosis with hypoglycemia; Proceedings of the Congress on Electrolyte Metabolism; 2024; 50; 20-23$71$YR$E$M$Y$$$20240909$$MD$JP$JP
242761631$24276163$1$I$$20240828$20240903$20240903$EXP$$JP-ALXN-202408JPN001887JP$ALEXION PHARMACEUTICALS$$7$DEC$$F$Y$$$20240903$$MD$JP$JP
242761641$24276164$1$I$20240714$20240826$20240903$20240903$EXP$$CA-JNJFOC-20240870195$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240903$$CN$CA$CA
242761651$24276165$1$I$20240611$20240829$20240903$20240903$EXP$$US-ABBVIE-5901696$ABBVIE$$63$YR$$F$Y$$$20240903$$CN$US$US
242761661$24276166$1$I$$20240902$20240903$20240903$EXP$$PT-SANDOZ INC.-SDZ2022PT000451$SANDOZ$$$$E$$Y$$$20240903$$HP$PT$PT
242761671$24276167$1$I$20240101$20240828$20240903$20240903$EXP$$US-ABBVIE-5899751$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242761681$24276168$1$I$$20240828$20240903$20240903$EXP$$CA-ABBVIE-5901909$ABBVIE$$$$A$F$Y$$$20240903$$CN$CA$CA
242761691$24276169$1$I$$20240829$20240903$20240903$PER$$US-ROCHE-10000070838$ROCHE$$71$YR$E$M$Y$$$20240903$$HP$US$US
242761701$24276170$1$I$20240624$20240823$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042873$AUROBINDO$$60$YR$$M$Y$82$KG$20240903$$PH$FR$FR
242761721$24276172$1$I$$20240829$20240903$20240903$EXP$$US-AMGEN-USASL2024174429$AMGEN$$63$YR$A$F$Y$$$20240903$$CN$US$US
242761742$24276174$2$F$$20240903$20240903$20240905$PER$$US-HALEON-2194812$Haleon PLC$$$$$F$Y$$$20240905$$CN$US$US
242761761$24276176$1$I$20240816$20240826$20240903$20240903$30DAY$$US-GSK-US2024106002$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240903$$CN$US$US
242761771$24276177$1$I$$20240902$20240903$20240903$EXP$$CA-SANDOZ INC.-SDZ2024CA077070$SANDOZ$$85$YR$$F$Y$$$20240903$$CN$CA$CA
242761781$24276178$1$I$$20240902$20240903$20240903$EXP$$DE-SANDOZ INC.-SDZ2024DE076979$SANDOZ$$62$YR$$M$Y$$$20240903$$MD$DE$DE
242761811$24276181$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-082341-2024$RECKITT BENCKISER$$90$YR$$M$Y$90.7$KG$20240903$$CN$US$US
242761831$24276183$1$I$$20240830$20240903$20240903$PER$$US-GILEAD-2024-0685940$GILEAD$$70$YR$E$F$Y$$$20240903$$CN$US$US
242761842$24276184$2$F$20230701$20240917$20240903$20240925$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-07333$IPSEN$$62$YR$A$M$Y$$$20240925$$HP$US$US
242761851$24276185$1$I$$20240829$20240903$20240903$EXP$$PA-ROCHE-10000070984$ROCHE$$$$$F$Y$$$20240903$$MD$PA$PA
242761861$24276186$1$I$20240803$20240826$20240903$20240903$EXP$$JP-ABBVIE-5882323$ABBVIE$$$$$$Y$$$20240903$$PH$JP$JP
242761871$24276187$1$I$$20240826$20240903$20240903$EXP$DE-EMA-DD-20210405-sandevhp-141110$DE-RDY-GER/GER/21/0134403$DR REDDYS$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313. doi:10.1093/jat/bkae011$37$YR$A$M$Y$$$20240903$$HP$DE$DE
242761881$24276188$1$I$$20240828$20240903$20240903$EXP$$CA-JNJFOC-20240900736$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240903$$HP$CA$CA
242761891$24276189$1$I$$20240902$20240903$20240903$EXP$$PT-SANDOZ INC.-SDZ2022PT000452$SANDOZ$$$$E$$Y$$$20240903$$HP$PT$PT
242761902$24276190$2$F$$20240916$20240903$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409000754$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240918$$CN$US$US
242761911$24276191$1$I$$20240822$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408014350$ELI LILLY AND CO$$$$$F$Y$$$20240903$$CN$US$US
242761923$24276192$3$F$20240101$20240923$20240903$20240926$EXP$$US-ABBVIE-5901996$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
242761931$24276193$1$I$$20240902$20240903$20240903$EXP$DE-EMA-DD-20240829-7482655-122936$DE-SANDOZ INC.-SDZ2024DE076948$SANDOZ$$8$YR$$$Y$$$20240903$$MD$DE$DE
242761941$24276194$1$I$$20240830$20240903$20240903$EXP$$US-ABBVIE-5903320$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242761951$24276195$1$I$20240101$20240828$20240903$20240903$EXP$$US-ABBVIE-5901479$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242761961$24276196$1$I$$20240830$20240903$20240903$PER$$US-ROCHE-10000071326$ROCHE$$$$$F$Y$$$20240903$$CN$US$US
242761971$24276197$1$I$20240627$20240827$20240903$20240903$EXP$FR-AFSSAPS-MP2024001318$FR-ROCHE-10000067399$ROCHE$$77$YR$E$M$Y$62$KG$20240903$$MD$FR$FR
242761991$24276199$1$I$20231001$20231120$20240903$20240903$PER$$US-APOTEX-2023AP016057$APOTEX$$$$$F$Y$$$20240903$$CN$US$US
242762001$24276200$1$I$20231001$20231122$20240903$20240903$PER$$US-APOTEX-2023AP016142$APOTEX$$$$$F$Y$$$20240903$$CN$US$US
242762022$24276202$2$F$20240827$20240910$20240903$20240913$30DAY$$US-AMGEN-USASP2024172330$AMGEN$$30$YR$A$F$Y$80$KG$20240912$$PH$US$US
242762031$24276203$1$I$$20240831$20240903$20240903$PER$$US-AMGEN-USASP2024174907$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242762043$24276204$3$F$20240830$20240909$20240903$20240912$PER$$US-AMGEN-USASP2024174666$AMGEN$$58$YR$A$M$Y$$$20240912$$CN$US$US
242762051$24276205$1$I$$20230822$20240903$20240903$PER$$US-APOTEX-2023AP012847$APOTEX$Lee CS, Sullivan K. Alectinib-induced hemolytic anemia. Journal of Oncology Pharmacy Practice. 2023;29(5):1251-1254$52$YR$$F$Y$$$20240903$$HP$US$US
242762061$24276206$1$I$$20230911$20240903$20240903$PER$$US-APOTEX-2023AP013752$APOTEX$Pechacek J, Webb T, Ferre EMN, Schmitt MM, Dimaggio T, Kobrin D, Rajasimhan S, Colton B, Lewis RE, Andes D et all. Successful Treatment of Paecilomyces variotii Pneumonia and Lupus Nephritis with Posaconazole-Cyclophosphamide Co-administration Without Drug Interaction-Induced Toxicity. Open Forum Infectious Diseases. 2023;10(8):1-7$43$YR$$F$Y$$$20240903$$HP$US$US
242762071$24276207$1$I$20240829$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024174333$AMGEN$$63$YR$A$M$Y$$$20240903$$CN$US$US
242762081$24276208$1$I$$20240830$20240903$20240903$EXP$GB-MHRA-MED-202408301753550230-QKHGW$GB-JNJFOC-20240902630$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240903$$PH$GB$GB
242762091$24276209$1$I$$20240829$20240903$20240903$PER$$US-AstraZeneca-2024A198165$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242762101$24276210$1$I$20240513$20240902$20240903$20240903$EXP$PT-INFARMED-J202408-657$PT-SANDOZ INC.-SDZ2024PT077041$SANDOZ$$46$YR$$F$Y$$$20240903$$PH$PT$PT
242762111$24276211$1$I$$20240819$20240903$20240903$EXP$$CN-EPICPHARMA-CN-2024EPCLIT01046$EPIC PHARM$Lei Pan.Hemophagocytic lymphohistiocytosis secondary to rifampin treatment: A case report.Medicine.28-JUN-2024;103:1-6$53$YR$A$F$Y$$$20240903$$HP$CN$CN
242762121$24276212$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-083772-2024$RECKITT BENCKISER$$77$YR$$M$Y$$$20240903$$CN$US$US
242762132$24276213$2$F$$20240910$20240903$20240925$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000517$BECTON DICKINSON$$$$$$Y$$$20240925$$CN$GB$GB
242762142$24276214$2$F$$20240906$20240903$20240923$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000518$BECTON DICKINSON$$$$$$Y$$$20240923$$CN$GB$GB
242762161$24276216$1$I$20240101$20240828$20240903$20240903$EXP$FI-FIMEA-202403014$FI-TEVA-VS-3238169$TEVA$$61$YR$$F$Y$$$20240903$$MD$FI$FI
242762171$24276217$1$I$20240830$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174358$AMGEN$$80$YR$E$M$Y$$$20240903$$CN$US$US
242762221$24276222$1$I$$20240825$20240903$20240903$PER$$US-ABBVIE-5896632$ABBVIE$$$$A$M$Y$$$20240903$$MD$US$US
242762231$24276223$1$I$20240810$20240812$20240903$20240903$30DAY$$US-BECTON DICKINSON-US-BD-24-000524$BECTON DICKINSON$$$$$$Y$$$20240903$$CN$US$US
242762261$24276226$1$I$$20240822$20240903$20240903$EXP$$NL-STERISCIENCE B.V.-2024-ST-001246$Steriscience PTE$Brakenhoff SM, Chi H, Friederich P, Doukas M, Den Hoed C, Flink HJ, et al.. A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report.. Case-Rep-Gastroenterol. 2024;18 (1):252-259$68$YR$$M$Y$$$20240903$$HP$NL$NL
242762271$24276227$1$I$20240708$20240823$20240903$20240903$EXP$$DE-AUROBINDO-AUR-APL-2024-042980$AUROBINDO$$$$$M$Y$70$KG$20240903$$MD$DE$DE
242762281$24276228$1$I$20240727$20240823$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042900$AUROBINDO$$24$YR$$M$Y$$$20240903$$MD$FR$FR
242762301$24276230$1$I$$20240828$20240903$20240903$EXP$$CA-AstraZeneca-2024A198858$ASTRAZENECA$$65$YR$$F$Y$$$20240903$$MD$CA$
242762341$24276234$1$I$$20240902$20240903$20240903$EXP$$PL-SANDOZ INC.-SDZ2024PL076984$SANDOZ$$56$YR$$F$Y$$$20240903$$HP$PL$PL
242762351$24276235$1$I$20220101$20240819$20240903$20240903$EXP$$BE-EPICPHARMA-BE-2024EPCLIT01040$EPIC PHARM$Arthur Iturriagagoitia.A rare cause of syndromic mitral valve prolapse.European Heart Journal Cardiovascular Imaging.23-JAN-2024;25:e184$36$YR$A$M$Y$$$20240903$$HP$BE$BE
242762361$24276236$1$I$20240801$20240829$20240903$20240903$EXP$$GB-ABBVIE-5904593$ABBVIE$$$$$$Y$$$20240903$$MD$GB$GB
242762371$24276237$1$I$$20240829$20240903$20240903$EXP$NL-LRB-00999075$NL-TEVA-VS-3238633$TEVA$$54$YR$$M$Y$86.2$KG$20240903$$CN$NL$NL
242762381$24276238$1$I$$20240829$20240903$20240903$EXP$$NVSC2024GB175758$NOVARTIS$$$$E$M$Y$$$20240903$$CN$GB$GB
242762391$24276239$1$I$$20240821$20240903$20240903$EXP$$AU-STERISCIENCE B.V.-2024-ST-001250$Steriscience PTE$Montarello NL, Irvine I, Warner V, Hare J, Kaye D, Cloud GC.. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report.. BMC-Neurol. 2024;24:1-6$51$YR$$F$Y$$$20240903$$HP$AU$AU
242762401$24276240$1$I$$20240827$20240903$20240903$EXP$$JP-ROCHE-10000069884$ROCHE$$$$$F$Y$$$20240903$$MD$JP$JP
242762411$24276241$1$I$20240817$20240828$20240903$20240903$EXP$ES-AEMPS-1562417$ES-TEVA-VS-3238327$TEVA$$52$YR$$F$Y$57$KG$20240903$$MD$ES$ES
242762421$24276242$1$I$$20240821$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133450$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240903$$HP$US$US
242762431$24276243$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139312$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240903$$CN$US$US
242762451$24276245$1$I$$20240824$20240903$20240903$EXP$$US-GSK-US2024AMR105774$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$CN$US$US
242762462$24276246$2$F$$20240905$20240903$20240906$EXP$$US-ABBVIE-5900427$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242762471$24276247$1$I$$20240826$20240903$20240903$EXP$$IN-NOVITIUMPHARMA-2024INNVP01745$NOVITIUM PHARMA$S. Kishore.A Case of Drug-Induced Autoimmune Like Hepatitis.Journal of Clinical and Experimental Hepatology.2024;14(1):102135$50$YR$A$F$Y$$$20240903$$HP$IN$IN
242762481$24276248$1$I$$20240826$20240903$20240903$EXP$$CA-APOTEX-2024AP009789$APOTEX$$74$YR$$M$Y$76$KG$20240903$$PH$CA$CA
242762491$24276249$1$I$$20240821$20240903$20240903$PER$$GR-AMX-008137$AMYLYX PHARMACEUTICALS$$49$YR$$M$Y$$$20240903$$CN$GR$GR
242762502$24276250$2$F$20240701$20240912$20240903$20240917$EXP$DE-BFARM-24006045$NVSC2024DE176303$NOVARTIS$$21$YR$$F$Y$54$KG$20240917$$MD$DE$DE
242762511$24276251$1$I$$20240829$20240903$20240903$EXP$$NVSC2024DE176560$NOVARTIS$$28$YR$$F$Y$$$20240903$$MD$DE$DE
242762532$24276253$2$F$$20240830$20240903$20240910$EXP$$US-ROCHE-10000067945$ROCHE$$81$YR$E$M$Y$81.2$KG$20240910$$CN$US$US
242762541$24276254$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174988$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242762551$24276255$1$I$$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173492$AMGEN$$70$YR$E$F$Y$$$20240903$$CN$US$US
242762561$24276256$1$I$20240101$20240820$20240903$20240903$PER$$US-SA-2024SA254258$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240903$$HP$US$US
242762571$24276257$1$I$20240801$20240822$20240903$20240903$PER$$US-SA-2024SA255049$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240903$$MD$US$US
242762581$24276258$1$I$$20240822$20240903$20240903$PER$$US-SA-2024SA253518$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240903$$CN$US$US
242762591$24276259$1$I$$20240828$20240903$20240903$PER$$US-SA-2024SA254172$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240903$$CN$US$US
242762601$24276260$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA254783$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240903$$MD$US$US
242762611$24276261$1$I$20240101$20240822$20240903$20240903$PER$$US-SA-2024SA252380$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240903$$MD$US$US
242762621$24276262$1$I$$20240822$20240903$20240903$PER$$US-SA-2024SA254367$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240903$$MD$US$US
242762631$24276263$1$I$$20240828$20240903$20240903$EXP$$US-Orion Corporation ORION PHARMA-24_00031478$ORION$Seitz V, Davidson E. Retained Tampon Fragment as an Unusual Cause of Vesicovaginal Fistula. Obstet Gynecol. 2024 JUL 01;144(1):E1-E3.$53$YR$A$F$Y$$$20240903$$MD$US$
242762642$24276264$2$F$20231201$20240830$20240903$20240903$PER$$US-GILEAD-2024-0685966$GILEAD$$64$YR$E$M$Y$$$20240903$$CN$US$US
242762651$24276265$1$I$20240101$20240820$20240903$20240903$EXP$$US-SA-2024SA253782$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240903$$CN$US$US
242762661$24276266$1$I$$20240829$20240903$20240903$PER$$US-ALXN-202408USA002094US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$HP$US$US
242762681$24276268$1$I$$20240830$20240903$20240903$PER$$US-ALXN-202408USA002142US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242762691$24276269$1$I$$20240901$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139692$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240903$$HP$US$US
242762701$24276270$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138176$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240903$$CN$US$US
242762711$24276271$1$I$$20240830$20240903$20240903$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-139432$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$81.65$KG$20240903$$CN$PR$PR
242762721$24276272$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139531$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240903$$CN$US$US
242762733$24276273$3$F$$20240916$20240903$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139606$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240919$$CN$US$US
242762742$24276274$2$F$$20240831$20240903$20240906$PER$$NVSC2024US176240$NOVARTIS$$$$$$Y$$$20240906$$CN$US$US
242762751$24276275$1$I$20240801$20240830$20240903$20240903$EXP$$ZA-ABBVIE-5902658$ABBVIE$$77$YR$$F$Y$$$20240903$$CN$ZA$ZA
242762761$24276276$1$I$20240527$20240823$20240903$20240903$EXP$SE-SEMPA-2024-006200$SE-AMGEN-SWESP2024169163$AMGEN$$61$YR$A$M$Y$$$20240903$$MD$SE$SE
242762771$24276277$1$I$$20240826$20240903$20240903$PER$$US-AMGEN-USASP2024171231$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242762781$24276278$1$I$20240716$20240826$20240903$20240903$EXP$$US-SA-2024SA209898$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240903$$MD$US$US
242762801$24276280$1$I$20240612$20240828$20240903$20240903$EXP$$DE-TEVA-VS-3238173$TEVA$$59$YR$$M$Y$78$KG$20240903$$MD$DE$DE
242762811$24276281$1$I$$20240822$20240903$20240903$EXP$$GB-CARNEGIE-000021$Carnegie Pharmaceuticals$$87$YR$E$F$Y$$$20240823$$MD$GB$GB
242762821$24276282$1$I$$20240822$20240903$20240903$EXP$$GB-CARNEGIE-000025$Carnegie Pharmaceuticals$$67$YR$E$M$Y$$$20240826$$HP$GB$GB
242762831$24276283$1$I$$20240822$20240903$20240903$EXP$$ES-CARNEGIE-000023$Carnegie Pharmaceuticals$$44$YR$A$M$Y$$$20240823$$HP$ES$ES
242762841$24276284$1$I$20240827$20240828$20240903$20240903$EXP$$JP-SA-2024SA251741$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240903$$MD$JP$JP
242762851$24276285$1$I$$20240822$20240903$20240903$EXP$$GB-CARNEGIE-000026$Carnegie Pharmaceuticals$$48$YR$A$F$Y$$$20240826$$HP$GB$GB
242762861$24276286$1$I$$20240822$20240903$20240903$EXP$$IE-STERISCIENCE B.V.-2024-ST-001260$Steriscience PTE$Moollan N, Durcan L. A tale of two pregnancies.. Pol-Arch-Med-Wewn. 2022;132 (Suppl.):11-12$35$YR$$F$Y$$$20240903$$HP$IE$IE
242762871$24276287$1$I$$20240822$20240903$20240903$EXP$$IN-CARNEGIE-000022$Carnegie Pharmaceuticals$$76$YR$E$M$Y$$$20240823$$MD$IN$IN
242762881$24276288$1$I$$20240826$20240903$20240903$PER$$US-ROCHE-10000066416$ROCHE$$$$$$Y$$$20240903$$CN$US$US
242762891$24276289$1$I$$20240823$20240903$20240903$EXP$$TN-CARNEGIE-000019$Carnegie Pharmaceuticals$$66$YR$E$F$Y$$$20240823$$MD$TN$TN
242762901$24276290$1$I$20240101$20240829$20240903$20240903$EXP$$US-ABBVIE-5901691$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242762911$24276291$1$I$$20240829$20240903$20240903$EXP$$ZA-AstraZeneca-2024A197560$ASTRAZENECA$$65$YR$$F$Y$$$20240903$$CN$ZA$
242762921$24276292$1$I$$20240808$20240903$20240903$PER$$US-AstraZeneca-2024A181079$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242762931$24276293$1$I$20080101$20240828$20240903$20240903$PER$$US-JNJFOC-20240876231$JOHNSON AND JOHNSON$$$$C$M$Y$$$20240903$$HP$US$US
242762941$24276294$1$I$$20240812$20240903$20240903$30DAY$$AU-JNJFOC-20240844634$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$HP$AU$AU
242762951$24276295$1$I$20240817$20240817$20240903$20240903$PER$$US-JNJFOC-20240845784$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240903$$CN$US$US
242762961$24276296$1$I$$20240827$20240903$20240903$PER$$US-JNJFOC-20240873702$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$MD$US$US
242762971$24276297$1$I$20111219$20240826$20240903$20240903$EXP$$CA-JNJFOC-20240473472$JOHNSON AND JOHNSON$$16$YR$T$M$Y$83$KG$20240903$$CN$CA$CA
242762992$24276299$2$F$$20240903$20240903$20240904$30DAY$$FR-SANDOZ INC.-SDZ2024FR077060$SANDOZ$$13$YR$$F$Y$$$20240904$$CN$FR$FR
242763001$24276300$1$I$20240101$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000559$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240903$$CN$US$US
242763011$24276301$1$I$$20240831$20240903$20240903$PER$$US-ROCHE-10000071458$ROCHE$$$$A$F$Y$$$20240903$$CN$US$US
242763041$24276304$1$I$20240401$20240829$20240903$20240903$EXP$$US-ABBVIE-5901624$ABBVIE$$52$YR$$M$Y$$$20240903$$CN$US$US
242763061$24276306$1$I$20240701$20240824$20240903$20240903$EXP$$GB-ASPEN-GLO2024GB005835$ASPEN$$$$$$Y$$$20240903$$MD$GB$GB
242763081$24276308$1$I$$20240829$20240903$20240903$EXP$$CA-ABBVIE-5902374$ABBVIE$$$$A$M$Y$$$20240903$$CN$CA$CA
242763111$24276311$1$I$$20240822$20240903$20240903$EXP$$MT-STERISCIENCE B.V.-2024-ST-001264$Steriscience PTE$Vassallo C, Saliba J, Bardon MP.. Leptospirosis: a clinical and diagnostic challenge.. BMJ-Case-Rep. 2024;17$6$DEC$$M$Y$$$20240903$$HP$MT$MT
242763122$24276312$2$F$$20240902$20240903$20240910$EXP$PT-SA-SAC20220203001919$PT-SANDOZ INC.-NVSC2022PT064658$SANDOZ$$$$E$$Y$$$20240910$$HP$PT$PT
242763131$24276313$1$I$20231114$20240827$20240903$20240903$EXP$$DE-EXELIXIS-CABO-24081050$EXELIXIS$$75$YR$$M$Y$$$20240903$$MD$DE$DE
242763142$24276314$2$F$20240101$20240902$20240903$20240911$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026653$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240911$$$US$US
242763151$24276315$1$I$$20240827$20240903$20240903$EXP$$CA-CELLTRION INC.-2024CA020500$CELLTRION$$$$$$Y$$$20240903$$CN$CA$CA
242763161$24276316$1$I$$20240829$20240903$20240903$EXP$$GB-TAKEDA-2024TUS079225$TAKEDA$$$$$M$Y$$$20240903$$CN$GB$GB
242763171$24276317$1$I$$20240822$20240903$20240903$EXP$$CN-STERISCIENCE B.V.-2024-ST-001266$Steriscience PTE$Kou X, An D.. A 48-year-old man with fever, nauseous, vomiting, and dizzy: A CARE case report.. Medicine. 2024;103 (31):e39015$48$YR$$M$Y$$$20240903$$HP$CN$CN
242763181$24276318$1$I$20240601$20240827$20240903$20240903$EXP$FR-AFSSAPS-AVLY2024000163$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111648$ZYDUS PHARM$$$$$$Y$$$20240903$$MD$FR$FR
242763201$24276320$1$I$20240809$20240819$20240903$20240903$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463904$RANBAXY$-. -. -. -;-:-$19$YR$A$F$Y$62.9$KG$20240903$$CN$AU$AU
242763212$24276321$2$F$20240801$20240906$20240903$20240916$EXP$$FR-GRUNENTHAL-2024-124470$AVERITAS$$$$A$F$Y$$$20240913$$HP$FR$FR
242763221$24276322$1$I$$20240825$20240903$20240903$PER$$US-AMGEN-USASP2024171785$AMGEN$Stitzlein L.M.; Sun Y.Y.; Munir F. et al.. CLINICAL CHARACTERISTICS AND THERAPEUTIC INTERVENTIONS IN A CASE SERIES OF PEDIATRIC PATIENTS WITH VESTIBULAR SCHWANNOMAS AND NEUROFIBROMATOSIS TYPE 2. Neuro-Oncology. 2024;26:iv170$$$$$Y$$$20240903$$HP$US$US
242763231$24276323$1$I$$20240812$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08106$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242763242$24276324$2$F$20240101$20240912$20240903$20240918$EXP$$US-ABBVIE-5901763$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
242763251$24276325$1$I$20240830$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174350$AMGEN$$71$YR$E$F$Y$$$20240903$$CN$US$US
242763261$24276326$1$I$20240101$20240825$20240903$20240903$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026679$UNITED THERAPEUTICS$$$$$F$Y$65.76$KG$20240903$$$US$US
242763272$24276327$2$F$$20240912$20240903$20240917$EXP$$NVSC2024US056906$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
242763281$24276328$1$I$20240601$20240828$20240903$20240903$EXP$$IT-ABBVIE-5901157$ABBVIE$$79$YR$$F$Y$$$20240903$$CN$IT$IT
242763292$24276329$2$F$20221001$20240904$20240903$20240906$EXP$$CN-SA-2024SA253399$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240906$$MD$CN$CN
242763301$24276330$1$I$$20240827$20240903$20240903$EXP$$ES-ROCHE-10000068917$ROCHE$$$$$F$Y$$$20240903$$MD$ES$ES
242763311$24276331$1$I$$20240823$20240903$20240903$EXP$$CN-STERISCIENCE B.V.-2024-ST-001285$Steriscience PTE$Haoyu C, Fan Y, Yixin Y, Shuqin Z, Yongping Z, Weijie Z, et al. Application of quantitative detection of multiple-source cytomegalovirus DNA in diagnosis of cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation.. Organ-Transplant. 2021;12 (1):96-102$$$$M$Y$$$20240903$$HP$CN$CN
242763321$24276332$1$I$$20240820$20240903$20240903$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111459$ZYDUS PHARM$Difiore E, Pittman J.. A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting. Case-Rep-Psychiatry. 2024$$$$$Y$$$20240903$$HP$US$US
242763331$24276333$1$I$20240701$20240827$20240903$20240903$EXP$$KR-AMGEN-KORSP2024170930$AMGEN$$70$YR$E$F$Y$$$20240903$$CN$KR$KR
242763341$24276334$1$I$$20240831$20240903$20240903$PER$$US-AMGEN-USASP2024175115$AMGEN$$$$$$Y$$$20240903$$HP$US$US
242763351$24276335$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139572$BRISTOL MYERS SQUIBB$$30$YR$A$M$Y$85.4$KG$20240903$$HP$US$US
242763361$24276336$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139185$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$PH$US$US
242763381$24276338$1$I$$20240902$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139640$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$77.11$KG$20240903$$CN$US$US
242763391$24276339$1$I$$20240829$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139671$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240903$$CN$US$US
242763401$24276340$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-140503-2023$RECKITT BENCKISER$$54$YR$$F$Y$$$20240903$$CN$US$US
242763411$24276341$1$I$$20240823$20240903$20240903$EXP$$CN-STERISCIENCE B.V.-2024-ST-001290$Steriscience PTE$Zhang S, Li J, Wan L, Yu J, Chen S, Jin Z.. Clinical Features and Antibiotic Treatment of Neonatal Listeriosis: A Hospital-Based Study.. Infect-Drug-Resist. 2023;16:6647-6659$$$N$M$Y$$$20240903$$HP$CN$CN
242763421$24276342$1$I$20141101$20240826$20240903$20240903$PER$$US-JNJFOC-20240872341$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240903$$HP$US$US
242763431$24276343$1$I$$20240829$20240903$20240903$EXP$$US-JNJFOC-20240877887$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$HP$US$US
242763441$24276344$1$I$$20240828$20240903$20240903$EXP$$US-JNJFOC-20240876568$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242763464$24276346$4$F$$20240917$20240903$20240919$EXP$$JP-JNJFOC-20240846371$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240920$$MD$JP$JP
242763471$24276347$1$I$20240827$20240827$20240903$20240903$PER$$US-HALEON-2193987$Haleon PLC$$$$$$Y$$$20240903$$CN$US$US
242763481$24276348$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A197811$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242763491$24276349$1$I$20240702$20240829$20240903$20240903$EXP$$ZA-AstraZeneca-2024A197798$ASTRAZENECA$$78$YR$$F$Y$$$20240903$$CN$ZA$
242763511$24276351$1$I$20240201$20240827$20240903$20240903$EXP$$US-ARGENX-2024-ARGX-US007255$ARGENX BVBA$$$$$$Y$$$20240903$$HP$US$US
242763521$24276352$1$I$$20240826$20240903$20240903$EXP$$BR-AstraZeneca-2024A197699$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$BR$
242763531$24276353$1$I$20240601$20240826$20240903$20240903$EXP$$JP-AstraZeneca-2024A196327$ASTRAZENECA$$87$YR$$F$Y$$$20240903$$MD$JP$
242763542$24276354$2$F$20240701$20240826$20240903$20240905$EXP$$NVSC2024BR176291$NOVARTIS$$44$YR$$F$Y$$$20240905$$CN$BR$BR
242763551$24276355$1$I$20231214$20240827$20240903$20240903$EXP$$DE-ROCHE-10000068338$ROCHE$$42$YR$A$M$Y$$$20240903$$MD$DE$DE
242763561$24276356$1$I$$20240826$20240903$20240903$EXP$$JP-TEVA-VS-3237423$TEVA$Nakura M, Nojima K, Yamazaki H, Takenaka S, Watanabe T, Takeshita M, et al. [Cases of Advanced Colorectal Cancer with Nephrotic Syndrome after FOLFIRI plus Ramucirumab Administration]. [Japanese]. Gan-To-Kagaku-Ryoho 2022; 49 (13): 1745-1747.$72$YR$$M$Y$$$20240903$$HP$JP$JP
242763571$24276357$1$I$$20240828$20240903$20240903$EXP$$US-AMGEN-USASP2024173612$AMGEN$Cheung A.Y.; Mansur S.. Treatment of Corneal Neovascularization before Deep Anterior Lamellar Keratoplasty. Cornea. 2024;1-6$31$YR$A$M$Y$$$20240903$$MD$US$US
242763581$24276358$1$I$$20240605$20240903$20240903$PER$$AU-TOLMAR, INC.-24AU050037$TOLMAR$$$$$M$Y$$$20240903$$CN$AU$AU
242763591$24276359$1$I$$20240807$20240903$20240903$PER$$CA-TOLMAR, INC.-24CA051695$TOLMAR$$$$$M$Y$$$20240903$$CN$CA$CA
242763601$24276360$1$I$$20240807$20240903$20240903$PER$$CA-TOLMAR, INC.-24CA051703$TOLMAR$$$$$M$Y$$$20240903$$CN$CA$CA
242763611$24276361$1$I$20240726$20240726$20240903$20240903$PER$$FR-TOLMAR, INC.-24FR051394$TOLMAR$$$$$F$Y$$$20240903$$PH$FR$FR
242763621$24276362$1$I$20240314$20240801$20240903$20240903$PER$$NL-TOLMAR, INC.-24NL051570$TOLMAR$$79$YR$$M$Y$$$20240903$$CN$NL$NL
242763631$24276363$1$I$20240824$20240829$20240903$20240903$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-17269$IPSEN$$76$YR$E$M$Y$89.35$KG$20240903$$HP$US$US
242763641$24276364$1$I$20240501$20240829$20240903$20240903$EXP$$US-ABBVIE-5901303$ABBVIE$$52$YR$$F$Y$$$20240903$$CN$US$US
242763652$24276365$2$F$20240826$20240910$20240903$20240919$EXP$$MX-ROCHE-10000071336$ROCHE$$52$YR$A$F$Y$72$KG$20240919$$CN$MX$MX
242763661$24276366$1$I$20240101$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174937$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242763671$24276367$1$I$20240522$20240827$20240903$20240903$EXP$FR-AFSSAPS-LL2024001567$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111620$ZYDUS PHARM$$$$$$Y$$$20240903$$PH$FR$FR
242763681$24276368$1$I$20240811$20240827$20240903$20240903$EXP$FR-AFSSAPS-LL2024001602$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111618$ZYDUS PHARM$$$$$$Y$$$20240903$$MD$FR$FR
242763692$24276369$2$F$20240801$20240830$20240903$20240909$EXP$$CO-AMGEN-COLSL2024171619$AMGEN$$59$YR$A$F$Y$$$20240909$$CN$CO$CO
242763701$24276370$1$I$20240601$20240829$20240903$20240903$EXP$$US-ABBVIE-5901620$ABBVIE$$65$YR$$F$Y$110$KG$20240903$$CN$US$US
242763711$24276371$1$I$$20240829$20240903$20240903$PER$$US-JNJFOC-20240881132$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$HP$US$US
242763721$24276372$1$I$$20240824$20240903$20240903$30DAY$$IN-JNJFOC-20240880219$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$MD$IN$IN
242763732$24276373$2$F$20240823$20240910$20240903$20240918$EXP$$NVSC2024NO175426$NOVARTIS$$85$YR$$M$Y$$$20240918$$CN$NO$NO
242763741$24276374$1$I$20240823$20240829$20240903$20240903$EXP$$US-ABBVIE-5897460$ABBVIE$$73$YR$$F$Y$58$KG$20240903$$HP$US$US
242763751$24276375$1$I$$20240829$20240903$20240903$PER$$US-LEO Pharma-373177$LEO PHARM$$57$YR$$M$Y$$$20240903$$CN$US$US
242763761$24276376$1$I$$20240810$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128334$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240903$$CN$US$US
242763772$24276377$2$F$20190130$20240823$20240903$20240904$EXP$$DE-AUROBINDO-AUR-APL-2022-027412$AUROBINDO$$68$YR$$F$Y$88.8$KG$20240904$$MD$DE$DE
242763781$24276378$1$I$20240713$20240828$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138893$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240903$$CN$US$US
242763791$24276379$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138670$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240903$$HP$US$US
242763801$24276380$1$I$20240827$20240828$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138586$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$63.96$KG$20240903$$CN$US$US
242763811$24276381$1$I$20240820$20240820$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133566$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$PH$US$US
242763821$24276382$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5901623$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242763831$24276383$1$I$$20240901$20240903$20240903$PER$$US-AMGEN-USASP2024175199$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242763841$24276384$1$I$20240817$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024174578$AMGEN$$72$YR$E$F$Y$$$20240903$$CN$US$US
242763851$24276385$1$I$$20240902$20240903$20240903$PER$$US-AMGEN-USASP2024175252$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242763861$24276386$1$I$$20240829$20240903$20240903$PER$$US-BIOGEN-2024BI01280759$BIOGEN$$$$$$Y$$$20240903$$CN$US$US
242763881$24276388$1$I$$20240902$20240903$20240903$EXP$FR-EMA-20150318-AUTODUP-412722$FR-SANDOZ INC.-SDZ2024FR076940$SANDOZ$$$$$M$Y$$$20240903$$HP$FR$FR
242763892$24276389$2$F$20240823$20240831$20240903$20240905$EXP$$RO-ABBVIE-5901881$ABBVIE$$70$YR$$M$Y$$$20240905$$CN$RO$RO
242763901$24276390$1$I$20240722$20240902$20240903$20240903$EXP$FR-AFSSAPS-TO2024001622$FR-SANDOZ INC.-SDZ2024FR077077$SANDOZ$$69$YR$$M$Y$49.4$KG$20240903$$PH$FR$FR
242763911$24276391$1$I$$20240829$20240903$20240903$EXP$$NVSC2024US175646$NOVARTIS$$$$$$Y$$$20240903$$CN$US$US
242763921$24276392$1$I$20240101$20240829$20240903$20240903$EXP$$US-ABBVIE-5901386$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242763931$24276393$1$I$20240829$20240829$20240903$20240903$EXP$$FR-ABBVIE-5904740$ABBVIE$$74$YR$$F$Y$$$20240903$$HP$FR$FR
242763941$24276394$1$I$20240501$20240830$20240903$20240903$EXP$$US-ABBVIE-5903648$ABBVIE$$65$YR$$F$Y$$$20240903$$CN$US$US
242763951$24276395$1$I$$20240812$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08136$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242763961$24276396$1$I$20240825$20240829$20240903$20240903$EXP$$CN-MYLANLABS-2024M1080119$MYLAN$$19$YR$$F$Y$45$KG$20240903$$HP$CN$CN
242763971$24276397$1$I$20240601$20240830$20240903$20240903$EXP$$US-ABBVIE-5903604$ABBVIE$$84$YR$$M$Y$$$20240903$$CN$US$US
242763981$24276398$1$I$20240829$20240829$20240903$20240903$EXP$$US-ABBVIE-5901678$ABBVIE$$48$YR$$F$Y$$$20240903$$CN$US$US
242763992$24276399$2$F$20240814$20240903$20240903$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-042750$AUROBINDO$$$$$$Y$$$20240910$$CN$GB$GB
242764001$24276400$1$I$$20240823$20240903$20240903$EXP$$US-UCBSA-2024043420$UCB$$$$$$Y$$$20240903$$CN$US$US
242764011$24276401$1$I$$20240819$20240903$20240903$EXP$$IN-SEBELA IRELAND LIMITED-2024SEB00060$SEBELA$Jaiswal A, Wagle V, Tantry B.V, Shetty G, Shenoy. Azathioprine induced bland cholestasis in a primigravida with systemic lupus erythromatosis: a case report.. J. Clin. Exp. Hepatol.. 2024;14$28$YR$$F$Y$$$20240903$$HP$IN$IN
242764021$24276402$1$I$$20240819$20240903$20240903$EXP$$US-SEBELA IRELAND LIMITED-2024SEB00061$SEBELA$Alamurova R, Nedelkopoulou N, Narula P.et al.. MYELOSUPPRESSION WITH PANCYTOPENIA AND ALOPECIA SECONDARY TO AZATHIOPRINE IN TWO PATIENTS WITH NUDT15?3 ALLELE WITH INFLAMMATORY BOWEL DISEASE (IBD).. Frontline Gastroenterol.. 2024;15(A17)$13$YR$$F$Y$$$20240903$$HP$US$GB
242764031$24276403$1$I$$20240829$20240903$20240903$PER$$US-BIOGEN-2024BI01280530$BIOGEN$$$$$F$Y$$$20240903$$MD$US$US
242764041$24276404$1$I$$20240814$20240903$20240903$PER$$US-TEVA-VS-3234620$TEVA$$$$$F$Y$$$20240903$$CN$US$US
242764051$24276405$1$I$$20240828$20240903$20240903$EXP$$JP-CHEPLA-2024011170$CHEPLAPHARM$$80$YR$$F$Y$$$20240903$$MD$COUNTRY NOT SPECIFIED$JP
242764063$24276406$3$F$20240101$20240923$20240903$20240930$EXP$$US-ABBVIE-5901756$ABBVIE$$$$$M$Y$71$KG$20240930$$CN$US$US
242764071$24276407$1$I$20240720$20240730$20240903$20240903$EXP$$IN-ROCHE-10000071805$ROCHE$$63$YR$A$M$Y$$$20240903$$MD$IN$IN
242764081$24276408$1$I$$20240830$20240903$20240903$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-117944$REGENERON$$$$$$Y$$$20240903$$MD$JP$JP
242764091$24276409$1$I$20240701$20240828$20240903$20240903$PER$$US-AMGEN-USASP2024172020$AMGEN$$84$YR$E$F$Y$$$20240903$$HP$US$US
242764101$24276410$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-082296-2024$RECKITT BENCKISER$$$$$$Y$$$20240903$$CN$US$US
242764111$24276411$1$I$$20240826$20240903$20240903$EXP$$JP-AstraZeneca-2024A197317$ASTRAZENECA$$$$A$$Y$$$20240903$$MD$JP$
242764121$24276412$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-140242-2023$RECKITT BENCKISER$$$$$$Y$$$20240903$$CN$US$US
242764131$24276413$1$I$$20240823$20240903$20240903$EXP$$GB-AUROBINDO-AUR-APL-2024-042623$AUROBINDO$$$$$F$Y$$$20240903$$CN$GB$GB
242764151$24276415$1$I$$20240828$20240903$20240903$EXP$$CA-APOTEX-2024AP010106$APOTEX$$71$YR$$F$Y$$$20240903$$CN$CA$CA
242764161$24276416$1$I$20220101$20240830$20240903$20240903$EXP$$US-ROCHE-10000071226$ROCHE$$59$YR$A$F$Y$104.32$KG$20240903$$CN$US$US
242764171$24276417$1$I$20240101$20240826$20240903$20240903$PER$$US-SA-2024SA252454$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240903$$MD$US$US
242764181$24276418$1$I$$20240822$20240903$20240903$PER$$US-SA-2024SA144999$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240903$$CN$US$US
242764191$24276419$1$I$$20240820$20240903$20240903$PER$$US-SA-2024SA252562$SANOFI AVENTIS$$$$A$F$Y$$$20240903$$MD$US$US
242764201$24276420$1$I$$20240822$20240903$20240903$PER$$US-SA-2024SA254823$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240903$$MD$US$US
242764212$24276421$2$F$$20240906$20240903$20240913$PER$$US-SA-2024SA254851$SANOFI AVENTIS$$$$A$M$Y$$$20240913$$CN$US$US
242764221$24276422$1$I$20240801$20240826$20240903$20240903$PER$$US-SA-2024SA252016$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240903$$CN$US$US
242764231$24276423$1$I$20240101$20240822$20240903$20240903$PER$$US-SA-2024SA255373$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240903$$MD$US$US
242764241$24276424$1$I$$20240820$20240903$20240903$PER$$US-SA-2024SA252004$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240903$$CN$US$US
242764251$24276425$1$I$20240712$20240827$20240903$20240903$EXP$FR-AFSSAPS-TO2024001443$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111630$ZYDUS PHARM$$$$$$Y$$$20240903$$PH$FR$FR
242764261$24276426$1$I$20240725$20240827$20240903$20240903$EXP$FR-AFSSAPS-MP2024001321$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111652$ZYDUS PHARM$$$$$$Y$$$20240903$$MD$FR$FR
242764271$24276427$1$I$20240619$20240827$20240903$20240903$EXP$FR-AFSSAPS-TS2024000926$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111639$ZYDUS PHARM$$$$$$Y$$$20240903$$MD$FR$FR
242764281$24276428$1$I$$20240828$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137741$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240903$$CN$US$US
242764291$24276429$1$I$20240819$20240827$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136067$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240903$$PH$US$US
242764301$24276430$1$I$$20240901$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139594$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$58.06$KG$20240903$$CN$US$US
242764311$24276431$1$I$$20240823$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134572$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240903$$HP$US$US
242764331$24276433$1$I$$20240821$20240903$20240903$EXP$$US-SA-2024SA253411$SANOFI AVENTIS$$$$A$F$Y$$$20240903$$MD$US$US
242764341$24276434$1$I$$20240826$20240903$20240903$EXP$$US-TAKEDA-2024TUS086533$TAKEDA$$$$$M$Y$107.4$KG$20240903$$MD$US$US
242764352$24276435$2$F$$20240829$20240903$20240906$EXP$$US-BIOGEN-2024BI01280632$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242764371$24276437$1$I$20240819$20240828$20240903$20240903$PER$$US-AMGEN-USASP2024172060$AMGEN$$$$$M$Y$$$20240903$$CN$US$US
242764381$24276438$1$I$20240522$20240827$20240903$20240903$EXP$SE-SEMPA-2024-006161$SE-TEVA-VS-3237628$TEVA$$71$YR$$M$Y$$$20240903$$MD$SE$SE
242764401$24276440$1$I$$20240812$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08118$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242764411$24276441$1$I$20240101$20240827$20240903$20240903$EXP$$US-ABBVIE-5888624$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242764421$24276442$1$I$$20240821$20240903$20240903$EXP$$CA-MYLANLABS-2024M1079117$MYLAN$$65$YR$$F$Y$69$KG$20240903$$HP$CA$CA
242764441$24276444$1$I$20240101$20240829$20240903$20240903$EXP$$US-ABBVIE-5902272$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242764451$24276445$1$I$20240721$20240828$20240903$20240903$EXP$$CA-JNJFOC-20240774776$JOHNSON AND JOHNSON$$89$YR$E$M$Y$77$KG$20240903$$HP$CA$CA
242764461$24276446$1$I$20240101$20240828$20240903$20240903$PER$$US-SA-2024SA254385$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240903$$HP$US$US
242764471$24276447$1$I$20240801$20240827$20240903$20240903$PER$$US-SA-2024SA254400$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240903$$MD$US$US
242764481$24276448$1$I$20240101$20240820$20240903$20240903$PER$$US-SA-2024SA252097$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240903$$MD$US$US
242764491$24276449$1$I$20240101$20240820$20240903$20240903$PER$$US-SA-2024SA252135$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240903$$HP$US$US
242764501$24276450$1$I$$20240822$20240903$20240903$EXP$$SE-ASTELLAS-2024-AER-001595$ASTELLAS$$59$YR$A$F$Y$$$20240903$$MD$SE$SE
242764511$24276451$1$I$$20240823$20240903$20240903$PER$$US-APOTEX-2024AP009842$APOTEX$Kuo C, Carlini SV, Tiwari S. Parkinsonism is a Red Herring: Broad Differential Diagnoses in a Case of Catatonia Secondary to Clozapine Withdrawal. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64 (Suppl.):S6-S7$56$YR$$F$Y$$$20240903$$HP$US$US
242764522$24276452$2$F$$20240906$20240903$20240916$EXP$$JP-TEVA-VS-3237425$TEVA$Yamada K, Ida-Ichikawa M, Fujimoto N, Ishida M, Dohi K. Takotsubo syndrome in a cancer patient treated with a combination of anti-cancer drugs including immune checkpoint inhibitors: A case report. Eur-Heart-J-Case-Rep 2024; 8 (8); Yamada K, Ida-Ichikawa M, Fujimoto N, Ishida M, Dohi K. Takotsubo syndrome in a cancer patient treated with a combination of anti-cancer drugs including immune checkpoint inhibitors: A case report. Eur-Heart-J-Case-Rep 2024; 8 (8):.; Yamada K, Ida-Ichikawa M, Fujim...$66$YR$$F$Y$$$20240916$$MD$JP$JP
242764531$24276453$1$I$$20240827$20240903$20240903$PER$$US-ROCHE-10000068015$ROCHE$$$$E$F$Y$53.52$KG$20240903$$CN$US$US
242764541$24276454$1$I$20240828$20240829$20240903$20240903$PER$$US-SA-2024SA253583$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240903$$CN$US$US
242764551$24276455$1$I$$20240826$20240903$20240903$EXP$$US-GSK-US2024106024$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$MD$US$US
242764561$24276456$1$I$$20240829$20240903$20240903$EXP$$NVSC2024CA115641$NOVARTIS$$63$YR$$F$Y$$$20240903$$CN$CA$CA
242764571$24276457$1$I$$20240828$20240903$20240903$EXP$$JP-AMGEN-JPNSP2024172332$AMGEN$$$$$$Y$$$20240903$$MD$JP$JP
242764581$24276458$1$I$$20240821$20240903$20240903$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004535$PAREXEL$$$$$$Y$$$20240903$$CN$US$US
242764592$24276459$2$F$$20240911$20240903$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409000347$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240916$$CN$US$US
242764601$24276460$1$I$$20240822$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408015155$ELI LILLY AND CO$$53$YR$A$$Y$$$20240903$$LW$US$US
242764611$24276461$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000247$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240903$$CN$US$US
242764621$24276462$1$I$20240826$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000741$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240903$$CN$US$US
242764631$24276463$1$I$20240725$20240823$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042930$AUROBINDO$$$DY$$F$Y$3.43$KG$20240903$$MD$FR$FR
242764641$24276464$1$I$20231111$20240826$20240903$20240903$EXP$$KR-AMGEN-KORSP2024173586$AMGEN$$58$YR$A$F$Y$$$20240903$$HP$KR$KR
242764651$24276465$1$I$$20240828$20240903$20240903$PER$$US-ALXN-202408USA001955US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$MD$US$US
242764662$24276466$2$F$$20240905$20240903$20240913$30DAY$$CA-JNJFOC-20240879903$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$HP$CA$CA
242764672$24276467$2$F$$20240920$20240903$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139366$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240924$$CN$US$US
242764681$24276468$1$I$$20240828$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138846$BRISTOL MYERS SQUIBB$$78$YR$E$$Y$100$KG$20240903$$HP$US$US
242764691$24276469$1$I$$20240901$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139402$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240903$$HP$US$US
242764701$24276470$1$I$20240101$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138158$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240903$$CN$US$US
242764711$24276471$1$I$$20240830$20240903$20240903$PER$$NVSC2024US176411$NOVARTIS$$$$$M$Y$87$KG$20240903$$CN$US$US
242764721$24276472$1$I$$20240829$20240903$20240903$EXP$$NVSC2024CA176567$NOVARTIS$$74$YR$$F$Y$70$KG$20240903$$MD$CA$CA
242764732$24276473$2$F$20240611$20240906$20240903$20240920$EXP$$JP-UCBSA-2024043140$UCB$$8$YR$$F$Y$18.5$KG$20240920$$MD$JP$JP
242764741$24276474$1$I$20240601$20240821$20240903$20240903$EXP$$CA-UCBSA-2024042864$UCB$$63$YR$$F$Y$$$20240903$$CN$CA$CA
242764761$24276476$1$I$$20240825$20240903$20240903$EXP$GB-MHRA-MED-202408251533267900-SPNVQ$GB-TEVA-VS-3237272$TEVA$$68$YR$$F$Y$56$KG$20240903$$MD$GB$GB
242764771$24276477$1$I$20240804$20240825$20240903$20240903$EXP$GB-MHRA-MED-202408251452442570-LZHFP$GB-TEVA-VS-3237267$TEVA$$39$YR$$M$Y$$$20240903$$PH$GB$GB
242764781$24276478$1$I$20240806$20240826$20240903$20240903$EXP$$AT-EMD Serono-2024045959$EMD SERONO INC$$81$YR$E$F$Y$80$KG$20240903$$MD$AT$AT
242764791$24276479$1$I$20240701$20240826$20240903$20240903$EXP$$CO-AstraZeneca-2024A196987$ASTRAZENECA$$1769$WK$$F$Y$$$20240903$$CN$CO$
242764801$24276480$1$I$$20240823$20240903$20240903$PER$$US-ABBVIE-5895025$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242764811$24276481$1$I$20240816$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194199$ASTRAZENECA$$87$YR$$F$Y$$$20240903$$CN$US$
242764821$24276482$1$I$$20240815$20240903$20240903$30DAY$$US-JNJFOC-20240853253$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242764831$24276483$1$I$$20240829$20240903$20240903$EXP$$ZA-JNJFOC-20240900126$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$HP$ZA$ZA
242764862$24276486$2$F$20240601$20240830$20240903$20240906$EXP$$ES-JNJFOC-20240876045$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240906$$CN$ES$ES
242764872$24276487$2$F$$20240829$20240903$20240918$30DAY$$MX-JNJFOC-20240879858$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$MX$MX
242764881$24276488$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-140199-2023$RECKITT BENCKISER$$79$YR$$F$Y$$$20240903$$CN$US$US
242764893$24276489$3$F$$20240925$20240903$20240930$30DAY$$BR-UCBSA-2024044671$UCB$$$$$M$Y$$$20240930$$CN$BR$BR
242764901$24276490$1$I$20240126$20240826$20240903$20240903$EXP$FR-AFSSAPS-MP2024000390$FR-CELLTRION INC.-2024FR020751$CELLTRION$$$$$$Y$$$20240903$$MD$FR$FR
242764911$24276491$1$I$$20240827$20240903$20240903$EXP$$US-TAKEDA-2024TUS086467$TAKEDA$$$$$M$Y$$$20240903$$CN$US$US
242764921$24276492$1$I$20240304$20240828$20240903$20240903$EXP$$ES-AMGEN-ESPNI2024171994$AMGEN$$71$YR$E$M$Y$65$KG$20240903$$MD$ES$ES
242764931$24276493$1$I$20240801$20240819$20240903$20240903$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00764$Phathom Pharmaceuticals$$8$DEC$$M$Y$$$20240903$$MD$JP$JP
242764941$24276494$1$I$$20240814$20240903$20240903$PER$$US-UniquePharma-US-2024UPLSPO00033$UNIQUE PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
242764971$24276497$1$I$20230101$20240829$20240903$20240903$EXP$$CA-ABBVIE-5904808$ABBVIE$$47$YR$$F$Y$$$20240903$$CN$CA$CA
242764982$24276498$2$F$$20240830$20240903$20240904$PER$$NVSC2024US176800$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
242764991$24276499$1$I$20240801$20240827$20240903$20240903$EXP$$CA-CELLTRION INC.-2024CA020726$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
242765002$24276500$2$F$20240824$20240902$20240903$20240904$EXP$$US-ROCHE-10000072019$ROCHE$$79$YR$E$M$Y$$$20240904$$CN$US$US
242765021$24276502$1$I$$20240826$20240903$20240903$EXP$$JP-ROCHE-10000071545$ROCHE$Takahashi T, Sato Y, Wakita A, Nagaki Y, Sasamori R, Sasaki Y. P11-10 A case of irAE cholangitis sclerosing developed after administration of pembrolizumab for relapse of metastases to lymph nodes which were noted after surgery for thoracic oesophageal carcinoma. The 78th Annual Meeting of The Japan Esophageal Society. 2024;223.$74$YR$E$M$Y$$$20240903$$MD$JP$JP
242765031$24276503$1$I$20240513$20240819$20240903$20240903$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465561$RANBAXY$$20$YR$$F$Y$$$20240903$$PH$ES$ES
242765041$24276504$1$I$$20240828$20240903$20240903$PER$$US-JNJFOC-20240877530$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$HP$US$US
242765051$24276505$1$I$$20240819$20240903$20240903$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465190$RANBAXY$Dornellas A, Bonadio RC, Moraes PM, Galhera D, Victor CR, Chen ATC, et al. Cisplatin and capecitabine as definitive chemoradiation for squamous cell carcinoma of the anal canal (SCCAC): A prospective cohort. J Clin Oncol. 2024;42 (Suppl.)(16)$$$$$Y$$$20240903$$HP$BR$BR
242765061$24276506$1$I$20240813$20240819$20240903$20240903$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465820$RANBAXY$$61$YR$$F$Y$52$KG$20240903$$CN$GB$GB
242765071$24276507$1$I$20240518$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465713$RANBAXY$$78$YR$$M$Y$$$20240903$$MD$FR$FR
242765081$24276508$1$I$$20240819$20240903$20240903$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465249$RANBAXY$Kline K, Chen W, Kallen ME, Koka R, Omili D, Fan X, et al. Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD). Hum Vaccin Immunother. 2023;19 (2):2216116/1-5$55$YR$$F$Y$$$20240903$$HP$US$US
242765091$24276509$1$I$$20240819$20240903$20240903$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465073$RANBAXY$Schwartz AH, Sieminski S. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event. Am J Ophthalmol Case Rep. 2023;30:101827 (1-4)$59$YR$$F$Y$$$20240903$$HP$US$US
242765101$24276510$1$I$20220616$20240819$20240903$20240903$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465623$RANBAXY$$81$YR$$M$Y$$$20240903$$MD$IT$IT
242765121$24276512$1$I$$20240819$20240903$20240903$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465279$RANBAXY$Tarda L, Sacco MA, Tarzia P, Verrina MC, Calafiore J, Aquila I. Analysis of toxicological findings related to immunofluorescence investigations. Clin Ter. 2024;175;S2(4):183-186$54$YR$$M$Y$$$20240903$$HP$IT$IT
242765131$24276513$1$I$$20240819$20240903$20240903$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465856$RANBAXY$Maung AC, Brain H, Ballav C, Sihota S. Severe bradycardia at acute medical take - Think about myxoedema coma. J R Coll Physicians Edinb. 2024;54(2):133-137$97$YR$$M$Y$$$20240903$$HP$GB$GB
242765141$24276514$1$I$$20240819$20240903$20240903$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465255$RANBAXY$Hoover E, Corlin T, Lohr J, Sabol B, Yamamura Y, Jacobs K, et al. TAVR Beyond Fetal Viability: An Alternative to Preterm Delivery in Symptomatic Severe Aortic Stenosis. JACC Case repo. 2023;DEC; 27:102104/1-5$33$YR$$F$Y$$$20240903$$MD$US$US
242765151$24276515$1$I$20210101$20240819$20240903$20240903$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465535$RANBAXY$$74$YR$$M$Y$77$KG$20240903$$CN$GB$GB
242765161$24276516$1$I$$20240819$20240903$20240903$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465226$RANBAXY$Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front Psychiatry. 2023;Jan;14:1332999(1-4)$$$A$F$Y$$$20240903$$HP$US$US
242765171$24276517$1$I$$20240819$20240903$20240903$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465517$RANBAXY$$14$YR$$M$Y$82$KG$20240903$$HP$GB$GB
242765181$24276518$1$I$20240418$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465712$RANBAXY$$47$YR$$F$Y$90$KG$20240903$$CN$FR$FR
242765191$24276519$1$I$$20240819$20240903$20240903$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465284$RANBAXY$Tarda L, Sacco MA, Tarzia P, Verrina MC, Calafiore J, Aquila I. Analysis of toxicological findings related to immunofluorescence investigations. Clin Ter. 2024;175;S2(4):183-186$45$YR$$M$Y$$$20240903$$HP$IT$IT
242765201$24276520$1$I$20240617$20240819$20240903$20240903$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464350$RANBAXY$$33$YR$A$F$Y$$$20240903$$MD$US$US
242765211$24276521$1$I$19990101$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465680$RANBAXY$$38$YR$$M$Y$$$20240903$$MD$FR$FR
242765221$24276522$1$I$$20240819$20240903$20240903$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465530$RANBAXY$$52$YR$$M$Y$101$KG$20240903$$CN$GB$GB
242765231$24276523$1$I$20240411$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465570$RANBAXY$$14$YR$$F$Y$$$20240903$$MD$FR$FR
242765241$24276524$1$I$$20240819$20240903$20240903$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465282$RANBAXY$Tarda L, Sacco MA, Tarzia P, Verrina MC, Calafiore J, Aquila I. Analysis of toxicological findings related to immunofluorescence investigations. Clin Ter. 2024;175;S2(4):183-186$56$YR$$F$Y$$$20240903$$HP$IT$IT
242765251$24276525$1$I$20240330$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465467$RANBAXY$$74$YR$$F$Y$77$KG$20240903$$MD$FR$FR
242765261$24276526$1$I$20240101$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465448$RANBAXY$$84$YR$$F$Y$80$KG$20240903$$PH$FR$FR
242765271$24276527$1$I$$20240819$20240903$20240903$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465463$RANBAXY$$$$$F$Y$$$20240903$$CN$DE$DE
242765291$24276529$1$I$20240319$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465685$RANBAXY$$$$E$F$Y$$$20240903$$CN$FR$FR
242765301$24276530$1$I$$20240819$20240903$20240903$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465823$RANBAXY$Maung AC, Brain H, Ballav C, Sihota S. Severe bradycardia at acute medical take - Think about myxoedema coma. J R Coll Physicians Edinb. 2024;54(2):133-137$82$YR$$M$Y$$$20240903$$HP$GB$GB
242765311$24276531$1$I$$20240819$20240903$20240903$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465578$RANBAXY$$70$YR$$F$Y$64$KG$20240903$$MD$GB$GB
242765321$24276532$1$I$20200201$20240819$20240903$20240903$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465542$RANBAXY$Konishi H, Nagasawa Y, Matsui H, Mano A, Saito E. The use of high-dose oxycodone with midazolam for dyspnea due to end-stage heart failure in an older patient with renal insufficiency. Nippon Ron Igak Zasshi Jpn J Geriatr. 2023;60 (3):301-306$91$YR$$F$Y$$$20240903$$HP$JP$JP
242765331$24276533$1$I$20240208$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465483$RANBAXY$$40$YR$$F$Y$$$20240903$$PH$FR$FR
242765341$24276534$1$I$20240521$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465534$RANBAXY$$39$YR$$F$Y$41$KG$20240903$$MD$FR$FR
242765351$24276535$1$I$$20240819$20240903$20240903$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465245$RANBAXY$Guner Ozenen G, Akaslan Kara A, Boncuoglu E, Kiymet E, Cem E, Sahinkaya S, et al. Evaluation of antithrombotic prophylaxis and thrombotic events in children with COVID-19 or MIS-C: A tertiary pediatric center experience. Arch Pediatr. 2023;30 (3):172-178$13$YR$$M$Y$$$20240903$$HP$TR$TR
242765363$24276536$3$F$$20240903$20240903$20240918$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465100$RANBAXY$Mazza F, Cicciarelli A, Rubino F, Leopizzi M, Di Maio V, Cerbelli B. Case Report: MPO-ANCA Associated Vasculitis AfterPfizer-BioNTech COVID-19 mRNA Vaccination. G Ital Nefrol. 2023;40:1$72$YR$$M$Y$$$20240918$$HP$IT$IT
242765381$24276538$1$I$$20240819$20240903$20240903$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465460$RANBAXY$Kawalec A, Cichon L, Wilczynski K, Janas-Kozik M. First onset of persistent neutropenia in patient undergoing long-term clozapine treatment after vaccination against COVID-19 and SARS-CoV-2 infection in short interval - a case report. Psychiatr Pol. 2024;0 (0):1-11$23$YR$$F$Y$$$20240903$$HP$PL$PL
242765391$24276539$1$I$$20240819$20240903$20240903$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465183$RANBAXY$Lopes DN, de Oliveira NP, de Campos AugustoKC, Milagres A, Miguez AL,Junior AS, et al. Co-occurrence of oral pemphigus vulgaris and herpes simplex virus infection in a young patient with Crohn^s disease: report of a rare case of oral lesions during anti-TFN alpha and immunomodulator therapy. Int J Colorectal Dis. 2024;39 (1):125$18$YR$$F$Y$$$20240903$$HP$BR$BR
242765401$24276540$1$I$$20240819$20240903$20240903$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465276$RANBAXY$Dutra RdM, Pinto FPJ, Craveiro MMS, Baima JP, Saad-Hossne R, Romeiro FG, et al. Risks and benefits of anti-TNF therapy for ulcerative colitis in a patient with autoimmune hepatitis-related cirrhosis Case report. Medicine. 2024;103:31;1-5$28$YR$$F$Y$$$20240903$$HP$BR$BR
242765411$24276541$1$I$20231201$20240819$20240903$20240903$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465539$RANBAXY$$66$YR$$F$Y$83$KG$20240903$$CN$DE$DE
242765432$24276543$2$F$20240611$20240828$20240903$20240911$EXP$$JP-AMGEN-JPNSP2024171787$AMGEN$$$$E$F$Y$$$20240911$$MD$JP$JP
242765441$24276544$1$I$$20240827$20240903$20240903$EXP$$JP-AMGEN-JPNSP2024171668$AMGEN$$$$E$$Y$$$20240903$$PH$JP$JP
242765453$24276545$3$F$$20240913$20240903$20240917$EXP$$US-TAKEDA-2024TUS087839$TAKEDA$$$$$F$Y$$$20240917$$MD$US$US
242765462$24276546$2$F$20230511$20240823$20240903$20240906$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465240$RANBAXY$$49$YR$$F$Y$46.9$KG$20240906$$MD$ES$ES
242765471$24276547$1$I$20231201$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465262$RANBAXY$$64$YR$$M$Y$$$20240903$$MD$FR$FR
242765481$24276548$1$I$20231219$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465112$RANBAXY$$75$YR$$M$Y$$$20240903$$PH$FR$FR
242765491$24276549$1$I$20240830$20240830$20240903$20240903$EXP$$US-TAKEDA-US201923176$TAKEDA$$25$YR$$M$Y$41$KG$20240903$$CN$US$US
242765501$24276550$1$I$20240601$20240819$20240903$20240903$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465195$RANBAXY$$61$YR$$M$Y$89$KG$20240903$$CN$DE$DE
242765511$24276551$1$I$20240509$20240819$20240903$20240903$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465513$RANBAXY$$63$YR$$F$Y$125$KG$20240903$$PH$DE$DE
242765521$24276552$1$I$20240220$20240819$20240903$20240903$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465390$RANBAXY$$68$YR$$M$Y$$$20240903$$PH$IT$IT
242765531$24276553$1$I$$20240819$20240903$20240903$EXP$$AT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465433$RANBAXY$$62$YR$$F$Y$$$20240903$$HP$AT$AT
242765541$24276554$1$I$20240517$20240819$20240903$20240903$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465499$RANBAXY$$60$YR$$M$Y$$$20240903$$MD$ES$ES
242765551$24276555$1$I$20231201$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465186$RANBAXY$$72$YR$$M$Y$$$20240903$$MD$FR$FR
242765561$24276556$1$I$20240310$20240819$20240903$20240903$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465259$RANBAXY$$41$YR$$F$Y$127$KG$20240903$$CN$GB$GB
242765571$24276557$1$I$$20240819$20240903$20240903$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465123$RANBAXY$Khouloud Razki, Uta Ouali, Chaima Najar, Sofiene Ben Aissa, Amina Gargouri Berrechid, Raba Jomli, Riadh Gouider. From levetiracetam to lithium: A journey of hope to manage suicidality and depression.. J Neurol Sci. 2023;455 (Suppl.):no pagination$20$YR$$M$Y$$$20240903$$HP$TN$TN
242765581$24276558$1$I$$20240819$20240903$20240903$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465256$RANBAXY$$58$YR$$M$Y$$$20240903$$PH$GB$GB
242765591$24276559$1$I$$20240819$20240903$20240903$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465319$RANBAXY$Shariff H, Luu T, Kavis H, Obuch J. Gastric Signet Ring Cell Adenocarcinoma With Metastasis to the Testicles and Leptomeninges. ACG Case Rep J. 2024;11 (8):e01419/1-5$38$YR$$M$Y$$$20240903$$MD$US$US
242765601$24276560$1$I$20240521$20240819$20240903$20240903$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464992$RANBAXY$$77$YR$$F$Y$98$KG$20240903$$MD$DE$DE
242765611$24276561$1$I$20240510$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465135$RANBAXY$$67$YR$$F$Y$$$20240903$$MD$FR$FR
242765626$24276562$6$F$$20240926$20240903$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139335$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240928$$CN$US$US
242765631$24276563$1$I$20240419$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465165$RANBAXY$$65$YR$$M$Y$98$KG$20240903$$PH$FR$FR
242765641$24276564$1$I$$20240829$20240903$20240903$PER$$US-ABBVIE-5903074$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242765651$24276565$1$I$$20240831$20240903$20240903$EXP$$US-SA-2024SA253764$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240903$$HP$US$US
242765661$24276566$1$I$20240821$20240822$20240903$20240903$PER$$US-SA-2024SA255399$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240903$$MD$US$US
242765671$24276567$1$I$20240515$20240829$20240903$20240903$EXP$$US-SA-2024SA253130$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240903$$CN$US$US
242765681$24276568$1$I$20240701$20240820$20240903$20240903$PER$$US-SA-2024SA252388$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240903$$CN$US$US
242765691$24276569$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-139770-2023$RECKITT BENCKISER$$$$$F$Y$$$20240903$$CN$US$US
242765701$24276570$1$I$$20240826$20240903$20240903$30DAY$$US-GSK-US2024AMR107370$GLAXOSMITHKLINE$$$$$M$Y$$$20240903$$CN$US$US
242765713$24276571$3$F$20240801$20240906$20240903$20240920$EXP$$CA-UCBSA-2024042852$UCB$$73$YR$$F$Y$$$20240920$$CN$CA$CA
242765721$24276572$1$I$$20240829$20240903$20240903$EXP$$IN-ROCHE-10000070814$ROCHE$$62$YR$A$F$Y$$$20240903$$CN$IN$IN
242765731$24276573$1$I$20240822$20240822$20240903$20240903$EXP$$US-NOVOPROD-1274727$NOVO NORDISK$$62$YR$$F$Y$$$20240903$$CN$US$US
242765751$24276575$1$I$$20240822$20240903$20240903$EXP$$US-NOVOPROD-1274366$NOVO NORDISK$$$$$$Y$$$20240903$$CN$US$US
242765761$24276576$1$I$$20240823$20240903$20240903$EXP$$AU-NOVOPROD-1274232$NOVO NORDISK$$41$YR$$F$Y$$$20240903$$MD$AU$AU
242765781$24276578$1$I$20240801$20240828$20240903$20240903$EXP$$US-ABBVIE-5900977$ABBVIE$$24$YR$$F$Y$$$20240903$$CN$US$US
242765791$24276579$1$I$$20240827$20240903$20240903$EXP$$GB-SANDOZ INC.-SDZ2024GB024710$SANDOZ$$$$$F$Y$$$20240903$$CN$GB$GB
242765801$24276580$1$I$$20240826$20240903$20240903$PER$$US-JNJFOC-20240868158$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$CN$US$US
242765821$24276582$1$I$20240527$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465777$RANBAXY$$32$YR$$M$Y$72$KG$20240903$$MD$FR$FR
242765831$24276583$1$I$20240412$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465494$RANBAXY$$34$YR$$F$Y$54$KG$20240903$$PH$FR$FR
242765841$24276584$1$I$20240322$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465526$RANBAXY$$37$YR$$M$Y$193$KG$20240903$$MD$FR$FR
242765851$24276585$1$I$$20240819$20240903$20240903$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465558$RANBAXY$Bellido-Cuellar S, Perez de la Fuente R, Lezana-Rosales JM, Sanchez-Calvin MT, Saiz-Diaz RA, Gonzalez de la Aleja J. Epilepsy and Autism spectrum disorder caused by a pathogenic variant in TNRC6B. Seizure. 2023;110:117-118$28$YR$$F$Y$$$20240903$$HP$ES$ES
242765861$24276586$1$I$$20240819$20240903$20240903$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465569$RANBAXY$$47$YR$$M$Y$69$KG$20240903$$PH$GB$GB
242765871$24276587$1$I$20240510$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465505$RANBAXY$$68$YR$$F$Y$$$20240903$$MD$FR$FR
242765881$24276588$1$I$$20240826$20240903$20240903$EXP$$JP-BAUSCH-BL-2024-013117$BAUSCH AND LOMB$Yamane M, Umayahara T, Aoyama Y, Hayashi H. 40 Three cases of plaque psoriasis progressing to psoriatic arthritis despite long-term administration of brodalumab. The 39th Annual Meeting of the Japanese Society for Psoriasis Research (2024.8.24). 2024;164.$3$DEC$$F$Y$$$20240903$$MD$JP$JP
242765891$24276589$1$I$20240526$20240903$20240903$20240903$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049155$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$$$20240903$$HP$AU$AU
242765901$24276590$1$I$20230101$20240823$20240903$20240903$EXP$$TR-NOVOPROD-1274862$NOVO NORDISK$$$$$F$Y$$$20240903$$CN$TR$TR
242765911$24276591$1$I$20240818$20240823$20240903$20240903$EXP$CN-NMPA-5001091002539202400631$CN-NOVOPROD-1274417$NOVO NORDISK$$69$YR$$F$Y$$$20240903$$HP$CN$CN
242765921$24276592$1$I$$20240823$20240903$20240903$EXP$$AU-NOVOPROD-1274865$NOVO NORDISK$$$$$F$Y$$$20240903$$CN$AU$AU
242765931$24276593$1$I$$20240823$20240903$20240903$EXP$$AR-NOVOPROD-1274241$NOVO NORDISK$$$$$M$Y$$$20240903$$MD$AR$AR
242765941$24276594$1$I$$20240823$20240903$20240903$EXP$$JP-NOVOPROD-1274558$NOVO NORDISK$$93$YR$$F$Y$$$20240903$$PH$JP$JP
242765952$24276595$2$F$20200101$20240901$20240903$20240913$EXP$$EG-NOVOPROD-1274869$NOVO NORDISK$$79$MON$$M$Y$21$KG$20240913$$CN$EG$EG
242765961$24276596$1$I$$20240830$20240903$20240903$PER$$US-TAKEDA-2024TUS087950$TAKEDA$$$$$F$Y$$$20240903$$CN$US$US
242765971$24276597$1$I$$20240822$20240903$20240903$EXP$$PL-Accord-443148$ACCORD$Podgorski Pawel. The use of tacrolimus in the treatment of exacerbation of lupus nephritis- a case report. Nefrologia i Dializoterapia Polska Nr 3/2016.2016;20:227-9$22$YR$A$F$Y$$$20240903$$HP$PL$PL
242765981$24276598$1$I$$20240826$20240903$20240903$EXP$$JP-BAUSCH-BL-2024-013120$BAUSCH AND LOMB$YAMANE M, UMAYAHARA T, AOYAMA Y, HAYASHI H. 40 Three cases of plaque psoriasis progressing to psoriatic arthritis despite long-term administration of brodalumab. The 39th Annual Meeting of the Japanese Society for Psoriasis Research(Aug 24-25, 2024). 2024;164.$3$DEC$$M$Y$$$20240903$$HP$JP$JP
242765991$24276599$1$I$$20240902$20240903$20240903$EXP$$CN-ROCHE-10000072150$ROCHE$$56$YR$A$F$Y$$$20240903$$CN$CN$CN
242766003$24276600$3$F$20240212$20240924$20240903$20240926$30DAY$$US-AMGEN-USASP2024172245$AMGEN$$$$$$Y$$$20240926$$HP$US$US
242766011$24276601$1$I$$20240831$20240903$20240903$PER$$US-BAYER-2024A125154$BAYER$$$$$$Y$$$20240903$$CN$US$US
242766021$24276602$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194376$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242766031$24276603$1$I$$20240828$20240903$20240903$EXP$$US-AstraZeneca-2024A196972$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242766041$24276604$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000273$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240903$$CN$US$US
242766052$24276605$2$F$20240801$20240830$20240903$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409000688$ELI LILLY AND CO$$11$YR$C$M$Y$$$20240905$$CN$US$US
242766061$24276606$1$I$$20240828$20240903$20240903$EXP$$JP-009507513-2408JPN003935J$MERCK$$7$DEC$$F$Y$70$KG$20240903$$MD$JP$JP
242766071$24276607$1$I$20240823$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000595$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240903$$CN$US$US
242766081$24276608$1$I$$20240831$20240903$20240903$PER$$US-BAYER-2024A125160$BAYER$$$$$$Y$$$20240903$$CN$US$US
242766091$24276609$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-138037-2023$RECKITT BENCKISER$$42$YR$$F$Y$152$KG$20240903$$CN$US$US
242766101$24276610$1$I$20240827$20240828$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137738$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240903$$HP$US$US
242766111$24276611$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-086713-2024$RECKITT BENCKISER$$$$$M$Y$$$20240903$$CN$US$US
242766121$24276612$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA252213$SANOFI AVENTIS$$$$$F$Y$$$20240903$$MD$US$US
242766131$24276613$1$I$$20240831$20240903$20240903$PER$$US-BAYER-2024A125241$BAYER$$$$$$Y$$$20240903$$CN$US$US
242766141$24276614$1$I$20240101$20240821$20240903$20240903$EXP$$US-SA-2024SA169416$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240903$$MD$US$US
242766161$24276616$1$I$$20240829$20240903$20240903$EXP$$JP-ABBVIE-5903822$ABBVIE$$$$$M$Y$$$20240903$$MD$JP$JP
242766171$24276617$1$I$$20240827$20240903$20240903$EXP$$AU-GSK-AU2024106312$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$MD$AU$AU
242766181$24276618$1$I$20240101$20240819$20240903$20240903$EXP$$US-UCBSA-2024028254$UCB$$$$$M$Y$$$20240903$$CN$US$US
242766191$24276619$1$I$$20240827$20240903$20240903$EXP$$US-ZENPEP LLC-2024AIMT01301$AIMMUNE$$$$$$Y$$$20240903$$CN$US$US
242766201$24276620$1$I$$20240824$20240903$20240903$30DAY$$US-GSK-US2024105609$GLAXOSMITHKLINE$$84$YR$$F$Y$$$20240903$$CN$US$US
242766213$24276621$3$F$$20240919$20240903$20240923$EXP$$JP-ADVANZ PHARMA-202408007108$ADVANZ PHARMA$$$$$$Y$$$20240923$$PH$JP$JP
242766221$24276622$1$I$20240806$20240827$20240903$20240903$EXP$$CA-CELLTRION INC.-2024CA019719$CELLTRION$$$$$$Y$$$20240903$$HP$CA$CA
242766232$24276623$2$F$$20240917$20240903$20240920$EXP$$AE-AMGEN-ARESP2024174336$AMGEN$$$$A$M$Y$$$20240919$$MD$AE$AE
242766242$24276624$2$F$$20240829$20240903$20240906$PER$$US-AMGEN-USASP2024175195$AMGEN$$$$$$Y$$$20240906$$CN$US$US
242766251$24276625$1$I$$20240827$20240903$20240903$PER$$US-ABBVIE-5899474$ABBVIE$$$$$$Y$$$20240903$$CN$US$US
242766261$24276626$1$I$$20240828$20240903$20240903$PER$$US-ABBVIE-5903295$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242766271$24276627$1$I$$20240828$20240903$20240903$EXP$$CO-ROCHE-10000063960$ROCHE$Escobar-Davila S, Rivas-Tafurt G, Melo-Burbano L, Osorio-Toro L, Benitez-Escobar E, Galindes-Casanova D, et al. Report of Henoch-Schonlein purpura associated with trastuzumab emtansine.. ecancermedicalscience. 2024-Jul-30;18: doi:10.3332/ecancer.2024.1732.$38$YR$A$F$Y$$$20240903$$HP$CO$CO
242766291$24276629$1$I$20240101$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173918$AMGEN$$$$A$F$Y$$$20240903$$MD$US$US
242766301$24276630$1$I$$20240827$20240903$20240903$EXP$$US-ABBVIE-5898710$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242766311$24276631$1$I$$20240801$20240903$20240903$EXP$$CA-AUROBINDO-AUR-APL-2024-016863$AUROBINDO$Muram S, Panchendrabose K, Eagles ME, Abdul Salam MS, Eesa M, Agbani EO, et al. Natural history of antiplatelet nonresponders undergoing carotid artery stenting. J-Neurosurg. 2023;139(3):661-669$$$$$Y$$$20240903$$MD$CA$CA
242766323$24276632$3$F$20240704$20240828$20240903$20240922$EXP$$CA-JNJFOC-20240840262$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240922$$HP$CA$CA
242766341$24276634$1$I$20240101$20240828$20240903$20240903$PER$$US-BAYER-2024A124242$BAYER$$80$YR$E$F$Y$73.9$KG$20240903$$CN$US$US
242766351$24276635$1$I$$20240826$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135719$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240903$$HP$US$US
242766361$24276636$1$I$$20240821$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133974$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$PH$US$US
242766372$24276637$2$F$$20240830$20240903$20240909$EXP$$CA-TAKEDA-2024TUS039703$TAKEDA$$$$$F$Y$74$KG$20240909$$HP$CA$CA
242766381$24276638$1$I$20240815$20240822$20240903$20240903$EXP$CN-HENLIUS-24CN016577$CN-Accord-444725$ACCORD$$55$YR$A$F$Y$$$20240903$$MD$CN$CN
242766391$24276639$1$I$$20240828$20240903$20240903$PER$$US-BAYER-2024A124302$BAYER$$$$$$Y$$$20240903$$CN$US$US
242766411$24276641$1$I$20180101$20240821$20240903$20240903$EXP$$CZ-AUROBINDO-AUR-APL-2024-042175$AUROBINDO$Novakova M, Kotolova H, Ustohal L.. EXPERIENCE WITH CLOZAPINE ADMINISTRATION AND LONG-TERM PALIPERIDONE PALMITE IN COMBINATION IN A PATIENT WITH PARANOID SCHIZOPHRENIA AND MARIHUANA ABUSE.. Czech and Psychiat.. 2024;120(3):151-6$45$YR$$M$Y$$$20240903$$PH$CZ$CZ
242766422$24276642$2$F$$20240902$20240903$20240906$EXP$$US-SANDOZ INC.-SDZ2024US077083$SANDOZ$$60$YR$$F$Y$$$20240906$$MD$US$US
242766432$24276643$2$F$20240101$20240903$20240903$20240906$EXP$$US-SA-2024SA254345$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240906$$MD$US$US
242766481$24276648$1$I$$20240829$20240903$20240903$PER$$US-BAYER-2024A124536$BAYER$$$$$F$Y$$$20240903$$CN$US$US
242766491$24276649$1$I$20240804$20240825$20240903$20240903$EXP$$GB-AUROBINDO-AUR-APL-2024-042801$AUROBINDO$$39$YR$$M$Y$$$20240903$$PH$GB$GB
242766502$24276650$2$F$20240827$20240913$20240903$20240922$PER$$US-JNJFOC-20240881116$JOHNSON AND JOHNSON$$82$YR$E$M$Y$65.376$KG$20240922$$HP$US$US
242766511$24276651$1$I$$20240826$20240903$20240903$PER$$US-JNJFOC-20240872806$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242766532$24276653$2$F$20240830$20240904$20240903$20240916$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01302$AIMMUNE$$$$$$Y$$$20240916$$HP$US$US
242766541$24276654$1$I$20240829$20240830$20240903$20240903$PER$$US-BAYER-2024A125161$BAYER$$92$YR$E$$Y$$$20240903$$CN$US$US
242766551$24276655$1$I$$20240828$20240903$20240903$EXP$$US-ABBVIE-5900219$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242766561$24276656$1$I$$20240902$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139707$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$67.59$KG$20240903$$CN$US$US
242766571$24276657$1$I$$20240902$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139662$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240903$$CN$US$US
242766581$24276658$1$I$$20240826$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136956$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240903$$CN$US$US
242766591$24276659$1$I$$20240902$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139761$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$83.46$KG$20240903$$CN$US$US
242766601$24276660$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138346$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240903$$HP$US$US
242766611$24276661$1$I$$20240830$20240903$20240903$PER$$US-BAYER-2024A125299$BAYER$$81$YR$E$F$Y$$$20240903$$CN$US$US
242766621$24276662$1$I$$20240829$20240903$20240903$EXP$$FR-ABBVIE-5904520$ABBVIE$$$$$M$Y$$$20240903$$MD$FR$FR
242766631$24276663$1$I$$20240829$20240903$20240903$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-138577$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$67$KG$20240903$$CN$FR$FR
242766641$24276664$1$I$$20240829$20240903$20240903$EXP$$US-SA-2024SA253125$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240903$$MD$US$US
242766651$24276665$1$I$20240101$20240820$20240903$20240903$PER$$US-SA-2024SA252286$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240903$$HP$US$US
242766661$24276666$1$I$20240101$20240820$20240903$20240903$PER$$US-SA-2024SA252312$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240903$$CN$US$US
242766671$24276667$1$I$$20240827$20240903$20240903$EXP$$KR-ROCHE-10000071267$ROCHE$$$$$$Y$$$20240903$$MD$KR$KR
242766691$24276669$1$I$20231101$20240822$20240903$20240903$EXP$$IR-Accord-443503$ACCORD$Zonooz YA, Alizadehasl A, Davani DN, Jebelli SFH, Aliabadi AY, Najdaghi S et al. Cardiac interventricular septum hemangioma in a colon cancer patient treated with Capecitabine: A case report and review of literature. Clin Case Rep. 2024 Aug 19;12(8):e9331.$21$YR$A$M$Y$$$20240903$$HP$IR$IR
242766701$24276670$1$I$$20240829$20240903$20240903$PER$$US-BAYER-2024A125657$BAYER$$$$$M$Y$$$20240903$$CN$US$US
242766711$24276671$1$I$$20240826$20240903$20240903$EXP$$BR-AstraZeneca-2024A198648$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$BR$
242766721$24276672$1$I$$20240822$20240903$20240903$PER$$US-AstraZeneca-2024A192085$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242766731$24276673$1$I$$20240823$20240903$20240903$PER$$US-AstraZeneca-2024A193230$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242766743$24276674$3$F$$20240907$20240903$20240918$EXP$$CA-ROCHE-10000068771$ROCHE$$$$A$F$Y$$$20240918$$CN$CA$CA
242766753$24276675$3$F$20240412$20240912$20240903$20240918$EXP$$US-ABBVIE-5899962$ABBVIE$$69$YR$$M$Y$102$KG$20240918$$CN$US$US
242766761$24276676$1$I$$20240827$20240903$20240903$PER$$US-BAYER-2024A123167$BAYER$$$$$$Y$$$20240903$$CN$US$US
242766771$24276677$1$I$$20240902$20240903$20240903$PER$$US-AMGEN-USASP2024175356$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242766781$24276678$1$I$$20240829$20240903$20240903$EXP$$US-TAKEDA-2023TUS028080$TAKEDA$$$$$F$Y$10.38$KG$20240903$$CN$US$US
242766791$24276679$1$I$$20240827$20240903$20240903$EXP$$JP-Taiho Oncology Inc-2024-007026$TAIHO ONCOLOGY INC$$8$DEC$E$$Y$$$20240903$$PH$JP$JP
242766801$24276680$1$I$$20240827$20240903$20240903$PER$$US-BAYER-2024A123922$BAYER$$$$$$Y$$$20240903$$CN$US$US
242766811$24276681$1$I$$20240816$20240903$20240903$PER$$US-TEVA-VS-3235582$TEVA$$63$YR$$F$Y$$$20240903$$CN$US$US
242766821$24276682$1$I$$20240827$20240903$20240903$EXP$$CN-ROCHE-10000071532$ROCHE$$$$$$Y$$$20240903$$MD$CN$CN
242766831$24276683$1$I$20240301$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-087335-2024$RECKITT BENCKISER$$$$$M$Y$$$20240903$$CN$US$US
242766842$24276684$2$F$20240723$20240829$20240903$20240911$EXP$$AU-BEH-2024178032$CSL BEHRING$$55$YR$A$F$Y$$$20240911$$HP$AU$AU
242766851$24276685$1$I$$20240828$20240903$20240903$EXP$NL-LRB-00997028$NL-TEVA-VS-3238080$TEVA$$56$YR$$F$Y$90$KG$20240903$$CN$NL$NL
242766861$24276686$1$I$20230101$20231113$20240903$20240903$EXP$$US-KHC-000159$Kilitch Healthcare$$75$YR$E$M$Y$$$20240903$$CN$US$IN
242766872$24276687$2$F$$20240906$20240903$20240916$EXP$$US-TEVA-VS-3238231$TEVA$Eisenberg J, Tedford NJ, Weaver N, Becker S, Moss MJ. Adverse Outcomes in Topical Lidocaine Exposure: A Pediatric Case Series From the United States National Poison Data System. Clin-Pediatr-Phila 2023; 62 (11): 1390-1397.; Eisenberg J, Tedford NJ, Weaver N, Becker S, Moss MJ. Adverse Outcomes in Topical Lidocaine Exposure: A Pediatric Case Series From the United States National Poison Data System. Clin-Pediatr-Phila 2023; 62 (11): 1390-1397.$$$$$Y$$$20240916$$MD$US$US
242766891$24276689$1$I$$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173631$AMGEN$$$$$F$Y$$$20240903$$CN$US$US
242766901$24276690$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-138306-2023$RECKITT BENCKISER$$$$$F$Y$$$20240903$$CN$US$US
242766911$24276691$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000573$ELI LILLY AND CO$$$$A$M$Y$$$20240903$$CN$US$US
242766921$24276692$1$I$$20240827$20240903$20240903$EXP$$IT-AMGEN-ITASP2024171671$AMGEN$Condorelli, A. Belantamab Mafodotin and Relapsed/ Refractory Multiple Myeloma: This Is Not Game Over. Acta Haematologica. 2024;147 (4):493-498$69$YR$E$F$Y$$$20240903$$HP$IT$IT
242766931$24276693$1$I$20240828$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024172945$AMGEN$$60$YR$A$M$Y$$$20240903$$CN$US$US
242766941$24276694$1$I$$20240503$20240903$20240903$PER$$US-CIPLA LTD.-2024US04634$CIPLA$$$$$$Y$$$20240829$$CN$US$US
242766951$24276695$1$I$$20240827$20240903$20240903$EXP$$IT-AMGEN-ITASP2024171625$AMGEN$Condorelli,A. Belantamab Mafodotin and Relapsed/ Refractory Multiple Myeloma: This Is Not Game Over. Acta Haematol. 2024;147:493-498$$$E$F$Y$$$20240903$$HP$IT$IT
242766961$24276696$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000539$ELI LILLY AND CO$$$$$$Y$$$20240903$$CN$US$US
242766972$24276697$2$F$20240822$20240912$20240903$20240921$EXP$$JP-ROCHE-10000071576$ROCHE$$55$YR$A$F$Y$$$20240921$$MD$JP$JP
242766981$24276698$1$I$$20240902$20240903$20240903$PER$$US-ROCHE-10000072437$ROCHE$$80$YR$E$M$Y$$$20240903$$MD$US$US
242766991$24276699$1$I$$20240826$20240903$20240903$PER$$US-BAYER-2024A122450$BAYER$$$$$$Y$$$20240903$$CN$US$US
242767001$24276700$1$I$20240829$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000324$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240903$$CN$US$US
242767011$24276701$1$I$20240827$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000425$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240903$$CN$US$US
242767021$24276702$1$I$20240528$20240819$20240903$20240903$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465504$RANBAXY$$68$YR$$F$Y$70$KG$20240903$$MD$FR$FR
242767032$24276703$2$F$20221231$20240912$20240903$20240920$EXP$$CO-UCBSA-2024044716$UCB$$25$YR$$F$Y$$$20240920$$CN$CO$CO
242767041$24276704$1$I$$20231009$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2023US076662$SANDOZ$KYRSHA GORBEA, ROSA I ROMAN-CARLO. IT IS ALL IN THE HISTORY AND PHYSICAL EXAMINATION. Chest Journal. 2023$72$YR$$M$Y$$$20240903$$HP$US$US
242767051$24276705$1$I$20240101$20240506$20240903$20240903$PER$$US-CIPLA LTD.-2024US04735$CIPLA$$$$$$Y$$$20240829$$CN$US$US
242767064$24276706$4$F$20240827$20240913$20240903$20240921$EXP$$CA-TAKEDA-2024TUS087399$TAKEDA$$76$YR$$M$Y$$$20240921$$CN$CA$CA
242767071$24276707$1$I$$20240821$20240903$20240903$EXP$$US-AUROBINDO-AUR-APL-2024-042082$AUROBINDO$Gabbay JM, Place AE, Ilowite M, Zhu J.. Use of the osmolal gap in diagnosing mixed physiology hyponatremia in a child with B-cell acute lymphoblastic leukemia. Clinical Case Reports. 2023;11(6):e7428$12$YR$$M$Y$$$20240903$$MD$US$US
242767081$24276708$1$I$$20240828$20240903$20240903$EXP$$GB-SANDOZ INC.-NVSC2021GB239281$SANDOZ$$$$$F$Y$$$20240903$$CN$GB$GB
242767091$24276709$1$I$20240201$20240829$20240903$20240903$EXP$$US-ABBVIE-5901873$ABBVIE$$71$YR$$F$Y$$$20240903$$CN$US$US
242767101$24276710$1$I$$20240827$20240903$20240903$EXP$$US-LUOXIN-LUX-2024-US-LIT-00048$LUOXIN AUROVITAS PHARMA(CHENGDU)$Maresch KJ.Arytenoid Dislocation and Vocal Cord Immobility After Emergent Fiberoptic Intubation: A Case Report..AANA-J.2020;88(6):459-463$53$YR$A$M$Y$82$KG$20240903$$HP$US$US
242767111$24276711$1$I$20240701$20240822$20240903$20240903$EXP$FR-AFSSAPS-CN2024000703$FR-Accord-443356$ACCORD$$31$YR$A$F$Y$$$20240903$$MD$FR$FR
242767151$24276715$1$I$20230310$20240827$20240903$20240903$EXP$$DE-ROCHE-10000067632$ROCHE$$61$YR$A$F$Y$65$KG$20240903$$MD$DE$DE
242767162$24276716$2$F$20240424$20240919$20240903$20240930$EXP$$JP-ROCHE-10000005516$ROCHE$$80$YR$E$F$Y$$$20240930$$MD$JP$JP
242767171$24276717$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5901903$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242767181$24276718$1$I$$20240826$20240903$20240903$EXP$$US-TEVA-VS-3238232$TEVA$Eisenberg J, Tedford NJ, Weaver N, Becker S, Moss MJ. Adverse Outcomes in Topical Lidocaine Exposure: A Pediatric Case Series From the United States National Poison Data System. Clin-Pediatr-Phila 2023; 62 (11): 1390-1397.$$$$$Y$$$20240903$$MD$US$US
242767191$24276719$1$I$$20240826$20240903$20240903$PER$$US-BAYER-2024A122608$BAYER$$80$YR$E$F$Y$$$20240903$$CN$US$US
242767211$24276721$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139458$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240903$$CN$US$US
242767221$24276722$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139282$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240903$$HP$US$US
242767231$24276723$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139166$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240903$$CN$US$US
242767243$24276724$3$F$20240801$20240916$20240903$20240918$EXP$$IL-ALXN-202408ISR002032IL$ALEXION PHARMACEUTICALS$$5$YR$$M$Y$$$20240918$$MD$IL$IL
242767251$24276725$1$I$$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173634$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242767261$24276726$1$I$$20240826$20240903$20240903$PER$$US-BAYER-2024A123135$BAYER$$72$YR$E$F$Y$$$20240903$$CN$US$US
242767271$24276727$1$I$20240901$20240902$20240903$20240903$EXP$$NVSC2024CY176640$NOVARTIS$$12$MON$$F$Y$7.45$KG$20240903$$MD$CY$CY
242767301$24276730$1$I$$20240822$20240903$20240903$EXP$$IT-MYLANLABS-2024M1079243$MYLAN$Conti EA, Chironi F, Petaccia A, Lanni S, Minoia F, Filocamo G. Safety and efficacy of concomitant use of anti IL17 and anti IL6 agents in a case of severe refractory systemic JIA: Report of the first 18 months of treatment. Pediatr-Rheumatol 2023; 21 (Suppl.).$$$$F$Y$$$20240903$$HP$IT$IT
242767311$24276731$1$I$$20240823$20240903$20240903$EXP$$US-MYLANLABS-2024M1079629$MYLAN$Kuno T, Shibata A, Imaeda S, Kodaira M, Numasawa Y. An extremely rare case of adult-onset kawasaki disease, with coronary computed tomography, intravascular ultrasound, and optical frequency domain imaging. J-Am-Coll-Cardiol 2019; 73 (Suppl.) (9): 2395.$18$YR$$F$Y$$$20240903$$HP$US$US
242767321$24276732$1$I$$20240822$20240903$20240903$EXP$$US-MYLANLABS-2024M1079229$MYLAN$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.$69$YR$$M$Y$$$20240903$$HP$US$US
242767331$24276733$1$I$20240501$20240823$20240903$20240903$EXP$$US-MYLANLABS-2024M1079059$MYLAN$$84$YR$$F$Y$61.68$KG$20240903$$CN$US$US
242767341$24276734$1$I$$20240822$20240903$20240903$EXP$$US-MYLANLABS-2024M1079228$MYLAN$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.$71$YR$$F$Y$$$20240903$$HP$US$US
242767351$24276735$1$I$$20240822$20240903$20240903$EXP$$US-MYLANLABS-2024M1079015$MYLAN$Bruno M, Strober B, Del Rosso JQ. Topical management of plaque psoriasis-A Review and Case Series Discussion with Focus on Aryl Hydrocarbon Receptor Modulation. J-Clin-Aesthet-Dermatol 2023; 16 (1) S3-S12.$79$YR$$F$Y$$$20240903$$HP$US$US
242767361$24276736$1$I$$20240822$20240903$20240903$EXP$$US-MYLANLABS-2024M1079231$MYLAN$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.$61$YR$$F$Y$$$20240903$$HP$US$US
242767371$24276737$1$I$$20240823$20240903$20240903$EXP$$US-MYLANLABS-2024M1079367$MYLAN$Bajwa NA, Bajwa AA, Ghazala S, Masood U. Dimethyl Fumarate-Associated Enterocolitis. Am-J-Ther 2024; 31 (4): e448-e450.$38$YR$$F$Y$$$20240903$$MD$US$US
242767381$24276738$1$I$$20240823$20240903$20240903$EXP$$DK-MYLANLABS-2024M1079611$MYLAN$Troan J, Hansen KNo, Noori M, Lassen JF, Jensen LO. Very late Magmaris scaffold restenosis: A 6-year serial optical coherence tomography case report. Eur-Heart-J-Case-Rep 2024; 8 (7): 1-4.$62$YR$$M$Y$$$20240903$$HP$DK$DK
242767391$24276739$1$I$$20240823$20240903$20240903$EXP$$US-MYLANLABS-2024M1079352$MYLAN$Belal AA, Slater A, Clapp WL, Ibrahim H, Santos A, Mehta RV. Tacrolimus-Induced Thrombotic Microangiopathy After Kidney Transplant. J-Am-Soc-Nephrol 2023; 34 613 abstr. FR-PO758.$73$YR$$F$Y$$$20240903$$HP$US$US
242767401$24276740$1$I$$20240822$20240903$20240903$EXP$$US-MYLANLABS-2024M1079264$MYLAN$Vincent MN, Jaggers J, Fiske C, Phillips EJ, Stollings JL. Amikacin symmetrical drug-related intertriginous and flexural exanthema on the basis of neomycin cross-reactivity managed with desensitization and treating through. Ann-Allergy-Asthma-Immunol 2024; 133 (2): 215-217.$70$YR$$F$Y$$$20240903$$PH$US$US
242767411$24276741$1$I$$20240822$20240903$20240903$EXP$$US-MYLANLABS-2024M1079002$MYLAN$Majid M, Yaker ZS, Brands C, Unai S, Klein AL. Not So Transient Effusive-Constrictive Pericarditis. JACC-Case-Rep 2023; 28.$63$YR$$M$Y$$$20240903$$MD$US$US
242767421$24276742$1$I$20240101$20240829$20240903$20240903$EXP$$US-ABBVIE-5901920$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242767441$24276744$1$I$20240716$20240829$20240903$20240903$EXP$$PT-AstraZeneca-2024A196808$ASTRAZENECA$$46$YR$$F$Y$$$20240903$$MD$PT$
242767451$24276745$1$I$$20240820$20240903$20240903$EXP$$US-UCBSA-2024042736$UCB$$$$$$Y$$$20240903$$CN$US$US
242767462$24276746$2$F$$20240912$20240903$20240920$PER$$US-BAYER-2024A123464$BAYER$$77$YR$E$F$Y$$$20240920$$CN$US$US
242767471$24276747$1$I$20240710$20240828$20240903$20240903$EXP$$DE-009507513-2408DEU009960$MERCK$$69$YR$$M$Y$$$20240903$$PH$DE$DE
242767481$24276748$1$I$20240101$20240829$20240903$20240903$EXP$$US-ABBVIE-5901710$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242767491$24276749$1$I$$20240829$20240903$20240903$EXP$$NVSC2024US175724$NOVARTIS$$$$$F$Y$$$20240903$$CN$US$US
242767501$24276750$1$I$$20240829$20240903$20240903$EXP$$NVSC2024GB175824$NOVARTIS$$$$A$F$Y$$$20240903$$HP$GB$GB
242767511$24276751$1$I$$20240829$20240903$20240903$EXP$$AU-ROCHE-10000069234$ROCHE$Narayanan S, Ngui N, Kinchington B, Choi J, Hughes T, Rutovitz J, et al. Pathological and clinical outcomes following neoadjuvant dual HER2 therapy for early stage breast cancer. An Australian institutional real-world experience; Cancer Medicine,. 2024;13 (12): doi:10.1002/cam4.7325.$$$$$Y$$$20240903$$HP$AU$AU
242767522$24276752$2$F$$20240915$20240903$20240920$EXP$$NVSJ2024JP010328$NOVARTIS$$58$YR$$M$Y$$$20240920$$MD$JP$JP
242767551$24276755$1$I$20240627$20240823$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042902$AUROBINDO$$29$YR$$M$Y$$$20240903$$MD$FR$FR
242767561$24276756$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139242$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$57.61$KG$20240903$$CN$US$US
242767571$24276757$1$I$$20240828$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137813$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240903$$HP$US$US
242767581$24276758$1$I$20240801$20240822$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002061$ALKERMES$$48$YR$$M$Y$77.098$KG$20240903$$HP$US$US
242767591$24276759$1$I$20240808$20240830$20240903$20240903$EXP$FR-AFSSAPS-PV2024000782$FR-ROCHE-10000070364$ROCHE$$15$YR$T$F$Y$48$KG$20240903$$MD$FR$FR
242767601$24276760$1$I$$20240820$20240903$20240903$PER$$US-Calliditas-2024CAL01641$CALLIDITAS THERAPEUTICS$$62$YR$A$F$Y$50$KG$20240903$$CN$US$US
242767612$24276761$2$F$20240828$20240903$20240903$20240905$PER$$US-ABBVIE-5902609$ABBVIE$$48$YR$$F$Y$$$20240905$$HP$US$US
242767632$24276763$2$F$$20240906$20240903$20240916$EXP$$US-TEVA-VS-3238459$TEVA$Torrie AM, Dunitz J, Brookman JC. Apparent Reversal of a Successful Peripheral Neural Blockade With Intravenous Lipid Emulsion After Treatment for Local Anesthetic Systemic Toxicity: A Case Report. A-A-Pract 2020; 14 (13):.; Torrie AM, Dunitz J, Brookman JC. Apparent Reversal of a Successful Peripheral Neural Blockade With Intravenous Lipid Emulsion After Treatment for Local Anesthetic Systemic Toxicity: A Case Report. A-A-Pract 2020; 14 (13):.; Torrie AM, Dunitz J, Brookman JC. Apparent Reve...$42$YR$$F$Y$56.7$KG$20240916$$MD$US$US
242767641$24276764$1$I$$20240509$20240903$20240903$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06633$HIKMA$Goyal A, Gaskill J, Osman O, Gibson D.. Goyal A, Gaskill J, Osman O, Gibson D. Analgesia to acidosis: metabolic acidosis due to chronic acetaminophen (paracetamol) use.. BMJ case reports.. 2024;17(4):e258396.$7$DEC$$M$Y$116.2$KG$20240903$$MD$US$US
242767651$24276765$1$I$20240702$20240823$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042919$AUROBINDO$$16$YR$$M$Y$$$20240903$$PH$FR$FR
242767662$24276766$2$F$$20240903$20240903$20240911$EXP$$JP-JNJFOC-20240903474$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$65$KG$20240911$$HP$JP$JP
242767682$24276768$2$F$20240813$20240904$20240903$20240915$EXP$$DE-AUROBINDO-AUR-APL-2024-042998$AUROBINDO$$76$YR$$M$Y$$$20240915$$MD$DE$DE
242767732$24276773$2$F$$20240906$20240903$20240916$EXP$$US-TEVA-VS-3238434$TEVA$Ratner S, Sloan S, Brewster K. COVID-19 or Clozapine? A Case of Likely Clozapine-Induced Systemic Inflammatory Response Syndrome. Am-J-Geriatr-Psychiatry 2024; 32 (Suppl.) (4): S76-S77.; Ratner S, Sloan S, Brewster K. COVID-19 or Clozapine? A Case of Likely Clozapine-Induced Systemic Inflammatory Response Syndrome. Am-J-Geriatr-Psychiatry 2024; 32 (Suppl.) (4): S76-S77.$$$E$F$Y$$$20240916$$HP$US$US
242767741$24276774$1$I$20240101$20240822$20240903$20240903$EXP$$US-SA-2024SA253717$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240903$$MD$US$US
242767751$24276775$1$I$$20240826$20240903$20240903$EXP$$AU-AMGEN-AUSSP2024171426$AMGEN$Pratap K.; Penglase R.; Roper E. et al.. Raynaud^s of the gut? Systemic sclerosis-associated microvascular ischaemic colitis responsive to intravenous iloprost. Rheumatology. 2024;63 (8):e219-e221$47$YR$A$F$Y$$$20240903$$HP$AU$AU
242767761$24276776$1$I$$20240825$20240903$20240903$PER$$US-BAYER-2024A122127$BAYER$$44$YR$A$M$Y$$$20240903$$CN$US$US
242767772$24276777$2$F$20240101$20240903$20240903$20240905$PER$$US-009507513-2408USA003512$MERCK$$$$$F$Y$85.714$KG$20240905$$HP$US$US
242767782$24276778$2$F$20240824$20240905$20240903$20240911$EXP$$US-BIOGEN-2024BI01280123$BIOGEN$$25$YR$$F$Y$$$20240911$$CN$US$US
242767792$24276779$2$F$20220826$20240922$20240903$20240926$EXP$$EG-SANDOZ INC.-SDZ2024EG036878$SANDOZ$$10$YR$$F$Y$35$KG$20240926$$HP$EG$EG
242767802$24276780$2$F$$20240904$20240903$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409000537$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240909$$HP$US$US
242767811$24276781$1$I$$20240826$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408016202$ELI LILLY AND CO$$$$$F$Y$$$20240903$$CN$US$US
242767821$24276782$1$I$20240801$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000251$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240903$$HP$US$US
242767831$24276783$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000530$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240903$$CN$US$US
242767851$24276785$1$I$$20240825$20240903$20240903$PER$$US-BAYER-2024A122451$BAYER$$$$$$Y$$$20240903$$CN$US$US
242767861$24276786$1$I$$20240823$20240903$20240903$EXP$$BR-CHIESI-2024CHF05465$CHIESI$$$$N$$Y$$$20240903$$MD$BR$BR
242767871$24276787$1$I$$20240826$20240903$20240903$EXP$$NL-AMGEN-NLDSP2024170295$AMGEN$Gorkom G. V.. Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas. Journal of Clinical Apheresis. 2016;32(5):1-7$$$$$Y$$$20240903$$HP$NL$NL
242767881$24276788$1$I$$20240829$20240903$20240903$EXP$$US-AMGEN-USASP2024173595$AMGEN$Gottiparthy A.; Lam K.; Kundu S. et al.. Neurofilament light chain in serum of cancer patients with acute neurological complications. CNS Oncology. 2024;13 (1):1-18$57$YR$A$F$Y$$$20240903$$HP$US$US
242767892$24276789$2$F$20240501$20240916$20240903$20240920$EXP$$DE-AUROBINDO-AUR-APL-2024-042654$AUROBINDO$$79$YR$$F$Y$65$KG$20240920$$PH$DE$DE
242767901$24276790$1$I$20240101$20240823$20240903$20240903$PER$$US-SA-2024SA253327$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240903$$HP$US$US
242767911$24276791$1$I$$20240823$20240903$20240903$PER$$US-SA-2024SA253056$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240903$$CN$US$US
242767921$24276792$1$I$$20240829$20240903$20240903$PER$$US-SA-2024SA254663$SANOFI AVENTIS$$23$YR$A$M$Y$77$KG$20240903$$CN$US$US
242767931$24276793$1$I$$20240828$20240903$20240903$PER$$US-HALEON-2194169$Haleon PLC$$$$$$Y$$$20240903$$CN$US$US
242767941$24276794$1$I$$20240826$20240903$20240903$30DAY$$US-GSK-US2024106052$GLAXOSMITHKLINE$$$$$M$Y$$$20240903$$CN$US$US
242767952$24276795$2$F$$20240829$20240903$20240904$EXP$$CA-AstraZeneca-2024A194533$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$CA$
242767971$24276797$1$I$$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024175113$AMGEN$$$$$F$Y$$$20240903$$CN$US$US
242767981$24276798$1$I$20240821$20240827$20240903$20240903$PER$$US-ABBVIE-5902335$ABBVIE$$16$YR$$F$Y$$$20240903$$HP$US$US
242767992$24276799$2$F$$20240821$20240903$20240904$EXP$$US-AUROBINDO-AUR-APL-2024-042147$AUROBINDO$Dana IN, Austin E, Asrani F. Mucocutaneous ulcers in an immunocompromised patient. JAAD Case Reports. 2024;51:48-50$49$YR$$F$Y$$$20240904$$MD$US$US
242768001$24276800$1$I$$20240827$20240903$20240903$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0323$GRAVITI PHARMACEUTICALS$Schwartz AH, Sieminski S.Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event..American Journal of Ophthalmology Case Reports.2023;30:1-4$59$YR$A$F$Y$$$20240903$$HP$US$US
242768021$24276802$1$I$20240305$20240819$20240903$20240903$EXP$GB-MHRA-MED-202408131609536260-DYWZV$GB-Accord-444781$ACCORD$$84$YR$E$F$Y$44$KG$20240903$$MD$GB$GB
242768031$24276803$1$I$$20240822$20240903$20240903$EXP$CA-MHPD-E2B_07209791$CA-Accord-442928$ACCORD$$$$$$Y$$$20240903$$HP$CA$CA
242768042$24276804$2$F$$20240905$20240903$20240910$EXP$$PT-SANDOZ INC.-SDZ2024PT076473$SANDOZ$$$$E$$Y$$$20240910$$HP$PT$PT
242768051$24276805$1$I$$20240822$20240903$20240903$EXP$$FR-Accord-443907$ACCORD$Vidil F. Myositis case during chemotherapy with docetaxel. Abstracts -Discussed Posters 2017.Societe Francaise de Pharmacologie et de Therapeutique. 2017,(SUPPL.1) 21-50:31-31.$43$YR$A$M$Y$$$20240903$$HP$FR$FR
242768062$24276806$2$F$$20240831$20240903$20240912$EXP$FR-AFSSAPS-TO2024001273$FR-Accord-435929$ACCORD$$77$YR$E$M$Y$82$KG$20240912$$PH$FR$FR
242768072$24276807$2$F$20240821$20240906$20240903$20240918$EXP$$US-Accord-443608$ACCORD$$36$YR$A$M$Y$$$20240918$$HP$US$US
242768081$24276808$1$I$20240723$20240822$20240903$20240903$EXP$FR-AFSSAPS-AN2024001092$FR-Accord-443530$ACCORD$$82$YR$E$M$Y$80.1$KG$20240903$$MD$FR$FR
242768091$24276809$1$I$$20240822$20240903$20240903$EXP$CA-MHPD-E2B_07224491$CA-Accord-443014$ACCORD$$$$$$Y$$$20240903$$HP$CA$CA
242768101$24276810$1$I$20140901$20240822$20240903$20240903$EXP$$PL-Accord-443365$ACCORD$CIOCH M, CIOCH. Allogeneic hematopoietic cell transplantation in a patient with myelodysplastic syndrome secondary to chemotherapy and radiotherapy given for breast cancer. ONCOLOGY IN CLINICAL PRACTICE - EDUCATION.. 2018;B(02)$52$YR$A$F$Y$$$20240903$$HP$PL$PL
242768111$24276811$1$I$20240713$20240822$20240903$20240903$EXP$FR-AFSSAPS-BR2024000681$FR-Accord-443135$ACCORD$$75$YR$E$F$Y$$$20240903$$MD$FR$FR
242768121$24276812$1$I$$20240822$20240903$20240903$EXP$$CN-Accord-443343$ACCORD$Liu Y, Li B, Wei H, Liu Y. Four cases of refractory hyponatremia caused by secondary adrenal cortical insufficiency after chemotherapy in children with tumours of lymphoid hematopoietic system. Chinese Journal of Applied Clinical Pediatrics. 2024;39(8):605-8.$4$YR$C$M$Y$$$20240903$$MD$CN$CN
242768131$24276813$1$I$$20240822$20240903$20240903$EXP$CA-MHPD-E2B_07224483$CA-Accord-443008$ACCORD$$$$$$Y$$$20240903$$HP$CA$CA
242768142$24276814$2$F$$20240822$20240903$20240904$EXP$$US-AUROBINDO-AUR-APL-2021-046037$AUROBINDO$Handel AS, Krugman J, Hymes S, Inkeles S, Beneri C.. A Case of Relapsed Vertically Transmitted Babesiosis.. J-Pediatric-Infect-Dis-Soc. 2021;10 (3):386-388$24$YR$$F$Y$$$20240904$$HP$US$US
242768151$24276815$1$I$$20240901$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139838$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240903$$HP$US$US
242768163$24276816$3$F$$20240913$20240903$20240926$EXP$$US-AUROBINDO-AUR-APL-2022-030207$AUROBINDO$Sriwastava S, Wu H, R S, Kaur A, Pasham SR, Upadhaya R, et al.. Single-center experience on progressive multifocal leukoencephalopathy (PML) cases, neuroimaging relevance, and management at West Virginia University (WVU). Journal of-Medical-Virology. 2022;94(8):4015-4022$42$YR$$F$Y$$$20240926$$HP$US$US
242768172$24276817$2$F$20240601$20240830$20240903$20240909$PER$$US-SA-2024SA254423$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240909$$MD$US$US
242768182$24276818$2$F$20220627$20240910$20240903$20240912$EXP$$LT-BAYER-2024A122190$BAYER$$47$YR$A$M$Y$$$20240912$$MD$LT$LT
242768191$24276819$1$I$$20240827$20240903$20240903$PER$$US-AVEVA-000729$AVEVA$$$$$F$Y$$$20240903$$CN$US$US
242768202$24276820$2$F$$20240819$20240903$20240903$PER$$US-AVEVA-000724$AVEVA$$$$$M$Y$$$20240903$$CN$US$US
242768211$24276821$1$I$$20240807$20240903$20240903$PER$$US-AVEVA-000721$AVEVA$$$$$M$Y$$$20240903$$CN$US$US
242768221$24276822$1$I$$20240826$20240903$20240903$PER$$US-AVEVA-000731$AVEVA$$$$$M$Y$$$20240903$$CN$US$US
242768231$24276823$1$I$$20240812$20240903$20240903$PER$$US-AVEVA-000722$AVEVA$$$$$M$Y$$$20240903$$CN$US$US
242768242$24276824$2$F$$20240820$20240903$20240903$PER$$US-AVEVA-000726$AVEVA$$$$$$Y$$$20240903$$CN$US$US
242768252$24276825$2$F$$20240909$20240903$20240930$PER$$US-AVEVA-000728$AVEVA$$64$YR$A$M$Y$$$20240930$$CN$US$US
242768261$24276826$1$I$$20240806$20240903$20240903$PER$$US-AVEVA-000720$AVEVA$Braun HM, Taylor JL, Axelrath S. Buprenorphine/naloxone - one formulation that doesn^t fit all: a case report. Harm Reduct J. 2024, 30;21(1):143. doi: 10.1186/s12954-024-01054-2. PMID: 39080714.$44$YR$A$F$Y$$$20240903$$HP$US$US
242768271$24276827$1$I$$20240827$20240903$20240903$EXP$$US-GSK-US2024106658$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$HP$US$US
242768321$24276832$1$I$$20240902$20240903$20240903$EXP$DE-EMA-DD-20240829-7482691-062433$DE-SANDOZ INC.-SDZ2024DE077005$SANDOZ$$5$YR$$$Y$$$20240903$$MD$DE$DE
242768331$24276833$1$I$20240829$20240829$20240903$20240903$PER$$US-TAKEDA-2024TUS087278$TAKEDA$$$$$$Y$$$20240903$$CN$US$US
242768341$24276834$1$I$$20240829$20240903$20240903$EXP$$PT-PFIZER INC-202400246369$PFIZER$Costa, C.. Rituximab in Steroid-Dependent Podocytopathies. Glomerular Diseases. 2024;4(1):129-136$51$YR$$F$Y$$$20240903$$HP$PT$PT
242768351$24276835$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-088377-2024$RECKITT BENCKISER$$$$$F$Y$$$20240903$$CN$US$US
242768361$24276836$1$I$20180101$20240823$20240903$20240903$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08084$HIKMA$Chowdhury RB, Shah SI, Milford E, Tullius SG, Rennke H, Bianchi G.. Chowdhury RB, Shah SI, Milford E, Tullius SG, Rennke H, Bianchi G. Extramedullary plasmacytoma exclusively localized in transplanted kidney: Post-transplant lymphoproliferative disorder or monoclonal gammopathy of renal significance?. Journal of Onco-Nephrology.. 2024;8(2):70-4$44$YR$$F$Y$$$20240903$$MD$US$US
242768372$24276837$2$F$$20240903$20240903$20240910$EXP$$US-GSK-US2019AMR180470$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
242768391$24276839$1$I$20240701$20240823$20240903$20240903$EXP$$ES-AUROBINDO-AUR-APL-2024-042812$AUROBINDO$$72$YR$$M$Y$$$20240903$$MD$ES$ES
242768402$24276840$2$F$20240826$20240830$20240903$20240903$EXP$$US-ROCHE-10000071309$ROCHE$$75$YR$E$F$Y$$$20240903$$CN$US$US
242768422$24276842$2$F$20240409$20240917$20240903$20240926$EXP$FR-AFSSAPS-DJ2024000936$FR-TEVA-VS-3237839$TEVA$$70$YR$$M$Y$64$KG$20240926$$MD$FR$FR
242768431$24276843$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139680$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240903$$HP$US$US
242768441$24276844$1$I$$20240825$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139566$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240903$$CN$US$US
242768451$24276845$1$I$$20240901$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139868$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240903$$HP$US$US
242768461$24276846$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139218$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240903$$CN$US$US
242768471$24276847$1$I$$20240830$20240903$20240903$PER$$US-TAKEDA-2024TUS087953$TAKEDA$$3$MON$$$Y$2.4$KG$20240903$$MD$US$US
242768491$24276849$1$I$20240428$20240823$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042934$AUROBINDO$$15$YR$$F$Y$$$20240903$$PH$FR$FR
242768501$24276850$1$I$$20240828$20240903$20240903$EXP$$CA-SANDOZ INC.-SDZ2023CA018584$SANDOZ$$$$$M$Y$$$20240903$$MD$CA$CA
242768511$24276851$1$I$$20240823$20240903$20240903$PER$$US-SA-2024SA253627$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240903$$HP$US$US
242768521$24276852$1$I$$20240820$20240903$20240903$PER$$US-SA-2024SA255511$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240903$$MD$US$US
242768531$24276853$1$I$20240801$20240826$20240903$20240903$PER$$US-SA-2024SA255228$SANOFI AVENTIS$$19$MON$I$F$Y$$$20240903$$MD$US$US
242768541$24276854$1$I$$20240826$20240903$20240903$PER$$US-SA-2024SA253450$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240903$$CN$US$US
242768551$24276855$1$I$$20240827$20240903$20240903$EXP$$NVSC2024BR175666$NOVARTIS$$$$$F$Y$$$20240903$$MD$BR$BR
242768562$24276856$2$F$$20240904$20240903$20240909$PER$$US-JNJFOC-20240876003$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$CN$US$US
242768571$24276857$1$I$20240101$20240829$20240903$20240903$EXP$$CA-JNJFOC-20240714458$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240903$$HP$CA$CA
242768582$24276858$2$F$20220201$20240913$20240903$20240918$EXP$$ES-JNJFOC-20240870025$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240918$$HP$ES$ES
242768591$24276859$1$I$20240819$20240830$20240903$20240903$EXP$$CN-GILEAD-2024-0685993$GILEAD$$42$YR$A$F$Y$$$20240903$$HP$CN$CN
242768621$24276862$1$I$$20240830$20240903$20240903$PER$$US-TAKEDA-2024TUS087955$TAKEDA$$$$N$$Y$$$20240903$$PH$US$US
242768641$24276864$1$I$20240823$20240827$20240903$20240903$EXP$$US-GSK-US2024106698$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$PH$US$US
242768651$24276865$1$I$20240828$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173278$AMGEN$$70$YR$E$M$Y$$$20240903$$CN$US$US
242768661$24276866$1$I$$20240827$20240903$20240903$EXP$$JP-AMGEN-JPNSP2024172216$AMGEN$$$$A$$Y$$$20240903$$MD$JP$JP
242768672$24276867$2$F$20240101$20240910$20240903$20240913$PER$$US-AMGEN-USASP2024173582$AMGEN$$82$YR$E$M$Y$$$20240912$$CN$US$US
242768681$24276868$1$I$20240506$20240828$20240903$20240903$EXP$$PL-AMGEN-POLSP2024172003$AMGEN$$69$YR$E$M$Y$85$KG$20240903$$MD$PL$PL
242768711$24276871$1$I$20240722$20240822$20240903$20240903$EXP$$US-PERRIGO-24US007893$PERRIGO$$92$YR$$F$Y$58.957$KG$20240903$$CN$US$US
242768722$24276872$2$F$$20240903$20240903$20240904$PER$$US-ABBVIE-5897497$ABBVIE$$83$YR$$$Y$$$20240904$$HP$US$US
242768731$24276873$1$I$$20240826$20240903$20240903$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006379$BIOCON$$$$$$Y$$$20240903$$CN$CA$CA
242768742$24276874$2$F$$20240828$20240903$20240904$EXP$$CA-JNJFOC-20201038638$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240904$$MD$CA$CA
242768751$24276875$1$I$20240801$20240826$20240903$20240903$PER$$US-SA-2024SA253052$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240903$$MD$US$US
242768762$24276876$2$F$20240823$20240926$20240903$20240928$PER$$US-SA-2024SA253618$SANOFI AVENTIS$$63$YR$A$F$Y$86.36$KG$20240928$$MD$US$US
242768771$24276877$1$I$20240101$20240821$20240903$20240903$PER$$US-SA-2024SA251959$SANOFI AVENTIS$$69$YR$E$M$Y$2$KG$20240903$$MD$US$US
242768781$24276878$1$I$$20240827$20240903$20240903$PER$$US-SA-2024SA252015$SANOFI AVENTIS$$64$YR$A$M$Y$83.91$KG$20240903$$CN$US$US
242768791$24276879$1$I$20240819$20240826$20240903$20240903$PER$$US-SA-2024SA251235$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240903$$CN$US$US
242768801$24276880$1$I$$20240902$20240903$20240903$EXP$GB-MHRA-MED-202408301134182040-PYMSL$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049165$BOEHRINGER INGELHEIM$$$$$M$Y$100$KG$20240903$$CN$GB$GB
242768811$24276881$1$I$20240823$20240828$20240903$20240903$EXP$$CN-ROCHE-10000068241$ROCHE$$48$YR$A$F$Y$46$KG$20240903$$HP$CN$CN
242768821$24276882$1$I$20240729$20240902$20240903$20240903$EXP$FR-AFSSAPS-AVCN2024000651$FR-SANDOZ INC.-SDZ2024FR076975$SANDOZ$$29$YR$$M$Y$$$20240903$$MD$FR$FR
242768832$24276883$2$F$20240620$20240911$20240903$20240918$EXP$$CO-GSK-CO2024AMR079332$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$CO$CO
242768841$24276884$1$I$$20240827$20240903$20240903$EXP$$CA-GSK-CA2024001689$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$CA$CA
242768851$24276885$1$I$$20240902$20240903$20240903$EXP$$MX-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048817$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240903$$MD$MX$MX
242768861$24276886$1$I$$20240822$20240903$20240903$EXP$$US-AUROBINDO-AUR-APL-2022-030206$AUROBINDO$Yu H, Wu H, R S, Kaur A, Pasham SR, Upadhaya R, et al.. Single-center experience on progressive multifocal leukoencephalopathy (PML) cases, neuroimaging relevance, and management at West Virginia University (WVU). J-Med-Virol. 2022;94(8):4015-4022$42$YR$$M$Y$$$20240903$$HP$US$US
242768871$24276887$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-087492-2024$RECKITT BENCKISER$$$$$$Y$$$20240903$$CN$US$US
242768901$24276890$1$I$20240801$20240821$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002192$ALKERMES$$$$$F$Y$$$20240903$$CN$US$US
242768912$24276891$2$F$20240524$20240926$20240903$20240930$EXP$$AR-MYLANLABS-2024M1048417$MYLAN$$65$YR$$M$Y$$$20240930$$HP$AR$AR
242768921$24276892$1$I$20240703$20240829$20240903$20240903$EXP$$NVSC2024US176624$NOVARTIS$$66$YR$$F$Y$$$20240903$$MD$US$US
242768931$24276893$1$I$20230901$20240828$20240903$20240903$EXP$NO-NOMAADVRE-PASRAPP-2024-Vj8rbb$NO-TEVA-VS-3238281$TEVA$$45$YR$$F$Y$81$KG$20240903$$CN$NO$NO
242768942$24276894$2$F$20040816$20240907$20240903$20240920$EXP$GB-MHRA-MED-202408240949589110-FRWHK$GB-MSNLABS-2024MSNSPO01882$MSN LABORATORIES$$$$$$Y$$$20240920$$CN$GB$GB
242768951$24276895$1$I$$20240827$20240903$20240903$EXP$$US-GSK-US2024106596$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
242768961$24276896$1$I$$20240830$20240903$20240903$PER$$NVSC2024US176024$NOVARTIS$$29$YR$$$Y$$$20240903$$MD$US$US
242768971$24276897$1$I$$20240828$20240903$20240903$EXP$$US-AMGEN-USASP2024172606$AMGEN$$$$$F$Y$$$20240903$$CN$US$US
242768981$24276898$1$I$$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024174570$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242768991$24276899$1$I$20240209$20240902$20240903$20240903$EXP$$DE-SANDOZ INC.-SDZ2024DE077026$SANDOZ$$9$DEC$$M$Y$73$KG$20240903$$MD$DE$DE
242769001$24276900$1$I$$20240902$20240903$20240903$EXP$GB-MHRA-MED-202409021439194220-ZVMFG$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049161$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$66$KG$20240903$$CN$GB$GB
242769022$24276902$2$F$$20240826$20240903$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136717$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240910$$CN$US$US
242769031$24276903$1$I$20240828$20240829$20240903$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139568$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240903$$MD$JP$JP
242769041$24276904$1$I$20220901$20240823$20240903$20240903$EXP$$SG-ROCHE-10000065845$ROCHE$$80$YR$E$F$Y$$$20240903$$CN$SG$SG
242769052$24276905$2$F$20240824$20240826$20240903$20240905$EXP$$RU-JNJFOC-20240873495$JOHNSON AND JOHNSON$$40$YR$A$M$Y$120$KG$20240905$$CN$RU$RU
242769061$24276906$1$I$$20240821$20240903$20240903$EXP$$US-SA-2022SA085925$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240903$$CN$US$US
242769071$24276907$1$I$20240802$20240829$20240903$20240903$PER$$US-ABBVIE-5904974$ABBVIE$$24$YR$$F$Y$$$20240903$$HP$US$US
242769093$24276909$3$F$20240101$20240905$20240903$20240913$EXP$$US-BAYER-2024A116301$BAYER$$47$YR$A$F$Y$49.887$KG$20240913$$CN$US$US
242769101$24276910$1$I$20240625$20240826$20240903$20240903$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020949$UNITED THERAPEUTICS$$73$YR$$F$Y$71.202$KG$20240903$$$US$US
242769111$24276911$1$I$$20240827$20240903$20240903$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR106940$VIIV$$$$$$Y$$$20240903$$CN$US$US
242769121$24276912$1$I$20240822$20240827$20240903$20240903$EXP$$JP-AMGEN-JPNSP2024173033$AMGEN$$8$DEC$E$M$Y$$$20240903$$MD$JP$JP
242769131$24276913$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-104577-2023$RECKITT BENCKISER$$79$YR$$M$Y$84.09$KG$20240903$$CN$US$US
242769141$24276914$1$I$$20240827$20240903$20240903$EXP$$SE-MYLANLABS-2024M1079543$MYLAN$$$$A$M$Y$$$20240903$$CN$SE$SE
242769151$24276915$1$I$$20240827$20240903$20240903$EXP$$GB-MYLANLABS-2024M1079402$MYLAN$$$$$M$Y$$$20240903$$HP$GB$GB
242769161$24276916$1$I$$20240827$20240903$20240903$EXP$$GB-MYLANLABS-2024M1079331$MYLAN$$$$$M$Y$$$20240903$$PH$GB$GB
242769171$24276917$1$I$20240803$20240827$20240903$20240903$EXP$$CN-MYLANLABS-2024M1079541$MYLAN$$15$YR$$F$Y$70$KG$20240903$$HP$CN$CN
242769181$24276918$1$I$$20240827$20240903$20240903$EXP$$GB-MYLANLABS-2024M1079325$MYLAN$$$$$M$Y$$$20240903$$PH$GB$GB
242769191$24276919$1$I$$20240829$20240903$20240903$PER$$US-LEO Pharma-373156$LEO PHARM$$70$YR$$M$Y$$$20240903$$PH$US$US
242769211$24276921$1$I$$20240820$20240903$20240903$EXP$$JP-JNJFOC-20240348688$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240903$$MD$JP$JP
242769221$24276922$1$I$20230101$20240824$20240903$20240903$EXP$$DE-TEVA-VS-3237684$TEVA$$65$YR$$F$Y$$$20240903$$CN$DE$DE
242769231$24276923$1$I$$20240826$20240903$20240903$EXP$$BR-TAKEDA-2024TUS087958$TAKEDA$$$$$M$Y$$$20240903$$CN$BR$BR
242769241$24276924$1$I$20240222$20240829$20240903$20240903$EXP$$CA-TAKEDA-2024TUS026386$TAKEDA$$65$YR$$F$Y$$$20240903$$CN$CA$CA
242769321$24276932$1$I$20240801$20240827$20240903$20240903$EXP$$US-SA-2024SA252177$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240903$$MD$US$US
242769331$24276933$1$I$$20240827$20240903$20240903$EXP$$US-GSK-US2024106554$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
242769341$24276934$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024175135$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242769351$24276935$1$I$$20240830$20240903$20240903$EXP$$NVSC2024DE166720$NOVARTIS$$33$YR$$F$Y$$$20240903$$CN$DE$DE
242769362$24276936$2$F$$20240902$20240903$20240905$PER$$NVSC2024US176798$NOVARTIS$$$$$$Y$$$20240905$$CN$US$US
242769372$24276937$2$F$20240826$20240910$20240903$20240912$PER$$US-ROCHE-10000068541$ROCHE$$$$$$Y$$$20240912$$HP$US$US
242769381$24276938$1$I$$20240812$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08139$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242769391$24276939$1$I$$20240822$20240903$20240903$EXP$$JP-ASTELLAS-2024-AER-001381$ASTELLAS$$$$$$Y$$$20240903$$MD$JP$JP
242769401$24276940$1$I$$20240830$20240903$20240903$PER$$US-AstraZeneca-2024A198351$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242769411$24276941$1$I$20240101$20240821$20240903$20240903$PER$$US-SA-2024SA252548$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240903$$MD$US$US
242769421$24276942$1$I$$20240831$20240903$20240903$EXP$$US-BAYER-2024A125169$BAYER$$$$$$Y$$$20240903$$CN$US$US
242769431$24276943$1$I$20240728$20240823$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042878$AUROBINDO$$77$YR$$M$Y$80$KG$20240903$$MD$FR$FR
242769441$24276944$1$I$$20240806$20240903$20240903$PER$$US-STERISCIENCE B.V.-2024-ST-001184$Steriscience PTE$Chan N, Dunn B. Bilateral Spontaneous Pneumothoraces in a Case of Tricuspid Valve Endocarditis and Septic Emboli: A Rare Complication. Case-Rep-Crit-Care. 2024$46$YR$$M$Y$$$20240903$$HP$US$US
242769451$24276945$1$I$$20240717$20240903$20240903$PER$$US-STERISCIENCE B.V.-2024-ST-001096$Steriscience PTE$Bollam RR, Reddy VK.. Persistent Pseudomonas Aeruginosa Pneumonia Due to Antimicrobial Resistance Development Requiring Lobectomy. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$56$YR$$F$Y$$$20240903$$HP$US$US
242769461$24276946$1$I$$20240704$20240903$20240903$PER$$US-STERISCIENCE B.V.-2024-ST-001004$Steriscience PTE$SHUKLA P, LUBRIN SI, SUBRAMANIAN R, JOSHI H. SEVERE ARDS AND IMMUNE RECONSTITUTION SYNDROME IN A RARE CASE OF MULTIDRUG-RESISTANT TUBERCULOSIS: A CASE REPORT AND REVIEW.. Chest. 2023;164 (Suppl.)(4):A1514$42$YR$$F$Y$$$20240903$$HP$US$US
242769481$24276948$1$I$$20240802$20240903$20240903$PER$$US-STERISCIENCE B.V.-2024-ST-001172$Steriscience PTE$Shuster A, Peng C.. Neisseria Flavescens Bacteremia in an Otherwise Immunocompetent Host.. Am-J-Respir-Crit-Care-Med. 2024;209:A1655.$62$YR$$F$Y$$$20240903$$HP$US$US
242769491$24276949$1$I$$20240827$20240903$20240903$EXP$$PT-SA-2024SA253850$SANOFI AVENTIS$$$$E$$Y$$$20240903$$HP$PT$PT
242769501$24276950$1$I$20240806$20240816$20240903$20240903$EXP$$CN-ASTELLAS-2024-AER-001772$ASTELLAS$$74$YR$E$M$Y$70$KG$20240903$$HP$CN$CN
242769511$24276951$1$I$$20240819$20240903$20240903$PER$$US-ASTELLAS-2024-AER-002231$ASTELLAS$$$$A$M$Y$$$20240903$$MD$US$US
242769521$24276952$1$I$20240802$20240827$20240903$20240903$EXP$FR-AFSSAPS-BX2024001687$FR-MYLANLABS-2024M1079101$MYLAN$$97$YR$$F$Y$39.4$KG$20240903$$PH$FR$FR
242769531$24276953$1$I$20240522$20240829$20240903$20240903$EXP$$CO-UCBSA-2024044705$UCB$$12$YR$$M$Y$$$20240903$$CN$CO$CO
242769541$24276954$1$I$$20240827$20240903$20240903$EXP$BE-FAMHP-DHH-N2024-122534$BE-MYLANLABS-2024M1079179$MYLAN$$$$A$F$Y$$$20240903$$HP$BE$BE
242769551$24276955$1$I$20240622$20240827$20240903$20240903$EXP$ES-AEMPS-1562975$ES-MYLANLABS-2024M1079182$MYLAN$$77$YR$$M$Y$$$20240903$$MD$ES$ES
242769561$24276956$1$I$20240712$20240827$20240903$20240903$EXP$FR-AFSSAPS-TO2024001443$FR-MYLANLABS-2024M1079223$MYLAN$$76$YR$$M$Y$71$KG$20240903$$PH$FR$FR
242769571$24276957$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139616$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240903$$CN$US$US
242769582$24276958$2$F$20240829$20240903$20240903$20240905$PER$$US-AMGEN-USASP2024174870$AMGEN$$80$YR$E$M$Y$$$20240904$$CN$US$US
242769591$24276959$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139677$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$61.69$KG$20240903$$CN$US$US
242769601$24276960$1$I$20240819$20240827$20240903$20240903$EXP$IT-MINISAL02-999712$IT-MYLANLABS-2024M1078961$MYLAN$$60$YR$$F$Y$$$20240903$$MD$IT$IT
242769611$24276961$1$I$20231121$20240902$20240903$20240903$EXP$FR-AFSSAPS-DJ2024000948$NVSC2024FR176253$NOVARTIS$$57$YR$$F$Y$96$KG$20240903$$MD$FR$FR
242769621$24276962$1$I$20240808$20240828$20240903$20240903$EXP$$JP-ROCHE-10000070221$ROCHE$$10$DEC$E$$Y$$$20240903$$PH$JP$JP
242769631$24276963$1$I$$20240828$20240903$20240903$EXP$$CA-TAKEDA-2024TUS024198$TAKEDA$$$$$F$Y$$$20240903$$CN$CA$CA
242769641$24276964$1$I$20231001$20240827$20240903$20240903$EXP$FR-AFSSAPS-PA2024001440$FR-TEVA-VS-3237682$TEVA$$66$YR$$M$Y$$$20240903$$MD$FR$FR
242769651$24276965$1$I$$20240827$20240903$20240903$EXP$$US-GSK-US2024106671$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
242769661$24276966$1$I$$20240822$20240903$20240903$EXP$$US-CHIESI-2024CHF05466$CHIESI$$$$$F$Y$$$20240903$$MD$US$US
242769671$24276967$1$I$$20240826$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408016194$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240903$$CN$US$US
242769681$24276968$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000302$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240903$$CN$US$US
242769691$24276969$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000221$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240903$$CN$US$US
242769702$24276970$2$F$20240101$20240903$20240903$20240911$EXP$$CA-CELLTRION INC.-2024CA020916$CELLTRION$$$$$$Y$$$20240911$$PH$CA$CA
242769711$24276971$1$I$20240807$20240826$20240903$20240903$EXP$$GB-AMGEN-GBRSP2024170918$AMGEN$$63$YR$A$F$Y$100$KG$20240903$$CN$GB$GB
242769721$24276972$1$I$$20240605$20240903$20240903$PER$$US-BAYER-2024A125545$BAYER$Fitch B.A.; Lynch K.L.; Liao H.-C.. Unexpected Fentanyl Detection during a Liver Transplant Evaluation. Fitch B.A.; Lynch K.L.; Liao H.-C.. 2023;69:3:222-225$40$YR$A$M$Y$$$20240903$$HP$US$US
242769731$24276973$1$I$$20240823$20240903$20240903$EXP$$PT-AUROBINDO-AUR-APL-2024-037264$AUROBINDO$Ferreira Da Costa RM, Lopes C, Ferreira Lopes D, Conde PV, Pereira JM, Mayor JS, et al. POSA-194 - (4967) -PNEUMONITE  EOSINOF?LICASECUND?RIA ?  AMIODARONA: UM ALERTASOBRE EFEITOS  ADVERSOS FARMACOL?GICO(EOSINOPHILIC PNEUMONITIS  SECONDARY TO AMIODARONE: A WARNING ABOUT  ADVERSE PHARMACOLOGICAL EFFECTS). Doen?as respirat?rias | Caso cl?nico (Respiratory diseases | Clinical case). 2024;1270$78$YR$$F$Y$$$20240903$$MD$PT$PT
242769741$24276974$1$I$$20240827$20240903$20240903$PER$$US-HALEON-2193958$Haleon PLC$$63$YR$$F$Y$$$20240903$$CN$US$US
242769752$24276975$2$F$$20240917$20240903$20240924$EXP$$NVSC2024US175938$NOVARTIS$$$$$M$Y$$$20240924$$CN$US$US
242769761$24276976$1$I$20240113$20240902$20240903$20240903$EXP$IT-MINISAL02-1000710$NVSC2024IT176462$NOVARTIS$$84$YR$$M$Y$$$20240903$$MD$IT$IT
242769771$24276977$1$I$20240823$20240823$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135273$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$60.78$KG$20240903$$HP$US$US
242769781$24276978$1$I$20240401$20240824$20240903$20240903$EXP$$GB-AUROBINDO-AUR-APL-2024-042746$AUROBINDO$$41$YR$$M$Y$70$KG$20240903$$CN$GB$GB
242769801$24276980$1$I$20240828$20240828$20240903$20240903$EXP$$GB-MYLANLABS-2024M1079593$MYLAN$$$$$F$Y$$$20240903$$CN$GB$GB
242769811$24276981$1$I$20240601$20240828$20240903$20240903$EXP$$KR-MYLANLABS-2024M1079569$MYLAN$$21$YR$$$Y$$$20240903$$CN$KR$KR
242769821$24276982$1$I$$20240828$20240903$20240903$EXP$$GB-MYLANLABS-2024M1080479$MYLAN$$$$$M$Y$$$20240903$$CN$GB$GB
242769831$24276983$1$I$20240822$20240828$20240903$20240903$EXP$$CN-MYLANLABS-2024M1079778$MYLAN$$74$YR$$M$Y$55$KG$20240903$$HP$CN$CN
242769842$24276984$2$F$$20240918$20240903$20240924$EXP$$GB-MYLANLABS-2024M1079923$MYLAN$$$$$M$Y$$$20240924$$PH$GB$GB
242769851$24276985$1$I$$20240828$20240903$20240903$EXP$$GB-MYLANLABS-2024M1079591$MYLAN$$76$YR$$M$Y$76$KG$20240903$$MD$GB$GB
242769861$24276986$1$I$20240809$20240828$20240903$20240903$EXP$GB-MHRA-MED-202408281525360300-MLZHB$GB-MYLANLABS-2024M1079624$MYLAN$$76$YR$$F$Y$69$KG$20240903$$HP$GB$GB
242769872$24276987$2$F$$20240918$20240903$20240925$EXP$$CA-MYLANLABS-2024M1080188$MYLAN$$$$$M$Y$$$20240925$$CN$CA$CA
242769882$24276988$2$F$$20240904$20240903$20240906$EXP$$NL-MYLANLABS-2024M1079776$MYLAN$$$$A$F$Y$$$20240906$$HP$NL$NL
242769892$24276989$2$F$$20240911$20240903$20240913$EXP$NL-LRB-00996759$NL-MYLANLABS-2024M1079187$MYLAN$$32$YR$$F$Y$58$KG$20240913$$CN$NL$NL
242769901$24276990$1$I$20240614$20240828$20240903$20240903$EXP$ES-AEMPS-1563194$ES-MYLANLABS-2024M1079579$MYLAN$$91$YR$$F$Y$$$20240903$$MD$ES$ES
242769911$24276991$1$I$20240702$20240828$20240903$20240903$EXP$FR-AFSSAPS-AVMA2024000361$FR-MYLANLABS-2024M1079683$MYLAN$$16$YR$$M$Y$$$20240903$$PH$FR$FR
242769922$24276992$2$F$20240904$20240906$20240903$20240910$EXP$$GB-MYLANLABS-2024M1079634$MYLAN$$$$$F$Y$$$20240910$$HP$GB$GB
242769931$24276993$1$I$20240824$20240824$20240903$20240903$EXP$$GB-AUROBINDO-AUR-APL-2024-042760$AUROBINDO$$80$YR$$F$Y$$$20240903$$CN$GB$GB
242769942$24276994$2$F$$20240913$20240903$20240926$EXP$$US-SMPA-2024SPA001932$SUNOVION$$$$$$Y$$$20240926$$CN$US$US
242769951$24276995$1$I$$20240827$20240903$20240903$EXP$$US-GSK-US2024AMR107479$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
242769981$24276998$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59883$$FDA-CTU$$56$YR$$F$N$$$20240830$N$$US$
242769991$24276999$1$I$$20240829$20240903$20240903$EXP$$NVSC2024PA176511$NOVARTIS$$$$$F$Y$$$20240903$$MD$PA$PA
242770011$24277001$1$I$$20240828$20240903$20240903$EXP$$NVSC2024US175161$NOVARTIS$$63$YR$$M$Y$$$20240903$$CN$US$US
242770031$24277003$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-137934-2023$RECKITT BENCKISER$$$$$$Y$$$20240903$$CN$US$US
242770042$24277004$2$F$$20240828$20240903$20240909$EXP$$DE-PFIZER INC-2018486095$PFIZER$Berger, F.. Flavonifractor (Eubacterium) plautii bloodstream infection following acute cholecystitis. IDCases. 2018;14:e00461$69$YR$$M$Y$$$20240909$$MD$DE$DE
242770051$24277005$1$I$$20240827$20240903$20240903$EXP$$PT-PFIZER INC-202400245624$PFIZER$Costa A.. PO-0184 - (2479) - HAEMOPHAGOCYTIC SYNDROME - WHEN TO CONSIDER THIS ENTITY? ABOUT A CLINICAL CASE. 30 CNMI National Congress of Internal Medicine. 2024;9 Congresso:492$50$YR$$F$Y$$$20240903$$HP$PT$PT
242770061$24277006$1$I$$20240702$20240829$20240829$DIR$FDA-CDER-CTU-2024-59994$$FDA-CTU$$$$$$N$$$20240702$N$PH$US$
242770072$24277007$2$F$$20240830$20240903$20240903$EXP$$JP-PFIZER INC-202400246468$PFIZER$Hata, K.. Acquired Hemophilia A Diagnosed Based on Gross Hematuria: A Case Report and Literature Review. Case reports in urology. 2024;2024:10.1155/2024/2760153$67$YR$$F$Y$$$20240903$$MD$JP$JP
242770082$24277008$2$F$$20240903$20240903$20240906$EXP$$US-PFIZER INC-202400246912$PFIZER$Davidson, E.. Retained Tampon Fragment as an Unusual Cause of Vesicovaginal Fistula. Obstetrics and Gynecology. 2024;144(1):e1-e3$53$YR$$F$Y$$$20240906$$MD$US$US
242770092$24277009$2$F$20220101$20240829$20240903$20240905$EXP$$CN-PFIZER INC-202400245446$PFIZER$Wang, H.. Contezolid for the Treatment of Drug-Resistant Tuberculosis in China: A Clinical Case Series. Infection and drug resistance. 2024;17:3491-3499$43$YR$$F$Y$$$20240905$$MD$CN$CN
242770111$24277011$1$I$$20240826$20240830$20240830$DIR$FDA-CDER-CTU-2024-59845$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242770121$24277012$1$I$20240805$20240827$20240903$20240903$EXP$$US-EXELIXIS-CABO-24078377$EXELIXIS$$71$YR$$F$Y$$$20240903$$HP$US$US
242770131$24277013$1$I$$20240826$20240903$20240903$EXP$$US-JNJFOC-20240868447$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$HP$US$US
242770141$24277014$1$I$$20240826$20240830$20240830$DIR$FDA-CDER-CTU-2024-59848$$FDA-CTU$$$$$M$N$$$20240826$N$HP$US$
242770152$24277015$2$F$20210801$20240903$20240903$20240911$EXP$$CA-CELLTRION INC.-2021CA011587$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
242770162$24277016$2$F$20240808$20240911$20240903$20240925$EXP$$US-MALLINCKRODT-MNK202405336$MALLINCKRODT$$63$YR$A$M$Y$$$20240925$$HP$US$US
242770171$24277017$1$I$20240628$20240815$20240903$20240903$PER$$US-Vifor (International) Inc.-VIT-2024-07441$VIFOR$$67$YR$$F$Y$$$20240903$$HP$US$US
242770181$24277018$1$I$20240708$20240815$20240903$20240903$EXP$$US-Vifor (International) Inc.-VIT-2024-07439$VIFOR$$81$YR$$M$Y$62.5$KG$20240903$$HP$US$US
242770191$24277019$1$I$$20240702$20240829$20240829$DIR$FDA-CDER-CTU-2024-59996$$FDA-CTU$$$$$$N$$$20240702$N$PH$US$
242770211$24277021$1$I$20240801$20240815$20240903$20240903$EXP$$US-Vifor (International) Inc.-VIT-2024-07443$VIFOR$$50$YR$$F$Y$$$20240903$$HP$US$US
242770221$24277022$1$I$20240826$20240827$20240903$20240903$PER$$US-JNJFOC-20240872954$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20240903$$CN$US$US
242770241$24277024$1$I$$20240826$20240903$20240903$EXP$$CN-JNJFOC-20240877416$JOHNSON AND JOHNSON$Jian Kang Z. The universal painkiller ibuprofen, misadministration is dangerous. 2024 AUG;8:30-31. doi:10.16662/j.cnki.1674-0742.2024.16.101$$$$M$Y$$$20240903$$HP$CN$CN
242770251$24277025$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080367$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$9$DEC$$$Y$$$20240903$$HP$US$US
242770261$24277026$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080480$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$6$DEC$$$Y$$$20240903$$HP$US$US
242770273$24277027$3$F$$20240826$20240903$20240909$EXP$$NL-ABBVIE-5899706$ABBVIE$Boot M, Raz Y. Een complex hematologisch beeld. Medisch Contact. 2024;34-35.; Max B, Raz Y. Een complex hematologisch beeld. Medisch Contact. 2024;34-35.$69$YR$$F$Y$$$20240909$$MD$NL$NL
242770281$24277028$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080087$MYLAN$Jalili MH, Cornman-Homonoff J. Suction thrombectomy for management of pulmonary tumor embolism in the setting of hepatocellular carcinoma with macrovascular invasion. Radiol-Case-Rep 2024; 19 (10): 4627-4630.$83$YR$$M$Y$$$20240903$$MD$US$US
242770291$24277029$1$I$$20240820$20240903$20240903$EXP$$AU-BAYER-2024A124952$BAYER$Wiener J, Wanaguru D, Currie B, Grant P, Russell C, Palasanthiran P, et al.. Mediastinal Nontuberculous Mycobacterial Infection in Children A Multidisciplinary Approach.. Pediatric Infectious Disease Journal.. 2024;43:7:e225-e230$14$MON$I$F$Y$$$20240903$$MD$AU$AU
242770301$24277030$1$I$$20240826$20240903$20240903$EXP$$AU-MYLANLABS-2024M1079935$MYLAN$Holford AG, Isoardi KZ. A fatal case of iatrogenic iodine toxicity. Clin-Toxicol-(Phila) 2023; 61 (1) 59-60 abstr. 124.$$$E$M$Y$$$20240903$$HP$AU$AU
242770311$24277031$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080483$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$6$DEC$$$Y$$$20240903$$HP$US$US
242770321$24277032$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080481$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$7$DEC$$$Y$$$20240903$$HP$US$US
242770331$24277033$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080427$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$5$DEC$$$Y$$$20240903$$HP$US$US
242770341$24277034$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080411$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$6$DEC$$$Y$$$20240903$$HP$US$US
242770351$24277035$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080366$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$5$DEC$$$Y$$$20240903$$HP$US$US
242770361$24277036$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080415$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$7$DEC$$$Y$$$20240903$$HP$US$US
242770371$24277037$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080365$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$9$DEC$$$Y$$$20240903$$HP$US$US
242770381$24277038$1$I$$20240826$20240903$20240903$EXP$$BE-MYLANLABS-2024M1080009$MYLAN$Chami M, Di Primio S. Energy drink consumption can induce cardiovascular events, two case reports and a literature review. Toxic-Analyt-Clinique 2024; 36 (1): 43-61.$25$YR$$$Y$$$20240903$$HP$BE$BE
242770391$24277039$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080257$MYLAN$$$$$M$Y$65.77$KG$20240903$$CN$US$US
242770401$24277040$1$I$20220109$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59936$$FDA-CTU$$24$YR$$F$N$63.5$KG$20240829$N$CN$US$
242770411$24277041$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080418$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$6$DEC$$$Y$$$20240903$$HP$US$US
242770421$24277042$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080441$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$7$DEC$$$Y$$$20240903$$HP$US$US
242770431$24277043$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080414$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$7$DEC$$$Y$$$20240903$$HP$US$US
242770441$24277044$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080416$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$5$DEC$$$Y$$$20240903$$HP$US$US
242770451$24277045$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1079930$MYLAN$Kinney RE, Nair S, Kim CH, Thomas MB, Delatorre M. Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer. Oncologist 2023; 28 (6): E478-E486.$69$YR$$F$Y$$$20240903$$MD$US$US
242770461$24277046$1$I$$20240829$20240903$20240903$EXP$$JP-ROCHE-10000071541$ROCHE$$$$A$F$Y$$$20240903$$MD$JP$JP
242770472$24277047$2$F$$20240903$20240903$20240905$EXP$$ES-BAUSCH-BL-2024-013144$BAUSCH AND LOMB$Closa M, Requena A, Garcia S, Ballar?n J. Anaesthetic management of thyroid storm in a patient with Friederich^s ataxia. A case report. Revista Espanola de Anestesiologia y Reanimaci?n. 2023 JUN 03;70(6):362-365. doi:10.1016/j.redare.2023.06.002.$26$YR$$M$Y$$$20240905$$HP$ES$ES
242770491$24277049$1$I$20231201$20240827$20240903$20240903$EXP$$SG-ROCHE-10000068297$ROCHE$$$$E$M$Y$$$20240903$$CN$SG$SG
242770502$24277050$2$F$$20240903$20240903$20240912$PER$$US-TAKEDA-2024TUS086993$TAKEDA$$$$$$Y$$$20240912$$CN$US$US
242770511$24277051$1$I$20240101$20240826$20240903$20240903$PER$$US-SA-2024SA253685$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240903$$MD$US$US
242770521$24277052$1$I$$20240826$20240903$20240903$PER$$US-SA-2024SA253774$SANOFI AVENTIS$$$$A$F$Y$$$20240903$$CN$US$US
242770533$24277053$3$F$20240701$20240910$20240903$20240918$EXP$$US-GSK-US2024106669$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$US$US
242770551$24277055$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59962$$FDA-CTU$$$$$$N$$$20240829$N$CN$US$
242770571$24277057$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139491$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$86.64$KG$20240903$$CN$US$US
242770581$24277058$1$I$$20240819$20240903$20240903$EXP$$US-SEBELA IRELAND LIMITED-2024SEB00062$SEBELA$Alamurova R, Nedelkopoulou N, Narula P.et.al.. MYELOSUPPRESSION WITH PANCYTOPENIA AND ALOPECIA SECONDARY TO AZATHIOPRINE IN TWO PATIENTS WITH NUDT15?3 ALLELE WITH INFLAMMATORY BOWEL DISEASE (IBD).. Frontline Gastroenterol.. 2024;15(A17)$5$YR$$F$Y$$$20240903$$HP$US$GB
242770601$24277060$1$I$20240821$20240826$20240903$20240903$EXP$$JP-009507513-2408JPN003219J$MERCK$$76$YR$$M$Y$$$20240903$$MD$JP$JP
242770611$24277061$1$I$$20240829$20240903$20240903$EXP$$JP-JNJFOC-20240903432$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240903$$HP$JP$JP
242770621$24277062$1$I$$20240902$20240903$20240903$EXP$$DE-GILEAD-2024-0686001$GILEAD$$$$$M$Y$$$20240903$$MD$DE$DE
242770651$24277065$1$I$$20240830$20240903$20240903$EXP$$GB-MYLANLABS-2024M1080262$MYLAN$$$$$M$Y$$$20240903$$PH$GB$GB
242770661$24277066$1$I$$20240830$20240903$20240903$EXP$$AU-MYLANLABS-2024M1080020$MYLAN$$$$$F$Y$$$20240903$$HP$AU$AU
242770671$24277067$1$I$20240826$20240830$20240903$20240903$EXP$GB-MHRA-MED-202408301212566200-GVZQK$GB-MYLANLABS-2024M1080224$MYLAN$$$$$F$Y$$$20240903$$MD$GB$GB
242770681$24277068$1$I$$20240830$20240903$20240903$EXP$$GB-MYLANLABS-2024M1080217$MYLAN$$19$YR$$F$Y$70$KG$20240903$$MD$GB$GB
242770691$24277069$1$I$$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59914$$FDA-CTU$$$$$$N$$$20240829$$CN$US$
242770701$24277070$1$I$$20240823$20240903$20240903$EXP$$DE-PERRIGO-24DE007901$PERRIGO$N?gele H, Rosenkranz M, N?gele MP. Hyponatremia-Induced Epileptic Seizure Provoked by Levetiracetam and Pain Medication Intake in a Patient with Central Diabetes Insipidus. Case reports in neurology. 2024;16(1):204-7. DOI:10.1159/000540320.$67$YR$$M$Y$$$20240903$$MD$DE$DE
242770711$24277071$1$I$20240827$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59946$$FDA-CTU$$58$YR$$M$N$$$20240829$Y$PH$US$
242770722$24277072$2$F$20240821$20240911$20240903$20240916$EXP$$JP-BEH-2024177895$CSL BEHRING$$44$YR$A$M$Y$69$KG$20240916$$CN$JP$JP
242770731$24277073$1$I$$20240705$20240829$20240829$DIR$FDA-CDER-CTU-2024-59981$$FDA-CTU$$$$$$N$$$20240705$N$PH$US$
242770751$24277075$1$I$$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59621$$FDA-CTU$$$$$M$N$$$20240828$N$HP$US$
242770791$24277079$1$I$$20240710$20240829$20240829$DIR$FDA-CDER-CTU-2024-59986$$FDA-CTU$$$$$$N$$$20240710$N$PH$US$
242770801$24277080$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59864$$FDA-CTU$$13$YR$$M$N$54.43$KG$20240830$N$$US$
242770811$24277081$1$I$20240801$20240828$20240829$20240829$DIR$FDA-CDER-CTU-2024-59615$$FDA-CTU$$49$YR$$F$N$$$20240828$N$HP$US$
242770831$24277083$1$I$20240724$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59629$$FDA-CTU$$74$YR$$M$N$$$20240829$Y$PH$US$
242770841$24277084$1$I$20230301$20240823$20240829$20240829$DIR$FDA-CDER-CTU-2024-60063$$FDA-CTU$$67$YR$$F$N$90.72$KG$20240823$N$CN$US$
242770861$24277086$1$I$20240824$20240829$20240829$20240829$DIR$FDA-CDER-CTU-2024-59661$$FDA-CTU$$70$YR$$F$N$$$20240829$Y$PH$US$
242770871$24277087$1$I$$20240710$20240829$20240829$DIR$FDA-CDER-CTU-2024-59988$$FDA-CTU$$$$$$N$$$20240710$N$PH$US$
242770881$24277088$1$I$$20240702$20240829$20240829$DIR$FDA-CDER-CTU-2024-59997$$FDA-CTU$$$$$$N$$$20240702$N$PH$US$
242770891$24277089$1$I$20240808$20240830$20240829$20240829$DIR$FDA-CDER-CTU-2024-59679$$FDA-CTU$$27$YR$$F$N$68$KG$20240830$N$$US$
242770901$24277090$1$I$20181217$20240828$20240903$20240903$EXP$FR-AFSSAPS-AN20221878$FR-TEVA-2022-FR-2073608$TEVA$$56$YR$$F$Y$$$20240903$$MD$FR$FR
242770911$24277091$1$I$$20240828$20240903$20240903$EXP$GB-MHRA-MED-202408281429427240-WCDNJ$GB-RDY-SPO/GBR/24/0012623$DR REDDYS$$$$$F$Y$$$20240903$$CN$GB$GB
242770921$24277092$1$I$20240818$20240826$20240903$20240903$EXP$AT-BASGAGES-2024-006311$AT-BAUSCH-BL-2024-013172$BAUSCH AND LOMB$$61$YR$$F$Y$$$20240903$$CN$AT$AT
242770931$24277093$1$I$20240731$20240824$20240903$20240903$EXP$$US-BAYER-2024A111175$BAYER$$78$YR$E$M$Y$$$20240903$$CN$US$US
242770941$24277094$1$I$20240228$20240903$20240903$20240903$EXP$FR-AFSSAPS-TO2024001646$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049158$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$46$KG$20240903$$MD$FR$FR
242770951$24277095$1$I$$20240828$20240903$20240903$EXP$$US-TAKEDA-2024TUS086797$TAKEDA$$68$YR$$F$Y$$$20240903$$MD$US$US
242770961$24277096$1$I$20240817$20240829$20240903$20240903$EXP$$CN-SA-2024SA254713$SANOFI AVENTIS$$9$YR$C$M$Y$61$KG$20240903$$HP$CN$CN
242770971$24277097$1$I$$20240819$20240903$20240903$EXP$$US-SERVIER-S24010544$SERVIER$Tajfiroozeh D, Silva R, Otsuka KN, Wai A.. A Rare Presentation of Hepatopulmonary Syndrome in the Setting of Chemotherapy Associated Steatohepatitis. American Journal of Respiratory and Critical Care Medicine. 2024;209$$$$$Y$$$20240903$$MD$US$US
242770981$24277098$1$I$20240601$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018772$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240903$$CN$US$US
242771001$24277100$1$I$20240827$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000303$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240903$$CN$US$US
242771011$24277101$1$I$$20240823$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408015988$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240903$$PH$US$US
242771021$24277102$1$I$$20240823$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408015882$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240903$$CN$US$US
242771031$24277103$1$I$$20240823$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408015505$ELI LILLY AND CO$$49$YR$A$$Y$$$20240903$$LW$US$US
242771041$24277104$1$I$20220101$20240828$20240903$20240903$EXP$$CN-PFIZER INC-PV202400112645$PFIZER$Liu, M.. Insights into uveitis from Brentuximab vedotin in refractory Hodgkin^s lymphoma: a case report and brief review. Frontiers in Oncology. 2024;14:10.3389/fonc.2024.1419145$16$YR$$M$Y$$$20240903$$HP$CN$CN
242771052$24277105$2$F$$20240905$20240903$20240909$EXP$$US-PFIZER INC-PV202400112738$PFIZER$Salk, G.. ALL-747 Methotrexate-Induced Neurotoxicity Due to Ommaya Reservoir Malfunction in a Patient with Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(Suppl 1):S282-S283$36$YR$$F$Y$$$20240909$$MD$US$US
242771062$24277106$2$F$$20240829$20240903$20240909$EXP$$US-PFIZER INC-202400246028$PFIZER$Cowan, M.. A Case Report of Delayed Opioid Toxidrome After Administration of Naloxone. Clinical practice and cases in emergency medicine. 2024;8(3):222-225$$$$M$Y$$$20240909$$MD$US$US
242771072$24277107$2$F$$20240830$20240903$20240904$EXP$$US-PFIZER INC-202400246465$PFIZER$Tanas, R.. The classic ^Rat-Bite^ erosions in gouty arthritis with normal uric acid levels. The American Journal of the Medical Sciences. 2024;368(3):e27-e28$82$YR$$M$Y$$$20240904$$MD$US$US
242771081$24277108$1$I$$20240829$20240903$20240903$EXP$$NVSC2024PA176723$NOVARTIS$$80$YR$$F$Y$$$20240903$$MD$PA$PA
242771091$24277109$1$I$$20240827$20240903$20240903$EXP$$CA-MYLANLABS-2024M1079475$MYLAN$$34$YR$$M$Y$$$20240903$$MD$CA$CA
242771111$24277111$1$I$$20240827$20240903$20240903$EXP$$CA-MYLANLABS-2024M1079449$MYLAN$$46$YR$$F$Y$100$KG$20240903$$HP$CA$CA
242771121$24277112$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139549$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$67.13$KG$20240903$$CN$US$US
242771131$24277113$1$I$$20240827$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137658$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$69.4$KG$20240903$$CN$US$US
242771141$24277114$1$I$$20240828$20240903$20240903$PER$$US-AMGEN-USASP2024173422$AMGEN$$55$YR$A$F$Y$$$20240903$$CN$US$US
242771151$24277115$1$I$$20240831$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139575$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240903$$MD$US$US
242771161$24277116$1$I$20240101$20240827$20240903$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-027016$UNITED THERAPEUTICS$$$$$F$Y$58.503$KG$20240903$$$US$US
242771171$24277117$1$I$20231021$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-136430-2023$RECKITT BENCKISER$$32$YR$$$Y$$$20240903$$CN$US$US
242771181$24277118$1$I$$20240823$20240903$20240903$EXP$$FR-AUROBINDO-AUR-APL-2024-042897$AUROBINDO$$20$YR$$F$Y$$$20240903$$PH$FR$FR
242771192$24277119$2$F$20240822$20240826$20240903$20240919$PER$$US-SA-2024SA253367$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240919$$CN$US$US
242771201$24277120$1$I$$20240828$20240903$20240903$PER$$US-SA-2024SA255243$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240903$$PH$US$US
242771211$24277121$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA254280$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240903$$MD$US$US
242771221$24277122$1$I$20240801$20240822$20240903$20240903$PER$$US-SA-2024SA254899$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240903$$MD$US$US
242771232$24277123$2$F$20240201$20240909$20240903$20240917$EXP$$NVSC2024ZA173282$NOVARTIS$$35$YR$$M$Y$$$20240917$$HP$ZA$ZA
242771251$24277125$1$I$20160101$20240827$20240903$20240903$EXP$$US-GSK-US2024106597$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
242771261$24277126$1$I$$20240821$20240903$20240903$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08482$LUPIN$Jacobs D, Metzler R, Anitescu M. Central pain syndrome after particulated juvenile articular cartilage allograft transplantation effectively treated with ketamine. The Journal of Pain. 2019;S47-S48$56$YR$$M$Y$$$20240903$$HP$US$US
242771281$24277128$1$I$$20240823$20240903$20240903$PER$$US-BAUSCHBL-2024BNL032301$BAUSCH AND LOMB$$$$$F$Y$$$20240903$$CN$US$US
242771291$24277129$1$I$$20240830$20240903$20240903$PER$$US-ALXN-202408USA002182US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
242771301$24277130$1$I$$20240828$20240903$20240903$EXP$$JP-009507513-2408JPN003869J$MERCK$$51$YR$$F$Y$$$20240903$$MD$JP$JP
242771311$24277131$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-101164-2023$RECKITT BENCKISER$$$$$F$Y$$$20240903$$CN$US$US
242771321$24277132$1$I$20240827$20240827$20240903$20240903$EXP$$PK-ROCHE-10000067200$ROCHE$$47$YR$A$M$Y$$$20240903$$CN$PK$PK
242771332$24277133$2$F$$20240830$20240903$20240912$PER$$US-HALEON-2194675$Haleon PLC$$$$$M$Y$$$20240912$$CN$US$US
242771342$24277134$2$F$$20240829$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US076459$SANDOZ$$$$$F$Y$$$20240903$$CN$US$US
242771351$24277135$1$I$20240823$20240823$20240903$20240903$PER$$US-BAUSCHBL-2024BNL032323$BAUSCH AND LOMB$$$$$M$Y$$$20240903$$CN$US$US
242771361$24277136$1$I$$20240827$20240903$20240903$EXP$RO-EMA-DD-20240826-7482655-094843$RO-RDY-SPO/ROU/24/0012535$DR REDDYS$Mustafa A, Danciu AI, Ionescu M. Acute coronary syndrome and cancer in a young patient. Medical Life. 2024;10:13$32$YR$A$M$Y$$$20240903$$MD$RO$RO
242771381$24277138$1$I$20240101$20240825$20240903$20240903$EXP$$GB-TEVA-VS-3237828$TEVA$$27$YR$$$Y$$$20240903$$CN$GB$GB
242771391$24277139$1$I$20220101$20240825$20240903$20240903$EXP$$CN-HQ-20240057$HQ SPECIALTY$Xiong Y, Xiao YU, Xie L, Gao L, Han YI, Huang P, et al. Contezolid for the Treatment of Drug-Resistant Tuberculosis in China: A Clinical Case Series. Infection and drug resistance. 2024;17:3491-9. DOI: 10.2147/IDR.S469509.$43$YR$A$F$Y$$$20240828$$MD$CN$
242771401$24277140$1$I$$20240828$20240903$20240903$PER$$US-EMD Serono-2024046534$EMD SERONO INC$$25$YR$A$F$Y$$$20240903$$CN$US$US
242771411$24277141$1$I$$20240823$20240903$20240903$EXP$$US-MALLINCKRODT-MNK202405340$MALLINCKRODT$$$$$F$Y$$$20240903$$HP$US$US
242771421$24277142$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174927$AMGEN$$$$$$Y$$$20240903$$MD$US$US
242771431$24277143$1$I$$20240830$20240903$20240903$EXP$$NVSC2024NP176544$NOVARTIS$$$$$F$Y$$$20240903$$CN$NP$NP
242771441$24277144$1$I$$20240821$20240903$20240903$EXP$$FR-MAIA Pharmaceuticals, Inc.-MAI202408-000033$MAIA PHARMACEUTICALS$$68$YR$E$M$Y$$$20240903$$MD$FR$
242771451$24277145$1$I$20240823$20240828$20240903$20240903$EXP$$PK-ROCHE-10000068837$ROCHE$$63$YR$A$F$Y$$$20240903$$CN$PK$PK
242771461$24277146$1$I$20240723$20240829$20240903$20240903$PER$$US-ABBVIE-5904923$ABBVIE$$27$YR$$F$Y$$$20240903$$HP$US$US
242771471$24277147$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139375$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240903$$HP$US$US
242771481$24277148$1$I$$20240828$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138213$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$81.65$KG$20240903$$CN$US$US
242771491$24277149$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139329$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$44$KG$20240903$$CN$US$US
242771511$24277151$1$I$20240405$20240826$20240903$20240903$EXP$GB-MHRA-MED-202408260710274140-NYRSF$GB-TEVA-VS-3237404$TEVA$$63$YR$$F$Y$74$KG$20240903$$CN$GB$GB
242771521$24277152$1$I$$20240831$20240903$20240903$EXP$$FR-GILEAD-2024-0686004$GILEAD$$$$$M$Y$$$20240903$$CN$FR$FR
242771531$24277153$1$I$20240724$20240829$20240903$20240903$EXP$FR-AFSSAPS-AM2024000685$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08145$HIKMA$$74$YR$$M$Y$85$KG$20240903$$MD$FR$FR
242771541$24277154$1$I$20231024$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-137285-2023$RECKITT BENCKISER$$74$YR$$M$Y$$$20240903$$CN$US$US
242771551$24277155$1$I$$20240829$20240903$20240903$EXP$$NL-JNJFOC-20240881310$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240903$$MD$NL$NL
242771561$24277156$1$I$$20240823$20240903$20240903$EXP$$US-BAYER-2024A125531$BAYER$Cruz-Saavedra L.A.; Patel J.; Siragusa D.; Silliman S.L.. Endovascular Mechanical Thrombectomy for Ischemic Stroke Treatment in the Setting of Aortic Dissection: Case Report. Case Reports in Neurology. 2024;16:1:159-170$67$YR$E$M$Y$$$20240903$$HP$US$US
242771571$24277157$1$I$20240801$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173440$AMGEN$$$$A$M$Y$$$20240903$$HP$US$US
242771581$24277158$1$I$20220601$20240827$20240903$20240903$EXP$$US-AMGEN-USASP2024171752$AMGEN$$$$$F$Y$$$20240903$$CN$US$US
242771592$24277159$2$F$20240101$20240903$20240903$20240910$EXP$$US-009507513-2408USA009640$MERCK$$$$$F$Y$98$KG$20240910$$CN$US$US
242771601$24277160$1$I$$20240830$20240903$20240903$PER$$US-ALXN-202408USA002180US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240903$$CN$US$US
242771611$24277161$1$I$$20240826$20240903$20240903$EXP$$US-SERVIER-S24010869$SERVIER$Cowen EA, Barrios DM, Dusza SW, Markova A, Pulitzer MP, Moy AP et al.. Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome) in Acute Myeloid Leukemia Patients: A 28-Year Institutional Experience. Acta Haematologica (Basel). 2024;147(4):457?64$$$$$Y$$$20240903$$MD$US$US
242771621$24277162$1$I$$20240826$20240903$20240903$30DAY$$US-GSK-US2024106132$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$CN$US$US
242771631$24277163$1$I$20240101$20240828$20240903$20240903$EXP$$CA-PFIZER INC-202400245697$PFIZER$$24$YR$$M$Y$$$20240903$$HP$CA$CA
242771641$24277164$1$I$$20240705$20240829$20240829$DIR$FDA-CDER-CTU-2024-59982$$FDA-CTU$$$$$$N$$$20240705$N$PH$US$
242771651$24277165$1$I$$20240823$20240903$20240903$30DAY$$CO-PFIZER INC-PV202400111231$PFIZER$$4$YR$$F$Y$$$20240903$$CN$CO$CO
242771661$24277166$1$I$$20240823$20240903$20240903$30DAY$$US-PFIZER INC-202400243239$PFIZER$$$$$$Y$$$20240903$$CN$US$US
242771682$24277168$2$F$20231118$20240925$20240903$20240925$EXP$$CN-PFIZER INC-PV202400113624$PFIZER$$48$YR$$M$Y$$$20240925$$CN$CN$CN
242771691$24277169$1$I$$20240712$20240829$20240829$DIR$FDA-CDER-CTU-2024-59989$$FDA-CTU$$$$$$N$$$20240712$N$PH$US$
242771711$24277171$1$I$20240101$20240829$20240903$20240903$EXP$$CA-PFIZER INC-202400040836$PFIZER$$91$YR$$F$Y$$$20240903$$MD$CA$CA
242771723$24277172$3$F$$20240909$20240903$20240912$30DAY$$CO-PFIZER INC-PV202400111837$PFIZER$$11$YR$$M$Y$$$20240912$$CN$CO$CO
242771732$24277173$2$F$$20240906$20240903$20240910$EXP$$US-PFIZER INC-PV202400113565$PFIZER$$$$$F$Y$$$20240910$$CN$US$US
242771741$24277174$1$I$$20240827$20240903$20240903$30DAY$$GB-PFIZER INC-PV202400112275$PFIZER$$19$YR$$M$Y$$$20240903$$CN$GB$GB
242771771$24277177$1$I$$20240827$20240903$20240903$30DAY$$CL-PFIZER INC-202400247496$PFIZER$$$$$$Y$$$20240903$$CN$CL$CL
242771781$24277178$1$I$$20240701$20240829$20240829$DIR$FDA-CDER-CTU-2024-59991$$FDA-CTU$$$$$$N$$$20240701$N$PH$US$
242771801$24277180$1$I$$20240830$20240903$20240903$EXP$$US-PFIZER INC-202400247879$PFIZER$$$$$$Y$$$20240903$$CN$US$US
242771812$24277181$2$F$$20240910$20240903$20240913$EXP$$IL-PFIZER INC-PV202400112978$PFIZER$$15$YR$$M$Y$$$20240913$$MD$IL$IL
242771821$24277182$1$I$20240101$20240829$20240903$20240903$EXP$$CA-PFIZER INC-202300444547$PFIZER$$25$YR$$M$Y$$$20240903$$CN$CA$CA
242771832$24277183$2$F$20240616$20240919$20240903$20240923$EXP$GB-MHRA-MED-202409011940310860-HKVND$GB-PFIZER INC-202400247643$PFIZER$$30$YR$$F$Y$64$KG$20240923$$CN$GB$GB
242771851$24277185$1$I$$20240710$20240829$20240829$DIR$FDA-CDER-CTU-2024-59985$$FDA-CTU$$$$$$N$$$20240710$N$PH$US$
242771871$24277187$1$I$20230101$20240829$20240903$20240903$EXP$$US-PFIZER INC-202400247291$PFIZER$$17$YR$$M$Y$38.56$KG$20240903$$PH$US$US
242771881$24277188$1$I$$20240829$20240903$20240903$EXP$$NVSC2024PA176663$NOVARTIS$$50$YR$$F$Y$$$20240903$$MD$PA$PA
242771891$24277189$1$I$20240823$20240830$20240903$20240903$EXP$$NVSC2024US167944$NOVARTIS$$64$YR$$F$Y$$$20240903$$CN$US$US
242771901$24277190$1$I$20240101$20240827$20240903$20240903$EXP$$DE-AMGEN-DEUSP2024171477$AMGEN$$$$$F$Y$$$20240903$$CN$DE$DE
242771914$24277191$4$F$20240803$20240918$20240903$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013999$JAZZ$$22$YR$$M$Y$$$20240924$$MD$US$US
242771922$24277192$2$F$20240822$20240905$20240903$20240911$EXP$$US-BIOGEN-2024BI01280199$BIOGEN$$26$YR$$F$Y$$$20240911$$CN$US$US
242771931$24277193$1$I$$20240825$20240903$20240903$EXP$$TW-RDY-SPO/TWN/24/0012718$DR REDDYS$Wu S, Hsu C, Yue C, Tsai Y. Large retroperitoneal extraskeletal Ewing^s sarcoma with renal pedicle invasion: a case report. BMC Urology. 2023 Dec 01;23(1): 1-6. doi:10.1186/s12894-023-01272-z.$57$YR$A$F$Y$$$20240903$$HP$TW$TW
242771941$24277194$1$I$20240807$20240827$20240903$20240903$EXP$$FI-MYLANLABS-2024M1079064$MYLAN$$6$DEC$$F$Y$85$KG$20240903$$MD$FI$FI
242771951$24277195$1$I$$20240828$20240903$20240903$EXP$$US-JNJFOC-20240900664$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$CN$US$US
242771971$24277197$1$I$$20240828$20240903$20240903$EXP$$CA-APOTEX-2024AP010058$APOTEX$$15$YR$$F$Y$$$20240903$$PH$CA$CA
242771982$24277198$2$F$$20240906$20240903$20240916$EXP$$US-TEVA-VS-3238430$TEVA$Lim O, Maher E, Miller DD. PD-1 Inhibitor Induced Hypertrophic Lichen Planus: A Case Report. Drugs-RD 2024; 24 (2): 353-357.; Lim O, Maher E, Miller DD. PD-1 Inhibitor Induced Hypertrophic Lichen Planus: A Case Report. Drugs-RD 2024; 24 (2): 353-357.$64$YR$$M$Y$$$20240916$$HP$US$US
242772001$24277200$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174928$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242772011$24277201$1$I$20240829$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000390$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240903$$CN$US$US
242772021$24277202$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024175337$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242772032$24277203$2$F$20240220$20240917$20240903$20240924$PER$$US-AMGEN-USASP2024172345$AMGEN$$$$$$Y$$$20240924$$HP$US$US
242772042$24277204$2$F$20231214$20240905$20240903$20240909$EXP$$BD-SANDOZ INC.-SDZ2024BD077184$SANDOZ$$71$YR$$F$Y$36$KG$20240909$$HP$BD$BD
242772051$24277205$1$I$$20240822$20240903$20240903$EXP$$US-Accord-443352$ACCORD$Hui J, Zhan X, Bashir A, Policeni F, Kim Hsieh SU. Epithelial-myoepithelial carcinoma occurrence in the site of previously treated ductal carcinoma in situ of the breast: Imaging features with histopathologic correlation, a case report and review of the literature. Clinical Case Reports. 2024;12(8):e9270$75$YR$E$F$Y$$$20240903$$MD$US$US
242772061$24277206$1$I$20240801$20240826$20240903$20240903$PER$$US-SA-2024SA253629$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240903$$CN$US$US
242772071$24277207$1$I$$20240826$20240903$20240903$EXP$$US-TEVA-VS-3238445$TEVA$Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front-Psychiatry 2024; 14.$$$A$M$Y$$$20240903$$HP$US$US
242772081$24277208$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-135729-2023$RECKITT BENCKISER$$92$YR$$F$Y$$$20240903$$CN$US$US
242772092$24277209$2$F$$20240830$20240903$20240905$PER$$US-AMGEN-USASP2024174056$AMGEN$$$$$F$Y$$$20240905$$HP$US$US
242772102$24277210$2$F$20230505$20240923$20240903$20240923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-100160$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$51.7$KG$20240923$$MD$JP$JP
242772121$24277212$1$I$20240720$20240822$20240903$20240903$EXP$$US-FARMAPROD-202408-3035$DOMPE FARMACEUTICI$$59$YR$A$F$Y$$$20240903$$CN$US$US
242772131$24277213$1$I$$20240829$20240903$20240903$EXP$$BR-Bion-013765$BIONPHARMA$$29$YR$A$F$Y$$$20240903$$HP$BR$BR
242772141$24277214$1$I$20240708$20240827$20240903$20240903$EXP$FR-AFSSAPS-LM2024000468$FR-009507513-2408FRA009514$MERCK$$68$YR$$M$Y$59.7$KG$20240903$$MD$FR$FR
242772151$24277215$1$I$$20240830$20240903$20240903$PER$$US-GILEAD-2024-0685878$GILEAD$$28$YR$A$M$Y$$$20240903$$CN$US$US
242772161$24277216$1$I$$20240827$20240903$20240903$EXP$$US-Bion-013769$BIONPHARMA$$72$YR$$F$Y$$$20240903$$CN$US$US
242772171$24277217$1$I$$20240827$20240903$20240903$EXP$$US-Bion-013770$BIONPHARMA$$$$$F$Y$$$20240903$$CN$US$US
242772181$24277218$1$I$20240628$20240827$20240903$20240903$EXP$FR-AFSSAPS-CN2024000724$FR-TEVA-VS-3237650$TEVA$$72$YR$$F$Y$73$KG$20240903$$MD$FR$FR
242772191$24277219$1$I$$20240827$20240903$20240903$EXP$$IN-MYLANLABS-2024M1080439$MYLAN$Goyal J, Kumar N. An interesting case report of serotonin syndrome in critically ill patient admitted with benzodiazepine overdose. Int-J-Life-Sci-Biotechnol-Pharma-Res 2024; 13 (8): 217-220.$32$YR$$M$Y$$$20240903$$MD$IN$IN
242772201$24277220$1$I$$20240827$20240903$20240903$EXP$$US-MYLANLABS-2024M1080421$MYLAN$Pico MJ, Badri M, Michalak N, Siefferman JW. Systemic allergic reaction to galcanezumab (emgality): a case report. Cephalalgia 2024; 44 (1):.$50$YR$$F$Y$$$20240903$$HP$US$US
242772221$24277222$1$I$$20240828$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137744$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240903$$CN$US$US
242772231$24277223$1$I$20230510$20240827$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137201$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240903$$MD$US$US
242772241$24277224$1$I$20240416$20240828$20240903$20240903$EXP$$DE-AMGEN-DEUNI2024171948$AMGEN$$50$YR$A$M$Y$87$KG$20240903$$MD$DE$DE
242772252$24277225$2$F$20240809$20240829$20240903$20240906$PER$$US-AMGEN-USASP2024173034$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242772261$24277226$1$I$$20240826$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135948$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240903$$HP$US$US
242772271$24277227$1$I$$20240822$20240903$20240903$EXP$$AU-SA-2024SA254523$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240903$$CN$AU$AU
242772281$24277228$1$I$20240603$20240902$20240903$20240903$EXP$FR-AFSSAPS-NC2024001018$NVSC2024FR176249$NOVARTIS$$62$YR$$F$Y$$$20240903$$MD$FR$FR
242772291$24277229$1$I$$20240822$20240903$20240903$PER$$US-SA-2024SA254278$SANOFI AVENTIS$$2$YR$C$F$Y$12.24$KG$20240903$$MD$US$US
242772301$24277230$1$I$$20240830$20240903$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US077164$SANDOZ$$$$$F$Y$$$20240903$$CN$US$US
242772311$24277231$1$I$$20240831$20240903$20240903$PER$$US-TAKEDA-2024TUS087855$TAKEDA$$$$$$Y$$$20240903$$CN$US$US
242772321$24277232$1$I$20200401$20240828$20240903$20240903$EXP$$AU-SANDOZ INC.-SDZ2024AU074152$SANDOZ$$41$YR$$M$Y$$$20240903$$HP$AU$AU
242772332$24277233$2$F$20240501$20240916$20240903$20240925$EXP$$DE-UCBSA-2024042929$UCB$$$$A$F$Y$128$KG$20240925$$MD$DE$DE
242772341$24277234$1$I$$20240902$20240903$20240903$EXP$DE-EMA-DD-20240829-7482707-105358$DE-SANDOZ INC.-SDZ2024DE076997$SANDOZ$$17$YR$$$Y$$$20240903$$MD$DE$DE
242772351$24277235$1$I$20240428$20240828$20240903$20240903$EXP$FR-AFSSAPS-AVMA2024000356$FR-MYLANLABS-2024M1079435$MYLAN$$15$YR$$F$Y$$$20240903$$PH$FR$FR
242772361$24277236$1$I$20240818$20240828$20240903$20240903$EXP$SE-SEMPA-2024-006283$SE-MYLANLABS-2024M1079512$MYLAN$$88$YR$$F$Y$$$20240903$$MD$SE$SE
242772371$24277237$1$I$20240601$20240828$20240903$20240903$EXP$$DE-MYLANLABS-2024M1079538$MYLAN$$$$$M$Y$$$20240903$$CN$DE$DE
242772381$24277238$1$I$20240806$20240828$20240903$20240903$EXP$FR-AFSSAPS-AVMA2024000360$FR-MYLANLABS-2024M1079345$MYLAN$$72$YR$$M$Y$$$20240903$$MD$FR$FR
242772391$24277239$1$I$20240703$20240828$20240903$20240903$EXP$FR-AFSSAPS-LY2024001332$FR-MYLANLABS-2024M1079390$MYLAN$$66$YR$$F$Y$$$20240903$$CN$FR$FR
242772401$24277240$1$I$$20240828$20240903$20240903$EXP$$GB-MYLANLABS-2024M1079500$MYLAN$$$$$$Y$$$20240903$$CN$GB$GB
242772411$24277241$1$I$$20240828$20240903$20240903$EXP$FR-AFSSAPS-AVNT2024000649$FR-MYLANLABS-2024M1079442$MYLAN$$20$YR$$F$Y$$$20240903$$PH$FR$FR
242772421$24277242$1$I$20240726$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59978$$FDA-CTU$$75$YR$$M$N$71$KG$20240830$Y$CN$US$
242772431$24277243$1$I$20240627$20240828$20240903$20240903$EXP$FR-AFSSAPS-AVCN2024000644$FR-MYLANLABS-2024M1079419$MYLAN$$29$YR$$M$Y$$$20240903$$MD$FR$FR
242772441$24277244$1$I$20240727$20240828$20240903$20240903$EXP$FR-AFSSAPS-AVNT2024000648$FR-MYLANLABS-2024M1079338$MYLAN$$24$YR$$M$Y$$$20240903$$MD$FR$FR
242772451$24277245$1$I$20230418$20240828$20240903$20240903$EXP$$GB-MYLANLABS-2024M1079501$MYLAN$$69$YR$$M$Y$91$KG$20240903$$MD$GB$GB
242772461$24277246$1$I$$20240826$20240903$20240903$EXP$$US-BAYER-2024A123177$BAYER$$88$YR$E$F$Y$$$20240903$$HP$US$US
242772471$24277247$1$I$20240725$20240828$20240903$20240903$EXP$FR-AFSSAPS-MP2024001321$FR-MYLANLABS-2024M1079361$MYLAN$$$$N$F$Y$3.43$KG$20240903$$MD$FR$FR
242772481$24277248$1$I$$20240901$20240903$20240903$PER$$US-HALEON-2194886$Haleon PLC$$$$$$Y$$$20240903$$CN$US$US
242772491$24277249$1$I$20240501$20240826$20240903$20240903$EXP$$CA-TAKEDA-2024TUS052789$TAKEDA$$0$YR$$F$Y$9.6$KG$20240903$$CN$CA$CA
242772501$24277250$1$I$$20240829$20240903$20240903$EXP$$AU-TAKEDA-2024TUS087443$TAKEDA$$$$$M$Y$$$20240903$$CN$AU$AU
242772511$24277251$1$I$$20240826$20240903$20240903$EXP$$US-TEVA-VS-3237348$TEVA$$$$$F$Y$$$20240903$$MD$US$US
242772531$24277253$1$I$20231011$20240827$20240903$20240903$PER$FR-AFSSAPS-LL2024001631$FR-PFM-2024-04754$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240903$$MD$FR$FR
242772541$24277254$1$I$20240624$20240827$20240903$20240903$PER$FR-AFSSAPS-AVPO2024000159$FR-PFM-2024-04749$PIERRE FABRE MEDICAMENT$$$$$$Y$$$20240903$$PH$FR$FR
242772552$24277255$2$F$20240101$20240826$20240903$20240904$PER$$US-SA-2024SA255232$SANOFI AVENTIS$$$$I$F$Y$$$20240904$$MD$US$US
242772561$24277256$1$I$20240829$20240829$20240903$20240903$EXP$$US-JNJFOC-20240901914$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240903$$MD$US$US
242772571$24277257$1$I$20240827$20240828$20240903$20240903$PER$$US-JNJFOC-20240874032$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240903$$CN$US$US
242772591$24277259$1$I$20240827$20240828$20240903$20240903$PER$$US-JNJFOC-20240873855$JOHNSON AND JOHNSON$$41$YR$$M$Y$$$20240903$$PH$US$US
242772602$24277260$2$F$$20240903$20240903$20240913$EXP$$KR-ROCHE-10000069928$ROCHE$J K, Kim J. Short-term outcomes of faricimab for neovascular age-related macular degeneration with limited response to ranibizumab or aflibercept.. Journal of the korean ophthalmological society. 2024;65 (8):515-24. doi:10.3341/jkos.2024.65.8.515.$77$YR$E$$Y$$$20240913$$HP$KR$KR
242772611$24277261$1$I$$20240826$20240903$20240903$EXP$$ZA-AstraZeneca-2024A195442$ASTRAZENECA$$39$YR$$F$Y$$$20240903$$CN$ZA$
242772621$24277262$1$I$$20240826$20240903$20240903$PER$$US-AstraZeneca-2024A197986$ASTRAZENECA$$65$YR$$F$Y$$$20240903$$CN$US$
242772641$24277264$1$I$$20240828$20240903$20240903$PER$$US-ABBVIE-5901353$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242772651$24277265$1$I$$20240822$20240903$20240903$EXP$$US-Accord-443348$ACCORD$Attieh RM, Roach D, Wadei HM, Parikh N, Me HM, Durvasula RV, et al. Case Report: Early-Onset Adenovirus Nephritis Without Hemorrhagic Cystitis Following Kidney Transplantation. Transplantation Proceedings. 2024;56(5):1196-9.$35$YR$A$M$Y$$$20240903$$MD$US$US
242772661$24277266$1$I$20240726$20240821$20240903$20240903$EXP$$CN-SA-2024SA254100$SANOFI AVENTIS$$77$YR$E$M$Y$47$KG$20240903$$HP$CN$CN
242772671$24277267$1$I$$20160718$20240903$20240903$EXP$$NVSC2016IT016554$NOVARTIS$$$$$$Y$$$20240903$$MD$IT$IT
242772681$24277268$1$I$20190201$20240902$20240903$20240903$EXP$FR-AFSSAPS-NY20191551$NVSC2019FR048969$NOVARTIS$$$$A$M$Y$$$20240903$$CN$FR$FR
242772691$24277269$1$I$$20240902$20240903$20240903$EXP$$PT-SANDOZ INC.-SDZ2024PT076964$SANDOZ$$28$YR$$F$Y$$$20240903$$MD$PT$PT
242772701$24277270$1$I$20210801$20240827$20240903$20240903$EXP$$LT-REGENERON PHARMACEUTICALS, INC.-2024-117413$REGENERON$$78$YR$$F$Y$$$20240903$$MD$LT$LT
242772711$24277271$1$I$20240704$20240826$20240903$20240903$EXP$$US-BAYER-2024A123471$BAYER$$86$YR$E$F$Y$$$20240903$$CN$US$US
242772731$24277273$1$I$$20240830$20240903$20240903$PER$$US-JNJFOC-20240880730$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$HP$US$US
242772741$24277274$1$I$$20240827$20240903$20240903$EXP$$US-MYLANLABS-2024M1080424$MYLAN$Edelbach BM, Gospodarev V, Raghavan R, Dye J. Primary intracranial sarcoma, DICER-1 mutant, with hemorrhagic presentation: A case report. Surg-Neurol-Int 2024; 15 (0): 1-6.$26$YR$$M$Y$$$20240903$$HP$US$US
242772751$24277275$1$I$$20240828$20240903$20240903$EXP$$US-GSK-US2024107086$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$CN$US$US
242772761$24277276$1$I$$20240901$20240903$20240903$PER$$US-HALEON-2194715$Haleon PLC$$$$$$Y$$$20240903$$CN$US$US
242772771$24277277$1$I$$20240814$20240903$20240903$PER$$US-TEVA-VS-3235259$TEVA$$55$YR$$F$Y$$$20240903$$MD$US$US
242772782$24277278$2$F$20240820$20240905$20240903$20240912$PER$$US-ABBVIE-5904010$ABBVIE$$27$YR$$F$Y$$$20240912$$MD$US$US
242772791$24277279$1$I$$20240827$20240903$20240903$EXP$$US-MYLANLABS-2024M1080422$MYLAN$Aamer S, Rajan A, Arora S. Vascular threads and nephron nests: exploring the association between takayasu arteritis and membranous nephropathy. Eur-J-Case-Rep-Intern-Med 2024; 11 (8):.$3$DEC$$F$Y$$$20240903$$HP$US$US
242772801$24277280$1$I$20240814$20240819$20240903$20240903$EXP$$JP-VERICEL-JP-VCEL-24-000322$VERICEL$$68$YR$$M$Y$$$20240903$$MD$JP$JP
242772811$24277281$1$I$$20240823$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139940$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240903$$CN$US$US
242772831$24277283$1$I$$20240813$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08157$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242772841$24277284$1$I$$20240826$20240903$20240903$EXP$$IT-MYLANLABS-2024M1079709$MYLAN$Brunoni B, Zadek F, Mulazzani F, Verza G, Marrazzo F, Spina S, et al. Calcium-Citrate Anticoagulation during Continuous Renal Replacement Therapy in Patients with Metformin Intoxication: A Case Series, Mathematical Estimation of Citrate Accumulation, and Literature Review. [Review]. Blood-Purif 2023; 52 802-811.$71$YR$$F$Y$75$KG$20240903$$HP$IT$IT
242772851$24277285$1$I$$20240825$20240903$20240903$EXP$$US-MPL-000058$MLV PHARMA$$37$YR$A$M$Y$70$KG$20240828$$PH$US$US
242772861$24277286$1$I$$20240826$20240903$20240903$EXP$$IT-MYLANLABS-2024M1079706$MYLAN$Brunoni B, Zadek F, Mulazzani F, Verza G, Marrazzo F, Spina S, et al. Calcium-Citrate Anticoagulation during Continuous Renal Replacement Therapy in Patients with Metformin Intoxication: A Case Series, Mathematical Estimation of Citrate Accumulation, and Literature Review. [Review]. Blood-Purif 2023; 52 802-811.$66$YR$$M$Y$75$KG$20240903$$HP$IT$IT
242772871$24277287$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1079711$MYLAN$Cecchini A, Stephenson E, Sill JM. An Uncommon Cause of Immunosuppression: Fatal Pneumocystis Jiroveci Pneumonia in a Patient With Cushing^s Syndrome. Am-J-Respir-Crit-Care-Med 2023; 207 A1341.$61$YR$$F$Y$$$20240903$$HP$US$US
242772881$24277288$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1079710$MYLAN$Peleman J, Lin JS, Lin HS. Total Laryngectomy for Respiratory Complications From Advanced Duchenne Muscular Dystrophy. Laryngoscope 2024; 134 (8): 3677-3678.$31$YR$$M$Y$$$20240903$$MD$US$US
242772891$24277289$1$I$20240826$20240826$20240903$20240903$EXP$$JP-VIATRISJAPAN-2024M1078876AA$MYLAN$$3$DEC$$F$Y$$$20240903$$MD$JP$JP
242772901$24277290$1$I$20240522$20240826$20240903$20240903$EXP$FR-AFSSAPS-LL2024001567$FR-MYLANLABS-2024M1078796$MYLAN$$2$MON$$M$Y$2.23$KG$20240903$$PH$FR$FR
242772921$24277292$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080485$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$5$DEC$$$Y$$$20240903$$HP$US$US
242772931$24277293$1$I$20240815$20240826$20240903$20240903$EXP$IT-MINISAL02-999575$IT-MYLANLABS-2024M1078819$MYLAN$$82$YR$$M$Y$$$20240903$$MD$IT$IT
242772941$24277294$1$I$$20240826$20240903$20240903$EXP$$US-BAYER-2024A125702$BAYER$$68$YR$E$F$Y$117.91$KG$20240903$$CN$US$US
242772951$24277295$1$I$$20240826$20240903$20240903$EXP$$IT-MYLANLABS-2024M1079708$MYLAN$Brunoni B, Zadek F, Mulazzani F, Verza G, Marrazzo F, Spina S, et al. Calcium-Citrate Anticoagulation during Continuous Renal Replacement Therapy in Patients with Metformin Intoxication: A Case Series, Mathematical Estimation of Citrate Accumulation, and Literature Review. [Review]. Blood-Purif 2023; 52 802-811.$66$YR$$F$Y$70$KG$20240903$$HP$IT$IT
242772961$24277296$1$I$$20240826$20240903$20240903$EXP$$FR-MYLANLABS-2024M1079874$MYLAN$Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, et al. Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study. Am-J-Hematol 2023; 98 (9): E259-E262.$70$YR$$M$Y$$$20240903$$HP$FR$FR
242772971$24277297$1$I$$20240826$20240903$20240903$EXP$$IT-MYLANLABS-2024M1078954$MYLAN$Giovanni Falcicchio, Roberta Pellicciari, Daniele Graziani, Francesca Mazzeo, Lidia Dalfino, Salvatore Grasso, Damiano Paolicelli, Giovanni Defazio. Early considerations about the safety of cenobamate in the treatment  of status epilepticus. Neurological Sciences. 2024$26$YR$$F$Y$$$20240903$$MD$IT$IT
242772981$24277298$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080436$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$7$DEC$$$Y$$$20240903$$HP$US$US
242772991$24277299$1$I$$20240826$20240903$20240903$EXP$$FR-MYLANLABS-2024M1079913$MYLAN$Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, et al. Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study. Am-J-Hematol 2023; 98 (9): E259-E262.$79$YR$$M$Y$$$20240903$$HP$FR$FR
242773001$24277300$1$I$20240801$20240826$20240903$20240903$EXP$$FR-MYLANLABS-2024M1078753$MYLAN$$73$YR$$M$Y$$$20240903$$CN$FR$FR
242773011$24277301$1$I$$20240826$20240903$20240903$EXP$$JP-MYE-2024M1079848AA$MYLAN$Yoshimura Y, Suwabe T, Miki K, Yokoyama T, Kono K, Kinowaki K, et al. Renal cell carcinoma preceded by a rheumatoid-like paraneoplastic syndrome: A case report. Oncol-Lett 2024; 28 (4):.. 2024;28 (4)$72$YR$$M$Y$54$KG$20240903$$HP$JP$JP
242773021$24277302$1$I$$20240826$20240903$20240903$EXP$$FR-MYLANLABS-2024M1079914$MYLAN$Eid R, Zamparini E, Ouchrif Y, Snanoudj R, Ottolenghi C, Zaidan M. A case report of Paracetamol related pyroglutamic acidosis: mind the gap in a malnourished patient. BMC-Nephrol 2024; 25 (1):.$67$YR$$M$Y$$$20240903$$HP$FR$FR
242773031$24277303$1$I$$20191231$20240903$20240903$EXP$$CA-Covis Pharma GmbH-2021COV21847$COVIS PHARMA$$34$YR$A$F$Y$$$20240903$$MD$CA$CA
242773041$24277304$1$I$20240828$20240830$20240903$20240903$EXP$$US-JNJFOC-20240902356$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240903$$MD$US$US
242773051$24277305$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60030$$FDA-CTU$$84$YR$$M$N$$$20240830$N$$US$
242773061$24277306$1$I$$20240830$20240903$20240903$EXP$$US-KYOWAKIRIN-2024KK020410$KYOWA$$$$$$Y$$$20240903$$HP$US$US
242773072$24277307$2$F$$20240829$20240903$20240906$EXP$$US-PFIZER INC-202400246340$PFIZER$Cowan, M.. A Case Report of Delayed Opioid Toxidrome After Administration of Naloxone. Clinical practice and cases in emergency medicine. 2024;8(3):222-225$30$YR$$M$Y$$$20240906$$MD$US$US
242773082$24277308$2$F$$20240905$20240903$20240910$EXP$$US-PFIZER INC-PV202400112753$PFIZER$Aifuwa, E.. Concomitant Methotrexate Withdrawal and Brentuximab Vedotin Therapy for Treatment of Methotrexate Associated Hodgkin Lymphoma. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(Supple 1):S446-S447$82$YR$$M$Y$$$20240910$$HP$US$US
242773093$24277309$3$F$$20240916$20240903$20240919$EXP$$US-PFIZER INC-202400247129$PFIZER$Hofkamp, M.. Apparent local anesthetic systemic toxicity following activation of an epidural catheter for cesarean delivery: Diagnosis and management of an uncommon obstetric anesthesia complication. Proceedings (Baylor University. Medical Center). 2024;37(5):874-876$25$YR$$F$Y$92$KG$20240919$$MD$US$US
242773101$24277310$1$I$$20240829$20240903$20240903$EXP$$TR-PFIZER INC-PV202400113313$PFIZER$Genc, N.. IMMUNOTHERAPY-RELATED LUNG AND DERMATOLOGIC TOXICITY IN A PATIENT WITH GASTRIC CANCER. European Journal of Case Reports in Internal Medicine. 2024;11 (Suppl 1):763-764$$$$$Y$$$20240903$$HP$TR$TR
242773112$24277311$2$F$$20240902$20240903$20240904$EXP$$ES-PFIZER INC-PV202400114208$PFIZER$Ramos, B.. ANTI-IL1 MOLECULE FOR IDIOPATHIC RECURRENT PERICARDITIS. European Journal of Case Reports in Internal Medicine. 2024;11(Supple 1):1007$37$YR$$F$Y$$$20240904$$HP$ES$ES
242773122$24277312$2$F$$20240902$20240903$20240904$EXP$$US-PFIZER INC-PV202400112702$PFIZER$Hameed, M.. TCL-732 A Rare Case of Rapid Onset Fatal HLH Secondary to Large Granular T-cell Lymphocytic Leukemia. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(Supple 1):S526-S527$66$YR$$M$Y$$$20240904$$MD$US$US
242773133$24277313$3$F$$20240916$20240903$20240918$EXP$$FI-PFIZER INC-2003021409$PFIZER$Luomanmaki, K.. Pharmacokinetics of diltiazem in massive overdose. Therapeutic Drug Monitoring. 1997;19(2):240-242$22$YR$$F$Y$$$20240918$$MD$FI$FI
242773141$24277314$1$I$$20240829$20240903$20240903$EXP$$US-PFIZER INC-PV202400113831$PFIZER$Traverse, J.. Acute hepatic injury after treatment with diltiazem. American Heart Journal. 1994;127(6):1636-9$74$YR$$F$Y$$$20240903$$MD$US$US
242773151$24277315$1$I$$20240829$20240903$20240903$EXP$$DK-PFIZER INC-PV202400114815$PFIZER$Toft, E.. Diltiazem-induced granulomatous hepatitis. Histopathology. 1991;18(5):474-475$68$YR$$F$Y$$$20240903$$HP$DK$DK
242773161$24277316$1$I$20240828$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174610$AMGEN$$68$YR$E$F$Y$$$20240903$$PH$US$US
242773171$24277317$1$I$20230101$20240827$20240903$20240903$EXP$$JP-TAKEDA-2024TUS088010$TAKEDA$$40$YR$$F$Y$$$20240903$$MD$JP$JP
242773181$24277318$1$I$$20240828$20240903$20240903$EXP$$NVSC2024US174871$NOVARTIS$$$$$F$Y$$$20240903$$CN$US$US
242773191$24277319$1$I$20240801$20240827$20240903$20240903$EXP$FR-AFSSAPS-LL2024001577$FR-TEVA-VS-3237738$TEVA$$86$YR$$M$Y$$$20240903$$PH$FR$FR
242773201$24277320$1$I$20240101$20240820$20240903$20240903$PER$$US-SA-2024SA254747$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240903$$MD$US$US
242773211$24277321$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA253204$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240903$$MD$US$US
242773221$24277322$1$I$20240101$20240826$20240903$20240903$PER$$US-UNITED THERAPEUTICS-UNT-2024-026884$UNITED THERAPEUTICS$$$$$F$Y$89.342$KG$20240903$$$US$US
242773233$24277323$3$F$20240720$20240910$20240903$20240923$EXP$$US-BAYER-2024A118602$BAYER$$64$YR$A$M$Y$94.785$KG$20240923$$CN$US$US
242773241$24277324$1$I$20240723$20240820$20240903$20240903$PER$$US-ABBVIE-5902889$ABBVIE$$19$YR$$F$Y$$$20240903$$MD$US$US
242773252$24277325$2$F$20240820$20240910$20240903$20240918$EXP$$NVSC2024AT132222$NOVARTIS$$39$YR$$F$Y$$$20240918$$CN$AT$AT
242773261$24277326$1$I$20240601$20240829$20240903$20240903$EXP$$MY-AstraZeneca-2024A197497$ASTRAZENECA$$726$MON$$F$Y$$$20240903$$CN$MY$
242773272$24277327$2$F$20240825$20240913$20240903$20240918$PER$$US-AstraZeneca-2024A194846$ASTRAZENECA$$20612$DY$$F$Y$$$20240918$$CN$US$
242773281$24277328$1$I$20240327$20240826$20240903$20240903$EXP$$FR-AstraZeneca-2024A189739$ASTRAZENECA$$79$YR$$M$Y$66$KG$20240903$$MD$FR$
242773293$24277329$3$F$$20240910$20240903$20240916$EXP$$CA-JNJFOC-20240881167$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240916$$PH$CA$CA
242773301$24277330$1$I$$20240827$20240903$20240903$30DAY$$US-GSK-US2024106724$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$CN$US$US
242773321$24277332$1$I$20230825$20240827$20240903$20240903$EXP$$IT-009507513-2408ITA009579$MERCK$Di Pietro FR, Verkhovskaia S, Falcone R, Poti G, Carbone ML, Morelli MF, et al.. Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients. Frontiers in Oncology. 2024;14$44$YR$$M$Y$$$20240903$$HP$IT$IT
242773331$24277333$1$I$$20240315$20240903$20240903$PER$$US-MEITHEAL-2024MPSPO00073$MEITHEAL PHARMACEUTICALS$$$$$$Y$$$20240902$$HP$US$US
242773342$24277334$2$F$$20240906$20240903$20240916$EXP$$US-TEVA-VS-3238646$TEVA$Heering G, Lin Z, Rosman M, Hara N, Shakil F, Georgostathis D. Side Effects of Stem Cell Transplant Mimicking Symptoms of Known Amyloidosis. Case-Rep-Gastroenterol 2024; 18 (1): 273-278.; Heering G, Lin Z, Rosman M, Hara N, Shakil F, Georgostathis D. Side Effects of Stem Cell Transplant Mimicking Symptoms of Known Amyloidosis. Case-Rep-Gastroenterol 2024; 18 (1): 273-278.$67$YR$$F$Y$$$20240916$$HP$US$US
242773353$24277335$3$F$20240101$20240907$20240903$20240920$PER$$US-SA-2024SA255276$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240920$$MD$US$US
242773361$24277336$1$I$$20240823$20240903$20240903$PER$$US-SA-2024SA253287$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240903$$MD$US$US
242773371$24277337$1$I$$20240829$20240903$20240903$PER$$US-SA-2024SA253440$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240903$$PH$US$US
242773382$24277338$2$F$20211114$20240909$20240903$20240923$EXP$$JP-RECORDATI RARE DISEASE INC.-2024006594$RECORDATI$$$$$$Y$$$20240923$$MD$JP$JP
242773391$24277339$1$I$20240801$20240829$20240903$20240903$PER$$US-SA-2024SA254666$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240903$$MD$US$US
242773411$24277341$1$I$$20240828$20240903$20240903$PER$$US-JNJFOC-20240880731$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$HP$US$US
242773421$24277342$1$I$20240603$20240828$20240903$20240903$EXP$GB-MHRA-MIDB-cc725918-2a3b-4cc2-9481-3ea6170e6391$GB-SA-2024SA252285$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240903$$PH$GB$GB
242773431$24277343$1$I$$20240902$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US077050$SANDOZ$$$$$$Y$$$20240903$$CN$US$US
242773441$24277344$1$I$20240101$20240830$20240903$20240903$EXP$$JP-GENMAB-2024-03170$GENMAB$$9$DEC$$$Y$$$20240903$$MD$JP$JP
242773451$24277345$1$I$$20240827$20240903$20240903$EXP$$US-MYLANLABS-2024M1079752$MYLAN$$$$$M$Y$90.72$KG$20240903$$CN$US$US
242773463$24277346$3$F$20240706$20240925$20240903$20240930$EXP$$JP-PFIZER INC-PV202400090339$PFIZER$$78$YR$$M$Y$63$KG$20240930$$MD$JP$JP
242773471$24277347$1$I$$20240902$20240903$20240903$PER$$US-AMGEN-USASP2024175382$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242773482$24277348$2$F$$20240906$20240903$20240916$EXP$$US-TEVA-VS-3238413$TEVA$Khurshid A, Paranji S, Kapur R, Weber A, Cohen M, Vegunta R, et al. Outcomes of R-MPV followed by ara-c in primary central nervous system lymphoma: A single-center retrospective analysis. J-Clin-Oncol 2024; 42 (Suppl.) (16):.; Khurshid A, Paranji S, Kapur R, Weber A, Cohen M, Vegunta R, et al. Outcomes of R-MPV followed by ara-c in primary central nervous system lymphoma: A single-center retrospective analysis. J-Clin-Oncol 2024; 42 (Suppl.) (16):.$$$$$Y$$$20240916$$HP$US$US
242773491$24277349$1$I$$20240827$20240903$20240903$EXP$$US-BAYER-2024A123145$BAYER$$72$YR$E$M$Y$$$20240903$$CN$US$US
242773501$24277350$1$I$$20240828$20240830$20240830$DIR$FDA-CDER-CTU-2024-60107$$FDA-CTU$$$$$M$N$$$20240828$N$HP$US$
242773511$24277351$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60105$$FDA-CTU$$63$YR$$F$N$67.13$KG$20240830$N$$US$
242773531$24277353$1$I$20240801$20240828$20240903$20240903$EXP$NL-LRB-00996944$NL-GSK-NL2024107121$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$HP$NL$NL
242773541$24277354$1$I$$20240830$20240903$20240903$EXP$$NVSC2024CA176767$NOVARTIS$$45$YR$$F$Y$$$20240903$$CN$CA$CA
242773552$24277355$2$F$$20240903$20240903$20240916$EXP$$CA-UCBSA-2024042606$UCB$$$$$F$Y$$$20240916$$MD$CA$CA
242773561$24277356$1$I$$20240821$20240903$20240903$EXP$$AU-EXELIXIS-CABO-24081051$EXELIXIS$$$$$$Y$$$20240903$$MD$AU$AU
242773571$24277357$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60116$$FDA-CTU$$4$YR$$F$N$$$20240830$N$$US$
242773581$24277358$1$I$20240801$20240822$20240903$20240903$PER$$US-SA-2024SA255200$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240903$$MD$US$US
242773591$24277359$1$I$20240101$20240820$20240903$20240903$PER$$US-SA-2024SA251994$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240903$$CN$US$US
242773601$24277360$1$I$$20240827$20240903$20240903$EXP$$US-SA-2024SA253190$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240903$$CN$US$US
242773611$24277361$1$I$20240822$20240822$20240903$20240903$PER$$US-SA-2024SA253265$SANOFI AVENTIS$$38$YR$A$$Y$$$20240903$$HP$US$US
242773621$24277362$1$I$20240826$20240826$20240903$20240903$PER$$US-SA-2024SA253391$SANOFI AVENTIS$$$$$M$Y$$$20240903$$MD$US$US
242773631$24277363$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60100$$FDA-CTU$$$$$M$N$$$20240830$N$HP$US$
242773642$24277364$2$F$20240101$20240919$20240903$20240923$EXP$$TW-BAYER-2024A123385$BAYER$$79$YR$E$M$Y$$$20240923$$MD$TW$TW
242773651$24277365$1$I$20240728$20240828$20240903$20240903$EXP$FR-AFSSAPS-NC2024000990$FR-MYLANLABS-2024M1079299$MYLAN$$77$YR$$M$Y$80$KG$20240903$$MD$FR$FR
242773671$24277367$1$I$20240801$20240827$20240903$20240903$EXP$$US-SA-2024SA255012$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240903$$HP$US$US
242773691$24277369$1$I$$20240823$20240903$20240903$PER$$US-ABBVIE-5896040$ABBVIE$$$$$F$Y$$$20240903$$PH$US$US
242773701$24277370$1$I$20240729$20240828$20240903$20240903$EXP$FR-AFSSAPS-NC2024000991$FR-MYLANLABS-2024M1079308$MYLAN$$53$YR$$F$Y$70$KG$20240903$$MD$FR$FR
242773721$24277372$1$I$20240803$20240829$20240903$20240903$EXP$$US-ABBVIE-5902067$ABBVIE$$48$YR$$M$Y$$$20240903$$CN$US$US
242773732$24277373$2$F$20240802$20240827$20240903$20240906$EXP$FR-AFSSAPS-RS2024000817$FR-009507513-2408FRA009617$MERCK$$77$YR$$M$Y$62$KG$20240906$$PH$FR$FR
242773741$24277374$1$I$$20240902$20240903$20240903$PER$$US-JNJFOC-20240903891$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242773751$24277375$1$I$20240829$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59976$$FDA-CTU$$75$YR$$$N$$$20240830$N$HP$US$
242773762$24277376$2$F$$20240830$20240903$20240912$EXP$$CA-GILEAD-2024-0685941$GILEAD$$63$YR$A$F$Y$$$20240912$$HP$CA$CA
242773771$24277377$1$I$20240826$20240827$20240903$20240903$EXP$$GB-MYLANLABS-2024M1079651$MYLAN$$$$$M$Y$$$20240903$$CN$GB$GB
242773781$24277378$1$I$$20240821$20240903$20240903$PER$$US-MYLANLABS-2024M1079817$MYLAN$$$$$F$Y$$$20240903$$CN$US$US
242773791$24277379$1$I$$20240827$20240903$20240903$EXP$NL-LRB-00999119$NL-MYLANLABS-2024M1079070$MYLAN$$43$YR$$F$Y$$$20240903$$MD$NL$NL
242773801$24277380$1$I$20240101$20240827$20240903$20240903$EXP$$PT-MYLANLABS-2024M1079545$MYLAN$$70$YR$$F$Y$53$KG$20240903$$CN$PT$PT
242773811$24277381$1$I$$20240829$20240903$20240903$EXP$$DE-009507513-2409DEU000667$MERCK$$$$$M$Y$$$20240903$$MD$DE$DE
242773823$24277382$3$F$20240801$20240917$20240903$20240918$PER$$US-ALXN-202408USA001724US$ALEXION PHARMACEUTICALS$$63$YR$$F$Y$$$20240918$$CN$US$US
242773831$24277383$1$I$$20240827$20240903$20240903$EXP$$CA-APOTEX-2024AP010030$APOTEX$$73$YR$$M$Y$66$KG$20240903$$HP$CA$CA
242773842$24277384$2$F$20220101$20240911$20240903$20240917$EXP$$NVSC2024MX132513$NOVARTIS$$$$$F$Y$81$KG$20240917$$CN$MX$MX
242773861$24277386$1$I$$20240821$20240903$20240903$EXP$$JP-SA-2024SA255008$SANOFI AVENTIS$Ryusuke Kobayashi et al.. A case of gastric perforation during chemotherapy and gastrectomy performed after preserved therapy. The 79th Japanese Society of Gastroenterological Surgery Program. 2024;unknown:2403$66$YR$E$F$Y$$$20240903$$MD$JP$JP
242773882$24277388$2$F$20240501$20240917$20240903$20240925$PER$$US-ASTELLAS-2024-AER-002135$ASTELLAS$$67$YR$E$M$Y$$$20240925$$HP$US$US
242773891$24277389$1$I$$20240829$20240903$20240903$PER$$US-BIOGEN-2024BI01280626$BIOGEN$$$$$F$Y$$$20240903$$CN$US$US
242773901$24277390$1$I$$20240829$20240903$20240903$PER$$US-BIOGEN-2024BI01280546$BIOGEN$$$$$F$Y$$$20240903$$CN$US$US
242773911$24277391$1$I$$20240829$20240903$20240903$PER$$US-BIOGEN-2024BI01280591$BIOGEN$$$$$F$Y$$$20240903$$CN$US$US
242773921$24277392$1$I$$20240829$20240903$20240903$PER$$US-BAYER-2024A124995$BAYER$$$$$$Y$$$20240903$$CN$US$US
242773931$24277393$1$I$20240101$20240827$20240903$20240903$EXP$$US-SA-2024SA253116$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240903$$CN$US$US
242773941$24277394$1$I$$20240830$20240903$20240903$PER$$US-JNJFOC-20240882107$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$CN$US$US
242773952$24277395$2$F$20240828$20240828$20240903$20240909$30DAY$$US-JNJFOC-20240873453$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240909$$CN$US$US
242773961$24277396$1$I$20240101$20240825$20240903$20240903$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017211$UNITED THERAPEUTICS$$$$$F$Y$119.73$KG$20240903$$$US$US
242773971$24277397$1$I$$20240828$20240903$20240903$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013881$VERTEX$$$$A$F$Y$$$20240903$$CN$GB$GB
242773981$24277398$1$I$$20240826$20240903$20240903$PER$$US-VERTEX PHARMACEUTICALS-2024-013749$VERTEX$$$$$F$Y$$$20240903$$PH$US$US
242773991$24277399$1$I$$20240828$20240903$20240903$PER$$US-VERTEX PHARMACEUTICALS-2024-013893$VERTEX$$$$$M$Y$$$20240903$$CN$US$US
242774001$24277400$1$I$20240809$20240826$20240903$20240903$EXP$$CO-AstraZeneca-2024A195710$ASTRAZENECA$$25056$DY$$F$Y$70$KG$20240903$$CN$CO$
242774011$24277401$1$I$20240801$20240826$20240903$20240903$PER$$US-SA-2024SA254282$SANOFI AVENTIS$$$$$$Y$$$20240903$$PH$US$US
242774024$24277402$4$F$$20240903$20240903$20240913$EXP$$CA-AstraZeneca-2024A199354$ASTRAZENECA$$$$$M$Y$$$20240913$$MD$CA$
242774031$24277403$1$I$$20240828$20240903$20240903$PER$$US-SA-2024SA255004$SANOFI AVENTIS$$$$$M$Y$$$20240903$$CN$US$US
242774041$24277404$1$I$20240801$20240822$20240903$20240903$PER$$US-SA-2024SA253432$SANOFI AVENTIS$$48$YR$A$F$Y$120$KG$20240903$$PH$US$US
242774051$24277405$1$I$20240401$20240820$20240903$20240903$PER$$US-SA-2024SA252096$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240903$$HP$US$US
242774061$24277406$1$I$20240501$20240820$20240903$20240903$PER$$US-SA-2024SA255571$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240903$$MD$US$US
242774071$24277407$1$I$20240806$20240827$20240903$20240903$PER$$US-SA-2023SA053234$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240903$$MD$US$US
242774081$24277408$1$I$$20240820$20240903$20240903$EXP$$BR-UCBSA-2024042837$UCB$$$$$F$Y$$$20240903$$CN$BR$BR
242774091$24277409$1$I$20240101$20240828$20240903$20240903$EXP$$NVSC2024DE175699$NOVARTIS$$$$$M$Y$$$20240903$$MD$DE$DE
242774101$24277410$1$I$20231101$20240828$20240903$20240903$PER$$US-ROCHE-10000069228$ROCHE$$99$YR$E$F$Y$50.8$KG$20240903$$CN$US$US
242774111$24277411$1$I$$20240830$20240903$20240903$30DAY$$US-SANDOZ INC.-SDZ2023US075930$SANDOZ$$$$$F$Y$$$20240903$$CN$US$US
242774121$24277412$1$I$$20240827$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US075979$SANDOZ$Hooper RN, Doan AM, Davis D, Morgan J et.al. Intrathecal Digoxin Administration During SpinalAnesthesia: A Case Report Outlining Recoveryand Rehabilitation. Cureus. 2024;16(7):e65376$24$YR$$F$Y$$$20240903$$HP$US$US
242774131$24277413$1$I$$20240830$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US076667$SANDOZ$$71$YR$$F$Y$$$20240903$$MD$US$US
242774141$24277414$1$I$$20240825$20240903$20240903$PER$$US-AMGEN-USASP2024172227$AMGEN$Lasky S.; Moshal T.; Shakoori P. et al.. Pediatric MRONJ Risk with Denosumab and Bisphosphonates. Journal of Oral and Maxillofacial Surgery. 2024;82 (9):S5-S6$$$$$Y$$$20240903$$HP$US$US
242774151$24277415$1$I$20240101$20240827$20240903$20240903$EXP$$US-BAYER-2024A124647$BAYER$$79$YR$E$F$Y$37.642$KG$20240903$$CN$US$US
242774161$24277416$1$I$20240830$20240830$20240903$20240903$PER$$US-BAYER-2024A125408$BAYER$$74$YR$E$F$Y$$$20240903$$CN$US$US
242774172$24277417$2$F$20240628$20240904$20240903$20240905$EXP$IT-MINISAL02-1000271$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-136776$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$60$KG$20240905$$MD$IT$IT
242774181$24277418$1$I$$20240827$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136618$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240903$$CN$US$US
242774191$24277419$1$I$$20240830$20240903$20240903$EXP$$US-GILEAD-2024-0685969$GILEAD$$$$E$M$Y$$$20240903$$HP$US$US
242774201$24277420$1$I$20240701$20240829$20240903$20240903$EXP$$BG-ABBVIE-5902749$ABBVIE$$$$$M$Y$$$20240903$$CN$BG$BG
242774211$24277421$1$I$$20240827$20240903$20240903$PER$$US-TAKEDA-2024TUS086708$TAKEDA$$$$$F$Y$84$KG$20240903$$MD$US$US
242774221$24277422$1$I$20240806$20240902$20240903$20240903$EXP$IT-MINISAL02-999767$IT-SANDOZ INC.-SDZ2024IT077218$SANDOZ$$83$YR$$F$Y$43$KG$20240903$$MD$IT$IT
242774231$24277423$1$I$$20240820$20240903$20240903$PER$$US-JNJFOC-20240851620$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242774241$24277424$1$I$$20240815$20240903$20240903$PER$$US-JNJFOC-20240839975$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$HP$US$US
242774251$24277425$1$I$$20240820$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002182$ALKERMES$$$$A$F$Y$$$20240903$$HP$US$US
242774261$24277426$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001078$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242774272$24277427$2$F$$20240826$20240903$20240910$EXP$$KR-ALXN-202408KOR000742KR$ALEXION PHARMACEUTICALS$$34$YR$$F$Y$$$20240910$$MD$KR$KR
242774281$24277428$1$I$$20240830$20240903$20240903$PER$$US-ALXN-202408USA002174US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242774291$24277429$1$I$$20240828$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137751$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$56.2$KG$20240903$$PH$US$US
242774301$24277430$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139550$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240903$$CN$US$US
242774311$24277431$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139673$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240903$$HP$US$US
242774323$24277432$3$F$$20240916$20240903$20240919$EXP$$US-BAYER-2024A123328$BAYER$$74$YR$E$M$Y$$$20240919$$CN$US$US
242774331$24277433$1$I$20240813$20240830$20240903$20240903$EXP$$CN-ROCHE-10000071127$ROCHE$$47$YR$A$F$Y$55$KG$20240903$$HP$CN$CN
242774341$24277434$1$I$$20240829$20240903$20240903$EXP$$CA-ROCHE-10000070853$ROCHE$$89$YR$E$F$Y$$$20240903$$MD$CA$CA
242774351$24277435$1$I$$20240827$20240903$20240903$EXP$$CA-TEVA-VS-3237784$TEVA$$63$YR$$F$Y$$$20240903$$PH$CA$CA
242774361$24277436$1$I$20240310$20240902$20240903$20240903$EXP$ES-AEMPS-1516835$NVSC2024ES176256$NOVARTIS$$23$YR$$M$Y$$$20240903$$MD$ES$ES
242774371$24277437$1$I$20240819$20240830$20240903$20240903$EXP$$NVSC2024CN176911$NOVARTIS$$15$YR$$M$Y$72$KG$20240903$$HP$CN$CN
242774381$24277438$1$I$$20240830$20240903$20240903$EXP$$NVSC2024US176320$NOVARTIS$$$$$M$Y$$$20240903$$CN$US$US
242774392$24277439$2$F$$20240920$20240903$20240927$EXP$$NVSC2024TR175481$NOVARTIS$Kaynar K, Alizade L, Uyar O, Mungan S, Rashidzade K. To screen or not to screen renal cell cancer in a kidney transplant patient.. HIPPOKRATIA. 2023;27(2):69-71$55$YR$$M$Y$$$20240927$$HP$TR$TR
242774402$24277440$2$F$$20240904$20240903$20240910$EXP$$PT-MYLANLABS-2024M1079694$MYLAN$Marques D, Le?o F, Lopes A, Pack T, Eus?bio S, Santos A, et al.. Refractory orthostatic hypotension - approach and treatment.. Congresses of the portuguese society of internal medicine. 2024;30:197$83$YR$$F$Y$$$20240910$$MD$PT$PT
242774411$24277441$1$I$20240819$20240827$20240903$20240903$PER$$US-BAYER-2024A123474$BAYER$$36$YR$A$F$Y$$$20240903$$CN$US$US
242774431$24277443$1$I$20240815$20240821$20240903$20240903$EXP$GB-MHRA-MED-202408211049488710-VGQTY$GB-OTSUKA-2024_023180$OTSUKA$$59$YR$$M$Y$79$KG$20240903$$PH$GB$GB
242774441$24277444$1$I$$20240827$20240903$20240903$EXP$$NL-MYLANLABS-2024M1078960$MYLAN$Ghambari K, de Jong DM, Bruno MJ, Polak WG, van Driel LMJW, den Hoed CM. Risks of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis After Liver Transplantation. Clinical Transplantation. 2024;38(7):1-9$60$YR$$F$Y$$$20240903$$HP$NL$NL
242774451$24277445$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139546$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240903$$MD$US$US
242774462$24277446$2$F$$20240910$20240903$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137620$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240911$$HP$US$US
242774471$24277447$1$I$$20240827$20240903$20240903$EXP$$FR-MYLANLABS-2024M1079072$MYLAN$Beurier P, Dallevet CA, Brissot E, Cholet C, Santin A, Lionnet F, et al.. Hematopoietic stem cell allograft remission of periarteritis nodosa associated with azacytidine-refractory myelodysplastic syndrome.. The Review of Internal Medicine. 2024;45:512-515.$32$YR$$M$Y$$$20240903$$MD$FR$FR
242774482$24277448$2$F$$20240911$20240903$20240916$EXP$$NL-MYLANLABS-2024M1079121$MYLAN$Ghambari K, de Jong DM, Bruno MJ, Polak WG, van Driel LMJW, den Hoed CM.. Risks of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis After Liver Transplantation. Clinical Transplantation. 2024;38(7):1-9$24$YR$$M$Y$$$20240916$$HP$NL$NL
242774491$24277449$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138102$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240903$$CN$US$US
242774501$24277450$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138426$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240903$$CN$US$US
242774521$24277452$1$I$20240101$20240823$20240903$20240903$PER$$US-SA-2024SA253638$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240903$$MD$US$US
242774532$24277453$2$F$$20240911$20240903$20240916$EXP$NL-LRB-00996759$NL-BAYER-2024A123716$BAYER$$32$YR$A$F$Y$58$KG$20240916$$CN$NL$NL
242774541$24277454$1$I$$20240829$20240903$20240903$EXP$$NVSC2024CA176837$NOVARTIS$$74$YR$$F$Y$70$KG$20240903$$MD$CA$CA
242774551$24277455$1$I$$20240822$20240903$20240903$EXP$$US-RDY-SPO/USA/23/0187535$DR REDDYS$Jones H, Bhakta A, Jia L, Wojciechowski D, Torrealba J. An Unusual Presentation of Metastatic BK Virus-Associated Urothelial Carcinoma Arising in the Allograft, Persisting After Transplant Nephrectomy. Int J Surg Pathol. 2023;31(8): 1586-92. doi:10.1177/10668969231160258.$32$YR$A$M$Y$$$20240903$$MD$US$US
242774561$24277456$1$I$$20240828$20240903$20240903$PER$$US-BAYER-2024A124293$BAYER$$78$YR$E$M$Y$$$20240903$$PH$US$US
242774571$24277457$1$I$20240101$20240823$20240903$20240903$EXP$$US-HBP-2024US031144$HELSINN HEALTHCARE$$$$$F$Y$$$20240903$$CN$US$US
242774583$24277458$3$F$20240823$20240913$20240903$20240920$EXP$$JP-MYLANLABS-2024M1078616$MYLAN$$59$YR$$M$Y$$$20240920$$MD$JP$JP
242774591$24277459$1$I$$20240827$20240903$20240903$EXP$PL-URPL-2-1354-2019$PL-MYLANLABS-2024M1078996$MYLAN$$70$YR$$M$Y$$$20240903$$CN$PL$PL
242774604$24277460$4$F$20240816$20240917$20240903$20240925$EXP$$ZA-MYLANLABS-2024M1077968$MYLAN$$35$YR$$M$Y$64$KG$20240925$$HP$ZA$ZA
242774611$24277461$1$I$$20240826$20240903$20240903$EXP$$DE-MYLANLABS-2024M1078680$MYLAN$Wildermann T, Becker F, Jesse S, Baier H, Wagner J.. Successful use of Fenfluramine in super-refractory status epilepticus in a patient with tuberous sclerosis complex and Lennox-Gastaut syndrome.. Epilepsy and Behavior Reports. 2024;27:1-5$24$YR$$F$Y$$$20240903$$HP$DE$DE
242774621$24277462$1$I$$20240826$20240903$20240903$EXP$$PT-MYLANLABS-2024M1078686$MYLAN$Assis JG, Santos A.. Myxedema Coma: Recognition of a Rare Endocrine Emergency.. Cureus. 2024;16(8):e66053$82$YR$$F$Y$$$20240903$$MD$PT$PT
242774631$24277463$1$I$20240828$20240829$20240903$20240903$PER$$US-AstraZeneca-2024A198111$ASTRAZENECA$$31034$DY$$$Y$$$20240903$$CN$US$
242774641$24277464$1$I$$20240819$20240903$20240903$EXP$$US-ELI_LILLY_AND_COMPANY-US202408011830$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240903$$CN$US$US
242774651$24277465$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000278$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240903$$CN$US$US
242774661$24277466$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000178$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240903$$CN$US$US
242774672$24277467$2$F$20240501$20240909$20240903$20240910$PER$$US-JNJFOC-20240865758$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240910$$CN$US$US
242774681$24277468$1$I$20240801$20240815$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08290$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242774691$24277469$1$I$$20240828$20240903$20240903$PER$$US-BAYER-2024A124428$BAYER$$46$YR$A$F$Y$$$20240903$$MD$US$US
242774701$24277470$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140030$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$CN$US$US
242774711$24277471$1$I$$20240830$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139678$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240903$$HP$US$US
242774721$24277472$1$I$20240821$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60059$$FDA-CTU$$71$YR$$F$N$$$20240830$N$HP$US$
242774731$24277473$1$I$$20240830$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139325$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240903$$CN$US$US
242774741$24277474$1$I$20240301$20240827$20240903$20240903$EXP$DK-DKMA-30729479$DK-TEVA-VS-3237588$TEVA$$18$YR$$M$Y$51$KG$20240903$$MD$DK$DK
242774751$24277475$1$I$20240813$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-60099$$FDA-CTU$$66$YR$$M$N$$$20240829$N$HP$US$
242774771$24277477$1$I$$20240827$20240903$20240903$EXP$$FI-BAYER-2024A124722$BAYER$$73$YR$E$M$Y$$$20240903$$CN$FI$FI
242774811$24277481$1$I$20240101$20240827$20240903$20240903$EXP$$US-ABBVIE-5899434$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242774821$24277482$1$I$20240701$20240821$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002183$ALKERMES$$$$$M$Y$$$20240903$$CN$US$US
242774831$24277483$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60015$$FDA-CTU$$57$YR$$M$N$$$20240830$N$$US$
242774841$24277484$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60042$$FDA-CTU$$53$YR$$F$N$113.4$KG$20240830$N$$US$
242774851$24277485$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60028$$FDA-CTU$$59$YR$$M$N$86.18$KG$20240830$N$$US$
242774861$24277486$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60018$$FDA-CTU$$54$YR$$F$N$$$20240830$N$$US$
242774871$24277487$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA255674$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240903$$MD$US$US
242774881$24277488$1$I$20240720$20240829$20240903$20240903$PER$$US-BAYER-2024A124520$BAYER$$47$YR$A$F$Y$$$20240903$$CN$US$US
242774893$24277489$3$F$20240813$20240902$20240903$20240910$EXP$$MY-VANTIVE-2024VAN019384$Vantive US Healthcare$$33$YR$$F$Y$$$20240910$$CN$SG$MY
242774901$24277490$1$I$20240813$20240814$20240830$20240830$DIR$FDA-CDER-CTU-2024-60108$$FDA-CTU$$49$YR$$F$N$$$20240814$N$HP$US$
242774912$24277491$2$F$$20240916$20240903$20240924$EXP$$GB-VANTIVE-2024VAN019437$Vantive US Healthcare$$$$$F$Y$$$20240924$$HP$GB$GB
242774922$24277492$2$F$$20240924$20240903$20240930$EXP$$IN-VANTIVE-2024VAN019386$Vantive US Healthcare$$73$YR$$M$Y$$$20240930$$CN$IN$IN
242774932$24277493$2$F$$20240916$20240903$20240919$EXP$$IN-VANTIVE-2024VAN019479$Vantive US Healthcare$$25$YR$$M$Y$$$20240919$$CN$IN$IN
242774941$24277494$1$I$$20240828$20240903$20240903$EXP$$GB-VANTIVE-2024VAN019438$Vantive US Healthcare$$$$$M$Y$$$20240903$$HP$GB$GB
242774951$24277495$1$I$20240817$20240828$20240903$20240903$EXP$$CO-VANTIVE-2024VAN019272$Vantive US Healthcare$$48$YR$$M$Y$64$KG$20240903$$HP$CO$CO
242774961$24277496$1$I$$20240828$20240903$20240903$EXP$$CA-JNJFOC-20240880512$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$HP$CA$CA
242774971$24277497$1$I$20240101$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174005$AMGEN$$33$YR$A$M$Y$$$20240903$$PH$US$US
242774981$24277498$1$I$$20240815$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08325$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242774991$24277499$1$I$$20240826$20240903$20240903$EXP$$US-SA-2024SA253688$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240903$$CN$US$US
242775001$24277500$1$I$20240827$20240902$20240903$20240903$EXP$$PK-ROCHE-10000072012$ROCHE$$52$YR$A$M$Y$$$20240903$$CN$PK$PK
242775012$24277501$2$F$20240801$20240918$20240903$20240919$PER$$US-BAYER-2024A124534$BAYER$$28$YR$A$F$Y$$$20240919$$MD$US$US
242775022$24277502$2$F$20240730$20240904$20240903$20240904$EXP$$US-BAYER-2024A123925$BAYER$$33$YR$A$F$Y$$$20240904$$MD$US$US
242775031$24277503$1$I$$20240823$20240903$20240903$EXP$$CA-BAXTER-2024BAX023803$BAXTER$$13$YR$$M$Y$$$20240903$$CN$CA$CA
242775041$24277504$1$I$$20240820$20240903$20240903$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01380$INTRA-CELLULAR THERAPIES$$$$$M$Y$$$20240903$$HP$US$US
242775052$24277505$2$F$20240101$20240904$20240903$20240918$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01387$INTRA-CELLULAR THERAPIES$$69$YR$$F$Y$71.655$KG$20240918$$HP$US$US
242775061$24277506$1$I$20230901$20240829$20240903$20240903$EXP$$IN-SANDOZ INC.-SDZ2024IN077068$SANDOZ$$37$YR$$M$Y$$$20240903$$CN$IN$IN
242775073$24277507$3$F$$20240913$20240903$20240916$EXP$$IS-TAKEDA-2024TUS088046$TAKEDA$$70$YR$$M$Y$$$20240916$$CN$IS$IS
242775081$24277508$1$I$$20240821$20240903$20240903$EXP$$SK-TAKEDA-2024TUS087758$TAKEDA$$$$$$Y$$$20240903$$MD$SK$SK
242775091$24277509$1$I$20240127$20240827$20240903$20240903$EXP$$US-GSK-US2024GSK106946$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$MD$US$US
242775101$24277510$1$I$$20240829$20240903$20240903$PER$$US-BAYER-2024A124807$BAYER$$$$$F$Y$$$20240903$$MD$US$US
242775111$24277511$1$I$20240719$20240827$20240903$20240903$EXP$FR-AFSSAPS-AM2024000681$FR-MYLANLABS-2024M1078994$MYLAN$$86$YR$$F$Y$$$20240903$$PH$FR$FR
242775121$24277512$1$I$$20240827$20240903$20240903$EXP$$GB-MYLANLABS-2024M1051549$MYLAN$$$$$M$Y$$$20240903$$MD$GB$GB
242775131$24277513$1$I$20230926$20240827$20240903$20240903$EXP$$GB-MYLANLABS-2023M1102745$MYLAN$$36$YR$$F$Y$$$20240903$$MD$GB$GB
242775141$24277514$1$I$$20240827$20240903$20240903$EXP$$ES-MYLANLABS-2024M1079054$MYLAN$$43$YR$$F$Y$62$KG$20240903$$MD$ES$ES
242775151$24277515$1$I$$20240828$20240903$20240903$EXP$$BR-TAKEDA-2024TUS088083$TAKEDA$$$$$F$Y$$$20240903$$CN$BR$BR
242775161$24277516$1$I$20240722$20240827$20240903$20240903$EXP$FR-AFSSAPS-LM2024000459$FR-TEVA-VS-3237513$TEVA$$66$YR$$F$Y$79$KG$20240903$$CN$FR$FR
242775181$24277518$1$I$20240101$20240829$20240903$20240903$EXP$$CO-SA-2024SA254389$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240903$$CN$CO$CO
242775193$24277519$3$F$20220120$20240920$20240903$20240930$EXP$$AR-JNJFOC-20240881785$JOHNSON AND JOHNSON$$19$YR$A$M$Y$51$KG$20240929$$CN$AR$AR
242775201$24277520$1$I$20240812$20240827$20240903$20240903$EXP$FR-AFSSAPS-MP2024001310$FR-MYLANLABS-2024M1079026$MYLAN$$31$YR$$F$Y$$$20240903$$MD$FR$FR
242775211$24277521$1$I$$20240823$20240903$20240903$EXP$$PT-Waylis Therapeutics LLC-ATNAHS20240802429$Waylis$Ferreira BS et al. PO-0251 - (2593) - A PROPOSITO DO DIAGNOSTICO DIFERENCIAL DA HEPATITE AGUDA. Congressos da Sociedade Portuguesa de Medicina Interna: 30.o Congresso Nacional. 2024;30:616$65$YR$E$F$Y$$$20240830$$MD$PT$PT
242775221$24277522$1$I$20240701$20240819$20240830$20240830$DIR$FDA-CDER-CTU-2024-60112$$FDA-CTU$$47$YR$$M$N$$$20240819$N$HP$US$
242775231$24277523$1$I$$20240902$20240903$20240903$PER$$US-ABBVIE-5905088$ABBVIE$$$$$$Y$$$20240903$$CN$US$US
242775241$24277524$1$I$$20240823$20240903$20240903$PER$$US-SA-2024SA253059$SANOFI AVENTIS$$$$A$F$Y$$$20240903$$MD$US$US
242775251$24277525$1$I$$20240827$20240903$20240903$PER$$US-SA-2024SA254806$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240903$$MD$US$US
242775261$24277526$1$I$20240816$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60122$$FDA-CTU$$15$YR$$M$N$$$20240830$N$HP$US$
242775291$24277529$1$I$$20240828$20240903$20240903$PER$$US-SA-2024SA255260$SANOFI AVENTIS$$$$A$F$Y$$$20240903$$HP$US$US
242775301$24277530$1$I$$20240827$20240903$20240903$PER$$US-SA-2024SA254442$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240903$$MD$US$US
242775311$24277531$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA254618$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240903$$CN$US$US
242775321$24277532$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60010$$FDA-CTU$$59$YR$$F$N$$$20240830$N$$US$
242775331$24277533$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60020$$FDA-CTU$$69$YR$$F$N$$$20240830$N$$US$
242775341$24277534$1$I$20240826$20240827$20240903$20240903$PER$$US-SA-2024SA253677$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240903$$CN$US$US
242775352$24277535$2$F$20240201$20240830$20240903$20240911$EXP$$CH-GSK-CH2024EME108767$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$CH$CH
242775361$24277536$1$I$20240717$20240829$20240903$20240903$EXP$$CA-TAKEDA-2024TUS073062$TAKEDA$$26$YR$$F$Y$$$20240903$$MD$CA$CA
242775372$24277537$2$F$20240715$20240904$20240903$20240919$EXP$$US-COOPERSURGICAL, INC.-2024CPS002209$COOPERSURGICAL$$32$YR$$F$Y$96.417$KG$20240919$$HP$US$US
242775381$24277538$1$I$20240703$20240820$20240903$20240903$EXP$$US-COOPERSURGICAL, INC.-2024CPS002536$COOPERSURGICAL$$45$YR$$F$Y$92.971$KG$20240903$$CN$US$US
242775391$24277539$1$I$20230909$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-112320-2023$RECKITT BENCKISER$$$$$F$Y$$$20240903$$CN$US$US
242775401$24277540$1$I$20240329$20240820$20240903$20240903$EXP$$US-COOPERSURGICAL, INC.-2024CPS002538$COOPERSURGICAL$$54$YR$$F$Y$107.48$KG$20240903$$CN$US$US
242775411$24277541$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60131$$FDA-CTU$$33$YR$$F$N$$$20240830$N$$US$
242775421$24277542$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60040$$FDA-CTU$$54$YR$$F$N$118.84$KG$20240830$N$$US$
242775431$24277543$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60132$$FDA-CTU$$33$YR$$F$N$$$20240830$N$$US$
242775441$24277544$1$I$20240824$20240829$20240903$20240903$PER$$US-BAYER-2024A124963$BAYER$$29$YR$A$F$Y$$$20240903$$HP$US$US
242775452$24277545$2$F$$20240828$20240903$20240905$EXP$$VN-MYLANLABS-2024M1077916$MYLAN$Nguyen THA, Tran MD, Dang THV, Nguyen HN. Medium-term progress of pulmonary hypertension in bronchopulmonary dysplasia. Journal of Medical Research. 2024;179 (6):10-18$$$I$$Y$$$20240905$$MD$VN$VN
242775461$24277546$1$I$$20240828$20240903$20240903$EXP$$MY-MYLANLABS-2024M1080700$MYLAN$Ding CH, Wahab WA, Saaid MS, Mokhtar MN, Abdullah FA, Azaharuddin I. Septicaemia due to Vibrio vulnificus: A tropical infection not to be taken lightly. Trop-Biomed 2024; 41 (2): 157-159.$67$YR$$M$Y$$$20240903$$HP$MY$MY
242775472$24277547$2$F$$20240828$20240903$20240905$EXP$$VN-MYLANLABS-2024M1077927$MYLAN$Nguyen, TH., Tran, MD., Dang, TH., Nguyen, HN. MEDIUM-TERM PROGRESS OF PULMONARY HYPERTENSION IN BRONCHOPULMONARY DYSPLASIA. Journal of Medical Research. 2024;179 (6)$$$I$$Y$$$20240905$$MD$VN$VN
242775482$24277548$2$F$$20240828$20240903$20240905$EXP$$VN-MYLANLABS-2024M1077924$MYLAN$Nguyen THA, Tran MD, Dang THV, Nguyen HN. Medium-term progress of pulmonary hypertension in bronchopulmonary dysplasia. Journal of Medical Research. 2024;179 (6):10-18$$$I$$Y$$$20240905$$MD$VN$VN
242775492$24277549$2$F$$20240828$20240903$20240905$EXP$$VN-MYLANLABS-2024M1077917$MYLAN$Nguyen THA, Tran MD, Dang THV, Nguyen HN. Medium-term progress of pulmonary hypertension in bronchopulmonary dysplasia. Journal of Medical Research. 2024;179 (6):10-18$$$I$$Y$$$20240905$$MD$VN$VN
242775502$24277550$2$F$$20240828$20240903$20240905$EXP$$VN-MYLANLABS-2024M1077914$MYLAN$Nguyen THA, Tran MD, Dang THV, Nguyen HN. Medium-term progress of pulmonary hypertension in bronchopulmonary dysplasia. Journal of Medical Research. 2024;179 (6):10-18$$$I$$Y$$$20240905$$MD$VN$VN
242775511$24277551$1$I$20240611$20240827$20240903$20240903$EXP$FR-AFSSAPS-MP2024001300$FR-TEVA-VS-3237729$TEVA$$39$YR$$M$Y$94$KG$20240903$$PH$FR$FR
242775522$24277552$2$F$20240610$20240826$20240903$20240906$EXP$$DE-OPKO PHARMACEUTICALS, LLC.-2024OPK00225$OPKO HEALTH$$71$YR$$M$Y$69.5$KG$20240905$$CN$DE$DE
242775541$24277554$1$I$$20240829$20240903$20240903$PER$$US-AstraZeneca-2024A197925$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242775551$24277555$1$I$$20240828$20240903$20240903$PER$$US-AstraZeneca-2024A198306$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242775561$24277556$1$I$$20240829$20240903$20240903$PER$$US-AstraZeneca-2024A198203$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242775571$24277557$1$I$$20240822$20240903$20240903$PER$$US-SA-2024SA254942$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240903$$MD$US$US
242775581$24277558$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA255000$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240903$$MD$US$US
242775591$24277559$1$I$20240801$20240826$20240903$20240903$PER$$US-SA-2024SA253810$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240903$$CN$US$US
242775601$24277560$1$I$20240601$20240830$20240903$20240903$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-006485$JAZZ$$63$YR$$F$Y$$$20240903$$CN$US$US
242775611$24277561$1$I$20240829$20240830$20240903$20240903$PER$$US-BAYER-2024A125214$BAYER$$44$YR$A$F$Y$$$20240903$$MD$US$US
242775621$24277562$1$I$20240301$20240826$20240903$20240903$PER$$US-SA-2024SA255680$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240903$$MD$US$US
242775631$24277563$1$I$20240801$20240823$20240903$20240903$PER$$US-SA-2024SA253258$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240903$$MD$US$US
242775641$24277564$1$I$20240101$20240830$20240903$20240903$EXP$$US-AMGEN-USASL2024174582$AMGEN$$66$YR$E$F$Y$$$20240903$$CN$US$US
242775651$24277565$1$I$$20240826$20240903$20240903$30DAY$$US-GSK-US2024AMR106808$GLAXOSMITHKLINE$$$$$F$Y$$$20240903$$CN$US$US
242775662$24277566$2$F$$20240917$20240903$20240918$EXP$$NZ-MYLANLABS-2024M1080688$MYLAN$$$$$F$Y$$$20240918$$HP$NZ$NZ
242775671$24277567$1$I$$20240823$20240903$20240903$PER$$US-ABBVIE-5894903$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242775691$24277569$1$I$$20240902$20240903$20240903$EXP$GB-MHRA-MED-202409021127353870-VBCKL$GB-MYLANLABS-2024M1080635$MYLAN$$$$$M$Y$$$20240903$$CN$GB$GB
242775701$24277570$1$I$$20240902$20240903$20240903$EXP$GB-MHRA-MED-202409020200033830-PJBSN$GB-TAKEDA-2024TUS087895$TAKEDA$$$$$F$Y$$$20240903$$HP$GB$GB
242775721$24277572$1$I$20240708$20240819$20240903$20240903$PER$$US-COSETTE-CP2024US000224$COSETTE PHARMACEUTICALS$$57$YR$A$F$Y$$$20240903$$HP$US$US
242775731$24277573$1$I$20240828$20240830$20240903$20240903$PER$$US-BAYER-2024A125372$BAYER$$25$YR$A$F$Y$$$20240903$$MD$US$US
242775741$24277574$1$I$$20240830$20240903$20240903$PER$$US-BAYER-2024A125359$BAYER$$39$YR$A$M$Y$$$20240903$$MD$US$US
242775752$24277575$2$F$20240530$20240916$20240903$20240926$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00222$OPKO HEALTH$$74$YR$$F$Y$$$20240924$$PH$US$US
242775761$24277576$1$I$20240731$20240822$20240903$20240903$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014399$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240903$$CN$US$US
242775771$24277577$1$I$$20240822$20240903$20240903$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016024$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240903$$CN$US$US
242775781$24277578$1$I$$20240822$20240903$20240903$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202408015432$ELI LILLY AND CO$$$$$F$Y$$$20240903$$MD$AE$AE
242775791$24277579$1$I$$20240822$20240903$20240903$EXP$GB-MHRA-MED-202408221000082650-KBPWM$GB-ELI_LILLY_AND_COMPANY-GB202408014960$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240903$$CN$GB$GB
242775801$24277580$1$I$20240701$20240823$20240903$20240903$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408014941$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240903$$CN$BR$BR
242775811$24277581$1$I$20240822$20240822$20240903$20240903$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408014830$ELI LILLY AND CO$$$$$F$Y$$$20240903$$HP$GB$GB
242775821$24277582$1$I$$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408019304$ELI LILLY AND CO$$68$YR$E$$Y$$$20240903$$CN$US$US
242775841$24277584$1$I$$20240822$20240903$20240903$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408013988$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240903$$PH$DE$DE
242775851$24277585$1$I$$20240829$20240903$20240903$EXP$$US-ELI_LILLY_AND_COMPANY-US202408019114$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240903$$CN$US$US
242775861$24277586$1$I$$20240822$20240903$20240903$EXP$GB-MHRA-MED-202408221655007790-BZYHL$GB-ELI_LILLY_AND_COMPANY-GB202408014980$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240903$$CN$GB$GB
242775871$24277587$1$I$$20240822$20240903$20240903$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014671$ELI LILLY AND CO$$76$YR$E$$Y$$$20240903$$CN$US$US
242775881$24277588$1$I$$20240822$20240903$20240903$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016380$ELI LILLY AND CO$$59$YR$A$$Y$$$20240903$$CN$US$US
242775891$24277589$1$I$20240828$20240828$20240903$20240903$EXP$$US-JNJFOC-20240879131$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$CN$US$US
242775903$24277590$3$F$$20240912$20240903$20240913$PER$$US-HALEON-2194609$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
242775911$24277591$1$I$$20240822$20240903$20240903$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014389$ELI LILLY AND CO$$$$$F$Y$$$20240903$$CN$US$US
242775921$24277592$1$I$$20240821$20240903$20240903$EXP$$BR-UCBSA-2024043136$UCB$$$$$M$Y$$$20240903$$CN$BR$BR
242775931$24277593$1$I$$20240829$20240903$20240903$PER$$US-BAYER-2024A125373$BAYER$$$$$F$Y$$$20240903$$CN$US$US
242775951$24277595$1$I$$20240723$20240903$20240903$PER$$US-WINDERLABS-2024WISPO00004$WINDER LABORATORY$$31$YR$A$F$Y$$$20240903$$CN$US$US
242775961$24277596$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139912$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240903$$CN$US$US
242775971$24277597$1$I$$20240827$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137859$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240903$$CN$US$US
242775981$24277598$1$I$20220301$20240829$20240903$20240903$EXP$SE-SEMPA-2024-006298$SE-TAKEDA-2024TUS087097$TAKEDA$$60$YR$$M$Y$$$20240903$$HP$SE$SE
242775991$24277599$1$I$20240723$20240827$20240903$20240903$PER$$US-AMGEN-USASP2024174267$AMGEN$$62$YR$A$M$Y$$$20240903$$HP$US$US
242776001$24277600$1$I$20240820$20240830$20240903$20240903$PER$$US-BAYER-2024A125377$BAYER$$27$YR$A$F$Y$$$20240903$$CN$US$US
242776011$24277601$1$I$$20240830$20240903$20240903$EXP$$GB-MYLANLABS-2024M1080280$MYLAN$$$$$F$Y$$$20240903$$HP$GB$GB
242776021$24277602$1$I$20240827$20240830$20240903$20240903$EXP$$GB-MYLANLABS-2024M1073195$MYLAN$$$$$M$Y$$$20240903$$MD$GB$GB
242776031$24277603$1$I$$20240830$20240903$20240903$PER$$US-TAKEDA-2024TUS087800$TAKEDA$$$$$$Y$$$20240903$$CN$US$US
242776042$24277604$2$F$20240903$20240913$20240903$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139030$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240920$$CN$US$US
242776051$24277605$1$I$20240819$20240822$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002212$ALKERMES$$22$YR$$M$Y$$$20240903$$CN$US$US
242776071$24277607$1$I$$20240826$20240903$20240903$EXP$$JP-JNJFOC-20240903847$JOHNSON AND JOHNSON$Akihiro ShimizuKotaro HaruharaIzumi ShiraiKyohei OgawaAkane MiuraKentaro OshiroMasato IkedaNobuo TsuboiHiroyuki UedaTakashi YokooShinya YokoteTakaya SasakiMasahiro Okabe.CASE REPORT Active flare of IgA nephropathy during long-term therapy with anti-tumor necrosis factor-Alpha antibody drugs for Crohns disease:three case reports and literature review.CEN Case Reports.2024.8;13:4:249-257$3$DEC$A$M$Y$$$20240903$$MD$JP$JP
242776091$24277609$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60134$$FDA-CTU$$33$YR$$F$N$$$20240830$N$$US$
242776101$24277610$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60022$$FDA-CTU$$19$YR$$F$N$$$20240830$N$$US$
242776111$24277611$1$I$20240826$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60129$$FDA-CTU$$39$YR$$F$N$$$20240830$N$$US$
242776131$24277613$1$I$20240327$20240902$20240903$20240903$EXP$FR-AFSSAPS-TO2024001638$NVSC2024FR176280$NOVARTIS$$88$YR$$F$Y$$$20240903$$MD$FR$FR
242776141$24277614$1$I$20240816$20240829$20240903$20240903$EXP$$US-SA-2024SA255427$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240903$$MD$US$US
242776161$24277616$1$I$20240101$20240826$20240903$20240903$EXP$$US-SA-2024SA253183$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240903$$CN$US$US
242776171$24277617$1$I$20240629$20240829$20240903$20240903$EXP$$CO-SA-2024SA255224$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240903$$CN$CO$CO
242776181$24277618$1$I$$20240902$20240903$20240903$PER$$US-AMGEN-USASP2024175374$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242776191$24277619$1$I$$20240827$20240903$20240903$EXP$$PK-AMGEN-PAKSP2024174411$AMGEN$$46$YR$A$M$Y$$$20240903$$CN$PK$PK
242776202$24277620$2$F$$20240909$20240903$20240911$PER$$US-AMGEN-USASP2024173376$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
242776211$24277621$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139565$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240903$$CN$US$US
242776231$24277623$1$I$20240722$20240822$20240903$20240903$EXP$$CN-REGENERON PHARMACEUTICALS, INC.-2024-117929$REGENERON$$79$YR$$M$Y$$$20240903$$HP$CN$CN
242776241$24277624$1$I$$20240826$20240903$20240903$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-117852$REGENERON$$73$YR$$M$Y$$$20240903$$HP$CO$CO
242776251$24277625$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413178$FRESENIUS KABI$$10$YR$C$F$Y$37$KG$20240903$$HP$CA$CA
242776261$24277626$1$I$20240803$20240826$20240903$20240903$EXP$FR-AFSSAPS-CN2024000814$FR-FreseniusKabi-FK202413079$FRESENIUS KABI$$70$YR$A$F$Y$89$KG$20240903$$PH$FR$FR
242776271$24277627$1$I$20240101$20240826$20240903$20240903$PER$$US-SA-2024SA255346$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240903$$MD$US$US
242776281$24277628$1$I$$20240820$20240903$20240903$PER$$US-RDY-SPO/USA/24/0012628$DR REDDYS$$31$YR$A$M$Y$$$20240903$$MD$US$US
242776291$24277629$1$I$20240815$20240822$20240903$20240903$PER$$US-RDY-SPO/USA/24/0012531$DR REDDYS$$26$YR$A$F$Y$$$20240903$$CN$US$US
242776301$24277630$1$I$20240722$20240828$20240903$20240903$PER$$US-BAYER-2024A125385$BAYER$$39$YR$A$F$Y$$$20240903$$CN$US$US
242776311$24277631$1$I$$20240819$20240903$20240903$PER$$US-COSETTE-CP2024US000225$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242776321$24277632$1$I$$20240805$20240903$20240903$PER$$US-LEX-000421$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
242776332$24277633$2$F$$20240829$20240903$20240911$30DAY$$CA-UCBSA-2024044859$UCB$$$$$F$Y$$$20240911$$PH$CA$CA
242776351$24277635$1$I$20230905$20240830$20240903$20240903$EXP$$GB-MYLANLABS-2023M1096108$MYLAN$$34$YR$$M$Y$$$20240903$$MD$GB$GB
242776361$24277636$1$I$20231127$20240830$20240903$20240903$EXP$FR-AFSSAPS-TS2024000941$FR-MYLANLABS-2024M1079996$MYLAN$$80$YR$$M$Y$68$KG$20240903$$MD$FR$FR
242776381$24277638$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194655$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242776391$24277639$1$I$$20240829$20240903$20240903$EXP$$US-AstraZeneca-2024A197721$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242776401$24277640$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A196584$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242776411$24277641$1$I$$20240829$20240903$20240903$PER$$US-BAYER-2024A125409$BAYER$$$$$F$Y$$$20240903$$HP$US$US
242776422$24277642$2$F$20210701$20240906$20240903$20240911$EXP$$BR-009507513-2409BRA000655$MERCK$$63$YR$$M$Y$$$20240911$$MD$BR$BR
242776431$24277643$1$I$$20240827$20240903$20240903$PER$$US-SA-2024SA254493$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240903$$MD$US$US
242776441$24277644$1$I$$20240829$20240903$20240903$PER$$US-BAYER-2024A125723$BAYER$$$$$F$Y$$$20240903$$HP$US$US
242776451$24277645$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139595$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240903$$HP$US$US
242776461$24277646$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139808$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240903$$HP$US$US
242776471$24277647$1$I$$20240831$20240903$20240903$PER$$NVSC2024US176890$NOVARTIS$$$$$$Y$$$20240903$$CN$US$US
242776481$24277648$1$I$$20240829$20240903$20240903$PER$$US-LEO Pharma-373174$LEO PHARM$$40$YR$$M$Y$$$20240903$$HP$US$US
242776491$24277649$1$I$$20240815$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08323$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242776501$24277650$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5902574$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242776511$24277651$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5904498$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242776521$24277652$1$I$20240801$20240819$20240903$20240903$PER$$US-COSETTE-CP2024US000235$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242776531$24277653$1$I$$20240830$20240903$20240903$PER$$US-BAYER-2024A125745$BAYER$$$$$F$Y$$$20240903$$CN$US$US
242776542$24277654$2$F$$20240909$20240903$20240912$EXP$NL-LRB-00996759$NL-LABORATORIOS LICONSA S.A.-2408NL06685$INSUD PHARMA$$32$YR$$F$Y$58$KG$20240912$$CN$NL$NL
242776551$24277655$1$I$$20240830$20240903$20240903$PER$$US-BAYER-2024A125788$BAYER$$$$$F$Y$$$20240903$$HP$US$US
242776561$24277656$1$I$$20240814$20240903$20240903$PER$$US-009507513-2408USA005184$MERCK$$$$$F$Y$$$20240903$$CN$US$US
242776571$24277657$1$I$$20240813$20240903$20240903$EXP$$US-OTSUKA-2024_024191$OTSUKA$$$$$F$Y$$$20240903$$CN$US$US
242776581$24277658$1$I$$20240814$20240903$20240903$EXP$$US-OTSUKA-2024_024100$OTSUKA$$$$$F$Y$$$20240903$$CN$US$US
242776593$24277659$3$F$$20240916$20240903$20240919$EXP$$TR-OTSUKA-2024_024285$OTSUKA$Meric Z, Karaaslan BG, Gungoren EY, Hortoglu MB, Cavas T, Aydemir S et.al.. Artemis deficiency: A large cohort including a novel variant with increased radiosensitivity. Pediatr Allergy Immunol. 2024;35 (6):1-10$2$MON$$M$Y$$$20240919$$HP$TR$TR
242776601$24277660$1$I$$20240830$20240903$20240903$PER$$US-ROCHE-10000071499$ROCHE$$$$E$F$Y$$$20240903$$CN$US$US
242776611$24277661$1$I$20240816$20240828$20240903$20240903$EXP$CZ-CZSUKL-24002386$CZ-INSUD PHARMA-2408CZ06740$INSUD PHARMA$$24$YR$$F$Y$70$KG$20240903$$CN$CZ$CZ
242776621$24277662$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-103890-2023$RECKITT BENCKISER$$$$$$Y$$$20240903$$CN$US$US
242776631$24277663$1$I$20240823$20240828$20240903$20240903$EXP$$US-BAUSCH-BL-2024-013058$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240903$$CN$US$US
242776641$24277664$1$I$$20240815$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08266$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242776651$24277665$1$I$$20240830$20240903$20240903$PER$$US-ABBVIE-5904097$ABBVIE$$$$$$Y$$$20240903$$CN$US$US
242776661$24277666$1$I$$20240827$20240903$20240903$PER$$US-BAYER-2024A123889$BAYER$$40$YR$A$F$Y$$$20240903$$CN$US$US
242776672$24277667$2$F$20240728$20240909$20240903$20240911$EXP$FR-AFSSAPS-BX2024001690$FR-FreseniusKabi-FK202412985$FRESENIUS KABI$$10$YR$C$M$Y$45$KG$20240911$$PH$FR$FR
242776681$24277668$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413005$FRESENIUS KABI$$46$YR$A$F$Y$88$KG$20240903$$PH$CA$CA
242776691$24277669$1$I$$20240827$20240903$20240903$PER$$US-BAYER-2024A123917$BAYER$$46$YR$A$F$Y$$$20240903$$MD$US$US
242776702$24277670$2$F$20240820$20240821$20240903$20240924$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16741$IPSEN$$64$YR$A$F$Y$$$20240924$$CN$US$US
242776721$24277672$1$I$20240830$20240830$20240903$20240903$PER$$US-BAUSCH-BL-2024-013135$BAUSCH AND LOMB$$$$$F$Y$$$20240903$$CN$US$US
242776732$24277673$2$F$20240827$20240903$20240903$20240905$PER$$US-AMGEN-USASP2024172715$AMGEN$$67$YR$E$F$Y$$$20240905$$CN$US$US
242776741$24277674$1$I$$20240830$20240903$20240903$PER$$US-ROCHE-10000071939$ROCHE$$$$$F$Y$$$20240903$$HP$US$US
242776751$24277675$1$I$20240806$20240827$20240903$20240903$EXP$CN-91110000556821568D-2024DRL001616$CN-RDY-SPO/CHN/24/0012619$DR REDDYS$$81$YR$E$M$Y$42$KG$20240903$$HP$CN$CN
242776761$24277676$1$I$20240815$20240822$20240903$20240903$PER$$US-RDY-CLI/USA/24/0012540$DR REDDYS$$1$MON$I$M$Y$$$20240903$$CN$US$US
242776791$24277679$1$I$$20240821$20240903$20240903$PER$$US-RDY-CLI/USA/24/0012429$DR REDDYS$$25$YR$A$M$Y$109$KG$20240903$$CN$US$US
242776801$24277680$1$I$20240824$20240828$20240903$20240903$EXP$CN-91110000556821568D-2024DRL001624$CN-RDY-SPO/CHN/24/0012666$DR REDDYS$$77$YR$E$F$Y$62$KG$20240903$$HP$CN$CN
242776811$24277681$1$I$20240201$20240827$20240903$20240903$EXP$FR-AFSSAPS-BX2024001668$FR-TEVA-VS-3237741$TEVA$$66$YR$$M$Y$68$KG$20240903$$MD$FR$FR
242776831$24277683$1$I$20240830$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174612$AMGEN$$72$YR$E$M$Y$$$20240903$$CN$US$US
242776841$24277684$1$I$$20240828$20240903$20240903$PER$$US-LEO Pharma-373163$LEO PHARM$$57$YR$$M$Y$$$20240903$$CN$US$US
242776861$24277686$1$I$$20240827$20240903$20240903$EXP$$CA-GSK-CA2024067112$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$CA$CA
242776871$24277687$1$I$$20240820$20240903$20240903$PER$$US-ALXN-202408USA001277US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242776901$24277690$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60013$$FDA-CTU$$51$YR$$F$N$81.65$KG$20240830$N$$US$
242776911$24277691$1$I$$20240827$20240903$20240903$PER$$US-LEO Pharma-373148$LEO PHARM$$18$YR$$F$Y$$$20240903$$PH$US$US
242776931$24277693$1$I$$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408019287$ELI LILLY AND CO$$$$$$Y$$$20240903$$CN$US$US
242776941$24277694$1$I$$20240830$20240903$20240903$EXP$NL-LRB-00999039$NL-MYLANLABS-2024M1080059$MYLAN$$56$YR$$M$Y$84$KG$20240903$$CN$NL$NL
242776951$24277695$1$I$20240818$20240830$20240903$20240903$EXP$FR-AFSSAPS-MA2024001413$FR-MYLANLABS-2024M1079952$MYLAN$$13$YR$$F$Y$$$20240903$$MD$FR$FR
242776961$24277696$1$I$20240829$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140142$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240903$$CN$US$US
242776971$24277697$1$I$20240501$20240830$20240903$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-116032$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240903$$MD$JP$JP
242776981$24277698$1$I$$20240830$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139605$BRISTOL MYERS SQUIBB$$29$YR$A$M$Y$$$20240903$$HP$US$US
242776991$24277699$1$I$$20240830$20240903$20240903$EXP$$GR-ARGENX-2024-ARGX-GR007354$ARGENX BVBA$$$$$$Y$$$20240903$$MD$GR$GR
242777001$24277700$1$I$$20240829$20240903$20240903$PER$$US-BAYER-2024A125550$BAYER$$$$$F$Y$$$20240903$$CN$US$US
242777011$24277701$1$I$$20240829$20240903$20240903$EXP$$JP-BAYER-2024A124562$BAYER$$40$YR$A$F$Y$$$20240903$$CN$JP$JP
242777021$24277702$1$I$$20230812$20240903$20240903$EXP$$BE-NOVOPROD-1082681$NOVO NORDISK$$$$$F$Y$$$20240903$$MD$BE$BE
242777031$24277703$1$I$$20240901$20240903$20240903$PER$$US-BAYER-2024A126197$BAYER$$$$$$Y$$$20240903$$CN$US$US
242777041$24277704$1$I$20240817$20240828$20240903$20240903$EXP$$CN-GSK-CN2024APC106824$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$HP$CN$CN
242777051$24277705$1$I$$20240827$20240903$20240903$EXP$$CA-TEVA-VS-3237804$TEVA$$15$YR$$F$Y$$$20240903$$PH$CA$CA
242777062$24277706$2$F$$20240905$20240903$20240906$EXP$$CA-BAYER-2024A124626$BAYER$$$$$F$Y$$$20240906$$MD$CA$CA
242777071$24277707$1$I$$20240829$20240903$20240903$EXP$$IN-TAKEDA-2023TUS010915$TAKEDA$$$$$M$Y$$$20240903$$CN$IN$IN
242777081$24277708$1$I$20240101$20240822$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002228$ALKERMES$$$$$F$Y$$$20240903$$HP$US$US
242777091$24277709$1$I$20240722$20240822$20240903$20240903$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000878$PAREXEL$$$$$$Y$$$20240903$$HP$CN$CN
242777102$24277710$2$F$20240710$20240906$20240903$20240920$PER$$US-LEADINGPHARMA-US-2024LEASPO00368$LEADING PHARMA$$61$YR$A$F$Y$70.03$KG$20240920$$CN$US$US
242777111$24277711$1$I$$20240822$20240903$20240903$PER$$US-SA-2023SA350688$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240903$$MD$US$US
242777121$24277712$1$I$$20240820$20240903$20240903$PER$$US-SA-2024SA255659$SANOFI AVENTIS$$$$A$F$Y$$$20240903$$MD$US$US
242777131$24277713$1$I$20240621$20240821$20240903$20240903$PER$$US-SA-2024SA255002$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240903$$MD$US$US
242777141$24277714$1$I$20240814$20240828$20240903$20240903$EXP$$US-AstraZeneca-2024A198443$ASTRAZENECA$$24254$DY$$F$Y$$$20240903$$CN$US$
242777151$24277715$1$I$$20240826$20240903$20240903$PER$$US-ABBVIE-5896198$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242777171$24277717$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139925$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240903$$CN$US$US
242777181$24277718$1$I$20240901$20240902$20240903$20240903$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049001$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240903$$PH$JP$JP
242777192$24277719$2$F$20230101$20240916$20240903$20240921$EXP$$US-ABBVIE-5427649$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
242777211$24277721$1$I$20230101$20240828$20240903$20240903$EXP$$US-ABBVIE-5901831$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242777221$24277722$1$I$$20240822$20240903$20240903$PER$$US-RDY-CLI/USA/24/0012578$DR REDDYS$$58$YR$A$F$Y$77.02$KG$20240903$$CN$US$US
242777231$24277723$1$I$$20240821$20240903$20240903$PER$$US-APELLIS-2024-APL-0000827$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240903$$CN$US$US
242777241$24277724$1$I$$20240813$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08246$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242777251$24277725$1$I$$20240830$20240903$20240903$EXP$$GR-MYLANLABS-2024M1079964$MYLAN$Verrou E, Papageorgiou S, Bouzani M, Sevastoudi A, Triantafyllou T, Daiou A, et al.. Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.. Hematological Oncology.. 2024;42 (5)$77$YR$$$Y$$$20240903$$HP$GR$GR
242777261$24277726$1$I$20231213$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-081429-2024$RECKITT BENCKISER$$84$YR$$F$Y$$$20240903$$CN$US$US
242777271$24277727$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5901969$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242777281$24277728$1$I$$20240814$20240903$20240903$PER$$US-TEVA-VS-3235532$TEVA$$69$YR$$F$Y$$$20240903$$HP$US$US
242777291$24277729$1$I$20240101$20240822$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002195$ALKERMES$$$$$M$Y$77.098$KG$20240903$$CN$US$US
242777301$24277730$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60016$$FDA-CTU$$19$YR$$F$N$74.84$KG$20240830$N$$US$
242777321$24277732$1$I$20240830$20240830$20240830$20240830$DIR$716616$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242777331$24277733$1$I$20240829$20240830$20240830$20240830$DIR$716623$$FDA-CTU$$70$YR$$UNK$N$$$20240830$N$HP$US$
242777341$24277734$1$I$$20240817$20240830$20240830$DIR$FDA-CDER-CTU-2024-60055$$FDA-CTU$$$$$F$N$$$20240817$N$HP$US$
242777351$24277735$1$I$20240810$20240828$20240830$20240830$DIR$FDA-CDER-CTU-2024-60051$$FDA-CTU$$54$YR$$F$N$$$20240828$N$HP$US$
242777361$24277736$1$I$$20240830$20240830$20240830$DIR$716620$$FDA-CTU$$$$$F$N$$$20240830$N$HP$US$
242777371$24277737$1$I$20240607$20240827$20240903$20240903$PER$$US-BAYER-2024A124142$BAYER$$68$YR$E$M$Y$$$20240903$$CN$US$US
242777381$24277738$1$I$$20240828$20240903$20240903$EXP$$FR-DSJP-DSE-2024-143047$DAIICHI$$$$E$F$Y$$$20240903$$MD$FR$FR
242777392$24277739$2$F$20231101$20240829$20240903$20240904$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013610$JAZZ$$53$YR$$F$Y$$$20240904$$MD$US$US
242777401$24277740$1$I$$20240819$20240903$20240903$PER$$US-GRANULES-US-2024GRASPO00379$GRANULES INDIA$$76$YR$E$M$Y$$$20240903$$PH$US$US
242777411$24277741$1$I$$20240814$20240903$20240903$PER$$CA-TOLMAR, INC.-24CA051529$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242777421$24277742$1$I$$20240826$20240903$20240903$30DAY$$JP-MYLANLABS-2024M1078929$MYLAN$$$$$$Y$$$20240903$$PH$JP$JP
242777431$24277743$1$I$20240101$20240814$20240903$20240903$PER$$CA-TOLMAR, INC.-24CA051538$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242777441$24277744$1$I$$20240816$20240903$20240903$PER$$CA-TOLMAR, INC.-24CA051576$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242777451$24277745$1$I$$20240815$20240903$20240903$PER$$CA-TOLMAR, INC.-24CA051575$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242777461$24277746$1$I$$20240814$20240903$20240903$PER$$CA-TOLMAR, INC.-24CA051582$TOLMAR$$$$$M$Y$$$20240902$$CN$CA$CA
242777471$24277747$1$I$20240805$20240814$20240903$20240903$PER$$CA-TOLMAR, INC.-24CA051634$TOLMAR$$94$YR$$M$Y$$$20240902$$CN$CA$CA
242777481$24277748$1$I$20240802$20240814$20240903$20240903$PER$$CA-TOLMAR, INC.-24CA051601$TOLMAR$$77$YR$$M$Y$$$20240902$$CN$CA$CA
242777491$24277749$1$I$20120412$20240816$20240903$20240903$PER$$CA-TOLMAR, INC.-24CA051645$TOLMAR$$59$YR$$M$Y$$$20240902$$CN$CA$CA
242777501$24277750$1$I$20240101$20240822$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002264$ALKERMES$$$$$M$Y$$$20240903$$HP$US$US
242777512$24277751$2$F$20240821$20240918$20240903$20240925$EXP$$US-APELLIS-2024-APL-0000881$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240925$$MD$US$US
242777523$24277752$3$F$20240408$20240909$20240903$20240913$EXP$$US-OTSUKA-2024_010263$OTSUKA$$48$YR$$F$Y$51.71$KG$20240913$$MD$US$US
242777531$24277753$1$I$$20240829$20240903$20240903$PER$$NVSC2024US175363$NOVARTIS$$$$$$Y$$$20240903$$CN$US$US
242777542$24277754$2$F$$20240829$20240903$20240909$EXP$$FR-DSJP-DSE-2024-142817$DAIICHI$$$$A$F$Y$60$KG$20240909$$MD$FR$FR
242777551$24277755$1$I$$20240829$20240903$20240903$EXP$$US-JNJFOC-20240880964$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242777561$24277756$1$I$$20240829$20240903$20240903$EXP$$US-BAYER-2024A125124$BAYER$$80$YR$E$F$Y$$$20240903$$CN$US$US
242777571$24277757$1$I$20240720$20240806$20240903$20240903$PER$$US-009507513-2408USA002319$MERCK$$67$YR$$M$Y$$$20240903$$HP$US$US
242777582$24277758$2$F$20240715$20240924$20240903$20240928$PER$$US-AMGEN-USASP2024165988$AMGEN$$24$YR$A$M$Y$93.6$KG$20240927$$PH$US$US
242777591$24277759$1$I$$20240830$20240903$20240903$EXP$$US-BAYER-2024A125164$BAYER$$62$YR$A$F$Y$$$20240903$$CN$US$US
242777601$24277760$1$I$20231209$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-081751-2024$RECKITT BENCKISER$$78$YR$$F$Y$138$KG$20240903$$CN$US$US
242777611$24277761$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008869$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242777621$24277762$1$I$$20240827$20240903$20240903$EXP$$CA-TEVA-VS-3237786$TEVA$$15$YR$$M$Y$62$KG$20240903$$PH$CA$CA
242777631$24277763$1$I$20240805$20240827$20240903$20240903$PER$$US-ABBVIE-5902228$ABBVIE$$40$YR$$F$Y$$$20240903$$HP$US$US
242777641$24277764$1$I$$20240826$20240903$20240903$PER$$US-BAYER-2024A124296$BAYER$$$$A$F$Y$$$20240903$$CN$US$US
242777651$24277765$1$I$20240820$20240822$20240903$20240903$EXP$$CA-OTSUKA-2024_023478$OTSUKA$$32$YR$$F$Y$$$20240903$$HP$CA$CA
242777661$24277766$1$I$$20240901$20240903$20240903$PER$$US-HALEON-2194835$Haleon PLC$$$$$$Y$$$20240903$$CN$US$US
242777671$24277767$1$I$$20240826$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135857$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240903$$CN$US$US
242777681$24277768$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139496$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240903$$MD$US$US
242777691$24277769$1$I$$20240819$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08495$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242777701$24277770$1$I$$20240806$20240830$20240830$DIR$FDA-CDER-CTU-2024-60111$$FDA-CTU$$$$$M$N$$$20240806$N$HP$US$
242777711$24277771$1$I$20240810$20240821$20240903$20240903$PER$$US-BAYER-2024A120601$BAYER$$9$YR$C$M$Y$$$20240903$$CN$US$US
242777731$24277773$1$I$20240701$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008865$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242777741$24277774$1$I$$20240824$20240903$20240903$EXP$$CO-NOVOPROD-1275503$NOVO NORDISK$$36$YR$$F$Y$60$KG$20240903$$CN$CO$CO
242777761$24277776$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60014$$FDA-CTU$$$$$F$N$$$20240830$N$HP$US$
242777771$24277777$1$I$20240826$20240826$20240903$20240903$EXP$$US-ABBVIE-5897452$ABBVIE$$63$YR$$F$Y$$$20240903$$CN$US$US
242777781$24277778$1$I$20240807$20240828$20240903$20240903$EXP$PT-INFARMED-J202408-356$PT-BAYER-2024A123614$BAYER$$46$YR$A$F$Y$70$KG$20240903$$MD$PT$PT
242777791$24277779$1$I$20240801$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008864$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242777801$24277780$1$I$20240826$20240828$20240903$20240903$EXP$$US-ABBVIE-5899703$ABBVIE$$37$YR$$F$Y$$$20240903$$CN$US$US
242777811$24277781$1$I$$20240830$20240903$20240903$PER$$US-ALXN-202408USA002155US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242777821$24277782$1$I$$20240903$20240903$20240903$EXP$$TW-BAYER-2024A126039$BAYER$$$$$M$Y$$$20240903$$HP$TW$TW
242777831$24277783$1$I$20240824$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60136$$FDA-CTU$$79$YR$$F$N$$$20240830$Y$PH$US$
242777841$24277784$1$I$20240820$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60138$$FDA-CTU$$84$YR$$F$N$$$20240830$Y$HP$US$
242777851$24277785$1$I$$20240902$20240903$20240903$EXP$$CA-SANDOZ INC.-SDZ2024CA077116$SANDOZ$$77$YR$$F$Y$$$20240903$$HP$CA$CA
242777861$24277786$1$I$20240329$20240823$20240903$20240903$EXP$CN-NMPACDR-3502031009366202400469$CN-BAXTER-2024BAX023808$BAXTER$$42$YR$$M$Y$$$20240903$$MD$CN$CN
242777871$24277787$1$I$$20240828$20240903$20240903$EXP$$US-ABBVIE-5900040$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242777881$24277788$1$I$20240801$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008858$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242777891$24277789$1$I$20240625$20240823$20240903$20240903$EXP$CN-NMPACDR-1401081035593202401115$CN-BAXTER-2024BAX023832$BAXTER$$69$YR$$M$Y$$$20240903$$MD$CN$CN
242777901$24277790$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000702$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240903$$CN$US$US
242777911$24277791$1$I$20240820$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018207$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240903$$CN$US$US
242777921$24277792$1$I$20240601$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000496$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240903$$CN$US$US
242777932$24277793$2$F$$20240912$20240903$20240927$EXP$$IN-CIPLA LTD.-2024IN09382$CIPLA$$$$$$Y$$$20240927$$CN$IN$IN
242777941$24277794$1$I$$20240829$20240903$20240903$EXP$$DE-TAKEDA-2024TUS087797$TAKEDA$$$$E$F$Y$$$20240903$$CN$DE$DE
242777951$24277795$1$I$20240101$20240827$20240903$20240903$EXP$$US-ABBVIE-5827877$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242777972$24277797$2$F$20240829$20240925$20240903$20240926$PER$$US-AMGEN-USASP2024174673$AMGEN$$92$YR$E$F$Y$$$20240926$$CN$US$US
242777981$24277798$1$I$20240101$20240828$20240903$20240903$EXP$$US-ABBVIE-5900124$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242777992$24277799$2$F$20240820$20240904$20240903$20240906$PER$$US-AMGEN-USASP2024173072$AMGEN$$86$YR$E$M$Y$$$20240906$$MD$US$US
242778012$24277801$2$F$20240814$20240903$20240903$20240912$EXP$ES-AEMPS-1563447$ES-ROCHE-10000067952$ROCHE$$74$YR$E$M$Y$$$20240912$$PH$ES$ES
242778021$24277802$1$I$$20240812$20240903$20240903$PER$$US-JUBILANT RADIOPHARMA-2024US000213$Jubilant Radiopharma$$$$$$Y$$$20240903$$HP$US$US
242778051$24277805$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008848$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242778061$24277806$1$I$$20240826$20240903$20240903$PER$$US-JNJFOC-20240872030$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240903$$CN$US$US
242778071$24277807$1$I$$20240828$20240903$20240903$EXP$$CA-JNJFOC-20240903811$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$HP$CA$CA
242778081$24277808$1$I$$20240901$20240903$20240903$PER$$US-BAYER-2024A126174$BAYER$$$$$$Y$$$20240903$$CN$US$US
242778091$24277809$1$I$20200514$20240827$20240903$20240903$EXP$PL-URPL-1-4175-2020$PL-TEVA-VS-3237748$TEVA$$60$YR$$M$Y$58.4$KG$20240903$$MD$PL$PL
242778101$24277810$1$I$20240716$20240826$20240903$20240903$EXP$FR-AFSSAPS-TS2024000917$FR-FreseniusKabi-FK202412922$FRESENIUS KABI$$38$YR$A$M$Y$$$20240903$$MD$FR$FR
242778111$24277811$1$I$$20240902$20240903$20240903$EXP$$PT-SANDOZ INC.-SDZ2022PT000450$SANDOZ$$$$E$$Y$$$20240903$$HP$PT$PT
242778121$24277812$1$I$20240101$20240829$20240903$20240903$EXP$$US-Eisai-EC-2024-173350$EISAI$$83$YR$E$M$Y$$$20240903$$HP$US$US
242778131$24277813$1$I$20240101$20240825$20240903$20240903$PER$$US-SA-2024SA255213$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240903$$CN$US$US
242778141$24277814$1$I$$20240822$20240903$20240903$PER$$US-SA-2024SA254959$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240903$$MD$US$US
242778151$24277815$1$I$20240801$20240822$20240903$20240903$PER$$US-SA-2024SA254225$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240903$$HP$US$US
242778162$24277816$2$F$20240810$20240827$20240903$20240905$PER$$US-SA-2024SA254221$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240905$$CN$US$US
242778171$24277817$1$I$$20240827$20240903$20240903$PER$$US-SA-2024SA254487$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240903$$MD$US$US
242778181$24277818$1$I$20240628$20240826$20240903$20240903$PER$$US-SA-2024SA255293$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240903$$MD$US$US
242778192$24277819$2$F$$20240826$20240903$20240909$PER$$US-SA-2024SA254396$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240909$$CN$US$US
242778201$24277820$1$I$$20240816$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08468$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242778211$24277821$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5901942$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242778221$24277822$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008832$INCYTE$$$$$$Y$$$20240903$$HP$US$US
242778231$24277823$1$I$$20240827$20240903$20240903$EXP$$CA-RDY-CLI/CAN/24/0012627$DR REDDYS$$69$YR$E$F$Y$$$20240903$$CN$CA$CA
242778241$24277824$1$I$$20240830$20240903$20240903$PER$$US-ALXN-202408USA002211US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
242778252$24277825$2$F$$20240905$20240903$20240905$PER$$US-ALXN-202408USA000783US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242778262$24277826$2$F$$20240907$20240903$20240918$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093280$GLENMARK$Park RB, Djalilian AR.. Resolution of Plaque Keratopathy in a Patient with Atopic Keratoconjunctivitis After Treatment with Leflunomide. Ocular Immunology and Inflammation. 2024;1-3$$$$$Y$$$20240918$$MD$US$US
242778271$24277827$1$I$20240822$20240828$20240903$20240903$EXP$$CN-BAYER-2024A123995$BAYER$$61$YR$A$F$Y$71$KG$20240903$$HP$CN$CN
242778281$24277828$1$I$20231011$20231013$20240903$20240903$PER$$US-PERRIGO-23US012004$PERRIGO$$79$YR$$F$Y$63.492$KG$20240903$$CN$US$US
242778291$24277829$1$I$20190801$20240828$20240903$20240903$EXP$$AU-TAKEDA-2024TUS087816$TAKEDA$$75$YR$$F$Y$58$KG$20240903$$MD$AU$AU
242778301$24277830$1$I$20231104$20231106$20240903$20240903$PER$$US-PERRIGO-23US012769$PERRIGO$$37$YR$$F$Y$113.38$KG$20240903$$CN$US$US
242778311$24277831$1$I$20240815$20240823$20240903$20240903$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000886$PAREXEL$$$$$$Y$$$20240903$$HP$CN$CN
242778321$24277832$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5901740$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242778331$24277833$1$I$$20240826$20240903$20240903$EXP$$JP-009507513-2408JPN003216J$MERCK$$$$$M$Y$$$20240903$$MD$JP$JP
242778351$24277835$1$I$20240829$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60061$$FDA-CTU$$64$YR$$F$N$$$20240830$Y$HP$US$
242778361$24277836$1$I$20240817$20240829$20240903$20240903$EXP$$US-BAYER-2024A125311$BAYER$$85$YR$E$F$Y$63.492$KG$20240903$$CN$US$US
242778371$24277837$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5901771$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242778381$24277838$1$I$$20240830$20240903$20240903$EXP$$CA-SANDOZ INC.-SDZ2023CA076660$SANDOZ$$44$YR$$F$Y$97$KG$20240903$$HP$CA$CA
242778391$24277839$1$I$20240830$20240830$20240903$20240903$PER$$US-BAYER-2024A125344$BAYER$$$$$F$Y$$$20240903$$MD$US$US
242778401$24277840$1$I$20240429$20240902$20240903$20240903$EXP$IT-MINISAL02-1000717$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-139559$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240903$$MD$IT$IT
242778411$24277841$1$I$20240825$20240830$20240830$20240830$DIR$716721$$FDA-CTU$$24$YR$$M$N$94.5$KG$20240830$N$CN$US$
242778421$24277842$1$I$20240830$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60135$$FDA-CTU$$51$YR$$F$N$$$20240830$Y$HP$US$
242778431$24277843$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60115$$FDA-CTU$$87$YR$$M$N$$$20240830$N$$US$
242778441$24277844$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008831$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242778451$24277845$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60133$$FDA-CTU$$90$YR$$F$N$$$20240830$N$$US$
242778471$24277847$1$I$20240701$20240829$20240903$20240903$EXP$$US-ABBVIE-5902079$ABBVIE$$68$YR$$M$Y$$$20240903$$CN$US$US
242778482$24277848$2$F$$20240909$20240903$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08501$LUPIN$$$$$$Y$$$20240924$$CN$US$US
242778493$24277849$3$F$20240801$20240901$20240903$20240911$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026437$UNITED THERAPEUTICS$$65$YR$$F$Y$81.179$KG$20240911$$$US$US
242778501$24277850$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008829$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242778521$24277852$1$I$$20240829$20240903$20240903$EXP$$UG-MYLANLABS-2024M1080011$MYLAN$$19$YR$$F$Y$$$20240903$$HP$UG$UG
242778531$24277853$1$I$$20240829$20240903$20240903$EXP$$IE-MYLANLABS-2024M1080360$MYLAN$$$$$M$Y$$$20240903$$CN$IE$IE
242778541$24277854$1$I$20220131$20240829$20240903$20240903$EXP$$UG-MYLANLABS-2024M1080013$MYLAN$$19$YR$$F$Y$$$20240903$$HP$UG$UG
242778551$24277855$1$I$20220326$20240829$20240903$20240903$EXP$$UG-MYLANLABS-2024M1079892$MYLAN$$20$YR$$F$Y$$$20240903$$HP$UG$UG
242778561$24277856$1$I$$20240829$20240903$20240903$EXP$$FR-MYLANLABS-2024M1080274$MYLAN$$70$YR$$F$Y$$$20240903$$CN$FR$FR
242778571$24277857$1$I$20240601$20240829$20240903$20240903$EXP$$CA-MYLANLABS-2024M1080295$MYLAN$$19$YR$$F$Y$$$20240903$$CN$CA$CA
242778581$24277858$1$I$20240821$20240829$20240903$20240903$EXP$$GB-MYLANLABS-2024M1079833$MYLAN$$60$YR$$M$Y$94$KG$20240903$$MD$GB$GB
242778591$24277859$1$I$20231101$20240829$20240903$20240903$EXP$GB-MHRA-MED-202408300017290670-NRMZL$GB-MYLANLABS-2024M1079921$MYLAN$$47$YR$$F$Y$80$KG$20240903$$CN$GB$GB
242778601$24277860$1$I$$20240829$20240903$20240903$EXP$$PT-MYLANLABS-2024M1079721$MYLAN$Campos ID, Moreira H, Portal F, Paiva JA. Unusual presentation of benzodiazepine withdrawal with Takotsubo syndrome: a case report. Eur-Heart-J-Case-Rep 2024; 8 (4):.$58$YR$$F$Y$$$20240903$$HP$PT$PT
242778611$24277861$1$I$$20240829$20240903$20240903$EXP$GB-MHRA-MED-202408292055208910-SGDFT$GB-MYLANLABS-2024M1079906$MYLAN$$$$$F$Y$$$20240903$$CN$GB$GB
242778621$24277862$1$I$20230613$20240829$20240903$20240903$EXP$$ZA-MYLANLABS-2024M1079816$MYLAN$$14$YR$$F$Y$$$20240903$$HP$ZA$ZA
242778631$24277863$1$I$$20240829$20240903$20240903$EXP$$DE-MYLANLABS-2024M1080109$MYLAN$Schmidt F, Erlacher M, Niemeyer C, Reinhardt D, Klusmann J-H. Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML. Front-Pediatr 2022; 10 1-8.$11$YR$$M$Y$$$20240903$$HP$DE$DE
242778641$24277864$1$I$20240301$20240829$20240903$20240903$EXP$$DE-MYLANLABS-2024M1079926$MYLAN$$58$YR$$M$Y$$$20240903$$MD$DE$DE
242778651$24277865$1$I$20230620$20240829$20240903$20240903$EXP$$UG-MYLANLABS-2024M1080100$MYLAN$$22$YR$$F$Y$$$20240903$$HP$UG$UG
242778661$24277866$1$I$20240820$20240829$20240903$20240903$EXP$$GB-MYLANLABS-2024M1079831$MYLAN$$73$YR$$M$Y$84$KG$20240903$$MD$GB$GB
242778671$24277867$1$I$$20240829$20240903$20240903$EXP$$GB-MYLANLABS-2024M1080037$MYLAN$$$$$M$Y$$$20240903$$CN$GB$GB
242778681$24277868$1$I$$20240829$20240903$20240903$EXP$GB-MHRA-MED-202408291214599110-TRYQJ$GB-MYLANLABS-2024M1079799$MYLAN$$44$YR$$F$Y$72$KG$20240903$$CN$GB$GB
242778692$24277869$2$F$20240826$20240925$20240903$20240930$EXP$$IE-MYLANLABS-2024M1079896$MYLAN$$$$$M$Y$$$20240930$$CN$IE$IE
242778702$24277870$2$F$$20240829$20240903$20240912$EXP$$DE-MYLANLABS-2024M1079927$MYLAN$Dyballa N, Hartel JA, Prangenberg J, Andresen-Streichert H.. A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting - clinical, toxicological and forensic aspects. Forensic science, medicine, and pathology. 2024$12$WK$$M$Y$$$20240912$$HP$DE$DE
242778711$24277871$1$I$20240314$20240829$20240903$20240903$EXP$GB-MHRA-MED-202408290739248290-NWBDM$GB-MYLANLABS-2024M1079701$MYLAN$$45$YR$$M$Y$79$KG$20240903$$CN$GB$GB
242778721$24277872$1$I$20220220$20240829$20240903$20240903$EXP$$UG-MYLANLABS-2024M1080024$MYLAN$$17$YR$$F$Y$$$20240903$$HP$UG$UG
242778731$24277873$1$I$$20240829$20240903$20240903$EXP$$AU-MYLANLABS-2024M1079955$MYLAN$$$$$F$Y$$$20240903$$HP$AU$AU
242778741$24277874$1$I$$20240902$20240903$20240903$EXP$$NVSC2024NP177059$NOVARTIS$$$$$F$Y$$$20240903$$CN$NP$NP
242778751$24277875$1$I$20240101$20240827$20240903$20240903$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000887$PAREXEL$$$$$$Y$$$20240903$$HP$CN$CN
242778761$24277876$1$I$20200401$20240829$20240903$20240903$PER$$US-BIOGEN-2020BI00895741$BIOGEN$$58$YR$$F$Y$$$20240903$$CN$US$US
242778771$24277877$1$I$$20240822$20240903$20240903$PER$$US-SA-2024SA254960$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240903$$MD$US$US
242778781$24277878$1$I$$20240827$20240903$20240903$PER$$US-SA-2024SA252686$SANOFI AVENTIS$$$$$F$Y$$$20240903$$MD$US$US
242778791$24277879$1$I$20240101$20240830$20240903$20240903$EXP$$US-ORGANON-O2409USA000058$ORGANON$$$$$F$Y$50.249$KG$20240903$$HP$US$US
242778801$24277880$1$I$$20240826$20240903$20240903$EXP$$IN-AstraZeneca-2024A194301$ASTRAZENECA$$55$YR$$F$Y$70$KG$20240903$$CN$IN$
242778811$24277881$1$I$20240406$20240829$20240903$20240903$EXP$$KR-AstraZeneca-2024A198925$ASTRAZENECA$$673$MON$$M$Y$$$20240903$$CN$KR$
242778821$24277882$1$I$20230827$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-105000-2023$RECKITT BENCKISER$$61$YR$$F$Y$70.45$KG$20240903$$CN$US$US
242778831$24277883$1$I$$20240221$20240903$20240903$PER$$US-CIPLA LTD.-2024US02221$CIPLA$$$$$$Y$$$20240903$$CN$US$US
242778841$24277884$1$I$20240717$20240828$20240903$20240903$EXP$$US-BAYER-2024A124633$BAYER$$68$YR$E$M$Y$$$20240903$$CN$US$US
242778851$24277885$1$I$$20240820$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08324$LUPIN$$$$$$Y$$$20240903$$MD$US$US
242778861$24277886$1$I$20240301$20240509$20240903$20240903$PER$$US-CIPLA LTD.-2024US04856$CIPLA$$$$$$Y$$$20240903$$CN$US$US
242778872$24277887$2$F$$20240919$20240903$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-075659$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$58.97$KG$20240920$$CN$US$US
242778881$24277888$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138369$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240903$$CN$US$US
242778891$24277889$1$I$20240801$20240830$20240903$20240903$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-139482$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240903$$MD$CN$CN
242778901$24277890$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139254$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240903$$CN$US$US
242778911$24277891$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138321$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$57.15$KG$20240903$$CN$US$US
242778931$24277893$1$I$$20240828$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137651$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$100.24$KG$20240903$$CN$US$US
242778941$24277894$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138660$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240903$$CN$US$US
242778951$24277895$1$I$$20240822$20240903$20240903$PER$$US-TAKEDA-2024TUS085191$TAKEDA$$$$$M$Y$$$20240903$$MD$US$US
242778961$24277896$1$I$20230901$20240531$20240903$20240903$PER$$US-CIPLA LTD.-2024US05876$CIPLA$$$$$$Y$$$20240903$$CN$US$US
242778981$24277898$1$I$$20240314$20240903$20240903$PER$$US-CIPLA LTD.-2024US02742$CIPLA$$$$$$Y$$$20240903$$CN$US$US
242778991$24277899$1$I$$20240830$20240903$20240903$EXP$$NVSC2024CA176418$NOVARTIS$$76$YR$$F$Y$$$20240903$$CN$CA$CA
242779001$24277900$1$I$20240826$20240830$20240903$20240903$EXP$$NVSC2024CN176903$NOVARTIS$$78$YR$$F$Y$55$KG$20240903$$HP$CN$CN
242779011$24277901$1$I$20240101$20240830$20240903$20240903$EXP$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000880$PAREXEL$$$$$$Y$$$20240903$$HP$US$US
242779021$24277902$1$I$20240828$20240830$20240903$20240903$EXP$$NVSC2024CN176901$NOVARTIS$$19$YR$$F$Y$47$KG$20240903$$HP$CN$CN
242779031$24277903$1$I$20240821$20240827$20240903$20240903$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000888$PAREXEL$$$$$$Y$$$20240903$$HP$CN$CN
242779041$24277904$1$I$20240601$20240822$20240903$20240903$PER$$US-SA-2024SA129816$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240903$$MD$US$US
242779051$24277905$1$I$20240429$20240502$20240903$20240903$PER$$US-PERRIGO-24US004356$PERRIGO$$82$YR$$M$Y$59.864$KG$20240903$$CN$US$US
242779062$24277906$2$F$20240101$20240829$20240903$20240910$EXP$$CA-UCBSA-2024031319$UCB$$$$$F$Y$$$20240910$$CN$CA$CA
242779071$24277907$1$I$20231112$20231212$20240903$20240903$PER$$US-PERRIGO-23US014234$PERRIGO$$$$$M$Y$$$20240903$$CN$US$US
242779081$24277908$1$I$20240831$20240903$20240903$20240903$PER$$US-BAYER-2024A126257$BAYER$$84$YR$E$M$Y$$$20240903$$CN$US$US
242779091$24277909$1$I$20230101$20240829$20240903$20240903$EXP$$CO-ABBVIE-5902681$ABBVIE$$$$$M$Y$59$KG$20240903$$CN$CO$CO
242779101$24277910$1$I$$20240831$20240903$20240903$EXP$$US-JNJFOC-20240901661$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242779111$24277911$1$I$$20240815$20240903$20240903$PER$$US-TEVA-VS-3235752$TEVA$$$$$F$Y$$$20240903$$CN$US$US
242779131$24277913$1$I$$20240828$20240903$20240903$EXP$$US-JNJFOC-20240877376$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$CN$US$US
242779141$24277914$1$I$$20240825$20240903$20240903$EXP$$GB-JNJFOC-20240868871$JOHNSON AND JOHNSON$$3$MON$I$F$Y$$$20240903$$HP$GB$GB
242779151$24277915$1$I$20240722$20240830$20240903$20240903$EXP$FR-AFSSAPS-AN2024001173$FR-JNJFOC-20240903120$JOHNSON AND JOHNSON$$73$YR$E$M$Y$68$KG$20240903$$PH$FR$FR
242779161$24277916$1$I$20220310$20240830$20240903$20240903$EXP$$BE-JNJFOC-20240901678$JOHNSON AND JOHNSON$$61$YR$A$F$Y$62$KG$20240903$$MD$BE$BE
242779172$24277917$2$F$$20240912$20240903$20240917$EXP$$ES-SANDOZ INC.-SDZ2024ES077015$SANDOZ$$28$YR$$F$Y$$$20240917$$HP$ES$ES
242779181$24277918$1$I$20240813$20240830$20240903$20240903$EXP$$CN-ORGANON-O2409CHN000054$ORGANON$$84$YR$$F$Y$65$KG$20240903$$HP$CN$CN
242779191$24277919$1$I$$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-100821-2023$RECKITT BENCKISER$$76$YR$$F$Y$$$20240903$$CN$US$US
242779201$24277920$1$I$20240619$20240828$20240903$20240903$EXP$$JP-009507513-2408JPN003785J$MERCK$$63$YR$$M$Y$$$20240903$$MD$JP$JP
242779211$24277921$1$I$$20240828$20240903$20240903$EXP$$JP-AMGEN-JPNSP2024174347$AMGEN$$54$YR$A$F$Y$$$20240903$$MD$JP$JP
242779222$24277922$2$F$20240801$20240830$20240903$20240909$PER$$US-AMGEN-USASP2024173771$AMGEN$$34$YR$A$M$Y$$$20240909$$HP$US$US
242779231$24277923$1$I$$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173766$AMGEN$$$$A$F$Y$$$20240903$$HP$US$US
242779241$24277924$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60128$$FDA-CTU$$33$YR$$F$N$$$20240830$N$$US$
242779251$24277925$1$I$$20240822$20240830$20240830$DIR$FDA-CDER-CTU-2024-60114$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242779261$24277926$1$I$20240819$20240820$20240830$20240830$DIR$FDA-CDER-CTU-2024-60054$$FDA-CTU$$66$YR$$M$N$$$20240820$N$HP$US$
242779271$24277927$1$I$$20240822$20240903$20240903$EXP$$IN-Accord-443405$ACCORD$Maheshwarappa HC, Singhai A, Mishra VN, Ingle V, Mukhopadhyay S. Disseminated Histoplasmosis Presenting as Pyrexia of Unknown Origin in a Rheumatoid Arthritis Patient. The Journal of the Association of Physicians of India. 2024;72(8):107-8.$56$YR$A$F$Y$$$20240903$$HP$IN$IN
242779281$24277928$1$I$$20240822$20240903$20240903$EXP$$FR-Accord-443541$ACCORD$Strizzolo R, Seneschal J, Soria A, Staumont-Salle D, Barbarot S, Viguier M, et al. French Atopic Dermatitis Network from the GREAT Research group. Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab. World Allergy Organ J. 2024 Jul 4;17(7):100923. doi: 10.1016/j.waojou.2024.100923.$$$A$$Y$$$20240903$$MD$FR$FR
242779302$24277930$2$F$20240821$20240903$20240903$20240912$EXP$GB-MHRA-MED-202408221624042960-LPFHY$GB-PERRIGO-24GB007852$PERRIGO$$45$YR$$F$Y$68$KG$20240912$$MD$GB$GB
242779331$24277933$1$I$20240826$20240903$20240903$20240903$EXP$GB-MHRA-MED-202409030643105750-YWLCV$GB-MYLANLABS-2024M1080769$MYLAN$$59$YR$$F$Y$$$20240903$$CN$GB$GB
242779341$24277934$1$I$20211119$20240822$20240903$20240903$EXP$$CN-Accord-444481$ACCORD$$62$YR$A$F$Y$61.7$KG$20240903$$MD$CN$CN
242779351$24277935$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139500$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240903$$CN$US$US
242779361$24277936$1$I$20240610$20240830$20240903$20240903$EXP$FR-AFSSAPS-AVMA2024000364$FR-MYLANLABS-2024M1079975$MYLAN$$43$YR$$M$Y$$$20240903$$PH$FR$FR
242779371$24277937$1$I$20240726$20240828$20240903$20240903$EXP$$TR-BAYER-2024A124843$BAYER$$31$YR$A$M$Y$72$KG$20240903$$PH$TR$TR
242779381$24277938$1$I$20221201$20240826$20240903$20240903$EXP$$FR-JNJFOC-20240901882$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240903$$HP$FR$FR
242779392$24277939$2$F$20240822$20240916$20240903$20240926$30DAY$$CA-JNJFOC-20240859328$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240926$$HP$CA$CA
242779401$24277940$1$I$20240601$20240829$20240903$20240903$EXP$$US-ABBVIE-5902758$ABBVIE$$80$YR$$M$Y$$$20240903$$CN$US$US
242779411$24277941$1$I$20201127$20240828$20240903$20240903$EXP$$RU-ABBVIE-5899602$ABBVIE$$70$YR$$F$Y$$$20240903$$CN$RU$RU
242779421$24277942$1$I$20240814$20240820$20240903$20240903$EXP$$CA-UCBSA-2024042585$UCB$$35$YR$$F$Y$$$20240903$$CN$CA$CA
242779431$24277943$1$I$20240729$20240827$20240903$20240903$EXP$FR-AFSSAPS-BX2024001674$FR-TEVA-VS-3237751$TEVA$$68$YR$$M$Y$$$20240903$$MD$FR$FR
242779441$24277944$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174695$AMGEN$$$$$F$Y$$$20240903$$CN$US$US
242779451$24277945$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5901877$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242779462$24277946$2$F$$20240903$20240903$20240910$EXP$$CA-AstraZeneca-2024A199082$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$CA$
242779471$24277947$1$I$20240801$20240829$20240903$20240903$EXP$$HU-ABBVIE-5902747$ABBVIE$$76$YR$$F$Y$$$20240903$$HP$HU$HU
242779481$24277948$1$I$$20240816$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08405$LUPIN$$$$$$Y$$$20240903$$CN$US$US
242779491$24277949$1$I$20240101$20240828$20240903$20240903$EXP$$US-ABBVIE-5901593$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242779501$24277950$1$I$$20240820$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002179$ALKERMES$$5$DEC$$F$Y$$$20240903$$HP$US$US
242779511$24277951$1$I$20240831$20240902$20240903$20240903$EXP$$UY-ABBVIE-5904840$ABBVIE$$88$YR$$F$Y$$$20240903$$CN$UY$UY
242779521$24277952$1$I$$20240823$20240903$20240903$PER$$US-ABBVIE-5894762$ABBVIE$$19$YR$$$Y$$$20240903$$HP$US$US
242779531$24277953$1$I$20240608$20240826$20240830$20240830$DIR$FDA-CDER-CTU-2024-60110$$FDA-CTU$$53$YR$$M$N$72.57$KG$20240826$N$HP$US$
242779551$24277955$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138343$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$48.08$KG$20240903$$HP$US$US
242779561$24277956$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138125$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240903$$HP$US$US
242779571$24277957$1$I$20240701$20240827$20240903$20240903$EXP$$AR-GSK-AR2024AMR107139$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$AR$AR
242779582$24277958$2$F$$20240830$20240903$20240905$PER$$NVSC2024US176860$NOVARTIS$$$$$$Y$$$20240905$$CN$US$US
242779591$24277959$1$I$20240101$20240828$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137152$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$84.37$KG$20240903$$CN$US$US
242779601$24277960$1$I$20240701$20240710$20240830$20240830$DIR$FDA-CDER-CTU-2024-60069$$FDA-CTU$$2$YR$$M$N$9.3$KG$20240710$N$HP$US$
242779611$24277961$1$I$$20240902$20240903$20240903$EXP$$JP-BAYER-2024A125880$BAYER$$$$$M$Y$$$20240903$$MD$JP$JP
242779621$24277962$1$I$20240709$20240826$20240903$20240903$PER$$US-ROCHE-10000068314$ROCHE$$84$YR$E$M$Y$$$20240903$$HP$US$US
242779631$24277963$1$I$$20240827$20240903$20240903$PER$$US-BAYER-2024A124340$BAYER$$37$YR$A$F$Y$$$20240903$$HP$US$US
242779641$24277964$1$I$20230501$20240821$20240903$20240903$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK093488$GLENMARK$Mavoor PP, George S, Chetambath R, Poornima MV. A Rare Parasitic Infection from the Common Cockroach: A Case of Lophomonas Blattarum from a Tertiary Center in Kerala. Indian Journal of Nephrology.. 2024;34(4):387-9$$$$$Y$$$20240903$$MD$IN$IN
242779651$24277965$1$I$$20240820$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002181$ALKERMES$$$$A$F$Y$$$20240903$$HP$US$US
242779661$24277966$1$I$$20240820$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002180$ALKERMES$$4$DEC$$M$Y$$$20240903$$HP$US$US
242779672$24277967$2$F$20240823$20240911$20240903$20240922$EXP$US-ABBVIE-5899914$GB-UCBSA-2024044678$UCB$$51$YR$$F$Y$48$KG$20240922$$PH$GB$GB
242779681$24277968$1$I$$20240828$20240903$20240903$EXP$$NVSC2024CN175584$NOVARTIS$Lu G, Jia L, Yang R, Lv Z, Cui J. Acquired hyperfibrinolysis as the presenting sign of metastatic breast cancer: a case report. ONCOLOGY LETTERS. 2023;25 (106):1-6$52$YR$$F$Y$$$20240903$$HP$CN$CN
242779691$24277969$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60064$$FDA-CTU$$$$$F$N$$$20240830$N$HP$US$
242779701$24277970$1$I$$20240816$20240903$20240903$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08370$LUPIN$$$$$$Y$$$20240903$$PH$US$US
242779711$24277971$1$I$$20240821$20240903$20240903$30DAY$$BE-MYLANLABS-2024M1079844$MYLAN$$$$$$Y$$$20240903$$CN$BE$BE
242779721$24277972$1$I$20190101$20240829$20240903$20240903$EXP$$NVSC2024ZA174437$NOVARTIS$$$$$M$Y$$$20240903$$CN$ZA$ZA
242779731$24277973$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5902659$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242779751$24277975$1$I$20240801$20240829$20240903$20240903$EXP$$US-ABBVIE-5902526$ABBVIE$$61$YR$$M$Y$$$20240903$$CN$US$US
242779761$24277976$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60011$$FDA-CTU$$$$$F$N$$$20240830$N$HP$US$
242779771$24277977$1$I$$20240820$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002210$ALKERMES$$$$$F$Y$$$20240903$$CN$US$US
242779781$24277978$1$I$$20240830$20240903$20240903$EXP$$US-ABBVIE-5903512$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242779792$24277979$2$F$$20240903$20240903$20240905$PER$$US-ROCHE-10000072136$ROCHE$$64$YR$A$M$Y$$$20240905$$CN$US$US
242779801$24277980$1$I$20240601$20240827$20240903$20240903$EXP$FR-AFSSAPS-LY2024001301$FR-TEVA-VS-3237859$TEVA$$71$YR$$M$Y$98$KG$20240903$$PH$FR$FR
242779811$24277981$1$I$20240823$20240823$20240830$20240830$DIR$FDA-CDER-CTU-2024-60083$$FDA-CTU$$66$YR$$F$N$$$20240823$N$HP$US$
242779821$24277982$1$I$$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-60026$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242779831$24277983$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60104$$FDA-CTU$$59$YR$$F$N$$$20240830$N$HP$US$
242779841$24277984$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60034$$FDA-CTU$$57$YR$$F$N$$$20240830$N$$US$
242779851$24277985$1$I$$20240828$20240903$20240903$EXP$$ZA-JNJFOC-20240877174$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240903$$MD$ZA$ZA
242779871$24277987$1$I$20240824$20240827$20240903$20240903$EXP$$US-JNJFOC-20240872404$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240903$$CN$US$US
242779882$24277988$2$F$20240714$20240913$20240903$20240925$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US002394$PAREXEL$$$$$$Y$$$20240924$$HP$US$US
242779901$24277990$1$I$$20240821$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002215$ALKERMES$$$$$M$Y$104.31$KG$20240903$$CN$US$US
242779911$24277991$1$I$$20240821$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002218$ALKERMES$$$$$F$Y$$$20240903$$CN$US$US
242779921$24277992$1$I$$20240826$20240903$20240903$PER$$US-RDY-SPO/USA/24/0012653$DR REDDYS$$56$YR$A$$Y$$$20240903$$MD$US$US
242779931$24277993$1$I$$20240814$20240903$20240903$PER$$US-TEVA-VS-3234759$TEVA$$67$YR$$M$Y$$$20240903$$CN$US$US
242779941$24277994$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60021$$FDA-CTU$$64$YR$$F$N$104.33$KG$20240830$N$$US$
242779951$24277995$1$I$20240101$20240831$20240903$20240903$EXP$$US-ABBVIE-5904589$ABBVIE$$$$$$Y$$$20240903$$CN$US$US
242779961$24277996$1$I$$20240829$20240903$20240903$PER$$US-BAYER-2024A124672$BAYER$$$$$$Y$$$20240903$$CN$US$US
242779972$24277997$2$F$$20240910$20240903$20240919$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US002781$PAREXEL$$$$$$Y$$$20240919$$PH$US$US
242779982$24277998$2$F$$20240910$20240903$20240919$PER$$US-BELCHER PHARMACEUTICALS, LLC-2024US002782$PAREXEL$$$$$$Y$$$20240919$$PH$US$US
242779991$24277999$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60012$$FDA-CTU$$62$YR$$F$N$78.47$KG$20240830$N$HP$US$
242780001$24278000$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60029$$FDA-CTU$$64$YR$$F$N$104.33$KG$20240830$N$$US$
242780011$24278001$1$I$20240101$20240815$20240903$20240903$PER$$US-009507513-2408USA005635$MERCK$$$$$F$Y$97.506$KG$20240903$$CN$US$US
242780021$24278002$1$I$$20130422$20240830$20240830$DIR$FDA-CDER-CTU-2024-60201$$FDA-CTU$$32$YR$$$N$160$LBS$20130422$N$$US$
242780031$24278003$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60056$$FDA-CTU$$62$YR$$F$N$131$LBS$20240830$N$$US$
242780041$24278004$1$I$$20240827$20240903$20240903$EXP$$JP-AMGEN-JPNSP2024171853$AMGEN$$$$$$Y$$$20240903$$MD$JP$JP
242780051$24278005$1$I$$20240902$20240903$20240903$PER$$US-ROCHE-10000072525$ROCHE$$$$A$M$Y$$$20240903$$CN$US$US
242780061$24278006$1$I$20240829$20240830$20240903$20240903$PER$$NVSC2024US176516$NOVARTIS$$92$YR$$F$Y$$$20240903$$CN$US$US
242780071$24278007$1$I$$20240819$20240830$20240830$DIR$FDA-CDER-CTU-2024-60123$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242780081$24278008$1$I$$20240828$20240903$20240903$EXP$$NVSC2024CN177075$NOVARTIS$$25$YR$$M$Y$$$20240903$$CN$CN$CN
242780091$24278009$1$I$$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-60096$$FDA-CTU$$$$$M$N$$$20240829$N$HP$US$
242780101$24278010$1$I$$20240826$20240903$20240903$EXP$$CA-TEVA-VS-3237614$TEVA$$75$YR$$F$Y$$$20240903$$HP$CA$CA
242780111$24278011$1$I$20240612$20240829$20240903$20240903$EXP$$JP-SHIONOGI + CO. LTD-2024001695$SHIONOGI$$63$YR$$M$Y$50$KG$20240903$$MD$JP$JP
242780121$24278012$1$I$$20240902$20240903$20240903$PER$$US-ROCHE-10000072340$ROCHE$$$$A$M$Y$$$20240903$$CN$US$US
242780131$24278013$1$I$20240821$20240902$20240903$20240903$PER$$US-ROCHE-10000072263$ROCHE$$49$YR$A$M$Y$$$20240903$$CN$US$US
242780141$24278014$1$I$20240818$20240902$20240903$20240903$PER$$US-ROCHE-10000072502$ROCHE$$21$YR$A$M$Y$$$20240903$$CN$US$US
242780151$24278015$1$I$20240801$20240827$20240903$20240903$EXP$$US-ABBVIE-5904556$ABBVIE$$70$YR$$M$Y$$$20240903$$CN$US$US
242780161$24278016$1$I$20240821$20240821$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002226$ALKERMES$$48$YR$$F$Y$$$20240903$$HP$US$US
242780172$24278017$2$F$20240515$20240829$20240903$20240926$EXP$$DE-ABBVIE-5903498$ABBVIE$$45$YR$$M$Y$$$20240926$$HP$DE$DE
242780191$24278019$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008867$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242780201$24278020$1$I$20240814$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000334$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240903$$CN$US$US
242780211$24278021$1$I$$20240902$20240903$20240903$EXP$$GB-ABBVIE-5904785$ABBVIE$$$$A$F$Y$$$20240903$$CN$GB$GB
242780221$24278022$1$I$$20240902$20240903$20240903$PER$$US-ROCHE-10000072177$ROCHE$$$$A$M$Y$$$20240903$$CN$US$US
242780232$24278023$2$F$20240825$20240911$20240903$20240912$PER$$US-ROCHE-10000072312$ROCHE$$8$YR$C$M$Y$$$20240912$$CN$US$US
242780251$24278025$1$I$20201101$20240826$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135862$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240903$$CN$US$US
242780271$24278027$1$I$20201101$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008868$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242780281$24278028$1$I$$20240822$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002206$ALKERMES$$40$YR$$M$Y$$$20240903$$MD$US$US
242780302$24278030$2$F$20240826$20240829$20240903$20240906$EXP$$AU-MYLANLABS-2024M1078972$MYLAN$$17$YR$$M$Y$$$20240906$$PH$AU$AU
242780311$24278031$1$I$$20240829$20240903$20240903$EXP$$AU-MYLANLABS-2024M1079599$MYLAN$$$$$M$Y$$$20240903$$HP$AU$AU
242780323$24278032$3$F$20240101$20240909$20240903$20240916$EXP$$US-AMGEN-USASP2024174014$AMGEN$$28$YR$A$F$Y$$$20240916$$PH$US$US
242780331$24278033$1$I$$20240831$20240903$20240903$EXP$$US-BAYER-2024A119339$BAYER$$76$YR$E$M$Y$$$20240903$$CN$US$US
242780341$24278034$1$I$$20240829$20240903$20240903$EXP$PL-URPL-1-1921-2020$PL-MYLANLABS-2024M1079675$MYLAN$$84$YR$$F$Y$50$KG$20240903$$MD$PL$PL
242780351$24278035$1$I$20240501$20240830$20240903$20240903$PER$$US-ABBVIE-5904106$ABBVIE$$$$$M$Y$$$20240903$$HP$US$US
242780361$24278036$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194079$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242780371$24278037$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA255325$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240903$$CN$US$US
242780381$24278038$1$I$20240702$20240829$20240903$20240903$EXP$DE-AMK-278310$DE-BAYER-2024A124400$BAYER$$30$YR$A$M$Y$82.4$KG$20240903$$PH$DE$DE
242780391$24278039$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080379$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$6$DEC$$$Y$$$20240903$$HP$US$US
242780401$24278040$1$I$$20240829$20240903$20240903$EXP$$US-MYLANLABS-2024M1080393$MYLAN$Steinbacher D, Murray B, Devlin T, Carson SS, Ford HJ. Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy. Pulm-Circ 2024; 14 (2):.$33$YR$$M$Y$$$20240903$$HP$US$US
242780411$24278041$1$I$$20240821$20240903$20240903$EXP$GB-MHRA-MED-202408211733525570-ZVMKT$GB-GLENMARK PHARMACEUTICALS-2024GMK093586$GLENMARK$$$$$$Y$$$20240903$$HP$GB$GB
242780421$24278042$1$I$20240801$20240827$20240903$20240903$EXP$$US-KARYOPHARM-2024KPT001476$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242780432$24278043$2$F$20240822$20240831$20240903$20240911$PER$$US-ALKERMES INC.-ALK-2024-002204$ALKERMES$$43$YR$$M$Y$$$20240911$$HP$US$US
242780441$24278044$1$I$20240701$20240829$20240903$20240903$EXP$$CA-ABBVIE-5902789$ABBVIE$$64$YR$$M$Y$$$20240903$$CN$CA$CA
242780451$24278045$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139939$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240903$$CN$US$US
242780461$24278046$1$I$20230119$20240827$20240903$20240903$PER$FR-AFSSAPS-ST2024001353$FR-Eisai-EC-2024-173003$EISAI$$60$YR$A$M$Y$77$KG$20240903$$HP$FR$FR
242780471$24278047$1$I$20240809$20240829$20240903$20240903$EXP$$GB-MYLANLABS-2024M1079879$MYLAN$$76$YR$$F$Y$69$KG$20240903$$HP$GB$GB
242780481$24278048$1$I$$20240829$20240903$20240903$EXP$$DE-MYLANLABS-2024M1079688$MYLAN$$$$$$Y$$$20240903$$MD$DE$DE
242780491$24278049$1$I$20240812$20240829$20240903$20240903$EXP$$CN-WAYLIS-2024-CN-000345$Waylis$$49$YR$$M$Y$$$20240903$$HP$CN$CN
242780501$24278050$1$I$$20240826$20240903$20240903$EXP$$US-JNJFOC-20240876622$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240903$$HP$US$US
242780511$24278051$1$I$20240823$20240823$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002225$ALKERMES$$45$YR$$M$Y$$$20240903$$HP$US$US
242780521$24278052$1$I$20240802$20240820$20240903$20240903$PER$$US-009507513-2408USA006936$MERCK$$67$YR$$M$Y$$$20240903$$PH$US$US
242780531$24278053$1$I$20240101$20240828$20240903$20240903$PER$$US-009507513-2409USA000490$MERCK$$12$YR$$$Y$$$20240903$$HP$US$US
242780551$24278055$1$I$20240826$20240830$20240903$20240903$EXP$$NVSC2024CN176905$NOVARTIS$$79$YR$$F$Y$$$20240903$$HP$CN$CN
242780561$24278056$1$I$20231223$20240827$20240903$20240903$EXP$$AU-009507513-2408AUS010794$MERCK$$65$YR$$M$Y$$$20240903$$CN$AU$AU
242780571$24278057$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60048$$FDA-CTU$$68$YR$$M$N$$$20240830$N$$US$
242780581$24278058$1$I$20240710$20240805$20240830$20240830$DIR$FDA-CDER-CTU-2024-60090$$FDA-CTU$$39$YR$$M$N$$$20240805$N$HP$US$
242780591$24278059$1$I$20240830$20240830$20240830$20240830$DIR$716608$$FDA-CTU$$$$$F$N$64.35$KG$20240830$N$HP$US$
242780611$24278061$1$I$$20240822$20240903$20240903$EXP$$SD-B.Braun Medical Inc.-2161108$B BRAUN$Literature Article$49$YR$$M$Y$$$20240903$$$SD$SD
242780621$24278062$1$I$$20240809$20240903$20240903$PER$$US-PharmaLex US Corporation-2161107$PHARMALEX$$$$$F$Y$$$20240903$$MD$US$US
242780642$24278064$2$F$$20240909$20240903$20240919$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161098$JIANGSU HENGRUI MEDICINE$$34$YR$$$Y$66$KG$20240919$$$CN$CN
242780651$24278065$1$I$$20240806$20240903$20240903$PER$$US-PharmaLex US Corporation-2161106$PHARMALEX$$73$YR$$F$Y$$$20240903$$MD$US$US
242780661$24278066$1$I$$20240809$20240903$20240903$PER$$US-PharmaLex US Corporation-2161104$PHARMALEX$$64$YR$$F$Y$$$20240903$$MD$US$US
242780671$24278067$1$I$$20240821$20240903$20240903$EXP$$FR-ALSI-2024000231$AIRGAS$$17$YR$$M$Y$$$20240903$$MD$FR$FR
242780681$24278068$1$I$20240112$20240827$20240903$20240903$EXP$FR-AFSSAPS-LL2024001576$FR-TEVA-VS-3237860$TEVA$$57$YR$$M$Y$$$20240903$$PH$FR$FR
242780691$24278069$1$I$$20240809$20240903$20240903$PER$$US-PharmaLex US Corporation-2161105$PHARMALEX$$63$YR$$M$Y$$$20240903$$MD$US$US
242780701$24278070$1$I$$20240819$20240903$20240903$EXP$$GB-Ascend Therapeutics US, LLC-2161112$ASCEND$$$$$F$Y$$$20240903$$$GB$GB
242780711$24278071$1$I$$20240822$20240903$20240903$EXP$$US-B.Braun Medical Inc.-2161111$B BRAUN$Literature Article$87$YR$$M$Y$$$20240903$$$US$US
242780721$24278072$1$I$20240101$20240823$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002234$ALKERMES$$$$$M$Y$74.376$KG$20240903$$PH$US$US
242780731$24278073$1$I$$20240822$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002205$ALKERMES$$$$$F$Y$$$20240903$$HP$US$US
242780741$24278074$1$I$20240823$20240823$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002227$ALKERMES$$47$YR$$F$Y$$$20240903$$MD$US$US
242780751$24278075$1$I$$20240828$20240903$20240903$EXP$$US-BEH-2024177991$CSL BEHRING$$71$YR$E$M$Y$60.771$KG$20240903$$CN$US$US
242780761$24278076$1$I$20240823$20240829$20240903$20240903$EXP$$CN-BAYER-2024A124596$BAYER$$73$YR$E$F$Y$50$KG$20240903$$HP$CN$CN
242780771$24278077$1$I$20240830$20240830$20240830$20240830$DIR$716672$$FDA-CTU$$17$YR$$M$N$51.75$KG$20240830$N$CN$US$
242780781$24278078$1$I$20240301$20240830$20240903$20240903$EXP$$US-BAYER-2024A125209$BAYER$$32$YR$A$M$Y$$$20240903$$CN$US$US
242780791$24278079$1$I$$20240822$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002194$ALKERMES$$$$$M$Y$$$20240903$$HP$US$US
242780801$24278080$1$I$20240814$20240902$20240903$20240903$EXP$$CN-BAYER-2024A126059$BAYER$$69$YR$E$M$Y$65$KG$20240903$$HP$CN$CN
242780811$24278081$1$I$20240822$20240829$20240903$20240903$EXP$$US-BAYER-2024A124623$BAYER$$45$YR$A$M$Y$$$20240903$$CN$US$US
242780822$24278082$2$F$$20240902$20240903$20240905$EXP$$JP-JNJFOC-20240900723$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$JP$JP
242780831$24278083$1$I$$20240830$20240903$20240903$EXP$$US-JNJFOC-20240903493$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242780841$24278084$1$I$20240822$20240829$20240903$20240903$EXP$$CN-BAYER-2024A124658$BAYER$$68$YR$E$F$Y$65$KG$20240903$$HP$CN$CN
242780851$24278085$1$I$20231111$20240903$20240903$20240903$EXP$$DE-SANDOZ INC.-SDZ2024DE077252$SANDOZ$$50$YR$$F$Y$$$20240903$$MD$DE$DE
242780861$24278086$1$I$$20240828$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137466$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240903$$CN$US$US
242780871$24278087$1$I$20240830$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60137$$FDA-CTU$$56$YR$$F$N$$$20240830$Y$HP$US$
242780881$24278088$1$I$$20240823$20240903$20240903$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03127$AMNEAL$$$$$$Y$$$20240903$$CN$US$US
242780901$24278090$1$I$$20240823$20240903$20240903$PER$$US-JNJFOC-20240871484$JOHNSON AND JOHNSON$$6$DEC$A$$Y$$$20240903$$CN$US$US
242780911$24278091$1$I$$20240826$20240903$20240903$EXP$$US-RDY-SPO/USA/24/0012704$DR REDDYS$Kinney RE, Nair S, Kim CH, Thomas MB, DelaTorre M. Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer. Oncologist. 2023 Jun 01;28(6): E478-E486. doi:10.1093/oncolo/oyad079.$69$YR$E$F$Y$$$20240903$$MD$US$US
242780921$24278092$1$I$$20240828$20240903$20240903$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004818$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240903$$CN$US$US
242780931$24278093$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008824$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242780941$24278094$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A195631$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242780951$24278095$1$I$$20240826$20240903$20240903$EXP$$ZA-AstraZeneca-2024A194551$ASTRAZENECA$$28$YR$$M$Y$$$20240903$$CN$ZA$
242780961$24278096$1$I$$20240902$20240903$20240903$EXP$$CA-SANDOZ INC.-SDZ2024CA077119$SANDOZ$$90$YR$$M$Y$101$KG$20240903$$MD$CA$CA
242780971$24278097$1$I$$20240902$20240903$20240903$PER$$US-HALEON-2194924$Haleon PLC$$36$YR$$F$Y$$$20240903$$HP$US$US
242780981$24278098$1$I$20240821$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60085$$FDA-CTU$$66$YR$$F$N$$$20240830$Y$PH$US$
242780991$24278099$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60127$$FDA-CTU$$33$YR$$F$N$$$20240830$N$$US$
242781001$24278100$1$I$20240812$20240813$20240830$20240830$DIR$FDA-CDER-CTU-2024-60103$$FDA-CTU$$86$YR$$F$N$$$20240813$N$HP$US$
242781011$24278101$1$I$20240801$20240820$20240830$20240830$DIR$FDA-CDER-CTU-2024-60027$$FDA-CTU$$86$YR$$F$N$$$20240820$N$HP$US$
242781021$24278102$1$I$$20240818$20240830$20240830$DIR$FDA-CDER-CTU-2024-60044$$FDA-CTU$$$$$F$N$$$20240818$N$HP$US$
242781041$24278104$1$I$20240715$20240823$20240903$20240903$EXP$SE-SEMPA-2024-006138$SE-ELI_LILLY_AND_COMPANY-SE202408015668$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240903$$CN$SE$SE
242781051$24278105$1$I$20240710$20240830$20240830$20240830$DIR$716688$$FDA-CTU$$49$YR$$M$N$$$20240830$N$HP$US$
242781071$24278107$1$I$20231120$20240822$20240903$20240903$EXP$ES-AEMPS-1483487$ES-ELI_LILLY_AND_COMPANY-ES202408015006$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240903$$CN$ES$ES
242781081$24278108$1$I$20240814$20240822$20240903$20240903$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408018374$ELI LILLY AND CO$$68$YR$E$M$Y$54$KG$20240903$$CN$DE$CN
242781091$24278109$1$I$20231001$20240822$20240903$20240903$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408013857$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240903$$MD$DE$DE
242781101$24278110$1$I$$20240828$20240903$20240903$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408018361$ELI LILLY AND CO$$$$$$Y$$$20240903$$CN$CN$CN
242781111$24278111$1$I$20240820$20240822$20240903$20240903$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408014499$ELI LILLY AND CO$$55$YR$A$F$Y$48$KG$20240903$$CN$CN$CN
242781121$24278112$1$I$$20240820$20240903$20240903$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000812$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240903$$CN$DE$JP
242781131$24278113$1$I$$20240823$20240903$20240903$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408016796$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240903$$CN$JP$JP
242781141$24278114$1$I$20231101$20240828$20240903$20240903$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408019356$ELI LILLY AND CO$$$$$$Y$$$20240903$$CN$FR$FR
242781153$24278115$3$F$$20240913$20240903$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408015095$ELI LILLY AND CO$$90$YR$E$F$Y$$$20240920$$CN$JP$JP
242781161$24278116$1$I$20240814$20240823$20240903$20240903$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408019158$ELI LILLY AND CO$$74$YR$E$F$Y$50$KG$20240903$$CN$DE$CN
242781171$24278117$1$I$20240621$20240902$20240903$20240903$EXP$$US-BAYER-2024A125843$BAYER$$43$YR$A$F$Y$$$20240903$$CN$US$US
242781181$24278118$1$I$20240830$20240830$20240830$20240830$DIR$716647$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242781192$24278119$2$F$20220101$20240908$20240903$20240916$EXP$$US-IMMUNOCORE, LTD.-2024-IMC-003015$IMMUNOCORE$Andoh J., Thangamathesvaran L., Fernando Arevalo, J.. Exudative subretinal fluid associated with tebentafusp immunotherapy. Canadian Journal of Ophthalmology. 2024$64$YR$$F$Y$$$20240916$$MD$US$US
242781201$24278120$1$I$20240607$20240828$20240903$20240903$EXP$$DE-TAKEDA-2024TUS086549$TAKEDA$$42$YR$$M$Y$$$20240903$$MD$DE$DE
242781211$24278121$1$I$20240730$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60109$$FDA-CTU$$60$YR$$F$N$$$20240830$N$$US$
242781222$24278122$2$F$20240801$20240903$20240903$20240912$PER$$US-ABBVIE-5896024$ABBVIE$$29$YR$$F$Y$$$20240912$$CN$US$US
242781231$24278123$1$I$$20240823$20240903$20240903$PER$$US-JNJFOC-20240865868$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242781241$24278124$1$I$$20240814$20240830$20240830$DIR$FDA-CDER-CTU-2024-60025$$FDA-CTU$$$$$M$N$$$20240814$N$HP$US$
242781251$24278125$1$I$20240822$20240830$20240903$20240903$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013987$JAZZ$$61$YR$$M$Y$$$20240903$$CN$US$US
242781272$24278127$2$F$20240824$20240830$20240903$20240909$EXP$$US-OTSUKA-2024_023471$OTSUKA$$54$YR$$M$Y$113.4$KG$20240909$$PH$US$US
242781291$24278129$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008826$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242781301$24278130$1$I$$20240830$20240903$20240903$PER$$US-ALXN-202408USA002171US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
242781311$24278131$1$I$20210625$20240828$20240903$20240903$EXP$$CA-TAKEDA-2021TUS040675$TAKEDA$$77$YR$$F$Y$$$20240903$$MD$CA$CA
242781321$24278132$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008825$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242781331$24278133$1$I$$20240830$20240903$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US076838$SANDOZ$$$$$F$Y$$$20240903$$CN$US$US
242781351$24278135$1$I$20240101$20240820$20240903$20240903$EXP$$BE-UCBSA-2024042772$UCB$$$$$F$Y$$$20240903$$CN$BE$BE
242781361$24278136$1$I$20240807$20240827$20240903$20240903$EXP$SE-SEMPA-2024-006181$SE-TEVA-VS-3237884$TEVA$$71$YR$$F$Y$90$KG$20240903$$MD$SE$SE
242781371$24278137$1$I$20240825$20240826$20240903$20240903$PER$$US-RDY-SPO/USA/24/0012648$DR REDDYS$$17$YR$T$F$Y$$$20240903$$CN$US$US
242781401$24278140$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60031$$FDA-CTU$$$$$M$N$$$20240830$N$HP$US$
242781432$24278143$2$F$20240826$20240903$20240903$20240910$EXP$$DE-BAXTER-2024BAX023921$BAXTER$$72$YR$$M$Y$$$20240910$$HP$DE$DE
242781441$24278144$1$I$$20240826$20240903$20240903$EXP$$JP-BAXTER-2024BAX023978$BAXTER$Naganuma K..MCVAC Conditioning Regimen Followed by Autologous ASCT in R/R B-cell Lymphoma.The 14th JSH International Symposium 2024 Program and Abstract Book 2024;:1-2.$$$A$$Y$$$20240903$$MD$JP$JP
242781454$24278145$4$F$20240101$20240909$20240903$20240917$PER$$US-AMGEN-USASP2024174554$AMGEN$$57$YR$A$F$Y$$$20240916$$HP$US$US
242781461$24278146$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024175131$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242781471$24278147$1$I$$20240828$20240903$20240903$EXP$$BG-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004838$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240903$$MD$BG$BG
242781492$24278149$2$F$$20240903$20240903$20240910$EXP$$US-TAKEDA-2024TUS029944$TAKEDA$$$$$F$Y$48.98$KG$20240910$$HP$US$US
242781501$24278150$1$I$$20240828$20240903$20240903$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004807$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240903$$HP$US$US
242781511$24278151$1$I$20240826$20240826$20240903$20240903$EXP$$BR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004835$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240903$$CN$BR$BR
242781521$24278152$1$I$$20240828$20240903$20240903$EXP$$BG-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004837$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240903$$MD$BG$BG
242781531$24278153$1$I$$20240819$20240830$20240830$DIR$FDA-CDER-CTU-2024-60101$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242781541$24278154$1$I$$20240826$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137015$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240903$$CN$US$US
242781551$24278155$1$I$20231022$20240903$20240903$20240903$PER$$US-PROD-AS2-212756134-RB-136239-2023$RECKITT BENCKISER$$36$YR$$M$Y$$$20240903$$CN$US$US
242781561$24278156$1$I$$20240822$20240903$20240903$PER$$US-ABBVIE-5894044$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242781571$24278157$1$I$$20240816$20240903$20240903$PER$$US-TEVA-VS-3235861$TEVA$$49$YR$$F$Y$$$20240903$$HP$US$US
242781581$24278158$1$I$$20240828$20240903$20240903$EXP$$BG-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004839$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240903$$MD$BG$BG
242781592$24278159$2$F$$20240904$20240903$20240910$EXP$$ES-TAKEDA-2024TUS087760$TAKEDA$$55$YR$$F$Y$$$20240910$$HP$ES$ES
242781601$24278160$1$I$$20240829$20240903$20240903$EXP$$JP-009507513-2408JPN004110J$MERCK$$70$YR$$M$Y$$$20240903$$MD$JP$JP
242781611$24278161$1$I$$20240828$20240903$20240903$EXP$$IT-MYLANLABS-2024M1080462$MYLAN$Tellini M, Di Nicola M, Fonte C, Castelli B, Guidi M, Giordano F, et al. Low dose carboplatin - etoposide regimen in pediatric patients with low grade glioma. Neuro-Oncol 2024; 26 (Suppl.) iv128.$$$C$$Y$$$20240903$$HP$IT$IT
242781631$24278163$1$I$20240324$20240827$20240903$20240903$EXP$$US-OTSUKA-2024_008091$OTSUKA$$41$YR$$F$Y$$$20240903$$CN$US$US
242781641$24278164$1$I$20240809$20240827$20240903$20240903$EXP$$CN-ABBVIE-5898333$ABBVIE$$62$YR$$F$Y$60$KG$20240903$$MD$CN$CN
242781652$24278165$2$F$$20240918$20240903$20240925$EXP$$NVSC2024IT143335$NOVARTIS$Guerrieri S, Rubin M, Gattuso I, Zanetta C, Genchi A, Preziosa P et al.. Can treatment adverse events be optimized by switching between different sphingosine 1?phosphate receptor modulators in multiple sclerosis? A case series.. JOURNAL OF NEUROLOGY. 2024;271(6):3678-81$49$YR$$F$Y$$$20240926$$HP$IT$IT
242781661$24278166$1$I$20240101$20240828$20240903$20240903$EXP$$US-ABBVIE-5900898$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242781671$24278167$1$I$$20240826$20240903$20240903$EXP$$ZA-AstraZeneca-2024A195608$ASTRAZENECA$$54$YR$$F$Y$$$20240903$$CN$ZA$
242781681$24278168$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A195327$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242781691$24278169$1$I$$20240822$20240903$20240903$EXP$$ID-B.Braun Medical Inc.-2161116$B BRAUN$Literature Article$6$YR$$M$Y$$$20240903$$$ID$ID
242781701$24278170$1$I$$20240826$20240903$20240903$EXP$$ZA-AstraZeneca-2024A195956$ASTRAZENECA$$85$YR$$M$Y$$$20240903$$CN$ZA$
242781711$24278171$1$I$$20240823$20240903$20240903$PER$$US-AstraZeneca-2024A193128$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242781721$24278172$1$I$$20240829$20240903$20240903$EXP$$US-AstraZeneca-2024A197767$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242781732$24278173$2$F$$20240911$20240903$20240917$EXP$$CA-AstraZeneca-2024A199299$ASTRAZENECA$$70$YR$$F$Y$$$20240918$$MD$CA$
242781741$24278174$1$I$20240705$20240826$20240903$20240903$EXP$$JP-AstraZeneca-2024A197970$ASTRAZENECA$$64$YR$$F$Y$$$20240903$$MD$JP$
242781751$24278175$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194085$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242781761$24278176$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194461$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242781771$24278177$1$I$20240101$20240828$20240903$20240903$PER$$US-009507513-2409USA000491$MERCK$$13$YR$$$Y$$$20240903$$HP$US$US
242781781$24278178$1$I$20010427$20240828$20240903$20240903$EXP$$NO-AstraZeneca-2024A193824$ASTRAZENECA$$59$YR$$M$Y$$$20240903$$MD$NO$
242781792$24278179$2$F$$20240826$20240903$20240909$EXP$$US-AstraZeneca-2024A194644$ASTRAZENECA$$84$YR$$F$Y$84.4$KG$20240909$$MD$US$
242781801$24278180$1$I$$20240828$20240903$20240903$EXP$$US-TAKEDA-2024TUS087192$TAKEDA$$16$YR$$F$Y$$$20240903$$CN$US$US
242781811$24278181$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194428$ASTRAZENECA$$$$$F$Y$$$20240903$$HP$US$
242781831$24278183$1$I$$20240829$20240903$20240903$PER$$US-Taiho Oncology Inc-2024-008309$TAIHO ONCOLOGY INC$$$$A$F$Y$$$20240903$$CN$US$US
242781841$24278184$1$I$20220101$20240826$20240903$20240903$EXP$$BR-BAYER-2024A095560$BAYER$$61$YR$A$F$Y$$$20240903$$CN$BR$BR
242781852$24278185$2$F$$20240906$20240903$20240909$EXP$DE-EMA-DD-20240829-7482650-105702$DE-SANDOZ INC.-SDZ2024DE077012$SANDOZ$$2$YR$$$Y$$$20240909$$MD$DE$DE
242781862$24278186$2$F$20230701$20240902$20240903$20240906$EXP$$GB-DSJP-DSE-2024-143046$DAIICHI$$83$YR$$F$Y$$$20240906$$CN$GB$GB
242781871$24278187$1$I$$20240828$20240903$20240903$EXP$$US-JNJFOC-20240873906$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$HP$US$US
242781881$24278188$1$I$20240105$20240829$20240903$20240903$EXP$$SE-JNJFOC-20240901688$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240903$$CN$SE$SE
242781891$24278189$1$I$20240709$20240815$20240903$20240903$PER$$US-Vifor (International) Inc.-VIT-2024-07436$VIFOR$$41$YR$$F$Y$35$KG$20240903$$HP$US$US
242781901$24278190$1$I$20240226$20240815$20240903$20240903$PER$$US-Vifor (International) Inc.-VIT-2024-07448$VIFOR$$78$YR$$M$Y$$$20240903$$HP$US$US
242781911$24278191$1$I$$20240829$20240903$20240903$EXP$$JP-Vifor (International) Inc.-VIT-2024-07827$VIFOR$$85$YR$$M$Y$$$20240903$$PH$JP$JP
242781921$24278192$1$I$20240722$20240815$20240903$20240903$PER$$US-Vifor (International) Inc.-VIT-2024-07444$VIFOR$$58$YR$$F$Y$93$KG$20240903$$HP$US$US
242781931$24278193$1$I$20240713$20240815$20240903$20240903$PER$$US-Vifor (International) Inc.-VIT-2024-07461$VIFOR$$79$YR$$F$Y$58.5$KG$20240903$$HP$US$US
242781941$24278194$1$I$$20240827$20240903$20240903$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07772$VIFOR$$84$YR$$F$Y$$$20240903$$HP$ZA$ZA
242781952$24278195$2$F$$20240909$20240903$20240911$EXP$$US-TAKEDA-2024TUS087679$TAKEDA$$$$$M$Y$$$20240911$$CN$US$US
242781961$24278196$1$I$$20240815$20240903$20240903$PER$$US-TEVA-VS-3235306$TEVA$$55$YR$$F$Y$$$20240903$$CN$US$US
242781971$24278197$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008823$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242781981$24278198$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000601$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240903$$CN$US$US
242782001$24278200$1$I$$20240825$20240903$20240903$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000820$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240903$$CN$DE$JP
242782011$24278201$1$I$20240828$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408019283$ELI LILLY AND CO$$$$A$F$Y$$$20240903$$CN$US$US
242782021$24278202$1$I$$20240825$20240903$20240903$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000824$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240903$$CN$DE$JP
242782031$24278203$1$I$$20240825$20240903$20240903$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000828$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240903$$CN$DE$JP
242782041$24278204$1$I$$20240825$20240903$20240903$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000825$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240903$$CN$DE$JP
242782051$24278205$1$I$20240101$20240901$20240903$20240903$PER$$US-ABBVIE-5903986$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242782061$24278206$1$I$20240816$20240825$20240903$20240903$EXP$$CN-BEIGENE-BGN-2024-013363$BEIGENE$$$$$$Y$$$20240903$$HP$CN$CN
242782071$24278207$1$I$20230723$20240827$20240903$20240903$EXP$$BR-BAYER-2023A106671$BAYER$$28$YR$A$F$Y$72$KG$20240903$$CN$BR$BR
242782082$24278208$2$F$20240730$20240913$20240903$20240930$PER$$US-TOLMAR, INC.-24US051595$TOLMAR$$80$YR$$M$Y$$$20240927$$PH$US$US
242782091$24278209$1$I$$20240810$20240903$20240903$PER$$CA-TOLMAR, INC.-24CA051850$TOLMAR$$$$$M$Y$$$20240903$$CN$CA$CA
242782131$24278213$1$I$20221221$20240808$20240903$20240903$PER$$US-TOLMAR, INC.-24US051732$TOLMAR$$41$YR$$F$Y$$$20240903$$HP$US$US
242782151$24278215$1$I$$20240808$20240903$20240903$PER$$US-TOLMAR, INC.-24US051776$TOLMAR$$$$$$Y$$$20240903$$HP$US$US
242782161$24278216$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139260$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240903$$CN$US$US
242782171$24278217$1$I$$20240808$20240903$20240903$PER$$US-TOLMAR, INC.-24US051784$TOLMAR$$$$$$Y$$$20240903$$HP$US$US
242782191$24278219$1$I$$20240807$20240903$20240903$PER$$US-TOLMAR, INC.-24US051786$TOLMAR$$$$$M$Y$$$20240903$$CN$US$US
242782212$24278221$2$F$20230101$20240904$20240903$20240909$EXP$$DE-JNJFOC-20240901547$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240910$$CN$DE$DE
242782221$24278222$1$I$$20240826$20240830$20240830$DIR$FDA-CDER-CTU-2024-60067$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242782231$24278223$1$I$20240715$20240827$20240903$20240903$EXP$FR-AFSSAPS-LM2024000463$FR-TEVA-VS-3237829$TEVA$$78$YR$$M$Y$60$KG$20240903$$MD$FR$FR
242782241$24278224$1$I$$20240829$20240903$20240903$PER$$US-ALXN-202408USA002172US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
242782271$24278227$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60117$$FDA-CTU$$63$YR$$M$N$$$20240830$N$$US$
242782281$24278228$1$I$20240813$20240825$20240903$20240903$EXP$$CN-BEIGENE-BGN-2024-013364$BEIGENE$$$$$$Y$$$20240903$$HP$CN$CN
242782291$24278229$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60039$$FDA-CTU$$81$YR$$F$N$$$20240830$N$$US$
242782301$24278230$1$I$$20240830$20240830$20240830$DIR$716630$$FDA-CTU$$$$$UNK$N$$$20240830$$CN$US$
242782321$24278232$1$I$20240830$20240830$20240830$20240830$DIR$716685$$FDA-CTU$$80$YR$$M$N$$$20240830$Y$HP$US$
242782341$24278234$1$I$$20240827$20240830$20240830$DIR$FDA-CDER-CTU-2024-60079$$FDA-CTU$$$$$F$N$$$20240827$N$HP$US$
242782361$24278236$1$I$20240812$20240826$20240830$20240830$DIR$FDA-CDER-CTU-2024-60049$$FDA-CTU$$31$YR$$F$N$$$20240826$N$HP$US$
242782381$24278238$1$I$20240709$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-60089$$FDA-CTU$$60$YR$$F$N$$$20240829$N$HP$US$
242782391$24278239$1$I$$20240830$20240830$20240830$DIR$716609$$FDA-CTU$$$$$UNK$N$$$20240830$$CN$US$
242782401$24278240$1$I$$20240814$20240830$20240830$DIR$FDA-CDER-CTU-2024-60120$$FDA-CTU$$$$$F$N$$$20240814$N$HP$US$
242782411$24278241$1$I$20240710$20240829$20240830$20240830$DIR$FDA-CDER-CTU-2024-60102$$FDA-CTU$$66$YR$$F$N$$$20240829$Y$HP$US$
242782421$24278242$1$I$$20240823$20240830$20240830$DIR$FDA-CDER-CTU-2024-60052$$FDA-CTU$$$$$F$N$$$20240823$N$HP$US$
242782431$24278243$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60043$$FDA-CTU$$73$YR$$F$N$$$20240830$N$$US$
242782451$24278245$1$I$20240830$20240830$20240830$20240830$DIR$716619$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242782471$24278247$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-PV202400112694$PFIZER$$$$$F$Y$$$20240903$$CN$US$US
242782481$24278248$1$I$$20240828$20240830$20240830$DIR$FDA-CDER-CTU-2024-60062$$FDA-CTU$$77$YR$$M$N$$$20240828$N$$US$
242782491$24278249$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60023$$FDA-CTU$$74$YR$$F$N$$$20240830$N$$US$
242782501$24278250$1$I$20231031$20240830$20240830$20240830$DIR$716724$$FDA-CTU$$$$$F$N$$$20240830$N$CN$US$
242782511$24278251$1$I$20240101$20240827$20240903$20240903$PER$$US-PFIZER INC-202400245936$PFIZER$$29$YR$$M$Y$$$20240903$$HP$US$US
242782521$24278252$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-202400245727$PFIZER$$$$$F$Y$$$20240903$$CN$US$US
242782531$24278253$1$I$20221130$20240821$20240903$20240903$PER$$US-PFIZER INC-202400243546$PFIZER$$73$YR$$F$Y$$$20240903$$MD$US$US
242782541$24278254$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-202400245686$PFIZER$$$$$F$Y$$$20240903$$PH$US$US
242782551$24278255$1$I$20240825$20240828$20240903$20240903$PER$$US-PFIZER INC-202400245709$PFIZER$$56$YR$$F$Y$$$20240903$$CN$US$US
242782562$24278256$2$F$$20240918$20240903$20240920$PER$$US-PFIZER INC-202400246286$PFIZER$$57$YR$$F$Y$90.72$KG$20240920$$CN$US$US
242782571$24278257$1$I$20240101$20240828$20240903$20240903$PER$$US-PFIZER INC-PV202400113208$PFIZER$$71$YR$$F$Y$$$20240903$$HP$US$US
242782582$24278258$2$F$20240801$20240902$20240903$20240904$PER$$US-PFIZER INC-202400246809$PFIZER$$53$YR$$F$Y$$$20240904$$HP$US$US
242782591$24278259$1$I$20240827$20240828$20240903$20240903$PER$$US-PFIZER INC-202400246284$PFIZER$$70$YR$$F$Y$$$20240903$$CN$US$US
242782601$24278260$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-PV202400113027$PFIZER$$75$YR$$F$Y$$$20240903$$PH$US$US
242782611$24278261$1$I$$20240827$20240903$20240903$PER$$US-PFIZER INC-202400245068$PFIZER$$70$YR$$F$Y$$$20240903$$MD$US$US
242782622$24278262$2$F$20240919$20240923$20240903$20240926$PER$$US-PFIZER INC-202400245916$PFIZER$$64$YR$$F$Y$$$20240926$$HP$US$US
242782631$24278263$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-202400246573$PFIZER$$$$A$F$Y$$$20240903$$MD$US$US
242782641$24278264$1$I$$20240827$20240903$20240903$PER$$US-PFIZER INC-PV202400112402$PFIZER$$46$YR$$F$Y$$$20240903$$CN$US$US
242782651$24278265$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-202400245809$PFIZER$$$$$F$Y$$$20240903$$PH$US$US
242782661$24278266$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-PV202400080509$PFIZER$$60$YR$$F$Y$$$20240903$$CN$US$US
242782671$24278267$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-PV202400113470$PFIZER$$43$YR$$F$Y$$$20240903$$CN$US$US
242782682$24278268$2$F$$20240829$20240903$20240904$PER$$US-PFIZER INC-PV202400112716$PFIZER$$11$YR$$M$Y$$$20240904$$CN$US$US
242782691$24278269$1$I$20240801$20240828$20240903$20240903$PER$$US-PFIZER INC-202400246281$PFIZER$$73$YR$$M$Y$$$20240903$$CN$US$US
242782701$24278270$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-202300376400$PFIZER$$26$YR$$M$Y$$$20240903$$CN$US$US
242782711$24278271$1$I$$20240827$20240903$20240903$PER$$US-PFIZER INC-PV202400112427$PFIZER$$67$YR$$F$Y$$$20240903$$CN$US$US
242782721$24278272$1$I$$20240827$20240903$20240903$PER$$US-PFIZER INC-PV202300024933$PFIZER$$65$YR$$F$Y$$$20240903$$CN$US$US
242782731$24278273$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-PV202400113098$PFIZER$$68$YR$$$Y$$$20240903$$CN$US$US
242782741$24278274$1$I$20240801$20240828$20240903$20240903$PER$$US-PFIZER INC-202400246046$PFIZER$$61$YR$$F$Y$$$20240903$$HP$US$US
242782751$24278275$1$I$20110401$20240830$20240830$20240830$DIR$716723$$FDA-CTU$$43$YR$$F$N$67.5$KG$20240830$N$CN$US$
242782761$24278276$1$I$20240405$20240807$20240830$20240830$DIR$FDA-CDER-CTU-2024-60050$$FDA-CTU$$12$MON$$M$N$$$20240807$N$HP$US$
242782771$24278277$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-202400246322$PFIZER$$40$YR$$M$Y$$$20240903$$CN$US$US
242782781$24278278$1$I$$20240827$20240903$20240903$PER$$US-PFIZER INC-202400245139$PFIZER$$93$YR$$F$Y$$$20240903$$CN$US$US
242782791$24278279$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-202400245961$PFIZER$$14$YR$$M$Y$$$20240903$$CN$US$US
242782801$24278280$1$I$$20240826$20240903$20240903$PER$$US-PFIZER INC-202400245054$PFIZER$$63$YR$$F$Y$$$20240903$$HP$US$US
242782812$24278281$2$F$20240801$20240828$20240903$20240904$EXP$$JP-009507513-2408JPN003768J$MERCK$$$$$F$Y$$$20240904$$MD$JP$JP
242782821$24278282$1$I$20240801$20240820$20240903$20240903$EXP$$TW-UCBSA-2024042533$UCB$$71$YR$$M$Y$$$20240903$$MD$TW$TW
242782831$24278283$1$I$20240826$20240826$20240903$20240903$EXP$$CN-BEIGENE-BGN-2024-013441$BEIGENE$$$$$$Y$$$20240903$$HP$CN$CN
242782841$24278284$1$I$20240101$20240902$20240903$20240903$EXP$$NVSC2024NP177067$NOVARTIS$$$$$M$Y$$$20240903$$MD$NP$NP
242782853$24278285$3$F$$20240912$20240903$20240919$PER$$US-BAYER-2024A126049$BAYER$$$$$F$Y$$$20240919$$HP$US$US
242782861$24278286$1$I$$20240814$20240903$20240903$PER$$US-TEVA-VS-3233609$TEVA$$23$YR$$M$Y$136.08$KG$20240903$$HP$US$US
242782871$24278287$1$I$$20240829$20240903$20240903$PER$$US-JNJFOC-20240881703$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$HP$US$US
242782881$24278288$1$I$20240101$20240820$20240903$20240903$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-012782$JAZZ$$$$$F$Y$$$20240903$$MD$JP$JP
242782891$24278289$1$I$20220201$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008816$INCYTE$$$$$$Y$$$20240903$$HP$US$US
242782901$24278290$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194967$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242782911$24278291$1$I$20240819$20240826$20240903$20240903$EXP$$CN-BEIGENE-BGN-2024-013442$BEIGENE$$$$$$Y$$$20240903$$HP$CN$CN
242782921$24278292$1$I$$20240826$20240903$20240903$PER$$US-AstraZeneca-2024A198293$ASTRAZENECA$$$$$$Y$$$20240903$$HP$US$
242782932$24278293$2$F$20240701$20240815$20240903$20240906$PER$$US-AstraZeneca-2024A199567$ASTRAZENECA$$57$YR$$F$Y$$$20240906$$CN$US$
242782941$24278294$1$I$$20240829$20240903$20240903$EXP$$US-AstraZeneca-2024A197924$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242782951$24278295$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A195319$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242782962$24278296$2$F$$20240911$20240903$20240917$EXP$$CA-AstraZeneca-2024A196770$ASTRAZENECA$$33$YR$$F$Y$68$KG$20240917$$MD$CA$
242782971$24278297$1$I$$20240829$20240903$20240903$EXP$$ZA-AstraZeneca-2024A197611$ASTRAZENECA$$73$YR$$M$Y$$$20240903$$CN$ZA$
242782981$24278298$1$I$20240807$20240826$20240903$20240903$EXP$$JP-AstraZeneca-2024A197306$ASTRAZENECA$$$$$F$Y$$$20240903$$MD$JP$
242782991$24278299$1$I$20240701$20240830$20240903$20240903$EXP$$NVSC2024CN176949$NOVARTIS$$66$YR$$F$Y$$$20240903$$HP$CN$CN
242783001$24278300$1$I$20240801$20240822$20240903$20240903$PER$$US-ABBVIE-5893983$ABBVIE$$$$$$Y$$$20240903$$CN$US$US
242783011$24278301$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008820$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242783021$24278302$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024175348$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242783031$24278303$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008821$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242783042$24278304$2$F$$20240909$20240903$20240912$PER$$US-JNJFOC-20240873896$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240912$$CN$US$US
242783051$24278305$1$I$20240903$20240903$20240903$20240903$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049222$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240903$$CN$US$US
242783061$24278306$1$I$$20240826$20240903$20240903$EXP$$CA-AstraZeneca-2024A199061$ASTRAZENECA$$34$YR$$F$Y$$$20240903$$MD$CA$
242783071$24278307$1$I$$20240822$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008822$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242783081$24278308$1$I$20240816$20240826$20240903$20240903$EXP$$CN-BEIGENE-BGN-2024-013446$BEIGENE$$$$$$Y$$$20240903$$HP$CN$CN
242783091$24278309$1$I$$20240830$20240903$20240903$EXP$$NVSC2024KR173382$NOVARTIS$$53$YR$$F$Y$$$20240903$$MD$KR$KR
242783101$24278310$1$I$20240818$20240826$20240903$20240903$EXP$$CN-BEIGENE-BGN-2024-013445$BEIGENE$$$$$$Y$$$20240903$$HP$CN$CN
242783111$24278311$1$I$20240101$20240828$20240903$20240903$EXP$$US-JNJFOC-20240874863$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240903$$HP$US$US
242783121$24278312$1$I$$20240825$20240903$20240903$EXP$$TW-AMGEN-TWNSP2024171666$AMGEN$Fu S.; Huang C.; Hung C. et al.. Real World Clinical Outcomes When Discontinuing Denosumab or Bisphosphonates in Patients with Surgically Managed Osteoporotic Vertebral Compression Fractures: A Population-Based Cohort Study. The Spine Journal. 2024;1-41$$$$$Y$$$20240903$$MD$TW$TW
242783131$24278313$1$I$20240713$20240902$20240903$20240903$EXP$FR-AFSSAPS-TS2024000939$FR-JNJFOC-20240901236$JOHNSON AND JOHNSON$$87$YR$E$M$Y$82$KG$20240903$$MD$FR$FR
242783141$24278314$1$I$$20240827$20240903$20240903$EXP$$CA-TEVA-VS-3237825$TEVA$$22$YR$$M$Y$105$KG$20240903$$HP$CA$CA
242783152$24278315$2$F$$20240902$20240903$20240905$EXP$$US-PFIZER INC-202400247715$PFIZER$Bell, A.. Pyoderma Gangrenosum in a 75-Year-Old Male With Follicular Diffuse Large B-cell Lymphoma.. Cureus. 2024;16(8):e67234$75$YR$$M$Y$$$20240905$$MD$US$US
242783161$24278316$1$I$20240822$20240822$20240903$20240903$PER$$US-ABBVIE-5894092$ABBVIE$$73$YR$$F$Y$$$20240903$$CN$US$US
242783171$24278317$1$I$$20240828$20240903$20240903$30DAY$$CA-MYLANLABS-2024M1080191$MYLAN$$$$$$Y$$$20240903$$PH$CA$CA
242783183$24278318$3$F$$20240906$20240903$20240910$EXP$$CA-Taiho Oncology Inc-2023-010833$TAIHO ONCOLOGY INC$$56$YR$A$M$Y$$$20240910$$CN$CA$CA
242783191$24278319$1$I$20240101$20240828$20240903$20240903$PER$$US-Eisai-EC-2024-173488$EISAI$$48$YR$A$F$Y$$$20240903$$CN$US$US
242783201$24278320$1$I$20240822$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60092$$FDA-CTU$$50$YR$$F$N$$$20240830$N$HP$US$
242783211$24278321$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60126$$FDA-CTU$$76$YR$$M$N$$$20240830$N$$US$
242783221$24278322$1$I$$20240828$20240903$20240903$EXP$$CA-APOTEX-2024AP010090$APOTEX$$61$YR$$M$Y$$$20240903$$CN$CA$CA
242783241$24278324$1$I$$20240828$20240903$20240903$PER$$US-JNJFOC-20240876560$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242783261$24278326$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-59980$$FDA-CTU$$$$$F$N$$$20240830$N$$US$
242783271$24278327$1$I$20240701$20240823$20240903$20240903$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK093645$GLENMARK$$$$$$Y$$$20240903$$MD$GB$GB
242783281$24278328$1$I$$20240825$20240903$20240903$EXP$$TW-AMGEN-TWNSP2024171680$AMGEN$Fu S.; Huang C.; Hung C. et al.. Real World Clinical Outcomes When Discontinuing Denosumab or Bisphosphonates in Patients with Surgically Managed Osteoporotic Vertebral Compression Fractures: A Population-Based Cohort Study. The Spine Journal. 2024;1-41$$$$$Y$$$20240903$$MD$TW$TW
242783292$24278329$2$F$20240101$20240906$20240903$20240910$PER$$US-BIOGEN-2024BI01267373$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
242783302$24278330$2$F$$20240924$20240903$20240927$PER$$US-BIOGEN-2024BI01280606$BIOGEN$$$$$F$Y$$$20240927$$CN$US$US
242783312$24278331$2$F$20240826$20240912$20240903$20240916$EXP$$CL-BIOMARINAP-CL-2024-160219$BIOMARIN$$$$$$Y$$$20240916$$CN$CL$CL
242783321$24278332$1$I$20240815$20240828$20240903$20240903$EXP$$US-BIOMARINAP-US-2024-160217$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242783341$24278334$1$I$$20240826$20240830$20240830$DIR$FDA-CDER-CTU-2024-60071$$FDA-CTU$$$$$F$N$$$20240826$N$$US$
242783352$24278335$2$F$20240814$20240913$20240903$20240919$PER$$US-ROCHE-10000071718$ROCHE$$54$YR$A$M$Y$$$20240919$$CN$US$US
242783361$24278336$1$I$$20240826$20240903$20240903$PER$$US-ABBVIE-5896010$ABBVIE$$$$$F$Y$$$20240903$$MD$US$US
242783371$24278337$1$I$20240820$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60124$$FDA-CTU$$74$YR$$F$N$$$20240830$N$HP$US$
242783381$24278338$1$I$$20240825$20240903$20240903$EXP$$US-AMGEN-USASP2024172496$AMGEN$Singh J..A.; Anzalone. A.; Jackson L.E. et. al. Long-Term Mortality Following SARS-CoV-2 Infection in Rural Versus Urban Dwellers with Autoimmune or Inflammatory Rheumatic Disease (AIRD)- A Retrospective Cohort Analysis from the National COVID Cohort Collaborative (N3C). Arthritis Care + Research. 2024;1-38$$$$$Y$$$20240903$$MD$US$US
242783391$24278339$1$I$20240701$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60081$$FDA-CTU$$64$YR$$M$N$$$20240830$N$PH$US$
242783401$24278340$1$I$$20240826$20240903$20240903$EXP$$US-AMGEN-USASP2024172723$AMGEN$Oring J.; Attieh R.M.; Roach D. et.al.. Case Report: Early-Onset Adenovirus Nephritis Without Hemorrhagic Cystitis Following Kidney Transplantation. Transplantation Proceedings. 2024;56 (5):1196-1199$35$YR$A$M$Y$$$20240903$$HP$US$US
242783411$24278341$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000758$ELI LILLY AND CO$$66$YR$E$$Y$$$20240903$$CN$US$US
242783421$24278342$1$I$20240801$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000522$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240903$$CN$US$US
242783431$24278343$1$I$$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408019451$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240903$$HP$US$US
242783441$24278344$1$I$20240101$20240827$20240903$20240903$EXP$$FR-DSJP-DSE-2024-142818$DAIICHI$$$$E$F$Y$$$20240903$$MD$FR$FR
242783453$24278345$3$F$20240101$20240909$20240903$20240921$EXP$$CA-UCBSA-2024042511$UCB$$$$$F$Y$$$20240921$$CN$CA$CA
242783461$24278346$1$I$$20240827$20240903$20240903$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006574$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242783471$24278347$1$I$20240701$20240827$20240903$20240903$EXP$ES-AEMPS-1562253$ES-TEVA-VS-3237527$TEVA$$53$YR$$M$Y$60$KG$20240903$$MD$ES$ES
242783481$24278348$1$I$20240501$20240826$20240903$20240903$EXP$$US-BAYER-2024A123180$BAYER$$63$YR$A$M$Y$$$20240903$$CN$US$US
242783493$24278349$3$F$20240101$20240903$20240903$20240919$EXP$$CA-KARYOPHARM-2024KPT001162$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240919$$CN$CA$CA
242783502$24278350$2$F$$20240916$20240903$20240917$PER$$US-ALXN-202408USA002118US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240917$$MD$US$US
242783512$24278351$2$F$20240817$20240925$20240903$20240927$EXP$$US-BAYER-2024A124618$BAYER$$38$YR$A$M$Y$76$KG$20240927$$CN$US$US
242783521$24278352$1$I$20240802$20240827$20240903$20240903$EXP$FR-AFSSAPS-TS2024000920$FR-TEVA-VS-3237723$TEVA$$92$YR$$F$Y$57$KG$20240903$$MD$FR$FR
242783531$24278353$1$I$$20240826$20240903$20240903$EXP$$ZA-AstraZeneca-2024A194332$ASTRAZENECA$$38$YR$$F$Y$$$20240903$$CN$ZA$
242783541$24278354$1$I$20240820$20240829$20240903$20240903$EXP$$ZA-AstraZeneca-2024A197502$ASTRAZENECA$$87$YR$$F$Y$$$20240903$$CN$ZA$
242783551$24278355$1$I$$20240826$20240903$20240903$EXP$$JP-AstraZeneca-2024A196325$ASTRAZENECA$$46$YR$$F$Y$$$20240903$$MD$JP$
242783561$24278356$1$I$20240819$20240823$20240903$20240903$PER$$US-ABBVIE-5896005$ABBVIE$$18$YR$$F$Y$$$20240903$$CN$US$US
242783571$24278357$1$I$$20240823$20240903$20240903$EXP$$AR-DSJP-DSJ-2024-143063$DAIICHI$$$$$F$Y$$$20240903$$CN$AR$AR
242783581$24278358$1$I$$20240830$20240903$20240903$EXP$$AU-SANDOZ INC.-SDZ2024AU076671$SANDOZ$$$$A$F$Y$$$20240903$$MD$AU$AU
242783611$24278361$1$I$$20240827$20240903$20240903$PER$$US-PFIZER INC-202400244993$PFIZER$$33$YR$$F$Y$$$20240903$$HP$US$US
242783622$24278362$2$F$20240801$20240904$20240903$20240906$PER$$US-AMGEN-USASP2024174644$AMGEN$$30$YR$A$F$Y$$$20240906$$MD$US$US
242783631$24278363$1$I$20240822$20240826$20240903$20240903$EXP$$CN-BEIGENE-BGN-2024-013467$BEIGENE$$$$$$Y$$$20240903$$HP$CN$CN
242783641$24278364$1$I$20240101$20240902$20240903$20240903$EXP$$NVSC2024NP177062$NOVARTIS$$$$$F$Y$$$20240903$$MD$NP$NP
242783651$24278365$1$I$20240826$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174843$AMGEN$$79$YR$E$M$Y$$$20240903$$CN$US$US
242783661$24278366$1$I$$20240827$20240903$20240903$PER$$US-Taiho Oncology Inc-2024-008274$TAIHO ONCOLOGY INC$$$$E$M$Y$71.49$KG$20240903$$CN$US$US
242783671$24278367$1$I$20240823$20240830$20240903$20240903$EXP$$CN-BAYER-2024A125292$BAYER$$87$YR$E$M$Y$60$KG$20240903$$HP$CN$CN
242783681$24278368$1$I$20240826$20240830$20240903$20240903$EXP$$AU-MYLANLABS-2024M1079258$MYLAN$$37$YR$$M$Y$$$20240903$$PH$AU$AU
242783691$24278369$1$I$20240829$20240830$20240830$20240830$DIR$716682$$FDA-CTU$$67$YR$$F$N$$$20240830$Y$HP$US$
242783701$24278370$1$I$$20240830$20240830$20240830$DIR$716657$$FDA-CTU$$$$$UNK$N$$$20240830$$CN$US$
242783721$24278372$1$I$$20240821$20240830$20240830$DIR$FDA-CDER-CTU-2024-60036$$FDA-CTU$$$$$M$N$$$20240821$N$HP$US$
242783731$24278373$1$I$$20240903$20240903$20240903$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049248$BOEHRINGER INGELHEIM$$$$$$Y$$$20240903$$CN$US$US
242783741$24278374$1$I$20240726$20240730$20240903$20240903$EXP$$US-JUBILANT RADIOPHARMA-2024US000211$Jubilant Radiopharma$$$$$$Y$$$20240903$$HP$US$US
242783751$24278375$1$I$20240829$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173601$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242783771$24278377$1$I$20240805$20240830$20240830$20240830$DIR$716719$$FDA-CTU$$42$YR$$F$N$76.05$KG$20240830$N$HP$US$
242783781$24278378$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246490$PFIZER$$$$$F$Y$$$20240903$$MD$US$US
242783822$24278382$2$F$$20240830$20240903$20240904$PER$$US-PFIZER INC-PV202400114860$PFIZER$$80$YR$$F$Y$78.912$KG$20240904$$MD$US$US
242783841$24278384$1$I$$20240830$20240903$20240903$EXP$$US-JNJFOC-20240901879$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240903$$HP$US$US
242783851$24278385$1$I$20240101$20240827$20240903$20240903$EXP$$US-JNJFOC-20240873544$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240903$$HP$US$US
242783862$24278386$2$F$20240401$20240904$20240903$20240913$EXP$$PL-TEVA-VS-3238014$TEVA$$84$YR$$F$Y$$$20240913$$CN$PL$PL
242783871$24278387$1$I$$20240823$20240903$20240903$PER$$US-ABBVIE-5894913$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242783881$24278388$1$I$20240830$20240830$20240903$20240903$EXP$$NVSC2024CA176816$NOVARTIS$$$$$M$Y$$$20240903$$HP$CA$CA
242783891$24278389$1$I$20240101$20240820$20240903$20240903$EXP$$US-UCBSA-2024041408$UCB$$$$$F$Y$$$20240903$$HP$US$US
242783932$24278393$2$F$20210101$20240905$20240903$20240910$PER$$US-ABBVIE-5898730$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
242783941$24278394$1$I$20240803$20240819$20240903$20240903$EXP$$IT-BRAEBURN-IT-BRA-24-000796$BRAEBURN PHARMACEUTICALS$$27$YR$$F$Y$$$20240903$$MD$IT$IT
242783951$24278395$1$I$20240823$20240830$20240903$20240903$EXP$$CN-BAYER-2024A125462$BAYER$$66$YR$E$F$Y$70$KG$20240903$$HP$CN$CN
242783963$24278396$3$F$20240101$20240918$20240903$20240925$PER$$US-SA-2024SA254667$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240925$$MD$US$US
242783971$24278397$1$I$$20240829$20240903$20240903$PER$$US-JNJFOC-20240880982$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242783981$24278398$1$I$$20240826$20240903$20240903$EXP$$CA-JNJFOC-20240704050$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240903$$HP$CA$CA
242783991$24278399$1$I$20240805$20240826$20240903$20240903$PER$$US-JNJFOC-20240902111$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240903$$MD$US$US
242784001$24278400$1$I$$20240827$20240903$20240903$PER$$US-PFIZER INC-PV202400111914$PFIZER$$20$YR$$M$Y$$$20240903$$CN$US$US
242784011$24278401$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-202400245991$PFIZER$$39$YR$$F$Y$$$20240903$$HP$US$US
242784021$24278402$1$I$$20240826$20240903$20240903$EXP$$CA-APOTEX-2024AP009787$APOTEX$$74$YR$$F$Y$78$KG$20240903$$MD$CA$CA
242784031$24278403$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140134$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240903$$CN$US$US
242784041$24278404$1$I$20240101$20240814$20240903$20240903$PER$$US-009507513-2408USA004728$MERCK$$$$$F$Y$$$20240903$$CN$US$US
242784051$24278405$1$I$$20240827$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136787$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240903$$HP$US$US
242784061$24278406$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139674$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240903$$HP$US$US
242784071$24278407$1$I$20230601$20240819$20240903$20240903$EXP$$CH-SAMSUNG BIOEPIS-SB-2024-25764$SAMSUNG BIOEPIS$Capoferri G, Ghielmetti G, Glatz B. Disseminated, fatal reactivation of bovine tuberculosis in a patient treated with adalimumab: a case report and review of the literature. Infection. 2024 Aug 14;doi:10.1007/s15010-024-02364-0.$78$YR$E$F$Y$$$20240903$$HP$CH$CH
242784081$24278408$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413181$FRESENIUS KABI$$77$YR$E$F$Y$73$KG$20240903$$PH$CA$CA
242784091$24278409$1$I$$20240221$20240903$20240903$PER$$US-ASTELLAS-2024US005886$ASTELLAS$$$$$M$Y$$$20240830$$MD$US$US
242784101$24278410$1$I$20220101$20240403$20240903$20240903$PER$$US-ASTELLAS-2024US008413$ASTELLAS$$27$YR$A$F$Y$$$20240830$$CN$US$US
242784111$24278411$1$I$$20240214$20240903$20240903$PER$$US-ASTELLAS-2024US005019$ASTELLAS$$$$$M$Y$$$20240830$$CN$US$US
242784121$24278412$1$I$$20240311$20240903$20240903$PER$$US-ASTELLAS-2024US009226$ASTELLAS$$84$YR$E$M$Y$$$20240830$$HP$US$US
242784131$24278413$1$I$20210605$20240212$20240903$20240903$PER$$US-ASTELLAS-2024US005015$ASTELLAS$$80$YR$E$M$Y$$$20240830$$CN$US$US
242784141$24278414$1$I$20240802$20240807$20240903$20240903$PER$$US-ASTELLAS-2024US022662$ASTELLAS$$81$YR$E$M$Y$$$20240830$$CN$US$US
242784151$24278415$1$I$$20240327$20240903$20240903$PER$$US-ASTELLAS-2024US009821$ASTELLAS$$$$E$$Y$$$20240830$$PH$US$US
242784161$24278416$1$I$$20240828$20240903$20240903$EXP$$US-AMGEN-USASP2024173561$AMGEN$Cheung A. Y.; Mansur S.. Treatment of Corneal Neovascularization before Deep Anterior Lamellar Keratoplasty. Cornea. 2024;1-6$62$YR$A$M$Y$$$20240903$$MD$US$US
242784171$24278417$1$I$$20240828$20240903$20240903$EXP$$US-AMGEN-USASP2024173758$AMGEN$Cheung A. Y.; Mansur S.. Treatment of Corneal Neovascularization Before Deep Anterior Lamellar Keratoplasty. Cornea. 2024;1-6$63$YR$A$F$Y$$$20240903$$MD$US$US
242784191$24278419$1$I$20240725$20240830$20240903$20240903$EXP$$CN-JNJFOC-20240900754$JOHNSON AND JOHNSON$$88$YR$E$M$Y$45$KG$20240903$$HP$CN$CN
242784201$24278420$1$I$20231201$20240827$20240903$20240903$EXP$FR-AFSSAPS-AN2024000971$FR-TEVA-VS-3237946$TEVA$$69$YR$$M$Y$$$20240903$$PH$FR$FR
242784211$24278421$1$I$20240823$20240823$20240903$20240903$PER$$US-ABBVIE-5896022$ABBVIE$$37$YR$$F$Y$$$20240903$$CN$US$US
242784221$24278422$1$I$20240627$20240827$20240903$20240903$EXP$FR-AFSSAPS-AVLY2024000134$FR-TEVA-VS-3237678$TEVA$$36$YR$$F$Y$$$20240903$$MD$FR$FR
242784231$24278423$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194489$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$US$
242784241$24278424$1$I$20240316$20240829$20240903$20240903$EXP$$DE-AstraZeneca-2024A198404$ASTRAZENECA$$30$YR$$F$Y$$$20240903$$HP$DE$
242784251$24278425$1$I$$20240826$20240903$20240903$EXP$$ZA-AstraZeneca-2024A194307$ASTRAZENECA$$55$YR$$F$Y$$$20240903$$CN$ZA$
242784261$24278426$1$I$$20240826$20240903$20240903$EXP$$ZA-AstraZeneca-2024A194549$ASTRAZENECA$$60$YR$$M$Y$$$20240903$$CN$ZA$
242784271$24278427$1$I$20240624$20240826$20240903$20240903$EXP$$GB-AstraZeneca-2024A193962$ASTRAZENECA$$76$YR$$F$Y$$$20240903$$MD$GB$
242784281$24278428$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A195317$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242784291$24278429$1$I$20240812$20240820$20240903$20240903$PER$$US-LEX-000449$LEXICON PHARMACEUTICALS$$87$YR$$M$Y$64.6$KG$20240903$$CN$US$US
242784301$24278430$1$I$$20240720$20240903$20240903$PER$$US-LUNDBECK-DKLU4002069$LUNDBECK$$$$$$Y$$$20240903$$CN$US$US
242784311$24278431$1$I$20240705$20240827$20240903$20240903$EXP$FR-AFSSAPS-LM2024000469$FR-009507513-2408FRA009609$MERCK$$68$YR$$M$Y$59.7$KG$20240903$$MD$FR$FR
242784331$24278433$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000432$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240903$$CN$US$US
242784341$24278434$1$I$$20240823$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408015861$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240903$$CN$US$US
242784351$24278435$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000516$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240903$$CN$US$US
242784361$24278436$1$I$20240818$20240828$20240903$20240903$EXP$$CN-ROCHE-10000068689$ROCHE$$71$YR$E$M$Y$$$20240903$$HP$CN$CN
242784371$24278437$1$I$$20240826$20240903$20240903$EXP$$US-OTSUKA-2024_017592$OTSUKA$$$$$F$Y$$$20240903$$MD$US$US
242784381$24278438$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024175134$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242784391$24278439$1$I$20230601$20240827$20240903$20240903$EXP$$US-AMGEN-USASP2024171146$AMGEN$$72$YR$E$F$Y$$$20240903$$CN$US$US
242784401$24278440$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139365$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240903$$CN$US$US
242784411$24278441$1$I$20240201$20240827$20240903$20240903$EXP$$AU-009507513-2408AUS009483$MERCK$$63$YR$$F$Y$$$20240903$$HP$AU$AU
242784431$24278443$1$I$$20240826$20240903$20240903$PER$$US-JNJFOC-20240867530$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242784441$24278444$1$I$20240814$20240827$20240903$20240903$EXP$$US-GSK-US2024106729$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
242784452$24278445$2$F$$20240903$20240903$20240905$EXP$$NVSC2024GB176617$NOVARTIS$$75$YR$$M$Y$$$20240905$$CN$GB$GB
242784462$24278446$2$F$20240101$20240826$20240903$20240904$PER$$US-SA-2024SA252081$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240904$$CN$US$US
242784471$24278447$1$I$$20240822$20240903$20240903$PER$$US-SA-2024SA254917$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240903$$MD$US$US
242784491$24278449$1$I$20230824$20240828$20240903$20240903$EXP$$CO-TAKEDA-2023TUS086504$TAKEDA$$62$YR$$F$Y$80$KG$20240903$$CN$CO$CO
242784501$24278450$1$I$20240728$20240827$20240903$20240903$EXP$FR-AFSSAPS-LM2024000470$FR-009507513-2408FRA009533$MERCK$$68$YR$$M$Y$59.7$KG$20240903$$MD$FR$FR
242784511$24278451$1$I$20240408$20240827$20240903$20240903$EXP$PT-INFARMED-A202408-377$PT-FreseniusKabi-FK202413059$FRESENIUS KABI$$60$YR$A$F$Y$$$20240903$$HP$PT$PT
242784521$24278452$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413203$FRESENIUS KABI$$22$YR$A$M$Y$105$KG$20240903$$HP$CA$CA
242784531$24278453$1$I$$20240826$20240903$20240903$PER$$US-RDY-SPO/USA/24/0012575$DR REDDYS$$$$$F$Y$$$20240903$$CN$US$US
242784551$24278455$1$I$20240819$20240828$20240903$20240903$EXP$GB-MHRA-MED-202408281511121410-CVZMW$GB-RDY-SPO/GBR/24/0012621$DR REDDYS$$68$YR$E$F$Y$$$20240903$$PH$GB$GB
242784561$24278456$1$I$$20240828$20240903$20240903$EXP$$JP-009507513-2408JPN004041J$MERCK$$$$$F$Y$$$20240903$$MD$JP$JP
242784571$24278457$1$I$$20240830$20240903$20240903$PER$$US-JNJFOC-20240882271$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242784581$24278458$1$I$$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173676$AMGEN$$$$$F$Y$$$20240903$$HP$US$US
242784591$24278459$1$I$$20240707$20240830$20240830$DIR$FDA-CDER-CTU-2024-60066$$FDA-CTU$$$$$$N$$$20240707$N$CN$US$
242784601$24278460$1$I$20240809$20240826$20240903$20240903$PER$$US-AMGEN-USASP2024170060$AMGEN$$71$YR$E$F$Y$$$20240903$$CN$US$US
242784611$24278461$1$I$20240829$20240830$20240830$20240830$DIR$716637$$FDA-CTU$$$$$UNK$N$$$20240830$N$$US$
242784621$24278462$1$I$20200619$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60068$$FDA-CTU$$74$YR$$F$N$91.17$KG$20240903$N$CN$US$
242784631$24278463$1$I$20240826$20240830$20240830$20240830$DIR$716702$$FDA-CTU$$58$YR$$M$N$74.25$KG$20240830$N$CN$US$
242784641$24278464$1$I$20240801$20240821$20240830$20240830$DIR$FDA-CDER-CTU-2024-60070$$FDA-CTU$$88$YR$$F$N$75.3$KG$20240821$N$CN$US$
242784671$24278467$1$I$20240730$20240825$20240830$20240830$DIR$FDA-CDER-CTU-2024-60072$$FDA-CTU$$89$YR$$F$N$45.36$KG$20240825$N$CN$US$
242784681$24278468$1$I$20240113$20240830$20240830$20240830$DIR$716699$$FDA-CTU$$65$YR$$F$N$85.5$KG$20240830$N$CN$US$
242784691$24278469$1$I$20231010$20240826$20240830$20240830$DIR$FDA-CDER-CTU-2024-60075$$FDA-CTU$$71$YR$$M$N$107.95$KG$20240826$N$CN$US$
242784731$24278473$1$I$20240127$20240829$20240903$20240903$EXP$$ZA-TAKEDA-2024TUS008907$TAKEDA$$74$YR$$M$Y$$$20240903$$CN$ZA$ZA
242784741$24278474$1$I$20240809$20240826$20240903$20240903$EXP$$CN-009507513-2408CHN009676$MERCK$$73$YR$$F$Y$54$KG$20240903$$HP$CN$CN
242784751$24278475$1$I$$20240829$20240903$20240903$EXP$$US-AstraZeneca-2024A197411$ASTRAZENECA$$$$$M$Y$$$20240903$$MD$US$
242784771$24278477$1$I$20240201$20240826$20240903$20240903$EXP$$FR-AstraZeneca-2024A193732$ASTRAZENECA$$62$YR$$F$Y$61$KG$20240903$$MD$FR$
242784781$24278478$1$I$$20240827$20240903$20240903$EXP$$BE-GILEAD-2024-0685742$GILEAD$$68$YR$E$M$Y$$$20240903$$MD$BE$BE
242784791$24278479$1$I$$20240828$20240903$20240903$PER$$US-AstraZeneca-2024A200003$ASTRAZENECA$$$$$$Y$$$20240903$$CN$US$
242784802$24278480$2$F$$20240903$20240903$20240904$PER$$US-JNJFOC-20240900839$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242784821$24278482$1$I$20240819$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A195461$ASTRAZENECA$$31579$DY$$F$Y$$$20240903$$CN$US$
242784831$24278483$1$I$$20240829$20240903$20240903$EXP$$US-AstraZeneca-2024A198029$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242784841$24278484$1$I$$20240826$20240903$20240903$EXP$$ZA-AstraZeneca-2024A194561$ASTRAZENECA$$76$YR$$F$Y$$$20240903$$CN$ZA$
242784852$24278485$2$F$20080101$20240902$20240903$20240910$EXP$$GB-AstraZeneca-2024A198831$ASTRAZENECA$Coutinho A,Glancey G.. Orlistat, an under-recognised cause of progressive renal impairment.. Nephrol Dial Transplant 2013;28(4):172-174.$66$YR$$F$Y$$$20240910$$MD$GB$
242784861$24278486$1$I$$20240819$20240903$20240903$EXP$$CN-ABBVIE-5896955$ABBVIE$Suo S, Sun S, Nguyen LXT, Qian J, Li F, Zhao D, et al. Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed. Med. 2024;5:1-15.$27$YR$$M$Y$$$20240903$$HP$CN$CN
242784871$24278487$1$I$$20240828$20240903$20240903$EXP$$ZA-AstraZeneca-2024A196639$ASTRAZENECA$$24106$DY$$M$Y$$$20240903$$CN$ZA$
242784881$24278488$1$I$$20240823$20240903$20240903$PER$$US-INCYTE CORPORATION-2024IN008928$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242784891$24278489$1$I$20220701$20240827$20240903$20240903$EXP$$US-INCYTE CORPORATION-2024IN009018$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242784901$24278490$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413191$FRESENIUS KABI$$54$YR$A$$Y$$$20240903$$PH$CA$CA
242784911$24278491$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413140$FRESENIUS KABI$$$$$M$Y$$$20240903$$CN$CA$CA
242784921$24278492$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413179$FRESENIUS KABI$$27$MON$C$F$Y$12$KG$20240903$$HP$CA$CA
242784931$24278493$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413192$FRESENIUS KABI$$68$YR$E$M$Y$$$20240903$$HP$CA$CA
242784941$24278494$1$I$20240701$20240826$20240903$20240903$EXP$$US-OTSUKA-2024_023587$OTSUKA$$47$YR$$M$Y$97.52$KG$20240903$$CN$US$US
242784951$24278495$1$I$$20240821$20240903$20240903$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08036$HIKMA$$$$I$$Y$$$20240903$$CN$US$US
242784961$24278496$1$I$$20240827$20240903$20240903$EXP$$DE-MYLANLABS-2024M1080407$MYLAN$Bugia L, Jungbauer F, Zaubitzer L, Horner C, Merx K, Yasser AM, et al. Nivolumab as a Promising Treatment Option for Metastatic Salivary Duct Carcinoma. J-Immunother 2024; 47 (7): 258-262.$65$YR$$M$Y$$$20240903$$HP$DE$DE
242784981$24278498$1$I$$20240828$20240903$20240903$EXP$$GB-OTSUKA-2024_024314$OTSUKA$$69$YR$$$Y$$$20240903$$HP$GB$GB
242784991$24278499$1$I$$20240820$20240903$20240903$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08382$NEUROCRINE BIOSCIENCES$$66$YR$$F$Y$$$20240903$$CN$US$US
242785001$24278500$1$I$20240605$20240606$20240903$20240903$PER$$US-GE HEALTHCARE-2024CSU006369$GE HEALTHCARE$$69$YR$$F$Y$$$20240903$$HP$US$US
242785011$24278501$1$I$20240606$20240606$20240903$20240903$PER$$US-GE HEALTHCARE-2024CSU006407$GE HEALTHCARE$$$$$$Y$$$20240903$$HP$US$US
242785021$24278502$1$I$20240829$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000458$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240903$$CN$US$US
242785031$24278503$1$I$20240826$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018177$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240903$$CN$US$US
242785041$24278504$1$I$20240701$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408019406$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240903$$CN$US$US
242785051$24278505$1$I$20240701$20240828$20240903$20240903$EXP$$US-GSK-US2024107189$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$CN$US$US
242785061$24278506$1$I$$20240902$20240903$20240903$EXP$$DK-SANDOZ INC.-PHHY2018DK051146$SANDOZ$$53$YR$$F$Y$$$20240903$$MD$DK$DK
242785071$24278507$1$I$20240101$20240820$20240903$20240903$EXP$$FR-UCBSA-2024043259$UCB$$70$YR$$F$Y$$$20240903$$CN$FR$FR
242785081$24278508$1$I$$20240829$20240903$20240903$PER$$US-BIOGEN-2024BI01280623$BIOGEN$$$$$F$Y$$$20240903$$CN$US$US
242785092$24278509$2$F$20230526$20240829$20240903$20240909$EXP$$ZW-MYLANLABS-2024M1080027$MYLAN$$$$$F$Y$$$20240909$$HP$ZW$ZW
242785101$24278510$1$I$20240704$20240830$20240903$20240903$EXP$FR-AFSSAPS-TS2024000940$FR-MYLANLABS-2024M1080063$MYLAN$$68$YR$$M$Y$108$KG$20240903$$MD$FR$FR
242785111$24278511$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080442$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$7$DEC$$$Y$$$20240903$$HP$US$US
242785121$24278512$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080430$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$5$DEC$$$Y$$$20240903$$HP$US$US
242785131$24278513$1$I$20240616$20240829$20240903$20240903$EXP$FR-AFSSAPS-AM2024000693$FR-MYLANLABS-2024M1079643$MYLAN$$81$YR$$F$Y$63$KG$20240903$$MD$FR$FR
242785141$24278514$1$I$$20240826$20240903$20240903$EXP$$US-MYLANLABS-2024M1080431$MYLAN$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$6$DEC$$$Y$$$20240903$$HP$US$US
242785151$24278515$1$I$$20240830$20240903$20240903$EXP$$GB-MYLANLABS-2024M1080251$MYLAN$$16$YR$$M$Y$$$20240903$$CN$GB$GB
242785161$24278516$1$I$20240630$20240820$20240903$20240903$EXP$$JP-SMPA-2024SPA001940$SUNOVION$$$$$$Y$$$20240903$$PH$JP$JP
242785171$24278517$1$I$$20240820$20240903$20240903$EXP$$US-SMPA-2024SPA001726$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785181$24278518$1$I$20240501$20240610$20240903$20240903$EXP$$HU-SMPA-2024SPA002092$SUNOVION$$$$$$Y$$$20240903$$MD$DE$DE
242785201$24278520$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139694$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240903$$CN$US$US
242785211$24278521$1$I$$20240830$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140103$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240903$$CN$US$US
242785221$24278522$1$I$20240703$20240806$20240903$20240903$EXP$$US-SMPA-2024SPA001029$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785231$24278523$1$I$$20240814$20240903$20240903$EXP$$US-SMPA-2022MYSCI0300558$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785241$24278524$1$I$$20240820$20240903$20240903$EXP$$US-SMPA-2024SPA001727$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785251$24278525$1$I$$20240826$20240903$20240903$EXP$$CA-OTSUKA-2024_020971$OTSUKA$$$$$M$Y$$$20240903$$MD$CA$CA
242785263$24278526$3$F$$20240913$20240903$20240916$EXP$$US-ROCHE-10000071245$ROCHE$$60$YR$A$F$Y$67.59$KG$20240916$$HP$US$US
242785271$24278527$1$I$$20240830$20240903$20240903$EXP$$FR-DSJP-DSE-2024-143239$DAIICHI$$$$A$F$Y$$$20240903$$MD$FR$FR
242785282$24278528$2$F$$20240904$20240903$20240906$EXP$$IT-GILEAD-2024-0685874$GILEAD$$$$E$M$Y$$$20240906$$HP$IT$IT
242785291$24278529$1$I$$20240828$20240903$20240903$PER$$US-EMD Serono-2024046558$EMD SERONO INC$$$$A$M$Y$$$20240903$$HP$US$US
242785301$24278530$1$I$$20240826$20240903$20240903$EXP$$US-TEVA-VS-3237543$TEVA$$5$YR$$F$Y$$$20240903$$CN$US$US
242785311$24278531$1$I$$20240827$20240903$20240903$PER$$US-MYLANLABS-2024M1079836$MYLAN$$$$$F$Y$$$20240903$$PH$US$US
242785321$24278532$1$I$20230417$20240828$20240903$20240903$EXP$FR-AFSSAPS-LY2023000951$FR-009507513-2408FRA009913$MERCK$$60$YR$$F$Y$71$KG$20240903$$PH$FR$FR
242785341$24278534$1$I$$20240830$20240830$20240830$DIR$716640$$FDA-CTU$$$$$UNK$N$$$20240830$$CN$US$
242785351$24278535$1$I$$20240830$20240830$20240830$DIR$716638$$FDA-CTU$$$$$UNK$N$$$20240830$N$$US$
242785361$24278536$1$I$20240830$20240830$20240830$20240830$DIR$716645$$FDA-CTU$$71$YR$$M$N$94.95$KG$20240830$N$PH$US$
242785381$24278538$1$I$$20240827$20240903$20240903$EXP$$GR-TAKEDA-2024TUS087960$TAKEDA$$71$YR$$F$Y$$$20240903$$CN$GR$GR
242785391$24278539$1$I$$20240828$20240903$20240903$EXP$$AU-ORGANON-O2408AUS002147$ORGANON$$$$$F$Y$$$20240903$$CN$AU$AU
242785401$24278540$1$I$20230630$20240828$20240903$20240903$EXP$ES-AEMPS-1556957$ES-SA-2024SA252861$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240903$$PH$ES$ES
242785411$24278541$1$I$20240813$20240826$20240903$20240903$EXP$$BR-PURDUE-USA-2024-0311741$PURDUE$$89$YR$$F$Y$45$KG$20240903$$CN$BR$BR
242785421$24278542$1$I$20240820$20240831$20240903$20240903$EXP$GB-MHRA-MED-202408311847559270-FNRMB$GB-PFIZER INC-202400247619$PFIZER$$32$YR$$F$Y$52$KG$20240903$$CN$GB$GB
242785431$24278543$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024175217$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242785441$24278544$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413149$FRESENIUS KABI$$73$YR$E$M$Y$$$20240903$$MD$CA$CA
242785451$24278545$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413163$FRESENIUS KABI$$70$YR$E$F$Y$$$20240903$$HP$CA$CA
242785461$24278546$1$I$20210719$20240827$20240903$20240903$EXP$PL-URPL-DML-MLP.4401.1.5026.2021$PL-FreseniusKabi-FK202413083$FRESENIUS KABI$$60$YR$A$M$Y$38$KG$20240903$$HP$PL$PL
242785471$24278547$1$I$20240823$20240829$20240903$20240903$EXP$$NVSC2024CN176007$NOVARTIS$$68$YR$$M$Y$62$KG$20240903$$HP$CN$CN
242785481$24278548$1$I$20240816$20240828$20240903$20240903$EXP$SE-SEMPA-2024-006179$SE-TEVA-VS-3238064$TEVA$$22$YR$$M$Y$$$20240903$$MD$SE$SE
242785491$24278549$1$I$20240822$20240823$20240903$20240903$PER$$US-ABBVIE-5896000$ABBVIE$$26$YR$$F$Y$$$20240903$$CN$US$US
242785501$24278550$1$I$$20240826$20240903$20240903$EXP$$IE-ROCHE-10000034923$ROCHE$$$$$F$Y$$$20240903$$CN$IE$IE
242785511$24278551$1$I$$20240827$20240903$20240903$EXP$$CA-SANDOZ INC.-SDZ2024CA031868$SANDOZ$$34$YR$$F$Y$$$20240903$$CN$CA$CA
242785521$24278552$1$I$$20240903$20240903$20240903$EXP$PL-EMA-20120111-raevhumanwt-143036792$PL-SANDOZ INC.-SDZ2024PL077235$SANDOZ$$12$YR$$F$Y$$$20240903$$HP$PL$PL
242785532$24278553$2$F$$20240903$20240903$20240904$PER$$US-JNJFOC-20240901136$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242785541$24278554$1$I$20240101$20240827$20240903$20240903$EXP$$US-SA-2024SA255436$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240903$$MD$US$US
242785551$24278555$1$I$$20240829$20240903$20240903$EXP$$US-AstraZeneca-2024A198770$ASTRAZENECA$$$$$F$Y$$$20240903$$MD$US$
242785561$24278556$1$I$$20240828$20240903$20240903$PER$$US-AstraZeneca-2024A199188$ASTRAZENECA$$$$$$Y$$$20240903$$CN$US$
242785571$24278557$1$I$$20240829$20240903$20240903$EXP$$US-AstraZeneca-2024A198023$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$US$
242785582$24278558$2$F$20190927$20240911$20240903$20240916$EXP$$CA-SA-2019SA280285$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240916$$CN$CA$CA
242785601$24278560$1$I$20240705$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194690$ASTRAZENECA$$28348$DY$$F$Y$$$20240903$$CN$US$
242785611$24278561$1$I$20240730$20240826$20240903$20240903$EXP$$CN-AstraZeneca-2024A196508$ASTRAZENECA$$51$YR$$M$Y$$$20240903$$MD$CN$
242785621$24278562$1$I$$20240826$20240903$20240903$EXP$$CA-AstraZeneca-2024A199041$ASTRAZENECA$$79$YR$$M$Y$$$20240903$$MD$CA$
242785631$24278563$1$I$$20240829$20240903$20240903$EXP$$CA-PFIZER INC-202400247745$PFIZER$$60$YR$$M$Y$$$20240903$$HP$CA$CA
242785641$24278564$1$I$20221111$20240826$20240903$20240903$EXP$$RU-AstraZeneca-2024A199039$ASTRAZENECA$Subbotina M.V., Prikhodko T.D., Barakin A.O., Butyrin O.M., Puzrenkova Yu.D., Bakhaeva O.S.. ULTRASONOGRAPHY FOR PERITONSILLAR ABSCESS DIAGNOSIS: BENEFITS AND DRAWBACKS. Russian Bulletin of Otorhinolaryngology 2024;89(4):81?85.$14$YR$$M$Y$$$20240903$$HP$RU$
242785651$24278565$1$I$$20240802$20240903$20240903$EXP$$ZA-AstraZeneca-2024A199521$ASTRAZENECA$$$$$F$Y$$$20240903$$CN$ZA$
242785661$24278566$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194419$ASTRAZENECA$$$$C$$Y$$$20240903$$CN$US$
242785671$24278567$1$I$$20240826$20240903$20240903$EXP$$US-AstraZeneca-2024A194619$ASTRAZENECA$$78$YR$$F$Y$84.6$KG$20240903$$CN$US$
242785681$24278568$1$I$20240823$20240826$20240903$20240903$PER$$US-SA-2024SA254692$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240903$$CN$US$US
242785691$24278569$1$I$$20240829$20240903$20240903$EXP$$NVSC2024US175540$NOVARTIS$$$$$$Y$$$20240903$$CN$US$US
242785701$24278570$1$I$$20240830$20240903$20240903$PER$$NVSC2024US176717$NOVARTIS$$$$$F$Y$$$20240903$$MD$US$US
242785711$24278571$1$I$$20240828$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137701$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240903$$HP$US$US
242785721$24278572$1$I$20230101$20240827$20240903$20240903$EXP$$CA-ABBVIE-5899060$ABBVIE$$$$A$M$Y$$$20240903$$CN$CA$CA
242785731$24278573$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA001021$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785742$24278574$2$F$$20240912$20240903$20240930$PER$$US-SMPA-2024SPA001066$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242785751$24278575$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001071$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785761$24278576$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024175222$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242785771$24278577$1$I$20180101$20240811$20240903$20240903$PER$$US-AMGEN-USASP2024164896$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240903$$MD$US$US
242785781$24278578$1$I$$20240805$20240903$20240903$PER$$US-SMPA-2024SPA000916$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785792$24278579$2$F$$20240909$20240903$20240923$PER$$US-SMPA-2024SPA000928$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242785801$24278580$1$I$20230701$20240827$20240903$20240903$EXP$FR-AFSSAPS-PO2024000917$FR-TEVA-VS-3237721$TEVA$$44$YR$$F$Y$$$20240903$$MD$FR$FR
242785811$24278581$1$I$$20240805$20240903$20240903$PER$$US-SMPA-2024SPA000897$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785821$24278582$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000986$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785833$24278583$3$F$$20240909$20240903$20240923$EXP$$US-SMPA-2024SPA001070$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242785841$24278584$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024MYSCI0700646$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785862$24278586$2$F$$20240913$20240903$20240930$PER$$US-SMPA-2024SPA001019$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242785891$24278589$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000995$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785901$24278590$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001053$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785912$24278591$2$F$$20240903$20240903$20240924$PER$$US-SMPA-2024SPA001058$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242785922$24278592$2$F$$20240831$20240903$20240924$PER$$US-SMPA-2024SPA001046$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242785932$24278593$2$F$$20240912$20240903$20240917$PER$$US-SMPA-2024SPA000989$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
242785952$24278595$2$F$$20240906$20240903$20240927$PER$$US-SMPA-2024SPA000981$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242785961$24278596$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000978$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785971$24278597$1$I$$20240805$20240903$20240903$PER$$US-SMPA-2024SPA000942$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785981$24278598$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001054$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242785991$24278599$1$I$$20240611$20240903$20240903$PER$$US-SMPA-2024SPA002000$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786011$24278601$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000984$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786032$24278603$2$F$$20240904$20240903$20240927$PER$$US-SMPA-2024SPA000980$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242786041$24278604$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001072$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786051$24278605$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001074$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786063$24278606$3$F$$20240916$20240903$20240930$PER$$US-SMPA-2024SPA001067$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242786071$24278607$1$I$20240501$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000964$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786082$24278608$2$F$$20240914$20240903$20240930$PER$$US-SMPA-2024SPA001010$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242786092$24278609$2$F$$20240904$20240903$20240911$PER$$US-SMPA-2024SPA001036$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
242786111$24278611$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA001003$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786121$24278612$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001017$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786131$24278613$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001052$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786141$24278614$1$I$$20240805$20240903$20240903$PER$$US-SMPA-2024SPA000971$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786151$24278615$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001014$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786161$24278616$1$I$20240830$20240830$20240830$20240830$DIR$716646$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242786171$24278617$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000879$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786181$24278618$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA001020$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786192$24278619$2$F$20240806$20240828$20240903$20240927$PER$$US-SMPA-2024SPA000997$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242786201$24278620$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000994$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786212$24278621$2$F$20240801$20240909$20240903$20240927$PER$$US-SMPA-2024SPA001050$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242786221$24278622$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000808$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786231$24278623$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA001001$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786241$24278624$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001039$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786271$24278627$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001065$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786291$24278629$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA001022$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786301$24278630$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000913$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786311$24278631$1$I$$20240805$20240903$20240903$PER$$US-SMPA-2024SPA000926$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786331$24278633$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001068$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786341$24278634$1$I$20240101$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001059$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786351$24278635$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001045$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786361$24278636$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000924$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786371$24278637$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001037$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786381$24278638$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000911$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786402$24278640$2$F$20240730$20240906$20240903$20240925$PER$$US-SMPA-2024SPA001111$SUNOVION$$$$$$Y$$$20240925$$MD$US$US
242786411$24278641$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60329$$FDA-CTU$$$$$$N$$$20240830$$CN$US$
242786422$24278642$2$F$$20240917$20240903$20240927$PER$$US-SMPA-2024SPA001069$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242786431$24278643$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001044$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786441$24278644$1$I$20240701$20240806$20240903$20240903$PER$$US-SMPA-202407-URV-000972$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786451$24278645$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001043$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786461$24278646$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA001025$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786471$24278647$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60308$$FDA-CTU$$$$$$N$$$20240830$N$CN$US$
242786481$24278648$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA001005$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786491$24278649$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA001023$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786501$24278650$1$I$$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001062$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786512$24278651$2$F$$20240904$20240903$20240924$PER$$US-SMPA-2024SPA000961$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242786521$24278652$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000982$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786531$24278653$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA001181$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786552$24278655$2$F$$20240913$20240903$20240927$PER$$US-SMPA-2024SPA000862$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242786562$24278656$2$F$$20240816$20240903$20240912$PER$$US-SMPA-2024SPA001063$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
242786571$24278657$1$I$$20240805$20240903$20240903$PER$$US-SMPA-2024SPA000229$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786582$24278658$2$F$$20240828$20240903$20240927$PER$$US-SMPA-2024SPA001028$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242786602$24278660$2$F$$20240917$20240903$20240925$PER$$US-SMPA-2024SPA000915$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242786611$24278661$1$I$$20240806$20240903$20240903$PER$$US-SMPA-2024SPA000993$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786621$24278662$1$I$20240102$20240830$20240903$20240903$EXP$$NVSC2024CN177052$NOVARTIS$$89$YR$$M$Y$$$20240903$$HP$CN$CN
242786641$24278664$1$I$20240807$20240807$20240903$20240903$PER$$US-SMPA-2024SPA001040$SUNOVION$$$$$$Y$$$20240903$$CN$US$US
242786651$24278665$1$I$$20240828$20240903$20240903$EXP$$CN-FERRINGPH-2024FE04890$FERRING$$$$$$Y$$$20240903$$CN$CN$CN
242786661$24278666$1$I$$20240829$20240903$20240903$EXP$$CN-FERRINGPH-2024FE04905$FERRING$$$$$$Y$$$20240903$$CN$CN$CN
242786671$24278667$1$I$20231101$20240828$20240903$20240903$EXP$$JP-FERRINGPH-2024FE04945$FERRING$$$$$$Y$$$20240903$$PH$JP$JP
242786681$24278668$1$I$20240301$20240828$20240903$20240903$EXP$$US-FERRINGPH-2024FE04894$FERRING$$$$$$Y$$$20240903$$CN$US$US
242786691$24278669$1$I$$20240828$20240903$20240903$EXP$$CN-FERRINGPH-2024FE04891$FERRING$$$$$$Y$$$20240903$$CN$CN$CN
242786701$24278670$1$I$20240101$20240822$20240903$20240903$PER$$US-SA-2024SA252429$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240903$$MD$US$US
242786711$24278671$1$I$20240701$20240827$20240903$20240903$EXP$$US-SA-2024SA255274$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240903$$MD$US$US
242786721$24278672$1$I$$20240830$20240903$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US016917$SANDOZ$$$$$M$Y$$$20240903$$CN$US$US
242786732$24278673$2$F$$20240906$20240903$20240916$EXP$$US-TEVA-VS-3238448$TEVA$Aiello M, Roy S, Chitty L, Johnson B, Warrick M. Prolonged administration of intrathecal baclofen in a patient with generalized grade 4 tetanus. Region-Anesth-Pain-Med 2024; 49 (7): 540-542.; Aiello M, Roy S, Chitty L, Johnson B, Warrick M. Prolonged administration of intrathecal baclofen in a patient with generalized grade 4 tetanus. Region-Anesth-Pain-Med 2024; 49 (7): 540-542.; Aiello M, Roy S, Chitty L, Johnson B, Warrick M. Prolonged administration of intrathecal baclofen in a patient wi...$62$YR$$F$Y$$$20240916$$HP$US$US
242786741$24278674$1$I$$20240830$20240830$20240830$DIR$716627$$FDA-CTU$$$$$F$N$$$20240830$N$HP$US$
242786751$24278675$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60397$$FDA-CTU$$$$$$N$$$20240830$$CN$US$
242786781$24278678$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413162$FRESENIUS KABI$$51$YR$A$F$Y$91$KG$20240903$$HP$CA$CA
242786801$24278680$1$I$20210712$20240827$20240903$20240903$EXP$PL-URPL-DML-MLP.4401.1.5025.2021$PL-FreseniusKabi-FK202413088$FRESENIUS KABI$$60$YR$A$M$Y$40$KG$20240903$$HP$PL$PL
242786811$24278681$1$I$20240901$20240903$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140210$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240903$$CN$US$US
242786821$24278682$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413128$FRESENIUS KABI$$$$$F$Y$$$20240903$$CN$CA$CA
242786831$24278683$1$I$$20240901$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US077293$SANDOZ$$$$$$Y$$$20240903$$CN$US$US
242786848$24278684$8$F$20240825$20240904$20240903$20240918$EXP$$CA-HLS-202402162$HLS THERAPEUTICS$$36$YR$A$M$Y$$$20240917$$PH$CA$CA
242786851$24278685$1$I$$20240829$20240903$20240903$EXP$$CA-SANDOZ INC.-SDZ2024CA076483$SANDOZ$$19$YR$$F$Y$131$KG$20240903$$HP$CA$CA
242786861$24278686$1$I$$20240830$20240903$20240903$PER$$US-ROCHE-10000071389$ROCHE$$82$YR$E$F$Y$$$20240903$$MD$US$US
242786871$24278687$1$I$$20240903$20240903$20240903$EXP$$GR-SANDOZ INC.-SDZ2024GR077274$SANDOZ$$57$YR$$M$Y$$$20240903$$CN$GR$GR
242786881$24278688$1$I$$20240903$20240903$20240903$PER$$NVSC2024US177146$NOVARTIS$$$$$$Y$$$20240903$$HP$US$US
242786891$24278689$1$I$20240706$20240830$20240903$20240903$EXP$$NVSC2024CN177004$NOVARTIS$$47$YR$$F$Y$60$KG$20240903$$HP$CN$CN
242786901$24278690$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139946$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240903$$CN$US$US
242786911$24278691$1$I$20240801$20240830$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139074$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240903$$HP$US$US
242786921$24278692$1$I$$20240829$20240903$20240903$EXP$$CA-BAUSCH-BL-2024-013156$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240903$$CN$CA$CA
242786941$24278694$1$I$20240701$20240903$20240903$20240903$EXP$DK-DKMA-30737890$DK-SANDOZ INC.-SDZ2024DK077314$SANDOZ$$8$DEC$$F$Y$$$20240903$$MD$DK$DK
242786951$24278695$1$I$20240702$20240827$20240903$20240903$EXP$$JP-009507513-2408JPN003558J$MERCK$$$$$F$Y$$$20240903$$PH$JP$JP
242786962$24278696$2$F$20240807$20240909$20240903$20240912$PER$$US-AMGEN-USASP2024169254$AMGEN$$66$YR$E$F$Y$$$20240912$$HP$US$US
242786971$24278697$1$I$$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60335$$FDA-CTU$$$$$$N$$$20240830$$CN$US$
242786981$24278698$1$I$20240830$20240830$20240830$20240830$DIR$716629$$FDA-CTU$$43$YR$$M$N$$$20240830$N$CN$US$
242786991$24278699$1$I$$20240826$20240903$20240903$EXP$$CA-SANDOZ INC.-NVSC2021CA183434$SANDOZ$$83$YR$$F$Y$$$20240903$$HP$CA$CA
242787001$24278700$1$I$20240726$20240827$20240903$20240903$EXP$FR-AFSSAPS-CN2024000805$FR-TEVA-VS-3237669$TEVA$$81$YR$$M$Y$141$KG$20240903$$PH$FR$FR
242787011$24278701$1$I$$20240830$20240903$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US050032$SANDOZ$$$$$F$Y$$$20240903$$CN$US$US
242787021$24278702$1$I$$20240829$20240903$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US050111$SANDOZ$$$$$$Y$$$20240903$$CN$US$US
242787031$24278703$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413171$FRESENIUS KABI$$74$YR$E$F$Y$$$20240903$$PH$CA$CA
242787041$24278704$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413175$FRESENIUS KABI$$58$YR$A$F$Y$78$KG$20240903$$PH$CA$CA
242787051$24278705$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413204$FRESENIUS KABI$$52$YR$A$M$Y$$$20240903$$PH$CA$CA
242787061$24278706$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174949$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242787071$24278707$1$I$20240823$20240827$20240903$20240903$PER$$US-RDY-SPO/USA/24/0012580$DR REDDYS$$15$YR$T$F$Y$$$20240903$$HP$US$US
242787081$24278708$1$I$20240301$20240830$20240903$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US077073$SANDOZ$$$$$F$Y$$$20240903$$CN$US$US
242787091$24278709$1$I$$20240902$20240903$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US050923$SANDOZ$$$$$M$Y$$$20240903$$CN$US$US
242787101$24278710$1$I$20240718$20240903$20240903$20240903$EXP$FR-AFSSAPS-GR2024001016$FR-SANDOZ INC.-SDZ2024FR077254$SANDOZ$$19$YR$$$Y$$$20240903$$PH$FR$FR
242787111$24278711$1$I$20240830$20240830$20240830$20240830$DIR$716642$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242787121$24278712$1$I$20180101$20240811$20240903$20240903$PER$$US-AMGEN-USASP2024164897$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240903$$MD$US$US
242787131$24278713$1$I$20240512$20240830$20240903$20240903$30DAY$$US-SANDOZ INC.-SDZ2024US048030$SANDOZ$$13$YR$$M$Y$$$20240903$$HP$US$US
242787141$24278714$1$I$20240731$20240903$20240903$20240903$EXP$ES-AEMPS-1556577$ES-SANDOZ INC.-SDZ2024ES077285$SANDOZ$$42$YR$$F$Y$$$20240903$$PH$ES$ES
242787151$24278715$1$I$$20240902$20240903$20240903$EXP$PL-EMA-20150323-AUTODUP-431175$PL-SANDOZ INC.-SDZ2024PL076970$SANDOZ$$65$YR$$F$Y$$$20240903$$HP$PL$PL
242787181$24278718$1$I$$20240831$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139635$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240903$$HP$US$US
242787191$24278719$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139290$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240903$$HP$US$US
242787201$24278720$1$I$20240822$20240823$20240903$20240903$PER$$US-ABBVIE-5896141$ABBVIE$$17$YR$$F$Y$$$20240903$$CN$US$US
242787212$24278721$2$F$$20240912$20240903$20240920$EXP$$NVSC2024HU173553$NOVARTIS$Patocs B. A cerebralis folathianyrol egy neurodegenerativ betegseget okozo folatreceptor genhiba kapcsan / On cerebral folate deficiency in the context of a folate receptor gene defect causing a neurodegenerative disease. GYERMEKGYOGYASZAT. 2024;267-70$1$YR$$$Y$$$20240920$$HP$HU$HU
242787221$24278722$1$I$$20240820$20240903$20240903$PER$$US-MYLANLABS-2024M1077664$MYLAN$$$$$$Y$$$20240903$$CN$US$US
242787231$24278723$1$I$20240327$20240829$20240903$20240903$EXP$$FR-SANDOZ INC.-SDZ2024FR042719$SANDOZ$$65$YR$$F$Y$$$20240903$$HP$FR$FR
242787241$24278724$1$I$20240808$20240829$20240903$20240903$PER$$US-JNJFOC-20240881451$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240903$$CN$US$US
242787251$24278725$1$I$$20240830$20240903$20240903$PER$$US-JNJFOC-20240902339$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$CN$US$US
242787261$24278726$1$I$20240830$20240830$20240830$20240830$DIR$716661$$FDA-CTU$$$$$F$N$$$20240830$N$$US$
242787271$24278727$1$I$20240829$20240830$20240830$20240830$DIR$FDA-CDER-CTU-2024-60139$$FDA-CTU$$62$YR$$F$N$$$20240830$N$$US$
242787281$24278728$1$I$$20240828$20240903$20240903$EXP$$US-GSK-US2024107242$GLAXOSMITHKLINE$$$$$M$Y$$$20240903$$CN$US$US
242787291$24278729$1$I$$20240830$20240830$20240830$DIR$716697$$FDA-CTU$$60$YR$$F$N$77.85$KG$20240830$N$CN$US$
242787301$24278730$1$I$$20240815$20240903$20240903$PER$$US-TEVA-VS-3234607$TEVA$$60$YR$$M$Y$$$20240903$$CN$US$US
242787312$24278731$2$F$20230101$20240904$20240903$20240912$EXP$$EG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048954$BOEHRINGER INGELHEIM$$53$YR$A$M$Y$99$KG$20240912$$CN$EG$EG
242787331$24278733$1$I$20240830$20240830$20240903$20240903$EXP$$AU-BEH-2024178145$CSL BEHRING$$65$YR$E$M$Y$$$20240903$$HP$AU$AU
242787341$24278734$1$I$20240610$20240827$20240903$20240903$EXP$FR-AFSSAPS-LL2024001598$FR-009507513-2408FRA009546$MERCK$$55$YR$$F$Y$66$KG$20240903$$MD$FR$FR
242787351$24278735$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413205$FRESENIUS KABI$$9$YR$C$F$Y$$$20240903$$HP$CA$CA
242787361$24278736$1$I$20240723$20240902$20240903$20240903$EXP$DK-DKMA-30737704$DK-FreseniusKabi-FK202413301$FRESENIUS KABI$$71$YR$E$M$Y$75$KG$20240903$$MD$DK$DK
242787371$24278737$1$I$20240805$20240902$20240903$20240903$EXP$PT-INFARMED-J202408-686$PT-FreseniusKabi-FK202413319$FRESENIUS KABI$$77$YR$E$M$Y$$$20240903$$PH$PT$PT
242787381$24278738$1$I$20240710$20240902$20240903$20240903$EXP$SE-SEMPA-2024-006201$SE-FreseniusKabi-FK202413278$FRESENIUS KABI$$55$YR$A$F$Y$$$20240903$$MD$SE$SE
242787391$24278739$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA254149$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240903$$MD$US$US
242787402$24278740$2$F$20240812$20240910$20240903$20240913$EXP$$TR-AMERICAN REGENT INC-2024003341$AMERICAN REGENT$$31$YR$$F$Y$63$KG$20240913$$HP$TR$TR
242787411$24278741$1$I$20240201$20240826$20240903$20240903$EXP$FR-AFSSAPS-BX2024001668$FR-BAYER-2024A122330$BAYER$$66$YR$E$M$Y$68$KG$20240903$$MD$FR$FR
242787421$24278742$1$I$$20240903$20240903$20240903$PER$$NVSC2024US177149$NOVARTIS$$$$$$Y$$$20240903$$HP$US$US
242787431$24278743$1$I$$20240830$20240903$20240903$PER$$US-ALXN-202408USA002215US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242787441$24278744$1$I$20240731$20240831$20240831$20240831$DIR$716731$$FDA-CTU$$34$YR$$F$N$61$KG$20240831$N$CN$US$
242787461$24278746$1$I$20240801$20240830$20240830$20240830$DIR$716641$$FDA-CTU$$50$YR$$F$N$63.9$KG$20240830$$CN$US$
242787471$24278747$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140133$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$82.1$KG$20240903$$CN$US$US
242787481$24278748$1$I$$20240903$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140161$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240903$$HP$US$US
242787491$24278749$1$I$20240825$20240827$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136975$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240903$$CN$US$US
242787503$24278750$3$F$$20240906$20240903$20240916$EXP$$US-TEVA-VS-3238220$TEVA$Credo R, Kesey J, Bharadia D, Griswold J, Pang A. Acute Intermittent Porphyria in a Burn Patient: Case Study and Review of the Literature. [Review]. J-Burn-Care-Res 2024; 45 (3): 790-795.; Credo R, Kesey J, Bharadia D, Griswold J, Pang A. Acute Intermittent Porphyria in a Burn Patient: Case Study and Review of the Literature. [Review]. J-Burn-Care-Res 2024; 45 (3): 790-795.$60$YR$$M$Y$$$20240916$$HP$US$US
242787511$24278751$1$I$20240601$20240831$20240903$20240903$EXP$$CN-BAYER-2024A125622$BAYER$$60$YR$A$F$Y$45$KG$20240903$$HP$CN$CN
242787523$24278752$3$F$20240713$20240919$20240903$20240923$EXP$$BE-PFIZER INC-PV202400113773$PFIZER$$72$YR$$M$Y$87$KG$20240923$$HP$BE$MA
242787541$24278754$1$I$$20240830$20240903$20240903$EXP$$US-PFIZER INC-202400106978$PFIZER$$36$YR$$F$Y$$$20240903$$HP$US$US
242787561$24278756$1$I$20240516$20240827$20240903$20240903$EXP$$DE-PFIZER INC-202400248129$PFIZER$$82$YR$$M$Y$$$20240903$$HP$DE$DE
242787582$24278758$2$F$20230510$20240902$20240903$20240905$EXP$$CN-PFIZER INC-2023SGN05115$PFIZER$$70$YR$$F$Y$65$KG$20240905$$MD$CN$CN
242787592$24278759$2$F$$20240923$20240903$20240926$EXP$$US-PFIZER INC-202400247570$PFIZER$$80$YR$$M$Y$$$20240926$$HP$US$US
242787601$24278760$1$I$20240201$20240829$20240903$20240903$EXP$$BR-TAKEDA-2024TUS088032$TAKEDA$$60$YR$$M$Y$$$20240903$$CN$BR$BR
242787611$24278761$1$I$20240726$20240829$20240903$20240903$EXP$FR-AFSSAPS-TO2024001632$FR-MYLANLABS-2024M1079745$MYLAN$$86$YR$$M$Y$$$20240903$$MD$FR$FR
242787621$24278762$1$I$$20240820$20240903$20240903$PER$$US-MYLANLABS-2024M1077346$MYLAN$$$$$M$Y$92.99$KG$20240903$$CN$US$US
242787631$24278763$1$I$$20240822$20240903$20240903$PER$$US-MYLANLABS-2024M1078421$MYLAN$$$$$F$Y$$$20240903$$CN$US$US
242787651$24278765$1$I$$20240829$20240903$20240903$EXP$$FR-MYLANLABS-2024M1054103$MYLAN$Messekher M, Francois H, Denis MG, Ferrer-Lopez P, Bost-Bezeaud F, Mazieres J, et al. Resistance to anti-EGFR through the successive and cumulative acquisition of two new oncogenic addictions: BRAF and ALK. Rev-Mal-Respir. 2024;41(6):451-454$52$YR$$F$Y$$$20240903$$HP$FR$FR
242787661$24278766$1$I$$20240719$20240903$20240903$PER$$US-LUNDBECK-DKLU4002036$LUNDBECK$$$$$$Y$$$20240903$$MD$US$US
242787671$24278767$1$I$$20240606$20240903$20240903$PER$$US-GE HEALTHCARE-2024CSU006415$GE HEALTHCARE$$$$$$Y$$$20240903$$HP$US$US
242787681$24278768$1$I$20240825$20240831$20240831$20240831$DIR$716778$$FDA-CTU$$93$YR$$M$N$79.2$KG$20240831$Y$CN$US$
242787691$24278769$1$I$20240823$20240830$20240830$20240830$DIR$716665$$FDA-CTU$$29$YR$$F$N$$$20240830$Y$HP$US$
242787712$24278771$2$F$$20240917$20240903$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137837$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240918$$CN$US$US
242787721$24278772$1$I$20240101$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139189$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240903$$HP$US$US
242787731$24278773$1$I$$20240826$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136917$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240903$$HP$US$US
242787741$24278774$1$I$20240614$20240822$20240903$20240903$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000013$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240903$$MD$US$US
242787751$24278775$1$I$$20240827$20240903$20240903$PER$$US-ABBVIE-5897889$ABBVIE$$62$YR$$F$Y$$$20240903$$MD$US$US
242787761$24278776$1$I$$20240830$20240903$20240903$PER$$US-BAYER-2024A125237$BAYER$$78$YR$E$F$Y$$$20240903$$CN$US$US
242787771$24278777$1$I$$20240826$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136040$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240903$$CN$US$US
242787811$24278781$1$I$20240830$20240830$20240830$20240830$DIR$716648$$FDA-CTU$$33$YR$$F$N$51.3$KG$20240830$N$PH$US$
242787831$24278783$1$I$20240909$20240830$20240830$20240830$DIR$716651$$FDA-CTU$$$$$UNK$N$$$20240830$N$CN$US$
242787841$24278784$1$I$20240830$20240831$20240831$20240831$DIR$716725$$FDA-CTU$$24$YR$$F$N$66.51$KG$20240831$N$CN$US$
242787851$24278785$1$I$20240830$20240831$20240831$20240831$DIR$716730$$FDA-CTU$$69$YR$$F$N$72$KG$20240831$N$CN$US$
242787891$24278789$1$I$20240705$20240830$20240830$20240830$DIR$716668$$FDA-CTU$$64$YR$$F$N$86.4$KG$20240830$N$CN$US$
242787901$24278790$1$I$20240608$20240831$20240831$20240831$DIR$716741$$FDA-CTU$$25$YR$$M$N$69.75$KG$20240831$N$CN$US$
242787911$24278791$1$I$20240830$20240831$20240831$20240831$DIR$716729$$FDA-CTU$$68$YR$$M$N$72$KG$20240831$N$CN$US$
242787921$24278792$1$I$20240827$20240831$20240831$20240831$DIR$716746$$FDA-CTU$$41$YR$$F$N$82.35$KG$20240831$N$CN$US$
242787931$24278793$1$I$20240825$20240831$20240831$20240831$DIR$716748$$FDA-CTU$$29$YR$$F$N$58.95$KG$20240831$N$CN$US$
242787951$24278795$1$I$$20240828$20240903$20240903$EXP$$US-INCYTE CORPORATION-2024IN008852$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242787971$24278797$1$I$$20240825$20240903$20240903$EXP$GB-MHRA-MED-202408251817464700-GCPQS$GB-TEVA-VS-3237287$TEVA$$28$YR$$F$Y$$$20240903$$HP$GB$GB
242787981$24278798$1$I$20211121$20240828$20240903$20240903$EXP$$US-INCYTE CORPORATION-2024IN009110$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242787991$24278799$1$I$$20240718$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001335$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242788001$24278800$1$I$20240501$20240529$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001136$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242788011$24278801$1$I$20240820$20240826$20240903$20240903$EXP$$CN-AstraZeneca-2024A198252$ASTRAZENECA$$25429$DY$$M$Y$70$KG$20240903$$MD$CN$
242788021$24278802$1$I$20200225$20240820$20240903$20240903$EXP$$US-SA-2024SA254148$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240903$$HP$US$US
242788032$24278803$2$F$20240101$20240916$20240903$20240919$PER$$US-JNJFOC-20240904124$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240919$$CN$US$US
242788051$24278805$1$I$20240903$20240903$20240903$20240903$EXP$$HK-GILEAD-2024-0686028$GILEAD$$$$$F$Y$$$20240903$$MD$HK$HK
242788061$24278806$1$I$$20240828$20240903$20240903$EXP$$US-CIVICARX-2024-US-046574$CIVICA$Osama M, Pendela VS, Mohamed M, Parikh V..Trigger-Point Bupivacaine Injection Causing a ^Heart-Break^.Journal of Cardiac Failure.2024;30(1):276-277.$59$YR$$F$Y$$$20240903$$HP$US$US
242788071$24278807$1$I$20240101$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139672$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240903$$HP$US$US
242788081$24278808$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140031$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240903$$CN$US$US
242788091$24278809$1$I$20240809$20240902$20240903$20240903$EXP$$TW-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049026$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$65.5$KG$20240903$$MD$TW$TW
242788101$24278810$1$I$20240712$20240827$20240903$20240903$EXP$$CZ-ABBVIE-5899066$ABBVIE$$11$YR$$F$Y$$$20240903$$MD$CZ$CZ
242788111$24278811$1$I$$20240830$20240903$20240903$PER$$NVSC2024US177170$NOVARTIS$$$$$F$Y$$$20240903$$HP$US$US
242788121$24278812$1$I$$20240828$20240903$20240903$EXP$$GB-TAKEDA-2024TUS052438$TAKEDA$$$$$F$Y$$$20240903$$CN$GB$GB
242788131$24278813$1$I$$20240828$20240903$20240903$PER$$US-SA-2024SA254560$SANOFI AVENTIS$$$$$M$Y$$$20240903$$HP$US$US
242788141$24278814$1$I$20170101$20240828$20240903$20240903$EXP$$US-INCYTE CORPORATION-2024IN009101$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242788151$24278815$1$I$20240829$20240830$20240903$20240903$PER$$US-ALXN-202408USA002218US$ALEXION PHARMACEUTICALS$$63$YR$$F$Y$$$20240903$$CN$US$US
242788161$24278816$1$I$$20240829$20240903$20240903$EXP$$CA-TAKEDA-2024TUS087763$TAKEDA$$$$$F$Y$$$20240903$$CN$CA$CA
242788171$24278817$1$I$20230513$20240829$20240903$20240903$EXP$$CA-TAKEDA-2023TUS058712$TAKEDA$$73$YR$$F$Y$$$20240903$$CN$CA$CA
242788181$24278818$1$I$$20240828$20240903$20240903$EXP$GB-MHRA-MED-202408280821493390-PRHWS$GB-ELI_LILLY_AND_COMPANY-GB202408018531$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240903$$CN$GB$GB
242788191$24278819$1$I$20240401$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000449$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240903$$PH$US$US
242788201$24278820$1$I$20240821$20240822$20240903$20240903$EXP$GB-MHRA-MED-202408221131054940-JSNWV$GB-ELI_LILLY_AND_COMPANY-GB202408014985$ELI LILLY AND CO$$42$YR$A$F$Y$83$KG$20240903$$CN$GB$GB
242788211$24278821$1$I$20240701$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018386$ELI LILLY AND CO$$74$YR$E$$Y$$$20240903$$CN$US$US
242788221$24278822$1$I$$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018594$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240903$$CN$US$US
242788231$24278823$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174948$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242788251$24278825$1$I$20240801$20240822$20240903$20240903$EXP$GB-MHRA-MED-202408221414445840-PKDTG$GB-ELI_LILLY_AND_COMPANY-GB202408014849$ELI LILLY AND CO$$52$YR$A$F$Y$89$KG$20240903$$CN$GB$GB
242788261$24278826$1$I$20240820$20240822$20240903$20240903$EXP$GB-MHRA-MED-202408220927261450-QSPZT$GB-ELI_LILLY_AND_COMPANY-GB202408014957$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240903$$CN$GB$GB
242788291$24278829$1$I$20240101$20240506$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001033$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242788311$24278831$1$I$20240823$20240823$20240903$20240903$PER$$US-ABBVIE-5896171$ABBVIE$$59$YR$$M$Y$$$20240903$$CN$US$US
242788331$24278833$1$I$20240717$20240902$20240903$20240903$EXP$FR-AFSSAPS-CN2024000819$FR-BAYER-2024A125655$BAYER$$71$YR$E$M$Y$$$20240903$$PH$FR$FR
242788341$24278834$1$I$$20240829$20240903$20240903$EXP$$CA-TAKEDA-2024TUS087917$TAKEDA$$$$$M$Y$$$20240903$$HP$CA$CA
242788351$24278835$1$I$$20240827$20240903$20240903$PER$$US-MYLANLABS-2024M1079767$MYLAN$$$$$F$Y$70.31$KG$20240903$$CN$US$US
242788361$24278836$1$I$20240702$20240828$20240903$20240903$EXP$$US-OTSUKA-2024_018926$OTSUKA$$$$$F$Y$$$20240903$$CN$US$US
242788371$24278837$1$I$20230615$20240831$20240831$20240831$DIR$716737$$FDA-CTU$$77$YR$$M$N$87.75$KG$20240831$N$CN$US$
242788391$24278839$1$I$20240807$20240831$20240831$20240831$DIR$716738$$FDA-CTU$$26$YR$$M$N$81$KG$20240831$Y$CN$US$
242788401$24278840$1$I$20240108$20240831$20240831$20240831$DIR$716743$$FDA-CTU$$55$YR$$F$N$66.15$KG$20240831$N$CN$US$
242788411$24278841$1$I$20240101$20240828$20240903$20240903$EXP$$US-SA-2024SA255288$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240903$$MD$US$US
242788421$24278842$1$I$$20240819$20240903$20240903$PER$$US-MYLANLABS-2024M1077307$MYLAN$$$$$F$Y$$$20240903$$CN$US$US
242788431$24278843$1$I$$20240823$20240903$20240903$PER$$US-ABBVIE-5895606$ABBVIE$$$$$F$Y$$$20240903$$MD$US$US
242788441$24278844$1$I$$20240821$20240903$20240903$PER$$US-BIOMARINAP-US-2024-160021$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242788451$24278845$1$I$20240726$20240821$20240903$20240903$PER$$US-BIOMARINAP-US-2024-160051$BIOMARIN$$$$$$Y$$$20240903$$HP$US$US
242788461$24278846$1$I$$20240803$20240903$20240903$PER$$US-BIOMARINAP-US-2024-160206$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242788471$24278847$1$I$20240101$20240815$20240903$20240903$PER$$US-BIOMARINAP-US-2024-160191$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242788481$24278848$1$I$20231114$20240816$20240903$20240903$PER$$US-BIOMARINAP-US-2024-160192$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242788491$24278849$1$I$20240101$20240822$20240903$20240903$PER$$US-BIOMARINAP-US-2024-160056$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242788501$24278850$1$I$20240814$20240819$20240903$20240903$PER$$US-BIOMARINAP-US-2024-160204$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242788511$24278851$1$I$$20240821$20240903$20240903$PER$$US-BIOMARINAP-US-2024-160037$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242788521$24278852$1$I$$20240813$20240903$20240903$PER$$US-BIOMARINAP-US-2024-160167$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242788531$24278853$1$I$$20240813$20240903$20240903$PER$$US-BIOMARINAP-US-2024-160165$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242788551$24278855$1$I$$20240820$20240903$20240903$PER$$US-BIOMARINAP-US-2024-160028$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242788561$24278856$1$I$$20240813$20240903$20240903$PER$$US-BIOMARINAP-US-2024-160166$BIOMARIN$$$$$$Y$$$20240903$$CN$US$US
242788571$24278857$1$I$20240826$20240831$20240831$20240831$DIR$716756$$FDA-CTU$$74$YR$$F$N$73.35$KG$20240831$N$CN$US$
242788581$24278858$1$I$20240715$20240725$20240903$20240903$PER$$US-LUNDBECK-DKLU4002212$LUNDBECK$$$$$$Y$$$20240903$$HP$US$US
242788591$24278859$1$I$$20240828$20240903$20240903$EXP$$US-OTSUKA-2024_023862$OTSUKA$$$$$F$Y$$$20240903$$CN$US$US
242788601$24278860$1$I$20240823$20240831$20240831$20240831$DIR$716776$$FDA-CTU$$41$YR$$F$N$76.95$KG$20240831$N$CN$US$
242788611$24278861$1$I$20240727$20240831$20240903$20240903$EXP$$NVSC2024IN176519$NOVARTIS$$58$YR$$F$Y$$$20240903$$CN$IN$IN
242788631$24278863$1$I$$20240829$20240903$20240903$EXP$$CA-TAKEDA-2024TUS087894$TAKEDA$$$$$M$Y$$$20240903$$CN$CA$CA
242788641$24278864$1$I$$20240828$20240903$20240903$EXP$$US-OTSUKA-2024_023913$OTSUKA$$$$$F$Y$$$20240903$$CN$US$US
242788651$24278865$1$I$$20240831$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139486$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240903$$HP$US$US
242788662$24278866$2$F$$20240918$20240903$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137714$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240920$$CN$US$US
242788671$24278867$1$I$$20240829$20240903$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-115605$BRISTOL MYERS SQUIBB$$64$YR$A$$Y$66.5$KG$20240903$$PH$JP$JP
242788681$24278868$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139966$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240903$$CN$US$US
242788691$24278869$1$I$20240824$20240829$20240903$20240903$EXP$$CN-SANDOZ INC.-SDZ2024CN077172$SANDOZ$$40$YR$$F$Y$48$KG$20240903$$HP$CN$CN
242788711$24278871$1$I$$20240828$20240903$20240903$EXP$$US-OTSUKA-2024_023980$OTSUKA$$$$$F$Y$$$20240903$$MD$US$US
242788721$24278872$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174936$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242788741$24278874$1$I$$20240826$20240903$20240903$EXP$GB-MHRA-MED-202408260747453490-ZHSNB$GB-TEVA-VS-3237407$TEVA$$29$YR$$F$Y$56$KG$20240903$$CN$GB$GB
242788752$24278875$2$F$20240827$20240911$20240903$20240918$EXP$$US-OTSUKA-2024_022079$OTSUKA$$55$YR$$F$Y$$$20240918$$CN$US$US
242788761$24278876$1$I$$20240809$20240903$20240903$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004581$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
242788771$24278877$1$I$$20240830$20240903$20240903$PER$$US-JNJFOC-20240901033$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$MD$US$US
242788781$24278878$1$I$20230124$20240827$20240903$20240903$EXP$$IE-TAKEDA-2023TUS015161$TAKEDA$$76$YR$$F$Y$$$20240903$$HP$IE$IE
242788792$24278879$2$F$20240101$20240917$20240903$20240924$EXP$$DE-MYLANLABS-2024M1079650$MYLAN$$55$YR$$M$Y$$$20240924$$CN$DE$DE
242788801$24278880$1$I$$20240828$20240903$20240903$EXP$$US-OTSUKA-2024_024148$OTSUKA$$$$$M$Y$$$20240903$$CN$US$US
242788811$24278881$1$I$$20240903$20240903$20240903$PER$$NVSC2024US177147$NOVARTIS$$$$$$Y$$$20240903$$HP$US$US
242788821$24278882$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139003$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$78.47$KG$20240903$$CN$US$US
242788831$24278883$1$I$20210802$20240830$20240830$20240830$DIR$716684$$FDA-CTU$$32$YR$$F$N$55$KG$20240830$N$CN$MX$
242788851$24278885$1$I$20240501$20240828$20240903$20240903$EXP$FR-AFSSAPS-PB2024000901$FR-009507513-2408FRA009930$MERCK$$66$YR$$F$Y$56.5$KG$20240903$$MD$FR$FR
242788861$24278886$1$I$20240827$20240828$20240903$20240903$PER$$US-ALXN-202408USA002039US$ALEXION PHARMACEUTICALS$$72$YR$$M$Y$$$20240903$$HP$US$US
242788871$24278887$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113307$PFIZER$$76$YR$$M$Y$$$20240903$$CN$US$US
242788881$24278888$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-PV202400114130$PFIZER$$49$YR$$F$Y$$$20240903$$CN$US$US
242788891$24278889$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247940$PFIZER$$14$YR$$F$Y$$$20240903$$MD$US$US
242788901$24278890$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247578$PFIZER$$36$YR$$F$Y$$$20240903$$CN$US$US
242788911$24278891$1$I$20240829$20240830$20240830$20240830$DIR$716606$$FDA-CTU$$31$YR$$M$N$87.75$KG$20240830$N$CN$US$
242788921$24278892$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113938$PFIZER$$69$YR$$M$Y$$$20240903$$CN$US$US
242788931$24278893$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247576$PFIZER$$33$YR$$F$Y$$$20240903$$HP$US$US
242788941$24278894$1$I$20240601$20240828$20240903$20240903$PER$$US-PFIZER INC-PV202400113460$PFIZER$$59$YR$$F$Y$$$20240903$$CN$US$US
242788971$24278897$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246680$PFIZER$$78$YR$$F$Y$$$20240903$$CN$US$US
242788981$24278898$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247154$PFIZER$$66$YR$$M$Y$$$20240903$$CN$US$US
242788991$24278899$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246850$PFIZER$$46$YR$$F$Y$$$20240903$$CN$US$US
242789001$24278900$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113531$PFIZER$$49$YR$$F$Y$$$20240903$$CN$US$US
242789011$24278901$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113486$PFIZER$$58$YR$$M$Y$$$20240903$$HP$US$US
242789021$24278902$1$I$20240828$20240831$20240831$20240831$DIR$716779$$FDA-CTU$$67$YR$$F$N$$$20240831$N$HP$US$
242789031$24278903$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113582$PFIZER$$$$$M$Y$$$20240903$$CN$US$US
242789041$24278904$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247131$PFIZER$$$$$F$Y$$$20240903$$CN$US$US
242789051$24278905$1$I$20240718$20240829$20240903$20240903$PER$$US-PFIZER INC-2020120837$PFIZER$$77$YR$$F$Y$$$20240903$$HP$US$US
242789061$24278906$1$I$$20240831$20240831$20240831$DIR$716733$$FDA-CTU$$43$YR$$F$N$67.5$KG$20240831$N$CN$US$
242789081$24278908$1$I$20231014$20240828$20240903$20240903$PER$$US-PFIZER INC-2023SGN11248$PFIZER$$76$YR$$F$Y$$$20240903$$CN$US$US
242789101$24278910$1$I$20240801$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246695$PFIZER$$$$$F$Y$$$20240903$$MD$US$US
242789121$24278912$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247561$PFIZER$$62$YR$$F$Y$$$20240903$$HP$US$US
242789131$24278913$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-PV202400092536$PFIZER$$38$YR$$M$Y$$$20240903$$HP$US$US
242789141$24278914$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-202400246068$PFIZER$$72$YR$$F$Y$$$20240903$$CN$US$US
242789151$24278915$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113835$PFIZER$$73$YR$$F$Y$98.4$KG$20240903$$MD$US$US
242789161$24278916$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246956$PFIZER$$41$YR$$F$Y$$$20240903$$HP$US$US
242789171$24278917$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113463$PFIZER$$64$YR$$$Y$$$20240903$$CN$US$US
242789181$24278918$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247240$PFIZER$$62$YR$$F$Y$$$20240903$$CN$US$US
242789193$24278919$3$F$$20240926$20240903$20240927$PER$$US-PFIZER INC-PV202400113334$PFIZER$$61$YR$$F$Y$$$20240927$$HP$US$US
242789201$24278920$1$I$20240827$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247292$PFIZER$$33$YR$$F$Y$$$20240903$$CN$US$US
242789211$24278921$1$I$20240826$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247118$PFIZER$$62$YR$$F$Y$$$20240903$$CN$US$US
242789222$24278922$2$F$$20240905$20240903$20240909$PER$$US-PFIZER INC-202400245940$PFIZER$$72$YR$$F$Y$$$20240909$$MD$US$US
242789231$24278923$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113913$PFIZER$$67$YR$$M$Y$$$20240903$$CN$US$US
242789241$24278924$1$I$20240828$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247188$PFIZER$$64$YR$$F$Y$$$20240903$$MD$US$US
242789252$24278925$2$F$$20240918$20240903$20240920$PER$$US-PFIZER INC-202400247106$PFIZER$$70$YR$$F$Y$$$20240920$$MD$US$US
242789261$24278926$1$I$20240827$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246848$PFIZER$$81$YR$$F$Y$$$20240903$$CN$US$US
242789271$24278927$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113514$PFIZER$$38$YR$$F$Y$$$20240903$$CN$US$US
242789281$24278928$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246943$PFIZER$$68$YR$$M$Y$$$20240903$$CN$US$US
242789291$24278929$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-202400245830$PFIZER$$$$$$Y$$$20240903$$MD$US$US
242789301$24278930$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247565$PFIZER$$14$YR$$F$Y$$$20240903$$HP$US$US
242789311$24278931$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-202400246784$PFIZER$$$$$$Y$$$20240903$$MD$US$US
242789321$24278932$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-PV202400079739$PFIZER$$75$YR$$F$Y$$$20240903$$CN$US$US
242789331$24278933$1$I$20240801$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247722$PFIZER$$57$YR$$F$Y$$$20240903$$CN$US$US
242789341$24278934$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113636$PFIZER$$61$YR$$F$Y$$$20240903$$HP$US$US
242789351$24278935$1$I$20240829$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247284$PFIZER$$78$YR$$M$Y$$$20240903$$CN$US$US
242789361$24278936$1$I$20240829$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247119$PFIZER$$51$YR$$F$Y$$$20240903$$CN$US$US
242789371$24278937$1$I$20240801$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246687$PFIZER$$$$$F$Y$$$20240903$$HP$US$US
242789381$24278938$1$I$20240828$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113542$PFIZER$$84$YR$$M$Y$$$20240903$$CN$US$US
242789391$24278939$1$I$20231201$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113777$PFIZER$$53$YR$$F$Y$$$20240903$$HP$US$US
242789401$24278940$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113708$PFIZER$$58$YR$$F$Y$$$20240903$$HP$US$US
242789411$24278941$1$I$20240801$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113553$PFIZER$$36$YR$$F$Y$$$20240903$$CN$US$US
242789421$24278942$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113551$PFIZER$$46$YR$$F$Y$$$20240903$$CN$US$US
242789442$24278944$2$F$20240827$20240919$20240903$20240923$PER$$US-PFIZER INC-202400246909$PFIZER$$74$YR$$F$Y$54.422$KG$20240923$$CN$US$US
242789451$24278945$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-PV202400113461$PFIZER$$$$$$Y$$$20240903$$CN$US$US
242789461$24278946$1$I$20240601$20240828$20240903$20240903$PER$$US-PFIZER INC-PV202400113335$PFIZER$$43$YR$$F$Y$102.04$KG$20240903$$CN$US$US
242789481$24278948$1$I$20240823$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247112$PFIZER$$63$YR$$F$Y$$$20240903$$HP$US$US
242789492$24278949$2$F$$20240906$20240903$20240910$PER$$US-PFIZER INC-202400246698$PFIZER$$$$$F$Y$$$20240910$$CN$US$US
242789501$24278950$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246732$PFIZER$$62$YR$$F$Y$$$20240903$$CN$US$US
242789512$24278951$2$F$$20240902$20240903$20240904$PER$$PR-PFIZER INC-202400247713$PFIZER$$60$YR$$F$Y$$$20240904$$HP$PR$PR
242789521$24278952$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246834$PFIZER$$$$$M$Y$$$20240903$$CN$US$US
242789531$24278953$1$I$$20240828$20240903$20240903$PER$$US-PFIZER INC-PV202400112482$PFIZER$$70$YR$$F$Y$$$20240903$$MD$US$US
242789541$24278954$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247130$PFIZER$$$$$$Y$$$20240903$$CN$US$US
242789551$24278955$1$I$20240827$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246919$PFIZER$$80$YR$$M$Y$$$20240903$$CN$US$US
242789561$24278956$1$I$20240808$20240828$20240903$20240903$PER$$US-PFIZER INC-202400245995$PFIZER$$15$YR$$M$Y$$$20240903$$MD$US$US
242789571$24278957$1$I$20240826$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246452$PFIZER$$43$YR$$F$Y$$$20240903$$CN$US$US
242789582$24278958$2$F$20240814$20240923$20240903$20240925$PER$$US-PFIZER INC-202400247270$PFIZER$$74$YR$$M$Y$72.562$KG$20240925$$CN$US$US
242789602$24278960$2$F$$20240904$20240903$20240909$PER$$US-PFIZER INC-202400245589$PFIZER$$$$A$F$Y$$$20240909$$HP$US$US
242789611$24278961$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246689$PFIZER$$$$$M$Y$$$20240903$$HP$US$US
242789621$24278962$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-202400247457$PFIZER$$49$YR$$F$Y$$$20240903$$MD$US$US
242789631$24278963$1$I$20240801$20240828$20240903$20240903$PER$$US-PFIZER INC-202400246793$PFIZER$$58$YR$$F$Y$87.982$KG$20240903$$HP$US$US
242789641$24278964$1$I$20230413$20240829$20240903$20240903$EXP$$UG-MYLANLABS-2024M1080023$MYLAN$$18$YR$$F$Y$$$20240903$$HP$UG$UG
242789651$24278965$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174947$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242789661$24278966$1$I$$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174910$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242789671$24278967$1$I$20240411$20240828$20240903$20240903$EXP$FR-AFSSAPS-GR2024000967$FR-009507513-2408FRA010048$MERCK$$41$YR$$F$Y$91$KG$20240903$$MD$FR$FR
242789681$24278968$1$I$20240820$20240831$20240903$20240903$EXP$$CN-AstraZeneca-2024A199462$ASTRAZENECA$$82$YR$$M$Y$55$KG$20240903$$MD$CN$
242789691$24278969$1$I$20240801$20240826$20240903$20240903$EXP$$CN-AstraZeneca-2024A196137$ASTRAZENECA$$79$YR$$F$Y$46$KG$20240903$$MD$CN$
242789702$24278970$2$F$$20240917$20240903$20240920$PER$$US-JNJFOC-20240882583$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$PH$US$US
242789712$24278971$2$F$20240825$20240917$20240903$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136627$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240925$$CN$US$US
242789721$24278972$1$I$20240801$20240827$20240903$20240903$EXP$$RO-BRISTOL-MYERS SQUIBB COMPANY-2024-140087$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240903$$MD$RO$RO
242789731$24278973$1$I$$20240826$20240903$20240903$PER$$US-ABBVIE-5896638$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242789741$24278974$1$I$$20240816$20240903$20240903$PER$$US-MYLANLABS-2024M1077261$MYLAN$$$$$$Y$$$20240903$$CN$US$US
242789751$24278975$1$I$$20240816$20240903$20240903$EXP$$US-MYLANLABS-2024M1077325$MYLAN$$$$$F$Y$91.17$KG$20240903$$HP$US$US
242789771$24278977$1$I$20240806$20240831$20240831$20240831$DIR$716744$$FDA-CTU$$48$YR$$F$N$99.9$KG$20240831$N$CN$US$
242789791$24278979$1$I$20240731$20240831$20240831$20240831$DIR$716749$$FDA-CTU$$28$YR$$F$N$94.5$KG$20240831$N$CN$US$
242789801$24278980$1$I$20240610$20240831$20240831$20240831$DIR$716751$$FDA-CTU$$53$YR$$F$N$99.45$KG$20240831$Y$CN$US$
242789811$24278981$1$I$20240527$20240901$20240901$20240901$DIR$716790$$FDA-CTU$$38$YR$$F$N$72$KG$20240901$N$CN$US$
242789831$24278983$1$I$$20240830$20240903$20240903$EXP$$US-ALXN-202408USA002179US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240903$$CN$US$US
242789841$24278984$1$I$$20240828$20240903$20240903$PER$$US-ALXN-202408USA002026US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240903$$CN$US$US
242789871$24278987$1$I$$20240827$20240903$20240903$EXP$$US-TAKEDA-2024TUS086369$TAKEDA$$$$E$M$Y$148.8$KG$20240903$$MD$US$US
242789881$24278988$1$I$$20240829$20240903$20240903$EXP$$JP-PFIZER INC-202400245930$PFIZER$$8$DEC$$M$Y$$$20240903$$PH$JP$JP
242789891$24278989$1$I$20240817$20240827$20240903$20240903$EXP$FR-AFSSAPS-RS2024000825$FR-PFIZER INC-202400247886$PFIZER$$72$YR$$M$Y$81.1$KG$20240903$$MD$FR$FR
242789901$24278990$1$I$20221221$20240829$20240903$20240903$EXP$FR-AFSSAPS-MA2024001243$FR-PFIZER INC-202400246293$PFIZER$$58$YR$$F$Y$72$KG$20240903$$PH$FR$FR
242789911$24278991$1$I$20240801$20240829$20240903$20240903$EXP$$CN-PFIZER INC-PV202400113465$PFIZER$$51$YR$$M$Y$61$KG$20240903$$HP$CN$CN
242789921$24278992$1$I$$20240829$20240903$20240903$EXP$$IL-PFIZER INC-PV202400114681$PFIZER$$69$YR$$F$Y$$$20240903$$CN$IL$IL
242789931$24278993$1$I$20240101$20240827$20240903$20240903$EXP$$JP-PFIZER INC-202400219617$PFIZER$$70$YR$$M$Y$$$20240903$$HP$JP$JP
242789951$24278995$1$I$20240805$20240827$20240903$20240903$EXP$$IT-PFIZER INC-202400247911$PFIZER$$74$YR$$M$Y$85$KG$20240903$$MD$IT$IT
242789961$24278996$1$I$$20240829$20240903$20240903$EXP$$US-PFIZER INC-202400247396$PFIZER$$88$YR$$F$Y$$$20240903$$CN$US$US
242789971$24278997$1$I$20240101$20240828$20240903$20240903$EXP$$JP-PFIZER INC-202400248145$PFIZER$$$$E$M$Y$$$20240903$$PH$JP$JP
242789981$24278998$1$I$20240821$20240829$20240903$20240903$EXP$$CN-PFIZER INC-PV202400113431$PFIZER$$52$YR$$F$Y$51$KG$20240903$$HP$CN$CN
242789991$24278999$1$I$20240723$20240827$20240903$20240903$EXP$$AT-PFIZER INC-202400248218$PFIZER$$58$YR$$M$Y$$$20240903$$MD$AT$AT
242790001$24279000$1$I$20240812$20240829$20240903$20240903$EXP$$CN-PFIZER INC-PV202400113436$PFIZER$$48$YR$$F$Y$70$KG$20240903$$HP$CN$CN
242790011$24279001$1$I$$20240902$20240903$20240903$EXP$$GB-PFIZER INC-PV202400114776$PFIZER$$72$YR$$M$Y$$$20240903$$HP$GB$GB
242790021$24279002$1$I$20240101$20240828$20240903$20240903$EXP$$CA-PFIZER INC-202300193643$PFIZER$$68$YR$$F$Y$$$20240903$$PH$CA$CA
242790031$24279003$1$I$20240718$20240828$20240903$20240903$EXP$$CN-PFIZER INC-PV202400112588$PFIZER$$34$YR$$F$Y$58$KG$20240903$$HP$CN$CN
242790044$24279004$4$F$20230828$20240913$20240903$20240918$EXP$$CA-PFIZER INC-202300141229$PFIZER$$53$YR$$F$Y$$$20240918$$MD$CA$CA
242790051$24279005$1$I$20240823$20240829$20240903$20240903$EXP$$US-PFIZER INC-202400247192$PFIZER$$77$YR$$M$Y$$$20240903$$CN$US$AS
242790061$24279006$1$I$$20240827$20240903$20240903$EXP$$JP-PFIZER INC-202400246992$PFIZER$$78$YR$$M$Y$$$20240903$$PH$JP$JP
242790072$24279007$2$F$20240816$20240904$20240903$20240905$EXP$$CN-PFIZER INC-PV202400113448$PFIZER$$9$YR$$M$Y$33$KG$20240905$$HP$CN$CN
242790081$24279008$1$I$$20240829$20240903$20240903$EXP$$IT-PFIZER INC-202400247212$PFIZER$$83$YR$$F$Y$43$KG$20240903$$MD$IT$IT
242790091$24279009$1$I$$20240828$20240903$20240903$EXP$$CA-PFIZER INC-202400245825$PFIZER$$57$YR$$F$Y$$$20240903$$MD$CA$CA
242790101$24279010$1$I$20230801$20240829$20240903$20240903$EXP$$DE-PFIZER INC-202400246238$PFIZER$$$$$M$Y$2.535$KG$20240903$$MD$DE$DE
242790112$24279011$2$F$20240101$20240924$20240903$20240927$EXP$$US-PFIZER INC-202400246587$PFIZER$$61$YR$$F$Y$69.4$KG$20240927$$CN$US$US
242790121$24279012$1$I$$20240829$20240903$20240903$EXP$$US-PFIZER INC-202400246677$PFIZER$$55$YR$$F$Y$$$20240903$$CN$US$US
242790141$24279014$1$I$20240819$20240829$20240903$20240903$EXP$$CN-PFIZER INC-PV202400113426$PFIZER$$12$YR$$M$Y$32.5$KG$20240903$$HP$CN$CN
242790151$24279015$1$I$$20240826$20240903$20240903$EXP$GB-MHRA-MED-202408260848292580-YLJDR$GB-TEVA-VS-3237411$TEVA$$$$$F$Y$$$20240903$$CN$GB$GB
242790161$24279016$1$I$$20240828$20240903$20240903$PER$$US-ROCHE-10000068366$ROCHE$$$$$F$Y$$$20240903$$MD$US$US
242790171$24279017$1$I$20240830$20240901$20240903$20240903$PER$$US-JNJFOC-20240901062$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$CN$US$US
242790181$24279018$1$I$20240811$20240902$20240903$20240903$EXP$FR-AFSSAPS-LL2024001648$FR-DSJP-DSE-2024-143197$DAIICHI$$68$YR$$M$Y$78$KG$20240903$$MD$FR$FR
242790191$24279019$1$I$20230630$20240826$20240903$20240903$EXP$PT-INFARMED-A202408-219$PT-TEVA-VS-3237215$TEVA$$3$YR$$M$Y$$$20240903$$MD$PT$PT
242790201$24279020$1$I$$20240827$20240903$20240903$PER$$US-JNJFOC-20240875604$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242790211$24279021$1$I$20240714$20240826$20240903$20240903$EXP$PT-INFARMED-R202408-323$PT-TEVA-VS-3237265$TEVA$$60$YR$$M$Y$$$20240903$$PH$PT$PT
242790221$24279022$1$I$20240317$20240826$20240903$20240903$EXP$FR-AFSSAPS-DJ2024000930$FR-FreseniusKabi-FK202413074$FRESENIUS KABI$$73$YR$E$M$Y$75$KG$20240903$$MD$FR$FR
242790231$24279023$1$I$20170101$20240827$20240903$20240903$EXP$$US-OTSUKA-2024_023691$OTSUKA$$$$$F$Y$$$20240903$$CN$US$US
242790241$24279024$1$I$$20240829$20240903$20240903$PER$$US-ALXN-202408USA002168US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
242790251$24279025$1$I$$20240826$20240903$20240903$EXP$GB-MHRA-MED-202408260857115660-VRDSP$GB-TEVA-VS-3237251$TEVA$$$$$F$Y$$$20240903$$CN$GB$GB
242790261$24279026$1$I$$20240826$20240903$20240903$EXP$$NVSC2024CN177021$NOVARTIS$Li Y, Liu Y, Niu Z, Lian M. Clinical study on naoxintong capsules combined with sacubactril valsartan in treatment of ischemic cardiomyopathy. DRUGS + CLINIC. 2024;39 (8)$$$$$Y$$$20240903$$HP$CN$CN
242790271$24279027$1$I$20240725$20240827$20240903$20240903$EXP$FR-AFSSAPS-MP2024001272$FR-TEVA-VS-3237667$TEVA$$84$YR$$F$Y$53$KG$20240903$$PH$FR$FR
242790291$24279029$1$I$20240824$20240825$20240830$20240830$DIR$FDA-CDER-CTU-2024-60074$$FDA-CTU$$70$YR$$M$N$127.91$KG$20240825$Y$CN$US$
242790301$24279030$1$I$20240708$20240827$20240903$20240903$EXP$FR-AFSSAPS-LM2024000468$FR-TEVA-VS-3237681$TEVA$$68$YR$$M$Y$59.7$KG$20240903$$MD$FR$FR
242790313$24279031$3$F$$20240830$20240903$20240923$30DAY$$US-JNJFOC-20240881892$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$CN$US$US
242790321$24279032$1$I$$20240826$20240903$20240903$EXP$$JP-BAUSCH-BL-2024-013116$BAUSCH AND LOMB$Yamane M, Umayahara T, Aoyama Y, Hayashi H. 40 Three cases of plaque psoriasis progressing to psoriatic arthritis despite long-term administration of Brodalumab. The 39th Annual Meeting of the Japanese Society for Psoriasis Research. 2024;164.$7$DEC$$M$Y$$$20240903$$HP$JP$JP
242790331$24279033$1$I$$20240901$20240903$20240903$EXP$$NL-BAUSCH-BL-2024-013161$BAUSCH AND LOMB$$$$$M$Y$$$20240903$$HP$NL$NL
242790342$24279034$2$F$20240814$20240906$20240903$20240911$EXP$IT-MINISAL02-1000258$IT-DSJP-DSE-2024-142978$DAIICHI$$86$YR$$M$Y$82$KG$20240911$$MD$IT$IT
242790351$24279035$1$I$$20240829$20240903$20240903$EXP$$NVSC2024DE176508$NOVARTIS$$$$A$F$Y$$$20240903$$MD$DE$DE
242790361$24279036$1$I$20240723$20240827$20240903$20240903$EXP$FR-AFSSAPS-RE2024000839$FR-TEVA-VS-3237713$TEVA$$78$YR$$M$Y$$$20240903$$MD$FR$FR
242790381$24279038$1$I$$20240828$20240903$20240903$EXP$$MY-PERRIGO-24MY008141$PERRIGO$Weeraj C, Kannan B. Mesenteric Ischemia in a Patient on Levonorgestrel Containing Oral Contraception. Journal of obstetrics and gynaecology Canada: JOGC = Journal d bstetrique et gynecologie du Canada: JOGC. 2024. DOI:10.1016/j.jogc.2024.102633.$44$YR$$F$Y$$$20240903$$MD$MY$MY
242790392$24279039$2$F$20080101$20240912$20240903$20240918$EXP$$US-PERRIGO-24US008138$PERRIGO$Ehrhardt C, M?kinen KK, Cobb CM. Development of Root Caries Associated With the Use of Sugar-Free Nicotine Lozenges: A Long-Term Case Report. Case reports in dentistry. 2024;6635130. DOI:10.1155/2024/6635130.$59$YR$$M$Y$81$KG$20240918$$MD$US$US
242790401$24279040$1$I$20240722$20240827$20240903$20240903$EXP$FR-AFSSAPS-PB2024000879$FR-TEVA-VS-3237719$TEVA$$41$YR$$F$Y$$$20240903$$MD$FR$FR
242790411$24279041$1$I$20230714$20240828$20240903$20240903$EXP$FR-AFSSAPS-BS2024000571$FR-MYLANLABS-2024M1079426$MYLAN$$87$YR$$F$Y$41$KG$20240903$$PH$FR$FR
242790421$24279042$1$I$20240816$20240830$20240903$20240903$EXP$$GB-ROCHE-10000072121$ROCHE$$87$YR$E$M$Y$$$20240903$$HP$GB$GB
242790441$24279044$1$I$$20240827$20240903$20240903$EXP$FR-AFSSAPS-NY2024000962$FR-TEVA-VS-3237726$TEVA$$51$YR$$F$Y$$$20240903$$MD$FR$FR
242790451$24279045$1$I$20240713$20240830$20240903$20240903$EXP$FR-AFSSAPS-TS2024000939$FR-MYLANLABS-2024M1079984$MYLAN$$87$YR$$M$Y$82$KG$20240903$$MD$FR$FR
242790461$24279046$1$I$$20240828$20240903$20240903$EXP$$DE-MYLANLABS-2024M1079908$MYLAN$Rauber C. Exacerbation of Myopathy in Glycogen Debrancher Deficiency After Liver Transplantation: Case Report and Review of the Literature. Transplantation Proceedings. 2024;5(56):1153-1156$27$YR$$M$Y$$$20240903$$HP$DE$DE
242790471$24279047$1$I$20240807$20240828$20240903$20240903$EXP$FR-AFSSAPS-NC2024000993$FR-MYLANLABS-2024M1079405$MYLAN$$59$YR$$M$Y$70$KG$20240903$$MD$FR$FR
242790481$24279048$1$I$$20240827$20240903$20240903$EXP$$US-ALXN-202408USA001904US$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240903$$MD$US$US
242790491$24279049$1$I$20240901$20240901$20240901$20240901$DIR$716823$$FDA-CTU$$22$YR$$F$N$$$20240901$N$CN$US$
242790501$24279050$1$I$20230101$20240827$20240903$20240903$EXP$FR-AFSSAPS-AVLY2024000135$FR-TEVA-VS-3237848$TEVA$$18$YR$$F$Y$83$KG$20240903$$MD$FR$FR
242790511$24279051$1$I$20240101$20240722$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001353$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242790521$24279052$1$I$20240101$20240827$20240903$20240903$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013684$JAZZ$$$$$F$Y$$$20240903$$CN$US$US
242790531$24279053$1$I$20240426$20240825$20240903$20240903$EXP$$US-FreseniusKabi-FK202412929$FRESENIUS KABI$$67$YR$E$M$Y$87.9$KG$20240903$$HP$US$US
242790551$24279055$1$I$20240101$20240802$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001394$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242790571$24279057$1$I$$20240827$20240903$20240903$EXP$$CA-FreseniusKabi-FK202413198$FRESENIUS KABI$$89$YR$E$M$Y$75$KG$20240903$$HP$CA$CA
242790581$24279058$1$I$20240810$20240827$20240903$20240903$EXP$FR-AFSSAPS-PA2024001472$FR-TEVA-VS-3237734$TEVA$$59$YR$$M$Y$79$KG$20240903$$MD$FR$FR
242790601$24279060$1$I$20240801$20240802$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001393$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242790612$24279061$2$F$20240801$20240916$20240903$20240925$PER$$US-KARYOPHARM-2024KPT001420$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240925$$CN$US$US
242790621$24279062$1$I$20240701$20240722$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001346$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242790631$24279063$1$I$$20240814$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001439$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$PH$US$US
242790641$24279064$1$I$$20240815$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001445$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242790651$24279065$1$I$$20240802$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001392$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242790661$24279066$1$I$20240101$20240819$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001451$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$HP$US$US
242790671$24279067$1$I$$20240817$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001450$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$HP$US$US
242790681$24279068$1$I$20240801$20240819$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001456$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242790711$24279071$1$I$20240816$20240819$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001452$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242790721$24279072$1$I$20240501$20240509$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001053$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242790731$24279073$1$I$20240101$20240821$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001461$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$HP$US$US
242790751$24279075$1$I$$20240826$20240903$20240903$PER$$US-KARYOPHARM-2024KPT001473$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240903$$HP$US$US
242790762$24279076$2$F$20240101$20240903$20240903$20240916$PER$$US-KARYOPHARM-2024KPT001472$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240916$$CN$US$US
242790771$24279077$1$I$$20240830$20240903$20240903$PER$$US-009507513-2409USA000342$MERCK$Davis MI, Dicaudo DJ, Swanson LA.. Lichenoid tissue eruption of the vulva associated with immune checkpoint inhibitor. International Journal of Women^s Dermatology. 2024;10(3):e161$78$YR$$F$Y$$$20240903$$HP$US$US
242790781$24279078$1$I$20191101$20240827$20240903$20240903$EXP$FR-AFSSAPS-BS2024000557$FR-TEVA-VS-3237870$TEVA$$33$YR$$F$Y$$$20240903$$MD$FR$FR
242790793$24279079$3$F$20240101$20240906$20240903$20240913$EXP$$US-KARYOPHARM-2024KPT001446$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240913$$CN$US$US
242790801$24279080$1$I$20240101$20240820$20240903$20240903$EXP$$GB-AMGEN-GBRSP2024171417$AMGEN$$$$$F$Y$$$20240903$$MD$GB$GB
242790831$24279083$1$I$$20240829$20240903$20240903$PER$$US-JNJFOC-20240878043$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242790841$24279084$1$I$20220101$20240827$20240903$20240903$EXP$FR-AFSSAPS-AVLY2024000136$FR-TEVA-VS-3237939$TEVA$$18$YR$$F$Y$83$KG$20240903$$MD$FR$FR
242790851$24279085$1$I$20240601$20240902$20240903$20240903$EXP$SE-SEMPA-2024-006412$NVSC2024SE176140$NOVARTIS$$67$YR$$F$Y$$$20240903$$MD$SE$SE
242790861$24279086$1$I$$20240718$20240903$20240903$PER$$US-SMPA-2024SPA002157$SUNOVION$$$$$$Y$$$20240903$$HP$US$US
242790871$24279087$1$I$20240101$20240826$20240903$20240903$PER$$US-SA-2024SA253136$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240903$$CN$US$US
242790881$24279088$1$I$20240401$20240828$20240903$20240903$EXP$DE-BFARM-24005827$DE-TEVA-VS-3238020$TEVA$$46$YR$$M$Y$68$KG$20240903$$MD$DE$DE
242790891$24279089$1$I$20240104$20240829$20240903$20240903$EXP$ES-AEMPS-1486988$ES-MYLANLABS-2024M1079748$MYLAN$$56$YR$$F$Y$68$KG$20240903$$MD$ES$ES
242790902$24279090$2$F$20240812$20240923$20240903$20240924$EXP$IE-HPRA-2024-114994$IE-009507513-2409IRL000772$MERCK$$90$YR$$M$Y$$$20240924$$MD$IE$IE
242790911$24279091$1$I$20231201$20240828$20240903$20240903$EXP$IE-HPRA-2024-114894$IE-TEVA-VS-3238070$TEVA$$$$$F$Y$$$20240903$$HP$IE$IE
242790921$24279092$1$I$$20240813$20240903$20240903$EXP$$US-ASTELLAS-2024-AER-000573$ASTELLAS$$$$E$M$Y$$$20240903$$CN$US$US
242790931$24279093$1$I$$20240828$20240903$20240903$EXP$PL-URPL-2-941-2019$PL-TEVA-VS-3238174$TEVA$$62$YR$$F$Y$$$20240903$$CN$PL$PL
242790941$24279094$1$I$$20240823$20240903$20240903$PER$$PR-ABBVIE-5895220$ABBVIE$$$$$F$Y$$$20240903$$MD$PR$PR
242790951$24279095$1$I$20240612$20240828$20240903$20240903$EXP$ES-AEMPS-1562312$ES-TEVA-VS-3238510$TEVA$$72$YR$$M$Y$90$KG$20240903$$MD$ES$ES
242790962$24279096$2$F$20240811$20240904$20240903$20240909$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048769$BOEHRINGER INGELHEIM$$53$YR$A$M$Y$70$KG$20240909$$HP$GB$GB
242790971$24279097$1$I$20240902$20240903$20240903$20240903$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049277$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240903$$CN$US$US
242790981$24279098$1$I$20240101$20240823$20240903$20240903$EXP$$US-TG THERAPEUTICS INC.-TGT003939$TG THERAPEUTICS$$$$$$Y$$$20240903$$CN$US$US
242791021$24279102$1$I$20240503$20240903$20240903$20240903$DIR$716918$$FDA-CTU$$60$YR$$F$N$55.8$KG$20240903$N$CN$US$
242791031$24279103$1$I$$20240822$20240903$20240903$PER$$US-SA-2024SA253551$SANOFI AVENTIS$$$$$$Y$$$20240903$$HP$US$US
242791052$24279105$2$F$20040101$20240912$20240903$20240919$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048845$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240919$$HP$BR$BR
242791061$24279106$1$I$$20240828$20240903$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139557$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240903$$MD$JP$JP
242791072$24279107$2$F$20240801$20240917$20240903$20240923$EXP$FR-AFSSAPS-PB2024000936$FR-MYLANLABS-2024M1079989$MYLAN$$84$YR$$F$Y$$$20240923$$PH$FR$FR
242791091$24279109$1$I$20240101$20240826$20240903$20240903$EXP$$US-RIGEL-20240800105$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242791101$24279110$1$I$20240101$20240829$20240903$20240903$EXP$$US-OTSUKA-2024_003044$OTSUKA$$76$YR$$F$Y$$$20240903$$CN$US$US
242791111$24279111$1$I$$20240828$20240903$20240903$EXP$$NVSC2024DE175853$NOVARTIS$$75$YR$$M$Y$$$20240903$$MD$DE$DE
242791131$24279113$1$I$20240701$20240829$20240903$20240903$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-009330$JAZZ$$29$YR$$F$Y$$$20240903$$CN$US$US
242791141$24279114$1$I$20150601$20240828$20240903$20240903$EXP$$GB-OTSUKA-2017_015858$OTSUKA$$52$YR$$M$Y$105$KG$20240903$$CN$GB$GB
242791162$24279116$2$F$$20240827$20240903$20240903$EXP$$GB-009507513-2408GBR010723$MERCK$$$$$M$Y$$$20240903$$HP$GB$GB
242791171$24279117$1$I$$20240823$20240903$20240903$PER$$US-ABBVIE-5896172$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242791191$24279119$1$I$20240813$20240830$20240830$20240830$DIR$716690$$FDA-CTU$$33$YR$$F$N$57.5$KG$20240830$N$HP$US$
242791211$24279121$1$I$$20240902$20240903$20240903$PER$$US-PURDUE PHARMA-USA-2024-0311727$PURDUE$$$$$M$Y$$$20240903$$CN$US$US
242791221$24279122$1$I$20240902$20240902$20240903$20240903$PER$$US-PURDUE PHARMA-USA-2024-0311728$PURDUE$$66$YR$$F$Y$$$20240903$$CN$US$US
242791232$24279123$2$F$20190101$20240902$20240903$20240906$PER$$US-PURDUE PHARMA-USA-2024-0311730$PURDUE$$$$$M$Y$$$20240907$$CN$US$US
242791241$24279124$1$I$$20240901$20240903$20240903$PER$$US-PURDUE PHARMA-USA-2024-0311743$PURDUE$$$$$M$Y$$$20240903$$CN$US$US
242791261$24279126$1$I$20240601$20240821$20240903$20240903$PER$$US-JNJFOC-20240856466$JOHNSON AND JOHNSON$$$$$M$Y$$$20240903$$CN$US$US
242791271$24279127$1$I$20240809$20240826$20240903$20240903$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409000975$ELI LILLY AND CO$$58$YR$A$M$Y$83$KG$20240903$$MD$DE$DE
242791281$24279128$1$I$20240701$20240829$20240903$20240903$EXP$$US-OTSUKA-2024_018582$OTSUKA$$75$YR$$M$Y$83.91$KG$20240903$$CN$US$US
242791294$24279129$4$F$20240716$20240909$20240903$20240912$EXP$$AR-MYLANLABS-2024M1080681$MYLAN$$16$YR$$F$Y$$$20240912$$CN$AR$AR
242791301$24279130$1$I$20240620$20240823$20240903$20240903$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202408014995$ELI LILLY AND CO$$58$YR$A$F$Y$77$KG$20240903$$CN$IT$IT
242791312$24279131$2$F$$20240830$20240903$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408019430$ELI LILLY AND CO$$$$$F$Y$$$20240904$$CN$US$US
242791321$24279132$1$I$20240804$20240903$20240903$20240903$EXP$GB-MHRA-MED-202409030914435580-NYKPV$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049214$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$67$KG$20240903$$HP$GB$GB
242791331$24279133$1$I$$20240903$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140138$BRISTOL MYERS SQUIBB$$29$YR$A$F$Y$$$20240903$$CN$US$US
242791341$24279134$1$I$20240712$20240827$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137971$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$72.4$KG$20240903$$HP$US$US
242791351$24279135$1$I$20240811$20240821$20240903$20240903$EXP$$US-FMCRTG-FMC-2408-001043$FRESENIUS MEDICAL CARE$$66$YR$E$F$Y$$$20240903$$HP$US$US
242791361$24279136$1$I$$20240822$20240903$20240903$EXP$$US-FMCRTG-FMC-2408-001082$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240903$$HP$US$US
242791372$24279137$2$F$$20240912$20240903$20240917$EXP$$NZ-TAKEDA-2024TUS087211$TAKEDA$$$$$$Y$$$20240917$$MD$NZ$NZ
242791381$24279138$1$I$$20240829$20240903$20240903$EXP$$JP-009507513-2408JPN004114J$MERCK$$8$DEC$$M$Y$$$20240903$$MD$JP$JP
242791391$24279139$1$I$20230807$20240828$20240903$20240903$EXP$FR-AFSSAPS-ST2024001333$FR-009507513-2408FRA010211$MERCK$$66$YR$$M$Y$69.9$KG$20240903$$HP$FR$FR
242791401$24279140$1$I$20240901$20240901$20240901$20240901$DIR$716819$$FDA-CTU$$12$YR$$F$N$$$20240901$N$CN$US$
242791411$24279141$1$I$20240819$20240830$20240830$20240830$DIR$716635$$FDA-CTU$$59$YR$$M$N$80.1$KG$20240830$N$CN$US$
242791421$24279142$1$I$$20240826$20240903$20240903$PER$$US-JNJFOC-20240871674$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242791433$24279143$3$F$$20240924$20240903$20240930$EXP$$TR-OTSUKA-2024_024029$OTSUKA$Meric Z, Karaaslan BG, Gungoren EY, Hortoglu MB, Cavas T, Aydemir S et.al.. Artemis deficiency: A large cohort including a novel variant with increased radiosensitivity. Pediatr Allergy Immunol. 2024;35(6):NIL_0001-NIL_0010$8$MON$$M$Y$$$20240930$$HP$TR$TR
242791442$24279144$2$F$20240821$20240826$20240903$20240906$EXP$$CN-DSJP-DSJ-2024-142307$DAIICHI$$72$YR$$F$Y$53$KG$20240906$$HP$CN$CN
242791461$24279146$1$I$$20240722$20240903$20240903$PER$$US-LUNDBECK-DKLU4002073$LUNDBECK$$$$$$Y$$$20240903$$HP$US$US
242791473$24279147$3$F$$20240911$20240903$20240920$PER$$US-ASTELLAS-2024-AER-002945$ASTELLAS$$56$YR$A$F$Y$$$20240920$$CN$US$US
242791481$24279148$1$I$20240801$20240830$20240903$20240903$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013780$JAZZ$$21$YR$$M$Y$$$20240903$$CN$US$US
242791491$24279149$1$I$$20240903$20240903$20240903$EXP$$SE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049215$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240903$$CN$SE$SE
242791501$24279150$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-PV202400114669$PFIZER$$58$YR$$F$Y$$$20240903$$HP$US$US
242791513$24279151$3$F$$20240904$20240903$20240909$PER$$US-PFIZER INC-202400247902$PFIZER$$74$YR$$F$Y$$$20240909$$CN$US$US
242791521$24279152$1$I$20240829$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247784$PFIZER$$69$YR$$F$Y$$$20240903$$CN$US$US
242791531$24279153$1$I$20240801$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247932$PFIZER$$52$YR$$F$Y$$$20240903$$HP$US$US
242791541$24279154$1$I$20240827$20240830$20240903$20240903$PER$$US-PFIZER INC-202400248113$PFIZER$$67$YR$$M$Y$77.11$KG$20240903$$CN$US$US
242791551$24279155$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400248163$PFIZER$$37$YR$$F$Y$$$20240903$$CN$US$US
242791561$24279156$1$I$20240828$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247721$PFIZER$$79$YR$$M$Y$$$20240903$$CN$US$US
242791571$24279157$1$I$20240830$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247742$PFIZER$$66$YR$$F$Y$$$20240903$$CN$US$US
242791591$24279159$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247516$PFIZER$$$$$F$Y$$$20240903$$MD$US$US
242791612$24279161$2$F$$20240904$20240903$20240905$PER$$US-PFIZER INC-PV202400114001$PFIZER$$$$$F$Y$$$20240905$$LW$US$US
242791622$24279162$2$F$20240504$20240830$20240903$20240904$PER$$US-PFIZER INC-PV202400083226$PFIZER$$66$YR$$F$Y$76.2$KG$20240904$$CN$US$US
242791631$24279163$1$I$20240801$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247845$PFIZER$$43$YR$$F$Y$$$20240903$$HP$US$US
242791641$24279164$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-PV202400114393$PFIZER$$$$$$Y$$$20240903$$CN$US$US
242791651$24279165$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247422$PFIZER$$76$YR$$F$Y$$$20240903$$CN$US$US
242791661$24279166$1$I$20240830$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247734$PFIZER$$59$YR$$M$Y$$$20240903$$CN$US$US
242791672$24279167$2$F$20240118$20240917$20240903$20240919$PER$$US-PFIZER INC-202400246613$PFIZER$$57$YR$$F$Y$$$20240919$$CN$US$US
242791681$24279168$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247712$PFIZER$$34$YR$$F$Y$$$20240903$$MD$US$US
242791691$24279169$1$I$20240828$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247559$PFIZER$$55$YR$$M$Y$$$20240903$$CN$US$US
242791701$24279170$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247795$PFIZER$$76$YR$$F$Y$$$20240903$$CN$US$US
242791711$24279171$1$I$20240807$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247748$PFIZER$$65$YR$$F$Y$$$20240903$$HP$US$US
242791721$24279172$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-PV202400114584$PFIZER$$38$YR$$F$Y$$$20240903$$CN$US$US
242791731$24279173$1$I$20240801$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247469$PFIZER$$$$$$Y$$$20240903$$CN$US$US
242791741$24279174$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247420$PFIZER$$71$YR$$F$Y$$$20240903$$CN$US$US
242791751$24279175$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-PV202400105152$PFIZER$$53$YR$$F$Y$$$20240903$$CN$US$US
242791762$24279176$2$F$20240802$20240905$20240903$20240909$PER$$US-PFIZER INC-PV202400113468$PFIZER$$53$YR$$F$Y$82.993$KG$20240909$$CN$US$US
242791771$24279177$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-PV202400114303$PFIZER$$70$YR$$F$Y$$$20240903$$HP$US$US
242791782$24279178$2$F$20240827$20240919$20240903$20240923$PER$$US-PFIZER INC-202400247871$PFIZER$$52$YR$$F$Y$50.8$KG$20240923$$MD$US$US
242791791$24279179$1$I$20240828$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247470$PFIZER$$41$YR$$F$Y$$$20240903$$HP$US$US
242791801$24279180$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247664$PFIZER$$77$YR$$M$Y$$$20240903$$CN$US$US
242791811$24279181$1$I$20240830$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247556$PFIZER$$23$YR$$F$Y$$$20240903$$MD$US$US
242791821$24279182$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247678$PFIZER$$56$YR$$M$Y$$$20240903$$CN$US$US
242791831$24279183$1$I$20240729$20240830$20240903$20240903$PER$$US-PFIZER INC-PV202400114291$PFIZER$$50$YR$$F$Y$$$20240903$$HP$US$US
242791842$24279184$2$F$20240827$20240905$20240903$20240909$PER$$US-PFIZER INC-202400247865$PFIZER$$35$YR$$F$Y$$$20240909$$CN$US$US
242791851$24279185$1$I$20240801$20240830$20240903$20240903$PER$$US-PFIZER INC-PV202400114532$PFIZER$$68$YR$$M$Y$$$20240903$$HP$US$US
242791861$24279186$1$I$20240101$20240830$20240903$20240903$PER$$US-PFIZER INC-PV202400114632$PFIZER$$48$YR$$F$Y$$$20240903$$HP$US$US
242791871$24279187$1$I$$20240829$20240903$20240903$PER$$US-PFIZER INC-PV202400113555$PFIZER$$66$YR$$M$Y$$$20240903$$CN$US$US
242791881$24279188$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400081022$PFIZER$$37$YR$$F$Y$$$20240903$$HP$US$US
242791891$24279189$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-PV202400114457$PFIZER$$65$YR$$F$Y$$$20240903$$HP$US$US
242791901$24279190$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247545$PFIZER$$$$$$Y$$$20240903$$CN$US$US
242791911$24279191$1$I$$20240828$20240903$20240903$PER$$US-ALXN-202408USA001993US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242791923$24279192$3$F$$20240923$20240903$20240930$EXP$$JP-Eisai-EC-2024-173176$EISAI$Yusuke Kawamura. A case of tumor lysis syndrome, impending rupture of hepatocellular carcinoma, and cytokine release syndrome during chemotherapy for unresectable advanced hepatocellular carcinoma in which intrahepatic disease was eventually controlled. The 30th Japan Association of Systemic Therapy for HCC Program and Abstracts. 2024: OS9-7(136)-OS9-7(136).$$$A$F$Y$$$20240930$$MD$JP$JP
242791932$24279193$2$F$20240829$20240924$20240903$20240927$PER$$US-PFIZER INC-202400247762$PFIZER$$68$YR$$F$Y$90.703$KG$20240927$$CN$US$US
242791941$24279194$1$I$20240825$20240827$20240903$20240903$PER$$US-Eisai-EC-2024-173201$EISAI$$80$YR$E$M$Y$$$20240903$$CN$US$US
242791951$24279195$1$I$$20240826$20240903$20240903$PER$$US-ABBVIE-5898155$ABBVIE$$$$A$F$Y$$$20240903$$MD$US$US
242791961$24279196$1$I$$20240829$20240903$20240903$PER$$JP-Eisai-EC-2024-173295$EISAI$$$$$F$Y$$$20240903$$MD$JP$JP
242791972$24279197$2$F$$20240829$20240903$20240910$EXP$$US-SMPA-2024SPA001828$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
242791981$24279198$1$I$$20240825$20240903$20240903$EXP$NL-LRB-00996930$EU-BAUSCHBL-2024BNL032281$BAUSCH AND LOMB$$62$YR$$F$Y$94$KG$20240903$$CN$EU$EU
242791991$24279199$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA253986$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240903$$MD$US$US
242792002$24279200$2$F$20240724$20240904$20240903$20240906$PER$$US-SA-2024SA221330$SANOFI AVENTIS$$$$$F$Y$$$20240906$$HP$US$US
242792011$24279201$1$I$$20240822$20240903$20240903$EXP$GB-MHRA-MED-202408221033596920-GYLSN$GB-ELI_LILLY_AND_COMPANY-GB202408014963$ELI LILLY AND CO$$$$$F$Y$$$20240903$$CN$GB$GB
242792021$24279202$1$I$20240801$20240901$20240901$20240901$DIR$716786$$FDA-CTU$$$$$UNK$N$$$20240901$N$CN$US$
242792031$24279203$1$I$$20240830$20240903$20240903$EXP$$IN-PFIZER INC-PV202400114735$PFIZER$$71$YR$$F$Y$$$20240903$$CN$IN$IN
242792041$24279204$1$I$$20240902$20240903$20240903$EXP$$JP-PFIZER INC-PV202400114656$PFIZER$$$$$$Y$$$20240903$$MD$JP$JP
242792051$24279205$1$I$20230101$20240902$20240903$20240903$EXP$$NP-PFIZER INC-PV202400114685$PFIZER$$60$YR$$M$Y$$$20240903$$MD$NP$NP
242792061$24279206$1$I$20240816$20240831$20240903$20240903$EXP$$CN-PFIZER INC-PV202400114214$PFIZER$$21$YR$$F$Y$59$KG$20240903$$HP$CN$CN
242792073$24279207$3$F$20240829$20240905$20240903$20240906$EXP$$AU-PFIZER INC-PV202400113983$PFIZER$$59$YR$$M$Y$$$20240906$$HP$AU$AU
242792083$24279208$3$F$20240807$20240917$20240903$20240919$EXP$$JP-PFIZER INC-PV202400113984$PFIZER$$40$YR$$F$Y$55$KG$20240919$$MD$JP$JP
242792091$24279209$1$I$20240828$20240830$20240903$20240903$EXP$$CN-PFIZER INC-PV202400114171$PFIZER$$44$YR$$F$Y$50$KG$20240903$$HP$CN$CN
242792105$24279210$5$F$$20240905$20240903$20240910$EXP$$US-PFIZER INC-PV202400114825$PFIZER$$66$YR$$F$Y$$$20240910$$CN$US$US
242792111$24279211$1$I$20240814$20240830$20240903$20240903$EXP$$CN-PFIZER INC-PV202400114100$PFIZER$$82$YR$$M$Y$65$KG$20240903$$HP$CN$CN
242792121$24279212$1$I$20240827$20240830$20240903$20240903$EXP$$CN-PFIZER INC-PV202400114159$PFIZER$$32$YR$$F$Y$86.4$KG$20240903$$HP$CN$CN
242792131$24279213$1$I$20240828$20240830$20240903$20240903$EXP$$CO-PFIZER INC-PV202400114766$PFIZER$$82$YR$$F$Y$$$20240903$$CN$CO$CO
242792141$24279214$1$I$$20240830$20240903$20240903$EXP$$TW-PFIZER INC-PV202400114294$PFIZER$$$$$F$Y$$$20240903$$HP$TW$TW
242792151$24279215$1$I$$20240830$20240903$20240903$EXP$$CA-PFIZER INC-PV202400114863$PFIZER$$5$DEC$$F$Y$$$20240903$$MD$CA$CA
242792161$24279216$1$I$$20240830$20240903$20240903$EXP$$JP-PFIZER INC-PV202400114020$PFIZER$$$$$F$Y$$$20240903$$MD$JP$JP
242792181$24279218$1$I$$20240830$20240903$20240903$EXP$$SB-PFIZER INC-PV202400113986$PFIZER$$10$YR$$$Y$$$20240903$$HP$SB$SB
242792191$24279219$1$I$20240619$20240829$20240903$20240903$EXP$$CN-PFIZER INC-PV202400113360$PFIZER$$59$YR$$M$Y$56$KG$20240903$$HP$CN$CN
242792201$24279220$1$I$$20240830$20240903$20240903$EXP$$MY-PFIZER INC-PV202400113577$PFIZER$$77$YR$$M$Y$$$20240903$$CN$MY$MY
242792211$24279221$1$I$20240801$20240902$20240903$20240903$EXP$$MA-PFIZER INC-PV202400115219$PFIZER$$62$YR$$F$Y$$$20240903$$CN$MA$MA
242792221$24279222$1$I$20240828$20240830$20240903$20240903$EXP$$IN-PFIZER INC-PV202400011185$PFIZER$$45$YR$$F$Y$$$20240903$$CN$IN$IN
242792231$24279223$1$I$$20240901$20240903$20240903$EXP$$MY-PFIZER INC-PV202400114127$PFIZER$$64$YR$$F$Y$$$20240903$$MD$MY$MY
242792241$24279224$1$I$20240805$20240829$20240903$20240903$EXP$$CN-PFIZER INC-PV202400113437$PFIZER$$32$YR$$F$Y$42$KG$20240903$$HP$CN$CN
242792251$24279225$1$I$$20240902$20240903$20240903$EXP$$JP-PFIZER INC-PV202400114458$PFIZER$$10$DEC$$F$Y$$$20240903$$MD$JP$JP
242792261$24279226$1$I$20240808$20240831$20240903$20240903$EXP$$CA-PFIZER INC-PV202400114872$PFIZER$$66$YR$$F$Y$$$20240903$$CN$CA$CA
242792271$24279227$1$I$20240811$20240831$20240903$20240903$EXP$$US-BAYER-2024A126229$BAYER$$71$YR$E$F$Y$$$20240903$$HP$US$US
242792282$24279228$2$F$$20240911$20240903$20240916$EXP$$FR-009507513-2408FRA009711$MERCK$Le Clainche Compagnie A, Degoutte C, Papouin B, Lamaison C, Gounot R, Ingen-Housz-Oro S.. Asteatotic eczema, a cutaneous manifestation of Hodgkin lymphoma in older patients. eJHaem. 2024;5:883-884$82$YR$$M$Y$$$20240916$$HP$FR$FR
242792292$24279229$2$F$20240911$20240914$20240903$20240917$EXP$$US-INCYTE CORPORATION-2024IN009234$INCYTE$$$$$$Y$$$20240917$$CN$US$US
242792301$24279230$1$I$$20240828$20240903$20240903$EXP$$JP-009507513-2408JPN004077J$MERCK$$6$DEC$$F$Y$$$20240903$$MD$JP$JP
242792312$24279231$2$F$20240101$20240918$20240903$20240927$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-014067$JAZZ$$$$$M$Y$$$20240927$$MD$JP$JP
242792321$24279232$1$I$$20240724$20240903$20240903$PER$$US-LUNDBECK-DKLU4002113$LUNDBECK$$$$$$Y$$$20240903$$CN$US$US
242792331$24279233$1$I$$20240829$20240903$20240903$EXP$$US-INCYTE CORPORATION-2024IN009153$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242792341$24279234$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138592$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240903$$HP$US$US
242792351$24279235$1$I$$20240830$20240903$20240903$EXP$$US-INCYTE CORPORATION-2024IN009203$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242792361$24279236$1$I$$20240829$20240903$20240903$EXP$$US-INCYTE CORPORATION-2024IN009150$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242792381$24279238$1$I$$20240903$20240903$20240903$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049235$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240903$$CN$US$US
242792391$24279239$1$I$$20240826$20240903$20240903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139537$BRISTOL MYERS SQUIBB$Imamura A, Matono T, Nakamura H, Shimada Y, Kanemitsu Y, Otsuka T, et al. A case of early emphysematous cholecystitis diagnosed by abdominal ultrasound. Proceedings of the 120th Meeting of the Kinki Branch of the Japanese Society of Gastroenterology (the 120th Meeting of the Kinki Branch of the Japanese Society of Gastroenterology).2024 Jan 01;Y7-3.$7$DEC$E$M$Y$$$20240903$$MD$JP$JP
242792402$24279240$2$F$$20240903$20240903$20240905$EXP$$US-INCYTE CORPORATION-2024IN009145$INCYTE$$$$$$Y$$$20240905$$CN$US$US
242792411$24279241$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139299$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$93.89$KG$20240903$$CN$US$US
242792421$24279242$1$I$$20240731$20240830$20240830$DIR$FDA-CDER-CTU-2024-60002$$FDA-CTU$$$$$$N$$$20240731$N$PH$US$
242792431$24279243$1$I$$20240826$20240903$20240903$PER$$US-ABBVIE-5897562$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242792442$24279244$2$F$20240828$20240910$20240903$20240920$EXP$$JP-009507513-2408JPN003865J$MERCK$$67$YR$$F$Y$78$KG$20240920$$MD$JP$JP
242792451$24279245$1$I$$20240829$20240903$20240903$PER$$US-ALXN-202408USA002097US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240903$$CN$US$US
242792461$24279246$1$I$20240719$20240722$20240903$20240903$PER$$US-LUNDBECK-DKLU4002071$LUNDBECK$$$$$$Y$$$20240903$$HP$US$US
242792471$24279247$1$I$$20240829$20240903$20240903$PER$$US-INSUD PHARMA-2408US06794$INSUD PHARMA$$$$$$Y$$$20240903$$CN$US$US
242792481$24279248$1$I$20240801$20240826$20240903$20240903$PER$$US-INSUD PHARMA-2408US06672$INSUD PHARMA$$$$$$Y$$$20240903$$CN$US$US
242792491$24279249$1$I$20240801$20240826$20240903$20240903$PER$$US-INSUD PHARMA-2408US06717$INSUD PHARMA$$$$$$Y$$$20240903$$CN$US$US
242792501$24279250$1$I$20240801$20240828$20240903$20240903$PER$$US-INSUD PHARMA-2408US06749$INSUD PHARMA$$$$$$Y$$$20240903$$CN$US$US
242792512$24279251$2$F$$20240901$20240903$20240924$PER$$US-SMPA-2024SPA001293$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242792521$24279252$1$I$$20240828$20240903$20240903$EXP$$NVSC2024PL174927$NOVARTIS$$42$YR$$M$Y$$$20240903$$MD$PL$PL
242792532$24279253$2$F$$20240903$20240903$20240916$EXP$$US-INSUD PHARMA-2408US06793$INSUD PHARMA$Zhang Y, Bangert M, Chun M, Mattingly T, Zheng C. ACUTE AND CHRONIC INFECTIOUS COMPLICATIONS FOLLOWING GUNSHOT INJURIUES: A CASE COMPARISON. Southern Medical Journal. 2022;115:561$$$$$Y$$$20240916$$HP$US$US
242792541$24279254$1$I$$20240827$20240903$20240903$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-016033$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240903$$MD$DE$DE
242792551$24279255$1$I$$20240829$20240903$20240903$EXP$$JP-OTSUKA-2024_024340$OTSUKA$Yamada S, Sakai K, Kubo M, Okumura H, Asakura H, Miyamoto T, et al.. Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy. Research and Practice in Thrombosis and Haemostasis. 2024;8(5):e102517$64$YR$$F$Y$$$20240903$$HP$JP$JP
242792561$24279256$1$I$20240801$20240816$20240903$20240903$PER$$US-009507513-2408USA006093$MERCK$$65$YR$$F$Y$$$20240903$$HP$US$US
242792571$24279257$1$I$20240710$20240724$20240903$20240903$PER$$US-LUNDBECK-DKLU4002154$LUNDBECK$$$$$$Y$$$20240903$$CN$US$US
242792581$24279258$1$I$20190101$20240826$20240903$20240903$PER$$US-JNJFOC-20240868412$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242792591$24279259$1$I$20240824$20240829$20240903$20240903$EXP$$US-INCYTE CORPORATION-2024IN008970$INCYTE$$$$$$Y$$$20240903$$CN$US$US
242792601$24279260$1$I$$20240828$20240903$20240903$PER$$US-JNJFOC-20240874818$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240903$$CN$US$US
242792612$24279261$2$F$$20240829$20240903$20240906$PER$$US-JAZZ PHARMACEUTICALS-2024-US-013896$JAZZ$$$$$F$Y$$$20240906$$HP$US$US
242792621$24279262$1$I$20240101$20240822$20240903$20240903$PER$$US-SA-2024SA253082$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240903$$CN$US$US
242792631$24279263$1$I$$20240821$20240903$20240903$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08442$NEUROCRINE BIOSCIENCES$$55$YR$$F$Y$$$20240903$$HP$US$US
242792642$24279264$2$F$20240801$20240910$20240903$20240914$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013980$JAZZ$$29$YR$$F$Y$$$20240914$$CN$US$US
242792651$24279265$1$I$20240627$20240719$20240903$20240903$PER$$US-LUNDBECK-DKLU4002462$LUNDBECK$$$$$$Y$$$20240903$$CN$US$US
242792671$24279267$1$I$$20240826$20240903$20240903$PER$$US-JNJFOC-20240903564$JOHNSON AND JOHNSON$$$$$$Y$$$20240903$$CN$US$US
242792681$24279268$1$I$$20240821$20240903$20240903$PER$$US-JNJFOC-20240856432$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242792691$24279269$1$I$20231201$20240828$20240903$20240903$EXP$$VN-009507513-2408VNM010605$MERCK$$61$YR$$F$Y$58$KG$20240903$$HP$VN$VN
242792701$24279270$1$I$$20240829$20240903$20240903$PER$$US-ALXN-202408USA002051US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
242792711$24279271$1$I$20240830$20240901$20240903$20240903$PER$$US-PFIZER INC-202400248134$PFIZER$$68$YR$$F$Y$$$20240903$$CN$US$US
242792721$24279272$1$I$$20240831$20240903$20240903$PER$$US-PFIZER INC-PV202400114124$PFIZER$$79$YR$$M$Y$$$20240903$$CN$US$US
242792732$24279273$2$F$20240901$20240918$20240903$20240920$PER$$US-PFIZER INC-202400248133$PFIZER$$69$YR$$F$Y$$$20240920$$CN$US$US
242792741$24279274$1$I$20240831$20240901$20240903$20240903$PER$$US-PFIZER INC-202400247920$PFIZER$$55$YR$$M$Y$$$20240903$$CN$US$US
242792751$24279275$1$I$20240830$20240831$20240903$20240903$PER$$US-PFIZER INC-202400248287$PFIZER$$74$YR$$M$Y$$$20240903$$CN$US$US
242792761$24279276$1$I$$20240831$20240903$20240903$PER$$US-PFIZER INC-202400247728$PFIZER$$$$$$Y$$$20240903$$CN$US$US
242792771$24279277$1$I$20240830$20240901$20240903$20240903$PER$$US-PFIZER INC-202400248100$PFIZER$$34$YR$$M$Y$$$20240903$$CN$US$US
242792781$24279278$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-PV202400113890$PFIZER$$39$YR$$M$Y$$$20240903$$HP$US$US
242792791$24279279$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400248012$PFIZER$$64$YR$$M$Y$65.77$KG$20240903$$CN$US$US
242792801$24279280$1$I$20240801$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247693$PFIZER$$8$YR$$F$Y$$$20240903$$CN$US$US
242792811$24279281$1$I$$20240902$20240903$20240903$PER$$US-PFIZER INC-PV202400115037$PFIZER$$65$YR$$F$Y$$$20240903$$HP$US$US
242792831$24279283$1$I$$20240902$20240903$20240903$PER$$US-PFIZER INC-PV202400114672$PFIZER$$28$YR$$F$Y$$$20240903$$CN$US$US
242792841$24279284$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247864$PFIZER$$85$YR$$F$Y$$$20240903$$CN$US$US
242792851$24279285$1$I$20240831$20240902$20240903$20240903$PER$$US-PFIZER INC-202400248219$PFIZER$$38$YR$$M$Y$$$20240903$$CN$US$US
242792861$24279286$1$I$20240901$20240901$20240903$20240903$PER$$US-PFIZER INC-202400247949$PFIZER$$58$YR$$F$Y$$$20240903$$CN$US$US
242792871$24279287$1$I$20240829$20240831$20240903$20240903$PER$$US-PFIZER INC-202400247819$PFIZER$$62$YR$$F$Y$$$20240903$$CN$US$US
242792882$24279288$2$F$20240829$20240905$20240903$20240906$PER$$US-PFIZER INC-202400247731$PFIZER$$68$YR$$M$Y$$$20240906$$CN$US$US
242792891$24279289$1$I$20240829$20240829$20240903$20240903$PER$$US-PFIZER INC-202400246636$PFIZER$$$$$$Y$$$20240903$$CN$US$US
242792901$24279290$1$I$20240830$20240901$20240903$20240903$PER$$US-PFIZER INC-202400248111$PFIZER$$68$YR$$F$Y$$$20240903$$CN$US$US
242792912$24279291$2$F$20240902$20240918$20240903$20240920$PER$$US-PFIZER INC-202400248657$PFIZER$$54$YR$$M$Y$64.399$KG$20240920$$CN$US$US
242792931$24279293$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-PV202400114454$PFIZER$$52$YR$$F$Y$$$20240903$$HP$US$US
242792941$24279294$1$I$$20240822$20240903$20240903$PER$$US-Covis Pharma GmbH-2024COV01043$COVIS PHARMA$$11$YR$C$M$Y$$$20240903$$$US$US
242792951$24279295$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400248265$PFIZER$$58$YR$$M$Y$$$20240903$$HP$US$US
242792961$24279296$1$I$$20240830$20240903$20240903$PER$$US-PFIZER INC-202400247623$PFIZER$$$$A$F$Y$$$20240903$$MD$US$US
242792971$24279297$1$I$20240306$20240821$20240903$20240903$EXP$$US-Covis Pharma GmbH-2024COV01072$COVIS PHARMA$$$$$F$Y$$$20240903$$CN$US$US
242792981$24279298$1$I$$20240829$20240903$20240903$EXP$$JP-009507513-2408JPN004109J$MERCK$$71$YR$$M$Y$68$KG$20240903$$MD$JP$JP
242792991$24279299$1$I$20221216$20240902$20240903$20240903$PER$SE-MPA-2022-022648$SE-Covis Pharma GmbH-2024COV01083$COVIS PHARMA$$41$YR$A$F$Y$63$KG$20240903$$CN$SE$SE
242793001$24279300$1$I$$20240903$20240903$20240903$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049318$BOEHRINGER INGELHEIM$$68$YR$E$$Y$$$20240903$$CN$US$US
242793011$24279301$1$I$$20240829$20240903$20240903$EXP$$NVSC2024US175776$NOVARTIS$$$$$F$Y$$$20240903$$CN$US$US
242793021$24279302$1$I$20230101$20240829$20240903$20240903$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-038621$JAZZ$$$$$M$Y$$$20240903$$CN$US$US
242793031$24279303$1$I$$20240829$20240903$20240903$EXP$$JP-009507513-2408JPN004115J$MERCK$$8$DEC$$F$Y$$$20240903$$MD$JP$JP
242793041$24279304$1$I$$20240828$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138011$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240903$$CN$US$US
242793061$24279306$1$I$$20240826$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136120$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$77.11$KG$20240903$$PH$US$US
242793071$24279307$1$I$20240811$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174483$AMGEN$$65$YR$E$F$Y$$$20240903$$PH$US$US
242793081$24279308$1$I$20150213$20240829$20240903$20240903$EXP$$FR-JAZZ PHARMACEUTICALS-2024-FR-013968$JAZZ$$$$$$Y$$$20240903$$MD$FR$FR
242793091$24279309$1$I$$20240821$20240903$20240903$EXP$$US-HLS-202401036$HLS THERAPEUTICS$$48$YR$A$M$Y$$$20240903$$PH$US$US
242793101$24279310$1$I$20240101$20240826$20240903$20240903$EXP$$US-BIOGEN-2024BI01280124$BIOGEN$$$$$F$Y$$$20240903$$MD$US$US
242793111$24279311$1$I$$20240822$20240903$20240903$PER$$US-EMERGENT BIOSOLUTIONS,-24000122$EMERGENT BIOSOLUTIONS$$$$A$$Y$$$20240903$$HP$US$US
242793121$24279312$1$I$$20240826$20240903$20240903$PER$$US-JNJFOC-20240868124$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242793131$24279313$1$I$$20240726$20240903$20240903$PER$$US-LUNDBECK-DKLU4002289$LUNDBECK$$$$$$Y$$$20240903$$CN$US$US
242793141$24279314$1$I$$20240528$20240903$20240903$EXP$$BR-APELLIS-APL-2023-003204$APELLIS PHARMACEUTICALS$$$$$$Y$60$KG$20240729$$CN$BR$BR
242793151$24279315$1$I$20240829$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024173973$AMGEN$$75$YR$E$M$Y$$$20240903$$CN$US$US
242793161$24279316$1$I$20240809$20240821$20240903$20240903$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08496$NEUROCRINE BIOSCIENCES$$40$YR$$F$Y$$$20240903$$CN$US$US
242793171$24279317$1$I$$20240826$20240903$20240903$EXP$$BR-AstraZeneca-2024A197575$ASTRAZENECA$$$$$M$Y$$$20240903$$CN$BR$
242793181$24279318$1$I$20240801$20240827$20240903$20240903$PER$$US-AMGEN-USASP2024171900$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242793191$24279319$1$I$20240704$20240826$20240903$20240903$EXP$$FR-ANIPHARMA-2024-FR-000148$ANI$$67$YR$$M$Y$$$20240903$$PH$FR$FR
242793202$24279320$2$F$20240326$20240905$20240903$20240905$EXP$$AU-009507513-2408AUS010727$MERCK$$81$YR$$M$Y$69.75$KG$20240905$$MD$AU$AU
242793214$24279321$4$F$$20240913$20240903$20240919$EXP$$US-AMGEN-USASP2024173726$AMGEN$$$$$M$Y$$$20240919$$PH$US$US
242793221$24279322$1$I$$20240719$20240903$20240903$PER$$US-LUNDBECK-DKLU4002237$LUNDBECK$$$$$$Y$$$20240903$$HP$US$US
242793231$24279323$1$I$20240630$20240830$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138719$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240903$$CN$US$US
242793241$24279324$1$I$20240805$20240826$20240903$20240903$EXP$$JP-AstraZeneca-2024A179261$ASTRAZENECA$$82$YR$$F$Y$$$20240903$$MD$JP$
242793251$24279325$1$I$20240713$20240829$20240903$20240903$EXP$$FR-ANIPHARMA-2024-FR-000149$ANI$$87$YR$$M$Y$82$KG$20240903$$MD$FR$FR
242793261$24279326$1$I$$20240819$20240903$20240903$EXP$$US-HLS-202400966$HLS THERAPEUTICS$$$$A$M$Y$$$20240903$$CN$US$US
242793271$24279327$1$I$20240328$20240826$20240903$20240903$EXP$$US-APELLIS-2024-APL-0000797$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240902$$HP$US$US
242793282$24279328$2$F$20240828$20240905$20240903$20240906$EXP$$JP-JNJFOC-20240903484$JOHNSON AND JOHNSON$$84$YR$E$$Y$39$KG$20240906$$PH$JP$JP
242793291$24279329$1$I$$20240819$20240903$20240903$EXP$$CA-CIPHER-2024-CA-000682$CIPHER$$$$$F$Y$$$20240903$$HP$CA$CA
242793301$24279330$1$I$20231116$20240819$20240903$20240903$EXP$$US-HLS-202400988$HLS THERAPEUTICS$$25$YR$A$M$Y$$$20240903$$HP$US$US
242793311$24279331$1$I$$20240822$20240903$20240903$PER$$US-SA-2024SA255738$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240904$$MD$US$US
242793321$24279332$1$I$$20240902$20240903$20240903$EXP$$CA-JNJFOC-20240903844$JOHNSON AND JOHNSON$$77$YR$E$M$Y$57$KG$20240903$$HP$CA$CA
242793331$24279333$1$I$$20240902$20240903$20240903$PER$$US-HALEON-2194883$Haleon PLC$$$$$$Y$$$20240903$$CN$US$US
242793341$24279334$1$I$20240716$20240828$20240903$20240903$EXP$$DE-009507513-2408DEU010177$MERCK$$30$YR$$F$Y$$$20240903$$PH$DE$DE
242793351$24279335$1$I$$20240816$20240903$20240903$PER$$US-JNJFOC-20240849305$JOHNSON AND JOHNSON$$$$$F$Y$$$20240903$$CN$US$US
242793361$24279336$1$I$$20240819$20240903$20240903$EXP$$US-HLS-202400973$HLS THERAPEUTICS$$$$A$$Y$$$20240903$$HP$US$US
242793371$24279337$1$I$20240624$20240828$20240903$20240903$EXP$FR-AFSSAPS-NT2024001064$FR-009507513-2408FRA010190$MERCK$$60$YR$$M$Y$82$KG$20240903$$PH$FR$FR
242793381$24279338$1$I$20240701$20240828$20240903$20240903$EXP$$JP-009507513-2408JPN003801J$MERCK$$8$DEC$$M$Y$$$20240903$$MD$JP$JP
242793391$24279339$1$I$20240101$20240826$20240903$20240903$PER$$US-SA-2024SA255546$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240904$$MD$US$US
242793401$24279340$1$I$20240814$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408019420$ELI LILLY AND CO$$$$$$Y$$$20240903$$CN$US$US
242793411$24279341$1$I$$20240827$20240903$20240903$PER$$US-009507513-2408USA009868$MERCK$Budhu G, Fridman S, Kuhns D, Davis J, Holland S, Ale H.. CGDilemma: Fitting Together the Puzzle Pieces for Definitive Diagnosis. Clinical Immunology. 2023;250S$4$YR$$M$Y$$$20240903$$HP$US$US
242793421$24279342$1$I$20240815$20240819$20240903$20240903$PER$$US-ALKERMES INC.-ALK-2024-002168$ALKERMES$$40$YR$$F$Y$$$20240904$$HP$US$US
242793433$24279343$3$F$20231101$20240827$20240903$20240906$EXP$$ES-009507513-2406ESP005943$MERCK$$63$YR$$M$Y$72$KG$20240906$$MD$ES$ES
242793441$24279344$1$I$$20240819$20240903$20240903$EXP$$US-SMPA-2024SPA001721$SUNOVION$$$$$$Y$$$20240903$$HP$US$US
242793451$24279345$1$I$$20240830$20240903$20240903$EXP$$DE-SANDOZ INC.-SDZ2024DE077144$SANDOZ$$$$$F$Y$$$20240903$$CN$DE$DE
242793461$24279346$1$I$20220830$20240831$20240903$20240903$EXP$$EG-SANDOZ INC.-SDZ2024EG077031$SANDOZ$$12$YR$$M$Y$30$KG$20240903$$CN$EG$EG
242793471$24279347$1$I$20240821$20240822$20240903$20240903$EXP$$RU-JNJFOC-20240903854$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240904$$HP$RU$RU
242793481$24279348$1$I$$20240903$20240903$20240903$PER$$NVSC2024US177150$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242793491$24279349$1$I$20230620$20240830$20240903$20240903$EXP$$JP-TAKEDA-SH202307723$TAKEDA$$12$YR$$F$Y$40.5$KG$20240903$$MD$JP$JP
242793502$24279350$2$F$20240823$20240905$20240903$20240913$EXP$$JP-ROCHE-10000070185$ROCHE$$60$YR$A$M$Y$$$20240913$$PH$JP$JP
242793511$24279351$1$I$20240720$20240830$20240903$20240903$EXP$$NVSJ2024JP009407$NOVARTIS$$$$E$F$Y$$$20240904$$PH$JP$JP
242793521$24279352$1$I$$20240820$20240903$20240903$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08388$NEUROCRINE BIOSCIENCES$$6$DEC$$M$Y$$$20240904$$HP$US$US
242793532$24279353$2$F$20240821$20240916$20240903$20240917$PER$$US-AMGEN-USASP2024174583$AMGEN$$62$YR$A$F$Y$$$20240917$$MD$US$US
242793541$24279354$1$I$$20240829$20240903$20240903$PER$$US-JNJFOC-20240877907$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$PH$US$US
242793551$24279355$1$I$$20240903$20240903$20240903$PER$$NVSC2024US177190$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242793561$24279356$1$I$$20240823$20240903$20240903$EXP$$GB-ROCHE-10000067392$ROCHE$$$$$$Y$$$20240904$$CN$GB$GB
242793571$24279357$1$I$$20240901$20240903$20240903$EXP$$NVSJ2024JP010406$NOVARTIS$$$$$F$Y$$$20240904$$MD$JP$JP
242793581$24279358$1$I$$20240903$20240903$20240903$PER$$NVSC2024US177189$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242793601$24279360$1$I$$20240903$20240903$20240903$PER$$NVSC2024US177191$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242793612$24279361$2$F$20240801$20240829$20240903$20240906$PER$$US-AMGEN-USASP2024175408$AMGEN$$$$$F$Y$$$20240905$$MD$US$US
242793622$24279362$2$F$20240101$20240924$20240903$20240930$EXP$$NVSC2024DE142812$NOVARTIS$$47$YR$$F$Y$$$20240930$$MD$DE$DE
242793631$24279363$1$I$20180101$20240811$20240903$20240903$PER$$US-AMGEN-USASP2024164898$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240903$$MD$US$US
242793641$24279364$1$I$$20240829$20240903$20240903$EXP$$US-JNJFOC-20240882469$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$CN$US$US
242793651$24279365$1$I$$20240826$20240903$20240903$PER$$US-JNJFOC-20240875626$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$HP$US$US
242793661$24279366$1$I$$20240827$20240903$20240903$EXP$$US-BAUSCHBL-2024BNL032494$BAUSCH AND LOMB$$$$$F$Y$$$20240904$$CN$US$US
242793671$24279367$1$I$20240101$20240826$20240903$20240903$PER$$US-BAUSCHBL-2024BNL032377$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240904$$CN$US$US
242793682$24279368$2$F$20240101$20240912$20240903$20240923$PER$$US-BAUSCHBL-2024BNL032261$BAUSCH AND LOMB$$65$YR$$F$Y$125.19$KG$20240923$$CN$US$US
242793691$24279369$1$I$20240123$20240815$20240903$20240903$EXP$$CN-BEIGENE-BGN-2024-012805$BEIGENE$$$$$$Y$$$20240903$$HP$CN$CN
242793711$24279371$1$I$$20240826$20240903$20240903$EXP$$DE-JNJFOC-20240876135$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240904$$CN$DE$DE
242793721$24279372$1$I$$20240823$20240903$20240903$PER$$US-ABBVIE-5895672$ABBVIE$$$$$$Y$$$20240903$$MD$US$US
242793742$24279374$2$F$$20240923$20240903$20240927$EXP$$CA-ORGANON-O2409CAN000093$ORGANON$$50$YR$$F$Y$68$KG$20240927$$HP$CA$CA
242793751$24279375$1$I$$20240829$20240903$20240903$EXP$$US-AstraZeneca-2024A197299$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242793761$24279376$1$I$$20240822$20240903$20240903$EXP$$DE-ABBVIE-5895375$ABBVIE$$$$$M$Y$$$20240903$$MD$DE$DE
242793771$24279377$1$I$$20240827$20240903$20240903$EXP$$RO-BIOGEN-2024BI01280536$BIOGEN$$$$$F$Y$6.2$KG$20240903$$MD$RO$RO
242793782$24279378$2$F$20240801$20240828$20240903$20240910$EXP$$US-BIOGEN-2024BI01280484$BIOGEN$$44$YR$$F$Y$$$20240910$$HP$US$US
242793791$24279379$1$I$$20240827$20240903$20240903$EXP$$BR-JNJFOC-20240881947$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$MD$BR$BR
242793801$24279380$1$I$20240701$20240903$20240903$20240903$PER$$NVSC2024US177109$NOVARTIS$$55$YR$$F$Y$$$20240904$$HP$US$US
242793811$24279381$1$I$$20240828$20240903$20240903$EXP$$US-BIOGEN-2024BI01280498$BIOGEN$$$$$F$Y$$$20240903$$CN$US$US
242793821$24279382$1$I$20240813$20240902$20240903$20240903$EXP$FR-AFSSAPS-NC2024001025$NVSC2024FR176254$NOVARTIS$$72$YR$$F$Y$63$KG$20240904$$MD$FR$FR
242793833$24279383$3$F$20240830$20240904$20240903$20240909$PER$$US-AMGEN-USASP2024175523$AMGEN$$75$YR$E$F$Y$$$20240909$$CN$US$US
242793841$24279384$1$I$20240801$20240828$20240903$20240903$EXP$$US-ABBVIE-5899946$ABBVIE$$76$YR$$F$Y$$$20240903$$CN$US$US
242793851$24279385$1$I$20240801$20240826$20240903$20240903$EXP$$US-JNJFOC-20240872565$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240904$$CN$US$US
242793861$24279386$1$I$$20240828$20240903$20240903$PER$$US-JNJFOC-20240875239$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$MD$US$US
242793871$24279387$1$I$$20240903$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409001187$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240903$$CN$US$US
242793881$24279388$1$I$$20240828$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018140$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240903$$CN$US$US
242793891$24279389$1$I$20240101$20240826$20240903$20240903$EXP$$JP-AMGEN-JPNSP2024154362$AMGEN$$$$E$F$Y$$$20240903$$MD$JP$JP
242793901$24279390$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA253209$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240904$$MD$US$US
242793911$24279391$1$I$20240701$20240828$20240903$20240903$EXP$$CO-ABBVIE-5901137$ABBVIE$$69$YR$$M$Y$77$KG$20240903$$CN$CO$CO
242793921$24279392$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA253559$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240904$$MD$US$US
242793931$24279393$1$I$$20240902$20240903$20240903$EXP$$IT-SANDOZ INC.-PHHY2019IT070924$SANDOZ$$43$YR$$F$Y$$$20240903$$MD$IT$IT
242793941$24279394$1$I$$20240828$20240903$20240903$EXP$$US-ABBVIE-5900712$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242793951$24279395$1$I$$20240827$20240903$20240903$EXP$$BR-ABBVIE-5904759$ABBVIE$$$$$F$Y$$$20240903$$CN$BR$BR
242793961$24279396$1$I$20240721$20240829$20240903$20240903$EXP$$CN-ABBVIE-5901389$ABBVIE$$74$YR$$M$Y$63$KG$20240903$$MD$CN$CN
242793971$24279397$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA253229$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240904$$$US$US
242793983$24279398$3$F$20161031$20240821$20240903$20240920$EXP$$JP-JNJFOC-A-CH2016-146301$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240920$$MD$JP$JP
242793991$24279399$1$I$20210101$20240827$20240903$20240903$EXP$$US-SANDOZ INC.-SDZ2024US077437$SANDOZ$$$$$F$Y$$$20240903$$CN$US$US
242794001$24279400$1$I$20240301$20240829$20240903$20240903$EXP$$US-ABBVIE-5902557$ABBVIE$$26$YR$$F$Y$$$20240903$$CN$US$US
242794021$24279402$1$I$$20240902$20240903$20240903$EXP$$IT-SANDOZ INC.-SDZ2024IT077020$SANDOZ$$79$YR$$M$Y$$$20240903$$MD$IT$IT
242794031$24279403$1$I$$20240902$20240903$20240903$EXP$$PL-SANDOZ INC.-SDZ2024PL077105$SANDOZ$$74$YR$$M$Y$$$20240903$$MD$PL$PL
242794041$24279404$1$I$$20240829$20240903$20240903$PER$$US-AMGEN-USASP2024173677$AMGEN$Gottiparthy G.; Lam K.; Kundu S. et al.. Neurofilament light chain in serum of cancer patients with acute neurological complications. CNS Oncology. 2024;13 (1):1-18$45$YR$A$$Y$$$20240903$$HP$US$US
242794051$24279405$1$I$20180101$20240811$20240903$20240903$PER$$US-AMGEN-USASP2024164889$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$M$Y$$$20240903$$MD$US$US
242794061$24279406$1$I$$20240903$20240903$20240903$EXP$$RO-SANDOZ INC.-NVSC2021RO087530$SANDOZ$$48$YR$$F$Y$$$20240903$$MD$RO$RO
242794071$24279407$1$I$20180101$20240811$20240903$20240903$PER$$US-AMGEN-USASP2024164904$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$F$Y$$$20240903$$MD$US$US
242794081$24279408$1$I$20240101$20240826$20240903$20240903$EXP$$BG-ABBVIE-5899524$ABBVIE$$70$YR$$F$Y$$$20240903$$CN$BG$BG
242794091$24279409$1$I$$20240903$20240903$20240903$EXP$PT-EMA-DD-20240820-7482647-090127$PT-SANDOZ INC.-SDZ2024PT077249$SANDOZ$$79$YR$$F$Y$$$20240903$$MD$PT$PT
242794101$24279410$1$I$20240826$20240827$20240903$20240903$EXP$$IE-ABBVIE-5901250$ABBVIE$$70$YR$$M$Y$$$20240903$$PH$IE$IE
242794112$24279411$2$F$$20240917$20240903$20240924$EXP$$JP-GSK-JP2024107598$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$PH$JP$JP
242794121$24279412$1$I$$20240827$20240903$20240903$EXP$$US-ABBVIE-5901900$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242794132$24279413$2$F$20230912$20240912$20240903$20240926$EXP$$DE-ABBVIE-5904570$ABBVIE$$54$YR$$F$Y$$$20240926$$HP$DE$DE
242794141$24279414$1$I$$20240827$20240903$20240903$PER$$US-AstraZeneca-2024A195553$ASTRAZENECA$$$$$$Y$$$20240904$$CN$US$
242794151$24279415$1$I$$20240826$20240903$20240903$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003987$CURRAX PHARMACEUTICALS$$61$YR$$F$Y$$$20240904$$HP$CA$CA
242794162$24279416$2$F$20230831$20240915$20240903$20240922$EXP$$AR-BIOGEN-2023BI01225272$BIOGEN$$45$YR$$M$Y$$$20240922$$CN$AR$AR
242794171$24279417$1$I$20240101$20240829$20240903$20240903$EXP$$US-ABBVIE-5901871$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242794181$24279418$1$I$$20240828$20240903$20240903$EXP$$US-ABBVIE-5901846$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242794191$24279419$1$I$20240826$20240827$20240903$20240903$EXP$$CA-ABBVIE-5903034$ABBVIE$$$$T$M$Y$$$20240903$$CN$CA$CA
242794201$24279420$1$I$20240810$20240830$20240903$20240903$EXP$$CA-ABBVIE-5903890$ABBVIE$$69$YR$$M$Y$$$20240903$$CN$CA$CA
242794212$24279421$2$F$20240101$20240906$20240903$20240913$EXP$$FR-ABBVIE-5875010$ABBVIE$$77$YR$$F$Y$$$20240913$$HP$FR$FR
242794221$24279422$1$I$$20240827$20240903$20240903$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001750$BLUEPRINT MEDICINES$$$$$F$Y$$$20240904$$CN$US$US
242794231$24279423$1$I$20240806$20240828$20240903$20240903$EXP$$US-BIOGEN-2024BI01280314$BIOGEN$$40$YR$$F$Y$$$20240903$$HP$US$US
242794241$24279424$1$I$$20240828$20240903$20240903$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001768$BLUEPRINT MEDICINES$$$$$F$Y$$$20240904$$CN$US$US
242794262$24279426$2$F$$20240824$20240903$20240906$EXP$$DK-ABBVIE-5905261$ABBVIE$$$$$$Y$$$20240906$$CN$DK$DK
242794271$24279427$1$I$$20240820$20240903$20240903$EXP$$CN-KAMADA LIMITED-2024-KAM-CN000312$PAREXEL$Jiaping Deng, BS,and Shuangle Li, MM. Ptosis Caused by Local Injection of Human Rabies Immunoglobulin. The Journal of Craniofacial Surgery. 2024;35:e403 - e 405$$$$$Y$$$20240903$$HP$CN$CN
242794291$24279429$1$I$20240822$20240823$20240903$20240903$PER$$US-SA-2024SA253645$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240904$$CN$US$US
242794304$24279430$4$F$20240820$20240909$20240903$20240920$EXP$$NVSC2024US175380$NOVARTIS$$70$YR$$F$Y$70$KG$20240920$$CN$US$US
242794312$24279431$2$F$$20240904$20240903$20240911$EXP$$DE-SANDOZ INC.-SDZ2024DE076879$SANDOZ$$67$YR$$M$Y$$$20240911$$HP$DE$DE
242794321$24279432$1$I$$20240902$20240903$20240903$PER$$NVSC2024US177025$NOVARTIS$$$$$$Y$$$20240904$$CN$US$US
242794331$24279433$1$I$$20240829$20240903$20240903$PER$$US-ABBVIE-5903222$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242794343$24279434$3$F$20190101$20240903$20240903$20240909$PER$$US-ABBVIE-5901818$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242794351$24279435$1$I$$20240514$20240903$20240903$PER$$US-ASTELLAS-2024US014027$ASTELLAS$$$$$M$Y$$$20240830$$HP$US$US
242794361$24279436$1$I$20240819$20240831$20240903$20240903$EXP$$CN-BEIGENE-BGN-2024-013815$BEIGENE$$$$$$Y$$$20240903$$HP$CN$CN
242794372$24279437$2$F$20240829$20240904$20240903$20240905$PER$$US-AMGEN-USASP2024174423$AMGEN$$59$YR$A$F$Y$75.737$KG$20240905$$HP$US$US
242794381$24279438$1$I$20240801$20240826$20240903$20240903$PER$$US-SA-2024SA252374$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240904$$MD$US$US
242794391$24279439$1$I$$20240820$20240903$20240903$EXP$$US-Noden Pharma DAC-NOD202408-000116$NODEN PHARMA$$46$YR$A$M$Y$$$20240904$$HP$US$
242794402$24279440$2$F$20200101$20240829$20240903$20240904$EXP$GB-MHRA-MED-202408291534428000-HKRZW$GB-ABBVIE-5901208$ABBVIE$$43$YR$$M$Y$$$20240904$$HP$GB$GB
242794411$24279441$1$I$$20240823$20240903$20240903$EXP$$HU-Unichem Pharmaceuticals (USA) Inc-UCM202408-001080$UNICHEM$$17$YR$T$$Y$$$20240904$$MD$HU$
242794431$24279443$1$I$$20240819$20240903$20240903$EXP$$CN-ABBVIE-5896957$ABBVIE$Suo S, Sun S, Nguyen LXT, Qian J, Li F, Zhao D, et al. Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed. Med. 2024;5:1-15.$17$YR$$M$Y$$$20240903$$HP$CN$CN
242794441$24279444$1$I$$20240821$20240903$20240903$PER$$US-JNJFOC-20240854518$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240904$$PH$US$US
242794451$24279445$1$I$$20240828$20240903$20240903$EXP$$NVSJ2024JP010149$NOVARTIS$$$$E$M$Y$$$20240904$$PH$JP$JP
242794461$24279446$1$I$$20240828$20240903$20240903$EXP$$US-TAKEDA-2024TUS087597$TAKEDA$Popat D, Sanghavi N, Singh A, Sawhney R. Parsonage turner syndrome complicating multiple myeloma therapy:nothing to shrug your sholuders at. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:s578$66$YR$$M$Y$$$20240903$$MD$US$US
242794471$24279447$1$I$20231101$20240829$20240903$20240903$EXP$$US-ABBVIE-5793967$ABBVIE$$64$YR$$F$Y$$$20240903$$CN$US$US
242794481$24279448$1$I$$20240830$20240903$20240903$EXP$$US-ABBVIE-5902547$ABBVIE$$$$$F$Y$$$20240903$$HP$US$US
242794491$24279449$1$I$$20240830$20240903$20240903$PER$$US-AstraZeneca-2024A198720$ASTRAZENECA$$$$$$Y$$$20240904$$HP$US$
242794501$24279450$1$I$20240101$20240820$20240903$20240903$PER$$US-SA-2024SA252075$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240904$$CN$US$US
242794511$24279451$1$I$20240801$20240829$20240903$20240903$EXP$$IE-TAKEDA-2024TUS088069$TAKEDA$$75$YR$$M$Y$$$20240903$$HP$IE$IE
242794531$24279453$1$I$20240201$20240826$20240903$20240903$PER$$US-ABBVIE-5896066$ABBVIE$$$$$M$Y$111$KG$20240903$$HP$US$US
242794541$24279454$1$I$20240811$20240827$20240903$20240903$EXP$$US-AstraZeneca-2024A195291$ASTRAZENECA$$19241$DY$$F$Y$$$20240904$$CN$US$
242794551$24279455$1$I$$20240830$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202409000305$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240903$$CN$US$US
242794561$24279456$1$I$20110101$20240827$20240903$20240903$EXP$$US-ABBVIE-5899352$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242794572$24279457$2$F$20230124$20240909$20240903$20240927$PER$$US-009507513-2408USA008771$MERCK$$$$A$M$Y$$$20240927$$MD$US$US
242794581$24279458$1$I$$20240827$20240903$20240903$PER$$US-JNJFOC-20240904991$JOHNSON AND JOHNSON$$$$E$M$Y$148.8$KG$20240904$$MD$US$US
242794591$24279459$1$I$$20240830$20240903$20240903$PER$$US-AstraZeneca-2024A198675$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242794601$24279460$1$I$20240101$20240829$20240903$20240903$EXP$$US-ABBVIE-5902060$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242794611$24279461$1$I$$20240829$20240903$20240903$EXP$$US-ABBVIE-5902407$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242794641$24279464$1$I$$20240827$20240903$20240903$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08654$NEUROCRINE BIOSCIENCES$$6$DEC$$F$Y$$$20240904$$MD$US$US
242794652$24279465$2$F$20240101$20240906$20240903$20240911$EXP$$CA-ABBVIE-5903469$ABBVIE$$75$YR$$F$Y$$$20240911$$CN$CA$CA
242794661$24279466$1$I$$20240823$20240903$20240903$PER$$US-SA-2024SA253659$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240904$$CN$US$US
242794681$24279468$1$I$$20240813$20240903$20240903$PER$$US-JNJFOC-20240833597$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$HP$US$US
242794691$24279469$1$I$$20240902$20240903$20240903$EXP$$JP-JNJFOC-20240903271$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240904$$PH$JP$JP
242794701$24279470$1$I$$20240830$20240903$20240903$PER$$US-ABBVIE-5903748$ABBVIE$$$$$M$Y$$$20240903$$HP$US$US
242794711$24279471$1$I$$20240827$20240903$20240903$EXP$$AT-ABBVIE-5840983$ABBVIE$$$$E$F$Y$$$20240903$$CN$AT$AT
242794721$24279472$1$I$20211110$20240828$20240903$20240903$EXP$$CN-BEIGENE-BGN-2024-013623$BEIGENE$MEI Dan, GONG Jun, WANG Hui-fang, NI Mei-xin. Two cases of immune-related diabetic ketoacidosis induced by tislelizumab. Chin J New Drugs Clin Rem. 2024;43(7):556-560$$$$$Y$$$20240903$$PH$CN$CN
242794731$24279473$1$I$20240615$20240829$20240903$20240903$EXP$$CN-ABBVIE-5901807$ABBVIE$$75$YR$$M$Y$60$KG$20240903$$MD$CN$CN
242794741$24279474$1$I$20240715$20240829$20240903$20240903$EXP$$CN-ABBVIE-5901392$ABBVIE$$64$YR$$M$Y$57$KG$20240903$$MD$CN$CN
242794751$24279475$1$I$$20240829$20240903$20240903$PER$$US-ALXN-202408USA002111US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
242794761$24279476$1$I$$20240901$20240903$20240903$PER$$US-ABBVIE-5904053$ABBVIE$$$$$M$Y$$$20240903$$CN$US$US
242794771$24279477$1$I$20240521$20240607$20240903$20240903$PER$$US-GE HEALTHCARE-2024CSU006452$GE HEALTHCARE$$76$YR$$F$Y$91$KG$20240904$$HP$US$US
242794781$24279478$1$I$20240723$20240826$20240903$20240903$EXP$PT-INFARMED-M202408-375$PT-GE HEALTHCARE-2024CSU009737$GE HEALTHCARE$$60$YR$$F$Y$$$20240904$$MD$PT$PT
242794791$24279479$1$I$$20240829$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138538$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$71.21$KG$20240904$$CN$US$US
242794801$24279480$1$I$20240809$20240830$20240903$20240903$EXP$$US-ABBVIE-5903511$ABBVIE$$58$YR$$M$Y$$$20240903$$CN$US$US
242794811$24279481$1$I$$20240829$20240903$20240903$PER$$US-ABBVIE-5902306$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242794821$24279482$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA253214$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240904$$MD$US$US
242794831$24279483$1$I$20240813$20240830$20240903$20240903$PER$$US-AMGEN-USASP2024174070$AMGEN$$77$YR$E$F$Y$$$20240903$$CN$US$US
242794841$24279484$1$I$$20240831$20240903$20240903$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-139593$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240904$$HP$PR$PR
242794851$24279485$1$I$$20240830$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139431$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$48.08$KG$20240904$$CN$US$US
242794861$24279486$1$I$$20240827$20240903$20240903$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140193$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$75.3$KG$20240904$$CN$US$US
242794871$24279487$1$I$$20240821$20240903$20240903$PER$$US-SA-2024SA253161$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240904$$MD$US$US
242794881$24279488$1$I$$20240829$20240903$20240903$EXP$JP-MMM-CTV2U63R$JP-VIIV HEALTHCARE LIMITED-JP2024107360$VIIV$$$$$$Y$$$20240903$$MD$JP$JP
242794891$24279489$1$I$$20240830$20240903$20240903$30DAY$$US-GSK-US2024108444$GLAXOSMITHKLINE$$$$$M$Y$$$20240903$$CN$US$US
242794901$24279490$1$I$20240812$20240903$20240903$20240903$EXP$FR-AFSSAPS-PB2024000959$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-140209$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240904$$MD$FR$FR
242794912$24279491$2$F$20240101$20240903$20240903$20240906$EXP$$TN-ABBVIE-5901174$ABBVIE$$51$YR$$M$Y$$$20240906$$CN$TN$TN
242794921$24279492$1$I$20240820$20240902$20240903$20240903$EXP$GB-MHRA-MED-202409022234579740-WNRKQ$GB-SANDOZ INC.-SDZ2024GB077289$SANDOZ$$48$YR$$M$Y$85$KG$20240903$$CN$GB$GB
242794931$24279493$1$I$$20240823$20240903$20240903$PER$$US-ABBVIE-5895150$ABBVIE$$$$$F$Y$$$20240903$$CN$US$US
242794941$24279494$1$I$20240101$20240822$20240903$20240903$PER$$US-SA-2024SA255428$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240904$$HP$US$US
242794953$24279495$3$F$$20240916$20240903$20240919$EXP$$US-ABBVIE-5901693$ABBVIE$$$$$F$Y$81$KG$20240919$$CN$US$US
242794961$24279496$1$I$$20240902$20240903$20240903$EXP$$CA-SANDOZ INC.-SDZ2024CA077092$SANDOZ$$53$YR$$M$Y$$$20240903$$CN$CA$CA
242794973$24279497$3$F$20240731$20240916$20240903$20240920$EXP$$US-ABBVIE-5901990$ABBVIE$$61$YR$$M$Y$$$20240920$$CN$US$US
242794981$24279498$1$I$20240718$20240830$20240903$20240903$EXP$$CN-ABBVIE-5901905$ABBVIE$$61$YR$$M$Y$60$KG$20240903$$MD$CN$CN
242794991$24279499$1$I$20160315$20240830$20240903$20240903$EXP$FR-AFSSAPS-PP2024000859$FR-ABBVIE-5904602$ABBVIE$$82$YR$$F$Y$$$20240903$$MD$FR$FR
242795011$24279501$1$I$$20240902$20240903$20240903$EXP$$NVSC2024NP177107$NOVARTIS$$$$$M$Y$$$20240904$$MD$NP$NP
242795021$24279502$1$I$$20240829$20240903$20240903$PER$$US-ELI_LILLY_AND_COMPANY-US202408018872$ELI LILLY AND CO$$24$YR$A$M$Y$$$20240903$$HP$US$US
242795041$24279504$1$I$$20240830$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139736$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240904$$HP$US$US
242795051$24279505$1$I$$20240903$20240903$20240903$EXP$DE-BFARM-24006098$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-140217$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$90$KG$20240904$$MD$DE$DE
242795061$24279506$1$I$20240101$20240830$20240903$20240903$EXP$$CA-ABBVIE-5903457$ABBVIE$$47$YR$$F$Y$$$20240903$$CN$CA$CA
242795072$24279507$2$F$$20240901$20240903$20240911$PER$$US-HALEON-2194887$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
242795081$24279508$1$I$$20240828$20240903$20240903$EXP$$AR-BEIGENE-BGN-2024-013797$BEIGENE$$$$$$Y$$$20240903$$MD$AR$AR
242795091$24279509$1$I$$20240902$20240903$20240903$EXP$$PL-SANDOZ INC.-PHHY2017PL156565$SANDOZ$$44$YR$$F$Y$$$20240903$$MD$PL$PL
242795101$24279510$1$I$$20240822$20240903$20240903$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135537$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$CN$US$US
242795112$24279511$2$F$20240801$20240913$20240903$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136221$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240919$$CN$US$US
242795122$24279512$2$F$$20240920$20240903$20240924$PER$$US-JAZZ PHARMACEUTICALS-2024-US-014082$JAZZ$$$$$F$Y$58$KG$20240924$$HP$US$US
242795131$24279513$1$I$20231201$20240828$20240903$20240903$EXP$DE-EMBRYOTOX-202310245$DE-GSK-DE2024107075$GLAXOSMITHKLINE$$$$$$Y$$$20240903$$MD$DE$DE
242795142$24279514$2$F$$20240903$20240903$20240911$PER$$US-ABBVIE-5905352$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
242795151$24279515$1$I$$20240830$20240903$20240903$EXP$$GB-AMGEN-GBRSP2024175170$AMGEN$$$$$M$Y$$$20240903$$CN$GB$GB
242795161$24279516$1$I$20240801$20240829$20240903$20240903$EXP$$CA-ABBVIE-5904753$ABBVIE$$66$YR$$F$Y$$$20240903$$CN$CA$CA
242795171$24279517$1$I$$20240902$20240903$20240903$PER$$US-AMGEN-USASP2024175380$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242795191$24279519$1$I$$20240902$20240903$20240903$EXP$$PT-SANDOZ INC.-SDZ2024PT077168$SANDOZ$$79$YR$$F$Y$$$20240903$$MD$PT$PT
242795201$24279520$1$I$20240829$20240903$20240903$20240903$EXP$GB-MHRA-MED-202409030805549230-HYDTM$GB-JNJFOC-20240903421$JOHNSON AND JOHNSON$$31$YR$A$M$Y$67$KG$20240904$$HP$GB$GB
242795211$24279521$1$I$20100121$20240826$20240903$20240903$PER$$US-JNJFOC-20240874055$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20240904$$HP$US$US
242795241$24279524$1$I$20240710$20240902$20240904$20240904$EXP$$DE-SANDOZ INC.-SDZ2024DE077216$SANDOZ$$72$YR$$M$Y$$$20240903$$MD$DE$DE
242795251$24279525$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA138187$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240904$$MD$US$US
242795261$24279526$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA255443$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240904$$MD$US$US
242795271$24279527$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139225$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240904$$CN$US$US
242795281$24279528$1$I$$20240831$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139547$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$70.31$KG$20240904$$CN$US$US
242795291$24279529$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139373$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240904$$CN$US$US
242795301$24279530$1$I$$20240831$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139512$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240904$$HP$US$US
242795313$24279531$3$F$20240101$20240924$20240904$20240928$EXP$$CA-ABBVIE-5903492$ABBVIE$$57$YR$$M$Y$$$20240928$$CN$CA$CA
242795331$24279533$1$I$$20240901$20240904$20240904$EXP$$NVSC2024US176486$NOVARTIS$$$$$$Y$$$20240904$$CN$US$US
242795341$24279534$1$I$20211112$20240829$20240904$20240904$EXP$$IE-TAKEDA-2021TUS077953$TAKEDA$$56$YR$$F$Y$$$20240904$$HP$IE$IE
242795351$24279535$1$I$$20240819$20240904$20240904$EXP$$CN-ABBVIE-5896956$ABBVIE$Suo S, Sun S, Nguyen LXT, Qian J, Li F, Zhao D, et al. Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed. Med. 2024;5:1-15.$82$YR$$F$Y$$$20240904$$HP$CN$CN
242795361$24279536$1$I$20240823$20240829$20240904$20240904$EXP$$US-AMGEN-USASP2024173577$AMGEN$$83$YR$E$F$Y$$$20240903$$CN$US$US
242795371$24279537$1$I$$20240827$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408017300$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240903$$CN$US$US
242795381$24279538$1$I$$20240823$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136248$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$MD$US$US
242795391$24279539$1$I$$20240819$20240904$20240904$EXP$$CN-ABBVIE-5896958$ABBVIE$Suo S, Sun S, Nguyen LXT, Qian J, Li F, Zhao D, et al. Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed. Med. 2024;5:1-15.$39$YR$$F$Y$$$20240904$$HP$CN$CN
242795401$24279540$1$I$$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024174182$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242795421$24279542$1$I$$20240819$20240904$20240904$EXP$$CN-ABBVIE-5896959$ABBVIE$Suo S, Sun S, Nguyen LXT, Qian J, Li F, Zhao D, et al. Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed. Med. 2024;S2666634024003003.$22$YR$$M$Y$$$20240904$$HP$CN$CN
242795431$24279543$1$I$$20240819$20240904$20240904$EXP$$CN-ABBVIE-5896960$ABBVIE$Suo S, Sun S, Nguyen LXT, Qian J, Li F, Zhao D, et al. Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed. Med. 2024;S2666634024003003.$33$YR$$M$Y$$$20240904$$HP$CN$CN
242795441$24279544$1$I$$20240828$20240904$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-123647$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240904$$PH$JP$JP
242795451$24279545$1$I$20240424$20240822$20240904$20240904$EXP$FR-AFSSAPS-AM2024000660$FR-Accord-443357$ACCORD$$71$YR$E$M$Y$74$KG$20240903$$MD$FR$FR
242795461$24279546$1$I$20201021$20240822$20240904$20240904$EXP$PL-URPL-1-2523-2020$PL-Accord-443106$ACCORD$$69$YR$E$F$Y$58$KG$20240903$$HP$PL$PL
242795471$24279547$1$I$$20240822$20240904$20240904$EXP$GB-MHRA-MIDB-0b987871-d6c4-4d3e-955e-e973ea10c63d$GB-Accord-443412$ACCORD$$85$YR$E$F$Y$$$20240903$$PH$GB$GB
242795481$24279548$1$I$20240109$20240822$20240904$20240904$EXP$SE-SEMPA-2024-006062$SE-Accord-443521$ACCORD$$74$YR$E$F$Y$100$KG$20240903$$CN$SE$SE
242795492$24279549$2$F$20240710$20240829$20240904$20240909$EXP$GB-MHRA-MED-202408221347087970-JSZRY$GB-Accord-443099$ACCORD$$74$YR$E$F$Y$90$KG$20240909$$MD$GB$GB
242795501$24279550$1$I$20240809$20240822$20240904$20240904$EXP$CN-HENLIUS-24CN016584$CN-Accord-444461$ACCORD$$61$YR$A$F$Y$$$20240903$$MD$CN$CN
242795511$24279551$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA253176$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240904$$MD$US$US
242795521$24279552$1$I$$20240822$20240904$20240904$EXP$$PT-Accord-443366$ACCORD$Le M, Ravin K, Hasan A, Clauss H, Muchant D, Pasko J, et al. Single donor-derived strongyloidiasis in three solid organ transplant recipients: case series and review of the literature. Am J Transplant 2014;14(5):1199-206.$14$YR$T$M$Y$$$20240903$$HP$PT$PT
242795531$24279553$1$I$20240815$20240823$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136210$BRISTOL MYERS SQUIBB$$25$YR$A$M$Y$$$20240904$$HP$US$US
242795541$24279554$1$I$$20240827$20240904$20240904$EXP$$ZA-AstraZeneca-2024A195653$ASTRAZENECA$$62$YR$$M$Y$$$20240904$$CN$ZA$
242795551$24279555$1$I$20240101$20240828$20240904$20240904$PER$$US-ABBVIE-5900855$ABBVIE$$25$YR$$F$Y$$$20240904$$HP$US$US
242795561$24279556$1$I$20240801$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139438$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$114.31$KG$20240904$$CN$US$US
242795571$24279557$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140351$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$114.8$KG$20240904$$CN$US$US
242795581$24279558$1$I$$20240828$20240904$20240904$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-138031$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240904$$MD$RU$RU
242795592$24279559$2$F$$20240916$20240904$20240918$PER$$NVSC2024US177298$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
242795601$24279560$1$I$$20240826$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140229$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$68.95$KG$20240904$$MD$US$US
242795611$24279561$1$I$$20240827$20240904$20240904$EXP$$IN-ABBVIE-5901686$ABBVIE$Nookala M, Gudapati RK. Retinal injury resulting from intravitreal dexamethasone implant injection in nonvitrectomized eye. Indian Journal of Ophthalmology - Case Reports. 2024;4(3):757-758.$62$YR$$M$Y$$$20240904$$HP$IN$IN
242795621$24279562$1$I$20240101$20240830$20240904$20240904$EXP$$BG-ABBVIE-5905139$ABBVIE$$63$YR$$F$Y$$$20240904$$CN$BG$BG
242795632$24279563$2$F$$20240902$20240904$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US051131$SANDOZ$$$$$$Y$$$20240904$$CN$US$US
242795641$24279564$1$I$20240819$20240823$20240904$20240904$EXP$$US-ABBVIE-5895493$ABBVIE$$73$YR$$F$Y$$$20240904$$CN$US$US
242795651$24279565$1$I$$20240823$20240904$20240904$EXP$DE-MLMSERVICE-20240816-PI165226-00196-1$DE-STRIDES ARCOLAB LIMITED-2024SP010802$STRIDES$N?gele H, Rosenkranz M, N?gele MP. Hyponatremia-Induced Epileptic Seizure Provoked by Levetiracetam and Pain Medication Intake in a Patient with Central Diabetes Insipidus. Case reports in neurology. 2024;16(1):204-7$67$YR$$M$Y$$$20240904$$MD$DE$DE
242795661$24279566$1$I$$20240830$20240904$20240904$EXP$AU-TGA-0000816815$AU-COLLEGIUM PHARMACEUTICAL, INC.-20240800679$COLLEGIUM PHARMACEUTICAL$$70$YR$$F$Y$$$20240903$$MD$AU$AU
242795671$24279567$1$I$$20240821$20240904$20240904$EXP$$CA-ASTELLAS-2024-AER-003191$ASTELLAS$UNKNOWN U.$50$YR$A$F$Y$$$20240904$$HP$CA$CA
242795681$24279568$1$I$20240827$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139651$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$83.46$KG$20240904$$HP$US$US
242795691$24279569$1$I$$20240827$20240904$20240904$PER$$US-AMGEN-USASP2024171582$AMGEN$$$$$$Y$$$20240903$$CN$US$US
242795701$24279570$1$I$20240801$20240903$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049391$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240904$$CN$US$US
242795711$24279571$1$I$$20240828$20240904$20240904$EXP$$US-CHATTEMPRD-2024OHG029991$CHATTEM$$54$YR$A$M$Y$$$20240904$$LW$US$US
242795721$24279572$1$I$$20240830$20240904$20240904$30DAY$$CA-SANDOZ INC.-NVSC2021CA133843$SANDOZ$$$$$F$Y$$$20240904$$CN$CA$CA
242795731$24279573$1$I$$20240828$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408019157$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240904$$CN$US$US
242795741$24279574$1$I$20240827$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000258$ELI LILLY AND CO$$58$YR$A$$Y$$$20240904$$CN$US$US
242795751$24279575$1$I$20240101$20240826$20240904$20240904$EXP$$CA-CURRAX PHARMACEUTICALS LLC-CA-2024CUR004041$CURRAX PHARMACEUTICALS$$$$$$Y$$$20240904$$CN$CA$CA
242795761$24279576$1$I$20240801$20240814$20240904$20240904$PER$$US-TEVA-VS-3235212$TEVA$$$$$$Y$$$20240904$$MD$US$US
242795771$24279577$1$I$$20240826$20240904$20240904$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP010973$STRIDES$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage.. Br-J-Clin-Pharmacol. 2023;89 (8):2497-2507$50$YR$$M$Y$$$20240904$$HP$ES$ES
242795782$24279578$2$F$$20240826$20240904$20240904$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP011020$STRIDES$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al.. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage.. Br-J-Clin-Pharmacol. 2023;89 (8):2497-2507$30$YR$$M$Y$$$20240904$$HP$ES$ES
242795792$24279579$2$F$20240801$20240925$20240904$20240930$EXP$$JP-ASTELLAS-2024-AER-002299$ASTELLAS$$7$DEC$$M$Y$$$20240930$$HP$JP$JP
242795801$24279580$1$I$$20240828$20240904$20240904$EXP$NO-NOMAADVRE-PASRAPP-2024-Vdk755$NO-GSK-NO2024107092$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$NO$NO
242795811$24279581$1$I$$20240826$20240904$20240904$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP010958$STRIDES$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al.. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage.. Br-J-Clin-Pharmacol. 2023;89 (8):2497-2507$51$YR$$M$Y$$$20240904$$HP$ES$ES
242795821$24279582$1$I$$20240828$20240904$20240904$PER$$US-JNJFOC-20240874595$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242795831$24279583$1$I$$20240826$20240904$20240904$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP010959$STRIDES$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al.. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage.. Br-J-Clin-Pharmacol. 2023;89 (8):2497-2507$46$YR$$M$Y$$$20240904$$HP$ES$ES
242795841$24279584$1$I$$20240902$20240904$20240904$EXP$$AU-ABBVIE-5904728$ABBVIE$$$$$M$Y$$$20240904$$HP$AU$AU
242795851$24279585$1$I$$20240827$20240904$20240904$EXP$$JP-AMGEN-JPNSP2024171432$AMGEN$$$$$$Y$$$20240903$$PH$JP$JP
242795861$24279586$1$I$$20240830$20240904$20240904$EXP$$JP-ABBVIE-5835099$ABBVIE$$$$E$$Y$$$20240904$$PH$JP$JP
242795871$24279587$1$I$20231101$20240827$20240904$20240904$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011022$STRIDES$Kong X, Yang J, Jiang Y.. Combined large-cell neuroendocrine carcinoma and small-cell lung cancer: A case report.. Oncol-Lett. 2024;28 (4):1-7$53$YR$$F$Y$$$20240904$$MD$CN$CN
242795882$24279588$2$F$20240101$20240830$20240904$20240908$EXP$$CO-ABBVIE-5904914$ABBVIE$$$$$M$Y$$$20240908$$MD$CO$CO
242795891$24279589$1$I$20240607$20240823$20240904$20240904$EXP$CN-HENLIUS-24CN016594$CN-Accord-444727$ACCORD$$49$YR$A$F$Y$59$KG$20240904$$MD$CN$CN
242795901$24279590$1$I$20240101$20240828$20240904$20240904$EXP$$US-ABBVIE-5901003$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242795911$24279591$1$I$$20240830$20240904$20240904$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013977$JAZZ$$$$$M$Y$$$20240903$$CN$US$US
242795921$24279592$1$I$$20240829$20240904$20240904$PER$$US-TAKEDA-2024TUS087328$TAKEDA$$$$$F$Y$82$KG$20240904$$CN$US$US
242795931$24279593$1$I$20230601$20240830$20240904$20240904$EXP$$DE-ABBVIE-5279292$ABBVIE$$87$YR$$M$Y$$$20240904$$MD$DE$DE
242795941$24279594$1$I$$20240826$20240904$20240904$EXP$$SK-JNJFOC-20240874874$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240904$$MD$SK$SK
242795951$24279595$1$I$20240827$20240828$20240904$20240904$PER$$US-ROCHE-10000069393$ROCHE$$90$YR$E$$Y$$$20240904$$MD$US$US
242795961$24279596$1$I$$20240624$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007717$STRIDES$Dhillon J, Gasbeck T, Misra N.. Rodent Invasion! A Case of Hantavirus in an Immunocompromised Patient Causing Hantavirus Pulmonary Syndrome.. Am-J-Respir-Crit-Care-Med. 2024;209$69$YR$$F$Y$$$20240904$$HP$US$US
242795971$24279597$1$I$$20240703$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008236$STRIDES$Youssefian L, Saeidian AH, Saffarian Z, Ariamanesh M, Abdollahimajd F, Molkara S, et al.. Whole-Transcriptome Sequencing-Based Profiling of the Cutaneous Virome in Patients with Secondary Immunodeficiency.. JID Innovations. 2024;4(4):100278$29$YR$$F$Y$$$20240904$$MD$US$US
242795981$24279598$1$I$$20240619$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007527$STRIDES$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients.. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster)$$$$$Y$$$20240904$$HP$US$US
242795991$24279599$1$I$$20240619$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007503$STRIDES$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients.. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster).$$$$$Y$$$20240904$$HP$US$US
242796001$24279600$1$I$$20240305$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002852$STRIDES$Goodman B, Alluri S, Abdulla H, Montecalvo J, Vander Woude T, Brown S, et al. Acute Fibrinous and Organizing Pneumonia Due to Sirolimus Induced Lung Toxicity in a Bilateral Lung Transplant Patient.. Am-J-Respir-Crit-Care-Med. 2023;207$67$YR$$M$Y$$$20240904$$HP$US$US
242796011$24279601$1$I$$20231114$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017343$STRIDES$Yibirin M, Mustafayev K, Hosry J, Pundhir P, Klingen J, Yepez Guevara E, et al.. Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients with Solid Tumors.. Am-J-Gastroenterol. 2023;118(9):1609-1617.$37$YR$$M$Y$$$20240904$$MD$US$US
242796021$24279602$1$I$$20230925$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015128$STRIDES$Eubanks BN, Seykora CM, Bandino JP.. Granulomatous Cheilitis Preceding Gastrointestinal Manifestations of Crohn^s Disease. Am J Dermatopathol. 2023;45(7):482-486$20$YR$$M$Y$$$20240904$$HP$US$US
242796031$24279603$1$I$$20231004$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015493$STRIDES$Coscia L, Cohen D, Dube GK, Hofmann RM, Moritz MJ, Gattis S, et al.. Outcomes With Belatacept Exposure During Pregnancy in Kidney Transplant Recipients: A Case Series.. Transplantation.. 2023;107(9):2047-2054.$37$YR$$F$Y$$$20240904$$MD$US$US
242796041$24279604$1$I$$20231208$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP018712$STRIDES$Aribi A, Budde LE, Alvarnas JC, Smith EP, Salhotra A, Al Malki MM, et al.. Durable Leukemia and HIV Remission without Antiviral Therapy Following an Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) Using a Donor with CCR5-DELTA32/DELTA32 Homozygosity for an Acute Myeloid Leukemia (AML) Patient.. Blood. 2022;140 (Suppl. 1):7597-7598.$$$$M$Y$$$20240904$$HP$US$US
242796051$24279605$1$I$$20231004$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015518$STRIDES$Coscia L, Cohen D, Dube GK, Hofmann RM, Moritz MJ, Gattis S, et al.. Outcomes With Belatacept Exposure During Pregnancy in Kidney Transplant Recipients: A Case Series.. Transplantation.. 2023;107(9):2047-2054.$$$$$Y$$$20240904$$MD$US$US
242796061$24279606$1$I$$20240429$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005230$STRIDES$Skowronski J, Hickey GW, Horn E, Rios J, Mathier MA, Levene J, et al. . A BRAVE NEW WORLD: UTILIZATION OF ASSISTED REPRODUCTIVE TECHNOLOGY AFTER HEART TRANSPLANTATION.   .. J-Am-Coll-Cardiol. 2024;83 (Suppl.) (13:2862$35$YR$$F$Y$$$20240904$$HP$US$US
242796071$24279607$1$I$$20231009$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015632$STRIDES$Gupta S, Wojciechowski D. Late Conversion to Belatacept in Biopsy Proven Tacrolimus Toxicity. J-Am-Soc-Nephrol. 2016;27622A(poster)abstr. FR-P01090$$$$$Y$$$20240904$$HP$US$US
242796081$24279608$1$I$$20240312$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003164$STRIDES$Melton MK, Stanley DN, Iqbal Z, Keene KS, Simiele E, McDonald A.. Acute Toxicity of Total Body Irradiation Using Volumetric Arc Therapy With a Focus on the Effect of Lung Dose Rate.. Adv-Radiat-Oncol. 2024;9 (4)$$$$$Y$$$20240904$$MD$US$US
242796091$24279609$1$I$$20231107$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016981$STRIDES$Walker AM, Bermas BL, Jacobe HT. Morphea disease activity during pregnancy: A case series. J-Dermatol. 2022;49(12):1278-1283$42$YR$$F$Y$$$20240904$$HP$US$US
242796102$24279610$2$F$20240101$20240904$20240904$20240916$EXP$$US-Emmaus Medical, Inc.-EMM202408-000425$EMMAUS LIFE SCIENCES$$55$YR$A$F$Y$$$20240916$$CN$US$
242796111$24279611$1$I$20240801$20240822$20240904$20240904$EXP$$US-Emmaus Medical, Inc.-EMM202408-000426$EMMAUS LIFE SCIENCES$$55$YR$A$F$Y$$$20240904$$CN$US$
242796121$24279612$1$I$$20240902$20240904$20240904$EXP$$GB-ABBVIE-5905129$ABBVIE$Wolfe C, Kennard B, Bewley A, Mehrtens S. A retrospective review of pregnancies in our psoriasis biologic cohort. Clinical and Experimental Dermatology. 2024;49(9):1080-1082.$43$YR$$F$Y$$$20240904$$HP$GB$GB
242796131$24279613$1$I$$20231031$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016629$STRIDES$Powers C, Corrente B, Stein W, Joyce J, Gunabushanam V, Khanna A, et al.. Covid-19 virus in Intestinal Transplant Patients: Allograft Survival Rate and Associated Therapies - An inclusive UPMC Intestinal Transplantation and Rehabilitation Center Study.. Transplantation.. 2023;107 (Suppl. 1):70 abstr. 122.$$$A$$Y$$$20240904$$MD$US$US
242796141$24279614$1$I$20240830$20240901$20240904$20240904$EXP$$DE-ABBVIE-5904769$ABBVIE$$68$YR$$F$Y$$$20240904$$CN$DE$DE
242796152$24279615$2$F$$20240903$20240904$20240904$PER$$NVSC2024US177302$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242796161$24279616$1$I$$20240828$20240904$20240904$EXP$$US-GSK-US2024AMR108289$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$US$US
242796171$24279617$1$I$$20240902$20240904$20240904$EXP$$CA-SANDOZ INC.-SDZ2024CA077069$SANDOZ$$43$YR$$F$Y$$$20240904$$CN$CA$CA
242796181$24279618$1$I$20240101$20240825$20240904$20240904$EXP$$RO-ASTELLAS-2024-AER-002046$ASTELLAS$$64$YR$A$M$Y$$$20240904$$MD$RO$RO
242796191$24279619$1$I$$20240829$20240904$20240904$PER$$US-ABBVIE-5902743$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242796201$24279620$1$I$20240829$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024173453$AMGEN$$74$YR$E$F$Y$$$20240903$$CN$US$US
242796211$24279621$1$I$$20240828$20240904$20240904$PER$$US-AMGEN-USASP2024172444$AMGEN$$$$$M$Y$$$20240903$$CN$US$US
242796221$24279622$1$I$$20240830$20240904$20240904$PER$$US-TAKEDA-2024TUS088148$TAKEDA$$$$$$Y$$$20240904$$MD$US$US
242796231$24279623$1$I$20240801$20240828$20240904$20240904$EXP$$US-ABBVIE-5901599$ABBVIE$$43$YR$$M$Y$$$20240904$$CN$US$US
242796261$24279626$1$I$$20240821$20240904$20240904$PER$$US-ASTELLAS-2024-AER-002276$ASTELLAS$$57$YR$A$M$Y$$$20240904$$HP$US$US
242796271$24279627$1$I$$20240829$20240904$20240904$PER$$US-ROCHE-10000070368$ROCHE$$$$$$Y$$$20240904$$MD$US$US
242796281$24279628$1$I$$20240826$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139631$BRISTOL MYERS SQUIBB$Gottiparthy A, Lam K, Kundu S, Yang Z, Tremont-Lukats I, Tummala S. Neurofilament light chain in serum of cancer patients with acute neurological complications. CNS Oncology. 2024 Aug 13;13(1):1-13. doi:10.1080/20450907.2024.2386233.$63$YR$A$F$Y$$$20240904$$HP$US$US
242796293$24279629$3$F$$20240909$20240904$20240912$EXP$DE-RDY-SPO/DEU/24/0012211$DE-UCBSA-2024044628$UCB$$12$WK$$M$Y$$$20240912$$HP$DE$DE
242796301$24279630$1$I$$20240826$20240904$20240904$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP011000$STRIDES$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al.. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage.. Br-J-Clin-Pharmacol. 2023;89 (8):2497-2507$37$YR$$M$Y$$$20240904$$HP$ES$ES
242796311$24279631$1$I$$20240826$20240904$20240904$EXP$$JP-ROCHE-10000071581$ROCHE$$10$DEC$E$F$Y$$$20240904$$MD$JP$JP
242796321$24279632$1$I$$20240827$20240904$20240904$EXP$$AU-CELLTRION INC.-2024AU020786$CELLTRION$$$$$$Y$$$20240904$$HP$AU$AU
242796332$24279633$2$F$20240828$20240903$20240904$20240905$30DAY$$US-AMGEN-USASP2024172903$AMGEN$$$$$M$Y$83$KG$20240904$$PH$US$US
242796341$24279634$1$I$20220419$20240903$20240904$20240904$EXP$$PL-SANDOZ INC.-NVSC2022PL135830$SANDOZ$$57$YR$$F$Y$66$KG$20240904$$MD$PL$PL
242796351$24279635$1$I$20240827$20240828$20240904$20240904$EXP$$FR-ABBVIE-5904521$ABBVIE$$62$YR$$M$Y$$$20240904$$CN$FR$FR
242796361$24279636$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA253484$SANOFI AVENTIS$$$$$F$Y$$$20240904$$HP$US$US
242796373$24279637$3$F$$20240901$20240904$20240906$EXP$$NVSC2024US176163$NOVARTIS$$52$YR$$$Y$$$20240906$$CN$US$US
242796391$24279639$1$I$20240101$20240830$20240904$20240904$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-139686$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240904$$PH$PR$PR
242796401$24279640$1$I$20240101$20240823$20240904$20240904$PER$$US-ABBVIE-5895045$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242796411$24279641$1$I$$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A198622$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242796421$24279642$1$I$$20240827$20240904$20240904$PER$$US-SA-2024SA252385$SANOFI AVENTIS$$$$A$F$Y$$$20240904$$MD$US$US
242796431$24279643$1$I$20240815$20240820$20240904$20240904$EXP$$US-ChurchDwight-2024-CDW-01374$CHURCH + DWIGHT$$$$$F$Y$$$20240830$$CN$US$US
242796441$24279644$1$I$20240101$20240822$20240904$20240904$PER$$US-SA-2024SA254216$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240904$$MD$US$US
242796451$24279645$1$I$$20240827$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136766$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240904$$HP$US$US
242796461$24279646$1$I$$20240827$20240904$20240904$EXP$$JP-AMGEN-JPNSP2024171321$AMGEN$$$$$M$Y$$$20240903$$CN$JP$JP
242796471$24279647$1$I$$20240901$20240904$20240904$EXP$$US-SANDOZ INC.-SDZ2024US077310$SANDOZ$$$$$$Y$$$20240904$$CN$US$US
242796481$24279648$1$I$20240801$20240829$20240904$20240904$EXP$$US-ABBVIE-5901974$ABBVIE$$37$YR$$M$Y$$$20240904$$CN$US$US
242796491$24279649$1$I$$20240828$20240904$20240904$EXP$$US-ABBVIE-5893174$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242796501$24279650$1$I$20240824$20240903$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049257$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$$$20240904$$CN$US$US
242796521$24279652$1$I$20240831$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001209$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240904$$CN$US$US
242796531$24279653$1$I$$20240820$20240904$20240904$EXP$$GB-AMGEN-GBRSP2024175504$AMGEN$$75$YR$E$F$Y$$$20240903$$MD$GB$GB
242796541$24279654$1$I$20240829$20240901$20240904$20240904$PER$$US-ABBVIE-5905015$ABBVIE$$$$$$Y$$$20240904$$CN$US$US
242796551$24279655$1$I$$20240829$20240904$20240904$EXP$$ZA-TAKEDA-2024TUS088019$TAKEDA$$$$$M$Y$$$20240904$$CN$ZA$ZA
242796561$24279656$1$I$$20240819$20240904$20240904$PER$$US-ASTELLAS-2024-AER-002020$ASTELLAS$$$$$F$Y$$$20240904$$HP$US$US
242796571$24279657$1$I$20240101$20240829$20240904$20240904$EXP$$US-ABBVIE-5901828$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242796581$24279658$1$I$20240828$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024173843$AMGEN$$$$$$Y$$$20240903$$HP$US$US
242796591$24279659$1$I$$20240821$20240904$20240904$EXP$$US-SA-2024SA253848$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240904$$HP$US$US
242796601$24279660$1$I$$20240829$20240904$20240904$EXP$$US-TAKEDA-2024TUS087487$TAKEDA$$$$$M$Y$$$20240904$$CN$US$US
242796622$24279662$2$F$$20240912$20240904$20240923$EXP$$GB-TAKEDA-2024TUS088073$TAKEDA$$$$$M$Y$$$20240923$$CN$GB$GB
242796632$24279663$2$F$$20240904$20240904$20240913$PER$$US-SA-2024SA255430$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240913$$MD$US$US
242796641$24279664$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA253864$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240904$$MD$US$US
242796651$24279665$1$I$20240101$20240831$20240904$20240904$PER$$NVSC2024US177126$NOVARTIS$$$$$M$Y$$$20240904$$CN$US$US
242796661$24279666$1$I$20240802$20240830$20240904$20240904$EXP$$CO-AMGEN-COLSL2024160670$AMGEN$$57$YR$A$F$Y$$$20240903$$CN$CO$CO
242796671$24279667$1$I$20240822$20240903$20240904$20240904$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049404$BOEHRINGER INGELHEIM$$93$YR$E$F$Y$$$20240904$$CN$US$US
242796681$24279668$1$I$$20240828$20240904$20240904$EXP$$US-BEIGENE-BGN-2024-013704$BEIGENE$$$$$$Y$$$20240904$$CN$US$US
242796691$24279669$1$I$20240603$20240821$20240904$20240904$EXP$$US-UCBSA-2024042800$UCB$$53$YR$$M$Y$$$20240904$$CN$US$US
242796701$24279670$1$I$$20240830$20240904$20240904$EXP$$US-SA-2024SA253603$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240904$$HP$US$US
242796711$24279671$1$I$20240821$20240823$20240904$20240904$EXP$$US-Accord-443612$ACCORD$$51$YR$A$M$Y$$$20240904$$HP$US$US
242796721$24279672$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A195769$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242796731$24279673$1$I$$20240830$20240904$20240904$PER$$US-AstraZeneca-2024A199328$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242796741$24279674$1$I$$20240828$20240904$20240904$PER$$US-AstraZeneca-2024A197729$ASTRAZENECA$$$$$$Y$$$20240904$$MD$US$
242796751$24279675$1$I$$20240828$20240904$20240904$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001766$BLUEPRINT MEDICINES$$$$$F$Y$$$20240904$$CN$US$US
242796761$24279676$1$I$20201218$20240821$20240904$20240904$PER$$US-AstraZeneca-2024A194383$ASTRAZENECA$$70$YR$$F$Y$$$20240904$$HP$US$
242796781$24279678$1$I$20230920$20240828$20240904$20240904$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR107558$VIIV$$63$YR$$M$Y$$$20240904$$PH$US$US
242796791$24279679$1$I$$20240829$20240904$20240904$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001773$BLUEPRINT MEDICINES$$$$$M$Y$$$20240904$$CN$US$US
242796801$24279680$1$I$20230922$20240828$20240904$20240904$30DAY$$US-AMGEN-USASP2024172629$AMGEN$$74$YR$E$M$Y$83.673$KG$20240903$$PH$US$US
242796811$24279681$1$I$20240801$20240829$20240904$20240904$EXP$NL-LRB-00999198$NL-GSK-NL2024107674$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$NL$NL
242796821$24279682$1$I$$20240826$20240904$20240904$EXP$$US-SA-2024SA253388$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240904$$CN$US$US
242796831$24279683$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA255010$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240904$$MD$US$US
242796842$24279684$2$F$20240101$20240826$20240904$20240910$PER$$US-SA-2023SA362577$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$MD$US$US
242796851$24279685$1$I$20240812$20240820$20240904$20240904$PER$$US-SA-2024SA252911$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240904$$MD$US$US
242796861$24279686$1$I$$20240827$20240904$20240904$PER$$US-SA-2024SA254340$SANOFI AVENTIS$$$$$M$Y$$$20240904$$HP$US$US
242796891$24279689$1$I$$20240828$20240904$20240904$PER$$US-ROCHE-10000068983$ROCHE$$60$YR$A$F$Y$$$20240904$$CN$US$US
242796901$24279690$1$I$$20240828$20240904$20240904$PER$$US-LEO Pharma-373180$LEO PHARM$$80$YR$$F$Y$$$20240904$$PH$US$US
242796921$24279692$1$I$$20240829$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000162$ELI LILLY AND CO$$54$YR$A$$Y$$$20240904$$CN$US$US
242796931$24279693$1$I$20240806$20240823$20240904$20240904$EXP$ES-AEMPS-1561852$ES-Accord-443394$ACCORD$$61$YR$A$F$Y$$$20240904$$PH$ES$ES
242796941$24279694$1$I$$20240901$20240904$20240904$PER$$US-ABBVIE-5905021$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242796951$24279695$1$I$20240401$20240829$20240904$20240904$30DAY$$US-GSK-US2024107696$GLAXOSMITHKLINE$$65$YR$$M$Y$$$20240904$$CN$US$US
242796961$24279696$1$I$20240829$20240829$20240904$20240904$PER$$US-ROCHE-10000070459$ROCHE$$$$$M$Y$$$20240904$$CN$US$US
242796971$24279697$1$I$20240628$20240828$20240904$20240904$EXP$DE-PEI-CADR2024330040$DE-ROCHE-10000067907$ROCHE$$33$YR$A$M$Y$75$KG$20240904$$MD$DE$DE
242796982$24279698$2$F$$20240918$20240904$20240919$PER$$NVSC2024US176487$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
242796991$24279699$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA253694$SANOFI AVENTIS$$$$A$$Y$$$20240904$$HP$US$US
242797001$24279700$1$I$$20240830$20240904$20240904$EXP$$US-ABBVIE-5903556$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242797011$24279701$1$I$20240822$20240830$20240904$20240904$PER$$US-AstraZeneca-2024A199256$ASTRAZENECA$$62$YR$$F$Y$$$20240904$$CN$US$
242797021$24279702$1$I$$20240830$20240904$20240904$EXP$$ZA-AstraZeneca-2024A198459$ASTRAZENECA$$63$YR$$F$Y$$$20240904$$CN$ZA$
242797031$24279703$1$I$$20240829$20240904$20240904$EXP$$US-AstraZeneca-2024A197426$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242797041$24279704$1$I$$20240829$20240904$20240904$EXP$$GB-AstraZeneca-2024A197791$ASTRAZENECA$$$$E$$Y$$$20240904$$MD$GB$
242797052$24279705$2$F$20240101$20240828$20240904$20240905$EXP$$US-AMGEN-USASP2024173476$AMGEN$$$$A$$Y$$$20240905$$HP$US$US
242797061$24279706$1$I$20240822$20240823$20240904$20240904$EXP$$US-Accord-444089$ACCORD$$29$YR$A$M$Y$$$20240904$$MD$US$US
242797071$24279707$1$I$$20240823$20240904$20240904$EXP$GB-MHRA-31583115$GB-Accord-443407$ACCORD$$$$$F$Y$$$20240904$$CN$GB$GB
242797082$24279708$2$F$$20240903$20240904$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005122$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242797091$24279709$1$I$20230101$20240830$20240904$20240904$EXP$$US-ABBVIE-5902461$ABBVIE$$55$YR$$M$Y$$$20240904$$CN$US$US
242797101$24279710$1$I$20231013$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-136200-2023$RECKITT BENCKISER$$73$YR$$F$Y$$$20240904$$CN$US$US
242797111$24279711$1$I$$20240902$20240904$20240904$PER$$US-ROCHE-10000072593$ROCHE$$69$YR$E$M$Y$$$20240904$$MD$US$US
242797123$24279712$3$F$20240801$20240918$20240904$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005006$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240927$$CN$US$US
242797132$24279713$2$F$20240507$20240829$20240904$20240907$EXP$$DE-AUROBINDO-AUR-APL-2024-043064$AUROBINDO$$67$YR$$F$Y$$$20240907$$MD$DE$DE
242797141$24279714$1$I$20240901$20240829$20240904$20240904$30DAY$$US-GSK-US2024AMR108568$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242797153$24279715$3$F$20240819$20240911$20240904$20240922$PER$$US-GSK-US2024106599$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240922$$HP$US$US
242797161$24279716$1$I$$20240902$20240904$20240904$PER$$US-ABBVIE-5904930$ABBVIE$$$$$$Y$$$20240904$$CN$US$US
242797171$24279717$1$I$20240806$20240823$20240904$20240904$EXP$$US-Accord-443615$ACCORD$$27$YR$A$F$Y$$$20240904$$HP$US$US
242797192$24279719$2$F$$20240830$20240904$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005156$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
242797201$24279720$1$I$20240601$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024173554$AMGEN$$77$YR$E$M$Y$$$20240903$$CN$US$US
242797211$24279721$1$I$$20240826$20240904$20240904$EXP$$US-NOVOPROD-1276044$NOVO NORDISK$$$$A$F$Y$$$20240904$$CN$US$US
242797222$24279722$2$F$$20240912$20240904$20240928$EXP$$PT-CELLTRION INC.-2024PT020757$CELLTRION$Caleca EF, Pereira R, Martins Dos Santos P, Abegao T.. Tumor Lysis Syndrome Rare Presentation As Uremic Pericarditis: A Case Report. Cureus. 2023;15(3)$$$$$Y$$$20240928$$HP$PT$PT
242797231$24279723$1$I$20240820$20240825$20240904$20240904$EXP$GB-MHRA-MED-202408251520555610-HYSJF$GB-NOVOPROD-1274825$NOVO NORDISK$$55$YR$$F$Y$83$KG$20240904$$CN$GB$GB
242797241$24279724$1$I$$20240822$20240904$20240904$EXP$$CN-NOVOPROD-1273701$NOVO NORDISK$$75$YR$$M$Y$60$KG$20240904$$CN$CN$CN
242797251$24279725$1$I$$20240824$20240904$20240904$EXP$$CO-NOVOPROD-1275507$NOVO NORDISK$$$$$M$Y$$$20240904$$CN$CO$CO
242797261$24279726$1$I$20230101$20240825$20240904$20240904$EXP$$CN-NOVOPROD-1274964$NOVO NORDISK$$49$YR$$F$Y$43$KG$20240904$$CN$CN$CN
242797271$24279727$1$I$$20240823$20240904$20240904$EXP$$US-ROCHE-10000065475$ROCHE$$$$A$F$Y$$$20240904$$HP$US$US
242797282$24279728$2$F$20240810$20240910$20240904$20240920$EXP$CH-NOVOPROD-1275474$CH-NOVOPROD-1275474$NOVO NORDISK$$56$YR$$M$Y$$$20240920$$MD$CH$CH
242797291$24279729$1$I$20240604$20240823$20240904$20240904$EXP$$US-NOVOPROD-1250788$NOVO NORDISK$$$$$F$Y$$$20240904$$CN$US$US
242797301$24279730$1$I$$20240826$20240904$20240904$EXP$$JP-NOVOPROD-1275173$NOVO NORDISK$$73$YR$$M$Y$$$20240904$$PH$JP$JP
242797311$24279731$1$I$$20240822$20240904$20240904$EXP$$CL-NOVOPROD-1273702$NOVO NORDISK$$$$T$F$Y$$$20240904$$MD$CL$CL
242797321$24279732$1$I$20240601$20240822$20240904$20240904$EXP$$US-NOVOPROD-1273257$NOVO NORDISK$$67$YR$$F$Y$$$20240904$$CN$US$US
242797331$24279733$1$I$$20240826$20240904$20240904$EXP$$US-NOVOPROD-1276138$NOVO NORDISK$$$$$M$Y$$$20240904$$HP$US$US
242797351$24279735$1$I$$20240822$20240904$20240904$EXP$$FR-NOVOPROD-1273706$NOVO NORDISK$$$$A$M$Y$$$20240904$$MD$FR$FR
242797361$24279736$1$I$20240814$20240825$20240904$20240904$EXP$$CN-NOVOPROD-1271704$NOVO NORDISK$$69$YR$$F$Y$$$20240904$$CN$CN$CN
242797371$24279737$1$I$$20240824$20240904$20240904$EXP$$US-NOVOPROD-1276206$NOVO NORDISK$$$$$M$Y$$$20240904$$CN$US$US
242797381$24279738$1$I$$20240824$20240904$20240904$EXP$GB-MHRA-MED-202408242354029620-HFNLD$GB-NOVOPROD-1274824$NOVO NORDISK$$42$YR$$F$Y$89$KG$20240904$$PH$GB$GB
242797403$24279740$3$F$20240624$20240910$20240904$20240923$EXP$$BR-NOVOPROD-1275416$NOVO NORDISK$$$$$F$Y$78$KG$20240923$$CN$BR$BR
242797411$24279741$1$I$$20240903$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049329$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240904$$MD$US$US
242797421$24279742$1$I$20240822$20240827$20240904$20240904$EXP$$CO-BIOVITRUM-2024-CO-011608$BIOVITRUM$$50$DY$$F$Y$4.3$KG$20240904$$CN$CO$CO
242797431$24279743$1$I$$20240820$20240904$20240904$EXP$$FR-ROCHE-10000071195$ROCHE$Faguer S, Delabesse E, Paul C, Pasquet M. IL-4Ralpha Inhibition for Severe ^^Eosinophilic Gastroenteritis, Allergy, and Anaphylaxis^^ Syndrome due to a Gain-of-Function Variant in STAT6. CLINICAL IMMUNOLOGY. 2024;44 (29):1-3. doi:10.1007/s10875-023-01639-9.$$$$F$Y$$$20240904$$HP$FR$FR
242797441$24279744$1$I$$20240903$20240904$20240904$PER$$US-AMGEN-USASP2024175510$AMGEN$$$$$F$Y$79.7$KG$20240903$$PH$US$US
242797451$24279745$1$I$$20240826$20240904$20240904$EXP$$US-NOVOPROD-1276527$NOVO NORDISK$$$$E$F$Y$$$20240904$$CN$US$US
242797461$24279746$1$I$20240803$20240826$20240904$20240904$EXP$$CO-NOVOPROD-1276752$NOVO NORDISK$$73$YR$$M$Y$80$KG$20240904$$CN$CO$CO
242797471$24279747$1$I$20240826$20240826$20240904$20240904$EXP$$CA-NOVOPROD-1277051$NOVO NORDISK$$$$$M$Y$$$20240904$$HP$CA$CA
242797481$24279748$1$I$20230827$20240826$20240904$20240904$EXP$AU-TGA-0000787347$AU-NOVOPROD-1276276$NOVO NORDISK$$47$YR$$F$Y$$$20240904$$CN$AU$AU
242797491$24279749$1$I$20230901$20240826$20240904$20240904$EXP$$US-NOVOPROD-1276280$NOVO NORDISK$$50$YR$$F$Y$$$20240904$$CN$US$US
242797501$24279750$1$I$$20240826$20240904$20240904$EXP$$CO-NOVOPROD-1276761$NOVO NORDISK$$65$YR$$F$Y$50$KG$20240904$$CN$CO$CO
242797511$24279751$1$I$$20240826$20240904$20240904$EXP$$GR-NOVOPROD-1276261$NOVO NORDISK$$$$$M$Y$$$20240904$$CN$GR$GR
242797521$24279752$1$I$20240806$20240826$20240904$20240904$EXP$$CO-NOVOPROD-1276774$NOVO NORDISK$$25$YR$$F$Y$$$20240904$$CN$CO$CO
242797531$24279753$1$I$$20240826$20240904$20240904$EXP$$FR-NOVOPROD-1276139$NOVO NORDISK$$$$$F$Y$$$20240904$$PH$FR$FR
242797541$24279754$1$I$20210101$20240826$20240904$20240904$EXP$$US-NOVOPROD-1276443$NOVO NORDISK$$$$A$M$Y$$$20240904$$CN$US$US
242797551$24279755$1$I$$20240826$20240904$20240904$EXP$$TR-NOVOPROD-1276919$NOVO NORDISK$$$$$F$Y$78$KG$20240904$$CN$TR$TR
242797562$24279756$2$F$$20240906$20240904$20240916$EXP$$FR-TEVA-VS-3238256$TEVA$Amar J, El Kaim P, Scemla B, Boumendil J, Chotard G, Gabison E, et al. Corneal perforations in patients on tyrosine kinase inhibitors. J-Fr-Ophtalmol 2023; 46 (9): 1111-1113.; Amar J, El Kaim P, Scemla B, Boumendil J, Chotard G, Gabison E, et al. Corneal perforations in patients on tyrosine kinase inhibitors. J-Fr-Ophtalmol 2023; 46 (9): 1111-1113.; Amar J, El Kaim P, Scemla B, Boumendil J, Chotard G, Gabison E, et al. Corneal perforations in patients on tyrosine kinase inhibitors. J-Fr-Ophta...$87$YR$$F$Y$$$20240916$$HP$FR$FR
242797571$24279757$1$I$20230913$20240826$20240904$20240904$EXP$AU-TGA-0000787121$AU-NOVOPROD-1276251$NOVO NORDISK$$70$YR$$F$Y$$$20240904$$CN$AU$AU
242797583$24279758$3$F$$20240905$20240904$20240909$EXP$$NVSC2023AU149611$NOVARTIS$$$$$F$Y$$$20240909$$HP$AU$AU
242797601$24279760$1$I$20240829$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A198642$ASTRAZENECA$$32502$DY$$F$Y$$$20240904$$CN$US$
242797612$24279761$2$F$20240904$20240903$20240904$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005179$ACADIA PHARMACEUTICALS$$70$YR$$F$Y$$$20240926$$CN$US$US
242797621$24279762$1$I$$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000279$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240904$$CN$US$US
242797631$24279763$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-083725-2024$RECKITT BENCKISER$$$$$M$Y$$$20240904$$CN$US$US
242797641$24279764$1$I$20240827$20240827$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136539$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240904$$CN$US$US
242797651$24279765$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139501$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240904$$HP$US$US
242797662$24279766$2$F$$20240906$20240904$20240913$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001763$BLUEPRINT MEDICINES$$$$$F$Y$$$20240913$$CN$US$US
242797672$24279767$2$F$$20240830$20240904$20240906$PER$$US-009507513-2408USA010355$MERCK$$$$$M$Y$$$20240906$$CN$US$US
242797682$24279768$2$F$$20240910$20240904$20240913$PER$$US-JAZZ PHARMACEUTICALS-2024-US-014010$JAZZ$$$$$F$Y$$$20240913$$CN$US$US
242797691$24279769$1$I$$20240830$20240904$20240904$EXP$$US-ABBVIE-5903350$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242797701$24279770$1$I$$20240828$20240904$20240904$PER$$US-BEH-2024177975$CSL BEHRING$$60$YR$A$M$Y$$$20240904$$HP$US$US
242797731$24279773$1$I$20071101$20240828$20240904$20240904$PER$$US-JNJFOC-20170419308$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240904$$LW$US$US
242797742$24279774$2$F$20240822$20240913$20240904$20240921$EXP$$CA-JNJFOC-20240873221$JOHNSON AND JOHNSON$$26$YR$A$F$Y$66$KG$20240921$$HP$CA$CA
242797751$24279775$1$I$$20240828$20240904$20240904$EXP$$GB-TAKEDA-2024TUS087356$TAKEDA$$$$$$Y$$$20240904$$HP$GB$GB
242797761$24279776$1$I$20200818$20240823$20240904$20240904$EXP$PL-URPL-1-1532-2020$PL-Accord-443750$ACCORD$$54$YR$A$M$Y$76$KG$20240904$$MD$PL$PL
242797771$24279777$1$I$$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024175209$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242797781$24279778$1$I$$20240820$20240904$20240904$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-25759$SAMSUNG BIOEPIS$$80$YR$E$M$Y$$$20240904$$CN$GB$GB
242797791$24279779$1$I$20240201$20240820$20240904$20240904$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25768$SAMSUNG BIOEPIS$$77$YR$E$F$Y$$$20240904$$CN$CA$CA
242797811$24279781$1$I$20240815$20240823$20240904$20240904$EXP$CN-HENLIUS-24CN016621$CN-Accord-444459$ACCORD$$50$YR$A$F$Y$59$KG$20240904$$MD$CN$CN
242797821$24279782$1$I$20231009$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-135674-2023$RECKITT BENCKISER$$101$YR$$M$Y$$$20240904$$CN$US$US
242797831$24279783$1$I$$20240826$20240904$20240904$EXP$$US-SANDOZ INC.-SDZ2024US077352$SANDOZ$$56$YR$$F$Y$$$20240904$$CN$US$US
242797841$24279784$1$I$$20240829$20240904$20240904$PER$$US-ROCHE-10000068147$ROCHE$$39$YR$A$F$Y$$$20240904$$CN$US$US
242797852$24279785$2$F$20230101$20240827$20240904$20240919$PER$$US-SA-2024SA254599$SANOFI AVENTIS$$7$YR$C$M$Y$34.019$KG$20240919$$MD$US$US
242797861$24279786$1$I$20240101$20240826$20240904$20240904$PER$$US-SA-2024SA255682$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240904$$MD$US$US
242797871$24279787$1$I$20240801$20240826$20240904$20240904$PER$$US-SA-2024SA255036$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240904$$MD$US$US
242797881$24279788$1$I$20240805$20240827$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137120$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$112.04$KG$20240904$$HP$US$US
242797892$24279789$2$F$20240101$20240909$20240904$20240912$PER$$US-JNJFOC-20240900967$JOHNSON AND JOHNSON$$87$YR$E$F$Y$49$KG$20240912$$CN$US$US
242797901$24279790$1$I$$20240828$20240904$20240904$EXP$$GB-ROCHE-10000069294$ROCHE$$$$E$M$Y$$$20240904$$CN$GB$GB
242797911$24279791$1$I$$20240820$20240904$20240904$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-25692$SAMSUNG BIOEPIS$$$$$F$Y$$$20240904$$CN$AU$AU
242797921$24279792$1$I$$20240830$20240904$20240904$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001780$BLUEPRINT MEDICINES$$$$$M$Y$$$20240904$$CN$US$US
242797931$24279793$1$I$$20240827$20240904$20240904$EXP$$US-SANDOZ INC.-SDZ2024US077277$SANDOZ$$$$$$Y$$$20240904$$MD$US$US
242797942$24279794$2$F$20240701$20240918$20240904$20240924$EXP$$JP-SA-2024SA252416$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240924$$MD$JP$JP
242797951$24279795$1$I$$20240828$20240904$20240904$EXP$$CA-TAKEDA-2024TUS087406$TAKEDA$$$$$F$Y$$$20240904$$CN$CA$CA
242797962$24279796$2$F$$20240903$20240904$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004895$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242797971$24279797$1$I$20240801$20240827$20240904$20240904$EXP$CN-NMPACDR-3213021804559202400263$CN-BAXTER-2024BAX023939$BAXTER$$55$YR$$F$Y$$$20240904$$MD$CN$CN
242797981$24279798$1$I$20240821$20240826$20240904$20240904$EXP$CN-NMPACDR-4409021008661202400790$CN-BAXTER-2024BAX023876$BAXTER$$16$YR$$F$Y$$$20240904$$MD$CN$CN
242797993$24279799$3$F$20220101$20240919$20240904$20240926$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048391$BOEHRINGER INGELHEIM$$71$YR$E$M$Y$100.2$KG$20240926$$CN$US$US
242798001$24279800$1$I$20240820$20240820$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408018649$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240904$$CN$US$US
242798011$24279801$1$I$20240701$20240829$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408018951$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240904$$CN$US$US
242798021$24279802$1$I$20240830$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000188$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240904$$CN$US$US
242798032$24279803$2$F$$20240903$20240904$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001215$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240905$$CN$US$US
242798041$24279804$1$I$20240811$20240826$20240904$20240904$EXP$CN-NMPACDR-3607011014819202400283$CN-BAXTER-2024BAX023883$BAXTER$$60$YR$$F$Y$57$KG$20240904$$MD$CN$CN
242798052$24279805$2$F$20240416$20240917$20240904$20240928$EXP$$BR-BAXTER-2024BAX023838$BAXTER$$53$YR$$F$Y$64$KG$20240928$$MD$BR$BR
242798062$24279806$2$F$20240718$20240823$20240904$20240916$EXP$$JP-AMGEN-JPNSP2024174254$AMGEN$$$$$$Y$$$20240916$$PH$JP$JP
242798071$24279807$1$I$$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024174906$AMGEN$$$$$F$Y$$$20240903$$HP$US$US
242798081$24279808$1$I$$20240902$20240904$20240904$EXP$$NZ-ROCHE-10000071612$ROCHE$$$$A$$Y$$$20240904$$MD$NZ$NZ
242798091$24279809$1$I$20200301$20240826$20240904$20240904$EXP$$US-NOVOPROD-1276164$NOVO NORDISK$$46$YR$$F$Y$$$20240904$$PH$US$US
242798101$24279810$1$I$20161117$20240828$20240904$20240904$EXP$$CA-TAKEDA-2024TUS087473$TAKEDA$$72$YR$$M$Y$$$20240904$$MD$CA$CA
242798111$24279811$1$I$$20240819$20240904$20240904$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-133992$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240904$$HP$CA$CA
242798121$24279812$1$I$$20240830$20240904$20240904$PER$$US-JNJFOC-20240881837$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$CN$US$US
242798131$24279813$1$I$$20240827$20240904$20240904$EXP$$BE-ABBVIE-5899664$ABBVIE$$61$YR$$F$Y$76$KG$20240904$$MD$BE$BE
242798141$24279814$1$I$$20171006$20240904$20240904$EXP$$RO-TAKEDA-2017MPI010322$TAKEDA$$49$YR$$M$Y$90$KG$20240904$$MD$RO$RO
242798152$24279815$2$F$$20240830$20240904$20240906$EXP$$CA-ROCHE-10000068697$ROCHE$$$$A$M$Y$$$20240906$$MD$CA$CA
242798162$24279816$2$F$$20240903$20240904$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-027107$UNITED THERAPEUTICS$$$$$F$Y$78.005$KG$20240910$$$US$US
242798171$24279817$1$I$20240827$20240828$20240904$20240904$PER$$US-SA-2024SA254412$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240904$$CN$US$US
242798181$24279818$1$I$20240101$20240820$20240904$20240904$PER$$US-SA-2024SA252432$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240904$$MD$US$US
242798201$24279820$1$I$20240623$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024173539$AMGEN$$59$YR$A$F$Y$$$20240903$$CN$US$US
242798211$24279821$1$I$20240401$20240827$20240904$20240904$EXP$$US-BIOGEN-2024BI01280411$BIOGEN$$36$YR$$M$Y$$$20240904$$CN$US$US
242798221$24279822$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA172152$SANOFI AVENTIS$$$$E$M$Y$$$20240904$$MD$US$US
242798231$24279823$1$I$20190805$20240828$20240904$20240904$EXP$$US-BIOGEN-2024BI01280461$BIOGEN$$88$YR$$F$Y$$$20240904$$CN$US$US
242798241$24279824$1$I$$20240827$20240904$20240904$EXP$$US-BIOGEN-2024BI01280513$BIOGEN$$$$$F$Y$91.17$KG$20240904$$MD$US$US
242798251$24279825$1$I$20231122$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-080912-2024$RECKITT BENCKISER$$72$YR$$F$Y$54.55$KG$20240904$$CN$US$US
242798261$24279826$1$I$$20240903$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049407$BOEHRINGER INGELHEIM$$$$$$Y$$$20240904$$MD$US$US
242798271$24279827$1$I$$20240823$20240904$20240904$PER$$US-AstraZeneca-2024A193616$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242798281$24279828$1$I$$20240829$20240904$20240904$PER$$US-AstraZeneca-2024A198164$ASTRAZENECA$$62$YR$$F$Y$$$20240904$$CN$US$
242798291$24279829$1$I$$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024175132$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242798301$24279830$1$I$$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024174965$AMGEN$$$$$$Y$$$20240903$$HP$US$US
242798311$24279831$1$I$20240830$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024174833$AMGEN$$57$YR$A$F$Y$$$20240903$$CN$US$US
242798321$24279832$1$I$$20240831$20240904$20240904$PER$$US-AMGEN-USASP2024174902$AMGEN$$$$A$F$Y$$$20240903$$CN$US$US
242798332$24279833$2$F$20240813$20240903$20240904$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004617$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$95.25$KG$20240926$$CN$US$US
242798342$24279834$2$F$$20240826$20240904$20240904$EXP$$US-BIOGEN-2024BI01280612$BIOGEN$$$$I$M$Y$$$20240904$$MD$US$US
242798351$24279835$1$I$$20240826$20240904$20240904$EXP$$US-BIOGEN-2024BI01279479$BIOGEN$$$$$M$Y$$$20240904$$HP$US$US
242798361$24279836$1$I$$20240828$20240904$20240904$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001764$BLUEPRINT MEDICINES$$$$$M$Y$$$20240904$$CN$US$US
242798381$24279838$1$I$20240601$20240828$20240904$20240904$PER$$US-ABBVIE-5901992$ABBVIE$$25$YR$$F$Y$$$20240904$$PH$US$US
242798391$24279839$1$I$20240326$20240902$20240904$20240904$EXP$$CN-ROCHE-10000072157$ROCHE$$64$YR$A$M$Y$69$KG$20240904$$HP$CN$CN
242798403$24279840$3$F$20240801$20240906$20240904$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-027207$UNITED THERAPEUTICS$$43$YR$$F$Y$77.098$KG$20240914$$$US$US
242798411$24279841$1$I$$20240816$20240904$20240904$PER$$US-CHATTEMPRD-2024OHG028312$CHATTEM$$$$A$$Y$$$20240904$$CN$US$US
242798421$24279842$1$I$20180430$20240829$20240904$20240904$EXP$SE-SEMPA-2024-006288$SE-TAKEDA-2024TUS087094$TAKEDA$$$$$M$Y$99$KG$20240904$$HP$SE$SE
242798431$24279843$1$I$$20240820$20240904$20240904$EXP$$CH-RISINGPHARMA-CH-2024RISLIT00299$RISING PHARMACEUTICALS$Christian Vetter.Coma After Droperidol Administration: A Case Report.A+A Practice.09-JUL-2024;18:e01831$32$YR$A$F$Y$65$KG$20240904$$MD$CH$CH
242798441$24279844$1$I$$20240826$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408016256$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240904$$CN$US$US
242798451$24279845$1$I$$20240822$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408018500$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240904$$CN$US$US
242798461$24279846$1$I$20240101$20240817$20240904$20240904$PER$$US-CHATTEMPRD-2024OHG029105$CHATTEM$$83$YR$E$F$Y$66.7$KG$20240904$$CN$US$US
242798471$24279847$1$I$$20240823$20240904$20240904$PER$$US-CHATTEMPRD-2024OHG030208$CHATTEM$$$$$$Y$$$20240904$$CN$US$US
242798481$24279848$1$I$$20240829$20240904$20240904$PER$$US-ABBVIE-5902150$ABBVIE$$$$$$Y$$$20240904$$MD$US$US
242798491$24279849$1$I$$20240830$20240904$20240904$EXP$$JP-009507513-2408JPN004032J$MERCK$$85$YR$$F$Y$$$20240904$$PH$JP$JP
242798501$24279850$1$I$$20240827$20240904$20240904$PER$$US-CHATTEMPRD-2024OHG030049$CHATTEM$$$$$$Y$$$20240904$$CN$US$US
242798511$24279851$1$I$$20240828$20240904$20240904$PER$$US-CHATTEMPRD-2024OHG030277$CHATTEM$$$$$F$Y$$$20240904$$CN$US$US
242798521$24279852$1$I$$20240827$20240904$20240904$PER$$US-ABBVIE-5900303$ABBVIE$$$$$$Y$$$20240904$$HP$US$US
242798533$24279853$3$F$20240701$20240911$20240904$20240913$PER$$US-AMGEN-USASP2024175890$AMGEN$$47$YR$A$F$Y$$$20240913$$CN$US$US
242798541$24279854$1$I$20240901$20240831$20240904$20240904$PER$$US-AMGEN-USASP2024175845$AMGEN$$65$YR$E$M$Y$$$20240903$$CN$US$US
242798551$24279855$1$I$20240301$20240820$20240904$20240904$PER$$US-SA-2024SA255420$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240904$$HP$US$US
242798561$24279856$1$I$20240703$20240823$20240904$20240904$PER$$US-SA-2024SA254721$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240904$$CN$US$US
242798571$24279857$1$I$$20240829$20240904$20240904$PER$$US-SA-2024SA255578$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240904$$MD$US$US
242798582$24279858$2$F$20240817$20240903$20240904$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004858$ACADIA PHARMACEUTICALS$$64$YR$$M$Y$$$20240926$$CN$US$US
242798591$24279859$1$I$$20240820$20240904$20240904$EXP$$CN-RISINGPHARMA-CN-2024RISLIT00301$RISING PHARMACEUTICALS$Han Wang.Successful treatment of Enterococcus  gallinarum infection in a neonate  with vancomycin: a case report.BMC Pediatrics.15-AUG-2024;24(1):1-4$$$N$M$Y$$$20240904$$HP$CN$CN
242798601$24279860$1$I$$20240827$20240904$20240904$EXP$$CA-EMD Serono-2024046289$EMD SERONO INC$$$$A$F$Y$$$20240904$$CN$CA$CA
242798611$24279861$1$I$$20240828$20240904$20240904$PER$$US-CHATTEMPRD-2024OHG030278$CHATTEM$$$$$M$Y$$$20240904$$CN$US$US
242798621$24279862$1$I$$20240830$20240904$20240904$PER$$US-AstraZeneca-2024A198625$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242798631$24279863$1$I$20240101$20240829$20240904$20240904$EXP$$US-ABBVIE-5901711$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242798641$24279864$1$I$20240808$20240823$20240904$20240904$EXP$CN-HENLIUS-24CN016595$CN-Accord-443533$ACCORD$$49$YR$A$F$Y$62$KG$20240904$$MD$CN$CN
242798661$24279866$1$I$$20240320$20240904$20240904$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00374$TARO$$$$$M$Y$$$20240904$$CN$US$US
242798671$24279867$1$I$20230801$20240322$20240904$20240904$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00390$TARO$$$$$$Y$$$20240904$$CN$US$US
242798681$24279868$1$I$$20231218$20240904$20240904$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR01339$TARO$$$$$$Y$$$20240904$$CN$US$US
242798691$24279869$1$I$$20240103$20240904$20240904$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00030$TARO$$$$$$Y$$$20240904$$CN$US$US
242798701$24279870$1$I$$20231227$20240904$20240904$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00031$TARO$$$$$$Y$$$20240904$$CN$US$US
242798711$24279871$1$I$$20231229$20240904$20240904$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00032$TARO$$$$$$Y$$$20240904$$CN$US$US
242798721$24279872$1$I$$20231229$20240904$20240904$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00033$TARO$$$$$$Y$$$20240904$$CN$US$US
242798731$24279873$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA255027$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240904$$MD$US$US
242798742$24279874$2$F$20240704$20240828$20240904$20240906$EXP$FR-AFSSAPS-AN2024001144$FR-TEVA-VS-3238177$TEVA$$67$YR$$M$Y$$$20240906$$PH$FR$FR
242798752$24279875$2$F$$20240903$20240904$20240915$EXP$$US-AUROBINDO-AUR-APL-2024-042351$AUROBINDO$Parikh SV, Madhavan S, Shapiro J, Knight R, Rosenberg AZ, Parikh CR, et al.. Characterization of Glomerular and Tubulointerstitial Proteomes in a Case of Nonsteroidal Anti-Inflammatory Drug?Attributed Acute Kidney Injury A Clinical Pathologic Molecular Correlation. Clinical Journal of the American Society of Nephrology. 2023;18(3):402-10$38$YR$$F$Y$$$20240915$$MD$US$US
242798762$24279876$2$F$20240827$20240828$20240904$20240911$PER$$US-SA-2024SA254728$SANOFI AVENTIS$$67$YR$E$F$Y$72.57$KG$20240911$$CN$US$US
242798772$24279877$2$F$$20240919$20240904$20240927$PER$$US-CHATTEMPRD-2024OHG030315$CHATTEM$$83$YR$E$F$Y$$$20240927$$CN$US$US
242798781$24279878$1$I$$20240826$20240904$20240904$EXP$$US-TEVA-VS-3238444$TEVA$Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front-Psychiatry 2024; 14.$$$A$M$Y$$$20240904$$HP$US$US
242798793$24279879$3$F$20240809$20240909$20240904$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004691$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240927$$CN$US$US
242798801$24279880$1$I$$20240830$20240904$20240904$PER$$US-CHATTEMPRD-2024OHG030340$CHATTEM$$$$$F$Y$$$20240904$$CN$US$US
242798812$24279881$2$F$$20240921$20240904$20240930$PER$$US-CHATTEMPRD-2024OHG030263$CHATTEM$$39$YR$A$F$Y$$$20240926$$CN$US$US
242798832$24279883$2$F$20240830$20240904$20240904$20240905$PER$$US-AMGEN-USASP2024175824$AMGEN$$64$YR$A$F$Y$$$20240904$$CN$US$US
242798842$24279884$2$F$$20240909$20240904$20240914$EXP$$US-TAKEDA-2024TUS086173$TAKEDA$$$$$F$Y$$$20240914$$CN$US$US
242798851$24279885$1$I$$20230921$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP014981$STRIDES$Shah CV, Hammad N, Bhasin-Chhabra B, Rashidi A. SGLT2 Inhibitors in Management of Severe Hypomagnesemia in Patients Without Diabetes: A Report of 4 Cases. Kidney-Med. 2023;5(No. 9)$6$DEC$$F$Y$$$20240904$$MD$US$US
242798861$24279886$1$I$$20240110$20240904$20240904$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00071$TARO$$$$$$Y$$$20240904$$CN$US$US
242798871$24279887$1$I$$20231206$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP018671$STRIDES$Gunther M, Jiang S, Banga A, Sher Y.. Delayed-Onset Psychosis Secondary to Tacrolimus Neurotoxicity After Lung Transplant: A Case Report and Systematic Review.. J-Acad-Consult-Liaison-Psychiatry. 2023$62$YR$$M$Y$$$20240904$$MD$US$US
242798881$24279888$1$I$$20240826$20240904$20240904$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000750$DECIPHERA PHARMACEUTICALS$$67$YR$A$F$Y$$$20240904$$CN$US$US
242798892$24279889$2$F$$20240830$20240904$20240909$30DAY$$US-GSK-US2024107916$GLAXOSMITHKLINE$$$$$M$Y$$$20240909$$CN$US$US
242798901$24279890$1$I$$20240827$20240904$20240904$EXP$$CA-CELLTRION INC.-2024CA020593$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
242798911$24279891$1$I$$20240828$20240904$20240904$EXP$$US-TAKEDA-2024TUS087185$TAKEDA$$$$$F$Y$$$20240904$$CN$US$US
242798931$24279893$1$I$$20240827$20240904$20240904$EXP$$JP-JNJFOC-20240901997$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$PH$JP$JP
242798941$24279894$1$I$$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024175344$AMGEN$$$$$$Y$$$20240903$$PH$US$US
242798951$24279895$1$I$20221001$20240821$20240904$20240904$EXP$$IT-AUROBINDO-AUR-APL-2024-042156$AUROBINDO$Frattari A, De Angelis MV, Battilana M, Polilli E, Ferrieri A, Onofrillo D, et al.. High viral load VZV encephalitis complicated by super refractory status epilepticus in a vaccinated child with in Acute Lymphocytic Leukemia: Case report and review of the literature. Neuroimmunology Reports. 2024;6:100223$6$YR$$M$Y$$$20240904$$MD$IT$IT
242798982$24279898$2$F$20210101$20240902$20240904$20240911$EXP$$PT-AUROBINDO-AUR-APL-2024-041318$AUROBINDO$santos T, Azenha  A , Cuco F.. Diarrhea: An adverse effect not to be forgotten/ Diarreia: um efeito adverso a n?o esquecer!. Journal of family medicine and general practice/Revista Portuguesa de Medicina G. 2024;40(Supp. 13):S49$66$YR$$F$Y$$$20240911$$MD$PT$PT
242798991$24279899$1$I$20240801$20240823$20240904$20240904$EXP$$ES-AUROBINDO-AUR-APL-2024-042904$AUROBINDO$$97$YR$$F$Y$$$20240904$$MD$ES$ES
242799001$24279900$1$I$20230401$20240820$20240904$20240904$PER$$US-SA-2024SA252438$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240904$$MD$US$US
242799011$24279901$1$I$20240201$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024172939$AMGEN$$$$$M$Y$$$20240903$$CN$US$US
242799021$24279902$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177183$NOVARTIS$$$$$$Y$$$20240904$$CN$US$US
242799031$24279903$1$I$$20231004$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015519$STRIDES$Coscia L, Cohen D, Dube GK, Hofmann RM, Moritz MJ, Gattis S, et al.. Outcomes With Belatacept Exposure During Pregnancy in Kidney Transplant Recipients: A Case Series.. Transplantation.. 2023;107(9):2047-2054.$$$$$Y$$$20240904$$MD$US$US
242799041$24279904$1$I$$20240823$20240904$20240904$EXP$$GB-AUROBINDO-AUR-APL-2024-042606$AUROBINDO$$59$YR$$F$Y$$$20240904$$PH$GB$GB
242799051$24279905$1$I$20171006$20240828$20240904$20240904$EXP$$US-SANDOZ INC.-SDZ2024US076492$SANDOZ$$$$$F$Y$$$20240904$$MD$US$US
242799061$24279906$1$I$$20230920$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP014901$STRIDES$Rust D, Hirano M, Martinez M, Kato T, Weiner J.. Multi-visceral transplantation for the treatment of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).. Transplantation. 2023;107 (Suppl. 1):68 abstr. 119$26$YR$$F$Y$$$20240904$$HP$US$US
242799071$24279907$1$I$$20240510$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005766$STRIDES$Magnabosco L, Joseph D, Misoi M, Nguyen VQ, Soones T.. Hard to Swallow: A Case of Posttransplant Lymphoproliferative Disorder.. J-Am-Geriatr-Soc. 2023;71:S101.$79$YR$$F$Y$$$20240904$$HP$US$US
242799081$24279908$1$I$$20231027$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016465$STRIDES$Cooper JP, Abkowitz JL. How I diagnose and treat acute graft-versus-host disease after solid organ transplantation. Blood. 2023;141(10):1136-1146$70$YR$$M$Y$$$20240904$$HP$US$US
242799091$24279909$1$I$$20240415$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004594$STRIDES$Mundra VRR, Mannon RB.. Thrombotic microangiopathy in a transplant recipient.. C-J-Am-Soc-Nephrol. 2018;13 (8):1251-1253.$4$DEC$$F$Y$$$20240904$$HP$US$US
242799101$24279910$1$I$$20240823$20240904$20240904$EXP$CA-MHPD-001097237$CA-Accord-443965$ACCORD$$45$YR$A$M$Y$79$KG$20240904$$HP$CA$CA
242799111$24279911$1$I$$20240307$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003018$STRIDES$Valdepenas B, Campara M, Pierce D, Benken J, Akshelyan S, Tzvetanov I, et al. Clinical Outcomes of Intestinal Transplant Recipients Receiving Maintenance Basiliximab, Sublingual Tacrolimus and Prednisone: A Case Series.. Am-J-Transplant. 2023;23 (Suppl.) (6):S733-S734 abstr. A283.$$$$$Y$$$20240904$$HP$US$US
242799121$24279912$1$I$$20240619$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007566$STRIDES$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients.. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster)$$$$$Y$$$20240904$$HP$US$US
242799131$24279913$1$I$$20231107$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016995$STRIDES$Burke GW, Chandar J, Sageshima J, Ortigosa-Goggins M, Amarapurkar P, Mitrofanova A, et al.. Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal.. Pediatr-Nephrol. 2023;38(1):145-159$78$YR$$F$Y$$$20240904$$HP$US$US
242799141$24279914$1$I$20240618$20240823$20240904$20240904$EXP$$ES-AUROBINDO-AUR-APL-2024-041855$AUROBINDO$$79$YR$$M$Y$78$KG$20240904$$MD$ES$ES
242799151$24279915$1$I$$20240829$20240904$20240904$PER$$US-AstraZeneca-2024A199146$ASTRAZENECA$$$$$M$Y$$$20240904$$MD$US$
242799161$24279916$1$I$$20240812$20240904$20240904$PER$$US-AstraZeneca-2024A141114$ASTRAZENECA$$66$YR$$F$Y$71.2$KG$20240904$$HP$US$
242799181$24279918$1$I$20240708$20240827$20240904$20240904$EXP$FR-AFSSAPS-PP2024000921$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111681$ZYDUS PHARM$$$$$$Y$$$20240904$$MD$FR$FR
242799192$24279919$2$F$20240825$20240918$20240904$20240927$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111715$ZYDUS PHARM$$$$$$Y$$$20240927$$MD$US$US
242799201$24279920$1$I$$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000254$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240904$$CN$US$US
242799211$24279921$1$I$$20240501$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005379$STRIDES$Sarkar M, Lee S, Bjelajac N, Bunnapradist S, Lum E.. Cannabidiol (CBD) Oil and Tacrolimus: The Unexpected High in Renal Transplant Recipients - Case Series and Review.. Transplantation. 2022;106 (Suppl.)(9):S576 abstr. P8.057$55$YR$$M$Y$$$20240904$$HP$US$US
242799221$24279922$1$I$20220613$20230724$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP012100$STRIDES$$63$YR$$F$Y$63.492$KG$20240904$$CN$US$US
242799231$24279923$1$I$$20240214$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002167$STRIDES$Gunther M, Sher Y, Jiang S.. (199) Delayed-Onset Psychosis After Lung Transplant Secondary to Tacrolimus Neurotoxicity.. J-Acad-Consult-Liaison-Psychiatry. 2023;64 (Suppl.):S99$$$$M$Y$$$20240904$$HP$US$US
242799241$24279924$1$I$$20240520$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006139$STRIDES$Crooker KG, Stedman ER, Hitt JR, Tompkins BJ, Repp AB.. Causes and outcomes of non-chemotherapy induced neutropenic fever in hospitalized adults: An observational study.. Medicine. 2024;103 (18)$$$A$$Y$$$20240904$$MD$US$US
242799251$24279925$1$I$$20240826$20240904$20240904$EXP$$ID-MSNLABS-2024MSNLIT01872$MSN LABORATORIES$Devanti AP, Sejahtera D, Khairani A, Murgyanto M.Strategic therapy of refractory epilepsy in insular lobe epilepsy with limited resources centre.Journal of the Neurological Sciences.2023;455:147-148$$$$$Y$$$20240904$$HP$ID$ID
242799261$24279926$1$I$20240829$20240903$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140286$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240904$$CN$US$US
242799271$24279927$1$I$20240801$20240825$20240904$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-026686$UNITED THERAPEUTICS$$27$YR$$F$Y$105.67$KG$20240904$$$US$US
242799281$24279928$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140109$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240904$$CN$US$US
242799291$24279929$1$I$20240501$20240903$20240904$20240904$EXP$IT-MINISAL02-999154$IT-SANDOZ INC.-SDZ2024IT077246$SANDOZ$$83$YR$$F$Y$83$KG$20240904$$MD$IT$IT
242799301$24279930$1$I$20240126$20240823$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042927$AUROBINDO$$57$YR$$M$Y$71$KG$20240904$$HP$FR$FR
242799311$24279931$1$I$$20231108$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017187$STRIDES$Athreya A, Azzouz L, Winstead R, Yancey L, Kumar D, Gupta G. Serial Donor Derived Cell Free DNA Monitoring During Belatacept Conversion in Kidney Transplant Recipients.. Am-J-Transplant. 2023;23 (Suppl.) (6):S975 abstr. C145$$$$$Y$$$20240904$$HP$US$US
242799321$24279932$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-138032-2023$RECKITT BENCKISER$$63$YR$$M$Y$107.73$KG$20240904$$CN$US$US
242799341$24279934$1$I$20230101$20240829$20240904$20240904$PER$$US-ROCHE-10000069873$ROCHE$$64$YR$A$M$Y$79.37$KG$20240904$$CN$US$US
242799351$24279935$1$I$20230807$20240823$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042867$AUROBINDO$$66$YR$$M$Y$69.9$KG$20240904$$HP$FR$FR
242799361$24279936$1$I$$20240823$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042924$AUROBINDO$$$$$F$Y$$$20240904$$CN$FR$FR
242799371$24279937$1$I$$20240826$20240904$20240904$EXP$$MX-AMGEN-MEXSP2024175282$AMGEN$$$$$F$Y$$$20240903$$CN$MX$MX
242799381$24279938$1$I$$20240827$20240904$20240904$EXP$$CA-CELLTRION INC.-2024CA020540$CELLTRION$$$$$$Y$$$20240904$$CN$CA$CA
242799391$24279939$1$I$20240101$20240826$20240904$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-013764$UNITED THERAPEUTICS$$$$$F$Y$75.737$KG$20240904$$$US$US
242799401$24279940$1$I$$20240826$20240904$20240904$EXP$$ES-ROCHE-10000069786$ROCHE$N M, Alvarez-Troncoso J, Robles-Marhuenda A, De la Calle Fernandez-Miranda M, Muner Hernando M, Bartha J. Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases. Journal of Autoimmunity. 2024;148:1-6. doi:10.1016/j.jaut.2024.103301.$$$$$Y$$$20240904$$MD$ES$ES
242799411$24279941$1$I$20240817$20240823$20240904$20240904$EXP$$GB-AUROBINDO-AUR-APL-2024-042653$AUROBINDO$$19$YR$$F$Y$55$KG$20240904$$CN$GB$GB
242799421$24279942$1$I$20240801$20240823$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042889$AUROBINDO$$65$YR$$F$Y$65$KG$20240904$$MD$FR$FR
242799431$24279943$1$I$$20240826$20240904$20240904$EXP$$TN-MSNLABS-2024MSNLIT01893$MSN LABORATORIES$Razki K, Ouali U, Najar C, Ben Aissa S, Gargouri Berrechid A, Jomli R.From levetiracetam to lithium: A journey of hope to manage suicidality and depression.Journal of the Neurological Sciences.2023;455:119-120$$$$$Y$$$20240904$$HP$TN$TN
242799441$24279944$1$I$20240101$20240821$20240904$20240904$PER$$US-SA-2024SA252384$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240904$$MD$US$US
242799452$24279945$2$F$20240101$20240916$20240904$20240924$PER$$US-SA-2024SA252427$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240924$$MD$US$US
242799461$24279946$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA254453$SANOFI AVENTIS$$$$$$Y$$$20240904$$HP$US$US
242799471$24279947$1$I$20240803$20240823$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042692$AUROBINDO$$70$YR$$F$Y$89$KG$20240904$$PH$FR$FR
242799481$24279948$1$I$$20240821$20240904$20240904$EXP$$US-SPECGX-T202401786$SPECGX$Gann LS, Kunin JR, Ebada M, Walker CM. Spectrum of thoracic imaging findings in the setting of substance abuse. J Comput Assist Tomogr. 2024;48(3):394-405$35$YR$$F$Y$$$20240904$$HP$US$US
242799491$24279949$1$I$$20240825$20240904$20240904$EXP$$GB-AUROBINDO-AUR-APL-2024-042787$AUROBINDO$$68$YR$$F$Y$56$KG$20240904$$MD$GB$GB
242799501$24279950$1$I$20240824$20240824$20240904$20240904$EXP$$GB-AUROBINDO-AUR-APL-2024-042762$AUROBINDO$$33$YR$$F$Y$$$20240904$$CN$GB$GB
242799521$24279952$1$I$$20240821$20240904$20240904$EXP$$PT-AUROBINDO-AUR-APL-2024-042871$AUROBINDO$Oliveira R; Abreu C; Cabrita M; Ferreira R; Klyeshtorna I. PLASMA CELL LEUKEMIA ? AN URGENT DIAGNOSIS. XIII NATIONAL CONGRESS OF CLINICAL PATHOLOGY. 43$73$YR$$M$Y$$$20240904$$HP$PT$PT
242799531$24279953$1$I$20240101$20240825$20240904$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-023516$UNITED THERAPEUTICS$$$$$M$Y$70.295$KG$20240904$$$US$US
242799541$24279954$1$I$20240101$20240821$20240904$20240904$PER$$US-SA-2024SA252511$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240904$$MD$US$US
242799551$24279955$1$I$$20240827$20240904$20240904$PER$$US-SA-2024SA252360$SANOFI AVENTIS$$$$A$F$Y$$$20240904$$MD$US$US
242799561$24279956$1$I$$20240903$20240904$20240904$EXP$$GB-SANDOZ INC.-SDZ2024GB077390$SANDOZ$$55$YR$$F$Y$79$KG$20240904$$MD$GB$GB
242799571$24279957$1$I$$20240830$20240904$20240904$PER$$US-JNJFOC-20240881898$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$PH$US$US
242799581$24279958$1$I$$20240823$20240904$20240904$PER$$US-AstraZeneca-2024A193596$ASTRAZENECA$$$$$F$Y$$$20240904$$HP$US$
242799591$24279959$1$I$20240819$20240820$20240904$20240904$PER$$US-RISINGPHARMA-US-2024RISSPO00304$RISING PHARMACEUTICALS$$38$YR$A$F$Y$160$KG$20240904$$CN$US$US
242799602$24279960$2$F$$20240905$20240904$20240909$PER$$US-AMGEN-USASP2024175302$AMGEN$$$$E$M$Y$$$20240909$$CN$US$US
242799611$24279961$1$I$$20240826$20240904$20240904$PER$$US-AMGEN-USASP2024174432$AMGEN$$$$$$Y$$$20240904$$MD$US$US
242799621$24279962$1$I$20240101$20240827$20240904$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-027072$UNITED THERAPEUTICS$$$$$M$Y$97.506$KG$20240904$$$US$US
242799631$24279963$1$I$$20240827$20240904$20240904$EXP$$KR-CELLTRION INC.-2024KR020775$CELLTRION$Sagong M, Kim KT, Jang BK.. Atezolizumab and bevacizumab induced encephalitis in a patient with advanced hepatocellular carcinoma: a case report and literature review. Journal of Cancer Research and Clinical Oncology. 2024;150(8):397$$$$$Y$$$20240904$$HP$KR$KR
242799641$24279964$1$I$20230101$20240815$20240904$20240904$PER$$US-TEVA-VS-3235636$TEVA$$$$$M$Y$$$20240904$$CN$US$US
242799651$24279965$1$I$$20240820$20240904$20240904$PER$$US-SA-2024SA252623$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240904$$MD$US$US
242799672$24279967$2$F$$20240906$20240904$20240916$EXP$$US-TEVA-VS-3238665$TEVA$Kim EB, Malespini J, Lei M, Branagan AR, Cirstea D, Han SS, et al. Rapid reduction of free light chains and improvement in renal outcomes in patients with newly diagnosed multiple myeloma admitted with acute kidney injury with daratumumab-based therapy and without plasmapheresis. J-Clin-Oncol 2024; 42 (Suppl.) (16); Kim EB, Malespini J, Lei M, Branagan AR, Cirstea D, Han SS, et al. Rapid reduction of free light chains and improvement in renal outcomes in patients with newly diagnosed multiple...$87$YR$$$Y$$$20240916$$HP$US$US
242799691$24279969$1$I$$20240819$20240904$20240904$PER$$US-ASTELLAS-2024-AER-002051$ASTELLAS$$$$A$F$Y$$$20240904$$CN$US$US
242799701$24279970$1$I$20240814$20240830$20240904$20240904$EXP$$CO-UCBSA-2024044909$UCB$$43$YR$$M$Y$$$20240904$$CN$CO$CO
242799721$24279972$1$I$$20240902$20240904$20240904$EXP$$GB-ROCHE-10000072116$ROCHE$$$$$$Y$$$20240904$$HP$GB$GB
242799732$24279973$2$F$$20240906$20240904$20240916$EXP$$US-TEVA-VS-3238458$TEVA$Shariff H, Luu T, Kavis H, Obuch J. Gastric Signet Ring Cell Adenocarcinoma with Metastasis to the Testicles and Leptomeninges. ACG-Case-Rep-J 2024; 11 (8):.; Shariff H, Luu T, Kavis H, Obuch J. Gastric Signet Ring Cell Adenocarcinoma with Metastasis to the Testicles and Leptomeninges. ACG-Case-Rep-J 2024; 11 (8):.$38$YR$$M$Y$$$20240916$$MD$US$US
242799741$24279974$1$I$$20240822$20240904$20240904$PER$$US-RISINGPHARMA-US-2024RISSPO00303$RISING PHARMACEUTICALS$$$$$M$Y$$$20240904$$HP$US$US
242799751$24279975$1$I$20240830$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000771$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240904$$CN$US$US
242799761$24279976$1$I$$20240827$20240904$20240904$PER$$US-JNJFOC-20240871330$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$HP$US$US
242799771$24279977$1$I$$20240903$20240904$20240904$PER$$US-ALXN-202409USA000034US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
242799781$24279978$1$I$$20240903$20240904$20240904$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-140227$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240904$$MD$DE$DE
242799792$24279979$2$F$$20240911$20240904$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139638$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240912$$CN$US$US
242799801$24279980$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139291$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240904$$HP$US$US
242799811$24279981$1$I$$20240826$20240904$20240904$EXP$$GB-TEVA-VS-3238708$TEVA$Edwards GM, Alejmi AA. Pure red cell aplasia secondary to erythropoietin therapy. Clin-Med-London 2024; 24 (4):.$65$YR$$F$Y$$$20240904$$HP$GB$GB
242799821$24279982$1$I$$20240829$20240904$20240904$EXP$NL-LRB-00999430$NL-ABBVIE-5905359$ABBVIE$$50$YR$$M$Y$66$KG$20240904$$CN$NL$NL
242799832$24279983$2$F$$20240903$20240904$20240906$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001770$BLUEPRINT MEDICINES$$$$$M$Y$$$20240906$$CN$US$US
242799842$24279984$2$F$$20240905$20240904$20240909$PER$$US-BIOGEN-2024BI01280611$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
242799851$24279985$1$I$$20240829$20240904$20240904$PER$$US-BIOGEN-2024BI01280593$BIOGEN$$$$$F$Y$$$20240904$$MD$US$US
242799862$24279986$2$F$20240801$20240913$20240904$20240917$PER$$US-BIOGEN-2024BI01280045$BIOGEN$$55$YR$$M$Y$$$20240917$$CN$US$US
242799871$24279987$1$I$20240601$20240826$20240904$20240904$PER$$US-BIOGEN-2024BI01276173$BIOGEN$$71$YR$$F$Y$$$20240904$$CN$US$US
242799881$24279988$1$I$20231208$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-080994-2024$RECKITT BENCKISER$$79$YR$$F$Y$$$20240904$$CN$US$US
242799891$24279989$1$I$$20240819$20240904$20240904$PER$$US-ASTELLAS-2024-AER-001957$ASTELLAS$$63$YR$A$F$Y$$$20240904$$CN$US$US
242799901$24279990$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009894$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242799911$24279991$1$I$20230101$20240903$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049387$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240904$$HP$US$US
242799921$24279992$1$I$20040101$20240826$20240904$20240904$EXP$$US-ENDO USA, INC.-2024-003364$ENDO$$$$$M$Y$$$20240904$$PH$US$US
242799931$24279993$1$I$$20240822$20240904$20240904$PER$$US-RISINGPHARMA-US-2024RISSPO00309$RISING PHARMACEUTICALS$$63$YR$A$F$Y$179$KG$20240904$$CN$US$US
242799941$24279994$1$I$$20240827$20240904$20240904$PER$$US-ABBVIE-5900521$ABBVIE$$$$$$Y$$$20240904$$MD$US$US
242799961$24279996$1$I$20240826$20240827$20240904$20240904$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024106592$VIIV$$41$YR$$F$Y$$$20240904$$HP$US$US
242799971$24279997$1$I$$20240830$20240904$20240904$EXP$$VN-AstraZeneca-2024A199149$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$VN$
242799981$24279998$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009895$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242799991$24279999$1$I$20240101$20240827$20240904$20240904$PER$$US-AMGEN-USASP2024174282$AMGEN$$$$$$Y$$$20240904$$CN$US$US
242800001$24280000$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009906$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242800011$24280001$1$I$20240812$20240819$20240904$20240904$PER$$US-TEVA-VS-3234718$TEVA$$$$$$Y$$$20240904$$HP$US$US
242800021$24280002$1$I$20240820$20240830$20240904$20240904$EXP$$US-ARGENX-2024-ARGX-US007360$ARGENX BVBA$$$$$$Y$$$20240904$$CN$US$US
242800031$24280003$1$I$$20240829$20240904$20240904$30DAY$$US-GSK-US2024AMR108528$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242800051$24280005$1$I$$20240822$20240904$20240904$EXP$$CA-RK PHARMA, INC-20240800049$RK PHARMA$Kayla M Cameron-Coffill. A Case of Delayed and Persistent Carbamazepine Overdose Treated With Hemodialysis, Plasmapheresis, and Neostigmine. J Pharm Pract. 2024;1-6$$$$$Y$$$20240904$$HP$CA$CA
242800061$24280006$1$I$$20240822$20240904$20240904$PER$$US-RISINGPHARMA-US-2024RISSPO00308$RISING PHARMACEUTICALS$$$$$$Y$$$20240904$$MD$US$US
242800071$24280007$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009907$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242800081$24280008$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177457$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242800091$24280009$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177463$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242800101$24280010$1$I$20240826$20240828$20240904$20240904$PER$$MX-REGENERON PHARMACEUTICALS, INC.-2024-117804$REGENERON$$71$YR$$M$Y$$$20240904$$CN$MX$MX
242800111$24280011$1$I$20240816$20240828$20240904$20240904$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-107298$REGENERON$$$$$M$Y$$$20240904$$CN$CA$CA
242800123$24280012$3$F$20240804$20240917$20240904$20240925$EXP$$CO-JNJFOC-20240878236$JOHNSON AND JOHNSON$$80$YR$E$F$Y$59$KG$20240925$$HP$CO$CO
242800131$24280013$1$I$$20240829$20240904$20240904$EXP$$BR-JNJFOC-20240863303$JOHNSON AND JOHNSON$$43$YR$A$F$Y$73$KG$20240904$$CN$BR$BR
242800141$24280014$1$I$$20240826$20240904$20240904$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006426$BIOCON$$$$$$Y$$$20240904$$MD$CA$CA
242800153$24280015$3$F$$20240910$20240904$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005182$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
242800161$24280016$1$I$$20240903$20240904$20240904$PER$$US-ALXN-202409USA000033US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
242800171$24280017$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177462$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242800181$24280018$1$I$20240820$20240827$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408017349$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240904$$CN$US$US
242800193$24280019$3$F$20240820$20240830$20240904$20240910$EXP$$US-ROCHE-10000067264$ROCHE$$$$$F$Y$$$20240910$$MD$US$US
242800201$24280020$1$I$20240701$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140295$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240904$$HP$US$US
242800211$24280021$1$I$20240317$20240828$20240904$20240904$EXP$FR-AFSSAPS-DJ2024000930$FR-ROCHE-10000068070$ROCHE$$73$YR$E$M$Y$75$KG$20240904$$MD$FR$FR
242800221$24280022$1$I$20240729$20240903$20240904$20240904$EXP$FR-AFSSAPS-BS2024000610$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-140184$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$76$KG$20240904$$MD$FR$FR
242800231$24280023$1$I$20240805$20240826$20240904$20240904$EXP$$US-ROCHE-10000049820$ROCHE$$77$YR$E$F$Y$59.09$KG$20240904$$MD$US$US
242800241$24280024$1$I$20240101$20240830$20240904$20240904$PER$$US-BIOGEN-2024BI01280756$BIOGEN$$$$$M$Y$$$20240904$$CN$US$US
242800251$24280025$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177458$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242800261$24280026$1$I$$20240826$20240904$20240904$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006380$BIOCON$$$$$$Y$$$20240904$$CN$CA$CA
242800272$24280027$2$F$20080101$20240905$20240904$20240918$EXP$$US-SPECGX-T202401763$SPECGX$$$$$F$Y$70$KG$20240918$$CN$US$US
242800281$24280028$1$I$$20240828$20240904$20240904$30DAY$$US-GSK-US2024107308$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242800291$24280029$1$I$$20240823$20240904$20240904$EXP$$US-AstraZeneca-2024A193158$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242800301$24280030$1$I$$20240829$20240904$20240904$EXP$$US-TERSERA THERAPEUTICS LLC-2024TRS004392$TERSERA THERAPEUTICS$$$$$$Y$$$20240904$$CN$US$US
242800323$24280032$3$F$$20240923$20240904$20240930$EXP$$DE-ASTELLAS-2024-AER-001251$ASTELLAS$$75$YR$E$M$Y$$$20240930$$PH$DE$DE
242800331$24280033$1$I$$20240826$20240904$20240904$PER$$US-APOTEX-2024AP010139$APOTEX$Varney SM, Watkins S, Stuteville H, Winter ML, Gao HT, Martin TG, et al.. An Analysis of Clinical Outcomes of Exploratory Pediatric Metformin Ingestions Reported to the Texas Poison Center Network From 2011 to 2021. Hospital Pharmacy. 2024;59 (4):465-470$$$C$$Y$$$20240904$$HP$US$US
242800341$24280034$1$I$20240816$20240830$20240904$20240904$PER$$PR-JNJFOC-20240902183$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240904$$CN$PR$PR
242800351$24280035$1$I$$20240826$20240904$20240904$EXP$$CA-APOTEX-2023AP000034$APOTEX$$66$YR$$F$Y$$$20240904$$HP$CA$CA
242800361$24280036$1$I$$20240903$20240904$20240904$EXP$FR-EMA-DD-20240830-7482827-093942$FR-SANDOZ INC.-SDZ2024FR077405$SANDOZ$$16$YR$$F$Y$$$20240904$$HP$FR$FR
242800381$24280038$1$I$20240201$20240828$20240904$20240904$EXP$$MX-TAKEDA-2023TUS122179$TAKEDA$$61$YR$$F$Y$$$20240904$$CN$MX$MX
242800391$24280039$1$I$$20240823$20240904$20240904$EXP$$JP-ROCHE-10000067790$ROCHE$$6$DEC$A$F$Y$$$20240904$$PH$JP$JP
242800401$24280040$1$I$$20240827$20240904$20240904$PER$$US-TAKEDA-2024TUS086735$TAKEDA$$$$$F$Y$75$KG$20240904$$CN$US$US
242800411$24280041$1$I$$20240828$20240904$20240904$PER$$US-JNJFOC-20240876504$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$CN$US$US
242800421$24280042$1$I$20240811$20240903$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140198$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240904$$CN$US$US
242800431$24280043$1$I$20240801$20240820$20240904$20240904$PER$$US-ASTELLAS-2024-AER-002117$ASTELLAS$$62$YR$A$F$Y$$$20240904$$CN$US$US
242800441$24280044$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-138571-2023$RECKITT BENCKISER$$84$YR$$F$Y$$$20240904$$CN$US$US
242800451$24280045$1$I$20180101$20240823$20240904$20240904$EXP$$US-AUROBINDO-AUR-APL-2024-042555$AUROBINDO$Chowdhury RB, Shah SI, Milford E, Tullius SG, Rennke H, Bianchi G. Extramedullary plasmacytoma exclusively localized in transplanted kidney: Post-transplant lymphoproliferative disorder or monoclonal gammopathy of renal significance?. Journal of Onco-Nephrology. 2024;8(2):70-4$44$YR$$F$Y$$$20240904$$MD$US$US
242800461$24280046$1$I$$20240826$20240904$20240904$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006378$BIOCON$$$$$$Y$$$20240904$$CN$CA$CA
242800481$24280048$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-081461-2024$RECKITT BENCKISER$$$$$F$Y$$$20240904$$CN$US$US
242800491$24280049$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177187$NOVARTIS$$50$YR$$F$Y$$$20240904$$MD$US$US
242800501$24280050$1$I$20240101$20240821$20240904$20240904$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000737$DECIPHERA PHARMACEUTICALS$$73$YR$E$M$Y$$$20240904$$CN$US$US
242800511$24280051$1$I$$20240805$20240904$20240904$30DAY$$US-VEROBIOTECH-2024USVEROSPO00196$VERO BIOTECH$$$$$$Y$$$20240904$$HP$US$US
242800521$24280052$1$I$20240815$20240823$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042840$AUROBINDO$$$$A$M$Y$133$KG$20240904$$HP$FR$FR
242800531$24280053$1$I$20240703$20240823$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042866$AUROBINDO$$55$YR$$F$Y$55$KG$20240904$$PH$FR$FR
242800542$24280054$2$F$$20240903$20240904$20240906$EXP$$AU-ROCHE-10000071962$ROCHE$$$$$$Y$$$20240906$$MD$AU$AU
242800552$24280055$2$F$20240816$20240911$20240904$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026951$UNITED THERAPEUTICS$$58$YR$$M$Y$66.213$KG$20240919$$PH$US$US
242800561$24280056$1$I$$20240828$20240904$20240904$EXP$$US-TAKEDA-2024TUS087559$TAKEDA$$$$$F$Y$$$20240904$$CN$US$US
242800582$24280058$2$F$$20240903$20240904$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004847$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242800591$24280059$1$I$$20240902$20240904$20240904$EXP$$NP-TAKEDA-2024TUS088106$TAKEDA$$$$$F$Y$$$20240904$$CN$NP$NP
242800601$24280060$1$I$$20240828$20240904$20240904$EXP$$GB-TAKEDA-2024TUS087922$TAKEDA$$$$$M$Y$$$20240904$$CN$GB$GB
242800611$24280061$1$I$20240729$20240823$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042875$AUROBINDO$$53$YR$$F$Y$70$KG$20240904$$MD$FR$FR
242800621$24280062$1$I$20230101$20240829$20240904$20240904$PER$$US-ALXN-202408USA002052US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$HP$US$US
242800631$24280063$1$I$20240101$20240816$20240904$20240904$PER$$US-APOTEX-2024AP009565$APOTEX$$$$A$M$Y$$$20240904$$CN$US$US
242800641$24280064$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A198743$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242800651$24280065$1$I$20230731$20240823$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042884$AUROBINDO$$1$DY$$M$Y$2.26$KG$20240904$$HP$FR$FR
242800662$24280066$2$F$20221113$20240912$20240904$20240913$EXP$DE-009507513-2408DEU009944$DE-SANDOZ INC.-SDZ2024DE077266$SANDOZ$$63$YR$$F$Y$53$KG$20240913$$MD$DE$DE
242800672$24280067$2$F$$20240903$20240904$20240910$EXP$$US-TAKEDA-2024TUS087606$TAKEDA$$$$$F$Y$111$KG$20240910$$MD$US$US
242800681$24280068$1$I$$20240827$20240904$20240904$EXP$$CA-CELLTRION INC.-2024CA020537$CELLTRION$$$$$$Y$$$20240904$$CN$CA$CA
242800691$24280069$1$I$$20240828$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408019463$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240904$$CN$US$US
242800702$24280070$2$F$$20240919$20240904$20240925$EXP$$NVSC2024US175710$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
242800712$24280071$2$F$20240830$20240905$20240904$20240910$EXP$$JP-JNJFOC-20240905453$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240910$$MD$JP$JP
242800721$24280072$1$I$20240801$20240820$20240904$20240904$PER$$US-JNJFOC-20240855615$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240904$$CN$US$US
242800731$24280073$1$I$20230918$20240827$20240904$20240904$EXP$$DE-CELLTRION INC.-2024DE020684$CELLTRION$$$$$$Y$$$20240904$$MD$DE$DE
242800741$24280074$1$I$20240701$20240903$20240904$20240904$PER$$US-ROCHE-10000072873$ROCHE$$55$YR$A$F$Y$$$20240904$$CN$US$US
242800751$24280075$1$I$20240201$20240829$20240904$20240904$EXP$FR-AFSSAPS-RE2024000808$FR-HALEON-2194390$Haleon PLC$$45$YR$$M$Y$59$KG$20240904$$PH$FR$FR
242800761$24280076$1$I$20230101$20240827$20240904$20240904$EXP$$CA-CURRAX PHARMACEUTICALS LLC-CA-2024CUR004037$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$CA$CA
242800771$24280077$1$I$20240701$20240823$20240904$20240904$EXP$$GB-AUROBINDO-AUR-APL-2024-042597$AUROBINDO$$70$YR$$M$Y$$$20240904$$MD$GB$GB
242800781$24280078$1$I$$20240815$20240904$20240904$PER$$US-ASTELLAS-2024-AER-002316$ASTELLAS$$59$YR$A$M$Y$$$20240904$$CN$US$US
242800801$24280080$1$I$20240801$20240823$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042942$AUROBINDO$$21$YR$$F$Y$$$20240904$$CN$FR$FR
242800811$24280081$1$I$$20240828$20240904$20240904$EXP$$US-ABBVIE-5901537$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242800821$24280082$1$I$$20240829$20240904$20240904$EXP$$CA-JNJFOC-20240900157$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240904$$HP$CA$CA
242800852$24280085$2$F$19540815$20240906$20240904$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-042757$AUROBINDO$$55$DY$$M$Y$89$KG$20240919$$CN$GB$GB
242800861$24280086$1$I$$20240823$20240904$20240904$EXP$$NZ-ROCHE-10000064413$ROCHE$$63$YR$A$M$Y$$$20240904$$CN$NZ$NZ
242800872$24280087$2$F$$20240819$20240904$20240924$PER$$US-TEVA-VS-3234741$TEVA$$60$YR$$F$Y$$$20240924$$PH$US$US
242800881$24280088$1$I$$20240822$20240904$20240904$EXP$$BR-ASTELLAS-2024-AER-003813$ASTELLAS$Goncalves LA. Cutaneous sporotrichosis disseminated in liver transplant recipient a rare and challenging infection. The Brazilian Journal of Infectious Diseases. 2023;27(S1): 227. doi:10.1016/j.bjid.2023.103245.$57$YR$A$F$Y$$$20240904$$HP$BR$BR
242800891$24280089$1$I$20240719$20240821$20240904$20240904$EXP$$CN-OCTA-ALB14224$OCTAPHARMA$$64$YR$A$M$Y$$$20240903$$HP$CN$CN
242800901$24280090$1$I$20240826$20240826$20240904$20240904$PER$$US-AMGEN-USASP2024170378$AMGEN$$73$YR$E$M$Y$$$20240904$$CN$US$US
242800911$24280091$1$I$$20231012$20240904$20240904$EXP$$HU-002147023-NVSC2020HU149558$Haleon PLC$$72$YR$$F$Y$$$20240904$$HP$HU$HU
242800921$24280092$1$I$$20240821$20240904$20240904$EXP$$CA-OCTA-ALB14324$OCTAPHARMA$$42$YR$A$F$Y$$$20240903$$HP$CA$CA
242800931$24280093$1$I$$20240821$20240904$20240904$EXP$$CA-OCTA-ALB14424$OCTAPHARMA$$$$$F$Y$$$20240903$$HP$CA$CA
242800941$24280094$1$I$20240815$20240830$20240904$20240904$EXP$$CO-UCBSA-2024044908$UCB$$90$YR$$M$Y$$$20240904$$CN$CO$CO
242800951$24280095$1$I$$20240827$20240904$20240904$EXP$$CA-CELLTRION INC.-2024CA020570$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
242800961$24280096$1$I$$20240821$20240904$20240904$EXP$$CA-OCTA-HAPL02524$OCTAPHARMA$$$$$M$Y$$$20240903$$HP$CA$CA
242800971$24280097$1$I$$20240829$20240904$20240904$EXP$$DE-EMD Serono-2024046700$EMD SERONO INC$$72$YR$E$F$Y$$$20240904$$CN$DE$DE
242800981$24280098$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177419$NOVARTIS$$$$$F$Y$$$20240904$$HP$US$US
242800991$24280099$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-081385-2024$RECKITT BENCKISER$$$$$$Y$$$20240904$$CN$US$US
242801001$24280100$1$I$20240805$20240829$20240904$20240904$EXP$$PK-ROCHE-10000069568$ROCHE$$43$YR$A$M$Y$$$20240904$$CN$PK$PK
242801011$24280101$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-081027-2024$RECKITT BENCKISER$$74$YR$$F$Y$$$20240904$$CN$US$US
242801021$24280102$1$I$20240422$20240903$20240904$20240904$EXP$FR-AFSSAPS-NT2024001054$FR-SANDOZ INC.-SDZ2024FR077304$SANDOZ$$14$YR$$F$Y$60$KG$20240904$$MD$FR$FR
242801031$24280103$1$I$$20240822$20240904$20240904$PER$$US-AstraZeneca-2024A191916$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242801041$24280104$1$I$20230201$20240827$20240904$20240904$PER$$US-ABBVIE-5898488$ABBVIE$$8$YR$$F$Y$$$20240904$$HP$US$US
242801051$24280105$1$I$$20240816$20240904$20240904$PER$$US-ASTELLAS-2024-AER-002124$ASTELLAS$$$$$F$Y$$$20240904$$MD$US$US
242801061$24280106$1$I$20240101$20240830$20240904$20240904$EXP$$JP-AMGEN-JPNSP2024072919$AMGEN$$$$E$M$Y$$$20240904$$PH$JP$JP
242801071$24280107$1$I$20240101$20240827$20240904$20240904$EXP$$BR-GENMAB-2024-03156$GENMAB$$$$$F$Y$$$20240904$$MD$BR$BR
242801081$24280108$1$I$$20240902$20240904$20240904$EXP$$DE-ORGANON-1712DEU013469$ORGANON$Kaschka WP, Steyer J, Kaschka IN, Jandl M, Hodgkinson S. The chemo brain: Severe cognitive decline following chemotherapy of breast cancer. New Horizons in Clinical Case Reports. 2017;2:4-6$43$YR$$F$Y$$$20240904$$HP$DE$DE
242801091$24280109$1$I$$20240828$20240904$20240904$PER$$US-TAKEDA-2024TUS087304$TAKEDA$$58$YR$$F$Y$$$20240904$$CN$US$US
242801101$24280110$1$I$$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024173304$AMGEN$$80$YR$E$F$Y$$$20240904$$CN$US$US
242801111$24280111$1$I$$20240828$20240904$20240904$EXP$$GB-AMGEN-GBRSP2024174691$AMGEN$$67$YR$E$M$Y$$$20240904$$CN$GB$GB
242801121$24280112$1$I$20200901$20240826$20240904$20240904$EXP$$US-TEVA-VS-3238208$TEVA$$48$YR$$F$Y$$$20240904$$CN$US$US
242801131$24280113$1$I$20240825$20240830$20240904$20240904$EXP$$US-BEH-2024178131$CSL BEHRING$$77$YR$E$M$Y$$$20240904$$HP$US$US
242801141$24280114$1$I$$20240820$20240904$20240904$PER$$US-ASTELLAS-2024-AER-002156$ASTELLAS$$$$$M$Y$$$20240904$$CN$US$US
242801151$24280115$1$I$$20240829$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001066$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240904$$CN$US$US
242801161$24280116$1$I$$20240827$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408013431$ELI LILLY AND CO$$$$A$F$Y$$$20240904$$CN$US$US
242801171$24280117$1$I$$20240829$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408018860$ELI LILLY AND CO$$$$$F$Y$$$20240904$$CN$US$US
242801181$24280118$1$I$$20240822$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000392$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240904$$CN$US$US
242801191$24280119$1$I$$20240829$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408019452$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240904$$HP$US$US
242801201$24280120$1$I$20240821$20240823$20240904$20240904$EXP$$US-Accord-443616$ACCORD$$56$YR$A$M$Y$$$20240904$$HP$US$US
242801212$24280121$2$F$$20240904$20240904$20240913$PER$$US-ASTELLAS-2024-AER-001500$ASTELLAS$$$$$F$Y$$$20240913$$MD$US$US
242801221$24280122$1$I$$20240830$20240904$20240904$EXP$$UY-ABBVIE-5904857$ABBVIE$$15$YR$$$Y$$$20240904$$MD$UY$UY
242801233$24280123$3$F$20240902$20240916$20240904$20240926$EXP$$US-RIGEL-20240800108$RIGEL PHARMACEUTICALS$$76$YR$$M$Y$104.33$KG$20240926$$CN$US$US
242801242$24280124$2$F$$20240906$20240904$20240916$EXP$$IL-TEVA-VS-3238330$TEVA$Gazit I, Wussuki-Lior O, Tauber T, Morad Y. Systemic Treatment With Cyclosporine A in Children With Severe Vernal Keratoconjunctivitis. Cornea 2024; 0 (0):; Gazit I, Wussuki-Lior O, Tauber T, Morad Y. Systemic Treatment With Cyclosporine A in Children With Severe Vernal Keratoconjunctivitis. Cornea 2024; 0 (0):.; Gazit I, Wussuki-Lior O, Tauber T, Morad Y. Systemic Treatment With Cyclosporine A in Children With Severe Vernal Keratoconjunctivitis. Cornea 2024; 0 (0):.$6$YR$$M$Y$$$20240916$$MD$IL$IL
242801252$24280125$2$F$$20240906$20240904$20240916$EXP$$US-TEVA-VS-3238455$TEVA$Bulleit C, Rho J, Fleisch SB, Radhakrishnan NS. Treating Malignant Catatonia With Liquid Amantadine: A Case Report and Literature Review. [Review]. J-Psychiatr-Pract 2024; 30 (4): 308-310.; Bulleit C, Rho J, Fleisch SB, Radhakrishnan NS. Treating Malignant Catatonia With Liquid Amantadine: A Case Report and Literature Review. [Review]. J-Psychiatr-Pract 2024; 30 (4): 308-310.$51$YR$$F$Y$$$20240916$$HP$US$US
242801261$24280126$1$I$20240101$20240821$20240904$20240904$EXP$$US-INSMED, INC.-2024-02885-US$INSMED$$$$$F$Y$$$20240904$$CN$US$US
242801271$24280127$1$I$20240708$20240828$20240904$20240904$EXP$$DE-009507513-2408DEU009750$MERCK$$$$$M$Y$70$KG$20240904$$MD$DE$DE
242801282$24280128$2$F$20221123$20240906$20240904$20240917$EXP$$JP-CHATTEMPRD-2024OHG030561$CHATTEM$$17$YR$T$M$Y$$$20240918$$MD$JP$JP
242801291$24280129$1$I$$20240830$20240904$20240904$EXP$$CL-SANDOZ INC.-SDZ2024CL077160$SANDOZ$$$$$M$Y$$$20240904$$CN$CL$CL
242801331$24280133$1$I$$20240822$20240904$20240904$EXP$$US-IBSA PHARMA INC.-2024IBS000395$IBSA INSTITUT BIOCHIMIQUE$$$$$$Y$$$20240903$$CN$US$US
242801341$24280134$1$I$20240501$20240831$20240904$20240904$EXP$GB-MHRA-MED-202408312202138740-VSRJQ$GB-ABBVIE-5905176$ABBVIE$$$$$F$Y$$$20240904$$CN$GB$GB
242801351$24280135$1$I$20240817$20240827$20240904$20240904$EXP$$CO-AstraZeneca-2024A196502$ASTRAZENECA$$3923$WK$$F$Y$$$20240904$$CN$CO$
242801361$24280136$1$I$$20240823$20240904$20240904$EXP$$US-Accord-444678$ACCORD$$38$YR$A$M$Y$$$20240904$$HP$US$US
242801371$24280137$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-082105-2024$RECKITT BENCKISER$$$$$M$Y$$$20240904$$CN$US$US
242801381$24280138$1$I$20240813$20240823$20240904$20240904$EXP$$US-Accord-443620$ACCORD$$21$YR$A$M$Y$$$20240904$$HP$US$US
242801391$24280139$1$I$$20240829$20240904$20240904$EXP$$FR-SANDOZ INC.-SDZ2024FR076693$SANDOZ$NA. Mennecier B, Creusto Q, Durand A et al.. The treatment of ALK NSCLC over the years: quite a story.. Tribune K.. 2024$61$YR$$M$Y$$$20240904$$HP$FR$FR
242801401$24280140$1$I$20240819$20240827$20240904$20240904$EXP$$CN-BEIGENE-BGN-2024-013533$BEIGENE$$$$$$Y$$$20240904$$HP$CN$CN
242801411$24280141$1$I$$20240827$20240904$20240904$EXP$$CA-CELLTRION INC.-2024CA020536$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
242801421$24280142$1$I$$20240826$20240904$20240904$PER$$US-ABBVIE-5896726$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242801432$24280143$2$F$$20240906$20240904$20240916$EXP$$FR-TEVA-VS-3238371$TEVA$Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon-Pennamen M-D, Rivet J, et al. Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib. J-Eur-Acad-Dermatol-Venereol 2023; 38 (1): e32-e34.; Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon-Pennamen M-D, Rivet J, et al. Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib. J-Eur-Acad-Dermatol-Venereol 2023; 38 (1): e...$60$YR$$M$Y$$$20240916$$HP$FR$FR
242801441$24280144$1$I$$20240823$20240904$20240904$30DAY$$US-JNJFOC-20240876784$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242801451$24280145$1$I$$20240820$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133479$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$PH$US$US
242801462$24280146$2$F$20240622$20240926$20240904$20240926$EXP$$CO-UCBSA-2024044944$UCB$$71$YR$$M$Y$$$20240926$$CN$CO$CO
242801471$24280147$1$I$20240830$20240830$20240904$20240904$PER$$US-JNJFOC-20240882604$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240904$$PH$US$US
242801481$24280148$1$I$20240801$20240823$20240904$20240904$PER$$US-JNJFOC-20240860917$JOHNSON AND JOHNSON$$51$YR$$M$Y$$$20240904$$HP$US$US
242801492$24280149$2$F$20240801$20240907$20240904$20240916$EXP$$CA-JNJFOC-20240900369$JOHNSON AND JOHNSON$$38$YR$A$M$Y$99$KG$20240916$$HP$CA$CA
242801501$24280150$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177504$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
242801511$24280151$1$I$$20240829$20240904$20240904$EXP$$US-JNJFOC-20240901037$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$MD$US$US
242801521$24280152$1$I$20240716$20240820$20240904$20240904$PER$$US-ASTELLAS-2024-AER-001993$ASTELLAS$$77$YR$E$M$Y$$$20240904$$HP$US$US
242801531$24280153$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-085829-2024$RECKITT BENCKISER$$$$$F$Y$$$20240904$$CN$US$US
242801542$24280154$2$F$$20240826$20240904$20240909$EXP$$JP-ASTELLAS-2024-AER-002235$ASTELLAS$$$$E$M$Y$$$20240909$$MD$JP$JP
242801551$24280155$1$I$20240620$20240902$20240904$20240904$EXP$SK-SUKLSK-20240531$SK-UCBSA-2024044651$UCB$$48$YR$$M$Y$92$KG$20240904$$MD$SK$SK
242801561$24280156$1$I$$20240830$20240904$20240904$EXP$$IN-ROCHE-10000071672$ROCHE$$49$YR$A$M$Y$$$20240904$$CN$IN$IN
242801581$24280158$1$I$20240710$20240829$20240904$20240904$EXP$$US-ABBVIE-5832547$ABBVIE$$75$YR$$M$Y$$$20240904$$CN$US$US
242801591$24280159$1$I$$20240903$20240904$20240904$PER$$US-HALEON-2195032$Haleon PLC$$$$$$Y$$$20240904$$CN$US$US
242801601$24280160$1$I$20240823$20240829$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408018861$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240904$$CN$US$US
242801611$24280161$1$I$20240731$20240826$20240904$20240904$EXP$$CN-BEIGENE-BGN-2024-013470$BEIGENE$$$$$$Y$$$20240904$$HP$CN$CN
242801622$24280162$2$F$20230101$20240830$20240904$20240911$EXP$$CA-ABBVIE-5904485$ABBVIE$$72$YR$$F$Y$$$20240911$$HP$CA$CA
242801631$24280163$1$I$20240612$20240902$20240904$20240904$EXP$FR-AFSSAPS-DJ2024000954$FR-UCBSA-2024044630$UCB$$80$YR$$M$Y$66$KG$20240904$$MD$FR$FR
242801641$24280164$1$I$$20240808$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07972$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242801651$24280165$1$I$$20240828$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138671$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240904$$CN$US$US
242801661$24280166$1$I$$20240828$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138686$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240904$$CN$US$US
242801671$24280167$1$I$$20240821$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133981$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240904$$HP$US$US
242801681$24280168$1$I$$20240831$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139670$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240904$$HP$US$US
242801691$24280169$1$I$20231116$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-140208-2023$RECKITT BENCKISER$$$$$M$Y$$$20240904$$CN$US$US
242801702$24280170$2$F$$20240906$20240904$20240916$EXP$$US-TEVA-VS-3238216$TEVA$Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, et al. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. J-Clin-Oncol 2024; 42 (Suppl.) (16):.; Stoff R, Markovic S, McWilliams RR, Yan Y, Tan W, Seetharam M, et al. Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma. J-Clin-Oncol 2024; 42 (Suppl.) (16):.$$$E$$Y$$$20240916$$HP$US$US
242801711$24280171$1$I$$20240830$20240904$20240904$EXP$$JP-GSK-JP2024108210$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$JP$JP
242801721$24280172$1$I$$20240830$20240904$20240904$EXP$$JP-GSK-JP2024108986$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$JP$JP
242801732$24280173$2$F$20240820$20240920$20240904$20240924$EXP$$IT-GSK-IT2004GSK000032$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$IT$IT
242801741$24280174$1$I$20240418$20240827$20240904$20240904$EXP$$CN-BEIGENE-BGN-2024-013536$BEIGENE$$$$$$Y$$$20240904$$HP$CN$CN
242801752$24280175$2$F$20240401$20240902$20240904$20240909$EXP$$BR-TAKEDA-BR201928824$TAKEDA$$38$YR$$M$Y$94$KG$20240909$$CN$BR$BR
242801761$24280176$1$I$$20240903$20240904$20240904$EXP$GB-MHRA-31738807$GB-ORGANON-O2409GBR000157$ORGANON$$$$$$Y$$$20240904$$CN$GB$GB
242801771$24280177$1$I$20240517$20240829$20240904$20240904$EXP$$ES-ABBVIE-5904561$ABBVIE$$80$YR$$M$Y$$$20240904$$MD$ES$ES
242801781$24280178$1$I$$20240822$20240904$20240904$PER$$US-ALXN-202408USA002232US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
242801791$24280179$1$I$20240502$20240903$20240904$20240904$EXP$$CN-ROCHE-10000073270$ROCHE$$$$$M$Y$76$KG$20240904$$HP$CN$CN
242801801$24280180$1$I$$20240823$20240904$20240904$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-111604$ZYDUS PHARM$Kumar S, Bolar A, Shetty R, Pramod M, Agadi J, Govindappa SK, et al.. NMO spectrum disorders: A single center experience.. J-Neurol-Sci. 2023;Abstract 121150$$$$$Y$$$20240904$$HP$IN$IN
242801811$24280181$1$I$20240822$20240822$20240904$20240904$PER$$US-JNJFOC-20240860007$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20240904$$CN$US$US
242801821$24280182$1$I$20240809$20240830$20240904$20240904$EXP$$CN-JNJFOC-20240900701$JOHNSON AND JOHNSON$$70$YR$E$F$Y$49$KG$20240904$$HP$CN$CN
242801831$24280183$1$I$20240823$20240827$20240904$20240904$EXP$$BR-JNJFOC-20240874805$JOHNSON AND JOHNSON$$58$YR$A$M$Y$87$KG$20240904$$MD$BR$BR
242801842$24280184$2$F$$20240902$20240904$20240909$PER$$US-AMGEN-USASP2024175231$AMGEN$$77$YR$E$F$Y$$$20240909$$CN$US$US
242801852$24280185$2$F$$20240905$20240904$20240906$EXP$$PT-SANDOZ INC.-SDZ2024PT077264$SANDOZ$$70$YR$$F$Y$$$20240906$$MD$PT$PT
242801861$24280186$1$I$$20240903$20240904$20240904$EXP$$PL-SANDOZ INC.-SDZ2024PL077385$SANDOZ$$31$YR$$F$Y$$$20240904$$MD$PL$PL
242801871$24280187$1$I$$20240830$20240904$20240904$EXP$$JP-GSK-JP2024109020$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$JP$JP
242801881$24280188$1$I$$20240830$20240904$20240904$EXP$$JP-GSK-JP2024109026$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$JP$JP
242801891$24280189$1$I$$20240829$20240904$20240904$EXP$$IT-GSK-IT2024EME108312$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$IT$IT
242801901$24280190$1$I$$20240828$20240904$20240904$EXP$$US-GSK-US2024107290$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242801911$24280191$1$I$20240101$20240806$20240904$20240904$PER$$US-009507513-2408USA001965$MERCK$$$$$F$Y$$$20240904$$CN$US$US
242801921$24280192$1$I$$20240826$20240904$20240904$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006429$BIOCON$$$$$$Y$$$20240904$$HP$CA$CA
242801931$24280193$1$I$20240101$20240829$20240904$20240904$EXP$$US-ABBVIE-5862114$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242801942$24280194$2$F$20240801$20240905$20240904$20240911$EXP$$US-ABBVIE-5894376$ABBVIE$$82$YR$$M$Y$$$20240911$$CN$US$US
242801951$24280195$1$I$$20240829$20240904$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US076608$SANDOZ$$$$$M$Y$$$20240904$$HP$US$US
242801961$24280196$1$I$20240821$20240830$20240904$20240904$EXP$$US-ABBVIE-5903939$ABBVIE$$59$YR$$F$Y$$$20240904$$CN$US$US
242801971$24280197$1$I$20240401$20240823$20240904$20240904$EXP$$IN-Accord-443379$ACCORD$Princy R, Neethu R. Methotrexate-Induced Mucositis Due to Accidental Overdose; a Case Report. African Journal of Biological Sciences. 2024;6(3):700-3.$71$YR$E$F$Y$49$KG$20240904$$PH$IN$IN
242801981$24280198$1$I$20221219$20240903$20240904$20240904$EXP$$US-UCBSA-2024044916$UCB$$36$YR$$F$Y$$$20240904$$HP$US$US
242801991$24280199$1$I$20240801$20240903$20240904$20240904$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049355$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240904$$HP$SG$SG
242802001$24280200$1$I$20240820$20240827$20240904$20240904$EXP$$CN-BEIGENE-BGN-2024-013532$BEIGENE$$$$$$Y$$$20240904$$HP$CN$CN
242802011$24280201$1$I$20240101$20240903$20240904$20240904$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049368$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$$$20240904$$HP$SG$SG
242802021$24280202$1$I$20240616$20240826$20240904$20240904$EXP$$ES-AUROBINDO-AUR-APL-2024-043047$AUROBINDO$$72$YR$$M$Y$96.4$KG$20240904$$PH$ES$ES
242802031$24280203$1$I$$20240826$20240904$20240904$EXP$$GB-AUROBINDO-AUR-APL-2024-042859$AUROBINDO$$29$YR$$F$Y$56$KG$20240904$$CN$GB$GB
242802041$24280204$1$I$20240807$20240903$20240904$20240904$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049370$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240904$$HP$SG$SG
242802051$24280205$1$I$$20240826$20240904$20240904$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006375$BIOCON$$$$$$Y$$$20240904$$CN$CA$CA
242802061$24280206$1$I$$20240826$20240904$20240904$EXP$$IT-AUROBINDO-AUR-APL-2024-043053$AUROBINDO$$59$YR$$$Y$$$20240904$$MD$IT$IT
242802071$24280207$1$I$20240829$20240902$20240904$20240904$EXP$$CN-ROCHE-10000072462$ROCHE$$43$YR$A$F$Y$56$KG$20240904$$HP$CN$CN
242802101$24280210$1$I$$20240826$20240904$20240904$EXP$$CA-JNJFOC-20240876742$JOHNSON AND JOHNSON$$72$YR$E$F$Y$54$KG$20240904$$PH$CA$CA
242802111$24280211$1$I$$20240823$20240904$20240904$EXP$CA-MHPD-001093395$CA-Accord-443966$ACCORD$$64$YR$A$M$Y$$$20240904$$HP$CA$CA
242802121$24280212$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177460$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242802131$24280213$1$I$$20240829$20240904$20240904$EXP$$US-AstraZeneca-2024A197693$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242802141$24280214$1$I$20240621$20240830$20240904$20240904$EXP$$JP-ABBVIE-5902065$ABBVIE$$87$YR$$F$Y$49$KG$20240904$$MD$JP$JP
242802152$24280215$2$F$$20240916$20240904$20240919$EXP$$ES-SANDOZ INC.-SDZ2024ES076945$SANDOZ$$36$YR$$F$Y$83.3$KG$20240919$$PH$ES$ES
242802161$24280216$1$I$20240101$20240830$20240904$20240904$EXP$$PR-ABBVIE-5904394$ABBVIE$$$$$M$Y$$$20240904$$CN$PR$PR
242802171$24280217$1$I$$20240823$20240904$20240904$EXP$CA-MHPD-001102586$CA-Accord-443968$ACCORD$$64$YR$A$M$Y$$$20240904$$HP$CA$CA
242802181$24280218$1$I$$20240822$20240904$20240904$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08558$LUPIN$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73(200):1-9$71$YR$$F$Y$$$20240904$$HP$US$US
242802191$24280219$1$I$$20240826$20240904$20240904$EXP$$FR-CTRS-202400177$ADDMEDICA$Beurier P, Dallevet CA, Brissot E, Cholet C, Santin A, Lionnet F, et al. Hematopoietic stem cell allograft remission of periarteritis nodosa associated with azacytidine-refractory myelodysplastic syndrome. The Review of Internal Medicine 45. 2024; 512-515. https://doi.org/10.1016/j.revmed.2024.06.002.$32$YR$$M$Y$$$20240904$$MD$FR$
242802202$24280220$2$F$$20240906$20240904$20240916$EXP$$US-TEVA-VS-3238217$TEVA$Weiner DM, Pierog O, Rozati S. Oral Mucosal Pigmentation in a Patient with Mycosis Fungoides. JAMA-Oncol 2023; 9 (10): 1455-1456.; Weiner DM, Pierog O, Rozati S. Oral Mucosal Pigmentation in a Patient with Mycosis Fungoides. JAMA-Oncol 2023; 9 (10): 1455-1456.$53$YR$$F$Y$$$20240916$$HP$US$US
242802211$24280221$1$I$$20240829$20240904$20240904$EXP$$US-ABBVIE-5902175$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242802231$24280223$1$I$20240101$20240829$20240904$20240904$EXP$$US-ABBVIE-5902404$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242802241$24280224$1$I$20240825$20240826$20240904$20240904$PER$$US-ABBVIE-5895878$ABBVIE$$33$YR$$F$Y$$$20240904$$CN$US$US
242802251$24280225$1$I$20240601$20240820$20240904$20240904$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-25683$SAMSUNG BIOEPIS$$22$YR$A$F$Y$$$20240904$$CN$AU$AU
242802261$24280226$1$I$$20240829$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138848$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240904$$HP$US$US
242802271$24280227$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140336$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240904$$HP$US$US
242802281$24280228$1$I$20240312$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-087230-2024$RECKITT BENCKISER$$$$$M$Y$$$20240904$$CN$US$US
242802291$24280229$1$I$20240701$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140303$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240904$$HP$US$US
242802301$24280230$1$I$20240820$20240823$20240904$20240904$EXP$$US-Accord-443614$ACCORD$$46$YR$A$M$Y$$$20240904$$HP$US$US
242802311$24280231$1$I$20240401$20240814$20240904$20240904$PER$$US-009507513-2408USA005051$MERCK$$$$$M$Y$$$20240904$$CN$US$US
242802321$24280232$1$I$$20240828$20240904$20240904$EXP$$US-GSK-US2024107104$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$US$US
242802331$24280233$1$I$20240801$20240830$20240904$20240904$EXP$$CN-Orion Corporation ORION PHARMA-ENT 2024-0042$ORION$$62$YR$A$M$Y$67$KG$20240904$$HP$CN$
242802341$24280234$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177567$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242802351$24280235$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139434$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$58.97$KG$20240904$$PH$US$US
242802361$24280236$1$I$20240826$20240826$20240904$20240904$PER$$US-ABBVIE-5896163$ABBVIE$$$$$$Y$$$20240904$$CN$US$US
242802371$24280237$1$I$20240701$20240827$20240904$20240904$EXP$$JP-009507513-2408JPN003401J$MERCK$$6$DEC$$M$Y$$$20240904$$MD$JP$JP
242802381$24280238$1$I$$20240829$20240904$20240904$EXP$$GR-009507513-2409GRC000601$MERCK$$$$$M$Y$$$20240904$$MD$GR$GR
242802391$24280239$1$I$20240201$20240605$20240904$20240904$EXP$$US-GILEAD-2024-0675789$GILEAD$$32$YR$A$F$Y$$$20240904$$CN$US$US
242802401$24280240$1$I$20240601$20240829$20240904$20240904$EXP$$JP-RECORDATI RARE DISEASES-2024006741$RECORDATI$$$$$$Y$$$20240904$$CN$JP$JP
242802411$24280241$1$I$$20240802$20240904$20240904$30DAY$$IN-ABBVIE-5901627$ABBVIE$$$$$$Y$$$20240904$$HP$IN$IN
242802421$24280242$1$I$20240825$20240826$20240904$20240904$PER$$US-TRIS PHARMA, INC.-24US011612$TRIS PHARM$$$$$$Y$$$20240904$$CN$US$US
242802431$24280243$1$I$20240429$20240903$20240904$20240904$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049376$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240904$$HP$SG$SG
242802442$24280244$2$F$$20240903$20240904$20240912$EXP$$JP-009507513-2409JPN000198J$MERCK$$9$DEC$$M$Y$$$20240912$$HP$JP$JP
242802451$24280245$1$I$$20240902$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139841$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$74.39$KG$20240904$$CN$US$US
242802471$24280247$1$I$20240408$20240826$20240904$20240904$EXP$$DE-AUROBINDO-AUR-APL-2024-043059$AUROBINDO$$56$YR$$F$Y$$$20240904$$MD$DE$DE
242802482$24280248$2$F$$20240905$20240904$20240912$EXP$$US-ABBVIE-5904490$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
242802491$24280249$1$I$$20240826$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136936$BRISTOL MYERS SQUIBB$$10$DEC$E$M$Y$$$20240904$$CN$US$US
242802501$24280250$1$I$20240801$20240830$20240904$20240904$EXP$$US-ABBVIE-5903651$ABBVIE$$55$YR$$F$Y$$$20240904$$CN$US$US
242802512$24280251$2$F$20240728$20240910$20240904$20240919$EXP$FR-AFSSAPS-NC2024000990$FR-EMD Serono-2024046153$EMD SERONO INC$$77$YR$E$M$Y$80$KG$20240919$$MD$FR$FR
242802522$24280252$2$F$20240101$20240912$20240904$20240925$EXP$$US-INSMED, INC.-2024-02680-US$INSMED$$$$$F$Y$$$20240925$$CN$US$US
242802541$24280254$1$I$20240809$20240825$20240904$20240904$EXP$GB-MHRA-MED-202408251108104900-LSWQG$GB-TEVA-VS-3237334$TEVA$$$$$F$Y$89$KG$20240904$$CN$GB$GB
242802552$24280255$2$F$$20240918$20240904$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU076797$SANDOZ$$64$YR$$M$Y$$$20240920$$MD$AU$AU
242802561$24280256$1$I$20240129$20240902$20240904$20240904$EXP$IT-MINISAL02-1000460$IT-GSK-IT2024109108$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$PH$IT$IT
242802571$24280257$1$I$$20240829$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408019282$ELI LILLY AND CO$$$$$F$Y$$$20240904$$CN$US$US
242802581$24280258$1$I$$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000770$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240904$$CN$US$US
242802592$24280259$2$F$20240101$20240911$20240904$20240921$EXP$$DE-AUROBINDO-AUR-APL-2024-043070$AUROBINDO$$55$YR$$M$Y$$$20240921$$CN$DE$DE
242802601$24280260$1$I$$20240830$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139138$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$107.95$KG$20240904$$CN$US$US
242802612$24280261$2$F$$20240927$20240904$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140221$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240930$$CN$US$US
242802621$24280262$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-081943-2024$RECKITT BENCKISER$$$$$F$Y$$$20240904$$CN$US$US
242802631$24280263$1$I$20240530$20240902$20240904$20240904$EXP$$CO-UCBSA-2024044935$UCB$$74$YR$$F$Y$$$20240904$$CN$CO$CO
242802651$24280265$1$I$20240805$20240826$20240904$20240904$EXP$$IT-AUROBINDO-AUR-APL-2024-043066$AUROBINDO$$74$YR$$M$Y$85$KG$20240904$$MD$IT$IT
242802661$24280266$1$I$20240820$20240826$20240904$20240904$EXP$$GB-AUROBINDO-AUR-APL-2024-042807$AUROBINDO$$45$YR$$F$Y$85$KG$20240904$$PH$GB$GB
242802682$24280268$2$F$20240823$20240903$20240904$20240910$30DAY$$US-AMGEN-USASP2024173307$AMGEN$$74$YR$E$F$Y$104.78$KG$20240910$$HP$US$US
242802691$24280269$1$I$$20240903$20240904$20240904$PER$$US-ALXN-202409USA000029US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240904$$HP$US$US
242802711$24280271$1$I$$20240830$20240904$20240904$EXP$$US-GILEAD-2024-0686072$GILEAD$$$$A$F$Y$$$20240904$$CN$US$US
242802721$24280272$1$I$20240826$20240903$20240904$20240904$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014102$JAZZ$$47$YR$$F$Y$$$20240904$$CN$US$US
242802733$24280273$3$F$$20240830$20240904$20240911$EXP$$US-ROCHE-10000066513$ROCHE$$59$YR$A$F$Y$$$20240911$$MD$US$US
242802741$24280274$1$I$20231129$20240826$20240904$20240904$EXP$$DE-AUROBINDO-AUR-APL-2024-043054$AUROBINDO$$68$YR$$F$Y$$$20240904$$MD$DE$DE
242802751$24280275$1$I$$20240826$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-043143$AUROBINDO$Zagzoog MM, Crawford SA, Davaine JM.. Complicated type B aortic dissection in a pregnant woman with Marfan syndrome.. Journal of Vascular Surgery Cases, Innovations and Techniques.. 2024;10:5:1-3$29$YR$$F$Y$$$20240904$$MD$FR$FR
242802761$24280276$1$I$$20240830$20240904$20240904$EXP$$AE-AMGEN-ARESP2024174684$AMGEN$Rabbani S. A.; Alkaabi M. M.; Rao P. G. et al.. Treatment patterns and factors associated with discontinuation of monoclonal antibodies. SAGE Open Medicine. 2024;12:1-12$$$$$Y$$$20240904$$HP$AE$AE
242802771$24280277$1$I$$20240829$20240904$20240904$EXP$$CA-TAKEDA-2021TUS003745$TAKEDA$$$$$M$Y$$$20240904$$MD$CA$CA
242802781$24280278$1$I$20240801$20240827$20240904$20240904$EXP$$JP-AMGEN-JPNSP2024175023$AMGEN$$$$$$Y$$$20240904$$MD$JP$JP
242802791$24280279$1$I$$20240828$20240904$20240904$PER$$US-JNJFOC-20240876115$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$CN$US$US
242802801$24280280$1$I$20240214$20240828$20240904$20240904$EXP$FR-AFSSAPS-AVMA2024000347$FR-CHEPLA-2024011133$CHEPLAPHARM$$59$YR$$M$Y$$$20240903$$PH$COUNTRY NOT SPECIFIED$FR
242802811$24280281$1$I$20240729$20240829$20240904$20240904$EXP$FR-AFSSAPS-NC2024000991$FR-CHEPLA-2024011203$CHEPLAPHARM$$53$YR$$F$Y$70$KG$20240904$$MD$COUNTRY NOT SPECIFIED$FR
242802821$24280282$1$I$$20240827$20240904$20240904$EXP$$US-CHEPLA-2024011097$CHEPLAPHARM$$82$YR$$M$Y$$$20240903$$CN$COUNTRY NOT SPECIFIED$US
242802831$24280283$1$I$$20240830$20240904$20240904$PER$$US-AstraZeneca-2024A198529$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242802841$24280284$1$I$$20240829$20240904$20240904$EXP$$CL-EMD Serono-2024046736$EMD SERONO INC$$$$A$F$Y$$$20240904$$CN$CL$CL
242802851$24280285$1$I$$20240826$20240904$20240904$EXP$$PL-AUROBINDO-AUR-APL-2024-043147$AUROBINDO$$23$YR$$F$Y$70$KG$20240904$$MD$PL$PL
242802862$24280286$2$F$20240821$20240905$20240904$20240910$EXP$$US-INTERCEPT-PM2024001727$INTERCEPT PHARMACEUTICALS$$88$YR$$M$Y$$$20240910$$CN$US$US
242802872$24280287$2$F$$20240821$20240904$20240912$PER$$US-HALEON-2193073$Haleon PLC$$$$$$Y$$$20240912$$CN$US$US
242802882$24280288$2$F$20240101$20240917$20240904$20240924$EXP$$US-INTERCEPT-PM2024001711$INTERCEPT PHARMACEUTICALS$$$$$F$Y$70.748$KG$20240924$$CN$US$US
242802892$24280289$2$F$$20240604$20240904$20240930$EXP$$DE-ASTELLAS-2024-AER-003972$ASTELLAS$$71$YR$E$M$Y$$$20240930$$HP$DE$DE
242802902$24280290$2$F$$20240906$20240904$20240910$EXP$$NVSC2024GB177092$NOVARTIS$$$$A$F$Y$$$20240910$$CN$GB$GB
242802911$24280291$1$I$20240401$20240826$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-043107$AUROBINDO$$76$YR$$F$Y$$$20240904$$MD$FR$FR
242802921$24280292$1$I$$20240815$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08287$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242802931$24280293$1$I$$20240830$20240904$20240904$EXP$$JP-009507513-2409JPN000150J$MERCK$$$$$F$Y$$$20240904$$HP$JP$JP
242802942$24280294$2$F$$20240906$20240904$20240912$EXP$$JP-ROCHE-10000069048$ROCHE$$8$DEC$E$M$Y$$$20240912$$MD$JP$JP
242802951$24280295$1$I$$20240830$20240904$20240904$EXP$$US-ABBVIE-5903644$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242802961$24280296$1$I$$20240823$20240904$20240904$EXP$CA-MHPD-E2B_07199565$CA-Accord-443947$ACCORD$$$$A$M$Y$$$20240904$$MD$CA$CA
242802971$24280297$1$I$20240830$20240903$20240904$20240904$PER$$US-AMGEN-USASP2024176052$AMGEN$$$$$$Y$$$20240904$$HP$US$US
242802982$24280298$2$F$20240901$20240904$20240904$20240905$PER$$US-AMGEN-USASP2024175993$AMGEN$$78$YR$E$F$Y$$$20240904$$CN$US$US
242802992$24280299$2$F$20240312$20240913$20240904$20240923$EXP$$JP-ROCHE-10000069066$ROCHE$$58$YR$A$F$Y$68.8$KG$20240923$$MD$JP$JP
242803012$24280301$2$F$20231123$20240830$20240904$20240910$EXP$$GB-ORGANON-O2408GBR002205$ORGANON$$$$E$F$Y$89$KG$20240910$$MD$GB$GB
242803021$24280302$1$I$$20240830$20240904$20240904$EXP$$AU-Orion Corporation ORION PHARMA-24_00031510$ORION$Skinner T, Liang S. Budesonide Orodispersible Tablet for the Treatment of Refractory Esophageal Lichen Planus. ACG Case Rep J. 2024 AUG 22;11(8):E01460.$61$YR$A$F$Y$$$20240904$$MD$AU$
242803033$24280303$3$F$20240101$20240912$20240904$20240923$PER$$US-ASTELLAS-2024-AER-001027$ASTELLAS$$62$YR$A$F$Y$$$20240923$$MD$US$US
242803042$24280304$2$F$20240817$20240912$20240904$20240920$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004495$BLUEPRINT MEDICINES$$$$$$Y$$$20240919$$CN$US$US
242803052$24280305$2$F$20240818$20240830$20240904$20240910$EXP$$JP-ULTRAGENYX PHARMACEUTICAL INC.-JP-UGX-24-01579$ULTRAGENYX PHARMACEUTICAL$$4$YR$$M$Y$15.7$KG$20240910$$MD$JP$JP
242803061$24280306$1$I$20240826$20240827$20240904$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027165$UNITED THERAPEUTICS$$$$$F$Y$$$20240904$$$US$US
242803071$24280307$1$I$$20240826$20240904$20240904$PER$$US-RDY-SPO/USA/24/0012652$DR REDDYS$$32$YR$A$$Y$$$20240904$$MD$US$US
242803091$24280309$1$I$20240801$20240822$20240904$20240904$PER$$US-RDY-SPO/USA/24/0012647$DR REDDYS$$$$$F$Y$$$20240904$$CN$US$US
242803101$24280310$1$I$$20240828$20240904$20240904$PER$US-MLMSERVICE-20240821-PI168723-00184-1$US-RDY-SPO/USA/24/0012630$DR REDDYS$Ghali H, Albers SE. Isotretinoin-Induced Skin Fragility in an Aerialist. Cutis. 2024;114(1):32-3. DOI: 10.12788/cutis.1042.$25$YR$A$F$Y$$$20240904$$MD$US$US
242803111$24280311$1$I$$20240827$20240904$20240904$PER$$US-RDY-SPO/USA/24/0012637$DR REDDYS$$18$YR$A$F$Y$$$20240904$$MD$US$US
242803121$24280312$1$I$$20240816$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08188$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242803131$24280313$1$I$$20240823$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408015148$ELI LILLY AND CO$$91$YR$E$$Y$$$20240904$$CN$US$US
242803141$24280314$1$I$$20240827$20240904$20240904$PER$$US-BEH-2024177900$CSL BEHRING$$$$T$F$Y$$$20240904$$HP$US$US
242803151$24280315$1$I$$20240823$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408015991$ELI LILLY AND CO$$61$YR$A$$Y$$$20240904$$LW$US$US
242803161$24280316$1$I$$20240823$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408015235$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240904$$MD$US$US
242803181$24280318$1$I$$20240826$20240904$20240904$EXP$$TR-TEVA-VS-3238802$TEVA$Temuroglu A, Abakay C, Sevinir B. LONG-TERM EVALUATION RESULTS OF OUR PATIENTS DIAGNOSED WITH NASOPHARYNGEAL CARCINOMA: A SINGLE CENTER EXPERIENCE. Hematol-Transfus-Cell-Ther 2023; 45 (Suppl. 3) S30.$$$$$Y$$$20240904$$HP$TR$TR
242803193$24280319$3$F$20240101$20240903$20240904$20240916$EXP$$US-INSMED, INC.-2024-03407-US$INSMED$$$$$F$Y$$$20240916$$CN$US$US
242803211$24280321$1$I$$20240902$20240904$20240904$EXP$$CN-GILEAD-2024-0686002$GILEAD$$$$$$Y$$$20240904$$CN$CN$CN
242803221$24280322$1$I$$20240830$20240904$20240904$EXP$$CA-TAKEDA-2024TUS088213$TAKEDA$$$$$M$Y$$$20240904$$CN$CA$CA
242803231$24280323$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139668$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$67.13$KG$20240904$$CN$US$US
242803241$24280324$1$I$$20240830$20240904$20240904$EXP$$US-ABBVIE-5903554$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242803251$24280325$1$I$$20240819$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08258$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242803261$24280326$1$I$20240524$20240827$20240904$20240904$EXP$$TR-AMGEN-TURSP2024172537$AMGEN$$62$YR$A$M$Y$$$20240904$$MD$TR$TR
242803271$24280327$1$I$20240801$20240831$20240904$20240904$EXP$$CN-ABBVIE-5903803$ABBVIE$$42$YR$$M$Y$57$KG$20240904$$MD$CN$CN
242803282$24280328$2$F$$20240906$20240904$20240916$EXP$$TR-TEVA-VS-3238803$TEVA$Temuroglu A, Abakay C, Sevinir B. LONG-TERM EVALUATION RESULTS OF OUR PATIENTS DIAGNOSED WITH NASOPHARYNGEAL CARCINOMA: A SINGLE CENTER EXPERIENCE. Hematol-Transfus-Cell-Ther 2023; 45 (Suppl. 3) S30; Temuroglu A, Abakay C, Sevinir B. LONG-TERM EVALUATION RESULTS OF OUR PATIENTS DIAGNOSED WITH NASOPHARYNGEAL CARCINOMA: A SINGLE CENTER EXPERIENCE. Hematol-Transfus-Cell-Ther 2023; 45 (Suppl. 3) S30.$$$$$Y$$$20240916$$HP$TR$TR
242803291$24280329$1$I$$20240823$20240904$20240904$PER$$US-ALXN-202408USA002234US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
242803301$24280330$1$I$20240616$20240826$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-043038$AUROBINDO$$81$YR$$F$Y$63$KG$20240904$$MD$FR$FR
242803312$24280331$2$F$$20240829$20240904$20240911$EXP$$US-TAKEDA-2024TUS087280$TAKEDA$$$$$$Y$$$20240911$$CN$US$US
242803331$24280333$1$I$$20240826$20240904$20240904$EXP$$VN-ROCHE-10000068591$ROCHE$$31$YR$A$F$Y$$$20240904$$CN$VN$VN
242803341$24280334$1$I$$20240819$20240904$20240904$PER$$US-ASTELLAS-2024-AER-003528$ASTELLAS$$$$$F$Y$$$20240904$$CN$US$US
242803351$24280335$1$I$20240807$20240826$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-043032$AUROBINDO$$35$YR$$M$Y$55.5$KG$20240904$$MD$FR$FR
242803361$24280336$1$I$$20240830$20240904$20240904$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001776$BLUEPRINT MEDICINES$$$$$M$Y$$$20240904$$CN$US$US
242803371$24280337$1$I$$20240830$20240904$20240904$EXP$$JP-GSK-JP2024108194$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$JP$JP
242803381$24280338$1$I$$20240903$20240904$20240904$EXP$$US-GILEAD-2024-0686090$GILEAD$$$$A$F$Y$$$20240904$$HP$US$US
242803391$24280339$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009854$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242803401$24280340$1$I$20240827$20240829$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138797$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$92.53$KG$20240904$$CN$US$US
242803411$24280341$1$I$20240714$20240826$20240904$20240904$EXP$$IT-AUROBINDO-AUR-APL-2024-043137$AUROBINDO$$40$YR$$F$Y$$$20240904$$PH$IT$IT
242803421$24280342$1$I$$20240820$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08330$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242803431$24280343$1$I$$20240823$20240904$20240904$EXP$$GB-ADVANZ PHARMA-202408007067$ADVANZ PHARMA$$$$$$Y$$$20240904$$MD$GB$GB
242803441$24280344$1$I$20240801$20240830$20240904$20240904$EXP$$NVSC2024DE177112$NOVARTIS$$$$A$F$Y$$$20240904$$MD$DE$DE
242803451$24280345$1$I$$20240826$20240904$20240904$PER$$US-ROCHE-10000066149$ROCHE$Kubiak J, Klevay M, Hilt E, Ferrieri P. Acute Meningoencephalitis Associated with Borrelia miyamotoi, Minnesota, USA. Emerging Infectious Diseases. 2024-Jul;30 (7):1472-1474. doi:10.3201/eid3007.231611.$68$YR$E$M$Y$$$20240904$$MD$US$US
242803461$24280346$1$I$$20240826$20240904$20240904$EXP$PL-AMGEN-POLSP2024161676$PL-ROCHE-10000067830$ROCHE$Adamczuk-nurzynska A.. Electrolyte disturbances in an elderly patient with colon cancer. Unknown. 2024;1-3$73$YR$E$M$Y$$$20240904$$MD$PL$PL
242803471$24280347$1$I$$20240827$20240904$20240904$PER$$US-JNJFOC-20240873125$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242803482$24280348$2$F$$20240923$20240904$20240927$EXP$$BR-JNJFOC-20240902762$JOHNSON AND JOHNSON$$47$YR$A$F$Y$113$KG$20240927$$CN$BR$BR
242803491$24280349$1$I$$20240829$20240904$20240904$EXP$$BR-AMGEN-BRASP2024174346$AMGEN$$$$$F$Y$$$20240904$$CN$BR$BR
242803501$24280350$1$I$20230309$20240830$20240904$20240904$EXP$$CO-UCBSA-2024044907$UCB$$81$YR$$M$Y$$$20240904$$CN$CO$CO
242803511$24280351$1$I$20240816$20240902$20240904$20240904$EXP$$CO-UCBSA-2024044930$UCB$$26$YR$$M$Y$$$20240904$$CN$CO$CO
242803521$24280352$1$I$$20240827$20240904$20240904$EXP$$JP-009507513-2408JPN003584J$MERCK$$$$$M$Y$$$20240904$$MD$JP$JP
242803531$24280353$1$I$20240815$20240827$20240904$20240904$EXP$$CA-CURRAX PHARMACEUTICALS LLC-CA-2024CUR004042$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$CA$CA
242803541$24280354$1$I$$20240825$20240904$20240904$EXP$$US-ASPIRO-ASP2024US02882$ASPIRO PHARMA$Soliman Y, Hatfield AA, McAllister RK, Fettiplace MR, Hofkamp MP. Apparent local anesthetic systemic toxicity following activation of an epidural catheter for cesarean delivery: diagnosis and management of an uncommon obstetric anesthesia complication. Taylor + Francis. 2024;37(5):874?876$25$YR$$F$Y$92$KG$20240904$$HP$US$US
242803552$24280355$2$F$$20240906$20240904$20240916$EXP$$US-TEVA-VS-3238541$TEVA$Shah PJ, Blair JE. Voriconazole-Induced Periostitis: A Mimicker of Skeletal Coccidioidomycosis. Am-J-Case-Rep 2024; 25.; Shah PJ, Blair JE. Voriconazole-Induced Periostitis: A Mimicker of Skeletal Coccidioidomycosis. Am-J-Case-Rep 2024; 25.; Shah PJ, Blair JE. Voriconazole-Induced Periostitis: A Mimicker of Skeletal Coccidioidomycosis. Am-J-Case-Rep 2024; 25.$50$YR$$F$Y$$$20240916$$HP$US$US
242803561$24280356$1$I$20240101$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140293$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240904$$CN$US$US
242803571$24280357$1$I$$20240826$20240904$20240904$EXP$$CA-ABBVIE-5904710$ABBVIE$$60$YR$$M$Y$71$KG$20240904$$PH$CA$CA
242803581$24280358$1$I$$20240812$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051839$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
242803591$24280359$1$I$$20240812$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051840$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
242803601$24280360$1$I$20240805$20240812$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051834$TOLMAR$$69$YR$$M$Y$$$20240904$$CN$CA$CA
242803611$24280361$1$I$20240812$20240812$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051846$TOLMAR$$72$YR$$M$Y$$$20240904$$CN$CA$CA
242803621$24280362$1$I$20240812$20240812$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051851$TOLMAR$$75$YR$$M$Y$$$20240904$$CN$CA$CA
242803631$24280363$1$I$20240812$20240812$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051871$TOLMAR$$82$YR$$M$Y$$$20240904$$CN$CA$CA
242803641$24280364$1$I$20240101$20240812$20240904$20240904$PER$$NL-TOLMAR, INC.-24NL051822$TOLMAR$$$$$M$Y$$$20240904$$CN$NL$NL
242803652$24280365$2$F$$20240826$20240904$20240920$PER$$IT-TOLMAR, INC.-24IT052090$TOLMAR$$$$$$Y$$$20240913$$MD$IT$IT
242803661$24280366$1$I$20240812$20240812$20240904$20240904$PER$$TR-TOLMAR, INC.-24TR051857$TOLMAR$$77$YR$$M$Y$$$20240904$$MD$TR$TR
242803671$24280367$1$I$20240812$20240812$20240904$20240904$PER$$NL-TOLMAR, INC.-24NL051856$TOLMAR$$68$YR$$M$Y$$$20240904$$CN$NL$NL
242803681$24280368$1$I$20190822$20240902$20240904$20240904$EXP$$CO-UCBSA-2024044934$UCB$$76$YR$$M$Y$$$20240904$$CN$CO$CO
242803691$24280369$1$I$20240606$20240812$20240904$20240904$PER$$NL-TOLMAR, INC.-24NL051855$TOLMAR$$66$YR$$M$Y$$$20240904$$CN$NL$NL
242803701$24280370$1$I$20240401$20240827$20240904$20240904$EXP$$JP-ALXN-202408JPN001747JP$ALEXION PHARMACEUTICALS$$49$YR$$M$Y$$$20240904$$PH$JP$JP
242803711$24280371$1$I$$20240829$20240904$20240904$EXP$$NVSC2024BE176936$NOVARTIS$$$$$$Y$$$20240904$$CN$BE$BE
242803721$24280372$1$I$20240801$20240829$20240904$20240904$EXP$$CA-JNJFOC-20240900124$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240904$$HP$CA$CA
242803731$24280373$1$I$$20240820$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08299$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242803741$24280374$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009855$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242803751$24280375$1$I$20240830$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139011$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240904$$HP$US$US
242803761$24280376$1$I$$20240823$20240904$20240904$EXP$PL-URPL-1-1959-2019$PL-Accord-443699$ACCORD$$44$YR$A$F$Y$56.8$KG$20240904$$MD$PL$PL
242803771$24280377$1$I$20240415$20240826$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042921$AUROBINDO$$86$YR$$F$Y$78.6$KG$20240904$$MD$FR$FR
242803781$24280378$1$I$$20240828$20240904$20240904$EXP$$ALC2024US004015$ALCON$$58$YR$$F$Y$$$20240904$$CN$US$US
242803791$24280379$1$I$$20240820$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08297$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242803801$24280380$1$I$20240301$20240828$20240904$20240904$EXP$$BE-JNJFOC-20240877489$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$68$KG$20240904$$MD$BE$BE
242803811$24280381$1$I$$20240825$20240904$20240904$EXP$$US-ASPIRO-ASP2024US02895$ASPIRO PHARMA$Cunningham BW, Shah S, Biswas S, Biswas S.. Vancomycin Anaphylaxis and Kounis Syndrome Case Report. Cureus. 2024;16(7):1-6$$$$$Y$$$20240904$$HP$US$US
242803831$24280383$1$I$$20240829$20240904$20240904$PER$$US-AstraZeneca-2024A197741$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242803841$24280384$1$I$20240818$20240829$20240904$20240904$EXP$$US-AstraZeneca-2024A197753$ASTRAZENECA$$31064$DY$$F$Y$48.4$KG$20240904$$CN$US$
242803851$24280385$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-082173-2024$RECKITT BENCKISER$$$$$F$Y$$$20240904$$CN$US$US
242803861$24280386$1$I$20240730$20240826$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-043028$AUROBINDO$$61$YR$$M$Y$$$20240904$$MD$FR$FR
242803873$24280387$3$F$20240807$20240918$20240904$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024758$UNITED THERAPEUTICS$$68$YR$$F$Y$54.422$KG$20240927$$$US$US
242803882$24280388$2$F$20240701$20240910$20240904$20240925$30DAY$2024.07.000215$BR-BECTON DICKINSON-BR-BD-24-000519$BECTON DICKINSON$$$$$$Y$$$20240925$$CN$BR$BR
242803891$24280389$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009856$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242803902$24280390$2$F$20240830$20240903$20240904$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005123$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240913$$CN$US$US
242803911$24280391$1$I$20240417$20240830$20240904$20240904$EXP$$US-AMGEN-USASP2024174596$AMGEN$$61$YR$A$F$Y$$$20240904$$CN$US$US
242803923$24280392$3$F$20240831$20240909$20240904$20240912$PER$$US-AMGEN-USASP2024175900$AMGEN$$64$YR$A$F$Y$$$20240911$$CN$US$US
242803931$24280393$1$I$$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000892$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240904$$CN$US$US
242803941$24280394$1$I$$20240826$20240904$20240904$EXP$$JP-ROCHE-10000068330$ROCHE$Matsui T, Nagai H, Mukozu T, Wakui N, Matsuda T, Igarashi Y. Variceal bleeding following treatment with atezolizumab plus bevacizumab in two patients with unresectable hepatocellular carcinoma. Clinical Journal of Gastroenterology. 2024-Jan;1-9. doi:10.1007/s12328-024-02031-9.$7$DEC$E$M$Y$$$20240904$$HP$JP$JP
242803951$24280395$1$I$$20240829$20240904$20240904$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-117784$REGENERON$$$$$M$Y$$$20240904$$CN$CA$CA
242803961$24280396$1$I$$20240820$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08504$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242803981$24280398$1$I$20240405$20240826$20240904$20240904$EXP$$GB-AUROBINDO-AUR-APL-2024-042852$AUROBINDO$$63$YR$$F$Y$74$KG$20240904$$CN$GB$GB
242803991$24280399$1$I$20240101$20240828$20240904$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-027309$UNITED THERAPEUTICS$$$$$F$Y$92.971$KG$20240904$$$US$US
242804001$24280400$1$I$20240323$20240902$20240904$20240904$EXP$FR-AFSSAPS-AN2024001185$FR-UCBSA-2024044595$UCB$$45$YR$$M$Y$95$KG$20240904$$MD$FR$FR
242804012$24280401$2$F$$20240828$20240904$20240904$PER$$US-ROCHE-10000068632$ROCHE$$$$A$F$Y$$$20240904$$CN$US$US
242804021$24280402$1$I$20240809$20240826$20240904$20240904$EXP$$PT-AUROBINDO-AUR-APL-2024-042933$AUROBINDO$$48$YR$$F$Y$$$20240904$$HP$PT$PT
242804031$24280403$1$I$20240101$20240826$20240904$20240904$PER$$US-TAKEDA-2024TUS086291$TAKEDA$$10$YR$$F$Y$$$20240904$$CN$US$US
242804041$24280404$1$I$20240529$20240829$20240904$20240904$EXP$$JP-AMGEN-JPNSP2024174840$AMGEN$$8$DEC$E$M$Y$$$20240904$$PH$JP$JP
242804051$24280405$1$I$20240828$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024173853$AMGEN$$56$YR$A$M$Y$$$20240904$$CN$US$US
242804062$24280406$2$F$20240829$20240902$20240904$20240905$PER$$US-AMGEN-USASP2024174459$AMGEN$$62$YR$A$F$Y$$$20240904$$CN$US$US
242804071$24280407$1$I$20240823$20240823$20240904$20240904$PER$$US-JNJFOC-20240868870$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$CN$US$US
242804081$24280408$1$I$$20240826$20240904$20240904$EXP$$GB-AUROBINDO-AUR-APL-2024-042809$AUROBINDO$$$$$F$Y$$$20240904$$CN$GB$GB
242804091$24280409$1$I$$20240830$20240904$20240904$PER$$US-ADVANZ PHARMA-202408007162$ADVANZ PHARMA$$$$$$Y$$$20240904$$CN$US$US
242804101$24280410$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009857$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242804111$24280411$1$I$20231201$20240826$20240904$20240904$EXP$$DE-AUROBINDO-AUR-APL-2024-043099$AUROBINDO$$$$$F$Y$2.6$KG$20240904$$MD$DE$DE
242804121$24280412$1$I$$20240830$20240904$20240904$EXP$$US-GILEAD-2024-0677633$GILEAD$$$$A$F$Y$$$20240904$$CN$US$US
242804131$24280413$1$I$$20240826$20240904$20240904$PER$$US-TAKEDA-2024TUS086772$TAKEDA$$$$$$Y$$$20240904$$CN$US$US
242804141$24280414$1$I$$20240829$20240904$20240904$EXP$$CA-TAKEDA-2024TUS087715$TAKEDA$$$$$F$Y$$$20240904$$CN$CA$CA
242804151$24280415$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009858$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242804161$24280416$1$I$$20240830$20240904$20240904$PER$$US-JNJFOC-20240903573$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240904$$CN$US$US
242804171$24280417$1$I$$20240826$20240904$20240904$PER$$US-ABBVIE-5904098$ABBVIE$$$$A$F$Y$$$20240904$$HP$US$US
242804181$24280418$1$I$$20240829$20240904$20240904$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07828$VIFOR$$44$YR$$F$Y$$$20240904$$HP$ZA$ZA
242804191$24280419$1$I$20240801$20240824$20240904$20240904$EXP$$US-SA-2024SA253716$SANOFI AVENTIS$$$$$M$Y$$$20240904$$HP$US$US
242804201$24280420$1$I$$20240828$20240904$20240904$EXP$$CA-TAKEDA-2024TUS087260$TAKEDA$$$$$F$Y$$$20240904$$MD$CA$CA
242804212$24280421$2$F$$20240912$20240904$20240918$EXP$$BR-009507513-2409BRA000633$MERCK$$80$YR$$M$Y$$$20240918$$MD$BR$BR
242804221$24280422$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009859$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242804231$24280423$1$I$20240601$20240823$20240904$20240904$EXP$CZ-CZSUKL-24002325$CZ-Accord-443689$ACCORD$$82$YR$E$F$Y$$$20240904$$MD$CZ$CZ
242804241$24280424$1$I$20240826$20240826$20240904$20240904$EXP$$GB-AUROBINDO-AUR-APL-2024-042822$AUROBINDO$$50$YR$$M$Y$75$KG$20240904$$MD$GB$GB
242804252$24280425$2$F$$20240826$20240904$20240904$PER$$US-APOTEX-2024AP010055$APOTEX$Jalili MH, Cornman-Homonoff J.. Suction thrombectomy for management of pulmonary tumor embolism in the setting of hepatocellular carcinoma with macrovascular invasion. Radiology Case Reports. 2024;19 (10):4627-4630$83$YR$$M$Y$$$20240904$$MD$US$US
242804262$24280426$2$F$20240902$20240904$20240904$20240906$PER$$US-AMGEN-USASP2024176029$AMGEN$$62$YR$A$F$Y$$$20240906$$CN$US$US
242804271$24280427$1$I$20240101$20240828$20240904$20240904$EXP$$BE-SA-2024SA254481$SANOFI AVENTIS$$$$A$$Y$$$20240904$$MD$BE$BE
242804332$24280433$2$F$$20240908$20240904$20240911$EXP$$IL-ALXN-202409ISR000004IL$ALEXION PHARMACEUTICALS$$51$YR$$M$Y$87$KG$20240911$$MD$IL$IL
242804341$24280434$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009860$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242804351$24280435$1$I$20240827$20240829$20240904$20240904$EXP$$CN-SA-2024SA255404$SANOFI AVENTIS$$71$YR$E$M$Y$40$KG$20240904$$HP$CN$CN
242804361$24280436$1$I$20240101$20240830$20240904$20240904$EXP$$US-SA-2024SA254864$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240904$$MD$US$US
242804372$24280437$2$F$20240101$20240911$20240904$20240918$PER$$US-ABBVIE-5900380$ABBVIE$$$$$F$Y$58$KG$20240918$$CN$US$US
242804381$24280438$1$I$20230630$20240823$20240904$20240904$EXP$PT-INFARMED-A202408-219$PT-Accord-443760$ACCORD$$3$YR$C$M$Y$$$20240904$$MD$PT$PT
242804391$24280439$1$I$20240805$20240827$20240904$20240904$EXP$$DE-AstraZeneca-2024A194766$ASTRAZENECA$$81$YR$$M$Y$80$KG$20240904$$MD$DE$
242804401$24280440$1$I$20240201$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A196583$ASTRAZENECA$$618$MON$$F$Y$93.9$KG$20240904$$CN$US$
242804411$24280441$1$I$$20240826$20240904$20240904$EXP$$US-AMGEN-USASP2024172260$AMGEN$File B.; Hari A. et al.. Discrepancy in PD-L1 expression between primary and metastatic tumors in two patients with recurrent cervical cancer. Gynecologic Oncology Reports. 2024;55:1-4$36$YR$A$F$Y$$$20240904$$HP$US$US
242804421$24280442$1$I$$20240902$20240904$20240904$PER$$US-ROCHE-10000072247$ROCHE$$$$E$M$Y$$$20240904$$CN$US$US
242804431$24280443$1$I$$20240823$20240904$20240904$EXP$$US-ABBVIE-5894684$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242804451$24280445$1$I$20240607$20240821$20240904$20240904$EXP$$US-AUROBINDO-AUR-APL-2024-042764$AUROBINDO$$81$YR$$M$Y$57.06$KG$20240904$$CN$US$US
242804462$24280446$2$F$20210401$20240909$20240904$20240913$EXP$$JP-UCBSA-2024037344$UCB$Okamura T, Futakuchi K, Fukuda K, Sato T, Morimoto D, Watanabe H, et al. A case of non-mosaic tetraploidy (92, XXXX). Journal of Japan Society of Perinatal and Neonatal Medicine. 2024;60(S1):P20-1$1$YR$$F$Y$$$20240913$$MD$JP$JP
242804471$24280447$1$I$20240601$20240903$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049275$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240904$$CN$US$US
242804481$24280448$1$I$$20240829$20240904$20240904$EXP$$BR-RDY-SPO/BRA/24/0012642$DR REDDYS$$77$YR$E$M$Y$69$KG$20240904$$CN$BR$BR
242804491$24280449$1$I$20240829$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000215$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240904$$CN$US$US
242804501$24280450$1$I$$20240827$20240904$20240904$EXP$$CA-TOLMAR, INC.-24CA052210$TOLMAR$$$$$M$Y$$$20240904$$PH$CA$CA
242804511$24280451$1$I$$20240827$20240904$20240904$EXP$$CA-TOLMAR, INC.-24CA052169$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
242804521$24280452$1$I$$20240827$20240904$20240904$EXP$$CA-TOLMAR, INC.-24CA052183$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
242804531$24280453$1$I$$20240827$20240904$20240904$EXP$$NL-TOLMAR, INC.-24NL052146$TOLMAR$$$$$M$Y$$$20240904$$CN$NL$NL
242804542$24280454$2$F$20240601$20240912$20240904$20240920$PER$$CA-TOLMAR, INC.-24CA052215$TOLMAR$$84$YR$$M$Y$$$20240920$$CN$CA$CA
242804551$24280455$1$I$$20240827$20240904$20240904$EXP$$CA-TOLMAR, INC.-24CA052211$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
242804562$24280456$2$F$20240101$20240904$20240904$20240919$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08765$LUPIN$$$$$$Y$$$20240919$$CN$US$US
242804571$24280457$1$I$20240301$20240826$20240904$20240904$PER$$US-ABBVIE-5896662$ABBVIE$$30$YR$$F$Y$$$20240904$$CN$US$US
242804581$24280458$1$I$20240726$20240830$20240904$20240904$EXP$$US-JNJFOC-20240882330$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$CN$US$US
242804601$24280460$1$I$$20240828$20240904$20240904$EXP$$CA-JNJFOC-20240880004$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240904$$CN$CA$CA
242804611$24280461$1$I$20220601$20240830$20240904$20240904$EXP$$US-AMGEN-USASP2024174372$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242804621$24280462$1$I$20240829$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024174127$AMGEN$$79$YR$E$F$Y$$$20240904$$CN$US$US
242804631$24280463$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139247$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240904$$HP$US$US
242804651$24280465$1$I$20240521$20240830$20240904$20240904$EXP$FR-AFSSAPS-AVPO2024000148$FR-ABBVIE-5905193$ABBVIE$$17$YR$$M$Y$$$20240904$$PH$FR$FR
242804661$24280466$1$I$$20240827$20240904$20240904$EXP$$ES-Encube-001304$ENCUBE ETHICALS$Chovi-Trull M, Ballesta-Lopez O, Navarro Buendia GA, Sivera-Mascaro R, Albert-Mari A, Ruiz Caldes MJ, Garcia-Pellicer J, Poveda-Andres JL. Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die. Eur J Hosp Pharm. 2024 Aug 22:ejhpharm-2024-004184. doi: 10.1136/ejhpharm-2024-004184$53$YR$A$M$Y$$$20240903$$MD$ES$
242804701$24280470$1$I$$20240902$20240904$20240904$EXP$$AU-ABBVIE-5905215$ABBVIE$$$$$M$Y$$$20240904$$CN$AU$AU
242804711$24280471$1$I$20240511$20240902$20240904$20240904$EXP$IT-MINISAL02-1000367$IT-JNJFOC-20240903988$JOHNSON AND JOHNSON$$93$YR$E$F$Y$55$KG$20240904$$CN$IT$IT
242804721$24280472$1$I$20240101$20240830$20240904$20240904$EXP$$US-AMGEN-USASP2024174839$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242804731$24280473$1$I$20240825$20240830$20240904$20240904$EXP$$CN-ABBVIE-5903819$ABBVIE$$60$YR$$M$Y$70$KG$20240904$$MD$CN$CN
242804741$24280474$1$I$$20240820$20240904$20240904$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465781$RANBAXY$Sharifi P, Moradi A, Moghadasi AN.. Fingolimod-associated Balo^s concentric sclerosis in multiple sclerosis: A case report.. Clin Case Rep. 2024;12 (8):1-5$37$YR$$F$Y$$$20240904$$HP$IR$IR
242804761$24280476$1$I$$20240820$20240904$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465817$RANBAXY$Gopalan R, Mitchel H, Matushinec S, Kerr R, Bolton A, Kamin A, et al. Feasibility of Outpatient Hemodialysis for Patients with Total Artificial Heart: A Case Series. ASAIO J. 2023;69 (6):E270-E273$54$YR$$M$Y$$$20240904$$MD$US$US
242804771$24280477$1$I$$20240820$20240904$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464524$RANBAXY$$79$YR$$F$Y$$$20240904$$HP$US$US
242804781$24280478$1$I$$20240820$20240904$20240904$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465414$RANBAXY$Basiri R, Ziaei Moghaddam A, Rikhtegar A, Jafarian AH. Primary Pulmonary Angiosarcoma Found Incidentally in a Complicated Patient: A Rare Case Report. Clin Respir J. 2024;18 (8):e13818$33$YR$$F$Y$$$20240904$$HP$IR$IR
242804791$24280479$1$I$$20240820$20240904$20240904$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465556$RANBAXY$Clarke E, Thu K, Bracey T.. Rectal gastric heterotopia with fundic gland polyps, mimicking a high-risk primary anorectal neoplasm: histological evidence of the effects of gastric acid-suppressing medication in a rectal ^outlet patch^. Diagn Histopathol. 2024;30 (6):344-347$78$YR$$$Y$$$20240904$$HP$GB$GB
242804801$24280480$1$I$$20240820$20240904$20240904$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465564$RANBAXY$Aaron Yee Shuen See, Ashton Zheng-Boon Lau, Srivathsan Thiruvengadam. Pyroglutamic acidosis in the setting of Staphylococcus aureus bacteremia treated with flucloxacillin?An uncommon cause of high anion gap metabolic acidosis. Clinical Case Reports. 2024;12 (Issue 8):no pagination$64$YR$$M$Y$$$20240904$$HP$AU$AU
242804811$24280481$1$I$$20240820$20240904$20240904$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465761$RANBAXY$Tamura T, Kanemasa Y, Nakamura S, Okuya T, Yagi Y, Matsuda S, et al. Management of HER2 positive and microsatellite instability-high advanced gastric cancer: a case report. Int Canc Conf J. 2024;0 (0)$75$YR$$M$Y$$$20240904$$HP$JP$JP
242804821$24280482$1$I$$20240820$20240904$20240904$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465991$RANBAXY$Inoue F, Okazaki Y, Huh K, Ichiba T, Chiba T, Namera A. Pharmacobezoar associated prolonged clinical course in a patient with immediate release quetiapine overdose. J Med Toxico. 2024;0:no pagination$57$YR$$F$Y$$$20240904$$HP$JP$JP
242804832$24280483$2$F$$20240830$20240904$20240913$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465091$RANBAXY$Yilmaz C, Sengor BG, Zehir R. Successful treatment of multidrug-resistant hypertension with catheter-based renal denervation in a patient with a renal artery stent. Hipertens Riesgo Vasc. 2023;Oct-Dec; 40(4):225-227$65$YR$$F$Y$$$20240913$$HP$TR$TR
242804851$24280485$1$I$$20240820$20240904$20240904$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464842$RANBAXY$Foppiani L, Poeta MG, Rutigliani M, Parodi S, Catrambone U, Cavalleri L, et al.. Catastrophic ACTH-secreting pheochromocytoma: an uncommon and challenging entity with multifaceted presentation. Endocrinol. Diabetes Metab. Case Rep. 2023;2 (May):no pagination$72$YR$$F$Y$$$20240904$$HP$IT$IT
242804861$24280486$1$I$$20240820$20240904$20240904$EXP$$JP-SUNPHARMA-2024R1-463882AA$RANBAXY$Okada T. A case of irAE enterocolitis and encephalitis following administration of GC + Durvalumab for hilar bile duct cancer. The 380th Regular Meeting of the Kanto Branch of the Japanese Society of Gastroe. 2024;42$64$YR$$M$Y$$$20240904$$HP$JP$JP
242804871$24280487$1$I$$20240820$20240904$20240904$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465398$RANBAXY$Altorbak NA, Daghistani RA, AOmaish HR, Alsaab TA, Alhomaiani SK. Pulmonary artery air embolism with consequent primary respiratory alkalosis and secondary metabolic alkalosis following ventilation therapy. Medicine. 2024;103 (30):e39078$70$YR$$M$Y$$$20240904$$MD$SA$SA
242804882$24280488$2$F$$20240902$20240904$20240917$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465229$RANBAXY$Tramacere F, Pisani AR, Maggiulli E, Moschetta M, Sardaro A, Altini C et al. Effective management of a patient with secondary male breast cancer after neck radiotherapy for tonsillar lymphoma. Int J Radiat Res. 2023;Jan; 21(1):163-167$59$YR$$M$Y$$$20240917$$HP$IT$IT
242804902$24280490$2$F$$20240913$20240904$20240927$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465962$RANBAXY$Clark SR, Wilton LR, Dawson JL, Chiew K, Jawahar MC, Toben C, et al. Dotting the I^s and crossing the T^s: A South Australian perspective on variability in troponin thresholds for myocarditis risk in clozapine treatment. Schizophr Res. 2024;268 (0):114-117$22$YR$$M$Y$$$20240927$$HP$AU$AU
242804911$24280491$1$I$$20240820$20240904$20240904$EXP$$JP-SUNPHARMA-2024R1-463890AA$RANBAXY$Takeshita H. Two cases of ureteric re-diversion from the left ureterocutaneous fistula to the ileal conduit. The 21st meeting society for reconstruction and regeneration in urologic surgery. 2024;35$75$YR$$M$Y$$$20240904$$HP$JP$JP
242804922$24280492$2$F$20240818$20240823$20240904$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465584$RANBAXY$$60$YR$$F$Y$$$20240906$$PH$GB$GB
242804931$24280493$1$I$20240815$20240820$20240904$20240904$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465241$RANBAXY$$51$YR$$F$Y$$$20240904$$CN$GB$GB
242804941$24280494$1$I$$20240820$20240904$20240904$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465315$RANBAXY$Honorato CMA, Carrascoza GG, Abed NM, Moya FG. Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor. Anais Brasil Dermatol. 2024;0 (0):1-4$72$YR$$M$Y$$$20240904$$HP$BR$BR
242804951$24280495$1$I$$20240820$20240904$20240904$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465297$RANBAXY$Hsieh C-Y, Tsai T-F. Treatment responses of four different biologics in a patient with recurrent generalized pustular psoriasis harboring  IL36RN mutation. Dermatol Sin. 2024;Apr-jun;42 (2):152-153$56$YR$$F$Y$57$KG$20240904$$HP$TW$TW
242804961$24280496$1$I$$20240820$20240904$20240904$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465260$RANBAXY$Cesur E. Withdrawal symptoms associated with bupropion. Dusunen Adam. 2024;37 (2):117-118$36$YR$$F$Y$$$20240904$$HP$TR$TR
242804971$24280497$1$I$$20240820$20240904$20240904$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465302$RANBAXY$Yamada K, Ida-Ichikawa M, Fujimoto N, Ishida M, Dohi K. Takotsubo syndrome in a cancer patient treated with a combination of anti-cancer drugs including immune checkpoint inhibitors: a case report. Eur Heart J Case Rep. 2024;8:ytae355; 1-5$66$YR$$F$Y$$$20240904$$HP$JP$JP
242804981$24280498$1$I$20240131$20240826$20240904$20240904$EXP$$JP-ROCHE-10000070240$ROCHE$$90$YR$E$F$Y$60$KG$20240904$$MD$JP$JP
242804992$24280499$2$F$$20240902$20240904$20240917$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465399$RANBAXY$Luciano A, Pietroluongo E, Ottaviano M, Grieco A, Peddio A, De Placido P, et al. Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor. Front Immunol. 2024;15 (0):01-05$6$DEC$$$Y$$$20240917$$HP$IT$IT
242805002$24280500$2$F$$20240830$20240904$20240910$EXP$$AT-ROCHE-10000065947$ROCHE$$$$E$M$Y$55.7$KG$20240910$$HP$AT$AT
242805011$24280501$1$I$$20240820$20240904$20240904$EXP$$MA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465299$RANBAXY$Giant cell arteritis and therapeutic response: a dual facet of immunotherapy in metastatic clear cell renal carcinoma$80$YR$$M$Y$$$20240904$$HP$MA$MA
242805031$24280503$1$I$$20240827$20240904$20240904$EXP$$BR-AstraZeneca-2024A199352$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$BR$
242805041$24280504$1$I$20240717$20240829$20240904$20240904$EXP$$FR-AstraZeneca-2024A196786$ASTRAZENECA$$64$YR$$M$Y$140$KG$20240904$$MD$FR$
242805051$24280505$1$I$$20240902$20240904$20240904$EXP$$US-SANDOZ INC.-SDZ2024US077180$SANDOZ$$53$YR$$F$Y$$$20240904$$MD$US$US
242805061$24280506$1$I$20240822$20240822$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134853$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240904$$CN$US$US
242805071$24280507$1$I$20240812$20240829$20240904$20240904$EXP$IT-MINISAL02-1000187$IT-ROCHE-10000069127$ROCHE$$78$YR$E$M$Y$$$20240904$$MD$IT$IT
242805081$24280508$1$I$20240121$20240826$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-043113$AUROBINDO$$87$YR$$F$Y$57$KG$20240904$$MD$FR$FR
242805101$24280510$1$I$$20240821$20240904$20240904$EXP$$US-UCBSA-2024042850$UCB$$$$$$Y$$$20240904$$CN$US$US
242805111$24280511$1$I$$20240826$20240904$20240904$30DAY$$US-GSK-US2024106139$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242805121$24280512$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177543$NOVARTIS$$$$$M$Y$$$20240904$$HP$US$US
242805131$24280513$1$I$20190501$20230906$20240904$20240904$PER$US-MLMSERVICE-20230831-4520743-1$US-STRIDES ARCOLAB LIMITED-2023SP014316$STRIDES$Levitte S, Ganguly A, Frolik S, Guevara-Tique AA, Patel S, Tadas A et al.. Precision Delivery of Steroids as a Rescue Therapy for Gastrointestinal Graft-versus-Host Disease in Pediatric Stem Cell Transplant Recipients. Journal of Clinical Medicine. 2023;12(13):4229$21$YR$$F$Y$92.7$KG$20240904$$MD$US$US
242805141$24280514$1$I$$20240820$20240904$20240904$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465797$RANBAXY$$$$$M$Y$$$20240904$$CN$GB$GB
242805151$24280515$1$I$$20240820$20240904$20240904$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465267$RANBAXY$Lin T-Y, Su T-H. Progression of portal hypertension after atezolizumab plus bevacizumab for hepatocellular carcinoma-report a case and literature review. J Formos Med Assoc. 2024;123 (8):916-919$81$YR$$M$Y$$$20240904$$HP$TW$TW
242805161$24280516$1$I$$20240820$20240904$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465598$RANBAXY$Shaikh M, Golzarian H, Hakim FA. Wide QRS tachycardia in a patient with atrial fibrillation: a case report and approach to diagnosis. Eur Heart J Case Rep. 2024;8 (8):1-6$87$YR$$M$Y$$$20240904$$HP$US$US
242805171$24280517$1$I$$20240820$20240904$20240904$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465306$RANBAXY$Yildirim HC, Guven DC, Ismayilov R, Chalabiyev E, Dizdar O. Deficient Mismatch Repair Jejunal Cancer Hyperprogression with Pembrolizumab. J Oncol Sci. 2024;10(2):122-124$58$YR$$M$Y$$$20240904$$HP$TR$TR
242805182$24280518$2$F$$20240904$20240904$20240919$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466014$RANBAXY$Kumakura Y, Hasuda N, Akita K, Iijima T, Matsukawa T. Epidural hematoma related to lower limb pain and massive liver bleeding in gorham-stout disease: a case report. Medicine. 2023;102(22):1-4$22$YR$$F$Y$$$20240919$$HP$JP$JP
242805191$24280519$1$I$$20240820$20240904$20240904$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465512$RANBAXY$Ustun NSG. Sertraline-induced visual hallucination in an adolescent girl. Dusunen Adam. 2024;37 (2):111-113$16$YR$$F$Y$$$20240904$$HP$TR$TR
242805211$24280521$1$I$$20240820$20240904$20240904$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465317$RANBAXY$Honorato CMA, Carrascoza GG, Abed NM, Moya FG. Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor. Anais Brasil Dermatol. 2024;0(0):1-4$62$YR$$M$Y$$$20240904$$HP$BR$BR
242805222$24280522$2$F$$20240906$20240904$20240910$EXP$$GR-GENMAB-2024-03159$GENMAB$$$$$M$Y$$$20240910$$MD$GR$GR
242805231$24280523$1$I$$20240827$20240904$20240904$EXP$$IT-GENMAB-2024-03164$GENMAB$$$$$M$Y$$$20240904$$MD$IT$IT
242805251$24280525$1$I$$20240827$20240904$20240904$PER$$US-ABBVIE-5899813$ABBVIE$$$$$$Y$$$20240904$$HP$US$US
242805261$24280526$1$I$$20240829$20240904$20240904$EXP$$US-ABBVIE-5901663$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242805271$24280527$1$I$20231101$20240829$20240904$20240904$EXP$$PL-ORPHANEU-2024006755$RECORDATI$$$$$$Y$$$20240904$$MD$PL$PL
242805281$24280528$1$I$$20240827$20240904$20240904$EXP$$US-ROCHE-10000068242$ROCHE$$91$YR$E$M$Y$$$20240904$$CN$US$US
242805292$24280529$2$F$20240801$20240828$20240904$20240906$EXP$$CA-CELLTRION INC.-2024CA020963$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
242805301$24280530$1$I$$20240826$20240904$20240904$EXP$$US-GSK-US2024106714$GLAXOSMITHKLINE$$$$$M$Y$$$20240904$$MD$US$US
242805311$24280531$1$I$$20240307$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003020$STRIDES$Valdepenas B, Campara M, Pierce D, Benken J, Akshelyan S, Tzvetanov I, et al.. Clinical Outcomes of Intestinal Transplant Recipients Receiving Maintenance Basiliximab, Sublingual Tacrolimus and Prednisone: A Case Series.. Am-J-Transplant. 2023;23 (Suppl.) (6):S733-S734 abstr. A283.$$$$$Y$$$20240904$$HP$US$US
242805321$24280532$1$I$$20240903$20240904$20240904$EXP$GB-MHRA-MED-202409020906128010-ZDPHQ$GB-GILEAD-2024-0686092$GILEAD$$$$$M$Y$$$20240904$$HP$GB$GB
242805341$24280534$1$I$$20240830$20240904$20240904$EXP$$GB-AMGEN-GBRSP2024175335$AMGEN$$$$$F$Y$$$20240904$$CN$GB$GB
242805351$24280535$1$I$20240824$20240830$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138965$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240904$$CN$US$US
242805361$24280536$1$I$$20240828$20240904$20240904$EXP$$JP-ABBVIE-5877760$ABBVIE$$82$YR$$M$Y$$$20240904$$PH$JP$JP
242805372$24280537$2$F$20230325$20240828$20240904$20240909$EXP$$JP-UCBSA-2024020348$UCB$$16$YR$$F$Y$35.8$KG$20240909$$MD$JP$JP
242805382$24280538$2$F$$20240902$20240904$20240911$EXP$$KE-ROCHE-10000070910$ROCHE$$$$A$M$Y$$$20240911$$MD$KE$KE
242805393$24280539$3$F$20240801$20240920$20240904$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-026663$UNITED THERAPEUTICS$$65$YR$$F$Y$68.481$KG$20240927$$$US$US
242805401$24280540$1$I$$20240619$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007529$STRIDES$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster)$$$$$Y$$$20240904$$HP$US$US
242805411$24280541$1$I$20240101$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000442$ELI LILLY AND CO$$17$YR$T$F$Y$$$20240904$$CN$US$US
242805421$24280542$1$I$$20231004$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015492$STRIDES$Coscia L, Cohen D, Dube GK, Hofmann RM, Moritz MJ, Gattis S, et al.. Outcomes With Belatacept Exposure During Pregnancy in Kidney Transplant Recipients: A Case Series.. Transplantation. 2023;107(9):2047-2054$39$YR$$F$Y$$$20240904$$MD$US$US
242805431$24280543$1$I$$20240820$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408012683$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240904$$CN$US$US
242805451$24280545$1$I$$20240821$20240904$20240904$EXP$$CA-UCBSA-2024042844$UCB$$$$$F$Y$$$20240904$$CN$CA$CA
242805461$24280546$1$I$$20240903$20240904$20240904$PER$$US-ROCHE-10000073309$ROCHE$$41$YR$A$F$Y$$$20240904$$CN$US$US
242805481$24280548$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140396$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$44$KG$20240904$$CN$US$US
242805491$24280549$1$I$20240827$20240827$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137775$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$PH$US$US
242805501$24280550$1$I$$20231101$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016756$STRIDES$Ibrahim MM, Manli S, Kareem S, Delos Santos R, Alhamad T, Liu C, et al.. Tacrolimus-Induced Thrombotic Microangiopathy (TMA) Complicated by Anamnestic Donor-Specific Antibodies Post-Kidney Transplantation.. Am-J-Transplant. 2023;23 (Suppl.1)(6):S629 abstr. A37.$44$YR$$F$Y$$$20240904$$HP$US$US
242805511$24280551$1$I$$20240829$20240904$20240904$PER$$US-ABBVIE-5903960$ABBVIE$$41$YR$$F$Y$$$20240904$$HP$US$US
242805521$24280552$1$I$$20240827$20240904$20240904$EXP$$GB-CELLTRION INC.-2024GB020847$CELLTRION$$$$$$Y$$$20240904$$CN$GB$GB
242805541$24280554$1$I$$20240902$20240904$20240904$EXP$$NVSC2024AU176747$NOVARTIS$$$$$M$Y$$$20240904$$CN$AU$AU
242805551$24280555$1$I$$20240902$20240904$20240904$EXP$$DE-SANDOZ INC.-NVSC2020DE061052$SANDOZ$$$$I$$Y$$$20240904$$MD$DE$DE
242805571$24280557$1$I$$20240229$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002724$STRIDES$Brahmandam S, Brahmandam S, Brahmandam BS, Brahmandam S, Ng AM.. An Unknown Association: Caroli Disease With Bullous Emphysema and Fibrocystic Lung Disease.. Am-J-Respir-Crit-Care-Med. 2023;207:A4921 (plus Poster)$63$YR$$M$Y$$$20240904$$HP$US$US
242805591$24280559$1$I$$20240821$20240904$20240904$EXP$$US-UCBSA-2024043087$UCB$$$$$F$Y$$$20240904$$HP$US$US
242805601$24280560$1$I$$20240826$20240904$20240904$EXP$$GB-JNJFOC-20240225454$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240904$$CN$GB$GB
242805611$24280561$1$I$$20240830$20240904$20240904$EXP$$US-BIOGEN-2024BI01280868$BIOGEN$$$$$F$Y$$$20240904$$CN$US$US
242805621$24280562$1$I$$20240903$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049396$BOEHRINGER INGELHEIM$$$$$$Y$$$20240904$$MD$US$US
242805631$24280563$1$I$$20240822$20240904$20240904$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08527$LUPIN$Zhang Y, Bangert M, Chun M, Mattingly T, Zheng C. Acute and chronic infectious complications following gunshot injuries: A case comparison. Southern Medical Journal. 2022;115:561$25$YR$$M$Y$$$20240904$$HP$US$US
242805641$24280564$1$I$$20240827$20240904$20240904$PER$$US-RDY-SPO/USA/24/0012725$DR REDDYS$Pico MJ, Badri M, Michalak N, Siefferman JW. Systemic allergic reaction to galcanezumab (emgality): a case report. Cephalalgia. 2024 Jan;1(44): doi:10.1177/03331024231222914.$50$YR$A$F$Y$$$20240904$$HP$US$US
242805651$24280565$1$I$$20240901$20240904$20240904$PER$$US-AMGEN-USASP2024174932$AMGEN$$$$A$F$Y$$$20240904$$CN$US$US
242805661$24280566$1$I$20240826$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024173535$AMGEN$$64$YR$A$F$Y$$$20240904$$CN$US$US
242805672$24280567$2$F$20240607$20240904$20240904$20240911$EXP$$US-ABBVIE-5899709$ABBVIE$$$$$F$Y$$$20240911$$HP$US$US
242805691$24280569$1$I$$20240821$20240904$20240904$EXP$$US-UCBSA-2024042807$UCB$$$$$$Y$$$20240904$$CN$US$US
242805701$24280570$1$I$20240821$20240823$20240904$20240904$EXP$$BG-IMMUNOCORE, LTD-2024-IMC-003022$IMMUNOCORE$$$$$$Y$$$20240904$$MD$BG$BG
242805741$24280574$1$I$20240801$20240828$20240904$20240904$EXP$$JP-ASTELLAS-2024-AER-003186$ASTELLAS$$9$DEC$E$F$Y$$$20240904$$MD$JP$JP
242805751$24280575$1$I$$20240822$20240904$20240904$EXP$$BR-CHIESI-2024CHF05420$CHIESI$$$$N$$Y$$$20240904$$MD$BR$BR
242805761$24280576$1$I$$20240828$20240904$20240904$30DAY$$CN-ABBVIE-5900439$ABBVIE$$$$$$Y$$$20240904$$HP$CN$CN
242805771$24280577$1$I$20240824$20240827$20240904$20240904$EXP$$US-ROCHE-10000068357$ROCHE$$18$YR$A$F$Y$$$20240904$$CN$US$US
242805781$24280578$1$I$$20240827$20240904$20240904$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00880$BIOCRYST PHARMACEUTICALS$$65$YR$$F$Y$$$20240904$$HP$US$US
242805792$24280579$2$F$$20240907$20240904$20240909$PER$$US-HALEON-2195058$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
242805801$24280580$1$I$20230901$20240822$20240904$20240904$EXP$$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2024-019374$VALIDUS$$$$$$Y$$$20240904$$CN$CA$CA
242805811$24280581$1$I$20240705$20240902$20240904$20240904$EXP$$CO-UCBSA-2024037184$UCB$$64$YR$$F$Y$$$20240904$$CN$CO$CO
242805821$24280582$1$I$$20240830$20240904$20240904$PER$$US-ALXN-202408USA002176US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$MD$US$US
242805832$24280583$2$F$$20240924$20240904$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140260$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$97.98$KG$20240925$$CN$US$US
242805842$24280584$2$F$$20240906$20240904$20240916$EXP$$AT-TEVA-VS-3239244$TEVA$Scorza CA, Finsterer J, Scorza FA. Takotsubo syndrome is triggered by hypoactive delirium and recognized by increased catecholamine requirement in the ICU. Clinics 2024; 79.; Scorza CA, Finsterer J, Scorza FA. Takotsubo syndrome is triggered by hypoactive delirium and recognized by increased catecholamine requirement in the ICU. Clinics 2024; 79.; Scorza CA, Finsterer J, Scorza FA. Takotsubo syndrome is triggered by hypoactive delirium and recognized by increased catecholamine requirement in ...$60$YR$$F$Y$75$KG$20240916$$HP$AT$AT
242805851$24280585$1$I$$20240611$20240904$20240904$EXP$$AO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464702$RANBAXY$Barata E, Ekundi E, Ulica E, Andrade N, Mariano G. THYROTOXIC PERIODIC PARALYSIS-A RARE CAUSE OF HYPOKALAEMIA IN PREGNANCY. Eur J Case Rep Intern Med. 2019;6 (Suppl.):229$26$YR$$F$Y$$$20240904$$HP$AO$AO
242805871$24280587$1$I$$20240823$20240904$20240904$EXP$$JP-ROCHE-10000069033$ROCHE$$$$A$$Y$$$20240904$$MD$JP$JP
242805881$24280588$1$I$20240101$20240821$20240904$20240904$EXP$$US-UCBSA-2024042793$UCB$$$$$M$Y$$$20240904$$HP$US$US
242805891$24280589$1$I$20230401$20240828$20240904$20240904$EXP$$CL-ROCHE-10000069710$ROCHE$$49$YR$A$F$Y$75$KG$20240904$$CN$CL$CL
242805901$24280590$1$I$$20240820$20240904$20240904$EXP$$US-ASTELLAS-2024-AER-002028$ASTELLAS$$51$YR$A$M$Y$$$20240904$$CN$US$US
242805911$24280591$1$I$$20240503$20240904$20240904$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-04168$HIKMA$$$$$F$Y$$$20240904$$CN$US$US
242805921$24280592$1$I$$20240902$20240904$20240904$EXP$PL-EMA-20171029-AUTODUP-478225$PL-SANDOZ INC.-PHHY2018PL037866$SANDOZ$$44$YR$$F$Y$$$20240904$$MD$PL$PL
242805941$24280594$1$I$$20240503$20240904$20240904$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-04169$HIKMA$$$$$F$Y$$$20240904$$CN$US$US
242805951$24280595$1$I$$20240516$20240904$20240904$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-04416$HIKMA$$$$$F$Y$$$20240904$$CN$US$US
242805961$24280596$1$I$$20240510$20240904$20240904$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-04464$HIKMA$$$$$F$Y$$$20240904$$CN$US$US
242805971$24280597$1$I$$20240827$20240904$20240904$EXP$$US-BIOGEN-2024BI01280439$BIOGEN$$$$$F$Y$$$20240904$$CN$US$US
242805981$24280598$1$I$$20240819$20240904$20240904$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06681$HIKMA$$$$$$Y$$$20240904$$CN$US$US
242805991$24280599$1$I$$20240729$20240904$20240904$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07325$HIKMA$$$$$$Y$$$20240904$$CN$US$US
242806001$24280600$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140469$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$71.21$KG$20240904$$HP$US$US
242806011$24280601$1$I$$20240827$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136314$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240904$$CN$US$US
242806021$24280602$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140241$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240904$$CN$US$US
242806031$24280603$1$I$$20240903$20240904$20240904$PER$$US-ROCHE-10000073210$ROCHE$$$$A$F$Y$$$20240904$$CN$US$US
242806041$24280604$1$I$20240624$20240826$20240904$20240904$EXP$GB-MHRA-MED-202408261330327800-LHBSQ$GB-TEVA-VS-3237367$TEVA$$76$YR$$F$Y$$$20240904$$CN$GB$GB
242806051$24280605$1$I$20240801$20240826$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042996$AUROBINDO$$62$YR$$F$Y$156$KG$20240904$$MD$FR$FR
242806061$24280606$1$I$$20240821$20240904$20240904$EXP$$CN-Harman-000066$HARMAN FINOCHEM$Chen X, Shu Y, Lin X. Impact of canagliflozin combined with metformin therapy on reducing cardiovascular risk in type 2 diabetes patients. Diabetol Metab Syndr. 2024 Aug 17;16(1):199. doi: 10.1186/s13098-024-01438-1. PMID: 39153984; PMCID: PMC11330023.$$$$M$Y$$$20240830$$HP$CN$
242806071$24280607$1$I$20240607$20240827$20240904$20240904$EXP$FR-AFSSAPS-LL2024001619$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111696$ZYDUS PHARM$$$$$$Y$$$20240904$$MD$FR$FR
242806081$24280608$1$I$20240801$20240827$20240904$20240904$EXP$ES-AEMPS-1563260$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111719$ZYDUS PHARM$$$$$$Y$$$20240904$$MD$ES$ES
242806091$24280609$1$I$$20231012$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015876$STRIDES$Miyatani Y, Choi D, Du X, Hart J, Rubin DT.. Medically Refractory Lymphocytic Colitis Successfully Treated with Upadacitinib.. ACG-Case-Rep-J. 2023;10(2):E00979.$61$YR$$F$Y$$$20240904$$MD$US$US
242806102$24280610$2$F$$20240910$20240904$20240917$EXP$$PL-SANDOZ INC.-SDZ2024PL077017$SANDOZ$$30$YR$$M$Y$$$20240917$$HP$PL$PL
242806111$24280611$1$I$20240801$20240827$20240904$20240904$PER$$US-AstraZeneca-2024A196682$ASTRAZENECA$$8809$DY$$F$Y$83.9$KG$20240904$$MD$US$
242806121$24280612$1$I$$20240827$20240904$20240904$PER$$US-AstraZeneca-2024A195210$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242806131$24280613$1$I$$20240429$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005231$STRIDES$Skowronski J, Hickey GW, Horn E, Rios J, Mathier MA, Levene J, et al.. A BRAVE NEW WORLD: UTILIZATION OF ASSISTED REPRODUCTIVE TECHNOLOGY AFTER HEART TRANSPLANTATION.. J-Am-Coll-Cardiol. 2024;83 (Suppl.) (13:2862$$$$$Y$$$20240904$$HP$US$US
242806141$24280614$1$I$$20240826$20240904$20240904$EXP$GB-MHRA-MED-202408261547572090-RHSJP$GB-TEVA-VS-3237386$TEVA$$50$YR$$M$Y$$$20240904$$PH$GB$GB
242806151$24280615$1$I$$20230807$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP013019$STRIDES$Isa RS, Clarke E, Fanous H, Jambusaria-Pahlajani A.. MERKEL CELL CARCINOMA IN A LIVER TRANSPLANT PATIENT.. J-Gen-Intern-Med. 2023;38 (Suppl. 2):S593-S594.$47$YR$$F$Y$$$20240904$$HP$US$US
242806161$24280616$1$I$$20231004$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015459$STRIDES$Coscia L, Cohen D, Dube GK, Hofmann RM, Moritz MJ, Gattis S, et al.. Outcomes With Belatacept Exposure During Pregnancy in Kidney Transplant Recipients: A Case Series.. Transplantation. 2023;107(9):2047-2054$4$DEC$$F$Y$$$20240904$$MD$US$US
242806171$24280617$1$I$$20240307$20240904$20240904$PER$US-MLMSERVICE-20240301-4864863-1$US-STRIDES ARCOLAB LIMITED-2024SP002960$STRIDES$Yamada M, Chen SF, Green M.. Chronic Epstein-Barr viral load carriage after pediatric organ transplantation.. Frontiers in Pediatrics. 2024;12:1335496$5$MON$$F$Y$$$20240904$$MD$US$US
242806181$24280618$1$I$$20231116$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017571$STRIDES$Patel S, Choi W-T, Andreadis C, Singh A.. Diffuse large B-cell lymphoma presenting as an ileocaecal mass in a post-transplant patient.. BMJ-Case-Rep. 2023;16(8):no pagination.$3$DEC$$M$Y$$$20240904$$HP$US$US
242806191$24280619$1$I$$20231010$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015698$STRIDES$Feuer G, Fu J, Jiao W, Muntnich CB, Frangaj K, Jones R, et al.. The first report of three-way macrochimerism in a patient receiving multivisceral transplantation following loss of an initial liver-intestine transplant. Transplantation. 2023;107 (Suppl.1):72 abstr. 124.$20$MON$$M$Y$$$20240904$$HP$US$US
242806201$24280620$1$I$$20231009$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015644$STRIDES$Gupta S, Wojciechowski D. Late Conversion to Belatacept in Biopsy Proven Tacrolimus Toxicity. J-Am-Soc-Nephrol. 2016;27622A(poster)abstr. FR-P01090$$$$$Y$$$20240904$$HP$US$US
242806211$24280621$1$I$$20230925$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015148$STRIDES$Golob S, Batra J, DeFilippis EM, Uriel M, Carey M, Gaine M et al.. Letermovir for cytomegalovirus prophylaxis in high-risk heart transplant recipients. Clin Transplant.. 2022;36(12):e14808.$$$$$Y$$$20240904$$HP$US$US
242806221$24280622$1$I$$20231101$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016773$STRIDES$Steele MV, Gupta R, Maguiness S, Boull C. Use of dupilumab for atopic dermatitis in young transplant patients-A case series of 3 patients. Pediatr-Dermatol. 2023;40(5):897-899.$1$DEC$$F$Y$$$20240904$$HP$US$US
242806231$24280623$1$I$$20240527$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006282$STRIDES$Pasham SR, Ghimire S, Jala SRA, Bernshteyn M, Ponnekanti SK, Lincoln M.. INTESTINAL TRACT-SPECIFIC CHRONIC ACTIVE RECURRENT EPSTEIN-BARR VIRUS INFECTION WITH PREVIOUSLY TREATED PTLD MIMICS INFLAMMATORY BOWEL DISEASE IN IMMUNOCOMPROMISED HOSTS.. Gastroenterology. 2023;164 (Suppl.)(6):S-675 abstr. Su1774.$31$YR$$M$Y$$$20240904$$HP$US$US
242806241$24280624$1$I$$20240715$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009101$STRIDES$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al.. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.. J-Ophthalmic-Inflamm-Infect. 2024;14$70$YR$$M$Y$$$20240904$$HP$US$US
242806251$24280625$1$I$$20240430$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005275$STRIDES$Griffin SP, Lee BJ, Doh J, Paradyse AR, Jeyakumar D, Arter Z, et al.. Strategies to Mitigate the Drug-Drug Interaction between Nirmatrelvir/Ritonavir and Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Azole Antifungals: Results of a Case Series.. Acta-Haematol. 2023$73$YR$$M$Y$$$20240904$$HP$US$US
242806261$24280626$1$I$$20240709$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008665$STRIDES$Kiskaddon AL, Wilsey M, Gonzalez-Gomez I, Laks J, Miles A, Carapellucci J, et al.. Basiliximab therapy for immune-mediated bowel disease in a pediatric heart transplant patient.. Pediatr-Transplant. 2023;27 (2):e14443$9$YR$$F$Y$$$20240904$$HP$US$US
242806271$24280627$1$I$$20240619$20240904$20240904$PER$$US-STRIDES PHARMA UK LTD.-2024SP007533$STRIDES$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster)$$$$$Y$$$20240904$$HP$US$US
242806281$24280628$1$I$$20240301$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002669$STRIDES$Lenka A, King C, Soni M, Hu N, Motamedi G.. Tacrolimus-induced generalized tremor with excellent response to primidone.. Ann-Mov-Disord. 2022;5 (1):74-76$68$YR$$F$Y$$$20240904$$MD$US$US
242806291$24280629$1$I$$20231031$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016604$STRIDES$Wobma H, Kapadia M, Kim HT, Alvarez-Calderon F, Baumeister SHC, Duncan C, et al.. Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease.. Blood-Adv. 2023;7(16):4647-4657.$1$DEC$$$Y$$$20240904$$HP$US$US
242806301$24280630$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001466$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240904$$CN$US$US
242806311$24280631$1$I$20240902$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001374$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240904$$CN$US$US
242806321$24280632$1$I$20240827$20240827$20240904$20240904$EXP$GB-MHRA-MED-202408270736420740-DNTKJ$GB-TEVA-VS-3237653$TEVA$$45$YR$$M$Y$78$KG$20240904$$CN$GB$GB
242806331$24280633$1$I$20240408$20240827$20240904$20240904$EXP$$JP-ROCHE-3547292$ROCHE$$2$DEC$A$$Y$$$20240904$$MD$JP$JP
242806341$24280634$1$I$20240625$20240829$20240904$20240904$EXP$$US-JNJFOC-20240772875$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240904$$CN$US$US
242806351$24280635$1$I$$20240826$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140403$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240904$$CN$US$US
242806361$24280636$1$I$$20240827$20240904$20240904$EXP$GB-MHRA-MED-202408260754075230-QCTSY$GB-TEVA-VS-3237808$TEVA$$46$YR$$F$Y$60$KG$20240904$$CN$GB$GB
242806372$24280637$2$F$20240708$20240905$20240904$20240913$EXP$$CA-TAKEDA-2024TUS087700$TAKEDA$$68$YR$$M$Y$$$20240913$$CN$CA$CA
242806381$24280638$1$I$$20240826$20240904$20240904$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006357$BIOCON$$$$$$Y$$$20240904$$MD$CA$CA
242806391$24280639$1$I$20240826$20240826$20240904$20240904$EXP$GB-MHRA-MED-202408261025433370-CNBJH$GB-TEVA-VS-3237326$TEVA$$50$YR$$M$Y$75$KG$20240904$$MD$GB$GB
242806401$24280640$1$I$$20240823$20240904$20240904$EXP$$RU-ROCHE-10000067223$ROCHE$$$$A$F$Y$$$20240904$$MD$RU$RU
242806411$24280641$1$I$$20240429$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005333$STRIDES$Bhatt N, Moulton EA, Melicoff-Portillo E, Schrader A.. Use of Letermovir for Cytomegalovirus Prophylaxis in Pediatric Lung Transplant Patients.. J-Heart-Lung-Transplant. 2024;43 (Suppl.) (4):S626-S627 abstr. 1361.$$$$$Y$$$20240904$$HP$US$US
242806432$24280643$2$F$20230630$20240911$20240904$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-043126$AUROBINDO$$76$YR$$M$Y$95$KG$20240921$$HP$FR$FR
242806441$24280644$1$I$$20240828$20240904$20240904$EXP$$US-ROCHE-10000069187$ROCHE$$$$$$Y$$$20240904$$MD$US$US
242806452$24280645$2$F$20240831$20240904$20240904$20240910$PER$$US-AMGEN-USASP2024176040$AMGEN$$$$$$Y$$$20240910$$HP$US$US
242806461$24280646$1$I$$20240828$20240904$20240904$EXP$$JP-ADVANZ PHARMA-202408007133$ADVANZ PHARMA$$$$$$Y$$$20240904$$PH$JP$JP
242806472$24280647$2$F$20240719$20240905$20240904$20240909$EXP$$BE-SANDOZ INC.-SDZ2024BE076715$SANDOZ$$$$$F$Y$$$20240909$$CN$BE$BE
242806481$24280648$1$I$20231207$20240902$20240904$20240904$EXP$$FR-SANDOZ INC.-SDZ2024FR077055$SANDOZ$$73$YR$$M$Y$70$KG$20240904$$MD$FR$FR
242806491$24280649$1$I$20240101$20240826$20240904$20240904$EXP$$JP-INSMED, INC.-2024-00520-JP$INSMED$$7$DEC$$F$Y$$$20240904$$HP$JP$JP
242806501$24280650$1$I$20190101$20240828$20240904$20240904$EXP$$US-BIOGEN-2020BI00935709$BIOGEN$$$$$F$Y$71.732$KG$20240904$$HP$US$US
242806511$24280651$1$I$$20240719$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009261$STRIDES$Satta T, Papadopoulos EB, Gyurkocza B, Susman P, Singh A, Calafiore M, et al.. Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd.. Blood. 2023;142 (Suppl. 1):7019$46$YR$$$Y$$$20240904$$HP$US$US
242806521$24280652$1$I$20240801$20240830$20240904$20240904$PER$$US-ABBVIE-5904481$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242806531$24280653$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177592$NOVARTIS$$$$$F$Y$$$20240904$$HP$US$US
242806541$24280654$1$I$$20240826$20240904$20240904$EXP$$DE-AUROBINDO-AUR-APL-2024-043112$AUROBINDO$$$$$$Y$$$20240904$$MD$DE$DE
242806551$24280655$1$I$$20240403$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004166$STRIDES$Zakka P, Zakka K, Stein-Merlob A, Vucicevic D, Kamath MY, Yang EH.. DOUBLE (TRANSPLANT) TROUBLE: SUCCESSFUL STEM CELL TRANSPLANT FOR ACUTE MYELOID LEUKEMIA IN A HEART TRANSPLANT RECIPIENT FOR ANTHRACYCLINE INDUCED CARDIOMYOPATHY.. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):2727$65$YR$$F$Y$$$20240904$$HP$US$US
242806571$24280657$1$I$$20240827$20240904$20240904$EXP$$US-GSK-US2024AMR107014$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242806581$24280658$1$I$20240322$20240829$20240904$20240904$EXP$$CO-AMGEN-COLSP2024174693$AMGEN$$$$$M$Y$$$20240904$$CN$CO$CO
242806612$24280661$2$F$20240827$20240830$20240904$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026970$UNITED THERAPEUTICS$$32$YR$$F$Y$$$20240906$$$US$US
242806621$24280662$1$I$$20240903$20240904$20240904$EXP$$FR-SANDOZ INC.-SDZ2024FR077318$SANDOZ$$$$A$F$Y$$$20240904$$MD$FR$FR
242806631$24280663$1$I$$20240617$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007341$STRIDES$Vu VA, Bhayana S, Sweiss H, Castro N, Hall R, Nelson J.. Impact of Cumulative 6 mg/kg Antithymocyte Globulin on Early Posttransplant Outcomes in Kidney Transplant Recipients with Delayed Graft Function.. Prog-Transplant. 2024;34 (1-2):47-52.$$$$$Y$$$20240904$$HP$US$US
242806642$24280664$2$F$20231208$20240924$20240904$20240927$EXP$$AT-TAKEDA-2023TUS120441$TAKEDA$$75$YR$$F$Y$$$20240927$$HP$AT$AT
242806661$24280666$1$I$$20240823$20240904$20240904$EXP$$US-AUROBINDO-AUR-APL-2024-043243$AUROBINDO$$$$$F$Y$$$20240904$$CN$US$US
242806671$24280667$1$I$$20240821$20240904$20240904$EXP$$US-MDD US Operations-MDD202408-003115$MDD OPERATIONS$$63$YR$$F$Y$$$20240904$$CN$US$
242806681$24280668$1$I$$20240903$20240904$20240904$PER$$US-JNJFOC-20240905356$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$HP$US$US
242806691$24280669$1$I$20240624$20240827$20240904$20240904$EXP$GB-MHRA-MED-202408261330327800-LHBSQ$GB-MSNLABS-2024MSNSPO01888$MSN LABORATORIES$$$$$$Y$$$20240904$$CN$GB$GB
242806701$24280670$1$I$20240829$20240830$20240904$20240904$EXP$$CO-UCBSA-2024045069$UCB$$48$YR$$M$Y$$$20240904$$CN$CO$CO
242806721$24280672$1$I$20240101$20240827$20240904$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024265$UNITED THERAPEUTICS$$$$$F$Y$59.41$KG$20240904$$$US$US
242806731$24280673$1$I$20240715$20240830$20240904$20240904$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013074$JAZZ$$48$YR$$F$Y$$$20240904$$CN$US$US
242806741$24280674$1$I$$20240830$20240904$20240904$EXP$$GB-TAKEDA-2024TUS088242$TAKEDA$$$$$M$Y$$$20240904$$CN$GB$GB
242806751$24280675$1$I$$20240829$20240904$20240904$PER$$US-GILEAD-2024-0686140$GILEAD$$$$$$Y$$$20240904$$CN$US$US
242806801$24280680$1$I$$20240828$20240904$20240904$EXP$$US-VIIV HEALTHCARE LIMITED-US2024107254$VIIV$$$$$M$Y$$$20240904$$HP$US$US
242806811$24280681$1$I$20240701$20240826$20240904$20240904$EXP$$US-VIIV HEALTHCARE LIMITED-US2024105970$VIIV$$65$YR$$M$Y$$$20240904$$CN$US$US
242806823$24280682$3$F$$20240912$20240904$20240920$EXP$$CA-CELLTRION INC.-2024CA020990$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
242806831$24280683$1$I$20240101$20240821$20240904$20240904$EXP$$US-MDD US Operations-MDD202408-003199$MDD OPERATIONS$$74$YR$$F$Y$$$20240904$$HP$US$
242806841$24280684$1$I$$20240814$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08326$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242806852$24280685$2$F$20240101$20240917$20240904$20240930$EXP$$JP-INSMED, INC.-2024-00790-JP$INSMED$$67$YR$$F$Y$$$20240930$$CN$JP$JP
242806861$24280686$1$I$$20240826$20240904$20240904$EXP$$PT-AUROBINDO-AUR-APL-2024-043135$AUROBINDO$Carneiro Martins AL, Miguel Martins R, Oliveira RC, Correia JG, Angelo MD, Tomas AR et al.. Dedifferentiated gist after therapy with imatinib.. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY.. 2024;50(2):138$72$YR$$M$Y$$$20240904$$HP$PT$PT
242806871$24280687$1$I$$20240718$20240904$20240904$PER$$US-STRIDES PHARMA UK LTD.-2024SP009205$STRIDES$Marvin JE, McSweeney T, Cohen E, Davis MW, Belfield K, Do V, et al.. Nocardiosis in Kidney Transplant Recipients and Possible Association With Decreased Utilization of Trimethoprim/Sulfamethoxazole During COVID-19.. Transplantation. 2024;108(7):e150-e151$$$$$Y$$$20240904$$MD$US$US
242806901$24280690$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A195658$ASTRAZENECA$$$$A$$Y$$$20240904$$CN$US$
242806912$24280691$2$F$$20240823$20240904$20240906$EXP$$BR-CHIESI-2024CHF05491$CHIESI$$$$N$$Y$$$20240906$$MD$BR$BR
242806921$24280692$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A195731$ASTRAZENECA$$$$$F$Y$64.3$KG$20240904$$CN$US$
242806951$24280695$1$I$$20240829$20240904$20240904$EXP$$CA-TAKEDA-2024TUS087833$TAKEDA$$$$$M$Y$$$20240904$$CN$CA$CA
242806961$24280696$1$I$$20240829$20240904$20240904$EXP$$US-TAKEDA-2021TUS063350$TAKEDA$$$$$F$Y$$$20240904$$CN$US$US
242806971$24280697$1$I$$20240828$20240904$20240904$EXP$$BR-AMGEN-BRASP2024174237$AMGEN$$64$YR$A$F$Y$$$20240904$$CN$BR$BR
242806981$24280698$1$I$20240731$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024173551$AMGEN$$80$YR$E$F$Y$$$20240904$$CN$US$US
242806991$24280699$1$I$20221026$20240828$20240904$20240904$EXP$$JP-TAKEDA-2022TUS088498$TAKEDA$$41$YR$$F$Y$$$20240904$$MD$JP$JP
242807001$24280700$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140257$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240904$$HP$US$US
242807021$24280702$1$I$$20240828$20240904$20240904$PER$$US-TAKEDA-2024TUS087189$TAKEDA$$$$$$Y$$$20240904$$CN$US$US
242807041$24280704$1$I$$20240827$20240904$20240904$EXP$$JP-Encube-001302$ENCUBE ETHICALS$Konishi T, Uemura J, Yamashita S, Mori H, Inoue T, Kurokawa K. A case of metronidazole-induced encephalopathy that is difficult to differentiate from Wernicke encephalopathy. Rinsho Shinkeigaku. 2024 Aug 24. Japanese. doi: 10.5692/clinicalneurol.cn-001972. Epub ahead of print. PMID: 39183051.$76$YR$E$M$Y$$$20240903$$HP$JP$
242807052$24280705$2$F$20240101$20240917$20240904$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-025819$UNITED THERAPEUTICS$$$$$F$Y$61.678$KG$20240924$$$US$US
242807061$24280706$1$I$$20240903$20240904$20240904$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049364$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240904$$HP$SG$SG
242807071$24280707$1$I$20240701$20240820$20240904$20240904$EXP$ES-AEMPS-1559129$ES-PHARMAAND GMBH-2024PHR00496$pharmaAND$$65$YR$$M$Y$62$KG$20240904$$MD$ES$ES
242807091$24280709$1$I$20220101$20240822$20240904$20240904$EXP$$US-UCBSA-2024040843$UCB$$59$YR$$F$Y$$$20240904$$HP$US$US
242807101$24280710$1$I$$20240829$20240904$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-027299$UNITED THERAPEUTICS$$$$$M$Y$90.703$KG$20240904$$$US$US
242807111$24280711$1$I$$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001259$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240904$$CN$US$US
242807131$24280713$1$I$$20240830$20240904$20240904$PER$$US-JNJFOC-20240900678$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242807141$24280714$1$I$$20240823$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408015904$ELI LILLY AND CO$$$$A$F$Y$$$20240904$$CN$US$US
242807152$24280715$2$F$$20240827$20240904$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US075717$SANDOZ$$$$$F$Y$$$20240904$$CN$US$US
242807161$24280716$1$I$$20240820$20240904$20240904$EXP$$US-PHARMAAND GMBH-2024PHR00489$pharmaAND$$$$$F$Y$51$KG$20240904$$CN$US$US
242807173$24280717$3$F$$20240903$20240904$20240909$EXP$$US-ALXN-202408USA002229US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242807182$24280718$2$F$$20240827$20240904$20240905$PER$$US-TAKEDA-2024TUS087687$TAKEDA$$$$$F$Y$$$20240905$$CN$US$US
242807192$24280719$2$F$20240822$20240912$20240904$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-026082$UNITED THERAPEUTICS$$46$YR$$F$Y$108.84$KG$20240921$$$US$US
242807202$24280720$2$F$20240826$20240829$20240904$20240909$EXP$$US-JNJFOC-20240874841$JOHNSON AND JOHNSON$$12$YR$T$M$Y$44.1$KG$20240909$$HP$US$US
242807211$24280721$1$I$20230401$20240826$20240904$20240904$PER$$US-ABBVIE-5896003$ABBVIE$$62$YR$$M$Y$84.368$KG$20240904$$CN$US$US
242807221$24280722$1$I$$20240819$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08509$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242807271$24280727$1$I$20240501$20240828$20240904$20240904$EXP$GB-MHRA-MED-202408271819015540-YDQLC$GB-MSNLABS-2024MSNSPO01896$MSN LABORATORIES$$$$$$Y$$$20240904$$CN$GB$GB
242807281$24280728$1$I$$20240828$20240904$20240904$PER$$US-ABBVIE-5902075$ABBVIE$$$$$$Y$$$20240904$$PH$US$US
242807291$24280729$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140452$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240904$$CN$US$US
242807301$24280730$1$I$$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024172911$AMGEN$$$$$M$Y$$$20240904$$CN$US$US
242807311$24280731$1$I$$20240826$20240904$20240904$PER$$US-ABBVIE-5896909$ABBVIE$$$$$$Y$$$20240904$$HP$US$US
242807321$24280732$1$I$20240701$20240715$20240904$20240904$PER$$US-TEVA-VS-3221207$TEVA$$$$$M$Y$$$20240904$$CN$US$US
242807331$24280733$1$I$$20240829$20240904$20240904$EXP$$CA-TAKEDA-2024TUS069829$TAKEDA$$$$$M$Y$$$20240904$$CN$CA$CA
242807341$24280734$1$I$$20240902$20240904$20240904$EXP$$JP-JNJFOC-20240906029$JOHNSON AND JOHNSON$$92$YR$E$M$Y$$$20240904$$HP$JP$JP
242807371$24280737$1$I$$20240828$20240904$20240904$PER$$US-BAUSCH-BL-2024-013039$BAUSCH AND LOMB$$$$$F$Y$$$20240904$$CN$US$US
242807392$24280739$2$F$$20240830$20240904$20240906$EXP$$DE-AstraZeneca-2024A198820$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$DE$
242807401$24280740$1$I$$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A199067$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242807411$24280741$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A197177$ASTRAZENECA$$$$$F$Y$$$20240904$$MD$US$
242807421$24280742$1$I$$20240826$20240904$20240904$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006428$BIOCON$$$$$$Y$$$20240904$$CN$CA$CA
242807431$24280743$1$I$$20240821$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08408$LUPIN$$$$$$Y$$$20240904$$MD$US$US
242807442$24280744$2$F$20240717$20240912$20240904$20240924$EXP$$NVSC2024IN168805$NOVARTIS$$2$YR$$M$Y$9.6$KG$20240924$$MD$IN$IN
242807451$24280745$1$I$20240821$20240828$20240904$20240904$EXP$$CN-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000202-2024$QILU PHARMACEUTICAL$$64$YR$A$F$Y$47.5$KG$20240904$$HP$CN$CN
242807471$24280747$1$I$$20240821$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08409$LUPIN$$$$$$Y$$$20240904$$MD$US$US
242807481$24280748$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009861$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242807501$24280750$1$I$20221001$20240821$20240904$20240904$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-08004$HIKMA$Frattari A, De Angelis MV, Battilana M, Polilli E, Ferrieri A, Onofrillo D, et al. Frattari A, De Angelis MV, Battilana M, Polilli E, Ferrieri A, Onofrillo D, et al. High viral load VZV encephalitis complicated by super refractory status epilepticus in a vaccinated child with in Acute Lymphocytic Leukemia: Case report and review of the literature. Neuroimmunology Reports. 2024;6:100223.$6$YR$$M$Y$$$20240903$$MD$IT$IT
242807511$24280751$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009862$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242807521$24280752$1$I$20240101$20240903$20240904$20240904$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049361$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240904$$HP$SG$SG
242807533$24280753$3$F$$20240910$20240904$20240917$EXP$$PL-SANDOZ INC.-SDZ2024PL076952$SANDOZ$$31$YR$$F$Y$$$20240917$$MD$PL$PL
242807551$24280755$1$I$$20240826$20240904$20240904$30DAY$$US-GSK-US2024106131$GLAXOSMITHKLINE$$$$$M$Y$$$20240904$$PH$US$US
242807571$24280757$1$I$$20240830$20240904$20240904$PER$$US-JNJFOC-20240901642$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$CN$US$US
242807581$24280758$1$I$$20240829$20240904$20240904$EXP$$BR-JNJFOC-20240900386$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$CN$BR$BR
242807591$24280759$1$I$20210101$20240823$20240904$20240904$EXP$$US-IBSA PHARMA INC.-2024IBS000397$IBSA INSTITUT BIOCHIMIQUE$$$$$$Y$$$20240904$$CN$US$US
242807611$24280761$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009863$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242807621$24280762$1$I$20240701$20240829$20240904$20240904$PER$$US-ABBVIE-5902182$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242807641$24280764$1$I$$20240827$20240904$20240904$EXP$$CA-CELLTRION INC.-2024CA020538$CELLTRION$$$$$$Y$$$20240904$$CN$CA$CA
242807652$24280765$2$F$20240713$20240902$20240904$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-043022$AUROBINDO$$89$YR$$F$Y$53$KG$20240910$$MD$DE$DE
242807661$24280766$1$I$20240901$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001679$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240904$$CN$US$US
242807671$24280767$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001396$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240904$$CN$US$US
242807681$24280768$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001683$ELI LILLY AND CO$$62$YR$A$$Y$$$20240904$$CN$US$US
242807691$24280769$1$I$20240806$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001263$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240904$$CN$US$US
242807711$24280771$1$I$20240821$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000230$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240904$$CN$US$US
242807721$24280772$1$I$$20240829$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000065$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240904$$CN$US$US
242807731$24280773$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001561$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240904$$CN$US$US
242807741$24280774$1$I$$20240830$20240904$20240904$EXP$$US-TAKEDA-2024TUS063221$TAKEDA$$$$$M$Y$$$20240904$$CN$US$US
242807751$24280775$1$I$$20240823$20240904$20240904$30DAY$$CA-JNJFOC-20240882688$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$CA$CA
242807761$24280776$1$I$$20240829$20240904$20240904$EXP$$US-JNJFOC-20240877492$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$CN$US$US
242807771$24280777$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009864$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242807781$24280778$1$I$$20240823$20240904$20240904$EXP$$BR-CHIESI-2024CHF05402$CHIESI$$$$N$$Y$$$20240904$$MD$BR$BR
242807791$24280779$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009865$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242807802$24280780$2$F$$20240906$20240904$20240916$EXP$$IT-TEVA-VS-3238706$TEVA$Bernasconi L, Schicchi A, Petrolini VM, Malovini A, Lonati D, Fassio F, et al. Clinical characteristics of acute lacosamide poisoning: Pavia Poison Control Centre experience. Br-J-Clin-Pharmacol 2023;.; Bernasconi L, Schicchi A, Petrolini VM, Malovini A, Lonati D, Fassio F, et al. Clinical characteristics of acute lacosamide poisoning: Pavia Poison Control Centre experience. Br-J-Clin-Pharmacol 2023;.; Bernasconi L, Schicchi A, Petrolini VM, Malovini A, Lonati D, Fassio F, et al. Clinical cha...$$$$$Y$$$20240916$$HP$IT$IT
242807811$24280781$1$I$20180101$20240823$20240904$20240904$EXP$$US-Accord-443374$ACCORD$Chowdhury RB, Shah SI, Milford E, Tullius SG, Rennke H, Bianchi G. Extramedullary plasmacytoma exclusively localized in transplanted kidney: Post-transplant lymphoproliferative disorder or monoclonal gammopathy of renal significance? Journal of Onco-Nephrology. 2024;8(2):70-4.$44$YR$A$F$Y$$$20240904$$MD$US$US
242807821$24280782$1$I$$20240822$20240904$20240904$EXP$$US-UCBSA-2024043217$UCB$$$$$$Y$$$20240904$$CN$US$US
242807831$24280783$1$I$$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A198864$ASTRAZENECA$$$$$F$Y$$$20240904$$MD$US$
242807841$24280784$1$I$20240731$20240826$20240904$20240904$PER$$US-AstraZeneca-2024A199357$ASTRAZENECA$$25643$DY$$F$Y$$$20240904$$CN$US$
242807851$24280785$1$I$$20240822$20240904$20240904$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08560$LUPIN$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73(200):1-9$61$YR$$F$Y$$$20240904$$HP$US$US
242807861$24280786$1$I$$20240902$20240904$20240904$EXP$BE-EMA-20150314-AUTODUP-388924$BE-SANDOZ INC.-SDZ2024BE076992$SANDOZ$$$$$F$Y$$$20240904$$HP$BE$BE
242807871$24280787$1$I$20240824$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024174825$AMGEN$$69$YR$E$F$Y$$$20240904$$CN$US$US
242807881$24280788$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009866$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242807891$24280789$1$I$20240809$20240826$20240904$20240904$EXP$$PE-ROCHE-10000067389$ROCHE$$48$YR$A$F$Y$$$20240904$$CN$PE$PE
242807901$24280790$1$I$$20240828$20240904$20240904$EXP$$NVSC2024AR175816$NOVARTIS$$70$YR$$F$Y$$$20240904$$MD$AR$AR
242807921$24280792$1$I$20240624$20240826$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-043088$AUROBINDO$$59$YR$$F$Y$$$20240904$$PH$FR$FR
242807932$24280793$2$F$$20240906$20240904$20240910$EXP$$NVSJ2024JP010368$NOVARTIS$$$$$$Y$$$20240910$$MD$JP$JP
242807941$24280794$1$I$20240819$20240830$20240904$20240904$EXP$$CN-ROCHE-10000070333$ROCHE$$61$YR$A$F$Y$41$KG$20240904$$HP$CN$CN
242807951$24280795$1$I$$20240901$20240904$20240904$EXP$$NVSJ2024JP010410$NOVARTIS$$30$YR$$M$Y$$$20240904$$CN$JP$JP
242807961$24280796$1$I$20240720$20240826$20240904$20240904$EXP$$ES-AUROBINDO-AUR-APL-2024-043058$AUROBINDO$$70$YR$$F$Y$$$20240904$$MD$ES$ES
242807971$24280797$1$I$20240824$20240826$20240904$20240904$30DAY$$US-GSK-US2024106150$GLAXOSMITHKLINE$$94$YR$$F$Y$$$20240904$$CN$US$US
242807981$24280798$1$I$20240101$20240819$20240904$20240904$EXP$$JP-JNJFOC-20240858253$JOHNSON AND JOHNSON$$87$YR$E$F$Y$45$KG$20240904$$MD$JP$JP
242808001$24280800$1$I$$20240827$20240904$20240904$EXP$$CA-CELLTRION INC.-2024CA020960$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
242808011$24280801$1$I$$20240827$20240904$20240904$EXP$$BR-JNJFOC-20240882223$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$MD$BR$BR
242808021$24280802$1$I$$20240828$20240904$20240904$EXP$$GB-JNJFOC-20240903611$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240904$$CN$GB$GB
242808031$24280803$1$I$20240901$20240903$20240904$20240904$PER$$US-AMGEN-USASP2024175793$AMGEN$$$$$M$Y$$$20240904$$CN$US$US
242808041$24280804$1$I$20200507$20240821$20240904$20240904$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-247074$RANBAXY$$57$YR$A$M$Y$$$20240904$$CN$US$US
242808051$24280805$1$I$20240801$20240823$20240904$20240904$EXP$$US-UCBSA-2024043329$UCB$$55$YR$$F$Y$75.737$KG$20240904$$HP$US$US
242808081$24280808$1$I$$20240823$20240904$20240904$EXP$$DE-Accord-443915$ACCORD$Hoeltzenbein M, Slimi S, Fietz AK, Stegherr R, Onken M, Beyersmann J, et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 2023,107:107-13$$$$F$Y$$$20240904$$MD$DE$DE
242808091$24280809$1$I$$20240826$20240904$20240904$EXP$$JP-ROCHE-10000069907$ROCHE$$$$$F$Y$$$20240904$$PH$JP$JP
242808101$24280810$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009867$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242808111$24280811$1$I$$20240902$20240904$20240904$EXP$$GB-MYLANLABS-2024M1080692$MYLAN$$$$$F$Y$$$20240904$$CN$GB$GB
242808121$24280812$1$I$$20240830$20240904$20240904$EXP$GB-SUNPHARMA-2024RR-463855AA$GB-MYLANLABS-2024M1080199$MYLAN$$50$YR$$F$Y$$$20240904$$HP$GB$GB
242808132$24280813$2$F$$20240927$20240904$20240930$EXP$$IE-MYLANLABS-2024M1081016$MYLAN$$70$YR$$M$Y$$$20240930$$HP$IE$IE
242808141$24280814$1$I$$20240830$20240904$20240904$EXP$$GB-MYLANLABS-2024M1080513$MYLAN$$$$$F$Y$$$20240904$$PH$GB$GB
242808151$24280815$1$I$$20240904$20240904$20240904$EXP$$CZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049439$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240904$$MD$CZ$CZ
242808161$24280816$1$I$$20240823$20240904$20240904$EXP$$US-Accord-444504$ACCORD$$52$YR$A$F$Y$$$20240904$$HP$US$US
242808171$24280817$1$I$20230322$20240829$20240904$20240904$EXP$$US-AMGEN-USASP2024173799$AMGEN$$63$YR$A$F$Y$$$20240904$$CN$US$US
242808181$24280818$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009868$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242808191$24280819$1$I$20240810$20240827$20240904$20240904$EXP$FR-AFSSAPS-PV2024000783$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111643$ZYDUS PHARM$$$$$$Y$$$20240904$$MD$FR$FR
242808201$24280820$1$I$20240812$20240827$20240904$20240904$EXP$FR-AFSSAPS-MP2024001310$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111636$ZYDUS PHARM$$$$$$Y$$$20240904$$MD$FR$FR
242808211$24280821$1$I$20240818$20240827$20240904$20240904$EXP$FR-AFSSAPS-MA2024001413$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111654$ZYDUS PHARM$$$$$$Y$$$20240904$$MD$FR$FR
242808221$24280822$1$I$20240428$20240827$20240904$20240904$EXP$FR-AFSSAPS-AVMA2024000356$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111671$ZYDUS PHARM$$$$$$Y$$$20240904$$PH$FR$FR
242808231$24280823$1$I$20240704$20240827$20240904$20240904$EXP$FR-AFSSAPS-AN2024001144$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111623$ZYDUS PHARM$$$$$$Y$$$20240904$$PH$FR$FR
242808241$24280824$1$I$20240713$20240827$20240904$20240904$EXP$FR-AFSSAPS-TS2024000939$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111679$ZYDUS PHARM$$$$$$Y$$$20240904$$MD$FR$FR
242808261$24280826$1$I$20240815$20240826$20240904$20240904$EXP$$DE-AUROBINDO-AUR-APL-2024-042914$AUROBINDO$$55$YR$$F$Y$57$KG$20240904$$CN$DE$DE
242808272$24280827$2$F$20240101$20240903$20240904$20240911$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026726$UNITED THERAPEUTICS$$$$$F$Y$$$20240911$$$US$US
242808281$24280828$1$I$20240101$20240903$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049413$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240904$$CN$US$US
242808291$24280829$1$I$$20240830$20240904$20240904$PER$$US-GILEAD-2024-0685897$GILEAD$$$$$$Y$$$20240904$$CN$US$US
242808301$24280830$1$I$20190901$20240829$20240904$20240904$EXP$$BR-TAKEDA-BR202022793$TAKEDA$$34$YR$$M$Y$58$KG$20240904$$CN$BR$BR
242808311$24280831$1$I$20240612$20240826$20240904$20240904$EXP$$ES-AUROBINDO-AUR-APL-2024-043132$AUROBINDO$$84$YR$$F$Y$60$KG$20240904$$MD$ES$ES
242808341$24280834$1$I$$20240829$20240904$20240904$PER$$US-ABBVIE-5902230$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242808351$24280835$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000445$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$7$YR$$M$Y$$$20240904$$HP$TH$TH
242808361$24280836$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000443$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$4$YR$$M$Y$$$20240904$$HP$TH$TH
242808371$24280837$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000444$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$5$YR$$F$Y$$$20240904$$HP$TH$TH
242808381$24280838$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000446$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate.. Sci. Rep.. 2024;14(1):18548$8$YR$$F$Y$$$20240904$$HP$TH$TH
242808391$24280839$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000448$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep. 2024;14(1):18548$10$YR$$M$Y$$$20240904$$HP$TH$TH
242808401$24280840$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000447$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$10$YR$$M$Y$$$20240904$$HP$TH$TH
242808411$24280841$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000449$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate.. Sci. Rep.. 2024;14(1):18548$11$YR$$F$Y$$$20240904$$HP$TH$TH
242808421$24280842$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000450$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate.. Sci. Rep.. 2024;14(1):18548$11$YR$$M$Y$$$20240904$$HP$TH$TH
242808431$24280843$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000451$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate.. Sci. Rep.. 2024;14(1):18548$11$YR$$M$Y$$$20240904$$HP$TH$TH
242808441$24280844$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000453$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate.. Sci. Rep.. 2024;14(1):18548$14$YR$$M$Y$$$20240904$$HP$TH$TH
242808452$24280845$2$F$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000454$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate.. Sci. Rep.. 2024;14(1):18548$14$YR$$M$Y$$$20240904$$HP$TH$TH
242808461$24280846$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000452$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate.. Sci. Rep.. 2024;14(1):18548$13$YR$$M$Y$$$20240904$$HP$TH$TH
242808471$24280847$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000455$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate.. Sci. Rep.. 2024;14(1):18548$14$YR$$M$Y$$$20240904$$HP$TH$TH
242808481$24280848$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000457$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate.. Sci. Rep.. 2024;14(1):18548$15$YR$$M$Y$$$20240904$$HP$TH$TH
242808491$24280849$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000456$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$14$YR$$M$Y$$$20240904$$HP$TH$TH
242808501$24280850$1$I$$20240827$20240904$20240904$PER$$US-BIOGEN-2024BI01280193$BIOGEN$$$$$F$Y$$$20240904$$CN$US$US
242808511$24280851$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009869$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242808532$24280853$2$F$$20240906$20240904$20240919$EXP$$IN-ALVOGEN-2024095422$ALVOGEN$Nanjappa H, Rodrigues AJ. Atrial Fibrillation Secondary to Levothyroxine Overdose with Underlying Secondary Infection. Journal of the Association of Physicians of India. 2024 Aug;72(8):96-98. doi:https://dx.doi.org/10.59556/japi.72.0602$62$YR$$F$Y$$$20240919$$MD$IN$IN
242808541$24280854$1$I$$20240827$20240904$20240904$EXP$$US-ALXN-202408USA001830US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
242808551$24280855$1$I$20240830$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001415$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240904$$CN$US$US
242808561$24280856$1$I$$20240829$20240904$20240904$EXP$$ES-AMGEN-ESPSP2024174671$AMGEN$Martinez-sanchez N.; Alvarez-troncoso J.; Robles-marhuenda A. et al.. Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases. Journal of Autoimmunity. 2024;148:1-6$$$$$Y$$$20240904$$MD$ES$ES
242808571$24280857$1$I$$20240829$20240904$20240904$EXP$$CN-AMGEN-CHNSP2024173222$AMGEN$Zhang S.; Li W.; Zheng C. et al.. Combined preoperative denosumab and adjuvant microwave ablation for high-risk giant cell tumor of bone: a retrospective study in a single center. Journal of orthopaedic surgery and research. 2024;19 (1):1-11$32$YR$A$M$Y$$$20240904$$HP$CN$CN
242808581$24280858$1$I$$20240826$20240904$20240904$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010967$STRIDES$Kawada S, Tanimoto M, Onishi N, Takaishi A, Morita H.. Successful use of lidocaine hydrochloride in the management of ventricular arrhythmias in a case of pilsicainide intoxication.. HeartRhythm-Case-Rep. 2023;10 (2):119-123$84$YR$$F$Y$51.8$KG$20240904$$MD$JP$JP
242808591$24280859$1$I$$20240827$20240904$20240904$EXP$$US-AMGEN-USASP2024173324$AMGEN$Uddin S.; Kaufman A.. Facial nerve palsy after ethylene vinyl alcohol arterial embolization of glomus tympanicum. American Journal of Otolaryngology - Head and Neck Medicine and Surgery. 2024;45 (5):1-5$57$YR$A$F$Y$$$20240904$$HP$US$US
242808601$24280860$1$I$20240101$20240829$20240904$20240904$PER$$US-MYLANLABS-2024M1080193$MYLAN$$$$$$Y$$$20240904$$CN$US$US
242808611$24280861$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009870$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242808621$24280862$1$I$$20240902$20240904$20240904$EXP$$US-SANDOZ INC.-NVSC2019US033070$SANDOZ$$26$YR$$M$Y$$$20240904$$MD$US$US
242808631$24280863$1$I$$20240816$20240904$20240904$PER$$US-TEVA-VS-3234732$TEVA$$$$$F$Y$$$20240904$$CN$US$US
242808641$24280864$1$I$$20240826$20240904$20240904$EXP$$IT-TEVA-VS-3238707$TEVA$Bernasconi L, Schicchi A, Petrolini VM, Malovini A, Lonati D, Fassio F, et al. Clinical characteristics of acute lacosamide poisoning: Pavia Poison Control Centre experience. Br-J-Clin-Pharmacol 2023;.; Bernasconi L, Schicchi A, Petrolini VM, Malovini A, Lonati D, Fassio F, et al. Clinical characteristics of acute lacosamide poisoning: Pavia Poison Control Centre experience. Br-J-Clin-Pharmacol 2023;.$$$$$Y$$$20240904$$HP$IT$IT
242808671$24280867$1$I$$20240826$20240904$20240904$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010960$STRIDES$Adachi K, Murata M, Inada A, Morimoto T, Shimizu M, Beppu S, et al.. Interaction of a caffeine overdose with clinical doses of contraceptive ethinyl estradiol in a young woman.. Acute-Med-Surg. 2024;11 (1):1-4$23$YR$$F$Y$$$20240904$$HP$JP$JP
242808681$24280868$1$I$$20240830$20240904$20240904$PER$$US-BIOGEN-2024BI01280748$BIOGEN$$$$$F$Y$$$20240904$$CN$US$US
242808691$24280869$1$I$20211101$20240830$20240904$20240904$PER$$US-BIOGEN-2021BI01066176$BIOGEN$$35$YR$$F$Y$$$20240904$$CN$US$US
242808702$24280870$2$F$$20240911$20240904$20240913$PER$$US-BIOGEN-2024BI01280739$BIOGEN$$$$$M$Y$108.41$KG$20240913$$CN$US$US
242808714$24280871$4$F$20240801$20240923$20240904$20240926$PER$$US-BIOGEN-2024BI01280750$BIOGEN$$45$YR$$M$Y$$$20240926$$CN$US$US
242808721$24280872$1$I$$20240826$20240904$20240904$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP010991$STRIDES$Nakasone ES, Bustillos HC, Gui X, Konnick EQ, Sham JG, Cohen SA.. Multidisciplinary Approach for the Management of Metastatic Poorly Differentiated Neuroendocrine Carcinoma of the Pancreas A Case Report of an Exceptional Responder.. Pancreas. 2024;53 (6):e487-e491$51$YR$$M$Y$$$20240904$$MD$US$US
242808731$24280873$1$I$$20240829$20240904$20240904$30DAY$$US-GSK-US2024108443$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242808741$24280874$1$I$$20240830$20240904$20240904$EXP$PT-SANDOZ-SDZ2024PT074386$PT-ROCHE-10000070349$ROCHE$Costa C, Antunes A, Oliveira J, Pereira M, Godinho I, Fernandes P, Jorge S, Lopes JA, Gameiro J. Rituximab in Steroid-Dependent Podocytopathies. Glomerular Diseases. 2024;4(1):129-136. doi:10.1159/000539922$51$YR$A$F$Y$$$20240904$$HP$PT$PT
242808751$24280875$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009871$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242808761$24280876$1$I$$20240826$20240904$20240904$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP010998$STRIDES$Imai K, Kodana M, Omachi R, Inoue T, Okada H, Maeda T.. A fatal case of peritonitis caused by Dysgonomonas capnocytophagoides harboring the novel metallo-beta-lactamase gene blaDYB-1.. Int-J-Infect-Dis. 2024;147$88$YR$$F$Y$$$20240904$$HP$JP$JP
242808771$24280877$1$I$$20240830$20240904$20240904$EXP$$US-AMGEN-USASP2024174055$AMGEN$$$$$M$Y$$$20240904$$PH$US$US
242808781$24280878$1$I$$20240828$20240904$20240904$PER$$US-AMGEN-USASP2024173611$AMGEN$Cheung A.Y.; Mansur S.. Treatment of Corneal Neovascularization before Deep Anterior Lamellar Keratoplasty. Cornea. 2024;1-6$41$YR$A$M$Y$$$20240904$$MD$US$US
242808791$24280879$1$I$$20240828$20240904$20240904$EXP$$US-AMGEN-USASP2024173613$AMGEN$Cheung A.Y.; Mansur S.. Treatment of Corneal Neovascularization before Deep Anterior Lamellar Keratoplasty. Cornea. 2024;1-6$56$YR$A$M$Y$$$20240904$$MD$US$US
242808801$24280880$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-082821-2024$RECKITT BENCKISER$$$$$F$Y$$$20240904$$CN$US$US
242808811$24280881$1$I$$20240828$20240904$20240904$PER$$US-AMGEN-USASP2024173620$AMGEN$Cheung A.Y.; Mansur S.. Treatment of Corneal Neovascularization Before Deep Anterior Lamellar Keratoplasty. Cornea. 2024;1-6$62$YR$A$F$Y$$$20240904$$MD$US$US
242808822$24280882$2$F$$20240920$20240904$20240930$PER$$US-GSK-US2024106138$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
242808831$24280883$1$I$$20240826$20240904$20240904$EXP$$US-GSK-US2024105997$GLAXOSMITHKLINE$$$$$M$Y$$$20240904$$MD$US$US
242808841$24280884$1$I$$20240903$20240904$20240904$PER$$US-HALEON-2195057$Haleon PLC$$77$YR$$F$Y$$$20240904$$CN$US$US
242808861$24280886$1$I$20120101$20240829$20240904$20240904$EXP$$US-ABBVIE-5901933$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242808871$24280887$1$I$$20240821$20240904$20240904$PER$$US-APOTEX-2024AP009872$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240904$$HP$US$US
242808881$24280888$1$I$20240326$20240826$20240904$20240904$EXP$$BY-BAYER-2024A123607$BAYER$$46$YR$A$F$Y$$$20240904$$CN$BY$BY
242808891$24280889$1$I$$20240827$20240904$20240904$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP010978$STRIDES$Baudriller A, Abbara C, Briet M, Jousset N, Malbranque S, Zabet D, et al.. Deaths related to pharmacobezoars: A report on two cases.. Toxic-Analyt-Clinique. 2024$55$YR$$F$Y$$$20240904$$HP$FR$FR
242808901$24280890$1$I$$20240827$20240904$20240904$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011009$STRIDES$Bains S, Garmany R, Neves R, Giudicessi JR, Gao X, Tester DJ, et al.. Temporal Association Between Vaping and Risk of Cardiac Events.. Mayo-Clin-Proc. 2024;99 (2):241-248$26$YR$$M$Y$$$20240904$$MD$US$US
242808912$24280891$2$F$20240909$20240909$20240904$20240912$PER$$US-BIOGEN-2024BI01280156$BIOGEN$$65$YR$$F$Y$$$20240912$$CN$US$US
242808921$24280892$1$I$$20240826$20240904$20240904$PER$$US-RDY-SPO/USA/24/0012721$DR REDDYS$Chang AS, Brown R, Li S, Betancourt N, Teng J. Assessment of Mammalian Target of Rapamycin Pathway Activation in Basal Cell Carcinoma as a New Therapeutic Approach. American Journal of Dermatopathology. 2024;9(46): 588-592. doi:10.1097/DAD.0000000000002718.$6$YR$C$F$Y$$$20240904$$MD$US$US
242808941$24280894$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140016$BRISTOL MYERS SQUIBB$$28$YR$A$M$Y$$$20240904$$CN$US$US
242808952$24280895$2$F$$20240903$20240904$20240906$PER$$NVSC2024US177675$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
242808971$24280897$1$I$20240904$20240904$20240904$20240904$EXP$$AE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049456$BOEHRINGER INGELHEIM$$51$YR$A$F$Y$$$20240904$$CN$AE$AE
242808981$24280898$1$I$$20240828$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140476$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$76.689$KG$20240904$$CN$US$US
242809002$24280900$2$F$$20240902$20240904$20240917$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-20192$ALKEM$Inoue K, Kainuma S, Yoshioka D, Toda K, Miyagawa S.. Tacrolimus-induced reversible cerebral vasoconstriction syndrome after Heart Transplant: Case Report. Research Square. 2022;Unk:Unk$44$YR$$F$Y$$$20240917$$HP$JP$JP
242809012$24280901$2$F$$20240828$20240904$20240912$EXP$$MA-ALKEM LABORATORIES LIMITED-MA-ALKEM-2024-20275$ALKEM$Razanapinaritra R, El Fetoiki FZ, Hali F, Chiheb S.. DRESS syndrome induced by clobazam in a child: a new case. Revue Francaise d Allergologie. 2019;59(4):346-349$13$YR$$F$Y$$$20240912$$HP$MA$MA
242809022$24280902$2$F$$20240902$20240904$20240917$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-20166$ALKEM$Baghbanian SM, Bakhshi A, et al.. Tumefactive Balo-like concentric sclerosis in treatment with Fingolimod. Multiple Sclerosis and Related Disorders. 2023;71:104259$32$YR$$F$Y$$$20240917$$HP$IR$IR
242809031$24280903$1$I$$20240821$20240904$20240904$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-20273$ALKEM$Caramaschi P, Biasi D, Carletto A, et al.. Clobazam-induced systemic lupus erythematosus. Clin Rheumatol. 1995;14(1):116$7$YR$$F$Y$$$20240904$$HP$IT$IT
242809041$24280904$1$I$$20240821$20240904$20240904$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-20211$ALKEM$Setterfield JF, Robinson R, MacDonald D, et al.. Coma-induced bullae and sweat gland necrosis following clobazam. Clin Exp Dermatol. 2000;25(3):215-218$4$YR$$F$Y$$$20240904$$HP$GB$GB
242809051$24280905$1$I$$20240827$20240904$20240904$EXP$$US-RDY-SPO/USA/24/0012742$DR REDDYS$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Cancer Journal. 2023;13(1): doi:10.1038/s41408-023-00859-x.$$$$M$Y$$$20240904$$HP$US$US
242809061$24280906$1$I$$20240821$20240904$20240904$EXP$$GR-ALKEM LABORATORIES LIMITED-GR-ALKEM-2024-18938$ALKEM$Dagklis IE, Rokkou I, Kazis D, Bostantjopoulou S.. Duloxetine-associated acute laryngeal dystonia: a case report.. J Clin Psychopharmacol. 2019;39 (6):678-9$56$YR$$F$Y$$$20240904$$MD$GR$GR
242809071$24280907$1$I$$20240821$20240904$20240904$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-20095$ALKEM$Karakas Ugurlu G, Onen S, Bayindirli D, et al. Acute dystonia after using single dose duloxetine: case report. Psychiatry Investig. 2013;13:95-97$$$$$Y$$$20240904$$HP$TR$TR
242809082$24280908$2$F$$20240828$20240904$20240912$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-20207$ALKEM$Hussain K, Zaheri S, Patel N.. Drug reaction with eosinophilia and systemic symptoms complicated by haemophagocytic lymphohistiocytosis: is screening required?. British Association of Dermatologists. 2020;183(Suppl1):pp9-25$49$YR$$M$Y$$$20240912$$HP$GB$GB
242809091$24280909$1$I$$20240821$20240904$20240904$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-20215$ALKEM$Aylett SE, Cross H, Berry D. Eye rolling as a manifestation of clobazam toxicity in a child with epilepsy. Dev Med Child Neurol. 2006;48(7):612-615$4$YR$$M$Y$$$20240904$$HP$GB$GB
242809102$24280910$2$F$$20240828$20240904$20240912$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-20261$ALKEM$Ulusoy I, Ocak R, Erdem M, Bayrakci B.. Meropenem induced respiratory arrest. Pediatric Critical Care Medicine. 2021;22(Suppl.1):71-72$6$YR$$M$Y$$$20240912$$HP$TR$TR
242809111$24280911$1$I$$20240829$20240904$20240904$EXP$$US-AMGEN-USASP2024173654$AMGEN$Gottiparthy A.; Lam K.; Kundu S. et al.. Neurofilament light chain in serum of cancer patients with acute neurological complications. CNS Oncology. 2024;13 (1):1-18$22$YR$A$M$Y$$$20240904$$HP$US$US
242809121$24280912$1$I$$20240829$20240904$20240904$EXP$$US-AMGEN-USASP2024173688$AMGEN$Gottiparthy A.; Lam K.; Kundu S. et al.. Neurofilament light chain in serum of cancer patients with acute neurological complications. CNS Oncology. 2024;13 (1):1-18$65$YR$E$M$Y$$$20240904$$HP$US$US
242809131$24280913$1$I$$20240821$20240904$20240904$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-20185$ALKEM$Scholl JH, van Eekeren R, van Puijenbroek EP. Six cases of (severe) hypoglycaemia associated with gabapentin use in both diabetic and non-diabetic patients. British Journal of Clinical Pharmacology. 2014;79(5):870-871$54$YR$$F$Y$$$20240904$$HP$NL$NL
242809141$24280914$1$I$$20240821$20240904$20240904$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-19212$ALKEM$Chandwani A, J S, Dwivedi A, Sivasami K, Jain H, Goel N, Kumar A, Vasdev V.. Azathioprine related alopecia totalis due to NUDT 15 mutation in a pregnant systemic lupus erythematosus patient with successful obstetric outcome. Rheumatology (Oxford). 2024;unk:keae431$28$YR$$F$Y$$$20240904$$HP$IN$IN
242809151$24280915$1$I$$20240821$20240904$20240904$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20419$ALKEM$Thomas RJ, Chawla J. Central hypoventilation in a paediatric patient with angelman syndrome. Journal of Sleep Research. 2018;27:unk$9$YR$$F$Y$$$20240904$$HP$US$US
242809161$24280916$1$I$$20240822$20240904$20240904$30DAY$$JP-JNJFOC-20240880151$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$JP$JP
242809171$24280917$1$I$$20240821$20240904$20240904$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20098$ALKEM$Chhakchhuak C, Anower M, Panda M. Reversible posterior leucoencephalopathy syndrome following duloxetine: a case report and review of literature. J Med Cases. 2011;2:24-7$$$$$Y$$$20240904$$HP$US$US
242809181$24280918$1$I$$20240821$20240904$20240904$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20217$ALKEM$Wakamoto H, Kume A, Nakano N, et.al.. Benign angiopathy of the central nervous system associated with phenytoin intoxication. Brain Dev .. 2006;28 (5):336-338$25$YR$$M$Y$$$20240904$$HP$US$US
242809192$24280919$2$F$20240701$20240829$20240904$20240905$PER$$US-009507513-2409USA000931$MERCK$$$$$$Y$$$20240905$$CN$US$US
242809201$24280920$1$I$$20240830$20240904$20240904$EXP$$US-TAKEDA-2024TUS088105$TAKEDA$$$$$F$Y$$$20240904$$CN$US$US
242809212$24280921$2$F$$20240828$20240904$20240912$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20285$ALKEM$Aung T, Shvarts V.. Rare but life-threatening aspiration pneumonia related to initiation of clobazam therapy. Epilepsy and Behavior Reports. 2020;14:100406$47$YR$$M$Y$$$20240912$$HP$US$US
242809221$24280922$1$I$$20240827$20240904$20240904$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP010954$STRIDES$Princy R, Neethu R.. Methotrexate-Induced Mucositis Due to Accidental Overdose; a Case Report.. Afr-J-Bol-Sci. 2024;6 (3):700-703$71$YR$$F$Y$$$20240904$$HP$IN$IN
242809231$24280923$1$I$$20240821$20240904$20240904$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-20416$ALKEM$Balamtekin N, Kilic S, Arslan M, et al.. Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine and valproic acid in a child. Allergy: European Journal of Allergy and Clinical Immunology. 2013;68:282$7$YR$$M$Y$$$20240904$$HP$TR$TR
242809242$24280924$2$F$$20240828$20240904$20240912$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20407$ALKEM$Bates BK, Fletcher JL, Hintze T, Hafeez SJ, Seifi A, Barthol C, Varney SM, Gao HT.. Acute encephalopathy in the setting of toxic clobazam (ONFI) metabolite levels and the unassuming antidote. Journal of Medical Toxicology. 2021;17:p.113$48$YR$$F$Y$$$20240912$$HP$US$US
242809253$24280925$3$F$$20240912$20240904$20240926$EXP$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20282$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20282$ALKEM$Aung T, Shvarts V.. Rare but life-threatening aspiration pneumonia related to initiation of clobazam therapy. Epilepsy and Behavior Reports. 2020;14:100406$52$YR$$M$Y$$$20240926$$HP$US$US
242809263$24280926$3$F$$20240912$20240904$20240926$EXP$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20280$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20280$ALKEM$Aung T, Shvarts V.. Rare but life-threatening aspiration pneumonia related to initiation of clobazam therapy. Epilepsy + Behavior Reports. 2020;14:100406$28$YR$$M$Y$$$20240926$$HP$US$US
242809272$24280927$2$F$$20240828$20240904$20240912$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20268$ALKEM$Parman MG, Holmes AP. Hypothermia in an Adolescent Due to Probable Drug-Drug Interaction Involving Clobazam. J Pediatr Pharmacol Ther. 2019;24(2):156-159$16$YR$$F$Y$34$KG$20240912$$HP$US$US
242809281$24280928$1$I$$20231031$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016599$STRIDES$Wobma H, Kapadia M, Kim HT, Alvarez-Calderon F, Baumeister SHC, Duncan C, et al.. Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease.. Blood-Adv. 2023;7(16):4647-4657$1$DEC$$$Y$$$20240904$$HP$US$US
242809291$24280929$1$I$$20240903$20240904$20240904$EXP$$BG-SANDOZ INC.-PHHY2018BG064336$SANDOZ$$27$YR$$M$Y$$$20240904$$MD$BG$BG
242809301$24280930$1$I$$20240816$20240904$20240904$PER$$US-ASTELLAS-2024US019904$ASTELLAS$$82$YR$E$F$Y$$$20240904$$CN$US$US
242809311$24280931$1$I$$20240816$20240904$20240904$PER$$US-ASTELLAS-2024-AER-001833$ASTELLAS$$54$YR$A$F$Y$$$20240904$$CN$US$US
242809321$24280932$1$I$$20240828$20240904$20240904$EXP$$PT-BAYER-2024A124771$BAYER$Ana Albuquerque ; Rafael Third; Carolina Palma ; Ivo Mendes ; Daniela Cruz ;  In?s Goldfinch. PERICARDITIS AN ATYPICAL MANIFESTATION. 30th National Congress of Internal Medicine. 2024;405 ABSTR PO-0031-2378$71$YR$E$M$Y$$$20240904$$HP$PT$PT
242809331$24280933$1$I$$20240827$20240904$20240904$EXP$$ID-STRIDES ARCOLAB LIMITED-2024SP010955$STRIDES$Lestari PM, Andrina H, Herponi A.. A Rare Case Report: Belly Dancer Dyskinesia and Symptomatic Epilpsy in Pregnancy Causing Incomplete Uterine Rupture.. J-acad-res-med. 2024;16 (4):455-457$33$YR$$F$Y$$$20240904$$HP$ID$ID
242809341$24280934$1$I$20240821$20240823$20240904$20240904$EXP$$CN-SA-2024SA254587$SANOFI AVENTIS$$57$YR$A$M$Y$59$KG$20240904$$HP$CN$CN
242809351$24280935$1$I$$20240828$20240904$20240904$EXP$$US-ROCHE-10000069572$ROCHE$$63$YR$A$M$Y$$$20240904$$CN$US$US
242809361$24280936$1$I$$20240822$20240904$20240904$EXP$$JP-SA-2024SA256273$SANOFI AVENTIS$$$$$$Y$$$20240904$$HP$JP$JP
242809371$24280937$1$I$20240517$20240902$20240904$20240904$EXP$$CO-UCBSA-2024044929$UCB$$85$YR$$F$Y$$$20240904$$CN$CO$CO
242809441$24280944$1$I$$20240430$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005299$STRIDES$Griffin SP, Lee BJ, Doh J, Paradyse AR, Jeyakumar D, Arter Z, et al.. Strategies to Mitigate the Drug-Drug Interaction between Nirmatrelvir/Ritonavir and Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Azole Antifungals: Results of a Case Series.. Acta-Haematol. 2023$36$YR$$M$Y$$$20240904$$HP$US$US
242809452$24280945$2$F$20240101$20240909$20240904$20240912$PER$$US-AMGEN-USASP2024176062$AMGEN$$41$YR$A$F$Y$$$20240912$$HP$US$US
242809462$24280946$2$F$20240801$20240910$20240904$20240919$30DAY$$US-AMGEN-USASP2024172716$AMGEN$$42$YR$A$M$Y$$$20240919$$HP$US$US
242809471$24280947$1$I$$20240826$20240904$20240904$EXP$$PL-AUROBINDO-AUR-APL-2024-043144$AUROBINDO$$84$YR$$F$Y$50$KG$20240904$$MD$PL$PL
242809481$24280948$1$I$$20240719$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009258$STRIDES$Morlend RM, Amin AA, Toto R, Araj FG, Hendren N, Grodin JL, et al.. BK NEPHROPATHY AND ACUTE KIDNEY INJURY IN A HEART TRANSPLANT RECIPIENT: IT^S IN THE DIFFERENTIAL DIAGNOSIS.. J-Am-Coll-Cardiol. 2024;83 (Suppl.)(13):2703 (plus Poster).$66$YR$$F$Y$$$20240904$$HP$US$US
242809491$24280949$1$I$$20240823$20240904$20240904$PER$$US-AstraZeneca-2024A193492$ASTRAZENECA$$$$A$F$Y$$$20240904$$MD$US$
242809501$24280950$1$I$20240801$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A197067$ASTRAZENECA$$1055$MON$$M$Y$$$20240904$$CN$US$
242809511$24280951$1$I$$20240830$20240904$20240904$EXP$$ZA-AstraZeneca-2024A199759$ASTRAZENECA$$69$YR$$M$Y$$$20240904$$CN$ZA$
242809531$24280953$1$I$$20240827$20240904$20240904$EXP$$JP-AstraZeneca-2024A197352$ASTRAZENECA$Tanigawa T, et al. Original Article Adverse events of PARP inhibitors in the treatment of. The Journal of the Japan Society of Gynecologic Oncology 2024;42(3):243-249.$$$A$F$Y$$$20240904$$MD$JP$
242809541$24280954$1$I$$20240117$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000919$STRIDES$Kosyakovsky J, Robinson TJ, Rao S, Taylor AC, Brayman KL, Agarwal AK. Management of ectopic intestinal variceal bleeding following pancreatic transplant: Two cases.. Clin-Transplant. 2024;38(1):1-4$49$YR$$F$Y$$$20240904$$HP$US$US
242809561$24280956$1$I$$20240902$20240904$20240904$EXP$$DE-SANDOZ INC.-NVSC2021DE073543$SANDOZ$$$$E$M$Y$$$20240904$$MD$DE$DE
242809571$24280957$1$I$$20240826$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2019-106482$AUROBINDO$Uzunov M, Demeret S, Quoc SN, Morel M, Bellanger A, Chavez H, et al. Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab. BRITISH JOURNAL OF HAEMATOLOGY. 2019;1-3$47$YR$$F$Y$$$20240904$$HP$FR$FR
242809581$24280958$1$I$20240510$20240828$20240904$20240904$EXP$FR-AFSSAPS-TS2024000944$FR-RDY-SPO/FRA/24/0012607$DR REDDYS$$80$YR$A$F$Y$65$KG$20240904$$MD$FR$FR
242809601$24280960$1$I$$20240903$20240904$20240904$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049363$BOEHRINGER INGELHEIM$$$$$$Y$$$20240904$$CN$US$US
242809611$24280961$1$I$20240725$20240731$20240904$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02809$AMNEAL$$$$$F$Y$$$20240904$$CN$US$US
242809621$24280962$1$I$20240603$20240724$20240904$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02153$AMNEAL$$$$$F$Y$$$20240904$$CN$US$US
242809641$24280964$1$I$20240530$20240716$20240904$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02068$AMNEAL$$$$$F$Y$$$20240904$$CN$US$US
242809651$24280965$1$I$$20240731$20240904$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02050$AMNEAL$$$$$F$Y$$$20240904$$CN$US$US
242809661$24280966$1$I$$20240903$20240904$20240904$EXP$$NVSC2024GN177506$NOVARTIS$$$$$M$Y$$$20240904$$MD$GN$GN
242809671$24280967$1$I$$20240829$20240904$20240904$EXP$$US-JNJFOC-20240880947$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$CN$US$US
242809682$24280968$2$F$20240814$20240904$20240904$20240905$EXP$$ZA-BAYER-2024A125939$BAYER$$48$YR$A$F$Y$$$20240905$$MD$ZA$ZA
242809691$24280969$1$I$20240710$20240815$20240904$20240904$PER$$US-Vifor (International) Inc.-VIT-2024-07457$VIFOR$$68$YR$$F$Y$48.3$KG$20240904$$HP$US$US
242809701$24280970$1$I$20240704$20240815$20240904$20240904$PER$$US-Vifor (International) Inc.-VIT-2024-07460$VIFOR$$71$YR$$M$Y$97$KG$20240904$$HP$US$US
242809711$24280971$1$I$$20240822$20240904$20240904$EXP$$JP-MACLEODS PHARMA-MAC2024049073$MACLEODS$Inami K, Tsutsumi S, Asagiri H, Yamataka M, Sugiyama N, Ueno H., et al..Recurrent hiccups associated with ipsilateral intracerebral hemorrhage and chronic subdural hematoma with immediate resolutions after evacuations..Radiology Case Reports.2024;19(10):4610-13$$$$$Y$$$20240903$$MD$JP$JP
242809721$24280972$1$I$20240702$20240815$20240904$20240904$PER$$US-Vifor (International) Inc.-VIT-2024-07455$VIFOR$$69$YR$$M$Y$112.8$KG$20240904$$HP$US$US
242809731$24280973$1$I$20240712$20240815$20240904$20240904$PER$$US-Vifor (International) Inc.-VIT-2024-07456$VIFOR$$62$YR$$M$Y$73$KG$20240904$$HP$US$US
242809741$24280974$1$I$20240710$20240815$20240904$20240904$PER$$US-Vifor (International) Inc.-VIT-2024-07451$VIFOR$$68$YR$$F$Y$66$KG$20240904$$HP$US$US
242809752$24280975$2$F$$20240806$20240904$20240924$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00629$MIRUM PHARMACEUTICALS$$$$C$F$Y$$$20240924$$CN$US$US
242809761$24280976$1$I$20240820$20240829$20240904$20240904$EXP$GB-MHRA-MED-202408211617041860-QGDJT$GB-SA-2024SA251040$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240904$$HP$GB$GB
242809771$24280977$1$I$$20240829$20240904$20240904$PER$$US-MYLANLABS-2024M1079793$MYLAN$$$$$F$Y$$$20240904$$HP$US$US
242809782$24280978$2$F$20230724$20240904$20240904$20240906$EXP$$CO-UCBSA-2023055338$UCB$$34$YR$$F$Y$65$KG$20240906$$CN$CO$CO
242809791$24280979$1$I$$20240823$20240904$20240904$EXP$$GB-UCBSA-2024044058$UCB$$$$A$$Y$$$20240904$$MD$GB$GB
242809801$24280980$1$I$$20240903$20240904$20240904$PER$$US-GILEAD-2024-0686177$GILEAD$$63$YR$A$M$Y$$$20240904$$CN$US$US
242809811$24280981$1$I$20240826$20240827$20240904$20240904$EXP$$CA-CELLTRION INC.-2024CA021080$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
242809821$24280982$1$I$$20240822$20240904$20240904$PER$$US-MYLANLABS-2024M1079039$MYLAN$$$$$F$Y$100.2$KG$20240904$$CN$US$US
242809831$24280983$1$I$20240101$20240829$20240904$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019811$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240904$$$US$US
242809843$24280984$3$F$20240831$20240913$20240904$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409001254$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240917$$CN$US$US
242809851$24280985$1$I$20240601$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001691$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240904$$CN$US$US
242809861$24280986$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001541$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240904$$CN$US$US
242809871$24280987$1$I$20240604$20240815$20240904$20240904$PER$$US-Vifor (International) Inc.-VIT-2024-07450$VIFOR$$74$YR$$M$Y$$$20240904$$HP$US$US
242809881$24280988$1$I$20240101$20240823$20240904$20240904$EXP$$US-INSMED, INC.-2024-02846-US$INSMED$$$$$M$Y$$$20240904$$CN$US$US
242809891$24280989$1$I$$20240828$20240904$20240904$EXP$$SA-STRIDES ARCOLAB LIMITED-2024SP011010$STRIDES$Al-Shamrani A, Al-Shamrani K, Mahfoudh AB, Mohamed AS, Mohamed S.. A Niemann-Pick Disease Type C2 with Severe Pulmonary Involvement and Limited Therapeutic Options: A Case Report.. Children-(Basel). 2022;9 (12)$3$YR$$M$Y$$$20240904$$HP$SA$SA
242809901$24280990$1$I$$20240826$20240904$20240904$EXP$$JP-MYLANLABS-2024M1080305$MYLAN$Okada S, Okada J, Okada K, Yamada E, Saito T, Kikkawa K, et al. Hot Water Eliminates the Bitter Taste of Oral Semaglutide: A Report of Four Cases. Intern-Med 2024; 63 (16): 2297-2300.. 2024;63 (16):2297-2300$59$YR$$F$Y$70$KG$20240904$$MD$JP$JP
242809911$24280991$1$I$$20240827$20240904$20240904$EXP$$US-MYLANLABS-2024M1079977$MYLAN$Abdelmageed S, Dalmage M, Mossner JM, Trierweiler R, Krater T, Raskin JS. Cervicothoracic ventral-dorsal rhizotomy for treatment of brachial hypertonia in cerebral palsy. Childs-Nerv-Syst 2024; 40 (9): 2835-2842.$22$YR$$M$Y$$$20240904$$HP$US$US
242809921$24280992$1$I$$20240826$20240904$20240904$EXP$$US-MYLANLABS-2024M1079731$MYLAN$Ahmad S, Goldsweig AM. Left atrial appendage occlusion and patent foramen ovale closure using a steerable sheath and intracardiac echocardiography. Catheter-Cardiovasc-Interv 2024; 104 (2): 416-418.$50$YR$$F$Y$$$20240904$$MD$US$US
242809931$24280993$1$I$$20240826$20240904$20240904$EXP$$US-MYLANLABS-2024M1080081$MYLAN$Varney SM, Watkins S, Stuteville H, Winter ML, Gao HT, Martin TG, et al. An Analysis of Clinical Outcomes of Exploratory Pediatric Metformin Ingestions Reported to the Texas Poison Center Network From 2011 to 2021. Hosp-Pharm 2024; 59 (4): 465-470.$$$C$$Y$$$20240904$$HP$US$US
242809941$24280994$1$I$$20240826$20240904$20240904$EXP$$US-MYLANLABS-2024M1079976$MYLAN$Das S, Mack JM. Chronic thromboembolic pulmonary hypertension in adolescents. Am-J-Med-Sci 2024; 367 (Suppl. 1) S170 abstr. 289.$16$YR$$M$Y$$$20240904$$HP$US$US
242809951$24280995$1$I$$20240826$20240904$20240904$EXP$$US-MYLANLABS-2024M1080434$MYLAN$Sunagawa SW, Havens JP, Podany A, Walker B, Scarsi KK, Bares SH. Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case Report. Open-Forum-Infect-Dis 2023; 10 (12):.$49$YR$$M$Y$$$20240904$$PH$US$US
242809961$24280996$1$I$$20240828$20240904$20240904$PER$$US-MYLANLABS-2024M1080068$MYLAN$$$$$F$Y$$$20240904$$HP$US$US
242809971$24280997$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140468$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240904$$CN$US$US
242809981$24280998$1$I$$20240822$20240904$20240904$EXP$$US-MYLANLABS-2024M1079234$MYLAN$Reinfeld S, Gill P. Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: A case series. CNS-Spectrums 2023; 28 (5): 587-591.$15$YR$$M$Y$$$20240904$$HP$US$US
242809991$24280999$1$I$$20240826$20240904$20240904$EXP$$JP-MYLANLABS-2024M1080306$MYLAN$Kawada S, Tanimoto M, Onishi N, Takaishi A, Morita H. Successful use of lidocaine hydrochloride in the management of ventricular arrhythmias in a case of pilsicainide intoxication. HeartRhythm-Case-Rep 2023; 10 (2): 119-123.. 2023;10 (2):119-123$84$YR$$F$Y$51.8$KG$20240904$$MD$JP$JP
242810001$24281000$1$I$$20240828$20240904$20240904$EXP$$SE-STRIDES ARCOLAB LIMITED-2024SP010963$STRIDES$Nikkarinen A, Glimelius I.. Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma -. A case report. EJHaem. 2024;5 (4):820-824$79$YR$$M$Y$$$20240904$$HP$SE$SE
242810011$24281001$1$I$20240826$20240828$20240904$20240904$30DAY$$US-GSK-US2024107304$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240904$$CN$US$US
242810021$24281002$1$I$$20240827$20240904$20240904$30DAY$$US-GSK-US2024106682$GLAXOSMITHKLINE$$$$$M$Y$$$20240904$$CN$US$US
242810031$24281003$1$I$$20240830$20240904$20240904$PER$$US-BAYER-2024A125703$BAYER$$33$YR$A$F$Y$$$20240904$$CN$US$US
242810051$24281005$1$I$20210101$20240820$20240904$20240904$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00706$GLAND PHARMA$Guo-fei Ren.Acute therapy-related myelodysplastic syndromes  following capecitabine and oxaliplatin therapy in  gastric malignant tumor.Medicine.JUL-2024;103:1-4$60$YR$A$M$Y$$$20240904$$HP$CN$CN
242810062$24281006$2$F$$20240905$20240904$20240917$5DAY$$US-ASTELLAS-2024-AER-001940$ASTELLAS$$$$$$Y$$$20240917$$MD$US$US
242810071$24281007$1$I$$20240828$20240904$20240904$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011003$STRIDES$Lu G, Jia L, Yang R, Lv Z, Cui J.. Acquired hyperfibrinolysis as the presenting sign of metastatic breast cancer: A case report.. Oncol-Lett. 2023;25 (3):13692.$52$YR$$F$Y$$$20240904$$HP$CN$CN
242810081$24281008$1$I$$20240827$20240904$20240904$PER$$US-MYLANLABS-2024M1080144$MYLAN$$$$$F$Y$$$20240904$$MD$US$US
242810091$24281009$1$I$$20240828$20240904$20240904$PER$$US-MYLANLABS-2024M1079812$MYLAN$$$$$$Y$$$20240904$$CN$US$US
242810121$24281012$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-139221-2023$RECKITT BENCKISER$$$$$F$Y$$$20240904$$CN$US$US
242810131$24281013$1$I$20240321$20240826$20240904$20240904$EXP$$IT-AUROBINDO-AUR-APL-2024-043138$AUROBINDO$$81$YR$$F$Y$$$20240904$$PH$IT$IT
242810151$24281015$1$I$20240801$20240826$20240904$20240904$EXP$$US-ORGANON-O2408USA001918$ORGANON$$$$$F$Y$$$20240904$$CN$US$US
242810161$24281016$1$I$$20240829$20240904$20240904$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP010999$STRIDES$Saxena M, Madabhavi IV, Patel A, Panchal H, Anand A.. Treating low. and intermediate-risk acute promyelocytic leukemia with and without chemotherapy: A comparison in a tertiary care center.. J-Cancer-Res-Ther. 2023;19 (5):1371-1378.$$$$$Y$$$20240904$$HP$IN$IN
242810181$24281018$1$I$$20240903$20240904$20240904$EXP$FR-BIOGARAN-B24001542$FR-SANDOZ INC.-SDZ2024FR077498$SANDOZ$$15$YR$$F$Y$$$20240904$$MD$FR$FR
242810191$24281019$1$I$$20240808$20240904$20240904$PER$$CA-TOLMAR, INC.-22CA036040$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
242810201$24281020$1$I$$20240808$20240904$20240904$PER$$CA-TOLMAR, INC.-23CA041467$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
242810211$24281021$1$I$$20240827$20240904$20240904$EXP$GB-MHRA-MED-202408271153381770-VWZMY$GB-TEVA-VS-3238000$TEVA$$55$YR$$M$Y$$$20240904$$CN$GB$GB
242810221$24281022$1$I$$20240826$20240904$20240904$EXP$$GB-AUROBINDO-AUR-APL-2024-042842$AUROBINDO$$50$YR$$M$Y$$$20240904$$PH$GB$GB
242810241$24281024$1$I$$20240903$20240904$20240904$PER$$US-HALEON-2195065$Haleon PLC$$$$$$Y$$$20240904$$CN$US$US
242810251$24281025$1$I$20240712$20240805$20240904$20240904$PER$$US-009507513-2408USA001473$MERCK$$$$$F$Y$$$20240904$$CN$US$US
242810281$24281028$1$I$$20240821$20240904$20240904$PER$$US-AstraZeneca-2024A189886$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242810291$24281029$1$I$$20240831$20240904$20240904$EXP$$CL-AstraZeneca-2024A199475$ASTRAZENECA$Fica, A; Galvez, L; et al. Infectious disease evaluations in a psychiatric unit, an observational study. Revista medica de Chile 2023;151(10):1271-1280.$$$$$Y$$$20240904$$HP$CL$
242810301$24281030$1$I$$20240903$20240904$20240904$EXP$$GB-SANDOZ INC.-SDZ2024GB077392$SANDOZ$$72$YR$$F$Y$78$KG$20240904$$HP$GB$GB
242810311$24281031$1$I$$20240827$20240904$20240904$EXP$$JP-AstraZeneca-2024A197350$ASTRAZENECA$Tanigawa T, et al.. Original Article Adverse events of PARP inhibitors in the treatment of. The Journal of the Japan Society of Gynecologic Oncology 2024;42(3):243-249.$$$A$F$Y$$$20240904$$MD$JP$
242810321$24281032$1$I$$20240827$20240904$20240904$EXP$$VN-AstraZeneca-2024A199348$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$VN$
242810331$24281033$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A195885$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242810341$24281034$1$I$20240729$20240729$20240904$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02794$AMNEAL$$$$$$Y$$$20240904$$PH$US$US
242810351$24281035$1$I$20240810$20240830$20240904$20240904$EXP$$US-BAYER-2024A126681$BAYER$$74$YR$E$F$Y$55.329$KG$20240904$$CN$US$US
242810361$24281036$1$I$$20240828$20240904$20240904$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP011102$STRIDES$Kozaci N, Aydin IE, Ersahin T, Taskiran B.. Diagnosis of Diffuse Pulmonary Hemorrhage by Ultrasonography: A Case Report.. Respir-Case-Rep. 2024;13 (2):95-99$72$YR$$M$Y$$$20240904$$HP$TR$TR
242810371$24281037$1$I$20240802$20240802$20240904$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02854$AMNEAL$$$$$M$Y$$$20240904$$PH$US$US
242810381$24281038$1$I$$20240722$20240904$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02732$AMNEAL$$$$$$Y$$$20240904$$CN$US$US
242810391$24281039$1$I$$20240826$20240904$20240904$EXP$$MY-AUROBINDO-AUR-APL-2024-043041$AUROBINDO$Tee TY, Tan YY, Husin M, Ibrahim KA, Rahman AKA, Nasir MNM, et al. Case report of chronic meningitis secondary to histoplasmosis in an immunocompromised patient. J-Neurol-Sci. 2023;455(Suppl.)77$53$YR$$M$Y$$$20240904$$HP$MY$MY
242810401$24281040$1$I$$20240827$20240904$20240904$EXP$$JP-AMGEN-JPNSP2024174366$AMGEN$Matsui T, Nagai H, Mukozu T, Wakui N, Matsuda T, Igarashi Y.. Variceal bleeding following treatment with atezolizumab plus bevacizumab in two patients with unresectable hepatocellular carcinoma. Clinical Journal of Gastroenterology.. 2024$70$YR$E$M$Y$$$20240904$$MD$JP$JP
242810411$24281041$1$I$$20240828$20240904$20240904$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011043$STRIDES$Cui J, Zhang Y, Li X, Ding Z, Kong Y, Yu Z, et al.. Antimicrobial resistance profiles and genome characteristics of Klebsiella isolated from the faeces of neonates in the neonatal intensive care unit.. J-Med-Microbiol. 2024;73 (8)$3$DY$$$Y$$$20240904$$HP$CN$CN
242810421$24281042$1$I$$20240828$20240904$20240904$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011040$STRIDES$Cui J, Zhang Y, Li X, Ding Z, Kong Y, Yu Z, et al.. Antimicrobial resistance profiles and genome characteristics of Klebsiella isolated from the faeces of neonates in the neonatal intensive care unit.. J-Med-Microbiol. 2024;73 (8)$4$DY$$$Y$$$20240904$$HP$CN$CN
242810431$24281043$1$I$20240820$20240830$20240904$20240904$EXP$$NVSC2024BE177077$NOVARTIS$$$$$F$Y$$$20240904$$MD$BE$BE
242810441$24281044$1$I$20240205$20240902$20240904$20240904$EXP$GB-MHRA-MED-202408272236429120-LYCFW$GB-STRIDES ARCOLAB LIMITED-2024SP011058$STRIDES$$19$YR$$F$Y$$$20240904$$CN$GB$GB
242810451$24281045$1$I$$20240820$20240904$20240904$EXP$$US-GLANDPHARMA-US-2024GLNLIT00707$GLAND PHARMA$Jessica Liang.Rare Case of Exogenous Vasopressin-Induced Hyponatremia.American Journal of Therapeutics.JUL-2024;31(4):e431$33$YR$A$F$Y$$$20240904$$MD$US$US
242810461$24281046$1$I$$20240826$20240904$20240904$PER$$US-MYLANLABS-2024M1079450$MYLAN$$45$YR$$M$Y$$$20240904$$CN$US$US
242810471$24281047$1$I$$20240902$20240904$20240904$EXP$$JP-SANDOZ INC.-NVSJ2019JP007928$SANDOZ$$38$YR$$F$Y$$$20240904$$MD$JP$JP
242810481$24281048$1$I$20240823$20240830$20240904$20240904$EXP$$US-BAYER-2024A126427$BAYER$$82$YR$E$F$Y$82.993$KG$20240904$$CN$US$US
242810491$24281049$1$I$$20240826$20240904$20240904$30DAY$$US-GSK-US2024106158$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$HP$US$US
242810501$24281050$1$I$20240801$20240829$20240904$20240904$30DAY$$US-GSK-US2024107920$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240904$$CN$US$US
242810511$24281051$1$I$$20240829$20240904$20240904$30DAY$$US-GSK-US2024107788$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242810521$24281052$1$I$$20240830$20240904$20240904$PER$$US-JNJFOC-20240900781$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242810534$24281053$4$F$20240523$20240913$20240904$20240920$EXP$FR-AFSSAPS-MA2024001242$FR-JNJFOC-20240906202$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240920$$MD$FR$FR
242810541$24281054$1$I$20230816$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-104407-2023$RECKITT BENCKISER$$87$YR$$F$Y$240$KG$20240904$$CN$US$US
242810551$24281055$1$I$20240801$20240829$20240904$20240904$EXP$$FR-ABBVIE-5904746$ABBVIE$$68$YR$$M$Y$$$20240904$$HP$FR$FR
242810561$24281056$1$I$$20240829$20240904$20240904$EXP$$CN-PFIZER INC-PV202400113892$PFIZER$Chen, H.. Necrotizing pneumonia secondary to Influenza A (H1N1) coinfection with Staphylococcus aureus: A case report. IDCases. 2024;37:10.1016/j.idcr.2024.e02066$39$YR$$F$Y$$$20240904$$HP$CN$CN
242810572$24281057$2$F$$20240904$20240904$20240909$EXP$$US-PFIZER INC-2004004557$PFIZER$Henrikson, C.. Calcium channel blocker overdose mimicking an acute myocardial infarction. Resuscitation. 2003;59 (3):361 - 364$42$YR$$M$Y$$$20240909$$MD$US$US
242810583$24281058$3$F$20231201$20240906$20240904$20240911$EXP$$JP-PFIZER INC-202400248627$PFIZER$Inoue, J.. Three consecutive cases of acute liver failure in young women due to acetaminophen overdose: insights into Japanese social issues and transplantation landscape. Clinical journal of gastroenterology. 2024;10.1007/s12328-024-02024-8.$19$YR$$F$Y$41$KG$20240911$$MD$JP$JP
242810592$24281059$2$F$20220101$20240911$20240904$20240912$EXP$$CN-PFIZER INC-202400245450$PFIZER$Wang, H.. Contezolid for the Treatment of Drug-Resistant Tuberculosis in China: A Clinical Case Series.. Infection and drug resistance. 2024;17:3491-3499$44$YR$$F$Y$$$20240912$$MD$CN$CN
242810601$24281060$1$I$$20240830$20240904$20240904$EXP$$US-PFIZER INC-PV202400114843$PFIZER$Pershadsingh, A.. Association of diltiazem therapy with increased insulin resistance in a patient with type I diabetes mellitus. JAMA : The Journal of the American Medical Association. 1987;257(7):930-931$38$YR$$F$Y$$$20240904$$MD$US$US
242810613$24281061$3$F$$20240905$20240904$20240910$EXP$$JP-PFIZER INC-202400248269$PFIZER$Nitta, Y.. Pelvic inflammatory disease associated with cytomegalovirus infection in an immunocompetent adult: Case report and literature review. Clinical Case Reports. 2024;12:10.1002/ccr3.9323$43$YR$$F$Y$$$20240910$$HP$JP$JP
242810621$24281062$1$I$20170101$20240828$20240904$20240904$EXP$$US-TAKEDA-2017BLT002939$TAKEDA$$$$$F$Y$$$20240904$$CN$US$US
242810631$24281063$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-085672-2024$RECKITT BENCKISER$$$$$F$Y$$$20240904$$CN$US$US
242810641$24281064$1$I$$20240830$20240904$20240904$EXP$$JP-AMGEN-JPNSP2024174971$AMGEN$$$$E$$Y$$$20240904$$MD$JP$JP
242810661$24281066$1$I$20240101$20240829$20240904$20240904$EXP$$FR-ABBVIE-5904647$ABBVIE$$73$YR$$M$Y$$$20240904$$HP$FR$FR
242810671$24281067$1$I$$20240829$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139643$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240904$$CN$US$US
242810681$24281068$1$I$20240801$20240826$20240904$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-026789$UNITED THERAPEUTICS$$53$YR$$F$Y$73.923$KG$20240904$$$US$US
242810691$24281069$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140641$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240904$$CN$US$US
242810731$24281073$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140412$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240904$$PH$US$US
242810741$24281074$1$I$$20240820$20240904$20240904$EXP$$DE-GLANDPHARMA-DE-2024GLNLIT00717$GLAND PHARMA$E Bienenstein.Acute Yew-Intoxication (Taxus baccata): Lessons to Be Learned for Pediatric Cardiologists.Thoracic and Cardiovascular Surgeon.13-FEB-2024;72(S02):S69-S96$16$YR$T$M$Y$$$20240904$$HP$DE$DE
242810751$24281075$1$I$20240401$20240828$20240904$20240904$EXP$$US-OTSUKA-2024_023894$OTSUKA$$$$$F$Y$$$20240904$$CN$US$US
242810761$24281076$1$I$$20240828$20240904$20240904$EXP$GB-MHRA-MIDB-2edbb7a0-83ef-468e-81ea-b57d1bb5355d$GB-ASPEN-GLO2024GB005939$ASPEN$$$$$$Y$$$20240904$$PH$GB$GB
242810771$24281077$1$I$20240703$20240826$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-043098$AUROBINDO$$66$YR$$F$Y$$$20240904$$CN$FR$FR
242810781$24281078$1$I$$20240823$20240904$20240904$EXP$$GR-Accord-443695$ACCORD$A350 Kofopoulos Lymperis E. et al., Rare Complication of Gastrointestinal Anastomotic Leak Following Chemotherapy, 33rd Panhellenic Surgical Congress +amp; International Surgical Forum, 11-15 November 2023, Athens, Greece p.470.$67$YR$E$F$Y$$$20240904$$MD$GR$GR
242810791$24281079$1$I$20240824$20240830$20240904$20240904$EXP$$US-AMGEN-USASP2024174816$AMGEN$$80$YR$E$F$Y$$$20240904$$CN$US$US
242810801$24281080$1$I$20240101$20240830$20240904$20240904$EXP$$US-AMGEN-USASP2024174189$AMGEN$$64$YR$A$F$Y$$$20240904$$HP$US$US
242810811$24281081$1$I$20180101$20240811$20240904$20240904$PER$$US-AMGEN-USASP2024164872$AMGEN$Fei, F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$M$Y$$$20240904$$MD$US$US
242810823$24281082$3$F$20240702$20240924$20240904$20240927$EXP$$KR-MYLANLABS-2024M1062273$MYLAN$$47$YR$$M$Y$$$20240927$$MD$KR$KR
242810832$24281083$2$F$20240101$20240906$20240904$20240920$EXP$$CA-UCBSA-2024043687$UCB$$$$$F$Y$$$20240920$$CN$CA$CA
242810851$24281085$1$I$20180201$20240903$20240904$20240904$EXP$FR-NOVPHSZ-PHHY2018FR073235$FR-SANDOZ INC.-PHHY2018FR073235$SANDOZ$$70$YR$$F$Y$$$20240904$$PH$FR$FR
242810861$24281086$1$I$20240825$20240828$20240904$20240904$EXP$$CN-ROCHE-10000068680$ROCHE$$37$YR$A$M$Y$52$KG$20240904$$HP$CN$CN
242810872$24281087$2$F$20240814$20240906$20240904$20240918$EXP$GB-MHRA-MED-202408240949589110-FRWHK$GB-Accord-443472$ACCORD$$55$DY$I$M$Y$89$KG$20240918$$CN$GB$GB
242810881$24281088$1$I$$20240823$20240904$20240904$EXP$GB-MHRA-MED-202408231918201240-SFTWV$GB-Accord-443266$ACCORD$$4$YR$C$F$Y$16$KG$20240904$$CN$GB$GB
242810891$24281089$1$I$$20240823$20240904$20240904$EXP$$US-Accord-443611$ACCORD$$24$YR$A$F$Y$$$20240904$$HP$US$US
242810901$24281090$1$I$20230610$20240823$20240904$20240904$EXP$GB-MHRA-MED-202408231545490490-FCLQJ$GB-Accord-443279$ACCORD$$70$YR$E$F$Y$$$20240904$$CN$GB$GB
242810911$24281091$1$I$$20240826$20240904$20240904$EXP$$PT-Accord-444754$ACCORD$Costa A, Faustino C, Correia F, Chaves V, Almeida J. PO-0184 - (2479) - HEMOPHAGOCYTIC SYNDROME - WHEN TO THINK ABOUT THIS ENTITY? ABOUT A CLINICAL CASE. 30 CNMI Oncological diseases. Clinical case.$50$YR$A$F$Y$$$20240904$$HP$PT$PT
242810921$24281092$1$I$20210101$20240823$20240904$20240904$EXP$$ES-Accord-443380$ACCORD$Garrido-Marin M, Kirkegaard Biosca E, Boixadera A, Fischer Fernandez R, Sanchez Vela L, Pardo Aranda A, et al. Multiresistant Candida Endophthalmitis Treated with Intravitreal Caspofungin: A Case Report. Ocular Immunology and Inflammation. 2024;32(6):858-62.$24$YR$A$M$Y$$$20240904$$MD$ES$ES
242810931$24281093$1$I$$20240823$20240904$20240904$EXP$$US-Accord-443619$ACCORD$$82$YR$E$F$Y$$$20240904$$HP$US$US
242810941$24281094$1$I$20240820$20240823$20240904$20240904$EXP$$US-Accord-443781$ACCORD$$57$YR$A$M$Y$$$20240904$$HP$US$US
242810961$24281096$1$I$20240101$20240828$20240904$20240904$PER$$US-UNITED THERAPEUTICS-UNT-2024-014852$UNITED THERAPEUTICS$$$$$F$Y$92.063$KG$20240904$$$US$US
242810971$24281097$1$I$20240819$20240826$20240904$20240904$EXP$$TR-PERRIGO-24TR007890$PERRIGO$$$$$F$Y$$$20240904$$CN$TR$TR
242810981$24281098$1$I$$20240830$20240904$20240904$EXP$$JP-GSK-JP2024109022$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$JP$JP
242810993$24281099$3$F$20240601$20240925$20240904$20240930$EXP$FR-AFSSAPS-SE2024000680$FR-JNJFOC-20240906256$JOHNSON AND JOHNSON$$88$YR$E$M$Y$74$KG$20240930$$MD$FR$FR
242811011$24281101$1$I$20240501$20240829$20240904$20240904$PER$$US-JNJFOC-20240900659$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240904$$CN$US$US
242811021$24281102$1$I$$20240823$20240904$20240904$EXP$$US-UCBSA-2024044042$UCB$$$$$$Y$$$20240904$$CN$US$US
242811031$24281103$1$I$$20240830$20240904$20240904$EXP$$GB-AstraZeneca-2024A199878$ASTRAZENECA$$$$$F$Y$$$20240904$$HP$GB$
242811041$24281104$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A196485$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242811051$24281105$1$I$20240814$20240823$20240904$20240904$PER$$US-MYLANLABS-2024M1078837$MYLAN$$56$YR$$F$Y$72.57$KG$20240904$$CN$US$US
242811061$24281106$1$I$20240805$20240902$20240904$20240904$EXP$$CN-BAYER-2024A126063$BAYER$$40$YR$A$F$Y$54$KG$20240904$$HP$CN$CN
242811071$24281107$1$I$20180101$20240811$20240904$20240904$PER$$US-AMGEN-USASP2024164870$AMGEN$Fei F. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$M$Y$$$20240904$$MD$US$US
242811082$24281108$2$F$$20240919$20240904$20240927$EXP$$FR-AMGEN-FRASP2024176141$AMGEN$$$$A$M$Y$$$20240927$$PH$FR$FR
242811091$24281109$1$I$$20240828$20240904$20240904$EXP$$IT-MYLANLABS-2024M1080732$MYLAN$Castelli B, Fonte C, Guidi M, Di Nicola M, Giunti L, Buccoliero AM, et al. Roles of gemcitabine-oxaliplatin (gemox) add-on therapy in infant-type brain tumors: a single center experience. Neuro-Oncol 2024; 26 (Suppl.) iv194.$$$I$$Y$$$20240904$$HP$IT$IT
242811102$24281110$2$F$$20240828$20240904$20240906$EXP$$VN-MYLANLABS-2024M1077921$MYLAN$Nguyen, TH., Tran, MD., Dang, TH., Nguyen, HN.. Medium-term progress of pulmonary hypertension in bronchopulmonary dysplasia. Journal of Medical Research. 2024;179 (6):10-18$$$I$$Y$$$20240906$$MD$VN$VN
242811112$24281111$2$F$20030101$20240828$20240904$20240911$EXP$FR-AFSSAPS-AVLY2024000167$FR-MYLANLABS-2024M1079609$MYLAN$$55$YR$$M$Y$80$KG$20240911$$MD$FR$FR
242811131$24281113$1$I$$20240828$20240904$20240904$EXP$$US-MYLANLABS-2024M1080527$MYLAN$Meyer AS, Cluster A, Ogle A, Brossier N, Beck M, Lampe A, et al. NOVEL TREATMENTS FOR ACNEIFORM ERUPTIONS CAUSED BY TARGETED THERAPIES IN THE PEDIATRIC POPULATION. Neuro-Oncol 2024; 26 (Suppl.) iv186-iv187.$$$T$F$Y$$$20240904$$HP$US$US
242811141$24281114$1$I$$20240828$20240904$20240904$EXP$$EG-MYLANLABS-2024M1080715$MYLAN$Ismail H-A. Rabies vaccine induced microangiopathy. Atherosclerosis 2024; 395 (Suppl. 1).$10$YR$$M$Y$$$20240904$$HP$EG$EG
242811151$24281115$1$I$20240901$20240901$20240904$20240904$EXP$$IL-GILEAD-2024-0685929$GILEAD$$$$$F$Y$$$20240904$$MD$IL$IL
242811161$24281116$1$I$20180801$20240828$20240904$20240904$EXP$$US-ABBVIE-5720409$ABBVIE$$49$YR$$F$Y$$$20240904$$CN$US$US
242811171$24281117$1$I$$20240827$20240904$20240904$EXP$$US-SANDOZ INC.-SDZ2024US076022$SANDOZ$$$$E$F$Y$$$20240904$$HP$US$US
242811181$24281118$1$I$20240723$20240830$20240904$20240904$PER$$US-JNJFOC-20240881695$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242811201$24281120$1$I$$20240826$20240904$20240904$30DAY$$US-GSK-US2024106125$GLAXOSMITHKLINE$$$$$M$Y$$$20240904$$CN$US$US
242811213$24281121$3$F$$20240904$20240904$20240911$EXP$$CN-ROCHE-10000070324$ROCHE$$50$YR$A$F$Y$$$20240911$$CN$CN$CN
242811221$24281122$1$I$20240301$20240903$20240904$20240904$EXP$$US-BAUSCH-BL-2024-013218$BAUSCH AND LOMB$$58$YR$$M$Y$$$20240904$$HP$US$US
242811231$24281123$1$I$20240828$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024174595$AMGEN$$$$$$Y$$$20240904$$HP$US$US
242811251$24281125$1$I$20240814$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024173432$AMGEN$$76$YR$E$F$Y$$$20240904$$CN$US$US
242811261$24281126$1$I$$20240903$20240904$20240904$PER$$US-HALEON-2195060$Haleon PLC$$$$$$Y$$$20240904$$CN$US$US
242811271$24281127$1$I$$20240807$20240904$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02436$AMNEAL$$$$$F$Y$$$20240904$$PH$US$US
242811281$24281128$1$I$20240803$20240813$20240904$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03021$AMNEAL$$81$YR$$F$Y$$$20240904$$PH$US$US
242811291$24281129$1$I$20240819$20240820$20240904$20240904$EXP$$US-PROCTER+GAMBLE-PH24006672$PROCTER AND GAMBLE$$17$YR$$F$Y$$$20240904$$CN$US$US
242811302$24281130$2$F$20220129$20240904$20240904$20240918$EXP$$DE-AUROBINDO-AUR-APL-2022-004284$AUROBINDO$$80$YR$$F$Y$60$KG$20240918$$MD$DE$DE
242811312$24281131$2$F$20160101$20240902$20240904$20240904$PER$$US-JNJFOC-20240880818$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240904$$HP$US$US
242811321$24281132$1$I$$20240828$20240904$20240904$PER$$US-ABBVIE-5902202$ABBVIE$$$$$$Y$$$20240904$$MD$US$US
242811332$24281133$2$F$20240826$20240905$20240904$20240912$PER$$EC-REGENERON PHARMACEUTICALS, INC.-2024-118334$REGENERON$$$$$F$Y$$$20240912$$CN$EC$EC
242811341$24281134$1$I$$20240814$20240904$20240904$PER$$US-ASTELLAS-2024-AER-001751$ASTELLAS$$$$$F$Y$$$20240904$$HP$US$US
242811351$24281135$1$I$$20240827$20240904$20240904$EXP$$FR-MYLANLABS-2024M1080401$MYLAN$Baudriller A, Abbara C, Briet M, Jousset N, Malbranque S, Zabet D, et al. Deaths related to pharmacobezoars: A report on two cases. Toxic-Analyt-Clinique 2024;.$55$YR$$F$Y$$$20240904$$HP$FR$FR
242811361$24281136$1$I$$20240827$20240904$20240904$EXP$$US-MYLANLABS-2024M1080447$MYLAN$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood-Can-J 2023; 13 (1):.$$$$$Y$$$20240904$$HP$US$US
242811371$24281137$1$I$$20240827$20240904$20240904$EXP$$US-MYLANLABS-2024M1080031$MYLAN$Bains S, Garmany R, Neves R, Giudicessi JR, Gao X, Tester DJ, et al. Temporal Association Between Vaping and Risk of Cardiac Events. Mayo-Clin-Proc 2024; 99 (2): 241-248.$26$YR$$M$Y$$$20240904$$MD$US$US
242811381$24281138$1$I$$20240829$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138703$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$PH$US$US
242811391$24281139$1$I$$20240827$20240904$20240904$EXP$$US-MYLANLABS-2024M1080370$MYLAN$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood-Can-J 2023; 13 (1):.$$$$$Y$$$20240904$$HP$US$US
242811401$24281140$1$I$$20240827$20240904$20240904$EXP$$PL-MYLANLABS-2024M1080515$MYLAN$Wozna J, Korecka K, Stepka J, Baloniak A, Zaba R, Schwartz RA. Acne fulminans treatment: case report and literature review. Front-Med 2024; 11 (0):.$14$YR$$M$Y$$$20240904$$HP$PL$PL
242811421$24281142$1$I$20240830$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140250$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$106.14$KG$20240904$$HP$US$US
242811431$24281143$1$I$$20240827$20240904$20240904$EXP$$US-MYLANLABS-2024M1080029$MYLAN$Mukherji S, Shoaib H, Jimenez X. Brief case report: A case of FOLFIRI-Induced psychosis. Psycho-Oncology 2023; 32 (10): 1625-1627.$72$YR$$M$Y$$$20240904$$HP$US$US
242811441$24281144$1$I$$20240827$20240904$20240904$PER$$US-ROCHE-10000067791$ROCHE$$$$$M$Y$51.6$KG$20240904$$MD$US$US
242811451$24281145$1$I$20240624$20240826$20240904$20240904$EXP$$GB-AUROBINDO-AUR-APL-2024-042839$AUROBINDO$$76$YR$$F$Y$$$20240904$$CN$GB$GB
242811461$24281146$1$I$20240702$20240825$20240904$20240904$EXP$$CN-009507513-2408CHN009734$MERCK$$90$YR$$F$Y$39$KG$20240904$$HP$CN$CN
242811481$24281148$1$I$$20240828$20240904$20240904$EXP$$US-GSK-US2024107261$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$US$US
242811511$24281151$1$I$$20240903$20240904$20240904$PER$$US-JNJFOC-20240905869$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$CN$US$US
242811521$24281152$1$I$$20240826$20240904$20240904$EXP$$PT-AUROBINDO-AUR-APL-2024-037308$AUROBINDO$Valente TC, Tenreiro P, Figueiredo S R, Fialho P, Coelho S, Barradas J. IMI-187 - (4449) - A CASE OF IMATINIB TOXIDERMIA (IMI-187 - (4449) - UM CASO DE TOXIDERMIA AO). Doen?as hematol?gicas (Hematological diseases). 1470$76$YR$$F$Y$$$20240904$$MD$PT$PT
242811532$24281153$2$F$20240816$20240905$20240904$20240913$EXP$$PY-TEVA-VS-3235357$TEVA$$41$YR$$F$Y$71$KG$20240913$$CN$PY$PY
242811541$24281154$1$I$$20240830$20240904$20240904$EXP$$US-MYLANLABS-2023M1098510$MYLAN$$$$$F$Y$56.24$KG$20240904$$CN$US$US
242811554$24281155$4$F$20240101$20240917$20240904$20240920$EXP$$AU-MYLANLABS-2024M1079262$MYLAN$$$$$M$Y$$$20240920$$HP$AU$AU
242811562$24281156$2$F$$20240903$20240904$20240905$EXP$$CN-PFIZER INC-202400248844$PFIZER$Xie, L.. A Case Report of a Rare Pulmonary Opportunistic Infection in an Infant Caused by Tsukamurella tyrosinosolvens.. International Medical Case Reports Journal. 2024;17:725-731$2$MON$$F$Y$$$20240905$$MD$CN$CN
242811572$24281157$2$F$$20240902$20240904$20240909$EXP$$TR-PFIZER INC-PV202400113998$PFIZER$Yilmazoglu, M.. LAMOTRIGINE-ASSOCIATED TOXIC EPIDERMAL NECROLYSIS: A CASE REPORT. European Journal of Case Reports in Internal Medicine. 2024;11(Supple 1):864-865$31$YR$$M$Y$$$20240909$$HP$TR$TR
242811581$24281158$1$I$$20240830$20240904$20240904$EXP$$US-PFIZER INC-PV202400115331$PFIZER$D^netto, M.. ALPS like: Trekking Sirolimus and its Fallouts. Clinical Immunology. 2023;250(Supplement):116-117$3$YR$$M$Y$$$20240904$$HP$US$US
242811591$24281159$1$I$$20240830$20240904$20240904$EXP$$TR-PFIZER INC-PV202400115040$PFIZER$Sagcan, B.. AN UNCOMMON CASE OF RITUXIMAB INDUCED BICYTOPENIA. European Journal of Case Reports in Internal Medicine. 2024;11(Suppl 1):1078$72$YR$$M$Y$$$20240904$$HP$TR$TR
242811602$24281160$2$F$$20240903$20240904$20240905$EXP$$CA-PFIZER INC-202400248274$PFIZER$Veettil, S.. Takotsubo Cardiomyopathy After Oxaliplatin Chemotherapy Exposure: A Case Report. CJC Open. 2024;1-4$69$YR$$F$Y$$$20240905$$MD$CA$CA
242811611$24281161$1$I$$20240830$20240904$20240904$EXP$$JP-GSK-JP2024108991$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$JP$JP
242811621$24281162$1$I$$20240826$20240904$20240904$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006351$BIOCON$$$$$$Y$$$20240904$$HP$CA$CA
242811632$24281163$2$F$$20240903$20240904$20240905$EXP$$CA-PFIZER INC-PV202400115141$PFIZER$Gilbert-Falardeau, A.. Remission of necrobiotic xanthogranuloma after intravenous immunoglobulin interruption: A case report. SAGE Open Medical Case Reports. 2024;12:1-3$92$YR$$F$Y$$$20240905$$HP$CA$CA
242811642$24281164$2$F$$20240830$20240904$20240906$EXP$$GB-ORGANON-O2409GBR000086$ORGANON$Unknown. Unknown. Unknown$50$YR$$F$Y$$$20240906$$HP$GB$GB
242811652$24281165$2$F$$20240906$20240904$20240916$EXP$$US-TEVA-VS-3238230$TEVA$Alicea DS, Santana Felipes R, McLellan BN. Management of refractory pruritus in Alagille syndrome with dupilumab treatment: A case report. JAAD-Case-Rep 2024; 51 63-65; Alicea DS, Santana Felipes R, McLellan BN. Management of refractory pruritus in Alagille syndrome with dupilumab treatment: A case report. JAAD-Case-Rep 2024; 51 63-65.; Alicea DS, Santana Felipes R, McLellan BN. Management of refractory pruritus in Alagille syndrome with dupilumab treatment: A case report. JAAD-Case-Rep 2024;...$45$YR$$F$Y$$$20240916$$HP$US$US
242811661$24281166$1$I$$20240829$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139600$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240904$$CN$US$US
242811672$24281167$2$F$$20240829$20240904$20240909$EXP$$CA-ROCHE-10000066310$ROCHE$$$$E$F$Y$$$20240909$$CN$CA$CA
242811681$24281168$1$I$$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024175129$AMGEN$$$$$$Y$$$20240904$$PH$US$US
242811691$24281169$1$I$$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024175808$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242811701$24281170$1$I$20180101$20240811$20240904$20240904$PER$$US-AMGEN-USASP2024164871$AMGEN$Fei, F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$M$Y$$$20240904$$MD$US$US
242811711$24281171$1$I$20240601$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024173545$AMGEN$$64$YR$A$M$Y$$$20240904$$CN$US$US
242811721$24281172$1$I$$20240826$20240904$20240904$PER$$US-ABBVIE-5896535$ABBVIE$$$$$F$Y$$$20240904$$HP$US$US
242811733$24281173$3$F$20240101$20240830$20240904$20240909$EXP$$CA-CELLTRION INC.-2024CA011102$CELLTRION$$$$$$Y$$$20240909$$CN$CA$CA
242811741$24281174$1$I$$20240827$20240904$20240904$EXP$$CA-APOTEX-2024AP010040$APOTEX$$69$YR$$F$Y$61$KG$20240904$$MD$CA$CA
242811751$24281175$1$I$20240101$20240829$20240904$20240904$PER$$US-ABBVIE-5901764$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242811761$24281176$1$I$$20240827$20240904$20240904$EXP$$JP-AstraZeneca-2024A129713$ASTRAZENECA$$59$YR$$M$Y$$$20240904$$MD$JP$
242811771$24281177$1$I$$20240828$20240904$20240904$30DAY$$US-GSK-US2024107312$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242811781$24281178$1$I$20180101$20240811$20240904$20240904$PER$$US-AMGEN-USASP2024164874$AMGEN$Fei. F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$M$Y$$$20240904$$MD$US$US
242811791$24281179$1$I$$20240830$20240904$20240904$EXP$$US-HORIZON THERAPEUTICS-HZN-2024-000667$AMGEN$$52$YR$A$F$Y$$$20240904$$CN$US$US
242811801$24281180$1$I$$20240816$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000098$ELI LILLY AND CO$$$$I$$Y$$$20240904$$CN$US$US
242811811$24281181$1$I$$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001332$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240904$$CN$US$US
242811821$24281182$1$I$20240814$20240815$20240904$20240904$PER$$US-ASTELLAS-2024-AER-001736$ASTELLAS$$61$YR$A$F$Y$$$20240904$$CN$US$US
242811851$24281185$1$I$$20240731$20240830$20240830$DIR$FDA-CDER-CTU-2024-60000$$FDA-CTU$$$$$$N$$$20240731$N$PH$US$
242811861$24281186$1$I$$20240903$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049315$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240904$$CN$US$US
242811881$24281188$1$I$$20240822$20240904$20240904$EXP$$US-AUROBINDO-AUR-APL-2024-042336$AUROBINDO$Justin O, Attieh RM, Roach D, Wadei HM, Parikh N, Me HM, et al.. Case Report: Early-Onset Adenovirus Nephritis Without Hemorrhagic Cystitis Following Kidney Transplantation. Transplantation Proceedings. 2024;56(5):1196-9$35$YR$$M$Y$$$20240904$$MD$US$US
242811891$24281189$1$I$20240821$20240829$20240904$20240904$EXP$$US-ABBVIE-5902090$ABBVIE$$65$YR$$M$Y$$$20240904$$CN$US$US
242811902$24281190$2$F$20230101$20240830$20240904$20240916$EXP$$CO-UCBSA-2024044952$UCB$$$$$F$Y$$$20240916$$CN$CO$CO
242811912$24281191$2$F$20240824$20240910$20240904$20240919$EXP$$IE-TAKEDA-2024TUS087403$TAKEDA$$80$YR$$M$Y$$$20240919$$HP$IE$IE
242811921$24281192$1$I$$20240822$20240904$20240904$EXP$$FR-AUROBINDO-AUR-APL-2024-042860$AUROBINDO$Castagna J, Amsler E, Kurihara F, Chasset F, Barbaud A, Soria A. Atypical features of cutaneous adverse drug reactions during therapy for hairy cell leukemia. J-Allergy-Clin-Immunol-Pract. 2020;8(9):3203-3206$$$$$Y$$$20240904$$HP$FR$FR
242811931$24281193$1$I$$20240828$20240904$20240904$EXP$$CA-ROCHE-10000071017$ROCHE$$$$A$M$Y$$$20240904$$MD$CA$CA
242811942$24281194$2$F$20240101$20240823$20240904$20240904$PER$$US-ROCHE-10000066033$ROCHE$$74$YR$E$F$Y$53.52$KG$20240904$$CN$US$US
242811951$24281195$1$I$$20240902$20240904$20240904$EXP$$JP-JNJFOC-20240906558$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240904$$MD$JP$JP
242811961$24281196$1$I$$20240822$20240904$20240904$EXP$$CA-AUROBINDO-AUR-APL-2023-081525$AUROBINDO$Hohl CM, Badke K, Zhao A, Wickham ME, Woo SA, Sivilotti MLA et al.. CME Information: Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug Events. Acad Emerg Med.. 2018;25:1015-1027$90$YR$$M$Y$$$20240904$$MD$CA$CA
242811971$24281197$1$I$20240801$20240903$20240904$20240904$EXP$$NVSC2024IE177213$NOVARTIS$$$$$F$Y$$$20240904$$HP$IE$IE
242811981$24281198$1$I$$20240822$20240904$20240904$EXP$$CA-AUROBINDO-AUR-APL-2023-081530$AUROBINDO$Hohl CM, Badke K, Zhao A, Wickham ME, Woo SA, Sivilotti MLA et al.. CME Information: Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug Events.. Acad Emerg Med.. 2018;25:1015-1027$84$YR$$M$Y$$$20240904$$MD$CA$CA
242811991$24281199$1$I$$20240826$20240904$20240904$PER$$US-ABBVIE-5896002$ABBVIE$$$$$$Y$$$20240904$$CN$US$US
242812001$24281200$1$I$20240701$20240822$20240904$20240904$EXP$$CN-AUROBINDO-AUR-APL-2024-042728$AUROBINDO$$33$YR$$F$Y$$$20240904$$HP$CN$CN
242812011$24281201$1$I$20240814$20240831$20240904$20240904$EXP$$CN-ABBVIE-5904002$ABBVIE$$69$YR$$M$Y$80$KG$20240904$$MD$CN$CN
242812041$24281204$1$I$$20231025$20240904$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03815$AMNEAL$$45$YR$$F$Y$$$20240904$$CN$US$US
242812051$24281205$1$I$20230701$20231122$20240904$20240904$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04080$AMNEAL$$$$$F$Y$$$20240904$$MD$US$US
242812061$24281206$1$I$$20240828$20240904$20240904$EXP$$US-TAKEDA-2024TUS087387$TAKEDA$$$$$M$Y$$$20240904$$CN$US$US
242812071$24281207$1$I$$20240822$20240904$20240904$EXP$$CA-AUROBINDO-AUR-APL-2023-081542$AUROBINDO$Hohl CM, Badke K, Zhao A, Wickham ME, Woo SA, Sivilotti MLA et al.. CME Information: Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug Events.. Academic Emergency Medicine. 2018;25(9):1015-1027$75$YR$$F$Y$$$20240904$$MD$CA$CA
242812081$24281208$1$I$$20240822$20240904$20240904$EXP$$US-AUROBINDO-AUR-APL-2024-042346$AUROBINDO$Hui J, Zhan X, Bashir A, Policeni F, Kim Hsieh SU. Epithelial-myoepithelial carcinoma occurrence in the site of previously treated ductal carcinoma in situ of the breast: Imaging features with histopathologic correlation, a case report and review of the literature. Clinical Case Reports. 2024;12(8):e9270$75$YR$$F$Y$$$20240904$$MD$US$US
242812091$24281209$1$I$20240801$20240826$20240904$20240904$EXP$$CO-ABBVIE-5905218$ABBVIE$$65$YR$$F$Y$56$KG$20240904$$HP$CO$CO
242812101$24281210$1$I$20240811$20240828$20240904$20240904$EXP$$CA-TAKEDA-2024TUS088323$TAKEDA$$0$YR$$$Y$$$20240904$$CN$CA$CA
242812111$24281211$1$I$$20240822$20240904$20240904$EXP$$US-AUROBINDO-AUR-APL-2024-042605$AUROBINDO$Kim SH, Erikson A, Lantz J. PNEUMOCYSTIS JIROVECIPNEUMONIA IN A PATIENT WITH SARCOIDOSIS ON CHRONIC STEROIDS. J-Gen-Intern-Med. 2022;37 (Suppl. 2):S501-S502$75$YR$$M$Y$$$20240904$$HP$US$US
242812121$24281212$1$I$$20240826$20240904$20240904$PER$$US-JNJFOC-20240880664$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$LW$US$US
242812131$24281213$1$I$20240824$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024174802$AMGEN$$$$$M$Y$$$20240904$$CN$US$US
242812141$24281214$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140375$BRISTOL MYERS SQUIBB$$63$YR$A$$Y$$$20240904$$CN$US$US
242812151$24281215$1$I$$20240814$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130282$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240904$$PH$US$US
242812161$24281216$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140430$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240904$$HP$US$US
242812171$24281217$1$I$20240320$20240829$20240904$20240904$EXP$$AU-ROCHE-10000069821$ROCHE$$47$YR$A$M$Y$$$20240904$$MD$AU$AU
242812181$24281218$1$I$$20240831$20240904$20240904$EXP$$US-GSK-US2024AMR108827$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$US$US
242812192$24281219$2$F$20240901$20240904$20240904$20240906$PER$$US-AMGEN-USASP2024175518$AMGEN$$65$YR$E$F$Y$$$20240906$$CN$US$US
242812211$24281221$1$I$20240827$20240830$20240830$20240830$DIR$716686$$FDA-CTU$$34$YR$$F$N$96.2$KG$20240830$N$HP$US$
242812221$24281222$1$I$$20240731$20240830$20240830$DIR$FDA-CDER-CTU-2024-60007$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242812231$24281223$1$I$$20240731$20240830$20240830$DIR$FDA-CDER-CTU-2024-60006$$FDA-CTU$$$$$$N$$$20240731$N$PH$US$
242812251$24281225$1$I$20240706$20240830$20240830$20240830$DIR$716607$$FDA-CTU$$81$YR$$F$N$57.6$KG$20240830$Y$HP$US$
242812281$24281228$1$I$$20240826$20240904$20240904$PER$$US-MYLANLABS-2024M1079130$MYLAN$$$$$F$Y$$$20240904$$CN$US$US
242812291$24281229$1$I$20240713$20240828$20240904$20240904$EXP$$US-009507513-2408USA010183$MERCK$$49$YR$$F$Y$$$20240904$$CN$US$US
242812301$24281230$1$I$20240807$20240827$20240904$20240904$EXP$GB-MHRA-MED-202408261731134380-MGSZV$GB-TEVA-VS-3237799$TEVA$$63$YR$$F$Y$100$KG$20240904$$CN$GB$GB
242812311$24281231$1$I$$20240221$20240904$20240904$PER$$US-AMERICAN REGENT INC-2024000645$AMERICAN REGENT$$$$$F$Y$$$20240904$$HP$US$US
242812321$24281232$1$I$20240825$20240825$20240904$20240904$PER$$US-JNJFOC-20240869037$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242812341$24281234$1$I$20240823$20240830$20240830$20240830$DIR$716613$$FDA-CTU$$68$YR$$F$N$54$KG$20240830$N$CN$US$
242812351$24281235$1$I$20240618$20240830$20240904$20240904$EXP$$CO-UCBSA-2024044928$UCB$$11$YR$$F$Y$$$20240904$$CN$CO$CO
242812361$24281236$1$I$20210329$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A195861$ASTRAZENECA$$2603$WK$$M$Y$$$20240904$$MD$US$
242812371$24281237$1$I$$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A200522$ASTRAZENECA$$$$$M$Y$$$20240904$$HP$US$
242812381$24281238$1$I$$20240731$20240830$20240830$DIR$FDA-CDER-CTU-2024-60009$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242812391$24281239$1$I$$20240820$20240904$20240904$EXP$$US-GLANDPHARMA-US-2024GLNLIT00720$GLAND PHARMA$W Harmouch.A challenging case of eosinophilic myocarditis leading to heart failure and transplantation.Cardiovascular Pathology.2024;72$$$$M$Y$$$20240904$$HP$US$US
242812402$24281240$2$F$20240827$20240906$20240904$20240913$EXP$$CA-AstraZeneca-2024A195696$ASTRAZENECA$$26288$DY$$F$Y$$$20240913$$HP$CA$
242812411$24281241$1$I$20240209$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-086584-2024$RECKITT BENCKISER$$80$YR$$F$Y$68.18$KG$20240904$$CN$US$US
242812421$24281242$1$I$$20240829$20240904$20240904$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR108837$VIIV$$$$$$Y$$$20240904$$HP$US$US
242812431$24281243$1$I$$20240827$20240904$20240904$EXP$GB-MHRA-MIDB-33d8498e-bc1d-4bf7-8719-cb9d03fc557a$GB-TEVA-VS-3238099$TEVA$$91$YR$$F$Y$$$20240904$$PH$GB$GB
242812441$24281244$1$I$$20240822$20240904$20240904$EXP$$CA-APOTEX-2024AP009712$APOTEX$$86$YR$$M$Y$70$KG$20240904$$PH$CA$CA
242812452$24281245$2$F$20240831$20240909$20240904$20240913$EXP$$GB-MYLANLABS-2024M1080691$MYLAN$$$$$M$Y$$$20240913$$HP$GB$GB
242812461$24281246$1$I$$20240902$20240904$20240904$EXP$$GB-MYLANLABS-2024M1080860$MYLAN$$48$YR$$M$Y$105$KG$20240904$$HP$GB$GB
242812471$24281247$1$I$$20240903$20240904$20240904$EXP$$NVSC2024IL177532$NOVARTIS$$46$YR$$M$Y$$$20240904$$PH$IL$IL
242812481$24281248$1$I$20220801$20240903$20240904$20240904$EXP$$US-UCBSA-2022056237$UCB$$63$YR$$M$Y$$$20240904$$CN$US$US
242812501$24281250$1$I$20040101$20240829$20240904$20240904$PER$$SG-BRACCO-2024SG05368$BRACCO$$$$$F$Y$$$20240904$$HP$SG$SG
242812511$24281251$1$I$$20240829$20240904$20240904$EXP$$GB-MYLANLABS-2024M1079992$MYLAN$$$$$F$Y$$$20240904$$MD$GB$GB
242812521$24281252$1$I$$20240829$20240904$20240904$EXP$$PT-MYLANLABS-2024M1049331$MYLAN$$46$YR$$F$Y$55$KG$20240904$$PH$PT$PT
242812531$24281253$1$I$$20240829$20240904$20240904$EXP$$NO-MYLANLABS-2024M1079787$MYLAN$$26$YR$$M$Y$$$20240904$$MD$NO$NO
242812541$24281254$1$I$20240804$20240827$20240904$20240904$EXP$$CA-CELLTRION INC.-2024CA020961$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
242812551$24281255$1$I$20240825$20240827$20240904$20240904$EXP$CN-NMPACDR-4103231508628202400145$CN-BAXTER-2024BAX023942$BAXTER$$48$YR$$F$Y$$$20240904$$MD$CN$CN
242812561$24281256$1$I$20240821$20240826$20240904$20240904$EXP$CN-NMPACDR-3708281020400202400597$CN-BAXTER-2024BAX023884$BAXTER$$37$YR$$F$Y$55$KG$20240904$$MD$CN$CN
242812571$24281257$1$I$20240801$20240903$20240904$20240904$EXP$$NVSC2024IE177235$NOVARTIS$$$$$F$Y$$$20240904$$CN$IE$IE
242812581$24281258$1$I$$20240822$20240904$20240904$EXP$$CA-BAXTER-2024BAX023756$BAXTER$$60$YR$$F$Y$$$20240904$$HP$CA$CA
242812591$24281259$1$I$$20240820$20240904$20240904$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00713$GLAND PHARMA$Kenichi Nonaka.Development of Fourniers gangrene after chemotherapy for the recurrence of testicular cancer despite the absence of anorectal lesions: A case report.Medicine.03-JUN-2024;103(30):e38688$54$YR$A$M$Y$$$20240904$$MD$JP$JP
242812601$24281260$1$I$20240829$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000214$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240904$$CN$US$US
242812621$24281262$1$I$$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001356$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240904$$CN$US$US
242812631$24281263$1$I$$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408019432$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240904$$CN$US$US
242812641$24281264$1$I$20240903$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001588$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240904$$CN$US$US
242812661$24281266$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140309$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$78.02$KG$20240904$$CN$US$US
242812671$24281267$1$I$20240809$20240830$20240904$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-140154$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$MD$JP$JP
242812681$24281268$1$I$$20240828$20240904$20240904$EXP$$GR-AMGEN-GRCSP2024173415$AMGEN$$70$YR$E$M$Y$$$20240904$$MD$GR$GR
242812692$24281269$2$F$20240903$20240904$20240904$20240905$PER$$US-AMGEN-USASP2024175765$AMGEN$$53$YR$A$F$Y$$$20240905$$CN$US$US
242812701$24281270$1$I$$20240827$20240904$20240904$EXP$$CA-APOTEX-2024AP010026$APOTEX$$68$YR$$M$Y$$$20240904$$CN$CA$CA
242812711$24281271$1$I$20230701$20240828$20240904$20240904$EXP$$PL-AMGEN-POLSP2024174500$AMGEN$$59$YR$A$M$Y$$$20240904$$MD$PL$PL
242812721$24281272$1$I$20240601$20240830$20240904$20240904$EXP$$JP-AMGEN-JPNSP2024174221$AMGEN$$$$$$Y$$$20240904$$PH$JP$JP
242812731$24281273$1$I$$20240820$20240904$20240904$EXP$$ES-GLANDPHARMA-ES-2024GLNLIT00709$GLAND PHARMA$Alvaro Lassaletta.Continuous response despite reduced dose of trametinib as single agent in an adolescent with a relapsed disseminated pediatric low-grade glioma KIAA1549-BRAF fusion positive: a case report and review of the literature.Frontiers in Oncology.23-MAY-2024;14:1-5$18$YR$T$M$Y$$$20240904$$HP$ES$ES
242812761$24281276$1$I$$20240731$20240830$20240830$DIR$FDA-CDER-CTU-2024-60008$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242812791$24281279$1$I$$20240903$20240904$20240904$EXP$GB-MHRA-MED-202409031758180500-JZTBF$GB-JNJFOC-20240905385$JOHNSON AND JOHNSON$$63$YR$A$$Y$$$20240904$$HP$GB$GB
242812811$24281281$1$I$20240827$20240830$20240904$20240904$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024108377$VIIV$$32$YR$$M$Y$$$20240904$$HP$US$US
242812821$24281282$1$I$$20240829$20240904$20240904$EXP$$US-AMGEN-USASP2024172882$AMGEN$$$$A$F$Y$$$20240904$$CN$US$US
242812832$24281283$2$F$20240830$20240904$20240904$20240906$PER$$US-AMGEN-USASP2024175968$AMGEN$$63$YR$A$F$Y$$$20240906$$CN$US$US
242812841$24281284$1$I$20240826$20240903$20240904$20240904$EXP$GB-MHRA-MED-202409030643105750-YWLCV$GB-BAYER-2024A126090$BAYER$$59$YR$A$F$Y$$$20240904$$CN$GB$GB
242812852$24281285$2$F$$20240905$20240904$20240918$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08529$LUPIN$$$$$$Y$$$20240918$$MD$US$US
242812861$24281286$1$I$20231201$20240821$20240904$20240904$PER$$US-ASTELLAS-2024-AER-002620$ASTELLAS$$67$YR$E$F$Y$$$20240904$$HP$US$US
242812871$24281287$1$I$$20240809$20240904$20240904$PER$$US-Covis Pharma GmbH-2024COV00992$COVIS PHARMA$$$$$F$Y$$$20240904$$CN$US$US
242812881$24281288$1$I$$20240828$20240904$20240904$PER$$US-Covis Pharma GmbH-2024COV01025$COVIS PHARMA$$$$$$Y$$$20240904$$CN$US$US
242812891$24281289$1$I$20240101$20240827$20240904$20240904$EXP$$CA-CELLTRION INC.-2024CA020967$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
242812901$24281290$1$I$$20240827$20240904$20240904$EXP$$CA-APOTEX-2024AP010033$APOTEX$$68$YR$$F$Y$$$20240904$$PH$CA$CA
242812911$24281291$1$I$20240528$20240821$20240904$20240904$PER$$US-MYLANLABS-2024M1078850$MYLAN$$88$YR$$M$Y$$$20240904$$MD$US$US
242812922$24281292$2$F$20240826$20240826$20240904$20240905$EXP$$US-CSL-2024-007969$CSL Plasma$$43$YR$$M$Y$$$20240905$$HP$US$US
242812941$24281294$1$I$$20240902$20240904$20240904$EXP$$CA-PFIZER INC-202400248550$PFIZER$$62$YR$$M$Y$$$20240904$$HP$CA$CA
242812951$24281295$1$I$20240101$20240829$20240904$20240904$EXP$$US-BEH-2024178044$CSL BEHRING$$39$YR$A$F$Y$120$KG$20240904$$CN$US$US
242812961$24281296$1$I$$20240829$20240904$20240904$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR108254$VIIV$$$$$M$Y$$$20240904$$HP$US$US
242812971$24281297$1$I$$20240825$20240904$20240904$PER$$US-JNJFOC-20240865970$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$CN$US$US
242812991$24281299$1$I$20240827$20240903$20240904$20240904$EXP$$US-BAYER-2024A126344$BAYER$$32$YR$A$M$Y$$$20240904$$CN$US$US
242813001$24281300$1$I$20230901$20240125$20240904$20240904$EXP$$FR-KYOWAKIRIN-2023KK017044$KYOWA$$$$$$Y$$$20240904$$HP$FR$FR
242813011$24281301$1$I$$20240830$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139587$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240904$$CN$US$US
242813021$24281302$1$I$20240830$20240830$20240830$20240830$DIR$716654$$FDA-CTU$$51$YR$$F$N$78.75$KG$20240830$N$HP$US$
242813031$24281303$1$I$20231120$20240829$20240904$20240904$EXP$ES-AEMPS-1483487$ES-TEVA-VS-3238593$TEVA$$85$YR$$F$Y$$$20240904$$MD$ES$ES
242813041$24281304$1$I$$20240829$20240904$20240904$EXP$$US-MYLANLABS-2024M1080120$MYLAN$$83$YR$$F$Y$$$20240904$$MD$US$US
242813051$24281305$1$I$$20240827$20240904$20240904$EXP$$US-ROCHE-10000067751$ROCHE$$$$E$M$Y$$$20240904$$CN$US$US
242813061$24281306$1$I$$20240731$20240830$20240830$DIR$FDA-CDER-CTU-2024-60004$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242813071$24281307$1$I$$20240820$20240904$20240904$EXP$$US-GLANDPHARMA-US-2024GLNLIT00691$GLAND PHARMA$M Murphy.Acute Onset of Abdominal Pain in a 3-year-old Boy with Acute Lymphoblastic Leukemia.Pediatrics in Review.OCT-2023;44 (Suppl. 1):S106-S109$3$YR$C$M$Y$$$20240904$$HP$US$US
242813081$24281308$1$I$$20240830$20240904$20240904$EXP$$GB-PFIZER INC-2863609$PFIZER$Gilhooly C.,Taggart I.,Bache SE.. Late-onset rhabdomyolysis in burn patients in the intensive care unit. Burns. 2011;37:1241-1247$17$YR$$$Y$$$20240904$$HP$GB$GB
242813101$24281310$1$I$$20240830$20240904$20240904$EXP$$GB-PFIZER INC-2863602$PFIZER$Bache, S. Late-onset rhabdomyolysis in burn patients in the intensive care unit. Burns. 2011;37:1241-1247$18$YR$$$Y$$$20240904$$HP$GB$GB
242813111$24281311$1$I$$20240821$20240904$20240904$PER$$US-Calliditas-2024CAL01642$CALLIDITAS THERAPEUTICS$$23$YR$A$M$Y$$$20240904$$MD$US$US
242813121$24281312$1$I$$20240903$20240904$20240904$PER$$US-AMGEN-USASP2024175666$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242813131$24281313$1$I$$20240829$20240904$20240904$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-139931$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$MD$NL$NL
242813141$24281314$1$I$$20240830$20240904$20240904$EXP$$GB-PFIZER INC-2863613$PFIZER$Bache S E., Gilhooly C., Taggart I.. Late-onset rhabdomyolysis in burn patients in the intensive care unit. Burns. 2011;37:1241-1247$35$YR$$$Y$$$20240904$$HP$GB$GB
242813151$24281315$1$I$20240805$20240830$20240904$20240904$EXP$$NVSC2024LT173610$NOVARTIS$$59$YR$$F$Y$$$20240904$$MD$LT$LT
242813161$24281316$1$I$20240101$20240827$20240904$20240904$EXP$$CA-CELLTRION INC.-2024CA021057$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
242813171$24281317$1$I$$20240827$20240904$20240904$EXP$$NVSC2024IN177097$NOVARTIS$Mishra VV, Choudhary S, Dharaiya N, Gaddagi RA, Vyas B.. Successful term pregnancy in post renal transplant patient. JOURNAL OF SOUTH ASIAN FEDERATION OF OBSTETRICS AND GYNAECOLOGY. 2015;7 (2):89-90$$$N$$Y$$$20240904$$HP$IN$IN
242813181$24281318$1$I$20231101$20240823$20240904$20240904$EXP$$US-UCBSA-2024043551$UCB$$62$YR$$F$Y$$$20240904$$HP$US$US
242813191$24281319$1$I$$20240902$20240904$20240904$EXP$$GB-MYLANLABS-2024M1080854$MYLAN$$$$$M$Y$$$20240904$$CN$GB$GB
242813211$24281321$1$I$$20240731$20240830$20240830$DIR$FDA-CDER-CTU-2024-60003$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242813221$24281322$1$I$20240619$20240830$20240830$20240830$DIR$716659$$FDA-CTU$$64$YR$$F$N$72$KG$20240830$N$CN$US$
242813231$24281323$1$I$$20240731$20240830$20240830$DIR$FDA-CDER-CTU-2024-60005$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242813241$24281324$1$I$$20240820$20240904$20240904$EXP$$US-GLANDPHARMA-US-2024GLNLIT00687$GLAND PHARMA$J Monge.Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy.American Journal of Hematology .FEB-2023;99:327-328$78$YR$E$M$Y$$$20240904$$HP$US$US
242813251$24281325$1$I$20240801$20240823$20240904$20240904$PER$$US-ALKERMES INC.-ALK-2024-002219$ALKERMES$$43$YR$$M$Y$81.633$KG$20240904$$CN$US$US
242813261$24281326$1$I$$20240829$20240904$20240904$PER$$US-BAYER-2024A125276$BAYER$$$$$$Y$$$20240904$$CN$US$US
242813271$24281327$1$I$20221101$20240902$20240904$20240904$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047531$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240904$$CN$BR$BR
242813281$24281328$1$I$$20240829$20240904$20240904$EXP$$FR-MYLANLABS-2024M1080822$MYLAN$Tardy C, Puszkiel A, Boudou-Rouquette P, De Percin S, Alexandre J, Berge M, et al. Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection. Cancer-Chemother-Pharmacol 2024; 93 169-175.$49$YR$$M$Y$$$20240904$$HP$FR$FR
242813301$24281330$1$I$$20240829$20240904$20240904$EXP$$BE-MYLANLABS-2024M1080472$MYLAN$Maerten A, Ramon I, Rasmont C, Thomas J, Khelif A, Lemaitre J. Emergency thyroidectomy for thyroid storm in a patient treated with amiodarone. [French]. Rev-Med-Brux 2024; 45 (3):.$57$YR$$M$Y$$$20240904$$HP$BE$BE
242813311$24281331$1$I$$20240828$20240904$20240904$EXP$$DE-VIIV HEALTHCARE LIMITED-DE2024EME108149$VIIV$$$$$$Y$$$20240904$$MD$DE$DE
242813321$24281332$1$I$20240830$20240830$20240904$20240904$30DAY$$US-GSK-US2024108471$GLAXOSMITHKLINE$$98$YR$$F$Y$$$20240904$$CN$US$US
242813331$24281333$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001529$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240904$$CN$US$US
242813341$24281334$1$I$20220601$20240827$20240904$20240904$EXP$$US-TAKEDA-US201804187$TAKEDA$$42$YR$$F$Y$$$20240904$$HP$US$US
242813351$24281335$1$I$$20240811$20240904$20240904$PER$$US-AstraZeneca-2024A184564$ASTRAZENECA$$$$$$Y$$$20240904$$HP$US$
242813361$24281336$1$I$$20240831$20240904$20240904$PER$$US-BAYER-2024A125170$BAYER$$$$$$Y$$$20240904$$CN$US$US
242813381$24281338$1$I$$20240830$20240904$20240904$PER$$US-BIOGEN-2024BI01280766$BIOGEN$$$$$M$Y$$$20240904$$CN$US$US
242813391$24281339$1$I$20230401$20240829$20240904$20240904$EXP$$AT-ROCHE-10000005836$ROCHE$$35$YR$A$M$Y$$$20240904$$MD$AT$AT
242813402$24281340$2$F$20240828$20240918$20240904$20240925$EXP$$JP-ROCHE-10000072278$ROCHE$$7$DEC$E$M$Y$$$20240925$$MD$JP$JP
242813411$24281341$1$I$20240101$20240827$20240904$20240904$EXP$$CA-CELLTRION INC.-2024CA020969$CELLTRION$$$$$$Y$$$20240904$$HP$CA$CA
242813421$24281342$1$I$$20231009$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015630$STRIDES$Gupta S, Wojciechowski D. Late Conversion to Belatacept in Biopsy Proven Tacrolimus Toxicity. J-Am-Soc-Nephrol. 2016;27622A(poster)abstr. FR-P01090$$$$$Y$$$20240904$$HP$US$US
242813431$24281343$1$I$$20240501$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005387$STRIDES$Sarkar M, Lee S, Bjelajac N, Bunnapradist S, Lum E.. Cannabidiol (CBD) Oil and Tacrolimus: The Unexpected High in Renal Transplant Recipients - Case Series and Review.. Transplantation. 2022;106 (Suppl.)(9):S576 abstr. P8.057$64$YR$$F$Y$$$20240904$$HP$US$US
242813441$24281344$1$I$$20240719$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009224$STRIDES$Satta T, Papadopoulos EB, Gyurkocza B, Susman P, Singh A, Calafiore M, et al.. Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd.. Blood. 2023;142 (Suppl. 1):7019$70$YR$$$Y$$$20240904$$HP$US$US
242813451$24281345$1$I$$20231009$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015631$STRIDES$Gupta S, Wojciechowski D. Late Conversion to Belatacept in Biopsy Proven Tacrolimus Toxicity. J-Am-Soc-Nephrol. 2016;27622A(poster)abstr. FR-P01090$$$$$Y$$$20240904$$HP$US$US
242813461$24281346$1$I$$20231123$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017928$STRIDES$Arman F, Krieger A, Hedvat J, Crew RJ, Stevens J.. A Case of AKI due to Letermovir and Tacrolimus Interaction.. J-Am-Soc-Nephrol. 2023;34:463-464.$68$YR$$M$Y$$$20240904$$HP$US$US
242813471$24281347$1$I$$20240620$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007612$STRIDES$Zaidi W, Saeed AI, Lundquist N, Nelson AR, Razia D, Lee R, et al.. Bronchoscopic Debridement of Endobronchial Rhizopus With 1.1 Mm Cryoprobe in Lung Transplant Recipient.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$67$YR$$M$Y$$$20240904$$HP$US$US
242813481$24281348$1$I$$20230925$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015147$STRIDES$Xu Z, Otrock ZK.. Extracorporeal photopheresis: A case of graft-versus-host-disease and hemophagocytic lymphohistiocytosis following liver transplantation.. Transfusion. 2022;62(11):2409-2413$63$YR$$M$Y$$$20240904$$HP$US$US
242813491$24281349$1$I$$20240307$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003019$STRIDES$Valdepenas B, Campara M, Pierce D, Benken J, Akshelyan S, Tzvetanov I, et al. Clinical Outcomes of Intestinal Transplant Recipients Receiving Maintenance Basiliximab, Sublingual Tacrolimus and Prednisone: A Case Series. Am-J-Transplant. 2023;23 (Suppl.) (6):S733-S734 abstr. A283.$$$$$Y$$$20240904$$HP$US$US
242813501$24281350$1$I$$20231009$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015643$STRIDES$Gupta S, Wojciechowski D. Late Conversion to Belatacept in Biopsy Proven Tacrolimus Toxicity. J-Am-Soc-Nephrol. 2016;27622A(poster)abstr. FR-P01090$$$$$Y$$$20240904$$HP$US$US
242813511$24281351$1$I$$20240619$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007536$STRIDES$Patel L, Lyons J, Scarola D, Warrior K.. Mycophenolate-induced Colitis in Lung Transplant Recipients. Am-J-Respir-Crit-Care-Med. 2024;209:1-2 (plus Poster)$$$$$Y$$$20240904$$HP$US$US
242813521$24281352$1$I$$20240326$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003777$STRIDES$Marsh J, Logan AT, Bilgili EP, Bowman LJ, Webb AR.. Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion.. Am-J-Health-Syst-Pharm. 2024$57$YR$$M$Y$93$KG$20240904$$MD$US$US
242813531$24281353$1$I$$20240430$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005296$STRIDES$Griffin SP, Lee BJ, Doh J, Paradyse AR, Jeyakumar D, Arter Z, et al.. Strategies to Mitigate the Drug-Drug Interaction between Nirmatrelvir/Ritonavir and Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Azole Antifungals: Results of a Case Series. Acta-Haematol. 2023$70$YR$$M$Y$$$20240904$$HP$US$US
242813541$24281354$1$I$$20231030$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016680$STRIDES$Hunley TE, Hidalgo G, Ng KH, Shirai Y, Miura K, Beng HM, et al.. Pioglitazone enhances proteinuria reduction in complicated pediatric nephrotic syndrome.. Pediatr-Nephrol. 2023;38(4):1127-1138.$16$YR$$M$Y$$$20240904$$HP$US$US
242813551$24281355$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-138970-2023$RECKITT BENCKISER$$$$$$Y$$$20240904$$CN$US$US
242813561$24281356$1$I$$20240820$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08537$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242813571$24281357$1$I$$20240222$20240904$20240904$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002429$STRIDES$Radhakrishnan Y, Sethi S, Fervenza FC, Zand L. A Case of Membranous Nephropathy Secondary to Chronic Lymphocytic Leukemia in Association with a Novel Antigen. J-Am-Soc-Nephrol. 2023;34:781$72$YR$$M$Y$$$20240904$$HP$US$US
242813581$24281358$1$I$$20240820$20240904$20240904$EXP$$US-GLANDPHARMA-US-2024GLNLIT00708$GLAND PHARMA$H. Suffian.COMPLICATIONS POST-CHEMOTHERAPY IN A CHILD WITH T-CELL LEUKEMIA AND ATAXIA TELANGIECTASIA.Annals of Allergy, Asthma and Immunology.NOV-2023;131$4$YR$C$M$Y$$$20240904$$HP$US$US
242813591$24281359$1$I$$20240902$20240904$20240904$PER$$US-BAYER-2024A126183$BAYER$$$$$$Y$$$20240904$$CN$US$US
242813601$24281360$1$I$$20240827$20240904$20240904$EXP$$CA-APOTEX-2024AP010021$APOTEX$$57$YR$$M$Y$94$KG$20240904$$MD$CA$CA
242813611$24281361$1$I$$20240703$20240904$20240904$PER$$US-MRZWEB-2024070000073$MERZ$$62$YR$$M$Y$$$20240904$$HP$US$US
242813622$24281362$2$F$$20240913$20240904$20240924$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08182$HIKMA$$$$E$F$Y$$$20240924$$CN$US$US
242813631$24281363$1$I$20240214$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-085645-2024$RECKITT BENCKISER$$82$YR$$M$Y$$$20240904$$CN$US$US
242813701$24281370$1$I$20240101$20240828$20240904$20240904$EXP$$JP-GENMAB-2024-03131$GENMAB$$8$DEC$$M$Y$$$20240904$$MD$JP$JP
242813713$24281371$3$F$20240801$20240904$20240904$20240912$PER$$US-MYLANLABS-2024M1076376$MYLAN$$54$YR$$F$Y$68.04$KG$20240912$$CN$US$US
242813721$24281372$1$I$20240817$20240830$20240830$20240830$DIR$716680$$FDA-CTU$$68$YR$$F$N$83.25$KG$20240830$N$CN$US$
242813731$24281373$1$I$$20240820$20240904$20240904$PER$$US-MYLANLABS-2024M1078011$MYLAN$$$$$F$Y$72.57$KG$20240904$$PH$US$US
242813741$24281374$1$I$20170101$20240829$20240904$20240904$EXP$$NL-SANDOZ INC.-SDZ2024NL077298$SANDOZ$$19$YR$$M$Y$$$20240904$$MD$NL$NL
242813751$24281375$1$I$$20230827$20240904$20240904$PER$$US-PUMA BIOTECHNOLOGY, LTD.-2023-PUM-US001439$PUMA$$$$$$Y$$$20240830$$HP$US$US
242813761$24281376$1$I$20240406$20240902$20240904$20240904$PER$$US-BAYER-2024A126346$BAYER$$52$YR$A$F$Y$$$20240904$$HP$US$US
242813771$24281377$1$I$$20240220$20240904$20240904$PER$$US-PUMA BIOTECHNOLOGY, LTD.-2024-PUM-US000279$PUMA$$$$$$Y$$$20240830$$CN$US$US
242813781$24281378$1$I$20230101$20231214$20240904$20240904$PER$$US-PUMA BIOTECHNOLOGY, LTD.-2023-PUM-US002186$PUMA$$$$$$Y$$$20240830$$CN$US$US
242813791$24281379$1$I$20230101$20230828$20240904$20240904$PER$$US-PUMA BIOTECHNOLOGY, LTD.-2023-PUM-US001437$PUMA$$$$$$Y$$$20240830$$CN$US$US
242813801$24281380$1$I$$20240402$20240904$20240904$PER$$US-PUMA BIOTECHNOLOGY, LTD.-2024-PUM-US000485$PUMA$$$$$$Y$$$20240830$$CN$US$US
242813811$24281381$1$I$$20240405$20240904$20240904$PER$$US-PUMA BIOTECHNOLOGY, LTD.-2024-PUM-US000521$PUMA$$$$$$Y$$$20240830$$HP$US$US
242813821$24281382$1$I$20240412$20240413$20240904$20240904$PER$$US-PUMA BIOTECHNOLOGY, LTD.-2024-PUM-US000561$PUMA$$$$$$Y$$$20240830$$CN$US$US
242813831$24281383$1$I$$20240418$20240904$20240904$PER$$US-PUMA BIOTECHNOLOGY, LTD.-2024-PUM-US000578$PUMA$$$$$$Y$$$20240830$$CN$US$US
242813841$24281384$1$I$20240826$20240829$20240904$20240904$EXP$$NVSC2024IN176629$NOVARTIS$$65$YR$$M$Y$$$20240904$$CN$IN$IN
242813851$24281385$1$I$20240825$20240831$20240904$20240904$EXP$$CA-GSK-CA2024109442$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$CA$CA
242813862$24281386$2$F$20240101$20240912$20240904$20240916$EXP$$LT-009507513-2409LTU000666$MERCK$$64$YR$$F$Y$59$KG$20240916$$MD$LT$LT
242813882$24281388$2$F$20240101$20240905$20240904$20240913$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-00951$CATALYST PHARMA$$$$$F$Y$39$KG$20240913$$CN$US$US
242813891$24281389$1$I$20240801$20240828$20240904$20240904$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00958$CATALYST PHARMA$$48$YR$$F$Y$54.739$KG$20240904$$CN$US$US
242813901$24281390$1$I$20240823$20240830$20240904$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US076846$SANDOZ$$58$YR$$F$Y$$$20240904$$MD$US$US
242813911$24281391$1$I$$20240807$20240904$20240904$30DAY$$US-VEROBIOTECH-2024USVEROSPO00197$VERO BIOTECH$$$$$$Y$$$20240904$$HP$US$US
242813921$24281392$1$I$20240801$20240828$20240904$20240904$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00959$CATALYST PHARMA$$81$YR$$F$Y$63.492$KG$20240904$$CN$US$US
242813931$24281393$1$I$$20240820$20240904$20240904$EXP$$US-GLANDPHARMA-US-2024GLNLIT00712$GLAND PHARMA$Nicholas Nelson.Isolated Myeloid Sarcoma Masquerading as Scattered Abscesses in a Septic Patient: A Case Report and Literature Review.Case Reports in Oncology.05-JAN-2024;17:39-48$76$YR$E$F$Y$$$20240904$$HP$US$US
242813941$24281394$1$I$$20240830$20240904$20240904$EXP$$GB-SANDOZ INC.-NVSC2022GB069395$SANDOZ$$$$$M$Y$$$20240904$$CN$GB$GB
242813953$24281395$3$F$20240101$20240905$20240904$20240912$PER$$US-AMGEN-USASP2024175529$AMGEN$$$$$M$Y$$$20240912$$CN$US$US
242813961$24281396$1$I$20240805$20240821$20240904$20240904$EXP$$US-UCBSA-2024040492$UCB$$$$$F$Y$$$20240904$$CN$US$US
242813971$24281397$1$I$$20240829$20240904$20240904$EXP$$US-ROCHE-10000070141$ROCHE$$$$A$M$Y$$$20240904$$MD$US$US
242813981$24281398$1$I$20240821$20240823$20240904$20240904$PER$$US-MYLANLABS-2024M1078564$MYLAN$$55$YR$$F$Y$88.45$KG$20240904$$CN$US$US
242813991$24281399$1$I$20240808$20240828$20240904$20240904$EXP$$US-GSK-US2024107212$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$US$US
242814001$24281400$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-080272-2024$RECKITT BENCKISER$$$$$$Y$$$20240904$$CN$US$US
242814011$24281401$1$I$$20240826$20240904$20240904$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006358$BIOCON$$$$$$Y$$$20240904$$MD$CA$CA
242814021$24281402$1$I$20240826$20240826$20240904$20240904$EXP$GB-MHRA-MED-202408261025433370-CNBJH$GB-TORRENT-00037750$TORRENT$$50$YR$A$M$Y$75$KG$20240904$$MD$GB$GB
242814031$24281403$1$I$20240624$20240826$20240904$20240904$EXP$GB-MHRA-MED-202408261330327800-LHBSQ$GB-TORRENT-00037747$TORRENT$$76$YR$E$F$Y$$$20240904$$CN$GB$GB
242814042$24281404$2$F$$20240909$20240904$20240919$EXP$$IN-TORRENT-00003648$TORRENT$$69$YR$E$F$Y$$$20240919$$MD$IN$IN
242814052$24281405$2$F$20240801$20240911$20240904$20240920$EXP$$NVSC2024BR177442$NOVARTIS$$53$YR$$M$Y$$$20240920$$CN$BR$BR
242814061$24281406$1$I$$20240827$20240904$20240904$EXP$$US-TORRENT-00013731$TORRENT$$60$YR$A$F$Y$$$20240904$$MD$US$US
242814071$24281407$1$I$$20240830$20240904$20240904$EXP$$DE-VELOXIS PHARMACEUTICALS, INC.-2020-VEL-00902$VELOXIS PHARMACEUTICALS$Kasper P, Gobel H, Michels G.. MTOR-induced pneumonitis in a 72-year-old patient after heart transplantation. Dtsch med weekly writer. 2020;185:189-94$72$YR$$M$Y$57.8$KG$20240904$$MD$DE$DE
242814081$24281408$1$I$20230712$20240902$20240904$20240904$EXP$FR-AFSSAPS-PA2023001726$FR-UCBSA-2024044644$UCB$$40$YR$$M$Y$87$KG$20240904$$CN$FR$FR
242814091$24281409$1$I$20240731$20240829$20240904$20240904$EXP$FR-AFSSAPS-TS2024000932$FR-ROCHE-10000069815$ROCHE$$30$YR$A$F$Y$88$KG$20240904$$MD$FR$FR
242814101$24281410$1$I$$20240903$20240904$20240904$EXP$$GB-GILEAD-2024-0686050$GILEAD$$$$A$M$Y$$$20240904$$HP$GB$GB
242814112$24281411$2$F$20240830$20240904$20240904$20240905$PER$$US-AMGEN-USASP2024176280$AMGEN$$75$YR$E$F$Y$$$20240905$$HP$US$US
242814121$24281412$1$I$$20240903$20240904$20240904$PER$$US-AMGEN-USASP2024175740$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242814131$24281413$1$I$20240901$20240903$20240904$20240904$PER$$US-AMGEN-USASP2024176112$AMGEN$$82$YR$E$F$Y$$$20240904$$CN$US$US
242814141$24281414$1$I$20240401$20240820$20240904$20240904$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01263$INTRA-CELLULAR THERAPIES$$34$YR$$F$Y$58.957$KG$20240904$$HP$US$US
242814151$24281415$1$I$20240701$20240902$20240904$20240904$EXP$HR-HALMED-300086399$HR-PFIZER INC-202400248038$PFIZER$$45$YR$$M$Y$90$KG$20240904$$MD$HR$HR
242814161$24281416$1$I$20240812$20240830$20240904$20240904$EXP$FR-AFSSAPS-BR2024000691$FR-PFIZER INC-202400247185$PFIZER$$17$YR$$F$Y$45$KG$20240904$$MD$FR$FR
242814171$24281417$1$I$20240801$20240830$20240904$20240904$EXP$$CA-PFIZER INC-202400248381$PFIZER$$72$YR$$F$Y$$$20240904$$HP$CA$CA
242814181$24281418$1$I$20240830$20240831$20240904$20240904$EXP$$US-PFIZER INC-202400247791$PFIZER$$$$$$Y$$$20240904$$CN$US$US
242814191$24281419$1$I$$20240830$20240904$20240904$EXP$$US-PFIZER INC-202400247663$PFIZER$$84$YR$$M$Y$101.6$KG$20240904$$MD$US$US
242814202$24281420$2$F$20240806$20240902$20240904$20240905$EXP$IT-MINISAL02-999767$IT-PFIZER INC-202400243532$PFIZER$$83$YR$$F$Y$43$KG$20240905$$MD$IT$IT
242814211$24281421$1$I$20230530$20240830$20240904$20240904$EXP$FR-AFSSAPS-AM2024000677$FR-PFIZER INC-202400247183$PFIZER$$91$YR$$F$Y$48$KG$20240904$$MD$FR$FR
242814222$24281422$2$F$$20240830$20240904$20240904$EXP$$AU-PFIZER INC-202400247260$PFIZER$$$$A$F$Y$$$20240904$$CN$AU$AU
242814232$24281423$2$F$20210208$20240904$20240904$20240906$EXP$$IN-PFIZER INC-2020481864$PFIZER$$65$YR$$F$Y$$$20240906$$CN$IN$IN
242814241$24281424$1$I$20201021$20240830$20240904$20240904$EXP$PL-URPL-1-2522-2020$PL-PFIZER INC-202400247161$PFIZER$$70$YR$$F$Y$70$KG$20240904$$HP$PL$PL
242814251$24281425$1$I$20240813$20240902$20240904$20240904$EXP$GR-GREOF-202400932$GR-PFIZER INC-202400248201$PFIZER$$55$YR$$F$Y$53$KG$20240904$$MD$GR$GR
242814261$24281426$1$I$$20240903$20240904$20240904$EXP$$IN-PFIZER INC-202400248702$PFIZER$$$$A$M$Y$$$20240904$$HP$IN$IN
242814271$24281427$1$I$$20240830$20240904$20240904$EXP$$ES-PFIZER INC-PV202400114759$PFIZER$Molina, Y.. Myelofibrosis associated with immune cytopenia in an infant: a diagnostic and therapeutic challenge. Pediatric Hematology and Oncology. 2024;41(5):382-387$8$MON$$F$Y$$$20240904$$HP$ES$ES
242814281$24281428$1$I$20240804$20240902$20240904$20240904$EXP$FR-AFSSAPS-TO2024001671$FR-PFIZER INC-202400248178$PFIZER$$49$YR$$M$Y$69$KG$20240904$$MD$FR$FR
242814291$24281429$1$I$20230101$20240830$20240904$20240904$EXP$$CA-PFIZER INC-202201114379$PFIZER$$60$YR$$F$Y$$$20240904$$MD$CA$CA
242814301$24281430$1$I$$20240830$20240904$20240904$EXP$$CA-PFIZER INC-202400247450$PFIZER$$27$YR$$$Y$$$20240904$$MD$CA$CA
242814311$24281431$1$I$20240801$20240830$20240904$20240904$EXP$$US-PFIZER INC-202400248044$PFIZER$$64$YR$$F$Y$$$20240904$$CN$US$US
242814321$24281432$1$I$20240501$20240827$20240904$20240904$EXP$GB-MHRA-MED-202408271819015540-YDQLC$GB-TEVA-VS-3238090$TEVA$$86$YR$$F$Y$66$KG$20240904$$CN$GB$GB
242814342$24281434$2$F$20240409$20240904$20240904$20240919$EXP$$CN-PFIZER INC-202400248244$PFIZER$$54$YR$$M$Y$82$KG$20240919$$HP$CN$CN
242814351$24281435$1$I$20240813$20240830$20240830$20240830$DIR$716692$$FDA-CTU$$45$YR$$F$N$92.5$KG$20240830$N$HP$US$
242814361$24281436$1$I$20240830$20240830$20240830$20240830$DIR$716694$$FDA-CTU$$33$YR$$F$N$108$KG$20240830$N$HP$US$
242814381$24281438$1$I$$20240828$20240904$20240904$EXP$$US-GSK-US2024107211$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$HP$US$US
242814391$24281439$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001563$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240904$$CN$US$US
242814401$24281440$1$I$20240831$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001718$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240904$$CN$US$US
242814411$24281441$1$I$$20240827$20240904$20240904$EXP$$TW-AstraZeneca-2024A197647$ASTRAZENECA$$$$$F$Y$$$20240904$$HP$TW$
242814421$24281442$1$I$20230829$20240823$20240904$20240904$EXP$$JP-JNJFOC-20240824227$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240904$$MD$JP$JP
242814432$24281443$2$F$20240101$20240830$20240904$20240905$EXP$$NVSC2024DE175721$NOVARTIS$$$$A$F$Y$$$20240905$$PH$DE$DE
242814454$24281445$4$F$20240815$20240918$20240904$20240927$EXP$$JP-GALDERMA-JP2024013262$GALDERMA$$$$$$Y$$$20240927$$MD$JP$JP
242814461$24281446$1$I$20240617$20240829$20240904$20240904$EXP$$FR-WAYLIS-2024-FR-000147$Waylis$$63$YR$$M$Y$$$20240904$$HP$FR$FR
242814471$24281447$1$I$$20240901$20240904$20240904$EXP$$US-GILEAD-2024-0686158$GILEAD$$$$E$F$Y$$$20240904$$CN$US$US
242814481$24281448$1$I$$20240829$20240904$20240904$EXP$$US-GILEAD-2024-0685980$GILEAD$$$$E$F$Y$$$20240904$$CN$US$US
242814491$24281449$1$I$$20240830$20240904$20240904$EXP$$US-GILEAD-2024-0686049$GILEAD$$45$YR$A$F$Y$$$20240904$$CN$US$US
242814501$24281450$1$I$$20240829$20240904$20240904$EXP$GB-MHRA-MED-202408292033091690-TLCWP$GB-TEVA-VS-3238878$TEVA$$76$YR$$F$Y$76$KG$20240904$$CN$GB$GB
242814511$24281451$1$I$20231124$20240828$20240904$20240904$EXP$FR-AFSSAPS-LY2023001904$FR-009507513-2408FRA009773$MERCK$$47$YR$$F$Y$$$20240904$$MD$FR$FR
242814531$24281453$1$I$$20240826$20240904$20240904$PER$$US-MYLANLABS-2024M1080265$MYLAN$$$$$F$Y$$$20240904$$CN$US$US
242814541$24281454$1$I$$20240826$20240904$20240904$PER$$US-MYLANLABS-2024M1079800$MYLAN$$$$$F$Y$$$20240904$$MD$US$US
242814561$24281456$1$I$20210804$20240904$20240904$20240904$DIR$717035$$FDA-CTU$$76$YR$$M$N$90$KG$20240904$Y$CN$US$
242814581$24281458$1$I$$20240822$20240904$20240904$PER$$US-JNJFOC-20240859314$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242814591$24281459$1$I$$20240901$20240901$20240901$DIR$716799$$FDA-CTU$$22$YR$$M$N$78.75$KG$20240901$N$CN$US$
242814611$24281461$1$I$20240101$20240823$20240904$20240904$EXP$$US-FARMAPROD-202408-3048$DOMPE FARMACEUTICI$$70$YR$E$M$Y$$$20240904$$CN$US$US
242814621$24281462$1$I$20210101$20240903$20240904$20240904$PER$$US-BAYER-2024A126394$BAYER$$83$YR$E$F$Y$$$20240904$$CN$US$US
242814631$24281463$1$I$20240415$20240903$20240904$20240904$EXP$$US-GILEAD-2024-0686091$GILEAD$$26$YR$A$F$Y$$$20240904$$HP$US$US
242814641$24281464$1$I$20240101$20240828$20240904$20240904$EXP$$NVSC2024US174758$NOVARTIS$$$$$F$Y$72$KG$20240904$$CN$US$US
242814651$24281465$1$I$$20240901$20240904$20240904$PER$$US-ABBVIE-5905602$ABBVIE$$$$$$Y$$$20240904$$CN$US$US
242814671$24281467$1$I$$20240826$20240904$20240904$EXP$$FR-UCBSA-2024043633$UCB$$$$$$Y$$$20240904$$MD$FR$FR
242814681$24281468$1$I$$20240902$20240904$20240904$30DAY$$ES-UCBSA-2024044496$UCB$$$$$M$Y$$$20240904$$PH$ES$ES
242814691$24281469$1$I$$20240828$20240904$20240904$EXP$$NL-ROCHE-10000069518$ROCHE$$$$$F$Y$$$20240904$$HP$NL$NL
242814721$24281472$1$I$$20181009$20240904$20240904$EXP$$DE-SA-2018SA271581$SANOFI AVENTIS$$$$A$$Y$$$20240904$$MD$DE$DE
242814733$24281473$3$F$20240901$20240909$20240904$20240911$PER$$US-AMGEN-USASP2024175756$AMGEN$$41$YR$A$F$Y$$$20240911$$CN$US$US
242814741$24281474$1$I$20190207$20190329$20240904$20240904$EXP$$US-SA-2019SA040617$SANOFI AVENTIS$$72$YR$E$M$Y$126.4$KG$20240904$$MD$US$US
242814751$24281475$1$I$20240827$20240903$20240904$20240904$PER$$US-BAYER-2024A126444$BAYER$$70$YR$E$M$Y$$$20240904$$CN$US$US
242814761$24281476$1$I$20240730$20240826$20240904$20240904$EXP$GR-ROCHE-10000043140$GR-Ipsen Biopharmaceuticals, Inc.-2024-17309$IPSEN$$75$YR$E$M$Y$100$KG$20240904$$MD$GR$GR
242814771$24281477$1$I$$20240828$20240904$20240904$EXP$$CA-APOTEX-2024AP010077$APOTEX$$46$YR$$M$Y$$$20240904$$CN$CA$CA
242814781$24281478$1$I$20240821$20240826$20240904$20240904$PER$$US-MYLANLABS-2024M1079128$MYLAN$$70$YR$$F$Y$121.11$KG$20240904$$CN$US$US
242814792$24281479$2$F$$20240920$20240904$20240930$PER$$US-GSK-US2024AMR106400$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$CN$US$US
242814801$24281480$1$I$$20240821$20240904$20240904$EXP$$US-SA-2024SA256051$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240904$$MD$US$US
242814811$24281481$1$I$20100101$20240829$20240904$20240904$PER$$US-JNJFOC-20240881156$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240904$$CN$US$US
242814821$24281482$1$I$$20240903$20240904$20240904$EXP$$US-GILEAD-2024-0686138$GILEAD$$55$YR$A$F$Y$$$20240904$$CN$US$US
242814831$24281483$1$I$$20240829$20240904$20240904$EXP$$CN-Bion-013763$BIONPHARMA$$4$YR$C$F$Y$$$20240904$$HP$CN$CN
242814841$24281484$1$I$20240201$20240826$20240904$20240904$EXP$$US-ROCHE-3524665$ROCHE$$58$YR$A$F$Y$44$KG$20240904$$CN$US$US
242814851$24281485$1$I$$20240820$20240904$20240904$EXP$$GB-AMGEN-GBRSP2024175508$AMGEN$$76$YR$E$F$Y$$$20240904$$MD$GB$GB
242814871$24281487$1$I$20240822$20240823$20240904$20240904$EXP$$US-SA-2024SA256479$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240904$$MD$US$US
242814881$24281488$1$I$$20240904$20240904$20240904$DIR$717042$$FDA-CTU$$$$$UNK$N$$$20240904$N$$US$
242814891$24281489$1$I$20240903$20240904$20240904$20240904$DIR$717033$$FDA-CTU$$54$YR$$F$N$85.5$KG$20240904$N$CN$US$
242814941$24281494$1$I$$20240904$20240904$20240904$DIR$717043$$FDA-CTU$$$$$UNK$N$$$20240904$N$CN$US$
242814961$24281496$1$I$$20240828$20240904$20240904$EXP$$US-Bion-013771$BIONPHARMA$$$$$M$Y$$$20240904$$CN$US$US
242814972$24281497$2$F$$20240925$20240904$20240927$EXP$$US-GILEAD-2024-0686134$GILEAD$$$$A$F$Y$$$20240927$$CN$US$US
242815001$24281500$1$I$20240705$20240830$20240904$20240904$EXP$$ZA-AstraZeneca-2024A199641$ASTRAZENECA$$61$YR$$F$Y$$$20240904$$CN$ZA$
242815011$24281501$1$I$20240809$20240827$20240904$20240904$EXP$$DE-SA-2024SA256527$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240904$$CN$DE$DE
242815021$24281502$1$I$20240101$20240827$20240904$20240904$EXP$$US-SA-2024SA254438$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240904$$CN$US$US
242815032$24281503$2$F$20240724$20240906$20240904$20240918$PER$$US-AstraZeneca-2024A188113$ASTRAZENECA$$82$YR$$F$Y$$$20240918$$CN$US$
242815052$24281505$2$F$20240101$20240917$20240904$20240920$PER$$US-JNJFOC-20240849116$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
242815061$24281506$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-135354-2023$RECKITT BENCKISER$$79$YR$$F$Y$79.55$KG$20240904$$CN$US$US
242815071$24281507$1$I$20230403$20240830$20240904$20240904$EXP$ES-AEMPS-1564682$ES-PFIZER INC-202400247143$PFIZER$$63$YR$$F$Y$$$20240904$$MD$ES$ES
242815081$24281508$1$I$20240101$20240830$20240904$20240904$EXP$$CA-PFIZER INC-202400247541$PFIZER$$83$YR$$F$Y$$$20240904$$MD$CA$CA
242815091$24281509$1$I$$20240829$20240904$20240904$EXP$$JP-PFIZER INC-202400247767$PFIZER$$$$$F$Y$$$20240904$$PH$JP$JP
242815101$24281510$1$I$20240816$20240830$20240904$20240904$EXP$$MX-PFIZER INC-202400247485$PFIZER$$81$YR$$M$Y$$$20240904$$MD$MX$MX
242815111$24281511$1$I$20240720$20240829$20240904$20240904$EXP$FR-AFSSAPS-AM2024000697$FR-PFIZER INC-202400246160$PFIZER$$64$YR$$M$Y$87$KG$20240904$$PH$FR$FR
242815131$24281513$1$I$20220210$20240830$20240904$20240904$EXP$$MY-PFIZER INC-PV202400114419$PFIZER$$69$YR$$F$Y$$$20240904$$MD$MY$MY
242815141$24281514$1$I$20240809$20240829$20240904$20240904$EXP$FR-AFSSAPS-ST2024001355$FR-PFIZER INC-202400246308$PFIZER$$84$YR$$F$Y$60$KG$20240904$$MD$FR$FR
242815151$24281515$1$I$20210719$20240829$20240904$20240904$EXP$FR-AFSSAPS-MA2024001291$FR-PFIZER INC-202400246300$PFIZER$$65$YR$$M$Y$$$20240904$$PH$FR$FR
242815161$24281516$1$I$20240801$20240902$20240904$20240904$EXP$FR-AFSSAPS-LL2024001650$FR-PFIZER INC-202400248197$PFIZER$$87$YR$$F$Y$$$20240904$$MD$FR$FR
242815171$24281517$1$I$$20240828$20240904$20240904$EXP$$JP-PFIZER INC-202400247858$PFIZER$$7$DEC$$F$Y$$$20240904$$MD$JP$JP
242815181$24281518$1$I$20240801$20240830$20240904$20240904$EXP$GB-MHRA-MED-202408291934575550-LZCSB$GB-PFIZER INC-202400247379$PFIZER$$79$YR$$F$Y$68$KG$20240904$$CN$GB$GB
242815191$24281519$1$I$$20240828$20240904$20240904$EXP$$US-SA-2024SA256633$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240904$$CN$US$US
242815201$24281520$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140278$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$64.41$KG$20240904$$CN$US$US
242815211$24281521$1$I$$20240828$20240904$20240904$EXP$$CA-GSK-CA2024107170$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$CA$CA
242815221$24281522$1$I$20240101$20240828$20240904$20240904$EXP$$US-BAYER-2024A123738$BAYER$$$$$$Y$$$20240904$$CN$US$US
242815233$24281523$3$F$20221229$20240919$20240904$20240923$EXP$$PT-SA-2024SA255860$SANOFI AVENTIS$Soares M, Rosa S, Bettencourt S, Ferreira R, Sardinha M, Dias M, et al.. Cytotoxic lesions of the corpus callosum due to FOLFIRINOX chemotherapy.. Brain Disorders.. 2024;15:1-4$47$YR$A$F$Y$$$20240923$$MD$PT$PT
242815241$24281524$1$I$20240601$20240829$20240904$20240904$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004832$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240904$$CN$US$US
242815251$24281525$1$I$$20240828$20240904$20240904$EXP$$US-BEH-2024178063$CSL BEHRING$$83$YR$E$F$Y$$$20240904$$CN$US$US
242815263$24281526$3$F$$20240911$20240904$20240912$EXP$$US-GILEAD-2024-0686152$GILEAD$$$$E$F$Y$$$20240912$$HP$US$US
242815271$24281527$1$I$$20240902$20240904$20240904$EXP$$US-GILEAD-2024-0686153$GILEAD$$$$E$F$Y$$$20240904$$CN$US$US
242815282$24281528$2$F$$20240903$20240904$20240906$EXP$$NL-SA-2024SA256221$SANOFI AVENTIS$Klingenberg MG, Sinkeler SJ, Koopmans N, Plaat RE.. Severe hypotension requiring resuscitation in tumour-related carotid sinus syndrome: a case report.. European Heart Journal - Case Reports.. 2024;8(8):1-4$57$YR$A$F$Y$$$20240906$$HP$NL$NL
242815291$24281529$1$I$$20240830$20240904$20240904$EXP$$US-AMGEN-USASP2024174399$AMGEN$$$$$$Y$$$20240904$$HP$US$US
242815311$24281531$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001540$ELI LILLY AND CO$$$$$M$Y$$$20240904$$CN$US$US
242815321$24281532$1$I$$20240822$20240904$20240904$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08564$LUPIN$Reinfeld S, Gill P.. Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: A case series. Central nervous system spectrums. 2022;28(5):587-591$12$YR$$F$Y$$$20240904$$HP$US$US
242815331$24281533$1$I$20240831$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001581$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240904$$CN$US$US
242815341$24281534$1$I$$20240829$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000014$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240904$$CN$US$US
242815351$24281535$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001680$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240904$$CN$US$US
242815361$24281536$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001334$ELI LILLY AND CO$$$$$F$Y$$$20240904$$CN$US$US
242815371$24281537$1$I$20240605$20240828$20240904$20240904$EXP$$JP-EXELIXIS-CABO-24081101$EXELIXIS$$6$DEC$$M$Y$$$20240904$$MD$JP$JP
242815381$24281538$1$I$$20240828$20240904$20240904$EXP$$JP-EXELIXIS-CABO-24079910$EXELIXIS$$7$DEC$$M$Y$$$20240904$$MD$JP$JP
242815391$24281539$1$I$20240821$20240828$20240904$20240904$PER$$US-JNJFOC-20240876242$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240904$$CN$US$US
242815402$24281540$2$F$$20240904$20240904$20240905$PER$$US-JNJFOC-20240907438$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242815411$24281541$1$I$$20240823$20240904$20240904$EXP$$PT-EMD Serono-2024045484$EMD SERONO INC$Novais C., Cruz AM . CO 55- Desafios inesperados: Reconhecer os efeitos adversos graves dos antidiab?ticos orais . Revista Portuguesa de Medicina Geral e Familiar, 41? Encontro Nacional de Medicina Geral e Familiar . 2024;Vol 40 (Suplemento 13):.$80$YR$E$F$Y$$$20240904$$MD$PT$PT
242815442$24281544$2$F$20240822$20240912$20240904$20240920$30DAY$$US-ALKERMES INC.-ALK-2024-002197$ALKERMES$$34$YR$$M$Y$$$20240920$$HP$US$US
242815461$24281546$1$I$20240101$20240826$20240904$20240904$PER$$US-ABBVIE-5897946$ABBVIE$$$$$F$Y$$$20240904$$MD$US$US
242815471$24281547$1$I$20230601$20240507$20240904$20240904$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06748$HIKMA$Haghparast P, Nadybal M, Yuan C.. Haghparast P, Nadybal M, Yuan C. Treatment-Resistant Priapism in a 61-Year-Old Male After Combined Use of Trazodone, Quetiapine, and Fluoxetine. Journal of clinical psychopharmacology. 2024;44(3):316-7$61$YR$$M$Y$105$KG$20240904$$PH$US$US
242815481$24281548$1$I$$20240830$20240904$20240904$EXP$$US-GILEAD-2024-0686083$GILEAD$$72$YR$E$F$Y$$$20240904$$CN$US$US
242815491$24281549$1$I$$20240826$20240904$20240904$EXP$$US-ROCHE-10000066961$ROCHE$$60$YR$A$F$Y$$$20240904$$CN$US$US
242815521$24281552$1$I$$20240902$20240904$20240904$EXP$$GB-AMGEN-GBRSP2024175384$AMGEN$$92$YR$E$M$Y$$$20240904$$CN$GB$GB
242815532$24281553$2$F$20240826$20240912$20240904$20240924$30DAY$$US-ALKERMES INC.-ALK-2024-002239$ALKERMES$$33$YR$$F$Y$$$20240925$$PH$US$US
242815541$24281554$1$I$$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024173084$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242815551$24281555$1$I$20240814$20240830$20240904$20240904$EXP$$US-GILEAD-2024-0685913$GILEAD$$70$YR$E$F$Y$$$20240904$$HP$US$US
242815561$24281556$1$I$$20240828$20240904$20240904$EXP$$CA-APOTEX-2024AP010121$APOTEX$$66$YR$$F$Y$$$20240904$$CN$CA$CA
242815571$24281557$1$I$$20240830$20240904$20240904$EXP$$NVSC2024US175692$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
242815581$24281558$1$I$20240807$20240901$20240901$20240901$DIR$716784$$FDA-CTU$$70$YR$$M$N$84.15$KG$20240901$Y$CN$US$
242815591$24281559$1$I$$20240904$20240904$20240904$DIR$717047$$FDA-CTU$$$$$UNK$N$$$20240904$N$CN$US$
242815601$24281560$1$I$20240801$20240901$20240901$20240901$DIR$716816$$FDA-CTU$$52$YR$$F$N$74.25$KG$20240901$N$CN$US$
242815631$24281563$1$I$20240808$20240901$20240901$20240901$DIR$716796$$FDA-CTU$$31$YR$$M$N$51.75$KG$20240901$Y$CN$US$
242815641$24281564$1$I$20240824$20240904$20240904$20240904$DIR$717030$$FDA-CTU$$44$YR$$F$N$72.9$KG$20240904$N$CN$US$
242815671$24281567$1$I$$20240829$20240904$20240904$PER$$US-ROCHE-10000069973$ROCHE$$$$$F$Y$$$20240904$$MD$US$US
242815681$24281568$1$I$$20240607$20240904$20240904$PER$$US-GE HEALTHCARE-2024CSU006408$GE HEALTHCARE$$$$$F$Y$$$20240904$$HP$US$US
242815691$24281569$1$I$20240521$20240607$20240904$20240904$PER$$US-GE HEALTHCARE-2024CSU006453$GE HEALTHCARE$$60$YR$$F$Y$71.655$KG$20240904$$HP$US$US
242815702$24281570$2$F$20240809$20240812$20240904$20240906$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000805$PAREXEL$$$$$$Y$$$20240906$$PH$US$US
242815721$24281572$1$I$$20240812$20240904$20240904$EXP$$BR-TAKEDA-2024TUS088162$TAKEDA$$$$$M$Y$$$20240904$$CN$BR$BR
242815731$24281573$1$I$$20240826$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136946$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$PH$US$US
242815741$24281574$1$I$20240101$20240715$20240904$20240904$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000101$UROGEN PHARMA$$$$$$Y$$$20240904$$MD$US$US
242815761$24281576$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-081999-2024$RECKITT BENCKISER$$80$YR$$M$Y$$$20240904$$CN$US$US
242815771$24281577$1$I$20240715$20240722$20240904$20240904$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000100$UROGEN PHARMA$$$$$$Y$$$20240904$$HP$US$US
242815781$24281578$1$I$20240803$20240813$20240904$20240904$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000099$UROGEN PHARMA$$$$$$Y$$$20240904$$MD$US$US
242815791$24281579$1$I$20240711$20240712$20240904$20240904$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000098$UROGEN PHARMA$$$$$$Y$$$20240904$$MD$US$US
242815811$24281581$1$I$$20240709$20240904$20240904$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000093$UROGEN PHARMA$$$$$$Y$$$20240904$$MD$US$US
242815821$24281582$1$I$$20240830$20240904$20240904$EXP$$CA-GILEAD-2024-0685930$GILEAD$$57$YR$A$M$Y$84$KG$20240904$$HP$CA$CA
242815831$24281583$1$I$$20240828$20240904$20240904$EXP$$NVSC2024US176016$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
242815851$24281585$1$I$20240627$20240829$20240904$20240904$EXP$$US-ABBVIE-5773184$ABBVIE$$30$YR$$F$Y$70.76$KG$20240904$$CN$US$US
242815861$24281586$1$I$$20240902$20240904$20240904$EXP$$AU-ABBVIE-5905221$ABBVIE$$73$YR$$F$Y$$$20240904$$HP$AU$AU
242815871$24281587$1$I$$20240819$20240904$20240904$PER$$US-APOTEX-2024AP009588$APOTEX$$$$$F$Y$$$20240904$$CN$US$US
242815882$24281588$2$F$$20240904$20240904$20240904$30DAY$$US-PFIZER INC-202400245827$PFIZER$$41$YR$$F$Y$$$20240904$$CN$US$US
242815891$24281589$1$I$$20240826$20240904$20240904$EXP$$US-ABBVIE-5898485$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242815901$24281590$1$I$20240630$20240829$20240904$20240904$EXP$$IE-PFIZER INC-PV202400093136$PFIZER$$8$YR$$M$Y$23$KG$20240904$$CN$IE$IE
242815921$24281592$1$I$$20240827$20240904$20240904$30DAY$$CA-PFIZER INC-202400249181$PFIZER$$$$$$Y$$$20240904$$CN$CA$CA
242815931$24281593$1$I$20240826$20240829$20240904$20240904$30DAY$$US-PFIZER INC-202400246851$PFIZER$$2$YR$$M$Y$10.091$KG$20240904$$CN$US$US
242815961$24281596$1$I$$20240822$20240904$20240904$30DAY$$CO-PFIZER INC-PV202400110423$PFIZER$$$$$M$Y$$$20240904$$CN$CO$CO
242815971$24281597$1$I$$20240901$20240904$20240904$EXP$$GB-PFIZER INC-PV202400114729$PFIZER$$66$YR$$M$Y$$$20240904$$CN$GB$GB
242815992$24281599$2$F$20240801$20240829$20240904$20240905$30DAY$$US-PFIZER INC-202400244207$PFIZER$$13$YR$$M$Y$33.57$KG$20240905$$CN$US$US
242816011$24281601$1$I$20240731$20240829$20240904$20240904$EXP$FR-AFSSAPS-PB2024000882$FR-009507513-2408FRA010779$MERCK$$58$YR$$F$Y$$$20240904$$MD$FR$FR
242816031$24281603$1$I$$20240826$20240904$20240904$EXP$$CA-GSK-CA2023130218$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$CA$CA
242816043$24281604$3$F$$20240905$20240904$20240911$30DAY$$US-PFIZER INC-202400244595$PFIZER$$12$YR$$M$Y$$$20240911$$CN$US$US
242816051$24281605$1$I$$20240830$20240904$20240904$30DAY$$KR-PFIZER INC-PV202400114554$PFIZER$$12$YR$$M$Y$$$20240904$$CN$KR$KR
242816072$24281607$2$F$20240903$20240904$20240904$20240909$PER$$US-AMGEN-USASP2024176023$AMGEN$$48$YR$A$F$Y$$$20240909$$CN$US$US
242816081$24281608$1$I$20240710$20240902$20240904$20240904$EXP$$DE-SANDOZ INC.-SDZ2024DE077104$SANDOZ$$75$YR$$M$Y$$$20240904$$MD$DE$DE
242816091$24281609$1$I$20240222$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-086332-2024$RECKITT BENCKISER$$69$YR$$F$Y$$$20240904$$CN$US$US
242816101$24281610$1$I$$20240823$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN008930$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242816111$24281611$1$I$20240801$20240624$20240904$20240904$PER$$US-SA-2024SA253110$SANOFI AVENTIS$$77$YR$E$F$Y$81.65$KG$20240904$$CN$US$US
242816121$24281612$1$I$20240101$20240821$20240904$20240904$PER$$US-SA-2024SA255790$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240904$$MD$US$US
242816131$24281613$1$I$20240101$20240820$20240904$20240904$PER$$US-SA-2024SA252353$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240904$$MD$US$US
242816141$24281614$1$I$20220101$20240821$20240904$20240904$PER$$US-SA-2024SA254220$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240904$$MD$US$US
242816152$24281615$2$F$20240101$20240906$20240904$20240920$PER$$US-SA-2024SA254575$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240920$$MD$US$US
242816161$24281616$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA252508$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240904$$CN$US$US
242816171$24281617$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA254574$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240904$$MD$US$US
242816181$24281618$1$I$20240817$20240821$20240904$20240904$PER$$US-SA-2024SA253030$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240904$$CN$US$US
242816191$24281619$1$I$20240101$20240821$20240904$20240904$PER$$US-SA-2024SA255803$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240904$$MD$US$US
242816201$24281620$1$I$$20240820$20240904$20240904$PER$$US-SA-2024SA252782$SANOFI AVENTIS$$$$A$M$Y$$$20240904$$MD$US$US
242816211$24281621$1$I$20230915$20240901$20240901$20240901$DIR$716817$$FDA-CTU$$63$YR$$F$N$78.75$KG$20240901$Y$CN$US$
242816221$24281622$1$I$20240715$20240901$20240901$20240901$DIR$716793$$FDA-CTU$$23$YR$$M$N$99$KG$20240901$N$CN$US$
242816231$24281623$1$I$20240101$20240821$20240904$20240904$PER$$US-SA-2024SA254681$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240904$$MD$US$US
242816241$24281624$1$I$20240801$20240821$20240904$20240904$PER$$US-SA-2024SA252768$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240904$$CN$US$US
242816251$24281625$1$I$20240101$20240821$20240904$20240904$PER$$US-SA-2024SA254930$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240904$$MD$US$US
242816262$24281626$2$F$20210301$20240821$20240904$20240916$PER$$US-SA-2024SA255820$SANOFI AVENTIS$$$$A$F$Y$1$KG$20240916$$MD$US$US
242816271$24281627$1$I$20240801$20240821$20240904$20240904$PER$$US-SA-2024SA254985$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240904$$MD$US$US
242816281$24281628$1$I$20240101$20240820$20240904$20240904$PER$$US-SA-2024SA252906$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240904$$CN$US$US
242816291$24281629$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA255899$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240904$$MD$US$US
242816301$24281630$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA255072$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240904$$MD$US$US
242816311$24281631$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA255907$SANOFI AVENTIS$$$$A$F$Y$$$20240904$$HP$US$US
242816321$24281632$1$I$20240101$20240821$20240904$20240904$PER$$US-SA-2024SA252325$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240904$$CN$US$US
242816331$24281633$1$I$20240601$20240821$20240904$20240904$PER$$US-SA-2024SA252317$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240904$$MD$US$US
242816341$24281634$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA255722$SANOFI AVENTIS$$$$A$F$Y$$$20240904$$CN$US$US
242816351$24281635$1$I$20240101$20240820$20240904$20240904$PER$$US-SA-2024SA254504$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240904$$CN$US$US
242816361$24281636$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA252486$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240904$$CN$US$US
242816371$24281637$1$I$20090101$20240821$20240904$20240904$PER$$US-SA-2024SA253837$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240904$$CN$US$US
242816381$24281638$1$I$20240801$20240821$20240904$20240904$PER$$US-SA-2024SA253089$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240904$$MD$US$US
242816391$24281639$1$I$20240801$20240821$20240904$20240904$PER$$US-SA-2024SA255543$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240904$$MD$US$US
242816401$24281640$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA255355$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240904$$MD$US$US
242816411$24281641$1$I$$20240820$20240904$20240904$PER$$US-SA-2024SA252404$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240904$$MD$US$US
242816421$24281642$1$I$20240101$20240821$20240904$20240904$PER$$US-SA-2024SA255670$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240904$$HP$US$US
242816431$24281643$1$I$$20240820$20240904$20240904$PER$$US-SA-2024SA252748$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240904$$CN$US$US
242816441$24281644$1$I$20240301$20240821$20240904$20240904$PER$$US-SA-2024SA256009$SANOFI AVENTIS$$$$A$F$Y$$$20240904$$CN$US$US
242816451$24281645$1$I$20240118$20240823$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN008927$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242816462$24281646$2$F$20230101$20240822$20240904$20240910$PER$$US-SA-2024SA252683$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240910$$MD$US$US
242816471$24281647$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA254969$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240904$$CN$US$US
242816482$24281648$2$F$20240909$20240909$20240904$20240918$PER$$US-SA-2024SA253093$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240918$$MD$US$US
242816491$24281649$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA254734$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240904$$MD$US$US
242816501$24281650$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA255056$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240904$$MD$US$US
242816511$24281651$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA253857$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240904$$HP$US$US
242816521$24281652$1$I$20240601$20240822$20240904$20240904$PER$$US-SA-2024SA253681$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240904$$CN$US$US
242816531$24281653$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA254971$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240904$$MD$US$US
242816541$24281654$1$I$20240101$20240820$20240904$20240904$PER$$US-SA-2024SA255746$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240904$$MD$US$US
242816551$24281655$1$I$$20240822$20240904$20240904$PER$$US-SA-2023SA101101$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240904$$MD$US$US
242816561$24281656$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA255615$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240904$$MD$US$US
242816571$24281657$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA254970$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240904$$MD$US$US
242816581$24281658$1$I$20240101$20240822$20240904$20240904$PER$$US-SA-2024SA252402$SANOFI AVENTIS$$$$A$F$Y$$$20240904$$MD$US$US
242816591$24281659$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA255718$SANOFI AVENTIS$$$$A$M$Y$$$20240904$$CN$US$US
242816601$24281660$1$I$20240701$20240822$20240904$20240904$PER$$US-SA-2024SA255741$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240904$$MD$US$US
242816613$24281661$3$F$20240822$20240830$20240904$20240917$PER$$US-SA-2024SA254289$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240918$$MD$US$US
242816621$24281662$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA256499$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240904$$MD$US$US
242816631$24281663$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA255463$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240904$$MD$US$US
242816641$24281664$1$I$20240101$20240822$20240904$20240904$PER$$US-SA-2024SA255938$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240904$$MD$US$US
242816652$24281665$2$F$$20240822$20240904$20240905$PER$$US-SA-2024SA253422$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240905$$HP$US$US
242816661$24281666$1$I$20240101$20240822$20240904$20240904$PER$$US-SA-2024SA252815$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240904$$CN$US$US
242816671$24281667$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA254763$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240904$$MD$US$US
242816681$24281668$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA256025$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240904$$MD$US$US
242816691$24281669$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA255053$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240904$$MD$US$US
242816701$24281670$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA252387$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240904$$MD$US$US
242816711$24281671$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA256071$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240904$$MD$US$US
242816721$24281672$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA255048$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240904$$MD$US$US
242816731$24281673$1$I$20240801$20240822$20240904$20240904$PER$$US-SA-2024SA254975$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240904$$MD$US$US
242816741$24281674$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA254752$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240904$$MD$US$US
242816751$24281675$1$I$20240101$20240823$20240904$20240904$PER$$US-SA-2024SA253269$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240904$$CN$US$US
242816761$24281676$1$I$20240101$20240822$20240904$20240904$PER$$US-SA-2024SA255664$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240904$$MD$US$US
242816772$24281677$2$F$20240101$20240822$20240904$20240917$PER$$US-SA-2024SA256537$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240918$$MD$US$US
242816781$24281678$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA255840$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240904$$MD$US$US
242816791$24281679$1$I$20240801$20240822$20240904$20240904$PER$$US-SA-2024SA255312$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240904$$MD$US$US
242816801$24281680$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA255814$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240904$$MD$US$US
242816811$24281681$1$I$20240101$20240822$20240904$20240904$PER$$US-SA-2024SA256493$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240904$$HP$US$US
242816821$24281682$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA254334$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240904$$CN$US$US
242816831$24281683$1$I$20240830$20240829$20240904$20240904$EXP$$GB-MYLANLABS-2024M1080270$MYLAN$$$$$M$Y$$$20240904$$MD$GB$GB
242816841$24281684$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA255983$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240904$$MD$US$US
242816851$24281685$1$I$$20240822$20240904$20240904$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08561$LUPIN$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73(200):1-9$75$YR$$F$Y$$$20240904$$HP$US$US
242816861$24281686$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA254080$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240904$$MD$US$US
242816871$24281687$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA255758$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240904$$MD$US$US
242816881$24281688$1$I$20240822$20240823$20240904$20240904$PER$$US-SA-2024SA253754$SANOFI AVENTIS$$90$YR$E$M$Y$$$20240904$$MD$US$US
242816891$24281689$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA253536$SANOFI AVENTIS$$$$$F$Y$$$20240904$$CN$US$US
242816901$24281690$1$I$20230101$20240823$20240904$20240904$PER$$US-SA-2024SA255324$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240904$$MD$US$US
242816911$24281691$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA256053$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240904$$MD$US$US
242816921$24281692$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA253277$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240904$$CN$US$US
242816931$24281693$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA255775$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240904$$MD$US$US
242816941$24281694$1$I$$20240828$20240904$20240904$EXP$$CA-APOTEX-2024AP010087$APOTEX$$56$YR$$F$Y$$$20240904$$CN$CA$CA
242816951$24281695$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA256060$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240904$$MD$US$US
242816961$24281696$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA255626$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240904$$MD$US$US
242816971$24281697$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA253115$SANOFI AVENTIS$$$$$F$Y$$$20240904$$HP$US$US
242816983$24281698$3$F$20240821$20240901$20240904$20240926$PER$$US-SA-2024SA255094$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240926$$CN$US$US
242816991$24281699$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA254253$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240904$$MD$US$US
242817001$24281700$1$I$20240101$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024174097$AMGEN$$47$YR$A$F$Y$$$20240904$$CN$US$US
242817011$24281701$1$I$$20240827$20240904$20240904$PER$$US-SA-2024SA254371$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240904$$CN$US$US
242817021$24281702$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA251063$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240904$$CN$US$US
242817041$24281704$1$I$20240826$20240826$20240904$20240904$PER$$US-SA-2024SA253487$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240904$$MD$US$US
242817052$24281705$2$F$$20240905$20240904$20240916$PER$$US-SA-2024SA256546$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240916$$HP$US$US
242817061$24281706$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA253631$SANOFI AVENTIS$$13$YR$T$F$Y$62$KG$20240904$$MD$US$US
242817071$24281707$1$I$20240824$20240826$20240904$20240904$PER$$US-SA-2024SA256223$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240904$$PH$US$US
242817081$24281708$1$I$20240827$20240828$20240904$20240904$PER$$US-SA-2024SA255619$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240904$$PH$US$US
242817091$24281709$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA254177$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240904$$CN$US$US
242817101$24281710$1$I$$20240828$20240904$20240904$PER$$US-SA-2024SA256342$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240904$$HP$US$US
242817111$24281711$1$I$20240801$20240826$20240904$20240904$PER$$US-SA-2024SA256048$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240904$$CN$US$US
242817121$24281712$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA255532$SANOFI AVENTIS$$$$$F$Y$$$20240904$$CN$US$US
242817131$24281713$1$I$20240726$20240826$20240904$20240904$PER$$US-SA-2024SA254156$SANOFI AVENTIS$$68$YR$E$F$Y$79.55$KG$20240904$$CN$US$US
242817151$24281715$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA253679$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240904$$MD$US$US
242817171$24281717$1$I$$20240827$20240904$20240904$PER$$US-SA-2024SA256375$SANOFI AVENTIS$$33$YR$A$$Y$$$20240904$$MD$US$US
242817181$24281718$1$I$20240101$20240826$20240904$20240904$PER$$US-SA-2024SA255577$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240904$$MD$US$US
242817191$24281719$1$I$20240801$20240828$20240904$20240904$PER$$US-SA-2024SA252727$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240904$$CN$US$US
242817201$24281720$1$I$$20240827$20240904$20240904$PER$$US-SA-2024SA198241$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240904$$MD$US$US
242817211$24281721$1$I$20240801$20240827$20240904$20240904$PER$$US-SA-2024SA252890$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240904$$CN$US$US
242817221$24281722$1$I$20240101$20240827$20240904$20240904$PER$$US-SA-2024SA255318$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240904$$CN$US$US
242817231$24281723$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA255636$SANOFI AVENTIS$$$$A$M$Y$$$20240904$$MD$US$US
242817251$24281725$1$I$20240101$20240828$20240904$20240904$PER$$US-SA-2024SA253058$SANOFI AVENTIS$$$$A$M$Y$$$20240904$$CN$US$US
242817262$24281726$2$F$20240101$20240912$20240904$20240923$PER$$US-SA-2024SA255724$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$MD$US$US
242817271$24281727$1$I$20240801$20240827$20240904$20240904$PER$$US-SA-2024SA252328$SANOFI AVENTIS$$$$A$M$Y$$$20240904$$CN$US$US
242817281$24281728$1$I$20240810$20240827$20240904$20240904$PER$$US-SA-2024SA256015$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240904$$MD$US$US
242817291$24281729$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA255032$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240904$$MD$US$US
242817301$24281730$1$I$20240801$20240826$20240904$20240904$PER$$US-SA-2024SA050419$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240904$$HP$US$US
242817311$24281731$1$I$$20240827$20240904$20240904$PER$$US-SA-2024SA255386$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240904$$MD$US$US
242817321$24281732$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA117058$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240904$$CN$US$US
242817331$24281733$1$I$20240823$20240826$20240904$20240904$PER$$US-SA-2024SA253191$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240904$$HP$US$US
242817341$24281734$1$I$20230201$20240823$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN008908$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242817351$24281735$1$I$$20240829$20240904$20240904$PER$$US-SA-2024SA255618$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240904$$HP$US$US
242817361$24281736$1$I$20240828$20240829$20240904$20240904$PER$$US-SA-2024SA253635$SANOFI AVENTIS$$14$YR$T$M$Y$57$KG$20240904$$MD$US$US
242817371$24281737$1$I$20240827$20240829$20240904$20240904$PER$$US-SA-2024SA255609$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240904$$MD$US$US
242817381$24281738$1$I$$20240827$20240904$20240904$PER$$US-SA-2024SA256337$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240904$$MD$US$US
242817391$24281739$1$I$$20240828$20240904$20240904$PER$$US-SA-2024SA255174$SANOFI AVENTIS$$15$YR$T$F$Y$57$KG$20240904$$HP$US$US
242817401$24281740$1$I$$20240828$20240904$20240904$PER$$US-SA-2024SA254885$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240904$$MD$US$US
242817411$24281741$1$I$$20240827$20240904$20240904$PER$$US-SA-2024SA254176$SANOFI AVENTIS$$$$$M$Y$$$20240904$$MD$US$US
242817421$24281742$1$I$20240801$20240829$20240904$20240904$PER$$US-SA-2024SA255424$SANOFI AVENTIS$$$$A$$Y$$$20240904$$HP$US$US
242817432$24281743$2$F$$20240828$20240904$20240906$PER$$US-SA-2024SA253579$SANOFI AVENTIS$$$$$F$Y$$$20240906$$HP$US$US
242817441$24281744$1$I$20240101$20240829$20240904$20240904$PER$$US-SA-2024SA255413$SANOFI AVENTIS$$$$$$Y$$$20240904$$HP$US$US
242817451$24281745$1$I$20240801$20240826$20240904$20240904$PER$$US-SA-2024SA256515$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240904$$MD$US$US
242817471$24281747$1$I$$20240829$20240904$20240904$PER$$US-SA-2024SA255572$SANOFI AVENTIS$$$$$F$Y$$$20240904$$CN$US$US
242817482$24281748$2$F$20240101$20240827$20240904$20240909$PER$$US-SA-2024SA252425$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240909$$CN$US$US
242817491$24281749$1$I$20240601$20240829$20240904$20240904$PER$$US-SA-2024SA253148$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240904$$CN$US$US
242817502$24281750$2$F$20240901$20240903$20240904$20240909$30DAY$$KR-PFIZER INC-PV202400114596$PFIZER$$$$$$Y$$$20240909$$CN$KR$KR
242817511$24281751$1$I$$20240828$20240904$20240904$EXP$$GB-ABBVIE-5902660$ABBVIE$$$$A$M$Y$$$20240904$$CN$GB$GB
242817521$24281752$1$I$20240818$20240829$20240904$20240904$30DAY$$US-PFIZER INC-202400247286$PFIZER$$31$YR$$F$Y$$$20240904$$CN$US$US
242817531$24281753$1$I$$20240902$20240904$20240904$30DAY$$CO-PFIZER INC-PV202400114840$PFIZER$$7$YR$$F$Y$$$20240904$$CN$CO$CO
242817541$24281754$1$I$$20240902$20240904$20240904$30DAY$$US-PFIZER INC-PV202400044394$PFIZER$$$$$$Y$$$20240904$$HP$US$US
242817551$24281755$1$I$20240801$20240826$20240904$20240904$30DAY$$US-PFIZER INC-202400244151$PFIZER$$8$YR$$M$Y$$$20240904$$CN$US$US
242817581$24281758$1$I$$20240829$20240904$20240904$30DAY$$GB-PFIZER INC-PV202400113062$PFIZER$$77$YR$$F$Y$$$20240904$$CN$GB$GB
242817592$24281759$2$F$$20240920$20240904$20240925$30DAY$$US-PFIZER INC-202400247479$PFIZER$$87$YR$$F$Y$63.5$KG$20240925$$CN$US$US
242817611$24281761$1$I$20240830$20240830$20240904$20240904$30DAY$$GB-PFIZER INC-PV202400113824$PFIZER$$7$YR$$M$Y$$$20240904$$CN$GB$GB
242817631$24281763$1$I$$20240902$20240904$20240904$EXP$$IN-PFIZER INC-202400248331$PFIZER$$$$$F$Y$$$20240904$$MD$IN$IN
242817641$24281764$1$I$20240801$20240830$20240904$20240904$EXP$$KR-PFIZER INC-202400247339$PFIZER$$10$YR$$M$Y$$$20240904$$CN$KR$KR
242817651$24281765$1$I$$20240904$20240904$20240904$30DAY$$US-PFIZER INC-PV202400099109$PFIZER$$$$$$Y$$$20240904$$CN$US$US
242817661$24281766$1$I$20240101$20240829$20240904$20240904$30DAY$$GR-PFIZER INC-PV202400113843$PFIZER$$17$YR$$M$Y$68$KG$20240904$$CN$GR$GR
242817682$24281768$2$F$$20240830$20240904$20240909$PER$$US-SA-2024SA255518$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240909$$CN$US$US
242817691$24281769$1$I$20230201$20240830$20240904$20240904$PER$$US-SA-2024SA255735$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240904$$MD$US$US
242817701$24281770$1$I$$20240830$20240904$20240904$PER$$US-SA-2024SA255614$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240904$$CN$US$US
242817712$24281771$2$F$20240801$20240902$20240904$20240913$PER$$US-SA-2024SA255982$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240913$$MD$US$US
242817721$24281772$1$I$20240101$20240826$20240904$20240904$EXP$$BR-TEVA-VS-3238212$TEVA$$$$$F$Y$$$20240904$$MD$BR$BR
242817731$24281773$1$I$$20240820$20240904$20240904$EXP$$PT-SA-2024SA255599$SANOFI AVENTIS$$$$E$$Y$$$20240904$$HP$PT$PT
242817741$24281774$1$I$$20240827$20240904$20240904$EXP$$US-RDY-SPO/USA/24/0012748$DR REDDYS$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Cancer Journal. 2023;13(1): doi:10.1038/s41408-023-00859-x.$$$$$Y$$$20240904$$HP$US$US
242817751$24281775$1$I$$20240827$20240904$20240904$EXP$$US-RDY-SPO/USA/24/0012745$DR REDDYS$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Cancer Journal. 2023;13(1): doi:10.1038/s41408-023-00859-x.$$$$$Y$$$20240904$$HP$US$US
242817761$24281776$1$I$$20240827$20240904$20240904$EXP$$US-RDY-SPO/USA/24/0012747$DR REDDYS$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Cancer Journal. 2023;13(1): doi:10.1038/s41408-023-00859-x.$$$$$Y$$$20240904$$HP$US$US
242817771$24281777$1$I$$20240827$20240904$20240904$EXP$$US-RDY-SPO/USA/24/0012744$DR REDDYS$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Cancer Journal. 2023;13(1): doi:10.1038/s41408-023-00859-x.$$$$$Y$$$20240904$$HP$US$US
242817781$24281778$1$I$$20240830$20240904$20240904$PER$$US-BIOGEN-2024BI01257843$BIOGEN$$$$$F$Y$$$20240904$$CN$US$US
242817791$24281779$1$I$$20240830$20240904$20240904$PER$$US-BIOGEN-2024BI01277499$BIOGEN$$$$$F$Y$$$20240904$$CN$US$US
242817801$24281780$1$I$$20240830$20240904$20240904$EXP$$US-SANDOZ INC.-SDZ2024US062131$SANDOZ$$$$$F$Y$$$20240904$$CN$US$US
242817811$24281781$1$I$20240816$20240823$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN008907$INCYTE$$$$$$Y$$$20240904$$HP$US$US
242817821$24281782$1$I$$20240830$20240904$20240904$PER$$US-HALEON-2194691$Haleon PLC$$$$$$Y$$$20240904$$CN$US$US
242817831$24281783$1$I$20231201$20240829$20240904$20240904$PER$$US-BAYER-2024A122180$BAYER$$56$YR$A$F$Y$$$20240904$$CN$US$US
242817841$24281784$1$I$20230628$20240902$20240904$20240904$EXP$$CO-UCBSA-2024044937$UCB$$65$YR$$F$Y$$$20240904$$CN$CO$CO
242817851$24281785$1$I$20240827$20240904$20240904$20240904$DIR$717040$$FDA-CTU$$64$YR$$F$N$91.35$KG$20240904$N$CN$US$
242817861$24281786$1$I$$20240823$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN008906$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242817871$24281787$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA255954$SANOFI AVENTIS$$$$A$F$Y$$$20240904$$MD$US$US
242817881$24281788$1$I$20240902$20240904$20240904$20240904$DIR$717031$$FDA-CTU$$$$$UNK$N$$$20240904$N$HP$US$
242817901$24281790$1$I$20240805$20240904$20240904$20240904$DIR$717037$$FDA-CTU$$43$YR$$M$N$110.7$KG$20240904$N$CN$US$
242817912$24281791$2$F$20240601$20240912$20240904$20240917$PER$$US-SA-2024SA255987$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240918$$MD$US$US
242817921$24281792$1$I$20240624$20240820$20240904$20240904$PER$$US-SA-2024SA256215$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240904$$MD$US$US
242817931$24281793$1$I$20240101$20240821$20240904$20240904$PER$$US-SA-2024SA256050$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240904$$MD$US$US
242817941$24281794$1$I$20240501$20240827$20240904$20240904$PER$$US-SA-2024SA255629$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240904$$HP$US$US
242817961$24281796$1$I$$20240901$20240904$20240904$PER$$US-SA-2024SA254049$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240904$$HP$US$US
242817971$24281797$1$I$20240101$20240821$20240904$20240904$PER$$US-SA-2024SA255796$SANOFI AVENTIS$$10$YR$C$M$Y$52$KG$20240904$$HP$US$US
242817981$24281798$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA255902$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240904$$MD$US$US
242817992$24281799$2$F$$20240917$20240904$20240923$PER$$US-SA-2023SA386422$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240923$$MD$US$US
242818001$24281800$1$I$20240101$20240820$20240904$20240904$PER$$US-SA-2024SA254234$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240904$$MD$US$US
242818021$24281802$1$I$20230101$20240823$20240904$20240904$EXP$$JP-UCBSA-2023045395$UCB$$3$DEC$$F$Y$$$20240904$$MD$JP$JP
242818031$24281803$1$I$$20240820$20240904$20240904$EXP$$TH-APCER-AZR202408-000460$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$11$YR$$M$Y$$$20240904$$HP$TH$TH
242818041$24281804$1$I$$20240820$20240904$20240904$EXP$$TH-APCER-AZR202408-000459$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$12$YR$$M$Y$$$20240904$$HP$TH$TH
242818051$24281805$1$I$$20240820$20240904$20240904$EXP$$TH-APCER-AZR202408-000461$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$23$YR$$F$Y$$$20240904$$HP$TH$TH
242818061$24281806$1$I$$20240820$20240904$20240904$EXP$$TH-AZURITY PHARMACEUTICALS, INC.-AZR202408-000458$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep. 2024;14(1):18548$12$YR$$F$Y$$$20240904$$HP$TH$TH
242818072$24281807$2$F$20240316$20240918$20240904$20240927$PER$$US-INCYTE CORPORATION-2024IN008891$INCYTE$$$$$$Y$$$20240927$$CN$US$US
242818081$24281808$1$I$$20240820$20240904$20240904$EXP$$TH-APCER-AZR202408-000462$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$67$YR$$M$Y$$$20240904$$HP$TH$TH
242818091$24281809$1$I$$20240820$20240904$20240904$EXP$$TH-APCER-AZR202408-000463$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$48$YR$$M$Y$$$20240904$$HP$TH$TH
242818101$24281810$1$I$$20240820$20240904$20240904$EXP$$TH-APCER-AZR202408-000464$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$51$YR$$M$Y$$$20240904$$HP$TH$TH
242818111$24281811$1$I$$20240820$20240904$20240904$EXP$$TH-APCER-AZR202408-000465$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$31$YR$$M$Y$$$20240904$$HP$TH$TH
242818121$24281812$1$I$$20240820$20240904$20240904$EXP$$TH-APCER-AZR202408-000466$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$64$YR$$F$Y$$$20240904$$HP$TH$TH
242818131$24281813$1$I$20240903$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001460$ELI LILLY AND CO$$48$YR$A$$Y$$$20240904$$CN$US$US
242818141$24281814$1$I$20240823$20240829$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000013$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240904$$CN$US$US
242818151$24281815$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001433$ELI LILLY AND CO$$$$$F$Y$$$20240904$$CN$US$US
242818161$24281816$1$I$20240801$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001434$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240904$$PH$US$US
242818181$24281818$1$I$$20240829$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000319$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240904$$CN$US$US
242818191$24281819$1$I$$20240820$20240904$20240904$EXP$$TH-APCER-AZR202408-000468$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate. Sci. Rep.. 2024;14(1):18548$19$YR$$M$Y$$$20240904$$HP$TH$TH
242818201$24281820$1$I$20240710$20240823$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408015733$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240904$$CN$US$US
242818211$24281821$1$I$20231205$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-080785-2024$RECKITT BENCKISER$$84$YR$$M$Y$$$20240904$$CN$US$US
242818221$24281822$1$I$$20240820$20240904$20240904$EXP$$TH-APCER-AZR202408-000467$AZURITY PHARMACEUTICALS$Apiraksattayakul N, Jitprapaikulsan J, Sanpakit K, Kumutpongpanich T.. Potential neurotoxicity associated with methotrexate.. Sci. Rep.. 2024;14(1):18548$26$YR$$M$Y$$$20240904$$HP$TH$TH
242818231$24281823$1$I$$20240902$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-055984$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240904$$HP$US$US
242818241$24281824$1$I$$20240826$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136315$BRISTOL MYERS SQUIBB$Gottiparthy A, Lam K, Kundu S, Yang Z, Tremont-Lukats I, Tummala S. Neurofilament light chain in serum of cancer patients with acute neurological complications. CNS Oncology. 2024 Aug 13;13(1):1-13. doi:10.1080/20450907.2024.2386233.$62$YR$A$M$Y$$$20240904$$HP$US$US
242818251$24281825$1$I$20220107$20240829$20240904$20240904$EXP$$NVSC2022DE116549$NOVARTIS$$$$A$F$Y$56$KG$20240904$$HP$DE$DE
242818261$24281826$1$I$20240825$20240825$20240904$20240904$EXP$GB-MHRA-MED-202408251635551540-YPRZL$GB-TEVA-VS-3237281$TEVA$$46$YR$$F$Y$$$20240904$$CN$GB$GB
242818271$24281827$1$I$$20240826$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137130$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240904$$CN$US$US
242818291$24281829$1$I$$20240826$20240904$20240904$EXP$$VN-ROCHE-10000068272$ROCHE$$$$$$Y$$$20240904$$MD$VN$VN
242818301$24281830$1$I$20230801$20240828$20240904$20240904$EXP$$US-AMGEN-USASP2024172781$AMGEN$$58$YR$A$M$Y$$$20240904$$CN$US$US
242818311$24281831$1$I$20240618$20240830$20240904$20240904$EXP$$US-ABBVIE-5903333$ABBVIE$$70$YR$$M$Y$$$20240904$$CN$US$US
242818341$24281834$1$I$20150102$20240821$20240904$20240904$EXP$$US-COOPERSURGICAL, INC.-2024CPS002589$COOPERSURGICAL$$$$A$F$Y$$$20240904$$LW$US$US
242818351$24281835$1$I$20230721$20240821$20240904$20240904$EXP$$US-COOPERSURGICAL, INC.-2024CPS002586$COOPERSURGICAL$$$$$F$Y$$$20240904$$LW$US$US
242818361$24281836$1$I$20220216$20240821$20240904$20240904$EXP$$US-COOPERSURGICAL, INC.-2024CPS002590$COOPERSURGICAL$$$$$F$Y$$$20240904$$LW$US$US
242818372$24281837$2$F$20240801$20240912$20240904$20240916$EXP$$JP-OTSUKA-2024_021984$OTSUKA$$80$YR$$F$Y$$$20240916$$PH$JP$JP
242818381$24281838$1$I$20240101$20240820$20240904$20240904$EXP$$US-SA-2024SA256298$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240904$$MD$US$US
242818402$24281840$2$F$20240101$20240923$20240904$20240930$30DAY$$CA-PFIZER INC-202400247454$PFIZER$$61$YR$$F$Y$$$20240930$$HP$CA$CA
242818411$24281841$1$I$$20240822$20240904$20240904$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08559$LUPIN$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73:1-9$69$YR$$M$Y$$$20240904$$HP$US$US
242818431$24281843$1$I$20240701$20240723$20240904$20240904$30DAY$$CR-PFIZER INC-202400223232$PFIZER$$10$YR$$M$Y$$$20240904$$HP$CR$CR
242818441$24281844$1$I$$20240903$20240904$20240904$EXP$$US-GILEAD-2024-0686048$GILEAD$$73$YR$E$F$Y$$$20240904$$MD$US$US
242818451$24281845$1$I$$20240828$20240904$20240904$PER$$US-ABBVIE-5900357$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242818481$24281848$1$I$$20240827$20240904$20240904$PER$$US-RDY-SPO/USA/24/0012650$DR REDDYS$$$$$$Y$$$20240904$$CN$US$US
242818491$24281849$1$I$20240101$20240827$20240904$20240904$PER$$US-SA-2024SA255709$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240904$$MD$US$US
242818501$24281850$1$I$$20240820$20240904$20240904$PER$$US-SA-2024SA256509$SANOFI AVENTIS$$$$A$F$Y$$$20240904$$MD$US$US
242818511$24281851$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA255926$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240904$$MD$US$US
242818521$24281852$1$I$20240801$20240821$20240904$20240904$PER$$US-SA-2024SA256505$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240904$$MD$US$US
242818531$24281853$1$I$20240101$20240822$20240904$20240904$PER$$US-SA-2024SA252403$SANOFI AVENTIS$$$$T$F$Y$$$20240904$$HP$US$US
242818541$24281854$1$I$$20240826$20240904$20240904$EXP$$FR-HALEON-2194755$Haleon PLC$$64$YR$$F$Y$$$20240904$$HP$FR$FR
242818551$24281855$1$I$$20240822$20240904$20240904$EXP$$FR-CIPLA LTD.-2024FR09337$CIPLA$$$$$$Y$$$20240904$$HP$FR$FR
242818561$24281856$1$I$$20240822$20240904$20240904$EXP$$US-CIPLA LTD.-2024US09449$CIPLA$Aboud AA, Huston j, Kim SH, O?Leary J,. Not your mama^s MI: chest pain in a postpartum woman. FIT Clinical Decision making. 2019;73(9)$$$$$Y$$$20240904$$HP$US$US
242818571$24281857$1$I$$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024174476$AMGEN$$$$$$Y$$$20240904$$CN$US$US
242818601$24281860$1$I$20240901$20240901$20240901$20240901$DIR$716787$$FDA-CTU$$44$YR$$M$N$93.8$KG$20240901$N$PH$US$
242818611$24281861$1$I$$20240830$20240904$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US016401$SANDOZ$$$$$F$Y$$$20240904$$HP$US$US
242818622$24281862$2$F$$20240904$20240904$20240906$EXP$$CA-PFIZER INC-202400248465$PFIZER$$91$YR$$F$Y$$$20240906$$HP$CA$CA
242818632$24281863$2$F$20240815$20240905$20240904$20240909$EXP$$CN-PFIZER INC-PV202400114154$PFIZER$$16$YR$$M$Y$48$KG$20240909$$HP$CN$CN
242818641$24281864$1$I$20240601$20240829$20240904$20240904$EXP$$CN-PFIZER INC-PV202400113397$PFIZER$$59$YR$$M$Y$59.5$KG$20240904$$HP$CN$CN
242818651$24281865$1$I$$20240902$20240904$20240904$EXP$$CA-PFIZER INC-202400248573$PFIZER$$$$$F$Y$$$20240904$$MD$CA$CA
242818662$24281866$2$F$$20240904$20240904$20240906$EXP$$US-PFIZER INC-PV202300088728$PFIZER$$80$YR$$F$Y$$$20240906$$CN$US$US
242818672$24281867$2$F$20240616$20240919$20240904$20240924$EXP$$US-PFIZER INC-202400247017$PFIZER$$67$YR$$M$Y$126.98$KG$20240924$$CN$US$US
242818681$24281868$1$I$$20240828$20240904$20240904$EXP$$US-PFIZER INC-202300008290$PFIZER$$76$YR$$M$Y$75.3$KG$20240904$$CN$US$US
242818691$24281869$1$I$20240614$20240830$20240904$20240904$EXP$$CN-PFIZER INC-PV202400114059$PFIZER$$23$YR$$F$Y$$$20240904$$HP$CN$CN
242818701$24281870$1$I$20240829$20240829$20240904$20240904$EXP$GB-MHRA-MED-202408291525028690-WMNYS$GB-PFIZER INC-202400246761$PFIZER$$66$YR$$F$Y$85$KG$20240904$$HP$GB$GB
242818711$24281871$1$I$20230101$20240829$20240904$20240904$EXP$$US-009507513-2408USA010561$MERCK$Gottiparthy, A., Lam, K., Kundu, S., Yang, Z., Tremont-Lukats, I., + Tummala, S.. Neurofilament light chain in serum of cancer patients with acute neurological complications. CNS Oncology. 2024;13:1:1-13$57$YR$$F$Y$$$20240904$$HP$US$US
242818731$24281873$1$I$$20240830$20240904$20240904$EXP$$NVSC2024MX177313$NOVARTIS$$$$$F$Y$$$20240904$$MD$MX$MX
242818741$24281874$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177867$NOVARTIS$$$$$F$Y$$$20240904$$HP$US$US
242818761$24281876$1$I$20240605$20240708$20240904$20240904$PER$$US-Merz Pharmaceuticals GmbH-2024070000097$MERZ$$$$$F$Y$$$20240904$$HP$US$US
242818771$24281877$1$I$$20240826$20240904$20240904$EXP$$JP-ROCHE-10000069845$ROCHE$Kanekatsu K, Takenaka M, Chiyonan A, Tomiyasu Y, Yamada A, Take N et al.. CPA2-8 A case of the onset of bronchial stump fistula following salvage surgery for lung cancer of the left upper lobe. The 57th Kyusyu Regional Annual Meeting of the Japanese Association for Thoracic. 2024;48$81$YR$E$M$Y$$$20240904$$MD$JP$JP
242818781$24281878$1$I$$20240822$20240904$20240904$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004577$PAREXEL$$$$$$Y$$$20240904$$CN$US$US
242818791$24281879$1$I$$20240826$20240904$20240904$PER$$US-ABBVIE-5896292$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242818801$24281880$1$I$20210401$20240827$20240904$20240904$EXP$$US-ABBVIE-5772181$ABBVIE$$61$YR$$M$Y$79$KG$20240904$$CN$US$US
242818811$24281881$1$I$$20240820$20240904$20240904$EXP$$US-GLANDPHARMA-US-2024GLNLIT00697$GLAND PHARMA$$67$YR$E$F$Y$$$20240904$$MD$US$US
242818821$24281882$1$I$$20240827$20240904$20240904$EXP$$US-AMGEN-USASP2024172347$AMGEN$Sener U.; Webb L. M.; Campian J. L. et al.. A Rare Case of Glioblastoma with Osseous Metastases. The Canadian journal of neurological sciences. Le journal canadien des sciences. 2024;51 (3):425-426$83$YR$E$M$Y$$$20240904$$HP$US$US
242818841$24281884$1$I$20240901$20240902$20240902$20240902$DIR$716831$$FDA-CTU$$42$YR$$M$N$83.25$KG$20240902$N$CN$US$
242818862$24281886$2$F$$20240912$20240904$20240913$30DAY$$US-PFIZER INC-202400249695$PFIZER$$$$$$Y$$$20240913$$PH$US$US
242818871$24281887$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001429$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240904$$CN$US$US
242818881$24281888$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001633$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240904$$CN$US$US
242818891$24281889$1$I$20240801$20240826$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408016104$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240904$$CN$US$US
242818901$24281890$1$I$$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001340$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240904$$CN$US$US
242818912$24281891$2$F$20240814$20240909$20240904$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140612$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240917$$CN$US$US
242818922$24281892$2$F$20240101$20240911$20240904$20240917$EXP$$NVSC2024DE177135$NOVARTIS$$$$A$M$Y$$$20240917$$MD$DE$DE
242818931$24281893$1$I$20240531$20240830$20240904$20240904$EXP$$NVSC2024US176412$NOVARTIS$$44$YR$$F$Y$$$20240904$$CN$US$US
242818942$24281894$2$F$20220101$20240919$20240904$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137609$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$100.2$KG$20240923$$CN$US$US
242818951$24281895$1$I$20240101$20240829$20240904$20240904$EXP$$US-ABBVIE-5901870$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242818971$24281897$1$I$$20240828$20240904$20240904$PER$$US-ABBVIE-5900895$ABBVIE$$$$$$Y$$$20240904$$CN$US$US
242818981$24281898$1$I$20240828$20240828$20240904$20240904$PER$$US-BEH-2024177996$CSL BEHRING$$86$YR$E$M$Y$$$20240904$$PH$US$US
242818991$24281899$1$I$$20240829$20240904$20240904$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013908$VERTEX$$$$$F$Y$$$20240904$$CN$GB$GB
242819001$24281900$1$I$$20240829$20240904$20240904$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013920$VERTEX$$$$$M$Y$$$20240904$$CN$GB$GB
242819012$24281901$2$F$20240701$20240918$20240904$20240924$EXP$$US-VERTEX PHARMACEUTICALS-2024-013506$VERTEX$$41$YR$$F$Y$$$20240924$$CN$US$US
242819031$24281903$1$I$$20240820$20240904$20240904$EXP$$US-GLANDPHARMA-US-2024GLNLIT00723$GLAND PHARMA$Shilpa Kesari.Dexamethasone swish and spit: A cause of iatrogenic adrenal insufficiency.Pediatric Blood and Cancer.2024;71:1-2$14$YR$T$M$Y$$$20240904$$HP$US$US
242819041$24281904$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-100989-2023$RECKITT BENCKISER$$77$YR$$F$Y$$$20240904$$CN$US$US
242819051$24281905$1$I$20240605$20240708$20240904$20240904$PER$$US-MRZWEB-2024070000098$MERZ$$$$$F$Y$$$20240904$$HP$US$US
242819061$24281906$1$I$$20240901$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139681$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240904$$HP$US$US
242819071$24281907$1$I$20240419$20240422$20240904$20240904$PER$$US-IGSA-BIG0028746$GRIFOLS$$86$YR$$M$Y$114.3$KG$20240904$$PH$US$US
242819081$24281908$1$I$20240801$20240824$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN008905$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242819101$24281910$1$I$$20240903$20240904$20240904$EXP$$US-INCYTE CORPORATION-2024IN009277$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242819111$24281911$1$I$$20240726$20240904$20240904$EXP$$SI-AMGEN-SVNSP2024172298$AMGEN$Maric D.; Homar V. et al.. OSTEOPOROTIC FRACTURES AND LONELINESS - CHALLENGES OF ELDERLY PATIENTS - A CASE REPORT WITH A SUCCESSFUL OUTCOME. 30th International Symposium on Emergency Medicine. 2024;352-354$86$YR$E$F$Y$$$20240904$$HP$SI$SI
242819121$24281912$1$I$$20240826$20240904$20240904$EXP$$TW-AMGEN-TWNSP2024174647$AMGEN$Kuo-chung Y.; Yu-pin S.; Wen-chung L. et al.. Bisphosphonate-related osteonecrosis of the jaw: Is the medication duration related to advanced disease stage?. Formosan Journal of Surgery. 2024;57 (4):151-156$68$YR$E$F$Y$$$20240904$$HP$TW$TW
242819131$24281913$1$I$$20240809$20240904$20240904$PER$$US-ALXN-202408USA002231US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
242819142$24281914$2$F$$20240916$20240904$20240923$EXP$$TR-GSK-TR2024TRK106962$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$TR$TR
242819161$24281916$1$I$$20240828$20240904$20240904$EXP$$US-CHEPLA-2024011143$CHEPLAPHARM$$$$$F$Y$$$20240904$$MD$COUNTRY NOT SPECIFIED$US
242819171$24281917$1$I$20240406$20240829$20240904$20240904$EXP$FR-AFSSAPS-RE2024000850$FR-CHEPLA-2024011189$CHEPLAPHARM$$53$YR$$M$Y$77.5$KG$20240904$$MD$COUNTRY NOT SPECIFIED$FR
242819191$24281919$1$I$20231001$20240829$20240904$20240904$EXP$$BR-CHEPLA-2024011194$CHEPLAPHARM$$55$YR$$F$Y$$$20240904$$MD$COUNTRY NOT SPECIFIED$BR
242819201$24281920$1$I$20230130$20240830$20240904$20240904$EXP$GB-MHRA-MED-202408291534428000-HKRZW$GB-AMGEN-GBRSP2024173395$AMGEN$$43$YR$A$M$Y$$$20240904$$HP$GB$GB
242819211$24281921$1$I$20240809$20240809$20240904$20240904$PER$$US-ABBVIE-5905804$ABBVIE$$73$YR$$$Y$128$KG$20240904$$HP$US$US
242819221$24281922$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140319$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240904$$HP$US$US
242819231$24281923$1$I$20231220$20240829$20240904$20240904$EXP$$EG-CHEPLA-2024011202$CHEPLAPHARM$$45$YR$$F$Y$$$20240904$$MD$COUNTRY NOT SPECIFIED$EG
242819241$24281924$1$I$$20240820$20240904$20240904$EXP$$US-GLANDPHARMA-US-2024GLNLIT00711$GLAND PHARMA$Yasaman Navari.When rhythm correction turns risky: rare right sided haemorrhagic pleural effusion post maze procedure.European Journal of Case Reports in Internal Medicine.27-JUN-2024;11 (No.7):1-3$$$$F$Y$$$20240904$$HP$US$US
242819251$24281925$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140259$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$52.62$KG$20240904$$CN$US$US
242819261$24281926$1$I$$20240901$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139632$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240904$$HP$US$US
242819271$24281927$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140467$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240904$$CN$US$US
242819281$24281928$1$I$$20230712$20240904$20240904$EXP$$NVSC2023GB281056$NOVARTIS$$$$$$Y$$$20240904$$HP$GB$GB
242819291$24281929$1$I$$20240821$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08521$LUPIN$$$$$$Y$$$20240904$$MD$US$US
242819301$24281930$1$I$20240818$20240828$20240904$20240904$EXP$$US-GSK-US2024107158$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$US$US
242819341$24281934$1$I$$20240901$20240901$20240901$DIR$716785$$FDA-CTU$$41$YR$$F$N$$$20240901$Y$CN$US$
242819351$24281935$1$I$20240801$20240826$20240904$20240904$PER$$US-ROCHE-10000066985$ROCHE$$$$$$Y$$$20240904$$PH$US$US
242819361$24281936$1$I$$20240827$20240904$20240904$EXP$$BR-TAKEDA-2024TUS087292$TAKEDA$$$$$M$Y$$$20240904$$CN$BR$BR
242819371$24281937$1$I$20240723$20240829$20240904$20240904$EXP$PT-INFARMED-R202408-248$PT-TEVA-VS-3238939$TEVA$$47$YR$$M$Y$$$20240904$$PH$PT$PT
242819381$24281938$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-100861-2023$RECKITT BENCKISER$$$$$$Y$$$20240904$$CN$US$US
242819392$24281939$2$F$$20240903$20240904$20240910$EXP$$GB-TAKEDA-2022TUS058976$TAKEDA$$$$$M$Y$$$20240910$$CN$GB$GB
242819421$24281942$1$I$$20240820$20240904$20240904$EXP$$GR-GLANDPHARMA-GR-2024GLNLIT00705$GLAND PHARMA$D Variadis.AN UNEXPLAINED CASE OF CENTRAL NERVOUS SYSTEM TOXICITY AFTER INTRATHECAL ADMINISTRATION OF HYPERBARIC BUPIVACAINE.Regional Anesthesia and Pain Medicine.11-AUG-2022;47:A204-A205$72$YR$E$F$Y$$$20240904$$HP$GR$GR
242819431$24281943$1$I$20240830$20240903$20240903$20240903$DIR$716897$$FDA-CTU$$53$YR$$F$N$83.7$KG$20240903$Y$CN$US$
242819441$24281944$1$I$$20240903$20240903$20240903$DIR$716900$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242819451$24281945$1$I$$20240830$20240904$20240904$EXP$$US-LUNDBECK-DKLU4003745$LUNDBECK$$$$$$Y$$$20240904$$CN$US$US
242819461$24281946$1$I$20240717$20240903$20240904$20240904$EXP$$FR-AMERICAN REGENT INC-2024002940$AMERICAN REGENT$$25$YR$$F$Y$58$KG$20240904$$CN$FR$FR
242819471$24281947$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139331$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240904$$CN$US$US
242819481$24281948$1$I$$20240827$20240904$20240904$EXP$$US-TAKEDA-2024TUS086478$TAKEDA$$$$$M$Y$$$20240904$$CN$US$US
242819491$24281949$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139285$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240904$$MD$US$US
242819502$24281950$2$F$$20240911$20240904$20240916$PER$$US-AMGEN-USASP2024175743$AMGEN$$$$$F$Y$$$20240916$$CN$US$US
242819511$24281951$1$I$$20240819$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08513$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242819521$24281952$1$I$$20240820$20240904$20240904$EXP$$FR-GLANDPHARMA-FR-2024GLNLIT00719$GLAND PHARMA$L Drouart.Pseudo-erysipele secondaire a l^administration de Gemcitabine sans irradiation prealable : un diagnostic differentiel rare des dermohypodermites infectieuses.Revue de Medecine Intern.DEC-2023;44 (Suppl.):A415$64$YR$A$F$Y$$$20240904$$HP$FR$FR
242819531$24281953$1$I$$20240829$20240904$20240904$EXP$$US-MYLANLABS-2024M1080815$MYLAN$Mohan A, Quingalahua E, Gunchick V, Paul S, Kumar-Sinha C, Crysler O, et al. PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma. Oncologist 2024; 29 (8): 725-730.$$$$F$Y$$$20240904$$MD$US$US
242819542$24281954$2$F$20230701$20240916$20240904$20240923$EXP$CA-MMM-GOZTLD2F$CA-GSK-CA2023105704$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$CA$CA
242819551$24281955$1$I$$20230907$20240904$20240904$PER$$NVSC2023US197707$NOVARTIS$$7$YR$$F$Y$$$20240904$$MD$US$US
242819561$24281956$1$I$20240808$20240829$20240904$20240904$EXP$FR-AFSSAPS-TS2024000937$FR-MYLANLABS-2024M1079671$MYLAN$$20$YR$$M$Y$$$20240904$$MD$FR$FR
242819571$24281957$1$I$20240701$20240903$20240904$20240904$EXP$FR-AFSSAPS-TS2024000951$FR-SANDOZ INC.-SDZ2024FR077466$SANDOZ$$47$YR$$M$Y$83$KG$20240904$$MD$FR$FR
242819581$24281958$1$I$$20240821$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08377$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242819601$24281960$1$I$20240826$20240830$20240904$20240904$EXP$$CN-AMGEN-CHNSP2024175169$AMGEN$$59$YR$A$F$Y$$$20240904$$HP$CN$CN
242819611$24281961$1$I$20240801$20240823$20240904$20240904$EXP$$US-SA-2024SA255874$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240904$$MD$US$US
242819621$24281962$1$I$20240701$20240826$20240904$20240904$EXP$$US-SA-2024SA256517$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240904$$MD$US$US
242819631$24281963$1$I$$20240903$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140294$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240904$$CN$US$US
242819641$24281964$1$I$20051110$20240823$20240904$20240904$EXP$FR-EMA-DD-20240816-7482677-114420$FR-SA-2024SA253047$SANOFI AVENTIS$$51$YR$A$F$Y$80$KG$20240904$$MD$FR$FR
242819651$24281965$1$I$$20240827$20240904$20240904$EXP$GB-MHRA-MIDB-696585cc-f7c3-4822-af83-2bb30f4a6440$GB-TEVA-VS-3238015$TEVA$$56$YR$$$Y$$$20240904$$PH$GB$GB
242819661$24281966$1$I$$20240903$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049276$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240904$$CN$US$US
242819672$24281967$2$F$$20240912$20240904$20240913$PER$$US-BIOVITRUM-2024-US-011628$BIOVITRUM$$53$YR$$F$Y$$$20240913$$CN$US$US
242819681$24281968$1$I$$20240823$20240904$20240904$PER$$US-ABBVIE-5896027$ABBVIE$$$$$F$Y$$$20240904$$MD$US$US
242819691$24281969$1$I$20231203$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-081075-2024$RECKITT BENCKISER$$71$YR$$F$Y$72.73$KG$20240904$$CN$US$US
242819701$24281970$1$I$20240807$20240827$20240904$20240904$EXP$GB-MHRA-MED-202408271354130470-TGMZL$GB-TEVA-VS-3238052$TEVA$$$$$M$Y$$$20240904$$HP$GB$GB
242819711$24281971$1$I$$20240830$20240904$20240904$EXP$$SG-GSK-SG2024APC108307$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$SG$SG
242819721$24281972$1$I$$20240820$20240904$20240904$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00718$GLAND PHARMA$K Okamoto.An autopsy case of progressive multifocal leukoencephalopathy with massive iron deposition in juxtacortical lesions. Neuropathology.OCT-2023;43:396-402$71$YR$E$F$Y$$$20240904$$HP$JP$JP
242819731$24281973$1$I$$20240710$20240904$20240904$PER$$US-MRZWEB-2024070000120$MERZ$$$$A$F$Y$$$20240904$$HP$US$US
242819742$24281974$2$F$$20240830$20240904$20240906$EXP$$US-GSK-US2024107285$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$US$US
242819751$24281975$1$I$20240822$20240827$20240904$20240904$EXP$GB-MHRA-MED-202408271516399340-RBNVW$GB-TEVA-VS-3238139$TEVA$$$$$F$Y$45$KG$20240904$$CN$GB$GB
242819761$24281976$1$I$$20240904$20240904$20240904$DIR$717050$$FDA-CTU$$$$$UNK$N$$$20240904$N$CN$US$
242819771$24281977$1$I$$20240903$20240903$20240903$DIR$716898$$FDA-CTU$$$$$UNK$N$$$20240903$$CN$US$
242819791$24281979$1$I$20240825$20240903$20240903$20240903$DIR$716890$$FDA-CTU$$65$YR$$F$N$85.5$KG$20240903$N$CN$US$
242819801$24281980$1$I$20240830$20240903$20240903$20240903$DIR$716912$$FDA-CTU$$7$YR$$F$N$$$20240903$N$HP$US$
242819822$24281982$2$F$20240802$20240903$20240904$20240909$EXP$$FR-GRUNENTHAL-2024-124540$AVERITAS$$40$YR$$F$Y$54$KG$20240909$$HP$FR$FR
242819832$24281983$2$F$20240902$20240916$20240904$20240920$EXP$$GB-MYLANLABS-2024M1080693$MYLAN$$$$$F$Y$$$20240920$$CN$GB$GB
242819841$24281984$1$I$20240830$20240903$20240903$20240903$DIR$716905$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242819852$24281985$2$F$$20240906$20240904$20240916$EXP$$TR-TEVA-VS-3238751$TEVA$Acar IH, Guvenc B. RICHTER SYNDROME TRANSFORMATION UNDER VENETOCLAX TREATMENT: A CASE REPORT OF A 51-YEAR-OLD FEMALE WITH CLL. Hematol-Transfus-Cell-Ther 2023; 45 (Suppl.) S33-S34.; Acar IH, Guvenc B. RICHTER SYNDROME TRANSFORMATION UNDER VENETOCLAX TREATMENT: A CASE REPORT OF A 51-YEAR-OLD FEMALE WITH CLL. Hematol-Transfus-Cell-Ther 2023; 45 (Suppl.) S33-S34.$51$YR$$F$Y$$$20240916$$HP$TR$TR
242819861$24281986$1$I$$20240829$20240904$20240904$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004868$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240904$$CN$US$US
242819871$24281987$1$I$20240101$20240828$20240904$20240904$EXP$$US-SA-2024SA252350$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240904$$MD$US$US
242819881$24281988$1$I$$20240829$20240904$20240904$EXP$$BR-BIOMARINAP-BR-2024-160000$BIOMARIN$$$$$$Y$$$20240904$$CN$BR$BR
242819891$24281989$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139257$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$102.06$KG$20240904$$CN$US$US
242819901$24281990$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139132$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240904$$HP$US$US
242819911$24281991$1$I$$20240827$20240904$20240904$PER$$US-RDY-SPO/USA/24/0012634$DR REDDYS$$13$YR$T$F$Y$$$20240904$$MD$US$US
242819921$24281992$1$I$20220101$20240827$20240904$20240904$EXP$US-MLMSERVICE-20240822-PI166551-00271-1$US-RDY-SPO/USA/24/0012595$DR REDDYS$Mann I, Morado-Aramburo O, Hasbun R. Emerging shadows: HHV-8-associated encephalitis unveiled in a solid organ transplant recipient. Transplant Infectious Disease. 2024;26(4):e14343. DOI: 10.1111/tid.14343.$73$YR$E$F$Y$$$20240904$$MD$US$US
242819932$24281993$2$F$$20240906$20240904$20240916$EXP$$CL-TEVA-VS-3238351$TEVA$Fica A, Galvez L, Teneb E, Fernandoi C, Acevedo S. Infectious disease evaluations in a psychiatric unit, an observational study. Rev-Med-Chil 2023; 151 (10): 1271-1280; Fica A, Galvez L, Teneb E, Fernandoi C, Acevedo S. Infectious disease evaluations in a psychiatric unit, an observational study. Rev-Med-Chil 2023; 151 (10): 1271-1280.$72$YR$$F$Y$$$20240916$$MD$CL$CL
242819941$24281994$1$I$$20240828$20240904$20240904$30DAY$$US-GSK-US2024AMR108142$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242819951$24281995$1$I$$20240827$20240904$20240904$EXP$$JP-JNJFOC-20240882501$JOHNSON AND JOHNSON$$9$MON$I$M$Y$$$20240904$$PH$JP$JP
242819961$24281996$1$I$$20240830$20240904$20240904$PER$$US-JNJFOC-20240903014$JOHNSON AND JOHNSON$$52$YR$A$F$Y$76.6$KG$20240904$$CN$US$US
242819971$24281997$1$I$$20240820$20240904$20240904$EXP$$US-GLANDPHARMA-US-2024GLNLIT00715$GLAND PHARMA$IP Rios.Foscarnet-induced nephropathy in a kidney transplant recipient.Kidney International.JUL-2024;106:156$53$YR$A$M$Y$$$20240904$$HP$US$US
242819981$24281998$1$I$$20240826$20240904$20240904$EXP$$TR-TEVA-VS-3238788$TEVA$Tacyildiz N, Ozdemir SI, Canakci CEM, Yigit HI, Maharramova V, Dincaslan H, et al. Multidisciplinary PAIN management features of pediatric oncology patients in a pediatric cancer center in Turkiye: A developing country experience. J-Clin-Oncol 2024; 42 (Suppl.) (16):.$$$$$Y$$$20240904$$HP$TR$TR
242819991$24281999$1$I$20240701$20240830$20240904$20240904$EXP$$US-INCYTE CORPORATION-2024IN009206$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242820001$24282000$1$I$$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A198240$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242820011$24282001$1$I$$20240903$20240904$20240904$PER$$US-AstraZeneca-2024A201135$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242820021$24282002$1$I$$20240903$20240904$20240904$EXP$$US-PFIZER INC-202400249541$PFIZER$$88$YR$$F$Y$$$20240904$$CN$US$US
242820031$24282003$1$I$$20240902$20240904$20240904$EXP$DE-BFARM-24006009$DE-PFIZER INC-202400247998$PFIZER$$$$E$M$Y$65$KG$20240904$$MD$DE$DE
242820041$24282004$1$I$$20240902$20240904$20240904$EXP$$CA-PFIZER INC-202400248521$PFIZER$$4$YR$$F$Y$$$20240904$$HP$CA$CA
242820051$24282005$1$I$$20240903$20240904$20240904$EXP$$CA-PFIZER INC-202400249248$PFIZER$$61$YR$$M$Y$67$KG$20240904$$HP$CA$CA
242820061$24282006$1$I$20240815$20240902$20240904$20240904$EXP$$CN-PFIZER INC-PV202400114949$PFIZER$$70$YR$$F$Y$87.5$KG$20240904$$HP$CN$CN
242820072$24282007$2$F$20230101$20240830$20240904$20240909$EXP$$US-PFIZER INC-PV202400114029$PFIZER$$71$YR$$M$Y$$$20240909$$CN$US$US
242820081$24282008$1$I$20240901$20240902$20240904$20240904$EXP$GB-MHRA-MED-202409021457263090-MJSLP$GB-PFIZER INC-202400248562$PFIZER$$61$YR$$M$Y$88$KG$20240904$$CN$GB$GB
242820091$24282009$1$I$$20240902$20240904$20240904$EXP$$CA-PFIZER INC-202400248510$PFIZER$$16$YR$$F$Y$$$20240904$$HP$CA$CA
242820101$24282010$1$I$20220101$20240902$20240904$20240904$EXP$SE-SEMPA-2024-006337$SE-PFIZER INC-202400248023$PFIZER$$$$$F$Y$$$20240904$$MD$SE$SE
242820112$24282011$2$F$$20240903$20240904$20240905$EXP$$US-PFIZER INC-202400249320$PFIZER$$67$YR$$M$Y$$$20240905$$CN$US$US
242820131$24282013$1$I$$20240901$20240904$20240904$EXP$$MY-PFIZER INC-202400247818$PFIZER$$68$YR$$F$Y$$$20240904$$MD$MY$MY
242820141$24282014$1$I$$20240830$20240904$20240904$EXP$$US-PFIZER INC-202300294588$PFIZER$$66$YR$$F$Y$$$20240904$$CN$US$US
242820151$24282015$1$I$20240902$20240902$20240904$20240904$EXP$GB-MHRA-MED-202409021246021840-NHLCY$GB-PFIZER INC-202400248506$PFIZER$$62$YR$$M$Y$87$KG$20240904$$HP$GB$GB
242820161$24282016$1$I$20240713$20240902$20240904$20240904$EXP$$JP-PFIZER INC-PV202400103599$PFIZER$$72$YR$$F$Y$36.2$KG$20240904$$PH$JP$JP
242820171$24282017$1$I$$20240902$20240904$20240904$EXP$$CA-PFIZER INC-202400248530$PFIZER$$16$YR$$F$Y$$$20240904$$HP$CA$CA
242820181$24282018$1$I$$20240902$20240904$20240904$EXP$$CA-PFIZER INC-202400248529$PFIZER$$5$YR$$F$Y$$$20240904$$HP$CA$CA
242820192$24282019$2$F$$20240902$20240904$20240911$EXP$$IN-PFIZER INC-202400248476$PFIZER$$25$YR$$M$Y$$$20240911$$MD$IN$IN
242820201$24282020$1$I$20240719$20240830$20240904$20240904$EXP$$CN-PFIZER INC-PV202400114173$PFIZER$$29$YR$$F$Y$40$KG$20240904$$HP$CN$CN
242820211$24282021$1$I$20240701$20240830$20240904$20240904$EXP$$SE-PFIZER INC-PV202400114690$PFIZER$$3$YR$$F$Y$17.8$KG$20240904$$MD$SE$SE
242820221$24282022$1$I$20240818$20240830$20240904$20240904$EXP$$CN-PFIZER INC-PV202400114132$PFIZER$$39$YR$$F$Y$$$20240904$$HP$CN$CN
242820231$24282023$1$I$$20240902$20240904$20240904$EXP$$DE-PFIZER INC-202400248161$PFIZER$$$$$$Y$$$20240904$$MD$DE$DE
242820241$24282024$1$I$20240613$20240903$20240904$20240904$EXP$$JP-PFIZER INC-PV202400115237$PFIZER$$84$YR$$M$Y$$$20240904$$PH$JP$JP
242820252$24282025$2$F$$20240904$20240904$20240906$EXP$$SA-PFIZER INC-PV202400113978$PFIZER$$37$YR$$M$Y$$$20240906$$MD$SA$SA
242820261$24282026$1$I$20231101$20240830$20240904$20240904$EXP$FR-AFSSAPS-TS2024000941$FR-PFIZER INC-202400246297$PFIZER$$80$YR$$M$Y$68$KG$20240904$$MD$FR$FR
242820271$24282027$1$I$$20240902$20240904$20240904$EXP$$DE-PFIZER INC-202400248980$PFIZER$$$$$F$Y$$$20240904$$CN$DE$DE
242820291$24282029$1$I$20240708$20240902$20240904$20240904$EXP$$CN-PFIZER INC-PV202400114991$PFIZER$$58$YR$$F$Y$56.4$KG$20240904$$HP$CN$CN
242820301$24282030$1$I$$20240902$20240904$20240904$EXP$$CA-PFIZER INC-202400248590$PFIZER$$60$YR$$M$Y$77$KG$20240904$$HP$CA$CA
242820311$24282031$1$I$$20240830$20240904$20240904$EXP$GB-MHRA-MIDB-f3fc2ddf-7714-46db-9048-8c21cba62f6f$GB-PFIZER INC-202400247499$PFIZER$$53$YR$$$Y$$$20240904$$PH$GB$GB
242820321$24282032$1$I$20240814$20240831$20240904$20240904$EXP$$CN-PFIZER INC-PV202400114228$PFIZER$$53$YR$$F$Y$62$KG$20240904$$HP$CN$CN
242820331$24282033$1$I$20240713$20240830$20240904$20240904$EXP$$CN-PFIZER INC-PV202400114182$PFIZER$$42$YR$$M$Y$80$KG$20240904$$HP$CN$CN
242820343$24282034$3$F$20240301$20240924$20240904$20240930$EXP$$CA-PFIZER INC-PV202400034818$PFIZER$$61$YR$$M$Y$$$20240930$$MD$CA$CA
242820352$24282035$2$F$$20240904$20240904$20240905$EXP$$CA-PFIZER INC-202400248486$PFIZER$$17$DY$$M$Y$$$20240905$$HP$CA$CA
242820361$24282036$1$I$20221130$20240830$20240904$20240904$EXP$$CA-PFIZER INC-202201256308$PFIZER$$41$YR$$M$Y$100$KG$20240904$$MD$CA$CA
242820371$24282037$1$I$20240401$20240902$20240904$20240904$EXP$FR-AFSSAPS-DJ2024000887$FR-PFIZER INC-202400248187$PFIZER$$81$YR$$M$Y$65$KG$20240904$$MD$FR$FR
242820381$24282038$1$I$20240101$20240903$20240904$20240904$EXP$$CA-PFIZER INC-202400249478$PFIZER$$66$YR$$F$Y$$$20240904$$HP$CA$CA
242820391$24282039$1$I$20240610$20240902$20240904$20240904$EXP$FR-AFSSAPS-LL2024001646$FR-PFIZER INC-202400248194$PFIZER$$55$YR$$F$Y$$$20240904$$MD$FR$FR
242820402$24282040$2$F$20240810$20240906$20240904$20240909$EXP$$CN-PFIZER INC-PV202400114139$PFIZER$$49$YR$$F$Y$51$KG$20240909$$HP$CN$CN
242820411$24282041$1$I$20240805$20240830$20240904$20240904$EXP$$IN-PFIZER INC-PV202400114904$PFIZER$$30$YR$$M$Y$$$20240904$$CN$IN$IN
242820421$24282042$1$I$20240831$20240831$20240904$20240904$EXP$$CA-PFIZER INC-2021515670$PFIZER$$53$YR$$F$Y$$$20240904$$MD$CA$CA
242820431$24282043$1$I$20230903$20240903$20240903$20240903$DIR$716917$$FDA-CTU$$35$YR$$M$N$67.5$KG$20240903$Y$CN$US$
242820441$24282044$1$I$20240805$20240902$20240904$20240904$EXP$IT-MINISAL02-1000465$IT-PFIZER INC-202400248028$PFIZER$$85$YR$$F$Y$$$20240904$$PH$IT$IT
242820451$24282045$1$I$$20240902$20240904$20240904$EXP$$CA-PFIZER INC-202400248520$PFIZER$$22$MON$$M$Y$$$20240904$$HP$CA$CA
242820461$24282046$1$I$$20240830$20240904$20240904$EXP$$US-PFIZER INC-PV202400083504$PFIZER$$59$YR$$F$Y$$$20240904$$MD$US$US
242820481$24282048$1$I$$20240904$20240904$20240904$PER$$US-PROD-AS2-212756134-RB-081386-2024$RECKITT BENCKISER$$$$$$Y$$$20240904$$CN$US$US
242820491$24282049$1$I$$20240820$20240904$20240904$EXP$$US-GLANDPHARMA-US-2024GLNLIT00714$GLAND PHARMA$Sameer Narula.Botulinum Treatment Induced Dropped Head Syndrome in a Patient With Chronic Migraines and Multiple Sclerosis.Pain Medicine Case Reports.may-2024;8 No.4:157-160$$$$F$Y$$$20240904$$MD$US$US
242820511$24282051$1$I$$20240828$20240904$20240904$EXP$$NVSC2024AU176588$NOVARTIS$$$$$F$Y$$$20240904$$HP$AU$AU
242820522$24282052$2$F$20240901$20240924$20240904$20240927$EXP$$CA-ABBVIE-5904854$ABBVIE$$69$YR$$M$Y$$$20240927$$CN$CA$CA
242820531$24282053$1$I$20240701$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140495$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240904$$CN$US$US
242820551$24282055$1$I$20240802$20240828$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138655$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240904$$PH$US$US
242820561$24282056$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139344$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$52.16$KG$20240904$$CN$US$US
242820571$24282057$1$I$20240801$20240903$20240904$20240904$EXP$HR-HALMED-300086424$HR-TAKEDA-2024TUS088207$TAKEDA$$27$YR$$M$Y$90$KG$20240904$$HP$HR$HR
242820581$24282058$1$I$$20240829$20240904$20240904$EXP$$CA-PFIZER INC-202400201062$PFIZER$$56$YR$$M$Y$$$20240904$$HP$CA$CA
242820591$24282059$1$I$20240705$20240827$20240904$20240904$EXP$FR-AFSSAPS-LM2024000469$FR-TEVA-VS-3237709$TEVA$$68$YR$$M$Y$59.7$KG$20240904$$MD$FR$FR
242820611$24282061$1$I$$20240801$20240904$20240904$PER$$US-GLANDPHARMA-US-2024GLNSPO00721$GLAND PHARMA$$$$$$Y$$$20240904$$PH$US$US
242820621$24282062$1$I$20200201$20240829$20240904$20240904$EXP$$US-INCYTE CORPORATION-2024IN009148$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242820631$24282063$1$I$20240828$20240828$20240904$20240904$30DAY$$US-GSK-US2024107324$GLAXOSMITHKLINE$$80$YR$$M$Y$$$20240904$$CN$US$US
242820641$24282064$1$I$$20240829$20240904$20240904$30DAY$$US-GSK-US2024107947$GLAXOSMITHKLINE$$$$$M$Y$$$20240904$$CN$US$US
242820651$24282065$1$I$20240816$20240830$20240904$20240904$EXP$$CA-JNJFOC-20240900001$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240904$$HP$CA$CA
242820663$24282066$3$F$20240817$20240906$20240904$20240909$PER$$US-AMGEN-USASP2024175631$AMGEN$$58$YR$A$F$Y$$$20240909$$CN$US$US
242820671$24282067$1$I$$20240821$20240904$20240904$EXP$$DE4445$SK LIFE SCIENCE$$$$$$Y$$$20240904$$MD$DE$DE
242820681$24282068$1$I$$20240820$20240904$20240904$EXP$$US-GLANDPHARMA-US-2024GLNLIT00710$GLAND PHARMA$Alexander bosley.Successful long term percutaneous transvalvular mechanical circulatory  support without anticoagulation as a bridge to heart transplant: a case report.ASAIO.MAY-2024;70:119-120$62$YR$A$M$Y$$$20240904$$HP$US$US
242820691$24282069$1$I$20240701$20240820$20240904$20240904$PER$$US-SA-2024SA253217$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240904$$MD$US$US
242820701$24282070$1$I$20240101$20240823$20240904$20240904$PER$$US-MYLANLABS-2024M1079175$MYLAN$$$$$F$Y$$$20240904$$CN$US$US
242820711$24282071$1$I$$20240829$20240904$20240904$PER$$US-MYLANLABS-2024M1080171$MYLAN$$$$$F$Y$$$20240904$$CN$US$US
242820721$24282072$1$I$20240801$20240828$20240904$20240904$PER$$US-MYLANLABS-2024M1080012$MYLAN$$69$YR$$F$Y$72.57$KG$20240904$$CN$US$US
242820731$24282073$1$I$$20240903$20240904$20240904$EXP$$CN-TAKEDA-2024TUS088292$TAKEDA$$$$$M$Y$$$20240904$$CN$CN$CN
242820741$24282074$1$I$$20240823$20240904$20240904$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001987$SK LIFE SCIENCE$$$$$$Y$$$20240904$$MD$US$US
242820751$24282075$1$I$$20240829$20240904$20240904$EXP$$US-MYLANLABS-2024M1081070$MYLAN$Desai AV, Naranjo A, Barre BL, Goldsmith KC, Granger MP, States L, et al. A pilot study of post-consolidation chemoimmunotherapy for high-risk neuroblastoma (ANBL19P1): A report from the Children^s Oncology Group. J-Clin-Oncol 2024; 42 (Suppl.) (16):.$$$C$$Y$$$20240904$$HP$US$US
242820761$24282076$1$I$$20240801$20240904$20240904$PER$$US-GLANDPHARMA-US-2024GLNSPO00722$GLAND PHARMA$$$$$$Y$$$20240904$$PH$US$US
242820771$24282077$1$I$$20240826$20240904$20240904$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-002020$SK LIFE SCIENCE$Elena A. Repnikova, Lei Zhang, Brent A. Orr, Jennifer Roberts, Timothy Zinkus, Melissa Gener, Alexander Kats. Focal cortical dysplasia type IIIb associated with a KRAS-mutant ganglioglioma. Cancer Genetics. 2024$$$$$Y$$$20240904$$MD$US$US
242820781$24282078$1$I$20240601$20240826$20240904$20240904$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2024-001848$SK LIFE SCIENCE$$$$$$Y$$$20240904$$CN$US$US
242820791$24282079$1$I$20230101$20240903$20240903$20240903$DIR$716921$$FDA-CTU$$53$YR$$M$N$86.4$KG$20240903$N$CN$US$
242820801$24282080$1$I$20220622$20240902$20240902$20240902$DIR$716881$$FDA-CTU$$46$YR$$F$N$84.15$KG$20240902$N$CN$US$
242820811$24282081$1$I$20240529$20240903$20240903$20240903$DIR$716913$$FDA-CTU$$60$YR$$F$N$60.75$KG$20240903$N$CN$US$
242820831$24282083$1$I$$20240904$20240904$20240904$DIR$717058$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242820851$24282085$1$I$$20240903$20240904$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US077587$SANDOZ$$$$$F$Y$$$20240904$$CN$US$US
242820861$24282086$1$I$$20240830$20240904$20240904$EXP$$US-SANDOZ INC.-SDZ2024US077604$SANDOZ$$$$$F$Y$110.91$KG$20240904$$CN$US$US
242820871$24282087$1$I$20240423$20240902$20240904$20240904$EXP$IT-MINISAL02-1000711$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-139407$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$77$KG$20240904$$MD$IT$IT
242820881$24282088$1$I$$20240828$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137929$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240904$$CN$US$US
242820891$24282089$1$I$$20240830$20240904$20240904$EXP$$NVSC2024ZA027339$NOVARTIS$$60$YR$$M$Y$$$20240904$$HP$ZA$ZA
242820902$24282090$2$F$$20240905$20240904$20240909$PER$$US-HALEON-2195047$Haleon PLC$$69$YR$$M$Y$78.018$KG$20240909$$CN$US$US
242820911$24282091$1$I$$20240820$20240904$20240904$EXP$$DE-LEADINGPHARMA-DE-2024LEALIT00366$LEADING PHARMA$Raw Bingart.Suicides of minors retrospective 22 year analysis of the post mortem and autopsy records of the Institute of Forensic  Medicine Rostock.Rechtsmedizin.30-JUN-2023;33:396-402$17$YR$T$F$Y$$$20240904$$HP$DE$DE
242820921$24282092$1$I$$20240903$20240904$20240904$EXP$$AU-SANDOZ INC.-SDZ2024AU077550$SANDOZ$$61$YR$$F$Y$$$20240904$$MD$AU$AU
242820932$24282093$2$F$20230824$20240917$20240904$20240923$EXP$$NZ-MYLANLABS-2024M1080388$MYLAN$$66$YR$$M$Y$$$20240923$$HP$NZ$NZ
242820942$24282094$2$F$$20240821$20240904$20240910$PER$$US-MYLANLABS-2024M1078572$MYLAN$$$$$$Y$$$20240910$$CN$US$US
242820951$24282095$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177865$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242820961$24282096$1$I$$20240710$20240904$20240904$PER$$US-Merz Pharmaceuticals GmbH-2024070000121$MERZ$$62$YR$$F$Y$$$20240904$$HP$US$US
242820972$24282097$2$F$20240111$20240920$20240904$20240924$EXP$FR-AFSSAPS-TO2024001442$FR-LUNDBECK-DKLU4003676$LUNDBECK$$$$$$Y$$$20240924$$PH$FR$FR
242820981$24282098$1$I$20240813$20240827$20240904$20240904$EXP$$GB-TEVA-VS-3237746$TEVA$$65$YR$$M$Y$83$KG$20240904$$MD$GB$GB
242820991$24282099$1$I$20240711$20240903$20240903$20240903$DIR$716924$$FDA-CTU$$67$YR$$F$N$76.8$KG$20240903$N$MD$US$
242821001$24282100$1$I$$20240828$20240904$20240904$PER$$US-AMGEN-USASP2024174562$AMGEN$Reynolds- Herbst T.; Lowe D.; Lozano J.M.et.al. The Association Between Early Initiation of Systemic Corticosteroids and the Hospital Length of Stay in Patients With Multisystem Inflammatory Syndrome in Children. Pediatric Emergency Care. 2024;40 (7):536-540$$$$$Y$$$20240904$$MD$US$US
242821021$24282102$1$I$20240830$20240902$20240902$20240902$DIR$716878$$FDA-CTU$$72$YR$$F$N$76.5$KG$20240902$N$CN$US$
242821031$24282103$1$I$20240903$20240903$20240903$20240903$DIR$716919$$FDA-CTU$$74$YR$$M$N$107.3$KG$20240903$Y$PH$US$
242821041$24282104$1$I$$20240801$20240904$20240904$PER$$US-GLANDPHARMA-US-2024GLNSPO00724$GLAND PHARMA$$$$$$Y$$$20240904$$PH$US$US
242821051$24282105$1$I$20240613$20240828$20240904$20240904$EXP$$JP-009507513-2406JPN004164J$MERCK$$51$YR$$F$Y$$$20240904$$MD$JP$JP
242821071$24282107$1$I$$20240820$20240904$20240904$EXP$CA-HPFB-001077238$CA-SERVIER-S24010494$SERVIER$$$$$$Y$$$20240904$$HP$CA$CA
242821081$24282108$1$I$$20240812$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08164$LUPIN$$$$$$Y$$$20240904$$HP$US$US
242821091$24282109$1$I$20240805$20240828$20240904$20240904$EXP$$CL-VANTIVE-2024VAN019205$Vantive US Healthcare$$68$YR$$M$Y$$$20240904$$HP$CL$CL
242821101$24282110$1$I$20240903$20240903$20240904$20240904$EXP$$US-VANTIVE-2024VAN019509$Vantive US Healthcare$$66$YR$$M$Y$$$20240904$$HP$US$US
242821111$24282111$1$I$20240825$20240830$20240904$20240904$EXP$$JP-VANTIVE-2024VAN019280$Vantive US Healthcare$$65$YR$$M$Y$$$20240904$$MD$JP$JP
242821121$24282112$1$I$$20240827$20240904$20240904$EXP$$CA-VANTIVE-2024VAN019414$Vantive US Healthcare$$$$$M$Y$$$20240904$$CN$CA$CA
242821132$24282113$2$F$$20240916$20240904$20240924$EXP$$GB-VANTIVE-2024VAN019436$Vantive US Healthcare$$$$$M$Y$$$20240924$$HP$GB$GB
242821141$24282114$1$I$$20240827$20240904$20240904$EXP$$JP-VANTIVE-2024VAN018978$Vantive US Healthcare$$75$YR$$M$Y$$$20240904$$MD$JP$JP
242821151$24282115$1$I$20240827$20240902$20240904$20240904$EXP$$SG-VANTIVE-2024VAN019469$Vantive US Healthcare$$65$YR$$F$Y$$$20240904$$CN$SG$SG
242821161$24282116$1$I$$20240827$20240904$20240904$EXP$$CN-AstraZeneca-2024A198352$ASTRAZENECA$$60$YR$$M$Y$56$KG$20240904$$MD$CN$
242821171$24282117$1$I$$20240828$20240904$20240904$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-109949$REGENERON$$$$$F$Y$$$20240904$$CN$US$US
242821191$24282119$1$I$20240827$20240830$20240904$20240904$EXP$$GB-AstraZeneca-2024A199879$ASTRAZENECA$$26528$DY$$M$Y$$$20240904$$HP$GB$
242821201$24282120$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA256068$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240904$$MD$US$US
242821211$24282121$1$I$$20240828$20240904$20240904$EXP$$US-MYLANLABS-2024M1080711$MYLAN$Long C, Mangum R, Keller L, Bristol RE, Ahmed SK, Kuwabara M, et al. Intracranial non-germinomatous germ cell tumor with malignant transformation to embryonal rhabdomysarcoma. Neuro-Oncol 2024; 26 (Suppl. 4) iv83.$13$YR$$M$Y$$$20240904$$HP$US$US
242821221$24282122$1$I$20240827$20240827$20240904$20240904$PER$$US-GILEAD-2024-0686187$GILEAD$$59$YR$A$F$Y$$$20240904$$CN$US$US
242821231$24282123$1$I$$20240825$20240904$20240904$30DAY$$US-GSK-US2024AMR106276$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$US$US
242821241$24282124$1$I$$20240820$20240904$20240904$EXP$$US-LEADINGPHARMA-US-2024LEALIT00365$LEADING PHARMA$$49$YR$A$F$Y$$$20240904$$MD$US$US
242821251$24282125$1$I$20240201$20240827$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN009028$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242821261$24282126$1$I$$20240813$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08147$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242821271$24282127$1$I$20150216$20240826$20240904$20240904$EXP$$CZ-BIOCON BIOLOGICS LIMITED-BBL2024006317$BIOCON$Z Donatova. The use of eribulin and vinorelbin in treating breast cancer - two case studies. ONKOLOGICKA REVUE. 2019;6(6):78-80$$$$$Y$$$20240904$$HP$CZ$CZ
242821281$24282128$1$I$20240816$20240904$20240904$20240904$DIR$717049$$FDA-CTU$$68$YR$$F$N$80.1$KG$20240904$N$CN$US$
242821291$24282129$1$I$20240829$20240903$20240903$20240903$DIR$716922$$FDA-CTU$$77$YR$$F$N$46.26$KG$20240903$N$$US$
242821301$24282130$1$I$$20240903$20240903$20240903$DIR$716930$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242821311$24282131$1$I$$20240827$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN009026$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242821322$24282132$2$F$20230101$20240912$20240904$20240919$EXP$$JP-009507513-2408JPN003783J$MERCK$$6$DEC$$F$Y$$$20240919$$MD$JP$JP
242821331$24282133$1$I$20230928$20240827$20240904$20240904$EXP$GB-MHRA-MED-202408270745395860-NYMJH$GB-TEVA-VS-3237802$TEVA$$67$YR$$F$Y$52$KG$20240904$$CN$GB$GB
242821341$24282134$1$I$20240204$20240829$20240904$20240904$EXP$GB-MHRA-MED-202408271644111340-HNPBR$GB-INDIVIOR US-INDV-156265-2024$RECKITT BENCKISER$$$$$$Y$$$20240904$$CN$GB$GB
242821351$24282135$1$I$$20240827$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN009025$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242821361$24282136$1$I$20240728$20240827$20240904$20240904$EXP$FR-AFSSAPS-LM2024000470$FR-TEVA-VS-3237830$TEVA$$68$YR$$M$Y$59.7$KG$20240904$$MD$FR$FR
242821371$24282137$1$I$$20240902$20240904$20240904$EXP$$NVSC2024ZA169365$NOVARTIS$$47$YR$$M$Y$$$20240904$$HP$ZA$ZA
242821381$24282138$1$I$$20240725$20240904$20240904$PER$$US-Merz Pharmaceuticals GmbH-2024070000152$MERZ$$$$$$Y$$$20240904$$HP$US$US
242821391$24282139$1$I$$20240827$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN009020$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242821401$24282140$1$I$20240101$20240821$20240904$20240904$EXP$$US-SMPA-2024SPA001747$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242821411$24282141$1$I$$20240821$20240904$20240904$EXP$$US-SMPA-2024SPA001746$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242821421$24282142$1$I$20240618$20240812$20240904$20240904$EXP$$US-SMPA-2024SPA001038$SUNOVION$$$$$$Y$$$20240904$$HP$US$US
242821431$24282143$1$I$$20240821$20240904$20240904$EXP$$US-SMPA-2024SPA001814$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242821441$24282144$1$I$$20240830$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140120$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240904$$CN$US$US
242821451$24282145$1$I$$20240821$20240904$20240904$EXP$$US-SMPA-2024SPA001806$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242821461$24282146$1$I$20240101$20240827$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138247$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240904$$HP$US$US
242821471$24282147$1$I$$20240813$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08149$LUPIN$$$$$$Y$$$20240904$$HP$US$US
242821481$24282148$1$I$$20240827$20240904$20240904$EXP$$US-MYLANLABS-2024M1080446$MYLAN$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood-Can-J 2023; 13 (1):.$$$$$Y$$$20240904$$HP$US$US
242821501$24282150$1$I$$20240805$20240904$20240904$PER$$US-009507513-2408USA003503$MERCK$$70$YR$$M$Y$$$20240904$$CN$US$US
242821511$24282151$1$I$20240712$20240830$20240904$20240904$EXP$FR-AFSSAPS-LY2024001115$FR-ABBVIE-5905200$ABBVIE$$69$YR$$M$Y$$$20240904$$PH$FR$FR
242821522$24282152$2$F$20240204$20240913$20240904$20240918$EXP$$JP-JNJFOC-20240905759$JOHNSON AND JOHNSON$$70$YR$E$M$Y$48.1$KG$20240918$$MD$JP$JP
242821531$24282153$1$I$$20240828$20240904$20240904$EXP$$JP-AMGEN-JPNSP2024172479$AMGEN$$$$$$Y$$$20240904$$MD$JP$JP
242821551$24282155$1$I$20240630$20240828$20240904$20240904$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07805$VIFOR$$60$YR$$F$Y$$$20240904$$HP$ZA$ZA
242821561$24282156$1$I$20240826$20240830$20240904$20240904$EXP$$AR-DSJP-DSJ-2024-143335$DAIICHI$$43$YR$$F$Y$$$20240904$$CN$AR$AR
242821571$24282157$1$I$20170701$20240823$20240904$20240904$EXP$FR-AFSSAPS-PB2024000877$FR-Merck Healthcare KGaA-2024045526$MERCK KGAA$$78$YR$E$F$Y$59$KG$20240902$$CN$FR$FR
242821581$24282158$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140538$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240904$$CN$US$US
242821591$24282159$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140624$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240904$$HP$US$US
242821601$24282160$1$I$20240829$20240903$20240903$20240903$DIR$716927$$FDA-CTU$$65$YR$$F$N$42.9$KG$20240903$N$PH$US$
242821612$24282161$2$F$20240827$20240925$20240904$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138702$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$PH$US$US
242821621$24282162$1$I$20240601$20240823$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134888$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$64.68$KG$20240904$$PH$US$US
242821631$24282163$1$I$$20240829$20240904$20240904$EXP$$US-AMGEN-USASP2024173503$AMGEN$$$$$F$Y$$$20240904$$MD$US$US
242821641$24282164$1$I$20240830$20240830$20240904$20240904$EXP$$US-AMGEN-USASP2024174807$AMGEN$$98$YR$E$F$Y$$$20240904$$CN$US$US
242821651$24282165$1$I$$20240813$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08150$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242821661$24282166$1$I$20240901$20240903$20240903$20240903$DIR$716929$$FDA-CTU$$22$YR$$F$N$54$KG$20240903$N$CN$US$
242821671$24282167$1$I$$20240829$20240904$20240904$EXP$$GB-JNJFOC-20240904082$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240904$$CN$GB$GB
242821681$24282168$1$I$20240901$20240903$20240904$20240904$PER$$US-JNJFOC-20240905069$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242821691$24282169$1$I$20240701$20240828$20240904$20240904$EXP$$US-GSK-US2024107268$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$US$US
242821701$24282170$1$I$$20240826$20240904$20240904$30DAY$$US-GSK-US2024106145$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242821711$24282171$1$I$$20240826$20240904$20240904$30DAY$$US-GSK-US2024106168$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242821721$24282172$1$I$$20240903$20240903$20240903$DIR$716932$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242821731$24282173$1$I$$20240826$20240904$20240904$EXP$$AT-Merck Healthcare KGaA-2024046467$MERCK KGAA$$$$$F$Y$$$20240903$$CN$AT$AT
242821741$24282174$1$I$$20240830$20240904$20240904$PER$$US-BAYER-2024A125171$BAYER$$$$$$Y$$$20240904$$CN$US$US
242821751$24282175$1$I$$20240827$20240904$20240904$PER$$US-BAYER-2024A123908$BAYER$$25$YR$A$F$Y$$$20240904$$MD$US$US
242821761$24282176$1$I$20240827$20240827$20240904$20240904$EXP$$IT-AstraZeneca-2024A198701$ASTRAZENECA$$$$$F$Y$$$20240904$$MD$IT$
242821771$24282177$1$I$20240711$20240903$20240903$20240903$DIR$716934$$FDA-CTU$$65$YR$$M$N$31.41$KG$20240903$N$MD$US$
242821781$24282178$1$I$20240720$20240903$20240903$20240903$DIR$716936$$FDA-CTU$$72$YR$$M$N$86.8$KG$20240903$N$HP$US$
242821791$24282179$1$I$20240722$20240903$20240903$20240903$DIR$716942$$FDA-CTU$$72$YR$$M$N$86.8$KG$20240903$N$HP$US$
242821802$24282180$2$F$$20240830$20240904$20240912$EXP$$CA-HLS-202402195$HLS THERAPEUTICS$$61$YR$A$M$Y$$$20240912$$HP$CA$CA
242821821$24282182$1$I$20231025$20240902$20240902$20240902$DIR$716885$$FDA-CTU$$48$YR$$M$N$74.25$KG$20240902$N$CN$US$
242821842$24282184$2$F$20240812$20240828$20240904$20240912$PER$$US-COSETTE-CP2024US000230$COSETTE PHARMACEUTICALS$$39$YR$A$F$Y$$$20240912$$HP$US$US
242821851$24282185$1$I$$20240825$20240904$20240904$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409001224$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240904$$CN$DE$JP
242821861$24282186$1$I$20240223$20240823$20240904$20240904$EXP$ES-AEMPS-1562708$ES-ELI_LILLY_AND_COMPANY-ES202408015655$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240904$$CN$ES$ES
242821871$24282187$1$I$20240826$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001528$ELI LILLY AND CO$$36$YR$A$$Y$$$20240904$$CN$US$US
242821882$24282188$2$F$20240801$20240827$20240904$20240906$EXP$FR-AFSSAPS-TO2024001636$FR-ELI_LILLY_AND_COMPANY-FR202408016670$ELI LILLY AND CO$$62$YR$A$F$Y$156$KG$20240906$$CN$FR$FR
242821891$24282189$1$I$$20240827$20240904$20240904$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409001314$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240904$$CN$DE$JP
242821901$24282190$1$I$$20240825$20240904$20240904$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000915$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240904$$CN$DE$JP
242821913$24282191$3$F$$20240827$20240904$20240910$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408017696$ELI LILLY AND CO$$79$YR$E$F$Y$57$KG$20240910$$CN$DE$DE
242821921$24282192$1$I$$20240825$20240904$20240904$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000904$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240904$$CN$DE$JP
242821931$24282193$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001591$ELI LILLY AND CO$$$$$M$Y$$$20240904$$CN$US$US
242821951$24282195$1$I$20240720$20240902$20240904$20240904$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409000883$ELI LILLY AND CO$$70$YR$E$M$Y$72$KG$20240904$$CN$CN$CN
242821961$24282196$1$I$$20240829$20240904$20240904$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407008926$ELI LILLY AND CO$$$$$$Y$$$20240904$$CN$CN$CN
242821971$24282197$1$I$20240805$20240823$20240904$20240904$EXP$ES-AEMPS-1562185$ES-ELI_LILLY_AND_COMPANY-ES202408015654$ELI LILLY AND CO$$51$YR$A$F$Y$67$KG$20240904$$CN$ES$ES
242821981$24282198$1$I$$20240829$20240904$20240904$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408018731$ELI LILLY AND CO$$$$$$Y$$$20240904$$CN$JP$JP
242821991$24282199$1$I$20240801$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001500$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240904$$CN$US$US
242822001$24282200$1$I$$20240825$20240904$20240904$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000853$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240904$$CN$DE$JP
242822041$24282204$1$I$20231207$20240829$20240904$20240904$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408018522$ELI LILLY AND CO$$73$YR$E$M$Y$70$KG$20240904$$CN$FR$FR
242822051$24282205$1$I$20240601$20240827$20240904$20240904$EXP$$JP-TEVA-VS-3225118$TEVA$$$$E$M$Y$$$20240904$$MD$JP$JP
242822062$24282206$2$F$20240101$20240904$20240904$20240912$EXP$$US-ABBVIE-5900927$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
242822081$24282208$1$I$$20240829$20240904$20240904$PER$$US-BAYER-2024A124996$BAYER$$$$$$Y$$$20240904$$CN$US$US
242822091$24282209$1$I$20240808$20240820$20240904$20240904$PER$$US-COSETTE-CP2024US000229$COSETTE PHARMACEUTICALS$$45$YR$A$F$Y$156$KG$20240904$$CN$US$US
242822101$24282210$1$I$$20240830$20240904$20240904$PER$$US-BAYER-2024A125926$BAYER$$$$$F$Y$$$20240904$$CN$US$US
242822111$24282211$1$I$$20240830$20240904$20240904$EXP$$BR-JNJFOC-20240870696$JOHNSON AND JOHNSON$$10$YR$C$F$Y$27$KG$20240904$$CN$BR$BR
242822121$24282212$1$I$$20240825$20240904$20240904$EXP$$US-JNJFOC-20240869748$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$HP$US$US
242822131$24282213$1$I$$20240812$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-06956$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242822141$24282214$1$I$20240101$20240830$20240904$20240904$PER$$US-BAYER-2024A125989$BAYER$$46$YR$A$F$Y$$$20240904$$HP$US$US
242822161$24282216$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140256$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240904$$HP$US$US
242822171$24282217$1$I$$20240828$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137724$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240904$$PH$US$US
242822181$24282218$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140507$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240904$$PH$US$US
242822191$24282219$1$I$$20240903$20240904$20240904$PER$$US-HALEON-2195107$Haleon PLC$$$$$$Y$$$20240904$$CN$US$US
242822201$24282220$1$I$$20240802$20240904$20240904$PER$$US-Eisai-EC-2024-171711$EISAI$$$$$$Y$$$20240904$$HP$US$US
242822212$24282221$2$F$20240822$20240905$20240904$20240911$PER$$JP-Eisai-EC-2024-173276$EISAI$$82$YR$E$M$Y$58.5$KG$20240911$$PH$JP$JP
242822224$24282222$4$F$20240501$20240912$20240904$20240919$PER$$JP-Eisai-EC-2024-168606$EISAI$$$$A$M$Y$$$20240920$$MD$JP$JP
242822231$24282223$1$I$20240731$20240805$20240904$20240904$PER$$US-Eisai-EC-2024-171561$EISAI$$$$E$F$Y$$$20240904$$CN$US$US
242822241$24282224$1$I$20230801$20240813$20240904$20240904$PER$$BR-TOLMAR, INC.-24BR051891$TOLMAR$$9$YR$$F$Y$$$20240904$$CN$BR$BR
242822261$24282226$1$I$20240801$20240813$20240904$20240904$PER$$BR-TOLMAR, INC.-24BR051892$TOLMAR$$9$YR$$F$Y$$$20240904$$CN$BR$BR
242822271$24282227$1$I$$20240831$20240904$20240904$PER$$US-BAYER-2024A125910$BAYER$$$$$F$Y$$$20240904$$CN$US$US
242822281$24282228$1$I$20240831$20240903$20240903$20240903$DIR$716928$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242822291$24282229$1$I$20230817$20240902$20240902$20240902$DIR$716846$$FDA-CTU$$66$YR$$M$N$90$KG$20240902$N$CN$US$
242822301$24282230$1$I$$20240813$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051127$TOLMAR$$$$$M$Y$$$20240904$$PH$CA$CA
242822311$24282231$1$I$20240101$20240813$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051740$TOLMAR$$$$$F$Y$$$20240904$$MD$CA$CA
242822321$24282232$1$I$20240813$20240813$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051836$TOLMAR$$68$YR$$M$Y$$$20240904$$CN$CA$CA
242822341$24282234$1$I$20240301$20240902$20240902$20240902$DIR$716877$$FDA-CTU$$59$YR$$F$N$63$KG$20240902$N$CN$US$
242822371$24282237$1$I$20240813$20240813$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051838$TOLMAR$$69$YR$$M$Y$$$20240904$$CN$CA$CA
242822381$24282238$1$I$20240425$20240813$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051866$TOLMAR$$65$YR$$M$Y$$$20240904$$CN$CA$CA
242822391$24282239$1$I$20240813$20240813$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051865$TOLMAR$$56$YR$$M$Y$$$20240904$$CN$CA$CA
242822401$24282240$1$I$$20240813$20240904$20240904$PER$$CA-TOLMAR, INC.-24CA051867$TOLMAR$$$$$M$Y$$$20240904$$CN$CA$CA
242822411$24282241$1$I$$20240826$20240904$20240904$PER$$US-ABBVIE-5900024$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242822431$24282243$1$I$$20240828$20240904$20240904$EXP$$CN-SA-2024SA254479$SANOFI AVENTIS$$$$A$M$Y$$$20240904$$HP$CN$CN
242822471$24282247$1$I$20240804$20240902$20240902$20240902$DIR$716830$$FDA-CTU$$$$$UNK$N$$$20240902$Y$CN$US$
242822491$24282249$1$I$20240801$20240902$20240902$20240902$DIR$716852$$FDA-CTU$$69$YR$$M$N$83.25$KG$20240902$N$CN$US$
242822512$24282251$2$F$$20240916$20240904$20240918$PER$$NVSC2024US177894$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
242822522$24282252$2$F$20240617$20240909$20240904$20240912$EXP$IT-MINISAL02-1000582$IT-DSJP-DSE-2024-143203$DAIICHI$$79$YR$$F$Y$60$KG$20240912$$MD$IT$IT
242822531$24282253$1$I$20240804$20240827$20240904$20240904$EXP$$CA-JNJFOC-20230516509$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240904$$HP$CA$CA
242822541$24282254$1$I$$20240902$20240904$20240904$PER$$US-BAYER-2024A126341$BAYER$$46$YR$A$F$Y$$$20240904$$MD$US$US
242822552$24282255$2$F$20230316$20240924$20240904$20240930$EXP$$CA-TAKEDA-2023TUS024595$TAKEDA$$52$YR$$M$Y$$$20240930$$CN$CA$CA
242822561$24282256$1$I$$20240830$20240904$20240904$EXP$$GB-TAKEDA-2024TUS084121$TAKEDA$$$$$F$Y$$$20240904$$CN$GB$GB
242822572$24282257$2$F$$20240903$20240904$20240906$EXP$$US-ABBVIE-5903349$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242822591$24282259$1$I$$20240828$20240904$20240904$EXP$$IN-ROCHE-10000069151$ROCHE$$65$YR$E$M$Y$$$20240904$$CN$IN$IN
242822601$24282260$1$I$$20240816$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08196$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242822611$24282261$1$I$20240827$20240829$20240904$20240904$EXP$$US-BAYER-2024A125332$BAYER$$70$YR$E$F$Y$$$20240904$$CN$US$US
242822621$24282262$1$I$20240826$20240828$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137806$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$88$KG$20240904$$PH$US$US
242822631$24282263$1$I$20240826$20240903$20240904$20240904$PER$$US-BAYER-2024A126332$BAYER$$63$YR$A$F$Y$$$20240904$$HP$US$US
242822641$24282264$1$I$20240628$20240829$20240904$20240904$EXP$$DE-ABBVIE-5902558$ABBVIE$$38$YR$$M$Y$$$20240904$$CN$DE$DE
242822651$24282265$1$I$20240730$20240829$20240904$20240904$EXP$$DE-TEVA-VS-3238999$TEVA$$66$YR$$M$Y$$$20240904$$MD$DE$DE
242822661$24282266$1$I$$20240826$20240904$20240904$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006376$BIOCON$$$$$$Y$$$20240904$$HP$CA$CA
242822671$24282267$1$I$$20240816$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08335$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242822681$24282268$1$I$$20240902$20240904$20240904$EXP$$JP-JNJFOC-20240906652$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240904$$MD$JP$JP
242822693$24282269$3$F$20240101$20240913$20240904$20240927$PER$$US-SA-2024SA256196$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240927$$MD$US$US
242822701$24282270$1$I$$20240829$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138461$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240904$$CN$US$US
242822711$24282271$1$I$20240801$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140716$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$158.76$KG$20240904$$CN$US$US
242822721$24282272$1$I$20240617$20240802$20240904$20240904$PER$$US-Eisai-EC-2024-171730$EISAI$$82$YR$E$M$Y$$$20240904$$CN$US$US
242822731$24282273$1$I$20240701$20240806$20240904$20240904$PER$$US-Eisai-EC-2024-171792$EISAI$$62$YR$A$M$Y$$$20240904$$MD$US$US
242822741$24282274$1$I$20240731$20240808$20240904$20240904$PER$$US-Eisai-EC-2024-171763$EISAI$$84$YR$E$M$Y$$$20240904$$CN$US$US
242822751$24282275$1$I$20240901$20240902$20240902$20240902$DIR$716845$$FDA-CTU$$$$$F$N$84$KG$20240902$N$CN$CA$
242822761$24282276$1$I$20240827$20240902$20240902$20240902$DIR$716860$$FDA-CTU$$46$YR$$M$N$103.05$KG$20240902$N$CN$US$
242822771$24282277$1$I$$20240816$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08283$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242822781$24282278$1$I$$20240828$20240904$20240904$EXP$$US-GILEAD-2024-0685822$GILEAD$$$$E$F$Y$$$20240904$$CN$US$US
242822791$24282279$1$I$$20240903$20240904$20240904$PER$$US-AMGEN-USASP2024176061$AMGEN$$$$E$F$Y$$$20240904$$HP$US$US
242822803$24282280$3$F$20240828$20240905$20240904$20240909$PER$$US-AMGEN-USASP2024175522$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
242822811$24282281$1$I$$20240826$20240904$20240904$EXP$$TW-AMGEN-TWNSP2024173213$AMGEN$Wei S.; Tsai T.; Wu J. et al.. Exacerbated gastrointestinal symptoms and long COVID in IBD patients with SARS-CoV-2 infection: A multi-center study from taiwan. Journal of the Formosan Medical Association. 2024;123 (8):866-874$$$$$Y$$$20240904$$HP$TW$TW
242822821$24282282$1$I$20240827$20240903$20240904$20240904$EXP$$NVSC2024US177378$NOVARTIS$$$$$F$Y$$$20240904$$MD$US$US
242822841$24282284$1$I$20240626$20240829$20240904$20240904$EXP$FR-AFSSAPS-LL2024001626$FR-MYLANLABS-2024M1079734$MYLAN$$35$YR$$F$Y$$$20240904$$MD$FR$FR
242822852$24282285$2$F$20240802$20240903$20240904$20240909$EXP$$US-KYOWAKIRIN-2024KK020567$KYOWA$$$$$$Y$$$20240909$$HP$US$US
242822861$24282286$1$I$$20240904$20240904$20240904$EXP$GB-MHRA-MED-202409041045552880-FPZHJ$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049466$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240904$$HP$GB$GB
242822881$24282288$1$I$$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000354$ELI LILLY AND CO$$$$$M$Y$$$20240904$$CN$US$US
242822891$24282289$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001483$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240904$$CN$US$US
242822902$24282290$2$F$$20240905$20240904$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409001394$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240910$$CN$US$US
242822911$24282291$1$I$$20240826$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408015707$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240904$$MD$US$US
242822921$24282292$1$I$20240831$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001583$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240904$$CN$US$US
242822931$24282293$1$I$20240501$20240823$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202408015862$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240904$$CN$US$US
242822951$24282295$1$I$$20240903$20240904$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US077530$SANDOZ$$$$$M$Y$$$20240904$$HP$US$US
242822961$24282296$1$I$20240815$20240903$20240904$20240904$PER$$US-BAYER-2024A126599$BAYER$$25$YR$A$F$Y$$$20240904$$MD$US$US
242822971$24282297$1$I$$20240605$20240904$20240904$EXP$$RU-BIOVITRUM-2024-RU-011630$BIOVITRUM$$$$C$$Y$$$20240904$$MD$RU$RU
242822981$24282298$1$I$$20240826$20240904$20240904$30DAY$$US-GSK-US2024106140$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242822991$24282299$1$I$$20240829$20240904$20240904$EXP$$US-AMGEN-USASP2024173151$AMGEN$Sharma S.; Ramos M.S.; Mammo D.A. et al.. VITREORETINAL LYMPHOMA WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT IN A PATIENT WITH SARCOIDOSIS: A CASE REPORT. Retinal Cases + Brief Reports. 2024;18 (4):464-467$59$YR$A$M$Y$$$20240904$$MD$US$US
242823015$24282301$5$F$$20240920$20240904$20240923$EXP$$US-GILEAD-2024-0686146$GILEAD$$56$YR$A$M$Y$$$20240923$$CN$US$US
242823021$24282302$1$I$$20240826$20240904$20240904$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08085$HIKMA$Gullickson C, Kersun L, Reilly A, Seif A, Chehab L.. Gullickson C, Kersun L, Reilly A, Seif A, Chehab L. Isolated central nervous system relapse in two adolescents with primary mediastinal large B-cell lymphoma after treatment with R-DA-EPOCH.. Pediatric Blood Cancer.. 2024;71(8):e31065:1-4 pgs$11$YR$$F$Y$$$20240904$$MD$US$US
242823101$24282310$1$I$$20240903$20240904$20240904$EXP$$TN-PFIZER INC-PV202400115934$PFIZER$$58$YR$$$Y$$$20240904$$MD$TN$TN
242823111$24282311$1$I$20240624$20240830$20240904$20240904$EXP$$CN-PFIZER INC-PV202400114107$PFIZER$$69$YR$$F$Y$56.5$KG$20240904$$HP$CN$CN
242823122$24282312$2$F$20240727$20240913$20240904$20240916$EXP$$IN-PFIZER INC-202400248083$PFIZER$$44$YR$$F$Y$56.5$KG$20240916$$CN$IN$US
242823141$24282314$1$I$20240828$20240830$20240904$20240904$EXP$$CN-PFIZER INC-PV202400114202$PFIZER$$7$YR$$F$Y$21$KG$20240904$$HP$CN$CN
242823151$24282315$1$I$20240819$20240830$20240904$20240904$EXP$$CN-PFIZER INC-PV202400114131$PFIZER$$83$YR$$M$Y$$$20240904$$HP$CN$CN
242823171$24282317$1$I$$20240903$20240904$20240904$EXP$$US-PFIZER INC-202400249389$PFIZER$$69$YR$$F$Y$$$20240904$$CN$US$US
242823182$24282318$2$F$$20240912$20240904$20240917$EXP$$AU-PFIZER INC-202400249124$PFIZER$$$$$F$Y$$$20240917$$CN$AU$AU
242823191$24282319$1$I$20240801$20240903$20240904$20240904$EXP$$US-PFIZER INC-202400249315$PFIZER$$82$YR$$F$Y$$$20240904$$CN$US$US
242823201$24282320$1$I$20240801$20240902$20240904$20240904$EXP$$JP-PFIZER INC-PV202400115165$PFIZER$$72$YR$$F$Y$$$20240904$$MD$JP$JP
242823211$24282321$1$I$$20240903$20240904$20240904$PER$$US-BAYER-2024A126349$BAYER$$20$YR$A$F$Y$$$20240904$$MD$US$US
242823221$24282322$1$I$20240826$20240903$20240904$20240904$EXP$$CN-PFIZER INC-PV202400115565$PFIZER$$20$YR$$M$Y$55$KG$20240904$$HP$CN$CN
242823231$24282323$1$I$$20240814$20240904$20240904$PER$$US-009507513-2408USA005629$MERCK$$$$$F$Y$$$20240904$$CN$US$US
242823241$24282324$1$I$$20240902$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140000$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$CN$US$US
242823251$24282325$1$I$20240613$20240903$20240904$20240904$EXP$$DE-SANDOZ INC.-SDZ2024DE077338$SANDOZ$$77$YR$$M$Y$65$KG$20240904$$MD$DE$DE
242823271$24282327$1$I$$20240903$20240904$20240904$EXP$CN-MLMSERVICE-20240826-PI171126-00060-1$CN-SANDOZ INC.-SDZ2024CN077509$SANDOZ$$$$I$F$Y$$$20240904$$MD$CN$CN
242823301$24282330$1$I$$20240726$20240904$20240904$PER$$US-MRZWEB-2024070000153$MERZ$$46$YR$$M$Y$$$20240904$$HP$US$US
242823312$24282331$2$F$20240828$20240912$20240904$20240918$EXP$$NVSC2024CO103115$NOVARTIS$$38$YR$$F$Y$45$KG$20240919$$CN$CO$CO
242823341$24282334$1$I$20231124$20240827$20240904$20240904$EXP$FR-AFSSAPS-LY2023001904$FR-AMGEN-FRASP2024170981$AMGEN$$47$YR$A$F$Y$$$20240904$$MD$FR$FR
242823351$24282335$1$I$20240608$20240820$20240904$20240904$EXP$$US-HLS-202400662$HLS THERAPEUTICS$$47$YR$A$M$Y$$$20240904$$MD$US$US
242823361$24282336$1$I$20240825$20240827$20240904$20240904$EXP$CN-NMPACDR-3704011509867202400741$CN-BAXTER-2024BAX023936$BAXTER$$43$YR$$F$Y$57$KG$20240904$$MD$CN$CN
242823381$24282338$1$I$$20240903$20240904$20240904$PER$$US-JNJFOC-20240905008$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$HP$US$US
242823411$24282341$1$I$$20240822$20240904$20240904$PER$$US-Calliditas-2024CAL01377$CALLIDITAS THERAPEUTICS$$30$YR$A$F$Y$$$20240904$$CN$US$US
242823421$24282342$1$I$$20240828$20240904$20240904$EXP$$JP-009507513-2408JPN004043J$MERCK$$$$$F$Y$$$20240904$$MD$JP$JP
242823431$24282343$1$I$20240101$20240822$20240904$20240904$PER$$US-SA-2024SA255502$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240904$$CN$US$US
242823441$24282344$1$I$20240427$20240830$20240904$20240904$EXP$GB-MHRA-MIDB-e3ffbe2f-4c0f-47ec-9c6b-f968b73335b6$GB-MYLANLABS-2024M1080202$MYLAN$$81$YR$$F$Y$$$20240904$$PH$GB$GB
242823451$24282345$1$I$20240725$20240826$20240904$20240904$PER$$US-SA-2024SA256037$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240904$$MD$US$US
242823541$24282354$1$I$20200601$20240801$20240904$20240904$EXP$$CN-HALEON-CA2021AMR01330$Haleon PLC$$80$YR$$M$Y$69$KG$20240904$$MD$CA$CA
242823571$24282357$1$I$20240903$20240903$20240903$20240903$DIR$716941$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242823581$24282358$1$I$20240801$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139386$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240904$$HP$US$US
242823611$24282361$1$I$20240825$20240903$20240904$20240904$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-140352$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240904$$MD$DE$DE
242823621$24282362$1$I$20240830$20240830$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139505$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240904$$PH$US$US
242823631$24282363$1$I$20240101$20240902$20240904$20240904$EXP$$GR-PFIZER INC-PV202400114767$PFIZER$$58$YR$$F$Y$$$20240904$$MD$GR$GR
242823641$24282364$1$I$20240701$20240821$20240904$20240904$PER$$US-Eisai-EC-2024-172646$EISAI$$76$YR$E$M$Y$$$20240904$$CN$US$US
242823651$24282365$1$I$$20240903$20240904$20240904$EXP$$DE-PFIZER INC-202400248885$PFIZER$$$$$$Y$$$20240904$$CN$DE$DE
242823661$24282366$1$I$20230928$20240902$20240904$20240904$EXP$FR-AFSSAPS-LL2024001590$FR-PFIZER INC-202400248191$PFIZER$$19$YR$$F$Y$71$KG$20240904$$PH$FR$FR
242823671$24282367$1$I$$20240830$20240904$20240904$EXP$$US-PFIZER INC-202400247769$PFIZER$$37$YR$$M$Y$$$20240904$$CN$US$US
242823681$24282368$1$I$20230914$20240902$20240904$20240904$EXP$$FR-PFIZER INC-202400248185$PFIZER$$66$YR$$F$Y$73$KG$20240904$$MD$FR$FR
242823691$24282369$1$I$$20240828$20240904$20240904$EXP$$CA-PFIZER INC-202400206038$PFIZER$$44$YR$$F$Y$$$20240904$$MD$CA$CA
242823701$24282370$1$I$$20240903$20240904$20240904$EXP$$CA-PFIZER INC-202400249252$PFIZER$$29$YR$$M$Y$$$20240904$$HP$CA$CA
242823711$24282371$1$I$20240101$20240902$20240904$20240904$EXP$$CA-PFIZER INC-202400206100$PFIZER$$76$YR$$F$Y$$$20240904$$HP$CA$CA
242823721$24282372$1$I$$20240828$20240904$20240904$EXP$$ES-PFIZER INC-202400245638$PFIZER$$81$YR$$F$Y$$$20240904$$PH$ES$ES
242823731$24282373$1$I$20240101$20240828$20240904$20240904$EXP$$US-PFIZER INC-PV202400113471$PFIZER$$54$YR$$F$Y$$$20240904$$HP$US$US
242823741$24282374$1$I$20240621$20240830$20240904$20240904$EXP$$JP-PFIZER INC-PV202400084237$PFIZER$$67$YR$$F$Y$45.7$KG$20240904$$PH$JP$JP
242823771$24282377$1$I$$20240828$20240904$20240904$PER$$US-009507513-2408USA010266$MERCK$Pant P, Grewal DS.. PENTOSAN POLYSULFATE MACULOPATHY-ASSOCIATED CYSTOID MACULAR EDEMA RESPONSIVE TO INTRAVITREAL STEROIDS. Retinal cases + brief reports. 2024;18 (5):549-552$48$YR$$F$Y$$$20240904$$HP$US$US
242823781$24282378$1$I$20240801$20240829$20240904$20240904$EXP$$FR-009507513-2409FRA000573$MERCK$$$$$F$Y$$$20240904$$MD$FR$FR
242823811$24282381$1$I$$20240903$20240904$20240904$PER$$US-JNJFOC-20240905368$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$CN$US$US
242823821$24282382$1$I$20240401$20240828$20240904$20240904$PER$$US-JNJFOC-20240876944$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240904$$HP$US$US
242823831$24282383$1$I$$20240830$20240904$20240904$EXP$$PT-KYOWAKIRIN-2024KK020511$KYOWA$L? AM, Peixeiro R, Lau C, Teixeira MD, Cabral R, Fernandes I.. Mogamulizumab for S?zary syndrome: long-term remission with associated autoimmune haemolytic anaemia. European journal of dermatology : EJD. 2024;34(4):457-459$$$$$Y$$$20240904$$HP$PT$PT
242823841$24282384$1$I$20240801$20240826$20240904$20240904$PER$$US-SA-2024SA253938$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240904$$MD$US$US
242823861$24282386$1$I$20240101$20240826$20240904$20240904$PER$$US-SA-2024SA252564$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240904$$MD$US$US
242823871$24282387$1$I$$20240827$20240904$20240904$PER$$US-SA-2024SA255714$SANOFI AVENTIS$$$$T$M$Y$$$20240904$$MD$US$US
242823881$24282388$1$I$20240101$20240822$20240904$20240904$PER$$US-SA-2024SA255813$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240904$$MD$US$US
242823891$24282389$1$I$20230101$20240830$20240904$20240904$PER$$US-SA-2024SA255721$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240904$$CN$US$US
242823901$24282390$1$I$20240506$20240826$20240904$20240904$PER$$US-SA-2024SA256013$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240904$$MD$US$US
242823911$24282391$1$I$$20240822$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160078$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242823921$24282392$1$I$$20240902$20240904$20240904$EXP$$CA-ORGANON-O2409CAN000051$ORGANON$$$$$F$Y$$$20240904$$MD$CA$CA
242823961$24282396$1$I$20240701$20240827$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN009014$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242823972$24282397$2$F$20200801$20240826$20240904$20240913$EXP$$JP-009507513-2009JPN001052J$MERCK$Ushijima T, Nasu H, Ikeda Y, Uchida H, Harai A, Park J, et al.. [3 A case of recurrent uterine carcinoma with systemic lupus erythematosus successfully treated with pembrolizumab]. The Journal of Fukuoka College of Obstetricians and Gynecologists, the 163rd Ann. 2022;45:35$64$YR$$F$Y$$$20240913$$MD$JP$JP
242823981$24282398$1$I$$20240826$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160177$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242823992$24282399$2$F$20240806$20240910$20240904$20240919$PER$$US-INCYTE CORPORATION-2024IN008997$INCYTE$$$$$$Y$$$20240919$$CN$US$US
242824001$24282400$1$I$$20240830$20240904$20240904$PER$$US-AstraZeneca-2024A199384$ASTRAZENECA$$$$$$Y$$$20240904$$CN$US$
242824021$24282402$1$I$$20240828$20240904$20240904$EXP$$US-AstraZeneca-2024A197037$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242824031$24282403$1$I$$20240829$20240904$20240904$EXP$$US-AstraZeneca-2024A197863$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242824051$24282405$1$I$$20240903$20240904$20240904$PER$$US-ALXN-202409USA000058US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240904$$CN$US$US
242824061$24282406$1$I$$20240831$20240904$20240904$EXP$$FI-MYLANLABS-2024M1080754$MYLAN$$26$YR$$F$Y$$$20240904$$MD$FI$FI
242824071$24282407$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140552$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$107.95$KG$20240904$$CN$US$US
242824081$24282408$1$I$20240829$20240829$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138721$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$PH$US$US
242824091$24282409$1$I$20240802$20240802$20240904$20240904$PER$$US-Eisai-EC-2024-171810$EISAI$$$$$$Y$$$20240904$$HP$US$US
242824101$24282410$1$I$$20240826$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN008988$INCYTE$$$$$$Y$$$20240904$$HP$US$US
242824201$24282420$1$I$20240813$20240904$20240904$20240904$DIR$717055$$FDA-CTU$$67$YR$$F$N$103$KG$20240904$N$HP$US$
242824211$24282421$1$I$20231101$20240828$20240904$20240904$EXP$$US-ABBVIE-5602058$ABBVIE$$31$YR$$F$Y$$$20240904$$CN$US$US
242824222$24282422$2$F$20240701$20240923$20240904$20240926$EXP$$US-BIOVITRUM-2024-US-008882$BIOVITRUM$$68$YR$$M$Y$$$20240926$$CN$US$US
242824241$24282424$1$I$20240501$20240829$20240904$20240904$EXP$$NVSC2024MX137382$NOVARTIS$$60$YR$$F$Y$44$KG$20240904$$CN$MX$MX
242824251$24282425$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA255683$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240904$$CN$US$US
242824261$24282426$1$I$20230101$20240826$20240904$20240904$PER$$US-SA-2024SA256252$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240904$$MD$US$US
242824271$24282427$1$I$$20240829$20240904$20240904$EXP$$CN-TAKEDA-2024TUS087919$TAKEDA$$$$$M$Y$$$20240904$$CN$CN$CN
242824281$24282428$1$I$$20240902$20240904$20240904$EXP$$JP-JNJFOC-20240906654$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240904$$MD$JP$JP
242824291$24282429$1$I$$20240903$20240904$20240904$PER$$US-JNJFOC-20240905033$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$CN$US$US
242824301$24282430$1$I$$20240816$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08331$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242824321$24282432$1$I$$20240822$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160076$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242824331$24282433$1$I$20240101$20240823$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160085$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242824341$24282434$1$I$$20240826$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160176$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242824351$24282435$1$I$$20240902$20240904$20240904$EXP$$ES-BIOVITRUM-2024-ES-011604$BIOVITRUM$$23$YR$$F$Y$$$20240904$$MD$ES$ES
242824361$24282436$1$I$$20240822$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160098$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242824381$24282438$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA253321$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240904$$MD$US$US
242824391$24282439$1$I$$20240830$20240904$20240904$PER$$US-SA-2024SA255681$SANOFI AVENTIS$$$$C$M$Y$$$20240904$$MD$US$US
242824401$24282440$1$I$20240801$20240822$20240904$20240904$PER$$US-SA-2024SA256045$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240904$$MD$US$US
242824411$24282441$1$I$$20240823$20240904$20240904$PER$$US-SA-2024SA255717$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240904$$MD$US$US
242824421$24282442$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA256118$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240904$$MD$US$US
242824431$24282443$1$I$20240822$20240826$20240904$20240904$PER$$US-SA-2024SA256501$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240904$$MD$US$US
242824441$24282444$1$I$20240829$20240830$20240904$20240904$PER$$US-BAYER-2024A125024$BAYER$$31$YR$A$F$Y$$$20240904$$MD$US$US
242824451$24282445$1$I$$20240816$20240904$20240904$PER$$US-ALXN-A202214974$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$CN$US$US
242824461$24282446$1$I$$20240816$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07368$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242824471$24282447$1$I$20240904$20240904$20240904$20240904$DIR$717070$$FDA-CTU$$70$YR$$F$N$67.95$KG$20240904$N$CN$US$
242824481$24282448$1$I$$20240827$20240904$20240904$EXP$$CA-FreseniusKabi-FK202413032$FRESENIUS KABI$$57$YR$A$M$Y$84$KG$20240904$$HP$CA$CA
242824492$24282449$2$F$20230801$20240910$20240904$20240912$PER$$US-BAYER-2024A125986$BAYER$$45$YR$A$F$Y$$$20240912$$MD$US$US
242824501$24282450$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177844$NOVARTIS$$43$YR$$F$Y$$$20240904$$HP$US$US
242824511$24282451$1$I$$20240827$20240904$20240904$EXP$$JP-AstraZeneca-2024A197662$ASTRAZENECA$$$$$F$Y$$$20240904$$PH$JP$
242824521$24282452$1$I$$20240904$20240904$20240904$DIR$717064$$FDA-CTU$$$$$UNK$N$$$20240904$$CN$US$
242824531$24282453$1$I$$20240903$20240903$20240903$DIR$716945$$FDA-CTU$$32$YR$$M$N$$$20240903$N$HP$US$
242824551$24282455$1$I$20240101$20240821$20240904$20240904$PER$$US-AstraZeneca-2024A191479$ASTRAZENECA$$10632$DY$$M$Y$$$20240904$$CN$US$
242824561$24282456$1$I$$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A198731$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242824571$24282457$1$I$$20240827$20240904$20240904$EXP$$BR-TEVA-VS-3238598$TEVA$$$$$$Y$$$20240904$$PH$BR$BR
242824581$24282458$1$I$$20240827$20240904$20240904$EXP$$CA-AstraZeneca-2024A163986$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$CA$
242824591$24282459$1$I$20240216$20240827$20240904$20240904$EXP$$CN-AstraZeneca-2024A196475$ASTRAZENECA$$28316$DY$$F$Y$46$KG$20240904$$MD$CN$
242824601$24282460$1$I$20240823$20240903$20240903$20240903$DIR$716944$$FDA-CTU$$76$YR$$F$N$$$20240903$Y$HP$US$
242824611$24282461$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001903$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240904$$CN$US$US
242824621$24282462$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001382$ELI LILLY AND CO$$42$YR$A$$Y$$$20240904$$CN$US$US
242824631$24282463$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001587$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240904$$CN$US$US
242824641$24282464$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001566$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240904$$CN$US$US
242824651$24282465$1$I$20240801$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A199117$ASTRAZENECA$$876$MON$$M$Y$$$20240904$$MD$US$
242824661$24282466$1$I$$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A198640$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242824671$24282467$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001462$ELI LILLY AND CO$$$$$F$Y$$$20240904$$CN$US$US
242824711$24282471$1$I$20240314$20240903$20240903$20240903$DIR$716939$$FDA-CTU$$35$YR$$M$N$$$20240903$N$CN$US$
242824721$24282472$1$I$$20240903$20240903$20240903$DIR$716956$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242824731$24282473$1$I$20240822$20240904$20240904$20240904$DIR$717062$$FDA-CTU$$37$YR$$F$N$65.25$KG$20240904$Y$HP$US$
242824751$24282475$1$I$20240826$20240903$20240903$20240903$DIR$716961$$FDA-CTU$$76$YR$$M$N$126.7$KG$20240903$N$HP$US$
242824771$24282477$1$I$20240101$20240820$20240904$20240904$PER$$US-SA-2024SA256672$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240904$$MD$US$US
242824781$24282478$1$I$$20240903$20240904$20240904$PER$$US-JNJFOC-20240905099$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$HP$US$US
242824791$24282479$1$I$$20240826$20240904$20240904$EXP$$GB-JNJFOC-20240879426$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240904$$CN$GB$GB
242824801$24282480$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA256538$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240904$$MD$US$US
242824811$24282481$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA252367$SANOFI AVENTIS$$$$A$F$Y$$$20240904$$MD$US$US
242824821$24282482$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA254673$SANOFI AVENTIS$$$$$F$Y$$$20240904$$MD$US$US
242824831$24282483$1$I$20240826$20240826$20240904$20240904$PER$$US-SA-2024SA253905$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240904$$HP$US$US
242824841$24282484$1$I$20240101$20240830$20240904$20240904$PER$$US-SA-2024SA255620$SANOFI AVENTIS$$$$$F$Y$$$20240904$$CN$US$US
242824851$24282485$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA256491$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240904$$MD$US$US
242824861$24282486$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA254144$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240904$$MD$US$US
242824871$24282487$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140640$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$53.98$KG$20240904$$CN$US$US
242824881$24282488$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139994$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240904$$HP$US$US
242824891$24282489$1$I$$20240829$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138353$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240904$$CN$US$US
242824901$24282490$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140276$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240904$$CN$US$US
242824911$24282491$1$I$$20240821$20240904$20240904$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08470$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240904$$HP$US$US
242824921$24282492$1$I$$20240903$20240904$20240904$PER$$US-BAYER-2024A126564$BAYER$$$$$F$Y$$$20240904$$HP$US$US
242824941$24282494$1$I$20240821$20240828$20240904$20240904$PER$$US-MYLANLABS-2024M1079794$MYLAN$$41$YR$$F$Y$$$20240904$$CN$US$US
242824952$24282495$2$F$$20240918$20240904$20240923$30DAY$$US-MYLANLABS-2024M1079389$MYLAN$$$$$$Y$$$20240923$$PH$US$US
242824961$24282496$1$I$$20240820$20240904$20240904$EXP$$IN-ACELLA PHARMACEUTICALS, LLC-2024ALO00426$Alora Pharma$Smily S, Tiwari S, Saini L, Yadav T, Manjunathan S, Panda A, et al.. Dextromethorphan Associated Neurotoxicity with Cerebellar Edema (DANCE) Syndrome in Young Children: Neuroimaging Features. American Journal of Neuroradiology. 2024;16:1-9$2$YR$$M$Y$$$20240904$$HP$IN$IN
242824971$24282497$1$I$$20240820$20240904$20240904$EXP$$IN-ACELLA PHARMACEUTICALS, LLC-2024ALO00425$Alora Pharma$Smily S, Tiwari S, Saini L, Yadav T, Manjunathan S, Panda A, et al.. Dextromethorphan Associated Neurotoxicity with Cerebellar Edema (DANCE) Syndrome in Young Children: Neuroimaging Features. American Journal of Neuroradiology. 2024;(16):A 8455$2$YR$$$Y$$$20240904$$HP$IN$IN
242824981$24282498$1$I$$20240820$20240904$20240904$EXP$$IN-ACELLA PHARMACEUTICALS, LLC-2024ALO00427$Alora Pharma$Smily S, Tiwari S, Saini L, Yadav T, Manjunathan S, Panda A, et al.. Dextromethorphan Associated Neurotoxicity with Cerebellar Edema (DANCE) Syndrome in Young Children: Neuroimaging Features. American Journal of Neuroradiology. 2024;16:1-9$1$YR$$F$Y$$$20240904$$HP$IN$IN
242824991$24282499$1$I$$20240820$20240904$20240904$EXP$$TH-ACELLA PHARMACEUTICALS, LLC-2024ALO00422$Alora Pharma$Kajornchaikul P, Thantiworasit P, Klaewsongkram J.. Pseudoephedrine-induced Fixed Drug Eruption in a Scuba Diver With Recurrent Palmoplantar Exfoliation. Journal of Preventative Medicine and Public Health. 2024$38$YR$$F$Y$$$20240904$$HP$TH$TH
242825001$24282500$1$I$$20240820$20240904$20240904$EXP$$IN-ACELLA PHARMACEUTICALS, LLC-2024ALO00424$Alora Pharma$Smily S, Tiwari S, Saini L, Yadav T, Manjunathan S, Panda A, et al.. Dextromethorphan Associated Neurotoxicity with Cerebellar Edema (DANCE) Syndrome in Young  Children: Neuroimaging Features. AJNR Am J Neuroradiol.. 2024;(16):A 8455$4$YR$$F$Y$$$20240904$$HP$IN$IN
242825012$24282501$2$F$$20240924$20240904$20240924$EXP$$GR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049244$BOEHRINGER INGELHEIM$Koutsovasilis A, Lanaras L. Clinical Examples / Diagnostic + Therapeutic Interventions in Ischemic Stroke with and without Atrial Fibrillation. 17th Panhellenic congress on cardiometabolic risk factors, 5-7 September 2024, Hotel Elite City Resort, Kalamata, Greece.$56$YR$A$M$Y$$$20240924$$MD$GR$GR
242825022$24282502$2$F$20240903$20240903$20240904$20240906$PER$$US-BAYER-2024A126777$BAYER$$$$$F$Y$$$20240906$$PH$US$US
242825041$24282504$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA256654$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240904$$HP$US$US
242825052$24282505$2$F$$20240911$20240904$20240918$EXP$$US-JNJFOC-20240901548$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240918$$MD$US$US
242825061$24282506$1$I$$20240831$20240904$20240904$PER$$US-JNJFOC-20240903309$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242825071$24282507$1$I$20240801$20240827$20240904$20240904$EXP$$US-AMGEN-USASP2024171484$AMGEN$$69$YR$E$F$Y$$$20240904$$CN$US$US
242825081$24282508$1$I$20240118$20240904$20240904$20240904$EXP$ES-AEMPS-1565597$NVSC2024ES177548$NOVARTIS$$66$YR$$F$Y$63.6$KG$20240904$$PH$ES$ES
242825091$24282509$1$I$$20240829$20240904$20240904$EXP$$NVSC2024DE176668$NOVARTIS$$$$$F$Y$$$20240904$$CN$DE$DE
242825111$24282511$1$I$$20240826$20240904$20240904$PER$$US-FreseniusKabi-FK202413094$FRESENIUS KABI$$$$$$Y$$$20240904$$HP$US$US
242825132$24282513$2$F$$20240905$20240904$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138388$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240906$$HP$US$US
242825141$24282514$1$I$$20240829$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139805$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240904$$CN$US$US
242825151$24282515$1$I$20240813$20240829$20240904$20240904$EXP$IT-MINISAL02-999681$IT-TEVA-VS-3239021$TEVA$$53$YR$$F$Y$$$20240904$$PH$IT$IT
242825161$24282516$1$I$$20240806$20240904$20240904$EXP$$GB-TEVA-VS-3235135$TEVA$$66$YR$$F$Y$$$20240904$$CN$GB$GB
242825171$24282517$1$I$$20240726$20240904$20240904$PER$$US-Merz Pharmaceuticals GmbH-2024070000154$MERZ$$$$A$F$Y$$$20240904$$CN$US$US
242825191$24282519$1$I$20240601$20240827$20240904$20240904$EXP$$US-JNJFOC-20240904611$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$PH$US$US
242825201$24282520$1$I$$20240902$20240904$20240904$EXP$$CA-BAUSCH-BL-2024-013187$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240904$$HP$CA$CA
242825211$24282521$1$I$$20240903$20240904$20240904$EXP$$US-BAUSCH-BL-2024-013231$BAUSCH AND LOMB$$83$YR$$F$Y$$$20240904$$CN$US$US
242825221$24282522$1$I$$20240902$20240904$20240904$EXP$$CA-ORGANON-O2409CAN000052$ORGANON$$43$YR$$F$Y$70$KG$20240904$$HP$CA$CA
242825232$24282523$2$F$20110401$20240906$20240904$20240916$EXP$$TW-TEVA-VS-3221627$TEVA$Hsieh C-Y, Tsai T-F. Treatment responses of four different biologics in a patient with recurrent generalized pustular psoriasis harboring IL36RN mutation. Dermatol-Sin 2024; 42 (2): 152-153.; Hsieh C-Y, Tsai T-F. Treatment responses of four different biologics in a patient with recurrent generalized pustular psoriasis harboring IL36RN mutation. Dermatol-Sin 2024; 42 (2): 152-153.; Hsieh C-Y, Tsai T-F. Treatment responses of four different biologics in a patient with recurrent generalized pust...$56$YR$$F$Y$57$KG$20240916$$HP$TW$TW
242825241$24282524$1$I$20240829$20240904$20240904$20240904$DIR$717073$$FDA-CTU$$76$YR$$F$N$59.4$KG$20240904$N$CN$US$
242825251$24282525$1$I$20240120$20240903$20240903$20240903$DIR$716940$$FDA-CTU$$68$YR$$M$N$$$20240903$N$HP$US$
242825271$24282527$1$I$$20240902$20240904$20240904$EXP$$CA-BAUSCH-BL-2024-013203$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240904$$CN$CA$CA
242825281$24282528$1$I$$20240904$20240904$20240904$DIR$717065$$FDA-CTU$$$$$UNK$N$$$20240904$N$CN$US$
242825291$24282529$1$I$$20240830$20240904$20240904$EXP$$US-SANDOZ INC.-SDZ2023US016132$SANDOZ$$70$YR$$F$Y$$$20240904$$HP$US$US
242825311$24282531$1$I$$20240904$20240904$20240904$DIR$717068$$FDA-CTU$$$$$UNK$N$$$20240904$N$CN$US$
242825321$24282532$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177910$NOVARTIS$$$$$M$Y$$$20240904$$HP$US$US
242825341$24282534$1$I$$20240829$20240904$20240904$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-138745$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$85.28$KG$20240904$$CN$PR$PR
242825352$24282535$2$F$$20240905$20240904$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139947$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$HP$US$US
242825371$24282537$1$I$$20240904$20240904$20240904$DIR$717060$$FDA-CTU$$76$YR$$F$N$$$20240904$N$PH$US$
242825391$24282539$1$I$$20240904$20240904$20240904$DIR$717080$$FDA-CTU$$$$$UNK$N$$$20240904$N$CN$US$
242825401$24282540$1$I$20230901$20240904$20240904$20240904$DIR$717079$$FDA-CTU$$76$YR$$M$N$77.85$KG$20240904$N$HP$US$
242825421$24282542$1$I$20240801$20240904$20240904$20240904$DIR$717085$$FDA-CTU$$59$YR$$F$N$47.25$KG$20240904$N$HP$US$
242825441$24282544$1$I$20240824$20240902$20240902$20240902$DIR$716826$$FDA-CTU$$46$YR$$F$N$54$KG$20240902$N$CN$IN$
242825451$24282545$1$I$20120101$20240826$20240904$20240904$EXP$$US-TEVA-VS-3238244$TEVA$$61$YR$$F$Y$$$20240904$$CN$US$US
242825461$24282546$1$I$$20240903$20240904$20240904$PER$$US-HALEON-2195126$Haleon PLC$$$$$$Y$$$20240904$$CN$US$US
242825491$24282549$1$I$$20240805$20240904$20240904$30DAY$$US-BAXTER-2024BAX024189$BAXTER$$$$$$Y$$$20240904$$CN$US$US
242825501$24282550$1$I$20240101$20240808$20240904$20240904$PER$$US-JNJFOC-20240823244$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240904$$HP$US$US
242825512$24282551$2$F$$20240904$20240904$20240905$PER$$US-JNJFOC-20240907367$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242825522$24282552$2$F$20200108$20240903$20240904$20240906$EXP$$FI-AstraZeneca-2024A200038$ASTRAZENECA$$51$YR$$M$Y$126$KG$20240906$$MD$FI$
242825532$24282553$2$F$$20240903$20240904$20240911$EXP$$NL-AstraZeneca-2024A200078$ASTRAZENECA$$33$YR$$M$Y$85$KG$20240911$$MD$NL$
242825541$24282554$1$I$$20240830$20240904$20240904$EXP$$JP-AMGEN-JPNSP2024174497$AMGEN$Sato H. Incidence and clinical course of femoral localized periosteal thickening and atypical femoral fracture over a 10- year period in patients with autoimmune inflammatory rheumatic disease. JBMR plus. 2024;8(9):1-10$$$$$Y$$$20240904$$HP$JP$JP
242825551$24282555$1$I$20240828$20240903$20240904$20240904$PER$$US-AMGEN-USASP2024176013$AMGEN$$54$YR$A$F$Y$$$20240904$$CN$US$US
242825561$24282556$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A195732$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242825571$24282557$1$I$$20240902$20240904$20240904$EXP$$CA-BAUSCH-BL-2024-013186$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240904$$HP$CA$CA
242825581$24282558$1$I$20230101$20240824$20240904$20240904$EXP$$US-JNJFOC-20240810171$JOHNSON AND JOHNSON$$58$YR$A$F$Y$53.1$KG$20240904$$HP$US$US
242825591$24282559$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A195702$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242825601$24282560$1$I$$20240827$20240904$20240904$EXP$$JP-AstraZeneca-2024A197446$ASTRAZENECA$$55$YR$$M$Y$$$20240904$$MD$JP$
242825621$24282562$1$I$$20240827$20240904$20240904$EXP$$AU-AstraZeneca-2024A196262$ASTRAZENECA$$$$$F$Y$$$20240904$$MD$AU$
242825631$24282563$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A196426$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242825641$24282564$1$I$$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A198796$ASTRAZENECA$$$$$$Y$$$20240904$$CN$US$
242825651$24282565$1$I$$20240827$20240904$20240904$EXP$$ZA-AstraZeneca-2024A195494$ASTRAZENECA$$55$YR$$F$Y$$$20240904$$CN$ZA$
242825661$24282566$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A195372$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242825671$24282567$1$I$20191213$20240828$20240904$20240904$EXP$$AR-AMGEN-ARGSP2024174822$AMGEN$$71$YR$E$F$Y$$$20240904$$CN$AR$AR
242825681$24282568$1$I$$20240829$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138288$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240904$$HP$US$US
242825691$24282569$1$I$$20240830$20240904$20240904$EXP$$AE-BAUSCH-BL-2024-013139$BAUSCH AND LOMB$Jumani A, Ibrahim H, Purra H, Alkhazraji A, Alnajjar M. Metformin-Induced Hemolysis in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient: A Case Report. Cureus. 2024 JUL 22;16(7):1-5. doi:10.7759/cureus.65081.$40$YR$$M$Y$$$20240904$$HP$AE$AE
242825701$24282570$1$I$20240828$20240828$20240904$20240904$PER$$US-BAYER-2024A124299$BAYER$$89$YR$E$M$Y$$$20240904$$CN$US$US
242825711$24282571$1$I$$20240830$20240904$20240904$PER$$US-BIOGEN-2024BI01280770$BIOGEN$$$$$M$Y$$$20240904$$CN$US$US
242825721$24282572$1$I$$20240828$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138345$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$99.79$KG$20240904$$CN$US$US
242825731$24282573$1$I$20240831$20240903$20240904$20240904$EXP$$US-TAKEDA-2024TUS088468$TAKEDA$$55$YR$$F$Y$$$20240904$$MD$US$US
242825741$24282574$1$I$$20240902$20240904$20240904$EXP$$CA-BAUSCH-BL-2024-013201$BAUSCH AND LOMB$$$$$$Y$$$20240904$$HP$CA$CA
242825751$24282575$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177531$NOVARTIS$$$$A$F$Y$$$20240904$$CN$US$US
242825761$24282576$1$I$20240718$20240815$20240904$20240904$PER$$US-Vifor (International) Inc.-VIT-2024-07447$VIFOR$$42$YR$$M$Y$80.5$KG$20240904$$HP$US$US
242825771$24282577$1$I$$20240826$20240904$20240904$EXP$$CA-MYLANLABS-2022M1125084$BIOCON$$$$$$Y$$$20240904$$CN$CA$CA
242825781$24282578$1$I$$20240828$20240904$20240904$EXP$$US-GSK-US2024AMR107573$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$US$US
242825791$24282579$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001422$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240904$$CN$US$US
242825811$24282581$1$I$$20240726$20240904$20240904$PER$$US-MRZWEB-2024070000155$MERZ$$$$$F$Y$$$20240904$$HP$US$US
242825821$24282582$1$I$20240827$20240827$20240904$20240904$EXP$$GB-TEVA-VS-3238191$TEVA$$20$YR$$F$Y$79$KG$20240904$$MD$GB$GB
242825831$24282583$1$I$$20240830$20240904$20240904$PER$$US-SA-2024SA255822$SANOFI AVENTIS$$$$$M$Y$$$20240904$$MD$US$US
242825841$24282584$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA256619$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240904$$HP$US$US
242825851$24282585$1$I$$20240904$20240904$20240904$PER$$US-BAYER-2024A126840$BAYER$$$$$$Y$$$20240904$$CN$US$US
242825861$24282586$1$I$$20240828$20240904$20240904$EXP$$US-TEVA-VS-3238517$TEVA$$32$YR$$M$Y$$$20240904$$HP$US$US
242825871$24282587$1$I$20240812$20240828$20240904$20240904$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17289$IPSEN$$76$YR$E$F$Y$56.69$KG$20240904$$CN$US$US
242825881$24282588$1$I$$20240827$20240904$20240904$EXP$GB-MHRA-MED-202408272155149930-PBJNH$GB-TEVA-VS-3238200$TEVA$$36$YR$$F$Y$$$20240904$$CN$GB$GB
242825901$24282590$1$I$20240831$20240902$20240902$20240902$DIR$716851$$FDA-CTU$$47$YR$$M$N$60.75$KG$20240902$N$CN$US$
242825923$24282592$3$F$20240704$20240911$20240904$20240917$EXP$$MX-BAYER-2024A126580$BAYER$$12$YR$C$F$Y$$$20240917$$CN$MX$MX
242825931$24282593$1$I$$20240819$20240904$20240904$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08262$LUPIN$$$$$$Y$$$20240904$$CN$US$US
242825941$24282594$1$I$$20240903$20240904$20240904$EXP$$CA-SANDOZ INC.-SDZ2024CA075129$SANDOZ$$$$$F$Y$$$20240904$$MD$CA$CA
242825952$24282595$2$F$$20240905$20240904$20240920$EXP$$AU-ORGANON-O2408AUS002178$ORGANON$$$$$F$Y$$$20240920$$CN$AU$AU
242825961$24282596$1$I$20240701$20240829$20240904$20240904$EXP$$GB-ABBVIE-5902740$ABBVIE$$$$A$M$Y$$$20240904$$CN$GB$GB
242825971$24282597$1$I$$20240827$20240904$20240904$PER$$US-AstraZeneca-2024A195420$ASTRAZENECA$$$$$$Y$$$20240904$$HP$US$
242825981$24282598$1$I$$20240827$20240904$20240904$EXP$$JP-AstraZeneca-2024A184406$ASTRAZENECA$$90$YR$$M$Y$$$20240904$$PH$JP$
242825991$24282599$1$I$$20240826$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN008979$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242826001$24282600$1$I$20240701$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A198542$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242826011$24282601$1$I$20240101$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A200425$ASTRAZENECA$$38$YR$$F$Y$$$20240904$$CN$US$
242826021$24282602$1$I$$20240827$20240904$20240904$EXP$$JP-AstraZeneca-2024A193333$ASTRAZENECA$$91$YR$$F$Y$$$20240904$$MD$JP$
242826031$24282603$1$I$20240814$20240827$20240904$20240904$EXP$$IN-AstraZeneca-2024A195471$ASTRAZENECA$$74$YR$$M$Y$72$KG$20240904$$CN$IN$
242826041$24282604$1$I$20240821$20240827$20240904$20240904$EXP$$CN-AstraZeneca-2024A196498$ASTRAZENECA$$26868$DY$$F$Y$39$KG$20240904$$MD$CN$
242826051$24282605$1$I$$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A198990$ASTRAZENECA$$$$$$Y$$$20240904$$HP$US$
242826061$24282606$1$I$20240902$20240902$20240902$20240902$DIR$716850$$FDA-CTU$$38$YR$$F$N$85.5$KG$20240902$N$CN$US$
242826071$24282607$1$I$$20240828$20240904$20240904$EXP$$CA-APOTEX-2024AP010089$APOTEX$$68$YR$$M$Y$$$20240904$$CN$CA$CA
242826081$24282608$1$I$$20240830$20240904$20240904$PER$$US-AstraZeneca-2024A198637$ASTRAZENECA$$$$$M$Y$$$20240904$$MD$US$
242826091$24282609$1$I$$20240827$20240904$20240904$EXP$$JP-AstraZeneca-2024A196573$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$JP$
242826101$24282610$1$I$$20240829$20240904$20240904$PER$$US-JNJFOC-20240901739$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$PH$US$US
242826111$24282611$1$I$20240823$20240903$20240904$20240904$EXP$$US-AstraZeneca-2024A200471$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242826121$24282612$1$I$$20240903$20240904$20240904$EXP$$US-BAYER-2024A126499$BAYER$$$$$M$Y$$$20240904$$MD$US$US
242826131$24282613$1$I$20240813$20240830$20240904$20240904$EXP$$ES-ANIPHARMA-2024-ES-000096$ANI$$67$YR$$M$Y$70$KG$20240904$$PH$ES$ES
242826141$24282614$1$I$20240813$20240828$20240904$20240904$EXP$$CN-ANIPHARMA-2024-CN-000355$ANI$$53$YR$$F$Y$48$KG$20240904$$HP$CN$CN
242826151$24282615$1$I$$20240827$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136958$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$74.39$KG$20240904$$CN$US$US
242826162$24282616$2$F$$20240926$20240904$20240930$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-138267$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$51.71$KG$20240930$$CN$PR$PR
242826171$24282617$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140692$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240904$$PH$US$US
242826181$24282618$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139664$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240904$$CN$US$US
242826201$24282620$1$I$$20240822$20240904$20240904$EXP$$ID-B.Braun Medical Inc.-2161122$B BRAUN$Literature Article$4$YR$$F$Y$$$20240904$$$ID$ID
242826212$24282621$2$F$20230101$20240902$20240904$20240917$EXP$$IT-Ascend Therapeutics US, LLC-2161125$ASCEND$$33$YR$$F$Y$$$20240917$$$IT$IT
242826221$24282622$1$I$$20240823$20240904$20240904$EXP$$JP-ACI HealthCare Limited-2161148$ACI HEALTHCARE$Abstract$$$$F$Y$$$20240904$$$JP$JP
242826231$24282623$1$I$$20240825$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN008902$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242826241$24282624$1$I$$20240828$20240904$20240904$EXP$$IT-OrBion Pharmaceuticals Private Limited-2161145$ORBION PHARMACEUTICALS$Puppo G, Novelli F, Pinelli V, Sivori M, Dessanti P, Moroni M, Gorji P, Canessa PA. Pleural effusion due to valproic acid. Rass Patol Apparato Respir 2023; 38 (1):53-56. doi.org/10.36166/2531-4920-N682$53$YR$$M$Y$$$20240904$$MD$IT$IT
242826251$24282625$1$I$20240525$20240903$20240904$20240904$EXP$$DE-SANDOZ INC.-SDZ2024DE077350$SANDOZ$$77$YR$$M$Y$65$KG$20240904$$MD$DE$DE
242826261$24282626$1$I$20240824$20240826$20240904$20240904$PER$$US-SA-2024SA254085$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240904$$MD$US$US
242826271$24282627$1$I$20220401$20240828$20240904$20240904$PER$$US-SA-2022SA263760$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240904$$CN$US$US
242826282$24282628$2$F$20231101$20240909$20240904$20240916$EXP$$NVSC2024BR175817$NOVARTIS$$53$YR$$M$Y$82$KG$20240916$$CN$BR$BR
242826292$24282629$2$F$20240723$20240917$20240904$20240926$EXP$$PT-Integrated Therapeutic Solutions Inc.-2161128$Integrated Therapeutic Solutions$$58$YR$$F$Y$$$20240926$$$PT$PT
242826302$24282630$2$F$20230101$20240902$20240904$20240917$EXP$$IT-Ascend Therapeutics US, LLC-2161129$ASCEND$$33$YR$$F$Y$$$20240917$$$IT$IT
242826311$24282631$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA253919$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240904$$MD$US$US
242826321$24282632$1$I$$20240830$20240904$20240904$EXP$$CN-JNJFOC-20240902777$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$MD$CN$CN
242826331$24282633$1$I$$20240822$20240904$20240904$EXP$$US-P+L Developments of Newyork Corporation-2161150$PL DEVELOPMENTS$Initial$51$YR$$M$Y$$$20240904$$MD$US$US
242826341$24282634$1$I$20240601$20240902$20240902$20240902$DIR$716824$$FDA-CTU$$57$YR$$F$N$76.5$KG$20240902$N$CN$US$
242826351$24282635$1$I$20240829$20240902$20240902$20240902$DIR$716837$$FDA-CTU$$37$YR$$F$N$66.6$KG$20240902$N$CN$US$
242826371$24282637$1$I$$20240828$20240904$20240904$EXP$$CA-ROCHE-10000069399$ROCHE$$44$YR$A$F$Y$$$20240904$$HP$CA$CA
242826391$24282639$1$I$$20240822$20240904$20240904$EXP$$DE-B.Braun Medical Inc.-2161153$B BRAUN$Literature Article$58$YR$$F$Y$$$20240904$$$DE$DE
242826401$24282640$1$I$$20240819$20240904$20240904$EXP$$DE-Ascend Therapeutics US, LLC-2161132$ASCEND$$$$$F$Y$$$20240904$$$DE$DE
242826411$24282641$1$I$$20240822$20240904$20240904$EXP$$US-B.Braun Medical Inc.-2161155$B BRAUN$Literature Article$51$YR$$M$Y$$$20240904$$$US$US
242826421$24282642$1$I$$20240828$20240904$20240904$EXP$$RU-OrBion Pharmaceuticals Private Limited-2161147$ORBION PHARMACEUTICALS$Malyshev SM, Popov KD, Simakov KV, Marichev AO, Topuzova MP, Smirnova AY, Ryzhkov AV, Basek IV, Yanishevskij SN, Alekseeva TM, Schlyakhto EV. Epilepticheskii status u beremennoi patsientki s vpervye vyyavlennym POLG-assotsiirovannym zabolevaniem [Status epilepticus in a pregnant patient with a previously unrecognized POLG-associated disease]. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(10):129-135. Russian. doi: 10.17116/jnevro2023123101129.$33$YR$$F$Y$$$20240904$$MD$RU$RU
242826431$24282643$1$I$20240824$20240826$20240904$20240904$PER$$US-Mission Pharmacal Company-2161137$MISSION$$8$YR$$M$Y$$$20240904$$$US$US
242826441$24282644$1$I$$20240822$20240904$20240904$EXP$$GB-B.Braun Medical Inc.-2161161$B BRAUN$$79$YR$$M$Y$$$20240904$$$GB$GB
242826451$24282645$1$I$$20240820$20240904$20240904$EXP$$JP-Changzhou Pharmaceutical Factory-2161154$CHANGZHOU PHARMACEUTICAL FACTORY$Abstract$$$$F$Y$$$20240904$$$JP$JP
242826461$24282646$1$I$$20240828$20240904$20240904$EXP$$IE-OrBion Pharmaceuticals Private Limited-2161146$ORBION PHARMACEUTICALS$Moollan N, Durcan L. A tale of two pregnancies. Pol Arch Med Wewn 2022;132 (Suppl.)11-12. doi: 10.20452/pamw.16376.$35$YR$$F$Y$$$20240904$$MD$IE$IE
242826471$24282647$1$I$$20240820$20240904$20240904$EXP$$CA-Amphastar Pharmaceuticals, Inc.-2161140$AMPHASTAR$$$$$$Y$$$20240904$$PH$CA$CA
242826481$24282648$1$I$$20240826$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160127$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242826491$24282649$1$I$$20240826$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160121$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242826501$24282650$1$I$$20240826$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160168$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242826511$24282651$1$I$$20240826$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160137$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242826521$24282652$1$I$20240101$20240826$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160129$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242826531$24282653$1$I$$20240826$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160164$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242826541$24282654$1$I$$20240829$20240904$20240904$PER$$US-Mission Pharmacal Company-2161149$MISSION$$70$YR$$M$Y$$$20240904$$$US$US
242826552$24282655$2$F$20240101$20240904$20240904$20240913$EXP$$BG-UCBSA-2024044071$UCB$$63$YR$$M$Y$$$20240913$$MD$BG$BG
242826561$24282656$1$I$20240801$20240826$20240904$20240904$EXP$$GB-Life Molecular Imaging Ltd-2161142$LIFE MOLECULAR IMAGING$$82$YR$$F$Y$$$20240904$$$GB$GB
242826571$24282657$1$I$$20240723$20240904$20240904$PER$$US-Breckenridge Pharmaceutical, Inc.-2161163$BRECKENRIDGE$$56$YR$$M$Y$65.909$KG$20240904$$$US$US
242826581$24282658$1$I$$20240828$20240904$20240904$EXP$$IN-OrBion Pharmaceuticals Private Limited-2161144$ORBION PHARMACEUTICALS$Singanamalla B, Gunasekaran P, Saini AG. Facial dysmorphism and Limb abnormalities of Fetal Valproate Syndrome. QJM. 2024 Aug 22:hcae165. doi: 10.1093/qjmed/hcae165.$$$$$Y$$$20240904$$MD$IN$IN
242826591$24282659$1$I$20240814$20240823$20240904$20240904$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161143$JIANGSU HANSOH PHARMACEUTICAL$$43$YR$$F$Y$60$KG$20240904$$MD$CN$CN
242826601$24282660$1$I$$20240822$20240904$20240904$EXP$$BD-B.Braun Medical Inc.-2161157$B BRAUN$Literature Article$35$YR$$F$Y$$$20240904$$$BD$BD
242826611$24282661$1$I$$20240821$20240904$20240904$EXP$$US-Oxford Pharmaceuticals, LLC-2161175$OXFORD PHARMACEUTICALS$Source document$6$DEC$$F$Y$$$20240904$$$US$US
242826621$24282662$1$I$$20240820$20240904$20240904$EXP$$US-WES Pharma Inc-2161158$WES PHARMA$Full text$49$YR$$F$Y$$$20240904$$MD$US$US
242826631$24282663$1$I$$20240903$20240904$20240904$PER$$US-ABBVIE-5905419$ABBVIE$$$$$M$Y$94$KG$20240904$$CN$US$US
242826641$24282664$1$I$$20240828$20240904$20240904$EXP$$CA-APOTEX-2024AP010111$APOTEX$$63$YR$$F$Y$$$20240904$$CN$CA$CA
242826651$24282665$1$I$$20240820$20240904$20240904$EXP$$DE-Chemistry + Health FZ LLC-2161156$Chemistry + Health FZ$Full text$17$YR$$F$Y$$$20240904$$$DE$DE
242826661$24282666$1$I$$20240821$20240904$20240904$EXP$$US-Eywa Pharma Inc.-2161162$EYWA PHARMA$Full text$54$YR$$M$Y$$$20240904$$$US$US
242826671$24282667$1$I$$20240821$20240904$20240904$EXP$$ES-Eywa Pharma Inc.-2161165$EYWA PHARMA$Abstract$59$YR$$F$Y$$$20240904$$$ES$ES
242826691$24282669$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001564$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240904$$CN$US$US
242826701$24282670$1$I$$20240820$20240904$20240904$EXP$$US-Changzhou Pharmaceutical Factory-2161168$CHANGZHOU PHARMACEUTICAL FACTORY$Full text$76$YR$$F$Y$$$20240904$$$US$US
242826711$24282671$1$I$20240301$20240830$20240904$20240904$PER$$US-JNJFOC-20240881615$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$CN$US$US
242826721$24282672$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA251791$SANOFI AVENTIS$$58$YR$A$F$Y$101.59$KG$20240904$$CN$US$US
242826731$24282673$1$I$20240101$20240826$20240904$20240904$PER$$US-SA-2024SA255530$SANOFI AVENTIS$$$$A$F$Y$$$20240904$$MD$US$US
242826741$24282674$1$I$$20240830$20240904$20240904$PER$$US-SA-2024SA255731$SANOFI AVENTIS$$$$C$$Y$$$20240904$$HP$US$US
242826751$24282675$1$I$$20240827$20240904$20240904$PER$$US-SA-2024SA253955$SANOFI AVENTIS$$95$YR$E$M$Y$$$20240904$$HP$US$US
242826762$24282676$2$F$$20240826$20240904$20240909$PER$$US-SA-2024SA255471$SANOFI AVENTIS$$76$YR$E$$Y$$$20240909$$CN$US$US
242826771$24282677$1$I$$20240821$20240904$20240904$EXP$$US-Innogenix, LLC-2161178$INNOGENIX$Full text$54$YR$$M$Y$$$20240904$$$US$US
242826781$24282678$1$I$20240813$20240826$20240904$20240904$EXP$$CN-SA-2024SA255535$SANOFI AVENTIS$$25$YR$A$F$Y$44$KG$20240904$$HP$CN$CN
242826791$24282679$1$I$$20240829$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139633$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240904$$HP$US$US
242826801$24282680$1$I$$20240823$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135523$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240904$$MD$US$US
242826811$24282681$1$I$$20240902$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139881$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$61.69$KG$20240904$$CN$US$US
242826831$24282683$1$I$20240801$20240826$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135440$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240904$$PH$US$US
242826842$24282684$2$F$20240601$20240917$20240904$20240927$EXP$SE-SEMPA-2024-006143$SE-TEVA-VS-3238267$TEVA$$75$YR$$F$Y$$$20240927$$MD$SE$SE
242826851$24282685$1$I$$20240826$20240904$20240904$EXP$$DE-AMGEN-DEUSP2024171564$AMGEN$Verheyen J.. Detection of hepatitis B virus DNA in the blood of a stem cell donor after granulocyte colony- stimulating factor treatment. Hepatology. 2016;64 (5):1803-1805$51$YR$A$M$Y$$$20240904$$MD$DE$DE
242826861$24282686$1$I$20240808$20240828$20240904$20240904$EXP$FR-AFSSAPS-AN2024001153$FR-TEVA-VS-3238163$TEVA$$60$YR$$F$Y$$$20240904$$MD$FR$FR
242826871$24282687$1$I$20240811$20240903$20240904$20240904$EXP$GB-MHRA-MED-202408170846196800-NVQDK$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049452$BOEHRINGER INGELHEIM$$53$YR$A$M$Y$110$KG$20240904$$PH$GB$GB
242826881$24282688$1$I$$20240827$20240904$20240904$EXP$$CA-GSK-CA2023AMR039753$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$CA$CA
242826891$24282689$1$I$20230723$20240828$20240904$20240904$EXP$$DE-AstraZeneca-2024A196790$ASTRAZENECA$$64$YR$$M$Y$77$KG$20240904$$MD$DE$
242826901$24282690$1$I$$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A198429$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242826911$24282691$1$I$$20240830$20240904$20240904$EXP$$GB-TAKEDA-2021TUS010153$TAKEDA$$$$$M$Y$$$20240904$$CN$GB$GB
242826921$24282692$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A195721$ASTRAZENECA$$$$$$Y$$$20240904$$MD$US$
242826931$24282693$1$I$$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A198821$ASTRAZENECA$$$$$F$Y$$$20240904$$HP$US$
242826941$24282694$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A196946$ASTRAZENECA$$$$$M$Y$$$20240904$$MD$US$
242826952$24282695$2$F$20240701$20240911$20240904$20240917$EXP$$MX-AstraZeneca-2024A190242$ASTRAZENECA$$858$MON$$M$Y$$$20240918$$CN$MX$
242826961$24282696$1$I$$20240827$20240904$20240904$EXP$$VN-AstraZeneca-2024A199327$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$VN$
242826971$24282697$1$I$$20240827$20240904$20240904$EXP$$US-AstraZeneca-2024A198955$ASTRAZENECA$Nobakht N, Hanna RM, Kamgar M, Sinclair J, Simon L, Emami S. Acute interstitial nephritis observed with three different triggering agents.. Clinical case reports. 2022;10:e05432.$70$YR$$F$Y$$$20240904$$HP$US$
242826981$24282698$1$I$$20240827$20240904$20240904$PER$$US-AstraZeneca-2024A195747$ASTRAZENECA$$$$$$Y$$$20240904$$CN$US$
242826991$24282699$1$I$20240101$20240826$20240904$20240904$PER$$US-SA-2024SA256657$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240904$$MD$US$US
242827001$24282700$1$I$20240823$20240826$20240904$20240904$PER$$US-SA-2024SA256100$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240904$$MD$US$US
242827011$24282701$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA256565$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240904$$HP$US$US
242827021$24282702$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA255446$SANOFI AVENTIS$$$$E$M$Y$$$20240904$$CN$US$US
242827031$24282703$1$I$$20240827$20240904$20240904$EXP$$HN-AstraZeneca-2024A196355$ASTRAZENECA$$$$$F$Y$$$20240904$$MD$HN$
242827041$24282704$1$I$20240826$20240902$20240902$20240902$DIR$716853$$FDA-CTU$$36$YR$$M$N$65$KG$20240902$Y$MD$US$
242827051$24282705$1$I$20240601$20240830$20240904$20240904$EXP$$CA-JNJFOC-20240808374$JOHNSON AND JOHNSON$$43$YR$A$F$Y$67$KG$20240904$$HP$CA$CA
242827061$24282706$1$I$20240101$20240723$20240904$20240904$PER$$US-LUNDBECK-DKLU4002155$LUNDBECK$$$$$$Y$$$20240904$$HP$US$US
242827071$24282707$1$I$$20240822$20240904$20240904$PER$$US-JNJFOC-20240876667$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242827081$24282708$1$I$$20240828$20240904$20240904$EXP$$CA-ANIPHARMA-2024-CA-003852$ANI$$70$YR$$F$Y$$$20240904$$HP$CA$CA
242827091$24282709$1$I$$20240828$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137823$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$PH$US$US
242827101$24282710$1$I$$20240723$20240904$20240904$PER$$US-LUNDBECK-DKLU4002318$LUNDBECK$$$$$$Y$$$20240904$$CN$US$US
242827111$24282711$1$I$$20240830$20240904$20240904$PER$$US-BIOGEN-2024BI01280761$BIOGEN$$$$$M$Y$$$20240904$$CN$US$US
242827131$24282713$1$I$20240902$20240902$20240902$20240902$DIR$716876$$FDA-CTU$$67$YR$$F$N$110.25$KG$20240902$N$CN$US$
242827141$24282714$1$I$$20240819$20240904$20240904$PER$$US-TEVA-VS-3235792$TEVA$$60$YR$$F$Y$$$20240904$$CN$US$US
242827152$24282715$2$F$20240808$20240910$20240904$20240920$EXP$HR-HALMED-300086380$HR-TEVA-VS-3238398$TEVA$$52$YR$$F$Y$55$KG$20240920$$CN$HR$HR
242827161$24282716$1$I$20240101$20240828$20240904$20240904$EXP$$CA-JNJFOC-20240230634$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240904$$HP$CA$CA
242827171$24282717$1$I$20150101$20240828$20240904$20240904$EXP$FR-AFSSAPS-AN2023001453$FR-TEVA-VS-3238468$TEVA$$29$YR$$F$Y$$$20240904$$MD$FR$FR
242827191$24282719$1$I$$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024174901$AMGEN$$$$$$Y$$$20240904$$PH$US$US
242827201$24282720$1$I$20231201$20240829$20240904$20240904$EXP$$DE-MYLANLABS-2024M1080073$MYLAN$$$$$F$Y$2.6$KG$20240904$$MD$DE$DE
242827211$24282721$1$I$20240820$20240826$20240904$20240904$EXP$$US-BAYER-2024A123603$BAYER$$71$YR$E$M$Y$$$20240904$$MD$US$US
242827221$24282722$1$I$$20240212$20240904$20240904$EXP$$NVSC2024ID177670$NOVARTIS$$$$$$Y$$$20240904$$MD$ID$ID
242827242$24282724$2$F$$20240903$20240904$20240906$PER$$NVSC2024US177909$NOVARTIS$$$$$M$Y$$$20240906$$CN$US$US
242827251$24282725$1$I$20240826$20240830$20240904$20240904$EXP$GB-MHRA-MED-202408301212566200-GVZQK$GB-TEVA-VS-3238973$TEVA$$$$$F$Y$$$20240904$$MD$GB$GB
242827262$24282726$2$F$20240704$20240911$20240904$20240919$EXP$CZ-CZSUKL-24002324$CZ-TEVA-VS-3238946$TEVA$$54$YR$$F$Y$$$20240919$$MD$CZ$CZ
242827271$24282727$1$I$20230430$20240831$20240904$20240904$EXP$GB-MHRA-MED-202408310839149090-JMDLV$GB-TEVA-VS-3239264$TEVA$$58$YR$$M$Y$72$KG$20240904$$CN$GB$GB
242827281$24282728$1$I$20240821$20240822$20240904$20240904$EXP$$GB-CIPLA (EU) LIMITED-2024GB09362$CIPLA$$$$$$Y$$$20240904$$MD$GB$GB
242827291$24282729$1$I$20230201$20240903$20240904$20240904$PER$$US-ALXN-202409USA000064US$ALEXION PHARMACEUTICALS$$42$YR$$M$Y$$$20240904$$CN$US$US
242827301$24282730$1$I$20240717$20240815$20240904$20240904$EXP$$US-Vifor (International) Inc.-VIT-2024-07462$VIFOR$$75$YR$$F$Y$77.5$KG$20240904$$HP$US$US
242827311$24282731$1$I$20240703$20240815$20240904$20240904$EXP$$US-Vifor (International) Inc.-VIT-2024-07452$VIFOR$$53$YR$$F$Y$103.5$KG$20240904$$HP$US$US
242827321$24282732$1$I$20240726$20240815$20240904$20240904$EXP$$US-Vifor (International) Inc.-VIT-2024-07463$VIFOR$$62$YR$$F$Y$89.6$KG$20240904$$HP$US$US
242827331$24282733$1$I$$20240809$20240904$20240904$EXP$$US-Vifor (International) Inc.-VIT-2024-07280$VIFOR$$$$A$F$Y$$$20240904$$CN$US$US
242827341$24282734$1$I$20240722$20240815$20240904$20240904$EXP$$US-Vifor (International) Inc.-VIT-2024-07464$VIFOR$$60$YR$$F$Y$118$KG$20240904$$HP$US$US
242827352$24282735$2$F$$20240828$20240904$20240905$EXP$$CA-APOTEX-2024AP010126$APOTEX$$82$YR$$M$Y$$$20240905$$CN$CA$CA
242827371$24282737$1$I$20230323$20240821$20240904$20240904$PER$$US-009507513-2408USA007439$MERCK$$$$$F$Y$$$20240904$$MD$US$US
242827381$24282738$1$I$$20240822$20240904$20240904$EXP$$GB-CIPLA LTD.-2024GB09327$CIPLA$$$$$$Y$$$20240904$$CN$GB$GB
242827391$24282739$1$I$20240630$20240902$20240902$20240902$DIR$716838$$FDA-CTU$$58$YR$$F$N$76.5$KG$20240902$Y$CN$US$
242827411$24282741$1$I$20240801$20240823$20240904$20240904$EXP$$US-SA-2024SA256187$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240904$$MD$US$US
242827421$24282742$1$I$20240828$20240830$20240904$20240904$EXP$$CN-JNJFOC-20240880879$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240904$$HP$CN$CN
242827431$24282743$1$I$$20240828$20240904$20240904$EXP$$CA-GSK-CA2023129548$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$CA$CA
242827441$24282744$1$I$$20240903$20240904$20240904$PER$$US-GILEAD-2024-0686160$GILEAD$$$$$F$Y$$$20240904$$HP$US$US
242827451$24282745$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA255713$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240904$$MD$US$US
242827461$24282746$1$I$20240301$20240826$20240904$20240904$PER$$US-SA-2024SA256529$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240904$$HP$US$US
242827471$24282747$1$I$$20240829$20240904$20240904$EXP$NL-LRB-00999119$NL-TEVA-VS-3238977$TEVA$$43$YR$$F$Y$$$20240904$$MD$NL$NL
242827481$24282748$1$I$20240101$20240826$20240904$20240904$PER$$US-SA-2024SA253048$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240904$$MD$US$US
242827491$24282749$1$I$20240402$20240829$20240904$20240904$EXP$ES-AEMPS-1561632$ES-MYLANLABS-2024M1079845$MYLAN$$80$YR$$F$Y$$$20240904$$MD$ES$ES
242827501$24282750$1$I$20240818$20240829$20240904$20240904$EXP$FR-AFSSAPS-PB2024000939$FR-MYLANLABS-2024M1079825$MYLAN$$28$YR$$F$Y$87$KG$20240904$$MD$FR$FR
242827511$24282751$1$I$$20240827$20240904$20240904$EXP$$JP-AstraZeneca-2024A197370$ASTRAZENECA$Tanigawa T, et al.. Adverse events of PARP inhibitors in the treatment of advanced or recurrent ovarian cancer: A real-world study. The Journal of the Japan Society of Gynecologic Oncology 2024;42(3):243-249.$$$A$F$Y$$$20240904$$MD$JP$
242827521$24282752$1$I$20240827$20240828$20240904$20240904$EXP$$US-GSK-US2024107325$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$CN$US$US
242827531$24282753$1$I$$20240828$20240904$20240904$EXP$$DE-GSK-DE2024107737$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$PH$DE$DE
242827541$24282754$1$I$$20240830$20240904$20240904$PER$$US-PFIZER INC-PV202400114425$PFIZER$$72$YR$$F$Y$$$20240904$$HP$US$US
242827551$24282755$1$I$20220414$20240830$20240904$20240904$PER$$US-PFIZER INC-PV202400114922$PFIZER$$41$YR$$F$Y$136$KG$20240904$$CN$US$US
242827562$24282756$2$F$20240101$20240918$20240904$20240923$EXP$$US-PFIZER INC-202400248464$PFIZER$$82$YR$$M$Y$80.7$KG$20240923$$HP$US$US
242827571$24282757$1$I$$20240830$20240904$20240904$PER$$US-PFIZER INC-202400247492$PFIZER$$$$$F$Y$$$20240904$$CN$US$US
242827581$24282758$1$I$20240101$20240830$20240904$20240904$PER$$US-PFIZER INC-202400032899$PFIZER$$41$YR$$F$Y$$$20240904$$CN$US$US
242827591$24282759$1$I$20240815$20240826$20240904$20240904$PER$$US-PFIZER INC-PV202400111273$PFIZER$$64$YR$$M$Y$59.87$KG$20240904$$CN$US$US
242827601$24282760$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001442$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240904$$CN$US$US
242827611$24282761$1$I$20240401$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001669$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240904$$CN$US$US
242827622$24282762$2$F$20231101$20240919$20240904$20240924$PER$$US-PFIZER INC-202400247764$PFIZER$$50$YR$$F$Y$68.027$KG$20240924$$CN$US$US
242827631$24282763$1$I$$20240829$20240904$20240904$PER$$US-PFIZER INC-PV202400113967$PFIZER$$55$YR$$F$Y$$$20240904$$HP$US$US
242827642$24282764$2$F$$20240905$20240904$20240906$PER$$US-PFIZER INC-202400246785$PFIZER$$67$YR$$M$Y$$$20240906$$CN$US$US
242827651$24282765$1$I$$20240830$20240904$20240904$PER$$US-PFIZER INC-PV202400114574$PFIZER$$55$YR$$F$Y$$$20240904$$CN$US$US
242827662$24282766$2$F$20240801$20240903$20240904$20240905$PER$$US-PFIZER INC-202400248514$PFIZER$$79$YR$$M$Y$$$20240905$$HP$US$US
242827671$24282767$1$I$$20240830$20240904$20240904$EXP$$CA-PFIZER INC-3001489$PFIZER$$71$YR$$F$Y$$$20240904$$HP$CA$CA
242827681$24282768$1$I$20240801$20240830$20240904$20240904$PER$$US-PFIZER INC-202400247546$PFIZER$$84$YR$$F$Y$$$20240904$$CN$US$US
242827691$24282769$1$I$20240826$20240830$20240904$20240904$PER$$US-PFIZER INC-PV202400114349$PFIZER$$49$YR$$F$Y$104.3$KG$20240904$$CN$US$US
242827702$24282770$2$F$$20240911$20240904$20240911$PER$$US-PFIZER INC-PV202400115403$PFIZER$$$$$$Y$$$20240911$$CN$US$US
242827711$24282771$1$I$20240801$20240830$20240904$20240904$PER$$US-PFIZER INC-202400248069$PFIZER$$83$YR$$M$Y$83.01$KG$20240904$$CN$US$US
242827722$24282772$2$F$$20240903$20240904$20240905$PER$$US-PFIZER INC-202400247714$PFIZER$$66$YR$$F$Y$90.72$KG$20240905$$CN$US$US
242827731$24282773$1$I$20240829$20240831$20240904$20240904$PER$$US-PFIZER INC-202400248036$PFIZER$$42$YR$$F$Y$$$20240904$$CN$US$US
242827741$24282774$1$I$20240829$20240831$20240904$20240904$PER$$US-PFIZER INC-202400248275$PFIZER$$57$YR$$M$Y$$$20240904$$CN$US$US
242827751$24282775$1$I$$20240830$20240904$20240904$PER$$US-PFIZER INC-202400247732$PFIZER$$30$YR$$F$Y$$$20240904$$MD$US$US
242827761$24282776$1$I$$20240830$20240904$20240904$PER$$US-PFIZER INC-PV202400114586$PFIZER$$31$YR$$$Y$$$20240904$$CN$US$US
242827771$24282777$1$I$$20240830$20240904$20240904$PER$$US-PFIZER INC-PV202400114719$PFIZER$$$$T$F$Y$$$20240904$$HP$US$US
242827781$24282778$1$I$$20240830$20240904$20240904$PER$$US-PFIZER INC-202400248105$PFIZER$$76$YR$$F$Y$$$20240904$$MD$US$US
242827801$24282780$1$I$20240801$20240830$20240904$20240904$PER$$US-PFIZER INC-202400247443$PFIZER$$64$YR$$M$Y$65.77$KG$20240904$$CN$US$US
242827821$24282782$1$I$20240310$20240902$20240902$20240902$DIR$716862$$FDA-CTU$$68$YR$$M$N$116$KG$20240902$N$CN$IL$
242827841$24282784$1$I$20240707$20240830$20240904$20240904$EXP$$US-JNJFOC-20240881531$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240904$$PH$US$US
242827851$24282785$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177934$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242827872$24282787$2$F$20240101$20240911$20240904$20240925$PER$$US-KARYOPHARM-2024KPT001493$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240925$$CN$US$US
242827881$24282788$1$I$$20130903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140423$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240904$$CN$US$US
242827891$24282789$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140863$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240904$$CN$US$US
242827911$24282791$1$I$$20240826$20240904$20240904$EXP$$CA-TEVA-VS-3237401$TEVA$$60$YR$$F$Y$$$20240904$$MD$CA$CA
242827923$24282792$3$F$20240801$20240906$20240904$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139917$BRISTOL MYERS SQUIBB$$6$DEC$A$F$Y$$$20240913$$MD$JP$JP
242827931$24282793$1$I$$20240828$20240904$20240904$EXP$$GB-GSK-GB2024EME106992$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$HP$GB$GB
242827941$24282794$1$I$20240831$20240903$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140681$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$$$20240904$$CN$US$US
242827951$24282795$1$I$20240812$20240829$20240904$20240904$EXP$LV-SAM-2024088328$LV-TEVA-VS-3239013$TEVA$$34$YR$$F$Y$70$KG$20240904$$CN$LV$LV
242827961$24282796$1$I$$20240830$20240904$20240904$EXP$$CN-AMGEN-CHNSP2024174731$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240904$$MD$CN$CN
242827971$24282797$1$I$$20240821$20240904$20240904$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093549$GLENMARK$Patel R, Elghawy O, Gibbs A, Gupta S, Kaur V.. A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma.. Cancer Reports.. 2024;7 (7):e2110$$$$$Y$$$20240904$$MD$US$US
242827981$24282798$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177920$NOVARTIS$$$$$F$Y$$$20240904$$HP$US$US
242827991$24282799$1$I$20220901$20240822$20240904$20240904$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16912$IPSEN$$$$$F$Y$$$20240904$$HP$US$US
242828001$24282800$1$I$$20240828$20240904$20240904$EXP$$US-GSK-US2024108519$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$US$US
242828012$24282801$2$F$20240821$20240918$20240904$20240923$PER$$US-PFIZER INC-202400248114$PFIZER$$53$YR$$F$Y$78.458$KG$20240923$$HP$US$US
242828021$24282802$1$I$20240831$20240831$20240904$20240904$PER$$US-PFIZER INC-202400248262$PFIZER$$62$YR$$F$Y$$$20240904$$CN$US$US
242828031$24282803$1$I$20240829$20240831$20240904$20240904$PER$$US-PFIZER INC-202400248137$PFIZER$$75$YR$$F$Y$$$20240904$$HP$US$US
242828041$24282804$1$I$20240831$20240831$20240904$20240904$PER$$US-PFIZER INC-202400247853$PFIZER$$55$YR$$F$Y$$$20240904$$CN$US$US
242828062$24282806$2$F$20240831$20240910$20240904$20240913$PER$$US-PFIZER INC-202400247933$PFIZER$$35$YR$$F$Y$136.05$KG$20240913$$CN$US$US
242828071$24282807$1$I$20240101$20240831$20240904$20240904$PER$$US-PFIZER INC-PV202400114305$PFIZER$$62$YR$$F$Y$63$KG$20240904$$CN$US$US
242828081$24282808$1$I$$20240830$20240904$20240904$EXP$$CA-APOTEX-2024AP010191$APOTEX$$64$YR$$F$Y$$$20240904$$MD$CA$CA
242828091$24282809$1$I$20240101$20240831$20240904$20240904$PER$$US-PFIZER INC-202400247827$PFIZER$$59$YR$$$Y$$$20240904$$CN$US$US
242828111$24282811$1$I$20240830$20240831$20240904$20240904$PER$$US-PFIZER INC-202400247855$PFIZER$$72$YR$$M$Y$$$20240904$$CN$US$US
242828121$24282812$1$I$20240831$20240831$20240904$20240904$PER$$US-PFIZER INC-202400247856$PFIZER$$37$YR$$M$Y$$$20240904$$CN$US$US
242828131$24282813$1$I$$20240828$20240904$20240904$PER$$US-PFIZER INC-202400246431$PFIZER$$60$YR$$F$Y$74.84$KG$20240904$$CN$US$US
242828141$24282814$1$I$20240831$20240831$20240904$20240904$PER$$US-PFIZER INC-202400248157$PFIZER$$29$YR$$M$Y$$$20240904$$CN$US$US
242828151$24282815$1$I$20240830$20240831$20240904$20240904$PER$$US-PFIZER INC-202400248099$PFIZER$$55$YR$$M$Y$$$20240904$$CN$US$US
242828171$24282817$1$I$20240821$20240901$20240904$20240904$PER$$US-PFIZER INC-202400248090$PFIZER$$78$YR$$F$Y$$$20240904$$CN$US$US
242828181$24282818$1$I$$20240831$20240904$20240904$PER$$US-PFIZER INC-202400248093$PFIZER$$45$YR$$F$Y$$$20240904$$CN$US$US
242828192$24282819$2$F$20230101$20240906$20240904$20240909$PER$$US-PFIZER INC-202400246812$PFIZER$$47$YR$$F$Y$$$20240909$$CN$US$US
242828202$24282820$2$F$$20240830$20240904$20240905$PER$$US-PFIZER INC-202400247805$PFIZER$$10$YR$$M$Y$$$20240905$$MD$US$US
242828211$24282821$1$I$20240813$20240830$20240904$20240904$EXP$ES-AEMPS-1562695$ES-TEVA-VS-3239178$TEVA$$67$YR$$M$Y$70$KG$20240904$$PH$ES$ES
242828221$24282822$1$I$$20240826$20240904$20240904$30DAY$$US-GSK-US2024106148$GLAXOSMITHKLINE$$$$$F$Y$$$20240904$$CN$US$US
242828231$24282823$1$I$$20240830$20240904$20240904$EXP$$CN-AMGEN-CHNSP2024174736$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240904$$MD$CN$CN
242828252$24282825$2$F$20240827$20240906$20240904$20240911$EXP$$US-ALXN-202408USA002197US$ALEXION PHARMACEUTICALS$$81$YR$$M$Y$$$20240911$$CN$US$US
242828261$24282826$1$I$$20240830$20240904$20240904$EXP$$CN-AMGEN-CHNSP2024174734$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. ICO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240904$$MD$CN$CN
242828271$24282827$1$I$20240824$20240904$20240904$20240904$DIR$717088$$FDA-CTU$$22$YR$$F$N$94.05$KG$20240904$Y$$US$
242828281$24282828$1$I$$20240827$20240904$20240904$EXP$$CA-FreseniusKabi-FK202413127$FRESENIUS KABI$$59$YR$A$M$Y$92$KG$20240904$$PH$CA$CA
242828291$24282829$1$I$20240801$20240902$20240902$20240902$DIR$716861$$FDA-CTU$$66$YR$$F$N$72$KG$20240902$N$CN$US$
242828301$24282830$1$I$$20240827$20240904$20240904$EXP$$BR-TEVA-VS-3238584$TEVA$$$$$$Y$$$20240904$$PH$BR$BR
242828311$24282831$1$I$$20240828$20240903$20240903$DIR$FDA-CDER-CTU-2024-60498$$FDA-CTU$$13$YR$$M$N$56.7$KG$20240828$N$CN$US$
242828321$24282832$1$I$$20240904$20240904$20240904$DIR$717089$$FDA-CTU$$18$YR$$F$N$135$KG$20240904$N$CN$US$
242828331$24282833$1$I$20240617$20240903$20240903$20240903$DIR$716914$$FDA-CTU$$66$YR$$M$N$107.6$KG$20240903$N$PH$US$
242828352$24282835$2$F$20240812$20240911$20240904$20240920$EXP$$IN-VANTIVE-2024VAN019188$Vantive US Healthcare$$52$YR$$F$Y$$$20240920$$CN$IN$IN
242828361$24282836$1$I$20240716$20240902$20240904$20240904$EXP$$GB-TAKEDA-2024TUS075501$TAKEDA$$77$YR$$M$Y$$$20240904$$CN$GB$GB
242828371$24282837$1$I$20240704$20240829$20240904$20240904$EXP$FR-AFSSAPS-BX2024001694$FR-MYLANLABS-2024M1079775$MYLAN$$52$YR$$F$Y$73$KG$20240904$$PH$FR$FR
242828381$24282838$1$I$$20240829$20240904$20240904$EXP$DE-EMA-DD-20240722-7482655-092319$DE-MYLANLABS-2024M1071639$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology. 2024;48(5):299-313$43$YR$$M$Y$$$20240904$$HP$DE$DE
242828391$24282839$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177939$NOVARTIS$$$$$$Y$$$20240904$$HP$US$US
242828401$24282840$1$I$$20240901$20240904$20240904$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-130089$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240904$$MD$IL$IL
242828411$24282841$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140254$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240904$$HP$US$US
242828421$24282842$1$I$20240902$20240902$20240904$20240904$EXP$$IE-MYLANLABS-2024M1045391$MYLAN$$$$$F$Y$$$20240904$$MD$IE$IE
242828431$24282843$1$I$$20240830$20240904$20240904$EXP$$CN-AMGEN-CHNSP2024174737$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240904$$MD$CN$CN
242828441$24282844$1$I$$20240830$20240904$20240904$EXP$$CN-AMGEN-CHNSP2024174741$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240904$$MD$CN$CN
242828451$24282845$1$I$20240901$20240903$20240904$20240904$PER$$US-AMGEN-USASP2024176470$AMGEN$$67$YR$E$F$Y$$$20240904$$CN$US$US
242828461$24282846$1$I$$20240826$20240904$20240904$EXP$$CA-TEVA-VS-3237952$TEVA$$62$YR$$M$Y$$$20240904$$CN$CA$CA
242828471$24282847$1$I$$20240830$20240904$20240904$EXP$$CN-AMGEN-CHNSP2024174742$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240904$$MD$CN$CN
242828481$24282848$1$I$$20240830$20240904$20240904$EXP$$CN-AMGEN-CHNSP2024174744$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240904$$MD$CN$CN
242828491$24282849$1$I$20240803$20240828$20240904$20240904$EXP$NO-NOMAADVRE-RELISSO-2024-Vg8rpe$NO-TEVA-VS-3238170$TEVA$$47$YR$$F$Y$72$KG$20240904$$PH$NO$NO
242828501$24282850$1$I$$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A199896$ASTRAZENECA$Chan-Hosokawa, Ayako; Marco, Stephanie M; Gitto, Lorenzo. Application of hair analysis in pediatric post-mortem toxicology. 61st Annual Meeting of the International Association of Forensic Toxicologists (TIAFT) Not Reported(Not Reported):$10$MON$$$Y$$$20240904$$HP$US$
242828511$24282851$1$I$20240708$20240830$20240904$20240904$EXP$$US-AstraZeneca-2024A199345$ASTRAZENECA$$22000$DY$$F$Y$$$20240904$$CN$US$
242828523$24282852$3$F$$20240912$20240904$20240918$EXP$$CA-AstraZeneca-2024A200630$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$CA$
242828531$24282853$1$I$$20240830$20240904$20240904$EXP$$AU-AstraZeneca-2024A200210$ASTRAZENECA$NOT REPORTED.$62$YR$$F$Y$$$20240904$$MD$AU$
242828541$24282854$1$I$$20240828$20240904$20240904$EXP$$US-AstraZeneca-2024A196548$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242828551$24282855$1$I$$20240903$20240903$20240903$DIR$716888$$FDA-CTU$$58$YR$$F$N$76.5$KG$20240903$N$CN$US$
242828561$24282856$1$I$20240831$20240901$20240904$20240904$PER$$US-PFIZER INC-202400248039$PFIZER$$58$YR$$F$Y$$$20240904$$CN$US$US
242828571$24282857$1$I$$20240901$20240904$20240904$PER$$US-PFIZER INC-202400248127$PFIZER$$59$YR$$F$Y$$$20240904$$CN$US$US
242828583$24282858$3$F$20240831$20240924$20240904$20240925$PER$$US-PFIZER INC-202400247938$PFIZER$$46$YR$$F$Y$61.2$KG$20240925$$CN$US$US
242828591$24282859$1$I$20240831$20240901$20240904$20240904$PER$$US-PFIZER INC-202400248108$PFIZER$$65$YR$$F$Y$$$20240904$$CN$US$US
242828602$24282860$2$F$$20240908$20240904$20240913$PER$$US-PFIZER INC-202400248095$PFIZER$$82$YR$$F$Y$56.7$KG$20240913$$CN$US$US
242828613$24282861$3$F$20240901$20240919$20240904$20240920$PER$$US-PFIZER INC-202400247945$PFIZER$$74$YR$$F$Y$58.97$KG$20240920$$MD$US$US
242828621$24282862$1$I$20240831$20240831$20240904$20240904$PER$$US-PFIZER INC-202400247622$PFIZER$$70$YR$$F$Y$$$20240904$$CN$US$US
242828632$24282863$2$F$$20240923$20240904$20240925$PER$$US-PFIZER INC-202400247810$PFIZER$$74$YR$$F$Y$$$20240925$$CN$US$US
242828642$24282864$2$F$$20240908$20240904$20240910$PER$$US-PFIZER INC-202400247913$PFIZER$$$$$$Y$$$20240910$$CN$US$US
242828651$24282865$1$I$20240901$20240901$20240904$20240904$PER$$US-PFIZER INC-202400247952$PFIZER$$32$YR$$F$Y$$$20240904$$CN$US$US
242828671$24282867$1$I$20240901$20240901$20240904$20240904$PER$$US-PFIZER INC-202400248076$PFIZER$$29$YR$$F$Y$$$20240904$$CN$US$US
242828681$24282868$1$I$20240101$20240831$20240904$20240904$PER$$US-PFIZER INC-202400247825$PFIZER$$$$$$Y$$$20240904$$CN$US$US
242828691$24282869$1$I$20240830$20240901$20240904$20240904$PER$$US-PFIZER INC-202400248124$PFIZER$$78$YR$$F$Y$$$20240904$$CN$US$US
242828701$24282870$1$I$$20240827$20240904$20240904$EXP$$CA-FreseniusKabi-FK202413173$FRESENIUS KABI$$3$YR$C$M$Y$$$20240904$$PH$CA$CA
242828711$24282871$1$I$20240830$20240901$20240904$20240904$PER$$US-PFIZER INC-202400248115$PFIZER$$33$YR$$M$Y$$$20240904$$CN$US$US
242828721$24282872$1$I$$20240823$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160130$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242828731$24282873$1$I$$20240827$20240904$20240904$EXP$$US-AMGEN-USASP2024171607$AMGEN$Frank S. M. Gastrointestinal Bleeding and Survival after a Nadir Hemoglobin {3.0 g/dL in 2 Jehovah^s Witness Patients: A Case Report. A + A Practice. 2024;18 (8):1-4$71$YR$E$M$Y$$$20240904$$MD$US$US
242828741$24282874$1$I$20240823$20240825$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160122$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242828752$24282875$2$F$$20240904$20240904$20240905$PER$$US-JNJFOC-20240907290$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242828761$24282876$1$I$$20240830$20240904$20240904$PER$$US-JNJFOC-20240901055$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$MD$US$US
242828771$24282877$1$I$20240801$20240830$20240904$20240904$PER$$PR-JNJFOC-20240902298$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240904$$CN$PR$PR
242828781$24282878$1$I$$20240830$20240904$20240904$PER$$US-TAKEDA-2024TUS087705$TAKEDA$$$$$F$Y$$$20240904$$MD$US$US
242828791$24282879$1$I$20240830$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001852$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240904$$CN$US$US
242828801$24282880$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001735$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240904$$CN$US$US
242828812$24282881$2$F$20240830$20240911$20240904$20240912$PER$$US-AMGEN-USASP2024176054$AMGEN$$70$YR$E$F$Y$$$20240912$$CN$US$US
242828821$24282882$1$I$$20240830$20240904$20240904$PER$$US-ROCHE-10000071871$ROCHE$$55$YR$A$F$Y$$$20240904$$CN$US$US
242828831$24282883$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA254812$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240904$$MD$US$US
242828841$24282884$1$I$$20240903$20240904$20240904$EXP$$US-SANDOZ INC.-SDZ2024US077620$SANDOZ$$$$$F$Y$$$20240904$$HP$US$US
242828851$24282885$1$I$20240101$20240826$20240904$20240904$PER$$US-ABBVIE-5897564$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242828871$24282887$1$I$$20240822$20240904$20240904$EXP$$DK-B.Braun Medical Inc.-2161195$B BRAUN$Literature Article$12$MON$$$Y$$$20240904$$$DK$DK
242828891$24282889$1$I$20240325$20240903$20240903$20240903$DIR$716937$$FDA-CTU$$70$YR$$F$N$73.7$KG$20240903$N$PH$US$
242828901$24282890$1$I$20240101$20240822$20240904$20240904$EXP$$US-SA-2024SA256549$SANOFI AVENTIS$$80$YR$E$$Y$$$20240904$$CN$US$US
242828912$24282891$2$F$20240101$20240903$20240904$20240918$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1326$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240918$$PH$US$US
242828921$24282892$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA256523$SANOFI AVENTIS$$3$YR$C$M$Y$13.6$KG$20240904$$HP$US$US
242828951$24282895$1$I$$20240821$20240904$20240904$30DAY$$AR-JNJFOC-20240861682$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$CN$AR$AR
242828961$24282896$1$I$20240823$20240829$20240904$20240904$EXP$$BR-BAYER-2024A125547$BAYER$$81$YR$E$F$Y$$$20240904$$CN$BR$BR
242828972$24282897$2$F$20240801$20240904$20240904$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140626$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$71$KG$20240911$$PH$US$US
242828982$24282898$2$F$20240101$20240828$20240904$20240912$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1325$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240912$$HP$US$US
242828991$24282899$1$I$$20240830$20240904$20240904$PER$$US-BAYER-2024A126736$BAYER$$87$YR$E$M$Y$$$20240904$$CN$US$US
242829001$24282900$1$I$$20240903$20240904$20240904$EXP$$US-AstraZeneca-2024A201167$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$US$
242829011$24282901$1$I$$20240828$20240904$20240904$EXP$$US-AstraZeneca-2024A197128$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242829031$24282903$1$I$20240720$20240828$20240904$20240904$EXP$$CN-BEH-2024178021$CSL BEHRING$$80$YR$E$M$Y$75$KG$20240904$$CN$CN$CN
242829041$24282904$1$I$$20240811$20240904$20240904$PER$$US-AMGEN-USASP2024164920$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$F$Y$$$20240904$$MD$US$US
242829051$24282905$1$I$20240101$20240826$20240904$20240904$PER$$US-SA-2024SA256384$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240904$$MD$US$US
242829061$24282906$1$I$$20240828$20240904$20240904$EXP$$NVSC2024CO175820$NOVARTIS$$$$$F$Y$$$20240904$$MD$CO$CO
242829071$24282907$1$I$20240701$20240823$20240904$20240904$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17019$IPSEN$$54$YR$A$F$Y$$$20240904$$HP$US$US
242829081$24282908$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139658$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240904$$CN$US$US
242829091$24282909$1$I$$20240819$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132773$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240904$$CN$US$US
242829101$24282910$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140670$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240904$$HP$US$US
242829111$24282911$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140324$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$63.5$KG$20240904$$HP$US$US
242829123$24282912$3$F$$20240913$20240904$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138265$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$53.07$KG$20240919$$CN$US$US
242829131$24282913$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140408$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240904$$CN$US$US
242829141$24282914$1$I$20240822$20240829$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138697$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240904$$CN$US$US
242829152$24282915$2$F$$20240912$20240904$20240920$EXP$$CA-TEVA-VS-3237948$TEVA$$62$YR$$M$Y$$$20240920$$CN$CA$CA
242829161$24282916$1$I$$20240824$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160100$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242829171$24282917$1$I$20240101$20240903$20240904$20240904$EXP$$US-ABBVIE-5905965$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242829181$24282918$1$I$20230505$20240827$20240904$20240904$PER$$US-009507513-2408USA009545$MERCK$$$$A$F$Y$$$20240904$$MD$US$US
242829191$24282919$1$I$20240622$20240829$20240904$20240904$EXP$ES-AEMPS-1562975$ES-TEVA-VS-3239059$TEVA$$77$YR$$M$Y$$$20240904$$MD$ES$ES
242829201$24282920$1$I$20240801$20240823$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160133$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242829211$24282921$1$I$20240821$20240901$20240904$20240904$PER$$US-PFIZER INC-202400247965$PFIZER$$62$YR$$F$Y$$$20240904$$CN$US$US
242829221$24282922$1$I$20240903$20240903$20240904$20240904$PER$$US-PFIZER INC-202400249496$PFIZER$$51$YR$$F$Y$$$20240904$$CN$US$US
242829232$24282923$2$F$20240903$20240906$20240904$20240909$PER$$US-PFIZER INC-202400249343$PFIZER$$$$$M$Y$$$20240909$$HP$US$US
242829241$24282924$1$I$20240831$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248660$PFIZER$$40$YR$$F$Y$$$20240904$$CN$US$US
242829251$24282925$1$I$20240903$20240903$20240904$20240904$PER$$US-PFIZER INC-202400249353$PFIZER$$59$YR$$F$Y$$$20240904$$CN$US$US
242829261$24282926$1$I$20240801$20240903$20240904$20240904$PER$$US-PFIZER INC-202400249173$PFIZER$$$$$F$Y$$$20240904$$CN$US$US
242829271$24282927$1$I$$20240902$20240904$20240904$PER$$US-PFIZER INC-PV202400115366$PFIZER$$69$YR$$$Y$$$20240904$$CN$US$US
242829281$24282928$1$I$$20240826$20240904$20240904$EXP$$PT-PFIZER INC-202400244841$PFIZER$Belchior, B.. PO-0122 - (2571) - TOXICIDADE PULMONAR PELO RITUXIMAB: UM DIAGNOSTICO DESAFIANTE. 30 CNMI Congresso Nacional de Medicina Interna. 2024;9 Congresso:492$71$YR$$M$Y$$$20240904$$HP$PT$PT
242829291$24282929$1$I$20240901$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248815$PFIZER$$72$YR$$M$Y$$$20240904$$CN$US$US
242829301$24282930$1$I$20240830$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248654$PFIZER$$73$YR$$F$Y$$$20240904$$CN$US$US
242829311$24282931$1$I$$20240902$20240904$20240904$PER$$JP-PFIZER INC-PV202400115123$PFIZER$$$$$$Y$$$20240904$$MD$JP$JP
242829321$24282932$1$I$$20240901$20240904$20240904$PER$$US-PFIZER INC-202400247934$PFIZER$$$$$$Y$$$20240904$$CN$US$US
242829331$24282933$1$I$20240901$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248633$PFIZER$$65$YR$$M$Y$$$20240904$$CN$US$US
242829351$24282935$1$I$20240901$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248787$PFIZER$$$$$$Y$$$20240904$$CN$US$US
242829361$24282936$1$I$20240901$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248517$PFIZER$$62$YR$$F$Y$$$20240904$$MD$US$US
242829371$24282937$1$I$20240902$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248650$PFIZER$$50$YR$$F$Y$$$20240904$$CN$US$US
242829381$24282938$1$I$20240831$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248664$PFIZER$$41$YR$$F$Y$$$20240904$$CN$US$US
242829391$24282939$1$I$$20240903$20240904$20240904$PER$$US-PFIZER INC-202400249327$PFIZER$$$$$$Y$$$20240904$$MD$US$US
242829402$24282940$2$F$20240831$20240908$20240904$20240913$PER$$US-PFIZER INC-202400248964$PFIZER$$32$YR$$M$Y$$$20240913$$CN$US$US
242829411$24282941$1$I$20240901$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248455$PFIZER$$68$YR$$M$Y$$$20240904$$CN$US$US
242829421$24282942$1$I$20240831$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248634$PFIZER$$71$YR$$F$Y$$$20240904$$CN$US$US
242829431$24282943$1$I$20240902$20240903$20240904$20240904$PER$$US-PFIZER INC-202400249515$PFIZER$$83$YR$$F$Y$$$20240904$$HP$US$US
242829441$24282944$1$I$20240114$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248628$PFIZER$$59$YR$$F$Y$$$20240904$$CN$US$US
242829451$24282945$1$I$$20240903$20240904$20240904$PER$$US-PFIZER INC-202400249241$PFIZER$$39$YR$$F$Y$$$20240904$$HP$US$US
242829461$24282946$1$I$$20240901$20240904$20240904$PER$$US-PFIZER INC-PV202400114866$PFIZER$$74$YR$$$Y$$$20240904$$CN$US$US
242829472$24282947$2$F$20240101$20240916$20240904$20240918$PER$$US-PFIZER INC-PV202400115646$PFIZER$$41$YR$$F$Y$$$20240918$$HP$US$US
242829481$24282948$1$I$20240831$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248663$PFIZER$$50$YR$$F$Y$$$20240904$$CN$US$US
242829491$24282949$1$I$$20240902$20240904$20240904$PER$$US-PFIZER INC-PV202400115367$PFIZER$$$$$M$Y$$$20240904$$CN$US$US
242829501$24282950$1$I$20240902$20240902$20240904$20240904$PER$$US-PFIZER INC-202400248933$PFIZER$$86$YR$$F$Y$$$20240904$$CN$US$US
242829511$24282951$1$I$20240828$20240901$20240904$20240904$PER$$US-PFIZER INC-202400247946$PFIZER$$29$YR$$F$Y$$$20240904$$HP$US$US
242829522$24282952$2$F$20240801$20240912$20240904$20240923$EXP$$US-NPI-000036$NIVAGEN PHARMACEUTICALS$$39$YR$A$M$Y$113$KG$20240829$$CN$US$US
242829561$24282956$1$I$$20240903$20240904$20240904$EXP$$PT-SANDOZ INC.-SDZ2024PT077241$SANDOZ$$48$YR$$F$Y$$$20240904$$HP$PT$PT
242829571$24282957$1$I$20240830$20240903$20240903$20240903$DIR$716978$$FDA-CTU$$51$YR$$UNK$N$$$20240903$N$HP$US$
242829581$24282958$1$I$$20240723$20240904$20240904$PER$$US-LUNDBECK-DKLU4002110$LUNDBECK$$$$$$Y$$$20240904$$CN$US$US
242829591$24282959$1$I$20230301$20240903$20240904$20240904$EXP$FR-EMA-DD-20240816-7482711-113725$FR-SANDOZ INC.-SDZ2024FR077418$SANDOZ$$79$YR$$M$Y$66$KG$20240904$$MD$FR$FR
242829601$24282960$1$I$20240903$20240903$20240903$20240903$DIR$716993$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242829611$24282961$1$I$$20240830$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409000377$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240904$$CN$US$US
242829621$24282962$1$I$20240810$20240823$20240904$20240904$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409000580$ELI LILLY AND CO$$25$YR$A$F$Y$35$KG$20240904$$CN$DE$CN
242829631$24282963$1$I$$20240828$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138383$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240904$$CN$US$US
242829642$24282964$2$F$20240101$20240910$20240904$20240918$EXP$$US-JNJFOC-20240881279$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240918$$CN$US$US
242829651$24282965$1$I$$20240827$20240904$20240904$EXP$$ZA-AstraZeneca-2024A196436$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$ZA$
242829661$24282966$1$I$20230901$20240809$20240904$20240904$EXP$$JP-AstraZeneca-2024A190607$ASTRAZENECA$$56$YR$$F$Y$42$KG$20240904$$MD$JP$
242829671$24282967$1$I$20240903$20240903$20240904$20240904$PER$$US-PFIZER INC-202400249486$PFIZER$$60$YR$$F$Y$$$20240904$$CN$US$US
242829681$24282968$1$I$20240801$20240903$20240904$20240904$PER$$US-PFIZER INC-PV202400115824$PFIZER$$79$YR$$F$Y$$$20240904$$HP$US$US
242829692$24282969$2$F$$20240903$20240904$20240905$PER$$US-PFIZER INC-PV202400115798$PFIZER$$35$YR$$F$Y$$$20240905$$CN$US$US
242829701$24282970$1$I$20240701$20240903$20240904$20240904$PER$$US-PFIZER INC-PV202400115703$PFIZER$$67$YR$$F$Y$$$20240904$$HP$US$US
242829712$24282971$2$F$20240902$20240905$20240904$20240906$PER$$US-PFIZER INC-202400249174$PFIZER$$80$YR$$F$Y$48.526$KG$20240906$$CN$US$US
242829722$24282972$2$F$20240903$20240923$20240904$20240926$PER$$US-PFIZER INC-202400249340$PFIZER$$70$YR$$M$Y$90.703$KG$20240926$$CN$US$US
242829731$24282973$1$I$$20240903$20240904$20240904$PER$$US-PFIZER INC-PV202400115465$PFIZER$$$$$$Y$$$20240904$$CN$US$US
242829741$24282974$1$I$20240829$20240903$20240904$20240904$PER$$US-PFIZER INC-202400249503$PFIZER$$$$A$M$Y$$$20240904$$CN$US$US
242829752$24282975$2$F$$20240903$20240904$20240905$PER$$US-PFIZER INC-202400249207$PFIZER$$30$YR$$M$Y$$$20240905$$CN$US$US
242829761$24282976$1$I$$20240903$20240904$20240904$PER$$US-PFIZER INC-PV202400115773$PFIZER$$48$YR$$F$Y$$$20240904$$HP$US$US
242829771$24282977$1$I$$20240903$20240904$20240904$PER$$US-PFIZER INC-PV202400115607$PFIZER$$61$YR$$M$Y$$$20240904$$HP$US$US
242829791$24282979$1$I$$20240903$20240904$20240904$PER$$US-PFIZER INC-PV202400115713$PFIZER$$76$YR$$F$Y$$$20240904$$HP$US$US
242829801$24282980$1$I$$20240903$20240904$20240904$PER$$US-PFIZER INC-PV202400115690$PFIZER$$66$YR$$F$Y$$$20240904$$HP$US$US
242829811$24282981$1$I$$20240903$20240904$20240904$PER$$US-PFIZER INC-202400249426$PFIZER$$28$YR$$F$Y$$$20240904$$HP$US$US
242829821$24282982$1$I$20240902$20240904$20240904$20240904$PER$$US-PFIZER INC-202400249744$PFIZER$$58$YR$$F$Y$$$20240904$$CN$US$US
242829831$24282983$1$I$$20240903$20240904$20240904$PER$$US-PFIZER INC-PV202400115615$PFIZER$$70$YR$$$Y$$$20240904$$CN$US$US
242829841$24282984$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA256608$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240904$$HP$US$US
242829851$24282985$1$I$$20240901$20240904$20240904$PER$$US-ABBVIE-5905917$ABBVIE$$$$$$Y$$$20240904$$CN$US$US
242829861$24282986$1$I$20240101$20240822$20240904$20240904$EXP$$US-SA-2024SA012858$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240904$$MD$US$US
242829871$24282987$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA255474$SANOFI AVENTIS$$$$$F$Y$$$20240904$$CN$US$US
242829891$24282989$1$I$$20240827$20240904$20240904$EXP$$US-RDY-SPO/USA/24/0012726$DR REDDYS$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Cancer Journal. 2023;13(1): doi:10.1038/s41408-023-00859-x.$$$$$Y$$$20240904$$HP$US$US
242829921$24282992$1$I$20240401$20240904$20240904$20240904$DIR$717095$$FDA-CTU$$$$$M$N$$$20240904$Y$HP$US$
242829932$24282993$2$F$$20240906$20240904$20240910$PER$$NVSC2024US177961$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
242829941$24282994$1$I$$20240822$20240904$20240904$PER$$US-JNJFOC-20240901616$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$CN$US$US
242829952$24282995$2$F$$20240917$20240904$20240920$PER$$US-JNJFOC-20240882518$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$PH$US$US
242829961$24282996$1$I$20240826$20240827$20240904$20240904$PER$$US-JNJFOC-20240906651$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240904$$HP$US$US
242829981$24282998$1$I$$20240903$20240904$20240904$EXP$$US-SANDOZ INC.-SDZ2024US077538$SANDOZ$$$$$F$Y$$$20240904$$CN$US$US
242829991$24282999$1$I$20240523$20240829$20240904$20240904$EXP$$CA-LUNDBECK-DKLU3078606$LUNDBECK$$$$$$Y$$$20240904$$HP$CA$CA
242830001$24283000$1$I$$20240827$20240904$20240904$PER$$US-ALXN-202408USA002230US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240904$$HP$US$US
242830011$24283001$1$I$20230101$20240828$20240904$20240904$EXP$$JP-009507513-2408JPN003585J$MERCK$$5$DEC$$F$Y$$$20240904$$MD$JP$JP
242830022$24283002$2$F$20240903$20240905$20240904$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US077675$SANDOZ$$10$YR$$F$Y$$$20240913$$CN$US$US
242830031$24283003$1$I$$20240902$20240904$20240904$EXP$$NVSC2024FR177683$NOVARTIS$$75$YR$$F$Y$$$20240904$$PH$FR$FR
242830042$24283004$2$F$$20240911$20240904$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140540$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240912$$CN$US$US
242830051$24283005$1$I$20240101$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140529$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240904$$CN$US$US
242830061$24283006$1$I$20240728$20240822$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122096$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240904$$CN$US$US
242830072$24283007$2$F$$20240904$20240904$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140577$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240910$$HP$US$US
242830081$24283008$1$I$$20240902$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139802$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$89.36$KG$20240904$$CN$US$US
242830091$24283009$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140633$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240904$$CN$US$US
242830101$24283010$1$I$20230920$20240828$20240904$20240904$PER$$US-JNJFOC-20240906195$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240904$$PH$US$US
242830111$24283011$1$I$$20240829$20240904$20240904$PER$$US-JNJFOC-20240907565$JOHNSON AND JOHNSON$$$$$M$Y$$$20240904$$HP$US$US
242830121$24283012$1$I$$20240827$20240904$20240904$EXP$$CA-SANDOZ INC.-SDZ2024CA077601$SANDOZ$$70$YR$$F$Y$$$20240904$$HP$CA$CA
242830131$24283013$1$I$$20240903$20240903$20240903$DIR$716990$$FDA-CTU$$82$YR$$M$N$$$20240903$N$$US$
242830141$24283014$1$I$20230101$20240827$20240904$20240904$EXP$GB-MHRA-MED-202408271457432090-BHSFG$GB-TEVA-VS-3238117$TEVA$$33$YR$$M$Y$65$KG$20240904$$CN$GB$GB
242830151$24283015$1$I$$20240903$20240904$20240904$EXP$$JP-BAYER-2024A126129$BAYER$$$$$M$Y$$$20240904$$MD$JP$JP
242830161$24283016$1$I$20240801$20240827$20240904$20240904$EXP$$CN-009507513-2408CHN010317$MERCK$$51$YR$$F$Y$50$KG$20240904$$HP$CN$CN
242830171$24283017$1$I$20240510$20240904$20240904$20240904$DIR$717093$$FDA-CTU$$29$YR$$F$N$60.3$KG$20240904$N$CN$US$
242830182$24283018$2$F$20240823$20240918$20240904$20240926$PER$$US-SA-2024SA224280$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240926$$MD$US$US
242830192$24283019$2$F$20240830$20240830$20240904$20240923$PER$$US-SA-2024SA255704$SANOFI AVENTIS$$65$YR$E$F$Y$58.18$KG$20240923$$MD$US$US
242830201$24283020$1$I$20240903$20240903$20240903$20240903$DIR$716992$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242830211$24283021$1$I$$20240902$20240904$20240904$EXP$PL-EMA-20150317-AUTODUP-407206$PL-SANDOZ INC.-SDZ2024PL076960$SANDOZ$$44$YR$$M$Y$$$20240904$$HP$PL$PL
242830231$24283023$1$I$$20240829$20240904$20240904$PER$$US-ROCHE-10000069811$ROCHE$$$$$$Y$$$20240904$$PH$US$US
242830241$24283024$1$I$$20240828$20240904$20240904$PER$$US-ROCHE-10000070807$ROCHE$$$$$$Y$$$20240904$$MD$US$US
242830252$24283025$2$F$20240516$20240903$20240904$20240925$PER$$US-Eisai-EC-2024-172524$EISAI$$73$YR$$F$Y$64$KG$20240925$$MD$US$US
242830261$24283026$1$I$20240824$20240902$20240904$20240904$PER$$US-ROCHE-10000072170$ROCHE$$28$YR$A$M$Y$$$20240904$$CN$US$US
242830271$24283027$1$I$$20240902$20240904$20240904$EXP$GB-MHRA-MED-202408301134182040-PYMSL$GB-SANDOZ INC.-SDZ2024GB077102$SANDOZ$$$$$M$Y$100$KG$20240904$$CN$GB$GB
242830281$24283028$1$I$$20240901$20240904$20240904$EXP$$GB-ORGANON-O2409GBR000088$ORGANON$Lonsdale H, Sawant R, Kinshuck A, Fleming J.. Airway consequences of alendronic acid aspiration. BMJ case reports. 2024;17(8):e260930$$$E$F$Y$$$20240904$$MD$GB$GB
242830291$24283029$1$I$$20240830$20240904$20240904$EXP$$US-BAYER-2024A125532$BAYER$$72$YR$E$M$Y$$$20240904$$MD$US$US
242830301$24283030$1$I$$20240903$20240904$20240904$EXP$$JP-BAYER-2024A126348$BAYER$$$$$M$Y$$$20240904$$MD$JP$JP
242830331$24283033$1$I$$20240904$20240904$20240904$DIR$717101$$FDA-CTU$$$$$UNK$N$$$20240904$$CN$US$
242830341$24283034$1$I$20240902$20240903$20240903$20240903$DIR$717008$$FDA-CTU$$61$YR$$F$N$57.6$KG$20240903$Y$CN$US$
242830361$24283036$1$I$$20240904$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409002256$ELI LILLY AND CO$$74$YR$E$$Y$$$20240904$$CN$US$US
242830372$24283037$2$F$20240830$20240917$20240904$20240919$PER$$NVSC2024US177935$NOVARTIS$$75$YR$$M$Y$$$20240919$$HP$US$US
242830381$24283038$1$I$$20240829$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160209$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242830391$24283039$1$I$20240801$20240827$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160148$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242830411$24283041$1$I$$20240903$20240904$20240904$EXP$$PL-SANDOZ INC.-PHHY2014PL151886$SANDOZ$$$$A$M$Y$$$20240904$$MD$PL$PL
242830421$24283042$1$I$$20240903$20240904$20240904$PER$$US-ROCHE-10000073392$ROCHE$$$$A$M$Y$$$20240904$$CN$US$US
242830431$24283043$1$I$20240815$20240830$20240904$20240904$EXP$$CN-SA-2024SA254838$SANOFI AVENTIS$$33$YR$A$F$Y$48$KG$20240904$$HP$CN$CN
242830441$24283044$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140240$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240904$$CN$US$US
242830451$24283045$1$I$20240101$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140090$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$66.22$KG$20240904$$CN$US$US
242830461$24283046$1$I$$20240902$20240904$20240904$PER$$US-JNJFOC-20240904458$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240904$$CN$US$US
242830471$24283047$1$I$$20240820$20240904$20240904$PER$$US-JNJFOC-20240852011$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$MD$US$US
242830481$24283048$1$I$$20240828$20240904$20240904$PER$$NVSC2024US174933$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
242830491$24283049$1$I$20240811$20240828$20240904$20240904$EXP$FR-AFSSAPS-LL2024001602$FR-TEVA-VS-3238166$TEVA$$67$YR$$M$Y$$$20240904$$MD$FR$FR
242830502$24283050$2$F$20240501$20240904$20240904$20240913$PER$$US-SA-2024SA256653$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240913$$MD$US$US
242830511$24283051$1$I$$20240827$20240904$20240904$EXP$$CA-FreseniusKabi-FK202413144$FRESENIUS KABI$$67$YR$E$M$Y$$$20240904$$PH$CA$CA
242830521$24283052$1$I$$20240828$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137532$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240904$$PH$US$US
242830531$24283053$1$I$20210315$20240830$20240904$20240904$EXP$$CA-TAKEDA-2021TUS023745$TAKEDA$$78$YR$$F$Y$$$20240904$$CN$CA$CA
242830541$24283054$1$I$$20240827$20240904$20240904$EXP$$CA-FreseniusKabi-FK202413166$FRESENIUS KABI$$76$YR$E$M$Y$$$20240904$$HP$CA$CA
242830552$24283055$2$F$$20240904$20240904$20240905$PER$$NVSC2024US177965$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242830571$24283057$1$I$$20240828$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160190$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242830582$24283058$2$F$20240827$20240904$20240904$20240925$PER$$US-BIOMARINAP-US-2024-160223$BIOMARIN$$$$$$Y$$$20240925$$CN$US$US
242830592$24283059$2$F$20240827$20240827$20240904$20240926$PER$$US-BIOMARINAP-US-2024-160222$BIOMARIN$$$$$$Y$$$20240926$$CN$US$US
242830601$24283060$1$I$$20240828$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160196$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242830611$24283061$1$I$20240904$20240904$20240904$20240904$DIR$717096$$FDA-CTU$$62$YR$$F$N$101$KG$20240904$N$PH$US$
242830631$24283063$1$I$20240802$20240828$20240904$20240904$EXP$$CN-ASTELLAS-2024-AER-002874$ASTELLAS$$53$YR$A$F$Y$66$KG$20240904$$HP$CN$CN
242830641$24283064$1$I$$20240904$20240904$20240904$DIR$717099$$FDA-CTU$$$$$UNK$N$$$20240904$$CN$US$
242830651$24283065$1$I$$20240829$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138623$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240904$$CN$US$US
242830661$24283066$1$I$$20240828$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137926$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240904$$CN$US$US
242830671$24283067$1$I$20230531$20240828$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137794$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$103$KG$20240904$$PH$US$US
242830681$24283068$1$I$$20240826$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136913$BRISTOL MYERS SQUIBB$Peshin S, Modi SK, Burwick N. Lenalidomide and dexamethasone in scleromyxedema: a case report of long-term efficacy and challenges in a 54-year-old patient. Cureus. 2024 Jun 26;16(6):1-4.doi:10.7759/cureus.63181.$54$YR$A$M$Y$$$20240904$$HP$US$US
242830691$24283069$1$I$$20240903$20240903$20240903$DIR$716989$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242830731$24283073$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60517$$FDA-CTU$$30$YR$$F$N$77.11$KG$20240903$N$CN$US$
242830741$24283074$1$I$20240426$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60541$$FDA-CTU$$36$YR$$F$N$55.34$KG$20240903$N$CN$US$
242830751$24283075$1$I$$20240904$20240904$20240904$DIR$717102$$FDA-CTU$$$$$UNK$N$$$20240904$N$CN$US$
242830761$24283076$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60495$$FDA-CTU$$$$$F$N$$$20240903$N$$US$
242830771$24283077$1$I$20240821$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60505$$FDA-CTU$$40$YR$$F$N$108.86$KG$20240903$Y$PH$US$
242830782$24283078$2$F$20210101$20240909$20240904$20240911$EXP$$AU-TAKEDA-2024TUS087577$TAKEDA$$$$$F$Y$65$KG$20240911$$MD$AU$AU
242830791$24283079$1$I$$20240822$20240904$20240904$PER$$US-SA-2024SA256382$SANOFI AVENTIS$$$$A$M$Y$$$20240904$$HP$US$US
242830811$24283081$1$I$20240103$20240901$20240904$20240904$EXP$$NVSC2024CN177676$NOVARTIS$$52$YR$$M$Y$76$KG$20240904$$HP$CN$CN
242830822$24283082$2$F$20240713$20240905$20240904$20240911$EXP$$DE-MYLANLABS-2024M1079670$MYLAN$$89$YR$$F$Y$53$KG$20240911$$HP$DE$DE
242830841$24283084$1$I$20240819$20240821$20240904$20240904$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002431$CORCEPT$$$$$$Y$$$20240904$$MD$US$US
242830852$24283085$2$F$20180501$20240827$20240904$20240905$EXP$$BR-AstraZeneca-2018SE77756$ASTRAZENECA$$701$MON$$F$Y$$$20240905$$CN$BR$
242830871$24283087$1$I$$20240821$20240904$20240904$EXP$$US-HLS-202401020$HLS THERAPEUTICS$$$$A$$Y$$$20240904$$PH$US$US
242830881$24283088$1$I$20240829$20240830$20240904$20240904$EXP$$US-PFIZER INC-202400247868$PFIZER$$69$YR$$F$Y$$$20240904$$CN$US$US
242830891$24283089$1$I$$20240903$20240904$20240904$PER$$US-ABBVIE-5906025$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242830911$24283091$1$I$20220603$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60552$$FDA-CTU$$25$YR$$F$N$68.04$KG$20240903$N$CN$US$
242830931$24283093$1$I$20240829$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60491$$FDA-CTU$$60$YR$$M$N$87.3$KG$20240903$Y$$US$
242830941$24283094$1$I$$20240904$20240904$20240904$DIR$717104$$FDA-CTU$$$$$UNK$N$$$20240904$$CN$US$
242830981$24283098$1$I$20240830$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60523$$FDA-CTU$$$$$$N$$$20240903$N$CN$US$
242831001$24283100$1$I$$20240902$20240904$20240904$EXP$$JP-BAYER-2024A126032$BAYER$$$$$$Y$$$20240904$$PH$JP$JP
242831011$24283101$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA256594$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240904$$HP$US$US
242831021$24283102$1$I$20240405$20240902$20240904$20240904$EXP$FR-AFSSAPS-PP2024000920$FR-FreseniusKabi-FK202413349$FRESENIUS KABI$$50$YR$A$F$Y$68$KG$20240904$$PH$FR$FR
242831031$24283103$1$I$$20240826$20240904$20240904$EXP$$US-TEVA-VS-3237575$TEVA$$76$YR$$F$Y$$$20240904$$CN$US$US
242831042$24283104$2$F$20240818$20240909$20240904$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138806$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240912$$MD$US$US
242831051$24283105$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140415$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240904$$HP$US$US
242831062$24283106$2$F$$20240918$20240904$20240925$EXP$FR-EMA-20150319-AUTODUP-416260$FR-SANDOZ INC.-SDZ2024FR076978$SANDOZ$$$$$M$Y$$$20240925$$HP$FR$FR
242831073$24283107$3$F$20240830$20240913$20240904$20240914$PER$$US-AMGEN-USASP2024176097$AMGEN$$62$YR$A$F$Y$$$20240914$$CN$US$US
242831082$24283108$2$F$20240104$20240905$20240904$20240912$EXP$$NVSC2024IN089901$NOVARTIS$$50$YR$$F$Y$$$20240913$$CN$IN$IN
242831092$24283109$2$F$20240823$20240910$20240904$20240919$PER$$US-MYLANLABS-2024M1079065$MYLAN$$$$$F$Y$79.83$KG$20240919$$CN$US$US
242831101$24283110$1$I$20240514$20240822$20240904$20240904$EXP$$IT-INCYTE CORPORATION-2024IN009006$INCYTE$$$$$$Y$$$20240904$$MD$IT$IT
242831111$24283111$1$I$$20240902$20240904$20240904$PER$$US-JNJFOC-20240904606$JOHNSON AND JOHNSON$$75$YR$E$F$Y$89.3$KG$20240904$$CN$US$US
242831121$24283112$1$I$20240426$20240902$20240904$20240904$EXP$$CN-BAYER-2024A126407$BAYER$$42$YR$A$M$Y$80$KG$20240904$$HP$CN$CN
242831141$24283114$1$I$$20240829$20240904$20240904$PER$$US-MYLANLABS-2024M1080847$MYLAN$$$$$F$Y$$$20240904$$CN$US$US
242831151$24283115$1$I$$20240903$20240904$20240904$30DAY$$US-SANDOZ INC.-SDZ2024US077687$SANDOZ$$$$$F$Y$$$20240904$$CN$US$US
242831161$24283116$1$I$$20240830$20240904$20240904$EXP$$US-BAYER-2024A126313$BAYER$$69$YR$E$M$Y$$$20240904$$CN$US$US
242831171$24283117$1$I$$20240418$20240904$20240904$PER$$US-Saptalis Pharmaceuticals LLC-2161199$SAPTALIS PHARMACEUTICALS$$$$$F$Y$$$20240904$$$US$US
242831181$24283118$1$I$$20240502$20240904$20240904$PER$$US-Saptalis Pharmaceuticals LLC-2161200$SAPTALIS PHARMACEUTICALS$$80$YR$$F$Y$$$20240904$$$US$US
242831191$24283119$1$I$$20240715$20240904$20240904$PER$$US-Saptalis Pharmaceuticals LLC-2161201$SAPTALIS PHARMACEUTICALS$$$$$F$Y$$$20240904$$$US$US
242831201$24283120$1$I$$20240315$20240904$20240904$PER$$US-Saptalis Pharmaceuticals LLC-2161198$SAPTALIS PHARMACEUTICALS$$$$$M$Y$$$20240904$$$US$US
242831211$24283121$1$I$20230812$20240206$20240904$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-140714$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$65$KG$20240904$$MD$JP$JP
242831221$24283122$1$I$$20240510$20240904$20240904$PER$$US-Saptalis Pharmaceuticals LLC-2161203$SAPTALIS PHARMACEUTICALS$$$$$F$Y$$$20240904$$$US$US
242831231$24283123$1$I$$20240828$20240904$20240904$EXP$$RO-ACIC Fine Chemicals Inc-2161202$ACIC FINE CHEMICALS$literature article$71$YR$$F$Y$$$20240904$$$RO$RO
242831241$24283124$1$I$$20240904$20240904$20240904$EXP$$US-PURDUE PHARMA-USA-2024-0311777$PURDUE$$$$$F$Y$$$20240904$$CN$US$US
242831251$24283125$1$I$$20240903$20240904$20240904$EXP$$US-PURDUE PHARMA-USA-2024-0311748$PURDUE$$47$YR$$F$Y$$$20240904$$CN$US$US
242831262$24283126$2$F$20190101$20240902$20240904$20240906$EXP$$US-PURDUE PHARMA-USA-2024-0311729$PURDUE$$$$$F$Y$$$20240906$$CN$US$US
242831271$24283127$1$I$$20240904$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049540$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240904$$CN$US$US
242831281$24283128$1$I$20240821$20240830$20240904$20240904$EXP$$US-BAYER-2024A126878$BAYER$$68$YR$E$M$Y$$$20240904$$CN$US$US
242831301$24283130$1$I$20240830$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60519$$FDA-CTU$$82$YR$$F$N$$$20240903$N$$US$
242831311$24283131$1$I$20240903$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60496$$FDA-CTU$$$$$$N$$$20240903$N$CN$US$
242831321$24283132$1$I$20240101$20240829$20240904$20240904$EXP$FR-AFSSAPS-PB2024000932$FR-009507513-2408FRA010354$MERCK$$36$YR$$F$Y$$$20240904$$MD$FR$FR
242831332$24283133$2$F$20240822$20240903$20240904$20240906$PER$$US-AMGEN-USASP2024176063$AMGEN$$79$YR$E$F$Y$$$20240906$$CN$US$US
242831342$24283134$2$F$20240101$20240910$20240904$20240910$EXP$$TW-BAYER-2024A126435$BAYER$$$$$M$Y$$$20240910$$HP$TW$TW
242831351$24283135$1$I$20240506$20240828$20240904$20240904$EXP$FR-AFSSAPS-AN2024001130$FR-TEVA-VS-3238405$TEVA$$62$YR$$F$Y$$$20240904$$MD$FR$FR
242831362$24283136$2$F$$20240912$20240904$20240917$EXP$$US-KYOWAKIRIN-2024KK020601$KYOWA$$$$$$Y$$$20240917$$HP$US$US
242831371$24283137$1$I$20240701$20240828$20240904$20240904$EXP$$US-OTSUKA-2024_020848$OTSUKA$$26$YR$$F$Y$91.44$KG$20240904$$HP$US$US
242831381$24283138$1$I$20240701$20240829$20240904$20240904$EXP$$US-SA-2024SA254250$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240904$$MD$US$US
242831391$24283139$1$I$$20240827$20240904$20240904$EXP$$CA-ABBVIE-5903804$ABBVIE$$$$$F$Y$$$20240904$$HP$CA$CA
242831401$24283140$1$I$20240801$20240903$20240904$20240904$EXP$$CN-BAYER-2024A126626$BAYER$$44$YR$A$F$Y$48$KG$20240904$$HP$CN$CN
242831411$24283141$1$I$20240720$20240829$20240904$20240904$EXP$ES-AEMPS-1560913$ES-MYLANLABS-2024M1079846$MYLAN$$70$YR$$F$Y$$$20240904$$MD$ES$ES
242831421$24283142$1$I$20240607$20240829$20240904$20240904$EXP$FR-AFSSAPS-LL2024001619$FR-MYLANLABS-2024M1079824$MYLAN$$73$YR$$F$Y$65$KG$20240904$$MD$FR$FR
242831432$24283143$2$F$20240826$20240910$20240904$20240916$EXP$$US-MYLANLABS-2024M1081227$MYLAN$$20$YR$$F$Y$$$20240916$$HP$US$US
242831441$24283144$1$I$$20240904$20240904$20240904$EXP$$US-GILEAD-2024-0686221$GILEAD$$79$YR$E$M$Y$$$20240904$$MD$US$US
242831451$24283145$1$I$$20240830$20240904$20240904$PER$$US-BAYER-2024A126761$BAYER$$73$YR$E$F$Y$$$20240904$$CN$US$US
242831461$24283146$1$I$20240803$20240830$20240904$20240904$EXP$$CA-ABBVIE-5903851$ABBVIE$$64$YR$$F$Y$$$20240904$$HP$CA$CA
242831471$24283147$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA157368$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240904$$MD$US$US
242831481$24283148$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-60545$$FDA-CTU$$32$YR$$M$N$153$LBS$20240904$N$HP$US$
242831491$24283149$1$I$$20240731$20240830$20240830$DIR$FDA-CDER-CTU-2024-60001$$FDA-CTU$$$$$$N$$$20240731$N$HP$US$
242831502$24283150$2$F$20240317$20240909$20240904$20240909$EXP$ES-AEMPS-1564837$ES-GILEAD-2024-0686069$GILEAD$$76$YR$E$F$Y$76$KG$20240909$$MD$ES$ES
242831511$24283151$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA256468$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240904$$HP$US$US
242831521$24283152$1$I$$20240821$20240904$20240904$EXP$$US-HLS-202401023$HLS THERAPEUTICS$$$$A$$Y$$$20240904$$MD$US$US
242831531$24283153$1$I$$20240822$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134844$BRISTOL MYERS SQUIBB$Cowen EA, Barrios DM, Pulitzer MP, Moy AP, Dusza SW, Wolf SD, et al. Acute febrile neutrophilic dermatosis (sweet syndrome) in acute myeloid leukemia patients: a 28-year institutional experience. Acta Haematologic. 2024 Jul 01;147(4):457-64. doi:10.1159/000535399.$8$DEC$E$M$Y$$$20240904$$HP$US$US
242831541$24283154$1$I$$20240822$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140666$BRISTOL MYERS SQUIBB$Cowen EA, Barrios DM, Pulitzer MP, Moy AP, Dusza SW, Wolf SD, et al. Acute febrile neutrophilic dermatosis (sweet syndrome) in acute myeloid leukemia patients: a 28-year institutional experience. Acta Haematologic. 2024 Jul 01;147(4):457-64. doi:10.1159/000535399.$6$DEC$A$F$Y$$$20240904$$HP$US$US
242831551$24283155$1$I$20240101$20240830$20240904$20240904$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17389$IPSEN$$64$YR$A$M$Y$$$20240904$$CN$US$US
242831562$24283156$2$F$20240501$20240904$20240904$20240913$EXP$$FR-BIOGEN-2024BI01280641$BIOGEN$$41$YR$$F$Y$$$20240913$$MD$FR$FR
242831572$24283157$2$F$20240601$20240904$20240904$20240913$EXP$$FR-BIOGEN-2024BI01280643$BIOGEN$$47$YR$$M$Y$$$20240913$$MD$FR$FR
242831592$24283159$2$F$20240101$20240911$20240904$20240919$PER$$US-ABBVIE-5896482$ABBVIE$$$$$F$Y$117.93$KG$20240919$$CN$US$US
242831601$24283160$1$I$20240601$20240829$20240904$20240904$EXP$FR-AFSSAPS-MA2024001406$FR-009507513-2408FRA010556$MERCK$$65$YR$$F$Y$$$20240904$$MD$FR$FR
242831611$24283161$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140652$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$HP$US$US
242831621$24283162$1$I$$20240830$20240904$20240904$EXP$$CA-009507513-2409CAN000818$MERCK$$73$YR$$F$Y$66$KG$20240904$$HP$CA$CA
242831631$24283163$1$I$20240801$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139718$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240904$$PH$US$US
242831641$24283164$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140484$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240904$$HP$US$US
242831651$24283165$1$I$$20240903$20240904$20240904$EXP$GB-MHRA-31738618$GB-SANDOZ INC.-SDZ2024GB077407$SANDOZ$$$$$$Y$$$20240904$$CN$GB$GB
242831661$24283166$1$I$20240903$20240903$20240903$20240903$DIR$717010$$FDA-CTU$$73$YR$$F$N$$$20240903$N$$US$
242831671$24283167$1$I$20240819$20240903$20240903$20240903$DIR$716968$$FDA-CTU$$64$YR$$F$N$$$20240903$N$PH$US$
242831681$24283168$1$I$$20240829$20240904$20240904$EXP$$DE-MYLANLABS-2024M1079716$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. Alpha-Pyrrolidinohexanophenone (alpha-PHP) vs. alpha-pyrrolidinoisohexanophenone (alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$44$YR$$M$Y$$$20240904$$HP$DE$DE
242831691$24283169$1$I$$20240829$20240904$20240904$EXP$$DE-MYLANLABS-2024M1080387$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology.. 2024;48:299-313$41$YR$$M$Y$$$20240904$$HP$DE$DE
242831701$24283170$1$I$20240101$20240812$20240904$20240904$PER$$US-009507513-2408USA004062$MERCK$$$$$M$Y$$$20240904$$CN$US$US
242831711$24283171$1$I$20240101$20240903$20240904$20240904$PER$$US-ABBVIE-5905617$ABBVIE$$$$$$Y$$$20240904$$CN$US$US
242831721$24283172$1$I$20240801$20240903$20240904$20240904$PER$$US-AMGEN-USASP2024176113$AMGEN$$72$YR$$F$Y$$$20240904$$PH$US$US
242831731$24283173$1$I$20240802$20240823$20240904$20240904$EXP$$US-PYROS PHARMACEUTICALS, INC-2024-PYROS-US000055$Pyros Pharmaceuticals$$0$YR$$M$Y$9.07$KG$20240904$$CN$US$US
242831741$24283174$1$I$20240701$20240725$20240904$20240904$PER$$US-Merz Pharmaceuticals GmbH-2024070000156$MERZ$$$$$F$Y$$$20240904$$HP$US$US
242831751$24283175$1$I$$20240826$20240904$20240904$EXP$$BR-DSJP-DSE-2024-142090$DAIICHI$$65$YR$$F$Y$$$20240904$$MD$BR$BR
242831771$24283177$1$I$$20240903$20240903$20240903$DIR$716995$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242831781$24283178$1$I$20240901$20240903$20240903$20240903$DIR$716959$$FDA-CTU$$30$YR$$M$N$$$20240903$N$$US$
242831791$24283179$1$I$20240903$20240903$20240903$20240903$DIR$716974$$FDA-CTU$$84$YR$$M$N$78.75$KG$20240903$N$CN$US$
242831811$24283181$1$I$20240903$20240903$20240903$20240903$DIR$716999$$FDA-CTU$$65$YR$$F$N$$$20240903$Y$PH$US$
242831821$24283182$1$I$20240801$20240903$20240903$20240903$DIR$717016$$FDA-CTU$$70$YR$$F$N$$$20240903$N$CN$US$
242831832$24283183$2$F$$20240910$20240904$20240912$EXP$PT-GT-20242013$PT-SANDOZ INC.-SDZ2024PT077443$SANDOZ$$20$YR$$F$Y$$$20240912$$MD$PT$PT
242831841$24283184$1$I$$20240828$20240904$20240904$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048401$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240904$$CN$US$US
242831861$24283186$1$I$20240531$20240829$20240904$20240904$EXP$$JP-DSJP-DSJ-2024-124518$DAIICHI$$$$$F$Y$$$20240904$$MD$JP$JP
242831872$24283187$2$F$20240806$20240828$20240904$20240911$EXP$$NVSC2024FR176178$NOVARTIS$$86$YR$$F$Y$65$KG$20240911$$MD$FR$FR
242831881$24283188$1$I$20240903$20240904$20240904$20240904$EXP$GB-MHRA-MED-202409041156478010-VWJZD$GB-MYLANLABS-2024M1081268$MYLAN$$79$YR$$F$Y$$$20240904$$MD$GB$GB
242831891$24283189$1$I$20230204$20240903$20240904$20240904$EXP$$BY-MYLANLABS-2024M1081222$MYLAN$$49$YR$$M$Y$62$KG$20240904$$MD$BY$BY
242831901$24283190$1$I$$20240821$20240904$20240904$EXP$$US-HLS-202401028$HLS THERAPEUTICS$$$$A$F$Y$$$20240904$$MD$US$US
242831911$24283191$1$I$$20240903$20240904$20240904$EXP$FR-EMA-DD-20220121-veeravajhul_p-090605$FR-SANDOZ INC.-SDZ2024FR077331$SANDOZ$$26$YR$$M$Y$$$20240904$$HP$FR$FR
242831921$24283192$1$I$$20240826$20240904$20240904$EXP$$US-MYLANLABS-2024M1079916$MYLAN$Correa S, Berman A. Glue Embolism Following Variceal Sclerotherapy. Am-J-Respir-Crit-Care-Med 2023; 207 A5498.$34$YR$$M$Y$$$20240904$$HP$US$US
242831931$24283193$1$I$20230801$20240826$20240904$20240904$EXP$$FR-TEVA-VS-3237213$TEVA$$$$A$F$Y$$$20240904$$HP$FR$FR
242831941$24283194$1$I$$20240828$20240904$20240904$EXP$$RO-009507513-2408ROU010224$MERCK$$49$YR$$M$Y$$$20240904$$MD$RO$RO
242831951$24283195$1$I$$20240826$20240904$20240904$EXP$$NVSC2024TR175495$NOVARTIS$Tunc A, Akbas AA, Bozkurt B, Oncel S. Beyond conventional therapies: ivig in treating severe fingolimod-rebound in a postpartum patient with ms. BMJ CASE REP.. 2024;17:1-4, e259932$4$DEC$$F$Y$$$20240904$$HP$TR$TR
242831961$24283196$1$I$$20240828$20240904$20240904$EXP$FR-AFSSAPS-PB2024000897$FR-TEVA-VS-3238158$TEVA$$63$YR$$M$Y$$$20240904$$PH$FR$FR
242831971$24283197$1$I$20240730$20240806$20240904$20240904$PER$$US-Eisai-EC-2024-171848$EISAI$$73$YR$E$F$Y$$$20240904$$CN$US$US
242831981$24283198$1$I$$20240809$20240904$20240904$PER$$US-Eisai-EC-2024-171860$EISAI$$74$YR$E$F$Y$$$20240904$$MD$US$US
242831991$24283199$1$I$$20240827$20240904$20240904$EXP$$US-MYLANLABS-2024M1080443$MYLAN$Tariq J, Townsend M, Parikh S, Bennett J. Case report: severe hypertrophic cardiomyopathy in a female neonate caused by de novo variant in NDUFB11. Eur-Heart-J-Case-Rep 2024; 8 (8):.$$$I$F$Y$$$20240904$$MD$US$US
242832001$24283200$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140744$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240904$$CN$US$US
242832011$24283201$1$I$20240808$20240828$20240904$20240904$EXP$FR-AFSSAPS-TO2024001595$FR-TEVA-VS-3238270$TEVA$$72$YR$$$Y$88$KG$20240904$$PH$FR$FR
242832021$24283202$1$I$$20240827$20240904$20240904$EXP$$IT-MYLANLABS-2024M1080103$MYLAN$Papetti L, Moltoni G, Longo D, Monte G, Dellepiane F, Pro S, et al. Isolated Intracranial Hypertensions as Onset of Myelin Oligodendrocyte Glycoprotein Antibody Disease. J-Clin-Med 2024; 13 (15):.$8$YR$$M$Y$$$20240904$$HP$IT$IT
242832041$24283204$1$I$20240429$20240829$20240904$20240904$EXP$FR-AFSSAPS-RS2024000822$FR-TEVA-VS-3238559$TEVA$$51$YR$$F$Y$$$20240904$$MD$FR$FR
242832051$24283205$1$I$20240815$20240828$20240904$20240904$EXP$IT-MINISAL02-999575$IT-TEVA-VS-3238292$TEVA$$82$YR$$M$Y$$$20240904$$MD$IT$IT
242832061$24283206$1$I$19981108$20240716$20240904$20240904$EXP$$DE-NOVOPROD-111992$NOVO NORDISK$$63$YR$$M$Y$65$KG$20240904$$MD$DE$DE
242832071$24283207$1$I$20240903$20240903$20240903$20240903$DIR$717017$$FDA-CTU$$56$YR$$F$N$70.2$KG$20240903$N$CN$US$
242832081$24283208$1$I$20240831$20240903$20240903$20240903$DIR$716981$$FDA-CTU$$58$YR$$F$N$77.4$KG$20240903$N$MD$US$
242832091$24283209$1$I$20240901$20240903$20240903$20240903$DIR$716965$$FDA-CTU$$49$YR$$F$N$$$20240903$N$HP$US$
242832101$24283210$1$I$20240903$20240903$20240903$20240903$DIR$716954$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242832111$24283211$1$I$$20240821$20240904$20240904$EXP$$US-HLS-202401027$HLS THERAPEUTICS$$$$A$$Y$$$20240904$$PH$US$US
242832121$24283212$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409002307$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240904$$CN$US$US
242832133$24283213$3$F$$20240918$20240904$20240921$PER$$NVSC2024US177704$NOVARTIS$$$$$F$Y$$$20240921$$CN$US$US
242832141$24283214$1$I$$20240902$20240904$20240904$EXP$$ES-SANDOZ INC.-SDZ2024ES077452$SANDOZ$$$$$M$Y$$$20240904$$CN$ES$ES
242832151$24283215$1$I$20240903$20240903$20240904$20240904$PER$$US-AMGEN-USASP2024176131$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242832161$24283216$1$I$20231204$20240829$20240904$20240904$EXP$FR-AFSSAPS-ST2024001337$FR-TEVA-VS-3239004$TEVA$$62$YR$$M$Y$$$20240904$$MD$FR$FR
242832171$24283217$1$I$20201201$20240829$20240904$20240904$EXP$PL-URPL-1-4130-2020$PL-TEVA-VS-3239023$TEVA$$59$YR$$M$Y$65$KG$20240904$$MD$PL$PL
242832181$24283218$1$I$20170101$20240829$20240904$20240904$EXP$$NVSC2019IT103865$NOVARTIS$Mendogni P, Henchi S, Morlacchi LC, Tosi D, Nosotti M, Tarsia P et al.. Epstein-barr virus-related post-transplant lymphoproliferative disorders in cystic fibrosis lung transplant recipients: a case series.. TRANSPLANTATION PROCEEDINGS. 2019;51(1):194-7$26$YR$$F$Y$$$20240904$$HP$IT$IT
242832191$24283219$1$I$20240807$20240829$20240904$20240904$EXP$PT-INFARMED-J202408-356$PT-TEVA-VS-3239050$TEVA$$46$YR$$F$Y$70$KG$20240904$$MD$PT$PT
242832201$24283220$1$I$20240501$20240820$20240904$20240904$PER$$US-RDY-SPO/USA/24/0012380$DR REDDYS$$23$YR$A$M$Y$$$20240904$$CN$US$US
242832212$24283221$2$F$20240426$20240904$20240904$20240913$PER$$US-Eisai-EC-2024-171659$EISAI$$77$YR$E$M$Y$54$KG$20240913$$MD$US$US
242832221$24283222$1$I$$20240826$20240904$20240904$PER$$US-RDY-SPO/USA/24/0012654$DR REDDYS$$18$YR$A$F$Y$$$20240904$$MD$US$US
242832231$24283223$1$I$20240701$20240809$20240904$20240904$PER$$US-Eisai-EC-2024-171869$EISAI$$79$YR$E$M$Y$88.72$KG$20240904$$PH$US$US
242832241$24283224$1$I$20240821$20240829$20240904$20240904$EXP$$JP-Eisai-EC-2024-173330$EISAI$$76$YR$E$F$Y$67$KG$20240904$$MD$JP$JP
242832251$24283225$1$I$$20240827$20240904$20240904$PER$$US-RDY-CLI/USA/24/0012606$DR REDDYS$$46$YR$A$M$Y$$$20240904$$CN$US$US
242832261$24283226$1$I$$20240826$20240904$20240904$EXP$$US-RDY-SPO/USA/24/0012722$DR REDDYS$Jain M, Ali EA, Pokhrel A, Wang JC, Mooppan U. Olaparib induced aplastic anemia in a patient with castrate resistant prostate cancer: A case report. Leukemia Research Reports. 2024;(22): doi:10.1016/j.lrr.2024.100473.$75$YR$E$M$Y$$$20240904$$HP$US$US
242832271$24283227$1$I$20240521$20240807$20240904$20240904$PER$$US-Eisai-EC-2024-171721$EISAI$$73$YR$E$F$Y$59.2$KG$20240904$$CN$US$US
242832281$24283228$1$I$20240801$20240829$20240904$20240904$EXP$PT-INFARMED-E202408-415$PT-TEVA-VS-3239073$TEVA$$70$YR$$M$Y$75$KG$20240904$$PH$PT$PT
242832291$24283229$1$I$20240816$20240830$20240904$20240904$EXP$ES-AEMPS-1562398$ES-TEVA-VS-3239330$TEVA$$46$YR$$F$Y$$$20240904$$MD$ES$ES
242832301$24283230$1$I$$20240826$20240904$20240904$EXP$$FR-MYLANLABS-2024M1079911$MYLAN$Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, et al. Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study. Am-J-Hematol 2023; 98 (9): E259-E262.$67$YR$$M$Y$$$20240904$$HP$FR$FR
242832312$24283231$2$F$20240804$20240905$20240904$20240909$EXP$$JP-PFIZER INC-PV202400115287$PFIZER$$11$MON$$F$Y$$$20240909$$MD$JP$JP
242832321$24283232$1$I$20240825$20240903$20240903$20240903$DIR$717013$$FDA-CTU$$26$YR$$F$N$55.8$KG$20240903$N$CN$US$
242832331$24283233$1$I$$20240903$20240903$20240903$DIR$716982$$FDA-CTU$$$$$F$N$$$20240903$N$$US$
242832341$24283234$1$I$$20240903$20240904$20240904$EXP$$US-PFIZER INC-PV202400115620$PFIZER$$79$YR$$M$Y$$$20240904$$CN$US$US
242832351$24283235$1$I$20240817$20240830$20240904$20240904$EXP$GB-MHRA-MED-202408301238146220-CLDQT$GB-TEVA-VS-3238974$TEVA$$65$YR$$F$Y$62$KG$20240904$$PH$GB$GB
242832371$24283237$1$I$20240903$20240903$20240903$20240903$DIR$716979$$FDA-CTU$$45$YR$$M$N$85.95$KG$20240903$N$HP$US$
242832381$24283238$1$I$20240720$20240828$20240904$20240904$EXP$$CN-009507513-2409CHN000127$MERCK$$43$YR$$F$Y$49.6$KG$20240904$$HP$CN$CN
242832392$24283239$2$F$$20240916$20240904$20240918$PER$$NVSC2024US177921$NOVARTIS$$$$$$Y$$$20240918$$MD$US$US
242832421$24283242$1$I$$20240904$20240904$20240904$PER$$NVSC2024US177948$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
242832432$24283243$2$F$$20240910$20240904$20240920$EXP$DE-BFARM-24005879$DE-ELI_LILLY_AND_COMPANY-DE202408015652$ELI LILLY AND CO$$83$YR$E$F$Y$105.4$KG$20240920$$CN$DE$DE
242832441$24283244$1$I$$20240822$20240904$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202408014658$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240904$$CN$US$US
242832451$24283245$1$I$20240726$20240823$20240904$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202408015250$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240904$$CN$US$US
242832461$24283246$1$I$20140101$20240823$20240904$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202408015453$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240904$$HP$US$US
242832471$24283247$1$I$20240101$20240823$20240904$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202408015215$ELI LILLY AND CO$$$$$F$Y$$$20240904$$CN$US$US
242832481$24283248$1$I$$20240823$20240904$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202408015497$ELI LILLY AND CO$$$$$F$Y$$$20240904$$CN$US$US
242832491$24283249$1$I$20240817$20240823$20240904$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016421$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240904$$CN$US$US
242832501$24283250$1$I$$20240827$20240904$20240904$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202408017837$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240904$$HP$TW$TW
242832511$24283251$1$I$$20240823$20240904$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016172$ELI LILLY AND CO$$$$$$Y$$$20240904$$CN$US$US
242832522$24283252$2$F$20240723$20240924$20240904$20240930$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407015914$ELI LILLY AND CO$$62$YR$A$M$Y$80.5$KG$20240930$$CN$JP$JP
242832541$24283254$1$I$20240819$20240823$20240904$20240904$EXP$GB-MHRA-MED-202408231731094300-MGTJP$GB-ELI_LILLY_AND_COMPANY-GB202408015661$ELI LILLY AND CO$$$$$M$Y$$$20240904$$CN$GB$GB
242832551$24283255$1$I$20240823$20240830$20240904$20240904$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409000474$ELI LILLY AND CO$$62$YR$A$F$Y$52$KG$20240904$$CN$CN$CN
242832571$24283257$1$I$$20240823$20240904$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202408015308$ELI LILLY AND CO$$$$$M$Y$$$20240904$$CN$US$US
242832581$24283258$1$I$$20240823$20240904$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202408015562$ELI LILLY AND CO$$$$$$Y$$$20240904$$MD$US$US
242832591$24283259$1$I$$20240829$20240904$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000111$ELI LILLY AND CO$$$$$F$Y$$$20240904$$CN$US$US
242832601$24283260$1$I$20240823$20240823$20240904$20240904$EXP$GB-MHRA-MED-202408232101314770-RGQWB$GB-ELI_LILLY_AND_COMPANY-GB202408015658$ELI LILLY AND CO$$32$YR$A$F$Y$153$KG$20240904$$CN$GB$GB
242832611$24283261$1$I$20240830$20240830$20240904$20240904$PER$$US-SA-2024SA254441$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240904$$CN$US$US
242832621$24283262$1$I$20240806$20240823$20240904$20240904$EXP$GB-MHRA-MED-202408230749285380-YMFKJ$GB-ELI_LILLY_AND_COMPANY-GB202408015709$ELI LILLY AND CO$$26$YR$A$F$Y$82$KG$20240904$$CN$GB$GB
242832631$24283263$1$I$$20240826$20240904$20240904$EXP$$US-ELI_LILLY_AND_COMPANY-US202408017596$ELI LILLY AND CO$$$$$$Y$$$20240904$$CN$US$US
242832641$24283264$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA254436$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240904$$MD$US$US
242832651$24283265$1$I$$20240830$20240904$20240904$EXP$$US-TAKEDA-2024TUS054547$TAKEDA$$$$$M$Y$$$20240904$$CN$US$US
242832661$24283266$1$I$$20240827$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137155$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$67$KG$20240904$$PH$US$US
242832671$24283267$1$I$20240601$20240828$20240904$20240904$EXP$$US-ABBVIE-5901941$ABBVIE$$66$YR$$M$Y$$$20240904$$CN$US$US
242832681$24283268$1$I$20240902$20240903$20240903$20240903$DIR$716991$$FDA-CTU$$46$YR$$F$N$$$20240903$N$HP$US$
242832711$24283271$1$I$20240720$20240903$20240903$20240903$DIR$717019$$FDA-CTU$$62$YR$$M$N$163.35$KG$20240903$N$CN$US$
242832721$24283272$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA254857$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240904$$MD$US$US
242832731$24283273$1$I$20240101$20240826$20240904$20240904$PER$$US-SA-2024SA253057$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240904$$CN$US$US
242832741$24283274$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA255872$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240904$$MD$US$US
242832751$24283275$1$I$$20240821$20240904$20240904$PER$$US-SA-2024SA255022$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240904$$MD$US$US
242832761$24283276$1$I$$20240830$20240904$20240904$PER$$US-SA-2024SA254620$SANOFI AVENTIS$$$$A$$Y$$$20240904$$CN$US$US
242832771$24283277$1$I$$20240826$20240904$20240904$PER$$US-RDY-CLI/USA/24/0012601$DR REDDYS$$9$YR$C$F$Y$$$20240904$$CN$US$US
242832781$24283278$1$I$$20240820$20240904$20240904$PER$$US-Covis Pharma GmbH-2024COV01035$COVIS PHARMA$$$$$F$Y$$$20240904$$CN$US$US
242832791$24283279$1$I$$20240903$20240904$20240904$PER$$US-JNJFOC-20240904628$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$HP$US$US
242832801$24283280$1$I$$20240822$20240904$20240904$PER$$US-Covis Pharma GmbH-2024COV01042$COVIS PHARMA$$$$$F$Y$$$20240904$$CN$US$US
242832811$24283281$1$I$20240606$20240829$20240904$20240904$EXP$$CA-LUNDBECK-DKLU4000233$LUNDBECK$$$$$$Y$$$20240904$$HP$CA$CA
242832821$24283282$1$I$$20240830$20240904$20240904$EXP$$NVSC2024US025965$NOVARTIS$$$$$F$Y$$$20240904$$CN$US$US
242832832$24283283$2$F$$20240911$20240904$20240916$PER$$US-NXDC-2024GLE00064$NX DEVELOPMENT CORPORATION$$$$E$$Y$$$20240916$$MD$US$US
242832842$24283284$2$F$$20240911$20240904$20240916$PER$$US-NXDC-2024GLE00065$NX DEVELOPMENT CORPORATION$$$$$$Y$$$20240916$$MD$US$US
242832851$24283285$1$I$20240830$20240903$20240903$20240903$DIR$716966$$FDA-CTU$$48$YR$$F$N$76.5$KG$20240903$N$HP$US$
242832861$24283286$1$I$20240825$20240903$20240903$20240903$DIR$716988$$FDA-CTU$$56$YR$$M$N$$$20240903$N$PH$US$
242832871$24283287$1$I$20231212$20240827$20240904$20240904$PER$FR-AFSSAPS-ST2024001331$FR-Eisai-EC-2024-172953$EISAI$$70$YR$E$M$Y$56$KG$20240904$$HP$FR$FR
242832882$24283288$2$F$$20240831$20240904$20240905$PER$$US-PURDUE PHARMA-USA-2024-0311749$PURDUE$$32$YR$$M$Y$$$20240905$$CN$US$US
242832892$24283289$2$F$$20240912$20240904$20240913$PER$$US-PURDUE PHARMA-USA-2024-0311764$PURDUE$$$$$F$Y$$$20240913$$CN$US$US
242832901$24283290$1$I$$20240903$20240904$20240904$PER$$US-PURDUE PHARMA-USA-2024-0311778$PURDUE$$64$YR$$F$Y$$$20240904$$CN$US$US
242832911$24283291$1$I$$20240903$20240904$20240904$PER$$US-PURDUE-USA-2024-0311774$PURDUE$$$$$M$Y$$$20240904$$PH$US$US
242832921$24283292$1$I$$20240831$20240904$20240904$PER$$US-PURDUE PHARMA-USA-2024-0311750$PURDUE$$27$YR$$F$Y$$$20240904$$CN$US$US
242832931$24283293$1$I$$20240831$20240904$20240904$PER$$US-PURDUE PHARMA-USA-2024-0311751$PURDUE$$5$YR$$M$Y$$$20240904$$CN$US$US
242832941$24283294$1$I$$20240831$20240904$20240904$PER$$US-PURDUE PHARMA-USA-2024-0311771$PURDUE$$$$$$Y$$$20240904$$CN$US$US
242832951$24283295$1$I$$20240903$20240904$20240904$PER$$US-PURDUE PHARMA-USA-2024-0311747$PURDUE$$$$A$M$Y$$$20240904$$CN$US$US
242832963$24283296$3$F$$20240903$20240904$20240910$PER$$US-PURDUE PHARMA-USA-2024-0311775$PURDUE$$$$$M$Y$63.5$KG$20240910$$CN$US$US
242832971$24283297$1$I$$20240812$20240904$20240904$PER$$US-INCYTE CORPORATION-2024IN009047$INCYTE$$$$$$Y$$$20240904$$CN$US$US
242832981$24283298$1$I$$20240827$20240904$20240904$PER$$US-JNJFOC-20240871677$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$MD$US$US
242832991$24283299$1$I$$20240828$20240904$20240904$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408017707$ELI LILLY AND CO$Xia J.,Wen Y.,Xiao M.,Ye D.,Gao Y.,Tang D.,Zhang X.,Chen J.,Li Q.,Yao Y..Sequential severe immune related adverse events induced by PD 1 inhibitor: a case report and literature review..Frontiers in Oncology 2024;14:1391698.DOI:10.3389/fonc.2024.1391698$66$YR$E$M$Y$$$20240904$$HP$CN$CN
242833002$24283300$2$F$$20240904$20240904$20240905$30DAY$$US-ELI_LILLY_AND_COMPANY-US202409002257$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240905$$CN$US$US
242833011$24283301$1$I$$20240828$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160198$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242833021$24283302$1$I$$20240828$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160186$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242833032$24283303$2$F$20230101$20240903$20240904$20240906$EXP$$CN-BAUSCH-BL-2024-013176$BAUSCH AND LOMB$Yuan C, Zhang Z, Guo M, Zhang N. Recurrent multisystem Langerhans cell histiocytosis involving the female genitalia: A case report. World Journal of Clinical Cases. 2024;12(28):6222-6229. doi:10.12998/wjcc.v12.i28.6222$52$YR$$F$Y$$$20240906$$HP$CN$CN
242833041$24283304$1$I$20240801$20240827$20240904$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024723$UNITED THERAPEUTICS$$80$YR$$F$Y$$$20240904$$$US$US
242833051$24283305$1$I$$20240903$20240904$20240904$EXP$$US-AstraZeneca-2024A201134$ASTRAZENECA$$$$$M$Y$$$20240904$$CN$US$
242833061$24283306$1$I$20240824$20240827$20240904$20240904$EXP$$CA-LUNDBECK-DKLU4003616$LUNDBECK$$$$$$Y$$$20240904$$CN$CA$CA
242833071$24283307$1$I$20231223$20240828$20240904$20240904$PER$FR-AFSSAPS-NT2024001069$FR-Eisai-EC-2024-173030$EISAI$$63$YR$A$F$Y$47$KG$20240904$$HP$FR$FR
242833081$24283308$1$I$20240729$20240827$20240904$20240904$PER$$US-Eisai-EC-2024-173219$EISAI$$85$YR$E$M$Y$78.65$KG$20240904$$HP$US$US
242833091$24283309$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140729$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240904$$CN$US$US
242833101$24283310$1$I$$20240903$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140615$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240904$$CN$US$US
242833111$24283311$1$I$$20240830$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140099$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240904$$CN$US$US
242833121$24283312$1$I$$20240827$20240904$20240904$EXP$$JP-LUNDBECK-DKLU4003737$LUNDBECK$$$$$$Y$$$20240904$$PH$JP$JP
242833131$24283313$1$I$20230101$20240827$20240904$20240904$PER$$US-JNJFOC-20240876234$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240904$$CN$US$US
242833142$24283314$2$F$$20240919$20240904$20240924$EXP$$CA-LUNDBECK-DKLU4003678$LUNDBECK$$$$$$Y$$$20240924$$HP$CA$CA
242833151$24283315$1$I$$20240821$20240904$20240904$EXP$$PL-PFIZER INC-PV202400115311$PFIZER$Osmanska, M.. Pembrolizumab in first-line treatment in metastatic squamous-cell lung cancer with PD-L1 expession below 1%. ONKOLOGIA W PRAKTYCE KLINICZNEJ- EDUKACJA. 2024;10(Supl. C)::C6-C9$73$YR$$M$Y$$$20240904$$MD$PL$PL
242833171$24283317$1$I$$20240827$20240904$20240904$PER$$KR-Eisai-EC-2024-173312$EISAI$$$$$$Y$$$20240904$$MD$KR$KR
242833181$24283318$1$I$$20240904$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140650$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240904$$CN$US$US
242833191$24283319$1$I$$20240903$20240904$20240904$PER$$NVSC2024US177936$NOVARTIS$$$$$$Y$$$20240904$$CN$US$US
242833202$24283320$2$F$20240701$20240905$20240904$20240910$EXP$$SE-INCYTE CORPORATION-2024IN009255$INCYTE$$$$$$Y$$$20240910$$MD$SE$SE
242833211$24283321$1$I$20240815$20240828$20240904$20240904$EXP$$CN-INCYTE CORPORATION-2024IN009198$INCYTE$$$$$$Y$$$20240904$$HP$CN$CN
242833221$24283322$1$I$$20240827$20240904$20240904$EXP$$CN-AstraZeneca-2024A197486$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$CN$
242833231$24283323$1$I$$20240827$20240904$20240904$EXP$$VN-AstraZeneca-2024A199285$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$VN$
242833252$24283325$2$F$20210101$20240906$20240904$20240913$EXP$$FR-ABBVIE-5905500$ABBVIE$$22$YR$$F$Y$54$KG$20240913$$MD$FR$FR
242833261$24283326$1$I$20240822$20240828$20240904$20240904$EXP$$US-LUNDBECK-DKLU4003612$LUNDBECK$$$$$$Y$$$20240904$$CN$US$US
242833271$24283327$1$I$20220420$20240830$20240904$20240904$EXP$$JP-009507513-2409JPN000200J$MERCK$$5$DEC$$F$Y$$$20240904$$MD$JP$JP
242833292$24283329$2$F$20240903$20240905$20240904$20240906$EXP$$US-PFIZER INC-202400249842$PFIZER$$59$YR$$F$Y$$$20240906$$HP$US$US
242833301$24283330$1$I$20240827$20240828$20240904$20240904$EXP$$CA-LUNDBECK-DKLU4003738$LUNDBECK$$$$$$Y$$$20240904$$HP$CA$CA
242833311$24283331$1$I$$20240828$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160197$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242833321$24283332$1$I$20240731$20240829$20240904$20240904$PER$FR-AFSSAPS-RN2024000924$FR-Eisai-EC-2024-173190$EISAI$$36$YR$A$F$Y$50$KG$20240904$$MD$FR$FR
242833332$24283333$2$F$20240101$20240913$20240904$20240923$PER$$JP-Eisai-EC-2024-173292$EISAI$$68$YR$E$M$Y$$$20240923$$MD$JP$JP
242833341$24283334$1$I$$20240822$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140665$BRISTOL MYERS SQUIBB$Cowen EA, Barrios DM, Pulitzer MP, Moy AP, Dusza SW, Wolf SD, et al. Acute febrile neutrophilic dermatosis (sweet syndrome) in acute myeloid leukemia patients: a 28-year institutional experience. Acta Haematologic. 2024 Jul 01;147(4):457-64. doi:10.1159/000535399.$5$DEC$E$F$Y$$$20240904$$HP$US$US
242833351$24283335$1$I$$20240821$20240904$20240904$EXP$$US-HLS-202401029$HLS THERAPEUTICS$$21$YR$A$M$Y$$$20240904$$HP$US$US
242833361$24283336$1$I$$20240826$20240904$20240904$30DAY$$CL-PFIZER INC-202400249259$PFIZER$$$$$$Y$$$20240904$$CN$CL$CL
242833371$24283337$1$I$20240823$20240903$20240903$20240903$DIR$717020$$FDA-CTU$$66$YR$$F$N$60.3$KG$20240903$N$CN$US$
242833392$24283339$2$F$20240901$20240918$20240904$20240923$30DAY$$AR-PFIZER INC-202400249138$PFIZER$$2$YR$$M$Y$$$20240923$$HP$AR$AR
242833403$24283340$3$F$20240823$20240905$20240904$20240910$30DAY$$CR-PFIZER INC-PV202400111159$PFIZER$$16$YR$$M$Y$$$20240910$$HP$CR$CR
242833411$24283341$1$I$20240813$20240828$20240904$20240904$EXP$$US-LUNDBECK-DKLU4003613$LUNDBECK$$$$$$Y$$$20240904$$CN$US$US
242833421$24283342$1$I$20240624$20240903$20240903$20240903$DIR$717025$$FDA-CTU$$46$YR$$F$N$56.25$KG$20240903$N$CN$US$
242833431$24283343$1$I$$20240903$20240903$20240903$DIR$716951$$FDA-CTU$$$$$UNK$N$$$20240903$$CN$US$
242833441$24283344$1$I$20240805$20240827$20240904$20240904$EXP$$BR-AstraZeneca-2024A199159$ASTRAZENECA$$$$$F$Y$$$20240904$$CN$BR$
242833451$24283345$1$I$$20240821$20240904$20240904$EXP$$JP-PFIZER INC-2015236525$PFIZER$Nakahara, S.. A Case of Nasopharyngeal Cancer with Febrile Neutropenia Followed by Death during Adjuvant Chemotherapy. Journal of Otolaryngology of Japan. 2015;118 (6):763-769$55$YR$$M$Y$$$20240904$$MD$JP$JP
242833462$24283346$2$F$20210912$20240909$20240904$20240923$EXP$$JP-RECORDATI RARE DISEASE INC.-2024006590$RECORDATI$$$$$$Y$$$20240923$$MD$JP$JP
242833481$24283348$1$I$$20240828$20240904$20240904$EXP$$NZ-TAKEDA-2024TUS087873$TAKEDA$$$$$$Y$$$20240904$$PH$NZ$NZ
242833491$24283349$1$I$$20240903$20240904$20240904$PER$$US-HALEON-2195085$Haleon PLC$$$$$$Y$$$20240904$$CN$US$US
242833501$24283350$1$I$20240130$20240903$20240903$20240903$DIR$716975$$FDA-CTU$$62$YR$$UNK$N$51.3$KG$20240903$N$CN$US$
242833511$24283351$1$I$20240902$20240903$20240903$20240903$DIR$716970$$FDA-CTU$$48$YR$$F$N$89.8$KG$20240903$N$PH$US$
242833521$24283352$1$I$$20240830$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139394$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$78.47$KG$20240904$$CN$US$US
242833531$24283353$1$I$$20240826$20240904$20240904$PER$$US-SA-2024SA256222$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240904$$CN$US$US
242833541$24283354$1$I$20240812$20240903$20240904$20240904$EXP$$US-AstraZeneca-2024A200719$ASTRAZENECA$$30077$DY$$M$Y$$$20240904$$CN$US$
242833551$24283355$1$I$$20240830$20240904$20240904$EXP$$AU-AstraZeneca-2024A199771$ASTRAZENECA$$70$YR$$F$Y$$$20240904$$MD$AU$
242833562$24283356$2$F$$20240903$20240904$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014084$JAZZ$$$$$F$Y$$$20240906$$CN$US$US
242833572$24283357$2$F$20240115$20240916$20240904$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013953$JAZZ$$25$YR$$F$Y$34.014$KG$20240918$$HP$US$US
242833601$24283360$1$I$$20240827$20240904$20240904$EXP$$NVSC2024CA066090$NOVARTIS$$34$YR$$F$Y$$$20240904$$CN$CA$CA
242833621$24283362$1$I$$20240829$20240904$20240904$EXP$$US-ABBVIE-5902304$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242833632$24283363$2$F$$20240828$20240904$20240911$PER$$US-SA-2024SA256145$SANOFI AVENTIS$$$$$F$Y$$$20240911$$CN$US$US
242833641$24283364$1$I$$20240830$20240904$20240904$EXP$$US-ABBVIE-5903542$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242833651$24283365$1$I$$20240822$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140664$BRISTOL MYERS SQUIBB$Cowen EA, Barrios DM, Pulitzer MP, Moy AP, Dusza SW, Wolf SD, et al. Acute febrile neutrophilic dermatosis (sweet syndrome) in acute myeloid leukemia patients: a 28-year institutional experience. Acta Haematologic. 2024 Jul 01;147(4):457-64. doi:10.1159/000535399.$6$DEC$A$F$Y$$$20240904$$HP$US$US
242833662$24283366$2$F$$20240916$20240904$20240918$EXP$$US-SANDOZ INC.-SDZ2024US077543$SANDOZ$$$$$F$Y$$$20240918$$CN$US$US
242833681$24283368$1$I$$20240827$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138305$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240904$$CN$US$US
242833692$24283369$2$F$$20240903$20240904$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140943$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240906$$CN$US$US
242833702$24283370$2$F$$20240903$20240904$20240911$EXP$$MY-AstraZeneca-2024A196156$ASTRAZENECA$$41$YR$$F$Y$$$20240911$$MD$MY$
242833711$24283371$1$I$$20240826$20240904$20240904$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08086$HIKMA$Gullickson C, Kersun L, Reilly A, Seif A, Chehab L.. Gullickson C, Kersun L, Reilly A, Seif A, Chehab L. Isolated central nervous system relapse in two adolescents with primary mediastinal large B-cell lymphoma after treatment with R-DA-EPOCH.. Pediatric Blood Cancer.. 2024;71(8):e31065.:1-4 pgs$15$YR$$F$Y$$$20240904$$MD$US$US
242833721$24283372$1$I$20240823$20240827$20240904$20240904$EXP$$BR-TAKEDA-2024TUS088366$TAKEDA$$58$YR$$M$Y$87$KG$20240904$$MD$BR$BR
242833731$24283373$1$I$20240101$20240824$20240904$20240904$PER$$US-JNJFOC-20240865535$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$CN$US$US
242833741$24283374$1$I$20240904$20240904$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049590$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240904$$CN$US$US
242833751$24283375$1$I$20240819$20240827$20240904$20240904$EXP$$CN-AstraZeneca-2024A197238$ASTRAZENECA$$27495$DY$$F$Y$58$KG$20240904$$MD$CN$
242833761$24283376$1$I$20240101$20240822$20240904$20240904$PER$$US-INSUD PHARMA-2408US06667$INSUD PHARMA$$$$$$Y$$$20240904$$CN$US$US
242833772$24283377$2$F$20240801$20240909$20240904$20240925$PER$$US-INSUD PHARMA-2408US06669$INSUD PHARMA$$$$$$Y$$$20240925$$CN$US$US
242833781$24283378$1$I$20240825$20240827$20240904$20240904$EXP$$CA-GILEAD-2024-0686053$GILEAD$$66$YR$E$F$Y$$$20240904$$CN$CA$CA
242833791$24283379$1$I$20240101$20240826$20240904$20240904$EXP$$AU-ROCHE-10000066653$ROCHE$$70$YR$E$F$Y$$$20240904$$CN$AU$AU
242833801$24283380$1$I$20240522$20240903$20240904$20240904$EXP$$US-GILEAD-2024-0686191$GILEAD$$0$YR$I$F$Y$3.02$KG$20240904$$HP$US$US
242833811$24283381$1$I$$20240826$20240904$20240904$EXP$$US-BIOMARINAP-US-2024-160155$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242833821$24283382$1$I$20240829$20240830$20240904$20240904$EXP$$CA-TAKEDA-2023TUS108928$TAKEDA$$62$YR$$M$Y$$$20240904$$CN$CA$CA
242833831$24283383$1$I$20240821$20240827$20240904$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027001$UNITED THERAPEUTICS$$69$YR$$F$Y$49.887$KG$20240904$$$US$US
242833841$24283384$1$I$20240823$20240829$20240904$20240904$PER$$US-BIOMARINAP-US-2024-160205$BIOMARIN$$$$$$Y$$$20240904$$CN$US$US
242833851$24283385$1$I$$20240829$20240904$20240904$PER$$US-APELLIS-2024-APL-0000899$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240904$$HP$US$US
242833871$24283387$1$I$20240813$20240815$20240904$20240904$PER$$US-009507513-2408USA005616$MERCK$$$$$F$Y$$$20240904$$HP$US$US
242833881$24283388$1$I$20240724$20240902$20240904$20240904$EXP$DE-PEI-CADR2024330161$DE-009507513-2409DEU000844$MERCK$$55$YR$$M$Y$$$20240904$$MD$DE$DE
242833891$24283389$1$I$20240101$20240826$20240904$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026818$UNITED THERAPEUTICS$$$$$F$Y$61.224$KG$20240904$$$US$US
242833901$24283390$1$I$$20240829$20240904$20240904$PER$$US-009507513-2409USA000436$MERCK$$$$$F$Y$$$20240904$$HP$US$US
242833911$24283391$1$I$$20240903$20240904$20240904$30DAY$$US-ELI_LILLY_AND_COMPANY-US202409002244$ELI LILLY AND CO$$$$$F$Y$$$20240904$$CN$US$US
242833921$24283392$1$I$$20240823$20240904$20240904$PER$$US-JNJFOC-20240865519$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$CN$US$US
242833941$24283394$1$I$$20240903$20240904$20240904$EXP$$TW-GILEAD-2024-0686193$GILEAD$$57$YR$A$F$Y$$$20240904$$CN$TW$TW
242833961$24283396$1$I$$20240903$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140946$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240904$$CN$US$US
242833971$24283397$1$I$$20240903$20240904$20240904$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014094$JAZZ$$$$$F$Y$$$20240904$$CN$US$US
242833981$24283398$1$I$$20240829$20240904$20240904$PER$$US-ABBVIE-5901936$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242833991$24283399$1$I$$20240821$20240904$20240904$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08462$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240904$$HP$US$US
242834001$24283400$1$I$$20240821$20240904$20240904$EXP$$CA-Ascend Therapeutics US, LLC-2161205$ASCEND$$46$YR$$F$Y$$$20240904$$PH$CA$CA
242834011$24283401$1$I$20240803$20240830$20240904$20240904$EXP$$IN-ROCHE-10000049073$ROCHE$$90$YR$E$M$Y$$$20240904$$CN$IN$IN
242834021$24283402$1$I$$20240822$20240904$20240904$PER$$US-009507513-2408USA008629$MERCK$$78$YR$$F$Y$$$20240904$$HP$US$US
242834031$24283403$1$I$20240903$20240904$20240904$20240904$EXP$$CZ-GILEAD-2024-0686040$GILEAD$$$$$F$Y$$$20240904$$MD$CZ$CZ
242834041$24283404$1$I$20240101$20240821$20240904$20240904$PER$$US-009507513-2408USA008577$MERCK$$$$$$Y$$$20240904$$MD$US$US
242834051$24283405$1$I$20240510$20240830$20240904$20240904$EXP$FR-AFSSAPS-TS2024000944$FR-ROCHE-10000071292$ROCHE$$80$YR$E$F$Y$65$KG$20240904$$MD$FR$FR
242834061$24283406$1$I$$20240827$20240904$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-016696$UNITED THERAPEUTICS$$$$$F$Y$118.82$KG$20240904$$$US$US
242834071$24283407$1$I$$20240822$20240904$20240904$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08576$NEUROCRINE BIOSCIENCES$$6$DEC$$M$Y$$$20240904$$HP$US$US
242834081$24283408$1$I$$20240822$20240904$20240904$EXP$$US-HLS-202401058$HLS THERAPEUTICS$$$$A$$Y$$$20240904$$MD$US$US
242834091$24283409$1$I$$20240903$20240904$20240904$PER$$US-JNJFOC-20240904853$JOHNSON AND JOHNSON$$$$$F$Y$$$20240904$$HP$US$US
242834101$24283410$1$I$20240904$20240904$20240904$20240904$PER$$US-JNJFOC-20240908492$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240904$$CN$US$US
242834111$24283411$1$I$20240701$20240826$20240904$20240904$PER$$US-JNJFOC-20240868152$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240904$$CN$US$US
242834132$24283413$2$F$20240820$20240912$20240904$20240923$PER$$US-ROCHE-10000065398$ROCHE$$13$YR$T$M$Y$41.73$KG$20240923$$CN$US$US
242834141$24283414$1$I$$20240829$20240904$20240904$PER$$US-ROCHE-10000070480$ROCHE$$$$A$F$Y$$$20240904$$CN$US$US
242834151$24283415$1$I$$20240903$20240904$20240904$EXP$$JP-JNJFOC-20240906311$JOHNSON AND JOHNSON$$$$$$Y$$$20240904$$PH$JP$JP
242834171$24283417$1$I$$20240904$20240904$20240904$EXP$$US-GILEAD-2024-0686224$GILEAD$$$$$$Y$$$20240904$$CN$US$US
242834181$24283418$1$I$20240101$20240815$20240904$20240904$PER$$US-JNJFOC-20240846408$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20240904$$CN$US$US
242834192$24283419$2$F$$20240821$20240904$20240919$EXP$$CA-Ascend Therapeutics US, LLC-2161207$ASCEND$$56$YR$$F$Y$$$20240919$$$CA$CA
242834212$24283421$2$F$20240101$20240828$20240904$20240906$EXP$$US-RADIUS HEALTH INC.-2024US006624$RADIUS PHARM$$$$$F$Y$$$20240906$$CN$US$US
242834221$24283422$1$I$$20240904$20240904$20240904$EXP$$JP-JNJFOC-20240907196$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20240904$$PH$JP$JP
242834232$24283423$2$F$$20240909$20240904$20240911$PER$$US-JNJFOC-20240848103$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$HP$US$US
242834243$24283424$3$F$20240601$20240830$20240904$20240910$EXP$$MX-JNJFOC-20240908493$JOHNSON AND JOHNSON$$79$YR$E$M$Y$68$KG$20240911$$CN$MX$MX
242834251$24283425$1$I$$20240830$20240904$20240904$EXP$$MX-JNJFOC-20240907984$JOHNSON AND JOHNSON$$80$YR$E$M$Y$45$KG$20240904$$CN$MX$MX
242834262$24283426$2$F$20240801$20240912$20240904$20240919$EXP$$JP-009507513-2409JPN000181J$MERCK$$75$YR$$M$Y$$$20240919$$PH$JP$JP
242834271$24283427$1$I$20240426$20240902$20240904$20240904$EXP$FR-AFSSAPS-AN2024001181$FR-009507513-2409FRA000828$MERCK$$78$YR$$F$Y$55$KG$20240904$$MD$FR$FR
242834291$24283429$1$I$20231026$20240821$20240904$20240904$EXP$$GB-Ascend Therapeutics US, LLC-2161208$ASCEND$$60$YR$$F$Y$$$20240904$$$GB$GB
242834301$24283430$1$I$20240817$20240829$20240904$20240904$EXP$$CN-SANDOZ INC.-SDZ2024CN077372$SANDOZ$$65$YR$$F$Y$54$KG$20240904$$HP$CN$CN
242834311$24283431$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001946$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240904$$CN$US$US
242834321$24283432$1$I$$20230124$20240904$20240904$EXP$$CA-SANDOZ INC.-NVSC2023CA017042$SANDOZ$$$$$F$Y$$$20240904$$CN$CA$CA
242834331$24283433$1$I$20240812$20240821$20240904$20240904$EXP$$EU-RADIUS HEALTH INC.-2024ES006646$RADIUS PHARM$$71$YR$$F$Y$$$20240904$$CN$EU$ES
242834341$24283434$1$I$$20240902$20240904$20240904$EXP$$NVSJ2024JP010460$NOVARTIS$$$$A$M$Y$$$20240905$$MD$JP$JP
242834351$24283435$1$I$20141114$20240902$20240904$20240904$EXP$$FR-SANDOZ INC.-PHHY2015FR012809$SANDOZ$$$$$$Y$$$20240904$$MD$FR$FR
242834361$24283436$1$I$$20240904$20240904$20240904$PER$$NVSC2024US177988$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242834371$24283437$1$I$20240828$20240828$20240904$20240904$PER$$US-BIOGEN-2024BI01280657$BIOGEN$$30$YR$$F$Y$$$20240904$$CN$US$US
242834381$24283438$1$I$$20240827$20240904$20240904$PER$$US-BIOGEN-2024BI01278302$BIOGEN$$$$$F$Y$$$20240904$$CN$US$US
242834392$24283439$2$F$$20240913$20240904$20240923$PER$$US-BIOGEN-2024BI01280285$BIOGEN$$$$$M$Y$$$20240923$$CN$US$US
242834401$24283440$1$I$$20240904$20240904$20240904$PER$$NVSC2024US177989$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242834411$24283441$1$I$20240101$20240827$20240904$20240904$EXP$$US-BIOGEN-2024BI01280470$BIOGEN$$$$$M$Y$136.2$KG$20240904$$MD$US$US
242834421$24283442$1$I$$20240827$20240904$20240904$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139014$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240905$$PH$JP$JP
242834431$24283443$1$I$$20240904$20240904$20240904$PER$$NVSC2024US177986$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242834441$24283444$1$I$20240715$20240821$20240904$20240904$EXP$$US-RADIUS HEALTH INC.-2024US006644$RADIUS PHARM$$81$YR$$F$Y$$$20240904$$CN$US$US
242834451$24283445$1$I$$20240903$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049599$BOEHRINGER INGELHEIM$$$$$$Y$$$20240905$$CN$US$US
242834462$24283446$2$F$$20240925$20240904$20240926$PER$$NVSC2024US177987$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
242834471$24283447$1$I$$20240904$20240904$20240904$PER$$NVSC2024US177990$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242834491$24283449$1$I$20240622$20240829$20240904$20240904$EXP$$DE-BEIGENE-BGN-2024-010046$BEIGENE$$$$$$Y$$$20240904$$PH$DE$DE
242834501$24283450$1$I$$20240902$20240904$20240904$EXP$$BR-ORGANON-O2409BRA000192$ORGANON$$$$$F$Y$$$20240904$$HP$BR$BR
242834512$24283451$2$F$20240730$20240906$20240904$20240909$PER$$US-AMGEN-USASP2024169839$AMGEN$$45$YR$A$F$Y$$$20240909$$MD$US$US
242834531$24283453$1$I$$20240826$20240904$20240904$PER$$US-BAUSCHBL-2024BNL032409$BAUSCH AND LOMB$$$$$F$Y$$$20240905$$CN$US$US
242834541$24283454$1$I$$20240828$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137668$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240905$$CN$US$US
242834551$24283455$1$I$$20240903$20240904$20240904$PER$$US-AstraZeneca-2024A200474$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
242834562$24283456$2$F$$20240912$20240904$20240927$PER$$US-SMPA-2024SPA001104$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242834571$24283457$1$I$20240101$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001134$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834581$24283458$1$I$$20240807$20240904$20240904$PER$$US-SMPA-2024SPA001076$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834592$24283459$2$F$$20240910$20240904$20240927$PER$$US-SMPA-2024SPA001190$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242834601$24283460$1$I$$20240807$20240904$20240904$PER$$US-SMPA-2024SPA001088$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834611$24283461$1$I$20240425$20240807$20240904$20240904$PER$$US-SMPA-2024SPA001099$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834621$24283462$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001116$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834631$24283463$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001119$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834651$24283465$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001115$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834661$24283466$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024MYSCI0700441$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834671$24283467$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001141$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834681$24283468$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001165$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834701$24283470$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001216$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834711$24283471$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001202$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834721$24283472$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001170$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834731$24283473$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001185$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834741$24283474$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001151$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834753$24283475$3$F$$20240911$20240904$20240925$EXP$$US-SMPA-2024SPA001174$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242834761$24283476$1$I$20240801$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001166$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834772$24283477$2$F$$20240819$20240904$20240913$PER$$US-SMPA-2024SPA001286$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
242834781$24283478$1$I$20240801$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001189$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834792$24283479$2$F$$20240808$20240904$20240925$PER$$US-SMPA-2024SPA001128$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242834801$24283480$1$I$$20240807$20240904$20240904$PER$$US-SMPA-2024SPA002003$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834821$24283482$1$I$20240807$20240807$20240904$20240904$PER$$US-SMPA-2024SPA001109$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834833$24283483$3$F$$20240910$20240904$20240930$PER$$US-SMPA-2024SPA001114$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242834841$24283484$1$I$$20240806$20240904$20240904$PER$$US-SMPA-2024SPA000990$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834851$24283485$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001218$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834861$24283486$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001143$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834872$24283487$2$F$$20240906$20240904$20240927$PER$$US-SMPA-2024SPA001140$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242834881$24283488$1$I$20240801$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001260$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834892$24283489$2$F$20240808$20240909$20240904$20240925$PER$$US-SMPA-2024SPA001276$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242834901$24283490$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001167$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834911$24283491$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001102$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834921$24283492$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001214$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834932$24283493$2$F$$20240909$20240904$20240925$PER$$US-SMPA-2024SPA001135$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242834941$24283494$1$I$$20240807$20240904$20240904$PER$$US-SMPA-2024SPA001089$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834951$24283495$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001215$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834981$24283498$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001193$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242834992$24283499$2$F$$20240830$20240904$20240923$PER$$US-SMPA-2024SPA001150$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242835001$24283500$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001155$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835011$24283501$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001149$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835021$24283502$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001112$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835031$24283503$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001132$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835041$24283504$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001213$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835051$24283505$1$I$20240801$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001162$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835061$24283506$1$I$$20240807$20240904$20240904$PER$$US-SMPA-2024SPA001096$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835071$24283507$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001158$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835081$24283508$1$I$$20240811$20240904$20240904$PER$$US-SMPA-2024SPA001250$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835091$24283509$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001171$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835101$24283510$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001153$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835113$24283511$3$F$$20240919$20240904$20240927$PER$$US-SMPA-2024SPA001237$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242835122$24283512$2$F$$20240823$20240904$20240919$PER$$US-SMPA-2024SPA001281$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
242835131$24283513$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001205$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835141$24283514$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001147$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835151$24283515$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2023MYSCI0500413$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835161$24283516$1$I$$20240810$20240904$20240904$PER$$US-SMPA-2024SPA001238$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835171$24283517$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001105$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835181$24283518$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001198$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835201$24283520$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001257$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835212$24283521$2$F$$20240904$20240904$20240924$PER$$US-SMPA-2024SPA002203$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242835221$24283522$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001139$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835231$24283523$1$I$$20240807$20240904$20240904$PER$$US-SMPA-2024SPA001086$SUNOVION$$$$$$Y$$$20240904$$$US$US
242835241$24283524$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001262$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835252$24283525$2$F$$20240912$20240904$20240927$PER$$US-SMPA-2024SPA001234$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242835261$24283526$1$I$20240801$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001136$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835271$24283527$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001204$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835281$24283528$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001130$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835291$24283529$1$I$$20240807$20240904$20240904$PER$$US-SMPA-2024SPA001087$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835301$24283530$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001225$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835312$24283531$2$F$$20240917$20240904$20240925$PER$$US-SMPA-2024SPA001195$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242835321$24283532$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001184$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835333$24283533$3$F$$20240912$20240904$20240926$EXP$$US-SMPA-2024SPA001101$SUNOVION$$$$$$Y$$$20240926$$CN$US$US
242835351$24283535$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001161$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835362$24283536$2$F$$20240906$20240904$20240925$PER$$US-SMPA-2024SPA001095$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242835371$24283537$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001169$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835381$24283538$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001110$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835391$24283539$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001217$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835401$24283540$1$I$$20240807$20240904$20240904$PER$$US-SMPA-2024SPA001097$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835411$24283541$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001310$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835421$24283542$1$I$$20240805$20240904$20240904$PER$$US-SMPA-2024SPA002201$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835431$24283543$1$I$$20240808$20240904$20240904$PER$$US-SMPA-2024SPA001103$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835442$24283544$2$F$$20240826$20240904$20240919$PER$$US-SMPA-2024SPA001223$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
242835451$24283545$1$I$$20240809$20240904$20240904$PER$$US-SMPA-2024SPA001201$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242835461$24283546$1$I$20220101$20240823$20240904$20240904$EXP$CN-MLMSERVICE-20240819-PI163732-00285-1$CN-ABBVIE-5905267$ABBVIE$Li S, Li Z, Wu Q, Luo X, Shen Y. Psychiatric assessment and therapy in an adolescent with ALG6-CDG: a six-month follow-up case report. Eur Child Adolesc Psychiatry. 2024.$$$$$Y$$$20240904$$MD$CN$CN
242835471$24283547$1$I$20240801$20240826$20240904$20240904$PER$$US-BAUSCHBL-2024BNL032367$BAUSCH AND LOMB$$75$YR$$M$Y$$$20240905$$CN$US$US
242835491$24283549$1$I$20240808$20240823$20240904$20240904$EXP$$US-RADIUS HEALTH, INC.-2024US005551$RADIUS PHARM$$83$YR$$F$Y$$$20240904$$CN$US$US
242835502$24283550$2$F$20240827$20240926$20240904$20240926$EXP$$NVSJ2024JP010511$NOVARTIS$$75$YR$$M$Y$$$20240927$$MD$JP$JP
242835511$24283551$1$I$$20240829$20240904$20240904$EXP$$NVSC2024IL176171$NOVARTIS$$77$YR$$F$Y$$$20240905$$PH$IL$IL
242835521$24283552$1$I$$20240830$20240904$20240904$EXP$$US-ABBVIE-5903523$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242835533$24283553$3$F$20240807$20240911$20240904$20240918$EXP$$IT-ABBVIE-5905254$ABBVIE$$$$$M$Y$$$20240918$$MD$IT$IT
242835541$24283554$1$I$20240101$20240830$20240904$20240904$EXP$$US-ABBVIE-5904939$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242835551$24283555$1$I$20240829$20240904$20240904$20240904$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049587$BOEHRINGER INGELHEIM$$98$YR$E$M$Y$$$20240905$$CN$US$US
242835561$24283556$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001939$ELI LILLY AND CO$$104$YR$E$M$Y$$$20240904$$CN$US$US
242835571$24283557$1$I$20240101$20240904$20240904$20240904$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049621$BOEHRINGER INGELHEIM$$39$YR$A$F$Y$$$20240905$$CN$US$US
242835581$24283558$1$I$$20240816$20240904$20240904$PER$$US-TEVA-VS-3234499$TEVA$$$$$F$Y$$$20240904$$PH$US$US
242835601$24283560$1$I$20240821$20240903$20240904$20240904$EXP$$US-TAKEDA-2024TUS088386$TAKEDA$$$$$M$Y$$$20240904$$CN$US$US
242835611$24283561$1$I$20240315$20240830$20240904$20240904$EXP$DE-CADRBFARM-2024330103$DE-ABBVIE-5905214$ABBVIE$$75$YR$$M$Y$81$KG$20240904$$MD$DE$DE
242835621$24283562$1$I$20240819$20240826$20240904$20240904$EXP$$JP-RADIUS HEALTH INC.-2024JP006484$RADIUS PHARM$$66$YR$$F$Y$$$20240904$$MD$JP$JP
242835642$24283564$2$F$$20240903$20240904$20240911$PER$$US-AMGEN-USASP2024174772$AMGEN$$71$YR$E$M$Y$$$20240910$$CN$US$US
242835651$24283565$1$I$$20240904$20240904$20240904$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049470$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240905$$CN$IT$IT
242835661$24283566$1$I$$20240814$20240904$20240904$PER$$US-009507513-2408USA004993$MERCK$$$$$F$Y$67.1$KG$20240904$$CN$US$US
242835671$24283567$1$I$$20240830$20240904$20240904$EXP$$US-ORGANON-O2409USA000005$ORGANON$$$$A$M$Y$$$20240904$$CN$US$US
242835681$24283568$1$I$20240901$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001269$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240904$$CN$US$US
242835691$24283569$1$I$$20240829$20240904$20240904$EXP$$US-BEIGENE-BGN-2024-013793$BEIGENE$$$$$$Y$$$20240904$$CN$US$US
242835701$24283570$1$I$$20240831$20240904$20240904$PER$$US-ABBVIE-5904128$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242835711$24283571$1$I$20240708$20240830$20240904$20240904$EXP$$CA-ORGANON-O2409CAN000162$ORGANON$$9$YR$$M$Y$$$20240904$$CN$CA$CA
242835741$24283574$1$I$$20240902$20240904$20240904$PER$$US-ABBVIE-5906688$ABBVIE$$$$$$Y$$$20240904$$MD$US$US
242835761$24283576$1$I$$20240829$20240904$20240904$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001774$BLUEPRINT MEDICINES$$$$$F$Y$$$20240905$$CN$US$US
242835771$24283577$1$I$$20240828$20240904$20240904$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001772$BLUEPRINT MEDICINES$$$$$F$Y$$$20240905$$CN$US$US
242835781$24283578$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001498$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240904$$CN$US$US
242835792$24283579$2$F$20240826$20240828$20240904$20240906$30DAY$$GR-SANDOZ INC.-SDZ2024GR076537$SANDOZ$$10$YR$$M$Y$$$20240906$$CN$GR$GR
242835801$24283580$1$I$$20240904$20240904$20240904$EXP$FR-CHEPLA-2024010573$FR-SANDOZ INC.-SDZ2024FR077617$SANDOZ$$32$YR$$M$Y$$$20240904$$MD$FR$FR
242835812$24283581$2$F$20240901$20240904$20240904$20240909$PER$$US-ABBVIE-5905597$ABBVIE$$63$YR$$F$Y$45$KG$20240909$$CN$US$US
242835821$24283582$1$I$$20240829$20240904$20240904$EXP$$NVSC2024CA176569$NOVARTIS$$66$YR$$F$Y$$$20240905$$CN$CA$CA
242835842$24283584$2$F$$20240903$20240904$20240909$EXP$$JP-JNJFOC-20240905442$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240909$$MD$JP$JP
242835851$24283585$1$I$$20240827$20240904$20240904$EXP$$BR-JNJFOC-20240882700$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$BR$BR
242835861$24283586$1$I$20201101$20240828$20240904$20240904$EXP$$RU-ABBVIE-5901229$ABBVIE$$69$YR$$F$Y$$$20240904$$CN$RU$RU
242835871$24283587$1$I$$20240831$20240904$20240904$EXP$$VN-AstraZeneca-2024A199140$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$VN$
242835881$24283588$1$I$$20240830$20240904$20240904$EXP$$GB-AstraZeneca-2024A198510$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$GB$
242835891$24283589$1$I$20240101$20240829$20240904$20240904$PER$$US-ABBVIE-5903355$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242835901$24283590$1$I$$20240824$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135393$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$92.53$KG$20240905$$CN$US$US
242835911$24283591$1$I$20240825$20240827$20240904$20240904$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137340$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240905$$HP$US$US
242835932$24283593$2$F$$20240826$20240904$20240912$EXP$$AR-ABBVIE-5906433$ABBVIE$$47$YR$$M$Y$$$20240912$$CN$AR$AR
242835941$24283594$1$I$$20240830$20240904$20240904$EXP$$IN-JNJFOC-20240867838$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$MD$IN$IN
242835951$24283595$1$I$20240828$20240902$20240904$20240904$EXP$$JP-TAKEDA-2024TJP012951$TAKEDA$$5$DEC$$M$Y$$$20240904$$MD$JP$JP
242835961$24283596$1$I$$20240816$20240904$20240904$PER$$US-TEVA-VS-3234551$TEVA$$63$YR$$F$Y$74.84$KG$20240904$$CN$US$US
242835981$24283598$1$I$$20240903$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140881$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240905$$HP$US$US
242835991$24283599$1$I$20240903$20240903$20240904$20240904$EXP$$GR-ABBVIE-5906434$ABBVIE$$84$YR$$F$Y$$$20240904$$CN$GR$GR
242836003$24283600$3$F$$20240923$20240904$20240930$EXP$$DE-009507513-2408DEU010243$MERCK$Br?ckl W.. Sustained response to ramucirumab + docetaxel after early first-line progression. Journal Onkologie. 2024;76-77$62$YR$$F$Y$$$20240930$$MD$DE$DE
242836011$24283601$1$I$20240719$20240830$20240904$20240904$EXP$GB-MHRA-MED-202408301419220610-WDVFZ$GB-AMGEN-GBRSP2024175645$AMGEN$$63$YR$A$M$Y$$$20240904$$MD$GB$GB
242836021$24283602$1$I$20240101$20240829$20240904$20240904$EXP$$CA-ABBVIE-5904504$ABBVIE$$$$A$F$Y$$$20240904$$MD$CA$CA
242836031$24283603$1$I$$20240826$20240904$20240904$PER$$US-JNJFOC-20240866009$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242836041$24283604$1$I$$20240829$20240904$20240904$EXP$$US-ABBVIE-5901867$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242836051$24283605$1$I$20240830$20240830$20240904$20240904$PER$$US-JNJFOC-20240901030$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$MD$US$US
242836061$24283606$1$I$20240723$20240829$20240904$20240904$EXP$$CN-ABBVIE-5900471$ABBVIE$$44$YR$$F$Y$66$KG$20240904$$MD$CN$CN
242836071$24283607$1$I$$20240902$20240904$20240904$EXP$$GR-ABBVIE-5905232$ABBVIE$$$$$M$Y$$$20240904$$CN$GR$GR
242836081$24283608$1$I$$20240830$20240904$20240904$EXP$$US-ABBVIE-5903466$ABBVIE$$$$$F$Y$$$20240904$$CN$US$US
242836091$24283609$1$I$20240601$20240902$20240904$20240904$EXP$$US-ABBVIE-5904962$ABBVIE$$91$YR$$M$Y$$$20240904$$CN$US$US
242836101$24283610$1$I$20240301$20240831$20240904$20240904$EXP$$GR-ABBVIE-5739740$ABBVIE$$58$YR$$M$Y$$$20240904$$HP$GR$GR
242836111$24283611$1$I$$20240903$20240904$20240904$EXP$$JP-ABBVIE-5906547$ABBVIE$$$$$$Y$$$20240904$$MD$JP$JP
242836121$24283612$1$I$$20240831$20240904$20240904$EXP$$US-ABBVIE-5904629$ABBVIE$$$$$M$Y$$$20240904$$HP$US$US
242836141$24283614$1$I$20240101$20240902$20240904$20240904$EXP$$US-ABBVIE-5905799$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242836151$24283615$1$I$$20240828$20240904$20240904$PER$$US-Blueprint Medicines Corporation-LT-US-2024-001767$BLUEPRINT MEDICINES$$55$YR$A$M$Y$$$20240905$$MD$US$US
242836161$24283616$1$I$$20240822$20240904$20240904$PER$$US-SMPA-2024SPA001824$SUNOVION$$$$$$Y$$$20240904$$CN$US$US
242836171$24283617$1$I$$20240830$20240904$20240904$EXP$$JP-GSK-JP2024108993$GLAXOSMITHKLINE$$$$$$Y$$$20240904$$MD$JP$JP
242836181$24283618$1$I$$20240829$20240904$20240904$PER$$US-AMGEN-USASP2024172991$AMGEN$$$$$M$Y$$$20240904$$CN$US$US
242836191$24283619$1$I$20240812$20240903$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140858$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240905$$CN$US$US
242836201$24283620$1$I$20240809$20240822$20240904$20240904$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161211$JIANGSU HANSOH PHARMACEUTICAL$$37$YR$$M$Y$83$KG$20240904$$MD$CN$CN
242836221$24283622$1$I$$20240828$20240904$20240904$EXP$$RS-JNJFOC-20240880284$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240905$$MD$RS$RS
242836231$24283623$1$I$$20240830$20240904$20240904$EXP$NL-LRB-00993315$NL-ABBVIE-5906472$ABBVIE$$33$YR$$F$Y$$$20240904$$CN$NL$NL
242836241$24283624$1$I$20240822$20240823$20240904$20240904$PER$$US-AMGEN-USASP2024175256$AMGEN$$$$$$Y$$$20240904$$HP$US$US
242836261$24283626$1$I$20240801$20240827$20240904$20240904$EXP$$US-SANDOZ INC.-SDZ2024US077817$SANDOZ$$$$$F$Y$$$20240904$$CN$US$US
242836271$24283627$1$I$20240817$20240826$20240904$20240904$EXP$$CN-BEIGENE-BGN-2024-013468$BEIGENE$$$$$$Y$$$20240904$$HP$CN$CN
242836281$24283628$1$I$20240815$20240822$20240904$20240904$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161212$JIANGSU HANSOH PHARMACEUTICAL$$65$YR$$F$Y$53$KG$20240904$$MD$CN$CN
242836291$24283629$1$I$20210101$20240827$20240904$20240904$PER$$US-ABBVIE-5905497$ABBVIE$$$$$M$Y$77$KG$20240904$$MD$US$US
242836301$24283630$1$I$20231104$20231109$20240904$20240904$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202311-001416$UNICHEM$$$$$M$Y$$$20240905$$PH$US$
242836312$24283631$2$F$$20240919$20240904$20240930$EXP$$JP-AMGEN-JPNSP2024175542$AMGEN$Kawasaki T, Oto H, Itou E, Fukuda N, Nagaoka M.. ORIGINAL PAPER A Case of Masticatory Muscle Interstitial Abscess Secondary to Medication-related Osteonecrosis of the Jaw. . ;144-8. OTO-RHINO-LARYNGOLOGY. 2024;67::144-8$80$YR$E$F$Y$$$20240930$$MD$JP$JP
242836321$24283632$1$I$$20240827$20240904$20240904$EXP$$GB-NOVITIUMPHARMA-2024GBNVP01755$NOVITIUM PHARMA$Aye Chan Maung.Severe bradycardia at acute medical take - Think about myxoedema coma.The Journal of the Royal College of Physicians of Edinburgh.10-APR-2024;54(2):133-137$97$YR$E$M$Y$$$20240905$$HP$GB$GB
242836332$24283633$2$F$20220101$20240905$20240904$20240910$EXP$$US-ABBVIE-5905782$ABBVIE$$$$$M$Y$83$KG$20240910$$CN$US$US
242836341$24283634$1$I$20240801$20240828$20240904$20240904$PER$$US-009507513-2408USA010685$MERCK$$$$$F$Y$$$20240904$$CN$US$US
242836351$24283635$1$I$20240901$20240903$20240904$20240904$EXP$$US-ABBVIE-5906277$ABBVIE$$90$YR$$F$Y$$$20240904$$CN$US$US
242836361$24283636$1$I$20240825$20240826$20240904$20240904$EXP$$BR-NALPROPION PHARMACEUTICALS INC.-BR-2024CUR004076$CURRAX PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$BR$BR
242836371$24283637$1$I$20240101$20240903$20240904$20240904$EXP$$US-ABBVIE-5906337$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242836381$24283638$1$I$20240828$20240828$20240904$20240904$EXP$$DE-ABBVIE-5906650$ABBVIE$$$$$$Y$$$20240904$$MD$DE$DE
242836391$24283639$1$I$$20240826$20240904$20240904$PER$$US-ABBVIE-5897789$ABBVIE$$$$$$Y$$$20240904$$HP$US$US
242836401$24283640$1$I$$20240826$20240904$20240904$EXP$$CN-JNJFOC-20240871615$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$HP$CN$CN
242836411$24283641$1$I$$20240828$20240904$20240904$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011110$STRIDES$Barrison L, Park S, Decherney A.. Spontaneous conception in a 40-year-old woman after allogeneic stem cell transplant with active graft-versus-host disease: A case report.. Case-Rep-Women-Health. 2024;43:1-3$$$$$Y$$$20240905$$HP$US$US
242836421$24283642$1$I$$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001360$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240904$$CN$US$US
242836431$24283643$1$I$$20240903$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140860$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240905$$CN$US$US
242836442$24283644$2$F$20240101$20240919$20240904$20240925$EXP$$JP-EMD Serono-2024046475$EMD SERONO INC$$8$DEC$E$M$Y$$$20240925$$MD$JP$JP
242836451$24283645$1$I$20220901$20240829$20240904$20240904$PER$$US-ALXN-A202211231$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240905$$CN$US$US
242836461$24283646$1$I$$20240829$20240904$20240904$PER$$US-JNJFOC-20240880432$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$HP$US$US
242836471$24283647$1$I$$20240903$20240904$20240904$EXP$$US-TAKEDA-2024TUS052146$TAKEDA$$$$$M$Y$$$20240904$$PH$US$US
242836481$24283648$1$I$$20240828$20240904$20240904$EXP$$US-NOVITIUMPHARMA-2024USNVP01762$NOVITIUM PHARMA$Heather Jones.An Unusual Presentation of Metastatic BK Virus-Associated Urothelial Carcinoma Arising in the Allograft, Persisting After Transplant Nephrectomy.International Journal of Surgical Pathology.03-APR-2023;31(8):1586-1592$32$YR$A$M$Y$$$20240905$$HP$US$US
242836491$24283649$1$I$20240101$20240827$20240904$20240904$PER$$US-ALKERMES INC.-ALK-2024-002178$ALKERMES$$37$YR$$F$Y$$$20240905$$HP$US$US
242836501$24283650$1$I$20240101$20240820$20240904$20240904$EXP$$BE-AMGEN-BELSP2024175754$AMGEN$$$$$F$Y$$$20240904$$CN$BE$BE
242836512$24283651$2$F$20240101$20240904$20240904$20240924$EXP$$US-SA-2024SA256347$SANOFI AVENTIS$$56$YR$A$M$Y$80.91$KG$20240924$$MD$US$US
242836521$24283652$1$I$20230401$20240830$20240904$20240904$EXP$$CA-TAKEDA-2023TUS039233$TAKEDA$$72$YR$$M$Y$$$20240904$$CN$CA$CA
242836541$24283654$1$I$20240101$20240827$20240904$20240904$EXP$$AU-CURRAX PHARMACEUTICALS LLC-AU-2024CUR004059$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240905$$MD$AU$AU
242836561$24283656$1$I$$20240903$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140851$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240905$$CN$US$US
242836571$24283657$1$I$$20240828$20240904$20240904$PER$$US-ABBVIE-5901179$ABBVIE$$$$$$Y$$$20240904$$CN$US$US
242836581$24283658$1$I$$20240826$20240904$20240904$PER$$US-ABBVIE-5897809$ABBVIE$$60$YR$$F$Y$$$20240904$$MD$US$US
242836591$24283659$1$I$20240101$20240829$20240904$20240904$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027348$UNITED THERAPEUTICS$$$$$F$Y$82.54$KG$20240904$$$US$US
242836602$24283660$2$F$20231201$20240826$20240904$20240915$EXP$$JP-009507513-2408JPN003387J$MERCK$Hayashi K. 2-(1) What I think about Lynch syndrome as a patient, remembering each experience. Lynch Syndrome Day 2024 Civil Public Forum. 36-7$69$YR$$M$Y$$$20240915$$CN$JP$JP
242836621$24283662$1$I$$20240903$20240904$20240904$EXP$$CN-TAKEDA-2024TUS088385$TAKEDA$$$$$F$Y$$$20240904$$CN$CN$CN
242836631$24283663$1$I$20240801$20240903$20240904$20240904$PER$$US-ELI_LILLY_AND_COMPANY-US202409001704$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240904$$HP$US$US
242836641$24283664$1$I$20240101$20240828$20240904$20240904$EXP$$MX-JNJFOC-20240882747$JOHNSON AND JOHNSON$$27$YR$A$M$Y$87$KG$20240905$$CN$MX$MX
242836651$24283665$1$I$$20240828$20240904$20240904$EXP$$US-NOVITIUMPHARMA-2024USNVP01763$NOVITIUM PHARMA$Isabella N. Dana.Mucocutaneous ulcers in an immunocompromised patient.JAAD Case Reports.04-JUL-2024;51:48-50$49$YR$A$F$Y$$$20240905$$HP$US$US
242836672$24283667$2$F$20240829$20240829$20240904$20240918$30DAY$$US-JNJFOC-20240878820$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240918$$PH$US$US
242836681$24283668$1$I$20240101$20240830$20240904$20240904$EXP$$US-ABBVIE-5904824$ABBVIE$$$$$M$Y$$$20240904$$CN$US$US
242836691$24283669$1$I$$20240903$20240904$20240904$EXP$$CA-ABBVIE-5905972$ABBVIE$$$$E$F$Y$$$20240904$$CN$CA$CA
242836701$24283670$1$I$20240831$20240902$20240904$20240904$30DAY$$IT-SANDOZ INC.-SDZ2024IT077401$SANDOZ$$66$YR$$M$Y$77$KG$20240904$$CN$IT$IT
242836712$24283671$2$F$20240101$20240909$20240904$20240913$EXP$$PR-ABBVIE-5902487$ABBVIE$$$$$M$Y$126.55$KG$20240913$$CN$PR$PR
242836721$24283672$1$I$$20240903$20240904$20240904$EXP$$CA-ABBVIE-5905939$ABBVIE$$$$A$M$Y$$$20240904$$CN$CA$CA
242836731$24283673$1$I$20240831$20240904$20240904$20240904$EXP$$IT-ABBVIE-5906407$ABBVIE$$80$YR$$F$Y$$$20240904$$CN$IT$IT
242836741$24283674$1$I$$20240830$20240904$20240904$PER$$US-AMGEN-USASP2024174606$AMGEN$$$$A$F$Y$$$20240904$$MD$US$US
242836751$24283675$1$I$20240801$20240826$20240904$20240904$EXP$$CO-ABBVIE-5904778$ABBVIE$$66$YR$$F$Y$93$KG$20240904$$HP$CO$CO
242836761$24283676$1$I$$20240903$20240904$20240904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140939$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240905$$CN$US$US
242836771$24283677$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178075$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242836781$24283678$1$I$20240822$20240823$20240904$20240904$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000252$DENDREON$$$$$$Y$$$20240904$$HP$US$US
242836801$24283680$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140892$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240905$$CN$US$US
242836811$24283681$1$I$$20240822$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135257$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240905$$HP$US$US
242836821$24283682$1$I$$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139174$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$82.1$KG$20240905$$CN$US$US
242836831$24283683$1$I$$20240830$20240905$20240905$PER$$US-ROCHE-10000070742$ROCHE$$$$$F$Y$$$20240905$$CN$US$US
242836841$24283684$1$I$$20240830$20240905$20240905$PER$$US-ROCHE-10000071851$ROCHE$$83$YR$E$F$Y$$$20240905$$CN$US$US
242836851$24283685$1$I$$20240828$20240905$20240905$EXP$$US-Encube-001310$ENCUBE ETHICALS$Bottenberg MM, Hegge KA, Eastman DK, Kumar R. Metronidazole-induced encephalopathy: a case report and review of the literature. J Clin Pharmacol. 2011 Jan;51(1):112-6. doi: 10.1177/0091270010362905.$55$YR$A$M$Y$$$20240903$$HP$US$
242836861$24283686$1$I$$20240902$20240905$20240905$PER$$US-ROCHE-10000072869$ROCHE$$80$YR$E$F$Y$$$20240905$$CN$US$US
242836872$24283687$2$F$20240501$20240903$20240905$20240911$EXP$$JP-ARDELYX-2024ARDX006658$ARDELYX$$66$YR$$M$Y$$$20240911$$MD$JP$JP
242836881$24283688$1$I$$20240902$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001257$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240904$$CN$US$US
242836891$24283689$1$I$$20240826$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408016861$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240904$$CN$US$US
242836902$24283690$2$F$20240831$20240904$20240905$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001902$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240906$$CN$US$US
242836911$24283691$1$I$$20240902$20240905$20240905$PER$$US-ROCHE-10000072739$ROCHE$Mundluru J, Ingawale S, Dhanjal K, Torka P, Dhanjal S. BTK Inhibitors: A Double-Edged Sword in Richter^s Transformation to Plasmablastic Lymphoma? Case Report (Abstract number: CLL-578). Clinical Lymphoma, Myeloma + Leukemia. 2024-Sep;24:S360. doi:10.1016/S2152-2650(24)01291-6.$57$YR$A$M$Y$$$20240905$$MD$US$US
242836921$24283692$1$I$$20240902$20240905$20240905$PER$$US-ROCHE-10000072611$ROCHE$$$$E$M$Y$$$20240905$$CN$US$US
242836931$24283693$1$I$$20240823$20240905$20240905$EXP$$DE-ESPERIONTHERAPEUTICS-2024DEU01363$ESPERION THERAPEUTICS$$$$$M$Y$$$20240905$$PH$DE$DE
242836951$24283695$1$I$$20240827$20240905$20240905$EXP$$US-NOVITIUMPHARMA-2024USNVP01752$NOVITIUM PHARMA$Michael K. Mansour.Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes.The New England Journal of Medicine.08-MAR-2023;388(10):926-937$70$YR$E$M$Y$$$20240905$$HP$US$US
242836961$24283696$1$I$20240101$20240828$20240905$20240905$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000305$EMCURE$$$$$$Y$$$20240905$$CN$US$US
242836971$24283697$1$I$$20240830$20240905$20240905$EXP$$US-ESPERIONTHERAPEUTICS-2024USA01366$ESPERION THERAPEUTICS$$$$$M$Y$$$20240905$$CN$US$US
242836981$24283698$1$I$$20240827$20240905$20240905$EXP$$US-SA-2024SA242673$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240905$$MD$US$US
242836991$24283699$1$I$20240729$20240903$20240905$20240905$EXP$LU-ALMPS-202404298$LU-BRISTOL-MYERS SQUIBB COMPANY-2024-140288$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$77$KG$20240905$$PH$LU$LU
242837001$24283700$1$I$$20240829$20240905$20240905$EXP$$CA-TAKEDA-CA201918072$TAKEDA$$$$$$Y$$$20240905$$CN$CA$CA
242837011$24283701$1$I$$20240903$20240905$20240905$PER$$US-HALEON-2195033$Haleon PLC$$65$YR$$F$Y$$$20240905$$CN$US$US
242837021$24283702$1$I$20240812$20240815$20240905$20240905$EXP$$US-ASTELLAS-2024-AER-001354$ASTELLAS$$$$E$F$Y$$$20240905$$CN$US$US
242837041$24283704$1$I$$20240825$20240905$20240905$EXP$$CN-JNJFOC-20240869214$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240905$$MD$CN$CN
242837051$24283705$1$I$20240201$20240902$20240905$20240905$EXP$$DE-ESPERIONTHERAPEUTICS-2024DEU01250$ESPERION THERAPEUTICS$$72$YR$$F$Y$59.5$KG$20240905$$MD$DE$DE
242837061$24283706$1$I$$20240903$20240905$20240905$EXP$$US-TAKEDA-2024TUS084884$TAKEDA$$$$$F$Y$$$20240905$$CN$US$US
242837071$24283707$1$I$$20240826$20240905$20240905$EXP$$CA-TAKEDA-2024TUS055888$TAKEDA$$$$$F$Y$$$20240905$$PH$CA$CA
242837081$24283708$1$I$$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140945$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240905$$CN$US$US
242837091$24283709$1$I$20240828$20240829$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138840$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240905$$HP$US$US
242837101$24283710$1$I$$20240830$20240905$20240905$EXP$$US-TAKEDA-2024TUS088288$TAKEDA$$$$$F$Y$$$20240905$$CN$US$US
242837111$24283711$1$I$20240814$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176469$AMGEN$$60$YR$A$F$Y$$$20240904$$CN$US$US
242837121$24283712$1$I$$20240830$20240905$20240905$EXP$$US-GSK-US2024AMR109293$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$US$US
242837131$24283713$1$I$$20240829$20240905$20240905$EXP$$US-JNJFOC-20240878302$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$HP$US$US
242837141$24283714$1$I$$20240830$20240905$20240905$EXP$$JP-ABBVIE-5905265$ABBVIE$$$$E$M$Y$$$20240905$$MD$JP$JP
242837161$24283716$1$I$$20240903$20240905$20240905$PER$$US-AstraZeneca-2024A200348$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242837171$24283717$1$I$$20240830$20240905$20240905$PER$$US-AstraZeneca-2024A198942$ASTRAZENECA$$$$$F$Y$$$20240905$$MD$US$
242837181$24283718$1$I$$20240827$20240905$20240905$PER$$US-ABBVIE-5897878$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242837191$24283719$1$I$$20240805$20240905$20240905$PER$$US-WW-2024-39090990$WOODWARD PHARMA SERVICES$Blair J.E and Shah P.J. Voriconazole-Induced Periostitis: A Mimicker of Skeletal Coccidioidomycosis. Am J Case Rep. 2024 Aug 2;25:e944102. doi: 10.12659/AJCR.944102.$50$YR$$F$Y$62$KG$20240902$$MD$US$US
242837201$24283720$1$I$$20240730$20240905$20240905$EXP$$PR-ABBVIE-5905532$ABBVIE$$$$$F$Y$$$20240905$$CN$PR$PR
242837211$24283721$1$I$$20240902$20240905$20240905$EXP$$JP-TAKEDA-2024TJP012958$TAKEDA$$13$YR$$M$Y$$$20240905$$MD$JP$JP
242837222$24283722$2$F$20240101$20240828$20240905$20240906$EXP$$CO-ABBVIE-5899418$ABBVIE$$$$$F$Y$74$KG$20240906$$CN$CO$CO
242837231$24283723$1$I$$20240828$20240905$20240905$EXP$$BR-NOVITIUMPHARMA-2024BRNVP01773$NOVITIUM PHARMA$Cecilia Mirelle Almeida Honorato.Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor.Anais Brasileiros de Dermatologia.05-AUG-2024;NA:1-4$62$YR$A$M$Y$$$20240905$$HP$BR$BR
242837241$24283724$1$I$$20240828$20240905$20240905$EXP$$US-JNJFOC-20240876715$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240905$$HP$US$US
242837251$24283725$1$I$$20240830$20240905$20240905$EXP$$US-JNJFOC-20240901810$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$US$US
242837261$24283726$1$I$$20240820$20240905$20240905$EXP$$JP-ASTELLAS-2024-AER-002070$ASTELLAS$Sanada Y, Sakuma Y, Onishi Y, Wakiya T, Okada N, Hirata Y, et al. Biliary atresia research update; Pregnancy after liver transplantation. Japanese Journal of Pediatric Surgery. 2024;56(2): 199-205.$$$N$$Y$1.96$KG$20240905$$MD$JP$JP
242837271$24283727$1$I$20240701$20240828$20240905$20240905$EXP$$US-ABBVIE-5901581$ABBVIE$$57$YR$$F$Y$$$20240905$$CN$US$US
242837281$24283728$1$I$20240101$20240826$20240905$20240905$EXP$$US-ABBVIE-5896730$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242837291$24283729$1$I$20240101$20240826$20240905$20240905$EXP$$DE-ABBVIE-5904877$ABBVIE$$81$YR$$F$Y$$$20240905$$HP$DE$DE
242837301$24283730$1$I$$20240903$20240905$20240905$EXP$$CA-ROCHE-10000073454$ROCHE$$$$A$M$Y$$$20240905$$CN$CA$CA
242837311$24283731$1$I$$20240826$20240905$20240905$EXP$$US-AMGEN-USASP2024172247$AMGEN$File B.; Hari A.. Discrepancy in PD-L1 expression between primary and metastatic tumors in two patients with recurrent cervical cancer. Gynecologic Oncology Reports. 2024;55:1-4$42$YR$A$F$Y$$$20240904$$HP$US$US
242837321$24283732$1$I$$20240830$20240905$20240905$EXP$$US-ABBVIE-5905815$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242837341$24283734$1$I$$20240825$20240905$20240905$EXP$$BR-CHATTEMPRD-2024OHG030457$CHATTEM$$$$$F$Y$$$20240905$$CN$BR$BR
242837371$24283737$1$I$20240801$20240829$20240905$20240905$EXP$$US-ABBVIE-5901891$ABBVIE$$79$YR$$M$Y$$$20240905$$CN$US$US
242837381$24283738$1$I$$20240829$20240905$20240905$EXP$$US-ABBVIE-5901791$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242837391$24283739$1$I$$20240903$20240905$20240905$30DAY$$US-SANDOZ INC.-SDZ2024US077522$SANDOZ$$$$$M$Y$$$20240905$$CN$US$US
242837401$24283740$1$I$20240814$20240816$20240905$20240905$PER$$US-TEVA-VS-3234576$TEVA$$$$$F$Y$$$20240905$$CN$US$US
242837411$24283741$1$I$$20240901$20240905$20240905$EXP$$SA-TAKEDA-2024TUS088096$TAKEDA$$$$$M$Y$$$20240905$$CN$SA$SA
242837421$24283742$1$I$$20240904$20240905$20240905$PER$$NVSC2024US177897$NOVARTIS$$$$$$Y$$$20240905$$CN$US$US
242837431$24283743$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140404$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240905$$PH$US$US
242837441$24283744$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140356$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$48.99$KG$20240905$$CN$US$US
242837452$24283745$2$F$$20240927$20240905$20240930$PER$$US-GILEAD-2024-0685939$GILEAD$$$$$$Y$$$20240930$$PH$US$US
242837461$24283746$1$I$$20240903$20240905$20240905$EXP$$CA-ROCHE-10000073183$ROCHE$$$$A$F$Y$$$20240905$$CN$CA$CA
242837471$24283747$1$I$20240101$20240827$20240905$20240905$EXP$$SE-ABBVIE-5904694$ABBVIE$$$$$$Y$$$20240905$$HP$SE$SE
242837481$24283748$1$I$$20240829$20240905$20240905$EXP$$US-ABBVIE-5832588$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242837491$24283749$1$I$20230601$20240829$20240905$20240905$EXP$$US-ABBVIE-5864388$ABBVIE$$59$YR$$F$Y$55$KG$20240905$$CN$US$US
242837501$24283750$1$I$20240829$20240830$20240905$20240905$EXP$$US-JNJFOC-20240902711$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240905$$HP$US$US
242837511$24283751$1$I$20240804$20240829$20240905$20240905$EXP$$NL-BIOGEN-2024BI01280800$BIOGEN$$55$YR$$F$Y$$$20240905$$HP$NL$NL
242837521$24283752$1$I$$20240829$20240905$20240905$EXP$$BG-ABBVIE-5904492$ABBVIE$$74$YR$$$Y$$$20240905$$HP$BG$BG
242837531$24283753$1$I$20240726$20240829$20240905$20240905$EXP$FR-AFSSAPS-LL2024001647$FR-TAKEDA-2024TUS088201$TAKEDA$$40$YR$$M$Y$$$20240905$$MD$FR$FR
242837541$24283754$1$I$20240824$20240903$20240905$20240905$EXP$$RO-ABBVIE-5906428$ABBVIE$$72$YR$$F$Y$$$20240905$$HP$RO$RO
242837551$24283755$1$I$20240829$20240903$20240905$20240905$EXP$$US-ABBVIE-5906072$ABBVIE$$95$YR$$F$Y$$$20240905$$HP$US$US
242837561$24283756$1$I$$20240823$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408015941$ELI LILLY AND CO$$$$$$Y$$$20240905$$CN$US$US
242837571$24283757$1$I$$20240828$20240905$20240905$PER$$US-ROCHE-10000069336$ROCHE$$$$A$M$Y$$$20240905$$CN$US$US
242837581$24283758$1$I$20240101$20240830$20240905$20240905$PER$$US-009507513-2409USA000044$MERCK$$$$$F$Y$81.6$KG$20240905$$HP$US$US
242837591$24283759$1$I$20180101$20240828$20240905$20240905$EXP$$TN-ABBVIE-5189578$ABBVIE$$63$YR$$F$Y$$$20240905$$CN$TN$TN
242837601$24283760$1$I$$20240830$20240905$20240905$PER$$US-ABBVIE-5905793$ABBVIE$$$$A$F$Y$$$20240905$$HP$US$US
242837611$24283761$1$I$$20240829$20240905$20240905$EXP$$US-ABBVIE-5901957$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242837621$24283762$1$I$$20240829$20240905$20240905$EXP$$US-ABBVIE-5901792$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242837631$24283763$1$I$20240101$20240829$20240905$20240905$EXP$$US-ABBVIE-5902604$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242837641$24283764$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140898$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240905$$CN$US$US
242837651$24283765$1$I$$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140544$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240905$$CN$US$US
242837662$24283766$2$F$$20240925$20240905$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140391$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$151.95$KG$20240926$$CN$US$US
242837672$24283767$2$F$$20240830$20240905$20240905$PER$$US-ROCHE-10000073048$ROCHE$$$$A$F$Y$$$20240905$$HP$US$US
242837681$24283768$1$I$$20240830$20240905$20240905$PER$$US-ROCHE-10000071669$ROCHE$$$$E$M$Y$$$20240905$$CN$US$US
242837692$24283769$2$F$20240829$20240830$20240905$20240905$PER$$US-ROCHE-10000072173$ROCHE$$5$YR$C$F$Y$15.4$KG$20240905$$CN$US$US
242837701$24283770$1$I$20240828$20240829$20240905$20240905$PER$$US-SA-2024SA253889$SANOFI AVENTIS$$1$YR$I$M$Y$9.53$KG$20240905$$CN$US$US
242837714$24283771$4$F$20240801$20240902$20240905$20240909$EXP$$MX-GENMAB-2024-03188$GENMAB$$74$YR$$M$Y$$$20240909$$MD$MX$MX
242837722$24283772$2$F$$20240912$20240905$20240913$PER$$US-ROCHE-10000072419$ROCHE$$$$A$F$Y$$$20240913$$CN$US$US
242837741$24283774$1$I$$20240902$20240905$20240905$EXP$$NL-ABBVIE-5906278$ABBVIE$$$$E$M$Y$$$20240905$$CN$NL$NL
242837751$24283775$1$I$20240101$20240902$20240905$20240905$EXP$$AR-ABBVIE-5904888$ABBVIE$$$$$F$Y$$$20240905$$CN$AR$AR
242837771$24283777$1$I$20240620$20240902$20240905$20240905$EXP$$CA-ABBVIE-5905923$ABBVIE$$77$YR$$M$Y$$$20240905$$HP$CA$CA
242837781$24283778$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175511$AMGEN$$$$$F$Y$103$KG$20240904$$PH$US$US
242837801$24283780$1$I$20240501$20240830$20240905$20240905$EXP$$US-ABBVIE-5797770$ABBVIE$$70$YR$$F$Y$$$20240905$$CN$US$US
242837811$24283781$1$I$20240801$20240903$20240905$20240905$EXP$$US-ABBVIE-5906413$ABBVIE$$80$YR$$F$Y$$$20240905$$CN$US$US
242837821$24283782$1$I$$20240828$20240905$20240905$EXP$$BR-NOVITIUMPHARMA-2024BRNVP01767$NOVITIUM PHARMA$Cecilia Mirelle Almeida Honorato.Squamoid eccrine ductal carcinoma: series of five cases of a rare tumor.Anais Brasileiros de Dermatologia.05-AUG-2024;NA:1-4$72$YR$E$M$Y$$$20240905$$HP$BR$BR
242837833$24283783$3$F$$20240907$20240905$20240918$PER$$US-ROCHE-10000067863$ROCHE$$$$A$M$Y$$$20240918$$MD$US$US
242837841$24283784$1$I$20240101$20240828$20240905$20240905$EXP$$US-ABBVIE-5901527$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242837851$24283785$1$I$$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140849$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240905$$CN$US$US
242837861$24283786$1$I$$20240903$20240905$20240905$EXP$$US-ABBVIE-5905601$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242837872$24283787$2$F$20240805$20240903$20240905$20240906$EXP$$CA-ABBVIE-5905564$ABBVIE$$83$YR$$F$Y$$$20240906$$CN$CA$CA
242837881$24283788$1$I$20240828$20240902$20240905$20240905$EXP$$SI-ABBVIE-5904509$ABBVIE$$83$YR$$M$Y$$$20240905$$HP$SI$SI
242837893$24283789$3$F$20240101$20240909$20240905$20240916$EXP$$GB-ABBVIE-5904784$ABBVIE$$20$YR$$F$Y$$$20240916$$CN$GB$GB
242837901$24283790$1$I$20240208$20240902$20240905$20240905$EXP$FR-AFSSAPS-TO2024001330$FR-ABBVIE-5905243$ABBVIE$$87$YR$$F$Y$$$20240905$$PH$FR$FR
242837911$24283791$1$I$20200101$20240903$20240905$20240905$EXP$$AU-ABBVIE-5906436$ABBVIE$$$$$M$Y$$$20240905$$CN$AU$AU
242837922$24283792$2$F$20240820$20240909$20240905$20240912$EXP$$IL-ABBVIE-5906267$ABBVIE$$90$YR$$M$Y$$$20240912$$CN$IL$IL
242837931$24283793$1$I$$20240830$20240905$20240905$EXP$$US-ABBVIE-5903641$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242837941$24283794$1$I$20240823$20240828$20240905$20240905$EXP$$IE-ABBVIE-5782444$ABBVIE$$79$YR$$M$Y$$$20240905$$HP$IE$IE
242837951$24283795$1$I$$20240830$20240905$20240905$EXP$$US-JNJFOC-20240903600$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240905$$CN$US$US
242837961$24283796$1$I$$20240903$20240905$20240905$EXP$$US-ABBVIE-5905688$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242837971$24283797$1$I$$20240826$20240905$20240905$EXP$$CA-TEVA-VS-3237633$TEVA$$62$YR$$M$Y$$$20240905$$HP$CA$CA
242837981$24283798$1$I$$20240904$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049644$BOEHRINGER INGELHEIM$$$$$$Y$$$20240905$$HP$US$US
242837991$24283799$1$I$20240601$20240820$20240905$20240905$PER$$US-ASTELLAS-2024-AER-002087$ASTELLAS$$76$YR$E$M$Y$$$20240905$$CN$US$US
242838001$24283800$1$I$$20240903$20240905$20240905$EXP$$US-SANDOZ INC.-SDZ2024US077782$SANDOZ$$$$$F$Y$$$20240905$$MD$US$US
242838021$24283802$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3237807$TEVA$$29$YR$$F$Y$97$KG$20240905$$HP$CA$CA
242838042$24283804$2$F$$20240904$20240905$20240912$EXP$$CA-AstraZeneca-2024A197495$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$CA$
242838051$24283805$1$I$$20240822$20240905$20240905$EXP$$NL-AUROBINDO-AUR-APL-2024-042481$AUROBINDO$Geerts PA, Hart N, Visser O, Ortiz-Maldonado V, Chamuleau ME. Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR-T cell infusion. Clinical Case Reports. 2023;11(6):e7361$67$YR$$M$Y$$$20240905$$HP$NL$NL
242838062$24283806$2$F$20240831$20240905$20240905$20240910$PER$$US-AMGEN-USASP2024176092$AMGEN$$$$$M$Y$$$20240910$$CN$US$US
242838071$24283807$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3237826$TEVA$$28$YR$$F$Y$$$20240905$$HP$CA$CA
242838091$24283809$1$I$$20240904$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140908$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240905$$CN$US$US
242838101$24283810$1$I$$20240823$20240905$20240905$EXP$$US-MACLEODS PHARMA-MAC2024049049$MACLEODS$$$$$$Y$$$20240904$$CN$US$US
242838111$24283811$1$I$20240704$20240823$20240905$20240905$EXP$ES-AEMPS-1563437$ES-MACLEODS PHARMA-MAC2024049112$MACLEODS$$$$$$Y$$$20240904$$PH$ES$ES
242838121$24283812$1$I$20240101$20240823$20240905$20240905$EXP$GB-MHRA-MED-202408231849259030-YDKNM$GB-MACLEODS PHARMA-MAC2024049115$MACLEODS$$$$$$Y$$$20240904$$CN$GB$GB
242838131$24283813$1$I$20240701$20240823$20240905$20240905$EXP$GB-MHRA-MED-202408231439294480-JKGRB$GB-MACLEODS PHARMA-MAC2024049114$MACLEODS$$$$$$Y$$$20240904$$MD$GB$GB
242838141$24283814$1$I$20240401$20240824$20240905$20240905$EXP$GB-MHRA-MED-202408241631166090-PDJYF$GB-MACLEODS PHARMA-MAC2024049127$MACLEODS$$$$$$Y$$$20240904$$CN$GB$GB
242838151$24283815$1$I$$20240823$20240905$20240905$EXP$$JP-MACLEODS PHARMA-MAC2024049119$MACLEODS$Yokota H, Akamine Y, Kobayashi M, Kitabayashi T, Horie M, Endo T, et al.Naldemedine-induced perforation of a diverticulum in the sigmoid colon of a patient with opioidrelated constipation: a case report..Journal of pharmaceutical health care and sciences.2024;10(1):50$$$$$Y$$$20240904$$PH$JP$JP
242838171$24283817$1$I$$20240828$20240905$20240905$EXP$$GB-CELLTRION INC.-2024GB020898$CELLTRION$$$$$$Y$$$20240905$$CN$GB$GB
242838181$24283818$1$I$$20240828$20240905$20240905$EXP$$GB-TAKEDA-2022TUS092877$TAKEDA$$$$$F$Y$$$20240905$$CN$GB$GB
242838191$24283819$1$I$20240101$20240829$20240905$20240905$EXP$$PT-009507513-2409PRT000703$MERCK$$$$$F$Y$$$20240905$$MD$PT$PT
242838201$24283820$1$I$$20240829$20240905$20240905$PER$$US-AMGEN-USASP2024173139$AMGEN$$$$$M$Y$$$20240904$$CN$US$US
242838211$24283821$1$I$20240815$20240823$20240905$20240905$EXP$$TR-ASTELLAS-2024-AER-004420$ASTELLAS$$51$YR$A$F$Y$$$20240905$$MD$TR$TR
242838221$24283822$1$I$$20240827$20240905$20240905$PER$$US-BEH-2024177924$CSL BEHRING$$$$$M$Y$$$20240905$$CN$US$US
242838231$24283823$1$I$$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140773$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240905$$CN$US$US
242838241$24283824$1$I$$20240824$20240905$20240905$EXP$CA-MHPD-001093020$CA-Accord-444029$ACCORD$$77$YR$E$M$Y$$$20240905$$PH$CA$CA
242838252$24283825$2$F$20240812$20240831$20240905$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043831$AUROBINDO$$92$YR$$F$Y$55$KG$20240906$$MD$FR$FR
242838271$24283827$1$I$$20240823$20240905$20240905$EXP$$DE-MACLEODS PHARMA-MAC2024049118$MACLEODS$Nagele H, Rosenkranz M, Nagele MP..Hyponatremia-Induced Epileptic Seizure Provoked by Levetiracetam and Pain Medication Intake in a Patient with Central Diabetes Insipidus.Case reports in neurology.2024;16(1):204-7$$$$$Y$$$20240904$$MD$DE$DE
242838281$24283828$1$I$$20240824$20240905$20240905$EXP$CA-MHPD-E2B_07192924$CA-Accord-444030$ACCORD$$6$DEC$A$M$Y$$$20240905$$HP$CA$CA
242838292$24283829$2$F$$20240924$20240905$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139551$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$108.41$KG$20240926$$CN$US$US
242838301$24283830$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140816$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240905$$HP$US$US
242838311$24283831$1$I$20240101$20240828$20240905$20240905$EXP$$US-ABBVIE-5901087$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242838321$24283832$1$I$20240822$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176189$AMGEN$$56$YR$A$M$Y$$$20240904$$CN$US$US
242838332$24283833$2$F$$20240910$20240905$20240920$EXP$$US-TEVA-VS-3238451$TEVA$Wang NC. Resolution of ventricular tachycardia following cavotricuspid isthmus ablation for atrial flutter: Potential implications of cross-chamber induction on catheter ablation strategies. HeartRhythm-Case-Rep 2023; 9 (3): 165-170.; Wang NC. Resolution of ventricular tachycardia following cavotricuspid isthmus ablation for atrial flutter: Potential implications of cross-chamber induction on catheter ablation strategies. HeartRhythm-Case-Rep 2023; 9 (3): 165-170.$87$YR$$M$Y$$$20240920$$MD$US$US
242838341$24283834$1$I$$20240902$20240905$20240905$EXP$$BG-ABBVIE-5905317$ABBVIE$$77$YR$$F$Y$$$20240905$$CN$BG$BG
242838353$24283835$3$F$$20240906$20240905$20240910$PER$$US-AMGEN-USASP2024176670$AMGEN$$$$$M$Y$$$20240910$$CN$US$US
242838361$24283836$1$I$20240705$20240828$20240905$20240905$EXP$$US-AstraZeneca-2024A199135$ASTRAZENECA$$53$YR$$F$Y$122.5$KG$20240905$$MD$US$
242838371$24283837$1$I$20240829$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175913$AMGEN$$59$YR$A$M$Y$$$20240904$$CN$US$US
242838381$24283838$1$I$20240729$20240827$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013548$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242838391$24283839$1$I$20240101$20240821$20240905$20240905$PER$$US-SA-2024SA252646$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240905$$CN$US$US
242838401$24283840$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA255777$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240905$$CN$US$US
242838411$24283841$1$I$20240101$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176297$AMGEN$$65$YR$E$F$Y$$$20240904$$CN$US$US
242838421$24283842$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA256900$SANOFI AVENTIS$$$$$F$Y$$$20240905$$HP$US$US
242838431$24283843$1$I$$20240821$20240905$20240905$PER$$US-APOTEX-2024AP009873$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240905$$HP$US$US
242838441$24283844$1$I$20240501$20240829$20240905$20240905$EXP$$CO-ABBVIE-5860641$ABBVIE$$63$YR$$M$Y$56$KG$20240905$$HP$CO$CO
242838451$24283845$1$I$20240620$20240626$20240905$20240905$EXP$$CN-AUROBINDO-AUR-APL-2024-033402$AUROBINDO$$72$YR$$F$Y$45$KG$20240905$$HP$CN$CN
242838461$24283846$1$I$20240101$20240815$20240905$20240905$PER$$US-ASTELLAS-2024-AER-000825$ASTELLAS$$$$$F$Y$$$20240905$$HP$US$US
242838471$24283847$1$I$20240821$20240830$20240905$20240905$EXP$$CN-ABBVIE-5903850$ABBVIE$$58$YR$$M$Y$63$KG$20240905$$MD$CN$CN
242838481$24283848$1$I$20240727$20240831$20240905$20240905$EXP$$CN-ABBVIE-5904091$ABBVIE$$42$YR$$M$Y$72$KG$20240905$$MD$CN$CN
242838491$24283849$1$I$20240801$20240831$20240905$20240905$EXP$$CN-ABBVIE-5904092$ABBVIE$$61$YR$$M$Y$60$KG$20240905$$MD$CN$CN
242838501$24283850$1$I$20240720$20240903$20240905$20240905$EXP$$US-ABBVIE-5905337$ABBVIE$$63$YR$$F$Y$$$20240905$$CN$US$US
242838521$24283852$1$I$20240815$20240828$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013606$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242838531$24283853$1$I$20240101$20240827$20240905$20240905$EXP$$US-AMGEN-USASP2024172794$AMGEN$$$$$F$Y$$$20240904$$HP$US$US
242838541$24283854$1$I$20240701$20240903$20240905$20240905$EXP$FR-AFSSAPS-SE2024000679$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-140659$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$62$KG$20240905$$PH$FR$FR
242838551$24283855$1$I$$20240826$20240905$20240905$EXP$$TW-AMGEN-TWNSP2024174640$AMGEN$Yang K.; Su Y.; Liu W. et al.. Bisphosphonate-related osteonecrosis of the jaw: Is the medication duration related to advanced disease stage?. Formosan Journal of Surgery. 2024;57 (4):151-156$58$YR$A$F$Y$$$20240904$$HP$TW$TW
242838562$24283856$2$F$20240101$20240910$20240905$20240930$PER$$US-APOTEX-2024AP009477$APOTEX$$$$$F$Y$$$20240930$$CN$US$US
242838571$24283857$1$I$$20240822$20240905$20240905$EXP$$US-AUROBINDO-AUR-APL-2024-043931$AUROBINDO$Marcos LA, Leung A, Kirkman L, Wormser GP. Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone.. IDCases. 2022;27:e01460$36$YR$$M$Y$$$20240905$$MD$US$US
242838581$24283858$1$I$20240827$20240903$20240905$20240905$PER$$US-ABBVIE-5905836$ABBVIE$$30$YR$$F$Y$$$20240905$$MD$US$US
242838591$24283859$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178129$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242838601$24283860$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178094$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242838611$24283861$1$I$20240101$20240826$20240905$20240905$PER$$US-SA-2024SA252458$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240905$$MD$US$US
242838621$24283862$1$I$$20240827$20240905$20240905$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011090$STRIDES$Mukherji S, Shoaib H, Jimenez X.. Brief case report: A case of FOLFIRI-Induced psychosis.. Psycho-Oncology. 2023;32 (10):1625-1627$72$YR$$M$Y$$$20240905$$HP$US$US
242838631$24283863$1$I$20240101$20240822$20240905$20240905$PER$$US-SA-2024SA255613$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240905$$HP$US$US
242838641$24283864$1$I$$20240828$20240905$20240905$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011104$STRIDES$Zhao C, Yu L, Li L, Su M.. Diffuse lymphoma involvement of the spinal cord showed on [18F]FDG PET/MRI.. Nucl-Med-Rev-Cent-East-Eur. 2024;27 (0):24-27.$61$YR$$F$Y$$$20240905$$HP$CN$CN
242838651$24283865$1$I$$20240828$20240905$20240905$EXP$$GT-NOVITIUMPHARMA-2024GTNVP01772$NOVITIUM PHARMA$Ada Chavez.Case Report: Avascular Necrosis of Femoral Head in Kidney Trasplant.Kidney International Reports.APR-2024;9(4):S440-S441$21$YR$A$M$Y$$$20240905$$HP$GT$GT
242838661$24283866$1$I$$20231214$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2023SP018867$STRIDES$Jarrin MA, Hoyos-Martinez A, Merchant N, Yuezhen L.. New Onset Diabetes in a Post-Renal Transplant Pediatric Patient with a Mutation of the Hepatocyte Nuclear Factor-1beta Gene.. J-Endocr-Soc. 2019;3(Suppl. 1):abstr. SUN-LB033$6$YR$$M$Y$$$20240905$$MD$US$US
242838671$24283867$1$I$$20240501$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005378$STRIDES$Sarkar M, Lee S, Bjelajac N, Bunnapradist S, Lum E.. Cannabidiol (CBD) Oil and Tacrolimus: The Unexpected High in Renal Transplant Recipients - Case Series and Review.. Transplantation. 2022;106 (Suppl.)(9):S576 abstr. P8.057$38$YR$$M$Y$$$20240905$$HP$US$US
242838691$24283869$1$I$$20240423$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005031$STRIDES$Bista R.. TACROLIMUS-INDUCED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) IN A HEART TRANSPLANT PATIENT.. J-Am-Coll-Cardiol. 2024;83 (Suppl.) (13:3552$64$YR$$F$Y$$$20240905$$HP$US$US
242838701$24283870$1$I$$20240626$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007898$STRIDES$Maradiaga RD, Ramsey ML, Kirkby SE, Sobotka LA.. The Role of Cystic Fibrosis Transmembrane Conductance Regulator Modulators after Liver Transplantation in Persons with Cystic Fibrosis.. ACG-Case-Rep-J. 2024;11 (1)$22$YR$$F$Y$$$20240905$$MD$US$US
242838711$24283871$1$I$$20240416$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004707$STRIDES$Mohamed I, Sanders K, Hillebrand DJ.. Chronic Hepatitis e Virus Manifesting as Elevated Transaminases in a Heart Transplant Patient.. ACG-Case-Rep-J. 2024;11 (3)$75$YR$$M$Y$$$20240905$$HP$US$US
242838721$24283872$1$I$$20230727$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2023SP012537$STRIDES$Pai RN, Del Pilar Fernandez M, Jadegondanahalli JPBT, Glass WF, Ahmed S, Abudayyeh A.. BK Nephropathy in Allogeneic Stem Cell Transplant Recipient without Thrombotic Microangiopathy and Graft-Versus-Host Disease: A Unique Observation.. J-Am-Soc-Nephrol. 2015;26371A$31$YR$$F$Y$$$20240905$$HP$US$US
242838731$24283873$1$I$$20240820$20240905$20240905$EXP$$US-SA-2024SA255869$SANOFI AVENTIS$$$$A$M$Y$$$20240905$$MD$US$US
242838741$24283874$1$I$$20231009$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015633$STRIDES$Gupta S, Wojciechowski D. Late Conversion to Belatacept in Biopsy Proven Tacrolimus Toxicity. J-Am-Soc-Nephrol. 2016;27622A(poster)abstr. FR-P01090$$$$$Y$$$20240905$$HP$US$US
242838751$24283875$1$I$$20240502$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005405$STRIDES$Wisel S, Nunez M, Gardner JM, Worner G, Roll GR, Syed SM, et al.. Strategies to Achieve Long-term Insulin Independence Using a Multimodal Approach to Beta-cell Replacement in Patients With Type I Diabetes.. Transplantation. 2022;106 (Suppl. 9):S34$$$$$Y$$$20240905$$HP$US$US
242838761$24283876$1$I$$20231009$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015642$STRIDES$Gupta S, Wojciechowski D. Late Conversion to Belatacept in Biopsy Proven Tacrolimus Toxicity. J-Am-Soc-Nephrol. 2016;27622A (poster):abstr. FR-P01090$$$$$Y$$$20240905$$HP$US$US
242838771$24283877$1$I$$20231011$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015777$STRIDES$VILAYET S, MENON AA, MOHAMMED W.. FOSCARNET^S DOUBLE WHAMMY: HYPOCALCEMIA AND HYPOMAGNESEMIA IN LUNG TRANSPLANT.. Chest.. 2023;164 (Suppl.)(4):A1058-A1059 (plus poster).$65$YR$$F$Y$$$20240905$$HP$US$US
242838781$24283878$1$I$$20240620$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007630$STRIDES$Maldarelli ME, Grier WR. A Noxious Mimic - Pulmonary Nocardiosis Presenting as a Lung Mass in an Orthotopic Liver Transplant Patient.. Am-J-Respir-Crit-Care-Med. 2024;209:A2434$72$YR$$M$Y$$$20240905$$HP$US$US
242838791$24283879$1$I$$20240708$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008496$STRIDES$Gondek S, Ogledzinski M, Lin W, Milejczyk K, Juengel B, Potter L, et al.. Persistence of long-term insulin independence after islet transplantation and two subsequent pregnancies.. Eur-J-Transl-Clin-Med. 2023;6 (1):9-13$$$$$Y$$$20240905$$HP$US$US
242838801$24283880$1$I$$20240229$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002686$STRIDES$Winter DL, Perelas A.. Rapidly Progressive Interstitial Lung Disease in the Setting of Anti- Melanoma Differentiation-Associated Gene 5 Positive Clinically Amyopathic Dermatomyositis.. Am-J-Respir-Crit-Care-Med. 2023;207$52$YR$$M$Y$$$20240905$$HP$US$US
242838811$24283881$1$I$20240820$20240825$20240905$20240905$EXP$$JP-NOVOPROD-1275243$NOVO NORDISK$$$$$F$Y$$$20240905$$CN$JP$JP
242838822$24283882$2$F$20240826$20240904$20240905$20240906$PER$$US-AMGEN-USASP2024175676$AMGEN$$76$YR$E$F$Y$$$20240905$$CN$US$US
242838831$24283883$1$I$$20231106$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016899$STRIDES$Hewlett J, Goka S, Nwaogazie U, Finkel R, Laskin B, LaRosa C, et al. Successful Use of Phenytoin/ Fosphenytoin in a Pediatric Transplant Recipient with Nimatrelvir/ Ritonavir Induced Tacrolimus Toxicity. Am-J-Transplant. 2023;23 (Suppl. 1)(6:S1121 abstr. D134$14$YR$$F$Y$66.5$KG$20240905$$HP$US$US
242838842$24283884$2$F$$20240902$20240905$20240916$EXP$$GB-AMGEN-GBRSP2024175509$AMGEN$$$$$F$Y$$$20240916$$MD$GB$GB
242838851$24283885$1$I$$20240828$20240905$20240905$EXP$$CO-STRIDES ARCOLAB LIMITED-2024SP011111$STRIDES$Biancha-Vasco JM, MunozPAL, Gomez J, Rios-Serna LJ, Ruiz-Ordonez I, Tobon GJ, et al.. Idiopathic gigantomastia exacerbated during pregnancy. Its relationship with autoimmunity: A case report.. Int-J-Rheum-Diseases. 2023;26 (12):2567-2571$$$$$Y$$$20240905$$HP$CO$CO
242838861$24283886$1$I$$20240828$20240905$20240905$EXP$$CO-STRIDES ARCOLAB LIMITED-2024SP011105$STRIDES$Biancha-Vasco JM, MunozPAL, Gomez J, Rios-Serna LJ, Ruiz-Ordonez I, Tobon GJ, et al.. Idiopathic gigantomastia exacerbated during pregnancy. Its relationship with autoimmunity: A case report.. Int-J-Rheum-Diseases. 2023;26 (12):2567-2571$29$YR$$F$Y$$$20240905$$HP$CO$CO
242838872$24283887$2$F$20240827$20240828$20240905$20240905$EXP$$US-AMGEN-USASP2024173504$AMGEN$$73$YR$E$M$Y$$$20240905$$PH$US$US
242838881$24283888$1$I$20240830$20240830$20240905$20240905$PER$$US-AMGEN-USASP2024176047$AMGEN$$$$$$Y$$$20240904$$HP$US$US
242838901$24283890$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176208$AMGEN$$$$$M$Y$$$20240904$$CN$US$US
242838911$24283891$1$I$$20240826$20240905$20240905$EXP$$TW-AMGEN-TWNSP2024174648$AMGEN$Yang K.; Su Y.; Liu W. et al.. Bisphosphonate-related osteonecrosis of the jaw: Is the medication duration related to advanced disease stage?. Formosan Journal of Surgery. 2024;57 (4):151-156$71$YR$E$F$Y$$$20240904$$HP$TW$TW
242838921$24283892$1$I$$20240829$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138562$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240905$$MD$US$US
242838932$24283893$2$F$20240723$20240916$20240905$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140556$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$$$20240920$$CN$US$US
242838941$24283894$1$I$20240701$20240826$20240905$20240905$EXP$$US-NOVOPROD-1276110$NOVO NORDISK$$$$$F$Y$$$20240905$$CN$US$US
242838951$24283895$1$I$$20240826$20240905$20240905$EXP$GB-MHRA-MED-202408261504329760-JQTMZ$GB-NOVOPROD-1275586$NOVO NORDISK$$$$$M$Y$$$20240905$$HP$GB$GB
242838962$24283896$2$F$20240809$20240918$20240905$20240930$EXP$$CO-NOVOPROD-1273069$NOVO NORDISK$$80$YR$$F$Y$64$KG$20240930$$CN$CO$CO
242838971$24283897$1$I$$20240826$20240905$20240905$EXP$$US-NOVOPROD-1276736$NOVO NORDISK$$$$$F$Y$$$20240905$$CN$US$US
242838981$24283898$1$I$$20240826$20240905$20240905$EXP$$US-NOVOPROD-1276538$NOVO NORDISK$$$$$F$Y$$$20240905$$CN$US$US
242838991$24283899$1$I$20240727$20240826$20240905$20240905$EXP$DK-DKMA-30737714$DK-NOVOPROD-1276565$NOVO NORDISK$$48$YR$$F$Y$125$KG$20240905$$MD$DK$DK
242839001$24283900$1$I$20200601$20240826$20240905$20240905$EXP$$US-NOVOPROD-1275947$NOVO NORDISK$$69$YR$$F$Y$$$20240905$$CN$US$US
242839011$24283901$1$I$20230829$20240826$20240905$20240905$EXP$AU-TGA-0000786271$AU-NOVOPROD-1275643$NOVO NORDISK$$34$YR$$M$Y$$$20240905$$HP$AU$AU
242839021$24283902$1$I$$20240826$20240905$20240905$EXP$$US-NOVOPROD-1276053$NOVO NORDISK$$70$YR$$$Y$$$20240905$$CN$US$US
242839031$24283903$1$I$20230901$20240826$20240905$20240905$EXP$AU-TGA-0000786950$AU-NOVOPROD-1276275$NOVO NORDISK$$43$YR$$M$Y$$$20240905$$MD$AU$AU
242839041$24283904$1$I$20230301$20240826$20240905$20240905$EXP$AU-TGA-0000786430$AU-NOVOPROD-1275654$NOVO NORDISK$$64$YR$$F$Y$$$20240905$$HP$AU$AU
242839051$24283905$1$I$20230706$20240826$20240905$20240905$EXP$AU-TGA-0000786914$AU-NOVOPROD-1276240$NOVO NORDISK$$38$YR$$F$Y$$$20240905$$HP$AU$AU
242839061$24283906$1$I$20240501$20240826$20240905$20240905$EXP$$CO-NOVOPROD-1276783$NOVO NORDISK$$83$YR$$M$Y$58$KG$20240905$$CN$CO$CO
242839071$24283907$1$I$$20240831$20240905$20240905$EXP$$IN-ROCHE-10000071984$ROCHE$$40$YR$A$M$Y$$$20240905$$CN$IN$IN
242839081$24283908$1$I$20240801$20240822$20240905$20240905$PER$$US-SA-2024SA255616$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240905$$MD$US$US
242839091$24283909$1$I$20240109$20240826$20240905$20240905$EXP$DK-DKMA-30737682$DK-NOVOPROD-1276568$NOVO NORDISK$$39$YR$$F$Y$$$20240905$$MD$DK$DK
242839102$24283910$2$F$$20240904$20240905$20240905$PER$$NVSC2024US177854$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
242839111$24283911$1$I$$20240828$20240905$20240905$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011087$STRIDES$Shi S-M, Li Z-H, Xu J-R, Cai X-X, Zhou X-X, Zheng R-C, et al.. An adult with hemorrhagic varicella co-infects with cytomegalovirus: a case report.. BMC-Infect-Dis. 2024;24$25$YR$$M$Y$$$20240905$$HP$CN$CN
242839121$24283912$1$I$$20240902$20240905$20240905$EXP$GB-PHARMVIT-4556-3352-ER24-RN1159$GB-STRIDES ARCOLAB LIMITED-2024SP011036$STRIDES$$82$YR$$M$Y$$$20240905$$MD$GB$GB
242839131$24283913$1$I$20220101$20240829$20240905$20240905$EXP$$US-ABBVIE-5901829$ABBVIE$$27$YR$$M$Y$$$20240905$$CN$US$US
242839141$24283914$1$I$20240801$20240829$20240905$20240905$EXP$$US-ABBVIE-5901985$ABBVIE$$47$YR$$M$Y$$$20240905$$CN$US$US
242839151$24283915$1$I$$20240830$20240905$20240905$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001782$BLUEPRINT MEDICINES$$$$$F$Y$$$20240905$$CN$US$US
242839161$24283916$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140900$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240905$$CN$US$US
242839171$24283917$1$I$$20240903$20240905$20240905$EXP$$GB-SANDOZ INC.-SDZ2024GB077467$SANDOZ$$$$$M$Y$$$20240905$$HP$GB$GB
242839181$24283918$1$I$20240801$20240829$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139625$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240905$$CN$US$US
242839193$24283919$3$F$20240821$20240916$20240905$20240923$PER$$US-SA-2024SA252688$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240923$$PH$US$US
242839201$24283920$1$I$20240607$20240826$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043095$AUROBINDO$$73$YR$$F$Y$65$KG$20240905$$MD$FR$FR
242839211$24283921$1$I$$20240821$20240905$20240905$EXP$$US-SPECGX-T202401788$SPECGX$Hemmer SA, Pasternak JF, Zecker SG, Trommer BL. Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol. 2001;24(2):99-102$6$YR$$F$Y$$$20240905$$HP$US$US
242839221$24283922$1$I$20240822$20240826$20240905$20240905$30DAY$$US-GSK-US2024105964$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240905$$CN$US$US
242839231$24283923$1$I$$20240830$20240905$20240905$EXP$$AU-ABBVIE-5902760$ABBVIE$$42$YR$$F$Y$$$20240905$$HP$AU$AU
242839241$24283924$1$I$$20240903$20240905$20240905$PER$$US-ALXN-202409USA000060US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242839251$24283925$1$I$20240402$20240826$20240905$20240905$EXP$$ES-AUROBINDO-AUR-APL-2024-043133$AUROBINDO$$80$YR$$F$Y$$$20240905$$MD$ES$ES
242839262$24283926$2$F$20240515$20240921$20240905$20240925$EXP$$CA-ABBVIE-5793480$ABBVIE$$75$YR$$M$Y$$$20240925$$CN$CA$CA
242839271$24283927$1$I$20240903$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176171$AMGEN$$59$YR$A$F$Y$$$20240904$$CN$US$US
242839281$24283928$1$I$$20240829$20240905$20240905$EXP$$US-AMGEN-USASP2024174557$AMGEN$$$$$F$Y$$$20240904$$CN$US$US
242839292$24283929$2$F$20240828$20240828$20240905$20240905$EXP$$US-AMGEN-USASP2024173513$AMGEN$$$$E$M$Y$$$20240905$$PH$US$US
242839312$24283931$2$F$20240805$20240903$20240905$20240910$EXP$$IT-ABBVIE-5905409$ABBVIE$$60$YR$$F$Y$$$20240910$$MD$IT$IT
242839321$24283932$1$I$$20240816$20240905$20240905$PER$$US-TEVA-VS-3234672$TEVA$$68$YR$$M$Y$95.25$KG$20240905$$CN$US$US
242839331$24283933$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA254867$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240905$$MD$US$US
242839341$24283934$1$I$$20240821$20240905$20240905$EXP$$US-GRANULES-US-2024GRALIT00385$GRANULES INDIA$Robert A. Sorabella.Central Extracorporeal Membrane Oxygenation Support  Following Calcium Channel Blocker Overdose in Children.ASAIO Journal.2024;70:e92-e96$17$YR$T$M$Y$85$KG$20240905$$HP$US$US
242839351$24283935$1$I$20240823$20240903$20240905$20240905$EXP$GB-MHRA-MED-202409031426178480-JKPYZ$GB-SANDOZ INC.-SDZ2024GB077634$SANDOZ$$83$YR$$F$Y$$$20240905$$PH$GB$GB
242839361$24283936$1$I$20231101$20240828$20240905$20240905$EXP$$NVSC2024CR175668$NOVARTIS$$89$YR$$F$Y$$$20240905$$PH$CR$CR
242839371$24283937$1$I$20240701$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175981$AMGEN$$82$YR$E$M$Y$$$20240904$$CN$US$US
242839381$24283938$1$I$$20240821$20240905$20240905$EXP$$US-SPECGX-T202401795$SPECGX$Hemmer SA, Pasternak JF, Zecker SG, Trommer BL. Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol. 2001;24(2):99-102$7$YR$$M$Y$$$20240905$$HP$US$US
242839391$24283939$1$I$20240801$20240819$20240905$20240905$PER$$US-JNJFOC-20240847220$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240905$$CN$US$US
242839401$24283940$1$I$20240101$20240819$20240905$20240905$EXP$$JP-TAKEDA-2024TUS088447$TAKEDA$$87$YR$$F$Y$45$KG$20240905$$MD$JP$JP
242839411$24283941$1$I$$20240828$20240905$20240905$EXP$$DE-AMGEN-DEUSP2024172793$AMGEN$$68$YR$E$F$Y$$$20240904$$MD$DE$DE
242839421$24283942$1$I$$20240815$20240905$20240905$PER$$US-ASTELLAS-2024-AER-001616$ASTELLAS$$62$YR$A$F$Y$$$20240905$$MD$US$US
242839432$24283943$2$F$20240801$20240903$20240905$20240908$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049545$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240909$$CN$US$US
242839441$24283944$1$I$$20240821$20240905$20240905$EXP$$US-SPECGX-T202401796$SPECGX$Hemmer SA, Pasternak JF, Zecker SG, Trommer BL. Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol. 2001;24(2):99-102$6$YR$$M$Y$$$20240905$$HP$US$US
242839451$24283945$1$I$$20240827$20240905$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-026969$UNITED THERAPEUTICS$$$$$F$Y$58.957$KG$20240905$$$US$US
242839463$24283946$3$F$$20240903$20240905$20240905$PER$$NVSC2024US177523$NOVARTIS$$$$$M$Y$$$20240905$$CN$US$US
242839471$24283947$1$I$$20240822$20240905$20240905$EXP$$US-UCBSA-2024043103$UCB$$$$$$Y$$$20240905$$CN$US$US
242839481$24283948$1$I$20240817$20240821$20240905$20240905$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25818$SAMSUNG BIOEPIS$$34$YR$A$M$Y$$$20240905$$HP$CA$CA
242839491$24283949$1$I$$20240821$20240905$20240905$EXP$$TR-GRANULES-TR-2024GRALIT00383$GRANULES INDIA$ME Ceylan.A Bell^s Palsy Case Probably Related to Sertraline Use.Psychopharmacology Bulletin.APR-2024;54:51-52$53$YR$A$M$Y$$$20240905$$HP$TR$TR
242839502$24283950$2$F$20210312$20240913$20240905$20240920$EXP$$CA-TAKEDA-2021TUS014090$TAKEDA$$45$YR$$F$Y$$$20240920$$HP$CA$CA
242839511$24283951$1$I$20240821$20240827$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013544$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242839521$24283952$1$I$$20240903$20240905$20240905$EXP$GB-MHRA-MED-202409031839459090-DFGPZ$GB-SANDOZ INC.-SDZ2024GB077739$SANDOZ$$$$$M$Y$$$20240905$$CN$GB$GB
242839531$24283953$1$I$20230228$20240829$20240905$20240905$EXP$$IN-SANDOZ INC.-NVSC2023IN069191$SANDOZ$$39$YR$$F$Y$$$20240905$$CN$IN$IN
242839541$24283954$1$I$$20240904$20240905$20240905$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049547$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240905$$CN$US$US
242839551$24283955$1$I$20240828$20240829$20240905$20240905$PER$$US-SA-2024SA255538$SANOFI AVENTIS$$$$A$F$Y$$$20240905$$CN$US$US
242839561$24283956$1$I$20240101$20240826$20240905$20240905$PER$$US-SA-2024SA255921$SANOFI AVENTIS$$$$A$M$Y$$$20240905$$MD$US$US
242839571$24283957$1$I$$20240829$20240905$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-027475$UNITED THERAPEUTICS$$$$$F$Y$64.853$KG$20240905$$$US$US
242839581$24283958$1$I$$20240821$20240905$20240905$EXP$$DE-GRANULES-DE-2024GRALIT00382$GRANULES INDIA$Raw. Bingart.Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock .Rechtsmedizin.30-JUN-2023;33:396-402$17$YR$T$M$Y$$$20240905$$HP$DE$DE
242839591$24283959$1$I$$20240822$20240905$20240905$EXP$$DE-UCBSA-2024044056$UCB$$$$$F$Y$$$20240905$$MD$DE$DE
242839602$24283960$2$F$20240625$20240919$20240905$20240923$EXP$$JP-TAKEDA-2024TJP012957$TAKEDA$$2$DEC$$M$Y$$$20240923$$PH$JP$JP
242839611$24283961$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178109$NOVARTIS$$$$$M$Y$$$20240905$$CN$US$US
242839623$24283962$3$F$20240101$20240925$20240905$20240930$PER$$US-AMGEN-USASP2024176125$AMGEN$$27$YR$A$F$Y$$$20240930$$CN$US$US
242839631$24283963$1$I$20240101$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175888$AMGEN$$46$YR$A$F$Y$$$20240904$$CN$US$US
242839641$24283964$1$I$20240902$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175785$AMGEN$$75$YR$E$F$Y$$$20240904$$CN$US$US
242839652$24283965$2$F$20240901$20240904$20240905$20240906$PER$$US-AMGEN-USASP2024176387$AMGEN$$71$YR$E$F$Y$$$20240906$$PH$US$US
242839662$24283966$2$F$20240827$20240912$20240905$20240918$30DAY$$US-AMGEN-USASP2024172506$AMGEN$$69$YR$E$F$Y$79.38$KG$20240917$$CN$US$US
242839671$24283967$1$I$$20240830$20240905$20240905$EXP$$CA-SANDOZ INC.-SDZ2024CA077571$SANDOZ$$$$$M$Y$$$20240905$$MD$CA$CA
242839681$24283968$1$I$$20240814$20240905$20240905$PER$$US-ASTELLAS-2024-AER-001749$ASTELLAS$$$$E$M$Y$$$20240905$$HP$US$US
242839691$24283969$1$I$20240101$20240827$20240905$20240905$PER$$US-ABBVIE-5898457$ABBVIE$$$$$F$Y$104$KG$20240905$$CN$US$US
242839702$24283970$2$F$$20240911$20240905$20240911$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049418$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240912$$CN$US$US
242839712$24283971$2$F$20240801$20240910$20240905$20240917$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026496$UNITED THERAPEUTICS$$55$YR$$F$Y$78.005$KG$20240917$$PH$US$US
242839721$24283972$1$I$$20240821$20240905$20240905$EXP$$JP-GRANULES-JP-2024GRALIT00384$GRANULES INDIA$N Imoto.Severe neuropsychiatric disorder developing during busulfan-containing regimen for stem cell transplantation.Rinsho Ketsueki.JAN-2023;64:1415-1420$66$YR$E$M$Y$$$20240905$$HP$JP$JP
242839731$24283973$1$I$$20240903$20240905$20240905$EXP$$DZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049514$BOEHRINGER INGELHEIM$$60$YR$A$M$Y$$$20240905$$MD$DZ$DZ
242839741$24283974$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA255707$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240905$$MD$US$US
242839751$24283975$1$I$20240615$20240821$20240905$20240905$PER$$US-SA-2024SA255703$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240905$$HP$US$US
242839761$24283976$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176303$AMGEN$$$$$M$Y$$$20240904$$HP$US$US
242839772$24283977$2$F$20240101$20240824$20240905$20240906$PER$$US-SA-2024SA255188$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240906$$MD$US$US
242839782$24283978$2$F$$20240910$20240905$20240920$EXP$$BG-TEVA-VS-3238255$TEVA$Tchernev G, Broshtilova V. ADVERSE DRUG EVENTS: LICHEN PLANUS OF THE PENIS AFTER INTAKE OF NEBIVOLOL- FIRST REPORTED CASE IN THE WORLD LITERATURE. Georgian-Med-News 2023; 350 115-116.; Tchernev G, Broshtilova V. ADVERSE DRUG EVENTS: LICHEN PLANUS OF THE PENIS AFTER INTAKE OF NEBIVOLOL- FIRST REPORTED CASE IN THE WORLD LITERATURE. Georgian-Med-News 2023; 350 115-116.$48$YR$$M$Y$$$20240920$$HP$BG$BG
242839791$24283979$1$I$20240829$20240829$20240905$20240905$PER$$US-JNJFOC-20240906341$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$HP$US$US
242839801$24283980$1$I$$20240805$20240905$20240905$EXP$$ID-JNJFOC-20240907975$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$MD$ID$ID
242839821$24283982$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043577$AUROBINDO$$19$YR$$F$Y$52.163$KG$20240905$$CN$CA$CA
242839831$24283983$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043753$AUROBINDO$$$$$F$Y$65$KG$20240905$$HP$CA$CA
242839841$24283984$1$I$20240101$20240827$20240905$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025252$UNITED THERAPEUTICS$$$$$M$Y$$$20240905$$$US$US
242839851$24283985$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004592$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242839861$24283986$1$I$20240817$20240828$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013615$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242839881$24283988$1$I$20240801$20240821$20240905$20240905$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25834$SAMSUNG BIOEPIS$$56$YR$A$M$Y$$$20240905$$CN$CA$CA
242839891$24283989$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004596$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242839902$24283990$2$F$20240828$20240903$20240905$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005211$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240926$$CN$US$US
242839911$24283991$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024108975$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242839921$24283992$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024108968$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242839942$24283994$2$F$20240826$20240829$20240905$20240907$EXP$$US-JNJFOC-20240876997$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240907$$HP$US$US
242839951$24283995$1$I$20240101$20240822$20240905$20240905$PER$$US-SA-2024SA252689$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240905$$MD$US$US
242839961$24283996$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA253845$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240905$$CN$US$US
242839971$24283997$1$I$20240729$20240819$20240905$20240905$PER$$US-NOVITIUMPHARMA-2024USNVP01761$NOVITIUM PHARMA$$81$YR$E$F$Y$180$KG$20240905$$CN$US$US
242839981$24283998$1$I$20240801$20240830$20240905$20240905$EXP$$US-009507513-2409USA000699$MERCK$$67$YR$$M$Y$$$20240905$$MD$US$US
242839991$24283999$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176192$AMGEN$$$$$$Y$$$20240904$$CN$US$US
242840001$24284000$1$I$$20240828$20240905$20240905$PER$$US-CHATTEMPRD-2024OHG030231$CHATTEM$$$$$F$Y$$$20240905$$CN$US$US
242840011$24284001$1$I$20240724$20240830$20240905$20240905$EXP$IT-MINISAL02-997251$IT-TAKEDA-2024TUS088074$TAKEDA$$59$YR$$F$Y$$$20240905$$HP$IT$IT
242840031$24284003$1$I$$20240828$20240905$20240905$PER$$US-CHATTEMPRD-2024OHG030236$CHATTEM$$$$$F$Y$$$20240905$$CN$US$US
242840041$24284004$1$I$$20240821$20240905$20240905$EXP$$US-GRANULES-US-2024GRALIT00386$GRANULES INDIA$Monique Leys.Multiple organ dysfunction syndrome and disseminated intravascular coagulation causing extensive multiple amalric triangular choroidal infarctions. Retinal Cases and Brief Reports .2024;18:251-254$49$YR$A$F$Y$$$20240905$$MD$US$US
242840051$24284005$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004595$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242840063$24284006$3$F$$20240912$20240905$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004744$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
242840071$24284007$1$I$$20240824$20240905$20240905$EXP$$US-AUROBINDO-AUR-APL-2024-043255$AUROBINDO$$$$$F$Y$$$20240905$$CN$US$US
242840082$24284008$2$F$20240801$20240909$20240905$20240916$PER$$US-CHATTEMPRD-2024OHG030230$CHATTEM$$$$$F$Y$$$20240916$$CN$US$US
242840091$24284009$1$I$$20240821$20240905$20240905$EXP$$JP-ABBVIE-5904985$ABBVIE$Miwa S, Ishida T, Mizuno M, Shimada M. A case of an anorexia nervosa that resulted in metabolic acidosis as a result of continued laxative prescription for the complaint of severe constipation. Seishin Shinkeigaku Zasshi. The 120th Annual Meeting of The Japanese Society of Psychiatry and Neurology. 2024;2-KP2-1.$7$DEC$$F$Y$$$20240905$$MD$JP$JP
242840101$24284010$1$I$20240101$20240823$20240905$20240905$EXP$$US-SA-2024SA255398$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240905$$MD$US$US
242840111$24284011$1$I$20240701$20240821$20240905$20240905$EXP$$GB-UCBSA-2024042541$UCB$$33$YR$$M$Y$$$20240905$$HP$GB$GB
242840131$24284013$1$I$$20240830$20240905$20240905$PER$$US-CHATTEMPRD-2024OHG030576$CHATTEM$$$$$$Y$$$20240905$$CN$US$US
242840142$24284014$2$F$20240101$20240913$20240905$20240923$PER$$US-ASTELLAS-2024-AER-001826$ASTELLAS$$72$YR$E$F$Y$$$20240923$$CN$US$US
242840151$24284015$1$I$$20240827$20240905$20240905$EXP$$CA-TAKEDA-2024TUS086531$TAKEDA$$$$$M$Y$$$20240905$$CN$CA$CA
242840161$24284016$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024108974$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242840171$24284017$1$I$$20240821$20240905$20240905$EXP$$US-GRANULES-US-2024GRALIT00381$GRANULES INDIA$Cate Enstrom.Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy.US Cardiology.2024;18$29$YR$A$M$Y$$$20240905$$HP$US$US
242840181$24284018$1$I$20240301$20240827$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013555$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242840201$24284020$1$I$20240827$20240828$20240905$20240905$PER$$US-BEH-2024177982$CSL BEHRING$$43$YR$A$F$Y$$$20240905$$HP$US$US
242840211$24284021$1$I$20240902$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001457$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240905$$CN$US$US
242840222$24284022$2$F$$20240904$20240905$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004916$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242840231$24284023$1$I$$20240902$20240905$20240905$PER$$US-AMGEN-USASP2024175378$AMGEN$$$$$$Y$$$20240904$$PH$US$US
242840241$24284024$1$I$20240815$20240827$20240905$20240905$EXP$$US-BIOGEN-2024BI01280472$BIOGEN$$26$YR$$F$Y$$$20240905$$CN$US$US
242840251$24284025$1$I$20240814$20240823$20240905$20240905$EXP$$CN-Shanghai Hengrui Pharmaceutical Co., Ltd.-2161215$SHANGHAI HENGRUI PHARMACEUTICAL$$70$YR$$F$Y$68$KG$20240905$$MD$CN$CN
242840272$24284027$2$F$20240804$20240910$20240905$20240916$EXP$$ES-BIOGEN-2024BI01280128$BIOGEN$$32$YR$$F$Y$$$20240916$$MD$ES$ES
242840281$24284028$1$I$$20240827$20240905$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-027199$UNITED THERAPEUTICS$$$$$F$Y$85.261$KG$20240905$$$US$US
242840291$24284029$1$I$$20240828$20240905$20240905$EXP$$CA-BIOGEN-2024BI01280531$BIOGEN$$$$$F$Y$$$20240905$$CN$CA$CA
242840311$24284031$1$I$20240101$20240903$20240905$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-027503$UNITED THERAPEUTICS$$$$$M$Y$$$20240905$$$US$US
242840321$24284032$1$I$20240801$20240826$20240905$20240905$EXP$$US-BEH-2021127290$CSL BEHRING$$60$YR$A$F$Y$$$20240905$$CN$US$US
242840331$24284033$1$I$20240101$20240831$20240905$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-027499$UNITED THERAPEUTICS$$$$$F$Y$34.921$KG$20240905$$$US$US
242840341$24284034$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004604$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242840351$24284035$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004589$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242840361$24284036$1$I$$20240827$20240905$20240905$EXP$$AU-AMGEN-AUSCT2024175761$AMGEN$Jay P T. Phase IB/II first line panitumumab, irinotecan, trifluridine/tipiracil in RAS wild-type patients with metastatic colorectal cancer: PIT study. Journal Of Clinical Oncology. 2024;42 (16)$$$A$$Y$$$20240904$$MD$AU$AU
242840372$24284037$2$F$20231201$20240912$20240905$20240914$PER$$US-AMGEN-USASP2024176134$AMGEN$$71$YR$E$F$Y$$$20240914$$CN$US$US
242840382$24284038$2$F$20240710$20240917$20240905$20240918$EXP$IT-MINISAL02-1000678$IT-ORGANON-O2409ITA000161$ORGANON$$55$YR$$M$Y$85$KG$20240918$$MD$IT$IT
242840401$24284040$1$I$20240822$20240828$20240905$20240905$PER$$US-BEH-2024177962$CSL BEHRING$$24$YR$A$F$Y$$$20240905$$HP$US$US
242840411$24284041$1$I$$20240827$20240905$20240905$EXP$$NO-NOVOPROD-1275639$NOVO NORDISK$$$$A$F$Y$$$20240905$$MD$NO$NO
242840421$24284042$1$I$$20240827$20240905$20240905$EXP$$CN-NOVOPROD-1275916$NOVO NORDISK$$77$YR$$M$Y$72$KG$20240905$$CN$CN$CN
242840431$24284043$1$I$20240601$20240827$20240905$20240905$EXP$$US-NOVOPROD-1276591$NOVO NORDISK$$66$YR$$F$Y$$$20240905$$CN$US$US
242840441$24284044$1$I$20240727$20240827$20240905$20240905$EXP$CN-NMPA-3412011017611202400605$CN-NOVOPROD-1275828$NOVO NORDISK$$95$YR$$M$Y$$$20240905$$HP$CN$CN
242840451$24284045$1$I$20240101$20240827$20240905$20240905$EXP$$BR-NOVOPROD-1276292$NOVO NORDISK$$50$YR$$M$Y$$$20240905$$MD$BR$BR
242840471$24284047$1$I$$20240827$20240905$20240905$EXP$$GB-NOVOPROD-1275656$NOVO NORDISK$$63$YR$$M$Y$$$20240905$$HP$GB$GB
242840481$24284048$1$I$20190901$20240827$20240905$20240905$EXP$$US-NOVOPROD-1276566$NOVO NORDISK$$55$YR$$M$Y$$$20240905$$CN$US$US
242840491$24284049$1$I$20220101$20240826$20240905$20240905$EXP$$SG-ROCHE-10000066528$ROCHE$$66$YR$E$M$Y$$$20240905$$CN$SG$SG
242840501$24284050$1$I$$20240829$20240905$20240905$PER$$US-ROCHE-10000070794$ROCHE$$$$$F$Y$$$20240905$$CN$US$US
242840511$24284051$1$I$$20240829$20240905$20240905$PER$$US-ROCHE-10000070458$ROCHE$$$$A$F$Y$$$20240905$$HP$US$US
242840522$24284052$2$F$$20240912$20240905$20240916$PER$$US-ROCHE-10000070430$ROCHE$$$$A$F$Y$$$20240916$$CN$US$US
242840541$24284054$1$I$$20240826$20240905$20240905$EXP$$CN-ROCHE-10000066005$ROCHE$Ding K, Peng Z, Liu D, Xu Y. Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation. Journal of Translational Medicine. 2024-Dec;22 (1): doi:10.1186/s12967-024-05522-y.$43$YR$A$M$Y$$$20240905$$HP$CN$CN
242840551$24284055$1$I$$20240829$20240905$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-027516$UNITED THERAPEUTICS$$79$YR$$F$Y$$$20240905$$$US$US
242840562$24284056$2$F$$20240910$20240905$20240919$EXP$$US-ROCHE-10000063431$ROCHE$$75$YR$E$M$Y$$$20240919$$HP$US$US
242840571$24284057$1$I$$20240830$20240905$20240905$PER$$US-ROCHE-10000071776$ROCHE$$$$A$F$Y$$$20240905$$CN$US$US
242840581$24284058$1$I$$20240827$20240905$20240905$EXP$$MX-NOVOPROD-1276938$NOVO NORDISK$$$$$F$Y$$$20240905$$CN$MX$MX
242840591$24284059$1$I$$20240827$20240905$20240905$EXP$$CO-NOVOPROD-1276777$NOVO NORDISK$$31$YR$$F$Y$$$20240905$$MD$CO$CO
242840601$24284060$1$I$$20240827$20240905$20240905$EXP$$US-NOVOPROD-1276939$NOVO NORDISK$$48$YR$$F$Y$$$20240905$$MD$US$US
242840611$24284061$1$I$20240731$20240827$20240905$20240905$EXP$$US-NOVOPROD-1276697$NOVO NORDISK$$46$YR$$F$Y$$$20240905$$CN$US$US
242840621$24284062$1$I$$20240827$20240905$20240905$EXP$$MX-NOVOPROD-1276966$NOVO NORDISK$$$$$$Y$$$20240905$$CN$MX$MX
242840631$24284063$1$I$20150101$20240827$20240905$20240905$EXP$$US-NOVOPROD-1276903$NOVO NORDISK$$$$$F$Y$$$20240905$$CN$US$US
242840641$24284064$1$I$$20240828$20240905$20240905$EXP$$BR-CURRAX PHARMACEUTICALS LLC-BR-2024CUR004060$CURRAX PHARMACEUTICALS$$40$YR$$M$Y$$$20240905$$CN$BR$BR
242840651$24284065$1$I$20240101$20240829$20240905$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-027361$UNITED THERAPEUTICS$$$$$F$Y$71.202$KG$20240905$$PH$US$US
242840661$24284066$1$I$$20240828$20240905$20240905$EXP$$BR-BIOGEN-2024BI01280651$BIOGEN$$$$$F$Y$$$20240905$$CN$BR$BR
242840671$24284067$1$I$20240828$20240829$20240905$20240905$EXP$GB-MHRA-MED-202408291406028150-RFQSW$GB-VIIV HEALTHCARE LIMITED-GB2024107681$VIIV$$$$$$Y$$$20240905$$MD$GB$GB
242840681$24284068$1$I$20240801$20240830$20240905$20240905$PER$$US-ROCHE-10000071181$ROCHE$$31$YR$A$F$Y$$$20240905$$MD$US$US
242840691$24284069$1$I$$20240828$20240905$20240905$EXP$$IM-BIOGEN-2024BI01280652$BIOGEN$$$$$F$Y$$$20240905$$CN$IM$IM
242840701$24284070$1$I$$20240829$20240905$20240905$PER$$US-AMGEN-USASP2024174529$AMGEN$$$$$M$Y$$$20240904$$CN$US$US
242840731$24284073$1$I$20240101$20240828$20240905$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-023731$UNITED THERAPEUTICS$$$$$F$Y$63.039$KG$20240905$$$US$US
242840742$24284074$2$F$$20240904$20240905$20240912$EXP$$CA-CELLTRION INC.-2024CA021068$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
242840752$24284075$2$F$20240831$20240901$20240905$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-027530$UNITED THERAPEUTICS$$65$YR$$F$Y$79.819$KG$20240910$$$US$US
242840761$24284076$1$I$$20240901$20240905$20240905$PER$$US-ROCHE-10000071705$ROCHE$$$$$$Y$$$20240905$$CN$US$US
242840792$24284079$2$F$$20240904$20240905$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004587$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
242840802$24284080$2$F$20220624$20240912$20240905$20240916$EXP$$JP-TAKEDA-2023TJP009443$TAKEDA$$78$YR$$F$Y$43.8$KG$20240916$$HP$JP$JP
242840811$24284081$1$I$20240825$20240902$20240905$20240905$EXP$$CN-ROCHE-10000072209$ROCHE$$70$YR$E$F$Y$37$KG$20240905$$HP$CN$CN
242840821$24284082$1$I$20231001$20240828$20240905$20240905$PER$$US-BIOGEN-2023BI01241036$BIOGEN$$68$YR$$F$Y$$$20240905$$CN$US$US
242840831$24284083$1$I$$20240821$20240905$20240905$EXP$$US-LEADINGPHARMA-US-2024LEASPO00367$LEADING PHARMA$$$$$M$Y$$$20240905$$CN$US$US
242840841$24284084$1$I$$20240828$20240905$20240905$EXP$$CA-ROCHE-10000069720$ROCHE$$$$A$F$Y$$$20240905$$CN$CA$CA
242840851$24284085$1$I$$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409000373$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240905$$CN$US$US
242840861$24284086$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001567$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240905$$CN$US$US
242840871$24284087$1$I$20240902$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001525$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240905$$CN$US$US
242840881$24284088$1$I$20240827$20240903$20240905$20240905$EXP$$US-ABBVIE-5906318$ABBVIE$$56$YR$$F$Y$$$20240905$$CN$US$US
242840891$24284089$1$I$20240809$20240823$20240905$20240905$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161216$JIANGSU HANSOH PHARMACEUTICAL$$67$YR$$M$Y$51$KG$20240905$$MD$CN$CN
242840901$24284090$1$I$20240101$20240903$20240905$20240905$EXP$$ZA-ABBVIE-5906534$ABBVIE$$69$YR$$M$Y$$$20240905$$CN$ZA$ZA
242840911$24284091$1$I$20240721$20240830$20240905$20240905$EXP$$CA-JNJFOC-20240901674$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240905$$HP$CA$CA
242840922$24284092$2$F$$20240909$20240905$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004584$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242840931$24284093$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3237875$TEVA$$72$YR$$M$Y$95$KG$20240905$$HP$CA$CA
242840941$24284094$1$I$20240101$20240826$20240905$20240905$EXP$DK-DKMA-30729347$DK-NOVOPROD-1276579$NOVO NORDISK$$$$$$Y$$$20240905$$MD$DK$DK
242840952$24284095$2$F$$20240918$20240905$20240924$EXP$$US-SPECGX-T202401814$SPECGX$$$$$$Y$$$20240924$$CN$US$US
242840961$24284096$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3238028$TEVA$$$$$$Y$$$20240905$$HP$CA$CA
242840971$24284097$1$I$20240115$20240830$20240905$20240905$EXP$$JP-EXELIXIS-CABO-24081117$EXELIXIS$$84$YR$$M$Y$$$20240904$$MD$JP$JP
242840982$24284098$2$F$20230101$20240905$20240905$20240912$EXP$$US-BIOGEN-2023BI01232744$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
242840991$24284099$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3237823$TEVA$$56$YR$$M$Y$76$KG$20240905$$HP$CA$CA
242841001$24284100$1$I$$20240820$20240905$20240905$PER$$US-ASTELLAS-2024-AER-002060$ASTELLAS$$75$YR$E$F$Y$$$20240905$$CN$US$US
242841011$24284101$1$I$20240501$20240826$20240905$20240905$PER$$US-SA-2024SA256920$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240905$$HP$US$US
242841022$24284102$2$F$$20240912$20240905$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004583$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
242841031$24284103$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3237883$TEVA$$72$YR$$M$Y$$$20240905$$MD$CA$CA
242841041$24284104$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140905$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240905$$CN$US$US
242841051$24284105$1$I$20240701$20240816$20240905$20240905$PER$$US-TEVA-VS-3234491$TEVA$$37$YR$$F$Y$$$20240905$$CN$US$US
242841062$24284106$2$F$$20240905$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049595$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240906$$CN$US$US
242841071$24284107$1$I$20240701$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004606$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240905$$HP$US$US
242841081$24284108$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004631$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242841091$24284109$1$I$$20240903$20240905$20240905$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-118309$REGENERON$$$$$M$Y$$$20240905$$CN$US$US
242841112$24284111$2$F$20240902$20240904$20240905$20240906$PER$$US-AMGEN-USASP2024175852$AMGEN$$79$YR$E$F$Y$$$20240906$$CN$US$US
242841121$24284112$1$I$20240902$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175720$AMGEN$$72$YR$E$M$Y$$$20240904$$CN$US$US
242841131$24284113$1$I$$20240830$20240905$20240905$PER$$US-ROCHE-10000071448$ROCHE$$$$E$F$Y$$$20240905$$CN$US$US
242841143$24284114$3$F$$20240827$20240905$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-022823$AUROBINDO$Waldner RC, Doulla M, Atallah J, Rathwell S, Grimbly C. Leuprolide Acetate and QTc Interval in Gender-Diverse Youth. Transgend-Health. 2023;8(1):84-88$13$YR$$F$Y$$$20240906$$MD$CA$CA
242841151$24284115$1$I$20240125$20240828$20240905$20240905$EXP$ES-AEMPS-1497527$ES-CELLTRION INC.-2024ES020816$CELLTRION$$$$$$Y$$$20240905$$MD$ES$ES
242841162$24284116$2$F$$20240910$20240905$20240920$EXP$$DE-TEVA-VS-3238248$TEVA$Dyballa N, Hartel JA, Prangenberg J, Andresen-Streichert H. A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting - clinical, toxicological and forensic aspects. Forensic-Sci-Med-Pathol 2024;.; Dyballa N, Hartel JA, Prangenberg J, Andresen-Streichert H. A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting - clinical, toxicological and forensic aspects. Forensic-Sci-Med-Pathol 2024;.$2$MON$$M$Y$$$20240920$$HP$DE$DE
242841171$24284117$1$I$$20240827$20240905$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000758$DECIPHERA PHARMACEUTICALS$$43$YR$A$F$Y$61.7$KG$20240905$$CN$US$US
242841181$24284118$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004579$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242841191$24284119$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004635$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242841202$24284120$2$F$20140801$20240910$20240905$20240920$EXP$$IT-TEVA-VS-3238723$TEVA$Luciano A, Pietroluongo E, Ottaviano M, Grieco A, Peddio A, De Placido P, et al. Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor. Front-Immunol 2024; 15.; Luciano A, Pietroluongo E, Ottaviano M, Grieco A, Peddio A, De Placido P, et al. Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor. ...$$$$$Y$$$20240920$$HP$IT$IT
242841213$24284121$3$F$$20240905$20240905$20240918$EXP$$PT-AUROBINDO-AUR-APL-2024-038063$AUROBINDO$Almeida R, Sitari C, Patraquim A, Blanco R, Pereira R, Mendon?a C. Azithromycin-induced thrombocytopenia ? about a clinical case. Congresses of the Portuguese Society of Internal Medicine:30.? Congresso Nacion. 2024;30:957$79$YR$$F$Y$$$20240918$$MD$PT$PT
242841221$24284122$1$I$20240729$20240823$20240905$20240905$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161217$JIANGSU HANSOH PHARMACEUTICAL$$52$YR$$M$Y$$$20240905$$MD$CN$CN
242841241$24284124$1$I$20240824$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176202$AMGEN$$81$YR$E$M$Y$$$20240904$$CN$US$US
242841251$24284125$1$I$20240101$20240830$20240905$20240905$EXP$$US-AMGEN-USASP2024174094$AMGEN$$80$YR$E$F$Y$$$20240904$$CN$US$US
242841261$24284126$1$I$20240826$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176362$AMGEN$$23$YR$A$F$Y$$$20240904$$PH$US$US
242841271$24284127$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004578$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242841282$24284128$2$F$$20240903$20240905$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003105$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
242841292$24284129$2$F$$20240905$20240905$20240911$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000756$DECIPHERA PHARMACEUTICALS$$76$YR$E$F$Y$$$20240911$$MD$US$US
242841301$24284130$1$I$$20240904$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049657$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240905$$CN$US$US
242841311$24284131$1$I$$20240826$20240905$20240905$30DAY$$US-GSK-US2024106153$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242841321$24284132$1$I$$20240903$20240905$20240905$PER$$US-JNJFOC-20240905469$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$HP$US$US
242841331$24284133$1$I$$20240828$20240905$20240905$EXP$$CA-JNJFOC-20240862928$JOHNSON AND JOHNSON$$14$YR$T$M$Y$48$KG$20240905$$CN$CA$CA
242841341$24284134$1$I$$20240821$20240905$20240905$PER$$US-CorePharma LLC-2161218$COREPHARMA$$$$$F$Y$$$20240905$$$US$US
242841351$24284135$1$I$$20240822$20240905$20240905$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093649$GLENMARK$$$$$$Y$$$20240905$$PH$US$US
242841361$24284136$1$I$$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140803$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240905$$MD$US$US
242841371$24284137$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004607$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242841381$24284138$1$I$$20240902$20240905$20240905$EXP$$IT-JAZZ PHARMACEUTICALS-2024-IT-014051$JAZZ$Salluce  C, Bosetti C, Battin R, Bartolini E. P240 Accidental chronic overdose of Cannabidiol in a child with congenital disorder of glycosylation: reversible drowsiness with no organ toxicity. 15 th European epilepsy congress. 2024$$$$$Y$$$20240904$$HP$IT$IT
242841391$24284139$1$I$$20240829$20240905$20240905$EXP$$CA-GSK-CA2023036611$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$CA$CA
242841401$24284140$1$I$20240301$20240827$20240905$20240905$EXP$$BR-BIOGEN-2024BI01280398$BIOGEN$$48$YR$$M$Y$75$KG$20240905$$CN$BR$BR
242841411$24284141$1$I$$20240823$20240905$20240905$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08599$LUPIN$Bajwa NA, Bajwa AA, Ghazala S, Masood U. Dimethyl fumarate-associated enterocolitis. American Journal of Therapeutics. 2024;31 (4):e448-e450$38$YR$$F$Y$$$20240905$$MD$US$US
242841421$24284142$1$I$20221201$20240827$20240905$20240905$EXP$$US-GSK-US2024106677$GLAXOSMITHKLINE$$29$YR$$F$Y$$$20240905$$CN$US$US
242841431$24284143$1$I$20240830$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175906$AMGEN$$$$$F$Y$$$20240904$$PH$US$US
242841441$24284144$1$I$$20240828$20240905$20240905$EXP$$RO-AstraZeneca-2024A198589$ASTRAZENECA$$89$YR$$F$Y$$$20240905$$CN$RO$
242841451$24284145$1$I$20240801$20240828$20240905$20240905$EXP$$US-JNJFOC-20240877793$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240905$$CN$US$US
242841461$24284146$1$I$20240801$20240821$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409000015$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240905$$CN$US$US
242841472$24284147$2$F$20240808$20240904$20240905$20240906$PER$$NVSC2024US178252$NOVARTIS$$$$$$Y$$$20240906$$HP$US$US
242841481$24284148$1$I$20240827$20240827$20240905$20240905$EXP$$GB-AUROBINDO-AUR-APL-2024-043399$AUROBINDO$$21$YR$$M$Y$74$KG$20240905$$CN$GB$GB
242841491$24284149$1$I$20240712$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004637$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240905$$CN$US$US
242841501$24284150$1$I$$20240902$20240905$20240905$EXP$$TW-AMGEN-TWNSP2024175692$AMGEN$$$$E$M$Y$$$20240904$$HP$TW$TW
242841513$24284151$3$F$$20240916$20240905$20240926$PER$$US-ABBVIE-5902162$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
242841521$24284152$1$I$$20240827$20240905$20240905$EXP$$GB-AUROBINDO-AUR-APL-2024-043373$AUROBINDO$$55$YR$$M$Y$$$20240905$$CN$GB$GB
242841531$24284153$1$I$20240805$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004639$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240905$$CN$US$US
242841541$24284154$1$I$20240828$20240829$20240905$20240905$EXP$$US-BIOGEN-2024BI01280795$BIOGEN$$28$YR$$F$Y$$$20240905$$CN$US$US
242841551$24284155$1$I$20240823$20240828$20240905$20240905$EXP$GB-MHRA-MED-202408280944061300-GKSLF$GB-BIOGEN-2024BI01280492$BIOGEN$$18$YR$$F$Y$$$20240905$$HP$GB$US
242841561$24284156$1$I$$20240828$20240905$20240905$EXP$$BR-BIOGEN-2024BI01280635$BIOGEN$$$$$F$Y$93$KG$20240905$$CN$BR$BR
242841581$24284158$1$I$$20240903$20240905$20240905$EXP$$US-JNJFOC-20240905563$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242841591$24284159$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004609$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242841601$24284160$1$I$$20240826$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135928$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240905$$HP$US$US
242841611$24284161$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043563$AUROBINDO$$32$YR$$F$Y$$$20240905$$HP$CA$CA
242841622$24284162$2$F$$20240910$20240905$20240920$EXP$$ES-TEVA-VS-3238840$TEVA$Rodriguez-Cuadrado FJ, Roustan-Gullon G, Suarez-Massa D, Hospital-Gil M. Multirefractory bullous pemphigoid, psoriasis and psoriatic arthritis successfully treated with guselkumab. Anais-Brasil-Dermatol 2024; 99 (5): 783-785; Rodriguez-Cuadrado FJ, Roustan-Gullon G, Suarez-Massa D, Hospital-Gil M. Multirefractory bullous pemphigoid, psoriasis and psoriatic arthritis successfully treated with guselkumab. Anais-Brasil-Dermatol 2024; 99 (5): 783-785.$48$YR$$M$Y$$$20240920$$HP$ES$ES
242841631$24284163$1$I$20240802$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004641$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240905$$CN$US$US
242841642$24284164$2$F$$20240910$20240905$20240920$EXP$$IL-TEVA-VS-3239242$TEVA$Bettach E, Wiener R, Brosh K, Zadok D, Goldberg M. Cystoid macular edema occurring after intracameral bimatoprost implantation. Eur-J-Ophthalmol 2024; 34 (4): NP20-NP24.; Bettach E, Wiener R, Brosh K, Zadok D, Goldberg M. Cystoid macular edema occurring after intracameral bimatoprost implantation. Eur-J-Ophthalmol 2024; 34 (4): NP20-NP24.$84$YR$$F$Y$$$20240920$$HP$IL$IL
242841652$24284165$2$F$$20240829$20240905$20240913$EXP$$DE-ALXN-202408EEA002047DE$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$MD$DE$DE
242841661$24284166$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004610$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242841671$24284167$1$I$20240820$20240902$20240905$20240905$EXP$$CN-ROCHE-10000072447$ROCHE$$58$YR$A$F$Y$$$20240905$$HP$CN$CN
242841682$24284168$2$F$$20240909$20240905$20240912$PER$$US-JNJFOC-20240879694$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$US$US
242841701$24284170$1$I$$20240902$20240905$20240905$EXP$$JP-JNJFOC-20240909145$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240905$$MD$JP$JP
242841711$24284171$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004611$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242841721$24284172$1$I$20240831$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175878$AMGEN$$56$YR$A$F$Y$$$20240904$$CN$US$US
242841731$24284173$1$I$20240825$20240902$20240905$20240905$EXP$$CN-ROCHE-10000072159$ROCHE$$61$YR$A$F$Y$53.5$KG$20240905$$HP$CN$CN
242841741$24284174$1$I$20230111$20240827$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043319$AUROBINDO$$58$YR$$F$Y$72$KG$20240905$$PH$FR$FR
242841751$24284175$1$I$20210418$20240826$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043026$AUROBINDO$$58$YR$$F$Y$$$20240905$$MD$FR$FR
242841761$24284176$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043309$AUROBINDO$$58$YR$$F$Y$$$20240905$$HP$CA$CA
242841771$24284177$1$I$$20240826$20240905$20240905$30DAY$$US-GSK-US2024AMR107372$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242841781$24284178$1$I$20240830$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175916$AMGEN$$69$YR$E$F$Y$$$20240904$$CN$US$US
242841791$24284179$1$I$$20240823$20240905$20240905$EXP$$US-LEADINGPHARMA-US-2024LEASPO00371$LEADING PHARMA$$$$$$Y$$$20240905$$CN$US$US
242841801$24284180$1$I$$20240821$20240905$20240905$PER$$US-AstraZeneca-2024A175272$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242841811$24284181$1$I$$20240830$20240905$20240905$PER$$US-AstraZeneca-2024A199338$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242841831$24284183$1$I$20230426$20240826$20240905$20240905$EXP$$DE-AUROBINDO-AUR-APL-2024-043111$AUROBINDO$$$$A$F$Y$57$KG$20240905$$HP$DE$DE
242841841$24284184$1$I$$20240829$20240905$20240905$EXP$$US-SPECGX-T202401821$SPECGX$Breland H, Larkins S, Antonini V, Freese T, McGovern M, Dunn J et al. Stimulant use among patients in opioid treatment settings: Provider perspectives. Journal of Substance Use and Addiction Treatment. 2023;151:1-8$26$YR$$M$Y$$$20240905$$HP$US$US
242841851$24284185$1$I$20240904$20240904$20240905$20240905$EXP$GB-MHRA-MED-202409042021491910-PKMHL$GB-JNJFOC-20240908806$JOHNSON AND JOHNSON$$16$YR$T$F$Y$50$KG$20240905$$CN$GB$GB
242841861$24284186$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175597$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
242841872$24284187$2$F$$20240906$20240905$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004572$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242841881$24284188$1$I$$20240826$20240905$20240905$EXP$$JP-ROCHE-10000070230$ROCHE$Komatsu S, Ishihara N, Kido M, Yanagimoto H, Toyama H, Fukumoto T. SHORT COMMUNICATION Novel concept of sequential particle radiotherapy with atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus. Surgery Today. 2024;8 (54):972-6. doi:10.1007/s00595-024-02805-1.$82$YR$E$F$Y$$$20240905$$MD$JP$JP
242841891$24284189$1$I$20240330$20240830$20240905$20240905$EXP$$MA-EMD Serono-2024046973$EMD SERONO INC$$62$YR$A$F$Y$$$20240905$$CN$MA$MA
242841901$24284190$1$I$$20240828$20240905$20240905$30DAY$$US-GSK-US2024AMR108001$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242841911$24284191$1$I$20240812$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004643$ACADIA PHARMACEUTICALS$$62$YR$$M$Y$$$20240905$$CN$US$US
242841921$24284192$1$I$$20240822$20240905$20240905$PER$$US-APOTEX-2024AP009783$APOTEX$Jones H, Bhakta A, Jia L, Wojciechowski D, Torrealba J.. An Unusual Presentation of Metastatic BK Virus-Associated Urothelial Carcinoma Arising in the Allograft, Persisting After Transplant Nephrectomy. International Journal of Surgical Pathology. 2023;31(8):1586-1592$32$YR$$M$Y$$$20240905$$MD$US$US
242841932$24284193$2$F$$20240906$20240905$20240917$EXP$$US-JNJFOC-20240874263$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$PH$US$US
242841941$24284194$1$I$$20240829$20240905$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR108770$VIIV$$40$YR$$M$Y$$$20240905$$PH$US$US
242841951$24284195$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002426$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240905$$CN$US$US
242841961$24284196$1$I$20240901$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001670$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240905$$CN$US$US
242841971$24284197$1$I$$20240821$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001999$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240905$$CN$US$US
242841981$24284198$1$I$$20240828$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408018508$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240905$$CN$US$US
242841992$24284199$2$F$$20240905$20240905$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004644$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
242842001$24284200$1$I$$20240709$20240905$20240905$EXP$$US-GRAVITIPHARMA-GRA-2407-US-SPO-0256$GRAVITI PHARMACEUTICALS$$$$$$Y$$$20240905$$CN$US$US
242842011$24284201$1$I$20240902$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175737$AMGEN$$70$YR$E$M$Y$$$20240905$$CN$US$US
242842021$24284202$1$I$$20240826$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043433$AUROBINDO$$77$YR$$M$Y$81$KG$20240905$$HP$CA$CA
242842031$24284203$1$I$20240801$20240831$20240905$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027197$UNITED THERAPEUTICS$$54$YR$$F$Y$51.701$KG$20240905$$$US$US
242842041$24284204$1$I$$20240829$20240905$20240905$EXP$$BR-ROCHE-10000073065$ROCHE$$$$$F$Y$$$20240905$$MD$BR$BR
242842051$24284205$1$I$20240701$20240812$20240905$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004566$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240905$$CN$US$US
242842061$24284206$1$I$$20240826$20240905$20240905$PER$$US-APOTEX-2024AP010054$APOTEX$Kinney RE, Nair S, Kim CH, Thomas MB, Delatorre M.. Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer. The Oncologist. 2023;28 (6):E478-E486$55$YR$$F$Y$$$20240905$$MD$US$US
242842071$24284207$1$I$$20240828$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138073$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240905$$CN$US$US
242842081$24284208$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140969$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240905$$CN$US$US
242842091$24284209$1$I$$20240820$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133478$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240905$$HP$US$US
242842101$24284210$1$I$$20240719$20240905$20240905$EXP$$US-GRAVITIPHARMA-GRA-2405-US-SPO-0167$GRAVITI PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242842111$24284211$1$I$20240514$20240829$20240905$20240905$EXP$$NVSC2024GR106247$NOVARTIS$$43$YR$$F$Y$$$20240905$$PH$GR$GR
242842121$24284212$1$I$$20240829$20240905$20240905$PER$$US-AMGEN-USASP2024174401$AMGEN$$61$YR$A$F$Y$$$20240905$$MD$US$US
242842131$24284213$1$I$$20240828$20240905$20240905$EXP$$US-TAKEDA-2024TUS087165$TAKEDA$$$$$F$Y$$$20240905$$CN$US$US
242842141$24284214$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004648$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242842151$24284215$1$I$20240820$20240827$20240905$20240905$EXP$$CO-BIOVITRUM-2024-CO-011623$BIOVITRUM$$48$DY$$F$Y$4.3$KG$20240905$$CN$CO$CO
242842161$24284216$1$I$20240622$20240813$20240905$20240905$PER$$US-ASTELLAS-2024US021055$ASTELLAS$$50$YR$A$F$Y$$$20240905$$MD$US$US
242842171$24284217$1$I$20240818$20240903$20240905$20240905$EXP$$US-AstraZeneca-2024A200572$ASTRAZENECA$$$$$F$Y$$$20240905$$MD$US$
242842181$24284218$1$I$$20240828$20240905$20240905$EXP$$ZA-AstraZeneca-2024A172499$ASTRAZENECA$$30$YR$$F$Y$$$20240905$$CN$ZA$
242842191$24284219$1$I$$20240828$20240905$20240905$EXP$$US-AstraZeneca-2024A196443$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
242842201$24284220$1$I$20240829$20240830$20240905$20240905$EXP$$JP-GILEAD-2024-0685894$GILEAD$$$$E$M$Y$$$20240905$$PH$JP$JP
242842211$24284221$1$I$$20240902$20240905$20240905$EXP$$JP-JNJFOC-20240909981$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$PH$JP$JP
242842221$24284222$1$I$$20240821$20240905$20240905$PER$$US-APOTEX-2024AP009874$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240905$$HP$US$US
242842232$24284223$2$F$$20240903$20240905$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004828$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242842241$24284224$1$I$$20240823$20240905$20240905$EXP$$BR-LUPIN PHARMACEUTICALS INC.-2024-08601$LUPIN$Prestes-Carneiro LE, de Abreu MAMM, Roncada EVM, Muchon DG, Caliani FM, Vasconcelos DM. Impact of treatment with ustekinumab on severe infections in a patient with uncontrolled psoriasis and late-onset combined primary immunodeficiency: Case report. Pathogens. 2023;12(9):1-8$28$YR$$M$Y$$$20240905$$HP$BR$BR
242842251$24284225$1$I$$20240821$20240905$20240905$PER$$US-APOTEX-2024AP009875$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240905$$HP$US$US
242842262$24284226$2$F$$20240904$20240905$20240906$PER$$NVSC2024US178255$NOVARTIS$$$$$F$Y$$$20240906$$MD$US$US
242842271$24284227$1$I$$20240825$20240905$20240905$EXP$GB-MHRA-MIDB-753fe7d8-9fa4-4b9b-b384-49d3b51cc92e$GB-DEXPHARM-2024-2972$DEXCEL$$93$YR$E$M$Y$$$20240905$$HP$GB$GB
242842281$24284228$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043766$AUROBINDO$$67$YR$$F$Y$$$20240905$$PH$CA$CA
242842291$24284229$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004614$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242842302$24284230$2$F$20240902$20240911$20240905$20240912$PER$$US-AMGEN-USASP2024176377$AMGEN$$79$YR$E$M$Y$$$20240912$$CN$US$US
242842311$24284231$1$I$20240321$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176276$AMGEN$$61$YR$A$F$Y$$$20240905$$HP$US$US
242842321$24284232$1$I$20240428$20240831$20240905$20240905$EXP$FR-AFSSAPS-PA2024001444$FR-BAUSCH-BL-2024-013143$BAUSCH AND LOMB$$53$YR$$F$Y$85$KG$20240905$$PH$FR$FR
242842331$24284233$1$I$$20240821$20240905$20240905$PER$$US-APOTEX-2024AP009876$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240905$$HP$US$US
242842341$24284234$1$I$$20240901$20240905$20240905$PER$$US-CHATTEMPRD-2024OHG030531$CHATTEM$$$$$M$Y$$$20240905$$CN$US$US
242842351$24284235$1$I$$20240827$20240905$20240905$EXP$$US-JNJFOC-20240870545$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240905$$PH$US$US
242842361$24284236$1$I$20240417$20240422$20240905$20240905$PER$$US-IGSA-BIG0028744$GRIFOLS$$79$YR$$F$Y$59.8$KG$20240905$$PH$US$US
242842371$24284237$1$I$20240901$20240902$20240905$20240905$EXP$$CN-ROCHE-10000071297$ROCHE$$47$YR$A$F$Y$$$20240905$$MD$CN$CN
242842381$24284238$1$I$$20240821$20240905$20240905$PER$$US-APOTEX-2024AP009877$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240905$$HP$US$US
242842391$24284239$1$I$$20240902$20240905$20240905$PER$$US-CHATTEMPRD-2024OHG030488$CHATTEM$$30$YR$A$F$Y$$$20240905$$HP$US$US
242842401$24284240$1$I$$20240814$20240905$20240905$PER$$US-ASTELLAS-2024-AER-001627$ASTELLAS$$65$YR$E$F$Y$$$20240905$$HP$US$US
242842413$24284241$3$F$20231001$20240923$20240905$20240930$EXP$$NO-TEVA-VS-3238920$TEVA$$59$YR$$M$Y$$$20240930$$MD$NO$NO
242842421$24284242$1$I$$20240814$20240905$20240905$PER$$US-ASTELLAS-2024-AER-001757$ASTELLAS$$$$$F$Y$$$20240905$$HP$US$US
242842443$24284244$3$F$$20240911$20240905$20240913$EXP$$CO-TAKEDA-2024TUS088264$TAKEDA$$$$$M$Y$46.2$KG$20240913$$HP$CO$CO
242842451$24284245$1$I$$20240829$20240905$20240905$EXP$$CA-CHEPLA-6000137865$CHEPLAPHARM$$51$YR$$F$Y$$$20240905$$CN$COUNTRY NOT SPECIFIED$CA
242842461$24284246$1$I$$20240827$20240905$20240905$EXP$$PL-CHEPLA-2024011297$CHEPLAPHARM$Kawalec A, Cichon L, Wilczynski K, Janas-Kozik M. First onset of persistent neutropenia in patient undergoing long-term clozapine treatment after vaccination against COVID-19 and SARS-CoV-2 infection in short interval - a case report. Psychiatr Pol. 2024;9:1-11.DOI: 10.12740/PP/OnlineFirst/174064.$23$YR$$F$Y$$$20240903$$HP$COUNTRY NOT SPECIFIED$PL
242842471$24284247$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024108973$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242842481$24284248$1$I$$20240831$20240905$20240905$EXP$$US-JNJFOC-20240903218$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242842491$24284249$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001792$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240905$$CN$US$US
242842501$24284250$1$I$$20240821$20240905$20240905$PER$$US-APOTEX-2024AP009878$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240905$$HP$US$US
242842511$24284251$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001308$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240905$$CN$US$US
242842521$24284252$1$I$20240901$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001738$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240905$$CN$US$US
242842531$24284253$1$I$20240831$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001618$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240905$$CN$US$US
242842541$24284254$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001631$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240905$$CN$US$US
242842551$24284255$1$I$20240828$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001590$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240905$$CN$US$US
242842561$24284256$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001951$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242842571$24284257$1$I$20240903$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001630$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240905$$CN$US$US
242842581$24284258$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001677$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240905$$CN$US$US
242842591$24284259$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004618$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242842601$24284260$1$I$$20240823$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135651$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240905$$CN$US$US
242842612$24284261$2$F$$20240910$20240905$20240920$EXP$$TR-TEVA-VS-3238724$TEVA$Yazdali Koylu N, Koc NS, Sancar EN, Sarinc S, Altun B. Everolimus-Related Chylothorax: A Rare Case Report. Exp-Clin-Transplant 2024; 22 (6): 471-474.; Yazdali Koylu N, Koc NS, Sancar EN, Sarinc S, Altun B. Everolimus-Related Chylothorax: A Rare Case Report. Exp-Clin-Transplant 2024; 22 (6): 471-474.; Yazdali Koylu N, Koc NS, Sancar EN, Sarinc S, Altun B. Everolimus-Related Chylothorax: A Rare Case Report. Exp-Clin-Transplant 2024; 22 (6): 471-474.$27$YR$$M$Y$$$20240920$$HP$TR$TR
242842621$24284262$1$I$20240801$20240902$20240905$20240905$EXP$$NVSJ2024JP010467$NOVARTIS$$$$A$M$Y$$$20240905$$MD$JP$JP
242842631$24284263$1$I$$20240827$20240905$20240905$EXP$$CA-APOTEX-2024AP010022$APOTEX$$$$$F$Y$$$20240905$$MD$CA$CA
242842642$24284264$2$F$$20240910$20240905$20240920$EXP$$GB-TEVA-VS-3238709$TEVA$Edwards GM, Alejmi AA. Pure red cell aplasia secondary to erythropoietin therapy. Clin-Med-London 2024; 24 (4):.; Edwards GM, Alejmi AA. Pure red cell aplasia secondary to erythropoietin therapy. Clin-Med-London 2024; 24 (4):.$53$YR$$M$Y$$$20240920$$HP$GB$GB
242842651$24284265$1$I$$20240828$20240905$20240905$EXP$$JP-ROCHE-10000072210$ROCHE$$6$DEC$A$F$Y$$$20240905$$PH$JP$JP
242842661$24284266$1$I$20240524$20240822$20240905$20240905$EXP$$US-UCBSA-2024043085$UCB$$36$YR$$F$Y$77.551$KG$20240905$$HP$US$US
242842671$24284267$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004619$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242842681$24284268$1$I$20240824$20240829$20240905$20240905$EXP$$US-BEH-2024178001$CSL BEHRING$$12$YR$T$M$Y$$$20240905$$CN$US$US
242842691$24284269$1$I$$20240826$20240905$20240905$EXP$$US-JNJFOC-20240867546$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242842701$24284270$1$I$20240809$20240826$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043102$AUROBINDO$$77$YR$$F$Y$93$KG$20240905$$PH$FR$FR
242842711$24284271$1$I$20240101$20240827$20240905$20240905$EXP$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000747$DECIPHERA PHARMACEUTICALS$$80$YR$E$M$Y$$$20240905$$CN$US$US
242842721$24284272$1$I$20200101$20240822$20240905$20240905$EXP$$GB-JUBILANT PHARMA LTD-2024GB001229$JUBILANT$$63$YR$$F$Y$80$KG$20240905$$CN$GB$GB
242842741$24284274$1$I$$20240702$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008168$STRIDES$Carroll BT, Scott SL, Theibert HPM, Slavnic B, Vellankl KD.. Krankheitsreste: The residual signs of catatonia. A case series.. Ann-Clin-Psychiatry. 2022;34(3):192-196$30$YR$$M$Y$$$20240905$$MD$US$US
242842751$24284275$1$I$$20240723$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009411$STRIDES$Majid M, Arockiam AD, Yaker ZS, Kumar A, Agrawal A, Bhalla JS, et al.. A CASE OF LONGSTANDING CHRONIC RECURRENT PERICARDITIS MANAGED WITH ADVANCED DIAGNOSTIC AND THERAPEUTIC METHODS.. J-Am-Coll-Cardiol. 2024;83 (13):3496$65$YR$$F$Y$$$20240905$$HP$US$US
242842761$24284276$1$I$$20240711$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008819$STRIDES$Betts C, Maxwell M, Floyd M, Pawlowski J.. Neoadjuvant Cemiplimab Followed by Radiation for Locally Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: A Case Report. Adv-Radiat-Oncol. 2024;9 (8)$60$YR$$F$Y$$$20240905$$HP$US$US
242842771$24284277$1$I$$20240812$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010354$STRIDES$Juneja P, Swor D.. An Evidence-Based Approach to Diagnosis and Prognosis in a Young Woman with New-Onset Super-Refractory Status Epilepticus: A Case Report.. Case-Rep-Neurol. 2022;14 (1):5-11$24$YR$$F$Y$$$20240905$$HP$US$US
242842781$24284278$1$I$$20240807$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010188$STRIDES$Nance M, Merten J, Grooms A.. (022) Catatonia: Where to Look When ECT Fails.. J-Acad-Consult-Liaison-Psychiatry. 2023;64 (Suppl.):S11-S12 abstr. 022.$65$YR$$F$Y$$$20240905$$HP$US$US
242842791$24284279$1$I$$20240612$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007097$STRIDES$Deshpande P, Vyata V, Diaz-Abad M, Konikkara J.. SLEEP-RELATED HALLUCINATIONS.. Sleep. 2024;47 (Suppl. 1):A511 abstr. 1195.$93$YR$$M$Y$$$20240905$$HP$US$US
242842801$24284280$1$I$$20240722$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009287$STRIDES$Schambach S, Esteitie R, Nader A.. Diffuse Disseminated Demyelination: A Detrimental Outcome. Am-J-Respir-Crit-Care-Med. 2023;207$27$YR$$M$Y$$$20240905$$HP$US$US
242842811$24284281$1$I$$20240726$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009651$STRIDES$Wang EJ, Berninger LE, Smith TJ, Pantelyat AY.. Scrambler Therapy for the Treatment of Pain and Sensory Symptoms in Corticobasal Syndrome: A Case Series.. Pain-Med-Case-Rep. 2023;7 (3):151-155.$70$YR$$M$Y$$$20240905$$MD$US$US
242842821$24284282$1$I$$20240719$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009259$STRIDES$Redmond MA, Begnaud A.. Dressler^s Syndrome Is Making a Comeback: Massive Pleural Effusion After Atrial Fibrillation Ablation.. Am-J-Respir-Crit-Care-Med. 2024;209:A1925 (plus Poster)$73$YR$$F$Y$$$20240905$$HP$US$US
242842831$24284283$1$I$$20240729$20240905$20240905$PER$US-MLMSERVICE-20240722-PI138982-00196-1$US-STRIDES ARCOLAB LIMITED-2024SP009714$STRIDES$Lopez-Canelas D, Delgado-Serrano LJ.. Rapid-onset obsessive-compulsive disorder with hallucinations in a post-seizure four-year-old male.. Cureus.. 2024;16(6):e62630.$4$YR$$M$Y$$$20240905$$MD$US$US
242842841$24284284$1$I$$20240715$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008899$STRIDES$King S, Johnson A, Jelsing E.. Gluteus Maximus Distal Myotendinous Junction Tear in a Pickleball Player: A Case Report.. Curr-Sports-Med-Rep. 2024;23 (6):213 - 215$72$YR$$M$Y$$$20240905$$MD$US$US
242842851$24284285$1$I$$20240822$20240905$20240905$EXP$$US-ALVOGEN-2024095404$ALVOGEN$Shaikh M, Golzarian H, Hakim F A. Wide QRS tachycardia in a patient with atrial  fibrillation: a case report and approach  to diagnosis. European Heart Journal. 2024;8:ytae328. doi:https://doi.org/10.1093/ehjcr/ytae328$87$YR$$M$Y$$$20240905$$HP$US$US
242842861$24284286$1$I$$20240717$20240905$20240905$PER$$US-STRIDES PHARMA UK LTD.-2024SP009139$STRIDES$Andrews T.. Hypersensitivity to Ibuprofen: Real-Life Experience in Children With History of Suspected Immediate Reactions.. Pediatrics. 2023;152 (Suppl. 3):S18-S19$$$$$Y$$$20240905$$MD$US$US
242842871$24284287$1$I$$20240828$20240905$20240905$EXP$$IT-TAKEDA-2014BAX075348$TAKEDA$$42$YR$$F$Y$$$20240905$$HP$IT$IT
242842881$24284288$1$I$20240902$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176216$AMGEN$$83$YR$E$F$Y$$$20240905$$CN$US$US
242842891$24284289$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176439$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242842901$24284290$1$I$20240213$20240827$20240905$20240905$EXP$$GB-AUROBINDO-AUR-APL-2024-043320$AUROBINDO$$$$$F$Y$92$KG$20240905$$CN$GB$GB
242842911$24284291$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140893$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240905$$CN$US$US
242842931$24284293$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140888$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240905$$CN$US$US
242842941$24284294$1$I$$20240828$20240905$20240905$EXP$$BR-GENMAB-2024-03192$GENMAB$$$$$M$Y$$$20240905$$MD$BR$BR
242842951$24284295$1$I$20240119$20240826$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-010298$AUROBINDO$$50$YR$$F$Y$62$KG$20240905$$MD$FR$FR
242842961$24284296$1$I$$20240827$20240905$20240905$PER$$US-ABBVIE-5898149$ABBVIE$$$$A$M$Y$$$20240905$$HP$US$US
242842971$24284297$1$I$20220101$20240826$20240905$20240905$EXP$$IT-AUROBINDO-AUR-APL-2024-043146$AUROBINDO$$65$YR$$F$Y$66$KG$20240905$$MD$IT$IT
242842981$24284298$1$I$20200804$20240826$20240905$20240905$EXP$$PL-AUROBINDO-AUR-APL-2024-043148$AUROBINDO$$38$YR$$F$Y$60$KG$20240905$$MD$PL$PL
242842991$24284299$1$I$$20240826$20240905$20240905$EXP$$NL-AUROBINDO-AUR-APL-2024-043284$AUROBINDO$$$$$F$Y$$$20240905$$MD$NL$NL
242843001$24284300$1$I$20240809$20240825$20240905$20240905$EXP$GB-MHRA-MED-202408251108104900-LSWQG$GB-Accord-443483$ACCORD$$$$$F$Y$89$KG$20240905$$CN$GB$GB
242843011$24284301$1$I$$20240828$20240905$20240905$EXP$$CA-GSK-CA2024GSK108137$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$CA$CA
242843021$24284302$1$I$20240801$20240830$20240905$20240905$EXP$$CA-JNJFOC-20240863838$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240905$$HP$CA$CA
242843031$24284303$1$I$$20240828$20240905$20240905$EXP$$GB-JNJFOC-20240903571$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240905$$CN$GB$GB
242843041$24284304$1$I$20240101$20240817$20240905$20240905$PER$$US-AstraZeneca-2024A141655$ASTRAZENECA$$62$YR$$$Y$60.4$KG$20240905$$CN$US$
242843051$24284305$1$I$20240830$20240831$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002501$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240905$$CN$US$US
242843061$24284306$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001655$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242843071$24284307$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001647$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240905$$CN$US$US
242843082$24284308$2$F$$20240910$20240905$20240920$EXP$$US-TEVA-VS-3238449$TEVA$Schwartz AH, Sieminski S. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event. Am-J-Ophthalmol-Case-Rep 2023; 30 1-4.; Schwartz AH, Sieminski S. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event. Am-J-Ophthalmol-Case-Rep 2023; 30 1-4.$59$YR$$F$Y$$$20240920$$HP$US$US
242843091$24284309$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043707$AUROBINDO$$91$YR$$F$Y$72$KG$20240905$$PH$CA$CA
242843102$24284310$2$F$$20240906$20240905$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004623$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
242843111$24284311$1$I$$20240819$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08310$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242843121$24284312$1$I$$20240826$20240905$20240905$EXP$$US-Accord-444098$ACCORD$$49$YR$$F$Y$$$20240905$$PH$US$US
242843141$24284314$1$I$$20240827$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043268$AUROBINDO$Pluchart H, Ferrer L, Giovannini D, Tetaz R, Pinsolle J, Stephanov O, et al.. Concomitant use of nivolumab and immunosuppressants in a renal transplant patient.. Journal of respiratory diseases.. 2019;1-5$71$YR$$M$Y$$$20240905$$HP$FR$FR
242843152$24284315$2$F$$20240828$20240905$20240912$EXP$$US-BEH-2024177463$CSL BEHRING$$74$YR$E$F$Y$55$KG$20240912$$CN$US$US
242843161$24284316$1$I$$20240820$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08555$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242843171$24284317$1$I$$20240823$20240905$20240905$PER$$US-LEADINGPHARMA-US-2024LEASPO00373$LEADING PHARMA$$$$$$Y$$$20240905$$CN$US$US
242843181$24284318$1$I$$20240823$20240905$20240905$EXP$$US-LEADINGPHARMA-US-2024LEASPO00372$LEADING PHARMA$$$$$M$Y$$$20240905$$CN$US$US
242843192$24284319$2$F$$20240906$20240905$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08477$LUPIN$$$$$$Y$$$20240921$$CN$US$US
242843201$24284320$1$I$$20240827$20240905$20240905$EXP$$CA-APOTEX-2024AP010023$APOTEX$$49$YR$$F$Y$$$20240905$$PH$CA$CA
242843223$24284322$3$F$20240825$20240918$20240905$20240919$PER$$US-AMGEN-USASP2024176392$AMGEN$$63$YR$A$F$Y$$$20240919$$CN$US$US
242843231$24284323$1$I$$20240823$20240905$20240905$PER$$US-LEADINGPHARMA-US-2024LEASPO00370$LEADING PHARMA$$$$$$Y$$$20240905$$CN$US$US
242843251$24284325$1$I$20240801$20240827$20240905$20240905$EXP$$JP-JNJFOC-20240907650$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$MD$JP$JP
242843261$24284326$1$I$20240124$20240827$20240905$20240905$EXP$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00412$Unknown Manufacturer$$$$$$Y$$$20240905$$HP$US$US
242843281$24284328$1$I$20240827$20240828$20240905$20240905$EXP$$US-JNJFOC-20240873643$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240905$$CN$US$US
242843291$24284329$1$I$$20240902$20240905$20240905$EXP$$AU-AstraZeneca-2024A199770$ASTRAZENECA$$$$$F$Y$$$20240905$$MD$AU$
242843301$24284330$1$I$20240815$20240831$20240905$20240905$EXP$$KE-AstraZeneca-2024A199554$ASTRAZENECA$$27986$DY$$F$Y$$$20240905$$CN$KE$
242843321$24284332$1$I$$20240820$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08531$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242843331$24284333$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178287$NOVARTIS$$$$$M$Y$$$20240905$$HP$US$US
242843351$24284335$1$I$$20240830$20240905$20240905$EXP$GB-CHEPLA-2024010962$GB-RDY-SPO/GBR/24/0012738$DR REDDYS$$16$YR$T$M$Y$$$20240905$$CN$GB$GB
242843361$24284336$1$I$$20240827$20240905$20240905$EXP$$CA-APOTEX-2024AP010031$APOTEX$$89$YR$$M$Y$$$20240905$$HP$CA$CA
242843371$24284337$1$I$20240818$20240901$20240905$20240905$EXP$$SA-SANDOZ INC.-SDZ2024SA077334$SANDOZ$$57$YR$$F$Y$$$20240905$$CN$SA$SA
242843381$24284338$1$I$$20240824$20240905$20240905$EXP$$JP-ASTELLAS-2024-AER-002897$ASTELLAS$Yamada S, Sakai K, Kubo M, Okumura H, Asakura H, Miyamoto T, et al. Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy. Research and Practice in Thrombosis and Haemostasis. 2024;8(5): 1-11. doi:10.1016/j.rpth.2024.102517.$64$YR$A$F$Y$$$20240905$$MD$JP$JP
242843391$24284339$1$I$20240711$20240903$20240905$20240905$EXP$FR-AFSSAPS-GR2024001010$FR-SANDOZ INC.-SDZ2024FR077268$SANDOZ$$53$YR$$F$Y$$$20240905$$PH$FR$FR
242843401$24284340$1$I$$20240829$20240905$20240905$EXP$$CA-TEVA-VS-3238580$TEVA$$46$YR$$F$Y$88$KG$20240905$$PH$CA$CA
242843411$24284341$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001723$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240905$$CN$US$US
242843421$24284342$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001961$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240905$$CN$US$US
242843431$24284343$1$I$20240818$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001661$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240905$$CN$US$US
242843441$24284344$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001518$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240905$$CN$US$US
242843451$24284345$1$I$$20240828$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408018248$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240905$$CN$US$US
242843461$24284346$1$I$20240903$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001759$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240905$$CN$US$US
242843471$24284347$1$I$20240101$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001598$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240905$$CN$US$US
242843481$24284348$1$I$20240902$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001489$ELI LILLY AND CO$$60$YR$A$$Y$$$20240905$$CN$US$US
242843491$24284349$1$I$20240901$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001418$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240905$$CN$US$US
242843501$24284350$1$I$20240826$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001674$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240905$$CN$US$US
242843511$24284351$1$I$20240826$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001760$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240905$$CN$US$US
242843521$24284352$1$I$20240801$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002569$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240905$$CN$US$US
242843531$24284353$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001472$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240905$$CN$US$US
242843541$24284354$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001494$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240905$$CN$US$US
242843551$24284355$1$I$$20240823$20240905$20240905$EXP$$GB-QUAGEN-2024QUALIT00251$QUAGEN PHARMACEUTICALS$Divya Khanna.A topical matter: iatrogenic adrenal crisis following excessive prescription corticosteroid use. .British Journal of Dermatology.JUL-2024;192:i188$39$YR$A$M$Y$$$20240905$$HP$GB$GB
242843561$24284356$1$I$20230101$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140878$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240905$$CN$US$US
242843571$24284357$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140966$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240905$$HP$US$US
242843581$24284358$1$I$20240401$20240828$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137696$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240905$$CN$US$US
242843591$24284359$1$I$20240819$20240828$20240905$20240905$EXP$$US-JNJFOC-20240876090$JOHNSON AND JOHNSON$$75$YR$E$F$Y$59.1$KG$20240905$$HP$US$US
242843601$24284360$1$I$$20240829$20240905$20240905$EXP$$CA-TEVA-VS-3238718$TEVA$$88$YR$$M$Y$$$20240905$$PH$CA$CA
242843611$24284361$1$I$20240901$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176053$AMGEN$$76$YR$E$F$Y$$$20240905$$CN$US$US
242843622$24284362$2$F$$20240911$20240905$20240917$PER$$US-TAKEDA-2024TUS086565$TAKEDA$$$$$$Y$$$20240917$$HP$US$US
242843631$24284363$1$I$20240902$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175907$AMGEN$$79$YR$E$M$Y$$$20240905$$CN$US$US
242843643$24284364$3$F$20240814$20240913$20240905$20240920$EXP$$US-EMD Serono-2024047313$EMD SERONO INC$$57$YR$A$F$Y$$$20240920$$CN$US$US
242843652$24284365$2$F$$20240905$20240905$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004625$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242843661$24284366$1$I$$20240829$20240905$20240905$EXP$$CA-TEVA-VS-3238672$TEVA$$70$YR$$F$Y$65$KG$20240905$$PH$CA$CA
242843671$24284367$1$I$$20240831$20240905$20240905$EXP$$IN-ROCHE-3533307$ROCHE$$75$YR$E$M$Y$$$20240905$$CN$IN$IN
242843681$24284368$1$I$20221102$20240903$20240905$20240905$EXP$$US-UCBSA-2024045076$UCB$$45$YR$$M$Y$$$20240905$$HP$US$US
242843691$24284369$1$I$20240819$20240830$20240905$20240905$EXP$$NVSC2024US175627$NOVARTIS$$51$YR$$M$Y$$$20240905$$CN$US$US
242843701$24284370$1$I$$20240826$20240905$20240905$EXP$$US-UCBSA-2024044964$UCB$Henry M, Shupak RP, Christensen B.. Are There Any Risk Factors for Serious Adverse Events in Procedural Outpatient Sedations by Oral and Maxillofacial Surgeons?. Journal of Oral and Maxillofacial Surgery. 2024;82(9):S15-7$$$$$Y$$$20240905$$HP$US$US
242843711$24284371$1$I$20221215$20240830$20240905$20240905$EXP$FR-AFSSAPS-MP2024001335$FR-EMD Serono-2024046730$EMD SERONO INC$$0$DY$N$F$Y$3$KG$20240905$$MD$FR$PF
242843721$24284372$1$I$$20240902$20240905$20240905$EXP$PT-SANDOZ-SDZ2024PT074387$PT-ROCHE-10000071975$ROCHE$Cl?udia Costa, Am?lia Antunes, Jo?o Oliveira, Marta Pereira, Lolanda Godinho, Paulo Fernandes, Sofia Jorge, Jos? Ant?nio Lopes, Joana Gameiro ,. Rituximab in Steroid-Dependent Podocytopathies. Glomerular Dis. 2024;4:129-136. doi:10.1159/000539922$38$YR$A$F$Y$$$20240905$$HP$PT$PT
242843731$24284373$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004624$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242843741$24284374$1$I$$20240826$20240905$20240905$30DAY$$US-GSK-US2024106126$GLAXOSMITHKLINE$$$$E$M$Y$$$20240905$$CN$US$US
242843751$24284375$1$I$$20240902$20240905$20240905$EXP$$CA-SANDOZ INC.-NVSC2020CA204505$SANDOZ$$75$YR$$F$Y$70$KG$20240905$$MD$CA$CA
242843761$24284376$1$I$20231207$20240830$20240905$20240905$EXP$$JP-ROCHE-10000067777$ROCHE$$80$YR$E$M$Y$53.7$KG$20240905$$MD$JP$JP
242843771$24284377$1$I$$20240830$20240905$20240905$EXP$$BR-ROCHE-10000072022$ROCHE$$$$$$Y$$$20240905$$MD$BR$BR
242843781$24284378$1$I$20231101$20240829$20240905$20240905$EXP$DE-DCGMA-24203783$DE-ROCHE-10000069155$ROCHE$$72$YR$E$F$Y$86$KG$20240905$$MD$DE$DE
242843791$24284379$1$I$20240607$20240829$20240905$20240905$EXP$FR-AFSSAPS-LL2024001619$FR-EMD Serono-2024046432$EMD SERONO INC$$73$YR$E$F$Y$65$KG$20240905$$MD$FR$FR
242843801$24284380$1$I$$20240823$20240905$20240905$EXP$$ES-QUAGEN-2024QUALIT00252$QUAGEN PHARMACEUTICALS$M Romero Carratala.Meropenem for the management of valproic acid intoxication: a case report and a review of the literature.Medicina Intensiva.JUL-2024$59$YR$A$F$Y$$$20240905$$HP$ES$ES
242843811$24284381$1$I$$20240902$20240905$20240905$EXP$$KR-ROCHE-10000072471$ROCHE$Jo H, Kang J, Choi S, Park S. Intravenous Immunoglobulin as a Key to Treating Recurrent COVID-19 in Rituximab-Induced Immunodeficiency: A Clinical Case Insight. Infection and Chemotherapy. 2024-Apr;56:S156.$47$YR$A$F$Y$$$20240905$$HP$KR$KR
242843821$24284382$1$I$$20240904$20240905$20240905$EXP$$CA-SANDOZ INC.-SDZ2024CA077802$SANDOZ$$79$YR$$F$Y$$$20240905$$CN$CA$CA
242843831$24284383$1$I$$20240828$20240905$20240905$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08209$HIKMA$$$$$F$Y$$$20240905$$CN$US$US
242843851$24284385$1$I$$20240826$20240905$20240905$30DAY$$US-GSK-US2024106159$GLAXOSMITHKLINE$$$$$M$Y$$$20240905$$CN$US$US
242843861$24284386$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004626$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242843871$24284387$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140203$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240905$$CN$US$US
242843892$24284389$2$F$$20240905$20240905$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004913$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
242843901$24284390$1$I$20240820$20240823$20240905$20240905$PER$$US-GRANULES-US-2024GRASPO00387$GRANULES INDIA$$60$YR$A$M$Y$203$KG$20240905$$CN$US$US
242843911$24284391$1$I$20240822$20240829$20240905$20240905$30DAY$$US-GSK-US2024107719$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240905$$CN$US$US
242843921$24284392$1$I$20240101$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176295$AMGEN$$54$YR$A$M$Y$$$20240905$$HP$US$US
242843931$24284393$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176071$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242843942$24284394$2$F$20240830$20240926$20240905$20240927$PER$$US-AMGEN-USASP2024176076$AMGEN$$82$YR$E$F$Y$$$20240927$$CN$US$US
242843951$24284395$1$I$$20240830$20240905$20240905$EXP$$US-SANDOZ INC.-SDZ2024US077612$SANDOZ$$$$$F$Y$16.78$KG$20240905$$CN$US$US
242843961$24284396$1$I$$20240904$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049613$BOEHRINGER INGELHEIM$$$$$$Y$$$20240905$$CN$US$US
242843971$24284397$1$I$$20240806$20240905$20240905$30DAY$$US-VEROBIOTECH-2024USVEROSPO00199$VERO BIOTECH$$$$$$Y$$$20240905$$HP$US$US
242843981$24284398$1$I$20240623$20240823$20240905$20240905$EXP$$US-GRANULES-US-2024GRASPO00388$GRANULES INDIA$$79$YR$E$M$Y$185$KG$20240905$$CN$US$US
242843991$24284399$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002700$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240905$$CN$US$US
242844011$24284401$1$I$20240801$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141016$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240905$$HP$US$US
242844021$24284402$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141023$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240905$$PH$US$US
242844032$24284403$2$F$20240802$20240909$20240905$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024143$UNITED THERAPEUTICS$$41$YR$$F$Y$71.202$KG$20240918$$PH$US$US
242844041$24284404$1$I$$20240621$20240905$20240905$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14099$ALKEM$Bhargava V, Malloy M, Fonseca R. The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit. BMC Pediatrics. 2017;17:50$$$N$$Y$$$20240905$$HP$US$US
242844051$24284405$1$I$$20240621$20240905$20240905$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12990$ALKEM$Bhargava V, Malloy M, Fonseca R.. The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit. BMC Pediatrics. 2017;17:50$$$N$$Y$$$20240905$$HP$US$US
242844061$24284406$1$I$20240702$20240716$20240905$20240905$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-16833$ALKEM$$3$YR$$M$Y$$$20240905$$MD$IN$IN
242844071$24284407$1$I$$20240726$20240905$20240905$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-16775$ALKEM$Toda Y, Yamazaki M, Ota T, Fujisawa Y, Kimura K.. A case of Cefepime encephalopathy, being difficult to distinguish from non-convulsive status epilepticus during the treatment of bacterial meningitis. Rinsho Shinkeigaku. 2016;56(10):678-683$64$YR$$M$Y$$$20240905$$MD$JP$JP
242844081$24284408$1$I$$20240717$20240905$20240905$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-16345$ALKEM$Wei J, Ning J.. Successful treatment of penicillin-resistant pneumococcal meningitis following ventriculo-peritoneal shunt for congenital hydrocephalus: A case report on the efficacy of linezolid. Asian Journal of Surgery. 2024;47:3389$1$YR$$F$Y$$$20240905$$HP$CN$CN
242844091$24284409$1$I$$20240625$20240905$20240905$EXP$$ZA-ALKEM LABORATORIES LIMITED-ZA-ALKEM-2024-14280$ALKEM$Fataar A, Pillay-Fuentes Lorente V, Decloedt EH, van Eck A, Reddy K, Dramowski A, Bekker A. A Retrospective Study Evaluating Neonatal Vancomycin Loading Doses to Achieve a Therapeutic Target. Ther Drug Monit. 2024;00 (00):1-9$$$N$$Y$$$20240905$$HP$ZA$ZA
242844101$24284410$1$I$$20240610$20240905$20240905$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-13208$ALKEM$Miyamori D, Shigemoto N, Une K, Kinoshita H, Harimoto S, Sakashita T, Ito M. Delayed onset septic pelvic thrombophlebitis treated by tissue-plasminogen activator following initial treatment for massive right ovarian vein thrombosis and methicillin-resistant Staphylococcus aureus bacteremia: A case report. J Obstet Gynaecol Res. 2024;unk:unk$40$YR$$F$Y$$$20240905$$HP$JP$JP
242844111$24284411$1$I$$20240715$20240905$20240905$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-15470$ALKEM$Zhao F, Lin L, Wang H, Wang L, Xu Y, Guo L. Application of next-generation sequencing in acute tonsillitis complicated with descending necrotizing mediastinitis: A case report. Medicine. 2024;103(27):e38798$56$YR$$F$Y$$$20240905$$HP$CN$CN
242844121$24284412$1$I$$20240605$20240905$20240905$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-12569$ALKEM$Yamada M, Shoji K, Fukuda T, Tao C, Myojin S, Ogiwara H, Usami K, Saito J.. Two Cases of Children With Black Hairy Tongue and Tooth Discoloration Caused by Antibacterial Agents. Cureus. 2024;16(4):e58354$2$YR$$M$Y$$$20240905$$HP$JP$JP
242844131$24284413$1$I$$20240722$20240905$20240905$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16813$ALKEM$Shrivastava S, Shrivastava S.. Vancomycin Flushing Syndrome: A Case Report. Cureus. 2024;16(4):e58487$44$YR$$F$Y$$$20240905$$HP$US$US
242844142$24284414$2$F$$20240612$20240905$20240905$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-13339$ALKEM$Stojanova J, Brown JD, Reuter SE, Marriott DJE. Very high linezolid clearance in a critically ill patient: A case report suggesting a novel metabolic induction mechanism. International Journal of Antimicrobial Agents. 2024;63:107170$19$YR$$M$Y$$$20240905$$HP$AU$AU
242844151$24284415$1$I$$20240809$20240905$20240905$EXP$$QA-ALKEM LABORATORIES LIMITED-QA-ALKEM-2024-17909$ALKEM$Ali MY, Fadul A, Ali MO, Mohamed MY.. Repeated Peritonitis in a Peritoneal Dialysis Patient: An Unusual Case of Bacillus licheniformis With Vancomycin Failure Despite Sensitivity. Cureus. 2024;16(7):e65205$55$YR$$F$Y$$$20240905$$HP$QA$QA
242844161$24284416$1$I$$20240724$20240905$20240905$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-17248$ALKEM$Sumiyoshi S, Hamaguchi S, Kimura K, Negishi K, Ninomiya K, Sasaki M, Kutsuna S.. Ruthenibacterium lactatiformans isolated from a human blood culture: a first report. BMC Infectious Diseases. 2024;24:1-4$82$YR$$M$Y$$$20240905$$HP$JP$JP
242844171$24284417$1$I$$20240726$20240905$20240905$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-17385$ALKEM$Shiiba R, Sano M, Kogure Y, Murao H, Takigawa Y, Torii A, Yamada A, Shinohara Y, Niwa H, Kitagawa C, Oki M.. A case of community-acquired Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus (MRSA) necrotizing pneumonia successfully treated with two anti-MRSA drugs. Respiratory Medicine Case Reports. 2024;49:102023$22$YR$$M$Y$$$20240905$$HP$JP$JP
242844181$24284418$1$I$$20240701$20240905$20240905$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14946$ALKEM$Guevara A, Siqueira NP, de Sousa RP, Dos Santos TB, Assis SB, de Camargo ZP, Rodrigues AM, Hagen F, Hahn RC.. Clinical response to prednisone in a severe case of infant-juvenile paracoccidioidomycosis. Revista Iberoamericana de Micologia. 2024;unk:unk$9$YR$$M$Y$$$20240905$$HP$BR$BR
242844191$24284419$1$I$$20240717$20240905$20240905$EXP$$CH-ALKEM LABORATORIES LIMITED-CH-ALKEM-2024-16371$ALKEM$Bausch S, Araschmid LJ, Hardmeier M, Osthoff M.. Cefepime-induced neurotoxicity in the setting of acute kidney injury: a case series and discussion of preventive measures. Cureus. 2022;14(6):e26392$75$YR$$F$Y$$$20240905$$HP$CH$CH
242844201$24284420$1$I$$20240715$20240905$20240905$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-16092$ALKEM$Ruze R, Jiang T, Zhang W, Zhang M, Zhang R, Guo Q, Aboduhelili A, Zhayier M, Mahmood A, Yu Z, Ye J, Shao Y, Aji T. Liver autotransplantation and atrial reconstruction on a patient with multiorgan alveolar echinococcosis: a case report. BMC Infectious Diseases. 2024;24:659$59$YR$$F$Y$$$20240905$$HP$CN$CN
242844211$24284421$1$I$$20240625$20240905$20240905$EXP$$ZA-ALKEM LABORATORIES LIMITED-ZA-ALKEM-2024-14281$ALKEM$Fataar A, Pillay-Fuentes Lorente V, Decloedt EH, Van Eck A, Reddy K, Dramowski A, Bekker A.. A Retrospective Study Evaluating Neonatal Vancomycin Loading Doses to Achieve a Therapeutic Target. Ther Drug Monit. 2024;00 (00):1-9$$$N$$Y$$$20240905$$HP$ZA$ZA
242844221$24284422$1$I$$20240528$20240905$20240905$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-11999$ALKEM$Sakata K, Katsumoto T, Kumagai T, Shinoda K.. Electroretinographic Evaluations Using Skin Electrode of Eyes with Bleb-Related Endophthalmitis Following Vitrectomy with 0.025 percent Povidone Iodine Irrigation. International Medical Case Reports Journal. 2024;17:447-454$63$YR$$M$Y$$$20240905$$HP$JP$JP
242844231$24284423$1$I$$20240528$20240905$20240905$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-11998$ALKEM$Sakata K, Katsumoto T, Kumagai T, Shinoda K. Electroretinographic Evaluations Using Skin Electrode of Eyes with Bleb-Related Endophthalmitis Following Vitrectomy with 0.025 percent Povidone Iodine Irrigation. International Medical Case Reports Journal. 2024;17:447-454$46$YR$$M$Y$$$20240905$$HP$JP$JP
242844241$24284424$1$I$$20240621$20240905$20240905$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-14100$ALKEM$Bhargava V, Malloy M, Fonseca R. The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit. BMC Pediatrics. 2017;17:50$$$N$$Y$$$20240905$$HP$US$US
242844251$24284425$1$I$$20240625$20240905$20240905$EXP$$ZA-ALKEM LABORATORIES LIMITED-ZA-ALKEM-2024-14284$ALKEM$Fataar A, Pillay-Fuentes Lorente V, Decloedt EH, Van Eck A, Reddy K, Dramowski A, Bekker A. A Retrospective Study Evaluating Neonatal Vancomycin Loading Doses to Achieve a Therapeutic Target. Ther Drug Monit. 2024;00 (00):1-9$$$N$$Y$$$20240905$$HP$ZA$ZA
242844261$24284426$1$I$$20240625$20240905$20240905$EXP$$ZA-ALKEM LABORATORIES LIMITED-ZA-ALKEM-2024-14283$ALKEM$Fataar A, Pillay-Fuentes Lorente V, Decloedt EH, Van Eck A, Reddy K, Dramowski A, Bekker A. A Retrospective Study Evaluating Neonatal Vancomycin Loading Doses to Achieve a Therapeutic Target. Ther Drug Monit. 2024;00 (00):1-9$$$N$$Y$$$20240905$$HP$ZA$ZA
242844271$24284427$1$I$20240903$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176228$AMGEN$$74$YR$E$M$Y$$$20240905$$PH$US$US
242844281$24284428$1$I$$20240711$20240905$20240905$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15805$ALKEM$Konda SM, Deaner JD, Proia AD, Jaffe GJ.. Primary Vitreoretinal Lymphoma Masquerading As Postoperative Endophthalmitis In A Pregnant Patient With Long-standing Idiopathic Panuveitis. RETINAL CASES + BRIEF REPORTS. 2024;18(4):468-472$37$YR$$F$Y$$$20240905$$MD$US$US
242844301$24284430$1$I$20240801$20240823$20240905$20240905$PER$$US-GRANULES-US-2024GRASPO00390$GRANULES INDIA$$78$YR$$F$Y$$$20240905$$CN$US$US
242844311$24284431$1$I$20240101$20240903$20240905$20240905$EXP$$US-AMGEN-USASP2024175941$AMGEN$$35$YR$A$F$Y$$$20240905$$CN$US$US
242844321$24284432$1$I$$20240830$20240905$20240905$30DAY$$US-SANDOZ INC.-SDZ2024US077658$SANDOZ$$$$$F$Y$$$20240905$$CN$US$US
242844331$24284433$1$I$20240829$20240829$20240905$20240905$EXP$$CA-GSK-CA2024095726$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$CA$CA
242844341$24284434$1$I$$20240830$20240905$20240905$PER$$US-009507513-2409USA000554$MERCK$$$$E$M$Y$$$20240905$$CN$US$US
242844352$24284435$2$F$$20240904$20240905$20240906$PER$$NVSC2024US178345$NOVARTIS$$$$$$Y$$$20240906$$HP$US$US
242844361$24284436$1$I$20240731$20240830$20240905$20240905$EXP$$CN-ORGANON-O2409CHN000066$ORGANON$$59$YR$$F$Y$50$KG$20240905$$HP$CN$CN
242844371$24284437$1$I$$20240903$20240905$20240905$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049150$BOEHRINGER INGELHEIM$Dhaliwal N, Roberts D. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study. CLINICAL TOXICOLOGY. 2024;$$$$$Y$$$20240905$$HP$AU$AU
242844381$24284438$1$I$$20240807$20240905$20240905$30DAY$$US-VEROBIOTECH-2024USVEROSPO00198$VERO BIOTECH$$$$$$Y$$$20240905$$HP$US$US
242844391$24284439$1$I$20240807$20240830$20240905$20240905$EXP$$JP-AMGEN-JPNSP2024175321$AMGEN$$8$DEC$E$M$Y$$$20240905$$MD$JP$JP
242844401$24284440$1$I$20240901$20240902$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139850$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240905$$HP$US$US
242844411$24284441$1$I$$20240828$20240905$20240905$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-139395$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240905$$MD$NL$NL
242844421$24284442$1$I$20240508$20240903$20240905$20240905$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-140518$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$80$KG$20240905$$MD$FR$FR
242844431$24284443$1$I$$20240903$20240905$20240905$EXP$$NVSC2024PL177950$NOVARTIS$$$$$F$Y$$$20240905$$MD$PL$PL
242844441$24284444$1$I$20240829$20240830$20240905$20240905$PER$$US-JNJFOC-20240902223$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$PH$US$US
242844451$24284445$1$I$20240720$20240826$20240905$20240905$EXP$$US-Accord-444140$ACCORD$$63$YR$A$M$Y$$$20240905$$MD$US$US
242844461$24284446$1$I$20240101$20240830$20240905$20240905$PER$$US-JNJFOC-20240881756$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$MD$US$US
242844471$24284447$1$I$$20240901$20240905$20240905$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014085$JAZZ$$$$$M$Y$$$20240905$$CN$US$US
242844481$24284448$1$I$$20240827$20240905$20240905$EXP$$GB-AUROBINDO-AUR-APL-2024-043375$AUROBINDO$$36$YR$$F$Y$$$20240905$$CN$GB$GB
242844491$24284449$1$I$$20240827$20240905$20240905$EXP$GB-MHRA-MED-202408260754075230-QCTSY$GB-AUROBINDO-AUR-APL-2024-042965$AUROBINDO$$46$YR$$F$Y$60$KG$20240905$$CN$GB$GB
242844501$24284450$1$I$20240823$20240826$20240905$20240905$EXP$$US-Accord-443690$ACCORD$$70$YR$E$F$Y$$$20240905$$PH$US$US
242844512$24284451$2$F$$20240912$20240905$20240916$PER$$US-ABBVIE-5905507$ABBVIE$$$$$M$Y$$$20240916$$HP$US$US
242844521$24284452$1$I$$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140335$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$63.05$KG$20240905$$HP$US$US
242844531$24284453$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140389$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$54.43$KG$20240905$$HP$US$US
242844542$24284454$2$F$20240831$20240904$20240905$20240906$PER$$US-AMGEN-USASP2024176241$AMGEN$$74$YR$E$M$Y$$$20240906$$CN$US$US
242844552$24284455$2$F$20240831$20240917$20240905$20240918$PER$$US-AMGEN-USASP2024176351$AMGEN$$44$YR$A$M$Y$$$20240918$$CN$US$US
242844561$24284456$1$I$$20240828$20240905$20240905$PER$$US-AstraZeneca-2024A197165$ASTRAZENECA$$$$$$Y$$$20240905$$HP$US$
242844572$24284457$2$F$20240826$20240906$20240905$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027044$UNITED THERAPEUTICS$$37$YR$$F$Y$117.91$KG$20240913$$$US$US
242844582$24284458$2$F$$20240904$20240905$20240913$EXP$$CA-AUROBINDO-AUR-APL-2024-043423$AUROBINDO$Farrell B, Galley E, Jeffs L, Howell P, McCarthy LM. Kind of blurry?: Deciphering clues to  prevent, investigate and manage prescribing cascades.. Plos One.. 2022;7(8):e0272418:1-20$70$YR$$F$Y$$$20240913$$HP$CA$CA
242844601$24284460$1$I$$20240829$20240905$20240905$EXP$$IT-PFIZER INC-202400247076$PFIZER$$89$YR$$F$Y$$$20240905$$CN$IT$IT
242844611$24284461$1$I$20240722$20240828$20240905$20240905$EXP$$CN-PFIZER INC-202400249171$PFIZER$$31$YR$$M$Y$65$KG$20240905$$HP$CN$CN
242844622$24284462$2$F$20240728$20240906$20240905$20240906$EXP$IT-MINISAL02-1000274$IT-PFIZER INC-202400247208$PFIZER$$85$YR$$F$Y$$$20240906$$MD$IT$IT
242844631$24284463$1$I$$20240903$20240905$20240905$EXP$$CA-PFIZER INC-202400249968$PFIZER$$54$YR$$F$Y$$$20240905$$HP$CA$CA
242844641$24284464$1$I$$20240826$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408016019$ELI LILLY AND CO$$66$YR$E$$Y$$$20240905$$LW$US$US
242844651$24284465$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001495$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240905$$CN$US$US
242844661$24284466$1$I$$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409000523$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240905$$CN$US$US
242844671$24284467$1$I$$20240826$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408016883$ELI LILLY AND CO$$52$YR$A$$Y$$$20240905$$LW$US$US
242844681$24284468$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001594$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240905$$CN$US$US
242844691$24284469$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001676$ELI LILLY AND CO$$$$$$Y$$$20240905$$CN$US$US
242844701$24284470$1$I$20240903$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001828$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240905$$CN$US$US
242844711$24284471$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001342$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242844721$24284472$1$I$$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001347$ELI LILLY AND CO$$$$$$Y$$$20240905$$CN$US$US
242844731$24284473$1$I$20240816$20240827$20240905$20240905$EXP$$US-ARDELYX-2024ARDX006550$ARDELYX$$72$YR$$$Y$$$20240905$$HP$US$US
242844742$24284474$2$F$20240101$20240905$20240905$20240915$EXP$$US-ARDELYX-2024ARDX006436$ARDELYX$$$$$M$Y$102$KG$20240916$$CN$US$US
242844751$24284475$1$I$20230101$20240813$20240905$20240905$PER$$US-JNJFOC-20240840588$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$US$US
242844762$24284476$2$F$$20240923$20240905$20240927$EXP$$BR-JNJFOC-20240882741$JOHNSON AND JOHNSON$$75$YR$E$M$Y$85$KG$20240927$$CN$BR$BR
242844771$24284477$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA253212$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240905$$MD$US$US
242844781$24284478$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA253322$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240905$$MD$US$US
242844791$24284479$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA254377$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240905$$MD$US$US
242844801$24284480$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA253123$SANOFI AVENTIS$$$$$M$Y$$$20240905$$HP$US$US
242844811$24284481$1$I$20240201$20240821$20240905$20240905$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00420$Alora Pharma$$24$YR$$F$Y$145.15$KG$20240905$$CN$US$US
242844821$24284482$1$I$20240101$20240826$20240905$20240905$PER$$US-SA-2024SA255918$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240905$$CN$US$US
242844831$24284483$1$I$$20240828$20240905$20240905$PER$$US-SA-2024SA255038$SANOFI AVENTIS$$$$$$Y$$$20240905$$CN$US$US
242844841$24284484$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA255416$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240905$$MD$US$US
242844851$24284485$1$I$20240101$20240822$20240905$20240905$PER$$US-SA-2024SA256027$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240905$$MD$US$US
242844861$24284486$1$I$20231101$20240823$20240905$20240905$PER$$US-SA-2024SA256984$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240905$$MD$US$US
242844871$24284487$1$I$$20240826$20240905$20240905$PER$$US-SA-2024SA255858$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240905$$CN$US$US
242844881$24284488$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA256632$SANOFI AVENTIS$$$$C$F$Y$$$20240905$$HP$US$US
242844891$24284489$1$I$20240101$20240822$20240905$20240905$PER$$US-SA-2024SA255627$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240905$$MD$US$US
242844902$24284490$2$F$$20240830$20240905$20240912$PER$$US-SA-2024SA255406$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240912$$MD$US$US
242844911$24284491$1$I$20240801$20240824$20240905$20240905$PER$$US-SA-2024SA256102$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240905$$MD$US$US
242844921$24284492$1$I$$20240823$20240905$20240905$PER$$US-SA-2024SA255823$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240905$$MD$US$US
242844931$24284493$1$I$20240828$20240828$20240905$20240905$PER$$US-SA-2024SA253054$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240905$$CN$US$US
242844941$24284494$1$I$$20240826$20240905$20240905$PER$$US-SA-2024SA256096$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240905$$MD$US$US
242844951$24284495$1$I$$20240826$20240905$20240905$PER$$US-SA-2024SA255873$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240905$$CN$US$US
242844961$24284496$1$I$$20240829$20240905$20240905$PER$$US-SA-2024SA255733$SANOFI AVENTIS$$$$$F$Y$$$20240905$$MD$US$US
242844971$24284497$1$I$$20240903$20240905$20240905$PER$$US-ROCHE-10000073970$ROCHE$$27$YR$A$M$Y$$$20240905$$HP$US$US
242844981$24284498$1$I$$20240829$20240905$20240905$PER$$US-ABBVIE-5905046$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242844991$24284499$1$I$20240801$20240826$20240905$20240905$PER$$US-ABBVIE-5896612$ABBVIE$$81$YR$$$Y$$$20240905$$CN$US$US
242845001$24284500$1$I$$20240830$20240905$20240905$EXP$$PL-ABBVIE-5904720$ABBVIE$$72$YR$$M$Y$$$20240905$$MD$PL$PL
242845011$24284501$1$I$20240901$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176060$AMGEN$$85$YR$E$M$Y$$$20240905$$CN$US$US
242845021$24284502$1$I$20240421$20240901$20240905$20240905$EXP$$CN-JNJFOC-20240901774$JOHNSON AND JOHNSON$$60$YR$A$M$Y$63.5$KG$20240905$$HP$CN$CN
242845031$24284503$1$I$$20240827$20240905$20240905$EXP$$US-JNJFOC-20240869948$JOHNSON AND JOHNSON$$47$YR$A$F$Y$49.94$KG$20240905$$HP$US$US
242845041$24284504$1$I$20240717$20240822$20240905$20240905$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00418$Unknown Manufacturer$$$$$$Y$$$20240905$$MD$CN$CN
242845051$24284505$1$I$20240828$20240828$20240905$20240905$EXP$$IE-CELLTRION INC.-2024IE020874$CELLTRION$$$$$$Y$$$20240905$$CN$IE$IE
242845061$24284506$1$I$20240826$20240826$20240905$20240905$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111599$ZYDUS PHARM$$$$$$Y$$$20240905$$PH$US$US
242845071$24284507$1$I$20240810$20240827$20240905$20240905$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111598$ZYDUS PHARM$$$$$$Y$$$20240905$$CN$US$US
242845081$24284508$1$I$20240818$20240828$20240905$20240905$EXP$GB-MHRA-MED-202408281129362100-VMBSK$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-111804$ZYDUS PHARM$$$$$$Y$$$20240905$$HP$GB$GB
242845091$24284509$1$I$20240808$20240827$20240905$20240905$EXP$FR-AFSSAPS-TS2024000937$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111704$ZYDUS PHARM$$$$$$Y$$$20240905$$MD$FR$FR
242845101$24284510$1$I$20240805$20240827$20240905$20240905$EXP$FR-AFSSAPS-PB2024000936$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111680$ZYDUS PHARM$$$$$$Y$$$20240905$$PH$FR$FR
242845111$24284511$1$I$$20240821$20240905$20240905$EXP$GB-MHRA-MED-202408211408286570-FQSWV$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-111562$ZYDUS PHARM$$$$$$Y$$$20240905$$HP$GB$GB
242845121$24284512$1$I$20240730$20240827$20240905$20240905$EXP$FR-AFSSAPS-TO2024001518$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111717$ZYDUS PHARM$$$$$$Y$$$20240905$$MD$FR$FR
242845131$24284513$1$I$20240622$20240827$20240905$20240905$EXP$ES-AEMPS-1562975$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111730$ZYDUS PHARM$$$$$$Y$$$20240905$$MD$ES$ES
242845141$24284514$1$I$20240614$20240827$20240905$20240905$EXP$ES-AEMPS-1563194$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111726$ZYDUS PHARM$$$$$$Y$$$20240905$$MD$ES$ES
242845151$24284515$1$I$$20240827$20240905$20240905$EXP$$CA-CELLTRION INC.-2023CA015650$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
242845161$24284516$1$I$$20240815$20240905$20240905$PER$$US-009507513-2408USA005592$MERCK$Pace JL, Hopstone MD, Conti PS, Tom C, Mohamed P, Gong Y et al.. Unresectable Metastatic Solid Pseudopapillary Pancreatic Neoplasm Treated with Liver Transplantation. ACG Case Reports Journal. 2024;11 (8):1-4$49$YR$$F$Y$$$20240905$$HP$US$US
242845171$24284517$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141017$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240905$$HP$US$US
242845181$24284518$1$I$20240701$20240823$20240905$20240905$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00419$Unknown Manufacturer$$$$$$Y$$$20240905$$CN$BR$BR
242845201$24284520$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004563$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242845211$24284521$1$I$$20240826$20240905$20240905$EXP$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00410$Unknown Manufacturer$$$$$$Y$$$20240905$$MD$US$US
242845221$24284522$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010098$APOTEX$$81$YR$$F$Y$$$20240905$$CN$CA$CA
242845231$24284523$1$I$$20240829$20240905$20240905$EXP$$CH-BEIGENE-BGN-2024-013747$BEIGENE$$$$$$Y$$$20240905$$MD$CH$CH
242845241$24284524$1$I$20240715$20240904$20240905$20240905$PER$$NVSC2024US178400$NOVARTIS$$$$$M$Y$$$20240905$$CN$US$US
242845251$24284525$1$I$$20240822$20240905$20240905$PER$$US-AstraZeneca-2024A191988$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242845272$24284527$2$F$$20240903$20240905$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139131$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$MD$JP$JP
242845281$24284528$1$I$$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139352$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240905$$CN$US$US
242845301$24284530$1$I$$20240904$20240905$20240905$PER$$US-HALEON-2195255$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
242845311$24284531$1$I$20240724$20240827$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043077$AUROBINDO$$84$YR$$M$Y$73.9$KG$20240905$$MD$FR$FR
242845322$24284532$2$F$$20240917$20240905$20240923$EXP$$AR-JNJFOC-20240832557$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$CN$AR$AR
242845331$24284533$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176311$AMGEN$$$$A$F$Y$$$20240905$$CN$US$US
242845341$24284534$1$I$$20240831$20240905$20240905$PER$$US-AMGEN-USASP2024175857$AMGEN$$68$YR$E$F$Y$$$20240905$$CN$US$US
242845351$24284535$1$I$$20240830$20240905$20240905$EXP$$US-JNJFOC-20240901995$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240905$$HP$US$US
242845361$24284536$1$I$20240807$20240827$20240905$20240905$EXP$$BE-AUROBINDO-AUR-APL-2024-043299$AUROBINDO$$$$A$F$Y$$$20240905$$CN$BE$BE
242845371$24284537$1$I$$20240820$20240905$20240905$EXP$$JP-ASTELLAS-2024-AER-002069$ASTELLAS$Sanada Y, Sakuma Y, Onishi Y, Wakiya T, Okada N, Hirata Y, et al. Biliary atresia research update; Pregnancy after liver transplantation. Japanese Journal of Pediatric Surgery. 2024;56(2): 199-205.$$$N$$Y$$$20240905$$MD$JP$JP
242845382$24284538$2$F$$20240910$20240905$20240920$EXP$$NL-TEVA-VS-3238685$TEVA$Brakenhoff SM, Chi H, Friederich P, Doukas M, Den Hoed C, Flink HJ, et al. A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report. Case-Rep-Gastroenterol 2024; 18 (1): 252-259.; Brakenhoff SM, Chi H, Friederich P, Doukas M, Den Hoed C, Flink HJ, et al. A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report. Case-Rep-Gastroenterol 2024; 18 (1): 252-259.$64$YR$$M$Y$$$20240920$$HP$NL$NL
242845391$24284539$1$I$$20240822$20240905$20240905$EXP$$US-AVYXA HOLDINGS, LLC-2024AVY000005$Avyxa Holdings$Bell AP Jr, Custer MK, Presley S.. Pyoderma Gangrenosum in a 75-Year-Old Male With Follicular Diffuse Large B-cell Lymphoma.. Cureus.. 2024;16 (8):e67234$75$YR$$M$Y$$$20240905$$HP$US$US
242845401$24284540$1$I$$20240827$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408017171$ELI LILLY AND CO$$59$YR$A$$Y$$$20240905$$LW$US$US
242845411$24284541$1$I$20240825$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001471$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240905$$CN$US$US
242845421$24284542$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001894$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240905$$CN$US$US
242845431$24284543$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001640$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240905$$CN$US$US
242845442$24284544$2$F$20240301$20240903$20240905$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001597$ELI LILLY AND CO$$15$YR$T$F$Y$$$20240909$$CN$US$US
242845451$24284545$1$I$$20240903$20240905$20240905$EXP$$US-GILEAD-2024-0686277$GILEAD$$$$E$F$Y$$$20240905$$CN$US$US
242845461$24284546$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001784$ELI LILLY AND CO$$24$YR$A$$Y$$$20240905$$CN$US$US
242845471$24284547$1$I$$20240828$20240905$20240905$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-138984$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240905$$HP$NL$NL
242845481$24284548$1$I$$20240827$20240905$20240905$EXP$$JP-JNJFOC-20240907465$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240905$$PH$JP$JP
242845491$24284549$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043817$AUROBINDO$$66$YR$$F$Y$69$KG$20240905$$HP$CA$CA
242845501$24284550$1$I$20240114$20240827$20240905$20240905$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03151$AMNEAL$$64$YR$$M$Y$$$20240905$$CN$US$US
242845511$24284551$1$I$20240801$20240829$20240905$20240905$EXP$$JP-ALXN-202408JPN002019JP$ALEXION PHARMACEUTICALS$$38$YR$$F$Y$$$20240905$$MD$JP$JP
242845521$24284552$1$I$$20240903$20240905$20240905$EXP$$BR-ALXN-202409SAM000077BR$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$HP$BR$BR
242845533$24284553$3$F$$20240907$20240905$20240921$EXP$$JP-UCBSA-2024044498$UCB$$59$YR$$M$Y$107$KG$20240921$$MD$JP$JP
242845541$24284554$1$I$20231101$20240827$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043304$AUROBINDO$$80$YR$$M$Y$68$KG$20240905$$MD$FR$FR
242845551$24284555$1$I$20240101$20240826$20240905$20240905$EXP$$AU-ADVANZ PHARMA-202408007120$ADVANZ PHARMA$$$$$$Y$$$20240905$$CN$AU$AU
242845561$24284556$1$I$$20240830$20240905$20240905$PER$$US-JNJFOC-20240901812$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$MD$US$US
242845571$24284557$1$I$$20240826$20240905$20240905$EXP$$PL-TEVA-VS-3238305$TEVA$Styczynski T, Sadlok J, Richert-Przygonska M, Debski R, Zalas-Wiecek P, Czyzewski K, et al. Infection With Saprochaete Clavata in Children After Hematopoietic Cell Transplantation. J-Pediatr-Hematol-Oncol 2023; 45 (8): e976-e979.; Styczynski T, Sadlok J, Richert-Przygonska M, Debski R, Zalas-Wiecek P, Czyzewski K, et al. Infection With Saprochaete Clavata in Children After Hematopoietic Cell Transplantation. J-Pediatr-Hematol-Oncol 2023; 45 (8): e976-e979.$14$YR$$F$Y$$$20240905$$MD$PL$PL
242845583$24284558$3$F$$20240919$20240905$20240930$EXP$$JP-AMGEN-JPNSP2024175029$AMGEN$$51$YR$A$F$Y$$$20240930$$MD$JP$JP
242845591$24284559$1$I$$20240830$20240905$20240905$EXP$$US-AstraZeneca-2024A198953$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242845601$24284560$1$I$20240827$20240828$20240905$20240905$EXP$$US-AMGEN-USASP2024172498$AMGEN$$74$YR$E$F$Y$$$20240905$$CN$US$US
242845611$24284561$1$I$20231227$20231231$20240905$20240905$EXP$$IN-SANDOZ INC.-SDZ2023IN076663$SANDOZ$$83$YR$$M$Y$$$20240905$$CN$IN$IN
242845621$24284562$1$I$20240824$20240902$20240905$20240905$30DAY$$IT-SANDOZ INC.-SDZ2024IT077399$SANDOZ$$14$YR$$$Y$48$KG$20240905$$CN$IT$IT
242845631$24284563$1$I$$20240812$20240905$20240905$PER$$CA-TOLMAR, INC.-24CA051804$TOLMAR$$$$$M$Y$$$20240905$$CN$CA$CA
242845651$24284565$1$I$$20240903$20240905$20240905$PER$$US-HALEON-2195135$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
242845661$24284566$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176106$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
242845672$24284567$2$F$20240801$20240925$20240905$20240928$EXP$$US-AMGEN-USASP2024174404$AMGEN$$$$$F$Y$$$20240928$$MD$US$US
242845681$24284568$1$I$20240822$20240823$20240905$20240905$30DAY$$US-AMGEN-USASP2024169431$AMGEN$$45$YR$A$F$Y$$$20240905$$HP$US$US
242845691$24284569$1$I$20240401$20240828$20240905$20240905$EXP$$US-AMGEN-USASP2024172756$AMGEN$$70$YR$E$F$Y$$$20240905$$CN$US$US
242845701$24284570$1$I$$20240808$20240905$20240905$PER$$US-CORMEDIX INC.-US-COR-24-00001$CORMEDIX$$$$$$Y$$$20240905$$CN$US$US
242845711$24284571$1$I$$20240822$20240905$20240905$EXP$$JP-Renata Limited-2161220$RENATA LIMITED$Abstract$$$$F$Y$$$20240905$$$JP$JP
242845722$24284572$2$F$20240101$20240907$20240905$20240920$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01565$AVADEL CNS PHARMA$$$$$M$Y$132.43$KG$20240920$$CN$US$US
242845742$24284574$2$F$20240628$20240919$20240905$20240921$EXP$$NZ-ABBVIE-5902058$ABBVIE$$66$YR$$M$Y$78$KG$20240921$$MD$NZ$NZ
242845751$24284575$1$I$20240101$20240829$20240905$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000761$DECIPHERA PHARMACEUTICALS$$63$YR$A$M$Y$$$20240905$$CN$US$US
242845762$24284576$2$F$$20240903$20240905$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004851$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
242845772$24284577$2$F$20240314$20240906$20240905$20240911$EXP$$NVSC2024US070902$NOVARTIS$$32$YR$$F$Y$$$20240911$$CN$US$US
242845782$24284578$2$F$$20240902$20240905$20240909$EXP$$NVSC2024AT178024$NOVARTIS$$$$E$$Y$$$20240909$$MD$AT$AT
242845791$24284579$1$I$20240101$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176183$AMGEN$$64$YR$A$F$Y$$$20240905$$CN$US$US
242845801$24284580$1$I$20240527$20240614$20240905$20240905$PER$$US-009507513-2406USA005974$MERCK$$81$YR$$M$Y$$$20240905$$CN$US$US
242845811$24284581$1$I$$20240904$20240905$20240905$EXP$$US-TAKEDA-2024TUS027410$TAKEDA$$$$$M$Y$$$20240905$$MD$US$US
242845821$24284582$1$I$20240801$20240827$20240905$20240905$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03161$AMNEAL$$0$YR$$M$Y$9.66$KG$20240905$$CN$US$US
242845831$24284583$1$I$$20240822$20240905$20240905$EXP$$PT-Renata Limited-2161221$RENATA LIMITED$Abstract$$$$M$Y$$$20240905$$$PT$PT
242845841$24284584$1$I$$20240903$20240905$20240905$PER$$US-009507513-2409USA001008$MERCK$$$$$F$Y$$$20240905$$HP$US$US
242845851$24284585$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002823$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240905$$CN$US$US
242845861$24284586$1$I$20240601$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001658$ELI LILLY AND CO$$78$YR$E$$Y$$$20240905$$CN$US$US
242845871$24284587$1$I$$20240827$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408016931$ELI LILLY AND CO$$44$YR$A$$Y$$$20240905$$LW$US$US
242845881$24284588$1$I$20240801$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001664$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240905$$CN$US$US
242845891$24284589$1$I$$20240831$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001509$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240905$$CN$US$US
242845901$24284590$1$I$$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409000265$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240905$$CN$US$US
242845911$24284591$1$I$20240815$20240828$20240905$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000760$DECIPHERA PHARMACEUTICALS$$71$YR$E$M$Y$$$20240905$$CN$US$US
242845921$24284592$1$I$20240501$20240827$20240905$20240905$EXP$$GB-AUROBINDO-AUR-APL-2024-043400$AUROBINDO$$86$YR$$F$Y$66$KG$20240905$$CN$GB$GB
242845931$24284593$1$I$$20240827$20240905$20240905$EXP$GB-MHRA-MIDB-2edbb7a0-83ef-468e-81ea-b57d1bb5355d$GB-TEVA-VS-3238130$TEVA$$68$YR$$$Y$$$20240905$$PH$GB$GB
242845941$24284594$1$I$20240801$20240830$20240905$20240905$PER$$FR-Blueprint Medicines Corporation-SP-FR-2024-001778$BLUEPRINT MEDICINES$$$$$M$Y$$$20240905$$CN$FR$FR
242845951$24284595$1$I$20240830$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175908$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242845961$24284596$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176056$AMGEN$$$$$M$Y$$$20240905$$CN$US$US
242845971$24284597$1$I$$20240902$20240905$20240905$EXP$$TW-AMGEN-TWNSP2024175714$AMGEN$$$$E$F$Y$$$20240905$$HP$TW$TW
242845981$24284598$1$I$20230901$20240828$20240905$20240905$EXP$$JP-AstraZeneca-2024A198892$ASTRAZENECA$$70$YR$$F$Y$$$20240905$$CN$JP$
242845991$24284599$1$I$20240831$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175693$AMGEN$$78$YR$E$M$Y$$$20240905$$MD$US$US
242846001$24284600$1$I$20240829$20240830$20240905$20240905$EXP$$US-ABBVIE-5903652$ABBVIE$$46$YR$$F$Y$$$20240905$$CN$US$US
242846011$24284601$1$I$$20240828$20240905$20240905$EXP$$CA-TOLMAR, INC.-24CA052209$TOLMAR$$$$$M$Y$$$20240905$$CN$CA$CA
242846021$24284602$1$I$20240822$20240826$20240905$20240905$EXP$$US-Accord-443842$ACCORD$$29$YR$A$M$Y$$$20240905$$HP$US$US
242846031$24284603$1$I$$20240821$20240905$20240905$EXP$$CA-TOLMAR, INC.-24CA052017$TOLMAR$$$$$M$Y$$$20240905$$CN$CA$CA
242846041$24284604$1$I$$20240828$20240905$20240905$PER$$CA-TOLMAR, INC.-24CA052228$TOLMAR$$$$$M$Y$$$20240905$$MD$CA$CA
242846052$24284605$2$F$$20240903$20240905$20240911$EXP$$CA-TOLMAR, INC.-24CA052212$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
242846061$24284606$1$I$$20240828$20240905$20240905$EXP$$CA-TOLMAR, INC.-24CA052230$TOLMAR$$$$$M$Y$$$20240905$$CN$CA$CA
242846071$24284607$1$I$$20240828$20240905$20240905$EXP$$CA-TOLMAR, INC.-24CA052233$TOLMAR$$74$YR$$M$Y$$$20240905$$CN$CA$CA
242846081$24284608$1$I$$20240828$20240905$20240905$EXP$$CA-TOLMAR, INC.-24CA052231$TOLMAR$$74$YR$$M$Y$$$20240905$$CN$CA$CA
242846091$24284609$1$I$$20240828$20240905$20240905$EXP$$CA-TOLMAR, INC.-24CA052232$TOLMAR$$92$YR$$M$Y$$$20240905$$CN$CA$CA
242846101$24284610$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043428$AUROBINDO$$40$YR$$F$Y$$$20240905$$HP$CA$CA
242846111$24284611$1$I$$20240829$20240905$20240905$EXP$$CA-TOLMAR, INC.-24CA052254$TOLMAR$$$$$M$Y$$$20240905$$CN$CA$CA
242846121$24284612$1$I$20240801$20240829$20240905$20240905$PER$$CA-TOLMAR, INC.-24CA052256$TOLMAR$$83$YR$$M$Y$$$20240905$$CN$CA$CA
242846131$24284613$1$I$$20240829$20240905$20240905$EXP$$CA-TOLMAR, INC.-24CA052286$TOLMAR$$$$$M$Y$$$20240905$$CN$CA$CA
242846142$24284614$2$F$$20240904$20240905$20240916$EXP$$US-TOLMAR, INC.-24US052257$TOLMAR$$$$$M$Y$$$20240916$$HP$US$US
242846151$24284615$1$I$$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139576$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240905$$HP$US$US
242846161$24284616$1$I$20240713$20240902$20240905$20240905$EXP$$GB-ABBVIE-5905401$ABBVIE$$65$YR$$M$Y$$$20240905$$HP$GB$GB
242846171$24284617$1$I$$20240903$20240905$20240905$EXP$$US-ABBVIE-5905432$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242846181$24284618$1$I$$20240822$20240905$20240905$EXP$$JP-Creekwood Pharmaceuticals LLC-2161222$CREEKWOOD PHARMACEUTICALS$Abstract$$$$F$Y$$$20240905$$$JP$JP
242846191$24284619$1$I$$20240904$20240905$20240905$EXP$$US-JNJFOC-20240907656$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$US$US
242846201$24284620$1$I$$20240903$20240905$20240905$EXP$$US-JNJFOC-20240907898$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242846212$24284621$2$F$20240701$20240904$20240905$20240908$EXP$$US-ABBVIE-5905059$ABBVIE$$76$YR$$F$Y$135.17$KG$20240908$$CN$US$US
242846221$24284622$1$I$20240601$20240903$20240905$20240905$EXP$$TR-ABBVIE-5906638$ABBVIE$$74$YR$$F$Y$$$20240905$$CN$TR$TR
242846232$24284623$2$F$$20240910$20240905$20240920$EXP$$US-TEVA-VS-3239292$TEVA$Maresch KJ. Arytenoid Dislocation and Vocal Cord Immobility After Emergent Fiberoptic Intubation: A Case Report. AANA-J 2020; 88 (6): 459-463.; Maresch KJ. Arytenoid Dislocation and Vocal Cord Immobility After Emergent Fiberoptic Intubation: A Case Report. AANA-J 2020; 88 (6): 459-463.$53$YR$$M$Y$$$20240920$$HP$US$US
242846241$24284624$1$I$20240901$20240903$20240905$20240905$EXP$$CA-ABBVIE-5906803$ABBVIE$$79$YR$$F$Y$$$20240905$$CN$CA$CA
242846251$24284625$1$I$$20240830$20240905$20240905$EXP$$NVSC2024US175833$NOVARTIS$$$$$$Y$75$KG$20240905$$CN$US$US
242846261$24284626$1$I$20240826$20240826$20240905$20240905$EXP$GB-MHRA-MED-202408261025433370-CNBJH$GB-Accord-443561$ACCORD$$50$YR$A$M$Y$75$KG$20240905$$MD$GB$GB
242846271$24284627$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043312$AUROBINDO$$75$YR$$F$Y$$$20240905$$HP$CA$CA
242846282$24284628$2$F$$20240910$20240905$20240920$EXP$$US-TEVA-VS-3239299$TEVA$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J-Drugs-Dermatol 2023; 22 (11): e12-e16.; Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J-Drugs-Dermatol 2023; 22 (11): e12-e16.$37$YR$$F$Y$$$20240920$$HP$US$US
242846301$24284630$1$I$20240806$20240827$20240905$20240905$EXP$$JP-ROCHE-10000072261$ROCHE$$$$E$$Y$$$20240905$$MD$JP$JP
242846311$24284631$1$I$20230217$20240828$20240905$20240905$EXP$$FR-CELLTRION INC.-2024FR020929$CELLTRION$$$$$$Y$$$20240905$$CN$FR$FR
242846332$24284633$2$F$20240830$20240903$20240905$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004679$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240926$$CN$US$US
242846341$24284634$1$I$20240830$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176221$AMGEN$$68$YR$E$M$Y$$$20240905$$CN$US$US
242846351$24284635$1$I$$20240828$20240905$20240905$EXP$$US-AMGEN-USASP2024173468$AMGEN$Britton J.W.; Smith K.M.; Budhram  A.et.al. Autoimmune-associated seizure disorders. Epileptic Disorder. 2024;26 (4):415-434$73$YR$E$M$Y$$$20240905$$HP$US$US
242846361$24284636$1$I$$20240822$20240905$20240905$EXP$$GB-Everest Life Sciences LLC-2161223$Everest Life Sciences$Full text$80$YR$$F$Y$$$20240905$$$GB$GB
242846371$24284637$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175777$AMGEN$$$$$M$Y$$$20240905$$CN$US$US
242846381$24284638$1$I$20240813$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175638$AMGEN$$18$YR$A$M$Y$$$20240905$$HP$US$US
242846391$24284639$1$I$$20240827$20240905$20240905$EXP$$GB-AUROBINDO-AUR-APL-2024-043344$AUROBINDO$$21$YR$$F$Y$80$KG$20240905$$PH$GB$GB
242846401$24284640$1$I$20240701$20240830$20240905$20240905$EXP$DE-CADRBFARM-2024329606$DE-ABBVIE-5904626$ABBVIE$$$$$$Y$$$20240905$$MD$DE$DE
242846412$24284641$2$F$$20240912$20240905$20240916$PER$$US-ALXN-202409USA000117US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
242846421$24284642$1$I$20240806$20240903$20240905$20240905$EXP$$CA-JNJFOC-20240906751$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240905$$HP$CA$CA
242846431$24284643$1$I$20240709$20240828$20240905$20240905$EXP$$US-AstraZeneca-2024A196337$ASTRAZENECA$$29173$DY$$M$Y$$$20240905$$CN$US$
242846441$24284644$1$I$$20240827$20240905$20240905$EXP$GB-MHRA-MED-202408271444016470-FSJRW$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-08133$HIKMA$$$$N$M$Y$$$20240905$$CN$GB$GB
242846451$24284645$1$I$$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001425$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240905$$CN$US$US
242846461$24284646$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002011$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240905$$CN$US$US
242846471$24284647$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002423$ELI LILLY AND CO$$$$$$Y$$$20240905$$CN$US$US
242846481$24284648$1$I$$20240313$20240905$20240905$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088924$GLENMARK$$$$$$Y$$$20240905$$CN$US$US
242846491$24284649$1$I$$20240830$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138983$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240905$$CN$US$US
242846502$24284650$2$F$$20240909$20240905$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140850$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240911$$HP$US$US
242846511$24284651$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141069$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240905$$HP$US$US
242846521$24284652$1$I$$20240830$20240905$20240905$PER$$US-HALEON-2194592$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
242846531$24284653$1$I$$20240829$20240905$20240905$EXP$$CA-TEVA-VS-3238475$TEVA$$5$YR$$F$Y$$$20240905$$HP$CA$CA
242846541$24284654$1$I$$20240826$20240905$20240905$PER$$US-ABBVIE-5896565$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242846551$24284655$1$I$$20240822$20240905$20240905$EXP$$US-Nuvo Pharmaceuticals Inc-2161224$NUVO PHARMACEUTICALS$Full text$29$YR$$M$Y$$$20240905$$$US$US
242846561$24284656$1$I$$20240826$20240905$20240905$EXP$$CA-APOTEX-2024AP009825$APOTEX$$11$YR$$M$Y$$$20240905$$MD$CA$CA
242846571$24284657$1$I$$20240829$20240905$20240905$EXP$$CA-TEVA-VS-3238673$TEVA$$79$YR$$M$Y$75$KG$20240905$$PH$CA$CA
242846581$24284658$1$I$$20240829$20240905$20240905$EXP$$CA-TEVA-VS-3238487$TEVA$$69$YR$$F$Y$$$20240905$$HP$CA$CA
242846591$24284659$1$I$20240901$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175947$AMGEN$$51$YR$A$F$Y$$$20240905$$CN$US$US
242846601$24284660$1$I$20240831$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175613$AMGEN$$78$YR$E$F$Y$$$20240905$$CN$US$US
242846611$24284661$1$I$$20240903$20240905$20240905$EXP$$US-KYOWAKIRIN-2024KK020569$KYOWA$$$$$$Y$$$20240905$$HP$US$US
242846621$24284662$1$I$20240830$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176317$AMGEN$$72$YR$E$F$Y$$$20240905$$PH$US$US
242846631$24284663$1$I$20240901$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176039$AMGEN$$53$YR$A$F$Y$$$20240905$$CN$US$US
242846641$24284664$1$I$20240807$20240820$20240905$20240905$PER$$US-ASTELLAS-2024US022703$ASTELLAS$$$$$$Y$$$20240905$$PH$US$US
242846652$24284665$2$F$20240101$20240913$20240905$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135912$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240920$$CN$US$US
242846661$24284666$1$I$$20240822$20240905$20240905$EXP$$PT-Apozeal Pharmaceuticals-2161225$Apozeal Pharmaceuticals$Abstract$$$$M$Y$$$20240905$$$PT$PT
242846671$24284667$1$I$$20240829$20240905$20240905$EXP$$CA-TEVA-VS-3238443$TEVA$$66$YR$$F$Y$$$20240905$$HP$CA$CA
242846681$24284668$1$I$$20240827$20240905$20240905$EXP$$GB-AUROBINDO-AUR-APL-2024-043396$AUROBINDO$$25$YR$$M$Y$$$20240905$$MD$GB$GB
242846701$24284670$1$I$20240701$20240822$20240905$20240905$EXP$$US-UCBSA-2024043120$UCB$$65$YR$$M$Y$$$20240905$$HP$US$US
242846711$24284671$1$I$$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-082290-2024$RECKITT BENCKISER$$$$$M$Y$$$20240905$$CN$US$US
242846722$24284672$2$F$20240826$20240906$20240905$20240913$EXP$$NVSC2024US177871$NOVARTIS$$42$YR$$M$Y$$$20240913$$HP$US$US
242846731$24284673$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178058$NOVARTIS$$$$$$Y$$$20240905$$CN$US$US
242846742$24284674$2$F$$20240827$20240905$20240908$PER$$US-JNJFOC-20240875981$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$CN$US$US
242846751$24284675$1$I$$20240829$20240905$20240905$PER$$US-AMGEN-USASP2024175469$AMGEN$$66$YR$E$F$Y$$$20240905$$HP$US$US
242846761$24284676$1$I$20240903$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176294$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
242846771$24284677$1$I$$20240904$20240905$20240905$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049608$BOEHRINGER INGELHEIM$$$$$$Y$$$20240905$$PH$JP$JP
242846781$24284678$1$I$20240805$20240830$20240905$20240905$EXP$$CN-KYOWAKIRIN-2024KK020617$KYOWA$$$$$$Y$$$20240905$$HP$FI$CN
242846792$24284679$2$F$$20240904$20240905$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004590$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242846811$24284681$1$I$$20240903$20240905$20240905$EXP$$US-TAKEDA-2024TUS022067$TAKEDA$$$$$F$Y$$$20240905$$CN$US$US
242846821$24284682$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010095$APOTEX$$80$YR$$F$Y$$$20240905$$CN$CA$CA
242846831$24284683$1$I$$20240826$20240905$20240905$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240900004$RIGEL PHARMACEUTICALS$$$$$$Y$$$20240905$$PH$JP$JP
242846841$24284684$1$I$20240801$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140526$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240905$$HP$US$US
242846851$24284685$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176186$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242846862$24284686$2$F$$20240821$20240905$20240905$EXP$$US-ASTELLAS-2024-AER-002000$ASTELLAS$$$$$M$Y$$$20240905$$MD$US$US
242846871$24284687$1$I$$20240826$20240905$20240905$EXP$$CA-TEVA-2021-CA-1947986$TEVA$$66$YR$$F$Y$$$20240905$$HP$CA$CA
242846881$24284688$1$I$$20240904$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049566$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240905$$MD$US$US
242846901$24284690$1$I$$20240830$20240905$20240905$EXP$$US-AstraZeneca-2024A198621$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242846921$24284692$1$I$$20240828$20240905$20240905$PER$$US-AstraZeneca-2024A197002$ASTRAZENECA$$$$$F$Y$$$20240905$$MD$US$
242846931$24284693$1$I$$20240828$20240905$20240905$EXP$$ZA-AstraZeneca-2024A196335$ASTRAZENECA$$76$YR$$F$Y$$$20240905$$CN$ZA$
242846941$24284694$1$I$20240828$20240829$20240905$20240905$PER$$US-AstraZeneca-2024A198135$ASTRAZENECA$$20918$DY$$F$Y$$$20240905$$CN$US$
242846951$24284695$1$I$$20240828$20240905$20240905$PER$$US-AstraZeneca-2024A196556$ASTRAZENECA$$$$$F$Y$81$KG$20240905$$CN$US$
242846961$24284696$1$I$$20240904$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-103725-2023$RECKITT BENCKISER$$$$$$Y$$$20240905$$CN$US$US
242846971$24284697$1$I$20240825$20240826$20240905$20240905$PER$$US-ABBVIE-5897897$ABBVIE$$63$YR$$F$Y$$$20240905$$CN$US$US
242846981$24284698$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175923$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242846991$24284699$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043589$AUROBINDO$$52$YR$$F$Y$$$20240905$$HP$CA$CA
242847001$24284700$1$I$$20240822$20240905$20240905$PER$$US-GRANULES-US-2024GRASPO00393$GRANULES INDIA$$$$$F$Y$$$20240905$$CN$US$US
242847011$24284701$1$I$$20240819$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08352$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242847021$24284702$1$I$20240831$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001441$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240905$$CN$US$US
242847031$24284703$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001873$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240905$$CN$US$US
242847041$24284704$1$I$20240902$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001799$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240905$$CN$US$US
242847051$24284705$1$I$20240801$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001595$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240905$$CN$US$US
242847061$24284706$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001458$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240905$$CN$US$US
242847071$24284707$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043160$AUROBINDO$$65$YR$$F$Y$$$20240905$$HP$CA$CA
242847081$24284708$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001622$ELI LILLY AND CO$$$$$M$Y$$$20240905$$CN$US$US
242847091$24284709$1$I$20240831$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001303$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240905$$CN$US$US
242847101$24284710$1$I$$20240826$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408016198$ELI LILLY AND CO$$53$YR$A$$Y$$$20240905$$LW$US$US
242847111$24284711$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001517$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240905$$CN$US$US
242847122$24284712$2$F$20240101$20240910$20240905$20240917$EXP$$US-AMGEN-USASL2024173452$AMGEN$$64$YR$A$F$Y$$$20240917$$CN$US$US
242847131$24284713$1$I$20240101$20240830$20240905$20240905$PER$$US-AMGEN-USASP2024174096$AMGEN$$77$YR$E$F$Y$$$20240905$$CN$US$US
242847141$24284714$1$I$$20240903$20240905$20240905$EXP$$CA-TAKEDA-2024TUS088513$TAKEDA$$$$$M$Y$$$20240905$$MD$CA$CA
242847151$24284715$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004629$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242847161$24284716$1$I$20020101$20240830$20240905$20240905$EXP$$US-EMD Serono-E2B_80002877$EMD SERONO INC$$32$YR$A$F$Y$$$20240905$$CN$US$US
242847171$24284717$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004630$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242847181$24284718$1$I$20200101$20240826$20240905$20240905$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00650$Unknown Manufacturer$$$$$M$Y$$$20240905$$CN$US$US
242847202$24284720$2$F$20240903$20240923$20240905$20240924$PER$$US-AMGEN-USASP2024176346$AMGEN$$76$YR$E$F$Y$$$20240924$$CN$US$US
242847211$24284721$1$I$$20240903$20240905$20240905$EXP$$NVSC2024US177250$NOVARTIS$$$$$$Y$$$20240905$$CN$US$US
242847221$24284722$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024108976$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242847231$24284723$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010100$APOTEX$$63$YR$$M$Y$$$20240905$$CN$CA$CA
242847241$24284724$1$I$$20240828$20240905$20240905$EXP$$ZA-ROCHE-10000069637$ROCHE$$$$E$F$Y$$$20240905$$MD$ZA$ZA
242847252$24284725$2$F$20240701$20240919$20240905$20240924$EXP$$CO-AMGEN-COLSL2024174668$AMGEN$$65$YR$E$F$Y$$$20240924$$CN$CO$CO
242847261$24284726$1$I$20240820$20240829$20240905$20240905$EXP$$CN-TAKEDA-2024TUS087206$TAKEDA$$61$YR$$F$Y$60$KG$20240905$$HP$CN$CN
242847272$24284727$2$F$20240101$20240911$20240905$20240926$PER$$US-GRANULES-US-2024GRASPO00391$GRANULES INDIA$$$$$F$Y$$$20240926$$CN$US$US
242847281$24284728$1$I$20240101$20240902$20240905$20240905$EXP$$JP-ARGENX-2024-ARGX-JP004965AA$ARGENX BVBA$$$$$$Y$$$20240905$$PH$JP$JP
242847291$24284729$1$I$$20240823$20240905$20240905$EXP$$BR-UCBSA-2024043885$UCB$$$$$F$Y$$$20240905$$CN$BR$BR
242847301$24284730$1$I$$20240820$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08304$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242847311$24284731$1$I$20240527$20240826$20240905$20240905$EXP$$FR-IMMUNOCORE, LTD-2024-IMC-002777$IMMUNOCORE$$$$$$Y$$$20240905$$MD$FR$FR
242847322$24284732$2$F$$20240806$20240905$20240920$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00630$MIRUM PHARMACEUTICALS$$$$A$M$Y$$$20240920$$CN$US$US
242847331$24284733$1$I$20240710$20240830$20240905$20240905$EXP$$CN-JNJFOC-20240902101$JOHNSON AND JOHNSON$$58$YR$A$M$Y$67.3$KG$20240905$$HP$CN$CN
242847341$24284734$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043298$AUROBINDO$$75$YR$$F$Y$$$20240905$$HP$CA$CA
242847351$24284735$1$I$$20240826$20240905$20240905$EXP$GB-MHRA-MED-202408261547572090-RHSJP$GB-Accord-443569$ACCORD$$50$YR$A$M$Y$$$20240905$$PH$GB$GB
242847361$24284736$1$I$$20240824$20240905$20240905$EXP$CA-MHPD-E2B_07214005$CA-Accord-444160$ACCORD$$75$YR$E$F$Y$$$20240905$$HP$CA$CA
242847371$24284737$1$I$20240715$20240824$20240905$20240905$EXP$FR-AFSSAPS-LM2024000463$FR-Accord-443900$ACCORD$$78$YR$E$M$Y$60$KG$20240905$$MD$FR$FR
242847381$24284738$1$I$20240624$20240826$20240905$20240905$EXP$GB-MHRA-MED-202408261330327800-LHBSQ$GB-Accord-443565$ACCORD$$76$YR$E$F$Y$$$20240905$$CN$GB$GB
242847391$24284739$1$I$20240816$20240824$20240905$20240905$EXP$$US-Accord-443841$ACCORD$$21$YR$A$M$Y$$$20240905$$PH$US$US
242847401$24284740$1$I$20240816$20240826$20240905$20240905$EXP$CN-HENLIUS-24CN016639$CN-Accord-444729$ACCORD$$58$YR$A$F$Y$54$KG$20240905$$MD$CN$CN
242847411$24284741$1$I$20240824$20240824$20240905$20240905$EXP$GB-MHRA-MED-202408241712263180-RYDCL$GB-Accord-443475$ACCORD$$80$YR$E$F$Y$$$20240905$$CN$GB$GB
242847421$24284742$1$I$20240823$20240824$20240905$20240905$EXP$$US-Accord-444267$ACCORD$$38$YR$A$M$Y$$$20240905$$HP$US$US
242847431$24284743$1$I$$20240824$20240905$20240905$EXP$CA-MHPD-001103084$CA-Accord-444018$ACCORD$$65$YR$E$F$Y$85$KG$20240905$$HP$CA$CA
242847441$24284744$1$I$20240819$20240826$20240905$20240905$EXP$$US-Accord-443834$ACCORD$$53$YR$A$F$Y$$$20240905$$MD$US$US
242847452$24284745$2$F$$20240826$20240905$20240917$EXP$$FI-ROCHE-10000073209$ROCHE$$53$YR$A$F$Y$$$20240917$$MD$FI$FI
242847461$24284746$1$I$$20240828$20240905$20240905$EXP$$CA-BEH-2024178034$CSL BEHRING$$14$YR$T$M$Y$59$KG$20240905$$CN$CA$CA
242847471$24284747$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043324$AUROBINDO$$$$$F$Y$$$20240905$$CN$CA$CA
242847481$24284748$1$I$20230908$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-109907-2023$RECKITT BENCKISER$$70$YR$$F$Y$$$20240905$$CN$US$US
242847491$24284749$1$I$20240101$20240827$20240905$20240905$EXP$$US-BEH-2024177833$CSL BEHRING$$25$YR$A$F$Y$$$20240905$$CN$US$US
242847501$24284750$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024108995$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242847511$24284751$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2020-030530$AUROBINDO$$54$YR$$F$Y$$$20240905$$HP$CA$CA
242847521$24284752$1$I$20240826$20240827$20240905$20240905$PER$$US-TAKEDA-2024TUS086716$TAKEDA$$$$$M$Y$$$20240905$$MD$US$US
242847532$24284753$2$F$$20240827$20240905$20240911$PER$$US-BEH-2024177843$CSL BEHRING$$25$YR$A$F$Y$$$20240911$$CN$US$US
242847541$24284754$1$I$$20240827$20240905$20240905$EXP$$CA-Encube-001303$ENCUBE ETHICALS$Lagace-Thomassin F, Nateghi A, Kechichian E, Veilleux M. Topical imiquimod adverse event: Beyond the local skin reaction-A case report. SAGE Open Med Case Rep. 2024 Aug 19;12:2050313X241274916. doi: 10.1177/2050313X241274916.$82$YR$E$M$Y$$$20240905$$MD$CA$
242847551$24284755$1$I$20240701$20240829$20240905$20240905$EXP$$US-EMD Serono-2024034158$EMD SERONO INC$$30$YR$A$F$Y$$$20240905$$CN$US$US
242847562$24284756$2$F$$20240826$20240905$20240923$EXP$AU-TGA-0000814431$AU-JNJFOC-20240903799$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240923$$MD$AU$AU
242847571$24284757$1$I$$20240822$20240905$20240905$PER$$US-GRANULES-US-2024GRASPO00395$GRANULES INDIA$$$$$$Y$$$20240905$$PH$US$US
242847582$24284758$2$F$$20240916$20240905$20240919$EXP$DE-EMA-DD-20240827-7482647-152111$DE-SANDOZ INC.-PHBS2004DE00723$SANDOZ$$14$YR$$F$Y$48$KG$20240919$$MD$DE$DE
242847591$24284759$1$I$20240815$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176037$AMGEN$$81$YR$E$F$Y$$$20240905$$CN$US$US
242847601$24284760$1$I$20240801$20240822$20240905$20240905$PER$$US-ASTELLAS-2024-AER-002444$ASTELLAS$$86$YR$E$F$Y$$$20240905$$MD$US$US
242847611$24284761$1$I$20240101$20240819$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133963$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240905$$HP$US$US
242847621$24284762$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140802$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240905$$CN$US$US
242847631$24284763$1$I$20240101$20240826$20240905$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-026370$UNITED THERAPEUTICS$$$$$F$Y$99.773$KG$20240905$$$US$US
242847641$24284764$1$I$$20240827$20240905$20240905$EXP$$US-BEH-2024177898$CSL BEHRING$$$$$$Y$$$20240905$$MD$US$US
242847661$24284766$1$I$20240822$20240830$20240905$20240905$EXP$$CN-EMD Serono-2024046982$EMD SERONO INC$$88$YR$E$F$Y$75$KG$20240905$$HP$CN$CN
242847671$24284767$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043548$AUROBINDO$$81$YR$$F$Y$$$20240905$$PH$CA$CA
242847701$24284770$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024109024$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242847711$24284771$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024109025$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242847721$24284772$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010105$APOTEX$$71$YR$$M$Y$$$20240905$$CN$CA$CA
242847731$24284773$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178476$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242847742$24284774$2$F$$20240826$20240905$20240920$PER$$US-JNJFOC-20240869073$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
242847752$24284775$2$F$$20240806$20240905$20240920$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00631$MIRUM PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
242847761$24284776$1$I$20240821$20240829$20240905$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027283$UNITED THERAPEUTICS$$75$YR$$M$Y$70.295$KG$20240905$$$US$US
242847772$24284777$2$F$20240517$20240916$20240905$20240926$EXP$$DE-AUROBINDO-AUR-APL-2024-028554$AUROBINDO$$67$YR$$F$Y$$$20240926$$MD$DE$DE
242847781$24284778$1$I$20231223$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-081792-2024$RECKITT BENCKISER$$72$YR$$M$Y$82.73$KG$20240905$$CN$US$US
242847791$24284779$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010127$APOTEX$$82$YR$$F$Y$$$20240905$$CN$CA$CA
242847801$24284780$1$I$$20240829$20240905$20240905$PER$$US-BEH-2024178114$CSL BEHRING$$$$A$F$Y$$$20240905$$PH$US$US
242847811$24284781$1$I$$20240827$20240905$20240905$EXP$$GB-LEO Pharma-373133$LEO PHARM$$17$YR$$M$Y$$$20240905$$CN$GB$GB
242847831$24284783$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043437$AUROBINDO$$44$YR$$M$Y$$$20240905$$HP$CA$CA
242847851$24284785$1$I$20200101$20240902$20240905$20240905$EXP$$JP-JNJFOC-20240909773$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240905$$MD$JP$JP
242847871$24284787$1$I$$20240903$20240905$20240905$PER$$US-ROCHE-10000073375$ROCHE$$70$YR$E$F$Y$$$20240905$$CN$US$US
242847881$24284788$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2019-077098$AUROBINDO$$58$YR$$M$Y$$$20240905$$MD$CA$CA
242847892$24284789$2$F$20240828$20240905$20240905$20240906$PER$$US-AMGEN-USASP2024176177$AMGEN$$77$YR$E$M$Y$$$20240906$$CN$US$US
242847902$24284790$2$F$20240902$20240906$20240905$20240911$PER$$US-AMGEN-USASP2024176314$AMGEN$$59$YR$A$M$Y$$$20240911$$CN$US$US
242847912$24284791$2$F$20240903$20240903$20240905$20240909$PER$$US-AMGEN-USASP2024176148$AMGEN$$65$YR$E$F$Y$$$20240909$$CN$US$US
242847921$24284792$1$I$$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140035$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$94.8$KG$20240905$$CN$US$US
242847931$24284793$1$I$$20240816$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133602$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240905$$CN$US$US
242847941$24284794$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140821$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240905$$HP$US$US
242847951$24284795$1$I$$20240904$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2021DE000514$SANDOZ$$16$YR$$M$Y$$$20240905$$HP$DE$DE
242847961$24284796$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141046$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240905$$HP$US$US
242847981$24284798$1$I$20240703$20240823$20240905$20240905$EXP$ES-AEMPS-1562656$ES-CIPLA LTD.-2024ES09412$CIPLA$$$$$$Y$$$20240905$$MD$ES$ES
242847991$24284799$1$I$20240101$20240826$20240905$20240905$PER$$US-Kiniksa Pharmaceuticals Ltd.-2024KPU001482$KINIKSA PHARMACEUTICALS$$74$YR$E$M$Y$$$20240904$$CN$US$US
242848001$24284800$1$I$$20240827$20240905$20240905$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08172$HIKMA$Cunningham BW, Shah S, Biswas S. Cunningham BW, Shah S, Biswas S. Vancomycin Anaphylaxis and Kounis Syndrome Case Report.. Cureus. 2024;16(7):e64740$67$YR$$M$Y$112$KG$20240905$$MD$US$US
242848022$24284802$2$F$20240101$20240910$20240905$20240920$EXP$$FR-BEH-2024177938$CSL BEHRING$$34$YR$A$F$Y$82$KG$20240920$$MD$FR$FR
242848031$24284803$1$I$20240830$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176046$AMGEN$$72$YR$E$M$Y$$$20240905$$CN$US$US
242848041$24284804$1$I$$20240828$20240905$20240905$EXP$$CA-AstraZeneca-2024A198539$ASTRAZENECA$$69$YR$$F$Y$76$KG$20240905$$MD$CA$
242848051$24284805$1$I$$20240827$20240905$20240905$EXP$$US-JNJFOC-20240880243$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$US$US
242848061$24284806$1$I$$20240830$20240905$20240905$EXP$$JP-JNJFOC-20240867424$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$PH$JP$JP
242848081$24284808$1$I$$20240822$20240905$20240905$EXP$$IT-ALVOGEN-2024095393$ALVOGEN$Corazzelli G, Cuccaro A,  Morelli E, Arcamone M, De?Chiara A, Paccone A, Petrillo A, IbelloF, Aversa C, Esposito M,  Volzone F, Saggese M, Capobianco G, Sarno S, Sirica L, Crisci S, De Filippi r, Pinto A. Long- term efficacy and safety of dose- dense and dose- intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15- year follow- up of the ABVD DD- DI phase II study. British Journal of Haemotology. 2024 Jul 04;00:1-6. doi: https://doi.org/10.1111/bjh.1964$44$YR$$M$Y$$$20240905$$HP$IT$IT
242848091$24284809$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010108$APOTEX$$73$YR$$M$Y$$$20240905$$CN$CA$CA
242848101$24284810$1$I$$20240830$20240905$20240905$EXP$GB-MHRA-MIDB-e3ffbe2f-4c0f-47ec-9c6b-f968b73335b6$GB-RDY-SPO/GBR/24/0012736$DR REDDYS$$81$YR$E$F$Y$$$20240905$$PH$GB$GB
242848111$24284811$1$I$20240101$20240823$20240905$20240905$EXP$$BR-UCBSA-2024043817$UCB$$$$$M$Y$$$20240905$$CN$BR$BR
242848121$24284812$1$I$$20240828$20240905$20240905$EXP$$GB-TEVA-VS-3238545$TEVA$$57$YR$$F$Y$$$20240905$$MD$GB$GB
242848131$24284813$1$I$20240701$20240821$20240905$20240905$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-24544$SAMSUNG BIOEPIS$$46$YR$A$F$Y$60$KG$20240905$$PH$CA$CA
242848141$24284814$1$I$20240821$20240827$20240905$20240905$EXP$$GB-AUROBINDO-AUR-APL-2024-043326$AUROBINDO$$$$$$Y$$$20240905$$CN$GB$GB
242848161$24284816$1$I$$20240827$20240905$20240905$EXP$$CZ-AUROBINDO-AUR-APL-2024-043270$AUROBINDO$Holubec L, Mrazkova P, Matejka VM, Fiala O, Finek J. Polyneuropathic pain therapy with a patient suffering from generalized castrate-resistant prostate cancer. Klinicka Onkologie.. 2013;26 (5):354-357$65$YR$$M$Y$$$20240905$$MD$CZ$CZ
242848181$24284818$1$I$$20240822$20240905$20240905$EXP$$IT-ALVOGEN-2024095392$ALVOGEN$Corazzelli G, Cuccaro A, Morelli E, Arcamone M, De?Chiara A, Paccone A, Petrillo A, IbelloF, Aversa C, Esposito M,  Volzone F, Saggese M, Capobianco G, Sarno S, Sirica L, Crisci S, De Filippi R, Pinto A. Long- term efficacy and safety of dose- dense and dose- intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15- year follow- up of the ABVD DD- DI phase II study. British Journal of Haemotology. 2024 Jul 04;00:1-6. doi: https://doi.org/10.1111/bjh.19646$35$YR$$M$Y$$$20240905$$HP$IT$IT
242848191$24284819$1$I$$20240828$20240905$20240905$EXP$$GB-TEVA-VS-3238264$TEVA$$82$YR$$M$Y$$$20240905$$MD$GB$GB
242848201$24284820$1$I$$20240830$20240905$20240905$EXP$$US-JNJFOC-20240902399$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242848211$24284821$1$I$$20240805$20240905$20240905$PER$$US-WT-2024-4883$Waylis$$$$$$Y$$$20240905$$CN$US$US
242848221$24284822$1$I$$20240828$20240905$20240905$EXP$GB-MHRA-MED-202408281425375760-GHMRZ$GB-TEVA-VS-3238476$TEVA$$79$YR$$F$Y$$$20240905$$CN$GB$GB
242848231$24284823$1$I$$20240905$20240905$20240905$EXP$$NZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049612$BOEHRINGER INGELHEIM$$51$YR$A$F$Y$$$20240905$$HP$NZ$NZ
242848242$24284824$2$F$$20240905$20240905$20240910$EXP$$PL-REGENERON PHARMACEUTICALS, INC.-2024-118778$REGENERON$$40$YR$$M$Y$$$20240910$$MD$PL$PL
242848251$24284825$1$I$20240824$20240828$20240905$20240905$EXP$GB-MHRA-MED-202408281653187830-DQPSY$GB-TEVA-VS-3238621$TEVA$$45$YR$$F$Y$$$20240905$$CN$GB$GB
242848261$24284826$1$I$$20240828$20240905$20240905$PER$$US-TAKEDA-2024TUS087323$TAKEDA$$$$$F$Y$64$KG$20240905$$MD$US$US
242848272$24284827$2$F$20240801$20240904$20240905$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140717$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240906$$PH$US$US
242848281$24284828$1$I$$20240828$20240905$20240905$EXP$$GB-TEVA-VS-3238662$TEVA$$53$YR$$F$Y$$$20240905$$MD$GB$GB
242848291$24284829$1$I$$20240822$20240905$20240905$EXP$$SE-ALVOGEN-2024095391$ALVOGEN$Sunebo S, Appelqvist H, H?ggqvist B, Danielsson O. Multiple Acyl-Coenzyme A Dehydrogenase De?ciency Is Associated with Sertraline Use-Is There an Acquired Form. ANNALS of Neurology. 2024 Aug 21;00:1-10. doi:10.1002/ana.27030$26$YR$$F$Y$$$20240905$$MD$SE$SE
242848301$24284830$1$I$$20240828$20240905$20240905$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08212$HIKMA$Seitz V, Davidson ER.. Seitz V, Davidson ER. Retained Tampon Fragment as an Unusual Cause of Vesicovaginal Fistula.. Obstetrics and Gynecology. 2024;144(1)::e1-e3$53$YR$$F$Y$$$20240905$$MD$US$US
242848311$24284831$1$I$$20240904$20240905$20240905$EXP$$CA-SANDOZ INC.-SDZ2023CA039465$SANDOZ$$67$YR$$M$Y$$$20240905$$CN$CA$CA
242848321$24284832$1$I$20240831$20240901$20240905$20240905$EXP$$CN-SANDOZ INC.-SDZ2024CN076857$SANDOZ$$65$YR$$F$Y$58$KG$20240905$$HP$CN$CN
242848341$24284834$1$I$20240726$20240903$20240905$20240905$EXP$IT-MINISAL02-1000698$IT-SANDOZ INC.-SDZ2024IT077727$SANDOZ$$29$YR$$M$Y$$$20240905$$MD$IT$IT
242848352$24284835$2$F$20240813$20240905$20240905$20240907$PER$$US-AMGEN-USASP2024177150$AMGEN$$66$YR$E$F$Y$$$20240907$$CN$US$US
242848361$24284836$1$I$20240101$20240830$20240905$20240905$EXP$$CA-ABBVIE-5903513$ABBVIE$$$$$F$Y$$$20240905$$CN$CA$CA
242848371$24284837$1$I$20240708$20240823$20240904$20240904$DIR$FDA-CDER-CTU-2024-60592$$FDA-CTU$$56$YR$$F$N$124$LBS$20240823$N$CN$US$
242848391$24284839$1$I$20240701$20240827$20240904$20240904$DIR$FDA-CDER-CTU-2024-60591$$FDA-CTU$$79$YR$$F$N$219$LBS$20240827$Y$CN$US$
242848401$24284840$1$I$20240804$20240831$20240905$20240905$EXP$$CN-ABBVIE-5903892$ABBVIE$$58$YR$$M$Y$65$KG$20240905$$MD$CN$CN
242848411$24284841$1$I$$20240829$20240905$20240905$PER$$US-BEH-2024178119$CSL BEHRING$$4$YR$C$M$Y$$$20240905$$MD$US$US
242848421$24284842$1$I$$20240830$20240905$20240905$EXP$$US-GILEAD-2024-0686121$GILEAD$$$$E$F$Y$$$20240905$$CN$US$US
242848433$24284843$3$F$20230401$20240912$20240905$20240912$EXP$$NZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039087$BOEHRINGER INGELHEIM$$53$YR$A$F$Y$97$KG$20240912$$MD$NZ$NZ
242848441$24284844$1$I$20240827$20240827$20240905$20240905$PER$$US-RDY-SPO/USA/24/0012641$DR REDDYS$$18$YR$A$F$Y$$$20240905$$HP$US$US
242848451$24284845$1$I$20240827$20240827$20240905$20240905$PER$$US-RDY-SPO/USA/24/0012655$DR REDDYS$$15$YR$T$F$Y$$$20240905$$HP$US$US
242848461$24284846$1$I$20240701$20240827$20240905$20240905$PER$$US-RDY-SPO/USA/24/0012692$DR REDDYS$$15$YR$T$$Y$$$20240905$$CN$US$US
242848471$24284847$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024108987$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242848481$24284848$1$I$$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-087435-2024$RECKITT BENCKISER$$$$$F$Y$$$20240905$$CN$US$US
242848491$24284849$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024109021$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242848501$24284850$1$I$$20240816$20240905$20240905$PER$$US-TEVA-VS-3235567$TEVA$$$$$F$Y$$$20240905$$CN$US$US
242848511$24284851$1$I$$20240822$20240905$20240905$EXP$$SE-ALVOGEN-2024095390$ALVOGEN$Sunebo S, Appelqvist H, H?ggqvist B, Danielsson O. Multiple Acyl-Coenzyme A Dehydrogenase De?ciency Is Associated with Sertraline Use-Is There an Acquired Form. ANNALS of Neurology. 2024 Aug 21;00:1-10. doi:10.1002/ana.27030$51$YR$$F$Y$$$20240905$$MD$SE$SE
242848521$24284852$1$I$$20240904$20240905$20240905$EXP$GB-MHRA-MED-202409031935018580-PJCTY$GB-SANDOZ INC.-SDZ2024GB077761$SANDOZ$$$$$F$Y$$$20240905$$CN$GB$GB
242848531$24284853$1$I$$20240830$20240905$20240905$EXP$GB-MHRA-MIDB-f3fc2ddf-7714-46db-9048-8c21cba62f6f$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-08243$HIKMA$$53$YR$$$Y$$$20240905$$PH$GB$GB
242848541$24284854$1$I$20240828$20240904$20240905$20240905$EXP$$DE-ABBVIE-5906913$ABBVIE$$65$YR$$M$Y$$$20240905$$HP$DE$DE
242848552$24284855$2$F$20240101$20240912$20240905$20240913$EXP$$US-ABBVIE-5906163$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
242848561$24284856$1$I$20240826$20240827$20240905$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-027036$UNITED THERAPEUTICS$$31$YR$$F$Y$133.79$KG$20240905$$$US$US
242848581$24284858$1$I$20210309$20240828$20240904$20240904$DIR$FDA-CDER-CTU-2024-60593$$FDA-CTU$$62$YR$$M$N$200$LBS$20240828$N$CN$US$
242848591$24284859$1$I$$20240830$20240905$20240905$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001781$BLUEPRINT MEDICINES$$$$$F$Y$$$20240905$$CN$US$US
242848602$24284860$2$F$$20240916$20240905$20240924$EXP$$PT-CELLTRION INC.-2024PT020894$CELLTRION$$$$$$Y$$$20240924$$CN$PT$PT
242848611$24284861$1$I$$20240826$20240905$20240905$EXP$$US-Accord-443783$ACCORD$$25$YR$A$F$Y$$$20240905$$MD$US$US
242848622$24284862$2$F$$20240904$20240905$20240906$PER$$US-ROCHE-10000073298$ROCHE$Finn M, Miller J. Atypical central retinal vein occlusion in an older man with multiple myeloma: a case report. Ophthalmic surgery, lasers + imaging retina. 2024-Aug-01;55:1-4. doi:10.3928/23258160-20240718-02.$72$YR$E$M$Y$$$20240906$$MD$US$US
242848631$24284863$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001968$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240905$$CN$US$US
242848641$24284864$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001610$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240905$$CN$US$US
242848651$24284865$1$I$20240827$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001532$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240905$$CN$US$US
242848661$24284866$1$I$$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002657$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240905$$CN$US$US
242848671$24284867$1$I$20240827$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001663$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240905$$CN$US$US
242848681$24284868$1$I$20240901$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002220$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240905$$CN$US$US
242848691$24284869$1$I$20240904$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002840$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240905$$CN$US$US
242848701$24284870$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001482$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240905$$CN$US$US
242848711$24284871$1$I$$20240827$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408017902$ELI LILLY AND CO$$43$YR$A$$Y$$$20240905$$LW$US$US
242848721$24284872$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001817$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240905$$CN$US$US
242848741$24284874$1$I$$20240828$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137795$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240905$$CN$US$US
242848751$24284875$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043335$AUROBINDO$$80$YR$$M$Y$$$20240905$$CN$CA$CA
242848761$24284876$1$I$20240809$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139195$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240905$$PH$US$US
242848772$24284877$2$F$$20240927$20240905$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140923$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240930$$CN$US$US
242848781$24284878$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178329$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
242848791$24284879$1$I$$20240903$20240905$20240905$PER$$US-ABBVIE-5906005$ABBVIE$$27$YR$$F$Y$$$20240905$$CN$US$US
242848801$24284880$1$I$20230628$20240829$20240905$20240905$EXP$$SA-GSK-SA2023EME095996$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$SA$SA
242848811$24284881$1$I$$20240829$20240905$20240905$30DAY$$US-GSK-US2024107896$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$US$US
242848821$24284882$1$I$$20240827$20240905$20240905$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024006341$BIOCON$$$$$$Y$$$20240905$$CN$AU$AU
242848833$24284883$3$F$20240801$20240919$20240905$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-026859$UNITED THERAPEUTICS$$49$YR$$F$Y$87.075$KG$20240928$$$US$US
242848841$24284884$1$I$20230901$20240829$20240905$20240905$EXP$$US-GSK-US2024107720$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$US$US
242848851$24284885$1$I$20240902$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176107$AMGEN$$69$YR$E$F$Y$$$20240905$$CN$US$US
242848861$24284886$1$I$20240621$20240830$20240905$20240905$EXP$FR-AFSSAPS-MA2024001417$FR-AMGEN-FRASP2024173958$AMGEN$$72$YR$E$F$Y$$$20240905$$MD$FR$FR
242848871$24284887$1$I$20240815$20240830$20240905$20240905$EXP$$JP-HALEON-2194618$Haleon PLC$$71$YR$$M$Y$90$KG$20240905$$PH$JP$JP
242848881$24284888$1$I$20240819$20240827$20240905$20240905$EXP$$CN-ASTELLAS-2024-AER-002721$ASTELLAS$$34$YR$A$M$Y$76$KG$20240905$$HP$CN$CN
242848891$24284889$1$I$$20240822$20240905$20240905$EXP$$SE-ALVOGEN-2024095389$ALVOGEN$Sunebo S, Appelqvist H, Haggqvist B, Danielsson O. Multiple Acyl-Coenzyme A Dehydrogenase De?ciency Is Associated with Sertraline Use-Is There an Acquired Form. ANNALS of Neurology. 2024 Aug 21;00:1-10. doi:10.1002/ana.27030$22$YR$$F$Y$$$20240905$$MD$SE$SE
242848902$24284890$2$F$$20240916$20240905$20240919$PER$$US-LEO Pharma-373235$LEO PHARM$$75$YR$$M$Y$$$20240919$$PH$US$US
242848911$24284891$1$I$$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-134706-2023$RECKITT BENCKISER$$$$$F$Y$$$20240905$$CN$US$US
242848922$24284892$2$F$$20240904$20240905$20240910$PER$$US-ROCHE-10000071803$ROCHE$$63$YR$A$M$Y$$$20240910$$CN$US$US
242848931$24284893$1$I$20240824$20240829$20240905$20240905$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111713$ZYDUS PHARM$$$$$$Y$$$20240905$$CN$US$US
242848941$24284894$1$I$$20240904$20240905$20240905$EXP$$DE-GILEAD-2024-0686223$GILEAD$$$$$M$Y$$$20240905$$MD$DE$DE
242848951$24284895$1$I$$20240904$20240905$20240905$PER$$US-ALXN-202409USA000136US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242848961$24284896$1$I$20240616$20240827$20240905$20240905$EXP$FR-AFSSAPS-AM2024000693$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111640$ZYDUS PHARM$$$$$$Y$$$20240905$$MD$FR$FR
242848974$24284897$4$F$20240414$20240923$20240905$20240926$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049402$BOEHRINGER INGELHEIM$$55$YR$A$M$Y$480.61$KG$20240926$$HP$US$US
242848981$24284898$1$I$20240101$20240905$20240905$20240905$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-015809$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240905$$CN$JP$JP
242848991$24284899$1$I$20240801$20240821$20240905$20240905$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01388$INTRA-CELLULAR THERAPIES$$32$YR$$M$Y$$$20240905$$HP$US$US
242849001$24284900$1$I$$20240822$20240905$20240905$EXP$$SE-ALVOGEN-2024095388$ALVOGEN$Sunebo S, Appelqvist H, H?ggqvist B, Danielsson O. Multiple Acyl-Coenzyme A Dehydrogenase De?ciency Is Associated with Sertraline Use-Is There an Acquired Form. ANNALS of Neurology. 2024 Aug 21;00:1-10. doi:10.1002/ana.27030$46$YR$$F$Y$$$20240905$$MD$SE$SE
242849021$24284902$1$I$$20240822$20240905$20240905$EXP$$SE-ALVOGEN-2024095387$ALVOGEN$Sunebo S, Appelqvist H, H?ggqvist B, Danielsson O. Multiple Acyl-Coenzyme A Dehydrogenase De?ciency Is Associated with Sertraline Use-Is There an Acquired Form. ANNALS of Neurology. 2024 Aug 21;00:1-10. doi:10.1002/ana.27030$35$YR$$F$Y$$$20240905$$MD$SE$SE
242849032$24284903$2$F$20240101$20240903$20240905$20240909$PER$$US-AMGEN-USASP2024175733$AMGEN$$68$YR$E$F$Y$$$20240909$$CN$US$US
242849041$24284904$1$I$20240818$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176031$AMGEN$$74$YR$E$F$Y$$$20240905$$CN$US$US
242849051$24284905$1$I$$20240803$20240830$20240830$DIR$FDA-CDER-CTU-2024-60598$$FDA-CTU$$76$YR$$F$N$$$20240803$N$$US$
242849062$24284906$2$F$20240808$20240904$20240905$20240909$PER$$US-AMGEN-USASP2024177070$AMGEN$$$$$$Y$$$20240909$$PH$US$US
242849071$24284907$1$I$20240724$20240827$20240905$20240905$EXP$$FR-AMGEN-FRASP2024171059$AMGEN$$74$YR$E$M$Y$85$KG$20240905$$MD$FR$FR
242849081$24284908$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043515$AUROBINDO$$66$YR$$F$Y$$$20240905$$CN$CA$CA
242849091$24284909$1$I$$20240901$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140700$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240905$$CN$US$US
242849101$24284910$1$I$20240801$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140512$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$102.97$KG$20240905$$CN$US$US
242849111$24284911$1$I$20240829$20240830$20240831$20240831$DIR$FDA-CDER-CTU-2024-60607$$FDA-CTU$$55$YR$$F$N$78.5$KG$20240830$N$$US$
242849121$24284912$1$I$20240828$20240829$20240831$20240831$DIR$FDA-CDER-CTU-2024-60608$$FDA-CTU$$73$YR$$M$N$82$KG$20240829$N$$US$
242849131$24284913$1$I$20240823$20240830$20240831$20240831$DIR$FDA-CDER-CTU-2024-60611$$FDA-CTU$$61$YR$$$N$$$20240830$N$$US$
242849141$24284914$1$I$20240823$20240830$20240831$20240831$DIR$FDA-CDER-CTU-2024-60612$$FDA-CTU$$2$YR$$F$N$11.9$KG$20240830$N$$US$
242849151$24284915$1$I$20240829$20240830$20240831$20240831$DIR$FDA-CDER-CTU-2024-60606$$FDA-CTU$$$$$M$N$77$KG$20240830$N$$US$
242849161$24284916$1$I$20240827$20240830$20240831$20240831$DIR$FDA-CDER-CTU-2024-60609$$FDA-CTU$$77$YR$$M$N$88.5$KG$20240830$N$$US$
242849171$24284917$1$I$20240701$20240830$20240831$20240831$DIR$FDA-CDER-CTU-2024-60615$$FDA-CTU$$62$YR$$F$N$48.6$KG$20240830$N$$US$
242849181$24284918$1$I$20240826$20240830$20240831$20240831$DIR$FDA-CDER-CTU-2024-60610$$FDA-CTU$$88$YR$$M$N$68.6$KG$20240830$N$$US$
242849191$24284919$1$I$20240814$20240830$20240831$20240831$DIR$FDA-CDER-CTU-2024-60613$$FDA-CTU$$76$YR$$M$N$90.2$KG$20240830$N$$US$
242849201$24284920$1$I$$20240831$20240831$20240831$DIR$FDA-CDER-CTU-2024-60595$$FDA-CTU$$4$YR$$M$N$$$20240831$N$$US$
242849211$24284921$1$I$$20240831$20240831$20240831$DIR$FDA-CDER-CTU-2024-60600$$FDA-CTU$$67$YR$$F$N$$$20240831$N$$US$
242849231$24284923$1$I$$20240831$20240831$20240831$DIR$FDA-CDER-CTU-2024-60596$$FDA-CTU$$67$YR$$M$N$$$20240831$N$$US$
242849241$24284924$1$I$$20240822$20240905$20240905$EXP$$SE-ALVOGEN-2024095386$ALVOGEN$Sunebo S, Appelqvist H, Haggqvist B, Danielsson O. Multiple Acyl-Coenzyme A Dehydrogenase De?ciency Is Associated with Sertraline Use-Is There an Acquired Form. ANNALS of Neurology. 2024 Aug 21;00:1-10. doi:10.1002/ana.27030$47$YR$$F$Y$$$20240905$$MD$SE$SE
242849251$24284925$1$I$20240101$20240828$20240905$20240905$EXP$$US-SA-2024SA256622$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240905$$MD$US$US
242849261$24284926$1$I$20230901$20240822$20240905$20240905$EXP$FR-AFSSAPS-NY2023001328$FR-Accord-387167$ACCORD$$75$YR$E$M$Y$70$KG$20240905$$MD$FR$FR
242849271$24284927$1$I$20240817$20240829$20240905$20240905$EXP$$IT-AstraZeneca-2024A201072$ASTRAZENECA$$58$YR$$F$Y$$$20240905$$MD$IT$
242849282$24284928$2$F$$20240910$20240905$20240917$PER$$US-AstraZeneca-2024A188939$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
242849291$24284929$1$I$$20240828$20240905$20240905$EXP$$CN-AstraZeneca-2024A183125$ASTRAZENECA$$71$YR$$M$Y$$$20240905$$CN$CN$
242849311$24284931$1$I$$20240822$20240905$20240905$EXP$$SE-ALVOGEN-2024095385$ALVOGEN$Sunebo S, Appelqvist H, Haggqvist B, Danielsson O. Multiple Acyl-Coenzyme A Dehydrogenase De?ciency Is Associated with Sertraline Use-Is There an Acquired Form. ANNALS of Neurology. 2024 Aug 21;00:1-10. doi:10.1002/ana.27030$74$YR$$M$Y$$$20240905$$MD$SE$SE
242849321$24284932$1$I$20240821$20240826$20240905$20240905$EXP$$US-Accord-443894$ACCORD$$69$YR$E$F$Y$$$20240905$$HP$US$US
242849332$24284933$2$F$$20240902$20240905$20240917$EXP$FR-MLMSERVICE-20240814-PI163203-00232-1$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-19931$ALKEM$Pinana M, Rapoport C, Champtiaux N, Lescaille G, Allenbach Y, Rochefort J.. Cytomegalovirus-induced oral ulcers: A case report and literature review. Clinical case reports. 2023;11(6):e7459$62$YR$$F$Y$$$20240917$$MD$FR$FR
242849342$24284934$2$F$20240901$20240906$20240905$20240907$PER$$US-AMGEN-USASP2024175987$AMGEN$$64$YR$A$M$Y$$$20240907$$CN$US$US
242849352$24284935$2$F$20240903$20240903$20240905$20240909$EXP$$US-ROCHE-10000073201$ROCHE$$18$YR$A$M$Y$$$20240909$$CN$US$US
242849361$24284936$1$I$20240214$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-085278-2024$RECKITT BENCKISER$$90$YR$$F$Y$$$20240905$$CN$US$US
242849371$24284937$1$I$$20240826$20240905$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109077$VIIV$$$$$$Y$$$20240905$$HP$US$US
242849381$24284938$1$I$$20240822$20240905$20240905$EXP$GB-MHRA-MED-202408211733525570-ZVMKT$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19936$ALKEM$$$$$F$Y$$$20240905$$HP$GB$GB
242849391$24284939$1$I$20230501$20240825$20240905$20240905$EXP$$IN-Accord-443969$ACCORD$Nanjappa H, Rodrigues AJ. Atrial Fibrillation Secondary to Levothyroxine Overdose with Underlying Secondary Infection. J Assoc Physicians India 2024;72(8):96-98.$62$YR$A$F$Y$$$20240905$$MD$IN$IN
242849401$24284940$1$I$$20240826$20240905$20240905$30DAY$$US-GSK-US2024105947$GLAXOSMITHKLINE$$$$$M$Y$$$20240905$$CN$US$US
242849411$24284941$1$I$20240903$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001364$ELI LILLY AND CO$$30$YR$A$$Y$$$20240905$$CN$US$US
242849421$24284942$1$I$20240809$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001823$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240905$$CN$US$US
242849431$24284943$1$I$$20240822$20240905$20240905$EXP$GB-MHRA-MED-202408211939013530-PSVHC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19937$ALKEM$$$$$M$Y$$$20240905$$CN$GB$GB
242849441$24284944$1$I$20240802$20240828$20240905$20240905$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000154-2024$QILU PHARMACEUTICAL$$71$YR$E$F$Y$41$KG$20240905$$HP$CN$CN
242849452$24284945$2$F$$20240902$20240905$20240917$EXP$TR-MLMSERVICE-20240814-PI162244-00097-1$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-19922$ALKEM$Kaynar K, Alizade L, Uyar O, Mungan S, Rashidzade K.. To screen or not to screen renal cell cancer in a kidney transplant patient. Hippokratia. 2023;27(2):69-71$55$YR$$M$Y$$$20240917$$MD$TR$TR
242849462$24284946$2$F$20230501$20240902$20240905$20240917$EXP$IN-MLMSERVICE-20240814-PI162594-00306-1$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-19920$ALKEM$Mavoor PP, George S, Chetambath R, Poornima MV.. A Rare Parasitic Infection from the Common Cockroach: A Case of Lophomonas Blattarum from a Tertiary Center in Kerala. Indian Journal of Nephrology. 2024;34(4):387-389$40$YR$$M$Y$$$20240917$$MD$IN$IN
242849471$24284947$1$I$$20240822$20240905$20240905$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20229$ALKEM$$$$$M$Y$$$20240905$$CN$US$US
242849482$24284948$2$F$$20240902$20240905$20240917$EXP$IN-MLMSERVICE-20240814-PI161939-00270-1$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-19918$ALKEM$Nimi G, Kirubakaran K, John J, Kumar P. Disseminated Protozoa Zopfii Infection in Liver transplant Recipient. Journal of Clinical and Experimental Hepatology. 2024;14(1):unk$62$YR$$M$Y$$$20240917$$MD$IN$IN
242849491$24284949$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3237795$TEVA$$1$YR$$F$Y$9$KG$20240905$$HP$CA$CA
242849501$24284950$1$I$$20240826$20240905$20240905$EXP$$CA-TEVA-VS-3237957$TEVA$$48$YR$$F$Y$$$20240905$$HP$CA$CA
242849512$24284951$2$F$20231201$20240918$20240905$20240927$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002573$PAREXEL$$$$$$Y$$$20240927$$CN$US$US
242849521$24284952$1$I$$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139462$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240905$$HP$US$US
242849531$24284953$1$I$$20240831$20240905$20240905$EXP$$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-140428$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240905$$CN$SE$SE
242849541$24284954$1$I$$20240826$20240905$20240905$EXP$$US-AUROBINDO-AUR-APL-2024-043039$AUROBINDO$Wang D, Lee D, Yeung A. AMI-CS with Misidentification of the Culprit Requiring Delayed Revascularization of LCX, Complicated by MR Requiring IABP and MV TEER. US-Cardiol. 2024;18 (Suppl. 1):13-14 abstr. 26$63$YR$$M$Y$$$20240905$$HP$US$US
242849551$24284955$1$I$20240823$20240826$20240905$20240905$EXP$$US-Accord-443780$ACCORD$$42$YR$A$M$Y$$$20240905$$HP$US$US
242849561$24284956$1$I$$20240828$20240905$20240905$EXP$$US-IMMUNOGEN, INC.-US-IMGN-24-00665$IMMUNOGEN$$$$$$Y$$$20240905$$MD$US$US
242849582$24284958$2$F$$20240911$20240905$20240917$EXP$$IN-VANTIVE-2024VAN017697$Vantive US Healthcare$$63$YR$$F$Y$$$20240917$$CN$IN$IN
242849591$24284959$1$I$$20240902$20240905$20240905$EXP$$JP-VANTIVE-2024VAN018810$Vantive US Healthcare$$$$$$Y$$$20240905$$MD$JP$JP
242849601$24284960$1$I$20230301$20240902$20240905$20240905$EXP$$FR-SANDOZ INC.-SDZ2024FR077489$SANDOZ$$58$YR$$F$Y$$$20240905$$MD$FR$FR
242849612$24284961$2$F$$20240904$20240905$20240913$EXP$$GB-VANTIVE-2024VAN019433$Vantive US Healthcare$$$$$M$Y$$$20240913$$HP$GB$GB
242849622$24284962$2$F$$20240904$20240905$20240911$EXP$$IN-VANTIVE-2024VAN019520$Vantive US Healthcare$$72$YR$$F$Y$$$20240911$$CN$IN$IN
242849631$24284963$1$I$$20240830$20240905$20240905$30DAY$$US-GSK-US2024108464$GLAXOSMITHKLINE$$$$$M$Y$$$20240905$$CN$US$US
242849661$24284966$1$I$20220201$20240826$20240905$20240905$EXP$$PL-AUROBINDO-AUR-APL-2024-040305$AUROBINDO$Kawalec A, Cichon L, Wilczynski K, Janas-Kozik M. First onset of persistent neutropenia in patient undergoing long-term clozapine treatment after vaccination against COVID-19 and SARS-CoV-2 infection in short interval - A case report. Psychiatria polska (Polish psychiatry). 2024;341:1-11$23$YR$$F$Y$$$20240905$$MD$PL$PL
242849671$24284967$1$I$$20240828$20240905$20240905$EXP$$US-NOVITIUMPHARMA-2024USNVP01770$NOVITIUM PHARMA$Kathryn Kline.Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD).Human Vaccines + Immunotherapeutics.06-JUN-2023;19(2):1-5$55$YR$A$F$Y$$$20240905$$HP$US$US
242849681$24284968$1$I$$20240831$20240831$20240831$DIR$FDA-CDER-CTU-2024-60604$$FDA-CTU$$73$YR$$F$N$$$20240831$N$$US$
242849691$24284969$1$I$$20240831$20240831$20240831$DIR$FDA-CDER-CTU-2024-60597$$FDA-CTU$$74$YR$$F$N$$$20240831$N$$US$
242849701$24284970$1$I$$20240831$20240831$20240831$DIR$FDA-CDER-CTU-2024-60599$$FDA-CTU$$84$YR$$F$N$$$20240831$N$$US$
242849761$24284976$1$I$20240816$20240826$20240905$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005053$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240905$$CN$US$US
242849771$24284977$1$I$20240820$20240827$20240905$20240905$EXP$$AE-LEO Pharma-373081$LEO PHARM$$22$YR$$M$Y$$$20240905$$CN$AE$AE
242849781$24284978$1$I$$20240829$20240905$20240905$PER$$US-ABBVIE-5903398$ABBVIE$$$$$$Y$$$20240905$$PH$US$US
242849791$24284979$1$I$$20240822$20240905$20240905$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004544$PAREXEL$$$$$$Y$$$20240905$$CN$US$US
242849811$24284981$1$I$20231225$20240903$20240905$20240905$EXP$$NVSC2023US276044$NOVARTIS$$77$YR$$M$Y$$$20240905$$CN$US$US
242849823$24284982$3$F$20240101$20240912$20240905$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000748$DECIPHERA PHARMACEUTICALS$$56$YR$A$F$Y$$$20240927$$CN$US$US
242849831$24284983$1$I$$20240830$20240905$20240905$EXP$$FR-Accord-444873$ACCORD$$$$$M$Y$$$20240905$$CN$FR$FR
242849851$24284985$1$I$20240903$20240904$20240905$20240905$PER$$US-ALXN-202409USA000132US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242849861$24284986$1$I$$20240826$20240905$20240905$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004765$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240905$$CN$US$US
242849871$24284987$1$I$$20240903$20240905$20240905$PER$$US-ALXN-202409USA000150US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242849901$24284990$1$I$$20240826$20240905$20240905$EXP$$US-TEVA-VS-3238693$TEVA$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J-Drugs-Dermatol 2023; 22 (11): e12-e16.$41$YR$$F$Y$$$20240905$$HP$US$US
242849911$24284991$1$I$20240704$20240808$20240901$20240901$DIR$FDA-CDER-CTU-2024-60657$$FDA-CTU$$37$YR$$F$N$$$20240808$N$HP$US$
242849942$24284994$2$F$$20240910$20240905$20240920$EXP$$US-TEVA-VS-3238446$TEVA$LeSaint KT, Kendric KJ, Logan AA. Successful administration of extended-release buprenorphine in the emergency department. Am-J-Emerg-Med 2024;.; LeSaint KT, Kendric KJ, Logan AA. Successful administration of extended-release buprenorphine in the emergency department. Am-J-Emerg-Med 2024;.; LeSaint KT, Kendric KJ, Logan AA. Successful administration of extended-release buprenorphine in the emergency department. Am-J-Emerg-Med 2024;.$38$YR$$M$Y$$$20240920$$MD$US$US
242849951$24284995$1$I$20240601$20240903$20240905$20240905$PER$$US-BIOGEN-2023BI01215039$BIOGEN$$60$YR$$F$Y$$$20240905$$HP$US$US
242849971$24284997$1$I$$20240829$20240905$20240905$EXP$$JP-GSK-JP2024108734$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242849981$24284998$1$I$$20240822$20240905$20240905$EXP$$GB-UCBSA-2024042810$UCB$$$$$F$Y$$$20240905$$CN$GB$GB
242850012$24285001$2$F$20231001$20240829$20240905$20240906$EXP$$TW-EMD Serono-2024046617$EMD SERONO INC$$12$YR$T$M$Y$$$20240906$$MD$TW$TW
242850022$24285002$2$F$20240903$20240906$20240905$20240909$PER$$US-AMGEN-USASP2024175990$AMGEN$$64$YR$A$M$Y$$$20240909$$CN$US$US
242850031$24285003$1$I$20240826$20240826$20240905$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005049$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240905$$CN$US$US
242850041$24285004$1$I$$20240903$20240905$20240905$EXP$$GB-ABBVIE-5906804$ABBVIE$$$$E$M$Y$$$20240905$$CN$GB$GB
242850051$24285005$1$I$20240101$20240827$20240905$20240905$EXP$$US-INSMED, INC.-2024-02917-US$INSMED$$$$$M$Y$$$20240905$$CN$US$US
242850061$24285006$1$I$20230525$20240828$20240905$20240905$EXP$$NVSC2023IN128316$NOVARTIS$$63$YR$$F$Y$$$20240905$$CN$IN$IN
242850072$24285007$2$F$20240701$20240910$20240905$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005064$ACADIA PHARMACEUTICALS$$89$YR$$M$Y$$$20240920$$CN$US$US
242850081$24285008$1$I$$20240826$20240905$20240905$EXP$$US-GSK-US2024106160$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242850091$24285009$1$I$$20240829$20240905$20240905$EXP$$DE-GSK-DE2024107873$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$DE$DE
242850101$24285010$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024108969$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242850131$24285013$1$I$$20240830$20240905$20240905$PER$$US-HALEON-2194423$Haleon PLC$$$$$F$Y$$$20240905$$CN$US$US
242850151$24285015$1$I$$20240904$20240905$20240905$PER$$US-ROCHE-10000074224$ROCHE$$$$$$Y$$$20240905$$CN$US$US
242850161$24285016$1$I$$20240828$20240905$20240905$EXP$$CA-CELLTRION INC.-2024CA021207$CELLTRION$$$$$$Y$$$20240905$$CN$CA$CA
242850171$24285017$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140933$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$89.36$KG$20240905$$CN$US$US
242850181$24285018$1$I$20240821$20240826$20240905$20240905$EXP$$CN-JNJFOC-20240868659$JOHNSON AND JOHNSON$$72$YR$E$M$Y$71$KG$20240905$$HP$CN$CN
242850191$24285019$1$I$$20240827$20240905$20240905$EXP$$SK-JNJFOC-20240880976$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240905$$MD$SK$SK
242850201$24285020$1$I$20240826$20240903$20240905$20240905$EXP$$CN-ABBVIE-5905698$ABBVIE$$58$YR$$F$Y$59$KG$20240905$$MD$CN$CN
242850211$24285021$1$I$$20240902$20240905$20240905$EXP$$NVSC2024MX177913$NOVARTIS$$$$$M$Y$$$20240905$$CN$MX$MX
242850222$24285022$2$F$$20240916$20240905$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005087$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242850231$24285023$1$I$$20240903$20240905$20240905$EXP$$US-VIIV HEALTHCARE LIMITED-US2024109464$VIIV$$$$$M$Y$$$20240905$$MD$US$US
242850241$24285024$1$I$$20240827$20240905$20240905$EXP$$JP-BIOCON BIOLOGICS LIMITED-BBL2024006499$BIOCON$Hidetaka Sanda, Ryo Koizumi, Reiji Kamitani, Noriyoshi Akashi, Yuta Yamashita, Mariko Momohara. et al. A case of palmoplantar pustulosis-like skin eruption in Behcet^s disease during adalimumab treatment. The 309th Meeting of the Tokai Division of Japanese Dermatological Association. 2024;10$$$$$Y$$$20240905$$HP$JP$JP
242850261$24285026$1$I$20240801$20240823$20240905$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000741$DECIPHERA PHARMACEUTICALS$$63$YR$A$M$Y$$$20240905$$CN$US$US
242850271$24285027$1$I$20221001$20240828$20240905$20240905$EXP$$PL-AMGEN-POLSP2024174507$AMGEN$$82$YR$E$M$Y$$$20240905$$MD$PL$PL
242850281$24285028$1$I$20240830$20240831$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001866$ELI LILLY AND CO$$$$$$Y$$$20240905$$CN$US$US
242850291$24285029$1$I$$20240903$20240905$20240905$PER$$US-ALXN-202409USA000147US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242850301$24285030$1$I$20240801$20240903$20240905$20240905$PER$$US-ALXN-202409USA000028US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242850322$24285032$2$F$20230101$20240830$20240905$20240907$EXP$$US-AMGEN-USASP2024174139$AMGEN$$56$YR$A$F$Y$$$20240907$$MD$US$US
242850332$24285033$2$F$$20240829$20240905$20240905$EXP$$US-ROCHE-10000070305$ROCHE$$$$$$Y$$$20240905$$CN$US$US
242850342$24285034$2$F$20240827$20240926$20240905$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137046$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240930$$PH$US$US
242850352$24285035$2$F$$20240903$20240905$20240906$PER$$US-JNJFOC-20240905537$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242850361$24285036$1$I$$20240902$20240905$20240905$EXP$$JP-JNJFOC-20240909454$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240905$$MD$JP$JP
242850371$24285037$1$I$$20240902$20240905$20240905$EXP$$AU-AMGEN-AUSSP2024174863$AMGEN$$$$$$Y$$$20240905$$MD$AU$AU
242850382$24285038$2$F$20231007$20240917$20240905$20240927$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00762$PARATEK PHARMACEUTICALS$$75$YR$$F$Y$58.2$KG$20240927$$MD$US$US
242850391$24285039$1$I$20240803$20240826$20240905$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005060$ACADIA PHARMACEUTICALS$$92$YR$$F$Y$$$20240905$$CN$US$US
242850401$24285040$1$I$20240101$20240823$20240905$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000749$DECIPHERA PHARMACEUTICALS$$47$YR$A$M$Y$$$20240905$$CN$US$US
242850411$24285041$1$I$$20240828$20240905$20240905$EXP$$US-MLMSERVICE-20181221-1540267-1$HIKMA$Chen J, Ngo D, Rosenthal J.. Chen J, Ngo D, Rosenthal J. Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease.. Journal of Oncology Pharmacy Practice. 2018;25(8):2027-30$26$YR$$M$Y$$$20240905$$HP$US$US
242850421$24285042$1$I$20240730$20240828$20240905$20240905$EXP$$CN-AstraZeneca-2024A198434$ASTRAZENECA$$25199$DY$$M$Y$$$20240905$$MD$CN$
242850431$24285043$1$I$$20240826$20240905$20240905$PER$$US-AstraZeneca-2024A199407$ASTRAZENECA$$$$E$F$Y$57.6$KG$20240905$$CN$US$
242850441$24285044$1$I$$20240904$20240905$20240905$PER$$US-ABBVIE-5906562$ABBVIE$$22$YR$$F$Y$$$20240905$$MD$US$US
242850451$24285045$1$I$20240828$20240829$20240905$20240905$30DAY$$US-SANDOZ INC.-SDZ2024US076421$SANDOZ$$62$YR$$F$Y$$$20240905$$CN$US$US
242850461$24285046$1$I$$20240829$20240905$20240905$PER$$NVSC2024US175688$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
242850471$24285047$1$I$$20240903$20240905$20240905$PER$$US-ABBVIE-5905551$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242850482$24285048$2$F$20240828$20240920$20240905$20240924$EXP$$GB-AMGEN-GBRSL2024172929$AMGEN$$78$YR$E$M$Y$$$20240923$$HP$GB$GB
242850491$24285049$1$I$$20240826$20240905$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005023$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$HP$US$US
242850501$24285050$1$I$20240722$20240831$20240905$20240905$EXP$$US-IMMUNOGEN, INC.-US-IMGN-24-00662$IMMUNOGEN$$63$YR$$F$Y$$$20240905$$CN$US$US
242850511$24285051$1$I$$20240829$20240901$20240901$DIR$FDA-CDER-CTU-2024-60630$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242850571$24285057$1$I$$20240901$20240901$20240901$DIR$FDA-CDER-CTU-2024-60619$$FDA-CTU$$77$YR$$F$N$$$20240901$N$$US$
242850591$24285059$1$I$$20240830$20240901$20240901$DIR$FDA-CDER-CTU-2024-60639$$FDA-CTU$$$$$F$N$$$20240830$N$HP$US$
242850611$24285061$1$I$20240806$20240816$20240901$20240901$DIR$FDA-CDER-CTU-2024-60655$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242850651$24285065$1$I$20240816$20240826$20240905$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005031$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240905$$CN$US$US
242850661$24285066$1$I$20240221$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-085890-2024$RECKITT BENCKISER$$66$YR$$F$Y$$$20240905$$CN$US$US
242850672$24285067$2$F$20240825$20240829$20240905$20240907$EXP$$CA-CELLTRION INC.-2024CA020756$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
242850681$24285068$1$I$$20240827$20240905$20240905$EXP$GB-MHRA-MED-202408271153381770-VWZMY$GB-Accord-443804$ACCORD$$55$YR$A$M$Y$$$20240905$$CN$GB$GB
242850701$24285070$1$I$$20220815$20240905$20240905$EXP$$CA-CELLTRION INC.-2021CA019722$CELLTRION$$$$$$Y$$$20240905$$MD$CA$CA
242850711$24285071$1$I$$20240903$20240905$20240905$PER$$US-ROCHE-10000073925$ROCHE$$66$YR$E$M$Y$$$20240905$$HP$US$US
242850721$24285072$1$I$20240301$20240828$20240905$20240905$EXP$$JP-ROCHE-10000073316$ROCHE$$7$DEC$E$M$Y$$$20240905$$MD$JP$JP
242850731$24285073$1$I$$20240826$20240905$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005045$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242850741$24285074$1$I$$20240621$20240905$20240905$EXP$$US-ROCHE-10000072755$ROCHE$Hammond W, Lalazar G, Saltsman J, Farber B, Danzer E, Sherpa T, et al. Intracranial Metastasis in Fibrolamellar Hepatocellular Carcinoma. Pediatr Blood Cancer. 2017-Dec-29;65 (4):1-5. doi:10.1002/pbc.26919.$18$YR$A$F$Y$$$20240905$$HP$US$US
242850752$24285075$2$F$$20240903$20240905$20240916$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-03239$AMNEAL$$$$$$Y$$$20240917$$PH$JP$JP
242850762$24285076$2$F$20240101$20240922$20240905$20240926$EXP$$US-ABBVIE-5905856$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
242850771$24285077$1$I$20240701$20240826$20240905$20240905$EXP$$US-ASTELLAS-2024-AER-003852$ASTELLAS$$63$YR$A$M$Y$$$20240905$$CN$US$US
242850782$24285078$2$F$$20240914$20240905$20240918$EXP$$IN-ROCHE-10000072521$ROCHE$$39$YR$A$F$Y$$$20240918$$CN$IN$IN
242850791$24285079$1$I$$20240819$20240905$20240905$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000728$DECIPHERA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242850801$24285080$1$I$$20240828$20240905$20240905$EXP$$CA-BAXTER-2024BAX024020$BAXTER$$48$YR$$F$Y$$$20240905$$HP$CA$CA
242850811$24285081$1$I$20240806$20240828$20240905$20240905$PER$$US-ASTELLAS-2024US022901$ASTELLAS$$88$YR$E$M$Y$$$20240905$$CN$US$US
242850831$24285083$1$I$$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139544$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240905$$HP$US$US
242850851$24285085$1$I$$20240828$20240905$20240905$PER$$US-JNJFOC-20240876567$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242850861$24285086$1$I$20240802$20240819$20240901$20240901$DIR$FDA-CDER-CTU-2024-60652$$FDA-CTU$$63$YR$$M$N$$$20240819$N$HP$US$
242850871$24285087$1$I$20240811$20240816$20240901$20240901$DIR$FDA-CDER-CTU-2024-60631$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242850891$24285089$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178346$NOVARTIS$$92$YR$$M$Y$$$20240905$$HP$US$US
242850901$24285090$1$I$$20240826$20240901$20240901$DIR$FDA-CDER-CTU-2024-60620$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242850922$24285092$2$F$20240827$20240912$20240905$20240920$EXP$$CA-CELLTRION INC.-2024CA021138$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
242850931$24285093$1$I$$20240814$20240901$20240901$DIR$FDA-CDER-CTU-2024-60656$$FDA-CTU$$$$$M$N$$$20240814$N$HP$US$
242850951$24285095$1$I$$20240828$20240905$20240905$EXP$$ZA-AstraZeneca-2024A197567$ASTRAZENECA$$28$YR$$F$Y$$$20240905$$CN$ZA$
242850961$24285096$1$I$$20240827$20240905$20240905$EXP$$JP-MYLANLABS-2024M1080347$MYLAN$Aoki M, Ishikawa M, Sato T, Taji Y, Kayano H, Takahashi N, et al. Effective treatment of relapsed/refractory CD19-positive B/T-type mixed-phenotype acute leukemia with blinatumomab: A case report. EJHaem 2024; 5 (4): 855-858.. 2024;5 (4):855-858$26$YR$$M$Y$$$20240905$$HP$JP$JP
242850971$24285097$1$I$$20240826$20240905$20240905$EXP$$JP-MYLANLABS-2024M1080316$MYLAN$Adachi K, Murata M, Inada A, Morimoto T, Shimizu M, Beppu S, et al. Interaction of a caffeine overdose with clinical doses of contraceptive ethinyl estradiol in a young woman. Acute-Med-Surg 2024; 11 (1): 1-4.. 2024;11 (1):1-4$23$YR$$F$Y$$$20240905$$HP$JP$JP
242850981$24285098$1$I$$20240827$20240905$20240905$EXP$$US-MYLANLABS-2024M1080385$MYLAN$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood-Can-J 2023; 13 (1):.$$$$M$Y$$$20240905$$HP$US$US
242850991$24285099$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001589$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240905$$CN$US$US
242851001$24285100$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002568$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242851011$24285101$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001478$ELI LILLY AND CO$$$$$$Y$$$20240905$$LW$US$US
242851021$24285102$1$I$20240801$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409000342$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240905$$CN$US$US
242851031$24285103$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001619$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240905$$CN$US$US
242851051$24285105$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001427$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240905$$CN$US$US
242851061$24285106$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001349$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240905$$CN$US$US
242851081$24285108$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024108972$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242851091$24285109$1$I$$20240828$20240905$20240905$EXP$$US-MYLANLABS-2024M1080703$MYLAN$Nanah A, Nair AS, Stoller J. Delayed Response to Glucocorticoids in Daptomycin Lung. Am-J-Ther 2024; 31 (4): e518-e521.$75$YR$$M$Y$$$20240905$$MD$US$US
242851101$24285110$1$I$$20240827$20240905$20240905$EXP$$US-MYLANLABS-2024M1080490$MYLAN$Ghezzi L, Levasseur VA, Perantie DC, Wu GF, Cross AH. Extensive rebound MS activity following dimethyl fumarate discontinuation in a 63 year old - A case report. Neuroimmunol-Rep 2023; 3 1-4.$63$YR$$F$Y$$$20240905$$HP$US$US
242851111$24285111$1$I$$20240829$20240901$20240901$DIR$FDA-CDER-CTU-2024-60654$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242851121$24285112$1$I$$20240828$20240905$20240905$EXP$$US-MYLANLABS-2024M1080716$MYLAN$Soike MH, Warren E, Goncalves FG, Cardenas A, Littrell ME, Metrock LK, et al. BASAL GANGLIA TOXICITY FOLLOWING PROTON THERAPY OF THE PINEAL REGION WITH BILATERAL ACTIONINDUCED MYOCLONUS. Neuro-Oncol 2024; 26 (Suppl. 4) iv218-iv219 abstr. RADT-08.$4$YR$$F$Y$$$20240905$$HP$US$US
242851131$24285113$1$I$$20240828$20240905$20240905$EXP$$GR-MYLANLABS-2024M1080733$MYLAN$Vasilopoulou A, Spaho M, Theotokis P, Grekou A, Meditskou S, Manthou ME. Fatal misdiagnosis of progressive disseminated histoplasmosis. Med-Mycol-Case-Reports 2024; 45 1-4.$39$YR$$M$Y$$$20240905$$HP$GR$GR
242851141$24285114$1$I$$20240828$20240905$20240905$EXP$$GB-MYLANLABS-2024M1080747$MYLAN$Hall R, Atmaja B, Sharma B, Cunningham D. Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin^s lymphoma, complicated by anthracycline-induced cardiomyopathy. BMJ-Case-Rep 2024; 17 (8):.$3$DEC$$F$Y$$$20240905$$HP$GB$GB
242851151$24285115$1$I$20240701$20240806$20240901$20240901$DIR$FDA-CDER-CTU-2024-60651$$FDA-CTU$$15$YR$$F$N$$$20240806$N$HP$US$
242851161$24285116$1$I$$20240830$20240901$20240901$DIR$FDA-CDER-CTU-2024-60647$$FDA-CTU$$$$$M$N$$$20240830$N$HP$US$
242851171$24285117$1$I$$20240825$20240901$20240901$DIR$FDA-CDER-CTU-2024-60650$$FDA-CTU$$$$$M$N$$$20240825$N$HP$US$
242851181$24285118$1$I$20240802$20240814$20240901$20240901$DIR$FDA-CDER-CTU-2024-60646$$FDA-CTU$$38$YR$$F$N$$$20240814$N$HP$US$
242851191$24285119$1$I$20230701$20230911$20240905$20240905$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-10528$ALKEM$$$$A$M$Y$80$KG$20240905$$CN$DE$DE
242851201$24285120$1$I$$20240823$20240905$20240905$EXP$$PL-AUROBINDO-AUR-APL-2024-043114$AUROBINDO$Stryjkowska G?ra A. Treatment of a non-small cell lung cancer patient with low PD-L1 expression using chemotherapy in combination with pembrolizumab. ONKOLOGIA W PRAKTYCE KLINICZNEJ - EDUKACJA (ONCOLOGY IN CLINICAL PRACTICE - EDUC. 2024;10(Supl. C):C40-C43$74$YR$$M$Y$$$20240905$$MD$PL$PL
242851211$24285121$1$I$$20240827$20240901$20240901$DIR$FDA-CDER-CTU-2024-60640$$FDA-CTU$$$$$M$N$$$20240827$N$HP$US$
242851221$24285122$1$I$$20240808$20240901$20240901$DIR$FDA-CDER-CTU-2024-60638$$FDA-CTU$$$$$M$N$$$20240808$N$HP$US$
242851231$24285123$1$I$20230901$20231003$20240905$20240905$EXP$DE-CADRBFARM-2023322814$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-12080$ALKEM$$87$YR$$F$Y$78$KG$20240905$$MD$DE$DE
242851241$24285124$1$I$$20230816$20240905$20240905$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09428$ALKEM$$76$YR$$M$Y$$$20240904$$HP$AU$AU
242851251$24285125$1$I$20210601$20230720$20240905$20240905$EXP$DE-CADRBFARM-2023320933$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-08478$ALKEM$$52$YR$$F$Y$77$KG$20240905$$CN$DE$DE
242851261$24285126$1$I$$20231011$20240905$20240905$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-12510$ALKEM$$29$YR$$F$Y$$$20240904$$HP$AU$AU
242851271$24285127$1$I$$20230816$20240905$20240905$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09466$ALKEM$$$$$F$Y$$$20240904$$HP$AU$AU
242851281$24285128$1$I$$20231107$20240905$20240905$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-13990$ALKEM$Hoeltzenbein M, Bartz I, Fietz AK, Lohse L, Onken M, Dathe K, Schaefer C. Antiepileptic treatment with levetiracetam during the first trimester and pregnancy outcome: an observational study. Epilepsia. 2023;unk:unk$40$YR$$F$Y$$$20240905$$HP$DE$DE
242851291$24285129$1$I$$20240327$20240905$20240905$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06601$ALKEM$$$$$F$Y$$$20240905$$HP$AU$AU
242851301$24285130$1$I$$20240327$20240905$20240905$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06597$ALKEM$$$$$$Y$$$20240904$$HP$AU$AU
242851311$24285131$1$I$$20230816$20240905$20240905$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09473$ALKEM$$$$$M$Y$$$20240904$$HP$AU$AU
242851321$24285132$1$I$$20231023$20240905$20240905$EXP$GB-MHRA-ADR 28256575$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-13191$ALKEM$$71$YR$$M$Y$$$20240905$$HP$GB$GB
242851331$24285133$1$I$$20230925$20240905$20240905$EXP$GB-MHRA-ADR 28195268$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-11554$ALKEM$$73$YR$$M$Y$$$20240905$$MD$GB$GB
242851341$24285134$1$I$$20240327$20240905$20240905$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06595$ALKEM$$$$$$Y$$$20240904$$HP$AU$AU
242851351$24285135$1$I$$20231030$20240905$20240905$EXP$GB-MHRA-ADR 28276203$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-13428$ALKEM$$55$YR$$M$Y$87$KG$20240905$$PH$GB$GB
242851361$24285136$1$I$$20231009$20240905$20240905$EXP$GB-MHRA-ADR 28222587$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-12310$ALKEM$$64$YR$$F$Y$86$KG$20240905$$MD$GB$GB
242851371$24285137$1$I$$20240327$20240905$20240905$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06605$ALKEM$$28$YR$$F$Y$$$20240905$$HP$AU$AU
242851381$24285138$1$I$$20240523$20240905$20240905$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-10876$ALKEM$El Ouni Amami N, Ali-Diabacte H, Ateb S, Ben Rejeb H, Bellis A, Bellis R, Januel D, Bouaziz N.. Clozapine-induced cholinergic urticaria: a case report. Therapeutic Advances in Psychopharmacology. 2024;14:1-8$25$YR$$M$Y$$$20240905$$HP$FR$FR
242851391$24285139$1$I$20190801$20240704$20240905$20240905$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-15006$ALKEM$$33$YR$$F$Y$$$20240905$$MD$DE$DE
242851401$24285140$1$I$20230908$20230915$20240905$20240905$EXP$GB-MHRA-ADR 28177002$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10919$ALKEM$$88$YR$$F$Y$58$KG$20240905$$HP$GB$GB
242851411$24285141$1$I$$20231211$20240905$20240905$EXP$GB-MHRA-ADR 28379394$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15832$ALKEM$$74$YR$$F$Y$$$20240905$$HP$GB$GB
242851421$24285142$1$I$$20230915$20240905$20240905$EXP$GB-MHRA-ADR 28175165$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10866$ALKEM$$88$YR$$F$Y$38$KG$20240905$$MD$GB$GB
242851431$24285143$1$I$20191023$20231114$20240905$20240905$EXP$GB-MHRA-ADR 28314102$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-14240$ALKEM$$44$YR$$F$Y$72$KG$20240905$$CN$GB$GB
242851441$24285144$1$I$20231010$20231220$20240905$20240905$EXP$GB-MHRA-ADR 28397316$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-16544$ALKEM$$84$YR$$F$Y$$$20240905$$CN$GB$GB
242851451$24285145$1$I$$20231215$20240905$20240905$EXP$GB-MHRA-ADR 28386456$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-16226$ALKEM$$81$YR$$F$Y$103$KG$20240905$$MD$GB$GB
242851461$24285146$1$I$$20230830$20240905$20240905$EXP$GB-MHRA-ADR 28122697$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09613$ALKEM$$45$YR$$$Y$$$20240905$$HP$GB$GB
242851471$24285147$1$I$$20230901$20240905$20240905$EXP$GB-MHRA-ADR 28152295$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10199$ALKEM$$23$YR$$F$Y$$$20240905$$PH$GB$GB
242851482$24285148$2$F$20181201$20240904$20240905$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-040490$AUROBINDO$Ibrahim A, Prasad G, Kilpatrick ES, Morris TJ. A case of autoimmune hepatitis associated with the PCSK9 inhibitor alirocumab. Annals of clinical biochemistry. 2024;00(00):45632241269657$61$YR$$F$Y$$$20240918$$MD$GB$GB
242851491$24285149$1$I$20231219$20231221$20240905$20240905$EXP$GB-MHRA-ADR 28410306$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-16595$ALKEM$$76$YR$$F$Y$92$KG$20240905$$HP$GB$GB
242851501$24285150$1$I$$20240830$20240905$20240905$EXP$$PL-AUROBINDO-AUR-APL-2024-043667$AUROBINDO$Sawosz M, Cieciura T, Perkowska-Ptasinska A, Sikora P, Beck B, Chmura A, et al. Late diagnosis of hyperoxaluria transplantation. case report. Post??py Nauk Medycznych (case report. Advances in Medical Sciences. 2014$65$YR$$F$Y$$$20240905$$HP$PL$PL
242851511$24285151$1$I$$20240827$20240905$20240905$EXP$$MA-ASTELLAS-2024-AER-003811$ASTELLAS$Saidi I. Bilateral Avascular Necrosis of the Femoral Head in Renal Transplant Recipient: A Case Report. Open Journal of Nephrology. 2024 Jun 28;14(2): 253-61. doi:10.4236/ojneph.2024.142024.$53$YR$A$M$Y$$$20240905$$HP$MA$MA
242851521$24285152$1$I$$20240422$20240905$20240905$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-08720$ALKEM$$21$YR$$F$Y$$$20240905$$MD$DE$DE
242851531$24285153$1$I$$20230911$20240905$20240905$EXP$GB-MHRA-ADR 28171352$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10552$ALKEM$$$$$M$Y$$$20240905$$PH$GB$GB
242851541$24285154$1$I$$20231211$20240905$20240905$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-14985$ALKEM$$$$A$F$Y$$$20240905$$CN$DE$DE
242851552$24285155$2$F$$20240917$20240905$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140942$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240919$$CN$US$US
242851561$24285156$1$I$$20231214$20240905$20240905$EXP$GB-MHRA-ADR 28380928$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-16064$ALKEM$$84$YR$$F$Y$53$KG$20240905$$MD$GB$GB
242851571$24285157$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140827$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240905$$CN$US$US
242851581$24285158$1$I$$20240115$20240905$20240905$EXP$GB-MHRA-ADR 28461842$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-00761$ALKEM$$43$YR$$M$Y$105$KG$20240905$$PH$GB$GB
242851591$24285159$1$I$$20240322$20240905$20240905$EXP$DE-EMA-DD-20240311-7482711-131033$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-04917$ALKEM$Tapia Perez JH, Voll C, Shararah S.. Treatment of Spinal Myoclonus Due to Degenerative Compression Myelopathy with Cervical Spinal Cord Stimulation: A Report of 2 Cases. World Neurosurgery. 2020;136:44-48$39$YR$$M$Y$$$20240905$$MD$DE$DE
242851601$24285160$1$I$20230902$20230908$20240905$20240905$EXP$GB-MHRA-ADR 28161521$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10472$ALKEM$$58$YR$$F$Y$146$KG$20240905$$MD$GB$GB
242851611$24285161$1$I$20240101$20240828$20240905$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-023852$UNITED THERAPEUTICS$$$$$F$Y$55.329$KG$20240905$$$US$US
242851622$24285162$2$F$$20240823$20240905$20240909$PER$$US-SA-2024SA253219$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240909$$CN$US$US
242851631$24285163$1$I$20220101$20240826$20240905$20240905$EXP$$US-AUROBINDO-AUR-APL-2024-042761$AUROBINDO$Desai D, Nohria A, Alhanshali L, Buontempo M, Lo Sicco KI, et al.. Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases. JAAD Case Reports. 2024;51:86-91$39$YR$$M$Y$$$20240905$$MD$US$US
242851641$24285164$1$I$$20240719$20240905$20240905$EXP$DE-EMA-DD-20240718-7482645-080313$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14582$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$35$YR$$M$Y$$$20240905$$HP$DE$DE
242851651$24285165$1$I$20170528$20240314$20240905$20240905$EXP$DE-EMA-DD-20240313-7482827-095752$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-05203$ALKEM$$78$YR$$F$Y$$$20240905$$PH$DE$DE
242851661$24285166$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA252903$SANOFI AVENTIS$$$$E$F$Y$$$20240905$$CN$US$US
242851671$24285167$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA252999$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240905$$CN$US$US
242851681$24285168$1$I$20240801$20240821$20240905$20240905$PER$$US-SA-2024SA255652$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240905$$MD$US$US
242851691$24285169$1$I$20140801$20240826$20240905$20240905$EXP$$IT-AUROBINDO-AUR-APL-2024-037903$AUROBINDO$Luciano A, Pietroluongo E, Ottaviano M, Grieco A, Peddio A, De Placido P, et al.. Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor.. Frontiers in immunology. 2024;15:1423800$64$YR$$M$Y$62$KG$20240905$$MD$IT$IT
242851701$24285170$1$I$20240101$20240821$20240905$20240905$PER$$US-SA-2024SA256156$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240905$$MD$US$US
242851711$24285171$1$I$20240801$20240821$20240905$20240905$PER$$US-SA-2024SA255426$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240905$$HP$US$US
242851721$24285172$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA253417$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240905$$CN$US$US
242851731$24285173$1$I$20240801$20240821$20240905$20240905$PER$$US-SA-2024SA255233$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240905$$MD$US$US
242851741$24285174$1$I$20240801$20240827$20240905$20240905$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026762$UNITED THERAPEUTICS$$68$YR$$M$Y$108.39$KG$20240905$$$US$US
242851751$24285175$1$I$$20240823$20240905$20240905$PER$$US-ABBVIE-5896025$ABBVIE$$$$$F$Y$$$20240905$$HP$US$US
242851761$24285176$1$I$20240718$20240827$20240905$20240905$EXP$$US-AMGEN-USASL2024171081$AMGEN$$55$YR$A$F$Y$$$20240905$$CN$US$US
242851771$24285177$1$I$20240824$20240826$20240905$20240905$EXP$$US-NEBO-667676$PHARMACOSMOS$$$$$F$Y$$$20240905$$CN$US$US
242851791$24285179$1$I$20240612$20240830$20240905$20240905$EXP$$US-ABBVIE-5904569$ABBVIE$$33$YR$$F$Y$60$KG$20240905$$MD$US$US
242851801$24285180$1$I$20240901$20240901$20240905$20240905$PER$$NVSC2024US177957$NOVARTIS$$13$YR$$F$Y$230$KG$20240905$$CN$US$US
242851811$24285181$1$I$$20240829$20240905$20240905$PER$$US-BEH-2024178139$CSL BEHRING$$62$YR$A$F$Y$$$20240905$$HP$US$US
242851821$24285182$1$I$$20240829$20240905$20240905$EXP$$DE-ABBVIE-5904760$ABBVIE$$62$YR$$M$Y$$$20240905$$MD$DE$DE
242851831$24285183$1$I$20240101$20240821$20240905$20240905$PER$$US-SA-2024SA256637$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240905$$CN$US$US
242851841$24285184$1$I$20240807$20240821$20240905$20240905$PER$$US-SA-2024SA254596$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240905$$MD$US$US
242851851$24285185$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA255445$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240905$$MD$US$US
242851861$24285186$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA253525$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240905$$CN$US$US
242851871$24285187$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA253043$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240905$$CN$US$US
242851881$24285188$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA255552$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240905$$MD$US$US
242851891$24285189$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA253228$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240905$$CN$US$US
242851902$24285190$2$F$20190101$20240828$20240905$20240910$PER$$US-SA-2024SA252600$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240910$$MD$US$US
242851911$24285191$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA255836$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240905$$MD$US$US
242851921$24285192$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA253135$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240905$$MD$US$US
242851931$24285193$1$I$20240101$20240821$20240905$20240905$PER$$US-SA-2024SA256218$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240905$$MD$US$US
242851941$24285194$1$I$20240101$20240821$20240905$20240905$PER$$US-SA-2024SA255564$SANOFI AVENTIS$$$$A$F$Y$$$20240905$$MD$US$US
242851951$24285195$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA255057$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240905$$MD$US$US
242851961$24285196$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA254200$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240905$$CN$US$US
242851971$24285197$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA253494$SANOFI AVENTIS$$$$$M$Y$$$20240905$$CN$US$US
242851981$24285198$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA256449$SANOFI AVENTIS$$$$E$F$Y$$$20240905$$MD$US$US
242851991$24285199$1$I$20240101$20240823$20240905$20240905$PER$$US-SA-2024SA257030$SANOFI AVENTIS$$$$C$F$Y$$$20240905$$HP$US$US
242852012$24285201$2$F$$20240918$20240905$20240927$PER$$US-SA-2024SA255728$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240927$$MD$US$US
242852022$24285202$2$F$20240101$20240916$20240905$20240925$PER$$US-SA-2024SA256957$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240925$$MD$US$US
242852031$24285203$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA253273$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240905$$CN$US$US
242852041$24285204$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA152457$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240905$$MD$US$US
242852051$24285205$1$I$20240101$20240821$20240905$20240905$PER$$US-SA-2024SA255364$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240905$$MD$US$US
242852061$24285206$1$I$20240101$20240821$20240905$20240905$PER$$US-SA-2024SA256393$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240905$$MD$US$US
242852071$24285207$1$I$20240801$20240821$20240905$20240905$PER$$US-SA-2024SA048228$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240905$$MD$US$US
242852081$24285208$1$I$$20240826$20240905$20240905$PER$$US-SA-2024SA254448$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240905$$CN$US$US
242852091$24285209$1$I$20240801$20240823$20240905$20240905$PER$$US-SA-2024SA256991$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240905$$HP$US$US
242852101$24285210$1$I$20240801$20240823$20240905$20240905$PER$$US-SA-2024SA257151$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240905$$HP$US$US
242852111$24285211$1$I$$20240823$20240905$20240905$PER$$US-SA-2024SA257004$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240905$$HP$US$US
242852121$24285212$1$I$20240301$20240823$20240905$20240905$PER$$US-SA-2024SA256989$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240905$$MD$US$US
242852131$24285213$1$I$20230801$20240826$20240905$20240905$PER$$US-SA-2024SA256183$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240905$$MD$US$US
242852141$24285214$1$I$$20240826$20240905$20240905$EXP$$JP-MYLANLABS-2024M1080307$MYLAN$Okada S, Okada J, Okada K, Yamada E, Saito T, Kikkawa K, et al. Hot Water Eliminates the Bitter Taste of Oral Semaglutide: A Report of Four Cases. Intern-Med 2024; 63 (16): 2297-2300.. 2024;63 (16):2297-2300$64$YR$$F$Y$64$KG$20240905$$MD$JP$JP
242852151$24285215$1$I$$20240826$20240905$20240905$EXP$$US-AUROBINDO-AUR-APL-2024-043048$AUROBINDO$Credo R, Kesey J, Bharadia D, Griswold J, Pang A. Acute Intermittent Porphyria in a Burn Patient: Case Study and Review of the Literature. J-Burn-Care-Res. 2024;45(3):790-795$60$YR$$M$Y$$$20240905$$HP$US$US
242852161$24285216$1$I$$20240828$20240905$20240905$PER$$US-SA-2024SA254447$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240905$$PH$US$US
242852171$24285217$1$I$20240828$20240903$20240905$20240905$PER$$US-SA-2024SA256773$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240905$$MD$US$US
242852181$24285218$1$I$20230101$20240828$20240905$20240905$PER$$US-SA-2024SA256463$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240905$$MD$US$US
242852191$24285219$1$I$20240101$20240826$20240905$20240905$PER$$US-SA-2024SA256421$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240905$$HP$US$US
242852201$24285220$1$I$$20240826$20240905$20240905$PER$$US-SA-2024SA256439$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240905$$MD$US$US
242852211$24285221$1$I$$20240821$20240905$20240905$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465612$RANBAXY$Aravind TK, Yadav S, Singh H. Rectus abdominis muscle flap in complex vesico?vaginal fistula repair: unique situation, uncommon option. Afr J Urol. 2024;30 (1):35 (1-4)$34$YR$$F$Y$$$20240905$$HP$IN$IN
242852222$24285222$2$F$$20240826$20240905$20240909$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465591$RANBAXY$Cooper J, Soneji D, Rieger K, Narala S, Kim Y. Primary Cutaneous CD30+ Large T Cell Lymphoproliferative Disorder Associated With Prolonged Exposure to Fingolimod. Mult Scler J. 2023;29 (Suppl.) (3):969 (P1519/117)$67$YR$$F$Y$$$20240909$$HP$US$US
242852231$24285223$1$I$$20240821$20240905$20240905$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465675$RANBAXY$Higley M, Lomax KG, Geldhof A, Esslinger S. Exposure to golimumab during pregnancy: Results from the Company^s global safety database. Pharmacol Res Perspect. 2024;12:e1240(1-5)$$$$F$Y$$$20240905$$HP$NL$NL
242852242$24285224$2$F$20210101$20240826$20240905$20240909$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465593$RANBAXY$Sterina E. Cognitive Decline in Older Adults with Schizophrenia-Bipolar Spectrum Disorder. Am J Geriatr Psychiatry. 2024;APR; 32 (S.)4:S36-S37$67$YR$$M$Y$$$20240909$$MD$US$US
242852251$24285225$1$I$$20240821$20240905$20240905$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465378$RANBAXY$Le X, Du R, Lewis WE, Hong L, Skoulidis F, Byers L, et al. Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer. J Thorac Oncol. 2022;17 (Suppl.) (9):EP08.02-163; S484$65$YR$$F$Y$$$20240905$$HP$US$US
242852261$24285226$1$I$$20240904$20240905$20240905$PER$$US-HALEON-2195336$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
242852271$24285227$1$I$$20240821$20240905$20240905$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465676$RANBAXY$Higley M, Lomax KG, Geldhof A, Esslinger S. Exposure to golimumab during pregnancy: Results from the Company^s global safety database. Pharmacol Res Perspect. 2024;12:e1240(1-5)$$$N$$Y$$$20240905$$HP$NL$NL
242852281$24285228$1$I$$20240821$20240905$20240905$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465684$RANBAXY$Higley M, Lomax KG, Geldhof A, Esslinger S. Exposure to golimumab during pregnancy: Results from the Company^s global safety database. Pharmacol Res Perspect. 2024;12:e1240(1-5)$$$$F$Y$$$20240905$$HP$NL$NL
242852291$24285229$1$I$20240404$20240821$20240905$20240905$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465960$RANBAXY$$77$YR$$M$Y$79$KG$20240905$$MD$FR$FR
242852301$24285230$1$I$$20240821$20240905$20240905$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465376$RANBAXY$Le X, Du R, Lewis WE, Hong L, Skoulidis F, Byers L, et al. Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer. J Thorac Oncol. 2022;17 (S9):S484 (EP08.02-163)$69$YR$$M$Y$$$20240905$$HP$US$US
242852311$24285231$1$I$$20240821$20240905$20240905$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465604$RANBAXY$Aboud AA, Huston J, Kim SH, O^Leary J. NOT YOUR MAMA^S MI: CHEST PAIN IN A POSTPARTUM WOMAN. J Am Coll Cardiol. 2019;73 (Suppl.) (9):2978$28$YR$$F$Y$$$20240905$$HP$US$US
242852321$24285232$1$I$$20240821$20240905$20240905$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465528$RANBAXY$Thurston L, Todd G, Parsapour S, Kong WM. The complexities of managing neuropathic pain. Br J Diabetes. 2024;24 (1):Abstract ID: 35/ 114$75$YR$$M$Y$$$20240905$$HP$GB$GB
242852331$24285233$1$I$$20240821$20240905$20240905$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465641$RANBAXY$Dimitrakopoulos F-I, Goussia A, Koliou G-A, Dadouli K, Batistatou A, Kourea HP, et al. Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide + epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes. Breast. 2024;73:103668 (1-12)$$$$F$Y$$$20240905$$HP$GR$GR
242852341$24285234$1$I$$20240821$20240905$20240905$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465609$RANBAXY$Kumari R, Jha P, Sinha P, Kundu S, Kundu SKr. A Rare Presentation of Acute Inversion of Uterus and PPH- A Maternal ^Near Miss^ Case. Int J Pharmac Clin Res. 2024;16(5):115-117$32$YR$$F$Y$$$20240905$$MD$IN$IN
242852351$24285235$1$I$$20240821$20240905$20240905$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465689$RANBAXY$Higley M, Lomax KG, Geldhof A, Esslinger S. Exposure to golimumab during pregnancy: Results from the Company^s global safety database. Pharmacol Res Perspect. 2024;12:e1240(1-5)$$$$F$Y$$$20240905$$HP$NL$NL
242852361$24285236$1$I$$20240821$20240905$20240905$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465672$RANBAXY$Santo A, Lombardo F, Roca E, Cucinella A, Comel A, Benato C et al. Weekly Sequential ACOCEV Chemotherapy (ADR,CTX, CBDCA, VP16, VCR) for Elderly - Poor PS SCLC Patients: An Observational Study. J Thorac Oncol. 2022;17 (Suppl.) (9):S528 (EP14.01-005)$$$E$$Y$$$20240905$$HP$IT$IT
242852371$24285237$1$I$$20240821$20240905$20240905$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465430$RANBAXY$Ferini G, Zagardo V, Viola A, Aiello MM, Harikar MM, Venkataram T, et al. Considerations on surgery invasiveness and response and toxicity patterns in classic palliative radiotherapy for acrometastases of the hand: a hint for a potential role of stereotactic body radiation therapy? A case report and literature review. Front Oncol. 2023;13:1-8$57$YR$$F$Y$$$20240905$$HP$IT$IT
242852382$24285238$2$F$$20240826$20240905$20240910$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465590$RANBAXY$Assante WJ, Kapoor A. Steroid-Dependent Minimal Change Disease in an Adult Responsive to Rituximab. J Am Soc Nephrol. 2023;34:302 (TH-PO761)$30$YR$$M$Y$$$20240910$$HP$US$US
242852391$24285239$1$I$$20240821$20240905$20240905$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465611$RANBAXY$Chahed F, Ben Fadhel N, Mejai S, Ben Romdhane H, Ben Fredj N, Chaabane A, et al. Hypersensitivity to paracetamol in the pediatric setting. Rev Fr Allergol. 2024;64 (Suppl.):103923/10/Medi-21$$$C$$Y$$$20240905$$HP$TN$TN
242852401$24285240$1$I$$20240821$20240905$20240905$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465952$RANBAXY$Rathi K, Papamargaritis D. A case of autoimmune diabetes with significant endogenous insulin secretion:challenges in diagnosis and management. Br J Diabetes. 2024;24(1):7-8/20$27$YR$$F$Y$$$20240905$$HP$GB$GB
242852411$24285241$1$I$20160101$20240821$20240905$20240905$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465889$RANBAXY$$42$YR$$M$Y$83$KG$20240905$$CN$ES$ES
242852421$24285242$1$I$$20240821$20240905$20240905$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465674$RANBAXY$Higley M, Lomax KG, Geldhof A, Esslinger S. Exposure to golimumab during pregnancy: Results from the Company^s global safety database. Pharmacol Res Perspect. 2024;12:e1240(1-5)$$$$F$Y$$$20240905$$HP$NL$NL
242852431$24285243$1$I$20240613$20240821$20240905$20240905$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465519$RANBAXY$$64$YR$$F$Y$43$KG$20240905$$MD$IT$IT
242852442$24285244$2$F$20210101$20240826$20240905$20240909$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465412$RANBAXY$Diot T, Mouchabac S, Giraud P, Ferreri F, Adrien V. Electroconvulsive therapy for major depressive disorder induced by androgen deprivation therapy: Report of 2 cases. J ECT. 2024;Jun; 40 (2):E7-E8$67$YR$$M$Y$$$20240909$$HP$FR$FR
242852451$24285245$1$I$20230824$20240821$20240905$20240905$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465652$RANBAXY$$$$A$M$Y$84.5$KG$20240905$$HP$GB$GB
242852461$24285246$1$I$$20240821$20240905$20240905$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465271$RANBAXY$$82$YR$$M$Y$83$KG$20240905$$PH$GB$GB
242852471$24285247$1$I$20230923$20240821$20240905$20240905$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465946$RANBAXY$$66$YR$$M$Y$67$KG$20240905$$MD$FR$FR
242852481$24285248$1$I$$20240821$20240905$20240905$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465667$RANBAXY$Santo A, Lombardo F, Roca E, Cucinella A, Comel A, Benato C et al. Weekly Sequential ACOCEV Chemotherapy (ADR,CTX, CBDCA, VP16, VCR) for Elderly - Poor PS SCLC Patients: An Observational Study. J Thorac Oncol. 2022;17 (Suppl.) (9):S528 (EP14.01-005)$$$E$$Y$$$20240905$$HP$IT$IT
242852491$24285249$1$I$$20240821$20240905$20240905$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465438$RANBAXY$Kalicka A, Buczynski M, Kaszynski M, et al. Extracorporeal Cardiopulmonary Resuscitation (ECPR) for in-hospital cardiac arrest (IHCA) in pediatric patient with heart failure resulting from a previously unrecognized dilated cardiomyopathy. Anestezjologia i Ratownictwo. 2024;18(2):90-94$7$MON$$$Y$7.5$KG$20240905$$HP$PL$PL
242852502$24285250$2$F$$20240909$20240905$20240924$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465298$RANBAXY$$60$YR$$M$Y$$$20240924$$MD$CH$CH
242852511$24285251$1$I$20240609$20240821$20240905$20240905$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465885$RANBAXY$$40$YR$$F$Y$$$20240905$$MD$IT$IT
242852521$24285252$1$I$$20240821$20240905$20240905$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465679$RANBAXY$Higley M, Lomax KG, Geldhof A, Esslinger S. Exposure to golimumab during pregnancy: Results from the Company^s global safety database. Pharmacol Res Perspect. 2024;12:e1240(1-5)$$$N$$Y$$$20240905$$HP$NL$NL
242852531$24285253$1$I$20240101$20240821$20240905$20240905$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465872$RANBAXY$$17$YR$$F$Y$51$KG$20240905$$MD$FR$FR
242852541$24285254$1$I$$20240821$20240905$20240905$EXP$$RS-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465531$RANBAXY$Dzunic M, Cvetanovic A, Petkovic I. Perimandibular Metastasis of Rectal Cancer: A Case Report. Acta Facult Med Naissen. 2023;40 (3):352-357$59$YR$$F$Y$$$20240905$$HP$RS$RS
242852551$24285255$1$I$20240505$20240821$20240905$20240905$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465955$RANBAXY$$90$YR$$M$Y$$$20240905$$PH$ES$ES
242852561$24285256$1$I$$20240821$20240905$20240905$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465638$RANBAXY$Dimitrakopoulos F-I, Goussia A, Koliou G-A, Dadouli K, Batistatou A, Kourea HP, et al. Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide + epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes. Breast. 2024;73:1-12, 03668$$$$F$Y$$$20240905$$HP$GR$GR
242852571$24285257$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010125$APOTEX$$67$YR$$M$Y$$$20240905$$CN$CA$CA
242852581$24285258$1$I$$20240821$20240905$20240905$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465452$RANBAXY$Nizinska I, Gattner K. Lithium intoxication in patients using angiotensin II receptor antagonists and hydrochlorothiazide: two case reports. Farmakoterapia w Psychiatrii i Neurologii. 2024;40 (1):53-60$69$YR$$F$Y$$$20240905$$HP$PL$PL
242852591$24285259$1$I$$20240821$20240905$20240905$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465497$RANBAXY$Ghosh R, Leon-Ruiz M, Dubey S, Benito-Leon J. Cerebral and spinal neurocysticercosis with extensive myocysticercosis presenting with new-onset convulsive status epilepticus and myopathic symptoms. Enfermedades Infecciosas y Microbiologia Clinica. 2024;42:221-226$23$YR$$M$Y$$$20240905$$HP$IN$IN
242852601$24285260$1$I$$20240821$20240905$20240905$EXP$$VN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465630$RANBAXY$Hoang BH, Tang TV, Phan NDN, Nguyen AD, Dinh MMQ. Airway breathing circulation dengue: a case of multifactorial shock due to major trauma and severe dengue infection. Int J Emerg Med. 2024;17 (1):90; 1-3$49$YR$$F$Y$$$20240905$$HP$VN$VN
242852621$24285262$1$I$20240327$20240902$20240905$20240905$EXP$FR-AFSSAPS-TO2024001638$FR-RDY-SPO/FRA/24/0012751$DR REDDYS$$88$YR$E$F$Y$$$20240905$$MD$FR$FR
242852631$24285263$1$I$20240520$20240821$20240905$20240905$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465888$RANBAXY$$12$YR$$M$Y$$$20240905$$PH$FR$FR
242852641$24285264$1$I$20240319$20240821$20240905$20240905$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465890$RANBAXY$$57$YR$$M$Y$$$20240905$$MD$ES$ES
242852651$24285265$1$I$20240319$20240821$20240905$20240905$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466112$RANBAXY$$89$YR$$F$Y$$$20240905$$MD$ES$ES
242852661$24285266$1$I$20240510$20240821$20240905$20240905$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465900$RANBAXY$$75$YR$$M$Y$$$20240905$$MD$ES$ES
242852671$24285267$1$I$$20240821$20240905$20240905$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466115$RANBAXY$Thurston L, Todd G, Parsapour S, Kong WM. The complexities of managing neuropathic pain. Br JDiabetes. 2024;24 (1):114$75$YR$$M$Y$$$20240905$$HP$GB$GB
242852681$24285268$1$I$20240211$20240821$20240905$20240905$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466050$RANBAXY$$33$YR$$M$Y$81$KG$20240905$$MD$FR$FR
242852691$24285269$1$I$$20240821$20240905$20240905$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425359$RANBAXY$Nakashima K,Kitani K,Kono K,Yoshihara K,Kawakado K,Kobayashi M,et al.. Cytokine Release Syndrome More than Two Years after Pembrolizumab Introduction. Intern Med. 2024;Dec 18; 63 (15):2163-2166$71$YR$$M$Y$$$20240905$$HP$JP$JP
242852701$24285270$1$I$20240615$20240821$20240905$20240905$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465963$RANBAXY$$29$YR$$M$Y$$$20240905$$MD$FR$FR
242852711$24285271$1$I$$20240821$20240905$20240905$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466076$RANBAXY$$$$$M$Y$$$20240905$$CN$GB$GB
242852721$24285272$1$I$20240501$20240821$20240905$20240905$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465832$RANBAXY$$63$YR$$F$Y$87$KG$20240905$$MD$FR$FR
242852731$24285273$1$I$$20240821$20240905$20240905$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466058$RANBAXY$$46$YR$$M$Y$$$20240905$$PH$FR$FR
242852742$24285274$2$F$$20240826$20240905$20240909$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465357$RANBAXY$Kotamarti V. Disentangling the Diagnoses of Psychotic Depression, Catatonia, Neurocognitive Disorders, and Delirium: A Multidisciplinary Approach. Am J Geriatr Psychiatry. 2024;Apr; 32 (4S):S35-S36$77$YR$$M$Y$$$20240909$$MD$US$US
242852751$24285275$1$I$$20240821$20240905$20240905$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465372$RANBAXY$Le X, Du R, Lewis WE, Hong L, Skoulidis F, Byers L, et al. Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer. J Thorac Oncol. 2022;17 (S9):S484 (EP08.02-163)$58$YR$$F$Y$$$20240905$$HP$US$US
242852761$24285276$1$I$$20240821$20240905$20240905$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465999$RANBAXY$$65$YR$$F$Y$$$20240905$$HP$FR$FR
242852771$24285277$1$I$20240613$20240821$20240905$20240905$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466055$RANBAXY$$57$YR$$F$Y$$$20240905$$PH$IT$IT
242852781$24285278$1$I$20240602$20240821$20240905$20240905$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466248$RANBAXY$$6$YR$$F$Y$23$KG$20240905$$MD$ES$ES
242852791$24285279$1$I$$20240821$20240905$20240905$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466070$RANBAXY$$15$YR$$M$Y$30.7$KG$20240905$$HP$IT$IT
242852802$24285280$2$F$20240604$20240906$20240905$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466000$RANBAXY$$55$YR$$F$Y$81.3$KG$20240920$$MD$FR$FR
242852811$24285281$1$I$$20240821$20240905$20240905$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466118$RANBAXY$Ebrahimi P, Nazari R, Senobari N, Mousavinezhad SM, Ghadimi DJ, Soleimani H. Kounis syndrome type I induced by an intramuscular injection of diclofenac: A literature review based on a case report. Clin Case Rep. 2024;12(7):no pagination$51$YR$$M$Y$$$20240905$$HP$IR$IR
242852821$24285282$1$I$20240513$20240809$20240901$20240901$DIR$FDA-CDER-CTU-2024-60653$$FDA-CTU$$32$YR$$F$N$$$20240809$N$HP$US$
242852831$24285283$1$I$20240301$20240821$20240905$20240905$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466263$RANBAXY$$19$YR$$M$Y$$$20240905$$HP$FR$FR
242852841$24285284$1$I$$20240821$20240905$20240905$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465360$RANBAXY$Maheswaran J, Rafiee MJ, Cordes S, Lefebvre B, Chetrit M. Multimodality Imaging of Acute Myocarditis in Cytokine Release Syndrome (CRS) Following CAR-T Therapy. CJC Open. 2024;6 (8):973-977$74$YR$$F$Y$$$20240905$$MD$CA$CA
242852851$24285285$1$I$20231001$20240821$20240905$20240905$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465655$RANBAXY$$$$E$F$Y$86$KG$20240905$$HP$GB$GB
242852861$24285286$1$I$$20240821$20240905$20240905$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465954$RANBAXY$Frattari A, De Angelis MV, Battilana M, Polilli E, Ferrieri A, Onofrillo D, et al.. High viral load VZV encephalitis complicated by super refractory status epilepticus in a vaccinated child with in Acute Lymphocytic Leukemia: Case report and review of the literature. Neuroimmunol Rep. 2024;6 (0):no pagination$6$YR$$M$Y$$$20240905$$HP$IT$IT
242852873$24285287$3$F$20190201$20240909$20240905$20240920$EXP$$CN-Accord-444017$ACCORD$Gan H, Ren X, Zou Y, Li L, Ding J, Peng L, et al. Rheumatoid arthritis complicated with cervical actinomycosis and ureteral obstruction: A case report and literature review. Zhong Nan Da Xue Xue Bao Yi Xue Ban (Journal of Central South University. Medical sciences). 2024 May 28;49(5):818-824. English, Chinese. doi: 10.11817/j.issn.1672-7347.2024.230501.$60$YR$A$F$Y$$$20240920$$HP$CN$CN
242852881$24285288$1$I$$20240903$20240905$20240905$PER$$US-JNJFOC-20240904754$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242852901$24285290$1$I$$20240812$20240905$20240905$30DAY$$BR-JNJFOC-20240907470$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$PH$BR$BR
242852911$24285291$1$I$20240219$20240822$20240905$20240905$EXP$FR-AFSSAPS-DJ2024000543$FR-BECTON DICKINSON-FR-BD-24-000530$BECTON DICKINSON$$72$YR$$F$Y$55$KG$20240905$$MD$FR$FR
242852921$24285292$1$I$20240810$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175970$AMGEN$$75$YR$E$F$Y$$$20240905$$CN$US$US
242852931$24285293$1$I$$20240828$20240905$20240905$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011071$STRIDES$Cui J, Zhang Y, Li X, Ding Z, Kong Y, Yu Z, et al.. Antimicrobial resistance profiles and genome characteristics of Klebsiella isolated from the faeces of neonates in the neonatal intensive care unit.. J-Med-Microbiol. 2024;73 (8)$6$DY$$$Y$$$20240905$$HP$CN$CN
242852951$24285295$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176488$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242852961$24285296$1$I$20240830$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176204$AMGEN$$63$YR$A$F$Y$$$20240905$$CN$US$US
242852972$24285297$2$F$20230530$20240902$20240905$20240910$EXP$$JP-Eisai-EC-2023-143559$EISAI$$65$YR$E$F$Y$49$KG$20240910$$MD$JP$JP
242852982$24285298$2$F$$20240913$20240905$20240924$EXP$$PL-AUROBINDO-AUR-APL-2024-043034$AUROBINDO$Fecko M, Klimek M, Zielinski T, Gawrychowski J, Mackiewicz M, Nowosielski K. An unusual presentation of acute pancreatitis associated with primary hyperparathyroidism in pregnant woman. Eur-J-Obstet-Gynecol-Reprod-Biol. 2024;293:85$30$YR$$F$Y$$$20240924$$HP$PL$PL
242852991$24285299$1$I$20240101$20240828$20240905$20240905$EXP$$CA-CELLTRION INC.-2024CA006856$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
242853011$24285301$1$I$$20240830$20240902$20240902$DIR$FDA-CDER-CTU-2024-60746$$FDA-CTU$$$$$F$N$$$20240830$N$HP$US$
242853051$24285305$1$I$20240817$20240831$20240902$20240902$DIR$FDA-CDER-CTU-2024-60740$$FDA-CTU$$67$YR$$F$N$$$20240831$N$HP$US$
242853061$24285306$1$I$$20240828$20240905$20240905$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011072$STRIDES$Cui J, Zhang Y, Li X, Ding Z, Kong Y, Yu Z, et al.. Antimicrobial resistance profiles and genome characteristics of Klebsiella isolated from the faeces of neonates in the neonatal intensive care unit.. J-Med-Microbiol. 2024;73 (8)$14$DY$$$Y$$$20240905$$HP$CN$CN
242853071$24285307$1$I$20240823$20240829$20240905$20240905$EXP$$IT-EMD Serono-2024047067$EMD SERONO INC$$69$YR$E$F$Y$$$20240905$$MD$IT$IT
242853082$24285308$2$F$$20240910$20240905$20240920$EXP$$US-TEVA-VS-3238442$TEVA$Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front-Psychiatry 2024; 14.; Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front-Psychiatry 2024; 14.$$$A$M$Y$$$20240920$$HP$US$US
242853091$24285309$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043427$AUROBINDO$$83$YR$$M$Y$100$KG$20240905$$PH$CA$CA
242853101$24285310$1$I$$20240828$20240905$20240905$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011073$STRIDES$Cui J, Zhang Y, Li X, Ding Z, Kong Y, Yu Z, et al.. Antimicrobial resistance profiles and genome characteristics of Klebsiella isolated from the faeces of neonates in the neonatal intensive care unit.. J-Med-Microbiol. 2024;73 (8)$6$DY$$$Y$$$20240905$$HP$CN$CN
242853111$24285311$1$I$20240727$20240827$20240905$20240905$EXP$FR-AFSSAPS-AVNT2024000648$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111665$ZYDUS PHARM$$$$$$Y$$$20240905$$MD$FR$FR
242853121$24285312$1$I$$20240828$20240905$20240905$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011086$STRIDES$Cui J, Zhang Y, Li X, Ding Z, Kong Y, Yu Z, et al.. Antimicrobial resistance profiles and genome characteristics of Klebsiella isolated from the faeces of neonates in the neonatal intensive care unit.. J-Med-Microbiol. 2024;73 (8)$8$DY$$$Y$$$20240905$$HP$CN$CN
242853131$24285313$1$I$20240728$20240827$20240905$20240905$EXP$FR-AFSSAPS-NC2024000990$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111657$ZYDUS PHARM$$$$$$Y$$$20240905$$MD$FR$FR
242853141$24285314$1$I$20221001$20240825$20240905$20240905$EXP$$CN-Accord-444091$ACCORD$Li Q, Guan W, Zhang J, Chen M, Zou Y. Anti-Infection of Nasopharyngeal Carcinoma Combined with Non-Tuberculous Mycobacteria: A Case Report and Literature Review. Infection and drug resistance. 2024;17:3527-35. DOI: 10.2147/IDR.S475377.$58$YR$A$M$Y$$$20240905$$HP$CN$CN
242853152$24285315$2$F$$20240822$20240905$20240905$PER$$US-ASTELLAS-2024-AER-002753$ASTELLAS$$8$DEC$E$M$Y$$$20240905$$MD$US$US
242853161$24285316$1$I$20140101$20240827$20240905$20240905$EXP$$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111718$ZYDUS PHARM$Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs). pharmacological intolerance vs Ig E-mediated allergy.. 2024;49:5-6$$$$$Y$$$20240905$$HP$FR$FR
242853171$24285317$1$I$$20240830$20240905$20240905$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011044$STRIDES$Tsujino A, Nakajima A, Yabuta H, Sekioka J, Amano M, Fujimura S, et al.. An Autopsy Case of Streptococcus dysgalactiae subsp. equisimilis Infectious Endocarditis Accompanied by Streptococcal Toxic Shock Syndrome.. Intern-Med. 2024;63 (15):2209-2214$66$YR$$F$Y$75$KG$20240905$$MD$JP$JP
242853181$24285318$1$I$20240228$20240827$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-019720$AUROBINDO$$44$YR$$F$Y$$$20240905$$MD$FR$FR
242853191$24285319$1$I$$20240902$20240905$20240905$EXP$GB-MHRA-MIDB-e3ffbe2f-4c0f-47ec-9c6b-f968b73335b6$GB-STRIDES ARCOLAB LIMITED-2024SP011094$STRIDES$$81$YR$$F$Y$$$20240905$$PH$GB$GB
242853201$24285320$1$I$$20240826$20240905$20240905$EXP$$US-AUROBINDO-AUR-APL-2024-043187$AUROBINDO$Kim EB, Malespini J, Lei M, Branagan AR, Cirstea D, Han SS, et al.. Rapid reduction of free light chains and improvement in renal outcomes in patients with newly diagnosed multiple myeloma admitted with acute kidney injury with daratumumab-based therapy and without plasmapheresis. JClin-Oncol. 2024;42 (Suppl.):No. 16$87$YR$$$Y$$$20240905$$HP$US$US
242853211$24285321$1$I$$20240825$20240905$20240905$EXP$$CN-Accord-444652$ACCORD$Wang D, Xue D, Chen X, Wu X, Gao W, Liang X, et al. Mycobacterium marseillense bloodstream infection combined with skin fungal infection: a case report and literature review. BMC Infect Dis. 2024 Aug 22;24(1):853. doi: 10.1186/s12879-024-09741-y.$55$YR$A$M$Y$$$20240905$$HP$CN$CN
242853221$24285322$1$I$20240101$20240828$20240905$20240905$EXP$$CA-CELLTRION INC.-2024CA021150$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
242853231$24285323$1$I$$20240902$20240905$20240905$EXP$GB-MLMSERVICE-20240807-PI154354-00233-1$GB-STRIDES ARCOLAB LIMITED-2024SP011095$STRIDES$Kubba F, Aliyeva-Derraz P, Gradassi AT.. An unusual case of drug-induced annular granulomatous vasculitis in a patient with rheumatoid arthritis and type 2 diabetes mellitus. British Journal of Dermatology. 2024;191(Supp_1):i117-i8$7$DEC$$F$Y$$$20240905$$MD$GB$GB
242853241$24285324$1$I$$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-085561-2024$RECKITT BENCKISER$$44$YR$$M$Y$$$20240905$$CN$US$US
242853251$24285325$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043584$AUROBINDO$$57$YR$$F$Y$$$20240905$$HP$CA$CA
242853261$24285326$1$I$20240401$20240825$20240905$20240905$EXP$$LV-Accord-443759$ACCORD$Renemane L, Rancans E. Sertraline induced acute hepatocellular liver injury in patient with major depressive disorder: a case report. Front Psychiatry. 2024 Aug 1;15:1456455.$36$YR$A$F$Y$$$20240905$$HP$LV$LV
242853271$24285327$1$I$$20240902$20240905$20240905$EXP$GB-MHRA-MED-202408271444016470-FSJRW$GB-STRIDES ARCOLAB LIMITED-2024SP011097$STRIDES$$89$DY$$$Y$$$20240905$$CN$GB$GB
242853291$24285329$1$I$$20240828$20240905$20240905$PER$$US-ALXN-202408USA002240US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242853301$24285330$1$I$$20240903$20240905$20240905$PER$$US-ALXN-202409USA000134US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242853311$24285331$1$I$20240903$20240903$20240905$20240905$EXP$$US-AstraZeneca-2024A200798$ASTRAZENECA$$27665$DY$$F$Y$$$20240905$$MD$US$
242853321$24285332$1$I$$20240902$20240905$20240905$EXP$GB-PHARMVIT-4556-3352-ER24-RN1158$GB-STRIDES ARCOLAB LIMITED-2024SP011034$STRIDES$$80$YR$$F$Y$$$20240905$$MD$GB$GB
242853331$24285333$1$I$$20240826$20240905$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004952$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242853341$24285334$1$I$$20240828$20240905$20240905$PER$$US-HALEON-2194171$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
242853351$24285335$1$I$20240802$20240826$20240902$20240902$DIR$FDA-CDER-CTU-2024-60723$$FDA-CTU$$79$YR$$M$N$$$20240826$N$HP$US$
242853371$24285337$1$I$20240717$20240827$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043158$AUROBINDO$$71$YR$$M$Y$$$20240905$$PH$FR$FR
242853381$24285338$1$I$$20240902$20240905$20240905$EXP$GB-PHARMVIT-4556-2425ER24-RN1154$GB-STRIDES ARCOLAB LIMITED-2024SP011035$STRIDES$$61$YR$$F$Y$$$20240905$$MD$GB$GB
242853411$24285341$1$I$$20240826$20240905$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005019$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242853431$24285343$1$I$$20240830$20240905$20240905$EXP$GB-MHRA-MED-202408292033091690-TLCWP$GB-862174955-ML2024-04716$Unknown Manufacturer$$76$YR$E$F$Y$76$KG$20240905$$CN$GB$GB
242853441$24285344$1$I$20240711$20240812$20240902$20240902$DIR$FDA-CDER-CTU-2024-60743$$FDA-CTU$$$$$F$N$$$20240812$N$HP$US$
242853451$24285345$1$I$$20240827$20240905$20240905$EXP$$US-862174955-ML2024-04704$Unknown Manufacturer$Schwartz AH, Sieminski S. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event. American Journal of Ophthalmology Case Reports. 2023 Mar 15;30: 1-4. doi:https://doi.org/10.1016/j.ajoc.2023.101827.$59$YR$A$F$Y$$$20240905$$HP$US$US
242853461$24285346$1$I$$20240902$20240902$20240902$DIR$FDA-CDER-CTU-2024-60684$$FDA-CTU$$84$YR$$F$N$$$20240902$N$$US$
242853471$24285347$1$I$$20240828$20240902$20240902$DIR$FDA-CDER-CTU-2024-60769$$FDA-CTU$$$$$M$N$$$20240828$N$HP$US$
242853481$24285348$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141085$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$67.59$KG$20240905$$CN$US$US
242853491$24285349$1$I$$20240830$20240905$20240905$EXP$$US-JNJFOC-20240881845$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$MD$US$US
242853501$24285350$1$I$$20240807$20240902$20240902$DIR$FDA-CDER-CTU-2024-60752$$FDA-CTU$$$$$F$N$$$20240807$N$HP$US$
242853531$24285353$1$I$$20240828$20240905$20240905$EXP$$US-JNJFOC-20240875040$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$HP$US$US
242853541$24285354$1$I$$20240822$20240905$20240905$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-25830$SAMSUNG BIOEPIS$$76$YR$E$F$Y$$$20240905$$CN$GB$GB
242853551$24285355$1$I$$20240816$20240905$20240905$PER$$US-TEVA-VS-3235994$TEVA$$$$$F$Y$$$20240905$$HP$US$US
242853561$24285356$1$I$$20240904$20240905$20240905$EXP$$US-TAKEDA-2024TUS088608$TAKEDA$$$$$M$Y$$$20240905$$CN$US$US
242853571$24285357$1$I$20240827$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175813$AMGEN$$30$YR$A$F$Y$$$20240905$$CN$US$US
242853581$24285358$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176521$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242853591$24285359$1$I$20240101$20240828$20240905$20240905$EXP$$CA-CELLTRION INC.-2024CA021169$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
242853601$24285360$1$I$$20240816$20240905$20240905$PER$$US-TEVA-VS-3236190$TEVA$$$$$M$Y$$$20240905$$CN$US$US
242853611$24285361$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002536$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240905$$CN$US$US
242853621$24285362$1$I$20240726$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409000406$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240905$$CN$US$US
242853631$24285363$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002704$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240905$$CN$US$US
242853641$24285364$1$I$$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001666$ELI LILLY AND CO$$73$YR$E$$Y$$$20240905$$LW$US$US
242853651$24285365$1$I$20240901$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002727$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240905$$CN$US$US
242853661$24285366$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001935$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240905$$CN$US$US
242853671$24285367$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002358$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242853681$24285368$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001698$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240905$$CN$US$US
242853692$24285369$2$F$20240902$20240903$20240905$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001780$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242853701$24285370$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002682$ELI LILLY AND CO$$$$$$Y$$$20240905$$CN$US$US
242853711$24285371$1$I$20240826$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001808$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240905$$CN$US$US
242853721$24285372$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001469$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240905$$CN$US$US
242853731$24285373$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001387$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240905$$CN$US$US
242853741$24285374$1$I$20240806$20240827$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043198$AUROBINDO$$44$YR$$F$Y$$$20240905$$MD$FR$FR
242853761$24285376$1$I$$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-087075-2024$RECKITT BENCKISER$$$$$M$Y$$$20240905$$CN$US$US
242853771$24285377$1$I$$20240827$20240905$20240905$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005137$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$HP$US$US
242853781$24285378$1$I$$20240826$20240905$20240905$EXP$$SK-TAKEDA-2024TUS088511$TAKEDA$Gabzdilova J,. Ig D myeloma and the use of daratumumab. Case Report$46$YR$$F$Y$$$20240905$$MD$SK$SK
242853792$24285379$2$F$20240101$20240905$20240905$20240913$EXP$$CA-CELLTRION INC.-2024CA019830$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
242853801$24285380$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140694$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240905$$CN$US$US
242853811$24285381$1$I$20240812$20240826$20240905$20240905$EXP$$US-Accord-444141$ACCORD$$51$YR$A$M$Y$$$20240905$$HP$US$US
242853821$24285382$1$I$20240820$20240827$20240905$20240905$30DAY$$AR-JNJFOC-20240881463$JOHNSON AND JOHNSON$$19$YR$A$M$Y$67$KG$20240905$$CN$AR$AR
242853831$24285383$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043704$AUROBINDO$$79$YR$$M$Y$$$20240905$$PH$CA$CA
242853841$24285384$1$I$20191201$20240821$20240905$20240905$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00785$Phathom Pharmaceuticals$Sugino A, Kouchi S, Kai T, Kawatoko S, Fujiwara M, Torisu T , et al. A case of gastric hyperplastic polyps which increased with hemorrhage after oral vonoprazan intake. The 332nd Kyushu Regional Meeting of the Japanese Society of Internal Medicine. 2021;49$54$YR$$M$Y$84.7$KG$20240905$$MD$JP$JP
242853851$24285385$1$I$$20240904$20240905$20240905$EXP$$US-SANDOZ INC.-SDZ2024US077815$SANDOZ$$$$$$Y$$$20240905$$CN$US$US
242853861$24285386$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176516$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242853931$24285393$1$I$20240725$20240807$20240902$20240902$DIR$FDA-CDER-CTU-2024-60673$$FDA-CTU$$88$YR$$M$N$$$20240807$N$HP$US$
242853941$24285394$1$I$$20240806$20240902$20240902$DIR$FDA-CDER-CTU-2024-60709$$FDA-CTU$$$$$F$N$$$20240806$N$HP$US$
242854011$24285401$1$I$20240802$20240826$20240905$20240905$EXP$PT-INFARMED-T202408-113$PT-SA-2024SA256868$SANOFI AVENTIS$$90$YR$E$M$Y$$$20240905$$PH$PT$PT
242854021$24285402$1$I$$20240826$20240905$20240905$EXP$$US-BAYER-2024A122755$BAYER$$$$$F$Y$$$20240905$$CN$US$US
242854031$24285403$1$I$20240811$20240829$20240905$20240905$EXP$$BR-GSK-BR2024AMR108958$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$BR$BR
242854051$24285405$1$I$20240903$20240903$20240905$20240905$EXP$$US-GILEAD-2024-0686176$GILEAD$$71$YR$E$F$Y$$$20240905$$CN$US$US
242854061$24285406$1$I$20240829$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024177142$AMGEN$$49$YR$A$F$Y$$$20240905$$CN$US$US
242854071$24285407$1$I$20240904$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024176849$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242854081$24285408$1$I$$20240829$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024175456$AMGEN$Fubin Q.; Na Z.; Shengda Z. et al.. Prognostic values of serum miR-140-5p and SFRP -5 for in-stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240905$$HP$CN$CN
242854091$24285409$1$I$$20240903$20240905$20240905$PER$$US-ROCHE-10000074436$ROCHE$$45$YR$A$F$Y$$$20240905$$CN$US$US
242854101$24285410$1$I$$20240827$20240905$20240905$EXP$$US-SA-2024SA256707$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240905$$HP$US$US
242854111$24285411$1$I$$20240828$20240905$20240905$EXP$$US-SA-2024SA254961$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240905$$MD$US$US
242854121$24285412$1$I$$20240830$20240905$20240905$EXP$$US-JNJFOC-20240902791$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242854131$24285413$1$I$$20240827$20240905$20240905$EXP$$US-APOTEX-2024AP010140$APOTEX$Hennen M-A, Zhang V, Opler DJ. An unwelcome side-effect of trazodone use in a trans-male.. Psychiatry and Clinical Neurosciences. 2024;78 (6):376-378$24$YR$$F$Y$$$20240905$$MD$US$US
242854141$24285414$1$I$20240730$20240828$20240905$20240905$EXP$$BE-JNJFOC-20240900949$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$83$KG$20240905$$MD$BE$BE
242854161$24285416$1$I$20200101$20240903$20240905$20240905$EXP$$CA-GILEAD-2024-0686145$GILEAD$$$$A$F$Y$$$20240905$$CN$CA$CA
242854171$24285417$1$I$20240101$20240828$20240905$20240905$EXP$SE-SEMPA-2024-006095$SE-SA-2024SA256938$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240905$$MD$SE$SE
242854181$24285418$1$I$20240803$20240822$20240902$20240902$DIR$FDA-CDER-CTU-2024-60711$$FDA-CTU$$63$YR$$M$N$$$20240822$N$HP$US$
242854191$24285419$1$I$$20240812$20240902$20240902$DIR$FDA-CDER-CTU-2024-60707$$FDA-CTU$$$$$M$N$$$20240812$N$HP$US$
242854201$24285420$1$I$$20240828$20240902$20240902$DIR$FDA-CDER-CTU-2024-60732$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
242854211$24285421$1$I$$20240830$20240905$20240905$PER$$US-TAKEDA-2024TUS087809$TAKEDA$$$$$$Y$$$20240905$$CN$US$US
242854221$24285422$1$I$20240101$20240830$20240905$20240905$PER$$US-UNITED THERAPEUTICS-UNT-2024-016960$UNITED THERAPEUTICS$$$$$F$Y$46.259$KG$20240905$$$US$US
242854241$24285424$1$I$$20240823$20240902$20240902$DIR$FDA-CDER-CTU-2024-60690$$FDA-CTU$$$$$M$N$$$20240823$N$HP$US$
242854281$24285428$1$I$$20240827$20240905$20240905$EXP$$US-BAYER-2024A126625$BAYER$Gerges M; Bathobakae L; Mahmoud A; Saad R; Elkattawy S; Shamoon F; Ismail M. THE GREAT MIMICKER: A UNIQUE CASE OF DIFFUSE SUBARACHNOID HAEMORRHAGE SIMULATING ACUTE MYOCARDIAL INFARCTION. European Journal of Case Reports in Internal Medicine (). 2024;11:8$44$YR$A$F$Y$$$20240905$$HP$US$US
242854291$24285429$1$I$20240811$20240827$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024172526$AMGEN$$64$YR$A$F$Y$71$KG$20240905$$HP$CN$CN
242854333$24285433$3$F$20240801$20240918$20240905$20240923$PER$$US-ROCHE-10000071234$ROCHE$$56$YR$A$F$Y$68.95$KG$20240923$$CN$US$US
242854341$24285434$1$I$$20240808$20240902$20240902$DIR$FDA-CDER-CTU-2024-60771$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
242854371$24285437$1$I$20240101$20240829$20240905$20240905$EXP$$US-SA-2024SA256834$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240905$$CN$US$US
242854381$24285438$1$I$20240520$20240827$20240905$20240905$EXP$$TR-AMGEN-TURSP2024172548$AMGEN$$79$YR$E$F$Y$70$KG$20240905$$HP$TR$TR
242854391$24285439$1$I$20240828$20240828$20240905$20240905$EXP$$US-BAYER-2024A103626$BAYER$$69$YR$E$M$Y$115.65$KG$20240905$$CN$US$US
242854401$24285440$1$I$20240730$20240827$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043185$AUROBINDO$$69$YR$$M$Y$49$KG$20240905$$MD$FR$FR
242854412$24285441$2$F$$20240906$20240905$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139246$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240911$$CN$US$US
242854421$24285442$1$I$$20240828$20240905$20240905$EXP$$BR-BAYER-2024A126136$BAYER$$$$$F$Y$$$20240905$$MD$BR$BR
242854432$24285443$2$F$$20240906$20240905$20240910$EXP$$SI-VANTIVE-2024VAN019495$Vantive US Healthcare$$$$E$F$Y$$$20240910$$HP$SI$SI
242854446$24285444$6$F$20240101$20240918$20240905$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026979$UNITED THERAPEUTICS$$$$$F$Y$103.4$KG$20240927$$$US$US
242854452$24285445$2$F$$20240905$20240905$20240911$EXP$$IN-VANTIVE-2024VAN019548$Vantive US Healthcare$$49$YR$$M$Y$$$20240911$$CN$IN$IN
242854461$24285446$1$I$$20240904$20240905$20240905$PER$$US-HALEON-2195260$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
242854481$24285448$1$I$$20240829$20240905$20240905$EXP$$ES-MYLANLABS-2024M1081060$MYLAN$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transpl-Infect-Dis 2024; 26 (3): e14276.$6$MON$$M$Y$$$20240905$$HP$ES$ES
242854491$24285449$1$I$20240401$20240829$20240905$20240905$EXP$$DE-MYLANLABS-2024M1079860$MYLAN$$$$$M$Y$2.44$KG$20240905$$MD$DE$DE
242854511$24285451$1$I$20240805$20240829$20240905$20240905$EXP$$IT-MYLANLABS-2024M1079830$MYLAN$$74$YR$$M$Y$85$KG$20240905$$MD$IT$IT
242854521$24285452$1$I$$20240829$20240905$20240905$EXP$$DK-MYLANLABS-2024M1081029$MYLAN$DiMicco V, Affronte L, Khinchi MS, Ronde G, Miranda MJ, Hammer TB, et al. Seizure and movement disorder in CACNA1E developmental and epileptic encephalopathy: Two sides of the same coin or same side of two different coins?. Epileptic-Disord 2024; 26 (4): 520-526.$6$MON$$F$Y$$$20240905$$HP$DK$DK
242854531$24285453$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043750$AUROBINDO$$80$YR$$F$Y$$$20240905$$PH$CA$CA
242854541$24285454$1$I$$20240829$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024175476$AMGEN$Fubin Q.; Na Z.; Shengda Z. et al.. Prognostic values of serum miR-140-5p and SFRP -5 for in-stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240905$$HP$CN$CN
242854551$24285455$1$I$$20240829$20240905$20240905$EXP$$FR-MYLANLABS-2024M1080826$MYLAN$Checri R, Dozieres-Puyravel B, Elmaleh-Berges M, Verloes A, Auvin S. PACS2 pathogenic variant associated with malformation of cortical development and epilepsy. Epileptic-Disord 2024; 26 (2): 215-218.$7$YR$$M$Y$$$20240905$$HP$FR$FR
242854561$24285456$1$I$20240101$20240821$20240905$20240905$PER$$US-SA-2024SA255368$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240905$$CN$US$US
242854581$24285458$1$I$20160301$20240829$20240905$20240905$EXP$$US-BAXALTA-2016BLT002380$TAKEDA$$62$YR$$F$Y$$$20240905$$CN$US$US
242854591$24285459$1$I$$20240826$20240905$20240905$EXP$$US-NOVOPROD-1276068$NOVO NORDISK$$$$A$$Y$$$20240905$$CN$US$US
242854602$24285460$2$F$20230101$20240903$20240905$20240915$EXP$$US-Accord-444171$ACCORD$Hosseini R, Brooks SP, Gadelha E, Schaap R, Cook J, Husan A. Effective Treatment of Methotrexate Induced Oral Mucositis With a Morphine Mouthwash Solution: A Case Report. J Pharm Pract. 2024 Aug 23:8971900241276077.$67$YR$E$F$Y$103.9$KG$20240915$$PH$US$US
242854611$24285461$1$I$$20240827$20240905$20240905$EXP$$CA-APOTEX-2024AP010013$APOTEX$$84$YR$$M$Y$$$20240905$$PH$CA$CA
242854631$24285463$1$I$20240101$20240822$20240905$20240905$PER$$US-SA-2024SA255409$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240905$$HP$US$US
242854642$24285464$2$F$20240415$20240822$20240905$20240916$PER$$US-SA-2024SA256035$SANOFI AVENTIS$$47$YR$A$M$Y$83$KG$20240916$$HP$US$US
242854651$24285465$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA253350$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240905$$MD$US$US
242854661$24285466$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA256724$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240905$$MD$US$US
242854671$24285467$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA253213$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240905$$MD$US$US
242854691$24285469$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA255985$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240905$$CN$US$US
242854721$24285472$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA252785$SANOFI AVENTIS$$$$$F$Y$$$20240905$$HP$US$US
242854731$24285473$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA256412$SANOFI AVENTIS$$$$T$F$Y$$$20240905$$MD$US$US
242854741$24285474$1$I$20240801$20240821$20240905$20240905$PER$$US-SA-2024SA256349$SANOFI AVENTIS$$$$E$F$Y$$$20240905$$MD$US$US
242854751$24285475$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA256085$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240905$$MD$US$US
242854761$24285476$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA255660$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240905$$MD$US$US
242854771$24285477$1$I$$20240823$20240905$20240905$PER$$US-SA-2024SA256970$SANOFI AVENTIS$$$$E$F$Y$$$20240905$$MD$US$US
242854781$24285478$1$I$20240801$20240821$20240905$20240905$PER$$US-SA-2024SA255369$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240905$$HP$US$US
242854792$24285479$2$F$20240701$20240916$20240905$20240925$PER$$US-SA-2024SA256087$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240925$$MD$US$US
242854801$24285480$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA255015$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240905$$MD$US$US
242854811$24285481$1$I$$20240823$20240905$20240905$EXP$$PK-ALKEM LABORATORIES LIMITED-PK-ALKEM-2024-20606$ALKEM$Muhammad ZA, Ahmad T, Rashid H.. Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-a cohort study. Expert Opinion on Drug Safety. 2024;unk:1-8$94$YR$$M$Y$$$20240905$$HP$PK$PK
242854821$24285482$1$I$$20240823$20240905$20240905$EXP$$PK-ALKEM LABORATORIES LIMITED-PK-ALKEM-2024-20605$ALKEM$Muhammad ZA, Ahmad T, Rashid H.. Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-a cohort study. EXPERT OPINION ON DRUG SAFETY. 2024;00(0):1-8$95$YR$$M$Y$$$20240905$$HP$PK$PK
242854831$24285483$1$I$$20240823$20240905$20240905$EXP$$HR-ALKEM LABORATORIES LIMITED-HR-ALKEM-2024-20531$ALKEM$Varda Brkic D, Babel J, Budimir A, Butic I, Guzvinec M, Juric D, Ferencak I, Bosnjak S, Marekovic I. Disseminated Infection Caused by Nocardia cyriacigeorgica in Immunocompromised Patient Confirmed by Whole Genome Sequencing. Chemotherapy. 2024;unk:1-17$87$YR$$M$Y$$$20240905$$HP$HR$HR
242854841$24285484$1$I$$20240823$20240905$20240905$EXP$JP-MLMSERVICE-20240820-PI165237-00306-1$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-19683$ALKEM$Nakako S, Koh H, Sogabe N, Kuno M, Makuuchi Y, Takakuwa T, Okamura H, Nishimoto M, Nakashima Y, Hino M, Nakamae H.. Successful treatment with mesenchymal stem cells for steroid-refractory late-onset idiopathic pneumonia syndrome following allogeneic hematopoietic cell transplantation. Transplant Immunology. 2024;86:102107$55$YR$$M$Y$$$20240905$$MD$JP$JP
242854851$24285485$1$I$$20240823$20240905$20240905$EXP$$PK-ALKEM LABORATORIES LIMITED-PK-ALKEM-2024-20602$ALKEM$Muhammad ZA, Ahmad T, Rashid H.. Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-a cohort study. Expert Opinion on Drug Safety. 2024;unk:1-8$86$YR$$M$Y$$$20240905$$HP$PK$PK
242854871$24285487$1$I$$20240823$20240905$20240905$EXP$TR-MLMSERVICE-20240815-PI164167-00306-1$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-20046$ALKEM$Yazdali Koylu N, Koc NS, Sancar EN, Sarinc S, Altun B.. Everolimus-Related Chylothorax: A Rare Case Report. Experimental and Clinical Transplantation. 2024;6:471-474$27$YR$$M$Y$$$20240905$$MD$TR$TR
242854881$24285488$1$I$$20240823$20240905$20240905$EXP$$PK-ALKEM LABORATORIES LIMITED-PK-ALKEM-2024-20607$ALKEM$Muhammad ZA, Ahmad T, Rashid H.. Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-a cohort study. Expert Opinion On Drug Safety. 2024;00:1-8$64$YR$$F$Y$$$20240905$$HP$PK$PK
242854891$24285489$1$I$$20240823$20240905$20240905$EXP$$PK-ALKEM LABORATORIES LIMITED-PK-ALKEM-2024-20603$ALKEM$Muhammad ZA, Ahmad T, Rashid H.. Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-a cohort study. Expert Opinion on Drug Safety. 2024;unk:1-8$75$YR$$F$Y$$$20240905$$HP$PK$PK
242854901$24285490$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA256010$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240905$$MD$US$US
242854911$24285491$1$I$$20240903$20240905$20240905$EXP$$NVSC2024US154213$NOVARTIS$$$$$F$Y$$$20240905$$CN$US$US
242854921$24285492$1$I$20240823$20240826$20240905$20240905$PER$$US-SA-2024SA256961$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240905$$MD$US$US
242854932$24285493$2$F$$20240906$20240905$20240906$EXP$$ES-BAYER-2024A126621$BAYER$$$$$F$Y$$$20240906$$CN$ES$ES
242854941$24285494$1$I$$20240904$20240905$20240905$PER$$US-BAYER-2024A127128$BAYER$$$$$$Y$$$20240905$$CN$US$US
242854951$24285495$1$I$$20240830$20240905$20240905$PER$$US-SA-2024SA256386$SANOFI AVENTIS$$8$YR$C$M$Y$26$KG$20240905$$CN$US$US
242854961$24285496$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA256668$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240905$$MD$US$US
242854971$24285497$1$I$20231001$20240826$20240905$20240905$PER$$US-SA-2023SA341866$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240905$$MD$US$US
242854981$24285498$1$I$$20240904$20240905$20240905$EXP$$GB-MYLANLABS-2024M1081409$MYLAN$$$$$M$Y$$$20240905$$HP$GB$GB
242854991$24285499$1$I$$20240826$20240905$20240905$EXP$$US-GSK-US2024106507$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242855001$24285500$1$I$$20240826$20240905$20240905$EXP$$US-GSK-US2024106014$GLAXOSMITHKLINE$$$$$M$Y$$$20240905$$MD$US$US
242855011$24285501$1$I$$20240904$20240905$20240905$PER$$US-BAYER-2024A127289$BAYER$$$$$$Y$$$20240905$$CN$US$US
242855021$24285502$1$I$$20240902$20240902$20240902$DIR$FDA-CDER-CTU-2024-60814$$FDA-CTU$$65$YR$$M$N$$$20240902$N$$US$
242855031$24285503$1$I$$20240828$20240905$20240905$EXP$$DE-NOVOPROD-1276409$NOVO NORDISK$$63$YR$$M$Y$$$20240905$$CN$DE$DE
242855041$24285504$1$I$20240802$20240826$20240902$20240902$DIR$FDA-CDER-CTU-2024-60728$$FDA-CTU$$79$YR$$M$N$$$20240826$N$HP$US$
242855051$24285505$1$I$$20240904$20240904$20240904$DIR$717120$$FDA-CTU$$$$$UNK$N$$$20240904$N$CN$US$
242855061$24285506$1$I$$20240807$20240902$20240902$DIR$FDA-CDER-CTU-2024-60715$$FDA-CTU$$$$$F$N$$$20240807$N$HP$US$
242855071$24285507$1$I$$20240902$20240902$20240902$DIR$FDA-CDER-CTU-2024-60663$$FDA-CTU$$71$YR$$M$N$$$20240902$N$$US$
242855082$24285508$2$F$20240101$20240920$20240905$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-027521$UNITED THERAPEUTICS$$$$$F$Y$69.841$KG$20240927$$$US$US
242855091$24285509$1$I$$20240826$20240902$20240902$DIR$FDA-CDER-CTU-2024-60733$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242855101$24285510$1$I$$20240807$20240902$20240902$DIR$FDA-CDER-CTU-2024-60659$$FDA-CTU$$$$$F$N$$$20240807$N$HP$US$
242855111$24285511$1$I$$20240821$20240902$20240902$DIR$FDA-CDER-CTU-2024-60695$$FDA-CTU$$$$$M$N$$$20240821$N$HP$US$
242855131$24285513$1$I$$20240904$20240904$20240904$DIR$717146$$FDA-CTU$$$$$UNK$N$$$20240904$$CN$US$
242855171$24285517$1$I$$20240829$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024175477$AMGEN$Fubin Q.; Na Z.; Shengda Z. et al.. Prognostic values of serum miR-140-5p and SFRP -5 for in-stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240905$$HP$CN$CN
242855183$24285518$3$F$20240830$20240923$20240905$20240924$PER$$US-AMGEN-USASP2024176004$AMGEN$$50$YR$A$M$Y$$$20240924$$MD$US$US
242855191$24285519$1$I$20240902$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024177112$AMGEN$$81$YR$E$M$Y$$$20240905$$PH$US$US
242855201$24285520$1$I$$20240829$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024175497$AMGEN$Fubin Q.; Na Z.; Shengda Z.. Prognostic values of serum miR-140-5p and SFRP -5 for in -stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240905$$HP$CN$CN
242855211$24285521$1$I$$20240904$20240905$20240905$PER$$US-BAYER-2024A127293$BAYER$$$$$$Y$$$20240905$$CN$US$US
242855221$24285522$1$I$20240820$20240827$20240905$20240905$EXP$$US-AMERICAN REGENT INC-2024003327$AMERICAN REGENT$$21$YR$$F$Y$$$20240905$$HP$US$US
242855231$24285523$1$I$$20240814$20240905$20240905$PER$$US-JNJFOC-20240842496$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242855261$24285526$1$I$20200101$20240828$20240905$20240905$EXP$$US-SA-2020SA082981$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240905$$MD$US$US
242855271$24285527$1$I$20240813$20240827$20240905$20240905$EXP$$GB-AUROBINDO-AUR-APL-2024-042964$AUROBINDO$$65$YR$$M$Y$83$KG$20240905$$MD$GB$GB
242855281$24285528$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA252650$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240905$$CN$US$US
242855291$24285529$1$I$20240820$20240821$20240905$20240905$PER$$US-SA-2024SA255984$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240905$$MD$US$US
242855301$24285530$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA255835$SANOFI AVENTIS$$$$A$F$Y$$$20240905$$MD$US$US
242855312$24285531$2$F$$20240823$20240905$20240913$PER$$US-SA-2024SA254945$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240913$$CN$US$US
242855321$24285532$1$I$20240801$20240822$20240905$20240905$PER$$US-SA-2024SA255896$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240905$$MD$US$US
242855331$24285533$1$I$$20240823$20240905$20240905$PER$$US-SA-2024SA257011$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240905$$MD$US$US
242855341$24285534$1$I$20240101$20240823$20240905$20240905$PER$$US-SA-2024SA256138$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240905$$HP$US$US
242855351$24285535$1$I$20240101$20240822$20240905$20240905$PER$$US-SA-2024SA256333$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240905$$CN$US$US
242855361$24285536$1$I$20240701$20240822$20240905$20240905$PER$$US-SA-2024SA255852$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240905$$MD$US$US
242855371$24285537$1$I$20230224$20240828$20240905$20240905$PER$$US-SA-2024SA194543$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240905$$MD$US$US
242855391$24285539$1$I$20240101$20240822$20240905$20240905$PER$$US-SA-2024SA256940$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240905$$CN$US$US
242855401$24285540$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA256839$SANOFI AVENTIS$$$$$F$Y$$$20240905$$HP$US$US
242855413$24285541$3$F$20240815$20240829$20240905$20240923$PER$$US-SA-2024SA255374$SANOFI AVENTIS$$43$YR$A$F$Y$46.36$KG$20240923$$MD$US$US
242855421$24285542$1$I$20240801$20240823$20240905$20240905$PER$$US-SA-2024SA254804$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240905$$MD$US$US
242855431$24285543$1$I$20240801$20240821$20240905$20240905$PER$$US-SA-2024SA254350$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240905$$MD$US$US
242855441$24285544$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA254956$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240905$$MD$US$US
242855451$24285545$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA255539$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240905$$MD$US$US
242855461$24285546$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA255044$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240905$$MD$US$US
242855471$24285547$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA257428$SANOFI AVENTIS$$$$A$M$Y$$$20240905$$HP$US$US
242855481$24285548$1$I$20240822$20240826$20240905$20240905$EXP$$US-Accord-443782$ACCORD$$27$YR$A$M$Y$$$20240905$$MD$US$US
242855491$24285549$1$I$$20240827$20240905$20240905$EXP$$PT-AUROBINDO-AUR-APL-2024-043283$AUROBINDO$Velho R, Fernandes B, Teixeira A, Borges A, Fonseca I, Santos L. Valproate-induced acute pancreatitis. Medicina Interna - Congressos Nacionais, 30CNMI. 2024;05:780$57$YR$$M$Y$$$20240905$$HP$PT$PT
242855501$24285550$1$I$20240830$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002035$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240905$$CN$US$US
242855511$24285551$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002641$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240905$$CN$US$US
242855521$24285552$1$I$20240701$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002599$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242855531$24285553$1$I$$20240826$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408017043$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240905$$CN$US$US
242855541$24285554$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002772$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240905$$CN$US$US
242855552$24285555$2$F$$20240913$20240905$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202408018946$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240919$$CN$US$US
242855561$24285556$1$I$$20240829$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408019184$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240905$$CN$US$US
242855571$24285557$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001366$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240905$$CN$US$US
242855581$24285558$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001700$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242855591$24285559$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001557$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240905$$CN$US$US
242855601$24285560$1$I$20240101$20240829$20240905$20240905$EXP$$US-SANDOZ INC.-SDZ2024US077991$SANDOZ$$48$YR$$F$Y$$$20240905$$CN$US$US
242855611$24285561$1$I$$20240829$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024175498$AMGEN$Fubin Q.; Na Z.; Shengda Z.. Prognostic values of serum miR-140-5p and SFRP -5 for in -stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240905$$HP$CN$CN
242855631$24285563$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140976$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240905$$HP$US$US
242855641$24285564$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140242$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240905$$CN$US$US
242855651$24285565$1$I$$20240902$20240905$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-141059$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240905$$MD$JP$JP
242855661$24285566$1$I$20240819$20240830$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139106$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240905$$CN$US$US
242855671$24285567$1$I$20240810$20240826$20240905$20240905$EXP$$CN-009507513-2408CHN009990$MERCK$$53$YR$$M$Y$$$20240905$$HP$CN$CN
242855681$24285568$1$I$20240730$20240830$20240905$20240905$EXP$FR-AFSSAPS-TO2024001518$FR-MYLANLABS-2024M1080061$MYLAN$$69$YR$$M$Y$49$KG$20240905$$MD$FR$FR
242855691$24285569$1$I$$20240807$20240902$20240902$DIR$FDA-CDER-CTU-2024-60841$$FDA-CTU$$$$$F$N$$$20240807$N$HP$US$
242855701$24285570$1$I$$20240902$20240905$20240905$PER$$US-BAYER-2024A126239$BAYER$$$$$$Y$$$20240905$$CN$US$US
242855711$24285571$1$I$20240702$20240902$20240905$20240905$EXP$$FR-AMERICAN REGENT INC-2024003370$AMERICAN REGENT$$49$YR$$F$Y$117$KG$20240905$$MD$FR$FR
242855721$24285572$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010083$APOTEX$$53$YR$$F$Y$$$20240905$$HP$CA$CA
242855731$24285573$1$I$20240101$20240826$20240905$20240905$EXP$$JP-009507513-2407JPN004352J$MERCK$$$$$M$Y$$$20240905$$MD$JP$JP
242855741$24285574$1$I$$20240829$20240905$20240905$PER$$US-BAYER-2024A124470$BAYER$$$$$F$Y$$$20240905$$CN$US$US
242855751$24285575$1$I$20240101$20240830$20240905$20240905$PER$$US-009507513-2409USA000572$MERCK$$$$$F$Y$$$20240905$$CN$US$US
242855761$24285576$1$I$$20240826$20240905$20240905$EXP$$IR-MACLEODS PHARMA-MAC2024049133$MACLEODS$Roshanzamiri S, Mousavizadeh SA, Razazzadeh S, Ziaie S..Acyclovir-induced psychiatric and renal adverse effects in a diabetic patient: A case report.Clinical case reports.19-AUG-2024;12(8):e9310:1-4$$$$$Y$$$20240905$$HP$IR$IR
242855771$24285577$1$I$$20240903$20240905$20240905$EXP$$US-JNJFOC-20240905273$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$HP$US$US
242855781$24285578$1$I$20240902$20240902$20240902$20240902$DIR$FDA-CDER-CTU-2024-60826$$FDA-CTU$$49$YR$$F$N$$$20240902$N$HP$US$
242855791$24285579$1$I$$20240826$20240905$20240905$EXP$$ZA-MACLEODS PHARMA-MAC2024049125$MACLEODS$$$$$$Y$$$20240905$$CN$ZA$ZA
242855801$24285580$1$I$20210101$20240826$20240905$20240905$EXP$$US-MACLEODS PHARMA-MAC2024049120$MACLEODS$Desai D, Nohria A, Alhanshali L, Buontempo M, Lo Sicco KI, Fern C, et al..Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide  injections: Report of two cases.JAAD Case Reports.2024;51:86-91$$$$$Y$$$20240905$$MD$US$US
242855812$24285581$2$F$$20240909$20240905$20240921$EXP$$IN-MACLEODS PHARMA-MAC2024049131$MACLEODS$Anandan S, Rajendran SS, Somarajan SA, Udayan A..A Very Rare Side Effect of a Very Commonly Used Drug: Pantoprazole-induced Seizure..The Journal of the Association of Physicians of India.AUG-2024;72(8):89$$$$$Y$$$20240921$$MD$IN$IN
242855821$24285582$1$I$20220101$20240826$20240905$20240905$EXP$$US-MACLEODS PHARMA-MAC2024049121$MACLEODS$Desai D, Nohria A, Alhanshali L, Buontempo M, Lo Sicco KI, Fern C, et al..Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases.JAAD Case Reports.2024;51:86-91$$$$$Y$$$20240905$$MD$US$US
242855831$24285583$1$I$$20240826$20240905$20240905$EXP$$US-MACLEODS PHARMA-MAC2024049134$MACLEODS$Robertson KM, Harvey CL, Cunningham JM..Acyclovir-induced neurotoxicity with a positive cerebrospinal fluid varicella zoster PCR result creating a management dilemma: a case report.Journal of Medical Case Reports..18-SEP-2020;14(1):156$$$$$Y$$$20240905$$HP$US$US
242855841$24285584$1$I$20240801$20240820$20240905$20240905$EXP$$JP-AMGEN-JPNSP2024175396$AMGEN$$3$YR$C$F$Y$$$20240905$$MD$JP$JP
242855851$24285585$1$I$$20240828$20240905$20240905$EXP$$US-AMGEN-USASP2024173757$AMGEN$Cheung A.Y.; Mansur S.. Treatment of Corneal Neovascularization Before Deep Anterior Lamellar Keratoplasty. Cornea. 2024;1-6$69$YR$E$F$Y$$$20240905$$MD$US$US
242855861$24285586$1$I$20240903$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024176825$AMGEN$$$$$$Y$74$KG$20240905$$PH$US$US
242855871$24285587$1$I$$20240829$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024175499$AMGEN$Fubin Q.; Na Z.; Shengda Z.. Prognostic values of serum miR-140-5p and SFRP -5 for in -stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240905$$HP$CN$CN
242855891$24285589$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043581$AUROBINDO$$32$YR$$F$Y$$$20240905$$PH$CA$CA
242855901$24285590$1$I$$20240828$20240905$20240905$EXP$$AR-AstraZeneca-2024A196796$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$AR$
242855911$24285591$1$I$$20240829$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024175500$AMGEN$Fubin Q.; Na Z.; Shengda Z.. Prognostic values of serum miR-140-5p and SFRP -5 for in -stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240905$$HP$CN$CN
242855921$24285592$1$I$$20240828$20240905$20240905$PER$$US-BAYER-2024A126649$BAYER$$$$$$Y$$$20240905$$CN$US$US
242855931$24285593$1$I$$20240904$20240905$20240905$PER$$US-GILEAD-2024-0686279$GILEAD$$$$A$F$Y$$$20240905$$HP$US$US
242855961$24285596$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140625$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$63.5$KG$20240905$$CN$US$US
242855982$24285598$2$F$$20240902$20240905$20240910$EXP$$DE-ABBVIE-5905159$ABBVIE$Topp MS, Duell J, Guijarro AMA, Odin M, Nielsen T, Rajeswaran A et al. Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma. Haematologica 2020;105:e256-60.$68$YR$$M$Y$$$20240910$$HP$DE$DE
242855992$24285599$2$F$20220714$20240904$20240905$20240912$EXP$$CA-CELLTRION INC.-2022CA009811$CELLTRION$$$$$$Y$$$20240912$$MD$CA$CA
242856001$24285600$1$I$$20240823$20240905$20240905$EXP$$JP-ASTELLAS-2024-AER-001507$ASTELLAS$$12$YR$T$$Y$45$KG$20240905$$PH$JP$JP
242856011$24285601$1$I$$20240801$20240905$20240905$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461801$RANBAXY$$$$A$F$Y$$$20240905$$CN$US$US
242856021$24285602$1$I$20240519$20240903$20240905$20240905$EXP$$NVSJ2024JP010455$NOVARTIS$$1$YR$$F$Y$9.8$KG$20240905$$PH$JP$JP
242856041$24285604$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043517$AUROBINDO$$$$$M$Y$$$20240905$$HP$CA$CA
242856061$24285606$1$I$$20240829$20240905$20240905$EXP$$NVSC2024CR176867$NOVARTIS$$$$$$Y$$$20240905$$MD$CR$CR
242856071$24285607$1$I$20240814$20240903$20240905$20240905$EXP$$US-JNJFOC-20240905492$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242856091$24285609$1$I$$20240829$20240902$20240902$DIR$FDA-CDER-CTU-2024-60839$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242856101$24285610$1$I$20240811$20240814$20240902$20240902$DIR$FDA-CDER-CTU-2024-60677$$FDA-CTU$$42$YR$$M$N$$$20240814$N$HP$US$
242856111$24285611$1$I$20201110$20240902$20240905$20240905$EXP$PL-URPL-1-2496-2020$PL-TAKEDA-2024TUS087830$TAKEDA$$9$YR$$M$Y$14$KG$20240905$$HP$PL$PL
242856121$24285612$1$I$$20240903$20240905$20240905$PER$$US-ALXN-202409USA000143US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242856131$24285613$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA256928$SANOFI AVENTIS$$$$E$F$Y$$$20240905$$MD$US$US
242856141$24285614$1$I$$20240827$20240905$20240905$EXP$$CA-APOTEX-2024AP010143$APOTEX$Benoit P, Wang S, Wang C, Chakravarti A, Villalba JA, Ali IKM, et al.. Brainstorm: A case of granulomatous encephalitis. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2024;9 (2):113-120$74$YR$$F$Y$$$20240905$$MD$CA$CA
242856152$24285615$2$F$20240101$20240828$20240905$20240909$PER$$US-SA-2024SA256943$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240909$$MD$US$US
242856161$24285616$1$I$20240829$20240830$20240905$20240905$PER$$US-SA-2024SA257162$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240905$$CN$US$US
242856181$24285618$1$I$$20240826$20240905$20240905$PER$$US-ABBVIE-5897803$ABBVIE$$38$YR$$F$Y$$$20240905$$MD$US$US
242856191$24285619$1$I$20230215$20240806$20240905$20240905$PER$$US-ASTELLAS-2024-AER-004039$ASTELLAS$$74$YR$E$M$Y$$$20240905$$MD$US$US
242856201$24285620$1$I$$20240830$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024174757$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240905$$MD$CN$CN
242856211$24285621$1$I$20240820$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024176914$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242856231$24285623$1$I$$20240903$20240905$20240905$EXP$$NVSC2024US177305$NOVARTIS$$$$$M$Y$$$20240905$$CN$US$US
242856241$24285624$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140806$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240905$$CN$US$US
242856251$24285625$1$I$$20240829$20240905$20240905$EXP$$NVSC2022MX006515$NOVARTIS$$$$$F$Y$$$20240905$$CN$MX$MX
242856261$24285626$1$I$$20240828$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137711$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240905$$CN$US$US
242856281$24285628$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140967$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$92.53$KG$20240905$$CN$US$US
242856291$24285629$1$I$20240808$20240827$20240905$20240905$EXP$FR-AFSSAPS-LL2024001596$FR-009507513-2408FRA009516$MERCK$$84$YR$$M$Y$85$KG$20240905$$PH$FR$FR
242856302$24285630$2$F$$20240905$20240905$20240909$5DAY$$US-ASTELLAS-2024-AER-001536$ASTELLAS$$$$$$Y$$$20240909$$MD$US$US
242856311$24285631$1$I$20240812$20240813$20240905$20240905$EXP$$US-ASTELLAS-2024US022212$ASTELLAS$$77$YR$E$M$Y$79$KG$20240905$$MD$US$US
242856321$24285632$1$I$$20240904$20240905$20240905$EXP$$CA-SANDOZ INC.-SDZ2024CA077783$SANDOZ$$19$YR$$F$Y$$$20240905$$HP$CA$CA
242856331$24285633$1$I$20240101$20240901$20240905$20240905$EXP$$KR-BAYER-2024A126125$BAYER$$41$YR$A$F$Y$$$20240905$$MD$KR$KR
242856341$24285634$1$I$20240701$20240830$20240905$20240905$EXP$$US-BAYER-2024A104594$BAYER$$71$YR$E$M$Y$$$20240905$$CN$US$US
242856351$24285635$1$I$$20240829$20240905$20240905$EXP$$CA-MYLANLABS-2024M1029982$MYLAN$Lafreniere S, Blier P. Remission from severe treatment-resistant depression with moclobemide: A case report. Encephale 2023; 49 (6): 649-650.$65$YR$$F$Y$$$20240905$$HP$CA$CA
242856361$24285636$1$I$20240101$20240827$20240905$20240905$EXP$$PT-JNJFOC-20240853065$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240905$$MD$PT$PT
242856371$24285637$1$I$$20240822$20240905$20240905$EXP$$JP-UCBSA-2024043524$UCB$$6$DEC$$F$Y$$$20240905$$PH$JP$JP
242856381$24285638$1$I$$20240830$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024174753$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240905$$MD$CN$CN
242856391$24285639$1$I$20240801$20240830$20240902$20240902$DIR$FDA-CDER-CTU-2024-60683$$FDA-CTU$$48$YR$$F$N$$$20240830$N$HP$US$
242856401$24285640$1$I$$20240830$20240902$20240902$DIR$FDA-CDER-CTU-2024-60741$$FDA-CTU$$$$$M$N$$$20240830$N$HP$US$
242856421$24285642$1$I$$20240828$20240905$20240905$EXP$$US-GALDERMA-US2024013565$GALDERMA$$$$$$Y$$$20240905$$CN$US$US
242856431$24285643$1$I$20240101$20240820$20240905$20240905$PER$$US-SA-2024SA256959$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240905$$MD$US$US
242856441$24285644$1$I$$20240829$20240905$20240905$EXP$$CA-009507513-2409CAN000269$MERCK$$65$YR$$F$Y$$$20240905$$HP$CA$CA
242856451$24285645$1$I$20210719$20240827$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043191$AUROBINDO$$65$YR$$M$Y$$$20240905$$PH$FR$FR
242856461$24285646$1$I$20240808$20240904$20240904$20240904$DIR$717208$$FDA-CTU$$65$YR$$M$N$74.7$KG$20240904$N$CN$US$
242856471$24285647$1$I$$20240828$20240905$20240905$30DAY$$US-GSK-US2024AMR107702$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242856482$24285648$2$F$20240727$20240917$20240905$20240927$EXP$$BE-AUROBINDO-AUR-APL-2024-043649$AUROBINDO$$71$YR$$M$Y$82.4$KG$20240927$$HP$BE$BE
242856491$24285649$1$I$$20240830$20240905$20240905$EXP$$US-LUPIN HEALTHCARE (UK) LIMITED-2024-07653$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242856501$24285650$1$I$$20240830$20240905$20240905$EXP$$JP-MYLANLABS-2024M1080672$MYLAN$Masuda Y, Yamazaki S, Honda A, Masamoto Y, Kurokawa M. Masuda Y, Yamazaki S, Honda A, Masamoto Y, Kurokawa M. Isolated massive pleural effusion as a manifestation of chronic graft versus host disease successfully treated with corticosteroid. Ann-Hematol 2024; 103 (4): 1403-1407.. Ann-Hematol. 2024;103 (4):1403-1407$58$YR$$F$Y$$$20240905$$HP$JP$JP
242856541$24285654$1$I$20240615$20240904$20240904$20240904$DIR$717129$$FDA-CTU$$24$YR$$F$N$62.1$KG$20240904$Y$HP$US$
242856551$24285655$1$I$20231207$20240815$20240905$20240905$PER$$US-ASTELLAS-2024-AER-001742$ASTELLAS$$69$YR$E$M$Y$$$20240905$$HP$US$US
242856561$24285656$1$I$$20240829$20240902$20240902$DIR$FDA-CDER-CTU-2024-60762$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242856571$24285657$1$I$$20240822$20240905$20240905$EXP$$US-UCBSA-2024043046$UCB$$$$$$Y$$$20240905$$MD$US$US
242856582$24285658$2$F$20240801$20240911$20240905$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-043203$AUROBINDO$$84$YR$$F$Y$$$20240921$$PH$FR$FR
242856591$24285659$1$I$$20240820$20240902$20240902$DIR$FDA-CDER-CTU-2024-60719$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242856601$24285660$1$I$$20240823$20240905$20240905$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-16906$IPSEN$$$$$F$Y$83.91$KG$20240905$$CN$US$US
242856631$24285663$1$I$$20240821$20240905$20240905$EXP$$US-SA-2023SA321069$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240905$$MD$US$US
242856641$24285664$1$I$$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-082235-2024$RECKITT BENCKISER$$58$YR$$F$Y$63.64$KG$20240905$$CN$US$US
242856653$24285665$3$F$$20240906$20240905$20240913$EXP$$CA-AstraZeneca-2024A201620$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$CA$
242856661$24285666$1$I$$20240829$20240905$20240905$EXP$$JP-BAYER-2024A124731$BAYER$$58$YR$A$M$Y$$$20240905$$MD$JP$JP
242856681$24285668$1$I$20240801$20240828$20240905$20240905$30DAY$$GR-PFIZER INC-PV202400113019$PFIZER$$13$YR$$M$Y$$$20240905$$CN$GR$GR
242856693$24285669$3$F$20240101$20240903$20240905$20240918$30DAY$$AR-PFIZER INC-202400249263$PFIZER$$4$YR$$M$Y$$$20240918$$HP$AR$AR
242856701$24285670$1$I$20240801$20240827$20240905$20240905$30DAY$$AR-PFIZER INC-202400245816$PFIZER$$9$YR$$M$Y$$$20240905$$HP$AR$AR
242856711$24285671$1$I$20240401$20240829$20240905$20240905$EXP$$AR-PFIZER INC-202400246718$PFIZER$$13$YR$$F$Y$$$20240905$$CN$AR$AR
242856722$24285672$2$F$20240827$20240910$20240905$20240916$30DAY$$GB-PFIZER INC-PV202400113011$PFIZER$$9$YR$$M$Y$$$20240916$$CN$GB$GB
242856751$24285675$1$I$20240101$20240902$20240905$20240905$EXP$$DE-ABBVIE-5905292$ABBVIE$$59$YR$$F$Y$$$20240905$$CN$DE$DE
242856762$24285676$2$F$$20240905$20240905$20240910$EXP$$US-ROCHE-10000070648$ROCHE$$62$YR$A$F$Y$$$20240910$$CN$US$US
242856771$24285677$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141102$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240905$$HP$US$US
242856781$24285678$1$I$20230401$20240902$20240905$20240905$EXP$ES-AEMPS-1498884$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-139590$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$63$KG$20240905$$PH$ES$ES
242856791$24285679$1$I$20240825$20240827$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136662$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240905$$CN$US$US
242856801$24285680$1$I$20240629$20240903$20240905$20240905$EXP$$GB-ABBVIE-5905461$ABBVIE$$82$YR$$F$Y$$$20240905$$PH$GB$GB
242856811$24285681$1$I$$20240827$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043264$AUROBINDO$$86$YR$$F$Y$$$20240905$$HP$FR$FR
242856821$24285682$1$I$$20240830$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024174748$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240905$$MD$CN$CN
242856832$24285683$2$F$$20240916$20240905$20240926$PER$$US-GSK-US2024107135$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$MD$US$US
242856841$24285684$1$I$20240827$20240827$20240905$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024106519$VIIV$$33$YR$$M$Y$$$20240905$$CN$US$US
242856851$24285685$1$I$$20240826$20240905$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109850$VIIV$$$$$$Y$$$20240905$$HP$US$US
242856861$24285686$1$I$$20240826$20240905$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109845$VIIV$$$$$$Y$$$20240905$$HP$US$US
242856871$24285687$1$I$$20240826$20240905$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109851$VIIV$$$$$$Y$$$20240905$$HP$US$US
242856881$24285688$1$I$$20240826$20240905$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109852$VIIV$$$$$$Y$$$20240905$$HP$US$US
242856891$24285689$1$I$$20240817$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2022-13923$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242856901$24285690$1$I$$20240904$20240905$20240905$PER$$US-HALEON-2195258$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
242856921$24285692$1$I$20240902$20240902$20240905$20240905$EXP$GB-MHRA-MED-202409020727012090-DHVRC$GB-MYLANLABS-2024M1080587$MYLAN$$54$YR$$F$Y$75$KG$20240905$$MD$GB$GB
242856931$24285693$1$I$20240802$20240902$20240905$20240905$EXP$FR-AFSSAPS-AVCF2024000551$FR-MYLANLABS-2024M1080616$MYLAN$$53$YR$$F$Y$$$20240905$$HP$FR$FR
242856941$24285694$1$I$20240819$20240902$20240905$20240905$EXP$GB-MHRA-MED-202409021357227910-DKPCY$GB-MYLANLABS-2024M1080772$MYLAN$$73$YR$$M$Y$$$20240905$$HP$GB$GB
242856951$24285695$1$I$$20240902$20240905$20240905$EXP$$GB-MYLANLABS-2024M1062159$MYLAN$$$$$M$Y$$$20240905$$MD$GB$GB
242856961$24285696$1$I$$20240902$20240905$20240905$EXP$$CA-MYLANLABS-2024M1040672$MYLAN$$$$$M$Y$105.7$KG$20240905$$HP$CA$CA
242856973$24285697$3$F$20240825$20240913$20240905$20240917$EXP$$NZ-MYLANLABS-2024M1080373$MYLAN$$76$YR$$F$Y$$$20240917$$HP$NZ$NZ
242856981$24285698$1$I$20240715$20240902$20240905$20240905$EXP$FR-AFSSAPS-AVCF2024000538$FR-MYLANLABS-2024M1080645$MYLAN$$21$YR$$F$Y$$$20240905$$MD$FR$FR
242856991$24285699$1$I$20240323$20240902$20240905$20240905$EXP$FR-AFSSAPS-AN2024001185$FR-MYLANLABS-2024M1080596$MYLAN$$45$YR$$M$Y$95$KG$20240905$$MD$FR$FR
242857001$24285700$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010092$APOTEX$$78$YR$$M$Y$$$20240905$$CN$CA$CA
242857011$24285701$1$I$20240101$20240903$20240905$20240905$EXP$$US-SANDOZ INC.-SDZ2024US077655$SANDOZ$$$$$M$Y$$$20240905$$CN$US$US
242857021$24285702$1$I$$20240902$20240905$20240905$EXP$GB-MHRA-TPP17487819C15244238YC1725026841314$GB-MYLANLABS-2024M1080855$MYLAN$$87$YR$$F$Y$77$KG$20240905$$MD$GB$GB
242857031$24285703$1$I$$20240827$20240905$20240905$EXP$$US-CELLTRION INC.-2024US021139$CELLTRION$Jones AA, Martin JS, Giangiacomo AL, Costakos DM.. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024;36$$$$$Y$$$20240905$$HP$US$US
242857041$24285704$1$I$$20240606$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006600$STRIDES$$$$$F$Y$$$20240905$$CN$US$US
242857051$24285705$1$I$20240824$20240829$20240905$20240905$EXP$$US-BAYER-2024A125328$BAYER$$79$YR$E$F$Y$$$20240905$$PH$US$US
242857061$24285706$1$I$$20240827$20240905$20240905$EXP$$CA-APOTEX-2024AP010025$APOTEX$$60$YR$$F$Y$$$20240905$$HP$CA$CA
242857072$24285707$2$F$20240911$20240911$20240905$20240917$EXP$$CA-TAKEDA-2024TUS088631$TAKEDA$$26$YR$$F$Y$$$20240917$$CN$CA$CA
242857081$24285708$1$I$20240811$20240816$20240905$20240905$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010405$STRIDES$$81$YR$$F$Y$55.782$KG$20240905$$CN$US$US
242857093$24285709$3$F$20240823$20240903$20240905$20240915$PER$$US-SA-2024SA253874$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240915$$MD$US$US
242857101$24285710$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA255547$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240905$$CN$US$US
242857111$24285711$1$I$$20240903$20240905$20240905$EXP$$CA-PFIZER INC-202400249962$PFIZER$$$$$$Y$$$20240905$$HP$CA$CA
242857121$24285712$1$I$$20240831$20240905$20240905$EXP$$BR-CHIESI-2024CHF05632$CHIESI$$$$N$M$Y$$$20240905$$MD$BR$BR
242857131$24285713$1$I$$20240816$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08288$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242857141$24285714$1$I$20240701$20240822$20240905$20240905$EXP$$US-UCBSA-2024043059$UCB$$45$YR$$F$Y$$$20240905$$HP$US$US
242857151$24285715$1$I$$20240902$20240905$20240905$EXP$$CA-PFIZER INC-202400248558$PFIZER$$32$YR$$M$Y$$$20240905$$HP$CA$CA
242857161$24285716$1$I$$20240826$20240905$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109855$VIIV$$$$$$Y$$$20240905$$HP$US$US
242857171$24285717$1$I$$20240826$20240905$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109853$VIIV$$$$$$Y$$$20240905$$HP$US$US
242857181$24285718$1$I$$20240829$20240905$20240905$EXP$$CZ-ROCHE-10000070930$ROCHE$$$$A$F$Y$$$20240905$$MD$CZ$CZ
242857191$24285719$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178406$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242857201$24285720$1$I$20240901$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175784$AMGEN$$81$YR$E$F$Y$$$20240905$$CN$US$US
242857212$24285721$2$F$20240701$20240920$20240905$20240927$EXP$$US-ASTELLAS-2024US021842$ASTELLAS$$77$YR$E$M$Y$$$20240927$$CN$US$US
242857221$24285722$1$I$$20240902$20240902$20240902$DIR$FDA-CDER-CTU-2024-60782$$FDA-CTU$$37$YR$$M$N$$$20240902$N$$US$
242857251$24285725$1$I$20240715$20240904$20240904$20240904$DIR$717149$$FDA-CTU$$42$YR$$F$N$49.5$KG$20240904$Y$CN$US$
242857281$24285728$1$I$20240814$20240827$20240902$20240902$DIR$FDA-CDER-CTU-2024-60812$$FDA-CTU$$72$YR$$F$N$$$20240827$N$HP$US$
242857291$24285729$1$I$$20240822$20240902$20240902$DIR$FDA-CDER-CTU-2024-60665$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242857311$24285731$1$I$$20240831$20240902$20240902$DIR$FDA-CDER-CTU-2024-60832$$FDA-CTU$$$$$F$N$$$20240831$N$HP$US$
242857321$24285732$1$I$$20240816$20240902$20240902$DIR$FDA-CDER-CTU-2024-60750$$FDA-CTU$$$$$F$N$$$20240816$N$HP$US$
242857331$24285733$1$I$20240229$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-087085-2024$RECKITT BENCKISER$$$$$F$Y$$$20240905$$CN$US$US
242857342$24285734$2$F$$20240906$20240905$20240918$EXP$$JP-SA-2024SA256799$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240918$$PH$JP$JP
242857351$24285735$1$I$$20240821$20240905$20240905$EXP$$US-SA-2024SA257070$SANOFI AVENTIS$$$$C$M$Y$$$20240905$$MD$US$US
242857361$24285736$1$I$$20240815$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08439$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242857371$24285737$1$I$20240101$20240828$20240905$20240905$EXP$$US-SA-2024SA256698$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240905$$MD$US$US
242857391$24285739$1$I$$20240827$20240905$20240905$EXP$$JP-TAKEDA-2024TUS088591$TAKEDA$Ishiai M, Nakamizo S, Murata T, Kabashima K. A case of acquired ichthyosis caused by ponatinib. Rinsho Derma. 2024;66(2):198-200$76$YR$$F$Y$$$20240905$$MD$JP$JP
242857401$24285740$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010084$APOTEX$$78$YR$$M$Y$$$20240905$$CN$CA$CA
242857411$24285741$1$I$$20240829$20240905$20240905$EXP$$US-ALKERMES INC.-ALK-2024-002296$ALKERMES$$$$$M$Y$$$20240905$$MD$US$US
242857431$24285743$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140339$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240905$$HP$US$US
242857441$24285744$1$I$20240901$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141034$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240905$$HP$US$US
242857451$24285745$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140371$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240905$$CN$US$US
242857462$24285746$2$F$20240601$20240905$20240905$20240910$EXP$$US-ALKERMES INC.-ALK-2024-002249$ALKERMES$$40$YR$$M$Y$$$20240910$$HP$US$US
242857471$24285747$1$I$$20240827$20240905$20240905$PER$$US-TAKEDA-2024TUS086771$TAKEDA$$$$$M$Y$$$20240905$$MD$US$US
242857481$24285748$1$I$$20240903$20240905$20240905$EXP$$US-BAYER-2024A127039$BAYER$$57$YR$A$M$Y$46.712$KG$20240905$$HP$US$US
242857501$24285750$1$I$20240724$20240830$20240905$20240905$EXP$$CO-AMGEN-COLSL2024168731$AMGEN$$25$YR$A$M$Y$$$20240905$$CN$CO$CO
242857511$24285751$1$I$$20240903$20240905$20240905$PER$$US-HALEON-2195108$Haleon PLC$$$$$F$Y$$$20240905$$CN$US$US
242857521$24285752$1$I$$20240829$20240905$20240905$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046715$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240905$$CN$BR$BR
242857531$24285753$1$I$$20240904$20240905$20240905$PER$$US-ROCHE-10000074203$ROCHE$$11$MON$I$M$Y$$$20240905$$CN$US$US
242857551$24285755$1$I$$20240903$20240905$20240905$EXP$$US-SA-2024SA257310$SANOFI AVENTIS$$$$A$M$Y$$$20240905$$CN$US$US
242857562$24285756$2$F$$20240830$20240905$20240906$PER$$US-MYLANLABS-2024M1080189$MYLAN$$$$$M$Y$$$20240906$$CN$US$US
242857581$24285758$1$I$$20240813$20240902$20240902$DIR$FDA-CDER-CTU-2024-60681$$FDA-CTU$$$$$F$N$$$20240813$N$HP$US$
242857591$24285759$1$I$$20240815$20240902$20240902$DIR$FDA-CDER-CTU-2024-60703$$FDA-CTU$$$$$M$N$$$20240815$N$HP$US$
242857601$24285760$1$I$$20240903$20240905$20240905$PER$$US-AstraZeneca-2024A200768$ASTRAZENECA$$$$$F$Y$$$20240905$$MD$US$
242857611$24285761$1$I$$20240903$20240905$20240905$EXP$$US-AstraZeneca-2024A200535$ASTRAZENECA$$$$$M$Y$$$20240905$$HP$US$
242857621$24285762$1$I$$20240903$20240905$20240905$EXP$$US-AstraZeneca-2024A200504$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
242857641$24285764$1$I$$20240826$20240905$20240905$EXP$$US-ACORDA-ACO_177856_2024$ACORDA$$$$$F$Y$$$20240905$$CN$US$US
242857651$24285765$1$I$$20240903$20240905$20240905$PER$$US-BAYER-2024A127405$BAYER$$$$$F$Y$$$20240905$$CN$US$US
242857661$24285766$1$I$$20240820$20240902$20240902$DIR$FDA-CDER-CTU-2024-60799$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242857671$24285767$1$I$$20240904$20240904$20240904$DIR$717156$$FDA-CTU$$76$YR$$F$N$58.5$KG$20240904$N$$US$
242857681$24285768$1$I$20240823$20240830$20240902$20240902$DIR$FDA-CDER-CTU-2024-60775$$FDA-CTU$$$$$M$N$$$20240830$N$HP$US$
242857691$24285769$1$I$$20240819$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08285$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242857701$24285770$1$I$$20240903$20240905$20240905$PER$$US-TAKEDA-2024TUS088510$TAKEDA$$47$YR$$F$Y$$$20240905$$MD$US$US
242857711$24285771$1$I$$20240828$20240905$20240905$EXP$$CN-ROCHE-10000069520$ROCHE$$69$YR$E$M$Y$$$20240905$$CN$CN$CN
242857721$24285772$1$I$$20240829$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024173221$AMGEN$Zhang S.; Li W.; Zheng C. et al.. Combined preoperative denosumab and adjuvant microwave ablation for high-risk giant cell tumor of bone: a retrospective study in a single center. Journal of orthopaedic surgery and research. 2024;19 (1):1-11$29$YR$A$M$Y$$$20240905$$HP$CN$CN
242857741$24285774$1$I$$20240830$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024174732$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240905$$MD$CN$CN
242857751$24285775$1$I$$20240830$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024174738$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240905$$MD$CN$CN
242857761$24285776$1$I$$20240829$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024173211$AMGEN$Zhang S.; Li W.; Zheng C. et al.. Combined preoperative denosumab and adjuvant microwave ablation for high-risk giant cell tumor of bone: a retrospective study in a single center. Journal of orthopaedic surgery and research. 2024;19 (1):1-11$24$YR$A$F$Y$$$20240905$$HP$CN$CN
242857771$24285777$1$I$$20240830$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024174739$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240905$$MD$CN$CN
242857781$24285778$1$I$$20240812$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08189$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242857791$24285779$1$I$$20240826$20240905$20240905$EXP$$ES-TEVA-VS-3238710$TEVA$Ayen-Rodriguez A, Gil-Villalba A, Ruiz-Villaverde R, Navarro-Trivino FJ. Methotrexate Toxicity in Dermatological Patients. Actas-Dermosifiliogr 2024; 115 (7): 741-743.; Ayen-Rodriguez A, Gil-Villalba A, Ruiz-Villaverde R, Navarro-Trivino FJ. Methotrexate Toxicity in Dermatological Patients. Actas-Dermosifiliogr 2024; 115 (7): 741-743.$86$YR$$M$Y$$$20240905$$HP$ES$ES
242857811$24285781$1$I$20240825$20240829$20240905$20240905$EXP$IT-MINISAL02-1000454$IT-RDY-SPO/ITA/24/0012643$DR REDDYS$$85$YR$E$M$Y$$$20240905$$MD$IT$IT
242857821$24285782$1$I$$20230518$20240905$20240905$EXP$$US-MYLANLABS-2024M1068957$MYLAN$$$$$F$Y$$$20240905$$CN$US$US
242857831$24285783$1$I$$20240830$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024174740$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240905$$MD$CN$CN
242857841$24285784$1$I$$20240819$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08261$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242857851$24285785$1$I$20240509$20240830$20240905$20240905$EXP$FR-AFSSAPS-AVMA2024000368$FR-INDIVIOR US-INDV-156274-2024$RECKITT BENCKISER$$$$$$Y$$$20240905$$MD$FR$FR
242857862$24285786$2$F$$20240826$20240905$20240905$EXP$$US-ROCHE-10000071367$ROCHE$$$$$M$Y$$$20240905$$CN$US$US
242857872$24285787$2$F$20240717$20240904$20240905$20240917$EXP$$US-NOVOPROD-1278241$NOVO NORDISK$$51$YR$$M$Y$$$20240918$$PH$US$US
242857881$24285788$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043374$AUROBINDO$$57$YR$$F$Y$$$20240905$$MD$CA$CA
242857891$24285789$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175945$AMGEN$$$$$F$Y$$$20240905$$MD$US$US
242857901$24285790$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176381$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242857911$24285791$1$I$$20240830$20240905$20240905$EXP$$TW-AMGEN-TWNSP2024175359$AMGEN$Wei J.; Shih P.; Lai C. et al.. Abatacept versus tumor necrosis factor inhibitors on mortality and medical utilizations in the treatment of rheumatoid arthritis associated interstitial lung disease: a large-scale real-world retrospective cohort study. Clinical and Experimental Medicine. 2024;24 (1):1-13$$$$$Y$$$20240905$$HP$TW$TW
242857921$24285792$1$I$$20240830$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024174746$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240905$$MD$CN$CN
242857951$24285795$1$I$20240703$20240904$20240905$20240905$PER$$US-JNJFOC-20240908534$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$US$US
242857961$24285796$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002542$ELI LILLY AND CO$$$$$$Y$$$20240905$$CN$US$US
242857971$24285797$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010103$APOTEX$$82$YR$$M$Y$$$20240905$$CN$CA$CA
242857981$24285798$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002718$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240905$$CN$US$US
242857991$24285799$1$I$20240901$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001716$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240905$$CN$US$US
242858001$24285800$1$I$$20240830$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024174760$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240905$$MD$CN$CN
242858012$24285801$2$F$$20240903$20240905$20240910$PER$$US-AMGEN-USASP2024175924$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
242858021$24285802$1$I$$20240829$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024175479$AMGEN$Fubin Q.; Na Z.; Shengda Z. et al.. Prognostic values of serum miR-140-5p and SFRP -5 for in-stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240905$$HP$CN$CN
242858031$24285803$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002560$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240905$$CN$US$US
242858041$24285804$1$I$$20240826$20240905$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024106231$VIIV$$$$$M$Y$$$20240905$$MD$US$US
242858051$24285805$1$I$20240818$20240826$20240905$20240905$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024106015$VIIV$$31$YR$$F$Y$$$20240905$$CN$US$US
242858061$24285806$1$I$20240801$20240823$20240905$20240905$PER$$US-SA-2024SA256925$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240905$$MD$US$US
242858071$24285807$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA255042$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240905$$MD$US$US
242858081$24285808$1$I$20240101$20240820$20240905$20240905$PER$$US-SA-2024SA256973$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240905$$MD$US$US
242858091$24285809$1$I$$20240827$20240905$20240905$EXP$$CA-AUROBINDO-AUR-APL-2024-043498$AUROBINDO$$76$YR$$F$Y$$$20240905$$MD$CA$CA
242858101$24285810$1$I$$20240814$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08267$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242858121$24285812$1$I$20240828$20240901$20240905$20240905$EXP$GB-MHRA-MED-202409011044173010-YRDTB$GB-PFIZER INC-202400247630$PFIZER$$54$YR$$F$Y$65$KG$20240905$$CN$GB$GB
242858141$24285814$1$I$$20240819$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08497$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242858151$24285815$1$I$20240815$20240829$20240905$20240905$EXP$$US-ABBVIE-5902102$ABBVIE$$74$YR$$M$Y$$$20240905$$CN$US$US
242858161$24285816$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010115$APOTEX$$64$YR$$M$Y$$$20240905$$CN$CA$CA
242858171$24285817$1$I$$20240904$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049563$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240905$$CN$US$US
242858181$24285818$1$I$$20240827$20240905$20240905$EXP$$JP-ASTELLAS-2024-AER-004026$ASTELLAS$Aoki T, Furuya R, Fukasawa M, Nozawa M, Takihana Y, Sudoh M, et al. Bladder cancer with urinary diversion by a sigmoid colon conduit after transverse colon stoma. IJU Case Reports. 2024;7(1): 46-9. doi:10.1002/iju5.12665.$70$YR$E$M$Y$$$20240905$$MD$JP$JP
242858202$24285820$2$F$$20240917$20240905$20240925$EXP$$US-ROCHE-10000054261$ROCHE$$$$A$F$Y$$$20240925$$CN$US$US
242858211$24285821$1$I$20231021$20240902$20240905$20240905$EXP$$GB-BAYER-2024A120360$BAYER$$27$YR$A$M$Y$190$KG$20240905$$HP$GB$GB
242858221$24285822$1$I$20240101$20240829$20240905$20240905$EXP$$US-ABBVIE-5901961$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242858231$24285823$1$I$$20240816$20240905$20240905$PER$$US-JNJFOC-20240849162$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242858241$24285824$1$I$$20240827$20240905$20240905$EXP$$US-CELLTRION INC.-2024US021141$CELLTRION$Jones AA, Martin JS, Giangiacomo AL, Costakos DM. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Opthalmology Case Reports. 2024;36:102131$$$$$Y$$$20240905$$HP$US$US
242858291$24285829$1$I$20240902$20240904$20240904$20240904$DIR$717107$$FDA-CTU$$65$YR$$F$N$54.9$KG$20240904$N$CN$US$
242858331$24285833$1$I$$20240830$20240902$20240902$DIR$FDA-CDER-CTU-2024-60764$$FDA-CTU$$$$$F$N$$$20240830$N$HP$US$
242858341$24285834$1$I$$20240819$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08481$LUPIN$$$$$$Y$$$20240905$$PH$US$US
242858351$24285835$1$I$$20240823$20240905$20240905$EXP$$US-UCBSA-2024043343$UCB$$$$$$Y$$$20240905$$CN$US$US
242858361$24285836$1$I$$20240823$20240905$20240905$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07047$HIKMA$$$$$F$Y$$$20240905$$CN$US$US
242858371$24285837$1$I$20240101$20240823$20240905$20240905$PER$$US-SA-2024SA256880$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240905$$HP$US$US
242858381$24285838$1$I$20240801$20240827$20240905$20240905$PER$$US-SA-2024SA254104$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240905$$CN$US$US
242858392$24285839$2$F$$20240906$20240905$20240916$PER$$US-SA-2024SA254175$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240916$$PH$US$US
242858422$24285842$2$F$$20240905$20240905$20240909$30DAY$$US-PFIZER INC-PV202400044535$PFIZER$$$$$$Y$$$20240909$$HP$US$US
242858532$24285853$2$F$$20240903$20240905$20240906$30DAY$$US-PFIZER INC-PV202400044365$PFIZER$$$$$$Y$$$20240906$$HP$US$US
242858572$24285857$2$F$20240101$20240903$20240905$20240906$30DAY$$US-PFIZER INC-202400247030$PFIZER$$15$YR$$M$Y$$$20240906$$CN$US$US
242858582$24285858$2$F$$20240829$20240905$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR108623$VIIV$$$$$M$Y$$$20240906$$HP$US$US
242858601$24285860$1$I$20240101$20240903$20240905$20240905$EXP$$US-ABBVIE-5906063$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242858611$24285861$1$I$20240213$20240829$20240905$20240905$EXP$$JP-ROCHE-10000072644$ROCHE$$3$MON$I$F$Y$$$20240905$$PH$JP$JP
242858622$24285862$2$F$$20240909$20240905$20240912$EXP$$IT-ROCHE-10000068580$ROCHE$Pilotto C, Coassin E, Borsatti E, Tuniz F, Pegolo E, D^Agostini S, et al. Using 18feet-PET/CT scan to differentiate radionecrosis from recurrence/new tumors: The case of a CNS Sarcoma.. Neuro-Oncology. 2024-Jun;26: doi:10.1093/neuonc/NOAE064.363.$5$YR$C$F$Y$$$20240912$$HP$IT$IT
242858631$24285863$1$I$$20240829$20240905$20240905$EXP$$ES-AMGEN-ESPSP2024174664$AMGEN$Martinez-sanchez N.; Alvarez-troncoso J.; Robles-marhuenda A. et al.. Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases. Journal of Autoimmunity. 2024;148:1-6$$$$F$Y$$$20240905$$MD$ES$ES
242858642$24285864$2$F$$20240904$20240905$20240915$EXP$$NL-AUROBINDO-AUR-APL-2024-043236$AUROBINDO$$74$YR$$M$Y$79.5$KG$20240915$$CN$NL$NL
242858652$24285865$2$F$$20240906$20240905$20240910$EXP$$US-ROCHE-10000071343$ROCHE$$48$YR$A$M$Y$$$20240910$$CN$US$US
242858671$24285867$1$I$$20240903$20240905$20240905$EXP$$US-ABBVIE-5905784$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242858691$24285869$1$I$20240818$20240904$20240905$20240905$EXP$$PH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049463$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240905$$CN$PH$PH
242858701$24285870$1$I$$20240826$20240905$20240905$EXP$$US-CHIESI-2024CHF05485$CHIESI$$$$N$M$Y$$$20240905$$MD$US$US
242858711$24285871$1$I$20230101$20240813$20240905$20240905$EXP$$DE-ABBVIE-5875082$ABBVIE$$$$E$F$Y$$$20240905$$CN$DE$DE
242858721$24285872$1$I$20240501$20240827$20240905$20240905$EXP$$GB-AUROBINDO-AUR-APL-2024-043385$AUROBINDO$$55$YR$$M$Y$$$20240905$$MD$GB$GB
242858741$24285874$1$I$20220101$20240902$20240905$20240905$EXP$$AT-ABBVIE-5905420$ABBVIE$$63$YR$$F$Y$$$20240905$$CN$AT$AT
242858751$24285875$1$I$20240101$20240901$20240905$20240905$EXP$$EG-ABBVIE-5904612$ABBVIE$$38$YR$$M$Y$$$20240905$$CN$EG$EG
242858761$24285876$1$I$20240101$20240826$20240905$20240905$PER$$US-ABBVIE-5903559$ABBVIE$$$$$M$Y$$$20240905$$MD$US$US
242858771$24285877$1$I$20240701$20240902$20240905$20240905$EXP$$CN-BAYER-2024A126533$BAYER$$57$YR$A$M$Y$$$20240905$$HP$CN$CN
242858782$24285878$2$F$20240601$20240916$20240905$20240917$PER$$US-AMGEN-USASP2024176886$AMGEN$$67$YR$E$F$Y$$$20240917$$CN$US$US
242858791$24285879$1$I$$20240830$20240905$20240905$PER$$US-AMGEN-USASP2024174853$AMGEN$$$$$M$Y$$$20240905$$CN$US$US
242858804$24285880$4$F$$20240911$20240905$20240919$PER$$US-AMGEN-USASP2024177011$AMGEN$$$$$M$Y$$$20240919$$HP$US$US
242858811$24285881$1$I$$20240826$20240905$20240905$EXP$$ES-TEVA-VS-3238711$TEVA$Ayen-Rodriguez A, Gil-Villalba A, Ruiz-Villaverde R, Navarro-Trivino FJ. Methotrexate Toxicity in Dermatological Patients. Actas-Dermosifiliogr 2024; 115 (7): 741-743.; Ayen-Rodriguez A, Gil-Villalba A, Ruiz-Villaverde R, Navarro-Trivino FJ. Methotrexate Toxicity in Dermatological Patients. Actas-Dermosifiliogr 2024; 115 (7): 741-743.$69$YR$$M$Y$$$20240905$$HP$ES$ES
242858822$24285882$2$F$$20240910$20240905$20240920$EXP$$DE-TEVA-VS-3238295$TEVA$Ritter M, Yomade O, Holtz B-O, Deinhardt-Emmer S, McLean AL, Hartinger S, et al. Chronic hepatitis E virus-induced spinal cord atrophy in a patient with chronic lymphatic leukemia: a case report and interdisciplinary management proposal. Front-Immunol 2024; 15 1-8.; Ritter M, Yomade O, Holtz B-O, Deinhardt-Emmer S, McLean AL, Hartinger S, et al. Chronic hepatitis E virus-induced spinal cord atrophy in a patient with chronic lymphatic leukemia: a case report and interdisciplinary management pr...$61$YR$$M$Y$$$20240920$$HP$DE$DE
242858831$24285883$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA256141$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240905$$MD$US$US
242858841$24285884$1$I$$20240902$20240905$20240905$EXP$$NL-ORGANON-O2409NLD000140$ORGANON$$$$$M$Y$$$20240905$$HP$NL$NL
242858851$24285885$1$I$20240829$20240829$20240905$20240905$PER$$US-SA-2024SA256815$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240905$$CN$US$US
242858861$24285886$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141101$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240905$$HP$US$US
242858871$24285887$1$I$20240824$20240826$20240905$20240905$EXP$$IL-009507513-2408ISR009939$MERCK$$$$$F$Y$$$20240905$$MD$IL$IL
242858881$24285888$1$I$20240801$20240828$20240905$20240905$EXP$$CA-CELLTRION INC.-2024CA021117$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
242858892$24285889$2$F$$20240905$20240905$20240911$EXP$$NL-AMGEN-NLDSP2024175069$AMGEN$$62$YR$A$M$Y$97$KG$20240911$$CN$NL$NL
242858911$24285891$1$I$$20240819$20240905$20240905$PER$$US-TEVA-VS-3235987$TEVA$$$$$$Y$$$20240905$$HP$US$US
242858921$24285892$1$I$20240802$20240827$20240905$20240905$EXP$$FR-AUROBINDO-AUR-APL-2024-043303$AUROBINDO$$78$YR$$F$Y$$$20240905$$MD$FR$FR
242858931$24285893$1$I$20240901$20240904$20240904$20240904$DIR$717197$$FDA-CTU$$73$YR$$F$N$97.2$KG$20240904$N$MD$US$
242858942$24285894$2$F$20240213$20240926$20240905$20240927$EXP$$BW-GILEAD-2024-0686230$GILEAD$$22$YR$A$F$Y$$$20240927$$HP$BW$BW
242858952$24285895$2$F$$20240912$20240905$20240920$EXP$$CA-TEVA-VS-3237582$TEVA$$62$YR$$M$Y$$$20240920$$HP$CA$CA
242858961$24285896$1$I$20240825$20240826$20240905$20240905$EXP$$US-ETON PHARMACEUTICALS, INC-2024ETO000213$ETON PHARMACEUTICALS$$$$$$Y$$$20240904$$CN$US$US
242858971$24285897$1$I$20190918$20221120$20240905$20240905$EXP$$NVSC2022HU304839$NOVARTIS$$$$$$Y$$$20240905$$MD$HU$HU
242858981$24285898$1$I$$20240823$20240905$20240905$EXP$$US-UCBSA-2024043500$UCB$$$$$F$Y$104.26$KG$20240905$$HP$US$US
242858991$24285899$1$I$20240501$20240827$20240905$20240905$EXP$GB-MHRA-MED-202408271819015540-YDQLC$GB-TORRENT-00037756$TORRENT$$86$YR$E$F$Y$66$KG$20240905$$CN$GB$GB
242859001$24285900$1$I$20210101$20240828$20240905$20240905$EXP$$DE-CELLTRION INC.-2024DE020892$CELLTRION$$$$$$Y$$$20240905$$MD$DE$DE
242859011$24285901$1$I$20220101$20240827$20240905$20240905$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08077$HIKMA$Mann I, Morado-Aramburo O, Hasbun R.. Mann I, Morado-Aramburo O, Hasbun R. Emerging shadows: HHV-8-associated encephalitis unveiled in a solid organ transplant recipient. Transplant Infectious Disease.. 2024;26(4):/$73$YR$$F$Y$$$20240905$$MD$US$US
242859021$24285902$1$I$$20240827$20240905$20240905$EXP$DE-EMBRYOTOX-202307169$DE-TORRENT-00027257$TORRENT$$$$$$Y$$$20240905$$MD$DE$DE
242859031$24285903$1$I$$20240828$20240905$20240905$EXP$GB-MHRA-MED-202408281425375760-GHMRZ$GB-TORRENT-00037771$TORRENT$$79$YR$E$F$Y$$$20240905$$CN$GB$GB
242859041$24285904$1$I$20240301$20240827$20240905$20240905$EXP$FR-AFSSAPS-PA2024001297$FR-ROCHE-10000067000$ROCHE$$40$YR$A$F$Y$$$20240905$$PH$FR$FR
242859051$24285905$1$I$20120403$20240828$20240905$20240905$EXP$GB-MHRA-MED-202407241045585120-DRSWJ$GB-TORRENT-00037757$TORRENT$$$$C$M$Y$$$20240905$$MD$GB$GB
242859061$24285906$1$I$$20240819$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08496$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242859071$24285907$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010079$APOTEX$$51$YR$$F$Y$$$20240905$$CN$CA$CA
242859081$24285908$1$I$$20240830$20240905$20240905$EXP$$BR-GENMAB-2024-03191$GENMAB$$83$YR$$M$Y$$$20240905$$MD$BR$BR
242859091$24285909$1$I$20240828$20240903$20240905$20240905$PER$$US-ROCHE-10000073055$ROCHE$$51$YR$A$F$Y$$$20240905$$HP$US$US
242859101$24285910$1$I$$20230623$20240905$20240905$EXP$$NVSC2023GR281034$NOVARTIS$$$$$$Y$$$20240905$$MD$GR$GR
242859111$24285911$1$I$$20230703$20240905$20240905$EXP$$NVSC2023DE281033$NOVARTIS$$$$$$Y$$$20240905$$MD$DE$DE
242859121$24285912$1$I$20200803$20240821$20240905$20240905$EXP$$FR-SERVIER-S21010607$SERVIER$$$$$$Y$$$20240905$$MD$FR$FR
242859142$24285914$2$F$$20240903$20240905$20240909$EXP$$AU-PFIZER INC-202400248961$PFIZER$Skinner, T.. Budesonide Orodispersible Tablet for the Treatment of Refractory Esophageal Lichen Planus. ACG case reports journal. 2024;11(8):10.14309/crj.0000000000001460$61$YR$$F$Y$52$KG$20240909$$MD$AU$AU
242859151$24285915$1$I$$20240902$20240905$20240905$EXP$$JP-PFIZER INC-PV202400115986$PFIZER$Miura, R.. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine (United States). 2024;103(34):10.1097/MD.0000000000039289$$$E$$Y$$$20240905$$MD$JP$JP
242859163$24285916$3$F$$20240917$20240905$20240920$EXP$$US-PFIZER INC-202400249312$PFIZER$Toy, B.. A case of herpes simplex virus and cytomegalovirus retinitis coinfection. Retinal Cases and Brief Reports. 2024;18(4):451-4$64$YR$$M$Y$$$20240920$$MD$US$US
242859182$24285918$2$F$$20240904$20240905$20240909$EXP$$JP-PFIZER INC-202400248270$PFIZER$Kinoshita, M.. Efgartigimod combined with steroids as a fast-acting therapy for myasthenic crisis: a case report. BMC Neurology. 2024;24 (1):292$70$YR$$F$Y$$$20240909$$MD$JP$JP
242859212$24285921$2$F$20240824$20240918$20240905$20240926$EXP$$PY-ROCHE-10000073927$ROCHE$$2$YR$C$F$Y$11.5$KG$20240926$$CN$PY$PY
242859221$24285922$1$I$$20240902$20240905$20240905$EXP$PL-URPL-2-173-2020$PL-AMGEN-POLSP2024174999$AMGEN$$$$$F$Y$$$20240905$$CN$PL$PL
242859231$24285923$1$I$$20240902$20240905$20240905$EXP$$CA-BAYER-2024A126973$BAYER$$46$YR$A$F$Y$132$KG$20240905$$HP$CA$CA
242859241$24285924$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010123$APOTEX$$82$YR$$F$Y$$$20240905$$CN$CA$CA
242859261$24285926$1$I$$20240814$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08440$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242859271$24285927$1$I$$20240819$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08260$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242859281$24285928$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175591$AMGEN$$$$$M$Y$$$20240905$$CN$US$US
242859292$24285929$2$F$$20240912$20240905$20240920$EXP$$JP-AMGEN-JPNSP2024173900$AMGEN$$$$E$M$Y$$$20240920$$MD$JP$JP
242859302$24285930$2$F$20221113$20240909$20240905$20240913$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409001010$ELI LILLY AND CO$$63$YR$A$F$Y$53$KG$20240913$$CN$DE$DE
242859311$24285931$1$I$20240801$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002535$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240905$$CN$US$US
242859321$24285932$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001274$ELI LILLY AND CO$$$$$$Y$$$20240905$$CN$US$US
242859341$24285934$1$I$20240904$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002877$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240905$$CN$US$US
242859351$24285935$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002543$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240905$$CN$US$US
242859361$24285936$1$I$20240903$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002528$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240905$$CN$US$US
242859371$24285937$1$I$$20240828$20240905$20240905$EXP$$US-JNJFOC-20240880133$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242859401$24285940$1$I$$20240822$20240905$20240905$30DAY$$NL-PFIZER INC-202400242623$PFIZER$$$$$$Y$$$20240905$$HP$NL$NL
242859411$24285941$1$I$$20240820$20240902$20240902$DIR$FDA-CDER-CTU-2024-60725$$FDA-CTU$$$$$F$N$$$20240820$N$HP$US$
242859421$24285942$1$I$$20240828$20240905$20240905$30DAY$$US-PFIZER INC-202400245717$PFIZER$$34$YR$$F$Y$$$20240905$$CN$US$US
242859431$24285943$1$I$20240724$20240904$20240904$20240904$DIR$717161$$FDA-CTU$$62$YR$$F$N$62.55$KG$20240904$N$CN$US$
242859441$24285944$1$I$20240520$20240820$20240902$20240902$DIR$FDA-CDER-CTU-2024-60783$$FDA-CTU$$33$YR$$F$N$$$20240820$N$HP$US$
242859461$24285946$1$I$$20240904$20240905$20240905$EXP$GB-MHRA-MIDB-9d7a6712-ee30-48c1-8355-7e996318c913$GB-PFIZER INC-202400249827$PFIZER$$54$YR$$$Y$$$20240905$$PH$GB$GB
242859471$24285947$1$I$$20240901$20240902$20240902$DIR$FDA-CDER-CTU-2024-60693$$FDA-CTU$$$$$M$N$$$20240901$N$HP$US$
242859481$24285948$1$I$20240819$20240904$20240904$20240904$DIR$717117$$FDA-CTU$$64$YR$$F$N$81$KG$20240904$N$$US$
242859501$24285950$1$I$20231001$20240829$20240905$20240905$30DAY$$CA-PFIZER INC-202300306614$PFIZER$$11$YR$$F$Y$$$20240905$$MD$CA$CA
242859521$24285952$1$I$20240818$20240829$20240905$20240905$30DAY$$US-PFIZER INC-202400247288$PFIZER$$31$YR$$F$Y$$$20240905$$CN$US$US
242859531$24285953$1$I$$20240826$20240902$20240902$DIR$FDA-CDER-CTU-2024-60712$$FDA-CTU$$$$$F$N$$$20240826$N$HP$US$
242859541$24285954$1$I$$20240819$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08319$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242859552$24285955$2$F$20240901$20240905$20240905$20240906$PER$$US-AMGEN-USASP2024177081$AMGEN$$85$YR$E$F$Y$$$20240906$$CN$US$US
242859561$24285956$1$I$$20240830$20240905$20240905$EXP$$JP-AMGEN-JPNSP2024174881$AMGEN$$$$E$F$Y$$$20240905$$MD$JP$JP
242859591$24285959$1$I$$20240903$20240905$20240905$EXP$NL-LRB-01000003$NL-PFIZER INC-202400248858$PFIZER$$17$YR$$F$Y$73$KG$20240905$$CN$NL$NL
242859601$24285960$1$I$$20240829$20240905$20240905$30DAY$$GB-PFIZER INC-PV202400113736$PFIZER$$$$$$Y$$$20240905$$HP$GB$GB
242859621$24285962$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010094$APOTEX$$62$YR$$M$Y$$$20240905$$CN$CA$CA
242859631$24285963$1$I$$20240828$20240905$20240905$30DAY$$US-GSK-US2024AMR108074$GLAXOSMITHKLINE$$$$$M$Y$$$20240905$$CN$US$US
242859641$24285964$1$I$20230613$20240829$20240905$20240905$EXP$FR-AFSSAPS-RE2024000277$FR-CELLTRION INC.-2024FR020924$CELLTRION$$$$$$Y$$$20240905$$MD$FR$FR
242859651$24285965$1$I$20240822$20240831$20240905$20240905$EXP$$CN-SANDOZ INC.-SDZ2024CN077772$SANDOZ$$39$YR$$F$Y$$$20240905$$HP$CN$CN
242859672$24285967$2$F$$20240917$20240905$20240919$EXP$$US-BAYER-2024A126996$BAYER$$58$YR$A$F$Y$$$20240919$$MD$US$US
242859681$24285968$1$I$20240901$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176214$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242859692$24285969$2$F$20240801$20240919$20240905$20240926$EXP$$JP-AMGEN-JPNSP2024172341$AMGEN$$$$$F$Y$$$20240926$$MD$JP$JP
242859701$24285970$1$I$$20240830$20240905$20240905$EXP$$US-009507513-2409USA000659$MERCK$$73$YR$$M$Y$$$20240905$$CN$US$US
242859711$24285971$1$I$$20240828$20240905$20240905$EXP$$IN-AstraZeneca-2024A197485$ASTRAZENECA$$59$YR$$M$Y$67$KG$20240905$$CN$IN$
242859721$24285972$1$I$20240903$20240903$20240905$20240905$EXP$$US-BAYER-2024A126464$BAYER$$69$YR$E$F$Y$$$20240905$$CN$US$US
242859731$24285973$1$I$20230501$20240813$20240905$20240905$PER$$US-009507513-2408USA004708$MERCK$$76$YR$$F$Y$$$20240905$$CN$US$US
242859742$24285974$2$F$20240901$20240919$20240905$20240925$EXP$$PY-ROCHE-10000074051$ROCHE$$12$YR$T$M$Y$41$KG$20240925$$CN$PY$PY
242859751$24285975$1$I$$20240819$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08500$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242859761$24285976$1$I$$20240828$20240905$20240905$EXP$$US-AMGEN-USASP2024172554$AMGEN$$$$$F$Y$$$20240905$$HP$US$US
242859771$24285977$1$I$20240801$20240828$20240905$20240905$EXP$$CA-CELLTRION INC.-2024CA021119$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
242859781$24285978$1$I$$20240902$20240905$20240905$EXP$$AU-INDIVIOR US-INDV-156306-2024$RECKITT BENCKISER$$$$$$Y$$$20240905$$HP$AU$AU
242859791$24285979$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178597$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242859801$24285980$1$I$$20240830$20240905$20240905$EXP$$US-SANDOZ INC.-SDZ2024US077463$SANDOZ$$$$$$Y$$$20240905$$CN$US$US
242859811$24285981$1$I$20240121$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-083420-2024$RECKITT BENCKISER$$$$$M$Y$$$20240905$$CN$US$US
242859821$24285982$1$I$$20240830$20240905$20240905$EXP$$US-PFIZER INC-PV202400115295$PFIZER$Popat, D.. MM-657 Parsonage Turner Syndrome Complicating Multiple Myeloma Therapy: ^Nothing to Shrug your Shoulders at^. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(Suppl 1):S578$66$YR$$M$Y$$$20240905$$MD$US$US
242859832$24285983$2$F$$20240911$20240905$20240913$EXP$$GB-PFIZER INC-202400248688$PFIZER$Saldana Chaparro, R.. A case of rhabdomyolysis. CPD Clinical Biochemistry. 2003;5(3):95-96$49$YR$$F$Y$$$20240913$$HP$GB$GB
242859841$24285984$1$I$$20240830$20240905$20240905$EXP$$US-PFIZER INC-202400249072$PFIZER$Popat, D.. MM-657 Parsonage Turner Syndrome Complicating Multiple Myeloma Therapy: ^Nothing to Shrug your Shoulders at^. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(Suppl 1):S578$$$$$Y$$$20240905$$MD$US$US
242859851$24285985$1$I$$20240902$20240905$20240905$EXP$$GB-PFIZER INC-A113369$PFIZER$Harley, C.. CARE OF THE CRITICALLY III. 2001;17 NO 2:65  -  66$57$YR$$M$Y$$$20240905$$HP$GB$GB
242859861$24285986$1$I$$20240902$20240905$20240905$EXP$$US-PFIZER INC-PV202400115450$PFIZER$Soliman, Y.. Apparent local anesthetic systemic toxicity following activation of an epidural catheter for cesarean delivery: diagnosis and management of an uncommon obstetric anesthesia complication. Baylor University Medical Center Proceedings. 2024;37(5):874-876$25$YR$$F$Y$92$KG$20240905$$HP$US$US
242859872$24285987$2$F$$20240903$20240905$20240909$EXP$$JP-PFIZER INC-202400248837$PFIZER$Imataki, O.. Bifidobacterium Bloodstream Infection in a Lymphoma Patient Undergoing Chemotherapy: A Case Study and Implications for Probiotic Use. American journal of case reports. 2024;25:e944687-1-e944687-3$75$YR$$F$Y$$$20240909$$MD$JP$JP
242859881$24285988$1$I$$20240903$20240905$20240905$PER$$US-ABBVIE-5906079$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242859891$24285989$1$I$$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141128$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240905$$CN$US$US
242859902$24285990$2$F$$20240830$20240905$20240906$EXP$$BR-JNJFOC-20240882736$JOHNSON AND JOHNSON$$12$YR$T$F$Y$43$KG$20240906$$CN$BR$BR
242859932$24285993$2$F$$20240918$20240905$20240920$30DAY$$US-PFIZER INC-PV202400044355$PFIZER$$$$$$Y$$$20240920$$CN$US$US
242859942$24285994$2$F$$20240915$20240905$20240925$EXP$$IL-ETON PHARMACEUTICALS, INC-2024ETO000219$ETON PHARMACEUTICALS$$7$WK$$F$Y$7$KG$20240925$$MD$IL$IL
242859951$24285995$1$I$$20240819$20240905$20240905$PER$$US-AstraZeneca-2024A188059$ASTRAZENECA$$$$$$Y$$$20240905$$HP$US$
242859961$24285996$1$I$20240831$20240904$20240904$20240904$DIR$717203$$FDA-CTU$$69$YR$$F$N$77.4$KG$20240904$N$CN$US$
242859971$24285997$1$I$20240101$20240902$20240905$20240905$EXP$$JP-AstraZeneca-2024A199961$ASTRAZENECA$$76$YR$$M$Y$$$20240905$$MD$JP$
242859981$24285998$1$I$$20240903$20240905$20240905$EXP$$JP-ROCHE-10000074468$ROCHE$$8$DEC$E$F$Y$$$20240905$$PH$JP$JP
242859991$24285999$1$I$20240201$20240821$20240905$20240905$EXP$$US-SA-2024SA256915$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240905$$MD$US$US
242860001$24286000$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175975$AMGEN$$$$$$Y$$$20240905$$MD$US$US
242860012$24286001$2$F$$20240902$20240905$20240910$EXP$$CA-AstraZeneca-2024A201007$ASTRAZENECA$$69$YR$$M$Y$$$20240910$$CN$CA$
242860022$24286002$2$F$20240829$20240905$20240905$20240908$PER$$US-AMGEN-USASP2024177123$AMGEN$$66$YR$E$M$Y$$$20240908$$CN$US$US
242860031$24286003$1$I$$20240902$20240905$20240905$EXP$$BG-ABBVIE-5905216$ABBVIE$$56$YR$$F$Y$$$20240905$$CN$BG$BG
242860041$24286004$1$I$20240101$20240829$20240905$20240905$EXP$$US-ABBVIE-5903322$ABBVIE$$59$YR$$F$Y$$$20240905$$HP$US$US
242860051$24286005$1$I$20240814$20240902$20240905$20240905$EXP$$FR-AstraZeneca-2024A200628$ASTRAZENECA$$57$YR$$M$Y$80$KG$20240905$$MD$FR$
242860061$24286006$1$I$$20240904$20240902$20240902$DIR$FDA-CDER-CTU-2024-60699$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242860071$24286007$1$I$20240801$20240903$20240905$20240905$EXP$$IN-PFIZER INC-PV202400105902$PFIZER$$53$YR$$M$Y$$$20240905$$CN$IN$IN
242860081$24286008$1$I$20240809$20240830$20240905$20240905$EXP$$CN-PFIZER INC-PV202400114156$PFIZER$$43$YR$$F$Y$$$20240905$$HP$CN$CN
242860091$24286009$1$I$$20240904$20240904$20240904$DIR$717139$$FDA-CTU$$$$$UNK$N$$$20240904$$CN$US$
242860101$24286010$1$I$$20240829$20240902$20240902$DIR$FDA-CDER-CTU-2024-60767$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242860111$24286011$1$I$$20240902$20240905$20240905$EXP$$CA-PFIZER INC-202400248595$PFIZER$$69$YR$$M$Y$78$KG$20240905$$HP$CA$CA
242860122$24286012$2$F$$20240904$20240905$20240910$EXP$$NL-PFIZER INC-202400248171$PFIZER$$$$$M$Y$$$20240910$$HP$NL$NL
242860132$24286013$2$F$20240823$20240911$20240905$20240913$EXP$$GB-PFIZER INC-202400249165$PFIZER$$51$YR$$F$Y$48$KG$20240913$$PH$GB$GB
242860141$24286014$1$I$$20240904$20240904$20240904$DIR$717141$$FDA-CTU$$$$$UNK$N$$$20240904$$CN$US$
242860151$24286015$1$I$20240826$20240827$20240902$20240902$DIR$FDA-CDER-CTU-2024-60658$$FDA-CTU$$44$YR$$F$N$74.84$KG$20240827$Y$CN$US$
242860162$24286016$2$F$20220101$20240904$20240905$20240912$EXP$$IT-PFIZER INC-202400249417$PFIZER$Caorsi, R.. Long-term efficacy of MAS825, a bispecific anti-IL1? and IL-18 monoclonal antibody, in two patients with sJIA and recurrent episodes of MAS.. Rheumatology. 2024;10.1093/rheumatology/keae440$20$YR$$M$Y$$$20240912$$MD$IT$IT
242860172$24286017$2$F$20240829$20240906$20240905$20240910$EXP$$CN-PFIZER INC-PV202400115000$PFIZER$$81$YR$$M$Y$50$KG$20240910$$HP$CN$CN
242860181$24286018$1$I$20240806$20240902$20240905$20240905$EXP$$CN-PFIZER INC-PV202400115027$PFIZER$$68$YR$$F$Y$51$KG$20240905$$HP$CN$CN
242860191$24286019$1$I$$20240903$20240905$20240905$EXP$$CA-PFIZER INC-202400249187$PFIZER$$62$YR$$M$Y$130$KG$20240905$$HP$CA$CA
242860202$24286020$2$F$$20240909$20240905$20240911$EXP$$ES-PFIZER INC-PV202400115205$PFIZER$Yaringano, J.. Sacituzumab govitecan response in extensive leptomeningeal carcinomatosis from triplenegative breast cancer: a case report. Frontiers in Oncology. 2024;14:10.3389/fonc.2024.1378248$62$YR$$F$Y$$$20240911$$HP$ES$ES
242860211$24286021$1$I$$20240902$20240905$20240905$EXP$$RO-PFIZER INC-PV202400115362$PFIZER$Dulamea, O.. Exploring the diverse phenotypes of anti-GAD 65 encephalitis, diagnosis and treatment challenges. Romanian Journal of Neurology. 2024;23(2):111-118$71$YR$$F$Y$$$20240905$$HP$RO$RO
242860221$24286022$1$I$20240821$20240903$20240905$20240905$EXP$$CN-PFIZER INC-PV202400115579$PFIZER$$16$YR$$M$Y$80.2$KG$20240905$$HP$CN$CN
242860231$24286023$1$I$20211124$20240902$20240905$20240905$EXP$$BE-PFIZER INC-202400248080$PFIZER$$78$YR$$M$Y$76.9$KG$20240905$$MD$BE$BE
242860241$24286024$1$I$$20240903$20240905$20240905$PER$$US-ABBVIE-5906042$ABBVIE$$$$$$Y$$$20240905$$HP$US$US
242860251$24286025$1$I$$20240828$20240905$20240905$EXP$$CA-APOTEX-2024AP010113$APOTEX$$64$YR$$F$Y$$$20240905$$CN$CA$CA
242860261$24286026$1$I$20240801$20240826$20240905$20240905$30DAY$$US-GSK-US2024106120$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240905$$CN$US$US
242860271$24286027$1$I$$20240829$20240905$20240905$EXP$$US-AMGEN-USASP2024174162$AMGEN$$54$YR$A$$Y$$$20240905$$CN$US$US
242860281$24286028$1$I$20240801$20240826$20240905$20240905$EXP$$US-UCBSA-2024044616$UCB$$53$YR$$M$Y$$$20240905$$HP$US$US
242860291$24286029$1$I$20240526$20240823$20240905$20240905$EXP$$GB-UCBSA-2024044082$UCB$$45$YR$$F$Y$94.4$KG$20240905$$HP$GB$GB
242860301$24286030$1$I$$20240826$20240905$20240905$PER$$US-MYLANLABS-2024M1079466$MYLAN$$$$$F$Y$$$20240905$$CN$US$US
242860312$24286031$2$F$$20240906$20240905$20240909$EXP$$PL-SANDOZ INC.-SDZ2024PL077494$SANDOZ$$31$YR$$F$Y$$$20240909$$MD$PL$PL
242860321$24286032$1$I$20240101$20240830$20240905$20240905$EXP$$US-ABBVIE-5903994$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242860331$24286033$1$I$$20240905$20240905$20240905$EXP$$US-BAYER-2024A127398$BAYER$$30$YR$A$F$Y$$$20240905$$CN$US$US
242860342$24286034$2$F$20230601$20240906$20240905$20240913$EXP$$CA-ABBVIE-5904491$ABBVIE$$52$YR$$F$Y$$$20240913$$CN$CA$CA
242860351$24286035$1$I$20230101$20240826$20240905$20240905$EXP$$JP-SA-2024SA257618$SANOFI AVENTIS$$$$E$M$Y$$$20240905$$CN$JP$JP
242860362$24286036$2$F$$20240910$20240905$20240920$EXP$$US-TEVA-VS-3238591$TEVA$Winston DJ, Young PA, Schlamm HT, Schiller GJ. Fosmanogepix Therapy of Disseminated Fusarium Infection. Clin-Infect-Dis 2023; 77 848-850.; Winston DJ, Young PA, Schlamm HT, Schiller GJ. Fosmanogepix Therapy of Disseminated Fusarium Infection. Clin-Infect-Dis 2023; 77 848-850.$26$YR$$F$Y$$$20240920$$HP$US$US
242860371$24286037$1$I$$20240823$20240905$20240905$EXP$$US-UCBSA-2024043352$UCB$$$$$$Y$$$20240905$$CN$US$US
242860381$24286038$1$I$$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140470$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240905$$CN$US$US
242860391$24286039$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140869$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240905$$CN$US$US
242860401$24286040$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140598$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240905$$HP$US$US
242860411$24286041$1$I$$20240904$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141245$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240905$$CN$US$US
242860421$24286042$1$I$$20240823$20240905$20240905$PER$$US-SA-2024SA256869$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240905$$MD$US$US
242860431$24286043$1$I$20240101$20240823$20240905$20240905$PER$$US-SA-2024SA256951$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240905$$MD$US$US
242860441$24286044$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA255958$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240905$$MD$US$US
242860451$24286045$1$I$20240101$20240830$20240905$20240905$PER$$US-SA-2024SA255793$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240905$$CN$US$US
242860461$24286046$1$I$$20240829$20240905$20240905$EXP$AU-MMM-D6K8CWN7$AU-GSK-AU2024107378$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$AU$AU
242860471$24286047$1$I$$20240827$20240905$20240905$30DAY$$US-GSK-US2024106629$GLAXOSMITHKLINE$$$$$M$Y$$$20240905$$CN$US$US
242860481$24286048$1$I$$20240829$20240905$20240905$EXP$$BR-GSK-BR2024AMR108537$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$BR$BR
242860501$24286050$1$I$20240301$20240903$20240905$20240905$EXP$$US-GILEAD-2024-0686227$GILEAD$$61$YR$A$M$Y$$$20240905$$HP$US$US
242860512$24286051$2$F$20240818$20240827$20240905$20240912$EXP$$NVSC2024DE175863$NOVARTIS$$34$YR$$M$Y$$$20240912$$MD$DE$DE
242860521$24286052$1$I$20240825$20240826$20240905$20240905$EXP$CN-NEBO-668280$CN-NEBO-668280$PHARMACOSMOS$$43$YR$$F$Y$57$KG$20240905$$HP$CN$CN
242860531$24286053$1$I$20240830$20240903$20240905$20240905$EXP$$US-SA-2024SA257364$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240905$$CN$US$US
242860541$24286054$1$I$20240806$20240903$20240905$20240905$EXP$$CN-ROCHE-10000073219$ROCHE$$55$YR$A$M$Y$60$KG$20240905$$HP$CN$CN
242860551$24286055$1$I$20240701$20240822$20240905$20240905$EXP$$US-UCBSA-2024043052$UCB$$61$YR$$F$Y$$$20240905$$HP$US$US
242860561$24286056$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001804$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242860571$24286057$1$I$$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409000542$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240905$$CN$US$US
242860581$24286058$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001853$ELI LILLY AND CO$$55$YR$A$$Y$$$20240905$$CN$US$US
242860591$24286059$1$I$20231101$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001650$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240905$$CN$US$US
242860601$24286060$1$I$20240826$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002763$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240905$$CN$US$US
242860611$24286061$1$I$$20240902$20240905$20240905$PER$$US-BAYER-2024A126272$BAYER$$$$$F$Y$$$20240905$$CN$US$US
242860621$24286062$1$I$$20240829$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408018914$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240905$$CN$US$US
242860631$24286063$1$I$$20240904$20240905$20240905$EXP$$GB-BAYER-2024A103698$BAYER$$85$YR$E$M$Y$$$20240905$$HP$GB$GB
242860641$24286064$1$I$$20240830$20240905$20240905$EXP$$US-JNJFOC-20240882161$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242860661$24286066$1$I$$20240830$20240905$20240905$PER$$US-SA-2024SA256043$SANOFI AVENTIS$$$$A$$Y$$$20240905$$HP$US$US
242860671$24286067$1$I$20231215$20240824$20240905$20240905$EXP$$JP-INSMED, INC.-2024-03438-JP$INSMED$$83$YR$$F$Y$37$KG$20240905$$MD$JP$JP
242860691$24286069$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA255701$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240905$$MD$US$US
242860701$24286070$1$I$20240807$20240904$20240904$20240904$DIR$717157$$FDA-CTU$$67$YR$$F$N$67.95$KG$20240904$N$HP$US$
242860711$24286071$1$I$$20240904$20240904$20240904$DIR$717127$$FDA-CTU$$$$$UNK$N$$$20240904$$CN$US$
242860721$24286072$1$I$$20240826$20240905$20240905$PER$$US-SA-2023SA291804$SANOFI AVENTIS$$$$A$M$Y$$$20240905$$CN$US$US
242860731$24286073$1$I$20240822$20240822$20240905$20240905$PER$$US-SA-2024SA256666$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240905$$CN$US$US
242860741$24286074$1$I$20240101$20240823$20240905$20240905$PER$$US-SA-2024SA256262$SANOFI AVENTIS$$$$T$M$Y$$$20240905$$CN$US$US
242860751$24286075$1$I$$20240902$20240905$20240905$EXP$GB-MHRA-MED-202408301134182040-PYMSL$GB-EMD Serono-2024047176$EMD SERONO INC$$$$$M$Y$100$KG$20240905$$CN$GB$GB
242860771$24286077$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140891$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240905$$CN$US$US
242860781$24286078$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140270$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240905$$HP$US$US
242860791$24286079$1$I$20240830$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141007$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240905$$HP$US$US
242860801$24286080$1$I$20240801$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140660$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240905$$CN$US$US
242860811$24286081$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140886$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240905$$CN$US$US
242860821$24286082$1$I$$20240824$20240905$20240905$PER$$US-IMP-2024000676$Harrow Health$$$$A$F$Y$$$20240905$$CN$US$US
242860831$24286083$1$I$20240217$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-086197-2024$RECKITT BENCKISER$$$$$M$Y$$$20240905$$CN$US$US
242860841$24286084$1$I$$20240902$20240905$20240905$PER$$US-BAYER-2024A126556$BAYER$$52$YR$A$F$Y$$$20240905$$MD$US$US
242860851$24286085$1$I$20240708$20240827$20240905$20240905$EXP$$US-ROCHE-10000028162$ROCHE$$66$YR$E$F$Y$103.42$KG$20240905$$CN$US$US
242860861$24286086$1$I$20240801$20240830$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001491$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240905$$CN$US$US
242860873$24286087$3$F$20240825$20240906$20240905$20240925$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049670$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$81$KG$20240925$$CN$DE$DE
242860881$24286088$1$I$20190101$20240827$20240905$20240905$PER$$US-AMGEN-USASP2024171254$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
242860893$24286089$3$F$20240801$20240917$20240905$20240918$PER$$US-AMGEN-USASP2024176456$AMGEN$$86$YR$E$M$Y$$$20240918$$CN$US$US
242860901$24286090$1$I$20240829$20240903$20240905$20240905$PER$$US-BAYER-2024A126268$BAYER$$26$YR$A$F$Y$$$20240905$$HP$US$US
242860911$24286091$1$I$20240801$20240823$20240905$20240905$PER$$US-SA-2024SA256926$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240905$$MD$US$US
242860921$24286092$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA254825$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240905$$MD$US$US
242860931$24286093$1$I$$20240904$20240905$20240905$EXP$$US-BAUSCH-BL-2024-013285$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240905$$PH$US$US
242860951$24286095$1$I$20240701$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140269$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240905$$HP$US$US
242860961$24286096$1$I$20240831$20240903$20240905$20240905$PER$$US-BAYER-2024A126492$BAYER$$33$YR$A$F$Y$$$20240905$$MD$US$US
242860971$24286097$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176882$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242860981$24286098$1$I$20240824$20240902$20240905$20240905$EXP$$CN-ROCHE-10000072382$ROCHE$$81$YR$E$F$Y$50$KG$20240905$$HP$CN$CN
242860991$24286099$1$I$$20240830$20240905$20240905$EXP$$US-ROCHE-10000071479$ROCHE$$71$YR$E$M$Y$$$20240905$$CN$US$US
242861001$24286100$1$I$$20240828$20240905$20240905$PER$$JP-Eisai-EC-2024-173275$EISAI$$$$E$F$Y$$$20240905$$MD$JP$JP
242861011$24286101$1$I$20240801$20240829$20240905$20240905$PER$$JP-Eisai-EC-2024-173278$EISAI$$$$E$M$Y$$$20240905$$MD$JP$JP
242861022$24286102$2$F$20240101$20240913$20240905$20240920$EXP$$JP-Eisai-EC-2024-173287$EISAI$Saeki Y. The use experience and discussion of Pembrolizumab + Lenvatinib therapy for renal cell carcinoma at our hospital. Renal Cell Carcinoma Seminar in Higashiharima.$51$YR$A$M$Y$$$20240920$$MD$JP$JP
242861031$24286103$1$I$20240806$20240828$20240905$20240905$EXP$$CN-Eisai-EC-2024-173243$EISAI$$11$YR$C$M$Y$65$KG$20240905$$HP$CN$CN
242861041$24286104$1$I$20220101$20240827$20240905$20240905$PER$$CN-Eisai-EC-2024-173308$EISAI$Li N. One case of acute myocardial infarction associated with lenvatinib after hepatocellular carcinoma surgery.. 2024 Aug 13;doi:10.13201/j.issn.1001-1439.2024.08.016.$63$YR$A$F$Y$$$20240905$$MD$CN$CN
242861052$24286105$2$F$20240301$20240909$20240905$20240919$PER$$JP-Eisai-EC-2024-173022$EISAI$Cases of LP therapy.$$$E$F$Y$$$20240919$$MD$JP$JP
242861062$24286106$2$F$20240523$20240904$20240905$20240911$EXP$$BR-ROCHE-10000070828$ROCHE$$79$YR$E$F$Y$$$20240911$$MD$BR$BR
242861071$24286107$1$I$20240101$20240903$20240905$20240905$PER$$US-BAYER-2024A126562$BAYER$$38$YR$A$F$Y$$$20240905$$HP$US$US
242861081$24286108$1$I$20240715$20240830$20240905$20240905$EXP$FR-AFSSAPS-LL2024001512$FR-LUNDBECK-DKLU4003828$LUNDBECK$$$$$$Y$$$20240905$$MD$FR$FR
242861092$24286109$2$F$20230115$20240916$20240905$20240926$EXP$$DE-UCBSA-2023057025$UCB$$$$A$F$Y$$$20240926$$MD$DE$DE
242861101$24286110$1$I$$20240828$20240905$20240905$EXP$$JP-009507513-2408JPN004080J$MERCK$$6$DEC$$F$Y$$$20240905$$MD$JP$JP
242861113$24286111$3$F$$20240828$20240905$20240912$PER$$US-SA-2024SA253859$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240912$$CN$US$US
242861131$24286113$1$I$$20240903$20240905$20240905$PER$$US-BAYER-2024A127174$BAYER$$$$$F$Y$$$20240905$$CN$US$US
242861142$24286114$2$F$20240515$20240902$20240905$20240912$EXP$DE-CADRBFARM-2024330079$DE-MYLANLABS-2024M1079798$MYLAN$$35$YR$$M$Y$66$KG$20240912$$CN$DE$DE
242861151$24286115$1$I$$20240816$20240905$20240905$PER$$US-TEVA-VS-3234399$TEVA$$65$YR$$F$Y$$$20240905$$PH$US$US
242861161$24286116$1$I$20230531$20230705$20240905$20240905$EXP$$IE-PFIZER INC-202300241101$PFIZER$$60$YR$$M$Y$$$20240905$$PH$IE$IE
242861171$24286117$1$I$20240309$20240831$20240905$20240905$EXP$$US-ABBVIE-5854119$ABBVIE$$73$YR$$M$Y$68$KG$20240905$$CN$US$US
242861181$24286118$1$I$20240819$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60847$$FDA-CTU$$30$YR$$F$N$$$20240903$N$$US$
242861191$24286119$1$I$20240801$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60891$$FDA-CTU$$$$$M$N$$$20240903$N$HP$US$
242861221$24286122$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60880$$FDA-CTU$$54$YR$$F$N$86.18$KG$20240903$N$HP$US$
242861241$24286124$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60887$$FDA-CTU$$54$YR$$M$N$$$20240903$N$$US$
242861261$24286126$1$I$20200817$20240827$20240905$20240905$EXP$$DE-HIKMA PHARMACEUTICALS-DE-H14001-24-08102$HIKMA$$$$$$Y$$$20240905$$MD$DE$DE
242861271$24286127$1$I$$20240828$20240905$20240905$EXP$$JP-009507513-2408JPN004042J$MERCK$$$$$F$Y$$$20240905$$MD$JP$JP
242861291$24286129$1$I$20240801$20240821$20240905$20240905$EXP$$US-SA-2024SA255473$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240905$$MD$US$US
242861301$24286130$1$I$$20240829$20240905$20240905$EXP$$IE-JNJFOC-20240904478$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240905$$HP$IE$IE
242861312$24286131$2$F$20240801$20240909$20240905$20240912$EXP$$FR-ASTELLAS-2024-AER-004366$ASTELLAS$$87$YR$E$M$Y$$$20240912$$PH$FR$FR
242861322$24286132$2$F$20230401$20240906$20240905$20240913$EXP$$JP-AstraZeneca-2024A200930$ASTRAZENECA$$60$YR$$F$Y$$$20240913$$MD$JP$
242861331$24286133$1$I$$20240831$20240905$20240905$EXP$$ES-VELOXIS PHARMACEUTICALS, INC.-2020-VEL-00304$VELOXIS PHARMACEUTICALS$Mensa J, Gutierrez CD, Cardozo C, Fernandez LR, Kestler M, Munoz P et al.. Neck infection after allogenic hematopoietic progenitors transplantation. Rev-Esp-Quimiot/ Official Journal of The Spanish Society of Chemotherapy. 2020;33:2:130-136$65$YR$$F$Y$$$20240905$$MD$ES$ES
242861341$24286134$1$I$$20240821$20240905$20240905$EXP$$US-UCBSA-2024043073$UCB$$57$YR$$F$Y$$$20240905$$CN$US$US
242861351$24286135$1$I$$20240830$20240905$20240905$EXP$$CO-ROCHE-10000070992$ROCHE$$$$$$Y$$$20240905$$HP$CO$CO
242861361$24286136$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141189$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240905$$CN$US$US
242861371$24286137$1$I$$20240823$20240905$20240905$PER$$US-SA-2024SA253355$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240905$$MD$US$US
242861381$24286138$1$I$20240101$20240822$20240905$20240905$PER$$US-SA-2024SA257120$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240905$$MD$US$US
242861391$24286139$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA255478$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240905$$MD$US$US
242861401$24286140$1$I$20240711$20240827$20240905$20240905$PER$$US-SA-2024SA257851$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240905$$MD$US$US
242861411$24286141$1$I$20240801$20240822$20240905$20240905$PER$$US-SA-2024SA257087$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240905$$MD$US$US
242861421$24286142$1$I$20240701$20240828$20240905$20240905$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17535$IPSEN$$13$YR$T$F$Y$31.1$KG$20240905$$MD$US$US
242861431$24286143$1$I$$20240903$20240903$20240903$DIR$716987$$FDA-CTU$$$$$UNK$N$$$20240903$N$CN$US$
242861441$24286144$1$I$20240813$20240827$20240905$20240905$EXP$$CN-Eisai-EC-2024-173039$EISAI$$58$YR$A$F$Y$50$KG$20240905$$HP$CN$CN
242861452$24286145$2$F$20240810$20240905$20240905$20240918$EXP$$US-UCBSA-2024043065$UCB$$57$YR$$F$Y$$$20240918$$CN$US$US
242861462$24286146$2$F$20240101$20240910$20240905$20240912$PER$$US-AMGEN-USASP2024174804$AMGEN$$63$YR$A$M$Y$$$20240912$$CN$US$US
242861471$24286147$1$I$$20240830$20240905$20240905$PER$$US-AMGEN-USASP2024175145$AMGEN$$$$$$Y$$$20240905$$MD$US$US
242861482$24286148$2$F$$20240819$20240905$20240927$PER$$US-TEVA-VS-3234924$TEVA$$85$YR$$M$Y$$$20240927$$CN$US$US
242861491$24286149$1$I$$20240904$20240903$20240903$DIR$FDA-CDER-CTU-2024-60848$$FDA-CTU$$28$YR$$F$N$$$20240904$N$$US$
242861501$24286150$1$I$$20240901$20240903$20240903$DIR$FDA-CDER-CTU-2024-60937$$FDA-CTU$$$$$F$N$$$20240901$N$HP$US$
242861511$24286151$1$I$20240101$20240830$20240905$20240905$EXP$$US-ABBVIE-5904019$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242861522$24286152$2$F$20240823$20240916$20240905$20240917$PER$$US-GRUNENTHAL-2024-124805$AVERITAS$$74$YR$$F$Y$$$20240917$$CN$US$US
242861531$24286153$1$I$$20240827$20240905$20240905$PER$$US-ABBVIE-5898170$ABBVIE$$$$$F$Y$43$KG$20240905$$CN$US$US
242861541$24286154$1$I$20240501$20240825$20240905$20240905$EXP$$US-SA-2024SA256935$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240905$$CN$US$US
242861551$24286155$1$I$$20240827$20240905$20240905$EXP$$NL-ROCHE-10000068600$ROCHE$$11$YR$C$$Y$$$20240905$$HP$NL$NL
242861561$24286156$1$I$20240819$20240902$20240905$20240905$EXP$$CN-ROCHE-10000072290$ROCHE$$53$YR$A$F$Y$54$KG$20240905$$HP$CN$CN
242861571$24286157$1$I$20240801$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002659$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240905$$CN$US$US
242861581$24286158$1$I$20230101$20240903$20240905$20240905$PER$$US-JNJFOC-20240908709$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240905$$CN$US$US
242861591$24286159$1$I$$20240820$20240905$20240905$PER$$US-ASTELLAS-2024-AER-002118$ASTELLAS$$6$DEC$A$F$Y$$$20240905$$MD$US$US
242861602$24286160$2$F$20240515$20240903$20240905$20240912$EXP$$US-ROCHE-10000071487$ROCHE$$65$YR$E$F$Y$$$20240912$$MD$US$US
242861611$24286161$1$I$20240217$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-086196-2024$RECKITT BENCKISER$$77$YR$$F$Y$$$20240905$$CN$US$US
242861621$24286162$1$I$20240801$20240826$20240905$20240905$PER$$US-SA-2024SA256559$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240905$$MD$US$US
242861632$24286163$2$F$$20240822$20240905$20240917$PER$$US-SA-2024SA252811$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240918$$CN$US$US
242861641$24286164$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA256851$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240905$$MD$US$US
242861651$24286165$1$I$20230101$20240830$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140405$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240905$$CN$US$US
242861661$24286166$1$I$20240214$20240902$20240905$20240905$EXP$$NVSC2024CR178040$NOVARTIS$$65$YR$$F$Y$$$20240905$$CN$CR$CR
242861672$24286167$2$F$$20240910$20240905$20240920$EXP$$CA-TEVA-VS-3238720$TEVA$Do A, Michaud V, Stephan J-F, Moreau M, Benoit E, Berube F-A, et al. Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report. Front-Psychiatry 2024; 15.; Do A, Michaud V, Stephan J-F, Moreau M, Benoit E, Berube F-A, et al. Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report. Front-Psychiatry 2024; 15.$50$YR$$M$Y$$$20240920$$HP$CA$CA
242861682$24286168$2$F$20230401$20240917$20240905$20240924$EXP$$FR-Ipsen Biopharmaceuticals, Inc.-2024-17122$IPSEN$$65$YR$E$F$Y$$$20240924$$MD$FR$FR
242861691$24286169$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176640$AMGEN$$$$$$Y$$$20240905$$MD$US$US
242861701$24286170$1$I$$20240827$20240905$20240905$EXP$$CA-AMGEN-CANSP2024172650$AMGEN$Khanolkar R. A.. Complete Response to Donor Lymphocyte Infusion for Primary Hemophagocytic Lymphohistiocytosis Relapse after Allogeneic Hematopoietic Cell Transplantation. Acta Hematologica. 2024;147:489-492$29$YR$A$M$Y$$$20240905$$HP$CA$CA
242861711$24286171$1$I$20240701$20240828$20240905$20240905$EXP$$NVSC2024BR155833$NOVARTIS$$52$YR$$F$Y$72$KG$20240905$$CN$BR$BR
242861721$24286172$1$I$20240201$20240823$20240905$20240905$EXP$$US-SA-2024SA256948$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240905$$MD$US$US
242861731$24286173$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60910$$FDA-CTU$$35$YR$$M$N$$$20240903$N$$US$
242861741$24286174$1$I$20240101$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60865$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
242861751$24286175$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60886$$FDA-CTU$$81$YR$$F$N$$$20240903$N$$US$
242861761$24286176$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60849$$FDA-CTU$$51$YR$$F$N$$$20240903$N$$US$
242861771$24286177$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60914$$FDA-CTU$$63$YR$$F$N$$$20240903$N$HP$US$
242861781$24286178$1$I$20240823$20240830$20240903$20240903$DIR$FDA-CDER-CTU-2024-60952$$FDA-CTU$$31$YR$$M$N$$$20240830$N$HP$US$
242861801$24286180$1$I$20240701$20240822$20240905$20240905$PER$$US-SA-2024SA257635$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240905$$HP$US$US
242861812$24286181$2$F$$20240903$20240905$20240916$PER$$US-SA-2024SA257548$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240916$$CN$US$US
242861821$24286182$1$I$$20240821$20240905$20240905$PER$$US-SA-2024SA254834$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240905$$MD$US$US
242861831$24286183$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA255461$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240905$$MD$US$US
242861842$24286184$2$F$$20240910$20240905$20240920$EXP$$US-TEVA-VS-3237642$TEVA$C Enstrom, et.al, Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy, US Cardiology Review, 7/2024, 18 (suppl 1) p.2; C Enstrom, et.al, Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy, US Cardiology Review, 7/2024, 18 (suppl 1) p.2$29$YR$$M$Y$$$20240920$$HP$US$US
242861851$24286185$1$I$20240701$20240821$20240905$20240905$PER$$US-SA-2024SA256014$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240905$$MD$US$US
242861861$24286186$1$I$20240701$20240823$20240905$20240905$PER$$US-SA-2024SA256211$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240905$$MD$US$US
242861871$24286187$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA257627$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240905$$HP$US$US
242861881$24286188$1$I$20240817$20240830$20240905$20240905$EXP$$CN-PFIZER INC-PV202400114201$PFIZER$$75$YR$$M$Y$62$KG$20240905$$HP$CN$CN
242861901$24286190$1$I$20240824$20240831$20240905$20240905$EXP$$CN-PFIZER INC-PV202400114219$PFIZER$$35$YR$$F$Y$63.5$KG$20240905$$HP$CN$CN
242861911$24286191$1$I$20240818$20240902$20240905$20240905$EXP$$CN-PFIZER INC-PV202400114984$PFIZER$$20$MON$$M$Y$13.5$KG$20240905$$HP$CN$CN
242861921$24286192$1$I$$20240902$20240905$20240905$EXP$$US-PFIZER INC-PV202400115442$PFIZER$$$$$$Y$$$20240905$$CN$US$US
242861931$24286193$1$I$20240829$20240904$20240905$20240905$EXP$$CN-PFIZER INC-PV202400116158$PFIZER$$28$YR$$F$Y$72$KG$20240905$$HP$CN$CN
242861941$24286194$1$I$20200327$20240902$20240905$20240905$EXP$PL-URPL-1-1602-2020$PL-PFIZER INC-202400248136$PFIZER$$75$YR$$F$Y$$$20240905$$MD$PL$PL
242861951$24286195$1$I$$20240904$20240905$20240905$EXP$GB-MHRA-MIDB-7bd7b744-88b9-46d2-8612-a0d5edc0b578$GB-PFIZER INC-202400249778$PFIZER$$89$YR$$F$Y$$$20240905$$PH$GB$GB
242861962$24286196$2$F$20240720$20240920$20240905$20240924$EXP$$JP-PFIZER INC-PV202400115463$PFIZER$$82$YR$$M$Y$60$KG$20240924$$MD$JP$JP
242861971$24286197$1$I$20240812$20240904$20240905$20240905$EXP$$IN-PFIZER INC-PV202400116468$PFIZER$$53$YR$$M$Y$$$20240905$$CN$IN$IN
242861981$24286198$1$I$20231207$20240902$20240905$20240905$EXP$$FR-PFIZER INC-202400248190$PFIZER$$73$YR$$M$Y$70$KG$20240905$$MD$FR$FR
242861991$24286199$1$I$$20240902$20240905$20240905$EXP$$SA-PFIZER INC-202400248349$PFIZER$$4$DEC$$F$Y$$$20240905$$MD$SA$SA
242862002$24286200$2$F$20240501$20240916$20240905$20240918$EXP$$ZA-PFIZER INC-PV202300120337$PFIZER$$51$YR$$F$Y$55$KG$20240918$$PH$ZA$ZA
242862011$24286201$1$I$20240903$20240903$20240905$20240905$EXP$$CA-PFIZER INC-202400249302$PFIZER$$76$YR$$F$Y$$$20240905$$HP$CA$CA
242862021$24286202$1$I$20240830$20240903$20240905$20240905$EXP$$CN-PFIZER INC-PV202400115502$PFIZER$$56$YR$$F$Y$48$KG$20240905$$HP$CN$CN
242862031$24286203$1$I$20240823$20240903$20240905$20240905$EXP$$CN-PFIZER INC-PV202400115545$PFIZER$$40$YR$$F$Y$53.5$KG$20240905$$HP$CN$CN
242862051$24286205$1$I$20210801$20240903$20240905$20240905$EXP$$CA-PFIZER INC-2018485989$PFIZER$$39$YR$$F$Y$89.6$KG$20240905$$MD$CA$CA
242862061$24286206$1$I$20240816$20240902$20240905$20240905$EXP$$CN-PFIZER INC-PV202400115020$PFIZER$$3$YR$$M$Y$14$KG$20240905$$HP$CN$CN
242862071$24286207$1$I$20240601$20240904$20240905$20240905$EXP$$CA-PFIZER INC-202400249980$PFIZER$$83$YR$$M$Y$$$20240905$$HP$CA$CA
242862081$24286208$1$I$$20240903$20240905$20240905$EXP$$CA-PFIZER INC-202400249261$PFIZER$$46$YR$$M$Y$$$20240905$$CN$CA$CA
242862091$24286209$1$I$20240117$20240902$20240905$20240905$EXP$$IN-PFIZER INC-PV202300204755$PFIZER$$49$YR$$F$Y$$$20240905$$CN$IN$IN
242862101$24286210$1$I$$20240903$20240905$20240905$EXP$$JP-PFIZER INC-PV202400115067$PFIZER$$$$$$Y$$$20240905$$PH$JP$JP
242862111$24286211$1$I$20240821$20240904$20240905$20240905$EXP$$CN-PFIZER INC-PV202400116163$PFIZER$$89$YR$$M$Y$65$KG$20240905$$HP$CN$CN
242862121$24286212$1$I$20240816$20240903$20240905$20240905$EXP$FR-AFSSAPS-AN2024001161$FR-PFIZER INC-202400248865$PFIZER$$77$YR$$F$Y$125$KG$20240905$$MD$FR$FR
242862131$24286213$1$I$20210717$20240902$20240905$20240905$EXP$FR-AFSSAPS-MA2024001302$FR-PFIZER INC-202400248011$PFIZER$$65$YR$$M$Y$$$20240905$$PH$FR$FR
242862141$24286214$1$I$$20240904$20240905$20240905$EXP$$JP-PFIZER INC-202400084069$PFIZER$$40$YR$$F$Y$$$20240905$$MD$JP$JP
242862151$24286215$1$I$20240903$20240904$20240905$20240905$EXP$$NO-PFIZER INC-PV202400116453$PFIZER$$8$DEC$$M$Y$$$20240905$$MD$NO$NO
242862162$24286216$2$F$$20240906$20240905$20240911$EXP$$IN-PFIZER INC-PV202400115485$PFIZER$$37$YR$$F$Y$$$20240911$$CN$IN$IN
242862171$24286217$1$I$20231119$20240903$20240905$20240905$EXP$$SE-PFIZER INC-PV202400115284$PFIZER$$67$YR$$F$Y$$$20240905$$CN$SE$SE
242862181$24286218$1$I$$20240902$20240905$20240905$EXP$$AU-PFIZER INC-PV202400115038$PFIZER$$$$E$M$Y$$$20240905$$MD$AU$AU
242862191$24286219$1$I$$20240903$20240905$20240905$EXP$GB-MHRA-MED-202409012307027310-QCRYG$GB-PFIZER INC-202400248995$PFIZER$$59$YR$$F$Y$69$KG$20240905$$CN$GB$GB
242862201$24286220$1$I$20240729$20240903$20240905$20240905$EXP$$FR-PFIZER INC-202400248929$PFIZER$$62$YR$$F$Y$$$20240905$$MD$FR$FR
242862211$24286221$1$I$20240125$20240902$20240905$20240905$EXP$FR-AFSSAPS-TO2024001641$FR-PFIZER INC-202400248189$PFIZER$$61$YR$$M$Y$75$KG$20240905$$PH$FR$FR
242862221$24286222$1$I$$20240903$20240905$20240905$EXP$$CA-PFIZER INC-202400249299$PFIZER$$$$$M$Y$$$20240905$$CN$CA$CA
242862231$24286223$1$I$20240812$20240903$20240905$20240905$EXP$FR-AFSSAPS-NT2024001096$FR-PFIZER INC-202400248925$PFIZER$$79$YR$$M$Y$55$KG$20240905$$PH$FR$FR
242862241$24286224$1$I$20240717$20240902$20240905$20240905$EXP$FR-AFSSAPS-TO2024001622$FR-PFIZER INC-202400248183$PFIZER$$69$YR$$M$Y$49.4$KG$20240905$$PH$FR$FR
242862251$24286225$1$I$$20240903$20240905$20240905$EXP$$US-PFIZER INC-202400250203$PFIZER$$49$YR$$F$Y$$$20240905$$HP$US$US
242862261$24286226$1$I$20240818$20240903$20240905$20240905$EXP$$US-PFIZER INC-202400249409$PFIZER$$81$YR$$M$Y$$$20240905$$MD$US$US
242862271$24286227$1$I$$20240903$20240905$20240905$EXP$$US-PFIZER INC-202400250086$PFIZER$$$$$$Y$$$20240905$$MD$US$US
242862281$24286228$1$I$20240101$20240903$20240905$20240905$EXP$$GB-PFIZER INC-202400249306$PFIZER$$41$YR$$F$Y$$$20240905$$CN$GB$GB
242862301$24286230$1$I$$20240903$20240905$20240905$EXP$$US-PFIZER INC-202400249714$PFIZER$$61$YR$$F$Y$$$20240905$$CN$US$US
242862311$24286231$1$I$20240827$20240903$20240905$20240905$EXP$$AR-PFIZER INC-202400249917$PFIZER$$55$YR$$F$Y$$$20240905$$CN$AR$AR
242862321$24286232$1$I$20141205$20240903$20240905$20240905$EXP$$US-PFIZER INC-PV202400115916$PFIZER$$42$YR$$F$Y$$$20240905$$MD$US$US
242862332$24286233$2$F$20240101$20240911$20240905$20240912$EXP$$IN-PFIZER INC-PV202400084783$PFIZER$$83$YR$$M$Y$65$KG$20240912$$CN$IN$IN
242862341$24286234$1$I$20240829$20240830$20240905$20240905$EXP$$US-PFIZER INC-202400247869$PFIZER$$49$YR$$F$Y$81$KG$20240905$$PH$US$US
242862351$24286235$1$I$20240801$20240903$20240905$20240905$EXP$$US-PFIZER INC-202400249265$PFIZER$$71$YR$$M$Y$$$20240905$$CN$US$US
242862361$24286236$1$I$$20240902$20240905$20240905$EXP$$CA-PFIZER INC-202400248608$PFIZER$$44$YR$$F$Y$151$KG$20240905$$HP$CA$CA
242862371$24286237$1$I$$20240902$20240905$20240905$EXP$$CA-PFIZER INC-202400249120$PFIZER$$70$YR$$F$Y$54$KG$20240905$$HP$CA$CA
242862381$24286238$1$I$$20240902$20240905$20240905$EXP$$CA-PFIZER INC-202400248607$PFIZER$$30$YR$$M$Y$99$KG$20240905$$HP$CA$CA
242862391$24286239$1$I$20240701$20240902$20240905$20240905$EXP$$JP-PFIZER INC-PV202400115193$PFIZER$$9$DEC$$M$Y$$$20240905$$MD$JP$JP
242862401$24286240$1$I$20240229$20240904$20240905$20240905$EXP$$IN-PFIZER INC-PV202400116114$PFIZER$$32$YR$$F$Y$$$20240905$$CN$IN$IN
242862411$24286241$1$I$$20240902$20240905$20240905$EXP$$CA-PFIZER INC-202400248480$PFIZER$$61$YR$$F$Y$$$20240905$$HP$CA$CA
242862421$24286242$1$I$$20240903$20240905$20240905$EXP$$US-PFIZER INC-202400042635$PFIZER$$32$YR$$M$Y$$$20240905$$HP$US$US
242862431$24286243$1$I$$20240902$20240905$20240905$EXP$$GB-PFIZER INC-202400249003$PFIZER$$$$$$Y$$$20240905$$MD$GB$GB
242862441$24286244$1$I$20240813$20240904$20240905$20240905$EXP$$IN-PFIZER INC-PV202400116366$PFIZER$$31$YR$$F$Y$$$20240905$$CN$IN$IN
242862451$24286245$1$I$$20240903$20240905$20240905$EXP$$CA-PFIZER INC-202400249203$PFIZER$$79$YR$$F$Y$$$20240905$$HP$CA$CA
242862461$24286246$1$I$$20240903$20240905$20240905$EXP$$GB-PFIZER INC-PV202400115359$PFIZER$$46$YR$$F$Y$$$20240905$$CN$GB$GB
242862471$24286247$1$I$$20240904$20240905$20240905$EXP$$US-PFIZER INC-202400249824$PFIZER$$15$YR$$F$Y$$$20240905$$MD$US$US
242862481$24286248$1$I$20240812$20240831$20240905$20240905$EXP$$CN-PFIZER INC-PV202400114240$PFIZER$$76$YR$$M$Y$$$20240905$$HP$CN$CN
242862491$24286249$1$I$$20240902$20240905$20240905$EXP$$CA-PFIZER INC-202400248604$PFIZER$$50$YR$$M$Y$150$KG$20240905$$HP$CA$CA
242862501$24286250$1$I$$20240902$20240905$20240905$EXP$$CA-PFIZER INC-202400249136$PFIZER$$69$YR$$M$Y$97$KG$20240905$$HP$CA$CA
242862511$24286251$1$I$$20240828$20240905$20240905$PER$$US-BIOGEN-2024BI01280427$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
242862521$24286252$1$I$20240401$20240828$20240905$20240905$EXP$$CA-BIOGEN-2024BI01262619$BIOGEN$$48$YR$$F$Y$$$20240905$$CN$CA$CA
242862531$24286253$1$I$$20240826$20240905$20240905$EXP$$US-TEVA-VS-3237643$TEVA$C Enstrom, et.al, Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy, US Cardiology Review, 7/2024, 18 (suppl 1) p.2$25$YR$$M$Y$$$20240905$$HP$US$US
242862541$24286254$1$I$$20240829$20240905$20240905$EXP$$JP-GSK-JP2024108686$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242862552$24286255$2$F$20240620$20240904$20240905$20240909$EXP$$NVSC2024US177963$NOVARTIS$$74$YR$$F$Y$$$20240909$$HP$US$US
242862561$24286256$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60884$$FDA-CTU$$58$YR$$F$N$68.04$KG$20240903$N$$US$
242862571$24286257$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60875$$FDA-CTU$$65$YR$$M$N$$$20240903$N$$US$
242862581$24286258$1$I$20240903$20240903$20240905$20240905$PER$$US-JNJFOC-20240908387$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$HP$US$US
242862591$24286259$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176606$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242862601$24286260$1$I$20240802$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175651$AMGEN$$22$YR$A$F$Y$$$20240905$$HP$US$US
242862621$24286262$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60898$$FDA-CTU$$85$YR$$F$N$64.41$KG$20240903$N$HP$US$
242862631$24286263$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60893$$FDA-CTU$$42$YR$$F$N$126.1$KG$20240903$N$$US$
242862641$24286264$1$I$20220701$20240828$20240905$20240905$EXP$$PL-AMGEN-POLSP2024174635$AMGEN$$61$YR$A$M$Y$$$20240905$$MD$PL$PL
242862651$24286265$1$I$$20240904$20240905$20240905$PER$$US-GILEAD-2024-0686306$GILEAD$$$$A$M$Y$$$20240905$$CN$US$US
242862661$24286266$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60904$$FDA-CTU$$41$YR$$F$N$98.43$KG$20240903$N$$US$
242862671$24286267$1$I$20240808$20240902$20240905$20240905$EXP$$CN-ROCHE-10000072442$ROCHE$$64$YR$A$M$Y$53$KG$20240905$$HP$CN$CN
242862681$24286268$1$I$20231010$20240320$20240905$20240905$EXP$$ME-TEVA-VS-3240268$TEVA$$57$YR$$F$Y$76$KG$20240905$$PH$ME$ME
242862692$24286269$2$F$20220301$20240912$20240905$20240918$EXP$$JP-ABBVIE-5907545$ABBVIE$Kaji D. Long-term efficacy and management of IBRUTINIB.$67$YR$$F$Y$47$KG$20240918$$MD$JP$JP
242862701$24286270$1$I$$20240819$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08492$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242862721$24286272$1$I$$20240827$20240905$20240905$EXP$$CA-EMD Serono-2024046407$EMD SERONO INC$$75$YR$E$F$Y$$$20240905$$CN$CA$CA
242862731$24286273$1$I$$20240902$20240905$20240905$PER$$US-ROCHE-10000073633$ROCHE$Thayer E, Weirich M, Roecker Z, Brenner S, Remick J, Patel A, et al. Induction chemotherapy with cemiplimab in a patient with coexistent vulvar cancer and autoimmune disease: A case report. Gynecologic Oncology Reports. 2024;55:1-3. doi:10.1016/j.gore.2024.101487.$61$YR$A$F$Y$$$20240905$$HP$US$US
242862741$24286274$1$I$$20240905$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049722$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240905$$CN$US$US
242862751$24286275$1$I$$20240822$20240905$20240905$EXP$$US-UCBSA-2024043048$UCB$$$$$F$Y$$$20240905$$MD$US$US
242862761$24286276$1$I$20240826$20240904$20240905$20240905$EXP$$CN-BAYER-2024A127098$BAYER$$52$YR$A$F$Y$$$20240905$$HP$CN$CN
242862771$24286277$1$I$$20240829$20240905$20240905$PER$$US-SA-2024SA255642$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240905$$MD$US$US
242862781$24286278$1$I$20240701$20240822$20240905$20240905$PER$$US-SA-2024SA256185$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240905$$MD$US$US
242862791$24286279$1$I$$20240829$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024175478$AMGEN$Fubin Q.; Na Z.; Shengda Z. et al.. Prognostic values of serum miR-140-5p and SFRP -5 for in-stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240905$$HP$CN$CN
242862801$24286280$1$I$20230828$20240828$20240905$20240905$EXP$FR-AFSSAPS-AN2023001183$FR-TEVA-2023-FR-2930113$TEVA$$45$YR$$M$Y$$$20240905$$MD$FR$FR
242862811$24286281$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178556$NOVARTIS$$$$$M$Y$$$20240905$$MD$US$US
242862821$24286282$1$I$20240101$20240901$20240905$20240905$EXP$$KR-BAYER-2024A126127$BAYER$$42$YR$A$F$Y$$$20240905$$MD$KR$KR
242862831$24286283$1$I$20240821$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139713$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240905$$PH$US$US
242862841$24286284$1$I$$20240829$20240905$20240905$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-138546$BRISTOL MYERS SQUIBB$Almeida R, Sitari C, Patraquim A, Blanco R, Pereira R, Medonca C. PO-0611 - (2544) - Azithromycin-induced thrombocytopenia - about a clinical case. Congresses of the Portuguese Society of Internal Medicine. 2024;957.$79$YR$E$F$Y$$$20240905$$HP$PT$PT
242862851$24286285$1$I$20240101$20240816$20240905$20240905$PER$$US-TEVA-VS-3221318$TEVA$$43$YR$$F$Y$$$20240905$$CN$US$US
242862871$24286287$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60863$$FDA-CTU$$57$YR$$F$N$48.53$KG$20240903$N$$US$
242862881$24286288$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60878$$FDA-CTU$$46$YR$$F$N$$$20240903$N$$US$
242862891$24286289$1$I$$20240815$20240903$20240903$DIR$FDA-CDER-CTU-2024-60969$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242862902$24286290$2$F$$20240904$20240905$20240907$EXP$$GB-JNJFOC-20240903920$JOHNSON AND JOHNSON$$$$$M$Y$$$20240907$$HP$GB$GB
242862911$24286291$1$I$20240807$20240829$20240905$20240905$EXP$FR-AFSSAPS-NC2024000993$FR-CHEPLA-2024011173$CHEPLAPHARM$$59$YR$$M$Y$70$KG$20240905$$MD$COUNTRY NOT SPECIFIED$FR
242862921$24286292$1$I$20240525$20240829$20240905$20240905$EXP$FR-AFSSAPS-ST2024001298$FR-CHEPLA-2024011175$CHEPLAPHARM$$72$YR$$F$Y$54$KG$20240905$$MD$COUNTRY NOT SPECIFIED$FR
242862931$24286293$1$I$$20240830$20240905$20240905$EXP$GB-MHRA-MED-202408271010130770-CRSBG$GB-CHEPLA-2024011259$CHEPLAPHARM$$$$$$Y$$$20240905$$PH$COUNTRY NOT SPECIFIED$GB
242862941$24286294$1$I$$20240830$20240905$20240905$EXP$$CA-CHEPLA-2024011234$CHEPLAPHARM$$76$YR$$M$Y$$$20240905$$MD$COUNTRY NOT SPECIFIED$CA
242862951$24286295$1$I$20240308$20240829$20240905$20240905$EXP$FR-AFSSAPS-AVMA2024000349$FR-CHEPLA-2024011210$CHEPLAPHARM$$32$YR$$M$Y$$$20240905$$PH$COUNTRY NOT SPECIFIED$FR
242862971$24286297$1$I$$20240828$20240905$20240905$EXP$$JP-ROCHE-10000071533$ROCHE$$7$DEC$E$F$Y$$$20240905$$MD$JP$JP
242862982$24286298$2$F$20220608$20240826$20240905$20240910$EXP$$NVSC2024TH172817$NOVARTIS$$62$YR$$M$Y$$$20240910$$MD$TH$TH
242862991$24286299$1$I$20240824$20240904$20240905$20240905$EXP$$IT-BAYER-2024A127166$BAYER$$90$YR$E$M$Y$$$20240905$$MD$IT$IT
242863001$24286300$1$I$$20240805$20240905$20240905$PER$$US-Covis Pharma GmbH-2024COV00971$COVIS PHARMA$$$$$M$Y$$$20240905$$CN$US$US
242863012$24286301$2$F$$20240919$20240905$20240925$EXP$$JP-GILEAD-2024-0683242$GILEAD$$64$YR$A$F$Y$$$20240925$$HP$JP$JP
242863021$24286302$1$I$$20240828$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000917$ELI LILLY AND CO$$$$$$Y$$$20240905$$MD$US$US
242863031$24286303$1$I$20240824$20240825$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018439$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240905$$CN$US$US
242863041$24286304$1$I$$20240826$20240905$20240905$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202408017522$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$FR$FR
242863052$24286305$2$F$20240601$20240917$20240905$20240926$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409002374$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240926$$CN$JP$JP
242863061$24286306$1$I$20240815$20240824$20240905$20240905$EXP$GB-MHRA-MED-202408241204435650-SKLNF$GB-ELI_LILLY_AND_COMPANY-GB202408015718$ELI LILLY AND CO$$36$YR$A$F$Y$105$KG$20240905$$CN$GB$GB
242863071$24286307$1$I$20240729$20240827$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202408017018$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240905$$CN$US$US
242863081$24286308$1$I$20240823$20240824$20240905$20240905$EXP$GB-MHRA-MED-202408242136244170-NQJZM$GB-ELI_LILLY_AND_COMPANY-GB202408015759$ELI LILLY AND CO$$28$YR$A$F$Y$88$KG$20240905$$CN$GB$GB
242863091$24286309$1$I$$20240823$20240905$20240905$EXP$GB-MHRA-MED-202408232330120130-HLQZM$GB-ELI_LILLY_AND_COMPANY-GB202408015657$ELI LILLY AND CO$$34$YR$A$F$Y$83$KG$20240905$$CN$GB$GB
242863101$24286310$1$I$$20240827$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018007$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242863111$24286311$1$I$$20240828$20240905$20240905$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408018787$ELI LILLY AND CO$$$$$M$Y$$$20240905$$CN$JP$JP
242863121$24286312$1$I$$20240826$20240905$20240905$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408016626$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$BR$BR
242863141$24286314$1$I$$20240827$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202408017612$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242863151$24286315$1$I$20240815$20240903$20240903$20240903$DIR$717018$$FDA-CTU$$52$YR$$F$N$168.75$KG$20240903$N$CN$US$
242863161$24286316$1$I$20221101$20240827$20240905$20240905$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408017580$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240905$$CN$DE$DE
242863172$24286317$2$F$$20240902$20240905$20240913$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408017594$ELI LILLY AND CO$$66$YR$E$F$Y$106$KG$20240913$$CN$GB$GB
242863181$24286318$1$I$$20240903$20240905$20240905$EXP$$US-BAYER-2024A126571$BAYER$$$$$$Y$$$20240905$$HP$US$US
242863191$24286319$1$I$$20240829$20240905$20240905$30DAY$$DE-PFIZER INC-202400247283$PFIZER$$$$$$Y$$$20240905$$HP$DE$DE
242863211$24286321$1$I$20240101$20240903$20240903$20240903$DIR$717022$$FDA-CTU$$26$YR$$M$N$63$KG$20240903$N$CN$US$
242863221$24286322$1$I$$20240830$20240905$20240905$EXP$$SK-MYLANLABS-2024M1081555$MYLAN$Blicharova A, Benetinova Z, Matyas T, Labaj P, Verboova, Tancos V, et al. Peliosis of the spleen as an unusual cause of splenic rupture: A case report and a review of literature. J-Forens-Legal-Med 2024; 103 (0):.$64$YR$$M$Y$$$20240905$$HP$SK$SK
242863231$24286323$1$I$$20240828$20240905$20240905$EXP$$CA-CELLTRION INC.-2024CA020643$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
242863242$24286324$2$F$$20240906$20240905$20240910$PER$$US-AMGEN-USASP2024176261$AMGEN$$$$$M$Y$$$20240910$$CN$US$US
242863261$24286326$1$I$$20240827$20240905$20240905$EXP$$BR-JNJFOC-20240882275$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$BR$BR
242863272$24286327$2$F$20240323$20240911$20240905$20240918$EXP$$NVSC2024AR136604$NOVARTIS$$54$YR$$M$Y$$$20240918$$CN$AR$AR
242863281$24286328$1$I$$20240829$20240905$20240905$EXP$$BR-ABBVIE-5902756$ABBVIE$$64$YR$$M$Y$$$20240905$$MD$BR$BR
242863292$24286329$2$F$20240816$20240816$20240905$20240905$EXP$$US-ASTELLAS-2024-AER-001853$ASTELLAS$$75$YR$E$M$Y$$$20240905$$CN$US$US
242863301$24286330$1$I$$20240903$20240905$20240905$EXP$$GB-MYLANLABS-2024M1030264$MYLAN$$$$$F$Y$$$20240905$$MD$GB$GB
242863321$24286332$1$I$$20240903$20240905$20240905$EXP$$GB-MYLANLABS-2024M1081261$MYLAN$$$$$M$Y$$$20240905$$HP$GB$GB
242863341$24286334$1$I$20240809$20240902$20240905$20240905$EXP$IT-MINISAL02-1000254$IT-MYLANLABS-2024M1080498$MYLAN$$51$YR$$M$Y$$$20240905$$MD$IT$IT
242863351$24286335$1$I$$20240903$20240905$20240905$EXP$GB-MHRA-MED-202409030938406780-SWYZQ$GB-MYLANLABS-2024M1080904$MYLAN$$50$YR$$F$Y$59$KG$20240905$$CN$GB$GB
242863361$24286336$1$I$20221225$20240902$20240905$20240905$EXP$$FR-AstraZeneca-2024A199262$ASTRAZENECA$$82$YR$$F$Y$90$KG$20240905$$MD$FR$
242863371$24286337$1$I$$20240830$20240905$20240905$EXP$$MX-009507513-2409MEX000964$MERCK$$64$YR$$$Y$$$20240905$$MD$MX$MX
242863381$24286338$1$I$20220601$20240829$20240905$20240905$EXP$$NVSC2024RU176703$NOVARTIS$$57$YR$$F$Y$$$20240905$$MD$RU$RU
242863391$24286339$1$I$20240702$20240903$20240905$20240905$EXP$$DE-BAYER-2024A096845$BAYER$$68$YR$E$F$Y$$$20240905$$CN$DE$DE
242863403$24286340$3$F$20240130$20240912$20240905$20240913$EXP$$NVSC2024EG177409$NOVARTIS$$38$YR$$F$Y$70$KG$20240913$$CN$EG$EG
242863411$24286341$1$I$20240801$20240827$20240905$20240905$PER$$US-ABBVIE-5899357$ABBVIE$$$$$$Y$$$20240905$$CN$US$US
242863421$24286342$1$I$$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-087292-2024$RECKITT BENCKISER$$$$$F$Y$$$20240905$$CN$US$US
242863432$24286343$2$F$20240101$20240903$20240905$20240912$EXP$$US-UCBSA-2024044083$UCB$$$$$F$Y$95$KG$20240912$$HP$US$US
242863441$24286344$1$I$$20231019$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-01266$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$$$20240905$$HP$US$US
242863451$24286345$1$I$$20230816$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-00936$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$24.86$KG$20240905$$CN$US$US
242863461$24286346$1$I$$20240827$20240905$20240905$EXP$$US-FreseniusKabi-FK202413299$FRESENIUS KABI$Mukherji S, Shoaib H, Jimenez X. Brief case report: A case of FOLFIRI?Induced psychosis. Oncology. 2023 Oct;32(10): 1625-1627. doi:10.1002/pon.6206.$72$YR$E$M$Y$$$20240905$$HP$US$US
242863471$24286347$1$I$$20240821$20240905$20240905$EXP$$CA-ASTELLAS-2024-AER-003180$ASTELLAS$$36$YR$A$M$Y$$$20240905$$HP$CA$CA
242863481$24286348$1$I$$20240827$20240905$20240905$EXP$$CA-FreseniusKabi-FK202413150$FRESENIUS KABI$$70$YR$E$M$Y$62$KG$20240905$$HP$CA$CA
242863491$24286349$1$I$$20240119$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-00124$ULTRAGENYX PHARMACEUTICAL$$$$$M$Y$$$20240905$$HP$US$US
242863501$24286350$1$I$$20231206$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-01267$ULTRAGENYX PHARMACEUTICAL$$$$T$$Y$$$20240905$$$US$US
242863511$24286351$1$I$$20231212$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-01589$ULTRAGENYX PHARMACEUTICAL$$$$$$Y$$$20240905$$HP$US$US
242863521$24286352$1$I$20221025$20230403$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-00776$ULTRAGENYX PHARMACEUTICAL$$2$YR$$F$Y$$$20240905$$CN$US$US
242863531$24286353$1$I$$20231116$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-01449$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$34.7$KG$20240905$$CN$US$US
242863541$24286354$1$I$$20231117$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-01451$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$$$20240905$$CN$US$US
242863551$24286355$1$I$$20230815$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-00954$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$58.97$KG$20240905$$CN$US$US
242863561$24286356$1$I$$20240827$20240905$20240905$EXP$$CA-FreseniusKabi-FK202413200$FRESENIUS KABI$$18$YR$A$F$Y$72$KG$20240905$$HP$CA$CA
242863571$24286357$1$I$$20240108$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-01554$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$$$20240905$$CN$US$US
242863581$24286358$1$I$$20231120$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-01465$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$62$KG$20240905$$CN$US$US
242863591$24286359$1$I$20230703$20231209$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-00768$ULTRAGENYX PHARMACEUTICAL$$0$YR$$$Y$6.36$KG$20240905$$MD$US$US
242863601$24286360$1$I$$20240318$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-00543$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$21.77$KG$20240905$$CN$US$US
242863611$24286361$1$I$$20231201$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-00853$ULTRAGENYX PHARMACEUTICAL$$$$$M$Y$65.8$KG$20240905$$CN$US$US
242863621$24286362$1$I$$20240830$20240905$20240905$EXP$$JP-GSK-JP2024108990$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$JP$JP
242863631$24286363$1$I$$20240329$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-00626$ULTRAGENYX PHARMACEUTICAL$$$$$$Y$$$20240905$$CN$US$US
242863641$24286364$1$I$$20240827$20240905$20240905$EXP$$CH-ROCHE-10000068547$ROCHE$$54$YR$A$M$Y$$$20240905$$MD$CH$CH
242863652$24286365$2$F$$20240913$20240905$20240920$EXP$$US-GSK-US2024107849$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
242863661$24286366$1$I$20240815$20240904$20240905$20240905$PER$$US-GILEAD-2024-0686269$GILEAD$$27$YR$A$M$Y$$$20240905$$MD$US$US
242863671$24286367$1$I$20240305$20240902$20240905$20240905$EXP$$NVSC2024CO073496$NOVARTIS$$40$YR$$F$Y$65$KG$20240905$$CN$CO$CO
242863681$24286368$1$I$$20240827$20240905$20240905$EXP$$US-MYLANLABS-2024M1081518$MYLAN$Hennen M-A, Zhang V, Opler DJ. An unwelcome side-effect of trazodone use in a trans-male. Psychiatr-Clin-Neurosci 2024; 78 (6): 376.$24$YR$$F$Y$$$20240905$$HP$US$US
242863691$24286369$1$I$20230417$20231121$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-00791$ULTRAGENYX PHARMACEUTICAL$$49$YR$$M$Y$$$20240905$$CN$US$US
242863701$24286370$1$I$$20240731$20240905$20240905$PER$$US-LUNDBECK-DKLU4002437$LUNDBECK$$$$$$Y$$$20240905$$PH$US$US
242863711$24286371$1$I$20240101$20240604$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-00718$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$$$20240905$$MD$US$US
242863721$24286372$1$I$$20240524$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-01046$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$$$20240905$$CN$US$US
242863731$24286373$1$I$$20240416$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-00752$ULTRAGENYX PHARMACEUTICAL$$$$$M$Y$120.8$KG$20240905$$CN$US$US
242863741$24286374$1$I$20240101$20240412$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-00720$ULTRAGENYX PHARMACEUTICAL$$$$$M$Y$$$20240905$$CN$US$US
242863751$24286375$1$I$20240101$20240412$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-00723$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$$$20240905$$CN$US$US
242863761$24286376$1$I$$20240425$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-00842$ULTRAGENYX PHARMACEUTICAL$$$$$$Y$$$20240905$$CN$US$US
242863771$24286377$1$I$$20240423$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-00826$ULTRAGENYX PHARMACEUTICAL$$$$$M$Y$23.5$KG$20240905$$CN$US$US
242863782$24286378$2$F$$20240904$20240905$20240909$PER$$US-HALEON-2195264$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
242863791$24286379$1$I$20240101$20240701$20240905$20240905$EXP$$GB-TEVA-VS-3235649$TEVA$$57$YR$$F$Y$$$20240905$$CN$GB$GB
242863801$24286380$1$I$20240704$20240903$20240905$20240905$EXP$$SA-GILEAD-2024-0686128$GILEAD$$54$YR$A$M$Y$$$20240905$$MD$SA$SA
242863811$24286381$1$I$$20240904$20240905$20240905$EXP$IT-CHIESI-2024CHF04968$IT-SANDOZ INC.-SDZ2024IT077686$SANDOZ$$26$YR$$M$Y$$$20240905$$HP$IT$IT
242863821$24286382$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60984$$FDA-CTU$$0$YR$$M$N$$$20240903$N$$US$
242863831$24286383$1$I$$20240821$20240903$20240903$DIR$FDA-CDER-CTU-2024-60990$$FDA-CTU$$$$$M$N$$$20240821$N$HP$US$
242863842$24286384$2$F$20240601$20240918$20240905$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019532$UNITED THERAPEUTICS$$68$YR$$M$Y$82.63$KG$20240927$$$US$US
242863851$24286385$1$I$$20240902$20240905$20240905$EXP$$IT-PFIZER INC-PV202400115454$PFIZER$Levi, V.. Bilateral Simultaneous Magnetic Resonance-Guided Focused Ultrasound Pallidotomy for Life-Threatening Status Dystonicus. Movement Disorders. 2024;39(8):1408-1412$19$YR$$F$Y$$$20240905$$MD$IT$IT
242863862$24286386$2$F$$20240906$20240905$20240911$EXP$$PH-PFIZER INC-202400250165$PFIZER$Ajon, A.. Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Due to Multiple Anti-Epileptic Drug Hypersensitivity. Cureus. 2024;16(7):e65417$41$YR$$F$Y$$$20240911$$MD$PH$PH
242863871$24286387$1$I$$20240904$20240905$20240905$EXP$$US-GILEAD-2024-0686286$GILEAD$$$$$F$Y$$$20240905$$MD$US$US
242863881$24286388$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140167$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240905$$HP$US$US
242863892$24286389$2$F$20240812$20240916$20240905$20240923$EXP$$US-Calliditas-2024CAL01689$CALLIDITAS THERAPEUTICS$$43$YR$A$M$Y$79.8$KG$20240923$$CN$US$US
242863901$24286390$1$I$20240821$20240821$20240905$20240905$PER$$US-ALKERMES INC.-ALK-2024-002184$ALKERMES$$34$YR$$M$Y$$$20240905$$HP$US$US
242863911$24286391$1$I$20240902$20240903$20240905$20240905$PER$$US-ALXN-202409USA000158US$ALEXION PHARMACEUTICALS$$77$YR$$F$Y$$$20240905$$CN$US$US
242863921$24286392$1$I$20231102$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-080362-2024$RECKITT BENCKISER$$$$$M$Y$$$20240905$$CN$US$US
242863931$24286393$1$I$$20240829$20240905$20240905$EXP$$BR-GSK-BR2024AMR108536$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$BR$BR
242863941$24286394$1$I$$20240902$20240905$20240905$EXP$$US-AMGEN-USASP2024175844$AMGEN$Nizamuddin I.; Watkins M.; Bartlett N. et al.. Characteristics and Outcomes in Patients With Marginal Zone Lymphoma Treated at a Large Tertiary Academic Medical Center. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S505$$$$$Y$$$20240905$$MD$US$US
242863951$24286395$1$I$$20240830$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024174743$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240905$$MD$CN$CN
242863961$24286396$1$I$20230101$20240903$20240905$20240905$EXP$$NVSC2024US177469$NOVARTIS$$$$$F$Y$73.94$KG$20240905$$CN$US$US
242863971$24286397$1$I$$20240826$20240905$20240905$EXP$$FR-TEVA-VS-3238372$TEVA$Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon-Pennamen M-D, Rivet J, et al. Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib. J-Eur-Acad-Dermatol-Venereol 2023; 38 (1): e32-e34.; Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon-Pennamen M-D, Rivet J, et al. Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib. J-Eur-Acad-Dermatol-Venereol 2023; 38 (1): e...$49$YR$$F$Y$$$20240905$$HP$FR$FR
242863981$24286398$1$I$$20240823$20240905$20240905$PER$$US-BAYER-2024A126450$BAYER$$64$YR$A$M$Y$$$20240905$$HP$US$US
242863991$24286399$1$I$$20240829$20240905$20240905$EXP$DE-002147023-NVSC2021DE073543$DE-KOANAAP-SML-DE-2021-00416$Unknown Manufacturer$$$$E$M$Y$$$20240905$$MD$DE$DE
242864001$24286400$1$I$$20240823$20240905$20240905$PER$$US-BAYER-2024A126451$BAYER$$66$YR$E$F$Y$$$20240905$$HP$US$US
242864011$24286401$1$I$$20240828$20240905$20240905$EXP$$CA-CELLTRION INC.-2024CA020653$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
242864021$24286402$1$I$20240125$20240830$20240905$20240905$EXP$FR-AFSSAPS-TO2024001641$FR-KOANAAP-SML-FR-2024-00903$Unknown Manufacturer$$61$YR$A$M$Y$75$KG$20240905$$PH$FR$FR
242864031$24286403$1$I$$20240827$20240905$20240905$EXP$$NL-KOANAAP-SML-NL-2024-00891$Unknown Manufacturer$Geerts P, Hart N, Visser O, Ortiz-Maldonado V, Chamuleau M. Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR-T cell infusion. Clinical Case Reports. 2023-Jun;11 (6): doi:10.1002/ccr3.7361.$36$YR$A$M$Y$$$20240905$$HP$NL$NL
242864041$24286404$1$I$20240701$20240903$20240903$20240903$DIR$717029$$FDA-CTU$$65$YR$$F$N$75.15$KG$20240903$N$CN$US$
242864051$24286405$1$I$20240824$20240903$20240905$20240905$EXP$$US-BAYER-2024A127290$BAYER$$88$YR$E$F$Y$50.34$KG$20240905$$CN$US$US
242864062$24286406$2$F$$20240910$20240905$20240920$EXP$$TR-TEVA-VS-3238787$TEVA$Tacyildiz N, Ozdemir SI, Canakci CEM, Yigit HI, Maharramova V, Dincaslan H, et al. Multidisciplinary PAIN management features of pediatric oncology patients in a pediatric cancer center in Turkiye: A developing country experience. J-Clin-Oncol 2024; 42 (Suppl.) (16):.; Tacyildiz N, Ozdemir SI, Canakci CEM, Yigit HI, Maharramova V, Dincaslan H, et al. Multidisciplinary PAIN management features of pediatric oncology patients in a pediatric cancer center in Turkiye: A developing country experien...$$$$$Y$$$20240920$$HP$TR$TR
242864071$24286407$1$I$$20240903$20240905$20240905$EXP$$NZ-BRISTOL-MYERS SQUIBB COMPANY-2024-140629$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240905$$PH$NZ$NZ
242864081$24286408$1$I$$20240826$20240905$20240905$EXP$$RU-TEVA-VS-3238397$TEVA$Malyshev SM, Popov KD, Simakov KV, Marichev AO, Topuzova MP, Smirnova AY, et al. [Status epilepticus in a pregnant patient with a previously unrecognized POLG-associated disease]. [Russian]. Zh-Nevropatol-Psikhiatr-Im-S-S-Korsakova 2023; 123 (10): 129-135.$33$YR$$F$Y$$$20240905$$HP$RU$RU
242864091$24286409$1$I$20240709$20240904$20240905$20240905$EXP$LT-SMCA-4778$LT-BAYER-2024A127228$BAYER$$37$YR$A$F$Y$54$KG$20240905$$CN$LT$LT
242864101$24286410$1$I$$20240827$20240905$20240905$EXP$$CA-FreseniusKabi-FK202413132$FRESENIUS KABI$$76$YR$E$M$Y$$$20240905$$HP$CA$CA
242864111$24286411$1$I$$20240827$20240905$20240905$EXP$$HU-FreseniusKabi-FK202412965$FRESENIUS KABI$$71$YR$E$F$Y$$$20240905$$HP$HU$HU
242864121$24286412$1$I$20240828$20240828$20240905$20240905$PER$$US-RDY-SPO/USA/24/0012766$DR REDDYS$$20$YR$A$$Y$$$20240905$$CN$US$US
242864131$24286413$1$I$$20240903$20240905$20240905$PER$$US-ABBVIE-5906585$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242864141$24286414$1$I$$20240827$20240905$20240905$EXP$$CA-FreseniusKabi-FK202413164$FRESENIUS KABI$$35$YR$A$M$Y$96$KG$20240905$$HP$CA$CA
242864151$24286415$1$I$$20240823$20240905$20240905$PER$$US-BAYER-2024A126452$BAYER$$58$YR$A$M$Y$$$20240905$$HP$US$US
242864161$24286416$1$I$20240129$20240829$20240905$20240905$EXP$FR-AFSSAPS-TO2024001644$FR-RDY-SPO/FRA/24/0012639$DR REDDYS$$74$YR$E$F$Y$$$20240905$$PH$FR$FR
242864171$24286417$1$I$20240101$20240829$20240905$20240905$EXP$$US-JNJFOC-20240872620$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240905$$MD$US$US
242864181$24286418$1$I$20240719$20240829$20240905$20240905$EXP$$JP-009507513-2407JPN004203J$MERCK$$8$DEC$$M$Y$$$20240905$$MD$JP$JP
242864191$24286419$1$I$$20240901$20240905$20240905$PER$$US-BAYER-2024A126255$BAYER$$$$$F$Y$$$20240905$$CN$US$US
242864201$24286420$1$I$$20240823$20240905$20240905$PER$$US-BAYER-2024A126453$BAYER$$76$YR$E$M$Y$$$20240905$$HP$US$US
242864211$24286421$1$I$$20240829$20240905$20240905$EXP$$US-EMD Serono-2024045318$EMD SERONO INC$$$$A$F$Y$$$20240905$$CN$US$US
242864221$24286422$1$I$20240101$20240814$20240905$20240905$PER$$US-009507513-2408USA005401$MERCK$$89$YR$$M$Y$$$20240905$$CN$US$US
242864231$24286423$1$I$$20240827$20240905$20240905$EXP$$US-AstraZeneca-2024A195845$ASTRAZENECA$$$$C$F$Y$22.7$KG$20240905$$HP$US$
242864241$24286424$1$I$20240101$20240822$20240905$20240905$30DAY$$DE-UCBSA-2024035413$UCB$$82$YR$$F$Y$$$20240905$$CN$DE$DE
242864251$24286425$1$I$20240904$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002863$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240905$$CN$US$US
242864261$24286426$1$I$20240526$20240903$20240903$20240903$DIR$717004$$FDA-CTU$$37$YR$$F$N$81$KG$20240903$N$CN$US$
242864281$24286428$1$I$$20240821$20240903$20240903$DIR$FDA-CDER-CTU-2024-60994$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
242864291$24286429$1$I$$20240902$20240903$20240903$DIR$FDA-CDER-CTU-2024-61001$$FDA-CTU$$$$$F$N$$$20240902$N$HP$US$
242864301$24286430$1$I$$20240828$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137537$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$63.96$KG$20240905$$CN$US$US
242864312$24286431$2$F$$20240916$20240905$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140822$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240920$$HP$US$US
242864321$24286432$1$I$$20240903$20240905$20240905$PER$$US-BAYER-2024A126816$BAYER$$$$$$Y$$$20240905$$CN$US$US
242864331$24286433$1$I$$20240903$20240905$20240905$PER$$US-BAYER-2024A127197$BAYER$$$$$F$Y$$$20240905$$CN$US$US
242864342$24286434$2$F$20240810$20240917$20240905$20240921$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-17545$IPSEN$$59$YR$A$F$Y$$$20240921$$MD$JP$JP
242864351$24286435$1$I$$20240826$20240905$20240905$EXP$$BR-ROCHE-10000067670$ROCHE$$62$YR$A$F$Y$$$20240905$$MD$BR$BR
242864361$24286436$1$I$20240119$20240905$20240905$20240905$PER$$US-PROD-AS2-212756134-RB-083422-2024$RECKITT BENCKISER$$69$YR$$M$Y$84.09$KG$20240905$$CN$US$US
242864381$24286438$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176422$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
242864391$24286439$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176642$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
242864401$24286440$1$I$20240830$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176593$AMGEN$$60$YR$A$M$Y$$$20240905$$CN$US$US
242864411$24286441$1$I$$20240903$20240905$20240905$EXP$$CA-PFIZER INC-202400249275$PFIZER$$$$$$Y$$$20240905$$HP$CA$CA
242864421$24286442$1$I$$20240904$20240905$20240905$EXP$$PT-SANDOZ INC.-SDZ2024PT077768$SANDOZ$$80$YR$$F$Y$$$20240905$$MD$PT$PT
242864431$24286443$1$I$$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141286$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240905$$CN$US$US
242864441$24286444$1$I$$20240902$20240905$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-141180$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240905$$PH$JP$JP
242864451$24286445$1$I$$20240827$20240905$20240905$EXP$$CA-FreseniusKabi-FK202413067$FRESENIUS KABI$$60$YR$A$F$Y$$$20240905$$PH$CA$CA
242864461$24286446$1$I$20210827$20240903$20240905$20240905$PER$$US-BIOGEN-2021BI01073271$BIOGEN$$30$YR$$F$Y$$$20240905$$CN$US$US
242864471$24286447$1$I$20240903$20240903$20240905$20240905$PER$$US-BIOGEN-2024BI01280917$BIOGEN$$45$YR$$F$Y$$$20240905$$CN$US$US
242864481$24286448$1$I$$20240903$20240905$20240905$PER$$US-BIOGEN-2024BI01280992$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
242864491$24286449$1$I$$20240831$20240905$20240905$PER$$US-BIOGEN-2024BI01280803$BIOGEN$$$$$F$Y$$$20240905$$HP$US$US
242864501$24286450$1$I$$20240831$20240905$20240905$PER$$US-BIOGEN-2022BI01166850$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
242864511$24286451$1$I$20240813$20240829$20240905$20240905$EXP$$CO-VANTIVE-2024VAN019417$Vantive US Healthcare$$67$YR$$M$Y$58$KG$20240905$$HP$CO$CO
242864521$24286452$1$I$20240818$20240829$20240905$20240905$EXP$$CO-VANTIVE-2024VAN019204$Vantive US Healthcare$$64$YR$$M$Y$65$KG$20240905$$HP$CO$CO
242864532$24286453$2$F$$20240904$20240905$20240911$EXP$$GB-VANTIVE-2024VAN018700$Vantive US Healthcare$$$$$F$Y$$$20240911$$HP$GB$GB
242864541$24286454$1$I$20240827$20240827$20240905$20240905$EXP$$CN-VANTIVE-2024VAN019350$Vantive US Healthcare$$69$YR$$$Y$89.4$KG$20240905$$CN$CN$CN
242864552$24286455$2$F$20230904$20240905$20240905$20240911$EXP$$CH-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2408CH06715$INSUD PHARMA$$36$YR$$F$Y$$$20240911$$MD$CH$CH
242864562$24286456$2$F$20240808$20240916$20240905$20240924$EXP$$PY-ROCHE-10000068619$ROCHE$$54$YR$A$F$Y$$$20240924$$CN$PY$PY
242864571$24286457$1$I$20230727$20240822$20240905$20240905$EXP$$ES-DUCHESNAY-2024ES000349$DUCHESNAY$$$$$$Y$$$20240905$$MD$ES$ES
242864591$24286459$1$I$20240708$20240830$20240905$20240905$EXP$FR-AFSSAPS-PP2024000921$FR-MYLANLABS-2024M1080101$MYLAN$$71$YR$$M$Y$85$KG$20240905$$MD$FR$FR
242864601$24286460$1$I$$20240903$20240905$20240905$EXP$GB-MHRA-MED-202409012307027310-QCRYG$GB-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2409GB06863$INSUD PHARMA$$59$YR$$F$Y$69$KG$20240905$$CN$GB$GB
242864611$24286461$1$I$$20240826$20240905$20240905$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006348$BIOCON$$$$$$Y$$$20240905$$HP$CA$CA
242864621$24286462$1$I$$20240828$20240902$20240902$DIR$FDA-CDER-CTU-2024-60678$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
242864631$24286463$1$I$$20240903$20240903$20240903$DIR$716960$$FDA-CTU$$$$$UNK$N$$$20240903$Y$CN$US$
242864641$24286464$1$I$20240604$20240830$20240902$20240902$DIR$FDA-CDER-CTU-2024-60818$$FDA-CTU$$52$YR$$F$N$$$20240830$N$HP$US$
242864651$24286465$1$I$20240808$20240814$20240903$20240903$DIR$FDA-CDER-CTU-2024-60995$$FDA-CTU$$83$YR$$M$N$$$20240814$N$HP$US$
242864661$24286466$1$I$$20240827$20240903$20240903$DIR$FDA-CDER-CTU-2024-61002$$FDA-CTU$$$$$F$N$$$20240827$N$HP$US$
242864691$24286469$1$I$20240815$20240820$20240903$20240903$DIR$FDA-CDER-CTU-2024-60987$$FDA-CTU$$15$YR$$M$N$$$20240820$N$HP$US$
242864721$24286472$1$I$$20240904$20240905$20240905$PER$$US-BAYER-2024A127338$BAYER$$28$YR$A$F$Y$$$20240905$$MD$US$US
242864732$24286473$2$F$$20240905$20240905$20240912$EXP$$IN-ROCHE-10000072702$ROCHE$$$$$M$Y$$$20240912$$CN$IN$IN
242864741$24286474$1$I$$20240904$20240904$20240904$DIR$717142$$FDA-CTU$$$$$UNK$N$$$20240904$$CN$US$
242864751$24286475$1$I$20221201$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60851$$FDA-CTU$$30$YR$$M$N$175$LBS$20240903$N$MD$US$
242864771$24286477$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60861$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
242864781$24286478$1$I$$20240902$20240903$20240903$DIR$FDA-CDER-CTU-2024-60940$$FDA-CTU$$$$$M$N$$$20240902$N$HP$US$
242864801$24286480$1$I$$20240829$20240903$20240903$DIR$FDA-CDER-CTU-2024-60988$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242864811$24286481$1$I$20240701$20240828$20240905$20240905$EXP$$CZ-VERTEX PHARMACEUTICALS-2024-013847$VERTEX$$11$YR$$F$Y$$$20240905$$CN$CZ$CZ
242864821$24286482$1$I$20240101$20240829$20240905$20240905$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013936$VERTEX$$$$A$M$Y$$$20240905$$CN$GB$GB
242864833$24286483$3$F$20230110$20240918$20240905$20240926$PER$$US-VERTEX PHARMACEUTICALS-2024-013754$VERTEX$$14$YR$$F$Y$$$20240926$$HP$US$US
242864841$24286484$1$I$$20230812$20240905$20240905$PER$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-23-00931$ULTRAGENYX PHARMACEUTICAL$$$$$$Y$$$20240905$$MD$US$US
242864851$24286485$1$I$$20240827$20240905$20240905$EXP$$US-MYLANLABS-2024M1080380$MYLAN$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood-Can-J 2023; 13 (1):.$$$$$Y$$$20240905$$HP$US$US
242864861$24286486$1$I$20240823$20240903$20240905$20240905$EXP$$GB-MYLANLABS-2024M1081069$MYLAN$$63$YR$$F$Y$$$20240905$$CN$GB$GB
242864871$24286487$1$I$20240826$20240827$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137816$BRISTOL MYERS SQUIBB$$25$YR$A$M$Y$$$20240905$$HP$US$US
242864881$24286488$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140574$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240905$$PH$US$US
242864891$24286489$1$I$$20240828$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137688$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240905$$CN$US$US
242864901$24286490$1$I$$20240902$20240905$20240905$EXP$$AU-AMGEN-AUSSP2024174858$AMGEN$$$$$$Y$$$20240905$$MD$AU$AU
242864912$24286491$2$F$20240903$20240905$20240905$20240909$PER$$US-AMGEN-USASP2024176032$AMGEN$$74$YR$E$F$Y$$$20240909$$CN$US$US
242864922$24286492$2$F$$20240828$20240905$20240911$30DAY$$US-MYLANLABS-2024M1079103$MYLAN$$$$$$Y$$$20240911$$CN$US$US
242864931$24286493$1$I$20240811$20240829$20240905$20240905$EXP$$CN-ROCHE-10000069148$ROCHE$$17$YR$T$M$Y$$$20240905$$HP$CN$CN
242864951$24286495$1$I$20240826$20240827$20240905$20240905$EXP$$US-TG THERAPEUTICS INC.-TGT003948$TG THERAPEUTICS$$$$$$Y$$$20240905$$CN$US$US
242864961$24286496$1$I$$20240828$20240905$20240905$EXP$$CA-CELLTRION INC.-2024CA020655$CELLTRION$$$$$$Y$$$20240905$$HP$CA$CA
242864971$24286497$1$I$$20240828$20240905$20240905$EXP$$JP-AstraZeneca-2024A197287$ASTRAZENECA$$76$YR$$F$Y$$$20240905$$PH$JP$
242864981$24286498$1$I$$20240903$20240905$20240905$PER$$US-AstraZeneca-2024A200495$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
242864993$24286499$3$F$$20240905$20240905$20240909$PER$$NVSC2024US178640$NOVARTIS$$$$$F$Y$$$20240909$$MD$US$US
242865001$24286500$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA256097$SANOFI AVENTIS$$$$$M$Y$$$20240905$$MD$US$US
242865011$24286501$1$I$20240701$20240829$20240905$20240905$EXP$$FR-AstraZeneca-2024A200678$ASTRAZENECA$$55$YR$$F$Y$$$20240905$$MD$FR$
242865021$24286502$1$I$$20240901$20240905$20240905$PER$$US-SA-2024SA257595$SANOFI AVENTIS$$$$A$F$Y$$$20240905$$HP$US$US
242865031$24286503$1$I$20190101$20240826$20240905$20240905$PER$$US-SA-2024SA255401$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240905$$CN$US$US
242865041$24286504$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA254379$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240905$$HP$US$US
242865052$24286505$2$F$$20240827$20240905$20240918$PER$$US-SA-2024SA253738$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240918$$CN$US$US
242865062$24286506$2$F$20240801$20240917$20240905$20240921$EXP$$CA-ABBVIE-5905944$ABBVIE$$66$YR$$F$Y$$$20240921$$CN$CA$CA
242865071$24286507$1$I$20240708$20240823$20240905$20240905$EXP$$CA-VER-202400391$VERITY PHARMACEUTICALS$$71$YR$E$M$Y$$$20240905$$HP$CA$CA
242865082$24286508$2$F$$20240923$20240905$20240926$PER$$US-BAYER-2024A124627$BAYER$$42$YR$A$F$Y$$$20240926$$CN$US$US
242865091$24286509$1$I$$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024177348$AMGEN$$$$$M$Y$$$20240905$$PH$US$US
242865101$24286510$1$I$20240902$20240903$20240905$20240905$EXP$$DE-ABBVIE-5905345$ABBVIE$$72$YR$$F$Y$$$20240905$$CN$DE$DE
242865111$24286511$1$I$20240101$20240831$20240905$20240905$EXP$$CA-ABBVIE-5791399$ABBVIE$$61$YR$$M$Y$$$20240905$$HP$CA$CA
242865121$24286512$1$I$$20240830$20240905$20240905$PER$$US-HALEON-2194577$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
242865131$24286513$1$I$20240701$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202406013702$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240905$$CN$US$US
242865141$24286514$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002488$ELI LILLY AND CO$$$$$$Y$$$20240905$$CN$US$US
242865151$24286515$1$I$$20240812$20240905$20240905$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004620$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242865162$24286516$2$F$20240812$20240910$20240905$20240916$EXP$$NVSC2024ZA176983$NOVARTIS$$60$YR$$F$Y$$$20240916$$MD$ZA$ZA
242865171$24286517$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141226$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240905$$CN$US$US
242865181$24286518$1$I$$20240827$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137044$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240905$$PH$US$US
242865221$24286522$1$I$$20240828$20240905$20240905$30DAY$$AU-MYLANLABS-2024M1079269$MYLAN$$$$$$Y$$$20240905$$CN$AU$AU
242865231$24286523$1$I$20240101$20240903$20240905$20240905$PER$$US-BAYER-2024A126278$BAYER$$72$YR$E$M$Y$$$20240905$$CN$US$US
242865241$24286524$1$I$20240801$20240822$20240905$20240905$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002453$CORCEPT$$$$$$Y$$$20240905$$MD$US$US
242865261$24286526$1$I$$20240902$20240905$20240905$EXP$$JP-PFIZER INC-202400249913$PFIZER$Miura, R.. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine (United States). 2024;103(34):10.1097/MD.0000000000039289$$$E$$Y$$$20240905$$MD$JP$JP
242865271$24286527$1$I$20240830$20240830$20240903$20240903$DIR$FDA-CDER-CTU-2024-60998$$FDA-CTU$$46$YR$$F$N$$$20240830$N$HP$US$
242865281$24286528$1$I$$20240821$20240903$20240903$DIR$FDA-CDER-CTU-2024-60986$$FDA-CTU$$$$$M$N$$$20240821$N$HP$US$
242865321$24286532$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60894$$FDA-CTU$$21$YR$$F$N$$$20240903$N$$US$
242865331$24286533$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60854$$FDA-CTU$$59$YR$$F$N$$$20240903$N$$US$
242865371$24286537$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60879$$FDA-CTU$$56$YR$$F$N$109.32$KG$20240903$N$$US$
242865381$24286538$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60899$$FDA-CTU$$46$YR$$F$N$$$20240903$N$$US$
242865391$24286539$1$I$$20240904$20240904$20240904$DIR$717137$$FDA-CTU$$$$$UNK$N$$$20240904$N$CN$US$
242865401$24286540$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60897$$FDA-CTU$$74$YR$$M$N$101.15$KG$20240903$N$$US$
242865411$24286541$1$I$$20240815$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08254$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242865431$24286543$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA256203$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240905$$MD$US$US
242865441$24286544$1$I$$20240826$20240905$20240905$EXP$$CA-TEVA-VS-3237421$TEVA$$80$YR$$M$Y$89$KG$20240905$$HP$CA$CA
242865451$24286545$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA125503$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240905$$CN$US$US
242865471$24286547$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA255069$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240905$$CN$US$US
242865481$24286548$1$I$20240826$20240827$20240905$20240905$PER$$US-SA-2024SA251554$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240905$$CN$US$US
242865492$24286549$2$F$20240101$20240827$20240905$20240918$PER$$US-SA-2024SA254168$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240918$$HP$US$US
242865501$24286550$1$I$20220701$20240828$20240905$20240905$PER$$US-SA-2024SA256541$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240905$$MD$US$US
242865511$24286551$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA257398$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240905$$HP$US$US
242865521$24286552$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175791$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
242865531$24286553$1$I$$20240903$20240905$20240905$EXP$$US-AMGEN-USASP2024175917$AMGEN$$$$A$M$Y$$$20240905$$CN$US$US
242865542$24286554$2$F$20240830$20240910$20240905$20240916$PER$$US-AMGEN-USASP2024175769$AMGEN$$$$T$F$Y$$$20240916$$CN$US$US
242865551$24286555$1$I$$20240815$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08311$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242865561$24286556$1$I$$20240830$20240905$20240905$PER$$US-AstraZeneca-2024A199195$ASTRAZENECA$$$$$F$Y$$$20240905$$MD$US$
242865571$24286557$1$I$20240827$20240901$20240905$20240905$PER$$US-PFIZER INC-202400247918$PFIZER$$46$YR$$M$Y$$$20240905$$CN$US$US
242865581$24286558$1$I$20240829$20240831$20240905$20240905$PER$$US-PFIZER INC-202400247826$PFIZER$$51$YR$$F$Y$$$20240905$$CN$US$US
242865601$24286560$1$I$20240828$20240901$20240905$20240905$PER$$US-PFIZER INC-202400248107$PFIZER$$64$YR$$F$Y$$$20240905$$CN$US$US
242865611$24286561$1$I$$20240830$20240905$20240905$PER$$US-PFIZER INC-202400247804$PFIZER$$80$YR$$F$Y$$$20240905$$CN$US$US
242865621$24286562$1$I$$20240830$20240905$20240905$PER$$US-PFIZER INC-202300335172$PFIZER$$13$YR$$F$Y$$$20240905$$CN$US$US
242865631$24286563$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60873$$FDA-CTU$$35$YR$$F$N$86.18$KG$20240903$N$$US$
242865641$24286564$1$I$20240830$20240831$20240905$20240905$PER$$US-PFIZER INC-202400247828$PFIZER$$66$YR$$F$Y$$$20240905$$HP$US$US
242865651$24286565$1$I$$20240830$20240905$20240905$PER$$US-PFIZER INC-202400247842$PFIZER$$69$YR$$M$Y$$$20240905$$CN$US$US
242865684$24286568$4$F$$20240918$20240905$20240923$PER$$US-PFIZER INC-PV202400114756$PFIZER$$72$YR$$M$Y$92.986$KG$20240923$$HP$US$US
242865701$24286570$1$I$20240901$20240901$20240905$20240905$PER$$US-PFIZER INC-202400247685$PFIZER$$$$A$F$Y$$$20240905$$CN$US$US
242865721$24286572$1$I$20240901$20240901$20240905$20240905$PER$$US-PFIZER INC-202400248098$PFIZER$$71$YR$$F$Y$$$20240905$$CN$US$US
242865731$24286573$1$I$$20240828$20240903$20240903$DIR$FDA-CDER-CTU-2024-60989$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
242865741$24286574$1$I$20240821$20240823$20240903$20240903$DIR$FDA-CDER-CTU-2024-60997$$FDA-CTU$$$$$F$N$$$20240823$N$HP$US$
242865751$24286575$1$I$$20240829$20240905$20240905$PER$$US-AMGEN-USASP2024174445$AMGEN$$79$YR$E$F$Y$$$20240905$$MD$US$US
242865762$24286576$2$F$$20240910$20240905$20240920$EXP$$DK-TEVA-VS-3238722$TEVA$Skajaa T, Faerch M, Hasle H. Acute kidney injury in a child treated with cisplatin and amphotericin B. Cancer-Chemother-Pharmacol 2024;.; Skajaa T, Faerch M, Hasle H. Acute kidney injury in a child treated with cisplatin and amphotericin B. Cancer-Chemother-Pharmacol 2024;.$17$YR$$F$Y$$$20240920$$HP$DK$DK
242865771$24286577$1$I$$20240826$20240905$20240905$EXP$$FR-TAKEDA-2024TUS088538$TAKEDA$$$$$$Y$$$20240905$$HP$FR$FR
242865782$24286578$2$F$$20240910$20240905$20240920$EXP$$PL-TEVA-VS-3238306$TEVA$Styczynski T, Sadlok J, Richert-Przygonska M, Debski R, Zalas-Wiecek P, Czyzewski K, et al. Infection With Saprochaete Clavata in Children After Hematopoietic Cell Transplantation. J-Pediatr-Hematol-Oncol 2023; 45 (8): e976-e979.; Styczynski T, Sadlok J, Richert-Przygonska M, Debski R, Zalas-Wiecek P, Czyzewski K, et al. Infection With Saprochaete Clavata in Children After Hematopoietic Cell Transplantation. J-Pediatr-Hematol-Oncol 2023; 45 (8): e976-e979.; Styczynski T, Sadlok J, Richert-Prz...$14$YR$$F$Y$$$20240920$$MD$PL$PL
242865791$24286579$1$I$$20240815$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08340$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242865801$24286580$1$I$$20240902$20240905$20240905$30DAY$$GB-PFIZER INC-PV202400114763$PFIZER$$13$YR$$F$Y$$$20240905$$CN$GB$GB
242865831$24286583$1$I$20240803$20240827$20240905$20240905$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07773$VIFOR$$75$YR$$M$Y$$$20240905$$HP$ZA$ZA
242865851$24286585$1$I$$20240823$20240905$20240905$EXP$$FR-B.Braun Medical Inc.-2161249$B BRAUN$$71$YR$$F$Y$68$KG$20240905$$$FR$FR
242865861$24286586$1$I$20240730$20240815$20240905$20240905$PER$$US-Vifor (International) Inc.-VIT-2024-07459$VIFOR$$75$YR$$F$Y$61$KG$20240905$$HP$US$US
242865871$24286587$1$I$$20240902$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139897$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$92.53$KG$20240905$$CN$US$US
242865881$24286588$1$I$20240101$20240902$20240905$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-141009$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240905$$MD$JP$JP
242865891$24286589$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140487$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240905$$HP$US$US
242865901$24286590$1$I$$20240829$20240905$20240905$EXP$$JP-Adaptis Pharma Private Limited-2161229$ADAPTIS PHARMA INDIA$Source document$$$$F$Y$$$20240905$$$JP$JP
242865921$24286592$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141165$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$57.61$KG$20240905$$CN$US$US
242865931$24286593$1$I$20240712$20240902$20240905$20240905$EXP$$TW-FreseniusKabi-FK202413417$FRESENIUS KABI$$43$YR$A$F$Y$65.6$KG$20240905$$PH$TW$TW
242865941$24286594$1$I$$20240826$20240905$20240905$EXP$$DE-Spectra Medical Devices, LLC-2161230$Spectra Medical Devices$Abstract$3$MON$$M$Y$$$20240905$$$DE$DE
242865951$24286595$1$I$20240722$20240902$20240905$20240905$EXP$FR-AFSSAPS-TO2024001622$FR-FreseniusKabi-FK202413351$FRESENIUS KABI$$69$YR$E$M$Y$49.4$KG$20240905$$PH$FR$FR
242865961$24286596$1$I$20231125$20240829$20240905$20240905$EXP$GB-MHRA-MED-202408291020440290-QKLFC$GB-OTSUKA-2024_024224$OTSUKA$$18$YR$$M$Y$$$20240905$$HP$GB$GB
242865971$24286597$1$I$$20240828$20240905$20240905$EXP$$US-Appco Pharma LLC-2161231$APPCO PHARMA$Initial$75$YR$$F$Y$$$20240905$$$US$US
242865981$24286598$1$I$$20240819$20240905$20240905$EXP$$GB-Ascend Therapeutics US, LLC-2161115$ASCEND$$$$$F$Y$$$20240905$$$GB$GB
242865991$24286599$1$I$$20240904$20240905$20240905$EXP$$FR-PFIZER INC-PV202400116000$PFIZER$$77$YR$$F$Y$$$20240905$$MD$FR$FR
242866001$24286600$1$I$20240827$20240903$20240905$20240905$EXP$$CN-PFIZER INC-PV202400115574$PFIZER$$66$YR$$F$Y$57$KG$20240905$$HP$CN$CN
242866011$24286601$1$I$20240830$20240830$20240905$20240905$EXP$GB-MHRA-MED-202408301731141620-JHKQN$GB-PFIZER INC-202400247543$PFIZER$$$$$M$Y$$$20240905$$HP$GB$GB
242866021$24286602$1$I$$20240903$20240905$20240905$EXP$$US-PFIZER INC-202400249509$PFIZER$$83$YR$$F$Y$$$20240905$$CN$US$US
242866031$24286603$1$I$$20240813$20240905$20240905$PER$$US-B.Braun Medical Inc.-2161233$B BRAUN$$$$$$Y$$$20240905$$$US$US
242866041$24286604$1$I$$20240822$20240905$20240905$EXP$$DK-B.Braun Medical Inc.-2161197$B BRAUN$Literature Article$12$MON$$$Y$$$20240905$$$DK$DK
242866051$24286605$1$I$20240819$20240829$20240905$20240905$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07821$VIFOR$$77$YR$$F$Y$$$20240905$$HP$ZA$ZA
242866071$24286607$1$I$20240805$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60877$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
242866081$24286608$1$I$$20240823$20240905$20240905$EXP$$CZ-B.Braun Medical Inc.-2161236$B BRAUN$$69$YR$$F$Y$115$KG$20240905$$$CZ$CZ
242866101$24286610$1$I$20240101$20240829$20240905$20240905$EXP$$US-ABBVIE-5863071$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242866111$24286611$1$I$$20240828$20240905$20240905$EXP$$US-Appco Pharma LLC-2161228$APPCO PHARMA$Initial$59$YR$$F$Y$$$20240905$$$US$US
242866121$24286612$1$I$$20240816$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08166$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242866141$24286614$1$I$$20240816$20240905$20240905$PER$$US-Apozeal Pharmaceuticals-2161227$Apozeal Pharmaceuticals$$$$$$Y$$$20240905$$$US$US
242866151$24286615$1$I$$20240827$20240905$20240905$PER$$US-Appco Pharma LLC-2161234$APPCO PHARMA$$$$$F$Y$51.3$KG$20240905$$$US$US
242866161$24286616$1$I$20170608$20240828$20240905$20240905$EXP$PL-URPL-2-423-2019$PL-TEVA-VS-3238279$TEVA$$$$$M$Y$$$20240905$$CN$PL$PL
242866171$24286617$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175734$AMGEN$$$$$M$Y$$$20240905$$CN$US$US
242866181$24286618$1$I$20240828$20240902$20240905$20240905$PER$$NO-PFIZER INC-202400249082$PFIZER$$$$$M$Y$$$20240905$$CN$NO$NO
242866191$24286619$1$I$20240831$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249506$PFIZER$$71$YR$$F$Y$$$20240905$$CN$US$US
242866201$24286620$1$I$20240901$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249318$PFIZER$$47$YR$$F$Y$$$20240905$$CN$US$US
242866211$24286621$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249316$PFIZER$$$$$$Y$$$20240905$$HP$US$US
242866221$24286622$1$I$20240902$20240902$20240905$20240905$PER$$US-PFIZER INC-202400248574$PFIZER$$34$YR$$F$Y$$$20240905$$CN$US$US
242866231$24286623$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249332$PFIZER$$52$YR$$M$Y$$$20240905$$MD$US$US
242866241$24286624$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400099093$PFIZER$$50$YR$$F$Y$$$20240905$$HP$US$US
242866251$24286625$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400116196$PFIZER$$49$YR$$M$Y$$$20240905$$HP$US$US
242866261$24286626$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400115461$PFIZER$$58$YR$$F$Y$$$20240905$$HP$US$US
242866271$24286627$1$I$20240820$20240902$20240905$20240905$PER$$US-PFIZER INC-202400248656$PFIZER$$66$YR$$F$Y$$$20240905$$CN$US$US
242866281$24286628$1$I$20240101$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400115728$PFIZER$$66$YR$$F$Y$$$20240905$$HP$US$US
242866291$24286629$1$I$20240801$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400116023$PFIZER$$59$YR$$F$Y$$$20240905$$CN$US$US
242866301$24286630$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249348$PFIZER$$$$$F$Y$$$20240905$$MD$US$US
242866311$24286631$1$I$$20240901$20240905$20240905$PER$$US-PFIZER INC-PV202400114008$PFIZER$$41$YR$$F$Y$$$20240905$$CN$US$US
242866322$24286632$2$F$20240101$20240906$20240905$20240920$PER$$US-SA-2024SA253768$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240920$$CN$US$US
242866332$24286633$2$F$20240101$20240905$20240905$20240906$PER$$US-PFIZER INC-202400250133$PFIZER$$92$YR$$M$Y$$$20240906$$HP$US$US
242866341$24286634$1$I$20240601$20240827$20240905$20240905$PER$$US-SA-2024SA256558$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240905$$MD$US$US
242866351$24286635$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA254185$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240905$$MD$US$US
242866361$24286636$1$I$20240902$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002499$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240905$$CN$US$US
242866371$24286637$1$I$20240815$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002627$ELI LILLY AND CO$$$$A$F$Y$$$20240905$$CN$US$US
242866391$24286639$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002677$ELI LILLY AND CO$$$$$$Y$$$20240905$$MD$US$US
242866401$24286640$1$I$20240101$20240905$20240905$20240905$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049718$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240905$$CN$US$US
242866411$24286641$1$I$$20240825$20240905$20240905$EXP$$AE-Saptalis Pharmaceuticals LLC-2161251$SAPTALIS PHARMACEUTICALS$This is a PubMed based literature; case with hemolytic Anaemea in G6PD-deficient patient. While metformin rarely causes drug-induced hemolysis, it is crucial for physicians to be aware of this potential side effect and consider testing high-risk populations for G6PD enzyme activity before starting metformin treatment. With an increasing number of reported cases, updating the list of medications known to induce hemolysis in G6PD-deficient patients may be warranted$40$YR$$M$Y$$$20240905$$$US$AE
242866421$24286642$1$I$$20240903$20240905$20240905$PER$$US-ALXN-202409USA000095US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$HP$US$US
242866432$24286643$2$F$$20240916$20240905$20240918$PER$$US-ALXN-202409USA000065US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
242866441$24286644$1$I$$20240815$20240905$20240905$PER$$US-B.Braun Medical Inc.-2161252$B BRAUN$$$$$F$Y$$$20240905$$$US$US
242866451$24286645$1$I$$20240903$20240905$20240905$PER$$US-ALXN-202409USA000183US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242866461$24286646$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140883$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240905$$CN$US$US
242866471$24286647$1$I$20240801$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140383$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240905$$HP$US$US
242866481$24286648$1$I$$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140194$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240905$$HP$US$US
242866491$24286649$1$I$$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140435$BRISTOL MYERS SQUIBB$$38$YR$A$$Y$$$20240905$$MD$US$US
242866503$24286650$3$F$$20240909$20240905$20240911$PER$$NVSC2024US178635$NOVARTIS$$$$$M$Y$$$20240911$$CN$US$US
242866531$24286653$1$I$$20240826$20240905$20240905$EXP$$TR-BIOCON BIOLOGICS LIMITED-BBL2024006368$BIOCON$Onder T, Karacin C.. Trastuzumab-induced optic neuritis: ^blindness^ side effect. Journal of Oncology Pharmacy Practice. 2024;1-4$$$$$Y$$$20240905$$HP$TR$TR
242866542$24286654$2$F$20240101$20240917$20240905$20240924$EXP$$CL-JNJFOC-20240904999$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240924$$CN$CL$CL
242866551$24286655$1$I$20240824$20240826$20240905$20240905$30DAY$$US-GSK-US2024106157$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240905$$CN$US$US
242866561$24286656$1$I$20230401$20240829$20240905$20240905$EXP$$AR-GSK-AR2023AMR078395$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$AR$AR
242866571$24286657$1$I$$20240819$20240905$20240905$PER$$US-TEVA-VS-3236223$TEVA$$57$YR$$F$Y$$$20240905$$CN$US$US
242866581$24286658$1$I$20240701$20240821$20240905$20240905$EXP$$US-JOURNEY MEDICAL CORPORATION-2024JNY00178$JOURNEY MEDICAL CORPORATION$$39$YR$$M$Y$136.05$KG$20240905$$HP$US$US
242866591$24286659$1$I$$20240816$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08458$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242866601$24286660$1$I$20240827$20240829$20240905$20240905$EXP$$CN-GSK-CN2024APC107460$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$CN$CN
242866621$24286662$1$I$$20240821$20240905$20240905$EXP$$CA-MEDEXUS PHARMA, INC.-2024MED00355$MEDEXUS PHARMA$$7$YR$$F$Y$33$KG$20240905$$HP$CA$CA
242866631$24286663$1$I$$20240830$20240905$20240905$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-00970$CATALYST PHARMA$$$$$F$Y$$$20240905$$CN$US$US
242866641$24286664$1$I$$20240904$20240905$20240905$PER$$US-BIOVITRUM-2024-US-011693$BIOVITRUM$$87$YR$$F$Y$$$20240905$$CN$US$US
242866651$24286665$1$I$20240827$20240830$20240905$20240905$EXP$$PH-OTSUKA-2024_011053$OTSUKA$$71$YR$$F$Y$$$20240905$$CN$PH$PH
242866662$24286666$2$F$20240901$20240909$20240905$20240910$PER$$US-AMGEN-USASP2024175984$AMGEN$$62$YR$A$F$Y$$$20240910$$CN$US$US
242866671$24286667$1$I$20240829$20240830$20240905$20240905$PER$$US-AMGEN-USASP2024175233$AMGEN$$$$$$Y$$$20240905$$HP$US$US
242866681$24286668$1$I$$20240827$20240905$20240905$EXP$$UY-ROCHE-10000068616$ROCHE$$59$YR$A$F$Y$$$20240905$$CN$UY$UY
242866691$24286669$1$I$20240822$20240826$20240905$20240905$EXP$$CN-GE HEALTHCARE-2024CSU009832$GE HEALTHCARE$$52$YR$$F$Y$64$KG$20240905$$HP$CN$CN
242866701$24286670$1$I$20240101$20240827$20240905$20240905$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-00943$CATALYST PHARMA$$16$YR$$F$Y$32.2$KG$20240905$$MD$US$US
242866711$24286671$1$I$20240815$20240904$20240904$20240904$DIR$717160$$FDA-CTU$$79$YR$$M$N$98.1$KG$20240904$N$CN$US$
242866721$24286672$1$I$$20240826$20240905$20240905$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006344$BIOCON$$$$$$Y$$$20240905$$HP$CA$CA
242866731$24286673$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178631$NOVARTIS$$$$$F$Y$$$20240905$$HP$US$US
242866741$24286674$1$I$20240816$20240819$20240903$20240903$DIR$FDA-CDER-CTU-2024-61000$$FDA-CTU$$22$YR$$F$N$$$20240819$N$HP$US$
242866751$24286675$1$I$20240101$20240826$20240905$20240905$EXP$$US-TEVA-VS-3238359$TEVA$$17$YR$$F$Y$$$20240905$$HP$US$US
242866761$24286676$1$I$$20240816$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08459$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242866801$24286680$1$I$20240827$20240829$20240905$20240905$PER$$US-ALXN-202408USA002149US$ALEXION PHARMACEUTICALS$$70$YR$$F$Y$$$20240905$$CN$US$US
242866811$24286681$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA255515$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240905$$MD$US$US
242866821$24286682$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60874$$FDA-CTU$$49$YR$$F$N$$$20240903$N$$US$
242866831$24286683$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA255489$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240905$$MD$US$US
242866841$24286684$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140119$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$79.38$KG$20240905$$CN$US$US
242866851$24286685$1$I$20240824$20240904$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141171$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240905$$CN$US$US
242866863$24286686$3$F$20240826$20240909$20240905$20240918$EXP$$US-Calliditas-2024CAL01681$CALLIDITAS THERAPEUTICS$$72$YR$E$M$Y$143$KG$20240918$$CN$US$US
242866871$24286687$1$I$$20240822$20240905$20240905$EXP$$US-JNJFOC-20240909796$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$US$US
242866891$24286689$1$I$20190101$20240829$20240905$20240905$EXP$$US-ABBVIE-5855135$ABBVIE$$$$$M$Y$97$KG$20240905$$CN$US$US
242866901$24286690$1$I$20240809$20240830$20240905$20240905$EXP$IE-HPRA-2024-114953$IE-MYLANLABS-2024M1080157$MYLAN$$41$YR$$F$Y$$$20240905$$MD$IE$IE
242866921$24286692$1$I$$20240816$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08460$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242866931$24286693$1$I$20240101$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400116053$PFIZER$$41$YR$$F$Y$$$20240905$$HP$US$US
242866941$24286694$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3237790$TEVA$$60$YR$$M$Y$101$KG$20240905$$HP$CA$CA
242866951$24286695$1$I$20230822$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400099698$PFIZER$$52$YR$$F$Y$$$20240905$$MD$US$US
242866962$24286696$2$F$20240530$20240918$20240905$20240920$PER$$US-PFIZER INC-202400249896$PFIZER$$62$YR$$M$Y$79.38$KG$20240920$$CN$US$US
242866971$24286697$1$I$20240101$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400115608$PFIZER$$47$YR$$F$Y$$$20240905$$HP$US$US
242866981$24286698$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249289$PFIZER$$$$$F$Y$$$20240905$$CN$US$US
242866991$24286699$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400115605$PFIZER$$66$YR$$F$Y$$$20240905$$CN$US$US
242867002$24286700$2$F$$20240916$20240905$20240917$PER$$US-PFIZER INC-202400239174$PFIZER$$16$YR$$F$Y$$$20240917$$MD$US$US
242867011$24286701$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400075731$PFIZER$$47$YR$$M$Y$$$20240905$$CN$US$US
242867021$24286702$1$I$20240601$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400085065$PFIZER$$58$YR$$F$Y$$$20240905$$HP$US$US
242867031$24286703$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400115618$PFIZER$$77$YR$$F$Y$$$20240905$$CN$US$US
242867041$24286704$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400115664$PFIZER$$58$YR$$$Y$$$20240905$$HP$US$US
242867051$24286705$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400100246$PFIZER$$47$YR$$F$Y$$$20240905$$HP$US$US
242867061$24286706$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249761$PFIZER$$71$YR$$M$Y$$$20240905$$CN$US$US
242867071$24286707$1$I$20240101$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249266$PFIZER$$73$YR$$M$Y$$$20240905$$CN$US$US
242867092$24286709$2$F$20240101$20240904$20240905$20240912$PER$$US-SA-2024SA256398$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240912$$MD$US$US
242867101$24286710$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA256219$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240905$$CN$US$US
242867111$24286711$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA253594$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240905$$MD$US$US
242867121$24286712$1$I$20240801$20240823$20240905$20240905$PER$$US-SA-2024SA256224$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240905$$CN$US$US
242867131$24286713$1$I$20240101$20240822$20240905$20240905$PER$$US-SA-2024SA256783$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240905$$MD$US$US
242867141$24286714$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA257714$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240905$$HP$US$US
242867151$24286715$1$I$20240101$20240822$20240905$20240905$PER$$US-SA-2024SA255460$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240905$$MD$US$US
242867161$24286716$1$I$$20240830$20240905$20240905$EXP$$US-SPRINGWORKS THERAPEUTICS-SW-001981$SPRINGWORKS THERAPEUTIC$$45$YR$$F$Y$$$20240905$$MD$US$US
242867171$24286717$1$I$20231201$20240822$20240905$20240905$EXP$$US-UCBSA-2024001901$UCB$$33$YR$$F$Y$73.469$KG$20240905$$CN$US$US
242867181$24286718$1$I$$20240827$20240905$20240905$EXP$$CA-FreseniusKabi-FK202413147$FRESENIUS KABI$$61$YR$A$M$Y$$$20240905$$PH$CA$CA
242867192$24286719$2$F$$20240921$20240905$20240924$PER$$US-BIOVITRUM-2024-US-011640$BIOVITRUM$$78$YR$$F$Y$$$20240924$$CN$US$US
242867201$24286720$1$I$20240101$20240828$20240905$20240905$EXP$$ES-TEVA-VS-3239588$TEVA$$87$YR$$M$Y$$$20240905$$MD$ES$ES
242867212$24286721$2$F$20240903$20240905$20240905$20240906$PER$$US-JNJFOC-20240905441$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240906$$CN$US$US
242867221$24286722$1$I$$20240724$20240905$20240905$PER$$US-LUNDBECK-DKLU4002112$LUNDBECK$$$$$$Y$$$20240905$$HP$US$US
242867232$24286723$2$F$$20240918$20240905$20240918$PER$$NVSC2024US178674$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
242867241$24286724$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178633$NOVARTIS$$$$$$Y$$$20240905$$MD$US$US
242867251$24286725$1$I$$20240827$20240905$20240905$PER$$US-AMGEN-USASP2024171527$AMGEN$$$$$$Y$$$20240905$$MD$US$US
242867261$24286726$1$I$20230101$20240826$20240905$20240905$EXP$$HU-TEVA-VS-3238573$TEVA$Bodn?r F, Lakatos E I, Szikszay E, Varga P, Szegedi I, Kiss Cs, Bessenyei M. Repeated spontaneous intracerebral hemorrhage of a patient suffering irom acute lymphoblastic leukaemia. Gyermekgy?gy?szat. 2024; 75(4): 295-300.$7$YR$$M$Y$$$20240905$$MD$HU$HU
242867271$24286727$1$I$$20240901$20240905$20240905$EXP$$US-BAYER-2024A126296$BAYER$$$$$$Y$$$20240905$$CN$US$US
242867282$24286728$2$F$20240820$20240912$20240905$20240924$PER$$US-SA-2023SA355255$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240924$$MD$US$US
242867291$24286729$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA253758$SANOFI AVENTIS$$$$$$Y$$$20240905$$MD$US$US
242867301$24286730$1$I$20240801$20240827$20240905$20240905$PER$$US-SA-2024SA257814$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240905$$MD$US$US
242867311$24286731$1$I$20240522$20240828$20240905$20240905$EXP$FR-AFSSAPS-LL2024001567$FR-TEVA-VS-3238268$TEVA$$2$MON$$M$Y$2.23$KG$20240905$$PH$FR$FR
242867322$24286732$2$F$$20240909$20240905$20240916$EXP$$CA-GSK-CA2023150188$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$CA$CA
242867331$24286733$1$I$$20240830$20240905$20240905$EXP$$GB-AstraZeneca-2024A198172$ASTRAZENECA$$52$YR$$M$Y$$$20240905$$MD$GB$
242867342$24286734$2$F$20240827$20240906$20240905$20240911$PER$$HN-REGENERON PHARMACEUTICALS, INC.-2024-118846$REGENERON$$$$$F$Y$$$20240911$$CN$HN$HN
242867351$24286735$1$I$20240822$20240826$20240905$20240905$EXP$$US-FARMAPROD-202408-3070$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240905$$CN$US$US
242867362$24286736$2$F$$20240912$20240905$20240921$EXP$$CH-TEVA-VS-3238752$TEVA$Umbricht F, Szajek K, Fehr T. When ions go crazy Unclear status epilepticus. Schweiz-Med-Forum 2024; 24 (29-32): 386-388.; Umbricht F, Szajek K, Fehr T. When ions go crazy Unclear status epilepticus. Schweiz-Med-Forum 2024; 24 (29-32): 386-388.$70$YR$$F$Y$$$20240921$$MD$CH$CH
242867371$24286737$1$I$20240825$20240904$20240904$20240904$DIR$717044$$FDA-CTU$$35$YR$$F$N$132.75$KG$20240904$N$CN$US$
242867382$24286738$2$F$$20240917$20240905$20240919$EXP$$US-PFIZER INC-2024SGN00818$PFIZER$$62$YR$$F$Y$$$20240919$$PH$US$US
242867391$24286739$1$I$20240823$20240830$20240903$20240903$DIR$FDA-CDER-CTU-2024-60948$$FDA-CTU$$31$YR$$M$N$$$20240830$N$HP$US$
242867401$24286740$1$I$20240101$20240830$20240905$20240905$EXP$$IN-PFIZER INC-PV202400114800$PFIZER$$34$YR$$F$Y$$$20240905$$CN$IN$IN
242867411$24286741$1$I$20240801$20240903$20240905$20240905$EXP$$IE-PFIZER INC-202400248869$PFIZER$$52$YR$$F$Y$$$20240905$$CN$IE$IE
242867421$24286742$1$I$20240816$20240902$20240905$20240905$EXP$$CN-PFIZER INC-PV202400115012$PFIZER$$4$YR$$M$Y$17$KG$20240905$$HP$CN$CN
242867431$24286743$1$I$20240902$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001998$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240905$$CN$US$US
242867441$24286744$1$I$20240830$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001346$ELI LILLY AND CO$$$$$$Y$$$20240905$$CN$US$US
242867451$24286745$1$I$20240903$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002764$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240905$$CN$US$US
242867461$24286746$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175682$AMGEN$$72$YR$E$F$Y$$$20240905$$CN$US$US
242867471$24286747$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002588$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242867481$24286748$1$I$$20240830$20240905$20240905$EXP$$PH-OTSUKA-2024_021477$OTSUKA$$$$$F$Y$$$20240905$$CN$PH$PH
242867491$24286749$1$I$$20240903$20240905$20240905$PER$$US-BIOGEN-2024BI01281008$BIOGEN$$$$$$Y$$$20240905$$CN$US$US
242867501$24286750$1$I$$20240902$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE077140$SANDOZ$$$$$M$Y$87$KG$20240905$$CN$DE$DE
242867511$24286751$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001911$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240905$$CN$US$US
242867521$24286752$1$I$20231001$20240830$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140160$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$178.72$KG$20240905$$CN$US$US
242867533$24286753$3$F$$20240909$20240905$20240918$EXP$$JP-TEVA-VS-3237255$TEVA$$74$YR$$F$Y$$$20240918$$PH$JP$JP
242867541$24286754$1$I$20240318$20240827$20240905$20240905$EXP$$FR-DSJP-DSE-2024-142164$DAIICHI$$$$E$F$Y$$$20240905$$MD$FR$FR
242867561$24286756$1$I$$20240829$20240905$20240905$EXP$$US-JNJFOC-20240900578$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242867571$24286757$1$I$$20240904$20240905$20240905$PER$$US-HALEON-2195357$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
242867581$24286758$1$I$20240805$20240830$20240905$20240905$EXP$FR-AFSSAPS-MP2024001332$FR-OTSUKA-2024_024253$OTSUKA$$13$YR$$F$Y$$$20240905$$PH$FR$FR
242867591$24286759$1$I$$20240904$20240905$20240905$EXP$$CO-PFIZER INC-PV202400116549$PFIZER$$$$$F$Y$$$20240905$$MD$CO$CO
242867601$24286760$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176373$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242867611$24286761$1$I$20240903$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024177077$AMGEN$$74$YR$E$F$Y$$$20240905$$CN$US$US
242867622$24286762$2$F$20240813$20240918$20240905$20240923$EXP$$IE-SA-2024SA256674$SANOFI AVENTIS$$56$YR$A$F$Y$120$KG$20240923$$HP$IE$IE
242867641$24286764$1$I$20240313$20240830$20240905$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-140499$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$52.2$KG$20240905$$PH$JP$JP
242867651$24286765$1$I$$20240827$20240905$20240905$EXP$$CA-FreseniusKabi-FK202413130$FRESENIUS KABI$$$$$M$Y$$$20240905$$LW$CA$CA
242867661$24286766$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA253904$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240905$$MD$US$US
242867671$24286767$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA256804$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240905$$CN$US$US
242867681$24286768$1$I$$20240823$20240905$20240905$PER$$US-SA-2024SA255928$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240905$$MD$US$US
242867691$24286769$1$I$20240801$20240827$20240905$20240905$PER$$US-SA-2024SA253960$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240905$$MD$US$US
242867701$24286770$1$I$20240826$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60881$$FDA-CTU$$92$YR$$M$N$$$20240903$Y$PH$US$
242867711$24286771$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA255833$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240905$$MD$US$US
242867721$24286772$1$I$$20240823$20240905$20240905$PER$$US-SA-2024SA255526$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240905$$MD$US$US
242867731$24286773$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA256271$SANOFI AVENTIS$$$$C$F$Y$$$20240905$$MD$US$US
242867741$24286774$1$I$$20240823$20240905$20240905$PER$$US-SA-2024SA255470$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240905$$MD$US$US
242867751$24286775$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA256428$SANOFI AVENTIS$$$$$F$Y$$$20240905$$CN$US$US
242867761$24286776$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA255838$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240905$$MD$US$US
242867771$24286777$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA256106$SANOFI AVENTIS$$$$$F$Y$$$20240905$$CN$US$US
242867791$24286779$1$I$20191229$20240828$20240905$20240905$EXP$$GR-TAKEDA-GR201945462$TAKEDA$$$$$F$Y$$$20240905$$CN$GR$GR
242867801$24286780$1$I$$20240901$20240905$20240905$EXP$$US-JNJFOC-20240901626$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242867811$24286781$1$I$20240827$20240828$20240905$20240905$EXP$$TW-JNJFOC-20240873966$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$TW$TW
242867821$24286782$1$I$20240528$20240902$20240905$20240905$EXP$ES-AEMPS-1557508$ES-ABBVIE-5906073$ABBVIE$$82$YR$$F$Y$$$20240905$$HP$ES$ES
242867841$24286784$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60930$$FDA-CTU$$86$YR$$M$N$$$20240903$N$CN$US$
242867861$24286786$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60928$$FDA-CTU$$65$YR$$M$N$$$20240903$N$$US$
242867881$24286788$1$I$$20240827$20240905$20240905$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17140$IPSEN$$$$$M$Y$$$20240905$$CN$US$US
242867891$24286789$1$I$20221215$20240830$20240905$20240905$EXP$FR-AFSSAPS-MP2024001335$FR-MYLANLABS-2024M1079961$MYLAN$$$$$F$Y$2.92$KG$20240905$$MD$FR$FR
242867901$24286790$1$I$$20240902$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139676$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240905$$CN$US$US
242867911$24286791$1$I$$20240903$20240905$20240905$PER$$US-JNJFOC-20240907695$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240905$$CN$US$US
242867921$24286792$1$I$$20240821$20240905$20240905$PER$$US-ASTELLAS-2024-AER-002115$ASTELLAS$$59$YR$A$F$Y$$$20240905$$HP$US$US
242867931$24286793$1$I$20230101$20240904$20240905$20240905$30DAY$$US-SANDOZ INC.-SDZ2024US077863$SANDOZ$$$$$F$Y$$$20240905$$CN$US$US
242867941$24286794$1$I$20240101$20240822$20240905$20240905$EXP$$CA-UCBSA-2024043078$UCB$$$$$M$Y$$$20240905$$CN$CA$CA
242867951$24286795$1$I$$20240821$20240903$20240903$DIR$FDA-CDER-CTU-2024-60974$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
242867961$24286796$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60856$$FDA-CTU$$37$YR$$F$N$$$20240903$N$$US$
242867971$24286797$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60889$$FDA-CTU$$34$YR$$F$N$$$20240903$N$$US$
242867981$24286798$1$I$$20240830$20240903$20240903$DIR$FDA-CDER-CTU-2024-60917$$FDA-CTU$$$$$F$N$$$20240830$N$HP$US$
242867991$24286799$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60853$$FDA-CTU$$71$YR$$F$N$$$20240903$N$HP$US$
242868001$24286800$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60869$$FDA-CTU$$73$YR$$F$N$$$20240903$N$$US$
242868011$24286801$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60965$$FDA-CTU$$74$YR$$M$N$$$20240903$N$$US$
242868021$24286802$1$I$20240719$20240904$20240904$20240904$DIR$717032$$FDA-CTU$$74$YR$$F$N$60$KG$20240904$N$HP$US$
242868031$24286803$1$I$$20240830$20240903$20240903$DIR$FDA-CDER-CTU-2024-60858$$FDA-CTU$$$$$M$N$$$20240830$N$HP$US$
242868041$24286804$1$I$20240830$20240830$20240903$20240903$DIR$FDA-CDER-CTU-2024-61005$$FDA-CTU$$46$YR$$F$N$$$20240830$N$HP$US$
242868051$24286805$1$I$$20240829$20240903$20240903$DIR$FDA-CDER-CTU-2024-60962$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242868061$24286806$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60902$$FDA-CTU$$54$YR$$F$N$112.94$KG$20240903$N$$US$
242868071$24286807$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60871$$FDA-CTU$$69$YR$$F$N$125.65$KG$20240903$N$$US$
242868081$24286808$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60907$$FDA-CTU$$52$YR$$F$N$136.08$KG$20240903$N$$US$
242868091$24286809$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60892$$FDA-CTU$$59$YR$$M$N$$$20240903$N$$US$
242868101$24286810$1$I$20240101$20240903$20240905$20240905$PER$$US-PFIZER INC-202400222653$PFIZER$$69$YR$$F$Y$$$20240905$$HP$US$US
242868112$24286811$2$F$20240101$20240903$20240905$20240906$PER$$US-PFIZER INC-PV202400116034$PFIZER$$82$YR$$M$Y$83.91$KG$20240906$$CN$US$US
242868131$24286813$1$I$20240601$20240829$20240905$20240905$EXP$$US-ROCHE-3098974$ROCHE$$68$YR$E$M$Y$95.25$KG$20240905$$MD$US$US
242868143$24286814$3$F$$20240912$20240905$20240913$PER$$US-PFIZER INC-PV202400116052$PFIZER$$33$YR$$F$Y$$$20240913$$MD$US$US
242868151$24286815$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249715$PFIZER$$64$YR$$F$Y$$$20240905$$CN$US$US
242868161$24286816$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400115767$PFIZER$$66$YR$$F$Y$$$20240905$$HP$US$US
242868171$24286817$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-202400250201$PFIZER$$47$YR$$F$Y$$$20240905$$MD$US$US
242868181$24286818$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249331$PFIZER$$66$YR$$M$Y$$$20240905$$CN$US$US
242868191$24286819$1$I$20240101$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400115909$PFIZER$$64$YR$$F$Y$$$20240905$$HP$US$US
242868201$24286820$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-2021599469$PFIZER$$23$YR$$F$Y$$$20240905$$HP$US$US
242868211$24286821$1$I$20240101$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249712$PFIZER$$62$YR$$$Y$$$20240905$$CN$US$US
242868221$24286822$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400115704$PFIZER$$60$YR$$F$Y$$$20240905$$HP$US$US
242868241$24286824$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-PV202400116522$PFIZER$$$$$F$Y$$$20240905$$HP$US$US
242868251$24286825$1$I$20200101$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400084678$PFIZER$$71$YR$$F$Y$$$20240905$$HP$US$US
242868261$24286826$1$I$20240801$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400115645$PFIZER$$63$YR$$F$Y$$$20240905$$CN$US$US
242868271$24286827$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202300034306$PFIZER$$65$YR$$F$Y$92.3$KG$20240905$$CN$US$US
242868281$24286828$1$I$20240801$20240903$20240905$20240905$PER$$US-PFIZER INC-PV202400115467$PFIZER$$64$YR$$F$Y$$$20240905$$HP$US$US
242868291$24286829$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249556$PFIZER$$54$YR$$F$Y$$$20240905$$CN$US$US
242868302$24286830$2$F$$20240919$20240905$20240923$PER$$US-PFIZER INC-202400250245$PFIZER$$68$YR$$M$Y$$$20240923$$CN$US$US
242868311$24286831$1$I$20240818$20240828$20240905$20240905$EXP$$CO-AstraZeneca-2024A197755$ASTRAZENECA$$15642$DY$$F$Y$64$KG$20240905$$CN$CO$
242868321$24286832$1$I$20240820$20240821$20240905$20240905$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08375$LUPIN$$$$$$Y$$$20240905$$CN$US$US
242868332$24286833$2$F$20240831$20240906$20240905$20240909$PER$$US-AMGEN-USASP2024176991$AMGEN$$64$YR$A$F$Y$$$20240909$$CN$US$US
242868341$24286834$1$I$20240801$20240821$20240905$20240905$PER$$US-ASTELLAS-2024-AER-002326$ASTELLAS$$58$YR$A$M$Y$$$20240905$$HP$US$US
242868351$24286835$1$I$20240717$20240904$20240905$20240905$EXP$$US-GILEAD-2024-0686287$GILEAD$$63$YR$A$M$Y$$$20240905$$CN$US$US
242868361$24286836$1$I$20240824$20240830$20240905$20240905$EXP$$US-ANIPHARMA-2024-US-047179$ANI$$67$YR$$F$Y$$$20240905$$HP$US$US
242868372$24286837$2$F$20240831$20240904$20240905$20240919$EXP$$CA-HLS-202401230$HLS THERAPEUTICS$$66$YR$E$M$Y$$$20240919$$HP$CA$CA
242868401$24286840$1$I$20240513$20240830$20240905$20240905$EXP$IE-HPRA-2024-114186$IE-MYLANLABS-2024M1080767$MYLAN$$51$YR$$F$Y$$$20240905$$PH$IE$IE
242868412$24286841$2$F$20240903$20240903$20240905$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001785$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240909$$CN$US$US
242868421$24286842$1$I$20240903$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002843$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240905$$CN$US$US
242868431$24286843$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140465$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$55.79$KG$20240905$$CN$US$US
242868441$24286844$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141513$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240905$$CN$US$US
242868451$24286845$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140522$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240905$$CN$US$US
242868461$24286846$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140600$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240905$$CN$US$US
242868471$24286847$1$I$$20240828$20240905$20240905$EXP$$NZ-TAKEDA-2024TUS087867$TAKEDA$$$$$$Y$$$20240905$$PH$NZ$NZ
242868481$24286848$1$I$20240101$20240903$20240905$20240905$EXP$$US-ORGANON-O2409USA000270$ORGANON$$16$YR$$F$Y$$$20240905$$CN$US$US
242868491$24286849$1$I$$20240830$20240905$20240905$EXP$$CA-ABBVIE-5908548$ABBVIE$$25$YR$$M$Y$$$20240905$$HP$CA$CA
242868501$24286850$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176450$AMGEN$$$$$$Y$$$20240905$$MD$US$US
242868511$24286851$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60864$$FDA-CTU$$81$YR$$F$N$75.3$KG$20240903$N$$US$
242868521$24286852$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176361$AMGEN$$$$$$Y$$$20240905$$HP$US$US
242868541$24286854$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3238214$TEVA$$80$YR$$M$Y$89$KG$20240905$$HP$CA$CA
242868551$24286855$1$I$$20240831$20240903$20240903$DIR$FDA-CDER-CTU-2024-60991$$FDA-CTU$$$$$M$N$$$20240831$N$HP$US$
242868561$24286856$1$I$20240704$20240815$20240903$20240903$DIR$FDA-CDER-CTU-2024-61003$$FDA-CTU$$78$YR$$M$N$$$20240815$N$HP$US$
242868571$24286857$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60946$$FDA-CTU$$86$YR$$F$N$$$20240903$N$$US$
242868581$24286858$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-60518$$FDA-CTU$$$$$$N$$$20240904$N$CN$US$
242868591$24286859$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-60516$$FDA-CTU$$$$$$N$$$20240904$N$CN$US$
242868601$24286860$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-60565$$FDA-CTU$$$$$$N$$$20240904$N$CN$US$
242868611$24286861$1$I$$20240815$20240903$20240903$DIR$FDA-CDER-CTU-2024-60957$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
242868621$24286862$1$I$$20240904$20240904$20240904$DIR$717162$$FDA-CTU$$$$$UNK$N$$$20240904$$CN$US$
242868631$24286863$1$I$$20240904$20240903$20240903$DIR$FDA-CDER-CTU-2024-60985$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
242868641$24286864$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60913$$FDA-CTU$$62$YR$$F$N$94.8$KG$20240903$N$$US$
242868651$24286865$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60906$$FDA-CTU$$42$YR$$F$N$95.25$KG$20240903$N$$US$
242868661$24286866$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-60536$$FDA-CTU$$$$$$N$$$20240904$N$CN$US$
242868671$24286867$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60922$$FDA-CTU$$68$YR$$F$N$63.5$KG$20240903$N$$US$
242868681$24286868$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-60544$$FDA-CTU$$$$$$N$$$20240904$$CN$US$
242868691$24286869$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60896$$FDA-CTU$$61$YR$$F$N$99.34$KG$20240903$N$$US$
242868702$24286870$2$F$$20240916$20240905$20240924$EXP$$GB-VANTIVE-2024VAN019471$Vantive US Healthcare$$$$$F$Y$$$20240924$$HP$GB$GB
242868711$24286871$1$I$$20240901$20240905$20240905$PER$$US-BAYER-2024A126825$BAYER$$$$$$Y$$$20240905$$CN$US$US
242868721$24286872$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA257098$SANOFI AVENTIS$$$$$F$Y$$$20240905$$CN$US$US
242868731$24286873$1$I$20240101$20240829$20240905$20240905$EXP$$FR-Genus_Lifesciences-USA-POI0580202400145$GENUS LIFESCIENCES$Zaidan M. A case report of Paracetamol related pyroglutamic acidosis mind the gap in a malnourished patient. BMC Nephrology. 2024 AUG 13;25(1):260.$67$YR$E$M$Y$$$20240904$$MD$FR$FR
242868741$24286874$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA257812$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240905$$HP$US$US
242868751$24286875$1$I$$20240824$20240905$20240905$PER$$US-SA-2024SA256914$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240905$$MD$US$US
242868761$24286876$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA254494$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240905$$MD$US$US
242868771$24286877$1$I$20240101$20240822$20240905$20240905$PER$$US-SA-2024SA256143$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240905$$MD$US$US
242868781$24286878$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA257852$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240905$$HP$US$US
242868791$24286879$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-60506$$FDA-CTU$$$$$$N$$$20240904$$CN$US$
242868801$24286880$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60938$$FDA-CTU$$56$YR$$F$N$72.12$KG$20240903$N$$US$
242868811$24286881$1$I$20240825$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-60563$$FDA-CTU$$36$YR$$F$N$204.8$LBS$20240904$Y$MD$US$
242868821$24286882$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60934$$FDA-CTU$$57$YR$$F$N$$$20240903$N$$US$
242868832$24286883$2$F$20230501$20240829$20240905$20240906$EXP$$NVSC2024EE123253$NOVARTIS$$8$YR$$M$Y$$$20240906$$MD$EE$EE
242868841$24286884$1$I$20200214$20240830$20240905$20240905$EXP$$CA-SANDOZ INC.-PHHY2018CA104315$SANDOZ$$62$YR$$F$Y$$$20240905$$CN$CA$CA
242868851$24286885$1$I$20240826$20240904$20240904$20240904$DIR$717121$$FDA-CTU$$37$YR$$M$N$$$20240904$N$CN$US$
242868861$24286886$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60905$$FDA-CTU$$35$YR$$F$N$$$20240903$N$$US$
242868871$24286887$1$I$$20240826$20240905$20240905$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-002007$SK LIFE SCIENCE$$$$$$Y$$$20240905$$CN$US$US
242868881$24286888$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-60561$$FDA-CTU$$$$$$N$$$20240904$$CN$US$
242868891$24286889$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60909$$FDA-CTU$$96$YR$$F$N$$$20240903$N$$US$
242868901$24286890$1$I$20240801$20240826$20240905$20240905$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001998$SK LIFE SCIENCE$$$$$$Y$$$20240905$$PH$US$US
242868911$24286891$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024177110$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242868921$24286892$1$I$20240205$20240902$20240905$20240905$EXP$$KR-GILEAD-2024-0685613$GILEAD$$62$YR$A$M$Y$$$20240905$$MD$KR$KR
242868931$24286893$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60845$$FDA-CTU$$68$YR$$F$N$$$20240903$N$$US$
242868941$24286894$1$I$20240827$20240904$20240904$20240904$DIR$717115$$FDA-CTU$$39$YR$$F$N$94.5$KG$20240904$Y$CN$US$
242868951$24286895$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60929$$FDA-CTU$$59$YR$$F$N$$$20240903$N$$US$
242868961$24286896$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60933$$FDA-CTU$$22$YR$$F$N$$$20240903$N$$US$
242868972$24286897$2$F$20240828$20240905$20240905$20240908$PER$$US-AMGEN-USASP2024176963$AMGEN$$73$YR$E$F$Y$$$20240908$$CN$US$US
242868981$24286898$1$I$$20240829$20240905$20240905$EXP$$CA-TAKEDA-2022TUS103601$TAKEDA$$$$$F$Y$$$20240905$$CN$CA$CA
242868991$24286899$1$I$20240826$20240830$20240905$20240905$EXP$$PR-ASTELLAS-2024-AER-004090$ASTELLAS$$60$YR$A$M$Y$97.52$KG$20240905$$CN$PR$PR
242869011$24286901$1$I$20240819$20240828$20240905$20240905$EXP$$CN-AstraZeneca-2024A198223$ASTRAZENECA$$50$YR$$F$Y$50$KG$20240905$$MD$CN$
242869022$24286902$2$F$$20240913$20240905$20240920$EXP$$CA-GSK-CA2024107839$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$CA$CA
242869032$24286903$2$F$$20240904$20240905$20240906$PER$$US-PFIZER INC-PV202400116245$PFIZER$$59$YR$$F$Y$$$20240906$$HP$US$US
242869041$24286904$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-202400249823$PFIZER$$15$YR$$F$Y$$$20240905$$MD$US$US
242869061$24286906$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-202400250533$PFIZER$$$$T$F$Y$$$20240905$$MD$US$US
242869071$24286907$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-PV202400116525$PFIZER$$46$YR$$M$Y$$$20240905$$CN$US$US
242869081$24286908$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-PV202400116509$PFIZER$$53$YR$$F$Y$$$20240905$$HP$US$US
242869091$24286909$1$I$20240902$20240904$20240905$20240905$PER$$US-PFIZER INC-202400249749$PFIZER$$43$YR$$F$Y$$$20240905$$MD$US$US
242869101$24286910$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-202400250314$PFIZER$$52$YR$$M$Y$$$20240905$$HP$US$US
242869111$24286911$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-202400250522$PFIZER$$$$A$$Y$$$20240905$$CN$US$US
242869122$24286912$2$F$$20240906$20240905$20240910$PER$$US-PFIZER INC-PV202400116018$PFIZER$$$$$F$Y$$$20240910$$LW$US$US
242869131$24286913$1$I$20240901$20240904$20240905$20240905$PER$$US-PFIZER INC-202400250277$PFIZER$$58$YR$$F$Y$$$20240905$$CN$US$US
242869141$24286914$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-PV202400115863$PFIZER$$$$$$Y$$$20240905$$CN$US$US
242869151$24286915$1$I$20240904$20240904$20240905$20240905$PER$$US-PFIZER INC-202400250379$PFIZER$$41$YR$$F$Y$$$20240905$$HP$US$US
242869161$24286916$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-PV202400115904$PFIZER$$13$YR$$F$Y$$$20240905$$MD$US$US
242869172$24286917$2$F$$20240905$20240905$20240905$PER$$US-PFIZER INC-PV202400115931$PFIZER$$61$YR$$F$Y$$$20240905$$CN$US$US
242869181$24286918$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-PV202400116239$PFIZER$$70$YR$$$Y$$$20240905$$CN$US$US
242869191$24286919$1$I$20240830$20240904$20240905$20240905$PER$$US-PFIZER INC-202400250501$PFIZER$$64$YR$$F$Y$$$20240905$$CN$US$US
242869201$24286920$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-PV202400116222$PFIZER$$64$YR$$F$Y$$$20240905$$HP$US$US
242869211$24286921$1$I$20240902$20240904$20240905$20240905$PER$$US-PFIZER INC-202400250196$PFIZER$$56$YR$$F$Y$$$20240905$$CN$US$US
242869222$24286922$2$F$$20240906$20240905$20240910$PER$$US-PFIZER INC-PV202400116049$PFIZER$$$$$M$Y$$$20240910$$LW$US$US
242869231$24286923$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA256706$SANOFI AVENTIS$$$$E$F$Y$$$20240905$$CN$US$US
242869242$24286924$2$F$20240101$20240828$20240905$20240911$PER$$US-SA-2024SA255597$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240911$$MD$US$US
242869251$24286925$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA253506$SANOFI AVENTIS$$80$YR$E$$Y$$$20240905$$CN$US$US
242869261$24286926$1$I$20240801$20240904$20240905$20240905$PER$$US-PFIZER INC-202400249825$PFIZER$$15$YR$$F$Y$$$20240905$$MD$US$US
242869271$24286927$1$I$$20240823$20240905$20240905$PER$$US-SA-2024SA256455$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240905$$CN$US$US
242869282$24286928$2$F$20240816$20240830$20240905$20240911$PER$$US-SA-2024SA254554$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240911$$CN$US$US
242869291$24286929$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA253500$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240905$$CN$US$US
242869303$24286930$3$F$20240813$20240823$20240905$20240920$PER$$US-SA-2024SA255995$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240920$$CN$US$US
242869311$24286931$1$I$$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139533$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240905$$HP$US$US
242869331$24286933$1$I$$20240904$20240905$20240905$EXP$$RO-GILEAD-2024-0686252$GILEAD$$55$YR$A$F$Y$$$20240905$$MD$RO$RO
242869341$24286934$1$I$20240201$20240827$20240905$20240905$EXP$$JP-TAKEDA-2024TUS088322$TAKEDA$$45$YR$$M$Y$$$20240905$$MD$JP$JP
242869351$24286935$1$I$20240818$20240830$20240905$20240905$PER$$US-AMGEN-USASP2024174859$AMGEN$$77$YR$E$M$Y$$$20240905$$CN$US$US
242869361$24286936$1$I$20240901$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024176883$AMGEN$$76$YR$E$F$Y$$$20240905$$PH$US$US
242869371$24286937$1$I$20240809$20240828$20240905$20240905$EXP$$CN-PURDUE-USA-2024-0311760$PURDUE$$74$YR$$F$Y$43$KG$20240905$$HP$CN$CN
242869382$24286938$2$F$20240801$20240905$20240905$20240914$PER$$US-SA-2024SA256034$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240914$$MD$US$US
242869391$24286939$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA256251$SANOFI AVENTIS$$$$$$Y$$$20240905$$HP$US$US
242869401$24286940$1$I$20220101$20240827$20240905$20240905$PER$$US-SA-2024SA256500$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240905$$CN$US$US
242869411$24286941$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA257001$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240905$$CN$US$US
242869422$24286942$2$F$20240807$20240905$20240905$20240910$PER$$US-AMGEN-USASP2024176164$AMGEN$$76$YR$E$F$Y$$$20240910$$CN$US$US
242869431$24286943$1$I$$20240828$20240905$20240905$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004858$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240905$$CN$FR$FR
242869441$24286944$1$I$$20240904$20240905$20240905$EXP$$GB-SANDOZ INC.-SDZ2024GB077841$SANDOZ$$$$$F$Y$$$20240905$$CN$GB$GB
242869452$24286945$2$F$$20240904$20240905$20240917$PER$$US-ABBVIE-5908110$ABBVIE$$50$YR$$M$Y$$$20240917$$HP$US$US
242869461$24286946$1$I$$20240826$20240905$20240905$EXP$$CA-Covis Pharma GmbH-2024COV01095$COVIS PHARMA$$52$YR$A$F$Y$$$20240905$$MD$CA$CA
242869471$24286947$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-60572$$FDA-CTU$$$$$$N$$$20240904$N$CN$US$
242869481$24286948$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-60570$$FDA-CTU$$$$$$N$$$20240904$N$CN$US$
242869491$24286949$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60920$$FDA-CTU$$63$YR$$M$N$194.14$KG$20240903$N$$US$
242869501$24286950$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-60566$$FDA-CTU$$$$$$N$$$20240904$N$CN$US$
242869511$24286951$1$I$20240828$20240829$20240903$20240903$DIR$FDA-CDER-CTU-2024-60947$$FDA-CTU$$77$YR$$M$N$$$20240829$N$HP$US$
242869521$24286952$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60924$$FDA-CTU$$52$YR$$F$N$$$20240903$N$$US$
242869531$24286953$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60926$$FDA-CTU$$29$YR$$M$N$104.33$KG$20240903$N$$US$
242869541$24286954$1$I$$20240826$20240905$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-141270$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240905$$MD$JP$JP
242869551$24286955$1$I$20240820$20240904$20240904$20240904$DIR$717140$$FDA-CTU$$61$YR$$M$N$96.3$KG$20240904$N$$US$
242869591$24286959$1$I$20240904$20240904$20240904$20240904$DIR$717178$$FDA-CTU$$68$YR$$M$N$76.5$KG$20240904$N$CN$US$
242869601$24286960$1$I$$20240904$20240905$20240905$EXP$$NVSC2024US178211$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242869621$24286962$1$I$$20240904$20240905$20240905$PER$$US-ROCHE-10000074365$ROCHE$$$$$F$Y$$$20240905$$PH$US$US
242869631$24286963$1$I$20240830$20240904$20240905$20240905$PER$$US-ROCHE-10000074343$ROCHE$$45$YR$A$M$Y$$$20240905$$CN$US$US
242869641$24286964$1$I$$20240904$20240905$20240905$PER$$US-ROCHE-10000074193$ROCHE$$$$$$Y$$$20240905$$CN$US$US
242869651$24286965$1$I$$20240826$20240905$20240905$30DAY$$US-GSK-US2024106146$GLAXOSMITHKLINE$$$$$M$Y$$$20240905$$CN$US$US
242869661$24286966$1$I$$20240822$20240905$20240905$PER$$US-SA-2024SA253621$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240905$$CN$US$US
242869671$24286967$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001455$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240905$$CN$US$US
242869681$24286968$1$I$20240101$20240821$20240905$20240905$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0850$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240905$$CN$US$US
242869701$24286970$1$I$$20240823$20240905$20240905$EXP$GB-MHRA-MIDB-f9244eb3-bae7-4267-849d-34b131672881$GB-SA-2024SA251563$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240905$$HP$GB$GB
242869711$24286971$1$I$20240817$20240830$20240905$20240905$EXP$SE-SEMPA-2024-006309$SE-MYLANLABS-2024M1079982$MYLAN$$39$YR$$F$Y$$$20240905$$MD$SE$SE
242869721$24286972$1$I$$20240901$20240905$20240905$PER$$US-BAYER-2024A125946$BAYER$$$$$F$Y$$$20240905$$CN$US$US
242869731$24286973$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141289$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240905$$CN$US$US
242869741$24286974$1$I$20240731$20240829$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138854$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240905$$HP$US$US
242869751$24286975$1$I$20240801$20240830$20240905$20240905$EXP$$US-AVEO PHARMACEUTICALS, INC.-2024-AVEO-US000516$PAREXEL$$$$$$Y$$$20240905$$MD$US$US
242869761$24286976$1$I$$20240903$20240905$20240905$PER$$US-BIOGEN-2020BI00893893$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
242869771$24286977$1$I$$20240904$20240905$20240905$PER$$US-JNJFOC-20240907590$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$US$US
242869781$24286978$1$I$$20240830$20240905$20240905$EXP$FR-AFSSAPS-AVCN2024000657$FR-MYLANLABS-2024M1079974$MYLAN$$$$$M$Y$$$20240905$$PH$FR$FR
242869791$24286979$1$I$20240717$20240830$20240905$20240905$EXP$FR-AFSSAPS-AM2024000696$FR-MYLANLABS-2024M1080147$MYLAN$$64$YR$$M$Y$140$KG$20240905$$PH$FR$FR
242869801$24286980$1$I$20240823$20240826$20240905$20240905$EXP$$US-FARMAPROD-202408-3072$DOMPE FARMACEUTICI$$86$YR$E$M$Y$$$20240905$$CN$US$US
242869811$24286981$1$I$20240711$20240904$20240905$20240905$PER$$US-BAYER-2024A126873$BAYER$$$$$F$Y$$$20240905$$CN$US$US
242869821$24286982$1$I$$20240902$20240905$20240905$EXP$$CN-AstraZeneca-2024A201256$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$CN$
242869831$24286983$1$I$$20240903$20240905$20240905$EXP$$DE-AstraZeneca-2024A200602$ASTRAZENECA$$83$YR$$F$Y$$$20240905$$MD$DE$
242869841$24286984$1$I$$20240902$20240905$20240905$PER$$US-AMGEN-USASP2024175460$AMGEN$Hui-yuen J. S.; Mian Z.; Calistro T. et al.. Discordant Perception of Disease Activity Between Providers and Adolescents with Systemic Lupus Erythematosus: A Cohort Study. Journal of Pediatrics. 2024;274:1-5$$$$$Y$$$20240905$$MD$US$US
242869852$24286985$2$F$20210726$20240829$20240905$20240913$EXP$$NVSC2024US175643$NOVARTIS$$54$YR$$F$Y$63.5$KG$20240913$$MD$US$US
242869861$24286986$1$I$20200817$20240827$20240905$20240905$EXP$$DE-BAXTER-2024BAX023915$BAXTER$$$$$M$Y$$$20240905$$MD$DE$DE
242869871$24286987$1$I$$20240826$20240905$20240905$EXP$$SA-BAXTER-2024BAX023855$BAXTER$$$$$$Y$$$20240905$$CN$SA$SA
242869881$24286988$1$I$20240119$20240827$20240905$20240905$EXP$FR-AFSSAPS-RE2024000187$FR-BAXTER-2024BAX013665$BAXTER$$50$YR$$F$Y$62$KG$20240905$$MD$FR$FR
242869891$24286989$1$I$$20240826$20240905$20240905$PER$$US-RDY-SPO/USA/24/0012698$DR REDDYS$Kinney RE, Nair S, Kim CH, Thomas MB, DelaTorre M. Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer. Oncologist. 2023 Jun 01;28(6): E478-E486. doi:10.1093/oncolo/oyad079.$55$YR$A$F$Y$$$20240905$$MD$US$US
242869901$24286990$1$I$$20240904$20240905$20240905$EXP$$US-GILEAD-2024-0686302$GILEAD$$$$E$M$Y$$$20240905$$CN$US$US
242869911$24286991$1$I$20240529$20240905$20240905$20240905$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-015389$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$$$20240905$$CN$JP$JP
242869921$24286992$1$I$$20240827$20240905$20240905$EXP$$AT-BAXTER-2024BAX023537$BAXTER$$66$YR$$F$Y$$$20240905$$HP$AT$AT
242869931$24286993$1$I$20240901$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176353$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242869951$24286995$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176188$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
242869961$24286996$1$I$$20240903$20240905$20240905$PER$$US-JNJFOC-20240905013$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242869971$24286997$1$I$20240903$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60850$$FDA-CTU$$14$YR$$M$N$$$20240903$Y$$US$
242869981$24286998$1$I$$20240822$20240905$20240905$EXP$$US-SA-2024SA257052$SANOFI AVENTIS$$$$A$M$Y$$$20240905$$MD$US$US
242869991$24286999$1$I$20240711$20240829$20240905$20240905$EXP$$US-SA-2024SA257493$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240905$$MD$US$US
242870001$24287000$1$I$$20240901$20240905$20240905$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014110$JAZZ$$$$$F$Y$$$20240905$$CN$US$US
242870011$24287001$1$I$$20240903$20240905$20240905$EXP$$US-SANDOZ INC.-SDZ2024US077803$SANDOZ$$36$YR$$F$Y$$$20240905$$CN$US$US
242870021$24287002$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA254832$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240905$$CN$US$US
242870031$24287003$1$I$20240830$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140610$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240905$$CN$US$US
242870041$24287004$1$I$$20240828$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211202792$BRISTOL MYERS SQUIBB$Ramaswami R, Polizzotto MN, Lurain K, Wyvill KM, Widell A, George J, et al. Safety, activity, and long-term outcomes of pomalidomide in the treatment of Kaposi sarcoma among individuals with or without HIV infection. Clinical Cancer Research. 2022 Mar 01;28(5):840-50. doi:10.1158/1078-0432.CCR-21-3364.$$$$$Y$$$20240905$$MD$US$US
242870051$24287005$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141340$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240905$$CN$US$US
242870061$24287006$1$I$$20240830$20240905$20240905$EXP$$FR-MEITHEAL-2024MPLIT00276$MEITHEAL PHARMACEUTICALS$Bouguennec M, et al..Allergological Management of a Cytokine Release Reaction to  Injectable Methylprednisolone.French Journal of Allergy.APR-2024;64 (10):103923$42$YR$A$F$Y$$$20240905$$HP$FR$FR
242870071$24287007$1$I$$20240826$20240905$20240905$EXP$$US-MEITHEAL-2024MPLIT00277$MEITHEAL PHARMACEUTICALS$Osama M, et al..Trigger-Point Bupivacaine Injection Causing A ^Heart-Break.Journal of Cardiac Failure.jan-2024;30 (1):276-7$59$YR$A$F$Y$$$20240905$$HP$US$US
242870081$24287008$1$I$20151001$20240826$20240905$20240905$EXP$$CN-MEITHEAL-2024MPLIT00272$MEITHEAL PHARMACEUTICALS$Song L, et al.Possible role of a malfunctioning immune system in discordant lymphoma with peripheral T-cell lymphoma secondary to classical Hodgkin lymphoma: A case report.Oncology Letters.2024;28(4):1-11$73$YR$E$M$Y$$$20240905$$HP$CN$CN
242870092$24287009$2$F$20240426$20240911$20240905$20240918$EXP$$NVSC2024AR095417$NOVARTIS$$0$YR$$F$Y$$$20240918$$CN$AR$AR
242870101$24287010$1$I$$20240829$20240905$20240905$EXP$$US-ABBVIE-5906667$ABBVIE$$$$$F$Y$$$20240905$$MD$US$US
242870121$24287012$1$I$$20240902$20240905$20240905$30DAY$$GT-PFIZER INC-PV202400115387$PFIZER$$10$YR$$F$Y$$$20240905$$CN$GT$GT
242870132$24287013$2$F$20221201$20240829$20240905$20240909$PER$$US-SA-2024SA256833$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240909$$MD$US$US
242870142$24287014$2$F$20240101$20240919$20240905$20240924$EXP$$US-SA-2024SA254863$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240924$$MD$US$US
242870151$24287015$1$I$20240602$20240903$20240905$20240905$EXP$FR-AFSSAPS-DJ2024000958$FR-009507513-2409FRA001276$MERCK$$70$YR$$M$Y$71$KG$20240905$$MD$FR$FR
242870161$24287016$1$I$20240115$20240822$20240905$20240905$EXP$$CA-UCBSA-2023043016$UCB$$67$YR$$F$Y$$$20240905$$CN$CA$CA
242870171$24287017$1$I$20240105$20240827$20240905$20240905$EXP$$FR-DAIICHI SANKYO, INC.-DSE-2024-142138$DAIICHI$$79$YR$$M$Y$94$KG$20240905$$MD$FR$FR
242870191$24287019$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA257433$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240905$$CN$US$US
242870201$24287020$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA253766$SANOFI AVENTIS$$71$YR$E$$Y$$$20240905$$HP$US$US
242870211$24287021$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA253781$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240905$$HP$US$US
242870221$24287022$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA253926$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240905$$CN$US$US
242870231$24287023$1$I$$20240830$20240905$20240905$EXP$$US-ABBVIE-5905708$ABBVIE$$$$$$Y$$$20240905$$CN$US$US
242870251$24287025$1$I$$20240725$20240905$20240905$PER$$US-FMCRTG-FMC-2407-000920$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240905$$CN$US$US
242870261$24287026$1$I$20240820$20240823$20240905$20240905$EXP$$US-FMCRTG-FMC-2408-001064$FRESENIUS MEDICAL CARE$$59$YR$A$M$Y$$$20240905$$HP$US$US
242870271$24287027$1$I$20240723$20240802$20240905$20240905$PER$$US-FMCRTG-FMC-2408-000955$FRESENIUS MEDICAL CARE$$83$YR$E$F$Y$62$KG$20240905$$HP$US$US
242870281$24287028$1$I$20240726$20240801$20240905$20240905$PER$$US-FMCRTG-FMC-2408-000935$FRESENIUS MEDICAL CARE$$75$YR$E$F$Y$$$20240905$$HP$US$US
242870291$24287029$1$I$$20240724$20240905$20240905$PER$$US-FMCRTG-FMC-2407-000917$FRESENIUS MEDICAL CARE$$61$YR$A$F$Y$83$KG$20240905$$HP$US$US
242870301$24287030$1$I$$20240805$20240905$20240905$PER$$US-FMCRTG-FMC-2408-000968$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240905$$CN$US$US
242870311$24287031$1$I$$20240802$20240905$20240905$PER$$US-FMCRTG-FMC-2408-000960$FRESENIUS MEDICAL CARE$$59$YR$A$M$Y$$$20240905$$HP$US$US
242870321$24287032$1$I$$20240808$20240905$20240905$PER$$US-FMCRTG-FMC-2408-000963$FRESENIUS MEDICAL CARE$$82$YR$E$M$Y$$$20240905$$HP$US$US
242870331$24287033$1$I$$20240812$20240905$20240905$PER$$US-FMCRTG-FMC-2408-000992$FRESENIUS MEDICAL CARE$$79$YR$E$M$Y$82.5$KG$20240905$$HP$US$US
242870341$24287034$1$I$$20240730$20240905$20240905$PER$$US-FMCRTG-FMC-2408-000940$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240905$$CN$US$US
242870351$24287035$1$I$$20240823$20240905$20240905$EXP$$US-FMCRTG-FMC-2409-001089$FRESENIUS MEDICAL CARE$$77$YR$E$F$Y$73.94$KG$20240905$$HP$US$US
242870361$24287036$1$I$20240715$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140291$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240905$$CN$US$US
242870371$24287037$1$I$20240101$20240904$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141332$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240905$$HP$US$US
242870381$24287038$1$I$20240814$20240904$20240905$20240905$EXP$$US-INCYTE CORPORATION-2024IN009322$INCYTE$$$$$$Y$$$20240905$$CN$US$US
242870401$24287040$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141163$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240905$$CN$US$US
242870411$24287041$1$I$20240711$20240828$20240905$20240905$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000890$PAREXEL$$$$$$Y$$$20240905$$HP$CN$CN
242870421$24287042$1$I$$20240830$20240905$20240905$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014117$JAZZ$$$$$M$Y$$$20240905$$CN$US$US
242870441$24287044$1$I$$20240903$20240905$20240905$EXP$$NVSC2024PL177932$NOVARTIS$$$$$F$Y$$$20240905$$MD$PL$PL
242870451$24287045$1$I$$20240903$20240905$20240905$EXP$$ZA-AstraZeneca-2024A200357$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$ZA$
242870461$24287046$1$I$$20240831$20240905$20240905$EXP$$US-AstraZeneca-2024A200322$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242870471$24287047$1$I$$20240828$20240905$20240905$EXP$$US-AstraZeneca-2024A196700$ASTRAZENECA$$$$$F$Y$68$KG$20240905$$MD$US$
242870481$24287048$1$I$$20240829$20240903$20240903$DIR$FDA-CDER-CTU-2024-60956$$FDA-CTU$$$$$M$N$$$20240829$N$HP$US$
242870501$24287050$1$I$$20240831$20240905$20240905$EXP$$US-AstraZeneca-2024A200661$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242870511$24287051$1$I$20240101$20240821$20240905$20240905$PER$$US-SA-2024SA257517$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240905$$HP$US$US
242870521$24287052$1$I$20240820$20240828$20240905$20240905$EXP$$CN-SA-2024SA253480$SANOFI AVENTIS$$72$YR$E$M$Y$64$KG$20240905$$HP$CN$CN
242870531$24287053$1$I$$20240617$20240905$20240905$PER$$US-PERRIGO-24US005955$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870541$24287054$1$I$$20240628$20240905$20240905$PER$$US-PERRIGO-24US006279$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870551$24287055$1$I$20240617$20240613$20240905$20240905$PER$$US-PERRIGO-24US005908$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870561$24287056$1$I$$20240902$20240903$20240903$DIR$FDA-CDER-CTU-2024-60895$$FDA-CTU$$$$$F$N$$$20240902$N$HP$US$
242870571$24287057$1$I$$20240612$20240905$20240905$PER$$US-PERRIGO-24US005745$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870581$24287058$1$I$$20240611$20240905$20240905$PER$$US-PERRIGO-24US005732$PERRIGO$$$$$M$Y$$$20240905$$CN$US$US
242870591$24287059$1$I$20240622$20240622$20240905$20240905$PER$$US-PERRIGO-24US006067$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870601$24287060$1$I$$20240625$20240905$20240905$PER$$US-PERRIGO-24US006141$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870611$24287061$1$I$$20240608$20240905$20240905$PER$$US-PERRIGO-24US005643$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870621$24287062$1$I$$20240617$20240905$20240905$PER$$US-PERRIGO-24US005921$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870631$24287063$1$I$$20240531$20240905$20240905$PER$$US-PERRIGO-24US005346$PERRIGO$$$$$M$Y$$$20240905$$CN$US$US
242870651$24287065$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001371$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240905$$CN$US$US
242870662$24287066$2$F$20240501$20240909$20240905$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409001409$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240911$$CN$US$US
242870671$24287067$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001431$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240905$$CN$US$US
242870681$24287068$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002778$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240905$$CN$US$US
242870691$24287069$1$I$$20240707$20240905$20240905$PER$$US-PERRIGO-24US006475$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870701$24287070$1$I$$20240719$20240905$20240905$PER$$US-PERRIGO-24US007010$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870711$24287071$1$I$$20240821$20240905$20240905$PER$$US-PERRIGO-24US007907$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870721$24287072$1$I$$20240722$20240905$20240905$PER$$US-PERRIGO-24US007038$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870731$24287073$1$I$$20240709$20240905$20240905$PER$$US-PERRIGO-24US006574$PERRIGO$$$$A$$Y$$$20240905$$CN$US$US
242870741$24287074$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60978$$FDA-CTU$$74$YR$$M$N$$$20240903$N$$US$
242870751$24287075$1$I$$20240722$20240905$20240905$PER$$US-PERRIGO-24US007043$PERRIGO$$$$$F$Y$$$20240905$$CN$US$US
242870761$24287076$1$I$$20240903$20240905$20240905$PER$$US-ROCHE-10000073312$ROCHE$$$$$$Y$$$20240905$$CN$US$US
242870771$24287077$1$I$$20240827$20240905$20240905$EXP$$US-ANIPHARMA-2024-US-046489$ANI$$$$$F$Y$$$20240905$$HP$US$US
242870781$24287078$1$I$$20240904$20240905$20240905$PER$$US-BAYER-2024A127487$BAYER$$$$$$Y$$$20240905$$CN$US$US
242870791$24287079$1$I$20240826$20240827$20240905$20240905$30DAY$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136511$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240905$$CN$US$US
242870802$24287080$2$F$20240831$20240913$20240905$20240916$EXP$$NVSC2024US178333$NOVARTIS$$71$YR$$F$Y$75.6$KG$20240916$$PH$US$US
242870811$24287081$1$I$$20240830$20240905$20240905$EXP$$BR-TAKEDA-2024TUS087947$TAKEDA$$$$$F$Y$$$20240905$$CN$BR$BR
242870821$24287082$1$I$$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139620$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240905$$CN$US$US
242870831$24287083$1$I$$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138743$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240905$$HP$US$US
242870841$24287084$1$I$$20240903$20240905$20240905$PER$$US-ROCHE-10000073156$ROCHE$$$$A$F$Y$$$20240905$$CN$US$US
242870852$24287085$2$F$$20240904$20240905$20240910$PER$$US-JNJFOC-20240904654$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
242870862$24287086$2$F$20240901$20240903$20240905$20240917$30DAY$$US-JNJFOC-20240904435$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240917$$PH$US$US
242870872$24287087$2$F$20240801$20240911$20240905$20240916$PER$$US-ABBVIE-5907381$ABBVIE$$51$YR$$F$Y$51.255$KG$20240916$$CN$US$US
242870881$24287088$1$I$20230901$20240830$20240905$20240905$EXP$$US-INCYTE CORPORATION-2024IN009263$INCYTE$$$$$$Y$$$20240905$$MD$US$US
242870892$24287089$2$F$20220101$20240904$20240905$20240906$PER$$US-PFIZER INC-202400249228$PFIZER$$97$YR$$M$Y$$$20240906$$CN$US$US
242870901$24287090$1$I$20010901$20240828$20240905$20240905$PER$$US-BAUSCH-BL-2024-013085$BAUSCH AND LOMB$$54$YR$$M$Y$$$20240905$$CN$US$US
242870912$24287091$2$F$$20240905$20240905$20240910$EXP$$JP-BAUSCH-BL-2024-013246$BAUSCH AND LOMB$Nishiofuku H, Mori M, Yokomichi N, Sakuma Y, Sugiyama K, Takashina Y, Miyagi A, Ishizuka M, Imai K, Morita T. Successful Management of Terminal Delirium With Transdermal Blonanserin Patch in a Terminally Ill Cancer Patient.. Journal of palliative medicine. 2024;27(8):1097-1101. doi:10.1089/jpm.2023.0584$73$YR$$M$Y$$$20240910$$MD$JP$JP
242870921$24287092$1$I$20240201$20240827$20240905$20240905$PER$$US-INCYTE CORPORATION-2024IN009022$INCYTE$$$$$$Y$$$20240905$$CN$US$US
242870931$24287093$1$I$$20240827$20240905$20240905$EXP$$CA-FreseniusKabi-FK202413208$FRESENIUS KABI$$50$YR$A$M$Y$127$KG$20240905$$HP$CA$CA
242870941$24287094$1$I$20240822$20240829$20240905$20240905$EXP$$CA-JNJFOC-20240533905$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240905$$CN$CA$CA
242870951$24287095$1$I$20240701$20240827$20240905$20240905$PER$$US-RDY-SPO/USA/24/0012700$DR REDDYS$$24$YR$A$F$Y$$$20240905$$HP$US$US
242870961$24287096$1$I$20240816$20240828$20240905$20240905$PER$$US-RDY-SPO/USA/24/0012761$DR REDDYS$$14$YR$T$$Y$$$20240905$$HP$US$US
242870971$24287097$1$I$$20240827$20240905$20240905$PER$$US-RDY-SPO/USA/24/0012716$DR REDDYS$Cromack SC, Lulu Y, Magdy MP. Prostaglandin Injection for Myoma Expulsion (PRIME): Case Series of a Novel Approach to Hysteroscopic Resection of FIGO Type 2 Myomas. Journal of Minimally Invasive Gynecology. 2024 Jul;31(7): 613-619. doi:10.1016/j.jmig.2024.03.011.$32$YR$A$F$Y$$$20240905$$HP$US$US
242870981$24287098$1$I$$20240827$20240905$20240905$EXP$$CA-FreseniusKabi-FK202413174$FRESENIUS KABI$$68$YR$E$M$Y$64$KG$20240905$$PH$CA$CA
242870991$24287099$1$I$$20240904$20240905$20240905$EXP$$US-ABBVIE-5908107$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242871011$24287101$1$I$$20240903$20240905$20240905$PER$$US-ROCHE-10000073141$ROCHE$$$$$F$Y$$$20240905$$PH$US$US
242871021$24287102$1$I$20240423$20240830$20240905$20240905$EXP$DK-DKMA-30735085$DK-MYLANLABS-2024M1079995$MYLAN$$60$YR$$M$Y$140.6$KG$20240905$$MD$DK$DK
242871041$24287104$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60911$$FDA-CTU$$52$YR$$F$N$$$20240903$N$$US$
242871051$24287105$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60890$$FDA-CTU$$43$YR$$F$N$$$20240903$N$$US$
242871061$24287106$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60883$$FDA-CTU$$56$YR$$F$N$$$20240903$N$$US$
242871091$24287109$1$I$20240904$20240904$20240904$20240904$DIR$717185$$FDA-CTU$$91$YR$$M$N$76.5$KG$20240904$N$HP$US$
242871101$24287110$1$I$20240904$20240904$20240904$20240904$DIR$717108$$FDA-CTU$$87$YR$$M$N$$$20240904$Y$HP$US$
242871111$24287111$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60900$$FDA-CTU$$28$YR$$F$N$99.79$KG$20240903$N$$US$
242871131$24287113$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60855$$FDA-CTU$$81$YR$$F$N$$$20240903$N$$US$
242871142$24287114$2$F$20240101$20240912$20240905$20240920$EXP$$TW-BAYER-2024A119596$BAYER$$7$DEC$E$M$Y$$$20240920$$HP$TW$TW
242871151$24287115$1$I$$20240829$20240905$20240905$EXP$$BR-GSK-BR2024AMR108410$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$BR$BR
242871161$24287116$1$I$20240101$20240830$20240905$20240905$EXP$$US-JNJFOC-20240902895$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240905$$MD$US$US
242871171$24287117$1$I$$20240826$20240905$20240905$PER$$US-INCYTE CORPORATION-2024IN008971$INCYTE$$$$$$Y$$$20240905$$CN$US$US
242871181$24287118$1$I$$20240825$20240905$20240905$PER$$US-INCYTE CORPORATION-2024IN008957$INCYTE$$$$$$Y$$$20240905$$MD$US$US
242871191$24287119$1$I$$20240829$20240905$20240905$EXP$$JP-009507513-2408JPN003991J$MERCK$$$$$M$Y$$$20240905$$MD$JP$JP
242871201$24287120$1$I$20240701$20240901$20240905$20240905$EXP$$GB-MYLANLABS-2024M1080402$MYLAN$$56$YR$$M$Y$12$KG$20240905$$CN$GB$GB
242871211$24287121$1$I$$20240830$20240905$20240905$EXP$$CA-009507513-2409CAN000755$MERCK$$79$YR$$F$Y$64$KG$20240905$$PH$CA$CA
242871231$24287123$1$I$$20240827$20240905$20240905$EXP$$US-TAKEDA-2024TUS086885$TAKEDA$$$$$M$Y$$$20240905$$CN$US$US
242871242$24287124$2$F$$20240905$20240905$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141306$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240910$$CN$US$US
242871251$24287125$1$I$$20240904$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141425$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240905$$CN$US$US
242871261$24287126$1$I$20180101$20240903$20240905$20240905$EXP$$US-ROCHE-10000073228$ROCHE$$45$YR$A$F$Y$$$20240905$$CN$US$US
242871271$24287127$1$I$$20240830$20240905$20240905$EXP$$CA-ABBVIE-5907326$ABBVIE$$21$YR$$F$Y$$$20240905$$HP$CA$CA
242871281$24287128$1$I$20240903$20240904$20240905$20240905$EXP$$AU-MYLANLABS-2024M1081096$MYLAN$$49$YR$$F$Y$$$20240905$$HP$AU$AU
242871291$24287129$1$I$20240613$20240829$20240905$20240905$EXP$$US-GSK-US2024AMR108260$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$HP$US$US
242871301$24287130$1$I$20240101$20240821$20240905$20240905$EXP$$US-SA-2024SA256996$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240905$$MD$US$US
242871311$24287131$1$I$$20240828$20240905$20240905$EXP$$US-AstraZeneca-2024A196773$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242871321$24287132$1$I$20240828$20240828$20240905$20240905$EXP$$JP-AstraZeneca-2024A197360$ASTRAZENECA$$68$YR$$M$Y$$$20240905$$MD$JP$
242871331$24287133$1$I$20240823$20240903$20240905$20240905$PER$$US-HALEON-2195275$Haleon PLC$$$$$F$Y$$$20240905$$CN$US$US
242871341$24287134$1$I$20240607$20240828$20240905$20240905$EXP$$FR-AstraZeneca-2024A195897$ASTRAZENECA$$73$YR$$F$Y$65$KG$20240905$$MD$FR$
242871351$24287135$1$I$20240818$20240902$20240905$20240905$EXP$$CN-AstraZeneca-2024A201407$ASTRAZENECA$$79$YR$$F$Y$79$KG$20240905$$MD$CN$
242871362$24287136$2$F$20240813$20240912$20240905$20240918$EXP$$US-FreseniusKabi-FK202413095$FRESENIUS KABI$$67$YR$E$F$Y$$$20240918$$HP$US$US
242871372$24287137$2$F$20240101$20240911$20240905$20240916$EXP$$CA-KARYOPHARM-2024KPT001494$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240916$$CN$CA$CA
242871381$24287138$1$I$$20240828$20240905$20240905$EXP$$CA-AstraZeneca-2024A198403$ASTRAZENECA$$85$YR$$F$Y$$$20240905$$MD$CA$
242871391$24287139$1$I$$20240829$20240905$20240905$EXP$$US-Eisai-EC-2024-173329$EISAI$$$$$F$Y$$$20240905$$HP$US$US
242871401$24287140$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141079$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240905$$CN$US$US
242871411$24287141$1$I$20240808$20240829$20240905$20240905$EXP$FR-AFSSAPS-RN2024000922$FR-Eisai-EC-2024-173188$EISAI$$36$YR$A$F$Y$50$KG$20240905$$MD$FR$FR
242871422$24287142$2$F$20240801$20240828$20240905$20240923$PER$$US-SA-2024SA254117$SANOFI AVENTIS$$20$YR$A$M$Y$66.82$KG$20240923$$HP$US$US
242871431$24287143$1$I$20170101$20240903$20240905$20240905$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-143634$DAIICHI$$$$$F$Y$$$20240905$$CN$US$US
242871441$24287144$1$I$$20240807$20240905$20240905$PER$$US-LEX-000423$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242871451$24287145$1$I$$20240904$20240903$20240903$DIR$FDA-CDER-CTU-2024-60932$$FDA-CTU$$12$YR$$M$N$36.29$KG$20240904$N$PH$US$
242871461$24287146$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60912$$FDA-CTU$$58$YR$$M$N$$$20240903$N$$US$
242871481$24287148$1$I$20240101$20240823$20240905$20240905$PER$$US-SA-2024SA257135$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240905$$HP$US$US
242871501$24287150$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA253964$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240905$$CN$US$US
242871511$24287151$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60921$$FDA-CTU$$79$YR$$F$N$81.65$KG$20240903$N$PH$US$
242871531$24287153$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60852$$FDA-CTU$$$$$M$N$$$20240903$N$HP$US$
242871541$24287154$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60903$$FDA-CTU$$59$YR$$F$N$90.72$KG$20240903$N$$US$
242871551$24287155$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60885$$FDA-CTU$$72$YR$$F$N$$$20240903$N$$US$
242871561$24287156$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002578$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240905$$CN$US$US
242871571$24287157$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002759$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240905$$CN$US$US
242871581$24287158$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002721$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240905$$CN$US$US
242871601$24287160$1$I$$20240829$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138768$BRISTOL MYERS SQUIBB$$$$$F$Y$66.68$KG$20240905$$CN$US$US
242871621$24287162$1$I$$20240819$20240903$20240903$DIR$FDA-CDER-CTU-2024-60935$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
242871651$24287165$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60866$$FDA-CTU$$66$YR$$M$N$111.13$KG$20240903$N$$US$
242871672$24287167$2$F$$20240911$20240905$20240917$EXP$$PL-ORGANON-O2409POL000150$ORGANON$Szlauer-stefanska A, Kaminska-winciorek G.. Patient with chronic cutaneous and mucosal forms of graft- versus-host disease.. DERMATOLOGIA PO DYPLOMIE. 2024;2$30$YR$$M$Y$$$20240917$$HP$PL$PL
242871701$24287170$1$I$$20240829$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138843$BRISTOL MYERS SQUIBB$$$$$F$Y$63.05$KG$20240905$$PH$US$US
242871711$24287171$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60862$$FDA-CTU$$68$YR$$M$N$$$20240903$N$$US$
242871741$24287174$1$I$20240731$20240904$20240904$20240904$DIR$717170$$FDA-CTU$$64$YR$$F$N$99$KG$20240904$N$PH$US$
242871801$24287180$1$I$20240801$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60859$$FDA-CTU$$32$YR$$M$N$$$20240903$N$HP$US$
242871811$24287181$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60870$$FDA-CTU$$61$YR$$M$N$$$20240903$N$$US$
242871821$24287182$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60925$$FDA-CTU$$76$YR$$M$N$$$20240903$N$$US$
242871831$24287183$1$I$20240716$20240808$20240903$20240903$DIR$FDA-CDER-CTU-2024-60931$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
242871841$24287184$1$I$$20240827$20240903$20240903$DIR$FDA-CDER-CTU-2024-60964$$FDA-CTU$$$$$M$N$$$20240827$N$HP$US$
242871851$24287185$1$I$20240903$20240904$20240904$20240904$DIR$717177$$FDA-CTU$$73$YR$$F$N$139$KG$20240904$Y$HP$US$
242871861$24287186$1$I$20240801$20240808$20240903$20240903$DIR$FDA-CDER-CTU-2024-60953$$FDA-CTU$$56$YR$$M$N$$$20240808$N$HP$US$
242871871$24287187$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60882$$FDA-CTU$$78$YR$$F$N$$$20240903$N$$US$
242871891$24287189$1$I$20240831$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176532$AMGEN$$81$YR$E$M$Y$$$20240905$$MD$US$US
242871901$24287190$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3237904$TEVA$$$$$F$Y$$$20240905$$HP$CA$CA
242871922$24287192$2$F$20240512$20240830$20240905$20240911$PER$$CN-Eisai-EC-2024-173516$EISAI$$66$YR$E$F$Y$65$KG$20240911$$HP$CN$CN
242871931$24287193$1$I$20240101$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024175929$AMGEN$$52$YR$A$F$Y$$$20240905$$PH$US$US
242871941$24287194$1$I$20240813$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60844$$FDA-CTU$$3$YR$$F$N$$$20240903$Y$PH$US$
242871951$24287195$1$I$20240815$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176166$AMGEN$$85$YR$E$F$Y$$$20240905$$CN$US$US
242871961$24287196$1$I$$20240904$20240905$20240905$PER$$US-ROCHE-10000074582$ROCHE$$52$YR$A$M$Y$$$20240905$$MD$US$US
242871971$24287197$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60939$$FDA-CTU$$88$YR$$F$N$$$20240903$N$$US$
242871981$24287198$1$I$$20240904$20240904$20240904$DIR$717132$$FDA-CTU$$$$$UNK$N$$$20240904$N$CN$US$
242871991$24287199$1$I$$20240903$20240903$20240903$DIR$FDA-CDER-CTU-2024-60949$$FDA-CTU$$65$YR$$F$N$154$LBS$20240903$N$$US$
242872001$24287200$1$I$$20240904$20240905$20240905$EXP$$AU-GILEAD-2024-0686208$GILEAD$$$$$F$Y$$$20240905$$MD$AU$AU
242872021$24287202$1$I$$20240904$20240904$20240904$DIR$717145$$FDA-CTU$$$$$UNK$N$$$20240904$N$CN$US$
242872031$24287203$1$I$$20240829$20240903$20240903$DIR$FDA-CDER-CTU-2024-60950$$FDA-CTU$$$$$F$N$$$20240829$N$HP$US$
242872041$24287204$1$I$20240819$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61098$$FDA-CTU$$30$YR$$F$N$$$20240903$N$HP$US$
242872051$24287205$1$I$$20240807$20240905$20240905$PER$$US-LEX-000427$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242872061$24287206$1$I$$20240829$20240903$20240903$DIR$FDA-CDER-CTU-2024-60960$$FDA-CTU$$$$$F$N$220$LBS$20240829$N$$US$
242872071$24287207$1$I$$20240829$20240905$20240905$EXP$$US-AstraZeneca-2024A200787$ASTRAZENECA$$64$YR$$F$Y$$$20240905$$HP$US$
242872081$24287208$1$I$20200201$20240831$20240905$20240905$EXP$$ID-AstraZeneca-2024A201540$ASTRAZENECA$$81$YR$$F$Y$$$20240905$$MD$ID$
242872091$24287209$1$I$$20240826$20240905$20240905$EXP$$US-AstraZeneca-2024A200487$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
242872101$24287210$1$I$20240601$20240827$20240905$20240905$PER$$US-SA-2024SA257511$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240905$$MD$US$US
242872112$24287211$2$F$$20240823$20240905$20240918$PER$$US-SA-2024SA256976$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$HP$US$US
242872122$24287212$2$F$20230101$20240906$20240905$20240913$EXP$$NZ-JNJFOC-20240900046$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$HP$NZ$NZ
242872131$24287213$1$I$$20240830$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024174759$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240905$$MD$CN$CN
242872141$24287214$1$I$$20240904$20240905$20240905$PER$$US-HALEON-2195366$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
242872151$24287215$1$I$20240501$20240828$20240905$20240905$EXP$$CA-GSK-CA2020AMR041615$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$MD$CA$CA
242872161$24287216$1$I$$20240829$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-126471$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240905$$CN$US$US
242872171$24287217$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141235$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$83.01$KG$20240905$$CN$US$US
242872191$24287219$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141202$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240905$$CN$US$US
242872201$24287220$1$I$$20240826$20240905$20240905$30DAY$$US-GSK-US2024106156$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242872211$24287221$1$I$20240903$20240903$20240905$20240905$EXP$$US-TAKEDA-US201833126$TAKEDA$$38$YR$$F$Y$$$20240905$$CN$US$US
242872221$24287222$1$I$$20240827$20240905$20240905$EXP$$CA-DENTSPLY-2024SCDP000248$DENTSPLY$$55$YR$$F$Y$80$KG$20240905$$MD$CA$CA
242872232$24287223$2$F$20240801$20240903$20240905$20240909$EXP$$NVSC2024EG167173$NOVARTIS$$31$YR$$F$Y$85$KG$20240909$$CN$EG$EG
242872241$24287224$1$I$$20240827$20240905$20240905$EXP$$CA-DENTSPLY-2024SCDP000251$DENTSPLY$$45$YR$$F$Y$$$20240905$$MD$CA$CA
242872251$24287225$1$I$$20240903$20240905$20240905$EXP$$US-JNJFOC-20240904987$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$HP$US$US
242872261$24287226$1$I$$20240903$20240905$20240905$EXP$FR-EMA-20150519-pdevhumanwt-113428381$FR-SANDOZ INC.-SDZ2024FR077447$SANDOZ$$58$YR$$M$Y$$$20240905$$HP$FR$FR
242872271$24287227$1$I$20240901$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61144$$FDA-CTU$$$$$M$N$72.6$KG$20240903$N$$US$
242872281$24287228$1$I$20240708$20240826$20240904$20240904$DIR$FDA-CDER-CTU-2024-61150$$FDA-CTU$$$$$F$N$70.9$KG$20240826$N$$US$
242872291$24287229$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61011$$FDA-CTU$$45$YR$$F$N$83.01$KG$20240904$N$$US$
242872301$24287230$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61104$$FDA-CTU$$51$YR$$M$N$$$20240904$N$CN$US$
242872312$24287231$2$F$$20240905$20240905$20240906$PER$$NVSC2024US178643$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
242872321$24287232$1$I$$20240904$20240904$20240904$DIR$717122$$FDA-CTU$$$$$UNK$N$$$20240904$$CN$US$
242872331$24287233$1$I$$20240903$20240905$20240905$EXP$$JP-Eisai-EC-2024-173700$EISAI$Kanasugi Masaru. A Case of Intestinal Emphysema Exacerbated after Completion of Lenvatinib Treatment. Journal of the Japanese Society of Gynecologic Oncology. 2024; 42(3): 364-.$53$YR$A$F$Y$$$20240905$$MD$JP$JP
242872341$24287234$1$I$20231006$20240904$20240905$20240905$EXP$$KR-009507513-2409KOR001035$MERCK$$$$A$M$Y$$$20240905$$HP$KR$KR
242872361$24287236$1$I$20240101$20240830$20240905$20240905$EXP$$JP-AMGEN-JPNSP2024175334$AMGEN$$$$$F$Y$$$20240905$$CN$JP$JP
242872371$24287237$1$I$$20240828$20240905$20240905$EXP$$US-MTPC-MTDA2024-0018375$Unknown Manufacturer$$$$A$$Y$$$20240905$$HP$US$US
242872381$24287238$1$I$$20240830$20240905$20240905$EXP$$US-KYOWAKIRIN-2024KK020518$KYOWA$$$$$$Y$$$20240905$$HP$US$US
242872391$24287239$1$I$20240826$20240828$20240904$20240904$DIR$FDA-CDER-CTU-2024-61147$$FDA-CTU$$$$$F$N$71.4$KG$20240828$N$$US$
242872401$24287240$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001756$ELI LILLY AND CO$$$$$M$Y$$$20240905$$CN$US$US
242872411$24287241$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3238209$TEVA$$60$YR$$M$Y$$$20240905$$HP$CA$CA
242872421$24287242$1$I$$20240821$20240905$20240905$EXP$$CA-ASTELLAS-2024-AER-002272$ASTELLAS$$86$YR$E$M$Y$70$KG$20240905$$PH$CA$CA
242872431$24287243$1$I$20240904$20240904$20240905$20240905$PER$$US-JNJFOC-20240908608$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240905$$CN$US$US
242872441$24287244$1$I$20240903$20240904$20240904$20240904$DIR$717172$$FDA-CTU$$77$YR$$F$N$63.9$KG$20240904$Y$HP$US$
242872451$24287245$1$I$20240101$20240903$20240905$20240905$PER$$US-JNJFOC-20240908577$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240905$$HP$US$US
242872462$24287246$2$F$$20240905$20240905$20240906$PER$$US-HALEON-2195270$Haleon PLC$$$$$F$Y$$$20240906$$HP$CA$CA
242872471$24287247$1$I$20240831$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140206$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240905$$CN$US$US
242872481$24287248$1$I$20240101$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140801$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240905$$CN$US$US
242872491$24287249$1$I$$20240829$20240905$20240905$EXP$$US-BIOMARINAP-US-2024-160257$BIOMARIN$$$$$$Y$$$20240905$$CN$US$US
242872501$24287250$1$I$20240809$20240828$20240905$20240905$EXP$$JP-BIOMARINAP-JP-2024-160249$BIOMARIN$$$$$$Y$$$20240905$$CN$JP$JP
242872512$24287251$2$F$20240820$20240924$20240905$20240930$EXP$$DE-BIOMARINAP-DE-2024-160291$BIOMARIN$$$$$$Y$$$20240930$$HP$DE$DE
242872522$24287252$2$F$20240826$20240904$20240905$20240909$EXP$$AR-BIOMARINAP-AR-2024-160256$BIOMARIN$$$$$$Y$$$20240909$$CN$AR$AR
242872531$24287253$1$I$20240901$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61137$$FDA-CTU$$9$YR$$M$N$27.7$KG$20240903$N$$US$
242872541$24287254$1$I$$20240902$20240905$20240905$EXP$$SA-BIOMARINAP-SA-2024-160275$BIOMARIN$$$$$$Y$$$20240905$$HP$SA$SA
242872551$24287255$1$I$20240808$20240828$20240905$20240905$EXP$FR-AFSSAPS-TS2024000925$FR-TEVA-VS-3238239$TEVA$$1$DY$$F$Y$$$20240905$$MD$FR$FR
242872562$24287256$2$F$$20240910$20240905$20240911$EXP$PT-EMA-DD-20240820-7482711-134005$PT-SANDOZ INC.-SDZ2024PT077684$SANDOZ$$20$YR$$F$Y$$$20240911$$MD$PT$PT
242872572$24287257$2$F$20220701$20240906$20240905$20240916$EXP$$JP-TAKEDA-2024TUS088254$TAKEDA$$8$DEC$$M$Y$$$20240916$$MD$JP$JP
242872581$24287258$1$I$$20240828$20240905$20240905$EXP$$ZA-AstraZeneca-2024A196208$ASTRAZENECA$$66$YR$$F$Y$$$20240905$$CN$ZA$
242872591$24287259$1$I$$20240828$20240905$20240905$EXP$$US-AstraZeneca-2024A197064$ASTRAZENECA$$$$$M$Y$$$20240905$$HP$US$
242872601$24287260$1$I$$20240830$20240905$20240905$EXP$$US-AstraZeneca-2024A200459$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242872611$24287261$1$I$$20240828$20240905$20240905$EXP$$US-AstraZeneca-2024A196641$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
242872621$24287262$1$I$$20240828$20240905$20240905$EXP$$JP-AstraZeneca-2024A196997$ASTRAZENECA$$$$$$Y$$$20240905$$MD$JP$
242872631$24287263$1$I$20240901$20240903$20240905$20240905$EXP$$US-AstraZeneca-2024A200708$ASTRAZENECA$$28876$DY$$F$Y$$$20240905$$CN$US$
242872642$24287264$2$F$20240901$20240924$20240905$20240926$PER$$US-PFIZER INC-202400249280$PFIZER$$75$YR$$M$Y$73.03$KG$20240926$$MD$US$US
242872651$24287265$1$I$$20240904$20240905$20240905$EXP$$US-PFIZER INC-PV202400116216$PFIZER$$54$YR$$F$Y$$$20240905$$CN$US$US
242872661$24287266$1$I$20240601$20240902$20240905$20240905$EXP$FR-AFSSAPS-NC2024001018$FR-PFIZER INC-202400248188$PFIZER$$62$YR$$F$Y$$$20240905$$MD$FR$FR
242872671$24287267$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61075$$FDA-CTU$$63$YR$$F$N$$$20240904$N$$US$
242872681$24287268$1$I$20240829$20240904$20240905$20240905$EXP$$GB-PFIZER INC-202400249849$PFIZER$$$$$F$Y$$$20240905$$CN$GB$GB
242872691$24287269$1$I$$20240903$20240905$20240905$EXP$$CA-PFIZER INC-202400249215$PFIZER$$52$YR$$F$Y$$$20240905$$HP$CA$CA
242872701$24287270$1$I$$20240903$20240905$20240905$EXP$$JP-PFIZER INC-202400248624$PFIZER$$$$$$Y$$$20240905$$PH$JP$JP
242872731$24287273$1$I$$20240903$20240905$20240905$EXP$$CA-PFIZER INC-202400249943$PFIZER$$67$YR$$F$Y$74$KG$20240905$$HP$CA$CA
242872741$24287274$1$I$$20240828$20240905$20240905$EXP$$HR-AstraZeneca-2024A199679$ASTRAZENECA$$$$$M$Y$$$20240905$$MD$HR$
242872751$24287275$1$I$$20240902$20240905$20240905$EXP$$TR-JNJFOC-20240902146$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240905$$MD$TR$TR
242872761$24287276$1$I$20200101$20240826$20240905$20240905$EXP$$PT-AMGEN-PRTSP2024173775$AMGEN$Martins B.; Seabra M.; Guimaraes J. et al.. NEUROMYELITIS OPTICA SPECTRUM DISORDERS WITH OVERLAPPING SYSTEMIC AUTOIMMUNE DISEASES A THERAPEUTIC CHALLENGE. A Therapeutic Challenge. 2023;23 (1):111$32$YR$A$F$Y$$$20240905$$HP$PT$PT
242872771$24287277$1$I$20231001$20240829$20240905$20240905$EXP$$NVSC2024DE153449$NOVARTIS$$$$$F$Y$$$20240905$$CN$DE$DE
242872781$24287278$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140897$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240905$$HP$US$US
242872791$24287279$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141477$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240905$$CN$US$US
242872802$24287280$2$F$$20240903$20240905$20240906$30DAY$$US-PFIZER INC-PV202400044188$PFIZER$$$$$$Y$$$20240906$$HP$US$US
242872821$24287282$1$I$$20240904$20240905$20240905$EXP$$CA-MYLANLABS-2024M1081319$MYLAN$$57$YR$$F$Y$95$KG$20240905$$CN$CA$CA
242872831$24287283$1$I$20161201$20240829$20240905$20240905$EXP$$NVSC2024RU176593$NOVARTIS$$73$YR$$F$Y$$$20240905$$MD$RU$RU
242872841$24287284$1$I$20240801$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61014$$FDA-CTU$$69$YR$$F$N$$$20240904$N$PH$US$
242872851$24287285$1$I$20240903$20240904$20240904$20240904$DIR$717148$$FDA-CTU$$72$YR$$F$N$57.6$KG$20240904$Y$$US$
242872861$24287286$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61108$$FDA-CTU$$87$YR$$F$N$$$20240904$N$$US$
242872871$24287287$1$I$20240901$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61073$$FDA-CTU$$77$YR$$M$N$$$20240904$N$CN$US$
242872892$24287289$2$F$$20240903$20240905$20240909$PER$$US-BIOGEN-2024BI01280925$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
242872901$24287290$1$I$20240101$20240903$20240905$20240905$PER$$US-BIOGEN-2024BI01281000$BIOGEN$$$$$M$Y$$$20240905$$CN$US$US
242872912$24287291$2$F$20240801$20240910$20240905$20240913$PER$$US-AMGEN-USASP2024176614$AMGEN$$$$$M$Y$$$20240913$$CN$US$US
242872921$24287292$1$I$$20240904$20240905$20240905$PER$$US-ALXN-202409USA000166US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242872931$24287293$1$I$$20240828$20240905$20240905$PER$$US-JNJFOC-20240876366$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242872962$24287296$2$F$$20240905$20240905$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139701$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240913$$MD$JP$JP
242872971$24287297$1$I$20240101$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140098$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240905$$CN$US$US
242872981$24287298$1$I$$20240903$20240905$20240905$PER$$US-ROCHE-3542261$ROCHE$$$$$$Y$$$20240905$$CN$US$US
242872991$24287299$1$I$20240101$20240827$20240905$20240905$PER$$US-009507513-2408USA010208$MERCK$$70$YR$$F$Y$$$20240905$$MD$US$US
242873001$24287300$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3237930$TEVA$$33$YR$$M$Y$$$20240905$$HP$CA$CA
242873011$24287301$1$I$20240827$20240904$20240905$20240905$EXP$$CA-ROCHE-10000035126$ROCHE$$61$YR$A$F$Y$$$20240905$$MD$CA$CA
242873021$24287302$1$I$$20240903$20240905$20240905$PER$$US-JNJFOC-20240907646$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$MD$US$US
242873031$24287303$1$I$$20240827$20240905$20240905$PER$$US-AMGEN-USASP2024173302$AMGEN$Miller J. B.; Finn M. J.. Atypical Central Retinal Vein Occlusion in an Older Man With Multiple Myeloma: A Case Report. Ophthalmic Surgery, Lasers, and Imaging Retina. 2024;55:1-5$72$YR$E$M$Y$$$20240905$$MD$US$US
242873041$24287304$1$I$$20240903$20240905$20240905$EXP$$US-GSK-US2024109405$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$US$US
242873051$24287305$1$I$$20240828$20240905$20240905$EXP$$US-AMGEN-USASP2024173552$AMGEN$Cheung A.Y.; Mansur S.. Treatment of Corneal Neovascularization Before Deep Anterior Lamellar Keratoplasty. Cornea. 2024;1-6$21$YR$A$M$Y$$$20240905$$MD$US$US
242873061$24287306$1$I$$20240830$20240905$20240905$PER$$US-FreseniusKabi-FK202413381$FRESENIUS KABI$$$$$$Y$$$20240905$$HP$US$US
242873071$24287307$1$I$$20240827$20240905$20240905$30DAY$$US-GSK-US2024106604$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242873081$24287308$1$I$$20240902$20240905$20240905$PER$$US-BAYER-2024A126190$BAYER$$$$$$Y$$$20240905$$CN$US$US
242873091$24287309$1$I$$20240903$20240905$20240905$PER$$US-Taiho Oncology Inc-2024-008419$TAIHO ONCOLOGY INC$$67$YR$E$F$Y$107.05$KG$20240905$$HP$US$US
242873101$24287310$1$I$20201223$20240903$20240905$20240905$EXP$$GB-AstraZeneca-2024A199948$ASTRAZENECA$$11$YR$$M$Y$$$20240905$$MD$GB$
242873111$24287311$1$I$$20240828$20240905$20240905$EXP$$CA-AstraZeneca-2024A155402$ASTRAZENECA$$$$$F$Y$$$20240905$$HP$CA$
242873121$24287312$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-202400250124$PFIZER$$$$$M$Y$$$20240905$$CN$US$US
242873132$24287313$2$F$20240801$20240911$20240905$20240917$PER$$US-AstraZeneca-2024A201037$ASTRAZENECA$$1030$MON$$M$Y$$$20240917$$CN$US$
242873142$24287314$2$F$$20240904$20240905$20240906$PER$$US-PFIZER INC-202400249587$PFIZER$$99$YR$$M$Y$$$20240906$$CN$US$US
242873151$24287315$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-PV202400115827$PFIZER$$$$$$Y$$$20240905$$CN$US$US
242873161$24287316$1$I$20240601$20240729$20240905$20240905$EXP$$US-PFIZER INC-202400250431$PFIZER$$63$YR$$M$Y$$$20240905$$HP$US$US
242873171$24287317$1$I$20191112$20240904$20240905$20240905$EXP$$US-ROCHE-10000064473$ROCHE$$39$YR$A$F$Y$$$20240905$$CN$US$US
242873181$24287318$1$I$20240807$20240828$20240905$20240905$EXP$FR-AFSSAPS-PV2024000769$FR-TEVA-VS-3238155$TEVA$$10$YR$$M$Y$27$KG$20240905$$MD$FR$FR
242873191$24287319$1$I$$20240827$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202408017790$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242873201$24287320$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001762$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240905$$CN$US$US
242873211$24287321$1$I$20240601$20240827$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000492$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240905$$CN$US$US
242873221$24287322$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002749$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240905$$CN$US$US
242873232$24287323$2$F$$20240903$20240905$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001468$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240909$$CN$US$US
242873241$24287324$1$I$20240829$20240902$20240905$20240905$EXP$GB-MHRA-MED-202408301158372430-THRFN$GB-ELI_LILLY_AND_COMPANY-GB202409001093$ELI LILLY AND CO$$$$$M$Y$$$20240905$$CN$GB$GB
242873251$24287325$1$I$$20240904$20240905$20240905$PER$$US-ALXN-202409USA000164US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242873261$24287326$1$I$20240902$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024177088$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242873271$24287327$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141319$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240905$$CN$US$US
242873281$24287328$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141313$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240905$$CN$US$US
242873291$24287329$1$I$20240827$20240827$20240905$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139165$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240905$$CN$JP$JP
242873301$24287330$1$I$$20240830$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141236$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240905$$HP$US$US
242873311$24287331$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141437$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$119.75$KG$20240905$$CN$US$US
242873321$24287332$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140399$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240905$$HP$US$US
242873331$24287333$1$I$20220111$20240903$20240905$20240905$EXP$$US-JNJFOC-20240907506$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20240905$$CN$US$US
242873341$24287334$1$I$20240701$20240829$20240905$20240905$PER$$US-JNJFOC-20240900632$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240905$$CN$US$US
242873351$24287335$1$I$20240822$20240822$20240905$20240905$PER$$US-JNJFOC-20240857763$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240905$$MD$US$US
242873361$24287336$1$I$20240902$20240904$20240905$20240905$EXP$$GB-JNJFOC-20240911294$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240905$$HP$GB$GB
242873371$24287337$1$I$20240810$20240827$20240905$20240905$30DAY$$US-GSK-US2024106607$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242873381$24287338$1$I$$20240830$20240905$20240905$EXP$$US-GSK-US2024108288$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$US$US
242873391$24287339$1$I$20240820$20240903$20240905$20240905$EXP$$US-KYOWAKIRIN-2024KK020625$KYOWA$$$$$$Y$$$20240905$$HP$US$US
242873401$24287340$1$I$$20240827$20240905$20240905$EXP$$CA-TEVA-VS-3238213$TEVA$$48$YR$$M$Y$$$20240905$$HP$CA$CA
242873411$24287341$1$I$$20240903$20240905$20240905$PER$$US-ROCHE-10000073395$ROCHE$$$$$M$Y$$$20240905$$CN$US$US
242873423$24287342$3$F$$20240919$20240905$20240923$PER$$US-ROCHE-10000065652$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
242873431$24287343$1$I$$20240903$20240905$20240905$PER$$US-ROCHE-10000073335$ROCHE$$$$A$M$Y$$$20240905$$CN$US$US
242873441$24287344$1$I$20240904$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024177254$AMGEN$$69$YR$E$F$Y$$$20240905$$CN$US$US
242873451$24287345$1$I$$20240903$20240905$20240905$EXP$$NVSC2024GB066578$NOVARTIS$$$$$F$Y$$$20240905$$CN$GB$GB
242873463$24287346$3$F$$20240906$20240905$20240909$EXP$$US-PFIZER INC-PV202400115681$PFIZER$$24$YR$$F$Y$110.93$KG$20240909$$MD$US$US
242873471$24287347$1$I$$20240903$20240905$20240905$EXP$$US-PFIZER INC-202400249453$PFIZER$$84$YR$$F$Y$$$20240905$$HP$US$US
242873481$24287348$1$I$$20240903$20240905$20240905$EXP$$JP-PFIZER INC-202400249793$PFIZER$$$$E$M$Y$$$20240905$$MD$JP$JP
242873491$24287349$1$I$$20240904$20240905$20240905$EXP$$US-PFIZER INC-PV202400116115$PFIZER$$68$YR$$M$Y$$$20240905$$PH$US$US
242873511$24287351$1$I$20240807$20240904$20240905$20240905$EXP$$CN-PFIZER INC-PV202400116165$PFIZER$$64$YR$$M$Y$$$20240905$$HP$CN$CN
242873521$24287352$1$I$$20240830$20240905$20240905$EXP$$JP-PFIZER INC-202400249657$PFIZER$$80$YR$$M$Y$$$20240905$$MD$JP$JP
242873531$24287353$1$I$20240819$20240831$20240905$20240905$EXP$$CN-PFIZER INC-PV202400114227$PFIZER$$37$YR$$F$Y$52$KG$20240905$$HP$CN$CN
242873541$24287354$1$I$$20240827$20240905$20240905$PER$$US-ABBVIE-5900519$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242873551$24287355$1$I$$20240830$20240905$20240905$EXP$$JP-PFIZER INC-202400249628$PFIZER$$75$YR$$F$Y$$$20240905$$MD$JP$JP
242873562$24287356$2$F$$20240910$20240905$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135795$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240911$$CN$US$US
242873571$24287357$1$I$$20240823$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135125$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240905$$HP$US$US
242873591$24287359$1$I$$20240903$20240905$20240905$PER$$US-ALXN-202409USA000137US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242873601$24287360$1$I$$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61042$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
242873611$24287361$1$I$$20240904$20240904$20240904$DIR$717124$$FDA-CTU$$$$$UNK$N$$$20240904$$CN$US$
242873621$24287362$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61049$$FDA-CTU$$81$YR$$M$N$$$20240904$N$$US$
242873641$24287364$1$I$20240829$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61140$$FDA-CTU$$66$YR$$M$N$77$KG$20240903$N$$US$
242873651$24287365$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61023$$FDA-CTU$$1$YR$$M$N$$$20240904$N$$US$
242873661$24287366$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61010$$FDA-CTU$$39$YR$$F$N$$$20240904$N$$US$
242873671$24287367$1$I$20240831$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61138$$FDA-CTU$$36$YR$$M$N$79.4$KG$20240903$N$$US$
242873681$24287368$1$I$20240322$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61143$$FDA-CTU$$78$YR$$M$N$75.8$KG$20240903$N$$US$
242873691$24287369$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61107$$FDA-CTU$$63$YR$$F$N$$$20240904$N$$US$
242873721$24287372$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61081$$FDA-CTU$$47$YR$$F$N$$$20240904$N$$US$
242873731$24287373$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61056$$FDA-CTU$$79$YR$$M$N$$$20240904$N$$US$
242873741$24287374$1$I$$20240904$20240904$20240904$DIR$717131$$FDA-CTU$$$$$UNK$N$$$20240904$N$CN$US$
242873751$24287375$1$I$20240801$20240804$20240904$20240904$DIR$FDA-CDER-CTU-2024-61094$$FDA-CTU$$74$YR$$M$N$$$20240804$N$PH$US$
242873761$24287376$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61064$$FDA-CTU$$65$YR$$M$N$270$LBS$20240904$N$$US$
242873771$24287377$1$I$20240718$20240904$20240904$20240904$DIR$717165$$FDA-CTU$$79$YR$$F$N$71.1$KG$20240904$N$$US$
242873781$24287378$1$I$$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61033$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
242873791$24287379$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61133$$FDA-CTU$$65$YR$$F$N$$$20240904$N$$US$
242873801$24287380$1$I$20210415$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61085$$FDA-CTU$$9$WK$$M$N$9388$LBS$20240904$Y$$US$
242873811$24287381$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61079$$FDA-CTU$$57$YR$$F$N$$$20240904$N$$US$
242873821$24287382$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61083$$FDA-CTU$$64$YR$$F$N$161$LBS$20240904$N$$US$
242873841$24287384$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61132$$FDA-CTU$$75$YR$$F$N$198$LBS$20240904$N$$US$
242873851$24287385$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61086$$FDA-CTU$$75$YR$$F$N$198$LBS$20240904$N$$US$
242873861$24287386$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61066$$FDA-CTU$$66$YR$$F$N$267$LBS$20240904$N$$US$
242873871$24287387$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61126$$FDA-CTU$$45$YR$$F$N$162$LBS$20240904$N$$US$
242873881$24287388$1$I$20240823$20240829$20240904$20240904$DIR$FDA-CDER-CTU-2024-61046$$FDA-CTU$$69$YR$$F$N$91$LBS$20240829$N$$US$
242873891$24287389$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61116$$FDA-CTU$$53$YR$$F$N$215$LBS$20240904$N$$US$
242873901$24287390$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61092$$FDA-CTU$$74$YR$$F$N$$$20240904$N$$US$
242873911$24287391$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61120$$FDA-CTU$$60$YR$$M$N$$$20240904$N$$US$
242873921$24287392$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61122$$FDA-CTU$$65$YR$$F$N$$$20240904$N$$US$
242873931$24287393$1$I$$20240905$20240905$20240905$DIR$717227$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242873941$24287394$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61102$$FDA-CTU$$72$YR$$F$N$$$20240904$N$$US$
242873951$24287395$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61141$$FDA-CTU$$57$YR$$M$N$$$20240904$N$$US$
242873961$24287396$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61110$$FDA-CTU$$72$YR$$F$N$$$20240904$N$$US$
242873971$24287397$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61030$$FDA-CTU$$47$YR$$M$N$$$20240904$N$$US$
242873981$24287398$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61063$$FDA-CTU$$81$YR$$F$N$$$20240904$N$$US$
242873991$24287399$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61019$$FDA-CTU$$51$YR$$F$N$88.45$KG$20240904$N$$US$
242874001$24287400$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61054$$FDA-CTU$$75$YR$$F$N$55.79$KG$20240904$N$$US$
242874011$24287401$1$I$20240905$20240905$20240905$20240905$DIR$717220$$FDA-CTU$$67$YR$$F$N$$$20240905$N$CN$US$
242874021$24287402$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61099$$FDA-CTU$$46$YR$$F$N$$$20240904$N$$US$
242874031$24287403$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61051$$FDA-CTU$$71$YR$$F$N$$$20240904$N$$US$
242874041$24287404$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61105$$FDA-CTU$$33$YR$$M$N$$$20240904$N$$US$
242874051$24287405$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61070$$FDA-CTU$$44$YR$$F$N$83.91$KG$20240904$N$$US$
242874061$24287406$1$I$20240817$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61028$$FDA-CTU$$36$YR$$F$N$$$20240904$N$$US$
242874071$24287407$1$I$20240804$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61053$$FDA-CTU$$69$YR$$M$N$$$20240904$N$PH$US$
242874081$24287408$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61103$$FDA-CTU$$75$YR$$F$N$$$20240904$N$$US$
242874091$24287409$1$I$$20240903$20240905$20240905$EXP$$US-INCYTE CORPORATION-2024IN009297$INCYTE$$$$$$Y$$$20240905$$CN$US$US
242874101$24287410$1$I$$20240903$20240905$20240905$EXP$$US-INCYTE CORPORATION-2024IN009281$INCYTE$$$$$$Y$$$20240905$$CN$US$US
242874111$24287411$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176326$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242874121$24287412$1$I$20240821$20240823$20240905$20240905$PER$$US-SA-2024SA253361$SANOFI AVENTIS$$9$YR$C$$Y$$$20240905$$HP$US$US
242874132$24287413$2$F$20240827$20240909$20240905$20240923$PER$$US-SA-2024SA254641$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240923$$MD$US$US
242874151$24287415$1$I$$20240903$20240905$20240905$EXP$$CA-GILEAD-2024-0686175$GILEAD$$$$E$F$Y$$$20240905$$CN$CA$CA
242874161$24287416$1$I$$20240903$20240905$20240905$PER$$US-AstraZeneca-2024A200907$ASTRAZENECA$$$$$M$Y$$$20240905$$CN$US$
242874171$24287417$1$I$$20240828$20240905$20240905$PER$$US-AstraZeneca-2024A198361$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
242874181$24287418$1$I$$20240903$20240905$20240905$EXP$$NVSC2024ZA151586$NOVARTIS$$65$YR$$F$Y$$$20240905$$CN$ZA$ZA
242874191$24287419$1$I$$20240903$20240905$20240905$EXP$$US-INCYTE CORPORATION-2024IN009177$INCYTE$$$$$$Y$$$20240905$$CN$US$US
242874201$24287420$1$I$20240801$20240829$20240905$20240905$EXP$$CO-GSK-CO2024AMR109183$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$CO$CO
242874211$24287421$1$I$20240306$20240903$20240905$20240905$EXP$$CA-LUNDBECK-DKLU4001984$LUNDBECK$$$$$$Y$$$20240905$$HP$CA$CA
242874221$24287422$1$I$20200101$20240830$20240905$20240905$PER$$US-BIOGEN-2020BI00924980$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
242874241$24287424$1$I$$20240830$20240905$20240905$EXP$$CN-ROCHE-10000071619$ROCHE$$49$YR$A$M$Y$$$20240905$$CN$CN$CN
242874251$24287425$1$I$20240701$20240828$20240905$20240905$EXP$FR-AFSSAPS-AVBX2024000457$FR-TEVA-VS-3238024$TEVA$$41$YR$$F$Y$$$20240905$$CN$FR$FR
242874261$24287426$1$I$$20240828$20240905$20240905$EXP$$ES-AstraZeneca-2024A196085$ASTRAZENECA$Vela-Casasempere P., Ca?o Alameda R., G?mez Sabater S., Cortell Aznar S., P?rez Pascual E.. Considering belimumab during pregnancy: A more viable option over time. Lupus 2024;33(7):700-715.$40$YR$$F$Y$$$20240905$$HP$ES$
242874271$24287427$1$I$$20240821$20240905$20240905$EXP$$JP-CMP PHARMA-2024CMP00045$CMP PHARMA$Sugimoto T, Suzuki S, Uzawa A.et.al.. Worsening of myasthenic symptoms associated with statins. Journal of the Neurological Sciences.. 2024;464$48$YR$$M$Y$$$20240905$$HP$JP$JP
242874281$24287428$1$I$$20240821$20240905$20240905$EXP$$JP-CMP PHARMA-2024CMP00050$CMP PHARMA$Sugimoto T, Suzuki S, Uzawa A, Yamanwaki T, Masuda M, Minami N, Et al.. Worsening of myasthenic symptoms associated with statins. Journal of the Neurological Sciences. 2024;464$59$YR$$M$Y$$$20240905$$HP$JP$JP
242874291$24287429$1$I$$20240821$20240905$20240905$EXP$$JP-CMP PHARMA-2024CMP00051$CMP PHARMA$Sugimoto T, Suzuki S, Uzawa A.et.al. Worsening of myasthenic symptoms associated with statins. Journal of the Neurological Sciences.. 2024;464$67$YR$$M$Y$$$20240905$$HP$JP$JP
242874301$24287430$1$I$$20240903$20240905$20240905$PER$$US-BIOGEN-2024BI01280967$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
242874311$24287431$1$I$$20240821$20240905$20240905$EXP$$JP-CMP PHARMA-2024CMP00049$CMP PHARMA$Sugimoto T, Suzuki S, Uzawa A.et.al. Worsening of myasthenic symptoms associated with statins. Journal of the Neurological Sciences.. 2024;464$68$YR$$F$Y$$$20240905$$HP$JP$JP
242874321$24287432$1$I$$20240821$20240905$20240905$EXP$$JP-CMP PHARMA-2024CMP00047$CMP PHARMA$Sugimoto T, Suzuki S, Uzawa A, Yamanwaki T, Masuda M, Minami N, Et al.. Worsening of myasthenic symptoms associated with statins. Journal of the Neurological Sciences. 2024;464$44$YR$$M$Y$$$20240905$$HP$JP$JP
242874331$24287433$1$I$$20240821$20240905$20240905$EXP$$JP-CMP PHARMA-2024CMP00046$CMP PHARMA$Sugimoto T, Suzuki S, Uzawa A, Yamanwaki T, Masuda M, Minami N, Et al.. Worsening of myasthenic symptoms associated with statins. Journal of the Neurological Sciences. 2024;464$71$YR$$F$Y$$$20240905$$HP$JP$JP
242874341$24287434$1$I$$20240821$20240905$20240905$EXP$$JP-CMP PHARMA-2024CMP00048$CMP PHARMA$Sugimoto T, Suzuki S, Uzawa A, Yamanwaki T, Masuda M, Minami N, Et al.. Worsening of myasthenic symptoms associated with statins. Journal of the Neurological Sciences. 2024;464$49$YR$$F$Y$$$20240905$$HP$JP$JP
242874351$24287435$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA253785$SANOFI AVENTIS$$$$A$F$Y$$$20240905$$HP$US$US
242874361$24287436$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA257834$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240905$$HP$US$US
242874371$24287437$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA256241$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240905$$CN$US$US
242874381$24287438$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA255875$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240905$$MD$US$US
242874391$24287439$1$I$$20240823$20240905$20240905$PER$$US-SA-2024SA257747$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240905$$HP$US$US
242874401$24287440$1$I$20240801$20240821$20240905$20240905$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1357$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240905$$CN$US$US
242874411$24287441$1$I$$20240904$20240905$20240905$EXP$$CA-BAUSCH-BL-2024-013269$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240905$$CN$CA$CA
242874421$24287442$1$I$20240903$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002592$ELI LILLY AND CO$$41$YR$A$$Y$$$20240905$$CN$US$US
242874431$24287443$1$I$$20240826$20240905$20240905$30DAY$$US-GSK-US2024106149$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242874441$24287444$1$I$$20240829$20240905$20240905$EXP$$US-GSK-US2024107765$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$US$US
242874451$24287445$1$I$$20240903$20240905$20240905$PER$$US-HALEON-2195052$Haleon PLC$$$$$M$Y$$$20240905$$CN$US$US
242874461$24287446$1$I$$20240904$20240905$20240905$EXP$$CA-BAUSCH-BL-2024-013268$BAUSCH AND LOMB$$60$YR$$F$Y$$$20240905$$CN$CA$CA
242874471$24287447$1$I$20240101$20240827$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137280$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$82.55$KG$20240905$$CN$US$US
242874492$24287449$2$F$20230617$20240401$20240905$20240906$EXP$$EG-009507513-2409SAU001622$MERCK$$38$YR$$M$Y$$$20240906$$MD$EG$SA
242874501$24287450$1$I$$20240904$20240905$20240905$EXP$$CA-BAUSCH-BL-2024-013274$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240905$$HP$CA$CA
242874511$24287451$1$I$20230101$20240828$20240905$20240905$EXP$$US-ALXN-202408USA002072US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$HP$US$US
242874521$24287452$1$I$$20240822$20240905$20240905$EXP$$US-HLS-202401047$HLS THERAPEUTICS$$$$A$$Y$$$20240905$$PH$US$US
242874531$24287453$1$I$20240715$20240826$20240905$20240905$PER$$US-BIOMARINAP-US-2024-160173$BIOMARIN$$$$$$Y$$$20240905$$CN$US$US
242874541$24287454$1$I$$20240829$20240905$20240905$EXP$GB-MHRA-MIDB-f3fc2ddf-7714-46db-9048-8c21cba62f6f$GB-009507513-2409GBR000930$MERCK$$53$YR$$$Y$$$20240905$$PH$GB$GB
242874551$24287455$1$I$$20240902$20240905$20240905$EXP$$E2B_07108379$SANDOZ$$43$YR$$F$Y$96$KG$20240905$$HP$CA$CA
242874561$24287456$1$I$20240801$20240827$20240905$20240905$EXP$$CA-LUNDBECK-DKLU4003837$LUNDBECK$$$$$$Y$$$20240905$$HP$CA$CA
242874571$24287457$1$I$$20240903$20240905$20240905$EXP$$IT-PFIZER INC-PV202400115697$PFIZER$Capecchi, R.. DRUG- INDUCED TROMBOCYTOPENIA AND ADVERSE REACTION TO RITUXIMAB: AN UNUSUAL CASE. European Journal of Case Reports in Internal Medicine. 2024;11 (Supple 1):956$66$YR$$F$Y$$$20240905$$HP$IT$IT
242874581$24287458$1$I$$20240820$20240905$20240905$PER$$US-009507513-2408USA006674$MERCK$$$$$F$Y$140.6$KG$20240905$$CN$US$US
242874591$24287459$1$I$$20240904$20240905$20240905$PER$$US-JNJFOC-20240909201$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242874601$24287460$1$I$20240801$20240904$20240905$20240905$PER$$US-JNJFOC-20240908212$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$HP$US$US
242874611$24287461$1$I$20240830$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176589$AMGEN$$57$YR$A$F$Y$$$20240905$$CN$US$US
242874621$24287462$1$I$$20240903$20240905$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-140766$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240905$$MD$JP$JP
242874631$24287463$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141343$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240905$$CN$US$US
242874641$24287464$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140204$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240905$$HP$US$US
242874651$24287465$1$I$$20240905$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141498$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240905$$CN$US$US
242874661$24287466$1$I$$20240613$20240905$20240905$EXP$$US-NOVOPROD-1278198$NOVO NORDISK$$$$$M$Y$$$20240905$$CN$US$US
242874671$24287467$1$I$20240520$20240829$20240905$20240905$EXP$$BR-GSK-BR2024AMR037014$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$BR$BR
242874681$24287468$1$I$20240701$20240829$20240905$20240905$EXP$$US-GSK-US2024107917$GLAXOSMITHKLINE$$$$$$Y$$$20240905$$CN$US$US
242874691$24287469$1$I$$20240827$20240905$20240905$EXP$$GB-MYLANLABS-2024M1079601$MYLAN$$$$$F$Y$$$20240905$$CN$GB$GB
242874701$24287470$1$I$$20240902$20240905$20240905$EXP$$SE-MYLANLABS-2024M1080497$MYLAN$$27$YR$$M$Y$$$20240905$$CN$SE$SE
242874721$24287472$1$I$20240825$20240829$20240905$20240905$EXP$$IL-AstraZeneca-2024A199668$ASTRAZENECA$$28434$DY$$F$Y$$$20240905$$CN$IL$
242874731$24287473$1$I$$20240821$20240905$20240905$PER$$US-AstraZeneca-2024A190826$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
242874741$24287474$1$I$$20240828$20240905$20240905$EXP$$US-AstraZeneca-2024A196795$ASTRAZENECA$$$$A$M$Y$$$20240905$$HP$US$
242874751$24287475$1$I$$20240828$20240905$20240905$EXP$$US-AstraZeneca-2024A197049$ASTRAZENECA$$71$YR$$F$Y$93$KG$20240905$$CN$US$
242874761$24287476$1$I$20171005$20240829$20240905$20240905$EXP$$US-AstraZeneca-2024A200342$ASTRAZENECA$$69$YR$$M$Y$$$20240905$$MD$US$
242874771$24287477$1$I$$20240902$20240905$20240905$EXP$$RU-AstraZeneca-2024A202080$ASTRAZENECA$Kostrygin NE; Chumachenko DS. Immunotherapy Prior to a Liver Transplant: Literature Review. Innovative Medicine of Kuban 2024;9(3):61?69.$46$YR$$F$Y$$$20240905$$HP$RU$
242874781$24287478$1$I$$20240830$20240905$20240905$EXP$$ES-AstraZeneca-2024A199471$ASTRAZENECA$Galarza Lopez A, Sofia Arguelles A, Gangoitia Gorrotxategi N, Salmeron G, Jimenez Ana, Olazaran L, Elso Echeverria B, Reyzabal Ereno I, Gonzalez De Los Martires P, Guerrero Perez G, Lopez Arbues S.. Choroidal Metastasis Regression of Non-Small Cell Lung Cancer After Systemic Treatment: A Case Report. 24th Annual Congress of the European Society of Retina Specialists (EURETINA) 2024;$82$YR$$F$Y$$$20240905$$HP$ES$
242874791$24287479$1$I$$20240826$20240905$20240905$EXP$$US-GSK-US2024106051$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242874802$24287480$2$F$20240904$20240912$20240905$20240913$PER$$US-AMGEN-USASP2024177225$AMGEN$$81$YR$E$F$Y$$$20240913$$CN$US$US
242874812$24287481$2$F$20231001$20240912$20240905$20240918$EXP$$US-OTSUKA-2024_001969$OTSUKA$$62$YR$$M$Y$$$20240918$$CN$US$US
242874821$24287482$1$I$$20240903$20240905$20240905$PER$$US-ALXN-202409USA000127US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242874833$24287483$3$F$20240901$20240909$20240905$20240910$PER$$US-AMGEN-USASP2024175556$AMGEN$$73$YR$E$F$Y$$$20240910$$CN$US$US
242874841$24287484$1$I$$20240828$20240905$20240905$EXP$GB-MHRA-MED-202408261119039190-VFJBS$GB-TEVA-VS-3238511$TEVA$$66$YR$$M$Y$$$20240905$$CN$GB$GB
242874851$24287485$1$I$20240803$20240827$20240905$20240905$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004948$SAREPTA THERAPEUTICS$$25$YR$$M$Y$$$20240905$$HP$US$US
242874861$24287486$1$I$$20240826$20240905$20240905$EXP$$US-GSK-US2024106012$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242874872$24287487$2$F$20240831$20240910$20240905$20240911$PER$$US-AMGEN-USASP2024176070$AMGEN$$79$YR$E$M$Y$$$20240911$$CN$US$US
242874881$24287488$1$I$$20240904$20240905$20240905$PER$$US-HALEON-2195289$Haleon PLC$$68$YR$$M$Y$$$20240905$$CN$US$US
242874891$24287489$1$I$$20240905$20240905$20240905$PER$$NVSC2024US178728$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242874901$24287490$1$I$$20240902$20240905$20240905$EXP$$PL-SA-2024SA256865$SANOFI AVENTIS$Woron J, Siwek M.. Sore throat as an undesirable consequence of drug interactions used in the treatment of a female patient with depression and obesity.. Practical medicine - psychiatry.. 2024;4:37-9$31$YR$A$F$Y$$$20240905$$MD$PL$PL
242874912$24287491$2$F$20221109$20240912$20240905$20240918$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2022-002810$SAREPTA THERAPEUTICS$$18$YR$$M$Y$95.084$KG$20240919$$HP$US$US
242874951$24287495$1$I$20240901$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61043$$FDA-CTU$$71$YR$$M$N$$$20240904$Y$PH$US$
242874961$24287496$1$I$20240812$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61134$$FDA-CTU$$79$YR$$M$N$$$20240904$Y$PH$US$
242874971$24287497$1$I$20240716$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61047$$FDA-CTU$$70$YR$$M$N$$$20240903$N$HP$US$
242874991$24287499$1$I$20240902$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61012$$FDA-CTU$$79$YR$$F$N$$$20240904$Y$PH$US$
242875011$24287501$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61123$$FDA-CTU$$65$YR$$M$N$$$20240904$N$CN$US$
242875071$24287507$1$I$20240827$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61097$$FDA-CTU$$71$YR$$F$N$$$20240904$N$$US$
242875081$24287508$1$I$20240801$20240904$20240904$20240904$DIR$717202$$FDA-CTU$$14$YR$$F$N$72$KG$20240904$N$CN$US$
242875101$24287510$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61040$$FDA-CTU$$71$YR$$F$N$$$20240904$N$$US$
242875111$24287511$1$I$$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61048$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
242875121$24287512$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61061$$FDA-CTU$$46$YR$$F$N$95.25$KG$20240904$N$$US$
242875131$24287513$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61015$$FDA-CTU$$51$YR$$F$N$57.61$KG$20240904$N$$US$
242875141$24287514$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61115$$FDA-CTU$$63$YR$$F$N$0$KG$20240904$N$$US$
242875151$24287515$1$I$20240903$20240904$20240904$20240904$DIR$717155$$FDA-CTU$$77$YR$$F$N$77.85$KG$20240904$Y$$US$
242875161$24287516$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61125$$FDA-CTU$$63$YR$$F$N$$$20240904$N$$US$
242875171$24287517$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61121$$FDA-CTU$$75$YR$$F$N$$$20240904$N$$US$
242875181$24287518$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA254189$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240905$$HP$US$US
242875191$24287519$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA254584$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240905$$HP$US$US
242875202$24287520$2$F$$20240906$20240905$20240910$PER$$US-MYLANLABS-2024M1080184$MYLAN$$$$$F$Y$88.45$KG$20240910$$CN$US$US
242875211$24287521$1$I$20240424$20240829$20240905$20240905$EXP$$JP-SHIONOGI + CO. LTD-2024002337$SHIONOGI$$32$YR$$M$Y$67$KG$20240905$$MD$JP$JP
242875221$24287522$1$I$20240809$20240821$20240905$20240905$PER$$US-SA-2024SA255702$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240905$$MD$US$US
242875241$24287524$1$I$20240801$20240821$20240905$20240905$PER$$US-SA-2024SA255834$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240905$$MD$US$US
242875252$24287525$2$F$$20240827$20240905$20240917$PER$$US-SA-2024SA253910$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240918$$CN$US$US
242875261$24287526$1$I$20231204$20240828$20240905$20240905$EXP$GB-MHRA-MED-202408281453067760-KDCVT$GB-TEVA-VS-3238395$TEVA$$$$$$Y$$$20240905$$CN$GB$GB
242875271$24287527$1$I$$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409000756$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240905$$CN$US$US
242875281$24287528$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002729$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240905$$CN$US$US
242875291$24287529$1$I$$20240827$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408017535$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240905$$CN$US$US
242875302$24287530$2$F$20240902$20240906$20240905$20240911$EXP$$JP-SHIONOGI INC.-2024002339$SHIONOGI$$$$$$Y$$$20240911$$MD$JP$JP
242875311$24287531$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61136$$FDA-CTU$$65$YR$$F$N$$$20240904$N$$US$
242875321$24287532$1$I$20200101$20240903$20240905$20240905$EXP$$IL-ABBVIE-5906902$ABBVIE$$$$$F$Y$$$20240905$$CN$IL$IL
242875331$24287533$1$I$$20240902$20240905$20240905$EXP$$KR-009507513-2409KOR001222$MERCK$$$$$F$Y$$$20240905$$CN$KR$KR
242875341$24287534$1$I$20240630$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61128$$FDA-CTU$$81$YR$$M$N$$$20240904$N$$US$
242875351$24287535$1$I$20240903$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61071$$FDA-CTU$$82$YR$$M$N$$$20240903$N$HP$US$
242875361$24287536$1$I$20240904$20240905$20240905$20240905$DIR$717245$$FDA-CTU$$49$YR$$F$N$54$KG$20240905$N$CN$US$
242875371$24287537$1$I$20240903$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141496$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240905$$MD$US$US
242875381$24287538$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141359$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240905$$CN$US$US
242875391$24287539$1$I$20240725$20240829$20240905$20240905$EXP$$JP-AMGEN-JPNSP2024148888$AMGEN$$85$YR$E$$Y$$$20240905$$PH$JP$JP
242875401$24287540$1$I$$20240828$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139321$BRISTOL MYERS SQUIBB$Popat D, Sanghavi N, Singh A, Sawhney R. Parsonage turner syndrome complicating multiple myeloma therapy: nothing to shrug your shoulders at. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep 01;24(Suppl 1):S578.$66$YR$E$M$Y$$$20240905$$MD$US$US
242875411$24287541$1$I$$20240903$20240905$20240905$PER$$US-ABBVIE-5908148$ABBVIE$$$$$F$Y$$$20240905$$MD$US$US
242875421$24287542$1$I$20240501$20240829$20240905$20240905$EXP$$GB-AstraZeneca-2024A197202$ASTRAZENECA$$86$YR$$F$Y$66$KG$20240905$$MD$GB$
242875431$24287543$1$I$20240209$20240903$20240905$20240905$EXP$$US-AstraZeneca-2024A200744$ASTRAZENECA$$$$$$Y$$$20240905$$CN$US$
242875441$24287544$1$I$$20240829$20240905$20240905$PER$$US-AstraZeneca-2024A197981$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
242875451$24287545$1$I$$20240905$20240905$20240905$PER$$NVSC2024US178730$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242875461$24287546$1$I$20240828$20240830$20240905$20240905$PER$$US-FreseniusKabi-FK202413260$FRESENIUS KABI$$92$YR$E$F$Y$50.5$KG$20240905$$HP$US$US
242875471$24287547$1$I$20240801$20240826$20240905$20240905$EXP$$US-TEVA-VS-3238574$TEVA$$51$YR$$F$Y$$$20240905$$CN$US$US
242875481$24287548$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61111$$FDA-CTU$$81$YR$$F$N$$$20240904$N$$US$
242875491$24287549$1$I$$20240905$20240905$20240905$DIR$717269$$FDA-CTU$$$$$UNK$N$$$20240905$$CN$US$
242875511$24287551$1$I$20240725$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61065$$FDA-CTU$$85$YR$$M$N$$$20240904$N$$US$
242875521$24287552$1$I$$20240905$20240905$20240905$DIR$717277$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242875531$24287553$1$I$$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61025$$FDA-CTU$$$$$M$N$$$20240903$N$HP$US$
242875551$24287555$1$I$20240902$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61135$$FDA-CTU$$62$YR$$F$N$49.4$KG$20240903$N$$US$
242875561$24287556$1$I$20240905$20240905$20240905$20240905$DIR$717279$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242875571$24287557$1$I$$20240905$20240905$20240905$DIR$717262$$FDA-CTU$$34$YR$$F$N$$$20240905$N$CN$US$
242875582$24287558$2$F$20240601$20240909$20240905$20240911$EXP$$IT-GILEAD-2024-0686370$GILEAD$$62$YR$A$M$Y$$$20240911$$CN$IT$IT
242875591$24287559$1$I$20240831$20240903$20240905$20240905$EXP$$NVSC2024ZA177238$NOVARTIS$$62$YR$$F$Y$$$20240905$$HP$ZA$ZA
242875602$24287560$2$F$20240802$20240923$20240905$20240926$EXP$$TR-ABBVIE-5870356$ABBVIE$$41$YR$$M$Y$85$KG$20240926$$MD$TR$TR
242875621$24287562$1$I$20240701$20240822$20240905$20240905$EXP$$US-SMPA-2024SPA001890$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242875631$24287563$1$I$$20240823$20240905$20240905$EXP$$US-SMPA-2024SPA000934$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242875641$24287564$1$I$$20240823$20240905$20240905$EXP$$US-SMPA-2024SPA001875$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242875651$24287565$1$I$$20240823$20240905$20240905$EXP$$US-SMPA-2024SPA001904$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242875661$24287566$1$I$$20240822$20240905$20240905$EXP$$US-SMPA-2024SPA001804$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242875671$24287567$1$I$$20240822$20240905$20240905$EXP$$US-SMPA-2024SPA001855$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242875681$24287568$1$I$20240616$20240902$20240905$20240905$EXP$$NL-BIOGEN-2024BI01281062$BIOGEN$$59$YR$$F$Y$$$20240905$$HP$NL$NL
242875691$24287569$1$I$20240101$20240827$20240905$20240905$PER$$US-SA-2024SA256550$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240905$$CN$US$US
242875701$24287570$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA257308$SANOFI AVENTIS$$$$$M$Y$$$20240905$$CN$US$US
242875711$24287571$1$I$20240101$20240828$20240905$20240905$EXP$$US-AMGEN-USASP2024172493$AMGEN$$51$YR$A$M$Y$$$20240905$$HP$US$US
242875722$24287572$2$F$$20240905$20240905$20240917$EXP$$US-SMPA-2024SPA001902$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
242875731$24287573$1$I$20240821$20240822$20240905$20240905$EXP$$US-SMPA-2024SPA001893$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242875741$24287574$1$I$20240420$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141291$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240905$$CN$US$US
242875751$24287575$1$I$$20240903$20240905$20240905$EXP$$GR-JAZZ PHARMACEUTICALS-2024-GR-014138$JAZZ$$$$$$Y$$$20240905$$MD$GR$GR
242875761$24287576$1$I$$20240901$20240905$20240905$PER$$US-AMGEN-USASP2024174931$AMGEN$$$$A$M$Y$$$20240905$$CN$US$US
242875771$24287577$1$I$20240904$20240904$20240905$20240905$PER$$US-JNJFOC-20240908503$JOHNSON AND JOHNSON$$70$DEC$E$F$Y$$$20240905$$HP$US$US
242875781$24287578$1$I$$20240904$20240905$20240905$PER$$US-JNJFOC-20240908549$JOHNSON AND JOHNSON$$63$YR$A$M$Y$97$KG$20240905$$PH$US$US
242875791$24287579$1$I$$20240901$20240905$20240905$EXP$$BR-TAKEDA-2024TUS088320$TAKEDA$$$$$F$Y$$$20240905$$CN$BR$BR
242875801$24287580$1$I$$20240828$20240905$20240905$EXP$$US-TEVA-VS-3239173$TEVA$$59$YR$$F$Y$$$20240905$$MD$US$US
242875811$24287581$1$I$$20240724$20240905$20240905$PER$$US-LUNDBECK-DKLU4003122$LUNDBECK$$$$$$Y$$$20240905$$CN$US$US
242875832$24287583$2$F$$20240903$20240905$20240909$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014112$JAZZ$$$$$M$Y$$$20240909$$CN$US$US
242875841$24287584$1$I$20240826$20240830$20240905$20240905$PER$$US-FreseniusKabi-FK202413261$FRESENIUS KABI$$83$YR$E$M$Y$77.1$KG$20240905$$HP$US$US
242875851$24287585$1$I$$20240829$20240905$20240905$EXP$$JP-Eisai-EC-2024-172402$EISAI$$$$E$F$Y$$$20240905$$MD$JP$JP
242875861$24287586$1$I$$20240823$20240905$20240905$EXP$$CN-STERISCIENCE B.V.-2024-ST-001278$Steriscience PTE$Haoyu C, Fan Y, Yixin Y, Shuqin Z, Yongping Z, Weijie Z, et al.. Application of quantitative detection of multiple-source cytomegalovirus DNA in diagnosis of cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation.. Organ-Transplant. 2021;12 (1):96-102$$$$F$Y$$$20240905$$HP$CN$CN
242875871$24287587$1$I$$20240823$20240905$20240905$EXP$$CN-STERISCIENCE B.V.-2024-ST-001280$Steriscience PTE$Haoyu C, Fan Y, Yixin Y, Shuqin Z, Yongping Z, Weijie Z, et al.. Application of quantitative detection of multiple-source cytomegalovirus DNA in diagnosis of cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation.. Organ-Transplant. 2021;12 (1):96-102$$$$F$Y$$$20240905$$HP$CN$CN
242875881$24287588$1$I$$20240823$20240905$20240905$EXP$$CN-STERISCIENCE B.V.-2024-ST-001277$Steriscience PTE$Haoyu C, Fan Y, Yixin Y, Shuqin Z, Yongping Z, Weijie Z, et al.. Application of quantitative detection of multiple-source cytomegalovirus DNA in diagnosis of cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation.. Organ-Transplant. 2021;12 (1):96-102$$$$M$Y$$$20240905$$HP$CN$CN
242875891$24287589$1$I$$20240823$20240905$20240905$EXP$$CN-STERISCIENCE B.V.-2024-ST-001291$Steriscience PTE$Zhang S, Li J, Wan L, Yu J, Chen S, Jin Z. Clinical Features and Antibiotic Treatment of Neonatal Listeriosis: A Hospital-Based Study.. Infect-Drug-Resist. 2023;16:6647-6659$$$N$M$Y$$$20240905$$HP$CN$CN
242875901$24287590$1$I$$20240903$20240905$20240905$PER$$US-ALXN-202409USA000120US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240905$$CN$US$US
242875911$24287591$1$I$$20240823$20240905$20240905$EXP$$LB-STERISCIENCE B.V.-2024-ST-001252$Steriscience PTE$Keyrouz E, Rizk M, Fouani MI, Mashlab H, Sadaka A, Avery R, et al.. Novel Cases of Invasive Rhino-Orbital-Cerebral Mucormycosis in 2 Patients Who had Recently Recovered From Coronavirus Disease 2019.. J-Neuroophthalmol. 2023;43 (3):E74-E75.$62$YR$$M$Y$$$20240905$$HP$LB$LB
242875921$24287592$1$I$$20240823$20240905$20240905$EXP$$CN-STERISCIENCE B.V.-2024-ST-001253$Steriscience PTE$He Y, Wang S, Deng J, Pu Q, Chen H, Huang L. Chlamydia psittaci Pneumonia Complicated with Lower Extremity Atherosclerotic Occlusive Disease.. Infect-Drug-Resist. 2023;16:2141-2145$48$YR$$M$Y$$$20240905$$HP$CN$CN
242875931$24287593$1$I$$20240823$20240905$20240905$EXP$$CN-STERISCIENCE B.V.-2024-ST-001283$Steriscience PTE$Haoyu C, Fan Y, Yixin Y, Shuqin Z, Yongping Z, Weijie Z, et al. Application of quantitative detection of multiple-source cytomegalovirus DNA in diagnosis of cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation.. Organ-Transplant. 2021;12 (1):96-102$$$$M$Y$$$20240905$$HP$CN$CN
242875941$24287594$1$I$20240820$20240905$20240905$20240905$EXP$$SK-GILEAD-2024-0686375$GILEAD$$$$$F$Y$$$20240905$$HP$SK$SK
242875951$24287595$1$I$$20240826$20240905$20240905$30DAY$$US-GSK-US2024106147$GLAXOSMITHKLINE$$$$$M$Y$$$20240905$$CN$US$US
242875961$24287596$1$I$$20240826$20240905$20240905$EXP$$DE-TAKEDA-2024TUS088174$TAKEDA$$$$$$Y$$$20240905$$CN$DE$DE
242875971$24287597$1$I$$20240902$20240905$20240905$EXP$$ZA-AstraZeneca-2024A200049$ASTRAZENECA$$27759$DY$$M$Y$$$20240905$$CN$ZA$
242875981$24287598$1$I$20240618$20240903$20240905$20240905$EXP$$US-AstraZeneca-2024A201046$ASTRAZENECA$$26914$DY$$M$Y$$$20240905$$CN$US$
242875992$24287599$2$F$$20240913$20240905$20240917$30DAY$$TR-PFIZER INC-202400245308$PFIZER$$$$$$Y$$$20240917$$CN$TR$TR
242876001$24287600$1$I$20240901$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001370$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240905$$CN$US$US
242876012$24287601$2$F$$20240910$20240905$20240910$30DAY$$CL-PFIZER INC-202400249918$PFIZER$$$$$$Y$$$20240910$$CN$CL$CL
242876021$24287602$1$I$$20240903$20240905$20240905$EXP$$US-PFIZER INC-202400241051$PFIZER$$26$YR$$M$Y$$$20240905$$HP$US$US
242876041$24287604$1$I$20240125$20240905$20240905$20240905$DIR$717248$$FDA-CTU$$63$YR$$F$N$65.25$KG$20240905$Y$CN$US$
242876061$24287606$1$I$20180301$20240905$20240905$20240905$DIR$717214$$FDA-CTU$$57$YR$$M$N$117.45$KG$20240905$N$CN$US$
242876071$24287607$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001730$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240905$$CN$US$US
242876081$24287608$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001732$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240905$$CN$US$US
242876091$24287609$1$I$$20240827$20240905$20240905$EXP$GB-MHRA-MIDB-15690096-b755-4913-9310-b5862e84faf5$GB-TEVA-VS-3237728$TEVA$$90$YR$$F$Y$$$20240905$$PH$GB$GB
242876101$24287610$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001491$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240905$$CN$US$US
242876111$24287611$1$I$$20240828$20240905$20240905$EXP$$AR-ELI_LILLY_AND_COMPANY-AR202409001624$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240905$$CN$DE$AR
242876121$24287612$1$I$20240830$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001803$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240905$$CN$US$US
242876131$24287613$1$I$20240802$20240902$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024175420$AMGEN$$78$YR$E$F$Y$45$KG$20240905$$HP$CN$CN
242876141$24287614$1$I$20210101$20240905$20240905$20240905$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049684$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240905$$MD$PL$PL
242876151$24287615$1$I$$20240905$20240905$20240905$DIR$717253$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242876161$24287616$1$I$$20240905$20240905$20240905$DIR$717234$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242876171$24287617$1$I$20240501$20240903$20240905$20240905$EXP$FR-AFSSAPS-TO2024001685$FR-SANDOZ INC.-SDZ2024FR077485$SANDOZ$$21$YR$$M$Y$$$20240905$$PH$FR$FR
242876181$24287618$1$I$20240824$20240828$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137704$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240905$$PH$US$US
242876191$24287619$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141195$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240905$$CN$US$US
242876201$24287620$1$I$20240828$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141358$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$55.79$KG$20240905$$CN$US$US
242876211$24287621$1$I$20240717$20240725$20240905$20240905$PER$$US-LUNDBECK-DKLU4002201$LUNDBECK$$$$$$Y$$$20240905$$CN$US$US
242876221$24287622$1$I$$20240904$20240905$20240905$EXP$$US-TAKEDA-2024TUS088653$TAKEDA$$$$$F$Y$$$20240905$$CN$US$US
242876231$24287623$1$I$$20240830$20240905$20240905$EXP$CH-MLMSERVICE-20240614-PI100527-00060-1$CH-SANDOZ INC.-SDZ2024CH076592$SANDOZ$$41$YR$$M$Y$$$20240905$$MD$CH$CH
242876241$24287624$1$I$$20240903$20240905$20240905$EXP$$US-KYOWAKIRIN-2024KK020623$KYOWA$$$$$$Y$$$20240905$$HP$US$US
242876252$24287625$2$F$20240819$20240910$20240905$20240913$EXP$$JP-BEH-2024177966$CSL BEHRING$$7$DEC$E$M$Y$$$20240913$$MD$JP$JP
242876261$24287626$1$I$$20240823$20240905$20240905$EXP$$DE-OPKO PHARMACEUTICALS, LLC.-2024OPK00223$OPKO HEALTH$$67$YR$$M$Y$90$KG$20240905$$CN$COUNTRY NOT SPECIFIED$DE
242876272$24287627$2$F$20240624$20240916$20240905$20240926$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00226$OPKO HEALTH$$84$YR$$F$Y$$$20240924$$PH$COUNTRY NOT SPECIFIED$US
242876282$24287628$2$F$20240829$20240911$20240905$20240917$EXP$$US-ORGANON-O2409USA000080$ORGANON$$62$YR$$F$Y$$$20240917$$CN$US$US
242876291$24287629$1$I$$20240903$20240905$20240905$PER$$US-ABBVIE-5907760$ABBVIE$$$$$$Y$$$20240905$$CN$US$US
242876301$24287630$1$I$20240101$20240822$20240905$20240905$EXP$$GB-Ascend Therapeutics US, LLC-2159832$ASCEND$$48$YR$$F$Y$$$20240905$$$GB$GB
242876311$24287631$1$I$$20240822$20240905$20240905$EXP$$US-Fagron Sterile Services-2161274$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$$$$$Y$$$20240905$$$US$US
242876321$24287632$1$I$20240603$20240830$20240905$20240905$EXP$$FR-Integrated Therapeutic Solutions Inc.-2161262$Integrated Therapeutic Solutions$$54$YR$$M$Y$$$20240905$$$FR$FR
242876331$24287633$1$I$$20240828$20240905$20240905$EXP$$US-AMERICAN REGENT INC-2024003148$AMERICAN REGENT$$$$$F$Y$$$20240905$$CN$US$US
242876342$24287634$2$F$$20240912$20240905$20240913$EXP$$PL-SANDOZ INC.-NVSC2021PL065179$SANDOZ$$30$YR$$M$Y$$$20240913$$MD$PL$PL
242876361$24287636$1$I$$20240813$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128947$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240905$$CN$US$US
242876371$24287637$1$I$20230101$20240829$20240905$20240905$EXP$$PL-ABBVIE-5902116$ABBVIE$$68$YR$$M$Y$$$20240905$$MD$PL$PL
242876391$24287639$1$I$20240812$20240903$20240905$20240905$EXP$FR-AFSSAPS-TS2024000947$FR-SANDOZ INC.-SDZ2024FR077449$SANDOZ$$64$YR$$M$Y$$$20240905$$MD$FR$FR
242876401$24287640$1$I$20240101$20240903$20240905$20240905$PER$$US-ABBVIE-5907915$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242876413$24287641$3$F$$20240923$20240905$20240925$EXP$$US-PFIZER INC-PV202400116199$PFIZER$$35$YR$$F$Y$$$20240925$$HP$US$US
242876421$24287642$1$I$$20240903$20240905$20240905$EXP$$US-PFIZER INC-PV202400100235$PFIZER$$58$YR$$F$Y$$$20240905$$HP$US$US
242876431$24287643$1$I$$20240816$20240905$20240905$PER$$US-Apozeal Pharmaceuticals-2161226$Apozeal Pharmaceuticals$$$$$M$Y$$$20240905$$$US$US
242876441$24287644$1$I$$20240902$20240905$20240905$EXP$$GB-SANDOZ INC.-SDZ2024GB076366$SANDOZ$$$$$F$Y$$$20240905$$CN$GB$GB
242876451$24287645$1$I$$20240904$20240905$20240905$EXP$GB-MHRA-MED-202409041405391010-BPMQY$GB-SANDOZ INC.-SDZ2024GB077866$SANDOZ$$73$YR$$F$Y$52$KG$20240905$$CN$GB$GB
242876461$24287646$1$I$$20240903$20240905$20240905$EXP$$US-TAKEDA-2023TUS090214$TAKEDA$$$$$M$Y$$$20240905$$CN$US$US
242876471$24287647$1$I$20240621$20240827$20240905$20240905$EXP$$ES-TAKEDA-2024TUS088509$TAKEDA$$81$YR$$F$Y$$$20240905$$MD$ES$ES
242876481$24287648$1$I$$20240904$20240905$20240905$EXP$$GB-TAKEDA-2024TUS088600$TAKEDA$$$$$M$Y$$$20240905$$HP$GB$GB
242876491$24287649$1$I$$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61119$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
242876501$24287650$1$I$20240905$20240905$20240905$20240905$DIR$717215$$FDA-CTU$$26$YR$$F$N$59.4$KG$20240905$N$CN$US$
242876511$24287651$1$I$$20240905$20240905$20240905$DIR$717256$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242876521$24287652$1$I$20240902$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61124$$FDA-CTU$$37$YR$$F$N$$$20240904$N$PH$US$
242876531$24287653$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61129$$FDA-CTU$$59$YR$$F$N$73.03$KG$20240904$N$$US$
242876541$24287654$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61055$$FDA-CTU$$62$YR$$F$N$45.81$KG$20240904$N$$US$
242876552$24287655$2$F$$20240905$20240905$20240909$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014141$JAZZ$$$$$M$Y$$$20240909$$CN$US$US
242876561$24287656$1$I$$20240829$20240905$20240905$PER$$US-JNJFOC-20240880399$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$HP$US$US
242876571$24287657$1$I$20240801$20240904$20240905$20240905$PER$$US-JNJFOC-20240909296$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$MD$US$US
242876581$24287658$1$I$$20240904$20240905$20240905$EXP$$CA-BAUSCH-BL-2024-013260$BAUSCH AND LOMB$$89$YR$$M$Y$$$20240905$$CN$CA$CA
242876591$24287659$1$I$$20240904$20240905$20240905$EXP$$CA-BAUSCH-BL-2024-013257$BAUSCH AND LOMB$$73$YR$$M$Y$66$KG$20240905$$HP$CA$CA
242876601$24287660$1$I$20240430$20240501$20240905$20240905$PER$$US-PERRIGO-24US004296$PERRIGO$$2$YR$$M$Y$$$20240905$$CN$US$US
242876611$24287661$1$I$$20240902$20240905$20240905$EXP$$US-SANDOZ INC.-SDZ2024US077299$SANDOZ$$$$T$F$Y$$$20240905$$MD$US$US
242876631$24287663$1$I$$20240527$20240905$20240905$PER$$US-PERRIGO-24US005184$PERRIGO$$5$YR$$$Y$$$20240905$$CN$US$US
242876641$24287664$1$I$20240624$20240829$20240905$20240905$EXP$DE-PEI-CADR2024330116$DE-BAUSCH-BL-2024-013287$BAUSCH AND LOMB$$21$YR$$M$Y$75$KG$20240905$$MD$DE$DE
242876651$24287665$1$I$20240508$20240508$20240905$20240905$PER$$US-PERRIGO-24US004503$PERRIGO$$3$YR$$F$Y$13.152$KG$20240905$$CN$US$US
242876661$24287666$1$I$20230101$20240828$20240905$20240905$EXP$$CA-AstraZeneca-2024A178353$ASTRAZENECA$$40$YR$$F$Y$$$20240905$$CN$CA$
242876671$24287667$1$I$$20240903$20240905$20240905$EXP$$US-TAKEDA-2024TUS088464$TAKEDA$$$$$F$Y$$$20240905$$CN$US$US
242876681$24287668$1$I$20240815$20240828$20240905$20240905$EXP$$CN-AstraZeneca-2024A198210$ASTRAZENECA$$21967$DY$$M$Y$67$KG$20240905$$MD$CN$
242876691$24287669$1$I$$20240602$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001702$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$MD$US$US
242876701$24287670$1$I$$20240305$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001454$SPRINGWORKS THERAPEUTIC$$29$YR$$F$Y$$$20240905$$MD$US$US
242876711$24287671$1$I$$20240601$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001707$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242876721$24287672$1$I$$20240605$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001714$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$HP$US$US
242876731$24287673$1$I$$20240604$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001704$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$CN$US$US
242876741$24287674$1$I$20240301$20240719$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001692$SPRINGWORKS THERAPEUTIC$$41$YR$$F$Y$$$20240905$$MD$US$US
242876751$24287675$1$I$$20240826$20240905$20240905$EXP$$US-GSK-US2024AMR106828$GLAXOSMITHKLINE$$$$$F$Y$95.25$KG$20240905$$CN$US$US
242876761$24287676$1$I$20240801$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141280$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240905$$HP$US$US
242876771$24287677$1$I$$20240601$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001709$SPRINGWORKS THERAPEUTIC$$$$$M$Y$$$20240905$$MD$US$US
242876781$24287678$1$I$$20240829$20240905$20240905$PER$$US-ABBVIE-5902271$ABBVIE$$$$$$Y$$$20240905$$CN$US$US
242876791$24287679$1$I$20240101$20240904$20240905$20240905$EXP$DK-DKMA-30729362$DK-SANDOZ INC.-SDZ2024DK077696$SANDOZ$$92$YR$$M$Y$$$20240905$$MD$DK$DK
242876801$24287680$1$I$$20240830$20240905$20240905$EXP$$BG-TAKEDA-2024TUS088313$TAKEDA$$$$$F$Y$$$20240905$$MD$BG$BG
242876811$24287681$1$I$$20240601$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001708$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$MD$US$US
242876821$24287682$1$I$$20240612$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001730$SPRINGWORKS THERAPEUTIC$$$$A$$Y$$$20240905$$MD$US$US
242876831$24287683$1$I$$20240826$20240905$20240905$EXP$$SK-TAKEDA-2024TUS088280$TAKEDA$$46$YR$$M$Y$$$20240905$$MD$SK$SK
242876841$24287684$1$I$$20240902$20240905$20240905$PER$$US-ABBVIE-5905342$ABBVIE$$$$$F$Y$$$20240905$$HP$US$US
242876853$24287685$3$F$$20240917$20240905$20240927$30DAY$$CA-JNJFOC-20240872825$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240927$$PH$CA$CA
242876861$24287686$1$I$20240808$20240904$20240905$20240905$EXP$FR-AFSSAPS-TS2024000936$FR-SANDOZ INC.-SDZ2024FR077779$SANDOZ$$76$YR$$F$Y$$$20240905$$MD$FR$FR
242876874$24287687$4$F$20240809$20240919$20240905$20240920$EXP$$NVSC2024US178731$NOVARTIS$$70$YR$$M$Y$70.2$KG$20240920$$HP$US$US
242876881$24287688$1$I$$20240620$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001759$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$MD$US$US
242876891$24287689$1$I$$20240703$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001802$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$MD$US$US
242876901$24287690$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61100$$FDA-CTU$$76$YR$$F$N$58.51$KG$20240904$N$$US$
242876911$24287691$1$I$$20240702$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001792$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242876921$24287692$1$I$$20240718$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001842$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$CN$US$US
242876931$24287693$1$I$$20240718$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001841$SPRINGWORKS THERAPEUTIC$$$$C$F$Y$$$20240905$$CN$US$US
242876941$24287694$1$I$$20240621$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001765$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$HP$US$US
242876951$24287695$1$I$$20240620$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001758$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$MD$US$US
242876961$24287696$1$I$20240701$20240720$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001847$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$CN$US$US
242876971$24287697$1$I$$20240620$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001760$SPRINGWORKS THERAPEUTIC$$$$A$F$Y$$$20240905$$MD$US$US
242876981$24287698$1$I$$20240717$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001839$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$CN$US$US
242876991$24287699$1$I$$20240902$20240905$20240905$EXP$$GB-AMERICAN REGENT INC-2024003371$AMERICAN REGENT$$80$YR$$F$Y$$$20240905$$HP$GB$GB
242877001$24287700$1$I$$20240816$20240905$20240905$PER$$US-SA-2024SA253071$SANOFI AVENTIS$$$$$$Y$$$20240905$$MD$US$US
242877011$24287701$1$I$20240401$20240723$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001853$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$CN$US$US
242877021$24287702$1$I$20240730$20240904$20240905$20240905$EXP$FR-AFSSAPS-TS2024000938$FR-SANDOZ INC.-SDZ2024FR077690$SANDOZ$$61$YR$$M$Y$$$20240905$$MD$FR$FR
242877032$24287703$2$F$$20240904$20240905$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409001886$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240912$$CN$US$US
242877041$24287704$1$I$20240902$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001421$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240905$$CN$US$US
242877051$24287705$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002222$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242877062$24287706$2$F$20240401$20240917$20240905$20240927$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408016544$ELI LILLY AND CO$$77$YR$E$M$Y$115$KG$20240927$$CN$DE$DE
242877081$24287708$1$I$20240831$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001719$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240905$$CN$US$US
242877091$24287709$1$I$$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409000535$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240905$$CN$US$US
242877101$24287710$1$I$$20240724$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001865$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242877111$24287711$1$I$$20240903$20240905$20240905$EXP$$DE-SANDOZ INC.-NVSC2022DE280265$SANDOZ$$71$YR$$M$Y$120$KG$20240905$$MD$DE$DE
242877121$24287712$1$I$$20240723$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001856$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$CN$US$US
242877131$24287713$1$I$20240601$20240726$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001871$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$CN$US$US
242877141$24287714$1$I$$20240723$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001854$SPRINGWORKS THERAPEUTIC$$19$YR$$M$Y$$$20240905$$CN$US$US
242877151$24287715$1$I$$20240724$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001864$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242877161$24287716$1$I$$20240724$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001863$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242877171$24287717$1$I$$20240724$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001866$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242877181$24287718$1$I$$20240724$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001862$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242877191$24287719$1$I$$20240723$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001857$SPRINGWORKS THERAPEUTIC$$42$YR$$F$Y$$$20240905$$CN$US$US
242877201$24287720$1$I$$20240902$20240905$20240905$EXP$$IN-TAKEDA-2024TUS087936$TAKEDA$Kumar NM, Bhargava R. ALL-766 asciminib as a bridge to allogenic transplant in 3 patients with relapsed/refractory philadelphia chromosome-positive ALL or CML lymphoid blast crisis refractory/intolerant to ponatinib. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(supp 1):S283-284$$$$F$Y$$$20240905$$MD$IN$IN
242877211$24287721$1$I$$20240904$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141150$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240905$$CN$US$US
242877221$24287722$1$I$$20240529$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001884$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242877231$24287723$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61009$$FDA-CTU$$64$YR$$F$N$$$20240904$N$$US$
242877241$24287724$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141292$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240905$$CN$US$US
242877251$24287725$1$I$$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140485$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240905$$CN$US$US
242877261$24287726$1$I$$20240529$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001885$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242877271$24287727$1$I$$20240729$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001879$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$MD$US$US
242877281$24287728$1$I$$20240529$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001883$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242877291$24287729$1$I$$20240726$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001873$SPRINGWORKS THERAPEUTIC$$$$A$$Y$$$20240905$$CN$US$US
242877301$24287730$1$I$$20240529$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001887$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242877311$24287731$1$I$$20240529$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001888$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$MD$US$US
242877321$24287732$1$I$20240417$20240731$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001891$SPRINGWORKS THERAPEUTIC$$36$YR$$M$Y$95.5$KG$20240905$$HP$US$US
242877331$24287733$1$I$$20240529$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001886$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242877341$24287734$1$I$$20240529$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001894$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$MD$US$US
242877351$24287735$1$I$$20240903$20240905$20240905$PER$$PR-JNJFOC-20240911461$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$PR$PR
242877361$24287736$1$I$20240522$20240903$20240905$20240905$EXP$$US-KYOWAKIRIN-2024KK020733$KYOWA$$$$$$Y$$$20240905$$HP$US$US
242877371$24287737$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61089$$FDA-CTU$$51$YR$$F$N$71.67$KG$20240904$N$$US$
242877381$24287738$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61062$$FDA-CTU$$36$YR$$F$N$$$20240904$N$$US$
242877401$24287740$1$I$$20240905$20240905$20240905$DIR$717271$$FDA-CTU$$$$$UNK$N$$$20240905$$CN$US$
242877411$24287741$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61088$$FDA-CTU$$67$YR$$F$N$$$20240904$N$$US$
242877421$24287742$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61034$$FDA-CTU$$84$YR$$F$N$$$20240904$N$$US$
242877431$24287743$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61038$$FDA-CTU$$0$YR$$M$N$$$20240904$N$$US$
242877441$24287744$1$I$$20240905$20240905$20240905$DIR$717273$$FDA-CTU$$$$$UNK$N$$$20240905$$CN$US$
242877451$24287745$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61029$$FDA-CTU$$64$YR$$M$N$$$20240904$N$$US$
242877461$24287746$1$I$$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61109$$FDA-CTU$$$$$M$N$$$20240903$N$HP$US$
242877471$24287747$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61112$$FDA-CTU$$$$$M$N$$$20240904$N$PH$US$
242877481$24287748$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61059$$FDA-CTU$$50$YR$$M$N$$$20240904$N$$US$
242877491$24287749$1$I$$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61013$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
242877501$24287750$1$I$20240831$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61060$$FDA-CTU$$45$YR$$F$N$$$20240903$N$HP$US$
242877511$24287751$1$I$20240801$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61057$$FDA-CTU$$63$YR$$M$N$$$20240904$N$$US$
242877521$24287752$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61037$$FDA-CTU$$$$$M$N$$$20240904$N$$US$
242877531$24287753$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61045$$FDA-CTU$$52$YR$$F$N$$$20240904$N$$US$
242877541$24287754$1$I$$20240827$20240905$20240905$EXP$$TW-ROCHE-10000072295$ROCHE$Huang JP, Yeh CM, Gong YW, Tsai MH, Lin YT, Tsai CK, et al. Risk and impact of cytomegalovirus infection in lymphoma patients treated with bendamustine. Ann Hematol. Annals of Hematology. 2024. doi: 10.1007/s00277-024-05839-0.$$$$$Y$$$20240905$$HP$TW$TW
242877551$24287755$1$I$$20240805$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001903$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$HP$US$US
242877571$24287757$1$I$$20240827$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001930$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$MD$US$US
242877581$24287758$1$I$$20240816$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001937$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$PH$US$US
242877591$24287759$1$I$$20240823$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001958$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$MD$US$US
242877601$24287760$1$I$$20240808$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001918$SPRINGWORKS THERAPEUTIC$$$$$F$Y$$$20240905$$CN$US$US
242877611$24287761$1$I$20240702$20240813$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001912$SPRINGWORKS THERAPEUTIC$$17$YR$$M$Y$$$20240905$$MD$US$US
242877621$24287762$1$I$$20240809$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001921$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240905$$CN$US$US
242877631$24287763$1$I$20240807$20240809$20240905$20240905$PER$$US-SPRINGWORKS THERAPEUTICS-SW-001923$SPRINGWORKS THERAPEUTIC$$58$YR$$M$Y$92.517$KG$20240905$$CN$US$US
242877642$24287764$2$F$$20240917$20240905$20240923$EXP$$US-BIOGEN-2024BI01281049$BIOGEN$$$$$M$Y$$$20240923$$CN$US$US
242877651$24287765$1$I$$20240903$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE077412$SANDOZ$$44$YR$$M$Y$$$20240905$$HP$DE$DE
242877671$24287767$1$I$$20240904$20240905$20240905$EXP$$CA-SANDOZ INC.-SDZ2024CA077773$SANDOZ$$66$YR$$F$Y$$$20240905$$HP$CA$CA
242877681$24287768$1$I$$20240828$20240905$20240905$30DAY$$US-GSK-US2024107224$GLAXOSMITHKLINE$$$$$M$Y$$$20240905$$HP$US$US
242877691$24287769$1$I$$20240904$20240905$20240905$EXP$$CLI/CAN/24/0004993$SANDOZ$$75$YR$$F$Y$$$20240905$$CN$CA$CA
242877701$24287770$1$I$$20240827$20240905$20240905$EXP$GB-MHRA-MIDB-2475276d-cc81-4d9e-974d-6a8f7058aee0$GB-TEVA-VS-3237992$TEVA$$89$YR$$F$Y$$$20240905$$PH$GB$GB
242877713$24287771$3$F$20230709$20240906$20240905$20240918$EXP$$US-ABBVIE-5906378$ABBVIE$$$$$M$Y$86$KG$20240918$$CN$US$US
242877731$24287773$1$I$$20240828$20240905$20240905$EXP$$CN-009507513-2409CHN000530$MERCK$Li R, Liu J, Yang L, Lin Z, Rong L, Chen G, et al.. Pulmonary abscess secondary to epididymitis caused by extended spectrum ?-lactamase-producing hypervirulent Klebsiella pneumoniae: a case report. BMC Infectious Diseases. 2024;24$71$YR$$M$Y$$$20240905$$HP$CN$CN
242877741$24287774$1$I$20181121$20240829$20240905$20240905$EXP$$PHHY2019DE007962$NOVARTIS$$$$A$M$Y$$$20240905$$MD$DE$DE
242877752$24287775$2$F$20240903$20240905$20240905$20240906$PER$$US-AMGEN-USASP2024177214$AMGEN$$61$YR$A$F$Y$$$20240906$$CN$US$US
242877761$24287776$1$I$20240807$20240903$20240905$20240905$EXP$$NVSC2024CN178418$NOVARTIS$$79$YR$$F$Y$$$20240905$$HP$CN$CN
242877771$24287777$1$I$$20240903$20240905$20240905$PER$$US-ALXN-202409USA000116US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242877781$24287778$1$I$$20240904$20240905$20240905$PER$$US-ABBVIE-5908644$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242877791$24287779$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141273$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240905$$CN$US$US
242877801$24287780$1$I$$20240904$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE077691$SANDOZ$$18$YR$$M$Y$$$20240905$$HP$DE$DE
242877811$24287781$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141390$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240905$$HP$US$US
242877821$24287782$1$I$20210201$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140671$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$$$20240905$$CN$US$US
242877831$24287783$1$I$20240801$20240903$20240905$20240905$EXP$$US-KYOWAKIRIN-2024KK020621$KYOWA$$$$$$Y$$$20240905$$HP$US$US
242877841$24287784$1$I$20240129$20240830$20240905$20240905$EXP$$CN-009507513-2409CHN000750$MERCK$$65$YR$$F$Y$$$20240905$$HP$CN$CN
242877852$24287785$2$F$20240904$20240905$20240905$20240906$EXP$$US-INCYTE CORPORATION-2024IN009321$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242877861$24287786$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61050$$FDA-CTU$$92$YR$$M$N$$$20240904$N$$US$
242877871$24287787$1$I$20230512$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61091$$FDA-CTU$$67$YR$$M$N$$$20240904$N$$US$
242877881$24287788$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61095$$FDA-CTU$$62$YR$$F$N$$$20240904$N$$US$
242877891$24287789$1$I$20210101$20240905$20240905$20240905$DIR$717212$$FDA-CTU$$59$YR$$F$N$67.5$KG$20240905$N$CN$US$
242877901$24287790$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61090$$FDA-CTU$$59$YR$$F$N$62.6$KG$20240904$N$$US$
242877911$24287791$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61077$$FDA-CTU$$63$YR$$F$N$82.55$KG$20240904$N$$US$
242877921$24287792$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61020$$FDA-CTU$$57$YR$$F$N$$$20240904$N$$US$
242877941$24287794$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61044$$FDA-CTU$$54$YR$$F$N$$$20240904$N$$US$
242877951$24287795$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61130$$FDA-CTU$$66$YR$$F$N$$$20240904$N$$US$
242877961$24287796$1$I$20240831$20240903$20240904$20240904$DIR$FDA-CDER-CTU-2024-61035$$FDA-CTU$$58$YR$$F$N$$$20240903$N$HP$US$
242877972$24287797$2$F$20230101$20240913$20240905$20240920$EXP$$JP-Eisai-EC-2024-173293$EISAI$$71$YR$E$M$Y$$$20240920$$MD$JP$JP
242877981$24287798$1$I$20240901$20240905$20240905$20240905$DIR$717236$$FDA-CTU$$53$YR$$F$N$62.1$KG$20240905$N$CN$US$
242877991$24287799$1$I$$20240828$20240905$20240905$PER$$NVSC2024US173982$NOVARTIS$$$$$F$Y$$$20240905$$HP$US$US
242878001$24287800$1$I$20240801$20240827$20240905$20240905$EXP$$US-Eisai-EC-2024-173725$EISAI$$81$YR$E$M$Y$$$20240905$$HP$US$US
242878021$24287802$1$I$20240820$20240829$20240905$20240905$PER$$US-Eisai-EC-2024-173484$EISAI$$82$YR$E$M$Y$$$20240905$$MD$US$US
242878031$24287803$1$I$20240823$20240830$20240905$20240905$EXP$$CA-FERRINGPH-2024FE05010$FERRING$$$$$$Y$$$20240905$$HP$CA$CA
242878041$24287804$1$I$20240827$20240827$20240905$20240905$PER$$US-JNJFOC-20240911368$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240905$$CN$US$US
242878052$24287805$2$F$$20240829$20240905$20240909$PER$$US-JNJFOC-20240911447$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$HP$US$US
242878061$24287806$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA257520$SANOFI AVENTIS$$19$YR$A$$Y$$$20240905$$CN$US$US
242878071$24287807$1$I$20240609$20240902$20240905$20240905$EXP$$CN-ROCHE-10000074272$ROCHE$$78$YR$E$M$Y$$$20240905$$HP$CN$CN
242878081$24287808$1$I$$20240827$20240905$20240905$PER$$US-ABBVIE-5898408$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242878091$24287809$1$I$$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409000329$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240905$$CN$US$US
242878101$24287810$1$I$$20240827$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202408017089$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240905$$CN$US$US
242878111$24287811$1$I$$20240823$20240905$20240905$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408016427$ELI LILLY AND CO$$$$$$Y$$$20240905$$MD$GB$GB
242878121$24287812$1$I$20240828$20240828$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202408017793$ELI LILLY AND CO$$$$$M$Y$$$20240905$$HP$US$US
242878131$24287813$1$I$$20240826$20240905$20240905$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408016581$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240905$$CN$BR$BR
242878141$24287814$1$I$20220101$20240826$20240905$20240905$EXP$PT-INFARMED-F202408-457$PT-ELI_LILLY_AND_COMPANY-PT202408016587$ELI LILLY AND CO$$55$YR$A$F$Y$78$KG$20240905$$CN$PT$PT
242878151$24287815$1$I$$20240827$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016951$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240905$$CN$US$US
242878161$24287816$1$I$20240825$20240830$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000249$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240905$$PH$US$US
242878171$24287817$1$I$20240701$20240826$20240905$20240905$EXP$FR-AFSSAPS-LL2024001601$FR-ELI_LILLY_AND_COMPANY-FR202409000959$ELI LILLY AND CO$$50$YR$A$M$Y$90$KG$20240905$$CN$DE$FR
242878181$24287818$1$I$$20240830$20240905$20240905$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409000694$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$DE$DE
242878191$24287819$1$I$$20240827$20240905$20240905$EXP$$AR-ELI_LILLY_AND_COMPANY-AR202409002873$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240905$$CN$DE$AR
242878201$24287820$1$I$20210201$20240826$20240905$20240905$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202407014417$ELI LILLY AND CO$$$$A$F$Y$$$20240905$$CN$JP$JP
242878211$24287821$1$I$20240710$20240826$20240905$20240905$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409000897$ELI LILLY AND CO$$77$YR$E$M$Y$57$KG$20240905$$CN$DE$CN
242878221$24287822$1$I$$20240831$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001253$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240905$$CN$US$US
242878241$24287824$1$I$$20240825$20240905$20240905$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409001211$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240905$$CN$JP$JP
242878251$24287825$1$I$$20240828$20240905$20240905$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002324$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240905$$CN$US$US
242878261$24287826$1$I$$20240902$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002228$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242878271$24287827$1$I$20231031$20240827$20240905$20240905$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000385$ELI LILLY AND CO$$67$YR$E$M$Y$57$KG$20240905$$CN$JP$JP
242878281$24287828$1$I$20240601$20240826$20240905$20240905$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202408016461$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240905$$CN$BE$BE
242878291$24287829$1$I$$20240904$20240905$20240905$EXP$$US-PFIZER INC-202400250054$PFIZER$$$$A$$Y$$$20240905$$MD$US$US
242878321$24287832$1$I$20230615$20240827$20240905$20240905$EXP$$CN-009507513-2409CHN000023$MERCK$$71$YR$$M$Y$65$KG$20240905$$HP$CN$CN
242878331$24287833$1$I$20240801$20240831$20240905$20240905$EXP$$CN-009507513-2409CHN001318$MERCK$$56$YR$$M$Y$60$KG$20240905$$HP$CN$CN
242878341$24287834$1$I$$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141465$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240905$$CN$US$US
242878351$24287835$1$I$20240903$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141524$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240905$$CN$US$US
242878371$24287837$1$I$$20240829$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138578$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240905$$HP$US$US
242878381$24287838$1$I$20240828$20240902$20240905$20240905$EXP$IT-MINISAL02-1000850$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-139553$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240905$$PH$IT$IT
242878391$24287839$1$I$$20240827$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137699$BRISTOL MYERS SQUIBB$$72$YR$A$F$Y$$$20240905$$CN$US$US
242878401$24287840$1$I$20191124$20240828$20240905$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139835$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240905$$MD$JP$JP
242878411$24287841$1$I$20240821$20240828$20240905$20240905$EXP$$NL-VER-202400055$VERITY PHARMACEUTICALS$$73$YR$E$M$Y$$$20240905$$HP$NL$NL
242878421$24287842$1$I$20240802$20240823$20240905$20240905$EXP$$GB-VER-202400009$VERITY PHARMACEUTICALS$$42$YR$A$F$Y$103$KG$20240905$$CN$GB$GB
242878431$24287843$1$I$$20240902$20240905$20240905$EXP$$SG-AstraZeneca-2024A200191$ASTRAZENECA$$$$$$Y$$$20240905$$PH$SG$
242878441$24287844$1$I$$20240902$20240905$20240905$EXP$$SG-AstraZeneca-2024A200201$ASTRAZENECA$$$$$$Y$$$20240905$$PH$SG$
242878451$24287845$1$I$20240728$20240829$20240905$20240905$EXP$$AR-EMD Serono-2024046779$EMD SERONO INC$$4$YR$C$M$Y$$$20240905$$MD$AR$AR
242878471$24287847$1$I$$20240904$20240905$20240905$PER$$US-PFIZER INC-202400250526$PFIZER$$$$A$F$Y$$$20240905$$MD$US$US
242878481$24287848$1$I$$20240903$20240905$20240905$PER$$US-PFIZER INC-202400249267$PFIZER$$79$YR$$F$Y$$$20240905$$HP$US$US
242878492$24287849$2$F$20240801$20240904$20240905$20240906$PER$$US-PFIZER INC-202400250140$PFIZER$$30$YR$$F$Y$42.18$KG$20240906$$CN$US$US
242878501$24287850$1$I$20240808$20240808$20240905$20240905$PER$$US-009507513-2408USA003639$MERCK$$$$$F$Y$$$20240905$$CN$US$US
242878512$24287851$2$F$20240903$20240904$20240905$20240906$PER$$NVSC2024US178298$NOVARTIS$$30$YR$$M$Y$$$20240906$$CN$US$US
242878521$24287852$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176644$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242878531$24287853$1$I$$20240826$20240905$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-140277$BRISTOL MYERS SQUIBB$Nakauchi Y, Toyoda Y, Morizumi S, Kondo Y, Shigehisa Y, Yorita K. A case of a patient with non-small cell lung cancer who developed colitis due to paclitaxel. Proceedings of the 69th Chugoku/Shikoku Regional Meeting of the Japanese Respiratory Society, the 32nd Chugoku/Shikoku Branch Meeting of the Japan Society for Respiratory Endoscopy, the 74th Chugoku/Shikoku Branch Meeting of the Japanese Society for Tuberculosis and Nontuberculous Mycobacteriosis.$68$YR$E$M$Y$$$20240905$$MD$JP$JP
242878551$24287855$1$I$$20240905$20240905$20240905$DIR$717229$$FDA-CTU$$59$YR$$F$N$$$20240905$N$CN$US$
242878561$24287856$1$I$$20240905$20240905$20240905$DIR$717233$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242878571$24287857$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA254161$SANOFI AVENTIS$$$$A$M$Y$$$20240905$$HP$US$US
242878581$24287858$1$I$$20240905$20240905$20240905$DIR$717221$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242878591$24287859$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000986$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878601$24287860$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000985$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878611$24287861$1$I$$20240426$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000988$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878621$24287862$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000987$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878631$24287863$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000990$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878641$24287864$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000991$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878651$24287865$1$I$20240624$20240903$20240905$20240905$EXP$FR-AFSSAPS-DJ2024000975$FR-009507513-2409FRA000952$MERCK$$51$YR$$F$Y$65$KG$20240905$$MD$FR$FR
242878661$24287866$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000989$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878671$24287867$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000992$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878681$24287868$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000993$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878691$24287869$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000994$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878701$24287870$1$I$$20240904$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE077719$SANDOZ$$21$YR$$M$Y$$$20240905$$HP$DE$DE
242878711$24287871$1$I$20240830$20240903$20240905$20240905$EXP$$US-KYOWAKIRIN-2024KK020729$KYOWA$$$$$$Y$$$20240905$$HP$US$US
242878721$24287872$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141275$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240905$$CN$US$US
242878731$24287873$1$I$20240516$20240828$20240905$20240905$EXP$FR-AFSSAPS-LL2024001593$FR-TEVA-VS-3238030$TEVA$$60$YR$$F$Y$50.6$KG$20240905$$MD$FR$FR
242878742$24287874$2$F$$20240905$20240905$20240908$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141246$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240909$$CN$US$US
242878751$24287875$1$I$20240814$20240828$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137645$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240905$$HP$US$US
242878761$24287876$1$I$$20240904$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE077726$SANDOZ$$27$YR$$F$Y$$$20240905$$PH$DE$DE
242878771$24287877$1$I$20240825$20240826$20240905$20240905$PER$$US-ABBVIE-5896072$ABBVIE$$47$YR$$M$Y$$$20240905$$CN$US$US
242878781$24287878$1$I$$20240828$20240905$20240905$EXP$FR-AFSSAPS-NY2024000979$FR-TEVA-VS-3237998$TEVA$$62$YR$$F$Y$68$KG$20240905$$CN$FR$FR
242878791$24287879$1$I$$20240830$20240905$20240905$EXP$FR-AFSSAPS-AVCN2024000648$FR-MYLANLABS-2024M1080045$MYLAN$$34$YR$$M$Y$$$20240905$$PH$FR$FR
242878801$24287880$1$I$20240901$20240902$20240905$20240905$EXP$$GB-MYLANLABS-2024M1080712$MYLAN$$$$$M$Y$$$20240905$$CN$GB$GB
242878811$24287881$1$I$20170101$20240830$20240905$20240905$EXP$FR-AFSSAPS-NY2024000980$FR-MYLANLABS-2024M1080053$MYLAN$$90$YR$$M$Y$$$20240905$$MD$FR$FR
242878821$24287882$1$I$20230418$20240828$20240905$20240905$EXP$$GB-TEVA-VS-3238431$TEVA$$69$YR$$M$Y$91$KG$20240905$$MD$GB$GB
242878831$24287883$1$I$20240809$20240902$20240905$20240905$EXP$FR-AFSSAPS-AN2024001174$FR-MYLANLABS-2024M1080502$MYLAN$$23$YR$$M$Y$$$20240905$$PH$FR$FR
242878841$24287884$1$I$20231219$20240903$20240905$20240905$EXP$GB-MHRA-MED-202409031803112940-JYWLM$GB-MYLANLABS-2024M1081140$MYLAN$$84$YR$$F$Y$76$KG$20240905$$MD$GB$GB
242878851$24287885$1$I$$20240830$20240905$20240905$EXP$$BE-AMGEN-BELSP2024175306$AMGEN$$$$$F$Y$$$20240905$$MD$BE$BE
242878861$24287886$1$I$$20240825$20240905$20240905$EXP$$CA-HLS-202402151$HLS THERAPEUTICS$$$$A$F$Y$$$20240905$$PH$CA$CA
242878871$24287887$1$I$20240717$20240903$20240905$20240905$EXP$FR-AFSSAPS-RN2024000926$FR-009507513-2409FRA001237$MERCK$$58$YR$$F$Y$$$20240905$$MD$FR$FR
242878881$24287888$1$I$$20240829$20240905$20240905$EXP$$IN-MYLANLABS-2024M1081033$MYLAN$Manju Bhargav BR, Radhakrishnan VV, Sivaprasad K. A Case Series of Thrombolysis in Prosthetic Valve Thrombosis. Indian-Heart-J 2023; 75 (Suppl.) S91-S93.$41$YR$$F$Y$$$20240905$$HP$IN$IN
242878891$24287889$1$I$$20240827$20240905$20240905$EXP$$US-RDY-SPO/USA/24/0012717$DR REDDYS$Cromack SC, Lulu Y, Magdy MP. Prostaglandin Injection for Myoma Expulsion (PRIME): Case Series of a Novel Approach to Hysteroscopic Resection of FIGO Type 2 Myomas. Journal of Minimally Invasive Gynecology. 2024 Jul;31(7): 613-619. doi:10.1016/j.jmig.2024.03.011.$33$YR$A$F$Y$$$20240905$$MD$US$US
242878901$24287890$1$I$20240903$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024177192$AMGEN$$81$YR$E$F$Y$$$20240905$$CN$US$US
242878912$24287891$2$F$$20240911$20240905$20240919$EXP$$US-ABBVIE-5906385$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
242878921$24287892$1$I$$20240905$20240905$20240905$DIR$717218$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242878931$24287893$1$I$20240624$20240905$20240905$20240905$EXP$FR-AFSSAPS-AM2024000706$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-141303$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$74$KG$20240905$$MD$FR$FR
242878951$24287895$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000998$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878961$24287896$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000995$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878971$24287897$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000999$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878981$24287898$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001002$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242878991$24287899$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001003$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879001$24287900$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001004$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879011$24287901$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000997$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879021$24287902$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT000996$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879031$24287903$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001000$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879041$24287904$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001001$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879051$24287905$1$I$$20240905$20240905$20240905$PER$$NVSC2024US178732$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242879061$24287906$1$I$$20240828$20240905$20240905$PER$$CN-Eisai-EC-2024-173259$EISAI$Xu S, Wu X, Chen E, Ying K. Anti-Helicobacter pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review  of the Literature. The Clinical Respiratory Journal. 2024;(18:e13816): 1-6. doi:10.1111/crj.13816.$45$YR$A$F$Y$$$20240905$$MD$CN$CN
242879071$24287907$1$I$20240814$20240905$20240905$20240905$DIR$717216$$FDA-CTU$$$$$UNK$N$$$20240905$Y$CN$US$
242879081$24287908$1$I$$20240828$20240905$20240905$PER$$JP-Eisai-EC-2024-173309$EISAI$Satoshi Hirakawa et al.. Tracing report: Small tips for continuing LEM/PEM therapy. Endometrial Cancer Seminar in Hamamatsu.$$$E$F$Y$70$KG$20240905$$MD$JP$JP
242879091$24287909$1$I$20240806$20240829$20240905$20240905$EXP$FR-AFSSAPS-CN2024000783$FR-Eisai-EC-2024-173191$EISAI$$57$YR$A$M$Y$67$KG$20240905$$PH$FR$FR
242879101$24287910$1$I$20240828$20240828$20240905$20240905$PER$$JP-Eisai-EC-2024-173660$EISAI$$68$YR$E$F$Y$$$20240905$$MD$JP$JP
242879111$24287911$1$I$$20240904$20240905$20240905$EXP$$JP-ABBVIE-5906386$ABBVIE$$25$YR$$$Y$$$20240905$$MD$JP$JP
242879122$24287912$2$F$$20240905$20240905$20240909$EXP$$NVSC2024GB178019$NOVARTIS$$$$$M$Y$$$20240909$$CN$GB$GB
242879131$24287913$1$I$$20240828$20240905$20240905$PER$$CN-Eisai-EC-2024-173260$EISAI$Xu S, Wu X, Chen E, Ying K. Anti-Helicobacter pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review  of the Literature. The Clinical Respiratory Journal. 2024;(18:e13816): 1-6. doi:10.1111/crj.13816.$36$YR$A$F$Y$$$20240905$$MD$CN$CN
242879141$24287914$1$I$20190304$20240827$20240905$20240905$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-139157$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$54$KG$20240905$$MD$KR$KR
242879151$24287915$1$I$20240705$20240905$20240905$20240905$DIR$717244$$FDA-CTU$$46$YR$$F$N$65.25$KG$20240905$Y$CN$US$
242879161$24287916$1$I$20240905$20240905$20240905$20240905$DIR$717247$$FDA-CTU$$44$YR$$F$N$123.75$KG$20240905$N$CN$US$
242879171$24287917$1$I$$20240905$20240905$20240905$DIR$717263$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242879181$24287918$1$I$$20240830$20240905$20240905$PER$$US-SA-2024SA256852$SANOFI AVENTIS$$$$$M$Y$$$20240905$$HP$US$US
242879191$24287919$1$I$20240724$20240725$20240905$20240905$PER$$US-LUNDBECK-DKLU4002205$LUNDBECK$$$$$$Y$$$20240905$$HP$US$US
242879201$24287920$1$I$20240806$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141134$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240905$$CN$US$US
242879211$24287921$1$I$20240812$20240904$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141225$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240905$$CN$US$US
242879221$24287922$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141550$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240905$$CN$US$US
242879231$24287923$1$I$20240905$20240905$20240905$20240905$DIR$717243$$FDA-CTU$$76$YR$$F$N$54$KG$20240905$N$CN$US$
242879251$24287925$1$I$$20240905$20240905$20240905$DIR$717261$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242879261$24287926$1$I$20240904$20240905$20240905$20240905$DIR$717223$$FDA-CTU$$66$YR$$F$N$$$20240905$N$HP$US$
242879271$24287927$1$I$20230620$20240828$20240905$20240905$EXP$$DE-AstraZeneca-2024A196869$ASTRAZENECA$$69$YR$$F$Y$66$KG$20240905$$MD$DE$
242879281$24287928$1$I$20211119$20240902$20240905$20240905$EXP$PL-URPL-DML-MLP.4401.1.5051.2021$PL-BAUSCH-BL-2024-013193$BAUSCH AND LOMB$$49$YR$$$Y$100$KG$20240905$$MD$PL$PL
242879291$24287929$1$I$20240902$20240903$20240905$20240905$EXP$$CA-GILEAD-2024-0686290$GILEAD$$41$YR$A$F$Y$$$20240905$$CN$CA$CA
242879301$24287930$1$I$20240801$20240904$20240905$20240905$EXP$GB-MHRA-MED-202409040830405940-DQVJB$GB-SANDOZ INC.-SDZ2024GB077745$SANDOZ$$62$YR$$M$Y$74$KG$20240905$$CN$GB$GB
242879311$24287931$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001007$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879321$24287932$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001008$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879331$24287933$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001005$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879341$24287934$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001009$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879351$24287935$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001010$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879361$24287936$1$I$$20240827$20240905$20240905$EXP$$CA-ANIPHARMA-2024-CA-003794$ANI$$21$YR$$M$Y$$$20240905$$HP$CA$CA
242879371$24287937$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001014$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879381$24287938$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001006$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879391$24287939$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001013$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879401$24287940$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001012$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879411$24287941$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001011$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879431$24287943$1$I$$20240904$20240905$20240905$EXP$$US-GILEAD-2024-0686316$GILEAD$$24$YR$A$F$Y$$$20240905$$CN$US$US
242879441$24287944$1$I$$20240903$20240905$20240905$PER$$US-HALEON-2195037$Haleon PLC$$$$E$$Y$$$20240905$$CN$US$US
242879451$24287945$1$I$$20240827$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049728$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240905$$CN$US$US
242879461$24287946$1$I$$20240830$20240905$20240905$EXP$$NVSC2024MA151988$NOVARTIS$$$$$F$Y$$$20240905$$CN$MA$MA
242879471$24287947$1$I$20240901$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024177175$AMGEN$$72$YR$E$F$Y$$$20240905$$CN$US$US
242879481$24287948$1$I$20240801$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002699$ELI LILLY AND CO$$$$$$Y$$$20240905$$CN$US$US
242879501$24287950$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001016$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al.. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879511$24287951$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001018$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879521$24287952$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001017$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashm, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879531$24287953$1$I$$20240429$20240905$20240905$PER$$US-KARYOPHARM-2024KPT001015$KARYOPHARM THERAPEUTICS$Aimaz Afrough, Hamza Hashmi, Doris K. Hansen et al. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. 2024;14:63:1-5$$$$$Y$$$20240905$$MD$US$US
242879541$24287954$1$I$$20240828$20240905$20240905$EXP$$GB-TEVA-VS-3238549$TEVA$$80$YR$$F$Y$$$20240905$$MD$GB$GB
242879551$24287955$1$I$$20240904$20240905$20240905$PER$$US-GILEAD-2024-0686265$GILEAD$$53$YR$A$M$Y$$$20240905$$CN$US$US
242879561$24287956$1$I$$20240829$20240905$20240905$EXP$BE-FAMHP-DHH-N2024-122534$BE-TEVA-VS-3239017$TEVA$$$$A$F$Y$$$20240905$$HP$BE$BE
242879581$24287958$1$I$$20240905$20240905$20240905$DIR$717240$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242879591$24287959$1$I$$20240904$20240905$20240905$EXP$$US-LUNDBECK-DKLU4003914$LUNDBECK$$$$$$Y$$$20240905$$HP$US$US
242879601$24287960$1$I$$20240904$20240905$20240905$EXP$$US-GILEAD-2024-0686282$GILEAD$$$$$F$Y$$$20240905$$MD$US$US
242879611$24287961$1$I$20240110$20240826$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137236$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$82.4$KG$20240905$$MD$US$US
242879621$24287962$1$I$$20240827$20240905$20240905$PER$$US-ABBVIE-5899256$ABBVIE$$$$$$Y$$$20240905$$CN$US$US
242879631$24287963$1$I$20240622$20240904$20240905$20240905$EXP$FR-AFSSAPS-PP2024000953$FR-009507513-2409FRA001749$MERCK$$64$YR$$F$Y$87$KG$20240905$$MD$FR$FR
242879641$24287964$1$I$20240802$20240902$20240905$20240905$EXP$FR-AFSSAPS-NC2024001000$FR-009507513-2409FRA000759$MERCK$$78$YR$$F$Y$$$20240905$$MD$FR$FR
242879651$24287965$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA256281$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240905$$CN$US$US
242879661$24287966$1$I$$20240828$20240905$20240905$EXP$AU-HALEON-2186448$AU-PERRIGO-24AU007984$PERRIGO$Kurtovic J, Riordan SM. Paracetamol-induced hepatotoxicity at recommended dosage. Journal of Internal Medicine. 2003; 253: 240-243. DOI: 0.1046/j.1365-2796.2003.01097.x.)$53$YR$$F$Y$$$20240905$$HP$AU$AU
242879671$24287967$1$I$20240703$20240828$20240905$20240905$EXP$$AU-PERRIGO-24AU007986$PERRIGO$$77$YR$$M$Y$$$20240905$$MD$AU$AU
242879681$24287968$1$I$$20240828$20240905$20240905$EXP$AU-RBHC-20-24-AUS-RB-0003694$AU-PERRIGO-24AU007981$PERRIGO$$7$YR$$F$Y$$$20240905$$CN$AU$AU
242879691$24287969$1$I$$20240829$20240905$20240905$EXP$$NVSC2024BR176662$NOVARTIS$$49$YR$$F$Y$$$20240905$$CN$BR$BR
242879702$24287970$2$F$20240101$20240903$20240905$20240923$PER$$US-KARYOPHARM-2024KPT001395$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240923$$CN$US$US
242879712$24287971$2$F$20240101$20240911$20240905$20240925$PER$$US-KARYOPHARM-2024KPT001500$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240925$$CN$US$US
242879741$24287974$1$I$20190201$20240905$20240905$20240905$DIR$717282$$FDA-CTU$$31$YR$$F$N$72$KG$20240905$N$CN$US$
242879771$24287977$1$I$20230614$20240903$20240905$20240905$EXP$$AR-MYLANLABS-2023M1064248$MYLAN$$26$YR$$M$Y$$$20240905$$CN$AR$AR
242879781$24287978$1$I$$20240902$20240905$20240905$EXP$$IE-MYLANLABS-2024M1080734$MYLAN$$56$YR$$M$Y$$$20240905$$MD$IE$IE
242879791$24287979$1$I$20240601$20240826$20240905$20240905$EXP$GB-MHRA-MED-202408261518310720-BZSFG$GB-ELI_LILLY_AND_COMPANY-GB202408016716$ELI LILLY AND CO$$28$YR$A$F$Y$69$KG$20240905$$CN$GB$GB
242879802$24287980$2$F$20240904$20240912$20240905$20240917$PER$$US-AMGEN-USASP2024176981$AMGEN$$62$YR$A$F$Y$$$20240917$$HP$US$US
242879812$24287981$2$F$$20240904$20240905$20240906$EXP$$US-SANDOZ INC.-SDZ2024US077955$SANDOZ$$$$$F$Y$$$20240906$$CN$US$US
242879821$24287982$1$I$20240830$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176890$AMGEN$$75$YR$E$M$Y$$$20240905$$CN$US$US
242879831$24287983$1$I$$20240821$20240905$20240905$EXP$$US-SMPA-2024SPA001764$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242879841$24287984$1$I$20240801$20240827$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136115$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240905$$CN$US$US
242879852$24287985$2$F$20230101$20240827$20240905$20240909$EXP$$US-Eisai-EC-2024-173755$EISAI$$63$YR$A$F$Y$$$20240909$$CN$US$US
242879861$24287986$1$I$20240830$20240831$20240905$20240905$EXP$$NVSC2024CN177648$NOVARTIS$$$$$F$Y$$$20240905$$CN$CN$CN
242879872$24287987$2$F$20240823$20240911$20240905$20240916$EXP$$GB-MYLANLABS-2024M1080766$MYLAN$$51$YR$$F$Y$48$KG$20240916$$PH$GB$GB
242879881$24287988$1$I$$20240905$20240905$20240905$DIR$717219$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242879891$24287989$1$I$20240730$20240828$20240905$20240905$EXP$$DE-009507513-2408DEU010080$MERCK$$66$YR$$M$Y$$$20240905$$MD$DE$DE
242879901$24287990$1$I$$20240821$20240905$20240905$EXP$$TR-Breckenridge Pharmaceutical, Inc.-2161280$BRECKENRIDGE$Literature$6$YR$$F$Y$$$20240905$$$IN$TR
242879911$24287991$1$I$20240814$20240830$20240905$20240905$EXP$$CN-PURDUE-USA-2024-0311799$PURDUE$$70$YR$$F$Y$49$KG$20240905$$HP$CN$CN
242879921$24287992$1$I$$20240904$20240905$20240905$EXP$$US-PURDUE PHARMA-USA-2024-0311783$PURDUE$$$$$F$Y$$$20240905$$CN$US$US
242879931$24287993$1$I$20240812$20240830$20240905$20240905$EXP$$CN-PURDUE-USA-2024-0311790$PURDUE$$37$YR$$F$Y$80$KG$20240905$$HP$CN$CN
242879942$24287994$2$F$$20240903$20240905$20240918$PER$$US-PURDUE PHARMA-USA-2024-0311780$PURDUE$$$$$F$Y$$$20240918$$CN$US$US
242879951$24287995$1$I$20240505$20240830$20240905$20240905$EXP$$CN-PURDUE-USA-2024-0311800$PURDUE$$42$YR$$F$Y$58$KG$20240905$$HP$CN$CN
242879961$24287996$1$I$20220101$20240904$20240905$20240905$EXP$$US-PURDUE PHARMA-USA-2024-0311781$PURDUE$$32$YR$$F$Y$$$20240905$$CN$US$US
242879971$24287997$1$I$20240821$20240829$20240905$20240905$EXP$$CN-PURDUE-USA-2024-0311798$PURDUE$$75$YR$$M$Y$60$KG$20240905$$HP$CN$CN
242879981$24287998$1$I$$20240904$20240905$20240905$EXP$$US-PURDUE PHARMA-USA-2024-0311782$PURDUE$$45$YR$$M$Y$$$20240905$$CN$US$US
242879992$24287999$2$F$$20240903$20240905$20240906$PER$$US-PURDUE PHARMA-USA-2024-0311779$PURDUE$$66$YR$$F$Y$$$20240907$$CN$US$US
242880011$24288001$1$I$$20240829$20240905$20240905$EXP$$CA-PURDUE-USA-2024-0311754$PURDUE$$40$YR$$F$Y$$$20240905$$HP$CA$CA
242880021$24288002$1$I$$20240905$20240905$20240905$PER$$NVSC2024US178733$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242880031$24288003$1$I$20240701$20240823$20240905$20240905$PER$$US-JNJFOC-20240900721$JOHNSON AND JOHNSON$$95$YR$E$F$Y$$$20240905$$CN$US$US
242880042$24288004$2$F$$20240910$20240905$20240914$PER$$US-AMGEN-USASP2024176619$AMGEN$$$$$F$Y$$$20240914$$CN$US$US
242880051$24288005$1$I$20240831$20240903$20240905$20240905$EXP$$US-ALXN-202409USA000094US$ALEXION PHARMACEUTICALS$$50$YR$$F$Y$83.9$KG$20240905$$HP$US$US
242880071$24288007$1$I$$20231017$20240905$20240905$PER$$US-TASMAN PHARMA, INC.-2023TSM00176$TASMAN PHARMA$$$$$M$Y$$$20240905$$CN$US$US
242880081$24288008$1$I$$20240331$20240905$20240905$PER$$US-TASMAN PHARMA, INC.-2024TSM00175$TASMAN PHARMA$$$$$$Y$$$20240905$$CN$US$US
242880091$24288009$1$I$$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024177181$AMGEN$$$$$M$Y$$$20240905$$MD$US$US
242880101$24288010$1$I$$20240826$20240905$20240905$PER$$US-BIOMARINAP-US-2024-160103$BIOMARIN$$$$$$Y$$$20240905$$CN$US$US
242880131$24288013$1$I$$20240829$20240905$20240905$EXP$$CA-PFIZER INC-PV202300059191$PFIZER$$1$YR$$F$Y$$$20240905$$HP$CA$CA
242880142$24288014$2$F$20240101$20240917$20240905$20240923$EXP$$ES-APELLIS-2024-APL-0000814$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240923$$MD$ES$ES
242880151$24288015$1$I$$20240826$20240905$20240905$EXP$$GB-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000028$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240904$$HP$GB$GB
242880161$24288016$1$I$$20240905$20240905$20240905$PER$$NVSC2024US178740$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242880182$24288018$2$F$20240801$20240924$20240905$20240927$EXP$CZ-CZSUKL-24002468$CZ-PFIZER INC-202400248860$PFIZER$$$$$F$Y$$$20240927$$CN$CZ$CZ
242880231$24288023$1$I$20230721$20240829$20240905$20240905$EXP$FR-AFSSAPS-AN2024000122$FR-TEVA-VS-3163441$TEVA$$38$YR$$M$Y$$$20240905$$PH$FR$FR
242880251$24288025$1$I$$20240725$20240905$20240905$PER$$US-LUNDBECK-DKLU4002207$LUNDBECK$$$$$$Y$$$20240905$$CN$US$US
242880261$24288026$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140503$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240905$$CN$US$US
242880271$24288027$1$I$$20240824$20240905$20240905$PER$$US-SA-2024SA256062$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240905$$MD$US$US
242880291$24288029$1$I$20240101$20240810$20240905$20240905$PER$$US-SMPA-2024SPA001230$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880302$24288030$2$F$$20240911$20240905$20240927$PER$$US-SMPA-2024SPA001252$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242880311$24288031$1$I$20240801$20240812$20240905$20240905$PER$$US-SMPA-2024SPA001263$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880321$24288032$1$I$$20240812$20240905$20240905$PER$$US-SMPA-2024SPA001277$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880341$24288034$1$I$$20240808$20240905$20240905$PER$$US-SMPA-2024SPA001159$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880352$24288035$2$F$$20240916$20240905$20240924$PER$$US-SMPA-2024SPA001248$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242880362$24288036$2$F$$20240916$20240905$20240924$PER$$US-SMPA-2024SPA001296$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242880381$24288038$1$I$$20240812$20240905$20240905$PER$$US-SMPA-2024SPA001285$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880391$24288039$1$I$$20240811$20240905$20240905$PER$$US-SMPA-2024SPA001246$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880401$24288040$1$I$$20240809$20240905$20240905$PER$$US-SMPA-2024SPA001208$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880411$24288041$1$I$$20240812$20240905$20240905$PER$$US-SMPA-2024SPA001275$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880422$24288042$2$F$$20240904$20240905$20240924$PER$$US-SMPA-2024SPA001339$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242880431$24288043$1$I$$20240809$20240905$20240905$PER$$US-SMPA-2024SPA001279$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880452$24288045$2$F$$20240807$20240905$20240906$PER$$JP-SMPA-2024SPA002297$SUNOVION$$$$$$Y$$$20240906$$PH$JP$JP
242880461$24288046$1$I$$20240809$20240905$20240905$PER$$US-SMPA-2024SPA001175$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880473$24288047$3$F$$20240909$20240905$20240923$PER$$US-SMPA-2024SPA000393$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242880481$24288048$1$I$$20240812$20240905$20240905$PER$$US-SMPA-2024SPA001243$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880501$24288050$1$I$$20240809$20240905$20240905$PER$$US-SMPA-2024SPA001221$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880511$24288051$1$I$$20240806$20240905$20240905$PER$$US-SMPA-2024SPA000991$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880522$24288052$2$F$$20240815$20240905$20240920$PER$$US-SMPA-2024SPA001172$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
242880531$24288053$1$I$$20240812$20240905$20240905$PER$$US-SMPA-2024SPA001271$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880541$24288054$1$I$$20240812$20240905$20240905$PER$$US-SMPA-2024SPA001307$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880551$24288055$1$I$20240101$20240809$20240905$20240905$PER$$US-SMPA-2024SPA001192$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880561$24288056$1$I$$20240809$20240905$20240905$PER$$US-SMPA-2024SPA001247$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242880572$24288057$2$F$$20240905$20240905$20240927$PER$$US-SMPA-2024SPA001148$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242880581$24288058$1$I$20240829$20240829$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138252$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$91.17$KG$20240905$$CN$US$US
242880591$24288059$1$I$20230905$20240820$20240905$20240905$PER$$US-BIOMARINAP-US-2024-160259$BIOMARIN$$$$$$Y$$$20240905$$CN$US$US
242880601$24288060$1$I$$20240904$20240905$20240905$PER$$NVSC2024US178601$NOVARTIS$$$$$$Y$$$20240905$$HP$US$US
242880651$24288065$1$I$$20240830$20240905$20240905$EXP$$JP-009507513-2409JPN000139J$MERCK$$8$DEC$$M$Y$$$20240905$$MD$JP$JP
242880662$24288066$2$F$20240904$20240906$20240905$20240911$PER$$US-AMGEN-USASP2024177238$AMGEN$$60$YR$A$F$Y$$$20240911$$PH$US$US
242880671$24288067$1$I$$20240830$20240905$20240905$PER$$NVSC2024US176582$NOVARTIS$$$$$$Y$$$20240905$$MD$US$US
242880681$24288068$1$I$20240824$20240826$20240905$20240905$EXP$$CA-HLS-202402140$HLS THERAPEUTICS$$65$YR$E$F$Y$$$20240905$$HP$CA$CA
242880691$24288069$1$I$$20240903$20240905$20240905$PER$$US-HALEON-2195377$Haleon PLC$$$$$$Y$$$20240905$$CN$US$US
242880731$24288073$1$I$20240819$20240901$20240905$20240905$DIR$FDA-CDER-CTU-2024-61204$$FDA-CTU$$50$YR$$M$N$74.84$KG$20240901$N$CN$US$
242880741$24288074$1$I$$20240903$20240905$20240905$EXP$$US-OTSUKA-2024_022817$OTSUKA$$$$$M$Y$68.4$KG$20240905$$CN$US$US
242880751$24288075$1$I$20240528$20240821$20240905$20240905$EXP$$US-HLS-202401077$HLS THERAPEUTICS$$13$YR$T$F$Y$$$20240905$$MD$US$US
242880761$24288076$1$I$20240719$20240829$20240905$20240905$EXP$FR-AFSSAPS-AM2024000681$FR-TEVA-VS-3239001$TEVA$$86$YR$$F$Y$$$20240905$$PH$FR$FR
242880771$24288077$1$I$$20240826$20240905$20240905$PER$$US-SA-2024SA256635$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240905$$MD$US$US
242880781$24288078$1$I$$20240904$20240905$20240905$PER$$US-ALXN-202409USA000167US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242880791$24288079$1$I$$20240831$20240905$20240905$DIR$FDA-CDER-CTU-2024-61205$$FDA-CTU$$34$YR$$F$N$$$20240831$N$CN$GB$
242880801$24288080$1$I$$20240827$20240905$20240905$PER$$US-JNJFOC-20240873407$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$CN$US$US
242880811$24288081$1$I$$20240904$20240905$20240905$PER$$US-JNJFOC-20240907756$JOHNSON AND JOHNSON$$$$$$Y$$$20240905$$CN$US$US
242880821$24288082$1$I$$20240822$20240905$20240905$EXP$$US-HLS-202401062$HLS THERAPEUTICS$$36$YR$A$M$Y$$$20240905$$HP$US$US
242880831$24288083$1$I$20240829$20240830$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409001163$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240905$$CN$US$US
242880861$24288086$1$I$$20240822$20240905$20240905$EXP$$US-HLS-202401054$HLS THERAPEUTICS$$$$A$$Y$$$20240905$$PH$US$US
242880881$24288088$1$I$$20240819$20240905$20240905$PER$$NVSC2024US178683$NOVARTIS$$$$$M$Y$$$20240905$$HP$US$US
242880891$24288089$1$I$$20240829$20240905$20240905$PER$$US-009507513-2409USA001840$MERCK$$$$$M$Y$$$20240905$$HP$US$US
242880911$24288091$1$I$20170403$20240830$20240905$20240905$EXP$$NL-009507513-2409NLD000932$MERCK$$19$YR$$M$Y$60$KG$20240905$$MD$NL$NL
242880921$24288092$1$I$$20240903$20240905$20240905$PER$$US-ALXN-202409USA000152US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240905$$CN$US$US
242880931$24288093$1$I$20240614$20240828$20240905$20240905$EXP$$CN-AstraZeneca-2024A198226$ASTRAZENECA$$21449$DY$$F$Y$65$KG$20240905$$MD$CN$
242880941$24288094$1$I$20231101$20240822$20240905$20240905$EXP$$US-HLS-202401049$HLS THERAPEUTICS$$18$YR$A$$Y$$$20240905$$MD$US$US
242880951$24288095$1$I$$20240905$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049712$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240905$$CN$US$US
242880961$24288096$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140525$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$40.69$KG$20240905$$PH$US$US
242880982$24288098$2$F$20240801$20240919$20240905$20240923$PER$$NVSC2024US178637$NOVARTIS$$63$YR$$M$Y$81.19$KG$20240923$$HP$US$US
242881011$24288101$1$I$$20240831$20240905$20240905$PER$$US-JNJFOC-20240903610$JOHNSON AND JOHNSON$$84$YR$E$M$Y$93.4$KG$20240905$$CN$US$US
242881111$24288111$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002858$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240905$$CN$US$US
242881121$24288112$1$I$$20240822$20240905$20240905$EXP$$US-HLS-202401053$HLS THERAPEUTICS$$$$A$$Y$$$20240905$$HP$US$US
242881131$24288113$1$I$$20240903$20240905$20240905$EXP$$NVSC2024KR178523$NOVARTIS$$16$YR$$F$Y$$$20240906$$MD$KR$KR
242881141$24288114$1$I$$20240903$20240905$20240905$PER$$US-Mission Pharmacal Company-2161282$MISSION$$58$YR$$M$Y$$$20240905$$$US$US
242881162$24288116$2$F$$20240919$20240905$20240925$EXP$$CA-HLS-202402135$HLS THERAPEUTICS$$$$A$F$Y$$$20240925$$PH$CA$CA
242881171$24288117$1$I$$20240803$20240905$20240905$PER$$US-BIOMARINAP-US-2024-160207$BIOMARIN$$$$$$Y$$$20240905$$CN$US$US
242881181$24288118$1$I$$20240903$20240905$20240905$PER$$US-Mission Pharmacal Company-2161283$MISSION$$58$YR$$M$Y$$$20240905$$$US$US
242881191$24288119$1$I$$20240829$20240905$20240905$EXP$$BR-BIOMARINAP-BR-2024-160309$BIOMARIN$$$$$$Y$$$20240905$$CN$BR$BR
242881201$24288120$1$I$$20240823$20240905$20240905$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08557$NEUROCRINE BIOSCIENCES$$31$YR$$F$Y$$$20240905$$PH$US$US
242881211$24288121$1$I$$20240904$20240905$20240905$PER$$US-JNJFOC-20240908711$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242881221$24288122$1$I$20240101$20240823$20240905$20240905$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08547$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240905$$MD$US$US
242881231$24288123$1$I$20240101$20240810$20240905$20240905$PER$$US-009507513-2408USA003775$MERCK$$$$$F$Y$79.4$KG$20240905$$CN$US$US
242881241$24288124$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002958$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240905$$CN$US$US
242881252$24288125$2$F$20240728$20240905$20240905$20240919$EXP$$CA-HLS-202402132$HLS THERAPEUTICS$$70$YR$E$F$Y$$$20240919$$CN$CA$CA
242881261$24288126$1$I$20240801$20240902$20240905$20240905$PER$$US-009507513-2409USA001352$MERCK$$57$YR$$F$Y$$$20240905$$MD$US$US
242881271$24288127$1$I$$20240830$20240905$20240905$PER$$US-AstraZeneca-2024A198856$ASTRAZENECA$$$$$F$Y$$$20240905$$CN$US$
242881281$24288128$1$I$20240530$20240822$20240905$20240905$EXP$$CA-HLS-202402128$HLS THERAPEUTICS$$40$YR$A$M$Y$$$20240905$$PH$CA$CA
242881291$24288129$1$I$20200824$20240905$20240905$20240905$EXP$PL-URPL-1-2186-2020$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049768$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$99$KG$20240905$$MD$PL$PL
242881301$24288130$1$I$20240801$20240830$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139081$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240905$$PH$US$US
242881311$24288131$1$I$20240731$20240904$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140924$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240905$$HP$US$US
242881321$24288132$1$I$$20240827$20240905$20240905$PER$$US-ABBVIE-5900330$ABBVIE$$$$$$Y$$$20240905$$HP$US$US
242881331$24288133$1$I$$20240828$20240905$20240905$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-143870$DAIICHI$$$$$F$Y$$$20240905$$PH$US$US
242881342$24288134$2$F$20240523$20240922$20240905$20240930$EXP$$CA-JNJFOC-20240911690$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20240930$$CN$CA$CA
242881352$24288135$2$F$20240822$20240905$20240905$20240910$EXP$$MX-JNJFOC-20240911248$JOHNSON AND JOHNSON$$94$YR$E$F$Y$$$20240910$$CN$MX$MX
242881362$24288136$2$F$$20240917$20240905$20240925$EXP$$US-ZENPEP LLC-2024AIMT01310$AIMMUNE$$$$$$Y$$$20240925$$CN$US$US
242881371$24288137$1$I$$20240903$20240905$20240905$EXP$$DE-JNJFOC-20240911493$JOHNSON AND JOHNSON$$$$$M$Y$$$20240905$$PH$DE$DE
242881391$24288139$1$I$20240101$20240902$20240905$20240905$EXP$$MX-JNJFOC-20240911003$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240905$$CN$MX$MX
242881401$24288140$1$I$$20240903$20240905$20240905$EXP$$DE-JNJFOC-20240909457$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20240905$$MD$DE$DE
242881421$24288142$1$I$20240801$20240830$20240905$20240905$PER$$US-JNJFOC-20240900687$JOHNSON AND JOHNSON$$$$$F$Y$$$20240905$$CN$US$US
242881431$24288143$1$I$20240101$20240903$20240905$20240905$PER$$US-009507513-2409USA001426$MERCK$$$$$F$Y$$$20240905$$CN$US$US
242881441$24288144$1$I$20240905$20240905$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409003243$ELI LILLY AND CO$$$$$F$Y$$$20240905$$CN$US$US
242881451$24288145$1$I$$20240830$20240905$20240905$PER$$US-AMGEN-USASP2024174574$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242881461$24288146$1$I$$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140245$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240905$$CN$US$US
242881471$24288147$1$I$20240101$20240903$20240905$20240905$PER$$US-AstraZeneca-2024A201246$ASTRAZENECA$$78$YR$$M$Y$$$20240906$$CN$US$
242881481$24288148$1$I$20240701$20240821$20240905$20240905$EXP$$US-RADIUS HEALTH INC.-2024US006661$RADIUS PHARM$$63$YR$$F$Y$$$20240905$$MD$US$US
242881492$24288149$2$F$20240605$20240904$20240905$20240912$EXP$$FR-BIOGEN-2024BI01280305$BIOGEN$$16$YR$$F$Y$46$KG$20240912$$MD$FR$FR
242881502$24288150$2$F$20240601$20240911$20240905$20240918$EXP$$US-BIOGEN-2024BI01280301$BIOGEN$$74$YR$$F$Y$$$20240918$$MD$US$US
242881512$24288151$2$F$20240825$20240905$20240905$20240907$PER$$US-AMGEN-USASP2024176996$AMGEN$$69$YR$E$F$Y$$$20240906$$CN$US$US
242881522$24288152$2$F$$20240828$20240905$20240910$PER$$US-SA-2024SA257085$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240910$$HP$US$US
242881531$24288153$1$I$$20240905$20240905$20240905$PER$$NVSC2024US178763$NOVARTIS$$$$$$Y$$$20240906$$HP$US$US
242881541$24288154$1$I$$20240829$20240905$20240905$EXP$$US-ABBVIE-5901978$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242881551$24288155$1$I$$20240905$20240905$20240905$PER$$NVSC2024US178764$NOVARTIS$$$$$$Y$$$20240906$$HP$US$US
242881561$24288156$1$I$$20240905$20240905$20240905$PER$$NVSC2024US178765$NOVARTIS$$$$$$Y$$$20240906$$HP$US$US
242881581$24288158$1$I$$20240904$20240905$20240905$EXP$$CA-SANDOZ INC.-NVSC2022CA170928$SANDOZ$$$$$F$Y$$$20240905$$CN$CA$CA
242881592$24288159$2$F$$20240918$20240905$20240919$PER$$NVSC2024US178767$NOVARTIS$$$$$M$Y$$$20240919$$HP$US$US
242881601$24288160$1$I$$20240823$20240905$20240905$PER$$US-SA-2024SA257160$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240906$$HP$US$US
242881612$24288161$2$F$20220101$20240919$20240905$20240926$EXP$$NVSJ2024JP010324$NOVARTIS$Sakakibara A, Kato T, Imai K, Yamada T, Numa S, Chou M et al.. Three Cases of Symptomatic Intracranial Artery Stenosis Suspected to be Related to Tyrosine Kinase Inhibitors. The 127th Kinki Regional Office of the Japanese Society of Neurology (2024.03.03. 2024;B-14$54$YR$$F$Y$$$20240927$$HP$JP$JP
242881621$24288162$1$I$$20240719$20240905$20240905$EXP$$US-SMPA-2024SPA002136$SUNOVION$$$$$$Y$$$20240905$$CN$US$US
242881631$24288163$1$I$20240903$20240903$20240905$20240905$PER$$US-JNJFOC-20240905484$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$PH$US$US
242881651$24288165$1$I$$20240826$20240905$20240905$PER$$US-BAUSCHBL-2024BNL032368$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240906$$CN$US$US
242881661$24288166$1$I$20240827$20240827$20240905$20240905$PER$$US-ABBVIE-5897942$ABBVIE$$76$YR$$F$Y$$$20240905$$CN$US$US
242881672$24288167$2$F$$20240903$20240905$20240909$EXP$$CN-SANDOZ INC.-SDZ2024CN077232$SANDOZ$Liang jingnan. Drugs for secondary prevention of coronary heart disease. Family Medicine. 2024$80$YR$$M$Y$$$20240909$$PH$CN$CN
242881681$24288168$1$I$$20240904$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409003314$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240905$$CN$US$US
242881691$24288169$1$I$$20240831$20240905$20240905$EXP$$JP-AMGEN-JPNSP2024175674$AMGEN$$$$$F$Y$$$20240905$$MD$JP$JP
242881701$24288170$1$I$$20240827$20240905$20240905$PER$$US-BAUSCHBL-2024BNL032611$BAUSCH AND LOMB$$$$$F$Y$$$20240906$$CN$US$US
242881711$24288171$1$I$20240903$20240904$20240905$20240905$PER$$US-JNJFOC-20240908148$JOHNSON AND JOHNSON$$33$YR$A$$Y$$$20240906$$PH$US$US
242881721$24288172$1$I$$20240830$20240905$20240905$EXP$$JP-AMGEN-JPNSP2024176155$AMGEN$$$$$$Y$$$20240905$$PH$JP$JP
242881731$24288173$1$I$$20240831$20240905$20240905$EXP$$JP-AMGEN-JPNSP2024176211$AMGEN$$$$$F$Y$$$20240905$$MD$JP$JP
242881741$24288174$1$I$$20240826$20240905$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-138454$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240906$$PH$JP$JP
242881751$24288175$1$I$20240828$20240828$20240905$20240905$EXP$$ES-ABBVIE-5900708$ABBVIE$$76$YR$$F$Y$$$20240905$$CN$ES$ES
242881761$24288176$1$I$20240101$20240904$20240905$20240905$EXP$$US-ABBVIE-5908146$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242881771$24288177$1$I$$20240904$20240905$20240905$EXP$$CA-SANDOZ INC.-NVSC2023CA012376$SANDOZ$$27$YR$$F$Y$$$20240905$$CN$CA$CA
242881781$24288178$1$I$20240819$20240828$20240905$20240905$EXP$$CA-HLS-202402180$HLS THERAPEUTICS$$81$YR$E$F$Y$$$20240905$$HP$CA$CA
242881792$24288179$2$F$20240613$20240911$20240905$20240920$EXP$$JP-BEH-2024177894$CSL BEHRING$$76$YR$E$M$Y$63.1$KG$20240920$$CN$JP$JP
242881801$24288180$1$I$20160418$20240902$20240905$20240905$EXP$DE-BFARM-16166912$DE-ORGANON-1605DEU010425$ORGANON$$45$YR$$M$Y$99$KG$20240905$$MD$DE$DE
242881812$24288181$2$F$20240819$20240830$20240905$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-133849$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240910$$PH$JP$JP
242881821$24288182$1$I$$20240905$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049861$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240906$$MD$US$US
242881831$24288183$1$I$20220730$20240827$20240905$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-047200$BRISTOL MYERS SQUIBB$Sumi T, Sekikawa M, Koshino Y, Nagayama D, Nagahisa Y, Matsuura K, et al. Risk factors for severe immune-related pneumonitis after nivolumab plus ipilimumab therapy for non-small cell lung cancer. Thoracic Cancer. 2024 Jun 03;1-10. doi:10.1111/1759-7714.15385.$78$YR$E$F$Y$51$KG$20240906$$MD$JP$JP
242881841$24288184$1$I$$20240828$20240905$20240905$EXP$$US-HLS-202401113$HLS THERAPEUTICS$$$$E$$Y$$$20240905$$PH$US$US
242881852$24288185$2$F$20240902$20240905$20240905$20240907$PER$$US-AMGEN-USASP2024177035$AMGEN$$79$YR$E$M$Y$$$20240907$$CN$US$US
242881861$24288186$1$I$20240823$20240829$20240905$20240905$PER$$US-AMGEN-USASP2024175934$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242881872$24288187$2$F$20240828$20240911$20240905$20240919$EXP$$US-JNJFOC-20240902294$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240919$$HP$US$US
242881881$24288188$1$I$20240829$20240903$20240905$20240905$PER$$US-ORGANON-O2409USA000274$ORGANON$$15$YR$$F$Y$48.526$KG$20240905$$HP$US$US
242881891$24288189$1$I$20240103$20240828$20240905$20240905$EXP$$CA-VER-202400457$VERITY PHARMACEUTICALS$$72$YR$E$M$Y$$$20240905$$HP$CA$CA
242881901$24288190$1$I$20240901$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176201$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242881911$24288191$1$I$$20240829$20240905$20240905$EXP$$US-JNJFOC-20240878187$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240906$$CN$US$US
242881921$24288192$1$I$$20240904$20240905$20240905$EXP$$NVSJ2024JP010564$NOVARTIS$$$$$$Y$$$20240906$$MD$JP$JP
242881932$24288193$2$F$$20240916$20240905$20240923$EXP$$US-BIOGEN-2024BI01280090$BIOGEN$$$$$M$Y$$$20240923$$CN$US$US
242881941$24288194$1$I$$20240829$20240905$20240905$PER$$US-BIOGEN-2024BI01277828$BIOGEN$$$$$F$Y$$$20240905$$CN$US$US
242881951$24288195$1$I$20240704$20240829$20240905$20240905$PER$$US-BIOGEN-2024BI01280658$BIOGEN$$33$YR$$M$Y$$$20240905$$CN$US$US
242881961$24288196$1$I$$20240827$20240905$20240905$EXP$$JP-JNJFOC-20240910499$JOHNSON AND JOHNSON$Horiuchi A, Watanabe N, Miyazato S, Konno H, Nitta M, Horiuchi A, et al. [A case report of euglycaemic diabetic ketoacidosis presenting with alkalemia] Journal of Japanese Association for Acute Medicine. 2024.8;35:8:263-268$5$DEC$A$F$Y$$$20240906$$MD$JP$JP
242881972$24288197$2$F$20240901$20240904$20240905$20240910$PER$$US-AMGEN-USASP2024177034$AMGEN$$59$YR$A$F$Y$$$20240909$$CN$US$US
242881991$24288199$1$I$$20240830$20240905$20240905$EXP$$CN-AstraZeneca-2024A200216$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$CN$
242882001$24288200$1$I$20240101$20240829$20240905$20240905$EXP$$US-ABBVIE-5743766$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242882011$24288201$1$I$$20240904$20240905$20240905$EXP$$CA-SANDOZ INC.-SDZ2024CA077808$SANDOZ$$13$YR$$M$Y$$$20240905$$CN$CA$CA
242882021$24288202$1$I$$20240827$20240905$20240905$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-138966$BRISTOL MYERS SQUIBB$Shinzato H, Nakamura S, Gakiya R, Matsuo K, Tokeshi S, Kakinohana M, et al. A case of thoracic subdural hematoma developing with a sense of constriction and pain in the chest after stomach cancer surgery. The 58th Annual Meeting of the Japan Society of Pain Clinicians (Abstracts). 2024;P49-2.$79$YR$E$M$Y$$$20240906$$MD$JP$JP
242882031$24288203$1$I$$20240830$20240905$20240905$PER$$US-BIOGEN-2024BI01280776$BIOGEN$$$$$$Y$$$20240905$$CN$US$US
242882041$24288204$1$I$20240730$20240828$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013613$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242882051$24288205$1$I$$20240827$20240905$20240905$PER$$US-SA-2024SA256535$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$HP$US$US
242882061$24288206$1$I$$20240903$20240905$20240905$EXP$$BG-ABBVIE-5906912$ABBVIE$$70$YR$$M$Y$$$20240905$$CN$BG$BG
242882071$24288207$1$I$$20240829$20240905$20240905$EXP$$US-JNJFOC-20240882318$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$MD$US$US
242882081$24288208$1$I$20240101$20240902$20240905$20240905$EXP$$BE-ABBVIE-5906601$ABBVIE$$$$E$F$Y$55$KG$20240905$$HP$BE$BE
242882091$24288209$1$I$20240714$20240827$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013553$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242882101$24288210$1$I$20240823$20240828$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013616$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242882113$24288211$3$F$$20240906$20240905$20240910$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049860$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240910$$PH$US$US
242882121$24288212$1$I$20240819$20240828$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013601$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242882131$24288213$1$I$$20240829$20240905$20240905$PER$$US-AMGEN-USASP2024175193$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242882142$24288214$2$F$$20240919$20240905$20240926$EXP$$US-ABBVIE-5906309$ABBVIE$$$$$F$Y$56$KG$20240926$$CN$US$US
242882151$24288215$1$I$$20240903$20240905$20240905$EXP$$BG-ABBVIE-5906910$ABBVIE$$80$YR$$M$Y$$$20240905$$CN$BG$BG
242882161$24288216$1$I$20240101$20240903$20240905$20240905$EXP$$US-ABBVIE-5906312$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242882171$24288217$1$I$$20240903$20240905$20240905$EXP$$NVSJ2024JP010542$NOVARTIS$$$$$$Y$$$20240906$$MD$JP$JP
242882182$24288218$2$F$$20240912$20240905$20240920$EXP$$CN-TAKEDA-2024TUS088809$TAKEDA$$$$A$$Y$$$20240920$$MD$CN$CN
242882192$24288219$2$F$$20240912$20240905$20240920$EXP$$CN-TAKEDA-2024TUS088808$TAKEDA$$$$A$$Y$$$20240920$$MD$CN$CN
242882211$24288221$1$I$$20240829$20240905$20240905$EXP$$BR-JNJFOC-20240882669$JOHNSON AND JOHNSON$$80$YR$E$F$Y$60$KG$20240906$$CN$BR$BR
242882222$24288222$2$F$$20240912$20240905$20240920$EXP$$CN-TAKEDA-2024TUS088865$TAKEDA$Yuan G, Peng D, Tingwu Y, Huan L, Lejia L, Yanyu W et al. Efficacy observation of different doses of bortezomib combined with chemotherapy for multiple myeloma. Cancer Research and Clinic. 2024;36(7):532-5$$$A$$Y$$$20240920$$MD$CN$CN
242882231$24288223$1$I$$20240828$20240905$20240905$EXP$$BR-JNJFOC-20240882678$JOHNSON AND JOHNSON$$52$YR$A$F$Y$50$KG$20240906$$CN$BR$BR
242882241$24288224$1$I$20240903$20240905$20240905$20240905$EXP$$GB-JNJFOC-20240911258$JOHNSON AND JOHNSON$$15$YR$T$M$Y$89$KG$20240906$$HP$GB$GB
242882251$24288225$1$I$$20240825$20240905$20240905$EXP$$CN-JNJFOC-20240869701$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$HP$CN$CN
242882261$24288226$1$I$$20240903$20240905$20240905$EXP$$US-TAKEDA-2024TUS044025$TAKEDA$$$$$M$Y$75$KG$20240905$$PH$US$US
242882271$24288227$1$I$20230301$20240826$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141490$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240906$$HP$US$US
242882281$24288228$1$I$$20240903$20240905$20240905$PER$$US-AstraZeneca-2024A200383$ASTRAZENECA$$$$$$Y$$$20240906$$CN$US$
242882291$24288229$1$I$20240816$20240829$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013692$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242882301$24288230$1$I$$20240829$20240905$20240905$EXP$$RO-AstraZeneca-2024A199635$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$RO$
242882321$24288232$1$I$20240707$20240829$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013708$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242882332$24288233$2$F$$20240925$20240905$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA077790$SANDOZ$$$$$M$Y$$$20240927$$CN$CA$CA
242882351$24288235$1$I$$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024177522$AMGEN$$$$$$Y$$$20240905$$MD$US$US
242882361$24288236$1$I$20240829$20240829$20240905$20240905$PER$$US-JNJFOC-20240882049$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$PH$US$US
242882372$24288237$2$F$$20240926$20240905$20240930$PER$$NVSC2024US178682$NOVARTIS$$$$$F$Y$$$20240930$$PH$US$US
242882381$24288238$1$I$$20240904$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE077699$SANDOZ$$39$YR$$F$Y$$$20240905$$PH$DE$DE
242882391$24288239$1$I$20240801$20240902$20240905$20240905$EXP$$JP-SA-2024SA255104$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240906$$MD$JP$JP
242882401$24288240$1$I$$20240903$20240905$20240905$EXP$$US-AstraZeneca-2024A201008$ASTRAZENECA$$$$$M$Y$$$20240906$$HP$US$
242882411$24288241$1$I$20240831$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176321$AMGEN$$82$YR$E$F$Y$$$20240905$$PH$US$US
242882421$24288242$1$I$$20240904$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE077712$SANDOZ$$28$YR$$F$Y$$$20240905$$HP$DE$DE
242882431$24288243$1$I$$20240903$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141026$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240906$$PH$US$US
242882441$24288244$1$I$$20240901$20240905$20240905$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-126157$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240906$$MD$AT$AT
242882452$24288245$2$F$20240425$20240913$20240905$20240917$EXP$$JP-TAKEDA-2024TJP012965$TAKEDA$$44$YR$$F$Y$$$20240917$$MD$JP$JP
242882461$24288246$1$I$20240101$20240902$20240905$20240905$EXP$$CA-ABBVIE-5814587$ABBVIE$$34$YR$$F$Y$$$20240905$$CN$CA$CA
242882472$24288247$2$F$20240801$20240910$20240905$20240914$EXP$$CO-ABBVIE-5906919$ABBVIE$$57$YR$$M$Y$$$20240914$$CN$CO$CO
242882481$24288248$1$I$20240905$20240905$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049707$BOEHRINGER INGELHEIM$$70$YR$E$$Y$$$20240906$$CN$US$US
242882492$24288249$2$F$20240709$20240917$20240905$20240918$EXP$$JP-TAKEDA-2024TJP013071$TAKEDA$$4$DEC$$M$Y$$$20240918$$MD$JP$JP
242882501$24288250$1$I$20240526$20240824$20240905$20240905$EXP$PT-INFARMED-T202408-148$PT-GE HEALTHCARE-2024CSU009418$GE HEALTHCARE$$42$YR$$F$Y$73$KG$20240906$$HP$PT$PT
242882521$24288252$1$I$20121115$20240828$20240905$20240905$PER$$US-JNJFOC-20240907608$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240906$$LW$US$US
242882532$24288253$2$F$20240822$20240918$20240905$20240925$EXP$$US-BIOGEN-2024BI01280481$BIOGEN$$7$YR$$M$Y$36.2$KG$20240925$$CN$US$US
242882551$24288255$1$I$20240813$20240830$20240905$20240905$EXP$$US-JNJFOC-20240904287$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240906$$HP$US$US
242882561$24288256$1$I$20240829$20240903$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013951$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242882571$24288257$1$I$$20240904$20240905$20240905$EXP$$CA-SANDOZ INC.-NVSC2023CA023923$SANDOZ$$39$YR$$M$Y$$$20240905$$CN$CA$CA
242882581$24288258$1$I$$20240904$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2021DE000513$SANDOZ$$15$YR$$M$Y$$$20240905$$HP$DE$DE
242882591$24288259$1$I$20231123$20240904$20240905$20240905$EXP$FR-AFSSAPS-RS2023000963$FR-SANDOZ INC.-SDZ2024FR077695$SANDOZ$$43$YR$$F$Y$92$KG$20240905$$MD$FR$FR
242882601$24288260$1$I$$20240904$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE077721$SANDOZ$$47$YR$$M$Y$$$20240905$$HP$DE$DE
242882611$24288261$1$I$20240816$20240827$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013550$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242882621$24288262$1$I$$20240905$20240905$20240905$PER$$NVSC2024US178810$NOVARTIS$$$$$M$Y$101$KG$20240906$$CN$US$US
242882641$24288264$1$I$$20240904$20240905$20240905$EXP$$CA-SANDOZ INC.-SDZ2024CA077765$SANDOZ$$62$YR$$M$Y$$$20240905$$CN$CA$CA
242882651$24288265$1$I$$20240904$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE077751$SANDOZ$$19$YR$$M$Y$$$20240905$$HP$DE$DE
242882661$24288266$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176042$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242882671$24288267$1$I$$20240826$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202408017301$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240905$$CN$US$US
242882681$24288268$1$I$$20240828$20240905$20240905$EXP$$US-SANDOZ INC.-SDZ2024US077814$SANDOZ$$$$$F$Y$$$20240905$$CN$US$US
242882691$24288269$1$I$20240903$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002922$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240905$$CN$US$US
242882701$24288270$1$I$20240903$20240903$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141272$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240906$$HP$US$US
242882711$24288271$1$I$20240828$20240828$20240905$20240905$PER$$US-JNJFOC-20240876807$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$HP$US$US
242882721$24288272$1$I$20240829$20240829$20240905$20240905$EXP$$IE-JNJFOC-20240900054$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240906$$HP$IE$IE
242882731$24288273$1$I$$20240904$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE077706$SANDOZ$$66$YR$$M$Y$$$20240905$$PH$DE$DE
242882741$24288274$1$I$$20240904$20240905$20240905$EXP$$DE-SANDOZ INC.-SDZ2024DE077729$SANDOZ$$67$YR$$F$Y$$$20240905$$PH$DE$DE
242882752$24288275$2$F$20240703$20240909$20240905$20240913$EXP$FR-AFSSAPS-TS2024000863$FR-SANDOZ INC.-SDZ2024FR077685$SANDOZ$$89$YR$$M$Y$103$KG$20240913$$MD$FR$FR
242882761$24288276$1$I$$20240829$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013682$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242882771$24288277$1$I$20240811$20240829$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013683$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242882781$24288278$1$I$$20240904$20240905$20240905$EXP$$GB-SANDOZ INC.-SDZ2024GB077959$SANDOZ$$69$YR$$M$Y$109$KG$20240905$$MD$GB$GB
242882792$24288279$2$F$20240903$20240911$20240905$20240917$EXP$$US-SANDOZ INC.-NVSC2023US148842$SANDOZ$$8$YR$$F$Y$18.594$KG$20240917$$CN$US$US
242882801$24288280$1$I$20240808$20240829$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013691$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242882811$24288281$1$I$20240101$20240905$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049869$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240906$$CN$US$US
242882832$24288283$2$F$20230901$20240909$20240905$20240918$EXP$$NL-ABBVIE-5906448$ABBVIE$$78$YR$$M$Y$$$20240918$$CN$NL$NL
242882841$24288284$1$I$20240101$20240903$20240905$20240905$EXP$$US-ABBVIE-5906470$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242882851$24288285$1$I$$20240823$20240905$20240905$PER$$US-ABBVIE-5906940$ABBVIE$$$$$$Y$$$20240905$$HP$US$US
242882861$24288286$1$I$$20240903$20240905$20240905$EXP$$US-ABBVIE-5906879$ABBVIE$$$$$$Y$$$20240905$$MD$US$US
242882872$24288287$2$F$20240801$20240905$20240905$20240911$EXP$$US-ABBVIE-5901876$ABBVIE$$78$YR$$F$Y$77$KG$20240911$$CN$US$US
242882882$24288288$2$F$20240823$20240828$20240905$20240906$PER$$US-BIOGEN-2024BI01280352$BIOGEN$$9$YR$$M$Y$$$20240906$$CN$US$US
242882893$24288289$3$F$20150101$20240920$20240905$20240925$EXP$$GB-ABBVIE-5833398$ABBVIE$$45$YR$$F$Y$$$20240925$$CN$GB$GB
242882901$24288290$1$I$$20240827$20240905$20240905$PER$$US-ROCHE-10000068337$ROCHE$$$$T$M$Y$$$20240906$$CN$US$US
242882911$24288291$1$I$$20240903$20240905$20240905$PER$$US-ELI_LILLY_AND_COMPANY-US202409002662$ELI LILLY AND CO$$$$$$Y$$$20240905$$CN$US$US
242882921$24288292$1$I$20240819$20240828$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013605$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242882932$24288293$2$F$20240901$20240905$20240905$20240908$PER$$US-AMGEN-USASP2024176304$AMGEN$$58$YR$A$F$Y$$$20240908$$CN$US$US
242882941$24288294$1$I$$20240905$20240905$20240905$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049870$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240906$$CN$US$US
242882951$24288295$1$I$20240827$20240904$20240905$20240905$PER$$US-ABBVIE-5905852$ABBVIE$$29$YR$$F$Y$$$20240905$$CN$US$US
242882961$24288296$1$I$$20240829$20240905$20240905$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001775$BLUEPRINT MEDICINES$$$$$M$Y$$$20240906$$CN$US$US
242882971$24288297$1$I$20240101$20240903$20240905$20240905$EXP$$US-ABBVIE-5906608$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242882982$24288298$2$F$20240820$20240910$20240905$20240913$EXP$$GB-TAKEDA-2024TUS088359$TAKEDA$$23$YR$$M$Y$$$20240913$$MD$GB$GB
242882991$24288299$1$I$$20180504$20240905$20240905$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161288$JIANGSU HENGRUI MEDICINE$Immune-related myocarditis and conduction abnormalities secondary to combination immunotherapy treatment with ipilimumab/nivolumab in a patient with merkel cell carcinoma$69$YR$$F$Y$$$20240905$$MD$US$CN
242883001$24288300$1$I$20240629$20240828$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013609$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242883011$24288301$1$I$20240101$20240830$20240905$20240905$EXP$$US-ABBVIE-5871038$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242883021$24288302$1$I$20240801$20240903$20240905$20240905$EXP$$US-ABBVIE-5905742$ABBVIE$$76$YR$$F$Y$$$20240905$$CN$US$US
242883031$24288303$1$I$$20240830$20240905$20240905$EXP$$BR-TAKEDA-2024TUS088732$TAKEDA$$$$$M$Y$$$20240905$$CN$BR$BR
242883041$24288304$1$I$$20240903$20240905$20240905$EXP$$US-ABBVIE-5907932$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242883051$24288305$1$I$20240101$20240903$20240905$20240905$EXP$$US-ABBVIE-5905867$ABBVIE$$$$$F$Y$$$20240905$$HP$US$US
242883061$24288306$1$I$20240101$20240903$20240905$20240905$EXP$$US-ABBVIE-5905963$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242883071$24288307$1$I$20240604$20240903$20240905$20240905$EXP$$CA-ABBVIE-5905587$ABBVIE$$62$YR$$F$Y$$$20240905$$CN$CA$CA
242883082$24288308$2$F$20240701$20240904$20240905$20240911$EXP$$US-ABBVIE-5795212$ABBVIE$$70$YR$$F$Y$$$20240911$$CN$US$US
242883091$24288309$1$I$$20240826$20240905$20240905$EXP$$US-UCBSA-2024043893$UCB$$$$$$Y$$$20240906$$CN$US$US
242883101$24288310$1$I$20240904$20240904$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141210$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240906$$HP$US$US
242883111$24288311$1$I$$20240828$20240905$20240905$PER$$US-ABBVIE-5901518$ABBVIE$$$$$$Y$$$20240905$$HP$US$US
242883131$24288313$1$I$20240101$20240904$20240905$20240905$EXP$$US-ABBVIE-5907014$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242883141$24288314$1$I$$20240904$20240905$20240905$EXP$$CA-ABBVIE-5908070$ABBVIE$$$$E$M$Y$$$20240905$$MD$CA$CA
242883151$24288315$1$I$20240902$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176313$AMGEN$$59$YR$A$F$Y$$$20240905$$CN$US$US
242883171$24288317$1$I$$20240903$20240905$20240905$EXP$$GB-ABBVIE-5906221$ABBVIE$$$$A$F$Y$$$20240905$$CN$GB$GB
242883181$24288318$1$I$20240726$20240903$20240905$20240905$EXP$$FR-SANDOZ INC.-SDZ2024FR077507$SANDOZ$$18$YR$$F$Y$$$20240905$$HP$FR$FR
242883191$24288319$1$I$$20240905$20240905$20240905$PER$$NVSC2024US178836$NOVARTIS$$$$$$Y$$$20240906$$CN$US$US
242883201$24288320$1$I$$20240830$20240905$20240905$EXP$$TR-JNJFOC-20240903661$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240906$$HP$TR$TR
242883211$24288321$1$I$$20240903$20240905$20240905$PER$$US-AMGEN-USASP2024176493$AMGEN$$$$$$Y$$$20240905$$PH$US$US
242883221$24288322$1$I$20230101$20240903$20240905$20240905$EXP$$US-ABBVIE-5399463$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242883231$24288323$1$I$$20240904$20240905$20240905$EXP$$CA-SANDOZ INC.-SDZ2024CA077724$SANDOZ$$$$$$Y$$$20240905$$CN$CA$CA
242883241$24288324$1$I$$20240830$20240905$20240905$EXP$$CN-AMGEN-CHNSP2024174745$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240905$$MD$CN$CN
242883252$24288325$2$F$20240801$20240905$20240905$20240906$PER$$US-AMGEN-USASP2024177068$AMGEN$$62$YR$A$F$Y$$$20240906$$CN$US$US
242883261$24288326$1$I$$20240828$20240905$20240905$PER$$US-SA-2024SA252746$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240906$$MD$US$US
242883271$24288327$1$I$20170101$20240903$20240905$20240905$EXP$$US-ABBVIE-5905520$ABBVIE$$$$$F$Y$52$KG$20240905$$CN$US$US
242883281$24288328$1$I$20240617$20240829$20240905$20240905$EXP$$US-JNJFOC-20240907910$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240906$$MD$US$US
242883291$24288329$1$I$$20240830$20240905$20240905$EXP$$PT-NOVITIUMPHARMA-2024PTNVP01775$NOVITIUM PHARMA$Isabel Duraes Campos.Unusual presentation of benzodiazepine withdrawal with Takotsubo syndrome: a case report.European Heart Journal - Case Reports.18-MAR-2024;8(4):1-4$58$YR$A$F$Y$$$20240906$$HP$PT$PT
242883302$24288330$2$F$$20240904$20240905$20240905$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049614$BOEHRINGER INGELHEIM$$6$DEC$A$M$Y$$$20240906$$MD$US$US
242883311$24288331$1$I$20240524$20240904$20240905$20240905$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141614$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240906$$CN$US$US
242883321$24288332$1$I$20230201$20240903$20240905$20240905$EXP$$CA-ABBVIE-5906943$ABBVIE$$$$A$F$Y$$$20240905$$CN$CA$CA
242883331$24288333$1$I$20240823$20240828$20240905$20240905$EXP$$US-BIOGEN-2024BI01280656$BIOGEN$$26$YR$$F$Y$$$20240905$$CN$US$US
242883341$24288334$1$I$20240729$20240829$20240905$20240905$PER$$US-SA-2024SA253668$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240906$$MD$US$US
242883351$24288335$1$I$20240825$20240826$20240905$20240905$PER$$US-ABBVIE-5897903$ABBVIE$$60$YR$$F$Y$$$20240905$$CN$US$US
242883362$24288336$2$F$20240901$20240904$20240905$20240911$EXP$$IT-ABBVIE-5906921$ABBVIE$$67$YR$$M$Y$$$20240911$$HP$IT$IT
242883371$24288337$1$I$$20240903$20240905$20240905$PER$$US-ROCHE-10000072197$ROCHE$$17$YR$T$M$Y$$$20240906$$CN$US$US
242883381$24288338$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141531$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240906$$HP$US$US
242883391$24288339$1$I$20240710$20240902$20240905$20240905$EXP$$JP-009507513-2407JPN004143J$MERCK$$70$YR$$M$Y$$$20240905$$MD$JP$JP
242883401$24288340$1$I$$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024176942$AMGEN$$$$$$Y$$$20240905$$MD$US$US
242883411$24288341$1$I$20240709$20240829$20240905$20240905$EXP$$CA-BIOGEN-2024BI01280813$BIOGEN$$71$YR$$M$Y$$$20240905$$PH$CA$CA
242883421$24288342$1$I$$20240902$20240905$20240905$EXP$$ZA-AstraZeneca-2024A199702$ASTRAZENECA$$75$YR$$F$Y$$$20240906$$CN$ZA$
242883431$24288343$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141567$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240906$$CN$US$US
242883443$24288344$3$F$20240825$20240923$20240905$20240928$EXP$$ES-ABBVIE-5902776$ABBVIE$$60$YR$$M$Y$$$20240928$$CN$ES$ES
242883451$24288345$1$I$$20240823$20240905$20240905$EXP$$US-HLS-202401075$HLS THERAPEUTICS$$$$E$$Y$$$20240905$$MD$US$US
242883461$24288346$1$I$$20240903$20240905$20240905$EXP$$US-ABBVIE-5905679$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242883471$24288347$1$I$20240101$20240830$20240905$20240905$EXP$$US-ABBVIE-5793444$ABBVIE$$$$$M$Y$$$20240905$$CN$US$US
242883481$24288348$1$I$20240601$20240828$20240905$20240905$EXP$$US-ABBVIE-5905029$ABBVIE$$65$YR$$F$Y$110$KG$20240905$$CN$US$US
242883491$24288349$1$I$20240901$20240902$20240905$20240905$EXP$$AR-ABBVIE-5905571$ABBVIE$$59$YR$$F$Y$$$20240905$$CN$AR$AR
242883501$24288350$1$I$20240201$20240827$20240905$20240905$PER$$US-ABBVIE-5899627$ABBVIE$$41$YR$$M$Y$$$20240905$$HP$US$US
242883511$24288351$1$I$20240827$20240829$20240905$20240905$EXP$$US-ABBVIE-5902420$ABBVIE$$60$YR$$F$Y$$$20240905$$CN$US$US
242883521$24288352$1$I$$20240904$20240905$20240905$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141551$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240906$$CN$US$US
242883531$24288353$1$I$20240101$20240830$20240905$20240905$EXP$$US-ABBVIE-5907809$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242883541$24288354$1$I$20240831$20240831$20240905$20240905$EXP$GB-MHRA-MED-202408311227243100-VLNGH$GB-ABBVIE-5905177$ABBVIE$$$$$M$Y$$$20240905$$MD$GB$GB
242883551$24288355$1$I$20240827$20240902$20240905$20240905$EXP$$CN-ABBVIE-5905444$ABBVIE$$31$YR$$M$Y$68$KG$20240905$$MD$CN$CN
242883561$24288356$1$I$20240730$20240829$20240905$20240905$EXP$$CN-BEIGENE-BGN-2024-013714$BEIGENE$$$$$$Y$$$20240905$$HP$CN$CN
242883571$24288357$1$I$20240902$20240904$20240905$20240905$PER$$US-AMGEN-USASP2024177363$AMGEN$$72$YR$E$M$Y$$$20240905$$CN$US$US
242883591$24288359$1$I$20240101$20240903$20240905$20240905$EXP$$US-ABBVIE-5906323$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242883601$24288360$1$I$20220101$20240829$20240905$20240905$EXP$$CA-AMGEN-CANSL2022027114$AMGEN$$42$YR$A$M$Y$$$20240905$$HP$CA$CA
242883611$24288361$1$I$$20240830$20240905$20240905$EXP$$US-ABBVIE-5907916$ABBVIE$$$$$F$Y$$$20240905$$CN$US$US
242883621$24288362$1$I$$20240827$20240905$20240905$30DAY$$US-GSK-US2024106713$GLAXOSMITHKLINE$$$$$F$Y$$$20240905$$CN$US$US
242883631$24288363$1$I$$20240823$20240906$20240906$EXP$$US-HLS-202401074$HLS THERAPEUTICS$$$$A$$Y$$$20240905$$MD$US$US
242883641$24288364$1$I$20240826$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200870$ASTRAZENECA$$27921$DY$$M$Y$$$20240906$$MD$US$
242883651$24288365$1$I$20240804$20240828$20240906$20240906$EXP$$CO-ABBVIE-5907162$ABBVIE$$74$YR$$M$Y$64$KG$20240906$$HP$CO$CO
242883671$24288367$1$I$$20240829$20240906$20240906$EXP$$CN-AMGEN-CHNSP2024175475$AMGEN$Fubin Q.; Na Z.; Shengda Z. et al.. Prognostic values of serum miR-140-5p and SFRP -5 for in-stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240905$$HP$CN$CN
242883681$24288368$1$I$$20240905$20240906$20240906$PER$$NVSC2024US178847$NOVARTIS$$$$$M$Y$74$KG$20240906$$CN$US$US
242883701$24288370$1$I$$20240824$20240906$20240906$PER$$US-SA-2024SA256910$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$$US$US
242883711$24288371$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176452$AMGEN$$$$$F$Y$$$20240905$$MD$US$US
242883721$24288372$1$I$$20240902$20240906$20240906$EXP$GB-MHRA-MED-202409021635079370-DKWVB$GB-GSK-GB2024108922$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$GB$GB
242883731$24288373$1$I$$20240829$20240906$20240906$PER$$US-SA-2024SA253824$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240906$$CN$US$US
242883741$24288374$1$I$$20240823$20240906$20240906$EXP$$US-HLS-202401069$HLS THERAPEUTICS$$$$A$$Y$$$20240906$$HP$US$US
242883751$24288375$1$I$20240903$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002754$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240905$$CN$US$US
242883761$24288376$1$I$20240903$20240903$20240906$20240906$EXP$$IL-ABBVIE-5906914$ABBVIE$$68$YR$$M$Y$$$20240906$$CN$IL$IL
242883771$24288377$1$I$$20240829$20240906$20240906$EXP$$CN-AMGEN-CHNSP2024175488$AMGEN$Fubin Q.; Na Z.; Shengda Z. et al.. Prognostic values of serum miR-140-5p and SFRP -5 for in-stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240905$$HP$CN$CN
242883781$24288378$1$I$$20240829$20240906$20240906$EXP$$US-ABBVIE-5715058$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242883791$24288379$1$I$$20240829$20240906$20240906$EXP$$US-ABBVIE-5901822$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242883801$24288380$1$I$$20240827$20240906$20240906$EXP$$BG-STRIDES ARCOLAB LIMITED-2024SP011119$STRIDES$Drenovska K, Valeva E, Shahid M, Vassileva S.. Case Report: Coexistence of bullous pemphigoid and psoriasis: Therapeutic challenge and IL17A-targeted parallel treatment strategy.. Front-Med. 2023;10$71$YR$$F$Y$$$20240906$$HP$BG$BG
242883811$24288381$1$I$20240901$20240904$20240906$20240906$EXP$$US-ABBVIE-5907949$ABBVIE$$73$YR$$M$Y$$$20240906$$CN$US$US
242883821$24288382$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176212$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
242883832$24288383$2$F$20240901$20240928$20240906$20240930$PER$$US-AMGEN-USASP2024177082$AMGEN$$66$YR$E$M$Y$$$20240930$$CN$US$US
242883842$24288384$2$F$20240606$20240906$20240906$20240912$EXP$$US-ABBVIE-5907325$ABBVIE$$65$YR$$M$Y$87$KG$20240912$$CN$US$US
242883851$24288385$1$I$$20240829$20240906$20240906$PER$$US-JNJFOC-20240882340$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$MD$US$US
242883861$24288386$1$I$20240101$20240902$20240906$20240906$EXP$$US-ABBVIE-5906905$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242883871$24288387$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA256835$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240906$$MD$US$US
242883881$24288388$1$I$20240115$20240827$20240906$20240906$EXP$$DE-SA-2024SA257291$SANOFI AVENTIS$$44$YR$A$F$Y$70$KG$20240906$$CN$DE$DE
242883891$24288389$1$I$20240101$20240902$20240906$20240906$EXP$$ZA-ABBVIE-5907073$ABBVIE$$45$YR$$F$Y$$$20240906$$CN$ZA$ZA
242883903$24288390$3$F$20240822$20240919$20240906$20240925$PER$$US-SA-2024SA252753$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240925$$CN$US$US
242883921$24288392$1$I$$20240829$20240906$20240906$EXP$$ZA-AstraZeneca-2024A198706$ASTRAZENECA$$51$YR$$F$Y$$$20240906$$CN$ZA$
242883931$24288393$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A200633$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242883941$24288394$1$I$$20240826$20240906$20240906$EXP$$PT-CELLTRION INC.-2024PT021032$CELLTRION$Belchior B., Henriques A., Paixao J., Fortuna J., Santos L.. PO-0122 - (2571) - RITUXIMAB PULMONARY TOXICITY: A CHALLENGING DIAGNOSIS. 30 Congresso Nacional de Medicina Interna. 2024;492$$$$$Y$$$20240906$$HP$PT$PT
242883951$24288395$1$I$20230101$20240903$20240906$20240906$EXP$$BR-ABBVIE-5906843$ABBVIE$$$$$M$Y$$$20240906$$CN$BR$BR
242883961$24288396$1$I$20240829$20240903$20240906$20240906$EXP$$SE-ABBVIE-5906915$ABBVIE$$79$YR$$F$Y$$$20240906$$HP$SE$SE
242883971$24288397$1$I$20240830$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176327$AMGEN$$79$YR$E$F$Y$$$20240905$$CN$US$US
242883981$24288398$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5907154$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242884001$24288400$1$I$$20240829$20240906$20240906$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP011194$STRIDES$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?.. Transpl-Infect-Dis. 2024;26 (3):e14276$6$MON$$M$Y$$$20240906$$HP$ES$ES
242884011$24288401$1$I$20240726$20240904$20240906$20240906$EXP$$JP-TAKEDA-2024TJP012588$TAKEDA$$8$DEC$$M$Y$$$20240906$$MD$JP$JP
242884021$24288402$1$I$$20240829$20240906$20240906$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP011197$STRIDES$Rubio-Mora E, Rodriguez JG, Carrascoso GR.. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?.. Transpl-Infect-Dis. 2024;26 (3):e14276$5$MON$$M$Y$$$20240906$$HP$ES$ES
242884031$24288403$1$I$$20240829$20240906$20240906$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP011259$STRIDES$Gokten DB, Kavak FY, Mercan R.. Bilateral hand dactylitis: An unusual presentation of the great imitator: Tuberculosis.. Mod-Rheumatol-Case-Rep. 2024;8 (2):365-367$42$YR$$M$Y$$$20240906$$HP$TR$TR
242884041$24288404$1$I$20240101$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177141$AMGEN$$63$YR$A$F$Y$$$20240905$$CN$US$US
242884051$24288405$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5906776$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242884061$24288406$1$I$20240801$20240902$20240906$20240906$EXP$$GR-CHATTEMPRD-2024OHG030634$CHATTEM$$24$YR$A$F$Y$55$KG$20240906$$CN$GR$GR
242884071$24288407$1$I$20240801$20240822$20240906$20240906$PER$$US-SA-2024SA253869$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240906$$MD$US$US
242884081$24288408$1$I$$20240827$20240906$20240906$EXP$$AE-EMD Serono-2024046067$EMD SERONO INC$$58$YR$A$F$Y$$$20240906$$MD$AE$AE
242884101$24288410$1$I$20240101$20240830$20240906$20240906$EXP$$CA-ABBVIE-5903817$ABBVIE$$$$E$F$Y$$$20240906$$CN$CA$CA
242884111$24288411$1$I$$20240826$20240906$20240906$EXP$$CN-ROCHE-10000073089$ROCHE$Sui Y, Zhao Y, Zhou N, Sun H, Sun Y, Liu J, et al. Case report: heart failure related to intravitreal injection of anti-VEGF. BMC CARDIOVASCULAR DISORDERS. 2024;24(418):1-7. doi:10.1186/s12872-024-04095-4$80$YR$E$M$Y$$$20240906$$HP$CN$CN
242884121$24288412$1$I$20240722$20240830$20240906$20240906$EXP$$US-ABBVIE-5903509$ABBVIE$$70$YR$$M$Y$$$20240906$$CN$US$US
242884131$24288413$1$I$20240831$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176434$AMGEN$$59$YR$A$F$Y$$$20240905$$CN$US$US
242884141$24288414$1$I$$20240903$20240906$20240906$PER$$US-JNJFOC-20240908094$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$HP$US$US
242884151$24288415$1$I$$20240828$20240906$20240906$EXP$$US-JNJFOC-20240873901$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$PH$US$US
242884161$24288416$1$I$$20240902$20240906$20240906$EXP$$ZA-AstraZeneca-2024A200148$ASTRAZENECA$$50$YR$$F$Y$$$20240906$$CN$ZA$
242884181$24288418$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176328$AMGEN$$$$$M$Y$$$20240905$$CN$US$US
242884201$24288420$1$I$20240821$20240903$20240906$20240906$EXP$$US-ABBVIE-5906476$ABBVIE$$2$YR$$F$Y$$$20240906$$CN$US$US
242884212$24288421$2$F$$20240829$20240906$20240923$PER$$US-SA-2024SA254799$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240923$$CN$US$US
242884221$24288422$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5868780$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242884231$24288423$1$I$$20240828$20240906$20240906$EXP$$PT-Appco Pharma LLC-2161291$APPCO PHARMA$Initial$73$YR$$F$Y$$$20240906$$$PT$PT
242884241$24288424$1$I$20240801$20240829$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027315$UNITED THERAPEUTICS$$52$YR$$F$Y$85.714$KG$20240906$$$US$US
242884251$24288425$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5905692$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242884262$24288426$2$F$20240101$20240919$20240906$20240926$EXP$$US-ABBVIE-5905904$ABBVIE$$$$$F$Y$73$KG$20240926$$CN$US$US
242884271$24288427$1$I$$20240829$20240906$20240906$EXP$$GB-009507513-2408GBR010711$MERCK$Bala L, Hussain K, Shetty R, Patel NP.. Pembrolizumab-induced hypertrophic lichenoid dermatitis with involvement of an old tattoo. Clinical and experimental dermatology. 2024$58$YR$$M$Y$$$20240906$$HP$GB$GB
242884281$24288428$1$I$20240902$20240904$20240906$20240906$EXP$$US-ABBVIE-5908092$ABBVIE$$67$YR$$M$Y$$$20240906$$CN$US$US
242884293$24288429$3$F$20240801$20240918$20240906$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-027396$UNITED THERAPEUTICS$$41$YR$$M$Y$66.213$KG$20240926$$$US$US
242884301$24288430$1$I$20240101$20240827$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027047$UNITED THERAPEUTICS$$$$$F$Y$49.887$KG$20240906$$$US$US
242884311$24288431$1$I$$20240829$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027327$UNITED THERAPEUTICS$$$$$F$Y$114.74$KG$20240906$$$US$US
242884321$24288432$1$I$20240430$20240903$20240906$20240906$EXP$IT-MINISAL02-1000566$IT-GSK-IT2024109359$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$PH$IT$IT
242884332$24288433$2$F$20240820$20240906$20240906$20240913$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03092$AMNEAL$$21$YR$$F$Y$$$20240913$$MD$US$US
242884341$24288434$1$I$20240820$20240903$20240906$20240906$EXP$$US-ABBVIE-5906854$ABBVIE$$51$YR$$F$Y$$$20240906$$CN$US$US
242884351$24288435$1$I$20240701$20240903$20240906$20240906$EXP$$ZA-ABBVIE-5905340$ABBVIE$$37$YR$$F$Y$$$20240906$$CN$ZA$ZA
242884361$24288436$1$I$$20240829$20240906$20240906$EXP$$CN-AMGEN-CHNSP2024175490$AMGEN$Fubin Q.; Na Z.; Shengda Z. et al.. Prognostic values of serum miR-140-5p and SFRP -5 for in-stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240905$$HP$CN$CN
242884372$24288437$2$F$20240901$20240905$20240906$20240906$PER$$US-AMGEN-USASP2024177128$AMGEN$$70$YR$E$F$Y$$$20240906$$CN$US$US
242884381$24288438$1$I$20240903$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177042$AMGEN$$77$YR$E$M$Y$$$20240905$$CN$US$US
242884391$24288439$1$I$$20240829$20240906$20240906$PER$$US-AMGEN-USASP2024174552$AMGEN$Loewenstern J.; Tan E. T.; Gfrerer L. et al.. Double echo steady-state free precession technique in MR neurography to evaluate extracranial facial nerve involvement in a case of Bell^s palsy. Radiology Case Reports. 2024;19 (11):4904-4907$35$YR$A$F$Y$$$20240905$$MD$US$US
242884401$24288440$1$I$20240601$20240903$20240906$20240906$EXP$$PR-ABBVIE-5842875$ABBVIE$$57$YR$$F$Y$95.254$KG$20240906$$CN$PR$PR
242884411$24288441$1$I$$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A201130$ASTRAZENECA$$$$$M$Y$$$20240906$$HP$US$
242884421$24288442$1$I$$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003376$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240906$$CN$US$US
242884431$24288443$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5906138$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242884441$24288444$1$I$$20240815$20240906$20240906$30DAY$$US-ASTELLAS-2024US022132$ASTELLAS$$$$$$Y$$$20240906$$MD$US$US
242884451$24288445$1$I$20240812$20240819$20240906$20240906$PER$$US-JNJFOC-20240847194$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240906$$CN$US$US
242884461$24288446$1$I$20240701$20240903$20240906$20240906$EXP$NO-NOMAADVRE-RELISV-2024-Vk8b63$NO-JNJFOC-20240911549$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240906$$MD$NO$NO
242884471$24288447$1$I$20230101$20240827$20240906$20240906$EXP$$US-JNJFOC-20240869974$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240906$$CN$US$US
242884482$24288448$2$F$$20240905$20240906$20240909$EXP$$US-JNJFOC-20240904323$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240909$$HP$US$US
242884492$24288449$2$F$$20240909$20240906$20240918$EXP$$CN-ABBVIE-5907403$ABBVIE$Yao S, Yan Z, Zhao S, Wang H, Chu J, Xu Y, et al. Observation of Efficacy and Safety of Low-Dose Decitabine Combined with Ibrutinib in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. Chinese Journal of Medical Guide. 2024;26(6):570-575.; Yao S, Zhao S, Wang H, Chu J, Xu Y, Zhang J, et.al.Efficacy and Safety of Low-Dose Decitabine Combined with Ibrutinib in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. Chinese Journal of Contemporary Pediatrics. 2024;2...$$$$$Y$$$20240918$$HP$CN$CN
242884501$24288450$1$I$20240101$20240829$20240906$20240906$EXP$$CA-ABBVIE-5907045$ABBVIE$$59$YR$$M$Y$$$20240906$$CN$CA$CA
242884511$24288451$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906876$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242884532$24288453$2$F$20240816$20240905$20240906$20240914$EXP$$DE-CELLTRION INC.-2024DE020762$CELLTRION$$$$$$Y$$$20240914$$MD$DE$DE
242884541$24288454$1$I$20240605$20240830$20240906$20240906$EXP$$CA-JNJFOC-20240754808$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240906$$HP$CA$CA
242884551$24288455$1$I$20240319$20240827$20240906$20240906$EXP$$KR-EXELIXIS-XL18424080526$EXELIXIS$$$$$$Y$$$20240905$$MD$KR$KR
242884571$24288457$1$I$$20240710$20240906$20240906$PER$$US-AUROBINDO-AUR-APL-2024-032039$AUROBINDO$$$$$F$Y$$$20240906$$HP$US$US
242884591$24288459$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000073259$ROCHE$$47$YR$A$F$Y$$$20240906$$CN$US$US
242884601$24288460$1$I$$20240827$20240906$20240906$EXP$$US-ABBVIE-5898487$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242884611$24288461$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906290$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242884622$24288462$2$F$20240902$20240913$20240906$20240917$PER$$US-AMGEN-USASP2024175257$AMGEN$$61$YR$A$M$Y$$$20240917$$CN$US$US
242884631$24288463$1$I$$20240830$20240906$20240906$EXP$$CA-ABBVIE-5902948$ABBVIE$$$$E$$Y$$$20240906$$CN$CA$CA
242884643$24288464$3$F$20240903$20240909$20240906$20240914$PER$$US-AMGEN-USASP2024177091$AMGEN$$63$YR$A$F$Y$$$20240914$$HP$US$US
242884651$24288465$1$I$$20240821$20240906$20240906$EXP$$CA-ASTELLAS-2024-AER-002285$ASTELLAS$$$$$F$Y$$$20240906$$PH$CA$CA
242884661$24288466$1$I$$20240903$20240906$20240906$30DAY$$US-SANDOZ INC.-SDZ2024US077534$SANDOZ$$$$$$Y$$$20240906$$PH$US$US
242884671$24288467$1$I$20240831$20240831$20240906$20240906$PER$$US-ABBVIE-5906645$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242884681$24288468$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141535$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240906$$PH$US$US
242884691$24288469$1$I$$20240825$20240906$20240906$EXP$$ET-Accord-443762$ACCORD$Tafese AM, Adela AY, Kebede AG, Tegegn AS, Asare ET, Awol M. Acute brachial artery occlusion following cisplatin-based chemotherapy: case report. SAGE open medical case reports. 2024;12:1-5.DOI: 10.1177/2050313X241269594.$50$YR$A$M$Y$$$20240906$$HP$ET$ET
242884711$24288471$1$I$20230101$20240830$20240906$20240906$EXP$$PL-ABBVIE-5903499$ABBVIE$$71$YR$$M$Y$$$20240906$$MD$PL$PL
242884723$24288472$3$F$20240827$20240909$20240906$20240916$PER$$US-AMGEN-USASP2024171362$AMGEN$$82$YR$E$F$Y$$$20240915$$CN$US$US
242884731$24288473$1$I$20240101$20240903$20240906$20240906$EXP$$CN-ABBVIE-5904908$ABBVIE$$$$$M$Y$52$KG$20240906$$MD$CN$CN
242884741$24288474$1$I$$20240904$20240906$20240906$EXP$GB-MHRA-MED-202409041301200300-DKHQN$GB-ORGANON-O2409GBR000306$ORGANON$$79$YR$$F$Y$$$20240906$$PH$GB$GB
242884751$24288475$1$I$20240601$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200576$ASTRAZENECA$$26050$DY$$F$Y$$$20240906$$CN$US$
242884761$24288476$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A199397$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242884771$24288477$1$I$$20240903$20240906$20240906$PER$$US-AstraZeneca-2024A200660$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242884781$24288478$1$I$$20240827$20240906$20240906$EXP$GB-MHRA-TPP2243927C11349871YC1724417664081$GB-Accord-443792$ACCORD$$21$YR$A$F$Y$80$KG$20240906$$PH$GB$GB
242884791$24288479$1$I$$20240830$20240906$20240906$PER$$US-ABBVIE-5903394$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242884801$24288480$1$I$$20240829$20240906$20240906$PER$$US-SA-2024SA254011$SANOFI AVENTIS$$$$$F$Y$$$20240906$$CN$US$US
242884811$24288481$1$I$20240903$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177136$AMGEN$$84$YR$E$F$Y$$$20240905$$CN$US$US
242884821$24288482$1$I$20240903$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002425$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240906$$CN$US$US
242884831$24288483$1$I$20240101$20240902$20240906$20240906$EXP$$MY-JNJFOC-20240902167$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$MD$MY$MY
242884841$24288484$1$I$$20240813$20240906$20240906$PER$$AU-TOLMAR, INC.-24AU051876$TOLMAR$$$$$M$Y$$$20240906$$CN$AU$AU
242884851$24288485$1$I$20240715$20240826$20240906$20240906$EXP$$DE-ABBVIE-5903187$ABBVIE$$55$YR$$M$Y$$$20240906$$MD$DE$DE
242884861$24288486$1$I$$20240813$20240906$20240906$PER$$AU-TOLMAR, INC.-24AU051877$TOLMAR$$$$$M$Y$$$20240906$$CN$AU$AU
242884871$24288487$1$I$$20240813$20240906$20240906$PER$$AU-TOLMAR, INC.-24AU051882$TOLMAR$$$$$M$Y$$$20240906$$CN$AU$AU
242884882$24288488$2$F$$20240912$20240906$20240920$EXP$$CN-TAKEDA-2024TUS088864$TAKEDA$Yuan G, Peng D, Tingwu Y, Huan L, Lejia L, Yanyu W, et al. Efficacy observation of different doses of bortezomib combined with chemotherapy for multiple myeloma. Cancer Research and Clinic. 2024;36(7):532-5$$$A$$Y$$$20240920$$MD$CN$CN
242884891$24288489$1$I$20240829$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177162$AMGEN$$$$$M$Y$$$20240905$$CN$US$US
242884911$24288491$1$I$20240101$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176372$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
242884921$24288492$1$I$20240717$20240829$20240906$20240906$EXP$$US-JNJFOC-20240905988$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240906$$MD$US$US
242884931$24288493$1$I$$20240831$20240906$20240906$PER$$US-CHATTEMPRD-2024OHG030682$CHATTEM$$$$$$Y$$$20240906$$CN$US$US
242884942$24288494$2$F$20240101$20240904$20240906$20240915$EXP$$JP-ROCHE-10000071549$ROCHE$$6$DEC$A$F$Y$$$20240915$$MD$JP$JP
242884951$24288495$1$I$$20240903$20240906$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014220$JAZZ$$$$$M$Y$$$20240905$$HP$US$US
242884961$24288496$1$I$20240501$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408271819015540-YDQLC$GB-Accord-443822$ACCORD$$86$YR$E$F$Y$66$KG$20240906$$CN$GB$GB
242884973$24288497$3$F$$20240913$20240906$20240918$EXP$$CA-ROCHE-10000070441$ROCHE$$40$YR$A$F$Y$$$20240918$$HP$CA$CA
242884981$24288498$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255611$SANOFI AVENTIS$$$$A$M$Y$$$20240906$$MD$US$US
242884991$24288499$1$I$20240101$20240824$20240906$20240906$PER$$US-SA-2024SA256367$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240906$$MD$US$US
242885001$24288500$1$I$20240601$20240904$20240906$20240906$EXP$$US-ABBVIE-5907419$ABBVIE$$62$YR$$M$Y$$$20240906$$CN$US$US
242885012$24288501$2$F$20240904$20240905$20240906$20240911$PER$$US-AMGEN-USASP2024176749$AMGEN$$75$YR$E$F$Y$$$20240911$$CN$US$US
242885021$24288502$1$I$20240831$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176566$AMGEN$$84$YR$E$F$Y$$$20240905$$CN$US$US
242885033$24288503$3$F$$20240916$20240906$20240920$PER$$US-CHATTEMPRD-2024OHG030678$CHATTEM$$$$$F$Y$$$20240920$$CN$US$US
242885042$24288504$2$F$20240823$20240829$20240906$20240920$EXP$$AU-BEH-2024178036$CSL BEHRING$$77$YR$E$M$Y$$$20240920$$HP$AU$AU
242885051$24288505$1$I$$20240902$20240906$20240906$PER$$US-CHATTEMPRD-2024OHG030601$CHATTEM$$$$$$Y$$$20240906$$CN$US$US
242885061$24288506$1$I$20240101$20240828$20240906$20240906$EXP$$US-JNJFOC-20240873691$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240906$$CN$US$US
242885071$24288507$1$I$$20240826$20240906$20240906$EXP$$US-AUROBINDO-AUR-APL-2024-042781$AUROBINDO$Gardner SM, Pavisian B, Ho PA, Rustad JK, Kasick DP, Stern TA. Dynamic Evolution of Catatonia in the Context of Cerebral Venous Sinus Thrombosis. Prim-Care-Comp-CNS-Disorders. 2023$70$YR$$F$Y$$$20240906$$HP$US$US
242885081$24288508$1$I$$20240826$20240906$20240906$EXP$$PT-Accord-444499$ACCORD$Lagarteira J, Ferreira CO, Sa S, Pera R, Carrascal A, Madureira E. PO-0091 - (4099) - A case of cardiotoxicity due to chemotherapy. 30 CNMI Cardiovascular diseases. Clinical case.$66$YR$E$M$Y$$$20240906$$HP$PT$PT
242885092$24288509$2$F$$20240912$20240906$20240920$EXP$$CN-TAKEDA-2024TUS088810$TAKEDA$Yuan G, Peng D, Tingwu Y, Huan L, Lejia L, Yanyu W, et al.. Efficacy observation of different doses of bortezomib combined with chemotherapy for multiple myeloma. Cancer Research and Clinic. 2024;36(7):532-5$$$A$$Y$$$20240920$$MD$CN$CN
242885101$24288510$1$I$$20240823$20240906$20240906$EXP$$US-UCBSA-2024043318$UCB$$$$$F$Y$$$20240906$$HP$US$US
242885112$24288511$2$F$$20240905$20240906$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004944$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242885121$24288512$1$I$$20240828$20240906$20240906$EXP$$NO-AMNEAL PHARMACEUTICALS-2024-AMRX-03218$AMNEAL$$$$$$Y$$$20240906$$CN$NO$US
242885131$24288513$1$I$$20240902$20240906$20240906$PER$$US-CHATTEMPRD-2024OHG030656$CHATTEM$$$$$F$Y$$$20240906$$HP$US$US
242885141$24288514$1$I$20240821$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141259$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240906$$CN$US$US
242885151$24288515$1$I$20240701$20240823$20240906$20240906$EXP$$US-UCBSA-2024043397$UCB$$60$YR$$F$Y$$$20240906$$HP$US$US
242885171$24288517$1$I$$20240828$20240906$20240906$PER$$US-CHATTEMPRD-2024OHG029974$CHATTEM$$$$$$Y$$$20240906$$CN$US$US
242885181$24288518$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002644$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240906$$CN$US$US
242885191$24288519$1$I$20240904$20240904$20240906$20240906$EXP$GB-MHRA-MED-202409040717567780-ZLMDV$GB-ABBVIE-5907307$ABBVIE$$59$YR$$M$Y$$$20240906$$CN$GB$GB
242885202$24288520$2$F$20240723$20240904$20240906$20240911$EXP$$US-ABBVIE-5907415$ABBVIE$$56$YR$$F$Y$$$20240911$$CN$US$US
242885211$24288521$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002746$ELI LILLY AND CO$$$$$F$Y$$$20240906$$CN$US$US
242885222$24288522$2$F$20240819$20240905$20240906$20240917$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004971$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240917$$CN$US$US
242885231$24288523$1$I$$20240823$20240906$20240906$EXP$$US-Accord-444125$ACCORD$$26$YR$$M$Y$$$20240906$$HP$US$US
242885243$24288524$3$F$20240901$20240905$20240906$20240911$PER$$US-AMGEN-USASP2024176949$AMGEN$$85$YR$E$F$Y$$$20240911$$CN$US$US
242885251$24288525$1$I$$20240903$20240906$20240906$PER$$US-CHATTEMPRD-2024OHG030690$CHATTEM$$$$$$Y$$$20240906$$CN$US$US
242885272$24288527$2$F$$20240826$20240906$20240910$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465718$RANBAXY$Bdiwi M, Ramaseshan K, Uddin M, Goel M, Razzaq S, Alrayyashi M, et al. Carcinoid heart disease: A potentially fatal complication of carcinoid syndrome. BMJ Case Rep. 2023;16:no pagination$$$A$M$Y$$$20240910$$HP$US$US
242885281$24288528$1$I$$20240903$20240906$20240906$PER$$NVSC2024US177477$NOVARTIS$$$$$M$Y$$$20240906$$CN$US$US
242885293$24288529$3$F$$20240906$20240906$20240913$PER$$US-AMGEN-USASP2024176038$AMGEN$$$$$$Y$$$20240912$$CN$US$US
242885301$24288530$1$I$20240902$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176010$AMGEN$$71$YR$E$F$Y$$$20240905$$CN$US$US
242885311$24288531$1$I$20240903$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176206$AMGEN$$$$$$Y$$$20240905$$HP$US$US
242885321$24288532$1$I$$20240830$20240906$20240906$PER$$US-AstraZeneca-2024A199150$ASTRAZENECA$$$$$F$Y$$$20240906$$MD$US$
242885332$24288533$2$F$20210101$20240905$20240906$20240906$PER$$US-AMGEN-USASP2024177163$AMGEN$$75$YR$E$F$Y$$$20240906$$CN$US$US
242885341$24288534$1$I$20240901$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177103$AMGEN$$65$YR$E$M$Y$$$20240905$$CN$US$US
242885351$24288535$1$I$20240830$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176075$AMGEN$$$$$$Y$$$20240905$$HP$US$US
242885362$24288536$2$F$$20240906$20240906$20240910$PER$$US-AMGEN-USASP2024176349$AMGEN$$$$$$Y$$$20240910$$PH$US$US
242885392$24288539$2$F$20240902$20240910$20240906$20240912$EXP$$IL-TAKEDA-2022TUS097646$TAKEDA$$98$YR$$M$Y$$$20240912$$CN$IL$IL
242885401$24288540$1$I$$20240830$20240906$20240906$EXP$$US-TAKEDA-2024TUS025407$TAKEDA$$$$$F$Y$$$20240906$$HP$US$US
242885412$24288541$2$F$$20240905$20240906$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004949$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$HP$US$US
242885431$24288543$1$I$$20240827$20240906$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-043332$AUROBINDO$$89$YR$$F$Y$$$20240906$$PH$GB$GB
242885441$24288544$1$I$20130201$20240827$20240906$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-043379$AUROBINDO$$41$YR$$M$Y$92$KG$20240906$$CN$GB$GB
242885452$24288545$2$F$$20240912$20240906$20240920$EXP$$CN-TAKEDA-2024TUS088866$TAKEDA$$$$A$$Y$$$20240920$$MD$CN$CN
242885461$24288546$1$I$20200728$20240830$20240906$20240906$EXP$PL-URPL-1-1834-2020$PL-ABBVIE-5906462$ABBVIE$$64$YR$$M$Y$76$KG$20240906$$MD$PL$PL
242885481$24288548$1$I$$20240829$20240906$20240906$EXP$$US-ROCHE-10000070180$ROCHE$$74$YR$E$F$Y$$$20240906$$CN$US$US
242885501$24288550$1$I$$20240902$20240906$20240906$EXP$$IN-TAKEDA-2024TUS087937$TAKEDA$Kumar NM, Bhargava R. ALL-766 Asciminib as a bridge to allogenic transplant in 3 patients with relapsed/refractory philadelphia chromosome-positive ALL or CML lymphoid blast crisis refractory/intolerant to ponatinib. Clinical Lymphoma, Myeloma and Leukemia. 24(supp 1):s283-84$$$$M$Y$$$20240906$$MD$IN$IN
242885511$24288551$1$I$20240801$20240823$20240906$20240906$PER$$US-SA-2024SA257073$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240906$$CN$US$US
242885521$24288552$1$I$20240823$20240823$20240906$20240906$PER$$US-SA-2024SA257137$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240906$$MD$US$US
242885532$24288553$2$F$20240730$20240912$20240906$20240930$PER$$US-TOLMAR, INC.-24US051461$TOLMAR$$$$$M$Y$$$20240927$$HP$US$US
242885541$24288554$1$I$$20240814$20240906$20240906$PER$$US-TOLMAR, INC.-24US051565$TOLMAR$$$$$M$Y$$$20240906$$HP$US$US
242885552$24288555$2$F$20240717$20240913$20240906$20240930$PER$$US-TOLMAR, INC.-24US051569$TOLMAR$$$$$$Y$$$20240927$$HP$US$US
242885561$24288556$1$I$20240807$20240815$20240906$20240906$PER$$US-TOLMAR, INC.-24US051758$TOLMAR$$$$$F$Y$$$20240906$$HP$COUNTRY NOT SPECIFIED$US
242885591$24288559$1$I$20240812$20240814$20240906$20240906$PER$$US-TOLMAR, INC.-24US051864$TOLMAR$$69$YR$$M$Y$$$20240906$$HP$US$US
242885601$24288560$1$I$20240814$20240820$20240906$20240906$PER$$US-TOLMAR, INC.-24US051893$TOLMAR$$$$$$Y$$$20240906$$HP$US$US
242885611$24288561$1$I$20240815$20240815$20240906$20240906$PER$$US-TOLMAR, INC.-24US051920$TOLMAR$$42$YR$$F$Y$$$20240906$$HP$US$US
242885631$24288563$1$I$20240814$20240816$20240906$20240906$PER$$US-TOLMAR, INC.-24US051894$TOLMAR$$62$YR$$M$Y$$$20240906$$HP$US$US
242885661$24288566$1$I$20240819$20240820$20240906$20240906$PER$$US-TOLMAR, INC.-24US051993$TOLMAR$$51$YR$$M$Y$$$20240906$$HP$US$US
242885691$24288569$1$I$20240814$20240830$20240906$20240906$30DAY$$US-AMGEN-USASP2024174021$AMGEN$$56$YR$A$M$Y$113.1$KG$20240905$$HP$US$US
242885701$24288570$1$I$$20240722$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009354$STRIDES$Chittal A, Kumar K, Rao S, Baydarian M. Chittal A, Kumar K, Rao S, Baydarian M.. Herpes Simplex Virus 1 Meningitis Presenting as Status Epilepticus.. Am-J-Respir-Crit-Care-Med. 2023;207$54$YR$$M$Y$$$20240906$$HP$US$US
242885711$24288571$1$I$$20240524$20240906$20240906$PER$US-MLMSERVICE-20240517-PI067444-00196-1$US-STRIDES ARCOLAB LIMITED-2024SP006265$STRIDES$Villa NA, Espiridion ED.. Neuropsychiatric Manifestations of Arteriovenous Malformation: A Case of Acute Mania.. Cureus. 2024;16(4):e58297$46$YR$$M$Y$$$20240906$$MD$US$US
242885721$24288572$1$I$20240824$20240824$20240906$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-138122$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240906$$MD$JP$JP
242885731$24288573$1$I$$20240829$20240906$20240906$EXP$$US-JNJFOC-20240877563$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$MD$US$US
242885741$24288574$1$I$20240205$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408272236429120-LYCFW$GB-Accord-443790$ACCORD$$19$YR$A$F$Y$$$20240906$$CN$GB$GB
242885751$24288575$1$I$$20240814$20240906$20240906$PER$US-MLMSERVICE-20240807-PI154460-00196-1$US-STRIDES ARCOLAB LIMITED-2024SP010424$STRIDES$Norman T, Guenther J, Wu K, DeClerck B, Worswick S. Vesiculopustular drug reaction with eosinophilia and systemic symptoms induced by levetiracetam.. Skin health and disease. 2024;4(4):e384$32$YR$$F$Y$$$20240906$$MD$US$US
242885761$24288576$1$I$$20240711$20240906$20240906$PER$$US-STRIDES PHARMA UK LTD.-2024SP008815$STRIDES$Allonce J, Patel V.. New-onset Refractory Status Epilepticus Induced by Synthetic Marijuana: A Case Report.. Am-J-Respir-Crit-Care-Med. 2024;209:A2117$$$$$Y$$$20240906$$HP$US$US
242885771$24288577$1$I$20240805$20240828$20240906$20240906$EXP$DE-AMK-279444$DE-EMD Serono-2024046185$EMD SERONO INC$$67$YR$E$F$Y$$$20240906$$PH$DE$DE
242885781$24288578$1$I$20240501$20240830$20240906$20240906$EXP$$US-BIOGEN-2024BI01280205$BIOGEN$$52$YR$$F$Y$$$20240906$$CN$US$US
242885791$24288579$1$I$$20240802$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009934$STRIDES$Cohen NT, Buraniqi E, Smith JD, Vezina LG, Gaillard WD.. Ictal Arterial Spin Labeling-Magnetic Resonance Imaging Identifies Seizure Onset Zone in Epilepsia Partialis Continua.. Ann-Neurol. 2024;95 (4):760-761$7$YR$$M$Y$$$20240906$$MD$US$US
242885802$24288580$2$F$20160101$20240621$20240906$20240906$EXP$$US-ROCHE-10000072681$ROCHE$$73$YR$E$M$Y$$$20240906$$CN$US$US
242885811$24288581$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177001$AMGEN$$$$$$Y$$$20240905$$CN$US$US
242885821$24288582$1$I$$20240905$20240906$20240906$PER$$US-AMGEN-USASP2024177738$AMGEN$$$$E$F$Y$$$20240905$$CN$US$US
242885841$24288584$1$I$20240903$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002478$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240906$$CN$US$US
242885851$24288585$1$I$$20240830$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001786$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240906$$CN$US$US
242885861$24288586$1$I$$20240821$20240906$20240906$PER$$US-ASTELLAS-2024-AER-002149$ASTELLAS$$68$YR$E$M$Y$$$20240906$$CN$US$US
242885871$24288587$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001318$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240906$$CN$US$US
242885881$24288588$1$I$20240904$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002945$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240906$$CN$US$US
242885891$24288589$1$I$$20240828$20240906$20240906$30DAY$$US-GSK-US2024107159$GLAXOSMITHKLINE$$$$$F$Y$71$KG$20240906$$MD$US$US
242885901$24288590$1$I$$20240828$20240906$20240906$30DAY$$US-GSK-US2024107186$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242885911$24288591$1$I$$20240829$20240906$20240906$EXP$$KR-SERVIER-S24011035$SERVIER$$$$$$Y$$$20240906$$MD$KR$KR
242885921$24288592$1$I$$20240830$20240906$20240906$EXP$$TR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048751$BOEHRINGER INGELHEIM$Odabasi Z, Kishiyeva A, Karabiber E, Tazegul G. Emphysematous pyelonephritis in a patient with G6PC3 deficiency using empagliflozin to restore neutropenia: a case report. European Journal of Case Reports in Internal Medicine. 2024;11(1): 893-894. doi:10.12890/2024_V11Sup1.$29$YR$A$M$Y$$$20240906$$HP$TR$TR
242885932$24288593$2$F$20240616$20240829$20240906$20240909$EXP$$FR-EMD Serono-2024046440$EMD SERONO INC$$81$YR$E$F$Y$63$KG$20240909$$MD$FR$FR
242885941$24288594$1$I$$20240904$20240906$20240906$EXP$$US-ABBVIE-5907755$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242885953$24288595$3$F$20240814$20240909$20240906$20240923$PER$$US-SA-2024SA243984$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240923$$MD$US$US
242885971$24288597$1$I$$20240904$20240906$20240906$EXP$$JP-TAKEDA-2024TJP013081$TAKEDA$$$$$M$Y$$$20240906$$MD$JP$JP
242885982$24288598$2$F$20240101$20240911$20240906$20240914$PER$$US-AMGEN-USASP2024175726$AMGEN$$41$YR$A$M$Y$65.76$KG$20240914$$CN$US$US
242886004$24288600$4$F$20240828$20240917$20240906$20240923$PER$$US-AMGEN-USASP2024174091$AMGEN$$55$YR$A$F$Y$2$KG$20240923$$PH$US$US
242886011$24288601$1$I$$20240829$20240906$20240906$PER$$US-RDY-SPO/USA/24/0012764$DR REDDYS$$18$YR$A$M$Y$$$20240906$$MD$US$US
242886021$24288602$1$I$20240829$20240829$20240906$20240906$PER$$US-RDY-SPO/USA/24/0012768$DR REDDYS$$41$YR$A$M$Y$$$20240906$$MD$US$US
242886031$24288603$1$I$$20240829$20240906$20240906$PER$$US-RDY-SPO/USA/24/0012767$DR REDDYS$$14$YR$T$M$Y$$$20240906$$MD$US$US
242886041$24288604$1$I$$20240828$20240906$20240906$PER$$US-RDY-SPO/USA/24/0012769$DR REDDYS$$22$YR$A$F$Y$$$20240906$$MD$US$US
242886051$24288605$1$I$$20240904$20240906$20240906$30DAY$$US-SANDOZ INC.-SDZ2024US077964$SANDOZ$$$$$M$Y$$$20240906$$CN$US$US
242886061$24288606$1$I$20240610$20240902$20240906$20240906$EXP$$JP-SANDOZ INC.-SDZ2024JP062079$SANDOZ$$$$$F$Y$$$20240906$$PH$JP$JP
242886072$24288607$2$F$$20240919$20240906$20240924$EXP$$US-ABBVIE-5906655$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
242886081$24288608$1$I$20240705$20240903$20240906$20240906$EXP$$US-ABBVIE-5906437$ABBVIE$$35$YR$$F$Y$$$20240906$$CN$US$US
242886091$24288609$1$I$20240401$20240825$20240906$20240906$EXP$GB-MHRA-MED-202408241631166090-PDJYF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-20316$ALKEM$$41$YR$$M$Y$70$KG$20240906$$CN$GB$GB
242886101$24288610$1$I$20240701$20240824$20240906$20240906$EXP$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-114012$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-20291$ALKEM$$70$YR$$M$Y$$$20240906$$MD$GB$GB
242886111$24288611$1$I$20231001$20240822$20240906$20240906$EXP$$CN-UCBSA-2024043039$UCB$$$$N$M$Y$1.87$KG$20240906$$CN$CN$CN
242886122$24288612$2$F$20240101$20240903$20240906$20240916$EXP$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000711$Day One Biopharmaceuticals$$61$YR$$M$Y$$$20240913$$CN$US$US
242886131$24288613$1$I$$20240831$20240906$20240906$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR109003$VIIV$$$$$$Y$$$20240906$$CN$US$US
242886151$24288615$1$I$20240701$20240903$20240906$20240906$PER$$US-TAKEDA-2024TUS088632$TAKEDA$$60$YR$$M$Y$$$20240906$$HP$US$US
242886161$24288616$1$I$$20240830$20240906$20240906$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001783$BLUEPRINT MEDICINES$$$$$F$Y$$$20240906$$CN$US$US
242886171$24288617$1$I$20240721$20240821$20240906$20240906$PER$$US-ASTELLAS-2024-AER-002265$ASTELLAS$$59$YR$A$F$Y$$$20240906$$HP$US$US
242886181$24288618$1$I$20240101$20240904$20240906$20240906$EXP$$US-ABBVIE-5898320$ABBVIE$$$$$F$Y$50$KG$20240906$$CN$US$US
242886191$24288619$1$I$$20240826$20240906$20240906$EXP$$CA-APOTEX-2024AP009793$APOTEX$$80$YR$$M$Y$$$20240906$$PH$CA$CA
242886201$24288620$1$I$20240702$20240827$20240906$20240906$EXP$$IE-AUROBINDO-AUR-APL-2024-043280$AUROBINDO$$88$YR$$F$Y$$$20240906$$PH$IE$IE
242886211$24288621$1$I$20240101$20240903$20240906$20240906$EXP$$GB-ABBVIE-5906949$ABBVIE$$35$YR$$F$Y$$$20240906$$CN$GB$GB
242886221$24288622$1$I$20240723$20240903$20240906$20240906$EXP$$US-ABBVIE-5906467$ABBVIE$$65$YR$$M$Y$$$20240906$$CN$US$US
242886231$24288623$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043511$AUROBINDO$$76$YR$$M$Y$$$20240906$$MD$CA$CA
242886241$24288624$1$I$20240824$20240904$20240906$20240906$EXP$$CN-ABBVIE-5906686$ABBVIE$$70$YR$$F$Y$55$KG$20240906$$MD$CN$CN
242886251$24288625$1$I$$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141344$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240906$$CN$US$US
242886261$24288626$1$I$$20240829$20240906$20240906$PER$$US-RDY-SPO/USA/24/0012776$DR REDDYS$$32$YR$A$F$Y$$$20240906$$MD$US$US
242886272$24288627$2$F$$20240905$20240906$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004813$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242886282$24288628$2$F$$20240904$20240906$20240918$PER$$US-Appco Pharma LLC-2161292$APPCO PHARMA$$$$$F$Y$$$20240918$$$US$US
242886292$24288629$2$F$$20240918$20240906$20240919$PER$$US-AMGEN-USASP2024177619$AMGEN$$$$$M$Y$$$20240919$$PH$US$US
242886301$24288630$1$I$20240101$20240828$20240906$20240906$EXP$$US-JNJFOC-20240880756$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$HP$US$US
242886311$24288631$1$I$20240801$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176607$AMGEN$$65$YR$E$F$Y$$$20240905$$CN$US$US
242886321$24288632$1$I$20240814$20240827$20240906$20240906$EXP$CN-HENLIUS-24CN016641$CN-Accord-444731$ACCORD$$59$YR$A$F$Y$54$KG$20240906$$MD$CN$CN
242886331$24288633$1$I$$20240904$20240906$20240906$EXP$$US-ABBVIE-5908749$ABBVIE$$$$$$Y$$$20240906$$HP$US$US
242886341$24288634$1$I$20160101$20240903$20240906$20240906$EXP$$US-BAXALTA-2016BLT005975$TAKEDA$$$$$F$Y$$$20240906$$CN$US$US
242886351$24288635$1$I$20240903$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002846$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240906$$CN$US$US
242886361$24288636$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002767$ELI LILLY AND CO$$$$$F$Y$$$20240906$$PH$US$US
242886371$24288637$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002493$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240906$$CN$US$US
242886381$24288638$1$I$20240805$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002622$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240906$$CN$US$US
242886391$24288639$1$I$20240904$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002670$ELI LILLY AND CO$$64$YR$E$F$Y$$$20240906$$CN$US$US
242886401$24288640$1$I$$20240904$20240906$20240906$EXP$DE-BAXTER-2021BAX004880$DE-SANDOZ INC.-SDZ2024DE077744$SANDOZ$$19$YR$$M$Y$$$20240906$$HP$DE$DE
242886412$24288641$2$F$$20240830$20240906$20240911$PER$$US-ORGANON-O2409USA000247$ORGANON$$$$$F$Y$$$20240911$$CN$US$US
242886423$24288642$3$F$$20240911$20240906$20240924$30DAY$$GB-JNJFOC-20240869426$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240924$$HP$GB$GB
242886431$24288643$1$I$20240101$20240904$20240906$20240906$PER$$US-JNJFOC-20240907912$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242886441$24288644$1$I$$20240829$20240906$20240906$PER$$US-SA-2024SA254853$SANOFI AVENTIS$$$$$$Y$$$20240906$$HP$US$US
242886451$24288645$1$I$20220101$20240826$20240906$20240906$PER$$US-SA-2024SA254336$SANOFI AVENTIS$$$$$$Y$$$20240906$$HP$US$US
242886471$24288647$1$I$$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408271052594920-GHCNB$GB-Accord-443793$ACCORD$$25$YR$A$M$Y$$$20240906$$MD$GB$GB
242886481$24288648$1$I$20240826$20240827$20240906$20240906$EXP$$JP-ROCHE-10000069965$ROCHE$$5$DEC$A$F$Y$$$20240906$$MD$JP$JP
242886491$24288649$1$I$$20240830$20240906$20240906$EXP$$ES-GSK-ES2024GSK109275$GLAXOSMITHKLINE$Gutierrez MV, Martin CH. Toxic epidermal necrolysis due to lamotrigine. European Journal of Case Reports in Internal Medicine. 2024;11(S1):911$$$$$Y$$$20240906$$HP$ES$ES
242886502$24288650$2$F$$20240904$20240906$20240912$EXP$PL-SYNOPTIS-048b/048d-L-012$PL-GSK-PL2024104917$GLAXOSMITHKLINE$Woron J, Siwek M. Sore throat as an adverse consequence of drug interactions used in the treatment of a patient with depression and obesity. Medycyna Praktyczna-Psychiatry. 2024;04:37-39$$$$$Y$$$20240912$$MD$PL$PL
242886521$24288652$1$I$$20240827$20240906$20240906$EXP$$CA-SANDOZ INC.-SDZ2024CA077355$SANDOZ$$43$YR$$F$Y$96$KG$20240906$$HP$CA$CA
242886531$24288653$1$I$$20240904$20240906$20240906$PER$$US-TAKEDA-2024TUS088870$TAKEDA$$$$$$Y$$$20240906$$CN$US$US
242886542$24288654$2$F$$20240911$20240906$20240914$PER$$US-ABBVIE-5906817$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
242886551$24288655$1$I$20240226$20240829$20240906$20240906$EXP$GR-GREOF-202400219$GR-CELLTRION INC.-2024GR020939$CELLTRION$$$$$$Y$$$20240906$$MD$GR$GR
242886561$24288656$1$I$$20240903$20240906$20240906$PER$$US-ABBVIE-5907011$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242886591$24288659$1$I$$20240829$20240906$20240906$EXP$$JP-009507513-2408JPN010751$MERCK$Okamoto K, Hijioka S, Nagashio Y, Okada M, Ohba A, Maruki Y, et al. Immune-related adverse event-associated sclerosing cholangitis due to immune checkpoint inhibitors: imaging findings and treatments. Japanese Journal of Clinical Oncology. 2024;54 (8):887-94$67$YR$$F$Y$$$20240906$$HP$JP$JP
242886601$24288660$1$I$20240701$20240831$20240906$20240906$EXP$$IN-ROCHE-10000072023$ROCHE$$72$YR$E$M$Y$$$20240906$$CN$IN$IN
242886611$24288661$1$I$20240816$20240903$20240906$20240906$PER$$US-BIOVITRUM-2024-US-011706$BIOVITRUM$$29$YR$$M$Y$$$20240906$$CN$US$US
242886621$24288662$1$I$$20240823$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08548$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242886631$24288663$1$I$$20240903$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140489$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240906$$PH$US$US
242886651$24288665$1$I$$20240903$20240906$20240906$PER$$US-BIOVITRUM-2024-US-011695$BIOVITRUM$$78$YR$$F$Y$$$20240906$$CN$US$US
242886661$24288666$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177429$AMGEN$$$$$F$Y$$$20240905$$CN$US$US
242886681$24288668$1$I$$20240827$20240906$20240906$EXP$NL-LRB-00996240$NL-Accord-443940$ACCORD$$65$YR$E$M$Y$86$KG$20240906$$CN$NL$NL
242886691$24288669$1$I$$20240904$20240906$20240906$PER$$US-HALEON-2195431$Haleon PLC$$$$$$Y$$$20240906$$CN$US$US
242886701$24288670$1$I$$20240904$20240906$20240906$PER$$US-ABBVIE-5906599$ABBVIE$$25$YR$$$Y$$$20240906$$CN$US$US
242886711$24288671$1$I$$20240820$20240906$20240906$PER$$US-ASTELLAS-2024-AER-002152$ASTELLAS$$$$$F$Y$$$20240906$$MD$US$US
242886721$24288672$1$I$20080101$20240904$20240906$20240906$EXP$$DE-SANDOZ INC.-PHHY2012DE085061$SANDOZ$$80$YR$$M$Y$$$20240906$$MD$DE$DE
242886731$24288673$1$I$$20240904$20240906$20240906$PER$$US-HALEON-2195279$Haleon PLC$$63$YR$$M$Y$$$20240906$$CN$US$US
242886741$24288674$1$I$$20240904$20240906$20240906$PER$$US-HALEON-2195297$Haleon PLC$$58$YR$$F$Y$$$20240906$$CN$US$US
242886751$24288675$1$I$$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140401$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240906$$HP$US$US
242886761$24288676$1$I$$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140959$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240906$$HP$US$US
242886771$24288677$1$I$$20240829$20240906$20240906$PER$$US-RDY-SPO/USA/24/0012773$DR REDDYS$$53$YR$A$F$Y$$$20240906$$CN$US$US
242886782$24288678$2$F$20240817$20240818$20240906$20240917$30DAY$$US-JNJFOC-20240846485$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240917$$CN$US$US
242886791$24288679$1$I$$20240904$20240906$20240906$EXP$$DE-SANDOZ INC.-SDZ2024DE077597$SANDOZ$$71$YR$$M$Y$120$KG$20240906$$CN$DE$DE
242886802$24288680$2$F$$20240910$20240906$20240920$EXP$$GR-TEVA-VS-3239418$TEVA$Chatzis G, Vlachopoulou M, Menemtsiadou G, Koliafas C, Ragazos N, Sarantakou M et al. Metabolic acidosis in dyslipidemia with acute renal failure in pioglitazone/metformin treatment a case report. Atherosclerosis. 2024 Aug 01;395(Supplement 1); Chatzis G, Vlachopoulou. Metabolic acidosis in dyslipidemia with acute renal failure in pioglitazone/metformin treatment a case report. Atherosclerosis. 395$50$YR$$F$Y$$$20240920$$HP$GR$GR
242886821$24288682$1$I$$20240829$20240906$20240906$EXP$$US-INTERCEPT-PM2024001724$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242886831$24288683$1$I$20240819$20240903$20240906$20240906$EXP$$ES-GSK-ES2024EME104634$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$ES$ES
242886841$24288684$1$I$$20240903$20240906$20240906$EXP$FR-AFSSAPS-LL2024001563$FR-SANDOZ INC.-SDZ2024FR077262$SANDOZ$$78$YR$$M$Y$69$KG$20240906$$PH$FR$FR
242886851$24288685$1$I$$20240816$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130546$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$96.6$KG$20240906$$HP$US$US
242886861$24288686$1$I$$20240829$20240906$20240906$EXP$$PL-Bion-013768$BIONPHARMA$$$$N$F$Y$$$20240906$$HP$PL$PL
242886871$24288687$1$I$$20240829$20240906$20240906$EXP$$US-INTERCEPT-PM2024001733$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242886881$24288688$1$I$$20240904$20240906$20240906$EXP$$JP-TAKEDA-2024TJP013139$TAKEDA$$3$DEC$$F$Y$$$20240906$$MD$JP$JP
242886891$24288689$1$I$20240101$20240829$20240906$20240906$PER$$US-009507513-2408USA010390$MERCK$$$$$F$Y$$$20240906$$CN$US$US
242886901$24288690$1$I$$20240829$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027352$UNITED THERAPEUTICS$$$$$F$Y$$$20240906$$$US$US
242886912$24288691$2$F$$20240619$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007591$STRIDES$Yousaf Z, Jyothi Ramachandran Nair D, Kamel A.. Nystatin Induced Laryngeal Edema - First Reported Case.. Am-J-Respir-Crit-Care-Med. 2024;209$64$YR$$F$Y$$$20240906$$HP$US$US
242886921$24288692$1$I$20240101$20240902$20240906$20240906$EXP$$US-ABBVIE-5906797$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242886931$24288693$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004649$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242886941$24288694$1$I$$20240826$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136826$BRISTOL MYERS SQUIBB$Peshin S, Modi SK, Burwick N. Lenalidomide and dexamethasone in scleromyxedema: a case report of long-term efficacy and challenges in a 54-year-old patient. Cureus. 2024 Jun 26;16(6):1-4. doi:10.7759/cureus.63181.$54$YR$A$M$Y$$$20240906$$MD$US$US
242886952$24288695$2$F$$20240905$20240906$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA078060$SANDOZ$$75$YR$$M$Y$$$20240912$$MD$CA$CA
242886961$24288696$1$I$$20240830$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139498$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$110.22$KG$20240906$$CN$US$US
242886972$24288697$2$F$20240828$20240907$20240906$20240917$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004651$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240917$$CN$US$US
242886981$24288698$1$I$$20240903$20240906$20240906$PER$$US-BIOGEN-2024BI01281072$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242886991$24288699$1$I$20040101$20240903$20240906$20240906$EXP$$US-ABBVIE-5905718$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242887001$24288700$1$I$20240101$20240831$20240906$20240906$EXP$$CN-ABBVIE-5904113$ABBVIE$$$$$F$Y$72$KG$20240906$$MD$CN$CN
242887012$24288701$2$F$20240101$20240919$20240906$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-022217$UNITED THERAPEUTICS$$$$$M$Y$92.154$KG$20240921$$$US$US
242887022$24288702$2$F$$20240903$20240906$20240912$EXP$$NL-AUROBINDO-AUR-APL-2024-043670$AUROBINDO$$$$E$M$Y$70$KG$20240912$$MD$NL$NL
242887031$24288703$1$I$$20240905$20240906$20240906$PER$$NVSC2024US178935$NOVARTIS$$$$$M$Y$$$20240906$$HP$US$US
242887041$24288704$1$I$$20240829$20240906$20240906$EXP$$US-ROCHE-10000069968$ROCHE$Kalangi H, Boadla L, Perlman D, Yancovitz S, George V, Salomon N. A true challenge: Disseminated tuberculosis with tuberculous meningitis in a patient with underlying chronic liver disease. IDCases. 2024-Jan;37:1-5. doi:10.1016/j.idcr.2024.e02065.$67$YR$E$F$Y$$$20240906$$HP$US$US
242887051$24288705$1$I$$20240830$20240906$20240906$EXP$$US-EMD Serono-2024045986$EMD SERONO INC$$$$A$M$Y$102$KG$20240906$$CN$US$US
242887062$24288706$2$F$20240701$20240920$20240906$20240923$EXP$$TR-ABBVIE-5906842$ABBVIE$$81$YR$$M$Y$$$20240923$$CN$TR$TR
242887073$24288707$3$F$20240731$20240918$20240906$20240923$EXP$$US-ABBVIE-5906752$ABBVIE$$72$YR$$F$Y$90$KG$20240923$$CN$US$US
242887083$24288708$3$F$20240801$20240905$20240906$20240909$EXP$$US-ABBVIE-5906463$ABBVIE$$82$YR$$F$Y$$$20240909$$CN$US$US
242887091$24288709$1$I$20240806$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004652$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240906$$CN$US$US
242887101$24288710$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5857883$ABBVIE$$$$$F$Y$111$KG$20240906$$CN$US$US
242887111$24288711$1$I$$20240903$20240906$20240906$EXP$$CA-JNJFOC-20240907925$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240906$$HP$CA$CA
242887121$24288712$1$I$20240801$20240829$20240906$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026361$UNITED THERAPEUTICS$$37$YR$$F$Y$57.596$KG$20240906$$$US$US
242887131$24288713$1$I$20240724$20240904$20240906$20240906$EXP$$JP-TAKEDA-2024TJP011263$TAKEDA$$16$YR$$M$Y$$$20240906$$MD$JP$JP
242887141$24288714$1$I$20221101$20230123$20240906$20240906$EXP$DE-BFARM-23000446$DE-Accord-419426$ACCORD$$1$DY$N$M$Y$3.55$KG$20240906$$MD$DE$DE
242887151$24288715$1$I$$20240828$20240906$20240906$EXP$$US-ORPHANEU-2024006638$RECORDATI$Lin Y, Khurana A, Rosenthal AC, Mohty R, Gaddam M, Bansal R et al.. Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management. Blood Cancer Journal. 2024;14:136:1-6$$$$$Y$$$20240906$$HP$US$US
242887161$24288716$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141288$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240906$$CN$US$US
242887171$24288717$1$I$20240812$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004655$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240906$$CN$US$US
242887181$24288718$1$I$$20240903$20240906$20240906$EXP$$CA-JNJFOC-20240907953$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$HP$CA$CA
242887191$24288719$1$I$$20240826$20240906$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-042739$AUROBINDO$Lonsdale Henry, Sawant Rupali, Kinshuck Andrew, Fleming Jason. Airway consequences of alendronic acid aspiration. BMJ Case Rep. 2024$8$DEC$$$Y$$$20240906$$HP$GB$GB
242887201$24288720$1$I$$20240902$20240906$20240906$EXP$$GR-ABBVIE-5908544$ABBVIE$$$$$F$Y$$$20240906$$MD$GR$GR
242887222$24288722$2$F$$20240811$20240906$20240910$PER$$NVSC2024US178899$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
242887232$24288723$2$F$$20240919$20240906$20240928$EXP$$US-AUROBINDO-AUR-APL-2024-042768$AUROBINDO$Cheung D, Ebach D, Davis B.. Pediatric eosinophilic gastritis treated with benralizumab: A case report. JPGN reports. 2024;5(3):394-7$8$YR$$M$Y$27.5$KG$20240928$$MD$US$US
242887241$24288724$1$I$20240610$20240902$20240906$20240906$EXP$$IT-AstraZeneca-2024A199429$ASTRAZENECA$$73$YR$$M$Y$69$KG$20240906$$MD$IT$
242887251$24288725$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002620$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240906$$CN$US$US
242887261$24288726$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004656$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242887271$24288727$1$I$20240827$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408270736420740-DNTKJ$GB-Accord-443801$ACCORD$$45$YR$A$M$Y$78$KG$20240906$$CN$GB$GB
242887281$24288728$1$I$20240826$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176153$AMGEN$$40$YR$A$F$Y$$$20240905$$CN$US$US
242887291$24288729$1$I$20240822$20240826$20240906$20240906$PER$$US-ABBVIE-5897989$ABBVIE$$66$YR$$F$Y$$$20240906$$CN$US$US
242887301$24288730$1$I$20240801$20240902$20240906$20240906$EXP$$NVSC2024AE173899$NOVARTIS$$36$YR$$F$Y$$$20240906$$CN$AE$AE
242887311$24288731$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009908$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242887321$24288732$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004585$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242887332$24288733$2$F$20240808$20240905$20240906$20240910$EXP$FR-AFSSAPS-TS2024000948$FR-PFIZER INC-202400248862$PFIZER$$46$YR$$F$Y$58$KG$20240910$$MD$FR$FR
242887341$24288734$1$I$$20240830$20240906$20240906$EXP$$JP-PFIZER INC-202400249624$PFIZER$$56$YR$$M$Y$$$20240906$$MD$JP$JP
242887351$24288735$1$I$20240701$20240903$20240906$20240906$EXP$FR-AFSSAPS-TS2024000951$FR-PFIZER INC-202400248843$PFIZER$$47$YR$$M$Y$83$KG$20240906$$MD$FR$FR
242887361$24288736$1$I$$20240903$20240906$20240906$EXP$$CA-PFIZER INC-202400249283$PFIZER$$70$YR$$F$Y$$$20240906$$HP$CA$CA
242887371$24288737$1$I$$20240903$20240906$20240906$EXP$$CA-PFIZER INC-202400249279$PFIZER$$73$YR$$F$Y$$$20240906$$MD$CA$CA
242887391$24288739$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009909$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242887411$24288741$1$I$$20240827$20240906$20240906$EXP$$JP-HBP-2024JP031139$HELSINN HEALTHCARE$Hayato Yokota, Yumiko Akamine, Mizuki Kobayashi, Takuro Kitabayashi, Misato Horie, Tentaro Endo, Takechiyo Yamada and Masafumi Kikuchi. Naldemedine-induced perforation of a diverticulum in the sigmoid colon of a patient with opioid-related constipation: a case report. Journal of Pharmaceutical Health Care and Sciences. 2024;10:50$65$YR$$M$Y$$$20240906$$HP$JP$JP
242887422$24288742$2$F$$20240905$20240906$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004717$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
242887431$24288743$1$I$20240813$20240902$20240906$20240906$EXP$$DE-JNJFOC-20240910330$JOHNSON AND JOHNSON$$71$YR$E$M$Y$65$KG$20240906$$CN$DE$DE
242887441$24288744$1$I$$20240901$20240906$20240906$EXP$$BR-TAKEDA-2024TUS088295$TAKEDA$$25$YR$$$Y$$$20240906$$CN$BR$BR
242887451$24288745$1$I$20240708$20240827$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043205$AUROBINDO$$71$YR$$M$Y$85$KG$20240906$$MD$FR$FR
242887462$24288746$2$F$20240101$20240909$20240906$20240911$PER$$US-AMGEN-USASP2024177107$AMGEN$$77$YR$E$M$Y$$$20240911$$PH$US$US
242887471$24288747$1$I$20240903$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177180$AMGEN$$$$$$Y$$$20240905$$HP$US$US
242887481$24288748$1$I$$20240821$20240906$20240906$EXP$$CA-TEVA-VS-3235876$TEVA$$44$YR$$F$Y$97$KG$20240902$$HP$CA$CA
242887491$24288749$1$I$$20240814$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08272$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242887501$24288750$1$I$$20240905$20240906$20240906$EXP$$CA-SANDOZ INC.-SDZ2024CA078085$SANDOZ$$$$$F$Y$$$20240906$$MD$CA$CA
242887511$24288751$1$I$20240824$20240904$20240906$20240906$EXP$$CN-ROCHE-10000074443$ROCHE$$73$YR$E$F$Y$67$KG$20240906$$HP$CN$CN
242887521$24288752$1$I$20240827$20240827$20240906$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-042967$AUROBINDO$$45$YR$$M$Y$78$KG$20240906$$CN$GB$GB
242887531$24288753$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010068$APOTEX$$67$YR$$F$Y$$$20240906$$HP$CA$CA
242887541$24288754$1$I$$20240826$20240906$20240906$EXP$$HR-Accord-443584$ACCORD$Bosnic Kovacic I, Matosevic M, Laganovic M, Dika Z, Fistrek Prlic M, Ivandic E, et al. Specific antigen-based stratification of membranous nephropathy in patients after haematopoietic stem cell allotransplantation-a case series and literature review. BMC Nephrology. 2024;25(1):254$41$YR$A$F$Y$$$20240906$$MD$HR$HR
242887551$24288755$1$I$$20240321$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003639$STRIDES$Hsueh J, Zhao W.. ADDITION OF VITAMIN C YIELDING IMPROVEMENT IN REFRACTORY CHRONIC SPONTANEOUS URTICARIA. Ann-Allergy-Asthma-Immunol. 2023;131 (Suppl.)(5):S129 abstr. M133.$64$YR$$M$Y$$$20240906$$HP$US$US
242887561$24288756$1$I$$20231011$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015808$STRIDES$Asghar A, Khan S, Anis KH, Garcia CG.. When the cure becomes the disease: A case of terbinafine use causing delayed-onset anaphylactic shock.. Chest. 2023;164 (Suppl.)(4):A117$52$YR$$F$Y$$$20240906$$HP$US$US
242887571$24288757$1$I$$20240110$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000600$STRIDES$Ankireddypalli AR, Sibley SD.. Acute Iridocyclitis Associated With Intravenous Zoledronic Acid.. J-Endocr-Soc. 2023;7 (Suppl. 1):A220 abstr. THU443.$71$YR$$F$Y$$$20240906$$MD$US$US
242887581$24288758$1$I$$20240227$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002520$STRIDES$Ocana JA, Bell MC, Heskett JB, Baker WH, Mousdicas N, Turner MJ. Treatment of estrogen-induced dermatitis with omalizumab.. JAAD-Case-Rep. 2019;5(6):481-483.$37$YR$$F$Y$$$20240906$$MD$US$US
242887591$24288759$1$I$20240811$20240903$20240906$20240906$EXP$$PK-ROCHE-3575898$ROCHE$$67$YR$E$M$Y$$$20240906$$CN$PK$PK
242887601$24288760$1$I$$20230920$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2023SP014895$STRIDES$Proshek C, Filkins P, Geller R. A 21-year review of pediatric cetirizine exposures as reported to a single regional poison center.. ClinToxicol-(Phila). 2023;61 (Suppl. 2):11 abstr. 21$$$$$Y$$$20240906$$HP$US$US
242887611$24288761$1$I$$20240226$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002594$STRIDES$Cannon L, Van Mater D, Van Mater H, Becker M.. Eye Swelling and Weight Loss in an 18-year-old Adolescent.. Pediatr-Rev. 2022;43 (6):350-352$18$YR$$M$Y$$$20240906$$MD$US$US
242887621$24288762$1$I$$20240228$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002534$STRIDES$Anjum S, Ciaccio C.. Transitioning from Peanut Allergen Powder-dnfp to Peanuts.. J-Allergy-Clin-Immunol. 2024;153 (Suppl.)(2):AB120 abstr. 369$$$$$Y$$$20240906$$HP$US$US
242887631$24288763$1$I$20230101$20240902$20240906$20240906$PER$$US-ABBVIE-5905124$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242887641$24288764$1$I$$20240319$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2024SP003460$STRIDES$Nicholson K, Jia L, Rowe M, Esselen K, Joseph N, Zera CA, et al.. Oxaliplatin desensitization for ovarian cancer in pregnancy: A case report.. Gynecol-Oncol-Rep. 2024;52 (0)$30$YR$$F$Y$$$20240906$$HP$US$US
242887651$24288765$1$I$20240801$20240828$20240906$20240906$PER$$US-AstraZeneca-2024A196428$ASTRAZENECA$$22365$DY$$F$Y$78$KG$20240906$$CN$US$
242887661$24288766$1$I$$20240830$20240906$20240906$EXP$$BR-AstraZeneca-2024A200408$ASTRAZENECA$$$$$M$Y$$$20240906$$MD$BR$
242887671$24288767$1$I$$20240827$20240906$20240906$PER$$US-AstraZeneca-2024A195480$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242887681$24288768$1$I$$20240828$20240906$20240906$PER$$US-ROCHE-10000068985$ROCHE$$$$E$F$Y$$$20240906$$MD$US$US
242887691$24288769$1$I$$20240904$20240906$20240906$EXP$$US-ABBVIE-5908777$ABBVIE$$$$$$Y$$$20240906$$HP$US$US
242887701$24288770$1$I$$20240829$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141261$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240906$$HP$US$US
242887711$24288771$1$I$20240801$20240830$20240906$20240906$EXP$$GB-BIOGEN-2024BI01281061$BIOGEN$$74$YR$$M$Y$$$20240906$$PH$GB$GB
242887721$24288772$1$I$$20240828$20240906$20240906$EXP$$US-ORPHANEU-2024006643$RECORDATI$Lin Y, Khurana A, Rosenthal AC, Mohty R, Gaddam M, Bansal R et al.. Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management. Blood Cancer Journal. 2024;14:136:1-6$$$$$Y$$$20240906$$HP$US$US
242887731$24288773$1$I$$20240830$20240906$20240906$EXP$$US-BIOGEN-2024BI01280950$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242887741$24288774$1$I$$20240815$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08264$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242887761$24288776$1$I$$20240826$20240906$20240906$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP010726$STRIDES$Wildermann T, Becker F, Jesse S, Baier H, Wagner J. Successful use of Fenfluramine in super-refractory status epilepticus in a patient with tuberous sclerosis complex and Lennox-Gastaut syndrome.. Epilepsy and Behavior Reports. 2024;27:1-5$24$YR$$F$Y$$$20240906$$HP$DE$DE
242887771$24288777$1$I$$20240902$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002715$ELI LILLY AND CO$$$$$F$Y$$$20240906$$CN$US$US
242887781$24288778$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002651$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240906$$CN$US$US
242887791$24288779$1$I$20240804$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003310$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240906$$CN$US$US
242887811$24288781$1$I$$20240829$20240906$20240906$EXP$$JP-ROCHE-10000072202$ROCHE$$75$YR$E$F$Y$$$20240906$$PH$JP$JP
242887821$24288782$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141499$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240906$$HP$US$US
242887831$24288783$1$I$$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141596$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240906$$CN$US$US
242887841$24288784$1$I$$20240903$20240906$20240906$EXP$$US-BIOGEN-2024BI01280963$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242887851$24288785$1$I$$20240904$20240906$20240906$EXP$$NVSC2024US178709$NOVARTIS$$$$$$Y$$$20240906$$HP$US$US
242887862$24288786$2$F$20240809$20240906$20240906$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004586$ACADIA PHARMACEUTICALS$$53$YR$$F$Y$$$20240927$$CN$US$US
242887871$24288787$1$I$$20240830$20240906$20240906$PER$$US-BIOGEN-2024BI01280859$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242887881$24288788$1$I$20180101$20240823$20240906$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093614$GLENMARK$Chowdhury RB, Shah SI, Milford E, Tullius SG, Rennke H, Bianchi G.. Extramedullary plasmacytoma exclusively localized in transplanted kidney: Post-transplant lymphoproliferative disorder or monoclonal gammopathy of renal significance?. Journal of Onco-Nephrology.. 2024;8 (2):70-4$$$$$Y$$$20240906$$MD$US$US
242887891$24288789$1$I$$20240904$20240906$20240906$PER$$US-HALEON-2195079$Haleon PLC$$$$$M$Y$$$20240906$$HP$US$US
242887901$24288790$1$I$20240801$20240903$20240906$20240906$EXP$$US-ABBVIE-5906246$ABBVIE$$40$YR$$M$Y$$$20240906$$CN$US$US
242887911$24288791$1$I$$20240830$20240906$20240906$EXP$$JP-GSK-JP2024109023$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$JP$JP
242887921$24288792$1$I$$20240827$20240906$20240906$30DAY$$US-GSK-US2024106710$GLAXOSMITHKLINE$$$$$M$Y$$$20240906$$CN$US$US
242887931$24288793$1$I$20240101$20240807$20240906$20240906$PER$$US-CIPLA LTD.-2024US08089$CIPLA$$$$$$Y$$$20240906$$HP$US$US
242887941$24288794$1$I$$20240823$20240906$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093634$GLENMARK$Li B, Chawla S, Tong M, Higgins A, Lee R. Temporary Biventricular Mechanical Circulatory Support for Primary Graft Dysfunction after Orthotopic Heart Transplantation. US Cardiology Review. 2024;18(Suppl 1):75$$$$$Y$$$20240906$$MD$US$US
242887951$24288795$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043231$AUROBINDO$$88$YR$$F$Y$$$20240906$$HP$CA$CA
242887963$24288796$3$F$20240620$20240919$20240906$20240927$EXP$$DE-EMD Serono-2024046673$EMD SERONO INC$$39$YR$A$F$Y$$$20240927$$MD$DE$DE
242887972$24288797$2$F$$20240903$20240906$20240909$EXP$$US-ABBVIE-5906697$ABBVIE$$$$$M$Y$$$20240909$$MD$US$US
242887981$24288798$1$I$$20240827$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136327$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240906$$CN$US$US
242887991$24288799$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141539$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240906$$CN$US$US
242888001$24288800$1$I$20240801$20240816$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08452$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242888011$24288801$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004602$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242888023$24288802$3$F$$20240906$20240906$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004598$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242888031$24288803$1$I$20240528$20240902$20240906$20240906$EXP$$AU-JNJFOC-20240902154$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$MD$AU$AU
242888041$24288804$1$I$$20240830$20240906$20240906$EXP$$US-BIOGEN-2024BI01280882$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242888051$24288805$1$I$$20240904$20240906$20240906$PER$$US-ROCHE-10000074670$ROCHE$$48$YR$A$F$Y$$$20240906$$CN$US$US
242888061$24288806$1$I$$20240903$20240906$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014229$JAZZ$$$$$M$Y$$$20240906$$CN$US$US
242888071$24288807$1$I$20240903$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176096$AMGEN$$69$YR$E$M$Y$$$20240906$$CN$US$US
242888082$24288808$2$F$$20240909$20240906$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004657$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
242888091$24288809$1$I$$20240822$20240906$20240906$EXP$$BR-CHIESI-2024CHF05427$CHIESI$$$$N$$Y$$$20240906$$MD$BR$BR
242888101$24288810$1$I$$20240902$20240906$20240906$EXP$$AR-TAKEDA-2024TUS088623$TAKEDA$$$$$F$Y$$$20240906$$CN$AR$AR
242888112$24288811$2$F$$20240905$20240906$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004773$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
242888122$24288812$2$F$$20240910$20240906$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004709$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242888131$24288813$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004621$ACADIA PHARMACEUTICALS$$$$$F$Y$52$KG$20240906$$CN$US$US
242888142$24288814$2$F$20240817$20240911$20240906$20240918$30DAY$$US-AMGEN-USASP2024174022$AMGEN$$$$A$M$Y$$$20240917$$PH$US$US
242888161$24288816$1$I$$20240816$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08464$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242888171$24288817$1$I$$20240824$20240906$20240906$PER$$US-JNJFOC-20240869598$JOHNSON AND JOHNSON$$58$YR$A$F$Y$49$KG$20240906$$CN$US$US
242888181$24288818$1$I$20240303$20240904$20240906$20240906$PER$$US-GILEAD-2024-0686272$GILEAD$$38$YR$A$M$Y$$$20240906$$HP$US$US
242888192$24288819$2$F$$20240912$20240906$20240917$EXP$$JP-TAKEDA-2024TJP013190$TAKEDA$$$$$F$Y$$$20240917$$MD$JP$JP
242888201$24288820$1$I$20191101$20240829$20240906$20240906$EXP$$CO-SANDOZ INC.-PHHY2018CO199442$SANDOZ$$50$YR$$F$Y$73$KG$20240906$$CN$CO$CO
242888211$24288821$1$I$$20240825$20240906$20240906$EXP$$AT-RDY-SPO/AUT/24/0012728$DR REDDYS$Bajons D, Frohlich R, Waltraud G, Miroslav K, Helmut R, Regina K. Lyme neuroborreliosis: Progressive cerebral vasculitis responsive to cyclophosphamide.  A case report and review of the literature.. Journal of Stroke and Cerebrovascular Diseases. 2023 Aug 01;32(8): doi:10.1016/j.jstrokecerebrovasdis.2023.107220.$71$YR$E$F$Y$$$20240906$$HP$AT$AT
242888231$24288823$1$I$$20240813$20240906$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003048$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242888241$24288824$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004712$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242888262$24288826$2$F$20240801$20240912$20240906$20240913$PER$$US-AMGEN-USASP2024176569$AMGEN$$63$YR$A$F$Y$$$20240913$$CN$US$US
242888271$24288827$1$I$20240301$20240906$20240906$20240906$EXP$FR-AFSSAPS-AM2024000694$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049911$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$64$KG$20240906$$MD$FR$FR
242888281$24288828$1$I$20240829$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176103$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242888291$24288829$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004733$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242888301$24288830$1$I$$20240829$20240906$20240906$EXP$$CA-ABBVIE-5904126$ABBVIE$$82$YR$$F$Y$$$20240906$$CN$CA$CA
242888311$24288831$1$I$$20240826$20240906$20240906$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK077542$GLENMARK$$$$$$Y$$$20240906$$HP$CA$CA
242888321$24288832$1$I$$20240904$20240906$20240906$EXP$$CN-TAKEDA-2024TUS088835$TAKEDA$$$$$F$Y$$$20240906$$CN$CN$CN
242888331$24288833$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001558$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240906$$CN$US$US
242888341$24288834$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002686$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240906$$CN$US$US
242888351$24288835$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002465$ELI LILLY AND CO$$$$$F$Y$$$20240906$$CN$US$US
242888361$24288836$1$I$$20240830$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409000553$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240906$$CN$US$US
242888371$24288837$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002554$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240906$$CN$US$US
242888381$24288838$1$I$20240901$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001807$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240906$$CN$US$US
242888391$24288839$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001560$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240906$$CN$US$US
242888401$24288840$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002976$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240906$$CN$US$US
242888411$24288841$1$I$20240904$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002866$ELI LILLY AND CO$$$$$$Y$$$20240906$$CN$US$US
242888421$24288842$1$I$20240904$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002882$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240906$$CN$US$US
242888432$24288843$2$F$$20240904$20240906$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409002974$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240911$$CN$US$US
242888442$24288844$2$F$20240831$20240905$20240906$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409002621$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240910$$CN$US$US
242888451$24288845$1$I$$20240830$20240906$20240906$EXP$$CA-TAKEDA-2024TUS088310$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
242888461$24288846$1$I$$20240826$20240906$20240906$EXP$$US-AUROBINDO-AUR-APL-2024-043182$AUROBINDO$Kim EB, Malespini J, Lei M, Branagan AR, Cirstea D, Han SS, et al. Rapid reduction of free light chains and improvement in renal outcomes in patients with newly diagnosed multiple myeloma admitted with acute kidney injury with daratumumab-based therapy and without plasmapheresis. J-Clin-Oncol. 2024;42 (Suppl.):16$86$YR$$$Y$$$20240906$$HP$US$US
242888471$24288847$1$I$$20240904$20240906$20240906$PER$$US-HALEON-2195394$Haleon PLC$$$$$$Y$$$20240906$$CN$US$US
242888481$24288848$1$I$$20240817$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08484$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242888491$24288849$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177409$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242888501$24288850$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177553$AMGEN$$$$$$Y$$$20240906$$CN$US$US
242888513$24288851$3$F$20240830$20240911$20240906$20240913$PER$$US-AMGEN-USASP2024177222$AMGEN$$54$YR$A$F$Y$$$20240913$$CN$US$US
242888531$24288853$1$I$$20240904$20240906$20240906$EXP$$PL-ADIENNEP-2024AD000717$ADIENNE PHARMA + BIOTECH$Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoeman H, Ljungman P, Kobbe G et al. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. Am J Transplant. 2015;15:705-14. doi: 10.1111/ajt.13017$5$YR$$M$Y$$$20240905$$MD$PL$
242888541$24288854$1$I$$20240827$20240906$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-043352$AUROBINDO$$80$YR$$$Y$$$20240906$$HP$GB$GB
242888561$24288856$1$I$$20240830$20240906$20240906$EXP$$CA-TAKEDA-2024TUS088321$TAKEDA$$$$$M$Y$$$20240906$$CN$CA$CA
242888571$24288857$1$I$$20240827$20240906$20240906$PER$$US-APOTEX-2024AP010142$APOTEX$Miklus V, Trout L, Even K. Levetiracetam Dosing Based on Glasgow Coma Scale Scores in Pediatric Traumatic Brain Injury Patients. Neuropediatrics. 2024;55(4):224-231$$$C$$Y$$$20240906$$HP$US$US
242888581$24288858$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004660$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242888601$24288860$1$I$20240827$20240828$20240906$20240906$EXP$GB-MHRA-TPP28384267C8778718YC1724828894972$GB-Accord-443873$ACCORD$$56$YR$A$M$Y$123$KG$20240906$$HP$GB$GB
242888611$24288861$1$I$$20240826$20240906$20240906$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK083971$GLENMARK$$$$$$Y$$$20240906$$HP$CA$CA
242888621$24288862$1$I$$20240904$20240906$20240906$EXP$$CA-SANDOZ INC.-SDZ2024CA077770$SANDOZ$$64$YR$$M$Y$$$20240906$$HP$CA$CA
242888631$24288863$1$I$$20230919$20240906$20240906$PER$$US-APOTEX-2023AP014039$APOTEX$$$$$M$Y$$$20240906$$MD$US$US
242888641$24288864$1$I$$20240828$20240906$20240906$EXP$$SE-TAKEDA-2024TUS087963$TAKEDA$Boberg E, Kimiaei A, Karlstrom C, Ljungqvist M, Agren A, Bruzelius M. Latrogenic hemorrhage and extensive venous thromboembolism during iTTP treatment with caplacizumab-a case report. eJHaem. 2024;5(4):768-71$30$YR$$F$Y$$$20240906$$HP$SE$SE
242888651$24288865$1$I$$20240903$20240906$20240906$PER$$US-JNJFOC-20240907398$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$PH$US$US
242888661$24288866$1$I$$20240831$20240906$20240906$PER$$US-ALXN-202408USA002236US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242888671$24288867$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004662$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242888681$24288868$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004687$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242888693$24288869$3$F$20240903$20240906$20240906$20240912$PER$$US-AMGEN-USASP2024176598$AMGEN$$72$YR$E$F$Y$$$20240912$$CN$US$US
242888702$24288870$2$F$20240710$20240918$20240906$20240926$EXP$$AU-TAKEDA-2024TUS070477$TAKEDA$$30$YR$$M$Y$$$20240926$$CN$AU$AU
242888711$24288871$1$I$$20240827$20240906$20240906$PER$$US-ABBVIE-5899190$ABBVIE$$$$$$Y$$$20240906$$MD$US$US
242888721$24288872$1$I$$20240827$20240906$20240906$EXP$$US-GSK-US2024106589$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$MD$US$US
242888731$24288873$1$I$20240519$20240827$20240906$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-043398$AUROBINDO$$67$YR$$F$Y$86$KG$20240906$$MD$GB$GB
242888741$24288874$1$I$$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141503$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240906$$HP$US$US
242888751$24288875$1$I$$20240819$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08257$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242888761$24288876$1$I$$20240904$20240906$20240906$PER$$US-ROCHE-10000074991$ROCHE$$6$YR$C$M$Y$$$20240906$$HP$US$US
242888771$24288877$1$I$$20240821$20240906$20240906$PER$$US-ASTELLAS-2024-AER-002244$ASTELLAS$$65$YR$E$M$Y$$$20240906$$CN$US$US
242888781$24288878$1$I$20221215$20240827$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043269$AUROBINDO$$$DY$$F$Y$2.92$KG$20240906$$MD$FR$FR
242888792$24288879$2$F$20240101$20240910$20240906$20240918$EXP$$AU-JNJFOC-20240902919$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240918$$HP$AU$AU
242888801$24288880$1$I$20240819$20240831$20240906$20240906$EXP$$CN-JNJFOC-20240901888$JOHNSON AND JOHNSON$$65$YR$E$M$Y$67$KG$20240906$$HP$CN$CN
242888811$24288881$1$I$$20240828$20240906$20240906$EXP$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-01633$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$$$20240906$$CN$US$US
242888822$24288882$2$F$$20240911$20240906$20240916$EXP$$US-TAKEDA-2023TUS042593$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
242888831$24288883$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004702$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242888841$24288884$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004627$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$MD$US$US
242888851$24288885$1$I$20240821$20240826$20240906$20240906$EXP$$US-Accord-444139$ACCORD$$31$YR$A$M$Y$$$20240906$$PH$US$US
242888861$24288886$1$I$20240809$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177101$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242888871$24288887$1$I$$20240827$20240906$20240906$PER$$US-AMGEN-USASP2024176773$AMGEN$$$$$M$Y$$$20240906$$CN$US$US
242888881$24288888$1$I$20240717$20240827$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043163$AUROBINDO$$64$YR$$M$Y$140$KG$20240906$$PH$FR$FR
242888902$24288890$2$F$$20240911$20240906$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004781$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
242888911$24288891$1$I$$20240905$20240906$20240906$EXP$$US-JNJFOC-20240912831$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240906$$CN$US$US
242888921$24288892$1$I$$20240831$20240906$20240906$EXP$$JP-AstraZeneca-2024A199962$ASTRAZENECA$$$$$$Y$$$20240906$$MD$JP$
242888931$24288893$1$I$$20240829$20240906$20240906$EXP$$JP-009507513-2408JPN004100J$MERCK$$47$YR$$M$Y$$$20240906$$MD$JP$JP
242888941$24288894$1$I$20240101$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024175616$AMGEN$$85$YR$E$F$Y$$$20240906$$CN$US$US
242888951$24288895$1$I$20230101$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002742$ELI LILLY AND CO$$91$YR$E$M$Y$$$20240906$$CN$US$US
242888961$24288896$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003352$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240906$$CN$US$US
242888971$24288897$1$I$$20240830$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002495$ELI LILLY AND CO$$$$$F$Y$$$20240906$$CN$US$US
242888981$24288898$1$I$$20240826$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002113$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240906$$CN$US$US
242888991$24288899$1$I$$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003540$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240906$$CN$US$US
242889001$24288900$1$I$$20240829$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409000102$ELI LILLY AND CO$$$$$F$Y$$$20240906$$CN$US$US
242889011$24288901$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002583$ELI LILLY AND CO$$55$YR$A$$Y$$$20240906$$CN$US$US
242889021$24288902$1$I$$20240826$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202408016186$ELI LILLY AND CO$$33$YR$A$$Y$$$20240906$$LW$US$US
242889031$24288903$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002943$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240906$$CN$US$US
242889041$24288904$1$I$20240808$20240809$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002590$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240906$$CN$US$US
242889051$24288905$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002693$ELI LILLY AND CO$$54$YR$A$$Y$$$20240906$$CN$US$US
242889061$24288906$1$I$20240531$20240828$20240906$20240906$EXP$FR-AFSSAPS-LL2024001538$FR-Accord-444646$ACCORD$$57$YR$A$F$Y$$$20240906$$MD$FR$FR
242889071$24288907$1$I$$20240830$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139806$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240906$$HP$US$US
242889081$24288908$1$I$20240610$20240827$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043168$AUROBINDO$$43$YR$$M$Y$$$20240906$$PH$FR$FR
242889091$24288909$1$I$$20240903$20240906$20240906$EXP$$GB-CHATTEMPRD-2024OHG030696$CHATTEM$$42$YR$A$F$Y$75$KG$20240906$$MD$GB$GB
242889101$24288910$1$I$20240827$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141502$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$69.4$KG$20240906$$HP$US$US
242889113$24288911$3$F$20190201$20240911$20240906$20240918$EXP$$TW-009507513-2409TWN000120$MERCK$Chang C, Yang S, Liu H, Chang W, Lee W, Wang P.. Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer. Taiwanese Journal of Obstetrics and Gynecology. 2024;63:651-64$55$YR$$F$Y$$$20240918$$HP$TW$TW
242889121$24288912$1$I$$20240819$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08376$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242889131$24288913$1$I$20240811$20240828$20240906$20240906$EXP$GB-MHRA-MED-202408281912158010-YHDTP$GB-ASTELLAS-2024-AER-003213$ASTELLAS$$26$YR$A$$Y$65$KG$20240906$$CN$GB$GB
242889141$24288914$1$I$20220101$20240827$20240906$20240906$EXP$$NL-AUROBINDO-AUR-APL-2024-043387$AUROBINDO$$4$YR$$F$Y$$$20240906$$CN$NL$NL
242889151$24288915$1$I$$20240905$20240906$20240906$EXP$$CA-SANDOZ INC.-SDZ2024CA078074$SANDOZ$$53$YR$$M$Y$$$20240906$$CN$CA$CA
242889161$24288916$1$I$20230301$20240829$20240906$20240906$EXP$$CN-TAKEDA-2023TUS039837$TAKEDA$$36$YR$$F$Y$50$KG$20240906$$MD$CN$CN
242889171$24288917$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004666$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242889181$24288918$1$I$$20240828$20240906$20240906$EXP$$US-ORPHANEU-2024006646$RECORDATI$Lin Y, Khurana A, Rosenthal AC, Mohty R, Gaddam M, Bansal R et al.. Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management. Blood Cancer Journal. 2024;14:136:1-6$$$$$Y$$$20240906$$HP$US$US
242889191$24288919$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043412$AUROBINDO$$37$YR$$M$Y$$$20240906$$CN$CA$CA
242889203$24288920$3$F$$20240920$20240906$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-027193$UNITED THERAPEUTICS$$$$$F$Y$108.84$KG$20240927$$$US$US
242889211$24288921$1$I$20240717$20240827$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043262$AUROBINDO$$48$YR$$F$Y$$$20240906$$PH$FR$FR
242889221$24288922$1$I$20240830$20240903$20240906$20240906$EXP$$IN-ROCHE-10000073530$ROCHE$$68$YR$E$M$Y$$$20240906$$CN$IN$IN
242889231$24288923$1$I$20240821$20240830$20240906$20240906$PER$$US-BEH-2024178138$CSL BEHRING$$61$YR$A$F$Y$$$20240906$$PH$US$US
242889241$24288924$1$I$20240805$20240902$20240906$20240906$EXP$$CL-ROCHE-10000072941$ROCHE$$69$YR$E$F$Y$$$20240906$$CN$CL$CL
242889251$24288925$1$I$$20240828$20240906$20240906$EXP$$PL-ASTELLAS-2024-AER-004434$ASTELLAS$$68$YR$E$M$Y$$$20240906$$MD$PL$PL
242889261$24288926$1$I$$20240903$20240906$20240906$EXP$$CA-TAKEDA-2024TUS088790$TAKEDA$$$$$M$Y$$$20240906$$MD$CA$CA
242889271$24288927$1$I$$20240812$20240906$20240906$EXP$$GB-BEH-2024177170$CSL BEHRING$$31$YR$A$F$Y$$$20240906$$HP$GB$GB
242889281$24288928$1$I$$20240828$20240906$20240906$EXP$$US-EMD Serono-2024047442$EMD SERONO INC$$$$E$M$Y$$$20240906$$CN$US$US
242889293$24288929$3$F$$20240905$20240906$20240909$PER$$NVSC2024US179047$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
242889301$24288930$1$I$$20240823$20240906$20240906$EXP$$US-UCBSA-2024044261$UCB$$$$$F$Y$135.96$KG$20240906$$HP$US$US
242889311$24288931$1$I$20240704$20240827$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043202$AUROBINDO$$68$YR$$M$Y$108$KG$20240906$$MD$FR$FR
242889321$24288932$1$I$$20240904$20240906$20240906$EXP$$NVSC2024BO178734$NOVARTIS$$$$$M$Y$$$20240906$$CN$BO$BO
242889332$24288933$2$F$$20240909$20240906$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004670$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
242889341$24288934$1$I$$20240819$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08493$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242889371$24288937$1$I$20240824$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177387$AMGEN$$83$YR$E$F$Y$$$20240906$$CN$US$US
242889381$24288938$1$I$20180101$20240811$20240906$20240906$PER$$US-AMGEN-USASP2024164916$AMGEN$Fei F. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1)$$$$F$Y$$$20240906$$MD$US$US
242889391$24288939$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010076$APOTEX$$46$YR$$M$Y$$$20240906$$CN$CA$CA
242889401$24288940$1$I$$20240903$20240906$20240906$EXP$$CA-SANDOZ INC.-SDZ2024CA077857$SANDOZ$$$$$M$Y$$$20240906$$CN$CA$CA
242889411$24288941$1$I$$20240826$20240906$20240906$EXP$$PT-JNJFOC-20240872278$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240906$$HP$PT$PT
242889421$24288942$1$I$20240210$20240829$20240906$20240906$EXP$HR-HALMED-300084432$HR-CELLTRION INC.-2024HR020964$CELLTRION$$$$$$Y$$$20240906$$PH$HR$HR
242889431$24288943$1$I$$20240904$20240906$20240906$30DAY$$GB-SANDOZ INC.-NVSC2022GB173300$SANDOZ$$$$A$M$Y$$$20240906$$CN$GB$GB
242889441$24288944$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009879$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242889451$24288945$1$I$20240627$20240827$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043277$AUROBINDO$$14$YR$$F$Y$86$KG$20240906$$MD$FR$FR
242889461$24288946$1$I$$20240820$20240906$20240906$PER$$US-TEVA-VS-3236579$TEVA$$45$YR$$F$Y$$$20240906$$MD$US$US
242889471$24288947$1$I$20240826$20240829$20240906$20240906$EXP$$BR-AMGEN-BRASP2024174405$AMGEN$$$$$F$Y$$$20240906$$CN$BR$BR
242889481$24288948$1$I$20230101$20240905$20240906$20240906$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049865$BOEHRINGER INGELHEIM$$$$$$Y$$$20240906$$PH$JP$JP
242889491$24288949$1$I$$20240902$20240906$20240906$EXP$PL-EMA-20150321-AUTODUP-423818$PL-SANDOZ INC.-PHHY2014PL124846$SANDOZ$$56$YR$$M$Y$$$20240906$$MD$PL$PL
242889502$24288950$2$F$20240101$20240905$20240906$20240917$EXP$$US-INSMED-2024-01874-USAA$INSMED$$$$$F$Y$$$20240917$$CN$US$US
242889511$24288951$1$I$$20240903$20240906$20240906$PER$$US-TAKEDA-2024TUS088691$TAKEDA$$$$$M$Y$$$20240906$$CN$US$US
242889521$24288952$1$I$20240101$20240904$20240906$20240906$PER$$US-ABBVIE-5907736$ABBVIE$$38$YR$$F$Y$$$20240906$$CN$US$US
242889531$24288953$1$I$$20240830$20240906$20240906$EXP$$TR-ACI HealthCare Limited-2161295$ACI HEALTHCARE$Full text$$$$$Y$$$20240906$$$TR$TR
242889541$24288954$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2021-036281$AUROBINDO$$78$YR$$F$Y$64.41$KG$20240906$$PH$CA$CA
242889551$24288955$1$I$20240801$20240829$20240906$20240906$EXP$$US-TEVA-VS-3239032$TEVA$$22$YR$$F$Y$72.57$KG$20240906$$CN$US$US
242889561$24288956$1$I$$20240828$20240906$20240906$EXP$$BR-GENMAB-2024-03218$GENMAB$$92$YR$$F$Y$$$20240906$$MD$BR$BR
242889571$24288957$1$I$20240709$20240827$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043274$AUROBINDO$$3$YR$$M$Y$$$20240906$$MD$FR$FR
242889581$24288958$1$I$$20240902$20240906$20240906$EXP$$TR-ROCHE-10000071826$ROCHE$Fidan K, Neslihan? Sanl? N, Akyol G, Keklik M, Unal A. Chronic Lymphocytic Leukemia: Immune Dysregulation and Management: A Case Report (Abstract number: CLL-232). Clinical Lymphoma, Myeloma and Leukemia. 2024-Sep;24:S348. doi:10.1016/S2152-2650(24)01269-2.$84$YR$E$M$Y$$$20240906$$MD$TR$TR
242889591$24288959$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009880$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242889602$24288960$2$F$$20240905$20240906$20240910$EXP$$IN-SANDOZ INC.-SDZ2024IN078048$SANDOZ$$$$$M$Y$$$20240910$$CN$IN$IN
242889611$24288961$1$I$$20240905$20240906$20240906$EXP$DE-GERMAN-LIT/DEU/24/0012403$DE-SANDOZ INC.-SDZ2024DE077967$SANDOZ$$61$YR$$M$Y$$$20240906$$HP$DE$DE
242889621$24288962$1$I$20240817$20240830$20240906$20240906$EXP$$CN-BEIGENE-BGN-2024-013723$BEIGENE$$$$$$Y$$$20240906$$HP$CN$CN
242889631$24288963$1$I$$20240819$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08498$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242889641$24288964$1$I$20240205$20240827$20240906$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-043365$AUROBINDO$$19$YR$$F$Y$$$20240906$$CN$GB$GB
242889651$24288965$1$I$20240807$20240829$20240906$20240906$EXP$$JP-GENMAB-2024-03158$GENMAB$$5$DEC$$F$Y$47$KG$20240906$$PH$JP$JP
242889661$24288966$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002829$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240906$$CN$US$US
242889671$24288967$1$I$20240904$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002724$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240906$$CN$US$US
242889681$24288968$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002995$ELI LILLY AND CO$$41$YR$A$$Y$$$20240906$$CN$US$US
242889691$24288969$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002937$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240906$$CN$US$US
242889701$24288970$1$I$$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003496$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240906$$CN$US$US
242889711$24288971$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004686$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242889721$24288972$1$I$20240823$20240830$20240906$20240906$EXP$$CN-BEIGENE-BGN-2024-013732$BEIGENE$$$$$$Y$$$20240906$$HP$CN$CN
242889731$24288973$1$I$20240829$20240830$20240906$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027582$UNITED THERAPEUTICS$$63$YR$$M$Y$84.807$KG$20240906$$PH$US$US
242889741$24288974$1$I$$20240819$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08499$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242889752$24288975$2$F$$20240815$20240906$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-129904$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240918$$HP$US$US
242889761$24288976$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009881$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242889771$24288977$1$I$$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141071$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240906$$HP$US$US
242889781$24288978$1$I$20240812$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004654$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240906$$CN$US$US
242889791$24288979$1$I$20240301$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004688$ACADIA PHARMACEUTICALS$$91$YR$$F$Y$$$20240906$$CN$US$US
242889801$24288980$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010114$APOTEX$$75$YR$$F$Y$$$20240906$$CN$CA$CA
242889811$24288981$1$I$$20240510$20240906$20240906$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06860$HIKMA$Gorham JW, Ansari F, Sethi R.. Gorham JW, Ansari F, Sethi R. The Effectiveness of Buprenorphine Transdermal Patch and Low Dose Sublingual Buprenorphine Induction to Transition to Long-Acting Subcutaneous Buprenorphine Injection in Opioid Use Disorder in Inpatient Setting.. Kansas Journal Of Medicine.. 2024;17(1):20-1:20-21$21$YR$$M$Y$$$20240906$$MD$US$US
242889821$24288982$1$I$20240701$20240823$20240906$20240906$EXP$$US-UCBSA-2024043331$UCB$$28$YR$$F$Y$$$20240906$$HP$US$US
242889831$24288983$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004690$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242889841$24288984$1$I$20200616$20240903$20240906$20240906$EXP$PL-URPL-1-1820-2020$PL-ROCHE-10000072370$ROCHE$$72$YR$E$M$Y$75$KG$20240906$$HP$PL$PL
242889861$24288986$1$I$$20240830$20240906$20240906$EXP$$US-TAKEDA-2024TUS088048$TAKEDA$$$$$F$Y$$$20240906$$CN$US$US
242889881$24288988$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004692$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242889891$24288989$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009882$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242889901$24288990$1$I$20240824$20240903$20240906$20240906$EXP$$CN-ABBVIE-5908751$ABBVIE$$61$YR$$M$Y$$$20240906$$HP$CN$CN
242889911$24288991$1$I$$20240822$20240906$20240906$EXP$$GT-ASTELLAS-2024-AER-003552$ASTELLAS$$$$$M$Y$$$20240906$$MD$GT$GT
242889922$24288992$2$F$$20240904$20240906$20240912$EXP$$US-HALEON-2195338$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
242889931$24288993$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004694$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242889942$24288994$2$F$20240824$20240911$20240906$20240917$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00972$CATALYST PHARMA$$12$YR$$M$Y$40.363$KG$20240917$$CN$US$US
242889951$24288995$1$I$$20240903$20240906$20240906$EXP$$AU-JNJFOC-20240905804$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$MD$AU$AU
242889961$24288996$1$I$$20240831$20240906$20240906$PER$$NVSC2024US178694$NOVARTIS$$35$YR$$M$Y$$$20240906$$CN$US$US
242889971$24288997$1$I$20240816$20240819$20240906$20240906$PER$$US-JNJFOC-20240848681$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20240906$$CN$US$US
242889982$24288998$2$F$20240101$20240923$20240906$20240930$EXP$$CL-JNJFOC-20240383089$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240930$$CN$CL$CL
242889991$24288999$1$I$$20240828$20240906$20240906$EXP$$GB-EMD Serono-2024046740$EMD SERONO INC$$$$A$F$Y$$$20240906$$CN$GB$GB
242890001$24289000$1$I$$20240823$20240906$20240906$EXP$$US-UCBSA-2024043334$UCB$$$$$$Y$$$20240906$$CN$US$US
242890011$24289001$1$I$20240815$20240823$20240906$20240906$PER$$US-AstraZeneca-2024A203027$ASTRAZENECA$$$$$F$Y$$$20240906$$HP$US$
242890021$24289002$1$I$$20240905$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-082133-2024$RECKITT BENCKISER$$79$YR$$M$Y$$$20240906$$CN$US$US
242890031$24289003$1$I$$20240902$20240906$20240906$EXP$$IN-TAKEDA-2024TUS088721$TAKEDA$$$$$M$Y$$$20240906$$MD$IN$IN
242890041$24289004$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009883$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242890051$24289005$1$I$$20240826$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136522$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240906$$CN$US$US
242890061$24289006$1$I$20230901$20240826$20240906$20240906$EXP$FR-AFSSAPS-AN2024001167$FR-BEH-2024177952$CSL BEHRING$$60$YR$A$M$Y$71$KG$20240906$$MD$FR$FR
242890071$24289007$1$I$20240101$20240823$20240906$20240906$EXP$$CA-UCBSA-2024043518$UCB$$$$$F$Y$$$20240906$$CN$CA$CA
242890081$24289008$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009884$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242890091$24289009$1$I$$20240830$20240906$20240906$PER$$US-ABBVIE-5907918$ABBVIE$$$$$$Y$$$20240906$$HP$US$US
242890102$24289010$2$F$20240408$20240910$20240906$20240912$EXP$$DE-SANDOZ INC.-SDZ2024DE078017$SANDOZ$$85$YR$$M$Y$80$KG$20240912$$MD$DE$DE
242890111$24289011$1$I$$20240830$20240906$20240906$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019375$VALIDUS$$$$$$Y$$$20240906$$CN$US$US
242890121$24289012$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004695$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242890131$24289013$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004696$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242890142$24289014$2$F$20240905$20240905$20240906$20240912$PER$$US-AMGEN-USASP2024177814$AMGEN$$77$YR$E$F$Y$$$20240911$$CN$US$US
242890152$24289015$2$F$$20240906$20240906$20240916$EXP$$BR-CELLTRION INC.-2022BR015587$CELLTRION$$$$$$Y$$$20240916$$CN$BR$BR
242890161$24289016$1$I$$20240823$20240906$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093484$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242890171$24289017$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009885$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242890181$24289018$1$I$20240601$20240830$20240906$20240906$EXP$ES-AEMPS-1559076$ES-NORMON-202400717$NORMON$$5$DY$N$F$Y$$$20240906$$MD$ES$
242890191$24289019$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043323$AUROBINDO$$79$YR$$F$Y$$$20240906$$MD$CA$CA
242890201$24289020$1$I$20240815$20240830$20240906$20240906$EXP$$CN-BEIGENE-BGN-2024-013728$BEIGENE$$$$$$Y$$$20240906$$HP$CN$CN
242890211$24289021$1$I$20240101$20240902$20240906$20240906$EXP$$PL-ABBVIE-5905567$ABBVIE$$72$YR$$F$Y$$$20240906$$MD$PL$PL
242890221$24289022$1$I$20240820$20240903$20240906$20240906$EXP$$US-ABBVIE-5905661$ABBVIE$$28$YR$$F$Y$$$20240906$$CN$US$US
242890231$24289023$1$I$$20240514$20240906$20240906$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07066$HIKMA$Sarkar S, Rav E, Stitzlein L, Gibson A, McCall D, Nunez C, et al.. Sanila Sarkar, Emily Rav, Lea Stitzlein, Amber Gibson, David McCall, Cesar Nunez, Michael Roth, Dristhi Ragoonanan, Jeremy Connors, Cynthia E Herzog, Branko Cuglievan, Miriam B Garcia. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia.. Pediatric Blood and Cancer. 2024;71(6):e30964$20$YR$$F$Y$$$20240906$$MD$US$US
242890243$24289024$3$F$20231018$20240912$20240906$20240928$EXP$$KR-ABBVIE-5905706$ABBVIE$$41$YR$$M$Y$70$KG$20240928$$MD$KR$KR
242890261$24289026$1$I$20240603$20240829$20240906$20240906$EXP$$US-EMD Serono-2024046853$EMD SERONO INC$$68$YR$E$M$Y$$$20240906$$CN$US$US
242890281$24289028$1$I$20240903$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002467$ELI LILLY AND CO$$$$$$Y$$$20240906$$CN$US$US
242890291$24289029$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002870$ELI LILLY AND CO$$$$$M$Y$$$20240906$$CN$US$US
242890301$24289030$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002861$ELI LILLY AND CO$$$$$M$Y$$$20240906$$CN$US$US
242890311$24289031$1$I$20240902$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001454$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240906$$CN$US$US
242890321$24289032$1$I$$20240823$20240906$20240906$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093778$GLENMARK$Ropp DL, Johnson PN, Stephens K, Neely S, Chaaban H, Miller JL.. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of Perinatology. 2024$$$$$Y$$$20240906$$HP$US$US
242890331$24289033$1$I$20240823$20240823$20240906$20240906$PER$$US-Kindeva Drug Delivery L.P.-2161296$KINDEVA DRUG DELIVERY$$93$YR$$M$Y$$$20240906$$$US$US
242890341$24289034$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5905321$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242890351$24289035$1$I$$20240903$20240906$20240906$EXP$$CA-ABBVIE-5905626$ABBVIE$$$$A$F$Y$$$20240906$$MD$CA$CA
242890361$24289036$1$I$20240701$20240828$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027157$UNITED THERAPEUTICS$$74$YR$$F$Y$111.97$KG$20240906$$$US$US
242890371$24289037$1$I$20240801$20240830$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027337$UNITED THERAPEUTICS$$63$YR$$F$Y$$$20240906$$$US$US
242890381$24289038$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009886$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242890391$24289039$1$I$20240814$20240827$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043201$AUROBINDO$$57$YR$$M$Y$80$KG$20240906$$MD$FR$FR
242890401$24289040$1$I$$20240830$20240906$20240906$EXP$$IT-TAKEDA-2024TUS088463$TAKEDA$$$$$F$Y$$$20240906$$CN$IT$IT
242890411$24289041$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141769$BRISTOL MYERS SQUIBB$$15$YR$T$F$Y$$$20240906$$HP$US$US
242890421$24289042$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141685$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$100.7$KG$20240906$$CN$US$US
242890431$24289043$1$I$$20240830$20240906$20240906$30DAY$$US-GSK-US2024108436$GLAXOSMITHKLINE$$$$$F$Y$74.84$KG$20240906$$CN$US$US
242890441$24289044$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141363$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240906$$MD$US$US
242890451$24289045$1$I$$20240828$20240906$20240906$EXP$$US-AUROBINDO-AUR-APL-2024-043154$AUROBINDO$Seitz V, Davidson ER.. Retained Tampon Fragment as an Unusual Cause of Vesicovaginal Fistula.. Obstetrics and Gynecology.. 2024;144(1):1-3$53$YR$$F$Y$$$20240906$$MD$US$US
242890461$24289046$1$I$$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-081888-2024$RECKITT BENCKISER$$$$$M$Y$$$20240906$$CN$US$US
242890471$24289047$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009887$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242890491$24289049$1$I$$20240826$20240906$20240906$PER$$US-ROCHE-10000070198$ROCHE$File B, Hari A. Discrepancy in PD-L1 expression between primary and metastatic tumors in two patients with recurrent cervical cancer. Gynecologic Oncology Reports. 2024;55:1-4. doi:10.1016/j.gore.2024.101484.$36$YR$A$F$Y$$$20240906$$HP$US$US
242890501$24289050$1$I$$20240903$20240906$20240906$EXP$$DE-AstraZeneca-2024A201566$ASTRAZENECA$$$$$$Y$$$20240906$$MD$DE$
242890521$24289052$1$I$20240301$20240829$20240906$20240906$EXP$$CO-ABBVIE-5906451$ABBVIE$$60$YR$$M$Y$81$KG$20240906$$HP$CO$CO
242890531$24289053$1$I$$20240830$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-026995$UNITED THERAPEUTICS$$$$$F$Y$86.168$KG$20240906$$$US$US
242890541$24289054$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009888$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242890551$24289055$1$I$20240601$20240826$20240906$20240906$EXP$$JP-ASTELLAS-2024JP004316$ASTELLAS$$9$DEC$E$M$Y$$$20240906$$MD$JP$JP
242890561$24289056$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009889$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242890571$24289057$1$I$$20240905$20240906$20240906$PER$$NVSC2024US179066$NOVARTIS$$$$$$Y$$$20240906$$HP$US$US
242890581$24289058$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5905875$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242890591$24289059$1$I$$20230529$20240906$20240906$EXP$$US-HALEON-2194607$Haleon PLC$$$$$M$Y$102$KG$20240906$$MD$US$US
242890601$24289060$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5905909$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242890611$24289061$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906762$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242890621$24289062$1$I$20240101$20240904$20240906$20240906$EXP$$US-ABBVIE-5907978$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242890631$24289063$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5905781$ABBVIE$$78$YR$$F$Y$$$20240906$$CN$US$US
242890643$24289064$3$F$20240101$20240916$20240906$20240917$PER$$US-JNJFOC-20240908169$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240917$$CN$US$US
242890661$24289066$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009890$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242890681$24289068$1$I$$20240904$20240906$20240906$EXP$$DE-SANDOZ INC.-SDZ2024DE077748$SANDOZ$$20$YR$$M$Y$$$20240906$$HP$DE$DE
242890691$24289069$1$I$20240501$20240904$20240906$20240906$EXP$$CH-ABBVIE-5906844$ABBVIE$$59$YR$$M$Y$$$20240906$$MD$CH$CH
242890701$24289070$1$I$20230101$20240826$20240906$20240906$EXP$$BR-UCBSA-2024043919$UCB$$$$$M$Y$$$20240906$$CN$BR$BR
242890712$24289071$2$F$20240701$20240906$20240906$20240912$EXP$$US-ABBVIE-5907200$ABBVIE$$32$YR$$F$Y$117.93$KG$20240912$$CN$US$US
242890722$24289072$2$F$20240101$20240917$20240906$20240920$EXP$$JP-JNJFOC-20240914242$JOHNSON AND JOHNSON$$17$YR$T$M$Y$65$KG$20240920$$MD$JP$JP
242890731$24289073$1$I$$20240830$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139170$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240906$$HP$US$US
242890741$24289074$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141613$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240906$$HP$US$US
242890751$24289075$1$I$$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140555$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240906$$CN$US$US
242890761$24289076$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009891$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242890771$24289077$1$I$20240816$20240830$20240906$20240906$PER$$US-Kindeva Drug Delivery L.P.-2161297$KINDEVA DRUG DELIVERY$$76$YR$$M$Y$$$20240906$$$US$US
242890781$24289078$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010081$APOTEX$$77$YR$$F$Y$$$20240906$$CN$CA$CA
242890801$24289080$1$I$$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-103885-2023$RECKITT BENCKISER$$$$$$Y$$$20240906$$CN$US$US
242890811$24289081$1$I$20240730$20240828$20240906$20240906$EXP$SE-SEMPA-2024-006157$SE-Accord-444632$ACCORD$$64$YR$A$F$Y$$$20240906$$MD$SE$SE
242890821$24289082$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906038$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242890831$24289083$1$I$20240903$20240903$20240906$20240906$EXP$$US-ABBVIE-5906513$ABBVIE$$31$YR$$M$Y$$$20240906$$CN$US$US
242890841$24289084$1$I$$20240904$20240906$20240906$EXP$$US-ABBVIE-5908750$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242890851$24289085$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009892$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242890861$24289086$1$I$$20240902$20240906$20240906$EXP$$PH-AstraZeneca-2024A199822$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$PH$
242890881$24289088$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003057$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240906$$CN$US$US
242890891$24289089$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002739$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240906$$CN$US$US
242890901$24289090$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002584$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240906$$CN$US$US
242890911$24289091$1$I$20240902$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002942$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240906$$CN$US$US
242890921$24289092$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002810$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240906$$CN$US$US
242890941$24289094$1$I$$20240827$20240906$20240906$PER$$US-HALEON-2194003$Haleon PLC$$$$$$Y$$$20240906$$CN$US$US
242890951$24289095$1$I$20230920$20240827$20240906$20240906$EXP$$CA-TAKEDA-2022TUS098247$TAKEDA$$34$YR$$F$Y$$$20240906$$CN$CA$CA
242890961$24289096$1$I$$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-103794-2023$RECKITT BENCKISER$$$$$F$Y$$$20240906$$CN$US$US
242890971$24289097$1$I$$20240903$20240906$20240906$EXP$$CA-TAKEDA-2024TUS088746$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
242890981$24289098$1$I$$20240829$20240906$20240906$PER$$US-ABBVIE-5905048$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242891001$24289100$1$I$20240601$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176819$AMGEN$$73$YR$E$F$Y$$$20240906$$CN$US$US
242891011$24289101$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177566$AMGEN$$$$$$Y$$$20240906$$MD$US$US
242891021$24289102$1$I$$20240829$20240906$20240906$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08168$HIKMA$$$$$M$Y$$$20240906$$HP$US$US
242891031$24289103$1$I$$20240828$20240906$20240906$PER$$US-Kindeva Drug Delivery L.P.-2161298$KINDEVA DRUG DELIVERY$$$$$F$Y$$$20240906$$$US$US
242891041$24289104$1$I$$20240830$20240906$20240906$EXP$$US-AMGEN-USASP2024174511$AMGEN$Jeffrey M.J.; Klevay M.; Hilt E.E. et al.. Acute Meningoencephalitis Associated with Borrelia miyamotoi, Minnesota, USA. Emerging Infectious Diseases. 2024;30 (7):1472-1474$68$YR$E$M$Y$$$20240906$$HP$US$US
242891051$24289105$1$I$$20240903$20240906$20240906$PER$$US-TAKEDA-2024TUS088466$TAKEDA$$$$$F$Y$$$20240906$$CN$US$US
242891061$24289106$1$I$20171122$20240830$20240906$20240906$EXP$DE-CADRBFARM-2024330026$DE-TEVA-VS-3239165$TEVA$$43$YR$$F$Y$$$20240906$$CN$DE$DE
242891071$24289107$1$I$$20240905$20240906$20240906$PER$$NVSC2024US179117$NOVARTIS$$$$$$Y$$$20240906$$HP$US$US
242891081$24289108$1$I$20240807$20240830$20240906$20240906$EXP$FR-AFSSAPS-RN2024000882$FR-TEVA-VS-3239144$TEVA$$78$YR$$M$Y$$$20240906$$MD$FR$FR
242891091$24289109$1$I$$20240826$20240906$20240906$EXP$$ES-STERISCIENCE B.V.-2024-ST-001305$Steriscience PTE$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al.. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage.. Br-J-Clin-Pharmacol. 2023;89 (8):2497-2507$46$YR$$M$Y$$$20240906$$HP$ES$ES
242891101$24289110$1$I$$20240826$20240906$20240906$EXP$$JP-STERISCIENCE B.V.-2024-ST-001293$Steriscience PTE$Yoshimura Y, Suwabe T, Miki K, Yokoyama T, Kono K, Kinowaki K, et al.. Renal cell carcinoma preceded by a rheumatoid-like paraneoplastic syndrome: A case report.. Oncol-Lett. 2024;28 (4)$72$YR$$M$Y$54$KG$20240906$$HP$JP$JP
242891111$24289111$1$I$$20240827$20240906$20240906$EXP$$IT-STERISCIENCE B.V.-2024-ST-001289$Steriscience PTE$Garri F, Puthenparampil M, Simonato D, Rinaldi F, Gallo P. A rare case of Listeria rhombencephalitis with a sudden onset and unusual brain MRI features. Neurol-Sci. 2024;45:353-355$$$$F$Y$$$20240906$$HP$IT$IT
242891132$24289113$2$F$$20240917$20240906$20240920$EXP$$JP-JNJFOC-20240914359$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$PH$JP$JP
242891141$24289114$1$I$20240828$20240829$20240906$20240906$EXP$$JP-ROCHE-10000072320$ROCHE$$7$DEC$E$F$Y$$$20240906$$MD$JP$JP
242891152$24289115$2$F$20240903$20240904$20240906$20240908$PER$$US-JNJFOC-20240911739$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240909$$CN$US$US
242891161$24289116$1$I$20240718$20240905$20240906$20240906$EXP$FR-AFSSAPS-RN2024000943$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-141621$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$60$KG$20240906$$MD$FR$FR
242891171$24289117$1$I$$20240904$20240906$20240906$EXP$$CA-SANDOZ INC.-SDZ2024CA077977$SANDOZ$$$$$F$Y$$$20240906$$CN$CA$CA
242891193$24289119$3$F$20240903$20240917$20240906$20240925$PER$$US-AMGEN-USASP2024175788$AMGEN$$$$$M$Y$$$20240925$$HP$US$US
242891201$24289120$1$I$20240809$20240827$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043267$AUROBINDO$$84$YR$$F$Y$60$KG$20240906$$MD$FR$FR
242891211$24289121$1$I$$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-081551-2024$RECKITT BENCKISER$$76$YR$$F$Y$$$20240906$$CN$US$US
242891222$24289122$2$F$$20240910$20240906$20240918$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005121$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
242891232$24289123$2$F$20240813$20240913$20240906$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005127$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240923$$CN$US$US
242891242$24289124$2$F$20240826$20240911$20240906$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005133$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240919$$HP$US$US
242891251$24289125$1$I$20240813$20240827$20240906$20240906$PER$$PR-ABBVIE-5899141$ABBVIE$$55$YR$$F$Y$$$20240906$$CN$PR$PR
242891261$24289126$1$I$$20240823$20240906$20240906$EXP$$US-ZPPROD-ZP24US000929$ZEALAND PHARMACEUTICALS$$$$E$$Y$$$20240906$$CN$US$US
242891271$24289127$1$I$20230928$20240827$20240906$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-042979$AUROBINDO$$67$YR$$F$Y$52$KG$20240906$$CN$GB$GB
242891281$24289128$1$I$$20240823$20240906$20240906$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-26200$SAMSUNG BIOEPIS$$76$YR$E$F$Y$$$20240906$$CN$CA$CA
242891291$24289129$1$I$$20240829$20240906$20240906$EXP$$CN-AMGEN-CHNSP2024175487$AMGEN$Fubin Q.; Na Z.; Shengda Z. et al.. Prognostic values of serum miR-140-5p and SFRP -5 for in-stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240906$$HP$CN$CN
242891301$24289130$1$I$20240830$20240830$20240906$20240906$EXP$$US-JNJFOC-20240900527$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240906$$HP$US$US
242891311$24289131$1$I$20240730$20240826$20240906$20240906$EXP$FR-AFSSAPS-BX2024001678$FR-ASTELLAS-2024-AER-004636$ASTELLAS$$63$YR$A$F$Y$44$KG$20240906$$PH$FR$FR
242891321$24289132$1$I$$20240830$20240906$20240906$EXP$$US-AMGEN-USASP2024175141$AMGEN$Malik S.M.; Mohy-ud-din N.; Lin F. et al.. Expedited liver transplantation as first-line therapy for severe alcohol hepatitis: ELFSAH; deferring corticosteroids in the sickest subset of patients. Clinical Transplantation. 2024;38 (7):1 -11$$$$$Y$$$20240906$$HP$US$US
242891342$24289134$2$F$$20240920$20240906$20240928$EXP$$US-ABBVIE-5907484$ABBVIE$$$$$F$Y$$$20240928$$HP$US$US
242891351$24289135$1$I$$20240904$20240906$20240906$PER$$US-BIOGEN-2024BI01281135$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242891371$24289137$1$I$20240830$20240830$20240906$20240906$EXP$$US-PTC THERAPEUTICS INC.-US-2024PTC001165$PTC THERAPEUTICS$$2$YR$$M$Y$12.018$KG$20240906$$HP$US$US
242891401$24289140$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004685$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242891411$24289141$1$I$20240831$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002834$ELI LILLY AND CO$$57$YR$A$$Y$$$20240906$$CN$US$US
242891421$24289142$1$I$$20240829$20240906$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020105$UNITED THERAPEUTICS$$$$$F$Y$67.574$KG$20240906$$$US$US
242891431$24289143$1$I$20240831$20240901$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002564$ELI LILLY AND CO$$$$$$Y$$$20240906$$CN$US$US
242891441$24289144$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002513$ELI LILLY AND CO$$$$$F$Y$$$20240906$$CN$US$US
242891451$24289145$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002825$ELI LILLY AND CO$$$$$M$Y$$$20240906$$CN$US$US
242891461$24289146$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002616$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240906$$CN$US$US
242891471$24289147$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004683$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242891491$24289149$1$I$$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003520$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240906$$CN$US$US
242891501$24289150$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004678$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242891511$24289151$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004671$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242891522$24289152$2$F$20240902$20240906$20240906$20240909$PER$$US-AMGEN-USASP2024177718$AMGEN$$63$YR$A$F$Y$$$20240909$$CN$US$US
242891531$24289153$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043450$AUROBINDO$$76$YR$$F$Y$$$20240906$$MD$CA$CA
242891541$24289154$1$I$20210101$20240429$20240906$20240906$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-06420$HIKMA$de Brito Marques F, Marques AP, SimOes de Carvalho F, Magalhaes H.. de Brito Marques F, Marques AP, SimOes de Carvalho F, Magalhaes H. Addison^s disease in metastatic neuroendocrine prostate cancer.. Endocrinol Diabetes Nutr. 2024;71(4):187-188$67$YR$$M$Y$$$20240906$$MD$PT$PT
242891551$24289155$1$I$$20240827$20240906$20240906$PER$$US-JNJFOC-20240875434$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$MD$US$US
242891561$24289156$1$I$20230301$20240905$20240906$20240906$EXP$$FR-SANDOZ INC.-SDZ2024FR078011$SANDOZ$$$$A$F$Y$$$20240906$$HP$FR$FR
242891571$24289157$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009893$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242891581$24289158$1$I$20240903$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141216$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240906$$PH$US$US
242891591$24289159$1$I$20240830$20240830$20240906$20240906$EXP$$GB-ROCHE-10000072109$ROCHE$$63$YR$A$M$Y$$$20240906$$HP$GB$GB
242891601$24289160$1$I$20240601$20240827$20240906$20240906$30DAY$$US-GSK-US2024078512$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240906$$MD$US$US
242891612$24289161$2$F$$20240826$20240906$20240906$PER$$US-ROCHE-10000071728$ROCHE$Corcione S, Lupia T, Vita D, Sidoti F, Zanotto E, Solidoro P et al. Maribavir treatment for resistant cytomegalovirus disseminated disease in kidney transplant recipients: A case-based scoping review of real life data in literature. Transplantation Reviews.2024;38(4):100873. doi: 10.1016/j.trre.2024.100873.$54$YR$A$F$Y$$$20240906$$HP$US$US
242891622$24289162$2$F$20240903$20240923$20240906$20240926$EXP$$US-GILEAD-2024-0686432$GILEAD$$76$YR$E$F$Y$$$20240926$$MD$US$US
242891631$24289163$1$I$$20240904$20240906$20240906$EXP$$US-SANDOZ INC.-NVSC2021US043141$SANDOZ$$$$$M$Y$$$20240906$$CN$US$US
242891641$24289164$1$I$$20231102$20240906$20240906$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-417483$RANBAXY$$$$A$F$Y$$$20240906$$CN$US$US
242891651$24289165$1$I$20240101$20240301$20240906$20240906$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436352$RANBAXY$$$$A$M$Y$$$20240906$$CN$US$US
242891661$24289166$1$I$20231130$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-080885-2024$RECKITT BENCKISER$$$$$M$Y$$$20240906$$CN$US$US
242891671$24289167$1$I$$20240903$20240906$20240906$EXP$$NVSC2024US177396$NOVARTIS$$$$$M$Y$$$20240906$$CN$US$US
242891681$24289168$1$I$20240903$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177266$AMGEN$$$$$$Y$$$20240906$$CN$US$US
242891691$24289169$1$I$20240901$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176081$AMGEN$$66$YR$E$F$Y$$$20240906$$CN$US$US
242891701$24289170$1$I$20240828$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176928$AMGEN$$63$YR$A$F$Y$$$20240906$$CN$US$US
242891711$24289171$1$I$20240818$20240827$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043266$AUROBINDO$$13$YR$$F$Y$$$20240906$$MD$FR$FR
242891721$24289172$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009896$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242891731$24289173$1$I$20240301$20240905$20240906$20240906$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049864$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240906$$CN$US$US
242891741$24289174$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141744$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240906$$HP$US$US
242891751$24289175$1$I$$20240821$20240906$20240906$PER$$US-APOTEX-2024AP009897$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240906$$HP$US$US
242891761$24289176$1$I$$20240827$20240906$20240906$PER$$US-ABBVIE-5899690$ABBVIE$$70$YR$$F$Y$$$20240906$$HP$US$US
242891771$24289177$1$I$20240830$20240904$20240906$20240906$EXP$GB-MHRA-MED-202409041658565300-DTGVC$GB-SANDOZ INC.-SDZ2024GB078007$SANDOZ$$63$YR$$F$Y$86$KG$20240906$$CN$GB$GB
242891782$24289178$2$F$$20240909$20240906$20240918$PER$$US-ROCHE-10000071056$ROCHE$$$$I$M$Y$$$20240918$$CN$US$US
242891791$24289179$1$I$20230101$20240903$20240906$20240906$PER$$US-BIOGEN-2024BI01281196$BIOGEN$$$$$M$Y$$$20240906$$CN$US$US
242891801$24289180$1$I$$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200609$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242891811$24289181$1$I$$20240829$20240906$20240906$EXP$$US-AstraZeneca-2024A197595$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242891821$24289182$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004727$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242891831$24289183$1$I$$20240903$20240906$20240906$EXP$$CA-ROCHE-10000073846$ROCHE$$79$YR$E$F$Y$$$20240906$$MD$CA$CA
242891842$24289184$2$F$$20240905$20240906$20240909$PER$$NVSC2024US178880$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
242891851$24289185$1$I$$20240905$20240906$20240906$PER$$NVSC2024US179120$NOVARTIS$$$$$$Y$$$20240906$$MD$US$US
242891861$24289186$1$I$$20240827$20240906$20240906$EXP$$US-Accord-443755$ACCORD$Rink DE, Abramson RH, Johnson NJ, Lee RY. Diagnostic Confounders in Brain Death A Woman with Unexplained Coma and Brainstem Areflexia. Annals of the American Thoracic Society. 2024;21(8):1204-8. DOI: 10.1513/AnnalsATS.202403-232CC.$60$YR$A$F$Y$$$20240906$$MD$US$US
242891872$24289187$2$F$$20240918$20240906$20240920$EXP$$JP-GILEAD-2024-0686106$GILEAD$Kunitsuka H. 3-4 A case of sudden deterioration in a COVID-19 patient who was unsure whether subarachnoid hemorrhage or a pseudo-subarachnoid hemorrhage. The 22nd Meeting of the Japan Society of Autopsy Imaging. unk;unk:19$60$YR$A$F$Y$$$20240920$$MD$JP$JP
242891881$24289188$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004500$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242891894$24289189$4$F$20230912$20240918$20240906$20240927$EXP$$BR-CELLTRION INC.-2023BR003739$CELLTRION$$$$$$Y$$$20240927$$CN$BR$BR
242891901$24289190$1$I$$20240822$20240906$20240906$EXP$$CA-APOTEX-2024AP010264$APOTEX$$18$YR$$F$Y$72$KG$20240906$$HP$CA$CA
242891911$24289191$1$I$$20240821$20240906$20240906$PER$$US-ASTELLAS-2024-AER-002346$ASTELLAS$$$$A$M$Y$$$20240906$$MD$US$US
242891921$24289192$1$I$20240903$20240904$20240906$20240906$PER$$US-ABBVIE-5907529$ABBVIE$$22$YR$$$Y$$$20240906$$HP$US$US
242891931$24289193$1$I$20230501$20240902$20240906$20240906$EXP$$DE-UCBSA-2024045157$UCB$$43$YR$$F$Y$65$KG$20240906$$MD$DE$DE
242891941$24289194$1$I$20240101$20240827$20240906$20240906$PER$$US-TAKEDA-2024TUS086283$TAKEDA$$56$YR$$F$Y$$$20240906$$CN$US$US
242891951$24289195$1$I$$20240831$20240906$20240906$PER$$US-009507513-2409USA000579$MERCK$$49$YR$$F$Y$$$20240906$$CN$US$US
242891962$24289196$2$F$20240101$20240905$20240906$20240911$EXP$$JP-009507513-2409JPN000186J$MERCK$$72$YR$$M$Y$$$20240911$$PH$JP$JP
242891971$24289197$1$I$$20240903$20240906$20240906$PER$$US-JNJFOC-20240908609$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$CN$US$US
242891982$24289198$2$F$$20240904$20240906$20240913$EXP$HU-MLMSERVICE-20240819-PI167507-00190-1$HU-JUBILANT CADISTA PHARMACEUTICALS-2024HU001241$JUBILANT$Killik P, Kostyal E, Toth G, Szentmary N, Nagy ZZ, Maneschg OA.. Ocular aspects of toxic epidermal necrolysis.. Orvosi hetilap. 2024;165(31):1206-12.$17$YR$$F$Y$$$20240913$$MD$HU$HU
242891991$24289199$1$I$20240728$20240904$20240906$20240906$EXP$$GB-JNJFOC-20240914039$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240906$$CN$GB$GB
242892001$24289200$1$I$20240829$20240830$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409000320$ELI LILLY AND CO$$$$$F$Y$$$20240906$$CN$US$US
242892011$24289201$1$I$$20240904$20240906$20240906$EXP$$US-BAUSCH-BL-2024-013295$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240906$$CN$US$US
242892021$24289202$1$I$$20240903$20240906$20240906$PER$$US-JNJFOC-20240904215$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242892031$24289203$1$I$20240103$20240904$20240906$20240906$EXP$$NVSC2023GB265464$NOVARTIS$$$$$F$Y$$$20240906$$CN$GB$GB
242892041$24289204$1$I$20240904$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177407$AMGEN$$23$YR$A$F$Y$$$20240906$$CN$US$US
242892051$24289205$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176473$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242892061$24289206$1$I$20240820$20240903$20240906$20240906$EXP$$US-ABBVIE-5906217$ABBVIE$$73$YR$$M$Y$$$20240906$$CN$US$US
242892072$24289207$2$F$20230101$20240913$20240906$20240918$EXP$$US-ABBVIE-5907137$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
242892081$24289208$1$I$$20240904$20240906$20240906$EXP$$MX-GILEAD-2024-0686215$GILEAD$$23$YR$A$M$Y$$$20240906$$MD$MX$MX
242892091$24289209$1$I$20240701$20240903$20240906$20240906$EXP$$US-ABBVIE-5906492$ABBVIE$$63$YR$$F$Y$$$20240906$$CN$US$US
242892102$24289210$2$F$20240729$20240905$20240906$20240912$EXP$$JP-ALXN-202408JPN002025JP$ALEXION PHARMACEUTICALS$$46$YR$$F$Y$$$20240912$$MD$JP$JP
242892111$24289211$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5905871$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242892121$24289212$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906473$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242892131$24289213$1$I$$20240819$20240906$20240906$PER$$US-TEVA-VS-3235859$TEVA$$69$YR$$F$Y$$$20240906$$PH$US$US
242892141$24289214$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906478$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242892151$24289215$1$I$20240901$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A201435$ASTRAZENECA$$89$YR$$F$Y$$$20240906$$CN$US$
242892173$24289217$3$F$$20240918$20240906$20240919$PER$$NVSC2024US179106$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
242892181$24289218$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004729$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242892191$24289219$1$I$$20240829$20240906$20240906$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-139627$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240906$$MD$BR$BR
242892201$24289220$1$I$$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140372$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240906$$CN$US$US
242892211$24289221$1$I$$20240829$20240906$20240906$EXP$$US-ROCHE-10000071008$ROCHE$$62$YR$A$F$Y$$$20240906$$CN$US$US
242892221$24289222$1$I$$20240829$20240906$20240906$PER$$US-JNJFOC-20240880099$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242892231$24289223$1$I$$20240827$20240906$20240906$30DAY$$US-GSK-US2024AMR107408$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$US$US
242892241$24289224$1$I$20240114$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-083045-2024$RECKITT BENCKISER$$$$$F$Y$$$20240906$$CN$US$US
242892261$24289226$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004672$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242892271$24289227$1$I$$20240828$20240906$20240906$EXP$PL-URPL-DML-MLP.4401.1.827.2023$PL-Accord-444324$ACCORD$$75$YR$E$M$Y$80$KG$20240906$$MD$PL$PL
242892281$24289228$1$I$20240823$20240827$20240906$20240906$EXP$$US-Accord-444986$ACCORD$$18$YR$A$M$Y$$$20240906$$MD$US$US
242892291$24289229$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043325$AUROBINDO$$55$YR$$F$Y$$$20240906$$CN$CA$CA
242892301$24289230$1$I$$20240903$20240906$20240906$PER$$US-ABBVIE-5907466$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242892312$24289231$2$F$20240825$20240904$20240906$20240911$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000754$DECIPHERA PHARMACEUTICALS$$79$YR$E$F$Y$94.1$KG$20240911$$CN$US$US
242892321$24289232$1$I$20240229$20240829$20240906$20240906$EXP$IE-HPRA-2024-111454$IE-CELLTRION INC.-2024IE020918$CELLTRION$$$$$$Y$$$20240906$$HP$IE$IE
242892331$24289233$1$I$$20240830$20240906$20240906$EXP$$GB-ASPEN-GLO2024GB006095$ASPEN$Nana M, Gregori M, Chandler E, Powell H, Goulden B, Nelson-piercy C et all.. Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study.. The Lancet Rheumatology. 2024;6(9):e625-e635$$$$$Y$$$20240906$$HP$GB$GB
242892341$24289234$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2023-044300$AUROBINDO$Hauck TS, Rochon S, Bahra P, Selby P. Outpatient Treatment of Chronic Designer Benzodiazepine Use: A Case Report. J-Addict-Med. 2022;16(2):E137-E139$25$YR$$M$Y$$$20240906$$MD$CA$CA
242892351$24289235$1$I$20240826$20240827$20240906$20240906$EXP$$US-Accord-444112$ACCORD$$66$YR$E$F$Y$$$20240906$$PH$US$US
242892361$24289236$1$I$20240810$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004721$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240906$$CN$US$US
242892371$24289237$1$I$20240809$20240831$20240906$20240906$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161299$JIANGSU HENGRUI MEDICINE$$73$YR$$M$Y$$$20240906$$MD$CN$CN
242892381$24289238$1$I$20240807$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176829$AMGEN$$$$$$Y$$$20240906$$HP$US$US
242892391$24289239$1$I$$20240827$20240906$20240906$EXP$$US-GSK-US2024AMR106984$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$MD$US$US
242892401$24289240$1$I$20240408$20240830$20240906$20240906$EXP$PT-INFARMED-A202408-377$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-08187$HIKMA$$60$YR$$F$Y$$$20240906$$HP$PT$PT
242892411$24289241$1$I$$20240903$20240906$20240906$PER$$US-ALXN-202409USA000090US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242892421$24289242$1$I$20230813$20240826$20240906$20240906$EXP$$CA-ROCHE-3405266$ROCHE$$61$YR$A$M$Y$$$20240906$$CN$CA$CA
242892441$24289244$1$I$$20240827$20240906$20240906$EXP$$ES-Accord-443764$ACCORD$Mena JI, Andreu H, Gimenez-Palomo A, Bueno L, Cesari E, De Juan o, et al. Manic episode in a patient with pancreatic adenocarcinoma: a case report. International Clinical Psychopharmacology. 2024;39(5):326-29.$61$YR$A$M$Y$$$20240906$$MD$ES$ES
242892451$24289245$1$I$20221201$20240829$20240906$20240906$EXP$$AU-ALXN-202408OCE001762AU$ALEXION PHARMACEUTICALS$$50$YR$$F$Y$$$20240906$$MD$AU$AU
242892461$24289246$1$I$$20240816$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08438$LUPIN$$$$$$Y$$$20240906$$MD$US$US
242892471$24289247$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5906183$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242892481$24289248$1$I$$20240829$20240906$20240906$EXP$$FR-ROCHE-10000038888$ROCHE$$68$YR$E$M$Y$$$20240906$$MD$FR$FR
242892491$24289249$1$I$$20240828$20240906$20240906$EXP$$JP-SPECGX-T202401837$SPECGX$$$$A$$Y$$$20240906$$MD$JP$JP
242892502$24289250$2$F$20240825$20240917$20240906$20240919$EXP$$US-ABBVIE-5908083$ABBVIE$$78$YR$$F$Y$$$20240919$$CN$US$US
242892511$24289251$1$I$$20240902$20240906$20240906$EXP$GB-002147023-NVSC2024GB174756$GB-RDY-SPO/GBR/24/0012804$DR REDDYS$$$$C$M$Y$$$20240906$$PH$GB$GB
242892521$24289252$1$I$20240831$20240904$20240906$20240906$EXP$$US-ABBVIE-5908771$ABBVIE$$65$YR$$F$Y$$$20240906$$CN$US$US
242892531$24289253$1$I$$20240828$20240906$20240906$EXP$$RU-RDY-SPO/RUS/24/0012787$DR REDDYS$Romanenko VA, Aksenova VA, Klevno NI, Kazakov AV, Sokolskaya EA. Non-injection chemotherapy schemes for pediatric multidrug-resistant tuberculosis. Infection and Chemotherapy. 2024 Apr;56: S172.$$$T$$Y$$$20240906$$HP$RU$RU
242892541$24289254$1$I$$20240823$20240906$20240906$EXP$$US-Zhejiang Yongtai pharmaceuticals Co..,Ltd.-2161300$ZHEJIANG YONGTAI$Full text$76$YR$$F$Y$$$20240906$$$US$US
242892551$24289255$1$I$$20240905$20240906$20240906$PER$$US-GILEAD-2024-0686414$GILEAD$$$$E$F$Y$$$20240906$$PH$US$US
242892561$24289256$1$I$20230629$20240828$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043211$AUROBINDO$$77$YR$$M$Y$75$KG$20240906$$MD$FR$FR
242892571$24289257$1$I$$20240903$20240906$20240906$PER$$US-ABBVIE-5908470$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242892581$24289258$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5905580$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242892591$24289259$1$I$20220101$20240827$20240906$20240906$EXP$$US-Accord-443754$ACCORD$Mann I, Morado-Aramburo O, Hasbun R. Emerging shadows: HHV-8-associated encephalitis unveiled in a solid organ transplant recipient. Transplant Infectious Disease. 2024;26(4):e14343.$73$YR$E$F$Y$$$20240906$$MD$US$US
242892601$24289260$1$I$20240121$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-083688-2024$RECKITT BENCKISER$$64$YR$$M$Y$77.27$KG$20240906$$CN$US$US
242892611$24289261$1$I$20240801$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002665$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240906$$CN$US$US
242892622$24289262$2$F$$20240910$20240906$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003563$ELI LILLY AND CO$$11$YR$C$F$Y$$$20240911$$CN$US$US
242892631$24289263$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002694$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240906$$CN$US$US
242892641$24289264$1$I$20240717$20240828$20240906$20240906$EXP$IT-MINISAL02-999684$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-08123$HIKMA$$60$YR$$F$Y$61$KG$20240906$$MD$IT$IT
242892651$24289265$1$I$20240831$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002856$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240906$$CN$US$US
242892681$24289268$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141049$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$80.29$KG$20240906$$CN$US$US
242892692$24289269$2$F$$20240905$20240906$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139955$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$PH$JP$JP
242892701$24289270$1$I$20240831$20240903$20240906$20240906$EXP$$FR-ABBVIE-5908227$ABBVIE$$63$YR$$F$Y$$$20240906$$CN$FR$FR
242892711$24289271$1$I$20230101$20240903$20240906$20240906$EXP$$US-ABBVIE-5457219$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242892721$24289272$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5905830$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242892731$24289273$1$I$$20240820$20240906$20240906$PER$$US-TEVA-VS-3236210$TEVA$$76$YR$$F$Y$$$20240906$$CN$US$US
242892741$24289274$1$I$20240726$20240829$20240906$20240906$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07102$HIKMA$$77$YR$$F$Y$$$20240906$$CN$US$US
242892751$24289275$1$I$20240825$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176386$AMGEN$$54$YR$A$F$Y$$$20240906$$CN$US$US
242892761$24289276$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5907126$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242892771$24289277$1$I$20240716$20240904$20240906$20240906$EXP$SE-SEMPA-2024-006370$SE-JNJFOC-20240906775$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20240906$$MD$SE$SE
242892781$24289278$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5906207$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242892791$24289279$1$I$20231129$20240828$20240906$20240906$EXP$$DE-TEVA-VS-3238420$TEVA$$12$YR$$M$Y$24$KG$20240906$$MD$DE$DE
242892801$24289280$1$I$20240516$20240828$20240906$20240906$EXP$FR-AFSSAPS-LL2024001593$FR-Accord-444440$ACCORD$$60$YR$A$F$Y$50.6$KG$20240906$$MD$FR$FR
242892811$24289281$1$I$20240701$20240827$20240906$20240906$EXP$$ES-TEVA-VS-3225015$TEVA$$62$YR$$F$Y$$$20240906$$CN$ES$ES
242892821$24289282$1$I$$20240828$20240906$20240906$EXP$$JP-009507513-2408JPN004044J$MERCK$$$$$F$Y$$$20240906$$MD$JP$JP
242892831$24289283$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010102$APOTEX$$81$YR$$M$Y$$$20240906$$CN$CA$CA
242892843$24289284$3$F$20240903$20240909$20240906$20240913$EXP$$US-AMGEN-USASP2024177342$AMGEN$$71$YR$E$F$Y$$$20240913$$CN$US$US
242892852$24289285$2$F$$20240912$20240906$20240917$EXP$$US-ABBVIE-5905797$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
242892862$24289286$2$F$$20240905$20240906$20240911$PER$$US-TAKEDA-2023TUS110260$TAKEDA$$$$$F$Y$$$20240911$$HP$US$US
242892871$24289287$1$I$20240714$20240903$20240906$20240906$EXP$$US-ABBVIE-5905696$ABBVIE$$86$YR$$M$Y$$$20240906$$CN$US$US
242892881$24289288$1$I$$20240828$20240906$20240906$EXP$$PT-AUROBINDO-AUR-APL-2024-043208$AUROBINDO$$74$YR$$M$Y$$$20240906$$CN$PT$PT
242892891$24289289$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5905915$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242892901$24289290$1$I$$20240904$20240906$20240906$EXP$$GB-ABBVIE-5907092$ABBVIE$$53$YR$$M$Y$$$20240906$$MD$GB$GB
242892911$24289291$1$I$20240131$20240904$20240906$20240906$EXP$$NVSC2024US024523$NOVARTIS$$57$YR$$M$Y$$$20240906$$CN$US$US
242892921$24289292$1$I$20240808$20240828$20240906$20240906$EXP$FR-AFSSAPS-AN2024001153$FR-Accord-444263$ACCORD$$60$YR$A$F$Y$$$20240906$$MD$FR$FR
242892931$24289293$1$I$$20240828$20240906$20240906$EXP$$NL-AUROBINDO-AUR-APL-2024-043713$AUROBINDO$$22$YR$$F$Y$52$KG$20240906$$CN$NL$NL
242892941$24289294$1$I$$20240828$20240906$20240906$EXP$$NL-AUROBINDO-AUR-APL-2024-043914$AUROBINDO$$54$YR$$M$Y$77$KG$20240906$$CN$NL$NL
242892951$24289295$1$I$20240701$20240822$20240906$20240906$EXP$$FR-SA-2024SA256536$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240906$$PH$FR$FR
242892961$24289296$1$I$$20240109$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000587$STRIDES$Nagarsheth K, Dunlap E, Fitzpatrick S, et al.. The use of intravascular lithotripsy in conjunction with transcarotid artery revascularization for high grade carotid artery stenosis.. Ann-Vasc-Surg-Brief-Rep-Innov. 2021;1 (1):1-4$83$YR$$F$Y$$$20240906$$HP$US$US
242892971$24289297$1$I$$20231116$20240906$20240906$PER$US-MLMSERVICE-20210706-2985734-1$US-STRIDES ARCOLAB LIMITED-2021SP025008$STRIDES$Ghayur A, Elahi Q, Patel C, Raj R. Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy. Endocrinology, Diabetes and Metabolism Case Reports. 2021;2021(1):1-4$68$YR$$M$Y$$$20240906$$MD$US$US
242892981$24289298$1$I$$20240417$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004845$STRIDES$Hwang J, Cheung B, Block R.. Different Manifestations of Familial Hypercholesterolemia in a Mother and Daughter Due to Differing Lipoprotein(a) Levels.. J-Clin-Lipidol. 2021;15 (5):e16$77$YR$$F$Y$$$20240906$$HP$US$US
242892991$24289299$1$I$$20240504$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2024SP005439$STRIDES$Luong M T, Danahy P, Ho G Y.. Spontaneous Development of Immune-Mediated Necrotizing Myopathy (IMNM) After Chronic Use of Statins: A Case Report. Cureus. 2023;15(7):e42266$55$YR$$M$Y$$$20240906$$HP$US$US
242893001$24289300$1$I$$20240827$20240906$20240906$EXP$$PL-ROCHE-10000068557$ROCHE$$77$YR$E$F$Y$$$20240906$$MD$PL$PL
242893011$24289301$1$I$$20231122$20240906$20240906$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017864$STRIDES$Saand AR, Drinnon AR, Mubeen F, Shakil J.. Severe Hypertriglyceridemia Post Liver Transplant- A Multifactorial Disorder.. J-Endocr-Soc. 2023;7 (Suppl.):A329-A330 abstr. FRI093.$68$YR$$M$Y$$$20240906$$MD$US$US
242893021$24289302$1$I$$20240820$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08298$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242893031$24289303$1$I$20230530$20240828$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043695$AUROBINDO$$91$YR$$F$Y$48$KG$20240906$$MD$FR$FR
242893041$24289304$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141564$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240906$$CN$US$US
242893051$24289305$1$I$20221201$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141563$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$69.85$KG$20240906$$CN$US$US
242893061$24289306$1$I$20240801$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141734$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240906$$CN$US$US
242893071$24289307$1$I$20240801$20240905$20240906$20240906$EXP$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-141553$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-141553$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240906$$CN$AT$AT
242893081$24289308$1$I$20240827$20240829$20240906$20240906$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900003$RIGEL PHARMACEUTICALS$$$$$M$Y$81.647$KG$20240906$$CN$US$US
242893091$24289309$1$I$$20240904$20240906$20240906$EXP$$DE-SANDOZ INC.-SDZ2021DE000512$SANDOZ$$34$YR$$M$Y$$$20240906$$HP$DE$DE
242893101$24289310$1$I$20240827$20240827$20240906$20240906$30DAY$$US-GSK-US2024106642$GLAXOSMITHKLINE$$50$YR$$M$Y$$$20240906$$CN$US$US
242893111$24289311$1$I$20240828$20240829$20240906$20240906$30DAY$$US-GSK-US2024107921$GLAXOSMITHKLINE$$31$YR$$F$Y$$$20240906$$PH$US$US
242893121$24289312$1$I$$20240905$20240906$20240906$EXP$GB-MHRA-MED-202409051036517840-DLRZS$GB-SANDOZ INC.-SDZ2024GB078055$SANDOZ$$$$$F$Y$$$20240906$$CN$GB$GB
242893131$24289313$1$I$$20240830$20240906$20240906$PER$$US-JNJFOC-20240902256$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$CN$US$US
242893141$24289314$1$I$20240901$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176277$AMGEN$$71$YR$E$$Y$$$20240906$$CN$US$US
242893151$24289315$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176217$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242893161$24289316$1$I$$20231215$20240906$20240906$EXP$$CA-AMGEN-CANSP2023235677$AMGEN$$45$YR$A$F$Y$$$20240906$$CN$CA$CA
242893181$24289318$1$I$20240201$20240830$20240906$20240906$EXP$$MX-AstraZeneca-2024A201127$ASTRAZENECA$$1156$MON$$F$Y$52$KG$20240906$$CN$MX$
242893191$24289319$1$I$$20240903$20240906$20240906$EXP$$CA-AstraZeneca-2024A201696$ASTRAZENECA$$$$$M$Y$$$20240906$$MD$CA$
242893201$24289320$1$I$$20240820$20240906$20240906$EXP$$US-UCBSA-2024042663$UCB$$$$$M$Y$$$20240906$$HP$US$US
242893211$24289321$1$I$20200123$20240828$20240906$20240906$EXP$$DE-AUROBINDO-AUR-APL-2024-043644$AUROBINDO$$79$YR$$M$Y$64$KG$20240906$$MD$DE$DE
242893221$24289322$1$I$$20240820$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08305$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242893231$24289323$1$I$$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-082127-2024$RECKITT BENCKISER$$$$$F$Y$$$20240906$$CN$US$US
242893241$24289324$1$I$20240801$20240828$20240906$20240906$EXP$$NL-AUROBINDO-AUR-APL-2024-043918$AUROBINDO$$$$E$F$Y$$$20240906$$CN$NL$NL
242893251$24289325$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177525$AMGEN$$$$E$F$Y$$$20240906$$HP$US$US
242893261$24289326$1$I$20221009$20240828$20240906$20240906$EXP$$ES-AUROBINDO-AUR-APL-2024-043651$AUROBINDO$$74$YR$$M$Y$77$KG$20240906$$MD$ES$ES
242893271$24289327$1$I$20240711$20240725$20240906$20240906$PER$$US-AMGEN-USASP2024176661$AMGEN$$63$YR$A$M$Y$$$20240906$$CN$US$US
242893281$24289328$1$I$20240826$20240904$20240906$20240906$EXP$$US-ABBVIE-5907402$ABBVIE$$37$YR$$F$Y$$$20240906$$HP$US$US
242893291$24289329$1$I$20231001$20240822$20240906$20240906$EXP$$CN-UCBSA-2024026702$UCB$$35$YR$$F$Y$55$KG$20240906$$MD$CN$CN
242893301$24289330$1$I$20240904$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002794$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240906$$CN$US$US
242893313$24289331$3$F$20240825$20240923$20240906$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005214$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240927$$CN$US$US
242893321$24289332$1$I$$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003672$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240906$$CN$US$US
242893331$24289333$1$I$20240801$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002968$ELI LILLY AND CO$$$$$M$Y$$$20240906$$CN$US$US
242893341$24289334$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002609$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240906$$CN$US$US
242893351$24289335$1$I$$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003448$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240906$$CN$US$US
242893371$24289337$1$I$$20240903$20240906$20240906$EXP$$GB-TAKEDA-2024TUS088672$TAKEDA$$$$$M$Y$$$20240906$$CN$GB$GB
242893381$24289338$1$I$$20240901$20240906$20240906$EXP$$IL-TAKEDA-2024TUS088822$TAKEDA$$$$$F$Y$$$20240906$$CN$IL$IL
242893391$24289339$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010097$APOTEX$$59$YR$$F$Y$$$20240906$$CN$CA$CA
242893401$24289340$1$I$$20240824$20240906$20240906$EXP$$US-UCBSA-2024045530$UCB$Wolf S, Wolf S, Wang R, Petchpradub M, Sacknovitz A, Strafella R.. Resolution of Fenfluramine-Associated Pulmonary Arterial Hypertension in Lennox-Gastaut Syndrome: A Case Report and Literature Review$4$YR$$F$Y$$$20240906$$MD$US$US
242893411$24289341$1$I$$20240902$20240906$20240906$EXP$$US-ROCHE-10000072913$ROCHE$Bender J, Damodharan S, Capitini C, Moskop A, Toner K, Vatsayan A, et al. Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood Advances. 2024-Jun-25;8 (15):4164-4168. doi:10.1182/bloodadvances.2024012928.$$$$$Y$$$20240906$$HP$US$US
242893421$24289342$1$I$$20240829$20240906$20240906$EXP$$CA-TEVA-VS-3238653$TEVA$$11$MON$$M$Y$$$20240906$$HP$CA$CA
242893431$24289343$1$I$$20240820$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08306$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242893451$24289345$1$I$20240904$20240904$20240906$20240906$PER$$US-JNJFOC-20240909367$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240906$$CN$US$US
242893462$24289346$2$F$$20240909$20240906$20240911$EXP$$JP-JNJFOC-20240913044$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240911$$MD$JP$JP
242893471$24289347$1$I$$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-088527-2024$RECKITT BENCKISER$$$$$F$Y$$$20240906$$CN$US$US
242893481$24289348$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176967$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242893491$24289349$1$I$$20240828$20240906$20240906$PER$US-DRL-USA-SPO/USA/24/0012669$US-RDY-SPO/USA/24/0012669$DR REDDYS$$23$YR$A$$Y$$$20240906$$MD$US$US
242893501$24289350$1$I$20240822$20240904$20240906$20240906$EXP$$US-ABBVIE-5907348$ABBVIE$$70$YR$$F$Y$$$20240906$$CN$US$US
242893521$24289352$1$I$$20240902$20240906$20240906$EXP$$GB-TAKEDA-2024TUS088670$TAKEDA$$$$$M$Y$$$20240906$$CN$GB$GB
242893532$24289353$2$F$20240401$20240905$20240906$20240912$EXP$$CA-TAKEDA-2024TUS031615$TAKEDA$$80$YR$$F$Y$$$20240912$$CN$CA$CA
242893541$24289354$1$I$20230315$20240828$20240906$20240906$EXP$HR-HALMED-300086373$HR-Accord-444426$ACCORD$$41$YR$A$F$Y$56$KG$20240906$$CN$HR$HR
242893551$24289355$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024177364$AMGEN$$$$$$Y$$$20240906$$CN$US$US
242893561$24289356$1$I$20240821$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177281$AMGEN$$83$YR$E$F$Y$$$20240906$$CN$US$US
242893571$24289357$1$I$20240829$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176795$AMGEN$$67$YR$E$F$Y$$$20240906$$HP$US$US
242893581$24289358$1$I$$20240827$20240906$20240906$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08156$HIKMA$Hassan AM, Hill H, Donley C, Leonelli C.. Hassan AM, Hill H, Donley C, Leonelli C. Potential anaphylactoid reaction to nicardipine.. J Am Coll Emerg Physicians Open. 2024;5(4):e13271$52$YR$$M$Y$$$20240906$$MD$US$US
242893591$24289359$1$I$$20240903$20240906$20240906$EXP$$US-AMGEN-USASP2024176364$AMGEN$$$$A$$Y$$$20240906$$MD$US$US
242893602$24289360$2$F$$20240920$20240906$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005134$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
242893611$24289361$1$I$$20240827$20240906$20240906$EXP$$BR-Accord-444438$ACCORD$$74$YR$E$$Y$$$20240906$$PH$BR$BR
242893621$24289362$1$I$20240723$20240904$20240906$20240906$EXP$FR-AFSSAPS-RN2024000941$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-140661$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240906$$PH$FR$FR
242893641$24289364$1$I$20240815$20240828$20240906$20240906$EXP$IT-MINISAL02-999575$IT-Accord-444437$ACCORD$$82$YR$E$M$Y$$$20240906$$MD$IT$IT
242893651$24289365$1$I$$20240904$20240906$20240906$EXP$$CA-TAKEDA-2024TUS089016$TAKEDA$$$$$M$Y$$$20240906$$CN$CA$CA
242893671$24289367$1$I$$20240829$20240906$20240906$EXP$GB-MHRA-MED-202408291146371510-GMSLN$GB-ROCHE-10000069670$ROCHE$$59$YR$A$M$Y$$$20240906$$HP$GB$GB
242893681$24289368$1$I$20240701$20240823$20240906$20240906$EXP$$US-UCBSA-2024043312$UCB$$36$YR$$F$Y$$$20240906$$HP$US$US
242893691$24289369$1$I$$20240904$20240906$20240906$EXP$$US-TAKEDA-2024TUS008843$TAKEDA$$$$$F$Y$53$KG$20240906$$CN$US$US
242893701$24289370$1$I$$20240827$20240906$20240906$EXP$US-MLMSERVICE-20240821-PI166205-00275-1$US-JUBILANT CADISTA PHARMACEUTICALS-2024US001243$JUBILANT$Rink DE, Abramson RH, Johnson NJ, Lee RY.. Diagnostic Confounders in Brain Death A Woman with Unexplained Coma and Brainstem Areflexia.. Annals of the American Thoracic Society. 2024;21(8):1204-8$60$YR$$F$Y$$$20240906$$MD$US$US
242893711$24289371$1$I$$20240903$20240906$20240906$EXP$$IN-ROCHE-10000073695$ROCHE$$76$YR$E$M$Y$$$20240906$$CN$IN$IN
242893721$24289372$1$I$20240827$20240829$20240906$20240906$EXP$$US-ORPHANEU-2024006734$RECORDATI$$$$$$Y$$$20240906$$CN$US$US
242893731$24289373$1$I$20240708$20240828$20240906$20240906$EXP$FR-AFSSAPS-LM2024000468$FR-Accord-444321$ACCORD$$68$YR$E$M$Y$59.7$KG$20240906$$MD$FR$FR
242893741$24289374$1$I$20240826$20240827$20240906$20240906$30DAY$$GB-JNJFOC-20240873834$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240906$$CN$GB$GB
242893751$24289375$1$I$$20240829$20240906$20240906$EXP$$BR-JNJFOC-20240904808$JOHNSON AND JOHNSON$$58$YR$A$F$Y$69$KG$20240906$$CN$BR$BR
242893761$24289376$1$I$$20240904$20240906$20240906$EXP$$US-JNJFOC-20240908061$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$CN$US$US
242893771$24289377$1$I$$20240904$20240906$20240906$EXP$$DE-JNJFOC-20240913381$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$MD$DE$DE
242893781$24289378$1$I$20240612$20240828$20240906$20240906$EXP$SE-SEMPA-2024-006205$SE-Accord-444433$ACCORD$$76$YR$E$F$Y$$$20240906$$MD$SE$SE
242893791$24289379$1$I$20230928$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408270745395860-NYMJH$GB-JUBILANT PHARMA LTD-2024GB001253$JUBILANT$$67$YR$$F$Y$52$KG$20240906$$CN$GB$GB
242893811$24289381$1$I$$20240828$20240906$20240906$PER$$US-TEVA-VS-3237979$TEVA$$66$YR$$$Y$$$20240906$$CN$US$US
242893821$24289382$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5906441$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242893831$24289383$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176822$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242893842$24289384$2$F$20240101$20240905$20240906$20240912$PER$$US-AMGEN-USASP2024177712$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
242893852$24289385$2$F$20240903$20240920$20240906$20240921$PER$$US-AMGEN-USASP2024177169$AMGEN$$33$YR$A$F$Y$$$20240921$$CN$US$US
242893861$24289386$1$I$20240805$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177373$AMGEN$$65$YR$E$M$Y$$$20240906$$CN$US$US
242893871$24289387$1$I$$20240826$20240906$20240906$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08920$LUPIN$Varney SM, Watkins S, Stuteville H, Winter ML, Gao HT, Martin TG, et al. An analysis of clinical outcomes of exploratory pediatric Metformin ingestions reported to the texas poison center network from 2011 to 2021. Hospital Pharmacy. 2024;59(4):465-470$$$C$$Y$$$20240906$$HP$US$US
242893881$24289388$1$I$20230901$20240822$20240906$20240906$EXP$$FR-AZURITY PHARMACEUTICALS, INC.-AZR202408-000546$AZURITY PHARMACEUTICALS$$44$YR$$F$Y$96.9$KG$20240906$$MD$FR$FR
242893892$24289389$2$F$20240731$20240909$20240906$20240912$EXP$$IE-CELLTRION INC.-2024IE021031$CELLTRION$$$$$$Y$$$20240912$$CN$IE$IE
242893901$24289390$1$I$$20240829$20240906$20240906$PER$$US-ROCHE-10000071227$ROCHE$$$$A$F$Y$104.32$KG$20240906$$CN$US$US
242893911$24289391$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002815$ELI LILLY AND CO$$$$$M$Y$$$20240906$$CN$US$US
242893921$24289392$1$I$20240801$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002911$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240906$$CN$US$US
242893931$24289393$1$I$$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003487$ELI LILLY AND CO$$51$YR$A$$Y$$$20240906$$CN$US$US
242893941$24289394$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002781$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240906$$CN$US$US
242893952$24289395$2$F$$20240904$20240906$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003055$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240910$$HP$US$US
242893961$24289396$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002464$ELI LILLY AND CO$$$$$F$Y$$$20240906$$CN$US$US
242893971$24289397$1$I$20240801$20240903$20240906$20240906$EXP$$US-AMGEN-USASP2024175982$AMGEN$$74$YR$E$M$Y$$$20240906$$CN$US$US
242893982$24289398$2$F$20240826$20240917$20240906$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027456$UNITED THERAPEUTICS$$73$YR$$F$Y$63.492$KG$20240926$$$US$US
242893991$24289399$1$I$20240104$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-083366-2024$RECKITT BENCKISER$$$$$M$Y$$$20240906$$CN$US$US
242894011$24289401$1$I$$20240828$20240906$20240906$EXP$GB-MHRA-MED-202408280906441100-ZYGRK$GB-Accord-443898$ACCORD$$$$$M$Y$$$20240906$$PH$GB$GB
242894021$24289402$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141757$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240906$$CN$US$US
242894031$24289403$1$I$$20240904$20240906$20240906$PER$$US-ROCHE-10000075050$ROCHE$$$$$$Y$$$20240906$$MD$US$US
242894041$24289404$1$I$$20240904$20240906$20240906$PER$$US-ROCHE-10000075133$ROCHE$$$$$$Y$$$20240906$$CN$US$US
242894051$24289405$1$I$$20240828$20240906$20240906$EXP$$DE-MSNLABS-2024MSNLIT01915$MSN LABORATORIES$Holzer MT, Kotter I, Xiong T, Ruffer N, Feindt FC, Melderis S, et al.Daratumumab for refractory systemic rheumatic diseases: a single center experience.Annals of the Rheumatic Diseases.83:2133-4$$$$$Y$$$20240906$$HP$DE$DE
242894061$24289406$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000073817$ROCHE$$66$YR$E$F$Y$$$20240906$$CN$US$US
242894071$24289407$1$I$20240105$20240828$20240906$20240906$EXP$$US-JNJFOC-20240901239$JOHNSON AND JOHNSON$$0$YR$$F$Y$5.64$KG$20240906$$HP$US$US
242894082$24289408$2$F$20240710$20240910$20240906$20240924$30DAY$$AR-JNJFOC-20240861824$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$AR$AR
242894091$24289409$1$I$$20240828$20240906$20240906$PER$$US-APOTEX-2024AP010182$APOTEX$Tuan JJ, Ogbuagu O, Kumar D, Altice F, Fikrig M. Acute kidney injury due to myoglobin cast nephropathy in the setting of coronavirus disease 2019-mediated rhabdomyolysis: a case report. Journal of Medical Case Reports. 2022;16:491:1-8$67$YR$$M$Y$$$20240906$$HP$US$US
242894101$24289410$1$I$20240717$20240726$20240906$20240906$PER$$US-ASCENT-2024ASSPO00019$ASCENT$$72$YR$E$M$Y$184$KG$20240906$$CN$US$US
242894111$24289411$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A199346$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242894121$24289412$1$I$$20240825$20240906$20240906$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07768$HIKMA$$$$$M$Y$$$20240906$$CN$US$US
242894132$24289413$2$F$$20240916$20240906$20240924$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08630$LUPIN$$$$$$Y$$$20240924$$HP$US$US
242894151$24289415$1$I$20160918$20240902$20240906$20240906$EXP$DE-EMA-DD-20190627-agrahari_p-134139$DE-RDY-GER/GER/19/0111504$DR REDDYS$$20$YR$A$F$Y$54$KG$20240906$$MD$DE$DE
242894161$24289416$1$I$20240728$20240906$20240906$20240906$EXP$FR-AFSSAPS-LM2024000487$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049943$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$63.8$KG$20240906$$MD$FR$FR
242894171$24289417$1$I$$20240904$20240906$20240906$PER$$US-ROCHE-10000074872$ROCHE$$54$YR$A$F$Y$$$20240906$$CN$US$US
242894181$24289418$1$I$20240527$20240828$20240906$20240906$EXP$$IN-ROCHE-10000069450$ROCHE$$65$YR$E$M$Y$$$20240906$$CN$IN$IN
242894191$24289419$1$I$20240831$20240903$20240906$20240906$PER$$US-009507513-2409USA001535$MERCK$$66$YR$$F$Y$$$20240906$$CN$US$US
242894203$24289420$3$F$$20240918$20240906$20240927$EXP$$CA-TEVA-VS-3238652$TEVA$$43$YR$$M$Y$$$20240927$$HP$CA$CA
242894211$24289421$1$I$$20240827$20240906$20240906$PER$$US-ABBVIE-5900496$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242894221$24289422$1$I$$20240903$20240906$20240906$EXP$$NVSC2024US177270$NOVARTIS$$25$YR$$$Y$$$20240906$$CN$US$US
242894231$24289423$1$I$$20240904$20240906$20240906$PER$$US-ROCHE-10000074942$ROCHE$$48$YR$A$F$Y$$$20240906$$CN$US$US
242894241$24289424$1$I$$20240904$20240906$20240906$PER$$US-ROCHE-10000074284$ROCHE$$40$YR$A$F$Y$$$20240906$$CN$US$US
242894251$24289425$1$I$$20240827$20240906$20240906$PER$$US-TAKEDA-2024TUS086593$TAKEDA$$$$$M$Y$$$20240906$$HP$US$US
242894262$24289426$2$F$20240308$20240912$20240906$20240919$EXP$FR-AFSSAPS-AVMA2024000349$FR-TEVA-VS-3238606$TEVA$$32$YR$$M$Y$$$20240919$$PH$FR$FR
242894271$24289427$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010085$APOTEX$$67$YR$$M$Y$$$20240906$$CN$CA$CA
242894281$24289428$1$I$$20240828$20240906$20240906$EXP$$JP-009507513-2408JPN003870J$MERCK$$64$YR$$F$Y$$$20240906$$MD$JP$JP
242894291$24289429$1$I$20240831$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177569$AMGEN$$96$YR$E$F$Y$$$20240906$$CN$US$US
242894301$24289430$1$I$$20240905$20240906$20240906$PER$$US-ROCHE-10000075675$ROCHE$$$$$$Y$$$20240906$$PH$US$US
242894311$24289431$1$I$$20240827$20240906$20240906$EXP$$US-CELLTRION INC.-2024US021140$CELLTRION$Jones AA, Martin JS, Giangiacomo AL, Costakos DM.. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity.. American Journal of Ophthalmology Case Reports. 2024;36:102131:1-4$$$$$Y$$$20240906$$HP$US$US
242894321$24289432$1$I$20240125$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004674$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240906$$CN$US$US
242894331$24289433$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000073621$ROCHE$$$$$$Y$$$20240906$$CN$US$US
242894341$24289434$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000073579$ROCHE$$$$A$F$Y$$$20240906$$CN$US$US
242894361$24289436$1$I$20240101$20240829$20240906$20240906$EXP$$US-ABBVIE-5904609$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242894371$24289437$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906456$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242894381$24289438$1$I$20231204$20240828$20240906$20240906$EXP$GB-MHRA-MED-202408281453067760-KDCVT$GB-Accord-444352$ACCORD$$$$$$Y$$$20240906$$CN$GB$GB
242894391$24289439$1$I$$20240905$20240906$20240906$PER$$US-ROCHE-10000075518$ROCHE$$$$T$F$Y$$$20240906$$MD$US$US
242894402$24289440$2$F$20231001$20240909$20240906$20240914$EXP$$US-ABBVIE-5906016$ABBVIE$$62$YR$$F$Y$$$20240914$$CN$US$US
242894411$24289441$1$I$20240101$20240904$20240906$20240906$EXP$$US-ABBVIE-5907369$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242894422$24289442$2$F$20240801$20240906$20240906$20240910$PER$$US-JNJFOC-20240900691$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240910$$CN$US$US
242894434$24289443$4$F$20240903$20240917$20240906$20240919$PER$$US-AMGEN-USASP2024177863$AMGEN$$58$YR$A$F$Y$$$20240919$$CN$US$US
242894452$24289445$2$F$20240829$20240912$20240906$20240914$PER$$US-AMGEN-USASP2024172955$AMGEN$$76$YR$E$F$Y$$$20240914$$MD$US$US
242894461$24289446$1$I$$20240829$20240906$20240906$EXP$$CA-TEVA-VS-3238676$TEVA$$74$YR$$F$Y$64$KG$20240906$$CN$CA$CA
242894471$24289447$1$I$$20240904$20240906$20240906$EXP$$CA-JNJFOC-20240910604$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240906$$HP$CA$CA
242894481$24289448$1$I$$20240829$20240906$20240906$EXP$$CA-APOTEX-2024AP010151$APOTEX$$67$YR$$F$Y$$$20240906$$PH$CA$CA
242894491$24289449$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5907292$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242894501$24289450$1$I$$20240821$20240906$20240906$PER$$US-ABBVIE-5907767$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242894511$24289451$1$I$$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-088529-2024$RECKITT BENCKISER$$$$$M$Y$$$20240906$$CN$US$US
242894521$24289452$1$I$$20240813$20240906$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004675$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242894531$24289453$1$I$20230701$20240829$20240906$20240906$EXP$DE-EMBRYOTOX-202305424$DE-HBP-2024DE031157$HELSINN HEALTHCARE$$$$$M$Y$2.535$KG$20240906$$MD$DE$DE
242894541$24289454$1$I$20240601$20240830$20240906$20240906$PER$$US-ABBVIE-5903397$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242894551$24289455$1$I$20240729$20240903$20240906$20240906$PER$$US-ABBVIE-5907574$ABBVIE$$37$YR$$F$Y$$$20240906$$HP$US$US
242894562$24289456$2$F$$20240823$20240906$20240921$EXP$GB-MHRA-MED-202408231918201240-SFTWV$GB-GLENMARK PHARMACEUTICALS-2024GMK093646$GLENMARK$$$$$$Y$$$20240921$$CN$GB$GB
242894572$24289457$2$F$$20240904$20240906$20240910$EXP$$CH-TAKEDA-2024TUS088616$TAKEDA$$84$YR$$F$Y$$$20240910$$MD$CH$CH
242894591$24289459$1$I$20240601$20240904$20240906$20240906$EXP$$AU-ABBVIE-5908077$ABBVIE$$81$YR$$F$Y$$$20240906$$HP$AU$AU
242894601$24289460$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5906370$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242894611$24289461$1$I$$20240829$20240906$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-141618$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240906$$MD$JP$JP
242894621$24289462$1$I$20230201$20240905$20240906$20240906$EXP$AT-BASGAGES-2024-006460$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-141529$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240906$$CN$AT$AT
242894631$24289463$1$I$20240701$20240903$20240906$20240906$EXP$$US-ABBVIE-5906088$ABBVIE$$67$YR$$F$Y$$$20240906$$CN$US$US
242894641$24289464$1$I$20230101$20240903$20240906$20240906$EXP$$US-ABBVIE-5906146$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242894651$24289465$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010116$APOTEX$$76$YR$$M$Y$$$20240906$$CN$CA$CA
242894661$24289466$1$I$20240809$20240828$20240906$20240906$EXP$$IT-AUROBINDO-AUR-APL-2024-043573$AUROBINDO$$51$YR$$M$Y$$$20240906$$MD$IT$IT
242894673$24289467$3$F$$20240920$20240906$20240930$EXP$$JP-ASTELLAS-2024-AER-002850$ASTELLAS$$96$YR$E$M$Y$$$20240930$$PH$JP$JP
242894691$24289469$1$I$20240820$20240904$20240906$20240906$EXP$$CN-ROCHE-10000074481$ROCHE$$67$YR$E$F$Y$$$20240906$$HP$CN$CN
242894701$24289470$1$I$20240812$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A199128$ASTRAZENECA$$23555$DY$$F$Y$65.3$KG$20240906$$CN$US$
242894711$24289471$1$I$$20240901$20240906$20240906$PER$$US-AstraZeneca-2024A201839$ASTRAZENECA$$$$$$Y$$$20240906$$HP$US$
242894721$24289472$1$I$$20240830$20240906$20240906$EXP$$FR-AstraZeneca-2024A200830$ASTRAZENECA$$$$$M$Y$$$20240906$$MD$FR$
242894731$24289473$1$I$$20240823$20240906$20240906$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08094$HIKMA$Kim K, Llanos D, Ramos C, Shahnavaz N, Adhyaru BB. Kim K, Llanos D, Ramos C, Shahnavaz N, Adhyaru BB. Finding the Balance: Venous Thromboembolism Prophylaxis during Hematochezia in Crohn^s Disease.. Case Reports in Gastroenterology. 2024;18(1):367-372$39$YR$$F$Y$$$20240906$$MD$US$US
242894741$24289474$1$I$20240701$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002917$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240906$$CN$US$US
242894751$24289475$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000073980$ROCHE$$$$$$Y$$$20240906$$CN$US$US
242894761$24289476$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002751$ELI LILLY AND CO$$$$$M$Y$$$20240906$$CN$US$US
242894771$24289477$1$I$20240903$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002503$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240906$$CN$US$US
242894781$24289478$1$I$20240824$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002956$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240906$$CN$US$US
242894791$24289479$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024175621$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242894801$24289480$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004676$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242894811$24289481$1$I$20240201$20240828$20240906$20240906$EXP$FR-AFSSAPS-BX2024001668$FR-Accord-444513$ACCORD$$66$YR$E$M$Y$68$KG$20240906$$MD$FR$FR
242894821$24289482$1$I$20240822$20240904$20240906$20240906$EXP$$US-TAKEDA-2024TUS088718$TAKEDA$$67$YR$$F$Y$$$20240906$$CN$US$US
242894831$24289483$1$I$$20240902$20240906$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-141087$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240906$$MD$JP$JP
242894841$24289484$1$I$20240101$20240830$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139277$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240906$$PH$US$US
242894851$24289485$1$I$20240101$20240827$20240906$20240906$EXP$$US-ORPHANEU-2024006647$RECORDATI$$$$$$Y$$$20240906$$CN$US$US
242894861$24289486$1$I$$20240826$20240906$20240906$PER$$US-HBP-2024US031012$HELSINN HEALTHCARE$$$$$M$Y$$$20240906$$CN$US$US
242894871$24289487$1$I$20230403$20240823$20240906$20240906$EXP$$AR-SANDOZ INC.-SDZ2024AR078080$SANDOZ$$66$YR$$F$Y$73$KG$20240906$$CN$AR$AR
242894881$24289488$1$I$$20240905$20240906$20240906$EXP$$CA-ROCHE-10000075228$ROCHE$$$$A$F$Y$$$20240906$$CN$CA$CA
242894891$24289489$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000073365$ROCHE$$$$$$Y$$$20240906$$CN$US$US
242894911$24289491$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000073803$ROCHE$$64$YR$A$F$Y$$$20240906$$CN$US$US
242894921$24289492$1$I$$20240830$20240906$20240906$PER$$US-ROCHE-10000071186$ROCHE$$$$E$F$Y$$$20240906$$CN$US$US
242894931$24289493$1$I$20240704$20240830$20240906$20240906$EXP$FR-AFSSAPS-TS2024000940$FR-EMD Serono-2024046839$EMD SERONO INC$$68$YR$E$M$Y$108$KG$20240906$$MD$FR$FR
242894941$24289494$1$I$$20240905$20240906$20240906$EXP$$US-SANDOZ INC.-SDZ2024US078212$SANDOZ$$$$$F$Y$$$20240906$$CN$US$US
242894951$24289495$1$I$$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-088476-2024$RECKITT BENCKISER$$$$$$Y$$$20240906$$CN$US$US
242894961$24289496$1$I$$20240902$20240906$20240906$PER$$US-ROCHE-10000071767$ROCHE$Lapite A, S?nchez L, Rae M, Ramirez A, Muscal E, Yildirim-Toruner C, et al. Concomitant sickle cell disease and systemic lupus erythematosus: A single-center case series. Pediatric Blood and Cancer. 2024-Oct;71 (10):1-5. doi:10.1002/pbc.31194.$15$YR$T$F$Y$$$20240906$$HP$US$US
242894971$24289497$1$I$20240729$20240827$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024106526$VIIV$$32$YR$$M$Y$$$20240906$$MD$US$US
242894981$24289498$1$I$20231201$20240828$20240906$20240906$EXP$IE-HPRA-2024-114894$IE-Accord-444339$ACCORD$$$$$F$Y$$$20240906$$HP$IE$IE
242894991$24289499$1$I$$20240829$20240906$20240906$PER$$US-JNJFOC-20240880904$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242895001$24289500$1$I$$20240828$20240906$20240906$EXP$$US-JNJFOC-20240876629$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242895011$24289501$1$I$$20240829$20240906$20240906$EXP$$US-JNJFOC-20240881250$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$CN$US$US
242895021$24289502$1$I$$20240826$20240906$20240906$PER$$US-JNJFOC-20240876847$JOHNSON AND JOHNSON$$$$$M$Y$43.2$KG$20240906$$CN$US$US
242895032$24289503$2$F$$20240905$20240906$20240912$PER$$US-AMGEN-USASP2024177690$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
242895041$24289504$1$I$$20240828$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-013513$AUROBINDO$Almulhim FA, McKinney ML, Gurpreet KK. A Winding Path to a Diagnosis: A Case of Alveolar Capillary Dysplasia With Misalignment of the Pulmonary Veins. Am-J-Respir-Crit-Care-Med. 2023;207:A3673$$$N$F$Y$$$20240906$$HP$CA$CA
242895051$24289505$1$I$20240903$20240904$20240906$20240906$PER$$US-AMGEN-USASL2024177438$AMGEN$$$$$M$Y$$$20240906$$CN$US$US
242895061$24289506$1$I$20230912$20240829$20240906$20240906$EXP$$CA-TAKEDA-2024TUS025703$TAKEDA$$58$YR$$F$Y$$$20240906$$MD$CA$CA
242895071$24289507$1$I$20240708$20240902$20240906$20240906$EXP$$PK-ROCHE-10000040117$ROCHE$$35$YR$A$F$Y$$$20240906$$CN$PK$PK
242895081$24289508$1$I$$20240827$20240906$20240906$PER$$US-ABBVIE-5900940$ABBVIE$$$$$$Y$$$20240906$$MD$US$US
242895091$24289509$1$I$20240825$20240827$20240906$20240906$PER$$US-ABBVIE-5898109$ABBVIE$$79$YR$$M$Y$68$KG$20240906$$CN$US$US
242895101$24289510$1$I$$20240904$20240906$20240906$PER$$US-ABBVIE-5907282$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242895111$24289511$1$I$$20240827$20240906$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005061$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242895121$24289512$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010086$APOTEX$$56$YR$$F$Y$$$20240906$$CN$CA$CA
242895141$24289514$1$I$20240808$20240827$20240906$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005062$ACADIA PHARMACEUTICALS$$87$YR$$F$Y$$$20240906$$CN$US$US
242895151$24289515$1$I$20240331$20240829$20240906$20240906$EXP$GB-MHRA-MED-202408291408435580-SVPLY$GB-CELLTRION INC.-2024GB020980$CELLTRION$$$$$$Y$$$20240906$$CN$GB$GB
242895161$24289516$1$I$$20240828$20240906$20240906$EXP$$JP-ROCHE-10000073656$ROCHE$$9$DEC$E$$Y$$$20240906$$MD$JP$JP
242895172$24289517$2$F$20240808$20240905$20240906$20240910$EXP$$US-ROCHE-10000075324$ROCHE$$45$YR$A$F$Y$115.67$KG$20240910$$CN$US$US
242895182$24289518$2$F$20240902$20240905$20240906$20240909$EXP$$US-ROCHE-10000075406$ROCHE$$59$YR$A$F$Y$52.61$KG$20240909$$CN$US$US
242895191$24289519$1$I$$20240829$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR108298$VIIV$$$$$M$Y$$$20240906$$PH$US$US
242895201$24289520$1$I$20240826$20240827$20240906$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005063$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240906$$CN$US$US
242895211$24289521$1$I$$20240827$20240906$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005066$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242895221$24289522$1$I$20240720$20240828$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043538$AUROBINDO$$37$YR$$M$Y$68.1$KG$20240906$$MD$FR$FR
242895232$24289523$2$F$$20240910$20240906$20240912$PER$$US-JNJFOC-20240873833$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
242895243$24289524$3$F$20240827$20240910$20240906$20240916$EXP$$IE-EMD Serono-2024046556$EMD SERONO INC$$71$YR$E$M$Y$$$20240916$$CN$IE$IE
242895251$24289525$1$I$20240705$20240828$20240906$20240906$EXP$FR-AFSSAPS-LM2024000469$FR-Accord-444531$ACCORD$$68$YR$E$M$Y$59.7$KG$20240906$$MD$FR$FR
242895261$24289526$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5906906$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242895271$24289527$1$I$$20240828$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043904$AUROBINDO$$62$YR$$M$Y$$$20240906$$HP$CA$CA
242895281$24289528$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5906636$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242895291$24289529$1$I$20240619$20240829$20240906$20240906$EXP$FR-AFSSAPS-TS2024000926$FR-TEVA-VS-3238996$TEVA$$45$YR$$M$Y$85.6$KG$20240906$$MD$FR$FR
242895301$24289530$1$I$$20240904$20240906$20240906$EXP$$US-ABBVIE-5908762$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242895311$24289531$1$I$20240701$20240828$20240906$20240906$EXP$$DE-AUROBINDO-AUR-APL-2024-043463$AUROBINDO$$72$YR$$F$Y$$$20240906$$MD$DE$DE
242895321$24289532$1$I$20240826$20240905$20240906$20240906$EXP$$CN-ROCHE-10000075197$ROCHE$$45$YR$A$M$Y$$$20240906$$HP$CN$CN
242895331$24289533$1$I$20201021$20240828$20240906$20240906$EXP$$PL-AUROBINDO-AUR-APL-2024-043637$AUROBINDO$$70$YR$$F$Y$70$KG$20240906$$HP$PL$PL
242895341$24289534$1$I$$20240827$20240906$20240906$EXP$$JP-ASTELLAS-2024JP003375$ASTELLAS$$60$YR$A$M$Y$$$20240906$$MD$JP$JP
242895351$24289535$1$I$$20240904$20240906$20240906$PER$$US-ABBVIE-5906994$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242895361$24289536$1$I$$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-087799-2024$RECKITT BENCKISER$$87$YR$$M$Y$54.55$KG$20240906$$CN$US$US
242895371$24289537$1$I$20240507$20240904$20240906$20240906$EXP$$NVSC2024US178875$NOVARTIS$$71$YR$$M$Y$$$20240906$$HP$US$US
242895381$24289538$1$I$20240807$20240827$20240906$20240906$EXP$$US-Accord-444104$ACCORD$$58$YR$A$M$Y$$$20240906$$MD$US$US
242895391$24289539$1$I$$20240828$20240906$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-043446$AUROBINDO$$71$YR$$F$Y$65$KG$20240906$$HP$GB$GB
242895401$24289540$1$I$20240829$20240903$20240906$20240906$EXP$$AU-ROCHE-10000072362$ROCHE$$17$YR$T$M$Y$85$KG$20240906$$MD$AU$AU
242895411$24289541$1$I$$20240830$20240906$20240906$EXP$$JP-GSK-JP2024109000$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$JP$JP
242895421$24289542$1$I$$20240830$20240906$20240906$EXP$$JP-GSK-JP2024108977$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$JP$JP
242895431$24289543$1$I$$20240828$20240906$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-043442$AUROBINDO$$21$YR$$F$Y$71$KG$20240906$$HP$GB$GB
242895441$24289544$1$I$$20240830$20240906$20240906$EXP$$ZA-AstraZeneca-2024A198545$ASTRAZENECA$$75$YR$$M$Y$$$20240906$$CN$ZA$
242895451$24289545$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A198899$ASTRAZENECA$$$$T$F$Y$41.7$KG$20240906$$HP$US$
242895461$24289546$1$I$$20240830$20240906$20240906$EXP$$DE-AstraZeneca-2024A198501$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$DE$
242895472$24289547$2$F$20240814$20240830$20240906$20240909$EXP$$CN-AstraZeneca-2024A198989$ASTRAZENECA$$58$YR$$M$Y$60$KG$20240909$$MD$CN$
242895481$24289548$1$I$$20240830$20240906$20240906$EXP$$TW-AMGEN-TWNSP2024176492$AMGEN$Hung Y.; Wu W.; Hsu C. et al.. Incorporating Tumor Genomic Profiling and Circulating Tumor Cell-derived Organoids into Clinical Practice for Gastrointestinal cancers. Anticancer research. 2024;44(8):3481-3491$43$YR$A$F$Y$$$20240906$$MD$TW$TW
242895491$24289549$1$I$20240822$20240828$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043601$AUROBINDO$$76$YR$$F$Y$45$KG$20240906$$MD$FR$FR
242895501$24289550$1$I$20210101$20240830$20240906$20240906$EXP$$DE-009507513-2409DEU001484$MERCK$$$$A$F$Y$$$20240906$$MD$DE$DE
242895511$24289551$1$I$$20240902$20240906$20240906$EXP$$SA-AMGEN-SAUSP2024177416$AMGEN$Aleid M.; Alrajhi A.; Alwadi M. et al.. Blinatumomab With Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S280$$$$$Y$$$20240906$$MD$SA$SA
242895521$24289552$1$I$20240805$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176776$AMGEN$$20$YR$A$F$Y$$$20240906$$HP$US$US
242895531$24289553$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010109$APOTEX$$73$YR$$F$Y$$$20240906$$CN$CA$CA
242895541$24289554$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141572$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240906$$HP$US$US
242895551$24289555$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141773$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$94.8$KG$20240906$$CN$US$US
242895561$24289556$1$I$$20240828$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043930$AUROBINDO$$62$YR$$M$Y$$$20240906$$HP$CA$CA
242895571$24289557$1$I$20240801$20240903$20240906$20240906$EXP$FR-AFSSAPS-MP2024001355$FR-ABBVIE-5906271$ABBVIE$$38$YR$$F$Y$60$KG$20240906$$CN$FR$FR
242895581$24289558$1$I$$20240828$20240906$20240906$EXP$$AU-CELLTRION INC.-2024AU021247$CELLTRION$$$$$$Y$$$20240906$$MD$AU$AU
242895591$24289559$1$I$20240819$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141574$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240906$$PH$US$US
242895601$24289560$1$I$$20240826$20240906$20240906$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08921$LUPIN$Varney SM, Watkins S, Stuteville H, Winter ML, Gao HT, Martin TG, et al. An analysis of clinical outcomes of exploratory pediatric Metformin ingestions reported to the texas poison center network from 2011 to 2021. Hospital Pharmacy. 2024;59(4):465-470$$$C$$Y$$$20240906$$HP$US$US
242895612$24289561$2$F$$20240910$20240906$20240917$EXP$$PT-TAKEDA-2024TUS088482$TAKEDA$$$$$F$Y$$$20240917$$HP$PT$PT
242895622$24289562$2$F$$20240913$20240906$20240923$EXP$$ES-AUROBINDO-AUR-APL-2024-043658$AUROBINDO$J.F. Orts Paco. NIKOLSKY POSITIVO: LA PUNTA DEL ICEBERG.(NIKOLSKY POSITIVE: THE TIP OF THE ICEBERG.). Actas Dermosifiliogr.. 2024;115:S58-S63$87$YR$$F$Y$$$20240923$$MD$ES$ES
242895631$24289563$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010091$APOTEX$$56$YR$$F$Y$$$20240906$$CN$CA$CA
242895642$24289564$2$F$$20240906$20240906$20240911$EXP$$NZ-JNJFOC-20240900249$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$HP$NZ$NZ
242895651$24289565$1$I$$20240826$20240906$20240906$PER$$US-JNJFOC-20240869047$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$CN$US$US
242895661$24289566$1$I$20240301$20240830$20240906$20240906$EXP$$US-JNJFOC-20240881491$JOHNSON AND JOHNSON$$78$YR$E$$Y$$$20240906$$HP$US$US
242895671$24289567$1$I$$20240820$20240906$20240906$PER$$US-JNJFOC-20240855606$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242895681$24289568$1$I$$20240905$20240906$20240906$PER$$US-GILEAD-2024-0686426$GILEAD$$$$$F$Y$$$20240906$$HP$US$US
242895691$24289569$1$I$$20240831$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002904$ELI LILLY AND CO$$$$$$Y$$$20240906$$CN$US$US
242895701$24289570$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001833$ELI LILLY AND CO$$$$$$Y$$$20240906$$CN$US$US
242895711$24289571$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002799$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240906$$CN$US$US
242895722$24289572$2$F$20240901$20240904$20240906$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409001824$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240910$$CN$US$US
242895731$24289573$1$I$20240829$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002991$ELI LILLY AND CO$$69$YR$E$$Y$$$20240906$$CN$US$US
242895743$24289574$3$F$20240101$20240909$20240906$20240926$EXP$$DE-SA-2024SA257840$SANOFI AVENTIS$$$$$F$Y$$$20240926$$HP$DE$DE
242895751$24289575$1$I$20240829$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177601$AMGEN$$64$YR$A$F$Y$$$20240906$$CN$US$US
242895771$24289577$1$I$$20240830$20240906$20240906$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001784$BLUEPRINT MEDICINES$$$$$M$Y$$$20240906$$HP$US$US
242895782$24289578$2$F$20240825$20240906$20240906$20240920$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001751$BLUEPRINT MEDICINES$$22$YR$A$F$Y$$$20240920$$CN$US$US
242895791$24289579$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010110$APOTEX$$74$YR$$F$Y$$$20240906$$CN$CA$CA
242895811$24289581$1$I$$20240903$20240906$20240906$PER$$US-ALXN-202409USA000089US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242895821$24289582$1$I$20240101$20240827$20240906$20240906$PER$$US-ABBVIE-5898976$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242895831$24289583$1$I$$20240903$20240906$20240906$EXP$$US-HALEON-2195249$Haleon PLC$$78$YR$$F$Y$$$20240906$$CN$US$US
242895841$24289584$1$I$$20240827$20240906$20240906$EXP$$US-Accord-444151$ACCORD$$59$YR$A$F$Y$$$20240906$$PH$US$US
242895851$24289585$1$I$20240826$20240827$20240906$20240906$EXP$$US-Accord-444103$ACCORD$$49$YR$A$M$Y$$$20240906$$PH$US$US
242895861$24289586$1$I$20230101$20240902$20240906$20240906$EXP$DE-EMBRYOTOX-202310245$DE-UCBSA-2024044636$UCB$$$$$F$Y$2.6$KG$20240906$$MD$DE$DE
242895871$24289587$1$I$$20240829$20240906$20240906$EXP$$US-Axsome Therapeutics, Inc.-AXS202408-001316$AXSOME THERAPEUTICS$$27$YR$A$F$Y$$$20240906$$$COUNTRY NOT SPECIFIED$
242895881$24289588$1$I$20240801$20240816$20240906$20240906$PER$$US-RDY-SPO/USA/24/0012803$DR REDDYS$$16$YR$T$M$Y$$$20240906$$CN$US$US
242895891$24289589$1$I$20240829$20240829$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024107847$VIIV$$38$YR$$M$Y$$$20240906$$HP$US$US
242895901$24289590$1$I$$20240828$20240906$20240906$PER$$US-ABBVIE-5900498$ABBVIE$$$$$F$Y$$$20240906$$HP$US$US
242895911$24289591$1$I$$20240830$20240906$20240906$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01776$NOVITIUM PHARMA$Ken Takahashi.Overdose of angiotensin II receptor blocker in the third trimester of pregnancy: A case report.The Journal of Obstetrics and Gynaecology Research.20-JUN-2024;50(8):1425-1428$23$YR$A$F$Y$$$20240906$$HP$JP$JP
242895921$24289592$1$I$20240426$20240827$20240906$20240906$EXP$$US-Accord-444614$ACCORD$$37$YR$A$$Y$$$20240906$$HP$US$US
242895951$24289595$1$I$20240828$20240829$20240906$20240906$EXP$$US-AstraZeneca-2024A199852$ASTRAZENECA$$20156$DY$$M$Y$$$20240906$$CN$US$
242895961$24289596$1$I$$20240902$20240906$20240906$EXP$$ZA-AstraZeneca-2024A200386$ASTRAZENECA$$51$YR$$F$Y$$$20240906$$CN$ZA$
242895971$24289597$1$I$20170606$20240903$20240906$20240906$EXP$$CO-UCBSA-2024045540$UCB$$45$YR$$F$Y$$$20240906$$CN$CO$CO
242895981$24289598$1$I$20240827$20240827$20240906$20240906$30DAY$$US-GSK-US2024106692$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242895991$24289599$1$I$20240826$20240827$20240906$20240906$EXP$$US-Accord-444119$ACCORD$$51$YR$A$M$Y$$$20240906$$MD$US$US
242896001$24289600$1$I$20240822$20240824$20240906$20240906$EXP$$US-BRAINTREE LABORATORIES, INC.-2024BTE00564$BRAINTREE$$53$YR$$M$Y$$$20240906$$CN$US$US
242896012$24289601$2$F$20240828$20240910$20240906$20240917$EXP$$CA-CELLTRION INC.-2024CA021248$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
242896021$24289602$1$I$20230101$20240823$20240906$20240906$EXP$$US-Axsome Therapeutics, Inc.-AXS202408-001291$AXSOME THERAPEUTICS$$37$YR$A$M$Y$$$20240906$$$US$
242896031$24289603$1$I$20240829$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141318$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240906$$CN$US$US
242896042$24289604$2$F$20240901$20240923$20240906$20240924$EXP$$CA-ROCHE-10000074476$ROCHE$$24$YR$A$M$Y$$$20240924$$CN$CA$CA
242896081$24289608$1$I$$20240904$20240906$20240906$PER$$NVSC2024US178866$NOVARTIS$$1$YR$$M$Y$$$20240906$$HP$US$US
242896091$24289609$1$I$$20240904$20240906$20240906$PER$$US-ROCHE-10000074150$ROCHE$$$$$F$Y$$$20240906$$MD$US$US
242896102$24289610$2$F$$20240902$20240906$20240910$EXP$$NVSC2024US055870$NOVARTIS$$$$$F$Y$$$20240910$$CN$US$US
242896111$24289611$1$I$$20240827$20240906$20240906$EXP$$US-Accord-444424$ACCORD$$35$YR$A$M$Y$$$20240906$$HP$US$US
242896121$24289612$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010088$APOTEX$$78$YR$$M$Y$$$20240906$$CN$CA$CA
242896131$24289613$1$I$20231201$20240903$20240906$20240906$EXP$$US-ABBVIE-5906909$ABBVIE$$74$YR$$F$Y$$$20240906$$CN$US$US
242896142$24289614$2$F$$20240924$20240906$20240930$EXP$$CA-Orion Corporation ORION PHARMA-24_00031541$ORION$Gilbert A, Drolet A. Remission of necrobiotic xanthogranuloma after intravenous immunoglobulin interruption: A case report. SAGE Open Medical Case Reports. 2024 AUG 19;12:1-3.$92$YR$E$F$Y$$$20240930$$MD$CA$
242896161$24289616$1$I$$20240814$20240906$20240906$PER$$AU-TOLMAR, INC.-24AU051884$TOLMAR$$$$$M$Y$$$20240906$$HP$AU$AU
242896171$24289617$1$I$$20240816$20240906$20240906$PER$$AU-TOLMAR, INC.-24AU051909$TOLMAR$$$$$M$Y$$$20240906$$CN$AU$AU
242896181$24289618$1$I$$20240814$20240906$20240906$PER$$AU-TOLMAR, INC.-24AU051914$TOLMAR$$$$$M$Y$$$20240906$$CN$AU$AU
242896191$24289619$1$I$20240101$20240814$20240906$20240906$PER$$AU-TOLMAR, INC.-24AU051915$TOLMAR$$$$$M$Y$$$20240906$$CN$AU$AU
242896201$24289620$1$I$$20240814$20240906$20240906$PER$$AU-TOLMAR, INC.-24AU051916$TOLMAR$$$$$M$Y$$$20240906$$CN$AU$AU
242896211$24289621$1$I$$20240815$20240906$20240906$PER$$AU-TOLMAR, INC.-24AU051939$TOLMAR$$$$$M$Y$$$20240906$$CN$AU$AU
242896221$24289622$1$I$$20240815$20240906$20240906$PER$$AU-TOLMAR, INC.-24AU051943$TOLMAR$$$$$M$Y$$$20240906$$CN$AU$AU
242896241$24289624$1$I$$20240905$20240906$20240906$PER$$NVSC2024US179109$NOVARTIS$$$$$$Y$$$20240906$$MD$US$US
242896251$24289625$1$I$$20240821$20240906$20240906$PER$$US-JNJFOC-20240854420$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$CN$US$US
242896261$24289626$1$I$20240725$20240905$20240906$20240906$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049914$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$96$KG$20240906$$HP$GB$GB
242896281$24289628$1$I$20240829$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177358$AMGEN$$75$YR$E$F$Y$$$20240906$$CN$US$US
242896292$24289629$2$F$20240101$20240909$20240906$20240913$PER$$US-AMGEN-USASP2024177152$AMGEN$$65$YR$E$F$Y$$$20240912$$CN$US$US
242896301$24289630$1$I$20240101$20240716$20240906$20240906$PER$$US-ALVOGEN-2024094866$ALVOGEN$$$$$F$Y$$$20240906$$CN$US$US
242896312$24289631$2$F$20240813$20240910$20240906$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004682$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240920$$CN$US$US
242896321$24289632$1$I$$20231208$20240906$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04394$AMNEAL$$$$A$F$Y$$$20240906$$CN$US$US
242896331$24289633$1$I$$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003492$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240906$$CN$US$US
242896342$24289634$2$F$20240801$20240920$20240906$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409002985$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240930$$CN$US$US
242896351$24289635$1$I$$20240903$20240906$20240906$EXP$$CN-TAKEDA-2024TUS088211$TAKEDA$$$$$M$Y$$$20240906$$CN$CN$CN
242896361$24289636$1$I$$20240828$20240906$20240906$EXP$$GB-LUPIN PHARMACEUTICALS INC.-2024-08612$LUPIN$$$$$$Y$$$20240906$$CN$GB$GB
242896371$24289637$1$I$$20240822$20240906$20240906$PER$$US-009507513-2408USA008013$MERCK$Greene A, Penner S, Edmond A, Camou M, Niu J, Abbott J. Successful treatment of PD1-inhibitor induced psoriasiform dermatitis using IL-17 blockade without compromising immunotherapy efficacy. Journal of Oncology Pharmacy Practice. 2024;0(0):1-5$68$YR$$M$Y$$$20240906$$HP$US$US
242896391$24289639$1$I$20240801$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141906$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240906$$CN$US$US
242896401$24289640$1$I$20240601$20240722$20240906$20240906$PER$$US-ALVOGEN-2024094836$ALVOGEN$$$$$F$Y$$$20240906$$CN$US$US
242896411$24289641$1$I$$20240827$20240906$20240906$PER$$US-ABBVIE-5899496$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242896421$24289642$1$I$20230101$20240824$20240906$20240906$EXP$$JP-INSMED, INC.-2023-04667-JP$INSMED$$$$$F$Y$33$KG$20240906$$CN$JP$JP
242896431$24289643$1$I$$20240831$20240906$20240906$EXP$$US-AMGEN-USASP2024175368$AMGEN$$$$A$M$Y$$$20240906$$CN$US$US
242896441$24289644$1$I$20240801$20240827$20240906$20240906$EXP$$US-INFO-20240264$INFORLIFE$$82$YR$E$F$Y$46$KG$20240828$$CN$US$
242896452$24289645$2$F$$20240909$20240906$20240919$EXP$IN-MLMSERVICE-20240821-PI169017-00256-1$IN-JUBILANT CADISTA PHARMACEUTICALS-2024IN001249$JUBILANT$Anandan S, Rajendran SS, Somarajan SA, Udayan A.. A Very Rare Side Effect of a Very Commonly Used Drug: Pantoprazole-induced Seizure.. The Journal of the Association of Physicians of India. 2024;72(8):89$69$YR$$F$Y$$$20240919$$MD$IN$IN
242896461$24289646$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A198462$ASTRAZENECA$$55$YR$$F$Y$$$20240906$$CN$US$
242896471$24289647$1$I$$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200874$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242896482$24289648$2$F$$20240903$20240906$20240909$EXP$$FR-AstraZeneca-2024A202210$ASTRAZENECA$$$$$M$Y$92$KG$20240909$$MD$FR$
242896491$24289649$1$I$20240828$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200743$ASTRAZENECA$$$$$M$Y$$$20240906$$PH$US$
242896502$24289650$2$F$$20240917$20240906$20240923$EXP$$US-AMGEN-USASP2024176793$AMGEN$$68$YR$E$M$Y$$$20240923$$CN$US$US
242896511$24289651$1$I$$20240813$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004684$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242896521$24289652$1$I$$20240905$20240906$20240906$PER$$US-HALEON-2195498$Haleon PLC$$$$$$Y$$$20240906$$CN$US$US
242896531$24289653$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043616$AUROBINDO$$61$YR$$M$Y$97.522$KG$20240906$$CN$CA$CA
242896552$24289655$2$F$$20240917$20240906$20240921$EXP$$US-ROCHE-10000073383$ROCHE$$$$E$F$Y$60.78$KG$20240921$$CN$US$US
242896561$24289656$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177279$AMGEN$$$$$$Y$$$20240906$$MD$US$US
242896571$24289657$1$I$$20240827$20240906$20240906$PER$$US-RDY-SPO/USA/24/0012832$DR REDDYS$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Cancer Journal. 2023;13(1): doi:10.1038/s41408-023-00859-x.$$$$$Y$$$20240906$$HP$US$US
242896582$24289658$2$F$$20240903$20240906$20240912$PER$$US-ALXN-202409USA000048US$ALEXION PHARMACEUTICALS$$$$$F$Y$62.585$KG$20240912$$CN$US$US
242896601$24289660$1$I$$20240829$20240906$20240906$EXP$$US-TAKEDA-2024TUS084010$TAKEDA$$$$$F$Y$$$20240906$$CN$US$US
242896611$24289661$1$I$20240701$20240903$20240906$20240906$EXP$FR-AFSSAPS-PB2024000945$FR-AMGEN-FRASP2024175601$AMGEN$$35$YR$A$F$Y$$$20240906$$PH$FR$FR
242896631$24289663$1$I$$20240830$20240906$20240906$EXP$$GB-ASPEN-GLO2024GB006030$ASPEN$Nana M, Gregori M, Chandler E, Powell H, Goulden B, Nelson-piercy C et all.. Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study. The Lancet Rheumatology. 2024;6(9):e625-e635$$$$$Y$$$20240906$$HP$GB$GB
242896641$24289664$1$I$$20240802$20240906$20240906$EXP$DE-CADRBFARM-2024329669$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-18289$ALKEM$$67$YR$$F$Y$66$KG$20240906$$CN$DE$DE
242896651$24289665$1$I$20150105$20240904$20240906$20240906$EXP$FR-EMA-20150311-AUTODUP-368343$FR-ROCHE-10000073732$ROCHE$$$$$$Y$$$20240906$$MD$FR$FR
242896661$24289666$1$I$20240719$20240827$20240906$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005101$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240906$$CN$US$US
242896671$24289667$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043556$AUROBINDO$$$$$$Y$$$20240906$$CN$CA$CA
242896681$24289668$1$I$$20240829$20240906$20240906$EXP$$US-ROCHE-10000070220$ROCHE$Mumtaz S, Balistreri L, Abril A, Ayala E, Butendieck R. Microvascular remodeling after autologous stem cell transplant in an overlap of systemic sclerosis and systemic lupus erythematosus: A case report. SAGE Open Medical Case Reports. 2024;12:1-5. doi:10.1177/2050313X241271811.$33$YR$A$F$Y$$$20240906$$HP$US$US
242896691$24289669$1$I$20240101$20240809$20240906$20240906$PER$$US-009507513-2408USA004033$MERCK$$80$YR$$M$Y$$$20240906$$CN$US$US
242896701$24289670$1$I$$20240903$20240906$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014191$JAZZ$$$$A$F$Y$$$20240906$$MD$US$US
242896711$24289671$1$I$$20240829$20240906$20240906$EXP$$CA-APOTEX-2024AP010147$APOTEX$$52$YR$$F$Y$$$20240906$$PH$CA$CA
242896722$24289672$2$F$20240828$20240918$20240906$20240923$PER$$US-AMGEN-USASP2024176036$AMGEN$$60$YR$A$M$Y$$$20240922$$CN$US$US
242896741$24289674$1$I$20240801$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177147$AMGEN$$49$YR$A$F$Y$$$20240906$$CN$US$US
242896751$24289675$1$I$20240829$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176449$AMGEN$$$$$F$Y$$$20240906$$PH$US$US
242896762$24289676$2$F$20240905$20240909$20240906$20240913$PER$$US-AMGEN-USASP2024178098$AMGEN$$47$YR$A$M$Y$$$20240913$$HP$US$US
242896772$24289677$2$F$20240903$20240923$20240906$20240925$EXP$$US-AMGEN-USASP2024176161$AMGEN$$62$YR$A$F$Y$$$20240925$$CN$US$US
242896783$24289678$3$F$20240101$20240905$20240906$20240913$EXP$$CA-CELLTRION INC.-2024CA021249$CELLTRION$$$$$$Y$$$20240913$$CN$CA$CA
242896791$24289679$1$I$20240601$20240716$20240906$20240906$PER$$US-ALVOGEN-2024094911$ALVOGEN$$$$$$Y$$$20240906$$CN$US$US
242896801$24289680$1$I$$20240829$20240906$20240906$EXP$$IE-ROCHE-10000070946$ROCHE$$56$YR$A$F$Y$84.6$KG$20240906$$MD$IE$IE
242896812$24289681$2$F$$20240917$20240906$20240925$PER$$CA-TRIS PHARMA, INC.-24CA011614$TRIS PHARM$$$$$$Y$$$20240925$$MD$CA$CA
242896821$24289682$1$I$$20240903$20240906$20240906$EXP$$TH-AMGEN-THASP2024176550$AMGEN$$69$YR$E$F$Y$$$20240906$$MD$TH$TH
242896831$24289683$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010096$APOTEX$$68$YR$$F$Y$$$20240906$$CN$CA$CA
242896841$24289684$1$I$$20240812$20240906$20240906$EXP$$MX-BEH-2024177234$CSL BEHRING$$$$$$Y$$$20240906$$PH$MX$MX
242896853$24289685$3$F$$20240904$20240906$20240911$EXP$$US-ROCHE-10000073653$ROCHE$Siddiqui F,  IgM flare leading to hyperviscosity syndrome in an elderly patient: case report. (Abstract  Number: P06.103). Reactions 1301-62nd Annual Meeting of the American Academy of Neurology. 2010-Apr-10;15:1301.$75$YR$E$M$Y$$$20240911$$HP$US$US
242896861$24289686$1$I$20221001$20240903$20240906$20240906$EXP$$PL-UCBSA-2024045244$UCB$Biernikowicz M, Pilch W, Wojturska W, Korkosz M, Nowakowski J. Certolizumab-induced sarcoidosis in a patient with psoriatic arthritis ? a case report and review of literature. Rheumatology international. 2024$56$YR$$M$Y$$$20240906$$HP$PL$PL
242896872$24289687$2$F$$20240906$20240906$20240912$PER$$NVSC2024US179144$NOVARTIS$$$$$M$Y$$$20240912$$MD$US$US
242896881$24289688$1$I$$20240905$20240906$20240906$EXP$$NVSC2024US022467$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
242896891$24289689$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043331$AUROBINDO$$$$$M$Y$$$20240906$$HP$CA$CA
242896901$24289690$1$I$$20240827$20240906$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005129$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242896931$24289693$1$I$$20240804$20240906$20240906$PER$$US-ALVOGEN-2024095042$ALVOGEN$$$$$M$Y$$$20240906$$CN$US$US
242896951$24289695$1$I$$20240903$20240906$20240906$EXP$$GB-GSK-GB2024EME110476$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$HP$GB$GB
242896961$24289696$1$I$$20240830$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR108640$VIIV$$35$YR$$M$Y$$$20240906$$PH$US$US
242896971$24289697$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043315$AUROBINDO$$$$$F$Y$$$20240906$$CN$CA$CA
242896981$24289698$1$I$$20240327$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06603$ALKEM$$28$YR$$F$Y$$$20240906$$HP$AU$AU
242896991$24289699$1$I$$20231116$20240906$20240906$EXP$GB-MHRA-ADR 28324064$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-14303$ALKEM$$$$$F$Y$$$20240906$$CN$GB$GB
242897001$24289700$1$I$$20240508$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-10025$ALKEM$$64$YR$$M$Y$$$20240906$$MD$DE$DE
242897011$24289701$1$I$$20230816$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09437$ALKEM$$44$YR$$F$Y$$$20240906$$HP$AU$AU
242897021$24289702$1$I$$20230817$20240906$20240906$EXP$DE-DCGMA-23201737$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-09537$ALKEM$$$$$M$Y$$$20240906$$CN$DE$DE
242897031$24289703$1$I$$20230816$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09465$ALKEM$$$$$M$Y$$$20240906$$HP$AU$AU
242897041$24289704$1$I$$20230816$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09474$ALKEM$$$$$M$Y$$$20240906$$HP$AU$AU
242897051$24289705$1$I$$20230816$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09449$ALKEM$$30$YR$$M$Y$$$20240906$$HP$AU$AU
242897061$24289706$1$I$$20231011$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-12508$ALKEM$$46$YR$$F$Y$$$20240906$$HP$AU$AU
242897071$24289707$1$I$$20230814$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-09252$ALKEM$$62$YR$$F$Y$$$20240906$$CN$DE$DE
242897081$24289708$1$I$$20240515$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-10488$ALKEM$$44$YR$$F$Y$$$20240906$$HP$AU$AU
242897091$24289709$1$I$$20230816$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09443$ALKEM$$35$YR$$F$Y$$$20240906$$HP$AU$AU
242897101$24289710$1$I$$20240327$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06617$ALKEM$$57$YR$$M$Y$$$20240906$$HP$AU$AU
242897111$24289711$1$I$$20240515$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-10483$ALKEM$$62$YR$$M$Y$$$20240906$$HP$AU$AU
242897121$24289712$1$I$$20240515$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-10470$ALKEM$$72$YR$$F$Y$$$20240906$$HP$AU$AU
242897131$24289713$1$I$$20240515$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-10467$ALKEM$$61$YR$$F$Y$$$20240906$$HP$AU$AU
242897141$24289714$1$I$$20240515$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-10464$ALKEM$$22$YR$$M$Y$$$20240906$$HP$AU$AU
242897151$24289715$1$I$$20230816$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09439$ALKEM$$87$YR$$M$Y$$$20240906$$HP$AU$AU
242897161$24289716$1$I$$20240613$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-12982$ALKEM$$$$$$Y$$$20240906$$CN$DE$DE
242897171$24289717$1$I$20240425$20240429$20240906$20240906$EXP$DE-CADRBFARM-2024327638$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-09380$ALKEM$$34$YR$$F$Y$80$KG$20240906$$CN$DE$DE
242897181$24289718$1$I$20220120$20240531$20240906$20240906$EXP$DE-CADRBFARM-2024328368$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-11967$ALKEM$$32$YR$$F$Y$77$KG$20240906$$CN$DE$DE
242897191$24289719$1$I$$20240327$20240906$20240906$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06599$ALKEM$$45$YR$$M$Y$$$20240906$$HP$AU$AU
242897201$24289720$1$I$$20240701$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14567$ALKEM$$$$$M$Y$$$20240906$$CN$DE$DE
242897211$24289721$1$I$$20230825$20240906$20240906$EXP$GB-MHRA-ADR 28136702$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09948$ALKEM$$62$YR$$F$Y$$$20240906$$PH$GB$GB
242897221$24289722$1$I$$20240628$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14461$ALKEM$$96$YR$$M$Y$$$20240906$$CN$DE$DE
242897231$24289723$1$I$$20240809$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14609$ALKEM$Paul LD, Welter-Luedeke J, Penzel S, Zangl A, Graw M.. Alpha-Pyrrolidinopentiothiophenone (?-PVT): A forensic case study including plasma concentrations. Forensic Science International. 2018;283:72-84$26$YR$$F$Y$$$20240906$$HP$DE$DE
242897241$24289724$1$I$20230107$20230912$20240906$20240906$EXP$GB-MHRA-ADR 28173651$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10586$ALKEM$$51$YR$$F$Y$68$KG$20240906$$CN$GB$GB
242897251$24289725$1$I$$20231205$20240906$20240906$EXP$GB-MHRA-ADR 28371401$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15571$ALKEM$$$$$F$Y$$$20240906$$PH$GB$GB
242897261$24289726$1$I$$20240826$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14620$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$37$YR$$M$Y$$$20240906$$HP$DE$DE
242897271$24289727$1$I$$20230925$20240906$20240906$EXP$GB-MHRA-ADR 28196330$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-11555$ALKEM$$$$$M$Y$$$20240906$$CN$GB$GB
242897281$24289728$1$I$$20230911$20240906$20240906$EXP$GB-MHRA-ADR 28147261$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10152$ALKEM$$57$YR$$F$Y$$$20240906$$CN$GB$GB
242897291$24289729$1$I$$20230810$20240906$20240906$EXP$GB-MHRA-ADR 28103142$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09087$ALKEM$$34$YR$$F$Y$80$KG$20240906$$CN$GB$GB
242897301$24289730$1$I$20230912$20230925$20240906$20240906$EXP$GB-MHRA-ADR 28197131$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-11558$ALKEM$$80$YR$$M$Y$91$KG$20240906$$MD$GB$GB
242897312$24289731$2$F$20230725$20230728$20240906$20240906$EXP$GB-MHRA-ADR 28077571$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-08723$ALKEM$$64$YR$$F$Y$81$KG$20240906$$PH$GB$GB
242897321$24289732$1$I$$20230804$20240906$20240906$EXP$GB-MHRA-ADR 28089010$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-08932$ALKEM$$$$$F$Y$$$20240906$$CN$GB$GB
242897331$24289733$1$I$20230901$20230908$20240906$20240906$EXP$GB-MHRA-ADR 28160012$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10469$ALKEM$$29$YR$$F$Y$57$KG$20240906$$MD$GB$GB
242897341$24289734$1$I$$20231212$20240906$20240906$EXP$GB-MHRA-ADR 28387723$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15910$ALKEM$$46$YR$$F$Y$$$20240906$$HP$GB$GB
242897351$24289735$1$I$20231215$20231227$20240906$20240906$EXP$GB-MHRA-ADR 28420298$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-16857$ALKEM$$30$YR$$F$Y$128$KG$20240906$$PH$GB$GB
242897361$24289736$1$I$$20240723$20240906$20240906$EXP$DE-EMA-DD-20240722-7482655-092319$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14658$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$43$YR$$M$Y$$$20240906$$HP$DE$DE
242897371$24289737$1$I$$20240826$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14633$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$54$YR$$M$Y$$$20240906$$HP$DE$DE
242897381$24289738$1$I$$20231020$20240906$20240906$EXP$GB-MHRA-ADR 28147287$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-13037$ALKEM$$$$$F$Y$$$20240906$$CN$GB$GB
242897391$24289739$1$I$$20240106$20240906$20240906$EXP$GB-MHRA-ADR 28434582$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-00164$ALKEM$$21$YR$$M$Y$62$KG$20240906$$CN$GB$GB
242897401$24289740$1$I$20231001$20240123$20240906$20240906$EXP$GB-MHRA-ADR 28478750$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-01328$ALKEM$$44$YR$$F$Y$63$KG$20240906$$CN$GB$GB
242897411$24289741$1$I$$20240118$20240906$20240906$EXP$GB-MHRA-ADR 28463624$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-01038$ALKEM$$23$YR$$F$Y$$$20240906$$MD$GB$GB
242897422$24289742$2$F$20231201$20240131$20240906$20240906$EXP$GB-MHRA-ADR 28497958$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-01945$ALKEM$$$$$$Y$$$20240906$$PH$GB$GB
242897431$24289743$1$I$20221026$20240126$20240906$20240906$EXP$GB-MHRA-ADR 28446274$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-00211$ALKEM$$61$YR$$M$Y$78$KG$20240906$$CN$GB$GB
242897441$24289744$1$I$$20240826$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14653$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$41$YR$$M$Y$$$20240906$$HP$DE$DE
242897451$24289745$1$I$$20240315$20240906$20240906$EXP$GB-MHRA-ADR 28604086$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05319$ALKEM$$$$$M$Y$$$20240906$$CN$GB$GB
242897462$24289746$2$F$$20240916$20240906$20240930$EXP$GB-MHRA-ADR 28594571$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-04736$ALKEM$$27$YR$$M$Y$$$20240930$$CN$GB$GB
242897471$24289747$1$I$20240201$20240209$20240906$20240906$EXP$GB-MHRA-ADR 28521394$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-02713$ALKEM$$53$YR$$F$Y$56$KG$20240906$$CN$GB$GB
242897481$24289748$1$I$$20240207$20240906$20240906$EXP$GB-MHRA-ADR 28517978$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-02890$ALKEM$$$$$M$Y$$$20240906$$HP$GB$GB
242897491$24289749$1$I$$20240323$20240906$20240906$EXP$GB-MHRA-ADR 28623408$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06524$ALKEM$$27$YR$$M$Y$$$20240906$$CN$GB$GB
242897501$24289750$1$I$20240207$20240212$20240906$20240906$EXP$GB-MHRA-ADR 28522586$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-02779$ALKEM$$76$YR$$F$Y$49$KG$20240906$$MD$GB$GB
242897512$24289751$2$F$$20240316$20240906$20240906$EXP$GB-MHRA-ADR 28607205$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05479$ALKEM$$59$YR$$$Y$$$20240906$$CN$GB$GB
242897521$24289752$1$I$$20240316$20240906$20240906$EXP$GB-MHRA-ADR 28609568$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05468$ALKEM$$$$$$Y$$$20240906$$CN$GB$GB
242897531$24289753$1$I$$20240226$20240906$20240906$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-04038$ALKEM$Pucci M, Singh Jutley G, Looms J, Ford L. N-desethyl isotonitazene detected in polydrug users admitted to hospital in Birmingham, United Kingdom. Clinical Toxicology. 2024;unk:1-7$43$YR$$M$Y$$$20240906$$HP$GB$GB
242897541$24289754$1$I$20240301$20240307$20240906$20240906$EXP$GB-MHRA-ADR 28586374$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-04591$ALKEM$$30$YR$$M$Y$90$KG$20240906$$CN$GB$GB
242897551$24289755$1$I$$20240328$20240906$20240906$EXP$GB-MHRA-ADR 28634056$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06403$ALKEM$$$$$F$Y$$$20240906$$CN$GB$GB
242897562$24289756$2$F$$20240323$20240906$20240906$EXP$GB-MHRA-ADR 28623523$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06529$ALKEM$$27$YR$$M$Y$$$20240906$$CN$GB$GB
242897571$24289757$1$I$$20240323$20240906$20240906$EXP$GB-MHRA-ADR 28623457$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06526$ALKEM$$$$$$Y$$$20240906$$CN$GB$GB
242897581$24289758$1$I$$20240323$20240906$20240906$EXP$GB-MHRA-ADR 28623528$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06532$ALKEM$$21$YR$$F$Y$$$20240906$$CN$GB$GB
242897591$24289759$1$I$20240212$20240319$20240906$20240906$EXP$GB-MHRA-ADR 28612666$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-05776$ALKEM$$43$YR$$F$Y$80$KG$20240906$$CN$GB$GB
242897611$24289761$1$I$$20240323$20240906$20240906$EXP$GB-MHRA-ADR 28624075$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06545$ALKEM$$$$$F$Y$$$20240906$$CN$GB$GB
242897621$24289762$1$I$$20240401$20240906$20240906$EXP$GB-MHRA-ADR 28634761$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06682$ALKEM$$53$YR$$F$Y$$$20240906$$CN$GB$GB
242897631$24289763$1$I$20230923$20240301$20240906$20240906$EXP$GB-MHRA-ADR 28571436$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-04128$ALKEM$$59$YR$$F$Y$106$KG$20240906$$PH$GB$GB
242897641$24289764$1$I$$20240404$20240906$20240906$EXP$GB-MHRA-ADR 28639834$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-07304$ALKEM$$80$YR$$F$Y$$$20240906$$PH$GB$GB
242897651$24289765$1$I$$20240427$20240906$20240906$EXP$GB-MHRA-ADR 28654541$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-07456$ALKEM$$62$YR$$F$Y$63$KG$20240906$$PH$GB$GB
242897661$24289766$1$I$20240401$20240518$20240906$20240906$EXP$GB-MHRA-ADR 28751648$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10932$ALKEM$$$$$F$Y$$$20240906$$CN$GB$GB
242897671$24289767$1$I$20061015$20240409$20240906$20240906$EXP$GB-MHRA-ADR 28661784$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-07689$ALKEM$$24$YR$$M$Y$89$KG$20240906$$CN$GB$GB
242897681$24289768$1$I$20240316$20240411$20240906$20240906$EXP$GB-MHRA-ADR 28666251$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-07825$ALKEM$$81$YR$$$Y$$$20240906$$HP$GB$GB
242897691$24289769$1$I$$20240505$20240906$20240906$EXP$GB-MHRA-ADR 28722463$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-09804$ALKEM$$$$$$Y$$$20240906$$CN$GB$GB
242897702$24289770$2$F$$20240427$20240906$20240906$EXP$GB-MHRA-ADR 28704929$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-09348$ALKEM$$77$YR$$M$Y$$$20240906$$MD$GB$GB
242897711$24289771$1$I$$20240613$20240906$20240906$EXP$GB-MHRA-EMIS-9910-b1f06d8a-3cca-4ecf-9e84-ac7e48f630a5$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-12963$ALKEM$$55$YR$$M$Y$76$KG$20240906$$PH$GB$GB
242897721$24289772$1$I$$20240416$20240906$20240906$EXP$GB-MHRA-ADR 28656379$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08234$ALKEM$$67$YR$$M$Y$$$20240906$$PH$GB$GB
242897731$24289773$1$I$20240312$20240706$20240906$20240906$EXP$GB-MHRA-MED-202405151015064380-PLTBZ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15349$ALKEM$$46$YR$$F$Y$$$20240906$$CN$GB$GB
242897741$24289774$1$I$20240430$20240705$20240906$20240906$EXP$GB-MHRA-MED-202405021240404060-HFZQB$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15165$ALKEM$$77$YR$$F$Y$81$KG$20240906$$PH$GB$GB
242897751$24289775$1$I$20240418$20240705$20240906$20240906$EXP$GB-MHRA-MED-202405011928139440-QLSMD$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15116$ALKEM$$82$YR$$M$Y$$$20240906$$CN$GB$GB
242897761$24289776$1$I$20240405$20240426$20240906$20240906$EXP$GB-MHRA-ADR 28702207$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-09224$ALKEM$$93$YR$$F$Y$52$KG$20240906$$PH$GB$GB
242897771$24289777$1$I$$20240704$20240906$20240906$EXP$GB-MHRA-TPP6015534C3208517YC1719858269091$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15009$ALKEM$$73$YR$$F$Y$105$KG$20240906$$MD$GB$GB
242897781$24289778$1$I$20240624$20240625$20240906$20240906$EXP$GB-MHRA-TPP11078819C11285570YC1719247254927$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14139$ALKEM$$82$YR$$F$Y$56$KG$20240906$$HP$GB$GB
242897791$24289779$1$I$$20240706$20240906$20240906$EXP$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-447723$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15361$ALKEM$$$$$F$Y$$$20240906$$CN$GB$GB
242897801$24289780$1$I$$20240709$20240906$20240906$EXP$GB-MHRA-MED-202407081413573870-MDSBH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15419$ALKEM$$49$YR$$F$Y$$$20240906$$PH$GB$GB
242897811$24289781$1$I$$20240511$20240906$20240906$EXP$GB-MHRA-ADR 28730985$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-10237$ALKEM$$90$YR$$F$Y$$$20240906$$PH$GB$GB
242897821$24289782$1$I$$20240424$20240906$20240906$EXP$GB-MHRA-ADR 28686144$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08987$ALKEM$$29$YR$$F$Y$70$KG$20240906$$PH$GB$GB
242897831$24289783$1$I$$20240828$20240906$20240906$EXP$$GB-PERRIGO-24GB008130$PERRIGO$$12$YR$$F$Y$$$20240906$$CN$GB$GB
242897841$24289784$1$I$20240714$20240715$20240906$20240906$EXP$GB-MHRA-MED-202407141157177170-CNLMG$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15876$ALKEM$$61$YR$$M$Y$88$KG$20240906$$CN$GB$GB
242897851$24289785$1$I$$20240223$20240906$20240906$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-03338$ALKEM$Schiavo A, Stagnaro FM, Salzano A, et al.. Pregabalin-induced first degree atrioventricular block in a young patient treated for pain from extrapulmonary tuberculosis. Monaldi Archives for Chest Disease. 2017;87(3):838$20$YR$$M$Y$$$20240906$$HP$IT$IT
242897861$24289786$1$I$$20240707$20240906$20240906$EXP$GB-MYLANLABS-2024M1062700$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15293$ALKEM$$$$$F$Y$$$20240906$$CN$GB$GB
242897871$24289787$1$I$20240626$20240705$20240906$20240906$EXP$GB-MHRA-MED-202407041111414050-SLGRW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15094$ALKEM$$2$DY$$F$Y$$$20240906$$MD$GB$GB
242897881$24289788$1$I$$20240605$20240906$20240906$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-12722$ALKEM$Irving G, Tanenberg RJ, Raskin J, Risser RC, Malcolm S.. Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain. The International Journal Of Clinical Practice. 2014;68(9):1130-1140$63$YR$$F$Y$$$20240906$$HP$US$US
242897891$24289789$1$I$$20240327$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-06613$ALKEM$$$$$F$Y$$$20240906$$CN$DE$DE
242897901$24289790$1$I$$20240313$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-05021$ALKEM$$$$$F$Y$$$20240906$$CN$DE$DE
242897911$24289791$1$I$$20240401$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-06874$ALKEM$$$$$F$Y$$$20240906$$PH$DE$DE
242897921$24289792$1$I$$20240321$20240906$20240906$EXP$DE-CADRBFARM-2024326830$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-06513$ALKEM$$56$YR$$F$Y$68$KG$20240906$$CN$DE$DE
242897931$24289793$1$I$20230910$20240705$20240906$20240906$EXP$GB-MHRA-MED-202405031033527580-SZPTF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15168$ALKEM$$$$$F$Y$$$20240906$$PH$GB$GB
242897941$24289794$1$I$$20240313$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-05024$ALKEM$$$$$F$Y$$$20240906$$CN$DE$DE
242897951$24289795$1$I$$20240828$20240906$20240906$EXP$$GB-PERRIGO-24GB008168$PERRIGO$$13$YR$$F$Y$$$20240906$$CN$GB$GB
242897961$24289796$1$I$$20240402$20240906$20240906$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-07417$ALKEM$Fujii Y, Harada T, Enomoto K, Nakai M. Hypoglycemia caused by pregabalin-induced insulin hypersecretion. Postgraduate Medical Journal. 2024;100 (1182):267-268$73$YR$$M$Y$$$20240906$$HP$JP$JP
242897971$24289797$1$I$$20230911$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-10527$ALKEM$$75$YR$$M$Y$$$20240906$$CN$DE$DE
242897981$24289798$1$I$20230701$20240202$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-02182$ALKEM$$68$YR$$F$Y$$$20240906$$CN$DE$DE
242897991$24289799$1$I$20230401$20231005$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-12218$ALKEM$$70$YR$$F$Y$$$20240906$$CN$DE$DE
242898001$24289800$1$I$$20231011$20240906$20240906$EXP$DE-CADRBFARM-2023322997$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-12426$ALKEM$$58$YR$$F$Y$83$KG$20240906$$CN$DE$DE
242898011$24289801$1$I$$20240823$20240906$20240906$EXP$$CA-UCBSA-2024043307$UCB$$$$$F$Y$$$20240906$$CN$CA$CA
242898021$24289802$1$I$$20240216$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-03209$ALKEM$$$$$F$Y$$$20240906$$MD$DE$DE
242898031$24289803$1$I$$20230825$20240906$20240906$EXP$DE-BFARM-23006619$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-09960$ALKEM$$$$$F$Y$$$20240906$$CN$DE$DE
242898041$24289804$1$I$$20230911$20240906$20240906$EXP$DE-CADRBFARM-2023322236$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-11083$ALKEM$$29$YR$$F$Y$60$KG$20240906$$CN$DE$DE
242898051$24289805$1$I$$20230817$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-09539$ALKEM$$$$$F$Y$$$20240906$$PH$DE$DE
242898061$24289806$1$I$$20240312$20240906$20240906$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-04901$ALKEM$$$$$F$Y$$$20240906$$CN$DE$DE
242898071$24289807$1$I$$20240223$20240906$20240906$EXP$DE-CADRBFARM-2024326287$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-03695$ALKEM$$44$YR$$M$Y$96$KG$20240906$$CN$DE$DE
242898081$24289808$1$I$$20231205$20240906$20240906$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-15681$ALKEM$Kulig CE, Hooda Z, Lebow E, Cerda L, Zaku B. Acute withdrawal in the postoperative setting in a patient taking standard therapeutic doses of Pregabalin. Journal of Surgical Case Reports. 2023;6:1-3$61$YR$$F$Y$48.5$KG$20240906$$HP$US$US
242898091$24289809$1$I$20240903$20240903$20240906$20240906$EXP$$BR-GENMAB-2024-03226$GENMAB$$63$YR$$M$Y$$$20240906$$MD$BR$BR
242898101$24289810$1$I$$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141146$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240906$$CN$US$US
242898111$24289811$1$I$20240601$20240802$20240906$20240906$PER$$US-ALVOGEN-2024094962$ALVOGEN$$$$$F$Y$$$20240906$$CN$US$US
242898121$24289812$1$I$$20240829$20240906$20240906$EXP$$CA-TEVA-VS-3238714$TEVA$$85$YR$$F$Y$$$20240906$$PH$CA$CA
242898131$24289813$1$I$$20240830$20240906$20240906$EXP$IN-MLMSERVICE-20240823-PI170614-00190-1$IN-JUBILANT CADISTA PHARMACEUTICALS-2024IN001258$JUBILANT$Sahukar S, Chandrappa Byranahalli V.. Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report From South India.. Cureus. 2024;16(7)$50$YR$$M$Y$$$20240906$$MD$IN$IN
242898141$24289814$1$I$20240809$20240828$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043540$AUROBINDO$$68$YR$$F$Y$70$KG$20240906$$PH$FR$FR
242898151$24289815$1$I$$20240402$20240906$20240906$EXP$US-MLMSERVICE-20220714-3675671-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-05786$ALKEM$Tejuoso A, Seroogy E, Mehrizi M, Bagga RS.. A Rare Case of Postherpetic Wallerian Degeneration of the Trigeminal nerve. Neurology. 2022;98(18 SUPPL):unk$60$YR$$F$Y$$$20240906$$MD$US$US
242898161$24289816$1$I$20240101$20240828$20240906$20240906$EXP$$CA-CELLTRION INC.-2024CA016163$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
242898171$24289817$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-022825$AUROBINDO$Waldner RC, Doulla M, Atallah J, Rathwell S, Grimbly C.. Leuprolide Acetate and QTc Interval in Gender-Diverse Youth. Transgend-Health. 2023;8(1):84-88$12$YR$$F$Y$$$20240906$$MD$CA$CA
242898181$24289818$1$I$$20240328$20240906$20240906$EXP$US-MLMSERVICE-20240311-4877023-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-05429$ALKEM$Undeberg MR, Bowers DR, Chau CN, McKeirnan KC. A Pharmacist^s Role in a Case of Allergy Labeling and Acute Bacterial Rhinosinusitis Treatment. Pharmacy. 2024;12(1):8$58$YR$$F$Y$$$20240906$$PH$US$US
242898192$24289819$2$F$20240610$20240827$20240906$20240910$EXP$$US-UCBSA-2024040049$UCB$$32$YR$$F$Y$52$KG$20240910$$HP$US$US
242898201$24289820$1$I$$20240902$20240906$20240906$PER$$US-ROCHE-10000072224$ROCHE$$$$$$Y$$$20240906$$CN$US$US
242898211$24289821$1$I$20240904$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177333$AMGEN$$71$YR$E$M$Y$$$20240906$$CN$US$US
242898221$24289822$1$I$20240710$20240828$20240906$20240906$EXP$$DE-AUROBINDO-AUR-APL-2024-043641$AUROBINDO$$72$YR$$M$Y$$$20240906$$MD$DE$DE
242898231$24289823$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043466$AUROBINDO$$$$$F$Y$$$20240906$$MD$CA$CA
242898241$24289824$1$I$$20240904$20240906$20240906$PER$$US-ROCHE-10000075508$ROCHE$$$$$$Y$$$20240906$$MD$US$US
242898251$24289825$1$I$$20240829$20240906$20240906$PER$$US-ROCHE-10000070281$ROCHE$$$$A$F$Y$$$20240906$$CN$US$US
242898261$24289826$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A200547$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242898271$24289827$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A198684$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242898281$24289828$1$I$$20240828$20240906$20240906$EXP$$US-AstraZeneca-2024A198431$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242898291$24289829$1$I$20240813$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003498$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240906$$CN$US$US
242898311$24289831$1$I$20240902$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002586$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240906$$CN$US$US
242898321$24289832$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002788$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240906$$CN$US$US
242898331$24289833$1$I$20240904$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003470$ELI LILLY AND CO$$$$$$Y$$$20240906$$CN$US$US
242898341$24289834$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002770$ELI LILLY AND CO$$$$$F$Y$$$20240906$$PH$US$US
242898351$24289835$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002967$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240906$$CN$US$US
242898361$24289836$1$I$$20240815$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202408010293$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240906$$CN$US$US
242898371$24289837$1$I$20240819$20240820$20240904$20240904$DIR$FDA-CDER-CTU-2024-61142$$FDA-CTU$$69$YR$$F$N$39.7$KG$20240820$N$$US$
242898381$24289838$1$I$20231001$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002695$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240906$$CN$US$US
242898391$24289839$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002999$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240906$$CN$US$US
242898401$24289840$1$I$20240901$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003047$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240906$$CN$US$US
242898412$24289841$2$F$20240903$20240910$20240906$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409002418$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240912$$CN$US$US
242898421$24289842$1$I$$20240902$20240906$20240906$PER$$US-ROCHE-10000073785$ROCHE$$$$$$Y$$$20240906$$CN$US$US
242898431$24289843$1$I$20240825$20240827$20240906$20240906$PER$$US-ROCHE-10000069643$ROCHE$$65$YR$E$F$Y$$$20240906$$CN$US$US
242898441$24289844$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141666$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$67.59$KG$20240906$$CN$US$US
242898461$24289846$1$I$$20240830$20240906$20240906$PER$$US-TAKEDA-2024TUS087967$TAKEDA$$9$YR$$F$Y$$$20240906$$CN$US$US
242898471$24289847$1$I$$20240827$20240906$20240906$EXP$$BR-GENMAB-2024-03132$GENMAB$$$$$M$Y$$$20240906$$MD$BR$BR
242898482$24289848$2$F$$20240923$20240906$20240927$PER$$US-ROCHE-10000071407$ROCHE$$$$A$M$Y$$$20240927$$CN$US$US
242898491$24289849$1$I$$20240830$20240906$20240906$PER$$US-ROCHE-10000071760$ROCHE$$33$YR$A$M$Y$$$20240906$$CN$US$US
242898501$24289850$1$I$20240801$20240829$20240906$20240906$EXP$$US-TEVA-VS-3239164$TEVA$$69$YR$$F$Y$89.36$KG$20240906$$CN$US$US
242898512$24289851$2$F$$20240924$20240906$20240930$EXP$$JP-EMD Serono-2024047033$EMD SERONO INC$$73$YR$E$M$Y$57$KG$20240930$$MD$JP$JP
242898521$24289852$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010099$APOTEX$$69$YR$$M$Y$$$20240906$$CN$CA$CA
242898531$24289853$1$I$20240626$20240903$20240906$20240906$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-118310$REGENERON$$$$$F$Y$$$20240906$$CN$US$US
242898541$24289854$1$I$20240401$20240903$20240906$20240906$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-118312$REGENERON$$$$$F$Y$$$20240906$$CN$US$US
242898553$24289855$3$F$20240101$20240927$20240906$20240930$PER$$US-AMGEN-USASP2024176244$AMGEN$$62$YR$A$F$Y$$$20240930$$CN$US$US
242898571$24289857$1$I$20240101$20240827$20240906$20240906$PER$$US-ABBVIE-5899251$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242898581$24289858$1$I$$20240906$20240906$20240906$PER$$US-PROD-AS2-212756134-RB-087234-2024$RECKITT BENCKISER$$$$$F$Y$$$20240906$$CN$US$US
242898591$24289859$1$I$$20240829$20240906$20240906$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08240$HIKMA$Soliman Y, Hatfield AA, McAllister RK, Fettiplace MR, Hofkamp MP. Soliman Y, Hatfield AA, McAllister RK, Fettiplace MR, Hofkamp MP. Apparent local anesthetic systemic toxicity following activation of an epidural catheter for cesarean delivery: Diagnosis and management of an uncommon obstetric anesthesia complication. Proceedings (Baylor University. Medical Center).. Proceedings (Baylor University. Medical Center).. 2024;37(5):874-6$25$YR$$F$Y$92$KG$20240906$$MD$US$US
242898601$24289860$1$I$$20240830$20240906$20240906$PER$$US-ROCHE-10000071386$ROCHE$$$$A$M$Y$$$20240906$$MD$US$US
242898611$24289861$1$I$$20240828$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043913$AUROBINDO$$59$YR$$F$Y$$$20240906$$CN$CA$CA
242898631$24289863$1$I$20220508$20240830$20240906$20240906$30DAY$$EG-SANDOZ INC.-SDZ2024EG020286$SANDOZ$$12$YR$$M$Y$$$20240906$$CN$EG$EG
242898643$24289864$3$F$$20240916$20240906$20240920$EXP$$US-ABBVIE-5908975$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
242898651$24289865$1$I$20240801$20240827$20240906$20240906$EXP$$US-GSK-US2024AMR107753$GLAXOSMITHKLINE$$$$$F$Y$51$KG$20240906$$CN$US$US
242898661$24289866$1$I$$20240903$20240906$20240906$EXP$$CA-GSK-CA2024094815$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$HP$CA$CA
242898671$24289867$1$I$$20240830$20240906$20240906$PER$$US-ROCHE-10000072141$ROCHE$$$$$$Y$$$20240906$$CN$US$US
242898681$24289868$1$I$20240829$20240829$20240906$20240906$EXP$$CA-RDY-CLI/CAN/24/0012765$DR REDDYS$$70$YR$E$M$Y$$$20240906$$CN$CA$CA
242898691$24289869$1$I$20231227$20240903$20240906$20240906$EXP$$AU-ROCHE-10000024561$ROCHE$$67$YR$E$F$Y$111$KG$20240906$$MD$AU$AU
242898703$24289870$3$F$20240820$20240917$20240906$20240926$30DAY$$US-JNJFOC-20240851021$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240926$$CN$US$US
242898711$24289871$1$I$20231001$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408230904294950-DJCKB$GB-SAMSUNG BIOEPIS-SB-2024-26056$SAMSUNG BIOEPIS$$$$$M$Y$$$20240906$$PH$GB$GB
242898721$24289872$1$I$$20240830$20240906$20240906$PER$$US-ROCHE-10000072047$ROCHE$$$$E$F$Y$$$20240906$$CN$US$US
242898731$24289873$1$I$20240827$20240830$20240906$20240906$PER$$US-BEH-2024178121$CSL BEHRING$$74$YR$E$F$Y$$$20240906$$HP$US$US
242898752$24289875$2$F$20240101$20240906$20240906$20240916$EXP$$CA-CELLTRION INC.-2024CA010408$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
242898762$24289876$2$F$$20240910$20240906$20240912$PER$$US-BIOGEN-2024BI01281207$BIOGEN$$$$$F$Y$$$20240912$$PH$US$US
242898771$24289877$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010101$APOTEX$$61$YR$$M$Y$$$20240906$$CN$CA$CA
242898781$24289878$1$I$20240605$20240822$20240906$20240906$EXP$GB-MHRA-MIDB-eeb7c531-1a52-4db5-bfc8-62a59572d727$GB-SA-2024SA257129$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240906$$PH$GB$GB
242898791$24289879$1$I$$20240828$20240906$20240906$EXP$$GB-AUROBINDO-AUR-APL-2024-043445$AUROBINDO$$68$YR$$M$Y$74$KG$20240906$$MD$GB$GB
242898801$24289880$1$I$$20240828$20240906$20240906$EXP$$IT-BEH-2024177951$CSL BEHRING$$54$YR$A$M$Y$$$20240906$$HP$IT$IT
242898814$24289881$4$F$$20240916$20240906$20240923$EXP$$US-ROCHE-10000074407$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
242898821$24289882$1$I$$20240903$20240906$20240906$PER$$US-ALXN-202409USA000248US$ALEXION PHARMACEUTICALS$$$$$F$Y$57.143$KG$20240906$$CN$US$US
242898831$24289883$1$I$20190101$20240903$20240906$20240906$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-118959$REGENERON$$$$$F$Y$$$20240906$$CN$US$US
242898841$24289884$1$I$20240801$20240903$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140751$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240906$$CN$US$US
242898851$24289885$1$I$20230301$20240509$20240906$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03587$AMNEAL$$$$$$Y$$$20240906$$CN$US$US
242898861$24289886$1$I$$20240129$20240906$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00469$AMNEAL$$73$YR$$M$Y$$$20240906$$CN$US$US
242898871$24289887$1$I$20240226$20240227$20240906$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00687$AMNEAL$$81$YR$$F$Y$68.027$KG$20240906$$CN$US$US
242898882$24289888$2$F$20240801$20240919$20240906$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-026689$UNITED THERAPEUTICS$$73$YR$$M$Y$59.864$KG$20240926$$$US$US
242898891$24289889$1$I$$20240830$20240906$20240906$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001786$BLUEPRINT MEDICINES$$$$$F$Y$$$20240906$$CN$US$US
242898902$24289890$2$F$20240901$20240906$20240906$20240909$PER$$US-AMGEN-USASP2024177715$AMGEN$$84$YR$E$M$Y$$$20240909$$CN$US$US
242898911$24289891$1$I$20240801$20240902$20240906$20240906$EXP$$GB-AMGEN-GBRSL2024166074$AMGEN$$62$YR$A$M$Y$$$20240906$$CN$GB$GB
242898921$24289892$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024177285$AMGEN$$46$YR$A$M$Y$$$20240906$$MD$US$US
242898931$24289893$1$I$$20240831$20240906$20240906$EXP$$EU-BAUSCHBL-2024BNL032631$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240906$$MD$EU$EU
242898941$24289894$1$I$$20240828$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043893$AUROBINDO$Donahoe L, Snelgrove J, de Perrot M, Sermer M, Silversides C, Granton J,..et.al. Pregnancy and pulmonary hypertension in the pre-lung transplant patient: Successfully saving two lives with extracorporeal lung support. JTCVS Techniques. 2023;20:186-191$37$YR$$F$Y$$$20240906$$MD$CA$CA
242898951$24289895$1$I$20240826$20240903$20240905$20240905$DIR$FDA-CDER-CTU-2024-61146$$FDA-CTU$$64$YR$$M$N$88$KG$20240903$N$$US$
242898961$24289896$1$I$20240904$20240905$20240905$20240905$DIR$717226$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242898971$24289897$1$I$$20240905$20240906$20240906$EXP$$CA-ROCHE-2854332$ROCHE$$44$YR$A$F$Y$$$20240906$$HP$CA$CA
242898991$24289899$1$I$20240830$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200577$ASTRAZENECA$$29399$DY$$M$Y$$$20240906$$CN$US$
242899001$24289900$1$I$$20240828$20240906$20240906$EXP$$AU-AstraZeneca-2024A198601$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$AU$
242899011$24289901$1$I$20230111$20240902$20240906$20240906$EXP$FR-AFSSAPS-MA2024001243$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08236$HIKMA$$58$YR$$F$Y$72$KG$20240906$$PH$FR$FR
242899022$24289902$2$F$20240101$20240919$20240906$20240923$PER$$US-BIOGEN-2024BI01281107$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
242899031$24289903$1$I$$20240904$20240906$20240906$PER$$US-BIOGEN-2023BI01236564$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242899041$24289904$1$I$$20240829$20240906$20240906$EXP$$CA-AstraZeneca-2024A194378$ASTRAZENECA$$$$$F$Y$$$20240906$$HP$CA$
242899051$24289905$1$I$$20240829$20240906$20240906$EXP$$ZA-AstraZeneca-2024A197565$ASTRAZENECA$$16436$DY$$M$Y$$$20240906$$CN$ZA$
242899061$24289906$1$I$$20240829$20240906$20240906$EXP$$US-AstraZeneca-2024A198110$ASTRAZENECA$$$$$$Y$$$20240906$$CN$US$
242899071$24289907$1$I$$20240829$20240906$20240906$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011139$STRIDES$Shi H, Wei W, Peng R, Chen H, Zhou N, Wu L, et al.. Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications.. Front-Oncol. 2023;13$66$YR$$M$Y$$$20240906$$HP$CN$CN
242899081$24289908$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004718$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242899091$24289909$1$I$20230101$20240826$20240906$20240906$EXP$$US-INSMED, INC.-2023-04312-US$INSMED$$$$$M$Y$$$20240906$$CN$US$US
242899101$24289910$1$I$20240807$20240828$20240906$20240906$EXP$$IT-AUROBINDO-AUR-APL-2024-043361$AUROBINDO$$6$YR$$M$Y$15$KG$20240906$$MD$IT$IT
242899121$24289912$1$I$$20240826$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137981$BRISTOL MYERS SQUIBB$Pant P, Grewal DS. Pentosan polysulfate maculopathy-associated cystoid macular edema responsive to intravitreal steroids. Retinal Cases + Brief Reports. 2024;18(5):549-52.$52$YR$A$F$Y$$$20240906$$HP$US$US
242899131$24289913$1$I$$20240827$20240906$20240906$EXP$$US-RDY-SPO/USA/24/0012724$DR REDDYS$Mukherji S, Shoaib H, Jimenez X. Brief case report: A case of FOLFIRI-Induced psychosis. Psycho-Oncology. 2023 Oct;32(10): 1625-1627. doi:10.1002/pon.6206.$72$YR$E$M$Y$$$20240906$$HP$US$US
242899141$24289914$1$I$$20240904$20240906$20240906$PER$$US-JNJFOC-20240909212$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$HP$US$US
242899151$24289915$1$I$20240101$20240829$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043739$AUROBINDO$$30$YR$$F$Y$$$20240906$$CN$FR$FR
242899161$24289916$1$I$$20240828$20240906$20240906$EXP$$US-ROCHE-10000072586$ROCHE$$$$A$F$Y$$$20240906$$CN$US$US
242899171$24289917$1$I$$20240905$20240906$20240906$PER$$NVSC2024US179247$NOVARTIS$$$$$$Y$$$20240906$$CN$US$US
242899181$24289918$1$I$$20240829$20240906$20240906$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011149$STRIDES$Tardy C, Puszkiel A, Boudou-Rouquette P, De Percin S, Alexandre J, Berge M, et al.. Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection.. Cancer-Chemother-Pharmacol. 2024;93:169-175$50$YR$$F$Y$$$20240906$$HP$FR$FR
242899191$24289919$1$I$20230228$20240905$20240906$20240906$EXP$$GB-MYLANLABS-2023M1022967$MYLAN$$60$YR$$M$Y$$$20240906$$MD$GB$GB
242899201$24289920$1$I$$20240905$20240906$20240906$EXP$$GB-MYLANLABS-2024M1081750$MYLAN$$$$$M$Y$$$20240906$$HP$GB$GB
242899211$24289921$1$I$$20240828$20240906$20240906$EXP$$DE-AUROBINDO-AUR-APL-2024-043619$AUROBINDO$$$$$F$Y$$$20240906$$CN$DE$DE
242899221$24289922$1$I$20240527$20240828$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043467$AUROBINDO$$55$YR$$M$Y$59$KG$20240906$$MD$FR$FR
242899231$24289923$1$I$20240101$20240903$20240906$20240906$EXP$$CA-Orion Corporation ORION PHARMA-24_00031062$ORION$$58$YR$A$F$Y$$$20240906$$MD$CA$
242899241$24289924$1$I$$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003564$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240906$$CN$US$US
242899251$24289925$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003150$ELI LILLY AND CO$$$$$F$Y$$$20240906$$PH$US$US
242899261$24289926$1$I$20240830$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002783$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240906$$MD$US$US
242899271$24289927$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002546$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240906$$CN$US$US
242899281$24289928$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002168$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240906$$CN$US$US
242899291$24289929$1$I$20240902$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003205$ELI LILLY AND CO$$30$YR$A$$Y$$$20240906$$CN$US$US
242899311$24289931$1$I$20240903$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177315$AMGEN$$77$YR$E$F$Y$$$20240906$$CN$US$US
242899321$24289932$1$I$20230101$20240823$20240906$20240906$EXP$$US-UCBSA-2024043726$UCB$$33$YR$$F$Y$$$20240906$$CN$US$US
242899331$24289933$1$I$20240101$20240830$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027551$UNITED THERAPEUTICS$$$$$M$Y$108.84$KG$20240906$$$US$US
242899341$24289934$1$I$$20240830$20240906$20240906$PER$$US-TAKEDA-2024TUS087888$TAKEDA$$$$$M$Y$$$20240906$$HP$US$US
242899351$24289935$1$I$$20240828$20240906$20240906$30DAY$$US-GSK-US2024107300$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242899361$24289936$1$I$$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140326$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$70.31$KG$20240906$$HP$US$US
242899371$24289937$1$I$20240830$20240830$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139340$BRISTOL MYERS SQUIBB$$$$A$F$Y$$$20240906$$CN$US$US
242899381$24289938$1$I$$20240830$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139520$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240906$$CN$US$US
242899391$24289939$1$I$$20240904$20240906$20240906$EXP$$GB-MYLANLABS-2024M1081448$MYLAN$$$$$M$Y$$$20240906$$CN$GB$GB
242899401$24289940$1$I$20240808$20240903$20240906$20240906$EXP$GB-MHRA-MED-202408311917190870-SBCNL$GB-MYLANLABS-2024M1080876$MYLAN$$53$YR$$M$Y$58$KG$20240906$$CN$GB$GB
242899411$24289941$1$I$20240823$20240903$20240906$20240906$EXP$$CN-MYLANLABS-2024M1081266$MYLAN$$79$YR$$M$Y$65$KG$20240906$$HP$CN$CN
242899421$24289942$1$I$$20240904$20240906$20240906$EXP$$GB-MYLANLABS-2024M1081406$MYLAN$$$$$M$Y$$$20240906$$PH$GB$GB
242899431$24289943$1$I$$20240826$20240906$20240906$PER$$US-BAUSCHBL-2024BNL032450$BAUSCH AND LOMB$$$$$$Y$$$20240906$$CN$US$US
242899441$24289944$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043321$AUROBINDO$$$$$M$Y$$$20240906$$MD$CA$CA
242899451$24289945$1$I$20240618$20240729$20240906$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02289$AMNEAL$$$$$M$Y$$$20240906$$PH$US$US
242899461$24289946$1$I$$20240905$20240906$20240906$PER$$US-ROCHE-10000075241$ROCHE$$43$YR$A$M$Y$$$20240906$$HP$US$US
242899471$24289947$1$I$$20240904$20240906$20240906$EXP$$US-EXELIXIS-CABO-24078284$EXELIXIS$$$$$F$Y$$$20240906$$HP$US$US
242899482$24289948$2$F$20240821$20240910$20240906$20240916$EXP$$IE-TAKEDA-2024TUS085437$TAKEDA$$67$YR$$F$Y$92$KG$20240916$$CN$IE$IE
242899491$24289949$1$I$$20240904$20240906$20240906$EXP$GB-MHRA-MED-202409041301200300-DKHQN$GB-MYLANLABS-2024M1081484$MYLAN$$79$YR$$F$Y$$$20240906$$PH$GB$GB
242899501$24289950$1$I$20240809$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61148$$FDA-CTU$$64$YR$$M$N$59.4$KG$20240904$N$$US$
242899511$24289951$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177478$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242899521$24289952$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61273$$FDA-CTU$$79$YR$$F$N$$$20240905$Y$$US$
242899541$24289954$1$I$$20240826$20240906$20240906$PER$$US-BAUSCHBL-2024BNL032465$BAUSCH AND LOMB$$41$YR$$F$Y$$$20240906$$CN$US$US
242899551$24289955$1$I$$20240827$20240906$20240906$PER$$US-BAUSCHBL-2024BNL032486$BAUSCH AND LOMB$$$$E$M$Y$$$20240906$$MD$US$US
242899561$24289956$1$I$$20240829$20240906$20240906$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011230$STRIDES$Shi H, Wei W, Peng R, Chen H, Zhou N, Wu L, et al.. Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications.. Front-Oncol. 2023;13$76$YR$$F$Y$$$20240906$$HP$CN$CN
242899571$24289957$1$I$$20240903$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024109496$VIIV$$$$$M$Y$$$20240906$$MD$US$US
242899581$24289958$1$I$$20240830$20240906$20240906$EXP$$NO-STRIDES ARCOLAB LIMITED-2024SP011295$STRIDES$Reitan Riibe S, Heitmann K, Schjott J, Riedel B.. Healthcare professionals^ information need related to antiseizure medication use in breastfeeding patients with epilepsy. Retrospective analysis of enquiries to Norwegian medicines information and pharmacovigilance centers.. Epilepsy-Behav-Rep. 2023;24$3$MON$$$Y$$$20240906$$HP$NO$NO
242899591$24289959$1$I$20240826$20240827$20240906$20240906$EXP$$US-Accord-444099$ACCORD$$48$YR$A$M$Y$$$20240906$$MD$US$US
242899601$24289960$1$I$$20240904$20240906$20240906$EXP$$US-SANDOZ INC.-SDZ2024US077683$SANDOZ$$68$YR$$F$Y$$$20240906$$CN$US$US
242899622$24289962$2$F$$20240830$20240906$20240906$EXP$$US-JNJFOC-20240901649$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242899631$24289963$1$I$20240902$20240904$20240906$20240906$EXP$$CA-JNJFOC-20240909627$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240906$$HP$CA$CA
242899641$24289964$1$I$20240824$20240904$20240906$20240906$EXP$GB-MHRA-MED-202409041204365160-JYGFH$GB-ORGANON-O2409GBR000278$ORGANON$$60$YR$$M$Y$75$KG$20240906$$CN$GB$GB
242899651$24289965$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177443$AMGEN$$$$$$Y$$$20240906$$HP$US$US
242899661$24289966$1$I$20240829$20240905$20240906$20240906$PER$$US-AMGEN-USASP2024177825$AMGEN$$69$YR$E$F$Y$$$20240906$$CN$US$US
242899671$24289967$1$I$$20240827$20240906$20240906$EXP$$US-UCBSA-2024043845$UCB$$$$$F$Y$55.782$KG$20240906$$HP$US$US
242899681$24289968$1$I$$20240902$20240906$20240906$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08222$HIKMA$$67$YR$$F$Y$65$KG$20240906$$MD$CA$CA
242899692$24289969$2$F$$20240902$20240906$20240912$EXP$$ZA-MYLANLABS-2024M1081173$MYLAN$$$$$M$Y$$$20240912$$MD$ZA$ZA
242899702$24289970$2$F$20240809$20240902$20240906$20240911$EXP$FR-AFSSAPS-CN2024000789$FR-MYLANLABS-2024M1080493$MYLAN$$68$YR$$F$Y$70$KG$20240911$$PH$FR$FR
242899711$24289971$1$I$$20240820$20240906$20240906$PER$$US-TEVA-VS-3235412$TEVA$$72$YR$$M$Y$88.45$KG$20240906$$CN$US$US
242899721$24289972$1$I$20240721$20240903$20240906$20240906$EXP$$FR-TAKEDA-2024TUS088221$TAKEDA$$7$YR$$M$Y$$$20240906$$HP$FR$FR
242899731$24289973$1$I$$20240902$20240906$20240906$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011336$STRIDES$Sonoda M, Ishimura M, Inoue H, Eguchi K, Ochiai M, Sakai Y, et al.. Non-conditioned cord blood transplantation for infection control in athymic CHARGE syndrome.. Pediatr-Blood-Cancer. 2024;71 (3)$$$I$F$Y$$$20240906$$HP$JP$JP
242899741$24289974$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010117$APOTEX$$65$YR$$F$Y$$$20240906$$CN$CA$CA
242899751$24289975$1$I$$20240823$20240906$20240906$EXP$$IT-ASTELLAS-2024-AER-003152$ASTELLAS$Castelli M. A Case of Polyserositis, Chylous Ascites and Hepatitis Induced by Immune Checkpoint Inhibitors. Eur J Case Rep Intern Med. 2024;11(7): Unknown-Unknown. doi:10.12890/2024_004237.$39$YR$A$M$Y$$$20240906$$HP$IT$IT
242899761$24289976$1$I$20240320$20240904$20240906$20240906$PER$$US-ABBVIE-5906990$ABBVIE$$60$YR$$F$Y$$$20240906$$HP$US$US
242899771$24289977$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A199690$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242899781$24289978$1$I$$20240827$20240906$20240906$EXP$$CA-AUROBINDO-AUR-APL-2024-043413$AUROBINDO$$72$YR$$M$Y$$$20240906$$HP$CA$CA
242899791$24289979$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A198738$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242899801$24289980$1$I$20240522$20240830$20240906$20240906$EXP$$SE-AstraZeneca-2024A201720$ASTRAZENECA$$60$YR$$F$Y$50$KG$20240906$$HP$SE$
242899811$24289981$1$I$$20240904$20240906$20240906$PER$$US-TAKEDA-2024TUS088974$TAKEDA$$$$$$Y$$$20240906$$CN$US$US
242899821$24289982$1$I$$20240904$20240906$20240906$EXP$$CA-JNJFOC-20240911087$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240906$$HP$CA$CA
242899832$24289983$2$F$20240101$20240918$20240906$20240921$PER$$US-BAYER-2024A127681$BAYER$$42$YR$A$F$Y$141.5$KG$20240921$$MD$US$US
242899841$24289984$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61337$$FDA-CTU$$$$$F$N$95.25$KG$20240904$N$$US$
242899852$24289985$2$F$$20240909$20240906$20240912$EXP$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-463358$GB-STRIDES ARCOLAB LIMITED-2024SP011315$STRIDES$Teoh YP, Gold A, Yesudian PD. Fats and figures_ how abnormal lipids unravel the truth. British Journal of Dermatology. 2024;191 (Suppl. 1):i127-8$22$YR$$M$Y$$$20240912$$MD$GB$GB
242899861$24289986$1$I$20240811$20240903$20240906$20240906$PER$$US-ALXN-202409USA000061US$ALEXION PHARMACEUTICALS$$70$YR$$M$Y$$$20240906$$CN$US$US
242899871$24289987$1$I$20240801$20240903$20240906$20240906$PER$$US-ALXN-202409USA000100US$ALEXION PHARMACEUTICALS$$28$YR$$F$Y$$$20240906$$CN$US$US
242899881$24289988$1$I$$20240905$20240905$20240905$DIR$717232$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242899891$24289989$1$I$$20240827$20240906$20240906$PER$$US-EMD Serono-2024046109$EMD SERONO INC$$$$A$F$Y$$$20240906$$CN$US$US
242899911$24289991$1$I$$20240319$20240906$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00951$AMNEAL$$$$$$Y$$$20240906$$CN$US$US
242899921$24289992$1$I$$20231211$20240906$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04507$AMNEAL$$$$$$Y$$$20240906$$CN$US$US
242899931$24289993$1$I$$20231227$20240906$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04648$AMNEAL$$$$$$Y$$$20240906$$CN$US$US
242899941$24289994$1$I$$20240905$20240906$20240906$PER$$US-HALEON-2195544$Haleon PLC$$$$$F$Y$$$20240906$$CN$US$US
242899952$24289995$2$F$20240801$20240923$20240906$20240930$PER$$US-ROCHE-10000075357$ROCHE$$34$YR$A$F$Y$$$20240930$$CN$US$US
242899962$24289996$2$F$20240101$20240903$20240906$20240913$PER$$US-AMGEN-USASP2024176354$AMGEN$$$$$F$Y$$$20240912$$HP$US$US
242899971$24289997$1$I$$20240822$20240906$20240906$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01395$INTRA-CELLULAR THERAPIES$$56$YR$$F$Y$$$20240906$$HP$US$US
242899981$24289998$1$I$$20240827$20240906$20240906$30DAY$$US-GSK-US2024106691$GLAXOSMITHKLINE$$$$$M$Y$$$20240906$$CN$US$US
242899991$24289999$1$I$20231111$20240509$20240906$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04214$AMNEAL$$66$YR$$F$Y$47.619$KG$20240906$$CN$US$US
242900001$24290000$1$I$20240820$20240831$20240906$20240906$EXP$$CN-AMGEN-CHNSP2024175514$AMGEN$$57$YR$A$F$Y$50$KG$20240906$$HP$CN$CN
242900011$24290001$1$I$20240820$20240829$20240906$20240906$EXP$$US-RIGEL-20240900005$RIGEL PHARMACEUTICALS$$$$$F$Y$89.675$KG$20240906$$CN$US$US
242900022$24290002$2$F$$20240828$20240906$20240912$PER$$US-AMGEN-USASP2024172852$AMGEN$$$$$F$Y$$$20240912$$HP$US$US
242900032$24290003$2$F$20240731$20240912$20240906$20240923$EXP$$ES-AUROBINDO-AUR-APL-2024-043653$AUROBINDO$$72$YR$$F$Y$66.5$KG$20240923$$HP$ES$ES
242900041$24290004$1$I$$20240829$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139096$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240906$$CN$US$US
242900051$24290005$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61174$$FDA-CTU$$73$YR$$F$N$63.05$KG$20240905$N$CN$US$
242900061$24290006$1$I$$20240830$20240906$20240906$EXP$$DE-BAYER-2024A126085$BAYER$$$$$F$Y$$$20240906$$PH$DE$DE
242900072$24290007$2$F$20080718$20240903$20240906$20240906$EXP$$US-ASTELLAS-2024-AER-004694$ASTELLAS$$51$YR$A$M$Y$49$KG$20240906$$HP$US$US
242900081$24290008$1$I$20220101$20240903$20240906$20240906$EXP$$AR-SANDOZ INC.-SDZ2024AR048537$SANDOZ$$$$$F$Y$44.5$KG$20240906$$CN$AR$AR
242900092$24290009$2$F$$20240909$20240906$20240916$EXP$$US-009507513-2409USA000574$MERCK$$$$$F$Y$$$20240916$$CN$US$US
242900101$24290010$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010128$APOTEX$$82$YR$$M$Y$$$20240906$$CN$CA$CA
242900111$24290011$1$I$$20240302$20240906$20240906$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088818$GLENMARK$$$$$$Y$$$20240906$$CN$US$US
242900121$24290012$1$I$20240716$20240813$20240906$20240906$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092525$GLENMARK$$$$$$Y$$$20240906$$CN$US$US
242900131$24290013$1$I$$20240213$20240906$20240906$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088951$GLENMARK$$$$$$Y$$$20240906$$CN$US$US
242900141$24290014$1$I$$20240702$20240906$20240906$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092093$GLENMARK$$$$$$Y$$$20240906$$CN$US$US
242900151$24290015$1$I$$20240806$20240906$20240906$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091509$GLENMARK$$$$$$Y$$$20240906$$PH$US$US
242900162$24290016$2$F$20240824$20240913$20240906$20240918$EXP$$US-BAYER-2024A123356$BAYER$$55$YR$A$M$Y$$$20240918$$CN$US$US
242900171$24290017$1$I$20240101$20240904$20240906$20240906$EXP$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000500$REVANCE THERAPEUTICS$$$$$$Y$$$20240906$$HP$US$US
242900181$24290018$1$I$20240701$20240902$20240906$20240906$EXP$$IL-AMGEN-ISRSP2024177177$AMGEN$$69$YR$E$F$Y$$$20240906$$MD$IL$IL
242900191$24290019$1$I$20240723$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61374$$FDA-CTU$$67$YR$$F$N$$$20240905$Y$PH$US$
242900201$24290020$1$I$20240901$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177302$AMGEN$$84$YR$E$F$Y$$$20240906$$CN$US$US
242900211$24290021$1$I$20240828$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177317$AMGEN$$86$YR$E$F$Y$$$20240906$$CN$US$US
242900241$24290024$1$I$20240810$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61283$$FDA-CTU$$90$YR$$F$N$$$20240904$N$HP$US$
242900251$24290025$1$I$20240510$20240828$20240906$20240906$EXP$$FR-AUROBINDO-AUR-APL-2024-043692$AUROBINDO$$80$YR$$F$Y$65$KG$20240906$$MD$FR$FR
242900261$24290026$1$I$$20240820$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08321$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242900271$24290027$1$I$20240904$20240905$20240905$20240905$DIR$717250$$FDA-CTU$$52$YR$$F$N$81$KG$20240905$Y$CN$US$
242900281$24290028$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61340$$FDA-CTU$$60$YR$$M$N$$$20240905$N$$US$
242900291$24290029$1$I$$20240905$20240906$20240906$EXP$$NVSC2024ET178824$NOVARTIS$$$$$F$Y$$$20240906$$MD$ET$ET
242900301$24290030$1$I$20240101$20240827$20240906$20240906$EXP$$US-UCBSA-2024036937$UCB$$$$$F$Y$$$20240906$$CN$US$US
242900311$24290031$1$I$20240829$20240904$20240906$20240906$EXP$IT-MINISAL02-1000925$IT-BAUSCH-BL-2024-013293$BAUSCH AND LOMB$$23$YR$$F$Y$$$20240906$$PH$IT$IT
242900331$24290033$1$I$20240727$20240820$20240906$20240906$PER$$US-SA-2024SA257629$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240906$$HP$US$US
242900341$24290034$1$I$$20240825$20240906$20240906$EXP$$JP-CPL-004565$CADILA$Kato T, Hiyama S, Sano M, Nakamura G, Sugiyama K. Transient Arginine Vasopressin Deficiency Induced by Valproic Acid Intoxication: A Case Report. Cureus. 2024 Jul 23;16(7):e65165.$42$YR$A$F$Y$$$20240906$$HP$JP$JP
242900351$24290035$1$I$$20240825$20240906$20240906$EXP$$IN-MankindUS-000247$MANKIND PHARMA$Anandan S, Rajendran SS, Somarajan SA, Udayan A. A Very Rare Side Effect of a Very Commonly Used Drug: Pantoprazole-induced Seizure. J Assoc Physicians India. 2024 Aug;72(8):89.$69$YR$E$F$Y$$$20240906$$HP$IN$IN
242900361$24290036$1$I$$20240825$20240906$20240906$EXP$$AE-Inventia-000746$INVENTIA HEALTHCARE$Jumani A, Ibrahim H, Purra H, Alkhazraji AK, AlNajjar MS. Metformin-Induced Hemolysis in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient: A Case Report. Cureus. 2024 Jul 22;16(7):e65081$40$YR$A$M$Y$$$20240906$$HP$AE$AE
242900371$24290037$1$I$20240816$20240820$20240906$20240906$PER$$US-SA-2024SA257938$SANOFI AVENTIS$$50$YR$A$M$Y$100$KG$20240906$$MD$US$US
242900381$24290038$1$I$20240501$20240822$20240906$20240906$PER$$US-SA-2024SA256553$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240906$$MD$US$US
242900391$24290039$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA256069$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240906$$MD$US$US
242900401$24290040$1$I$20240813$20240820$20240906$20240906$PER$$US-SA-2024SA257579$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240906$$MD$US$US
242900411$24290041$1$I$20240820$20240822$20240906$20240906$PER$$US-SA-2024SA249872$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240906$$HP$US$US
242900421$24290042$1$I$20240101$20240820$20240906$20240906$PER$$US-SA-2024SA256947$SANOFI AVENTIS$$10$MON$I$M$Y$$$20240906$$MD$US$US
242900431$24290043$1$I$$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003553$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240906$$CN$US$US
242900441$24290044$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003064$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240906$$CN$US$US
242900451$24290045$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002669$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240906$$CN$US$US
242900461$24290046$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002633$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240906$$CN$US$US
242900472$24290047$2$F$$20240828$20240906$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-043926$AUROBINDO$$64$YR$$F$Y$$$20240909$$HP$CA$CA
242900481$24290048$1$I$$20240830$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409000226$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240906$$CN$US$US
242900491$24290049$1$I$$20240820$20240906$20240906$PER$$US-Covis Pharma GmbH-2024COV01036$COVIS PHARMA$$$$$F$Y$$$20240906$$$US$US
242900501$24290050$1$I$20240828$20240829$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141033$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$116.98$KG$20240906$$CN$US$US
242900511$24290051$1$I$20180101$20240822$20240906$20240906$PER$$US-SA-2024SA254155$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240906$$CN$US$US
242900521$24290052$1$I$20240101$20240822$20240906$20240906$PER$$US-SA-2024SA254472$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240906$$CN$US$US
242900531$24290053$1$I$20240101$20240822$20240906$20240906$PER$$US-SA-2024SA256561$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240906$$MD$US$US
242900541$24290054$1$I$$20240827$20240906$20240906$30DAY$$US-GSK-US2024106693$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242900551$24290055$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA254281$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240906$$CN$US$US
242900561$24290056$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA254858$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240906$$MD$US$US
242900571$24290057$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255464$SANOFI AVENTIS$$$$E$M$Y$$$20240906$$HP$US$US
242900581$24290058$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA256081$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240906$$MD$US$US
242900591$24290059$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA254948$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240906$$MD$US$US
242900601$24290060$1$I$20240701$20240822$20240906$20240906$PER$$US-SA-2024SA255760$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240906$$MD$US$US
242900611$24290061$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255692$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240906$$MD$US$US
242900621$24290062$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA254953$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240906$$MD$US$US
242900631$24290063$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA258071$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240906$$HP$US$US
242900641$24290064$1$I$20240101$20240822$20240906$20240906$PER$$US-SA-2024SA256685$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240906$$CN$US$US
242900652$24290065$2$F$20240101$20240831$20240906$20240913$PER$$US-SA-2024SA255303$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240913$$MD$US$US
242900661$24290066$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255007$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240906$$MD$US$US
242900671$24290067$1$I$20240101$20240822$20240906$20240906$PER$$US-SA-2024SA253792$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240906$$CN$US$US
242900681$24290068$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA253154$SANOFI AVENTIS$$$$A$$Y$90$KG$20240906$$PH$US$US
242900691$24290069$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA253658$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240906$$MD$US$US
242900701$24290070$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255706$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240906$$MD$US$US
242900711$24290071$1$I$20240701$20240822$20240906$20240906$PER$$US-SA-2024SA254269$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240906$$HP$US$US
242900721$24290072$1$I$20240601$20240822$20240906$20240906$PER$$US-SA-2024SA255885$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240906$$MD$US$US
242900731$24290073$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA254136$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240906$$CN$US$US
242900741$24290074$1$I$20240101$20240822$20240906$20240906$PER$$US-SA-2024SA191265$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240906$$CN$US$US
242900751$24290075$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA254833$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240906$$MD$US$US
242900761$24290076$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA254736$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240906$$MD$US$US
242900781$24290078$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA257744$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240906$$MD$US$US
242900791$24290079$1$I$20240801$20240823$20240906$20240906$PER$$US-SA-2024SA256760$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$MD$US$US
242900801$24290080$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA256057$SANOFI AVENTIS$$$$I$M$Y$$$20240906$$CN$US$US
242900811$24290081$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255876$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240906$$MD$US$US
242900821$24290082$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255725$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240906$$MD$US$US
242900831$24290083$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA256061$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240906$$MD$US$US
242900851$24290085$1$I$20240201$20240822$20240906$20240906$PER$$US-SA-2024SA258046$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240906$$MD$US$US
242900861$24290086$1$I$20240101$20240822$20240906$20240906$PER$$US-SA-2024SA258283$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240906$$HP$US$US
242900871$24290087$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255018$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240906$$MD$US$US
242900892$24290089$2$F$20240821$20240823$20240906$20240913$PER$$US-SA-2024SA254286$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240913$$MD$US$US
242900901$24290090$1$I$20240801$20240823$20240906$20240906$PER$$US-SA-2024SA254629$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240906$$MD$US$US
242900921$24290092$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255617$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240906$$MD$US$US
242900931$24290093$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA254124$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240906$$MD$US$US
242900941$24290094$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA254802$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240906$$MD$US$US
242900951$24290095$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA256885$SANOFI AVENTIS$$$$T$F$Y$$$20240906$$CN$US$US
242900961$24290096$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA255959$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240906$$MD$US$US
242900971$24290097$1$I$20240819$20240823$20240906$20240906$PER$$US-SA-2024SA256440$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240906$$MD$US$US
242900981$24290098$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255772$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240906$$MD$US$US
242900991$24290099$1$I$$20240831$20240906$20240906$EXP$$NVSC2024AU177868$NOVARTIS$$60$YR$$$Y$$$20240906$$HP$AU$AU
242901001$24290100$1$I$20240801$20240823$20240906$20240906$PER$$US-SA-2024SA254564$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240906$$CN$US$US
242901011$24290101$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA161554$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240906$$MD$US$US
242901021$24290102$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA257442$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240906$$MD$US$US
242901031$24290103$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA255947$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240906$$MD$US$US
242901041$24290104$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA257656$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240906$$MD$US$US
242901051$24290105$1$I$20240817$20240823$20240906$20240906$PER$$US-SA-2024SA253700$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240906$$MD$US$US
242901061$24290106$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA256719$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$MD$US$US
242901071$24290107$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA257089$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240906$$CN$US$US
242901081$24290108$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA257154$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240906$$CN$US$US
242901091$24290109$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA255727$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240906$$MD$US$US
242901101$24290110$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA257835$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240906$$CN$US$US
242901111$24290111$1$I$20240301$20240823$20240906$20240906$PER$$US-SA-2024SA257708$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240906$$MD$US$US
242901122$24290112$2$F$$20240826$20240906$20240913$PER$$US-SA-2024SA255637$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240913$$CN$US$US
242901131$24290113$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA254826$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240906$$HP$US$US
242901151$24290115$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA253682$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240906$$CN$US$US
242901161$24290116$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA257570$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240906$$MD$US$US
242901171$24290117$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA257057$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240906$$MD$US$US
242901181$24290118$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA253374$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240906$$CN$US$US
242901191$24290119$1$I$20220501$20240823$20240906$20240906$PER$$US-SA-2024SA256624$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240906$$MD$US$US
242901201$24290120$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA256552$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$MD$US$US
242901221$24290122$1$I$20240627$20240905$20240905$20240905$DIR$717213$$FDA-CTU$$20$YR$$F$N$75.9$KG$20240905$N$PH$US$
242901231$24290123$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61312$$FDA-CTU$$69$YR$$F$N$$$20240905$N$$US$
242901261$24290126$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA253423$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240906$$CN$US$US
242901271$24290127$1$I$20240823$20240823$20240906$20240906$PER$$US-SA-2024SA254893$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240906$$CN$US$US
242901281$24290128$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61371$$FDA-CTU$$86$YR$$F$N$$$20240905$N$MD$US$
242901291$24290129$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA258391$SANOFI AVENTIS$$67$YR$E$$Y$$$20240906$$MD$US$US
242901301$24290130$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA254434$SANOFI AVENTIS$$$$$M$Y$$$20240906$$CN$US$US
242901311$24290131$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA257621$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240906$$MD$US$US
242901321$24290132$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA258006$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240906$$HP$US$US
242901332$24290133$2$F$20240822$20240827$20240906$20240913$PER$$US-SA-2024SA254422$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240913$$CN$US$US
242901342$24290134$2$F$$20240827$20240906$20240913$PER$$US-SA-2024SA254773$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240913$$CN$US$US
242901351$24290135$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA256278$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240906$$MD$US$US
242901361$24290136$1$I$20240801$20240823$20240906$20240906$PER$$US-SA-2024SA257040$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240906$$HP$US$US
242901381$24290138$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA253376$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240906$$MD$US$US
242901391$24290139$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA257325$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240906$$MD$US$US
242901401$24290140$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA257673$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240906$$HP$US$US
242901411$24290141$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA254755$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240906$$CN$US$US
242901421$24290142$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA254370$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240906$$CN$US$US
242901432$24290143$2$F$$20240823$20240906$20240915$PER$$US-SA-2024SA254369$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240915$$CN$US$US
242901441$24290144$1$I$20240101$20240824$20240906$20240906$PER$$US-SA-2024SA257828$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240906$$MD$US$US
242901451$24290145$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA254947$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240906$$HP$US$US
242901461$24290146$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA254920$SANOFI AVENTIS$$$$$F$Y$$$20240906$$CN$US$US
242901471$24290147$1$I$20240701$20240823$20240906$20240906$PER$$US-SA-2024SA257691$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240906$$MD$US$US
242901481$24290148$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA256340$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240906$$MD$US$US
242901491$24290149$1$I$20240819$20240823$20240906$20240906$PER$$US-SA-2024SA254949$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240906$$CN$US$US
242901501$24290150$1$I$$20240903$20240906$20240906$EXP$$CA-JNJFOC-20240910060$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240906$$CN$CA$CA
242901511$24290151$1$I$$20240824$20240906$20240906$PER$$US-SA-2024SA256039$SANOFI AVENTIS$$$$E$M$Y$$$20240906$$CN$US$US
242901521$24290152$1$I$20240101$20240825$20240906$20240906$PER$$US-SA-2024SA256677$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240906$$HP$US$US
242901531$24290153$1$I$$20240826$20240906$20240906$EXP$$US-MYLANLABS-2024M1079737$MYLAN$Xia J, Ahmed R. Rapidly progressive locked-in syndrome secondary to atypical herpes simplex virus-1 rhombencephalitis in an immunocompromised individual. IDCases 2024; 37.$61$YR$$M$Y$$$20240906$$HP$US$US
242901541$24290154$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA254661$SANOFI AVENTIS$$9$YR$C$$Y$$$20240906$$PH$US$US
242901551$24290155$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA257681$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240906$$HP$US$US
242901561$24290156$1$I$20240101$20240825$20240906$20240906$PER$$US-SA-2024SA256442$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240906$$CN$US$US
242901571$24290157$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA258505$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240906$$HP$US$US
242901581$24290158$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA258365$SANOFI AVENTIS$$68$YR$E$$Y$$$20240906$$CN$US$US
242901591$24290159$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA257467$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240906$$HP$US$US
242901601$24290160$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA258509$SANOFI AVENTIS$$47$YR$A$F$Y$101.36$KG$20240906$$CN$US$US
242901611$24290161$1$I$20240101$20240826$20240906$20240906$PER$$US-SA-2024SA258504$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240906$$MD$US$US
242901621$24290162$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA254410$SANOFI AVENTIS$$$$A$$Y$$$20240906$$MD$US$US
242901631$24290163$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA257547$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240906$$CN$US$US
242901641$24290164$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA250549$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240906$$MD$US$US
242901651$24290165$1$I$20240822$20240827$20240906$20240906$PER$$US-SA-2024SA258431$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240906$$HP$US$US
242901661$24290166$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA257935$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240906$$MD$US$US
242901671$24290167$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA254889$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240906$$MD$US$US
242901691$24290169$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA258199$SANOFI AVENTIS$$$$A$$Y$$$20240906$$CN$US$US
242901701$24290170$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA257818$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240906$$CN$US$US
242901711$24290171$1$I$20230101$20240826$20240906$20240906$PER$$US-SA-2024SA257413$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240906$$MD$US$US
242901721$24290172$1$I$$20240827$20240906$20240906$PER$$US-SA-2024SA258421$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240906$$HP$US$US
242901731$24290173$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA254841$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240906$$HP$US$US
242901741$24290174$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA257830$SANOFI AVENTIS$$$$A$M$Y$$$20240906$$HP$US$US
242901751$24290175$1$I$20240827$20240828$20240906$20240906$PER$$US-SA-2024SA253409$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240906$$CN$US$US
242901761$24290176$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA254570$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240906$$HP$US$US
242901771$24290177$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA257526$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240906$$CN$US$US
242901781$24290178$1$I$20240101$20240825$20240906$20240906$PER$$US-SA-2024SA256208$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240906$$MD$US$US
242901791$24290179$1$I$20240101$20240826$20240906$20240906$PER$$US-SA-2024SA257509$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$MD$US$US
242901801$24290180$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA254373$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240906$$PH$US$US
242901811$24290181$1$I$20240101$20240826$20240906$20240906$PER$$US-SA-2024SA258478$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240906$$MD$US$US
242901821$24290182$1$I$20230501$20240904$20240906$20240906$EXP$$US-ABBVIE-5907368$ABBVIE$$57$YR$$F$Y$$$20240906$$CN$US$US
242901841$24290184$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA258394$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240906$$MD$US$US
242901851$24290185$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA256011$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240906$$MD$US$US
242901861$24290186$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA255402$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240906$$CN$US$US
242901871$24290187$1$I$20220101$20240828$20240906$20240906$PER$$US-SA-2024SA258227$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240906$$CN$US$US
242901881$24290188$1$I$20200101$20240828$20240906$20240906$PER$$US-SA-2024SA254593$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240906$$CN$US$US
242901892$24290189$2$F$$20240829$20240906$20240912$PER$$US-SA-2024SA257990$SANOFI AVENTIS$$$$$F$Y$$$20240912$$CN$US$US
242901901$24290190$1$I$$20240827$20240906$20240906$PER$$US-SA-2024SA254213$SANOFI AVENTIS$$$$A$$Y$$$20240906$$PH$US$US
242901911$24290191$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA258030$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$MD$US$US
242901921$24290192$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA258216$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240906$$CN$US$US
242901931$24290193$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA258596$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240906$$HP$US$US
242901942$24290194$2$F$$20240917$20240906$20240926$PER$$US-SA-2024SA257883$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240926$$CN$US$US
242901951$24290195$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA258177$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240906$$HP$US$US
242901961$24290196$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA254688$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240906$$HP$US$US
242901971$24290197$1$I$20240814$20240828$20240906$20240906$PER$$US-SA-2024SA258360$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240906$$CN$US$US
242901981$24290198$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA258223$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240906$$CN$US$US
242901991$24290199$1$I$20240601$20240828$20240906$20240906$PER$$US-SA-2024SA254644$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240906$$MD$US$US
242902001$24290200$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA258209$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240906$$CN$US$US
242902011$24290201$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA258225$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240906$$CN$US$US
242902021$24290202$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA256610$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240906$$MD$US$US
242902031$24290203$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA258043$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240906$$MD$US$US
242902041$24290204$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA258203$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240906$$CN$US$US
242902051$24290205$1$I$20240101$20240826$20240906$20240906$PER$$US-SA-2024SA258592$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240906$$MD$US$US
242902061$24290206$1$I$20240825$20240827$20240906$20240906$PER$$US-SA-2024SA254414$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240906$$CN$US$US
242902071$24290207$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA257957$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240906$$CN$US$US
242902082$24290208$2$F$$20240827$20240906$20240910$PER$$US-SA-2024SA258029$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240910$$CN$US$US
242902091$24290209$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA257904$SANOFI AVENTIS$$67$YR$E$$Y$$$20240906$$CN$US$US
242902101$24290210$1$I$$20240830$20240906$20240906$PER$$US-SA-2024SA254675$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240906$$CN$US$US
242902111$24290211$1$I$20230101$20240826$20240906$20240906$PER$$US-SA-2024SA255610$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240906$$HP$US$US
242902121$24290212$1$I$20230303$20240829$20240906$20240906$PER$$US-SA-2024SA258427$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240906$$MD$US$US
242902131$24290213$1$I$20240619$20240829$20240906$20240906$PER$$US-SA-2024SA258414$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240906$$CN$US$US
242902141$24290214$1$I$20240829$20240829$20240906$20240906$PER$$US-SA-2024SA254761$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240906$$CN$US$US
242902151$24290215$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA258286$SANOFI AVENTIS$$$$A$$Y$$$20240906$$HP$US$US
242902161$24290216$1$I$20240823$20240829$20240906$20240906$PER$$US-SA-2024SA254757$SANOFI AVENTIS$$24$YR$A$M$Y$90$KG$20240906$$HP$US$US
242902181$24290218$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA257092$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240906$$CN$US$US
242902191$24290219$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA257862$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240906$$$US$US
242902201$24290220$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA246221$SANOFI AVENTIS$$$$$$Y$$$20240906$$HP$US$US
242902211$24290221$1$I$20240825$20240826$20240906$20240906$PER$$US-SA-2024SA257231$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240906$$CN$US$US
242902221$24290222$1$I$20220708$20240905$20240905$20240905$DIR$717225$$FDA-CTU$$61$YR$$M$N$85.5$KG$20240905$Y$CN$US$
242902231$24290223$1$I$20240801$20240826$20240906$20240906$PER$$US-SA-2024SA244227$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240906$$HP$US$US
242902241$24290224$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A199139$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242902251$24290225$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61287$$FDA-CTU$$$$$M$N$$$20240905$N$PH$US$
242902261$24290226$1$I$20240816$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61378$$FDA-CTU$$86$YR$$F$N$$$20240905$N$PH$US$
242902282$24290228$2$F$20230925$20240830$20240906$20240906$PER$$US-SA-2024SA254496$SANOFI AVENTIS$$29$YR$A$M$Y$90.72$KG$20240906$$HP$US$US
242902291$24290229$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA257497$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240906$$HP$US$US
242902301$24290230$1$I$20240801$20240826$20240906$20240906$PER$$US-SA-2024SA257982$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240906$$MD$US$US
242902313$24290231$3$F$20240101$20240903$20240906$20240913$PER$$US-SA-2024SA187537$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240913$$MD$US$US
242902321$24290232$1$I$20240802$20240828$20240906$20240906$PER$$US-SA-2024SA254906$SANOFI AVENTIS$$$$$$Y$$$20240906$$HP$US$US
242902331$24290233$1$I$$20240902$20240906$20240906$PER$$US-SA-2024SA258014$SANOFI AVENTIS$$8$YR$C$$Y$$$20240906$$MD$US$US
242902341$24290234$1$I$20240828$20240828$20240906$20240906$PER$$US-SA-2024SA253962$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240906$$CN$US$US
242902351$24290235$1$I$$20240830$20240906$20240906$PER$$US-SA-2024SA255779$SANOFI AVENTIS$$$$$F$Y$$$20240906$$MD$US$US
242902361$24290236$1$I$$20240823$20240906$20240906$PER$$US-ABBVIE-5907685$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242902371$24290237$1$I$$20240625$20240906$20240906$EXP$$CH-ROCHE-10000019418$ROCHE$$55$YR$A$F$Y$$$20240906$$MD$CH$CH
242902391$24290239$1$I$$20240820$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08322$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242902411$24290241$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141803$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$101.6$KG$20240906$$CN$US$US
242902421$24290242$1$I$20240101$20240904$20240906$20240906$EXP$$US-ABBVIE-5908813$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242902441$24290244$1$I$20240713$20240823$20240906$20240906$EXP$$CZ-SAMSUNG BIOEPIS-SB-2024-25926$SAMSUNG BIOEPIS$$63$YR$A$M$Y$$$20240906$$HP$CZ$CZ
242902451$24290245$1$I$$20240816$20240906$20240906$PER$$US-JNJFOC-20240879447$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$CN$US$US
242902463$24290246$3$F$20240828$20240916$20240906$20240924$30DAY$$US-JNJFOC-20240900496$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240924$$CN$US$US
242902472$24290247$2$F$$20240909$20240906$20240912$PER$$US-JNJFOC-20240855057$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
242902491$24290249$1$I$20220930$20240901$20240906$20240906$EXP$$SA-GSK-SA2022EME147714$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$SA$SA
242902501$24290250$1$I$20240729$20240903$20240906$20240906$PER$$US-BAYER-2024A126343$BAYER$$38$YR$A$F$Y$$$20240906$$MD$US$US
242902511$24290251$1$I$$20240905$20240906$20240906$PER$$NVSC2024US179286$NOVARTIS$$$$$$Y$$$20240906$$CN$US$US
242902522$24290252$2$F$$20240911$20240906$20240923$EXP$$DE-AUROBINDO-AUR-APL-2021-015012$AUROBINDO$$$$E$M$Y$$$20240923$$MD$DE$DE
242902531$24290253$1$I$$20240829$20240906$20240906$EXP$$CA-TEVA-VS-3238470$TEVA$$65$YR$$F$Y$$$20240906$$HP$CA$CA
242902542$24290254$2$F$20240101$20240828$20240906$20240909$EXP$$US-SA-2024SA256913$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240909$$MD$US$US
242902551$24290255$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010129$APOTEX$$91$YR$$M$Y$$$20240906$$CN$CA$CA
242902562$24290256$2$F$20240903$20240905$20240906$20240910$PER$$US-AMGEN-USASP2024177203$AMGEN$$67$YR$E$F$Y$$$20240910$$CN$US$US
242902581$24290258$1$I$20240101$20240822$20240906$20240906$PER$$US-SA-2024SA256158$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240906$$MD$US$US
242902591$24290259$1$I$$20240902$20240906$20240906$EXP$$CA-BAYER-2024A126598$BAYER$$56$YR$A$F$Y$58.957$KG$20240906$$CN$CA$CA
242902601$24290260$1$I$20240827$20240903$20240905$20240905$DIR$FDA-CDER-CTU-2024-61154$$FDA-CTU$$71$YR$$M$N$58$KG$20240903$N$$US$
242902611$24290261$1$I$20240901$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61164$$FDA-CTU$$83$YR$$F$N$$$20240904$N$HP$US$
242902621$24290262$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61368$$FDA-CTU$$62$YR$$F$N$$$20240905$N$$US$
242902631$24290263$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61279$$FDA-CTU$$37$YR$$M$N$82.55$KG$20240905$N$$US$
242902651$24290265$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA256461$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240906$$MD$US$US
242902661$24290266$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024177473$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242902672$24290267$2$F$20240905$20240906$20240906$20240909$PER$$US-AMGEN-USASP2024177826$AMGEN$$80$YR$E$F$Y$$$20240909$$CN$US$US
242902681$24290268$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177206$AMGEN$$$$$M$Y$$$20240906$$CN$US$US
242902691$24290269$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA256590$SANOFI AVENTIS$$$$A$M$Y$$$20240906$$MD$US$US
242902701$24290270$1$I$20240724$20240830$20240906$20240906$EXP$FR-AFSSAPS-AM2024000685$FR-TEVA-VS-3239117$TEVA$$74$YR$$M$Y$85$KG$20240906$$MD$FR$FR
242902721$24290272$1$I$20240801$20240823$20240906$20240906$PER$$US-SA-2024SA257418$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240906$$CN$US$US
242902731$24290273$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA258497$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240906$$CN$US$US
242902741$24290274$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA257028$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240906$$MD$US$US
242902751$24290275$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA256238$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240906$$MD$US$US
242902761$24290276$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA257088$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240906$$HP$US$US
242902771$24290277$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA257000$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240906$$MD$US$US
242902781$24290278$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA256522$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$MD$US$US
242902791$24290279$1$I$20240801$20240828$20240906$20240906$PER$$US-SA-2024SA257971$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240906$$MD$US$US
242902801$24290280$1$I$20240826$20240829$20240906$20240906$PER$$US-SA-2024SA253442$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240906$$CN$US$US
242902821$24290282$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA258501$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240906$$CN$US$US
242902851$24290285$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61330$$FDA-CTU$$47$YR$$F$N$$$20240905$N$$US$
242902871$24290287$1$I$20240801$20240830$20240906$20240906$EXP$ES-AEMPS-1563260$ES-TEVA-VS-3239357$TEVA$$97$YR$$F$Y$$$20240906$$MD$ES$ES
242902881$24290288$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5908803$ABBVIE$$$$A$F$Y$$$20240906$$MD$US$US
242902891$24290289$1$I$$20240829$20240906$20240906$EXP$$PT-AUROBINDO-AUR-APL-2024-043794$AUROBINDO$Vicente B, Rodrigues C, Serrao C, Baptista M, Carvalho V, Antunes AP et al. C-05 -Headache secondary to inflammatory orbitopathy due to zoledronic acid: a rare complication of frequent treatment.. Sinapse. 2023;Sup: 1:200$57$YR$$F$Y$$$20240906$$HP$PT$PT
242902901$24290290$1$I$$20240820$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08332$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242902911$24290291$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61258$$FDA-CTU$$68$YR$$M$N$$$20240905$N$$US$
242902921$24290292$1$I$20240820$20240905$20240905$20240905$DIR$717298$$FDA-CTU$$66$YR$$F$N$$$20240905$Y$PH$US$
242902932$24290293$2$F$20240129$20240902$20240906$20240909$EXP$FR-AFSSAPS-TO2024001644$NVSC2024FR176028$NOVARTIS$$74$YR$$F$Y$$$20240909$$PH$FR$FR
242902941$24290294$1$I$20240904$20240905$20240905$20240905$DIR$717328$$FDA-CTU$$6$YR$$F$N$$$20240905$N$HP$US$
242902951$24290295$1$I$20240820$20240820$20240906$20240906$PER$$US-JNJFOC-20240855471$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240906$$CN$US$US
242902961$24290296$1$I$$20240903$20240906$20240906$PER$$US-ALXN-202409USA000133US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242902972$24290297$2$F$$20240917$20240906$20240920$EXP$$CA-BAYER-2024A126579$BAYER$$39$YR$A$F$Y$$$20240920$$PH$CA$CA
242902981$24290298$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141641$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240906$$HP$US$US
242902991$24290299$1$I$$20240827$20240906$20240906$30DAY$$US-GSK-US2024106699$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242903001$24290300$1$I$$20240827$20240906$20240906$EXP$$DE-EMD Serono-2024046585$EMD SERONO INC$Groth O, Roider G, Graw M. [Fatalities associated with failure to adjust drug dose in patients with renal insufficiency: A retrospective study at the Institute of Forensic Medicine in Munich (2019-2023)]. Medikamenteninduzierte Todesfalle bei Niereninsuffizienz.. MMW Fortschritte der Medizin. 2024 Aug 01;166(13): 48-51.$59$YR$A$F$Y$$$20240906$$MD$DE$DE
242903011$24290301$1$I$$20240827$20240906$20240906$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17156$IPSEN$$$$$$Y$$$20240906$$HP$US$US
242903021$24290302$1$I$20240801$20240825$20240906$20240906$PER$$US-JNJFOC-20240872389$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240906$$CN$US$US
242903031$24290303$1$I$$20240829$20240906$20240906$EXP$$CA-APOTEX-2024AP010154$APOTEX$$80$YR$$M$Y$68$KG$20240906$$HP$CA$CA
242903041$24290304$1$I$20240824$20240827$20240906$20240906$EXP$$US-GSK-US2024106609$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240906$$CN$US$US
242903051$24290305$1$I$$20240902$20240906$20240906$EXP$$JP-ROCHE-10000074498$ROCHE$$8$DEC$E$M$Y$$$20240906$$MD$JP$JP
242903061$24290306$1$I$20240801$20240904$20240906$20240906$PER$$US-ABBVIE-5908847$ABBVIE$$$$A$M$Y$$$20240906$$MD$US$US
242903071$24290307$1$I$20230101$20240826$20240906$20240906$EXP$$IT-PBT-009668$PANACEA BIOTEC$Corcione S, Lupia T, Vita D, Sidoti F, Zanotto E, Solidoro P, et al. Maribavir treatment for resistant cytomegalovirus disseminated disease in kidney transplant recipients: A case-based scoping review of real life data in literature. Transplant Rev (Orlando). 2024 Aug 21;38(4):100873. doi: 10.1016/j.trre.2024.100873.$54$YR$A$F$Y$$$20240906$$HP$IT$IT
242903081$24290308$1$I$20240101$20240827$20240906$20240906$PER$$US-ABBVIE-5899635$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242903091$24290309$1$I$$20240828$20240906$20240906$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17302$IPSEN$$56$YR$A$M$Y$$$20240906$$CN$US$US
242903111$24290311$1$I$$20240814$20240906$20240906$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004720$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242903121$24290312$1$I$$20240829$20240906$20240906$EXP$$JO-AstraZeneca-2024A197787$ASTRAZENECA$$$$$M$Y$$$20240906$$HP$JO$
242903132$24290313$2$F$20240827$20240827$20240906$20240911$PER$$US-AMGEN-USASP2024171840$AMGEN$$58$YR$A$F$Y$$$20240911$$CN$US$US
242903141$24290314$1$I$20180101$20240811$20240906$20240906$PER$$US-AMGEN-USASP2024173944$AMGEN$Fei F.. Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in multiple Myeloma Patients: A Single Institution Experience. Blood. 2018;132 (suppl. 1):3349$$$$$Y$$$20240906$$MD$US$US
242903151$24290315$1$I$$20240825$20240906$20240906$EXP$$AE-Indicus Pharma-001036$INDICUS$Jumani A, Ibrahim H, Purra H, Alkhazraji AK, AlNajjar MS. Metformin-Induced Hemolysis in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient: A Case Report. Cureus. 2024 Jul 22;16(7):e65081$40$YR$A$M$Y$$$20240906$$HP$AE$AE
242903161$24290316$1$I$20240904$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003608$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240906$$CN$US$US
242903171$24290317$1$I$20240603$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202407015526$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240906$$CN$US$US
242903181$24290318$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003034$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240906$$CN$US$US
242903191$24290319$1$I$$20240829$20240906$20240906$EXP$$CA-TEVA-VS-3238539$TEVA$$52$YR$$M$Y$$$20240906$$HP$CA$CA
242903201$24290320$1$I$$20240827$20240906$20240906$EXP$$DE-EMD Serono-2024046583$EMD SERONO INC$Groth O, Roider G, Graw M. Fatalities associated with failure to adjust drug dose in patients with renal insufficiency: A retrospective study at the Institute of Forensic Medicine in Munich (2019-2023). Medikamenteninduzierte Todesfalle bei Niereninsuffizienz. MMW Fortschritte der Medizin. 2024 Aug 01;166(13): 48-51.$59$YR$A$F$Y$$$20240906$$MD$DE$DE
242903221$24290322$1$I$$20240820$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08333$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242903241$24290324$1$I$$20230503$20240906$20240906$EXP$$NVSC2023US281106$NOVARTIS$$$$$$Y$$$20240906$$CN$US$US
242903252$24290325$2$F$$20240910$20240906$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004722$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
242903261$24290326$1$I$$20240903$20240906$20240906$EXP$$US-009507513-2409USA001487$MERCK$$50$YR$$M$Y$$$20240906$$MD$US$US
242903281$24290328$1$I$$20240829$20240906$20240906$PER$$US-ROCHE-10000070751$ROCHE$$$$$$Y$$$20240906$$PH$US$US
242903293$24290329$3$F$20240903$20240906$20240906$20240917$PER$$US-AMGEN-USASP2024177883$AMGEN$$86$YR$E$F$Y$$$20240917$$CN$US$US
242903301$24290330$1$I$$20240903$20240906$20240906$EXP$$US-JNJFOC-20240909996$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242903331$24290333$1$I$$20240827$20240906$20240906$EXP$$DE-EMD Serono-2024046586$EMD SERONO INC$Groth O, Roider G, Graw M. Fatalities associated with failure to adjust drug dose in patients with renal insufficiency: A retrospective study at the Institute of Forensic Medicine in Munich (2019-2023). Medikamenteninduzier te Todesfalle bei Niereninsuffizie. MMW Fortschritte der Medizin. 2024 Aug 01;166(13): 48-51.$72$YR$E$F$Y$$$20240906$$MD$DE$DE
242903351$24290335$1$I$$20240827$20240906$20240906$EXP$$JP-MYE-2024M1080343AA$MYLAN$Higashigawa M, Nakamura T, Hattori T, Yoshino A, Ito M, Ichimi R. Combination of prednisolone and cyclosporine A as third-line therapy for refractory Kawasaki disease. Minerva-Pediatr 2023; 75 (5): 682-688.. 2023;75 (5):682-688$5$YR$$M$Y$$$20240906$$HP$JP$JP
242903361$24290336$1$I$$20240828$20240906$20240906$PER$$US-ABBVIE-5900361$ABBVIE$$$$$F$Y$55$KG$20240906$$CN$US$US
242903371$24290337$1$I$$20240827$20240906$20240906$EXP$$JP-MYE-2024M1080357AA$MYLAN$Kamijo Y, Usuda M, Matsuno A, Katoh N, Morita Y, Tamaru F, et al. Successful Maintenance Therapy with Intravenous Immunoglobulin to Reduce Relapse Attacks and Steroid Dose in a Patient with Refractory Myelin Oligodendrocyte Glycoprotein Antibody-positive Optic Neuritis. Intern-Med 2024; 0 (0):.. 2024;0 (0)$25$YR$$M$Y$$$20240906$$HP$JP$JP
242903381$24290338$1$I$$20240901$20240906$20240906$PER$$US-BEH-2024178183$CSL BEHRING$$$$E$M$Y$$$20240906$$MD$US$US
242903391$24290339$1$I$20240801$20240823$20240906$20240906$PER$$US-SA-2024SA257992$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240906$$HP$US$US
242903401$24290340$1$I$20240822$20240822$20240906$20240906$PER$$US-SA-2024SA257950$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240906$$MD$US$US
242903411$24290341$1$I$$20240902$20240906$20240906$EXP$$JP-PFIZER INC-202400249907$PFIZER$Miura, R.. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine (United States). 2024;103(34):10.1097/MD.0000000000039289$$$E$$Y$$$20240906$$MD$JP$JP
242903421$24290342$1$I$$20240902$20240906$20240906$EXP$$JP-PFIZER INC-202400249908$PFIZER$Miura, R.. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine (United States). 2024;103(34):10.1097/MD.0000000000039289$$$E$$Y$$$20240906$$MD$JP$JP
242903431$24290343$1$I$$20240904$20240906$20240906$EXP$$GR-PFIZER INC-PV202400115998$PFIZER$Servitzoglou, M.. ADMINISTRATION OF TEMOZOLOMIDE AND IRINOTECAN IN THE TREATMENT OF REFRACTORY AND RECURRENT NEUROBLASTOMA: RESULTS OF THE NATIONWIDE (PANHELLENIC) REGISTRATION OF THE GSPHO NEUROBLASTOMA TEAM. 7th PANHELLENIC CONGRESS OF PEDIATRIC HEMATOLOGY ONCOLOGY (Bulletin). 2023;73(1):24-27$$$C$$Y$$$20240906$$MD$GR$GR
242903442$24290344$2$F$$20240916$20240906$20240918$EXP$$JP-PFIZER INC-202400249903$PFIZER$Miura, R.. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine (United States). 2024;103(34):e39289$$$E$$Y$$$20240918$$MD$JP$JP
242903451$24290345$1$I$20240904$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61369$$FDA-CTU$$$$$F$N$50.3$KG$20240905$N$$US$
242903461$24290346$1$I$$20240902$20240906$20240906$EXP$$JP-PFIZER INC-202400249905$PFIZER$Miura, R.. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine (United States). 2024;103(34):e39289$$$E$$Y$$$20240906$$MD$JP$JP
242903471$24290347$1$I$$20240904$20240906$20240906$EXP$$CA-PFIZER INC-202400250134$PFIZER$$32$YR$$M$Y$$$20240906$$HP$CA$CA
242903481$24290348$1$I$$20240902$20240906$20240906$EXP$$JP-PFIZER INC-202400249910$PFIZER$Miura, R.. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine (United States). 2024;103(34):10.1097/MD.0000000000039289$$$E$$Y$$$20240906$$MD$JP$JP
242903491$24290349$1$I$20240801$20240826$20240906$20240906$PER$$US-SA-2024SA257853$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240906$$HP$US$US
242903501$24290350$1$I$20240904$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61370$$FDA-CTU$$$$$M$N$93.6$KG$20240905$N$$US$
242903511$24290351$1$I$$20240904$20240906$20240906$EXP$$CA-PFIZER INC-202400250087$PFIZER$$$$$$Y$$$20240906$$HP$CA$CA
242903522$24290352$2$F$$20240916$20240906$20240918$EXP$$JP-PFIZER INC-202400249906$PFIZER$Miura, R.. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine (United States). 2024;103(34):e39289$$$E$$Y$$$20240918$$MD$JP$JP
242903531$24290353$1$I$$20240902$20240906$20240906$EXP$$JP-PFIZER INC-202400249902$PFIZER$Miura, R.. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine (United States). 2024;103(34):e39289$$$E$$Y$$$20240906$$MD$JP$JP
242903541$24290354$1$I$$20240827$20240906$20240906$PER$$US-SA-2024SA254145$SANOFI AVENTIS$$15$MON$I$$Y$$$20240906$$HP$US$US
242903551$24290355$1$I$20240101$20240829$20240906$20240906$PER$$US-SA-2024SA253060$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240906$$CN$US$US
242903561$24290356$1$I$20240812$20240827$20240906$20240906$PER$$US-SA-2024SA127662$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240906$$CN$US$US
242903571$24290357$1$I$$20240827$20240906$20240906$EXP$$DE-EMD Serono-2024046588$EMD SERONO INC$Groth O, Roider G, Graw M. Fatalities associated with failure to adjust drug dose in patients with renal insufficiency: A retrospective study at the Institute of Forensic Medicine in Munich (2019-2023). Medikamenteninduzierte Todesfalle bei Niereninsuffizienz. MMW Fortschritte der Medizin. 2024 Aug 01;166(13): 48-51.$79$YR$E$M$Y$$$20240906$$MD$DE$DE
242903581$24290358$1$I$$20240904$20240906$20240906$PER$$US-009507513-2409USA001573$MERCK$$$$$F$Y$$$20240906$$CN$US$US
242903591$24290359$1$I$20240808$20240828$20240906$20240906$EXP$$CN-009507513-2409CHN000055$MERCK$$51$YR$$F$Y$56$KG$20240906$$HP$CN$CN
242903611$24290361$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA255486$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240906$$MD$US$US
242903631$24290363$1$I$20240822$20240830$20240906$20240906$EXP$$IN-ROCHE-10000071790$ROCHE$$54$YR$A$F$Y$$$20240906$$CN$IN$IN
242903641$24290364$1$I$$20240827$20240906$20240906$EXP$$DE-EMD Serono-2024046591$EMD SERONO INC$Groth O, Roider G, Graw M. [Fatalities associated with failure to adjust drug dose in patients with renal insufficiency: A retrospective study at the Institute of Forensic Medicine in Munich (2019-2023)]. Medikamenteninduzierte Todesfalle bei Niereninsuffizienz. MMW Fortschritte der Medizin. 2024 Aug 01;166(13): 48-51.$80$YR$E$F$Y$$$20240906$$MD$DE$DE
242903652$24290365$2$F$$20240829$20240906$20240906$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-17425$IPSEN$$$$$M$Y$11.79$KG$20240906$$CN$US$US
242903671$24290367$1$I$20221110$20240828$20240906$20240906$EXP$$SE-JNJFOC-20240874532$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$MD$SE$SE
242903681$24290368$1$I$$20240828$20240906$20240906$30DAY$$US-GSK-US2024107236$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242903691$24290369$1$I$$20240802$20240906$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02863$AMNEAL$$$$$$Y$$$20240906$$PH$US$US
242903701$24290370$1$I$$20240831$20240906$20240906$PER$$US-LEO Pharma-373258$LEO PHARM$$47$YR$$F$Y$$$20240906$$CN$US$US
242903721$24290372$1$I$20230829$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61372$$FDA-CTU$$$$$F$N$96.2$KG$20240904$N$$US$
242903741$24290374$1$I$20240726$20240807$20240906$20240906$DIR$FDA-CDER-CTU-2024-61380$$FDA-CTU$$61$YR$$F$N$50.3$KG$20240807$N$$US$
242903751$24290375$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61152$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242903761$24290376$1$I$20240828$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61373$$FDA-CTU$$$$$F$N$90.7$KG$20240904$N$$US$
242903771$24290377$1$I$20230511$20240827$20240906$20240906$DIR$FDA-CDER-CTU-2024-61381$$FDA-CTU$$31$YR$$F$N$306$KG$20240827$N$$US$
242903781$24290378$1$I$20240304$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61382$$FDA-CTU$$78$YR$$M$N$75.8$KG$20240905$N$$US$
242903791$24290379$1$I$20240820$20240903$20240906$20240906$DIR$FDA-CDER-CTU-2024-61379$$FDA-CTU$$59$YR$$M$N$86$KG$20240903$N$$US$
242903801$24290380$1$I$20240905$20240905$20240905$20240905$DIR$717370$$FDA-CTU$$48$YR$$F$N$67.5$KG$20240905$N$CN$US$
242903811$24290381$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61383$$FDA-CTU$$$$$M$N$$$20240905$N$HP$US$
242903821$24290382$1$I$$20240903$20240906$20240906$EXP$$CA-TAKEDA-2024TUS088620$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
242903831$24290383$1$I$$20240829$20240906$20240906$EXP$$RU-TAKEDA-2024TUS088498$TAKEDA$$$$C$$Y$$$20240906$$CN$RU$RU
242903841$24290384$1$I$$20240904$20240906$20240906$PER$$US-BIOGEN-2024BI01281198$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242903851$24290385$1$I$$20240904$20240906$20240906$PER$$US-BIOGEN-2020BI00878240$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242903862$24290386$2$F$20240812$20240906$20240906$20240909$EXP$$US-GILEAD-2024-0682402$GILEAD$$75$YR$E$F$Y$$$20240909$$CN$US$US
242903871$24290387$1$I$20240902$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024175986$AMGEN$$66$YR$E$F$Y$$$20240906$$CN$US$US
242903881$24290388$1$I$20240829$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177354$AMGEN$$68$YR$E$M$Y$$$20240906$$CN$US$US
242903891$24290389$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177536$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242903901$24290390$1$I$$20240820$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08334$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242903921$24290392$1$I$$20240828$20240906$20240906$EXP$$GB-TEVA-VS-3238462$TEVA$$71$YR$$F$Y$65$KG$20240906$$HP$GB$GB
242903931$24290393$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA258496$SANOFI AVENTIS$$$$A$M$Y$$$20240906$$MD$US$US
242903951$24290395$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61357$$FDA-CTU$$59$YR$$F$N$111.13$KG$20240905$N$$US$
242903961$24290396$1$I$20240301$20240822$20240906$20240906$PER$$US-SA-2024SA253026$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240906$$MD$US$US
242903971$24290397$1$I$20240501$20240828$20240906$20240906$PER$$US-SA-2024SA258090$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240906$$MD$US$US
242903981$24290398$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61292$$FDA-CTU$$71$YR$$F$N$84.82$KG$20240905$N$$US$
242903991$24290399$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61309$$FDA-CTU$$57$YR$$M$N$83.91$KG$20240905$N$$US$
242904001$24290400$1$I$20240801$20240826$20240906$20240906$PER$$US-SA-2024SA257607$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240906$$MD$US$US
242904021$24290402$1$I$$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140285$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240906$$CN$US$US
242904031$24290403$1$I$20191114$20240829$20240906$20240906$EXP$$CA-CELLTRION INC.-2024CA021266$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
242904051$24290405$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61319$$FDA-CTU$$63$YR$$F$N$90.72$KG$20240905$N$$US$
242904061$24290406$1$I$$20240906$20240906$20240906$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049153$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$$$20240906$$PH$AU$AU
242904071$24290407$1$I$$20240904$20240906$20240906$PER$$US-GILEAD-2024-0686516$GILEAD$$$$$M$Y$$$20240906$$PH$US$US
242904081$24290408$1$I$20240710$20240823$20240906$20240906$EXP$$US-BAXTER-2024BAX023850$BAXTER$$76$YR$$M$Y$108.1$KG$20240906$$PH$US$US
242904091$24290409$1$I$20210501$20240827$20240906$20240906$EXP$FR-EMA-DD-20240821-7482701-063031$FR-BAXTER-2024BAX023806$BAXTER$$71$YR$$M$Y$$$20240906$$MD$FR$FR
242904101$24290410$1$I$20240821$20240827$20240906$20240906$EXP$IT-MINISAL02-999955$IT-BAXTER-2024BAX023788$BAXTER$$53$YR$$F$Y$$$20240906$$MD$IT$IT
242904132$24290413$2$F$$20240906$20240906$20240912$EXP$$CA-JNJFOC-20240906868$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240912$$HP$CA$CA
242904141$24290414$1$I$20240816$20240830$20240906$20240906$EXP$$FR-AstraZeneca-2024A197809$ASTRAZENECA$$81$YR$$M$Y$86$KG$20240906$$MD$FR$
242904151$24290415$1$I$$20240828$20240906$20240906$PER$$US-AstraZeneca-2024A196934$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242904161$24290416$1$I$$20240904$20240906$20240906$EXP$$US-AstraZeneca-2024A201824$ASTRAZENECA$$$$$$Y$$$20240906$$HP$US$
242904171$24290417$1$I$$20240904$20240906$20240906$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004909$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240906$$HP$FR$FR
242904191$24290419$1$I$$20240828$20240906$20240906$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-08146$HIKMA$$66$YR$$M$Y$$$20240906$$CN$GB$GB
242904211$24290421$1$I$$20240904$20240906$20240906$EXP$$CA-PFIZER INC-202400250029$PFIZER$$$$$$Y$$$20240906$$HP$CA$CA
242904231$24290423$1$I$$20240822$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466399$RANBAXY$Sasidharan A, Iftikhar M, Kyaw NK, Sighakoli S, Shah SS. First presentation of gestational diabetes mellitus with impending DKA and hypertriglyceridemia. Br J Diabetes. 2024;24 (1):10-11$$$N$$Y$$$20240906$$HP$GB$GB
242904242$24290424$2$F$$20240827$20240906$20240911$EXP$$ID-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466254$RANBAXY$Lestari PM, Andrina H, Herponi A. A Rare Case Report: Belly Dancer Dyskinesia and Symptomatic Epilepsy in Pregnancy Causing Incomplete Uterine Rupture.. J SAFOG. 2024;16 (4):455-457$33$YR$$F$Y$$$20240911$$HP$ID$ID
242904251$24290425$1$I$$20240822$20240906$20240906$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466244$RANBAXY$A M Oprean, D A Epure, R S Perjoc, A C Paslaru, R I Teleanu. Neurodevelopmental disorder related to TANC2 gene. Revista de Neurologie si Psihiatrie a Copilului si Adolescentului din Romania. 2024;Vol. 30, No. 1:65-69$12$YR$$F$Y$$$20240906$$HP$RO$RO
242904261$24290426$1$I$20200101$20240822$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466247$RANBAXY$$63$YR$$F$Y$80$KG$20240906$$CN$GB$GB
242904271$24290427$1$I$20240509$20240902$20240906$20240906$EXP$$AU-009507513-2409AUS001727$MERCK$$70$YR$$F$Y$$$20240906$$MD$AU$AU
242904281$24290428$1$I$$20240829$20240906$20240906$EXP$$FR-MYLANLABS-2024M1080828$MYLAN$Krouma M, Aboudou Soilihi A, Pech-Gourg G, Arnaud S, Fadoua EL, Caruselli M, et al. Takotsubo syndrome linked to paroxysmal sympathetic hyperactivity as a postoperative complication after brain tumor removal: a case report and literature review. [Review]. Childs-Nerv-Syst 2024; 40 (8): 2573-2579.$8$YR$$F$Y$$$20240906$$HP$FR$FR
242904292$24290429$2$F$$20240917$20240906$20240924$EXP$$ES-MYLANLABS-2024M1081063$MYLAN$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transpl-Infect-Dis 2024; 26 (3): e14276.$4$MON$$F$Y$$$20240924$$HP$ES$ES
242904301$24290430$1$I$$20240829$20240906$20240906$EXP$$ES-MYLANLABS-2024M1081062$MYLAN$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transpl-Infect-Dis 2024; 26 (3): e14276.$5$MON$$M$Y$$$20240906$$HP$ES$ES
242904311$24290431$1$I$$20240822$20240906$20240906$EXP$$IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466238$RANBAXY$Moollan N, Durcan L.. A tale of two pregnancies.. Pol Arch Med Wewn. 2022;132 (Suppl.):11-12$35$YR$$F$Y$$$20240906$$HP$IE$IE
242904321$24290432$1$I$$20240903$20240906$20240906$PER$$NVSC2024US179242$NOVARTIS$$$$$$Y$$$20240906$$CN$US$US
242904331$24290433$1$I$$20240826$20240906$20240906$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2024-08470$LUPIN$$$$$$Y$$$20240906$$MD$DE$DE
242904341$24290434$1$I$$20240827$20240906$20240906$EXP$$DE-EMD Serono-2024046290$EMD SERONO INC$Groth O, Roider G, Graw M. Fatalities associated with failure to adjust drug dose in patients with renal insufficiency: A retrospective study at the Institute of Forensic Medicine in Munich (2019-2023). Medikamenteninduzier te Todesfalle bei Niereninsuffizie. MMW Fortschritte der Medizin. 2024 Aug 01;166(13): 48-51.$84$YR$E$F$Y$$$20240906$$MD$DE$DE
242904352$24290435$2$F$20240801$20240903$20240906$20240913$PER$$US-SA-2024SA256866$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240913$$MD$US$US
242904361$24290436$1$I$20240821$20240822$20240906$20240906$PER$$US-SA-2024SA258832$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240906$$HP$US$US
242904371$24290437$1$I$$20240829$20240906$20240906$EXP$$FR-MYLANLABS-2024M1080823$MYLAN$Tardy C, Puszkiel A, Boudou-Rouquette P, De Percin S, Alexandre J, Berge M, et al. Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection. Cancer-Chemother-Pharmacol 2024; 93 169-175.$50$YR$$F$Y$$$20240906$$HP$FR$FR
242904381$24290438$1$I$$20240905$20240906$20240906$EXP$$IN-ROCHE-10000074925$ROCHE$$$$E$M$Y$$$20240906$$MD$IN$IN
242904391$24290439$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA255588$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240906$$MD$US$US
242904401$24290440$1$I$$20240902$20240906$20240906$EXP$$TW-JNJFOC-20240911809$JOHNSON AND JOHNSON$$70$YR$E$M$Y$56$KG$20240906$$CN$TW$TW
242904412$24290441$2$F$20240101$20240910$20240906$20240918$EXP$$RO-JNJFOC-20240904380$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240918$$MD$RO$RO
242904422$24290442$2$F$$20240909$20240906$20240919$EXP$$BE-EXELIXIS-CABO-24081232$EXELIXIS$$$$$$Y$$$20240919$$CN$BE$BE
242904431$24290443$1$I$$20240829$20240906$20240906$EXP$$CA-GSK-CA2024107806$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$CA$CA
242904441$24290444$1$I$20230928$20240830$20240906$20240906$EXP$GB-MHRA-MED-202408270745395860-NYMJH$GB-CHEPLA-2024011253$CHEPLAPHARM$$67$YR$$F$Y$52$KG$20240906$$CN$COUNTRY NOT SPECIFIED$GB
242904451$24290445$1$I$20240701$20240902$20240906$20240906$EXP$FR-AFSSAPS-LL2024001634$FR-CHEPLA-2024011306$CHEPLAPHARM$$83$YR$$F$Y$$$20240906$$PH$COUNTRY NOT SPECIFIED$FR
242904461$24290446$1$I$$20240902$20240906$20240906$EXP$$VN-CHEPLA-2024011318$CHEPLAPHARM$$67$YR$$F$Y$$$20240906$$MD$COUNTRY NOT SPECIFIED$VN
242904471$24290447$1$I$20240816$20240830$20240906$20240906$EXP$$CN-CHEPLA-2024011312$CHEPLAPHARM$$66$YR$$M$Y$$$20240906$$HP$COUNTRY NOT SPECIFIED$CN
242904481$24290448$1$I$$20240829$20240906$20240906$EXP$$DK-CHEPLA-2024011328$CHEPLAPHARM$Hoeck PR, Kessing LV, Pagsberg AK, Andersen MLM. 15-year-old with bipolar affective disorder treated with ECT. Ugeskr L?ger 2024;186:V02240137. doi: 10.61409/V02240137.$15$YR$$F$Y$$$20240906$$HP$COUNTRY NOT SPECIFIED$DK
242904511$24290451$1$I$$20240822$20240906$20240906$PER$$US-BAYER-2024A124375$BAYER$$7$YR$C$$Y$$$20240906$$CN$US$US
242904521$24290452$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003130$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240906$$CN$US$US
242904531$24290453$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002524$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240906$$CN$US$US
242904541$24290454$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002820$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240906$$CN$US$US
242904551$24290455$1$I$$20240826$20240906$20240906$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000844$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240906$$CN$JP$JP
242904561$24290456$1$I$$20240829$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003285$ELI LILLY AND CO$$$$$F$Y$$$20240906$$CN$US$US
242904572$24290457$2$F$20221212$20240920$20240906$20240927$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000821$ELI LILLY AND CO$$37$YR$A$F$Y$55$KG$20240927$$CN$JP$JP
242904581$24290458$1$I$$20240820$20240906$20240906$PER$$US-TEVA-VS-3235653$TEVA$$$$$M$Y$$$20240906$$PH$US$US
242904591$24290459$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61275$$FDA-CTU$$60$YR$$F$N$$$20240905$N$$US$
242904601$24290460$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61289$$FDA-CTU$$68$YR$$F$N$$$20240905$N$$US$
242904612$24290461$2$F$20210101$20240830$20240906$20240913$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465710$RANBAXY$Mahajan S, Karishetti MSK. CARDINAL SIN OF SOFT TISSUE SARCOMA IN A RENAL TRANSPLANT PATIENT. Indian J Nephrol. 2023;33 (Suppl.1):S119 (229)$37$YR$$M$Y$$$20240913$$HP$IN$IN
242904621$24290462$1$I$$20240822$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466060$RANBAXY$$45$YR$$F$Y$83$KG$20240906$$HP$GB$GB
242904641$24290464$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466093$RANBAXY$Zhang PL, Metcalf BD, Khan S, Abukhaled J, Zafar K, Li W, et al. Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis. Ultrastruct Pathol. 2024;48 (4):317-322$67$YR$$F$Y$$$20240906$$HP$US$US
242904651$24290465$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176169$AMGEN$$$$$F$Y$$$20240906$$MD$US$US
242904661$24290466$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61365$$FDA-CTU$$47$YR$$F$N$121.11$KG$20240905$N$$US$
242904671$24290467$1$I$$20240903$20240905$20240905$DIR$FDA-CDER-CTU-2024-61158$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
242904681$24290468$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61366$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
242904691$24290469$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465327$RANBAXY$Torrie AM, Dunitz J, Brookman JC. Apparent Reversal of a Successful Peripheral Neural Blockade With Intravenous Lipid Emulsion After Treatment for Local Anesthetic Systemic Toxicity: A Case Report. A A Pract. 2020;14 (13):no pagination$42$YR$$F$Y$56.7$KG$20240906$$MD$US$US
242904701$24290470$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024175874$AMGEN$Sataloff R.T.; Reich J.S.; Sethi H.K. Bilateral Sensorineural Hearing Loss in the Setting of Acute Methamphetamine Overdose. Ear, nose and throat journal. 2024;103 (8):NP491-NP493$28$YR$A$M$Y$$$20240906$$MD$US$US
242904721$24290472$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465874$RANBAXY$Majid M, Yaker ZS, Brands C, Unai S, Klein AL. Not So Transient Effusive-Constrictive Pericarditis. JACC Case Rep. 2023;28:1-3$63$YR$$M$Y$$$20240906$$MD$US$US
242904731$24290473$1$I$$20240822$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465919$RANBAXY$Thomas EH, Woodward S, Ahmad S. Managing pregnancy-related stroke risk with known bilateral internal carotid artery webs. Obstet Med. 2024;17(1):63-65$39$YR$$F$Y$$$20240906$$HP$GB$GB
242904742$24290474$2$F$$20240910$20240906$20240925$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464414$RANBAXY$$$$A$F$Y$$$20240925$$MD$US$US
242904761$24290476$1$I$$20240822$20240906$20240906$EXP$$MD-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465456$RANBAXY$Hadjiu S, Calistru I, Sprincean M, Capestru E, Istratuc I, Constantin O et al. Clinical-genetic and neuroimaging particularities in Aicardi-Goutieres syndrome. RJCANP. 2024;Mar;30(1):37-48$14$MON$$M$Y$$$20240906$$HP$MD$MD
242904771$24290477$1$I$20240817$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465459$RANBAXY$$48$YR$$F$Y$$$20240906$$MD$US$US
242904781$24290478$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465846$RANBAXY$Kim EB, Malespini J, Lei M, Branagan AR, Cirstea D, Han SS, et al. Rapid reduction of free light chains and improvement in renal outcomes in patients with newly diagnosed multiple myeloma admitted with acute kidney injury with daratumumab-based therapy and without plasmapheresis. J Clin Oncol. 2024;42(Suppl)(16):7525$87$YR$$$Y$$$20240906$$HP$US$US
242904792$24290479$2$F$$20240910$20240906$20240925$EXP$$MT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465767$RANBAXY$Saliba J, Vassallo C, Saliba J, Bardon MP. Leptospirosis: a clinical and diagnostic challenge. BMJ Case Rep. 2024;17 (5):e256905$$$A$M$Y$$$20240925$$HP$MT$MT
242904802$24290480$2$F$$20240922$20240906$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141916$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$54.43$KG$20240923$$CN$US$US
242904811$24290481$1$I$$20240822$20240906$20240906$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465671$RANBAXY$Glimelius B, Khan T, Adolfsson K, Angenete E, Berglund A, Bonde K, et al. Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US). E Clinical Medicine. 2024;Sep; 75:1-12$61$YR$$F$Y$$$20240906$$HP$SE$SE
242904821$24290482$1$I$$20240822$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465699$RANBAXY$Jose B, Gopinath S, Kannoth S, Anandakuttan A. Autoimmune meningitis - a hidden culprit?. J Neurol Sci. 2023;455 (Suppl.):15(1212080)$35$YR$$F$Y$$$20240906$$HP$IN$IN
242904841$24290484$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465844$RANBAXY$Kim EB, Malespini J, Lei M, Branagan AR, Cirstea D, Han SS, et al. Rapid reduction of free light chains and improvement in renal outcomes in patients with newly diagnosed multiple myeloma admitted with acute kidney injury with daratumumab-based therapy and without plasmapheresis. J Clin Oncol. 2024;42(Suppl)(16):7525$86$YR$$$Y$$$20240906$$HP$US$US
242904851$24290485$1$I$$20240822$20240906$20240906$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465934$RANBAXY$R. T. Popeanga, R. Perjoc, E. Roza, R. I. Teleanu. A case of epilepsy in a patient previously diagnosed with TUBA1A tubulinopathy. Revista de Neurologie si Psihiatrie a Copilului si Adolescentului din Romania. 2024;Vol. 30, No. 1:49-54$6$YR$$M$Y$$$20240906$$HP$RO$RO
242904861$24290486$1$I$$20240822$20240906$20240906$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464964$RANBAXY$Shiraishi H, Teramoto T, Yokoshiki S, Tohyama J, Ueda Y, Egawa K, et al. Efficacy of sirolimus for epileptic seizures in childhood associated with focal cortical dysplasia type II. Brain Dev. 2023;45 (6):343-347$2$YR$$F$Y$$$20240906$$HP$JP$JP
242904871$24290487$1$I$$20240822$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466224$RANBAXY$$63$YR$$M$Y$$$20240906$$HP$GB$GB
242904881$24290488$1$I$$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141439$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240906$$HP$US$US
242904891$24290489$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466106$RANBAXY$Jones AA, Martin JS, Giangiacomo AL, Costakos DM. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. Am J Ophthalmol Case Rep. 2024;36 (0):102131$$$I$$Y$$$20240906$$HP$US$US
242904901$24290490$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466092$RANBAXY$Zhang PL, Metcalf BD, Khan S, Abukhaled J, Zafar K, Li W, et al. Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis. Ultrastruct Pathol. 2024;48 (4):317-322$87$YR$$F$Y$$$20240906$$HP$US$US
242904911$24290491$1$I$$20240822$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466110$RANBAXY$$77$YR$$M$Y$$$20240906$$PH$GB$GB
242904921$24290492$1$I$$20240822$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466071$RANBAXY$$78$YR$$M$Y$$$20240906$$PH$GB$GB
242904931$24290493$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465840$RANBAXY$Ahmad M, Murphy MJ, Damsky W, Leventhal J.. Dupilumab-induced psoriasis in the setting of pembrolizumab therapy: an analysis of cytokine expression. Int-J-Dermatol. 2023;62 (8):e424-e426.$84$YR$$F$Y$$$20240906$$HP$US$US
242904941$24290494$1$I$$20240822$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465824$RANBAXY$Bennassi A, Rivin Del Campo E, Theodore C, Huguet F. Breast cancer in a transgender man and hypofractionated radiotherapy: A case report and review of literature. Cancer-Radiother. 2024;28 (3):272-274$77$YR$$M$Y$$$20240906$$HP$FR$FR
242904951$24290495$1$I$$20240823$20240906$20240906$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419361$RANBAXY$Omori K,  Kitagawa H, Takada M, Maeda R, Nomura T, Kubo Y et al. Fosfomycin as salvage therapy for persistent methicillin-resistantStaphylococcus aureus bacteremia: A case series and review of the literature. J Infect Chemother. 2024;Apr; 30(4):352-356$57$YR$$F$Y$$$20240906$$HP$JP$JP
242904961$24290496$1$I$$20240823$20240906$20240906$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466020$RANBAXY$Fijen ML, Petersan SR, Cohn MD. Facial swelling due to angioedema:often mast cell mediated, but not always. Dutch Journal of Medicine. 2023;167:D7610$18$YR$$F$Y$$$20240906$$MD$NL$NL
242904971$24290497$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466121$RANBAXY$Jones H, Bhakta A, Jia L, Wojciechowski D, Torrealba J. An Unusual Presentation of Metastatic BK Virus-Associated Urothelial Carcinoma Arising in the Allograft, Persisting After Transplant Nephrectomy. Int J Surg Pathol. 2023;31 (8):1586-1592$32$YR$$M$Y$$$20240906$$MD$US$US
242904981$24290498$1$I$$20240822$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465843$RANBAXY$Zhu C, Wang P, Long Q, Lin S, Lin L, Xiao X et al.. Panniculitis during avapritinib therapy for gastrointestinal stromal tumour. Eur J Dermatol. 2023;33(6):703-705$63$YR$$M$Y$$$20240906$$HP$CN$CN
242904991$24290499$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466091$RANBAXY$Zhang PL, Metcalf BD, Khan S, Abukhaled J, Zafar K, Li W, et al. Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis. Ultrastruct Pathol. 2024;48 (4):317-322$73$YR$$F$Y$$$20240906$$HP$US$US
242905001$24290500$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466128$RANBAXY$Zahran NA, Zeller WP, Charnogursky GA. Hyperglycemia and multiple organ failure in a male adolescent. J Clin Transl Endocrinol Case Rep. 2023;28:100140$14$YR$$M$Y$54$KG$20240906$$HP$US$US
242905011$24290501$1$I$$20240823$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464579$RANBAXY$Jiang S, Li X, Lin J. Application of sovantinib in large cell neuroendocrine carcinoma of tonsil: A case report and literature review. Oral Oncol. 2023;140:106365$65$YR$$M$Y$$$20240906$$HP$CN$CN
242905021$24290502$1$I$$20240822$20240906$20240906$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466365$RANBAXY$Pozzi E, Corsini C, Bertini A, Belladelli F, Raffo M, Negri F, et al. Spontaneous erectile function recovery among young men with erectile dysfunction taking tadalafil 5 mg once a day. J Sex Med. 2024;21(8):671-675$$$$M$Y$$$20240906$$HP$IT$IT
242905031$24290503$1$I$$20240823$20240906$20240906$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-346355$RANBAXY$Balestri R, Bortolotti R, Rech G, Girardelli CR, Zorzi MG, Magnano M. Treatment of Oral Erosive Lichen Planus With Upadacitinib. JAMA Dermatol. 2022;Apr; 158(4):457-458$45$YR$$F$Y$$$20240906$$MD$IT$IT
242905042$24290504$2$F$$20240902$20240906$20240917$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465964$RANBAXY$Eyre DW, Sanderson ND, Lord E, Regisford-Reimmer N, Chau K, Barker L, et al. Gonorrhoea  treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill. 2018;23 (7):1800323 (1-6)$$$$M$Y$$$20240917$$HP$GB$GB
242905051$24290505$1$I$$20240822$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465729$RANBAXY$Amjad W, Venu M. Dilemma of neuropathy. Br J Diabetes. 2024;24 (1):3; Abs ID: 7$35$YR$$F$Y$$$20240906$$HP$GB$GB
242905061$24290506$1$I$$20240822$20240906$20240906$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466189$RANBAXY$Stawarz K, Galazka A, Gorzelnik A, Durzynska M, Bienkowska-Pluta K, Zwolinski J. Case report: An uncommon presentation of extramedullary plasmacytoma without a concurrent diagnosis of multiple myeloma. Front Oncol. 2024;14 (0):no pagination$72$YR$$M$Y$$$20240906$$HP$PL$PL
242905071$24290507$1$I$$20240822$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460123$RANBAXY$Gao W, Li P, Zhao L. Analysis on the occurrence of adverse reactions of empagliflozin in hospitalized patients with type 2 diabetes mellitus. Advers Drug React J. 2021;23(6):293-297$44$YR$$M$Y$$$20240906$$HP$CN$CN
242905081$24290508$1$I$20230702$20240823$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465111$RANBAXY$Li Z. Study of Zanidatamab in Combination with Chemotherapy with or without Tislelizumab in Subjects with HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA). -. 2024;-:-$75$YR$$M$Y$49$KG$20240906$$HP$CN$CN
242905091$24290509$1$I$20190318$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465831$RANBAXY$Schmalz L, Bloomer C, Zhang W, Petty W. Durable response to amivantamab in treatment refractory NSCLC harboring EGFR and complex MET mutations: A case report. Lung Cancer. 2023;186:107400;1-4$47$YR$$F$Y$$$20240906$$HP$US$US
242905101$24290510$1$I$$20240823$20240906$20240906$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465381$RANBAXY$$$$$$Y$$$20240906$$PH$BR$BR
242905111$24290511$1$I$$20240822$20240906$20240906$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466358$RANBAXY$Pozzi E, Corsini C, Bertini A, Belladelli F, Raffo M, Negri F, et al. Spontaneous erectile function recovery among young men with erectile dysfunction taking tadalafil 5 mg once a day. J Sex Med. 2024;21(8):671-675$$$$M$Y$$$20240906$$HP$IT$IT
242905122$24290512$2$F$$20240913$20240906$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-465920$RANBAXY$Horiuchi A, Akehi S, Fujiwara Y, Kawaharada S, Anai T. A Case of Long-Term Survival with Recurrent Liver Metastases from Gastric Cancer Treated with Nivolumab. Case Rep Oncol. 2024;17 (1):438-446$67$YR$$M$Y$$$20240927$$HP$JP$JP
242905141$24290514$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465981$RANBAXY$Mariyam S, Chowdhary H, Sharma S, Arora C. Efficacy of Pre-Surgical Bupivacaine Infiltration in Reducing Postoperative Pain in Laparoscopic Gynecologic Surgery: A Randomized Controlled Trial. Int J Pharmac Clin Res. 2024;16 (7):138-142$$$$F$Y$$$20240906$$HP$IN$IN
242905151$24290515$1$I$$20240822$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465637$RANBAXY$Chen L, Hao Z, Ning W, Jingjie L, Yanqi C, Suying Y. Efficacy and safety analysis of sodium valproate for epileptic seizure prevention during the perioperative period in neurosurgical patients. ADRJ. 2022;24(8):404-409$79$YR$$F$Y$$$20240906$$HP$CN$CN
242905161$24290516$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465979$RANBAXY$Mariyam S, Chowdhary H, Sharma S, Arora C. Efficacy of Pre-Surgical Bupivacaine Infiltration in Reducing Postoperative Pain in Laparoscopic Gynecologic Surgery: A Randomized Controlled Trial. Int J Pharmac Clin Res. 2024;16 (7):138-142$$$$F$Y$$$20240906$$HP$IN$IN
242905172$24290517$2$F$$20240827$20240906$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466011$RANBAXY$Balashova O, Rosoph S, Buryk Y. Multiple Pneumothoraces Due to COVID-19 Related Interstitial Lung Disease in a Middle-aged Female with AIDS. South Med J. 2023;116:114-115$59$YR$$F$Y$$$20240911$$HP$US$US
242905182$24290518$2$F$$20240827$20240906$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466054$RANBAXY$Kuo C, Carlini SV, Tiwari S. Parkinsonism is a Red Herring: Broad Differential Diagnoses in a Case of Catatonia Secondary to Clozapine Withdrawal. J Acad Consult Liaison Psychiatry. 2023;64 (Suppl.):S6$56$YR$$F$Y$$$20240911$$HP$US$US
242905191$24290519$1$I$$20240822$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466033$RANBAXY$$66$YR$$F$Y$60$KG$20240906$$MD$GB$GB
242905201$24290520$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466094$RANBAXY$Zhang PL, Metcalf BD, Khan S, Abukhaled J, Zafar K, Li W, et al. Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis. Ultrastruct Pathol. 2024;48 (4):317-322$85$YR$$F$Y$$$20240906$$HP$US$US
242905221$24290522$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466258$RANBAXY$Credo R, Kesey J, Bharadia D, Griswold J, Pang A. Acute Intermittent Porphyria in a Burn Patient: Case Study and Review of the Literature [Review]. J Burn Care Res. 2024;45 (3):790-795$60$YR$$M$Y$$$20240906$$HP$US$US
242905231$24290523$1$I$$20240822$20240906$20240906$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466264$RANBAXY$$$$A$M$Y$$$20240906$$CN$DE$DE
242905241$24290524$1$I$$20240823$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466021$RANBAXY$Soldera J. Navigating treatment resistance: Janus kinase inhibitors for ulcerative colitis. World J Clin Cases. 2024;12(24):5468-5472$57$YR$$M$Y$$$20240906$$MD$GB$GB
242905251$24290525$1$I$$20240822$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465909$RANBAXY$Wang L, Zhang X, Huang B, Hou Y, Liu X, Jiao H. Ruxolitinib as an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report. Infect Drug Resist. 2023;16:2467-2473$$$$M$Y$$$20240906$$HP$CN$CN
242905261$24290526$1$I$$20240823$20240906$20240906$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464598$RANBAXY$Brito-Santana L, Medinas RL, Neves A, Gago J. Steroid-induced psychosis: a spectrum of neuropsychiatric glucocorticoid side effects. BMJ Case Rep. 2024;17 (7):1-5$$$A$M$Y$$$20240906$$HP$PT$PT
242905271$24290527$1$I$$20240822$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466301$RANBAXY$Sasidharan A, Iftikhar M, Kyaw NK, Sighakoli S, Shah SS. First presentation of gestational diabetes mellitus with impending DKA and hypertriglyceridemia. Br J Diabetes. 2024;24 (1):10-11$29$YR$$F$Y$$$20240906$$HP$GB$GB
242905291$24290529$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466111$RANBAXY$Ashinne B, Zablah G, Colombo R. THE USE OF IMPELLA FOR RIGHT VENTRICLE DECOMPRESSION: A LIFE SAVER. JACC. 2019;12 Mar; 73(9):2505$49$YR$$M$Y$$$20240906$$HP$US$US
242905301$24290530$1$I$$20240827$20240906$20240906$EXP$$AE-EMD Serono-2024046178$EMD SERONO INC$Jumani A, Purra H, Alkhazraji AK, AlNajjar MS, Ibrahim H. Metformin-Induced Hemolysis in a Glucose-6- Phosphate Dehydrogenase-Deficient Patient: A Case Report. Cureus. 2024 Jul 01;16(7): 1-5. doi:10.7759/cureus.65081.$40$YR$A$M$Y$$$20240906$$HP$AE$AE
242905311$24290531$1$I$$20240904$20240906$20240906$EXP$$US-INCYTE CORPORATION-2024IN009332$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242905321$24290532$1$I$$20240823$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466101$RANBAXY$Cui H-M, Shu X-P, Wei Z-Q, Wu X-Y. The ^appearing^ and ^disappearing^ ascites in the treatment of colorectal cancer: a case report. Front Oncol. 2024;14 (0):1372812(1-7)$65$YR$$M$Y$$$20240906$$HP$CN$CN
242905331$24290533$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466063$RANBAXY$Nyamagoud SB, Swamy AHV, Chacko A, James J. Actinomycetoma of Left Foot-A Case Report of Neglected Tropical Disease and Medication Non-adherence. Arch Pharmacy Practice. 2023;14 (3):21-25$26$YR$$M$Y$$$20240906$$HP$IN$IN
242905341$24290534$1$I$$20240823$20240906$20240906$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466087$RANBAXY$Gumeniuk OI, Yanin KR, Fisun AV, Chernenkov YV, Stepanov AA. Clinical case of rare mitochondrial disease in a child. Russian Open Med J. 2024;13 (2):1-2$$$$M$Y$$$20240906$$HP$RU$RU
242905351$24290535$1$I$20190401$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466546$RANBAXY$$64$YR$$M$Y$$$20240906$$MD$FR$FR
242905361$24290536$1$I$$20240823$20240906$20240906$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466120$RANBAXY$Troan J, Hansen KNo, Noori M, Lassen JF, Jensen LO. Very late Magmaris scaffold restenosis: a 6-year serial optical coherence tomography case report. Eur Heart J Case Rep. 2024;8 (7):ytae344 (1-4)$62$YR$$M$Y$$$20240906$$HP$DK$DK
242905371$24290537$1$I$$20240823$20240906$20240906$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466242$RANBAXY$Posado-Dominguez L, Figuero-Perez L, Olivares-Hernandez A, Chinchilla-Tabora L,Antunez-Plaza P, Rivas-Hernandez R, et al. Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review. Chin Clin Oncol. 2024;13(3):1-7$65$YR$$M$Y$$$20240906$$HP$ES$ES
242905381$24290538$1$I$$20240823$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466212$RANBAXY$Zeng D-H, Chen X-H, Li Y, Zhu X-Y, Wang B-L, Ma X-G et al. Clinical and pathological characteristics of acute kidney injury caused by diquat poisoning. Clin Toxicol. 2023;61(9):705-708$26$YR$$M$Y$$$20240906$$HP$CN$CN
242905391$24290539$1$I$$20240823$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466286$RANBAXY$Tariq U, Stern D, Gabriels J. ACUTE CORONARY SYNDROME IN A TEENAGER: IMPORTANCE OF RECOGNIZING EARLY ONSET CORONARY ARTERY DISEASE. J Am Coll Cardiol. 2019;MAR; 73 (S.)9:2866$18$YR$$M$Y$$$20240906$$HP$US$US
242905401$24290540$1$I$$20240823$20240906$20240906$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466652$RANBAXY$Ragone N, Barbini B, Passani C, Seghi F, Colombo C. Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case. Int Clin Psychopharmacol. 2024;39(2):117-119$64$YR$$F$Y$$$20240906$$HP$IT$IT
242905411$24290541$1$I$$20240823$20240906$20240906$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466059$RANBAXY$Prestes-Carneiro LE, de Abreu MAMM, Roncada EVM, Muchon DG, Caliani FM, Vasconcelos DM. Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report. Pathogens. 2023;Sep;12 (9):1156(1-8)$33$YR$$M$Y$$$20240906$$HP$BR$BR
242905421$24290542$1$I$$20240823$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466209$RANBAXY$Zeng D-H, Chen X-H, Li Y, Zhu X-Y, Wang B-L, Ma X-G et al. Clinical and pathological characteristics of acute kidney injury caused by diquat poisoning. Clin Toxicol. 2023;61(9):705-708$17$YR$$F$Y$$$20240906$$HP$CN$CN
242905432$24290543$2$F$20240610$20240906$20240906$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466495$RANBAXY$$23$YR$$M$Y$$$20240920$$MD$FR$FR
242905441$24290544$1$I$20231208$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466519$RANBAXY$$61$YR$$M$Y$86.9$KG$20240906$$MD$FR$FR
242905451$24290545$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466352$RANBAXY$Newbigging NS, Lenin A, Jasmine S, Alexander S, Thomas N, Livingstone J. Secondary hyperaldosteronism due to renal agenesis: Rare cause of secondary hypertension in pregnancy. Int J Womens Cardiovascular Health. 2024;36:101104/31-32/ISSHP0104$$$N$$Y$$$20240906$$HP$IN$IN
242905461$24290546$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466357$RANBAXY$Sunitha B. Case of chorioamnionitis in ANA positive in second trimester of pregnancy. Int J women^s Cardio health. 2024;36:101104;ISSHP0114$42$YR$$F$Y$$$20240906$$HP$IN$IN
242905471$24290547$1$I$20240501$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466552$RANBAXY$$51$YR$$F$Y$$$20240906$$MD$FR$FR
242905481$24290548$1$I$$20240823$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466083$RANBAXY$He Y, Wang S, Deng J, Pu Q, Chen H, Huang L. Chlamydia psittaci Pneumonia Complicated with Lower Extremity Atherosclerotic Occlusive Disease. Infect Drug Resist. 2023;16:2141-2145$48$YR$$M$Y$$$20240906$$HP$CN$CN
242905491$24290549$1$I$20240610$20240823$20240906$20240906$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466311$RANBAXY$$75$YR$$F$Y$$$20240906$$MD$ES$ES
242905501$24290550$1$I$$20240828$20240906$20240906$30DAY$$US-GSK-US2024107298$GLAXOSMITHKLINE$$$$$M$Y$$$20240906$$CN$US$US
242905511$24290551$1$I$$20240823$20240906$20240906$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464580$RANBAXY$Talha Ozgun O, Kandemir Yilmaz M, Mert Atmaca M, Keskin Guler S, Bulus E, Duman A, et al. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide. Epilepsy Behav. 2023;Aug; 145:109355(1-6)$$$$M$Y$$$20240906$$HP$TR$TR
242905521$24290552$1$I$$20240823$20240906$20240906$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466057$RANBAXY$Dos SantosSilva RP, Lopes AJM, Bezerra RB, Andrade RA, Andrade RG, da Costa LMF, et al. Persistent hypotension and other complications of celiac plexus neurolysis: A case report and literature review. Clin case Rep. 2023;11 (6):e7505(1-4)$41$YR$$F$Y$$$20240906$$HP$BR$BR
242905531$24290553$1$I$$20240823$20240906$20240906$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466672$RANBAXY$Gomez-Puerta JA, Ponce A, Triguero A, de Larrea CF, Sanmarti R. Transient palindromic rheumatism induced by chimeric antigen receptor T-cell therapy. Rheumatology. 2024;8:215-216$55$YR$$F$Y$$$20240906$$HP$ES$ES
242905541$24290554$1$I$20240614$20240823$20240906$20240906$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466403$RANBAXY$$50$YR$$F$Y$$$20240906$$PH$IT$IT
242905551$24290555$1$I$$20240823$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466470$RANBAXY$Liu L, Zhang R, Nie N, Wang D Lin Y, Gao Z, et al. Chronic recurrent multifocal osteomyelitis Case report and review of the literature. Medicine. 2024;103 (30):e38850$14$YR$$M$Y$$$20240906$$HP$CN$CN
242905561$24290556$1$I$20240501$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466647$RANBAXY$$59$YR$$M$Y$$$20240906$$PH$FR$FR
242905571$24290557$1$I$20240122$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466510$RANBAXY$$59$YR$$M$Y$$$20240906$$MD$FR$FR
242905581$24290558$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61145$$FDA-CTU$$57$YR$$F$N$$$20240905$N$$US$
242905591$24290559$1$I$20240217$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466525$RANBAXY$$13$YR$$F$Y$57.5$KG$20240906$$PH$FR$FR
242905601$24290560$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466278$RANBAXY$Veeramani D, Sivasubramaniam B, Swaminathan P, Chandrasekar A, Thirugnanam A. Caroli^s disease and pregnancy - Do we expect the unexpected?. Eur J Obstet Gynecol Reprod Biol. 2024;293:206-207$21$YR$$F$Y$$$20240906$$HP$IN$IN
242905611$24290561$1$I$20240616$20240616$20240905$20240905$DIR$FDA-CDER-CTU-2024-61375$$FDA-CTU$$40$YR$$M$N$84.5$KG$20240616$N$PH$US$
242905621$24290562$1$I$$20240808$20240905$20240905$DIR$FDA-CDER-CTU-2024-61161$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
242905631$24290563$1$I$20240814$20240823$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466066$RANBAXY$$30$YR$$F$Y$$$20240906$$HP$GB$GB
242905641$24290564$1$I$20240701$20240825$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464678$RANBAXY$$67$YR$$F$Y$155$KG$20240906$$CN$GB$GB
242905651$24290565$1$I$20230327$20240823$20240906$20240906$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466515$RANBAXY$$74$YR$$F$Y$$$20240906$$MD$ES$ES
242905661$24290566$1$I$$20240823$20240906$20240906$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466578$RANBAXY$Hiroshima Y, Ishikawa H, Sumiya T, Murakami M, Nakamura M, Ishida T, et al. Clinical Impact of Proton Beam Therapy for Postoperative Lymph Node Oligorecurrence of Esophageal Cancer. In Vivo. 2023;37 (3):1253-1259$68$YR$$M$Y$$$20240906$$HP$JP$JP
242905671$24290567$1$I$$20240823$20240906$20240906$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466132$RANBAXY$Hadavand F, Naseri SR, Mardani M, Tabarsi P, Keyvanfar A, Gachkar L, et al. An Outbreak of Pandrug Resistant Providencia Species in an Intensive Care Unit: A Case-Series. Arch Clin Infect Dis. 2024;19 (3):e145826$48$YR$$M$Y$$$20240906$$HP$IR$IR
242905681$24290568$1$I$20240814$20240824$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466768$RANBAXY$$$$$$Y$$$20240906$$CN$GB$GB
242905691$24290569$1$I$20220101$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466536$RANBAXY$$33$YR$$F$Y$$$20240906$$MD$FR$FR
242905701$24290570$1$I$20240610$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466356$RANBAXY$$72$YR$$M$Y$75.2$KG$20240906$$MD$FR$FR
242905711$24290571$1$I$$20240823$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466015$RANBAXY$Cheney A, Krieger E, Dardas T, Vincent L. FROM MULTIPLE MYELOMA TO MYOCARDITIS. J Am Coll Cardiol. 2019;Mar 12;73(S9):2597$53$YR$$M$Y$$$20240906$$HP$US$US
242905721$24290572$1$I$$20240823$20240906$20240906$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466240$RANBAXY$Posado-Dominguez L, Figuero-Perez L, Olivares-Hernandez A, Chinchilla-Tabora L,Antunez-Plaza P, Rivas-Hernandez R, et al. Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review. Chin Clin Oncol. 2024;13(3):1-7$60$YR$$F$Y$$$20240906$$HP$ES$ES
242905731$24290573$1$I$$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466452$RANBAXY$$50$YR$$F$Y$74$KG$20240906$$PH$FR$FR
242905741$24290574$1$I$$20240823$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466400$RANBAXY$Lin L, Xue S, Chen J, Gu C, Zhang J, Xing E, et al. Olaparib combined with low-dose chemotherapy for relapsed AML1::ETO positive acute myeloid leukemia in elderly patient. Leuk Lymphoma. 2024;65(8):1181-1185$77$YR$$F$Y$$$20240906$$HP$CN$CN
242905751$24290575$1$I$$20240823$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466156$RANBAXY$Gaston FN, Chatterjee T. Spontaneous Iliac Artery Dissection in a 66-Year Old Male Complicated By Hemorrhage, GI Bleeding, and Bilateral DVT/PE. Blood. 2023;Nov; 142 (1):5416?5417$66$YR$$M$Y$$$20240906$$MD$US$US
242905761$24290576$1$I$20240118$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466325$RANBAXY$$60$YR$$F$Y$$$20240906$$PH$FR$FR
242905771$24290577$1$I$$20240823$20240906$20240906$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466416$RANBAXY$Watanabe S, Yasuda K, Tada T, Ishibashi A, Suzuki T. Electroconvulsive Therapy in a Patient With Depression on Hemodialysis. Journal of ECT. 2023;39 (2):71-73$74$YR$$M$Y$$$20240906$$MD$JP$JP
242905781$24290578$1$I$20240528$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466451$RANBAXY$$50$YR$$M$Y$$$20240906$$PH$FR$FR
242905801$24290580$1$I$20240520$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466459$RANBAXY$$58$YR$$F$Y$90$KG$20240906$$PH$FR$FR
242905811$24290581$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466393$RANBAXY$Kumaraswamy R, Bagde NK, Agarwal S. SLE - Can we prevent pre-eclampsia?. Pregnancy Hypertens. 2024;36(Suppl):ISSHP0151/61$$$N$$Y$$$20240906$$HP$IN$IN
242905821$24290582$1$I$$20240823$20240906$20240906$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466200$RANBAXY$Kawajiri-Manako C, Mishina T, Tsujimura H, Maruyama S, Sato A, Sugawara T, et al. Double?hit follicular lymphoma diagnosed due to central nervous system symptoms. Ann Hematol. 2023;102(5):1281-1282$73$YR$$F$Y$$$20240906$$HP$JP$JP
242905831$24290583$1$I$20240610$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466447$RANBAXY$$63$YR$$M$Y$103$KG$20240906$$MD$FR$FR
242905841$24290584$1$I$20240601$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466605$RANBAXY$$20$YR$$F$Y$$$20240906$$MD$FR$FR
242905851$24290585$1$I$$20240823$20240906$20240906$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466018$RANBAXY$Fijen ML, Petersan SR, Cohn MD. Facial swelling due to angioedema:often mast cell mediated, but not always. Dutch Journal of Medicine. 2023;167:D7610$30$YR$$M$Y$$$20240906$$HP$NL$NL
242905861$24290586$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465947$RANBAXY$Paul S, Salunkhe SR, Patil MG, Mane SV. Atypical Haemolytic Uraemic Syndrome in an infant with Ventricular Septal Defect: A Case Report. J Clin Diagnostic Res. 2024;18(7):SD01-SD03$6$MON$$F$Y$$$20240906$$HP$IN$IN
242905871$24290587$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466391$RANBAXY$Kumaraswamy R, Bagde NK, Agarwal S. SLE - Can we prevent pre-eclampsia?. Pregnancy Hypertens. 2024;36(Suppl):61/ ISSHP0151$$$$F$Y$$$20240906$$HP$IN$IN
242905881$24290588$1$I$20240727$20240823$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466233$RANBAXY$$34$YR$$M$Y$$$20240906$$MD$GB$GB
242905891$24290589$1$I$20240608$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466442$RANBAXY$$31$YR$$M$Y$$$20240906$$MD$FR$FR
242905901$24290590$1$I$$20240823$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466469$RANBAXY$Mansour MK, King JD, Chen ST, Fishman JA, Nazarian RM. Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes. N Engl J Med. 2023;Mar; 388 (10):926-937$$$$M$Y$$$20240906$$MD$US$US
242905911$24290591$1$I$20240822$20240824$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466765$RANBAXY$$33$YR$$M$Y$80$KG$20240906$$CN$GB$GB
242905921$24290592$1$I$20240525$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466453$RANBAXY$$49$YR$$F$Y$89$KG$20240906$$MD$FR$FR
242905931$24290593$1$I$20240614$20240823$20240906$20240906$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466431$RANBAXY$$46$YR$$F$Y$$$20240906$$MD$SE$SE
242905941$24290594$1$I$20240503$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466440$RANBAXY$$85$YR$$F$Y$$$20240906$$MD$FR$FR
242905951$24290595$1$I$20231224$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466575$RANBAXY$$34$YR$$M$Y$69$KG$20240906$$MD$FR$FR
242905961$24290596$1$I$$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466396$RANBAXY$$$$$M$Y$$$20240906$$PH$FR$FR
242905971$24290597$1$I$20231220$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466361$RANBAXY$$55$YR$$M$Y$$$20240906$$PH$FR$FR
242905992$24290599$2$F$$20240830$20240906$20240906$EXP$$US-ROCHE-10000070988$ROCHE$$$$$$Y$$$20240906$$CN$US$US
242906001$24290600$1$I$$20240828$20240906$20240906$EXP$$US-MYLANLABS-2024M1080714$MYLAN$D^Netto M, Kuhn A, Ferdjallah A, Joshi A. ALPS like: Trekking Sirolimus and its Fallouts. Clin-Immunol 2023; 250 (Suppl.).$3$YR$$M$Y$$$20240906$$HP$US$US
242906011$24290601$1$I$$20240828$20240906$20240906$EXP$$PL-MYLANLABS-2024M1080649$MYLAN$Komarnicki P, Musialkiewicz J, Maciejewski A, Gut P, Ruchala M. Rapid-onset Cushing syndrome induced by adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor: a therapeutic challenge. Pol-Arch-Med-Wewn 2024; 134 (7-8):.$25$YR$$M$Y$$$20240906$$MD$PL$PL
242906021$24290602$1$I$$20240904$20240906$20240906$PER$$US-TAKEDA-2024TUS088701$TAKEDA$$$$$M$Y$$$20240906$$HP$US$US
242906041$24290604$1$I$$20240828$20240906$20240906$EXP$$GB-MYLANLABS-2024M1080489$MYLAN$Reisz Z, Pereira R, Nevis S, Mackay A, Bhaw L, Grabovska Y, et al. An exceptionally rare case of a diffuse midline glioma with concomitant h3.1 k27m and g34r mutations in the hist1h3c (h3c3) gene. Neuro-Oncol 2024; 26 (Suppl.) iv30 abstr. DIPG-53.$2$YR$$F$Y$$$20240906$$HP$GB$GB
242906061$24290606$1$I$20120301$20240905$20240905$20240905$DIR$717365$$FDA-CTU$$61$YR$$F$N$69.75$KG$20240905$N$CN$US$
242906101$24290610$1$I$20240830$20240905$20240905$20240905$DIR$717363$$FDA-CTU$$45$YR$$M$N$$$20240905$N$PH$US$
242906111$24290611$1$I$20240905$20240905$20240905$20240905$DIR$717286$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242906131$24290613$1$I$$20240729$20240906$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02835$AMNEAL$$$$$F$Y$$$20240906$$MD$US$US
242906141$24290614$1$I$$20240710$20240906$20240906$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02571$AMNEAL$$$$$M$Y$$$20240906$$MD$US$US
242906151$24290615$1$I$20240701$20240903$20240906$20240906$EXP$$US-INCYTE CORPORATION-2024IN002579$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242906161$24290616$1$I$20240829$20240829$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139628$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240906$$CN$US$US
242906171$24290617$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141155$BRISTOL MYERS SQUIBB$$73$YR$A$F$Y$94.8$KG$20240906$$MD$US$US
242906181$24290618$1$I$$20240827$20240906$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005132$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242906191$24290619$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466086$RANBAXY$Zhang PL, Metcalf BD, Khan S, Abukhaled J, Zafar K, Li W, et al. Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis. Ultrastruct Pathol. 2024;48 (4):317-322$84$YR$$M$Y$$$20240906$$HP$US$US
242906201$24290620$1$I$20240717$20240822$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-464636$RANBAXY$$25$YR$$M$Y$$$20240906$$CN$GB$GB
242906211$24290621$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466088$RANBAXY$Zhang PL, Metcalf BD, Khan S, Abukhaled J, Zafar K, Li W, et al. Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis. Ultrastruct Pathol. 2024;48 (4):317-322$77$YR$$F$Y$$$20240906$$HP$US$US
242906221$24290622$1$I$$20240822$20240906$20240906$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466197$RANBAXY$Thomsen M, Vemuri R, Huygens F, Clarke S, Vitetta L.. An exploratory study of a multi-species probiotic formulation and markers of health in a real world oncological cohort in the time of covid.. Inflammopharmacology. 2024;32 (4):2317-2335$39$YR$$F$Y$52$KG$20240906$$HP$AU$AU
242906231$24290623$1$I$$20240822$20240906$20240906$EXP$$SK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466273$RANBAXY$Jana Gabajova. Optimal treatment sequence in the treatment of locally advanced unresectable and metastatic urothelial carcinoma under current reimbursement mechanisms in Slovakia. Oncology. 2024;19(3):210-214$60$YR$$M$Y$$$20240906$$MD$SK$SK
242906241$24290624$1$I$$20240822$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465901$RANBAXY$Farag M, Bahra A. Secondary cough headache: Independent course of headache and response to a COX-2 inhibitor. Clin Neurol Neurosurg. 2023;227:107646(1-2)$51$YR$$F$Y$$$20240906$$HP$GB$GB
242906251$24290625$1$I$$20240822$20240906$20240906$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465906$RANBAXY$Klimaszyk D, Klimaszyk S. Fentanyl and other opioid poisoning. Toxicology. 2024;(7-8):81-85$26$YR$$F$Y$$$20240906$$HP$PL$PL
242906261$24290626$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465605$RANBAXY$Zhang PL, Metcalf BD, Khan S, Abukhaled J, Zafar K, Li W, et al. Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis. Ultrastruct Pathol. 2024;48 (4):317-322$47$YR$$M$Y$$$20240906$$HP$US$US
242906271$24290627$1$I$$20240822$20240906$20240906$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465764$RANBAXY$Atzenhoefer M, Setty S. High Risk Plaque, Harbinger Of Acute Coronary Syndromes. J Cardiovas Comput Tomo. 2024;18:S22(P51)$$$$F$Y$$$20240906$$HP$US$US
242906283$24290628$3$F$$20240910$20240906$20240925$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465760$RANBAXY$Malyshev SM, Popov KD, Simakov KV, Marichev AO, Topuzova MP, Smirnova AY, et al. Status epilepticus in a pregnant patient with a previously unrecognized POLG-associated disease. Zh Nevropatol Psikhiatr Im S S Korsakova. 2023;123:129-135$33$YR$$F$Y$$$20240925$$HP$RU$RU
242906291$24290629$1$I$$20240828$20240906$20240906$EXP$$CA-ROCHE-10000069521$ROCHE$$$$$M$Y$$$20240906$$MD$CA$CA
242906301$24290630$1$I$20240208$20240903$20240906$20240906$EXP$$US-INCYTE CORPORATION-2024IN009300$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242906311$24290631$1$I$20240807$20240904$20240906$20240906$EXP$$CN-ROCHE-10000074385$ROCHE$$66$YR$E$F$Y$48$KG$20240906$$HP$CN$CN
242906321$24290632$1$I$$20240829$20240906$20240906$30DAY$$US-GSK-US2024AMR108527$GLAXOSMITHKLINE$$95$YR$$F$Y$$$20240906$$CN$US$US
242906331$24290633$1$I$$20240829$20240906$20240906$30DAY$$US-GSK-US2024107891$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242906341$24290634$1$I$$20240829$20240906$20240906$30DAY$$US-GSK-US2024107909$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$PH$US$US
242906351$24290635$1$I$20230101$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466332$RANBAXY$$37$YR$$M$Y$$$20240906$$PH$FR$FR
242906361$24290636$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465980$RANBAXY$Mariyam S, Chowdhary H, Sharma S, Arora C. Efficacy of Pre-Surgical Bupivacaine Infiltration in Reducing Postoperative Pain in Laparoscopic Gynecologic Surgery: A Randomized Controlled Trial. Int J Pharmac Clin Res. 2024;16 (7):138-142$$$$F$Y$$$20240906$$HP$IN$IN
242906381$24290638$1$I$$20240905$20240905$20240905$DIR$717322$$FDA-CTU$$$$$UNK$N$$$20240905$$CN$US$
242906391$24290639$1$I$20240208$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466555$RANBAXY$$38$YR$$M$Y$$$20240906$$PH$FR$FR
242906401$24290640$1$I$20240401$20240824$20240906$20240906$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466780$RANBAXY$$41$YR$$M$Y$70$KG$20240906$$CN$GB$GB
242906411$24290641$1$I$20240527$20240823$20240906$20240906$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466317$RANBAXY$$67$YR$$F$Y$$$20240906$$MD$IT$IT
242906421$24290642$1$I$20240201$20240823$20240906$20240906$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466283$RANBAXY$$$$$F$Y$3.58$KG$20240906$$MD$DE$DE
242906431$24290643$1$I$20240422$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466543$RANBAXY$$67$YR$$M$Y$85$KG$20240906$$MD$FR$FR
242906441$24290644$1$I$20230725$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466547$RANBAXY$$55$YR$$F$Y$$$20240906$$MD$FR$FR
242906451$24290645$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466279$RANBAXY$Veeramani D, Sivasubramaniam B, Swaminathan P, Chandrasekar A, Thirugnanam A. Caroli^s disease and pregnancy - Do we expect the unexpected?. Eur J Obstet Gynecol Reprod Biol. 2024;293:206-207$$$N$M$Y$$$20240906$$HP$IN$IN
242906461$24290646$1$I$20231122$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466460$RANBAXY$$31$YR$$F$Y$67$KG$20240906$$MD$FR$FR
242906491$24290649$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61167$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242906501$24290650$1$I$20240423$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466462$RANBAXY$$57$YR$$M$Y$$$20240906$$MD$FR$FR
242906511$24290651$1$I$20240527$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466329$RANBAXY$$87$YR$$M$Y$$$20240906$$MD$FR$FR
242906521$24290652$1$I$20240104$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466455$RANBAXY$$20$YR$$F$Y$37$KG$20240906$$MD$FR$FR
242906531$24290653$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466397$RANBAXY$Sharma J, Rengaraj S, Veeramuthu M, Yavanasuriya, Veena Ranjan J. Diagnostic challenges of Thrombotic Microangiopathy (TMA) in a pregnant woman remote from term and a case report of atypical TTP. Pregnancy Hypertens. 2024;36(Suppl):ISSHP0014$24$YR$$F$Y$$$20240906$$HP$IN$IN
242906541$24290654$1$I$20230301$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466642$RANBAXY$$42$YR$$M$Y$$$20240906$$MD$FR$FR
242906551$24290655$1$I$20240507$20240823$20240906$20240906$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466383$RANBAXY$$78$YR$$F$Y$$$20240906$$MD$FR$FR
242906561$24290656$1$I$20240211$20240823$20240906$20240906$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466331$RANBAXY$$70$YR$$M$Y$$$20240906$$MD$IT$IT
242906571$24290657$1$I$20240610$20240823$20240906$20240906$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466141$RANBAXY$$30$YR$$F$Y$75$KG$20240906$$CN$DE$DE
242906581$24290658$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466342$RANBAXY$Newbigging NS, Lenin A, Jasmine S, Alexander S, Thomas N, Livingstone J. Secondary hyperaldosteronism due to renal agenesis: Rare cause of secondary hypertension in pregnancy. Int J Womens Cardiovascular Health. 2024;36:101104/31-32/ISSHP0104$21$YR$$F$Y$$$20240906$$HP$IN$IN
242906591$24290659$1$I$20240420$20240823$20240906$20240906$EXP$$MT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466548$RANBAXY$$26$YR$$M$Y$90$KG$20240906$$CN$MT$MT
242906601$24290660$1$I$$20240823$20240906$20240906$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466123$RANBAXY$Fang Y, Zhou X, Bai J, Lin Q. A CARE compliant article: A case report of retroperitoneal endometrial stromal sarcoma with multiple pulmonary metastases and literature review. Medicine. 2024;103 (32):e39093$40$YR$$F$Y$$$20240906$$MD$CN$CN
242906611$24290661$1$I$$20240823$20240906$20240906$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464905$RANBAXY$Kumaraswamy R, Bagde NK, Agarwal S. SLE - Can we prevent pre-eclampsia?. Pregnancy Hypertens. 2024;Aug;36(S1):101104;ISSHP0151$$$$F$Y$$$20240906$$HP$IN$IN
242906621$24290662$1$I$20240801$20240822$20240906$20240906$PER$$US-SA-2024SA256873$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240906$$CN$US$US
242906631$24290663$1$I$$20240823$20240906$20240906$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466129$RANBAXY$Hadavand F, Naseri SR, Mardani M, Tabarsi P, Keyvanfar A, Gachkar L, et al. An Outbreak of Pandrug Resistant Providencia Species in an Intensive Care Unit: A Case-Series. Arch Clin Infect Dis. 2024;19 (3):e145826$50$YR$$F$Y$$$20240906$$HP$IR$IR
242906641$24290664$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA257905$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240906$$HP$US$US
242906651$24290665$1$I$$20240827$20240906$20240906$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005141$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240906$$CN$US$US
242906661$24290666$1$I$20240801$20240823$20240906$20240906$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00789$Phathom Pharmaceuticals$$$$$M$Y$$$20240906$$MD$JP$JP
242906671$24290667$1$I$$20230807$20240906$20240906$EXP$$HK-JNJFOC-20240880691$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240906$$HP$HK$HK
242906681$24290668$1$I$$20240826$20240906$20240906$30DAY$$US-JNJFOC-20240905651$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242906692$24290669$2$F$20100810$20240903$20240906$20240906$PER$$US-ASTELLAS-2024-AER-004631$ASTELLAS$$58$YR$A$F$Y$$$20240906$$HP$US$US
242906701$24290670$1$I$$20240903$20240906$20240906$EXP$$BR-BIOGEN-2024BI01281070$BIOGEN$$$$C$$Y$$$20240906$$MD$BR$BR
242906711$24290671$1$I$$20240829$20240906$20240906$EXP$$US-BIOGEN-2024BI01280788$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242906721$24290672$1$I$$20240829$20240906$20240906$EXP$$US-BIOGEN-2024BI01280771$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242906731$24290673$1$I$$20240826$20240906$20240906$EXP$$DE-UCBSA-2024043829$UCB$$$$$F$Y$$$20240906$$MD$DE$DE
242906742$24290674$2$F$20210101$20240909$20240906$20240910$EXP$$PT-PFIZER INC-202400249887$PFIZER$Fernandes, C.. ENCEFALOPATIA HEPATICA CRONICA SECUNDARIA AO METOTREXATO. Sinapse. 2023;23:339$61$YR$$F$Y$$$20240910$$HP$PT$PT
242906751$24290675$1$I$$20240903$20240906$20240906$EXP$$PT-PFIZER INC-202400249768$PFIZER$Antunes, A. PO-0248 - (2340) - HIPERTENSAO PORTAL NAO CIRROTICA APOS TRASTUZUMAB EMTANSINE. Medicina Interna - Congressos Nacionais. 30CNMI. 2024;613$69$YR$$F$Y$$$20240906$$MD$PT$PT
242906782$24290678$2$F$20240101$20240823$20240906$20240917$PER$$US-SA-2024SA256845$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240918$$MD$US$US
242906791$24290679$1$I$$20240903$20240906$20240906$EXP$$FR-PFIZER INC-202400249061$PFIZER$Bottosso, M.. Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome. JCO Precision Oncology. 2024;8():1-6$28$YR$$F$Y$$$20240906$$MD$FR$FR
242906801$24290680$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA258038$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240906$$MD$US$US
242906811$24290681$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA253488$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$HP$US$US
242906821$24290682$1$I$20240618$20240903$20240906$20240906$EXP$$CN-ROCHE-10000073202$ROCHE$$60$YR$A$F$Y$64$KG$20240906$$HP$CN$CN
242906831$24290683$1$I$20080703$20240903$20240906$20240906$EXP$$US-ASTELLAS-2024-AER-004411$ASTELLAS$$66$YR$E$M$Y$105$KG$20240906$$HP$US$US
242906841$24290684$1$I$20240101$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140896$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240906$$CN$US$US
242906851$24290685$1$I$$20240824$20240906$20240906$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466935$RANBAXY$Chung YR, Lee HS, Lee DY, Lee SH, Jeong JS, Kim B. Podocyte Disease Following Treatment with Intravenous Ibandronate in an Older Patient. Ann Geriatr Med Res. 2024;28(2)$88$YR$$F$Y$$$20240906$$HP$KR$KR
242906861$24290686$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141168$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240906$$HP$US$US
242906871$24290687$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140772$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240906$$CN$US$US
242906881$24290688$1$I$20240801$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141230$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240906$$CN$US$US
242906891$24290689$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141061$BRISTOL MYERS SQUIBB$$11$YR$C$M$Y$$$20240906$$HP$US$US
242906901$24290690$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141561$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240906$$CN$US$US
242906911$24290691$1$I$20240804$20240904$20240906$20240906$PER$$US-BAYER-2024A127526$BAYER$$31$YR$A$F$Y$$$20240906$$MD$US$US
242906921$24290692$1$I$20210101$20240826$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136512$BRISTOL MYERS SQUIBB$Desai D, Nohria A, Alhanshali L, Buontempo M, Lo Sicco KI, Fern C, et al. Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: report of two cases. JAAD Case Reports. 2024;51:86-91.doi:10.1016/j.jdcr.2024.06.034.$58$YR$A$F$Y$$$20240906$$HP$US$US
242906931$24290693$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177885$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242906941$24290694$1$I$$20240905$20240906$20240906$PER$$US-AMGEN-USASP2024177794$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242906951$24290695$1$I$$20240828$20240906$20240906$EXP$$TR-AMGEN-TURSP2024172419$AMGEN$Arslan S.; Kocaoglu I.; Yarali O. et al.. A successful liver transplantation in a patient with neonatal-onset carbamoyl phosphate synthetase-1 deficiency. Journal of pediatric endocrinology + metabolism : JPEM. 2024;1-6$$$$M$Y$$$20240906$$HP$TR$TR
242906961$24290696$1$I$20220701$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176680$AMGEN$$53$YR$A$F$Y$$$20240906$$CN$US$US
242906971$24290697$1$I$$20240829$20240906$20240906$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR107613$VIIV$$$$$$Y$$$20240906$$MD$US$US
242906981$24290698$1$I$20240804$20240905$20240906$20240906$EXP$$CN-BAYER-2024A127703$BAYER$$86$YR$E$M$Y$44$KG$20240906$$HP$CN$CN
242906991$24290699$1$I$$20240827$20240906$20240906$EXP$$US-BIOCODEX2-2024001221$BIOCODEX$$$$$M$Y$83.5$KG$20240905$$HP$US$US
242907001$24290700$1$I$20240801$20240828$20240906$20240906$PER$$US-EMD Serono-2024046535$EMD SERONO INC$$46$YR$A$F$Y$64$KG$20240906$$CN$US$US
242907011$24290701$1$I$20240801$20240827$20240906$20240906$EXP$$US-MYLANLABS-2024M1079489$MYLAN$$60$YR$$F$Y$$$20240906$$CN$US$US
242907031$24290703$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024178265$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242907042$24290704$2$F$20240830$20240916$20240906$20240924$PER$$US-AMGEN-USASP2024174394$AMGEN$$51$YR$A$F$Y$$$20240924$$CN$US$US
242907051$24290705$1$I$20240101$20240831$20240906$20240906$EXP$$US-SA-2024SA258295$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240906$$MD$US$US
242907061$24290706$1$I$20230101$20240830$20240906$20240906$EXP$$US-SA-2024SA257833$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240906$$CN$US$US
242907071$24290707$1$I$$20240828$20240906$20240906$PER$$US-ABBVIE-5902146$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242907081$24290708$1$I$$20240829$20240906$20240906$EXP$$ZA-AstraZeneca-2024A198788$ASTRAZENECA$$64$YR$$F$Y$$$20240906$$CN$ZA$
242907091$24290709$1$I$$20240830$20240906$20240906$EXP$$SA-MYLANLABS-2024M1081553$MYLAN$Sayed J, Nasir A, Sayed AG, Alghamdi OA, Alsharif EJ. A case report of MoCD etiology in a neonate: A novel homozygous MoCS2 variant. Clin-Case-Rep 2024; 12 (7): 1-6.$1$WK$$M$Y$2.9$KG$20240906$$HP$SA$SA
242907101$24290710$1$I$$20240830$20240906$20240906$EXP$$DE-MYLANLABS-2024M1081403$MYLAN$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.$1$YR$$M$Y$$$20240906$$MD$DE$DE
242907111$24290711$1$I$$20240830$20240906$20240906$EXP$$US-MYLANLABS-2024M1081401$MYLAN$Ansari AN, Johnson EF, Wang KL, Koster MJ, Cantwell HM. SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing. JAAD-Case-Rep 2024; 43 57-59.$50$YR$$M$Y$$$20240906$$MD$US$US
242907121$24290712$1$I$20240624$20240830$20240906$20240906$EXP$$US-MYLANLABS-2024M1080925$MYLAN$$89$YR$$F$Y$79.83$KG$20240906$$CN$US$US
242907131$24290713$1$I$20240802$20240830$20240906$20240906$EXP$FR-AFSSAPS-NC2024001000$FR-MYLANLABS-2024M1080030$MYLAN$$78$YR$$F$Y$$$20240906$$MD$FR$FR
242907141$24290714$1$I$20240808$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200934$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242907151$24290715$1$I$$20240830$20240906$20240906$EXP$$TR-MYLANLABS-2024M1081566$MYLAN$Ciftci E, Altunova D, Unal B, Yasar SA, Demiroz D, Caliskan AM, et al. Isotretinoin-related depression: A case report. Psychiatr-Clin-Psychopharmacolog 2019; 29 251-252 abstr. 0554.$20$YR$$F$Y$$$20240906$$HP$TR$TR
242907161$24290716$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA257065$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240906$$HP$US$US
242907171$24290717$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA255923$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240906$$MD$US$US
242907181$24290718$1$I$20240817$20240820$20240906$20240906$PER$$US-SA-2024SA257646$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240906$$MD$US$US
242907191$24290719$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA258679$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240906$$MD$US$US
242907202$24290720$2$F$20110412$20240904$20240906$20240906$PER$$US-ASTELLAS-2024-AER-004785$ASTELLAS$$56$YR$A$F$Y$64.5$KG$20240906$$HP$US$US
242907211$24290721$1$I$$20240902$20240906$20240906$EXP$$JP-ROCHE-10000071653$ROCHE$Fukuhara H, Nishida H, Takai S, Nawano T, Takehara T, Takai Y, et al. Dialysis Duration, Time Interaction, and Visceral Fat Accumulation: A 6-Year Posttransplantation Study. Clinical and Experimental Nephrology. 2024-Sep;28 (9):943-52. doi:10.1007/s10157-024-02492-9.$$$$$Y$$$20240906$$HP$JP$JP
242907221$24290722$1$I$$20240903$20240906$20240906$EXP$$CA-GSK-CA2024AMR109661$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$HP$CA$CA
242907231$24290723$1$I$20240830$20240830$20240906$20240906$PER$$US-SA-2024SA254514$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240906$$CN$US$US
242907241$24290724$1$I$$20240905$20240906$20240906$PER$$NVSC2024US179301$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
242907251$24290725$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA256646$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240906$$CN$US$US
242907271$24290727$1$I$$20240905$20240906$20240906$EXP$$CN-TAKEDA-2024TUS089111$TAKEDA$$$$$F$Y$$$20240906$$CN$CN$CN
242907282$24290728$2$F$$20240828$20240906$20240917$EXP$$US-TERSERA THERAPEUTICS LLC-2024TRS004506$TERSERA THERAPEUTICS$$$$$$Y$$$20240917$$CN$US$US
242907291$24290729$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61256$$FDA-CTU$$55$YR$$F$N$$$20240905$N$$US$
242907321$24290732$1$I$$20240904$20240906$20240906$PER$$US-JNJFOC-20240913765$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$HP$US$US
242907331$24290733$1$I$$20240828$20240906$20240906$EXP$$US-JNJFOC-20240875073$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$HP$US$US
242907341$24290734$1$I$$20240903$20240906$20240906$EXP$$GB-JNJFOC-20240906734$JOHNSON AND JOHNSON$$50$YR$A$F$Y$59$KG$20240906$$CN$GB$GB
242907351$24290735$1$I$20220101$20240902$20240906$20240906$EXP$ES-AEMPS-1559078$ES-MYLANLABS-2024M1080841$MYLAN$$68$YR$$M$Y$$$20240906$$MD$ES$ES
242907361$24290736$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61220$$FDA-CTU$$48$YR$$F$N$136.08$KG$20240905$N$$US$
242907371$24290737$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61247$$FDA-CTU$$47$YR$$F$N$$$20240905$N$$US$
242907381$24290738$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61277$$FDA-CTU$$55$YR$$F$N$107.05$KG$20240905$N$$US$
242907391$24290739$1$I$$20240828$20240906$20240906$PER$$US-ABBVIE-5900126$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242907411$24290741$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002926$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240906$$CN$US$US
242907421$24290742$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003246$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240906$$HP$US$US
242907431$24290743$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA255492$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240906$$MD$US$US
242907441$24290744$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001512$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240906$$CN$US$US
242907451$24290745$1$I$20240701$20240830$20240906$20240906$PER$$US-Kiniksa Pharmaceuticals Ltd.-2024KPU000034$KINIKSA PHARMACEUTICALS$$39$YR$A$F$Y$$$20240905$$CN$US$US
242907461$24290746$1$I$$20240905$20240906$20240906$EXP$$NVSC2024PL178684$NOVARTIS$$$$$M$Y$$$20240906$$MD$PL$PL
242907471$24290747$1$I$20240820$20240827$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137089$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240906$$HP$US$US
242907481$24290748$1$I$$20240829$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139581$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240906$$HP$US$US
242907491$24290749$1$I$$20240903$20240906$20240906$PER$$NVSC2024US177481$NOVARTIS$$$$$$Y$$$20240906$$CN$US$US
242907501$24290750$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141605$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240906$$CN$US$US
242907511$24290751$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140930$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240906$$CN$US$US
242907531$24290753$1$I$20240824$20240904$20240906$20240906$EXP$$CN-ROCHE-10000074415$ROCHE$$60$YR$A$F$Y$65.5$KG$20240906$$HP$CN$CN
242907541$24290754$1$I$$20240828$20240906$20240906$EXP$$HU-CELLTRION INC.-2024HU020976$CELLTRION$Szamosi S, Bodoki L. Beszamolo a Magyar Reumatologusok Egyesulete Eszak-Kelet-Magyarorszagi Szekciojanak 2023. oszi egri szekciouleserol. Magyar Reumatologia. 2024;1:25 - 28$$$$$Y$$$20240906$$MD$HU$HU
242907551$24290755$1$I$20240724$20240829$20240906$20240906$EXP$$JP-ROCHE-10000053280$ROCHE$$7$DEC$E$M$Y$$$20240906$$MD$JP$JP
242907561$24290756$1$I$$20240829$20240906$20240906$EXP$$CA-TEVA-VS-3238441$TEVA$$62$YR$$F$Y$$$20240906$$HP$CA$CA
242907571$24290757$1$I$$20240828$20240906$20240906$30DAY$$US-GSK-US2024AMR110574$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$US$US
242907581$24290758$1$I$$20240905$20240906$20240906$EXP$$IN-ROCHE-10000075501$ROCHE$$$$$$Y$$$20240906$$MD$IN$IN
242907591$24290759$1$I$20240101$20240904$20240906$20240906$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-143677$DAIICHI$$$$$F$Y$$$20240906$$MD$US$US
242907601$24290760$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140895$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$63$KG$20240906$$PH$US$US
242907611$24290761$1$I$$20240903$20240906$20240906$PER$$US-ABBVIE-5907618$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242907621$24290762$1$I$20240801$20240830$20240906$20240906$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004461$BLUEPRINT MEDICINES$$$$$$Y$$$20240905$$CN$US$US
242907631$24290763$1$I$20240816$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408271401441210-QTVDB$GB-CURIUM-2024000596$CURIUM PHARMACEUTICALS$$40$YR$$M$Y$85$KG$20240906$$HP$GB$GB
242907641$24290764$1$I$$20240905$20240906$20240906$PER$$US-ROCHE-10000075816$ROCHE$$55$YR$A$M$Y$$$20240906$$MD$US$US
242907651$24290765$1$I$20230414$20240829$20240906$20240906$EXP$$CN-009507513-2409CHN000465$MERCK$Chen H, Duan H, Zhao J, Sun K, Shan K.. Necrotizing pneumonia secondary to Influenza A (H1N1) coinfection with Staphylococcus aureus: A case report. IDCases. 2024;37$39$YR$$F$Y$$$20240906$$HP$CN$CN
242907661$24290766$1$I$20121101$20240827$20240906$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027358$UNITED THERAPEUTICS$$15$YR$$M$Y$46.4$KG$20240906$$$US$US
242907671$24290767$1$I$$20240826$20240906$20240906$EXP$$US-UCBSA-2024043889$UCB$$$$$$Y$$$20240906$$CN$US$US
242907681$24290768$1$I$$20240830$20240906$20240906$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004497$BLUEPRINT MEDICINES$$$$$$Y$$$20240905$$CN$US$US
242907692$24290769$2$F$20240830$20240906$20240906$20240912$EXP$$CN-AstraZeneca-2024A201175$ASTRAZENECA$$54$MON$$F$Y$$$20240912$$MD$CN$
242907702$24290770$2$F$20220526$20240819$20240906$20240913$EXP$$NVSC2022JP304841$NOVARTIS$$23$MON$$M$Y$$$20240913$$MD$JP$JP
242907711$24290771$1$I$20240809$20240830$20240906$20240906$EXP$$NVSC2024AR165258$NOVARTIS$$40$YR$$F$Y$$$20240906$$MD$AR$AR
242907721$24290772$1$I$20240728$20240830$20240906$20240906$EXP$$CN-AstraZeneca-2024A202230$ASTRAZENECA$$19900$DY$$M$Y$72.5$KG$20240906$$MD$CN$
242907731$24290773$1$I$$20240903$20240906$20240906$PER$$US-BAYER-2024A126352$BAYER$$20$YR$A$F$Y$$$20240906$$MD$US$US
242907741$24290774$1$I$$20240829$20240906$20240906$EXP$$CA-APOTEX-2024AP010170$APOTEX$$51$YR$$M$Y$102$KG$20240906$$PH$CA$CA
242907751$24290775$1$I$$20240828$20240906$20240906$EXP$$US-RDY-SPO/USA/24/0012702$DR REDDYS$$34$YR$A$F$Y$$$20240906$$HP$US$US
242907762$24290776$2$F$$20240911$20240906$20240920$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004464$BLUEPRINT MEDICINES$$$$$$Y$$$20240918$$CN$US$US
242907771$24290777$1$I$20240824$20240902$20240906$20240906$EXP$GB-MHRA-MED-202409021420190550-KJMHY$GB-RDY-SPO/GBR/24/0012807$DR REDDYS$$66$YR$E$F$Y$$$20240906$$PH$GB$GB
242907781$24290778$1$I$20220328$20240827$20240906$20240906$EXP$$JP-ROCHE-3123622$ROCHE$$82$YR$E$F$Y$55.8$KG$20240906$$PH$JP$JP
242907792$24290779$2$F$20230522$20240906$20240906$20240913$EXP$$NVSC2024GB162603$NOVARTIS$$$$A$F$Y$$$20240913$$MD$GB$GB
242907801$24290780$1$I$20240801$20240829$20240906$20240906$EXP$$US-VIIV HEALTHCARE LIMITED-US2024107868$VIIV$$32$YR$$M$Y$$$20240906$$CN$US$US
242907811$24290781$1$I$20240827$20240827$20240906$20240906$30DAY$$PR-VIIV HEALTHCARE LIMITED-PR2024106624$VIIV$$62$YR$$F$Y$$$20240906$$MD$PR$US
242907822$24290782$2$F$20240501$20240903$20240906$20240916$EXP$$JP-UCBSA-2024044851$UCB$$29$YR$$M$Y$$$20240916$$MD$JP$JP
242907831$24290783$1$I$$20240809$20240906$20240906$30DAY$$US-VEROBIOTECH-2024USVEROSPO00200$VERO BIOTECH$$$$$$Y$$$20240906$$HP$US$US
242907841$24290784$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A198747$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242907851$24290785$1$I$20240905$20240905$20240905$20240905$DIR$717327$$FDA-CTU$$82$YR$$M$N$$$20240905$$CN$US$
242907861$24290786$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61280$$FDA-CTU$$76$YR$$F$N$58.06$KG$20240905$N$HP$US$
242907871$24290787$1$I$$20240810$20240906$20240906$PER$$US-LEX-000432$LEXICON PHARMACEUTICALS$$77$YR$$F$Y$$$20240906$$CN$US$US
242907881$24290788$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61253$$FDA-CTU$$69$YR$$F$N$$$20240905$N$HP$US$
242907891$24290789$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61341$$FDA-CTU$$27$YR$$M$N$87.09$KG$20240905$N$$US$
242907901$24290790$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61359$$FDA-CTU$$29$YR$$F$N$$$20240905$N$$US$
242907921$24290792$1$I$20240821$20240826$20240906$20240906$EXP$$CN-GE HEALTHCARE-2024CSU009818$GE HEALTHCARE$$70$YR$$F$Y$$$20240906$$HP$CN$CN
242907931$24290793$1$I$$20240904$20240906$20240906$EXP$DE-BAXTER-2021BAX004883$DE-SANDOZ INC.-SDZ2024DE077740$SANDOZ$$27$YR$$F$Y$$$20240906$$HP$DE$DE
242907951$24290795$1$I$20240824$20240903$20240906$20240906$EXP$$CO-AMGEN-COLSL2022216868$AMGEN$$83$YR$E$F$Y$$$20240906$$CN$CO$CO
242907962$24290796$2$F$20170925$20240909$20240906$20240918$EXP$$US-ROCHE-2006025$ROCHE$$46$YR$A$F$Y$72.57$KG$20240918$$CN$US$US
242907971$24290797$1$I$$20240809$20240906$20240906$30DAY$$US-VEROBIOTECH-2024USVEROSPO00201$VERO BIOTECH$$$$$$Y$$$20240906$$HP$US$US
242907981$24290798$1$I$20240827$20240828$20240906$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013825$JAZZ$$53$YR$$F$Y$$$20240906$$CN$US$US
242908001$24290800$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141581$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240906$$CN$US$US
242908011$24290801$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141889$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240906$$MD$US$US
242908021$24290802$1$I$$20240905$20240906$20240906$EXP$$LT-BRISTOL-MYERS SQUIBB COMPANY-2024-141778$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240906$$MD$LT$LT
242908031$24290803$1$I$$20240902$20240906$20240906$EXP$$US-MYLANLABS-2024M1081751$MYLAN$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J-Forens-Legal-Med 2024; 101.$69$YR$$$Y$$$20240906$$HP$US$US
242908051$24290805$1$I$20240814$20240905$20240906$20240906$EXP$$CN-BAYER-2024A127861$BAYER$$51$YR$A$F$Y$60$KG$20240906$$HP$CN$CN
242908071$24290807$1$I$$20240808$20240906$20240906$30DAY$$US-VEROBIOTECH-2024USVEROSPO00202$VERO BIOTECH$$$$$$Y$$$20240906$$HP$US$US
242908081$24290808$1$I$20210601$20240904$20240906$20240906$EXP$FR-AFSSAPS-ST2024001335$FR-SANDOZ INC.-SDZ2024FR077733$SANDOZ$$37$YR$$F$Y$$$20240906$$MD$FR$FR
242908092$24290809$2$F$20240301$20240916$20240906$20240920$EXP$$DE-MYLANLABS-2024M1080571$MYLAN$$$$E$F$Y$60$KG$20240920$$HP$DE$DE
242908101$24290810$1$I$20200106$20240827$20240906$20240906$EXP$$FR-CELLTRION INC.-2024FR020706$CELLTRION$$$$$$Y$$$20240906$$PH$FR$FR
242908121$24290812$1$I$20220428$20240830$20240906$20240906$EXP$$DE-PFIZER INC-202300322854$PFIZER$$$$A$F$Y$$$20240906$$CN$DE$DE
242908131$24290813$1$I$20240901$20240904$20240906$20240906$EXP$GB-MHRA-MED-202409042014369140-MYTLQ$GB-PFIZER INC-202400250110$PFIZER$$40$YR$$F$Y$53$KG$20240906$$CN$GB$GB
242908141$24290814$1$I$$20240904$20240906$20240906$EXP$$DO-PFIZER INC-202400249926$PFIZER$$65$YR$$F$Y$$$20240906$$MD$DO$DO
242908152$24290815$2$F$$20240904$20240906$20240909$EXP$$US-PFIZER INC-PV202400116234$PFIZER$$$$$M$Y$$$20240909$$HP$US$US
242908161$24290816$1$I$20240801$20240826$20240906$20240906$30DAY$$CA-PFIZER INC-202400244506$PFIZER$$63$YR$$F$Y$$$20240906$$HP$CA$CA
242908171$24290817$1$I$20240101$20240904$20240906$20240906$EXP$$GB-PFIZER INC-PV202400116521$PFIZER$$82$YR$$F$Y$$$20240906$$CN$GB$GB
242908181$24290818$1$I$20240901$20240905$20240906$20240906$EXP$$AR-PFIZER INC-202400250898$PFIZER$$75$YR$$M$Y$$$20240906$$CN$AR$AR
242908191$24290819$1$I$$20240904$20240906$20240906$EXP$$DO-PFIZER INC-202400250951$PFIZER$$57$YR$$F$Y$$$20240906$$MD$DO$DO
242908201$24290820$1$I$20220101$20240902$20240906$20240906$EXP$$PT-PFIZER INC-202400248518$PFIZER$Goncalves Pinto, Rita. Cerebral nocardiosis as a complication of immunosuppression case report. National Internal Medicine Congress. 2024;801$60$YR$$M$Y$$$20240906$$MD$PT$PT
242908221$24290822$1$I$20221107$20240903$20240906$20240906$EXP$$FR-PFIZER INC-PV202300127157$PFIZER$$19$YR$$F$Y$$$20240906$$MD$FR$FR
242908241$24290824$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61325$$FDA-CTU$$21$YR$$F$N$$$20240905$N$$US$
242908251$24290825$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61363$$FDA-CTU$$54$YR$$F$N$$$20240905$N$$US$
242908261$24290826$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61322$$FDA-CTU$$43$YR$$F$N$$$20240905$N$HP$US$
242908271$24290827$1$I$$20240904$20240906$20240906$EXP$$DE-PFIZER INC-PV202400116438$PFIZER$Heinig-Menhard, K.. Tuberculosis in the intensive care unit: When to think about it - how to treat it?. Intensivmedizin up2date. 2024;20(03):325 - 340$20$YR$$M$Y$$$20240906$$MD$DE$DE
242908291$24290829$1$I$$20240827$20240906$20240906$30DAY$$US-PFIZER INC-202400245103$PFIZER$$10$YR$$M$Y$27.67$KG$20240906$$CN$US$US
242908302$24290830$2$F$20240101$20240911$20240906$20240919$PER$$US-SA-2024SA258456$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240919$$HP$US$US
242908311$24290831$1$I$20240101$20240822$20240906$20240906$PER$$US-SA-2024SA178781$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240906$$HP$US$US
242908322$24290832$2$F$20240101$20240826$20240906$20240910$PER$$US-SA-2024SA255604$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240910$$CN$US$US
242908331$24290833$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255994$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240906$$MD$US$US
242908341$24290834$1$I$20240601$20240822$20240906$20240906$PER$$US-SA-2024SA256261$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240906$$MD$US$US
242908351$24290835$1$I$20240815$20240826$20240906$20240906$EXP$$JP-UCBSA-2024043956$UCB$$$$$F$Y$75$KG$20240906$$PH$JP$JP
242908362$24290836$2$F$20210901$20240909$20240906$20240912$EXP$$TW-009507513-2409TWN001615$MERCK$$48$YR$$M$Y$$$20240912$$MD$TW$TW
242908381$24290838$1$I$$20240822$20240906$20240906$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25907$SAMSUNG BIOEPIS$$83$YR$E$F$Y$$$20240906$$CN$CA$CA
242908391$24290839$1$I$20240904$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177351$AMGEN$$73$YR$E$F$Y$$$20240906$$CN$US$US
242908401$24290840$1$I$$20240813$20240906$20240906$30DAY$$US-VEROBIOTECH-2024USVEROSPO00203$VERO BIOTECH$$$$$$Y$$$20240906$$HP$US$US
242908411$24290841$1$I$20240828$20240829$20240906$20240906$30DAY$$US-GSK-US2024AMR108066$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240906$$CN$US$US
242908421$24290842$1$I$$20240829$20240906$20240906$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006585$AURINIA PHARMACEUTICALS$$$$A$F$Y$$$20240906$$MD$US$US
242908431$24290843$1$I$20240601$20240904$20240906$20240906$EXP$$US-GILEAD-2024-0686347$GILEAD$$60$YR$A$F$Y$$$20240906$$CN$US$US
242908441$24290844$1$I$$20240826$20240906$20240906$EXP$$US-UCBSA-2024044065$UCB$$$$$$Y$$$20240906$$CN$US$US
242908451$24290845$1$I$$20240826$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN008958$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242908461$24290846$1$I$$20240811$20240906$20240906$30DAY$$US-VEROBIOTECH-2024USVEROSPO00204$VERO BIOTECH$$27$WK$$$Y$$$20240906$$HP$US$US
242908481$24290848$1$I$20240721$20240904$20240906$20240906$EXP$$US-PFIZER INC-202400250866$PFIZER$$89$YR$$F$Y$$$20240906$$HP$US$US
242908491$24290849$1$I$20240826$20240904$20240906$20240906$EXP$$CN-PFIZER INC-PV202400116156$PFIZER$$3$YR$$F$Y$13$KG$20240906$$HP$CN$CN
242908501$24290850$1$I$$20240904$20240906$20240906$EXP$$CA-PFIZER INC-202400250032$PFIZER$$$$$M$Y$$$20240906$$HP$CA$CA
242908513$24290851$3$F$20240715$20240916$20240906$20240918$EXP$$GR-PFIZER INC-PV202400116544$PFIZER$$31$YR$$M$Y$53$KG$20240918$$MD$GR$GR
242908531$24290853$1$I$$20240904$20240906$20240906$EXP$$CA-PFIZER INC-202400250774$PFIZER$$$$$M$Y$$$20240906$$CN$CA$CA
242908551$24290855$1$I$20240101$20240901$20240906$20240906$EXP$$SA-PFIZER INC-202400250656$PFIZER$$37$YR$$M$Y$$$20240906$$MD$SA$YE
242908561$24290856$1$I$20240828$20240904$20240906$20240906$EXP$IT-MINISAL02-1000924$IT-PFIZER INC-202400249640$PFIZER$$56$YR$$M$Y$$$20240906$$PH$IT$IT
242908571$24290857$1$I$$20240905$20240906$20240906$EXP$$CA-PFIZER INC-PV202400116651$PFIZER$$79$YR$$F$Y$$$20240906$$HP$CA$CA
242908581$24290858$1$I$$20240904$20240906$20240906$EXP$$UA-PFIZER INC-202400249818$PFIZER$$67$YR$$M$Y$$$20240906$$MD$UA$UA
242908591$24290859$1$I$$20240903$20240906$20240906$EXP$$CA-PFIZER INC-PV202400116583$PFIZER$$77$YR$$M$Y$$$20240906$$CN$CA$CA
242908601$24290860$1$I$20240825$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61214$$FDA-CTU$$86$YR$$F$N$$$20240905$N$HP$US$
242908611$24290861$1$I$$20240905$20240906$20240906$EXP$$CA-PFIZER INC-202400250792$PFIZER$$60$YR$$F$Y$$$20240906$$PH$CA$CA
242908631$24290863$1$I$20240806$20240903$20240906$20240906$EXP$$CN-PFIZER INC-PV202400115580$PFIZER$$53$YR$$F$Y$$$20240906$$HP$CN$CN
242908641$24290864$1$I$20240902$20240905$20240905$20240905$DIR$717361$$FDA-CTU$$46$YR$$M$N$87.75$KG$20240905$N$CN$US$
242908651$24290865$1$I$20240705$20240904$20240906$20240906$EXP$GB-MHRA-MED-202409041346417310-ZHQWC$GB-PFIZER INC-202400250023$PFIZER$$$$$F$Y$76$KG$20240906$$HP$GB$GB
242908671$24290867$1$I$20240801$20240904$20240906$20240906$EXP$$CN-PFIZER INC-PV202400116137$PFIZER$$31$YR$$F$Y$55$KG$20240906$$HP$CN$CN
242908681$24290868$1$I$$20240903$20240906$20240906$EXP$$US-PFIZER INC-202400249776$PFIZER$$6$YR$$F$Y$$$20240906$$CN$US$US
242908693$24290869$3$F$20240109$20240918$20240906$20240919$EXP$$DE-PFIZER INC-PV202400081347$PFIZER$$67$YR$$F$Y$70$KG$20240919$$MD$DE$DE
242908702$24290870$2$F$$20240919$20240906$20240925$EXP$$JP-ASTELLAS-2024JP003834$ASTELLAS$$88$YR$E$M$Y$$$20240925$$MD$JP$JP
242908711$24290871$1$I$20220101$20240828$20240906$20240906$PER$$US-SA-2024SA257892$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240906$$MD$US$US
242908721$24290872$1$I$20210802$20240904$20240906$20240906$EXP$$BE-PFIZER INC-202400249623$PFIZER$$55$YR$$F$Y$50.1$KG$20240906$$MD$BE$BE
242908731$24290873$1$I$$20240904$20240906$20240906$EXP$$US-PFIZER INC-202400250896$PFIZER$$49$YR$$M$Y$$$20240906$$HP$US$US
242908741$24290874$1$I$20240801$20240821$20240906$20240906$PER$$US-SA-2024SA257965$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240906$$MD$US$US
242908751$24290875$1$I$20240801$20240823$20240906$20240906$PER$$US-SA-2024SA256007$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240906$$MD$US$US
242908761$24290876$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA255482$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240906$$MD$US$US
242908771$24290877$1$I$$20240823$20240906$20240906$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408016791$ELI LILLY AND CO$$23$YR$A$M$Y$$$20240906$$CN$JP$JP
242908781$24290878$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002934$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240906$$CN$US$US
242908801$24290880$1$I$$20240902$20240906$20240906$EXP$$US-MYLANLABS-2024M1081869$MYLAN$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240906$$MD$US$US
242908811$24290881$1$I$$20240821$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137291$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240906$$CN$US$US
242908821$24290882$1$I$$20240904$20240906$20240906$EXP$$NVSC2024CA178760$NOVARTIS$$70$YR$$F$Y$65$KG$20240906$$PH$CA$CA
242908831$24290883$1$I$$20240830$20240906$20240906$EXP$$NVSC2024DE177847$NOVARTIS$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD OPEN. 2024;10 (3):e004381$15$YR$$F$Y$$$20240906$$HP$DE$DE
242908841$24290884$1$I$$20240827$20240906$20240906$EXP$$US-APOTEX-2024AP010181$APOTEX$Bains S, Garmany R, Neves R, Giudicessi JR, Gao X, Tester DJ, et al. Temporal Association Between Vaping and Risk of Cardiac Events. MAYO CLINIC PROCEEDINGS. 2024;99(2):241-248$26$YR$$M$Y$$$20240906$$HP$US$US
242908851$24290885$1$I$$20240827$20240906$20240906$30DAY$$US-GSK-US2024106705$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240906$$HP$US$US
242908872$24290887$2$F$$20240825$20240906$20240918$30DAY$$US-VEROBIOTECH-2024USVEROSPO00205$VERO BIOTECH$$$$A$M$Y$$$20240918$$HP$US$US
242908881$24290888$1$I$20240815$20240904$20240906$20240906$PER$$US-BAYER-2024A126871$BAYER$$22$YR$A$F$Y$$$20240906$$HP$US$US
242908891$24290889$1$I$$20240903$20240906$20240906$EXP$$RU-TAKEDA-2024TUS089052$TAKEDA$$24$YR$$F$Y$60$KG$20240906$$HP$RU$RU
242908901$24290890$1$I$20240828$20240904$20240906$20240906$EXP$$AR-JNJFOC-20240911998$JOHNSON AND JOHNSON$$64$YR$A$F$Y$69$KG$20240906$$CN$AR$AR
242908911$24290891$1$I$$20240830$20240906$20240906$EXP$$PL-ABBVIE-5903491$ABBVIE$$71$YR$$M$Y$$$20240906$$MD$PL$PL
242908921$24290892$1$I$$20240903$20240906$20240906$EXP$$CA-GSK-CA2024AMR109675$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$CA$CA
242908932$24290893$2$F$20240701$20240905$20240906$20240910$EXP$$US-GILEAD-2024-0686475$GILEAD$$55$YR$A$M$Y$$$20240910$$CN$US$US
242908941$24290894$1$I$$20240902$20240906$20240906$EXP$$NVSC2024CL178688$NOVARTIS$$$$$M$Y$$$20240906$$MD$CL$CL
242908951$24290895$1$I$$20240904$20240906$20240906$PER$$US-BAYER-2024A127499$BAYER$$$$$$Y$$$20240906$$CN$US$US
242908962$24290896$2$F$20230101$20240830$20240906$20240913$EXP$$JP-AstraZeneca-2024A199652$ASTRAZENECA$$65$YR$$F$Y$$$20240913$$MD$JP$
242908981$24290898$1$I$20240823$20240829$20240906$20240906$EXP$$US-AstraZeneca-2024A197618$ASTRAZENECA$$71$YR$$M$Y$$$20240906$$CN$US$
242908991$24290899$1$I$20240813$20240813$20240906$20240906$PER$$US-LEX-000435$LEXICON PHARMACEUTICALS$$68$YR$$M$Y$99.79$KG$20240906$$CN$US$US
242909001$24290900$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142227$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240906$$MD$US$US
242909011$24290901$1$I$20240819$20240830$20240906$20240906$EXP$$CN-AstraZeneca-2024A198929$ASTRAZENECA$$84$YR$$F$Y$54$KG$20240906$$MD$CN$
242909021$24290902$1$I$$20240824$20240906$20240906$EXP$$CO-NOVOPROD-1277581$NOVO NORDISK$$65$YR$$F$Y$101$KG$20240906$$CN$CO$CO
242909031$24290903$1$I$20240507$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61171$$FDA-CTU$$74$YR$$F$N$74.84$KG$20240904$N$CN$US$
242909041$24290904$1$I$$20240826$20240906$20240906$EXP$$US-UCBSA-2024043853$UCB$$$$$$Y$$$20240906$$CN$US$US
242909061$24290906$1$I$$20240903$20240906$20240906$PER$$US-ABBVIE-5905979$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242909071$24290907$1$I$20210101$20240903$20240906$20240906$EXP$$BE-GILEAD-2024-0686367$GILEAD$$39$YR$A$M$Y$$$20240906$$MD$BE$BE
242909081$24290908$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61219$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242909091$24290909$1$I$20240822$20240905$20240905$20240905$DIR$717341$$FDA-CTU$$21$YR$$F$N$61.65$KG$20240905$N$$US$
242909101$24290910$1$I$20240522$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176715$AMGEN$$78$YR$E$F$Y$$$20240906$$CN$US$US
242909111$24290911$1$I$$20240905$20240906$20240906$PER$$NVSC2024US179363$NOVARTIS$$$$$M$Y$$$20240906$$HP$US$US
242909121$24290912$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61300$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242909131$24290913$1$I$20240818$20240829$20240906$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027346$UNITED THERAPEUTICS$$68$YR$$F$Y$84.354$KG$20240906$$$US$US
242909151$24290915$1$I$$20240829$20240906$20240906$30DAY$$US-GSK-US2024AMR108011$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$US$US
242909161$24290916$1$I$$20240823$20240906$20240906$PER$$US-LEADINGPHARMA-US-2024LEASPO00369$LEADING PHARMA$$$$$$Y$$$20240906$$CN$US$US
242909171$24290917$1$I$$20240829$20240906$20240906$EXP$$US-SANDOZ INC.-SDZ2024US078120$SANDOZ$$$$$$Y$$$20240906$$PH$US$US
242909181$24290918$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61274$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
242909201$24290920$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010112$APOTEX$$74$YR$$M$Y$$$20240906$$CN$CA$CA
242909211$24290921$1$I$$20240904$20240906$20240906$PER$$NVSC2024US178206$NOVARTIS$$$$$$Y$$$20240906$$CN$US$US
242909222$24290922$2$F$$20240902$20240906$20240917$EXP$$JP-ORPHANEU-2024006791$RECORDATI$Hosoi H, Miyachi M, Teramukai S, Sakabayashi S, Tsuchiya K, Kuwahara Y et al.. Results of?the?JRS-I LRA0401 and?LRB0402 Japan Rhabdomyosarcoma Study Group trials for?low-risk embryonal rhabdomyosarcoma. International Journal of Clinical Oncology. 2024$$$$$Y$$$20240917$$HP$JP$JP
242909231$24290923$1$I$20200618$20240826$20240906$20240906$EXP$$PL-SANDOZ INC.-SDZ2024PL078042$SANDOZ$$$$$F$Y$52$KG$20240906$$MD$PL$PL
242909241$24290924$1$I$$20240904$20240906$20240906$EXP$$JP-SANDOZ INC.-SDZ2024JP077914$SANDOZ$Matsuda R, Hamaba K, Tachibana K. A case of an infant with Schaaf-Yang syndrome treated with general anesthesia. The 29th Annual Meeting of the Japanese Society of Pediatric Anesthesiology (Pro. 2024;P1-7-5$9$MON$$M$Y$8.9$KG$20240906$$MD$JP$JP
242909251$24290925$1$I$20240829$20240829$20240906$20240906$PER$$US-MYLANLABS-2024M1080187$MYLAN$$57$YR$$M$Y$$$20240906$$CN$US$US
242909261$24290926$1$I$20240701$20240902$20240906$20240906$EXP$$JP-009507513-2409JPN000361J$MERCK$$$$E$$Y$$$20240906$$MD$JP$JP
242909281$24290928$1$I$$20240905$20240906$20240906$EXP$GB-MHRA-MED-202409051515367150-DZBPM$GB-SANDOZ INC.-SDZ2024GB078226$SANDOZ$$$$$M$Y$$$20240906$$HP$GB$GB
242909311$24290931$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61343$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
242909321$24290932$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61268$$FDA-CTU$$$$$F$N$$$20240905$N$HP$US$
242909331$24290933$1$I$20240810$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61262$$FDA-CTU$$78$YR$$F$N$$$20240905$N$HP$US$
242909341$24290934$1$I$$20240905$20240905$20240905$DIR$717307$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242909361$24290936$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61364$$FDA-CTU$$29$YR$$F$N$66$KG$20240905$N$$US$
242909411$24290941$1$I$20240101$20240826$20240906$20240906$EXP$$US-UCBSA-2024043847$UCB$$$$$F$Y$75.283$KG$20240906$$HP$US$US
242909422$24290942$2$F$$20240909$20240906$20240923$PER$$US-EPICPHARMA-US-2024EPCSPO01086$EPIC PHARM$$36$YR$A$F$Y$160$KG$20240923$$CN$US$US
242909431$24290943$1$I$$20240905$20240906$20240906$PER$$US-BAYER-2024A127696$BAYER$$24$YR$A$M$Y$$$20240906$$CN$US$US
242909441$24290944$1$I$20240826$20240828$20240906$20240906$EXP$$MX-ASTELLAS-2024-AER-003416$ASTELLAS$$80$YR$E$M$Y$$$20240906$$CN$MX$MX
242909451$24290945$1$I$$20240829$20240906$20240906$PER$$US-JNJFOC-20240882357$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$MD$US$US
242909471$24290947$1$I$$20240905$20240905$20240905$DIR$717318$$FDA-CTU$$$$$UNK$N$$$20240905$$CN$US$
242909481$24290948$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61163$$FDA-CTU$$54$YR$$F$N$$$20240905$N$$US$
242909491$24290949$1$I$20240701$20240826$20240906$20240906$EXP$$US-UCBSA-2024043678$UCB$$52$YR$$F$Y$$$20240906$$HP$US$US
242909501$24290950$1$I$$20240903$20240906$20240906$EXP$$CA-TAKEDA-2024TUS088639$TAKEDA$$$$$M$Y$$$20240906$$CN$CA$CA
242909521$24290952$1$I$$20240904$20240906$20240906$EXP$$GB-MYLANLABS-2024M1079608$MYLAN$$$$$F$Y$$$20240906$$HP$GB$GB
242909531$24290953$1$I$$20240503$20240906$20240906$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06585$HIKMA$Kethireddy M, Lee T, Rodrigues M, Munir I, Kim DI.. Kethireddy M, Lee T, Rodrigues M, Munir I, Kim DI. A Rare Case of Giant Bilateral Adrenal Myelolipomas in a Patient With Classical Congenital Hyperplasia. Cureus. 2024;16(3):e56953:1-7$40$YR$$F$Y$$$20240906$$MD$US$US
242909541$24290954$1$I$20230905$20240905$20240906$20240906$EXP$GB-MHRA-MED-202409050707446380-QNDPF$GB-MYLANLABS-2024M1081629$MYLAN$$45$YR$$M$Y$69$KG$20240906$$MD$GB$GB
242909562$24290956$2$F$$20240910$20240906$20240913$EXP$$CO-ASTELLAS-2024-AER-004455$ASTELLAS$$55$YR$A$F$Y$$$20240913$$CN$CO$CO
242909571$24290957$1$I$$20240825$20240906$20240906$EXP$$US-RDY-SPO/USA/24/0012922$DR REDDYS$$$$$F$Y$$$20240906$$MD$US$US
242909581$24290958$1$I$$20240903$20240906$20240906$EXP$$US-AMGEN-USASP2024176335$AMGEN$$$$A$M$Y$$$20240906$$MD$US$US
242909591$24290959$1$I$20210101$20240830$20240906$20240906$EXP$$US-GILEAD-2024-0686135$GILEAD$$$$A$M$Y$$$20240906$$CN$US$US
242909602$24290960$2$F$20240517$20240905$20240906$20240912$EXP$$CA-GSK-CA2023AMR097042$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$CA$CA
242909611$24290961$1$I$$20240828$20240906$20240906$EXP$$IN-ROCHE-3533282$ROCHE$$57$YR$A$F$Y$$$20240906$$CN$IN$IN
242909621$24290962$1$I$$20240826$20240906$20240906$EXP$$US-UCBSA-2024043906$UCB$$$$$$Y$$$20240906$$CN$US$US
242909631$24290963$1$I$$20240826$20240906$20240906$EXP$$US-UCBSA-2024043833$UCB$$$$$$Y$$$20240906$$CN$US$US
242909641$24290964$1$I$$20240826$20240906$20240906$EXP$$US-UCBSA-2024043899$UCB$$$$$$Y$$$20240906$$CN$US$US
242909651$24290965$1$I$$20240902$20240906$20240906$EXP$$DZ-AMGEN-DZASP2024176937$AMGEN$Nadjat S.. Place of Romiplostim in the Treatment of Bone Marrow Aplasia-Experience of the Sidi Bel Abbes Hematology Department, Algeria. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (SUPPL_1):S585$$$$$Y$$$20240906$$MD$DZ$DZ
242909661$24290966$1$I$$20240823$20240906$20240906$PER$$US-JNJFOC-20240865278$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20240906$$CN$US$US
242909671$24290967$1$I$20240801$20240830$20240906$20240906$EXP$$CA-SANDOZ INC.-SDZ2023CA032298$SANDOZ$$50$YR$$F$Y$$$20240906$$CN$CA$CA
242909681$24290968$1$I$20211001$20240828$20240906$20240906$EXP$$PL-AMGEN-POLSP2024174487$AMGEN$$38$YR$A$F$Y$$$20240906$$MD$PL$PL
242909691$24290969$1$I$20240301$20240828$20240906$20240906$PER$$US-SA-2024SA258575$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240906$$HP$US$US
242909702$24290970$2$F$20240801$20240910$20240906$20240918$PER$$US-SA-2024SA255501$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240918$$MD$US$US
242909711$24290971$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141936$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240906$$CN$US$US
242909721$24290972$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141712$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240906$$HP$US$US
242909741$24290974$1$I$20240903$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141898$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240906$$HP$US$US
242909751$24290975$1$I$$20240828$20240906$20240906$PER$$US-VERTEX PHARMACEUTICALS-2024-013859$VERTEX$$$$$F$Y$$$20240906$$MD$US$US
242909761$24290976$1$I$$20240828$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137826$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240906$$CN$US$US
242909771$24290977$1$I$20240101$20240829$20240906$20240906$PER$$US-VERTEX PHARMACEUTICALS-2024-013964$VERTEX$$$$A$M$Y$$$20240906$$HP$US$US
242909781$24290978$1$I$$20240807$20240906$20240906$PER$$US-AstraZeneca-2024A180195$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242909791$24290979$1$I$$20240829$20240906$20240906$PER$$US-VERTEX PHARMACEUTICALS-2024-013957$VERTEX$$$$A$M$Y$$$20240906$$HP$US$US
242909801$24290980$1$I$$20240828$20240906$20240906$PER$$US-VERTEX PHARMACEUTICALS-2024-013853$VERTEX$$24$YR$$F$Y$$$20240906$$HP$US$US
242909812$24290981$2$F$$20240903$20240906$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-014072$VERTEX$$$$$F$Y$$$20240912$$CN$US$US
242909821$24290982$1$I$$20240829$20240906$20240906$EXP$$ZA-AstraZeneca-2024A198506$ASTRAZENECA$$88$YR$$F$Y$$$20240906$$CN$ZA$
242909831$24290983$1$I$$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200371$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242909841$24290984$1$I$$20240903$20240906$20240906$EXP$$JP-AstraZeneca-2024A201917$ASTRAZENECA$$80$YR$$F$Y$$$20240906$$MD$JP$
242909851$24290985$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A198924$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242909861$24290986$1$I$$20240826$20240906$20240906$EXP$$AU-BAYER-2024A123538$BAYER$$$$$$Y$$$20240906$$MD$AU$AU
242909871$24290987$1$I$20240810$20240904$20240906$20240906$EXP$$US-GSK-US2024110147$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$HP$US$US
242909901$24290990$1$I$20240101$20240905$20240906$20240906$PER$$US-BAYER-2024A127551$BAYER$$33$YR$A$F$Y$$$20240906$$MD$US$US
242909911$24290991$1$I$20240902$20240904$20240906$20240906$PER$$US-TAKEDA-2024TUS089232$TAKEDA$$12$YR$$F$Y$48$KG$20240906$$MD$US$US
242909922$24290992$2$F$20240101$20240916$20240906$20240924$EXP$$US-ORPHANEU-2024006706$RECORDATI$$$$$$Y$$$20240924$$CN$US$US
242909941$24290994$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61296$$FDA-CTU$$$$$F$N$$$20240905$N$PH$US$
242909951$24290995$1$I$$20240905$20240905$20240905$DIR$717287$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242909961$24290996$1$I$20240905$20240905$20240905$20240905$DIR$717332$$FDA-CTU$$51$YR$$M$N$92.25$KG$20240905$Y$HP$US$
242909971$24290997$1$I$20240905$20240905$20240905$20240905$DIR$717309$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242909982$24290998$2$F$20240201$20240917$20240906$20240926$PER$$FR-Blueprint Medicines Corporation-SP-FR-2024-001760$BLUEPRINT MEDICINES$$66$YR$E$M$Y$$$20240926$$MD$FR$FR
242909991$24290999$1$I$20240101$20240829$20240906$20240906$EXP$$US-AMGEN-USASP2024176649$AMGEN$$$$$M$Y$$$20240906$$CN$US$US
242910001$24291000$1$I$20240601$20240906$20240906$20240906$EXP$FR-AFSSAPS-RN2024000946$NVSC2024FR179184$NOVARTIS$$46$YR$$F$Y$$$20240906$$MD$FR$FR
242910021$24291002$1$I$$20240826$20240906$20240906$EXP$$TW-UCBSA-2024043744$UCB$$$$A$$Y$$$20240906$$MD$TW$TW
242910031$24291003$1$I$$20240904$20240906$20240906$PER$$US-BAYER-2024A127631$BAYER$$29$YR$A$F$Y$$$20240906$$MD$US$US
242910041$24291004$1$I$20240701$20240829$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR108673$VIIV$$64$YR$$M$Y$$$20240906$$HP$US$US
242910051$24291005$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906244$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242910061$24291006$1$I$$20240902$20240906$20240906$EXP$$IT-INDIVIOR UK LIMITED-INDV-156296-2024$RECKITT BENCKISER$$$$$$Y$$$20240906$$HP$IT$IT
242910071$24291007$1$I$20240501$20240831$20240906$20240906$EXP$GB-MHRA-MED-202408312202138740-VSRJQ$GB-TORRENT-00037798$TORRENT$$$$$F$Y$$$20240906$$CN$GB$GB
242910081$24291008$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176115$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242910091$24291009$1$I$20231001$20240830$20240906$20240906$EXP$$JP-TAKEDA-2024TUS088939$TAKEDA$$6$DEC$$F$Y$$$20240906$$MD$JP$JP
242910101$24291010$1$I$20240826$20240830$20240906$20240906$EXP$GB-MHRA-MED-202408301212566200-GVZQK$GB-TORRENT-00037801$TORRENT$$$$$F$Y$$$20240906$$MD$GB$GB
242910111$24291011$1$I$$20240903$20240906$20240906$PER$$US-TAKEDA-2024TUS088825$TAKEDA$$$$$$Y$$$20240906$$HP$US$US
242910121$24291012$1$I$$20240904$20240906$20240906$PER$$US-BAYER-2024A127635$BAYER$$34$YR$A$F$Y$$$20240906$$CN$US$US
242910131$24291013$1$I$20240827$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200330$ASTRAZENECA$$31663$DY$$F$Y$$$20240906$$CN$US$
242910151$24291015$1$I$$20240830$20240906$20240906$EXP$$ZA-AstraZeneca-2024A198421$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$ZA$
242910162$24291016$2$F$20240101$20240911$20240906$20240919$PER$$US-SA-2024SA255606$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240919$$MD$US$US
242910171$24291017$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140919$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240906$$HP$US$US
242910181$24291018$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141105$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240906$$HP$US$US
242910191$24291019$1$I$20240904$20240904$20240906$20240906$PER$$US-BAYER-2024A127643$BAYER$$33$YR$A$F$Y$$$20240906$$MD$US$US
242910201$24291020$1$I$$20240823$20240906$20240906$EXP$$AU-ASTELLAS-2024-AER-001885$ASTELLAS$$67$YR$E$F$Y$$$20240906$$CN$AU$AU
242910211$24291021$1$I$$20240826$20240906$20240906$EXP$$CA-APOTEX-2024AP009799$APOTEX$$63$YR$$F$Y$$$20240906$$CN$CA$CA
242910221$24291022$1$I$20240101$20240828$20240906$20240906$EXP$$CA-CELLTRION INC.-2024CA008407$CELLTRION$$$$$$Y$$$20240906$$HP$CA$CA
242910231$24291023$1$I$$20240829$20240906$20240906$EXP$$US-BAYER-2024A127314$BAYER$Salmasi G.; Murray D.L.; Padmanabhan A.. Myeloma Therapy for Monoclonal Gammopathy of Thrombotic Significance. New England Journal of Medicine. 2024;391:6:(570-571)$67$YR$E$M$Y$$$20240906$$HP$US$US
242910241$24291024$1$I$$20240903$20240906$20240906$EXP$$US-Indivior Limited-INDV-156334-2024$RECKITT BENCKISER$$$$$$Y$$$20240906$$HP$US$US
242910251$24291025$1$I$20240831$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177289$AMGEN$$82$YR$E$M$Y$$$20240906$$CN$US$US
242910261$24291026$1$I$$20240904$20240906$20240906$PER$$US-BAYER-2024A127652$BAYER$$28$YR$A$F$Y$$$20240906$$MD$US$US
242910272$24291027$2$F$20240830$20240910$20240906$20240916$EXP$$US-AMGEN-USASP2024174085$AMGEN$$69$YR$E$F$Y$$$20240916$$MD$US$US
242910281$24291028$1$I$$20240905$20240906$20240906$PER$$US-BAYER-2024A127662$BAYER$$45$YR$A$F$Y$$$20240906$$MD$US$US
242910291$24291029$1$I$$20240829$20240906$20240906$EXP$$US-BAYER-2024A127352$BAYER$Kone G.; Kvantaliani N.; Cucchiara B.. Spot Sign in Hemorrhagic Transformation of Ischemic Stroke. Annals of Neurology (2024) 96:3 (591-592). 2024;96:3:(591-592)$52$YR$A$M$Y$$$20240906$$MD$US$US
242910321$24291032$1$I$20240727$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61351$$FDA-CTU$$64$YR$$F$N$$$20240905$N$HP$US$
242910331$24291033$1$I$20230916$20240905$20240905$20240905$DIR$717360$$FDA-CTU$$74$YR$$F$N$103.5$KG$20240905$N$CN$US$
242910341$24291034$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61149$$FDA-CTU$$82$YR$$F$N$$$20240905$N$$US$
242910351$24291035$1$I$20240904$20240905$20240905$20240905$DIR$717333$$FDA-CTU$$83$YR$$M$N$$$20240905$Y$PH$US$
242910361$24291036$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61252$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242910371$24291037$1$I$20240823$20240905$20240905$20240905$DIR$717303$$FDA-CTU$$60$YR$$F$N$81$KG$20240905$N$PH$US$
242910381$24291038$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61298$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242910391$24291039$1$I$20240719$20240905$20240905$20240905$DIR$717310$$FDA-CTU$$64$YR$$F$N$141.75$KG$20240905$N$PH$US$
242910401$24291040$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61239$$FDA-CTU$$82$YR$$F$N$67.13$KG$20240905$N$$US$
242910411$24291041$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61260$$FDA-CTU$$50$YR$$F$N$$$20240905$N$$US$
242910421$24291042$1$I$$20230615$20240906$20240906$EXP$$NVSC2023GB281045$NOVARTIS$$$$$$Y$$$20240906$$PH$GB$GB
242910431$24291043$1$I$$20240906$20240906$20240906$EXP$$ES-SANDOZ INC.-SDZ2024ES078279$SANDOZ$$86$YR$$M$Y$$$20240906$$HP$ES$ES
242910441$24291044$1$I$$20240905$20240906$20240906$PER$$US-BAYER-2024A127668$BAYER$$42$YR$A$F$Y$$$20240906$$MD$US$US
242910451$24291045$1$I$$20240823$20240906$20240906$PER$$US-LEADINGPHARMA-US-2024LEASPO00375$LEADING PHARMA$$20$YR$A$M$Y$$$20240906$$CN$US$US
242910461$24291046$1$I$$20240828$20240906$20240906$EXP$$US-009507513-2408USA009964$MERCK$$$$$F$Y$$$20240906$$MD$US$US
242910471$24291047$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255503$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240906$$MD$US$US
242910481$24291048$1$I$$20240719$20240906$20240906$PER$$US-SA-2024SA258033$SANOFI AVENTIS$$$$E$F$Y$$$20240906$$MD$US$US
242910491$24291049$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA258013$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240906$$HP$US$US
242910501$24291050$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA253981$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240906$$CN$US$US
242910511$24291051$1$I$20240828$20240905$20240906$20240906$PER$$US-BAYER-2024A127672$BAYER$$47$YR$A$F$Y$$$20240906$$CN$US$US
242910523$24291052$3$F$20240717$20240917$20240906$20240925$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17515$IPSEN$$84$YR$E$M$Y$$$20240925$$MD$US$US
242910531$24291053$1$I$$20240823$20240906$20240906$PER$$US-LEADINGPHARMA-US-2024LEASPO00376$LEADING PHARMA$$$$$M$Y$$$20240906$$CN$US$US
242910541$24291054$1$I$20240805$20240904$20240906$20240906$PER$$US-BAYER-2024A127749$BAYER$$27$YR$A$F$Y$$$20240906$$MD$US$US
242910551$24291055$1$I$20240701$20240826$20240906$20240906$EXP$$US-UCBSA-2024043651$UCB$$25$YR$$F$Y$$$20240906$$HP$US$US
242910562$24291056$2$F$20240801$20240828$20240906$20240911$EXP$$CA-UCBSA-2024041935$UCB$$68$YR$$F$Y$$$20240911$$CN$CA$CA
242910581$24291058$1$I$20240719$20240903$20240906$20240906$EXP$FR-AFSSAPS-NC2024001022$FR-009507513-2409FRA001250$MERCK$$73$YR$$F$Y$60$KG$20240906$$HP$FR$FR
242910591$24291059$1$I$$20240902$20240906$20240906$EXP$$US-MYLANLABS-2024M1081872$MYLAN$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240906$$MD$US$US
242910601$24291060$1$I$$20240902$20240906$20240906$EXP$$US-MYLANLABS-2024M1081865$MYLAN$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240906$$MD$US$US
242910611$24291061$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61225$$FDA-CTU$$69$YR$$M$N$113.4$KG$20240905$N$$US$
242910641$24291064$1$I$$20240904$20240906$20240906$PER$$US-BAYER-2024A127777$BAYER$$34$YR$A$F$Y$$$20240906$$MD$US$US
242910651$24291065$1$I$20240826$20240905$20240906$20240906$EXP$$US-TAKEDA-2024TUS089136$TAKEDA$$43$YR$$M$Y$$$20240906$$CN$US$US
242910661$24291066$1$I$$20240815$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130900$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240906$$CN$US$US
242910671$24291067$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141151$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240906$$CN$US$US
242910682$24291068$2$F$$20240904$20240906$20240910$EXP$$CA-LUNDBECK-DKLU4003835$LUNDBECK$$$$$$Y$$$20240910$$CN$CA$CA
242910691$24291069$1$I$20240904$20240905$20240906$20240906$PER$$US-BAYER-2024A127807$BAYER$$37$YR$A$F$Y$$$20240906$$MD$US$US
242910701$24291070$1$I$20240822$20240905$20240905$20240905$DIR$717334$$FDA-CTU$$43$YR$$F$N$85.5$KG$20240905$N$CN$US$
242910711$24291071$1$I$$20240904$20240906$20240906$PER$$US-HALEON-2195306$Haleon PLC$$$$$M$Y$$$20240906$$CN$US$US
242910721$24291072$1$I$$20240828$20240906$20240906$30DAY$$US-GSK-US2024107307$GLAXOSMITHKLINE$$$$A$F$Y$$$20240906$$CN$US$US
242910731$24291073$1$I$$20240903$20240906$20240906$EXP$$CA-GSK-CA2022169174$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$HP$CA$CA
242910751$24291075$1$I$$20240903$20240906$20240906$PER$$US-ALXN-202409USA000149US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242910761$24291076$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61228$$FDA-CTU$$69$YR$$M$N$250$LBS$20240905$N$$US$
242910781$24291078$1$I$20240101$20240904$20240906$20240906$PER$$US-JNJFOC-20240908478$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240906$$CN$US$US
242910801$24291080$1$I$$20240905$20240906$20240906$PER$$US-BAYER-2024A127837$BAYER$$21$YR$A$F$Y$$$20240906$$MD$US$US
242910811$24291081$1$I$20240728$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A202179$ASTRAZENECA$$$$$$Y$$$20240906$$CN$US$
242910821$24291082$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61227$$FDA-CTU$$37$YR$$M$N$$$20240905$N$$US$
242910831$24291083$1$I$$20240830$20240906$20240906$EXP$$JP-AstraZeneca-2024A199855$ASTRAZENECA$$$$$F$Y$$$20240906$$MD$JP$
242910841$24291084$1$I$$20240829$20240906$20240906$EXP$$US-AstraZeneca-2024A198927$ASTRAZENECA$$$$$F$Y$65.2$KG$20240906$$CN$US$
242910851$24291085$1$I$20230701$20240903$20240906$20240906$EXP$$JP-AstraZeneca-2024A201395$ASTRAZENECA$$68$YR$$M$Y$$$20240906$$MD$JP$
242910861$24291086$1$I$$20240823$20240906$20240906$PER$$US-LEADINGPHARMA-US-2024LEASPO00374$LEADING PHARMA$$$$$M$Y$$$20240906$$CN$US$US
242910871$24291087$1$I$20240327$20240906$20240906$20240906$EXP$FR-AFSSAPS-TO2024001638$FR-BAYER-2024A127812$BAYER$$88$YR$E$F$Y$$$20240906$$MD$FR$FR
242910881$24291088$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255545$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240906$$MD$US$US
242910901$24291090$1$I$20240401$20240830$20240906$20240906$PER$$US-MYLANLABS-2024M1080953$MYLAN$$62$YR$$F$Y$68.03$KG$20240906$$CN$US$US
242910911$24291091$1$I$20240801$20240830$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027614$UNITED THERAPEUTICS$$27$YR$$F$Y$50.794$KG$20240906$$$US$US
242910921$24291092$1$I$$20240830$20240906$20240906$PER$$US-SA-2024SA255444$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240906$$CN$US$US
242910931$24291093$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA254478$SANOFI AVENTIS$$32$YR$A$$Y$$$20240906$$CN$US$US
242910941$24291094$1$I$20240701$20240823$20240906$20240906$PER$$US-SA-2024SA256975$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$HP$US$US
242910951$24291095$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010082$APOTEX$$52$YR$$M$Y$$$20240906$$CN$CA$CA
242910961$24291096$1$I$20240801$20240903$20240906$20240906$EXP$$CA-ABBVIE-5906143$ABBVIE$$61$YR$$F$Y$$$20240906$$CN$CA$CA
242910971$24291097$1$I$$20240831$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027710$UNITED THERAPEUTICS$$$$$F$Y$72.109$KG$20240906$$$US$US
242910981$24291098$1$I$20240101$20240904$20240906$20240906$EXP$$US-ABBVIE-5907977$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242911001$24291100$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61358$$FDA-CTU$$68$YR$$M$N$$$20240905$N$$US$
242911012$24291101$2$F$20240902$20240912$20240906$20240917$EXP$$CA-ABBVIE-5906144$ABBVIE$$90$YR$$M$Y$$$20240917$$CN$CA$CA
242911021$24291102$1$I$$20240904$20240906$20240906$EXP$$US-ABBVIE-5907103$ABBVIE$$$$$M$Y$$$20240906$$HP$US$US
242911031$24291103$1$I$20240820$20240905$20240905$20240905$DIR$717302$$FDA-CTU$$81$YR$$M$N$83.25$KG$20240905$N$CN$US$
242911041$24291104$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61233$$FDA-CTU$$72$YR$$F$N$$$20240905$N$$US$
242911051$24291105$1$I$20240101$20240904$20240906$20240906$EXP$$US-ABBVIE-5908130$ABBVIE$$49$YR$$F$Y$$$20240906$$CN$US$US
242911061$24291106$1$I$20240901$20240905$20240905$20240905$DIR$717372$$FDA-CTU$$55$YR$$F$N$60.75$KG$20240905$N$CN$US$
242911071$24291107$1$I$20240824$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61224$$FDA-CTU$$72$YR$$F$N$$$20240905$Y$PH$US$
242911081$24291108$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61396$$FDA-CTU$$$$$F$N$$$20240905$N$HP$US$
242911101$24291110$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61367$$FDA-CTU$$$$$M$N$$$20240905$N$HP$US$
242911111$24291111$1$I$20240421$20240905$20240905$20240905$DIR$717305$$FDA-CTU$$69$YR$$F$N$$$20240905$N$CN$US$
242911131$24291113$1$I$$20240827$20240906$20240906$30DAY$$US-GSK-US2024106727$GLAXOSMITHKLINE$$$$A$F$Y$$$20240906$$CN$US$US
242911141$24291114$1$I$$20240830$20240906$20240906$EXP$$JP-VANTIVE-2024VAN019145$Vantive US Healthcare$$92$YR$$F$Y$$$20240906$$HP$JP$JP
242911151$24291115$1$I$20240815$20240822$20240906$20240906$EXP$$DE-IMP-2024000683$Harrow Health$$$$E$M$Y$$$20240906$$CN$DE$DE
242911162$24291116$2$F$$20240905$20240906$20240910$EXP$$IN-VANTIVE-2024VAN019565$Vantive US Healthcare$$34$YR$$F$Y$$$20240910$$CN$IN$IN
242911172$24291117$2$F$$20240905$20240906$20240913$EXP$$IN-VANTIVE-2024VAN019562$Vantive US Healthcare$$64$YR$$M$Y$$$20240913$$CN$IN$IN
242911181$24291118$1$I$20240817$20240903$20240906$20240906$EXP$$US-VANTIVE-2024VAN019539$Vantive US Healthcare$$$$$M$Y$$$20240906$$HP$US$US
242911191$24291119$1$I$$20240904$20240906$20240906$EXP$$US-VANTIVE-2024VAN019553$Vantive US Healthcare$$$$$M$Y$$$20240906$$HP$US$US
242911203$24291120$3$F$$20240916$20240906$20240926$EXP$$GB-VANTIVE-2024VAN019435$Vantive US Healthcare$$$$$F$Y$$$20240926$$HP$GB$GB
242911211$24291121$1$I$20240828$20240904$20240906$20240906$EXP$$CO-VANTIVE-2024VAN019518$Vantive US Healthcare$$62$YR$$M$Y$73.9$KG$20240906$$HP$CO$CO
242911221$24291122$1$I$20231201$20240826$20240906$20240906$EXP$$DE-LUPIN HEALTHCARE (UK) LIMITED-2024-08467$LUPIN$$$$$$Y$$$20240906$$MD$DE$DE
242911232$24291123$2$F$20240826$20240827$20240906$20240919$EXP$$CA-JNJFOC-20240869406$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240919$$HP$CA$CA
242911241$24291124$1$I$20240820$20240820$20240906$20240906$PER$$US-UniquePharma-US-2024UPLSPO00034$UNIQUE PHARMACEUTICALS$$52$YR$A$M$Y$$$20240906$$CN$US$US
242911251$24291125$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA204756$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240906$$MD$US$US
242911261$24291126$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141405$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240906$$CN$US$US
242911271$24291127$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141881$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240906$$CN$US$US
242911281$24291128$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142238$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240906$$CN$US$US
242911302$24291130$2$F$20240716$20240717$20240906$20240923$EXP$$CO-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00904$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240923$$CN$CO$CO
242911314$24291131$4$F$20230701$20240910$20240906$20240917$EXP$$SI-009507513-2409SVN000741$MERCK$$43$YR$$F$Y$$$20240917$$MD$SI$SI
242911321$24291132$1$I$20231201$20240828$20240906$20240906$EXP$$US-TG THERAPEUTICS INC.-TGT003949$TG THERAPEUTICS$$$$$$Y$$$20240906$$CN$US$US
242911341$24291134$1$I$$20240903$20240906$20240906$PER$$US-ALXN-202409USA000121US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242911351$24291135$1$I$$20240904$20240906$20240906$EXP$$US-ABBVIE-5908144$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242911361$24291136$1$I$$20240904$20240906$20240906$PER$$US-ALXN-202409USA000153US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242911371$24291137$1$I$$20240828$20240906$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026915$UNITED THERAPEUTICS$Mathavan A, Mathavan A, Eagan C, Alnuaimat H, Ataya A. Progressive exertional dyspnea in a patient with epistaxis, telangiectasias, and arteriovenous malformations. Ann Am Thorac Soc. 2024;21(6):971-976$48$YR$$F$Y$$$20240906$$MD$US$US
242911381$24291138$1$I$20240215$20240905$20240905$20240905$DIR$717321$$FDA-CTU$$74$YR$$M$N$72$KG$20240905$N$CN$US$
242911402$24291140$2$F$$20240918$20240906$20240919$PER$$US-GRUNENTHAL-2024-124858$AVERITAS$$$$A$F$Y$$$20240919$$CN$US$US
242911411$24291141$1$I$20240825$20240827$20240906$20240906$EXP$$US-ETON PHARMACEUTICALS, INC-2024ETO000220$ETON PHARMACEUTICALS$$$$$$Y$$$20240906$$CN$US$US
242911421$24291142$1$I$20240821$20240902$20240906$20240906$EXP$$CN-AMERICAN REGENT INC-2024003373$AMERICAN REGENT$$84$YR$$F$Y$50$KG$20240906$$HP$CN$CN
242911431$24291143$1$I$$20240830$20240906$20240906$EXP$$JP-PFIZER INC-202400249646$PFIZER$$77$YR$$M$Y$$$20240906$$MD$JP$JP
242911441$24291144$1$I$20240905$20240905$20240905$20240905$DIR$717284$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242911451$24291145$1$I$20240830$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61295$$FDA-CTU$$55$YR$$F$N$$$20240905$N$$US$
242911461$24291146$1$I$20240715$20240830$20240906$20240906$EXP$$CN-HALEON-2194624$Haleon PLC$$24$YR$$M$Y$$$20240906$$HP$CN$CN
242911471$24291147$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61254$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
242911491$24291149$1$I$$20240903$20240906$20240906$EXP$$US-PFIZER INC-202400250145$PFIZER$$73$YR$$M$Y$$$20240906$$CN$US$US
242911501$24291150$1$I$$20240904$20240906$20240906$EXP$$CA-PFIZER INC-202400250722$PFIZER$$57$YR$$F$Y$71$KG$20240906$$HP$CA$CA
242911511$24291151$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61355$$FDA-CTU$$81$YR$$F$N$$$20240905$N$$US$
242911532$24291153$2$F$20230822$20240910$20240906$20240913$EXP$$CN-PFIZER INC-2023SGN09657$PFIZER$$40$YR$$F$Y$47$KG$20240913$$MD$CN$CN
242911541$24291154$1$I$20240830$20240905$20240906$20240906$EXP$$US-BAYER-2024A127711$BAYER$$75$YR$E$M$Y$$$20240906$$CN$US$US
242911551$24291155$1$I$$20240904$20240906$20240906$PER$$US-GRUNENTHAL-2024-124245$AVERITAS$$73$YR$$M$Y$$$20240906$$MD$US$US
242911561$24291156$1$I$$20240830$20240906$20240906$EXP$$MY-INCYTE CORPORATION-2024IN009222$INCYTE$$$$$$Y$$$20240906$$MD$MY$MY
242911571$24291157$1$I$$20240903$20240906$20240906$EXP$$US-SANDOZ INC.-SDZ2024US077671$SANDOZ$$$$$F$Y$$$20240906$$CN$US$US
242911581$24291158$1$I$20081031$20240903$20240906$20240906$EXP$$US-ASTELLAS-2024-AER-004625$ASTELLAS$$44$YR$A$F$Y$95$KG$20240906$$CN$US$US
242911591$24291159$1$I$20240101$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176871$AMGEN$$55$YR$A$M$Y$$$20240906$$HP$US$US
242911601$24291160$1$I$$20240902$20240906$20240906$PER$$US-AMGEN-USASP2024176555$AMGEN$Bouhadana, A.; Steinberg A.. DAIR to Be Different: Successful Use of DAIR Regimen, a Novel Treatment Combination for EBV-induced HLH. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S613-S613$29$YR$A$F$Y$$$20240906$$HP$US$US
242911611$24291161$1$I$20240418$20240904$20240906$20240906$EXP$ES-AEMPS-1514945$ES-MYLANLABS-2024M1081316$MYLAN$$87$YR$$F$Y$$$20240906$$MD$ES$ES
242911621$24291162$1$I$$20240902$20240906$20240906$EXP$$IN-MYLANLABS-2024M1081442$MYLAN$Priya L, Alamanda VA, Javali M, Acharya P, Rangaiah P, Nagabushana D. Gabapentin-induced Multifocal Myoclonus. J-Assoc-Physicians-India 2024; 72 (8): 78-79.$66$YR$$M$Y$$$20240906$$HP$IN$IN
242911631$24291163$1$I$$20240829$20240906$20240906$EXP$$TH-INCYTE CORPORATION-2024IN009199$INCYTE$$$$$$Y$$$20240906$$MD$TH$TH
242911641$24291164$1$I$20240101$20240827$20240906$20240906$EXP$$US-ABBVIE-5899661$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242911671$24291167$1$I$$20240903$20240906$20240906$EXP$$IT-ARGENX-2024-ARGX-IT007461$ARGENX BVBA$$$$$$Y$$$20240906$$HP$IT$IT
242911681$24291168$1$I$$20240905$20240905$20240905$DIR$717288$$FDA-CTU$$$$$UNK$N$$$20240905$N$CN$US$
242911693$24291169$3$F$20240317$20240925$20240906$20240930$EXP$$NVSC2024CA064436$NOVARTIS$$58$YR$$F$Y$$$20240930$$CN$CA$CA
242911701$24291170$1$I$20240830$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002652$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240906$$CN$US$US
242911711$24291171$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61170$$FDA-CTU$$47$YR$$M$N$$$20240905$N$$US$
242911751$24291175$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61271$$FDA-CTU$$62$YR$$M$N$$$20240905$N$CN$US$
242911761$24291176$1$I$$20240905$20240905$20240905$DIR$717319$$FDA-CTU$$$$$UNK$N$$$20240905$$CN$US$
242911771$24291177$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141739$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240906$$HP$US$US
242911803$24291180$3$F$$20240913$20240906$20240917$PER$$US-ALXN-202409USA000108US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
242911831$24291183$1$I$$20240829$20240906$20240906$EXP$$TH-INCYTE CORPORATION-2024IN009197$INCYTE$$$$$$Y$$$20240906$$MD$TH$TH
242911851$24291185$1$I$$20240905$20240906$20240906$PER$$NVSC2024US179138$NOVARTIS$$$$$F$Y$$$20240906$$MD$US$US
242911861$24291186$1$I$$20240829$20240906$20240906$EXP$$US-GSK-US2024107878$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$MD$US$US
242911871$24291187$1$I$20240816$20240829$20240906$20240906$EXP$$CN-BEIGENE-BGN-2024-013591$BEIGENE$$$$$$Y$$$20240906$$MD$CN$CN
242911881$24291188$1$I$20240814$20240826$20240906$20240906$EXP$$JP-ROCHE-10000069930$ROCHE$$76$YR$E$F$Y$43$KG$20240906$$MD$JP$JP
242911891$24291189$1$I$$20240831$20240906$20240906$EXP$$JP-AMGEN-JPNSP2024176190$AMGEN$$$$$F$Y$$$20240906$$MD$JP$JP
242911901$24291190$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024175565$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242911911$24291191$1$I$20230206$20240823$20240906$20240906$EXP$$SV-IMP-2024000699$Harrow Health$$$$$M$Y$$$20240906$$MD$SV$SV
242911921$24291192$1$I$20240101$20240823$20240906$20240906$EXP$$CA-UCBSA-2024035033$UCB$$$$$F$Y$$$20240906$$CN$CA$CA
242911931$24291193$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142007$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$67.13$KG$20240906$$HP$US$US
242911942$24291194$2$F$$20240830$20240906$20240906$PER$$US-ROCHE-10000071518$ROCHE$$$$$F$Y$$$20240906$$HP$US$US
242911951$24291195$1$I$$20240816$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN008648$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242911961$24291196$1$I$20240819$20240829$20240906$20240906$EXP$$ZA-CELLTRION INC.-2024ZA020638$CELLTRION$$$$$$Y$$$20240906$$HP$ZA$ZA
242911971$24291197$1$I$20240501$20240816$20240906$20240906$PER$$US-LEX-000440$LEXICON PHARMACEUTICALS$$81$YR$$F$Y$$$20240906$$CN$US$US
242911981$24291198$1$I$$20240902$20240906$20240906$EXP$$AR-JNJFOC-20240907446$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$MD$AR$AR
242911991$24291199$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010104$APOTEX$$63$YR$$F$Y$$$20240906$$CN$CA$CA
242912001$24291200$1$I$$20240814$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN008646$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242912011$24291201$1$I$$20240816$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN008643$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242912021$24291202$1$I$20230701$20240904$20240906$20240906$EXP$$US-TAKEDA-2024TUS088905$TAKEDA$$32$YR$$F$Y$$$20240906$$CN$US$US
242912031$24291203$1$I$$20240902$20240906$20240906$PER$CA-LEO Pharma-373211$CA-LEO Pharma-373211$LEO PHARM$$$$$F$Y$$$20240906$$MD$CA$CA
242912041$24291204$1$I$20230804$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2346$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240903$$CN$US$
242912051$24291205$1$I$$20230913$20240906$20240906$PER$$US-FARMAPROD-202308-2356$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912061$24291206$1$I$$20230808$20240906$20240906$PER$$US-FARMAPROD-202308-2373$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242912071$24291207$1$I$20230801$20230915$20240906$20240906$PER$$US-FARMAPROD-202308-2369$DOMPE FARMACEUTICI$$41$YR$A$F$Y$$$20240903$$CN$US$
242912081$24291208$1$I$$20230807$20240906$20240906$PER$$US-FARMAPROD-202308-2360$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242912091$24291209$1$I$20230806$20230807$20240906$20240906$PER$$US-FARMAPROD-202308-2365$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240903$$CN$US$
242912101$24291210$1$I$$20230821$20240906$20240906$PER$$US-FARMAPROD-202308-2344$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912111$24291211$1$I$20230801$20230817$20240906$20240906$PER$$US-FARMAPROD-202308-2337$DOMPE FARMACEUTICI$$75$YR$E$M$Y$$$20240903$$CN$US$
242912121$24291212$1$I$$20230804$20240906$20240906$PER$$US-FARMAPROD-202308-2343$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912131$24291213$1$I$$20230807$20240906$20240906$PER$$US-FARMAPROD-202308-2364$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242912141$24291214$1$I$20230804$20230805$20240906$20240906$PER$$US-FARMAPROD-202308-2354$DOMPE FARMACEUTICI$$82$YR$E$M$Y$$$20240903$$CN$US$
242912151$24291215$1$I$$20230804$20240906$20240906$PER$$US-FARMAPROD-202308-2342$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912161$24291216$1$I$20230805$20230805$20240906$20240906$PER$$US-FARMAPROD-202308-2357$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240903$$CN$US$
242912171$24291217$1$I$$20230807$20240906$20240906$PER$$US-FARMAPROD-202308-2361$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912181$24291218$1$I$$20230824$20240906$20240906$PER$$US-FARMAPROD-202308-2347$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912191$24291219$1$I$20230806$20230913$20240906$20240906$PER$$US-FARMAPROD-202308-2370$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240903$$CN$US$
242912201$24291220$1$I$20230803$20230804$20240906$20240906$PER$$US-FARMAPROD-202308-2345$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240903$$CN$US$
242912211$24291221$1$I$20230802$20230803$20240906$20240906$PER$$US-FARMAPROD-202308-2336$DOMPE FARMACEUTICI$$87$YR$E$F$Y$51.26$KG$20240903$$CN$US$
242912221$24291222$1$I$20230802$20230814$20240906$20240906$PER$$US-FARMAPROD-202308-2368$DOMPE FARMACEUTICI$$55$YR$A$F$Y$$$20240903$$CN$US$
242912231$24291223$1$I$$20230808$20240906$20240906$PER$$US-FARMAPROD-202308-2378$DOMPE FARMACEUTICI$$$$$$Y$$$20240903$$MD$US$
242912241$24291224$1$I$$20231229$20240906$20240906$PER$$US-FARMAPROD-202308-2348$DOMPE FARMACEUTICI$$$$A$F$Y$56.7$KG$20240903$$MD$US$
242912251$24291225$1$I$$20230929$20240906$20240906$PER$$US-FARMAPROD-202308-2367$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912261$24291226$1$I$$20230822$20240906$20240906$PER$$US-FARMAPROD-202308-2359$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912271$24291227$1$I$$20230914$20240906$20240906$PER$$US-FARMAPROD-202308-2372$DOMPE FARMACEUTICI$$$$E$F$Y$68.49$KG$20240903$$CN$US$
242912281$24291228$1$I$20230801$20230905$20240906$20240906$PER$$US-FARMAPROD-202308-2374$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240903$$CN$US$
242912291$24291229$1$I$$20230804$20240906$20240906$PER$$US-FARMAPROD-202308-2352$DOMPE FARMACEUTICI$$$$$F$Y$83.73$KG$20240903$$CN$US$
242912301$24291230$1$I$20230811$20230811$20240906$20240906$PER$$US-FARMAPROD-202308-2413$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240903$$CN$US$
242912311$24291231$1$I$$20230803$20240906$20240906$PER$$US-FARMAPROD-202308-2338$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242912321$24291232$1$I$$20230809$20240906$20240906$PER$$US-FARMAPROD-202308-2387$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242912331$24291233$1$I$$20230829$20240906$20240906$PER$$US-FARMAPROD-202308-2394$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242912341$24291234$1$I$$20230810$20240906$20240906$PER$$US-FARMAPROD-202308-2399$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242912351$24291235$1$I$$20230808$20240906$20240906$PER$$US-FARMAPROD-202308-2377$DOMPE FARMACEUTICI$$$$$$Y$$$20240903$$MD$US$
242912361$24291236$1$I$$20230809$20240906$20240906$PER$$US-FARMAPROD-202308-2391$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912371$24291237$1$I$$20230906$20240906$20240906$PER$$US-FARMAPROD-202308-2376$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242912381$24291238$1$I$20230811$20230811$20240906$20240906$PER$$US-FARMAPROD-202308-2408$DOMPE FARMACEUTICI$$87$YR$E$F$Y$$$20240903$$CN$US$
242912391$24291239$1$I$20230810$20230810$20240906$20240906$PER$$US-FARMAPROD-202308-2400$DOMPE FARMACEUTICI$$52$YR$A$F$Y$$$20240903$$CN$US$
242912401$24291240$1$I$20230801$20230824$20240906$20240906$PER$$US-FARMAPROD-202308-2340$DOMPE FARMACEUTICI$$55$YR$A$F$Y$$$20240903$$CN$US$
242912411$24291241$1$I$20230801$20230810$20240906$20240906$PER$$US-FARMAPROD-202308-2403$DOMPE FARMACEUTICI$$39$YR$A$M$Y$$$20240903$$CN$US$
242912421$24291242$1$I$$20230808$20240906$20240906$PER$$US-FARMAPROD-202308-2384$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912431$24291243$1$I$20230802$20230803$20240906$20240906$PER$$US-FARMAPROD-202308-2341$DOMPE FARMACEUTICI$$80$YR$E$F$Y$50.8$KG$20240903$$CN$US$
242912441$24291244$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2381$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242912451$24291245$1$I$$20230808$20240906$20240906$PER$$US-FARMAPROD-202308-2379$DOMPE FARMACEUTICI$$$$$$Y$$$20240903$$MD$US$
242912461$24291246$1$I$$20230816$20240906$20240906$PER$$US-FARMAPROD-202308-2353$DOMPE FARMACEUTICI$$$$A$F$Y$56.7$KG$20240903$$CN$US$
242912471$24291247$1$I$$20230810$20240906$20240906$PER$$US-FARMAPROD-202308-2405$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242912481$24291248$1$I$$20230914$20240906$20240906$PER$$US-FARMAPROD-202308-2404$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242912491$24291249$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202308-2355$DOMPE FARMACEUTICI$$$$A$M$Y$63.5$KG$20240903$$CN$US$
242912501$24291250$1$I$$20230911$20240906$20240906$PER$$US-FARMAPROD-202308-2402$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912511$24291251$1$I$$20230823$20240906$20240906$PER$$US-FARMAPROD-202308-2410$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912521$24291252$1$I$$20230810$20240906$20240906$PER$$US-FARMAPROD-202308-2396$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912531$24291253$1$I$$20230810$20240906$20240906$PER$$US-FARMAPROD-202308-2401$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242912541$24291254$1$I$$20230809$20240906$20240906$PER$$US-FARMAPROD-202308-2393$DOMPE FARMACEUTICI$$$$E$F$Y$49.44$KG$20240903$$CN$US$
242912551$24291255$1$I$$20230809$20240906$20240906$PER$$US-FARMAPROD-202308-2388$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242912561$24291256$1$I$$20230731$20240906$20240906$PER$$US-FARMAPROD-202308-2292$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242912571$24291257$1$I$20230801$20230825$20240906$20240906$PER$$US-FARMAPROD-202308-2380$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240903$$CN$US$
242912581$24291258$1$I$20230808$20240131$20240906$20240906$PER$$US-FARMAPROD-202308-2386$DOMPE FARMACEUTICI$$89$YR$E$F$Y$$$20240903$$MD$US$
242912591$24291259$1$I$20230801$20230802$20240906$20240906$PER$$US-FARMAPROD-202308-2324$DOMPE FARMACEUTICI$$29$YR$A$M$Y$$$20240904$$CN$US$
242912601$24291260$1$I$$20230927$20240906$20240906$PER$$US-FARMAPROD-202308-2395$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242912611$24291261$1$I$$20230802$20240906$20240906$PER$$US-FARMAPROD-202308-2310$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242912621$24291262$1$I$$20230803$20240906$20240906$PER$$US-FARMAPROD-202308-2332$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242912631$24291263$1$I$$20231019$20240906$20240906$PER$$US-FARMAPROD-202308-2383$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912641$24291264$1$I$20230801$20230808$20240906$20240906$PER$$US-FARMAPROD-202308-2375$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240903$$CN$US$
242912651$24291265$1$I$$20230823$20240906$20240906$PER$$US-FARMAPROD-202308-2412$DOMPE FARMACEUTICI$$$$E$F$Y$137.8$KG$20240903$$CN$US$
242912661$24291266$1$I$$20230803$20240906$20240906$PER$$US-FARMAPROD-202308-2331$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242912671$24291267$1$I$$20230811$20240906$20240906$PER$$US-FARMAPROD-202308-2409$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242912681$24291268$1$I$20230701$20230811$20240906$20240906$PER$$US-FARMAPROD-202308-2300$DOMPE FARMACEUTICI$$90$YR$E$M$Y$$$20240904$$CN$US$
242912691$24291269$1$I$$20230811$20240906$20240906$PER$$US-FARMAPROD-202308-2430$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912701$24291270$1$I$20230803$20230803$20240906$20240906$PER$$US-FARMAPROD-202308-2334$DOMPE FARMACEUTICI$$70$YR$E$M$Y$$$20240904$$CN$US$
242912711$24291271$1$I$$20230811$20240906$20240906$PER$$US-FARMAPROD-202308-2420$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242912721$24291272$1$I$20230802$20231101$20240906$20240906$PER$$US-FARMAPROD-202308-2318$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240904$$MD$US$
242912731$24291273$1$I$$20230813$20240906$20240906$PER$$US-FARMAPROD-202308-2433$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242912741$24291274$1$I$$20230802$20240906$20240906$PER$$US-FARMAPROD-202308-2323$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242912751$24291275$1$I$$20230731$20240906$20240906$PER$$US-FARMAPROD-202308-2296$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242912761$24291276$1$I$$20230811$20240906$20240906$PER$$US-FARMAPROD-202308-2422$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242912771$24291277$1$I$$20230822$20240906$20240906$PER$$US-FARMAPROD-202308-2320$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242912781$24291278$1$I$$20230719$20240906$20240906$PER$$US-FARMAPROD-202308-2317$DOMPE FARMACEUTICI$$$$E$F$Y$54.7$KG$20240904$$CN$US$
242912791$24291279$1$I$$20230802$20240906$20240906$PER$$US-FARMAPROD-202308-2309$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242912801$24291280$1$I$20230801$20230811$20240906$20240906$PER$$US-FARMAPROD-202308-2417$DOMPE FARMACEUTICI$$51$YR$A$M$Y$$$20240903$$CN$US$
242912811$24291281$1$I$$20230821$20240906$20240906$PER$$US-FARMAPROD-202308-2301$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242912821$24291282$1$I$$20230801$20240906$20240906$PER$$US-FARMAPROD-202308-2304$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242912831$24291283$1$I$20230820$20230815$20240906$20240906$PER$$US-FARMAPROD-202308-2447$DOMPE FARMACEUTICI$$77$YR$E$F$Y$66.68$KG$20240903$$CN$US$
242912841$24291284$1$I$$20230925$20240906$20240906$PER$$US-FARMAPROD-202308-2419$DOMPE FARMACEUTICI$$$$$F$Y$51.12$KG$20240903$$CN$US$
242912851$24291285$1$I$20230801$20230901$20240906$20240906$PER$$US-FARMAPROD-202308-2445$DOMPE FARMACEUTICI$$69$YR$E$M$Y$$$20240903$$CN$US$
242912861$24291286$1$I$$20230802$20240906$20240906$PER$$US-FARMAPROD-202308-2322$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242912871$24291287$1$I$$20230731$20240906$20240906$PER$$US-FARMAPROD-202308-2298$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242912881$24291288$1$I$$20230809$20240906$20240906$PER$$US-FARMAPROD-202308-2414$DOMPE FARMACEUTICI$$$$$$Y$$$20240903$$MD$US$
242912891$24291289$1$I$$20230801$20240906$20240906$PER$$US-FARMAPROD-202308-2314$DOMPE FARMACEUTICI$$$$A$F$Y$78.47$KG$20240904$$CN$US$
242912901$24291290$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2305$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242912911$24291291$1$I$$20230822$20240906$20240906$PER$$US-FARMAPROD-202308-2523$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242912921$24291292$1$I$$20230803$20240906$20240906$PER$$US-FARMAPROD-202308-2335$DOMPE FARMACEUTICI$$$$E$M$Y$68.49$KG$20240904$$CN$US$
242912931$24291293$1$I$$20230802$20240906$20240906$PER$$US-FARMAPROD-202308-2307$DOMPE FARMACEUTICI$$$$E$F$Y$89.36$KG$20240904$$CN$US$
242912941$24291294$1$I$$20230802$20240906$20240906$PER$$US-FARMAPROD-202308-2327$DOMPE FARMACEUTICI$$$$E$F$Y$61.23$KG$20240904$$CN$US$
242912951$24291295$1$I$20230801$20231013$20240906$20240906$PER$$US-FARMAPROD-202308-2444$DOMPE FARMACEUTICI$$41$YR$A$M$Y$$$20240903$$CN$US$
242912961$24291296$1$I$20231001$20231027$20240906$20240906$PER$$US-FARMAPROD-202308-2538$DOMPE FARMACEUTICI$$68$YR$E$F$Y$68.58$KG$20240903$$CN$US$
242912971$24291297$1$I$$20231121$20240906$20240906$PER$$US-FARMAPROD-202308-2326$DOMPE FARMACEUTICI$$64$YR$A$F$Y$$$20240904$$CN$US$
242912981$24291298$1$I$$20230922$20240906$20240906$PER$$US-FARMAPROD-202308-2415$DOMPE FARMACEUTICI$$56$YR$A$F$Y$$$20240903$$CN$US$
242912991$24291299$1$I$20230801$20231031$20240906$20240906$PER$$US-FARMAPROD-202308-2333$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$
242913001$24291300$1$I$$20230815$20240906$20240906$PER$$US-FARMAPROD-202308-2460$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242913011$24291301$1$I$20231201$20240102$20240906$20240906$EXP$$US-FARMAPROD-202308-2325$DOMPE FARMACEUTICI$$60$YR$A$M$Y$$$20240904$$CN$US$
242913021$24291302$1$I$$20230815$20240906$20240906$PER$$US-FARMAPROD-202308-2448$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242913031$24291303$1$I$20230818$20230823$20240906$20240906$PER$$US-FARMAPROD-202308-2541$DOMPE FARMACEUTICI$$47$YR$A$M$Y$$$20240903$$CN$US$
242913041$24291304$1$I$$20230814$20240906$20240906$PER$$US-FARMAPROD-202308-2440$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242913051$24291305$1$I$20230726$20230810$20240906$20240906$PER$$US-FARMAPROD-202308-2297$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240904$$CN$US$
242913061$24291306$1$I$20230802$20230905$20240906$20240906$PER$$US-FARMAPROD-202308-2321$DOMPE FARMACEUTICI$$77$YR$E$M$Y$$$20240904$$CN$US$
242913071$24291307$1$I$20230801$20230813$20240906$20240906$PER$$US-FARMAPROD-202308-2416$DOMPE FARMACEUTICI$$79$YR$E$F$Y$$$20240903$$CN$US$
242913081$24291308$1$I$$20230822$20240906$20240906$PER$$US-FARMAPROD-202308-2424$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242913091$24291309$1$I$$20230814$20240906$20240906$PER$$US-FARMAPROD-202308-2436$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242913101$24291310$1$I$$20231016$20240906$20240906$PER$$US-FARMAPROD-202308-2529$DOMPE FARMACEUTICI$$94$YR$E$F$Y$$$20240903$$CN$US$
242913111$24291311$1$I$$20230823$20240906$20240906$PER$$US-FARMAPROD-202308-2556$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242913121$24291312$1$I$$20230824$20240906$20240906$PER$$US-FARMAPROD-202308-2306$DOMPE FARMACEUTICI$$$$E$F$Y$62.51$KG$20240904$$CN$US$
242913131$24291313$1$I$20230814$20230814$20240906$20240906$PER$$US-FARMAPROD-202308-2319$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240904$$CN$US$
242913141$24291314$1$I$$20230814$20240906$20240906$PER$$US-FARMAPROD-202308-2449$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242913151$24291315$1$I$20230801$20230815$20240906$20240906$PER$$US-FARMAPROD-202308-2461$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240903$$CN$US$
242913161$24291316$1$I$20230812$20231005$20240906$20240906$PER$$US-FARMAPROD-202308-2418$DOMPE FARMACEUTICI$$53$YR$A$F$Y$168.28$KG$20240903$$HP$US$
242913171$24291317$1$I$$20230811$20240906$20240906$PER$$US-FARMAPROD-202308-2431$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242913181$24291318$1$I$$20230824$20240906$20240906$PER$$US-FARMAPROD-202308-2558$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242913191$24291319$1$I$20230701$20230731$20240906$20240906$PER$$US-FARMAPROD-202308-2293$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240904$$CN$US$
242913201$24291320$1$I$20230801$20230821$20240906$20240906$PER$$US-FARMAPROD-202308-2509$DOMPE FARMACEUTICI$$29$YR$A$F$Y$$$20240903$$CN$US$
242913211$24291321$1$I$$20230914$20240906$20240906$PER$$US-FARMAPROD-202308-2451$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242913221$24291322$1$I$20230814$20230814$20240906$20240906$PER$$US-FARMAPROD-202308-2450$DOMPE FARMACEUTICI$$51$YR$A$F$Y$$$20240903$$CN$US$
242913231$24291323$1$I$20230701$20231010$20240906$20240906$PER$$US-FARMAPROD-202308-2443$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240903$$MD$US$
242913241$24291324$1$I$$20231004$20240906$20240906$PER$$US-FARMAPROD-202308-2459$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$MD$US$
242913251$24291325$1$I$$20230814$20240906$20240906$PER$$US-FARMAPROD-202308-2434$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242913261$24291326$1$I$20230821$20230926$20240906$20240906$PER$$US-FARMAPROD-202308-2504$DOMPE FARMACEUTICI$$74$YR$E$F$Y$58.69$KG$20240903$$CN$US$
242913271$24291327$1$I$$20230822$20240906$20240906$PER$$US-FARMAPROD-202308-2531$DOMPE FARMACEUTICI$$$$$F$Y$$$20240903$$MD$US$
242913281$24291328$1$I$20230810$20230906$20240906$20240906$PER$$US-FARMAPROD-202308-2432$DOMPE FARMACEUTICI$$68$YR$E$M$Y$82.55$KG$20240903$$CN$US$
242913291$24291329$1$I$20221201$20230814$20240906$20240906$PER$$US-FARMAPROD-202308-2439$DOMPE FARMACEUTICI$$82$YR$E$M$Y$$$20240903$$CN$US$
242913301$24291330$1$I$20230820$20230821$20240906$20240906$PER$$US-FARMAPROD-202308-2512$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240903$$CN$US$
242913311$24291331$1$I$20230801$20230919$20240906$20240906$PER$$US-FARMAPROD-202308-2507$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240903$$CN$US$
242913321$24291332$1$I$$20230823$20240906$20240906$PER$$US-FARMAPROD-202308-2544$DOMPE FARMACEUTICI$$$$$$Y$$$20240903$$HP$US$
242913331$24291333$1$I$20220818$20230821$20240906$20240906$PER$$US-FARMAPROD-202308-2502$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240903$$CN$US$
242913341$24291334$1$I$$20230816$20240906$20240906$PER$$US-FARMAPROD-202308-2466$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242913351$24291335$1$I$$20230830$20240906$20240906$PER$$US-FARMAPROD-202308-2524$DOMPE FARMACEUTICI$$84$YR$E$F$Y$$$20240903$$CN$US$
242913361$24291336$1$I$$20230824$20240906$20240906$PER$$US-FARMAPROD-202308-2560$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242913371$24291337$1$I$$20230822$20240906$20240906$PER$$US-FARMAPROD-202308-2530$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242913381$24291338$1$I$20230822$20230823$20240906$20240906$PER$$US-FARMAPROD-202308-2532$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240903$$CN$US$
242913391$24291339$1$I$$20230907$20240906$20240906$PER$$US-FARMAPROD-202308-2513$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240903$$CN$US$
242913401$24291340$1$I$20230801$20230921$20240906$20240906$PER$$US-FARMAPROD-202308-2510$DOMPE FARMACEUTICI$$82$YR$E$M$Y$$$20240903$$CN$US$
242913411$24291341$1$I$$20231009$20240906$20240906$PER$$US-FARMAPROD-202308-2522$DOMPE FARMACEUTICI$$$$E$M$Y$65.77$KG$20240903$$CN$US$
242913421$24291342$1$I$$20230816$20240906$20240906$PER$$US-FARMAPROD-202308-2475$DOMPE FARMACEUTICI$$$$E$F$Y$73.26$KG$20240903$$CN$US$
242913431$24291343$1$I$20230801$20230919$20240906$20240906$PER$$US-FARMAPROD-202308-2574$DOMPE FARMACEUTICI$$85$YR$E$F$Y$$$20240903$$CN$US$
242913441$24291344$1$I$20230820$20230907$20240906$20240906$PER$$US-FARMAPROD-202308-2511$DOMPE FARMACEUTICI$$79$YR$E$F$Y$$$20240903$$CN$US$
242913451$24291345$1$I$$20230906$20240906$20240906$PER$$US-FARMAPROD-202308-2533$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242913461$24291346$1$I$20230728$20230901$20240906$20240906$PER$$US-FARMAPROD-202308-2423$DOMPE FARMACEUTICI$$84$YR$E$M$Y$$$20240903$$CN$US$
242913471$24291347$1$I$20230801$20240322$20240906$20240906$PER$$US-FARMAPROD-202308-2545$DOMPE FARMACEUTICI$$65$YR$E$F$Y$$$20240903$$CN$US$
242913481$24291348$1$I$$20230823$20240906$20240906$PER$$US-FARMAPROD-202308-2539$DOMPE FARMACEUTICI$$$$E$F$Y$52.62$KG$20240903$$CN$US$
242913491$24291349$1$I$20230815$20230918$20240906$20240906$PER$$US-FARMAPROD-202308-2469$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240903$$CN$US$
242913501$24291350$1$I$20230804$20231012$20240906$20240906$PER$$US-FARMAPROD-202308-2583$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240903$$MD$US$
242913511$24291351$1$I$20230901$20230921$20240906$20240906$PER$$US-FARMAPROD-202308-2554$DOMPE FARMACEUTICI$$89$YR$E$F$Y$$$20240903$$CN$US$
242913521$24291352$1$I$$20230816$20240906$20240906$PER$$US-FARMAPROD-202308-2473$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242913531$24291353$1$I$20230825$20230927$20240906$20240906$PER$$US-FARMAPROD-202308-2573$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240903$$CN$US$
242913541$24291354$1$I$20230801$20230905$20240906$20240906$PER$$US-FARMAPROD-202308-2553$DOMPE FARMACEUTICI$$51$YR$A$M$Y$$$20240903$$CN$US$
242913551$24291355$1$I$20230801$20230821$20240906$20240906$PER$$US-FARMAPROD-202308-2518$DOMPE FARMACEUTICI$$83$YR$E$M$Y$$$20240903$$CN$US$
242913561$24291356$1$I$$20230817$20240906$20240906$PER$$US-FARMAPROD-202308-2486$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242913571$24291357$1$I$20230816$20230818$20240906$20240906$PER$$US-FARMAPROD-202308-2485$DOMPE FARMACEUTICI$$$$$M$Y$$$20240903$$CN$US$
242913581$24291358$1$I$$20230821$20240906$20240906$PER$$US-FARMAPROD-202308-2521$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242913591$24291359$1$I$$20230822$20240906$20240906$PER$$US-FARMAPROD-202308-2528$DOMPE FARMACEUTICI$$$$E$M$Y$78.02$KG$20240903$$CN$US$
242913601$24291360$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2435$DOMPE FARMACEUTICI$$88$YR$E$F$Y$81.19$KG$20240903$$CN$US$
242913611$24291361$1$I$$20230817$20240906$20240906$PER$$US-FARMAPROD-202308-2484$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242913621$24291362$1$I$$20230824$20240906$20240906$PER$$US-FARMAPROD-202308-2563$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242913631$24291363$1$I$$20230824$20240906$20240906$PER$$US-FARMAPROD-202308-2565$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242913641$24291364$1$I$$20230823$20240906$20240906$PER$$US-FARMAPROD-202308-2543$DOMPE FARMACEUTICI$$$$$F$Y$75.75$KG$20240903$$CN$US$
242913651$24291365$1$I$20230801$20230912$20240906$20240906$PER$$US-FARMAPROD-202308-2482$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240903$$CN$US$
242913661$24291366$1$I$20230815$20231010$20240906$20240906$PER$$US-FARMAPROD-202308-2480$DOMPE FARMACEUTICI$$89$YR$E$F$Y$$$20240903$$CN$US$
242913671$24291367$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2588$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242913681$24291368$1$I$20230815$20230918$20240906$20240906$PER$$US-FARMAPROD-202308-2472$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240903$$CN$US$
242913691$24291369$1$I$20230801$20230818$20240906$20240906$PER$$US-FARMAPROD-202308-2500$DOMPE FARMACEUTICI$$22$YR$A$F$Y$48.99$KG$20240903$$CN$US$
242913701$24291370$1$I$$20230818$20240906$20240906$PER$$US-FARMAPROD-202308-2488$DOMPE FARMACEUTICI$$$$$M$Y$$$20240903$$MD$US$
242913711$24291371$1$I$20230817$20230927$20240906$20240906$PER$$US-FARMAPROD-202308-2489$DOMPE FARMACEUTICI$$69$YR$E$F$Y$52.16$KG$20240903$$CN$US$
242913721$24291372$1$I$20230701$20230913$20240906$20240906$PER$$US-FARMAPROD-202308-2465$DOMPE FARMACEUTICI$$66$YR$E$F$Y$$$20240903$$CN$US$
242913731$24291373$1$I$$20230815$20240906$20240906$PER$$US-FARMAPROD-202308-2464$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242913741$24291374$1$I$$20230817$20240906$20240906$PER$$US-FARMAPROD-202308-2478$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242913751$24291375$1$I$20230801$20230912$20240906$20240906$PER$$US-FARMAPROD-202308-2572$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240903$$CN$US$
242913761$24291376$1$I$$20230818$20240906$20240906$PER$$US-FARMAPROD-202308-2499$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242913771$24291377$1$I$20230801$20230815$20240906$20240906$PER$$US-FARMAPROD-202308-2462$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240903$$CN$US$
242913781$24291378$1$I$$20230824$20240906$20240906$PER$$US-FARMAPROD-202308-2570$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242913791$24291379$1$I$20230815$20230816$20240906$20240906$PER$$US-FARMAPROD-202308-2470$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240903$$CN$US$
242913801$24291380$1$I$$20230908$20240906$20240906$PER$$US-FARMAPROD-202308-2561$DOMPE FARMACEUTICI$$$$A$F$Y$62.6$KG$20240903$$CN$US$
242913811$24291381$1$I$20230829$20230830$20240906$20240906$PER$$US-FARMAPROD-202308-2619$DOMPE FARMACEUTICI$$$$$F$Y$$$20240903$$MD$US$
242913821$24291382$1$I$20230818$20230819$20240906$20240906$PER$$US-FARMAPROD-202308-2501$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240903$$CN$US$
242913831$24291383$1$I$$20230817$20240906$20240906$PER$$US-FARMAPROD-202308-2490$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242913841$24291384$1$I$20240501$20240815$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN008591$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242913851$24291385$1$I$20240801$20240815$20240906$20240906$PER$$US-009507513-2408USA005566$MERCK$$50$YR$$F$Y$$$20240906$$HP$US$US
242913861$24291386$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2596$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242913871$24291387$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2582$DOMPE FARMACEUTICI$$77$YR$E$M$Y$$$20240903$$MD$US$
242913881$24291388$1$I$20230801$20231122$20240906$20240906$PER$$US-FARMAPROD-202308-2566$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240903$$CN$US$
242913891$24291389$1$I$$20230829$20240906$20240906$PER$$US-FARMAPROD-202308-2618$DOMPE FARMACEUTICI$$91$YR$E$M$Y$$$20240903$$MD$US$
242913901$24291390$1$I$$20230816$20240906$20240906$PER$$US-FARMAPROD-202308-2474$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242913911$24291391$1$I$20230830$20230830$20240906$20240906$PER$$US-FARMAPROD-202309-2638$DOMPE FARMACEUTICI$$80$YR$E$F$Y$52.16$KG$20240903$$CN$US$
242913921$24291392$1$I$20230801$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2467$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240903$$CN$US$
242913931$24291393$1$I$$20230816$20240906$20240906$PER$$US-FARMAPROD-202308-2479$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242913941$24291394$1$I$20230825$20230825$20240906$20240906$PER$$US-FARMAPROD-202308-2575$DOMPE FARMACEUTICI$$97$YR$E$M$Y$$$20240903$$CN$US$
242913951$24291395$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2585$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242913961$24291396$1$I$$20230830$20240906$20240906$PER$$US-FARMAPROD-202309-2650$DOMPE FARMACEUTICI$$51$YR$A$F$Y$$$20240903$$CN$US$
242913971$24291397$1$I$$20230815$20240906$20240906$PER$$US-FARMAPROD-202308-2463$DOMPE FARMACEUTICI$$$$E$F$Y$61.23$KG$20240903$$CN$US$
242913981$24291398$1$I$20230801$20240118$20240906$20240906$PER$$US-FARMAPROD-202308-2498$DOMPE FARMACEUTICI$$25$YR$A$F$Y$$$20240903$$MD$US$
242913991$24291399$1$I$20230801$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2597$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240903$$CN$US$
242914001$24291400$1$I$$20230912$20240906$20240906$PER$$US-FARMAPROD-202308-2580$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242914011$24291401$1$I$20230818$20230818$20240906$20240906$PER$$US-FARMAPROD-202308-2497$DOMPE FARMACEUTICI$$49$YR$A$F$Y$60.46$KG$20240903$$CN$US$
242914021$24291402$1$I$20230810$20230816$20240906$20240906$PER$$US-FARMAPROD-202308-2476$DOMPE FARMACEUTICI$$51$YR$A$F$Y$77.11$KG$20240903$$CN$US$
242914031$24291403$1$I$$20230825$20240906$20240906$PER$$US-FARMAPROD-202308-2578$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914041$24291404$1$I$20230825$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2595$DOMPE FARMACEUTICI$$58$YR$A$F$Y$66.22$KG$20240903$$CN$US$
242914051$24291405$1$I$20230827$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2608$DOMPE FARMACEUTICI$$56$YR$A$F$Y$71.21$KG$20240903$$CN$US$
242914061$24291406$1$I$20230912$20230919$20240906$20240906$PER$$US-FARMAPROD-202308-2483$DOMPE FARMACEUTICI$$75$YR$E$F$Y$71.21$KG$20240903$$CN$US$
242914071$24291407$1$I$$20230829$20240906$20240906$PER$$US-FARMAPROD-202308-2629$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914081$24291408$1$I$20230821$20230824$20240906$20240906$PER$$US-FARMAPROD-202308-2567$DOMPE FARMACEUTICI$$83$YR$E$F$Y$83.91$KG$20240903$$CN$US$
242914091$24291409$1$I$20230823$20230927$20240906$20240906$PER$$US-FARMAPROD-202308-2576$DOMPE FARMACEUTICI$$87$YR$E$M$Y$69.85$KG$20240903$$CN$US$
242914101$24291410$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2593$DOMPE FARMACEUTICI$$$$E$M$Y$67.63$KG$20240903$$CN$US$
242914111$24291411$1$I$20230904$20231019$20240906$20240906$PER$$US-FARMAPROD-202308-2568$DOMPE FARMACEUTICI$$88$YR$E$F$Y$63.96$KG$20240903$$CN$US$
242914121$24291412$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2591$DOMPE FARMACEUTICI$$$$A$F$Y$75.11$KG$20240903$$CN$US$
242914131$24291413$1$I$$20230915$20240906$20240906$PER$$US-FARMAPROD-202309-2645$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240903$$CN$US$
242914141$24291414$1$I$$20230829$20240906$20240906$PER$$US-FARMAPROD-202308-2626$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242914151$24291415$1$I$$20230829$20240906$20240906$PER$$US-FARMAPROD-202308-2613$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242914161$24291416$1$I$20230828$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2598$DOMPE FARMACEUTICI$$52$YR$A$F$Y$$$20240903$$CN$US$
242914171$24291417$1$I$$20230830$20240906$20240906$PER$$US-FARMAPROD-202308-2627$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914181$24291418$1$I$20230828$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2604$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240903$$CN$US$
242914191$24291419$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2611$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242914201$24291420$1$I$$20230831$20240906$20240906$PER$$US-FARMAPROD-202309-2643$DOMPE FARMACEUTICI$$$$$F$Y$$$20240903$$MD$US$
242914211$24291421$1$I$$20230829$20240906$20240906$PER$$US-FARMAPROD-202308-2628$DOMPE FARMACEUTICI$$$$A$F$Y$81.65$KG$20240903$$CN$US$
242914221$24291422$1$I$20230821$20230922$20240906$20240906$PER$$US-FARMAPROD-202309-2637$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240903$$CN$US$
242914231$24291423$1$I$$20230831$20240906$20240906$PER$$US-FARMAPROD-202309-2655$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240903$$CN$US$
242914241$24291424$1$I$$20230929$20240906$20240906$PER$$US-FARMAPROD-202308-2571$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914251$24291425$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2605$DOMPE FARMACEUTICI$$$$E$M$Y$80.83$KG$20240903$$CN$US$
242914261$24291426$1$I$$20230823$20240906$20240906$PER$$US-FARMAPROD-202308-2620$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914271$24291427$1$I$20230801$20230830$20240906$20240906$PER$$US-FARMAPROD-202309-2636$DOMPE FARMACEUTICI$$56$YR$A$F$Y$$$20240903$$CN$US$
242914281$24291428$1$I$20230801$20230919$20240906$20240906$PER$$US-FARMAPROD-202309-2674$DOMPE FARMACEUTICI$$72$YR$E$M$Y$$$20240903$$CN$US$
242914291$24291429$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2586$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242914301$24291430$1$I$20230801$20230829$20240906$20240906$PER$$US-FARMAPROD-202308-2589$DOMPE FARMACEUTICI$$65$YR$E$F$Y$135.35$KG$20240903$$CN$US$
242914321$24291432$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2584$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914331$24291433$1$I$$20230829$20240906$20240906$PER$$US-FARMAPROD-202309-2633$DOMPE FARMACEUTICI$$$$E$M$Y$90.26$KG$20240903$$CN$US$
242914341$24291434$1$I$$20230829$20240906$20240906$PER$$US-FARMAPROD-202308-2609$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240903$$CN$US$
242914351$24291435$1$I$20230829$20230829$20240906$20240906$PER$$US-FARMAPROD-202308-2631$DOMPE FARMACEUTICI$$84$YR$E$F$Y$$$20240903$$CN$US$
242914361$24291436$1$I$20230825$20230826$20240906$20240906$PER$$US-FARMAPROD-202308-2581$DOMPE FARMACEUTICI$$71$YR$E$M$Y$$$20240903$$CN$US$
242914371$24291437$1$I$20230808$20231004$20240906$20240906$PER$$US-FARMAPROD-202309-2639$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240903$$CN$US$
242914381$24291438$1$I$$20230831$20240906$20240906$PER$$US-FARMAPROD-202309-2663$DOMPE FARMACEUTICI$$79$YR$E$F$Y$81.01$KG$20240903$$CN$US$
242914391$24291439$1$I$20230823$20230824$20240906$20240906$PER$$US-FARMAPROD-202308-2569$DOMPE FARMACEUTICI$$56$YR$A$F$Y$$$20240903$$CN$US$
242914401$24291440$1$I$$20230901$20240906$20240906$PER$$US-FARMAPROD-202309-2671$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914411$24291441$1$I$20240807$20240902$20240906$20240906$EXP$IT-MINISAL02-1000242$IT-MYLANLABS-2024M1080500$MYLAN$$6$YR$$M$Y$15$KG$20240906$$MD$IT$IT
242914421$24291442$1$I$$20230830$20240906$20240906$PER$$US-FARMAPROD-202309-2654$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242914431$24291443$1$I$20230830$20231005$20240906$20240906$PER$$US-FARMAPROD-202309-2653$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240903$$CN$US$
242914441$24291444$1$I$$20240126$20240906$20240906$PER$$US-FARMAPROD-202309-2672$DOMPE FARMACEUTICI$$$$E$F$Y$91.72$KG$20240903$$MD$US$
242914451$24291445$1$I$20230801$20230830$20240906$20240906$PER$$US-FARMAPROD-202309-2634$DOMPE FARMACEUTICI$$56$YR$A$F$Y$$$20240903$$CN$US$
242914461$24291446$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2606$DOMPE FARMACEUTICI$$$$E$F$Y$42.64$KG$20240903$$CN$US$
242914471$24291447$1$I$20230901$20230905$20240906$20240906$PER$$US-FARMAPROD-202309-2681$DOMPE FARMACEUTICI$$64$YR$A$F$Y$$$20240903$$CN$US$
242914481$24291448$1$I$$20230901$20240906$20240906$PER$$US-FARMAPROD-202309-2668$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242914491$24291449$1$I$$20230828$20240906$20240906$PER$$US-FARMAPROD-202308-2614$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242914501$24291450$1$I$20230801$20240212$20240906$20240906$PER$$US-FARMAPROD-202309-2642$DOMPE FARMACEUTICI$$35$YR$A$F$Y$$$20240903$$MD$US$
242914511$24291451$1$I$$20230905$20240906$20240906$PER$$US-FARMAPROD-202309-2678$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242914521$24291452$1$I$$20230905$20240906$20240906$PER$$US-FARMAPROD-202309-2679$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914531$24291453$1$I$$20230830$20240906$20240906$PER$$US-FARMAPROD-202309-2647$DOMPE FARMACEUTICI$$54$YR$A$F$Y$$$20240903$$CN$US$
242914541$24291454$1$I$$20231004$20240906$20240906$PER$$US-FARMAPROD-202309-2659$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240903$$CN$US$
242914551$24291455$1$I$$20230901$20240906$20240906$PER$$US-FARMAPROD-202309-2664$DOMPE FARMACEUTICI$$$$A$F$Y$58.06$KG$20240903$$CN$US$
242914561$24291456$1$I$$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2691$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914571$24291457$1$I$$20230901$20240906$20240906$PER$$US-FARMAPROD-202309-2673$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914581$24291458$1$I$$20230907$20240906$20240906$PER$$US-FARMAPROD-202309-2723$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242914591$24291459$1$I$20230801$20231012$20240906$20240906$PER$$US-FARMAPROD-202309-2646$DOMPE FARMACEUTICI$$79$YR$E$F$Y$81.19$KG$20240903$$CN$US$
242914601$24291460$1$I$20230801$20230907$20240906$20240906$PER$$US-FARMAPROD-202309-2714$DOMPE FARMACEUTICI$$38$YR$A$M$Y$$$20240903$$CN$US$
242914611$24291461$1$I$20230901$20230902$20240906$20240906$PER$$US-FARMAPROD-202309-2676$DOMPE FARMACEUTICI$$49$YR$A$F$Y$$$20240903$$CN$US$
242914621$24291462$1$I$$20230901$20240906$20240906$PER$$US-FARMAPROD-202309-2687$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242914631$24291463$1$I$20230826$20231218$20240906$20240906$PER$$US-FARMAPROD-202308-2630$DOMPE FARMACEUTICI$$78$YR$E$F$Y$81.65$KG$20240903$$CN$US$
242914641$24291464$1$I$$20230830$20240906$20240906$PER$$US-FARMAPROD-202309-2652$DOMPE FARMACEUTICI$$17$YR$T$F$Y$$$20240903$$CN$US$
242914651$24291465$1$I$$20230910$20240906$20240906$PER$$US-FARMAPROD-202309-2740$DOMPE FARMACEUTICI$$9$YR$C$F$Y$$$20240904$$MD$US$
242914661$24291466$1$I$$20230831$20240906$20240906$PER$$US-FARMAPROD-202309-2670$DOMPE FARMACEUTICI$$$$$M$Y$$$20240903$$MD$US$
242914671$24291467$1$I$20230801$20230907$20240906$20240906$PER$$US-FARMAPROD-202309-2712$DOMPE FARMACEUTICI$$88$YR$E$F$Y$$$20240903$$CN$US$
242914681$24291468$1$I$$20230906$20240906$20240906$PER$$US-FARMAPROD-202309-2704$DOMPE FARMACEUTICI$$$$E$M$Y$51.26$KG$20240903$$CN$US$
242914691$24291469$1$I$20240307$20240502$20240906$20240906$PER$$US-FARMAPROD-202309-2640$DOMPE FARMACEUTICI$$70$YR$E$F$Y$111.58$KG$20240903$$MD$US$
242914701$24291470$1$I$20230801$20230901$20240906$20240906$PER$$US-FARMAPROD-202309-2669$DOMPE FARMACEUTICI$$65$YR$E$F$Y$$$20240903$$CN$US$
242914711$24291471$1$I$$20231117$20240906$20240906$PER$$US-FARMAPROD-202308-2621$DOMPE FARMACEUTICI$$$$A$F$Y$49.71$KG$20240903$$CN$US$
242914721$24291472$1$I$$20230831$20240906$20240906$PER$$US-FARMAPROD-202309-2662$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240903$$CN$US$
242914731$24291473$1$I$$20230906$20240906$20240906$PER$$US-FARMAPROD-202309-2709$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242914741$24291474$1$I$20230901$20230928$20240906$20240906$PER$$US-FARMAPROD-202309-2657$DOMPE FARMACEUTICI$$52$YR$A$F$Y$$$20240903$$CN$US$
242914751$24291475$1$I$$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2711$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914761$24291476$1$I$$20230918$20240906$20240906$PER$$US-FARMAPROD-202309-2715$DOMPE FARMACEUTICI$$45$YR$A$F$Y$$$20240903$$CN$US$
242914771$24291477$1$I$20230801$20231009$20240906$20240906$PER$$US-FARMAPROD-202309-2696$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240903$$CN$US$
242914781$24291478$1$I$$20230911$20240906$20240906$PER$$US-FARMAPROD-202309-2743$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242914791$24291479$1$I$20230801$20230831$20240906$20240906$PER$$US-FARMAPROD-202309-2661$DOMPE FARMACEUTICI$$69$YR$E$F$Y$53.52$KG$20240903$$CN$US$
242914801$24291480$1$I$$20230907$20240906$20240906$PER$$US-FARMAPROD-202309-2651$DOMPE FARMACEUTICI$$$$A$M$Y$63.37$KG$20240903$$CN$US$
242914811$24291481$1$I$$20230830$20240906$20240906$PER$$US-FARMAPROD-202309-2648$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914821$24291482$1$I$20230908$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2728$DOMPE FARMACEUTICI$$80$YR$E$F$Y$54.43$KG$20240903$$CN$US$
242914831$24291483$1$I$$20230927$20240906$20240906$PER$$US-FARMAPROD-202309-2767$DOMPE FARMACEUTICI$$$$A$F$Y$61.23$KG$20240904$$CN$US$
242914841$24291484$1$I$20230822$20230825$20240906$20240906$PER$$US-FARMAPROD-202308-2615$DOMPE FARMACEUTICI$$73$YR$E$F$Y$99.79$KG$20240903$$CN$US$
242914851$24291485$1$I$20230801$20230905$20240906$20240906$PER$$US-FARMAPROD-202309-2698$DOMPE FARMACEUTICI$$43$YR$A$F$Y$$$20240903$$CN$US$
242914861$24291486$1$I$$20230906$20240906$20240906$PER$$US-FARMAPROD-202309-2700$DOMPE FARMACEUTICI$$$$$F$Y$$$20240903$$MD$US$
242914871$24291487$1$I$$20230922$20240906$20240906$PER$$US-FARMAPROD-202309-2705$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914881$24291488$1$I$$20230914$20240906$20240906$PER$$US-FARMAPROD-202309-2763$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242914891$24291489$1$I$$20230830$20240906$20240906$PER$$US-FARMAPROD-202309-2649$DOMPE FARMACEUTICI$$63$YR$A$F$Y$$$20240903$$CN$US$
242914901$24291490$1$I$20230801$20230926$20240906$20240906$PER$$US-FARMAPROD-202309-2732$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240903$$CN$US$
242914911$24291491$1$I$20230901$20230906$20240906$20240906$PER$$US-FARMAPROD-202309-2702$DOMPE FARMACEUTICI$$63$YR$A$M$Y$$$20240903$$CN$US$
242914921$24291492$1$I$20230907$20231003$20240906$20240906$PER$$US-FARMAPROD-202309-2729$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240903$$CN$US$
242914931$24291493$1$I$$20231012$20240906$20240906$PER$$US-FARMAPROD-202309-2697$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914941$24291494$1$I$$20230906$20240906$20240906$PER$$US-FARMAPROD-202309-2710$DOMPE FARMACEUTICI$$$$$$Y$$$20240903$$MD$US$
242914951$24291495$1$I$20230902$20230906$20240906$20240906$PER$$US-FARMAPROD-202309-2699$DOMPE FARMACEUTICI$$57$YR$A$F$Y$$$20240903$$CN$US$
242914961$24291496$1$I$$20230907$20240906$20240906$PER$$US-FARMAPROD-202309-2716$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242914971$24291497$1$I$$20230919$20240906$20240906$PER$$US-FARMAPROD-202309-2812$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242914981$24291498$1$I$$20230912$20240906$20240906$PER$$US-FARMAPROD-202309-2760$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242914991$24291499$1$I$20230909$20230922$20240906$20240906$PER$$US-FARMAPROD-202309-2761$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$
242915001$24291500$1$I$$20230907$20240906$20240906$PER$$US-FARMAPROD-202309-2726$DOMPE FARMACEUTICI$$$$E$F$Y$82.55$KG$20240903$$CN$US$
242915011$24291501$1$I$20231001$20231002$20240906$20240906$PER$$US-FARMAPROD-202309-2680$DOMPE FARMACEUTICI$$68$YR$E$M$Y$90.72$KG$20240903$$CN$US$
242915021$24291502$1$I$20230825$20230828$20240906$20240906$PER$$US-FARMAPROD-202309-2720$DOMPE FARMACEUTICI$$57$YR$A$F$Y$$$20240903$$CN$US$
242915031$24291503$1$I$20230831$20230905$20240906$20240906$PER$$US-FARMAPROD-202309-2692$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240903$$CN$US$
242915041$24291504$1$I$20230901$20230907$20240906$20240906$PER$$US-FARMAPROD-202309-2717$DOMPE FARMACEUTICI$$25$YR$A$F$Y$44.41$KG$20240903$$CN$US$
242915051$24291505$1$I$$20230913$20240906$20240906$PER$$US-FARMAPROD-202309-2765$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242915061$24291506$1$I$$20231004$20240906$20240906$PER$$US-FARMAPROD-202309-2695$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915071$24291507$1$I$$20230929$20240906$20240906$PER$$US-FARMAPROD-202309-2770$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242915081$24291508$1$I$$20230914$20240906$20240906$PER$$US-FARMAPROD-202309-2780$DOMPE FARMACEUTICI$$$$$F$Y$$$20240903$$MD$US$
242915091$24291509$1$I$$20230911$20240906$20240906$PER$$US-FARMAPROD-202309-2748$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242915101$24291510$1$I$$20230906$20240906$20240906$PER$$US-FARMAPROD-202309-2703$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915111$24291511$1$I$20230910$20231030$20240906$20240906$PER$$US-FARMAPROD-202309-2759$DOMPE FARMACEUTICI$$61$YR$A$F$Y$$$20240904$$MD$US$
242915121$24291512$1$I$20230901$20231002$20240906$20240906$PER$$US-FARMAPROD-202309-2768$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$
242915131$24291513$1$I$$20230907$20240906$20240906$PER$$US-FARMAPROD-202309-2713$DOMPE FARMACEUTICI$$49$YR$A$F$Y$81.65$KG$20240903$$CN$US$
242915141$24291514$1$I$20230908$20230918$20240906$20240906$PER$$US-FARMAPROD-202309-2733$DOMPE FARMACEUTICI$$79$YR$E$F$Y$$$20240904$$CN$US$
242915151$24291515$1$I$20230907$20230915$20240906$20240906$PER$$US-FARMAPROD-202309-2792$DOMPE FARMACEUTICI$$88$YR$E$M$Y$$$20240903$$CN$US$
242915161$24291516$1$I$20230913$20231009$20240906$20240906$PER$$US-FARMAPROD-202309-2766$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240904$$CN$US$
242915171$24291517$1$I$$20230913$20240906$20240906$PER$$US-FARMAPROD-202309-2756$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242915181$24291518$1$I$$20230901$20240906$20240906$PER$$US-FARMAPROD-202309-2675$DOMPE FARMACEUTICI$$$$E$F$Y$60.24$KG$20240903$$CN$US$
242915191$24291519$1$I$$20240126$20240906$20240906$PER$$US-FARMAPROD-202309-2738$DOMPE FARMACEUTICI$$72$YR$E$M$Y$$$20240904$$MD$US$
242915201$24291520$1$I$$20230918$20240906$20240906$PER$$US-FARMAPROD-202309-2795$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242915211$24291521$1$I$20230831$20230902$20240906$20240906$PER$$US-FARMAPROD-202309-2677$DOMPE FARMACEUTICI$$65$YR$E$M$Y$97.52$KG$20240903$$CN$US$
242915221$24291522$1$I$$20230921$20240906$20240906$PER$$US-FARMAPROD-202309-2727$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242915231$24291523$1$I$20230910$20230911$20240906$20240906$PER$$US-FARMAPROD-202309-2745$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240904$$CN$US$
242915241$24291524$1$I$20230909$20230911$20240906$20240906$PER$$US-FARMAPROD-202309-2741$DOMPE FARMACEUTICI$$83$YR$E$M$Y$$$20240904$$CN$US$
242915251$24291525$1$I$$20230913$20240906$20240906$PER$$US-FARMAPROD-202309-2775$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242915261$24291526$1$I$$20230921$20240906$20240906$PER$$US-FARMAPROD-202309-2842$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242915271$24291527$1$I$$20230912$20240906$20240906$PER$$US-FARMAPROD-202309-2753$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242915281$24291528$1$I$$20230911$20240906$20240906$PER$$US-FARMAPROD-202309-2739$DOMPE FARMACEUTICI$$$$A$F$Y$64.41$KG$20240904$$CN$US$
242915291$24291529$1$I$$20240223$20240906$20240906$PER$$US-FARMAPROD-202309-2689$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915301$24291530$1$I$$20230911$20240906$20240906$PER$$US-FARMAPROD-202309-2752$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242915311$24291531$1$I$$20231016$20240906$20240906$PER$$US-FARMAPROD-202309-2774$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242915321$24291532$1$I$20230910$20230913$20240906$20240906$PER$$US-FARMAPROD-202309-2764$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$
242915331$24291533$1$I$20230905$20230914$20240906$20240906$PER$$US-FARMAPROD-202309-2782$DOMPE FARMACEUTICI$$73$YR$E$F$Y$66.68$KG$20240903$$CN$US$
242915341$24291534$1$I$20230901$20230913$20240906$20240906$PER$$US-FARMAPROD-202309-2776$DOMPE FARMACEUTICI$$71$YR$E$M$Y$$$20240903$$CN$US$
242915351$24291535$1$I$$20231004$20240906$20240906$PER$$US-FARMAPROD-202309-2813$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915361$24291536$1$I$20230908$20231003$20240906$20240906$PER$$US-FARMAPROD-202309-2736$DOMPE FARMACEUTICI$$58$YR$A$M$Y$$$20240904$$CN$US$
242915371$24291537$1$I$$20230912$20240906$20240906$PER$$US-FARMAPROD-202309-2755$DOMPE FARMACEUTICI$$$$E$M$Y$72.62$KG$20240904$$CN$US$
242915381$24291538$1$I$20230901$20230919$20240906$20240906$PER$$US-FARMAPROD-202309-2809$DOMPE FARMACEUTICI$$58$YR$A$F$Y$$$20240903$$CN$US$
242915391$24291539$1$I$$20230915$20240906$20240906$PER$$US-FARMAPROD-202309-2784$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240903$$PH$US$
242915401$24291540$1$I$20230916$20230918$20240906$20240906$PER$$US-FARMAPROD-202309-2801$DOMPE FARMACEUTICI$$72$YR$E$M$Y$$$20240903$$CN$US$
242915411$24291541$1$I$20230901$20231031$20240906$20240906$PER$$US-FARMAPROD-202309-2751$DOMPE FARMACEUTICI$$70$YR$E$M$Y$$$20240904$$CN$US$
242915421$24291542$1$I$20230901$20231128$20240906$20240906$PER$$US-FARMAPROD-202309-2769$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240904$$CN$US$
242915431$24291543$1$I$$20230927$20240906$20240906$PER$$US-FARMAPROD-202309-2803$DOMPE FARMACEUTICI$$$$A$F$Y$80.06$KG$20240903$$CN$US$
242915441$24291544$1$I$$20230918$20240906$20240906$PER$$US-FARMAPROD-202309-2786$DOMPE FARMACEUTICI$$$$$$Y$$$20240903$$MD$US$
242915451$24291545$1$I$$20230920$20240906$20240906$PER$$US-FARMAPROD-202309-2821$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915461$24291546$1$I$$20230912$20240906$20240906$PER$$US-FARMAPROD-202309-2754$DOMPE FARMACEUTICI$$$$A$F$Y$78.93$KG$20240904$$CN$US$
242915471$24291547$1$I$20230909$20231023$20240906$20240906$PER$$US-FARMAPROD-202309-2747$DOMPE FARMACEUTICI$$75$YR$E$F$Y$58.97$KG$20240904$$CN$US$
242915481$24291548$1$I$$20230918$20240906$20240906$PER$$US-FARMAPROD-202309-2794$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242915491$24291549$1$I$20230901$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2785$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240903$$CN$US$
242915501$24291550$1$I$$20230918$20240906$20240906$PER$$US-FARMAPROD-202309-2793$DOMPE FARMACEUTICI$$$$$F$Y$$$20240903$$MD$US$
242915511$24291551$1$I$$20230918$20240906$20240906$PER$$US-FARMAPROD-202309-2798$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242915521$24291552$1$I$$20230920$20240906$20240906$PER$$US-FARMAPROD-202309-2818$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242915531$24291553$1$I$20230913$20230928$20240906$20240906$PER$$US-FARMAPROD-202309-2783$DOMPE FARMACEUTICI$$87$YR$E$F$Y$$$20240903$$CN$US$
242915541$24291554$1$I$$20230919$20240906$20240906$PER$$US-FARMAPROD-202309-2810$DOMPE FARMACEUTICI$$$$A$F$Y$72.57$KG$20240903$$CN$US$
242915551$24291555$1$I$$20230929$20240906$20240906$PER$$US-FARMAPROD-202309-2855$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915561$24291556$1$I$$20230907$20240906$20240906$PER$$US-FARMAPROD-202309-2719$DOMPE FARMACEUTICI$$$$E$M$Y$108.86$KG$20240903$$CN$US$
242915571$24291557$1$I$20230901$20231016$20240906$20240906$PER$$US-FARMAPROD-202309-2859$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240903$$CN$US$
242915581$24291558$1$I$$20231011$20240906$20240906$PER$$US-FARMAPROD-202309-2744$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242915591$24291559$1$I$$20230913$20240906$20240906$PER$$US-FARMAPROD-202309-2778$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242915601$24291560$1$I$$20240827$20240906$20240906$PER$$US-ABBVIE-5900092$ABBVIE$$$$$$Y$$$20240906$$HP$US$US
242915611$24291561$1$I$$20230913$20240906$20240906$PER$$US-FARMAPROD-202309-2777$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242915621$24291562$1$I$20230906$20231005$20240906$20240906$PER$$US-FARMAPROD-202309-2791$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240903$$CN$US$
242915631$24291563$1$I$$20230918$20240906$20240906$PER$$US-FARMAPROD-202309-2802$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915641$24291564$1$I$$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2781$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242915651$24291565$1$I$20231017$20231017$20240906$20240906$PER$$US-FARMAPROD-202309-2779$DOMPE FARMACEUTICI$$85$YR$E$F$Y$$$20240903$$CN$US$
242915661$24291566$1$I$$20230920$20240906$20240906$PER$$US-FARMAPROD-202309-2827$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915671$24291567$1$I$$20230919$20240906$20240906$PER$$US-FARMAPROD-202309-2816$DOMPE FARMACEUTICI$$$$$F$Y$$$20240903$$MD$US$
242915681$24291568$1$I$20230901$20231004$20240906$20240906$PER$$US-FARMAPROD-202309-2828$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240903$$CN$US$
242915691$24291569$1$I$20230801$20230922$20240906$20240906$PER$$US-FARMAPROD-202309-2854$DOMPE FARMACEUTICI$$60$YR$A$M$Y$$$20240903$$CN$US$
242915701$24291570$1$I$20230901$20230919$20240906$20240906$PER$$US-FARMAPROD-202309-2817$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240903$$CN$US$
242915711$24291571$1$I$20230916$20231006$20240906$20240906$PER$$US-FARMAPROD-202309-2811$DOMPE FARMACEUTICI$$49$YR$A$F$Y$$$20240903$$CN$US$
242915721$24291572$1$I$20230901$20231009$20240906$20240906$PER$$US-FARMAPROD-202309-2834$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240903$$CN$US$
242915731$24291573$1$I$$20231004$20240906$20240906$PER$$US-FARMAPROD-202309-2804$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915741$24291574$1$I$$20230918$20240906$20240906$PER$$US-FARMAPROD-202309-2806$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915751$24291575$1$I$$20230921$20240906$20240906$PER$$US-FARMAPROD-202309-2838$DOMPE FARMACEUTICI$$$$E$F$Y$59.42$KG$20240903$$CN$US$
242915761$24291576$1$I$$20231019$20240906$20240906$PER$$US-FARMAPROD-202309-2830$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242915771$24291577$1$I$$20230922$20240906$20240906$PER$$US-FARMAPROD-202309-2853$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915781$24291578$1$I$$20230919$20240906$20240906$PER$$US-FARMAPROD-202309-2807$DOMPE FARMACEUTICI$$$$E$F$Y$47.72$KG$20240903$$CN$US$
242915791$24291579$1$I$$20230920$20240906$20240906$PER$$US-FARMAPROD-202309-2824$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242915801$24291580$1$I$$20230919$20240906$20240906$PER$$US-FARMAPROD-202309-2808$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915811$24291581$1$I$20230901$20230920$20240906$20240906$PER$$US-FARMAPROD-202309-2826$DOMPE FARMACEUTICI$$68$YR$E$F$Y$110.68$KG$20240903$$CN$US$
242915821$24291582$1$I$$20230926$20240906$20240906$PER$$US-FARMAPROD-202309-2883$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915831$24291583$1$I$$20230921$20240906$20240906$PER$$US-FARMAPROD-202309-2845$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915841$24291584$1$I$20230901$20230921$20240906$20240906$PER$$US-FARMAPROD-202309-2835$DOMPE FARMACEUTICI$$67$YR$E$F$Y$76.2$KG$20240903$$CN$US$
242915851$24291585$1$I$20230925$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2872$DOMPE FARMACEUTICI$$42$YR$A$F$Y$$$20240903$$CN$US$
242915861$24291586$1$I$20230916$20230921$20240906$20240906$PER$$US-FARMAPROD-202309-2836$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240903$$CN$US$
242915871$24291587$1$I$20230901$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2870$DOMPE FARMACEUTICI$$55$YR$A$F$Y$$$20240903$$CN$US$
242915881$24291588$1$I$20230922$20230922$20240906$20240906$PER$$US-FARMAPROD-202309-2852$DOMPE FARMACEUTICI$$45$YR$A$F$Y$$$20240903$$CN$US$
242915891$24291589$1$I$20230901$20230921$20240906$20240906$PER$$US-FARMAPROD-202309-2832$DOMPE FARMACEUTICI$$75$YR$E$M$Y$$$20240903$$CN$US$
242915901$24291590$1$I$$20230921$20240906$20240906$PER$$US-FARMAPROD-202309-2833$DOMPE FARMACEUTICI$$$$A$F$Y$54.43$KG$20240903$$CN$US$
242915911$24291591$1$I$20230901$20230922$20240906$20240906$PER$$US-FARMAPROD-202309-2856$DOMPE FARMACEUTICI$$$$$F$Y$$$20240903$$MD$US$
242915921$24291592$1$I$$20231012$20240906$20240906$PER$$US-FARMAPROD-202309-2829$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242915931$24291593$1$I$20230913$20231030$20240906$20240906$PER$$US-FARMAPROD-202309-2815$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240903$$CN$US$
242915941$24291594$1$I$20230901$20231116$20240906$20240906$PER$$US-FARMAPROD-202309-2820$DOMPE FARMACEUTICI$$78$YR$E$M$Y$$$20240903$$CN$US$
242915951$24291595$1$I$20230901$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2875$DOMPE FARMACEUTICI$$27$YR$A$F$Y$$$20240903$$CN$US$
242915961$24291596$1$I$20230915$20231107$20240906$20240906$PER$$US-FARMAPROD-202309-2787$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240903$$CN$US$
242915971$24291597$1$I$20230901$20230920$20240906$20240906$PER$$US-FARMAPROD-202309-2819$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240903$$CN$US$
242915981$24291598$1$I$20230913$20230921$20240906$20240906$PER$$US-FARMAPROD-202309-2839$DOMPE FARMACEUTICI$$63$YR$A$F$Y$$$20240903$$CN$US$
242915991$24291599$1$I$$20230922$20240906$20240906$PER$$US-FARMAPROD-202309-2860$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242916001$24291600$1$I$20230926$20230927$20240906$20240906$PER$$US-FARMAPROD-202309-2906$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240903$$CN$US$
242916011$24291601$1$I$$20230921$20240906$20240906$PER$$US-FARMAPROD-202309-2837$DOMPE FARMACEUTICI$$$$A$M$Y$94.39$KG$20240903$$CN$US$
242916021$24291602$1$I$$20231002$20240906$20240906$PER$$US-FARMAPROD-202309-2840$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242916031$24291603$1$I$$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2869$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242916041$24291604$1$I$20230911$20231004$20240906$20240906$PER$$US-FARMAPROD-202309-2831$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240903$$CN$US$
242916051$24291605$1$I$$20230926$20240906$20240906$PER$$US-FARMAPROD-202309-2889$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242916061$24291606$1$I$20230927$20230927$20240906$20240906$PER$$US-FARMAPROD-202309-2908$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240903$$CN$US$
242916071$24291607$1$I$20230901$20231016$20240906$20240906$PER$$US-FARMAPROD-202309-2882$DOMPE FARMACEUTICI$$66$YR$E$F$Y$$$20240903$$CN$US$
242916081$24291608$1$I$20231019$20231021$20240906$20240906$PER$$US-FARMAPROD-202309-2863$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240903$$CN$US$
242916091$24291609$1$I$20230901$20230926$20240906$20240906$PER$$US-FARMAPROD-202309-2892$DOMPE FARMACEUTICI$$83$YR$E$M$Y$$$20240903$$CN$US$
242916101$24291610$1$I$20230920$20230922$20240906$20240906$PER$$US-FARMAPROD-202309-2862$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240903$$CN$US$
242916112$24291611$2$F$20240819$20240912$20240906$20240919$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005003$SAREPTA THERAPEUTICS$$$$$$Y$$$20240919$$CN$PR$PR
242916121$24291612$1$I$20230901$20231016$20240906$20240906$PER$$US-FARMAPROD-202309-2901$DOMPE FARMACEUTICI$$47$YR$A$M$Y$$$20240903$$CN$US$
242916131$24291613$1$I$20230901$20231016$20240906$20240906$PER$$US-FARMAPROD-202310-2920$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240903$$CN$US$
242916141$24291614$1$I$20230901$20230926$20240906$20240906$PER$$US-FARMAPROD-202309-2886$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240903$$CN$US$
242916151$24291615$1$I$20230925$20231103$20240906$20240906$PER$$US-FARMAPROD-202309-2902$DOMPE FARMACEUTICI$$40$YR$A$M$Y$$$20240903$$CN$US$
242916161$24291616$1$I$$20230926$20240906$20240906$PER$$US-FARMAPROD-202309-2891$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242916171$24291617$1$I$$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2881$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242916181$24291618$1$I$20230927$20230928$20240906$20240906$PER$$US-FARMAPROD-202310-2911$DOMPE FARMACEUTICI$$77$YR$E$M$Y$$$20240903$$CN$US$
242916191$24291619$1$I$20230924$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2867$DOMPE FARMACEUTICI$$68$YR$E$M$Y$$$20240903$$CN$US$
242916211$24291621$1$I$$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2877$DOMPE FARMACEUTICI$$$$E$F$Y$97.98$KG$20240903$$CN$US$
242916221$24291622$1$I$$20230929$20240906$20240906$PER$$US-FARMAPROD-202310-2921$DOMPE FARMACEUTICI$$$$$M$Y$$$20240903$$CN$US$
242916231$24291623$1$I$$20230921$20240906$20240906$PER$$US-FARMAPROD-202309-2844$DOMPE FARMACEUTICI$$$$E$M$Y$66.22$KG$20240903$$CN$US$
242916241$24291624$1$I$20230901$20230926$20240906$20240906$PER$$US-FARMAPROD-202309-2896$DOMPE FARMACEUTICI$$70$YR$E$M$Y$$$20240903$$CN$US$
242916251$24291625$1$I$20230901$20230926$20240906$20240906$PER$$US-FARMAPROD-202309-2894$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240903$$CN$US$
242916261$24291626$1$I$20230101$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2865$DOMPE FARMACEUTICI$$$$$F$Y$$$20240903$$MD$US$
242916271$24291627$1$I$20231001$20240429$20240906$20240906$EXP$$US-FARMAPROD-202310-2940$DOMPE FARMACEUTICI$$77$YR$E$M$Y$$$20240903$$CN$US$
242916281$24291628$1$I$20230901$20231002$20240906$20240906$PER$$US-FARMAPROD-202310-2939$DOMPE FARMACEUTICI$$10$YR$C$F$Y$$$20240903$$CN$US$
242916291$24291629$1$I$$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2946$DOMPE FARMACEUTICI$$$$E$F$Y$60.92$KG$20240903$$CN$US$
242916301$24291630$1$I$20230901$20231025$20240906$20240906$PER$$US-FARMAPROD-202309-2887$DOMPE FARMACEUTICI$$70$YR$E$M$Y$$$20240903$$CN$US$
242916321$24291632$1$I$$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2871$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242916331$24291633$1$I$$20230922$20240906$20240906$PER$$US-FARMAPROD-202309-2864$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242916341$24291634$1$I$20230901$20230926$20240906$20240906$PER$$US-FARMAPROD-202309-2885$DOMPE FARMACEUTICI$$79$YR$E$F$Y$$$20240903$$CN$US$
242916351$24291635$1$I$20230901$20231016$20240906$20240906$PER$$US-FARMAPROD-202310-2927$DOMPE FARMACEUTICI$$64$YR$A$F$Y$64.86$KG$20240903$$CN$AE$
242916361$24291636$1$I$$20231016$20240906$20240906$PER$$US-FARMAPROD-202309-2876$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$HP$US$
242916371$24291637$1$I$$20230929$20240906$20240906$PER$$US-FARMAPROD-202310-2923$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242916381$24291638$1$I$20230901$20230925$20240906$20240906$PER$$US-FARMAPROD-202309-2873$DOMPE FARMACEUTICI$$40$YR$A$F$Y$$$20240903$$CN$US$
242916391$24291639$1$I$$20231103$20240906$20240906$PER$$US-FARMAPROD-202310-2942$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242916401$24291640$1$I$$20230927$20240906$20240906$PER$$US-FARMAPROD-202309-2897$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242916411$24291641$1$I$20230901$20230928$20240906$20240906$PER$$US-FARMAPROD-202310-2912$DOMPE FARMACEUTICI$$66$YR$E$M$Y$86.36$KG$20240903$$CN$US$
242916421$24291642$1$I$$20230929$20240906$20240906$PER$$US-FARMAPROD-202310-2925$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242916431$24291643$1$I$20230921$20231013$20240906$20240906$PER$$US-FARMAPROD-202309-2895$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240903$$CN$US$
242916441$24291644$1$I$$20230930$20240906$20240906$PER$$US-FARMAPROD-202310-2933$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242916451$24291645$1$I$$20230929$20240906$20240906$PER$$US-FARMAPROD-202310-2926$DOMPE FARMACEUTICI$$$$E$F$Y$59.1$KG$20240903$$CN$US$
242916461$24291646$1$I$$20230929$20240906$20240906$PER$$US-FARMAPROD-202310-2930$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242916481$24291648$1$I$$20230922$20240906$20240906$PER$$US-FARMAPROD-202309-2857$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242916493$24291649$3$F$$20240913$20240906$20240924$PER$$US-SA-2024SA253466$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240924$$CN$US$US
242916501$24291650$1$I$$20240901$20240906$20240906$EXP$$IL-SA-2024SA256658$SANOFI AVENTIS$$$$$M$Y$$$20240906$$MD$IL$IL
242916511$24291651$1$I$20230901$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-2914$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240903$$CN$US$
242916521$24291652$1$I$20230928$20230928$20240906$20240906$PER$$US-FARMAPROD-202310-2909$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240903$$CN$US$
242916531$24291653$1$I$20230923$20230927$20240906$20240906$PER$$US-FARMAPROD-202309-2905$DOMPE FARMACEUTICI$$76$YR$E$M$Y$128.82$KG$20240903$$CN$US$
242916541$24291654$1$I$$20240827$20240906$20240906$EXP$$US-JNJFOC-20240870072$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$CN$US$US
242916551$24291655$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA258607$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240906$$HP$US$US
242916561$24291656$1$I$20240101$20240820$20240906$20240906$PER$$US-SA-2024SA257920$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240906$$MD$US$US
242916571$24291657$1$I$$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140235$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240906$$HP$US$US
242916581$24291658$1$I$20240819$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142099$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240906$$CN$US$US
242916591$24291659$1$I$20240625$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141974$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240906$$MD$US$US
242916601$24291660$1$I$$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2945$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242916611$24291661$1$I$$20240827$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137289$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240906$$HP$US$US
242916621$24291662$1$I$$20230928$20240906$20240906$PER$$US-FARMAPROD-202310-2910$DOMPE FARMACEUTICI$$$$E$F$Y$43.54$KG$20240903$$CN$US$
242916631$24291663$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141209$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240906$$CN$US$US
242916641$24291664$1$I$20230927$20230929$20240906$20240906$PER$$US-FARMAPROD-202310-2932$DOMPE FARMACEUTICI$$59$YR$A$M$Y$$$20240903$$CN$US$
242916651$24291665$1$I$$20240815$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN008580$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242916661$24291666$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61213$$FDA-CTU$$56$YR$$F$N$158$LBS$20240905$N$$US$
242916671$24291667$1$I$$20240825$20240906$20240906$PER$$US-SA-2024SA256427$SANOFI AVENTIS$$$$T$F$Y$$$20240906$$MD$US$US
242916681$24291668$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA258089$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240906$$HP$US$US
242916691$24291669$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61222$$FDA-CTU$$18$YR$$F$N$$$20240905$N$$US$
242916701$24291670$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61173$$FDA-CTU$$71$YR$$F$N$$$20240905$N$$US$
242916711$24291671$1$I$20240701$20240824$20240906$20240906$PER$$US-SA-2024SA258355$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240906$$MD$US$US
242916721$24291672$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61412$$FDA-CTU$$52$YR$$M$N$$$20240906$N$$US$
242916731$24291673$1$I$$20240905$20240905$20240905$DIR$717283$$FDA-CTU$$88$YR$$F$N$$$20240905$N$PH$US$
242916741$24291674$1$I$20230929$20240228$20240906$20240906$PER$$US-FARMAPROD-202310-2929$DOMPE FARMACEUTICI$$66$YR$E$F$Y$$$20240903$$CN$US$
242916751$24291675$1$I$$20231128$20240906$20240906$PER$$US-FARMAPROD-202310-2941$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242916761$24291676$1$I$20230901$20240219$20240906$20240906$PER$$US-FARMAPROD-202309-2898$DOMPE FARMACEUTICI$$92$YR$E$F$Y$59.78$KG$20240903$$CN$US$
242916771$24291677$1$I$$20231002$20240906$20240906$PER$$US-FARMAPROD-202310-2938$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242916781$24291678$1$I$$20231010$20240906$20240906$PER$$US-FARMAPROD-202309-2899$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242916791$24291679$1$I$20230928$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-2924$DOMPE FARMACEUTICI$$77$YR$E$M$Y$$$20240903$$CN$US$
242916801$24291680$1$I$20240830$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61403$$FDA-CTU$$76$YR$$F$N$$$20240906$N$$US$
242916811$24291681$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61236$$FDA-CTU$$35$YR$$F$N$145$LBS$20240905$N$$US$
242916821$24291682$1$I$20240426$20240905$20240905$20240905$DIR$717335$$FDA-CTU$$51$YR$$F$N$99$KG$20240905$N$CN$US$
242916831$24291683$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61284$$FDA-CTU$$47$YR$$F$N$240$LBS$20240905$N$$US$
242916841$24291684$1$I$20240903$20240905$20240905$20240905$DIR$717344$$FDA-CTU$$51$YR$$M$N$102.6$KG$20240905$N$CN$US$
242916851$24291685$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61286$$FDA-CTU$$71$YR$$F$N$$$20240905$N$$US$
242916861$24291686$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61212$$FDA-CTU$$56$YR$$F$N$$$20240905$N$$US$
242916871$24291687$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61395$$FDA-CTU$$$$$F$N$$$20240905$N$HP$US$
242916881$24291688$1$I$20240819$20240905$20240905$20240905$DIR$717316$$FDA-CTU$$53$YR$$F$N$81.8$KG$20240905$N$PH$US$
242916921$24291692$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61411$$FDA-CTU$$$$$F$N$$$20240905$N$HP$US$
242916941$24291694$1$I$20240726$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61407$$FDA-CTU$$77$YR$$M$N$$$20240905$N$HP$US$
242916951$24291695$1$I$20240809$20240830$20240906$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027548$UNITED THERAPEUTICS$$66$YR$$F$Y$58.503$KG$20240906$$$US$US
242916961$24291696$1$I$$20240830$20240906$20240906$EXP$$US-MYLANLABS-2024M1081398$MYLAN$Gondal M, Shirali AC. Isolated Hyperphosphatemia with Suppressed Urinary Phosphate Excretion in a Patient with Undifferentiated Leukemia. J-Am-Soc-Nephrol 2016; 27 (Suppl.) (11): 1025A abstr. PUB529.$27$YR$$F$Y$$$20240906$$HP$US$US
242916981$24291698$1$I$$20240828$20240906$20240906$30DAY$$US-GSK-US2024AMR108669$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242916991$24291699$1$I$$20240904$20240906$20240906$PER$$NVSC2024US178295$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
242917001$24291700$1$I$$20240830$20240906$20240906$EXP$$IN-AstraZeneca-2024A198739$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$IN$
242917012$24291701$2$F$20240221$20240905$20240906$20240911$EXP$$DE-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004893$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240911$$MD$DE$DE
242917022$24291702$2$F$20240408$20240911$20240906$20240913$EXP$$IL-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004948$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240913$$MD$IL$IL
242917031$24291703$1$I$20240824$20240828$20240906$20240906$EXP$$GB-TEVA-VS-3238486$TEVA$$56$YR$$F$Y$81$KG$20240906$$MD$GB$GB
242917041$24291704$1$I$20240803$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61409$$FDA-CTU$$46$YR$$M$N$183$KG$20240905$N$PH$US$
242917061$24291706$1$I$20240905$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61215$$FDA-CTU$$65$YR$$M$N$$$20240905$N$$US$
242917071$24291707$1$I$$20240904$20240906$20240906$EXP$$US-AstraZeneca-2024A201784$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242917082$24291708$2$F$$20240905$20240906$20240910$PER$$US-JNJFOC-20240904308$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
242917091$24291709$1$I$20240831$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61217$$FDA-CTU$$48$YR$$F$N$211$LBS$20240905$N$MD$US$
242917101$24291710$1$I$20240905$20240905$20240905$20240905$DIR$717299$$FDA-CTU$$32$YR$$F$N$$$20240905$N$PH$US$
242917111$24291711$1$I$20240904$20240904$20240906$20240906$EXP$$JP-PFIZER INC-PV202400115854$PFIZER$$$$$$Y$$$20240906$$PH$JP$JP
242917122$24291712$2$F$$20240924$20240906$20240927$EXP$$IN-PFIZER INC-PV202400114727$PFIZER$$62$YR$$F$Y$$$20240927$$CN$IN$IN
242917131$24291713$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61237$$FDA-CTU$$77$YR$$F$N$189$LBS$20240905$N$$US$
242917141$24291714$1$I$20240829$20240903$20240905$20240905$DIR$FDA-CDER-CTU-2024-61162$$FDA-CTU$$78$YR$$M$N$$$20240903$N$HP$US$
242917151$24291715$1$I$$20240906$20240906$20240906$EXP$$RU-PFIZER INC-202400251349$PFIZER$$$$E$F$Y$$$20240906$$MD$RU$RU
242917161$24291716$1$I$$20240905$20240906$20240906$EXP$$TW-PFIZER INC-PV202400116694$PFIZER$$$$E$F$Y$$$20240906$$HP$TW$TW
242917171$24291717$1$I$20240814$20240905$20240906$20240906$EXP$$CN-PFIZER INC-PV202400116732$PFIZER$$8$YR$$M$Y$27$KG$20240906$$HP$CN$CN
242917181$24291718$1$I$20240828$20240829$20240906$20240906$30DAY$$US-PFIZER INC-202400247242$PFIZER$$$$$F$Y$$$20240906$$PH$US$US
242917192$24291719$2$F$20240828$20240910$20240906$20240911$EXP$$CN-PFIZER INC-PV202400112650$PFIZER$$17$YR$$M$Y$50$KG$20240911$$HP$CN$CN
242917201$24291720$1$I$20240727$20240904$20240906$20240906$EXP$$CN-PFIZER INC-PV202400116202$PFIZER$$87$YR$$M$Y$$$20240906$$HP$CN$CN
242917221$24291722$1$I$20240726$20240830$20240906$20240906$EXP$$CN-PFIZER INC-PV202400114062$PFIZER$$69$YR$$M$Y$$$20240906$$HP$CN$CN
242917231$24291723$1$I$$20240904$20240906$20240906$EXP$$EG-PFIZER INC-PV202400116005$PFIZER$$70$YR$$M$Y$$$20240906$$HP$EG$EG
242917251$24291725$1$I$20240801$20240904$20240906$20240906$EXP$$TW-PFIZER INC-PV202400116698$PFIZER$$61$YR$$M$Y$$$20240906$$HP$TW$TW
242917261$24291726$1$I$$20240904$20240906$20240906$EXP$$US-PFIZER INC-PV202400116454$PFIZER$$42$YR$$F$Y$$$20240906$$HP$US$US
242917271$24291727$1$I$$20240906$20240906$20240906$EXP$$JP-PFIZER INC-202400251324$PFIZER$$$$$$Y$$$20240906$$PH$JP$JP
242917281$24291728$1$I$$20240905$20240906$20240906$EXP$$MA-PFIZER INC-PV202400117066$PFIZER$$$$$F$Y$$$20240906$$CN$MA$MA
242917301$24291730$1$I$$20240905$20240906$20240906$EXP$$JP-PFIZER INC-PV202400107305$PFIZER$$83$YR$$M$Y$$$20240906$$MD$JP$JP
242917311$24291731$1$I$$20240904$20240906$20240906$EXP$$US-PFIZER INC-202400251224$PFIZER$$31$YR$$M$Y$$$20240906$$HP$US$US
242917331$24291733$1$I$20240820$20240904$20240906$20240906$EXP$$CN-PFIZER INC-PV202400116141$PFIZER$$44$YR$$F$Y$55$KG$20240906$$HP$CN$CN
242917341$24291734$1$I$20240901$20240901$20240906$20240906$30DAY$$GB-PFIZER INC-PV202400114713$PFIZER$$7$YR$$M$Y$$$20240906$$CN$GB$GB
242917351$24291735$1$I$20240829$20240904$20240906$20240906$EXP$$CN-PFIZER INC-PV202400116155$PFIZER$$65$YR$$M$Y$67.5$KG$20240906$$HP$CN$CN
242917362$24291736$2$F$20240829$20240911$20240906$20240912$EXP$$US-PFIZER INC-202400249445$PFIZER$$81$YR$$M$Y$$$20240912$$HP$US$US
242917372$24291737$2$F$$20240906$20240906$20240909$30DAY$$US-PFIZER INC-202400246862$PFIZER$$47$YR$$F$Y$$$20240909$$CN$US$US
242917381$24291738$1$I$$20240828$20240906$20240906$EXP$$CA-TAKEDA-2024TUS076720$TAKEDA$$$$$F$Y$$$20240906$$CN$CA$CA
242917412$24291741$2$F$$20240830$20240906$20240916$PER$$US-SMPA-2024SPA001421$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
242917421$24291742$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001333$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917431$24291743$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001422$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917441$24291744$1$I$$20240807$20240906$20240906$PER$$US-SMPA-2024SPA001253$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917451$24291745$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001325$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917462$24291746$2$F$$20240808$20240906$20240906$PER$$JP-SMPA-2024SPA002287$SUNOVION$$$$$$Y$$$20240906$$PH$JP$JP
242917471$24291747$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001282$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917491$24291749$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001239$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917511$24291751$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001347$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917522$24291752$2$F$$20240812$20240906$20240911$PER$$US-SMPA-2024MYSCI0601180$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
242917532$24291753$2$F$$20240812$20240906$20240919$PER$$US-SMPA-2024SPA001412$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
242917551$24291755$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001321$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917561$24291756$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001345$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917571$24291757$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001267$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917581$24291758$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001298$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917591$24291759$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001433$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917611$24291761$1$I$20240101$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001423$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917622$24291762$2$F$$20240912$20240906$20240927$PER$$US-SMPA-2024SPA001393$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242917631$24291763$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001406$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917652$24291765$2$F$$20240906$20240906$20240927$PER$$US-SMPA-2024SPA001278$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242917671$24291767$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001258$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917681$24291768$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001999$SUNOVION$$$$$$Y$$$20240906$$MD$US$US
242917691$24291769$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001273$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917702$24291770$2$F$$20240911$20240906$20240930$PER$$US-SMPA-2024SPA001294$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242917711$24291771$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA000273$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917721$24291772$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001329$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917742$24291774$2$F$$20240911$20240906$20240930$PER$$US-SMPA-2024SPA001401$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242917751$24291775$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001280$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917761$24291776$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001348$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917771$24291777$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001419$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917781$24291778$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001384$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917791$24291779$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001327$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917801$24291780$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001365$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917811$24291781$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001305$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917821$24291782$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001352$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242917831$24291783$1$I$$20240903$20240906$20240906$EXP$$BR-JNJFOC-20240914247$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$CN$BR$BR
242917841$24291784$1$I$20240820$20240828$20240906$20240906$EXP$CN-NMPACDR-4510011028128202400710$CN-BAXTER-2024BAX023998$BAXTER$$51$YR$$F$Y$37.8$KG$20240906$$MD$CN$CN
242917851$24291785$1$I$$20240816$20240906$20240906$PER$$US-LEX-000441$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242917861$24291786$1$I$20230101$20240905$20240906$20240906$EXP$$DE-SANDOZ INC.-SDZ2024DE078136$SANDOZ$$$$E$F$Y$$$20240906$$CN$DE$DE
242917871$24291787$1$I$$20240828$20240906$20240906$EXP$$SE-MYLANLABS-2024M1080381$MYLAN$Nikkarinen A, Glimelius I. Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma - A case report. EJHaem 2024; 5 (4): 820-824.$79$YR$$M$Y$$$20240906$$HP$SE$SE
242917882$24291788$2$F$$20240909$20240906$20240910$EXP$$GB-PFIZER INC-044-9033-M0100006$PFIZER$$57$YR$$M$Y$$$20240910$$HP$GB$GB
242917902$24291790$2$F$$20240913$20240906$20240913$30DAY$$US-PFIZER INC-202400251072$PFIZER$$$$$F$Y$$$20240913$$CN$US$US
242917911$24291791$1$I$20210920$20240904$20240906$20240906$EXP$$AR-PFIZER INC-202101511569$PFIZER$$64$YR$$F$Y$$$20240906$$CN$AR$AR
242917921$24291792$1$I$$20240902$20240906$20240906$30DAY$$GB-PFIZER INC-PV202400115357$PFIZER$$$$$$Y$$$20240906$$HP$GB$GB
242917931$24291793$1$I$20231219$20240826$20240906$20240906$EXP$ES-AEMPS-1475186$ES-ELI_LILLY_AND_COMPANY-ES202408016551$ELI LILLY AND CO$$36$YR$A$F$Y$55$KG$20240906$$CN$ES$ES
242917941$24291794$1$I$20240212$20240827$20240906$20240906$EXP$GB-MHRA-31621193$GB-ELI_LILLY_AND_COMPANY-GB202408017717$ELI LILLY AND CO$$$$$F$Y$92$KG$20240906$$CN$GB$GB
242917951$24291795$1$I$20240825$20240826$20240906$20240906$EXP$$NL-ELI_LILLY_AND_COMPANY-NL202408017347$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240906$$MD$NL$NL
242917972$24291797$2$F$20240830$20240913$20240906$20240919$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409003380$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240919$$CN$JP$JP
242917981$24291798$1$I$20240513$20240827$20240906$20240906$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406008223$ELI LILLY AND CO$$63$YR$A$F$Y$51$KG$20240906$$CN$JP$JP
242918001$24291800$1$I$20240717$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003054$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240906$$CN$US$US
242918011$24291801$1$I$20240904$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003659$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240906$$CN$US$US
242918021$24291802$1$I$20240101$20240827$20240906$20240906$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408016993$ELI LILLY AND CO$$$$$M$Y$$$20240906$$CN$DE$DE
242918031$24291803$1$I$20210801$20240826$20240906$20240906$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408016592$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240906$$CN$BR$BR
242918043$24291804$3$F$$20240904$20240906$20240927$30DAY$$US-JNJFOC-20240909153$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$US$US
242918051$24291805$1$I$20240815$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61211$$FDA-CTU$$58$YR$$F$N$$$20240904$N$HP$US$
242918061$24291806$1$I$$20240827$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137857$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240906$$CN$US$US
242918071$24291807$1$I$$20240830$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140334$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240906$$CN$US$US
242918081$24291808$1$I$20240902$20240905$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141978$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240906$$CN$US$US
242918101$24291810$1$I$20240815$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61169$$FDA-CTU$$60$YR$$M$N$$$20240905$N$PH$US$
242918111$24291811$1$I$$20240904$20240906$20240906$PER$$US-ABBVIE-5908314$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242918121$24291812$1$I$$20240904$20240906$20240906$PER$$US-ALXN-202409USA000254US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242918131$24291813$1$I$20240819$20240829$20240906$20240906$EXP$IT-MINISAL02-999712$IT-TEVA-VS-3238595$TEVA$$60$YR$$F$Y$$$20240906$$MD$IT$IT
242918141$24291814$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000073890$ROCHE$$53$YR$A$M$Y$$$20240906$$CN$US$US
242918151$24291815$1$I$$20240902$20240906$20240906$EXP$$ES-MYLANLABS-2024M1081085$MYLAN$J.F. Orts Paco.. NIKOLSKY POSITIVE: THE TIP OF THE ICEBERG. Actas Dermosifiliogr. 2024;115 (s1):S58-S63$87$YR$$F$Y$$$20240906$$MD$ES$ES
242918161$24291816$1$I$$20240906$20240906$20240906$DIR$717393$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242918171$24291817$1$I$20240726$20240828$20240906$20240906$EXP$$DE-ROCHE-10000069422$ROCHE$$39$YR$A$F$Y$$$20240906$$MD$DE$DE
242918182$24291818$2$F$20240903$20240906$20240906$20240910$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014364$JAZZ$$48$YR$$M$Y$$$20240909$$CN$US$US
242918191$24291819$1$I$20240901$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177349$AMGEN$$58$YR$A$F$Y$$$20240906$$CN$US$US
242918211$24291821$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010120$APOTEX$$66$YR$$F$Y$$$20240906$$CN$CA$CA
242918241$24291824$1$I$$20240826$20240906$20240906$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000344$Unknown Manufacturer$$$$$$Y$$$20240906$$CN$US$US
242918251$24291825$1$I$20240903$20240904$20240906$20240906$EXP$$US-BAYER-2024A126955$BAYER$$88$YR$E$F$Y$$$20240906$$CN$US$US
242918261$24291826$1$I$$20240829$20240906$20240906$EXP$$NVSC2024GB177952$NOVARTIS$Glen C, Adam S, McDowell K, Waterston A, Tan YY, Petrie MC et al. Cardiotoxicity of BRAF/MEK Inhibitors A Longitudinal Study Incorporating Contemporary Definitions and Risk Scores. JACC: CARDIOONCOLOGY. 2023;5:628-37$$$$$Y$$$20240906$$HP$GB$GB
242918272$24291827$2$F$$20240910$20240906$20240918$EXP$$NVSC2024DE177823$NOVARTIS$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD-OPEN. 2024;10(3):1-10$2$YR$$M$Y$$$20240918$$HP$DE$DE
242918281$24291828$1$I$$20240902$20240906$20240906$EXP$$NVSC2024BE178957$NOVARTIS$$$$$M$Y$$$20240906$$MD$BE$BE
242918301$24291830$1$I$20240101$20240904$20240906$20240906$EXP$$US-ABBVIE-5908801$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242918311$24291831$1$I$$20240905$20240906$20240906$PER$$US-ROCHE-10000074894$ROCHE$$56$YR$A$F$Y$$$20240906$$CN$US$US
242918341$24291834$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61226$$FDA-CTU$$51$YR$$F$N$184$LBS$20240905$N$$US$
242918371$24291837$1$I$20240816$20240830$20240906$20240906$EXP$$CN-PFIZER INC-202400250484$PFIZER$$38$YR$$F$Y$48$KG$20240906$$HP$CN$CN
242918381$24291838$1$I$$20240903$20240906$20240906$EXP$$CA-PFIZER INC-202400250041$PFIZER$$$$$F$Y$$$20240906$$MD$CA$CA
242918391$24291839$1$I$$20240903$20240906$20240906$EXP$$US-PFIZER INC-202400249725$PFIZER$$68$YR$$F$Y$$$20240906$$PH$US$US
242918411$24291841$1$I$$20240903$20240906$20240906$EXP$$CA-PFIZER INC-202400250079$PFIZER$$$$$F$Y$$$20240906$$CN$CA$CA
242918421$24291842$1$I$$20240904$20240906$20240906$EXP$$US-PFIZER INC-202400250138$PFIZER$$67$YR$$M$Y$63.492$KG$20240906$$CN$US$US
242918431$24291843$1$I$$20240903$20240906$20240906$EXP$$US-PFIZER INC-202400250035$PFIZER$$$$$M$Y$$$20240906$$MD$US$US
242918441$24291844$1$I$$20240904$20240906$20240906$EXP$$CA-PFIZER INC-202400250713$PFIZER$$$$$M$Y$$$20240906$$CN$CA$CA
242918451$24291845$1$I$20240831$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61210$$FDA-CTU$$58$YR$$F$N$57.4$KG$20240905$N$PH$US$
242918461$24291846$1$I$$20240905$20240906$20240906$EXP$GB-MHRA-MED-202409051453393970-JDWLQ$GB-PFIZER INC-202400250844$PFIZER$$$$$F$Y$$$20240906$$PH$GB$GB
242918471$24291847$1$I$$20240903$20240906$20240906$EXP$$CA-PFIZER INC-202400249881$PFIZER$$70$YR$$F$Y$62$KG$20240906$$HP$CA$CA
242918491$24291849$1$I$20240829$20240904$20240906$20240906$EXP$IT-MINISAL02-1000925$IT-PFIZER INC-202400249635$PFIZER$$23$YR$$F$Y$$$20240906$$PH$IT$IT
242918501$24291850$1$I$$20240819$20240906$20240906$PER$$US-LEX-000442$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242918511$24291851$1$I$20230615$20230619$20240906$20240906$EXP$$NVSC2023HU281037$NOVARTIS$$$$$$Y$$$20240906$$CN$HU$HU
242918521$24291852$1$I$$20240819$20240906$20240906$PER$$US-TEVA-VS-3234823$TEVA$$58$YR$$M$Y$$$20240906$$CN$US$US
242918531$24291853$1$I$20240201$20240828$20240906$20240906$EXP$$US-TEVA-VS-3238919$TEVA$$70$YR$$F$Y$$$20240906$$PH$US$US
242918551$24291855$1$I$$20240829$20240906$20240906$EXP$$CA-AstraZeneca-2024A199898$ASTRAZENECA$$$$$M$Y$$$20240906$$MD$CA$
242918561$24291856$1$I$20240625$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A201233$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242918571$24291857$1$I$$20240902$20240906$20240906$EXP$$NL-AstraZeneca-2024A199169$ASTRAZENECA$$51$YR$$M$Y$80$KG$20240906$$MD$NL$
242918581$24291858$1$I$$20240905$20240906$20240906$EXP$$DE-AstraZeneca-2024A202768$ASTRAZENECA$$$$$F$Y$$$20240906$$MD$DE$
242918591$24291859$1$I$$20240829$20240906$20240906$EXP$$GB-AstraZeneca-2024A199070$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$GB$
242918601$24291860$1$I$$20240829$20240906$20240906$EXP$$JP-AstraZeneca-2024A199091$ASTRAZENECA$$$$$M$Y$$$20240906$$MD$JP$
242918611$24291861$1$I$$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200637$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242918621$24291862$1$I$$20240905$20240906$20240906$PER$$NVSC2024US179371$NOVARTIS$$$$$F$Y$$$20240906$$HP$US$US
242918631$24291863$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176503$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242918641$24291864$1$I$$20240902$20240906$20240906$EXP$$JP-AMGEN-JPNSP2024175425$AMGEN$$$$E$F$Y$$$20240906$$MD$JP$JP
242918651$24291865$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61314$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242918661$24291866$1$I$20240904$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177338$AMGEN$$68$YR$E$F$Y$$$20240906$$CN$US$US
242918671$24291867$1$I$20240101$20240827$20240906$20240906$EXP$$JP-RADIUS HEALTH INC.-2024JP006522$RADIUS PHARM$$80$YR$$F$Y$$$20240906$$CN$JP$JP
242918681$24291868$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61218$$FDA-CTU$$68$YR$$F$N$118.84$KG$20240905$N$$US$
242918691$24291869$1$I$20190528$20240829$20240906$20240906$EXP$$BG-CELLTRION INC.-2024BG020938$CELLTRION$$$$$$Y$$$20240906$$MD$BG$BG
242918711$24291871$1$I$$20240904$20240906$20240906$PER$$US-ALXN-202409USA000163US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242918721$24291872$1$I$$20240827$20240906$20240906$PER$$US-EMD Serono-2024047380$EMD SERONO INC$$84$YR$E$F$Y$$$20240906$$CN$US$US
242918731$24291873$1$I$$20240828$20240906$20240906$PER$$US-TEVA-VS-3239250$TEVA$$45$YR$$M$Y$$$20240906$$CN$US$US
242918741$24291874$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61234$$FDA-CTU$$46$YR$$F$N$$$20240905$N$$US$
242918751$24291875$1$I$$20240830$20240906$20240906$EXP$$US-BEH-2024178133$CSL BEHRING$$54$YR$A$F$Y$$$20240906$$CN$US$US
242918761$24291876$1$I$$20240903$20240906$20240906$EXP$$PT-SANDOZ INC.-SDZ2024PT077368$SANDOZ$$$$E$$Y$$$20240906$$HP$PT$PT
242918781$24291878$1$I$$20240903$20240906$20240906$EXP$$CA-LUNDBECK-DKLU4003924$LUNDBECK$$$$$$Y$$$20240906$$CN$CA$CA
242918791$24291879$1$I$20240905$20240906$20240906$20240906$DIR$717394$$FDA-CTU$$51$YR$$F$N$$$20240906$N$HP$US$
242918801$24291880$1$I$20240830$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024175846$AMGEN$$79$YR$E$F$Y$$$20240906$$CN$US$US
242918811$24291881$1$I$$20240904$20240906$20240906$PER$$US-TAKEDA-2024TUS088978$TAKEDA$$$$$$Y$$$20240906$$CN$US$US
242918831$24291883$1$I$$20240827$20240906$20240906$EXP$$US-TORRENT-00013735$TORRENT$$20$YR$A$M$Y$$$20240906$$HP$US$US
242918841$24291884$1$I$$20240826$20240906$20240906$EXP$CA-SEPTODONT-2024018953$CA-SEPTODONT-2024018953$SEPTODONT$$71$YR$E$F$Y$$$20240906$$HP$CA$CA
242918851$24291885$1$I$20240801$20240904$20240906$20240906$PER$$US-ABBVIE-5907766$ABBVIE$$38$YR$$F$Y$58$KG$20240906$$MD$US$US
242918871$24291887$1$I$$20240905$20240906$20240906$EXP$$FR-PFIZER INC-202400250677$PFIZER$$$$$$Y$$$20240906$$MD$FR$FR
242918881$24291888$1$I$20240905$20240905$20240906$20240906$EXP$$US-PFIZER INC-202400250981$PFIZER$$98$YR$$F$Y$$$20240906$$CN$US$US
242918891$24291889$1$I$20240801$20240904$20240906$20240906$EXP$$US-PFIZER INC-202400251002$PFIZER$$65$YR$$F$Y$$$20240906$$HP$US$US
242918911$24291891$1$I$20240701$20240902$20240906$20240906$EXP$$US-VIIV HEALTHCARE LIMITED-US2024109404$VIIV$$37$YR$$M$Y$$$20240906$$CN$US$US
242918921$24291892$1$I$$20240829$20240906$20240906$30DAY$$US-GSK-US2024107897$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242918931$24291893$1$I$20240828$20240828$20240906$20240906$EXP$$US-GSK-US2024107162$GLAXOSMITHKLINE$$63$YR$$F$Y$$$20240906$$CN$US$US
242918961$24291896$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61304$$FDA-CTU$$93$YR$$F$N$$$20240905$N$$US$
242918971$24291897$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61216$$FDA-CTU$$78$YR$$F$N$$$20240905$N$$US$
242918981$24291898$1$I$20240325$20240906$20240906$20240906$DIR$717402$$FDA-CTU$$24$YR$$F$N$63$KG$20240906$Y$HP$US$
242918991$24291899$1$I$20240901$20240901$20240906$20240906$EXP$$MY-DSJP-DSJ-2024-143843$DAIICHI$$$$E$M$Y$$$20240906$$HP$MY$MY
242919001$24291900$1$I$20240816$20240905$20240906$20240906$EXP$FR-AFSSAPS-TS2024000951$FR-TAKEDA-2024TUS088727$TAKEDA$$47$YR$$M$Y$83$KG$20240906$$HP$FR$FR
242919011$24291901$1$I$20240802$20240819$20240906$20240906$PER$$US-LEX-000443$LEXICON PHARMACEUTICALS$$77$YR$$F$Y$$$20240906$$CN$US$US
242919021$24291902$1$I$20240813$20240903$20240906$20240906$EXP$$CN-ORGANON-O2409CHN000371$ORGANON$$71$YR$$M$Y$65$KG$20240906$$HP$CN$CN
242919032$24291903$2$F$20240829$20240912$20240906$20240925$PER$$US-BEH-2024178229$CSL BEHRING$$32$YR$A$F$Y$60$KG$20240925$$CN$US$US
242919042$24291904$2$F$$20240904$20240906$20240913$EXP$$CA-CELLTRION INC.-2024CA021273$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
242919051$24291905$1$I$$20240903$20240906$20240906$EXP$$KR-009507513-2409KOR002171$MERCK$$$$$M$Y$$$20240906$$CN$KR$KR
242919071$24291907$1$I$$20240830$20240906$20240906$EXP$$CA-ABBVIE-5908488$ABBVIE$$21$YR$$M$Y$$$20240906$$CN$CA$CA
242919081$24291908$1$I$20240831$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001611$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240906$$CN$US$US
242919091$24291909$1$I$20240902$20240905$20240906$20240906$PER$$US-BAYER-2024A127616$BAYER$$104$YR$E$M$Y$$$20240906$$CN$US$US
242919101$24291910$1$I$$20240904$20240906$20240906$PER$$US-ALXN-202409USA000168US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242919111$24291911$1$I$$20240826$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135907$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240906$$MD$US$US
242919121$24291912$1$I$20240801$20240830$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139467$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$61.23$KG$20240906$$HP$US$US
242919131$24291913$1$I$$20240829$20240906$20240906$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-140345$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240906$$MD$DE$DE
242919141$24291914$1$I$$20240830$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140050$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240906$$HP$US$US
242919151$24291915$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141907$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240906$$HP$US$US
242919161$24291916$1$I$20240901$20240905$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142063$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240906$$HP$US$US
242919172$24291917$2$F$20240601$20240916$20240906$20240930$30DAY$$US-JNJFOC-20240915306$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240930$$CN$US$US
242919181$24291918$1$I$$20240905$20240906$20240906$PER$$US-BAYER-2024A128073$BAYER$$$$$$Y$$$20240906$$CN$US$US
242919191$24291919$1$I$$20240903$20240906$20240906$EXP$$PE-JNJFOC-20240904773$JOHNSON AND JOHNSON$$31$YR$A$M$Y$80$KG$20240906$$CN$PE$PE
242919201$24291920$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177949$AMGEN$$$$$$Y$$$20240906$$HP$US$US
242919212$24291921$2$F$20240714$20240829$20240906$20240917$EXP$$CN-SA-2024SA253083$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240917$$HP$CN$CN
242919241$24291924$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA256438$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240906$$HP$US$US
242919252$24291925$2$F$$20240924$20240906$20240926$PER$$US-ROCHE-10000075775$ROCHE$$$$E$F$Y$$$20240926$$CN$US$US
242919261$24291926$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61235$$FDA-CTU$$57$YR$$M$N$$$20240905$N$$US$
242919271$24291927$1$I$20240701$20240903$20240906$20240906$EXP$$GB-AstraZeneca-2024A201373$ASTRAZENECA$$700$MON$$M$Y$$$20240906$$HP$GB$
242919281$24291928$1$I$20240828$20240903$20240906$20240906$PER$$US-ABBVIE-5907034$ABBVIE$$$$A$F$Y$$$20240906$$HP$US$US
242919302$24291930$2$F$$20240909$20240906$20240912$EXP$$US-AstraZeneca-2024A200649$ASTRAZENECA$$64$YR$$F$Y$$$20240912$$HP$US$
242919311$24291931$1$I$$20240829$20240906$20240906$EXP$$CA-TEVA-VS-3238587$TEVA$$$$$F$Y$$$20240906$$LW$CA$CA
242919321$24291932$1$I$$20240829$20240906$20240906$EXP$$US-AstraZeneca-2024A198000$ASTRAZENECA$$$$$$Y$$$20240906$$CN$US$
242919332$24291933$2$F$20240802$20240911$20240906$20240919$PER$$US-BAYER-2024A128093$BAYER$$36$YR$A$F$Y$108.84$KG$20240919$$MD$US$US
242919341$24291934$1$I$20240101$20240822$20240906$20240906$PER$$US-SA-2024SA257891$SANOFI AVENTIS$$$$A$M$Y$$$20240906$$MD$US$US
242919351$24291935$1$I$20230201$20240822$20240906$20240906$PER$$US-SA-2023SA268756$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240906$$CN$US$US
242919361$24291936$1$I$$20240903$20240906$20240906$EXP$BE-FAMHP-DHH-N2024-122566$BE-MYLANLABS-2024M1080870$MYLAN$$$$$M$Y$$$20240906$$PH$BE$BE
242919371$24291937$1$I$20230220$20240902$20240906$20240906$EXP$ES-AEMPS-1565829$ES-ORGANON-O2409ESP000119$ORGANON$$69$YR$$F$Y$65$KG$20240906$$PH$ES$ES
242919381$24291938$1$I$$20230515$20240906$20240906$EXP$$NVSC2023US281117$NOVARTIS$$$$$M$Y$$$20240906$$CN$US$US
242919391$24291939$1$I$20240801$20240830$20240906$20240906$EXP$$US-MALLINCKRODT-MNK202405473$MALLINCKRODT$$$$$F$Y$$$20240906$$HP$US$US
242919401$24291940$1$I$20240801$20240830$20240906$20240906$EXP$$JP-Eisai-EC-2024-173392$EISAI$$$$E$F$Y$$$20240906$$MD$JP$JP
242919413$24291941$3$F$20240904$20240910$20240906$20240913$PER$$SG-Eisai-EC-2024-173715$EISAI$$65$YR$E$F$Y$$$20240913$$MD$SG$SG
242919421$24291942$1$I$$20240823$20240906$20240906$PER$$US-Calliditas-2024CAL01403$CALLIDITAS THERAPEUTICS$$49$YR$A$F$Y$$$20240906$$CN$US$US
242919431$24291943$1$I$20240707$20240829$20240906$20240906$EXP$FR-AFSSAPS-LL2024001613$FR-TEVA-VS-3238338$TEVA$$75$YR$$M$Y$73.1$KG$20240906$$PH$FR$FR
242919441$24291944$1$I$20240807$20240829$20240906$20240906$PER$$US-Eisai-EC-2024-173474$EISAI$$68$YR$E$F$Y$68.49$KG$20240906$$CN$US$US
242919461$24291946$1$I$20240810$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61317$$FDA-CTU$$47$YR$$F$N$$$20240905$N$$US$
242919481$24291948$1$I$$20240829$20240906$20240906$EXP$$CA-APOTEX-2024AP010162$APOTEX$$74$YR$$M$Y$$$20240906$$PH$CA$CA
242919491$24291949$1$I$$20240906$20240906$20240906$PER$$US-BAYER-2024A128098$BAYER$$$$$$Y$$$20240906$$CN$US$US
242919502$24291950$2$F$20240618$20240924$20240906$20240926$EXP$$JP-DSJP-DSJ-2024-137821$DAIICHI$$75$YR$$F$Y$35.3$KG$20240926$$MD$JP$JP
242919511$24291951$1$I$$20240905$20240906$20240906$EXP$GB-MHRA-MED-202409051142525450-WZVKS$GB-ORGANON-O2409GBR000368$ORGANON$$$$$M$Y$$$20240906$$CN$GB$GB
242919521$24291952$1$I$20240806$20240830$20240906$20240906$EXP$$NL-VER-202400056$VERITY PHARMACEUTICALS$$76$YR$E$M$Y$$$20240906$$HP$NL$NL
242919531$24291953$1$I$$20240903$20240906$20240906$EXP$$US-ORG100016242-2024000519$PACIRA$$78$YR$E$F$Y$$$20240906$$CN$US$US
242919541$24291954$1$I$20240814$20240828$20240906$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027341$UNITED THERAPEUTICS$$83$YR$$F$Y$65.306$KG$20240906$$$US$US
242919571$24291957$1$I$20240826$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61348$$FDA-CTU$$57$YR$$M$N$$$20240904$N$PH$US$
242919611$24291961$1$I$20240320$20240829$20240906$20240906$EXP$$CN-ROCHE-10000070448$ROCHE$$12$YR$T$M$Y$50$KG$20240906$$CN$CN$CN
242919621$24291962$1$I$20240827$20240828$20240906$20240906$EXP$$US-GSK-US2024107113$GLAXOSMITHKLINE$$72$YR$$M$Y$$$20240906$$CN$US$US
242919631$24291963$1$I$20240802$20240819$20240906$20240906$PER$$US-LEX-000444$LEXICON PHARMACEUTICALS$$80$YR$$F$Y$$$20240906$$CN$US$US
242919641$24291964$1$I$20240801$20240826$20240906$20240906$PER$$US-SA-2024SA257468$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240906$$HP$US$US
242919651$24291965$1$I$$20240829$20240906$20240906$PER$$US-SA-2024SA258372$SANOFI AVENTIS$$$$$F$Y$$$20240906$$HP$US$US
242919662$24291966$2$F$20240531$20240903$20240906$20240923$EXP$$CA-SA-2024SA169428$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240923$$PH$CA$CA
242919671$24291967$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA258558$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240906$$MD$US$US
242919681$24291968$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA257420$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240906$$MD$US$US
242919691$24291969$1$I$20210801$20240826$20240906$20240906$PER$$US-SA-2024SA257745$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240906$$HP$US$US
242919701$24291970$1$I$$20240904$20240906$20240906$EXP$$AR-SANDOZ INC.-SDZ2024AR078159$SANDOZ$$$$$F$Y$37$KG$20240906$$CN$AR$AR
242919711$24291971$1$I$$20240902$20240906$20240906$30DAY$$GB-PFIZER INC-PV202400115356$PFIZER$$$$$$Y$$$20240906$$HP$GB$GB
242919731$24291973$1$I$20240101$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141084$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240906$$CN$US$US
242919741$24291974$1$I$20240829$20240905$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141955$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240906$$CN$US$US
242919751$24291975$1$I$$20240903$20240906$20240906$PER$$US-ABBVIE-5908995$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242919761$24291976$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141966$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240906$$PH$US$US
242919771$24291977$1$I$20240901$20240903$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141223$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240906$$CN$US$US
242919782$24291978$2$F$20240701$20240909$20240906$20240912$PER$$US-AMGEN-USASP2024176835$AMGEN$$75$YR$E$F$Y$23$KG$20240911$$MD$US$US
242919791$24291979$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010072$APOTEX$$$$$F$Y$$$20240906$$MD$CA$CA
242919811$24291981$1$I$$20240902$20240906$20240906$EXP$$NVSC2024TR178697$NOVARTIS$$$$$$Y$$$20240906$$MD$TR$TR
242919831$24291983$1$I$20231201$20240829$20240906$20240906$EXP$$US-TEVA-VS-3238849$TEVA$$$$$$Y$$$20240906$$CN$US$US
242919841$24291984$1$I$$20240904$20240906$20240906$EXP$$US-SANDOZ INC.-SDZ2024US078105$SANDOZ$$$$$F$Y$$$20240906$$CN$US$US
242919852$24291985$2$F$20070401$20240903$20240906$20240906$PER$$US-ASTELLAS-2024-AER-004435$ASTELLAS$$49$YR$A$M$Y$105$KG$20240906$$HP$US$US
242919861$24291986$1$I$20240801$20240903$20240906$20240906$30DAY$$FR-PFIZER INC-202400248998$PFIZER$$52$YR$$F$Y$$$20240906$$PH$FR$FR
242919891$24291989$1$I$$20240830$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027584$UNITED THERAPEUTICS$$$$$F$Y$88.435$KG$20240906$$$US$US
242919931$24291993$1$I$20100204$20240903$20240906$20240906$EXP$$US-ASTELLAS-2024-AER-004701$ASTELLAS$$29$YR$A$M$Y$79$KG$20240906$$CN$US$US
242919951$24291995$1$I$$20240903$20240906$20240906$EXP$$CA-PFIZER INC-202400250078$PFIZER$$$$$M$Y$$$20240906$$HP$CA$CA
242919961$24291996$1$I$$20240903$20240906$20240906$EXP$$CA-PFIZER INC-202400250047$PFIZER$$60$YR$$M$Y$$$20240906$$CN$CA$CA
242919981$24291998$1$I$$20240828$20240906$20240906$PER$$US-JNJFOC-20240911997$JOHNSON AND JOHNSON$$$$$M$Y$70$KG$20240906$$MD$US$US
242920011$24292001$1$I$$20240904$20240906$20240906$EXP$$AU-Eisai-EC-2024-173770$EISAI$$$$$$Y$$$20240906$$MD$AU$AU
242920021$24292002$1$I$$20240828$20240906$20240906$EXP$$US-TEVA-VS-3239442$TEVA$$$$$M$Y$$$20240906$$CN$US$US
242920031$24292003$1$I$20210615$20240830$20240906$20240906$EXP$$CA-VER-202400460$VERITY PHARMACEUTICALS$$82$YR$E$M$Y$$$20240906$$HP$CA$CA
242920041$24292004$1$I$20190101$20240905$20240906$20240906$EXP$GB-MHRA-MED-202409051047363520-LJFDC$GB-ORGANON-O2409GBR000365$ORGANON$$$$$$Y$65$KG$20240906$$CN$GB$GB
242920051$24292005$1$I$20240101$20240904$20240906$20240906$PER$$US-BAUSCH-BL-2024-013289$BAUSCH AND LOMB$$15$YR$$$Y$$$20240906$$CN$US$US
242920061$24292006$1$I$20240801$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A200838$ASTRAZENECA$$700$MON$$F$Y$$$20240906$$CN$US$
242920071$24292007$1$I$$20240904$20240906$20240906$PER$$US-ALXN-202409USA000160US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242920081$24292008$1$I$$20240904$20240906$20240906$30DAY$$GB-PFIZER INC-PV202400115933$PFIZER$$59$YR$$F$Y$$$20240906$$CN$GB$GB
242920091$24292009$1$I$$20240905$20240906$20240906$EXP$$CA-SANDOZ INC.-SDZ2024CA078088$SANDOZ$$54$YR$$F$Y$$$20240906$$CN$CA$CA
242920101$24292010$1$I$$20240904$20240906$20240906$PER$$US-BAUSCH-BL-2024-013296$BAUSCH AND LOMB$$15$YR$$F$Y$$$20240906$$CN$US$US
242920112$24292011$2$F$$20240902$20240906$20240912$EXP$$US-MYLANLABS-2024M1081770$MYLAN$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024; 67 (0).$49$YR$$F$Y$$$20240912$$HP$US$US
242920122$24292012$2$F$$20240926$20240906$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141850$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240930$$CN$US$US
242920131$24292013$1$I$20240904$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142314$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240906$$HP$US$US
242920141$24292014$1$I$20240820$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141846$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$58.51$KG$20240906$$CN$US$US
242920151$24292015$1$I$20240801$20240905$20240906$20240906$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-142043$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240906$$MD$DE$DE
242920162$24292016$2$F$$20240902$20240906$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139278$BRISTOL MYERS SQUIBB$Koshino Y, Sumi T, Suzuki K, Ikeda T, Yamada Y, Keiya T, et al. A case of pleurisy as immune-related adverse events of neoadjuvant nivolumab and chemotherapy after lobectomy. Japanese Journal of Lung Cancer. 2024 Aug 20;64(4):315-20.$63$YR$A$M$Y$73$KG$20240920$$MD$JP$JP
242920171$24292017$1$I$20240830$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140246$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$53.52$KG$20240906$$HP$US$US
242920181$24292018$1$I$$20240828$20240906$20240906$EXP$$GB-TEVA-VS-3239388$TEVA$$47$YR$$F$Y$$$20240906$$CN$GB$GB
242920191$24292019$1$I$$20240904$20240906$20240906$PER$$US-JNJFOC-20240912274$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$HP$US$US
242920201$24292020$1$I$20240714$20240904$20240906$20240906$EXP$ES-AEMPS-1559952$ES-TAKEDA-2024TUS089006$TAKEDA$$39$YR$$F$Y$$$20240906$$HP$ES$ES
242920211$24292021$1$I$20200101$20240828$20240906$20240906$PER$$US-ABBVIE-5900014$ABBVIE$$$$$F$Y$112.49$KG$20240906$$CN$US$US
242920221$24292022$1$I$$20240828$20240906$20240906$EXP$$US-GSK-US2024AMR108532$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242920231$24292023$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5905907$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242920241$24292024$1$I$20240801$20240816$20240906$20240906$PER$$US-JNJFOC-20240900774$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240906$$CN$US$US
242920251$24292025$1$I$$20240827$20240906$20240906$EXP$$CA-FreseniusKabi-FK202413169$FRESENIUS KABI$$$$$F$Y$$$20240906$$MD$CA$CA
242920261$24292026$1$I$$20240903$20240906$20240906$EXP$$US-ORGANON-O2409USA000268$ORGANON$$$$$F$Y$$$20240906$$MD$US$US
242920272$24292027$2$F$$20240905$20240906$20240918$EXP$$NVSC2024US178881$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
242920291$24292029$1$I$20221107$20240829$20240906$20240906$EXP$$ES-JNJFOC-20240903572$JOHNSON AND JOHNSON$$73$YR$E$M$Y$76$KG$20240906$$MD$ES$ES
242920321$24292032$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61230$$FDA-CTU$$89$YR$$F$N$$$20240905$N$$US$
242920331$24292033$1$I$20240829$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61231$$FDA-CTU$$90$YR$$M$N$$$20240905$N$HP$US$
242920351$24292035$1$I$$20240906$20240906$20240906$DIR$717415$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242920391$24292039$1$I$20240801$20240827$20240906$20240906$EXP$$US-GSK-US2024AMR108223$GLAXOSMITHKLINE$$62$YR$$F$Y$67$KG$20240906$$CN$US$US
242920401$24292040$1$I$20220707$20240902$20240906$20240906$EXP$$JP-OTSUKA-2024_024527AA$OTSUKA$$9$DEC$$M$Y$47.8$KG$20240906$$MD$JP$JP
242920411$24292041$1$I$20240903$20240905$20240906$20240906$PER$$NVSC2024US179246$NOVARTIS$$70$YR$$M$Y$$$20240906$$CN$US$US
242920421$24292042$1$I$20240904$20240905$20240906$20240906$PER$$US-AMGEN-USASP2024178218$AMGEN$$71$YR$E$F$Y$$$20240906$$CN$US$US
242920431$24292043$1$I$20240801$20240827$20240906$20240906$PER$$US-FARMAPROD-202408-2971$DOMPE FARMACEUTICI$$64$YR$A$F$Y$$$20240906$$CN$US$US
242920441$24292044$1$I$$20240903$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140789$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240906$$CN$US$US
242920451$24292045$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141843$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240906$$CN$US$US
242920461$24292046$1$I$$20240830$20240906$20240906$PER$$US-ROCHE-10000071768$ROCHE$$$$E$M$Y$$$20240906$$CN$US$US
242920471$24292047$1$I$20240517$20240829$20240906$20240906$PER$$US-ROCHE-10000070223$ROCHE$$68$YR$E$M$Y$$$20240906$$PH$US$US
242920481$24292048$1$I$$20240828$20240906$20240906$PER$$US-JNJFOC-20240876651$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$CN$US$US
242920491$24292049$1$I$20140701$20240906$20240906$20240906$EXP$$DE-SANDOZ INC.-SDZ2024DE078305$SANDOZ$$51$YR$$M$Y$74$KG$20240906$$MD$DE$DE
242920513$24292051$3$F$$20240909$20240906$20240912$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-118779$REGENERON$$$$$F$Y$$$20240913$$CN$CA$CA
242920521$24292052$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000073853$ROCHE$$58$YR$A$F$Y$$$20240906$$CN$US$US
242920531$24292053$1$I$$20240902$20240906$20240906$EXP$$BG-AstraZeneca-2024A201541$ASTRAZENECA$$$$$F$Y$$$20240906$$HP$BG$
242920541$24292054$1$I$$20240829$20240906$20240906$EXP$$IT-BIOCON BIOLOGICS LIMITED-BBL2024006452$BIOCON$Burlo F, Tumminelli C, Pastore S, Stocco G, Curci D, Lucafo M... Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report.. Pediatric Rheumatology.. 2023;21:1-6$$$$$Y$$$20240906$$HP$IT$IT
242920551$24292055$1$I$20240318$20240906$20240906$20240906$DIR$717407$$FDA-CTU$$72$YR$$M$N$90$KG$20240906$N$CN$US$
242920561$24292056$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000073855$ROCHE$$$$E$M$Y$$$20240906$$CN$US$US
242920571$24292057$1$I$$20240904$20240906$20240906$EXP$$CA-SANDOZ INC.-SDZ2024CA077800$SANDOZ$$29$YR$$F$Y$$$20240906$$PH$CA$CA
242920581$24292058$1$I$20240806$20240906$20240906$20240906$DIR$717410$$FDA-CTU$$67$YR$$M$N$87.75$KG$20240906$N$CN$US$
242920592$24292059$2$F$20240801$20240920$20240906$20240926$EXP$$US-BIOGEN-2024BI01280758$BIOGEN$$80$YR$$F$Y$$$20240926$$CN$US$US
242920601$24292060$1$I$20240801$20240828$20240906$20240906$30DAY$$US-GSK-US2024107244$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240906$$CN$US$US
242920611$24292061$1$I$20240905$20240906$20240906$20240906$DIR$717417$$FDA-CTU$$73$YR$$M$N$96.3$KG$20240906$N$HP$US$
242920621$24292062$1$I$$20240905$20240906$20240906$EXP$GB-MHRA-MED-202409051036517840-DLRZS$GB-ORGANON-O2409GBR000367$ORGANON$$$$$F$Y$$$20240906$$CN$GB$GB
242920631$24292063$1$I$$20240829$20240906$20240906$EXP$$CA-TEVA-VS-3238576$TEVA$$$$$F$Y$$$20240906$$LW$CA$CA
242920651$24292065$1$I$$20240827$20240906$20240906$EXP$$US-FreseniusKabi-FK202413300$FRESENIUS KABI$Kong S, Nagraj S, Cooper DL, Ferrick KJ, Zhang L. A case report of fudarabine associated  ectopic atrial bradycardia and literature review  of fudarabine induced bradycardia. Cardio-Oncology. 2024;10(1): 1-8. doi:https://dx.doi.org/10.1186/s40959-024-00253-x.$30$YR$A$F$Y$$$20240906$$HP$US$US
242920661$24292066$1$I$20240901$20240902$20240906$20240906$EXP$GB-MHRA-MED-202409021438380780-JMKWT$GB-RDY-SPO/GBR/24/0012781$DR REDDYS$$$$$$Y$$$20240906$$PH$GB$GB
242920672$24292067$2$F$$20240905$20240906$20240910$EXP$$GB-JNJFOC-20240906953$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20240910$$CN$GB$GB
242920691$24292069$1$I$$20240827$20240906$20240906$EXP$$CA-FreseniusKabi-FK202413187$FRESENIUS KABI$$38$YR$A$M$Y$$$20240906$$HP$CA$CA
242920701$24292070$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176603$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242920711$24292071$1$I$20240101$20240830$20240906$20240906$PER$$US-Eisai-EC-2024-171769$EISAI$$63$YR$A$M$Y$133$KG$20240906$$CN$US$US
242920722$24292072$2$F$20220701$20240910$20240906$20240917$EXP$$US-ABBVIE-5903553$ABBVIE$$41$YR$$F$Y$72.574$KG$20240917$$CN$US$US
242920731$24292073$1$I$$20240904$20240906$20240906$PER$$US-ALXN-202409USA000182US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242920741$24292074$1$I$$20240829$20240906$20240906$EXP$$US-BAYER-2024A127303$BAYER$McGinnis S.M.; McCann R.F.; Patel V.; Doughty C.T.; Miller M.B.; Gale S.A.; Silbersweig D.A.; Daffner K.R.. Case Study 5: A 74-Year-Old Man With Dysphagia, Weakness, and Memory Loss. Journal of Neuropsychiatry and Clinical Neurosciences. 2023;35:3:(210-217)$74$YR$E$M$Y$$$20240906$$MD$US$US
242920751$24292075$1$I$20230914$20230914$20240906$20240906$PER$$US-FARMAPROD-202302-0374$DOMPE FARMACEUTICI$$53$YR$A$F$Y$117.93$KG$20240904$$CN$US$
242920761$24292076$1$I$20230101$20231006$20240906$20240906$PER$$US-FARMAPROD-202305-1563$DOMPE FARMACEUTICI$$28$YR$A$F$Y$$$20240903$$CN$US$
242920771$24292077$1$I$$20240221$20240906$20240906$PER$$US-FARMAPROD-202305-1533$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242920781$24292078$1$I$20230528$20240214$20240906$20240906$PER$$US-FARMAPROD-202305-1582$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240903$$CN$US$
242920791$24292079$1$I$$20230913$20240906$20240906$PER$$US-FARMAPROD-202003-0318$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240902$$CN$US$
242920801$24292080$1$I$20230601$20230706$20240906$20240906$PER$$US-FARMAPROD-202307-2028$DOMPE FARMACEUTICI$$23$YR$A$F$Y$$$20240903$$CN$US$
242920811$24292081$1$I$$20230706$20240906$20240906$PER$$US-FARMAPROD-202307-2036$DOMPE FARMACEUTICI$$$$A$F$Y$88.45$KG$20240903$$CN$US$
242920821$24292082$1$I$20200919$20240604$20240906$20240906$PER$$US-FARMAPROD-202009-1264$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240902$$CN$US$US
242920831$24292083$1$I$20240723$20240904$20240906$20240906$EXP$SE-SEMPA-2024-006345$SE-REGENERON PHARMACEUTICALS, INC.-2024-119376$REGENERON$$63$YR$$M$Y$$$20240906$$MD$SE$SE
242920841$24292084$1$I$$20230709$20240906$20240906$PER$$US-FARMAPROD-202307-2045$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242920851$24292085$1$I$20231124$20240102$20240906$20240906$PER$$US-FARMAPROD-202009-1263$DOMPE FARMACEUTICI$$69$YR$E$F$Y$51.71$KG$20240902$$CN$US$
242920861$24292086$1$I$$20230707$20240906$20240906$PER$$US-FARMAPROD-202307-2040$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242920871$24292087$1$I$$20230707$20240906$20240906$PER$$US-FARMAPROD-202307-2038$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242920881$24292088$1$I$$20230710$20240906$20240906$PER$$US-FARMAPROD-202307-2049$DOMPE FARMACEUTICI$$60$YR$A$M$Y$$$20240903$$MD$US$
242920891$24292089$1$I$$20230707$20240906$20240906$PER$$US-FARMAPROD-202307-2044$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242920901$24292090$1$I$$20230706$20240906$20240906$PER$$US-FARMAPROD-202307-2032$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242920911$24292091$1$I$$20230706$20240906$20240906$PER$$US-FARMAPROD-202307-2029$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242920921$24292092$1$I$20230724$20230919$20240906$20240906$PER$$US-FARMAPROD-202307-2005$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240903$$MD$US$
242920931$24292093$1$I$$20230831$20240906$20240906$PER$$US-FARMAPROD-202307-2034$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242920941$24292094$1$I$20240201$20240220$20240906$20240906$PER$$US-FARMAPROD-202306-1716$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240903$$CN$US$
242920951$24292095$1$I$$20230706$20240906$20240906$PER$$US-FARMAPROD-202307-2030$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242920961$24292096$1$I$$20230707$20240906$20240906$PER$$US-FARMAPROD-202307-2047$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242920971$24292097$1$I$$20230706$20240906$20240906$PER$$US-FARMAPROD-202307-2037$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242920981$24292098$1$I$20231005$20231204$20240906$20240906$PER$$US-FARMAPROD-202307-2020$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240903$$MD$US$
242920991$24292099$1$I$20230601$20230706$20240906$20240906$PER$$US-FARMAPROD-202307-2031$DOMPE FARMACEUTICI$$63$YR$A$M$Y$$$20240903$$CN$US$
242921001$24292100$1$I$20230707$20230814$20240906$20240906$PER$$US-FARMAPROD-202307-2048$DOMPE FARMACEUTICI$$79$YR$E$F$Y$83.01$KG$20240903$$CN$US$
242921011$24292101$1$I$20230706$20230706$20240906$20240906$PER$$US-FARMAPROD-202307-2017$DOMPE FARMACEUTICI$$85$YR$E$F$Y$87.09$KG$20240903$$CN$US$
242921021$24292102$1$I$20230516$20231011$20240906$20240906$PER$$US-FARMAPROD-202305-1601$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240903$$CN$US$
242921031$24292103$1$I$$20231215$20240906$20240906$PER$$US-FARMAPROD-202306-1698$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242921041$24292104$1$I$20230706$20231006$20240906$20240906$PER$$US-FARMAPROD-202307-2039$DOMPE FARMACEUTICI$$80$YR$E$F$Y$75.3$KG$20240903$$CN$US$
242921051$24292105$1$I$$20230711$20240906$20240906$PER$$US-FARMAPROD-202306-1824$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242921061$24292106$1$I$$20230724$20240906$20240906$PER$$US-FARMAPROD-202306-1890$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242921071$24292107$1$I$$20240829$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR108256$VIIV$$$$$$Y$$$20240906$$HP$US$US
242921081$24292108$1$I$$20230717$20240906$20240906$PER$$US-FARMAPROD-202307-2136$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242921091$24292109$1$I$$20230717$20240906$20240906$PER$$US-FARMAPROD-202307-2135$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242921101$24292110$1$I$$20230719$20240906$20240906$PER$$US-FARMAPROD-202307-2174$DOMPE FARMACEUTICI$$$$A$F$Y$64.86$KG$20240903$$CN$US$
242921111$24292111$1$I$$20231010$20240906$20240906$PER$$US-FARMAPROD-202306-1889$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242921121$24292112$1$I$20230612$20230907$20240906$20240906$PER$$US-FARMAPROD-202306-1904$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240903$$MD$US$
242921131$24292113$1$I$$20230717$20240906$20240906$PER$$US-FARMAPROD-202307-2141$DOMPE FARMACEUTICI$$$$E$M$Y$121.56$KG$20240903$$CN$US$
242921141$24292114$1$I$$20230726$20240906$20240906$PER$$US-FARMAPROD-202307-2170$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242921151$24292115$1$I$$20230721$20240906$20240906$PER$$US-FARMAPROD-202307-2112$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242921161$24292116$1$I$$20230721$20240906$20240906$PER$$US-FARMAPROD-202307-2119$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242921171$24292117$1$I$$20230731$20240906$20240906$PER$$US-FARMAPROD-202307-2159$DOMPE FARMACEUTICI$$$$E$F$Y$75.93$KG$20240903$$CN$US$
242921181$24292118$1$I$$20231023$20240906$20240906$PER$$US-FARMAPROD-202306-1892$DOMPE FARMACEUTICI$$$$E$F$Y$93.44$KG$20240903$$CN$US$
242921191$24292119$1$I$$20231130$20240906$20240906$PER$$US-FARMAPROD-202306-1881$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242921201$24292120$1$I$$20230717$20240906$20240906$PER$$US-FARMAPROD-202307-2134$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242921211$24292121$1$I$$20230717$20240906$20240906$PER$$US-FARMAPROD-202307-2138$DOMPE FARMACEUTICI$$$$$$Y$$$20240903$$MD$US$
242921221$24292122$1$I$20230716$20240312$20240906$20240906$PER$$US-FARMAPROD-202307-2148$DOMPE FARMACEUTICI$$33$YR$A$F$Y$$$20240903$$CN$US$
242921231$24292123$1$I$$20231026$20240906$20240906$PER$$US-FARMAPROD-202307-2002$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242921241$24292124$1$I$$20230717$20240906$20240906$PER$$US-FARMAPROD-202307-2152$DOMPE FARMACEUTICI$$$$E$M$Y$83.91$KG$20240903$$CN$US$
242921251$24292125$1$I$$20240104$20240906$20240906$PER$$US-FARMAPROD-202307-2153$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242921261$24292126$1$I$$20230716$20240906$20240906$PER$$US-FARMAPROD-202307-2160$DOMPE FARMACEUTICI$$$$$$Y$$$20240903$$MD$US$
242921271$24292127$1$I$20230719$20230822$20240906$20240906$PER$$US-FARMAPROD-202307-2169$DOMPE FARMACEUTICI$$70$YR$E$F$Y$110$KG$20240903$$CN$US$
242921281$24292128$1$I$$20230720$20240906$20240906$PER$$US-FARMAPROD-202307-2180$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242921291$24292129$1$I$$20230713$20240906$20240906$PER$$US-FARMAPROD-202307-2116$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242921301$24292130$1$I$$20230717$20240906$20240906$PER$$US-FARMAPROD-202307-2144$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242921311$24292131$1$I$$20230707$20240906$20240906$PER$$US-FARMAPROD-202307-2051$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242921321$24292132$1$I$20230701$20231204$20240906$20240906$PER$$US-FARMAPROD-202307-2125$DOMPE FARMACEUTICI$$55$YR$A$M$Y$$$20240904$$CN$US$
242921331$24292133$1$I$$20230717$20240906$20240906$PER$$US-FARMAPROD-202307-2140$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242921341$24292134$1$I$$20230712$20240906$20240906$PER$$US-FARMAPROD-202307-2095$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242921351$24292135$1$I$$20230731$20240906$20240906$PER$$US-FARMAPROD-202307-2137$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242921361$24292136$1$I$20230701$20230728$20240906$20240906$PER$$US-FARMAPROD-202307-2158$DOMPE FARMACEUTICI$$59$YR$A$F$Y$$$20240903$$CN$US$
242921371$24292137$1$I$$20230719$20240906$20240906$PER$$US-FARMAPROD-202307-2168$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242921381$24292138$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202307-2176$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242921391$24292139$1$I$$20230713$20240906$20240906$PER$$US-FARMAPROD-202307-2110$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$CN$US$
242921401$24292140$1$I$$20230911$20240906$20240906$PER$$US-FARMAPROD-202307-2127$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240904$$HP$US$
242921411$24292141$1$I$$20230717$20240906$20240906$PER$$US-FARMAPROD-202307-2142$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242921421$24292142$1$I$$20230710$20240906$20240906$PER$$US-FARMAPROD-202307-2071$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242921431$24292143$1$I$$20230719$20240906$20240906$PER$$US-FARMAPROD-202307-2175$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242921441$24292144$1$I$$20230714$20240906$20240906$PER$$US-FARMAPROD-202307-2129$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242921451$24292145$1$I$$20230813$20240906$20240906$PER$$US-FARMAPROD-202307-2154$DOMPE FARMACEUTICI$$$$A$F$Y$74.3$KG$20240903$$CN$US$
242921461$24292146$1$I$20230925$20230929$20240906$20240906$PER$$US-FARMAPROD-202307-2139$DOMPE FARMACEUTICI$$58$YR$A$F$Y$$$20240903$$CN$US$
242921471$24292147$1$I$$20230714$20240906$20240906$PER$$US-FARMAPROD-202307-2121$DOMPE FARMACEUTICI$$$$A$F$Y$94.35$KG$20240904$$CN$US$
242921481$24292148$1$I$$20230712$20240906$20240906$PER$$US-FARMAPROD-202307-2093$DOMPE FARMACEUTICI$$$$A$M$Y$66.32$KG$20240904$$CN$US$
242921491$24292149$1$I$20230626$20230808$20240906$20240906$PER$$US-FARMAPROD-202307-2182$DOMPE FARMACEUTICI$$86$YR$E$M$Y$$$20240903$$CN$US$
242921501$24292150$1$I$$20230720$20240906$20240906$PER$$US-FARMAPROD-202307-2178$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242921511$24292151$1$I$20230711$20230711$20240906$20240906$PER$$US-FARMAPROD-202307-2074$DOMPE FARMACEUTICI$$66$YR$E$F$Y$$$20240904$$CN$US$
242921521$24292152$1$I$$20230719$20240906$20240906$PER$$US-FARMAPROD-202307-2166$DOMPE FARMACEUTICI$$$$E$M$Y$82.1$KG$20240903$$CN$US$
242921531$24292153$1$I$$20230714$20240906$20240906$PER$$US-FARMAPROD-202307-2131$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242921541$24292154$1$I$$20230706$20240906$20240906$PER$$US-FARMAPROD-202307-2114$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242921551$24292155$1$I$$20230713$20240906$20240906$PER$$US-FARMAPROD-202307-2103$DOMPE FARMACEUTICI$$59$YR$A$F$Y$$$20240904$$MD$US$
242921561$24292156$1$I$$20230712$20240906$20240906$PER$$US-FARMAPROD-202307-2092$DOMPE FARMACEUTICI$$$$E$F$Y$55.34$KG$20240904$$CN$US$
242921571$24292157$1$I$$20230714$20240906$20240906$PER$$US-FARMAPROD-202307-2126$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242921581$24292158$1$I$$20230712$20240906$20240906$PER$$US-FARMAPROD-202307-2096$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242921591$24292159$1$I$$20230831$20240906$20240906$PER$$US-FARMAPROD-202307-2143$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242921601$24292160$1$I$20230701$20230810$20240906$20240906$PER$$US-FARMAPROD-202307-2120$DOMPE FARMACEUTICI$$66$YR$E$F$Y$96.62$KG$20240904$$CN$US$
242921611$24292161$1$I$$20230724$20240906$20240906$PER$$US-FARMAPROD-202307-2219$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242921621$24292162$1$I$$20230720$20240906$20240906$PER$$US-FARMAPROD-202307-2179$DOMPE FARMACEUTICI$$$$E$F$Y$67.49$KG$20240903$$CN$US$
242921631$24292163$1$I$$20230731$20240906$20240906$PER$$US-FARMAPROD-202307-2117$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242921641$24292164$1$I$20230601$20230728$20240906$20240906$PER$$US-FARMAPROD-202307-2091$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240904$$CN$US$
242921651$24292165$1$I$$20230721$20240906$20240906$PER$$US-FARMAPROD-202307-2193$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242921661$24292166$1$I$20230701$20230814$20240906$20240906$PER$$US-FARMAPROD-202307-2113$DOMPE FARMACEUTICI$$58$YR$A$F$Y$$$20240904$$MD$US$
242921671$24292167$1$I$20230711$20230809$20240906$20240906$PER$$US-FARMAPROD-202307-2156$DOMPE FARMACEUTICI$$76$YR$E$F$Y$68.04$KG$20240903$$CN$US$
242921681$24292168$1$I$$20230713$20240906$20240906$PER$$US-FARMAPROD-202307-2109$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242921691$24292169$1$I$$20230713$20240906$20240906$PER$$US-FARMAPROD-202307-2102$DOMPE FARMACEUTICI$$$$E$F$Y$44$KG$20240904$$CN$US$
242921701$24292170$1$I$$20230713$20240906$20240906$PER$$US-FARMAPROD-202307-2105$DOMPE FARMACEUTICI$$$$E$F$Y$80.74$KG$20240904$$CN$US$
242921711$24292171$1$I$$20230816$20240906$20240906$PER$$US-FARMAPROD-202307-2128$DOMPE FARMACEUTICI$$$$E$M$Y$68.4$KG$20240904$$CN$US$
242921721$24292172$1$I$$20230731$20240906$20240906$PER$$US-FARMAPROD-202307-2130$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242921731$24292173$1$I$$20230707$20240906$20240906$PER$$US-FARMAPROD-202307-2057$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242921741$24292174$1$I$$20230710$20240906$20240906$PER$$US-FARMAPROD-202307-2065$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242921751$24292175$1$I$$20230721$20240906$20240906$PER$$US-FARMAPROD-202307-2206$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242921761$24292176$1$I$20221010$20230714$20240906$20240906$PER$$US-FARMAPROD-202307-2115$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240904$$CN$US$
242921771$24292177$1$I$$20230711$20240906$20240906$PER$$US-FARMAPROD-202307-2077$DOMPE FARMACEUTICI$$$$E$M$Y$63.96$KG$20240904$$CN$US$
242921781$24292178$1$I$$20230811$20240906$20240906$PER$$US-FARMAPROD-202307-2078$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242921791$24292179$1$I$$20230710$20240906$20240906$PER$$US-FARMAPROD-202307-2061$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242921801$24292180$1$I$$20230710$20240906$20240906$PER$$US-FARMAPROD-202307-2059$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242921811$24292181$1$I$$20240425$20240906$20240906$PER$$US-FARMAPROD-202404-1626$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242921821$24292182$1$I$20230710$20230719$20240906$20240906$PER$$US-FARMAPROD-202307-2064$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$
242921831$24292183$1$I$$20230906$20240906$20240906$PER$$US-FARMAPROD-202307-2108$DOMPE FARMACEUTICI$$$$E$F$Y$50.62$KG$20240904$$CN$US$
242921841$24292184$1$I$$20240529$20240906$20240906$PER$$US-FARMAPROD-202307-2107$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242921851$24292185$1$I$20230701$20230712$20240906$20240906$PER$$US-FARMAPROD-202307-2086$DOMPE FARMACEUTICI$$27$YR$A$M$Y$$$20240904$$CN$US$
242921861$24292186$1$I$20230601$20230710$20240906$20240906$PER$$US-FARMAPROD-202307-2067$DOMPE FARMACEUTICI$$52$YR$A$F$Y$$$20240904$$CN$US$
242921871$24292187$1$I$$20230710$20240906$20240906$PER$$US-FARMAPROD-202307-2054$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$CN$US$
242921881$24292188$1$I$$20230710$20240906$20240906$PER$$US-FARMAPROD-202307-2066$DOMPE FARMACEUTICI$$$$A$M$Y$122.61$KG$20240904$$CN$US$
242921891$24292189$1$I$$20230710$20240906$20240906$PER$$US-FARMAPROD-202307-2072$DOMPE FARMACEUTICI$$$$$M$Y$$$20240904$$MD$US$
242921901$24292190$1$I$20230701$20230726$20240906$20240906$PER$$US-FARMAPROD-202307-2241$DOMPE FARMACEUTICI$$85$YR$E$F$Y$$$20240903$$CN$US$
242921911$24292191$1$I$20230401$20230710$20240906$20240906$PER$$US-FARMAPROD-202307-2058$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240904$$CN$US$
242921921$24292192$1$I$20230707$20230707$20240906$20240906$PER$$US-FARMAPROD-202307-2050$DOMPE FARMACEUTICI$$51$YR$A$F$Y$$$20240904$$CN$US$
242921931$24292193$1$I$$20230711$20240906$20240906$PER$$US-FARMAPROD-202307-2089$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242921941$24292194$1$I$20230701$20230921$20240906$20240906$PER$$US-FARMAPROD-202307-2088$DOMPE FARMACEUTICI$$56$YR$A$F$Y$$$20240904$$CN$US$
242921951$24292195$1$I$$20230723$20240906$20240906$PER$$US-FARMAPROD-202307-2196$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242921961$24292196$1$I$$20230707$20240906$20240906$PER$$US-FARMAPROD-202307-2055$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242921971$24292197$1$I$$20230710$20240906$20240906$PER$$US-FARMAPROD-202307-2070$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242921981$24292198$1$I$$20230720$20240906$20240906$PER$$US-FARMAPROD-202307-2192$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242921991$24292199$1$I$$20230724$20240906$20240906$PER$$US-FARMAPROD-202307-2207$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242922001$24292200$1$I$$20230724$20240906$20240906$PER$$US-FARMAPROD-202307-2215$DOMPE FARMACEUTICI$$$$A$M$Y$63.5$KG$20240903$$CN$US$
242922011$24292201$1$I$$20230712$20240906$20240906$PER$$US-FARMAPROD-202307-2094$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242922021$24292202$1$I$$20230724$20240906$20240906$PER$$US-FARMAPROD-202307-2218$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242922031$24292203$1$I$$20230711$20240906$20240906$PER$$US-FARMAPROD-202307-2076$DOMPE FARMACEUTICI$$$$E$F$Y$55.34$KG$20240904$$CN$US$
242922041$24292204$1$I$$20230912$20240906$20240906$PER$$US-FARMAPROD-202307-2229$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242922051$24292205$1$I$20230701$20230722$20240906$20240906$PER$$US-FARMAPROD-202307-2205$DOMPE FARMACEUTICI$$88$YR$E$F$Y$$$20240903$$CN$US$
242922061$24292206$1$I$20230614$20230711$20240906$20240906$PER$$US-FARMAPROD-202307-2084$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240904$$CN$US$
242922071$24292207$1$I$$20230724$20240906$20240906$PER$$US-FARMAPROD-202307-2222$DOMPE FARMACEUTICI$$$$A$F$Y$106.59$KG$20240903$$CN$US$
242922081$24292208$1$I$$20230728$20240906$20240906$PER$$US-FARMAPROD-202308-2281$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242922091$24292209$1$I$20230601$20230804$20240906$20240906$PER$$US-FARMAPROD-202307-2060$DOMPE FARMACEUTICI$$73$YR$E$M$Y$$$20240904$$CN$US$
242922101$24292210$1$I$$20230727$20240906$20240906$PER$$US-FARMAPROD-202307-2267$DOMPE FARMACEUTICI$$$$E$M$Y$104.33$KG$20240903$$CN$US$
242922111$24292211$1$I$20230706$20230709$20240906$20240906$PER$$US-FARMAPROD-202307-2052$DOMPE FARMACEUTICI$$90$YR$E$F$Y$$$20240904$$CN$US$
242922121$24292212$1$I$$20230726$20240906$20240906$PER$$US-FARMAPROD-202307-2240$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242922131$24292213$1$I$$20230725$20240906$20240906$PER$$US-FARMAPROD-202307-2236$DOMPE FARMACEUTICI$$$$E$M$Y$74.84$KG$20240903$$CN$US$
242922141$24292214$1$I$20230723$20230807$20240906$20240906$PER$$US-FARMAPROD-202307-2202$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240903$$CN$US$US
242922151$24292215$1$I$$20230724$20240906$20240906$PER$$US-FARMAPROD-202307-2224$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242922161$24292216$1$I$$20230723$20240906$20240906$PER$$US-FARMAPROD-202307-2211$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242922171$24292217$1$I$$20230728$20240906$20240906$PER$$US-FARMAPROD-202307-2277$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242922181$24292218$1$I$20230723$20230724$20240906$20240906$PER$$US-FARMAPROD-202307-2221$DOMPE FARMACEUTICI$$61$YR$A$F$Y$$$20240903$$CN$US$
242922191$24292219$1$I$$20230806$20240906$20240906$PER$$US-FARMAPROD-202307-2220$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242922201$24292220$1$I$$20230728$20240906$20240906$PER$$US-FARMAPROD-202308-2286$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242922211$24292221$1$I$$20230724$20240906$20240906$PER$$US-FARMAPROD-202307-2223$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242922221$24292222$1$I$20230901$20230911$20240906$20240906$PER$$US-FARMAPROD-202307-2201$DOMPE FARMACEUTICI$$68$YR$E$M$Y$$$20240903$$CN$US$
242922231$24292223$1$I$20230709$20230925$20240906$20240906$PER$$US-FARMAPROD-202307-2063$DOMPE FARMACEUTICI$$75$YR$E$F$Y$53.98$KG$20240904$$MD$US$
242922243$24292224$3$F$$20240924$20240906$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA075365$SANDOZ$$$$$M$Y$$$20240927$$CN$CA$CA
242922251$24292225$1$I$20230614$20230721$20240906$20240906$PER$$US-FARMAPROD-202307-2212$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240903$$CN$US$
242922261$24292226$1$I$$20230803$20240906$20240906$PER$$US-FARMAPROD-202307-2204$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242922281$24292228$1$I$$20240904$20240906$20240906$EXP$$GB-SANDOZ INC.-SDZ2024GB078162$SANDOZ$$$$$M$Y$$$20240906$$CN$GB$GB
242922291$24292229$1$I$20231227$20231229$20240906$20240906$PER$$US-FARMAPROD-202307-2062$DOMPE FARMACEUTICI$$77$YR$E$M$Y$68.04$KG$20240904$$CN$US$
242922301$24292230$1$I$$20230720$20240906$20240906$PER$$US-FARMAPROD-202307-2191$DOMPE FARMACEUTICI$$$$A$M$Y$66.22$KG$20240903$$CN$US$
242922311$24292231$1$I$20230726$20230726$20240906$20240906$PER$$US-FARMAPROD-202307-2243$DOMPE FARMACEUTICI$$40$YR$A$F$Y$63.46$KG$20240903$$CN$US$
242922321$24292232$1$I$20230601$20230726$20240906$20240906$PER$$US-FARMAPROD-202307-2245$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240903$$CN$US$
242922331$24292233$1$I$$20230726$20240906$20240906$PER$$US-FARMAPROD-202307-2239$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242922341$24292234$1$I$$20230927$20240906$20240906$PER$$US-FARMAPROD-202307-2242$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242922351$24292235$1$I$20230726$20230726$20240906$20240906$PER$$US-FARMAPROD-202307-2252$DOMPE FARMACEUTICI$$46$YR$A$F$Y$$$20240903$$CN$US$
242922361$24292236$1$I$$20240903$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140542$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240906$$HP$US$US
242922371$24292237$1$I$$20230824$20240906$20240906$PER$$US-FARMAPROD-202307-2226$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242922381$24292238$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142101$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240906$$HP$US$US
242922391$24292239$1$I$$20230724$20240906$20240906$PER$$US-FARMAPROD-202307-2214$DOMPE FARMACEUTICI$$$$E$F$Y$52.16$KG$20240903$$CN$US$
242922401$24292240$1$I$20230724$20230725$20240906$20240906$PER$$US-FARMAPROD-202307-2235$DOMPE FARMACEUTICI$$92$YR$E$F$Y$$$20240903$$CN$US$
242922411$24292241$1$I$$20230707$20240906$20240906$PER$$US-FARMAPROD-202307-2053$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242922421$24292242$1$I$$20230721$20240906$20240906$PER$$US-FARMAPROD-202307-2197$DOMPE FARMACEUTICI$$$$E$F$Y$78.06$KG$20240903$$CN$US$
242922431$24292243$1$I$20230701$20230731$20240906$20240906$PER$$US-FARMAPROD-202308-2291$DOMPE FARMACEUTICI$$53$YR$A$F$Y$$$20240903$$CN$US$
242922441$24292244$1$I$$20230726$20240906$20240906$PER$$US-FARMAPROD-202307-2246$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$
242922451$24292245$1$I$20230701$20230816$20240906$20240906$PER$$US-FARMAPROD-202307-2256$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240903$$CN$US$
242922461$24292246$1$I$20230726$20230906$20240906$20240906$PER$$US-FARMAPROD-202307-2251$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240903$$CN$US$
242922471$24292247$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA256994$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240906$$CN$US$US
242922481$24292248$1$I$$20230811$20240906$20240906$PER$$US-FARMAPROD-202307-2198$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240903$$CN$US$US
242922491$24292249$1$I$$20230829$20240906$20240906$PER$$US-FARMAPROD-202307-2278$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242922501$24292250$1$I$20230701$20230726$20240906$20240906$PER$$US-FARMAPROD-202307-2250$DOMPE FARMACEUTICI$$58$YR$A$F$Y$$$20240903$$CN$US$
242922521$24292252$1$I$20230707$20230825$20240906$20240906$PER$$US-FARMAPROD-202307-2056$DOMPE FARMACEUTICI$$88$YR$E$F$Y$$$20240904$$CN$US$
242922531$24292253$1$I$$20230727$20240906$20240906$PER$$US-FARMAPROD-202307-2255$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242922541$24292254$1$I$20230730$20230901$20240906$20240906$PER$$US-FARMAPROD-202308-2290$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240903$$CN$US$
242922551$24292255$1$I$$20230724$20240906$20240906$PER$$US-FARMAPROD-202307-2203$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240903$$CN$US$
242922561$24292256$1$I$$20230727$20240906$20240906$PER$$US-FARMAPROD-202307-2259$DOMPE FARMACEUTICI$$$$$F$Y$62.14$KG$20240903$$CN$US$
242922571$24292257$1$I$$20230727$20240906$20240906$PER$$US-FARMAPROD-202307-2268$DOMPE FARMACEUTICI$$$$$M$Y$49.9$KG$20240903$$CN$US$
242922581$24292258$1$I$$20240904$20240906$20240906$PER$$ZA-REGENERON PHARMACEUTICALS, INC.-2024-117744$REGENERON$$$$$F$Y$$$20240906$$HP$ZA$ZA
242922591$24292259$1$I$$20230726$20240906$20240906$PER$$US-FARMAPROD-202307-2247$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242922601$24292260$1$I$$20230814$20240906$20240906$PER$$US-FARMAPROD-202308-2284$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240903$$CN$US$
242922611$24292261$1$I$20230701$20231114$20240906$20240906$PER$$US-FARMAPROD-202307-2253$DOMPE FARMACEUTICI$$43$YR$A$F$Y$$$20240903$$CN$US$
242922631$24292263$1$I$$20230726$20240906$20240906$PER$$US-FARMAPROD-202307-2249$DOMPE FARMACEUTICI$$$$A$F$Y$85.46$KG$20240903$$CN$US$
242922641$24292264$1$I$$20240902$20240906$20240906$EXP$$EG-TAKEDA-2024TUS088080$TAKEDA$$$$$F$Y$$$20240906$$MD$EG$EG
242922651$24292265$1$I$20230721$20230825$20240906$20240906$PER$$US-FARMAPROD-202307-2237$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240903$$CN$US$
242922661$24292266$1$I$20230301$20240826$20240906$20240906$EXP$ES-AEMPS-1448675$ES-REGENERON PHARMACEUTICALS, INC.-2024-119552$REGENERON$$61$YR$$F$Y$$$20240906$$PH$ES$ES
242922671$24292267$1$I$$20240820$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08353$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242922691$24292269$1$I$$20240902$20240906$20240906$EXP$$US-ROCHE-10000071996$ROCHE$$$$$$Y$$$20240906$$CN$US$US
242922701$24292270$1$I$$20230727$20240906$20240906$PER$$US-FARMAPROD-202307-2257$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242922711$24292271$1$I$$20240906$20240906$20240906$DIR$717398$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242922721$24292272$1$I$$20230728$20240906$20240906$PER$$US-FARMAPROD-202308-2283$DOMPE FARMACEUTICI$$$$E$F$Y$74.84$KG$20240903$$CN$US$
242922731$24292273$1$I$20240729$20240829$20240906$20240906$EXP$$DE-EMD Serono-2024046527$EMD SERONO INC$$80$YR$E$M$Y$$$20240906$$MD$DE$DE
242922741$24292274$1$I$20230727$20230825$20240906$20240906$PER$$US-FARMAPROD-202308-2282$DOMPE FARMACEUTICI$$88$YR$E$M$Y$80.29$KG$20240903$$MD$US$
242922752$24292275$2$F$20240703$20240903$20240906$20240911$EXP$$DE-ROCHE-10000035093$ROCHE$$45$YR$A$F$Y$110$KG$20240911$$MD$DE$DE
242922761$24292276$1$I$$20240906$20240906$20240906$DIR$717400$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242922771$24292277$1$I$20240829$20240906$20240906$20240906$DIR$717384$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242922781$24292278$1$I$$20240829$20240906$20240906$EXP$$US-SA-2024SA257138$SANOFI AVENTIS$$$$$M$Y$$$20240906$$HP$US$US
242922792$24292279$2$F$20240208$20240917$20240906$20240926$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001248$AKEBIA THERAPEUTICS$$46$YR$$F$Y$55.4$KG$20240926$$MD$JP$JP
242922801$24292280$1$I$20240906$20240906$20240906$20240906$DIR$717399$$FDA-CTU$$77$YR$$M$N$$$20240906$N$HP$US$
242922811$24292281$1$I$$20230809$20240906$20240906$PER$$US-FARMAPROD-202307-2244$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240903$$CN$US$
242922821$24292282$1$I$20230722$20230811$20240906$20240906$PER$$US-FARMAPROD-202307-2213$DOMPE FARMACEUTICI$$64$YR$A$F$Y$$$20240903$$CN$US$US
242922831$24292283$1$I$20240808$20240903$20240906$20240906$EXP$$US-SA-2024SA258300$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240906$$MD$US$US
242922841$24292284$1$I$$20240822$20240906$20240906$EXP$$CA-MEDEXUS PHARMA, INC.-2024MED00357$MEDEXUS PHARMA$$70$YR$$M$Y$$$20240906$$MD$CA$CA
242922851$24292285$1$I$$20240903$20240906$20240906$PER$$US-PFIZER INC-202400249424$PFIZER$$$$$$Y$$$20240906$$HP$US$US
242922861$24292286$1$I$$20240903$20240906$20240906$PER$$US-PFIZER INC-PV202400115639$PFIZER$$$$$$Y$$$20240906$$HP$US$US
242922871$24292287$1$I$$20240822$20240906$20240906$EXP$$CA-MEDEXUS PHARMA, INC.-2024MED00366$MEDEXUS PHARMA$$46$YR$$F$Y$$$20240906$$PH$CA$CA
242922881$24292288$1$I$$20240822$20240906$20240906$EXP$$CA-MEDEXUS PHARMA, INC.-2024MED00372$MEDEXUS PHARMA$$57$YR$$F$Y$101$KG$20240906$$HP$CA$CA
242922892$24292289$2$F$20240101$20240917$20240906$20240926$PER$$US-SA-2024SA257076$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240926$$MD$US$US
242922902$24292290$2$F$20240101$20240825$20240906$20240909$PER$$US-SA-2024SA257978$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240909$$HP$US$US
242922911$24292291$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA257155$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240906$$HP$US$US
242922921$24292292$1$I$$20240827$20240906$20240906$PER$$US-SA-2024SA258117$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240906$$HP$US$US
242922931$24292293$1$I$$20240822$20240906$20240906$EXP$$CA-MEDEXUS PHARMA, INC.-2024MED00373$MEDEXUS PHARMA$$34$YR$$M$Y$93$KG$20240906$$HP$CA$CA
242922941$24292294$1$I$$20240827$20240906$20240906$EXP$$CA-FreseniusKabi-FK202413202$FRESENIUS KABI$$62$WK$I$F$Y$$$20240906$$MD$CA$CA
242922951$24292295$1$I$$20240828$20240906$20240906$PER$$US-FreseniusKabi-FK202413222$FRESENIUS KABI$$$$$M$Y$$$20240906$$HP$US$US
242922962$24292296$2$F$20240830$20240906$20240906$20240913$PER$$GB-Eisai-EC-2024-173721$EISAI$$69$YR$E$$Y$70.15$KG$20240913$$MD$GB$GB
242922971$24292297$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA257946$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240906$$HP$US$US
242922981$24292298$1$I$$20240826$20240906$20240906$EXP$$US-INSUD PHARMA-2408US06874$INSUD PHARMA$Cecchini A, Stephenson E, Sill JM. An Uncommon Cause of Immunosuppression: Fatal Pneumocystis Jiroveci Pneumonia in a Patient With Cushing^s Syndrome. Am J Respir Crit Care Med. 2023;207:A1341$$$$$Y$$$20240906$$HP$US$US
242922991$24292299$1$I$$20240820$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08395$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242923002$24292300$2$F$20190101$20240827$20240906$20240911$EXP$$AU-ALXN-202408OCE001754AU$ALEXION PHARMACEUTICALS$$41$YR$$F$Y$$$20240911$$MD$AU$AU
242923011$24292301$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250603$PFIZER$$78$YR$$F$Y$125.64$KG$20240906$$CN$US$US
242923021$24292302$1$I$20230830$20240902$20240906$20240906$EXP$$KR-GILEAD-2023-0643621$GILEAD$$$$A$F$Y$68$KG$20240906$$MD$KR$KR
242923051$24292305$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA258193$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240906$$HP$US$US
242923061$24292306$1$I$20240809$20240820$20240906$20240906$PER$$US-TEVA-VS-3236200$TEVA$$74$YR$$$Y$$$20240906$$CN$US$US
242923071$24292307$1$I$20240701$20240827$20240906$20240906$EXP$$GB-SA-2024SA257198$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240906$$CN$GB$GB
242923081$24292308$1$I$$20240830$20240906$20240906$EXP$$US-Calliditas-2024CAL01716$CALLIDITAS THERAPEUTICS$$69$YR$E$F$Y$54.8$KG$20240906$$CN$US$US
242923091$24292309$1$I$$20240902$20240906$20240906$EXP$$US-ROCHE-10000072231$ROCHE$$$$A$F$Y$$$20240906$$HP$US$US
242923101$24292310$1$I$$20240830$20240906$20240906$EXP$$CA-MYLANLABS-2024M1081595$MYLAN$$$$N$$Y$$$20240906$$HP$CA$CA
242923112$24292311$2$F$$20240906$20240906$20240916$PER$$US-TAKEDA-2024TUS088565$TAKEDA$$$$$F$Y$75$KG$20240916$$MD$US$US
242923121$24292312$1$I$20240101$20240820$20240906$20240906$PER$$US-TEVA-VS-3235335$TEVA$$33$YR$$$Y$$$20240906$$PH$US$US
242923141$24292314$1$I$20220401$20240902$20240906$20240906$EXP$FR-AFSSAPS-PP2024000915$FR-ROCHE-10000072240$ROCHE$$46$YR$A$M$Y$69$KG$20240906$$MD$FR$FR
242923151$24292315$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61185$$FDA-CTU$$$$$F$N$$$20240904$N$$US$
242923161$24292316$1$I$20240904$20240906$20240906$20240906$DIR$717373$$FDA-CTU$$62$YR$$M$N$96.75$KG$20240906$N$CN$US$
242923171$24292317$1$I$$20240906$20240906$20240906$DIR$717381$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242923181$24292318$1$I$$20240906$20240906$20240906$DIR$717382$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242923191$24292319$1$I$$20240906$20240906$20240906$DIR$717383$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242923201$24292320$1$I$$20240906$20240906$20240906$DIR$717388$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242923211$24292321$1$I$20240823$20240827$20240905$20240905$DIR$FDA-CDER-CTU-2024-61360$$FDA-CTU$$62$YR$$M$N$$$20240827$N$PH$US$
242923221$24292322$1$I$20240904$20240906$20240906$20240906$DIR$717395$$FDA-CTU$$60$YR$$F$N$53.1$KG$20240906$N$CN$US$
242923231$24292323$1$I$$20240906$20240906$20240906$DIR$717397$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242923241$24292324$1$I$20240815$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61168$$FDA-CTU$$73$YR$$M$N$$$20240905$N$PH$US$
242923251$24292325$1$I$$20240828$20240906$20240906$EXP$$US-ChurchDwight-2024-CDW-01411$CHURCH + DWIGHT$$$$$$Y$$$20240906$$CN$US$US
242923261$24292326$1$I$$20240905$20240906$20240906$EXP$$GB-SANDOZ INC.-SDZ2024GB078154$SANDOZ$$$$$F$Y$$$20240906$$CN$GB$GB
242923271$24292327$1$I$20240805$20240902$20240906$20240906$EXP$$AU-TAKEDA-2023TUS020767$TAKEDA$$30$YR$$M$Y$$$20240906$$CN$AU$AU
242923281$24292328$1$I$$20240830$20240906$20240906$PER$$US-JNJFOC-20240903480$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$CN$US$US
242923291$24292329$1$I$$20240903$20240906$20240906$EXP$$PH-OTSUKA-2024_010687$OTSUKA$$$$$M$Y$$$20240906$$CN$PH$PH
242923301$24292330$1$I$20240509$20240902$20240906$20240906$EXP$$CN-009507513-2409CHN002139$MERCK$$61$YR$$M$Y$55$KG$20240906$$HP$CN$CN
242923313$24292331$3$F$20240901$20240911$20240906$20240916$PER$$US-ALXN-202409USA000006US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
242923321$24292332$1$I$20240823$20240903$20240906$20240906$EXP$$US-ABBVIE-5894701$ABBVIE$$29$YR$$M$Y$$$20240906$$CN$US$US
242923331$24292333$1$I$20230821$20240830$20240906$20240906$EXP$$CN-GSK-CN2024APC108082$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$HP$CN$CN
242923341$24292334$1$I$20240821$20240830$20240906$20240906$EXP$$CO-VANTIVE-2024VAN019419$Vantive US Healthcare$$73$YR$$M$Y$71.5$KG$20240906$$HP$CO$CO
242923351$24292335$1$I$$20240726$20240906$20240906$PER$$US-LUNDBECK-DKLU4002298$LUNDBECK$$$$$$Y$$$20240906$$CN$US$US
242923361$24292336$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141073$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240906$$CN$US$US
242923371$24292337$1$I$$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142327$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240906$$CN$US$US
242923381$24292338$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141977$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240906$$HP$US$US
242923392$24292339$2$F$20240828$20240904$20240906$20240912$PER$$US-AMGEN-USASP2024177220$AMGEN$$$$$M$Y$$$20240912$$PH$US$US
242923401$24292340$1$I$20240101$20240830$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-026066$UNITED THERAPEUTICS$$$$$M$Y$88.435$KG$20240906$$$US$US
242923421$24292342$1$I$$20240821$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08202$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242923431$24292343$1$I$20230527$20240905$20240906$20240906$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049898$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$94$KG$20240906$$MD$DE$DE
242923441$24292344$1$I$20240615$20240904$20240906$20240906$EXP$$US-AstraZeneca-2024A201752$ASTRAZENECA$$22982$DY$$M$Y$$$20240906$$CN$US$
242923451$24292345$1$I$20240822$20240822$20240906$20240906$PER$$US-BRACCO-2024US05227$BRACCO$$$$$$Y$$$20240906$$CN$US$US
242923461$24292346$1$I$20240904$20240904$20240906$20240906$EXP$$FR-ABBVIE-5909055$ABBVIE$$68$YR$$M$Y$$$20240906$$CN$FR$FR
242923472$24292347$2$F$20240829$20240830$20240906$20240912$EXP$$CN-SA-2024SA256019$SANOFI AVENTIS$$66$YR$E$F$Y$53$KG$20240912$$HP$CN$CN
242923481$24292348$1$I$20200121$20240828$20240906$20240906$EXP$$CA-TEVA-VS-3240234$TEVA$$59$YR$$F$Y$86.3$KG$20240906$$CN$CA$CA
242923491$24292349$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA254452$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240906$$MD$US$US
242923501$24292350$1$I$$20240827$20240906$20240906$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001748$BLUEPRINT MEDICINES$$$$$M$Y$$$20240906$$CN$US$US
242923511$24292351$1$I$$20240827$20240906$20240906$EXP$$CA-EMD Serono-2024046222$EMD SERONO INC$$$$A$F$Y$$$20240906$$CN$CA$CA
242923521$24292352$1$I$20240806$20240905$20240906$20240906$PER$$US-ROCHE-10000075315$ROCHE$$56$YR$A$M$Y$$$20240906$$CN$US$US
242923531$24292353$1$I$$20240906$20240906$20240906$DIR$717404$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242923541$24292354$1$I$20200527$20240902$20240906$20240906$EXP$PL-URPL-1-1597-2020$PL-FreseniusKabi-FK202413307$FRESENIUS KABI$$81$YR$E$F$Y$68$KG$20240906$$HP$PL$PL
242923552$24292355$2$F$$20240909$20240906$20240911$EXP$NL-LRB-00999766$NL-FreseniusKabi-FK202413304$FRESENIUS KABI$$67$YR$E$F$Y$94$KG$20240911$$CN$NL$NL
242923561$24292356$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000074938$ROCHE$$$$$M$Y$$$20240906$$CN$US$US
242923571$24292357$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000074937$ROCHE$$$$$M$Y$$$20240906$$CN$US$US
242923581$24292358$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000074935$ROCHE$$$$$M$Y$$$20240906$$CN$US$US
242923591$24292359$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000074926$ROCHE$$$$$M$Y$$$20240906$$CN$US$US
242923612$24292361$2$F$20240801$20240904$20240906$20240911$EXP$$US-GSK-US2024106708$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$US$US
242923621$24292362$1$I$$20240904$20240906$20240906$EXP$$CA-SANDOZ INC.-SDZ2024CA076860$SANDOZ$$$$$F$Y$$$20240906$$MD$CA$CA
242923641$24292364$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61177$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
242923651$24292365$1$I$$20240904$20240905$20240905$DIR$FDA-CDER-CTU-2024-61176$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
242923661$24292366$1$I$$20240906$20240906$20240906$DIR$717413$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242923671$24292367$1$I$$20240906$20240906$20240906$DIR$717414$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242923681$24292368$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61265$$FDA-CTU$$63$YR$$M$N$$$20240905$N$$US$
242923691$24292369$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61243$$FDA-CTU$$75$YR$$F$N$69.4$KG$20240905$N$$US$
242923711$24292371$1$I$$20240821$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08354$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242923721$24292372$1$I$$20240830$20240906$20240906$EXP$$US-Indivior Limited-INDV-156285-2024$RECKITT BENCKISER$$$$$$Y$$$20240906$$MD$US$US
242923731$24292373$1$I$$20240823$20240906$20240906$EXP$$US-PHARMAAND GMBH-2024PHR00501$pharmaAND$$$$$F$Y$$$20240906$$CN$US$US
242923741$24292374$1$I$20240607$20240823$20240906$20240906$EXP$GB-MHRA-MIDB-0e08d91e-2039-4396-ab27-24e114cef9d1$GB-PHARMAAND GMBH-2024PHR00499$pharmaAND$$34$YR$$$Y$$$20240906$$PH$GB$GB
242923751$24292375$1$I$20240830$20240903$20240906$20240906$EXP$$AR-JNJFOC-20240907963$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240906$$CN$AR$AR
242923761$24292376$1$I$20240130$20240822$20240906$20240906$EXP$$BE-JNJFOC-20240908231$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$80$KG$20240906$$MD$BE$BE
242923771$24292377$1$I$$20240904$20240906$20240906$EXP$$US-TAKEDA-2024TUS089204$TAKEDA$$$$$F$Y$$$20240906$$MD$US$US
242923781$24292378$1$I$$20240904$20240906$20240906$PER$$US-JNJFOC-20240911330$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$CN$US$US
242923811$24292381$1$I$$20240903$20240906$20240906$EXP$$CA-ABBVIE-5906951$ABBVIE$$$$A$F$Y$$$20240906$$HP$CA$CA
242923831$24292383$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906970$ABBVIE$$$$$F$Y$$$20240906$$HP$US$US
242923841$24292384$1$I$20240610$20240903$20240906$20240906$EXP$FR-AFSSAPS-LL2024001646$FR-009507513-2409FRA001124$MERCK$$55$YR$$F$Y$$$20240906$$MD$FR$FR
242923851$24292385$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5906489$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242923861$24292386$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906857$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242923881$24292388$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142088$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240906$$CN$US$US
242923891$24292389$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141670$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$64.86$KG$20240906$$CN$US$US
242923901$24292390$1$I$20240630$20240905$20240905$20240905$DIR$717358$$FDA-CTU$$62$YR$$F$N$55.35$KG$20240905$N$CN$US$
242923911$24292391$1$I$20230101$20240829$20240906$20240906$EXP$$US-BIOGEN-2024BI01280604$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242923921$24292392$1$I$19910101$20240902$20240906$20240906$EXP$FR-AFSSAPS-AVCN2024000670$FR-INDIVIOR US-INDV-156294-2024$RECKITT BENCKISER$$$$$$Y$$$20240906$$MD$FR$FR
242923931$24292393$1$I$$20240904$20240906$20240906$EXP$$US-SANDOZ INC.-SDZ2024US078091$SANDOZ$$40$YR$$M$Y$$$20240906$$CN$US$US
242923941$24292394$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA001284$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240906$$MD$US$US
242923951$24292395$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA258032$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240906$$MD$US$US
242923961$24292396$1$I$$20240828$20240906$20240906$30DAY$$US-GSK-US2024AMR107991$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242923971$24292397$1$I$$20240821$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08356$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242923981$24292398$1$I$$20240830$20240906$20240906$EXP$$TW-MYLANLABS-2024M1081558$MYLAN$Hsu J-Y, Lin Y-S, Huang L-H, Wen W-C, Gao H-W, Hsu C-Y, et al. A case report on the atypical metastatic pathway of prostate cancer to the kidney and stomach. Urol-Case-Rep 2024; 56 1-5.$73$YR$$M$Y$$$20240906$$HP$TW$TW
242923991$24292399$1$I$20240730$20240831$20240906$20240906$EXP$$US-MYLANLABS-2024M1080477$MYLAN$$41$YR$$F$Y$$$20240906$$HP$US$US
242924001$24292400$1$I$20240101$20240903$20240906$20240906$EXP$$CA-SANDOZ INC.-SDZ2024CA077605$SANDOZ$$$$$F$Y$$$20240906$$MD$CA$CA
242924011$24292401$1$I$20240101$20240822$20240906$20240906$EXP$$FR-SA-2024SA237648$SANOFI AVENTIS$$$$A$F$Y$63$KG$20240906$$MD$FR$FR
242924022$24292402$2$F$20240814$20240830$20240906$20240907$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026316$UNITED THERAPEUTICS$$81$YR$$F$Y$45.805$KG$20240907$$PH$US$US
242924031$24292403$1$I$20240701$20240902$20240906$20240906$EXP$$DE-FreseniusKabi-FK202413337$FRESENIUS KABI$$72$YR$E$F$Y$$$20240906$$MD$DE$DE
242924041$24292404$1$I$$20240828$20240906$20240906$EXP$$US-FreseniusKabi-FK202413397$FRESENIUS KABI$Nanah A, Nair AS, Stoller J. Delayed Response to Glucocorticoids in Daptomycin Lung. American Journal of Therapeutics. 2024 Mar 26;31(4): e518-e521. doi:https://dx.doi.org/10.1097/MJT.0000000000001728.$75$YR$E$M$Y$$$20240906$$MD$US$US
242924051$24292405$1$I$20240729$20240902$20240906$20240906$EXP$$FR-FreseniusKabi-FK202413372$FRESENIUS KABI$$62$YR$A$F$Y$$$20240906$$MD$FR$FR
242924061$24292406$1$I$20240827$20240902$20240906$20240906$PER$$CN-Eisai-EC-2024-173605$EISAI$$62$YR$E$M$Y$65$KG$20240906$$HP$CN$CN
242924071$24292407$1$I$$20240830$20240906$20240906$EXP$$GB-SA-2024SA257769$SANOFI AVENTIS$$$$E$M$Y$$$20240906$$MD$GB$GB
242924091$24292409$1$I$20240523$20240821$20240906$20240906$PER$$US-SA-2024SA258623$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240906$$MD$US$US
242924101$24292410$1$I$$20240827$20240906$20240906$PER$$US-SA-2024SA258370$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240906$$HP$US$US
242924111$24292411$1$I$20240827$20240904$20240906$20240906$EXP$$CL-ABBVIE-5906922$ABBVIE$$53$YR$$F$Y$$$20240906$$CN$CL$CL
242924121$24292412$1$I$20240808$20240823$20240906$20240906$PER$$US-SA-2024SA257146$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240906$$MD$US$US
242924131$24292413$1$I$$20240827$20240906$20240906$PER$$US-GILEAD-2024-0685548$GILEAD$$$$$M$Y$$$20240906$$MD$US$US
242924141$24292414$1$I$$20240828$20240906$20240906$EXP$$US-JNJFOC-20240878693$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$HP$US$US
242924151$24292415$1$I$20240904$20240904$20240906$20240906$PER$$US-JNJFOC-20240909117$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240906$$HP$US$US
242924161$24292416$1$I$$20240830$20240906$20240906$EXP$$GB-JNJFOC-20240900865$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240906$$MD$GB$GB
242924181$24292418$1$I$$20240826$20240906$20240906$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004066$PAREXEL$$$$$$Y$$$20240906$$CN$US$US
242924191$24292419$1$I$20240831$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200786$ASTRAZENECA$$29145$DY$$F$Y$$$20240906$$CN$US$
242924201$24292420$1$I$20240601$20240827$20240906$20240906$EXP$$ES-BEH-2024177992$CSL BEHRING$$$$$M$Y$$$20240906$$MD$ES$ES
242924211$24292421$1$I$20240402$20240829$20240906$20240906$EXP$$CN-AstraZeneca-2024A199468$ASTRAZENECA$$64$YR$$M$Y$75$KG$20240906$$MD$CN$
242924221$24292422$1$I$$20240902$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027540$UNITED THERAPEUTICS$$$$$M$Y$113.38$KG$20240906$$$US$US
242924231$24292423$1$I$20240702$20240819$20240906$20240906$PER$$US-LEX-000448$LEXICON PHARMACEUTICALS$$93$YR$$F$Y$$$20240906$$CN$US$US
242924241$24292424$1$I$$20240904$20240906$20240906$EXP$$JP-009507513-2409JPN001642$MERCK$Hokamura N, Fukagawa T, Fukushima R, Kiyokawa T, Horikawa M, Soeda N, et al. Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma. BMC Gastroenterol. 2024;24 (1):295$57$YR$$M$Y$$$20240906$$HP$JP$JP
242924253$24292425$3$F$20240101$20240920$20240906$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-027588$UNITED THERAPEUTICS$$$$$F$Y$79.819$KG$20240927$$$US$US
242924261$24292426$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61445$$FDA-CTU$$$$$M$N$$$20240906$N$HP$US$
242924271$24292427$1$I$$20240821$20240906$20240906$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08379$LUPIN$$$$$$Y$$$20240906$$CN$US$US
242924282$24292428$2$F$20240801$20240913$20240906$20240923$PER$$US-ABBVIE-5909330$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
242924301$24292430$1$I$$20240904$20240906$20240906$EXP$$GB-SANDOZ INC.-NVSC2020GB070282$SANDOZ$$$$$F$Y$$$20240906$$CN$GB$GB
242924321$24292432$1$I$$20240826$20240906$20240906$EXP$$US-SA-2024SA257899$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240906$$CN$US$US
242924331$24292433$1$I$20240101$20240829$20240906$20240906$EXP$$US-SA-2024SA231693$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240906$$MD$US$US
242924341$24292434$1$I$20240101$20240903$20240906$20240906$EXP$$US-ABBVIE-5801999$ABBVIE$$$$$M$Y$40$KG$20240906$$HP$US$US
242924351$24292435$1$I$$20240829$20240906$20240906$EXP$$US-SA-2024SA258189$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$MD$US$US
242924361$24292436$1$I$20240101$20240829$20240906$20240906$PER$$US-SA-2024SA255385$SANOFI AVENTIS$$$$I$$Y$$$20240906$$CN$US$US
242924371$24292437$1$I$20240101$20240825$20240906$20240906$PER$$US-SA-2024SA257735$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240906$$MD$US$US
242924381$24292438$1$I$20240823$20240823$20240906$20240906$PER$$US-SA-2024SA254677$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240906$$CN$US$US
242924391$24292439$1$I$20240101$20240829$20240906$20240906$PER$$US-SA-2024SA258480$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240906$$CN$US$US
242924401$24292440$1$I$20240801$20240823$20240906$20240906$PER$$US-SA-2024SA256722$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240906$$MD$US$US
242924411$24292441$1$I$20240726$20240821$20240906$20240906$PER$$US-SA-2024SA258535$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240906$$CN$US$US
242924421$24292442$1$I$20240801$20240823$20240906$20240906$PER$$US-SA-2024SA255477$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240906$$MD$US$US
242924431$24292443$1$I$20240701$20240830$20240906$20240906$PER$$US-SA-2024SA256454$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240906$$CN$US$US
242924441$24292444$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA255269$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240906$$CN$US$US
242924451$24292445$1$I$$20240829$20240906$20240906$PER$$US-JNJFOC-20240880696$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242924461$24292446$1$I$$20240904$20240906$20240906$EXP$$US-BAYER-2024A127741$BAYER$$$$$$Y$$$20240906$$HP$US$US
242924471$24292447$1$I$20220701$20240830$20240906$20240906$EXP$$ES-JNJFOC-20240485779$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240906$$CN$ES$ES
242924491$24292449$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA258760$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240906$$MD$US$US
242924501$24292450$1$I$$20240903$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027669$UNITED THERAPEUTICS$$$$$M$Y$62.585$KG$20240906$$$US$US
242924511$24292451$1$I$$20240830$20240906$20240906$PER$$US-SA-2024SA254484$SANOFI AVENTIS$$$$A$$Y$$$20240906$$CN$US$US
242924521$24292452$1$I$20240112$20240823$20240906$20240906$PER$$US-SA-2024SA256254$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240906$$MD$US$US
242924531$24292453$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA257710$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240906$$HP$US$US
242924541$24292454$1$I$20240808$20240830$20240906$20240906$EXP$$CO-ABBVIE-5908361$ABBVIE$$74$YR$$F$Y$79$KG$20240906$$HP$CO$CO
242924552$24292455$2$F$$20240909$20240906$20240912$PER$$US-ABBVIE-5908887$ABBVIE$$$$$$Y$$$20240912$$HP$US$US
242924561$24292456$1$I$$20240905$20240906$20240906$EXP$$JP-ABBVIE-5908772$ABBVIE$$$$$F$Y$$$20240906$$MD$JP$JP
242924571$24292457$1$I$20160101$20240905$20240906$20240906$EXP$$NVSC2024TW179225$NOVARTIS$$40$YR$$F$Y$$$20240906$$MD$TW$TW
242924581$24292458$1$I$$20240829$20240906$20240906$PER$$US-GILEAD-2024-0685832$GILEAD$$$$$M$Y$$$20240906$$MD$US$US
242924591$24292459$1$I$$20240827$20240906$20240906$EXP$$CA-FreseniusKabi-FK202413129$FRESENIUS KABI$$84$YR$E$M$Y$49$KG$20240906$$PH$CA$CA
242924601$24292460$1$I$20240801$20240904$20240906$20240906$PER$$US-JNJFOC-20240913489$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240906$$CN$US$US
242924611$24292461$1$I$20240701$20240906$20240906$20240906$DIR$717403$$FDA-CTU$$58$YR$$F$N$$$20240906$N$HP$US$
242924621$24292462$1$I$$20240822$20240906$20240906$DIR$FDA-CDER-CTU-2024-61449$$FDA-CTU$$$$$F$N$$$20240822$N$HP$US$
242924631$24292463$1$I$$20240901$20240906$20240906$EXP$$CN-JNJFOC-20240908448$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$HP$CN$PK
242924641$24292464$1$I$20240904$20240904$20240906$20240906$PER$$US-AMGEN-USASL2024177678$AMGEN$$$$$M$Y$$$20240906$$CN$US$US
242924661$24292466$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61456$$FDA-CTU$$53$YR$$F$N$$$20240906$N$$US$
242924671$24292467$1$I$20240101$20240830$20240906$20240906$EXP$$CO-AMGEN-COLSL2024175336$AMGEN$$70$YR$E$F$Y$$$20240906$$CN$CO$CO
242924692$24292469$2$F$20230101$20240912$20240906$20240917$EXP$$CA-ABBVIE-5903464$ABBVIE$$30$YR$$F$Y$$$20240917$$MD$CA$CA
242924701$24292470$1$I$20240814$20240814$20240906$20240906$PER$$FR-TOLMAR, INC.-24FR051883$TOLMAR$$75$YR$$M$Y$$$20240905$$PH$FR$FR
242924711$24292471$1$I$20240814$20240814$20240906$20240906$PER$$FR-TOLMAR, INC.-24FR051889$TOLMAR$$76$YR$$M$Y$$$20240905$$HP$FR$FR
242924721$24292472$1$I$20240815$20240815$20240906$20240906$PER$$IE-TOLMAR, INC.-24IE051945$TOLMAR$$$$$$Y$$$20240905$$PH$IE$IE
242924731$24292473$1$I$20240812$20240814$20240906$20240906$PER$$GT-TOLMAR, INC.-24GT051941$TOLMAR$$74$YR$$M$Y$$$20240905$$CN$GT$GT
242924741$24292474$1$I$$20240815$20240906$20240906$PER$$NL-TOLMAR, INC.-24NL051813$TOLMAR$$$$$M$Y$$$20240905$$CN$NL$NL
242924751$24292475$1$I$20240507$20240815$20240906$20240906$PER$$NL-TOLMAR, INC.-24NL051797$TOLMAR$$73$YR$$M$Y$$$20240905$$CN$NL$NL
242924761$24292476$1$I$20240815$20240815$20240906$20240906$PER$$NL-TOLMAR, INC.-24NL051944$TOLMAR$$66$YR$$M$Y$$$20240905$$HP$NL$NL
242924771$24292477$1$I$20240511$20240816$20240906$20240906$PER$$NL-TOLMAR, INC.-24NL051946$TOLMAR$$86$YR$$M$Y$$$20240905$$CN$NL$NL
242924781$24292478$1$I$20240711$20240814$20240906$20240906$PER$$PA-TOLMAR, INC.-24PA051906$TOLMAR$$65$YR$$M$Y$$$20240905$$CN$PA$PA
242924791$24292479$1$I$$20240816$20240906$20240906$PER$NL-LRB-00996333$NL-TOLMAR, INC.-24NL051948$TOLMAR$$82$YR$$M$Y$$$20240905$$PH$NL$NL
242924801$24292480$1$I$20240801$20240814$20240906$20240906$PER$$TR-TOLMAR, INC.-24TR051764$TOLMAR$$72$YR$$M$Y$$$20240905$$MD$TR$TR
242924811$24292481$1$I$$20240814$20240906$20240906$PER$$PA-TOLMAR, INC.-24PA051908$TOLMAR$$$$$M$Y$$$20240905$$CN$PA$PA
242924821$24292482$1$I$20240815$20240815$20240906$20240906$PER$$TR-TOLMAR, INC.-24TR051887$TOLMAR$$65$YR$$M$Y$$$20240905$$HP$TR$TR
242924832$24292483$2$F$$20240905$20240906$20240909$EXP$$NVSC2024AU178746$NOVARTIS$$$$$F$Y$$$20240909$$CN$AU$AU
242924842$24292484$2$F$$20240906$20240906$20240910$EXP$$NVSC2024GB178099$NOVARTIS$$$$$$Y$$$20240910$$HP$GB$GB
242924852$24292485$2$F$20200130$20240825$20240906$20240909$EXP$$NVSC2020SG086701$NOVARTIS$Yoon KH. Paradoxical Erythrodermic Psoriasis After Secukinumab Treatment In a Patient With Psoriatic Arthritis: A Case Report And Literature Review. 26TH ASIA-PACIFIC LEAGUE OF ASSOCIATIONS FOR RHEUMATOLOGY CONGRESS. 2024$$$A$F$Y$$$20240909$$HP$SG$SG
242924861$24292486$1$I$$20240904$20240906$20240906$EXP$$CA-LUNDBECK-DKLU4003916$LUNDBECK$$$$$$Y$$$20240906$$MD$CA$CA
242924871$24292487$1$I$20240822$20240827$20240906$20240906$PER$$US-ABBVIE-5902057$ABBVIE$$78$YR$$M$Y$$$20240906$$CN$US$US
242924881$24292488$1$I$20240802$20240904$20240906$20240906$EXP$$CA-BAYER-2024A117971$BAYER$$51$YR$A$F$Y$$$20240906$$CN$CA$CA
242924892$24292489$2$F$20240830$20240903$20240906$20240909$PER$$US-BIOGEN-2024BI01281079$BIOGEN$$57$YR$$M$Y$$$20240909$$CN$US$US
242924902$24292490$2$F$20240901$20240917$20240906$20240919$PER$$US-BIOGEN-2024BI01281222$BIOGEN$$56$YR$$F$Y$$$20240919$$CN$US$US
242924931$24292493$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61452$$FDA-CTU$$68$YR$$F$N$$$20240906$N$$US$
242924941$24292494$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61455$$FDA-CTU$$$$$M$N$$$20240905$N$HP$US$
242924951$24292495$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61443$$FDA-CTU$$60$YR$$F$N$$$20240906$N$$US$
242924971$24292497$1$I$20240826$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61439$$FDA-CTU$$47$YR$$F$N$$$20240906$Y$HP$US$
242924991$24292499$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61446$$FDA-CTU$$63$YR$$M$N$$$20240906$N$HP$US$
242925021$24292502$1$I$$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61444$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242925031$24292503$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61416$$FDA-CTU$$78$YR$$M$N$$$20240905$N$CN$US$
242925061$24292506$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61451$$FDA-CTU$$$$$M$N$$$20240905$N$HP$US$
242925071$24292507$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61437$$FDA-CTU$$62$YR$$F$N$$$20240906$N$$US$
242925081$24292508$1$I$$20240903$20240906$20240906$DIR$FDA-CDER-CTU-2024-61426$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
242925111$24292511$1$I$20240830$20240905$20240905$20240905$DIR$717371$$FDA-CTU$$58$YR$$M$N$70$KG$20240905$Y$CN$AU$
242925121$24292512$1$I$$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61427$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242925131$24292513$1$I$$20240819$20240906$20240906$DIR$FDA-CDER-CTU-2024-61442$$FDA-CTU$$$$$M$N$$$20240819$N$HP$US$
242925151$24292515$1$I$$20240904$20240906$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014381$JAZZ$$$$$M$Y$$$20240906$$CN$US$US
242925161$24292516$1$I$$20240905$20240906$20240906$EXP$$NVSC2024GB178841$NOVARTIS$$$$$$Y$$$20240906$$HP$GB$GB
242925171$24292517$1$I$$20240906$20240906$20240906$EXP$$US-TAKEDA-2024TUS088561$TAKEDA$$$$$M$Y$66.667$KG$20240906$$CN$US$US
242925191$24292519$1$I$$20240904$20240906$20240906$PER$$US-009507513-2409USA001957$MERCK$$$$$M$Y$$$20240906$$HP$US$US
242925201$24292520$1$I$$20240830$20240906$20240906$EXP$$CA-TAKEDA-2024TUS088236$TAKEDA$$$$$M$Y$$$20240906$$CN$CA$CA
242925221$24292522$1$I$20240101$20240903$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-024088$UNITED THERAPEUTICS$$$$$M$Y$136.05$KG$20240906$$$US$US
242925231$24292523$1$I$$20240903$20240906$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027497$UNITED THERAPEUTICS$$$$$F$Y$$$20240906$$$US$US
242925242$24292524$2$F$20240101$20240906$20240906$20240911$PER$$US-UNITED THERAPEUTICS-UNT-2024-022723$UNITED THERAPEUTICS$$$$$F$Y$70.295$KG$20240911$$$US$US
242925252$24292525$2$F$20240101$20240916$20240906$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-027745$UNITED THERAPEUTICS$$$$$F$Y$83.9$KG$20240919$$$US$US
242925261$24292526$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A198970$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242925271$24292527$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176382$AMGEN$$$$$M$Y$$$20240906$$CN$US$US
242925281$24292528$1$I$20240808$20240831$20240906$20240906$EXP$$BY-AstraZeneca-2024A201945$ASTRAZENECA$$22748$DY$$F$Y$60$KG$20240906$$CN$BY$
242925291$24292529$1$I$20240819$20240903$20240906$20240906$EXP$$CN-AstraZeneca-2024A201598$ASTRAZENECA$$15805$DY$$F$Y$$$20240906$$MD$CN$
242925301$24292530$1$I$20240827$20240829$20240906$20240906$EXP$$US-AstraZeneca-2024A200062$ASTRAZENECA$$21727$DY$$F$Y$$$20240906$$CN$US$
242925311$24292531$1$I$$20240903$20240906$20240906$EXP$$ZA-AstraZeneca-2024A201800$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$ZA$
242925321$24292532$1$I$$20240904$20240906$20240906$EXP$$US-AstraZeneca-2024A201779$ASTRAZENECA$$$$$$Y$$$20240906$$CN$US$
242925331$24292533$1$I$$20240829$20240906$20240906$EXP$$US-AstraZeneca-2024A197942$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242925341$24292534$1$I$20240724$20240902$20240906$20240906$EXP$$UA-009507513-2407UKR014360$MERCK$$58$YR$$M$Y$76$KG$20240906$$MD$UA$UA
242925351$24292535$1$I$20240807$20240906$20240906$20240906$EXP$PT-INFARMED-E202408-877$NVSC2024PT179178$NOVARTIS$$72$YR$$M$Y$$$20240906$$PH$PT$PT
242925361$24292536$1$I$20200627$20240905$20240906$20240906$EXP$PL-URPL-1-2134-2020$PL-GSK-PL2024110578$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$PL$PL
242925371$24292537$1$I$20210503$20240830$20240906$20240906$EXP$$RU-Eisai-EC-2024-173843$EISAI$$53$YR$A$M$Y$$$20240906$$MD$RU$RU
242925381$24292538$1$I$20240726$20240903$20240906$20240906$EXP$FR-AFSSAPS-MA2024001287$FR-GSK-FR2024109355$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$FR$FR
242925391$24292539$1$I$$20240904$20240906$20240906$EXP$GB-MHRA-MIDB-9164c202-6e82-4692-99ec-442ea1f6539b$GB-DSJP-DSE-2024-143635$DAIICHI$$67$YR$$M$Y$$$20240906$$PH$GB$GB
242925411$24292541$1$I$$20240902$20240906$20240906$PER$US-MLMSERVICE-20240826-PI172745-00083-1$US-RDY-SPO/USA/24/0012829$DR REDDYS$Cohen M, Jones C. Patient and physician perspectives on the benefits and risks of antiplatelet therapy for acute coronary syndrome. Cardiology and Therapy. 2024;13(3):631-43. DOI:10.1007/s40119-024-00372-7.$41$YR$A$M$Y$$$20240906$$MD$US$US
242925421$24292542$1$I$20240824$20240830$20240906$20240906$EXP$$MM-BIOCON BIOLOGICS LIMITED-BBL2024006471$BIOCON$$$$$$Y$$$20240906$$CN$MM$MM
242925432$24292543$2$F$$20240904$20240906$20240911$EXP$$US-AMGEN-USASP2024176622$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
242925441$24292544$1$I$$20240830$20240906$20240906$EXP$$US-AMGEN-USASP2024177130$AMGEN$$$$$$Y$$$20240906$$CN$US$US
242925461$24292546$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003421$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240906$$CN$US$US
242925471$24292547$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001637$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240906$$CN$US$US
242925481$24292548$1$I$20240625$20240828$20240906$20240906$PER$$US-SA-2024SA257995$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240906$$MD$US$US
242925492$24292549$2$F$$20240828$20240906$20240920$PER$$US-SA-2024SA256257$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240920$$CN$US$US
242925501$24292550$1$I$$20240903$20240906$20240906$PER$$US-UNITED THERAPEUTICS-UNT-2024-027765$UNITED THERAPEUTICS$$$$$F$Y$74.376$KG$20240906$$$US$US
242925511$24292551$1$I$20240801$20240828$20240906$20240906$PER$$US-SA-2024SA258345$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240906$$MD$US$US
242925521$24292552$1$I$$20240827$20240906$20240906$PER$$US-SA-2024SA258530$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240906$$MD$US$US
242925531$24292553$1$I$$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61447$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
242925541$24292554$1$I$$20240905$20240905$20240905$DIR$717323$$FDA-CTU$$$$$F$N$$$20240905$N$CN$US$
242925552$24292555$2$F$20231029$20240905$20240906$20240911$EXP$$US-GSK-US2023099681$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$US$US
242925564$24292556$4$F$20240807$20240919$20240906$20240924$PER$$US-AMGEN-USASP2024168266$AMGEN$$52$YR$A$F$Y$75.8$KG$20240924$$PH$US$US
242925571$24292557$1$I$20240716$20240823$20240906$20240906$EXP$$RU-PIERREL S.P.A.-2024PIR00056$PIERREL$$31$YR$$M$Y$$$20240906$$HP$RU$RU
242925581$24292558$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61450$$FDA-CTU$$76$YR$$F$N$$$20240906$N$$US$
242925591$24292559$1$I$20240829$20240904$20240906$20240906$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027847$UNITED THERAPEUTICS$$78$YR$$M$Y$69.388$KG$20240906$$$US$US
242925601$24292560$1$I$20240901$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61438$$FDA-CTU$$57$YR$$M$N$$$20240905$N$HP$US$
242925671$24292567$1$I$20240905$20240906$20240906$20240906$DIR$717379$$FDA-CTU$$25$YR$$UNK$N$56.25$KG$20240906$$CN$US$
242925681$24292568$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61453$$FDA-CTU$$69$YR$$F$N$$$20240906$N$$US$
242925691$24292569$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61424$$FDA-CTU$$$$$M$N$$$20240905$N$HP$US$
242925701$24292570$1$I$20240903$20240905$20240905$20240905$DIR$717293$$FDA-CTU$$21$YR$$M$N$55.8$KG$20240905$Y$CN$US$
242925731$24292573$1$I$20240612$20240821$20240906$20240906$DIR$FDA-CDER-CTU-2024-61454$$FDA-CTU$$5$MON$$M$N$$$20240821$N$HP$US$
242925761$24292576$1$I$20240903$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61440$$FDA-CTU$$27$YR$$M$N$$$20240906$N$$US$
242925771$24292577$1$I$20240823$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61425$$FDA-CTU$$57$YR$$$N$$$20240906$N$$US$
242925791$24292579$1$I$$20240828$20240906$20240906$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17364$IPSEN$$24$YR$A$F$Y$$$20240906$$HP$US$US
242925801$24292580$1$I$$20240828$20240906$20240906$EXP$$IL-Taiho Oncology Inc-2024-005938$TAIHO ONCOLOGY INC$$74$YR$E$M$Y$$$20240906$$CN$IL$IL
242925811$24292581$1$I$$20240830$20240906$20240906$EXP$$CA-ABBVIE-5908678$ABBVIE$$52$YR$$F$Y$$$20240906$$HP$CA$CA
242925821$24292582$1$I$$20240827$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109844$VIIV$$$$$$Y$$$20240906$$HP$US$US
242925831$24292583$1$I$20240902$20240906$20240906$20240906$DIR$717376$$FDA-CTU$$5$YR$$M$N$21$KG$20240906$Y$PH$RU$
242925841$24292584$1$I$$20240827$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109846$VIIV$$$$$$Y$$$20240906$$HP$US$US
242925851$24292585$1$I$20240320$20240906$20240906$20240906$DIR$717377$$FDA-CTU$$53$YR$$F$N$127.8$KG$20240906$N$CN$US$
242925861$24292586$1$I$$20240827$20240906$20240906$EXP$$MA-BIOMARINAP-MA-2024-160324$BIOMARIN$$$$$$Y$$$20240906$$CN$US$MA
242925881$24292588$1$I$$20240827$20240906$20240906$PER$$US-TAKEDA-2024TUS086523$TAKEDA$$63$YR$$M$Y$94$KG$20240906$$MD$US$US
242925901$24292590$1$I$20240831$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A201140$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242925911$24292591$1$I$20240701$20240829$20240906$20240906$EXP$$JP-AstraZeneca-2024A198893$ASTRAZENECA$$$$A$F$Y$$$20240906$$MD$JP$
242925921$24292592$1$I$$20240808$20240906$20240906$PER$$US-AstraZeneca-2024A182529$ASTRAZENECA$$$$$$Y$$$20240906$$HP$US$
242925941$24292594$1$I$20240821$20240829$20240906$20240906$EXP$$CN-AstraZeneca-2024A198276$ASTRAZENECA$$27571$DY$$M$Y$55$KG$20240906$$MD$CN$
242925951$24292595$1$I$$20240829$20240906$20240906$EXP$$CA-AstraZeneca-2024A199362$ASTRAZENECA$$$$$M$Y$$$20240906$$HP$CA$
242925961$24292596$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA255912$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240906$$MD$US$US
242925971$24292597$1$I$20240101$20240830$20240906$20240906$PER$$US-SA-2024SA255466$SANOFI AVENTIS$$$$$F$Y$$$20240906$$CN$US$US
242925981$24292598$1$I$$20240903$20240906$20240906$EXP$$SE-AstraZeneca-2024A203188$ASTRAZENECA$$61$YR$$F$Y$$$20240906$$HP$SE$
242925992$24292599$2$F$20240702$20240906$20240906$20240913$PER$$US-SA-2024SA255499$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240913$$CN$US$US
242926011$24292601$1$I$$20240830$20240906$20240906$EXP$$VN-AstraZeneca-2024A202041$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$VN$
242926021$24292602$1$I$20240814$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200665$ASTRAZENECA$$33242$DY$$F$Y$$$20240906$$CN$US$
242926031$24292603$1$I$20240101$20240830$20240906$20240906$EXP$$GB-AstraZeneca-2024A193100$ASTRAZENECA$$57$YR$$M$Y$55.6$KG$20240906$$MD$GB$
242926041$24292604$1$I$$20240903$20240906$20240906$EXP$$VN-AstraZeneca-2024A201528$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$VN$
242926051$24292605$1$I$$20240903$20240906$20240906$EXP$$BR-DAIICHI SANKYO, INC.-DSE-2024-143814$DAIICHI$$$$$F$Y$$$20240906$$MD$BR$BR
242926061$24292606$1$I$$20240830$20240906$20240906$EXP$$VN-AstraZeneca-2024A201731$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$VN$
242926071$24292607$1$I$$20240903$20240906$20240906$EXP$$IT-AstraZeneca-2024A199927$ASTRAZENECA$$60$YR$$M$Y$94$KG$20240906$$MD$IT$
242926081$24292608$1$I$$20240905$20240906$20240906$EXP$$US-AstraZeneca-2024A202384$ASTRAZENECA$Mina Gerges, Lefika Bathobakae, Anas Mahmoud, Remon Saad, Sherif Elkattawy, Fayez Shamoon, Mourad Ismail. The great mimicker: a unique case of diffuse subarachnoid haemorrhage simulating acute myocardial infarction.. European Journal of Case Reports in Internal Medicine 2024;$44$YR$$F$Y$$$20240906$$HP$US$
242926091$24292609$1$I$$20240829$20240906$20240906$EXP$$US-AstraZeneca-2024A198141$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242926101$24292610$1$I$$20240830$20240906$20240906$EXP$$JP-AstraZeneca-2024A199617$ASTRAZENECA$$$$$F$Y$$$20240906$$MD$JP$
242926111$24292611$1$I$$20240830$20240906$20240906$EXP$$AR-AstraZeneca-2024A198919$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$AR$
242926121$24292612$1$I$$20240830$20240906$20240906$PER$$US-AstraZeneca-2024A198255$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242926131$24292613$1$I$20240902$20240905$20240906$20240906$EXP$$US-AstraZeneca-2024A202760$ASTRAZENECA$$$$$F$Y$$$20240906$$MD$US$
242926141$24292614$1$I$20230903$20240903$20240906$20240906$EXP$$RO-AstraZeneca-2024A202671$ASTRAZENECA$$77$YR$$F$Y$$$20240906$$MD$RO$
242926151$24292615$1$I$$20240827$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109917$VIIV$$$$$$Y$$$20240906$$HP$US$US
242926161$24292616$1$I$$20240827$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109847$VIIV$$$$$$Y$$$20240906$$HP$US$US
242926171$24292617$1$I$$20240829$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109854$VIIV$$$$$$Y$$$20240906$$HP$US$US
242926181$24292618$1$I$$20240827$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109877$VIIV$$$$$$Y$$$20240906$$HP$US$US
242926191$24292619$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141645$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240906$$HP$US$US
242926201$24292620$1$I$$20240903$20240906$20240906$EXP$$NVSC2024KR178521$NOVARTIS$$17$YR$$M$Y$$$20240906$$MD$KR$KR
242926211$24292621$1$I$$20240830$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139543$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240906$$HP$US$US
242926221$24292622$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142127$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$66.22$KG$20240906$$CN$US$US
242926231$24292623$1$I$20240731$20240905$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141924$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240906$$CN$US$US
242926251$24292625$1$I$$20240905$20240906$20240906$EXP$$NVSC2024US179098$NOVARTIS$$$$$F$Y$$$20240906$$HP$US$US
242926261$24292626$1$I$20240808$20240904$20240906$20240906$EXP$$KR-DAIICHI SANKYO, INC.-DSJ-2024-143566$DAIICHI$$54$YR$$F$Y$$$20240906$$CN$KR$KR
242926271$24292627$1$I$$20240826$20240906$20240906$EXP$$SE-B.Braun Medical Inc.-2161323$B BRAUN$Literature Article$24$MON$$F$Y$2.005$KG$20240906$$$SE$SE
242926281$24292628$1$I$20240828$20240828$20240906$20240906$PER$$US-ABBVIE-5900452$ABBVIE$$62$YR$$F$Y$$$20240906$$CN$US$US
242926291$24292629$1$I$20240717$20240829$20240906$20240906$EXP$$DE-TEVA-VS-3239320$TEVA$$55$YR$$F$Y$130$KG$20240906$$PH$DE$DE
242926301$24292630$1$I$$20240826$20240906$20240906$EXP$$CA-B.Braun Medical Inc.-2161325$B BRAUN$$84$YR$$M$Y$49$KG$20240906$$$CA$CA
242926311$24292631$1$I$$20240826$20240906$20240906$EXP$$CN-B.Braun Medical Inc.-2161324$B BRAUN$$87$YR$$F$Y$40$KG$20240906$$$CN$CN
242926321$24292632$1$I$$20240826$20240906$20240906$EXP$$RU-B.Braun Medical Inc.-2161319$B BRAUN$$32$YR$$F$Y$55$KG$20240906$$$RU$RU
242926331$24292633$1$I$$20240826$20240906$20240906$EXP$$US-B.Braun Medical Inc.-2161320$B BRAUN$Literature Article$39$YR$$F$Y$$$20240906$$$US$US
242926341$24292634$1$I$$20240903$20240906$20240906$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-143514$DAIICHI$$$$$F$Y$$$20240906$$MD$JP$JP
242926352$24292635$2$F$20240827$20240910$20240906$20240912$EXP$IT-MINISAL02-1000941$IT-DSJP-DSE-2024-143534$DAIICHI$$63$YR$$F$Y$60$KG$20240912$$MD$IT$IT
242926361$24292636$1$I$20240816$20240830$20240906$20240906$EXP$$CN-DSJP-DSJ-2024-143058$DAIICHI$$38$YR$$F$Y$59$KG$20240906$$HP$CN$CN
242926371$24292637$1$I$$20240903$20240906$20240906$EXP$$US-TAKEDA-2024TUS088432$TAKEDA$$$$$M$Y$$$20240906$$HP$US$US
242926381$24292638$1$I$20240701$20240829$20240906$20240906$EXP$$GR-KARYOPHARM-2024KPT001512$KARYOPHARM THERAPEUTICS$$64$YR$$F$Y$90$KG$20240906$$CN$GR$GR
242926391$24292639$1$I$$20240905$20240906$20240906$EXP$$US-PFIZER INC-202400251024$PFIZER$$67$YR$$F$Y$$$20240906$$CN$US$US
242926401$24292640$1$I$20240717$20240902$20240906$20240906$EXP$$CN-PFIZER INC-PV202400116825$PFIZER$$64$YR$$M$Y$$$20240906$$HP$CN$CN
242926411$24292641$1$I$$20240826$20240906$20240906$EXP$$CA-B.Braun Medical Inc.-2161327$B BRAUN$$65$YR$$F$Y$34$KG$20240906$$$CA$CA
242926421$24292642$1$I$20240101$20240905$20240906$20240906$EXP$$CI-PFIZER INC-PV202400117062$PFIZER$$48$YR$$M$Y$$$20240906$$MD$CI$CI
242926431$24292643$1$I$20220129$20240906$20240906$20240906$EXP$$DE-PFIZER INC-202400251292$PFIZER$$80$YR$$F$Y$60$KG$20240906$$MD$DE$DE
242926441$24292644$1$I$$20240906$20240906$20240906$EXP$$JP-PFIZER INC-202400251223$PFIZER$$$$A$$Y$$$20240906$$MD$JP$JP
242926451$24292645$1$I$20240101$20240903$20240906$20240906$EXP$$US-PFIZER INC-202400249410$PFIZER$$$$$$Y$$$20240906$$MD$US$US
242926463$24292646$3$F$$20240903$20240906$20240915$PER$$US-SMPA-2024SPA002247$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
242926472$24292647$2$F$20240805$20240914$20240906$20240920$EXP$$MX-VANTIVE-2024VAN019566$Vantive US Healthcare$$61$YR$$M$Y$81.5$KG$20240920$$CN$MX$MX
242926481$24292648$1$I$20240830$20240906$20240906$20240906$DIR$717396$$FDA-CTU$$34$YR$$F$N$69.75$KG$20240906$N$CN$US$
242926491$24292649$1$I$20240415$20240905$20240905$20240905$DIR$717359$$FDA-CTU$$65$YR$$M$N$85.5$KG$20240905$N$CN$US$
242926501$24292650$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA258318$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240906$$MD$US$US
242926511$24292651$1$I$20240101$20240822$20240906$20240906$PER$$US-SA-2024SA257130$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240906$$MD$US$US
242926521$24292652$1$I$20090101$20240825$20240906$20240906$PER$$US-SA-2024SA256905$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$CN$US$US
242926581$24292658$1$I$20240515$20240905$20240905$20240905$DIR$717339$$FDA-CTU$$67$YR$$F$N$123.75$KG$20240905$$CN$US$
242926602$24292660$2$F$$20240917$20240906$20240922$EXP$$US-BIOGEN-2024BI01279990$BIOGEN$$$$$F$Y$$$20240922$$CN$US$US
242926611$24292661$1$I$$20240827$20240906$20240906$EXP$$CA-FreseniusKabi-FK202413137$FRESENIUS KABI$$48$YR$A$M$Y$$$20240906$$HP$CA$CA
242926621$24292662$1$I$20240723$20240903$20240906$20240906$EXP$$GB-GSK-GB2024GSK110297$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$GB$GB
242926631$24292663$1$I$20240724$20240830$20240906$20240906$EXP$$CN-JNJFOC-20240900972$JOHNSON AND JOHNSON$$21$YR$A$M$Y$80$KG$20240906$$HP$CN$CN
242926641$24292664$1$I$20240815$20240816$20240906$20240906$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000818$PAREXEL$$$$$$Y$$$20240906$$HP$US$US
242926651$24292665$1$I$20240808$20240812$20240906$20240906$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000790$PAREXEL$$$$$$Y$$$20240906$$HP$US$US
242926671$24292667$1$I$$20240904$20240906$20240906$EXP$$CA-BIOMARINAP-CA-2024-160323$BIOMARIN$$$$$$Y$$$20240906$$CN$CA$CA
242926681$24292668$1$I$20240821$20240830$20240906$20240906$EXP$$MX-BIOMARINAP-MX-2024-160320$BIOMARIN$$$$$$Y$$$20240906$$CN$MX$MX
242926691$24292669$1$I$$20240905$20240906$20240906$PER$$US-TAKEDA-2024TUS089133$TAKEDA$$$$$F$Y$$$20240906$$CN$US$US
242926701$24292670$1$I$20240809$20240904$20240906$20240906$EXP$ES-AEMPS-1565578$ES-DSJP-DSE-2024-143543$DAIICHI$$79$YR$$M$Y$$$20240906$$MD$ES$ES
242926711$24292671$1$I$$20240827$20240906$20240906$EXP$$JP-ROCHE-10000013967$ROCHE$$9$DEC$E$$Y$$$20240906$$MD$JP$JP
242926721$24292672$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176258$AMGEN$$53$YR$A$F$Y$$$20240906$$CN$US$US
242926731$24292673$1$I$$20240827$20240906$20240906$EXP$FR-AFSSAPS-MP2024001335$FR-ELI_LILLY_AND_COMPANY-PF202408017582$ELI LILLY AND CO$$$$N$F$Y$2.92$KG$20240906$$CN$PF$PF
242926741$24292674$1$I$$20240827$20240906$20240906$EXP$$KW-ELI_LILLY_AND_COMPANY-KW202408018350$ELI LILLY AND CO$$$$$F$Y$$$20240906$$MD$KW$KW
242926751$24292675$1$I$20240823$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408271113543720-RSKYW$GB-ELI_LILLY_AND_COMPANY-GB202408017773$ELI LILLY AND CO$$58$YR$A$F$Y$86$KG$20240906$$CN$GB$GB
242926761$24292676$1$I$$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408271210156700-HKDRP$GB-ELI_LILLY_AND_COMPANY-GB202408017632$ELI LILLY AND CO$$$$$F$Y$$$20240906$$CN$GB$GB
242926771$24292677$1$I$20220401$20240826$20240906$20240906$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202408017398$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240906$$CN$KR$KR
242926781$24292678$1$I$20240825$20240827$20240906$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US202408017678$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240906$$CN$US$US
242926791$24292679$1$I$$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408270921022300-JYWLF$GB-ELI_LILLY_AND_COMPANY-GB202408017743$ELI LILLY AND CO$$$$$F$Y$$$20240906$$CN$GB$GB
242926801$24292680$1$I$$20240827$20240906$20240906$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408017870AA$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240906$$CN$JP$JP
242926811$24292681$1$I$$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408271506256430-NWBFC$GB-ELI_LILLY_AND_COMPANY-GB202408017667$ELI LILLY AND CO$$$$$$Y$$$20240906$$CN$GB$GB
242926821$24292682$1$I$$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408271207429850-RFQCM$GB-ELI_LILLY_AND_COMPANY-GB202408017628$ELI LILLY AND CO$$$$$M$Y$$$20240906$$CN$GB$GB
242926831$24292683$1$I$$20240826$20240906$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016384$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240906$$CN$US$US
242926841$24292684$1$I$20230101$20240826$20240906$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016564$ELI LILLY AND CO$$92$YR$E$F$Y$$$20240906$$CN$US$US
242926851$24292685$1$I$20240715$20240826$20240906$20240906$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408011386$ELI LILLY AND CO$$49$YR$A$M$Y$95$KG$20240906$$CN$JP$JP
242926871$24292687$1$I$20240805$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61461$$FDA-CTU$$$$$$N$$$20240904$N$$US$
242926881$24292688$1$I$20220224$20240826$20240906$20240906$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202408018343$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240906$$CN$KR$KR
242926891$24292689$1$I$$20240827$20240906$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018276$ELI LILLY AND CO$$$$$$Y$$$20240906$$CN$US$US
242926901$24292690$1$I$20240608$20240827$20240906$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018003$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240906$$CN$US$US
242926911$24292691$1$I$$20240827$20240906$20240906$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202408017435$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240906$$MD$SA$SA
242926922$24292692$2$F$20201123$20240906$20240906$20240911$EXP$PL-URPL-1-3286-2020$PL-BIOVITRUM-2024-PL-011701$BIOVITRUM$$2$YR$$F$Y$12$KG$20240911$$MD$PL$PL
242926931$24292693$1$I$$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2947$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242926941$24292694$1$I$$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2955$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242926951$24292695$1$I$$20231004$20240906$20240906$PER$$US-FARMAPROD-202310-2981$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$MD$US$
242926961$24292696$1$I$$20231005$20240906$20240906$PER$$US-FARMAPROD-202310-2983$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242926971$24292697$1$I$20230930$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-2962$DOMPE FARMACEUTICI$$65$YR$E$M$Y$$$20240904$$CN$US$
242926981$24292698$1$I$20230901$20231005$20240906$20240906$PER$$US-FARMAPROD-202310-2987$DOMPE FARMACEUTICI$$51$YR$A$F$Y$$$20240904$$CN$US$
242926991$24292699$1$I$$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2949$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927001$24292700$1$I$$20231016$20240906$20240906$PER$$US-FARMAPROD-202310-2980$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927011$24292701$1$I$$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2956$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242927021$24292702$1$I$$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2951$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927031$24292703$1$I$$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2961$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242927041$24292704$1$I$20231005$20231018$20240906$20240906$PER$$US-FARMAPROD-202310-2989$DOMPE FARMACEUTICI$$49$YR$A$F$Y$$$20240904$$CN$US$
242927051$24292705$1$I$$20231004$20240906$20240906$PER$$US-FARMAPROD-202310-2970$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242927061$24292706$1$I$20230801$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2948$DOMPE FARMACEUTICI$$59$YR$A$F$Y$$$20240904$$CN$US$
242927071$24292707$1$I$$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2960$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927091$24292709$1$I$20230901$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2958$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240904$$CN$US$
242927101$24292710$1$I$$20231005$20240906$20240906$PER$$US-FARMAPROD-202310-2988$DOMPE FARMACEUTICI$$$$E$M$Y$79.38$KG$20240904$$CN$US$
242927111$24292711$1$I$$20231019$20240906$20240906$PER$$US-FARMAPROD-202310-2985$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242927121$24292712$1$I$20231003$20231004$20240906$20240906$PER$$US-FARMAPROD-202310-2977$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$
242927131$24292713$1$I$$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2959$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927141$24292714$1$I$$20240828$20240906$20240906$EXP$$ZA-TEVA-VS-3238508$TEVA$$68$YR$$F$Y$$$20240906$$CN$ZA$ZA
242927151$24292715$1$I$$20240827$20240906$20240906$EXP$$US-SA-2024SA258164$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240906$$CN$US$US
242927171$24292717$1$I$$20231009$20240906$20240906$PER$$US-FARMAPROD-202310-3024$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242927181$24292718$1$I$$20231003$20240906$20240906$PER$$US-FARMAPROD-202310-2954$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927191$24292719$1$I$$20231113$20240906$20240906$PER$$US-FARMAPROD-202310-2982$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927201$24292720$1$I$20230901$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-2952$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$
242927211$24292721$1$I$20231002$20231005$20240906$20240906$PER$$US-FARMAPROD-202310-2986$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240904$$CN$US$
242927221$24292722$1$I$$20231009$20240906$20240906$PER$$US-FARMAPROD-202310-3013$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927231$24292723$1$I$$20231004$20240906$20240906$PER$$US-FARMAPROD-202310-2969$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927241$24292724$1$I$20231005$20231006$20240906$20240906$PER$$US-FARMAPROD-202310-2992$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240904$$CN$US$
242927251$24292725$1$I$$20231009$20240906$20240906$PER$$US-FARMAPROD-202310-3021$DOMPE FARMACEUTICI$$$$A$M$Y$86.18$KG$20240904$$CN$US$
242927261$24292726$1$I$20231003$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-2957$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240904$$CN$US$
242927271$24292727$1$I$20231003$20231121$20240906$20240906$PER$$US-FARMAPROD-202310-2971$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$
242927281$24292728$1$I$$20231010$20240906$20240906$PER$$US-FARMAPROD-202310-3031$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242927291$24292729$1$I$$20231004$20240906$20240906$PER$$US-FARMAPROD-202310-2978$DOMPE FARMACEUTICI$$$$A$F$Y$94.03$KG$20240904$$CN$US$
242927301$24292730$1$I$20231001$20231009$20240906$20240906$PER$$US-FARMAPROD-202310-3025$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240904$$CN$US$
242927311$24292731$1$I$$20231004$20240906$20240906$PER$$US-FARMAPROD-202310-2964$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927321$24292732$1$I$$20231006$20240906$20240906$PER$$US-FARMAPROD-202310-3001$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242927331$24292733$1$I$20231001$20231023$20240906$20240906$PER$$US-FARMAPROD-202310-2953$DOMPE FARMACEUTICI$$58$YR$A$F$Y$69.85$KG$20240904$$CN$US$
242927341$24292734$1$I$$20231009$20240906$20240906$PER$$US-FARMAPROD-202310-3026$DOMPE FARMACEUTICI$$$$E$F$Y$70.76$KG$20240904$$CN$US$
242927351$24292735$1$I$20231001$20231018$20240906$20240906$PER$$US-FARMAPROD-202310-3011$DOMPE FARMACEUTICI$$45$YR$A$F$Y$$$20240904$$CN$US$
242927361$24292736$1$I$$20231009$20240906$20240906$PER$$US-FARMAPROD-202310-3028$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927371$24292737$1$I$$20231006$20240906$20240906$PER$$US-FARMAPROD-202310-3000$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927381$24292738$1$I$20230901$20231006$20240906$20240906$PER$$US-FARMAPROD-202310-3009$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240904$$CN$US$
242927391$24292739$1$I$$20231006$20240906$20240906$PER$$US-FARMAPROD-202310-3004$DOMPE FARMACEUTICI$$$$E$F$Y$85.28$KG$20240904$$CN$US$
242927401$24292740$1$I$$20231023$20240906$20240906$PER$$US-FARMAPROD-202310-3018$DOMPE FARMACEUTICI$$$$E$M$Y$92.08$KG$20240904$$CN$US$
242927411$24292741$1$I$20231006$20231007$20240906$20240906$PER$$US-FARMAPROD-202310-3012$DOMPE FARMACEUTICI$$86$YR$E$F$Y$$$20240904$$CN$US$
242927421$24292742$1$I$20231001$20231110$20240906$20240906$PER$$US-FARMAPROD-202310-3032$DOMPE FARMACEUTICI$$94$YR$E$F$Y$59.69$KG$20240904$$CN$US$
242927431$24292743$1$I$20231009$20231030$20240906$20240906$PER$$US-FARMAPROD-202310-3027$DOMPE FARMACEUTICI$$51$YR$A$F$Y$72.57$KG$20240904$$HP$US$
242927441$24292744$1$I$$20240607$20240906$20240906$PER$$US-FARMAPROD-202310-3022$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242927451$24292745$1$I$20231006$20231010$20240906$20240906$PER$$US-FARMAPROD-202310-3029$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240904$$CN$US$
242927461$24292746$1$I$$20231103$20240906$20240906$PER$$US-FARMAPROD-202310-3015$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242927471$24292747$1$I$$20231102$20240906$20240906$PER$$US-FARMAPROD-202310-2999$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927481$24292748$1$I$20231006$20231006$20240906$20240906$PER$$US-FARMAPROD-202310-3003$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$
242927492$24292749$2$F$20240523$20240913$20240906$20240918$EXP$FR-AFSSAPS-MA2024001242$FR-VIIV HEALTHCARE LIMITED-FR2024109102$VIIV$$$$$$Y$$$20240918$$MD$FR$FR
242927501$24292750$1$I$$20231024$20240906$20240906$PER$$US-FARMAPROD-202310-3002$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927511$24292751$1$I$20230801$20231006$20240906$20240906$PER$$US-FARMAPROD-202310-2997$DOMPE FARMACEUTICI$$81$YR$E$M$Y$69.4$KG$20240904$$CN$US$
242927521$24292752$1$I$$20231110$20240906$20240906$PER$$US-FARMAPROD-202310-3005$DOMPE FARMACEUTICI$$50$YR$A$F$Y$$$20240904$$CN$US$
242927531$24292753$1$I$20240826$20240906$20240906$20240906$EXP$$DE-SANDOZ INC.-SDZ2024DE078280$SANDOZ$$67$YR$$M$Y$100.6$KG$20240906$$MD$DE$DE
242927541$24292754$1$I$$20231013$20240906$20240906$PER$$US-FARMAPROD-202310-3064$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927551$24292755$1$I$$20231016$20240906$20240906$PER$$US-FARMAPROD-202310-3084$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927561$24292756$1$I$$20231016$20240906$20240906$PER$$US-FARMAPROD-202310-3090$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242927571$24292757$1$I$$20231025$20240906$20240906$PER$$US-FARMAPROD-202310-3035$DOMPE FARMACEUTICI$$$$E$F$Y$59.92$KG$20240904$$CN$US$
242927581$24292758$1$I$20231016$20231010$20240906$20240906$PER$$US-FARMAPROD-202310-3030$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240904$$CN$US$
242927591$24292759$1$I$$20231025$20240906$20240906$PER$$US-FARMAPROD-202310-3040$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927601$24292760$1$I$20230920$20231013$20240906$20240906$PER$$US-FARMAPROD-202310-3062$DOMPE FARMACEUTICI$$33$YR$A$F$Y$$$20240904$$CN$US$
242927611$24292761$1$I$$20231013$20240906$20240906$PER$$US-FARMAPROD-202310-3067$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242927621$24292762$1$I$$20231117$20240906$20240906$PER$$US-FARMAPROD-202310-2998$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927631$24292763$1$I$20231013$20231129$20240906$20240906$PER$$US-FARMAPROD-202310-3074$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$
242927641$24292764$1$I$$20231016$20240906$20240906$PER$$US-FARMAPROD-202310-3085$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242927651$24292765$1$I$20231007$20231110$20240906$20240906$PER$$US-FARMAPROD-202310-3016$DOMPE FARMACEUTICI$$75$YR$E$M$Y$$$20240904$$CN$US$
242927661$24292766$1$I$$20231011$20240906$20240906$PER$$US-FARMAPROD-202310-3038$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927671$24292767$1$I$20231001$20231023$20240906$20240906$PER$$US-FARMAPROD-202310-3046$DOMPE FARMACEUTICI$$75$YR$E$M$Y$$$20240904$$CN$US$
242927681$24292768$1$I$$20230925$20240906$20240906$PER$$US-FARMAPROD-202310-3044$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927691$24292769$1$I$$20231012$20240906$20240906$PER$$US-FARMAPROD-202310-3056$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927711$24292771$1$I$$20231012$20240906$20240906$PER$$US-FARMAPROD-202310-3061$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927721$24292772$1$I$$20231030$20240906$20240906$PER$$US-FARMAPROD-202310-3089$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927731$24292773$1$I$20231001$20231110$20240906$20240906$PER$$US-FARMAPROD-202310-3019$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$
242927741$24292774$1$I$$20231010$20240906$20240906$PER$$US-FARMAPROD-202310-3036$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242927751$24292775$1$I$20231012$20231012$20240906$20240906$PER$$US-FARMAPROD-202310-3048$DOMPE FARMACEUTICI$$69$YR$E$M$Y$106.59$KG$20240904$$CN$US$
242927761$24292776$1$I$$20240829$20240906$20240906$PER$$US-AMGEN-USASP2024177726$AMGEN$$$$$$Y$$$20240906$$CN$US$US
242927771$24292777$1$I$20180915$20240905$20240906$20240906$EXP$FR-AFSSAPS-LM2024000484$FR-GSK-FR2024110601$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$MD$FR$FR
242927781$24292778$1$I$20230915$20231010$20240906$20240906$PER$$US-FARMAPROD-202310-3039$DOMPE FARMACEUTICI$$33$YR$A$F$Y$$$20240904$$CN$US$
242927791$24292779$1$I$$20231012$20240906$20240906$PER$$US-FARMAPROD-202310-3059$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242927801$24292780$1$I$$20231010$20240906$20240906$PER$$US-FARMAPROD-202310-3041$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$MD$US$
242927811$24292781$1$I$20231012$20231014$20240906$20240906$PER$$US-FARMAPROD-202310-3078$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$
242927821$24292782$1$I$20230901$20231128$20240906$20240906$PER$$US-FARMAPROD-202310-3057$DOMPE FARMACEUTICI$$57$YR$A$M$Y$$$20240904$$CN$US$
242927831$24292783$1$I$20231001$20231124$20240906$20240906$PER$$US-FARMAPROD-202310-3092$DOMPE FARMACEUTICI$$88$YR$E$F$Y$$$20240904$$CN$US$
242927841$24292784$1$I$$20231013$20240906$20240906$PER$$US-FARMAPROD-202310-3075$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927851$24292785$1$I$$20231013$20240906$20240906$PER$$US-FARMAPROD-202310-3076$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242927861$24292786$1$I$20240701$20240826$20240906$20240906$EXP$$US-JNJFOC-20240903223$JOHNSON AND JOHNSON$$$$E$M$Y$69$KG$20240906$$HP$US$US
242927871$24292787$1$I$$20231018$20240906$20240906$PER$$US-FARMAPROD-202310-3129$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242927881$24292788$1$I$$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-3097$DOMPE FARMACEUTICI$$$$$M$Y$66.68$KG$20240904$$CN$US$
242927891$24292789$1$I$20231018$20231102$20240906$20240906$PER$$US-FARMAPROD-202310-3130$DOMPE FARMACEUTICI$$65$YR$E$F$Y$$$20240904$$CN$US$
242927901$24292790$1$I$$20231018$20240906$20240906$PER$$US-FARMAPROD-202310-3115$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242927911$24292791$1$I$$20231013$20240906$20240906$PER$$US-FARMAPROD-202310-3081$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927921$24292792$1$I$$20231012$20240906$20240906$PER$$US-FARMAPROD-202310-3058$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242927931$24292793$1$I$20240326$20240327$20240906$20240906$PER$$US-FARMAPROD-202310-3088$DOMPE FARMACEUTICI$$64$YR$A$M$Y$$$20240904$$CN$US$
242927941$24292794$1$I$20231017$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-3096$DOMPE FARMACEUTICI$$66$YR$E$F$Y$$$20240904$$CN$US$
242927951$24292795$1$I$20230901$20231106$20240906$20240906$PER$$US-FARMAPROD-202310-3107$DOMPE FARMACEUTICI$$87$YR$E$F$Y$$$20240904$$CN$US$
242927961$24292796$1$I$$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-3100$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242927971$24292797$1$I$20231001$20231030$20240906$20240906$PER$$US-FARMAPROD-202310-3034$DOMPE FARMACEUTICI$$67$YR$E$F$Y$42.64$KG$20240904$$CN$US$
242927981$24292798$1$I$$20231019$20240906$20240906$PER$$US-FARMAPROD-202310-3124$DOMPE FARMACEUTICI$$$$A$F$Y$68.86$KG$20240904$$CN$US$
242927991$24292799$1$I$$20231113$20240906$20240906$PER$$US-FARMAPROD-202310-3126$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928001$24292800$1$I$$20240826$20240906$20240906$PER$$US-JNJFOC-20240906658$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$CN$US$US
242928011$24292801$1$I$$20231018$20240906$20240906$PER$$US-FARMAPROD-202310-3113$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928021$24292802$1$I$$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-3109$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242928031$24292803$1$I$$20231020$20240906$20240906$PER$$US-FARMAPROD-202310-3135$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242928041$24292804$1$I$$20231018$20240906$20240906$PER$$US-FARMAPROD-202310-3114$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928051$24292805$1$I$20231012$20231027$20240906$20240906$PER$$US-FARMAPROD-202310-3063$DOMPE FARMACEUTICI$$61$YR$A$F$Y$$$20240904$$CN$US$
242928061$24292806$1$I$$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-3094$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242928071$24292807$1$I$20230801$20231113$20240906$20240906$PER$$US-FARMAPROD-202310-3037$DOMPE FARMACEUTICI$$72$YR$E$F$Y$75.7$KG$20240904$$CN$US$
242928081$24292808$1$I$20231019$20231019$20240906$20240906$PER$$US-FARMAPROD-202310-3128$DOMPE FARMACEUTICI$$55$YR$E$F$Y$58.51$KG$20240904$$CN$US$
242928091$24292809$1$I$20231001$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-3093$DOMPE FARMACEUTICI$$75$YR$E$M$Y$$$20240904$$CN$US$
242928101$24292810$1$I$20231001$20231018$20240906$20240906$PER$$US-FARMAPROD-202310-3112$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240904$$CN$US$
242928111$24292811$1$I$$20231115$20240906$20240906$PER$$US-FARMAPROD-202310-3111$DOMPE FARMACEUTICI$$$$E$M$Y$71.99$KG$20240904$$CN$US$
242928121$24292812$1$I$$20240905$20240906$20240906$PER$$US-JNJFOC-20240911919$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$CN$US$US
242928131$24292813$1$I$$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-3108$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928141$24292814$1$I$$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-3101$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242928151$24292815$1$I$20231001$20231019$20240906$20240906$PER$$US-FARMAPROD-202310-3132$DOMPE FARMACEUTICI$$63$YR$A$M$Y$$$20240904$$CN$US$
242928161$24292816$1$I$$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200624$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242928171$24292817$1$I$20231010$20240418$20240906$20240906$PER$$US-FARMAPROD-202310-3125$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242928181$24292818$1$I$20231001$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-3095$DOMPE FARMACEUTICI$$79$YR$E$F$Y$$$20240904$$CN$US$
242928191$24292819$1$I$$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-3099$DOMPE FARMACEUTICI$$$$A$F$Y$95.8$KG$20240904$$CN$US$
242928201$24292820$1$I$20231018$20240408$20240906$20240906$PER$$US-FARMAPROD-202310-3134$DOMPE FARMACEUTICI$$84$YR$E$F$Y$$$20240904$$CN$US$
242928211$24292821$1$I$$20231018$20240906$20240906$PER$$US-FARMAPROD-202310-3110$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242928221$24292822$1$I$20231130$20231202$20240906$20240906$PER$$US-FARMAPROD-202310-3127$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$
242928231$24292823$1$I$20231001$20231017$20240906$20240906$PER$$US-FARMAPROD-202310-3098$DOMPE FARMACEUTICI$$92$YR$E$F$Y$$$20240904$$CN$US$
242928241$24292824$1$I$20231001$20231022$20240906$20240906$PER$$US-FARMAPROD-202310-3137$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240904$$MD$US$
242928251$24292825$1$I$20231110$20231115$20240906$20240906$PER$$US-FARMAPROD-202310-3131$DOMPE FARMACEUTICI$$49$YR$A$M$Y$$$20240904$$CN$US$
242928261$24292826$1$I$20231020$20231020$20240906$20240906$PER$$US-FARMAPROD-202310-3141$DOMPE FARMACEUTICI$$80$YR$E$M$Y$90.72$KG$20240904$$CN$US$
242928271$24292827$1$I$20231001$20231026$20240906$20240906$PER$$US-FARMAPROD-202310-3182$DOMPE FARMACEUTICI$$58$YR$A$F$Y$$$20240904$$CN$US$
242928281$24292828$1$I$$20231020$20240906$20240906$PER$$US-FARMAPROD-202310-3139$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242928291$24292829$1$I$$20231024$20240906$20240906$PER$$US-FARMAPROD-202310-3166$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928301$24292830$1$I$$20231025$20240906$20240906$PER$$US-FARMAPROD-202310-3176$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242928311$24292831$1$I$$20231024$20240906$20240906$PER$$US-FARMAPROD-202310-3168$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242928321$24292832$1$I$20231001$20231027$20240906$20240906$PER$$US-FARMAPROD-202310-3117$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240904$$CN$US$
242928331$24292833$1$I$$20231025$20240906$20240906$PER$$US-FARMAPROD-202310-3177$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928341$24292834$1$I$20231024$20231024$20240906$20240906$PER$$US-FARMAPROD-202310-3167$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$
242928351$24292835$1$I$$20231025$20240906$20240906$PER$$US-FARMAPROD-202310-3170$DOMPE FARMACEUTICI$$$$E$M$Y$74.03$KG$20240904$$CN$US$
242928361$24292836$1$I$$20231023$20240906$20240906$PER$$US-FARMAPROD-202310-3143$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242928371$24292837$1$I$$20240521$20240906$20240906$PER$$US-FARMAPROD-202310-3162$DOMPE FARMACEUTICI$$$$A$F$Y$81.65$KG$20240904$$CN$US$
242928381$24292838$1$I$$20231024$20240906$20240906$PER$$US-FARMAPROD-202310-3164$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928391$24292839$1$I$20231020$20231026$20240906$20240906$PER$$US-FARMAPROD-202310-3160$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$
242928401$24292840$1$I$20231001$20231026$20240906$20240906$PER$$US-FARMAPROD-202310-3180$DOMPE FARMACEUTICI$$77$YR$E$M$Y$$$20240904$$CN$US$
242928411$24292841$1$I$$20231024$20240906$20240906$PER$$US-FARMAPROD-202310-3165$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242928421$24292842$1$I$$20231023$20240906$20240906$PER$$US-FARMAPROD-202310-3154$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242928431$24292843$1$I$$20231026$20240906$20240906$PER$$US-FARMAPROD-202310-3181$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242928441$24292844$1$I$$20231023$20240906$20240906$PER$$US-FARMAPROD-202310-3156$DOMPE FARMACEUTICI$$$$E$F$Y$59.33$KG$20240904$$CN$US$
242928451$24292845$1$I$20240830$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A198520$ASTRAZENECA$$27923$DY$$M$Y$64$KG$20240906$$CN$US$
242928461$24292846$1$I$20231004$20231024$20240906$20240906$PER$$US-FARMAPROD-202310-3169$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$
242928471$24292847$1$I$$20240829$20240906$20240906$EXP$$CA-AstraZeneca-2024A199872$ASTRAZENECA$$47$YR$$F$Y$$$20240906$$MD$CA$
242928481$24292848$1$I$$20240902$20240906$20240906$EXP$$ZA-AstraZeneca-2024A200392$ASTRAZENECA$$65$YR$$F$Y$$$20240906$$CN$ZA$
242928491$24292849$1$I$20240814$20240829$20240906$20240906$EXP$$CN-AstraZeneca-2024A198988$ASTRAZENECA$$83$YR$$M$Y$62$KG$20240906$$MD$CN$
242928501$24292850$1$I$$20240807$20240906$20240906$PER$$US-AstraZeneca-2024A180283$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242928511$24292851$1$I$$20240830$20240906$20240906$EXP$$ZA-AstraZeneca-2024A198409$ASTRAZENECA$$80$YR$$F$Y$$$20240906$$CN$ZA$
242928521$24292852$1$I$20231109$20231205$20240906$20240906$PER$$US-FARMAPROD-202310-3153$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242928531$24292853$1$I$20240901$20240903$20240906$20240906$EXP$$GB-AstraZeneca-2024A202587$ASTRAZENECA$$39$YR$$F$Y$$$20240906$$MD$GB$
242928541$24292854$1$I$$20240830$20240906$20240906$EXP$$US-AstraZeneca-2024A198714$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$US$
242928551$24292855$1$I$20231020$20231127$20240906$20240906$PER$$US-FARMAPROD-202310-3157$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$
242928561$24292856$1$I$$20231023$20240906$20240906$PER$$US-FARMAPROD-202310-3163$DOMPE FARMACEUTICI$$$$A$F$Y$77.11$KG$20240904$$CN$US$
242928571$24292857$1$I$$20231108$20240906$20240906$PER$$US-FARMAPROD-202310-3155$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928581$24292858$1$I$$20231027$20240906$20240906$PER$$US-FARMAPROD-202310-3204$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928591$24292859$1$I$$20231030$20240906$20240906$PER$$US-FARMAPROD-202310-3209$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242928601$24292860$1$I$$20231023$20240906$20240906$PER$$US-FARMAPROD-202310-3152$DOMPE FARMACEUTICI$$$$E$M$Y$72.08$KG$20240904$$HP$US$
242928611$24292861$1$I$$20231028$20240906$20240906$PER$$US-FARMAPROD-202310-3203$DOMPE FARMACEUTICI$$$$A$F$Y$76.66$KG$20240904$$CN$US$
242928621$24292862$1$I$$20231026$20240906$20240906$PER$$US-FARMAPROD-202310-3188$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242928631$24292863$1$I$20231023$20231108$20240906$20240906$PER$$US-FARMAPROD-202310-3159$DOMPE FARMACEUTICI$$56$YR$A$F$Y$97.52$KG$20240904$$CN$US$
242928641$24292864$1$I$$20231023$20240906$20240906$PER$$US-FARMAPROD-202310-3158$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928651$24292865$1$I$$20231027$20240906$20240906$PER$$US-FARMAPROD-202310-3202$DOMPE FARMACEUTICI$$$$E$F$Y$90.72$KG$20240904$$CN$US$
242928661$24292866$1$I$$20231026$20240906$20240906$PER$$US-FARMAPROD-202310-3185$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242928671$24292867$1$I$$20231030$20240906$20240906$PER$$US-FARMAPROD-202311-3212$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242928681$24292868$1$I$20231021$20231113$20240906$20240906$PER$$US-FARMAPROD-202310-3142$DOMPE FARMACEUTICI$$68$YR$E$F$Y$73.48$KG$20240904$$CN$US$
242928691$24292869$1$I$20231021$20240429$20240906$20240906$PER$$US-FARMAPROD-202310-3151$DOMPE FARMACEUTICI$$84$YR$E$F$Y$61.78$KG$20240904$$CN$US$
242928701$24292870$1$I$20231026$20231026$20240906$20240906$PER$$US-FARMAPROD-202310-3190$DOMPE FARMACEUTICI$$61$YR$A$M$Y$95.25$KG$20240904$$CN$US$
242928711$24292871$1$I$$20231030$20240906$20240906$PER$$US-FARMAPROD-202311-3213$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242928721$24292872$1$I$20231001$20231113$20240906$20240906$PER$$US-FARMAPROD-202310-3195$DOMPE FARMACEUTICI$$49$YR$A$F$Y$$$20240904$$CN$US$
242928731$24292873$1$I$20231028$20231121$20240906$20240906$PER$$US-FARMAPROD-202310-3197$DOMPE FARMACEUTICI$$56$YR$A$F$Y$77.11$KG$20240904$$CN$US$
242928741$24292874$1$I$20231023$20231030$20240906$20240906$PER$$US-FARMAPROD-202311-3225$DOMPE FARMACEUTICI$$84$YR$E$F$Y$$$20240904$$CN$US$
242928751$24292875$1$I$$20231128$20240906$20240906$PER$$US-FARMAPROD-202310-3192$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928761$24292876$1$I$20231001$20231027$20240906$20240906$PER$$US-FARMAPROD-202310-3196$DOMPE FARMACEUTICI$$50$YR$A$F$Y$$$20240904$$CN$US$
242928771$24292877$1$I$$20231109$20240906$20240906$PER$$US-FARMAPROD-202310-3178$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928781$24292878$1$I$20231029$20231117$20240906$20240906$PER$$US-FARMAPROD-202311-3216$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240904$$CN$US$
242928791$24292879$1$I$20231027$20231027$20240906$20240906$PER$$US-FARMAPROD-202310-3198$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240904$$CN$US$
242928801$24292880$1$I$20231001$20240112$20240906$20240906$PER$$US-FARMAPROD-202310-3208$DOMPE FARMACEUTICI$$66$YR$E$F$Y$$$20240904$$CN$US$
242928811$24292881$1$I$$20231222$20240906$20240906$PER$$US-FARMAPROD-202310-3206$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242928821$24292882$1$I$20231026$20240305$20240906$20240906$PER$$US-FARMAPROD-202311-3223$DOMPE FARMACEUTICI$$37$YR$A$M$Y$$$20240904$$MD$US$
242928831$24292883$1$I$20231018$20231124$20240906$20240906$PER$$US-FARMAPROD-202310-3191$DOMPE FARMACEUTICI$$85$YR$E$F$Y$$$20240904$$CN$US$
242928841$24292884$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3219$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242928851$24292885$1$I$20240830$20240830$20240906$20240906$PER$$US-Prasco Laboratories-PRAS20241135$PRASCO$$$$$F$Y$$$20240906$$CN$US$US
242928861$24292886$1$I$20231001$20231113$20240906$20240906$PER$$US-FARMAPROD-202311-3211$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242928871$24292887$1$I$$20240828$20240906$20240906$PER$$US-ABBVIE-5901085$ABBVIE$$$$$$Y$$$20240906$$MD$US$US
242928881$24292888$1$I$20231001$20240131$20240906$20240906$PER$$US-FARMAPROD-202311-3215$DOMPE FARMACEUTICI$$46$YR$A$F$Y$63.78$KG$20240904$$CN$US$
242928891$24292889$1$I$$20240902$20240906$20240906$EXP$$US-MYLANLABS-2024M1081874$MYLAN$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240906$$MD$US$US
242928901$24292890$1$I$20231027$20231208$20240906$20240906$PER$$US-FARMAPROD-202310-3207$DOMPE FARMACEUTICI$$80$YR$E$M$Y$$$20240904$$CN$US$
242928911$24292891$1$I$20231001$20231031$20240906$20240906$PER$$US-FARMAPROD-202311-3236$DOMPE FARMACEUTICI$$52$YR$A$M$Y$$$20240904$$CN$US$
242928921$24292892$1$I$$20231101$20240906$20240906$PER$$US-FARMAPROD-202311-3237$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242928931$24292893$1$I$$20231101$20240906$20240906$PER$$US-FARMAPROD-202311-3238$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242928941$24292894$1$I$20231029$20231030$20240906$20240906$PER$$US-FARMAPROD-202311-3218$DOMPE FARMACEUTICI$$69$YR$E$M$Y$$$20240904$$CN$US$
242928951$24292895$1$I$20231001$20231030$20240906$20240906$PER$$US-FARMAPROD-202311-3217$DOMPE FARMACEUTICI$$71$YR$E$M$Y$$$20240904$$CN$US$
242928961$24292896$1$I$$20231110$20240906$20240906$PER$$US-FARMAPROD-202311-3214$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242928971$24292897$1$I$$20231031$20240906$20240906$PER$$US-FARMAPROD-202311-3227$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242928981$24292898$1$I$20231029$20231101$20240906$20240906$PER$$US-FARMAPROD-202311-3254$DOMPE FARMACEUTICI$$30$YR$A$F$Y$$$20240904$$CN$US$
242928991$24292899$1$I$20231001$20231101$20240906$20240906$PER$$US-FARMAPROD-202311-3248$DOMPE FARMACEUTICI$$79$YR$E$M$Y$$$20240904$$CN$US$
242929001$24292900$1$I$20231001$20231102$20240906$20240906$PER$$US-FARMAPROD-202311-3268$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240904$$CN$US$
242929011$24292901$1$I$20231026$20231115$20240906$20240906$PER$$US-FARMAPROD-202310-3189$DOMPE FARMACEUTICI$$80$YR$E$M$Y$$$20240904$$CN$US$
242929021$24292902$1$I$$20240509$20240906$20240906$PER$$US-FARMAPROD-202311-3220$DOMPE FARMACEUTICI$$$$E$F$Y$74.39$KG$20240904$$CN$US$
242929031$24292903$1$I$$20240902$20240906$20240906$EXP$$US-MYLANLABS-2024M1081757$MYLAN$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J-Forens-Legal-Med 2024; 101.$82$YR$$$Y$$$20240906$$HP$US$US
242929041$24292904$1$I$20231001$20231101$20240906$20240906$PER$$US-FARMAPROD-202311-3252$DOMPE FARMACEUTICI$$56$YR$A$F$Y$42.64$KG$20240904$$CN$US$
242929051$24292905$1$I$$20231103$20240906$20240906$PER$$US-FARMAPROD-202311-3273$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242929061$24292906$1$I$20231028$20231031$20240906$20240906$PER$$US-FARMAPROD-202311-3239$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242929071$24292907$1$I$20231001$20231030$20240906$20240906$PER$$US-FARMAPROD-202311-3226$DOMPE FARMACEUTICI$$60$YR$A$M$Y$$$20240904$$CN$US$
242929081$24292908$1$I$20231001$20231030$20240906$20240906$PER$$US-FARMAPROD-202311-3265$DOMPE FARMACEUTICI$$69$YR$E$M$Y$$$20240904$$CN$US$
242929091$24292909$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3251$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929101$24292910$1$I$$20231113$20240906$20240906$PER$$US-FARMAPROD-202311-3224$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929111$24292911$1$I$20231102$20231102$20240906$20240906$PER$$US-FARMAPROD-202311-3270$DOMPE FARMACEUTICI$$46$YR$A$F$Y$$$20240904$$CN$US$
242929121$24292912$1$I$$20231201$20240906$20240906$PER$$US-FARMAPROD-202311-3230$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242929131$24292913$1$I$$20231206$20240906$20240906$PER$$US-FARMAPROD-202311-3259$DOMPE FARMACEUTICI$$$$E$M$Y$63.5$KG$20240904$$CN$US$
242929141$24292914$1$I$$20231122$20240906$20240906$PER$$US-FARMAPROD-202311-3247$DOMPE FARMACEUTICI$$$$E$F$Y$85.28$KG$20240904$$CN$US$
242929151$24292915$1$I$20231001$20231101$20240906$20240906$PER$$US-FARMAPROD-202311-3255$DOMPE FARMACEUTICI$$66$YR$E$F$Y$$$20240904$$CN$US$
242929161$24292916$1$I$20231101$20231101$20240906$20240906$PER$$US-FARMAPROD-202311-3256$DOMPE FARMACEUTICI$$76$YR$E$M$Y$87.54$KG$20240904$$CN$US$
242929171$24292917$1$I$$20231102$20240906$20240906$PER$$US-FARMAPROD-202311-3274$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929181$24292918$1$I$20231001$20231101$20240906$20240906$PER$$US-FARMAPROD-202311-3250$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$
242929191$24292919$1$I$$20240901$20240906$20240906$PER$$US-SA-2024SA257597$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240906$$CN$US$US
242929211$24292921$1$I$20231101$20231101$20240906$20240906$PER$$US-FARMAPROD-202311-3258$DOMPE FARMACEUTICI$$64$YR$E$F$Y$$$20240904$$CN$US$
242929221$24292922$1$I$$20231204$20240906$20240906$PER$$US-FARMAPROD-202311-3249$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242929232$24292923$2$F$20240807$20240910$20240906$20240917$EXP$$NVSC2024ZA178497$NOVARTIS$$42$YR$$F$Y$$$20240918$$HP$ZA$ZA
242929241$24292924$1$I$20240715$20240830$20240906$20240906$EXP$$CN-FreseniusKabi-FK202413286$FRESENIUS KABI$$87$YR$E$M$Y$45$KG$20240906$$HP$CN$CN
242929251$24292925$1$I$20231017$20231031$20240906$20240906$PER$$US-FARMAPROD-202311-3235$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240904$$CN$US$
242929261$24292926$1$I$20231102$20231206$20240906$20240906$PER$$US-FARMAPROD-202311-3271$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242929271$24292927$1$I$$20231108$20240906$20240906$PER$$US-FARMAPROD-202311-3257$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242929281$24292928$1$I$20231101$20231117$20240906$20240906$PER$$US-FARMAPROD-202311-3269$DOMPE FARMACEUTICI$$82$YR$E$F$Y$57.79$KG$20240904$$CN$US$
242929291$24292929$1$I$$20231102$20240906$20240906$PER$$US-FARMAPROD-202311-3272$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242929301$24292930$1$I$20240820$20240902$20240906$20240906$EXP$PT-INFARMED-F202408-595$PT-FreseniusKabi-FK202413315$FRESENIUS KABI$$72$YR$E$M$Y$88$KG$20240906$$PH$PT$PT
242929311$24292931$1$I$20240211$20240328$20240906$20240906$PER$$US-FARMAPROD-202311-3229$DOMPE FARMACEUTICI$$90$YR$E$F$Y$63.96$KG$20240904$$CN$US$
242929321$24292932$1$I$20231001$20231113$20240906$20240906$PER$$US-FARMAPROD-202311-3253$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$HP$US$
242929331$24292933$1$I$$20240828$20240906$20240906$30DAY$$US-GSK-US2024107190$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$HP$US$US
242929341$24292934$1$I$$20240905$20240906$20240906$EXP$$US-TAKEDA-2024TUS089163$TAKEDA$$$$$F$Y$$$20240906$$CN$US$US
242929351$24292935$1$I$20240901$20240905$20240905$20240905$DIR$717224$$FDA-CTU$$76$YR$$F$N$55.8$KG$20240905$N$CN$US$
242929361$24292936$1$I$20240101$20240827$20240906$20240906$EXP$$JP-DSJP-DSJ-2024-127987$DAIICHI$$84$YR$$M$Y$$$20240906$$CN$JP$JP
242929371$24292937$1$I$$20231102$20240906$20240906$PER$$US-FARMAPROD-202311-3278$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242929381$24292938$1$I$$20231103$20240906$20240906$PER$$US-FARMAPROD-202311-3284$DOMPE FARMACEUTICI$$$$$M$Y$$$20240904$$MD$US$
242929391$24292939$1$I$$20231103$20240906$20240906$PER$$US-FARMAPROD-202311-3282$DOMPE FARMACEUTICI$$28$YR$A$M$Y$$$20240904$$CN$US$
242929401$24292940$1$I$$20231103$20240906$20240906$PER$$US-FARMAPROD-202311-3283$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$
242929411$24292941$1$I$20231101$20231102$20240906$20240906$PER$$US-FARMAPROD-202311-3288$DOMPE FARMACEUTICI$$77$YR$E$M$Y$$$20240904$$CN$US$
242929421$24292942$1$I$$20231102$20240906$20240906$PER$$US-FARMAPROD-202311-3285$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929431$24292943$1$I$$20231102$20240906$20240906$PER$$US-FARMAPROD-202311-3277$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242929441$24292944$1$I$20231102$20231103$20240906$20240906$PER$$US-FARMAPROD-202311-3281$DOMPE FARMACEUTICI$$85$YR$E$F$Y$$$20240904$$CN$US$
242929451$24292945$1$I$20231001$20231102$20240906$20240906$PER$$US-FARMAPROD-202311-3279$DOMPE FARMACEUTICI$$55$YR$A$F$Y$$$20240904$$CN$US$
242929471$24292947$1$I$20231105$20231106$20240906$20240906$PER$$US-FARMAPROD-202311-3295$DOMPE FARMACEUTICI$$64$YR$A$F$Y$$$20240904$$CN$US$
242929481$24292948$1$I$20231102$20231103$20240906$20240906$PER$$US-FARMAPROD-202311-3294$DOMPE FARMACEUTICI$$48$YR$A$F$Y$$$20240904$$CN$US$
242929491$24292949$1$I$$20231102$20240906$20240906$PER$$US-FARMAPROD-202311-3280$DOMPE FARMACEUTICI$$$$A$F$Y$52.62$KG$20240904$$CN$US$
242929501$24292950$1$I$$20231103$20240906$20240906$PER$$US-FARMAPROD-202311-3290$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242929511$24292951$1$I$$20231103$20240906$20240906$PER$$US-FARMAPROD-202311-3291$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929521$24292952$1$I$$20231102$20240906$20240906$PER$$US-FARMAPROD-202311-3276$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242929531$24292953$1$I$$20231103$20240906$20240906$PER$$US-FARMAPROD-202311-3293$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929541$24292954$1$I$$20231106$20240906$20240906$PER$$US-FARMAPROD-202311-3303$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929551$24292955$1$I$$20231106$20240906$20240906$PER$$US-FARMAPROD-202311-3296$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242929561$24292956$1$I$20231104$20231212$20240906$20240906$PER$$US-FARMAPROD-202311-3309$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$
242929581$24292958$1$I$$20231124$20240906$20240906$PER$$US-FARMAPROD-202311-3300$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242929591$24292959$1$I$$20240903$20240906$20240906$PER$$US-ALXN-202409USA000312US$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240906$$MD$US$US
242929601$24292960$1$I$$20240829$20240906$20240906$EXP$GB-MHRA-MED-202408291257256700-VTFZW$GB-TEVA-VS-3238961$TEVA$$$$$$Y$$$20240906$$HP$GB$GB
242929611$24292961$1$I$20231105$20231107$20240906$20240906$PER$$US-FARMAPROD-202311-3305$DOMPE FARMACEUTICI$$64$YR$A$F$Y$74.84$KG$20240904$$CN$US$
242929621$24292962$1$I$$20231115$20240906$20240906$PER$$US-FARMAPROD-202311-3301$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242929631$24292963$1$I$$20231106$20240906$20240906$PER$$US-FARMAPROD-202311-3302$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929641$24292964$1$I$20231031$20231103$20240906$20240906$PER$$US-FARMAPROD-202311-3292$DOMPE FARMACEUTICI$$55$YR$A$M$Y$$$20240904$$CN$US$
242929651$24292965$1$I$20240827$20240829$20240906$20240906$EXP$GB-MHRA-MED-202408281601191460-VRTND$GB-TEVA-VS-3238864$TEVA$$83$YR$$M$Y$$$20240906$$HP$GB$GB
242929661$24292966$1$I$20231105$20231122$20240906$20240906$PER$$US-FARMAPROD-202311-3311$DOMPE FARMACEUTICI$$64$YR$A$M$Y$90.31$KG$20240904$$CN$US$
242929671$24292967$1$I$20231027$20231106$20240906$20240906$PER$$US-FARMAPROD-202311-3310$DOMPE FARMACEUTICI$$62$YR$A$M$Y$$$20240904$$CN$US$
242929681$24292968$1$I$20231001$20231116$20240906$20240906$PER$$US-FARMAPROD-202311-3287$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242929691$24292969$1$I$20231003$20231206$20240906$20240906$PER$$US-FARMAPROD-202311-3289$DOMPE FARMACEUTICI$$61$YR$A$F$Y$83.01$KG$20240904$$CN$US$
242929701$24292970$1$I$$20231102$20240906$20240906$PER$$US-FARMAPROD-202311-3286$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929711$24292971$1$I$$20231019$20240906$20240906$PER$$US-FARMAPROD-202311-3317$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242929721$24292972$1$I$$20231107$20240906$20240906$PER$$US-FARMAPROD-202311-3330$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929731$24292973$1$I$20231105$20231106$20240906$20240906$PER$$US-FARMAPROD-202311-3307$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240904$$CN$US$
242929741$24292974$1$I$$20231106$20240906$20240906$PER$$US-FARMAPROD-202311-3318$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242929751$24292975$1$I$20231108$20231214$20240906$20240906$PER$$US-FARMAPROD-202311-3346$DOMPE FARMACEUTICI$$89$YR$E$F$Y$$$20240904$$CN$US$
242929761$24292976$1$I$$20231108$20240906$20240906$PER$$US-FARMAPROD-202311-3344$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242929771$24292977$1$I$$20231107$20240906$20240906$PER$$US-FARMAPROD-202311-3321$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929781$24292978$1$I$$20231107$20240906$20240906$PER$$US-FARMAPROD-202311-3323$DOMPE FARMACEUTICI$$$$A$F$Y$87.95$KG$20240904$$CN$US$
242929791$24292979$1$I$20231103$20231129$20240906$20240906$PER$$US-FARMAPROD-202311-3319$DOMPE FARMACEUTICI$$85$YR$E$F$Y$57.15$KG$20240904$$CN$US$
242929801$24292980$1$I$$20231108$20240906$20240906$PER$$US-FARMAPROD-202311-3345$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242929811$24292981$1$I$$20231106$20240906$20240906$PER$$US-FARMAPROD-202311-3314$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929821$24292982$1$I$20231101$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3325$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242929831$24292983$1$I$20231113$20231115$20240906$20240906$PER$$US-FARMAPROD-202311-3342$DOMPE FARMACEUTICI$$44$YR$A$F$Y$63.5$KG$20240904$$CN$US$
242929841$24292984$1$I$20231001$20231109$20240906$20240906$PER$$US-FARMAPROD-202311-3349$DOMPE FARMACEUTICI$$51$YR$A$M$Y$$$20240904$$CN$US$
242929851$24292985$1$I$20231106$20231222$20240906$20240906$PER$$US-FARMAPROD-202311-3320$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$
242929861$24292986$1$I$$20231122$20240906$20240906$PER$$US-FARMAPROD-202311-3351$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242929871$24292987$1$I$$20231108$20240906$20240906$PER$$US-FARMAPROD-202311-3331$DOMPE FARMACEUTICI$$$$E$F$Y$55.34$KG$20240904$$CN$US$
242929881$24292988$1$I$$20231107$20240906$20240906$PER$$US-FARMAPROD-202311-3333$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929891$24292989$1$I$$20231108$20240906$20240906$PER$$US-FARMAPROD-202311-3347$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242929901$24292990$1$I$$20231108$20240906$20240906$PER$$US-FARMAPROD-202311-3328$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242929911$24292991$1$I$$20240829$20240906$20240906$EXP$$DE-DAIICHI SANKYO, INC.-DSE-2024-143200$DAIICHI$$62$YR$$F$Y$$$20240906$$MD$DE$DE
242929921$24292992$1$I$$20240828$20240906$20240906$EXP$$AU-DSJP-DSJ-2024-143724$DAIICHI$$$$A$M$Y$$$20240906$$CN$AU$AU
242929931$24292993$1$I$$20231107$20240906$20240906$PER$$US-FARMAPROD-202311-3326$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242929941$24292994$1$I$$20231108$20240906$20240906$PER$$US-FARMAPROD-202311-3350$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242929951$24292995$1$I$$20231115$20240906$20240906$PER$$US-FARMAPROD-202311-3329$DOMPE FARMACEUTICI$$$$E$F$Y$63.96$KG$20240904$$CN$US$
242929961$24292996$1$I$$20240226$20240906$20240906$PER$$US-FARMAPROD-202311-3343$DOMPE FARMACEUTICI$$80$YR$E$M$Y$$$20240904$$MD$US$
242929971$24292997$1$I$20231101$20231228$20240906$20240906$PER$$US-FARMAPROD-202311-3364$DOMPE FARMACEUTICI$$49$YR$A$F$Y$$$20240904$$CN$US$
242929981$24292998$1$I$$20231113$20240906$20240906$PER$$US-FARMAPROD-202311-3380$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242929991$24292999$1$I$$20231109$20240906$20240906$PER$$US-FARMAPROD-202311-3360$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242930001$24293000$1$I$$20240829$20240906$20240906$EXP$$CA-TEVA-VS-3227591$TEVA$$76$YR$$M$Y$$$20240906$$HP$CA$CA
242930011$24293001$1$I$$20231110$20240906$20240906$PER$$US-FARMAPROD-202311-3375$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930021$24293002$1$I$$20231113$20240906$20240906$PER$$US-FARMAPROD-202311-3376$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930031$24293003$1$I$20231104$20231120$20240906$20240906$PER$$US-FARMAPROD-202311-3324$DOMPE FARMACEUTICI$$86$YR$E$F$Y$$$20240904$$CN$US$
242930041$24293004$1$I$$20231113$20240906$20240906$PER$$US-FARMAPROD-202311-3377$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930051$24293005$1$I$$20231109$20240906$20240906$PER$$US-FARMAPROD-202311-3359$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930061$24293006$1$I$$20231113$20240906$20240906$PER$$US-FARMAPROD-202311-3387$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930071$24293007$1$I$20231220$20231220$20240906$20240906$PER$$US-FARMAPROD-202311-3391$DOMPE FARMACEUTICI$$56$YR$A$F$Y$$$20240904$$CN$US$
242930081$24293008$1$I$$20240306$20240906$20240906$PER$$US-FARMAPROD-202311-3313$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$MD$US$
242930091$24293009$1$I$$20231114$20240906$20240906$PER$$US-FARMAPROD-202311-3392$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930101$24293010$1$I$$20231116$20240906$20240906$PER$$US-FARMAPROD-202311-3369$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930111$24293011$1$I$$20231204$20240906$20240906$PER$$US-FARMAPROD-202311-3373$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930121$24293012$1$I$20231101$20231121$20240906$20240906$PER$$US-FARMAPROD-202311-3357$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240904$$CN$US$
242930131$24293013$1$I$20231101$20231113$20240906$20240906$PER$$US-FARMAPROD-202311-3379$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242930141$24293014$1$I$$20231108$20240906$20240906$PER$$US-FARMAPROD-202311-3352$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242930151$24293015$1$I$$20231107$20240906$20240906$PER$$US-FARMAPROD-202311-3334$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242930161$24293016$1$I$20231110$20231113$20240906$20240906$PER$$US-FARMAPROD-202311-3382$DOMPE FARMACEUTICI$$72$YR$E$M$Y$$$20240904$$CN$US$
242930171$24293017$1$I$20231101$20231114$20240906$20240906$PER$$US-FARMAPROD-202311-3395$DOMPE FARMACEUTICI$$52$YR$A$F$Y$69.85$KG$20240904$$CN$US$
242930181$24293018$1$I$20231101$20231113$20240906$20240906$PER$$US-FARMAPROD-202311-3389$DOMPE FARMACEUTICI$$75$YR$E$F$Y$65.09$KG$20240904$$CN$US$
242930191$24293019$1$I$20231105$20231229$20240906$20240906$PER$$US-FARMAPROD-202311-3312$DOMPE FARMACEUTICI$$67$YR$E$F$Y$103.87$KG$20240904$$CN$US$
242930201$24293020$1$I$$20231108$20240906$20240906$PER$$US-FARMAPROD-202311-3353$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930211$24293021$1$I$20231108$20231120$20240906$20240906$PER$$US-FARMAPROD-202311-3370$DOMPE FARMACEUTICI$$88$YR$E$F$Y$$$20240904$$CN$US$
242930221$24293022$1$I$$20231120$20240906$20240906$PER$$US-FARMAPROD-202311-3385$DOMPE FARMACEUTICI$$$$E$F$Y$52.62$KG$20240904$$CN$US$
242930231$24293023$1$I$$20231207$20240906$20240906$PER$$US-FARMAPROD-202311-3355$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930241$24293024$1$I$$20231108$20240906$20240906$PER$$US-FARMAPROD-202311-3354$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930251$24293025$1$I$$20240903$20240906$20240906$EXP$$IN-ROCHE-10000073250$ROCHE$$34$YR$A$M$Y$$$20240906$$CN$IN$IN
242930261$24293026$1$I$$20231109$20240906$20240906$PER$$US-FARMAPROD-202311-3361$DOMPE FARMACEUTICI$$$$E$F$Y$81.65$KG$20240904$$CN$US$
242930271$24293027$1$I$$20231122$20240906$20240906$PER$$US-FARMAPROD-202311-3363$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930281$24293028$1$I$$20231221$20240906$20240906$PER$$US-FARMAPROD-202311-3423$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930291$24293029$1$I$$20231116$20240906$20240906$PER$$US-FARMAPROD-202311-3431$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930301$24293030$1$I$$20231107$20240906$20240906$PER$$US-FARMAPROD-202311-3322$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930311$24293031$1$I$20231113$20231204$20240906$20240906$PER$$US-FARMAPROD-202311-3419$DOMPE FARMACEUTICI$$82$YR$E$M$Y$$$20240904$$CN$US$
242930321$24293032$1$I$$20231113$20240906$20240906$PER$$US-FARMAPROD-202311-3384$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242930331$24293033$1$I$20231113$20240208$20240906$20240906$PER$$US-FARMAPROD-202311-3405$DOMPE FARMACEUTICI$$87$YR$E$F$Y$$$20240904$$MD$US$
242930341$24293034$1$I$$20231109$20240906$20240906$PER$$US-FARMAPROD-202311-3362$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930351$24293035$1$I$20231106$20240108$20240906$20240906$PER$$US-FARMAPROD-202311-3358$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$
242930361$24293036$1$I$$20231110$20240906$20240906$PER$$US-FARMAPROD-202311-3367$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930371$24293037$1$I$$20231115$20240906$20240906$PER$$US-FARMAPROD-202311-3426$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930381$24293038$1$I$$20231116$20240906$20240906$PER$$US-FARMAPROD-202311-3424$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930391$24293039$1$I$$20231116$20240906$20240906$PER$$US-FARMAPROD-202311-3427$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242930401$24293040$1$I$20231101$20231116$20240906$20240906$PER$$US-FARMAPROD-202311-3416$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242930411$24293041$1$I$$20231108$20240906$20240906$PER$$US-FARMAPROD-202311-3356$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242930421$24293042$1$I$$20231116$20240906$20240906$PER$$US-FARMAPROD-202311-3429$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242930431$24293043$1$I$$20231115$20240906$20240906$PER$$US-FARMAPROD-202311-3418$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242930441$24293044$1$I$20231114$20231115$20240906$20240906$PER$$US-FARMAPROD-202311-3415$DOMPE FARMACEUTICI$$22$YR$A$F$Y$$$20240904$$CN$US$
242930451$24293045$1$I$$20231114$20240906$20240906$PER$$US-FARMAPROD-202311-3406$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930461$24293046$1$I$$20231116$20240906$20240906$PER$$US-FARMAPROD-202311-3432$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242930471$24293047$1$I$20231110$20240122$20240906$20240906$PER$$US-FARMAPROD-202311-3372$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242930481$24293048$1$I$$20231115$20240906$20240906$PER$$US-FARMAPROD-202311-3409$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242930491$24293049$1$I$$20231115$20240906$20240906$PER$$US-FARMAPROD-202311-3420$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930501$24293050$1$I$$20231114$20240906$20240906$PER$$US-FARMAPROD-202311-3396$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$CN$US$
242930511$24293051$1$I$20231113$20231114$20240906$20240906$PER$$US-FARMAPROD-202311-3398$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242930521$24293052$1$I$$20231116$20240906$20240906$PER$$US-FARMAPROD-202311-3428$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930531$24293053$1$I$$20231117$20240906$20240906$PER$$US-FARMAPROD-202311-3436$DOMPE FARMACEUTICI$$$$E$M$Y$86.18$KG$20240904$$CN$US$
242930541$24293054$1$I$$20231114$20240906$20240906$PER$$US-FARMAPROD-202311-3401$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242930551$24293055$1$I$20231024$20240312$20240906$20240906$PER$$US-FARMAPROD-202311-3402$DOMPE FARMACEUTICI$$82$YR$E$M$Y$$$20240904$$MD$US$
242930571$24293057$1$I$$20231117$20240906$20240906$PER$$US-FARMAPROD-202311-3441$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930581$24293058$1$I$$20231129$20240906$20240906$PER$$US-FARMAPROD-202311-3421$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242930591$24293059$1$I$$20231120$20240906$20240906$PER$$US-FARMAPROD-202311-3449$DOMPE FARMACEUTICI$$$$$M$Y$$$20240904$$CN$US$
242930601$24293060$1$I$20231117$20240102$20240906$20240906$PER$$US-FARMAPROD-202311-3440$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240904$$CN$US$
242930611$24293061$1$I$$20231121$20240906$20240906$PER$$US-FARMAPROD-202311-3397$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930621$24293062$1$I$$20231120$20240906$20240906$PER$$US-FARMAPROD-202311-3468$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930631$24293063$1$I$$20240902$20240906$20240906$EXP$$JP-DSJP-DSJ-2024-143412$DAIICHI$$8$DEC$$M$Y$$$20240906$$MD$JP$JP
242930641$24293064$1$I$$20240328$20240906$20240906$PER$$US-FARMAPROD-202311-3408$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$MD$US$
242930651$24293065$1$I$$20231124$20240906$20240906$PER$$US-FARMAPROD-202311-3457$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930661$24293066$1$I$$20231117$20240906$20240906$PER$$US-FARMAPROD-202311-3443$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930671$24293067$1$I$20231116$20231117$20240906$20240906$PER$$US-FARMAPROD-202311-3454$DOMPE FARMACEUTICI$$42$YR$A$F$Y$$$20240904$$CN$US$
242930681$24293068$1$I$20231114$20240306$20240906$20240906$PER$$US-FARMAPROD-202311-3390$DOMPE FARMACEUTICI$$79$YR$E$F$Y$62.14$KG$20240904$$CN$US$
242930691$24293069$1$I$$20231124$20240906$20240906$PER$$US-FARMAPROD-202311-3425$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930701$24293070$1$I$$20231117$20240906$20240906$PER$$US-FARMAPROD-202311-3445$DOMPE FARMACEUTICI$$$$A$M$Y$66.22$KG$20240904$$CN$US$
242930711$24293071$1$I$$20231117$20240906$20240906$PER$$US-FARMAPROD-202311-3435$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930721$24293072$1$I$$20231121$20240906$20240906$PER$$US-FARMAPROD-202311-3465$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930731$24293073$1$I$20231101$20231120$20240906$20240906$PER$$US-FARMAPROD-202311-3446$DOMPE FARMACEUTICI$$51$YR$A$F$Y$81.65$KG$20240904$$CN$US$
242930741$24293074$1$I$20231113$20231229$20240906$20240906$PER$$US-FARMAPROD-202311-3451$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240904$$CN$US$
242930751$24293075$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3404$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930761$24293076$1$I$20231113$20231206$20240906$20240906$PER$$US-FARMAPROD-202311-3417$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$
242930771$24293077$1$I$$20231221$20240906$20240906$PER$$US-FARMAPROD-202311-3477$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930781$24293078$1$I$$20231201$20240906$20240906$PER$$US-FARMAPROD-202311-3433$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930791$24293079$1$I$$20231116$20240906$20240906$PER$$US-FARMAPROD-202311-3430$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930801$24293080$1$I$$20231211$20240906$20240906$PER$$US-FARMAPROD-202311-3471$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930811$24293081$1$I$$20231117$20240906$20240906$PER$$US-FARMAPROD-202311-3438$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$CN$US$
242930821$24293082$1$I$$20231121$20240906$20240906$PER$$US-FARMAPROD-202311-3472$DOMPE FARMACEUTICI$$$$A$F$Y$59.42$KG$20240904$$CN$US$
242930831$24293083$1$I$$20231120$20240906$20240906$PER$$US-FARMAPROD-202311-3467$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242930841$24293084$1$I$$20231121$20240906$20240906$PER$$US-FARMAPROD-202311-3461$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930851$24293085$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202311-3462$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930861$24293086$1$I$$20240227$20240906$20240906$PER$$US-FARMAPROD-202311-3518$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242930871$24293087$1$I$20240801$20240905$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141597$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240906$$HP$US$US
242930881$24293088$1$I$20231101$20231121$20240906$20240906$PER$$US-FARMAPROD-202311-3466$DOMPE FARMACEUTICI$$69$YR$E$F$Y$55.34$KG$20240904$$CN$US$
242930891$24293089$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202311-3463$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930901$24293090$1$I$$20231124$20240906$20240906$PER$$US-FARMAPROD-202311-3500$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242930911$24293091$1$I$20231118$20231120$20240906$20240906$PER$$US-FARMAPROD-202311-3447$DOMPE FARMACEUTICI$$82$YR$E$M$Y$$$20240904$$CN$US$
242930921$24293092$1$I$$20231121$20240906$20240906$PER$$US-FARMAPROD-202311-3464$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242930931$24293093$1$I$20231101$20231120$20240906$20240906$PER$$US-FARMAPROD-202311-3448$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$MD$US$
242930941$24293094$1$I$$20231120$20240906$20240906$PER$$US-FARMAPROD-202311-3460$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242930951$24293095$1$I$20240620$20240815$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-130356$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$58.97$KG$20240906$$PH$US$US
242930961$24293096$1$I$20231117$20231124$20240906$20240906$PER$$US-FARMAPROD-202311-3497$DOMPE FARMACEUTICI$$77$YR$E$F$Y$61.42$KG$20240904$$CN$US$
242930971$24293097$1$I$$20240110$20240906$20240906$PER$$US-FARMAPROD-202311-3459$DOMPE FARMACEUTICI$$$$E$M$Y$79.38$KG$20240904$$CN$US$
242930981$24293098$1$I$$20240108$20240906$20240906$PER$$US-FARMAPROD-202311-3499$DOMPE FARMACEUTICI$$$$A$M$Y$131.54$KG$20240904$$CN$US$
242930991$24293099$1$I$20231115$20231222$20240906$20240906$PER$$US-FARMAPROD-202311-3458$DOMPE FARMACEUTICI$$60$YR$A$M$Y$$$20240904$$MD$US$
242931001$24293100$1$I$20231114$20231122$20240906$20240906$PER$$US-FARMAPROD-202311-3487$DOMPE FARMACEUTICI$$84$YR$E$M$Y$56.7$KG$20240904$$CN$US$
242931011$24293101$1$I$20231121$20231130$20240906$20240906$PER$$US-FARMAPROD-202311-3501$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240904$$CN$US$
242931021$24293102$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3519$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242931031$24293103$1$I$$20231124$20240906$20240906$PER$$US-FARMAPROD-202311-3494$DOMPE FARMACEUTICI$$$$$M$Y$123.01$KG$20240904$$CN$US$
242931041$24293104$1$I$$20231204$20240906$20240906$PER$$US-FARMAPROD-202311-3507$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242931051$24293105$1$I$$20231122$20240906$20240906$PER$$US-FARMAPROD-202311-3479$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242931061$24293106$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3508$DOMPE FARMACEUTICI$$$$E$F$Y$51.71$KG$20240904$$CN$US$
242931071$24293107$1$I$20231101$20231215$20240906$20240906$PER$$US-FARMAPROD-202311-3495$DOMPE FARMACEUTICI$$29$YR$A$F$Y$$$20240904$$CN$US$
242931081$24293108$1$I$20231205$20231206$20240906$20240906$PER$$US-FARMAPROD-202311-3522$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$
242931091$24293109$1$I$$20231122$20240906$20240906$PER$$US-FARMAPROD-202311-3483$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242931101$24293110$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3515$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931111$24293111$1$I$$20231211$20240906$20240906$PER$$US-FARMAPROD-202311-3485$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931121$24293112$1$I$20231101$20231122$20240906$20240906$PER$$US-FARMAPROD-202311-3484$DOMPE FARMACEUTICI$$69$YR$E$M$Y$$$20240904$$CN$US$
242931131$24293113$1$I$$20231122$20240906$20240906$PER$$US-FARMAPROD-202311-3481$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242931142$24293114$2$F$20240101$20240905$20240906$20240913$EXP$$TW-SA-2024SA258920$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240913$$CN$TW$TW
242931151$24293115$1$I$$20231204$20240906$20240906$PER$$US-FARMAPROD-202311-3444$DOMPE FARMACEUTICI$$$$E$F$Y$88.9$KG$20240904$$CN$US$
242931161$24293116$1$I$$20231222$20240906$20240906$PER$$US-FARMAPROD-202311-3496$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242931171$24293117$1$I$$20231124$20240906$20240906$PER$$US-FARMAPROD-202311-3498$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931181$24293118$1$I$$20231120$20240906$20240906$PER$$US-FARMAPROD-202311-3456$DOMPE FARMACEUTICI$$$$E$M$Y$88.9$KG$20240904$$CN$US$
242931191$24293119$1$I$20231121$20240130$20240906$20240906$PER$$US-FARMAPROD-202311-3480$DOMPE FARMACEUTICI$$49$YR$A$F$Y$$$20240904$$CN$US$
242931201$24293120$1$I$$20231222$20240906$20240906$PER$$US-FARMAPROD-202311-3505$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931211$24293121$1$I$$20231124$20240906$20240906$PER$$US-FARMAPROD-202311-3493$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242931221$24293122$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3520$DOMPE FARMACEUTICI$$$$A$F$Y$52.16$KG$20240904$$CN$US$
242931241$24293124$1$I$20231124$20231220$20240906$20240906$PER$$US-FARMAPROD-202311-3504$DOMPE FARMACEUTICI$$74$YR$E$M$Y$79.83$KG$20240904$$CN$US$
242931251$24293125$1$I$20240812$20240825$20240906$20240906$EXP$GB-MHRA-MED-202408250135499570-SQHZF$GB-GLENMARK PHARMACEUTICALS-2024GMK093655$GLENMARK$$$$$$Y$$$20240906$$CN$GB$GB
242931261$24293126$1$I$$20231124$20240906$20240906$PER$$US-FARMAPROD-202311-3506$DOMPE FARMACEUTICI$$$$A$F$Y$90.72$KG$20240904$$CN$US$
242931271$24293127$1$I$20231101$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3521$DOMPE FARMACEUTICI$$38$YR$A$M$Y$$$20240904$$CN$US$
242931281$24293128$1$I$20231101$20231124$20240906$20240906$PER$$US-FARMAPROD-202311-3502$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240904$$CN$US$
242931291$24293129$1$I$20231101$20231122$20240906$20240906$PER$$US-FARMAPROD-202311-3490$DOMPE FARMACEUTICI$$80$YR$E$F$Y$77.56$KG$20240904$$CN$US$
242931301$24293130$1$I$20231111$20231120$20240906$20240906$PER$$US-FARMAPROD-202311-3455$DOMPE FARMACEUTICI$$66$YR$E$M$Y$124.74$KG$20240904$$CN$US$
242931311$24293131$1$I$$20231122$20240906$20240906$PER$$US-FARMAPROD-202311-3482$DOMPE FARMACEUTICI$$$$E$F$Y$59.6$KG$20240904$$CN$US$
242931321$24293132$1$I$$20231129$20240906$20240906$PER$$US-FARMAPROD-202312-3551$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242931331$24293133$1$I$$20231129$20240906$20240906$PER$$US-FARMAPROD-202312-3546$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931341$24293134$1$I$$20231222$20240906$20240906$PER$$US-FARMAPROD-202312-3548$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242931351$24293135$1$I$20231201$20231229$20240906$20240906$PER$$US-FARMAPROD-202312-3556$DOMPE FARMACEUTICI$$61$YR$A$F$Y$$$20240904$$CN$US$
242931361$24293136$1$I$20231101$20231229$20240906$20240906$PER$$US-FARMAPROD-202312-3549$DOMPE FARMACEUTICI$$58$YR$A$F$Y$$$20240904$$CN$US$
242931371$24293137$1$I$$20240106$20240906$20240906$EXP$$US-FARMAPROD-202312-3564$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$MD$US$
242931381$24293138$1$I$$20231130$20240906$20240906$PER$$US-FARMAPROD-202312-3553$DOMPE FARMACEUTICI$$$$$M$Y$$$20240904$$MD$US$
242931391$24293139$1$I$20231101$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3523$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$
242931401$24293140$1$I$$20231128$20240906$20240906$PER$$US-FARMAPROD-202311-3533$DOMPE FARMACEUTICI$$33$YR$A$M$Y$$$20240904$$MD$US$
242931411$24293141$1$I$$20240117$20240906$20240906$PER$$US-FARMAPROD-202311-3541$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242931421$24293142$1$I$$20231129$20240906$20240906$PER$$US-FARMAPROD-202312-3545$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242931431$24293143$1$I$20231129$20231130$20240906$20240906$PER$$US-FARMAPROD-202312-3563$DOMPE FARMACEUTICI$$39$YR$A$F$Y$$$20240904$$CN$US$
242931441$24293144$1$I$$20231128$20240906$20240906$PER$$US-FARMAPROD-202311-3539$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242931451$24293145$1$I$$20231129$20240906$20240906$PER$$US-FARMAPROD-202312-3557$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242931461$24293146$1$I$$20240319$20240906$20240906$PER$$US-FARMAPROD-202311-3538$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$MD$US$
242931471$24293147$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3527$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931481$24293148$1$I$$20231128$20240906$20240906$PER$$US-FARMAPROD-202311-3532$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931491$24293149$1$I$20231101$20231129$20240906$20240906$PER$$US-FARMAPROD-202312-3552$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240904$$CN$US$
242931501$24293150$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA257582$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240906$$CN$US$US
242931511$24293151$1$I$20240101$20240829$20240906$20240906$PER$$US-SA-2024SA258502$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240906$$MD$US$US
242931521$24293152$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA258296$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240906$$MD$US$US
242931531$24293153$1$I$20240824$20240828$20240906$20240906$PER$$US-SA-2024SA258176$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240906$$MD$US$US
242931541$24293154$1$I$20240101$20240828$20240906$20240906$PER$$US-SA-2024SA258275$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240906$$MD$US$US
242931551$24293155$1$I$$20231129$20240906$20240906$PER$$US-FARMAPROD-202312-3555$DOMPE FARMACEUTICI$$$$E$F$Y$52.62$KG$20240904$$CN$US$
242931561$24293156$1$I$20231101$20231130$20240906$20240906$PER$$US-FARMAPROD-202312-3562$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240904$$CN$US$
242931571$24293157$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3526$DOMPE FARMACEUTICI$$$$E$F$Y$73.48$KG$20240904$$CN$US$
242931581$24293158$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3528$DOMPE FARMACEUTICI$$$$A$F$Y$72.48$KG$20240904$$CN$US$
242931591$24293159$1$I$$20231129$20240906$20240906$PER$$US-FARMAPROD-202312-3554$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242931601$24293160$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA258202$SANOFI AVENTIS$$$$E$F$Y$$$20240906$$HP$US$US
242931611$24293161$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA258246$SANOFI AVENTIS$$$$C$M$Y$$$20240906$$HP$US$US
242931621$24293162$1$I$$20240904$20240906$20240906$PER$$US-ABBVIE-5908435$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242931631$24293163$1$I$20231122$20231201$20240906$20240906$PER$$US-FARMAPROD-202312-3565$DOMPE FARMACEUTICI$$92$YR$E$M$Y$$$20240904$$CN$US$
242931641$24293164$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3530$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931651$24293165$1$I$$20231201$20240906$20240906$PER$$US-FARMAPROD-202312-3579$DOMPE FARMACEUTICI$$$$E$F$Y$45.99$KG$20240904$$CN$US$
242931661$24293166$1$I$$20231205$20240906$20240906$PER$$US-FARMAPROD-202312-3599$DOMPE FARMACEUTICI$$$$E$M$Y$72.57$KG$20240904$$CN$US$US
242931671$24293167$1$I$20231101$20231205$20240906$20240906$PER$$US-FARMAPROD-202312-3597$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$US
242931681$24293168$1$I$$20231205$20240906$20240906$PER$$US-FARMAPROD-202312-3601$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931691$24293169$1$I$$20231204$20240906$20240906$PER$$US-FARMAPROD-202312-3581$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242931701$24293170$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3525$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931711$24293171$1$I$$20231127$20240906$20240906$PER$$US-FARMAPROD-202311-3529$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931721$24293172$1$I$$20240822$20240906$20240906$PER$$US-SA-2024SA255969$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$MD$US$US
242931741$24293174$1$I$$20231130$20240906$20240906$PER$$US-FARMAPROD-202312-3569$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242931751$24293175$1$I$$20240510$20240906$20240906$PER$$US-FARMAPROD-202312-3558$DOMPE FARMACEUTICI$$$$E$M$Y$5.18$KG$20240904$$CN$US$
242931761$24293176$1$I$$20240116$20240906$20240906$PER$$US-FARMAPROD-202312-3575$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931776$24293177$6$F$20240606$20240913$20240906$20240923$EXP$$JP-009507513-2409JPN001128$MERCK$$51$YR$$M$Y$71$KG$20240923$$MD$JP$JP
242931781$24293178$1$I$$20231226$20240906$20240906$PER$$US-FARMAPROD-202312-3583$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$HP$US$
242931791$24293179$1$I$$20231130$20240906$20240906$PER$$US-FARMAPROD-202312-3568$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242931801$24293180$1$I$20231128$20231205$20240906$20240906$PER$$US-FARMAPROD-202312-3596$DOMPE FARMACEUTICI$$49$YR$A$F$Y$$$20240904$$CN$US$
242931811$24293181$1$I$20240301$20240401$20240906$20240906$PER$$US-FARMAPROD-202311-3540$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242931821$24293182$1$I$20231101$20240208$20240906$20240906$PER$$US-FARMAPROD-202312-3584$DOMPE FARMACEUTICI$$59$YR$A$F$Y$$$20240904$$MD$US$
242931831$24293183$1$I$20231101$20240119$20240906$20240906$PER$$US-FARMAPROD-202312-3578$DOMPE FARMACEUTICI$$44$YR$A$F$Y$$$20240904$$CN$US$
242931841$24293184$1$I$$20240205$20240906$20240906$PER$$US-FARMAPROD-202312-3591$DOMPE FARMACEUTICI$$$$E$F$Y$46.27$KG$20240904$$CN$US$
242931851$24293185$1$I$$20231204$20240906$20240906$PER$$US-FARMAPROD-202312-3587$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931861$24293186$1$I$$20231201$20240906$20240906$PER$$US-FARMAPROD-202312-3576$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$CN$US$
242931871$24293187$1$I$20231202$20240105$20240906$20240906$PER$$US-FARMAPROD-202312-3598$DOMPE FARMACEUTICI$$74$YR$E$M$Y$179.9$KG$20240904$$CN$US$
242931881$24293188$1$I$$20231207$20240906$20240906$PER$$US-FARMAPROD-202312-3577$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242931891$24293189$1$I$20230101$20231206$20240906$20240906$PER$$US-FARMAPROD-202312-3609$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$
242931902$24293190$2$F$20240902$20240904$20240906$20240911$PER$$US-AMGEN-USASP2024177366$AMGEN$$85$YR$E$M$Y$$$20240911$$CN$US$US
242931911$24293191$1$I$20231129$20240123$20240906$20240906$PER$$US-FARMAPROD-202312-3547$DOMPE FARMACEUTICI$$76$YR$E$F$Y$89.36$KG$20240904$$MD$US$
242931921$24293192$1$I$$20231213$20240906$20240906$PER$$US-FARMAPROD-202312-3588$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242931931$24293193$1$I$$20240830$20240906$20240906$EXP$$CN-AMGEN-CHNSP2024174812$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240906$$MD$CN$CN
242931942$24293194$2$F$$20240913$20240906$20240918$EXP$$NVSC2024CN179336$NOVARTIS$$72$YR$$F$Y$$$20240919$$CN$CN$CN
242931951$24293195$1$I$20231205$20231218$20240906$20240906$PER$$US-FARMAPROD-202312-3590$DOMPE FARMACEUTICI$$62$YR$A$F$Y$93.39$KG$20240904$$CN$US$
242931961$24293196$1$I$$20240906$20240906$20240906$EXP$$TR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049953$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240906$$MD$TR$TR
242931971$24293197$1$I$$20240103$20240906$20240906$PER$$US-FARMAPROD-202312-3616$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242931981$24293198$1$I$$20231222$20240906$20240906$PER$$US-FARMAPROD-202312-3586$DOMPE FARMACEUTICI$$$$A$F$Y$52.16$KG$20240904$$CN$US$
242931991$24293199$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3643$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$PH$US$
242932001$24293200$1$I$20231208$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3644$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242932011$24293201$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3651$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932021$24293202$1$I$20231101$20231206$20240906$20240906$PER$$US-FARMAPROD-202312-3617$DOMPE FARMACEUTICI$$35$YR$A$F$Y$$$20240904$$CN$US$
242932031$24293203$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3637$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242932041$24293204$1$I$20231126$20231218$20240906$20240906$PER$$US-FARMAPROD-202312-3611$DOMPE FARMACEUTICI$$63$YR$A$F$Y$$$20240904$$CN$US$
242932051$24293205$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3652$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932061$24293206$1$I$20231129$20240102$20240906$20240906$PER$$US-FARMAPROD-202312-3589$DOMPE FARMACEUTICI$$55$YR$A$F$Y$52.16$KG$20240904$$CN$US$
242932071$24293207$1$I$$20240903$20240906$20240906$EXP$$HR-AMGEN-HRVSP2024175943$AMGEN$Turudic D.; Zupan D.; Perkovic D. T. et al.. Successful avatrombopag salvage treatment in a pediatric patient with ANA-positive refractory thrombocytopenia. Pediatr Blood Cancer. 2024;71 (10):1-3$$$$M$Y$$$20240906$$HP$HR$HR
242932081$24293208$1$I$20231206$20231207$20240906$20240906$PER$$US-FARMAPROD-202312-3633$DOMPE FARMACEUTICI$$68$YR$E$M$Y$$$20240904$$CN$US$
242932091$24293209$1$I$$20231205$20240906$20240906$PER$$US-FARMAPROD-202312-3602$DOMPE FARMACEUTICI$$$$E$M$Y$88.9$KG$20240904$$CN$US$US
242932101$24293210$1$I$20231201$20231226$20240906$20240906$PER$$US-FARMAPROD-202312-3650$DOMPE FARMACEUTICI$$57$YR$A$F$Y$$$20240904$$CN$US$
242932111$24293211$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3649$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242932121$24293212$1$I$20231203$20240403$20240906$20240906$PER$$US-FARMAPROD-202312-3585$DOMPE FARMACEUTICI$$89$YR$E$F$Y$$$20240904$$MD$US$
242932131$24293213$1$I$$20231206$20240906$20240906$PER$$US-FARMAPROD-202312-3614$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242932141$24293214$1$I$20231204$20240108$20240906$20240906$PER$$US-FARMAPROD-202312-3638$DOMPE FARMACEUTICI$$72$YR$E$F$Y$73.48$KG$20240904$$CN$US$
242932151$24293215$1$I$20231205$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3647$DOMPE FARMACEUTICI$$27$YR$A$F$Y$$$20240904$$CN$US$
242932161$24293216$1$I$20231129$20240207$20240906$20240906$PER$$US-FARMAPROD-202312-3567$DOMPE FARMACEUTICI$$49$YR$A$M$Y$$$20240904$$CN$US$
242932171$24293217$1$I$20231210$20231218$20240906$20240906$PER$$US-FARMAPROD-202312-3662$DOMPE FARMACEUTICI$$36$YR$A$F$Y$$$20240904$$CN$US$
242932181$24293218$1$I$$20231212$20240906$20240906$PER$$US-FARMAPROD-202312-3672$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242932191$24293219$1$I$20231127$20231130$20240906$20240906$PER$$US-FARMAPROD-202312-3566$DOMPE FARMACEUTICI$$57$YR$A$F$Y$$$20240904$$CN$US$
242932201$24293220$1$I$$20231206$20240906$20240906$PER$$US-FARMAPROD-202312-3619$DOMPE FARMACEUTICI$$$$A$M$Y$90.72$KG$20240904$$CN$US$
242932211$24293221$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3641$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932221$24293222$1$I$20231208$20231210$20240906$20240906$PER$$US-FARMAPROD-202312-3653$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$CN$US$
242932231$24293223$1$I$20231128$20231206$20240906$20240906$PER$$US-FARMAPROD-202312-3613$DOMPE FARMACEUTICI$$59$YR$A$F$Y$$$20240904$$CN$US$
242932241$24293224$1$I$20231201$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3645$DOMPE FARMACEUTICI$$79$YR$E$F$Y$53.98$KG$20240904$$CN$US$
242932251$24293225$1$I$$20231206$20240906$20240906$PER$$US-FARMAPROD-202312-3580$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932261$24293226$1$I$$20231213$20240906$20240906$PER$$US-FARMAPROD-202312-3689$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932271$24293227$1$I$$20231206$20240906$20240906$PER$$US-FARMAPROD-202312-3610$DOMPE FARMACEUTICI$$$$E$M$Y$132.45$KG$20240904$$CN$US$
242932281$24293228$1$I$$20231215$20240906$20240906$PER$$US-FARMAPROD-202312-3600$DOMPE FARMACEUTICI$$$$E$F$Y$87.59$KG$20240904$$CN$US$
242932291$24293229$1$I$$20231207$20240906$20240906$PER$$US-FARMAPROD-202312-3621$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242932301$24293230$1$I$$20231206$20240906$20240906$PER$$US-FARMAPROD-202312-3612$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932311$24293231$1$I$20231209$20231212$20240906$20240906$PER$$US-FARMAPROD-202312-3681$DOMPE FARMACEUTICI$$64$YR$A$F$Y$83.1$KG$20240904$$CN$US$
242932321$24293232$1$I$20231205$20231219$20240906$20240906$PER$$US-FARMAPROD-202312-3624$DOMPE FARMACEUTICI$$42$YR$A$F$Y$$$20240904$$CN$US$
242932331$24293233$1$I$20231205$20240122$20240906$20240906$PER$$US-FARMAPROD-202312-3625$DOMPE FARMACEUTICI$$44$YR$A$F$Y$$$20240904$$CN$US$
242932341$24293234$1$I$20231223$20240201$20240906$20240906$PER$$US-FARMAPROD-202312-3648$DOMPE FARMACEUTICI$$64$YR$A$F$Y$$$20240904$$CN$US$
242932351$24293235$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3640$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242932361$24293236$1$I$$20231207$20240906$20240906$PER$$US-FARMAPROD-202312-3622$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242932371$24293237$1$I$$20231215$20240906$20240906$PER$$US-FARMAPROD-202312-3713$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932381$24293238$1$I$$20240327$20240906$20240906$PER$$US-FARMAPROD-202312-3690$DOMPE FARMACEUTICI$$$$E$F$Y$74.84$KG$20240904$$MD$US$
242932391$24293239$1$I$20231101$20240126$20240906$20240906$PER$$US-FARMAPROD-202311-3531$DOMPE FARMACEUTICI$$56$YR$A$M$Y$91.35$KG$20240904$$CN$US$
242932401$24293240$1$I$$20231206$20240906$20240906$PER$$US-FARMAPROD-202312-3620$DOMPE FARMACEUTICI$$$$A$M$Y$87$KG$20240904$$CN$US$
242932411$24293241$1$I$$20231212$20240906$20240906$PER$$US-FARMAPROD-202312-3680$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932421$24293242$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3639$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242932431$24293243$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3642$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242932441$24293244$1$I$$20231211$20240906$20240906$PER$$US-FARMAPROD-202312-3668$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242932451$24293245$1$I$20231212$20240115$20240906$20240906$PER$$US-FARMAPROD-202312-3691$DOMPE FARMACEUTICI$$80$YR$E$F$Y$59.87$KG$20240904$$CN$US$
242932461$24293246$1$I$20231224$20231229$20240906$20240906$PER$$US-FARMAPROD-202312-3664$DOMPE FARMACEUTICI$$63$YR$A$M$Y$$$20240904$$CN$US$
242932471$24293247$1$I$$20231214$20240906$20240906$PER$$US-FARMAPROD-202312-3704$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932481$24293248$1$I$$20231214$20240906$20240906$PER$$US-FARMAPROD-202312-3706$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242932491$24293249$1$I$$20231211$20240906$20240906$PER$$US-FARMAPROD-202312-3669$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242932501$24293250$1$I$$20231221$20240906$20240906$PER$$US-FARMAPROD-202312-3765$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932511$24293251$1$I$$20231214$20240906$20240906$PER$$US-FARMAPROD-202312-3702$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242932521$24293252$1$I$20231214$20231213$20240906$20240906$PER$$US-FARMAPROD-202312-3697$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$CN$US$
242932531$24293253$1$I$$20231214$20240906$20240906$PER$$US-FARMAPROD-202312-3703$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242932541$24293254$1$I$$20231215$20240906$20240906$PER$$US-FARMAPROD-202312-3711$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242932551$24293255$1$I$$20231207$20240906$20240906$PER$$US-FARMAPROD-202312-3623$DOMPE FARMACEUTICI$$$$A$F$Y$74.84$KG$20240904$$CN$US$
242932562$24293256$2$F$$20240904$20240906$20240909$EXP$$JP-PFIZER INC-202400250337$PFIZER$Aiba, M.. Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma. Journal of Infection and Chemotherapy. 2024;30(10):1065-1068$6$DEC$$F$Y$$$20240909$$HP$JP$JP
242932571$24293257$1$I$$20231215$20240906$20240906$PER$$US-FARMAPROD-202312-3712$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242932581$24293258$1$I$$20240122$20240906$20240906$PER$$US-FARMAPROD-202312-3746$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$
242932591$24293259$1$I$$20231227$20240906$20240906$PER$$US-FARMAPROD-202312-3679$DOMPE FARMACEUTICI$$$$A$F$Y$70.31$KG$20240904$$CN$US$
242932601$24293260$1$I$$20231212$20240906$20240906$PER$$US-FARMAPROD-202312-3678$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242932611$24293261$1$I$$20231212$20240906$20240906$PER$$US-FARMAPROD-202312-3677$DOMPE FARMACEUTICI$$$$E$F$Y$99.02$KG$20240904$$CN$US$
242932621$24293262$1$I$$20240830$20240906$20240906$EXP$$US-FreseniusKabi-FK202413455$FRESENIUS KABI$Erol LA, Layman CP. Paraneoplastic Hyperthyroidism Secondary to a Chemotherapy-Induced Surge in Beta-hCG in a Patient with Non-Seminomatous Germ Cell Tumor. Hawaii Journal of Health and Social Welfare. 2024 Feb;83(2): 45-47. doi:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10850865/.$21$YR$A$M$Y$$$20240906$$MD$US$US
242932632$24293263$2$F$20240821$20240916$20240906$20240920$EXP$AT-BASGAGES-2024-006502$AT-FreseniusKabi-FK202413343$FRESENIUS KABI$$67$YR$E$M$Y$100$KG$20240920$$PH$AT$AT
242932641$24293264$1$I$$20231229$20240906$20240906$PER$$US-FARMAPROD-202312-3726$DOMPE FARMACEUTICI$$$$C$M$Y$$$20240904$$CN$US$
242932651$24293265$1$I$$20231214$20240906$20240906$PER$$US-FARMAPROD-202312-3705$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932661$24293266$1$I$20231208$20231211$20240906$20240906$PER$$US-FARMAPROD-202312-3666$DOMPE FARMACEUTICI$$94$YR$E$F$Y$51.71$KG$20240904$$CN$US$
242932671$24293267$1$I$20231201$20231218$20240906$20240906$PER$$US-FARMAPROD-202312-3724$DOMPE FARMACEUTICI$$67$YR$E$M$Y$72.57$KG$20240904$$CN$US$
242932681$24293268$1$I$$20231215$20240906$20240906$PER$$US-FARMAPROD-202312-3721$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932691$24293269$1$I$$20231227$20240906$20240906$PER$$US-FARMAPROD-202312-3819$DOMPE FARMACEUTICI$$$$E$M$Y$86.18$KG$20240904$$CN$US$
242932701$24293270$1$I$$20231208$20240906$20240906$PER$$US-FARMAPROD-202312-3655$DOMPE FARMACEUTICI$$$$A$F$Y$138.16$KG$20240904$$CN$US$
242932711$24293271$1$I$$20231219$20240906$20240906$PER$$US-FARMAPROD-202312-3654$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242932721$24293272$1$I$$20231212$20240906$20240906$PER$$US-FARMAPROD-202312-3685$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932731$24293273$1$I$$20231221$20240906$20240906$PER$$US-FARMAPROD-202312-3762$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242932741$24293274$1$I$$20231220$20240906$20240906$PER$$US-FARMAPROD-202312-3744$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932751$24293275$1$I$$20231221$20240906$20240906$PER$$US-FARMAPROD-202312-3758$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$CN$US$
242932761$24293276$1$I$20231201$20231214$20240906$20240906$PER$$US-FARMAPROD-202312-3701$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$
242932771$24293277$1$I$$20231220$20240906$20240906$PER$$US-FARMAPROD-202312-3751$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242932781$24293278$1$I$$20231221$20240906$20240906$PER$$US-FARMAPROD-202312-3764$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932791$24293279$1$I$20231201$20231222$20240906$20240906$PER$$US-FARMAPROD-202312-3722$DOMPE FARMACEUTICI$$94$YR$E$M$Y$$$20240904$$CN$US$
242932801$24293280$1$I$$20231213$20240906$20240906$PER$$US-FARMAPROD-202312-3682$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242932811$24293281$1$I$$20240130$20240906$20240906$PER$$US-FARMAPROD-202312-3743$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242932821$24293282$1$I$$20231226$20240906$20240906$PER$$US-FARMAPROD-202312-3792$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242932831$24293283$1$I$20231224$20231224$20240906$20240906$PER$$US-FARMAPROD-202312-3778$DOMPE FARMACEUTICI$$70$YR$E$M$Y$$$20240904$$CN$US$
242932841$24293284$1$I$$20231221$20240906$20240906$PER$$US-FARMAPROD-202312-3767$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242932851$24293285$1$I$$20231221$20240906$20240906$PER$$US-FARMAPROD-202312-3761$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242932861$24293286$1$I$$20231229$20240906$20240906$PER$$US-FARMAPROD-202312-3733$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242932871$24293287$1$I$$20231219$20240906$20240906$PER$$US-FARMAPROD-202312-3745$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242932881$24293288$1$I$20231201$20240118$20240906$20240906$PER$$US-FARMAPROD-202312-3729$DOMPE FARMACEUTICI$$60$YR$A$F$Y$78.47$KG$20240904$$CN$US$
242932891$24293289$1$I$$20231220$20240906$20240906$PER$$US-FARMAPROD-202312-3750$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242932901$24293290$1$I$$20231227$20240906$20240906$PER$$US-FARMAPROD-202312-3780$DOMPE FARMACEUTICI$$$$E$F$Y$68.36$KG$20240904$$CN$US$
242932911$24293291$1$I$20231217$20231218$20240906$20240906$PER$$US-FARMAPROD-202312-3730$DOMPE FARMACEUTICI$$30$YR$A$F$Y$$$20240904$$CN$US$
242932921$24293292$1$I$$20231226$20240906$20240906$PER$$US-FARMAPROD-202312-3786$DOMPE FARMACEUTICI$$$$$M$Y$73.48$KG$20240904$$CN$US$
242932931$24293293$1$I$$20231226$20240906$20240906$PER$$US-FARMAPROD-202312-3794$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242932941$24293294$1$I$20231213$20231215$20240906$20240906$PER$$US-FARMAPROD-202312-3716$DOMPE FARMACEUTICI$$44$YR$A$F$Y$72.57$KG$20240904$$CN$US$
242932951$24293295$1$I$$20240105$20240906$20240906$PER$$US-FARMAPROD-202401-0057$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242932961$24293296$1$I$$20231221$20240906$20240906$PER$$US-FARMAPROD-202312-3757$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242932971$24293297$1$I$20231219$20231220$20240906$20240906$PER$$US-FARMAPROD-202312-3755$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240904$$CN$US$
242932981$24293298$1$I$$20231219$20240906$20240906$PER$$US-FARMAPROD-202312-3735$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242932991$24293299$1$I$$20240103$20240906$20240906$PER$$US-FARMAPROD-202312-3714$DOMPE FARMACEUTICI$$$$E$M$Y$47.17$KG$20240904$$CN$US$
242933001$24293300$1$I$20191001$20240820$20240906$20240906$PER$$US-SA-2024SA258056$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240906$$MD$US$US
242933011$24293301$1$I$20240817$20240904$20240906$20240906$EXP$$NVSC2024CR178736$NOVARTIS$$79$YR$$F$Y$$$20240906$$CN$CR$CR
242933021$24293302$1$I$$20240111$20240906$20240906$PER$$US-FARMAPROD-202312-3799$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933031$24293303$1$I$$20240104$20240906$20240906$PER$$US-FARMAPROD-202401-0055$DOMPE FARMACEUTICI$$$$A$F$Y$101.15$KG$20240904$$CN$US$
242933041$24293304$1$I$$20231215$20240906$20240906$PER$$US-FARMAPROD-202312-3720$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242933051$24293305$1$I$20231201$20240116$20240906$20240906$PER$$US-FARMAPROD-202312-3728$DOMPE FARMACEUTICI$$55$YR$A$F$Y$$$20240904$$CN$US$
242933061$24293306$1$I$$20231227$20240906$20240906$PER$$US-FARMAPROD-202312-3821$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242933071$24293307$1$I$20231201$20231226$20240906$20240906$PER$$US-FARMAPROD-202312-3800$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$
242933081$24293308$1$I$$20231221$20240906$20240906$PER$$US-FARMAPROD-202312-3766$DOMPE FARMACEUTICI$$$$E$F$Y$70.31$KG$20240904$$CN$US$
242933091$24293309$1$I$$20240424$20240906$20240906$PER$$US-FARMAPROD-202312-3732$DOMPE FARMACEUTICI$$$$A$F$Y$106.14$KG$20240904$$CN$US$
242933101$24293310$1$I$$20231219$20240906$20240906$PER$$US-FARMAPROD-202312-3734$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933111$24293311$1$I$$20231227$20240906$20240906$PER$$US-FARMAPROD-202312-3817$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242933121$24293312$1$I$20240101$20240119$20240906$20240906$PER$$US-FARMAPROD-202312-3781$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240904$$CN$US$
242933131$24293313$1$I$$20231211$20240906$20240906$PER$$US-FARMAPROD-202312-3670$DOMPE FARMACEUTICI$$$$E$F$Y$43.09$KG$20240904$$CN$US$
242933141$24293314$1$I$$20240201$20240906$20240906$PER$$US-FARMAPROD-202312-3731$DOMPE FARMACEUTICI$$$$E$F$Y$65.77$KG$20240904$$CN$US$
242933151$24293315$1$I$$20240822$20240906$20240906$PER$$US-JNJFOC-20240857809$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$HP$US$US
242933161$24293316$1$I$$20231227$20240906$20240906$PER$$US-FARMAPROD-202312-3813$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242933171$24293317$1$I$$20231228$20240906$20240906$PER$$US-FARMAPROD-202401-0001$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$
242933181$24293318$1$I$$20231227$20240906$20240906$PER$$US-FARMAPROD-202312-3795$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242933191$24293319$1$I$$20231226$20240906$20240906$PER$$US-FARMAPROD-202312-3793$DOMPE FARMACEUTICI$$37$YR$A$F$Y$51.26$KG$20240904$$CN$US$
242933201$24293320$1$I$$20231226$20240906$20240906$PER$$US-FARMAPROD-202312-3782$DOMPE FARMACEUTICI$$90$YR$E$M$Y$$$20240904$$CN$US$
242933211$24293321$1$I$$20231226$20240906$20240906$PER$$US-FARMAPROD-202312-3785$DOMPE FARMACEUTICI$$$$E$F$Y$72.57$KG$20240904$$CN$US$
242933221$24293322$1$I$20231228$20231229$20240906$20240906$PER$$US-FARMAPROD-202401-0011$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$
242933231$24293323$1$I$20231228$20231228$20240906$20240906$PER$$US-FARMAPROD-202312-3825$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$CN$US$
242933241$24293324$1$I$20231201$20240109$20240906$20240906$PER$$US-FARMAPROD-202401-0094$DOMPE FARMACEUTICI$$66$YR$E$M$Y$$$20240904$$CN$US$
242933251$24293325$1$I$$20231220$20240906$20240906$PER$$US-FARMAPROD-202312-3752$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242933261$24293326$1$I$$20240115$20240906$20240906$PER$$US-FARMAPROD-202312-3820$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242933271$24293327$1$I$20231201$20240102$20240906$20240906$PER$$US-FARMAPROD-202401-0039$DOMPE FARMACEUTICI$$58$YR$A$F$Y$143.34$KG$20240904$$CN$US$
242933281$24293328$1$I$$20240327$20240906$20240906$PER$$US-FARMAPROD-202401-0048$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242933291$24293329$1$I$$20231226$20240906$20240906$PER$$US-FARMAPROD-202312-3791$DOMPE FARMACEUTICI$$64$YR$A$F$Y$$$20240904$$CN$US$
242933301$24293330$1$I$$20231222$20240906$20240906$PER$$US-FARMAPROD-202312-3777$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933311$24293331$1$I$$20240904$20240906$20240906$PER$$US-ABBVIE-5908429$ABBVIE$$$$$$Y$$$20240906$$HP$US$US
242933321$24293332$1$I$$20231227$20240906$20240906$PER$$US-FARMAPROD-202312-3816$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933331$24293333$1$I$20231201$20231229$20240906$20240906$PER$$US-FARMAPROD-202401-0010$DOMPE FARMACEUTICI$$59$YR$A$M$Y$$$20240904$$CN$US$
242933341$24293334$1$I$$20231227$20240906$20240906$PER$$US-FARMAPROD-202312-3818$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933361$24293336$1$I$$20231228$20240906$20240906$PER$$US-FARMAPROD-202401-0004$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242933371$24293337$1$I$$20231229$20240906$20240906$PER$$US-FARMAPROD-202401-0007$DOMPE FARMACEUTICI$$81$YR$E$M$Y$63.5$KG$20240904$$CN$US$
242933381$24293338$1$I$20231226$20240218$20240906$20240906$PER$$US-FARMAPROD-202312-3824$DOMPE FARMACEUTICI$$35$YR$A$F$Y$$$20240904$$CN$US$
242933391$24293339$1$I$20220601$20240408$20240906$20240906$EXP$$CL-JNJFOC-20240908767$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240906$$MD$CL$CL
242933401$24293340$1$I$20240101$20240110$20240906$20240906$PER$$US-FARMAPROD-202401-0099$DOMPE FARMACEUTICI$$33$YR$A$F$Y$$$20240904$$CN$US$
242933411$24293341$1$I$$20240122$20240906$20240906$PER$$US-FARMAPROD-202312-3779$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$
242933421$24293342$1$I$$20240104$20240906$20240906$PER$$US-FARMAPROD-202312-3798$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242933431$24293343$1$I$$20240110$20240906$20240906$PER$$US-FARMAPROD-202401-0108$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242933441$24293344$1$I$$20240108$20240906$20240906$PER$$US-FARMAPROD-202401-0076$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242933451$24293345$1$I$20231201$20240124$20240906$20240906$PER$$US-FARMAPROD-202401-0015$DOMPE FARMACEUTICI$$59$YR$A$F$Y$76.2$KG$20240904$$CN$US$
242933461$24293346$1$I$$20231229$20240906$20240906$PER$$US-FARMAPROD-202401-0017$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242933471$24293347$1$I$$20240102$20240906$20240906$PER$$US-FARMAPROD-202401-0019$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$CN$US$
242933481$24293348$1$I$$20240108$20240906$20240906$PER$$US-FARMAPROD-202401-0084$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933491$24293349$1$I$20231228$20231228$20240906$20240906$PER$$US-FARMAPROD-202401-0002$DOMPE FARMACEUTICI$$34$YR$A$F$Y$98.47$KG$20240904$$CN$US$
242933501$24293350$1$I$20231222$20240528$20240906$20240906$PER$$US-FARMAPROD-202312-3815$DOMPE FARMACEUTICI$$65$YR$E$F$Y$$$20240904$$CN$US$US
242933511$24293351$1$I$20231231$20231231$20240906$20240906$PER$$US-FARMAPROD-202401-0012$DOMPE FARMACEUTICI$$32$YR$A$F$Y$$$20240904$$CN$US$
242933521$24293352$1$I$$20231228$20240906$20240906$PER$$US-FARMAPROD-202401-0003$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933531$24293353$1$I$$20240103$20240906$20240906$PER$$US-FARMAPROD-202401-0042$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242933541$24293354$1$I$20231201$20240109$20240906$20240906$PER$$US-FARMAPROD-202312-3797$DOMPE FARMACEUTICI$$94$YR$E$M$Y$$$20240904$$CN$US$
242933551$24293355$1$I$20231201$20240117$20240906$20240906$PER$$US-FARMAPROD-202401-0056$DOMPE FARMACEUTICI$$63$YR$A$F$Y$$$20240904$$CN$US$
242933561$24293356$1$I$$20240112$20240906$20240906$PER$$US-FARMAPROD-202401-0016$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933571$24293357$1$I$$20240118$20240906$20240906$PER$$US-FARMAPROD-202401-0045$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933581$24293358$1$I$20231231$20240102$20240906$20240906$PER$$US-FARMAPROD-202401-0018$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$CN$US$
242933591$24293359$1$I$$20231231$20240906$20240906$PER$$US-FARMAPROD-202401-0030$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933601$24293360$1$I$20240103$20240126$20240906$20240906$PER$$US-FARMAPROD-202401-0028$DOMPE FARMACEUTICI$$55$YR$A$F$Y$82.64$KG$20240904$$MD$US$
242933611$24293361$1$I$$20240829$20240906$20240906$EXP$$CA-AstraZeneca-2024A199837$ASTRAZENECA$$48$YR$$F$Y$$$20240906$$MD$CA$
242933621$24293362$1$I$$20240102$20240906$20240906$PER$$US-FARMAPROD-202401-0036$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242933631$24293363$1$I$20240104$20240209$20240906$20240906$PER$$US-FARMAPROD-202401-0058$DOMPE FARMACEUTICI$$26$YR$A$F$Y$$$20240904$$CN$US$
242933641$24293364$1$I$20231118$20240118$20240906$20240906$PER$$US-FARMAPROD-202401-0032$DOMPE FARMACEUTICI$$81$YR$E$M$Y$$$20240904$$MD$US$
242933651$24293365$1$I$$20240110$20240906$20240906$PER$$US-FARMAPROD-202401-0102$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242933661$24293366$1$I$$20240110$20240906$20240906$PER$$US-FARMAPROD-202401-0095$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933671$24293367$1$I$$20240104$20240906$20240906$PER$$US-FARMAPROD-202401-0047$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933681$24293368$1$I$20240101$20240219$20240906$20240906$PER$$US-FARMAPROD-202401-0093$DOMPE FARMACEUTICI$$63$YR$A$F$Y$80.74$KG$20240904$$CN$US$
242933691$24293369$1$I$20231201$20240304$20240906$20240906$PER$$US-FARMAPROD-202401-0077$DOMPE FARMACEUTICI$$50$YR$A$M$Y$$$20240904$$CN$US$
242933701$24293370$1$I$20240201$20240603$20240906$20240906$PER$$US-FARMAPROD-202401-0013$DOMPE FARMACEUTICI$$55$YR$A$F$Y$$$20240904$$CN$US$US
242933711$24293371$1$I$$20240105$20240906$20240906$PER$$US-FARMAPROD-202401-0067$DOMPE FARMACEUTICI$$$$A$F$Y$76.2$KG$20240904$$CN$US$
242933721$24293372$1$I$$20240109$20240906$20240906$PER$$US-FARMAPROD-202401-0096$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933731$24293373$1$I$$20231227$20240906$20240906$PER$$US-FARMAPROD-202312-3814$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242933741$24293374$1$I$20240104$20240117$20240906$20240906$PER$$US-FARMAPROD-202401-0054$DOMPE FARMACEUTICI$$85$YR$E$F$Y$83.91$KG$20240904$$CN$US$
242933751$24293375$1$I$20231201$20240125$20240906$20240906$PER$$US-FARMAPROD-202401-0043$DOMPE FARMACEUTICI$$65$YR$E$F$Y$$$20240904$$CN$US$
242933761$24293376$1$I$20231226$20231227$20240906$20240906$PER$$US-FARMAPROD-202401-0005$DOMPE FARMACEUTICI$$38$YR$A$F$Y$$$20240904$$CN$US$
242933771$24293377$1$I$$20240104$20240906$20240906$PER$$US-FARMAPROD-202401-0061$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242933781$24293378$1$I$$20240105$20240906$20240906$PER$$US-FARMAPROD-202401-0070$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933791$24293379$1$I$20240820$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A202821$ASTRAZENECA$$25163$DY$$F$Y$$$20240906$$CN$US$
242933801$24293380$1$I$$20240108$20240906$20240906$PER$$US-FARMAPROD-202401-0074$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242933811$24293381$1$I$$20240105$20240906$20240906$PER$$US-FARMAPROD-202401-0068$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242933821$24293382$1$I$20240101$20240108$20240906$20240906$PER$$US-FARMAPROD-202401-0080$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240904$$CN$US$
242933831$24293383$1$I$$20240105$20240906$20240906$PER$$US-FARMAPROD-202401-0069$DOMPE FARMACEUTICI$$$$A$F$Y$73.03$KG$20240904$$CN$US$
242933841$24293384$1$I$$20240110$20240906$20240906$PER$$US-FARMAPROD-202401-0103$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242933851$24293385$1$I$$20240903$20240906$20240906$EXP$$CN-AstraZeneca-2024A202458$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$CN$
242933861$24293386$1$I$$20240903$20240906$20240906$EXP$$VN-AstraZeneca-2024A203216$ASTRAZENECA$$$$$M$Y$$$20240906$$MD$VN$
242933871$24293387$1$I$20240111$20240111$20240906$20240906$PER$$US-FARMAPROD-202401-0109$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242933881$24293388$1$I$$20240110$20240906$20240906$PER$$US-FARMAPROD-202401-0097$DOMPE FARMACEUTICI$$$$A$M$Y$86.18$KG$20240904$$CN$US$
242933891$24293389$1$I$$20240103$20240906$20240906$PER$$US-FARMAPROD-202401-0040$DOMPE FARMACEUTICI$$$$E$F$Y$4.77$KG$20240904$$CN$US$
242933901$24293390$1$I$$20240108$20240906$20240906$PER$$US-FARMAPROD-202401-0073$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242933911$24293391$1$I$$20240108$20240906$20240906$PER$$US-FARMAPROD-202401-0100$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$PH$US$
242933921$24293392$1$I$$20240110$20240906$20240906$PER$$US-FARMAPROD-202401-0087$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242933931$24293393$1$I$$20240104$20240906$20240906$PER$$US-FARMAPROD-202401-0064$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242933941$24293394$1$I$$20240115$20240906$20240906$PER$$US-FARMAPROD-202401-0155$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242933951$24293395$1$I$$20240830$20240906$20240906$EXP$$CN-AstraZeneca-2024A199903$ASTRAZENECA$$$$$F$Y$83$KG$20240906$$MD$CN$
242933961$24293396$1$I$20130927$20240829$20240906$20240906$EXP$$FR-AstraZeneca-2024A202589$ASTRAZENECA$$70$YR$$M$Y$56$KG$20240906$$MD$FR$
242933971$24293397$1$I$$20240122$20240906$20240906$PER$$US-FARMAPROD-202401-0081$DOMPE FARMACEUTICI$$$$A$F$Y$128.37$KG$20240904$$CN$US$
242933981$24293398$1$I$$20240108$20240906$20240906$PER$$US-FARMAPROD-202401-0075$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242933991$24293399$1$I$20231201$20240110$20240906$20240906$PER$$US-FARMAPROD-202401-0101$DOMPE FARMACEUTICI$$61$YR$A$M$Y$$$20240904$$CN$US$
242934001$24293400$1$I$$20240904$20240906$20240906$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409002221$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240906$$HP$GB$GB
242934011$24293401$1$I$20240901$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002787$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240906$$CN$US$US
242934021$24293402$1$I$$20240903$20240906$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001883$ELI LILLY AND CO$$$$$M$Y$$$20240906$$CN$US$US
242934031$24293403$1$I$$20240110$20240906$20240906$PER$$US-FARMAPROD-202401-0112$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242934041$24293404$1$I$20231201$20240108$20240906$20240906$PER$$US-FARMAPROD-202401-0085$DOMPE FARMACEUTICI$$61$YR$A$F$Y$$$20240904$$CN$US$
242934051$24293405$1$I$20240112$20240118$20240906$20240906$PER$$US-FARMAPROD-202401-0147$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$
242934061$24293406$1$I$$20240115$20240906$20240906$PER$$US-FARMAPROD-202401-0156$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934071$24293407$1$I$$20240112$20240906$20240906$PER$$US-FARMAPROD-202401-0131$DOMPE FARMACEUTICI$$$$E$F$Y$63.5$KG$20240904$$CN$US$
242934081$24293408$1$I$$20240905$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003604$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240906$$CN$US$US
242934092$24293409$2$F$$20240903$20240906$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001449$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240913$$CN$US$US
242934101$24293410$1$I$$20240830$20240906$20240906$EXP$$ZA-AstraZeneca-2024A198552$ASTRAZENECA$$52$YR$$M$Y$$$20240906$$CN$ZA$
242934111$24293411$1$I$20240116$20240212$20240906$20240906$PER$$US-FARMAPROD-202401-0059$DOMPE FARMACEUTICI$$89$YR$E$M$Y$$$20240904$$CN$US$
242934121$24293412$1$I$20240306$20240829$20240906$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US202408019106$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240906$$CN$US$US
242934131$24293413$1$I$$20240830$20240906$20240906$EXP$$VN-AstraZeneca-2024A201748$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$VN$
242934141$24293414$1$I$20230101$20240112$20240906$20240906$PER$$US-FARMAPROD-202401-0132$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934151$24293415$1$I$$20240111$20240906$20240906$PER$$US-FARMAPROD-202401-0130$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$HP$US$
242934161$24293416$1$I$20231205$20240110$20240906$20240906$PER$$US-FARMAPROD-202401-0113$DOMPE FARMACEUTICI$$85$YR$E$F$Y$$$20240904$$CN$US$
242934171$24293417$1$I$$20240830$20240906$20240906$EXP$$NVSC2024US176850$NOVARTIS$$$$$$Y$$$20240906$$HP$US$US
242934181$24293418$1$I$$20240223$20240906$20240906$PER$$US-FARMAPROD-202401-0038$DOMPE FARMACEUTICI$$82$YR$E$F$Y$69.85$KG$20240904$$CN$US$
242934191$24293419$1$I$20240114$20240223$20240906$20240906$PER$$US-FARMAPROD-202401-0153$DOMPE FARMACEUTICI$$59$YR$A$F$Y$$$20240904$$CN$US$
242934201$24293420$1$I$$20240108$20240906$20240906$PER$$US-FARMAPROD-202401-0078$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934211$24293421$1$I$$20240112$20240906$20240906$PER$$US-FARMAPROD-202401-0144$DOMPE FARMACEUTICI$$$$A$M$Y$75.3$KG$20240904$$CN$US$
242934221$24293422$1$I$$20240112$20240906$20240906$PER$$US-FARMAPROD-202401-0140$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242934231$24293423$1$I$$20240111$20240906$20240906$PER$$US-FARMAPROD-202401-0119$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934241$24293424$1$I$20240108$20240110$20240906$20240906$PER$$US-FARMAPROD-202401-0135$DOMPE FARMACEUTICI$$36$YR$A$M$Y$$$20240904$$CN$US$
242934251$24293425$1$I$20240110$20240124$20240906$20240906$PER$$US-FARMAPROD-202401-0111$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242934261$24293426$1$I$20231201$20240112$20240906$20240906$PER$$US-FARMAPROD-202401-0142$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240904$$CN$US$
242934271$24293427$1$I$$20240209$20240906$20240906$PER$$US-FARMAPROD-202401-0121$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242934281$24293428$1$I$$20240112$20240906$20240906$PER$$US-FARMAPROD-202401-0138$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934291$24293429$1$I$$20240111$20240906$20240906$PER$$US-FARMAPROD-202401-0110$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934301$24293430$1$I$$20240529$20240906$20240906$PER$$US-FARMAPROD-202401-0123$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$US
242934311$24293431$1$I$$20240112$20240906$20240906$PER$$US-FARMAPROD-202401-0141$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934321$24293432$1$I$20240317$20240829$20240906$20240906$EXP$$FR-AstraZeneca-2024A203059$ASTRAZENECA$$0$DY$$M$Y$2.3$KG$20240906$$MD$FR$
242934331$24293433$1$I$$20240206$20240906$20240906$PER$$US-FARMAPROD-202401-0122$DOMPE FARMACEUTICI$$$$A$F$Y$96.98$KG$20240904$$CN$US$
242934341$24293434$1$I$20230101$20240829$20240906$20240906$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-014390$JAZZ$$49$YR$$M$Y$56.3$KG$20240906$$MD$JP$JP
242934351$24293435$1$I$20240101$20240115$20240906$20240906$PER$$US-FARMAPROD-202401-0154$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$CN$US$
242934362$24293436$2$F$20240824$20240829$20240906$20240916$EXP$$BR-AstraZeneca-2024A199535$ASTRAZENECA$$$$$M$Y$$$20240916$$MD$BR$
242934371$24293437$1$I$$20240124$20240906$20240906$PER$$US-FARMAPROD-202401-0063$DOMPE FARMACEUTICI$$$$A$M$Y$138.98$KG$20240904$$CN$US$
242934381$24293438$1$I$20240110$20240124$20240906$20240906$PER$$US-FARMAPROD-202401-0134$DOMPE FARMACEUTICI$$54$YR$A$F$Y$$$20240904$$CN$US$
242934391$24293439$1$I$$20240229$20240906$20240906$PER$$US-FARMAPROD-202401-0146$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242934401$24293440$1$I$$20240112$20240906$20240906$PER$$US-FARMAPROD-202401-0143$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934411$24293441$1$I$$20240215$20240906$20240906$PER$$US-FARMAPROD-202401-0139$DOMPE FARMACEUTICI$$$$E$M$Y$87.09$KG$20240904$$CN$US$
242934421$24293442$1$I$$20240119$20240906$20240906$PER$$US-FARMAPROD-202401-0214$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242934431$24293443$1$I$20240221$20240305$20240906$20240906$PER$$US-FARMAPROD-202401-0117$DOMPE FARMACEUTICI$$52$YR$A$M$Y$$$20240904$$CN$US$
242934441$24293444$1$I$$20240202$20240906$20240906$PER$$US-FARMAPROD-202401-0187$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934451$24293445$1$I$$20240117$20240906$20240906$PER$$US-FARMAPROD-202401-0174$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934461$24293446$1$I$20240115$20240118$20240906$20240906$PER$$US-FARMAPROD-202401-0192$DOMPE FARMACEUTICI$$53$YR$A$F$Y$$$20240904$$CN$US$
242934471$24293447$1$I$20240101$20240116$20240906$20240906$PER$$US-FARMAPROD-202401-0168$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$CN$US$
242934481$24293448$1$I$$20240118$20240906$20240906$PER$$US-FARMAPROD-202401-0190$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242934491$24293449$1$I$$20240112$20240906$20240906$PER$$US-FARMAPROD-202401-0145$DOMPE FARMACEUTICI$$$$E$M$Y$86.18$KG$20240904$$CN$US$
242934501$24293450$1$I$$20240115$20240906$20240906$PER$$US-FARMAPROD-202401-0165$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934511$24293451$1$I$20240115$20240116$20240906$20240906$PER$$US-FARMAPROD-202401-0167$DOMPE FARMACEUTICI$$44$YR$A$F$Y$$$20240904$$CN$US$
242934521$24293452$1$I$$20240118$20240906$20240906$PER$$US-FARMAPROD-202401-0206$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242934531$24293453$1$I$$20240902$20240906$20240906$PER$$US-EMD Serono-2024047509$EMD SERONO INC$$$$A$F$Y$$$20240906$$CN$US$US
242934541$24293454$1$I$$20240116$20240906$20240906$PER$$US-FARMAPROD-202401-0166$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934551$24293455$1$I$$20240122$20240906$20240906$PER$$US-FARMAPROD-202401-0219$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934561$24293456$1$I$20240119$20240119$20240906$20240906$PER$$US-FARMAPROD-202401-0210$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240904$$CN$US$
242934571$24293457$1$I$$20240118$20240906$20240906$PER$$US-FARMAPROD-202401-0211$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934581$24293458$1$I$20240111$20240111$20240906$20240906$PER$$US-FARMAPROD-202401-0120$DOMPE FARMACEUTICI$$66$YR$E$F$Y$48.08$KG$20240904$$CN$US$
242934591$24293459$1$I$$20240118$20240906$20240906$PER$$US-FARMAPROD-202401-0204$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934601$24293460$1$I$$20240202$20240906$20240906$PER$$US-FARMAPROD-202401-0213$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934611$24293461$1$I$$20240205$20240906$20240906$PER$$US-FARMAPROD-202401-0183$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934621$24293462$1$I$20240201$20240219$20240906$20240906$PER$$US-FARMAPROD-202401-0161$DOMPE FARMACEUTICI$$63$YR$A$M$Y$$$20240904$$CN$US$
242934631$24293463$1$I$20240101$20240119$20240906$20240906$PER$$US-FARMAPROD-202401-0220$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$
242934641$24293464$1$I$$20240117$20240906$20240906$PER$$US-FARMAPROD-202401-0184$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934651$24293465$1$I$$20240115$20240906$20240906$PER$$US-FARMAPROD-202401-0160$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934661$24293466$1$I$$20240214$20240906$20240906$PER$$US-FARMAPROD-202401-0189$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934671$24293467$1$I$$20240830$20240906$20240906$EXP$$GB-BIOGEN-2024BI01280869$BIOGEN$$$$A$M$Y$$$20240906$$CN$GB$GB
242934681$24293468$1$I$20240101$20240212$20240906$20240906$PER$$US-FARMAPROD-202401-0236$DOMPE FARMACEUTICI$$45$YR$A$F$Y$$$20240904$$CN$US$
242934701$24293470$1$I$$20240903$20240906$20240906$PER$$US-ROCHE-10000073762$ROCHE$$$$$$Y$$$20240906$$CN$US$US
242934711$24293471$1$I$$20240228$20240906$20240906$PER$$US-FARMAPROD-202401-0201$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934721$24293472$1$I$20240115$20240117$20240906$20240906$PER$$US-FARMAPROD-202401-0185$DOMPE FARMACEUTICI$$86$YR$E$F$Y$$$20240904$$CN$US$
242934731$24293473$1$I$20240101$20240122$20240906$20240906$PER$$US-FARMAPROD-202401-0235$DOMPE FARMACEUTICI$$69$YR$E$M$Y$$$20240904$$CN$US$
242934741$24293474$1$I$$20240122$20240906$20240906$PER$$US-FARMAPROD-202401-0234$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934751$24293475$1$I$20240119$20240119$20240906$20240906$PER$$US-FARMAPROD-202401-0207$DOMPE FARMACEUTICI$$66$YR$E$F$Y$$$20240904$$CN$US$
242934761$24293476$1$I$$20240124$20240906$20240906$PER$$US-FARMAPROD-202401-0264$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242934771$24293477$1$I$$20240119$20240906$20240906$PER$$US-FARMAPROD-202401-0225$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934781$24293478$1$I$$20240215$20240906$20240906$PER$$US-FARMAPROD-202401-0181$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934791$24293479$1$I$$20240123$20240906$20240906$PER$$US-FARMAPROD-202401-0252$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242934801$24293480$1$I$$20240122$20240906$20240906$PER$$US-FARMAPROD-202401-0241$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934811$24293481$1$I$$20240123$20240906$20240906$PER$$US-FARMAPROD-202401-0256$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934821$24293482$1$I$$20240115$20240906$20240906$PER$$US-FARMAPROD-202401-0163$DOMPE FARMACEUTICI$$$$E$F$Y$51.53$KG$20240904$$CN$US$
242934831$24293483$1$I$$20240124$20240906$20240906$PER$$US-FARMAPROD-202401-0262$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934841$24293484$1$I$$20240119$20240906$20240906$PER$$US-FARMAPROD-202401-0242$DOMPE FARMACEUTICI$$83$YR$E$F$Y$$$20240904$$MD$US$
242934851$24293485$1$I$$20240115$20240906$20240906$PER$$US-FARMAPROD-202401-0164$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934861$24293486$1$I$$20240122$20240906$20240906$PER$$US-FARMAPROD-202401-0244$DOMPE FARMACEUTICI$$65$YR$E$F$Y$$$20240904$$MD$US$
242934871$24293487$1$I$$20240122$20240906$20240906$PER$$US-FARMAPROD-202401-0237$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934881$24293488$1$I$$20240123$20240906$20240906$PER$$US-FARMAPROD-202401-0243$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240904$$MD$US$
242934891$24293489$1$I$$20240123$20240906$20240906$PER$$US-FARMAPROD-202401-0249$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934901$24293490$1$I$$20240124$20240906$20240906$PER$$US-FARMAPROD-202401-0261$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242934911$24293491$1$I$$20240122$20240906$20240906$PER$$US-FARMAPROD-202401-0229$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934921$24293492$1$I$$20240123$20240906$20240906$PER$$US-FARMAPROD-202401-0251$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242934931$24293493$1$I$$20240119$20240906$20240906$PER$$US-FARMAPROD-202401-0226$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242934941$24293494$1$I$$20240123$20240906$20240906$PER$$US-FARMAPROD-202401-0257$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$HP$US$
242934951$24293495$1$I$$20240124$20240906$20240906$PER$$US-FARMAPROD-202401-0263$DOMPE FARMACEUTICI$$$$T$F$Y$$$20240904$$CN$US$
242934961$24293496$1$I$20240125$20240129$20240906$20240906$PER$$US-FARMAPROD-202401-0312$DOMPE FARMACEUTICI$$28$YR$A$F$Y$$$20240904$$CN$US$
242934971$24293497$1$I$$20240131$20240906$20240906$PER$$US-FARMAPROD-202402-0338$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242934981$24293498$1$I$20240123$20240123$20240906$20240906$PER$$US-FARMAPROD-202401-0250$DOMPE FARMACEUTICI$$79$YR$E$F$Y$$$20240904$$CN$US$
242934991$24293499$1$I$$20240228$20240906$20240906$PER$$US-FARMAPROD-202401-0224$DOMPE FARMACEUTICI$$$$A$F$Y$49.9$KG$20240904$$CN$US$
242935001$24293500$1$I$$20240125$20240906$20240906$PER$$US-FARMAPROD-202401-0267$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242935011$24293501$1$I$20240118$20240122$20240906$20240906$PER$$US-FARMAPROD-202401-0238$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242935021$24293502$1$I$$20240830$20240906$20240906$EXP$$US-GSK-US2024AMR109094$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$US$US
242935031$24293503$1$I$$20240829$20240906$20240906$EXP$$CA-TEVA-VS-3240210$TEVA$$65$YR$$M$Y$$$20240906$$CN$CA$CA
242935041$24293504$1$I$$20240221$20240906$20240906$PER$$US-FARMAPROD-202401-0208$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935051$24293505$1$I$$20240122$20240906$20240906$PER$$US-FARMAPROD-202401-0239$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242935061$24293506$1$I$$20240125$20240906$20240906$PER$$US-FARMAPROD-202401-0270$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242935071$24293507$1$I$$20240129$20240906$20240906$PER$$US-FARMAPROD-202401-0309$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242935081$24293508$1$I$20240108$20240214$20240906$20240906$PER$$US-FARMAPROD-202401-0227$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$
242935091$24293509$1$I$$20240215$20240906$20240906$PER$$US-FARMAPROD-202401-0231$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935101$24293510$1$I$$20240131$20240906$20240906$PER$$US-FARMAPROD-202402-0336$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242935111$24293511$1$I$20240125$20240125$20240906$20240906$PER$$US-FARMAPROD-202401-0269$DOMPE FARMACEUTICI$$78$YR$E$M$Y$$$20240904$$CN$US$
242935121$24293512$1$I$$20240125$20240906$20240906$PER$$US-FARMAPROD-202401-0275$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242935131$24293513$1$I$20240202$20240202$20240906$20240906$PER$$US-FARMAPROD-202402-0381$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240904$$CN$US$
242935141$24293514$1$I$$20240126$20240906$20240906$PER$$US-FARMAPROD-202401-0305$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935151$24293515$1$I$$20240209$20240906$20240906$PER$$US-FARMAPROD-202401-0205$DOMPE FARMACEUTICI$$$$E$F$Y$88.45$KG$20240904$$CN$US$
242935161$24293516$1$I$$20240126$20240906$20240906$PER$$US-FARMAPROD-202401-0291$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242935171$24293517$1$I$$20240122$20240906$20240906$PER$$US-FARMAPROD-202401-0228$DOMPE FARMACEUTICI$$$$A$F$Y$116.8$KG$20240904$$CN$US$
242935181$24293518$1$I$$20240119$20240906$20240906$PER$$US-FARMAPROD-202401-0233$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242935191$24293519$1$I$$20240208$20240906$20240906$PER$$US-FARMAPROD-202401-0278$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242935201$24293520$1$I$20240101$20240304$20240906$20240906$PER$$US-FARMAPROD-202401-0308$DOMPE FARMACEUTICI$$86$YR$E$F$Y$$$20240904$$CN$US$
242935211$24293521$1$I$20240101$20240209$20240906$20240906$PER$$US-FARMAPROD-202402-0326$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240904$$CN$US$
242935221$24293522$1$I$$20240209$20240906$20240906$PER$$US-FARMAPROD-202402-0356$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242935231$24293523$1$I$20240202$20240202$20240906$20240906$PER$$US-FARMAPROD-202402-0372$DOMPE FARMACEUTICI$$73$YR$E$M$Y$$$20240904$$CN$US$
242935241$24293524$1$I$$20240304$20240906$20240906$PER$$US-FARMAPROD-202402-0383$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935251$24293525$1$I$$20240122$20240906$20240906$PER$$US-FARMAPROD-202401-0232$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935261$24293526$1$I$20240101$20240126$20240906$20240906$PER$$US-FARMAPROD-202401-0272$DOMPE FARMACEUTICI$$42$YR$A$M$Y$$$20240904$$CN$US$
242935271$24293527$1$I$$20240126$20240906$20240906$PER$$US-FARMAPROD-202401-0293$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242935281$24293528$1$I$20240101$20240123$20240906$20240906$PER$$US-FARMAPROD-202401-0253$DOMPE FARMACEUTICI$$70$YR$E$M$Y$$$20240904$$CN$US$
242935291$24293529$1$I$$20240308$20240906$20240906$PER$$US-FARMAPROD-202402-0348$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$
242935301$24293530$1$I$20240101$20240129$20240906$20240906$PER$$US-FARMAPROD-202401-0313$DOMPE FARMACEUTICI$$69$YR$E$F$Y$58.97$KG$20240904$$CN$US$
242935311$24293531$1$I$$20240304$20240906$20240906$PER$$US-FARMAPROD-202402-0340$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242935321$24293532$1$I$20240210$20240212$20240906$20240906$PER$$US-FARMAPROD-202402-0328$DOMPE FARMACEUTICI$$81$YR$E$F$Y$58.97$KG$20240904$$CN$US$
242935331$24293533$1$I$$20240130$20240906$20240906$PER$$US-FARMAPROD-202402-0327$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242935341$24293534$1$I$$20240126$20240906$20240906$PER$$US-FARMAPROD-202401-0292$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242935351$24293535$1$I$$20240201$20240906$20240906$PER$$US-FARMAPROD-202402-0350$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242935361$24293536$1$I$$20240129$20240906$20240906$PER$$US-FARMAPROD-202401-0314$DOMPE FARMACEUTICI$$$$E$F$Y$59.87$KG$20240904$$CN$US$
242935371$24293537$1$I$$20240311$20240906$20240906$PER$$US-FARMAPROD-202401-0317$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935381$24293538$1$I$$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0332$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935391$24293539$1$I$20240124$20240214$20240906$20240906$PER$$US-FARMAPROD-202401-0316$DOMPE FARMACEUTICI$$54$YR$A$F$Y$$$20240904$$CN$US$
242935401$24293540$1$I$$20240131$20240906$20240906$PER$$US-FARMAPROD-202402-0339$DOMPE FARMACEUTICI$$$$C$F$Y$15.42$KG$20240904$$CN$US$
242935411$24293541$1$I$20240101$20240201$20240906$20240906$PER$$US-FARMAPROD-202402-0351$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240904$$CN$US$
242935421$24293542$1$I$20240101$20240129$20240906$20240906$PER$$US-FARMAPROD-202401-0310$DOMPE FARMACEUTICI$$70$YR$E$M$Y$$$20240904$$CN$US$
242935431$24293543$1$I$$20240325$20240906$20240906$PER$$US-FARMAPROD-202401-0315$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935441$24293544$1$I$$20240201$20240906$20240906$PER$$US-FARMAPROD-202402-0353$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242935451$24293545$1$I$$20240205$20240906$20240906$PER$$US-FARMAPROD-202402-0390$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935461$24293546$1$I$20240101$20240227$20240906$20240906$PER$$US-FARMAPROD-202401-0271$DOMPE FARMACEUTICI$$66$YR$E$F$Y$$$20240904$$CN$US$
242935471$24293547$1$I$$20240307$20240906$20240906$PER$$US-FARMAPROD-202402-0384$DOMPE FARMACEUTICI$$$$E$M$Y$102.97$KG$20240904$$CN$US$
242935481$24293548$1$I$$20240222$20240906$20240906$PER$$US-FARMAPROD-202401-0318$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242935491$24293549$1$I$$20240202$20240906$20240906$PER$$US-FARMAPROD-202402-0393$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242935501$24293550$1$I$$20240206$20240906$20240906$PER$$US-FARMAPROD-202402-0417$DOMPE FARMACEUTICI$$$$A$F$Y$59.87$KG$20240904$$CN$US$
242935511$24293551$1$I$$20240228$20240906$20240906$PER$$US-FARMAPROD-202402-0335$DOMPE FARMACEUTICI$$$$E$F$Y$64.41$KG$20240904$$CN$US$
242935521$24293552$1$I$20231201$20240131$20240906$20240906$PER$$US-FARMAPROD-202402-0342$DOMPE FARMACEUTICI$$84$YR$E$M$Y$$$20240904$$HP$US$
242935531$24293553$1$I$$20240320$20240906$20240906$PER$$US-FARMAPROD-202402-0352$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935541$24293554$1$I$20240129$20240206$20240906$20240906$PER$$US-FARMAPROD-202402-0418$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240904$$CN$US$
242935551$24293555$1$I$20240201$20240201$20240906$20240906$PER$$US-FARMAPROD-202402-0354$DOMPE FARMACEUTICI$$46$YR$A$F$Y$$$20240904$$CN$US$
242935571$24293557$1$I$20240201$20240206$20240906$20240906$PER$$US-FARMAPROD-202402-0414$DOMPE FARMACEUTICI$$89$YR$E$M$Y$$$20240904$$CN$US$
242935581$24293558$1$I$$20240202$20240906$20240906$PER$$US-FARMAPROD-202402-0371$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935601$24293560$1$I$$20240212$20240906$20240906$PER$$US-FARMAPROD-202402-0329$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935611$24293561$1$I$20240130$20240202$20240906$20240906$PER$$US-FARMAPROD-202402-0365$DOMPE FARMACEUTICI$$46$YR$A$F$Y$71.3$KG$20240904$$CN$US$
242935621$24293562$1$I$20240127$20240128$20240906$20240906$PER$$US-FARMAPROD-202401-0289$DOMPE FARMACEUTICI$$74$YR$E$M$Y$$$20240904$$CN$US$
242935631$24293563$1$I$$20240202$20240906$20240906$PER$$US-FARMAPROD-202402-0367$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242935641$24293564$1$I$20240202$20240202$20240906$20240906$PER$$US-FARMAPROD-202402-0370$DOMPE FARMACEUTICI$$76$YR$E$M$Y$99.79$KG$20240904$$CN$US$
242935651$24293565$1$I$$20240208$20240906$20240906$PER$$US-FARMAPROD-202402-0374$DOMPE FARMACEUTICI$$$$E$F$Y$80.29$KG$20240904$$CN$US$
242935661$24293566$1$I$$20240202$20240906$20240906$PER$$US-FARMAPROD-202402-0375$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242935671$24293567$1$I$20240130$20240201$20240906$20240906$PER$$US-FARMAPROD-202402-0355$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$
242935681$24293568$1$I$20240131$20240202$20240906$20240906$PER$$US-FARMAPROD-202402-0368$DOMPE FARMACEUTICI$$61$YR$A$F$Y$$$20240904$$CN$US$
242935691$24293569$1$I$$20240220$20240906$20240906$PER$$US-FARMAPROD-202402-0369$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935701$24293570$1$I$20240203$20240312$20240906$20240906$PER$$US-FARMAPROD-202402-0377$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240904$$CN$US$
242935711$24293571$1$I$20240303$20240301$20240906$20240906$PER$$US-FARMAPROD-202402-0407$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242935721$24293572$1$I$$20240201$20240906$20240906$PER$$US-FARMAPROD-202402-0349$DOMPE FARMACEUTICI$$$$A$F$Y$88.9$KG$20240904$$CN$US$
242935731$24293573$1$I$$20240903$20240906$20240906$EXP$$CA-JNJFOC-20240907006$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240906$$HP$CA$CA
242935741$24293574$1$I$$20240529$20240906$20240906$PER$$US-FARMAPROD-202401-0273$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242935751$24293575$1$I$$20240314$20240906$20240906$PER$$US-FARMAPROD-202402-0376$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242935761$24293576$1$I$$20240206$20240906$20240906$PER$$US-FARMAPROD-202402-0409$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$CN$US$
242935771$24293577$1$I$$20240205$20240906$20240906$PER$$US-FARMAPROD-202402-0404$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242935781$24293578$1$I$$20240202$20240906$20240906$PER$$US-FARMAPROD-202402-0366$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935791$24293579$1$I$20240202$20240202$20240906$20240906$PER$$US-FARMAPROD-202402-0378$DOMPE FARMACEUTICI$$44$YR$A$F$Y$$$20240904$$CN$US$
242935801$24293580$1$I$20240201$20240223$20240906$20240906$PER$$US-FARMAPROD-202402-0401$DOMPE FARMACEUTICI$$80$YR$E$F$Y$$$20240904$$CN$US$
242935811$24293581$1$I$20240205$20240205$20240906$20240906$PER$$US-FARMAPROD-202402-0395$DOMPE FARMACEUTICI$$59$YR$A$F$Y$$$20240904$$CN$US$
242935821$24293582$1$I$20240131$20240205$20240906$20240906$PER$$US-FARMAPROD-202402-0392$DOMPE FARMACEUTICI$$84$YR$E$F$Y$$$20240904$$CN$US$
242935831$24293583$1$I$20240203$20240305$20240906$20240906$PER$$US-FARMAPROD-202402-0387$DOMPE FARMACEUTICI$$43$YR$A$F$Y$$$20240904$$CN$US$
242935841$24293584$1$I$$20240208$20240906$20240906$PER$$US-FARMAPROD-202402-0448$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242935851$24293585$1$I$$20240202$20240906$20240906$PER$$US-FARMAPROD-202402-0373$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242935861$24293586$1$I$20240204$20240207$20240906$20240906$PER$$US-FARMAPROD-202402-0424$DOMPE FARMACEUTICI$$65$YR$A$F$Y$$$20240904$$CN$US$
242935871$24293587$1$I$$20240205$20240906$20240906$PER$$US-FARMAPROD-202402-0391$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242935881$24293588$1$I$20240203$20240320$20240906$20240906$PER$$US-FARMAPROD-202402-0422$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$
242935891$24293589$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177485$AMGEN$$$$$$Y$$$20240906$$HP$US$US
242935901$24293590$1$I$$20240206$20240906$20240906$PER$$US-FARMAPROD-202402-0416$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242935911$24293591$1$I$$20240205$20240906$20240906$PER$$US-FARMAPROD-202402-0389$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242935921$24293592$1$I$$20240222$20240906$20240906$PER$$US-FARMAPROD-202402-0413$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242935931$24293593$1$I$$20240209$20240906$20240906$PER$$US-FARMAPROD-202402-0466$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242935941$24293594$1$I$20240204$20240204$20240906$20240906$PER$$US-FARMAPROD-202402-0382$DOMPE FARMACEUTICI$$70$YR$E$F$Y$53.98$KG$20240904$$CN$US$
242935951$24293595$1$I$20240201$20240417$20240906$20240906$PER$$US-FARMAPROD-202402-0420$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$MD$US$
242935961$24293596$1$I$$20240827$20240906$20240906$EXP$$CA-FreseniusKabi-FK202413170$FRESENIUS KABI$$64$YR$A$M$Y$$$20240906$$PH$CA$CA
242935971$24293597$1$I$$20240305$20240906$20240906$PER$$US-FARMAPROD-202402-0415$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242935981$24293598$1$I$20240205$20240311$20240906$20240906$PER$$US-FARMAPROD-202402-0421$DOMPE FARMACEUTICI$$87$YR$E$F$Y$$$20240904$$CN$US$
242935991$24293599$1$I$20240201$20240223$20240906$20240906$PER$$US-FARMAPROD-202402-0398$DOMPE FARMACEUTICI$$63$YR$A$F$Y$$$20240904$$CN$US$
242936001$24293600$1$I$$20240904$20240906$20240906$PER$$US-009507513-2409USA002302$MERCK$$$$$M$Y$$$20240906$$HP$US$US
242936011$24293601$1$I$$20240207$20240906$20240906$PER$$US-FARMAPROD-202402-0429$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242936021$24293602$1$I$20240202$20240318$20240906$20240906$PER$$US-FARMAPROD-202402-0403$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240904$$CN$US$
242936031$24293603$1$I$$20240214$20240906$20240906$PER$$US-FARMAPROD-202402-0504$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242936041$24293604$1$I$20240201$20240210$20240906$20240906$PER$$US-FARMAPROD-202402-0471$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$
242936051$24293605$1$I$$20240214$20240906$20240906$PER$$US-FARMAPROD-202402-0511$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242936061$24293606$1$I$$20240210$20240906$20240906$PER$$US-FARMAPROD-202402-0473$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936071$24293607$1$I$$20240412$20240906$20240906$PER$$US-FARMAPROD-202402-0406$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936081$24293608$1$I$$20240207$20240906$20240906$PER$$US-FARMAPROD-202402-0433$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242936091$24293609$1$I$$20240213$20240906$20240906$PER$$US-FARMAPROD-202402-0493$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936101$24293610$1$I$20240204$20240205$20240906$20240906$PER$$US-FARMAPROD-202402-0400$DOMPE FARMACEUTICI$$57$YR$A$F$Y$$$20240904$$CN$US$
242936111$24293611$1$I$$20240206$20240906$20240906$PER$$US-FARMAPROD-202402-0419$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242936121$24293612$1$I$20240210$20240212$20240906$20240906$PER$$US-FARMAPROD-202402-0467$DOMPE FARMACEUTICI$$84$YR$E$F$Y$43.54$KG$20240904$$CN$US$
242936131$24293613$1$I$$20240528$20240906$20240906$PER$$US-FARMAPROD-202402-0408$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242936141$24293614$1$I$$20240212$20240906$20240906$PER$$US-FARMAPROD-202402-0486$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242936151$24293615$1$I$$20240215$20240906$20240906$PER$$US-FARMAPROD-202402-0515$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242936161$24293616$1$I$20240201$20240209$20240906$20240906$PER$$US-FARMAPROD-202402-0468$DOMPE FARMACEUTICI$$70$YR$E$F$Y$54.79$KG$20240904$$CN$US$
242936171$24293617$1$I$$20240209$20240906$20240906$PER$$US-FARMAPROD-202402-0465$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242936181$24293618$1$I$20240209$20240209$20240906$20240906$PER$$US-FARMAPROD-202402-0462$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242936191$24293619$1$I$$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0402$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936201$24293620$1$I$20240131$20240208$20240906$20240906$PER$$US-FARMAPROD-202402-0447$DOMPE FARMACEUTICI$$84$YR$E$F$Y$$$20240904$$CN$US$
242936211$24293621$1$I$20240208$20240403$20240906$20240906$PER$$US-FARMAPROD-202402-0479$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242936221$24293622$1$I$20240201$20240319$20240906$20240906$PER$$US-FARMAPROD-202402-0439$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$
242936231$24293623$1$I$20240208$20240212$20240906$20240906$PER$$US-FARMAPROD-202402-0476$DOMPE FARMACEUTICI$$73$YR$E$F$Y$112.04$KG$20240904$$CN$US$
242936241$24293624$1$I$$20240207$20240906$20240906$PER$$US-FARMAPROD-202402-0430$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936251$24293625$1$I$20240212$20240212$20240906$20240906$PER$$US-FARMAPROD-202402-0469$DOMPE FARMACEUTICI$$79$YR$E$M$Y$$$20240904$$CN$US$
242936261$24293626$1$I$20240209$20240209$20240906$20240906$PER$$US-FARMAPROD-202402-0453$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242936271$24293627$1$I$$20240209$20240906$20240906$PER$$US-FARMAPROD-202402-0461$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936281$24293628$1$I$$20240205$20240906$20240906$PER$$US-FARMAPROD-202402-0426$DOMPE FARMACEUTICI$$$$E$F$Y$54.88$KG$20240904$$CN$US$
242936291$24293629$1$I$$20240227$20240906$20240906$PER$$US-FARMAPROD-202402-0399$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$
242936301$24293630$1$I$$20240207$20240906$20240906$PER$$US-FARMAPROD-202402-0434$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242936311$24293631$1$I$$20240209$20240906$20240906$PER$$US-FARMAPROD-202402-0464$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242936321$24293632$1$I$$20240210$20240906$20240906$PER$$US-FARMAPROD-202402-0454$DOMPE FARMACEUTICI$$$$E$$Y$$$20240904$$MD$US$
242936331$24293633$1$I$$20240213$20240906$20240906$PER$$US-FARMAPROD-202402-0498$DOMPE FARMACEUTICI$$$$A$F$Y$53.52$KG$20240904$$CN$US$
242936341$24293634$1$I$20240322$20240325$20240906$20240906$PER$$US-FARMAPROD-202402-0478$DOMPE FARMACEUTICI$$73$YR$E$M$Y$$$20240904$$CN$US$
242936351$24293635$1$I$20240201$20240208$20240906$20240906$PER$$US-FARMAPROD-202402-0438$DOMPE FARMACEUTICI$$64$YR$A$F$Y$48.53$KG$20240904$$CN$US$
242936361$24293636$1$I$$20240208$20240906$20240906$PER$$US-FARMAPROD-202402-0451$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242936371$24293637$1$I$$20240208$20240906$20240906$PER$$US-FARMAPROD-202402-0443$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242936381$24293638$1$I$20240201$20240209$20240906$20240906$PER$$US-FARMAPROD-202402-0460$DOMPE FARMACEUTICI$$59$YR$A$F$Y$$$20240904$$CN$US$
242936391$24293639$1$I$$20240207$20240906$20240906$PER$$US-FARMAPROD-202402-0431$DOMPE FARMACEUTICI$$$$E$M$Y$118.39$KG$20240904$$CN$US$
242936401$24293640$1$I$20240829$20240830$20240906$20240906$EXP$$US-SA-2024SA257868$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240906$$MD$US$US
242936411$24293641$1$I$$20240207$20240906$20240906$PER$$US-FARMAPROD-202402-0432$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936421$24293642$1$I$$20240319$20240906$20240906$PER$$US-FARMAPROD-202402-0540$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242936431$24293643$1$I$$20240209$20240906$20240906$PER$$US-FARMAPROD-202402-0482$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242936441$24293644$1$I$$20240208$20240906$20240906$PER$$US-FARMAPROD-202402-0450$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936451$24293645$1$I$20240206$20240326$20240906$20240906$PER$$US-FARMAPROD-202402-0551$DOMPE FARMACEUTICI$$79$YR$E$M$Y$$$20240904$$CN$US$
242936461$24293646$1$I$$20240210$20240906$20240906$PER$$US-FARMAPROD-202402-0470$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242936471$24293647$1$I$20240215$20240215$20240906$20240906$PER$$US-FARMAPROD-202402-0514$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$
242936481$24293648$1$I$$20240216$20240906$20240906$PER$$US-FARMAPROD-202402-0545$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242936491$24293649$1$I$$20240405$20240906$20240906$PER$$US-FARMAPROD-202402-0480$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936501$24293650$1$I$$20240312$20240906$20240906$PER$$US-FARMAPROD-202402-0449$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$
242936511$24293651$1$I$$20240212$20240906$20240906$PER$$US-FARMAPROD-202402-0483$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242936521$24293652$1$I$$20240326$20240906$20240906$PER$$US-FARMAPROD-202402-0494$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936531$24293653$1$I$$20240301$20240906$20240906$PER$$US-FARMAPROD-202402-0488$DOMPE FARMACEUTICI$$$$E$F$Y$64.59$KG$20240904$$CN$US$
242936541$24293654$1$I$20240207$20240208$20240906$20240906$PER$$US-FARMAPROD-202402-0444$DOMPE FARMACEUTICI$$68$YR$E$F$Y$53.52$KG$20240904$$CN$US$
242936551$24293655$1$I$$20240214$20240906$20240906$EXP$$US-FARMAPROD-202402-0516$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242936561$24293656$1$I$20240301$20240326$20240906$20240906$PER$$US-FARMAPROD-202402-0505$DOMPE FARMACEUTICI$$74$YR$E$F$Y$58.97$KG$20240904$$CN$US$
242936571$24293657$1$I$$20240214$20240906$20240906$PER$$US-FARMAPROD-202402-0506$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242936581$24293658$1$I$20240206$20240229$20240906$20240906$PER$$US-FARMAPROD-202402-0463$DOMPE FARMACEUTICI$$55$YR$A$M$Y$$$20240904$$CN$US$
242936591$24293659$1$I$20240405$20240409$20240906$20240906$PER$$US-FARMAPROD-202402-0507$DOMPE FARMACEUTICI$$63$YR$A$F$Y$$$20240904$$CN$US$
242936601$24293660$1$I$$20240314$20240906$20240906$PER$$US-FARMAPROD-202402-0560$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936611$24293661$1$I$$20240306$20240906$20240906$PER$$US-FARMAPROD-202402-0487$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936621$24293662$1$I$20240213$20240507$20240906$20240906$PER$$US-FARMAPROD-202402-0508$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240904$$MD$US$
242936631$24293663$1$I$20240214$20240215$20240906$20240906$PER$$US-FARMAPROD-202402-0527$DOMPE FARMACEUTICI$$61$YR$A$M$Y$$$20240904$$CN$US$
242936641$24293664$1$I$20240201$20240212$20240906$20240906$PER$$US-FARMAPROD-202402-0484$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$CN$US$
242936651$24293665$1$I$20240210$20240325$20240906$20240906$PER$$US-FARMAPROD-202402-0485$DOMPE FARMACEUTICI$$70$YR$E$F$Y$77.11$KG$20240904$$CN$US$
242936661$24293666$1$I$20240212$20240213$20240906$20240906$PER$$US-FARMAPROD-202402-0496$DOMPE FARMACEUTICI$$72$YR$E$M$Y$$$20240904$$CN$US$US
242936671$24293667$1$I$20240201$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0437$DOMPE FARMACEUTICI$$78$YR$E$M$Y$$$20240904$$CN$US$
242936681$24293668$1$I$$20240213$20240906$20240906$PER$$US-FARMAPROD-202402-0499$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936691$24293669$1$I$$20240401$20240906$20240906$PER$$US-FARMAPROD-202402-0522$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936701$24293670$1$I$20240216$20240216$20240906$20240906$PER$$US-FARMAPROD-202402-0543$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242936711$24293671$1$I$20240213$20240312$20240906$20240906$PER$$US-FARMAPROD-202402-0541$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$
242936721$24293672$1$I$$20240314$20240906$20240906$PER$$US-FARMAPROD-202402-0525$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936731$24293673$1$I$20240208$20240401$20240906$20240906$PER$$US-FARMAPROD-202402-0452$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$
242936741$24293674$1$I$$20240227$20240906$20240906$PER$$US-FARMAPROD-202402-0495$DOMPE FARMACEUTICI$$$$E$F$Y$73.21$KG$20240904$$CN$US$
242936751$24293675$1$I$20240216$20240311$20240906$20240906$PER$$US-FARMAPROD-202402-0547$DOMPE FARMACEUTICI$$37$YR$A$F$Y$$$20240904$$CN$US$
242936761$24293676$1$I$20240214$20240223$20240906$20240906$PER$$US-FARMAPROD-202402-0526$DOMPE FARMACEUTICI$$64$YR$A$F$Y$$$20240904$$CN$US$
242936771$24293677$1$I$$20240318$20240906$20240906$PER$$US-FARMAPROD-202402-0519$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242936781$24293678$1$I$$20240227$20240906$20240906$PER$$US-FARMAPROD-202402-0481$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936791$24293679$1$I$$20240408$20240906$20240906$PER$$US-FARMAPROD-202402-0539$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$HP$US$
242936801$24293680$1$I$$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0594$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936811$24293681$1$I$$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0569$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242936821$24293682$1$I$20240215$20240425$20240906$20240906$PER$$US-FARMAPROD-202402-0538$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240904$$MD$US$
242936831$24293683$1$I$$20240218$20240906$20240906$PER$$US-FARMAPROD-202402-0550$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242936841$24293684$1$I$$20240215$20240906$20240906$PER$$US-FARMAPROD-202402-0521$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936851$24293685$1$I$$20240220$20240906$20240906$PER$$US-FARMAPROD-202402-0580$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242936861$24293686$1$I$$20240220$20240906$20240906$PER$$US-FARMAPROD-202402-0575$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$CN$US$
242936871$24293687$1$I$$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0595$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242936881$24293688$1$I$$20240219$20240906$20240906$PER$$US-FARMAPROD-202402-0570$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242936891$24293689$1$I$20240201$20240301$20240906$20240906$PER$$US-FARMAPROD-202402-0524$DOMPE FARMACEUTICI$$95$YR$E$F$Y$$$20240904$$CN$US$
242936901$24293690$1$I$$20240216$20240906$20240906$PER$$US-FARMAPROD-202402-0537$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242936911$24293691$1$I$$20240216$20240906$20240906$PER$$US-FARMAPROD-202402-0536$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242936921$24293692$1$I$20240101$20240219$20240906$20240906$PER$$US-FARMAPROD-202402-0567$DOMPE FARMACEUTICI$$57$YR$A$F$Y$$$20240904$$CN$US$
242936931$24293693$1$I$$20240904$20240906$20240906$EXP$$NVSC2024CN179367$NOVARTIS$$66$YR$$F$Y$$$20240906$$CN$CN$CN
242936941$24293694$1$I$$20240216$20240906$20240906$PER$$US-FARMAPROD-202402-0549$DOMPE FARMACEUTICI$$$$E$F$Y$90.17$KG$20240904$$CN$US$
242936951$24293695$1$I$20240220$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0592$DOMPE FARMACEUTICI$$17$YR$T$M$Y$$$20240904$$CN$US$
242936961$24293696$1$I$$20240319$20240906$20240906$PER$$US-FARMAPROD-202402-0566$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242936971$24293697$1$I$$20240215$20240906$20240906$PER$$US-FARMAPROD-202402-0517$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242936981$24293698$1$I$$20240215$20240906$20240906$PER$$US-FARMAPROD-202402-0523$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242936991$24293699$1$I$$20240219$20240906$20240906$PER$$US-FARMAPROD-202402-0561$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937001$24293700$1$I$20240201$20240220$20240906$20240906$PER$$US-FARMAPROD-202402-0579$DOMPE FARMACEUTICI$$54$YR$A$F$Y$$$20240904$$CN$US$
242937011$24293701$1$I$20240215$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0548$DOMPE FARMACEUTICI$$78$YR$E$F$Y$87.54$KG$20240904$$CN$US$
242937021$24293702$1$I$$20240212$20240906$20240906$PER$$US-FARMAPROD-202402-0477$DOMPE FARMACEUTICI$$$$E$M$Y$104.33$KG$20240904$$CN$US$
242937031$24293703$1$I$$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0591$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242937041$24293704$1$I$$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0544$DOMPE FARMACEUTICI$$$$E$M$Y$87.59$KG$20240904$$CN$US$
242937051$24293705$1$I$$20240306$20240906$20240906$PER$$US-FARMAPROD-202402-0542$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242937061$24293706$1$I$$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0597$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937071$24293707$1$I$$20240307$20240906$20240906$PER$$US-FARMAPROD-202402-0585$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242937081$24293708$1$I$20240220$20240229$20240906$20240906$PER$$US-FARMAPROD-202402-0581$DOMPE FARMACEUTICI$$67$YR$E$M$Y$$$20240904$$CN$US$
242937091$24293709$1$I$$20240219$20240906$20240906$PER$$US-FARMAPROD-202402-0568$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937101$24293710$1$I$20240222$20240222$20240906$20240906$PER$$US-FARMAPROD-202402-0612$DOMPE FARMACEUTICI$$26$YR$A$F$Y$122.2$KG$20240904$$CN$US$
242937111$24293711$1$I$20231211$20240215$20240906$20240906$PER$$US-FARMAPROD-202402-0518$DOMPE FARMACEUTICI$$57$YR$A$F$Y$58.97$KG$20240904$$CN$US$
242937121$24293712$1$I$$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0588$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937131$24293713$1$I$$20240220$20240906$20240906$PER$$US-FARMAPROD-202402-0574$DOMPE FARMACEUTICI$$$$$$Y$$$20240904$$MD$US$
242937141$24293714$1$I$20240217$20240219$20240906$20240906$PER$$US-FARMAPROD-202402-0572$DOMPE FARMACEUTICI$$43$YR$A$F$Y$$$20240904$$CN$US$
242937151$24293715$1$I$$20240220$20240906$20240906$PER$$US-FARMAPROD-202402-0583$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937161$24293716$1$I$$20240219$20240906$20240906$PER$$US-FARMAPROD-202402-0563$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937171$24293717$1$I$$20240215$20240906$20240906$PER$$US-FARMAPROD-202402-0520$DOMPE FARMACEUTICI$$$$A$M$Y$110.86$KG$20240904$$CN$US$
242937181$24293718$1$I$$20240220$20240906$20240906$PER$$US-FARMAPROD-202402-0584$DOMPE FARMACEUTICI$$$$E$M$Y$88.9$KG$20240904$$CN$US$
242937191$24293719$1$I$$20240223$20240906$20240906$PER$$US-FARMAPROD-202402-0624$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242937201$24293720$1$I$20240219$20240326$20240906$20240906$PER$$US-FARMAPROD-202402-0573$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242937211$24293721$1$I$$20240220$20240906$20240906$PER$$US-FARMAPROD-202402-0598$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242937221$24293722$1$I$$20240219$20240906$20240906$PER$$US-FARMAPROD-202402-0564$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242937231$24293723$1$I$20240222$20240223$20240906$20240906$PER$$US-FARMAPROD-202402-0635$DOMPE FARMACEUTICI$$61$YR$A$F$Y$$$20240904$$CN$US$
242937241$24293724$1$I$$20240216$20240906$20240906$PER$$US-FARMAPROD-202402-0535$DOMPE FARMACEUTICI$$$$E$F$Y$62.87$KG$20240904$$CN$US$
242937251$24293725$1$I$20240201$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0582$DOMPE FARMACEUTICI$$79$YR$E$F$Y$76.2$KG$20240904$$CN$US$
242937261$24293726$1$I$$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0590$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937271$24293727$1$I$20240806$20240905$20240905$20240905$DIR$717366$$FDA-CTU$$60$YR$$M$N$103.5$KG$20240905$Y$MD$US$
242937281$24293728$1$I$$20240829$20240906$20240906$PER$$US-JNJFOC-20240910291$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240906$$PH$US$US
242937291$24293729$1$I$$20240829$20240906$20240906$PER$$US-BAYER-2024A124947$BAYER$$$$$F$Y$$$20240906$$CN$US$US
242937301$24293730$1$I$20240224$20240224$20240906$20240906$PER$$US-FARMAPROD-202402-0671$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$
242937311$24293731$1$I$20240711$20240905$20240906$20240906$EXP$GB-MHRA-MED-202409051602228240-CRTJQ$GB-SANDOZ INC.-SDZ2024GB078238$SANDOZ$$$$$$Y$$$20240906$$HP$GB$GB
242937321$24293732$1$I$$20240829$20240906$20240906$EXP$$CA-TEVA-VS-3238669$TEVA$$85$YR$$F$Y$$$20240906$$CN$CA$CA
242937331$24293733$1$I$$20240301$20240906$20240906$PER$$US-FARMAPROD-202402-0565$DOMPE FARMACEUTICI$$72$YR$E$M$Y$$$20240904$$CN$US$
242937341$24293734$1$I$$20240304$20240906$20240906$PER$$US-FARMAPROD-202402-0586$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937351$24293735$1$I$$20240311$20240906$20240906$PER$$US-FARMAPROD-202402-0593$DOMPE FARMACEUTICI$$$$E$F$Y$51.26$KG$20240904$$CN$US$
242937361$24293736$1$I$$20240222$20240906$20240906$PER$$US-FARMAPROD-202402-0611$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242937371$24293737$1$I$$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0589$DOMPE FARMACEUTICI$$$$A$F$Y$138.8$KG$20240904$$CN$US$
242937381$24293738$1$I$20240318$20240319$20240906$20240906$PER$$US-FARMAPROD-202402-0571$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240904$$CN$US$
242937391$24293739$1$I$$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0600$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937401$24293740$1$I$$20240221$20240906$20240906$PER$$US-FARMAPROD-202402-0601$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242937411$24293741$1$I$20240213$20240223$20240906$20240906$PER$$US-FARMAPROD-202402-0631$DOMPE FARMACEUTICI$$83$YR$E$M$Y$$$20240904$$CN$US$
242937421$24293742$1$I$20240219$20240326$20240906$20240906$PER$$US-FARMAPROD-202402-0602$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240904$$CN$US$
242937431$24293743$1$I$$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0638$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242937441$24293744$1$I$$20240222$20240906$20240906$PER$$US-FARMAPROD-202402-0615$DOMPE FARMACEUTICI$$$$E$F$Y$57.79$KG$20240904$$CN$US$
242937451$24293745$1$I$20240308$20240308$20240906$20240906$PER$$US-FARMAPROD-202402-0632$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242937461$24293746$1$I$$20240227$20240906$20240906$PER$$US-FARMAPROD-202402-0673$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937471$24293747$1$I$$20240228$20240906$20240906$PER$$US-FARMAPROD-202403-0676$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242937481$24293748$1$I$$20240223$20240906$20240906$PER$$US-FARMAPROD-202402-0630$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937491$24293749$1$I$$20240220$20240906$20240906$PER$$US-FARMAPROD-202402-0623$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937501$24293750$1$I$$20240222$20240906$20240906$PER$$US-FARMAPROD-202402-0599$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242937511$24293751$1$I$$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0636$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$CN$US$
242937521$24293752$1$I$20240701$20240906$20240906$20240906$EXP$FR-AFSSAPS-LL2024001662$NVSC2024FR179254$NOVARTIS$$26$YR$$M$Y$$$20240906$$MD$FR$FR
242937531$24293753$1$I$$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0640$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242937541$24293754$1$I$20240226$20240326$20240906$20240906$PER$$US-FARMAPROD-202402-0664$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$
242937551$24293755$1$I$20240226$20240227$20240906$20240906$PER$$US-FARMAPROD-202402-0668$DOMPE FARMACEUTICI$$85$YR$E$F$Y$$$20240904$$CN$US$
242937561$24293756$1$I$20240224$20240225$20240906$20240906$PER$$US-FARMAPROD-202402-0637$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242937571$24293757$1$I$$20240506$20240906$20240906$PER$$US-FARMAPROD-202402-0614$DOMPE FARMACEUTICI$$$$A$F$Y$67.59$KG$20240904$$CN$US$
242937581$24293758$1$I$20240828$20240906$20240906$20240906$DIR$717411$$FDA-CTU$$60$YR$$M$N$82$KG$20240906$N$HP$US$
242937591$24293759$1$I$$20240222$20240906$20240906$PER$$US-FARMAPROD-202402-0610$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242937601$24293760$1$I$20240201$20240328$20240906$20240906$PER$$US-FARMAPROD-202402-0660$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240904$$CN$US$
242937611$24293761$1$I$20240220$20240223$20240906$20240906$PER$$US-FARMAPROD-202402-0650$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240904$$CN$US$
242937621$24293762$1$I$$20240228$20240906$20240906$PER$$US-FARMAPROD-202403-0680$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242937631$24293763$1$I$20240226$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0633$DOMPE FARMACEUTICI$$51$YR$A$M$Y$$$20240904$$CN$US$
242937641$24293764$1$I$20240220$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0649$DOMPE FARMACEUTICI$$41$YR$A$M$Y$$$20240904$$CN$US$
242937651$24293765$1$I$$20240227$20240906$20240906$PER$$US-FARMAPROD-202402-0669$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242937661$24293766$1$I$$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0655$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242937671$24293767$1$I$20240222$20240223$20240906$20240906$PER$$US-FARMAPROD-202402-0627$DOMPE FARMACEUTICI$$79$YR$E$F$Y$$$20240904$$CN$US$
242937681$24293768$1$I$$20240405$20240906$20240906$PER$$US-FARMAPROD-202402-0603$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$
242937691$24293769$1$I$20240301$20240325$20240906$20240906$PER$$US-FARMAPROD-202402-0659$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$
242937701$24293770$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142374$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240906$$CN$US$US
242937711$24293771$1$I$20240302$20240308$20240906$20240906$PER$$US-FARMAPROD-202402-0644$DOMPE FARMACEUTICI$$71$YR$E$M$Y$$$20240904$$CN$US$
242937721$24293772$1$I$20240201$20240227$20240906$20240906$PER$$US-FARMAPROD-202402-0662$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240904$$CN$US$
242937731$24293773$1$I$$20240223$20240906$20240906$PER$$US-FARMAPROD-202402-0629$DOMPE FARMACEUTICI$$$$A$F$Y$63.5$KG$20240904$$CN$US$
242937741$24293774$1$I$20240215$20240222$20240906$20240906$PER$$US-FARMAPROD-202402-0607$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$
242937751$24293775$1$I$20240323$20240325$20240906$20240906$PER$$US-FARMAPROD-202402-0653$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240904$$CN$US$
242937761$24293776$1$I$$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0652$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242937771$24293777$1$I$20240221$20240222$20240906$20240906$PER$$US-FARMAPROD-202402-0605$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$CN$US$
242937781$24293778$1$I$$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0645$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937791$24293779$1$I$20240415$20240416$20240906$20240906$PER$$US-FARMAPROD-202402-0643$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$
242937801$24293780$1$I$$20240229$20240906$20240906$PER$$US-FARMAPROD-202403-0678$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242937811$24293781$1$I$20240226$20240327$20240906$20240906$PER$$US-FARMAPROD-202402-0641$DOMPE FARMACEUTICI$$61$YR$A$M$Y$$$20240904$$CN$US$
242937821$24293782$1$I$$20240417$20240906$20240906$PER$$US-FARMAPROD-202402-0626$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937831$24293783$1$I$$20240227$20240906$20240906$PER$$US-FARMAPROD-202402-0665$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242937841$24293784$1$I$$20240829$20240906$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142308$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240906$$MD$JP$JP
242937851$24293785$1$I$$20240223$20240906$20240906$PER$$US-FARMAPROD-202402-0619$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242937861$24293786$1$I$20240201$20240306$20240906$20240906$PER$$US-FARMAPROD-202402-0661$DOMPE FARMACEUTICI$$86$YR$E$M$Y$$$20240904$$CN$US$
242937871$24293787$1$I$$20240227$20240906$20240906$PER$$US-FARMAPROD-202402-0672$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242937881$24293788$1$I$20240101$20240827$20240906$20240906$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17482$IPSEN$$$$$$Y$$$20240906$$CN$US$US
242937891$24293789$1$I$$20240829$20240906$20240906$EXP$$JP-ROCHE-10000074447$ROCHE$$7$YR$C$M$Y$$$20240906$$MD$JP$JP
242937901$24293790$1$I$$20240227$20240906$20240906$PER$$US-FARMAPROD-202402-0667$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242937911$24293791$1$I$$20240827$20240906$20240906$30DAY$$US-GSK-US2024106702$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$CN$US$US
242937921$24293792$1$I$$20240905$20240906$20240906$EXP$$NVSC2024US178816$NOVARTIS$$$$$M$Y$$$20240906$$HP$US$US
242937932$24293793$2$F$20240811$20240920$20240906$20240920$EXP$$JP-BAYER-2024A127895$BAYER$$89$YR$E$M$Y$$$20240920$$MD$JP$JP
242937941$24293794$1$I$20240228$20240228$20240906$20240906$PER$$US-FARMAPROD-202403-0679$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242937951$24293795$1$I$$20240228$20240906$20240906$PER$$US-FARMAPROD-202403-0675$DOMPE FARMACEUTICI$$$$E$F$Y$70.49$KG$20240904$$CN$US$
242937961$24293796$1$I$$20240423$20240906$20240906$PER$$US-FARMAPROD-202402-0674$DOMPE FARMACEUTICI$$$$E$F$Y$79.38$KG$20240904$$CN$US$
242937971$24293797$1$I$20240201$20240412$20240906$20240906$PER$$US-FARMAPROD-202402-0666$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$
242937991$24293799$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61463$$FDA-CTU$$43$YR$$F$N$$$20240905$N$$US$
242938001$24293800$1$I$20240201$20240328$20240906$20240906$PER$$US-FARMAPROD-202402-0651$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242938011$24293801$1$I$$20240529$20240906$20240906$PER$$US-FARMAPROD-202402-0616$DOMPE FARMACEUTICI$$$$A$F$Y$96.07$KG$20240904$$MD$US$US
242938021$24293802$1$I$$20240226$20240906$20240906$PER$$US-FARMAPROD-202402-0648$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242938031$24293803$1$I$$20240312$20240906$20240906$PER$$US-FARMAPROD-202403-0722$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242938041$24293804$1$I$20240201$20240301$20240906$20240906$PER$$US-FARMAPROD-202403-0716$DOMPE FARMACEUTICI$$74$YR$E$F$Y$59.87$KG$20240904$$CN$US$
242938051$24293805$1$I$20240407$20240408$20240906$20240906$PER$$US-FARMAPROD-202403-0694$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242938061$24293806$1$I$$20240228$20240906$20240906$PER$$US-FARMAPROD-202403-0681$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242938071$24293807$1$I$$20240301$20240906$20240906$PER$$US-FARMAPROD-202403-0721$DOMPE FARMACEUTICI$$$$E$M$Y$53.52$KG$20240904$$CN$US$
242938081$24293808$1$I$$20240304$20240906$20240906$PER$$US-FARMAPROD-202403-0723$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242938091$24293809$1$I$$20240229$20240906$20240906$PER$$US-FARMAPROD-202403-0705$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242938101$24293810$1$I$$20240301$20240906$20240906$PER$$US-FARMAPROD-202403-0717$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242938111$24293811$1$I$$20240304$20240906$20240906$PER$$US-FARMAPROD-202403-0725$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242938121$24293812$1$I$20240201$20240228$20240906$20240906$PER$$US-FARMAPROD-202403-0696$DOMPE FARMACEUTICI$$79$YR$E$M$Y$$$20240904$$CN$US$
242938131$24293813$1$I$$20240301$20240906$20240906$PER$$US-FARMAPROD-202403-0713$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242938141$24293814$1$I$$20240301$20240906$20240906$PER$$US-FARMAPROD-202403-0719$DOMPE FARMACEUTICI$$$$$M$Y$$$20240904$$CN$US$
242938151$24293815$1$I$20240226$20240229$20240906$20240906$PER$$US-FARMAPROD-202403-0703$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242938161$24293816$1$I$$20240228$20240906$20240906$PER$$US-FARMAPROD-202403-0697$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242938171$24293817$1$I$$20240304$20240906$20240906$PER$$US-FARMAPROD-202403-0730$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242938181$24293818$1$I$$20240314$20240906$20240906$PER$$US-FARMAPROD-202403-0704$DOMPE FARMACEUTICI$$$$E$F$Y$73.48$KG$20240904$$CN$US$
242938191$24293819$1$I$20240201$20240229$20240906$20240906$PER$$US-FARMAPROD-202403-0700$DOMPE FARMACEUTICI$$71$YR$E$F$Y$$$20240904$$CN$US$
242938201$24293820$1$I$$20240902$20240906$20240906$EXP$$IT-REGENERON PHARMACEUTICALS, INC.-2024-119569$REGENERON$Vincenzo De Falco, Stefania Napolitano, Renato Franco, Federica Zito Marino, Luigi Formisano, Daniela Esposito, et al.. Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.. Oncoimmunology. 2024;13:1$$$$$Y$$$20240906$$MD$IT$IT
242938211$24293821$1$I$20240201$20240304$20240906$20240906$PER$$US-FARMAPROD-202403-0731$DOMPE FARMACEUTICI$$67$YR$E$M$Y$$$20240904$$CN$US$
242938221$24293822$1$I$$20240902$20240906$20240906$EXP$$IT-REGENERON PHARMACEUTICALS, INC.-2024-119240$REGENERON$Vincenzo De Falco, Stefania Napolitano, Renato Franco, Federica Zito Marino, Luigi Formisano, Daniela Esposito, et al.. Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.. Oncoimmunology. 2024;13:1$$$$$Y$$$20240906$$MD$IT$IT
242938231$24293823$1$I$$20240304$20240906$20240906$PER$$US-FARMAPROD-202403-0732$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242938241$24293824$1$I$$20240902$20240906$20240906$EXP$$BE-AMGEN-BELSP2024175054$AMGEN$$56$YR$A$F$Y$$$20240906$$CN$BE$BE
242938251$24293825$1$I$20240201$20240313$20240906$20240906$PER$$US-FARMAPROD-202403-0682$DOMPE FARMACEUTICI$$81$YR$E$M$Y$$$20240904$$CN$US$
242938261$24293826$1$I$20240229$20240301$20240906$20240906$PER$$US-FARMAPROD-202403-0720$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242938271$24293827$1$I$20240229$20240321$20240906$20240906$PER$$US-FARMAPROD-202403-0707$DOMPE FARMACEUTICI$$66$YR$E$F$Y$$$20240904$$CN$US$
242938281$24293828$1$I$$20240314$20240906$20240906$PER$$US-FARMAPROD-202403-0714$DOMPE FARMACEUTICI$$$$E$M$Y$95.25$KG$20240904$$CN$US$
242938291$24293829$1$I$20240313$20240329$20240906$20240906$PER$$US-FARMAPROD-202403-0684$DOMPE FARMACEUTICI$$70$YR$E$M$Y$93.89$KG$20240904$$CN$US$
242938301$24293830$1$I$20240201$20240228$20240906$20240906$PER$$US-FARMAPROD-202403-0692$DOMPE FARMACEUTICI$$77$YR$E$M$Y$$$20240904$$CN$US$
242938311$24293831$1$I$$20240320$20240906$20240906$PER$$US-FARMAPROD-202403-0712$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242938321$24293832$1$I$20240201$20240301$20240906$20240906$PER$$US-FARMAPROD-202403-0711$DOMPE FARMACEUTICI$$79$YR$E$F$Y$$$20240904$$CN$US$
242938331$24293833$1$I$20240830$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176330$AMGEN$$37$YR$A$F$Y$$$20240906$$CN$US$US
242938342$24293834$2$F$20240830$20240906$20240906$20240911$PER$$US-AMGEN-USASP2024177639$AMGEN$$74$YR$E$F$Y$$$20240911$$HP$US$US
242938351$24293835$1$I$$20240409$20240906$20240906$PER$$US-FARMAPROD-202403-0706$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242938361$24293836$1$I$$20240301$20240906$20240906$PER$$US-FARMAPROD-202403-0708$DOMPE FARMACEUTICI$$$$A$F$Y$70.76$KG$20240904$$CN$US$
242938371$24293837$1$I$20240301$20240620$20240906$20240906$PER$$US-FARMAPROD-202403-0710$DOMPE FARMACEUTICI$$70$YR$E$F$Y$92.53$KG$20240904$$CN$US$US
242938381$24293838$1$I$20240301$20240305$20240906$20240906$PER$$US-FARMAPROD-202403-0751$DOMPE FARMACEUTICI$$53$YR$A$F$Y$$$20240904$$CN$US$
242938391$24293839$1$I$20240305$20240313$20240906$20240906$PER$$US-FARMAPROD-202403-0743$DOMPE FARMACEUTICI$$64$YR$A$M$Y$$$20240904$$CN$US$
242938401$24293840$1$I$$20240304$20240906$20240906$PER$$US-FARMAPROD-202403-0760$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242938411$24293841$1$I$$20240306$20240906$20240906$PER$$US-FARMAPROD-202403-0762$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242938421$24293842$1$I$$20240326$20240906$20240906$PER$$US-FARMAPROD-202403-0769$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242938431$24293843$1$I$20240201$20240326$20240906$20240906$PER$$US-FARMAPROD-202403-0772$DOMPE FARMACEUTICI$$83$YR$E$F$Y$$$20240904$$CN$US$
242938441$24293844$1$I$$20240405$20240906$20240906$PER$$US-FARMAPROD-202403-0783$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242938451$24293845$1$I$$20240305$20240906$20240906$PER$$US-FARMAPROD-202403-0734$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242938461$24293846$1$I$$20240305$20240906$20240906$PER$$US-FARMAPROD-202403-0740$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$HP$US$
242938471$24293847$1$I$$20240307$20240906$20240906$PER$$US-FARMAPROD-202403-0786$DOMPE FARMACEUTICI$$$$E$F$Y$71.67$KG$20240904$$CN$US$
242938481$24293848$1$I$20240201$20240328$20240906$20240906$PER$$US-FARMAPROD-202403-0766$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$
242938491$24293849$1$I$20240306$20240306$20240906$20240906$PER$$US-FARMAPROD-202403-0765$DOMPE FARMACEUTICI$$70$YR$E$F$Y$69.85$KG$20240904$$CN$US$
242938501$24293850$1$I$20240201$20240406$20240906$20240906$PER$$US-FARMAPROD-202403-0759$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$
242938511$24293851$1$I$20240304$20240305$20240906$20240906$PER$$US-FARMAPROD-202403-0756$DOMPE FARMACEUTICI$$70$YR$E$M$Y$88.9$KG$20240904$$CN$US$
242938521$24293852$1$I$$20240306$20240906$20240906$PER$$US-FARMAPROD-202403-0785$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242938531$24293853$1$I$$20240305$20240906$20240906$PER$$US-FARMAPROD-202403-0750$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242938541$24293854$1$I$20240201$20240304$20240906$20240906$PER$$US-FARMAPROD-202403-0733$DOMPE FARMACEUTICI$$61$YR$A$F$Y$90.22$KG$20240904$$CN$US$
242938551$24293855$1$I$20240304$20240305$20240906$20240906$PER$$US-FARMAPROD-202403-0749$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$CN$US$
242938561$24293856$1$I$20240306$20240404$20240906$20240906$PER$$US-FARMAPROD-202403-0770$DOMPE FARMACEUTICI$$73$YR$E$F$Y$81.19$KG$20240904$$CN$US$
242938571$24293857$1$I$20240304$20240304$20240906$20240906$PER$$US-FARMAPROD-202403-0737$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240904$$CN$US$
242938581$24293858$1$I$$20240306$20240906$20240906$PER$$US-FARMAPROD-202403-0763$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242938591$24293859$1$I$20240301$20240318$20240906$20240906$PER$$US-FARMAPROD-202403-0753$DOMPE FARMACEUTICI$$82$YR$E$M$Y$$$20240904$$CN$US$
242938601$24293860$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906789$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242938611$24293861$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906855$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242938621$24293862$1$I$$20240827$20240906$20240906$EXP$$US-PHARMING-PHAUS2024000737$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242938632$24293863$2$F$20240801$20240913$20240906$20240918$PER$$US-PHARMING-PHAUS2024000745$PHARMING GROUP$$$$$$Y$$$20240918$$CN$US$US
242938641$24293864$1$I$$20240320$20240906$20240906$PER$$US-FARMAPROD-202403-0754$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242938651$24293865$1$I$20240302$20240307$20240906$20240906$PER$$US-FARMAPROD-202403-0790$DOMPE FARMACEUTICI$$67$YR$E$M$Y$$$20240904$$CN$US$
242938661$24293866$1$I$20240421$20240421$20240906$20240906$PER$$US-FARMAPROD-202403-0764$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$
242938671$24293867$1$I$$20240306$20240906$20240906$PER$$US-FARMAPROD-202403-0774$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242938681$24293868$1$I$$20240307$20240906$20240906$PER$$US-FARMAPROD-202403-0813$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242938691$24293869$1$I$20240307$20240308$20240906$20240906$PER$$US-FARMAPROD-202403-0837$DOMPE FARMACEUTICI$$79$YR$E$M$Y$87.54$KG$20240904$$CN$US$
242938701$24293870$1$I$20240229$20240305$20240906$20240906$PER$$US-FARMAPROD-202403-0739$DOMPE FARMACEUTICI$$71$YR$E$M$Y$$$20240904$$CN$US$
242938711$24293871$1$I$$20240308$20240906$20240906$PER$$US-FARMAPROD-202403-0803$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242938721$24293872$1$I$20240201$20240327$20240906$20240906$PER$$US-FARMAPROD-202403-0820$DOMPE FARMACEUTICI$$68$YR$E$F$Y$44.09$KG$20240904$$CN$US$
242938731$24293873$1$I$$20240307$20240906$20240906$PER$$US-FARMAPROD-202403-0795$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242938741$24293874$1$I$$20240305$20240906$20240906$PER$$US-FARMAPROD-202403-0755$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242938751$24293875$1$I$20240307$20240320$20240906$20240906$PER$$US-FARMAPROD-202403-0791$DOMPE FARMACEUTICI$$60$YR$A$M$Y$$$20240904$$CN$US$
242938761$24293876$1$I$20240307$20240308$20240906$20240906$PER$$US-FARMAPROD-202403-0814$DOMPE FARMACEUTICI$$67$YR$E$F$Y$60.78$KG$20240904$$CN$US$
242938771$24293877$1$I$$20240307$20240906$20240906$PER$$US-FARMAPROD-202403-0788$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242938781$24293878$1$I$$20240307$20240906$20240906$PER$$US-FARMAPROD-202403-0799$DOMPE FARMACEUTICI$$$$A$M$Y$158.8$KG$20240904$$CN$US$
242938791$24293879$1$I$20240302$20240308$20240906$20240906$PER$$US-FARMAPROD-202403-0806$DOMPE FARMACEUTICI$$58$YR$A$F$Y$$$20240904$$CN$US$
242938801$24293880$1$I$$20240307$20240906$20240906$PER$$US-FARMAPROD-202403-0789$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242938811$24293881$1$I$20240308$20240317$20240906$20240906$PER$$US-FARMAPROD-202403-0815$DOMPE FARMACEUTICI$$75$YR$E$F$Y$56.7$KG$20240904$$CN$US$
242938821$24293882$1$I$$20240308$20240906$20240906$PER$$US-FARMAPROD-202403-0809$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242938831$24293883$1$I$20240227$20240307$20240906$20240906$PER$$US-FARMAPROD-202403-0794$DOMPE FARMACEUTICI$$53$YR$A$M$Y$$$20240904$$CN$US$
242938841$24293884$1$I$20240301$20240404$20240906$20240906$PER$$US-FARMAPROD-202403-0830$DOMPE FARMACEUTICI$$70$YR$E$M$Y$$$20240904$$CN$US$
242938851$24293885$1$I$$20240320$20240906$20240906$PER$$US-FARMAPROD-202403-0812$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242938861$24293886$1$I$$20240307$20240906$20240906$PER$$US-FARMAPROD-202403-0798$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242938871$24293887$1$I$$20240410$20240906$20240906$PER$$US-FARMAPROD-202403-0742$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242938881$24293888$1$I$20240319$20240501$20240906$20240906$PER$$US-FARMAPROD-202403-0758$DOMPE FARMACEUTICI$$73$YR$E$F$Y$52.16$KG$20240904$$CN$US$
242938891$24293889$1$I$$20240308$20240906$20240906$PER$$US-FARMAPROD-202403-0804$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242938901$24293890$1$I$20240405$20240405$20240906$20240906$PER$$US-FARMAPROD-202403-0808$DOMPE FARMACEUTICI$$81$YR$E$F$Y$54.43$KG$20240904$$CN$US$
242938911$24293891$1$I$$20240307$20240906$20240906$PER$$US-FARMAPROD-202403-0800$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242938921$24293892$1$I$$20240308$20240906$20240906$PER$$US-FARMAPROD-202403-0805$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242938932$24293893$2$F$20220101$20240910$20240906$20240914$EXP$$US-ABBVIE-5907097$ABBVIE$$$$$F$Y$58.966$KG$20240914$$CN$US$US
242938941$24293894$1$I$20240101$20240904$20240906$20240906$EXP$$US-ABBVIE-5907905$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242938951$24293895$1$I$$20240902$20240906$20240906$EXP$$IT-REGENERON PHARMACEUTICALS, INC.-2024-119571$REGENERON$Vincenzo De Falco, Stefania Napolitano, Renato Franco, Federica Zito Marino, Luigi Formisano, Daniela Esposito, et al.. Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.. Oncoimmunology. 2024;13:1$$$$$Y$$$20240906$$MD$IT$IT
242938961$24293896$1$I$$20240308$20240906$20240906$PER$$US-FARMAPROD-202403-0810$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242938971$24293897$1$I$20240307$20240310$20240906$20240906$PER$$US-FARMAPROD-202403-0816$DOMPE FARMACEUTICI$$73$YR$E$M$Y$$$20240904$$CN$US$
242938981$24293898$1$I$20240305$20240307$20240906$20240906$PER$$US-FARMAPROD-202403-0792$DOMPE FARMACEUTICI$$80$YR$E$F$Y$80.74$KG$20240904$$CN$US$
242938991$24293899$1$I$20240301$20240320$20240906$20240906$PER$$US-FARMAPROD-202403-0869$DOMPE FARMACEUTICI$$78$YR$E$M$Y$$$20240904$$CN$US$
242939001$24293900$1$I$$20240327$20240906$20240906$PER$$US-FARMAPROD-202403-0895$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$
242939011$24293901$1$I$20240221$20240329$20240906$20240906$PER$$US-FARMAPROD-202403-0947$DOMPE FARMACEUTICI$$43$YR$A$F$Y$$$20240904$$CN$US$
242939021$24293902$1$I$20240307$20240308$20240906$20240906$PER$$US-FARMAPROD-202403-0852$DOMPE FARMACEUTICI$$83$YR$E$F$Y$$$20240904$$CN$US$
242939031$24293903$1$I$20240313$20240402$20240906$20240906$PER$$US-FARMAPROD-202403-0932$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240904$$CN$US$
242939041$24293904$1$I$20240313$20240405$20240906$20240906$PER$$US-FARMAPROD-202403-0931$DOMPE FARMACEUTICI$$55$YR$A$F$Y$$$20240904$$CN$US$
242939051$24293905$1$I$20240309$20240310$20240906$20240906$PER$$US-FARMAPROD-202403-0818$DOMPE FARMACEUTICI$$65$YR$E$F$Y$$$20240904$$CN$US$
242939061$24293906$1$I$20240311$20240405$20240906$20240906$PER$$US-FARMAPROD-202403-0841$DOMPE FARMACEUTICI$$67$YR$E$F$Y$74.39$KG$20240904$$CN$US$
242939071$24293907$1$I$$20240322$20240906$20240906$PER$$US-FARMAPROD-202403-0927$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939081$24293908$1$I$20240314$20240321$20240906$20240906$PER$$US-FARMAPROD-202403-0923$DOMPE FARMACEUTICI$$32$YR$A$F$Y$$$20240904$$CN$US$
242939091$24293909$1$I$20240217$20240218$20240906$20240906$PER$$US-FARMAPROD-202403-0921$DOMPE FARMACEUTICI$$41$YR$A$F$Y$$$20240904$$CN$US$
242939101$24293910$1$I$20240301$20240409$20240906$20240906$PER$$US-FARMAPROD-202403-0807$DOMPE FARMACEUTICI$$55$YR$A$M$Y$$$20240904$$CN$US$
242939111$24293911$1$I$$20240603$20240906$20240906$PER$$US-FARMAPROD-202403-0796$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$MD$US$US
242939121$24293912$1$I$$20240307$20240906$20240906$PER$$US-FARMAPROD-202403-0797$DOMPE FARMACEUTICI$$$$E$F$Y$82.74$KG$20240904$$CN$US$
242939131$24293913$1$I$20240301$20240422$20240906$20240906$PER$$US-FARMAPROD-202403-0946$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$CN$US$
242939141$24293914$1$I$20240408$20240410$20240906$20240906$PER$$US-FARMAPROD-202403-0925$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$
242939151$24293915$1$I$$20240312$20240906$20240906$PER$$US-FARMAPROD-202403-0849$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242939161$24293916$1$I$$20240304$20240906$20240906$PER$$US-FARMAPROD-202403-0736$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939171$24293917$1$I$$20240325$20240906$20240906$PER$$US-FARMAPROD-202403-0944$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939181$24293918$1$I$$20240329$20240906$20240906$PER$$US-FARMAPROD-202403-0839$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939191$24293919$1$I$20240311$20240424$20240906$20240906$PER$$US-FARMAPROD-202403-0876$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$
242939201$24293920$1$I$$20240517$20240906$20240906$PER$$US-FARMAPROD-202403-0862$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939211$24293921$1$I$$20240409$20240906$20240906$PER$$US-FARMAPROD-202403-0822$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939221$24293922$1$I$20240408$20240410$20240906$20240906$PER$$US-FARMAPROD-202403-0897$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$
242939231$24293923$1$I$20240729$20240829$20240906$20240906$EXP$$FR-AstraZeneca-2024A202335$ASTRAZENECA$$53$YR$$F$Y$70$KG$20240906$$MD$FR$
242939241$24293924$1$I$$20240830$20240906$20240906$EXP$$NO-AstraZeneca-2024A201623$ASTRAZENECA$$$$A$F$Y$$$20240906$$HP$NO$
242939251$24293925$1$I$20240301$20240405$20240906$20240906$PER$$US-FARMAPROD-202403-0894$DOMPE FARMACEUTICI$$84$YR$E$F$Y$63.05$KG$20240904$$CN$US$
242939261$24293926$1$I$$20240416$20240906$20240906$PER$$US-FARMAPROD-202403-0949$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242939271$24293927$1$I$20240325$20240325$20240906$20240906$PER$$US-FARMAPROD-202403-0889$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$CN$US$
242939281$24293928$1$I$$20240416$20240906$20240906$PER$$US-FARMAPROD-202403-0903$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939291$24293929$1$I$20240301$20240409$20240906$20240906$PER$$US-FARMAPROD-202403-0845$DOMPE FARMACEUTICI$$67$YR$E$M$Y$$$20240904$$CN$US$
242939301$24293930$1$I$$20240429$20240906$20240906$PER$$US-FARMAPROD-202403-0890$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939311$24293931$1$I$20240307$20240412$20240906$20240906$PER$$US-FARMAPROD-202403-0896$DOMPE FARMACEUTICI$$60$YR$A$F$Y$$$20240904$$CN$US$
242939321$24293932$1$I$$20240905$20240906$20240906$PER$$US-PFIZER INC-202400250871$PFIZER$$56$YR$$F$Y$$$20240906$$CN$US$US
242939341$24293934$1$I$20160415$20240904$20240906$20240906$PER$$US-PFIZER INC-2017510897$PFIZER$$68$YR$$F$Y$$$20240906$$MD$US$US
242939351$24293935$1$I$20240905$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251313$PFIZER$$63$YR$$F$Y$$$20240906$$CN$US$US
242939361$24293936$1$I$20240101$20240905$20240906$20240906$PER$$US-PFIZER INC-PV202400116975$PFIZER$$74$YR$$$Y$$$20240906$$CN$US$US
242939372$24293937$2$F$$20240919$20240906$20240925$PER$$US-PFIZER INC-202400251250$PFIZER$$72$YR$$F$Y$$$20240925$$CN$US$US
242939381$24293938$1$I$$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251116$PFIZER$$72$YR$$F$Y$$$20240906$$CN$US$US
242939392$24293939$2$F$$20240909$20240906$20240911$PER$$US-PFIZER INC-PV202400116862$PFIZER$$77$YR$$F$Y$$$20240911$$CN$US$US
242939401$24293940$1$I$20240301$20240403$20240906$20240906$PER$$US-FARMAPROD-202403-0898$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240904$$CN$US$
242939411$24293941$1$I$$20240415$20240906$20240906$PER$$US-FARMAPROD-202403-0911$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939421$24293942$1$I$20240904$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251303$PFIZER$$40$YR$$F$Y$$$20240906$$CN$US$US
242939431$24293943$1$I$20240830$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251160$PFIZER$$73$YR$$M$Y$$$20240906$$PH$US$US
242939442$24293944$2$F$20240701$20240905$20240906$20240909$PER$$US-PFIZER INC-202400250920$PFIZER$$63$YR$$F$Y$$$20240909$$CN$US$US
242939451$24293945$1$I$$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251135$PFIZER$$56$YR$$F$Y$$$20240906$$HP$US$US
242939462$24293946$2$F$20240905$20240905$20240906$20240909$PER$$US-PFIZER INC-202400250947$PFIZER$$72$YR$$M$Y$95.71$KG$20240909$$CN$US$US
242939472$24293947$2$F$20240529$20240909$20240906$20240909$EXP$$US-PFIZER INC-202400251065$PFIZER$$60$YR$$M$Y$$$20240909$$HP$US$US
242939481$24293948$1$I$20240831$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251489$PFIZER$$71$YR$$F$Y$$$20240906$$CN$US$US
242939491$24293949$1$I$$20240903$20240906$20240906$EXP$$IN-PFIZER INC-PV202400073957$PFIZER$$57$YR$$M$Y$44.5$KG$20240906$$CN$IN$IN
242939501$24293950$1$I$20240307$20240411$20240906$20240906$PER$$US-FARMAPROD-202403-0844$DOMPE FARMACEUTICI$$54$YR$A$M$Y$83.46$KG$20240904$$CN$US$
242939511$24293951$1$I$$20240903$20240906$20240906$PER$$US-PHARMING-PHAUS2024000757$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242939521$24293952$1$I$$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251370$PFIZER$$$$$F$Y$$$20240906$$CN$US$US
242939531$24293953$1$I$$20240830$20240906$20240906$EXP$$VN-AstraZeneca-2024A201717$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$VN$
242939551$24293955$1$I$$20240830$20240906$20240906$PER$$US-PHARMING-PHAUS2024000754$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242939562$24293956$2$F$$20240913$20240906$20240918$PER$$US-PHARMING-PHAUS2024000747$PHARMING GROUP$$$$$$Y$$$20240918$$CN$US$US
242939581$24293958$1$I$20240904$20240905$20240906$20240906$PER$$US-PFIZER INC-202400250939$PFIZER$$58$YR$$F$Y$$$20240906$$CN$US$US
242939591$24293959$1$I$$20240903$20240906$20240906$PER$$US-PHARMING-PHAUS2024000763$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242939601$24293960$1$I$$20240904$20240906$20240906$PER$$US-PHARMING-PHAUS2024000762$PHARMING GROUP$$$$$$Y$$$20240906$$HP$US$US
242939611$24293961$1$I$20240831$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251289$PFIZER$$60$YR$$F$Y$$$20240906$$CN$US$US
242939621$24293962$1$I$$20240828$20240906$20240906$PER$$US-PHARMING-PHAUS2024000742$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242939631$24293963$1$I$20240713$20240829$20240906$20240906$PER$$US-PHARMING-PHAUS2024000753$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242939641$24293964$1$I$$20240903$20240906$20240906$PER$$US-PHARMING-PHAUS2024000755$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242939651$24293965$1$I$$20240826$20240906$20240906$PER$$US-PHARMING-PHAUS2024000738$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242939671$24293967$1$I$$20240903$20240906$20240906$PER$$US-PHARMING-PHAUS2024000758$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242939681$24293968$1$I$$20240828$20240906$20240906$PER$$US-PHARMING-PHAUS2024000748$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242939691$24293969$1$I$$20240902$20240906$20240906$EXP$$US-PHARMING-PHAUS2024000756$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242939702$24293970$2$F$$20240913$20240906$20240923$PER$$US-PHARMING-PHAUS2024000733$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
242939732$24293973$2$F$20240815$20240910$20240906$20240916$PER$$US-PHARMING-PHAUS2024000734$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
242939741$24293974$1$I$$20240904$20240906$20240906$EXP$$US-AstraZeneca-2024A203267$ASTRAZENECA$$$$$M$Y$90.7$KG$20240906$$CN$US$
242939751$24293975$1$I$20240903$20240903$20240906$20240906$EXP$$GB-AstraZeneca-2024A200187$ASTRAZENECA$$70$YR$$F$Y$$$20240906$$MD$GB$
242939761$24293976$1$I$$20240829$20240906$20240906$EXP$$ZA-AstraZeneca-2024A197512$ASTRAZENECA$$33603$DY$$F$Y$$$20240906$$CN$ZA$
242939771$24293977$1$I$20240806$20240828$20240906$20240906$EXP$$US-PHARMING-PHAUS2024000750$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242939781$24293978$1$I$$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A200575$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$US$
242939791$24293979$1$I$$20240830$20240906$20240906$EXP$$EG-AstraZeneca-2024A199452$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$EG$
242939801$24293980$1$I$$20240829$20240906$20240906$PER$$US-PHARMING-PHAUS2024000751$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242939811$24293981$1$I$$20240408$20240906$20240906$PER$$US-FARMAPROD-202403-1125$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939821$24293982$1$I$20240316$20240419$20240906$20240906$PER$$US-FARMAPROD-202403-1046$DOMPE FARMACEUTICI$$53$YR$A$M$Y$$$20240904$$HP$US$
242939831$24293983$1$I$$20240320$20240906$20240906$EXP$$US-FARMAPROD-202403-1011$DOMPE FARMACEUTICI$$$$$M$Y$$$20240904$$MD$US$
242939841$24293984$1$I$20240301$20240416$20240906$20240906$PER$$US-FARMAPROD-202403-1096$DOMPE FARMACEUTICI$$46$YR$A$F$Y$$$20240904$$HP$US$
242939851$24293985$1$I$$20240404$20240906$20240906$PER$$US-FARMAPROD-202403-1123$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242939861$24293986$1$I$20240301$20240408$20240906$20240906$PER$$US-FARMAPROD-202403-1044$DOMPE FARMACEUTICI$$69$YR$E$M$Y$$$20240904$$CN$US$
242939871$24293987$1$I$$20240412$20240906$20240906$PER$$US-FARMAPROD-202403-1009$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242939881$24293988$1$I$20240326$20240417$20240906$20240906$PER$$US-FARMAPROD-202403-1006$DOMPE FARMACEUTICI$$75$YR$E$M$Y$$$20240904$$MD$US$
242939891$24293989$1$I$20240301$20240329$20240906$20240906$PER$$US-FARMAPROD-202403-0956$DOMPE FARMACEUTICI$$78$YR$E$F$Y$57.88$KG$20240904$$CN$US$
242939901$24293990$1$I$$20240403$20240906$20240906$PER$$US-FARMAPROD-202403-1097$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242939911$24293991$1$I$$20240516$20240906$20240906$PER$$US-FARMAPROD-202403-1037$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939921$24293992$1$I$20240301$20240422$20240906$20240906$PER$$US-FARMAPROD-202403-0965$DOMPE FARMACEUTICI$$65$YR$E$F$Y$$$20240904$$CN$US$
242939931$24293993$1$I$$20240424$20240906$20240906$PER$$US-FARMAPROD-202403-1070$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939941$24293994$1$I$20240501$20240517$20240906$20240906$PER$$US-FARMAPROD-202403-1083$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240904$$CN$US$
242939951$24293995$1$I$$20240326$20240906$20240906$PER$$US-FARMAPROD-202403-1007$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242939961$24293996$1$I$$20240214$20240906$20240906$PER$$US-FARMAPROD-202403-0994$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242939971$24293997$1$I$$20240403$20240906$20240906$PER$$US-FARMAPROD-202403-0984$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242939981$24293998$1$I$$20240422$20240906$20240906$PER$$US-FARMAPROD-202403-0958$DOMPE FARMACEUTICI$$$$E$M$Y$81.6$KG$20240904$$CN$US$
242939991$24293999$1$I$20240301$20240329$20240906$20240906$PER$$US-FARMAPROD-202403-1048$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240904$$CN$US$
242940001$24294000$1$I$$20240902$20240906$20240906$EXP$$IT-REGENERON PHARMACEUTICALS, INC.-2024-119570$REGENERON$Vincenzo De Falco, Stefania Napolitano, Renato Franco, Federica Zito Marino, Luigi Formisano, Daniela Esposito, et al.. Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.. Oncoimmunology. 2024;13:1$$$$$Y$$$20240906$$MD$IT$IT
242940011$24294001$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176401$AMGEN$$$$$$Y$$$20240906$$MD$US$US
242940021$24294002$1$I$$20240829$20240906$20240906$EXP$$CN-AMGEN-CHNSP2024175489$AMGEN$Fubin Q.; Na Z.; Shengda Z. et al.. Prognostic values of serum miR-140-5p and SFRP -5 for in-stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240906$$HP$CN$CN
242940031$24294003$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400203216$PFIZER$$72$YR$$F$Y$$$20240906$$CN$US$US
242940041$24294004$1$I$$20240415$20240906$20240906$PER$$US-FARMAPROD-202403-1028$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242940051$24294005$1$I$$20240903$20240906$20240906$PER$$US-PFIZER INC-PV202400116419$PFIZER$$60$YR$$M$Y$90.703$KG$20240906$$MD$US$US
242940061$24294006$1$I$20240828$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250353$PFIZER$$59$YR$$F$Y$$$20240906$$HP$US$US
242940071$24294007$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250101$PFIZER$$$$$F$Y$$$20240906$$CN$US$US
242940081$24294008$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250236$PFIZER$$$$$$Y$$$20240906$$PH$US$US
242940091$24294009$1$I$20240302$20240429$20240906$20240906$PER$$US-FARMAPROD-202403-1095$DOMPE FARMACEUTICI$$91$YR$E$F$Y$46.72$KG$20240904$$CN$US$
242940101$24294010$1$I$$20240603$20240906$20240906$PER$$US-FARMAPROD-202403-1026$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242940111$24294011$1$I$20240830$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250000$PFIZER$$74$YR$$F$Y$74.84$KG$20240906$$CN$US$US
242940122$24294012$2$F$20240903$20240906$20240906$20240911$PER$$US-PFIZER INC-202400251037$PFIZER$$61$YR$$M$Y$$$20240911$$CN$US$US
242940131$24294013$1$I$$20240319$20240906$20240906$PER$$US-FARMAPROD-202403-1008$DOMPE FARMACEUTICI$$$$E$F$Y$79.83$KG$20240904$$CN$US$
242940141$24294014$1$I$$20240401$20240906$20240906$PER$$US-FARMAPROD-202403-1118$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242940151$24294015$1$I$20240401$20240416$20240906$20240906$PER$$US-FARMAPROD-202403-0999$DOMPE FARMACEUTICI$$95$YR$E$F$Y$54.88$KG$20240904$$CN$US$
242940161$24294016$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250162$PFIZER$$$$$$Y$$$20240906$$CN$US$US
242940171$24294017$1$I$$20240415$20240906$20240906$PER$$US-FARMAPROD-202403-0953$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242940181$24294018$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-PV202400116467$PFIZER$$$$$$Y$$$20240906$$CN$US$US
242940191$24294019$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250159$PFIZER$$$$$$Y$$$20240906$$PH$US$US
242940201$24294020$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-PV202400116502$PFIZER$$81$YR$$M$Y$$$20240906$$CN$US$US
242940211$24294021$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-PV202400116517$PFIZER$$44$YR$$M$Y$$$20240906$$HP$US$US
242940221$24294022$1$I$20240101$20240904$20240906$20240906$PER$$US-PFIZER INC-PV202400116458$PFIZER$$42$YR$$F$Y$$$20240906$$HP$US$US
242940231$24294023$1$I$$20240329$20240906$20240906$PER$$US-FARMAPROD-202403-0963$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242940241$24294024$1$I$20240313$20240513$20240906$20240906$PER$$US-FARMAPROD-202403-1025$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240904$$CN$US$
242940251$24294025$1$I$$20240903$20240906$20240906$PER$$US-PFIZER INC-PV202400116116$PFIZER$$$$A$M$Y$$$20240906$$HP$US$US
242940261$24294026$1$I$20240301$20240506$20240906$20240906$PER$$US-FARMAPROD-202403-1001$DOMPE FARMACEUTICI$$54$YR$A$F$Y$$$20240904$$CN$US$
242940271$24294027$1$I$20240902$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250295$PFIZER$$44$YR$$M$Y$$$20240906$$CN$US$US
242940281$24294028$1$I$20240317$20240502$20240906$20240906$PER$$US-FARMAPROD-202403-0977$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$
242940291$24294029$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-PV202400116244$PFIZER$$82$YR$$M$Y$$$20240906$$HP$US$US
242940301$24294030$1$I$$20240903$20240906$20240906$PER$$US-PFIZER INC-202400249632$PFIZER$$26$YR$$F$Y$$$20240906$$CN$US$US
242940311$24294031$1$I$$20240903$20240906$20240906$PER$$US-PFIZER INC-202400250467$PFIZER$$75$YR$$M$Y$73.03$KG$20240906$$MD$US$US
242940321$24294032$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-PV202400116824$PFIZER$$79$YR$$M$Y$$$20240906$$HP$US$US
242940331$24294033$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400251026$PFIZER$$58$YR$$F$Y$$$20240906$$MD$US$US
242940341$24294034$1$I$$20240903$20240906$20240906$PER$$US-PFIZER INC-202400250456$PFIZER$$74$YR$$M$Y$73.03$KG$20240906$$MD$US$US
242940351$24294035$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-PV202400116519$PFIZER$$47$YR$$F$Y$$$20240906$$CN$US$US
242940361$24294036$1$I$$20240903$20240906$20240906$PER$$US-PFIZER INC-PV202400116044$PFIZER$$56$YR$$M$Y$77.8$KG$20240906$$HP$US$US
242940371$24294037$1$I$$20240903$20240906$20240906$EXP$$NVSC2024KR179147$NOVARTIS$$$$$$Y$$$20240906$$MD$KR$KR
242940381$24294038$1$I$20220101$20240904$20240906$20240906$PER$$US-PFIZER INC-202400251029$PFIZER$$57$YR$$F$Y$$$20240906$$HP$US$US
242940392$24294039$2$F$$20240904$20240906$20240909$PER$$US-PFIZER INC-PV202400116462$PFIZER$$39$YR$$F$Y$$$20240909$$HP$US$US
242940401$24294040$1$I$$20240827$20240906$20240906$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00790$Phathom Pharmaceuticals$$73$YR$$M$Y$$$20240906$$PH$JP$JP
242940411$24294041$1$I$20231212$20240905$20240906$20240906$EXP$$FR-AMERICAN REGENT INC-2024003401$AMERICAN REGENT$$32$YR$$F$Y$55$KG$20240906$$PH$FR$FR
242940421$24294042$1$I$$20240823$20240906$20240906$EXP$$US-HLS-202401076$HLS THERAPEUTICS$$79$YR$E$F$Y$$$20240906$$PH$US$US
242940431$24294043$1$I$20240101$20240828$20240906$20240906$EXP$$US-RADIUS HEALTH INC.-2024US003026$RADIUS PHARM$$$$$$Y$$$20240906$$CN$US$US
242940441$24294044$1$I$$20240401$20240906$20240906$PER$$US-FARMAPROD-202404-1183$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$CN$US$
242940451$24294045$1$I$$20240415$20240906$20240906$EXP$$US-FARMAPROD-202404-1266$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242940461$24294046$1$I$20240331$20240418$20240906$20240906$PER$$US-FARMAPROD-202404-1194$DOMPE FARMACEUTICI$$55$YR$A$M$Y$$$20240904$$CN$US$
242940471$24294047$1$I$20240301$20240410$20240906$20240906$PER$$US-FARMAPROD-202404-1164$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240904$$CN$US$
242940481$24294048$1$I$$20240422$20240906$20240906$PER$$US-FARMAPROD-202404-1231$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$MD$US$
242940491$24294049$1$I$$20240423$20240906$20240906$PER$$US-FARMAPROD-202404-1204$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242940501$24294050$1$I$$20240416$20240906$20240906$EXP$$US-FARMAPROD-202404-1272$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242940511$24294051$1$I$$20240422$20240906$20240906$PER$$US-FARMAPROD-202404-1229$DOMPE FARMACEUTICI$$$$A$F$Y$90.72$KG$20240904$$CN$US$
242940521$24294052$1$I$$20240416$20240906$20240906$PER$$US-FARMAPROD-202404-1180$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242940531$24294053$1$I$$20240424$20240906$20240906$EXP$$US-FARMAPROD-202404-1282$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242940541$24294054$1$I$20240301$20240418$20240906$20240906$PER$$US-FARMAPROD-202404-1151$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$
242940551$24294055$1$I$$20240402$20240906$20240906$PER$$US-FARMAPROD-202404-1172$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242940561$24294056$1$I$20240327$20240507$20240906$20240906$PER$$US-FARMAPROD-202404-1227$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242940571$24294057$1$I$20240329$20240405$20240906$20240906$PER$$US-FARMAPROD-202404-1177$DOMPE FARMACEUTICI$$64$YR$A$F$Y$$$20240904$$CN$US$
242940581$24294058$1$I$20240327$20240603$20240906$20240906$PER$$US-FARMAPROD-202404-1182$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$US
242940591$24294059$1$I$20240521$20240605$20240906$20240906$PER$$US-FARMAPROD-202404-1171$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240904$$CN$US$US
242940601$24294060$1$I$$20240415$20240906$20240906$PER$$US-FARMAPROD-202404-1224$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242940611$24294061$1$I$20240401$20240417$20240906$20240906$PER$$US-FARMAPROD-202404-1200$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$
242940621$24294062$1$I$$20240403$20240906$20240906$PER$$US-FARMAPROD-202403-1133$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242940631$24294063$1$I$20240403$20240403$20240906$20240906$PER$$US-FARMAPROD-202404-1251$DOMPE FARMACEUTICI$$86$YR$E$F$Y$$$20240904$$CN$US$
242940641$24294064$1$I$$20240422$20240906$20240906$PER$$US-FARMAPROD-202403-1127$DOMPE FARMACEUTICI$$$$E$M$Y$47.99$KG$20240904$$CN$US$
242940651$24294065$1$I$$20240507$20240906$20240906$PER$$US-FARMAPROD-202403-1137$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242940661$24294066$1$I$$20240902$20240906$20240906$EXP$$IT-REGENERON PHARMACEUTICALS, INC.-2024-119572$REGENERON$Vincenzo De Falco, Stefania Napolitano, Renato Franco, Federica Zito Marino, Luigi Formisano, Daniela Esposito, et al.. Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.. Oncoimmunology. 2024;13:1$$$$$Y$$$20240906$$MD$IT$IT
242940671$24294067$1$I$$20240614$20240906$20240906$PER$$US-FARMAPROD-202403-1134$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$US
242940681$24294068$1$I$$20240422$20240906$20240906$EXP$$US-FARMAPROD-202404-1386$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242940691$24294069$1$I$$20240423$20240906$20240906$EXP$$US-FARMAPROD-202404-1310$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242940701$24294070$1$I$$20240627$20240906$20240906$PER$$US-FARMAPROD-202403-1135$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$US
242940711$24294071$1$I$20240401$20240422$20240906$20240906$PER$$US-FARMAPROD-202404-1426$DOMPE FARMACEUTICI$$62$YR$A$F$Y$$$20240904$$CN$US$
242940721$24294072$1$I$$20240426$20240906$20240906$PER$$US-FARMAPROD-202404-1442$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242940731$24294073$1$I$$20240515$20240906$20240906$PER$$US-FARMAPROD-202404-1381$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242940741$24294074$1$I$$20240510$20240906$20240906$PER$$US-FARMAPROD-202404-1179$DOMPE FARMACEUTICI$$$$E$F$Y$81.65$KG$20240904$$MD$US$
242940751$24294075$1$I$20240401$20240416$20240906$20240906$PER$$US-FARMAPROD-202404-1199$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240904$$CN$US$
242940761$24294076$1$I$$20240619$20240906$20240906$PER$$US-FARMAPROD-202404-1145$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$US
242940771$24294077$1$I$20240301$20240327$20240906$20240906$PER$$US-FARMAPROD-202403-1142$DOMPE FARMACEUTICI$$66$YR$E$M$Y$$$20240904$$CN$US$
242940781$24294078$1$I$20240408$20240423$20240906$20240906$EXP$$US-FARMAPROD-202404-1340$DOMPE FARMACEUTICI$$86$YR$E$M$Y$$$20240904$$CN$US$
242940791$24294079$1$I$$20240506$20240906$20240906$PER$$US-FARMAPROD-202404-1456$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$MD$US$
242940801$24294080$1$I$$20240507$20240906$20240906$EXP$$US-FARMAPROD-202404-1329$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242940811$24294081$1$I$20240401$20240508$20240906$20240906$EXP$$US-FARMAPROD-202404-1369$DOMPE FARMACEUTICI$$85$YR$E$F$Y$$$20240904$$CN$US$
242940821$24294082$1$I$$20240501$20240906$20240906$PER$$US-FARMAPROD-202404-1428$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$
242940831$24294083$1$I$$20240515$20240906$20240906$PER$$US-FARMAPROD-202404-1487$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242940841$24294084$1$I$20240404$20240411$20240906$20240906$EXP$$US-FARMAPROD-202404-1286$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$
242940851$24294085$1$I$$20240513$20240906$20240906$EXP$$US-FARMAPROD-202404-1385$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242940861$24294086$1$I$20240403$20240628$20240906$20240906$PER$$US-FARMAPROD-202404-1233$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$MD$US$US
242940871$24294087$1$I$$20240429$20240906$20240906$EXP$$US-FARMAPROD-202404-1309$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242940881$24294088$1$I$$20240617$20240906$20240906$PER$$US-FARMAPROD-202404-1457$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$US
242940891$24294089$1$I$20240401$20240422$20240906$20240906$EXP$$US-FARMAPROD-202404-1364$DOMPE FARMACEUTICI$$60$YR$A$F$Y$47.54$KG$20240904$$CN$US$
242940901$24294090$1$I$$20240612$20240906$20240906$PER$$US-FARMAPROD-202404-1372$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$US
242940911$24294091$1$I$20240407$20240513$20240906$20240906$PER$$US-FARMAPROD-202404-1316$DOMPE FARMACEUTICI$$74$YR$E$F$Y$51.62$KG$20240904$$CN$US$
242940921$24294092$1$I$20240410$20240620$20240906$20240906$PER$$US-FARMAPROD-202404-1367$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240904$$CN$US$US
242940931$24294093$1$I$$20240422$20240906$20240906$EXP$$US-FARMAPROD-202404-1376$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$
242940951$24294095$1$I$$20240902$20240906$20240906$EXP$$IT-REGENERON PHARMACEUTICALS, INC.-2024-119573$REGENERON$Vincenzo De Falco, Stefania Napolitano, Renato Franco, Federica Zito Marino, Luigi Formisano, Daniela Esposito, et al.. Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.. Oncoimmunology. 2024;13:1$$$$$Y$$$20240906$$MD$IT$IT
242940961$24294096$1$I$$20240902$20240906$20240906$EXP$$IT-REGENERON PHARMACEUTICALS, INC.-2024-119574$REGENERON$Vincenzo De Falco, Stefania Napolitano, Renato Franco, Federica Zito Marino, Luigi Formisano, Daniela Esposito, et al.. Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.. Oncoimmunology. 2024;13:1$$$$$Y$$$20240906$$MD$IT$IT
242940971$24294097$1$I$$20240829$20240906$20240906$EXP$$CN-AMGEN-CHNSP2024175491$AMGEN$Fubin Q.; Na Z.; Shengda Z. et al.. Prognostic values of serum miR-140-5p and SFRP -5 for in-stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240906$$HP$CN$CN
242940981$24294098$1$I$$20240516$20240906$20240906$PER$$US-FARMAPROD-202404-1318$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242940991$24294099$1$I$20240315$20240515$20240906$20240906$PER$$US-FARMAPROD-202404-1267$DOMPE FARMACEUTICI$$77$YR$E$F$Y$64.41$KG$20240904$$MD$US$
242941001$24294100$1$I$$20240528$20240906$20240906$PER$$US-FARMAPROD-202405-1684$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242941011$24294101$1$I$$20240509$20240906$20240906$PER$$US-FARMAPROD-202404-1492$DOMPE FARMACEUTICI$$$$E$F$Y$53.52$KG$20240904$$CN$US$
242941021$24294102$1$I$$20240502$20240906$20240906$PER$$US-FARMAPROD-202404-1486$DOMPE FARMACEUTICI$$$$E$F$Y$69.76$KG$20240904$$CN$US$
242941031$24294103$1$I$$20240703$20240906$20240906$PER$$US-FARMAPROD-202404-1455$DOMPE FARMACEUTICI$$$$E$F$Y$61.69$KG$20240904$$CN$US$US
242941041$24294104$1$I$20240401$20240520$20240906$20240906$PER$$US-FARMAPROD-202405-1661$DOMPE FARMACEUTICI$$54$YR$A$F$Y$$$20240904$$CN$US$
242941051$24294105$1$I$20240511$20240513$20240906$20240906$PER$$US-FARMAPROD-202405-1677$DOMPE FARMACEUTICI$$66$YR$E$F$Y$$$20240904$$CN$US$
242941061$24294106$1$I$20240502$20240528$20240906$20240906$PER$$US-FARMAPROD-202405-1736$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$US
242941071$24294107$1$I$20240401$20240522$20240906$20240906$PER$$US-FARMAPROD-202404-1476$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240904$$CN$US$
242941081$24294108$1$I$20240401$20240508$20240906$20240906$PER$$US-FARMAPROD-202404-1637$DOMPE FARMACEUTICI$$80$YR$E$M$Y$$$20240904$$CN$US$
242941091$24294109$1$I$20240506$20240507$20240906$20240906$PER$$US-FARMAPROD-202404-1523$DOMPE FARMACEUTICI$$72$YR$E$M$Y$$$20240904$$CN$US$
242941101$24294110$1$I$20240501$20240524$20240906$20240906$PER$$US-FARMAPROD-202404-1571$DOMPE FARMACEUTICI$$70$YR$E$F$Y$$$20240904$$CN$US$US
242941111$24294111$1$I$$20240502$20240906$20240906$PER$$US-FARMAPROD-202405-1662$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242941121$24294112$1$I$$20240522$20240906$20240906$PER$$US-FARMAPROD-202404-1565$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242941131$24294113$1$I$20240414$20240503$20240906$20240906$PER$$US-FARMAPROD-202404-1405$DOMPE FARMACEUTICI$$83$YR$E$F$Y$$$20240904$$CN$US$
242941141$24294114$1$I$20240401$20240506$20240906$20240906$PER$$US-FARMAPROD-202404-1553$DOMPE FARMACEUTICI$$71$YR$E$F$Y$82.15$KG$20240904$$CN$US$
242941151$24294115$1$I$$20240605$20240906$20240906$PER$$US-FARMAPROD-202405-1660$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242941161$24294116$1$I$20240501$20240617$20240906$20240906$PER$$US-FARMAPROD-202405-1735$DOMPE FARMACEUTICI$$74$YR$E$F$Y$76.66$KG$20240904$$CN$US$US
242941171$24294117$1$I$$20240429$20240906$20240906$EXP$$US-FARMAPROD-202404-1363$DOMPE FARMACEUTICI$$$$E$F$Y$83.64$KG$20240904$$CN$US$
242941181$24294118$1$I$$20240705$20240906$20240906$PER$$US-FARMAPROD-202404-1366$DOMPE FARMACEUTICI$$$$E$F$Y$85.73$KG$20240904$$CN$US$US
242941191$24294119$1$I$$20240627$20240906$20240906$PER$$US-FARMAPROD-202405-1674$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$US
242941201$24294120$1$I$20240423$20240430$20240906$20240906$PER$$US-FARMAPROD-202404-1636$DOMPE FARMACEUTICI$$68$YR$E$M$Y$$$20240904$$CN$US$
242941211$24294121$1$I$20240602$20240603$20240906$20240906$PER$$US-FARMAPROD-202404-1525$DOMPE FARMACEUTICI$$84$YR$E$F$Y$$$20240904$$CN$US$US
242941221$24294122$1$I$$20240604$20240906$20240906$PER$$US-FARMAPROD-202405-1688$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242941231$24294123$1$I$$20240528$20240906$20240906$PER$$US-FARMAPROD-202405-1657$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$US
242941241$24294124$1$I$20240417$20240429$20240906$20240906$PER$$US-FARMAPROD-202404-1520$DOMPE FARMACEUTICI$$75$YR$E$F$Y$61.69$KG$20240904$$CN$US$
242941251$24294125$1$I$20240430$20240509$20240906$20240906$PER$$US-FARMAPROD-202405-1823$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$
242941261$24294126$1$I$20240501$20240518$20240906$20240906$PER$$US-FARMAPROD-202405-1752$DOMPE FARMACEUTICI$$61$YR$A$F$Y$$$20240904$$CN$US$
242941271$24294127$1$I$$20240507$20240906$20240906$PER$$US-FARMAPROD-202404-1502$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$MD$US$
242941281$24294128$1$I$20240425$20240620$20240906$20240906$PER$$US-FARMAPROD-202404-1639$DOMPE FARMACEUTICI$$83$YR$E$M$Y$$$20240904$$CN$US$US
242941291$24294129$1$I$20240423$20240524$20240906$20240906$PER$$US-FARMAPROD-202404-1561$DOMPE FARMACEUTICI$$64$YR$A$F$Y$$$20240904$$CN$US$US
242941301$24294130$1$I$20240423$20240520$20240906$20240906$PER$$US-FARMAPROD-202404-1607$DOMPE FARMACEUTICI$$76$YR$E$M$Y$$$20240904$$CN$US$
242941311$24294131$1$I$20240415$20240628$20240906$20240906$PER$$US-FARMAPROD-202404-1643$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$MD$US$US
242941321$24294132$1$I$$20240604$20240906$20240906$PER$$US-FARMAPROD-202405-1687$DOMPE FARMACEUTICI$$$$E$F$Y$51.44$KG$20240904$$CN$US$US
242941331$24294133$1$I$20240501$20240507$20240906$20240906$PER$$US-FARMAPROD-202405-1796$DOMPE FARMACEUTICI$$58$YR$A$F$Y$$$20240904$$CN$US$
242941341$24294134$1$I$$20240524$20240906$20240906$PER$$US-FARMAPROD-202405-1846$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242941351$24294135$1$I$$20240514$20240906$20240906$PER$$US-FARMAPROD-202405-1882$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$
242941361$24294136$1$I$$20240506$20240906$20240906$PER$$US-FARMAPROD-202405-1755$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$
242941371$24294137$1$I$20240506$20240508$20240906$20240906$PER$$US-FARMAPROD-202405-1849$DOMPE FARMACEUTICI$$65$YR$E$F$Y$$$20240904$$CN$US$
242941381$24294138$1$I$$20240625$20240906$20240906$PER$$US-FARMAPROD-202405-1770$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242941391$24294139$1$I$$20240528$20240906$20240906$PER$$US-FARMAPROD-202405-1921$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242941401$24294140$1$I$20240429$20240614$20240906$20240906$PER$$US-FARMAPROD-202405-1779$DOMPE FARMACEUTICI$$83$YR$E$M$Y$$$20240904$$CN$US$US
242941414$24294141$4$F$20240101$20240912$20240906$20240913$PER$$US-PFIZER INC-202400250021$PFIZER$$$$A$M$Y$$$20240913$$HP$US$US
242941421$24294142$1$I$20240404$20240703$20240906$20240906$PER$$US-FARMAPROD-202404-1631$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$US
242941431$24294143$1$I$$20240531$20240906$20240906$PER$$US-FARMAPROD-202405-1886$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242941441$24294144$1$I$$20240705$20240906$20240906$PER$$US-FARMAPROD-202404-1406$DOMPE FARMACEUTICI$$$$E$F$Y$57.15$KG$20240904$$CN$US$US
242941451$24294145$1$I$20240508$20240522$20240906$20240906$PER$$US-FARMAPROD-202405-1803$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$
242941461$24294146$1$I$20240510$20240517$20240906$20240906$PER$$US-FARMAPROD-202405-1920$DOMPE FARMACEUTICI$$82$YR$E$F$Y$$$20240904$$CN$US$
242941471$24294147$1$I$$20240829$20240906$20240906$EXP$$CN-AMGEN-CHNSP2024175501$AMGEN$Fubin Q.; Na Z.; Shengda Z. et al.. Prognostic values of serum miR-140-5p and SFRP -5 for in-stent restenosis in diabetes patients combined with coronary heart disease after percutaneous coronary intervention. Hebei Medical Journal. 2024;46 (14):2103-2112$$$$$Y$$$20240906$$HP$CN$CN
242941481$24294148$1$I$20240513$20240607$20240906$20240906$PER$$US-FARMAPROD-202405-1879$DOMPE FARMACEUTICI$$63$YR$A$F$Y$$$20240904$$CN$US$US
242941491$24294149$1$I$$20240605$20240906$20240906$PER$$US-FARMAPROD-202405-1788$DOMPE FARMACEUTICI$$$$A$F$Y$60.92$KG$20240904$$CN$US$US
242941501$24294150$1$I$$20240522$20240906$20240906$PER$$US-FARMAPROD-202405-1804$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$MD$US$
242941511$24294151$1$I$20240422$20240624$20240906$20240906$PER$$US-FARMAPROD-202404-1552$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$MD$US$US
242941521$24294152$1$I$20240602$20240611$20240906$20240906$PER$$US-FARMAPROD-202405-1699$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$US
242941531$24294153$1$I$20240903$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177467$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242941541$24294154$1$I$20240504$20240617$20240906$20240906$PER$$US-FARMAPROD-202405-1743$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$US
242941551$24294155$1$I$$20240625$20240906$20240906$PER$$US-FARMAPROD-202405-1906$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$US
242941561$24294156$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176368$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242941571$24294157$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400218300$PFIZER$$74$YR$$F$Y$$$20240906$$MD$US$US
242941581$24294158$1$I$$20240610$20240906$20240906$PER$$US-FARMAPROD-202405-1769$DOMPE FARMACEUTICI$$$$E$F$Y$53.07$KG$20240904$$CN$US$US
242941591$24294159$1$I$20240505$20240620$20240906$20240906$PER$$US-FARMAPROD-202405-1765$DOMPE FARMACEUTICI$$63$YR$A$M$Y$$$20240904$$CN$US$US
242941601$24294160$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400249997$PFIZER$$$$A$F$Y$$$20240906$$HP$US$US
242941611$24294161$1$I$20240904$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250480$PFIZER$$73$YR$$F$Y$$$20240906$$CN$US$US
242941621$24294162$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250478$PFIZER$$63$YR$$M$Y$$$20240906$$HP$US$US
242941632$24294163$2$F$$20240908$20240906$20240911$PER$$US-PFIZER INC-202400251064$PFIZER$$55$YR$$F$Y$$$20240911$$HP$US$US
242941654$24294165$4$F$$20240918$20240906$20240919$PER$$US-PFIZER INC-202400237563$PFIZER$$31$YR$$M$Y$$$20240919$$CN$US$US
242941661$24294166$1$I$$20240624$20240906$20240906$PER$$US-FARMAPROD-202405-1924$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242941681$24294168$1$I$$20240903$20240906$20240906$PER$$US-PFIZER INC-PV202400111497$PFIZER$$36$YR$$M$Y$$$20240906$$CN$US$US
242941692$24294169$2$F$$20240912$20240906$20240913$PER$$US-PFIZER INC-PV202400116228$PFIZER$$$$$$Y$$$20240913$$HP$US$US
242941701$24294170$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400251085$PFIZER$$62$YR$$F$Y$$$20240906$$HP$US$US
242941711$24294171$1$I$20230101$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250120$PFIZER$$84$YR$$F$Y$63.96$KG$20240906$$CN$US$US
242941721$24294172$1$I$$20240606$20240906$20240906$PER$$US-FARMAPROD-202405-1768$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242941731$24294173$1$I$20240901$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250117$PFIZER$$78$YR$$F$Y$$$20240906$$CN$US$US
242941742$24294174$2$F$$20240908$20240906$20240910$PER$$US-PFIZER INC-PV202400116380$PFIZER$$67$YR$$F$Y$$$20240910$$CN$US$US
242941751$24294175$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250297$PFIZER$$85$YR$$F$Y$63.96$KG$20240906$$CN$US$US
242941771$24294177$1$I$$20240903$20240906$20240906$PER$$US-PFIZER INC-PV202400046261$PFIZER$$28$YR$$F$Y$$$20240906$$CN$US$US
242941781$24294178$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250273$PFIZER$$74$YR$$M$Y$100.52$KG$20240906$$CN$US$US
242941791$24294179$1$I$$20240522$20240906$20240906$PER$$US-FARMAPROD-202405-1922$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242941801$24294180$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-PV202400116485$PFIZER$$54$YR$$F$Y$$$20240906$$CN$US$US
242941811$24294181$1$I$$20240904$20240906$20240906$PER$$JP-PFIZER INC-202400249463$PFIZER$$$$$$Y$$$20240906$$PH$JP$JP
242941821$24294182$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-PV202400116361$PFIZER$$57$YR$$F$Y$$$20240906$$HP$US$US
242941841$24294184$1$I$$20240828$20240906$20240906$EXP$$US-BAXTER-2024BAX023891$BAXTER$$$$$M$Y$$$20240906$$CN$US$US
242941851$24294185$1$I$20240801$20240829$20240906$20240906$EXP$CN-NMPACDR-3210011030242202400363$CN-BAXTER-2024BAX024066$BAXTER$$60$YR$$F$Y$66$KG$20240906$$MD$CN$CN
242941862$24294186$2$F$20240829$20240906$20240906$20240913$EXP$$DE-BAXTER-2024BAX024030$BAXTER$$44$YR$$M$Y$$$20240913$$HP$DE$DE
242941871$24294187$1$I$20240509$20240529$20240906$20240906$PER$$US-FARMAPROD-202405-1828$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$US
242941882$24294188$2$F$20240813$20240912$20240906$20240923$EXP$$US-BAXTER-2024BAX023862$BAXTER$$67$YR$$F$Y$$$20240923$$MD$US$US
242941892$24294189$2$F$$20240909$20240906$20240918$EXP$$NO-BAXTER-2024BAX023792$BAXTER$$59$YR$$M$Y$$$20240918$$MD$NO$NO
242941901$24294190$1$I$20240510$20240624$20240906$20240906$PER$$US-FARMAPROD-202405-1880$DOMPE FARMACEUTICI$$76$YR$E$F$Y$44.91$KG$20240904$$CN$US$US
242941911$24294191$1$I$20240601$20240702$20240906$20240906$PER$$US-FARMAPROD-202405-1878$DOMPE FARMACEUTICI$$73$YR$E$F$Y$$$20240904$$CN$US$US
242941921$24294192$1$I$$20240904$20240906$20240906$PER$$US-PFIZER INC-202400250283$PFIZER$$76$YR$$F$Y$$$20240906$$HP$US$US
242941931$24294193$1$I$20240621$20240624$20240906$20240906$PER$$US-FARMAPROD-202405-1761$DOMPE FARMACEUTICI$$66$YR$E$F$Y$113.4$KG$20240904$$CN$US$US
242941941$24294194$1$I$20240516$20240625$20240906$20240906$PER$$US-FARMAPROD-202405-1919$DOMPE FARMACEUTICI$$63$YR$A$F$Y$83.01$KG$20240904$$CN$US$US
242941951$24294195$1$I$20240516$20240530$20240906$20240906$PER$$US-FARMAPROD-202405-1950$DOMPE FARMACEUTICI$$89$YR$E$F$Y$$$20240904$$CN$US$US
242941961$24294196$1$I$$20240528$20240906$20240906$PER$$US-FARMAPROD-202405-1957$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242941971$24294197$1$I$20240526$20240528$20240906$20240906$PER$$US-FARMAPROD-202405-1992$DOMPE FARMACEUTICI$$52$YR$A$F$Y$$$20240904$$CN$US$US
242941981$24294198$1$I$$20240610$20240906$20240906$PER$$US-FARMAPROD-202405-1929$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242941991$24294199$1$I$$20240607$20240906$20240906$PER$$US-FARMAPROD-202405-1942$DOMPE FARMACEUTICI$$$$A$F$Y$45.36$KG$20240904$$CN$US$US
242942001$24294200$1$I$$20240618$20240906$20240906$PER$$US-FARMAPROD-202405-2024$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942011$24294201$1$I$$20240617$20240906$20240906$PER$$US-FARMAPROD-202405-1946$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$US
242942021$24294202$1$I$$20240624$20240906$20240906$PER$$US-FARMAPROD-202405-2051$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942031$24294203$1$I$$20240624$20240906$20240906$PER$$US-FARMAPROD-202406-2080$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942041$24294204$1$I$$20240604$20240906$20240906$PER$$US-FARMAPROD-202405-1966$DOMPE FARMACEUTICI$$$$A$F$Y$66.5$KG$20240904$$CN$US$US
242942051$24294205$1$I$20240602$20240611$20240906$20240906$PER$$US-FARMAPROD-202406-2104$DOMPE FARMACEUTICI$$85$YR$E$F$Y$81.65$KG$20240904$$CN$US$US
242942061$24294206$1$I$$20240624$20240906$20240906$PER$$US-FARMAPROD-202406-2074$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242942071$24294207$1$I$$20240626$20240906$20240906$PER$$US-FARMAPROD-202405-1956$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242942081$24294208$1$I$$20240614$20240906$20240906$PER$$US-FARMAPROD-202405-2042$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942091$24294209$1$I$$20240615$20240906$20240906$PER$$US-FARMAPROD-202405-1985$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$US
242942101$24294210$1$I$$20240702$20240906$20240906$PER$$US-FARMAPROD-202406-2065$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$US
242942111$24294211$1$I$20240517$20240612$20240906$20240906$PER$$US-FARMAPROD-202405-1933$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240904$$CN$US$US
242942121$24294212$1$I$20240826$20240830$20240906$20240906$EXP$$US-BIOGEN-2024BI01280862$BIOGEN$$49$YR$$F$Y$$$20240906$$CN$US$US
242942131$24294213$1$I$$20240830$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141928$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240906$$HP$US$US
242942141$24294214$1$I$$20240612$20240906$20240906$PER$$US-FARMAPROD-202405-2006$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942151$24294215$1$I$$20240628$20240906$20240906$PER$$US-FARMAPROD-202406-2092$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942161$24294216$1$I$$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142217$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240906$$CN$US$US
242942171$24294217$1$I$$20240604$20240906$20240906$PER$$US-FARMAPROD-202406-2142$DOMPE FARMACEUTICI$$$$$F$Y$$$20240904$$MD$US$US
242942181$24294218$1$I$$20240618$20240906$20240906$PER$$US-FARMAPROD-202405-1965$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942191$24294219$1$I$20240528$20240618$20240906$20240906$PER$$US-FARMAPROD-202405-2057$DOMPE FARMACEUTICI$$89$YR$E$F$Y$$$20240904$$CN$US$US
242942201$24294220$1$I$20240517$20240621$20240906$20240906$PER$$US-FARMAPROD-202405-1944$DOMPE FARMACEUTICI$$75$YR$E$M$Y$$$20240904$$CN$US$US
242942211$24294221$1$I$$20240607$20240906$20240906$PER$$US-FARMAPROD-202406-2203$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$US
242942221$24294222$1$I$20240523$20240531$20240906$20240906$PER$$US-FARMAPROD-202405-2030$DOMPE FARMACEUTICI$$77$YR$E$F$Y$$$20240904$$CN$US$US
242942241$24294224$1$I$$20240605$20240906$20240906$PER$$US-FARMAPROD-202406-2169$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$US
242942251$24294225$1$I$$20240624$20240906$20240906$PER$$US-FARMAPROD-202405-1994$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942261$24294226$1$I$$20240604$20240906$20240906$PER$$US-FARMAPROD-202406-2148$DOMPE FARMACEUTICI$$$$E$F$Y$44$KG$20240904$$CN$US$US
242942271$24294227$1$I$$20240625$20240906$20240906$PER$$US-FARMAPROD-202405-2004$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242942281$24294228$1$I$$20240621$20240906$20240906$PER$$US-FARMAPROD-202406-2149$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942291$24294229$1$I$20240607$20240616$20240906$20240906$PER$$US-FARMAPROD-202406-2212$DOMPE FARMACEUTICI$$83$YR$E$F$Y$$$20240904$$CN$US$US
242942301$24294230$1$I$20240606$20240606$20240906$20240906$PER$$US-FARMAPROD-202406-2187$DOMPE FARMACEUTICI$$76$YR$E$M$Y$90.72$KG$20240904$$CN$US$US
242942311$24294231$1$I$$20240610$20240906$20240906$PER$$US-FARMAPROD-202406-2116$DOMPE FARMACEUTICI$$$$A$F$Y$54.88$KG$20240904$$CN$US$US
242942321$24294232$1$I$$20240624$20240906$20240906$PER$$US-FARMAPROD-202406-2197$DOMPE FARMACEUTICI$$$$E$F$Y$53.52$KG$20240904$$CN$US$US
242942331$24294233$1$I$$20240606$20240906$20240906$PER$$US-FARMAPROD-202406-2186$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942341$24294234$1$I$$20240619$20240906$20240906$PER$$US-FARMAPROD-202406-2162$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242942351$24294235$1$I$$20240522$20240906$20240906$PER$$US-FARMAPROD-202405-1936$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240904$$CN$US$
242942361$24294236$1$I$20240522$20240605$20240906$20240906$PER$$US-FARMAPROD-202406-2161$DOMPE FARMACEUTICI$$49$YR$A$F$Y$97.75$KG$20240904$$CN$US$US
242942371$24294237$1$I$20240606$20240621$20240906$20240906$PER$$US-FARMAPROD-202406-2198$DOMPE FARMACEUTICI$$50$YR$A$F$Y$$$20240904$$CN$US$US
242942381$24294238$1$I$20240609$20240610$20240906$20240906$PER$$US-FARMAPROD-202406-2123$DOMPE FARMACEUTICI$$78$YR$E$M$Y$$$20240904$$CN$US$US
242942391$24294239$1$I$$20240616$20240906$20240906$PER$$US-FARMAPROD-202406-2209$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242942401$24294240$1$I$20240601$20240702$20240906$20240906$PER$$US-FARMAPROD-202406-2133$DOMPE FARMACEUTICI$$68$YR$E$F$Y$68.95$KG$20240904$$CN$US$US
242942411$24294241$1$I$20240901$20240902$20240906$20240906$EXP$$NVSC2024CN179132$NOVARTIS$$$$$F$Y$55$KG$20240906$$HP$CN$CN
242942421$24294242$1$I$20240601$20240606$20240906$20240906$PER$$US-FARMAPROD-202406-2185$DOMPE FARMACEUTICI$$69$YR$E$F$Y$$$20240904$$CN$US$US
242942431$24294243$1$I$$20240621$20240906$20240906$PER$$US-FARMAPROD-202406-2173$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942441$24294244$1$I$20240606$20240607$20240906$20240906$PER$$US-FARMAPROD-202406-2289$DOMPE FARMACEUTICI$$79$YR$E$M$Y$$$20240904$$CN$US$US
242942451$24294245$1$I$$20240701$20240906$20240906$PER$$US-FARMAPROD-202406-2167$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242942461$24294246$1$I$$20240614$20240906$20240906$PER$$US-FARMAPROD-202406-2184$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942471$24294247$1$I$20240606$20240629$20240906$20240906$PER$$US-FARMAPROD-202406-2182$DOMPE FARMACEUTICI$$70$YR$E$M$Y$$$20240904$$CN$US$US
242942481$24294248$1$I$$20240904$20240906$20240906$EXP$$CA-BAUSCH-BL-2024-013255$BAUSCH AND LOMB$$49$YR$$F$Y$$$20240906$$PH$CA$CA
242942491$24294249$1$I$20240531$20240705$20240906$20240906$PER$$US-FARMAPROD-202406-2126$DOMPE FARMACEUTICI$$81$YR$E$F$Y$$$20240904$$CN$US$US
242942501$24294250$1$I$$20240626$20240906$20240906$PER$$US-FARMAPROD-202406-2229$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942511$24294251$1$I$$20240617$20240906$20240906$PER$$US-FARMAPROD-202406-2288$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942521$24294252$1$I$$20240612$20240906$20240906$PER$$US-FARMAPROD-202406-2249$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942531$24294253$1$I$20240612$20240613$20240906$20240906$PER$$US-FARMAPROD-202406-2269$DOMPE FARMACEUTICI$$74$YR$E$F$Y$$$20240904$$CN$US$US
242942542$24294254$2$F$$20240909$20240906$20240919$EXP$$US-FARMAPROD-202406-2286$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240919$$CN$US$US
242942551$24294255$1$I$$20240627$20240906$20240906$PER$$US-FARMAPROD-202406-2301$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242942561$24294256$1$I$$20240625$20240906$20240906$PER$$US-FARMAPROD-202406-2307$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942571$24294257$1$I$$20240610$20240906$20240906$PER$$US-FARMAPROD-202406-2231$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942581$24294258$1$I$20240616$20240627$20240906$20240906$PER$$US-FARMAPROD-202406-2313$DOMPE FARMACEUTICI$$85$YR$E$F$Y$$$20240904$$CN$US$US
242942591$24294259$1$I$$20240702$20240906$20240906$PER$$US-FARMAPROD-202406-2239$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942601$24294260$1$I$$20240621$20240906$20240906$PER$$US-FARMAPROD-202406-2146$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242942611$24294261$1$I$20240616$20240617$20240906$20240906$PER$$US-FARMAPROD-202406-2292$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$US
242942621$24294262$1$I$$20240703$20240906$20240906$PER$$US-FARMAPROD-202406-2316$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942631$24294263$1$I$$20240618$20240906$20240906$PER$$US-FARMAPROD-202406-2261$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242942641$24294264$1$I$20240612$20240628$20240906$20240906$PER$$US-FARMAPROD-202406-2270$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240904$$CN$US$US
242942651$24294265$1$I$20240613$20240703$20240906$20240906$PER$$US-FARMAPROD-202406-2267$DOMPE FARMACEUTICI$$51$YR$A$F$Y$74.84$KG$20240904$$CN$US$US
242942661$24294266$1$I$$20240619$20240906$20240906$PER$$US-FARMAPROD-202406-2328$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942671$24294267$1$I$$20240619$20240906$20240906$PER$$US-FARMAPROD-202406-2331$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$US
242942681$24294268$1$I$$20240621$20240906$20240906$PER$$US-FARMAPROD-202406-2356$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942691$24294269$1$I$$20240627$20240906$20240906$PER$$US-FARMAPROD-202406-2251$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942701$24294270$1$I$$20240619$20240906$20240906$PER$$US-FARMAPROD-202406-2325$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242942711$24294271$1$I$$20240626$20240906$20240906$PER$$US-FARMAPROD-202406-2217$DOMPE FARMACEUTICI$$$$E$M$Y$81.65$KG$20240904$$CN$US$US
242942721$24294272$1$I$$20240620$20240906$20240906$PER$$US-FARMAPROD-202406-2344$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942731$24294273$1$I$$20240701$20240906$20240906$PER$$US-FARMAPROD-202406-2297$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942741$24294274$1$I$20240614$20240705$20240906$20240906$PER$$US-FARMAPROD-202406-2295$DOMPE FARMACEUTICI$$76$YR$E$F$Y$$$20240904$$CN$US$US
242942751$24294275$1$I$20240609$20240627$20240906$20240906$PER$$US-FARMAPROD-202406-2238$DOMPE FARMACEUTICI$$71$YR$E$F$Y$66.5$KG$20240904$$CN$US$US
242942761$24294276$1$I$$20240701$20240906$20240906$PER$$US-FARMAPROD-202406-2223$DOMPE FARMACEUTICI$$$$E$F$Y$48.08$KG$20240904$$CN$US$US
242942771$24294277$1$I$20240622$20240622$20240906$20240906$PER$$US-FARMAPROD-202406-2370$DOMPE FARMACEUTICI$$67$YR$E$F$Y$$$20240904$$CN$US$US
242942781$24294278$1$I$$20240623$20240906$20240906$PER$$US-FARMAPROD-202406-2368$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942791$24294279$1$I$$20240624$20240906$20240906$PER$$US-FARMAPROD-202406-2385$DOMPE FARMACEUTICI$$$$E$M$Y$78.47$KG$20240904$$CN$US$US
242942801$24294280$1$I$$20240627$20240906$20240906$PER$$US-FARMAPROD-202407-2419$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942811$24294281$1$I$$20240620$20240906$20240906$PER$$US-FARMAPROD-202406-2343$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942821$24294282$1$I$$20240701$20240906$20240906$PER$$US-FARMAPROD-202406-2338$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242942831$24294283$1$I$20240101$20240902$20240906$20240906$EXP$$US-ABBVIE-5866917$ABBVIE$$74$YR$$M$Y$$$20240906$$CN$US$US
242942851$24294285$1$I$$20240626$20240906$20240906$PER$$US-FARMAPROD-202406-2400$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240904$$CN$US$US
242942861$24294286$1$I$20240623$20240624$20240906$20240906$PER$$US-FARMAPROD-202406-2383$DOMPE FARMACEUTICI$$79$YR$E$F$Y$$$20240904$$CN$US$US
242942871$24294287$1$I$$20240626$20240906$20240906$PER$$US-FARMAPROD-202406-2406$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942881$24294288$1$I$20240620$20240621$20240906$20240906$PER$$US-FARMAPROD-202406-2357$DOMPE FARMACEUTICI$$84$YR$E$M$Y$$$20240904$$CN$US$US
242942891$24294289$1$I$$20240817$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN008699$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242942901$24294290$1$I$$20240626$20240906$20240906$PER$$US-FARMAPROD-202406-2402$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242942911$24294291$1$I$$20240829$20240906$20240906$EXP$$CN-ROCHE-10000069650$ROCHE$Zhang X, Zhao X, Chen S, Hao M, Zhang L, Gong M, et al. Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients. Bone Marrow Transplant. 2024;59 (7):997-1005. doi:10.1038/s41409-024-02266-7.$$$$$Y$$$20240906$$HP$CN$CN
242942921$24294292$1$I$$20240827$20240906$20240906$PER$$US-SA-2024SA254418$SANOFI AVENTIS$$$$T$M$Y$$$20240906$$MD$US$US
242942941$24294294$1$I$20240701$20240820$20240906$20240906$PER$$US-TEVA-VS-3236456$TEVA$$51$YR$$F$Y$$$20240906$$CN$US$US
242942961$24294296$1$I$20240613$20240628$20240906$20240906$PER$$US-FARMAPROD-202406-2296$DOMPE FARMACEUTICI$$75$YR$E$M$Y$$$20240904$$CN$US$US
242942971$24294297$1$I$$20240626$20240906$20240906$PER$$US-FARMAPROD-202406-2409$DOMPE FARMACEUTICI$$$$E$M$Y$86.18$KG$20240904$$CN$US$US
242942981$24294298$1$I$$20240703$20240906$20240906$PER$$US-FARMAPROD-202406-2346$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242942991$24294299$1$I$$20240702$20240906$20240906$PER$$US-FARMAPROD-202406-2378$DOMPE FARMACEUTICI$$$$E$F$Y$63.5$KG$20240904$$CN$US$US
242943001$24294300$1$I$20240101$20240829$20240906$20240906$EXP$$US-JNJFOC-20240877950$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$CN$US$US
242943011$24294301$1$I$$20240626$20240906$20240906$PER$$US-FARMAPROD-202406-2408$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242943021$24294302$1$I$20240328$20240905$20240905$20240905$DIR$717308$$FDA-CTU$$47$YR$$F$N$120.15$KG$20240905$N$CN$US$
242943031$24294303$1$I$20240830$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024176074$AMGEN$$55$YR$A$F$Y$$$20240906$$CN$US$US
242943041$24294304$1$I$$20240828$20240906$20240906$EXP$$GB-AMGEN-GBRSP2024172764$AMGEN$$$$$F$Y$$$20240906$$CN$GB$GB
242943051$24294305$1$I$20240805$20240830$20240906$20240906$EXP$IT-MINISAL02-1000057$IT-BIOGEN-2024BI01280866$BIOGEN$$36$YR$$F$Y$55$KG$20240906$$MD$IT$IT
242943061$24294306$1$I$$20240705$20240906$20240906$PER$$US-FARMAPROD-202406-2337$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240904$$CN$US$US
242943071$24294307$1$I$$20240628$20240906$20240906$EXP$$US-FARMAPROD-202406-2250$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240904$$CN$US$US
242943081$24294308$1$I$20240828$20240828$20240906$20240906$PER$$US-RDY-SPO/USA/24/0012674$DR REDDYS$$35$YR$A$$Y$$$20240906$$HP$US$US
242943091$24294309$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61476$$FDA-CTU$$$$$$N$$$20240904$N$CN$US$
242943101$24294310$1$I$$20240827$20240906$20240906$PER$$US-RDY-SPO/USA/24/0012685$DR REDDYS$$19$YR$A$M$Y$$$20240906$$MD$US$US
242943111$24294311$1$I$$20240828$20240906$20240906$PER$$US-RDY-SPO/USA/24/0012676$DR REDDYS$$19$YR$A$F$Y$$$20240906$$MD$US$US
242943131$24294313$1$I$$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141264$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$$$20240906$$CN$US$US
242943141$24294314$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142014$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240906$$CN$US$US
242943151$24294315$1$I$$20240903$20240906$20240906$EXP$GB-MHRA-MED-202409020906128010-ZDPHQ$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-141909$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240906$$HP$GB$GB
242943161$24294316$1$I$20230301$20240829$20240906$20240906$EXP$$CA-ABBVIE-5902761$ABBVIE$$77$YR$$F$Y$$$20240906$$CN$CA$CA
242943171$24294317$1$I$20240801$20240904$20240906$20240906$PER$$US-JNJFOC-20240909606$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242943181$24294318$1$I$$20240829$20240906$20240906$EXP$$US-AstraZeneca-2024A197936$ASTRAZENECA$$$$$F$Y$$$20240906$$MD$US$
242943201$24294320$1$I$$20240902$20240906$20240906$EXP$$IL-AstraZeneca-2024A200104$ASTRAZENECA$Shalata,W.; Abu Jama, A.; Dudnik, Y.; Abu Saleh, O.; Shalata, S.; Tourkey, L.; Sheva, K.; Meirovitz, A.; Yakobson, A.. Adverse Events in Osimertinib Treatment for EGFRMutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening Myelosuppression.. Medicina 2024;(60):1270.$60$YR$$F$Y$$$20240906$$HP$IL$
242943211$24294321$1$I$20240904$20240905$20240906$20240906$PER$$US-AMGEN-USASP2024178030$AMGEN$$$$E$F$Y$$$20240906$$CN$US$US
242943221$24294322$1$I$$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024176946$AMGEN$$$$$M$Y$$$20240906$$HP$US$US
242943232$24294323$2$F$20240904$20240923$20240906$20240924$PER$$US-AMGEN-USASP2024176831$AMGEN$$70$YR$E$F$Y$$$20240924$$CN$US$US
242943241$24294324$1$I$20231223$20240830$20240906$20240906$EXP$$EG-AstraZeneca-2024A199447$ASTRAZENECA$$66$YR$$F$Y$$$20240906$$CN$EG$
242943251$24294325$1$I$$20240903$20240906$20240906$EXP$$MX-AstraZeneca-2024A201642$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$MX$
242943261$24294326$1$I$20240831$20240904$20240906$20240906$EXP$$US-AstraZeneca-2024A201643$ASTRAZENECA$$$$$F$Y$$$20240906$$HP$US$
242943271$24294327$1$I$$20240829$20240906$20240906$EXP$$JP-AstraZeneca-2024A198687$ASTRAZENECA$$72$YR$$F$Y$$$20240906$$PH$JP$
242943281$24294328$1$I$20240817$20240903$20240906$20240906$EXP$$NVSC2024CN179230$NOVARTIS$$64$YR$$F$Y$51$KG$20240906$$HP$CN$CN
242943291$24294329$1$I$20240813$20240904$20240906$20240906$EXP$$US-BAYER-2024A127758$BAYER$$58$YR$A$F$Y$64.853$KG$20240906$$CN$US$US
242943301$24294330$1$I$$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A201340$ASTRAZENECA$$9$YR$$F$Y$35$KG$20240906$$MD$US$
242943311$24294331$1$I$$20240831$20240906$20240906$EXP$$JP-AstraZeneca-2024A199908$ASTRAZENECA$$75$YR$$M$Y$$$20240906$$MD$JP$
242943321$24294332$1$I$20230822$20240830$20240906$20240906$EXP$$DE-AstraZeneca-2023A204386$ASTRAZENECA$$80$YR$$F$Y$90$KG$20240906$$MD$DE$
242943331$24294333$1$I$$20240904$20240906$20240906$EXP$$US-ABBVIE-5907407$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242943341$24294334$1$I$20120427$20240903$20240906$20240906$EXP$$PL-SANDOZ INC.-PHHY2017PL126160$SANDOZ$$55$YR$$F$Y$$$20240906$$MD$PL$PL
242943361$24294336$1$I$$20240827$20240906$20240906$EXP$$US-GSK-US2024106726$GLAXOSMITHKLINE$$$$$F$Y$$$20240906$$PH$US$US
242943371$24294337$1$I$$20240830$20240906$20240906$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR109611$VIIV$$$$$$Y$$$20240906$$PH$US$US
242943381$24294338$1$I$$20240827$20240906$20240906$PER$$US-ABBVIE-5900802$ABBVIE$$$$$$Y$$$20240906$$HP$US$US
242943401$24294340$1$I$20240901$20240906$20240906$20240906$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050054$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240906$$CN$US$US
242943421$24294342$1$I$$20240830$20240906$20240906$PER$$US-HALEON-2194588$Haleon PLC$$$$$F$Y$$$20240906$$CN$US$US
242943431$24294343$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61466$$FDA-CTU$$$$$$N$$$20240904$N$CN$US$
242943441$24294344$1$I$$20240904$20240904$20240904$DIR$FDA-CDER-CTU-2024-61473$$FDA-CTU$$$$$$N$$$20240904$N$CN$US$
242943451$24294345$1$I$$20240904$20240906$20240906$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-127894$DAIICHI$$$$$F$Y$$$20240906$$HP$US$US
242943461$24294346$1$I$$20240828$20240906$20240906$EXP$$US-JNJFOC-20240901485$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$HP$US$US
242943471$24294347$1$I$$20240828$20240906$20240906$EXP$$US-JNJFOC-20240832701$JOHNSON AND JOHNSON$$49$YR$A$F$Y$65$KG$20240906$$PH$US$US
242943481$24294348$1$I$20240826$20240828$20240906$20240906$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00785$PARATEK PHARMACEUTICALS$$48$YR$$M$Y$60$KG$20240906$$HP$CN$CN
242943491$24294349$1$I$$20240826$20240906$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016374$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240906$$CN$US$US
242943501$24294350$1$I$$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001086$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240906$$CN$US$US
242943511$24294351$1$I$20160101$20240827$20240906$20240906$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408017291$ELI LILLY AND CO$$66$YR$E$M$Y$145$KG$20240906$$CN$DE$DE
242943522$24294352$2$F$$20240904$20240906$20240912$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018650$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240912$$CN$US$US
242943531$24294353$1$I$20240902$20240903$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409001083$ELI LILLY AND CO$$28$YR$A$M$Y$$$20240906$$CN$US$US
242943541$24294354$1$I$$20240826$20240906$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016314$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240906$$CN$US$US
242943551$24294355$1$I$20240826$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408271910195630-LZSKJ$GB-ELI_LILLY_AND_COMPANY-GB202408017597$ELI LILLY AND CO$$42$YR$A$F$Y$55$KG$20240906$$CN$GB$GB
242943561$24294356$1$I$$20240827$20240906$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016740$ELI LILLY AND CO$$29$YR$A$M$Y$$$20240906$$CN$US$US
242943572$24294357$2$F$20240814$20240919$20240906$20240930$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202408017485$ELI LILLY AND CO$$63$YR$A$F$Y$135$KG$20240930$$HP$GB$GB
242943581$24294358$1$I$$20240711$20240906$20240906$EXP$$BR-PFIZER INC-202400250751$PFIZER$$$$$$Y$$$20240906$$MD$BR$BR
242943591$24294359$1$I$20240801$20240905$20240906$20240906$EXP$$US-PFIZER INC-202400250993$PFIZER$$91$YR$$F$Y$$$20240906$$CN$US$US
242943601$24294360$1$I$$20240901$20240906$20240906$EXP$$US-AMGEN-USASP2024178067$AMGEN$Yu E. Y.; Kolinsky M. P.; Berry W. R. et al.. Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer:Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study. European Urology. 2022;82 (1):22-30$$$$$Y$$$20240906$$HP$US$US
242943611$24294361$1$I$$20240901$20240906$20240906$EXP$$US-AMGEN-USASP2024178083$AMGEN$Yu E. Y.; Kolinsky M. P.; Berry W. R. et al.. Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer:Long-term Results from the Phase lb/2 KEYNOTE-365 Cohort B Study. European Urology. 2022;82 (1):22-30$$$$$Y$$$20240906$$HP$US$US
242943621$24294362$1$I$$20240830$20240906$20240906$EXP$$BR-BIOGEN-2024BI01280885$BIOGEN$$$$$F$Y$83$KG$20240906$$CN$BR$BR
242943633$24294363$3$F$20240718$20240910$20240906$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142140$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$95$KG$20240919$$PH$US$US
242943641$24294364$1$I$20230101$20240829$20240906$20240906$EXP$$US-TEVA-2023-US-2937267$TEVA$$35$YR$$F$Y$$$20240906$$CN$US$US
242943651$24294365$1$I$$20240827$20240906$20240906$EXP$$US-GSK-US2024AMR106908$GLAXOSMITHKLINE$$$$$M$Y$$$20240906$$CN$US$US
242943661$24294366$1$I$20240801$20240904$20240906$20240906$EXP$FR-AFSSAPS-TS2024000954$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-141122$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$45$KG$20240906$$MD$FR$FR
242943672$24294367$2$F$20240101$20240910$20240906$20240920$EXP$$CA-AMRYT PHARMACEUTICALS DAC-AEGR007208$AEGERION$$$$$$Y$$$20240920$$CN$CA$CA
242943681$24294368$1$I$$20240827$20240906$20240906$30DAY$$US-GSK-US2024AMR107550$GLAXOSMITHKLINE$$$$$M$Y$$$20240906$$CN$US$US
242943691$24294369$1$I$20240817$20240830$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139887$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$55.34$KG$20240906$$PH$US$US
242943701$24294370$1$I$20230101$20240830$20240906$20240906$EXP$$JP-AstraZeneca-2024A199651$ASTRAZENECA$$75$YR$$M$Y$$$20240906$$MD$JP$
242943721$24294372$1$I$20240818$20240829$20240906$20240906$EXP$IT-MINISAL02-999710$IT-TEVA-VS-3239011$TEVA$$58$YR$$F$Y$$$20240906$$MD$IT$IT
242943731$24294373$1$I$$20240830$20240906$20240906$EXP$$GR-AstraZeneca-2024A200762$ASTRAZENECA$$$$A$F$Y$$$20240906$$CN$GR$
242943741$24294374$1$I$20140101$20240830$20240906$20240906$EXP$$BR-AstraZeneca-2024A200321$ASTRAZENECA$$63$YR$$M$Y$$$20240906$$CN$BR$
242943751$24294375$1$I$20240103$20240831$20240906$20240906$EXP$$CN-AstraZeneca-2024A199459$ASTRAZENECA$$62$YR$$F$Y$73$KG$20240906$$MD$CN$
242943761$24294376$1$I$$20240904$20240906$20240906$EXP$$CN-AstraZeneca-2024A202444$ASTRAZENECA$$$$$M$Y$$$20240906$$CN$CN$
242943771$24294377$1$I$$20240904$20240906$20240906$EXP$$US-AstraZeneca-2024A201801$ASTRAZENECA$Rink D.E., Abramson R.H., Johnson N.J., Lee R.Y.. Diagnostic Confounders in Brain Death : A Woman with Unexplained Coma and Brainstem Areflexia. Annals of the American Thoracic Society 2024;21(8):1204-1208.$60$YR$$F$Y$$$20240906$$MD$US$
242943782$24294378$2$F$20240101$20240905$20240906$20240926$PER$$US-Eisai-EC-2024-172787$EISAI$$66$YR$E$F$Y$81$KG$20240926$$CN$US$US
242943791$24294379$1$I$$20240828$20240906$20240906$PER$$US-ABBVIE-5901556$ABBVIE$$$$$$Y$$$20240906$$CN$US$US
242943801$24294380$1$I$20240722$20240903$20240906$20240906$EXP$FR-AFSSAPS-TO2024001622$FR-009507513-2409FRA001187$MERCK$$69$YR$$M$Y$49.4$KG$20240906$$PH$FR$FR
242943811$24294381$1$I$20240705$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61524$$FDA-CTU$$16$YR$$M$N$78.47$KG$20240906$N$HP$US$
242943821$24294382$1$I$20240101$20240903$20240906$20240906$PER$$US-ABBVIE-5908582$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242943831$24294383$1$I$$20240820$20240906$20240906$EXP$$US-NOVOPROD-1275945$NOVO NORDISK$$$$$F$Y$$$20240906$$CN$US$US
242943841$24294384$1$I$$20220628$20240906$20240906$EXP$$US-NOVOPROD-1279266$NOVO NORDISK$$$$$M$Y$$$20240906$$CN$US$US
242943851$24294385$1$I$$20240615$20240906$20240906$EXP$$IN-NOVOPROD-1240296$NOVO NORDISK$$16$YR$$F$Y$$$20240906$$CN$IN$IN
242943861$24294386$1$I$$20240905$20240906$20240906$EXP$$NVSC2024GB178868$NOVARTIS$$$$$$Y$$$20240906$$MD$GB$GB
242943872$24294387$2$F$$20240913$20240906$20240923$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-143887$DAIICHI$$$$$M$Y$$$20240923$$CN$US$US
242943881$24294388$1$I$$20240902$20240906$20240906$EXP$NL-LRB-00999590$NL-MYLANLABS-2024M1080560$MYLAN$$58$YR$$F$Y$80$KG$20240906$$CN$NL$NL
242943891$24294389$1$I$20240820$20240820$20240906$20240906$PER$$US-LEX-000452$LEXICON PHARMACEUTICALS$$70$YR$$F$Y$$$20240906$$CN$US$US
242943911$24294391$1$I$20210101$20240830$20240906$20240906$EXP$$CL-JNJFOC-20240902554$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$HP$CL$CL
242943921$24294392$1$I$$20240828$20240906$20240906$EXP$$GB-TEVA-VS-3238657$TEVA$$52$YR$$$Y$$$20240906$$MD$GB$GB
242943933$24294393$3$F$$20240906$20240906$20240921$EXP$$US-AMGEN-USASP2024177778$AMGEN$$$$$F$Y$$$20240920$$CN$US$US
242943941$24294394$1$I$$20240902$20240906$20240906$EXP$$FR-AMGEN-FRASP2024175183$AMGEN$$$$$F$Y$$$20240906$$HP$FR$FR
242943961$24294396$1$I$$20240830$20240906$20240906$EXP$$RU-BIOGEN-2024BI01280772$BIOGEN$UNKNOWN U. Choice of Multiple sclerosis disease modifying drug therapy in infectious and oncological risks. Medical Association of Physicians and Centers for Multiple Sclerosis and Other Neuroimmunological Diseases. 2024;.$$$$$Y$$$20240906$$MD$RU$RU
242943972$24294397$2$F$20240101$20240918$20240906$20240924$EXP$$BR-BIOGEN-2024BI01281047$BIOGEN$$30$YR$$F$Y$65$KG$20240924$$CN$BR$BR
242943981$24294398$1$I$$20240903$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141544$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240906$$CN$US$US
242943991$24294399$1$I$20240904$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61514$$FDA-CTU$$74$YR$$F$N$$$20240905$N$$US$
242944001$24294400$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141949$BRISTOL MYERS SQUIBB$$20$YR$A$F$Y$$$20240906$$HP$US$US
242944011$24294401$1$I$20240801$20240822$20240906$20240906$PER$$US-SA-2024SA256360$SANOFI AVENTIS$$80$YR$E$F$Y$92.27$KG$20240906$$MD$US$US
242944021$24294402$1$I$$20240826$20240906$20240906$EXP$$GB-B.Braun Medical Inc.-2161335$B BRAUN$$$$$F$Y$$$20240906$$$GB$GB
242944032$24294403$2$F$20240902$20240906$20240906$20240911$EXP$$US-KYOWAKIRIN-2024KK020816$KYOWA$$$$$$Y$$$20240911$$HP$US$US
242944041$24294404$1$I$$20240902$20240906$20240906$PER$$US-MYLANLABS-2024M1081186$MYLAN$$$$$$Y$$$20240906$$CN$US$US
242944051$24294405$1$I$$20240904$20240906$20240906$EXP$GB-MHRA-MED-202409031429539670-ZJPQL$GB-GILEAD-2024-0686216$GILEAD$$$$$M$Y$$$20240906$$HP$GB$GB
242944063$24294406$3$F$20240904$20240920$20240906$20240924$EXP$$US-Taiho Oncology Inc-2024-007402$TAIHO ONCOLOGY INC$$73$YR$E$M$Y$$$20240924$$CN$US$US
242944071$24294407$1$I$20240822$20240823$20240906$20240906$EXP$$JP-JOURNEY MEDICAL CORPORATION-2024JNY00202$JOURNEY MEDICAL CORPORATION$$2$DEC$$F$Y$$$20240906$$CN$JP$JP
242944081$24294408$1$I$20240823$20240830$20240906$20240906$EXP$$CN-AstraZeneca-2024A201259$ASTRAZENECA$$23535$DY$$M$Y$60$KG$20240906$$MD$CN$
242944091$24294409$1$I$20240905$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61511$$FDA-CTU$$$$$$N$$$20240905$N$CN$US$
242944102$24294410$2$F$20240101$20240925$20240906$20240926$EXP$$BR-JNJFOC-20240902445$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240926$$CN$BR$BR
242944111$24294411$1$I$$20240829$20240906$20240906$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-142208$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240906$$HP$KR$KR
242944131$24294413$1$I$$20240829$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141771$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$78.458$KG$20240906$$HP$US$US
242944152$24294415$2$F$20240819$20240909$20240906$20240923$EXP$$JP-GUERBET / LLC-JP-20240125$GUERBET$$24$YR$A$F$Y$$$20240923$$MD$JP$JP
242944161$24294416$1$I$20240827$20240827$20240906$20240906$PER$$PR-JNJFOC-20240915536$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240906$$MD$PR$US
242944171$24294417$1$I$20240829$20240829$20240906$20240906$PER$$US-JNJFOC-20240915077$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240906$$HP$US$US
242944181$24294418$1$I$$20240829$20240906$20240906$PER$$US-JNJFOC-20240915048$JOHNSON AND JOHNSON$$$$$M$Y$$$20240906$$PH$US$US
242944191$24294419$1$I$20240701$20240829$20240906$20240906$PER$$US-JNJFOC-20240915611$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240906$$HP$US$US
242944201$24294420$1$I$20240829$20240904$20240906$20240906$EXP$$US-AMGEN-USASP2024177083$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242944211$24294421$1$I$$20240819$20240906$20240906$PER$$US-LEX-000445$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242944221$24294422$1$I$20240101$20240829$20240906$20240906$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00403$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240906$$CN$US$US
242944231$24294423$1$I$20240825$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61500$$FDA-CTU$$61$YR$$M$N$95.4$KG$20240905$Y$MD$US$
242944241$24294424$1$I$20240905$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61498$$FDA-CTU$$$$$$N$$$20240905$N$CN$US$
242944252$24294425$2$F$20240726$20240911$20240906$20240912$EXP$$TR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049687$BOEHRINGER INGELHEIM$$60$YR$A$M$Y$83$KG$20240912$$CN$TR$TR
242944261$24294426$1$I$$20240830$20240906$20240906$30DAY$$GB-MYLANLABS-2024M1080768$MYLAN$$$$$M$Y$$$20240906$$CN$GB$GB
242944291$24294429$1$I$$20240905$20240906$20240906$PER$$US-JNJFOC-20240912649$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$HP$US$US
242944301$24294430$1$I$$20240830$20240906$20240906$PER$$US-JNJFOC-20240915461$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240906$$PH$US$US
242944311$24294431$1$I$20240823$20240823$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136384$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240906$$HP$US$US
242944321$24294432$1$I$20230401$20240904$20240906$20240906$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-142079$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240906$$MD$DE$DE
242944331$24294433$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141940$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$$$20240906$$CN$US$US
242944341$24294434$1$I$$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140944$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240906$$HP$US$US
242944351$24294435$1$I$20240823$20240823$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136234$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240906$$HP$US$US
242944361$24294436$1$I$20240528$20240827$20240906$20240906$EXP$$JP-RADIUS HEALTH INC.-2024JP006523$RADIUS PHARM$$65$YR$$F$Y$$$20240906$$MD$JP$JP
242944381$24294438$1$I$20240216$20240830$20240906$20240906$EXP$$CA-SA-2024SA088167$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240906$$CN$CA$CA
242944401$24294440$1$I$$20240905$20240905$20240905$DIR$FDA-CDER-CTU-2024-61507$$FDA-CTU$$$$$F$N$68.04$KG$20240905$Y$CN$US$
242944411$24294441$1$I$20240101$20240827$20240906$20240906$PER$$US-SA-2024SA258234$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240906$$HP$US$US
242944421$24294442$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA256710$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240906$$CN$US$US
242944441$24294444$1$I$$20240903$20240906$20240906$PER$$US-ABBVIE-5906939$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242944451$24294445$1$I$$20240904$20240906$20240906$EXP$$GB-ABBVIE-5908564$ABBVIE$$$$A$F$Y$$$20240906$$PH$GB$GB
242944462$24294446$2$F$20240727$20240910$20240906$20240913$30DAY$$MX-PFIZER INC-202400234948$PFIZER$$65$YR$$F$Y$52$KG$20240913$$HP$MX$MX
242944472$24294447$2$F$20240801$20240912$20240906$20240916$30DAY$$CO-PFIZER INC-PV202400113188$PFIZER$$$$$F$Y$$$20240916$$CN$CO$CO
242944492$24294449$2$F$20240827$20240923$20240906$20240926$30DAY$$JP-PFIZER INC-202400245496$PFIZER$$$$$$Y$$$20240926$$HP$JP$JP
242944501$24294450$1$I$$20240902$20240906$20240906$30DAY$$GB-PFIZER INC-PV202400115358$PFIZER$$$$$$Y$$$20240906$$MD$GB$GB
242944512$24294451$2$F$20240902$20240918$20240906$20240926$EXP$$CA-TAKEDA-2024TUS065278$TAKEDA$$55$YR$$F$Y$$$20240926$$CN$CA$CA
242944521$24294452$1$I$20220101$20240815$20240906$20240906$EXP$$GB-TAKEDA-2024TUS088871$TAKEDA$$87$YR$$F$Y$$$20240906$$HP$GB$GB
242944531$24294453$1$I$$20240826$20240906$20240906$EXP$$IT-GUERBET / LLC-IT-20240081$GUERBET$Facial nerve palsy after?middle meningeal artery embolization for?chronic subdural hematoma: a?case report. Acta Neurochirurgica 2024; 166 (312): 1-7.$61$YR$A$F$Y$$$20240906$$MD$IT$IT
242944541$24294454$1$I$$20240904$20240906$20240906$EXP$$US-JNJFOC-20240909221$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242944552$24294455$2$F$$20240904$20240906$20240906$PER$$US-JNJFOC-20240910561$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$HP$US$US
242944561$24294456$1$I$$20240829$20240906$20240906$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142226$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240906$$MD$JP$JP
242944581$24294458$1$I$$20240830$20240906$20240906$EXP$$CA-ABBVIE-5649904$ABBVIE$$$$E$M$Y$$$20240906$$CN$CA$CA
242944612$24294461$2$F$20240801$20240919$20240906$20240924$EXP$$CA-TAKEDA-2023TUS049422$TAKEDA$$65$YR$$F$Y$$$20240924$$HP$CA$CA
242944621$24294462$1$I$20240101$20240830$20240906$20240906$EXP$$CN-ABBVIE-5904594$ABBVIE$$69$YR$$M$Y$69$KG$20240906$$MD$CN$CN
242944631$24294463$1$I$20240829$20240905$20240906$20240906$EXP$$GB-SANDOZ INC.-SDZ2024GB078076$SANDOZ$$50$YR$$F$Y$93$KG$20240906$$HP$GB$GB
242944641$24294464$1$I$$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409003464$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240906$$CN$US$US
242944652$24294465$2$F$$20240905$20240906$20240910$EXP$$JP-PFIZER INC-202400249702$PFIZER$Kawada, H.. Acute myeloid leukemia with a ZMYND11::MBTD1 fusion gene following chemotherapy and radiotherapy for breast cancer: A case report. Leukemia Research Reports. 2024;22:10.1016/j.lrr.2024.100478$67$YR$$F$Y$$$20240910$$MD$JP$JP
242944663$24294466$3$F$$20240909$20240906$20240911$PER$$US-PFIZER INC-202400251152$PFIZER$$76$YR$$F$Y$$$20240911$$MD$US$US
242944671$24294467$1$I$20240829$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251501$PFIZER$$64$YR$$F$Y$$$20240906$$CN$US$US
242944681$24294468$1$I$$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251212$PFIZER$$17$YR$$M$Y$$$20240906$$MD$US$US
242944691$24294469$1$I$20240904$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251476$PFIZER$$63$YR$$M$Y$$$20240906$$MD$US$US
242944701$24294470$1$I$$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251435$PFIZER$$65$YR$$F$Y$$$20240906$$CN$US$US
242944711$24294471$1$I$$20240905$20240906$20240906$PER$$US-PFIZER INC-202400250807$PFIZER$$71$YR$$F$Y$$$20240906$$CN$US$US
242944732$24294473$2$F$20240903$20240909$20240906$20240911$EXP$$US-PFIZER INC-202400250874$PFIZER$$73$YR$$F$Y$54.43$KG$20240911$$CN$US$US
242944741$24294474$1$I$$20240905$20240906$20240906$PER$$US-PFIZER INC-PV202400116908$PFIZER$$33$YR$$F$Y$$$20240906$$HP$US$US
242944751$24294475$1$I$$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251331$PFIZER$$65$YR$$F$Y$$$20240906$$MD$US$US
242944761$24294476$1$I$$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251393$PFIZER$$$$$$Y$$$20240906$$CN$US$US
242944771$24294477$1$I$$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251367$PFIZER$$59$YR$$F$Y$$$20240906$$HP$US$US
242944781$24294478$1$I$20240903$20240905$20240906$20240906$PER$$US-PFIZER INC-202400251439$PFIZER$$73$YR$$F$Y$$$20240906$$CN$US$US
242944791$24294479$1$I$$20240902$20240906$20240906$EXP$$ZA-TAKEDA-2024TUS088714$TAKEDA$$$$$$Y$$$20240906$$CN$ZA$ZA
242944801$24294480$1$I$$20240826$20240906$20240906$EXP$$FR-B.Braun Medical Inc.-2161337$B BRAUN$Literature Article$67$YR$$M$Y$$$20240906$$$FR$FR
242944811$24294481$1$I$$20240828$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN009117$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242944821$24294482$1$I$20240830$20240906$20240906$20240906$PER$$US-BAYER-2024A128116$BAYER$$41$YR$A$F$Y$$$20240906$$MD$US$US
242944832$24294483$2$F$$20240828$20240906$20240919$PER$$US-INCYTE CORPORATION-2024IN009113$INCYTE$$$$$$Y$$$20240919$$CN$US$US
242944851$24294485$1$I$20240903$20240905$20240906$20240906$PER$$US-AMGEN-USASP2024178269$AMGEN$$70$YR$E$F$Y$$$20240906$$CN$US$US
242944861$24294486$1$I$$20240905$20240906$20240906$EXP$FI-FIMEA-202403168$FI-GSK-FI2024110582$GLAXOSMITHKLINE$$$$$$Y$$$20240906$$CN$FI$FI
242944871$24294487$1$I$20240101$20240830$20240906$20240906$EXP$$US-ABBVIE-5906479$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242944881$24294488$1$I$20240904$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177405$AMGEN$$77$YR$E$F$Y$$$20240906$$MD$US$US
242944891$24294489$1$I$$20240828$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN009109$INCYTE$$$$$$Y$$$20240906$$PH$US$US
242944911$24294491$1$I$$20240903$20240906$20240906$EXP$$CA-JNJFOC-20240910571$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240906$$CN$CA$CA
242944921$24294492$1$I$$20240828$20240906$20240906$PER$$US-ABBVIE-5900646$ABBVIE$$$$$M$Y$$$20240906$$CN$US$US
242944931$24294493$1$I$$20240826$20240906$20240906$EXP$$CA-B.Braun Medical Inc.-2161338$B BRAUN$$48$YR$$M$Y$$$20240906$$$CA$CA
242944941$24294494$1$I$$20240826$20240906$20240906$EXP$$BE-GUERBET / LLC-BE-20240007$GUERBET$Early and severe aortic endograft infection after percutaneous coil embolization of type 2 endoleak: A case report. International Journal of Surgery Case Reports. 2024;122: 110140. doi:https://doi.org/10.1016/j.ijscr.2024.110140.$75$YR$E$M$Y$$$20240906$$MD$BE$BE
242944951$24294495$1$I$$20240903$20240906$20240906$EXP$$AU-Eisai-EC-2024-173708$EISAI$$$$$F$Y$$$20240906$$MD$AU$AU
242944971$24294497$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5905603$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242944981$24294498$1$I$$20240904$20240906$20240906$EXP$$PT-SA-2024SA257409$SANOFI AVENTIS$Gomes AR, Saleiro C, Teixeira R, Do Carmo Cachulo M, Gon?alves L. Conservative Management of Pneumopericardium: A Case of Unexpected Success. J Invasive Cardiol.. 2023;37(9):E75-83$79$YR$E$M$Y$$$20240906$$MD$PT$PT
242944991$24294499$1$I$$20240821$20240906$20240906$PER$$US-LEX-000454$LEXICON PHARMACEUTICALS$$$$$M$Y$$$20240906$$CN$US$US
242945001$24294500$1$I$20240301$20240905$20240906$20240906$EXP$$US-EXELIXIS-CABO-24081242$EXELIXIS$$61$YR$$M$Y$$$20240906$$CN$US$US
242945021$24294502$1$I$20240701$20240812$20240906$20240906$PER$$US-TOLMAR, INC.-24US051447$TOLMAR$$75$YR$$M$Y$$$20240906$$MD$US$US
242945042$24294504$2$F$20240101$20240905$20240906$20240925$PER$$US-TOLMAR, INC.-24US052040$TOLMAR$$$$$F$Y$$$20240925$$MD$US$US
242945051$24294505$1$I$20240101$20240820$20240906$20240906$PER$$US-TOLMAR, INC.-24US052041$TOLMAR$$$$$$Y$$$20240906$$MD$US$US
242945071$24294507$1$I$20240517$20240823$20240906$20240906$PER$$US-TOLMAR, INC.-24US052142$TOLMAR$$11$YR$$F$Y$$$20240906$$HP$US$US
242945081$24294508$1$I$$20240823$20240906$20240906$PER$$US-TOLMAR, INC.-24US052165$TOLMAR$$9$YR$$F$Y$$$20240906$$CN$US$US
242945091$24294509$1$I$$20240823$20240906$20240906$PER$$US-TOLMAR, INC.-24US052166$TOLMAR$$$$$F$Y$$$20240906$$CN$US$US
242945101$24294510$1$I$$20240823$20240906$20240906$PER$$US-TOLMAR, INC.-24US052167$TOLMAR$$$$$F$Y$$$20240906$$CN$US$US
242945113$24294511$3$F$$20240905$20240906$20240916$EXP$$GB-INCYTE CORPORATION-2024IN002970$INCYTE$$$$$$Y$$$20240916$$CN$GB$GB
242945121$24294512$1$I$$20240829$20240906$20240906$EXP$RU-RZN -2536039$RU-VERTEX PHARMACEUTICALS-2024-013938$VERTEX$$17$YR$$M$Y$64$KG$20240906$$MD$RU$RU
242945131$24294513$1$I$20230201$20240903$20240906$20240906$EXP$GB-MHRA-MED-202409030927141430-BGJZT$GB-VERTEX PHARMACEUTICALS-2024-014061$VERTEX$$6$YR$$M$Y$26$KG$20240906$$PH$GB$GB
242945141$24294514$1$I$$20240905$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141935$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240906$$HP$US$US
242945151$24294515$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142146$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240906$$HP$US$US
242945161$24294516$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142006$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240906$$HP$US$US
242945171$24294517$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141862$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240906$$HP$US$US
242945181$24294518$1$I$$20240903$20240906$20240906$EXP$$MA-INCYTE CORPORATION-2024IN009382$INCYTE$$$$$$Y$$$20240906$$MD$MA$MA
242945191$24294519$1$I$$20240819$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN008723$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242945201$24294520$1$I$$20240819$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN008677$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242945211$24294521$1$I$20240101$20240830$20240906$20240906$EXP$$US-SA-2024SA258192$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240906$$HP$US$US
242945221$24294522$1$I$$20240819$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN008673$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242945231$24294523$1$I$20240809$20240823$20240906$20240906$PER$$US-SA-2024SA257097$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240906$$MD$US$US
242945241$24294524$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA257112$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240906$$MD$US$US
242945251$24294525$1$I$20240801$20240822$20240906$20240906$PER$$US-SA-2024SA256092$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240906$$CN$US$US
242945261$24294526$1$I$20240101$20240822$20240906$20240906$PER$$US-SA-2024SA258785$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240906$$MD$US$US
242945271$24294527$1$I$20240101$20240823$20240906$20240906$PER$$US-SA-2024SA258252$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240906$$HP$US$US
242945281$24294528$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA257153$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240906$$HP$US$US
242945291$24294529$1$I$$20240904$20240906$20240906$EXP$$US-BAUSCH-BL-2023-017340$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240906$$CN$US$US
242945301$24294530$1$I$$20240905$20240906$20240906$EXP$$US-BAUSCH-BL-2024-013309$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240906$$CN$US$US
242945311$24294531$1$I$$20240824$20240906$20240906$PER$$US-SA-2024SA256259$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240906$$MD$US$US
242945322$24294532$2$F$20240801$20240916$20240906$20240923$PER$$US-SA-2024SA257610$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240923$$MD$US$US
242945332$24294533$2$F$20240801$20240826$20240906$20240918$PER$$US-SA-2024SA257948$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240918$$MD$US$US
242945341$24294534$1$I$20240829$20240829$20240906$20240906$PER$$US-SA-2024SA258003$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240906$$CN$US$US
242945351$24294535$1$I$20240711$20240819$20240906$20240906$PER$$US-INCYTE CORPORATION-2024IN008671$INCYTE$$$$$$Y$$$20240906$$CN$US$US
242945381$24294538$1$I$$20240816$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133435$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240906$$CN$US$US
242945391$24294539$1$I$20220101$20240829$20240906$20240906$EXP$$JP-Eisai-EC-2022-115127$EISAI$Kondo T. Tokyo wemen^s Medical University, Adachi Medical Center. New drug therapy for renal cancer - Therapeutic strategy in clinical practice. Lecture.$71$YR$E$M$Y$$$20240906$$MD$JP$JP
242945401$24294540$1$I$$20240904$20240906$20240906$EXP$$US-ABBVIE-5907983$ABBVIE$$$$$F$Y$$$20240906$$HP$US$US
242945411$24294541$1$I$$20240905$20240906$20240906$EXP$$US-ABBVIE-5909405$ABBVIE$$$$$F$Y$$$20240906$$CN$US$US
242945422$24294542$2$F$20240601$20240909$20240906$20240919$EXP$$JP-SMPA-2024SMP012505$SUNOVION$$$$$$Y$$$20240919$$CN$JP$JP
242945431$24294543$1$I$20240808$20240808$20240906$20240906$PER$$US-LEX-000429$LEXICON PHARMACEUTICALS$$61$YR$$F$Y$$$20240906$$CN$US$US
242945441$24294544$1$I$20231101$20240828$20240906$20240906$EXP$$US-JNJFOC-20240875189$JOHNSON AND JOHNSON$$32$YR$$F$Y$$$20240906$$CN$US$US
242945451$24294545$1$I$20240201$20240904$20240906$20240906$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049619$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240906$$CN$US$US
242945461$24294546$1$I$$20240826$20240906$20240906$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408016703$ELI LILLY AND CO$$$$$$Y$$$20240906$$MD$CN$CN
242945471$24294547$1$I$20240329$20240902$20240906$20240906$EXP$ES-AEMPS-1506134$ES-ELI_LILLY_AND_COMPANY-ES202409001017$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240906$$PH$ES$ES
242945481$24294548$1$I$20240818$20240827$20240906$20240906$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408017503$ELI LILLY AND CO$$69$YR$E$M$Y$60$KG$20240906$$CN$CN$CN
242945491$24294549$1$I$20240801$20240827$20240906$20240906$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202408018495$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240906$$CN$BR$BR
242945501$24294550$1$I$20240704$20240828$20240906$20240906$EXP$GB-MHRA-MED-202408272042183930-BPZMW$GB-ELI_LILLY_AND_COMPANY-GB202408017595$ELI LILLY AND CO$$71$YR$E$M$Y$62$KG$20240906$$CN$GB$GB
242945512$24294551$2$F$$20240903$20240906$20240911$EXP$$US-JNJFOC-20240910043$JOHNSON AND JOHNSON$$$$$M$Y$$$20240911$$CN$US$US
242945521$24294552$1$I$$20240904$20240906$20240906$EXP$$US-BAYER-2024A127751$BAYER$$67$YR$E$F$Y$48.073$KG$20240906$$HP$US$US
242945531$24294553$1$I$20240904$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142166$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240906$$CN$US$US
242945551$24294555$1$I$20240823$20240827$20240906$20240906$PER$$US-ABBVIE-5900283$ABBVIE$$60$YR$$M$Y$$$20240906$$CN$US$US
242945561$24294556$1$I$20240719$20240906$20240906$20240906$EXP$FR-AFSSAPS-AN2024001176$NVSC2024FR179189$NOVARTIS$$24$YR$$M$Y$$$20240906$$MD$FR$FR
242945571$24294557$1$I$$20240904$20240906$20240906$EXP$$JP-KYOWAKIRIN-2024KK020571$KYOWA$$$$$$Y$$$20240906$$HP$JP$JP
242945581$24294558$1$I$$20240904$20240906$20240906$EXP$$JP-KYOWAKIRIN-2024KK020576$KYOWA$$$$$$Y$$$20240906$$HP$JP$JP
242945591$24294559$1$I$$20240903$20240906$20240906$EXP$$US-ABBVIE-5906379$ABBVIE$$$$$$Y$$$20240906$$HP$US$US
242945611$24294561$1$I$$20240830$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140232$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240906$$PH$US$US
242945621$24294562$1$I$$20240904$20240906$20240906$EXP$$US-KYOWAKIRIN-2024KK020748$KYOWA$$$$$$Y$$$20240906$$HP$US$US
242945631$24294563$1$I$20240826$20240904$20240906$20240906$EXP$$NVSC2024CN179337$NOVARTIS$$62$YR$$F$Y$54$KG$20240906$$HP$CN$CN
242945641$24294564$1$I$$20240903$20240906$20240906$EXP$$NVSC2024KR178518$NOVARTIS$$8$YR$$M$Y$$$20240906$$MD$KR$KR
242945651$24294565$1$I$$20240829$20240906$20240906$EXP$$US-HLS-202401140$HLS THERAPEUTICS$$$$A$$Y$$$20240906$$HP$US$US
242945681$24294568$1$I$20240801$20240828$20240906$20240906$PER$$US-TOLMAR, INC.-24US051688$TOLMAR$$$$$$Y$$$20240906$$HP$US$US
242945702$24294570$2$F$20240901$20240911$20240906$20240913$PER$$US-AMGEN-USASP2024177196$AMGEN$$71$YR$E$M$Y$$$20240913$$CN$US$US
242945711$24294571$1$I$20240801$20240905$20240906$20240906$PER$$US-JNJFOC-20240912802$JOHNSON AND JOHNSON$$$$$F$Y$$$20240906$$CN$US$US
242945721$24294572$1$I$$20240903$20240906$20240906$EXP$$NVSC2024US037329$NOVARTIS$$$$$F$Y$$$20240906$$CN$US$US
242945731$24294573$1$I$20240101$20240905$20240906$20240906$PER$$US-JNJFOC-20240912135$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$CN$US$US
242945741$24294574$1$I$20240426$20240829$20240906$20240906$PER$$US-SA-2024SA252595$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240906$$MD$US$US
242945761$24294576$1$I$$20240828$20240906$20240906$EXP$$JP-RIGEL-20240600048$RIGEL PHARMACEUTICALS$$71$YR$$M$Y$$$20240906$$MD$JP$JP
242945771$24294577$1$I$20240528$20240905$20240906$20240906$EXP$FR-AFSSAPS-DJ2024000934$FR-BAUSCH-BL-2024-013307$BAUSCH AND LOMB$$51$YR$$M$Y$65$KG$20240906$$MD$FR$FR
242945781$24294578$1$I$20240801$20240829$20240906$20240906$EXP$$US-RIGEL-20240900012$RIGEL PHARMACEUTICALS$$73$YR$$M$Y$$$20240906$$CN$US$US
242945792$24294579$2$F$20240829$20240829$20240906$20240923$PER$$US-SA-2024SA257127$SANOFI AVENTIS$$77$YR$E$F$Y$98.18$KG$20240923$$MD$US$US
242945801$24294580$1$I$$20240904$20240906$20240906$EXP$$CA-MYLANLABS-2024M1081337$MYLAN$$54$YR$$F$Y$$$20240906$$CN$CA$CA
242945811$24294581$1$I$20240701$20240829$20240906$20240906$EXP$$US-SA-2024SA256683$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240906$$MD$US$US
242945821$24294582$1$I$$20240825$20240906$20240906$DIR$FDA-CDER-CTU-2024-61530$$FDA-CTU$$$$$F$N$$$20240825$Y$CN$US$
242945831$24294583$1$I$20240829$20240902$20240906$20240906$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-027956$UNITED THERAPEUTICS$$60$YR$$M$Y$$$20240906$$$JP$JP
242945841$24294584$1$I$20240101$20240903$20240906$20240906$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049393$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240906$$HP$US$US
242945851$24294585$1$I$20240101$20240821$20240906$20240906$EXP$$US-RADIUS HEALTH INC.-2024US006704$RADIUS PHARM$$$$$F$Y$$$20240906$$CN$US$US
242945861$24294586$1$I$$20240903$20240906$20240906$EXP$$CA-009507513-2409CAN001777$MERCK$$92$YR$$F$Y$$$20240906$$HP$CA$CA
242945881$24294588$1$I$20240902$20240905$20240906$20240906$PER$$US-AMGEN-USASP2024177769$AMGEN$$73$YR$E$F$Y$$$20240906$$CN$US$US
242945893$24294589$3$F$$20240903$20240906$20240909$EXP$$KR-JAZZ PHARMACEUTICALS-2024-KR-014421$JAZZ$$$$$M$Y$$$20240909$$HP$KR$KR
242945901$24294590$1$I$20240622$20240903$20240906$20240906$EXP$$NVSC2024CN179387$NOVARTIS$$51$YR$$M$Y$$$20240906$$HP$CN$CN
242945911$24294591$1$I$20240827$20240829$20240906$20240906$EXP$$US-Eisai-EC-2024-173358$EISAI$$$$$F$Y$$$20240906$$MD$US$US
242945921$24294592$1$I$$20240829$20240906$20240906$EXP$$US-TEVA-VS-3238982$TEVA$$75$YR$$M$Y$$$20240906$$CN$US$US
242945932$24294593$2$F$20210101$20240904$20240906$20240927$EXP$$MT-SA-2024SA253288$SANOFI AVENTIS$Gauci L, Scerri C, Mifsud M, Gauci J.. Interstitial lung disease secondary to oxaliplatin-raltitrexed based chemotherapy.. Malta Medical Journal. 2024;36(3):73-7$72$YR$E$M$Y$$$20240927$$MD$MT$MT
242945941$24294594$1$I$20240716$20240830$20240906$20240906$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-118352$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240906$$MD$DE$DE
242945951$24294595$1$I$$20240903$20240906$20240906$EXP$$US-PURDUE-USA-2024-0311802$PURDUE$Phan T, Klouda E, Jackson CD.. Chorea - Is Diabetes Mellitus the Cause?. Journal of General Internal Medicine. 2024;39(12):2347-235$61$YR$$M$Y$$$20240906$$MD$US$US
242945961$24294596$1$I$20240721$20240905$20240906$20240906$EXP$GB-MHRA-MED-202409050905336560-HNZRQ$GB-ABBVIE-5909327$ABBVIE$$65$YR$$M$Y$$$20240906$$MD$GB$GB
242945971$24294597$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142260$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240906$$CN$US$US
242945981$24294598$1$I$20240815$20240904$20240906$20240906$EXP$$GB-PURDUE-USA-2024-0311829$PURDUE$$81$YR$$M$Y$90$KG$20240906$$MD$GB$GB
242945991$24294599$1$I$20240902$20240905$20240906$20240906$EXP$$TW-PFIZER INC-PV202400116707$PFIZER$$73$YR$$M$Y$$$20240906$$HP$TW$TW
242946001$24294600$1$I$$20240904$20240906$20240906$EXP$$JP-PFIZER INC-202400249461$PFIZER$$$$$$Y$$$20240906$$PH$JP$JP
242946011$24294601$1$I$20230410$20240905$20240906$20240906$EXP$$GB-PFIZER INC-202400250696$PFIZER$$68$YR$$F$Y$69$KG$20240906$$HP$GB$GB
242946022$24294602$2$F$20230807$20240918$20240906$20240920$EXP$$FR-PFIZER INC-PV202400115349$PFIZER$$50$YR$$M$Y$75$KG$20240920$$MD$FR$FR
242946043$24294604$3$F$20240824$20240911$20240906$20240920$PER$$US-ABBVIE-5900204$ABBVIE$$38$YR$$F$Y$$$20240920$$CN$US$US
242946061$24294606$1$I$$20240824$20240906$20240906$EXP$$US-FMCRTG-FMC-2408-001074$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240906$$CN$US$US
242946071$24294607$1$I$$20240805$20240906$20240906$PER$$US-FMCRTG-FMC-2408-000965$FRESENIUS MEDICAL CARE$$76$YR$E$M$Y$$$20240906$$HP$US$US
242946081$24294608$1$I$$20240828$20240906$20240906$PER$$JP-Eisai-EC-2024-173289$EISAI$Nishikawa Mayo et.al. Considerations from our experience with combination therapy of pembrolizumab and lenvatinib for recurrent uterine cancer$$$A$F$Y$$$20240906$$MD$JP$JP
242946091$24294609$1$I$20240625$20240830$20240906$20240906$EXP$$CN-Eisai-EC-2024-173592$EISAI$$58$YR$A$M$Y$72$KG$20240906$$HP$CN$CN
242946101$24294610$1$I$20240701$20240830$20240906$20240906$EXP$$JP-Eisai-EC-2024-173384$EISAI$$$$$F$Y$$$20240906$$CN$JP$JP
242946111$24294611$1$I$20240707$20240905$20240906$20240906$EXP$$SA-LUNDBECK-DKLU4003965$LUNDBECK$$$$$$Y$$$20240906$$MD$SA$SA
242946121$24294612$1$I$$20240829$20240906$20240906$PER$$US-ABBVIE-5909468$ABBVIE$$$$A$M$Y$$$20240906$$MD$US$US
242946131$24294613$1$I$20240801$20240827$20240906$20240906$EXP$$US-RADIUS HEALTH INC.-2024US006655$RADIUS PHARM$$57$YR$$F$Y$$$20240906$$CN$US$US
242946142$24294614$2$F$$20240912$20240906$20240917$EXP$$JP-GILEAD-2024-0686331$GILEAD$$72$YR$E$M$Y$$$20240917$$MD$JP$JP
242946151$24294615$1$I$$20240828$20240906$20240906$PER$$US-ABBVIE-5901062$ABBVIE$$$$$F$Y$$$20240906$$HP$US$US
242946161$24294616$1$I$20240816$20240830$20240906$20240906$EXP$$US-ABBVIE-5903552$ABBVIE$$28$YR$$F$Y$$$20240906$$CN$US$US
242946172$24294617$2$F$$20240906$20240906$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-024700$JAZZ$$$$$F$Y$$$20240911$$HP$US$US
242946181$24294618$1$I$20240101$20240903$20240906$20240906$EXP$SE-SEMPA-2024-006397$SE-MYLANLABS-2024M1080893$MYLAN$$62$YR$$M$Y$$$20240906$$MD$SE$SE
242946192$24294619$2$F$$20240830$20240906$20240927$PER$$US-SA-2024SA258655$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240927$$MD$US$US
242946201$24294620$1$I$$20240905$20240906$20240906$PER$$US-HALEON-2195607$Haleon PLC$$$$$F$Y$$$20240906$$CN$US$US
242946213$24294621$3$F$$20240912$20240906$20240917$EXP$$JP-GILEAD-2024-0686337$GILEAD$$67$YR$E$M$Y$$$20240917$$MD$JP$JP
242946222$24294622$2$F$$20240827$20240906$20240923$EXP$$IT-Ipsen Biopharmaceuticals, Inc.-2024-17294$IPSEN$Artusi, Carlo Alberto, Rinaldi, Domiziana, Tangari, Marta Maria, et al. ^CACNA1A variant associated with generalized dystonia^, Neurological Sciences, 01-Jan-2024, Vol. 45.0, Iss. 9.0, Pp. 4589-4592. doi:10.1007/s10072-024-07592-8$57$YR$A$F$Y$$$20240923$$HP$IT$IT
242946231$24294623$1$I$20240501$20240904$20240906$20240906$PER$$US-AMGEN-USASP2024177355$AMGEN$$46$YR$A$F$Y$$$20240906$$PH$US$US
242946241$24294624$1$I$$20240903$20240906$20240906$EXP$$US-MYLANLABS-2024M1081695$MYLAN$$$$$M$Y$77.11$KG$20240906$$CN$US$US
242946261$24294626$1$I$$20240905$20240906$20240906$PER$$US-PFIZER INC-PV202400117138$PFIZER$$65$YR$$F$Y$$$20240906$$HP$US$US
242946271$24294627$1$I$20240801$20240903$20240906$20240906$PER$$US-PFIZER INC-202400249395$PFIZER$$52$YR$$F$Y$$$20240906$$MD$US$US
242946281$24294628$1$I$$20240827$20240906$20240906$EXP$$JP-BAUSCHBL-2024BNL032769$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240906$$$COUNTRY NOT SPECIFIED$JP
242946291$24294629$1$I$20240814$20240823$20240906$20240906$EXP$GB-MHRA-MED-202408231607265850-WDBYV$GB-ETHYPHARM-2024002322$ETHYPHARM$$$$$$Y$$$20240906$$HP$GB$
242946302$24294630$2$F$20190101$20240904$20240906$20240914$EXP$$US-ABBVIE-5907405$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
242946313$24294631$3$F$$20240912$20240906$20240917$EXP$$JP-GILEAD-2024-0686338$GILEAD$$79$YR$E$F$Y$$$20240917$$MD$JP$JP
242946331$24294633$1$I$$20240826$20240906$20240906$PER$$US-SA-2024SA257245$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240906$$HP$US$US
242946341$24294634$1$I$20230101$20240823$20240906$20240906$PER$$US-SA-2024SA258670$SANOFI AVENTIS$$$$A$F$Y$$$20240906$$HP$US$US
242946351$24294635$1$I$20240101$20240830$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139636$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240906$$CN$US$US
242946361$24294636$1$I$20240903$20240904$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140903$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240906$$CN$US$US
242946371$24294637$1$I$20240905$20240905$20240906$20240906$PER$$US-AMGEN-USASP2024177976$AMGEN$$81$YR$E$F$Y$$$20240906$$CN$US$US
242946381$24294638$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA258569$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240906$$HP$US$US
242946391$24294639$1$I$$20240901$20240906$20240906$EXP$$MX-JNJFOC-20240908021$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$HP$MX$MX
242946401$24294640$1$I$$20240905$20240906$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014356$JAZZ$$$$$F$Y$$$20240906$$CN$US$US
242946412$24294641$2$F$20240902$20240923$20240906$20240924$PER$$US-AMGEN-USASP2024176341$AMGEN$$76$YR$E$M$Y$$$20240923$$CN$US$US
242946421$24294642$1$I$20240821$20240904$20240906$20240906$EXP$$US-AMGEN-USASP2024176916$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242946431$24294643$1$I$20240825$20240828$20240906$20240906$EXP$$GB-RIGEL-20240900023$RIGEL PHARMACEUTICALS$$62$YR$$M$Y$$$20240906$$MD$GB$GB
242946442$24294644$2$F$$20240904$20240906$20240911$PER$$US-JAZZ PHARMACEUTICALS-2024-US-014318$JAZZ$$$$$M$Y$$$20240911$$CN$US$US
242946451$24294645$1$I$$20240812$20240906$20240906$PER$$US-Covis Pharma GmbH-2024COV01048$COVIS PHARMA$$82$YR$E$F$Y$$$20240906$$MD$US$US
242946461$24294646$1$I$20240725$20240905$20240906$20240906$PER$$JP-Eisai-EC-2024-172005$EISAI$$75$YR$E$F$Y$$$20240906$$MD$JP$JP
242946471$24294647$1$I$$20240905$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141693$BRISTOL MYERS SQUIBB$$73$YR$E$$Y$65.32$KG$20240906$$HP$US$US
242946482$24294648$2$F$20191201$20240829$20240906$20240926$EXP$$IT-BAYER-2024A124940$BAYER$Fassi E.; Amoroso V.; Cosentini D.; Ferrari V.; Lagana M.; Berruti A.; di Mauro P. Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report. Frontiers in Oncology. 2024;14:1398055$58$YR$A$F$Y$$$20240926$$HP$IT$IT
242946491$24294649$1$I$$20240905$20240906$20240906$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014433$JAZZ$$$$$M$Y$$$20240906$$HP$US$US
242946501$24294650$1$I$20240821$20240831$20240906$20240906$EXP$$CN-AstraZeneca-2024A199446$ASTRAZENECA$$71$YR$$M$Y$60$KG$20240906$$MD$CN$
242946513$24294651$3$F$20240731$20240912$20240906$20240917$EXP$$US-EXELIXIS-CABO-24080057$EXELIXIS$$86$YR$$M$Y$$$20240917$$MD$US$US
242946521$24294652$1$I$20240101$20240903$20240906$20240906$EXP$$US-GILEAD-2024-0686231$GILEAD$$34$YR$A$M$Y$$$20240906$$CN$US$US
242946541$24294654$1$I$$20240726$20240906$20240906$PER$$US-LUNDBECK-DKLU4002292$LUNDBECK$$$$$$Y$$$20240906$$HP$US$US
242946551$24294655$1$I$$20240902$20240906$20240906$EXP$$EU-BAUSCHBL-2024BNL032693$BAUSCH AND LOMB$$$$$M$Y$$$20240906$$CN$EU$EU
242946561$24294656$1$I$$20240807$20240906$20240906$PER$$US-009507513-2408USA003193$MERCK$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. Journal of Oncology Pharmacy Practice. 2024;0 (0):1-4$56$YR$$F$Y$$$20240906$$HP$US$US
242946571$24294657$1$I$$20240727$20240906$20240906$PER$$US-LUNDBECK-DKLU4002373$LUNDBECK$$$$$$Y$$$20240906$$HP$US$US
242946591$24294659$1$I$$20240807$20240906$20240906$PER$$US-009507513-2408USA007740$MERCK$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. Journal of Oncology Pharmacy Practice. 2024;0 (0):1-4$61$YR$$M$Y$$$20240906$$HP$US$US
242946601$24294660$1$I$20240815$20240829$20240906$20240906$EXP$FR-AFSSAPS-RS2024000821$FR-TEVA-VS-3238334$TEVA$$64$YR$$M$Y$76$KG$20240906$$MD$FR$FR
242946611$24294661$1$I$20240712$20240829$20240906$20240906$EXP$FR-AFSSAPS-TO2024001443$FR-TEVA-VS-3238988$TEVA$$76$YR$$M$Y$71$KG$20240906$$PH$FR$FR
242946621$24294662$1$I$$20240827$20240906$20240906$PER$$US-ABBVIE-5900913$ABBVIE$$$$A$M$Y$$$20240906$$HP$US$US
242946631$24294663$1$I$20240301$20240829$20240906$20240906$EXP$FR-AFSSAPS-PA2024001297$FR-TEVA-VS-3239000$TEVA$$40$YR$$F$Y$$$20240906$$PH$FR$FR
242946641$24294664$1$I$20240807$20240829$20240906$20240906$EXP$FR-AFSSAPS-MP2024001316$FR-TEVA-VS-3239010$TEVA$$91$YR$$M$Y$59$KG$20240906$$PH$FR$FR
242946661$24294666$1$I$20240725$20240829$20240906$20240906$EXP$FR-AFSSAPS-LL2024001543$FR-TEVA-VS-3239012$TEVA$$56$YR$$F$Y$$$20240906$$MD$FR$FR
242946682$24294668$2$F$20240730$20240910$20240906$20240911$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-136118$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$96.9$KG$20240912$$MD$AU$AU
242946691$24294669$1$I$20240826$20240902$20240906$20240906$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-141124$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$57$KG$20240906$$CN$CN$CN
242946701$24294670$1$I$$20240807$20240906$20240906$PER$$US-009507513-2408USA007739$MERCK$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. Journal of Oncology Pharmacy Practice. 2024;0 (0):1-4$69$YR$$F$Y$$$20240906$$HP$US$US
242946711$24294671$1$I$20240101$20240826$20240906$20240906$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000181$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240906$$CN$US$US
242946721$24294672$1$I$20230528$20240902$20240906$20240906$EXP$$JP-AstraZeneca-2023A203252$ASTRAZENECA$$81$YR$$M$Y$78$KG$20240906$$MD$JP$
242946731$24294673$1$I$$20240827$20240906$20240906$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000184$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240906$$CN$US$US
242946741$24294674$1$I$$20240904$20240906$20240906$PER$$JP-Eisai-EC-2024-173783$EISAI$$$$E$F$Y$$$20240906$$MD$JP$JP
242946751$24294675$1$I$20240809$20240902$20240906$20240906$EXP$FR-AFSSAPS-ST2024001355$FR-009507513-2409FRA000581$MERCK$$84$YR$$F$Y$60$KG$20240906$$MD$FR$FR
242946761$24294676$1$I$$20240906$20240906$20240906$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050005$BOEHRINGER INGELHEIM$$$$$$Y$$$20240906$$CN$US$US
242946771$24294677$1$I$20240813$20240829$20240906$20240906$EXP$$CN-009507513-2409CHN000583$MERCK$$68$YR$$M$Y$70$KG$20240906$$HP$CN$CN
242946781$24294678$1$I$20221215$20240902$20240906$20240906$EXP$FR-AFSSAPS-MP2024001335$FR-009507513-2409FRA000751$MERCK$$$$N$F$Y$2.92$KG$20240906$$MD$FR$FR
242946791$24294679$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA257069$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240906$$MD$US$US
242946801$24294680$1$I$$20240723$20240906$20240906$PER$$US-PFIZER INC-202400222790$PFIZER$$30$YR$$$Y$$$20240906$$CN$US$US
242946811$24294681$1$I$20240826$20240830$20240906$20240906$EXP$$CN-009507513-2409CHN000963$MERCK$$57$YR$$M$Y$66$KG$20240906$$HP$CN$CN
242946821$24294682$1$I$20240816$20240830$20240906$20240906$EXP$$CN-009507513-2409CHN000863$MERCK$$71$YR$$F$Y$46.3$KG$20240906$$HP$CN$CN
242946831$24294683$1$I$$20240904$20240906$20240906$EXP$$PL-009507513-2409POL001859$MERCK$Stryjkowska-Gora, A.. Treatment of a non-small cell lung cancer patient with low PD-L1 expression using chemotherapy in combination with pembrolizumab.. ONKOLOGIA W PRAKTYCE KLINICZNEJ - EDUKACJA. 2024;10(Supl. C):C40-3$74$YR$$M$Y$$$20240906$$MD$PL$PL
242946841$24294684$1$I$20240904$20240904$20240906$20240906$PER$$US-PHARMING-PHAUS2024000760$PHARMING GROUP$$$$$$Y$$$20240906$$CN$US$US
242946851$24294685$1$I$20240819$20240830$20240906$20240906$EXP$$CN-009507513-2409CHN000760$MERCK$$80$YR$$F$Y$60$KG$20240906$$HP$CN$CN
242946861$24294686$1$I$20240802$20240902$20240906$20240906$EXP$$DE-Taiho Oncology Inc-2024-008368$TAIHO ONCOLOGY INC$$72$YR$E$F$Y$83$KG$20240906$$MD$DE$DE
242946872$24294687$2$F$$20240906$20240906$20240913$EXP$$US-Eisai-EC-2024-173391$EISAI$$$$$F$Y$$$20240913$$MD$US$US
242946881$24294688$1$I$20240821$20240828$20240906$20240906$EXP$$CA-LUNDBECK-DKLU4002358$LUNDBECK$$$$$$Y$$$20240906$$HP$CA$CA
242946891$24294689$1$I$$20240830$20240906$20240906$EXP$$CN-AstraZeneca-2024A201248$ASTRAZENECA$$57$YR$$F$Y$$$20240906$$CN$CN$
242946901$24294690$1$I$$20240829$20240906$20240906$PER$$US-SA-2024SA258432$SANOFI AVENTIS$$$$$F$Y$$$20240906$$CN$US$US
242946911$24294691$1$I$$20240905$20240906$20240906$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141752$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$52.16$KG$20240906$$CN$US$US
242946922$24294692$2$F$20240831$20240909$20240906$20240916$PER$$US-PHARMING-PHAUS2024000764$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
242946931$24294693$1$I$$20240828$20240906$20240906$PER$$US-009507513-2408USA010790$MERCK$$$$$$Y$$$20240906$$MD$US$US
242946941$24294694$1$I$20240716$20240727$20240906$20240906$PER$$US-LUNDBECK-DKLU4002374$LUNDBECK$$$$$$Y$$$20240906$$HP$US$US
242946951$24294695$1$I$20240819$20240829$20240906$20240906$EXP$$IT-AstraZeneca-2024A193825$ASTRAZENECA$$60$YR$$F$Y$$$20240906$$MD$IT$
242946961$24294696$1$I$20240809$20240830$20240906$20240906$PER$$US-APELLIS-2024-APL-0000918$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240906$$CN$US$US
242946971$24294697$1$I$$20240906$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409004200$ELI LILLY AND CO$$74$YR$E$$Y$$$20240906$$CN$US$US
242946991$24294699$1$I$$20240904$20240906$20240906$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142065$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240906$$CN$US$US
242947001$24294700$1$I$20230101$20240902$20240906$20240906$EXP$$CA-009507513-2312CAN002165$MERCK$$70$YR$$M$Y$76$KG$20240906$$MD$CA$CA
242947011$24294701$1$I$$20240827$20240906$20240906$EXP$$NVSC2024ID175613$NOVARTIS$Lestari PM, Andrina H, Herponi A. A rare case report: belly dancer dyskinesia and symptomatic epilepsy in pregnancy causing incomplete uterine rupture.. JOURNAL OF SOUTH ASIAN FEDERATION OF OBSTETRICS AND GYNAECOLOGY. 2024;16 (4):455-7$33$YR$$F$Y$$$20240907$$HP$ID$ID
242947021$24294702$1$I$$20240904$20240906$20240906$EXP$$NVSC2024US178057$NOVARTIS$$$$$F$Y$$$20240907$$CN$US$US
242947041$24294704$1$I$$20240830$20240906$20240906$EXP$$AU-AstraZeneca-2024A200202$ASTRAZENECA$$$$$M$Y$$$20240906$$PH$AU$
242947061$24294706$1$I$$20240830$20240906$20240906$EXP$$US-GILEAD-2024-0686590$GILEAD$$$$$F$Y$$$20240906$$MD$US$US
242947072$24294707$2$F$20240830$20240905$20240906$20240911$PER$$PL-JAZZ PHARMACEUTICALS-2024-PL-014233$JAZZ$$$$$$Y$$$20240911$$MD$PL$PL
242947081$24294708$1$I$$20240826$20240906$20240906$EXP$GB-MHRA-MED-202408261119418810-FTWJY$GB-ELI_LILLY_AND_COMPANY-GB202408016710$ELI LILLY AND CO$$$$$M$Y$$$20240906$$CN$GB$GB
242947092$24294709$2$F$20240821$20240926$20240906$20240927$EXP$$US-GILEAD-2024-0686424$GILEAD$$80$YR$E$M$Y$$$20240927$$HP$US$US
242947101$24294710$1$I$$20240826$20240906$20240906$EXP$$US-ELI_LILLY_AND_COMPANY-US202408016593$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240906$$CN$US$US
242947111$24294711$1$I$20240819$20240827$20240906$20240906$EXP$GB-MHRA-MED-202408271700340270-BKSZC$GB-ELI_LILLY_AND_COMPANY-GB202408017598$ELI LILLY AND CO$$58$YR$A$F$Y$113$KG$20240906$$CN$GB$GB
242947131$24294713$1$I$20240904$20240904$20240906$20240906$EXP$$US-009507513-2409USA001856$MERCK$$$$$F$Y$$$20240906$$CN$US$US
242947141$24294714$1$I$20240802$20240906$20240906$20240906$EXP$GB-MHRA-MED-202409061016593120-NDJFL$GB-GILEAD-2024-0686525$GILEAD$$56$YR$A$M$Y$$$20240906$$CN$GB$GB
242947151$24294715$1$I$$20240905$20240906$20240906$EXP$$US-GILEAD-2024-0686465$GILEAD$$$$A$M$Y$$$20240906$$CN$US$US
242947161$24294716$1$I$20240829$20240904$20240906$20240906$EXP$$NVSC2024US178076$NOVARTIS$$46$YR$$F$Y$$$20240907$$CN$US$US
242947171$24294717$1$I$$20240903$20240906$20240906$EXP$$FR-AstraZeneca-2024A201547$ASTRAZENECA$$$$$M$Y$80$KG$20240906$$MD$FR$
242947181$24294718$1$I$$20240826$20240906$20240906$EXP$$CA-HLS-202402168$HLS THERAPEUTICS$$$$E$F$Y$$$20240906$$PH$CA$CA
242947191$24294719$1$I$$20240827$20240906$20240906$EXP$$JP-009507513-2407JPN001853J$MERCK$Furusako R, Suwa K, Kikuchi M, Miyabe R, Mastushima H, Kobayashi J, et al.. EP-1157 Four cases of breast cancer in which secondary adrenal insufficiency developed after preoperative chemotherapy with pembrolizumab. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 467$58$YR$$F$Y$$$20240906$$MD$JP$JP
242947201$24294720$1$I$$20240905$20240906$20240906$EXP$$CN-AstraZeneca-2024A203569$ASTRAZENECA$$$$$F$Y$$$20240906$$CN$CN$
242947222$24294722$2$F$$20240909$20240906$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003238$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240911$$CN$US$US
242947231$24294723$1$I$$20240903$20240906$20240906$EXP$$US-AstraZeneca-2024A202077$ASTRAZENECA$$$$$F$Y$$$20240907$$CN$US$
242947241$24294724$1$I$$20240826$20240906$20240906$EXP$$CA-HLS-202402155$HLS THERAPEUTICS$$$$E$F$Y$$$20240906$$HP$CA$CA
242947251$24294725$1$I$$20240828$20240906$20240906$PER$$US-BIOGEN-2024BI01280373$BIOGEN$$$$$F$Y$$$20240906$$CN$US$US
242947261$24294726$1$I$20240629$20240826$20240906$20240906$EXP$$CA-HLS-202402154$HLS THERAPEUTICS$$81$YR$E$M$Y$$$20240906$$HP$CA$CA
242947271$24294727$1$I$$20240827$20240906$20240906$EXP$$CA-HLS-202402174$HLS THERAPEUTICS$$$$A$F$Y$$$20240906$$PH$CA$CA
242947282$24294728$2$F$$20240905$20240906$20240910$EXP$$JP-009507513-2409JPN001568$MERCK$Terashima Y, Matsumoto M, Ozaki S, Nakagawa M, Nakagome S, Terasaki Y, et al.. IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report. Frontiers in Immunology. 2024$73$YR$$M$Y$$$20240910$$HP$JP$JP
242947291$24294729$1$I$$20240905$20240906$20240906$PER$$US-JNJFOC-20240913293$JOHNSON AND JOHNSON$$$$$$Y$$$20240906$$HP$US$US
242947301$24294730$1$I$$20240902$20240906$20240906$PER$$US-BIOMARINAP-US-2024-160273$BIOMARIN$$$$$$Y$$$20240906$$CN$US$US
242947311$24294731$1$I$20240826$20240829$20240906$20240906$EXP$$KR-MALLINCKRODT-MNK202405430$MALLINCKRODT$$2$DY$N$$Y$2$KG$20240906$$MD$KR$KR
242947321$24294732$1$I$$20240829$20240906$20240906$PER$$US-BIOMARINAP-US-2024-160267$BIOMARIN$$$$$$Y$$$20240906$$CN$US$US
242947332$24294733$2$F$$20240909$20240906$20240918$PER$$US-BIOMARINAP-US-2024-160289$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
242947341$24294734$1$I$20240812$20240830$20240906$20240906$PER$$US-BIOMARINAP-US-2024-160270$BIOMARIN$$$$$$Y$$$20240906$$CN$US$US
242947351$24294735$1$I$$20240828$20240906$20240906$EXP$$US-HLS-202401110$HLS THERAPEUTICS$$20$YR$A$M$Y$$$20240906$$PH$US$US
242947361$24294736$1$I$20240829$20240830$20240906$20240906$PER$$US-BIOMARINAP-US-2024-160262$BIOMARIN$$$$$$Y$$$20240906$$CN$US$US
242947371$24294737$1$I$20240828$20240830$20240906$20240906$PER$$US-BIOMARINAP-US-2024-160264$BIOMARIN$$$$$$Y$$$20240906$$CN$US$US
242947381$24294738$1$I$$20240829$20240906$20240906$EXP$$US-RADIUS HEALTH INC.-2024US006709$RADIUS PHARM$$$$$F$Y$$$20240906$$CN$US$US
242947392$24294739$2$F$20240822$20240829$20240906$20240909$EXP$$JP-RADIUS HEALTH INC.-2024JP006628$RADIUS PHARM$$82$YR$$F$Y$$$20240909$$MD$JP$JP
242947411$24294741$1$I$$20240825$20240906$20240906$PER$$US-SA-2024SA256862$SANOFI AVENTIS$$$$T$M$Y$$$20240907$$HP$US$US
242947422$24294742$2$F$20211201$20240903$20240906$20240911$PER$$US-SA-2024SA257754$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240911$$HP$US$US
242947431$24294743$1$I$20240904$20240905$20240906$20240906$PER$$US-AMGEN-USASP2024177689$AMGEN$$79$YR$E$M$Y$$$20240906$$CN$US$US
242947441$24294744$1$I$20240101$20240905$20240906$20240906$PER$$US-PURDUE-USA-2024-0311804$PURDUE$$79$YR$$M$Y$106.14$KG$20240907$$CN$US$US
242947451$24294745$1$I$20230101$20240905$20240906$20240906$PER$$US-PURDUE PHARMA-USA-2024-0311825$PURDUE$$$$$F$Y$$$20240907$$CN$US$US
242947461$24294746$1$I$$20240906$20240906$20240906$PER$$US-PURDUE PHARMA-USA-2024-0311818$PURDUE$$$$$F$Y$$$20240907$$CN$US$US
242947472$24294747$2$F$20240820$20240903$20240906$20240912$EXP$$US-PHARMING-PHAUS2024000741$PHARMING GROUP$$$$$$Y$$$20240912$$CN$US$US
242947481$24294748$1$I$$20240903$20240906$20240906$PER$$US-SA-2024SA258713$SANOFI AVENTIS$$$$$F$Y$$$20240907$$MD$US$US
242947492$24294749$2$F$20240101$20240905$20240906$20240912$PER$$US-AMGEN-USASP2024177705$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
242947501$24294750$1$I$$20240828$20240906$20240906$EXP$$CA-APOTEX-2024AP010122$APOTEX$$66$YR$$M$Y$$$20240906$$CN$CA$CA
242947511$24294751$1$I$20240801$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001386$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242947522$24294752$2$F$$20240904$20240906$20240919$PER$$US-SMPA-2024SPA001297$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
242947531$24294753$1$I$$20240809$20240906$20240906$PER$$US-SMPA-2024MYSCI0600091$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242947551$24294755$1$I$$20240812$20240906$20240906$PER$$US-SMPA-2024SPA001398$SUNOVION$$$$$$Y$$$20240906$$CN$US$US
242947561$24294756$1$I$$20240903$20240906$20240906$PER$$US-AMGEN-USASP2024178177$AMGEN$$$$A$F$Y$$$20240906$$MD$US$US
242947571$24294757$1$I$$20240903$20240906$20240906$PER$$US-SA-2024SA258660$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240907$$CN$US$US
242947581$24294758$1$I$$20240828$20240906$20240906$PER$$US-SA-2024SA258726$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240907$$MD$US$US
242947621$24294762$1$I$20240901$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002854$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240906$$CN$US$US
242947661$24294766$1$I$$20240904$20240906$20240906$EXP$$US-AMGEN-USASP2024177105$AMGEN$$$$$$Y$$$20240906$$MD$US$US
242947681$24294768$1$I$$20240823$20240906$20240906$PER$$US-SA-2024SA258062$SANOFI AVENTIS$$$$A$F$Y$$$20240907$$HP$US$US
242947691$24294769$1$I$20240903$20240904$20240906$20240906$PER$$US-ELI_LILLY_AND_COMPANY-US202409002932$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240906$$CN$US$US
242947721$24294772$1$I$$20240829$20240906$20240906$EXP$$US-APOTEX-2024AP010212$APOTEX$$$$E$M$Y$$$20240906$$MD$US$US
242947751$24294775$1$I$$20240826$20240906$20240906$EXP$$US-JNJFOC-20240876577$JOHNSON AND JOHNSON$$$$$$Y$$$20240907$$CN$US$US
242947761$24294776$1$I$$20240828$20240906$20240906$EXP$$IR-PRINSTON PHARMACEUTICAL INC.-2024PRN00330$PRINSTON PHARMACEUTICAL$Roshanzamiri S., Mousavizadeh S.A., Razazzadeh S., Ziaie S.. Acyclovir-induced psychiatric and renal adverse effects in a  diabetic patient: A case report. Clinical Case Reports. 2024;(12) 8$52$YR$$F$Y$$$20240906$$HP$IR$IR
242947792$24294779$2$F$$20240917$20240906$20240923$PER$$US-AMGEN-USASP2024174879$AMGEN$$$$$M$Y$$$20240922$$CN$US$US
242947801$24294780$1$I$$20240904$20240907$20240907$PER$$US-ELI_LILLY_AND_COMPANY-US202409002949$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240906$$CN$US$US
242947811$24294781$1$I$$20240904$20240907$20240907$PER$$US-ELI_LILLY_AND_COMPANY-US202409003827$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240906$$CN$US$US
242947841$24294784$1$I$$20240903$20240907$20240907$PER$$US-AMGEN-USASP2024176048$AMGEN$$$$$F$Y$$$20240906$$CN$US$US
242947861$24294786$1$I$20240828$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178095$AMGEN$$$$$$Y$$$20240906$$HP$US$US
242947881$24294788$1$I$20240714$20240829$20240907$20240907$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023028$UNITED THERAPEUTICS$$76$YR$$F$Y$53.515$KG$20240907$$$US$US
242947901$24294790$1$I$20240903$20240905$20240907$20240907$PER$$US-ELI_LILLY_AND_COMPANY-US202409003822$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240907$$CN$US$US
242947951$24294795$1$I$$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178633$AMGEN$$$$$$Y$$$20240906$$CN$US$US
242947961$24294796$1$I$20240822$20240827$20240907$20240907$EXP$$US-Accord-444111$ACCORD$$81$YR$E$F$Y$$$20240907$$HP$US$US
242947981$24294798$1$I$20220101$20240830$20240907$20240907$EXP$$IT-AMGEN-ITASP2024171760$AMGEN$$66$YR$E$F$Y$$$20240906$$CN$IT$IT
242947991$24294799$1$I$$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024177389$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242948012$24294801$2$F$20240826$20240912$20240907$20240925$EXP$$US-Accord-444097$ACCORD$$45$YR$A$M$Y$$$20240925$$HP$US$US
242948041$24294804$1$I$20240522$20240828$20240907$20240907$EXP$SE-SEMPA-2024-006161$SE-Accord-444595$ACCORD$$71$YR$E$M$Y$$$20240907$$MD$SE$SE
242948061$24294806$1$I$20240905$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178361$AMGEN$$67$YR$E$F$Y$$$20240906$$CN$US$US
242948111$24294811$1$I$20240905$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024177991$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242948121$24294812$1$I$$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178396$AMGEN$$$$$$Y$$$20240906$$HP$US$US
242948131$24294813$1$I$20240819$20240828$20240907$20240907$PER$$US-SA-2024SA254921$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240907$$PH$US$US
242948142$24294814$2$F$20240731$20240919$20240907$20240926$EXP$$NVSC2024US177509$NOVARTIS$$82$YR$$F$Y$$$20240926$$CN$US$US
242948151$24294815$1$I$$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178400$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242948171$24294817$1$I$20240612$20240828$20240907$20240907$EXP$DE-BFARM-24005820$DE-Accord-444448$ACCORD$$59$YR$A$M$Y$78$KG$20240907$$MD$DE$DE
242948181$24294818$1$I$20240503$20240904$20240907$20240907$EXP$$US-GSK-US2024110184$GLAXOSMITHKLINE$$$$$$Y$$$20240907$$CN$US$US
242948201$24294820$1$I$20240826$20240826$20240907$20240907$PER$$US-JNJFOC-20240903695$JOHNSON AND JOHNSON$$$$$F$Y$$$20240907$$CN$US$US
242948211$24294821$1$I$20240904$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024178171$AMGEN$$68$YR$E$M$Y$$$20240906$$CN$US$US
242948221$24294822$1$I$$20240828$20240907$20240907$EXP$FR-AFSSAPS-PB2024000897$FR-Accord-444486$ACCORD$$63$YR$A$M$Y$$$20240907$$PH$FR$FR
242948231$24294823$1$I$$20240830$20240907$20240907$PER$$US-JNJFOC-20240901051$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20240907$$MD$US$US
242948241$24294824$1$I$$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024178402$AMGEN$$$$$$Y$$$20240906$$PH$US$US
242948251$24294825$1$I$$20240902$20240907$20240907$PER$$US-JNJFOC-20240907267$JOHNSON AND JOHNSON$$$$$$Y$$$20240907$$CN$US$US
242948261$24294826$1$I$20240901$20240903$20240907$20240907$PER$$US-AMGEN-USASP2024175552$AMGEN$$71$YR$E$F$Y$$$20240907$$CN$US$US
242948271$24294827$1$I$$20240830$20240907$20240907$EXP$$US-AMGEN-USASP2024175118$AMGEN$Jaffe G.J.; Konda S.M..; Deaner J.D. et.al.. Primary vitreoretinal lymphoma masquerading as postoperative endophthalmitis in a pregnant patient with long-standing idiopathic panuveitis. Retinal Cases + Brief Reports. 2023;18 (4):468-472$37$YR$A$F$Y$$$20240907$$MD$US$US
242948281$24294828$1$I$$20240828$20240907$20240907$PER$$US-SA-2024SA257568$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240907$$CN$US$US
242948291$24294829$1$I$20230801$20240829$20240907$20240907$EXP$GB-MHRA-MED-202408291513231100-LJWGN$GB-TEVA-VS-3238862$TEVA$$$$$F$Y$$$20240907$$CN$GB$GB
242948301$24294830$1$I$20230501$20230919$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT00996$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948311$24294831$1$I$$20231005$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01077$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242948321$24294832$1$I$$20231012$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01124$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948331$24294833$1$I$20230901$20231018$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01019$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948341$24294834$1$I$$20231024$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01108$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948351$24294835$1$I$20230901$20231010$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT00998$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242948361$24294836$1$I$$20230921$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01013$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948371$24294837$1$I$20231002$20231030$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01076$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948381$24294838$1$I$20231003$20231017$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01071$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948391$24294839$1$I$20231007$20231107$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01131$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948401$24294840$1$I$$20231011$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01113$AIMMUNE$$$$$$Y$$$20240907$$MD$US$US
242948411$24294841$1$I$20230801$20231017$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01078$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948421$24294842$1$I$20230922$20230925$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01036$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948431$24294843$1$I$20230901$20230925$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01035$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948441$24294844$1$I$$20231011$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01033$AIMMUNE$$$$$$Y$$$20240907$$PH$US$US
242948451$24294845$1$I$20230928$20230929$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01054$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948461$24294846$1$I$$20240902$20240907$20240907$PER$$US-JNJFOC-20240903794$JOHNSON AND JOHNSON$$$$$M$Y$$$20240907$$CN$US$US
242948471$24294847$1$I$20231018$20231106$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01149$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948481$24294848$1$I$$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178412$AMGEN$$$$$$Y$$$20240907$$HP$US$US
242948491$24294849$1$I$20230901$20231102$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01143$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242948501$24294850$1$I$20210101$20231016$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01144$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948511$24294851$1$I$$20240103$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01366$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242948521$24294852$1$I$$20231127$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01248$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948531$24294853$1$I$20231016$20231017$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01142$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948541$24294854$1$I$20231108$20231110$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01245$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948551$24294855$1$I$$20231101$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01191$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948561$24294856$1$I$$20231208$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01382$AIMMUNE$$$$$$Y$$$20240907$$MD$US$US
242948571$24294857$1$I$$20231107$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01181$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948581$24294858$1$I$20231018$20231018$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01150$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948591$24294859$1$I$20230101$20231110$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01173$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948601$24294860$1$I$20230901$20231031$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01189$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948611$24294861$1$I$20230815$20231228$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01351$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948621$24294862$1$I$20231029$20231205$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01362$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948631$24294863$1$I$$20231206$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01369$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242948641$24294864$1$I$$20231218$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01381$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948651$24294865$1$I$20231001$20231204$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01324$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242948661$24294866$1$I$$20231209$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01393$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948671$24294867$1$I$$20231222$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01402$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948681$24294868$1$I$$20240108$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01464$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948691$24294869$1$I$20231221$20240122$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01445$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948701$24294870$1$I$20240101$20240117$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00076$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948711$24294871$1$I$20230101$20240301$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00214$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242948721$24294872$1$I$20230101$20231128$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01343$AIMMUNE$$$$$$Y$$$20240907$$MD$US$US
242948731$24294873$1$I$20231213$20240109$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01432$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948741$24294874$1$I$20231101$20240216$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00188$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948751$24294875$1$I$$20240108$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00035$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948761$24294876$1$I$$20240119$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00091$AIMMUNE$$$$$$Y$$$20240907$$MD$US$US
242948771$24294877$1$I$20231201$20240223$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00038$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242948781$24294878$1$I$20240212$20240212$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00232$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948791$24294879$1$I$$20240226$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00144$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948801$24294880$1$I$$20240205$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00109$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948811$24294881$1$I$$20240123$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00113$AIMMUNE$$$$$$Y$$$20240907$$MD$US$US
242948821$24294882$1$I$20240219$20240219$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00251$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948831$24294883$1$I$20231215$20231229$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT01469$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948841$24294884$1$I$20240129$20240216$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00175$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242948851$24294885$1$I$$20240206$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00116$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242948861$24294886$1$I$20231001$20240126$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00036$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242948871$24294887$1$I$20240201$20240221$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00273$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948881$24294888$1$I$20240101$20240209$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00220$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948891$24294889$1$I$$20240123$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00115$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948901$24294890$1$I$20240201$20240411$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00288$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948911$24294891$1$I$$20240227$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00290$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948921$24294892$1$I$20240407$20240408$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00652$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948931$24294893$1$I$20240324$20240430$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00568$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242948941$24294894$1$I$20240411$20240411$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00658$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948951$24294895$1$I$20231001$20240320$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00298$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948961$24294896$1$I$$20240405$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00645$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948971$24294897$1$I$$20240301$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00319$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948981$24294898$1$I$$20240312$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00411$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242948991$24294899$1$I$$20240429$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00632$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242949001$24294900$1$I$20240214$20240412$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00608$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949011$24294901$1$I$20240301$20240321$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00523$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949021$24294902$1$I$20240301$20240508$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00679$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242949031$24294903$1$I$$20240307$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00384$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949041$24294904$1$I$20240422$20240606$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00741$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949051$24294905$1$I$20240401$20240506$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00764$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949061$24294906$1$I$20240320$20240424$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00715$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949071$24294907$1$I$$20240502$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00743$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242949081$24294908$1$I$$20240430$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00664$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949091$24294909$1$I$$20240430$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00667$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949101$24294910$1$I$$20240429$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00733$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949111$24294911$1$I$$20240417$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00699$AIMMUNE$$$$$$Y$$$20240907$$MD$US$US
242949121$24294912$1$I$$20240507$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00775$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949131$24294913$1$I$$20240618$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00876$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949141$24294914$1$I$$20240509$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00787$AIMMUNE$$$$$$Y$$$20240907$$PH$US$US
242949151$24294915$1$I$20240427$20240610$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00792$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242949161$24294916$1$I$20240214$20240513$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00803$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949171$24294917$1$I$$20240605$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00919$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949181$24294918$1$I$20240528$20240619$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00881$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242949191$24294919$1$I$$20231010$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT00902$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242949201$24294920$1$I$20240401$20240521$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00850$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949211$24294921$1$I$20230101$20230830$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT00904$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949221$24294922$1$I$20230101$20230921$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT00937$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949231$24294923$1$I$$20230911$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT00958$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949241$24294924$1$I$20230830$20230830$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT00900$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949251$24294925$1$I$$20230918$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT00908$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949261$24294926$1$I$$20230914$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT00895$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949271$24294927$1$I$$20230829$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2023AIMT00894$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949281$24294928$1$I$20110111$20240806$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2022AIMT01423$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242949301$24294930$1$I$$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024177496$AMGEN$$$$$$Y$$$20240907$$PH$US$US
242949311$24294931$1$I$20230601$20240904$20240907$20240907$EXP$$US-AMGEN-USASP2024176994$AMGEN$$78$YR$E$F$Y$$$20240907$$MD$US$US
242949321$24294932$1$I$20240801$20240823$20240907$20240907$PER$$US-SA-2024SA255955$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240907$$MD$US$US
242949331$24294933$1$I$20240815$20240905$20240907$20240907$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014414$JAZZ$$41$YR$$F$Y$$$20240907$$CN$US$US
242949341$24294934$1$I$$20240808$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01220$AIMMUNE$$$$$$Y$$$20240907$$PH$US$US
242949351$24294935$1$I$$20240806$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01209$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242949361$24294936$1$I$20240715$20240808$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01115$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242949371$24294937$1$I$20240715$20240729$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01170$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949381$24294938$1$I$$20240628$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01036$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949391$24294939$1$I$20240718$20240719$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01136$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949401$24294940$1$I$$20240717$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01128$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242949411$24294941$1$I$$20240711$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00951$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949421$24294942$1$I$$20240708$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01073$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949431$24294943$1$I$20240617$20240710$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00978$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242949441$24294944$1$I$$20240618$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00982$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949451$24294945$1$I$$20240801$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01070$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949461$24294946$1$I$$20240716$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01108$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949471$24294947$1$I$20240517$20240606$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00929$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949481$24294948$1$I$20240101$20240708$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01079$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949491$24294949$1$I$$20240729$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01168$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949501$24294950$1$I$20240702$20240702$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01056$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949511$24294951$1$I$$20240808$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01100$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949521$24294952$1$I$$20240724$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01047$AIMMUNE$$$$$$Y$$$20240907$$MD$US$US
242949531$24294953$1$I$20240618$20240619$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00986$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949541$24294954$1$I$$20240807$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01223$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949551$24294955$1$I$$20240612$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT00960$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949561$24294956$1$I$$20240812$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01240$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949571$24294957$1$I$$20240828$20240907$20240907$EXP$$RO-CELLTRION INC.-2024RO021411$CELLTRION$$$$$$Y$$$20240907$$MD$RO$RO
242949581$24294958$1$I$20240101$20240820$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01272$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949591$24294959$1$I$20240101$20240821$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01281$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949601$24294960$1$I$$20240822$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01280$AIMMUNE$$$$$$Y$$$20240907$$HP$US$US
242949611$24294961$1$I$$20240823$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01296$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949621$24294962$1$I$20240101$20240822$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01288$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949631$24294963$1$I$20240101$20240812$20240907$20240907$PER$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01243$AIMMUNE$$$$$$Y$$$20240907$$CN$US$US
242949641$24294964$1$I$$20240828$20240907$20240907$EXP$$GB-TEVA-VS-3238566$TEVA$$58$YR$$M$Y$104$KG$20240907$$MD$GB$GB
242949651$24294965$1$I$20240101$20240822$20240907$20240907$EXP$$CA-CELLTRION INC.-2024CA020766$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
242949661$24294966$1$I$20240701$20240823$20240907$20240907$PER$$US-SA-2024SA257147$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240907$$HP$US$US
242949671$24294967$1$I$$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024177379$AMGEN$$$$$$Y$$$20240907$$PH$US$US
242949682$24294968$2$F$20240101$20240903$20240907$20240912$PER$$US-SA-2024SA258717$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240912$$MD$US$US
242949692$24294969$2$F$20221201$20240902$20240907$20240911$EXP$$DE-CELLTRION INC.-2024DE021413$CELLTRION$$$$$$Y$$$20240911$$MD$DE$DE
242949701$24294970$1$I$$20240828$20240907$20240907$EXP$$US-GSK-US2024107240$GLAXOSMITHKLINE$$$$$M$Y$$$20240907$$MD$US$US
242949711$24294971$1$I$20240101$20240903$20240907$20240907$EXP$$IE-AMGEN-IRLSP2024176576$AMGEN$$$$$F$Y$$$20240907$$CN$IE$IE
242949721$24294972$1$I$$20240822$20240907$20240907$PER$$US-SA-2024SA256578$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240907$$CN$US$US
242949731$24294973$1$I$$20240827$20240907$20240907$PER$$US-SA-2024SA258605$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240907$$MD$US$US
242949741$24294974$1$I$20240101$20240903$20240907$20240907$EXP$$PL-AMGEN-POLSP2024176467$AMGEN$$$$$$Y$$$20240907$$HP$PL$PL
242949751$24294975$1$I$$20240902$20240907$20240907$EXP$$FR-AstraZeneca-2024A199817$ASTRAZENECA$Zullo L., Castanet E., Maaradji Z., Ghigna M.R., Bonhomme B., Alam? M., Besse B., Cousin S., Aldea M.. Disease Course and Treatment Outcomes in Patients With De Novo Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 20 Insertion: Two Case Reports. JCO Precision Oncology 2024;8:$61$YR$$F$Y$$$20240907$$MD$FR$
242949761$24294976$1$I$$20240901$20240907$20240907$EXP$$US-AMGEN-USASP2024176001$AMGEN$Hameed M.; Garcia G.; Apugliese A. et al.. A Rare Case of Rapid Onset Fatal HLH Secondary to Large Granular T-cell Lymphocytic Leukemia. Clinical Lymphoma, Myeloma + Leukemia. 2024;24:S526- S527$66$YR$E$M$Y$$$20240907$$MD$US$US
242949771$24294977$1$I$$20240830$20240907$20240907$EXP$$FR-AMGEN-FRASP2024175293$AMGEN$Legoff J.. Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant. International Journal of Antimicrobial Agents. 2024;64 (3):1-7$37$YR$A$F$Y$$$20240907$$HP$FR$FR
242949781$24294978$1$I$20240827$20240902$20240907$20240907$EXP$$NVSC2024EG178842$NOVARTIS$$68$YR$$F$Y$112$KG$20240907$$PH$EG$EG
242949791$24294979$1$I$$20240828$20240907$20240907$EXP$$US-JNJFOC-20240879401$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240907$$HP$US$US
242949811$24294981$1$I$20240817$20240901$20240907$20240907$PER$$US-AMGEN-USASP2024176088$AMGEN$$75$YR$E$F$Y$$$20240907$$CN$US$US
242949821$24294982$1$I$20240821$20240829$20240907$20240907$EXP$$GB-TEVA-VS-3238558$TEVA$$60$YR$$M$Y$94$KG$20240907$$MD$GB$GB
242949831$24294983$1$I$$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178360$AMGEN$$$$$$Y$$$20240907$$PH$US$US
242949841$24294984$1$I$20240101$20240826$20240907$20240907$PER$$US-SA-2024SA258636$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240907$$MD$US$US
242949851$24294985$1$I$20240902$20240903$20240907$20240907$PER$$US-AMGEN-USASP2024175707$AMGEN$$52$YR$A$F$Y$$$20240907$$CN$US$US
242949861$24294986$1$I$$20240828$20240907$20240907$EXP$GB-MHRA-MED-202408280906441100-ZYGRK$GB-TEVA-VS-3238407$TEVA$$$$$M$Y$$$20240907$$PH$GB$GB
242949871$24294987$1$I$$20240903$20240907$20240907$PER$$US-AMGEN-USASP2024176182$AMGEN$$$$$$Y$$$20240907$$CN$US$US
242949881$24294988$1$I$$20240828$20240907$20240907$30DAY$$US-GSK-US2024AMR109930$GLAXOSMITHKLINE$$25$YR$$F$Y$$$20240907$$HP$US$US
242949901$24294990$1$I$$20240826$20240907$20240907$EXP$$US-AUROBINDO-AUR-APL-2024-042894$AUROBINDO$Brakenhoff SM, Chi H, Friederich P, Doukas M, Den Hoed C, Flink HJ, et al. A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report.. Case-Rep-Gastroenterol. 2024;18(1):252-259$64$YR$$M$Y$$$20240907$$HP$US$NL
242949911$24294991$1$I$$20240826$20240907$20240907$EXP$$US-AUROBINDO-AUR-APL-2024-042759$AUROBINDO$Shariff H, Luu T, Kavis H, Obuch J. Gastric Signet Ring Cell Adenocarcinoma with Metastasis to the Testicles and Leptomeninges. ACG-Case-Rep-J. 2024;11No. 8$38$YR$$M$Y$$$20240907$$MD$US$US
242949921$24294992$1$I$$20240905$20240907$20240907$PER$$US-ELI_LILLY_AND_COMPANY-US202409003508$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240907$$CN$US$US
242949931$24294993$1$I$20240828$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178445$AMGEN$$68$YR$E$F$Y$$$20240907$$CN$US$US
242949941$24294994$1$I$$20240826$20240907$20240907$EXP$$US-AUROBINDO-AUR-APL-2024-044308$AUROBINDO$Winston DJ, Young PA, Schlamm HT, Schiller GJ. Fosmanogepix Therapy of Disseminated Fusarium Infection. Clin-Infect-Dis. 2023;77:848-850$26$YR$$F$Y$$$20240907$$HP$US$US
242949951$24294995$1$I$$20240827$20240907$20240907$EXP$$US-TAKEDA-2024TUS087376$TAKEDA$$$$$M$Y$$$20240907$$MD$US$US
242949961$24294996$1$I$$20240826$20240907$20240907$EXP$$US-AUROBINDO-AUR-APL-2024-042837$AUROBINDO$Peshin S, Modi SK, Burwick N. Lenalidomide and Dexamethasone in Scleromyxedema: A Case Report of Long-Term Efficacy and Challenges in a 54-Year-Old Patient. Cureus. 2024;16 (6):e63181$54$YR$$M$Y$$$20240907$$MD$US$US
242949971$24294997$1$I$$20240905$20240907$20240907$EXP$$CN-TAKEDA-2024TUS089062$TAKEDA$$$$$F$Y$$$20240907$$CN$CN$CN
242949981$24294998$1$I$$20240826$20240907$20240907$EXP$$US-AUROBINDO-AUR-APL-2024-043194$AUROBINDO$Winston DJ, Young PA, Schlamm HT, Schiller GJ. Fosmanogepix Therapy of Disseminated Fusarium Infection. Clin-Infect-Dis. 2023;77:848-850$26$YR$$F$Y$$$20240907$$HP$US$US
242949992$24294999$2$F$20180713$20240830$20240907$20240911$EXP$$CA-CELLTRION INC.-2021CA010931$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
242950002$24295000$2$F$$20240826$20240907$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-042742$AUROBINDO$Peshin S, Modi SK, Burwick N. Lenalidomide and Dexamethasone in Scleromyxedema: A Case Report of Long-Term Efficacy and Challenges in a 54-Year-Old Patient. Cureus. 2024;16(6):e63181$54$YR$$M$Y$$$20240909$$MD$US$US
242950012$24295001$2$F$20240808$20240903$20240907$20240912$EXP$$US-TEVA-VS-3239900$TEVA$$23$YR$$F$Y$$$20240912$$HP$US$US
242950021$24295002$1$I$20240801$20240829$20240907$20240907$EXP$$CA-CELLTRION INC.-2024CA021374$CELLTRION$$$$$$Y$$$20240907$$CN$CA$CA
242950032$24295003$2$F$20230108$20240830$20240907$20240910$EXP$FR-AFSSAPS-LL2023000462$FR-CELLTRION INC.-2024FR021431$CELLTRION$$$$$$Y$$$20240910$$MD$FR$FR
242950041$24295004$1$I$20240710$20240829$20240907$20240907$EXP$$CA-CELLTRION INC.-2024CA021375$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
242950052$24295005$2$F$20240101$20240828$20240907$20240909$EXP$$SK-AUROBINDO-AUR-APL-2024-043216$AUROBINDO$$68$YR$$F$Y$$$20240909$$MD$SK$SK
242950064$24295006$4$F$20240301$20240920$20240907$20240930$EXP$$DE-AUROBINDO-AUR-APL-2024-043634$AUROBINDO$$$$E$F$Y$60$KG$20240930$$HP$DE$DE
242950072$24295007$2$F$$20240828$20240907$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043532$AUROBINDO$$$$$M$Y$$$20240909$$PH$GB$GB
242950081$24295008$1$I$20240809$20240828$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043514$AUROBINDO$$76$YR$$F$Y$69$KG$20240907$$HP$GB$GB
242950091$24295009$1$I$$20240904$20240907$20240907$PER$$US-ELI_LILLY_AND_COMPANY-US202409002696$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240907$$CN$US$US
242950101$24295010$1$I$20240404$20240828$20240907$20240907$EXP$$IT-AUROBINDO-AUR-APL-2024-043593$AUROBINDO$$49$YR$$F$Y$$$20240907$$PH$IT$IT
242950111$24295011$1$I$$20240828$20240907$20240907$EXP$$ES-AUROBINDO-AUR-APL-2024-043660$AUROBINDO$Elena Ca?adillas S?nchez. S?ndrome Rhupus: a prop?sito deun caso. Revista Electr?nica de PortalesMedicos.com. 2024;14:476$78$YR$$M$Y$$$20240907$$MD$ES$ES
242950121$24295012$1$I$20240810$20240830$20240907$20240907$PER$$US-AMGEN-USASP2024174434$AMGEN$$56$YR$A$F$Y$$$20240907$$HP$US$US
242950131$24295013$1$I$20240101$20240829$20240907$20240907$EXP$$AU-CELLTRION INC.-2022AU009159$CELLTRION$$$$$$Y$$$20240907$$MD$AU$AU
242950141$24295014$1$I$20240101$20240830$20240907$20240907$PER$$US-SA-2024SA255789$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240907$$HP$US$US
242950151$24295015$1$I$20240903$20240903$20240907$20240907$PER$$US-AMGEN-USASP2024175768$AMGEN$$70$YR$E$F$Y$$$20240907$$CN$US$US
242950161$24295016$1$I$20240811$20240830$20240907$20240907$PER$$US-SA-2024SA255837$SANOFI AVENTIS$$49$YR$A$F$Y$54.55$KG$20240907$$MD$US$US
242950171$24295017$1$I$$20240828$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043483$AUROBINDO$$$$$$Y$$$20240907$$CN$GB$GB
242950182$24295018$2$F$20240808$20240919$20240907$20240926$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-17522$IPSEN$$90$YR$E$M$Y$$$20240926$$PH$JP$JP
242950191$24295019$1$I$$20240823$20240907$20240907$PER$$US-SA-2024SA149348$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240907$$HP$US$US
242950201$24295020$1$I$20240527$20240829$20240907$20240907$EXP$$SE-TEVA-VS-3238414$TEVA$$81$YR$$F$Y$$$20240907$$LW$SE$SE
242950211$24295021$1$I$20240830$20240830$20240907$20240907$EXP$GB-MHRA-MED-202408301731141620-JHKQN$GB-TEVA-VS-3239125$TEVA$$$$$M$Y$$$20240907$$HP$GB$GB
242950221$24295022$1$I$20240101$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178543$AMGEN$$$$$$Y$$$20240907$$CN$US$US
242950231$24295023$1$I$$20240828$20240907$20240907$PER$$US-UNITED THERAPEUTICS-UNT-2024-027972$UNITED THERAPEUTICS$$$$$F$Y$$$20240907$$$US$US
242950241$24295024$1$I$20240809$20240829$20240907$20240907$EXP$$GB-TEVA-VS-3238821$TEVA$$76$YR$$F$Y$69$KG$20240907$$HP$GB$GB
242950251$24295025$1$I$20240819$20240903$20240907$20240907$EXP$$NVSC2024BR178902$NOVARTIS$$1$YR$$M$Y$$$20240907$$CN$BR$BR
242950261$24295026$1$I$$20240903$20240907$20240907$PER$$US-ELI_LILLY_AND_COMPANY-US202409002776$ELI LILLY AND CO$$$$$F$Y$$$20240907$$PH$US$US
242950271$24295027$1$I$20230101$20240829$20240907$20240907$EXP$$CA-CELLTRION INC.-2023CA023534$CELLTRION$$$$$$Y$$$20240907$$HP$CA$CA
242950281$24295028$1$I$20240823$20240830$20240907$20240907$EXP$GB-MHRA-MED-202408291934575550-LZCSB$GB-TEVA-VS-3238947$TEVA$$79$YR$$F$Y$68$KG$20240907$$CN$GB$GB
242950291$24295029$1$I$20240826$20240827$20240907$20240907$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17190$IPSEN$$52$YR$A$F$Y$$$20240907$$HP$US$US
242950302$24295030$2$F$20240701$20240823$20240907$20240916$PER$$US-SA-2024SA256821$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240916$$MD$US$US
242950311$24295031$1$I$$20240903$20240907$20240907$PER$$US-SA-2024SA258416$SANOFI AVENTIS$$$$$F$Y$$$20240907$$HP$US$US
242950321$24295032$1$I$20240101$20240825$20240907$20240907$PER$$US-SA-2024SA255453$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240907$$MD$US$US
242950332$24295033$2$F$20240101$20240916$20240907$20240924$EXP$$CA-CELLTRION INC.-2024CA021331$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
242950341$24295034$1$I$20230130$20240829$20240907$20240907$EXP$GB-MHRA-MED-202408291534428000-HKRZW$GB-CELLTRION INC.-2024GB020973$CELLTRION$$$$$$Y$$$20240907$$HP$GB$GB
242950351$24295035$1$I$20240905$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178206$AMGEN$$73$YR$E$$Y$$$20240907$$CN$US$US
242950371$24295037$1$I$$20240902$20240907$20240907$EXP$$GB-JNJFOC-20240915622$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240907$$CN$GB$GB
242950381$24295038$1$I$$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024177458$AMGEN$$$$$$Y$$$20240907$$CN$US$US
242950391$24295039$1$I$20240828$20240828$20240907$20240907$30DAY$$US-GSK-US2024107289$GLAXOSMITHKLINE$$30$YR$$F$Y$$$20240907$$CN$US$US
242950401$24295040$1$I$$20240829$20240907$20240907$30DAY$$US-GSK-US2024107713$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$HP$US$US
242950412$24295041$2$F$$20240919$20240907$20240919$PER$$NVSC2024US179576$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
242950421$24295042$1$I$20240101$20240830$20240907$20240907$EXP$$ZA-JNJFOC-20240901604$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240907$$MD$ZA$ZA
242950431$24295043$1$I$$20240828$20240907$20240907$30DAY$$US-GSK-US2024107109$GLAXOSMITHKLINE$$$$$M$Y$$$20240907$$CN$US$US
242950442$24295044$2$F$$20240828$20240907$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-041555$AUROBINDO$$$$$$Y$$$20240909$$CN$CA$CA
242950451$24295045$1$I$$20240828$20240907$20240907$EXP$$GB-TEVA-VS-3238498$TEVA$$68$YR$$M$Y$74$KG$20240907$$MD$GB$GB
242950461$24295046$1$I$$20240903$20240907$20240907$EXP$$US-AMGEN-USASP2024175803$AMGEN$$$$$F$Y$$$20240907$$CN$US$US
242950471$24295047$1$I$$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024177156$AMGEN$$$$$$Y$$$20240907$$CN$US$US
242950481$24295048$1$I$20240828$20240829$20240907$20240907$EXP$GB-MHRA-MED-202408291147217460-PFQYV$GB-TEVA-VS-3238602$TEVA$$80$YR$$M$Y$$$20240907$$PH$GB$GB
242950501$24295050$1$I$20240904$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178080$AMGEN$$57$YR$A$F$Y$$$20240907$$CN$US$US
242950511$24295051$1$I$$20240823$20240907$20240907$PER$$US-SA-2024SA257148$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240907$$MD$US$US
242950531$24295053$1$I$$20240828$20240907$20240907$30DAY$$US-GSK-US2024107313$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$CN$US$US
242950541$24295054$1$I$20240701$20240824$20240907$20240907$PER$$US-SA-2024SA256661$SANOFI AVENTIS$$$$A$F$Y$$$20240907$$HP$US$US
242950551$24295055$1$I$20240101$20240823$20240907$20240907$PER$$US-SA-2024SA258652$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240907$$HP$US$US
242950561$24295056$1$I$20230101$20240826$20240907$20240907$EXP$$IT-AUROBINDO-AUR-APL-2024-040991$AUROBINDO$Cosi DM, Fragale C, Magri C, Carnevale A, Ciancetta A, Bronte G, et al. Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report. International Journal of Molecular Sciences. 2024;25(14):7508$81$YR$$M$Y$$$20240907$$MD$IT$IT
242950571$24295057$1$I$$20240826$20240907$20240907$EXP$$PT-AUROBINDO-AUR-APL-2024-042803$AUROBINDO$Dias MP, Veloso MF, Oliveira ASN, Lemos J. Managing urachal sinus in older age. Atencio?n Primaria Pra?ctica (Practical Primary Care). 2024;6(3):1-3$70$YR$$M$Y$$$20240907$$HP$PT$PT
242950581$24295058$1$I$$20240826$20240907$20240907$EXP$$US-AUROBINDO-AUR-APL-2024-044301$AUROBINDO$Hakim FA, Shaikh M, Golzarian H. Wide QRS tachycardia in a patient with atrial fibrillation: A case report and approach to diagnosis. Eur-Heart-J-Case-Rep. 2024;8No. 8:ytae328$87$YR$$M$Y$$$20240907$$HP$US$US
242950591$24295059$1$I$$20240826$20240907$20240907$EXP$$FR-AUROBINDO-AUR-APL-2024-043318$AUROBINDO$Schwarz C, Morel A, Matignon M, Grimbert P, Rondeau E, Ouali N, et al.. Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept.. Kidney-Int-Rep. 2023;8(8):1531-1541$46$YR$$$Y$$$20240907$$HP$FR$FR
242950601$24295060$1$I$$20240826$20240907$20240907$EXP$$US-AUROBINDO-AUR-APL-2024-044274$AUROBINDO$Maresch KJ. Arytenoid Dislocation and Vocal Cord Immobility After Emergent Fiberoptic Intubation: A Case Report.. AANA-J. 2020;88(6):459-463$53$YR$$M$Y$$$20240907$$HP$US$US
242950612$24295061$2$F$$20240910$20240907$20240913$EXP$$DE-AUROBINDO-AUR-APL-2024-043456$AUROBINDO$Obermaier B, Braun C, Hensen L, Ahmad O, Faul C, Lang P et al.. Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience.. Transpl Infect Dis.. 2024;26(4):14296$56$YR$$$Y$$$20240913$$MD$DE$DE
242950621$24295062$1$I$$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178501$AMGEN$$$$$$Y$$$20240907$$PH$US$US
242950632$24295063$2$F$20230501$20240907$20240907$20240919$EXP$$PL-AUROBINDO-AUR-APL-2024-044228$AUROBINDO$Kwinta ?. Long-term response to pembrolizumab-based  immunochemotherapy in patient diagnosed with  metastatic lung adenocarcinoma with PD-L1 expression  less than 1%.. ONKOLOGIA W PRAKTYCE KLINICZNEJ - EDUKACJA(ONCOLOGY IN CLINICAL PRACTICE - EDUCA. 2024;10(Supl. C):C59-C61$67$YR$$F$Y$$$20240919$$HP$PL$PL
242950641$24295064$1$I$$20240830$20240907$20240907$EXP$$US-JNJFOC-20240902787$JOHNSON AND JOHNSON$$$$$$Y$$$20240907$$HP$US$US
242950651$24295065$1$I$$20240829$20240907$20240907$EXP$$US-JNJFOC-20240908003$JOHNSON AND JOHNSON$$$$$$Y$$$20240907$$MD$US$US
242950661$24295066$1$I$20230403$20240829$20240907$20240907$EXP$$SE-CELLTRION INC.-2023SE014975$CELLTRION$$$$$$Y$$$20240907$$CN$SE$SE
242950671$24295067$1$I$$20240827$20240907$20240907$EXP$$US-AUROBINDO-AUR-APL-2024-042959$AUROBINDO$Rink DE, Abramson RH, Johnson NJ, Lee RY. Diagnostic Confounders in Brain Death A Woman with Unexplained Coma and Brainstem Areflexia. Annals of the American Thoracic Society. 2024;21(8):1204-8$60$YR$$F$Y$$$20240907$$MD$US$US
242950681$24295068$1$I$$20240829$20240907$20240907$EXP$$CA-AUROBINDO-AUR-APL-2024-043974$AUROBINDO$$56$YR$$F$Y$88.435$KG$20240907$$CN$CA$CA
242950691$24295069$1$I$$20240827$20240907$20240907$EXP$$US-AUROBINDO-AUR-APL-2024-042963$AUROBINDO$Rink DE, Abramson RH, Johnson NJ, Lee RY. Diagnostic Confounders in Brain Death A Woman with Unexplained Coma and Brainstem Areflexia. Annals of the American Thoracic Society. 2024;21(8):1204-8$60$YR$$F$Y$$$20240907$$MD$US$US
242950701$24295070$1$I$20240818$20240828$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043521$AUROBINDO$$70$YR$$M$Y$$$20240907$$HP$GB$GB
242950711$24295071$1$I$$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178517$AMGEN$$$$$$Y$$$20240907$$PH$US$US
242950721$24295072$1$I$$20240828$20240907$20240907$EXP$$PL-AUROBINDO-AUR-APL-2024-043562$AUROBINDO$$18$YR$$F$Y$100$KG$20240907$$MD$PL$PL
242950731$24295073$1$I$$20240828$20240907$20240907$EXP$$CA-AUROBINDO-AUR-APL-2023-061975$AUROBINDO$Youssef D, Richards S, Sheppard C, Hornberger L, Pietrosanu M, Bates A.. Preteen with Prenatal Agenesis of the Ductus Venosus Presenting with a Portosystemic Shunt and Severe Delayed-Onset Pulmonary Arterial Hypertension: A Rare Case Report.. The Journal of Heart and Lung Transplantation,. 2023;42 (Suppl.)(4S):S490$10$YR$$F$Y$$$20240907$$HP$CA$CA
242950742$24295074$2$F$$20240913$20240907$20240925$EXP$$ES-AUROBINDO-AUR-APL-2024-039335$AUROBINDO$Mestres CC. Mejora de la adherencia y estado de salud de una paciente joven con pluripatolog?a mediante el servicio de seguimiento con SPD en farmacia comunitaria.. Farm Comunitarios.. 2024;16(3):43-48$36$YR$$F$Y$83.3$KG$20240925$$PH$ES$ES
242950751$24295075$1$I$$20240829$20240907$20240907$EXP$$US-TEVA-VS-3238900$TEVA$$52$YR$$F$Y$$$20240907$$CN$US$US
242950761$24295076$1$I$$20240828$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043516$AUROBINDO$$72$YR$$F$Y$$$20240907$$MD$GB$GB
242950771$24295077$1$I$20240731$20240828$20240907$20240907$EXP$$FR-AUROBINDO-AUR-APL-2024-043474$AUROBINDO$$23$YR$$M$Y$$$20240907$$CN$FR$FR
242950781$24295078$1$I$20240314$20240829$20240907$20240907$EXP$$ES-AUROBINDO-AUR-APL-2024-043960$AUROBINDO$$61$YR$$F$Y$67$KG$20240907$$MD$ES$ES
242950791$24295079$1$I$$20240829$20240907$20240907$EXP$$US-JNJFOC-20240908048$JOHNSON AND JOHNSON$$$$$$Y$$$20240907$$MD$US$US
242950801$24295080$1$I$20240715$20240828$20240907$20240907$EXP$$FR-AUROBINDO-AUR-APL-2024-043551$AUROBINDO$$21$YR$$F$Y$$$20240907$$MD$FR$FR
242950811$24295081$1$I$20240101$20240903$20240907$20240907$EXP$$CA-JNJFOC-20231245602$JOHNSON AND JOHNSON$$81$YR$E$M$Y$59$KG$20240907$$HP$CA$CA
242950821$24295082$1$I$$20240828$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043465$AUROBINDO$$$$$M$Y$$$20240907$$CN$GB$GB
242950831$24295083$1$I$$20240828$20240907$20240907$EXP$$PL-AUROBINDO-AUR-APL-2024-043579$AUROBINDO$$59$YR$$F$Y$$$20240907$$MD$PL$PL
242950841$24295084$1$I$$20240903$20240907$20240907$EXP$$IN-AstraZeneca-2024A200720$ASTRAZENECA$Ghosh, A.; Bhattacharyya, S.. Dapagliflozin- Induced Cutaneous Vasculitis, a Hitherto Unreported Adverse Effect. Indian Journal of Dermatology 2024;69(4):355-357.$69$YR$$M$Y$$$20240907$$MD$IN$
242950851$24295085$1$I$20200901$20240828$20240907$20240907$EXP$$PL-AUROBINDO-AUR-APL-2024-043472$AUROBINDO$$31$YR$$M$Y$94$KG$20240907$$HP$PL$PL
242950861$24295086$1$I$20240831$20240831$20240907$20240907$EXP$GB-MHRA-MED-202408311227243100-VLNGH$GB-TEVA-VS-3239124$TEVA$$40$YR$$M$Y$82$KG$20240907$$MD$GB$GB
242950871$24295087$1$I$20240830$20240902$20240907$20240907$EXP$$GB-TEVA-VS-3239920$TEVA$$31$YR$$M$Y$68$KG$20240907$$MD$GB$GB
242950881$24295088$1$I$20240101$20240823$20240907$20240907$PER$$US-SA-2024SA257956$SANOFI AVENTIS$$$$$F$Y$$$20240907$$CN$US$US
242950891$24295089$1$I$20240824$20240828$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043537$AUROBINDO$$56$YR$$F$Y$81$KG$20240907$$MD$GB$GB
242950901$24295090$1$I$20230715$20240829$20240907$20240907$EXP$$CN-TAKEDA-2024TUS087732$TAKEDA$$56$YR$$F$Y$42$KG$20240907$$MD$CN$CN
242950912$24295091$2$F$20240801$20240903$20240907$20240909$EXP$$US-AMGEN-USASP2024175914$AMGEN$$27$YR$A$M$Y$$$20240909$$MD$US$US
242950921$24295092$1$I$20240825$20240829$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043597$AUROBINDO$$67$YR$$F$Y$$$20240907$$HP$GB$GB
242950931$24295093$1$I$$20240829$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043578$AUROBINDO$$76$YR$$F$Y$76$KG$20240907$$CN$GB$GB
242950942$24295094$2$F$20240505$20240906$20240907$20240916$EXP$$BR-CELLTRION INC.-2024BR020986$CELLTRION$$$$$$Y$$$20240916$$CN$BR$BR
242950955$24295095$5$F$$20240923$20240907$20240927$EXP$$PL-AUROBINDO-AUR-APL-2024-043901$AUROBINDO$Mo?d?e? K. Stan padaczkowy u pacjentek w ci??y ? opis dw?ch przypadk?w i przegl?d literatury (Status epilepticus in pregnant patients - a report of two cases and a review of the literature). POLSKI PRZEGL?D NEUROLOGICZNY (Polish Neurological Review). 2024;115-128:1734-5251$34$YR$$F$Y$$$20240927$$MD$PL$PL
242950961$24295096$1$I$20240807$20240828$20240907$20240907$EXP$$IT-AUROBINDO-AUR-APL-2024-043571$AUROBINDO$$$$A$M$Y$$$20240907$$MD$IT$IT
242950971$24295097$1$I$$20240828$20240907$20240907$EXP$$IT-AUROBINDO-AUR-APL-2024-043734$AUROBINDO$Esposito P, Cappadona F, Sangregorio F, Costa E, Mallia L, Zanetti V et al. Combined extracorporeal CO2 removal and renal replacement therapy in a pregnant patient with COVID-19: a case report. Giornale Italiano di Nefrologia (Italian Journal of Nephrology). 2023;40(2)$$$N$F$Y$0.8$KG$20240907$$MD$IT$IT
242950981$24295098$1$I$20240729$20240828$20240907$20240907$EXP$$FR-AUROBINDO-AUR-APL-2024-043528$AUROBINDO$$46$YR$$M$Y$$$20240907$$MD$FR$FR
242950991$24295099$1$I$20240904$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024177278$AMGEN$$68$YR$E$F$Y$$$20240907$$CN$US$US
242951001$24295100$1$I$$20240829$20240907$20240907$EXP$$CA-AUROBINDO-AUR-APL-2024-043910$AUROBINDO$$14$YR$$M$Y$48$KG$20240907$$MD$CA$CA
242951011$24295101$1$I$20220101$20240828$20240907$20240907$EXP$$CA-CELLTRION INC.-2022CA021869$CELLTRION$$$$$$Y$$$20240907$$MD$CA$CA
242951021$24295102$1$I$20240712$20240829$20240907$20240907$EXP$$DE-AUROBINDO-AUR-APL-2024-043777$AUROBINDO$$$$E$M$Y$56.6$KG$20240907$$MD$DE$DE
242951031$24295103$1$I$$20240829$20240907$20240907$EXP$$CA-AUROBINDO-AUR-APL-2024-043976$AUROBINDO$$66$YR$$F$Y$88$KG$20240907$$HP$CA$CA
242951041$24295104$1$I$20240829$20240829$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043724$AUROBINDO$$45$YR$$F$Y$$$20240907$$MD$GB$GB
242951051$24295105$1$I$20240101$20240829$20240907$20240907$EXP$$US-TEVA-VS-3239257$TEVA$$68$YR$$M$Y$$$20240907$$CN$US$US
242951061$24295106$1$I$20240101$20240829$20240907$20240907$EXP$$SE-AUROBINDO-AUR-APL-2024-043808$AUROBINDO$$62$YR$$M$Y$$$20240907$$MD$SE$SE
242951071$24295107$1$I$$20240829$20240907$20240907$EXP$$CA-AUROBINDO-AUR-APL-2024-044232$AUROBINDO$$42$YR$$F$Y$$$20240907$$MD$CA$CA
242951081$24295108$1$I$$20240829$20240907$20240907$EXP$$CA-AUROBINDO-AUR-APL-2024-044199$AUROBINDO$$$$$M$Y$$$20240907$$HP$CA$CA
242951091$24295109$1$I$20240314$20240829$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043608$AUROBINDO$$45$YR$$M$Y$79$KG$20240907$$CN$GB$GB
242951101$24295110$1$I$20240821$20240829$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043546$AUROBINDO$$60$YR$$M$Y$94$KG$20240907$$MD$GB$GB
242951111$24295111$1$I$$20240829$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043586$AUROBINDO$$26$YR$$F$Y$57$KG$20240907$$CN$GB$GB
242951121$24295112$1$I$20240812$20240829$20240907$20240907$EXP$$FR-AUROBINDO-AUR-APL-2024-043453$AUROBINDO$$77$YR$$M$Y$92$KG$20240907$$MD$FR$FR
242951131$24295113$1$I$$20240826$20240907$20240907$PER$$US-SA-2024SA257412$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240907$$HP$US$US
242951141$24295114$1$I$$20240903$20240907$20240907$PER$$US-SA-2024SA258675$SANOFI AVENTIS$$$$A$F$Y$$$20240907$$HP$US$US
242951151$24295115$1$I$20240828$20240829$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043599$AUROBINDO$$27$YR$$F$Y$$$20240907$$MD$GB$GB
242951161$24295116$1$I$20240603$20240828$20240907$20240907$EXP$GB-MHRA-MIDB-cc725918-2a3b-4cc2-9481-3ea6170e6391$GB-TEVA-VS-3238611$TEVA$$73$YR$$F$Y$$$20240907$$PH$GB$GB
242951171$24295117$1$I$20240803$20240903$20240907$20240907$EXP$$BR-JNJFOC-20240912583$JOHNSON AND JOHNSON$$79$YR$E$M$Y$74.2$KG$20240907$$PH$BR$BR
242951181$24295118$1$I$20240808$20240829$20240907$20240907$EXP$$FR-AUROBINDO-AUR-APL-2024-043454$AUROBINDO$$27$YR$$M$Y$100$KG$20240907$$CN$FR$FR
242951192$24295119$2$F$20240901$20240912$20240907$20240913$PER$$US-AMGEN-USASP2024175806$AMGEN$$62$YR$A$F$Y$$$20240913$$CN$US$US
242951201$24295120$1$I$20240828$20240829$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043620$AUROBINDO$$93$YR$$F$Y$$$20240907$$HP$GB$GB
242951211$24295121$1$I$20240825$20240829$20240907$20240907$EXP$$IT-AUROBINDO-AUR-APL-2024-043687$AUROBINDO$$85$YR$$M$Y$$$20240907$$MD$IT$IT
242951221$24295122$1$I$20240827$20240829$20240907$20240907$EXP$GB-MHRA-MED-202408291728596080-RQGZC$GB-CELLTRION INC.-2024GB021024$CELLTRION$$$$$$Y$$$20240907$$HP$GB$GB
242951231$24295123$1$I$20240731$20240829$20240907$20240907$EXP$$IT-AUROBINDO-AUR-APL-2024-043685$AUROBINDO$$50$YR$$F$Y$$$20240907$$MD$IT$IT
242951241$24295124$1$I$$20240827$20240907$20240907$PER$$US-SA-2024SA258583$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240907$$MD$US$US
242951251$24295125$1$I$20200327$20240829$20240907$20240907$EXP$$PL-AUROBINDO-AUR-APL-2024-043771$AUROBINDO$$75$YR$$F$Y$$$20240907$$MD$PL$PL
242951261$24295126$1$I$20240808$20240829$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043614$AUROBINDO$$39$YR$$F$Y$54$KG$20240907$$CN$GB$GB
242951271$24295127$1$I$$20240829$20240907$20240907$EXP$$GB-AUROBINDO-AUR-APL-2024-043606$AUROBINDO$$$$$M$Y$$$20240907$$CN$GB$GB
242951281$24295128$1$I$20240807$20240829$20240907$20240907$EXP$$IT-AUROBINDO-AUR-APL-2024-043682$AUROBINDO$$71$YR$$M$Y$81$KG$20240907$$MD$IT$IT
242951291$24295129$1$I$20240715$20240902$20240907$20240907$EXP$$AU-JNJFOC-20240902868$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240907$$CN$AU$AU
242951301$24295130$1$I$$20240829$20240907$20240907$EXP$$CA-AUROBINDO-AUR-APL-2024-044035$AUROBINDO$$44$YR$$F$Y$$$20240907$$MD$CA$CA
242951311$24295131$1$I$$20240829$20240907$20240907$EXP$$CA-AUROBINDO-AUR-APL-2024-044255$AUROBINDO$$69$YR$$F$Y$$$20240907$$PH$CA$CA
242951331$24295133$1$I$$20240829$20240907$20240907$EXP$$CA-AUROBINDO-AUR-APL-2024-044237$AUROBINDO$$45$YR$$M$Y$$$20240907$$CN$CA$CA
242951341$24295134$1$I$$20240829$20240907$20240907$EXP$$PT-AUROBINDO-AUR-APL-2024-043810$AUROBINDO$Alves A. Tubulointerstitial nephritis acute associated with pembrolizumab.. 30 CNMI Congresso Nacional de Medicina Interna - Livro de resumos.. 2024;354$33$YR$$F$Y$$$20240907$$MD$PT$PT
242951351$24295135$1$I$20240401$20240902$20240907$20240907$EXP$$AU-JNJFOC-20240903017$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240907$$HP$AU$AU
242951361$24295136$1$I$$20240829$20240907$20240907$EXP$$NL-AUROBINDO-AUR-APL-2024-043768$AUROBINDO$$70$YR$$M$Y$83$KG$20240907$$CN$NL$NL
242951371$24295137$1$I$20240824$20240829$20240907$20240907$EXP$$FR-AUROBINDO-AUR-APL-2024-043674$AUROBINDO$$24$YR$$M$Y$$$20240907$$PH$FR$FR
242951381$24295138$1$I$20240729$20240829$20240907$20240907$EXP$$ES-AUROBINDO-AUR-APL-2024-043633$AUROBINDO$$86$YR$$F$Y$56.4$KG$20240907$$MD$ES$ES
242951391$24295139$1$I$$20240829$20240907$20240907$EXP$$PT-AUROBINDO-AUR-APL-2024-043797$AUROBINDO$Mort?gua Velho R, Pedro Fernandes B, Teixeira AS, Borges AL, Fonseca I, Santos L.. PO-0419 - (4300) - PANCREATITE AGUDA GRAVE SECUND?RIA AO VALPROATO.. Congresso Nacional de Medicina Interna. 2024;23-26$57$YR$$M$Y$$$20240907$$HP$PT$PT
242951401$24295140$1$I$$20240829$20240907$20240907$EXP$$CA-AUROBINDO-AUR-APL-2024-000874$AUROBINDO$Todd CM, Yu A, Lay C, Lagman-Bartolome AM. Effect of testosterone therapy on  migraine frequency and disability in two transgender patients: a case report.. BMJ CASE REPORTS. 2023;16:1-3$$$$F$Y$$$20240907$$HP$CA$CA
242951411$24295141$1$I$20240826$20240903$20240907$20240907$EXP$$GB-TEVA-VS-3239683$TEVA$$44$YR$$F$Y$102$KG$20240907$$CN$GB$GB
242951422$24295142$2$F$$20240830$20240907$20240913$EXP$$BR-JNJFOC-20240902959$JOHNSON AND JOHNSON$$$$$$Y$$$20240914$$MD$BR$BR
242951431$24295143$1$I$$20240826$20240907$20240907$PER$$US-SA-2024SA257591$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240907$$MD$US$US
242951441$24295144$1$I$20170101$20240829$20240907$20240907$EXP$$BR-TEVA-VS-3239984$TEVA$$43$YR$$F$Y$$$20240907$$CN$BR$BR
242951451$24295145$1$I$20240624$20240826$20240907$20240907$EXP$GB-MHRA-MED-202408261330327800-LHBSQ$GB-GLENMARK PHARMACEUTICALS-2024GMK093707$GLENMARK$$$$$$Y$$$20240907$$CN$GB$GB
242951461$24295146$1$I$$20240906$20240907$20240907$EXP$$NZ-ROCHE-10000065635$ROCHE$$68$YR$E$M$Y$96$KG$20240907$$MD$NZ$NZ
242951473$24295147$3$F$20240731$20240910$20240907$20240919$EXP$$BR-CELLTRION INC.-2024BR020982$CELLTRION$$$$$$Y$$$20240919$$CN$BR$BR
242951482$24295148$2$F$20240830$20240913$20240907$20240914$PER$$US-AMGEN-USASP2024176656$AMGEN$$55$YR$A$M$Y$$$20240914$$CN$US$US
242951501$24295150$1$I$$20240823$20240907$20240907$PER$$US-SA-2024SA255653$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240907$$MD$US$US
242951511$24295151$1$I$$20240822$20240907$20240907$PER$$US-JNJFOC-20240859483$JOHNSON AND JOHNSON$$$$$F$Y$$$20240907$$CN$US$US
242951531$24295153$1$I$$20240829$20240907$20240907$PER$$US-SA-2024SA258684$SANOFI AVENTIS$$$$$F$Y$$$20240907$$CN$US$US
242951541$24295154$1$I$20240101$20240828$20240907$20240907$PER$$US-SA-2024SA258724$SANOFI AVENTIS$$$$A$F$Y$$$20240907$$MD$US$US
242951551$24295155$1$I$$20240904$20240907$20240907$EXP$$US-ROCHE-10000074372$ROCHE$$81$YR$E$M$Y$$$20240907$$CN$US$US
242951561$24295156$1$I$$20240903$20240907$20240907$PER$$US-AMGEN-USASL2024176463$AMGEN$$$$$$Y$$$20240907$$CN$US$US
242951571$24295157$1$I$$20240905$20240907$20240907$EXP$$CN-TAKEDA-2024TUS089127$TAKEDA$$$$$M$Y$$$20240907$$CN$CN$CN
242951581$24295158$1$I$20240821$20240904$20240907$20240907$EXP$CZ-CZSUKL-24002425$CZ-TAKEDA-2024TUS088391$TAKEDA$$70$YR$$M$Y$89$KG$20240907$$HP$CZ$CZ
242951591$24295159$1$I$$20240829$20240907$20240907$30DAY$$US-GSK-US2024107898$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$PH$US$US
242951601$24295160$1$I$$20240903$20240907$20240907$EXP$$BR-TAKEDA-2024TUS088717$TAKEDA$$$$A$F$Y$$$20240907$$CN$BR$BR
242951611$24295161$1$I$$20240826$20240907$20240907$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK093711$GLENMARK$$$$$$Y$$$20240907$$MD$CA$CA
242951621$24295162$1$I$$20240827$20240907$20240907$EXP$$SK-TAKEDA-2024TUS088862$TAKEDA$$78$YR$$F$Y$$$20240907$$MD$SK$SK
242951631$24295163$1$I$20240101$20240829$20240907$20240907$PER$$US-SA-2024SA258390$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240907$$MD$US$US
242951642$24295164$2$F$20240828$20240829$20240907$20240912$PER$$US-SA-2024SA253925$SANOFI AVENTIS$$23$YR$A$M$Y$113.85$KG$20240912$$HP$US$US
242951651$24295165$1$I$20240901$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178017$AMGEN$$74$YR$E$M$Y$$$20240907$$PH$US$US
242951661$24295166$1$I$$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024176728$AMGEN$$$$$F$Y$$$20240907$$CN$US$US
242951671$24295167$1$I$$20240826$20240907$20240907$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK093713$GLENMARK$$$$$$Y$$$20240907$$HP$CA$CA
242951681$24295168$1$I$$20240826$20240907$20240907$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK093714$GLENMARK$$$$$$Y$$$20240907$$MD$CA$CA
242951691$24295169$1$I$$20240829$20240907$20240907$PER$$US-SA-2024SA255333$SANOFI AVENTIS$$$$A$$Y$$$20240907$$MD$US$US
242951711$24295171$1$I$$20240826$20240907$20240907$EXP$SY-MLMSERVICE-20240820-PI166513-00059-1$SY-STRIDES ARCOLAB LIMITED-2024SP010949$STRIDES$Alhalabi M, Alziadan SM. A diagnostic dilemma: cytomegalovirus colitis as an uncommon comorbidity in inflammatory bowel disease: a case report.. Virology journal. 2024;21(1):188$28$YR$$F$Y$$$20240907$$MD$SY$SY
242951721$24295172$1$I$$20240830$20240907$20240907$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011318$STRIDES$Gondal M, Shirali AC.. Isolated Hyperphosphatemia with Suppressed Urinary Phosphate Excretion in a Patient with Undifferentiated Leukemia.. J-Am-Soc-Nephro. 2016;27 (Suppl.)(11):1025A abstr. PUB529$27$YR$$F$Y$$$20240907$$HP$US$US
242951732$24295173$2$F$$20240830$20240907$20240909$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011325$STRIDES$Erol LA, Layman CP.. Paraneoplastic Hyperthyroidism Secondary to a Chemotherapy-Induced Surge in beta-hCG in a Patient with Non-Seminomatous Germ Cell Tumor. [Review].. Hawaii-J-Health-Soc-Welf. 2024;83 (2):45-47$21$YR$$M$Y$$$20240909$$MD$US$US
242951741$24295174$1$I$$20240826$20240907$20240907$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK093763$GLENMARK$$$$$$Y$$$20240907$$MD$CA$CA
242951751$24295175$1$I$20240819$20240904$20240907$20240907$EXP$GB-MHRA-MED-202409021357227910-DKPCY$GB-STRIDES ARCOLAB LIMITED-2024SP011310$STRIDES$$73$YR$$M$Y$$$20240907$$HP$GB$GB
242951771$24295177$1$I$$20240828$20240907$20240907$30DAY$$US-GSK-US2024AMR108156$GLAXOSMITHKLINE$$$$$$Y$$$20240907$$CN$US$US
242951781$24295178$1$I$20240701$20240903$20240907$20240907$EXP$$US-JNJFOC-20240911085$JOHNSON AND JOHNSON$$46$YR$$M$Y$$$20240907$$CN$US$US
242951791$24295179$1$I$$20240902$20240907$20240907$EXP$$TN-TAKEDA-2024TUS088924$TAKEDA$Ayed A, Brahim. Uncommon presentation of nonsecretory multiple myeloma. European Journal of Case Reports in Internal Medicine. 11:762$63$YR$$M$Y$$$20240907$$MD$TN$TN
242951812$24295181$2$F$$20240916$20240907$20240919$EXP$$BR-TAKEDA-2024TUS088981$TAKEDA$$$$$F$Y$$$20240919$$CN$BR$BR
242951821$24295182$1$I$$20240829$20240907$20240907$EXP$$US-JNJFOC-20240900619$JOHNSON AND JOHNSON$$$$$$Y$$$20240907$$CN$US$US
242951831$24295183$1$I$$20240903$20240907$20240907$PER$$US-AMGEN-USASP2024176215$AMGEN$$$$$F$Y$$$20240907$$CN$US$US
242951841$24295184$1$I$20240701$20240823$20240907$20240907$PER$$US-SA-2024SA257624$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240907$$HP$US$US
242951851$24295185$1$I$20240101$20240826$20240907$20240907$PER$$US-SA-2024SA258672$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240907$$MD$US$US
242951871$24295187$1$I$$20240830$20240907$20240907$EXP$$US-JNJFOC-20240903415$JOHNSON AND JOHNSON$$$$$$Y$$$20240907$$CN$US$US
242951881$24295188$1$I$$20240904$20240907$20240907$PER$$US-JNJFOC-20240913999$JOHNSON AND JOHNSON$$$$$F$Y$$$20240907$$CN$US$US
242951891$24295189$1$I$20240825$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024177264$AMGEN$$24$YR$A$F$Y$$$20240907$$CN$US$US
242951901$24295190$1$I$20240801$20240829$20240907$20240907$PER$$US-SA-2024SA258395$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240907$$CN$US$US
242951911$24295191$1$I$$20240830$20240907$20240907$EXP$$US-JNJFOC-20240881296$JOHNSON AND JOHNSON$$$$$M$Y$$$20240907$$HP$US$US
242951921$24295192$1$I$$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024177797$AMGEN$$$$$F$Y$$$20240907$$CN$US$US
242951931$24295193$1$I$20240905$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178369$AMGEN$$82$YR$E$F$Y$$$20240907$$CN$US$US
242951972$24295197$2$F$$20240912$20240907$20240921$EXP$$JP-ARDELYX-2024ARDX006722$ARDELYX$$81$YR$$F$Y$$$20240921$$MD$JP$JP
242951982$24295198$2$F$$20240913$20240907$20240924$EXP$$JP-ARDELYX-2024ARDX006724$ARDELYX$$$$$M$Y$$$20240924$$MD$JP$JP
242951991$24295199$1$I$$20240831$20240907$20240907$EXP$$US-JNJFOC-20240901753$JOHNSON AND JOHNSON$$$$$$Y$$$20240907$$CN$US$US
242952001$24295200$1$I$20240829$20240829$20240907$20240907$EXP$$US-RDY-CLI/USA/24/0012840$DR REDDYS$$25$YR$A$F$Y$$$20240907$$MD$US$US
242952011$24295201$1$I$$20240830$20240907$20240907$EXP$US-MLMSERVICE-20240827-PI170933-00128-1$US-RDY-SPO/USA/24/0012755$DR REDDYS$Lopez J, Hua H, Toy BC. A case of herpes simplex virus and cytomegalovirus retinitis coinfection. Retinal Cases and Brief Reports. 2024;18(4):451-4. Doi: 10.1097/ICB.0000000000001424.$64$YR$A$M$Y$$$20240907$$MD$US$US
242952021$24295202$1$I$20240903$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024178103$AMGEN$$77$YR$E$F$Y$$$20240907$$CN$US$US
242952041$24295204$1$I$$20240823$20240907$20240907$PER$$US-SA-2024SA255568$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240907$$MD$US$US
242952051$24295205$1$I$20240810$20240829$20240907$20240907$PER$$US-SA-2024SA257205$SANOFI AVENTIS$$$$$M$Y$$$20240907$$HP$US$US
242952061$24295206$1$I$20240801$20240823$20240907$20240907$PER$$US-SA-2024SA255585$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240907$$MD$US$US
242952071$24295207$1$I$20240330$20240827$20240907$20240907$EXP$$CA-TAKEDA-2024TUS087105$TAKEDA$$39$YR$$F$Y$$$20240907$$CN$CA$CA
242952091$24295209$1$I$20240411$20240903$20240907$20240907$EXP$$US-TAKEDA-2024TUS033681$TAKEDA$$57$YR$$F$Y$$$20240907$$CN$US$US
242952101$24295210$1$I$20240827$20240827$20240907$20240907$PER$$US-RDY-SPO/USA/24/0012699$DR REDDYS$$22$YR$A$F$Y$$$20240907$$CN$US$US
242952111$24295211$1$I$20240828$20240828$20240907$20240907$PER$$US-RDY-SPO/USA/24/0012703$DR REDDYS$$45$YR$A$F$Y$$$20240907$$HP$US$US
242952121$24295212$1$I$$20240827$20240907$20240907$PER$$US-RDY-SPO/USA/24/0012695$DR REDDYS$$25$YR$A$F$Y$$$20240907$$HP$US$US
242952131$24295213$1$I$20240101$20240903$20240907$20240907$EXP$$US-009507513-2409USA000996$MERCK$$$$$F$Y$$$20240907$$CN$US$US
242952141$24295214$1$I$20240101$20240830$20240907$20240907$EXP$$JP-AMGEN-JPNSP2024174968$AMGEN$$81$YR$E$F$Y$$$20240907$$MD$JP$JP
242952151$24295215$1$I$$20240829$20240907$20240907$EXP$$US-GSK-US2024107915$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$CN$US$US
242952161$24295216$1$I$$20240828$20240907$20240907$30DAY$$US-GSK-US2024107291$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$CN$US$US
242952171$24295217$1$I$$20240830$20240907$20240907$EXP$$US-TAKEDA-2024TUS088987$TAKEDA$$$$$F$Y$$$20240907$$MD$US$US
242952181$24295218$1$I$20240903$20240905$20240907$20240907$PER$$US-JNJFOC-20240912888$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240907$$PH$US$US
242952191$24295219$1$I$$20240905$20240907$20240907$PER$$US-ELI_LILLY_AND_COMPANY-US202409003598$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240907$$CN$US$US
242952201$24295220$1$I$20240830$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024176889$AMGEN$$$$$$Y$$$20240907$$CN$US$US
242952211$24295221$1$I$$20240829$20240907$20240907$EXP$$US-GSK-US2024107729$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$MD$US$US
242952221$24295222$1$I$$20240829$20240907$20240907$30DAY$$US-GSK-US2024107919$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$CN$US$US
242952231$24295223$1$I$$20240829$20240907$20240907$30DAY$$US-GSK-US2024107910$GLAXOSMITHKLINE$$$$$M$Y$$$20240907$$CN$US$US
242952241$24295224$1$I$$20240826$20240907$20240907$PER$$US-SA-2024SA258078$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240907$$HP$US$US
242952251$24295225$1$I$$20240903$20240907$20240907$EXP$$US-TAKEDA-2024TUS088689$TAKEDA$$$$$M$Y$$$20240907$$CN$US$US
242952261$24295226$1$I$20240903$20240903$20240907$20240907$PER$$US-AMGEN-USASP2024175912$AMGEN$$83$YR$E$F$Y$$$20240907$$CN$US$US
242952271$24295227$1$I$$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178407$AMGEN$$$$$$Y$$$20240907$$MD$US$US
242952281$24295228$1$I$$20240905$20240907$20240907$EXP$$CN-TAKEDA-2024TUS089030$TAKEDA$$$$$M$Y$$$20240907$$CN$CN$CN
242952292$24295229$2$F$20240831$20240910$20240907$20240925$PER$$US-SA-2024SA256151$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240925$$MD$US$US
242952301$24295230$1$I$20240812$20240829$20240907$20240907$30DAY$$US-GSK-US2024107707$GLAXOSMITHKLINE$$87$YR$$F$Y$$$20240907$$CN$US$US
242952311$24295231$1$I$$20240829$20240907$20240907$30DAY$$US-GSK-US2024107747$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$CN$US$US
242952321$24295232$1$I$20240904$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024178300$AMGEN$$70$YR$E$F$Y$$$20240907$$CN$US$US
242952331$24295233$1$I$$20240904$20240907$20240907$EXP$$CN-AMGEN-CHNSP2024177002$AMGEN$Hu Q.; Lu J.; Bao X. et al.. Safety and efficacy of blinatumomab as bridge-to transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease. Blood Cancer Journal. 2024;14 (1):1-5$$$$$Y$$$20240907$$HP$CN$CN
242952341$24295234$1$I$20240814$20240827$20240907$20240907$EXP$$JP-VANTIVE-2024VAN019057$Vantive US Healthcare$$65$YR$$M$Y$$$20240907$$MD$JP$JP
242952351$24295235$1$I$$20240903$20240907$20240907$EXP$$CA-TAKEDA-2024TUS088703$TAKEDA$$$$$M$Y$$$20240907$$MD$CA$CA
242952361$24295236$1$I$$20240904$20240907$20240907$EXP$$CN-AMGEN-CHNSP2024177018$AMGEN$Hu Q.; Lu J.; Bao X. et al.. Safety and efficacy of blinatumomab as bridge-to transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease. Blood Cancer Journal. 2024;14 (1):1-5$$$$$Y$$$20240907$$HP$CN$CN
242952371$24295237$1$I$20240830$20240830$20240907$20240907$EXP$$CA-HLS-202402203$HLS THERAPEUTICS$$62$YR$A$M$Y$$$20240907$$PH$CA$CA
242952381$24295238$1$I$$20240828$20240907$20240907$30DAY$$US-GSK-US2024107249$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$CN$US$US
242952391$24295239$1$I$20240301$20240902$20240907$20240907$EXP$$US-AMGEN-USASP2024176932$AMGEN$Lavastida D.R.; Filippis S.D.; Torres E.R. et al.. Novel Treatment Modality for Chimeric Antigen Receptor T-cell Therapy Complications: A Case Report. Cureus. 2024;16 (7):1-7$54$YR$A$M$Y$$$20240907$$HP$US$US
242952401$24295240$1$I$$20240904$20240907$20240907$EXP$$CN-AMGEN-CHNSP2024177019$AMGEN$Hu Q.; Lu J.; Bao X. et al.. Safety and efficacy of blinatumomab as bridge-to transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease. Blood Cancer Journal. 2024;14 (1):1-5$$$$$Y$$$20240907$$HP$CN$CN
242952411$24295241$1$I$$20240828$20240907$20240907$EXP$$CA-BAXTER-2024BAX024023$BAXTER$$34$YR$$M$Y$$$20240907$$HP$CA$CA
242952421$24295242$1$I$20240805$20240829$20240907$20240907$EXP$CN-NMPACDR-5301001027759202401246$CN-BAXTER-2024BAX024086$BAXTER$$53$YR$$M$Y$80$KG$20240907$$MD$CN$CN
242952431$24295243$1$I$20240809$20240829$20240907$20240907$EXP$CN-NMPACDR-5301001027759202401251$CN-BAXTER-2024BAX024092$BAXTER$$74$YR$$M$Y$46$KG$20240907$$MD$CN$CN
242952441$24295244$1$I$$20240830$20240907$20240907$EXP$$CN-BAXTER-2024BAX024106$BAXTER$$2$MON$$F$Y$$$20240907$$HP$CN$CN
242952451$24295245$1$I$20240724$20240829$20240907$20240907$PER$$US-SA-2024SA258503$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240907$$HP$US$US
242952461$24295246$1$I$$20240902$20240907$20240907$EXP$$HU-AMGEN-HUNSP2024175942$AMGEN$Rakonczai A.; Kenez L.; Bodor C. et al.. Adult Onset Familial Common B-Cell Acute Lymphoblastic Leukemia With Shared ZEB2 Mutation. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S263$27$YR$A$M$Y$$$20240907$$MD$HU$HU
242952471$24295247$1$I$$20240902$20240907$20240907$EXP$$US-AMGEN-USASP2024176954$AMGEN$Ganguly A.; Abbagoni V.; Meleveedu K. et al.. Diffuse Large B-Cell Lymphoma of the Bone Recurring in the Skin: A Case Report. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S488$69$YR$E$F$Y$$$20240907$$MD$US$US
242952481$24295248$1$I$20190109$20240904$20240907$20240907$EXP$$CA-TAKEDA-2024TUS089236$TAKEDA$$62$YR$$F$Y$$$20240907$$CN$CA$CA
242952491$24295249$1$I$20231001$20240902$20240907$20240907$EXP$$PT-AMGEN-PRTSP2024175267$AMGEN$Lopes N.; Neves D.; Brito U.. OCULAR METASTASIS, A RARE MANIFESTATION. Pulmonology. 2024;30:S67$63$YR$A$F$Y$$$20240907$$HP$PT$PT
242952501$24295250$1$I$$20240903$20240907$20240907$EXP$$US-AMGEN-USASP2024177113$AMGEN$Jabbour E.; Short N.; Jain N. et al.. Very Promising Results of the Dose Dense (D-D) Mini-Hyper-CVD-Inotuzumab-Blinatumomab Phase 2 Trial in Patients with Relapsed-Refractory Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S284-S285$$$$$Y$$$20240907$$MD$US$US
242952513$24295251$3$F$$20240905$20240907$20240920$EXP$$CA-BAXTER-2024BAX023949$BAXTER$$58$YR$$F$Y$$$20240920$$HP$CA$CA
242952521$24295252$1$I$$20240828$20240907$20240907$30DAY$$US-GSK-US2024107148$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$CN$US$US
242952541$24295254$1$I$$20240822$20240907$20240907$PER$$US-ASTELLAS-2024-AER-002430$ASTELLAS$$70$YR$E$F$Y$$$20240907$$HP$US$US
242952551$24295255$1$I$20210101$20240826$20240907$20240907$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093639$GLENMARK$Desai D, Nohria A, Alhanshali L, Buontempo M, Lo Sicco KI, Fern C, et al.. Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases.. JAAD Case Reports.. 2024;51:86-91$$$$$Y$$$20240907$$MD$US$US
242952561$24295256$1$I$20220101$20240826$20240907$20240907$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093638$GLENMARK$Desai D, Nohria A, Alhanshali L, Buontempo M, Lo Sicco KI, Fern C, et al.. Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases.. JAAD Case Reports.. 2024;51:86-91$$$$$Y$$$20240907$$MD$US$US
242952571$24295257$1$I$20230901$20240830$20240907$20240907$EXP$$FR-VER-202400014$VERITY PHARMACEUTICALS$$44$YR$A$F$Y$97$KG$20240907$$HP$FR$FR
242952581$24295258$1$I$$20240822$20240907$20240907$PER$$US-ASTELLAS-2024-AER-002455$ASTELLAS$$$$$M$Y$$$20240907$$HP$US$US
242952591$24295259$1$I$$20240830$20240907$20240907$EXP$$TW-AMGEN-TWNSP2024176474$AMGEN$Hung Y.; Wu W.; Hsu C. et al.. Incorporating Tumor Genomic Profiling and Circulating Tumor Cell-derived Organoids into Clinical Practice for Gastrointestinal cancers. Anticancer research. 2024;44 (8):3481-3491$69$YR$E$F$Y$$$20240907$$MD$TW$TW
242952601$24295260$1$I$$20240828$20240907$20240907$EXP$$US-GSK-US2024107084$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$MD$US$US
242952611$24295261$1$I$20240806$20240826$20240907$20240907$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093643$GLENMARK$$$$$$Y$$$20240907$$HP$US$US
242952621$24295262$1$I$$20240830$20240907$20240907$EXP$$CN-AMGEN-CHNSP2024174747$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240907$$MD$CN$CN
242952631$24295263$1$I$$20240830$20240907$20240907$EXP$$CN-AMGEN-CHNSP2024174750$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240907$$MD$CN$CN
242952641$24295264$1$I$$20240830$20240907$20240907$EXP$$CN-AMGEN-CHNSP2024174755$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240907$$MD$CN$CN
242952651$24295265$1$I$$20240830$20240907$20240907$EXP$$CN-AMGEN-CHNSP2024174756$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240907$$MD$CN$CN
242952661$24295266$1$I$$20240830$20240907$20240907$EXP$$CN-AMGEN-CHNSP2024174758$AMGEN$Zheng B.; Wu H.; Xia C. et al.. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone. JCO Precision Oncology. 2024;8:1-10$$$$$Y$$$20240907$$MD$CN$CN
242952671$24295267$1$I$$20240828$20240907$20240907$30DAY$$US-GSK-US2024107303$GLAXOSMITHKLINE$$$$$M$Y$$$20240907$$CN$US$US
242952681$24295268$1$I$20240329$20240826$20240907$20240907$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093668$GLENMARK$$$$$$Y$$$20240907$$CN$US$US
242952691$24295269$1$I$$20240903$20240907$20240907$EXP$$US-AMGEN-USASP2024177117$AMGEN$Jabbour E.; Short N.; Jain N. et al.. Very Promising Results of the Dose Dense (D-D) Mini-Hyper-CVD-Inotuzumab-Blinatumomab Phase 2 Trial in Patients with Relapsed-Refractory Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S284-S285$$$A$$Y$$$20240907$$MD$US$US
242952701$24295270$1$I$$20240903$20240907$20240907$EXP$$US-AMGEN-USASP2024177115$AMGEN$Jabbour E.; Short N.; Jain N. et al.. Very Promising Results of the Dose Dense (D-D) Mini-Hyper-CVD-Inotuzumab-Blinatumomab Phase 2 Trial in Patients with Relapsed-Refractory Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S284-S285$$$A$$Y$$$20240907$$MD$US$US
242952711$24295271$1$I$20240821$20240827$20240907$20240907$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17216$IPSEN$$$$$F$Y$$$20240907$$HP$US$US
242952721$24295272$1$I$20240101$20240829$20240907$20240907$PER$$US-SA-2024SA258609$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240907$$HP$US$US
242952731$24295273$1$I$$20240827$20240907$20240907$EXP$$US-HLS-202400858$HLS THERAPEUTICS$$24$YR$A$M$Y$$$20240907$$HP$US$US
242952741$24295274$1$I$$20240826$20240907$20240907$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093762$GLENMARK$Hassan AM, Hill H, Donley C, Leonelli C.. Potential anaphylactoid reaction to nicardipine.. JACEP Open.. 2024;5:e13271:1-3$$$$$Y$$$20240907$$MD$US$US
242952751$24295275$1$I$$20240828$20240907$20240907$EXP$$US-GSK-US2024107310$GLAXOSMITHKLINE$$$$$$Y$$$20240907$$HP$US$US
242952761$24295276$1$I$$20240829$20240907$20240907$30DAY$$US-GSK-US2024107924$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$CN$US$US
242952771$24295277$1$I$$20240829$20240907$20240907$30DAY$$US-GSK-US2024107902$GLAXOSMITHKLINE$$$$$F$Y$$$20240907$$CN$US$US
242952782$24295278$2$F$$20240918$20240907$20240927$EXP$$US-JNJFOC-20240900489$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
242952791$24295279$1$I$20240701$20240823$20240907$20240907$PER$$US-SA-2024SA256695$SANOFI AVENTIS$$$$E$M$Y$$$20240907$$MD$US$US
242952801$24295280$1$I$$20240825$20240907$20240907$PER$$US-SA-2024SA257026$SANOFI AVENTIS$$$$A$F$Y$$$20240907$$MD$US$US
242952811$24295281$1$I$$20240823$20240907$20240907$PER$$US-SA-2024SA255948$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240907$$CN$US$US
242952821$24295282$1$I$$20240823$20240907$20240907$PER$$US-SA-2024SA256580$SANOFI AVENTIS$$$$I$M$Y$$$20240907$$MD$US$US
242952831$24295283$1$I$20240827$20240828$20240907$20240907$PER$$US-SA-2024SA258382$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240907$$MD$US$US
242952841$24295284$1$I$$20240823$20240907$20240907$PER$$US-SA-2024SA258748$SANOFI AVENTIS$$$$A$F$Y$$$20240907$$CN$US$US
242952851$24295285$1$I$$20240829$20240907$20240907$EXP$$KR-Ipsen Biopharmaceuticals, Inc.-2024-17760$IPSEN$$48$YR$A$M$Y$$$20240907$$MD$KR$KR
242952861$24295286$1$I$$20240903$20240907$20240907$PER$$US-AMGEN-USASP2024176639$AMGEN$$$$$$Y$$$20240907$$MD$US$US
242952881$24295288$1$I$$20240903$20240907$20240907$PER$$US-RDY-SPO/USA/24/0012918$DR REDDYS$$$$$M$Y$$$20240907$$CN$US$US
242952901$24295290$1$I$$20240819$20240907$20240907$PER$$US-009507513-2408USA006762$MERCK$$$$$M$Y$$$20240907$$CN$US$US
242952911$24295291$1$I$$20240823$20240907$20240907$PER$$US-SA-2024SA255030$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240907$$MD$US$US
242952921$24295292$1$I$$20240824$20240907$20240907$PER$$US-SA-2024SA256470$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240907$$MD$US$US
242952931$24295293$1$I$20240905$20240905$20240907$20240907$PER$$US-AMGEN-USASP2024177974$AMGEN$$66$YR$E$M$Y$$$20240907$$CN$US$US
242952941$24295294$1$I$$20240904$20240907$20240907$PER$$US-AMGEN-USASP2024177474$AMGEN$$$$$$Y$$$20240907$$HP$US$US
242952951$24295295$1$I$20240301$20240820$20240907$20240907$PER$$US-SA-2024SA257371$SANOFI AVENTIS$$9$YR$C$F$Y$31.72$KG$20240907$$HP$US$US
242952961$24295296$1$I$20240826$20240826$20240907$20240907$PER$$US-SA-2024SA257729$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240907$$MD$US$US
242952971$24295297$1$I$20240801$20240823$20240907$20240907$PER$$US-SA-2024SA256041$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240907$$MD$US$US
242952981$24295298$1$I$20240801$20240826$20240907$20240907$PER$$US-SA-2024SA258650$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240907$$HP$US$US
242952992$24295299$2$F$20240101$20240911$20240907$20240925$PER$$US-SA-2024SA254425$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240925$$CN$US$US
242953001$24295300$1$I$$20240823$20240907$20240907$PER$$US-SA-2024SA256765$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240907$$MD$US$US
242953011$24295301$1$I$20230101$20240826$20240907$20240907$PER$$US-SA-2024SA258687$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240907$$MD$US$US
242953021$24295302$1$I$$20240826$20240907$20240907$PER$$US-SA-2024SA258053$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240907$$MD$US$US
242953031$24295303$1$I$20240801$20240826$20240907$20240907$PER$$US-SA-2024SA257113$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240907$$MD$US$US
242953041$24295304$1$I$20240101$20240830$20240907$20240907$PER$$US-JNJFOC-20240900686$JOHNSON AND JOHNSON$$$$$M$Y$$$20240907$$CN$US$US
242953051$24295305$1$I$20240101$20240821$20240907$20240907$PER$$US-SA-2024SA255208$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240907$$MD$US$US
242953061$24295306$1$I$$20240823$20240907$20240907$PER$$US-SA-2024SA255353$SANOFI AVENTIS$$$$A$F$Y$$$20240907$$MD$US$US
242953071$24295307$1$I$20240801$20240826$20240907$20240907$PER$$US-SA-2024SA257293$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240907$$HP$US$US
242953081$24295308$1$I$20240903$20240904$20240907$20240907$EXP$$AU-GE HEALTHCARE-2024CSU010174$GE HEALTHCARE$$66$YR$$F$Y$$$20240907$$HP$AU$AU
242953091$24295309$1$I$$20240905$20240907$20240907$PER$$US-ROCHE-10000075680$ROCHE$$80$YR$E$M$Y$$$20240907$$CN$US$US
242953101$24295310$1$I$20240801$20240826$20240907$20240907$PER$$US-SA-2024SA257554$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240907$$CN$US$US
242953112$24295311$2$F$$20240829$20240907$20240913$PER$$US-SA-2024SA255334$SANOFI AVENTIS$$7$YR$C$M$Y$26.36$KG$20240913$$CN$US$US
242953121$24295312$1$I$20240727$20240826$20240907$20240907$PER$$US-JNJFOC-20240909905$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240907$$CN$US$US
242953131$24295313$1$I$$20240828$20240907$20240907$EXP$$US-GSK-US2024107044$GLAXOSMITHKLINE$$$$$M$Y$$$20240907$$CN$US$US
242953141$24295314$1$I$$20240826$20240907$20240907$PER$$US-SA-2024SA257499$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240908$$MD$US$US
242953151$24295315$1$I$$20240826$20240907$20240907$PER$$US-SA-2024SA257560$SANOFI AVENTIS$$$$C$F$Y$$$20240908$$MD$US$US
242953161$24295316$1$I$$20240826$20240907$20240907$PER$$US-SA-2024SA257622$SANOFI AVENTIS$$$$E$F$Y$$$20240908$$MD$US$US
242953171$24295317$1$I$$20240307$20240907$20240907$PER$$US-B.Braun Medical Inc.-2161342$B BRAUN$$$$$$Y$$$20240907$$$US$US
242953181$24295318$1$I$$20240807$20240907$20240907$30DAY$$CH-Amphastar Pharmaceuticals, Inc.-2161346$AMPHASTAR$$$$$$Y$$$20240907$$$CH$CH
242953191$24295319$1$I$$20240826$20240907$20240907$EXP$$CA-B.Braun Medical Inc.-2161340$B BRAUN$$68$YR$$M$Y$64$KG$20240907$$$CA$CA
242953211$24295321$1$I$20240815$20240905$20240907$20240907$EXP$$PE-JNJFOC-20240915892$JOHNSON AND JOHNSON$$$$$$Y$$$20240907$$MD$PE$PE
242953221$24295322$1$I$20240830$20240902$20240907$20240907$EXP$$GB-JNJFOC-20240903356$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20240908$$HP$GB$GB
242953232$24295323$2$F$20240702$20240916$20240907$20240918$EXP$$SK-JNJFOC-20240905541$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240918$$MD$SK$SK
242953241$24295324$1$I$20240101$20240829$20240907$20240907$PER$$US-Millicent Holdings Ltd.-MILL20241131$MILLICENT HOLDINGS$$76$YR$E$F$Y$$$20240908$$CN$US$US
242953251$24295325$1$I$20240101$20240829$20240907$20240907$EXP$$US-GSK-US2024107845$GLAXOSMITHKLINE$$62$YR$$M$Y$$$20240907$$CN$US$US
242953281$24295328$1$I$20240814$20240903$20240907$20240907$EXP$$GB-009507513-2409GBR001324$MERCK$$67$YR$$M$Y$170$KG$20240907$$PH$GB$GB
242953311$24295331$1$I$20240427$20240902$20240907$20240907$EXP$$JP-SHIONOGI INC.-2024001058$SHIONOGI$$$$$$Y$$$20240907$$MD$JP$JP
242953331$24295333$1$I$20240901$20240903$20240907$20240907$PER$$US-AMGEN-USASP2024176025$AMGEN$$82$YR$E$F$Y$$$20240907$$CN$US$US
242953391$24295339$1$I$$20240829$20240907$20240907$EXP$$US-APOTEX-2024AP010218$APOTEX$Dcunha NJ, Wei Q, Thakral B, Medeiros LJ.. From the archives of MD Anderson Cancer Center: Monomorphic epitheliotropic intestinal T-cell lymphoma: A case with an unusual immunophenotype and discussion of differential diagnosis. Annals of Diagnostic Pathology. 2024;70 (152293):1-4$68$YR$$M$Y$$$20240907$$HP$US$US
242953401$24295340$1$I$20240724$20240727$20240907$20240907$PER$$US-LUNDBECK-DKLU4002386$LUNDBECK$$$$$$Y$$$20240908$$HP$US$US
242953411$24295341$1$I$$20240727$20240907$20240907$PER$$US-LUNDBECK-DKLU4002385$LUNDBECK$$$$$$Y$$$20240908$$HP$US$US
242953471$24295347$1$I$20231214$20240903$20240907$20240907$EXP$$NVSC2023US273196$NOVARTIS$$52$YR$$F$Y$$$20240908$$CN$US$US
242953501$24295350$1$I$20240701$20240823$20240907$20240907$PER$$US-SA-2024SA258734$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240908$$MD$US$US
242953511$24295351$1$I$20140101$20240827$20240907$20240907$PER$$US-SA-2024SA253353$SANOFI AVENTIS$$$$A$M$Y$$$20240908$$CN$US$US
242953531$24295353$1$I$$20240823$20240907$20240907$PER$$US-SA-2024SA255675$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240908$$MD$US$US
242953571$24295357$1$I$20240101$20240828$20240907$20240907$PER$$US-SA-2024SA258131$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240908$$MD$US$US
242953611$24295361$1$I$20240801$20240828$20240907$20240907$PER$$US-BIOGEN-2024BI01280473$BIOGEN$$32$YR$$F$Y$$$20240907$$CN$US$US
242953661$24295366$1$I$20240101$20240824$20240908$20240908$PER$$US-SA-2024SA258022$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240908$$HP$US$US
242953671$24295367$1$I$$20240823$20240908$20240908$PER$$US-SA-2024SA257894$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240908$$HP$US$US
242953681$24295368$1$I$20240601$20240828$20240908$20240908$PER$$US-SA-2024SA258133$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240908$$MD$US$US
242953761$24295376$1$I$20231115$20240903$20240908$20240908$EXP$FR-AFSSAPS-LL2024001645$FR-ROCHE-10000072515$ROCHE$$56$YR$A$F$Y$$$20240908$$MD$FR$FR
242953771$24295377$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA257707$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240908$$HP$US$US
242953781$24295378$1$I$$20240902$20240908$20240908$EXP$$ZA-ROCHE-10000072881$ROCHE$$$$$$Y$$$20240908$$MD$ZA$ZA
242953791$24295379$1$I$20240426$20240903$20240908$20240908$EXP$IT-MINISAL02-1000498$IT-ROCHE-10000072688$ROCHE$$56$YR$A$M$Y$80$KG$20240908$$MD$IT$IT
242953802$24295380$2$F$20240801$20240909$20240908$20240916$EXP$$SK-ROCHE-10000072861$ROCHE$$65$YR$E$M$Y$$$20240916$$MD$SK$SK
242953811$24295381$1$I$20240826$20240902$20240908$20240908$EXP$$EG-ROCHE-10000072480$ROCHE$$27$YR$A$M$Y$$$20240908$$HP$EG$EG
242953834$24295383$4$F$$20240911$20240908$20240914$EXP$$US-ROCHE-10000071397$ROCHE$$$$A$F$Y$$$20240914$$CN$US$US
242953841$24295384$1$I$$20240830$20240908$20240908$PER$$US-SA-2024SA256577$SANOFI AVENTIS$$$$A$M$Y$$$20240908$$MD$US$US
242953851$24295385$1$I$$20240829$20240908$20240908$PER$$US-BIOGEN-2024BI01280630$BIOGEN$$$$$M$Y$$$20240908$$CN$US$US
242953861$24295386$1$I$$20240829$20240908$20240908$PER$$US-SA-2024SA257218$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240908$$MD$US$US
242953871$24295387$1$I$$20240831$20240908$20240908$PER$$US-SA-2024SA256289$SANOFI AVENTIS$$$$A$F$Y$190$KG$20240908$$MD$US$US
242953881$24295388$1$I$$20240821$20240908$20240908$PER$$US-SA-2024SA255082$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240908$$MD$US$US
242953891$24295389$1$I$$20240829$20240908$20240908$PER$$US-SA-2024SA258671$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240908$$CN$US$US
242953901$24295390$1$I$$20240829$20240908$20240908$EXP$$US-GSK-US2024AMR108635$GLAXOSMITHKLINE$$$$$$Y$$$20240908$$CN$US$US
242953911$24295391$1$I$20240826$20240827$20240908$20240908$PER$$US-SA-2024SA253800$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240908$$CN$US$US
242953921$24295392$1$I$20240101$20240829$20240908$20240908$PER$$US-SA-2024SA258728$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240908$$CN$US$US
242953933$24295393$3$F$20240101$20240906$20240908$20240913$PER$$US-SA-2024SA256176$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240913$$CN$US$US
242953941$24295394$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA257267$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240908$$CN$US$US
242953951$24295395$1$I$$20240828$20240908$20240908$EXP$$US-RDY-SPO/USA/24/0012729$DR REDDYS$Wang N. Neurologic Complications of Cancer Immunotherapy. CONTINUUM Lifelong Learning in Neurology. 2023 Dec 01;29: 1827-1843. doi:10.1212/CON.0000000000001362.$42$YR$A$F$Y$$$20240908$$MD$US$US
242953961$24295396$1$I$$20240828$20240908$20240908$EXP$$US-RDY-SPO/USA/24/0012792$DR REDDYS$Marvin JE, Trubin PA, Azar MM. Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient. Transplant Infectious Disease. 2024 Aug;26(4): 1-3. doi:10.1111/tid.14329.$63$YR$A$M$Y$$$20240908$$HP$US$US
242953971$24295397$1$I$$20240828$20240908$20240908$EXP$$US-RDY-SPO/USA/24/0012844$DR REDDYS$Meyer AS, Cluster A, Ogle A, Brossier N, Beck M, Lampe A, et al. NOVEL TREATMENTS FOR ACNEIFORM ERUPTIONS CAUSED BY TARGETED THERAPIES IN THE PEDIATRIC POPULATION. Neuro-Oncology. 2024 Jun;26: iv186-iv187. doi:10.1093/neuonc/noae064.649.$$$T$F$Y$$$20240908$$HP$US$US
242953981$24295398$1$I$$20240827$20240908$20240908$EXP$GB-MHRA-MED-202408270903368730-JBYTR$GB-MACLEODS PHARMA-MAC2024049150$MACLEODS$$75$YR$E$F$Y$$$20240906$$PH$GB$GB
242953992$24295399$2$F$$20240903$20240908$20240916$EXP$$KZ-MACLEODS PHARMA-MAC2024049179$MACLEODS$$$$$$Y$$$20240916$$HP$KZ$KZ
242954001$24295400$1$I$$20240827$20240908$20240908$EXP$$AE-MACLEODS PHARMA-MAC2024049153$MACLEODS$Jumani A, Ibrahim H, Purra H, Alkhazraji AK, AlNajjar MS, AlNajjar M.Metformin-Induced Hemolysis in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient: A Case Report..Cureus.22-JUL-2024;16(7):e65081$$$$$Y$$$20240908$$HP$AE$AE
242954011$24295401$1$I$$20240827$20240908$20240908$EXP$$ZA-MACLEODS PHARMA-MAC2024049143$MACLEODS$$$$$$Y$$$20240906$$HP$ZA$ZA
242954021$24295402$1$I$$20240827$20240908$20240908$EXP$$US-MACLEODS PHARMA-MAC2024049151$MACLEODS$Rink DE, Abramson RH, Johnson NJ, Lee RY..Diagnostic Confounders in Brain Death A Woman with Unexplained Coma and Brainstem Areflexia.Annals of the American Thoracic Society.2024;21(8)::1204-8$$$$$Y$$$20240908$$MD$US$US
242954031$24295403$1$I$20240826$20240826$20240908$20240908$EXP$GB-MHRA-MED-202408261025433370-CNBJH$GB-MACLEODS PHARMA-MAC2024049139$MACLEODS$$$$$$Y$$$20240908$$MD$GB$GB
242954041$24295404$1$I$20240827$20240827$20240908$20240908$EXP$GB-MHRA-MED-202408270736420740-DNTKJ$GB-MACLEODS PHARMA-MAC2024049149$MACLEODS$$$$$$Y$$$20240906$$CN$GB$GB
242954051$24295405$1$I$$20240826$20240908$20240908$EXP$$JP-MACLEODS PHARMA-MAC2024049128$MACLEODS$Kato T, Hiyama S, Sano M, Nakamura G, Sugiyama K.Transient Arginine Vasopressin Deficiency Induced by Valproic Acid Intoxication: A Case Report..Cureus.23-JUL-2024;16(7):e65165$$$$$Y$$$20240906$$MD$JP$JP
242954061$24295406$1$I$$20240826$20240908$20240908$EXP$$KR-MACLEODS PHARMA-MAC2024049241$MACLEODS$Lee JH, Lee J, Sung SH, Bae SH, Kim SG, Oh HK..A case of Methimazole-induced pancytopenia: Successful treatment with recombinant human granulocyte colony-stimulating factor.The Journal of the Korean Endocrine Society.2006;21(6):548-51$$$$$Y$$$20240908$$HP$KR$KR
242954071$24295407$1$I$$20240827$20240908$20240908$EXP$$US-MACLEODS PHARMA-MAC2024049156$MACLEODS$Packer CD, Hornick TR, Augustine SA..Fatal hemolytic anemia associated with metformin: a case report..Journal of Medical Case Reports.2008;2:1-4$$$$$Y$$$20240908$$HP$US$US
242954081$24295408$1$I$$20240903$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409002804$ELI LILLY AND CO$$$$$M$Y$$$20240908$$CN$US$US
242954091$24295409$1$I$$20240905$20240908$20240908$PER$$US-ALXN-202409USA000279US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$CN$US$US
242954101$24295410$1$I$$20240828$20240908$20240908$EXP$$US-RDY-SPO/USA/24/0012789$DR REDDYS$Nanah A, Nair AS, Stoller J. Delayed Response to Glucocorticoids in Daptomycin Lung. American Journal of Therapeutics. 2024 Mar 26;31(4): e518-e521. doi:10.1097/MJT.0000000000001728.$75$YR$E$M$Y$$$20240908$$MD$US$US
242954111$24295411$1$I$$20240904$20240908$20240908$EXP$$US-GSK-US2024AMR110607$GLAXOSMITHKLINE$$$$$$Y$$$20240908$$CN$US$US
242954121$24295412$1$I$$20240905$20240908$20240908$PER$$US-ALXN-202409USA000360US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$CN$US$US
242954141$24295414$1$I$$20240904$20240908$20240908$PER$$US-ALXN-202409USA000284US$ALEXION PHARMACEUTICALS$$$$$M$Y$143.76$KG$20240908$$CN$US$US
242954152$24295415$2$F$20240902$20240905$20240908$20240909$PER$$US-ALXN-202409USA000370US$ALEXION PHARMACEUTICALS$$79$YR$$F$Y$$$20240909$$CN$US$US
242954162$24295416$2$F$20240601$20240909$20240908$20240917$PER$$US-SA-2024SA257255$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240918$$MD$US$US
242954172$24295417$2$F$20240828$20240910$20240908$20240916$PER$$US-SA-2024SA258759$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240916$$CN$US$US
242954181$24295418$1$I$20240801$20240830$20240908$20240908$PER$$US-SA-2024SA255500$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240908$$CN$US$US
242954192$24295419$2$F$20240705$20240902$20240908$20240911$EXP$$NVSC2024CN178594$NOVARTIS$$$$$F$Y$60$KG$20240911$$CN$CN$CN
242954201$24295420$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA258333$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240908$$CN$US$US
242954211$24295421$1$I$20240101$20240826$20240908$20240908$PER$$US-SA-2024SA257295$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240908$$MD$US$US
242954221$24295422$1$I$$20240905$20240908$20240908$PER$$US-ALXN-202409USA000326US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$CN$US$US
242954231$24295423$1$I$$20240904$20240908$20240908$PER$$US-ALXN-202409USA000292US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240908$$CN$US$US
242954241$24295424$1$I$$20240903$20240908$20240908$EXP$$US-AVEVA-000733$AVEVA$Schwetye KE, Nair LR, Boyle J, Barash JA. Histopathologic correlates of opioid-associated injury in CHANTER syndrome: first report of a post-mortem examination. Acta Neuropathol. 2024;148(1):33. doi: 10.1007/s00401-024-02797-9. PMID: 39215828.$45$YR$A$M$Y$$$20240908$$HP$US$US
242954251$24295425$1$I$$20240905$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003718$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240908$$CN$US$US
242954261$24295426$1$I$$20240905$20240908$20240908$PER$$US-ALXN-202409USA000310US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$CN$US$US
242954272$24295427$2$F$20240801$20240913$20240908$20240915$PER$$US-ALXN-202409USA000337US$ALEXION PHARMACEUTICALS$$72$YR$$F$Y$$$20240915$$CN$US$US
242954281$24295428$1$I$20240601$20240829$20240908$20240908$30DAY$$US-GSK-US2024107689$GLAXOSMITHKLINE$$37$YR$$F$Y$$$20240908$$HP$US$US
242954291$24295429$1$I$$20240903$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409002831$ELI LILLY AND CO$$$$$M$Y$$$20240908$$CN$US$US
242954301$24295430$1$I$20240101$20240828$20240908$20240908$PER$$US-SA-2024SA065504$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240908$$HP$US$US
242954312$24295431$2$F$20240904$20240904$20240908$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409002807$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240910$$CN$US$US
242954322$24295432$2$F$$20240909$20240908$20240913$PER$$US-SA-2024SA257086$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240913$$MD$US$US
242954331$24295433$1$I$$20240904$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409002927$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240908$$CN$US$US
242954341$24295434$1$I$$20240904$20240908$20240908$PER$$US-ALXN-202409USA000255US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$CN$US$US
242954351$24295435$1$I$$20240905$20240908$20240908$PER$$US-ALXN-202409USA000277US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$CN$US$US
242954361$24295436$1$I$20240801$20240820$20240908$20240908$PER$$US-TEVA-VS-3235321$TEVA$$20$YR$$F$Y$$$20240908$$CN$US$US
242954371$24295437$1$I$20240801$20240823$20240908$20240908$PER$$US-ASTELLAS-2024US022822$ASTELLAS$$92$YR$E$M$Y$$$20240908$$MD$US$US
242954381$24295438$1$I$$20240903$20240908$20240908$PER$$US-ROCHE-10000073536$ROCHE$$59$YR$A$F$Y$$$20240908$$MD$US$US
242954391$24295439$1$I$20240801$20240823$20240908$20240908$PER$$US-ASTELLAS-2024-AER-002618$ASTELLAS$$73$YR$E$M$Y$$$20240908$$CN$US$US
242954401$24295440$1$I$$20240905$20240908$20240908$PER$$US-ALXN-202409USA000316US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$CN$US$US
242954412$24295441$2$F$$20240906$20240908$20240910$PER$$US-ALXN-202409USA000321US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$HP$US$US
242954421$24295442$1$I$$20240828$20240908$20240908$EXP$$DK-RDY-SPO/DNK/24/0012790$DR REDDYS$Mollerup S, Elmeskov C, Pinholt M, Sejersen TS, Pedersen MS, Worning P, et al. Rapid in vivo development of resistance to daptomycin in vancomycin-resistant Enterococcus faecium due to genomic alterations. FEMS Microbiology Letters. 2022 Aug 03;369(1): doi:10.1093/femsle/fnac063.$$$$$Y$$$20240908$$HP$DK$DK
242954431$24295443$1$I$20240827$20240830$20240908$20240908$EXP$$RU-RDY-SPO/RUS/24/0012701$DR REDDYS$$17$YR$T$F$Y$82$KG$20240908$$HP$RU$RU
242954441$24295444$1$I$$20240904$20240908$20240908$PER$$US-ROCHE-10000074403$ROCHE$$$$$M$Y$$$20240908$$HP$US$US
242954451$24295445$1$I$20240228$20240905$20240908$20240908$PER$$US-ALXN-202409USA000273US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240908$$HP$US$US
242954461$24295446$1$I$$20240829$20240908$20240908$30DAY$$US-GSK-US2024107930$GLAXOSMITHKLINE$$$$A$F$Y$$$20240908$$CN$US$US
242954471$24295447$1$I$20240801$20240905$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003782$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240908$$HP$US$US
242954482$24295448$2$F$$20240923$20240908$20240930$EXP$GB-GERMAN-SPO/GBR/24/0012860$GB-RDY-SPO/GBR/24/0012860$DR REDDYS$Boal A, Millar C. Case series: Assessment of two anti-HMG-COA reductase antibody-associated immune-mediated necrotising myopathy patients in a Scottish Lipid Clinic. Atherosclerosis. 2024;395(Supplement 1):118050. DOI:10.1016/j.atherosclerosis.2024.118050.$74$YR$E$F$Y$$$20240930$$MD$GB$GB
242954491$24295449$1$I$20240818$20240829$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202408018939$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240908$$CN$US$US
242954501$24295450$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA257528$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240908$$HP$US$US
242954511$24295451$1$I$$20240829$20240908$20240908$EXP$$US-GSK-US2024AMR108267$GLAXOSMITHKLINE$$$$$$Y$$$20240908$$CN$US$US
242954521$24295452$1$I$$20240905$20240908$20240908$EXP$$TR-ALXN-202409TUR000346TR$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240908$$MD$TR$TR
242954531$24295453$1$I$$20240823$20240908$20240908$PER$$US-RDY-SPO/USA/24/0012452$DR REDDYS$$$$$F$Y$$$20240908$$CN$US$US
242954541$24295454$1$I$20190101$20240828$20240908$20240908$PER$$US-SA-2024SA258529$SANOFI AVENTIS$$$$A$F$Y$$$20240908$$MD$US$US
242954551$24295455$1$I$$20240905$20240908$20240908$PER$$US-JNJFOC-20240911609$JOHNSON AND JOHNSON$$$$$$Y$$$20240908$$PH$US$US
242954561$24295456$1$I$20240101$20240828$20240908$20240908$PER$$US-SA-2024SA258500$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240908$$HP$US$US
242954571$24295457$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA258235$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240908$$CN$US$US
242954581$24295458$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA257634$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240908$$MD$US$US
242954591$24295459$1$I$$20240904$20240908$20240908$PER$$US-ALXN-202409USA000197US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$PH$US$US
242954601$24295460$1$I$20240815$20240905$20240908$20240908$EXP$$US-ROCHE-10000075371$ROCHE$$24$YR$A$F$Y$65.31$KG$20240908$$CN$US$US
242954612$24295461$2$F$$20240905$20240908$20240909$EXP$$US-ROCHE-10000075325$ROCHE$$38$YR$A$F$Y$$$20240909$$CN$US$US
242954621$24295462$1$I$$20240905$20240908$20240908$PER$$US-ROCHE-10000075814$ROCHE$$$$A$F$Y$$$20240908$$CN$US$US
242954631$24295463$1$I$20240301$20240905$20240908$20240908$EXP$$CA-ROCHE-10000075537$ROCHE$$53$YR$A$F$Y$$$20240908$$CN$CA$CA
242954641$24295464$1$I$$20240829$20240908$20240908$EXP$$PR-GSK-PR2024107800$GLAXOSMITHKLINE$$69$YR$$M$Y$$$20240908$$MD$PR$US
242954651$24295465$1$I$$20240904$20240908$20240908$PER$$US-AMGEN-USASP2024177490$AMGEN$$$$$$Y$$$20240908$$PH$US$US
242954661$24295466$1$I$20240903$20240904$20240908$20240908$EXP$$CA-ROCHE-10000074961$ROCHE$$53$YR$A$F$Y$$$20240908$$CN$CA$CA
242954682$24295468$2$F$$20240912$20240908$20240915$PER$$US-ALXN-A202204995$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240915$$CN$US$US
242954691$24295469$1$I$$20240904$20240908$20240908$EXP$$CA-ROCHE-10000075031$ROCHE$$49$YR$A$F$Y$$$20240908$$CN$CA$CA
242954701$24295470$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA258589$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240908$$HP$US$US
242954711$24295471$1$I$$20240905$20240908$20240908$PER$$US-AMGEN-USASP2024178457$AMGEN$$$$$$Y$$$20240908$$CN$US$US
242954731$24295473$1$I$$20240828$20240908$20240908$30DAY$$US-GSK-US2024107297$GLAXOSMITHKLINE$$$$$M$Y$$$20240908$$CN$US$US
242954742$24295474$2$F$$20240911$20240908$20240915$EXP$$US-ROCHE-10000075330$ROCHE$$81$YR$E$M$Y$$$20240915$$CN$US$US
242954751$24295475$1$I$20240201$20240905$20240908$20240908$EXP$$US-ROCHE-3518183$ROCHE$$56$YR$A$F$Y$116.12$KG$20240908$$CN$US$US
242954761$24295476$1$I$20240101$20240905$20240908$20240908$PER$$US-AMGEN-USASP2024177934$AMGEN$$66$YR$E$M$Y$$$20240908$$CN$US$US
242954781$24295478$1$I$20240803$20240826$20240908$20240908$PER$$US-SA-2024SA258584$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240908$$MD$US$US
242954791$24295479$1$I$$20240904$20240908$20240908$PER$$US-ALXN-202409USA000256US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240908$$CN$US$US
242954801$24295480$1$I$20240829$20240829$20240908$20240908$30DAY$$US-GSK-US2024107943$GLAXOSMITHKLINE$$42$YR$$F$Y$$$20240908$$CN$US$US
242954811$24295481$1$I$$20240903$20240908$20240908$PER$$US-ALXN-202409USA000119US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240908$$CN$US$US
242954821$24295482$1$I$$20240904$20240908$20240908$PER$$US-ALXN-202409USA000144US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240908$$CN$US$US
242954832$24295483$2$F$$20240911$20240908$20240912$EXP$$CA-ROCHE-10000075189$ROCHE$$$$A$F$Y$$$20240912$$CN$CA$CA
242954841$24295484$1$I$$20240830$20240908$20240908$EXP$$PL-ROCHE-10000074996$ROCHE$$43$YR$A$F$Y$$$20240908$$MD$PL$PL
242954851$24295485$1$I$$20240903$20240908$20240908$PER$$US-ALXN-202409USA000104US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240908$$CN$US$US
242954861$24295486$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA258568$SANOFI AVENTIS$$$$A$M$Y$$$20240908$$HP$US$US
242954881$24295488$1$I$20240627$20240828$20240908$20240908$EXP$$NVSC2024FR149382$NOVARTIS$$$$E$M$Y$74$KG$20240908$$MD$FR$FR
242954891$24295489$1$I$$20240903$20240908$20240908$PER$$US-ALXN-202409USA000096US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240908$$CN$US$US
242954901$24295490$1$I$$20240829$20240908$20240908$30DAY$$US-GSK-US2024AMR108498$GLAXOSMITHKLINE$$$$$F$Y$$$20240908$$CN$US$US
242954911$24295491$1$I$$20240903$20240908$20240908$EXP$$US-ALXN-202409USA000123US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240908$$CN$US$US
242954921$24295492$1$I$$20240826$20240908$20240908$PER$$US-RDY-SPO/USA/24/0012651$DR REDDYS$$20$YR$A$F$Y$$$20240908$$MD$US$US
242954931$24295493$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA258559$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240908$$MD$US$US
242954941$24295494$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA258598$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240908$$HP$US$US
242954961$24295496$1$I$20240801$20240905$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003762$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240908$$CN$US$US
242954972$24295497$2$F$$20240917$20240908$20240925$EXP$$GB-ORPHANEU-2024006771$RECORDATI$$$$$$Y$$$20240925$$CN$GB$GB
242954981$24295498$1$I$$20240903$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140494$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240908$$HP$US$US
242954992$24295499$2$F$20240830$20240903$20240908$20240910$PER$$US-AMGEN-USASP2024176960$AMGEN$$80$YR$E$F$Y$$$20240910$$CN$US$US
242955011$24295501$1$I$$20240904$20240908$20240908$PER$$US-JNJFOC-20240916338$JOHNSON AND JOHNSON$$$$$M$Y$$$20240908$$HP$US$US
242955023$24295502$3$F$$20240919$20240908$20240930$EXP$$PL-DENTSPLY-2024SCDP000253$DENTSPLY$$31$YR$$F$Y$$$20240930$$MD$PL$PL
242955041$24295504$1$I$20240101$20240826$20240908$20240908$PER$$US-SA-2024SA258637$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240908$$HP$US$US
242955051$24295505$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA257677$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240908$$MD$US$US
242955061$24295506$1$I$$20240905$20240908$20240908$PER$$US-AMGEN-USASP2024178077$AMGEN$$$$$M$Y$$$20240908$$CN$US$US
242955091$24295509$1$I$$20240826$20240908$20240908$PER$$US-SA-2022SA402001$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240908$$HP$US$US
242955101$24295510$1$I$20240101$20240829$20240908$20240908$PER$$US-SA-2024SA258721$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240908$$HP$US$US
242955111$24295511$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA258041$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240908$$HP$US$US
242955121$24295512$1$I$20240905$20240905$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003579$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240908$$CN$US$US
242955171$24295517$1$I$$20240830$20240908$20240908$PER$$US-SA-2024SA255956$SANOFI AVENTIS$$$$A$M$Y$$$20240908$$HP$US$US
242955211$24295521$1$I$20240801$20240904$20240908$20240908$PER$$US-AMGEN-USASP2024177172$AMGEN$$$$$F$Y$$$20240908$$CN$US$US
242955262$24295526$2$F$20210514$20240904$20240908$20240911$EXP$$ES-JNJFOC-20240903003$JOHNSON AND JOHNSON$$71$YR$E$M$Y$63$KG$20240912$$MD$ES$ES
242955292$24295529$2$F$$20240826$20240908$20240910$PER$$US-SA-2024SA254474$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240910$$CN$US$US
242955301$24295530$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA257715$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240908$$HP$US$US
242955311$24295531$1$I$20240101$20240826$20240908$20240908$PER$$US-SA-2024SA258775$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240908$$HP$US$US
242955322$24295532$2$F$$20240906$20240908$20240913$PER$$US-SA-2024SA258653$SANOFI AVENTIS$$$$$M$Y$$$20240913$$CN$US$US
242955331$24295533$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA258510$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240908$$HP$US$US
242955341$24295534$1$I$20240824$20240830$20240908$20240908$PER$$US-SA-2024SA255469$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240908$$CN$US$US
242955351$24295535$1$I$20240831$20240903$20240908$20240908$PER$$US-SA-2024SA258383$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240908$$MD$US$US
242955381$24295538$1$I$$20240904$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141480$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240908$$CN$US$US
242955391$24295539$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA258474$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240908$$MD$US$US
242955401$24295540$1$I$$20240904$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003690$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240908$$CN$US$US
242955411$24295541$1$I$20240201$20240905$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003739$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240908$$CN$US$US
242955421$24295542$1$I$20231114$20240827$20240908$20240908$PER$$US-SA-2024SA258465$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240908$$CN$US$US
242955431$24295543$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA258697$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240908$$HP$US$US
242955441$24295544$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA258167$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240908$$HP$US$US
242955451$24295545$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA258743$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240908$$HP$US$US
242955461$24295546$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA258737$SANOFI AVENTIS$$$$E$F$Y$70.3$KG$20240908$$MD$US$US
242955481$24295548$1$I$$20240904$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141560$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240908$$PH$US$US
242955491$24295549$1$I$$20240904$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140963$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240908$$HP$US$US
242955511$24295551$1$I$$20240904$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142144$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240908$$CN$US$US
242955521$24295552$1$I$$20240904$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409002518$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240908$$CN$US$US
242955531$24295553$1$I$$20240905$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003794$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240908$$CN$US$US
242955541$24295554$1$I$$20240903$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409001860$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240908$$CN$US$US
242955551$24295555$1$I$$20240904$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409002557$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240908$$CN$US$US
242955561$24295556$1$I$$20240904$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003006$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240908$$CN$US$US
242955571$24295557$1$I$$20240903$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141718$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$102.06$KG$20240908$$CN$US$US
242955581$24295558$1$I$20240821$20240905$20240908$20240908$PER$$US-AMGEN-USASP2024178172$AMGEN$$59$YR$A$M$Y$$$20240908$$CN$US$US
242955591$24295559$1$I$$20240905$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141740$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240908$$HP$US$US
242955602$24295560$2$F$$20240927$20240908$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141745$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240930$$HP$US$US
242955611$24295561$1$I$$20240905$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141688$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240908$$CN$US$US
242955621$24295562$1$I$20240701$20240826$20240908$20240908$PER$$US-SA-2024SA257764$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240908$$HP$US$US
242955631$24295563$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA258668$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240908$$MD$US$US
242955641$24295564$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA258682$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240908$$HP$US$US
242955671$24295567$1$I$20240801$20240828$20240908$20240908$EXP$$JP-GALDERMA-JP2024012527$GALDERMA$$$$$$Y$$$20240908$$MD$JP$JP
242955681$24295568$1$I$20240701$20240828$20240908$20240908$EXP$$US-IOVANCE BIOTHERAPEUTICS, INC-2024IOV000069$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240908$$CN$US$US
242955691$24295569$1$I$$20240903$20240908$20240908$EXP$$US-AstraZeneca-2024A200428$ASTRAZENECA$$$$$F$Y$$$20240908$$CN$US$
242955701$24295570$1$I$$20240905$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141831$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240908$$CN$US$US
242955711$24295571$1$I$20240816$20240905$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142162$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240908$$CN$US$US
242955721$24295572$1$I$20240801$20240904$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003438$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240908$$CN$US$US
242955731$24295573$1$I$20190101$20240905$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003594$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240908$$CN$US$US
242955741$24295574$1$I$$20240905$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003588$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240908$$CN$US$US
242955751$24295575$1$I$$20240829$20240908$20240908$EXP$$US-ARDELYX-2024ARDX006653$ARDELYX$$$$$M$Y$$$20240908$$HP$US$US
242955761$24295576$1$I$20240809$20240829$20240908$20240908$EXP$$US-ARDELYX-2024ARDX006234$ARDELYX$$50$YR$$F$Y$$$20240908$$CN$US$US
242955771$24295577$1$I$20240701$20240903$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409002143$ELI LILLY AND CO$$56$YR$A$$Y$$$20240908$$CN$US$US
242955801$24295580$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA257375$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240908$$HP$US$US
242955811$24295581$1$I$20240101$20240820$20240908$20240908$PER$$US-SA-2024SA257701$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240908$$HP$US$US
242955822$24295582$2$F$20221227$20240905$20240908$20240912$EXP$$ES-JNJFOC-20240902247$JOHNSON AND JOHNSON$$73$YR$E$M$Y$67$KG$20240912$$MD$ES$ES
242955831$24295583$1$I$$20240821$20240908$20240908$PER$$US-SA-2024SA258088$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240908$$MD$US$US
242955841$24295584$1$I$20240101$20240827$20240908$20240908$PER$$US-SA-2024SA258103$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240908$$HP$US$US
242955851$24295585$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA257903$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240908$$MD$US$US
242955861$24295586$1$I$$20240903$20240908$20240908$PER$$US-RDY-SPO/USA/24/0012917$DR REDDYS$$26$YR$A$F$Y$63$KG$20240908$$CN$US$US
242955872$24295587$2$F$$20240910$20240908$20240920$EXP$US-MLMSERVICE-20240827-PI175164-00306-1$US-RDY-SPO/USA/24/0012830$DR REDDYS$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. Journal Journal of Oncology Pharmacy Practice. 2024:1-4. DOI: 10.1177/10781552241265884.$56$YR$A$F$Y$$$20240920$$PH$US$US
242955881$24295588$1$I$$20240828$20240908$20240908$PER$$US-RDY-SPO/USA/24/0012865$DR REDDYS$Meyer AS, Cluster A, Ogle A, Brossier N, Beck M, Lampe A, et al. NOVEL TREATMENTS FOR ACNEIFORM ERUPTIONS CAUSED BY TARGETED THERAPIES IN THE PEDIATRIC POPULATION. Neuro-Oncology. 2024 Jun;26: iv186-iv187. doi:10.1093/neuonc/noae064.649.$$$T$F$Y$$$20240908$$HP$US$US
242955961$24295596$1$I$20240101$20240906$20240908$20240908$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-034663$BOEHRINGER INGELHEIM$$63$YR$A$F$Y$$$20240908$$CN$CA$CA
242956021$24295602$1$I$20240801$20240826$20240908$20240908$PER$$US-SA-2024SA258182$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240908$$MD$US$US
242956031$24295603$1$I$20240101$20240826$20240908$20240908$PER$$US-SA-2024SA257773$SANOFI AVENTIS$$$$E$M$Y$$$20240908$$MD$US$US
242956041$24295604$1$I$$20240827$20240908$20240908$PER$$US-RDY-SPO/USA/24/0012873$DR REDDYS$Cromack SC, Lulu Y, Magdy MP. Prostaglandin Injection for Myoma Expulsion (PRIME): Case Series of a Novel Approach to Hysteroscopic Resection of FIGO Type 2 Myomas. Journal of Minimally Invasive Gynecology. 2024 Jul;31(7): 613-619. doi:10.1016/j.jmig.2024.03.011.$44$YR$A$F$Y$$$20240908$$HP$US$US
242956111$24295611$1$I$20240101$20240820$20240908$20240908$PER$$US-SA-2024SA257537$SANOFI AVENTIS$$$$$F$Y$$$20240908$$HP$US$US
242956121$24295612$1$I$$20240905$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003528$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240908$$CN$US$US
242956131$24295613$1$I$$20240904$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202409003031$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240908$$CN$US$US
242956141$24295614$1$I$$20240827$20240908$20240908$PER$$US-RDY-SPO/USA/24/0012874$DR REDDYS$Cromack SC, Lulu Y, Magdy MP. Prostaglandin Injection for Myoma Expulsion (PRIME): Case Series of a Novel Approach to Hysteroscopic Resection of FIGO Type 2 Myomas. Journal of Minimally Invasive Gynecology. 2024 Jul;31(7): 613-619. doi:10.1016/j.jmig.2024.03.011.$44$YR$A$F$Y$$$20240908$$HP$US$US
242956151$24295615$1$I$$20240905$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141957$BRISTOL MYERS SQUIBB$$27$YR$A$F$Y$$$20240908$$HP$US$US
242956161$24295616$1$I$$20240823$20240908$20240908$PER$$US-SA-2024SA257064$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240908$$HP$US$US
242956171$24295617$1$I$$20240827$20240908$20240908$PER$$US-RDY-SPO/USA/24/0012876$DR REDDYS$Cromack SC, Lulu Y, Magdy MP. Prostaglandin Injection for Myoma Expulsion (PRIME): Case Series of a Novel Approach to Hysteroscopic Resection of FIGO Type 2 Myomas. Journal of Minimally Invasive Gynecology. 2024 Jul;31(7): 613-619. doi:10.1016/j.jmig.2024.03.011.$45$YR$A$F$Y$$$20240908$$HP$US$US
242956181$24295618$1$I$$20240827$20240908$20240908$PER$$US-RDY-SPO/USA/24/0012875$DR REDDYS$Cromack SC, Lulu Y, Magdy MP. Prostaglandin Injection for Myoma Expulsion (PRIME): Case Series of a Novel Approach to Hysteroscopic Resection of FIGO Type 2 Myomas. Journal of Minimally Invasive Gynecology. 2024 Jul;31(7): 613-619. doi:10.1016/j.jmig.2024.03.011.$44$YR$A$F$Y$$$20240908$$HP$US$US
242956191$24295619$1$I$$20240826$20240908$20240908$PER$$US-SA-2024SA258196$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240908$$HP$US$US
242956201$24295620$1$I$$20240904$20240908$20240908$PER$$US-ALXN-202409USA000191US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$CN$US$US
242956211$24295621$1$I$20240822$20240829$20240908$20240908$EXP$$US-JNJFOC-20240877407$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240908$$CN$US$US
242956221$24295622$1$I$$20240903$20240908$20240908$PER$$US-ELI_LILLY_AND_COMPANY-US202408001146$ELI LILLY AND CO$$$$$M$Y$$$20240908$$CN$US$US
242956231$24295623$1$I$$20240905$20240908$20240908$PER$$US-ROCHE-10000075754$ROCHE$$$$A$F$Y$$$20240908$$CN$US$US
242956241$24295624$1$I$20240801$20240827$20240908$20240908$PER$$US-SA-2024SA258068$SANOFI AVENTIS$$9$MON$I$M$Y$$$20240908$$HP$US$US
242956251$24295625$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000563$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$$$$$Y$52$KG$20240908$$HP$CN$CN
242956261$24295626$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000559$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$$$$$Y$$$20240908$$HP$CN$CN
242956271$24295627$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000557$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$55$YR$A$$Y$69$KG$20240908$$HP$CN$CN
242956281$24295628$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000572$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$63$YR$A$$Y$57$KG$20240908$$HP$CN$CN
242956291$24295629$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000560$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$$$$$Y$$$20240908$$HP$CN$CN
242956301$24295630$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000582$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$58$YR$A$$Y$59$KG$20240908$$HP$CN$CN
242956311$24295631$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000579$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$43$YR$A$$Y$70$KG$20240908$$HP$CN$CN
242956321$24295632$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000577$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$$$$$Y$50$KG$20240908$$HP$CN$CN
242956331$24295633$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000561$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$$$$$Y$75$KG$20240908$$HP$CN$CN
242956341$24295634$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000556$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$$$$$Y$$$20240908$$HP$CN$CN
242956351$24295635$1$I$20240607$20240830$20240908$20240908$EXP$$DE-TEVA-VS-3239298$TEVA$$42$YR$$M$Y$$$20240908$$MD$DE$DE
242956361$24295636$1$I$20240817$20240826$20240908$20240908$PER$$US-SA-2024SA257811$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240908$$MD$US$US
242956372$24295637$2$F$20221101$20240903$20240908$20240912$PER$$US-SA-2024SA257465$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240912$$MD$US$US
242956381$24295638$1$I$$20240830$20240908$20240908$PER$$US-SA-2024SA256524$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240908$$MD$US$US
242956391$24295639$1$I$20240819$20240830$20240908$20240908$EXP$FR-AFSSAPS-MA2024001397$FR-TEVA-VS-3239253$TEVA$$77$YR$$F$Y$$$20240908$$MD$FR$FR
242956401$24295640$1$I$20240701$20240830$20240908$20240908$EXP$ES-AEMPS-1562658$ES-TEVA-VS-3239303$TEVA$$72$YR$$M$Y$$$20240908$$MD$ES$ES
242956411$24295641$1$I$20240101$20240827$20240908$20240908$PER$$US-SA-2024SA258323$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240908$$MD$US$US
242956421$24295642$1$I$$20240828$20240908$20240908$PER$$US-JNJFOC-20240900589$JOHNSON AND JOHNSON$$$$$F$Y$$$20240908$$CN$US$US
242956431$24295643$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000580$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$$$$$Y$$$20240908$$HP$CN$CN
242956441$24295644$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000565$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$57$YR$A$$Y$58$KG$20240908$$HP$CN$CN
242956451$24295645$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000558$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$71$YR$E$$Y$62$KG$20240908$$HP$CN$CN
242956461$24295646$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000570$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$$$$$Y$66$KG$20240908$$HP$CN$CN
242956471$24295647$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000568$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$53$YR$A$$Y$45$KG$20240908$$HP$CN$CN
242956481$24295648$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000553$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15(1):7116$$$$$Y$55$KG$20240908$$HP$CN$CN
242956491$24295649$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000581$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15(1):7116$$$$$Y$$$20240908$$HP$CN$CN
242956501$24295650$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000529$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$69$YR$E$$Y$55$KG$20240908$$HP$CN$CN
242956511$24295651$1$I$$20240826$20240908$20240908$EXP$$IR-TEYRO-2024-TY-000533$Teyro Labs$Zonooz YA, Alizadehasl A, Davani DN, Jebelli SFH, Aliabadi AY, Najdaghi S, et.al.Cardiac interventricular septum hemangioma in a colon cancer patient treated with Capecitabine: A case report and review of literature..Clin Case Rep.2024;12:e9331$21$YR$A$M$Y$$$20240908$$HP$IR$IR
242956521$24295652$1$I$$20240826$20240908$20240908$PER$$CN-TEYRO-2024-TY-000578$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$$$$$Y$$$20240908$$HP$CN$CN
242956531$24295653$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000552$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al.Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$49$YR$A$$Y$54$KG$20240908$$HP$CN$CN
242956541$24295654$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000576$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$58$YR$A$$Y$67$KG$20240908$$HP$CN$CN
242956551$24295655$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000554$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$54$YR$A$$Y$53$KG$20240908$$HP$CN$CN
242956561$24295656$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000555$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$67$YR$E$$Y$56$KG$20240908$$HP$CN$CN
242956571$24295657$1$I$$20240826$20240908$20240908$EXP$$CN-TEYRO-2024-TY-000564$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$73$YR$E$$Y$40$KG$20240908$$HP$CN$CN
242956581$24295658$1$I$20240101$20240828$20240908$20240908$PER$$US-JNJFOC-20240876197$JOHNSON AND JOHNSON$$$$$M$Y$$$20240908$$CN$US$US
242956591$24295659$1$I$20240830$20240903$20240908$20240908$PER$$US-SA-2024SA258157$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240908$$CN$US$US
242956601$24295660$1$I$20240904$20240904$20240908$20240908$PER$$US-JNJFOC-20240911574$JOHNSON AND JOHNSON$$$$$F$Y$$$20240908$$CN$US$US
242956611$24295661$1$I$$20240904$20240908$20240908$PER$$UM-BRISTOL-MYERS SQUIBB COMPANY-2024-141747$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240908$$CN$UM$UM
242956621$24295662$1$I$$20240904$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141554$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240908$$CN$US$US
242956632$24295663$2$F$$20240831$20240908$20240913$PER$$US-SA-2024SA258185$SANOFI AVENTIS$$$$E$M$Y$84.73$KG$20240913$$MD$US$US
242956641$24295664$1$I$$20240828$20240908$20240908$EXP$$JP-GALDERMA-JP2024002923$GALDERMA$$$$$$Y$$$20240908$$MD$JP$JP
242956651$24295665$1$I$20240101$20240827$20240908$20240908$PER$$US-SA-2024SA258464$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240909$$MD$US$US
242956671$24295667$1$I$$20240828$20240908$20240908$EXP$$JP-GALDERMA-JP2024002926$GALDERMA$$$$$$Y$$$20240908$$MD$JP$JP
242956681$24295668$1$I$$20240904$20240908$20240908$PER$$US-ALXN-202409USA000169US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240908$$CN$US$US
242956691$24295669$1$I$$20240828$20240908$20240908$30DAY$$US-GSK-US2024107317$GLAXOSMITHKLINE$$$$$M$Y$$$20240908$$CN$US$US
242956701$24295670$1$I$20120101$20240829$20240908$20240908$PER$$US-JNJFOC-20240880092$JOHNSON AND JOHNSON$$7$DEC$E$F$Y$$$20240908$$CN$US$US
242956711$24295671$1$I$$20240904$20240908$20240908$PER$$US-JNJFOC-20240911204$JOHNSON AND JOHNSON$$$$$F$Y$$$20240908$$CN$US$US
242956721$24295672$1$I$$20240903$20240908$20240908$EXP$$MX-JNJFOC-20240915978$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240908$$CN$MX$MX
242956731$24295673$1$I$20240101$20240904$20240908$20240908$PER$$US-JNJFOC-20240913785$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240908$$CN$US$US
242956751$24295675$1$I$20240904$20240905$20240908$20240908$PER$$US-AMGEN-USASP2024177964$AMGEN$$71$YR$E$F$Y$$$20240908$$CN$US$US
242956761$24295676$1$I$$20240904$20240908$20240908$EXP$GB-MHRA-MED-202409042114059660-BCHJZ$GB-SANDOZ INC.-SDZ2024GB078012$SANDOZ$$58$YR$$M$Y$83$KG$20240908$$CN$GB$GB
242956771$24295677$1$I$$20240828$20240908$20240908$EXP$$DE-AMGEN-DEUSP2024177736$AMGEN$$73$YR$E$F$Y$$$20240908$$CN$DE$DE
242956781$24295678$1$I$$20240902$20240908$20240908$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049154$BOEHRINGER INGELHEIM$$$$$$Y$$$20240909$$CN$US$US
242956791$24295679$1$I$20240904$20240905$20240908$20240908$PER$$US-AMGEN-USASP2024177959$AMGEN$$73$YR$E$M$Y$$$20240908$$CN$US$US
242956801$24295680$1$I$20240320$20240905$20240908$20240908$EXP$GB-MHRA-MED-202408280843547120-ZMGBC$GB-SANDOZ INC.-SDZ2024GB078232$SANDOZ$$40$YR$$F$Y$48$KG$20240908$$CN$GB$GB
242956811$24295681$1$I$20240514$20240906$20240908$20240908$EXP$FR-AFSSAPS-NC2024001046$FR-SANDOZ INC.-SDZ2024FR078326$SANDOZ$$17$YR$$F$Y$$$20240908$$MD$FR$FR
242956821$24295682$1$I$20240101$20240828$20240908$20240908$EXP$$BR-JNJFOC-20240882696$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240909$$CN$BR$BR
242956831$24295683$1$I$$20240903$20240908$20240908$EXP$$CA-JNJFOC-20240760715$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$HP$CA$CA
242956841$24295684$1$I$20240903$20240905$20240908$20240908$PER$$US-AMGEN-USASP2024178058$AMGEN$$72$YR$E$F$Y$$$20240908$$CN$US$US
242956851$24295685$1$I$20240902$20240905$20240908$20240908$PER$$US-AMGEN-USASP2024178001$AMGEN$$83$YR$E$F$Y$$$20240908$$CN$US$US
242956861$24295686$1$I$$20240905$20240908$20240908$EXP$$JP-SANDOZ INC.-SDZ2024JP078282$SANDOZ$$59$YR$$F$Y$$$20240908$$MD$JP$JP
242956871$24295687$1$I$$20240830$20240908$20240908$EXP$$US-SANDOZ INC.-SDZ2024US076840$SANDOZ$$$$$$Y$$$20240908$$CN$US$US
242956881$24295688$1$I$20240828$20240904$20240908$20240908$PER$$US-AMGEN-USASP2024177275$AMGEN$$$$$$Y$$$20240908$$PH$US$US
242956891$24295689$1$I$20240101$20240816$20240908$20240908$PER$$US-AstraZeneca-2024A188046$ASTRAZENECA$$79$YR$$M$Y$$$20240909$$CN$US$
242956901$24295690$1$I$$20240905$20240908$20240908$30DAY$$IT-SANDOZ INC.-SDZ2024IT078122$SANDOZ$$13$YR$$M$Y$$$20240908$$CN$IT$IT
242956911$24295691$1$I$$20240905$20240908$20240908$EXP$$BE-SANDOZ INC.-PHHY2014BE092694$SANDOZ$$55$YR$$F$Y$$$20240908$$MD$BE$BE
242956921$24295692$1$I$$20240904$20240908$20240908$EXP$$NVSJ2024JP010527$NOVARTIS$$89$YR$$M$Y$75.2$KG$20240909$$MD$JP$JP
242956931$24295693$1$I$20240524$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013722$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242956941$24295694$1$I$$20240829$20240908$20240908$EXP$$US-JNJFOC-20240877945$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$CN$US$US
242956951$24295695$1$I$$20240828$20240908$20240908$PER$$US-BAUSCHBL-2024BNL032579$BAUSCH AND LOMB$$$$$F$Y$$$20240909$$CN$US$US
242956973$24295697$3$F$20240903$20240909$20240908$20240915$30DAY$$US-SANDOZ INC.-SDZ2024US077569$SANDOZ$$11$YR$$M$Y$$$20240915$$CN$US$US
242956981$24295698$1$I$20240904$20240904$20240908$20240908$30DAY$$US-SANDOZ INC.-SDZ2024US077978$SANDOZ$$12$YR$$M$Y$$$20240908$$CN$US$US
242956991$24295699$1$I$20240806$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013730$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957001$24295700$1$I$20240828$20240828$20240908$20240908$PER$$US-ABBVIE-5899852$ABBVIE$$54$YR$$F$Y$$$20240908$$CN$US$US
242957011$24295701$1$I$$20240829$20240908$20240908$PER$$US-BAUSCHBL-2024BNL032572$BAUSCH AND LOMB$$$$E$F$Y$$$20240909$$MD$US$US
242957033$24295703$3$F$20240904$20240904$20240908$20240911$EXP$$US-ABBVIE-5909813$ABBVIE$$71$YR$$F$Y$$$20240911$$CN$US$US
242957042$24295704$2$F$$20240920$20240908$20240930$PER$$US-BAUSCHBL-2024BNL032636$BAUSCH AND LOMB$$$$$F$Y$$$20241001$$CN$US$US
242957051$24295705$1$I$$20240904$20240908$20240908$PER$$US-ABBVIE-5907342$ABBVIE$$$$$$Y$$$20240908$$CN$US$US
242957061$24295706$1$I$20240826$20240829$20240908$20240908$EXP$$US-SANDOZ INC.-SDZ2024US078033$SANDOZ$$$$$F$Y$$$20240908$$CN$US$US
242957071$24295707$1$I$20240805$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013774$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957081$24295708$1$I$$20240905$20240908$20240908$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141913$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240909$$HP$US$US
242957091$24295709$1$I$20240801$20240828$20240908$20240908$PER$$US-BAUSCHBL-2024BNL032515$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240909$$CN$US$US
242957101$24295710$1$I$$20240828$20240908$20240908$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137752$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240909$$MD$US$US
242957111$24295711$1$I$20240101$20240903$20240908$20240908$EXP$$CO-ABBVIE-5905455$ABBVIE$$$$$F$Y$77$KG$20240908$$CN$CO$CO
242957121$24295712$1$I$20230814$20240829$20240908$20240908$EXP$$IL-TAKEDA-2023TUS082523$TAKEDA$$52$YR$$F$Y$$$20240908$$CN$IL$IL
242957131$24295713$1$I$20210712$20240829$20240908$20240908$EXP$$IL-ABBVIE-22K-082-4512627-00$ABBVIE$$77$YR$$M$Y$91$KG$20240908$$MD$IL$IL
242957142$24295714$2$F$20230101$20240906$20240908$20240912$EXP$$US-ABBVIE-5898721$ABBVIE$$$$$F$Y$63.956$KG$20240912$$CN$US$US
242957151$24295715$1$I$$20240904$20240908$20240908$EXP$$US-ABBVIE-5908765$ABBVIE$$$$$M$Y$$$20240908$$CN$US$US
242957161$24295716$1$I$20240507$20240902$20240908$20240908$EXP$$GB-ABBVIE-5905456$ABBVIE$$71$YR$$F$Y$$$20240908$$CN$GB$GB
242957171$24295717$1$I$20231121$20240904$20240908$20240908$EXP$$US-ABBVIE-5907489$ABBVIE$$63$YR$$M$Y$104$KG$20240908$$HP$US$US
242957181$24295718$1$I$$20240904$20240908$20240908$PER$$US-JNJFOC-20240909451$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242957191$24295719$1$I$20240101$20240903$20240908$20240908$PER$$US-JNJFOC-20240905222$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240909$$CN$US$US
242957201$24295720$1$I$20240815$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013731$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957211$24295721$1$I$$20240902$20240908$20240908$EXP$$US-SANDOZ INC.-SDZ2024US077562$SANDOZ$$$$$$Y$$$20240908$$CN$US$US
242957221$24295722$1$I$20240801$20240826$20240908$20240908$PER$$US-SA-2024SA258543$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240909$$HP$US$US
242957231$24295723$1$I$$20240903$20240908$20240908$EXP$$CA-JNJFOC-20240911469$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240909$$HP$CA$CA
242957241$24295724$1$I$20240818$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013777$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957251$24295725$1$I$20240828$20240902$20240908$20240908$EXP$$CN-AstraZeneca-2024A201240$ASTRAZENECA$$33119$DY$$M$Y$70$KG$20240909$$MD$CN$
242957261$24295726$1$I$20240728$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013780$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957271$24295727$1$I$$20240903$20240908$20240908$EXP$$CA-TAKEDA-2024TUS088761$TAKEDA$$$$$F$Y$$$20240908$$CN$CA$CA
242957281$24295728$1$I$20080310$20240901$20240908$20240908$EXP$$US-BIOGEN-2008BI013969$BIOGEN$$45$YR$$F$Y$$$20240908$$MD$US$US
242957291$24295729$1$I$20240816$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013790$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957301$24295730$1$I$20240703$20240905$20240908$20240908$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142076$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240909$$CN$US$US
242957311$24295731$1$I$20240801$20240902$20240908$20240908$EXP$$FR-TAKEDA-2024TUS089267$TAKEDA$$$$A$M$Y$$$20240908$$MD$FR$FR
242957321$24295732$1$I$20240816$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013734$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957331$24295733$1$I$$20240904$20240908$20240908$EXP$$US-JNJFOC-20240912182$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240909$$HP$US$US
242957341$24295734$1$I$20240801$20240829$20240908$20240908$PER$$US-SA-2024SA254824$SANOFI AVENTIS$$$$$F$Y$$$20240909$$MD$US$US
242957351$24295735$1$I$$20240903$20240908$20240908$EXP$$US-JNJFOC-20240907828$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$US$US
242957361$24295736$1$I$20240801$20240902$20240908$20240908$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-140854$BRISTOL MYERS SQUIBB$$70$YR$E$$Y$$$20240909$$PH$CO$CO
242957371$24295737$1$I$$20240904$20240908$20240908$EXP$$NVSC2024CN179131$NOVARTIS$$71$YR$$M$Y$$$20240909$$CN$CN$CN
242957381$24295738$1$I$20240816$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013792$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957391$24295739$1$I$$20240903$20240908$20240908$EXP$$US-JNJFOC-20240911223$JOHNSON AND JOHNSON$$88$YR$E$M$Y$$$20240909$$CN$US$US
242957401$24295740$1$I$$20240903$20240908$20240908$EXP$$US-ABBVIE-5905619$ABBVIE$$$$$F$Y$$$20240908$$CN$US$US
242957411$24295741$1$I$$20240904$20240908$20240908$30DAY$$FR-SANDOZ INC.-SDZ2024FR044318$SANDOZ$$10$YR$$M$Y$$$20240908$$CN$FR$FR
242957422$24295742$2$F$20240826$20240919$20240908$20240925$EXP$$CA-ABBVIE-5905880$ABBVIE$$$$E$F$Y$$$20240925$$CN$CA$CA
242957431$24295743$1$I$20240819$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013800$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957441$24295744$1$I$20240904$20240904$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142318$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240909$$CN$US$US
242957451$24295745$1$I$20240612$20240904$20240908$20240908$EXP$$US-ABBVIE-5907882$ABBVIE$$52$YR$$M$Y$$$20240908$$CN$US$US
242957461$24295746$1$I$20240701$20240904$20240908$20240908$EXP$$FR-ABBVIE-5907586$ABBVIE$$27$YR$$F$Y$$$20240908$$MD$FR$FR
242957471$24295747$1$I$$20240904$20240908$20240908$EXP$$US-ABBVIE-5907823$ABBVIE$$$$$F$Y$$$20240908$$CN$US$US
242957483$24295748$3$F$20240820$20240913$20240908$20240922$EXP$$US-ABBVIE-5907502$ABBVIE$$50$YR$$F$Y$65$KG$20240922$$CN$US$US
242957491$24295749$1$I$20240702$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013803$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957501$24295750$1$I$$20240905$20240908$20240908$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142048$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240909$$HP$US$US
242957511$24295751$1$I$$20240830$20240908$20240908$PER$$US-JNJFOC-20240881062$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$CN$US$US
242957521$24295752$1$I$$20240904$20240908$20240908$PER$$US-JNJFOC-20240909006$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$CN$US$US
242957531$24295753$1$I$20240101$20240904$20240908$20240908$EXP$$US-ABBVIE-5908578$ABBVIE$$$$$F$Y$$$20240908$$CN$US$US
242957541$24295754$1$I$20240101$20240904$20240908$20240908$EXP$$US-ABBVIE-5795365$ABBVIE$$$$$M$Y$$$20240908$$CN$US$US
242957551$24295755$1$I$20240101$20240828$20240908$20240908$PER$$US-SA-2024SA257382$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240909$$CN$US$US
242957561$24295756$1$I$$20240828$20240908$20240908$PER$$US-SA-2024SA259168$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240909$$CN$US$US
242957571$24295757$1$I$$20240829$20240908$20240908$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138573$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240909$$HP$US$US
242957581$24295758$1$I$$20240828$20240908$20240908$PER$$US-SA-2024SA257262$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240909$$MD$US$US
242957591$24295759$1$I$20240101$20240904$20240908$20240908$EXP$$US-ABBVIE-5908647$ABBVIE$$$$$F$Y$$$20240908$$CN$US$US
242957601$24295760$1$I$20240825$20240904$20240908$20240908$EXP$$US-ABBVIE-5908532$ABBVIE$$57$YR$$M$Y$$$20240908$$CN$US$US
242957611$24295761$1$I$20240901$20240904$20240908$20240908$EXP$$US-ABBVIE-5908134$ABBVIE$$69$YR$$M$Y$$$20240908$$CN$US$US
242957621$24295762$1$I$20240815$20240826$20240908$20240908$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161369$JIANGSU HANSOH PHARMACEUTICAL$$65$YR$$M$Y$$$20240908$$MD$CN$CN
242957631$24295763$1$I$20240101$20240903$20240908$20240908$EXP$$NVSJ2024JP010670$NOVARTIS$$42$YR$$$Y$$$20240909$$MD$JP$JP
242957641$24295764$1$I$20190101$20210607$20240908$20240908$EXP$$DE-TAKEDA-2024TUS089432$TAKEDA$$$$$M$Y$$$20240908$$CN$DE$DE
242957651$24295765$1$I$20240801$20240904$20240908$20240908$PER$$US-AMGEN-USASP2024178145$AMGEN$$38$YR$A$M$Y$$$20240908$$CN$US$US
242957661$24295766$1$I$$20240905$20240908$20240908$EXP$$JP-TAKEDA-2024TJP013159$TAKEDA$Yurina Takahata, Takeshi Morimoto. A case of asthma attack induced by immunotherapy for lung adenocarcinoma. Medical Journal Aomori. 2023;68(4):174-6$8$DEC$$F$Y$$$20240908$$MD$JP$JP
242957672$24295767$2$F$20180801$20240909$20240908$20240914$EXP$$US-ABBVIE-5908651$ABBVIE$$58$YR$$F$Y$$$20240914$$CN$US$US
242957681$24295768$1$I$20240101$20240905$20240908$20240908$PER$$US-AMGEN-USASP2024177893$AMGEN$$54$YR$A$M$Y$$$20240908$$HP$US$US
242957691$24295769$1$I$$20240904$20240908$20240908$EXP$$US-ABBVIE-5907775$ABBVIE$$$$$M$Y$$$20240908$$CN$US$US
242957701$24295770$1$I$20240101$20240904$20240908$20240908$EXP$$US-ABBVIE-5907998$ABBVIE$$$$$F$Y$$$20240908$$CN$US$US
242957711$24295771$1$I$20240829$20240830$20240908$20240908$EXP$$US-JNJFOC-20240903220$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240909$$MD$US$US
242957721$24295772$1$I$$20240827$20240908$20240908$PER$$US-JNJFOC-20240870511$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240909$$CN$US$US
242957731$24295773$1$I$$20240905$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142053$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240909$$CN$US$US
242957741$24295774$1$I$$20240905$20240908$20240908$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142301$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240909$$CN$US$US
242957751$24295775$1$I$$20240828$20240908$20240908$PER$$US-ABBVIE-5901012$ABBVIE$$$$$$Y$$$20240908$$HP$US$US
242957761$24295776$1$I$$20240904$20240908$20240908$EXP$$US-ABBVIE-5908183$ABBVIE$$$$$M$Y$$$20240908$$CN$US$US
242957772$24295777$2$F$20230701$20240909$20240908$20240912$EXP$$KR-ABBVIE-5906637$ABBVIE$$27$YR$$M$Y$77$KG$20240912$$MD$KR$KR
242957781$24295778$1$I$20240830$20240905$20240908$20240908$PER$$US-AMGEN-USASP2024177948$AMGEN$$70$YR$E$F$Y$$$20240908$$CN$US$US
242957791$24295779$1$I$$20240828$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137158$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240909$$CN$US$US
242957801$24295780$1$I$20240821$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013824$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957812$24295781$2$F$20240710$20240909$20240908$20240912$EXP$$US-ABBVIE-5908529$ABBVIE$$70$YR$$F$Y$98.883$KG$20240912$$CN$US$US
242957822$24295782$2$F$$20240916$20240908$20240918$EXP$$CA-ABBVIE-5909094$ABBVIE$$$$E$M$Y$$$20240918$$CN$CA$CA
242957851$24295785$1$I$20170106$20240829$20240908$20240908$EXP$$BE-ABBVIE-17K-013-3082071-00$ABBVIE$$76$YR$$M$Y$$$20240908$$HP$BE$BE
242957861$24295786$1$I$20240826$20240830$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142378$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240909$$CN$US$US
242957871$24295787$1$I$$20240905$20240908$20240908$EXP$$US-ABBVIE-5703270$ABBVIE$$$$$F$Y$$$20240908$$CN$US$US
242957881$24295788$1$I$20240819$20240903$20240908$20240908$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-142418$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$0$KG$20240909$$CN$CN$CN
242957891$24295789$1$I$20240730$20240830$20240908$20240908$EXP$FR-AFSSAPS-TO2024001518$FR-EMD Serono-2024046729$EMD SERONO INC$$69$YR$E$M$Y$49$KG$20240909$$MD$FR$FR
242957901$24295790$1$I$$20240830$20240908$20240908$EXP$$US-SANDOZ INC.-SDZ2024US077679$SANDOZ$$$$$F$Y$$$20240908$$HP$US$US
242957911$24295791$1$I$$20240826$20240908$20240908$EXP$$IN-Unichem Pharmaceuticals (USA) Inc-UCM202409-001090$UNICHEM$$59$YR$A$F$Y$$$20240909$$HP$IN$
242957921$24295792$1$I$20240903$20240904$20240908$20240908$EXP$$US-AstraZeneca-2024A201467$ASTRAZENECA$$30026$DY$$M$Y$$$20240909$$HP$US$
242957941$24295794$1$I$20240826$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013819$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957951$24295795$1$I$$20240903$20240908$20240908$PER$$US-ABBVIE-5908341$ABBVIE$$$$$$Y$$$20240908$$CN$US$US
242957961$24295796$1$I$20240520$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013820$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242957971$24295797$1$I$$20240905$20240908$20240908$EXP$$DE-ABBVIE-5908874$ABBVIE$$78$YR$$F$Y$$$20240908$$MD$DE$DE
242957981$24295798$1$I$$20240827$20240908$20240908$PER$$US-ABBVIE-5900399$ABBVIE$$$$$$Y$$$20240908$$HP$US$US
242957991$24295799$1$I$20240801$20240903$20240908$20240908$PER$$US-ABBVIE-5908179$ABBVIE$$44$YR$$F$Y$$$20240908$$HP$US$US
242958002$24295800$2$F$20240101$20240906$20240908$20240912$EXP$$US-ABBVIE-5905754$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
242958011$24295801$1$I$20240401$20240903$20240908$20240908$PER$$US-AMGEN-USASP2024176535$AMGEN$$67$YR$E$F$Y$$$20240908$$CN$US$US
242958021$24295802$1$I$$20240904$20240908$20240908$EXP$$US-ABBVIE-5908504$ABBVIE$$$$$F$Y$$$20240908$$CN$US$US
242958031$24295803$1$I$20240904$20240904$20240908$20240908$EXP$$RO-ABBVIE-5908152$ABBVIE$$81$YR$$F$Y$$$20240908$$CN$RO$RO
242958041$24295804$1$I$20240904$20240905$20240908$20240908$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141834$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240909$$HP$US$US
242958051$24295805$1$I$20240802$20240905$20240908$20240908$PER$$US-AMGEN-USASP2024177803$AMGEN$$3$YR$C$F$Y$$$20240908$$HP$US$US
242958061$24295806$1$I$20230101$20240904$20240908$20240908$EXP$$AU-ABBVIE-5908122$ABBVIE$$$$$F$Y$$$20240908$$MD$AU$AU
242958071$24295807$1$I$$20240904$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141876$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240909$$CN$US$US
242958081$24295808$1$I$20240816$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013822$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242958091$24295809$1$I$$20240829$20240908$20240908$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-136659$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$HP$KR$KR
242958101$24295810$1$I$20240903$20240904$20240908$20240908$EXP$$US-ABBVIE-5907527$ABBVIE$$57$YR$$F$Y$$$20240908$$CN$US$US
242958111$24295811$1$I$20240715$20240830$20240908$20240908$EXP$$CN-BEIGENE-BGN-2024-013823$BEIGENE$$$$$$Y$$$20240908$$HP$CN$CN
242958121$24295812$1$I$20240201$20240902$20240908$20240908$EXP$$AU-AstraZeneca-2024A200584$ASTRAZENECA$$77$YR$$F$Y$$$20240909$$CN$AU$
242958131$24295813$1$I$20240903$20240903$20240908$20240908$EXP$$US-ABBVIE-5906512$ABBVIE$$84$YR$$F$Y$$$20240908$$CN$US$US
242958141$24295814$1$I$20240830$20240905$20240908$20240908$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141893$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240909$$CN$US$US
242958151$24295815$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA257487$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240909$$CN$US$US
242958161$24295816$1$I$20240824$20240826$20240908$20240908$PER$$US-SA-2024SA256986$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240909$$MD$US$US
242958171$24295817$1$I$$20240903$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141887$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240909$$CN$US$US
242958181$24295818$1$I$$20240829$20240908$20240908$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142201$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$MD$JP$JP
242958191$24295819$1$I$$20240903$20240908$20240908$EXP$$US-SANDOZ INC.-SDZ2024US050566$SANDOZ$$$$$$Y$$$20240908$$CN$US$US
242958201$24295820$1$I$20240101$20240904$20240908$20240908$EXP$$US-ABBVIE-5908181$ABBVIE$$$$$M$Y$$$20240908$$CN$US$US
242958211$24295821$1$I$20240101$20240903$20240908$20240908$EXP$$US-ABBVIE-5906391$ABBVIE$$$$$F$Y$$$20240908$$CN$US$US
242958221$24295822$1$I$20220403$20240830$20240908$20240908$EXP$$CA-ABBVIE-5906942$ABBVIE$$60$YR$$M$Y$$$20240908$$CN$CA$CA
242958231$24295823$1$I$20240801$20240903$20240908$20240908$EXP$$CA-ABBVIE-5906946$ABBVIE$$69$YR$$F$Y$$$20240908$$CN$CA$CA
242958241$24295824$1$I$20240801$20240903$20240908$20240908$EXP$$US-ABBVIE-5906229$ABBVIE$$70$YR$$F$Y$$$20240908$$CN$US$US
242958251$24295825$1$I$$20240903$20240908$20240908$30DAY$$US-SANDOZ INC.-SDZ2024US077582$SANDOZ$$$$$F$Y$$$20240908$$CN$US$US
242958261$24295826$1$I$$20240903$20240908$20240908$30DAY$$US-SANDOZ INC.-SDZ2024US077853$SANDOZ$$$$$F$Y$$$20240908$$HP$US$US
242958271$24295827$1$I$20240801$20240904$20240908$20240908$EXP$$US-ABBVIE-5907435$ABBVIE$$61$YR$$F$Y$$$20240908$$CN$US$US
242958302$24295830$2$F$20240701$20240906$20240908$20240911$EXP$$US-ABBVIE-5906396$ABBVIE$$70$YR$$F$Y$82.553$KG$20240911$$CN$US$US
242958311$24295831$1$I$20240825$20240904$20240908$20240908$EXP$$CN-ABBVIE-5906901$ABBVIE$$73$YR$$M$Y$70$KG$20240908$$MD$CN$CN
242958321$24295832$1$I$$20240903$20240908$20240908$EXP$$US-ABBVIE-5907131$ABBVIE$$$$$M$Y$$$20240908$$CN$US$US
242958331$24295833$1$I$20240101$20240904$20240908$20240908$EXP$$US-ABBVIE-5908124$ABBVIE$$$$$F$Y$$$20240908$$CN$US$US
242958341$24295834$1$I$$20240906$20240908$20240908$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050129$BOEHRINGER INGELHEIM$$$$$$Y$$$20240909$$CN$US$US
242958352$24295835$2$F$20240101$20240910$20240908$20240913$EXP$$US-ABBVIE-5907490$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
242958362$24295836$2$F$$20240905$20240908$20240910$EXP$$NVSC2024PL179343$NOVARTIS$$$$$$Y$$$20240910$$MD$PL$PL
242958371$24295837$1$I$$20240905$20240908$20240908$PER$$NVSC2024US179592$NOVARTIS$$$$$M$Y$104$KG$20240909$$CN$US$US
242958381$24295838$1$I$$20240903$20240908$20240908$EXP$$NVSC2024CN179157$NOVARTIS$$$$$F$Y$$$20240909$$CN$CN$CN
242958392$24295839$2$F$20240101$20240905$20240908$20240912$EXP$$ES-ABBVIE-5907029$ABBVIE$$$$$M$Y$$$20240912$$HP$ES$ES
242958401$24295840$1$I$$20240826$20240908$20240908$EXP$$US-KVK-TECH, INC-20240800126$KVK-TECH$Jennifer L Swatek. Over-the-counter medications encountered in the postmortem pediatric population from 2010-2020. J Anal Toxicol. 2024;48 (7):473-481$$$$$Y$$$20240908$$HP$US$US
242958411$24295841$1$I$20240531$20240904$20240908$20240908$EXP$$US-ABBVIE-5907886$ABBVIE$$58$YR$$M$Y$$$20240908$$CN$US$US
242958421$24295842$1$I$20240831$20240904$20240908$20240908$EXP$$CA-ABBVIE-5909142$ABBVIE$$79$YR$$M$Y$$$20240908$$HP$CA$CA
242958431$24295843$1$I$$20240830$20240908$20240908$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142373$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$MD$JP$JP
242958441$24295844$1$I$20240801$20240827$20240908$20240908$PER$$US-ABBVIE-5900432$ABBVIE$$$$$M$Y$$$20240908$$CN$US$US
242958451$24295845$1$I$20240801$20240826$20240908$20240908$PER$$US-SA-2024SA257072$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240909$$MD$US$US
242958461$24295846$1$I$$20240825$20240908$20240908$PER$$US-SA-2024SA258106$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240909$$CN$US$US
242958471$24295847$1$I$$20240827$20240908$20240908$PER$$US-SA-2024SA257964$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240909$$MD$US$US
242958481$24295848$1$I$$20240828$20240908$20240908$EXP$$IN-AMNEAL PHARMACEUTICALS-2024-AMRX-03232$AMNEAL$Sharma S, Tiwari S, Saini L, Yadav T, Manjunathan S, et al.. Dextromethorphan Associated Neurotoxicity with Cerebellar Edema (DANCE) Syndrome in Young Children: Neuroimaging Features. AJNR Am. J. Neuroradiol.. 2024$$$$$Y$$$20240909$$HP$IN$IN
242958491$24295849$1$I$$20240905$20240908$20240908$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141653$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$69.85$KG$20240909$$CN$US$US
242958501$24295850$1$I$$20240819$20240908$20240908$PER$$US-JNJFOC-20240859870$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240909$$CN$US$US
242958511$24295851$1$I$$20240902$20240908$20240908$PER$$US-AMGEN-USASP2024178539$AMGEN$Akhdar G.; Akpan I. et al.. MM-388 Navigating the Nexus: Lenalidomide-Associated Thrombotic Thrombocytopenic Purpura (TTP). Clinical Lymphoma Myeloma and Leukemia. 2024;24:S555$56$YR$A$M$Y$$$20240908$$MD$US$US
242958521$24295852$1$I$$20240903$20240908$20240908$EXP$$US-AMGEN-USASP2024175399$AMGEN$Alaniz J.A.; Armstrong P.; Bosley A. et al.. Unexpected spontaneous expectoration of a grass bur: A case report. SAGE Open Medical Case Reports. 2024;12:1-4$63$YR$A$M$Y$$$20240908$$HP$US$US
242958531$24295853$1$I$$20240821$20240909$20240909$PER$$US-AstraZeneca-2024A192161$ASTRAZENECA$$$$$F$Y$$$20240909$$MD$US$
242958541$24295854$1$I$$20240904$20240909$20240909$PER$$US-ALXN-202409USA000288US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242958551$24295855$1$I$$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142164$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$123.38$KG$20240909$$MD$US$US
242958563$24295856$3$F$$20240918$20240909$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142261$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240919$$CN$US$US
242958571$24295857$1$I$$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142237$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240909$$PH$US$US
242958581$24295858$1$I$20240814$20240905$20240909$20240909$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-141840$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240909$$HP$PR$PR
242958601$24295860$1$I$$20240829$20240909$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-141749$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$MD$JP$JP
242958611$24295861$1$I$$20240904$20240909$20240909$EXP$$US-JNJFOC-20240909615$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$US$US
242958621$24295862$1$I$20231227$20240904$20240909$20240909$EXP$FR-AFSSAPS-TS2024000955$FR-JNJFOC-20240915173$JOHNSON AND JOHNSON$$63$YR$A$F$Y$73$KG$20240909$$MD$FR$FR
242958632$24295863$2$F$20240101$20240911$20240909$20240916$EXP$$CA-JNJFOC-20240873176$JOHNSON AND JOHNSON$$59$YR$A$M$Y$76$KG$20240917$$HP$CA$CA
242958641$24295864$1$I$$20240904$20240909$20240909$PER$$US-JNJFOC-20240913838$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$CN$US$US
242958652$24295865$2$F$20230101$20240911$20240909$20240916$EXP$DE-CADRBFARM-2024330252$DE-JNJFOC-20240917936$JOHNSON AND JOHNSON$$71$YR$E$M$Y$89$KG$20240916$$MD$DE$DE
242958662$24295866$2$F$$20240904$20240909$20240911$EXP$$US-ABBVIE-5908010$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
242958671$24295867$1$I$20240902$20240903$20240909$20240909$EXP$$US-ABBVIE-5906880$ABBVIE$$38$YR$$F$Y$$$20240909$$CN$US$US
242958681$24295868$1$I$20240701$20240903$20240909$20240909$EXP$$US-ABBVIE-5907128$ABBVIE$$70$YR$$F$Y$$$20240909$$CN$US$US
242958691$24295869$1$I$20190101$20240904$20240909$20240909$EXP$$US-ABBVIE-5907249$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242958701$24295870$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA258604$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240909$$HP$US$US
242958711$24295871$1$I$$20240903$20240909$20240909$EXP$$US-AMGEN-USASP2024177098$AMGEN$Jabbour E.; Short N.; Jain N. et al.. Very Promising Results of the Dose Dense (D-D) Mini-Hyper-CVD-Inotuzumab-Blinatumomab Phase 2 Trial in Patients with Relapsed-Refractory Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S284-S285$$$A$$Y$$$20240908$$MD$US$US
242958721$24295872$1$I$20240101$20240828$20240909$20240909$PER$$US-SA-2024SA258681$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240909$$CN$US$US
242958731$24295873$1$I$20240904$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024177987$AMGEN$$66$YR$E$F$Y$$$20240908$$CN$US$US
242958742$24295874$2$F$20240905$20240909$20240909$20240910$PER$$US-AMGEN-USASP2024179098$AMGEN$$45$YR$A$F$Y$$$20240910$$CN$US$US
242958751$24295875$1$I$20240827$20240903$20240909$20240909$EXP$$FR-ABBVIE-5909069$ABBVIE$$61$YR$$M$Y$$$20240909$$CN$FR$FR
242958761$24295876$1$I$$20240503$20240909$20240909$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445644$RANBAXY$$$$$F$Y$$$20240909$$CN$US$US
242958771$24295877$1$I$$20230302$20240909$20240909$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419400$RANBAXY$$$$$$Y$$$20240909$$CN$US$US
242958781$24295878$1$I$$20240418$20240909$20240909$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-443636$RANBAXY$$$$$M$Y$$$20240909$$CN$US$US
242958791$24295879$1$I$$20231120$20240909$20240909$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420862$RANBAXY$$$$$M$Y$$$20240909$$CN$US$US
242958801$24295880$1$I$$20240825$20240909$20240909$EXP$$US-RDY-SPO/USA/24/0012924$DR REDDYS$$$$I$$Y$$$20240909$$MD$US$US
242958811$24295881$1$I$$20240827$20240909$20240909$PER$$US-ABBVIE-5902203$ABBVIE$$$$A$M$Y$$$20240909$$HP$US$US
242958821$24295882$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009898$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242958831$24295883$1$I$20240807$20240905$20240909$20240909$EXP$$JP-TAKEDA-2024TJP013189$TAKEDA$$2$DEC$$F$Y$$$20240909$$MD$JP$JP
242958841$24295884$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201848$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242958861$24295886$1$I$$20240903$20240909$20240909$EXP$$US-AstraZeneca-2024A200481$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242958871$24295887$1$I$20240101$20240903$20240909$20240909$EXP$$US-ABBVIE-5906325$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242958881$24295888$1$I$$20240905$20240909$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US078221$SANDOZ$$$$$F$Y$$$20240909$$CN$US$US
242958911$24295891$1$I$$20240830$20240909$20240909$EXP$$US-EMD Serono-2024046937$EMD SERONO INC$$$$A$F$Y$$$20240909$$CN$US$US
242958921$24295892$1$I$$20240904$20240909$20240909$EXP$$US-ABBVIE-5596686$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242958931$24295893$1$I$20240905$20240905$20240909$20240909$EXP$$JP-009507513-2409JPN000795J$MERCK$$80$YR$$F$Y$$$20240909$$PH$JP$JP
242958941$24295894$1$I$20240101$20240903$20240909$20240909$EXP$$US-BIOGEN-2024BI01280896$BIOGEN$$$$$F$Y$$$20240909$$HP$US$US
242958951$24295895$1$I$20240801$20240903$20240909$20240909$EXP$$US-BIOGEN-2024BI01280952$BIOGEN$$68$YR$$F$Y$$$20240909$$CN$US$US
242958961$24295896$1$I$$20240903$20240909$20240909$EXP$$CO-ABBVIE-5906923$ABBVIE$$$$$F$Y$$$20240909$$CN$CO$CO
242958971$24295897$1$I$20240826$20240904$20240909$20240909$EXP$$TW-AMGEN-TWNSP2024175699$AMGEN$$$$E$M$Y$$$20240908$$HP$TW$TW
242958981$24295898$1$I$20240101$20240904$20240909$20240909$EXP$$US-ABBVIE-5907333$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242958991$24295899$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA257679$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240909$$HP$US$US
242959001$24295900$1$I$20240801$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142425$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240909$$CN$US$US
242959011$24295901$1$I$20240806$20240905$20240909$20240909$EXP$$US-ABBVIE-5909948$ABBVIE$$42$YR$$M$Y$$$20240909$$CN$US$US
242959031$24295903$1$I$20240101$20240904$20240909$20240909$EXP$$US-ABBVIE-5887830$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242959041$24295904$1$I$20240101$20240904$20240909$20240909$EXP$$US-ABBVIE-5908291$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242959051$24295905$1$I$$20240904$20240909$20240909$EXP$$BR-JNJFOC-20240917686$JOHNSON AND JOHNSON$$58$YR$A$F$Y$53$KG$20240909$$CN$BR$BR
242959061$24295906$1$I$20240707$20240904$20240909$20240909$EXP$$US-JNJFOC-20240911842$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240909$$MD$US$US
242959071$24295907$1$I$$20240903$20240909$20240909$PER$$US-JNJFOC-20240905559$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$MD$US$US
242959081$24295908$1$I$20240801$20240904$20240909$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US077870$SANDOZ$$$$$F$Y$$$20240909$$CN$US$US
242959091$24295909$1$I$$20240906$20240909$20240909$PER$$NVSC2024US179705$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
242959102$24295910$2$F$20240226$20240830$20240909$20240910$PER$$NVSC2024US176712$NOVARTIS$$$$$F$Y$$$20240910$$MD$US$US
242959111$24295911$1$I$$20240822$20240909$20240909$PER$$US-ASTELLAS-2024-AER-003149$ASTELLAS$$$$$M$Y$$$20240909$$HP$US$US
242959121$24295912$1$I$$20240903$20240909$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US077804$SANDOZ$$$$$F$Y$$$20240909$$CN$US$US
242959131$24295913$1$I$$20240903$20240909$20240909$EXP$$JP-AstraZeneca-2024A200989$ASTRAZENECA$$37$YR$$F$Y$$$20240909$$MD$JP$
242959141$24295914$1$I$$20240902$20240909$20240909$EXP$$GB-AstraZeneca-2024A199493$ASTRAZENECA$$$$$F$Y$$$20240909$$MD$GB$
242959151$24295915$1$I$$20240902$20240909$20240909$EXP$$ZA-AstraZeneca-2024A199520$ASTRAZENECA$$76$YR$$M$Y$$$20240909$$CN$ZA$
242959163$24295916$3$F$20240826$20240913$20240909$20240918$EXP$$US-AstraZeneca-2024A200468$ASTRAZENECA$$24689$DY$$M$Y$$$20240918$$HP$US$
242959171$24295917$1$I$$20240903$20240909$20240909$EXP$$ZA-AstraZeneca-2024A200457$ASTRAZENECA$$53$YR$$M$Y$$$20240909$$CN$ZA$
242959182$24295918$2$F$$20240904$20240909$20240916$EXP$$GB-AMGEN-GBRSP2024178436$AMGEN$$77$YR$E$F$Y$$$20240916$$HP$GB$GB
242959191$24295919$1$I$$20240904$20240909$20240909$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-140965$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240909$$MD$DE$DE
242959201$24295920$1$I$20240108$20240905$20240909$20240909$EXP$$CA-SANDOZ INC.-SDZ2024CA078308$SANDOZ$$91$YR$$F$Y$$$20240909$$MD$CA$CA
242959211$24295921$1$I$20240801$20240904$20240909$20240909$EXP$$US-ABBVIE-5908510$ABBVIE$$28$YR$$M$Y$$$20240909$$CN$US$US
242959231$24295923$1$I$$20240901$20240909$20240909$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000310$EMCURE$Goldlust SA, Singer S, Cappello LA, AlMekkawi AK, Lee KD, Ingenito AC at el.. Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastoma. Neuro-Oncology advances. 2024;6(1):vdae129$64$YR$$F$Y$$$20240909$$MD$US$US
242959241$24295924$1$I$$20240901$20240909$20240909$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000308$EMCURE$Ansari A, Dirani K, Malik A, Matthews S.. Silent Manifestations of Disseminated Nocardia in a Renal Transplant Patient. Cureus. 2024;16(7):e65523$45$YR$$M$Y$$$20240909$$HP$US$US
242959251$24295925$1$I$20240828$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178691$AMGEN$$61$YR$A$F$Y$$$20240908$$CN$US$US
242959261$24295926$1$I$$20240827$20240909$20240909$EXP$$US-Emmaus Medical, Inc.-EMM202408-000436$EMMAUS LIFE SCIENCES$$$$$M$Y$$$20240909$$CN$US$
242959272$24295927$2$F$20240101$20240905$20240909$20240916$EXP$$US-Emmaus Medical, Inc.-EMM202408-000437$EMMAUS LIFE SCIENCES$$12$YR$T$M$Y$50.2$KG$20240916$$CN$US$
242959281$24295928$1$I$$20240904$20240909$20240909$EXP$$CA-TAKEDA-2024TUS089064$TAKEDA$$$$$M$Y$$$20240909$$CN$CA$CA
242959291$24295929$1$I$20230504$20240826$20240909$20240909$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-000688$Alvotech$$35$YR$$F$Y$$$20240909$$MD$CA$CA
242959301$24295930$1$I$$20240828$20240909$20240909$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002212$Alvotech$$83$YR$$M$Y$$$20240909$$CN$CA$CA
242959311$24295931$1$I$20230701$20240827$20240909$20240909$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-000906$Alvotech$$66$YR$$F$Y$$$20240909$$MD$CA$CA
242959321$24295932$1$I$20240802$20240905$20240909$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US078214$SANDOZ$$13$YR$$M$Y$$$20240909$$CN$US$US
242959331$24295933$1$I$20231201$20240904$20240909$20240909$EXP$$US-ABBVIE-5907908$ABBVIE$$61$YR$$F$Y$$$20240909$$CN$US$US
242959341$24295934$1$I$$20240903$20240909$20240909$EXP$$US-TAKEDA-2024TUS089154$TAKEDA$$$$$M$Y$$$20240909$$MD$US$US
242959351$24295935$1$I$20240801$20240904$20240909$20240909$EXP$$US-ABBVIE-5908545$ABBVIE$$31$YR$$F$Y$$$20240909$$CN$US$US
242959361$24295936$1$I$$20240830$20240909$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142193$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$MD$JP$JP
242959371$24295937$1$I$20240801$20240903$20240909$20240909$EXP$$US-ABBVIE-5906845$ABBVIE$$19$YR$$M$Y$$$20240909$$CN$US$US
242959381$24295938$1$I$$20240903$20240909$20240909$EXP$$BR-ABBVIE-5907355$ABBVIE$$$$$F$Y$$$20240909$$CN$BR$BR
242959391$24295939$1$I$$20240830$20240909$20240909$EXP$$SA-STRIDES ARCOLAB LIMITED-2024SP011323$STRIDES$Sayed J, Nasir A, Sayed AG, Alghamdi OA, Alsharif EJ.. A case report of MoCD etiology in a neonate: A novel homozygous MoCS2 variant.. Clin-Case-Rep. 2024;12 (7):1-6.$1$WK$$M$Y$2.9$KG$20240909$$HP$SA$SA
242959401$24295940$1$I$$20240830$20240909$20240909$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP011306$STRIDES$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD-Open. 2024;10 (3)$2$DEC$$F$Y$$$20240909$$MD$DE$DE
242959411$24295941$1$I$$20240830$20240909$20240909$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP011308$STRIDES$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD-Open. 2024;10 (3)$2$DEC$$F$Y$$$20240909$$MD$DE$DE
242959421$24295942$1$I$20240101$20240902$20240909$20240909$EXP$$ZA-ABBVIE-5890818$ABBVIE$$39$YR$$F$Y$$$20240909$$CN$ZA$ZA
242959431$24295943$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201819$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242959441$24295944$1$I$$20240903$20240909$20240909$EXP$$JP-AstraZeneca-2024A201033$ASTRAZENECA$$$$$M$Y$$$20240909$$PH$JP$
242959451$24295945$1$I$20240819$20240904$20240909$20240909$EXP$$GB-AstraZeneca-2024A201628$ASTRAZENECA$$19159$DY$$F$Y$$$20240909$$CN$GB$
242959461$24295946$1$I$20240902$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201408$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242959471$24295947$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A202200$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242959491$24295949$1$I$20050101$20240830$20240909$20240909$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP011285$STRIDES$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD-Open. 2024;10 (3)$1$DEC$$M$Y$$$20240909$$MD$DE$DE
242959501$24295950$1$I$20230101$20240904$20240909$20240909$EXP$$US-ABBVIE-5908630$ABBVIE$$71$YR$$F$Y$$$20240909$$CN$US$US
242959511$24295951$1$I$20240904$20240904$20240909$20240909$EXP$$CA-TAKEDA-2020TUS036769$TAKEDA$$67$YR$$F$Y$$$20240909$$CN$CA$CA
242959521$24295952$1$I$$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142311$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240909$$CN$US$US
242959531$24295953$1$I$$20240904$20240909$20240909$EXP$$CA-ABBVIE-5907895$ABBVIE$$$$E$F$Y$$$20240909$$HP$CA$CA
242959541$24295954$1$I$$20240904$20240909$20240909$EXP$$US-JNJFOC-20240908239$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$CN$US$US
242959551$24295955$1$I$20230101$20240827$20240909$20240909$EXP$$US-ENDO USA, INC.-2024-003354$ENDO$$$$$M$Y$$$20240909$$CN$US$US
242959561$24295956$1$I$20020101$20240830$20240909$20240909$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP011288$STRIDES$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.. RMD-Open. 2024;10 (3$1$DEC$$M$Y$$$20240909$$MD$DE$DE
242959571$24295957$1$I$$20240902$20240909$20240909$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011200$STRIDES$Oguni K, Fukushima S, Hagiya H, Kato A, Suyama A, Iwata T, et al.. Cryptococcal prostatitis in an immunocompromised patient with tocilizumab and glucocorticoid therapy: A case report.. J-Infect-Chemother. 2024$72$YR$$M$Y$$$20240909$$HP$JP$JP
242959581$24295958$1$I$$20240812$20240909$20240909$EXP$$DE-AUROBINDO-AUR-APL-2024-002722$AUROBINDO$Spangemacher M, Hart XM, Saalfrank E, Gr?nder G, Reinwald J, Sartorius A. Elevation of Alpha-1 Acid Glycoprotein During Acute Infection Increases Clozapine Levels Without Signs of Intoxication.. J Clin Psychopharmacol.. 2024;44(1):60-63$58$YR$$M$Y$$$20240909$$MD$DE$DE
242959591$24295959$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA257636$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240909$$MD$US$US
242959601$24295960$1$I$$20240828$20240909$20240909$PER$$US-SA-2024SA257758$SANOFI AVENTIS$$$$E$F$Y$$$20240909$$MD$US$US
242959611$24295961$1$I$20240101$20240829$20240909$20240909$PER$$US-SA-2024SA258526$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240909$$HP$US$US
242959622$24295962$2$F$20240101$20240904$20240909$20240913$PER$$US-SA-2024SA257975$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240913$$MD$US$US
242959631$24295963$1$I$$20240830$20240909$20240909$EXP$$US-EMD Serono-2024047346$EMD SERONO INC$$$$A$F$Y$$$20240909$$CN$US$US
242959641$24295964$1$I$$20240903$20240909$20240909$PER$$US-JNJFOC-20240907871$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$US$US
242959651$24295965$1$I$$20240830$20240909$20240909$30DAY$$US-GSK-US2024108467$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242959671$24295967$1$I$$20240827$20240909$20240909$EXP$$IN-KOANAAP-SML-IN-2024-00894$SHILPA MEDICARE$Madhav S, Panayanthatta S, K A. Imatinib Induced Iron Overload. European Journal of Cardiovascular Medicine. 2023;13(2): 930-932.$46$YR$A$M$Y$$$20240909$$MD$IN$IN
242959681$24295968$1$I$$20240827$20240909$20240909$EXP$$US-KOANAAP-SML-US-2024-00892$SHILPA MEDICARE$Hamzah S, Tristan L, Haluk K, Haluk K. Gastric Signet Ring Cell Adenocarcinoma with Metastasis tothe Testicles and Leptomeninges. ACG CASE REPORTS JOURNAL. 2024 Jul 27;Volume 11: doi:10.14309/crj.0000000000001419.$38$YR$A$M$Y$$$20240909$$MD$US$US
242959691$24295969$1$I$$20240827$20240909$20240909$EXP$$US-KOANAAP-SML-US-2024-00895$SHILPA MEDICARE$Pillai AB, Yousef MM, Yousef AM, Hurd MW, Wang H, Maitra A. Molecular and clinicalfeatures of pancreatic acinar cell carcinoma: A single institutional experience. J-Clin-Oncol. 2024;42(16):$$$$$Y$$$20240909$$MD$US$US
242959701$24295970$1$I$20240711$20240904$20240909$20240909$EXP$$CA-JNJFOC-20240708880$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240909$$HP$CA$CA
242959711$24295971$1$I$$20240902$20240909$20240909$EXP$$ZA-TAKEDA-2023TUS011859$TAKEDA$$$$$F$Y$$$20240909$$CN$ZA$ZA
242959721$24295972$1$I$$20240904$20240909$20240909$EXP$$CA-ABBVIE-5910523$ABBVIE$$$$E$M$Y$$$20240909$$HP$CA$CA
242959731$24295973$1$I$$20240828$20240909$20240909$EXP$$IT-AUROBINDO-AUR-APL-2024-042007$AUROBINDO$Esposito P, Cappadona F, Sangregorio F, Costa E, Mallia L, Zanetti V, et al. Combined extracorporeal CO2 removal and renal replacement therapy in a pregnant patient with COVID-19: a case repor. G-Ital-Nefrol. 2023;40:2$34$YR$$F$Y$$$20240909$$MD$IT$IT
242959741$24295974$1$I$$20240827$20240909$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-043647$AUROBINDO$$82$YR$$F$Y$$$20240909$$PH$CA$CA
242959751$24295975$1$I$20240902$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024177323$AMGEN$$74$YR$E$F$Y$$$20240908$$HP$US$US
242959762$24295976$2$F$20240904$20240909$20240909$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142304$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240911$$HP$US$US
242959772$24295977$2$F$$20240911$20240909$20240923$EXP$$PL-AUROBINDO-AUR-APL-2024-043311$AUROBINDO$Jankowski T. Long-term response of a  patient with metastatic lung squamous  cell carcinoma with PD-L1 expression  below 1% to pembrolizumab therapy. ONKOLOGIA W PRAKTYCE KLINICZNEJ - EDUKACJA. 2024;10(Supl. C):C55-C58$69$YR$$M$Y$$$20240923$$MD$PL$PL
242959781$24295978$1$I$20240902$20240904$20240909$20240909$EXP$$US-ABBVIE-5908525$ABBVIE$$56$YR$$F$Y$$$20240909$$CN$US$US
242959792$24295979$2$F$$20240910$20240909$20240926$PER$$TR-TOLMAR, INC.-24TR052056$TOLMAR$$$$$$Y$$$20240926$$PH$TR$TR
242959801$24295980$1$I$20240819$20240820$20240909$20240909$PER$$TR-TOLMAR, INC.-24TR052011$TOLMAR$$62$YR$$$Y$$$20240909$$HP$TR$TR
242959811$24295981$1$I$20240819$20240826$20240909$20240909$PER$$US-SA-2024SA258005$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240909$$MD$US$US
242959821$24295982$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA258197$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240909$$MD$US$US
242959831$24295983$1$I$$20240820$20240909$20240909$PER$$NL-TOLMAR, INC.-24NL052047$TOLMAR$$$$E$M$Y$$$20240909$$HP$NL$NL
242959841$24295984$1$I$20240501$20240903$20240909$20240909$EXP$$CO-ABBVIE-5906920$ABBVIE$$82$YR$$M$Y$80$KG$20240909$$CN$CO$CO
242959851$24295985$1$I$$20240816$20240909$20240909$PER$$US-AstraZeneca-2024A187799$ASTRAZENECA$$$$$$Y$$$20240909$$CN$US$
242959861$24295986$1$I$20240904$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141672$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$76.66$KG$20240909$$CN$US$US
242959871$24295987$1$I$$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142155$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240909$$HP$US$US
242959881$24295988$1$I$$20240905$20240909$20240909$30DAY$$BE-SANDOZ INC.-SDZ2024BE074201$SANDOZ$$45$YR$$M$Y$$$20240909$$HP$BE$BE
242959901$24295990$1$I$$20240905$20240909$20240909$PER$$US-ROCHE-10000075399$ROCHE$$$$T$M$Y$$$20240909$$CN$US$US
242959912$24295991$2$F$$20240919$20240909$20240930$EXP$$PL-AUROBINDO-AUR-APL-2024-043308$AUROBINDO$Borowiec S.. Long-term benefit of chemoimmunotherapy in metastatic KRASmutated lung adenocarcinoma with low PD-L1 expression and active tuberculosis upon diagnosis. ONCOLOGY IN CLINICAL PRACTICE - EDUCATION (Onkol Prakt Klin Edu). 2024;10 suppl. C:C44-C46$52$YR$$M$Y$$$20240930$$HP$PL$PL
242959921$24295992$1$I$20240805$20240903$20240909$20240909$EXP$$CO-JNJFOC-20240843726$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240909$$HP$CO$CO
242959931$24295993$1$I$20240901$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024176627$AMGEN$$80$YR$E$F$Y$$$20240908$$CN$US$US
242959941$24295994$1$I$$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024176972$AMGEN$$$$$F$Y$$$20240908$$CN$US$US
242959951$24295995$1$I$20230101$20240830$20240909$20240909$PER$$US-SA-2024SA256055$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240909$$CN$US$US
242959962$24295996$2$F$20240904$20240905$20240909$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003578$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240911$$CN$US$US
242959981$24295998$1$I$$20240826$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043175$AUROBINDO$Atanackovic D, Kline K, Chen W, Kallen ME, Koka R, Omili D, et al. Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD). Hum-Vaccin-Immunother. 2023;19No. 2:1-5$55$YR$$F$Y$$$20240909$$HP$US$US
242959991$24295999$1$I$$20240903$20240909$20240909$EXP$$CA-TAKEDA-2024TUS088693$TAKEDA$$$$$M$Y$$$20240909$$CN$CA$CA
242960001$24296000$1$I$$20240819$20240909$20240909$PER$$AU-TOLMAR, INC.-24AU051960$TOLMAR$$$$$M$Y$$$20240909$$CN$AU$AU
242960011$24296001$1$I$$20240819$20240909$20240909$PER$$AU-TOLMAR, INC.-24AU052038$TOLMAR$$$$$M$Y$$$20240909$$CN$AU$AU
242960021$24296002$1$I$$20240819$20240909$20240909$PER$$AU-TOLMAR, INC.-24AU051962$TOLMAR$$$$$M$Y$$$20240909$$CN$AU$AU
242960031$24296003$1$I$20240730$20240819$20240909$20240909$PER$$BR-TOLMAR, INC.-24BR052043$TOLMAR$$8$YR$$F$Y$$$20240909$$CN$BR$BR
242960041$24296004$1$I$20240101$20240819$20240909$20240909$PER$$BR-TOLMAR, INC.-24BR052046$TOLMAR$$$$$M$Y$$$20240909$$CN$BR$BR
242960051$24296005$1$I$20240301$20240819$20240909$20240909$PER$$BR-TOLMAR, INC.-24BR052044$TOLMAR$$9$YR$$F$Y$$$20240909$$CN$BR$BR
242960061$24296006$1$I$20240101$20240819$20240909$20240909$PER$$CA-TOLMAR, INC.-24CA051694$TOLMAR$$$$$M$Y$$$20240909$$CN$CA$CA
242960071$24296007$1$I$$20240819$20240909$20240909$PER$$CA-TOLMAR, INC.-24CA051988$TOLMAR$$$$$M$Y$$$20240909$$CN$CA$CA
242960081$24296008$1$I$$20240819$20240909$20240909$PER$$CA-TOLMAR, INC.-24CA051989$TOLMAR$$$$$M$Y$$$20240909$$CN$CA$CA
242960091$24296009$1$I$20240819$20240819$20240909$20240909$PER$$CA-TOLMAR, INC.-24CA051986$TOLMAR$$81$YR$$M$Y$$$20240909$$CN$CA$CA
242960111$24296011$1$I$$20240905$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US078125$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242960121$24296012$1$I$20240501$20240826$20240909$20240909$EXP$$BR-NOVOPROD-1275677$NOVO NORDISK$$$$$F$Y$$$20240909$$CN$BR$BR
242960131$24296013$1$I$20181016$20240904$20240909$20240909$EXP$$CA-TAKEDA-2018TUS027830$TAKEDA$$28$YR$$F$Y$$$20240909$$HP$CA$CA
242960141$24296014$1$I$20240501$20240830$20240909$20240909$30DAY$$PR-VIIV HEALTHCARE LIMITED-US2024AMR109727$VIIV$$67$YR$$M$Y$$$20240909$$CN$PR$US
242960151$24296015$1$I$$20240828$20240909$20240909$EXP$$US-RDY-SPO/USA/24/0012786$DR REDDYS$D^Netto M, Kuhn A, Ferdjallah A, Joshi A. ALPS like: Trekking Sirolimus and its Fallouts. Clinical Immunology. 2023 May 23;250: doi:10.1016/j.clim.2023.109547.$3$YR$C$M$Y$$$20240909$$HP$US$US
242960161$24296016$1$I$20240806$20240826$20240909$20240909$EXP$DK-DKMA-30737727$DK-NOVOPROD-1276559$NOVO NORDISK$$63$YR$$M$Y$$$20240909$$MD$DK$DK
242960171$24296017$1$I$20240601$20240826$20240909$20240909$EXP$$US-NOVOPROD-1275423$NOVO NORDISK$$$$$M$Y$$$20240909$$CN$US$US
242960182$24296018$2$F$20240305$20240902$20240909$20240912$EXP$$UA-NOVOPROD-1275340$NOVO NORDISK$$61$YR$$M$Y$92$KG$20240912$$CN$UA$UA
242960191$24296019$1$I$$20240826$20240909$20240909$EXP$AU-TGA-0000786573$AU-NOVOPROD-1275623$NOVO NORDISK$$34$YR$$F$Y$$$20240909$$CN$AU$AU
242960201$24296020$1$I$$20240826$20240909$20240909$EXP$$US-NOVOPROD-1276730$NOVO NORDISK$$$$$F$Y$$$20240909$$CN$US$US
242960212$24296021$2$F$20240902$20240906$20240909$20240910$PER$$US-AstraZeneca-2024A202294$ASTRAZENECA$$50$YR$$F$Y$$$20240910$$CN$US$
242960221$24296022$1$I$$20240903$20240909$20240909$EXP$$US-ESPERIONTHERAPEUTICS-2024USA01387$ESPERION THERAPEUTICS$$$$$F$Y$$$20240909$$HP$US$US
242960231$24296023$1$I$20240718$20240902$20240909$20240909$EXP$$IT-AstraZeneca-2024A199431$ASTRAZENECA$$64$YR$$F$Y$$$20240909$$MD$IT$
242960241$24296024$1$I$$20240902$20240909$20240909$EXP$$JP-AstraZeneca-2024A201005$ASTRAZENECA$$$$$F$Y$$$20240909$$MD$JP$
242960252$24296025$2$F$20240101$20240910$20240909$20240919$PER$$US-SA-2024SA258947$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240919$$HP$US$US
242960261$24296026$1$I$20240801$20240904$20240909$20240909$PER$$US-AstraZeneca-2024A202313$ASTRAZENECA$$834$MON$$M$Y$$$20240909$$CN$US$
242960271$24296027$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA257018$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240909$$HP$US$US
242960281$24296028$1$I$20240801$20240820$20240909$20240909$PER$$US-SA-2024SA257383$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240909$$MD$US$US
242960291$24296029$1$I$20231001$20240827$20240909$20240909$EXP$$BR-NOVOPROD-1275700$NOVO NORDISK$$$$$F$Y$$$20240909$$CN$BR$BR
242960301$24296030$1$I$$20240826$20240909$20240909$EXP$$CN-NOVOPROD-1278009$NOVO NORDISK$$$$$M$Y$$$20240909$$CN$CN$CN
242960311$24296031$1$I$20240801$20240827$20240909$20240909$EXP$$US-NOVOPROD-1265846$NOVO NORDISK$$67$YR$$M$Y$$$20240909$$CN$US$US
242960321$24296032$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141964$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240909$$CN$US$US
242960341$24296034$1$I$$20240829$20240909$20240909$EXP$$GB-ESPERIONTHERAPEUTICS-2024GBR01371$ESPERION THERAPEUTICS$$$$$$Y$$$20240909$$MD$GB$GB
242960361$24296036$1$I$20240112$20240828$20240909$20240909$EXP$FR-AFSSAPS-LL2024001576$FR-Accord-444537$ACCORD$$57$YR$A$M$Y$$$20240909$$PH$FR$FR
242960371$24296037$1$I$$20240904$20240909$20240909$EXP$$CA-TAKEDA-2024TUS089051$TAKEDA$$$$$M$Y$$$20240909$$MD$CA$CA
242960381$24296038$1$I$$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024177209$AMGEN$$$$$$Y$$$20240908$$PH$US$US
242960391$24296039$1$I$$20240904$20240909$20240909$PER$$US-ABBVIE-5909260$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242960402$24296040$2$F$20240601$20240912$20240909$20240923$EXP$$DE-NOVOPROD-1271748$NOVO NORDISK$$672$MON$$M$Y$111$KG$20240923$$MD$DE$DE
242960411$24296041$1$I$20230601$20240827$20240909$20240909$30DAY$$US-NOVOPROD-1276535$NOVO NORDISK$$26$YR$$F$Y$$$20240909$$CN$US$US
242960421$24296042$1$I$20240805$20240827$20240909$20240909$EXP$CN-NMPA-5101321031136202400231$CN-NOVOPROD-1275820$NOVO NORDISK$$52$YR$$F$Y$69$KG$20240909$$HP$CN$CN
242960432$24296043$2$F$$20240906$20240909$20240918$EXP$$US-NOVOPROD-1276145$NOVO NORDISK$$$$A$F$Y$$$20240918$$PH$US$US
242960441$24296044$1$I$$20240827$20240909$20240909$EXP$$US-NOVOPROD-1276466$NOVO NORDISK$$70$YR$$M$Y$$$20240909$$MD$US$US
242960451$24296045$1$I$20240601$20240827$20240909$20240909$EXP$$US-NOVOPROD-1276596$NOVO NORDISK$$58$YR$$F$Y$$$20240909$$CN$US$US
242960461$24296046$1$I$$20240827$20240909$20240909$EXP$$US-NOVOPROD-1276577$NOVO NORDISK$$$$$M$Y$$$20240909$$MD$US$US
242960472$24296047$2$F$$20240909$20240909$20240910$PER$$US-AMGEN-USASP2024178776$AMGEN$$52$YR$A$F$Y$$$20240910$$CN$US$US
242960481$24296048$1$I$20240823$20240828$20240909$20240909$EXP$CN-HENLIUS-24CN016715$CN-Accord-445312$ACCORD$$47$YR$A$F$Y$$$20240909$$MD$CN$CN
242960492$24296049$2$F$$20240913$20240909$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139764$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240920$$PH$JP$JP
242960501$24296050$1$I$20240808$20240829$20240909$20240909$EXP$$US-862174955-ML2024-04710$MICRO LABS$$42$YR$A$F$Y$72.57$KG$20240909$$CN$US$US
242960522$24296052$2$F$20240801$20240916$20240909$20240920$EXP$$US-862174955-ML2024-04694$MICRO LABS$$66$YR$E$F$Y$$$20240920$$CN$US$US
242960532$24296053$2$F$20240823$20240911$20240909$20240918$EXP$$GB-862174955-ML2024-04751$MICRO LABS$$51$YR$A$F$Y$48$KG$20240918$$PH$GB$GB
242960541$24296054$1$I$20231201$20240830$20240909$20240909$EXP$$DE-862174955-ML2024-04724$MICRO LABS$$$$$F$Y$2.6$KG$20240909$$MD$DE$DE
242960551$24296055$1$I$$20240828$20240909$20240909$EXP$$US-Oxford Pharmaceuticals, LLC-2161372$OXFORD PHARMACEUTICALS$Source document$24$YR$$M$Y$$$20240909$$$US$US
242960561$24296056$1$I$$20240829$20240909$20240909$EXP$$DE-ROCHE-10000070680$ROCHE$$$$$$Y$$$20240909$$MD$DE$DE
242960571$24296057$1$I$20240101$20240821$20240909$20240909$PER$$US-SA-2024SA258368$SANOFI AVENTIS$$$$E$F$Y$$$20240909$$MD$US$US
242960581$24296058$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA257989$SANOFI AVENTIS$$$$A$F$Y$$$20240909$$HP$US$US
242960591$24296059$1$I$$20240904$20240909$20240909$PER$$US-ABBVIE-5909355$ABBVIE$$$$$$Y$$$20240909$$CN$US$US
242960601$24296060$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003669$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240909$$CN$US$US
242960611$24296061$1$I$20231127$20240903$20240909$20240909$30DAY$$US-GSK-US2024109452$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240909$$CN$US$US
242960622$24296062$2$F$$20240925$20240909$20240927$PER$$US-BIOVITRUM-2024-US-011656$BIOVITRUM$$73$YR$$M$Y$$$20240927$$CN$US$US
242960641$24296064$1$I$20240812$20240827$20240909$20240909$EXP$$GB-AMGEN-GBRNI2024177655$AMGEN$$73$YR$E$F$Y$60.1$KG$20240908$$HP$GB$GB
242960651$24296065$1$I$20240904$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024177166$AMGEN$$64$YR$A$M$Y$$$20240908$$CN$US$US
242960661$24296066$1$I$$20240903$20240909$20240909$PER$$US-AMGEN-USASP2024178181$AMGEN$$$$$M$Y$$$20240908$$HP$US$US
242960671$24296067$1$I$$20240830$20240909$20240909$PER$$US-AstraZeneca-2024A194901$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242960681$24296068$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201840$ASTRAZENECA$$$$$M$Y$131$KG$20240909$$CN$US$
242960692$24296069$2$F$$20240912$20240909$20240924$EXP$$CA-APOTEX-2024AP010152$APOTEX$$69$YR$$F$Y$$$20240924$$HP$CA$CA
242960701$24296070$1$I$$20240827$20240909$20240909$EXP$$US-PADAGIS-2024PAD01407$PADAGIS$Wilson P, Rosenstengle C, Spak C. Underrecognized cause diarrhea in solid organ transplant: a report of astroviridae enteritis in liver transplant. Transplant Infectious Diseases. 2024;26(2):e14257$$$$$Y$$$20240909$$MD$US$US
242960711$24296071$1$I$20240813$20240905$20240909$20240909$EXP$$JP-SANDOZ INC.-SDZ2024JP077852$SANDOZ$$94$YR$$F$Y$$$20240909$$PH$JP$JP
242960721$24296072$1$I$$20240903$20240909$20240909$EXP$$US-AMGEN-USASP2024176418$AMGEN$Ajlan R.S.; Dalla S.; Mainster M.A. et.al.. UNILATERAL COVID-19-ASSOCIATED VASCULITIC CENTRAL RETINAL VEIN OCCLUSION: PHLEBITIS with SUBHYALOID, INTRARETINAL, and SUBRETINAL HEMORR14AGES. Retinal Cases and Brief Reports. 2024;18 (5):589-592$39$YR$A$M$Y$$$20240908$$MD$US$US
242960731$24296073$1$I$$20240905$20240909$20240909$PER$$US-ABBVIE-5910240$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242960741$24296074$1$I$$20240827$20240909$20240909$EXP$$US-PADAGIS-2024PAD01412$PADAGIS$Labere B, Christian E, Kapadia M, Prockop S, McDonald D R, Johnston A M. A Novel Combination of Compound Heterozygous Variants in IFNGR1 Causing Complete IFNGR1 Deficiency. Journal of Clinical Immunology. 2024;44(5):111$$$$$Y$$$20240909$$HP$US$US
242960751$24296075$1$I$$20240905$20240909$20240909$EXP$$GB-SANDOZ INC.-SDZ2024GB078319$SANDOZ$$64$YR$$F$Y$69$KG$20240909$$PH$GB$GB
242960761$24296076$1$I$20210401$20240827$20240909$20240909$EXP$$US-NOVOPROD-1276693$NOVO NORDISK$$38$YR$$$Y$$$20240909$$CN$US$US
242960782$24296078$2$F$$20240917$20240909$20240927$EXP$$JP-NOVOPROD-1276927$NOVO NORDISK$Y.Sakai et al.. Glycogenic hepatopathy in a patient with type I diabetes mellitus was confirmed to have improved by liver biopsy. The 252nd Tokai Regional Meeting of the Japanese Society of Internal Medicine. 2024;19$14$YR$$$Y$58.7$KG$20240927$$MD$JP$JP
242960791$24296079$1$I$20240801$20240827$20240909$20240909$EXP$$US-NOVOPROD-1277711$NOVO NORDISK$$$$$M$Y$$$20240909$$CN$US$US
242960801$24296080$1$I$$20240827$20240909$20240909$EXP$$MX-NOVOPROD-1276950$NOVO NORDISK$$$$$$Y$$$20240909$$CN$MX$MX
242960811$24296081$1$I$$20240827$20240909$20240909$EXP$$CO-NOVOPROD-1277495$NOVO NORDISK$$64$YR$$M$Y$100$KG$20240909$$CN$CO$CO
242960821$24296082$1$I$20230822$20240827$20240909$20240909$EXP$$US-NOVOPROD-1276960$NOVO NORDISK$$64$YR$$F$Y$$$20240909$$CN$US$US
242960831$24296083$1$I$$20240827$20240909$20240909$EXP$$CA-NOVOPROD-1276718$NOVO NORDISK$$45$YR$$F$Y$$$20240909$$HP$CA$CA
242960841$24296084$1$I$20240607$20240827$20240909$20240909$EXP$$US-NOVOPROD-1276702$NOVO NORDISK$$62$YR$$M$Y$$$20240909$$CN$US$US
242960861$24296086$1$I$20240101$20240905$20240909$20240909$PER$$US-ABBVIE-5909817$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242960871$24296087$1$I$$20240827$20240909$20240909$EXP$$US-NOVOPROD-1276941$NOVO NORDISK$$61$YR$$F$Y$$$20240909$$MD$US$US
242960881$24296088$1$I$$20240904$20240909$20240909$EXP$DE-BFARM-24006097$DE-JNJFOC-20240915465$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$CN$DE$DE
242960891$24296089$1$I$20240728$20240828$20240909$20240909$EXP$FR-AFSSAPS-LM2024000470$FR-Accord-444649$ACCORD$$68$YR$E$M$Y$59.7$KG$20240909$$MD$FR$FR
242960901$24296090$1$I$$20240829$20240909$20240909$PER$$US-ROCHE-10000070016$ROCHE$$$$E$F$Y$$$20240909$$CN$US$US
242960911$24296091$1$I$20240903$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024177190$AMGEN$$$$$$Y$$$20240908$$HP$US$US
242960921$24296092$1$I$20240905$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178144$AMGEN$$73$YR$E$F$Y$$$20240908$$CN$US$US
242960931$24296093$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA258329$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240909$$MD$US$US
242960942$24296094$2$F$20240801$20240917$20240909$20240918$EXP$$JP-SA-2024SA257298$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240919$$MD$JP$JP
242960951$24296095$1$I$20240101$20240827$20240909$20240909$PER$$US-SA-2024SA258600$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240909$$HP$US$US
242960981$24296098$1$I$$20240831$20240909$20240909$PER$$US-SA-2024SA255909$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240909$$MD$US$US
242960992$24296099$2$F$$20240924$20240909$20240930$EXP$$JP-AMGEN-JPNSP2024175391$AMGEN$Nagashima; Y. A case of generalized pustular psoriasis preceded by psoriasis vulgaris in which spesolimab was effective. Program/abstracts of the 39th Annual Meeting of the Japanese Society for Psorias. 2024;54$66$YR$E$M$Y$$$20240930$$MD$JP$JP
242961001$24296100$1$I$$20240829$20240909$20240909$EXP$$US-ROCHE-10000070847$ROCHE$$73$YR$E$F$Y$$$20240909$$CN$US$US
242961011$24296101$1$I$20240901$20240903$20240909$20240909$PER$$US-AMGEN-USASP2024176100$AMGEN$$$$$$Y$$$20240908$$CN$US$US
242961022$24296102$2$F$20240827$20240906$20240909$20240910$PER$$US-ROCHE-10000074164$ROCHE$$18$YR$A$M$Y$$$20240910$$CN$US$US
242961031$24296103$1$I$20240718$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A202078$ASTRAZENECA$$$$$M$Y$$$20240909$$MD$US$
242961041$24296104$1$I$20240903$20240904$20240909$20240909$PER$$US-ROCHE-10000074274$ROCHE$$$$$$Y$$$20240909$$CN$US$US
242961051$24296105$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A203249$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242961063$24296106$3$F$$20240919$20240909$20240924$EXP$$NL-CHATTEMPRD-2024OHG030723$CHATTEM$Hutten EM, Roeloffzen WW, Lambeck AJ, van den Born-Bondt T, Oude Elberink HN, van de Ven AAJ. Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization. J-Investig-Allergol-Clin-Immunol. 2024;34(3):214-6. DOI: 10.18176/jiaci.0990.$52$YR$A$F$Y$$$20240924$$HP$NL$NL
242961071$24296107$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201760$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242961081$24296108$1$I$20240828$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002836$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240909$$CN$US$US
242961091$24296109$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003785$ELI LILLY AND CO$$$$A$M$Y$$$20240909$$CN$US$US
242961101$24296110$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004178$ELI LILLY AND CO$$$$$M$Y$$$20240909$$CN$US$US
242961111$24296111$1$I$20240101$20240905$20240909$20240909$EXP$$US-AMGEN-USASP2024178185$AMGEN$$$$A$M$Y$$$20240908$$CN$US$US
242961131$24296113$1$I$$20240902$20240909$20240909$EXP$$JP-JNJFOC-20240914607$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240909$$MD$JP$JP
242961141$24296114$1$I$$20240828$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141932$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240909$$CN$US$US
242961151$24296115$1$I$$20240904$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141250$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240909$$HP$US$US
242961161$24296116$1$I$20240701$20240904$20240909$20240909$EXP$FR-AFSSAPS-TS2024000951$FR-JNJFOC-20240915617$JOHNSON AND JOHNSON$$47$YR$A$M$Y$83$KG$20240909$$MD$FR$FR
242961171$24296117$1$I$20240821$20240903$20240909$20240909$EXP$$CN-EMD Serono-2024047587$EMD SERONO INC$$60$YR$A$F$Y$72$KG$20240909$$HP$CN$CN
242961181$24296118$1$I$20240801$20240826$20240909$20240909$PER$$US-SA-2024SA256855$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240909$$HP$US$US
242961191$24296119$1$I$20240101$20240820$20240909$20240909$PER$$US-SA-2024SA257612$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240909$$MD$US$US
242961201$24296120$1$I$20240125$20240904$20240909$20240909$EXP$$NVSC2024CN179332$NOVARTIS$$56$YR$$F$Y$$$20240909$$HP$CN$CN
242961211$24296121$1$I$$20240906$20240909$20240909$PER$$US-ROCHE-10000076122$ROCHE$$76$YR$E$F$Y$$$20240909$$PH$US$US
242961221$24296122$1$I$20240101$20240902$20240909$20240909$EXP$$GR-AMGEN-GRCSP2024177341$AMGEN$$58$YR$A$F$Y$$$20240908$$MD$GR$GR
242961231$24296123$1$I$$20240827$20240909$20240909$EXP$$JP-AMGEN-JPNSP2024175001$AMGEN$Matsui T, Nagai H, Mukozu T, Wakui N, Matsuda T, Igarashi Y. Variceal bleeding following treatment with atezolizumab plus bevacizumab in two patients with unresectable hepatocellular carcinoma.. Clinical Journal of Gastroenterology. 2024$60$YR$A$M$Y$$$20240908$$MD$JP$JP
242961242$24296124$2$F$20240513$20240913$20240909$20240924$EXP$$JP-BEH-2024172333$CSL BEHRING$$68$YR$E$M$Y$$$20240924$$MD$JP$JP
242961261$24296126$1$I$20240901$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201377$ASTRAZENECA$$$$$F$Y$$$20240909$$MD$US$
242961271$24296127$1$I$$20240903$20240909$20240909$EXP$$US-AstraZeneca-2024A201815$ASTRAZENECA$$$$$F$Y$60.3$KG$20240909$$CN$US$
242961281$24296128$1$I$20240417$20240828$20240909$20240909$EXP$$VN-ROCHE-3561939$ROCHE$$73$YR$E$M$Y$$$20240909$$MD$VN$VN
242961291$24296129$1$I$$20240831$20240909$20240909$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001195$ALEMBIC$Paulmann R, Backe K, Pinsonnault J, Humble M, Kelly K.. Incidence of Venous Thromboembolism Among Commonly Prescribed Second-Generation Antipsychotics. Journal of Pharmacy Practice. 2024;37 (4):845-853$$$$$Y$$$20240909$$PH$US$US
242961301$24296130$1$I$20240831$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141619$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240909$$CN$US$US
242961311$24296131$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141724$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240909$$CN$US$US
242961321$24296132$1$I$$20240830$20240909$20240909$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001278$ALEMBIC$$$$$$Y$$$20240909$$CN$US$US
242961331$24296133$1$I$$20240829$20240909$20240909$EXP$$US-RDY-SPO/USA/24/0012951$DR REDDYS$Desai AV, Naranjo A, LaBarre B, Granger MP, Goldsmith KC, States L, et al. A pilot study of post-consolidation chemoimmunotherapy for high-risk neuroblastoma (ANBL19P1): A report from the Children^s Oncology Group. Journal of Clinical Oncology. 2024;42(16):$$$C$$Y$$$20240909$$HP$US$US
242961341$24296134$1$I$20240806$20240829$20240909$20240909$PER$$US-JNJFOC-20240880712$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240909$$CN$US$US
242961361$24296136$1$I$$20240830$20240909$20240909$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001286$ALEMBIC$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B. et.al.. AML-713 Hematological Malignancies and Pregnancy: A Single-Institution Experience. Clinical Lymphoma, Myeloma and Leukemia. 2024;24 (supplem 1):S333-S334$$$$$Y$$$20240909$$HP$US$US
242961371$24296137$1$I$20240816$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002890$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240909$$CN$US$US
242961391$24296139$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003546$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240909$$CN$US$US
242961401$24296140$1$I$$20240830$20240909$20240909$EXP$$GB-AUROBINDO PHARMA GMBH-AUR-APL-2014-06239$AUROBINDO$Sureja D, Arif H... Topiramate induced proximal renal tubular acidosis (RTA): How late is late recovery?. American Journal of Kidney Diseases. 2014;63:A107$28$YR$$F$Y$$$20240909$$MD$US$US
242961411$24296141$1$I$20240619$20240905$20240909$20240909$EXP$$JP-TAKEDA-2024TJP011658$TAKEDA$$2$DEC$$M$Y$$$20240909$$MD$JP$JP
242961421$24296142$1$I$$20240829$20240909$20240909$PER$$US-SA-2024SA258150$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240909$$CN$US$US
242961432$24296143$2$F$$20240917$20240909$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-043421$AUROBINDO$Hosseini R, Brooks SP, Gadelha S, Schaap R, Husan A, Cook J. Effective Treatment of Methotrexate Induced Oral Mucositis With a Morphine Mouthwash Solution: A Case Report. J Pharm Pract. 2024$67$YR$$F$Y$$$20240927$$HP$US$US
242961441$24296144$1$I$$20240830$20240909$20240909$30DAY$$US-GSK-US2024108463$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242961451$24296145$1$I$20220101$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-042956$AUROBINDO$Mann I, Morado-Aramburo O, Hasbun R. Emerging shadows: HHV-8-associated encephalitis unveiled in a solid organ transplant recipient. Transplant Infectious Disease. 2024;26 (4):e14343$73$YR$$F$Y$$$20240909$$MD$US$US
242961461$24296146$1$I$20240825$20240830$20240909$20240909$EXP$$CN-BEIGENE-BGN-2024-013804$BEIGENE$$$$$$Y$$$20240909$$HP$CN$CN
242961471$24296147$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043500$AUROBINDO$Marion Javellana, William H Asbury, Prem Kandiah, Cederic Pimentel, Jay P Kinariwala, Brian M Howard, et al. Use of dual intraventricular vasodilators for refractory cerebral vasospasm in a pediatric patient with traumatic subarachnoid hemorrhage: A case report. Am J Health Syst Pharm. 2024$11$YR$$M$Y$$$20240909$$HP$US$US
242961482$24296148$2$F$$20240906$20240909$20240916$PER$$US-SA-2024SA258644$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240916$$CN$US$US
242961492$24296149$2$F$20240801$20240821$20240909$20240912$PER$$US-SA-2024SA255055$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240912$$MD$US$US
242961501$24296150$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004715$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242961511$24296151$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA258392$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240909$$MD$US$US
242961521$24296152$1$I$20240101$20240820$20240909$20240909$PER$$US-SA-2024SA259550$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240909$$CN$US$US
242961531$24296153$1$I$$20240830$20240909$20240909$EXP$$BE-TAKEDA-2024TUS087995$TAKEDA$$$$$$Y$$$20240909$$MD$BE$BE
242961541$24296154$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004716$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242961551$24296155$1$I$$20240906$20240909$20240909$EXP$$NVSC2024CN179358$NOVARTIS$$68$YR$$F$Y$$$20240909$$CN$CN$CN
242961561$24296156$1$I$20240801$20240826$20240909$20240909$EXP$$US-ASTELLAS-2024-AER-003896$ASTELLAS$$$$$F$Y$$$20240909$$MD$US$US
242961571$24296157$1$I$$20240904$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US078227$SANDOZ$$$$$F$Y$$$20240909$$CN$US$US
242961582$24296158$2$F$20231201$20240916$20240909$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142325$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$54.43$KG$20240919$$CN$US$US
242961591$24296159$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142117$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240909$$HP$US$US
242961601$24296160$1$I$20240101$20240828$20240909$20240909$EXP$$BR-NOVOPROD-1276278$NOVO NORDISK$$49$YR$$F$Y$$$20240909$$MD$BR$BR
242961611$24296161$1$I$$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142361$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240909$$CN$US$US
242961621$24296162$1$I$20240805$20240828$20240909$20240909$EXP$LT-SMCA-4776$LT-Accord-444488$ACCORD$$54$YR$A$M$Y$135$KG$20240909$$MD$LT$LT
242961632$24296163$2$F$20231107$20240913$20240909$20240924$EXP$$ZA-NOVOPROD-1276262$NOVO NORDISK$$$$$F$Y$133$KG$20240924$$MD$ZA$ZA
242961641$24296164$1$I$20210101$20240828$20240909$20240909$EXP$$BR-NOVOPROD-1269822$NOVO NORDISK$$53$YR$$M$Y$$$20240909$$MD$BR$BR
242961661$24296166$1$I$$20240828$20240909$20240909$EXP$$GB-NOVOPROD-1276264$NOVO NORDISK$$$$$F$Y$$$20240909$$HP$GB$GB
242961671$24296167$1$I$$20240902$20240909$20240909$EXP$GB-MHRA-TPP23887284C4550782YC1725005135272$GB-GSK-GB2024108825$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$HP$GB$GB
242961681$24296168$1$I$$20240827$20240909$20240909$EXP$$IT-AUROBINDO-AUR-APL-2024-043220$AUROBINDO$Bernasconi L, Schicchi A, Petrolini VM, Malovini A, Lonati D, Fassio F, et al.. Clinical characteristics of acute lacosamide poisoning: Pavia Poison Control Centre experience. Br-J-ClinPharmacol. 2023$$$$$Y$$$20240909$$HP$IT$IT
242961691$24296169$1$I$20240814$20240827$20240909$20240909$EXP$$US-ENDO USA, INC.-2024-003357$ENDO$$61$YR$$M$Y$$$20240909$$CN$US$US
242961701$24296170$1$I$$20240905$20240909$20240909$PER$$US-GILEAD-2024-0686467$GILEAD$$30$YR$A$F$Y$$$20240908$$HP$US$US
242961711$24296171$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A202172$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242961721$24296172$1$I$20240528$20240903$20240909$20240909$EXP$$FR-AstraZeneca-2024A199966$ASTRAZENECA$$38$YR$$F$Y$102.5$KG$20240909$$MD$FR$
242961731$24296173$1$I$$20240829$20240909$20240909$PER$$US-AstraZeneca-2024A197547$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242961741$24296174$1$I$$20240904$20240909$20240909$EXP$$DE-AstraZeneca-2024A201888$ASTRAZENECA$$65$YR$$M$Y$$$20240909$$MD$DE$
242961751$24296175$1$I$$20240903$20240909$20240909$EXP$$US-AstraZeneca-2024A200822$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242961761$24296176$1$I$20240815$20240827$20240909$20240909$EXP$$CN-AMGEN-CHNSP2024177636$AMGEN$$54$YR$A$M$Y$$$20240908$$HP$CN$CN
242961771$24296177$1$I$$20240828$20240909$20240909$EXP$$US-NOVOPROD-1276934$NOVO NORDISK$$$$$F$Y$$$20240909$$CN$US$US
242961782$24296178$2$F$$20240909$20240909$20240919$EXP$$US-NOVOPROD-1276953$NOVO NORDISK$$$$A$F$Y$$$20240919$$MD$US$US
242961791$24296179$1$I$$20240828$20240909$20240909$EXP$$JP-SPC-000483$SOLARIS PHARMA$Konishi T, Uemura J, Yamashita S, Mori H, Inoue T, Kurokawa K. (A case of metronidazole-induced encephalopathy that is difficult to differentiate from Wernicke encephalopathy). Rinsho Shinkeigaku. 2024 Aug 24. Japanese. doi: 10.5692/clinicalneurol.cn-001972.$76$YR$E$M$Y$$$20240909$$HP$JP$JP
242961801$24296180$1$I$$20240828$20240909$20240909$EXP$$ES-SPC-000482$SOLARIS PHARMA$Chovi-Trull M, Ballesta-Lopez O, Navarro Buendia GA, Sivera-Mascaro R, Albert-Mari A, Ruiz Caldes MJ, et al. Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die. Eur J Hosp Pharm. 2024 Aug 22:ejhpharm-2024-004184. doi: 10.1136/ejhpharm-2024-004184.$53$YR$A$M$Y$$$20240909$$HP$ES$ES
242961811$24296181$1$I$$20240828$20240909$20240909$EXP$$IN-SPC-000481$SOLARIS PHARMA$Nilofar F, Babu N, Kumar M, Palanisamy S, T G. From Hemorrhage to Diarrhea: The Comprehensive Clinical Journey of a Patient With Pseudomembranous Colitis. Cureus. 2024 Jul 23;16(7):e65176. doi: 10.7759/cureus.65176.$48$YR$A$M$Y$$$20240909$$HP$IN$IN
242961821$24296182$1$I$20240301$20240828$20240909$20240909$EXP$$US-NOVOPROD-1276593$NOVO NORDISK$$48$YR$$M$Y$$$20240909$$CN$US$US
242961831$24296183$1$I$$20240828$20240909$20240909$EXP$$US-NOVOPROD-1276700$NOVO NORDISK$$$$A$F$Y$$$20240909$$CN$US$US
242961842$24296184$2$F$20210415$20240909$20240909$20240920$EXP$$AU-NOVOPROD-1276392$NOVO NORDISK$$$$$F$Y$$$20240920$$CN$AU$AU
242961851$24296185$1$I$$20240828$20240909$20240909$EXP$$IL-NOVOPROD-1276958$NOVO NORDISK$$15$YR$$M$Y$$$20240909$$MD$IL$IL
242961871$24296187$1$I$$20240906$20240909$20240909$PER$$NVSC2024US179813$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
242961882$24296188$2$F$20240101$20240924$20240909$20240930$EXP$$JP-GSK-JP2024JPN108982$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$JP$JP
242961891$24296189$1$I$20240729$20240830$20240909$20240909$EXP$$CN-BEIGENE-BGN-2024-013807$BEIGENE$$$$$$Y$$$20240909$$HP$CN$CN
242961901$24296190$1$I$$20240830$20240909$20240909$EXP$$CA-APOTEX-2024AP010183$APOTEX$$64$YR$$F$Y$77.098$KG$20240909$$CN$CA$CA
242961911$24296191$1$I$$20240829$20240909$20240909$EXP$$US-ASTELLAS-2024-AER-004321$ASTELLAS$$84$YR$E$M$Y$$$20240909$$PH$US$US
242961921$24296192$1$I$$20240830$20240909$20240909$PER$$US-AMGEN-USASP2024174569$AMGEN$$$$$$Y$$$20240908$$CN$US$US
242961942$24296194$2$F$$20240911$20240909$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004728$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
242961952$24296195$2$F$20240101$20240916$20240909$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142229$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$89.81$KG$20240919$$CN$US$US
242961961$24296196$1$I$20240315$20240902$20240909$20240909$EXP$$BG-ASTELLAS-2024-AER-004376$ASTELLAS$$82$YR$E$M$Y$$$20240909$$MD$BG$BG
242961971$24296197$1$I$$20240830$20240909$20240909$PER$$US-ROCHE-10000071505$ROCHE$$$$$$Y$$$20240909$$PH$US$US
242961981$24296198$1$I$$20240103$20240909$20240909$EXP$$US-ORGANON-O2409USA000438$ORGANON$$$$$F$Y$$$20240909$$HP$US$US
242961991$24296199$1$I$$20240904$20240909$20240909$PER$$US-GILEAD-2024-0686365$GILEAD$$$$$M$Y$$$20240908$$HP$US$US
242962001$24296200$1$I$$20240515$20240909$20240909$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-447549$RANBAXY$$$$E$F$Y$$$20240909$$CN$US$US
242962021$24296202$1$I$$20240906$20240909$20240909$EXP$$JP-TAKEDA-2024TJP013232$TAKEDA$$$$$F$Y$$$20240909$$MD$JP$JP
242962031$24296203$1$I$20240101$20240905$20240909$20240909$EXP$$US-JNJFOC-20240917538$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240909$$HP$US$US
242962041$24296204$1$I$$20240902$20240909$20240909$EXP$$JP-009507513-2409JPN000751J$MERCK$$5$DEC$$F$Y$$$20240909$$HP$JP$JP
242962051$24296205$1$I$$20240903$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001811$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240909$$CN$US$US
242962061$24296206$1$I$20240829$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002973$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240909$$CN$US$US
242962071$24296207$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003985$ELI LILLY AND CO$$$$$M$Y$$$20240909$$CN$US$US
242962081$24296208$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003680$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240909$$CN$US$US
242962091$24296209$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003701$ELI LILLY AND CO$$63$YR$A$$Y$$$20240909$$CN$US$US
242962101$24296210$1$I$20240701$20240904$20240909$20240909$PER$$US-ROCHE-10000075061$ROCHE$$72$YR$E$F$Y$$$20240909$$HP$US$US
242962111$24296211$1$I$$20240904$20240909$20240909$PER$$US-ROCHE-10000074158$ROCHE$$$$$$Y$$$20240909$$CN$US$US
242962121$24296212$1$I$$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024177318$AMGEN$$$$$M$Y$$$20240908$$CN$US$US
242962131$24296213$1$I$$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024177057$AMGEN$Lozano Chinga M. M.; Bussel J. B.; Fluchel M. N. et al.. Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome. Pediatric Blood + Cancer. 2024;71 (10):1-8$12$YR$T$F$Y$$$20240908$$HP$US$US
242962141$24296214$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004734$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242962151$24296215$1$I$$20240830$20240909$20240909$EXP$$TW-AMGEN-TWNSP2024176490$AMGEN$Hung Y.; Wu W.; Hsu C. et al.. Incorporating Tumor Genomic Profiling and Circulating Tumor Cell-derived Organoids into Clinical Practice for Gastrointestinal cancers. Anticancer research. 2024;44(8):3481-3491$54$YR$A$F$Y$$$20240908$$MD$TW$TW
242962161$24296216$1$I$$20240904$20240909$20240909$EXP$$US-TAKEDA-2024TUS076036$TAKEDA$$$$$F$Y$86.17$KG$20240909$$HP$US$US
242962182$24296218$2$F$20240905$20240916$20240909$20240917$PER$$US-AMGEN-USASP2024178117$AMGEN$$47$YR$A$F$Y$$$20240917$$HP$US$US
242962191$24296219$1$I$$20240905$20240909$20240909$PER$$US-HALEON-2195608$Haleon PLC$$$$C$M$Y$$$20240909$$MD$US$US
242962202$24296220$2$F$$20240903$20240909$20240913$EXP$$ZA-AstraZeneca-2024A201841$ASTRAZENECA$$56$YR$$M$Y$$$20240913$$CN$ZA$
242962211$24296221$1$I$20240904$20240904$20240909$20240909$PER$$US-AstraZeneca-2024A201627$ASTRAZENECA$$70$YR$$M$Y$$$20240909$$CN$US$
242962221$24296222$1$I$20240701$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141855$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240909$$CN$US$US
242962241$24296224$1$I$20240821$20240904$20240909$20240909$EXP$$CN-ROCHE-10000074457$ROCHE$$54$YR$A$F$Y$63$KG$20240909$$HP$CN$CN
242962251$24296225$1$I$$20240829$20240909$20240909$PER$$US-EMD Serono-2024047849$EMD SERONO INC$$$$A$$Y$$$20240909$$CN$US$US
242962261$24296226$1$I$$20240905$20240909$20240909$PER$$NVSC2024US179795$NOVARTIS$$$$$$Y$77$KG$20240909$$CN$US$US
242962271$24296227$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004743$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242962281$24296228$1$I$20240830$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178243$AMGEN$$$$$F$Y$$$20240908$$CN$US$US
242962292$24296229$2$F$$20240912$20240909$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004742$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
242962301$24296230$1$I$$20240828$20240909$20240909$PER$$US-ABBVIE-5901038$ABBVIE$$$$$$Y$$$20240909$$CN$US$US
242962311$24296231$1$I$$20240703$20240909$20240909$PER$$US-CHATTEMPRD-2024OHG023552$CHATTEM$$$$A$$Y$$$20240909$$CN$US$US
242962321$24296232$1$I$$20240829$20240909$20240909$EXP$$CA-INTERCEPT-PM2024001770$INTERCEPT PHARMACEUTICALS$$72$YR$$F$Y$$$20240909$$CN$CA$CA
242962341$24296234$1$I$$20240906$20240909$20240909$EXP$$PT-SANDOZ INC.-SDZ2024PT078355$SANDOZ$$61$YR$$F$Y$$$20240909$$HP$PT$PT
242962351$24296235$1$I$20240101$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178548$AMGEN$$57$YR$A$F$Y$$$20240908$$CN$US$US
242962361$24296236$1$I$20100101$20240830$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2011-04777$AUROBINDO$$65$YR$$M$Y$$$20240909$$HP$GB$GB
242962371$24296237$1$I$$20240904$20240909$20240909$PER$$US-ABBVIE-5908400$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242962381$24296238$1$I$20240101$20240902$20240909$20240909$EXP$$LV-VIWITPHARMA-2024VWTLIT00006$VIWIT PHARMACEUTICAL$Renemane L, Rancans E.Sertraline induced acute hepatocellular liver injury in patient with major depressive disorder: a case report.Frontiers in Psychiatry.01-AUG-2024;15$36$YR$A$F$Y$$$20240906$$HP$LV$LV
242962391$24296239$1$I$$20240904$20240909$20240909$PER$$US-ABBVIE-5909064$ABBVIE$$$$$$Y$$$20240909$$HP$US$US
242962401$24296240$1$I$20220822$20240906$20240909$20240909$EXP$$DE-SANDOZ INC.-NVSC2022DE211578$SANDOZ$$74$YR$$M$Y$$$20240909$$MD$DE$DE
242962412$24296241$2$F$20240626$20240904$20240909$20240911$EXP$FR-AFSSAPS-AM2024000689$FR-SANDOZ INC.-SDZ2024FR077824$SANDOZ$$61$YR$$F$Y$44$KG$20240911$$MD$FR$FR
242962423$24296242$3$F$$20240917$20240909$20240924$PER$$US-CHATTEMPRD-2024OHG030228$CHATTEM$$72$YR$E$F$Y$$$20240924$$CN$US$US
242962431$24296243$1$I$$20240821$20240909$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08387$LUPIN$$$$$$Y$$$20240909$$CN$US$US
242962452$24296245$2$F$20240801$20240905$20240909$20240911$PER$$US-AMGEN-USASP2024178124$AMGEN$$71$YR$E$F$Y$$$20240910$$CN$US$US
242962461$24296246$1$I$20240607$20240828$20240909$20240909$EXP$FR-AFSSAPS-TO2024001224$FR-Accord-444306$ACCORD$$54$YR$A$F$Y$74.5$KG$20240909$$PH$FR$FR
242962471$24296247$1$I$$20230914$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2023-059824$AUROBINDO$$97$YR$$M$Y$$$20240909$$CN$US$US
242962481$24296248$1$I$20230719$20240905$20240909$20240909$EXP$$NVSC2024PL179347$NOVARTIS$$$$$$Y$$$20240909$$MD$PL$PL
242962491$24296249$1$I$$20240904$20240909$20240909$PER$$US-ABBVIE-5909072$ABBVIE$$$$$$Y$$$20240909$$HP$US$US
242962501$24296250$1$I$$20240904$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142234$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240909$$CN$US$US
242962511$24296251$1$I$20240801$20240903$20240909$20240909$EXP$RO-NMA-2024-SP0556$RO-RDY-SPO/ROU/24/0012809$DR REDDYS$$64$YR$A$F$Y$$$20240909$$MD$RO$RO
242962521$24296252$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043491$AUROBINDO$Gopalan R, Mitchel H, Matushinec S, Kerr R, Bolton A, Kamin A, et al.. Feasibility of Outpatient Hemodialysis for Patients with Total Artificial Heart: A Case Series. ASAIO-J. 2023;69(6):E270-E273$56$YR$$F$Y$$$20240909$$MD$US$US
242962531$24296253$1$I$$20240828$20240909$20240909$EXP$$US-NOVOPROD-1276959$NOVO NORDISK$$$$$F$Y$$$20240909$$CN$US$US
242962541$24296254$1$I$20190101$20240904$20240909$20240909$EXP$$US-ABBVIE-5882205$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242962552$24296255$2$F$$20240920$20240909$20240925$EXP$$NVSJ2024JP010531$NOVARTIS$$$$$$Y$$$20240925$$MD$JP$JP
242962562$24296256$2$F$20240704$20240905$20240909$20240911$EXP$$FR-AMGEN-FRASP2024175251$AMGEN$$56$YR$A$F$Y$$$20240911$$MD$FR$FR
242962571$24296257$1$I$20240903$20240904$20240909$20240909$EXP$GB-MHRA-MED-202409041514510640-DCSGJ$GB-AMGEN-GBRSP2024177038$AMGEN$$76$YR$E$F$Y$$$20240908$$HP$GB$GB
242962581$24296258$1$I$$20240830$20240909$20240909$EXP$$DE-AUROBINDO-AUR-APL-2022-035419$AUROBINDO$Schwarz N, Seiffert S, Pendziwiat M, Rademacher AV, Brunger T, Y Weber  et al.. Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants. Neurology. 2022;98(20):e2046-e2059$10$YR$$F$Y$$$20240909$$MD$DE$DE
242962591$24296259$1$I$$20240821$20240909$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08407$LUPIN$$$$$$Y$$$20240909$$PH$US$US
242962601$24296260$1$I$$20230926$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2023-059918$AUROBINDO$$$$$F$Y$56.6$KG$20240909$$CN$US$US
242962612$24296261$2$F$$20240917$20240909$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409003088$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240919$$CN$US$US
242962621$24296262$1$I$$20240828$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408018528$ELI LILLY AND CO$$73$YR$E$$Y$$$20240909$$LW$US$US
242962631$24296263$1$I$20240729$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003784$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240909$$CN$US$US
242962641$24296264$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003402$ELI LILLY AND CO$$66$YR$E$$Y$$$20240909$$LW$US$US
242962651$24296265$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003430$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240909$$CN$US$US
242962661$24296266$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003793$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242962671$24296267$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003797$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242962681$24296268$1$I$$20240828$20240909$20240909$EXP$$AU-NOVOPROD-1277007$NOVO NORDISK$$$$A$F$Y$$$20240909$$MD$AU$AU
242962691$24296269$1$I$$20240828$20240909$20240909$EXP$$US-NOVOPROD-1277026$NOVO NORDISK$$$$A$F$Y$$$20240909$$PH$US$US
242962701$24296270$1$I$$20240828$20240909$20240909$EXP$$US-NOVOPROD-1277025$NOVO NORDISK$$$$$F$Y$$$20240909$$CN$US$US
242962711$24296271$1$I$20240701$20240828$20240909$20240909$EXP$$US-NOVOPROD-1277040$NOVO NORDISK$$$$A$F$Y$$$20240909$$CN$US$US
242962721$24296272$1$I$20180101$20240828$20240909$20240909$EXP$$US-NOVOPROD-1277047$NOVO NORDISK$$86$YR$$M$Y$$$20240909$$CN$US$US
242962731$24296273$1$I$$20240828$20240909$20240909$EXP$$US-NOVOPROD-1277020$NOVO NORDISK$$57$YR$$F$Y$$$20240909$$HP$US$US
242962741$24296274$1$I$$20240828$20240909$20240909$EXP$$US-NOVOPROD-1277036$NOVO NORDISK$$$$A$F$Y$$$20240909$$HP$US$US
242962751$24296275$1$I$$20240828$20240909$20240909$EXP$$JP-NOVOPROD-1276993$NOVO NORDISK$$77$YR$$F$Y$$$20240909$$CN$JP$JP
242962761$24296276$1$I$20240728$20240828$20240909$20240909$EXP$IT-MINISAL02-1000330$IT-NOVOPROD-1276978$NOVO NORDISK$$32$YR$$M$Y$110$KG$20240909$$PH$IT$IT
242962771$24296277$1$I$20240201$20240904$20240909$20240909$PER$$US-BIOGEN-2024BI01281143$BIOGEN$$38$YR$$F$Y$$$20240909$$CN$US$US
242962781$24296278$1$I$$20240830$20240909$20240909$PER$$US-ROCHE-10000071273$ROCHE$$59$YR$A$M$Y$$$20240909$$CN$US$US
242962791$24296279$1$I$$20240828$20240909$20240909$EXP$$US-NOVOPROD-1276981$NOVO NORDISK$$$$$F$Y$$$20240909$$CN$US$US
242962801$24296280$1$I$20240330$20240829$20240909$20240909$EXP$$CN-ASTELLAS-2024-AER-002888$ASTELLAS$$12$YR$T$M$Y$62$KG$20240909$$HP$CN$CN
242962812$24296281$2$F$20240101$20240910$20240909$20240919$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000764$DECIPHERA PHARMACEUTICALS$$81$YR$E$F$Y$$$20240919$$CN$US$US
242962821$24296282$1$I$20231104$20231106$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2023-068523$AUROBINDO$$75$YR$$F$Y$48$KG$20240909$$CN$US$US
242962831$24296283$1$I$20240701$20240903$20240909$20240909$30DAY$$US-GSK-US2024109460$GLAXOSMITHKLINE$$$$$M$Y$$$20240909$$CN$US$US
242962851$24296285$1$I$20240223$20240830$20240909$20240909$EXP$$US-TAKEDA-2024TUS018648$TAKEDA$$62$YR$$M$Y$$$20240909$$CN$US$US
242962862$24296286$2$F$$20240905$20240909$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005097$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
242962871$24296287$1$I$$20240830$20240909$20240909$PER$$US-CHATTEMPRD-2024OHG030747$CHATTEM$$$$$$Y$$$20240909$$CN$US$US
242962881$24296288$1$I$$20240903$20240909$20240909$PER$$US-ABBVIE-5907781$ABBVIE$$$$$$Y$$$20240909$$HP$US$US
242962891$24296289$1$I$20231114$20231116$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2023-074122$AUROBINDO$$75$YR$$F$Y$61.6$KG$20240909$$CN$US$US
242962901$24296290$1$I$$20231109$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2023-068953$AUROBINDO$$$$$F$Y$$$20240909$$PH$US$US
242962911$24296291$1$I$20240801$20240905$20240909$20240909$EXP$$FR-ASTELLAS-2024-AER-003756$ASTELLAS$$$$A$M$Y$$$20240909$$PH$FR$FR
242962921$24296292$1$I$$20240904$20240909$20240909$EXP$GB-MHRA-MED-202409041021371930-DCWGM$GB-ABBVIE-5910068$ABBVIE$$33$YR$$F$Y$$$20240909$$CN$GB$GB
242962931$24296293$1$I$$20231204$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2023-077718$AUROBINDO$$80$YR$$F$Y$$$20240909$$CN$US$US
242962942$24296294$2$F$20200101$20240910$20240909$20240912$PER$$US-BIOGEN-2024BI01281224$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
242962951$24296295$1$I$$20240222$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2023-074590$AUROBINDO$$82$YR$$F$Y$56.6$KG$20240909$$CN$US$US
242962962$24296296$2$F$$20240912$20240909$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141927$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240918$$CN$US$US
242962971$24296297$1$I$$20240115$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-002756$AUROBINDO$$$$$M$Y$$$20240909$$CN$US$US
242962981$24296298$1$I$$20231214$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2023-079897$AUROBINDO$$$$$F$Y$$$20240909$$CN$US$US
242962991$24296299$1$I$$20240129$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-002870$AUROBINDO$$$$$F$Y$$$20240909$$PH$US$US
242963001$24296300$1$I$$20240902$20240909$20240909$PER$$US-ROCHE-10000073681$ROCHE$$$$$$Y$$$20240909$$CN$US$US
242963011$24296301$1$I$$20240831$20240909$20240909$PER$$US-CHATTEMPRD-2024OHG030751$CHATTEM$$$$A$$Y$$$20240909$$CN$US$US
242963021$24296302$1$I$20240601$20240829$20240909$20240909$PER$$US-JNJFOC-20240878057$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240909$$CN$US$US
242963031$24296303$1$I$$20240213$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-008285$AUROBINDO$$$$$M$Y$$$20240909$$CN$US$US
242963041$24296304$1$I$$20240316$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-013803$AUROBINDO$$$$$F$Y$$$20240909$$CN$US$US
242963051$24296305$1$I$$20240117$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-003214$AUROBINDO$$67$YR$$M$Y$86.182$KG$20240909$$CN$US$US
242963061$24296306$1$I$$20240327$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-015928$AUROBINDO$$$$$M$Y$$$20240909$$CN$US$US
242963071$24296307$1$I$20210101$20240828$20240909$20240909$EXP$$US-NOVOPROD-1276970$NOVO NORDISK$$$$$F$Y$$$20240909$$CN$US$US
242963081$24296308$1$I$$20240828$20240909$20240909$EXP$$CA-APOTEX-2024AP010107$APOTEX$$72$YR$$F$Y$$$20240909$$CN$CA$CA
242963091$24296309$1$I$$20240831$20240909$20240909$PER$$US-CHATTEMPRD-2024OHG030801$CHATTEM$$$$$$Y$$$20240909$$CN$US$US
242963101$24296310$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043492$AUROBINDO$Gopalan R, Mitchel H, Matushinec S, Kerr R, Bolton A, Kamin A, et al.. Feasibility of Outpatient Hemodialysis for Patients with Total Artificial Heart: A Case Series. ASAIO-J. 2023;69(6):E270-E273$61$YR$$F$Y$$$20240909$$MD$US$US
242963111$24296311$1$I$$20240419$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-020718$AUROBINDO$$$$$M$Y$$$20240909$$PH$US$US
242963121$24296312$1$I$$20240408$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-016498$AUROBINDO$$$$$$Y$$$20240909$$HP$US$US
242963131$24296313$1$I$$20240904$20240909$20240909$PER$$US-ROCHE-3511216$ROCHE$$$$E$F$Y$$$20240909$$CN$US$US
242963152$24296315$2$F$$20240904$20240909$20240919$PER$$US-ROCHE-10000075023$ROCHE$$$$A$F$Y$$$20240919$$CN$US$US
242963161$24296316$1$I$$20240904$20240909$20240909$PER$$US-ROCHE-10000073405$ROCHE$$$$T$F$Y$$$20240909$$MD$US$US
242963171$24296317$1$I$$20240904$20240909$20240909$PER$$US-ROCHE-10000074888$ROCHE$$$$A$M$Y$$$20240909$$CN$US$US
242963181$24296318$1$I$$20240619$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-029547$AUROBINDO$$$$$$Y$$$20240909$$HP$US$US
242963191$24296319$1$I$$20240904$20240909$20240909$PER$$US-BIOGEN-2022BI01174264$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
242963201$24296320$1$I$$20240712$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-029399$AUROBINDO$$$$$F$Y$$$20240909$$PH$US$US
242963211$24296321$1$I$20240119$20240706$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-027729$AUROBINDO$$72$YR$$F$Y$61.6$KG$20240909$$CN$US$US
242963222$24296322$2$F$20240818$20240905$20240909$20240916$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000739$DECIPHERA PHARMACEUTICALS$$64$YR$A$M$Y$93.1$KG$20240916$$CN$US$US
242963231$24296323$1$I$$20240831$20240909$20240909$PER$$US-CHATTEMPRD-2024OHG030362$CHATTEM$$$$$F$Y$$$20240909$$CN$US$US
242963241$24296324$1$I$$20240829$20240909$20240909$PER$$US-ROCHE-10000070562$ROCHE$$$$A$$Y$$$20240909$$MD$US$US
242963261$24296326$1$I$20240801$20240813$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004697$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240909$$CN$US$US
242963271$24296327$1$I$$20240829$20240909$20240909$EXP$$CA-APOTEX-2024AP010155$APOTEX$$83$YR$$F$Y$60$KG$20240909$$PH$CA$CA
242963281$24296328$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043226$AUROBINDO$Schwartz AH, Sieminski S. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event. American Journal of Ophthalmology Case Reports. 2023;301-4$59$YR$$F$Y$$$20240909$$HP$US$US
242963294$24296329$4$F$20190201$20240919$20240909$20240920$EXP$$CN-SA-2024SA256908$SANOFI AVENTIS$Gan H, Ren X, Zou Y, Li L, Ding J, Peng L, et al. Rheumatoid arthritis complicated with cervical actinomycosis and ureteral obstruction: A case report and literature review.  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. 2024;49(5):818-24$60$YR$A$F$Y$$$20240920$$MD$CN$CN
242963301$24296330$1$I$$20240902$20240909$20240909$PER$$US-CHATTEMPRD-2024OHG030757$CHATTEM$$$$A$$Y$$$20240909$$CN$US$US
242963311$24296331$1$I$$20240904$20240909$20240909$PER$$US-HALEON-2195265$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
242963321$24296332$1$I$20240808$20240828$20240909$20240909$EXP$CN-HENLIUS-24CN016722$CN-Accord-445507$ACCORD$$65$YR$E$M$Y$49.6$KG$20240909$$MD$CN$CN
242963331$24296333$1$I$20200301$20240902$20240909$20240909$EXP$DE-CADRBFARM-2024329655$DE-ABBVIE-5908500$ABBVIE$$$$$$Y$$$20240909$$CN$DE$DE
242963341$24296334$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004713$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242963351$24296335$1$I$$20240813$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004646$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$HP$US$US
242963361$24296336$1$I$$20240828$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043408$AUROBINDO$Al Aboud A, Huston J, Kim SH, O^Leary J. CHEST PAIN IN A POSTPARTUM WOMAN. J-Am-Coll-Cardiol. 2019;73 (Suppl.1)(9):2978$28$YR$$F$Y$$$20240909$$HP$US$US
242963372$24296337$2$F$$20240904$20240909$20240916$EXP$$JP-AMGEN-JPNSP2024171244$AMGEN$$$$$F$Y$$$20240916$$MD$JP$JP
242963381$24296338$1$I$20240101$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141806$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240909$$MD$US$US
242963391$24296339$1$I$$20240904$20240909$20240909$EXP$$DE-SANDOZ INC.-SDZ2024DE077710$SANDOZ$$62$YR$$M$Y$$$20240909$$PH$DE$DE
242963401$24296340$1$I$20240829$20240905$20240909$20240909$PER$$US-ROCHE-10000075592$ROCHE$$49$YR$A$F$Y$$$20240909$$MD$US$US
242963431$24296343$1$I$$20240830$20240909$20240909$EXP$$DE-ABBVIE-5908575$ABBVIE$$$$$$Y$$$20240909$$PH$DE$DE
242963441$24296344$1$I$$20240905$20240909$20240909$PER$$US-ROCHE-10000075575$ROCHE$$$$A$F$Y$$$20240909$$MD$US$US
242963451$24296345$1$I$$20240819$20240909$20240909$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000732$DECIPHERA PHARMACEUTICALS$$89$YR$E$F$Y$$$20240909$$HP$US$US
242963461$24296346$1$I$20240831$20240904$20240909$20240909$EXP$$US-MTPC-MTDA2024-0018800$MITSUBISHI TANABE PHARMA$$$$A$F$Y$$$20240909$$CN$US$US
242963471$24296347$1$I$$20240903$20240909$20240909$PER$$US-MTPC-MTDA2024-0018695$MITSUBISHI TANABE PHARMA$$$$E$M$Y$$$20240909$$CN$US$US
242963481$24296348$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003769$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240909$$MD$US$US
242963491$24296349$1$I$$20240828$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408018237$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240909$$CN$US$US
242963501$24296350$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003779$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240909$$CN$US$US
242963511$24296351$1$I$$20240828$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408018308$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240909$$CN$US$US
242963521$24296352$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003806$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240909$$CN$US$US
242963531$24296353$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003971$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242963541$24296354$1$I$20240831$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003958$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240909$$CN$US$US
242963551$24296355$1$I$$20240819$20240909$20240909$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000731$DECIPHERA PHARMACEUTICALS$$36$YR$A$F$Y$84.3$KG$20240909$$CN$US$US
242963561$24296356$1$I$20240903$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024177872$AMGEN$$74$YR$E$M$Y$94.4$KG$20240909$$PH$US$US
242963573$24296357$3$F$20240101$20240917$20240909$20240919$PER$$US-AMGEN-USASP2024176194$AMGEN$$76$YR$E$F$Y$$$20240919$$MD$US$US
242963581$24296358$1$I$$20240903$20240909$20240909$EXP$$JP-009507513-2409JPN000399J$MERCK$$8$DEC$$M$Y$$$20240909$$MD$JP$JP
242963591$24296359$1$I$20240904$20240905$20240909$20240909$PER$$US-ROCHE-10000075338$ROCHE$$75$YR$E$F$Y$$$20240909$$HP$US$US
242963602$24296360$2$F$20240809$20240905$20240909$20240913$30DAY$$AR-JNJFOC-20240869595$JOHNSON AND JOHNSON$$53$YR$A$F$Y$60$KG$20240913$$CN$AR$AR
242963611$24296361$1$I$$20240828$20240909$20240909$EXP$$US-MTPC-MTDA2024-0018420$MITSUBISHI TANABE PHARMA$$$$E$F$Y$$$20240909$$CN$US$US
242963621$24296362$1$I$$20240905$20240909$20240909$PER$$US-ROCHE-10000075390$ROCHE$$$$A$F$Y$$$20240909$$CN$US$US
242963631$24296363$1$I$20240801$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004767$ACADIA PHARMACEUTICALS$$84$YR$$F$Y$$$20240909$$HP$US$US
242963641$24296364$1$I$20240428$20240829$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-043564$AUROBINDO$$53$YR$$F$Y$85$KG$20240909$$PH$FR$FR
242963651$24296365$1$I$$20240826$20240909$20240909$EXP$$CN-TEYRO-2024-TY-000571$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$57$YR$A$$Y$57$KG$20240909$$HP$CN$CN
242963661$24296366$1$I$$20240905$20240909$20240909$EXP$$JP-TAKEDA-2024TJP013179$TAKEDA$$51$YR$$M$Y$$$20240909$$PH$JP$JP
242963671$24296367$1$I$20240511$20240829$20240909$20240909$EXP$$IT-AUROBINDO-AUR-APL-2024-043705$AUROBINDO$$93$YR$$F$Y$55$KG$20240909$$CN$IT$IT
242963682$24296368$2$F$$20240910$20240909$20240915$EXP$$DE-AUROBINDO-AUR-APL-2024-043455$AUROBINDO$Obermaier B, Braun C, Hensen L, Ahmad O, Faul C, Lang P et al.. Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience.. Transpl Infect Dis.. 2024;26(4):14296$70$YR$$$Y$$$20240915$$MD$DE$DE
242963691$24296369$1$I$$20240830$20240909$20240909$EXP$$CA-APOTEX-2024AP010200$APOTEX$$$$$F$Y$$$20240909$$HP$CA$CA
242963701$24296370$1$I$$20240903$20240909$20240909$EXP$$DE-AstraZeneca-2024A201754$ASTRAZENECA$$$$$$Y$$$20240909$$MD$DE$
242963712$24296371$2$F$$20240913$20240909$20240918$EXP$$KR-EMD Serono-2024047322$EMD SERONO INC$$$$T$$Y$$$20240918$$CN$KR$KR
242963721$24296372$1$I$$20240903$20240909$20240909$PER$$US-AstraZeneca-2024A200747$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242963732$24296373$2$F$20240805$20240906$20240909$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004768$ACADIA PHARMACEUTICALS$$65$YR$$M$Y$$$20240927$$CN$US$US
242963741$24296374$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004770$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242963751$24296375$1$I$$20240903$20240909$20240909$EXP$$DE-AstraZeneca-2024A201593$ASTRAZENECA$$$$$$Y$$$20240909$$MD$DE$
242963761$24296376$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA258045$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240909$$MD$US$US
242963771$24296377$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA258024$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240909$$MD$US$US
242963781$24296378$1$I$20240801$20240827$20240909$20240909$PER$$US-SA-2024SA259061$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240909$$HP$US$US
242963791$24296379$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA257544$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240909$$HP$US$US
242963801$24296380$1$I$20240101$20240904$20240909$20240909$PER$$US-ABBVIE-5909073$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242963811$24296381$1$I$$20240826$20240909$20240909$EXP$$CN-TEYRO-2024-TY-000569$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al.Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15(1):7116$67$YR$E$$Y$64$KG$20240909$$HP$CN$CN
242963831$24296383$1$I$20240805$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141738$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240909$$CN$US$US
242963841$24296384$1$I$$20240711$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-035531$AUROBINDO$$45$YR$$F$Y$$$20240909$$CN$US$US
242963851$24296385$1$I$20240606$20240624$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-032094$AUROBINDO$$36$YR$$F$Y$130.18$KG$20240909$$HP$US$US
242963861$24296386$1$I$$20230628$20240909$20240909$EXP$$US-HALEON-2195102$Haleon PLC$$37$YR$$F$Y$$$20240909$$MD$US$US
242963881$24296388$1$I$$20240723$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-038299$AUROBINDO$$$$$F$Y$$$20240909$$CN$US$US
242963891$24296389$1$I$$20240827$20240909$20240909$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2024US001263$JUBILANT$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024$$$N$$Y$$$20240909$$HP$US$US
242963901$24296390$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004772$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242963923$24296392$3$F$20240801$20240911$20240909$20240913$EXP$$NVSJ2024JP010563$NOVARTIS$$75$YR$$F$Y$$$20240913$$PH$JP$JP
242963931$24296393$1$I$$20240826$20240909$20240909$EXP$$CN-TEYRO-2024-TY-000575$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$68$YR$E$$Y$58.6$KG$20240909$$HP$CN$CN
242963941$24296394$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024177931$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
242963951$24296395$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004779$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242963961$24296396$1$I$$20240820$20240909$20240909$PER$$US-TEVA-VS-3236982$TEVA$$$$$$Y$$$20240909$$HP$US$US
242963971$24296397$1$I$$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142270$BRISTOL MYERS SQUIBB$$4$DEC$A$M$Y$$$20240909$$HP$US$US
242963981$24296398$1$I$$20240826$20240909$20240909$EXP$$CN-TEYRO-2024-TY-000562$Teyro Labs$Wu, L., Li, B., Wan, G. Wang, Y., Zhu, J., Liu Y., et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$55$YR$A$$Y$71$KG$20240909$$HP$CN$CN
242964001$24296400$1$I$20240819$20240905$20240909$20240909$PER$$US-BIOVITRUM-2024-US-011728$BIOVITRUM$$66$YR$$M$Y$$$20240909$$CN$US$US
242964011$24296401$1$I$20240721$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003776$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240909$$CN$US$US
242964021$24296402$1$I$$20240903$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001843$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240909$$CN$US$US
242964031$24296403$1$I$20240905$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003752$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242964042$24296404$2$F$$20240826$20240909$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202408017124$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240925$$CN$US$US
242964051$24296405$1$I$20240801$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003988$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242964061$24296406$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003895$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240909$$CN$US$US
242964071$24296407$1$I$$20240903$20240909$20240909$PER$$US-AMGEN-USASP2024177032$AMGEN$$$$$F$Y$$$20240909$$MD$US$US
242964082$24296408$2$F$20240903$20240910$20240909$20240914$PER$$US-AMGEN-USASP2024177942$AMGEN$$83$YR$E$F$Y$$$20240914$$CN$US$US
242964091$24296409$1$I$20240701$20240905$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US078310$SANDOZ$$73$YR$$M$Y$$$20240909$$CN$US$US
242964101$24296410$1$I$20240901$20240903$20240909$20240909$PER$$US-AMGEN-USASP2024175636$AMGEN$$58$YR$A$F$Y$42.75$KG$20240909$$CN$US$US
242964111$24296411$1$I$$20240826$20240909$20240909$EXP$$CN-TEYRO-2024-TY-000573$Teyro Labs$Wu L, Li B, Wan G, Wang Y, Zhu J, Liu Y, et al..Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.Nature Communications.2024;15:7116$55$YR$A$$Y$56$KG$20240909$$HP$CN$CN
242964122$24296412$2$F$$20240916$20240909$20240920$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000753$DECIPHERA PHARMACEUTICALS$$59$YR$A$F$Y$$$20240920$$CN$US$US
242964131$24296413$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004780$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242964141$24296414$1$I$$20240905$20240909$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US078173$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242964151$24296415$1$I$$20240904$20240909$20240909$EXP$$US-JNJFOC-20240915035$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242964161$24296416$1$I$$20240828$20240909$20240909$30DAY$$US-GSK-US2024107309$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242964171$24296417$1$I$$20240904$20240909$20240909$EXP$$VN-AstraZeneca-2024A202908$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$VN$
242964181$24296418$1$I$20100801$20240830$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2011-04658$AUROBINDO$$53$YR$$F$Y$78$KG$20240909$$HP$GB$GB
242964191$24296419$1$I$$20240826$20240909$20240909$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-26266$SAMSUNG BIOEPIS$$54$YR$A$F$Y$$$20240909$$CN$GB$GB
242964201$24296420$1$I$$20240826$20240909$20240909$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-26258$SAMSUNG BIOEPIS$$71$YR$E$F$Y$$$20240909$$CN$CA$CA
242964211$24296421$1$I$$20240611$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-030634$AUROBINDO$Bangolo AI, Yelton-Torres K, Mahajan A, Patel V, Sajjad L, Ansong PO, et al. Case of Diltiazem-Induced Pustular Rash in an 83-Year-Old Female. . Case Reports in Dermatological Medicine. 2024:9547206. 2024;9547206$83$YR$$F$Y$$$20240909$$MD$US$US
242964221$24296422$1$I$20240809$20240828$20240909$20240909$EXP$$US-Accord-444337$ACCORD$$72$YR$E$F$Y$$$20240909$$HP$US$US
242964231$24296423$1$I$$20240904$20240909$20240909$PER$$US-ROCHE-10000074612$ROCHE$$$$$$Y$$$20240909$$CN$US$US
242964241$24296424$1$I$$20240828$20240909$20240909$30DAY$$US-GSK-US2024AMR108540$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242964251$24296425$1$I$20240101$20240823$20240909$20240909$PER$$US-SA-2024SA243954$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240909$$MD$US$US
242964261$24296426$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA258091$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240909$$HP$US$US
242964271$24296427$1$I$20240807$20240901$20240909$20240909$EXP$$CN-BEIGENE-BGN-2024-013776$BEIGENE$$$$$$Y$$$20240909$$HP$CN$CN
242964281$24296428$1$I$$20240829$20240909$20240909$EXP$$IN-ROCHE-10000070791$ROCHE$$68$YR$E$M$Y$$$20240909$$CN$IN$IN
242964292$24296429$2$F$$20240925$20240909$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141965$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240926$$CN$US$US
242964301$24296430$1$I$20240830$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178161$AMGEN$$66$YR$E$M$Y$$$20240909$$CN$US$US
242964311$24296431$1$I$20240831$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024179000$AMGEN$$68$YR$E$F$Y$$$20240909$$CN$US$US
242964321$24296432$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004782$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242964331$24296433$1$I$20240801$20240821$20240909$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004956$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240909$$CN$US$US
242964341$24296434$1$I$20240807$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004746$ACADIA PHARMACEUTICALS$$65$YR$$F$Y$$$20240909$$CN$US$US
242964351$24296435$1$I$20240815$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004748$ACADIA PHARMACEUTICALS$$65$YR$$M$Y$$$20240909$$CN$US$US
242964361$24296436$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-042970$AUROBINDO$Cunningham BW, Shah S, Biswas S. Vancomycin Anaphylaxis and Kounis Syndrome Case Report. Cureus. 2024;16(7):e64740$67$YR$$M$Y$112$KG$20240909$$MD$US$US
242964371$24296437$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004247$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240909$$CN$US$US
242964382$24296438$2$F$$20240925$20240909$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409003984$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240927$$CN$US$US
242964391$24296439$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003730$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240909$$CN$US$US
242964401$24296440$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004246$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240909$$CN$US$US
242964411$24296441$1$I$$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004320$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240909$$CN$US$US
242964421$24296442$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003181$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240909$$CN$US$US
242964431$24296443$1$I$$20240828$20240909$20240909$EXP$$BR-NOVOPROD-1277164$NOVO NORDISK$$$$$F$Y$$$20240909$$CN$BR$BR
242964441$24296444$1$I$$20240828$20240909$20240909$EXP$$US-NOVOPROD-1277219$NOVO NORDISK$$$$$$Y$$$20240909$$CN$US$US
242964451$24296445$1$I$20240815$20240829$20240909$20240909$EXP$$US-JNJFOC-20240853341$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240909$$HP$US$US
242964461$24296446$1$I$20240701$20240828$20240909$20240909$EXP$SI-JAZMP-NCPHV-2024SI0853_0853$SI-NOVOPROD-1277216$NOVO NORDISK$$84$YR$$M$Y$$$20240909$$CN$SI$SI
242964472$24296447$2$F$20240829$20240911$20240909$20240919$EXP$$CA-EMD Serono-2024046891$EMD SERONO INC$$46$YR$A$F$Y$$$20240919$$CN$CA$CA
242964481$24296448$1$I$$20240902$20240909$20240909$EXP$$CA-APOTEX-2024AP010257$APOTEX$$$$$$Y$$$20240909$$MD$CA$CA
242964491$24296449$1$I$$20240905$20240909$20240909$EXP$$US-ABBVIE-5910634$ABBVIE$$$$$M$Y$$$20240909$$HP$US$US
242964501$24296450$1$I$$20240828$20240909$20240909$EXP$$US-Accord-444657$ACCORD$Tanas R, Shah V, Henderson C. The classic ^Rat-Bite^ erosions in gouty arthritis with normal uric acid levels. American Journal of the Medical Sciences. 2024;368(3):e27-8.$82$YR$E$M$Y$$$20240909$$MD$US$US
242964511$24296451$1$I$$20240828$20240909$20240909$PER$$US-TRIS PHARMA, INC.-24US011611$TRIS PHARM$$$$$$Y$$$20240909$$CN$US$US
242964521$24296452$1$I$$20240828$20240909$20240909$EXP$$US-NOVOPROD-1277242$NOVO NORDISK$$$$$$Y$$$20240909$$CN$US$US
242964531$24296453$1$I$$20240828$20240909$20240909$EXP$$DE-NOVOPROD-1277235$NOVO NORDISK$$$$E$M$Y$84$KG$20240909$$MD$DE$DE
242964541$24296454$1$I$20240602$20240828$20240909$20240909$EXP$GB-MHRA-MED-202408281037459330-TSFVJ$GB-NOVOPROD-1275630$NOVO NORDISK$$47$YR$$F$Y$89$KG$20240909$$MD$GB$GB
242964551$24296455$1$I$$20240902$20240909$20240909$EXP$$US-AMGEN-USASP2024175883$AMGEN$Godin S.; El Warrack S.; Meleveedu K.. Lymphoma Diagnosis Delay: Biopsy Strategy Insights. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S448$55$YR$A$F$Y$$$20240909$$MD$US$US
242964571$24296457$1$I$20240904$20240904$20240909$20240909$EXP$$US-JNJFOC-20240908913$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240909$$MD$US$US
242964581$24296458$1$I$$20240830$20240909$20240909$EXP$$US-GSK-US2024108330$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$MD$US$US
242964591$24296459$1$I$$20240830$20240909$20240909$EXP$$US-NEBO-668336$PHARMACOSMOS$$$$$M$Y$$$20240909$$HP$US$US
242964601$24296460$1$I$20240829$20240829$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139001$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240909$$CN$US$US
242964611$24296461$1$I$$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142303$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240909$$CN$US$US
242964621$24296462$1$I$$20230213$20240909$20240909$EXP$$GB-TEVA-VS-3239950$TEVA$Wanstall H, Chakravorty M, Goonoo MS, Bickle I, Macinerney R, Fairburn K, et al. P30 A case of small bowel and leukocytoclastic vasculitis associated with acitretin therapy. Rheumatol Adv Pract. 2022;6(1):i37-i38.; Wanstall H, Chakravorty M, Goonoo MS, Bickle I, Macinerney R, Fairburn K et al. A case of small bowel and leukocytoclastic vasculitis associated with Acitretin therapy. Rheumatology Advances in Practice. 2022;6:i37-i38$53$YR$$M$Y$$$20240909$$MD$GB$GB
242964631$24296463$1$I$$20240903$20240909$20240909$EXP$$US-AMGEN-USASP2024175776$AMGEN$$$$$M$Y$$$20240909$$CN$US$US
242964641$24296464$1$I$20240819$20240903$20240909$20240909$EXP$$ES-ROCHE-10000072933$ROCHE$$63$YR$A$F$Y$$$20240909$$MD$ES$ES
242964652$24296465$2$F$$20240905$20240909$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004965$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
242964671$24296467$1$I$$20240819$20240909$20240909$PER$$US-ALK-ABELLO A/S-2024AA003236$ALK-ABELLO$$$$$$Y$$$20240909$$CN$US$US
242964681$24296468$1$I$20240820$20240828$20240909$20240909$EXP$$US-Accord-445194$ACCORD$$54$YR$A$M$Y$$$20240909$$HP$US$US
242964691$24296469$1$I$$20240902$20240909$20240909$EXP$$KR-CHEPLA-2024011358$CHEPLAPHARM$Jeong S. Cytomegalovirus retinitis with panretinal occlusive vasculopathy concealed by hypertensive uveitis: a case report. J Yeungnam Med Sci. 2024. doi:10.12701/jyms.2024.00584$72$YR$$M$Y$$$20240909$$MD$COUNTRY NOT SPECIFIED$KR
242964701$24296470$1$I$20240101$20240830$20240909$20240909$EXP$$US-ROCHE-10000071915$ROCHE$$37$YR$A$M$Y$$$20240909$$CN$US$US
242964721$24296472$1$I$$20240830$20240909$20240909$EXP$$US-SA-2024SA258975$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240909$$CN$US$US
242964731$24296473$1$I$$20240904$20240909$20240909$EXP$$DE-SANDOZ INC.-SDZ2024DE077756$SANDOZ$$59$YR$$F$Y$$$20240909$$PH$DE$DE
242964741$24296474$1$I$20240904$20240905$20240909$20240909$30DAY$$PT-SANDOZ INC.-SDZ2024PT078375$SANDOZ$$$$$F$Y$$$20240909$$CN$PT$PT
242964751$24296475$1$I$$20240906$20240909$20240909$EXP$BG-EMA-DD-20240902-7482701-081717$BG-SANDOZ INC.-SDZ2024BG078309$SANDOZ$$64$YR$$F$Y$$$20240909$$MD$BG$BG
242964761$24296476$1$I$20240830$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178345$AMGEN$$85$YR$E$M$Y$$$20240909$$CN$US$US
242964771$24296477$1$I$$20240902$20240909$20240909$EXP$$JP-AMGEN-JPNSP2024175855$AMGEN$Tsutsui, Y.. Our experience in treating psoriasis patients with asthma with biologics in our department. Program/abstracts of the 39th Annual Meeting of the Japanese Society for Psorias. 2024;33$65$YR$E$M$Y$$$20240909$$HP$JP$JP
242964781$24296478$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024179018$AMGEN$$$$$$Y$$$20240909$$PH$US$US
242964791$24296479$1$I$20240827$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024176716$AMGEN$$74$YR$E$F$Y$$$20240909$$CN$US$US
242964801$24296480$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004750$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242964811$24296481$1$I$20240129$20240902$20240909$20240909$EXP$ES-AEMPS-1490428$ES-CHEPLA-2024011390$CHEPLAPHARM$$68$YR$$F$Y$72$KG$20240909$$MD$COUNTRY NOT SPECIFIED$ES
242964821$24296482$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043489$AUROBINDO$Gopalan R, Mitchel H, Matushinec S, Kerr R, Bolton A, Kamin A, et al.. Feasibility of Outpatient Hemodialysis for Patients with Total Artificial Heart: A Case Series. ASAIO-J. 2023;69(6):E270-E273$54$YR$$M$Y$$$20240909$$MD$US$US
242964831$24296483$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004751$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242964841$24296484$1$I$$20240827$20240909$20240909$EXP$$CA-AUROBINDO-AUR-APL-2023-044420$AUROBINDO$Sharma V, Al-Farayedhi M.. Postpartum-onset obsessive-compulsive disorder: A harbinger of bipolar disorder.. Bipolar Disorders.. 2023;25(3):254-256$32$YR$$F$Y$$$20240909$$MD$CA$CA
242964851$24296485$1$I$20240814$20240906$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142610$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240909$$CN$US$US
242964861$24296486$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043230$AUROBINDO$Cooper J, Soneji D, Rieger K, Narala S, Kim Y. Primary Cutaneous CD30+ Large T Cell Lymphoproliferative Disorder Associated With Prolonged Exposure to Fingolimod.. Mult-Scler-J. 2023;29 (Suppl. 3):969$67$YR$$$Y$$$20240909$$HP$US$US
242964871$24296487$1$I$$20240903$20240909$20240909$EXP$$CA-AMGEN-CANNI2024177865$AMGEN$$$$$F$Y$$$20240909$$CN$CA$CA
242964881$24296488$1$I$$20240905$20240909$20240909$PER$$US-ABBVIE-5909419$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242964891$24296489$1$I$20240819$20240829$20240909$20240909$EXP$IT-MINISAL02-999712$IT-Accord-444613$ACCORD$$60$YR$A$F$Y$$$20240909$$MD$IT$IT
242964901$24296490$1$I$20150216$20240902$20240909$20240909$EXP$CZ-EMA-DD-20240823-7482711-141415$CZ-CHEPLA-1200123251$CHEPLAPHARM$Donatova Z. Uplatneni eribulinu a vinorelbinu v lecbe karcinomu prsu. ONKOLOGICKa REVUE 2019;6 (6):78-80.$66$YR$$F$Y$$$20240909$$MD$COUNTRY NOT SPECIFIED$CZ
242964911$24296491$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043493$AUROBINDO$Gopalan R, Mitchel H, Matushinec S, Kerr R, Bolton A, Kamin A, et al.. Feasibility of Outpatient Hemodialysis for Patients with Total Artificial Heart: A Case Series. ASAIO-J. 2023;69(6):E270-E273$31$YR$$M$Y$$$20240909$$MD$US$US
242964921$24296492$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004754$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242964931$24296493$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003927$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240909$$CN$US$US
242964941$24296494$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004707$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242964951$24296495$1$I$20240823$20240828$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408018889$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$US$US
242964961$24296496$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003477$ELI LILLY AND CO$$31$YR$A$M$Y$$$20240909$$CN$US$US
242964971$24296497$1$I$20240904$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003225$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240909$$HP$US$US
242964981$24296498$1$I$20240801$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003534$ELI LILLY AND CO$$63$YR$A$$Y$$$20240909$$CN$US$US
242964991$24296499$1$I$20240801$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003833$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240909$$CN$US$US
242965001$24296500$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003538$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240909$$CN$US$US
242965011$24296501$1$I$$20240904$20240909$20240909$EXP$$US-JNJFOC-20240908229$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$US$US
242965021$24296502$1$I$20231201$20240904$20240909$20240909$EXP$$US-TAKEDA-2024TUS089019$TAKEDA$$71$YR$$M$Y$$$20240909$$CN$US$US
242965031$24296503$1$I$20240823$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024177779$AMGEN$$$$$M$Y$$$20240909$$CN$US$US
242965041$24296504$1$I$$20240820$20240909$20240909$PER$$US-BEIGENE-BGN-2024-013220$BEIGENE$$$$$$Y$$$20240909$$CN$US$US
242965051$24296505$1$I$$20240831$20240909$20240909$PER$$US-AMGEN-USASP2024177445$AMGEN$$$$$$Y$$$20240909$$CN$US$US
242965061$24296506$1$I$$20240902$20240909$20240909$EXP$$ES-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00456$VELOXIS PHARMACEUTICALS$Abelleira R.. Reversible diffuse lung disease after mycophenolate mofetil withdrawal. Pulmonology. 2018;24(6):361-362$72$YR$$F$Y$$$20240909$$HP$ES$ES
242965071$24296507$1$I$$20240830$20240909$20240909$EXP$$US-VIIV HEALTHCARE LIMITED-US2024108266$VIIV$$$$$M$Y$$$20240909$$HP$US$US
242965081$24296508$1$I$$20240827$20240909$20240909$EXP$$JP-ENDO USA, INC.-2024-003341$ENDO$Inaba T, Yamamoto Y, Hirayama K, Kobayashi T, Izumi N, Sakamoto H, et al.. Esophageal and Ileal Ulcers Caused by Hydroxycarbamide: A Case Report and Literature Review. The Japanese Society of Internal Medicine. 2024;1-5$74$YR$$F$Y$$$20240909$$HP$JP$JP
242965091$24296509$1$I$$20240904$20240909$20240909$EXP$$DE-SANDOZ INC.-SDZ2024DE077730$SANDOZ$$42$YR$$M$Y$$$20240909$$HP$DE$DE
242965101$24296510$1$I$$20240827$20240909$20240909$EXP$$US-ENDO USA, INC.-2024-003342$ENDO$Khurshid Y, Kathula S, Hillman N, Pacheo J, Barde CJ, Gopalswamy N.. A case of bleeding jejunal ulcer due to vasculitis from hydroxyurea. The American Journal of Gastroenterology. 2000;95(9):2616$54$YR$$M$Y$$$20240909$$MD$US$US
242965111$24296511$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004706$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242965123$24296512$3$F$20240828$20240926$20240909$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139704$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240930$$PH$JP$JP
242965131$24296513$1$I$$20240904$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US077976$SANDOZ$$$$$F$Y$$$20240909$$CN$US$US
242965141$24296514$1$I$20150609$20240827$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043394$AUROBINDO$$39$DY$$M$Y$$$20240909$$CN$GB$GB
242965151$24296515$1$I$20230102$20240904$20240909$20240909$EXP$$CO-UCBSA-2024045739$UCB$$75$YR$$F$Y$$$20240909$$CN$CO$CO
242965161$24296516$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201989$ASTRAZENECA$$$$$F$Y$49$KG$20240909$$HP$US$
242965171$24296517$1$I$20240814$20240829$20240909$20240909$EXP$CN-HENLIUS-24CN016764$CN-Accord-445313$ACCORD$$34$YR$A$F$Y$50$KG$20240909$$MD$CN$CN
242965181$24296518$1$I$$20240904$20240909$20240909$PER$$US-JNJFOC-20240908330$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240909$$MD$US$US
242965191$24296519$1$I$$20240827$20240909$20240909$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08149$HIKMA$Cowan M, Kumar P, McManus J, Bilodeau S, Beck A.. Cowan M, Kumar P, McManus J, Bilodeau S, Beck A. A Case Report of Delayed Opioid Toxidrome After Administration of Naloxone.. Clinical Practice and Cases in Emergency Medicine. 2024;8(3)::222-225$$$$$Y$$$20240909$$MD$US$US
242965201$24296520$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004756$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242965212$24296521$2$F$$20240828$20240909$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466386$RANBAXY$Cecchini A, Stephenson E, Sill JM. An Uncommon Cause of Immunosuppression: Fatal Pneumocystis Jiroveci Pneumonia in a Patient With Cushing^s Syndrome. Am J Respir Crit Care Med. 2023;207:A1341$61$YR$$F$Y$$$20240912$$HP$US$US
242965222$24296522$2$F$$20240828$20240909$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466863$RANBAXY$Correa S, Berman A. Glue Embolism Following Variceal Sclerotherapy.. Am J Respir Ctrit Care Med. 2023;207:A5498$34$YR$$M$Y$$$20240912$$HP$US$US
242965231$24296523$1$I$20230103$20240905$20240909$20240909$EXP$$CO-UCBSA-2024045743$UCB$$63$YR$$F$Y$$$20240909$$CN$CO$CO
242965241$24296524$1$I$20240101$20240903$20240909$20240909$PER$$US-AMGEN-USASP2024176290$AMGEN$$32$YR$A$M$Y$$$20240909$$CN$US$US
242965251$24296525$1$I$20240101$20240903$20240909$20240909$PER$$US-AMGEN-USASP2024176690$AMGEN$$78$YR$E$F$Y$$$20240909$$CN$US$US
242965261$24296526$1$I$$20240903$20240909$20240909$PER$$US-AMGEN-USASP2024178003$AMGEN$$54$YR$A$F$Y$$$20240909$$HP$US$US
242965271$24296527$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004755$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242965281$24296528$1$I$20240101$20240830$20240909$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003538$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240909$$CN$US$US
242965291$24296529$1$I$20240726$20240830$20240909$20240909$30DAY$$US-GSK-US2024108324$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242965301$24296530$1$I$$20240828$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043409$AUROBINDO$Fatima R, Altorok N.. Secukinumab-Induced Bullous Pemphigoid in a Patient with Psoriatic Arthritis. Am-J-Ther. 2024;31(4):e434-e435$62$YR$$M$Y$$$20240909$$HP$US$US
242965311$24296531$1$I$$20240903$20240909$20240909$EXP$$US-SA-2024SA258608$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240909$$HP$US$US
242965321$24296532$1$I$$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142511$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240909$$CN$US$US
242965331$24296533$1$I$20240820$20240905$20240909$20240909$PER$$US-JNJFOC-20240912734$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240909$$CN$US$US
242965341$24296534$1$I$20240828$20240904$20240909$20240909$EXP$$CA-JNJFOC-20240914916$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240909$$HP$CA$CA
242965351$24296535$1$I$20240729$20240829$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-043749$AUROBINDO$$29$YR$$M$Y$$$20240909$$MD$FR$FR
242965361$24296536$1$I$20240816$20240826$20240909$20240909$EXP$$US-ENDO USA, INC.-2024-003340$ENDO$$8$YR$$F$Y$$$20240909$$PH$US$US
242965371$24296537$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004760$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$HP$US$US
242965381$24296538$1$I$20210719$20240829$20240909$20240909$EXP$PL-URPL-DML-MLP.4401.1.5026.2021$PL-Accord-444622$ACCORD$$60$YR$A$M$Y$38$KG$20240909$$HP$PL$PL
242965391$24296539$1$I$20240824$20240826$20240909$20240909$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005016$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240909$$CN$US$US
242965412$24296541$2$F$$20240913$20240909$20240916$EXP$$NZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050146$BOEHRINGER INGELHEIM$$$$$$Y$$$20240916$$MD$NZ$NZ
242965423$24296542$3$F$$20240924$20240909$20240927$EXP$$JP-SA-2024SA258218$SANOFI AVENTIS$$$$$$Y$$$20240927$$MD$JP$JP
242965431$24296543$1$I$$20240903$20240909$20240909$EXP$$US-AMGEN-USASP2024176348$AMGEN$$$$$$Y$$$20240909$$CN$US$US
242965441$24296544$1$I$20240718$20240829$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-043676$AUROBINDO$$69$YR$$F$Y$$$20240909$$MD$FR$FR
242965451$24296545$1$I$$20240904$20240909$20240909$EXP$$US-ABBVIE-5907874$ABBVIE$$$$$F$Y$$$20240909$$MD$US$US
242965461$24296546$1$I$20240830$20240904$20240909$20240909$EXP$$CA-ABBVIE-5908118$ABBVIE$$32$YR$$M$Y$$$20240909$$CN$CA$CA
242965471$24296547$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003548$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240909$$CN$US$US
242965481$24296548$1$I$$20240903$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001923$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240909$$CN$US$US
242965491$24296549$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003723$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240909$$CN$US$US
242965501$24296550$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003586$ELI LILLY AND CO$$44$YR$A$$Y$$$20240909$$LW$US$US
242965511$24296551$1$I$$20240903$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003903$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240909$$CN$US$US
242965521$24296552$1$I$20230101$20240903$20240909$20240909$EXP$$US-ABBVIE-5907055$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242965531$24296553$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004763$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242965541$24296554$1$I$$20240829$20240909$20240909$EXP$$DE-AUROBINDO-AUR-APL-2024-043773$AUROBINDO$$62$YR$$M$Y$$$20240909$$MD$DE$DE
242965551$24296555$1$I$20240101$20240904$20240909$20240909$EXP$$US-ABBVIE-5907899$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242965561$24296556$1$I$20240101$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024179184$AMGEN$$82$YR$E$F$Y$$$20240909$$CN$US$US
242965571$24296557$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004764$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242965581$24296558$1$I$20240101$20240820$20240909$20240909$PER$$PR-TEVA-VS-3235597$TEVA$$25$YR$$M$Y$$$20240909$$CN$PR$PR
242965591$24296559$1$I$20240729$20240829$20240909$20240909$EXP$FR-AFSSAPS-NC2024000991$FR-Accord-445029$ACCORD$$53$YR$A$F$Y$70$KG$20240909$$MD$FR$FR
242965601$24296560$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004758$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242965612$24296561$2$F$$20240924$20240909$20240930$EXP$$JP-GSK-JP2024JPN109072$GLAXOSMITHKLINE$Koga Y, Sugiyama Y, Ogata S, Bekki M, Honda A, Tahara N, et al. OR19-6 - A case of IgG4 related disease seven months after introduction of epoprostenol. The 9th Annual Meeting of Japanese Pulmonary Circulation and Pulmonary Hypertens. 222$$$$$Y$$$20240930$$MD$JP$JP
242965622$24296562$2$F$20240613$20240919$20240909$20240927$EXP$$US-UROGEN PHARMA LTD.-2024-UGN-000125$UROGEN PHARMA$$$$$$Y$$$20240927$$MD$US$US
242965632$24296563$2$F$20240902$20240905$20240909$20240911$EXP$$KR-TAKEDA-2024TUS089107$TAKEDA$$49$YR$$F$Y$43.3$KG$20240911$$MD$KR$KR
242965641$24296564$1$I$$20240904$20240909$20240909$EXP$$US-ABBVIE-5908414$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242965651$24296565$1$I$$20240905$20240909$20240909$EXP$$GB-ABBVIE-5908782$ABBVIE$$$$E$F$Y$$$20240909$$CN$GB$GB
242965681$24296568$1$I$20240101$20240903$20240909$20240909$EXP$$JP-GSK-JP2024JPN109168$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$MD$JP$JP
242965691$24296569$1$I$20240812$20240905$20240909$20240909$EXP$$JP-GSK-JP2024JPN110273$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$PH$JP$JP
242965701$24296570$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142412$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$128.82$KG$20240909$$CN$US$US
242965711$24296571$1$I$$20240902$20240909$20240909$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-141873$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240909$$PH$FR$FR
242965721$24296572$1$I$$20240827$20240909$20240909$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2024US001251$JUBILANT$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024$$$N$M$Y$$$20240909$$HP$US$US
242965731$24296573$1$I$$20240827$20240909$20240909$EXP$$US-JUBILANT PHARMA LTD-2024US001262$JUBILANT$Vaidya R, Hashmi N, Kakshapati S, Chang W, Beachy J. Non epileptiform abnormal neurologic signs in newborns following in-utero psychotropic medication exposure. Journal of Neonatal-Perinatal Medicine. 2024$$$N$F$Y$$$20240909$$HP$US$US
242965741$24296574$1$I$$20240904$20240909$20240909$EXP$$US-ABBVIE-5907924$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242965751$24296575$1$I$$20240827$20240909$20240909$EXP$$NP-SPECGX-T202401807$SPECGX$Banjade P, Beltran C, ltani A, Sharma M. Pulmonary foreign body granulomatosis following intravenous injection of oral medication: A rare case report. Cureus. 2024;16(7)$62$YR$$F$Y$$$20240909$$HP$NP$US
242965761$24296576$1$I$$20240903$20240909$20240909$EXP$$CA-ABBVIE-5907063$ABBVIE$$74$YR$$M$Y$$$20240909$$CN$CA$CA
242965771$24296577$1$I$20240903$20240903$20240909$20240909$PER$$US-AMGEN-USASP2024175541$AMGEN$$66$YR$E$M$Y$$$20240909$$HP$US$US
242965781$24296578$1$I$$20240830$20240909$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005102$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242965791$24296579$1$I$$20240904$20240909$20240909$EXP$$US-ABBVIE-5907284$ABBVIE$$$$$$Y$$$20240909$$CN$US$US
242965802$24296580$2$F$20220301$20240920$20240909$20240930$EXP$$CA-TAKEDA-2022TUS070580$TAKEDA$$16$YR$$F$Y$$$20240930$$CN$CA$CA
242965811$24296581$1$I$20240608$20240904$20240909$20240909$EXP$$US-ABBVIE-5909059$ABBVIE$$27$YR$$M$Y$$$20240909$$CN$US$US
242965822$24296582$2$F$20220101$20240924$20240909$20240928$EXP$$JP-009507513-2409JPN000553J$MERCK$$$$$F$Y$$$20240928$$MD$JP$JP
242965831$24296583$1$I$$20240827$20240909$20240909$PER$$US-ABBVIE-5901415$ABBVIE$$$$$$Y$$$20240909$$HP$US$US
242965841$24296584$1$I$$20240903$20240909$20240909$EXP$$IN-ROCHE-10000049081$ROCHE$$66$YR$E$M$Y$$$20240909$$MD$IN$IN
242965851$24296585$1$I$20240820$20240904$20240909$20240909$EXP$$IT-TAKEDA-2024TUS088586$TAKEDA$$73$YR$$F$Y$$$20240909$$HP$IT$IT
242965861$24296586$1$I$20240705$20240904$20240909$20240909$EXP$$CO-UCBSA-2024045741$UCB$$85$YR$$F$Y$$$20240909$$CN$CO$CO
242965872$24296587$2$F$20240101$20240913$20240909$20240917$EXP$$AU-ABBVIE-5910265$ABBVIE$$$$$F$Y$$$20240917$$CN$AU$AU
242965882$24296588$2$F$20230810$20240909$20240909$20240917$EXP$$CA-TAKEDA-2024TUS036720$TAKEDA$$30$YR$$F$Y$$$20240917$$MD$CA$CA
242965891$24296589$1$I$20240801$20240904$20240909$20240909$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-118977$REGENERON$$82$YR$$F$Y$$$20240909$$MD$DE$DE
242965901$24296590$1$I$$20240827$20240909$20240909$EXP$$US-SPECGX-T202401809$SPECGX$Castillejo Becerra CM, Kaplan TM, Mogil RS, Olsen TW. Subretinal phialophora abscess in chronic granulomatous disease. Retinal Cases and Brief Reports. 2024;18(5):566-8$21$YR$$M$Y$$$20240909$$HP$US$US
242965911$24296591$1$I$20240429$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A202199$ASTRAZENECA$$29269$DY$$M$Y$$$20240909$$CN$US$
242965921$24296592$1$I$20240401$20240905$20240909$20240909$EXP$DK-DKMA-30737681$DK-009507513-2409DNK002025$MERCK$$67$YR$$F$Y$95.6$KG$20240909$$MD$DK$DK
242965931$24296593$1$I$20240101$20240906$20240909$20240909$EXP$$SE-AstraZeneca-2024A203782$ASTRAZENECA$$70$YR$$F$Y$60$KG$20240909$$MD$SE$
242965942$24296594$2$F$$20240903$20240909$20240909$PER$$US-ROCHE-10000074094$ROCHE$$$$$$Y$$$20240909$$CN$US$US
242965951$24296595$1$I$20240308$20240905$20240909$20240909$EXP$IT-BAXTER-2024BAX023710$IT-ROCHE-10000074844$ROCHE$$64$YR$A$F$Y$41$KG$20240909$$HP$IT$IT
242965961$24296596$1$I$20240704$20240828$20240909$20240909$EXP$FR-AFSSAPS-AN2024001144$FR-Accord-444430$ACCORD$$67$YR$E$M$Y$$$20240909$$PH$FR$FR
242965971$24296597$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003244$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242965981$24296598$1$I$20240826$20240828$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409000068$ELI LILLY AND CO$$$$$M$Y$$$20240909$$CN$US$US
242965991$24296599$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003566$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240909$$CN$US$US
242966001$24296600$1$I$20240801$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003309$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240909$$CN$US$US
242966011$24296601$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003862$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$US$US
242966021$24296602$1$I$20240801$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003708$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240909$$CN$US$US
242966031$24296603$1$I$20240903$20240903$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002792$ELI LILLY AND CO$$$$$$Y$$$20240909$$HP$US$US
242966041$24296604$1$I$$20240830$20240909$20240909$EXP$$US-GSK-US2024AMR108788$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242966051$24296605$1$I$20240827$20240827$20240909$20240909$30DAY$$US-GSK-US2024106652$GLAXOSMITHKLINE$$29$YR$$F$Y$$$20240909$$CN$US$US
242966061$24296606$1$I$$20240902$20240909$20240909$EXP$$ES-AMGEN-ESPSP2024177388$AMGEN$Salaberri M.; Naranjo V.; Barbera N. et al.. THE IMPORTANCE OF HISTOPATHOLOGICAL DIAGNOSIS. European journal of case reports in internal medicine. 2024;11:901$73$YR$E$F$Y$$$20240909$$HP$ES$ES
242966071$24296607$1$I$$20240905$20240909$20240909$EXP$$US-JNJFOC-20240912621$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242966081$24296608$1$I$$20240905$20240909$20240909$EXP$$US-ALXN-202409USA000327US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240909$$HP$US$US
242966101$24296610$1$I$$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140990$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$56.7$KG$20240909$$HP$US$US
242966111$24296611$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142202$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$134.26$KG$20240909$$CN$US$US
242966121$24296612$1$I$$20240902$20240909$20240909$EXP$$US-TAKEDA-2020TUS053313$TAKEDA$$$$$F$Y$$$20240909$$CN$US$US
242966131$24296613$1$I$20240703$20240829$20240909$20240909$EXP$FR-AFSSAPS-BX2024001695$FR-Accord-445055$ACCORD$$55$YR$A$F$Y$55$KG$20240909$$PH$FR$FR
242966141$24296614$1$I$20240820$20240828$20240909$20240909$EXP$$US-Accord-444335$ACCORD$$51$YR$A$M$Y$$$20240909$$HP$US$US
242966162$24296616$2$F$20240801$20240905$20240909$20240912$PER$$US-AMGEN-USASP2024176961$AMGEN$$72$YR$E$F$Y$$$20240912$$CN$US$US
242966171$24296617$1$I$20240601$20240902$20240909$20240909$EXP$FR-AFSSAPS-MA2024001406$FR-CHEPLA-2024011301$CHEPLAPHARM$$65$YR$A$F$Y$$$20240909$$MD$COUNTRY NOT SPECIFIED$FR
242966181$24296618$1$I$20240820$20240904$20240909$20240909$EXP$$CA-PFIZER INC-PV202400116667$PFIZER$$80$YR$$F$Y$$$20240909$$CN$CA$CA
242966191$24296619$1$I$$20240902$20240909$20240909$EXP$$BR-PFIZER INC-202400250890$PFIZER$$76$YR$$M$Y$68$KG$20240909$$CN$BR$BR
242966201$24296620$1$I$20230101$20240904$20240909$20240909$EXP$$US-PFIZER INC-202400251222$PFIZER$$67$YR$$F$Y$$$20240909$$HP$US$US
242966221$24296622$1$I$20240101$20240904$20240909$20240909$EXP$$CA-PFIZER INC-202200454996$PFIZER$$71$YR$$F$Y$$$20240909$$HP$CA$CA
242966231$24296623$1$I$$20240827$20240909$20240909$PER$$US-ABBVIE-5901196$ABBVIE$$$$$$Y$$$20240909$$HP$US$US
242966241$24296624$1$I$$20240821$20240909$20240909$PER$$US-ASTELLAS-2024-AER-002252$ASTELLAS$$65$YR$E$F$Y$$$20240909$$CN$US$US
242966251$24296625$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142245$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240909$$HP$US$US
242966261$24296626$1$I$$20240906$20240909$20240909$PER$$US-ROCHE-10000076278$ROCHE$$65$YR$E$M$Y$$$20240909$$MD$US$US
242966272$24296627$2$F$$20240906$20240909$20240909$PER$$US-JNJFOC-20240915697$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$MD$US$US
242966281$24296628$1$I$$20240905$20240909$20240909$EXP$$KR-JNJFOC-20240913529$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$HP$KR$KR
242966291$24296629$1$I$20240902$20240906$20240909$20240909$EXP$$CN-GILEAD-2024-0686498$GILEAD$$55$YR$A$F$Y$42$KG$20240909$$HP$CN$CN
242966301$24296630$1$I$20240726$20240904$20240909$20240909$EXP$$CO-UCBSA-2024045766$UCB$$92$YR$$F$Y$$$20240909$$CN$CO$CO
242966311$24296631$1$I$$20240829$20240909$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-044070$AUROBINDO$$51$YR$$F$Y$77.098$KG$20240909$$CN$CA$CA
242966321$24296632$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178104$AMGEN$$$$$M$Y$$$20240909$$MD$US$US
242966331$24296633$1$I$20240804$20240826$20240909$20240909$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-26515$SAMSUNG BIOEPIS$$62$YR$$M$Y$$$20240909$$HP$CA$CA
242966341$24296634$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043342$AUROBINDO$Eisenberg J, Tedford NJ, Weaver N, Becker S, Moss MJ. Adverse Outcomes in Topical Lidocaine Exposure: A Pediatric Case Series From the United States National Poison Data System. ClinPediatr-Phila. 2023;62(11):1390-1397$$$T$$Y$$$20240909$$HP$US$US
242966361$24296636$1$I$20240315$20240902$20240909$20240909$EXP$$JP-ROCHE-10000075849$ROCHE$$70$YR$E$M$Y$$$20240909$$MD$JP$JP
242966371$24296637$1$I$$20240904$20240909$20240909$PER$$US-JNJFOC-20240909352$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242966382$24296638$2$F$20240828$20240904$20240909$20240918$30DAY$$US-JNJFOC-20240908936$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240918$$CN$US$US
242966391$24296639$1$I$20240904$20240904$20240909$20240909$PER$$US-JNJFOC-20240908991$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240909$$CN$US$US
242966401$24296640$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-044453$AUROBINDO$Eisenberg J, Tedford NJ, Weaver N, Becker S, Moss MJ. Adverse Outcomes in Topical Lidocaine Exposure: A Pediatric Case Series From the United States National Poison Data System. ClinPediatr-Phila. 2023;62(11):1390-1397$$$T$$Y$$$20240909$$HP$US$US
242966411$24296641$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004775$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242966431$24296643$1$I$20240501$20240903$20240909$20240909$PER$$US-TAKEDA-2024TUS088638$TAKEDA$$67$YR$$F$Y$57$KG$20240909$$MD$US$US
242966441$24296644$1$I$$20240821$20240909$20240909$PER$$US-ASTELLAS-2024-AER-002284$ASTELLAS$$$$$F$Y$$$20240909$$MD$US$US
242966451$24296645$1$I$20240201$20240830$20240909$20240909$EXP$$ES-SA-2024SA254060$SANOFI AVENTIS$$41$YR$A$F$Y$83$KG$20240909$$MD$ES$ES
242966461$24296646$1$I$20240902$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A203126$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242966471$24296647$1$I$20240823$20240828$20240909$20240909$EXP$$US-Accord-444506$ACCORD$$48$YR$A$F$Y$$$20240909$$MD$US$US
242966481$24296648$1$I$$20240828$20240909$20240909$EXP$$PT-Accord-445000$ACCORD$Cardoso T, Reis F, Silva BD, Lopes A, Dias A, Marques J, et al. POSA-144 - (4518) - Caso de PJ. Congressos da Sociedade Portuguesa de Medicina Interna: 30. CNMI. 2024,1220$79$YR$E$F$Y$$$20240909$$MD$PT$PT
242966492$24296649$2$F$20221020$20240911$20240909$20240917$EXP$$US-SA-2024SA253625$SANOFI AVENTIS$$52$YR$A$M$Y$77.1$KG$20240917$$HP$US$US
242966502$24296650$2$F$$20240925$20240909$20240930$PER$$US-AstraZeneca-2024A201621$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$PH$US$US
242966511$24296651$1$I$20240827$20240828$20240909$20240909$PER$$US-AstraZeneca-2024A196304$ASTRAZENECA$$23071$DY$$F$Y$$$20240909$$CN$US$
242966521$24296652$1$I$$20240904$20240909$20240909$EXP$$US-ROCHE-10000074544$ROCHE$$66$YR$E$M$Y$$$20240909$$HP$US$US
242966531$24296653$1$I$$20240829$20240909$20240909$EXP$$FR-IPCA LABORATORIES LIMITED-IPC-2024-FR-002133$IPCA$Lea Fath, Francois Simon, Raphael Levy, et al. Dangers and therapeutic difficulties of intracranial hemangioma in infants: A care case report. European Annals of Otorhinolaryngology, Head and Neck diseases. 2024;141:227-230$$$$$Y$$$20240909$$HP$FR$FR
242966543$24296654$3$F$20240829$20240913$20240909$20240917$PER$$US-AMGEN-USASP2024178140$AMGEN$$71$YR$E$F$Y$$$20240916$$CN$US$US
242966551$24296655$1$I$20240905$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024177982$AMGEN$$$$$$Y$$$20240909$$CN$US$US
242966563$24296656$3$F$20240827$20240920$20240909$20240920$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049941$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$60$KG$20240920$$PH$ES$ES
242966581$24296658$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004761$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242966591$24296659$1$I$20240611$20240830$20240909$20240909$EXP$$US-BEH-2024178132$CSL BEHRING$$72$YR$E$F$Y$$$20240909$$HP$US$US
242966601$24296660$1$I$20240101$20240905$20240909$20240909$EXP$$US-GILEAD-2024-0686567$GILEAD$$$$A$F$Y$$$20240909$$CN$US$US
242966611$24296661$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043279$AUROBINDO$Rios JRR, Richardson A, Rivas A, Isache C, Franchi F. AN UNCOMMON CAUSE OF INFECTIVE ENDOCARDITIS. J-Am-Coll-Cardiol. 2019;73 (Suppl. 1)(9:2572$44$YR$$M$Y$$$20240909$$HP$US$US
242966621$24296662$1$I$$20240904$20240909$20240909$EXP$$GB-ROCHE-10000075488$ROCHE$$52$YR$A$F$Y$$$20240909$$CN$GB$GB
242966631$24296663$1$I$$20240829$20240909$20240909$EXP$$CN-ROCHE-10000070241$ROCHE$$54$YR$A$M$Y$$$20240909$$MD$CN$CN
242966641$24296664$1$I$20240805$20240828$20240909$20240909$EXP$$CN-ROCHE-10000069256$ROCHE$$77$YR$E$M$Y$52.5$KG$20240909$$CN$CN$CN
242966651$24296665$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043221$AUROBINDO$Shah SP, Patel N, Madi P, Monteiro I. The anesthetic management of a child with ohtahara syndrome and severe stridor: a case report. BMC-Pediatr. 2024;24No. 1$14$MON$$M$Y$9$KG$20240909$$HP$US$US
242966661$24296666$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003982$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240909$$CN$US$US
242966671$24296667$1$I$$20240828$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408018924$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242966683$24296668$3$F$$20240918$20240909$20240925$PER$$US-GSK-US2024AMR111487$GLAXOSMITHKLINE$$$$$F$Y$70.295$KG$20240925$$CN$US$US
242966691$24296669$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003612$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240909$$CN$US$US
242966701$24296670$1$I$20240904$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003624$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240909$$CN$US$US
242966711$24296671$1$I$20240702$20240826$20240909$20240909$EXP$$FR-CIPLA LTD.-2024FR09442$CIPLA$$$$$$Y$$$20240909$$MD$FR$FR
242966721$24296672$1$I$20240801$20240826$20240909$20240909$EXP$$US-CIPLA LTD.-2024US09547$CIPLA$$$$$$Y$$$20240909$$CN$US$US
242966731$24296673$1$I$$20240826$20240909$20240909$EXP$$US-CIPLA LTD.-2024US09523$CIPLA$Peshin S, Modi SK, Burwick N. Lenalidomide and Dexamethasone in scleromyxedema: a case report of long-term efficacy and challenges in a 54-year-old patient.. Cureus. 2024;16(6): e63181$$$$$Y$$$20240909$$MD$US$US
242966741$24296674$1$I$$20240830$20240909$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005233$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$HP$US$US
242966752$24296675$2$F$20200101$20240912$20240909$20240918$EXP$$US-ABBVIE-5907815$ABBVIE$$$$$M$Y$81$KG$20240918$$CN$US$US
242966761$24296676$1$I$$20240904$20240909$20240909$PER$$US-ABBVIE-5909199$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242966771$24296677$1$I$$20240815$20240909$20240909$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004825$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242966781$24296678$1$I$$20240828$20240909$20240909$EXP$$SE-MSNLABS-2024MSNLIT01910$MSN LABORATORIES$Krstic A, Rezayee F, Saft L, Hammarsjo A, Svenberg P, Barbany G.Case Report: Whole genome sequencing identifies CCDC88C as a novel JAK2 fusion partner in pediatric T-cell acute lymphoblastic leukemia.Front Pediatr.2023;10:1082986$$$$$Y$$$20240909$$HP$SE$SE
242966791$24296679$1$I$$20240827$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043225$AUROBINDO$Torrie AM, Dunitz J, Brookman JC. Apparent Reversal of a Successful Peripheral Neural Blockade With Intravenous Lipid Emulsion After Treatment for Local Anesthetic Systemic Toxicity: A Case Report.. A-A-Pract. 2020;14No:13$42$YR$$F$Y$56$KG$20240909$$HP$US$US
242966801$24296680$1$I$$20240904$20240909$20240909$PER$$US-ALXN-202409USA000176US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242966823$24296682$3$F$20240101$20240905$20240909$20240925$PER$$US-AMGEN-USASP2024177750$AMGEN$$$$$M$Y$$$20240925$$CN$US$US
242966841$24296684$1$I$20240824$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142358$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240909$$HP$US$US
242966851$24296685$1$I$20240601$20240904$20240909$20240909$EXP$FR-AFSSAPS-LM2024000485$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-141334$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240909$$MD$FR$FR
242966861$24296686$1$I$20200406$20240611$20240909$20240909$EXP$$US-SANDOZ INC.-NVSC2021US071196$SANDOZ$$54$YR$$F$Y$90.9$KG$20240909$$MD$US$US
242966871$24296687$1$I$20240501$20240906$20240909$20240909$EXP$$GB-SANDOZ INC.-SDZ2024GB078380$SANDOZ$$2$YR$$F$Y$$$20240909$$MD$GB$GB
242966881$24296688$1$I$20190101$20240905$20240909$20240909$EXP$$US-GILEAD-2024-0686585$GILEAD$$40$YR$A$M$Y$$$20240909$$CN$US$US
242966891$24296689$1$I$$20240828$20240909$20240909$EXP$$PT-Accord-444721$ACCORD$Pereira P, Ling T, Loureiro A, et al. Juvenile myelomonocytic leukemia with chromosome 7 monosomy - clinical case report. Laboratory Medicine Magazine. 2024;5:132-136.$13$MON$I$F$Y$$$20240909$$HP$PT$PT
242966901$24296690$1$I$$20240828$20240909$20240909$EXP$PT-EMA-DD-20240820-7482675-100131$PT-MSNLABS-2024MSNLIT01912$MSN LABORATORIES$$$$$$Y$$$20240909$$MD$PT$PT
242966911$24296691$1$I$$20240828$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043406$AUROBINDO$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Ravi Salgia et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. CancerImmunol-Immunother. 2024;73:200$61$YR$$F$Y$$$20240909$$HP$US$US
242966921$24296692$1$I$20240801$20240828$20240909$20240909$PER$$US-ABBVIE-5901340$ABBVIE$$55$YR$$F$Y$$$20240909$$HP$US$US
242966931$24296693$1$I$$20240828$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043426$AUROBINDO$Mangini P, Serdenes R, Ortiz N. Hyperactive Delirium in Heroin Toxic Leukoencephalopathy Complicated by Atypical NMS. J-Acad-Consult-Liaison-Psychiatry. 2023;64 (Suppl.)S50:101$52$YR$$M$Y$$$20240909$$HP$US$US
242966941$24296694$1$I$$20240906$20240909$20240909$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050171$BOEHRINGER INGELHEIM$$$$$$Y$$$20240909$$CN$US$US
242966951$24296695$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009899$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242966961$24296696$1$I$$20240903$20240909$20240909$EXP$$CA-009507513-2409CAN001519$MERCK$$70$YR$$M$Y$77$KG$20240909$$MD$CA$CA
242966972$24296697$2$F$20240101$20240903$20240909$20240912$PER$$US-AMGEN-USASP2024176371$AMGEN$$80$YR$E$F$Y$$$20240912$$CN$US$US
242966981$24296698$1$I$$20240830$20240909$20240909$EXP$$GB-ABBVIE-5909452$ABBVIE$$$$$$Y$$$20240909$$HP$GB$GB
242966991$24296699$1$I$20240809$20240829$20240909$20240909$EXP$GB-MHRA-TPP26437211C1817042YC1724857308251$GB-Accord-444392$ACCORD$$76$YR$E$F$Y$69$KG$20240909$$HP$GB$GB
242967001$24296700$1$I$20240809$20240829$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043565$AUROBINDO$$76$YR$$F$Y$69$KG$20240909$$HP$GB$GB
242967011$24296701$1$I$$20240905$20240909$20240909$EXP$$DE-ADIENNEP-2024AD000718$ADIENNE PHARMA + BIOTECH$Obermaier B, Braun C, Hensen L, Ahmad O, Faul C, Lang P et al. Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience. Transpl Infect Dis. 2024;26(4):e14296. DOI: 10.1111/tid.14296$46$YR$$$Y$$$20240905$$MD$DE$
242967021$24296702$1$I$20240801$20240830$20240909$20240909$EXP$$CA-CELLTRION INC.-2024CA015346$CELLTRION$$$$$$Y$$$20240909$$MD$CA$CA
242967031$24296703$1$I$20240101$20240904$20240909$20240909$EXP$$CA-ABBVIE-5908131$ABBVIE$$74$YR$$M$Y$$$20240909$$CN$CA$CA
242967041$24296704$1$I$$20240829$20240909$20240909$PER$$US-MSNLABS-2024MSNSPO01916$MSN LABORATORIES$$$$$$Y$$$20240909$$CN$US$US
242967051$24296705$1$I$$20240904$20240909$20240909$EXP$$US-ABBVIE-5908309$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242967061$24296706$1$I$20240830$20240903$20240909$20240909$PER$$US-AMGEN-USASP2024176666$AMGEN$$59$YR$A$F$Y$$$20240909$$CN$US$US
242967071$24296707$1$I$20240101$20240904$20240909$20240909$EXP$$US-ABBVIE-5907408$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242967081$24296708$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009900$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242967101$24296710$1$I$$20240829$20240909$20240909$EXP$GB-MHRA-MED-202408290050018860-RSWYM$GB-Accord-444177$ACCORD$$33$YR$A$M$Y$$$20240909$$CN$GB$GB
242967111$24296711$1$I$$20240904$20240909$20240909$EXP$$US-ABBVIE-5908348$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242967121$24296712$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009901$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242967131$24296713$1$I$$20240905$20240909$20240909$EXP$$DE-ADIENNEP-2024AD000719$ADIENNE PHARMA + BIOTECH$Obermaier B, Braun C, Hensen L, Ahmad O, Faul C, Lang P et al. Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience. Transpl Infect Dis. 2024;26(4):e14296. DOI: 10.1111/tid.14296$24$YR$$$Y$$$20240905$$MD$DE$
242967141$24296714$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009902$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242967151$24296715$1$I$20211117$20240716$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US063897$SANDOZ$$33$YR$$M$Y$82.96$KG$20240909$$MD$US$US
242967161$24296716$1$I$20240827$20240830$20240909$20240909$30DAY$$US-GSK-US2024107275$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240909$$CN$US$US
242967172$24296717$2$F$$20240916$20240909$20240927$EXP$$IE-AMGEN-IRLSP2024179196$AMGEN$Tomkins E, Ruttledge M. Case study 2: Layering multiple migraine treatments - tales of the unexpected. NEUROLOGY. 2024;30 (7):24-7$50$YR$A$F$Y$$$20240927$$HP$IE$IE
242967181$24296718$1$I$20240627$20240829$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-043830$AUROBINDO$$84$YR$$F$Y$$$20240909$$PH$FR$FR
242967191$24296719$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178128$AMGEN$$$$$$Y$$$20240909$$CN$US$US
242967201$24296720$1$I$20240712$20240830$20240909$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005197$ACADIA PHARMACEUTICALS$$93$YR$$F$Y$$$20240909$$HP$US$US
242967211$24296721$1$I$$20240902$20240909$20240909$EXP$$CA-ROCHE-10000073022$ROCHE$$$$A$M$Y$59$KG$20240909$$MD$CA$CA
242967221$24296722$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009903$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242967231$24296723$1$I$20240601$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003777$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240909$$CN$US$US
242967241$24296724$1$I$20240901$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004233$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242967251$24296725$1$I$20240801$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002909$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240909$$CN$US$US
242967261$24296726$1$I$20240101$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003928$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240909$$HP$US$US
242967271$24296727$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003804$ELI LILLY AND CO$$$$A$M$Y$$$20240909$$CN$US$US
242967281$24296728$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003647$ELI LILLY AND CO$$64$YR$A$$Y$$$20240909$$CN$US$US
242967291$24296729$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003663$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240909$$CN$US$US
242967312$24296731$2$F$$20240911$20240909$20240922$PER$$US-GSK-US2024AMR108251$GLAXOSMITHKLINE$$$$$F$Y$54.42$KG$20240922$$CN$US$US
242967321$24296732$1$I$20240101$20240831$20240909$20240909$PER$$US-ABBVIE-5907183$ABBVIE$$$$$$Y$$$20240909$$CN$US$US
242967331$24296733$1$I$$20240906$20240909$20240909$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050122$BOEHRINGER INGELHEIM$$$$$$Y$$$20240909$$CN$US$US
242967341$24296734$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009904$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242967352$24296735$2$F$20240101$20240926$20240909$20240927$EXP$$US-SANDOZ INC.-SDZ2024US077735$SANDOZ$$$$$F$Y$$$20240927$$CN$US$US
242967361$24296736$1$I$$20240905$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US064513$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242967371$24296737$1$I$20240603$20240829$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-043709$AUROBINDO$$62$YR$$F$Y$$$20240909$$MD$FR$FR
242967381$24296738$1$I$$20240904$20240909$20240909$PER$$US-JNJFOC-20240912124$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240909$$CN$US$US
242967391$24296739$1$I$$20240905$20240909$20240909$PER$$US-ABBVIE-5910406$ABBVIE$$$$$$Y$$$20240909$$PH$US$US
242967401$24296740$1$I$$20240829$20240909$20240909$EXP$$JP-ROCHE-10000072371$ROCHE$$7$DEC$E$$Y$$$20240909$$MD$JP$JP
242967411$24296741$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009905$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242967421$24296742$1$I$$20240830$20240909$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005250$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240909$$PH$US$US
242967431$24296743$1$I$20240809$20240830$20240909$20240909$EXP$$US-GSK-US2024108302$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240909$$CN$US$US
242967441$24296744$1$I$$20240830$20240909$20240909$PER$$US-ROCHE-10000070777$ROCHE$$49$YR$A$F$Y$90.72$KG$20240909$$MD$US$US
242967451$24296745$1$I$20240802$20240902$20240909$20240909$EXP$$TW-JNJFOC-20240911793$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240909$$MD$TW$TW
242967461$24296746$1$I$$20240903$20240909$20240909$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001790$BLUEPRINT MEDICINES$$$$$F$Y$$$20240909$$CN$US$US
242967471$24296747$1$I$$20240906$20240909$20240909$PER$$US-JNJFOC-20240917582$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$LW$US$US
242967481$24296748$1$I$$20240830$20240909$20240909$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001785$BLUEPRINT MEDICINES$$$$$F$Y$$$20240909$$CN$US$US
242967491$24296749$1$I$$20240904$20240909$20240909$PER$$US-ALXN-202409USA000268US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242967501$24296750$1$I$20240611$20240830$20240909$20240909$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07885$VIFOR$$72$YR$$M$Y$$$20240909$$HP$ZA$ZA
242967511$24296751$1$I$$20240903$20240909$20240909$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001792$BLUEPRINT MEDICINES$$$$$F$Y$$$20240909$$CN$US$US
242967521$24296752$1$I$$20240905$20240909$20240909$EXP$$CA-SANDOZ INC.-SDZ2023CA021225$SANDOZ$$$$$M$Y$$$20240909$$CN$CA$CA
242967531$24296753$1$I$$20240905$20240909$20240909$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001806$BLUEPRINT MEDICINES$$$$$M$Y$$$20240909$$CN$US$US
242967541$24296754$1$I$$20240904$20240909$20240909$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001800$BLUEPRINT MEDICINES$$$$$F$Y$$$20240909$$CN$US$US
242967551$24296755$1$I$$20240904$20240909$20240909$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001795$BLUEPRINT MEDICINES$$$$$M$Y$$$20240909$$CN$US$US
242967561$24296756$1$I$$20240903$20240909$20240909$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001794$BLUEPRINT MEDICINES$$$$$M$Y$$$20240909$$CN$US$US
242967571$24296757$1$I$20240701$20240830$20240909$20240909$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001787$BLUEPRINT MEDICINES$$58$YR$A$F$Y$$$20240909$$CN$US$US
242967581$24296758$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009910$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242967591$24296759$1$I$$20240623$20240909$20240909$PER$$US-AUROBINDO-AUR-APL-2024-032038$AUROBINDO$$$$A$F$Y$$$20240909$$MD$US$US
242967601$24296760$1$I$$20240830$20240909$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005229$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242967611$24296761$1$I$20230601$20240830$20240909$20240909$EXP$$CN-ABBVIE-5909889$ABBVIE$Shi W. Neutrophilic leukocytosis and thrombocytosis caused by ceftazidime and avibactam sodium:a case report. Clinical Medication Journal. 2024;22(7):90-92.$48$YR$$M$Y$83$KG$20240909$$HP$CN$CN
242967621$24296762$1$I$$20240903$20240909$20240909$EXP$$CA-ROCHE-10000072948$ROCHE$$$$$F$Y$$$20240909$$MD$CA$CA
242967631$24296763$1$I$20240801$20240826$20240909$20240909$EXP$$US-UCBSA-2024043720$UCB$$35$YR$$F$Y$93.878$KG$20240909$$HP$US$US
242967642$24296764$2$F$20240101$20240829$20240909$20240912$EXP$$CA-UCBSA-2024044229$UCB$$$$$M$Y$$$20240912$$HP$CA$CA
242967651$24296765$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009911$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242967663$24296766$3$F$20240904$20240917$20240909$20240920$PER$$US-AMGEN-USASP2024179189$AMGEN$$42$YR$A$F$Y$55$KG$20240919$$PH$US$US
242967671$24296767$1$I$$20240829$20240909$20240909$PER$$US-AMGEN-USASP2024174868$AMGEN$$$$$$Y$$$20240909$$CN$US$US
242967681$24296768$1$I$20240905$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024178677$AMGEN$$40$YR$A$$Y$$$20240909$$CN$US$US
242967691$24296769$1$I$$20240902$20240909$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-141528$BRISTOL MYERS SQUIBB$Sato Y, et al. A case of successful chemoradiotherapy and immune checkpoint inhibitor therapy for advanced oesophageal cancer in an elderly patient. The 78th Annual Meeting of the Japan Esophageal Society. 2024;p29-1.$80$YR$E$M$Y$$$20240909$$MD$JP$JP
242967701$24296770$1$I$$20240830$20240909$20240909$30DAY$$US-GSK-US2024108460$GLAXOSMITHKLINE$$$$$M$Y$$$20240909$$CN$US$US
242967711$24296771$1$I$20240822$20240902$20240909$20240909$EXP$$AR-TAKEDA-2024TUS088607$TAKEDA$$74$YR$$M$Y$$$20240909$$CN$AR$AR
242967721$24296772$1$I$$20240904$20240909$20240909$PER$$US-ABBVIE-5909456$ABBVIE$$$$A$$Y$$$20240909$$MD$US$US
242967731$24296773$1$I$20120101$20240830$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2014-00954$AUROBINDO$MowryJ B, Spyker DA, Cantilena L R, Bailey JE, Ford M. 2012 Annual Report of the American Association of Poison Control Centers? National Poison Data System (NPDS): 30th Annual Report. Clinical Toxicology. 2013;51:949 - 1229$86$YR$$F$Y$$$20240909$$PH$US$US
242967741$24296774$1$I$$20231006$20240909$20240909$EXP$$US-SANDOZ INC.-NVSC2023US017780$SANDOZ$$$$$F$Y$$$20240909$$CN$US$US
242967751$24296775$1$I$20240828$20240828$20240909$20240909$EXP$$US-Accord-444630$ACCORD$$30$YR$A$M$Y$$$20240909$$MD$US$US
242967762$24296776$2$F$$20240912$20240909$20240920$EXP$$IE-TEVA-VS-3240985$TEVA$Rico Rios N, Bransfield A, Joyce CM, Cahill MR, O^shaughnessy M, Costelloe SJ. Challenges of providing biochemistry results in a patient with Evans syndrome. Biochem-Med-Zagreb 2024; 34 (1):.; Rico Rios N, Bransfield A, Joyce CM, Cahill MR, O^shaughnessy M, Costelloe SJ. Challenges of providing biochemistry results in a patient with Evans syndrome. Biochem-Med-Zagreb 2024; 34 (1):.$40$YR$$F$Y$$$20240920$$HP$IE$IE
242967771$24296777$1$I$$20240904$20240909$20240909$PER$$US-JNJFOC-20240916913$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242967781$24296778$1$I$$20240828$20240909$20240909$EXP$$US-NOVOPROD-1277440$NOVO NORDISK$$$$$F$Y$$$20240909$$CN$US$US
242967792$24296779$2$F$$20240917$20240909$20240923$PER$$US-LEO Pharma-373294$LEO PHARM$$62$YR$$M$Y$$$20240923$$MD$US$US
242967801$24296780$1$I$$20240904$20240909$20240909$EXP$$GB-ABBVIE-5906643$ABBVIE$$$$$M$Y$$$20240909$$CN$GB$GB
242967812$24296781$2$F$$20240906$20240909$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005147$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
242967821$24296782$1$I$$20240829$20240909$20240909$EXP$$US-ROCHE-10000069964$ROCHE$$76$YR$E$F$Y$$$20240909$$CN$US$US
242967831$24296783$1$I$20240511$20240515$20240909$20240909$PER$$US-ITALFARMACO SPA-2161373$ITALFARMACO$$65$YR$$M$Y$$$20240909$$$US$US
242967841$24296784$1$I$$20240903$20240909$20240909$EXP$US-MLMSERVICE-20181221-1540267-1$US-CHEPLA-2024011343$CHEPLAPHARM$Chen J, Ngo D, Rosenthal J. Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease. Journal of Oncology Pharmacy Practice. 2018;25(8):2027-30  DOI: 10.1177/1078155218817817.$26$YR$$M$Y$$$20240909$$HP$COUNTRY NOT SPECIFIED$US
242967851$24296785$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003691$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240909$$PH$US$US
242967861$24296786$1$I$20240905$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003864$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240909$$CN$US$US
242967871$24296787$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003951$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240909$$CN$US$US
242967881$24296788$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003660$ELI LILLY AND CO$$$$$F$Y$$$20240909$$HP$US$US
242967891$24296789$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003707$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240909$$CN$US$US
242967901$24296790$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003685$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240909$$CN$US$US
242967911$24296791$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004064$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242967921$24296792$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003848$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240909$$CN$US$US
242967931$24296793$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003460$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240909$$MD$US$US
242967941$24296794$1$I$$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004413$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$US$US
242967951$24296795$1$I$20240904$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003654$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240909$$CN$US$US
242967962$24296796$2$F$20240701$20240917$20240909$20240920$EXP$$JP-ABBVIE-5874334$ABBVIE$$40$YR$$F$Y$$$20240920$$MD$JP$JP
242967971$24296797$1$I$$20240828$20240909$20240909$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-08105$HIKMA$Assis JG, Santos A.. Assis JG, Santos A. Myxedema Coma: Recognition of a Rare Endocrine Emergency. Cureus. 2024;16(8): e66053.$$$$$Y$$$20240909$$MD$PT$PT
242967981$24296798$1$I$20240410$20240524$20240909$20240909$PER$$US-ITALFARMACO SPA-2161374$ITALFARMACO$$67$YR$$M$Y$$$20240909$$$US$US
242967991$24296799$1$I$20240416$20240530$20240909$20240909$PER$$US-ITALFARMACO SPA-2161375$ITALFARMACO$$58$YR$$F$Y$$$20240909$$$US$US
242968002$24296800$2$F$20240101$20240906$20240909$20240909$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050133$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240909$$MD$US$US
242968011$24296801$1$I$20210701$20240828$20240909$20240909$EXP$$PT-Accord-444665$ACCORD$Oliveira C, Queiroz L, Almeida M, Fernandes R, Caeiro C. Hepatoxicidade grave com ribociclib, a proposito de um caso desafiante Challenging case of severe hepatotoxicity with ribociclib. REVISTA PORTUGUESA DE ONCOLOGIA. 2024;7 (N1-2):46-8.$45$YR$A$F$Y$$$20240909$$HP$PT$PT
242968022$24296802$2$F$20240820$20240913$20240909$20240919$PER$$US-AMGEN-USASP2024168706$AMGEN$$41$YR$A$F$Y$73.1$KG$20240919$$HP$US$US
242968041$24296804$1$I$$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024176979$AMGEN$Babu B.; Satyal P.; Sukhcharan Walia. et.al.. Cracking the code: high ferritin load with Salmon-Colored skin episodes. Oxford Medical Case Reports. 2024;2024 (8):360-361$37$YR$A$M$Y$$$20240909$$HP$US$US
242968051$24296805$1$I$$20240901$20240909$20240909$PER$$US-AMGEN-USASP2024175946$AMGEN$Soliman S.; Haider A.; Taveras S. et.al. Hemophagocytic Lymphohistiocytosis (HLH) in Pregnancy: Management of a Case With Steroid Monotherapy and Review of the Literature. Clinical Lymphoma, Myeloma + Leukemia. 2024;24 (SUPPL_1):S320$38$YR$A$F$Y$$$20240909$$MD$US$US
242968061$24296806$1$I$20240813$20240830$20240909$20240909$EXP$$BR-TAKEDA-2024TUS088764$TAKEDA$$56$YR$$F$Y$$$20240909$$CN$BR$BR
242968071$24296807$1$I$20240426$20240828$20240909$20240909$EXP$$FR-INSMED, INC.-2024-03513-FR$INSMED$$57$YR$$F$Y$49$KG$20240909$$PH$FR$FR
242968081$24296808$1$I$20240801$20240905$20240909$20240909$PER$$US-JNJFOC-20240913075$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240909$$HP$US$US
242968091$24296809$1$I$$20240903$20240909$20240909$EXP$$US-AMGEN-USASP2024177114$AMGEN$Jabbour E.; Short N.; Jain N. et al.. Very Promising Results of the Dose Dense (D-D) Mini-Hyper-CVD-Inotuzumab-Blinatumomab Phase 2 Trial in Patients with Relapsed-Refractory Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S284-S285$$$A$$Y$$$20240909$$MD$US$US
242968101$24296810$1$I$20230101$20240829$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-043741$AUROBINDO$$17$YR$$M$Y$$$20240909$$MD$FR$FR
242968111$24296811$1$I$$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024178480$AMGEN$$$$$M$Y$$$20240909$$CN$US$US
242968123$24296812$3$F$$20240913$20240909$20240926$EXP$$JP-AMGEN-JPNSP2024171080$AMGEN$$$$$F$Y$$$20240926$$MD$JP$JP
242968132$24296813$2$F$$20240904$20240909$20240927$EXP$$IN-CHIESI-2024CHF05648$CHIESI$$$$N$F$Y$$$20240927$$MD$IN$IN
242968141$24296814$1$I$$20240904$20240909$20240909$EXP$$CN-CHIESI-2024CHF05691$CHIESI$$$$N$M$Y$$$20240909$$MD$CN$CN
242968151$24296815$1$I$$20240812$20240909$20240909$EXP$$RO-ABBVIE-5910575$ABBVIE$$$$$$Y$$$20240909$$CN$RO$RO
242968161$24296816$1$I$$20240830$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043801$AUROBINDO$$73$YR$$F$Y$$$20240909$$HP$GB$GB
242968171$24296817$1$I$$20240830$20240909$20240909$EXP$$US-CHIESI-2024CHF05614$CHIESI$$$$$F$Y$$$20240909$$CN$US$US
242968181$24296818$1$I$20230101$20240830$20240909$20240909$EXP$$CA-CELLTRION INC.-2023CA009898$CELLTRION$$$$$$Y$$$20240909$$MD$CA$CA
242968191$24296819$1$I$$20240902$20240909$20240909$EXP$$ES-IPCA LABORATORIES LIMITED-IPC-2024-ES-002173$IPCA$Pablo Aranda Laserna, Monica Castro Fajardo, Javier Mart?nez De Victoria Carazo et al.. Don ^t forget the drugs. An atypical case of renopulmonary syndrome in an adult male. European Journal of Case Reports in Internal Medicine. 2024;1018$$$$$Y$$$20240909$$HP$ES$ES
242968212$24296821$2$F$20240301$20240905$20240909$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-043629$AUROBINDO$$77$YR$$M$Y$$$20240912$$MD$FR$FR
242968251$24296825$1$I$$20240904$20240909$20240909$EXP$$FR-TAKEDA-2024TUS089191$TAKEDA$$$$$$Y$$$20240909$$CN$FR$FR
242968261$24296826$1$I$$20240814$20240909$20240909$PER$$US-BEIGENE-BGN-2024-012861$BEIGENE$$$$$$Y$$$20240909$$MD$US$US
242968271$24296827$1$I$20240810$20240829$20240909$20240909$EXP$ES-AEMPS-1562974$ES-Accord-444786$ACCORD$$92$YR$E$M$Y$$$20240909$$MD$ES$ES
242968281$24296828$1$I$$20240906$20240909$20240909$EXP$$US-TAKEDA-2024TUS089512$TAKEDA$$$$$F$Y$$$20240909$$CN$US$US
242968291$24296829$1$I$$20240906$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US078470$SANDOZ$$$$$F$Y$$$20240909$$CN$US$US
242968301$24296830$1$I$20240812$20240904$20240909$20240909$EXP$$FR-TAKEDA-2024TUS088595$TAKEDA$$13$YR$$M$Y$$$20240909$$HP$FR$FR
242968311$24296831$1$I$20240828$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178137$AMGEN$$$$$$Y$$$20240909$$PH$US$US
242968321$24296832$1$I$$20240829$20240909$20240909$PER$$US-ABBVIE-5902243$ABBVIE$$$$$$Y$$$20240909$$CN$US$US
242968331$24296833$1$I$$20240828$20240909$20240909$EXP$$US-SA-2024SA258938$SANOFI AVENTIS$$45$YR$A$M$Y$106.58$KG$20240909$$MD$US$US
242968341$24296834$1$I$$20240902$20240909$20240909$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049939$BOEHRINGER INGELHEIM$$89$YR$E$F$Y$$$20240909$$CN$ES$ES
242968351$24296835$1$I$$20240904$20240909$20240909$PER$$US-ABBVIE-5909785$ABBVIE$$$$A$$Y$$$20240909$$MD$US$US
242968361$24296836$1$I$20240701$20240830$20240909$20240909$EXP$$US-SA-2024SA258256$SANOFI AVENTIS$$$$$M$Y$$$20240909$$MD$US$US
242968371$24296837$1$I$20240812$20240829$20240909$20240909$EXP$$CN-SA-2024SA253769$SANOFI AVENTIS$$26$YR$A$M$Y$66$KG$20240909$$HP$CN$CN
242968381$24296838$1$I$20240101$20240902$20240909$20240909$EXP$$JP-SA-2024SA254540$SANOFI AVENTIS$$$$$$Y$$$20240909$$PH$JP$JP
242968391$24296839$1$I$20240801$20240830$20240909$20240909$EXP$$GB-VERTICAL PHARMACEUTICALS-2024ALO00444$Alora Pharma$$56$YR$$F$Y$55$KG$20240909$$CN$GB$GB
242968402$24296840$2$F$$20240916$20240909$20240918$PER$$US-AMGEN-USASP2024179110$AMGEN$$$$$F$Y$$$20240917$$MD$US$US
242968411$24296841$1$I$20240823$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178349$AMGEN$$21$YR$A$F$Y$$$20240909$$CN$US$US
242968421$24296842$1$I$20240731$20240905$20240909$20240909$EXP$$US-GSK-US2024110597$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$CN$US$US
242968431$24296843$1$I$$20240905$20240909$20240909$EXP$$US-TAKEDA-2024TUS089365$TAKEDA$$$$$F$Y$$$20240909$$CN$US$US
242968441$24296844$1$I$$20240903$20240909$20240909$PER$$US-ABBVIE-5906284$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242968451$24296845$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009912$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242968461$24296846$1$I$20240731$20240830$20240909$20240909$EXP$$CA-TAKEDA-2024TUS088267$TAKEDA$$87$YR$$F$Y$$$20240909$$CN$CA$CA
242968471$24296847$1$I$$20230915$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2023US033015$SANDOZ$$76$YR$$F$Y$$$20240909$$CN$US$US
242968481$24296848$1$I$$20240905$20240909$20240909$EXP$$CA-TAKEDA-2024TUS089511$TAKEDA$$$$$F$Y$$$20240909$$CN$CA$CA
242968491$24296849$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009913$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242968502$24296850$2$F$20240713$20240909$20240909$20240917$EXP$$SG-ROCHE-10000073916$ROCHE$$61$YR$A$M$Y$$$20240917$$HP$SG$SG
242968511$24296851$1$I$$20240828$20240909$20240909$EXP$$US-ABBVIE-5905131$ABBVIE$$$$$M$Y$3$KG$20240909$$HP$US$US
242968521$24296852$1$I$$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004420$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240909$$CN$US$US
242968531$24296853$1$I$20240901$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003673$ELI LILLY AND CO$$55$YR$A$$Y$$$20240909$$CN$US$US
242968541$24296854$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003766$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240909$$CN$US$US
242968551$24296855$1$I$$20240904$20240909$20240909$PER$$US-ALXN-202409USA000389US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242968561$24296856$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004014$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240909$$CN$US$US
242968571$24296857$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009914$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242968581$24296858$1$I$20240101$20240905$20240909$20240909$EXP$$GB-ABBVIE-5908738$ABBVIE$$$$$F$Y$56$KG$20240909$$CN$GB$GB
242968611$24296861$1$I$$20240903$20240909$20240909$EXP$$BR-TAKEDA-2024TUS089172$TAKEDA$$84$YR$$M$Y$$$20240909$$CN$BR$BR
242968621$24296862$1$I$$20240905$20240909$20240909$EXP$$JP-009507513-2409JPN000816J$MERCK$$84$YR$$F$Y$$$20240909$$PH$JP$JP
242968631$24296863$1$I$20240716$20240903$20240909$20240909$EXP$$CA-JNJFOC-20240766814$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240909$$HP$CA$CA
242968641$24296864$1$I$$20240904$20240909$20240909$EXP$$US-JNJFOC-20240908460$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$MD$US$US
242968651$24296865$1$I$$20240901$20240909$20240909$EXP$$GB-JNJFOC-20240911307$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240909$$CN$GB$GB
242968671$24296867$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009915$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242968681$24296868$1$I$$20240617$20240909$20240909$PER$$US-ABBVIE-5910250$ABBVIE$$$$A$$Y$$$20240909$$MD$US$US
242968701$24296870$1$I$$20240617$20240909$20240909$PER$$US-ABBVIE-5909977$ABBVIE$$$$A$$Y$$$20240909$$HP$US$US
242968711$24296871$1$I$$20240902$20240909$20240909$EXP$$US-UCBSA-2024045242$UCB$Wells K, Calleo V. Safety and Depth of Sedation With Ketamine Alone Versus Ketamine With Midazolam in Pediatric Fracture Reduction: A Retrospective Chart Review. Pediatric emergency care. 2024;00:1-5$$$$$Y$$$20240909$$MD$US$US
242968721$24296872$1$I$$20240905$20240909$20240909$PER$$NVSC2024US179824$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
242968731$24296873$1$I$$20240903$20240909$20240909$EXP$$GB-009507513-2409GBR001203$MERCK$Lee K.K., Bain T., Flapan A.. Cardiogenic shock secondary to immune checkpoint inhibitor associated myocarditis. The journal of the Royal College of Physicians of Edinburgh. 2024;0(0):1-6$64$YR$$M$Y$$$20240909$$HP$GB$GB
242968741$24296874$1$I$$20240902$20240909$20240909$EXP$$NVSJ2024JP009632$NOVARTIS$$$$$$Y$$$20240909$$PH$JP$JP
242968751$24296875$1$I$$20240906$20240909$20240909$PER$$NVSC2024US179910$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
242968763$24296876$3$F$20230412$20240911$20240909$20240917$EXP$$NVSC2022AU241404$NOVARTIS$$60$YR$$M$Y$$$20240917$$HP$AU$AU
242968771$24296877$1$I$$20240905$20240909$20240909$PER$$NVSC2024US179490$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
242968781$24296878$1$I$$20240905$20240909$20240909$PER$$NVSC2024US179610$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
242968791$24296879$1$I$$20240905$20240909$20240909$PER$$NVSC2024US179675$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
242968801$24296880$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180025$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
242968811$24296881$1$I$$20240904$20240909$20240909$EXP$$NVSC2024ES178872$NOVARTIS$$$$$M$Y$$$20240909$$MD$ES$ES
242968821$24296882$1$I$$20240906$20240909$20240909$EXP$$NVSC2024CN179374$NOVARTIS$$73$YR$$M$Y$$$20240909$$CN$CN$CN
242968831$24296883$1$I$$20240905$20240909$20240909$PER$$NVSC2024US179559$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
242968841$24296884$1$I$20240818$20240903$20240909$20240909$EXP$$NVSC2024CL086253$NOVARTIS$$68$YR$$F$Y$$$20240909$$CN$CL$CL
242968851$24296885$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009916$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242968861$24296886$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009917$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242968871$24296887$1$I$$20240826$20240909$20240909$PER$$US-ROCHE-10000067607$ROCHE$- ,  Cytokine release syndrome due to intravenous trastuzumab with tolerance of subcutaneous administration. European Academy of Allergy and Clinical Immunology (EAACI) Congress. 2024;$$$$$Y$$$20240909$$HP$US$US
242968881$24296888$1$I$$20240905$20240909$20240909$PER$$US-ABBVIE-5910262$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242968891$24296889$1$I$20240828$20240903$20240909$20240909$EXP$$CN-TAKEDA-2024TUS088497$TAKEDA$$73$YR$$M$Y$$$20240909$$HP$CN$CN
242968901$24296890$1$I$$20240826$20240909$20240909$EXP$$CH-SEBELA IRELAND LIMITED-2024SEB00064$SEBELA$Luscher D, Maeder M.T, and Scheler E.. A case report of reversible left ventricular dysfunction due to azathioprine hypersensitivity syndrome.. Eur. Heart J.- Case Rep.. 2024;(8)8$68$YR$$M$Y$$$20240909$$HP$CH$CH
242968911$24296891$1$I$20240830$20240904$20240909$20240909$EXP$$CN-ORGANON-O2409CHN000389$ORGANON$$79$YR$$M$Y$50$KG$20240909$$HP$CN$CN
242968921$24296892$1$I$$20240826$20240909$20240909$EXP$$US-SEBELA IRELAND LIMITED-2024SEB00063$SEBELA$$$$$F$Y$$$20240909$$CN$US$US
242968931$24296893$1$I$20240623$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A202028$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242968941$24296894$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A203415$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242968951$24296895$1$I$20240903$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201727$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242968961$24296896$1$I$$20240901$20240909$20240909$EXP$$CA-AstraZeneca-2024A199831$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$CA$
242968971$24296897$1$I$20240814$20240903$20240909$20240909$EXP$$IN-ROCHE-10000073712$ROCHE$$32$YR$A$M$Y$$$20240909$$CN$IN$IN
242968982$24296898$2$F$$20240918$20240909$20240919$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-118922$REGENERON$$45$YR$$F$Y$$$20240919$$MD$JP$JP
242969001$24296900$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009918$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242969021$24296902$1$I$20220101$20240827$20240909$20240909$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093673$GLENMARK$Mann I, Morado-Aramburo O, Hasbun R.. Emerging shadows: HHV-8-associated encephalitis unveiled in a solid organ transplant recipient.. Transplant Infectious Disease. 2024;26(4):e14343$$$$$Y$$$20240909$$MD$US$US
242969031$24296903$1$I$$20240829$20240909$20240909$EXP$$CA-APOTEX-2024AP010150$APOTEX$$69$YR$$M$Y$70$KG$20240909$$HP$CA$CA
242969041$24296904$1$I$$20240904$20240909$20240909$EXP$$US-ABBVIE-5907485$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242969051$24296905$1$I$$20240825$20240909$20240909$EXP$$ES-ABBVIE-5909708$ABBVIE$Cantera R, Fernandez-Barge T, Salmanton-Garcia J, Yanez L. Holding the therapy in CLLp53: mechanisms to achieve durable responses. Anti-Cancer Drugs. 2024.$73$YR$$F$Y$$$20240909$$HP$ES$ES
242969061$24296906$1$I$20230601$20240830$20240909$20240909$EXP$$JP-TAKEDA-2024TUS088928$TAKEDA$$4$DEC$$M$Y$$$20240909$$MD$JP$JP
242969071$24296907$1$I$20240901$20240904$20240909$20240909$EXP$$US-ABBVIE-5907216$ABBVIE$$45$YR$$F$Y$$$20240909$$CN$US$US
242969091$24296909$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142276$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240909$$MD$US$US
242969101$24296910$1$I$$20240906$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142635$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240909$$HP$US$US
242969111$24296911$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142295$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$42.18$KG$20240909$$CN$US$US
242969122$24296912$2$F$$20240918$20240909$20240928$PER$$US-GSK-US2024105572$GLAXOSMITHKLINE$$$$$F$Y$$$20240928$$HP$US$US
242969131$24296913$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009919$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242969141$24296914$1$I$$20240905$20240909$20240909$PER$$US-ALXN-202409USA000358US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242969151$24296915$1$I$20240821$20240904$20240909$20240909$PER$$US-ALXN-202409USA000142US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240909$$HP$US$US
242969161$24296916$1$I$20240822$20240830$20240909$20240909$EXP$$PL-ROCHE-10000072844$ROCHE$$$$$$Y$$$20240909$$MD$PL$PL
242969171$24296917$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009920$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242969181$24296918$1$I$20240830$20240903$20240909$20240909$EXP$$IN-ROCHE-10000073686$ROCHE$$60$YR$A$F$Y$$$20240909$$CN$IN$IN
242969191$24296919$1$I$$20240903$20240909$20240909$EXP$$US-PHARMING-PHAUS2024000766$PHARMING GROUP$$$$$$Y$$$20240909$$CN$US$US
242969212$24296921$2$F$$20240906$20240909$20240913$PER$$NVSC2024US180068$NOVARTIS$$$$$$Y$$$20240913$$HP$US$US
242969221$24296922$1$I$$20240617$20240909$20240909$PER$$US-ABBVIE-5910003$ABBVIE$$$$A$$Y$$$20240909$$HP$US$US
242969232$24296923$2$F$$20240907$20240909$20240910$PER$$US-HALEON-2195783$Haleon PLC$$56$YR$$F$Y$$$20240910$$CN$US$US
242969242$24296924$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686726$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242969251$24296925$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009921$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242969261$24296926$1$I$$20240903$20240909$20240909$EXP$$US-TAKEDA-2024TUS041171$TAKEDA$$$$$M$Y$56$KG$20240909$$CN$US$US
242969271$24296927$1$I$$20240830$20240909$20240909$PER$$US-BAUSCHBL-2024BNL031222$BAUSCH AND LOMB$$$$$F$Y$$$20240909$$CN$US$US
242969281$24296928$1$I$$20231009$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2023US045619$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242969291$24296929$1$I$20160101$20240904$20240909$20240909$EXP$$US-ABBVIE-5907756$ABBVIE$$26$YR$$F$Y$$$20240909$$CN$US$US
242969301$24296930$1$I$20240801$20240904$20240909$20240909$EXP$$US-ABBVIE-5908650$ABBVIE$$61$YR$$F$Y$$$20240909$$CN$US$US
242969311$24296931$1$I$20240904$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178157$AMGEN$$67$YR$E$M$Y$$$20240909$$PH$US$US
242969321$24296932$1$I$20240903$20240903$20240909$20240909$EXP$$BR-AMGEN-BRASP2024175966$AMGEN$$$$$M$Y$$$20240909$$MD$BR$BR
242969331$24296933$1$I$$20240902$20240909$20240909$EXP$$JP-CHEPLA-2024011405$CHEPLAPHARM$Katayama M, Funo T, Kawamura H, Sotodate Y, Honda M, Suzuki N, et al. 3-4 A Case of Drug-Induced Interstitial Pneumonia During Capox Therapy as Adjuvant Chemotherapy After Surgery for Large Intestine Carcinoma. The 10th Annual Congress of the Japan Surgical association Fukushima Branch. 2024;20$70$YR$$F$Y$$$20240909$$MD$COUNTRY NOT SPECIFIED$JP
242969341$24296934$1$I$$20240827$20240909$20240909$PER$$US-ABBVIE-5901026$ABBVIE$$$$A$F$Y$$$20240909$$HP$US$US
242969351$24296935$1$I$20230701$20240901$20240909$20240909$EXP$$US-MSNLABS-2024MSNSPO01918$MSN LABORATORIES$$$$$$Y$$$20240909$$HP$US$US
242969361$24296936$1$I$20240906$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004452$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240909$$CN$US$US
242969371$24296937$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003699$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240909$$CN$US$US
242969381$24296938$1$I$$20240828$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408019166$ELI LILLY AND CO$$60$YR$A$$Y$$$20240909$$LW$US$US
242969391$24296939$1$I$20240904$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003667$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240909$$CN$US$US
242969401$24296940$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009922$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242969411$24296941$1$I$20240801$20240829$20240909$20240909$PER$$US-BAUSCHBL-2024BNL032647$BAUSCH AND LOMB$$$$$F$Y$$$20240909$$CN$US$US
242969424$24296942$4$F$$20240917$20240909$20240920$EXP$$US-SANDOZ INC.-SDZ2024US078513$SANDOZ$$$$$F$Y$101.13$KG$20240920$$CN$US$US
242969431$24296943$1$I$20240829$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178207$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
242969441$24296944$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142671$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240909$$CN$US$US
242969451$24296945$1$I$20240801$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142188$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240909$$CN$US$US
242969471$24296947$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142058$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240909$$CN$US$US
242969481$24296948$1$I$$20240828$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138459$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240909$$CN$US$US
242969491$24296949$1$I$20240829$20240904$20240909$20240909$EXP$$US-ABBVIE-5908343$ABBVIE$$71$YR$$F$Y$$$20240909$$CN$US$US
242969501$24296950$1$I$$20240830$20240909$20240909$EXP$$CA-GSK-CA2023090071$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$CN$CA$CA
242969511$24296951$1$I$$20240905$20240909$20240909$PER$$US-BIOGEN-2024BI01270188$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
242969521$24296952$1$I$20240904$20240906$20240909$20240909$EXP$$TR-ABBVIE-5910654$ABBVIE$$$$$$Y$$$20240909$$MD$TR$TR
242969531$24296953$1$I$$20240827$20240909$20240909$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093675$GLENMARK$Rink DE, Abramson RH, Johnson NJ, Lee RY.. Diagnostic Confounders in Brain Death A Woman with Unexplained Coma and Brainstem Areflexia.. Annals of the American Thoracic Society.. 2024;21 (8):1204-8$$$$$Y$$$20240909$$MD$US$US
242969541$24296954$1$I$20240820$20240826$20240909$20240909$PER$$US-JNJFOC-20240866417$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242969551$24296955$1$I$20240101$20240903$20240909$20240909$EXP$$US-ABBVIE-5906254$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242969561$24296956$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009923$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242969571$24296957$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009924$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242969591$24296959$1$I$20240802$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A202922$ASTRAZENECA$$22957$DY$$F$Y$$$20240909$$CN$US$
242969601$24296960$1$I$20240904$20240905$20240909$20240909$PER$$US-AstraZeneca-2024A202913$ASTRAZENECA$$22623$DY$$M$Y$$$20240909$$CN$US$
242969611$24296961$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201389$ASTRAZENECA$$$$$M$Y$$$20240909$$MD$US$
242969621$24296962$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A202344$ASTRAZENECA$$$$$M$Y$$$20240909$$HP$US$
242969631$24296963$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A203338$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242969641$24296964$1$I$$20240829$20240909$20240909$EXP$$JP-AstraZeneca-2024A203868$ASTRAZENECA$$$$A$M$Y$$$20240909$$MD$JP$
242969651$24296965$1$I$$20240904$20240909$20240909$EXP$$ZA-AstraZeneca-2024A201755$ASTRAZENECA$$56$YR$$F$Y$$$20240909$$CN$ZA$
242969661$24296966$1$I$$20240903$20240909$20240909$EXP$$ZA-AstraZeneca-2024A202173$ASTRAZENECA$$80$YR$$M$Y$$$20240909$$CN$ZA$
242969671$24296967$1$I$20240802$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202783$ASTRAZENECA$$30732$DY$$M$Y$$$20240909$$MD$US$
242969681$24296968$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009925$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242969691$24296969$1$I$20240726$20240904$20240909$20240909$EXP$FR-AFSSAPS-AN2024001220$FR-RDY-SPO/FRA/24/0012911$DR REDDYS$$54$YR$A$F$Y$67$KG$20240909$$MD$FR$FR
242969701$24296970$1$I$20240901$20240902$20240909$20240909$EXP$$IN-ROCHE-10000072683$ROCHE$$71$YR$E$F$Y$$$20240909$$CN$IN$IN
242969712$24296971$2$F$20240101$20240910$20240909$20240913$EXP$$US-ABBVIE-5907867$ABBVIE$$$$$M$Y$78$KG$20240913$$CN$US$US
242969721$24296972$1$I$$20240902$20240909$20240909$EXP$$CN-RDY-SPO/CHN/24/0012992$DR REDDYS$Tao R, Liu C, Zhang W, Zhu Y, Ma Y, Hao S. Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade. Oncologist. 2024;29: E90-E96. doi:10.1093/oncolo/oyad241.$53$YR$A$M$Y$$$20240909$$HP$CN$CN
242969731$24296973$1$I$20240801$20240903$20240909$20240909$PER$$US-ABBVIE-5907095$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242969741$24296974$1$I$$20240829$20240909$20240909$EXP$$CA-APOTEX-2024AP010148$APOTEX$$60$YR$$F$Y$$$20240909$$PH$CA$CA
242969761$24296976$1$I$20240905$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024179298$AMGEN$$$$$$Y$$$20240909$$CN$US$US
242969772$24296977$2$F$20240101$20240829$20240909$20240912$PER$$US-AMGEN-USASP2024177471$AMGEN$$41$YR$A$F$Y$$$20240912$$PH$US$US
242969781$24296978$1$I$$20240901$20240909$20240909$EXP$$US-AMGEN-USASP2024178084$AMGEN$Yu E.Y.; Kolinsky M.P.; Berry W.R. et al.. Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer:Long-term Results from the Phase lb/2 KEYNOTE-365 Cohort B Study. European Urology. 2022;82 (1):22-30$$$$$Y$$$20240909$$HP$US$US
242969791$24296979$1$I$$20240903$20240909$20240909$EXP$$US-AMGEN-USASP2024176500$AMGEN$Bag R..; Teja Boppanaa L.K.; Sluzevich J. et.al.. Chromoblastomycosis: A Potential Mimic of Squamous Cell Carcinoma in Transplant Recipients. Transplantation Proceedings. 2024;56 (6):1454-1456$75$YR$E$M$Y$$$20240909$$HP$US$US
242969801$24296980$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178326$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
242969812$24296981$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686698$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242969821$24296982$1$I$$20240904$20240909$20240909$EXP$$CO-AMGEN-COLSP2024177276$AMGEN$$$$E$F$Y$$$20240909$$HP$CO$CO
242969831$24296983$1$I$$20240826$20240909$20240909$EXP$$BR-UCBSA-2024044107$UCB$$$$$$Y$$$20240909$$MD$BR$BR
242969841$24296984$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009926$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242969851$24296985$1$I$$20220822$20240909$20240909$EXP$$GB-TEVA-VS-3240088$TEVA$Doolan BJ, Paolino A, Greenblatt DT, Mellerio E. Retinoid-induced skeletal hyperostosis in disorders of keratinisation. Clinical and experimental dermatology. 2022;ePub ahead of print$25$YR$$F$Y$$$20240909$$MD$GB$GB
242969862$24296986$2$F$$20240829$20240909$20240913$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08100$HIKMA$Bell AP Jr, Custer MK, Presley S. Bell AP Jr, Custer MK, Presley S. Pyoderma Gangrenosum in a 75-Year-Old Male With Follicular Diffuse Large B-cell Lymphoma. Cureus. 2024;16(8):e67234$75$YR$$M$Y$$$20240913$$MD$US$US
242969871$24296987$1$I$$20240905$20240909$20240909$PER$$US-BIOVITRUM-2024-US-009874$BIOVITRUM$$37$YR$$F$Y$$$20240909$$CN$US$US
242969891$24296989$1$I$20240830$20240904$20240909$20240909$EXP$$US-AMGEN-USASP2024177446$AMGEN$$66$YR$E$F$Y$$$20240909$$HP$US$US
242969902$24296990$2$F$20240906$20240909$20240909$20240912$PER$$US-AMGEN-USASP2024179356$AMGEN$$57$YR$A$F$Y$$$20240911$$CN$US$US
242969911$24296991$1$I$20240729$20240904$20240909$20240909$EXP$$FR-AMGEN-FRASP2024176727$AMGEN$$62$YR$A$F$Y$$$20240909$$MD$FR$FR
242969921$24296992$1$I$$20240905$20240909$20240909$EXP$$US-AMGEN-USASP2024178120$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
242969931$24296993$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141767$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240909$$HP$US$US
242969942$24296994$2$F$20240101$20240906$20240909$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141592$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240913$$CN$US$US
242969951$24296995$1$I$$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142346$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$77.1$KG$20240909$$CN$US$US
242969961$24296996$1$I$$20240830$20240909$20240909$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-142268$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240909$$CN$DE$DE
242969971$24296997$1$I$20240801$20240829$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138027$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240909$$PH$US$US
242969981$24296998$1$I$$20240904$20240909$20240909$EXP$$US-JNJFOC-20240909510$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$HP$US$US
242969991$24296999$1$I$$20240826$20240909$20240909$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00805$Phathom Pharmaceuticals$$$$$$Y$$$20240909$$PH$JP$JP
242970001$24297000$1$I$$20240821$20240909$20240909$PER$$US-APOTEX-2024AP009927$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240909$$HP$US$US
242970011$24297001$1$I$$20240906$20240909$20240909$PER$$US-ROCHE-10000076428$ROCHE$$27$YR$A$F$Y$$$20240909$$HP$US$US
242970021$24297002$1$I$20220101$20240903$20240909$20240909$EXP$$CN-REGENERON PHARMACEUTICALS, INC.-2024-120036$REGENERON$Sui YY; Zhao Y; Zhou NN; Sun HH; Sun YY; Liu JN; Wang ZZ; Wang JC. Case report: heart failure related to intravitreal injection of anti-VEGF.. BMC Cardiovascular Disorders. 2024;24 (418):1-7$80$YR$$M$Y$$$20240909$$HP$CN$CN
242970032$24297003$2$F$$20240829$20240909$20240917$EXP$$DE-BEH-2024178073$CSL BEHRING$$$$$M$Y$$$20240917$$CN$DE$DE
242970041$24297004$1$I$$20240905$20240909$20240909$EXP$$NVSC2024US179498$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
242970051$24297005$1$I$20240801$20240903$20240909$20240909$PER$$US-ALXN-202409USA000203US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242970061$24297006$1$I$$20240905$20240909$20240909$PER$$US-ALXN-202409USA000361US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242970071$24297007$1$I$$20240830$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139504$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240909$$HP$US$US
242970081$24297008$1$I$$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142683$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240909$$PH$US$US
242970091$24297009$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142018$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240909$$CN$US$US
242970101$24297010$1$I$$20240831$20240909$20240909$EXP$GB-MHRA-MIDB-0b3f951d-0bb7-4252-a6b4-6bf3d338b00d$GB-ASPEN-GLO2024GB006010$ASPEN$$$$$$Y$$$20240909$$PH$GB$GB
242970111$24297011$1$I$$20240826$20240909$20240909$PER$$US-JNJFOC-20240869982$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240909$$CN$US$US
242970121$24297012$1$I$$20240828$20240909$20240909$EXP$$US-Accord-444861$ACCORD$$$$$M$Y$$$20240909$$MD$US$US
242970131$24297013$1$I$20240301$20240904$20240909$20240909$EXP$SE-SEMPA-2024-005991$SE-TAKEDA-2024TUS089012$TAKEDA$$58$YR$$M$Y$$$20240909$$HP$SE$SE
242970141$24297014$1$I$$20240904$20240909$20240909$EXP$$ES-AstraZeneca-2024A203199$ASTRAZENECA$$70$YR$$F$Y$$$20240909$$CN$ES$
242970151$24297015$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A203226$ASTRAZENECA$$$$$M$Y$$$20240909$$MD$US$
242970161$24297016$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A202146$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242970171$24297017$1$I$$20240902$20240909$20240909$EXP$$JP-CHEPLA-2024011319$CHEPLAPHARM$So S, Shiomi C, Kurokawa K, Murakami K, Imai M, Tsuboi M et al. 30 A case of post-heart transplant de novo IBD that successfully responded to risankizumab. The 380th Kanto Branch Regular Meeting of the Japanese Society of Gastroenterolo. 2024;31.$38$YR$$F$Y$$$20240909$$MD$COUNTRY NOT SPECIFIED$JP
242970181$24297018$1$I$20240904$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178208$AMGEN$$57$YR$A$F$Y$$$20240909$$CN$US$US
242970191$24297019$1$I$20240822$20240830$20240909$20240909$EXP$$PL-ROCHE-10000072841$ROCHE$$$$$$Y$$$20240909$$MD$PL$PL
242970201$24297020$1$I$20240903$20240905$20240909$20240909$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001808$BLUEPRINT MEDICINES$$49$YR$A$F$Y$$$20240909$$CN$US$US
242970211$24297021$1$I$$20240905$20240909$20240909$PER$$NVSC2024US179263$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
242970221$24297022$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003909$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240909$$CN$US$US
242970231$24297023$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003860$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240909$$CN$US$US
242970241$24297024$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003733$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240909$$CN$US$US
242970251$24297025$1$I$20240904$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003857$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240909$$CN$US$US
242970261$24297026$1$I$$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004350$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240909$$CN$US$US
242970271$24297027$1$I$$20240502$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US030484$SANDOZ$$$$$F$Y$$$20240909$$CN$US$US
242970281$24297028$1$I$20240822$20240828$20240909$20240909$EXP$$US-Accord-444871$ACCORD$$63$YR$A$M$Y$$$20240909$$MD$US$US
242970291$24297029$1$I$20240314$20240903$20240909$20240909$EXP$$JP-EMD Serono-2024040613$EMD SERONO INC$$76$YR$E$M$Y$$$20240909$$MD$JP$JP
242970301$24297030$1$I$20230101$20240903$20240909$20240909$EXP$$IT-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00460$VELOXIS PHARMACEUTICALS$Corcione S, Lupia T, Vita D, Sidoti F, Zanotto E, Solidoro P, et al.. Maribavir treatment for resistant cytomegalovirus disseminated disease in kidney transplant recipients: A case-based scoping review of real-life data in literature.. Transplantation Reviews.. 2024;38(4)$54$YR$$F$Y$$$20240909$$MD$IT$IT
242970321$24297032$1$I$20240822$20240904$20240909$20240909$EXP$$CN-ROCHE-10000074461$ROCHE$$63$YR$A$M$Y$$$20240909$$HP$CN$CN
242970331$24297033$1$I$$20240828$20240909$20240909$EXP$$US-Accord-444079$ACCORD$Seitz V, Davidson ER. Retained Tampon Fragment as an Unusual Cause of Vesicovaginal Fistula. Obstetrics and Gynecology. 2024;144(1):e1-e3.$53$YR$A$F$Y$$$20240909$$MD$US$US
242970341$24297034$1$I$20240524$20240603$20240909$20240909$PER$$US-ITALFARMACO SPA-2161376$ITALFARMACO$$88$YR$$F$Y$$$20240909$$$US$US
242970351$24297035$1$I$$20240904$20240909$20240909$EXP$$CA-TAKEDA-2024TUS007017$TAKEDA$$$$$F$Y$$$20240909$$MD$CA$CA
242970361$24297036$1$I$20240101$20240904$20240909$20240909$EXP$$US-ABBVIE-5907986$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242970371$24297037$1$I$$20240830$20240909$20240909$PER$$US-RDY-SPO/USA/24/0012841$DR REDDYS$$48$YR$A$M$Y$$$20240909$$MD$US$US
242970381$24297038$1$I$20240815$20240830$20240909$20240909$PER$$US-RDY-SPO/USA/24/0012782$DR REDDYS$$49$YR$A$M$Y$$$20240909$$CN$US$US
242970391$24297039$1$I$20240903$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142633$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240909$$CN$US$US
242970401$24297040$1$I$$20240904$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142064$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240909$$CN$US$US
242970411$24297041$1$I$$20240821$20240909$20240909$PER$$US-TEVA-VS-3236994$TEVA$$$$$$Y$$$20240909$$HP$US$US
242970421$24297042$1$I$$20240905$20240909$20240909$EXP$$GR-ARGENX-2024-ARGX-GR007542$ARGENX BVBA$Howard J, Li G, Vu T, Korobko D, Smilowski M, Banaszkiewicz K et al. Long-term safety, tolerability, and efficacy of subcutaneous efgartigimod ph20 in patients with generalized myasthenia gravis: interim results of the adapt-sc+ study. Neupoyoyias. 2024;59$$$$$Y$$$20240909$$HP$GR$GR
242970432$24297043$2$F$$20240912$20240909$20240921$EXP$$JP-ROCHE-10000074529$ROCHE$$8$DEC$E$F$Y$$$20240921$$PH$JP$JP
242970441$24297044$1$I$20240831$20240903$20240909$20240909$30DAY$$US-GSK-US2024109393$GLAXOSMITHKLINE$$72$YR$$M$Y$$$20240909$$CN$US$US
242970451$24297045$1$I$$20240903$20240909$20240909$EXP$$CA-JNJFOC-20240910941$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240909$$HP$CA$CA
242970461$24297046$1$I$$20240903$20240909$20240909$EXP$$MY-TAKEDA-2023TUS093596$TAKEDA$$$$$F$Y$$$20240909$$MD$MY$MY
242970471$24297047$1$I$20240101$20240822$20240909$20240909$EXP$$NL-ABBVIE-5910649$ABBVIE$$$$E$M$Y$$$20240909$$CN$NL$NL
242970482$24297048$2$F$$20240925$20240909$20240928$EXP$$US-ROCHE-10000068346$ROCHE$$62$YR$A$F$Y$$$20240928$$MD$US$US
242970491$24297049$1$I$$20240905$20240909$20240909$EXP$$US-ABBVIE-5910159$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242970502$24297050$2$F$$20240829$20240909$20240911$PER$$NVSC2024US179858$NOVARTIS$$$$$$Y$$$20240911$$MD$US$US
242970522$24297052$2$F$$20240906$20240909$20240910$PER$$NVSC2024US180087$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
242970531$24297053$1$I$$20240828$20240909$20240909$PER$$US-ROCHE-10000069014$ROCHE$$$$$F$Y$$$20240909$$CN$US$US
242970541$24297054$1$I$20240830$20240830$20240909$20240909$30DAY$$US-GSK-US2024108442$GLAXOSMITHKLINE$$46$YR$$M$Y$$$20240909$$CN$US$US
242970551$24297055$1$I$20200714$20240829$20240909$20240909$EXP$$PL-AUROBINDO-AUR-APL-2024-044075$AUROBINDO$$$$A$F$Y$$$20240909$$MD$PL$PL
242970562$24297056$2$F$$20240920$20240909$20240925$PER$$US-AMGEN-USASP2024176444$AMGEN$$32$YR$A$F$Y$$$20240925$$CN$US$US
242970572$24297057$2$F$20240101$20240903$20240909$20240912$PER$$US-AMGEN-USASP2024175915$AMGEN$$69$YR$E$F$Y$$$20240912$$CN$US$US
242970581$24297058$1$I$20231207$20240829$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-043743$AUROBINDO$$73$YR$$M$Y$70$KG$20240909$$MD$FR$FR
242970591$24297059$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202723$ASTRAZENECA$$$$$$Y$$$20240909$$CN$US$
242970601$24297060$1$I$$20240903$20240909$20240909$EXP$$CA-AstraZeneca-2024A201129$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$CA$
242970623$24297062$3$F$20240125$20240920$20240909$20240924$EXP$$CA-TAKEDA-2024TUS002118$TAKEDA$$63$YR$$M$Y$$$20240924$$CN$CA$CA
242970631$24297063$1$I$$20240904$20240909$20240909$EXP$$VN-AstraZeneca-2024A202883$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$VN$
242970641$24297064$1$I$$20240905$20240909$20240909$PER$$US-ABBVIE-5913804$ABBVIE$$$$$F$Y$$$20240909$$HP$US$US
242970651$24297065$1$I$$20240902$20240909$20240909$EXP$$CH-CHEPLA-2024011354$CHEPLAPHARM$N?gele K, Battig V, Gosert R, Walti CS, Prince SS, Halter J, et al. Revealing the unseen: next generation sequencing for early detection of drug-resistant cytomegalovirus variants upon letermovir prophylaxis failure. The Journal of Infectious Diseases. 2024:jiae414. doi: 10.1093/infdis/jiae414.$63$YR$$M$Y$$$20240909$$HP$COUNTRY NOT SPECIFIED$CH
242970661$24297066$1$I$$20240904$20240909$20240909$EXP$$US-AMGEN-USASP2024178223$AMGEN$Khadka S.; Dong N.; Chavez J.. Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CUP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Single-Center Experience. Clinical Lymphoma, Myeloma + Leukemia. 2024;24:S480$$$$$Y$$$20240909$$MD$US$US
242970694$24297069$4$F$20240101$20240924$20240909$20240927$PER$$US-AMGEN-USASP2024177649$AMGEN$$81$YR$E$M$Y$$$20240927$$CN$US$US
242970711$24297071$1$I$20240222$20240828$20240909$20240909$EXP$$CN-TAKEDA-2024TUS087666$TAKEDA$$75$YR$$M$Y$60$KG$20240909$$MD$CN$CN
242970721$24297072$1$I$$20240903$20240909$20240909$EXP$$RU-ORGANON-O2409RUS000478$ORGANON$$$$$F$Y$$$20240909$$MD$RU$RU
242970741$24297074$1$I$20210421$20240904$20240909$20240909$EXP$$CA-TAKEDA-2021TUS026244$TAKEDA$$93$YR$$F$Y$$$20240909$$CN$CA$CA
242970751$24297075$1$I$20240701$20240827$20240909$20240909$EXP$$US-UCBSA-2024043824$UCB$$60$YR$$M$Y$39.184$KG$20240909$$HP$US$US
242970761$24297076$1$I$$20240903$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002701$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240909$$CN$US$US
242970771$24297077$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002819$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240909$$CN$US$US
242970781$24297078$1$I$20240904$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004558$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240909$$CN$US$US
242970791$24297079$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003682$ELI LILLY AND CO$$44$YR$A$$Y$$$20240909$$CN$US$US
242970801$24297080$1$I$20240904$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003582$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240909$$CN$US$US
242970811$24297081$1$I$20240817$20240827$20240909$20240909$EXP$FR-AFSSAPS-RS2024000825$FR-GLENMARK PHARMACEUTICALS-2024GMK093721$GLENMARK$$$$$$Y$$$20240909$$MD$FR$FR
242970821$24297082$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142615$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240909$$HP$US$US
242970831$24297083$1$I$$20240905$20240909$20240909$EXP$$CA-TAKEDA-2024TUS089518$TAKEDA$$$$$F$Y$$$20240909$$CN$CA$CA
242970841$24297084$1$I$$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141290$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240909$$CN$US$US
242970852$24297085$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686723$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242970861$24297086$1$I$$20240904$20240909$20240909$EXP$$US-MYLANLABS-2024M1081939$MYLAN$$20$YR$$F$Y$$$20240909$$CN$US$US
242970871$24297087$1$I$$20240903$20240909$20240909$EXP$$US-MYLANLABS-2024M1081654$MYLAN$$$$$F$Y$$$20240909$$CN$US$US
242970881$24297088$1$I$$20240829$20240909$20240909$EXP$$IE-ROCHE-10000069658$ROCHE$$$$$F$Y$$$20240909$$CN$IE$IE
242970891$24297089$1$I$$20240830$20240909$20240909$EXP$$NL-TOLMAR, INC.-24NL052291$TOLMAR$$$$$M$Y$$$20240909$$HP$NL$NL
242970901$24297090$1$I$$20240830$20240909$20240909$EXP$$CA-TOLMAR, INC.-24CA052287$TOLMAR$$$$$M$Y$$$20240909$$PH$CA$CA
242970911$24297091$1$I$$20240903$20240909$20240909$PER$$US-HALEON-2195118$Haleon PLC$$36$YR$$$Y$$$20240909$$CN$US$US
242970931$24297093$1$I$$20240826$20240909$20240909$EXP$$US-CIPLA LTD.-2024US09514$CIPLA$$$$$$Y$$$20240909$$HP$US$US
242970941$24297094$1$I$$20240826$20240909$20240909$EXP$$US-UCBSA-2024043959$UCB$$$$$$Y$$$20240909$$CN$US$US
242970951$24297095$1$I$$20240903$20240909$20240909$EXP$$AT-UCBSA-2024045479$UCB$Konrath E, Marhold F, Kindler W, Scheichel F, Popadic B, Blauensteiner K, et al.. Perioperative levetiracetam for seizure prophylaxis in seizure-naive brain tumor patients with focus on neurocognitive functioning. BMC neurology. 2022;22(1):1-11$$$A$$Y$$$20240909$$HP$AT$AT
242970971$24297097$1$I$20240722$20240829$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-044069$AUROBINDO$$69$YR$$M$Y$49.4$KG$20240909$$PH$FR$FR
242970991$24297099$1$I$$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024179001$AMGEN$$$$$$Y$$$20240909$$CN$US$US
242971001$24297100$1$I$$20240829$20240909$20240909$EXP$$PT-AUROBINDO-AUR-APL-2024-043786$AUROBINDO$Vale C, Matias P, Toste A, Pinheiro I, Sousa S, Goncalves M, et al.. Tubulointerstitial nephritis due to pembrolizumab.. Abstract book - 30 Internal Medicine National Congress. 2024;652$45$YR$$F$Y$$$20240909$$MD$PT$PT
242971011$24297101$1$I$$20240830$20240909$20240909$EXP$$US-ROCHE-10000071938$ROCHE$$82$YR$E$F$Y$$$20240909$$CN$US$US
242971021$24297102$1$I$20240811$20240826$20240909$20240909$EXP$$FR-CIPLA LTD.-2024FR09433$CIPLA$$$$$$Y$$$20240909$$PH$FR$FR
242971031$24297103$1$I$20231011$20240829$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-043652$AUROBINDO$$66$YR$$F$Y$73$KG$20240909$$MD$FR$FR
242971051$24297105$1$I$$20240906$20240909$20240909$EXP$NL-EMA-DD-20240902-7482647-181329$NL-SANDOZ INC.-PHHY2019NL149305$SANDOZ$$51$YR$$F$Y$$$20240909$$MD$NL$NL
242971061$24297106$1$I$20240829$20240830$20240909$20240909$PER$$US-BEH-2024178108$CSL BEHRING$$73$YR$E$M$Y$$$20240909$$HP$US$US
242971071$24297107$1$I$20220201$20240829$20240909$20240909$EXP$$DE-AUROBINDO-AUR-APL-2024-043761$AUROBINDO$$$$A$F$Y$$$20240909$$MD$DE$DE
242971081$24297108$1$I$$20240904$20240909$20240909$EXP$$CA-JNJFOC-20240910455$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$HP$CA$CA
242971091$24297109$1$I$20240428$20240830$20240909$20240909$EXP$FR-AFSSAPS-AVMA2024000356$FR-TEVA-VS-3239075$TEVA$$15$YR$$F$Y$$$20240909$$PH$FR$FR
242971101$24297110$1$I$$20240903$20240909$20240909$PER$$US-AstraZeneca-2024A200447$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242971111$24297111$1$I$$20240903$20240909$20240909$PER$$US-AstraZeneca-2024A202085$ASTRAZENECA$$$$$$Y$$$20240909$$CN$US$
242971121$24297112$1$I$20240710$20240829$20240909$20240909$EXP$$DE-AUROBINDO-AUR-APL-2024-043933$AUROBINDO$$75$YR$$M$Y$$$20240909$$MD$DE$DE
242971131$24297113$1$I$$20240903$20240909$20240909$EXP$$GB-AstraZeneca-2024A201753$ASTRAZENECA$$56$YR$$M$Y$$$20240909$$CN$GB$
242971141$24297114$1$I$$20240830$20240909$20240909$EXP$$CA-APOTEX-2024AP010187$APOTEX$$71$YR$$M$Y$$$20240909$$PH$CA$CA
242971162$24297116$2$F$20240601$20240923$20240909$20240923$EXP$IT-MINISAL02-1001398$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050181$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240923$$MD$IT$IT
242971171$24297117$1$I$$20240901$20240909$20240909$EXP$$JP-AstraZeneca-2024A200884$ASTRAZENECA$$90$YR$$M$Y$$$20240909$$MD$JP$
242971181$24297118$1$I$20240129$20240829$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-043744$AUROBINDO$$74$YR$$F$Y$$$20240909$$PH$FR$FR
242971191$24297119$1$I$20220524$20240903$20240909$20240909$EXP$$CO-UCBSA-2023054800$UCB$$57$YR$$F$Y$60$KG$20240909$$CN$CO$CO
242971202$24297120$2$F$20240701$20240912$20240909$20240916$EXP$$TN-UCBSA-2024045768$UCB$$53$YR$$M$Y$70$KG$20240916$$MD$TN$TN
242971221$24297122$1$I$$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141262$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240909$$CN$US$US
242971231$24297123$1$I$20240828$20240828$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137758$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240909$$CN$US$US
242971242$24297124$2$F$$20240913$20240909$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142504$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240917$$CN$US$US
242971251$24297125$1$I$$20240902$20240909$20240909$EXP$$CN-ROCHE-10000073373$ROCHE$Liu J, Du Q, Shao Y, Xu H, Liu X, Zhang W, et al. Real-world status, efficacy and prognosis analysis of first-line treatment for unresectable hepatocellular carcinoma in patients treated at multiple centres. Annals of Medicine. 2024-Jan;56 (1):1-15. doi:10.1080/07853890.2024.2393291.$$$$$Y$$$20240909$$HP$CN$CN
242971261$24297126$1$I$$20240829$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139914$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$PH$US$US
242971271$24297127$1$I$$20240904$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142038$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240909$$CN$US$US
242971281$24297128$1$I$20240201$20240901$20240909$20240909$EXP$$CA-BEH-2024169543$CSL BEHRING$$61$YR$A$M$Y$136.36$KG$20240909$$CN$CA$CA
242971301$24297130$1$I$$20240905$20240909$20240909$EXP$$CA-GSK-CA2024AMR110945$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$CN$CA$CA
242971311$24297131$1$I$20240828$20240828$20240909$20240909$PER$$US-ABBVIE-5901863$ABBVIE$$43$YR$$F$Y$$$20240909$$CN$US$US
242971321$24297132$1$I$20240820$20240829$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043544$AUROBINDO$$73$YR$$M$Y$84$KG$20240909$$MD$GB$GB
242971331$24297133$1$I$$20240821$20240909$20240909$PER$$US-SA-2024SA259424$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240909$$MD$US$US
242971341$24297134$1$I$$20240820$20240909$20240909$PER$$US-SA-2024SA259444$SANOFI AVENTIS$$$$A$F$Y$$$20240909$$MD$US$US
242971351$24297135$1$I$20240821$20240821$20240909$20240909$PER$$US-SA-2024SA259439$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240909$$CN$US$US
242971361$24297136$1$I$20240801$20240820$20240909$20240909$PER$$US-SA-2024SA257678$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240909$$MD$US$US
242971371$24297137$1$I$20230901$20240820$20240909$20240909$PER$$US-SA-2024SA256861$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240909$$MD$US$US
242971381$24297138$1$I$20240720$20240821$20240909$20240909$PER$$US-SA-2024SA256489$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240909$$MD$US$US
242971391$24297139$1$I$20240101$20240820$20240909$20240909$PER$$US-SA-2024SA258051$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240909$$HP$US$US
242971401$24297140$1$I$$20240821$20240909$20240909$PER$$US-SA-2024SA259526$SANOFI AVENTIS$$$$A$F$Y$$$20240909$$MD$US$US
242971411$24297141$1$I$20240821$20240821$20240909$20240909$PER$$US-SA-2024SA259553$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240909$$MD$US$US
242971421$24297142$1$I$20240715$20240830$20240909$20240909$EXP$$CN-ROCHE-10000071138$ROCHE$$64$YR$A$M$Y$65$KG$20240909$$HP$CN$CN
242971431$24297143$1$I$$20240906$20240909$20240909$PER$$US-ROCHE-3573293$ROCHE$$87$YR$E$F$Y$$$20240909$$MD$US$US
242971441$24297144$1$I$$20240829$20240909$20240909$PER$$US-JNJFOC-20240880661$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242971451$24297145$1$I$20210101$20240830$20240909$20240909$EXP$$US-ROCHE-10000071243$ROCHE$$54$YR$A$F$Y$$$20240909$$CN$US$US
242971461$24297146$1$I$$20240903$20240909$20240909$EXP$$CA-JNJFOC-20240910519$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$HP$CA$CA
242971471$24297147$1$I$$20240903$20240909$20240909$EXP$$CA-JNJFOC-20240910727$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240909$$HP$CA$CA
242971482$24297148$2$F$$20240828$20240909$20240911$PER$$US-SA-2024SA256811$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240911$$CN$US$US
242971491$24297149$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA260181$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240909$$CN$US$US
242971501$24297150$1$I$20240101$20240825$20240909$20240909$PER$$US-SA-2024SA257307$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240909$$MD$US$US
242971511$24297151$1$I$20240101$20240827$20240909$20240909$PER$$US-SA-2024SA259140$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240909$$MD$US$US
242971521$24297152$1$I$$20240828$20240909$20240909$PER$$US-SA-2024SA258507$SANOFI AVENTIS$$$$A$M$Y$$$20240909$$HP$US$US
242971531$24297153$1$I$$20240823$20240909$20240909$PER$$US-SA-2024SA218703$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240909$$CN$US$US
242971541$24297154$1$I$20240801$20240823$20240909$20240909$PER$$US-SA-2024SA258573$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240909$$HP$US$US
242971551$24297155$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA258073$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240909$$HP$US$US
242971561$24297156$1$I$20240801$20240823$20240909$20240909$PER$$US-SA-2024SA258040$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240909$$CN$US$US
242971571$24297157$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024179299$AMGEN$$$$$$Y$$$20240909$$PH$US$US
242971591$24297159$1$I$$20240129$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US007961$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242971611$24297161$1$I$20240801$20240826$20240909$20240909$PER$$US-SA-2024SA259693$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240909$$HP$US$US
242971621$24297162$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259464$SANOFI AVENTIS$$$$A$M$Y$$$20240909$$MD$US$US
242971631$24297163$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA258546$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240909$$HP$US$US
242971641$24297164$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA254308$SANOFI AVENTIS$$$$$$Y$$$20240909$$HP$US$US
242971651$24297165$1$I$20240704$20240826$20240909$20240909$PER$$US-SA-2024SA256748$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240909$$MD$US$US
242971661$24297166$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA256966$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240909$$HP$US$US
242971672$24297167$2$F$$20240918$20240909$20240918$EXP$$MY-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050160$BOEHRINGER INGELHEIM$$65$YR$E$F$Y$$$20240918$$MD$MY$MY
242971681$24297168$1$I$20240801$20240826$20240909$20240909$PER$$US-SA-2024SA256708$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240909$$MD$US$US
242971701$24297170$1$I$20240101$20240827$20240909$20240909$PER$$US-SA-2024SA259724$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240909$$HP$US$US
242971711$24297171$1$I$20240101$20240827$20240909$20240909$PER$$US-SA-2024SA259494$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240909$$CN$US$US
242971721$24297172$1$I$$20240828$20240909$20240909$PER$$US-SA-2021SA292343$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240909$$MD$US$US
242971731$24297173$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA257786$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240909$$HP$US$US
242971741$24297174$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA257979$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240909$$MD$US$US
242971751$24297175$1$I$20240801$20240828$20240909$20240909$PER$$US-SA-2024SA259044$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240909$$HP$US$US
242971771$24297177$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA257455$SANOFI AVENTIS$$$$A$F$Y$$$20240909$$HP$US$US
242971801$24297180$1$I$20240820$20240903$20240909$20240909$EXP$CN-91110000556821568D-2024DRL001665$CN-RDY-SPO/CHN/24/0012956$DR REDDYS$$17$YR$T$F$Y$$$20240909$$HP$CN$CN
242971811$24297181$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA258960$SANOFI AVENTIS$$22$YR$A$$Y$$$20240909$$CN$US$US
242971821$24297182$1$I$20240101$20240827$20240909$20240909$PER$$US-SA-2024SA259033$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240909$$MD$US$US
242971831$24297183$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA257300$SANOFI AVENTIS$$$$$$Y$$$20240909$$CN$US$US
242971851$24297185$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA260087$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240909$$CN$US$US
242971861$24297186$1$I$20240627$20240827$20240909$20240909$EXP$FR-AFSSAPS-AVCN2024000644$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111666$ZYDUS PHARM$$$$$$Y$$$20240909$$MD$FR$FR
242971871$24297187$1$I$20240704$20240827$20240909$20240909$EXP$FR-AFSSAPS-TS2024000940$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111674$ZYDUS PHARM$$$$$$Y$$$20240909$$MD$FR$FR
242971881$24297188$1$I$20210418$20240827$20240909$20240909$EXP$FR-AFSSAPS-MA2024001149$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111701$ZYDUS PHARM$$$$$$Y$$$20240909$$MD$FR$FR
242971891$24297189$1$I$20221215$20240827$20240909$20240909$EXP$FR-AFSSAPS-MP2024001335$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111661$ZYDUS PHARM$$$$$$Y$$$20240909$$MD$FR$FR
242971901$24297190$1$I$20240729$20240827$20240909$20240909$EXP$FR-AFSSAPS-NC2024000991$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111655$ZYDUS PHARM$$$$$$Y$$$20240909$$MD$FR$FR
242971912$24297191$2$F$20230101$20240904$20240909$20240912$EXP$$CA-CELLTRION INC.-2023CA006375$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
242971921$24297192$1$I$20240101$20240905$20240909$20240909$PER$$US-BIOGEN-2024BI01281400$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
242971931$24297193$1$I$20240101$20240829$20240909$20240909$PER$$US-SA-2024SA254788$SANOFI AVENTIS$$$$$$Y$$$20240909$$MD$US$US
242971942$24297194$2$F$20240828$20240910$20240909$20240923$PER$$US-SA-2024SA252942$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240923$$CN$US$US
242971951$24297195$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA258901$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240909$$MD$US$US
242971961$24297196$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA258897$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240909$$MD$US$US
242971981$24297198$1$I$20240818$20240827$20240909$20240909$PER$$US-SA-2024SA259730$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240909$$CN$US$US
242971991$24297199$1$I$20240801$20240826$20240909$20240909$PER$$US-SA-2024SA257473$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240909$$MD$US$US
242972001$24297200$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA258369$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240909$$MD$US$US
242972011$24297201$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA257877$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240909$$MD$US$US
242972021$24297202$1$I$20240901$20240826$20240909$20240909$PER$$US-SA-2024SA257742$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240909$$MD$US$US
242972031$24297203$1$I$20240101$20240903$20240909$20240909$EXP$$CO-AMGEN-COLSP2024177855$AMGEN$$$$$F$Y$$$20240909$$CN$CO$CO
242972041$24297204$1$I$20240821$20240905$20240909$20240909$EXP$$CN-ROCHE-10000075206$ROCHE$$54$YR$A$F$Y$54$KG$20240909$$HP$CN$CN
242972051$24297205$1$I$$20240830$20240909$20240909$30DAY$$US-GSK-US2024108465$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242972062$24297206$2$F$20240820$20240910$20240909$20240919$EXP$$CA-CELLTRION INC.-2024CA018573$CELLTRION$$$$$$Y$$$20240919$$CN$CA$CA
242972081$24297208$1$I$$20240903$20240909$20240909$PER$$US-ABBVIE-5906153$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242972091$24297209$1$I$20240701$20240827$20240909$20240909$EXP$$US-UCBSA-2024044125$UCB$$27$YR$$F$Y$$$20240909$$HP$US$US
242972101$24297210$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004019$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240909$$CN$US$US
242972111$24297211$1$I$$20240828$20240909$20240909$EXP$$PT-Accord-444599$ACCORD$Lopes T, Antas J, Melo B, Goncalves F, Cruz C. CO-0237-(4707) PNEUMONIA ORGANIZATIVA POR METAPNEUMOVIRUS HUMANO EM TRANSPLANTADO PULMONAR (CO 0237 - (4707)-ORGANIZATIONAL PNEUMONIA DUE TO HUMAN METAPNEUMOVIRUS IN LUNG TRANSPLANT). Doencas respiratorias Caso clinico (Respiratory diseases). 331$25$YR$A$M$Y$$$20240909$$HP$PT$PT
242972121$24297212$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003887$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240909$$CN$US$US
242972131$24297213$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003639$ELI LILLY AND CO$$$$$$Y$$$20240909$$PH$US$US
242972141$24297214$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004250$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242972151$24297215$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003632$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240909$$CN$US$US
242972161$24297216$1$I$$20240907$20240909$20240909$EXP$GB-MHRA-MED-202409071631171890-RPVDB$GB-SANDOZ INC.-SDZ2024GB078504$SANDOZ$$71$YR$$M$Y$84$KG$20240909$$CN$GB$GB
242972171$24297217$1$I$$20240826$20240909$20240909$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08117$HIKMA$$$$$$Y$$$20240909$$HP$US$US
242972181$24297218$1$I$$20240906$20240909$20240909$EXP$GB-MHRA-MED-202408191528579690-FHGPQ$GB-SANDOZ INC.-SDZ2024GB078341$SANDOZ$$$$$F$Y$$$20240909$$PH$GB$GB
242972193$24297219$3$F$$20240905$20240909$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US078005$SANDOZ$$43$YR$$M$Y$$$20240913$$CN$US$US
242972201$24297220$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141976$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$68.95$KG$20240909$$CN$US$US
242972211$24297221$1$I$$20240906$20240909$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US078497$SANDOZ$$$$$M$Y$$$20240909$$HP$US$US
242972222$24297222$2$F$20240917$20240918$20240909$20240919$PER$$NVSC2024US180134$NOVARTIS$$68$YR$$M$Y$78$KG$20240919$$CN$US$US
242972231$24297223$1$I$20240804$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202779$ASTRAZENECA$$32682$DY$$M$Y$$$20240909$$CN$US$
242972242$24297224$2$F$20240801$20240916$20240909$20240917$EXP$$NVSC2024DE179480$NOVARTIS$$$$A$F$Y$$$20240917$$MD$DE$DE
242972252$24297225$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686730$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242972261$24297226$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A203013$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242972271$24297227$1$I$20231201$20240213$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US016277$SANDOZ$$47$YR$$F$Y$$$20240909$$CN$US$US
242972282$24297228$2$F$$20240910$20240909$20240911$PER$$US-JNJFOC-20240906958$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240911$$CN$US$US
242972291$24297229$1$I$20240906$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024178993$AMGEN$$57$YR$A$F$Y$$$20240909$$PH$US$US
242972302$24297230$2$F$20240826$20240909$20240909$20240911$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-120038$REGENERON$$8$DEC$$M$Y$$$20240911$$MD$JP$JP
242972311$24297231$1$I$20240201$20240829$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-043740$AUROBINDO$$34$YR$$M$Y$$$20240909$$HP$FR$FR
242972321$24297232$1$I$$20240829$20240909$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-043936$AUROBINDO$$41$YR$$F$Y$59$KG$20240909$$HP$CA$CA
242972332$24297233$2$F$$20240905$20240909$20240911$PER$$NVSC2024US179471$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
242972342$24297234$2$F$20141114$20240910$20240909$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-044018$AUROBINDO$$$$$$Y$$$20240920$$MD$FR$FR
242972352$24297235$2$F$$20240906$20240909$20240912$EXP$BG-EMA-DD-20240902-7482701-080400$BG-SANDOZ INC.-SDZ2024BG078275$SANDOZ$$64$YR$$F$Y$$$20240912$$MD$BG$BG
242972361$24297236$1$I$20220818$20240829$20240909$20240909$EXP$$ES-AUROBINDO-AUR-APL-2024-043954$AUROBINDO$$65$YR$$M$Y$71$KG$20240909$$MD$ES$ES
242972371$24297237$1$I$$20240827$20240909$20240909$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111736$ZYDUS PHARM$Kline K, Chen W, Kallen ME, Koka R, Omili D, Fan X, et al.. Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD).. Hum-Vaccin-Immunother. 2023;19 No. 2.$$$$$Y$$$20240909$$HP$US$US
242972391$24297239$1$I$$20240906$20240909$20240909$PER$$US-HALEON-2195750$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
242972402$24297240$2$F$20240901$20240904$20240909$20240910$PER$$US-AMGEN-USASP2024176933$AMGEN$$$$$M$Y$$$20240910$$CN$US$US
242972411$24297241$1$I$20240905$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178155$AMGEN$$75$YR$E$M$Y$$$20240909$$HP$US$US
242972431$24297243$1$I$20231101$20240829$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043727$AUROBINDO$$47$YR$$F$Y$80$KG$20240909$$CN$GB$GB
242972441$24297244$1$I$20240813$20240830$20240909$20240909$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005200$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240909$$CN$US$US
242972451$24297245$1$I$20240708$20240826$20240909$20240909$EXP$FR-AFSSAPS-LM2024000468$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-08046$HIKMA$$68$YR$$M$Y$59.7$KG$20240909$$MD$FR$FR
242972471$24297247$1$I$$20240829$20240909$20240909$EXP$$GB-HBP-2024GB031164$HELSINN HEALTHCARE$$$$$M$Y$$$20240909$$PH$GB$GB
242972481$24297248$1$I$$20240829$20240909$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-043924$AUROBINDO$$44$YR$$F$Y$$$20240909$$MD$CA$CA
242972491$24297249$1$I$$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142070$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240909$$CN$US$US
242972501$24297250$1$I$20240812$20240904$20240909$20240909$PER$$US-ABBVIE-5910478$ABBVIE$$7$YR$$F$Y$$$20240909$$HP$US$US
242972511$24297251$1$I$$20240904$20240909$20240909$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049490$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240909$$MD$IT$IT
242972521$24297252$1$I$20240201$20240904$20240909$20240909$PER$$US-ABBVIE-5908819$ABBVIE$$49$YR$$F$Y$$$20240909$$MD$US$US
242972551$24297255$1$I$$20240830$20240909$20240909$EXP$$US-VIIV HEALTHCARE LIMITED-US2024108401$VIIV$$$$$M$Y$$$20240909$$CN$US$US
242972561$24297256$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA257492$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240909$$HP$US$US
242972572$24297257$2$F$20240901$20240916$20240909$20240925$PER$$US-SA-2024SA257536$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240925$$HP$US$US
242972581$24297258$1$I$$20240821$20240909$20240909$PER$$US-SA-2024SA259448$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240909$$CN$US$US
242972591$24297259$1$I$20240101$20240827$20240909$20240909$PER$$US-SA-2024SA259505$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240909$$CN$US$US
242972601$24297260$1$I$$20240903$20240909$20240909$PER$$US-ALXN-202409USA000122US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242972612$24297261$2$F$$20240912$20240909$20240918$EXP$$GB-ROCHE-10000074291$ROCHE$$53$YR$A$F$Y$$$20240918$$HP$GB$GB
242972621$24297262$1$I$20230627$20230627$20240909$20240909$EXP$$CN-ROCHE-10000075550$ROCHE$$$$$$Y$$$20240909$$MD$CN$CN
242972641$24297264$1$I$20220101$20231121$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2023US035245$SANDOZ$$$$$F$Y$$$20240909$$CN$US$US
242972651$24297265$1$I$$20240830$20240909$20240909$EXP$$CA-APOTEX-2024AP010204$APOTEX$$61$YR$$F$Y$$$20240909$$HP$CA$CA
242972661$24297266$1$I$20231229$20240823$20240909$20240909$EXP$$US-SA-2024SA259306$SANOFI AVENTIS$$82$YR$E$M$Y$181$KG$20240909$$CN$US$US
242972671$24297267$1$I$$20240828$20240909$20240909$EXP$$CZ-Accord-444756$ACCORD$Vesely S, Katolicka J, Ptacnik V, Capoun O. PSMA-PET in the diagnosis and treatment of prostate cancer-expectations versus clinical experience. Current topics in oncology (through the eyes of Czech doctors). 2024; 9(2):171-5. 171-175.$70$YR$E$M$Y$$$20240909$$MD$CZ$CZ
242972681$24297268$1$I$$20240829$20240909$20240909$EXP$$IT-AUROBINDO-AUR-APL-2024-043757$AUROBINDO$Serrao A, Canichella M, De Luca ML, Tartaglia G, Annechini G, D^Elia GM. Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma. ANNALS OF HEMATOLOGY. 2019;98(5):1505-6$50$YR$$M$Y$$$20240909$$HP$IT$IT
242972691$24297269$1$I$20240801$20240829$20240909$20240909$PER$$US-JNJFOC-20240880406$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242972701$24297270$1$I$$20240829$20240909$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-043971$AUROBINDO$$88$YR$$M$Y$63$KG$20240909$$PH$CA$CA
242972711$24297271$1$I$$20240828$20240909$20240909$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111792$ZYDUS PHARM$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.. Cancer-Immunol-Immunother. 2024$$$$$Y$$$20240909$$HP$US$US
242972721$24297272$1$I$$20240828$20240909$20240909$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111790$ZYDUS PHARM$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.. Cancer Immunology, Immunotherapy. 2024;73:200:1-9$$$$$Y$$$20240909$$HP$US$US
242972731$24297273$1$I$20200601$20240903$20240909$20240909$EXP$$US-SA-2024SA258338$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240909$$MD$US$US
242972741$24297274$1$I$$20240905$20240909$20240909$EXP$$NVSC2024GR179454$NOVARTIS$$62$YR$$F$Y$$$20240909$$MD$GR$GR
242972753$24297275$3$F$$20240911$20240909$20240926$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08637$LUPIN$$$$$$Y$$$20240926$$CN$US$US
242972763$24297276$3$F$20240701$20240904$20240909$20240927$EXP$$TW-SA-2024SA258990$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240927$$PH$TW$TW
242972771$24297277$1$I$$20240829$20240909$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-044048$AUROBINDO$$69$YR$$M$Y$$$20240909$$HP$CA$CA
242972781$24297278$1$I$$20240830$20240909$20240909$EXP$$US-GSK-US2024108395$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242972791$24297279$1$I$20240727$20240826$20240909$20240909$EXP$$US-UCBSA-2024039273$UCB$$27$YR$$F$Y$62$KG$20240909$$CN$US$US
242972801$24297280$1$I$20240820$20240820$20240909$20240909$PER$$US-SA-2024SA257817$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240909$$MD$US$US
242972811$24297281$1$I$$20240827$20240909$20240909$EXP$$US-INSMED, INC.-2024-03469-US$INSMED$$$$$M$Y$$$20240909$$CN$US$US
242972821$24297282$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA260295$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240909$$CN$US$US
242972831$24297283$1$I$20240814$20240827$20240909$20240909$PER$$US-SA-2024SA259731$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240909$$HP$US$US
242972841$24297284$1$I$20240101$20240823$20240909$20240909$PER$$US-SA-2024SA259428$SANOFI AVENTIS$$$$C$F$Y$$$20240909$$MD$US$US
242972851$24297285$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA256806$SANOFI AVENTIS$$$$A$F$Y$$$20240909$$MD$US$US
242972861$24297286$1$I$$20240904$20240909$20240909$EXP$$US-TAKEDA-2024TUS088826$TAKEDA$$$$$M$Y$$$20240909$$CN$US$US
242972871$24297287$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202767$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242972881$24297288$1$I$$20240826$20240909$20240909$PER$$US-ASTELLAS-2024-AER-003557$ASTELLAS$$$$E$M$Y$$$20240909$$MD$US$US
242972901$24297290$1$I$$20240903$20240909$20240909$EXP$$US-AstraZeneca-2024A201403$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242972911$24297291$1$I$20240501$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202701$ASTRAZENECA$$$$E$F$Y$$$20240909$$MD$US$
242972921$24297292$1$I$20240823$20240905$20240909$20240909$EXP$$TR-AstraZeneca-2024A203301$ASTRAZENECA$$$$$F$Y$$$20240909$$MD$TR$
242972931$24297293$1$I$$20240906$20240909$20240909$PER$$NVSC2024US179882$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
242972941$24297294$1$I$$20240904$20240909$20240909$EXP$$AU-AstraZeneca-2024A201660$ASTRAZENECA$$$$$F$Y$$$20240909$$MD$AU$
242972972$24297297$2$F$$20240826$20240909$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202408016890$ELI LILLY AND CO$$24$YR$A$M$Y$$$20240911$$CN$US$US
242972981$24297298$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003885$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240909$$CN$US$US
242972991$24297299$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004035$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240909$$CN$US$US
242973001$24297300$1$I$20240830$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002988$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240909$$CN$US$US
242973011$24297301$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004436$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$US$US
242973021$24297302$1$I$20240903$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004518$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242973031$24297303$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004371$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240909$$CN$US$US
242973041$24297304$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003642$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240909$$CN$US$US
242973051$24297305$1$I$20240601$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004164$ELI LILLY AND CO$$$$$M$Y$$$20240909$$CN$US$US
242973061$24297306$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003461$ELI LILLY AND CO$$34$YR$A$$Y$$$20240909$$LW$US$US
242973071$24297307$1$I$20231207$20240826$20240909$20240909$EXP$$JP-GALDERMA-JP2024009816$GALDERMA$$$$$$Y$$$20240909$$MD$JP$JP
242973081$24297308$1$I$$20240903$20240909$20240909$EXP$$US-TAKEDA-2024TUS088737$TAKEDA$$$$$$Y$$$20240909$$CN$US$US
242973102$24297310$2$F$$20240921$20240909$20240925$EXP$$GB-TAKEDA-2024TUS089263$TAKEDA$$$$$M$Y$$$20240925$$CN$GB$GB
242973111$24297311$1$I$20231003$20231005$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2023US040022$SANDOZ$$41$YR$$M$Y$$$20240909$$CN$US$US
242973121$24297312$1$I$20240828$20240828$20240909$20240909$PER$$US-JNJFOC-20240873425$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242973131$24297313$1$I$$20240905$20240909$20240909$EXP$$US-TAKEDA-2024TUS089161$TAKEDA$$$$$M$Y$$$20240909$$CN$US$US
242973141$24297314$1$I$$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142249$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240909$$CN$US$US
242973151$24297315$1$I$$20240828$20240909$20240909$EXP$$MK-BRISTOL-MYERS SQUIBB COMPANY-2024-141032$BRISTOL MYERS SQUIBB$Sallteku L, Gashi F, Komani G, Ukimeraj A, Krasniqi E, Gashi R. Skin presentation of CML transformation to AML. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep 01;24(Supplement 1):S294.$70$YR$E$M$Y$$$20240909$$MD$MK$MK
242973161$24297316$1$I$$20240905$20240909$20240909$PER$$US-ROCHE-10000075484$ROCHE$$$$A$F$Y$$$20240909$$MD$US$US
242973171$24297317$1$I$20240307$20240905$20240909$20240909$EXP$PT-INFARMED-A202408-549$PT-ROCHE-10000074431$ROCHE$$49$YR$A$F$Y$74$KG$20240909$$HP$PT$PT
242973181$24297318$1$I$$20240717$20240909$20240909$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009117$STRIDES$Haynes TM, Kukuc L, Proute M, Fishberg R.. A PCSK9 and APOB Double Heterozygote Presenting Phenotypically Similar to Homozygous Familial Hypercholesterolemia. Circulation. 2023;148 (Suppl.)$73$YR$$F$Y$$$20240909$$HP$US$US
242973191$24297319$1$I$20240814$20240828$20240909$20240909$EXP$$US-Accord-444625$ACCORD$$36$YR$A$M$Y$$$20240909$$HP$US$US
242973201$24297320$1$I$$20240906$20240909$20240909$EXP$$US-AMGEN-USASP2024178994$AMGEN$$$$$F$Y$$$20240909$$HP$US$US
242973212$24297321$2$F$20240830$20240913$20240909$20240923$PER$$US-GSK-US2024108483$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240923$$CN$US$US
242973222$24297322$2$F$$20240905$20240909$20240915$EXP$$US-UCBSA-2024043874$UCB$$$$$F$Y$$$20240915$$HP$US$US
242973231$24297323$1$I$20240101$20240903$20240909$20240909$EXP$$US-ABBVIE-5908763$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242973241$24297324$1$I$20240101$20240904$20240909$20240909$EXP$$US-ABBVIE-5908656$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242973251$24297325$1$I$20200101$20240829$20240909$20240909$EXP$$JP-Accord-444685$ACCORD$Horaguchi T, Tanaka Y, Sato Y, Yamamoto K, Fukada M, Yasufuku I, et al. Successful direct oral anticoagulant management of asymptomatic superior mesenteric vein thrombosis after adjuvant chemotherapy for colorectal cancer patient: A case report. Exp Ther Med. 2024 Aug 8;28(4):396.$71$YR$E$F$Y$$$20240909$$HP$JP$JP
242973272$24297327$2$F$$20240912$20240909$20240915$PER$$US-ALXN-202409USA000156US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
242973291$24297329$1$I$$20240829$20240909$20240909$EXP$$PL-MYLANLABS-2024M1081061$MYLAN$Blaszczyk E, Firek-Pedras M, Berdej-Szczot E, Mizia-Malarz A, Gruenpeter A, Lachor-Motyka I, et al. A case of an 11-year-old boy with paediatric inflammatory multisystem syndrome associated with coronavirus disease, haemophagocytic lymphohistiocytosis, and systemic juvenile idiopathic arthritis. Ped-Polska 2024; 99 (2): 167-174.$11$YR$$M$Y$$$20240909$$HP$PL$PL
242973301$24297330$1$I$20240818$20240821$20240909$20240909$PER$$US-TEVA-VS-3235906$TEVA$$$$$F$Y$$$20240909$$CN$US$US
242973311$24297331$1$I$20240601$20240822$20240909$20240909$PER$$US-SA-2024SA259167$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240909$$MD$US$US
242973321$24297332$1$I$$20240828$20240909$20240909$PER$$US-JNJFOC-20240876447$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242973332$24297333$2$F$20240901$20240919$20240909$20240923$EXP$$JP-JNJFOC-20240914314$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240923$$PH$JP$JP
242973341$24297334$1$I$$20240906$20240909$20240909$PER$$US-JNJFOC-20240916310$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242973352$24297335$2$F$$20240905$20240909$20240909$EXP$$GR-ARGENX-2024-ARGX-GR007536$ARGENX BVBA$Howard J, Li G, Vu T, Korobko D, Smilowski M, Banaszkiewicz K et al. Long-term safety, tolerability, and efficacy of subcutaneous efgartigimod ph20 in patients with generalized myasthenia gravis: interim results of the adapt-sc+ study. Neupoyoyias. 2024;59$$$$$Y$$$20240909$$HP$GR$GR
242973361$24297336$1$I$$20240829$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043716$AUROBINDO$$44$YR$$F$Y$72$KG$20240909$$CN$GB$GB
242973371$24297337$1$I$20240817$20240830$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-043862$AUROBINDO$$50$YR$$$Y$110$KG$20240909$$MD$FR$FR
242973381$24297338$1$I$20240313$20240830$20240909$20240909$EXP$$ES-AUROBINDO-AUR-APL-2024-043762$AUROBINDO$$88$YR$$M$Y$$$20240909$$MD$ES$ES
242973402$24297340$2$F$20030101$20240919$20240909$20240919$EXP$$NVSC2024FR179154$NOVARTIS$$74$YR$$M$Y$87$KG$20240919$$CN$FR$FR
242973411$24297341$1$I$$20240123$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2023US045839$SANDOZ$$$$$F$Y$$$20240909$$CN$US$US
242973421$24297342$1$I$20240814$20240906$20240906$20240906$DIR$717495$$FDA-CTU$$76$YR$$F$N$81.3$KG$20240906$Y$HP$US$
242973431$24297343$1$I$20240819$20240906$20240906$20240906$DIR$717430$$FDA-CTU$$38$YR$$F$N$$$20240906$N$HP$US$
242973441$24297344$1$I$$20240906$20240906$20240906$DIR$717478$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242973451$24297345$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61695$$FDA-CTU$$76$YR$$M$N$$$20240906$N$$US$
242973471$24297347$1$I$$20240906$20240906$20240906$DIR$717481$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242973481$24297348$1$I$20240625$20240704$20240909$20240909$EXP$GB-MHRA-MED-202407031617161450-BWSKV$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15014$ALKEM$$$$$F$Y$$$20240909$$HP$GB$GB
242973491$24297349$1$I$20240108$20240327$20240909$20240909$EXP$GB-MHRA-ADR 28632007$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06583$ALKEM$$$$$F$Y$$$20240909$$MD$GB$GB
242973501$24297350$1$I$20240404$20240409$20240909$20240909$EXP$GB-MHRA-ADR 28659790$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-07681$ALKEM$$75$YR$$M$Y$100$KG$20240909$$MD$GB$GB
242973511$24297351$1$I$20230228$20240308$20240909$20240909$EXP$GB-MHRA-ADR 28576958$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-04791$ALKEM$$52$YR$$M$Y$79$KG$20240909$$PH$GB$GB
242973521$24297352$1$I$$20240223$20240909$20240909$EXP$GB-MHRA-ADR 28551738$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03713$ALKEM$$$$$F$Y$$$20240909$$CN$GB$GB
242973531$24297353$1$I$$20240619$20240909$20240909$EXP$GB-MHRA-TPP28139621C9437843YC1718623034019$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13831$ALKEM$$63$YR$$M$Y$98$KG$20240909$$MD$GB$GB
242973541$24297354$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61569$$FDA-CTU$$85$YR$$M$N$$$20240906$N$$US$
242973551$24297355$1$I$20180101$20240305$20240909$20240909$EXP$UY-MLMSERVICE-20240227-4788358-1$UY-ALKEM LABORATORIES LIMITED-UY-ALKEM-2024-00876$ALKEM$Cunetti L, Oricchio F, Vazquez M, Peyraube R, Manzo L, Nalerio C, Curi L, Maldonado C. Drug-Drug Interaction Between Cannabidiol, Cyclosporine, and Mycophenolate Mofetil: A Case Report. Transplantation Proceedings. 2024;56(1):252-6$50$YR$$M$Y$$$20240909$$PH$UY$UY
242973562$24297356$2$F$$20240413$20240909$20240909$EXP$GB-MHRA-ADR 28672292$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08115$ALKEM$$$$$$Y$$$20240909$$HP$GB$GB
242973571$24297357$1$I$20240410$20240412$20240909$20240909$EXP$GB-MHRA-ADR 28668785$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-07953$ALKEM$$55$YR$$M$Y$78$KG$20240909$$MD$GB$GB
242973581$24297358$1$I$$20240607$20240909$20240909$EXP$GB-MHRA-TPP15685039C7203228YC1712563096286$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-12522$ALKEM$$64$YR$$M$Y$66$KG$20240909$$PH$GB$GB
242973591$24297359$1$I$$20240329$20240909$20240909$EXP$GB-MHRA-ADR 28636434$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06739$ALKEM$$$$$F$Y$$$20240909$$CN$GB$GB
242973601$24297360$1$I$$20240213$20240909$20240909$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-03411$ALKEM$Thaipisuttikul I, Chapman P, Avila EK. Peripheral neuropathy associated with ipilimumab: A report of 2 cases. J Immunother. 2015;38(2):77-79$57$YR$$M$Y$$$20240909$$HP$US$US
242973611$24297361$1$I$20210101$20240330$20240909$20240909$EXP$GB-MHRA-ADR 28639157$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-06840$ALKEM$$$$$F$Y$$$20240909$$HP$GB$GB
242973621$24297362$1$I$20240504$20240705$20240909$20240909$EXP$GB-MHRA-MED-202405061107084590-BCYGS$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15133$ALKEM$$41$YR$$F$Y$128$KG$20240909$$CN$GB$GB
242973631$24297363$1$I$$20240416$20240909$20240909$EXP$GB-MHRA-ADR 28656393$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-08236$ALKEM$$60$YR$$M$Y$$$20240909$$PH$GB$GB
242973641$24297364$1$I$$20240222$20240909$20240909$EXP$GB-MHRA-ADR 28547286$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03616$ALKEM$$65$YR$$F$Y$120$KG$20240909$$MD$GB$GB
242973651$24297365$1$I$$20240723$20240909$20240909$EXP$US-MLMSERVICE-20240703-PI117753-00163-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15533$ALKEM$Naumann J, Naumann T. Acute Precipitated Opioid Withdrawal With Akathisia, Delirium, and Lactic Acidosis from Low-Dose Naltrexone for Chronic Pain: Case Report. Pain Medicine Case Reports. 2023;7(8):353-356$66$YR$$M$Y$$$20240909$$HP$US$US
242973662$24297366$2$F$20240219$20240307$20240909$20240909$EXP$GB-MHRA-ADR 28585950$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-04583$ALKEM$$76$YR$$M$Y$86$KG$20240909$$MD$GB$GB
242973671$24297367$1$I$$20240226$20240909$20240909$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-04043$ALKEM$Pucci M, Singh Jutley G, Looms J, Ford L.. N-desethyl isotonitazene detected in polydrug users admitted to hospital in Birmingham, United Kingdom. Clinical Toxicology. 2024;unk:1-7$37$YR$$F$Y$$$20240909$$HP$GB$GB
242973681$24297368$1$I$$20230803$20240909$20240909$EXP$GB-MHRA-ADR 28076962$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-08876$ALKEM$$78$YR$$M$Y$93$KG$20240909$$PH$GB$GB
242973692$24297369$2$F$$20240610$20240909$20240909$EXP$US-MLMSERVICE-20240522-PI072431-00163-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-11849$ALKEM$Damia C, Monceaux B, Hall C, Bhamrah P, Koothirezhi R, Liendo C, Ho MT, Ghildiyal N, Chernyshev O.. Initiation of Methadone for Refractory Restless Leg Syndrome with Significant Improvement of Symptoms. Sleep. 2024;47 Supplement 1:A516-A517$62$YR$$F$Y$$$20240909$$HP$US$US
242973701$24297370$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61554$$FDA-CTU$$76$YR$$M$N$$$20240906$N$$US$
242973712$24297371$2$F$20231102$20231106$20240909$20240909$EXP$GB-MHRA-ADR 28300503$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-13770$ALKEM$$78$YR$$F$Y$47$KG$20240909$$MD$GB$GB
242973721$24297372$1$I$$20240126$20240909$20240909$EXP$GB-MHRA-ADR 28489162$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-01711$ALKEM$$$$$$Y$$$20240909$$PH$GB$GB
242973731$24297373$1$I$20240110$20240120$20240909$20240909$EXP$GB-MHRA-ADR 28473308$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-01207$ALKEM$$79$YR$$F$Y$$$20240909$$MD$GB$GB
242973741$24297374$1$I$$20240826$20240909$20240909$EXP$DE-INDIVIOR EUROPE LIMITED-INDV-145808-2024$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14587$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD, et al.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$36$YR$$F$Y$$$20240909$$HP$DE$DE
242973751$24297375$1$I$$20240219$20240909$20240909$EXP$GB-MHRA-ADR 28522585$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-03332$ALKEM$$43$YR$$F$Y$142$KG$20240909$$MD$GB$GB
242973761$24297376$1$I$$20240610$20240909$20240909$EXP$US-MLMSERVICE-20240522-PI072442-00163-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-11851$ALKEM$Bliton K, Jordan M, Patterson P, Warren J.. Restlessness Is a Pain: Methadone Induced Augmentation. Sleep. 2024;47(Supplement1):A504-A505$75$YR$$M$Y$$$20240909$$HP$US$US
242973771$24297377$1$I$$20231205$20240909$20240909$EXP$GB-MHRA-ADR 28368912$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15553$ALKEM$$$$$F$Y$$$20240909$$PH$GB$GB
242973781$24297378$1$I$$20230918$20240909$20240909$EXP$GB-MHRA-ADR 28182902$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-11064$ALKEM$$$$$F$Y$$$20240909$$CN$GB$GB
242973791$24297379$1$I$$20231130$20240909$20240909$EXP$GB-MHRA-ADR 28354117$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15308$ALKEM$$96$YR$$F$Y$$$20240909$$HP$GB$GB
242973801$24297380$1$I$$20240826$20240909$20240909$EXP$DE-EMA-DD-20240718-7482643-075622$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14659$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul L D.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$44$YR$$M$Y$$$20240909$$HP$DE$DE
242973811$24297381$1$I$$20240826$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14590$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$41$YR$$M$Y$$$20240909$$HP$DE$DE
242973821$24297382$1$I$20240816$20240906$20240906$20240906$DIR$717503$$FDA-CTU$$57$YR$$M$N$70.81$KG$20240906$N$HP$US$
242973831$24297383$1$I$20240103$20240105$20240909$20240909$EXP$GB-MHRA-ADR 28439750$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-00141$ALKEM$$57$YR$$F$Y$115$KG$20240909$$PH$GB$GB
242973841$24297384$1$I$20240106$20240112$20240909$20240909$EXP$GB-MHRA-ADR 28453934$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-00589$ALKEM$$37$YR$$F$Y$63$KG$20240909$$MD$GB$GB
242973851$24297385$1$I$$20230927$20240909$20240909$EXP$GB-MHRA-ADR 28205809$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-11832$ALKEM$$$$$F$Y$$$20240909$$HP$GB$GB
242973861$24297386$1$I$$20231204$20240909$20240909$EXP$GB-MHRA-ADR 28365640$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15489$ALKEM$$$$$F$Y$$$20240909$$PH$GB$GB
242973871$24297387$1$I$$20230911$20240909$20240909$EXP$GB-MHRA-ADR 28170821$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10550$ALKEM$$$$$F$Y$$$20240909$$HP$GB$GB
242973881$24297388$1$I$$20240826$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14660$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$20$YR$$M$Y$$$20240909$$HP$DE$DE
242973891$24297389$1$I$$20240826$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14651$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$48$YR$$M$Y$$$20240909$$HP$DE$DE
242973901$24297390$1$I$$20240826$20240909$20240909$EXP$DE-EMA-DD-20240722-7482655-092319$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14600$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$43$YR$$M$Y$$$20240909$$HP$DE$DE
242973911$24297391$1$I$20240109$20240112$20240909$20240909$EXP$GB-MHRA-ADR 28454939$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-00596$ALKEM$$79$YR$$M$Y$66$KG$20240909$$MD$GB$GB
242973921$24297392$1$I$$20240826$20240909$20240909$EXP$DE-EMA-DD-20240722-7482655-092319$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14611$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$43$YR$$M$Y$$$20240909$$HP$DE$DE
242973931$24297393$1$I$$20231114$20240909$20240909$EXP$GB-MHRA-ADR 28319564$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-14209$ALKEM$$$$$F$Y$$$20240909$$PH$GB$GB
242973941$24297394$1$I$20231003$20231009$20240909$20240909$EXP$GB-MHRA-ADR 28224384$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-12286$ALKEM$$86$YR$$F$Y$55$KG$20240909$$MD$GB$GB
242973951$24297395$1$I$20231227$20231229$20240909$20240909$EXP$GB-MHRA-ADR 28427821$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-17054$ALKEM$$34$YR$$F$Y$$$20240909$$PH$GB$GB
242973961$24297396$1$I$20231101$20231221$20240909$20240909$EXP$GB-MHRA-ADR 28407659$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-16572$ALKEM$$35$YR$$F$Y$$$20240909$$CN$GB$GB
242973971$24297397$1$I$20231228$20231230$20240909$20240909$EXP$GB-MHRA-ADR 28429203$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-17040$ALKEM$$66$YR$$M$Y$100$KG$20240909$$MD$GB$GB
242973981$24297398$1$I$$20230811$20240909$20240909$EXP$GB-MHRA-ADR 28108280$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09137$ALKEM$$82$YR$$F$Y$$$20240909$$PH$GB$GB
242973991$24297399$1$I$$20230925$20240909$20240909$EXP$GB-MHRA-ADR 28134211$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09888$ALKEM$$88$YR$$M$Y$$$20240909$$CN$GB$GB
242974001$24297400$1$I$$20230818$20240909$20240909$EXP$GB-MHRA-ADR 28117745$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09562$ALKEM$$73$YR$$M$Y$96$KG$20240909$$MD$GB$GB
242974011$24297401$1$I$20230713$20230810$20240909$20240909$EXP$GB-MHRA-ADR 28103280$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09088$ALKEM$$$$$F$Y$$$20240909$$HP$GB$GB
242974021$24297402$1$I$20230721$20230724$20240909$20240909$EXP$GB-MHRA-ADR 28069111$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-08553$ALKEM$$62$YR$$M$Y$85$KG$20240909$$MD$GB$GB
242974031$24297403$1$I$$20240426$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-09860$ALKEM$$$$$F$Y$$$20240909$$CN$DE$DE
242974041$24297404$1$I$20240410$20240617$20240909$20240909$EXP$DE-CADRBFARM-2024328721$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-13275$ALKEM$$68$YR$$M$Y$88$KG$20240909$$MD$DE$DE
242974051$24297405$1$I$$20231023$20240909$20240909$EXP$GB-MHRA-ADR 28259450$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-13118$ALKEM$$34$YR$$F$Y$73$KG$20240909$$PH$GB$GB
242974061$24297406$1$I$$20231103$20240909$20240909$EXP$DE-BFARM-23008463$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-13673$ALKEM$$$$$F$Y$$$20240909$$CN$DE$DE
242974071$24297407$1$I$20230809$20230828$20240909$20240909$EXP$GB-MHRA-ADR 28137158$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-09981$ALKEM$$78$YR$$F$Y$84$KG$20240909$$HP$GB$GB
242974081$24297408$1$I$20231101$20231110$20240909$20240909$EXP$GB-MHRA-ADR 28310792$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-14225$ALKEM$$47$YR$$F$Y$129$KG$20240909$$PH$GB$GB
242974091$24297409$1$I$20231127$20231130$20240909$20240909$EXP$GB-MHRA-ADR 28355215$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-15329$ALKEM$$57$YR$$M$Y$$$20240909$$MD$GB$GB
242974101$24297410$1$I$$20231003$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-12098$ALKEM$$$$$$Y$$$20240909$$MD$DE$DE
242974111$24297411$1$I$$20240116$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-16654$ALKEM$$$$$F$Y$$$20240909$$CN$DE$DE
242974121$24297412$1$I$$20240105$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-00088$ALKEM$$$$$M$Y$$$20240909$$CN$DE$DE
242974131$24297413$1$I$$20231127$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-15014$ALKEM$$55$YR$$M$Y$$$20240909$$HP$DE$DE
242974141$24297414$1$I$$20240318$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-05293$ALKEM$$74$YR$$F$Y$$$20240909$$PH$DE$DE
242974151$24297415$1$I$20190101$20240313$20240909$20240909$EXP$DE-TAKEDA-2019TEU007129$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-05022$ALKEM$$56$YR$$F$Y$$$20240909$$MD$DE$DE
242974161$24297416$1$I$$20230908$20240909$20240909$EXP$GB-MHRA-ADR 28160137$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-10470$ALKEM$$29$YR$$F$Y$57$KG$20240909$$MD$GB$GB
242974171$24297417$1$I$20240625$20240711$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-15088$ALKEM$$52$YR$$F$Y$$$20240909$$CN$DE$DE
242974181$24297418$1$I$$20231024$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-13566$ALKEM$$$$$M$Y$$$20240909$$CN$DE$DE
242974191$24297419$1$I$$20230720$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-08487$ALKEM$$$$$F$Y$$$20240909$$CN$DE$DE
242974201$24297420$1$I$20190101$20230816$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-09381$ALKEM$$42$YR$$F$Y$$$20240909$$MD$DE$DE
242974211$24297421$1$I$20230701$20230803$20240909$20240909$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2023-08843$ALKEM$$$$$F$Y$$$20240909$$MD$DE$DE
242974221$24297422$1$I$20230718$20230721$20240909$20240909$EXP$GB-MHRA-ADR 28054687$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-08506$ALKEM$$74$YR$$F$Y$96$KG$20240909$$MD$GB$GB
242974232$24297423$2$F$$20240327$20240909$20240909$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06591$ALKEM$$35$YR$$M$Y$$$20240909$$HP$AU$AU
242974241$24297424$1$I$$20240903$20240909$20240909$PER$$US-ABBVIE-5907265$ABBVIE$$$$$$Y$$$20240909$$MD$US$US
242974251$24297425$1$I$$20230918$20240909$20240909$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2023-10722$ALKEM$Gilron I, Robb S, Tu D, Holden RR, Jackson AC, Duggan S, Milev R. Randomized, double-blind, controlled trial of a combination of alpha-lipoic acid and pregabalin for neuropathic pain: the PAIN-CARE trial. Pain. 2023;00 (00):1-9$$$$$Y$$$20240909$$HP$CA$CA
242974261$24297426$1$I$$20240327$20240909$20240909$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06619$ALKEM$$60$YR$$M$Y$$$20240909$$HP$AU$AU
242974271$24297427$1$I$$20240327$20240909$20240909$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06620$ALKEM$$$$$F$Y$$$20240909$$HP$AU$AU
242974281$24297428$1$I$$20240327$20240909$20240909$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06609$ALKEM$$$$$F$Y$$$20240909$$HP$AU$AU
242974291$24297429$1$I$$20240117$20240909$20240909$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-00793$ALKEM$$51$YR$$F$Y$$$20240909$$HP$AU$AU
242974301$24297430$1$I$$20240327$20240909$20240909$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-06590$ALKEM$$46$YR$$M$Y$$$20240909$$HP$AU$AU
242974311$24297431$1$I$$20230816$20240909$20240909$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09475$ALKEM$$$$$F$Y$$$20240909$$HP$AU$AU
242974321$24297432$1$I$$20240523$20240909$20240909$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-11612$ALKEM$Chtompel Y, Eghtesadi M, Vargas-Schaffer G. A Case Report of Refractory Notalgia Paresthetica Treated with Lidocaine Infusions. American Journal of Case Reports. 2017;18:1225-1228$50$YR$$F$Y$$$20240909$$HP$CA$CA
242974331$24297433$1$I$$20230816$20240909$20240909$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09471$ALKEM$$41$YR$$M$Y$$$20240909$$HP$AU$AU
242974341$24297434$1$I$$20230816$20240909$20240909$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09446$ALKEM$$83$YR$$M$Y$$$20240909$$HP$AU$AU
242974351$24297435$1$I$$20230816$20240909$20240909$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09463$ALKEM$$54$YR$$F$Y$$$20240909$$HP$AU$AU
242974361$24297436$1$I$20240808$20240829$20240909$20240909$EXP$FR-AFSSAPS-CF2024000432$FR-Accord-445036$ACCORD$$62$YR$A$F$Y$42.5$KG$20240909$$PH$FR$FR
242974371$24297437$1$I$20210322$20240828$20240909$20240909$EXP$$CA-GSK-CA2021AMR068438$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$CN$CA$CA
242974381$24297438$1$I$$20230816$20240909$20240909$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09469$ALKEM$$23$YR$$M$Y$$$20240909$$HP$AU$AU
242974391$24297439$1$I$$20240828$20240909$20240909$EXP$$NO-Accord-444663$ACCORD$Sommerfelt H, Sandvik LF, Bachmann IM, Brekke RL, Svendsen HL, Guttormsen AB. Toxic epidermal necrolysis after immune checkpoint inhibition, case report, and review of the literature. Acta Oncologica. 2022;61(10):1295-1299.$34$YR$A$M$Y$$$20240909$$HP$NO$NO
242974401$24297440$1$I$$20230816$20240909$20240909$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-09445$ALKEM$$$$$M$Y$$$20240909$$HP$AU$AU
242974411$24297441$1$I$$20240827$20240909$20240909$EXP$$JP-GALDERMA-JP2024013434$GALDERMA$$$$$$Y$$$20240909$$MD$JP$JP
242974421$24297442$1$I$20240731$20240830$20240909$20240909$EXP$$FR-AUROBINDO-AUR-APL-2024-043955$AUROBINDO$$43$YR$$M$Y$86.3$KG$20240909$$MD$FR$FR
242974441$24297444$1$I$$20240515$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02409$AMNEAL$$$$$M$Y$$$20240909$$CN$US$US
242974451$24297445$1$I$$20230914$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03272$AMNEAL$$$$$F$Y$$$20240909$$CN$US$US
242974461$24297446$1$I$$20240514$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01845$AMNEAL$$$$$F$Y$$$20240909$$CN$US$US
242974471$24297447$1$I$$20240403$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01140$AMNEAL$$$$$F$Y$$$20240909$$CN$COUNTRY NOT SPECIFIED$US
242974481$24297448$1$I$20240413$20240419$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01369$AMNEAL$$$$$F$Y$$$20240909$$CN$US$US
242974491$24297449$1$I$$20240621$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02318$AMNEAL$$$$$M$Y$48.526$KG$20240909$$CN$US$US
242974501$24297450$1$I$$20240827$20240909$20240909$EXP$$CA-DENTSPLY-2024SCDP000250$DENTSPLY$$71$YR$$F$Y$$$20240909$$HP$CA$CA
242974511$24297451$1$I$$20240905$20240909$20240909$PER$$NVSC2024US180180$NOVARTIS$$$$$F$Y$$$20240909$$MD$US$US
242974521$24297452$1$I$$20231004$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03541$AMNEAL$$$$$F$Y$$$20240909$$CN$US$US
242974531$24297453$1$I$$20240422$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01381$AMNEAL$$$$$F$Y$$$20240909$$CN$US$US
242974541$24297454$1$I$$20230905$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03170$AMNEAL$$$$$F$Y$$$20240909$$CN$US$US
242974561$24297456$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61544$$FDA-CTU$$83$YR$$M$N$$$20240906$N$$US$
242974581$24297458$1$I$$20240829$20240909$20240909$EXP$$US-ROCHE-10000070745$ROCHE$$83$YR$E$F$Y$$$20240909$$CN$US$US
242974591$24297459$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142794$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240909$$HP$US$US
242974601$24297460$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142579$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$97.07$KG$20240909$$CN$US$US
242974611$24297461$1$I$$20240906$20240909$20240909$PER$$US-JNJFOC-20240916283$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$US$US
242974621$24297462$1$I$$20240906$20240906$20240906$DIR$717443$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242974631$24297463$1$I$20240905$20240906$20240906$20240906$DIR$717446$$FDA-CTU$$87$YR$$F$N$$$20240906$N$HP$US$
242974641$24297464$1$I$$20240904$20240909$20240909$EXP$$JP-AMGEN-JPNSP2024176367$AMGEN$$$$E$M$Y$$$20240909$$PH$JP$JP
242974652$24297465$2$F$$20240909$20240909$20240917$PER$$US-ROCHE-10000076315$ROCHE$$$$$$Y$$$20240917$$CN$US$US
242974661$24297466$1$I$$20240904$20240909$20240909$EXP$$KR-AMGEN-KORSP2024175419$AMGEN$$$$$$Y$$$20240909$$MD$KR$KR
242974673$24297467$3$F$20240831$20240913$20240909$20240916$PER$$US-AMGEN-USASP2024178743$AMGEN$$76$YR$E$F$Y$$$20240916$$CN$US$US
242974681$24297468$1$I$$20240903$20240909$20240909$PER$$US-PHARMING-PHAUS2024000768$PHARMING GROUP$$$$$$Y$$$20240909$$CN$US$US
242974691$24297469$1$I$$20240903$20240909$20240909$EXP$$US-PHARMING-PHAUS2024000770$PHARMING GROUP$$$$$$Y$$$20240909$$CN$US$US
242974701$24297470$1$I$$20240904$20240909$20240909$EXP$$US-AMGEN-USASP2024177440$AMGEN$Lapite A.; Sanchez L.; Altaffer A.L. et al.. Concomitant sickle cell disease and systemic lupus erythematosus: A single-center case series. Pediatric Blood and Cancer. 2024;71 (10):1-5$19$YR$A$F$Y$$$20240909$$HP$US$US
242974711$24297471$1$I$$20240903$20240909$20240909$EXP$$US-PHARMING-PHAUS2024000769$PHARMING GROUP$$$$$$Y$$$20240909$$CN$US$US
242974721$24297472$1$I$$20240903$20240909$20240909$PER$$US-PHARMING-PHAUS2024000767$PHARMING GROUP$$$$$$Y$$$20240909$$CN$US$US
242974731$24297473$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61595$$FDA-CTU$$63$YR$$F$N$81.19$KG$20240906$N$$US$
242974741$24297474$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61543$$FDA-CTU$$21$YR$$F$N$95.25$KG$20240906$N$HP$US$
242974751$24297475$1$I$$20240906$20240906$20240906$DIR$717453$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242974762$24297476$2$F$20240805$20240906$20240909$20240918$EXP$$US-ROCHE-10000076267$ROCHE$$64$YR$A$M$Y$83.91$KG$20240918$$CN$US$US
242974772$24297477$2$F$20240830$20240923$20240909$20240924$PER$$US-ROCHE-10000076359$ROCHE$$$$$F$Y$$$20240924$$CN$US$US
242974781$24297478$1$I$20230323$20240902$20240909$20240909$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-001465$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240909$$MD$JP$JP
242974791$24297479$1$I$20240723$20240830$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139580$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$83.46$KG$20240909$$HP$US$US
242974801$24297480$1$I$$20240813$20240909$20240909$EXP$$CN-BAYER-2024A127469$BAYER$Lu Y; Zhou L; Zou Y; Wei H.; Zhou Y.; Guo XR.; Li QC.; Ye YQ; Zhang LW. Antibiotic-induced severe cutaneous adverse reactions: a single-center retrospective study over ten years. Frontiers in Immunology. 2024;15:1415830$$$$$Y$$$20240909$$HP$CN$CN
242974811$24297481$1$I$20240824$20240901$20240909$20240909$EXP$GB-MHRA-MED-202409011709084720-FNWCM$GB-ASTELLAS-2024-AER-004019$ASTELLAS$$68$YR$E$F$Y$$$20240909$$MD$GB$GB
242974821$24297482$1$I$20240821$20240822$20240909$20240909$PER$$US-UniquePharma-US-2024UPLSPO00035$UNIQUE PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242974831$24297483$1$I$20231001$20231024$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2023US048593$SANDOZ$$59$YR$$F$Y$$$20240909$$CN$US$US
242974841$24297484$1$I$20240905$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024177990$AMGEN$$64$YR$A$F$Y$$$20240909$$CN$US$US
242974851$24297485$1$I$20240903$20240903$20240909$20240909$PER$$US-AMGEN-USASP2024177076$AMGEN$$$$$F$Y$$$20240909$$HP$US$US
242974861$24297486$1$I$20240725$20240826$20240909$20240909$EXP$$CA-UCBSA-2024037507$UCB$$54$YR$$F$Y$$$20240909$$MD$CA$CA
242974871$24297487$1$I$$20240829$20240909$20240909$EXP$GB-MHRA-MED-202408291214599110-TRYQJ$GB-Accord-444180$ACCORD$$44$YR$A$F$Y$72$KG$20240909$$CN$GB$GB
242974881$24297488$1$I$20230201$20240906$20240909$20240909$PER$$US-ROCHE-10000076336$ROCHE$$65$YR$E$F$Y$72.57$KG$20240909$$CN$US$US
242974892$24297489$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686682$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242974901$24297490$1$I$$20240830$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043541$AUROBINDO$Lopez J, Hua H, Toy BC. A case of herpes simplex virus and cytomegalovirus retinitis coinfection. Retinal Cases and Brief Reports. 2024;18(4):451-4$64$YR$$M$Y$$$20240909$$MD$US$US
242974911$24297491$1$I$20240826$20240830$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043791$AUROBINDO$$$$$F$Y$$$20240909$$MD$GB$GB
242974941$24297494$1$I$20240814$20240905$20240909$20240909$PER$$US-ROCHE-10000076123$ROCHE$$$$$$Y$$$20240909$$PH$US$US
242974951$24297495$1$I$$20240905$20240909$20240909$PER$$US-TAKEDA-2024TUS089149$TAKEDA$$$$$M$Y$$$20240909$$CN$US$US
242974961$24297496$1$I$$20240903$20240909$20240909$EXP$$FR-VELOXIS PHARMACEUTICALS, INC.-2022-VEL-00037$VELOXIS PHARMACEUTICALS$Altwegg R, Combes R, Laharie D, De Ledinghen V, Radenne S, Conti F et al.. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.. Dig-Liver-Dis.. 2018;50(7):668-674$26$YR$$M$Y$$$20240909$$HP$FR$FR
242974971$24297497$1$I$20240301$20240830$20240909$20240909$30DAY$$US-GSK-US2024108452$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240909$$CN$US$US
242974981$24297498$1$I$20231201$20240830$20240909$20240909$EXP$$US-VIIV HEALTHCARE LIMITED-US2024108437$VIIV$$66$YR$$F$Y$$$20240909$$HP$US$US
242975001$24297500$1$I$$20240827$20240909$20240909$EXP$$JP-ASTELLAS-2024-AER-003106$ASTELLAS$Yamane A, Kubo R, Koura T, Awaya Y. Two cases of drug-induced interstitial pneumonia due to enzalutamide. The 69th Shikoku Regional Meeting of the Japanese Respiratory Society/The 32nd Annual Meeting of the Chinese Shikoku Branch of the Japanese Respiratory Endoscopy Society Program and Abstracts (2023.12.16-2023.12.17). 2023;R-079.$87$YR$E$M$Y$$$20240909$$MD$JP$JP
242975011$24297501$1$I$20240314$20240829$20240909$20240909$EXP$GB-MHRA-MED-202408290739248290-NWBDM$GB-Accord-444181$ACCORD$$45$YR$A$M$Y$79$KG$20240909$$CN$GB$GB
242975021$24297502$1$I$$20240621$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02347$AMNEAL$$$$$F$Y$$$20240909$$PH$US$US
242975031$24297503$1$I$$20240628$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02423$AMNEAL$$$$$$Y$$$20240909$$CN$US$US
242975041$24297504$1$I$20240704$20240903$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02617$AMNEAL$$59$YR$$F$Y$67.574$KG$20240909$$CN$US$US
242975051$24297505$1$I$$20240830$20240909$20240909$EXP$$CA-AUROBINDO-AUR-APL-2024-003700$AUROBINDO$$$$$$Y$$$20240909$$MD$CA$CA
242975061$24297506$1$I$20240624$20240829$20240909$20240909$EXP$FR-AFSSAPS-NT2024001064$FR-Accord-444580$ACCORD$$60$YR$A$M$Y$82$KG$20240909$$PH$FR$FR
242975071$24297507$1$I$$20231025$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2023US049173$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242975091$24297509$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004066$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240909$$CN$US$US
242975101$24297510$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003697$ELI LILLY AND CO$$69$YR$E$$Y$$$20240909$$CN$US$US
242975111$24297511$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003826$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242975121$24297512$1$I$$20240828$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408018416$ELI LILLY AND CO$$$$$F$Y$$$20240909$$HP$US$US
242975131$24297513$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003789$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240909$$CN$US$US
242975141$24297514$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3239375$TEVA$$71$YR$$F$Y$$$20240909$$HP$CA$CA
242975151$24297515$1$I$$20240829$20240909$20240909$PER$$US-ROCHE-10000070660$ROCHE$$$$A$$Y$$$20240909$$MD$US$US
242975161$24297516$1$I$20240902$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003439$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240909$$CN$US$US
242975192$24297519$2$F$$20240912$20240909$20240920$EXP$$CA-TEVA-VS-3239310$TEVA$$70$YR$$F$Y$$$20240920$$HP$CA$CA
242975202$24297520$2$F$20240815$20240828$20240909$20240909$EXP$$CL-PFIZER INC-202400238448$PFIZER$$79$YR$$M$Y$80$KG$20240909$$PH$CL$CL
242975211$24297521$1$I$$20240903$20240909$20240909$EXP$$US-ABBVIE-5905644$ABBVIE$$$$$$Y$$$20240909$$HP$US$US
242975221$24297522$1$I$$20240904$20240909$20240909$EXP$$US-ABBVIE-5908119$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242975231$24297523$1$I$20240903$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024176959$AMGEN$$79$YR$E$M$Y$$$20240909$$CN$US$US
242975241$24297524$1$I$20240823$20240829$20240909$20240909$EXP$$IT-AUROBINDO-AUR-APL-2024-043691$AUROBINDO$$69$YR$$F$Y$$$20240909$$MD$IT$IT
242975252$24297525$2$F$20240901$20240909$20240909$20240913$PER$$US-AMGEN-USASP2024179026$AMGEN$$59$YR$A$F$Y$$$20240913$$HP$US$US
242975261$24297526$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178188$AMGEN$$$$$$Y$$$20240909$$CN$US$US
242975271$24297527$1$I$$20240902$20240909$20240909$EXP$$IL-ROCHE-10000072573$ROCHE$Strahilevitz J, Motro Y, Temper V, Merezhko D, Ayalon O, Moshe Y. In vivo selection of carbapenem resistance during persistent Klebsiella pneumoniae sequence type 395 bloodstream infection due to OmpK36 deletion. Antimicrobial Agents and Chemotherapy. 2024-Aug;68 (8):1-8. doi:10.1128/aac.00663-24.$85$YR$E$M$Y$$$20240909$$HP$IL$IL
242975281$24297528$1$I$$20240903$20240909$20240909$EXP$$US-ABBVIE-5906870$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242975292$24297529$2$F$$20240910$20240909$20240914$EXP$$US-ABBVIE-5907398$ABBVIE$$$$$F$Y$95$KG$20240914$$CN$US$US
242975301$24297530$1$I$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686563$GILEAD$$$$A$M$Y$$$20240909$$CN$US$US
242975311$24297531$1$I$20191221$20240905$20240909$20240909$EXP$$JP-GSK-JP2024JPN110354$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$MD$JP$JP
242975322$24297532$2$F$$20240914$20240909$20240920$EXP$$CA-GSK-CA2024108286$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$CA$CA
242975331$24297533$1$I$20220101$20240827$20240909$20240909$EXP$$US-SA-2024SA260098$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240909$$MD$US$US
242975341$24297534$1$I$$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61693$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242975351$24297535$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61536$$FDA-CTU$$48$YR$$F$N$119.29$KG$20240906$N$HP$US$
242975361$24297536$1$I$$20240903$20240909$20240909$EXP$$CA-TAKEDA-2024TUS074427$TAKEDA$$$$$F$Y$$$20240909$$CN$CA$CA
242975371$24297537$1$I$20240828$20240828$20240909$20240909$EXP$$US-Accord-444864$ACCORD$$27$YR$A$F$Y$$$20240909$$PH$US$US
242975421$24297542$1$I$$20240904$20240909$20240909$EXP$$CA-PFIZER INC-202300241647$PFIZER$$32$YR$$F$Y$80$KG$20240909$$HP$CA$CA
242975431$24297543$1$I$$20240829$20240909$20240909$EXP$$BE-JNJFOC-20240900413$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$MD$BE$BE
242975441$24297544$1$I$$20231027$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2023US049636$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242975451$24297545$1$I$$20240829$20240909$20240909$PER$$US-ABBVIE-5902198$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242975462$24297546$2$F$$20240919$20240909$20240926$EXP$$JP-AMGEN-JPNSP2024177921$AMGEN$$83$YR$E$M$Y$$$20240925$$PH$JP$JP
242975473$24297547$3$F$20240905$20240913$20240909$20240914$PER$$US-AMGEN-USASP2024178642$AMGEN$$70$YR$E$M$Y$$$20240914$$CN$US$US
242975482$24297548$2$F$20240101$20240905$20240909$20240916$PER$$US-AMGEN-USASP2024178399$AMGEN$$$$$F$Y$$$20240916$$CN$US$US
242975492$24297549$2$F$20240801$20240916$20240909$20240924$EXP$$BR-AMGEN-BRASL2024175320$AMGEN$$56$YR$A$F$Y$$$20240924$$CN$BR$BR
242975501$24297550$1$I$$20240904$20240909$20240909$EXP$$JP-AMGEN-JPNSP2024120492$AMGEN$$8$DEC$E$M$Y$$$20240909$$MD$JP$JP
242975511$24297551$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3239188$TEVA$$3$YR$$F$Y$$$20240909$$HP$CA$CA
242975531$24297553$1$I$$20240830$20240909$20240909$EXP$$US-BAYER-2024A128158$BAYER$Cardoso E.R.; Abbas R.; Stone E.M.; Patel S.. Combined pterional burr hole and coagulation of middle meningeal artery for chronic subdural hematoma~. Surgical Neurology International. 2024;15:254$86$YR$E$F$Y$$$20240909$$HP$US$US
242975541$24297554$1$I$$20240906$20240906$20240906$DIR$717452$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242975551$24297555$1$I$20240904$20240906$20240906$20240906$DIR$717433$$FDA-CTU$$$$$F$N$$$20240906$Y$PH$US$
242975561$24297556$1$I$$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61538$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242975571$24297557$1$I$20240817$20240827$20240909$20240909$EXP$$US-ALVOGEN-2024095430$ALVOGEN$$$$$M$Y$$$20240909$$CN$US$US
242975582$24297558$2$F$$20240912$20240909$20240926$EXP$$US-ALVOGEN-2024095416$ALVOGEN$$$$$F$Y$$$20240926$$CN$US$US
242975591$24297559$1$I$$20240830$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043783$AUROBINDO$$57$YR$$$Y$$$20240909$$PH$GB$GB
242975601$24297560$1$I$20240906$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61656$$FDA-CTU$$62$YR$$F$N$$$20240906$N$HP$US$
242975611$24297561$1$I$20240218$20240906$20240906$20240906$DIR$717473$$FDA-CTU$$29$YR$$F$N$54$KG$20240906$N$HP$US$
242975621$24297562$1$I$20240711$20240906$20240909$20240909$EXP$GB-MHRA-MED-202409051602228240-CRTJQ$GB-ORGANON-O2409GBR000397$ORGANON$$$$$$Y$$$20240909$$HP$GB$GB
242975631$24297563$1$I$20240906$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61582$$FDA-CTU$$25$YR$$F$N$$$20240906$Y$HP$US$
242975651$24297565$1$I$20200403$20240830$20240909$20240909$EXP$$PL-AUROBINDO-AUR-APL-2024-043868$AUROBINDO$$66$YR$$F$Y$77$KG$20240909$$PH$PL$PL
242975661$24297566$1$I$$20240724$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2023US057146$SANDOZ$$$$$F$Y$$$20240909$$CN$US$US
242975681$24297568$1$I$20231122$20240906$20240909$20240909$EXP$$NVSC2024FR179105$NOVARTIS$$45$YR$$F$Y$$$20240909$$MD$FR$FR
242975692$24297569$2$F$$20240910$20240909$20240919$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-141234$BRISTOL MYERS SQUIBB$Kirmizidemir IN, Akkoyun A, Eren E, Karaca A, Saygin B, Sahin O, et al. Vanishing bile duct syndrome after therapy with nivolumab and cabozantinib in a patient with advanced clear cell renal carcinoma. European Journal of Case Reports in Internal Medicine. 2024 Jan 01;11(Supplement 1):759. doi:10.12890/2024_V11Sup1.$56$YR$A$M$Y$$$20240919$$HP$TR$TR
242975701$24297570$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142754$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240909$$HP$US$US
242975711$24297571$1$I$$20240830$20240909$20240909$EXP$GB-MHRA-MIDB-4035c570-4526-4c0b-a68b-35af2137afec$GB-TEVA-VS-3239212$TEVA$$78$YR$$M$Y$$$20240909$$PH$GB$GB
242975731$24297573$1$I$$20240902$20240909$20240909$EXP$$FR-MYLANLABS-2024M1077850$MYLAN$$80$YR$$M$Y$$$20240909$$CN$FR$FR
242975741$24297574$1$I$$20240830$20240909$20240909$EXP$GB-MHRA-MIDB-f3fc2ddf-7714-46db-9048-8c21cba62f6f$GB-TEVA-VS-3239225$TEVA$$53$YR$$$Y$$$20240909$$PH$GB$GB
242975751$24297575$1$I$20240729$20240902$20240909$20240909$EXP$FR-AFSSAPS-RN2024000913$FR-MYLANLABS-2024M1080508$MYLAN$$50$YR$$F$Y$$$20240909$$MD$FR$FR
242975761$24297576$1$I$$20240830$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043787$AUROBINDO$$15$YR$$F$Y$$$20240909$$PH$GB$GB
242975772$24297577$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686683$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242975781$24297578$1$I$20240814$20240903$20240909$20240909$EXP$$IE-TAKEDA-2024TUS089184$TAKEDA$$32$YR$$M$Y$$$20240909$$MD$IE$IE
242975791$24297579$1$I$$20240830$20240909$20240909$EXP$$GB-TEVA-VS-3239228$TEVA$$16$YR$$M$Y$$$20240909$$CN$GB$GB
242975801$24297580$1$I$20240901$20240909$20240909$20240909$PER$$US-AMGEN-USASP2024178478$AMGEN$$83$YR$E$F$Y$$$20240909$$PH$US$US
242975811$24297581$1$I$$20240907$20240909$20240909$PER$$US-ROCHE-10000076511$ROCHE$$5$YR$C$M$Y$$$20240909$$MD$US$US
242975821$24297582$1$I$20220926$20240830$20240909$20240909$EXP$$US-ABBVIE-5905269$ABBVIE$$50$YR$$F$Y$66.5$KG$20240909$$MD$US$US
242975841$24297584$1$I$$20240902$20240909$20240909$EXP$$CA-MYLANLABS-2024M1081716$MYLAN$$43$YR$$F$Y$96$KG$20240909$$HP$CA$CA
242975861$24297586$1$I$20240101$20240829$20240909$20240909$EXP$$US-BIOCODEX2-2024001229$BIOCODEX$$$$$M$Y$33.8$KG$20240905$$CN$US$US
242975871$24297587$1$I$$20240903$20240909$20240909$EXP$$US-SA-2024SA258716$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240909$$MD$US$US
242975881$24297588$1$I$20240818$20240829$20240909$20240909$EXP$IT-MINISAL02-999710$IT-Accord-444518$ACCORD$$58$YR$A$F$Y$$$20240909$$MD$IT$IT
242975891$24297589$1$I$$20240830$20240909$20240909$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024108430$VIIV$$$$$F$Y$$$20240909$$HP$US$US
242975901$24297590$1$I$$20240830$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-043557$AUROBINDO$Kornblau IS, Pritchett DY, Wilson MW. Testosterone-Induced Central Serous Chorioretinopathy Mimicking a Choroidal Mass. Retinal cases + brief reports. 2023$63$YR$$M$Y$$$20240909$$MD$US$US
242975911$24297591$1$I$20240808$20240830$20240909$20240909$EXP$$CA-CELLTRION INC.-2024CA021433$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
242975921$24297592$1$I$20240903$20240903$20240909$20240909$EXP$$FR-ABBVIE-5908941$ABBVIE$$52$YR$$M$Y$$$20240909$$HP$FR$FR
242975931$24297593$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA259991$SANOFI AVENTIS$$$$A$M$Y$$$20240909$$MD$US$US
242975941$24297594$1$I$20240826$20240826$20240909$20240909$PER$$US-SA-2024SA257563$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240909$$MD$US$US
242975951$24297595$1$I$20240801$20240827$20240909$20240909$PER$$US-SA-2024SA258784$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240909$$MD$US$US
242975961$24297596$1$I$$20240826$20240909$20240909$PER$$US-SA-2023SA341902$SANOFI AVENTIS$$$$C$M$Y$$$20240909$$MD$US$US
242975971$24297597$1$I$20240101$20240828$20240909$20240909$PER$$US-SA-2024SA258357$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240909$$MD$US$US
242975981$24297598$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259533$SANOFI AVENTIS$$$$A$M$Y$$$20240909$$MD$US$US
242975991$24297599$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA257512$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240909$$MD$US$US
242976001$24297600$1$I$20240905$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178270$AMGEN$$82$YR$E$M$Y$$$20240909$$CN$US$US
242976011$24297601$1$I$20240101$20240904$20240909$20240909$EXP$$US-ABBVIE-5874837$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242976021$24297602$1$I$$20240830$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043802$AUROBINDO$$$$$$Y$$$20240909$$MD$GB$GB
242976031$24297603$1$I$20240817$20240830$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043821$AUROBINDO$$65$YR$$F$Y$62$KG$20240909$$PH$GB$GB
242976052$24297605$2$F$20240812$20240912$20240909$20240920$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-26246$SAMSUNG BIOEPIS$$65$YR$E$F$Y$$$20240920$$HP$CA$CA
242976061$24297606$1$I$20231201$20240329$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2023US072439$SANDOZ$$75$YR$$F$Y$$$20240909$$CN$US$US
242976071$24297607$1$I$$20240904$20240909$20240909$EXP$$US-UCBSA-2024045491$UCB$Lombardi A, Pappas F, Nedelman J, Hickman D, Jaw-Tsai S, Olugbosi M et al.. Pharmacokinetics and safety of TBAJ-876, a novel antimycobacterial diarylquinoline, in healthy subjects. Antimicrobial agents and chemotherapy. 2024;00:1-17$$$$$Y$$$20240909$$HP$US$US
242976081$24297608$1$I$20231122$20240831$20240909$20240909$EXP$$FR-ABBVIE-5541149$ABBVIE$$59$YR$$F$Y$$$20240909$$MD$FR$FR
242976091$24297609$1$I$$20240827$20240909$20240909$EXP$$IR-AMNEAL PHARMACEUTICALS-2024-AMRX-03235$AMNEAL$Roshanzamiri S, Mousavizadeh S.A, Razazzadeh S, Ziaie S.. Acyclovir-induced psychiatric and renal adverse effects in a diabetic patient: A case report. Clin Case Rep.. 2024;12 (8):e9310$52$YR$$F$Y$$$20240909$$HP$IR$IR
242976101$24297610$1$I$20240525$20240904$20240909$20240909$EXP$IT-MINISAL02-1000922$NVSC2024IT177549$NOVARTIS$$66$YR$$F$Y$$$20240909$$MD$IT$IT
242976121$24297612$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61698$$FDA-CTU$$66$YR$$F$N$$$20240906$N$$US$
242976131$24297613$1$I$20240822$20240906$20240909$20240909$EXP$$NVSC2024KR179359$NOVARTIS$$61$YR$$F$Y$53$KG$20240909$$HP$KR$KR
242976151$24297615$1$I$$20240904$20240909$20240909$EXP$$NVSJ2024JP010592$NOVARTIS$$$$A$F$Y$$$20240909$$MD$JP$JP
242976161$24297616$1$I$$20240904$20240909$20240909$EXP$$NVSC2024BR154974$NOVARTIS$$$$$F$Y$$$20240909$$CN$BR$BR
242976171$24297617$1$I$20240803$20240906$20240909$20240909$EXP$FR-AFSSAPS-SE2024000684$NVSC2024FR179317$NOVARTIS$$49$YR$$M$Y$63.2$KG$20240909$$MD$FR$FR
242976181$24297618$1$I$$20240906$20240909$20240909$PER$$US-HALEON-2195824$Haleon PLC$$63$YR$$M$Y$$$20240909$$CN$US$US
242976191$24297619$1$I$$20231110$20240909$20240909$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016915$STRIDES$$$$$F$Y$$$20240909$$CN$US$US
242976201$24297620$1$I$$20240524$20240909$20240909$PER$$US-STRIDES ARCOLAB LIMITED-2024SP006347$STRIDES$Crista J.. Case Report: Antifungal Agents in the Treatment of Asthma and Allergy After Water-Damaged Building Exposure.. Altern-Ther-Health-Med. 2023;29 (6):82-91$53$YR$$M$Y$$$20240909$$MD$US$US
242976211$24297621$1$I$20240819$20240902$20240909$20240909$EXP$$CN-GSK-CN2024APC108997$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$HP$CN$CN
242976221$24297622$1$I$$20240828$20240909$20240909$EXP$$US-RECORDATI RARE DISEASE INC.-2024006645$RECORDATI$Lin Y, Khurana A, Rosenthal AC, Mohty R, Gaddam M, Bansal R et al.. Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management. Blood Cancer Journal. 2024;14:136:1-6$$$$$Y$$$20240909$$HP$US$US
242976231$24297623$1$I$$20240212$20240909$20240909$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002233$STRIDES$$$$$F$Y$$$20240909$$CN$US$US
242976241$24297624$1$I$$20240902$20240909$20240909$EXP$$NVSC2024CA179285$NOVARTIS$Jewels E, Bergeron-Gravel S, Lagace S, Hazrati L-N, Saikali S, Dunham C, et al.. YAP1-MAML2 fusion in young children with pediatric high-grade glioma: a case report. NEURO-ONCOLOGY. 2024;26(Suppl. 4):iv87$4$YR$$$Y$$$20240909$$HP$CA$CA
242976261$24297626$1$I$20240904$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178182$AMGEN$$62$YR$A$F$Y$$$20240909$$CN$US$US
242976271$24297627$1$I$20240905$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178602$AMGEN$$79$YR$E$F$Y$$$20240909$$CN$US$US
242976282$24297628$2$F$$20240903$20240909$20240910$EXP$$NVSC2024IT177295$NOVARTIS$$76$YR$$M$Y$$$20240910$$MD$IT$IT
242976292$24297629$2$F$20240801$20240905$20240909$20240911$PER$$NVSC2024US180132$NOVARTIS$$$$$$Y$$$20240911$$MD$US$US
242976301$24297630$1$I$20240622$20240829$20240909$20240909$EXP$ES-AEMPS-1562975$ES-Accord-444633$ACCORD$$77$YR$E$M$Y$$$20240909$$MD$ES$ES
242976311$24297631$1$I$$20240906$20240909$20240909$EXP$$NVSC2024US046334$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
242976322$24297632$2$F$20240901$20240910$20240909$20240919$PER$$US-MYLANLABS-2024M1081641$MYLAN$$71$YR$$F$Y$60.78$KG$20240919$$CN$US$US
242976331$24297633$1$I$$20240902$20240909$20240909$EXP$$US-MYLANLABS-2024M1081858$MYLAN$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240909$$MD$US$US
242976341$24297634$1$I$$20240902$20240909$20240909$EXP$$US-MYLANLABS-2024M1081864$MYLAN$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240909$$MD$US$US
242976361$24297636$1$I$$20240902$20240909$20240909$EXP$$US-MYLANLABS-2024M1081862$MYLAN$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240909$$MD$US$US
242976371$24297637$1$I$$20240902$20240909$20240909$EXP$$US-MYLANLABS-2024M1081870$MYLAN$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240909$$MD$US$US
242976381$24297638$1$I$$20240902$20240909$20240909$EXP$$US-MYLANLABS-2024M1081861$MYLAN$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240909$$MD$US$US
242976391$24297639$1$I$$20240902$20240909$20240909$EXP$$US-MYLANLABS-2024M1081863$MYLAN$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240909$$MD$US$US
242976401$24297640$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142185$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240909$$CN$US$US
242976411$24297641$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142604$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240909$$CN$US$US
242976421$24297642$1$I$$20240902$20240909$20240909$EXP$$US-MYLANLABS-2024M1081860$MYLAN$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240909$$MD$US$US
242976431$24297643$1$I$20240827$20240830$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043796$AUROBINDO$$63$YR$$M$Y$75$KG$20240909$$CN$GB$GB
242976441$24297644$1$I$$20240828$20240909$20240909$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03236$AMNEAL$$$$$F$Y$$$20240909$$CN$US$US
242976451$24297645$1$I$20240101$20240902$20240909$20240909$EXP$$NVSJ2024JP010446$NOVARTIS$$$$E$F$Y$$$20240909$$MD$JP$JP
242976461$24297646$1$I$20230720$20240902$20240909$20240909$EXP$$NVSJ2023JP017298$NOVARTIS$$76$YR$$F$Y$33.05$KG$20240909$$MD$JP$JP
242976471$24297647$1$I$20180101$20240902$20240909$20240909$EXP$$NVSC2024MX164116$NOVARTIS$$$$$F$Y$74$KG$20240909$$CN$MX$MX
242976481$24297648$1$I$$20240830$20240909$20240909$30DAY$$US-GSK-US2024108482$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242976491$24297649$1$I$$20240828$20240909$20240909$PER$$US-AstraZeneca-2024A197929$ASTRAZENECA$$$$A$M$Y$$$20240909$$HP$US$
242976501$24297650$1$I$$20240827$20240909$20240909$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08733$LUPIN$Zhang V, Hennen M-A, Opler DJ. An unwelcome side-effect of trazodone use in a trans-male. Psychiatry and Clinical Neurosciences. 2024;78 (6):376$$$$$Y$$$20240909$$MD$US$US
242976511$24297651$1$I$$20240827$20240909$20240909$EXP$$ZA-LUPIN PHARMACEUTICALS INC.-2024-08895$LUPIN$$$$$$Y$$$20240909$$CN$ZA$ZA
242976521$24297652$1$I$$20240830$20240909$20240909$EXP$$PT-AUROBINDO-AUR-APL-2024-043844$AUROBINDO$Galvao SI, Mesquita PD, Candeias MI, Salvado MC, Vale L, Silva JM, et al.. CUIDADO COM AS APARENCIAS ? INSUFICIENCIA CARDIACA COMO CAUSA DE DISFUNCAO HEPATICA/BE CAREFUL WITH APPEARANCES-HEART FAILURE AS A CAUSE OF LIVER DYSFUNCTION... Medicina Interna - Congressos Nacionais. 30CNMI. 2024;05:597$70$YR$$M$Y$$$20240909$$HP$PT$PT
242976531$24297653$1$I$$20240905$20240909$20240909$EXP$$CA-JNJFOC-20240918017$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240909$$HP$CA$CA
242976541$24297654$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA258680$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240909$$MD$US$US
242976551$24297655$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA258035$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240909$$HP$US$US
242976561$24297656$1$I$$20240904$20240909$20240909$EXP$$US-JNJFOC-20240909113$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242976581$24297658$1$I$20240101$20240823$20240909$20240909$PER$$US-SA-2024SA256492$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240909$$MD$US$US
242976591$24297659$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA257628$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240909$$MD$US$US
242976601$24297660$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142573$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240909$$CN$US$US
242976611$24297661$1$I$$20240828$20240909$20240909$EXP$$AE-LAURUS LABS LIMITED-2024LAU000063$LAURUS LABS LIMITED$Jumani A, Ibrahim H, Purra H, Alkhazraji AK, AlNajjar MS.. Metformin-Induced Hemolysis in a Glucose-6- Phosphate Dehydrogenase-Deficient Patient: A Case Report. Cureus. 2024;16(7)$40$YR$$M$Y$$$20240909$$HP$AE$AE
242976621$24297662$1$I$$20240828$20240909$20240909$EXP$$AU-LAURUS LABS LIMITED-2024LAU000064$LAURUS LABS LIMITED$Roy Choudhury A, Gadaga C, Moodley L, Moodley A.. Metformin-Induced Hemolysis in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency Presenting With Concurrent Idiopathic Steven- Johnson Syndrome/Toxic Epidermal Necrolysis. Cureus. 2021;13(10)$35$YR$$F$Y$$$20240909$$HP$AU$AU
242976631$24297663$1$I$20240814$20240830$20240909$20240909$EXP$$CN-AUROBINDO-AUR-APL-2024-044628$AUROBINDO$$54$YR$$F$Y$55$KG$20240909$$HP$CN$CN
242976641$24297664$1$I$20230814$20240904$20240909$20240909$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-118979$REGENERON$$$$$F$Y$$$20240909$$CN$US$US
242976651$24297665$1$I$20240830$20240830$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043799$AUROBINDO$$87$YR$$F$Y$$$20240909$$MD$GB$GB
242976661$24297666$1$I$20240830$20240903$20240909$20240909$PER$$US-RDY-SPO/USA/24/0012890$DR REDDYS$$61$YR$A$F$Y$$$20240909$$HP$US$US
242976671$24297667$1$I$20240901$20240904$20240909$20240909$EXP$$US-RDY-SPO/USA/24/0012978$DR REDDYS$$53$YR$A$F$Y$$$20240909$$HP$US$US
242976681$24297668$1$I$20240829$20240830$20240909$20240909$EXP$$US-RDY-SPO/USA/24/0013003$DR REDDYS$$45$YR$A$F$Y$$$20240909$$PH$US$US
242976691$24297669$1$I$$20240901$20240909$20240909$PER$$US-RDY-SPO/USA/24/0012923$DR REDDYS$$$$$F$Y$$$20240909$$CN$US$US
242976701$24297670$1$I$$20240903$20240909$20240909$PER$$US-RDY-SPO/USA/24/0012872$DR REDDYS$Cromack SC, Lulu Y, Magdy MP. Prostaglandin Injection for Myoma Expulsion (PRIME): Case Series of a Novel Approach to Hysteroscopic Resection of FIGO Type 2 Myomas. Journal of Minimally Invasive Gynecology. 2024 Jul;31(7): 613-619. doi:10.1016/j.jmig.2024.03.011.$37$YR$A$F$Y$$$20240909$$HP$US$US
242976711$24297671$1$I$$20240904$20240909$20240909$EXP$FR-EMA-DD-20240903-7482675-072106$FR-RDY-SPO/FRA/24/0012906$DR REDDYS$Franchi V, Labussiere-Wallet H, Chouik Y, Heiblig M, Larcher M. Tandem duplications (tds) of the ubtf gene in acute myeloid leukaemia complicated by post hematopoietic stem cell transplantation venoocclusive disease treated by liver transplantation. Letters In Oncology-Haematology. 2023;18 (6):349-51$25$YR$A$M$Y$$$20240909$$HP$FR$FR
242976721$24297672$1$I$20240906$20240906$20240909$20240909$PER$$NVSC2024US180091$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
242976731$24297673$1$I$$20240902$20240909$20240909$EXP$$NVSC2024MX163836$NOVARTIS$$$$$F$Y$74$KG$20240909$$CN$MX$MX
242976751$24297675$1$I$20240811$20240906$20240906$20240906$DIR$717504$$FDA-CTU$$56$YR$$F$N$58.5$KG$20240906$N$CN$US$
242976761$24297676$1$I$20240905$20240906$20240906$20240906$DIR$717423$$FDA-CTU$$69$YR$$F$N$72.6$KG$20240906$N$PH$US$
242976771$24297677$1$I$20240903$20240906$20240906$20240906$DIR$717492$$FDA-CTU$$85$YR$$M$N$76.5$KG$20240906$Y$CN$US$
242976781$24297678$1$I$$20240906$20240909$20240909$PER$$US-HALEON-2195737$Haleon PLC$$68$YR$$F$Y$$$20240909$$CN$US$US
242976791$24297679$1$I$$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024177494$AMGEN$$$$$$Y$$$20240909$$CN$US$US
242976801$24297680$1$I$20240820$20240906$20240906$20240906$DIR$717511$$FDA-CTU$$75$YR$$M$N$72$KG$20240906$N$CN$US$
242976812$24297681$2$F$$20240902$20240909$20240918$EXP$GB-SUNPHARMA-2024RR-463855AA$GB-LEO Pharma-373220$LEO PHARM$$50$YR$$F$Y$$$20240918$$HP$GB$GB
242976821$24297682$1$I$20240430$20240830$20240909$20240909$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024108381$VIIV$$54$YR$$F$Y$$$20240909$$PH$US$US
242976831$24297683$1$I$$20240830$20240909$20240909$EXP$$GB-AUROBINDO-AUR-APL-2024-043752$AUROBINDO$$16$YR$$M$Y$$$20240909$$CN$GB$GB
242976841$24297684$1$I$$20240830$20240909$20240909$30DAY$$US-GSK-US2024108355$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242976851$24297685$1$I$20231208$20240830$20240909$20240909$EXP$$CA-GSK-CA2023156184$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$HP$CA$CA
242976861$24297686$1$I$20240801$20240826$20240909$20240909$PER$$US-SA-2024SA257645$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240909$$HP$US$US
242976871$24297687$1$I$$20240831$20240909$20240909$PER$$US-SA-2024SA260029$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240909$$HP$US$US
242976882$24297688$2$F$20240711$20240909$20240909$20240911$EXP$$US-ALXN-202409USA000406US$ALEXION PHARMACEUTICALS$$59$YR$$F$Y$40.816$KG$20240911$$PH$US$US
242976893$24297689$3$F$20240101$20240918$20240909$20240923$EXP$$US-ORGANON-O2409USA000441$ORGANON$$$$$F$Y$75.749$KG$20240923$$MD$US$US
242976901$24297690$1$I$$20240827$20240909$20240909$30DAY$$CO-PFIZER INC-202400246599$PFIZER$$$$$F$Y$$$20240909$$CN$CO$CO
242976911$24297691$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61652$$FDA-CTU$$65$YR$$F$N$$$20240906$N$$US$
242976931$24297693$1$I$$20240830$20240909$20240909$30DAY$$US-GSK-US2024108394$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242976942$24297694$2$F$$20240910$20240909$20240917$EXP$$CA-GSK-CA2024036336$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
242976952$24297695$2$F$$20240906$20240909$20240910$PER$$NVSC2024US180062$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
242976961$24297696$1$I$$20240904$20240909$20240909$EXP$$NVSC2024US178652$NOVARTIS$$$$$F$Y$$$20240909$$HP$US$US
242976971$24297697$1$I$20240101$20240902$20240909$20240909$EXP$$NVSC2024DE159481$NOVARTIS$$$$E$M$Y$$$20240909$$MD$DE$DE
242976982$24297698$2$F$$20240913$20240909$20240913$30DAY$$PR-PFIZER INC-202400244504$PFIZER$$27$YR$$M$Y$$$20240913$$CN$PR$PR
242977022$24297702$2$F$$20240913$20240909$20240913$30DAY$$US-PFIZER INC-PV202400112994$PFIZER$$$$$F$Y$$$20240913$$CN$US$US
242977033$24297703$3$F$20240622$20240920$20240909$20240925$30DAY$$GB-PFIZER INC-202400247351$PFIZER$$40$YR$$F$Y$$$20240925$$PH$GB$GB
242977041$24297704$1$I$20230201$20240903$20240909$20240909$EXP$$US-PFIZER INC-202400249376$PFIZER$$85$YR$$F$Y$45.36$KG$20240909$$CN$US$US
242977051$24297705$1$I$$20240904$20240909$20240909$EXP$$ES-PFIZER INC-202400250018$PFIZER$$$$C$M$Y$$$20240909$$MD$ES$ES
242977091$24297709$1$I$$20240902$20240909$20240909$EXP$$DE-MYLANLABS-2024M1081745$MYLAN$Toskov V, Cseh A, Claviez A, Drexler B, Rotari N, Schwarz-Furlan S, et al. Variable Clinical Courses of Varicella Zoster Virus Infection-related or Vaccination-related Bone Marrow Failure. J-Pediatr-Hematol-Oncol 2024; 46 (5): e354-e359.$4$YR$$F$Y$$$20240909$$MD$DE$DE
242977101$24297710$1$I$$20240902$20240909$20240909$EXP$$IT-MYLANLABS-2024M1081762$MYLAN$Montalto S, Di Filippo M, Capra V, Manzitti C, Sementa AR, De Marco P, et al. Abdominal rhabdoid tumor presenting with symptomatic spinal epidural compression in a newborn. A case report. Front-Pediatr 2023; 11 1-6.$$$N$F$Y$$$20240909$$HP$IT$IT
242977111$24297711$1$I$$20240902$20240909$20240909$EXP$$ES-MYLANLABS-2024M1080501$MYLAN$Mestres Catala C. Improvement of adherence and health status of a young patientwith multiple pathologies through the follow-up service with SPD in a community pharmacy. Community Farms. 2024;16(3):43-48$36$YR$$F$Y$83.3$KG$20240909$$PH$ES$ES
242977121$24297712$1$I$$20240826$20240909$20240909$EXP$$US-ENDO USA, INC.-2024-003330$ENDO$$$$$M$Y$$$20240909$$PH$US$US
242977152$24297715$2$F$20180101$20240912$20240909$20240918$EXP$$ES-MYLANLABS-2024M1080786$MYLAN$Sneyers Closa M, Perez Requena A, Sanchez Garcia S, Sistac Ballar?n J.. Anaesthetic management of thyroid storm in a patient with Friederich?s ataxia. A case report.. Anaesthesiology and Resuscitation. 2023;70(6):362-365$26$YR$$M$Y$$$20240918$$HP$ES$ES
242977162$24297716$2$F$$20240902$20240909$20240912$EXP$$US-MYLANLABS-2024M1081758$MYLAN$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024; 67 (0):$37$YR$$F$Y$$$20240912$$HP$US$US
242977172$24297717$2$F$$20240905$20240909$20240912$EXP$$CA-BAUSCH-BL-2024-013252$BAUSCH AND LOMB$Salter B, Radford J, Berg T, Leber B. The successful management of acute promyelocytic leukemia during pregnancy: a case report. Leukemia and Lymphoma. 2024;65 (4):526-529. doi:10.1080/10428194.2023.2295786$39$YR$$F$Y$$$20240912$$HP$CA$CA
242977191$24297719$1$I$$20240829$20240909$20240909$EXP$$US-BIOCODEX2-2024001231$BIOCODEX$$$$$F$Y$19.8$KG$20240905$$CN$US$US
242977231$24297723$1$I$$20240827$20240909$20240909$30DAY$$CO-PFIZER INC-PV202400113187$PFIZER$$16$YR$$M$Y$$$20240909$$CN$CO$CO
242977262$24297726$2$F$20240828$20240911$20240909$20240917$PER$$US-PFIZER INC-202400247808$PFIZER$$$$$M$Y$$$20240917$$CN$US$US
242977271$24297727$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA259409$SANOFI AVENTIS$$$$C$F$Y$$$20240909$$MD$US$US
242977281$24297728$1$I$$20240904$20240909$20240909$EXP$$CN-SA-2024SA258400$SANOFI AVENTIS$Du R, Geng J, Liu Z, Sui X, Li S, Tang L, Wang Z, Zhang X, et.al.. Neoadjuvant Toripalimab plus Concurrent Chemoradiotherapy in the Locally Advanced Adenocarcinoma of Esophagogastric Junction: A Phase II Trial. International Journal of Radiation Oncology Biology Physics.. 2024;120(2):S48.$$$E$$Y$$$20240909$$HP$CN$CN
242977291$24297729$1$I$20240801$20240826$20240909$20240909$PER$$US-SA-2024SA257807$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240909$$MD$US$US
242977301$24297730$1$I$20240802$20240906$20240909$20240909$EXP$DK-DKMA-30737894$DK-JNJFOC-20240919404$JOHNSON AND JOHNSON$$73$YR$E$F$Y$54.8$KG$20240909$$MD$DK$DK
242977311$24297731$1$I$20240415$20240904$20240909$20240909$EXP$$UY-JNJFOC-20240511329$JOHNSON AND JOHNSON$$56$YR$A$F$Y$99$KG$20240909$$CN$UY$UY
242977321$24297732$1$I$$20240903$20240909$20240909$EXP$$IN-ROCHE-10000073523$ROCHE$$77$YR$E$F$Y$$$20240909$$CN$IN$IN
242977331$24297733$1$I$$20240830$20240909$20240909$EXP$$DE-MYLANLABS-2024M1081392$MYLAN$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.$15$YR$$F$Y$$$20240909$$MD$DE$DE
242977341$24297734$1$I$$20240830$20240909$20240909$EXP$$NO-MYLANLABS-2024M1081416$MYLAN$Reitan Riibe S, Heitmann K, Schjott J, Riedel B. Healthcare professionals^ information need related to antiseizure medication use in breastfeeding patients with epilepsy. Retrospective analysis of enquiries to Norwegian medicines information and pharmacovigilance centers. Epilepsy-Behav-Rep 2023; 24.$3$MON$$$Y$$$20240909$$HP$NO$NO
242977351$24297735$1$I$$20240830$20240909$20240909$EXP$$US-MYLANLABS-2024M1081466$MYLAN$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$55$YR$$F$Y$$$20240909$$MD$US$US
242977361$24297736$1$I$$20240830$20240909$20240909$EXP$$US-MYLANLABS-2024M1081402$MYLAN$Erol LA, Layman CP. Paraneoplastic Hyperthyroidism Secondary to a Chemotherapy-Induced Surge in beta-hCG in a Patient with Non-Seminomatous Germ Cell Tumor. [Review]. Hawaii-J-Health-Soc-Welf 2024; 83 (2): 45-47.$21$YR$$M$Y$$$20240909$$MD$US$US
242977371$24297737$1$I$$20240830$20240909$20240909$EXP$$JP-VIATRISJAPAN-2024M1080359AA$MYLAN$$$$A$M$Y$$$20240909$$MD$JP$JP
242977381$24297738$1$I$$20240830$20240909$20240909$EXP$$US-MYLANLABS-2024M1081454$MYLAN$Blackmon J, Blackmon L, Goode C, Douthit N. Systemic Cobalt Toxicity Secondary to Metal-on-Metal Prosthetic Hip Replacement: a Case Report. J-Gen-Intern-Med 2024; 39 133-137.$58$YR$$M$Y$$$20240909$$MD$US$US
242977391$24297739$1$I$$20240830$20240909$20240909$EXP$$DE-MYLANLABS-2024M1081395$MYLAN$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.$6$YR$$F$Y$$$20240909$$MD$DE$DE
242977401$24297740$1$I$$20240830$20240909$20240909$EXP$$DE-MYLANLABS-2024M1081396$MYLAN$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.$13$YR$$F$Y$$$20240909$$MD$DE$DE
242977411$24297741$1$I$$20240830$20240909$20240909$EXP$$US-MYLANLABS-2024M1081460$MYLAN$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$45$YR$$F$Y$$$20240909$$MD$US$US
242977421$24297742$1$I$$20240830$20240909$20240909$EXP$$US-MYLANLABS-2024M1081421$MYLAN$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$43$YR$$M$Y$$$20240909$$MD$US$US
242977431$24297743$1$I$$20240830$20240909$20240909$EXP$$DE-MYLANLABS-2024M1081438$MYLAN$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.$14$YR$$F$Y$$$20240909$$MD$DE$DE
242977441$24297744$1$I$$20240830$20240909$20240909$EXP$$US-MYLANLABS-2024M1081464$MYLAN$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$44$YR$$M$Y$$$20240909$$MD$US$US
242977451$24297745$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142539$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240909$$CN$US$US
242977461$24297746$1$I$$20240904$20240909$20240909$PER$$US-ABBVIE-5908469$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242977471$24297747$1$I$$20240831$20240909$20240909$PER$$JP-Eisai-EC-2024-173667$EISAI$$76$YR$E$M$Y$$$20240909$$MD$JP$JP
242977481$24297748$1$I$$20240830$20240909$20240909$EXP$$IN-MYLANLABS-2024M1081405$MYLAN$Anandan S, Rajendran SS, Somarajan SA, Udayan A. A Very Rare Side Effect of a Very Commonly Used Drug: Pantoprazole-induced Seizure. J-Assoc-Physicians-India 2024; 72 (8): 89.$69$YR$$F$Y$$$20240909$$MD$IN$IN
242977491$24297749$1$I$$20240830$20240909$20240909$EXP$$US-MYLANLABS-2024M1081439$MYLAN$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$56$YR$$F$Y$$$20240909$$MD$US$US
242977501$24297750$1$I$$20240830$20240909$20240909$EXP$$US-MYLANLABS-2024M1081437$MYLAN$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$84$YR$$F$Y$$$20240909$$MD$US$US
242977511$24297751$1$I$20240801$20240903$20240909$20240909$EXP$$US-AMGEN-USASP2024175620$AMGEN$$$$$M$Y$$$20240909$$CN$US$US
242977522$24297752$2$F$20240904$20240916$20240909$20240923$30DAY$$US-AMGEN-USASP2024177292$AMGEN$$31$YR$A$M$Y$108.9$KG$20240923$$PH$US$US
242977533$24297753$3$F$20240823$20240917$20240909$20240924$30DAY$$US-AMGEN-USASP2024176546$AMGEN$$60$YR$A$F$Y$$$20240924$$HP$US$US
242977541$24297754$1$I$20240201$20240830$20240909$20240909$PER$$US-AMGEN-USASP2024174852$AMGEN$$72$YR$E$F$Y$$$20240909$$CN$US$US
242977551$24297755$1$I$$20240906$20240909$20240909$EXP$GB-MHRA-MED-202408191528579690-FHGPQ$GB-ORGANON-O2409GBR000461$ORGANON$$$$$F$Y$$$20240909$$PH$GB$GB
242977561$24297756$1$I$20240827$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178014$AMGEN$$$$$$Y$$$20240909$$PH$US$US
242977571$24297757$1$I$20240901$20240902$20240909$20240909$EXP$$AR-GSK-AR2024AMR102341$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$CN$AR$AR
242977581$24297758$1$I$$20240827$20240909$20240909$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08577$LUPIN$Rink DE, Abramson RH, Johnson NJ, Lee RY. Diagnostic confounders in brain death a woman with unexplained coma and brainstem areflexia. Annals of the American Thoracic Society. 2024;21(8):1204-1208$60$YR$$F$Y$$$20240909$$MD$US$US
242977591$24297759$1$I$20220312$20240828$20240909$20240909$EXP$$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-08159$HIKMA$$$$$$Y$$$20240909$$MD$DE$DE
242977601$24297760$1$I$20230801$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61776$$FDA-CTU$$56$YR$$F$N$92.3$KG$20240909$N$PH$US$
242977612$24297761$2$F$$20240904$20240909$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409003517$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240912$$CN$US$US
242977621$24297762$1$I$20240817$20240904$20240909$20240909$EXP$$US-BAYER-2024A127707$BAYER$$74$YR$E$M$Y$101.13$KG$20240909$$HP$US$US
242977631$24297763$1$I$$20240828$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408019151$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240909$$CN$US$US
242977641$24297764$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004170$ELI LILLY AND CO$$$$$M$Y$$$20240909$$CN$US$US
242977651$24297765$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003486$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240909$$CN$US$US
242977661$24297766$1$I$$20240828$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202408018005$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$US$US
242977672$24297767$2$F$$20240909$20240909$20240911$30DAY$$US-ELI_LILLY_AND_COMPANY-US202409003516$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240911$$CN$US$US
242977681$24297768$1$I$20240905$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004614$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242977692$24297769$2$F$20240820$20240902$20240909$20240913$EXP$GB-MHRA-MED-202409022234579740-WNRKQ$GB-SA-2024SA258976$SANOFI AVENTIS$$48$YR$A$M$Y$85$KG$20240913$$CN$GB$GB
242977701$24297770$1$I$$20240903$20240909$20240909$PER$$US-ALXN-202409USA000083US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242977711$24297771$1$I$$20240902$20240909$20240909$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-140236$BRISTOL MYERS SQUIBB$Aktas GN, Gundogdu A, Tazegul G, Sari M, Odabasi Z. Nivolumab-induced autoimmune cholestatic hepatitis: a case report. European Journal of Case Reports in Internal Medicine. 2024 Jan 01;11(Supplement 1):763. doi:10.12890/2024_V11Sup1.$53$YR$A$M$Y$$$20240909$$HP$TR$TR
242977731$24297773$1$I$$20240903$20240909$20240909$EXP$$UA-PFIZER INC-202400250380$PFIZER$$30$YR$$M$Y$$$20240909$$CN$UA$UA
242977741$24297774$1$I$20240505$20240904$20240909$20240909$EXP$$DE-PFIZER INC-202400191605$PFIZER$$59$YR$$M$Y$$$20240909$$HP$DE$DE
242977751$24297775$1$I$$20240906$20240906$20240906$DIR$717449$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242977771$24297777$1$I$20240520$20240904$20240909$20240909$EXP$$DE-PFIZER INC-PV202400116487$PFIZER$$65$YR$$M$Y$$$20240909$$MD$DE$DE
242977781$24297778$1$I$20240402$20240830$20240909$20240909$EXP$$CN-PFIZER INC-2024SGN06198$PFIZER$$54$YR$$M$Y$87$KG$20240909$$MD$CN$CN
242977791$24297779$1$I$20240613$20240827$20240909$20240909$PER$$US-SA-2024SA259544$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240909$$CN$US$US
242977801$24297780$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA258835$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240909$$MD$US$US
242977811$24297781$1$I$$20240906$20240906$20240906$DIR$717439$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242977821$24297782$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259326$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240909$$HP$US$US
242977841$24297784$1$I$20240901$20240906$20240906$20240906$DIR$717528$$FDA-CTU$$67$YR$$F$N$82.8$KG$20240906$N$CN$US$
242977851$24297785$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61555$$FDA-CTU$$74$YR$$F$N$$$20240906$N$$US$
242977861$24297786$1$I$$20240906$20240906$20240906$DIR$717466$$FDA-CTU$$46$YR$$M$N$99.9$KG$20240906$Y$$US$
242977871$24297787$1$I$20240904$20240906$20240906$20240906$DIR$717522$$FDA-CTU$$54$YR$$F$N$72$KG$20240906$N$CN$US$
242977891$24297789$1$I$20240801$20240909$20240906$20240906$DIR$FDA-CDER-CTU-2024-61553$$FDA-CTU$$52$YR$$F$N$$$20240909$N$PH$US$
242977912$24297791$2$F$20240903$20240913$20240909$20240919$EXP$$NVSC2024ZA178536$NOVARTIS$$70$YR$$M$Y$$$20240919$$HP$ZA$ZA
242977921$24297792$1$I$$20240902$20240909$20240909$EXP$$NVSC2024IT177445$NOVARTIS$Benevolo G, Bertuglia G, Bringhen S, Maletta F, Bruno B. An atypical presentation of visceral leishmaniasis mimicking multiple myeloma relapse. AM. J. HEMATOL.. 2024;99(1):137-141$79$YR$$M$Y$$$20240909$$HP$IT$IT
242977931$24297793$1$I$$20240724$20240909$20240909$EXP$$US-AUROBINDO-AUR-APL-2024-037881$AUROBINDO$Snowdin JW, Mercuro NJ, Madaio MP, Rawlings SA.. Case report: Successful treatment of OXA-23 Acinetobacter baumannii neurosurgical infection and meningitis with sulbactam-durlobactam combination therapy.. Frontiers in Medicine. 2024;11:111-5, 1381123$75$YR$$F$Y$$$20240909$$HP$US$US
242977941$24297794$1$I$$20240830$20240909$20240909$30DAY$$US-GSK-US2024108476$GLAXOSMITHKLINE$$$$$M$Y$$$20240909$$PH$US$US
242977961$24297796$1$I$20240801$20240828$20240909$20240909$PER$$US-SA-2024SA259239$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240909$$HP$US$US
242977971$24297797$1$I$20230101$20240827$20240909$20240909$EXP$$US-SA-2024SA258848$SANOFI AVENTIS$$63$YR$A$M$Y$87.27$KG$20240909$$MD$US$US
242977991$24297799$1$I$20200101$20240827$20240909$20240909$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08732$LUPIN$Ghezzi L, Levasseur VA, Perantie DC, Wu GF, Cross AH. Extensive rebound MS activity following dimethyl fumarate discontinuation in a 63-year-old-A case report. Neuroimmunology Reports. 2023;3:1-4$63$YR$$F$Y$$$20240909$$HP$US$US
242978001$24297800$1$I$$20230629$20240909$20240909$EXP$$NL-INCYTE CORPORATION-2023IN013842$INCYTE$$$$$$Y$$$20240909$$MD$NL$NL
242978011$24297801$1$I$20240801$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142631$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240909$$CN$US$US
242978021$24297802$1$I$$20240906$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142534$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$78.02$KG$20240909$$MD$US$US
242978031$24297803$1$I$$20230629$20240909$20240909$EXP$$NL-INCYTE CORPORATION-2023IN013841$INCYTE$$$$$$Y$$$20240909$$MD$NL$NL
242978042$24297804$2$F$20240701$20240905$20240909$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139147$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240913$$MD$JP$JP
242978051$24297805$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143021$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240909$$CN$US$US
242978061$24297806$1$I$$20240827$20240909$20240909$EXP$$NVSC2021NL240335$NOVARTIS$$38$YR$$F$Y$$$20240909$$HP$NL$NL
242978071$24297807$1$I$20240101$20240904$20240909$20240909$EXP$$NVSC2024BR179777$NOVARTIS$$2$YR$$M$Y$$$20240909$$CN$BR$BR
242978081$24297808$1$I$$20240831$20240909$20240909$EXP$$BR-ROCHE-10000072028$ROCHE$$64$YR$A$F$Y$$$20240909$$MD$BR$BR
242978091$24297809$1$I$$20240903$20240909$20240909$PER$$US-RDY-SPO/USA/24/0012933$DR REDDYS$$$$$$Y$$$20240909$$HP$US$US
242978101$24297810$1$I$20240801$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61581$$FDA-CTU$$46$YR$$F$N$$$20240906$N$CN$US$
242978111$24297811$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61647$$FDA-CTU$$77$YR$$F$N$77.11$KG$20240906$N$$US$
242978121$24297812$1$I$20240830$20240906$20240906$20240906$DIR$717422$$FDA-CTU$$23$YR$$F$N$$$20240906$N$$US$
242978131$24297813$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61570$$FDA-CTU$$67$YR$$F$N$114.31$KG$20240906$N$$US$
242978151$24297815$1$I$20240828$20240906$20240906$20240906$DIR$717419$$FDA-CTU$$59$YR$$F$N$68$KG$20240906$N$PH$US$
242978161$24297816$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61596$$FDA-CTU$$74$YR$$F$N$65.32$KG$20240905$N$$US$
242978171$24297817$1$I$20240903$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61617$$FDA-CTU$$30$YR$$F$N$$$20240906$N$HP$US$
242978181$24297818$1$I$20240510$20240902$20240909$20240909$EXP$FR-AFSSAPS-TS2024000944$FR-MYLANLABS-2024M1080504$MYLAN$$80$YR$$F$Y$65$KG$20240909$$MD$FR$FR
242978191$24297819$1$I$20240822$20240902$20240909$20240909$EXP$FR-AFSSAPS-BR2024000696$FR-MYLANLABS-2024M1080601$MYLAN$$76$YR$$F$Y$45$KG$20240909$$MD$FR$FR
242978201$24297820$1$I$20240728$20240902$20240909$20240909$EXP$IT-MINISAL02-1000274$IT-MYLANLABS-2024M1080609$MYLAN$$85$YR$$F$Y$$$20240909$$MD$IT$IT
242978211$24297821$1$I$20220428$20240902$20240909$20240909$EXP$$DE-MYLANLABS-2023M1108456$MYLAN$$$$A$F$Y$$$20240909$$CN$DE$DE
242978222$24297822$2$F$20230530$20240902$20240909$20240912$EXP$FR-AFSSAPS-AM2024000677$FR-MYLANLABS-2024M1080518$MYLAN$$91$YR$$F$Y$48$KG$20240912$$MD$FR$FR
242978231$24297823$1$I$$20240903$20240909$20240909$EXP$$CA-AMGEN-CANSP2024178068$AMGEN$Margolin E.; Handzic A.; Wong J. et al.. Giant Cell Arteritis Presenting With Kaleidoscopic Visual Phenomenon. Journal of Neuro-Ophthalmology. 2024;44 (3):e339-e340$82$YR$E$F$Y$$$20240909$$MD$CA$CA
242978241$24297824$1$I$20240720$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178129$AMGEN$$80$YR$E$F$Y$$$20240909$$CN$US$US
242978251$24297825$1$I$$20240828$20240909$20240909$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08211$HIKMA$Zafar SJ, Wynne Z, John T, Buzzalino LG, Shishido AA, Riedel DJ. Zafar SJ, Wynne Z, John T, Buzzalino LG, Shishido AA, Riedel DJ. Cefazolin-induced hemolytic anemia in septic arthritis: A case report.. IDCases. 2024;37:e02057$50$YR$$F$Y$54.4$KG$20240909$$MD$US$US
242978281$24297828$1$I$20240707$20240828$20240909$20240909$EXP$$GB-BEH-2024176970$CSL BEHRING$$14$YR$T$M$Y$65$KG$20240909$$MD$GB$GB
242978291$24297829$1$I$20240801$20240903$20240909$20240909$EXP$$CN-BAYER-2024A126463$BAYER$$33$YR$A$F$Y$$$20240909$$HP$CN$CN
242978301$24297830$1$I$$20240828$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009122$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242978311$24297831$1$I$20240828$20240828$20240909$20240909$PER$$US-ABBVIE-5901906$ABBVIE$$41$YR$$F$Y$$$20240909$$CN$US$US
242978321$24297832$1$I$$20240905$20240909$20240909$EXP$$CN-ROCHE-10000074517$ROCHE$Xiong D, Cai W. Risk factors of HBV reactivation in leukemia patients with resolved HBV infection after allogeneic hematopoietic stem cell transplantation. Clinics and Research in Hepatology and Gastroenterology. 2024-Oct;48 (8): doi:10.1016/j.clinre.2024.102447.$$$$$Y$$$20240909$$HP$CN$CN
242978331$24297833$1$I$$20240826$20240909$20240909$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08079$HIKMA$Peshin S, Modi SK, Burwick N.. Peshin S, Modi SK, Burwick N. Lenalidomide and Dexamethasone in Scleromyxedema: A Case Report of Long-Term Efficacy and Challenges in a 54-Year-Old Patient.. Cureus.. 2024;16(6):e63181$$$$$Y$$$20240909$$MD$US$US
242978341$24297834$1$I$$20240904$20240909$20240909$PER$$US-ALXN-202409USA000281US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242978351$24297835$1$I$$20240828$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009116$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242978361$24297836$1$I$$20240828$20240909$20240909$EXP$$IN-MACLEODS PHARMA-MAC2024049165$MACLEODS$Sood RV, Chauhan AB, Tiwari RR, Kurani MK, Trivedi NR, Bhatt MG..Tissue Necrosis as a Rare Complication of Local Anaesthesia - A Case Series.Annals of Maxillofacial Surgery.2024;14(1):120-123$$$$$Y$$$20240909$$HP$IN$IN
242978371$24297837$1$I$$20240828$20240909$20240909$EXP$$IN-MACLEODS PHARMA-MAC2024049164$MACLEODS$Sood RV, Chauhan AB, Tiwari RR, Kurani MK, Trivedi NR, Bhatt MG..Tissue Necrosis as a Rare Complication of Local Anaesthesia-A Case Series..Annals of Maxillofacial Surgery.01-JAN-2024;14(1):120-123$$$$$Y$$$20240909$$HP$IN$IN
242978381$24297838$1$I$$20240828$20240909$20240909$EXP$$IN-MACLEODS PHARMA-MAC2024049166$MACLEODS$Sood RV, Chauhan AB, Tiwari RR, Kurani MK, Trivedi NR, Bhatt MG..Tissue Necrosis as a Rare Complication of Local Anaesthesia - A Case Series.Annals of Maxillofacial Surgery.2024;14(1):120-123$$$$$Y$$$20240909$$HP$IN$IN
242978391$24297839$1$I$$20240828$20240909$20240909$EXP$$IN-MACLEODS PHARMA-MAC2024049163$MACLEODS$Sood RV, Chauhan AB, Tiwari RR, Kurani MK, Trivedi NR, Bhatt MG..Tissue Necrosis as a Rare Complication of Local Anaesthesia - A Case Series.Annals of Maxillofacial Surgery.01-JAN-2024;14(1):120-123$$$$$Y$$$20240909$$HP$IN$IN
242978401$24297840$1$I$$20240828$20240909$20240909$EXP$$IN-MACLEODS PHARMA-MAC2024049167$MACLEODS$Sood RV, Chauhan AB, Tiwari RR, Kurani MK, Trivedi NR, Bhatt MG.Tissue Necrosis as a Rare Complication of Local Anaesthesia -A Case Series.Annals of Maxillofacial Surgery.2024;14(1):120-123$35$YR$A$F$Y$$$20240909$$HP$IN$IN
242978411$24297841$1$I$$20240828$20240909$20240909$EXP$$IN-MACLEODS PHARMA-MAC2024049168$MACLEODS$Sood RV, Chauhan AB, Tiwari RR, Kurani MK, Trivedi NR, Bhatt MG.Tissue Necrosis as a Rare Complication of Local Anaesthesia - A Case Series.Annals of Maxillofacial Surgery.2024;14(1):120-3$$$$$Y$$$20240909$$HP$IN$IN
242978421$24297842$1$I$$20240828$20240909$20240909$EXP$$IN-MACLEODS PHARMA-MAC2024049169$MACLEODS$Sood RV, Chauhan AB, Tiwari RR, Kurani MK, Trivedi NR, Bhatt MG.Tissue Necrosis as a Rare Complication of Local Anaesthesia-A Case Series..Annals of Maxillofacial Surgery.2024;14(1):120-3$$$$$Y$$$20240909$$HP$IN$IN
242978431$24297843$1$I$$20240828$20240909$20240909$EXP$GB-MHRA-MED-202408261119039190-VFJBS$GB-MACLEODS PHARMA-MAC2024049185$MACLEODS$$$$$$Y$$$20240909$$CN$GB$GB
242978441$24297844$1$I$$20240828$20240909$20240909$EXP$$GB-MACLEODS PHARMA-MAC2024049184$MACLEODS$$$$$$Y$$$20240909$$CN$GB$GB
242978451$24297845$1$I$$20240828$20240909$20240909$EXP$$TR-MACLEODS PHARMA-MAC2024049172$MACLEODS$Balan K, Aydin F, Akdogan N..Acute Localized Exanthematous Pustulosis in a 5-Year-Old Boy With Zosteriform Distrubiton.Cureus.26-JUL-2024;16(7):e65402$$$$$Y$$$20240909$$HP$TR$TR
242978461$24297846$1$I$$20240828$20240909$20240909$EXP$$ZA-MACLEODS PHARMA-MAC2024049190$MACLEODS$$$$$$Y$$$20240909$$CN$ZA$ZA
242978471$24297847$1$I$$20240828$20240909$20240909$EXP$$US-MACLEODS PHARMA-MAC2024049170$MACLEODS$$$$$$Y$$$20240909$$MD$US$US
242978481$24297848$1$I$$20240904$20240909$20240909$EXP$$US-MYLANLABS-2024M1082037$MYLAN$$$$$$Y$$$20240909$$CN$US$US
242978491$24297849$1$I$$20240904$20240909$20240909$EXP$$GB-MYLANLABS-2024M1081934$MYLAN$$$$$F$Y$$$20240909$$CN$GB$GB
242978501$24297850$1$I$$20240831$20240909$20240909$EXP$GB-MHRA-MED-202408311729053580-QJVBY$GB-FDC-2024GBSPO00670$FDC LIMITED$$93$YR$$F$Y$47$KG$20240909$$MD$GB$GB
242978511$24297851$1$I$$20240828$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009105$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242978521$24297852$1$I$$20240904$20240909$20240909$EXP$$US-MYLANLABS-2024M1081942$MYLAN$$$$$M$Y$$$20240909$$CN$US$US
242978531$24297853$1$I$$20240904$20240909$20240909$EXP$$US-MYLANLABS-2024M1081961$MYLAN$$$$$$Y$$$20240909$$CN$US$US
242978542$24297854$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686732$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242978551$24297855$1$I$20240715$20240826$20240909$20240909$EXP$FR-AFSSAPS-LM2024000463$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08055$HIKMA$$78$YR$$M$Y$60$KG$20240909$$MD$FR$FR
242978561$24297856$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202756$ASTRAZENECA$$$$$M$Y$$$20240909$$HP$US$
242978571$24297857$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202551$ASTRAZENECA$$$$$$Y$$$20240909$$CN$US$
242978581$24297858$1$I$$20240830$20240909$20240909$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024108358$VIIV$$$$$M$Y$$$20240909$$MD$US$US
242978593$24297859$3$F$$20240910$20240909$20240920$EXP$$US-GSK-US2024108446$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
242978601$24297860$1$I$20240829$20240830$20240909$20240909$30DAY$$US-GSK-US2024108356$GLAXOSMITHKLINE$$33$YR$$M$Y$$$20240909$$HP$US$US
242978611$24297861$1$I$$20240829$20240909$20240909$EXP$$IT-MACLEODS PHARMA-MAC2024049193$MACLEODS$$$$$$Y$$$20240909$$HP$IT$IT
242978631$24297863$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA258257$SANOFI AVENTIS$$$$$M$Y$$$20240909$$CN$US$US
242978643$24297864$3$F$20240801$20240917$20240909$20240919$EXP$$IT-TAKEDA-2024TUS089434$TAKEDA$$$$$F$Y$$$20240919$$CN$GB$IT
242978651$24297865$1$I$$20240902$20240909$20240909$EXP$$RO-TAKEDA-2024TUS088560$TAKEDA$Rusu, Teodor C, Postolea. What is hiding behind multiple osteolytic lesions. European Journal of Case Reports in Internal Medicine. 2024;11:704$73$YR$$M$Y$$$20240909$$MD$RO$RO
242978661$24297866$1$I$$20240908$20240909$20240909$PER$$US-HALEON-2195823$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
242978672$24297867$2$F$$20240904$20240909$20240918$30DAY$$GR-PFIZER INC-PV202400116601$PFIZER$$12$YR$$M$Y$30$KG$20240918$$CN$GR$GR
242978682$24297868$2$F$20240828$20240903$20240909$20240912$30DAY$$KR-PFIZER INC-202400251991$PFIZER$$11$YR$$$Y$$$20240912$$CN$KR$KR
242978691$24297869$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142559$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$67.13$KG$20240909$$CN$US$US
242978702$24297870$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686734$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242978722$24297872$2$F$20240902$20240906$20240909$20240912$30DAY$$GR-PFIZER INC-PV202400115927$PFIZER$$7$YR$$M$Y$$$20240912$$HP$GR$GR
242978741$24297874$1$I$20240822$20240905$20240909$20240909$PER$$US-AMGEN-USASL2024178239$AMGEN$$$$$$Y$$$20240909$$CN$US$US
242978761$24297876$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178969$AMGEN$$$$$$Y$$$20240909$$PH$US$US
242978771$24297877$1$I$20240701$20240904$20240909$20240909$EXP$$DE-BAYER-2024A126837$BAYER$$34$YR$A$F$Y$$$20240909$$CN$DE$DE
242978781$24297878$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61677$$FDA-CTU$$63$YR$$F$N$100.24$KG$20240906$N$$US$
242978791$24297879$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61690$$FDA-CTU$$46$YR$$F$N$$$20240906$N$$US$
242978811$24297881$1$I$$20240903$20240909$20240909$EXP$$ZA-BAYER-2024A126223$BAYER$$36$YR$A$F$Y$$$20240909$$CN$ZA$ZA
242978822$24297882$2$F$$20240905$20240909$20240910$PER$$US-BIOVITRUM-2024-US-011729$BIOVITRUM$$65$YR$$F$Y$$$20240910$$CN$US$US
242978831$24297883$1$I$20240601$20240830$20240909$20240909$EXP$$VN-ROCHE-10000072365$ROCHE$$62$YR$A$M$Y$$$20240909$$MD$VN$VN
242978841$24297884$1$I$20240507$20240827$20240909$20240909$EXP$GB-MHRA-MED-202408221012306470-JGQBH$GB-SAMSUNG BIOEPIS-SB-2024-26085$SAMSUNG BIOEPIS$$60$YR$A$F$Y$$$20240909$$HP$GB$GB
242978851$24297885$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61622$$FDA-CTU$$56$YR$$F$N$$$20240906$N$$US$
242978861$24297886$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61559$$FDA-CTU$$67$YR$$F$N$$$20240906$N$$US$
242978871$24297887$1$I$$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61532$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
242978882$24297888$2$F$20240724$20240911$20240909$20240913$EXP$$AT-BIOVITRUM-2024-AT-011741$BIOVITRUM$$61$YR$$F$Y$$$20240913$$MD$AT$AT
242978891$24297889$1$I$$20240830$20240909$20240909$EXP$$US-EMD Serono-2024047070$EMD SERONO INC$$$$E$F$Y$$$20240909$$CN$US$US
242978901$24297890$1$I$20240815$20240830$20240909$20240909$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024108493$VIIV$$$$$$Y$$$20240909$$CN$US$US
242978912$24297891$2$F$$20240910$20240909$20240917$EXP$$CA-TAKEDA-2024TUS086315$TAKEDA$$$$$M$Y$$$20240917$$CN$CA$CA
242978921$24297892$1$I$$20240821$20240909$20240909$PER$$US-TEVA-VS-3235891$TEVA$$$$$$Y$$$20240909$$CN$US$US
242978931$24297893$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003729$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240909$$CN$US$US
242978941$24297894$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61631$$FDA-CTU$$69$YR$$F$N$63.5$KG$20240906$N$$US$
242978951$24297895$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004535$ELI LILLY AND CO$$$$A$F$Y$$$20240909$$CN$US$US
242978961$24297896$1$I$$20240823$20240909$20240909$PER$$US-SA-2024SA259345$SANOFI AVENTIS$$$$E$M$Y$$$20240909$$MD$US$US
242978982$24297898$2$F$20240101$20240906$20240909$20240913$PER$$US-SA-2024SA255623$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240913$$MD$US$US
242978991$24297899$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA259147$SANOFI AVENTIS$$$$A$M$Y$$$20240909$$MD$US$US
242979001$24297900$1$I$20240401$20240826$20240909$20240909$PER$$US-SA-2024SA258872$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240909$$MD$US$US
242979011$24297901$1$I$$20240902$20240909$20240909$EXP$$ES-TAKEDA-2024TUS089160$TAKEDA$Abinzano Guillen ML, Goni Abinzano N, Martinez Velasco MC, Jarne Betran V, Arteaga Mazuelas M, Badiola Urquiaga L. Old drugs are still effective and useful. European Journal of Case Reports in Internal Medicine. 2024;11 (1):986$84$YR$$F$Y$$$20240909$$HP$ES$ES
242979031$24297903$1$I$$20240905$20240909$20240909$PER$$US-HALEON-2195764$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
242979041$24297904$1$I$$20240727$20240909$20240909$PER$$US-LUNDBECK-DKLU4002371$LUNDBECK$$$$$$Y$$$20240909$$HP$US$US
242979051$24297905$1$I$$20240826$20240909$20240909$PER$$US-Aarkish Pharmaceuticals NJ Inc.-2161379$Aarkish Pharmaceuticals$$$$$$Y$$$20240909$$$US$US
242979061$24297906$1$I$20240819$20240904$20240909$20240909$EXP$$US-BAYER-2024A127392$BAYER$$16$YR$T$M$Y$$$20240909$$CN$US$US
242979101$24297910$1$I$20240825$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61576$$FDA-CTU$$79$YR$$F$N$$$20240906$N$HP$US$
242979111$24297911$1$I$$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61552$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
242979151$24297915$1$I$20240824$20240828$20240909$20240909$PER$$US-ROCHE-10000069318$ROCHE$$72$YR$E$F$Y$$$20240909$$CN$US$US
242979162$24297916$2$F$20240829$20240909$20240909$20240913$EXP$$US-BAUSCH-BL-2024-013326$BAUSCH AND LOMB$$42$YR$$F$Y$$$20240913$$CN$US$US
242979171$24297917$1$I$$20240907$20240909$20240909$EXP$$BE-BAUSCH-BL-2024-013384$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240909$$MD$BE$BE
242979181$24297918$1$I$$20240907$20240909$20240909$PER$$US-HALEON-2195846$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
242979191$24297919$1$I$20230520$20240907$20240909$20240909$EXP$FR-AFSSAPS-AM2024000710$FR-BAUSCH-BL-2024-013381$BAUSCH AND LOMB$$71$YR$$F$Y$62$KG$20240909$$MD$FR$FR
242979201$24297920$1$I$$20240905$20240909$20240909$PER$$US-ABBVIE-5914769$ABBVIE$$$$A$F$Y$$$20240909$$HP$US$US
242979211$24297921$1$I$20240731$20240902$20240909$20240909$EXP$$TW-VIIV HEALTHCARE LIMITED-TW2024APC108852$VIIV$$$$$$Y$$$20240909$$MD$TW$TW
242979221$24297922$1$I$$20240829$20240909$20240909$EXP$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14652$DE-TORRENT-00027246$TORRENT$$39$YR$A$F$Y$$$20240909$$HP$DE$DE
242979231$24297923$1$I$$20240829$20240909$20240909$EXP$GB-MHRA-MED-202408292033091690-TLCWP$GB-TORRENT-00037788$TORRENT$$76$YR$E$F$Y$76$KG$20240909$$CN$GB$GB
242979241$24297924$1$I$20240831$20240831$20240909$20240909$EXP$GB-MHRA-MED-202408311227243100-VLNGH$GB-TORRENT-00037805$TORRENT$$40$YR$A$M$Y$82$KG$20240909$$MD$GB$GB
242979251$24297925$1$I$$20240903$20240909$20240909$EXP$$NVSC2024AU178223$NOVARTIS$$73$YR$$F$Y$$$20240909$$MD$AU$AU
242979261$24297926$1$I$$20240829$20240909$20240909$EXP$$US-TORRENT-00013739$TORRENT$$54$YR$A$M$Y$$$20240909$$HP$US$US
242979271$24297927$1$I$$20240830$20240909$20240909$EXP$$IN-TORRENT-00003652$TORRENT$$50$YR$A$M$Y$$$20240909$$MD$IN$IN
242979281$24297928$1$I$$20240905$20240909$20240909$EXP$$NVSC2024HR179692$NOVARTIS$$$$A$F$Y$$$20240909$$MD$HR$HR
242979291$24297929$1$I$$20240905$20240909$20240909$EXP$$AU-MYLANLABS-2024M1081632$MYLAN$$$$$M$Y$$$20240909$$HP$AU$AU
242979311$24297931$1$I$$20240905$20240909$20240909$EXP$GB-MHRA-MED-202409051142525450-WZVKS$GB-MYLANLABS-2024M1081715$MYLAN$$$$$M$Y$$$20240909$$CN$GB$GB
242979321$24297932$1$I$$20240905$20240909$20240909$EXP$GB-MHRA-MED-202409051047363520-LJFDC$GB-MYLANLABS-2024M1081697$MYLAN$$$$$$Y$65$KG$20240909$$CN$GB$GB
242979331$24297933$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61694$$FDA-CTU$$19$YR$$F$N$78.93$KG$20240906$N$$US$
242979341$24297934$1$I$20230410$20240905$20240909$20240909$EXP$$GB-MYLANLABS-2024M1081748$MYLAN$$68$YR$$F$Y$69$KG$20240909$$HP$GB$GB
242979351$24297935$1$I$$20240905$20240909$20240909$EXP$$AU-MYLANLABS-2024M1081789$MYLAN$$$$$F$Y$$$20240909$$PH$AU$AU
242979361$24297936$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61684$$FDA-CTU$$63$YR$$M$N$$$20240906$N$$US$
242979371$24297937$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61557$$FDA-CTU$$28$YR$$F$N$69.4$KG$20240906$N$$US$
242979381$24297938$1$I$20240829$20240905$20240909$20240909$EXP$$GB-MYLANLABS-2024M1081799$MYLAN$$50$YR$$F$Y$93$KG$20240909$$HP$GB$GB
242979391$24297939$1$I$20240708$20240905$20240909$20240909$EXP$$GB-MYLANLABS-2024M1064532$MYLAN$$$$$F$Y$$$20240909$$CN$GB$GB
242979401$24297940$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61560$$FDA-CTU$$11$YR$$M$N$37.19$KG$20240906$N$$US$
242979411$24297941$1$I$$20240903$20240909$20240909$30DAY$$GB-PFIZER INC-PV202400115355$PFIZER$$11$YR$$M$Y$$$20240909$$CN$GB$GB
242979421$24297942$1$I$$20240904$20240909$20240909$EXP$$US-AMGEN-USASP2024178224$AMGEN$Khadka S.; Dong N.; Chavez J.. Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CUP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Single-Center Experience. Clinical Lymphoma, Myeloma + Leukemia. 2024;24:S480$$$$$Y$$$20240909$$MD$US$US
242979431$24297943$1$I$$20240827$20240909$20240909$EXP$GB-MHRA-MED-202408271444016470-FSJRW$GB-Axellia-005343$XELLIA PHARMACEUTICALS$$89$DY$I$$Y$$$20240909$$CN$GB$GB
242979451$24297945$1$I$$20240905$20240909$20240909$EXP$$US-ROCHE-10000012051$ROCHE$$75$YR$E$F$Y$$$20240909$$MD$US$US
242979461$24297946$1$I$$20240830$20240909$20240909$EXP$$JP-ASTELLAS-2024-AER-003564$ASTELLAS$$84$YR$E$M$Y$$$20240909$$PH$JP$JP
242979471$24297947$1$I$20240815$20240829$20240909$20240909$PER$$US-JNJFOC-20240878064$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240909$$CN$US$US
242979482$24297948$2$F$20240831$20240911$20240909$20240918$EXP$$NVSC2024US179938$NOVARTIS$$0$YR$$M$Y$4.7$KG$20240918$$HP$US$US
242979491$24297949$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180086$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
242979501$24297950$1$I$$20240902$20240909$20240909$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08273$HIKMA$$58$YR$$M$Y$110$KG$20240909$$HP$CA$CA
242979521$24297952$1$I$$20240822$20240909$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08471$LUPIN$$$$$$Y$$$20240909$$CN$US$US
242979531$24297953$1$I$$20240830$20240909$20240909$30DAY$$GB-PFIZER INC-202400248411$PFIZER$$$$$$Y$$$20240909$$HP$GB$GB
242979542$24297954$2$F$20240905$20240909$20240909$20240911$PER$$US-AMGEN-USASP2024178574$AMGEN$$80$YR$E$M$Y$$$20240910$$CN$US$US
242979551$24297955$1$I$$20240906$20240909$20240909$EXP$$US-BAYER-2024A128142$BAYER$$74$YR$E$M$Y$$$20240909$$MD$US$US
242979611$24297961$1$I$20240815$20240829$20240909$20240909$EXP$$BR-ROCHE-10000074221$ROCHE$$54$YR$A$M$Y$60$KG$20240909$$MD$BR$BR
242979621$24297962$1$I$$20240903$20240909$20240909$EXP$$US-MYLANLABS-2024M1081712$MYLAN$$$$$F$Y$$$20240909$$CN$US$US
242979631$24297963$1$I$$20240830$20240909$20240909$PER$$US-ROCHE-10000071334$ROCHE$$$$E$F$Y$$$20240909$$CN$US$US
242979641$24297964$1$I$20240905$20240905$20240909$20240909$EXP$$PK-ROCHE-10000074987$ROCHE$$45$YR$A$M$Y$$$20240909$$CN$PK$PK
242979652$24297965$2$F$$20240903$20240909$20240909$EXP$$US-AMGEN-USASP2024177116$AMGEN$Jabbour E.; Short N.; Jain N. et al.. Very Promising Results of the Dose Dense (D-D) Mini-Hyper-CVD-Inotuzumab-Blinatumomab Phase 2 Trial in Patients with Relapsed-Refractory Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S284-S285$$$A$$Y$$$20240909$$MD$US$US
242979661$24297966$1$I$$20240902$20240909$20240909$EXP$$US-CHEPLA-2024011450$CHEPLAPHARM$Au-Yeung N M, Regennitter N S, Stepherson J, et al. Folate Deficiency and Medication-Induced Severe Pancytopenia in a Bilateral Lung Transplantee. Cureus. 2024;16(7): e65780. doi:10.7759/cureus.65780.$74$YR$$M$Y$$$20240909$$HP$COUNTRY NOT SPECIFIED$US
242979671$24297967$1$I$$20240903$20240909$20240909$EXP$$JP-AMGEN-JPNSP2024176296$AMGEN$$$$$$Y$$$20240909$$MD$JP$JP
242979682$24297968$2$F$$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024178211$AMGEN$Khadka S.; Dong N.; Chavez J. et.al. Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CUP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Single-Center Experience. Clinical Lymphoma Clinical Lymphoma. 2024;24:S480$$$$$Y$$$20240909$$MD$US$US
242979692$24297969$2$F$$20240912$20240909$20240919$EXP$$GR-MYLANLABS-2024M1081627$MYLAN$A. Koutsovassilis, L. Lanaras. Clinical Examples Diagnostic + Pharmaceutical Interventions in Ischemic stroke with and without  Atrial Fibrillation. 17th Panhellenic congress on cardiometabolic risk factors. 2024$56$YR$$M$Y$$$20240919$$MD$GR$GR
242979701$24297970$1$I$$20240905$20240909$20240909$PER$$US-ALXN-202409USA000355US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242979713$24297971$3$F$$20240919$20240909$20240925$EXP$$AU-PFIZER INC-202400250723$PFIZER$$$$$F$Y$$$20240925$$CN$AU$AU
242979722$24297972$2$F$20240904$20240909$20240909$20240916$EXP$$US-BAYER-2024A128353$BAYER$$54$YR$A$F$Y$77.098$KG$20240916$$HP$US$US
242979731$24297973$1$I$20240701$20240902$20240909$20240909$EXP$$JP-009507513-2409JPN000358J$MERCK$$$$E$$Y$$$20240909$$MD$JP$JP
242979741$24297974$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61526$$FDA-CTU$$76$YR$$M$N$112.5$KG$20240906$Y$CN$US$
242979751$24297975$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61663$$FDA-CTU$$60$YR$$F$N$$$20240906$N$$US$
242979771$24297977$1$I$20240819$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61580$$FDA-CTU$$90$YR$$M$N$$$20240906$N$HP$US$
242979781$24297978$1$I$20240807$20240809$20240906$20240906$DIR$FDA-CDER-CTU-2024-61549$$FDA-CTU$$91$YR$$M$N$$$20240809$N$HP$US$
242979801$24297980$1$I$20240717$20240902$20240909$20240909$EXP$FR-AFSSAPS-RN2024000912$FR-ROCHE-10000071667$ROCHE$$86$YR$E$M$Y$$$20240909$$MD$FR$FR
242979811$24297981$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61604$$FDA-CTU$$74$YR$$F$N$$$20240906$N$$US$
242979841$24297984$1$I$$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61545$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
242979851$24297985$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61565$$FDA-CTU$$$$$F$N$$$20240905$N$HP$US$
242979861$24297986$1$I$20240801$20240904$20240909$20240909$EXP$$US-ROCHE-10000074334$ROCHE$$90$YR$E$F$Y$$$20240909$$CN$US$US
242979871$24297987$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142946$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240909$$CN$US$US
242979881$24297988$1$I$$20240904$20240909$20240909$EXP$$EG-PFIZER INC-PV202400116008$PFIZER$$$$$$Y$$$20240909$$HP$EG$EG
242979891$24297989$1$I$20230801$20240903$20240909$20240909$EXP$$TR-PFIZER INC-202400249928$PFIZER$$75$YR$$F$Y$$$20240909$$MD$TR$TR
242979901$24297990$1$I$$20240904$20240909$20240909$EXP$$CA-PFIZER INC-202400250716$PFIZER$$$$$M$Y$$$20240909$$CN$CA$CA
242979921$24297992$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259549$SANOFI AVENTIS$$$$A$F$Y$$$20240909$$MD$US$US
242979931$24297993$1$I$$20240903$20240909$20240909$EXP$$CA-PFIZER INC-202400249274$PFIZER$$75$YR$$F$Y$$$20240909$$HP$CA$CA
242979943$24297994$3$F$20240101$20240912$20240909$20240920$PER$$US-SA-2024SA258884$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240920$$MD$US$US
242979951$24297995$1$I$20240501$20240824$20240909$20240909$PER$$US-SA-2024SA259452$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240909$$HP$US$US
242979961$24297996$1$I$20240204$20240904$20240909$20240909$EXP$$IT-PFIZER INC-202400249639$PFIZER$$64$YR$$F$Y$41$KG$20240909$$HP$IT$IT
242979971$24297997$1$I$20231015$20240826$20240909$20240909$PER$$US-SA-2024SA260503$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240909$$MD$US$US
242979981$24297998$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA259365$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240909$$MD$US$US
242979991$24297999$1$I$20240701$20240826$20240909$20240909$PER$$US-SA-2024SA259372$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240909$$HP$US$US
242980001$24298000$1$I$$20240821$20240909$20240909$PER$$US-SA-2024SA257156$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240909$$CN$US$US
242980011$24298001$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259476$SANOFI AVENTIS$$$$$F$Y$$$20240909$$CN$US$US
242980021$24298002$1$I$$20240117$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US006556$SANDOZ$$$$$F$Y$$$20240909$$CN$US$US
242980041$24298004$1$I$$20240827$20240909$20240909$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-26342$SAMSUNG BIOEPIS$$74$YR$E$F$Y$$$20240909$$CN$GB$GB
242980061$24298006$1$I$$20240822$20240909$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08472$LUPIN$$$$$$Y$$$20240909$$CN$US$US
242980072$24298007$2$F$20240801$20240918$20240909$20240925$EXP$$GB-AMGEN-GBRSP2024178301$AMGEN$$75$YR$E$M$Y$$$20240925$$CN$GB$GB
242980081$24298008$1$I$$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024179457$AMGEN$$$$$M$Y$$$20240909$$HP$US$US
242980091$24298009$1$I$$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024177561$AMGEN$$$$$$Y$$$20240909$$HP$US$US
242980101$24298010$1$I$$20240904$20240909$20240909$EXP$$PL-AstraZeneca-2024A204197$ASTRAZENECA$$$$$M$Y$$$20240909$$MD$PL$
242980111$24298011$1$I$$20240905$20240909$20240909$PER$$US-ROCHE-10000076559$ROCHE$$$$$$Y$$$20240909$$CN$US$US
242980131$24298013$1$I$$20240830$20240909$20240909$EXP$$US-ARGENX-2024-ARGX-US007334$ARGENX BVBA$$$$$$Y$$$20240909$$CN$US$US
242980141$24298014$1$I$20240815$20240827$20240909$20240909$EXP$IT-MINISAL02-999575$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-08074$HIKMA$$82$YR$$M$Y$$$20240909$$MD$IT$IT
242980151$24298015$1$I$20240422$20240903$20240909$20240909$EXP$FR-AFSSAPS-NT2024001071$FR-MYLANLABS-2024M1080897$MYLAN$$63$YR$$F$Y$67$KG$20240909$$PH$FR$FR
242980161$24298016$1$I$20240101$20240905$20240909$20240909$PER$$US-BIOGEN-2024BI01281481$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
242980171$24298017$1$I$20240830$20240905$20240909$20240909$PER$$US-BIOGEN-2024BI01281439$BIOGEN$$39$YR$$F$Y$$$20240909$$CN$US$US
242980181$24298018$1$I$$20240903$20240909$20240909$EXP$$US-AstraZeneca-2024A200737$ASTRAZENECA$$$$E$M$Y$81$KG$20240909$$CN$US$
242980201$24298020$1$I$$20240903$20240909$20240909$PER$$US-LEO Pharma-373301$LEO PHARM$$24$YR$$M$Y$$$20240909$$PH$US$US
242980212$24298021$2$F$20240827$20240905$20240909$20240916$EXP$$US-BEH-2024178295$CSL BEHRING$$50$YR$A$M$Y$$$20240916$$HP$US$US
242980221$24298022$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003603$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240909$$CN$US$US
242980231$24298023$1$I$20240905$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003519$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240909$$CN$US$US
242980242$24298024$2$F$$20240826$20240909$20240913$PER$$US-SA-2024SA259575$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240913$$MD$US$US
242980251$24298025$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259809$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240909$$HP$US$US
242980261$24298026$1$I$$20240829$20240909$20240909$PER$$US-SA-2024SA259111$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240909$$CN$US$US
242980272$24298027$2$F$20240831$20240926$20240909$20240927$EXP$$US-ROCHE-10000075285$ROCHE$$27$YR$A$M$Y$83.9$KG$20240927$$CN$US$US
242980281$24298028$1$I$$20240904$20240909$20240909$EXP$$CA-AstraZeneca-2024A173806$ASTRAZENECA$$$$$F$Y$$$20240909$$MD$CA$
242980291$24298029$1$I$20200525$20240906$20240909$20240909$EXP$PL-URPL-1-2116-2020$PL-ROCHE-10000075535$ROCHE$$60$YR$A$$Y$68$KG$20240909$$MD$PL$PL
242980311$24298031$1$I$$20240905$20240909$20240909$EXP$$DE-MYLANLABS-2024M1081508$MYLAN$$$$$M$Y$$$20240909$$MD$DE$DE
242980321$24298032$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142531$BRISTOL MYERS SQUIBB$$25$YR$A$F$Y$$$20240909$$CN$US$US
242980331$24298033$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142821$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$74.39$KG$20240909$$CN$US$US
242980341$24298034$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142119$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240909$$CN$US$US
242980351$24298035$1$I$$20240828$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142565$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240909$$HP$US$US
242980371$24298037$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142552$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$84$KG$20240909$$PH$US$US
242980381$24298038$1$I$$20240904$20240909$20240909$EXP$$VN-AstraZeneca-2024A202907$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$VN$
242980391$24298039$1$I$$20240813$20240909$20240909$30DAY$$US-Kaleo, Inc.-2024KL000033$KALEO$$5$YR$C$F$Y$$$20240906$$CN$US$US
242980401$24298040$1$I$$20240607$20240909$20240909$PER$$US-SCIEGENP-2024SCSPO00352$SCIEGEN$$$$$$Y$$$20240830$$CN$US$US
242980412$24298041$2$F$20220603$20240909$20240909$20240913$EXP$$US-009507513-2408USA009214$MERCK$$$$A$$Y$$$20240913$$MD$US$US
242980421$24298042$1$I$$20240828$20240909$20240909$EXP$$IR-SCIEGENP-2024SCLIT00363$SCIEGEN$MEHDIPOUR DALIVAND et al..Hypokalemic quadriplegia in Sjogren^s syndrome: A case report.Clinical Case Reports.2024;12 (8):1-5$38$YR$A$F$Y$$$20240909$$HP$IR$IR
242980431$24298043$1$I$20240808$20240902$20240909$20240909$EXP$$BR-TAKEDA-2024TUS088033$TAKEDA$$74$YR$$M$Y$$$20240909$$CN$BR$BR
242980441$24298044$1$I$$20240905$20240909$20240909$PER$$US-ABBVIE-5909996$ABBVIE$$$$$$Y$$$20240909$$HP$US$US
242980452$24298045$2$F$20240827$20240909$20240909$20240917$EXP$$CA-AKCEA THERAPEUTICS, INC.-2024IS006409$AKCEA THERAPEUTICS$$$$$$Y$$$20240917$$CN$CA$CA
242980461$24298046$1$I$$20240826$20240909$20240909$EXP$$US-UCBSA-2024043857$UCB$$$$$$Y$$$20240909$$CN$US$US
242980471$24298047$1$I$$20240903$20240909$20240909$EXP$$JP-AstraZeneca-2024A200948$ASTRAZENECA$$49$YR$$F$Y$$$20240909$$MD$JP$
242980481$24298048$1$I$20240731$20240905$20240909$20240909$EXP$DE-BFARM-24006087$DE-PFIZER INC-202400250453$PFIZER$$15$YR$$F$Y$70$KG$20240909$$MD$DE$DE
242980491$24298049$1$I$20240122$20240904$20240909$20240909$EXP$$IN-PFIZER INC-PV202300202225$PFIZER$$66$YR$$M$Y$$$20240909$$CN$IN$IN
242980501$24298050$1$I$$20240904$20240909$20240909$EXP$$CA-PFIZER INC-202400250785$PFIZER$$$$$M$Y$$$20240909$$CN$CA$CA
242980511$24298051$1$I$$20240822$20240909$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08473$LUPIN$$$$$$Y$$$20240909$$CN$US$US
242980541$24298054$1$I$20240822$20240905$20240909$20240909$EXP$$CN-PFIZER INC-PV202400116789$PFIZER$$86$YR$$M$Y$65$KG$20240909$$HP$CN$CN
242980551$24298055$1$I$20240101$20240904$20240909$20240909$EXP$$CA-PFIZER INC-202300450885$PFIZER$$63$YR$$M$Y$$$20240909$$MD$CA$CA
242980561$24298056$1$I$20240101$20240904$20240909$20240909$EXP$$CA-PFIZER INC-202400214411$PFIZER$$44$YR$$M$Y$138$KG$20240909$$HP$CA$CA
242980571$24298057$1$I$20230821$20240904$20240909$20240909$EXP$$KR-009507513-2409KOR001034$MERCK$$$$$F$Y$$$20240909$$HP$KR$KR
242980581$24298058$1$I$$20240828$20240909$20240909$EXP$$IT-Eywa Pharma Inc.-2161380$EYWA PHARMA$Full text$53$YR$$M$Y$$$20240909$$$IT$IT
242980601$24298060$1$I$20240827$20240906$20240909$20240909$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050126$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$82.9$KG$20240909$$PH$JP$JP
242980611$24298061$1$I$$20240830$20240909$20240909$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004485$BLUEPRINT MEDICINES$$$$$$Y$$$20240906$$CN$US$US
242980621$24298062$1$I$$20240607$20240909$20240909$PER$$US-BIOCON-BCN-2024-000109$BIOCON$$$$$$Y$$$20240909$$CN$US$US
242980631$24298063$1$I$20240722$20240722$20240909$20240909$PER$$US-BIOCON-BCN-2024-000141$BIOCON$$64$YR$E$M$Y$78.02$KG$20240909$$CN$US$US
242980641$24298064$1$I$20230701$20231218$20240909$20240909$PER$$US-BIOCON-BCN-2023-021295$BIOCON$$66$YR$E$M$Y$88$KG$20240909$$CN$US$US
242980651$24298065$1$I$$20240904$20240909$20240909$EXP$$US-ALXN-202409USA000171US$ALEXION PHARMACEUTICALS$$57$YR$$F$Y$$$20240909$$CN$US$US
242980661$24298066$1$I$$20240815$20240909$20240909$PER$$US-BIOCON-BCN-2024-000166$BIOCON$$63$YR$A$M$Y$$$20240909$$CN$US$US
242980671$24298067$1$I$$20240404$20240909$20240909$PER$$US-BIOCON-BCN-2024-000054$BIOCON$$60$YR$A$M$Y$$$20240909$$CN$US$US
242980682$24298068$2$F$$20240920$20240909$20240926$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-26347$SAMSUNG BIOEPIS$$$$$F$Y$$$20240926$$CN$GB$GB
242980691$24298069$1$I$20240701$20240826$20240909$20240909$EXP$$FR-SAMSUNG BIOEPIS-SB-2024-26196$SAMSUNG BIOEPIS$$37$YR$A$F$Y$$$20240909$$PH$FR$FR
242980701$24298070$1$I$20240824$20240903$20240909$20240909$EXP$FR-AFSSAPS-TO2024001663$FR-MYLANLABS-2024M1080805$MYLAN$$24$YR$$M$Y$$$20240909$$PH$FR$FR
242980711$24298071$1$I$$20240903$20240909$20240909$EXP$$GB-MYLANLABS-2024M1081525$MYLAN$$$$$F$Y$$$20240909$$MD$GB$GB
242980721$24298072$1$I$20240831$20240903$20240909$20240909$PER$$US-Eisai-EC-2024-173648$EISAI$$64$YR$A$M$Y$83$KG$20240909$$CN$US$US
242980731$24298073$1$I$$20240903$20240909$20240909$EXP$$IT-MYLANLABS-2024M1081211$MYLAN$$$$$M$Y$$$20240909$$CN$IT$IT
242980751$24298075$1$I$$20240828$20240909$20240909$EXP$$US-UCBSA-2024044565$UCB$$$$$M$Y$88.6$KG$20240909$$CN$US$US
242980761$24298076$1$I$$20240408$20240909$20240909$PER$$US-BIOCON-BCN-2024-000061$BIOCON$$$$$$Y$$$20240909$$CN$US$US
242980771$24298077$1$I$$20240903$20240909$20240909$EXP$NL-LRB-00999843$NL-MYLANLABS-2024M1080889$MYLAN$$70$YR$$M$Y$83$KG$20240909$$CN$NL$NL
242980781$24298078$1$I$20240101$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178042$AMGEN$$65$YR$E$F$Y$$$20240909$$CN$US$US
242980811$24298081$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61681$$FDA-CTU$$$$$F$N$$$20240906$N$HP$US$
242980821$24298082$1$I$$20240903$20240906$20240906$DIR$FDA-CDER-CTU-2024-61649$$FDA-CTU$$$$$M$N$$$20240903$N$HP$US$
242980831$24298083$1$I$$20240906$20240906$20240906$DIR$717418$$FDA-CTU$$$$$UNK$N$$$20240906$N$$US$
242980851$24298085$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61688$$FDA-CTU$$$$$F$N$$$20240906$N$HP$US$
242980871$24298087$1$I$$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61644$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
242980891$24298089$1$I$$20240528$20240909$20240909$PER$$US-BIOCON-BCN-2024-000092$BIOCON$$63$YR$E$F$Y$101.15$KG$20240909$$CN$US$US
242980901$24298090$1$I$$20240214$20240909$20240909$PER$$US-BIOCON-BCN-2024-000027$BIOCON$$73$YR$E$F$Y$$$20240909$$HP$US$US
242980921$24298092$1$I$20240701$20240726$20240909$20240909$PER$$US-BIOCON-BCN-2024-000148$BIOCON$$70$YR$E$F$Y$$$20240909$$CN$US$US
242980931$24298093$1$I$$20240215$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US018763$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242980941$24298094$1$I$20220608$20240905$20240909$20240909$EXP$$ES-PFIZER INC-202400250463$PFIZER$$76$YR$$M$Y$85.6$KG$20240909$$MD$ES$ES
242980951$24298095$1$I$20240802$20240905$20240909$20240909$EXP$FR-AFSSAPS-PA2024001508$FR-PFIZER INC-202400250496$PFIZER$$48$YR$$M$Y$$$20240909$$MD$FR$FR
242980961$24298096$1$I$20221128$20240905$20240909$20240909$EXP$FR-AFSSAPS-PC2024000682$FR-PFIZER INC-202400250509$PFIZER$$52$YR$$F$Y$83$KG$20240909$$PH$FR$FR
242980971$24298097$1$I$$20240905$20240909$20240909$EXP$$US-PFIZER INC-202400251300$PFIZER$$$$$M$Y$$$20240909$$CN$US$US
242980981$24298098$1$I$20240829$20240905$20240909$20240909$EXP$$CN-PFIZER INC-PV202400116744$PFIZER$$78$YR$$F$Y$40.5$KG$20240909$$HP$CN$CN
242981001$24298100$1$I$20240822$20240905$20240909$20240909$EXP$$CN-PFIZER INC-PV202400116754$PFIZER$$83$YR$$M$Y$75$KG$20240909$$HP$CN$CN
242981011$24298101$1$I$20240822$20240905$20240909$20240909$EXP$FR-AFSSAPS-PB2024000958$FR-PFIZER INC-202400250506$PFIZER$$67$YR$$F$Y$$$20240909$$MD$FR$FR
242981021$24298102$1$I$20240501$20240905$20240909$20240909$EXP$$US-PFIZER INC-PV202400117120$PFIZER$$67$YR$$M$Y$$$20240909$$HP$US$US
242981041$24298104$1$I$20240718$20240909$20240909$20240909$EXP$FR-AFSSAPS-CN2024000807$NVSC2024FR179918$NOVARTIS$$71$YR$$M$Y$92$KG$20240909$$MD$FR$FR
242981051$24298105$1$I$$20240903$20240909$20240909$EXP$$AE-STEMLINE THERAPEUTICS B.V.-2024-STML-AE004723$PAREXEL$$$$$$Y$$$20240909$$HP$AE$AE
242981061$24298106$1$I$$20240909$20240909$20240909$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050226$BOEHRINGER INGELHEIM$$52$YR$A$F$Y$$$20240909$$MD$DE$DE
242981072$24298107$2$F$20240101$20240917$20240909$20240925$EXP$$US-009507513-2409USA001450$MERCK$$$$$F$Y$90$KG$20240925$$HP$US$US
242981091$24298109$1$I$$20240822$20240909$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08474$LUPIN$$$$$$Y$$$20240909$$CN$US$US
242981101$24298110$1$I$$20240826$20240909$20240909$EXP$$IR-AMNEAL PHARMACEUTICALS-2024-AMRX-03269$AMNEAL$Zonooz YA, Alizadehasl A, Davani DN, Jebelli SFH, Aliabadi AY, et. al. Cardiac interventricular septum. Clin Case Rep. 2024;12(8)$21$YR$$M$Y$$$20240909$$HP$IR$IR
242981141$24298114$1$I$20240904$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61691$$FDA-CTU$$65$YR$$M$N$$$20240904$N$HP$US$
242981152$24298115$2$F$20091101$20240912$20240909$20240923$PER$$US-ROCHE-10000072148$ROCHE$$56$YR$A$F$Y$81.65$KG$20240923$$CN$US$US
242981161$24298116$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61534$$FDA-CTU$$88$YR$$M$N$$$20240906$N$$US$
242981171$24298117$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259080$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240909$$MD$US$US
242981181$24298118$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61602$$FDA-CTU$$65$YR$$M$N$$$20240906$N$$US$
242981191$24298119$1$I$20240817$20240827$20240909$20240909$PER$$US-SA-2024SA259487$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240909$$HP$US$US
242981201$24298120$1$I$$20240829$20240909$20240909$PER$$US-SA-2024SA258908$SANOFI AVENTIS$$$$E$F$Y$$$20240909$$CN$US$US
242981211$24298121$1$I$20240101$20240821$20240909$20240909$PER$$US-SA-2024SA258870$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240909$$MD$US$US
242981221$24298122$1$I$$20240219$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2023US073064$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242981231$24298123$1$I$20240830$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024177829$AMGEN$$68$YR$E$F$Y$$$20240909$$CN$US$US
242981241$24298124$1$I$$20240827$20240909$20240909$PER$$US-BEH-2024178359$CSL BEHRING$$$$$F$Y$$$20240909$$HP$US$US
242981261$24298126$1$I$20240805$20240830$20240909$20240909$EXP$DE-AMK-279444$DE-TEVA-VS-3238942$TEVA$$67$YR$$F$Y$$$20240909$$PH$DE$DE
242981271$24298127$1$I$$20240904$20240909$20240909$EXP$$GB-MYLANLABS-2024M1081541$MYLAN$$$$$F$Y$$$20240909$$MD$GB$GB
242981281$24298128$1$I$$20240904$20240909$20240909$EXP$$GB-MYLANLABS-2024M1081539$MYLAN$$$$$M$Y$$$20240909$$PH$GB$GB
242981291$24298129$1$I$$20240904$20240909$20240909$EXP$$US-MYLANLABS-2024M1081587$MYLAN$$$$$F$Y$$$20240909$$PH$US$US
242981301$24298130$1$I$19980303$20240904$20240909$20240909$EXP$$AU-MYLANLABS-2024M1081581$MYLAN$$18$YR$$M$Y$$$20240909$$HP$AU$AU
242981321$24298132$1$I$20240904$20240904$20240909$20240909$EXP$GB-MHRA-MED-202409042021491910-PKMHL$GB-MYLANLABS-2024M1081500$MYLAN$$16$YR$$F$Y$50$KG$20240909$$CN$GB$GB
242981331$24298133$1$I$$20240903$20240909$20240909$EXP$$DE-MYLANLABS-2024M1080791$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul L D. Alpha-Pyrrolidinohexanophenone (alpha-PHP) vs. alpha-pyrrolidinoisohexanophenone (alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology. 2024;48(5):299-313$36$YR$$M$Y$$$20240909$$HP$DE$DE
242981341$24298134$1$I$$20240903$20240909$20240909$EXP$$ES-MYLANLABS-2020M1013912$MYLAN$Sisinni L, Gasior M, Paz RD, Querol S, Bueno D, Fernandez L et al... Unexpected High Incidence of Human Herpesvirus-6 Encephalitis after Naive T Cell-Depleted Graft of Haploidentical Stem Cell Transplantation in Pediatric Patients.. BIOL. BLOOD MARROW TRANSPLANT. 2018;24(11):2316-23$13$YR$$M$Y$$$20240909$$HP$ES$ES
242981351$24298135$1$I$$20240904$20240909$20240909$EXP$$GB-MYLANLABS-2024M1081526$MYLAN$$55$YR$$F$Y$89$KG$20240909$$PH$GB$GB
242981361$24298136$1$I$$20240904$20240909$20240909$EXP$$AU-MYLANLABS-2024M1081572$MYLAN$$$$$M$Y$$$20240909$$PH$AU$AU
242981371$24298137$1$I$20240101$20240905$20240909$20240909$EXP$$US-KYOWAKIRIN-2024KK020751$KYOWA$$$$$$Y$$$20240909$$HP$US$US
242981381$24298138$1$I$$20240827$20240909$20240909$30DAY$$CA-PFIZER INC-202400250922$PFIZER$$$$$$Y$$$20240909$$HP$CA$CA
242981391$24298139$1$I$20240823$20240826$20240909$20240909$PER$$US-BIOCON-BCN-2024-000180$BIOCON$$63$YR$A$F$Y$66.22$KG$20240909$$MD$US$US
242981401$24298140$1$I$$20240903$20240909$20240909$EXP$GB-MHRA-MED-202409030938406780-SWYZQ$GB-RDY-SPO/GBR/24/0012864$DR REDDYS$$50$YR$A$F$Y$59$KG$20240909$$CN$GB$GB
242981411$24298141$1$I$$20240823$20240909$20240909$PER$$US-BIOCON-BCN-2024-000176$BIOCON$$$$$F$Y$$$20240909$$CN$US$US
242981421$24298142$1$I$$20240830$20240909$20240909$EXP$$US-CELLTRION INC.-2024US021111$CELLTRION$$$$$$Y$$$20240909$$CN$US$US
242981431$24298143$1$I$$20240903$20240909$20240909$PER$$US-ALXN-202409USA000093US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242981441$24298144$1$I$$20240906$20240909$20240909$EXP$$JP-BAYER-2024A128283$BAYER$$$$$M$Y$$$20240909$$MD$JP$JP
242981451$24298145$1$I$$20240905$20240909$20240909$PER$$US-ROCHE-10000075431$ROCHE$$41$YR$A$F$Y$$$20240909$$CN$US$US
242981461$24298146$1$I$$20240815$20240909$20240909$EXP$$CZ-TEVA-VS-3239913$TEVA$Zik?n M. Niraparib in the maintenance treatment of advanced ovarian cancer - case report. ONKOLOGICK? REVUE. 2024;11(4):303-305?Zik?n M. Niraparib v udrzovaci lecbe pokrocileho karcinomu vajecniku - kazuistika. ONKOLOGICK? REVUE. 2024;11(4):303-305; Zik?n M. Niraparib in the maintenance treatment of advanced ovarian cancer - case report. ONKOLOGICK? REVUE. 2024;11(4):303-305$52$YR$$F$Y$$$20240909$$MD$CZ$CZ
242981471$24298147$1$I$$20240809$20240909$20240909$PER$$US-TEVA-VS-3233097$TEVA$$58$YR$$F$Y$$$20240909$$CN$US$US
242981481$24298148$1$I$$20240822$20240909$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08475$LUPIN$$$$$$Y$$$20240909$$CN$US$US
242981491$24298149$1$I$20240727$20240903$20240909$20240909$EXP$FR-AFSSAPS-LL2024001590$FR-MYLANLABS-2024M1080795$MYLAN$$19$YR$$F$Y$71$KG$20240909$$PH$FR$FR
242981511$24298151$1$I$$20240827$20240909$20240909$EXP$$CA-UCBSA-2024043918$UCB$$64$YR$$F$Y$$$20240909$$HP$CA$CA
242981521$24298152$1$I$20240101$20240831$20240909$20240909$EXP$$US-SA-2024SA105885$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240909$$CN$US$US
242981532$24298153$2$F$20240322$20240902$20240909$20240911$EXP$$AU-009507513-2409AUS001405$MERCK$$78$YR$$M$Y$$$20240911$$HP$AU$AU
242981541$24298154$1$I$20240812$20240826$20240909$20240909$PER$$US-SA-2024SA258875$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240909$$MD$US$US
242981551$24298155$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA259459$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240909$$MD$US$US
242981561$24298156$1$I$20240701$20240827$20240909$20240909$PER$$US-SA-2024SA259593$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240909$$MD$US$US
242981571$24298157$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259180$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240909$$HP$US$US
242981581$24298158$1$I$$20240827$20240909$20240909$EXP$$JP-B.Braun Medical Inc.-2161381$B BRAUN$Literature Article$99$YR$$F$Y$$$20240909$$$JP$JP
242981591$24298159$1$I$$20240905$20240909$20240909$PER$$NVSC2024US179505$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
242981601$24298160$1$I$$20240903$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003986$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242981611$24298161$1$I$$20240827$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001520$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240909$$CN$US$US
242981621$24298162$1$I$20240830$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003523$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240909$$CN$US$US
242981631$24298163$1$I$20240904$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003732$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240909$$CN$US$US
242981641$24298164$1$I$20240827$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004656$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240909$$CN$US$US
242981651$24298165$1$I$20240901$20240904$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142198$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240909$$CN$US$US
242981671$24298167$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142639$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$122.92$KG$20240909$$CN$US$US
242981681$24298168$1$I$20240820$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202999$ASTRAZENECA$$24710$DY$$M$Y$$$20240909$$HP$US$
242981701$24298170$1$I$20200603$20240903$20240909$20240909$EXP$PL-URPL-1-1628-2020$PL-MYLANLABS-2024M1080802$MYLAN$$35$YR$$F$Y$$$20240909$$MD$PL$PL
242981711$24298171$1$I$20240905$20240905$20240909$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US078209$SANDOZ$$$$$$Y$$$20240909$$CN$US$US
242981722$24298172$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686764$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242981733$24298173$3$F$20240829$20240911$20240909$20240930$30DAY$$JP-JNJFOC-20240900731$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$JP$JP
242981741$24298174$1$I$$20240903$20240909$20240909$EXP$$CA-TAKEDA-2024TUS088722$TAKEDA$$$$$M$Y$$$20240909$$CN$CA$CA
242981751$24298175$1$I$$20240826$20240909$20240909$EXP$$GB-INCYTE CORPORATION-2024IN009439$INCYTE$$$$$$Y$$$20240909$$MD$GB$GB
242981761$24298176$1$I$$20240903$20240909$20240909$EXP$$PT-GILEAD-2024-0686060$GILEAD$Ant?o D, Costa JB, Sousa M, et al. EP-217 - CAR T CELLS AND NEUROTOXICITY. Sinapse. 2023;Sup1 Vol 1:345$48$YR$A$M$Y$$$20240909$$HP$PT$PT
242981771$24298177$1$I$$20240820$20240909$20240909$EXP$$US-SA-2024SA257543$SANOFI AVENTIS$$$$A$M$Y$$$20240909$$MD$US$US
242981781$24298178$1$I$20240614$20240830$20240909$20240909$EXP$ES-AEMPS-1563194$ES-TEVA-VS-3239311$TEVA$$91$YR$$F$Y$$$20240909$$MD$ES$ES
242981801$24298180$1$I$$20240830$20240909$20240909$PER$$NVSC2024US176504$NOVARTIS$$$$$$Y$$$20240909$$MD$US$US
242981811$24298181$1$I$20240419$20240902$20240909$20240909$EXP$$NVSC2024DE153361$NOVARTIS$$66$YR$$F$Y$67$KG$20240909$$MD$DE$DE
242981831$24298183$1$I$20240801$20240905$20240909$20240909$EXP$$CA-PFIZER INC-202400251720$PFIZER$$75$YR$$M$Y$$$20240909$$HP$CA$CA
242981841$24298184$1$I$$20240905$20240909$20240909$EXP$$CA-PFIZER INC-202400250867$PFIZER$$72$YR$$F$Y$$$20240909$$HP$CA$CA
242981851$24298185$1$I$$20240905$20240909$20240909$EXP$$US-PFIZER INC-202400251036$PFIZER$$77$YR$$F$Y$$$20240909$$MD$US$US
242981864$24298186$4$F$$20240924$20240909$20240926$EXP$$US-PFIZER INC-202400032812$PFIZER$$13$YR$$M$Y$$$20240926$$CN$US$US
242981872$24298187$2$F$20240813$20240909$20240909$20240909$EXP$$US-PFIZER INC-202400251203$PFIZER$$78$YR$$M$Y$106.59$KG$20240909$$CN$US$US
242981881$24298188$1$I$$20240905$20240909$20240909$EXP$$CA-PFIZER INC-202400250905$PFIZER$$73$YR$$F$Y$$$20240909$$CN$CA$CA
242981891$24298189$1$I$$20240905$20240909$20240909$EXP$$US-PFIZER INC-202400250950$PFIZER$$$$$$Y$$$20240909$$MD$US$US
242981901$24298190$1$I$20230120$20240905$20240909$20240909$EXP$FR-AFSSAPS-PC2024000680$FR-PFIZER INC-202400250507$PFIZER$$50$YR$$F$Y$$$20240909$$PH$FR$FR
242981911$24298191$1$I$20240701$20240905$20240909$20240909$EXP$$US-PFIZER INC-PV202400116911$PFIZER$$53$YR$$F$Y$$$20240909$$HP$US$US
242981921$24298192$1$I$20240828$20240905$20240909$20240909$EXP$$CN-PFIZER INC-PV202400116743$PFIZER$$6$YR$$F$Y$20.5$KG$20240909$$HP$CN$CN
242981931$24298193$1$I$20240223$20240905$20240909$20240909$EXP$$DE-PFIZER INC-202400250459$PFIZER$$15$YR$$F$Y$39$KG$20240909$$MD$DE$DE
242981941$24298194$1$I$20240809$20240903$20240909$20240909$EXP$$US-ALKERMES INC.-ALK-2024-002306$ALKERMES$$36$YR$$M$Y$$$20240909$$HP$US$US
242981951$24298195$1$I$$20240828$20240909$20240909$EXP$$US-ALKERMES INC.-ALK-2024-002232$ALKERMES$$8$DEC$$F$Y$$$20240909$$MD$US$US
242981972$24298197$2$F$20240827$20240919$20240909$20240924$30DAY$$US-ALKERMES INC.-ALK-2024-002251$ALKERMES$$41$YR$$F$Y$$$20240925$$HP$US$US
242981981$24298198$1$I$$20240829$20240909$20240909$EXP$$US-ALKERMES INC.-ALK-2024-002285$ALKERMES$$$$$M$Y$$$20240909$$MD$US$US
242981991$24298199$1$I$$20240815$20240909$20240909$30DAY$$US-VEROBIOTECH-2024USVEROSPO00208$VERO BIOTECH$$$$$$Y$$$20240909$$HP$US$US
242982002$24298200$2$F$$20240909$20240909$20240916$EXP$$IT-GILEAD-2024-0686369$GILEAD$$$$E$M$Y$$$20240916$$HP$IT$IT
242982011$24298201$1$I$$20240828$20240909$20240909$30DAY$$CO-PFIZER INC-PV202400113837$PFIZER$$13$YR$$M$Y$$$20240909$$CN$CO$CO
242982021$24298202$1$I$20240819$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024178874$AMGEN$$72$YR$E$F$Y$$$20240909$$CN$US$US
242982031$24298203$1$I$$20240904$20240909$20240909$EXP$$US-AMGEN-USASP2024177372$AMGEN$$59$YR$A$F$Y$$$20240909$$MD$US$US
242982042$24298204$2$F$20240101$20240906$20240909$20240912$30DAY$$US-PFIZER INC-202400250227$PFIZER$$3$YR$$M$Y$$$20240912$$CN$US$US
242982051$24298205$1$I$$20240812$20240909$20240909$30DAY$$US-VEROBIOTECH-2024USVEROSPO00206$VERO BIOTECH$$$$$$Y$$$20240909$$HP$US$US
242982061$24298206$1$I$$20240905$20240909$20240909$EXP$$GB-TAKEDA-2024TUS089688$TAKEDA$$$$$M$Y$$$20240909$$CN$GB$GB
242982071$24298207$1$I$20240314$20240904$20240909$20240909$EXP$FI-FIMEA-202402895$FI-TAKEDA-2024TUS089594$TAKEDA$$59$YR$$M$Y$$$20240909$$HP$FI$FI
242982081$24298208$1$I$$20240903$20240909$20240909$EXP$$CA-TAKEDA-2024TUS088758$TAKEDA$$$$$M$Y$$$20240909$$MD$CA$CA
242982091$24298209$1$I$$20240903$20240909$20240909$EXP$$JP-CHEPLA-1000002613$CHEPLAPHARM$$25$YR$$F$Y$$$20240909$$CN$COUNTRY NOT SPECIFIED$JP
242982101$24298210$1$I$$20240904$20240909$20240909$EXP$$US-MYLANLABS-2024M1082004$MYLAN$$$$$M$Y$$$20240909$$CN$US$US
242982111$24298211$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61673$$FDA-CTU$$54$YR$$M$N$$$20240906$N$$US$
242982121$24298212$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61573$$FDA-CTU$$75$YR$$M$N$$$20240906$N$$US$
242982141$24298214$1$I$20240601$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61699$$FDA-CTU$$63$YR$$M$N$$$20240906$N$PH$US$
242982161$24298216$1$I$$20240903$20240906$20240906$DIR$FDA-CDER-CTU-2024-61625$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
242982201$24298220$1$I$20240904$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61558$$FDA-CTU$$33$YR$$F$N$$$20240906$N$HP$US$
242982211$24298221$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61566$$FDA-CTU$$$$$F$N$$$20240905$N$HP$US$
242982241$24298224$1$I$20240904$20240904$20240906$20240906$DIR$FDA-CDER-CTU-2024-61628$$FDA-CTU$$95$YR$$F$N$$$20240904$N$HP$US$
242982251$24298225$1$I$$20240822$20240909$20240909$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08505$LUPIN$$$$$$Y$$$20240909$$CN$US$US
242982261$24298226$1$I$20240811$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61572$$FDA-CTU$$75$YR$$F$N$$$20240905$N$HP$US$
242982271$24298227$1$I$$20240828$20240909$20240909$EXP$$JP-JNJFOC-20240917544$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$HP$JP$JP
242982281$24298228$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61562$$FDA-CTU$$68$YR$$F$N$81.65$KG$20240906$N$$US$
242982301$24298230$1$I$$20240904$20240909$20240909$EXP$$US-AMGEN-USASP2024177573$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
242982311$24298231$1$I$$20240820$20240909$20240909$PER$$US-TEVA-VS-3236949$TEVA$$$$T$$Y$$$20240909$$PH$US$US
242982321$24298232$1$I$20240807$20240809$20240906$20240906$DIR$FDA-CDER-CTU-2024-61539$$FDA-CTU$$91$YR$$M$N$$$20240809$N$HP$US$
242982331$24298233$1$I$20240501$20240828$20240909$20240909$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08167$HIKMA$$41$YR$$M$Y$$$20240909$$HP$US$US
242982341$24298234$1$I$$20240906$20240909$20240909$EXP$$NVSC2024AU178937$NOVARTIS$$$$$M$Y$$$20240909$$HP$AU$AU
242982351$24298235$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180019$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
242982362$24298236$2$F$20240904$20240923$20240909$20240925$EXP$$US-GILEAD-2024-0686637$GILEAD$$$$$F$Y$$$20240925$$HP$US$US
242982372$24298237$2$F$$20240905$20240909$20240909$EXP$$US-ROCHE-10000075732$ROCHE$$$$A$F$Y$$$20240909$$HP$US$US
242982381$24298238$1$I$$20240903$20240909$20240909$PER$$US-MYLANLABS-2024M1081561$MYLAN$$90$YR$$M$Y$$$20240909$$CN$US$US
242982391$24298239$1$I$$20240902$20240909$20240909$EXP$$CA-ROCHE-10000074056$ROCHE$$$$E$M$Y$59$KG$20240909$$MD$CA$CA
242982401$24298240$1$I$$20240902$20240909$20240909$PER$$US-ROCHE-10000071600$ROCHE$Peshin S, Modi S, Kolagatla S, Moka N. An Unusual Case of Renal Infiltration in Chronic Lymphocytic Leukemia (Abstract number:CLL-033). Clinical Lymphoma, Myeloma and Leukemia. 2024-Sep;24:S340-1. doi:10.1016/S2152-2650(24)01254-0.$67$YR$E$F$Y$$$20240909$$MD$US$US
242982411$24298241$1$I$$20240830$20240909$20240909$EXP$$US-TEVA-VS-3240754$TEVA$$59$YR$$M$Y$$$20240909$$HP$US$US
242982431$24298243$1$I$20240101$20240903$20240909$20240909$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004532$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240909$$HP$US$US
242982441$24298244$1$I$20240904$20240905$20240909$20240909$EXP$$BR-JNJFOC-20240919606$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$BR$BR
242982451$24298245$1$I$$20230925$20240909$20240909$EXP$$US-SANDOZ INC.-NVSC2023US130108$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242982462$24298246$2$F$20240101$20240916$20240909$20240917$PER$$US-AMGEN-USASP2024177801$AMGEN$$55$YR$A$F$Y$$$20240917$$MD$US$US
242982471$24298247$1$I$20240720$20240905$20240909$20240909$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-120420$REGENERON$$$$$F$Y$$$20240909$$PH$DE$DE
242982482$24298248$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686765$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242982491$24298249$1$I$20240802$20240822$20240909$20240909$PER$$US-LEX-000456$LEXICON PHARMACEUTICALS$$55$YR$$F$Y$114.76$KG$20240909$$CN$US$US
242982501$24298250$1$I$$20240828$20240909$20240909$EXP$$US-SLATERUN-2024SRSPO00146$SLATE RUN$$64$YR$A$F$Y$$$20240909$$CN$US$US
242982512$24298251$2$F$20240906$20240916$20240909$20240920$EXP$$US-TAKEDA-2024TUS089441$TAKEDA$$66$YR$$F$Y$$$20240920$$CN$US$US
242982521$24298252$1$I$$20240905$20240909$20240909$PER$$NVSC2024US180281$NOVARTIS$$$$$F$Y$72$KG$20240909$$CN$US$US
242982531$24298253$1$I$20240723$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202705$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242982541$24298254$1$I$20240811$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202819$ASTRAZENECA$$$$$$Y$$$20240909$$CN$US$
242982551$24298255$1$I$20240825$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201721$ASTRAZENECA$$29836$DY$$F$Y$$$20240909$$CN$US$
242982561$24298256$1$I$$20240904$20240909$20240909$EXP$$ID-AstraZeneca-2024A204268$ASTRAZENECA$$65$YR$$M$Y$$$20240909$$MD$ID$
242982571$24298257$1$I$$20240827$20240909$20240909$EXP$$CA-B.Braun Medical Inc.-2161382$B BRAUN$$$$$F$Y$$$20240909$$$CA$CA
242982581$24298258$1$I$20240821$20240830$20240909$20240909$EXP$GB-MHRA-MED-202408301533565850-VYPSK$GB-TEVA-VS-3239095$TEVA$$89$YR$$F$Y$$$20240909$$HP$GB$GB
242982591$24298259$1$I$$20240829$20240909$20240909$PER$$US-SA-2024SA259467$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240909$$MD$US$US
242982601$24298260$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA260097$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240909$$CN$US$US
242982611$24298261$1$I$$20240828$20240909$20240909$PER$$US-SA-2024SA258800$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240909$$MD$US$US
242982621$24298262$1$I$20140901$20240903$20240909$20240909$EXP$$US-TAKEDA-US-001345$TAKEDA$$25$YR$$F$Y$$$20240909$$CN$US$US
242982631$24298263$1$I$$20240830$20240909$20240909$EXP$GB-MHRA-TPP18978005C7016075YC1724924261304$GB-TEVA-VS-3239194$TEVA$$60$YR$$F$Y$88$KG$20240909$$MD$GB$GB
242982652$24298265$2$F$$20240917$20240909$20240917$EXP$$NZ-MYLANLABS-2024M1082061$MYLAN$$$$$M$Y$$$20240917$$HP$NZ$NZ
242982661$24298266$1$I$$20240902$20240909$20240909$EXP$$CA-ROCHE-10000073476$ROCHE$$$$E$M$Y$120$KG$20240909$$MD$CA$CA
242982671$24298267$1$I$20240816$20240906$20240909$20240909$EXP$$GB-MYLANLABS-2024M1082055$MYLAN$$$$$M$Y$$$20240909$$HP$GB$GB
242982682$24298268$2$F$20240905$20240909$20240909$20240912$EXP$$AU-MYLANLABS-2024M1082077$MYLAN$$50$YR$$F$Y$$$20240912$$HP$AU$AU
242982692$24298269$2$F$$20240906$20240909$20240916$EXP$$KR-MYLANLABS-2024M1081975$MYLAN$Hongil Ha, Sungmin Moon, Minji Kang, Jihyun Kim. Drug Intoxication Associated with Pregabalin: An Autopsy Case. Korean Journal of Legal Medicine. 2024;48(3):128-131$27$YR$$M$Y$80$KG$20240916$$HP$KR$KR
242982711$24298271$1$I$20240501$20240827$20240909$20240909$EXP$GB-MHRA-MED-202408271819015540-YDQLC$GB-GLENMARK PHARMACEUTICALS-2024GMK093726$GLENMARK$$$$$$Y$$$20240909$$CN$GB$GB
242982722$24298272$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686737$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242982731$24298273$1$I$20240702$20240905$20240909$20240909$EXP$$US-TAKEDA-2024TUS068072$TAKEDA$$21$YR$$$Y$$$20240909$$CN$US$US
242982741$24298274$1$I$$20230918$20240909$20240909$EXP$$US-SANDOZ INC.-NVSC2023US087492$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242982752$24298275$2$F$20240101$20240916$20240909$20240918$PER$$US-ABBVIE-5913810$ABBVIE$$$$$$Y$$$20240918$$HP$US$US
242982761$24298276$1$I$$20240906$20240909$20240909$PER$$US-HALEON-2195763$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
242982771$24298277$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA259939$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240909$$CN$US$US
242982781$24298278$1$I$20240904$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024177970$AMGEN$$91$YR$E$M$Y$$$20240909$$CN$US$US
242982791$24298279$1$I$20240101$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178296$AMGEN$$69$YR$E$F$Y$$$20240909$$CN$US$US
242982801$24298280$1$I$$20240830$20240909$20240909$EXP$GB-MHRA-MIDB-0b3f951d-0bb7-4252-a6b4-6bf3d338b00d$GB-TEVA-VS-3239209$TEVA$$87$YR$$$Y$$$20240909$$PH$GB$GB
242982811$24298281$1$I$$20240829$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139708$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240909$$CN$US$US
242982821$24298282$1$I$$20240827$20240909$20240909$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08171$HIKMA$Rink DE, Abramson RH, Johnson NJ, Lee RY.. Rink DE, Abramson RH, Johnson NJ, Lee RY. Diagnostic Confounders in Brain Death A Woman with Unexplained Coma and Brainstem Areflexia.. Annals of the American Thoracic Society. 2024;21(8):/$60$YR$$F$Y$$$20240909$$MD$US$US
242982831$24298283$1$I$$20240816$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133258$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$CN$US$US
242982841$24298284$1$I$$20240830$20240909$20240909$EXP$GB-MHRA-MIDB-e3ffbe2f-4c0f-47ec-9c6b-f968b73335b6$GB-LABORATORIOS LICONSA S.A.-2408GB06812$INSUD PHARMA$$81$YR$$F$Y$$$20240909$$PH$GB$GB
242982871$24298287$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61542$$FDA-CTU$$49$YR$$F$N$$$20240906$N$$US$
242982881$24298288$1$I$20240903$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61568$$FDA-CTU$$76$YR$$F$N$$$20240906$N$$US$
242982891$24298289$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61541$$FDA-CTU$$69$YR$$F$N$78.02$KG$20240906$N$$US$
242982901$24298290$1$I$20240906$20240907$20240907$20240907$DIR$717540$$FDA-CTU$$47$YR$$M$N$114.75$KG$20240907$N$CN$US$
242982911$24298291$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61548$$FDA-CTU$$59$YR$$F$N$52.16$KG$20240906$N$$US$
242982931$24298293$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61535$$FDA-CTU$$89$YR$$M$N$83.46$KG$20240906$N$$US$
242982971$24298297$1$I$20240822$20240903$20240906$20240906$DIR$FDA-CDER-CTU-2024-61546$$FDA-CTU$$53$YR$$F$N$$$20240903$N$HP$US$
242982981$24298298$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61585$$FDA-CTU$$$$$F$N$$$20240905$N$HP$US$
242982991$24298299$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61599$$FDA-CTU$$$$$M$N$$$20240906$N$HP$US$
242983001$24298300$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61556$$FDA-CTU$$45$YR$$F$N$$$20240906$N$$US$
242983021$24298302$1$I$$20240904$20240909$20240909$PER$$US-ABBVIE-5909084$ABBVIE$$$$$$Y$$$20240909$$CN$US$US
242983041$24298304$1$I$$20240815$20240909$20240909$PER$$US-SMPA-2024SPA001526$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983052$24298305$2$F$$20240910$20240909$20240923$PER$$US-SMPA-2024SPA001483$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242983061$24298306$1$I$$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001528$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983071$24298307$1$I$$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001567$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983081$24298308$1$I$$20240813$20240909$20240909$PER$$US-SMPA-2024SPA001453$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983091$24298309$1$I$$20240813$20240909$20240909$PER$$US-SMPA-2024SPA001206$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983101$24298310$1$I$20240813$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001543$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983121$24298312$1$I$$20240813$20240909$20240909$PER$$US-SMPA-2024SPA001326$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983131$24298313$1$I$20240101$20240815$20240909$20240909$PER$$US-SMPA-2024SPA001440$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983141$24298314$1$I$$20240815$20240909$20240909$PER$$US-SMPA-2024SPA001576$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983151$24298315$1$I$$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001405$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983161$24298316$1$I$$20240813$20240909$20240909$PER$$US-SMPA-2024SPA001349$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983171$24298317$1$I$20240101$20240813$20240909$20240909$PER$$US-SMPA-2024SPA001328$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983191$24298319$1$I$$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001540$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983201$24298320$1$I$$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001598$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983222$24298322$2$F$$20240902$20240909$20240924$PER$$US-SMPA-2024SPA001369$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242983231$24298323$1$I$$20240815$20240909$20240909$PER$$US-SMPA-2024SPA001504$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983241$24298324$1$I$$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001559$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983251$24298325$1$I$$20240815$20240909$20240909$PER$$US-SMPA-2024SPA001554$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983261$24298326$1$I$$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001591$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983272$24298327$2$F$$20240906$20240909$20240923$PER$$US-SMPA-2024SPA001470$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242983281$24298328$1$I$$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001466$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983291$24298329$1$I$$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001524$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983301$24298330$1$I$$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001350$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983311$24298331$1$I$20240812$20240813$20240909$20240909$PER$$US-SMPA-2024SPA001408$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983321$24298332$1$I$20240101$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001551$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983331$24298333$1$I$$20240813$20240909$20240909$PER$$US-SMPA-2024SPA001354$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983342$24298334$2$F$$20240916$20240909$20240924$PER$$US-SMPA-2024SPA001475$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
242983352$24298335$2$F$20240816$20240904$20240909$20240920$PER$$US-SMPA-2024SPA001568$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
242983361$24298336$1$I$$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001578$SUNOVION$$$$$$Y$$$20240909$$HP$US$US
242983372$24298337$2$F$$20240913$20240909$20240919$PER$$US-SMPA-2024SPA001611$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
242983382$24298338$2$F$20240811$20240913$20240909$20240930$PER$$US-SMPA-2024SPA001539$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
242983391$24298339$1$I$$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001884$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983402$24298340$2$F$$20240826$20240909$20240919$PER$$US-SMPA-2024SPA001340$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
242983411$24298341$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61547$$FDA-CTU$$52$YR$$F$N$$$20240906$N$$US$
242983422$24298342$2$F$$20240830$20240909$20240923$PER$$US-SMPA-2024SPA001484$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242983441$24298344$1$I$$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001515$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983471$24298347$1$I$$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001505$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983491$24298349$1$I$$20240809$20240906$20240906$DIR$FDA-CDER-CTU-2024-61620$$FDA-CTU$$$$$F$N$$$20240809$N$HP$US$
242983502$24298350$2$F$$20240904$20240909$20240927$PER$$US-SMPA-2024SPA001614$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
242983521$24298352$1$I$$20240818$20240909$20240909$PER$$US-SMPA-2024SPA001626$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983531$24298353$1$I$20240101$20240815$20240909$20240909$PER$$US-SMPA-2024SPA001444$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983541$24298354$1$I$$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001605$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983551$24298355$1$I$$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001536$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983561$24298356$1$I$$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001579$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983581$24298358$1$I$$20240815$20240909$20240909$PER$$US-SMPA-2024SPA001535$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983591$24298359$1$I$$20240813$20240909$20240909$PER$$US-SMPA-2024SPA001314$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983611$24298361$1$I$$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001353$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983631$24298363$1$I$$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001613$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983641$24298364$1$I$$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001490$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983651$24298365$1$I$$20240814$20240909$20240909$PER$$US-SMPA-2024SPA001517$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983661$24298366$1$I$$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001445$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983672$24298367$2$F$$20240903$20240909$20240918$PER$$US-SMPA-2024SPA001521$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
242983681$24298368$1$I$$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001602$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983691$24298369$1$I$20240101$20240816$20240909$20240909$PER$$US-SMPA-2024SPA001580$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983701$24298370$1$I$$20240813$20240909$20240909$PER$$US-SMPA-2024SPA001920$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983711$24298371$1$I$$20240813$20240909$20240909$PER$$US-SMPA-2024SPA001379$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983722$24298372$2$F$$20240829$20240909$20240923$PER$$US-SMPA-2024SPA001438$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
242983732$24298373$2$F$$20240916$20240909$20240925$PER$$US-SMPA-2024SPA001506$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
242983741$24298374$1$I$$20240815$20240909$20240909$PER$$US-SMPA-2022MYSCI0600557$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983751$24298375$1$I$$20240815$20240909$20240909$PER$$US-SMPA-2024SPA001450$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983761$24298376$1$I$$20240813$20240909$20240909$PER$$US-SMPA-2024SPA001318$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983771$24298377$1$I$20240801$20240813$20240909$20240909$PER$$US-SMPA-2024SPA001362$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242983781$24298378$1$I$$20240829$20240909$20240909$PER$$US-SA-2024SA258974$SANOFI AVENTIS$$65$YR$E$$Y$$$20240909$$CN$US$US
242983791$24298379$1$I$$20240903$20240909$20240909$30DAY$$JP-SA-2024SA258267$SANOFI AVENTIS$$$$A$$Y$$$20240909$$PH$JP$JP
242983811$24298381$1$I$20210222$20240830$20240909$20240909$EXP$FR-EMA-DD-20240829-7482711-121727$FR-BIOCON BIOLOGICS LIMITED-BBL2024006477$BIOCON$$$$$$Y$$$20240909$$MD$FR$FR
242983841$24298384$1$I$$20240903$20240909$20240909$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004910$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240909$$CN$US$US
242983851$24298385$1$I$20230601$20230821$20240909$20240909$EXP$$US-SANDOZ INC.-NVSC2023US144561$SANDOZ$$60$YR$$F$Y$$$20240909$$CN$US$US
242983862$24298386$2$F$20230815$20240910$20240909$20240916$EXP$$US-MYLANLABS-2023M1109030$MYLAN$$55$YR$$F$Y$86.18$KG$20240916$$CN$US$US
242983871$24298387$1$I$$20240904$20240909$20240909$EXP$$DK-MYLANLABS-M-EU-2012070052$MYLAN$Juel J, Pedersen BT, Langfrits SC, Jensen ES. Administration of tramadol or ibuprofen increases the inr level in patients on warfarin. Eur J Clin Pharmacol. 2012;69:291 - 292$74$YR$$M$Y$$$20240909$$HP$DK$DK
242983881$24298388$1$I$20230711$20240806$20240909$20240909$EXP$$JP-AstraZeneca-2023A196710$ASTRAZENECA$$72$YR$$M$Y$59$KG$20240909$$PH$JP$
242983891$24298389$1$I$$20240902$20240909$20240909$EXP$$MQ-AstraZeneca-2024A202993$ASTRAZENECA$$$$$M$Y$$$20240909$$MD$FR$
242983901$24298390$1$I$$20240827$20240909$20240909$EXP$$US-ETON PHARMACEUTICALS, INC-2024ETO000223$ETON PHARMACEUTICALS$$$$$$Y$$$20240909$$CN$US$US
242983912$24298391$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686751$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242983921$24298392$1$I$20240705$20240830$20240909$20240909$EXP$$IN-ROCHE-10000071863$ROCHE$$56$YR$A$M$Y$$$20240909$$MD$IN$IN
242983931$24298393$1$I$$20240828$20240909$20240909$EXP$$US-UCBSA-2024044138$UCB$$$$A$F$Y$$$20240909$$CN$US$US
242983951$24298395$1$I$$20240905$20240909$20240909$EXP$$US-PFIZER INC-202400251346$PFIZER$$67$YR$$F$Y$$$20240909$$CN$US$US
242983961$24298396$1$I$20240816$20240906$20240909$20240909$EXP$$TW-PFIZER INC-PV202400117292$PFIZER$$$$E$F$Y$$$20240909$$HP$TW$TW
242983971$24298397$1$I$$20240906$20240909$20240909$EXP$$US-PFIZER INC-PV202400117603$PFIZER$$91$YR$$M$Y$$$20240909$$CN$US$US
242983981$24298398$1$I$$20240905$20240909$20240909$EXP$GB-MHRA-MED-202409051119214520-ZNMFS$GB-PFIZER INC-202400250679$PFIZER$$82$YR$$F$Y$63$KG$20240909$$PH$GB$GB
242983991$24298399$1$I$$20240906$20240909$20240909$EXP$$MA-PFIZER INC-PV202400117072$PFIZER$$$$$M$Y$$$20240909$$CN$MA$MA
242984001$24298400$1$I$$20240905$20240909$20240909$EXP$$US-PFIZER INC-202400251847$PFIZER$$69$YR$$F$Y$$$20240909$$CN$US$US
242984011$24298401$1$I$20240724$20240905$20240909$20240909$EXP$$JP-PFIZER INC-PV202400117429$PFIZER$$92$YR$$F$Y$44.1$KG$20240909$$PH$JP$JP
242984021$24298402$1$I$20240508$20240905$20240909$20240909$EXP$$FR-PFIZER INC-202400250488$PFIZER$$56$YR$$M$Y$80$KG$20240909$$MD$FR$FR
242984031$24298403$1$I$$20240905$20240909$20240909$EXP$$US-PFIZER INC-PV202400117050$PFIZER$$$$$$Y$$$20240909$$MD$US$US
242984041$24298404$1$I$20190101$20240905$20240909$20240909$EXP$$US-PFIZER INC-PV202400116958$PFIZER$$55$YR$$F$Y$$$20240909$$HP$US$US
242984051$24298405$1$I$20240101$20240905$20240909$20240909$EXP$$US-PFIZER INC-202400251149$PFIZER$$72$YR$$F$Y$$$20240909$$MD$US$US
242984061$24298406$1$I$$20240905$20240909$20240909$EXP$$US-PFIZER INC-202400251580$PFIZER$$$$E$F$Y$$$20240909$$MD$US$US
242984081$24298408$1$I$$20240906$20240909$20240909$EXP$$CA-PFIZER INC-202400251706$PFIZER$$17$YR$$M$Y$188$KG$20240909$$HP$CA$CA
242984091$24298409$1$I$20240823$20240905$20240909$20240909$EXP$$CN-PFIZER INC-PV202400116785$PFIZER$$14$YR$$M$Y$$$20240909$$HP$CN$CN
242984111$24298411$1$I$$20240906$20240909$20240909$EXP$$JP-PFIZER INC-202400250982$PFIZER$$$$$$Y$$$20240909$$PH$JP$JP
242984121$24298412$1$I$20240901$20240906$20240909$20240909$EXP$GB-MHRA-MED-202409060802265550-WNDZF$GB-PFIZER INC-202400251374$PFIZER$$42$YR$$F$Y$$$20240909$$HP$GB$GB
242984131$24298413$1$I$20240101$20240905$20240909$20240909$EXP$$US-PFIZER INC-202400251856$PFIZER$$64$YR$$F$Y$$$20240909$$CN$US$US
242984141$24298414$1$I$$20240906$20240909$20240909$EXP$$US-PFIZER INC-202400251786$PFIZER$$75$YR$$F$Y$$$20240909$$CN$US$US
242984151$24298415$1$I$20240824$20240906$20240909$20240909$EXP$$AU-PFIZER INC-202400252142$PFIZER$$73$YR$$F$Y$$$20240909$$HP$AU$AU
242984161$24298416$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141758$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240909$$CN$US$US
242984171$24298417$1$I$$20240905$20240909$20240909$EXP$$DE-PFIZER INC-202400250461$PFIZER$$$$$F$Y$$$20240909$$MD$DE$DE
242984182$24298418$2$F$20240705$20240910$20240909$20240918$EXP$$BR-CELLTRION INC.-2023BR020098$CELLTRION$$$$$$Y$$$20240918$$CN$BR$BR
242984191$24298419$1$I$20240701$20240826$20240909$20240909$EXP$$US-UCBSA-2024043657$UCB$$38$YR$$F$Y$$$20240909$$HP$US$US
242984202$24298420$2$F$20240905$20240909$20240909$20240910$PER$$US-AMGEN-USASP2024178637$AMGEN$$54$YR$A$F$Y$$$20240910$$CN$US$US
242984211$24298421$1$I$$20240823$20240909$20240909$PER$$US-LEX-000458$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242984221$24298422$1$I$$20240904$20240909$20240909$EXP$$IN-ROCHE-10000074697$ROCHE$$68$YR$E$M$Y$$$20240909$$CN$IN$IN
242984231$24298423$1$I$$20240830$20240909$20240909$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004697$PAREXEL$$$$$$Y$$$20240909$$MD$US$US
242984241$24298424$1$I$$20240905$20240909$20240909$EXP$$GB-MYLANLABS-2024M1081696$MYLAN$$82$YR$$F$Y$$$20240909$$PH$GB$GB
242984251$24298425$1$I$$20240903$20240909$20240909$EXP$$IT-MYLANLABS-2024M1082233$MYLAN$De Zen L, Divisic A, Molinaro G, Solidoro S, Barbi E. Dexmedetomidine at Home for Intractable Dystonia and Insomnia in Children With Special Needs: A Case Series. J-Pain-Symptom-Manage 2023; 66 (6): e653-e657.$$$$F$Y$$$20240909$$HP$IT$IT
242984262$24298426$2$F$$20240909$20240909$20240910$EXP$$US-BAUSCH-BL-2023-008952$BAUSCH AND LOMB$$79$YR$$M$Y$$$20240910$$CN$US$US
242984273$24298427$3$F$$20240912$20240909$20240930$EXP$$JP-JNJFOC-20240906145$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20241001$$PH$JP$JP
242984281$24298428$1$I$$20240902$20240909$20240909$EXP$$GB-MYLANLABS-2024M1082263$MYLAN$Lin R, Muaadz A, Gwo Fuang H. A promising response of refractory uterine leiomyosarcoma to pembrolizumab and temozolomide combination therapy. Gynecol-Oncol-Rep 2024; 51 1-4.$68$YR$$F$Y$$$20240909$$HP$GB$GB
242984301$24298430$1$I$20240905$20240906$20240909$20240909$EXP$$US-BAUSCH-BL-2024-013353$BAUSCH AND LOMB$$84$YR$$M$Y$$$20240909$$CN$US$US
242984312$24298431$2$F$$20240909$20240909$20240910$EXP$$US-BAUSCH-BL-2024-013370$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240910$$CN$US$US
242984321$24298432$1$I$20240801$20240821$20240909$20240909$PER$$US-SA-2024SA259514$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240909$$MD$US$US
242984331$24298433$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259819$SANOFI AVENTIS$$$$A$F$Y$$$20240909$$HP$US$US
242984341$24298434$1$I$20240824$20240829$20240909$20240909$EXP$$CN-GE HEALTHCARE-2024CSU009994$GE HEALTHCARE$$45$YR$$F$Y$56$KG$20240909$$HP$CN$CN
242984351$24298435$1$I$$20240903$20240909$20240909$EXP$$BG-MYLANLABS-2024M1081253$MYLAN$Vasilev P, Viteva E.. Clinical cases of paradoxical seizure aggravation from brivaracetam.. Bulgarian Neurology.. 2024;25:50-51$66$YR$$M$Y$$$20240909$$MD$BG$BG
242984361$24298436$1$I$20240701$20240828$20240909$20240909$EXP$$CN-GE HEALTHCARE-2024CSU009924$GE HEALTHCARE$$81$YR$$F$Y$$$20240909$$HP$CN$CN
242984372$24298437$2$F$20240711$20240827$20240909$20240911$EXP$$JP-UCBSA-2024044543$UCB$$62$YR$$M$Y$65.7$KG$20240911$$PH$JP$JP
242984381$24298438$1$I$$20240827$20240909$20240909$EXP$$GB-UCBSA-2024037318$UCB$$$$$F$Y$$$20240909$$CN$GB$GB
242984391$24298439$1$I$20240701$20240828$20240909$20240909$EXP$$US-UCBSA-2024044078$UCB$$44$YR$$F$Y$$$20240909$$HP$US$US
242984402$24298440$2$F$20240119$20240910$20240909$20240913$EXP$$JP-BEH-2024177796$CSL BEHRING$$8$DEC$E$M$Y$$$20240913$$MD$JP$JP
242984421$24298442$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61561$$FDA-CTU$$25$YR$$F$N$$$20240906$N$$US$
242984432$24298443$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686769$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242984441$24298444$1$I$$20240830$20240909$20240909$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024108466$VIIV$$$$$F$Y$$$20240909$$PH$US$US
242984451$24298445$1$I$20240830$20240830$20240909$20240909$EXP$$US-VANTIVE-2024VAN019533$Vantive US Healthcare$$$$$$Y$$$20240909$$HP$US$US
242984461$24298446$1$I$20240827$20240827$20240909$20240909$EXP$$CN-GE HEALTHCARE-2024CSU009868$GE HEALTHCARE$$67$YR$$M$Y$80$KG$20240909$$HP$CN$CN
242984471$24298447$1$I$$20240906$20240909$20240909$EXP$$BE-BAUSCH-BL-2024-013346$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240909$$HP$BE$BE
242984481$24298448$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61578$$FDA-CTU$$88$YR$$F$N$$$20240906$N$$US$
242984491$24298449$1$I$$20240904$20240909$20240909$EXP$$US-BAUSCH-BL-2024-013288$BAUSCH AND LOMB$$$$$$Y$$$20240909$$PH$US$US
242984501$24298450$1$I$20240801$20240902$20240909$20240909$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-141111$BRISTOL MYERS SQUIBB$$72$YR$E$$Y$$$20240909$$PH$CO$CO
242984511$24298451$1$I$20240401$20240904$20240909$20240909$EXP$$PL-BAUSCH-BL-2024-013290$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240909$$MD$PL$PL
242984521$24298452$1$I$$20240903$20240909$20240909$PER$$US-ALXN-202409USA000115US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242984531$24298453$1$I$$20240903$20240909$20240909$EXP$$US-ALXN-202409USA000046US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242984561$24298456$1$I$20240628$20240904$20240909$20240909$EXP$FR-AFSSAPS-PA2024001358$FR-RDY-SPO/FRA/24/0012904$DR REDDYS$$36$YR$A$M$Y$72.9$KG$20240909$$MD$FR$FR
242984571$24298457$1$I$$20240822$20240909$20240909$EXP$NL-LRB-00999624$NL-ALXN-202408GLO002071NL$ALEXION PHARMACEUTICALS$$80$YR$$M$Y$85$KG$20240909$$MD$NL$NL
242984581$24298458$1$I$$20230629$20240909$20240909$EXP$$NVSC2023CN281065$NOVARTIS$$$$$$Y$$$20240909$$CN$CN$CN
242984591$24298459$1$I$$20240728$20240909$20240909$PER$$US-LUNDBECK-DKLU4002370$LUNDBECK$$$$$$Y$$$20240909$$CN$US$US
242984602$24298460$2$F$$20240913$20240909$20240923$EXP$$CA-TEVA-VS-3239362$TEVA$$69$YR$$M$Y$$$20240923$$HP$CA$CA
242984612$24298461$2$F$20240829$20240909$20240909$20240911$PER$$US-AMGEN-USASP2024178906$AMGEN$$86$YR$E$M$Y$$$20240910$$CN$US$US
242984621$24298462$1$I$20240824$20240905$20240909$20240909$EXP$$CN-ROCHE-10000076410$ROCHE$$49$YR$A$M$Y$90$KG$20240909$$HP$CN$CN
242984631$24298463$1$I$20240905$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61700$$FDA-CTU$$70$YR$$M$N$91.63$KG$20240906$N$HP$US$
242984641$24298464$1$I$20200127$20240906$20240906$20240906$DIR$717507$$FDA-CTU$$20$YR$$F$N$58.05$KG$20240906$N$CN$US$
242984651$24298465$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61550$$FDA-CTU$$32$YR$$F$N$$$20240906$N$$US$
242984661$24298466$1$I$$20240812$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN008488$INCYTE$$$$$$Y$$$20240909$$PH$US$US
242984671$24298467$1$I$$20240826$20240909$20240909$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408016699$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$CN$CN
242984681$24298468$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004169$ELI LILLY AND CO$$21$YR$A$M$Y$$$20240909$$CN$US$US
242984701$24298470$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003529$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240909$$CN$US$US
242984711$24298471$1$I$20240904$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61551$$FDA-CTU$$51$YR$$F$N$$$20240905$N$HP$US$
242984721$24298472$1$I$20240829$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61579$$FDA-CTU$$$$$F$N$$$20240906$N$HP$US$
242984731$24298473$1$I$$20240906$20240909$20240909$EXP$$US-BAUSCH-BL-2024-013354$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240909$$CN$US$US
242984761$24298476$1$I$$20240907$20240909$20240909$EXP$$SK-BAUSCH-BL-2024-013385$BAUSCH AND LOMB$$46$YR$$M$Y$$$20240909$$MD$SK$SK
242984771$24298477$1$I$$20240903$20240909$20240909$EXP$$US-VIIV HEALTHCARE LIMITED-US2024109458$VIIV$$$$$$Y$$$20240909$$CN$US$US
242984781$24298478$1$I$$20240903$20240909$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142495$BRISTOL MYERS SQUIBB$$74$YR$E$$Y$$$20240909$$MD$JP$JP
242984801$24298480$1$I$20191101$20240829$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009163$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242984831$24298483$1$I$20240901$20240904$20240909$20240909$PER$$US-GILEAD-2024-0686313$GILEAD$$59$YR$A$F$Y$$$20240909$$PH$US$US
242984842$24298484$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686752$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242984862$24298486$2$F$$20240830$20240909$20240910$PER$$US-JNJFOC-20240902063$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
242984871$24298487$1$I$$20240826$20240909$20240909$PER$$US-009507513-2408USA008818$MERCK$$$$$F$Y$61.4$KG$20240909$$HP$US$US
242984881$24298488$1$I$20230101$20240908$20240909$20240909$EXP$$HU-BAUSCH-BL-2024-013418$BAUSCH AND LOMB$Bodnar F, Lakatos I, Szikszay E, Varga E, Szegedi I, Kiss C, Bessenyei M. Repeated spontaneous intracerebral hemorrhage of a patient suffering irom acute lymphoblastic leukaemia. Gyermekgyogyaszat. 2024;75(4):295-300.$7$YR$$M$Y$$$20240909$$MD$HU$HU
242984892$24298489$2$F$20220912$20240918$20240909$20240923$EXP$$ES-BAUSCH-BL-2024-013184$BAUSCH AND LOMB$Carreras M, Suarez L, Garc?a L, Reula L, Del Rosario A, Batista F, Santos M, Prados-Ojeda J, Diaz-Marsa M, Martin-Carrasco M, Cardenas A. Towards full recovery with lurasidone: effective doses in the treatment of agitation, affective, positive, and cognitive symptoms in schizophrenia and of dual psychosis. Drugs in Context. 2024;13:1-18. doi:10.7573/dic.2024-4-4$42$YR$$F$Y$$$20240923$$HP$ES$ES
242984901$24298490$1$I$$20240905$20240909$20240909$PER$$US-AstraZeneca-2024A202687$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242984911$24298491$1$I$20240701$20240820$20240909$20240909$PER$$US-TEVA-VS-3236924$TEVA$$$$$F$Y$$$20240909$$CN$US$US
242984921$24298492$1$I$$20240908$20240909$20240909$EXP$$DE-BAUSCH-BL-2024-013399$BAUSCH AND LOMB$$$$$F$Y$$$20240909$$CN$DE$DE
242984931$24298493$1$I$20240731$20240905$20240909$20240909$EXP$$US-BAUSCH-BL-2023-006829$BAUSCH AND LOMB$$76$YR$$F$Y$100.15$KG$20240909$$HP$US$US
242984941$24298494$1$I$$20240821$20240909$20240909$PER$$US-TEVA-VS-3237187$TEVA$$34$YR$$F$Y$$$20240909$$MD$US$US
242984951$24298495$1$I$$20240904$20240909$20240909$EXP$$JP-SHIONOGI INC.-2024002371$SHIONOGI$$$$$$Y$$$20240909$$PH$JP$JP
242984961$24298496$1$I$$20240830$20240909$20240909$EXP$$US-GSK-US2024108285$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242984981$24298498$1$I$$20230724$20240909$20240909$EXP$$NVSC2023CN281077$NOVARTIS$$$$$$Y$$$20240909$$CN$CN$CN
242984991$24298499$1$I$20240803$20240829$20240909$20240909$EXP$$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08142$HIKMA$$$$$$Y$$$20240909$$PH$FR$FR
242985001$24298500$1$I$$20240729$20240909$20240909$PER$$US-LUNDBECK-DKLU4002367$LUNDBECK$$$$$$Y$$$20240909$$CN$US$US
242985071$24298507$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61564$$FDA-CTU$$52$YR$$F$N$$$20240906$N$$US$
242985081$24298508$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61608$$FDA-CTU$$46$YR$$M$N$154.22$KG$20240906$N$$US$
242985091$24298509$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61575$$FDA-CTU$$83$YR$$M$N$$$20240906$N$$US$
242985101$24298510$1$I$20240813$20240906$20240906$20240906$DIR$717462$$FDA-CTU$$92$YR$$M$N$$$20240906$Y$PH$US$
242985111$24298511$1$I$20240101$20240904$20240909$20240909$EXP$$DE-JNJFOC-20240919612$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240909$$CN$DE$DE
242985121$24298512$1$I$20240905$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024179149$AMGEN$$84$YR$E$M$Y$$$20240909$$CN$US$US
242985131$24298513$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178319$AMGEN$$$$$$Y$$$20240909$$PH$US$US
242985141$24298514$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61611$$FDA-CTU$$67$YR$$F$N$64.41$KG$20240906$N$HP$US$
242985151$24298515$1$I$20240604$20240906$20240906$20240906$DIR$717525$$FDA-CTU$$66$YR$$F$N$82.8$KG$20240906$N$CN$US$
242985162$24298516$2$F$20240101$20240911$20240909$20240916$EXP$$CA-SA-2024SA113762$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240916$$CN$CA$CA
242985171$24298517$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61537$$FDA-CTU$$38$YR$$F$N$$$20240906$N$$US$
242985181$24298518$1$I$20240827$20240906$20240906$20240906$DIR$717524$$FDA-CTU$$46$YR$$F$N$58.5$KG$20240906$N$CN$US$
242985192$24298519$2$F$$20240912$20240909$20240916$EXP$$BG-SA-2024SA258690$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240916$$HP$BG$BG
242985211$24298521$1$I$20230929$20240904$20240909$20240909$EXP$$GB-MYLANLABS-2023M1104413$MYLAN$$$$A$F$Y$$$20240909$$MD$GB$GB
242985221$24298522$1$I$20240827$20240908$20240909$20240909$EXP$$CN-BAYER-2024A128467$BAYER$$17$YR$T$F$Y$53$KG$20240909$$HP$CN$CN
242985231$24298523$1$I$20070626$20240904$20240909$20240909$EXP$$GB-MYLANLABS-MK-6035999$MYLAN$$55$YR$$M$Y$$$20240909$$HP$GB$GB
242985241$24298524$1$I$20240101$20240904$20240909$20240909$EXP$$US-ABBVIE-5841389$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242985251$24298525$1$I$20240101$20240903$20240909$20240909$PER$$US-SA-2024SA259100$SANOFI AVENTIS$$$$$M$Y$$$20240909$$CN$US$US
242985261$24298526$1$I$20240701$20240821$20240909$20240909$PER$$US-SA-2024SA258913$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240909$$MD$US$US
242985271$24298527$1$I$20240801$20240826$20240909$20240909$PER$$US-SA-2024SA257654$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240909$$MD$US$US
242985281$24298528$1$I$$20240830$20240909$20240909$EXP$$US-GSK-US2024AMR109060$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242985291$24298529$1$I$$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141113$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$59.42$KG$20240909$$CN$US$US
242985301$24298530$1$I$$20240826$20240909$20240909$EXP$$JP-EAGLE PHARMACEUTICALS, INC.-JP-2024EAG000209$EAGLE$Iriyama N et al.. Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience.. Leukemia + lymphoma. 2023;64(1):171-177$74$YR$$M$Y$$$20240909$$PH$JP$JP
242985311$24298531$1$I$20240601$20240902$20240909$20240909$EXP$$JP-TAKEDA-2024TUS086050$TAKEDA$$$$$$Y$$$20240909$$PH$JP$JP
242985321$24298532$1$I$$20240905$20240909$20240909$EXP$$NVSC2024US179076$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
242985331$24298533$1$I$20240902$20240906$20240909$20240909$EXP$$CN-BAYER-2024A128360$BAYER$$76$YR$E$M$Y$60$KG$20240909$$HP$CN$CN
242985341$24298534$1$I$20240801$20240903$20240909$20240909$EXP$$US-ABBVIE-5908138$ABBVIE$$72$YR$$M$Y$$$20240909$$CN$US$US
242985351$24298535$1$I$$20240904$20240909$20240909$PER$$US-ALXN-202409USA000290US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242985362$24298536$2$F$20240305$20240916$20240909$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027619$UNITED THERAPEUTICS$$64$YR$$F$Y$57.143$KG$20240926$$$US$US
242985372$24298537$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686754$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242985382$24298538$2$F$$20240918$20240909$20240925$PER$$US-GSK-US2024108447$GLAXOSMITHKLINE$$$$$F$Y$96.2$KG$20240925$$HP$US$US
242985391$24298539$1$I$20240117$20240909$20240909$20240909$EXP$FR-AFSSAPS-PC2024000696$FR-BAYER-2024A128589$BAYER$$31$YR$A$F$Y$72$KG$20240909$$CN$FR$FR
242985401$24298540$1$I$20240824$20240903$20240909$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142520$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240909$$PH$JP$JP
242985412$24298541$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686770$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242985421$24298542$1$I$20240828$20240828$20240909$20240909$PER$$US-AMGEN-USASP2024178244$AMGEN$$70$YR$E$F$Y$$$20240909$$CN$US$US
242985431$24298543$1$I$$20240827$20240909$20240909$PER$$US-009507513-2408USA009415$MERCK$$$$$$Y$$$20240909$$HP$US$US
242985451$24298545$1$I$$20240903$20240909$20240909$EXP$$CA-TAKEDA-2024TUS088613$TAKEDA$$$$$F$Y$$$20240909$$CN$CA$CA
242985461$24298546$1$I$20240822$20240902$20240909$20240909$EXP$$CN-009507513-2409CHN001986$MERCK$$60$YR$$F$Y$$$20240909$$HP$CN$CN
242985471$24298547$1$I$20240830$20240906$20240909$20240909$EXP$$CN-BAYER-2024A128370$BAYER$$64$YR$A$M$Y$80$KG$20240909$$HP$CN$CN
242985482$24298548$2$F$20240801$20240909$20240909$20240920$PER$$US-JNJFOC-20240907394$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240920$$CN$US$US
242985491$24298549$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A203240$ASTRAZENECA$$$$$F$Y$71.2$KG$20240909$$HP$US$
242985501$24298550$1$I$20240904$20240906$20240909$20240909$EXP$$CN-JNJFOC-20240915549$JOHNSON AND JOHNSON$$73$YR$E$M$Y$84$KG$20240909$$HP$CN$CN
242985511$24298551$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201672$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242985521$24298552$1$I$$20240902$20240909$20240909$EXP$$PT-AstraZeneca-2024A203787$ASTRAZENECA$$$$$$Y$$$20240909$$CN$PT$
242985531$24298553$1$I$20240903$20240903$20240909$20240909$EXP$$US-ABBVIE-5907601$ABBVIE$$78$YR$$M$Y$$$20240909$$CN$US$US
242985541$24298554$1$I$$20230815$20240909$20240909$EXP$$NVSC2023CA281061$NOVARTIS$$$$$$Y$$$20240909$$MD$CA$CA
242985561$24298556$1$I$20240401$20240903$20240909$20240909$EXP$FR-AFSSAPS-AVMA2024000376$FR-Waylis Therapeutics LLC-ATNAHS20240902513$Waylis$$52$YR$A$M$Y$$$20240906$$PH$FR$FR
242985571$24298557$1$I$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686639$GILEAD$$$$T$M$Y$$$20240909$$MD$US$US
242985581$24298558$1$I$$20240901$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139896$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240909$$HP$US$US
242985591$24298559$1$I$$20240829$20240909$20240909$PER$$US-MYLANLABS-2024M1069960$MYLAN$$$$$M$Y$$$20240909$$CN$US$US
242985601$24298560$1$I$20240802$20240902$20240909$20240909$EXP$FR-AFSSAPS-TS2024000952$FR-Waylis Therapeutics LLC-ATNAHS20240902507$Waylis$$73$YR$E$M$Y$70$KG$20240906$$MD$FR$FR
242985621$24298562$1$I$$20240902$20240909$20240909$EXP$$JP-009507513-2409JPN000749J$MERCK$$5$DEC$$F$Y$$$20240909$$HP$JP$JP
242985631$24298563$1$I$$20230824$20240909$20240909$EXP$$NVSC2023ID281118$NOVARTIS$$$$$$Y$$$20240909$$MD$ID$ID
242985641$24298564$1$I$$20230824$20240909$20240909$EXP$$NVSC2023FR281047$NOVARTIS$$$$$$Y$$$20240909$$MD$FR$FR
242985651$24298565$1$I$$20240812$20240909$20240909$PER$$US-009507513-2408USA004020$MERCK$$$$$F$Y$97.506$KG$20240909$$CN$US$US
242985661$24298566$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3239159$TEVA$$35$YR$$M$Y$96$KG$20240909$$HP$CA$CA
242985671$24298567$1$I$20240829$20240902$20240909$20240909$EXP$IT-MINISAL02-1000925$IT-Waylis Therapeutics LLC-ATNAHS20240902511$Waylis$$23$YR$A$F$Y$$$20240906$$PH$IT$IT
242985691$24298569$1$I$$20240905$20240909$20240909$EXP$$CA-JNJFOC-20240914732$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$HP$CA$CA
242985711$24298571$1$I$20240101$20240902$20240909$20240909$EXP$$US-SA-2024SA258034$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240909$$HP$US$US
242985722$24298572$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686771$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242985731$24298573$1$I$20160101$20240908$20240909$20240909$EXP$$US-BAYER-2024A128379$BAYER$$$$$$Y$$$20240909$$CN$US$US
242985751$24298575$1$I$$20240904$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142393$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240909$$CN$US$US
242985761$24298576$1$I$$20240816$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133272$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$CN$US$US
242985771$24298577$1$I$$20240828$20240909$20240909$30DAY$$CO-PFIZER INC-202400246605$PFIZER$$$$$F$Y$$$20240909$$CN$CO$CO
242985781$24298578$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142298$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240909$$MD$US$US
242985791$24298579$1$I$20240820$20240904$20240909$20240909$EXP$$CN-SA-2024SA258446$SANOFI AVENTIS$$33$YR$A$F$Y$55$KG$20240909$$HP$CN$CN
242985801$24298580$1$I$20240801$20240823$20240909$20240909$PER$$US-SA-2024SA255509$SANOFI AVENTIS$$$$$$Y$$$20240909$$HP$US$US
242985811$24298581$1$I$20240601$20240821$20240909$20240909$PER$$US-SA-2024SA259071$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240909$$MD$US$US
242985821$24298582$1$I$20240807$20240827$20240909$20240909$PER$$US-SA-2024SA259009$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240909$$MD$US$US
242985831$24298583$1$I$20240327$20240902$20240909$20240909$EXP$FR-AFSSAPS-TO2024001638$FR-Atnahs Limited-ATNAHS20240902506$Atnahs Healthcare$$88$YR$E$F$Y$$$20240909$$MD$FR$FR
242985841$24298584$1$I$$20240905$20240909$20240909$EXP$$US-TAKEDA-US202019616$TAKEDA$$$$$M$Y$$$20240909$$MD$US$US
242985853$24298585$3$F$$20240918$20240909$20240924$EXP$$CA-TAKEDA-2024TUS088630$TAKEDA$$$$$F$Y$$$20240924$$CN$CA$CA
242985861$24298586$1$I$$20240903$20240906$20240906$DIR$FDA-CDER-CTU-2024-61540$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
242985871$24298587$1$I$$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-61533$$FDA-CTU$$$$$F$N$$$20240905$N$HP$US$
242985881$24298588$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61594$$FDA-CTU$$71$YR$$F$N$$$20240906$N$$US$
242985891$24298589$1$I$$20240903$20240906$20240906$DIR$FDA-CDER-CTU-2024-61615$$FDA-CTU$$$$$F$N$$$20240903$N$$US$
242985901$24298590$1$I$20240905$20240906$20240906$20240906$DIR$717520$$FDA-CTU$$77$YR$$F$N$66.15$KG$20240906$N$CN$US$
242985921$24298592$1$I$20240825$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61660$$FDA-CTU$$78$YR$$F$N$$$20240906$N$PH$US$
242985931$24298593$1$I$20240826$20240907$20240907$20240907$DIR$717531$$FDA-CTU$$30$YR$$F$N$69.75$KG$20240907$N$CN$US$
242985961$24298596$1$I$$20240906$20240906$20240906$DIR$717438$$FDA-CTU$$$$$F$N$$$20240906$Y$PH$US$
242986001$24298600$1$I$20240530$20240903$20240909$20240909$EXP$FR-AFSSAPS-DJ2024000957$FR-009507513-2409FRA001440$MERCK$$70$YR$$M$Y$71$KG$20240909$$MD$FR$FR
242986011$24298601$1$I$20240730$20240907$20240907$20240907$DIR$717563$$FDA-CTU$$42$YR$$F$N$84.6$KG$20240907$N$CN$US$
242986022$24298602$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686648$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986031$24298603$1$I$$20240119$20240909$20240909$EXP$$NVSC2024CA015174$NOVARTIS$$16$YR$$F$Y$$$20240909$$CN$CA$CA
242986041$24298604$1$I$20240619$20240815$20240909$20240909$PER$$US-Vifor (International) Inc.-VIT-2024-07438$VIFOR$$57$YR$$F$Y$67.5$KG$20240909$$HP$US$US
242986051$24298605$1$I$$20240904$20240909$20240909$EXP$$CN-AMGEN-CHNSP2024177021$AMGEN$Hu Q.; Lu J.; Bao X. et al.. Safety and efficacy of blinatumomab as bridge-to transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease. Blood Cancer Journal. 2024;14 (1):1-5$$$$$Y$$$20240909$$HP$CN$CN
242986061$24298606$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3239412$TEVA$$45$YR$$F$Y$$$20240909$$HP$CA$CA
242986071$24298607$1$I$$20240906$20240906$20240906$DIR$717426$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242986081$24298608$1$I$$20240827$20240909$20240909$EXP$$CA-B.Braun Medical Inc.-2161384$B BRAUN$$66$YR$$M$Y$$$20240909$$$CA$CA
242986091$24298609$1$I$$20240905$20240909$20240909$PER$$US-BIOGEN-2024BI01281470$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
242986101$24298610$1$I$20240801$20240826$20240909$20240909$PER$$US-SA-2024SA259712$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240909$$HP$US$US
242986112$24298611$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686650$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986121$24298612$1$I$20160823$20240903$20240909$20240909$EXP$$CA-TAKEDA-2024TUS088980$TAKEDA$$71$YR$$F$Y$$$20240909$$CN$CA$CA
242986151$24298615$1$I$$20240829$20240909$20240909$EXP$$IN-Everest Life Sciences LLC-2161386$Everest Life Sciences$Abstract$50$YR$$F$Y$$$20240909$$$IN$IN
242986162$24298616$2$F$20240831$20240913$20240909$20240923$EXP$$CA-TAKEDA-2024TUS089031$TAKEDA$$74$YR$$F$Y$$$20240923$$CN$CA$CA
242986171$24298617$1$I$$20240904$20240909$20240909$EXP$$CA-TAKEDA-2024TUS089116$TAKEDA$$$$$F$Y$$$20240909$$CN$CA$CA
242986181$24298618$1$I$$20240820$20240909$20240909$PER$$US-TEVA-VS-3238263$TEVA$$34$YR$$F$Y$$$20240909$$MD$US$US
242986192$24298619$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686651$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986202$24298620$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686652$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986211$24298621$1$I$$20240212$20240909$20240909$EXP$$NVSC2024CA031889$NOVARTIS$$52$YR$$M$Y$$$20240909$$CN$CA$CA
242986221$24298622$1$I$$20240904$20240909$20240909$EXP$$GB-ABBVIE-5908904$ABBVIE$$$$A$F$Y$$$20240909$$CN$GB$GB
242986231$24298623$1$I$20210421$20240904$20240909$20240909$EXP$$CA-TAKEDA-2020TUS047038$TAKEDA$$30$YR$$F$Y$$$20240909$$MD$CA$CA
242986242$24298624$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686653$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986252$24298625$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686654$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986262$24298626$2$F$20240101$20240829$20240909$20240910$EXP$$CO-ORG100014127-2024000244$HRA PHARMA$$33$YR$$M$Y$72$KG$20240910$$HP$CO$CO
242986271$24298627$1$I$20240101$20240826$20240909$20240909$EXP$$US-SA-2024SA257350$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240909$$HP$US$US
242986291$24298629$1$I$$20240903$20240909$20240909$EXP$$CA-AstraZeneca-2024A200931$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$CA$
242986302$24298630$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686662$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986311$24298631$1$I$$20240827$20240909$20240909$PER$$US-AstraZeneca-2024A195910$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242986322$24298632$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686664$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986331$24298633$1$I$20240517$20240904$20240909$20240909$EXP$$US-ABBVIE-5908040$ABBVIE$$35$YR$$F$Y$$$20240909$$CN$US$US
242986341$24298634$1$I$20240906$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142814$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$PH$US$US
242986351$24298635$1$I$$20240903$20240909$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142488$BRISTOL MYERS SQUIBB$$74$YR$E$$Y$$$20240909$$MD$JP$JP
242986371$24298637$1$I$20240709$20240904$20240909$20240909$30DAY$$AR-PFIZER INC-202400239353$PFIZER$$8$YR$$M$Y$20$KG$20240909$$CN$AR$AR
242986381$24298638$1$I$$20240905$20240909$20240909$PER$$US-TAKEDA-2024TUS089289$TAKEDA$$$$$M$Y$$$20240909$$CN$US$US
242986391$24298639$1$I$20221101$20240422$20240909$20240909$EXP$FR-AFSSAPS-RN2024000423$NVSC2024FR084640$NOVARTIS$$83$YR$$M$Y$$$20240909$$MD$FR$FR
242986402$24298640$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686666$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986412$24298641$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686665$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986421$24298642$1$I$$20240903$20240909$20240909$PER$$US-BAYER-2024A126472$BAYER$$75$YR$E$M$Y$$$20240909$$CN$US$US
242986432$24298643$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686667$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986441$24298644$1$I$20240820$20240903$20240909$20240909$PER$$US-Millicent Holdings Ltd.-MILL20241136$MILLICENT HOLDINGS$$56$YR$A$F$Y$$$20240909$$CN$US$US
242986451$24298645$1$I$20210601$20240830$20240909$20240909$EXP$FR-AFSSAPS-ST2024001335$FR-TEVA-VS-3239154$TEVA$$37$YR$$F$Y$$$20240909$$MD$FR$FR
242986461$24298646$1$I$$20240830$20240909$20240909$EXP$$TW-AMGEN-TWNSP2024176478$AMGEN$Hung Y.; Wu W.; Hsu C. et al.. Incorporating Tumor Genomic Profiling and Circulating Tumor Cell-derived Organoids into Clinical Practice for Gastrointestinal cancers. Anticancer research. 2024;44 (8):3481-3491$47$YR$A$F$Y$$$20240909$$MD$TW$TW
242986472$24298647$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686668$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986482$24298648$2$F$$20240905$20240909$20240919$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-20692$ALKEM$Baytunca MB, Erermis S, Bildik T, Kayahan B.. Isoniazid-induced psychosis with obsessive-compulsive symptoms (schizo-obsessive disorder) in a female child. Journal Of Child and Adolescent Psychopharmacology. 2015;25(10):819-820$11$YR$$F$Y$$$20240919$$MD$TR$TR
242986501$24298650$1$I$$20240826$20240909$20240909$EXP$$LK-ALKEM LABORATORIES LIMITED-LK-ALKEM-2024-20698$ALKEM$Demartini B, Camisasca M, Zuin M et al. A case of isoniazid-induced delirium. J Neuropsychiatry Clin Neurosci. 2013;25(2):e68- e69$56$YR$$M$Y$$$20240909$$HP$LK$LK
242986511$24298651$1$I$$20240826$20240909$20240909$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-20667$ALKEM$Madan A, Jain NK, Sharma TN, et al.. Attempted suicide following treatment with isoniazid. Tubercle. 1989;70(2):147-149$20$YR$$M$Y$$$20240909$$HP$IN$IN
242986521$24298652$1$I$$20240826$20240909$20240909$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20449$ALKEM$Dahabra L, Kassem A, Sattar S, Muhammad M, Assaad M, Narula N, Elsayegh D. Conventional Dialysis in Amlodipine Overdose. Am J Respir Crit Care Med. 2022;205:A1586$30$YR$$M$Y$$$20240909$$HP$US$US
242986531$24298653$1$I$$20240826$20240909$20240909$EXP$$CN-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-20648$ALKEM$Gnam W, Flint A, Goldbloom D. Isoniazid-induced hallucinosis: response to pyridoxine. Psychosomatics. 1993;34(6):537-539$67$YR$$F$Y$$$20240909$$HP$CN$CN
242986552$24298655$2$F$20180101$20240906$20240909$20240920$EXP$US-MLMSERVICE-20240816-PI161771-00232-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20369$ALKEM$Chowdhury RB, Shah SI, Milford E, Tullius SG, Rennke H, Bianchi G.. Extramedullary plasmacytoma exclusively localized in transplanted kidney: Post-transplant lymphoproliferative disorder or monoclonal gammopathy of renal significance?. Journal of Onco-Nephrology. 2024;8(2):70-74$44$YR$$F$Y$$$20240920$$MD$US$US
242986561$24298656$1$I$$20240826$20240909$20240909$EXP$$AE-ALKEM LABORATORIES LIMITED-AE-ALKEM-2024-20643$ALKEM$Alsaadi T, Kassie S, Farook F, Nasreddine W, Wani S, Saleh B. Antiseizure drugs use during pregnancy and congenital malformations: A retrospective review from the United Arab Emirates. Epilepsy Research. 2020;159:106259$$$N$$Y$$$20240909$$HP$AE$AE
242986571$24298657$1$I$$20240826$20240909$20240909$EXP$$AE-ALKEM LABORATORIES LIMITED-AE-ALKEM-2024-20646$ALKEM$Alsaadi T, Kassie S, Farook F, Nasreddine W, Wani S, Saleh B. Antiseizure drugs use during pregnancy and congenital malformations: A retrospective review from the United Arab Emirates. Epilepsy Research. 2020;159:106259$$$$$Y$$$20240909$$HP$AE$AE
242986581$24298658$1$I$$20240826$20240909$20240909$EXP$$AE-ALKEM LABORATORIES LIMITED-AE-ALKEM-2024-20652$ALKEM$Alsaadi T, Kassie S, Farook F, Nasreddine W, Wani S, Saleh B. Antiseizure drugs use during pregnancy and congenital malformations: A retrospective review from the United Arab Emirates. Epilepsy Research. 2020;159:106259$$$$$Y$$$20240909$$HP$AE$AE
242986591$24298659$1$I$$20240826$20240909$20240909$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-20632$ALKEM$Chen Y, Wu J, Zhang H, Chen H, Tian X, Jing W, Wang X.. Anti-Seizure Monotherapy and Early Abortion Under Real-World Conditions. Neurology India. 2023;71:928-32$$$$F$Y$$$20240909$$HP$CN$CN
242986601$24298660$1$I$$20240826$20240909$20240909$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-20633$ALKEM$Chen Y, Wu J, Zhang H, Chen H, Tian X, Jing W, Wang X. Anti-Seizure Monotherapy and Early Abortion Under Real-World Conditions. Neurology India. 2023;71(5):928-932$$$$F$Y$$$20240909$$HP$CN$CN
242986611$24298661$1$I$$20240826$20240909$20240909$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-20634$ALKEM$Chen Y, Wu J, Zhang H, Chen H, Tian X, Jing W, Wang X. Anti-Seizure Monotherapy and Early Abortion Under Real-World Conditions. Neurology India. 2023;71(5):928-932$$$$F$Y$$$20240909$$HP$CN$CN
242986621$24298662$1$I$$20240826$20240909$20240909$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-20636$ALKEM$Chen Y, Wu J, Zhang H, Chen H, Tian X, Jing W, Wang X. Anti-Seizure Monotherapy and Early Abortion Under Real-World Conditions. Neurology India. 2023;71(5):928-932$$$$F$Y$$$20240909$$HP$CN$CN
242986632$24298663$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686681$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986641$24298664$1$I$$20240826$20240909$20240909$EXP$$AE-ALKEM LABORATORIES LIMITED-AE-ALKEM-2024-20650$ALKEM$Alsaadi T, Kassie S, Farook F, Nasreddine W, Wani S, Saleh B. Antiseizure drugs use during pregnancy and congenital malformations: A retrospective review from the United Arab Emirates. Epilepsy Research. 2020;159:106259$$$N$$Y$$$20240909$$HP$AE$AE
242986651$24298665$1$I$20240824$20240904$20240909$20240909$EXP$$SG-JNJFOC-20240914435$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240909$$HP$SG$SG
242986661$24298666$1$I$$20240827$20240909$20240909$PER$$US-JNJFOC-20240870462$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$US$US
242986673$24298667$3$F$$20240912$20240909$20240921$EXP$$US-TEVA-VS-3235174$TEVA$Chaisrimaneepan N, Saowapa S, Pangkanon W, Thongpiya J, Yingchoncharoen P, Polpichai N, Siladech P. Neutrophilic eccrine hidradenitis from granulocyte-stimulating factor in a patient with ANCA vasculitis. Clin Case Rep. 2024 Jun 23;12(7):e9114.; Chaisrimaneepan N, Saowapa S, Pangkanon W, Thongpiya J, Yingchoncharoen P, Polpichai N, Siladech P. Neutrophilic eccrine hidradenitis from granulocyte-stimulating factor in a patient with ANCA vasculitis. Clin Case Rep. 2024 Jun 23;12(7):e9114.$$$A$M$Y$$$20240921$$HP$US$US
242986681$24298668$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003892$ELI LILLY AND CO$$$$$$Y$$$20240909$$HP$US$US
242986701$24298670$1$I$$20240906$20240909$20240909$EXP$GB-MHRA-TPP14815718C9405995YC1725541081820$GB-SANDOZ INC.-SDZ2024GB078403$SANDOZ$$91$YR$$M$Y$61$KG$20240909$$HP$GB$GB
242986711$24298671$1$I$$20240829$20240909$20240909$PER$$US-SA-2024SA258789$SANOFI AVENTIS$$$$A$M$Y$$$20240909$$HP$US$US
242986721$24298672$1$I$$20240828$20240909$20240909$PER$$US-SA-2024SA259158$SANOFI AVENTIS$$62$YR$A$$Y$$$20240909$$CN$US$US
242986731$24298673$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA257953$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240909$$MD$US$US
242986741$24298674$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259083$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240909$$HP$US$US
242986751$24298675$1$I$20220101$20240828$20240909$20240909$PER$$US-SA-2024SA259233$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240909$$CN$US$US
242986771$24298677$1$I$$20240903$20240909$20240909$PER$$NVSC2024US179683$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
242986781$24298678$1$I$$20240905$20240909$20240909$EXP$$NVSC2024CA179655$NOVARTIS$$54$YR$$F$Y$$$20240909$$CN$CA$CA
242986791$24298679$1$I$$20240828$20240909$20240909$EXP$$US-FARMAPROD-202408-3090$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240909$$CN$US$US
242986802$24298680$2$F$20240903$20240923$20240909$20240930$EXP$$NVSC2024DE179607$NOVARTIS$$$$A$F$Y$$$20240930$$MD$DE$DE
242986811$24298681$1$I$20240829$20240903$20240909$20240909$PER$$US-BAYER-2024A126269$BAYER$$37$YR$A$F$Y$$$20240909$$HP$US$US
242986832$24298683$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686663$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986841$24298684$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178299$AMGEN$$$$$$Y$$$20240909$$HP$US$US
242986852$24298685$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686670$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986861$24298686$1$I$$20240903$20240909$20240909$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049724$BOEHRINGER INGELHEIM$$$$$$Y$$$20240909$$CN$US$US
242986871$24298687$1$I$$20240903$20240909$20240909$EXP$GB-MHRA-MED-202409020906128010-ZDPHQ$GB-MYLANLABS-2024M1081451$MYLAN$$$$$M$Y$$$20240909$$HP$GB$GB
242986882$24298688$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686671$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986891$24298689$1$I$20210101$20240906$20240909$20240909$EXP$NL-EMA-DD-20240902-7482663-153157$NL-SANDOZ INC.-SDZ2024NL078318$SANDOZ$$48$YR$$M$Y$$$20240909$$HP$NL$NL
242986922$24298692$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686672$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242986931$24298693$1$I$$20240908$20240908$20240908$DIR$FDA-CDER-CTU-2024-61591$$FDA-CTU$$64$YR$$F$N$$$20240908$N$$US$
242986951$24298695$1$I$20240905$20240906$20240906$20240906$DIR$717480$$FDA-CTU$$38$YR$$F$N$75.15$KG$20240906$N$CN$US$
242986961$24298696$1$I$20240815$20240906$20240906$20240906$DIR$717465$$FDA-CTU$$79$YR$$M$N$98.1$KG$20240906$N$CN$US$
242986971$24298697$1$I$20240816$20240826$20240907$20240907$DIR$FDA-CDER-CTU-2024-61584$$FDA-CTU$$$$$F$N$899$KG$20240826$N$$US$
242986991$24298699$1$I$20240820$20240906$20240906$20240906$DIR$717518$$FDA-CTU$$46$YR$$F$N$73$KG$20240906$N$PH$US$
242987001$24298700$1$I$$20240908$20240908$20240908$DIR$FDA-CDER-CTU-2024-61592$$FDA-CTU$$77$YR$$M$N$$$20240908$N$$US$
242987031$24298703$1$I$20230930$20230930$20240909$20240909$PER$$US-CHIESI-2023CHF05124$CHIESI$$$$$$Y$$$20240909$$HP$US$US
242987051$24298705$1$I$$20240902$20240909$20240909$EXP$$JP-009507513-2409JPN000230J$MERCK$$63$YR$$M$Y$$$20240909$$MD$JP$JP
242987061$24298706$1$I$20240612$20240709$20240909$20240909$PER$$US-CHIESI-2024CHF03573$CHIESI$$$$$F$Y$$$20240909$$MD$US$US
242987071$24298707$1$I$$20240829$20240909$20240909$EXP$$CA-JNJFOC-20240816727$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240909$$HP$CA$CA
242987081$24298708$1$I$$20240124$20240909$20240909$PER$$US-CHIESI-2024CHF00419$CHIESI$$$$$$Y$$$20240909$$HP$US$US
242987091$24298709$1$I$$20240905$20240909$20240909$EXP$$AU-GILEAD-2024-0686688$GILEAD$$$$E$M$Y$$$20240909$$CN$AU$AU
242987102$24298710$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686673$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242987112$24298711$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686674$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242987121$24298712$1$I$20230101$20240829$20240909$20240909$PER$$US-BAYER-2024A128225$BAYER$$65$YR$E$$Y$$$20240909$$CN$US$US
242987131$24298713$1$I$20240829$20240829$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009159$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242987142$24298714$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686675$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242987151$24298715$1$I$$20240902$20240909$20240909$PER$$US-BAYER-2024A126589$BAYER$$$$$$Y$$$20240909$$CN$US$US
242987161$24298716$1$I$$20240829$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009155$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242987172$24298717$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686676$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242987182$24298718$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686677$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242987191$24298719$1$I$$20240715$20240909$20240909$EXP$$PT-TEVA-VS-3237448$TEVA$Jo?o Coutinho De Sousa; Teresa Pinto; Filipe Gomes Pereira; Maria In?s Risto. PANCYTOPENIA IN A PATIENT WITH SEVERE FOLIC ACID DEFICIENCY DUE TO METHOTREXATE THERAPY. Doen?as hematol?gicas | Caso cl?nico. PO-0179 - (2250)$75$YR$$F$Y$$$20240909$$MD$PT$PT
242987211$24298721$1$I$20240805$20240906$20240906$20240906$DIR$717493$$FDA-CTU$$54$YR$$F$N$51.75$KG$20240906$N$CN$US$
242987221$24298722$1$I$$20240906$20240908$20240908$DIR$FDA-CDER-CTU-2024-61706$$FDA-CTU$$$$$F$N$$$20240906$N$HP$US$
242987231$24298723$1$I$$20240908$20240908$20240908$DIR$FDA-CDER-CTU-2024-61593$$FDA-CTU$$97$YR$$F$N$$$20240908$N$$US$
242987241$24298724$1$I$20240620$20240906$20240906$20240906$DIR$717425$$FDA-CTU$$70$YR$$M$N$$$20240906$N$PH$US$
242987251$24298725$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA258434$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240909$$MD$US$US
242987261$24298726$1$I$$20240828$20240909$20240909$PER$$US-SA-2024SA259133$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240909$$HP$US$US
242987271$24298727$1$I$$20240907$20240907$20240907$DIR$FDA-CDER-CTU-2024-61590$$FDA-CTU$$70$YR$$F$N$$$20240907$N$$US$
242987281$24298728$1$I$$20240907$20240907$20240907$DIR$FDA-CDER-CTU-2024-61589$$FDA-CTU$$85$YR$$M$N$$$20240907$N$$US$
242987291$24298729$1$I$$20240907$20240907$20240907$DIR$FDA-CDER-CTU-2024-61705$$FDA-CTU$$50$YR$$F$N$$$20240907$N$$US$
242987301$24298730$1$I$20240101$20240821$20240909$20240909$PER$$US-SA-2024SA258985$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240909$$MD$US$US
242987311$24298731$1$I$$20240909$20240909$20240909$PER$$NVSC2024US180374$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
242987321$24298732$1$I$$20240905$20240909$20240909$EXP$$US-GILEAD-2024-0686679$GILEAD$$51$YR$A$M$Y$$$20240909$$CN$US$US
242987331$24298733$1$I$$20240906$20240906$20240906$DIR$717451$$FDA-CTU$$$$$UNK$N$$$20240906$N$CN$US$
242987341$24298734$1$I$20240901$20240905$20240907$20240907$DIR$FDA-CDER-CTU-2024-61701$$FDA-CTU$$55$YR$$F$N$83.9$KG$20240905$N$$US$
242987352$24298735$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686772$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242987361$24298736$1$I$20240415$20240905$20240907$20240907$DIR$FDA-CDER-CTU-2024-61588$$FDA-CTU$$$$$F$N$$$20240905$N$$US$
242987381$24298738$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141968$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240909$$CN$US$US
242987391$24298739$1$I$20240101$20240826$20240909$20240909$EXP$$CA-UCBSA-2024020302$UCB$$$$$F$Y$$$20240909$$CN$CA$CA
242987411$24298741$1$I$20240830$20240830$20240907$20240907$DIR$FDA-CDER-CTU-2024-61702$$FDA-CTU$$67$YR$$M$N$68.49$KG$20240830$N$$US$
242987422$24298742$2$F$$20240906$20240909$20240909$PER$$US-GILEAD-2024-0686706$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242987442$24298744$2$F$$20240913$20240909$20240919$EXP$$US-INCYTE CORPORATION-2024IN009152$INCYTE$$$$$$Y$$$20240919$$MD$US$US
242987451$24298745$1$I$$20240827$20240909$20240909$EXP$$AT-ROVI-20240867$ROVIPHARM SAS$$$$A$M$Y$$$20240909$$PH$AT$AT
242987461$24298746$1$I$$20240906$20240906$20240906$DIR$717440$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242987471$24298747$1$I$$20240830$20240909$20240909$EXP$$US-GSK-US2024108459$GLAXOSMITHKLINE$$$$$F$Y$$$20240909$$CN$US$US
242987491$24298749$1$I$20240416$20240829$20240907$20240907$DIR$FDA-CDER-CTU-2024-61587$$FDA-CTU$$$$$M$N$66.2$KG$20240829$N$$US$
242987502$24298750$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686710$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242987511$24298751$1$I$20240821$20240827$20240907$20240907$DIR$FDA-CDER-CTU-2024-61583$$FDA-CTU$$$$$F$N$86.2$KG$20240827$N$$US$
242987521$24298752$1$I$$20240906$20240906$20240906$DIR$717467$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242987531$24298753$1$I$20240630$20240903$20240909$20240909$EXP$$NVSC2024IN179107$NOVARTIS$$73$YR$$M$Y$$$20240909$$HP$IN$IN
242987541$24298754$1$I$20240715$20240903$20240909$20240909$PER$$US-BAYER-2024A126387$BAYER$$$$$F$Y$$$20240909$$MD$US$US
242987551$24298755$1$I$20240416$20240829$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009151$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242987561$24298756$1$I$20240905$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024178983$AMGEN$$$$$$Y$$$20240909$$PH$US$US
242987571$24298757$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178820$AMGEN$$$$$$Y$$$20240909$$PH$US$US
242987581$24298758$1$I$20240905$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024179427$AMGEN$$55$YR$A$M$Y$$$20240909$$CN$US$US
242987591$24298759$1$I$20240902$20240905$20240909$20240909$EXP$$CN-SA-2024SA258556$SANOFI AVENTIS$$31$YR$A$M$Y$54$KG$20240909$$HP$CN$CN
242987601$24298760$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA258979$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240909$$CN$US$US
242987611$24298761$1$I$20240712$20240827$20240909$20240909$PER$$US-SA-2024SA259156$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240909$$MD$US$US
242987621$24298762$1$I$20240812$20240905$20240907$20240907$DIR$FDA-CDER-CTU-2024-61586$$FDA-CTU$$$$$F$N$73.3$KG$20240905$N$$US$
242987641$24298764$1$I$20240826$20240906$20240907$20240907$DIR$FDA-CDER-CTU-2024-61704$$FDA-CTU$$88$YR$$M$N$68.6$KG$20240906$N$$US$
242987651$24298765$1$I$20240828$20240905$20240907$20240907$DIR$FDA-CDER-CTU-2024-61703$$FDA-CTU$$54$YR$$F$N$59.7$KG$20240905$N$$US$
242987661$24298766$1$I$20240722$20240907$20240907$20240907$DIR$717552$$FDA-CTU$$73$YR$$F$N$60.75$KG$20240907$N$CN$US$
242987672$24298767$2$F$20240521$20240626$20240909$20240920$EXP$$PR-GUERBET / LLC-PR-20240003$GUERBET$$81$YR$E$F$Y$63.5$KG$20240920$$HP$PR$PR
242987682$24298768$2$F$$20240912$20240909$20240917$EXP$$CA-MYLANLABS-2024M1082022$MYLAN$$$$$M$Y$$$20240917$$MD$CA$CA
242987691$24298769$1$I$$20240906$20240909$20240909$EXP$$NZ-MYLANLABS-2024M1082058$MYLAN$$$$$F$Y$$$20240909$$HP$NZ$NZ
242987701$24298770$1$I$$20240821$20240909$20240909$PER$$US-TEVA-VS-3237139$TEVA$$68$YR$$F$Y$$$20240909$$CN$US$US
242987712$24298771$2$F$20240731$20240828$20240909$20240926$PER$$US-BEH-2024178368$CSL BEHRING$$55$YR$A$M$Y$71.202$KG$20240926$$CN$US$US
242987741$24298774$1$I$20230807$20240830$20240909$20240909$EXP$FR-AFSSAPS-ST2024001333$FR-TEVA-VS-3239272$TEVA$$66$YR$$M$Y$69.9$KG$20240909$$HP$FR$FR
242987752$24298775$2$F$20240627$20240920$20240909$20240928$EXP$NO-NOMAADVRE-FHI-2024-Vqd5ka$NO-ABBVIE-5909560$ABBVIE$$41$YR$$F$Y$$$20240928$$HP$NO$NO
242987771$24298777$1$I$$20240829$20240909$20240909$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202408019321$ELI LILLY AND CO$Wu W.-C.,Hsu C.-F.,Chen M.-H.,Chen S.-C.,Hung Y.-P.,Chiang N.-J..Incorporating Tumor Genomic Profiling and Circulating Tumor Cell-derived Organoids into Clinical Practice for Gastrointestinal Cancers..Anticancer Research 2024;44(8):3481-3491.DOI:10.21873/anticanres.17168$69$YR$E$F$Y$$$20240909$$MD$TW$TW
242987781$24298778$1$I$20240904$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003403$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242987791$24298779$1$I$$20240905$20240909$20240909$EXP$$AU-MYLANLABS-2024M1081785$MYLAN$$$$$M$Y$$$20240909$$PH$AU$AU
242987801$24298780$1$I$$20240905$20240909$20240909$PER$$US-ABBVIE-5909774$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
242987821$24298782$1$I$$20240820$20240909$20240909$PER$$US-TEVA-VS-3236712$TEVA$$78$YR$$M$Y$$$20240909$$CN$US$US
242987831$24298783$1$I$20240718$20240826$20240909$20240909$EXP$$US-HLS-202401084$HLS THERAPEUTICS$$66$YR$E$F$Y$$$20240909$$HP$US$US
242987842$24298784$2$F$20240628$20240923$20240909$20240925$PER$$US-AMGEN-USASP2024177879$AMGEN$$87$YR$E$F$Y$$$20240925$$MD$US$US
242987852$24298785$2$F$20240904$20240909$20240909$20240911$PER$$US-AMGEN-USASP2024179163$AMGEN$$78$YR$E$F$Y$$$20240911$$CN$US$US
242987861$24298786$1$I$20240904$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178295$AMGEN$$79$YR$E$F$Y$$$20240909$$CN$US$US
242987872$24298787$2$F$20240902$20240924$20240909$20240924$PER$$US-BAYER-2024A126740$BAYER$$87$YR$E$F$Y$$$20240924$$CN$US$US
242987881$24298788$1$I$$20240904$20240909$20240909$PER$$US-BAYER-2024A127147$BAYER$$66$YR$E$F$Y$$$20240909$$CN$US$US
242987891$24298789$1$I$20210101$20240905$20240909$20240909$PER$$US-BIOGEN-2024BI01261319$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
242987911$24298791$1$I$20240812$20240906$20240909$20240909$DIR$FDA-CDER-CTU-2024-61708$$FDA-CTU$$51$YR$$M$N$61.2$KG$20240906$N$$US$
242987921$24298792$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61822$$FDA-CTU$$73$YR$$M$N$$$20240909$N$$US$
242987931$24298793$1$I$$20240906$20240906$20240906$DIR$717470$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242987941$24298794$1$I$$20240828$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137818$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240909$$MD$US$US
242987962$24298796$2$F$$20240909$20240909$20240910$PER$$US-JNJFOC-20240919719$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
242987972$24298797$2$F$20240521$20240626$20240909$20240920$EXP$$PR-GUERBET / LLC-PR-20240001$GUERBET$$46$YR$A$M$Y$118.8$KG$20240920$$HP$PR$PR
242987981$24298798$1$I$$20240827$20240909$20240909$EXP$$CA-FreseniusKabi-FK202413145$FRESENIUS KABI$$$$$F$Y$$$20240909$$CN$CA$CA
242987991$24298799$1$I$20231219$20240829$20240909$20240909$EXP$$US-FreseniusKabi-FK202413257$FRESENIUS KABI$$$$$F$Y$$$20240909$$CN$US$US
242988001$24298800$1$I$$20240830$20240909$20240909$EXP$$US-FreseniusKabi-FK202413481$FRESENIUS KABI$Jih MH, Asadi LK, Goldberg LH. Paradoxical Reaction to TNF-alpha Inhibitor Therapy in a Patient With Hidradenitis Suppurativa. Cutis. 112(05): 23-25. doi:doi:10.12788/cutis.0898.$38$YR$A$F$Y$$$20240909$$MD$US$US
242988012$24298801$2$F$$20240912$20240909$20240920$EXP$$CA-TEVA-VS-3239392$TEVA$$66$YR$$M$Y$$$20240920$$HP$CA$CA
242988061$24298806$1$I$20240901$20240906$20240906$20240906$DIR$717510$$FDA-CTU$$73$YR$$F$N$90.45$KG$20240906$N$CN$US$
242988071$24298807$1$I$$20240906$20240906$20240906$DIR$717447$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242988101$24298810$1$I$$20240904$20240909$20240909$PER$$US-BAYER-2024A127319$BAYER$$$$$F$Y$$$20240909$$CN$US$US
242988111$24298811$1$I$20210820$20240826$20240909$20240909$EXP$$US-UCBSA-2024001693$UCB$$35$YR$$F$Y$$$20240909$$CN$US$US
242988122$24298812$2$F$$20240911$20240909$20240918$PER$$US-LEO Pharma-373299$LEO PHARM$$66$YR$$F$Y$$$20240918$$HP$US$US
242988151$24298815$1$I$$20240830$20240909$20240909$EXP$$CA-TAKEDA-2024TUS087827$TAKEDA$$$$$F$Y$$$20240909$$CN$CA$CA
242988161$24298816$1$I$20240622$20240830$20240909$20240909$EXP$ES-AEMPS-1563440$ES-TEVA-VS-3239296$TEVA$$44$YR$$M$Y$$$20240909$$MD$ES$ES
242988171$24298817$1$I$20240901$20240906$20240906$20240906$DIR$717464$$FDA-CTU$$74$YR$$M$N$$$20240906$N$PH$US$
242988181$24298818$1$I$$20240906$20240906$20240906$DIR$717484$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242988191$24298819$1$I$20230817$20240904$20240909$20240909$EXP$$KR-009507513-2409KOR001032$MERCK$$$$$M$Y$$$20240909$$HP$KR$KR
242988201$24298820$1$I$20240801$20240828$20240909$20240909$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2024-001936$SK LIFE SCIENCE$$$$$$Y$$$20240909$$CN$US$US
242988211$24298821$1$I$20240905$20240905$20240909$20240909$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-143886$DAIICHI$$42$YR$$M$Y$$$20240909$$HP$US$US
242988222$24298822$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686773$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242988231$24298823$1$I$20230204$20240904$20240909$20240909$EXP$$BY-JNJFOC-20240915297$JOHNSON AND JOHNSON$$$$A$M$Y$62$KG$20240909$$MD$BY$BY
242988241$24298824$1$I$$20240904$20240909$20240909$PER$$US-BAYER-2024A126980$BAYER$$$$$M$Y$$$20240909$$CN$US$US
242988251$24298825$1$I$20240901$20240905$20240909$20240909$PER$$US-ALXN-202409USA000323US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242988261$24298826$1$I$20240906$20240906$20240909$20240909$PER$$US-HALEON-2195769$Haleon PLC$$82$YR$$$Y$$$20240909$$CN$US$US
242988271$24298827$1$I$20240903$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024177071$AMGEN$$52$YR$A$F$Y$$$20240909$$CN$US$US
242988281$24298828$1$I$$20240905$20240909$20240909$PER$$US-HALEON-2195726$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
242988292$24298829$2$F$20240713$20240903$20240909$20240913$EXP$FR-AFSSAPS-TS2024000939$FR-TEVA-VS-3239024$TEVA$$87$YR$$M$Y$82$KG$20240913$$MD$FR$FR
242988302$24298830$2$F$20240730$20240903$20240909$20240913$EXP$$AU-AMGEN-AUSSP2024156830$AMGEN$$$$$F$Y$$$20240913$$CN$AU$AU
242988311$24298831$1$I$$20240905$20240909$20240909$PER$$US-BAYER-2024A127619$BAYER$$$$$M$Y$$$20240909$$CN$US$US
242988321$24298832$1$I$$20240903$20240909$20240909$PER$$US-009507513-2409USA001323$MERCK$$$$$F$Y$$$20240909$$MD$US$US
242988341$24298834$1$I$$20240830$20240909$20240909$EXP$$IT-AMGEN-ITASP2024176355$AMGEN$Barzaghi, F. ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Immunology. 2018;9:1-6$4$YR$C$F$Y$$$20240909$$HP$IT$IT
242988351$24298835$1$I$20240101$20240829$20240909$20240909$EXP$$US-SA-2024SA260395$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240909$$MD$US$US
242988361$24298836$1$I$20240903$20240904$20240909$20240909$PER$$US-BAYER-2024A127409$BAYER$$12$YR$C$M$Y$$$20240909$$CN$US$US
242988371$24298837$1$I$20211119$20240905$20240909$20240909$EXP$$JP-JNJFOC-20240918255$JOHNSON AND JOHNSON$$7$DEC$$F$Y$$$20240909$$MD$JP$JP
242988381$24298838$1$I$20240826$20240903$20240909$20240909$PER$$US-JNJFOC-20240907355$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242988392$24298839$2$F$20240603$20240626$20240909$20240920$EXP$$PR-GUERBET / LLC-PR-20240002$GUERBET$$65$YR$E$M$Y$92.5$KG$20240920$$HP$PR$PR
242988401$24298840$1$I$20231215$20240902$20240909$20240909$EXP$FR-AFSSAPS-TO2024001475$FR-FreseniusKabi-FK202413345$FRESENIUS KABI$$71$YR$E$M$Y$$$20240909$$MD$FR$FR
242988411$24298841$1$I$20240814$20240831$20240909$20240909$EXP$$CN-FreseniusKabi-FK202413296$FRESENIUS KABI$$1$MON$I$M$Y$1.76$KG$20240909$$HP$CN$CN
242988421$24298842$1$I$20200123$20240902$20240909$20240909$EXP$$DE-FreseniusKabi-FK202413338$FRESENIUS KABI$$79$YR$E$M$Y$64$KG$20240909$$MD$DE$DE
242988431$24298843$1$I$20240902$20240903$20240909$20240909$EXP$$CN-FreseniusKabi-FK202413433$FRESENIUS KABI$$1$YR$I$M$Y$11.6$KG$20240909$$HP$CN$CN
242988441$24298844$1$I$20240803$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024178883$AMGEN$$74$YR$E$F$Y$39.4$KG$20240909$$PH$US$US
242988453$24298845$3$F$20240905$20240910$20240909$20240912$PER$$US-AMGEN-USASP2024178784$AMGEN$$66$YR$E$F$Y$$$20240912$$CN$US$US
242988461$24298846$1$I$$20240905$20240909$20240909$EXP$$US-AMGEN-USASL2024177904$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
242988471$24298847$1$I$$20240905$20240909$20240909$PER$$US-BAYER-2024A127614$BAYER$$$$$$Y$$$20240909$$CN$US$US
242988481$24298848$1$I$20240825$20240829$20240909$20240909$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409000962$ELI LILLY AND CO$$34$YR$A$M$Y$50$KG$20240909$$CN$DE$CN
242988491$24298849$1$I$20240730$20240828$20240909$20240909$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408018704$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240909$$CN$JP$JP
242988501$24298850$1$I$$20240830$20240909$20240909$EXP$GB-MHRA-MED-202408301006379660-JZWKQ$GB-TEVA-VS-3239174$TEVA$$87$YR$$F$Y$$$20240909$$HP$GB$GB
242988512$24298851$2$F$20240713$20240830$20240909$20240912$EXP$IT-MINISAL02-1000265$IT-ELI_LILLY_AND_COMPANY-IT202408018584$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240912$$CN$IT$IT
242988521$24298852$1$I$$20240830$20240909$20240909$EXP$GB-MHRA-MIDB-3b0a4ae1-73d0-4847-b68e-93def85e8301$GB-TEVA-VS-3239020$TEVA$$57$YR$$$Y$$$20240909$$PH$GB$GB
242988531$24298853$1$I$20240731$20240828$20240909$20240909$EXP$FR-AFSSAPS-TO2024001649$FR-ELI_LILLY_AND_COMPANY-FR202408018488$ELI LILLY AND CO$$55$YR$A$F$Y$77$KG$20240909$$CN$FR$FR
242988541$24298854$1$I$20240830$20240830$20240909$20240909$EXP$GB-MHRA-MED-202408301434208730-KHWLD$GB-TEVA-VS-3239221$TEVA$$87$YR$$F$Y$$$20240909$$MD$GB$GB
242988551$24298855$1$I$20240701$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003406$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240909$$CN$US$US
242988561$24298856$1$I$$20240830$20240909$20240909$EXP$$CA-CELLTRION INC.-2024CA020878$CELLTRION$$$$$$Y$$$20240909$$HP$CA$CA
242988571$24298857$1$I$$20240906$20240909$20240909$DIR$FDA-CDER-CTU-2024-61778$$FDA-CTU$$$$$F$N$$$20240906$N$HP$US$
242988592$24298859$2$F$$20240905$20240909$20240924$PER$$US-BAYER-2024A127625$BAYER$$$$$F$Y$$$20240924$$CN$US$US
242988601$24298860$1$I$20240101$20240820$20240909$20240909$PER$$US-TEVA-VS-3235417$TEVA$$4$YR$$M$Y$$$20240909$$CN$US$US
242988611$24298861$1$I$20240815$20240903$20240909$20240909$PER$$US-JNJFOC-20240907207$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240909$$CN$US$US
242988632$24298863$2$F$20200719$20240906$20240909$20240912$EXP$$CA-JNJFOC-20230454505$JOHNSON AND JOHNSON$$11$YR$C$M$Y$60$KG$20240912$$HP$CA$CA
242988641$24298864$1$I$$20240906$20240909$20240909$PER$$US-BAYER-2024A128233$BAYER$$$$$$Y$$$20240909$$CN$US$US
242988661$24298866$1$I$20240906$20240906$20240906$20240906$DIR$717527$$FDA-CTU$$27$YR$$M$N$80$KG$20240906$N$CN$US$
242988672$24298867$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686755$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242988681$24298868$1$I$20240906$20240906$20240906$20240906$DIR$717442$$FDA-CTU$$49$YR$$M$N$$$20240906$N$HP$US$
242988692$24298869$2$F$$20240906$20240909$20240909$EXP$$US-GILEAD-2024-0686774$GILEAD$$$$$$Y$$$20240909$$LW$US$US
242988701$24298870$1$I$$20240908$20240909$20240909$DIR$FDA-CDER-CTU-2024-61827$$FDA-CTU$$$$$M$N$$$20240908$N$HP$US$
242988711$24298871$1$I$20240815$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61829$$FDA-CTU$$78$YR$$M$N$$$20240909$N$$US$
242988721$24298872$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142690$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$87.54$KG$20240909$$CN$US$US
242988731$24298873$1$I$20240906$20240906$20240906$20240906$DIR$717445$$FDA-CTU$$50$YR$$M$N$$$20240906$N$HP$US$
242988741$24298874$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61793$$FDA-CTU$$15$YR$$F$N$$$20240909$N$$US$
242988751$24298875$1$I$$20240906$20240906$20240906$DIR$717497$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242988761$24298876$1$I$20240101$20240905$20240909$20240909$PER$$US-BAYER-2024A127657$BAYER$$40$YR$A$F$Y$$$20240909$$CN$US$US
242988771$24298877$1$I$$20240904$20240909$20240909$PER$$US-BAYER-2024A127998$BAYER$$$$$F$Y$$$20240909$$CN$US$US
242988791$24298879$1$I$$20240906$20240909$20240909$PER$$US-JNJFOC-20240916651$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$MD$US$US
242988802$24298880$2$F$20240101$20240903$20240909$20240916$EXP$$NVSC2024CN179412$NOVARTIS$$$$$M$Y$$$20240916$$CN$CN$CN
242988811$24298881$1$I$20240901$20240905$20240909$20240909$PER$$US-BAYER-2024A128013$BAYER$$$$$$Y$$$20240909$$CN$US$US
242988832$24298883$2$F$20240902$20240909$20240909$20240911$PER$$US-AMGEN-USASP2024178904$AMGEN$$76$YR$E$F$Y$$$20240910$$CN$US$US
242988851$24298885$1$I$20240903$20240906$20240909$20240909$PER$$US-JNJFOC-20240916660$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$CN$US$US
242988861$24298886$1$I$20240101$20240904$20240909$20240909$EXP$$BR-JNJFOC-20240912566$JOHNSON AND JOHNSON$$70$YR$E$$Y$$$20240909$$MD$BR$BR
242988871$24298887$1$I$$20240901$20240909$20240909$EXP$$NVSC2024US176215$NOVARTIS$$$$$M$Y$$$20240909$$CN$US$US
242988882$24298888$2$F$20240604$20240626$20240909$20240920$EXP$$PR-GUERBET / LLC-PR-20240004$GUERBET$$68$YR$E$M$Y$83.9$KG$20240920$$HP$PR$PR
242988891$24298889$1$I$20240712$20240902$20240909$20240909$EXP$IT-MINISAL02-1000757$IT-FreseniusKabi-FK202413378$FRESENIUS KABI$$77$YR$E$F$Y$59$KG$20240909$$MD$IT$IT
242988901$24298890$1$I$20240827$20240902$20240909$20240909$EXP$IT-MINISAL02-1000564$IT-FreseniusKabi-FK202413377$FRESENIUS KABI$$71$YR$E$F$Y$$$20240909$$HP$IT$IT
242988911$24298891$1$I$20240729$20240903$20240909$20240909$EXP$FR-AFSSAPS-AVCN2024000651$FR-MYLANLABS-2024M1080980$MYLAN$$29$YR$$M$Y$$$20240909$$MD$FR$FR
242988921$24298892$1$I$20240621$20240902$20240909$20240909$EXP$FR-AFSSAPS-PO2024000937$FR-FreseniusKabi-FK202413356$FRESENIUS KABI$$57$YR$A$M$Y$$$20240909$$PH$FR$FR
242988931$24298893$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASL2024178274$AMGEN$$$$$F$Y$$$20240909$$HP$US$US
242988941$24298894$1$I$$20240905$20240909$20240909$PER$$US-BAYER-2024A128095$BAYER$$$$$$Y$$$20240909$$CN$US$US
242988951$24298895$1$I$$20240813$20240909$20240909$30DAY$$US-VEROBIOTECH-2024USVEROSPO00207$VERO BIOTECH$$$$$$Y$$$20240909$$HP$US$US
242988991$24298899$1$I$20240101$20240904$20240909$20240909$EXP$$CA-PFIZER INC-202400251338$PFIZER$$66$YR$$F$Y$$$20240909$$HP$CA$CA
242989001$24298900$1$I$$20240829$20240909$20240909$30DAY$$CL-PFIZER INC-202400251600$PFIZER$$$$$$Y$$$20240909$$CN$CL$CL
242989011$24298901$1$I$$20240905$20240909$20240909$30DAY$$CL-PFIZER INC-PV202400117165$PFIZER$$15$YR$$M$Y$$$20240909$$CN$CL$CL
242989021$24298902$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259773$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240909$$HP$US$US
242989031$24298903$1$I$$20240905$20240909$20240909$EXP$$DE-SA-2024SA260294$SANOFI AVENTIS$$$$$M$Y$$$20240909$$HP$DE$DE
242989041$24298904$1$I$20240719$20240903$20240909$20240909$EXP$FR-AFSSAPS-AVCN2024000666$FR-MYLANLABS-2024M1080978$MYLAN$$57$YR$$M$Y$$$20240909$$MD$FR$FR
242989051$24298905$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142272$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$63.96$KG$20240909$$PH$US$US
242989061$24298906$1$I$$20240903$20240909$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-141176$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240909$$MD$JP$JP
242989071$24298907$1$I$$20240905$20240909$20240909$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144117$DAIICHI$$$$$F$Y$$$20240909$$HP$US$US
242989081$24298908$1$I$20240901$20240906$20240909$20240909$PER$$US-ALXN-202409USA000425US$ALEXION PHARMACEUTICALS$$90$YR$$F$Y$$$20240909$$CN$US$US
242989091$24298909$1$I$20240101$20240902$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140346$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$54.9$KG$20240909$$CN$US$US
242989111$24298911$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61849$$FDA-CTU$$28$YR$$F$N$80.74$KG$20240909$N$$US$
242989121$24298912$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61851$$FDA-CTU$$70$YR$$F$N$$$20240909$N$$US$
242989141$24298914$1$I$20240320$20240907$20240907$20240907$DIR$717536$$FDA-CTU$$62$YR$$F$N$51.75$KG$20240907$N$CN$US$
242989161$24298916$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61839$$FDA-CTU$$9$YR$$F$N$$$20240909$N$$US$
242989171$24298917$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61848$$FDA-CTU$$55$YR$$F$N$$$20240909$N$$US$
242989181$24298918$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61847$$FDA-CTU$$75$YR$$F$N$$$20240909$N$$US$
242989201$24298920$1$I$20240821$20240907$20240907$20240907$DIR$717556$$FDA-CTU$$46$YR$$F$N$67.5$KG$20240907$N$CN$US$
242989211$24298921$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61828$$FDA-CTU$$50$YR$$M$N$$$20240909$N$$US$
242989231$24298923$1$I$$20240907$20240909$20240909$DIR$FDA-CDER-CTU-2024-61853$$FDA-CTU$$$$$M$N$$$20240907$N$HP$US$
242989281$24298928$1$I$20240906$20240906$20240906$20240906$DIR$717450$$FDA-CTU$$28$YR$$F$N$82.8$KG$20240906$Y$HP$US$
242989311$24298931$1$I$20240225$20240907$20240907$20240907$DIR$717545$$FDA-CTU$$85$YR$$M$N$75.6$KG$20240907$N$CN$US$
242989332$24298933$2$F$$20240919$20240909$20240920$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144119$DAIICHI$$$$$F$Y$$$20240921$$HP$US$US
242989341$24298934$1$I$$20240904$20240909$20240909$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144058$DAIICHI$$$$$$Y$$$20240909$$CN$US$US
242989351$24298935$1$I$20240901$20240905$20240909$20240909$EXP$$CN-SANDOZ INC.-SDZ2024CN078256$SANDOZ$$73$YR$$F$Y$46$KG$20240909$$HP$CN$CN
242989361$24298936$1$I$20220901$20240826$20240909$20240909$EXP$$US-UCBSA-2024021035$UCB$$34$YR$$F$Y$120.18$KG$20240909$$CN$US$US
242989371$24298937$1$I$$20240830$20240909$20240909$EXP$$US-SA-2024SA259173$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240909$$CN$US$US
242989381$24298938$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259772$SANOFI AVENTIS$$12$YR$T$F$Y$36$KG$20240909$$HP$US$US
242989391$24298939$1$I$20240627$20240830$20240909$20240909$EXP$FR-AFSSAPS-AVCN2024000644$FR-TEVA-VS-3239134$TEVA$$29$YR$$M$Y$$$20240909$$MD$FR$FR
242989401$24298940$1$I$20240101$20240905$20240909$20240909$EXP$$US-PFIZER INC-PV202400074652$PFIZER$$37$YR$$F$Y$$$20240909$$HP$US$US
242989412$24298941$2$F$20240905$20240905$20240909$20240913$PER$$US-AMGEN-USASP2024178281$AMGEN$$77$YR$E$F$Y$$$20240913$$CN$US$US
242989431$24298943$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143194$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240909$$CN$US$US
242989451$24298945$1$I$20240826$20240830$20240909$20240909$EXP$$US-OTSUKA-2024_024634$OTSUKA$$68$YR$$F$Y$$$20240909$$CN$US$US
242989461$24298946$1$I$20240521$20240612$20240909$20240909$EXP$$PR-GUERBET / LLC-PR-20240005$GUERBET$$72$YR$E$M$Y$72.57$KG$20240909$$HP$PR$PR
242989471$24298947$1$I$$20240906$20240909$20240909$PER$$US-BAYER-2024A128249$BAYER$$$$$$Y$$$20240909$$CN$US$US
242989481$24298948$1$I$$20240902$20240909$20240909$EXP$$CA-GSK-CA2023167921$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$CN$CA$CA
242989491$24298949$1$I$$20240826$20240909$20240909$EXP$$US-SMPA-2024SPA001966$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242989501$24298950$1$I$20240101$20240826$20240909$20240909$EXP$$US-SMPA-2024SPA001961$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242989521$24298952$1$I$20240805$20240907$20240907$20240907$DIR$717553$$FDA-CTU$$35$YR$$F$N$$$20240907$N$PH$US$
242989531$24298953$1$I$20230101$20240827$20240909$20240909$EXP$$US-SMPA-2024MYSCI0400626$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242989541$24298954$1$I$20240701$20240827$20240909$20240909$EXP$$US-SMPA-2024SPA002002$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242989571$24298957$1$I$$20240826$20240909$20240909$EXP$$US-SMPA-2024SPA001970$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242989581$24298958$1$I$$20240826$20240909$20240909$EXP$$US-SMPA-2024SPA002012$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242989591$24298959$1$I$$20240827$20240909$20240909$EXP$$US-SMPA-2024SPA001997$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242989601$24298960$1$I$$20240906$20240906$20240906$DIR$717479$$FDA-CTU$$$$$UNK$N$$$20240906$$CN$US$
242989611$24298961$1$I$20240821$20240907$20240907$20240907$DIR$717549$$FDA-CTU$$76$YR$$M$N$67.5$KG$20240907$N$CN$US$
242989621$24298962$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003911$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240909$$CN$US$US
242989631$24298963$1$I$$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004519$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240909$$CN$US$US
242989642$24298964$2$F$20060701$20240920$20240909$20240923$EXP$$SK-SANDOZ INC.-PHHY2018SK115409$SANDOZ$$29$YR$$M$Y$$$20240923$$MD$SK$SK
242989651$24298965$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004175$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$US$US
242989662$24298966$2$F$$20240910$20240909$20240919$EXP$$AR-SA-2024SA257974$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240919$$HP$AR$AR
242989671$24298967$1$I$19940101$20240830$20240909$20240909$PER$$US-SA-2024SA258673$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240909$$CN$US$US
242989681$24298968$1$I$20240410$20240908$20240909$20240909$EXP$$US-TAKEDA-2024TUS089671$TAKEDA$$79$YR$$M$Y$$$20240909$$HP$US$US
242989702$24298970$2$F$20240401$20240401$20240909$20240916$EXP$$NVSC2024NL179611$NOVARTIS$$$$$F$Y$$$20240916$$CN$NL$NL
242989712$24298971$2$F$20240905$20240923$20240909$20240925$PER$$US-AMGEN-USASP2024178953$AMGEN$$76$YR$E$F$Y$$$20240924$$CN$US$US
242989721$24298972$1$I$20240611$20240908$20240908$20240908$DIR$717614$$FDA-CTU$$43$YR$$F$N$123.75$KG$20240908$N$CN$US$
242989741$24298974$1$I$20240905$20240908$20240908$20240908$DIR$717597$$FDA-CTU$$35$YR$$F$N$60.75$KG$20240908$N$CN$US$
242989751$24298975$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61854$$FDA-CTU$$37$YR$$F$N$43.09$KG$20240909$N$$US$
242989771$24298977$1$I$20240101$20240823$20240909$20240909$EXP$$GB-SA-2024SA260405$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240909$$MD$GB$GB
242989781$24298978$1$I$20210101$20240902$20240909$20240909$EXP$$RO-AMGEN-ROUSP2024175178$AMGEN$$60$YR$A$F$Y$$$20240909$$MD$RO$RO
242989791$24298979$1$I$$20240904$20240909$20240909$PER$$US-TAKEDA-2024TUS088886$TAKEDA$$89$YR$$M$Y$$$20240909$$CN$US$US
242989801$24298980$1$I$$20240902$20240909$20240909$EXP$$TR-AMGEN-TURSP2024175152$AMGEN$Menguc M.K; Gunhan H.G; Sisman I.T. Retrospective Analysis of a Weekly Carfilzomib-Dexamethasone Regimen in Relapsed/Refractory Multiple Myeloma: Single Center Experience. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S539$$$$$Y$$$20240909$$MD$TR$TR
242989811$24298981$1$I$20240101$20240901$20240909$20240909$PER$$US-SA-2024SA257259$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240909$$MD$US$US
242989821$24298982$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA256408$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240909$$MD$US$US
242989831$24298983$1$I$20240904$20240906$20240909$20240909$PER$$US-BAYER-2024A128266$BAYER$$51$YR$A$F$Y$$$20240909$$CN$US$US
242989842$24298984$2$F$20240801$20240917$20240909$20240918$EXP$$LT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050183$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240918$$MD$LT$LT
242989861$24298986$1$I$$20240906$20240909$20240909$PER$$US-BAYER-2024A128279$BAYER$$65$YR$E$F$Y$$$20240909$$CN$US$US
242989871$24298987$1$I$20240823$20240906$20240909$20240909$DIR$FDA-CDER-CTU-2024-61858$$FDA-CTU$$46$YR$$F$N$$$20240906$N$HP$US$
242989881$24298988$1$I$20240101$20240830$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139327$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240909$$CN$US$US
242989891$24298989$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61857$$FDA-CTU$$66$YR$$F$N$$$20240909$N$$US$
242989901$24298990$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61859$$FDA-CTU$$69$YR$$F$N$$$20240909$N$$US$
242989911$24298991$1$I$20240803$20240904$20240909$20240909$EXP$$CN-HALEON-2195236$Haleon PLC$$88$YR$$F$Y$60$KG$20240909$$HP$CN$CN
242989921$24298992$1$I$$20240827$20240909$20240909$PER$$US-JNJFOC-20240870969$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$HP$US$US
242989931$24298993$1$I$$20240902$20240909$20240909$EXP$$CN-JNJFOC-20240907945$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$CN$CN
242989941$24298994$1$I$20240820$20240820$20240909$20240909$PER$$CA-TOLMAR, INC.-24CA051260$TOLMAR$$77$YR$$M$Y$$$20240906$$CN$CA$CA
242989951$24298995$1$I$$20240820$20240909$20240909$PER$$CA-TOLMAR, INC.-24CA051992$TOLMAR$$$$$M$Y$$$20240906$$CN$CA$CA
242989961$24298996$1$I$20240101$20240820$20240909$20240909$PER$$CA-TOLMAR, INC.-24CA051783$TOLMAR$$$$$M$Y$$$20240906$$CN$CA$CA
242989971$24298997$1$I$$20240906$20240909$20240909$PER$$US-BAYER-2024A128280$BAYER$$49$YR$A$F$Y$$$20240909$$HP$US$US
242989981$24298998$1$I$20240820$20240820$20240909$20240909$PER$$CA-TOLMAR, INC.-24CA052039$TOLMAR$$70$YR$$M$Y$$$20240906$$CN$CA$CA
242989991$24298999$1$I$20240101$20240820$20240909$20240909$PER$$CA-TOLMAR, INC.-24CA052035$TOLMAR$$$$$M$Y$$$20240906$$CN$CA$CA
242990001$24299000$1$I$$20240820$20240909$20240909$PER$$CA-TOLMAR, INC.-24CA052057$TOLMAR$$$$$M$Y$$$20240906$$CN$CA$CA
242990011$24299001$1$I$20240820$20240820$20240909$20240909$PER$$CA-TOLMAR, INC.-24CA052282$TOLMAR$$77$YR$$M$Y$$$20240906$$CN$CA$CA
242990021$24299002$1$I$$20240820$20240909$20240909$PER$$CA-TOLMAR, INC.-24CA052066$TOLMAR$$$$$M$Y$$$20240906$$CN$CA$CA
242990031$24299003$1$I$20240820$20240820$20240909$20240909$PER$$FR-TOLMAR, INC.-24FR052032$TOLMAR$$81$YR$$M$Y$$$20240906$$PH$FR$FR
242990042$24299004$2$F$$20240910$20240909$20240925$PER$$CA-TOLMAR, INC.-24CA052062$TOLMAR$$$$$M$Y$$$20240925$$CN$CA$CA
242990052$24299005$2$F$20240617$20240627$20240909$20240920$EXP$$US-GUERBET / LLC-US-20240102$GUERBET$$50$YR$A$F$Y$102.96$KG$20240920$$HP$US$US
242990061$24299006$1$I$20240425$20240820$20240909$20240909$PER$$NL-TOLMAR, INC.-24NL051910$TOLMAR$$75$YR$$M$Y$$$20240906$$CN$NL$NL
242990071$24299007$1$I$$20240903$20240909$20240909$EXP$$US-TAKEDA-2024TUS018893$TAKEDA$$$$$F$Y$$$20240909$$MD$US$US
242990081$24299008$1$I$20240802$20240902$20240909$20240909$EXP$FR-AFSSAPS-NC2024001000$FR-FreseniusKabi-FK202413347$FRESENIUS KABI$$78$YR$E$F$Y$$$20240909$$MD$FR$FR
242990091$24299009$1$I$20240901$20240904$20240909$20240909$EXP$$CN-FreseniusKabi-FK202413475$FRESENIUS KABI$$71$YR$E$F$Y$$$20240909$$HP$CN$CN
242990102$24299010$2$F$20240101$20240911$20240909$20240925$EXP$$US-TEVA-VS-3241030$TEVA$$72$YR$$F$Y$$$20240925$$CN$US$US
242990111$24299011$1$I$$20240827$20240909$20240909$EXP$$CA-B.Braun Medical Inc.-2161390$B BRAUN$$71$YR$$F$Y$$$20240909$$$CA$CA
242990121$24299012$1$I$20240824$20240828$20240909$20240909$EXP$$US-SMPA-2024SPA002093$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242990132$24299013$2$F$$20240827$20240909$20240913$EXP$$US-SMPA-2024SPA002290$SUNOVION$$$$$$Y$$$20240913$$MD$US$US
242990141$24299014$1$I$$20240827$20240909$20240909$EXP$$US-SMPA-2024SPA002146$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242990151$24299015$1$I$$20240828$20240909$20240909$EXP$$US-SMPA-2024SPA002088$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242990161$24299016$1$I$$20240828$20240909$20240909$EXP$$US-SMPA-2024SPA002084$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242990171$24299017$1$I$20240822$20240827$20240909$20240909$EXP$$US-SMPA-2024SPA002036$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242990181$24299018$1$I$$20240828$20240909$20240909$EXP$$US-SMPA-2024SPA002141$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242990191$24299019$1$I$20231207$20240902$20240909$20240909$EXP$$FR-FreseniusKabi-FK202413362$FRESENIUS KABI$$73$YR$E$M$Y$70$KG$20240909$$MD$FR$FR
242990201$24299020$1$I$$20240828$20240909$20240909$EXP$$US-SMPA-2024SPA002114$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242990211$24299021$1$I$$20240828$20240909$20240909$EXP$$US-SMPA-2024SPA002110$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242990222$24299022$2$F$$20240911$20240909$20240925$EXP$$HU-SMPA-2024SPA002102$SUNOVION$$$$$$Y$$$20240925$$CN$AU$AU
242990231$24299023$1$I$$20240828$20240909$20240909$EXP$$US-SMPA-2024SPA002112$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242990241$24299024$1$I$$20240903$20240909$20240909$EXP$$ZA-AstraZeneca-2024A201462$ASTRAZENECA$$29$YR$$F$Y$$$20240909$$CN$ZA$
242990251$24299025$1$I$$20240904$20240909$20240909$EXP$$US-JNJFOC-20240916807$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240909$$MD$US$US
242990261$24299026$1$I$$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024178417$AMGEN$$40$YR$A$M$Y$$$20240909$$CN$US$US
242990271$24299027$1$I$20240301$20240906$20240909$20240909$PER$$US-BAYER-2024A128297$BAYER$$88$YR$E$M$Y$$$20240909$$CN$US$US
242990281$24299028$1$I$$20240905$20240909$20240909$PER$$US-GILEAD-2024-0686468$GILEAD$$$$$F$Y$$$20240909$$HP$US$US
242990291$24299029$1$I$$20240906$20240909$20240909$PER$$US-ALXN-202409USA000395US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242990301$24299030$1$I$$20240906$20240909$20240909$PER$$US-BAYER-2024A128282$BAYER$$49$YR$A$F$Y$$$20240909$$CN$US$US
242990311$24299031$1$I$$20240909$20240909$20240909$EXP$GB-MHRA-MED-202409090854508520-FQSTV$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050244$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240909$$HP$GB$GB
242990321$24299032$1$I$20240619$20240903$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US077330$SANDOZ$$84$YR$$F$Y$$$20240909$$HP$US$US
242990331$24299033$1$I$$20240906$20240909$20240909$PER$$US-BAYER-2024A128329$BAYER$$$$$$Y$$$20240909$$CN$US$US
242990341$24299034$1$I$20240703$20240830$20240909$20240909$EXP$FR-AFSSAPS-BX2024001695$FR-TEVA-VS-3239254$TEVA$$55$YR$$F$Y$55$KG$20240909$$PH$FR$FR
242990351$24299035$1$I$20240905$20240906$20240909$20240909$PER$$US-BAYER-2024A128474$BAYER$$26$YR$A$F$Y$$$20240909$$CN$US$US
242990361$24299036$1$I$20231201$20240826$20240909$20240909$EXP$$US-SA-2024SA258871$SANOFI AVENTIS$$58$YR$A$M$Y$136$KG$20240909$$MD$US$US
242990371$24299037$1$I$$20240906$20240909$20240909$PER$$US-BAYER-2024A128385$BAYER$$31$YR$A$F$Y$$$20240909$$CN$US$US
242990381$24299038$1$I$$20240904$20240909$20240909$EXP$$NVSC2024CN179369$NOVARTIS$$$$$F$Y$$$20240909$$CN$CN$CN
242990391$24299039$1$I$20240809$20240902$20240909$20240909$EXP$$CN-JNJFOC-20240903966$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240909$$HP$CN$CN
242990402$24299040$2$F$$20240910$20240909$20240912$EXP$$NVSC2024GB179605$NOVARTIS$$$$A$F$Y$$$20240912$$MD$GB$GB
242990412$24299041$2$F$20240815$20240918$20240909$20240925$EXP$$MX-GILEAD-2024-0685123$GILEAD$$26$YR$A$M$Y$74$KG$20240925$$CN$MX$MX
242990421$24299042$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142904$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240909$$MD$US$US
242990431$24299043$1$I$20240321$20240902$20240909$20240909$EXP$$GB-009507513-2409GBR002801$MERCK$$60$YR$$M$Y$67.3$KG$20240909$$MD$GB$GB
242990451$24299045$1$I$20240909$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61856$$FDA-CTU$$30$YR$$M$N$59.6$KG$20240909$N$HP$US$
242990461$24299046$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61863$$FDA-CTU$$70$YR$$F$N$$$20240909$N$$US$
242990471$24299047$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61866$$FDA-CTU$$41$YR$$M$N$$$20240909$N$$US$
242990481$24299048$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61824$$FDA-CTU$$67$YR$$M$N$$$20240909$N$$US$
242990491$24299049$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61868$$FDA-CTU$$55$YR$$F$N$134$LBS$20240909$N$$US$
242990521$24299052$1$I$20240702$20240904$20240909$20240909$EXP$IE-HPRA-2024-114999$IE-FreseniusKabi-FK202413454$FRESENIUS KABI$$88$YR$E$F$Y$$$20240909$$PH$IE$IE
242990531$24299053$1$I$$20240906$20240909$20240909$PER$$US-BAYER-2024A128496$BAYER$$$$$F$Y$$$20240909$$HP$US$US
242990541$24299054$1$I$$20240907$20240909$20240909$PER$$US-BAYER-2024A128263$BAYER$$$$$$Y$$$20240909$$CN$US$US
242990561$24299056$1$I$$20240904$20240909$20240909$EXP$$ES-MYLANLABS-2024M1082249$MYLAN$Pozo IB, Comesana MS, Castillo AC, Oliva MP, Vazquez GP. Putting pieces together to reach the diagnosis. Eur-J-Case-Rep-Intern-Med 2024; 11 (Suppl. 1) 791 abstr. 2900.$66$YR$$M$Y$$$20240909$$HP$ES$ES
242990571$24299057$1$I$$20240907$20240909$20240909$PER$$US-BAYER-2024A128295$BAYER$$$$$$Y$$$20240909$$CN$US$US
242990582$24299058$2$F$20240830$20240919$20240909$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024108478$VIIV$$31$YR$$F$Y$$$20240929$$HP$US$US
242990591$24299059$1$I$$20240905$20240909$20240909$PER$$US-HALEON-2195506$Haleon PLC$$$$$F$Y$$$20240909$$CN$US$US
242990601$24299060$1$I$20240501$20240828$20240909$20240909$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17338$IPSEN$$33$YR$A$F$Y$$$20240909$$HP$US$US
242990611$24299061$1$I$20240906$20240906$20240909$20240909$EXP$$NVSC2024AU179574$NOVARTIS$$59$YR$$M$Y$$$20240909$$CN$AU$AU
242990621$24299062$1$I$20240305$20240904$20240909$20240909$EXP$$NVSC2024GB055377$NOVARTIS$$$$$F$Y$$$20240909$$CN$GB$GB
242990631$24299063$1$I$20240801$20240904$20240909$20240909$EXP$$US-SA-2024SA259354$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240909$$MD$US$US
242990641$24299064$1$I$20240522$20240830$20240909$20240909$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409001830$ELI LILLY AND CO$$61$YR$A$M$Y$71$KG$20240909$$CN$DE$CN
242990651$24299065$1$I$20240729$20240903$20240909$20240909$EXP$LU-ALMPS-202404298$LU-ELI_LILLY_AND_COMPANY-LU202409002045$ELI LILLY AND CO$$69$YR$E$M$Y$77$KG$20240909$$CN$LU$LU
242990661$24299066$1$I$$20240828$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018620$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240909$$CN$US$US
242990671$24299067$1$I$$20240904$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002520$ELI LILLY AND CO$$$$A$F$Y$$$20240909$$CN$US$US
242990681$24299068$1$I$20240810$20240830$20240909$20240909$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409001814$ELI LILLY AND CO$$25$YR$A$F$Y$35$KG$20240909$$CN$DE$CN
242990691$24299069$1$I$$20240904$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003678$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240909$$HP$US$US
242990701$24299070$1$I$20240828$20240828$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001137$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$US$US
242990721$24299072$1$I$$20240828$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018113$ELI LILLY AND CO$$92$YR$E$M$Y$$$20240909$$MD$US$US
242990731$24299073$1$I$20240130$20240903$20240909$20240909$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202406013438$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240909$$CN$JP$JP
242990741$24299074$1$I$20240801$20240828$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018391$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240909$$CN$US$US
242990751$24299075$1$I$$20240903$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001401$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240909$$CN$US$US
242990761$24299076$1$I$$20240828$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018499$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242990771$24299077$1$I$$20240828$20240909$20240909$EXP$GB-MHRA-MED-202408281055037750-ZWSBF$GB-ELI_LILLY_AND_COMPANY-GB202408018564$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$GB$GB
242990783$24299078$3$F$20230801$20240916$20240909$20240925$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202409000783$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240925$$MD$IN$IN
242990802$24299080$2$F$$20240917$20240909$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409002353$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$JP$JP
242990811$24299081$1$I$$20240828$20240909$20240909$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408017581$ELI LILLY AND CO$$$$$M$Y$$$20240909$$CN$DE$DE
242990821$24299082$1$I$20240715$20240904$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002606$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240909$$CN$US$US
242990831$24299083$1$I$20240712$20240830$20240909$20240909$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000822$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$JP$JP
242990841$24299084$1$I$20240301$20240828$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202408019445$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$US$US
242990851$24299085$1$I$$20240828$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018000$ELI LILLY AND CO$$22$YR$A$M$Y$$$20240909$$CN$US$US
242990861$24299086$1$I$$20240828$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000073$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240909$$CN$US$US
242990871$24299087$1$I$20221001$20240903$20240909$20240909$EXP$$RO-ELI_LILLY_AND_COMPANY-RO202409003416$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240909$$MD$RO$RO
242990891$24299089$1$I$$20240904$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002849$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240909$$CN$US$US
242990901$24299090$1$I$20240903$20240903$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002757$ELI LILLY AND CO$$$$A$M$Y$$$20240909$$CN$US$US
242990911$24299091$1$I$$20240828$20240909$20240909$PER$$US-SA-2024SA258853$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240909$$MD$US$US
242990921$24299092$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA258791$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240909$$HP$US$US
242990931$24299093$1$I$$20240828$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018467$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242990941$24299094$1$I$$20240828$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000949$ELI LILLY AND CO$$56$YR$A$F$Y$80.3$KG$20240909$$CN$US$US
242990951$24299095$1$I$$20240725$20240909$20240909$30DAY$$CL-PFIZER INC-202400225718$PFIZER$$$$$F$Y$$$20240909$$CN$CL$CL
242990971$24299097$1$I$20240801$20240905$20240909$20240909$EXP$$US-ABBVIE-5909731$ABBVIE$$46$YR$$F$Y$$$20240909$$CN$US$US
242990981$24299098$1$I$$20240907$20240909$20240909$DIR$FDA-CDER-CTU-2024-61850$$FDA-CTU$$$$$M$N$$$20240907$N$HP$US$
242990991$24299099$1$I$20240821$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61855$$FDA-CTU$$73$YR$$F$N$$$20240909$N$$US$
242991002$24299100$2$F$20240101$20240903$20240909$20240911$EXP$$CA-ABBVIE-5845956$ABBVIE$$$$$M$Y$$$20240911$$PH$CA$CA
242991011$24299101$1$I$$20240830$20240909$20240909$EXP$$ZA-ABBVIE-5908741$ABBVIE$$60$YR$$M$Y$$$20240909$$CN$ZA$ZA
242991022$24299102$2$F$20240701$20240921$20240909$20240927$EXP$$CO-GSK-CO2024AMR094576$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$CO$CO
242991031$24299103$1$I$20240715$20240830$20240909$20240909$PER$$US-ABBVIE-5903571$ABBVIE$$64$YR$$F$Y$$$20240909$$CN$US$US
242991041$24299104$1$I$$20240903$20240909$20240909$EXP$$US-ABBVIE-5905822$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242991051$24299105$1$I$20240317$20240830$20240909$20240909$EXP$FR-AFSSAPS-DJ2024000930$FR-TEVA-VS-3239149$TEVA$$73$YR$$M$Y$75$KG$20240909$$MD$FR$FR
242991061$24299106$1$I$$20240907$20240909$20240909$PER$$US-BAYER-2024A128498$BAYER$$$$$$Y$$$20240909$$CN$US$US
242991071$24299107$1$I$$20240904$20240909$20240909$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014146$VERTEX$$$$A$M$Y$$$20240909$$CN$GB$GB
242991081$24299108$1$I$20240111$20240903$20240909$20240909$EXP$$CA-VERTEX PHARMACEUTICALS-2024-014056$VERTEX$$$$$F$Y$53$KG$20240909$$MD$CA$CA
242991091$24299109$1$I$20230901$20240902$20240909$20240909$EXP$$FR-VERTEX PHARMACEUTICALS-2024-014017$VERTEX$$38$YR$$M$Y$$$20240909$$MD$FR$FR
242991102$24299110$2$F$20240521$20240910$20240909$20240918$PER$$US-VERTEX PHARMACEUTICALS-2024-014040$VERTEX$$8$YR$$F$Y$$$20240918$$PH$US$US
242991111$24299111$1$I$20240705$20240901$20240909$20240909$EXP$RU-RZN-2538459$RU-VERTEX PHARMACEUTICALS-2024-013982$VERTEX$$2$YR$$F$Y$12$KG$20240909$$MD$RU$RU
242991121$24299112$1$I$$20240903$20240909$20240909$PER$$US-VERTEX PHARMACEUTICALS-2024-014073$VERTEX$$$$$M$Y$$$20240909$$HP$US$US
242991131$24299113$1$I$20240101$20240904$20240909$20240909$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014157$VERTEX$$$$A$M$Y$$$20240909$$CN$GB$GB
242991142$24299114$2$F$$20240909$20240909$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08604$LUPIN$$$$$$Y$$$20240921$$MD$US$US
242991151$24299115$1$I$$20240905$20240909$20240909$PER$$US-GILEAD-2024-0686466$GILEAD$$34$YR$A$F$Y$$$20240909$$HP$US$US
242991161$24299116$1$I$$20240830$20240909$20240909$EXP$FR-AFSSAPS-AVNT2024000649$FR-TEVA-VS-3239110$TEVA$$20$YR$$F$Y$$$20240909$$PH$FR$FR
242991171$24299117$1$I$20240101$20240904$20240909$20240909$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014328$JAZZ$$62$YR$$M$Y$$$20240909$$CN$US$US
242991181$24299118$1$I$$20240908$20240909$20240909$PER$$US-BAYER-2024A128300$BAYER$$$$$$Y$$$20240909$$CN$US$US
242991191$24299119$1$I$$20240905$20240909$20240909$EXP$$CA-ABBVIE-5913648$ABBVIE$$$$E$F$Y$$$20240909$$CN$CA$CA
242991201$24299120$1$I$20240821$20240829$20240909$20240909$EXP$$CN-GE HEALTHCARE-2024CSU010036$GE HEALTHCARE$$67$YR$$F$Y$54$KG$20240909$$HP$CN$CN
242991211$24299121$1$I$20201108$20240901$20240909$20240909$EXP$PL-URPL-1-2521-2020$PL-GE HEALTHCARE-2024CSU009965$GE HEALTHCARE$$70$YR$$F$Y$60$KG$20240909$$HP$PL$PL
242991221$24299122$1$I$20240823$20240905$20240909$20240909$EXP$$ES-ABBVIE-5913646$ABBVIE$$78$YR$$F$Y$60$KG$20240909$$CN$ES$ES
242991231$24299123$1$I$20220101$20240826$20240909$20240909$EXP$$FR-Merck Healthcare KGaA-2024046285$MERCK KGAA$$$$E$F$Y$$$20240903$$CN$FR$FR
242991241$24299124$1$I$$20240826$20240909$20240909$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000900$PAREXEL$$$$$$Y$$$20240909$$CN$CN$CN
242991261$24299126$1$I$$20240902$20240909$20240909$EXP$$HR-SANDOZ INC.-NVSC2011HR000448$SANDOZ$$31$YR$$F$Y$$$20240909$$MD$HR$HR
242991271$24299127$1$I$$20240905$20240909$20240909$EXP$$NVSC2024IE179800$NOVARTIS$$64$YR$$F$Y$$$20240909$$HP$IE$IE
242991282$24299128$2$F$$20240906$20240909$20240911$PER$$NVSC2024US180179$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
242991291$24299129$1$I$$20240903$20240909$20240909$EXP$$US-009507513-2409USA002148$MERCK$$$$$F$Y$$$20240909$$CN$US$US
242991302$24299130$2$F$$20240912$20240909$20240913$PER$$US-ALXN-202409USA000366US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
242991311$24299131$1$I$$20240904$20240909$20240909$PER$$US-ALXN-202409USA000363US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240909$$MD$US$US
242991321$24299132$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61823$$FDA-CTU$$85$YR$$F$N$128$LBS$20240909$N$$US$
242991331$24299133$1$I$20240901$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142612$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240909$$CN$US$US
242991341$24299134$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141897$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240909$$CN$US$US
242991361$24299136$1$I$$20240829$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138529$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240909$$CN$US$US
242991371$24299137$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180309$NOVARTIS$$$$$F$Y$$$20240909$$HP$US$US
242991391$24299139$1$I$$20240828$20240909$20240909$PER$$US-BAYER-2024A128481$BAYER$$$$$$Y$$$20240909$$CN$US$US
242991401$24299140$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61852$$FDA-CTU$$67$YR$$M$N$$$20240909$N$$US$
242991411$24299141$1$I$$20240830$20240909$20240909$EXP$$US-BAYER-2024A128156$BAYER$Cardoso E.R.; Abbas R.; Stone E.M.; Patel S.. Combined pterional burr hole and coagulation of middle meningeal artery for chronic subdural hematoma. Surgical Neurology International. 2024;15:254$67$YR$E$F$Y$$$20240909$$HP$US$US
242991422$24299142$2$F$20240826$20240906$20240909$20240918$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-IBA-000351$THERATECHNOLOGIES$$$$$$Y$$$20240918$$HP$US$US
242991431$24299143$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61825$$FDA-CTU$$75$YR$$M$N$205$LBS$20240909$N$$US$
242991441$24299144$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024179402$AMGEN$$$$$$Y$$$20240909$$PH$US$US
242991453$24299145$3$F$20240625$20240917$20240909$20240923$PER$$US-AMGEN-USASP2024176986$AMGEN$$69$YR$E$M$Y$108.39$KG$20240923$$HP$US$US
242991471$24299147$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024179358$AMGEN$$66$YR$E$F$Y$$$20240909$$MD$US$US
242991481$24299148$1$I$$20240902$20240909$20240909$EXP$$NVSC2024DE179520$NOVARTIS$$$$$M$Y$$$20240909$$MD$DE$DE
242991491$24299149$1$I$20240805$20240904$20240909$20240909$EXP$$US-BAYER-2024A126979$BAYER$$31$YR$A$M$Y$$$20240909$$HP$US$US
242991501$24299150$1$I$$20240904$20240909$20240909$PER$$US-PFIZER INC-202400251259$PFIZER$$53$YR$$F$Y$$$20240909$$CN$US$US
242991511$24299151$1$I$20240825$20240908$20240908$20240908$DIR$717612$$FDA-CTU$$65$YR$$F$N$58.5$KG$20240908$N$CN$US$
242991521$24299152$1$I$$20240904$20240909$20240909$PER$$US-PFIZER INC-202400250732$PFIZER$$$$$F$Y$$$20240909$$MD$US$US
242991531$24299153$1$I$20240908$20240908$20240908$20240908$DIR$717607$$FDA-CTU$$76$YR$$F$N$$$20240908$N$HP$US$
242991541$24299154$1$I$$20240909$20240909$20240909$DIR$717644$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
242991551$24299155$1$I$20240801$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251144$PFIZER$$53$YR$$F$Y$$$20240909$$HP$US$US
242991561$24299156$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251304$PFIZER$$76$YR$$F$Y$$$20240909$$MD$US$US
242991571$24299157$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251652$PFIZER$$47$YR$$F$Y$$$20240909$$MD$US$US
242991581$24299158$1$I$$20240909$20240909$20240909$DIR$717645$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
242991591$24299159$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-PV202400117162$PFIZER$$$$$$Y$$$20240909$$CN$US$US
242991601$24299160$1$I$20240905$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251499$PFIZER$$29$YR$$F$Y$$$20240909$$CN$US$US
242991611$24299161$1$I$20240101$20240905$20240909$20240909$PER$$US-PFIZER INC-PV202400117326$PFIZER$$52$YR$$F$Y$$$20240909$$HP$US$US
242991621$24299162$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400250794$PFIZER$$44$YR$$F$Y$$$20240909$$CN$US$US
242991641$24299164$1$I$20240901$20240904$20240909$20240909$PER$$US-PFIZER INC-202400251137$PFIZER$$43$YR$$F$Y$$$20240909$$HP$US$US
242991671$24299167$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251993$PFIZER$$67$YR$$M$Y$69.85$KG$20240909$$HP$US$US
242991681$24299168$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251295$PFIZER$$$$$M$Y$$$20240909$$CN$US$US
242991691$24299169$1$I$20230915$20240904$20240909$20240909$PER$$US-PFIZER INC-202400250858$PFIZER$$60$YR$$F$Y$$$20240909$$MD$US$US
242991701$24299170$1$I$20240902$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251721$PFIZER$$60$YR$$M$Y$$$20240909$$CN$US$US
242991711$24299171$1$I$20240101$20240904$20240909$20240909$PER$$US-PFIZER INC-202400250311$PFIZER$$$$$$Y$$$20240909$$CN$US$US
242991722$24299172$2$F$20240828$20240913$20240909$20240923$PER$$US-AMGEN-USASP2024177875$AMGEN$$61$YR$A$F$Y$46.7$KG$20240923$$HP$US$US
242991732$24299173$2$F$$20240910$20240909$20240910$PER$$US-PFIZER INC-202400252076$PFIZER$$$$$M$Y$$$20240910$$HP$US$US
242991741$24299174$1$I$20240101$20240905$20240909$20240909$PER$$US-PFIZER INC-PV202400092795$PFIZER$$58$YR$$$Y$$$20240909$$CN$US$US
242991751$24299175$1$I$20240101$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251046$PFIZER$$73$YR$$F$Y$$$20240909$$CN$US$US
242991761$24299176$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251863$PFIZER$$72$YR$$F$Y$$$20240909$$CN$US$US
242991771$24299177$1$I$$20240904$20240909$20240909$PER$$US-PFIZER INC-202400251141$PFIZER$$47$YR$$M$Y$$$20240909$$HP$US$US
242991781$24299178$1$I$20240901$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251038$PFIZER$$15$YR$$F$Y$$$20240909$$HP$US$US
242991791$24299179$1$I$$20240903$20240909$20240909$PER$$US-PFIZER INC-202400250094$PFIZER$$52$YR$$F$Y$50.6$KG$20240909$$HP$US$US
242991801$24299180$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251839$PFIZER$$39$YR$$M$Y$$$20240909$$HP$US$US
242991811$24299181$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-PV202400116909$PFIZER$$24$YR$$F$Y$$$20240909$$HP$US$US
242991821$24299182$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400250954$PFIZER$$74$YR$$F$Y$$$20240909$$CN$US$US
242991831$24299183$1$I$$20240904$20240909$20240909$PER$$US-PFIZER INC-PV202400116520$PFIZER$$55$YR$$F$Y$$$20240909$$CN$US$US
242991841$24299184$1$I$20240601$20240904$20240909$20240909$PER$$US-PFIZER INC-202400251151$PFIZER$$52$YR$$M$Y$$$20240909$$HP$US$US
242991851$24299185$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251841$PFIZER$$78$YR$$F$Y$$$20240909$$HP$US$US
242991861$24299186$1$I$20240905$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251336$PFIZER$$57$YR$$F$Y$$$20240909$$CN$US$US
242991871$24299187$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251845$PFIZER$$47$YR$$F$Y$$$20240909$$HP$US$US
242991882$24299188$2$F$$20240905$20240909$20240913$EXP$$US-PFIZER INC-202400251848$PFIZER$$41$YR$$$Y$$$20240913$$CN$US$US
242991893$24299189$3$F$20240801$20240912$20240909$20240913$PER$$US-PFIZER INC-202400251843$PFIZER$$47$YR$$F$Y$$$20240913$$HP$US$US
242991901$24299190$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251290$PFIZER$$$$$F$Y$$$20240909$$MD$US$US
242991911$24299191$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251859$PFIZER$$77$YR$$F$Y$$$20240909$$CN$US$US
242991922$24299192$2$F$20231011$20240910$20240909$20240912$PER$$US-PFIZER INC-202400251397$PFIZER$$83$YR$$F$Y$$$20240912$$PH$US$US
242991931$24299193$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-PV202400117242$PFIZER$$76$YR$$$Y$$$20240909$$MD$US$US
242991941$24299194$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251844$PFIZER$$62$YR$$F$Y$$$20240909$$HP$US$US
242991951$24299195$1$I$20240101$20240904$20240909$20240909$PER$$US-PFIZER INC-202400251273$PFIZER$$50$YR$$F$Y$$$20240909$$HP$US$US
242991961$24299196$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-PV202400116985$PFIZER$$52$YR$$F$Y$$$20240909$$HP$US$US
242991971$24299197$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251861$PFIZER$$73$YR$$F$Y$$$20240909$$PH$US$US
242991981$24299198$1$I$$20240903$20240909$20240909$PER$$US-PFIZER INC-PV202300150980$PFIZER$$39$YR$$F$Y$$$20240909$$CN$US$US
242991991$24299199$1$I$20240301$20240905$20240909$20240909$PER$$US-PFIZER INC-PV202400116469$PFIZER$$37$YR$$F$Y$87.982$KG$20240909$$CN$US$US
242992001$24299200$1$I$$20240904$20240909$20240909$PER$$US-PFIZER INC-202400250521$PFIZER$$60$YR$$M$Y$90.7$KG$20240909$$MD$US$US
242992011$24299201$1$I$20240904$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251644$PFIZER$$49$YR$$F$Y$$$20240909$$HP$US$US
242992021$24299202$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251833$PFIZER$$$$$F$Y$$$20240909$$HP$US$US
242992031$24299203$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-PV202400117228$PFIZER$$53$YR$$F$Y$$$20240909$$HP$US$US
242992041$24299204$1$I$20240101$20240905$20240909$20240909$PER$$US-PFIZER INC-202400250797$PFIZER$$76$YR$$F$Y$$$20240909$$CN$US$US
242992051$24299205$1$I$$20240904$20240909$20240909$PER$$US-BAYER-2024A127627$BAYER$$$$$F$Y$$$20240909$$CN$US$US
242992071$24299207$1$I$$20240831$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139649$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240909$$HP$US$US
242992082$24299208$2$F$20240824$20240910$20240909$20240911$PER$$US-PFIZER INC-PV202400117064$PFIZER$$67$YR$$F$Y$$$20240911$$HP$US$US
242992091$24299209$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180409$NOVARTIS$$$$$$Y$$$20240909$$HP$US$US
242992102$24299210$2$F$$20240916$20240909$20240918$EXP$$NVSC2024AT179513$NOVARTIS$$$$$$Y$$$20240918$$MD$AT$AT
242992111$24299211$1$I$20240815$20240903$20240909$20240909$EXP$SE-SEMPA-2024-006362$SE-MYLANLABS-2024M1080977$MYLAN$$53$YR$$M$Y$$$20240909$$MD$SE$SE
242992121$24299212$1$I$20240307$20240903$20240909$20240909$EXP$$DE-MYLANLABS-2024M1080807$MYLAN$$$$A$F$Y$$$20240909$$MD$DE$DE
242992131$24299213$1$I$$20240829$20240909$20240909$EXP$$JP-009507513-2408JPN004076J$MERCK$$57$YR$$M$Y$$$20240909$$MD$JP$JP
242992141$24299214$1$I$20240602$20240905$20240909$20240909$EXP$$DE-MYLANLABS-2024M1081537$MYLAN$$84$YR$$F$Y$$$20240909$$MD$DE$DE
242992151$24299215$1$I$20240905$20240905$20240909$20240909$PER$$US-BAYER-2024A128278$BAYER$$31$YR$A$F$Y$$$20240909$$HP$US$US
242992161$24299216$1$I$20240801$20240826$20240909$20240909$EXP$$US-SA-2024SA257653$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240909$$HP$US$US
242992171$24299217$1$I$20240101$20240828$20240909$20240909$EXP$$US-SA-2024SA259824$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240909$$MD$US$US
242992181$24299218$1$I$$20240829$20240909$20240909$EXP$$JP-AstraZeneca-2024A203800$ASTRAZENECA$$73$YR$$M$Y$$$20240909$$MD$JP$
242992191$24299219$1$I$$20240909$20240909$20240909$EXP$DE-ROCHE-10000015890$DE-SANDOZ INC.-SDZ2024DE078512$SANDOZ$$68$YR$$F$Y$$$20240909$$MD$DE$DE
242992201$24299220$1$I$20240410$20240903$20240909$20240909$EXP$$JP-009507513-2405JPN002508J$MERCK$$7$DEC$$F$Y$$$20240909$$MD$JP$JP
242992211$24299221$1$I$20240619$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201764$ASTRAZENECA$$$$$M$Y$$$20240909$$HP$US$
242992232$24299223$2$F$20240624$20240909$20240909$20240917$EXP$$FR-AstraZeneca-2024A204130$ASTRAZENECA$$59$YR$$F$Y$$$20240917$$MD$FR$
242992251$24299225$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-PV202400116684$PFIZER$$16$YR$$M$Y$$$20240909$$PH$US$US
242992282$24299228$2$F$$20240905$20240909$20240910$PER$$US-PFIZER INC-PV202400116903$PFIZER$$30$YR$$M$Y$$$20240910$$HP$US$US
242992291$24299229$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-PV202400116835$PFIZER$$41$YR$$$Y$$$20240909$$CN$US$US
242992302$24299230$2$F$$20240905$20240909$20240913$PER$$US-PFIZER INC-202400251852$PFIZER$$9$YR$$M$Y$$$20240913$$CN$US$US
242992324$24299232$4$F$20190201$20240909$20240909$20240913$EXP$$CN-PFIZER INC-202400248956$PFIZER$Wei, X.. Rheumatoid arthritis complicated with cervical actinomycosis and ureteral obstruction: A case report and literature review. Journal of Central South University. Medical sciences. 2024;49(5):818-24$60$YR$$F$Y$$$20240913$$MD$CN$CN
242992331$24299233$1$I$$20240905$20240909$20240909$EXP$$CA-PFIZER INC-202400250859$PFIZER$$42$YR$$F$Y$$$20240909$$HP$CA$CA
242992341$24299234$1$I$$20240903$20240909$20240909$PER$$US-PFIZER INC-202400249747$PFIZER$$16$YR$$M$Y$70.31$KG$20240909$$CN$US$US
242992361$24299236$1$I$$20240903$20240909$20240909$30DAY$$US-PFIZER INC-202400249560$PFIZER$$13$YR$$F$Y$$$20240909$$CN$US$US
242992371$24299237$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-PV202400116596$PFIZER$$71$YR$$M$Y$$$20240909$$CN$US$US
242992381$24299238$1$I$20230830$20240904$20240909$20240909$PER$$US-PFIZER INC-202400251434$PFIZER$$11$YR$$M$Y$$$20240909$$CN$US$US
242992391$24299239$1$I$20240712$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201705$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242992402$24299240$2$F$$20240904$20240909$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002919$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240916$$CN$US$US
242992411$24299241$1$I$$20240828$20240909$20240909$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409003922$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240909$$CN$DE$GB
242992421$24299242$1$I$20240722$20240828$20240909$20240909$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408019060$ELI LILLY AND CO$$57$YR$A$F$Y$56$KG$20240909$$CN$CN$CN
242992432$24299243$2$F$20170510$20240829$20240909$20240912$EXP$$JP-AstraZeneca-2024A203813$ASTRAZENECA$$90$YR$$F$Y$60$KG$20240912$$MD$JP$
242992442$24299244$2$F$$20240829$20240909$20240912$EXP$$CA-AstraZeneca-2024A203850$ASTRAZENECA$$53$YR$$F$Y$$$20240912$$MD$CA$
242992451$24299245$1$I$20240811$20240909$20240909$20240909$DIR$717636$$FDA-CTU$$24$YR$$F$N$71.1$KG$20240909$N$CN$US$
242992461$24299246$1$I$$20240909$20240909$20240909$DIR$717646$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
242992471$24299247$1$I$20240819$20240909$20240909$20240909$DIR$717650$$FDA-CTU$$69$YR$$M$N$$$20240909$N$PH$US$
242992481$24299248$1$I$20200201$20240908$20240908$20240908$DIR$717617$$FDA-CTU$$64$YR$$M$N$$$20240908$N$CN$US$
242992491$24299249$1$I$$20240909$20240909$20240909$DIR$717649$$FDA-CTU$$48$YR$$F$N$112.5$KG$20240909$N$CN$US$
242992501$24299250$1$I$20240705$20240908$20240908$20240908$DIR$717587$$FDA-CTU$$61$YR$$F$N$130.5$KG$20240908$N$CN$US$
242992521$24299252$1$I$$20240909$20240909$20240909$DIR$717656$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
242992531$24299253$1$I$20230915$20240908$20240908$20240908$DIR$717608$$FDA-CTU$$64$YR$$M$N$117$KG$20240908$N$CN$US$
242992541$24299254$1$I$20240824$20240903$20240909$20240909$EXP$$US-ANIPHARMA-2024-US-047705$ANI$$32$YR$$M$Y$$$20240909$$HP$US$US
242992551$24299255$1$I$$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142439$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240909$$CN$US$US
242992561$24299256$1$I$20240523$20240904$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142031$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240909$$CN$US$US
242992571$24299257$1$I$$20240828$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142817$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$93.98$KG$20240909$$CN$US$US
242992581$24299258$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400117027$PFIZER$$51$YR$$F$Y$$$20240909$$CN$US$US
242992591$24299259$1$I$20240101$20240905$20240909$20240909$PER$$US-JNJFOC-20240912508$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242992611$24299261$1$I$20240201$20240828$20240909$20240909$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17342$IPSEN$$50$YR$A$F$Y$$$20240909$$HP$US$US
242992621$24299262$1$I$$20240906$20240909$20240909$PER$$US-BAYER-2024A128808$BAYER$$$$$F$Y$$$20240909$$HP$US$US
242992631$24299263$1$I$$20240905$20240909$20240909$EXP$$US-INCYTE CORPORATION-2024IN009400$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242992641$24299264$1$I$20240824$20240828$20240909$20240909$PER$$US-ABBVIE-5902156$ABBVIE$$62$YR$$F$Y$$$20240909$$CN$US$US
242992652$24299265$2$F$$20240910$20240909$20240912$EXP$$FR-SANDOZ INC.-SDZ2024FR078360$SANDOZ$$30$YR$$F$Y$$$20240912$$MD$FR$FR
242992661$24299266$1$I$20240808$20240905$20240909$20240909$EXP$$US-INCYTE CORPORATION-2024IN009398$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242992681$24299268$1$I$$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024179407$AMGEN$$$$$M$Y$$$20240909$$CN$US$US
242992691$24299269$1$I$20240501$20240905$20240909$20240909$EXP$$US-INCYTE CORPORATION-2024IN009387$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242992712$24299271$2$F$$20240923$20240909$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141736$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240924$$CN$US$US
242992721$24299272$1$I$$20240909$20240909$20240909$DIR$717658$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
242992731$24299273$1$I$20240907$20240908$20240908$20240908$DIR$717570$$FDA-CTU$$45$YR$$F$N$90$KG$20240908$Y$CN$US$
242992741$24299274$1$I$20240822$20240830$20240909$20240909$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-139029$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$68.95$KG$20240909$$CN$PR$PR
242992751$24299275$1$I$$20240909$20240909$20240909$PER$$US-BAYER-2024A128821$BAYER$$$$$M$Y$$$20240909$$CN$US$US
242992761$24299276$1$I$20240903$20240909$20240909$20240909$DIR$717637$$FDA-CTU$$58$YR$$F$N$76.5$KG$20240909$N$CN$US$
242992771$24299277$1$I$20240528$20240905$20240909$20240909$EXP$FR-AFSSAPS-DJ2024000934$FR-OTSUKA-2024_024965$OTSUKA$$51$YR$$M$Y$65$KG$20240909$$MD$FR$FR
242992781$24299278$1$I$$20240827$20240909$20240909$EXP$$CA-B.Braun Medical Inc.-2161392$B BRAUN$$3$YR$$M$Y$$$20240909$$$CA$CA
242992791$24299279$1$I$20240907$20240908$20240908$20240908$DIR$717575$$FDA-CTU$$70$YR$$F$N$76.5$KG$20240908$N$CN$US$
242992801$24299280$1$I$20230714$20240909$20240909$20240909$DIR$717639$$FDA-CTU$$33$YR$$F$N$126$KG$20240909$N$CN$US$
242992811$24299281$1$I$20240101$20240903$20240909$20240909$EXP$$US-009507513-2409USA001364$MERCK$$$$$F$Y$$$20240909$$CN$US$US
242992831$24299283$1$I$20240908$20240908$20240908$20240908$DIR$717580$$FDA-CTU$$79$YR$$M$N$72$KG$20240908$N$CN$US$
242992841$24299284$1$I$$20240906$20240909$20240909$PER$$US-HALEON-2195849$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
242992851$24299285$1$I$$20240830$20240909$20240909$EXP$$US-TEVA-VS-3239170$TEVA$$59$YR$$M$Y$$$20240909$$CN$US$US
242992861$24299286$1$I$$20240828$20240909$20240909$PER$$US-SA-2024SA258921$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240909$$HP$US$US
242992871$24299287$1$I$$20240826$20240909$20240909$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08630$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240909$$HP$US$US
242992881$24299288$1$I$$20240827$20240909$20240909$PER$$US-ALKERMES INC.-ALK-2024-002292$ALKERMES$$$$$F$Y$$$20240909$$CN$US$US
242992891$24299289$1$I$20240823$20240903$20240909$20240909$EXP$IT-MINISAL02-1000409$IT-MYLANLABS-2024M1080784$MYLAN$$69$YR$$F$Y$$$20240909$$MD$IT$IT
242992902$24299290$2$F$$20240912$20240909$20240921$EXP$$US-TEVA-VS-3232675$TEVA$Korzec J, Strausbaugh R, Mikolay Jr JJ, Churchwell MD. Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A missed opportunity for pharmacist involvement. J-Am-Pharmacists-Assoc 2024; 1-5.; Korzec J, Strausbaugh R, Mikolay Jr JJ, Churchwell MD. Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidn...$74$YR$$M$Y$$$20240921$$PH$US$US
242992921$24299292$1$I$20240628$20240908$20240908$20240908$DIR$717585$$FDA-CTU$$52$YR$$F$N$77.85$KG$20240908$N$CN$US$
242992941$24299294$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61877$$FDA-CTU$$81$YR$$F$N$$$20240909$N$$US$
242992951$24299295$1$I$20240905$20240906$20240909$20240909$DIR$FDA-CDER-CTU-2024-61878$$FDA-CTU$$74$YR$$F$N$$$20240906$N$HP$US$
242992971$24299297$1$I$20240101$20240829$20240909$20240909$EXP$$ES-Genus_Lifesciences-USA-POI0580202400146$GENUS LIFESCIENCES$Laiseca Garcia J. Drug Induced Enterocolitis Syndrome due to Acetaminophen in an Adult A Call for Diagnostic Tools and Accurate Management. Journal of Investigational Allergology and Clinical Immunology. 2024 JUL 29;34(4):266-276.$45$YR$A$M$Y$$$20240906$$MD$ES$ES
242992981$24299298$1$I$20210101$20240826$20240909$20240909$EXP$$FR-Merck Healthcare KGaA-2024046275$MERCK KGAA$$73$YR$E$F$Y$$$20240904$$CN$FR$FR
242992991$24299299$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61879$$FDA-CTU$$60$YR$$F$N$132.45$KG$20240909$N$$US$
242993001$24299300$1$I$$20240821$20240909$20240909$EXP$$US-SA-2024SA259518$SANOFI AVENTIS$$55$YR$A$F$Y$144$KG$20240909$$MD$US$US
242993011$24299301$1$I$20240817$20240827$20240909$20240909$PER$$US-ALKERMES INC.-ALK-2024-002238$ALKERMES$$15$YR$$$Y$$$20240909$$HP$US$US
242993021$24299302$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201433$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242993031$24299303$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201605$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242993041$24299304$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201515$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242993051$24299305$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201782$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242993061$24299306$1$I$20240809$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A202053$ASTRAZENECA$$28616$DY$$M$Y$$$20240909$$CN$US$
242993071$24299307$1$I$20240823$20240826$20240909$20240909$PER$$US-SA-2024SA257578$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240909$$MD$US$US
242993081$24299308$1$I$20240101$20240827$20240909$20240909$PER$$US-SA-2024SA258843$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240909$$MD$US$US
242993092$24299309$2$F$20240601$20240916$20240909$20240923$EXP$$GB-SA-2024SA258733$SANOFI AVENTIS$$43$YR$A$M$Y$90$KG$20240923$$HP$GB$GB
242993101$24299310$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A203079$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242993111$24299311$1$I$20240827$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201837$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242993121$24299312$1$I$$20240904$20240909$20240909$EXP$$VN-AstraZeneca-2024A204147$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$VN$
242993131$24299313$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202664$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$US$
242993141$24299314$1$I$$20240902$20240909$20240909$EXP$$FR-AstraZeneca-2024A202924$ASTRAZENECA$$76$YR$$M$Y$$$20240909$$MD$FR$
242993151$24299315$1$I$$20240904$20240909$20240909$EXP$$VN-AstraZeneca-2024A203161$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$VN$
242993161$24299316$1$I$$20240904$20240909$20240909$EXP$$IL-AstraZeneca-2024A204267$ASTRAZENECA$$66$YR$$F$Y$$$20240909$$MD$IL$
242993171$24299317$1$I$20240601$20240828$20240909$20240909$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17282$IPSEN$$42$YR$A$F$Y$$$20240909$$HP$US$US
242993182$24299318$2$F$20240622$20240904$20240909$20240911$EXP$$JP-Eisai-EC-2024-173936$EISAI$$73$YR$E$F$Y$55$KG$20240911$$MD$JP$JP
242993191$24299319$1$I$20240820$20240903$20240909$20240909$EXP$$US-TG THERAPEUTICS INC.-TGT003965$TG THERAPEUTICS$$$$$$Y$$$20240909$$CN$US$US
242993201$24299320$1$I$$20240906$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142972$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240909$$CN$US$US
242993212$24299321$2$F$20240801$20240906$20240909$20240920$EXP$$NL-MDD US Operations-MDD202409-003264$MDD OPERATIONS$$74$YR$E$F$Y$$$20240920$$$COUNTRY NOT SPECIFIED$
242993221$24299322$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3238954$TEVA$$80$YR$$M$Y$$$20240909$$PH$CA$CA
242993231$24299323$1$I$$20240829$20240909$20240909$EXP$$US-The Proactiv LLC-2161393$PROACTIV$$52$YR$$F$Y$$$20240909$$$US$US
242993241$24299324$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3239482$TEVA$$68$YR$$M$Y$$$20240909$$HP$CA$CA
242993251$24299325$1$I$$20240902$20240909$20240909$EXP$$NVSC2024KR178702$NOVARTIS$$53$YR$$F$Y$$$20240909$$MD$KR$KR
242993261$24299326$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3239156$TEVA$$16$YR$$F$Y$$$20240909$$HP$CA$CA
242993271$24299327$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3239208$TEVA$$9$YR$$M$Y$$$20240909$$HP$CA$CA
242993281$24299328$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3239461$TEVA$$54$YR$$$Y$$$20240909$$PH$CA$CA
242993291$24299329$1$I$$20240904$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142661$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240909$$CN$US$US
242993301$24299330$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142730$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240909$$CN$US$US
242993311$24299331$1$I$$20240816$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-131742$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240909$$CN$US$US
242993321$24299332$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3239185$TEVA$$89$YR$$M$Y$75$KG$20240909$$HP$CA$CA
242993331$24299333$1$I$$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141042$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240909$$HP$US$US
242993341$24299334$1$I$$20240904$20240909$20240909$EXP$$JP-009507513-2409JPN000797J$MERCK$$7$DEC$$F$Y$$$20240909$$MD$JP$JP
242993351$24299335$1$I$$20240902$20240909$20240909$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006504$BIOCON$$$$$$Y$$$20240909$$MD$CA$CA
242993361$24299336$1$I$20240701$20240903$20240909$20240909$PER$$US-JNJFOC-20240907387$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240909$$CN$US$US
242993371$24299337$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3239030$TEVA$$83$YR$$F$Y$60$KG$20240909$$PH$CA$CA
242993381$24299338$1$I$$20240906$20240909$20240909$EXP$$ES-SANDOZ INC.-SDZ2024ES078290$SANDOZ$$57$YR$$M$Y$$$20240909$$HP$ES$ES
242993391$24299339$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61880$$FDA-CTU$$71$YR$$F$N$$$20240909$N$PH$US$
242993401$24299340$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61881$$FDA-CTU$$77$YR$$M$N$105.23$KG$20240909$N$$US$
242993411$24299341$1$I$20240711$20240906$20240906$20240906$DIR$717420$$FDA-CTU$$75$YR$$M$N$57$KG$20240906$N$$US$
242993421$24299342$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3239200$TEVA$$$$$F$Y$$$20240909$$MD$CA$CA
242993431$24299343$1$I$20190101$20240902$20240909$20240909$EXP$$CO-BIOGEN-2023BI01200113$BIOGEN$$$$$F$Y$69$KG$20240909$$CN$CO$CO
242993441$24299344$1$I$$20240903$20240909$20240909$30DAY$$CL-PFIZER INC-PV202400115963$PFIZER$$13$YR$$M$Y$$$20240909$$CN$CL$CL
242993451$24299345$1$I$20240829$20240830$20240909$20240909$30DAY$$CL-PFIZER INC-202400251640$PFIZER$$$$$$Y$$$20240909$$CN$CL$CL
242993461$24299346$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3240839$TEVA$$62$YR$$F$Y$$$20240909$$CN$CA$CA
242993471$24299347$1$I$20230731$20240830$20240909$20240909$EXP$FR-AFSSAPS-PO2024000872$FR-TEVA-VS-3239121$TEVA$$1$DY$$M$Y$2.26$KG$20240909$$HP$FR$FR
242993481$24299348$1$I$20240601$20240906$20240909$20240909$EXP$$US-BAYER-2024A128627$BAYER$$$$$M$Y$$$20240909$$HP$US$US
242993491$24299349$1$I$$20240827$20240909$20240909$EXP$$CA-B.Braun Medical Inc.-2161394$B BRAUN$$37$YR$$F$Y$$$20240909$$$CA$CA
242993501$24299350$1$I$20240801$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142830$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240909$$CN$US$US
242993513$24299351$3$F$$20240912$20240909$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142791$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$HP$US$US
242993521$24299352$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143222$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240909$$CN$US$US
242993531$24299353$1$I$20240601$20240828$20240909$20240909$EXP$$JP-SMPA-2024SMP009471$SUNOVION$$$$$$Y$$$20240909$$CN$JP$JP
242993541$24299354$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142515$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240909$$CN$US$US
242993551$24299355$1$I$20240815$20240829$20240909$20240909$EXP$$US-JNJFOC-20240920015$JOHNSON AND JOHNSON$$19$YR$A$F$Y$55.3$KG$20240909$$MD$US$US
242993561$24299356$1$I$$20240905$20240909$20240909$EXP$$US-ALXN-202408USA001002US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240909$$CN$US$US
242993571$24299357$1$I$20240801$20240830$20240909$20240909$EXP$$GB-TEVA-VS-3239926$TEVA$$35$YR$$F$Y$$$20240909$$CN$GB$GB
242993601$24299360$1$I$20240701$20240827$20240909$20240909$EXP$$US-UCBSA-2024043868$UCB$$32$YR$$F$Y$$$20240909$$HP$US$US
242993611$24299361$1$I$20240905$20240906$20240906$20240906$DIR$717468$$FDA-CTU$$46$YR$$F$N$90$KG$20240906$N$CN$US$
242993621$24299362$1$I$$20240831$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140445$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$95.25$KG$20240909$$CN$US$US
242993631$24299363$1$I$20170101$20240830$20240909$20240909$EXP$$IT-AMGEN-ITASP2024175144$AMGEN$Zinzani P.. Management of central nervous system relapse in a young patient affected by primarymediastinal large B-cell lymphoma: A case report. Clinical Case Report. 2020;8 (06):933-937$25$YR$A$F$Y$$$20240909$$HP$IT$IT
242993651$24299365$1$I$$20240904$20240909$20240909$PER$$US-JNJFOC-20240913047$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
242993661$24299366$1$I$$20240827$20240909$20240909$EXP$$US-UCBSA-2024044102$UCB$$$$C$$Y$$$20240909$$CN$US$US
242993671$24299367$1$I$20240828$20240828$20240909$20240909$PER$$US-ALKERMES INC.-ALK-2024-002258$ALKERMES$$55$YR$$F$Y$$$20240909$$HP$US$US
242993681$24299368$1$I$20240101$20240828$20240909$20240909$PER$$US-ALKERMES INC.-ALK-2024-002276$ALKERMES$$$$$M$Y$$$20240909$$MD$US$US
242993691$24299369$1$I$20240101$20240823$20240909$20240909$EXP$$US-SA-2024SA259470$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240909$$HP$US$US
242993701$24299370$1$I$20240719$20240822$20240909$20240909$EXP$$US-SA-2024SA258977$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240909$$MD$US$US
242993711$24299371$1$I$20240223$20240905$20240909$20240909$EXP$$US-OTSUKA-2024_025046$OTSUKA$$82$YR$$F$Y$$$20240909$$CN$US$US
242993722$24299372$2$F$20240722$20240906$20240909$20240916$EXP$FR-AFSSAPS-CN2024000780$FR-OTSUKA-2024_024465$OTSUKA$$15$YR$$M$Y$67.5$KG$20240916$$MD$FR$FR
242993731$24299373$1$I$20240601$20240729$20240909$20240909$PER$$US-LUNDBECK-DKLU4002455$LUNDBECK$$$$$$Y$$$20240909$$CN$US$US
242993741$24299374$1$I$20240824$20240904$20240909$20240909$EXP$$CN-SA-2024SA258630$SANOFI AVENTIS$$55$YR$A$F$Y$41$KG$20240909$$HP$CN$CN
242993761$24299376$1$I$$20240905$20240909$20240909$EXP$$US-BAYER-2024A128222$BAYER$$77$YR$E$M$Y$$$20240909$$CN$US$US
242993771$24299377$1$I$20240828$20240828$20240909$20240909$PER$$US-ALKERMES INC.-ALK-2024-002261$ALKERMES$$$$$F$Y$$$20240909$$HP$US$US
242993781$24299378$1$I$20240401$20240828$20240909$20240909$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17285$IPSEN$$44$YR$A$F$Y$$$20240909$$HP$US$US
242993811$24299381$1$I$20240904$20240906$20240906$20240906$DIR$717424$$FDA-CTU$$55$YR$$F$N$67.5$KG$20240906$N$CN$US$
242993831$24299383$1$I$20240904$20240906$20240906$20240906$DIR$717515$$FDA-CTU$$67$YR$$F$N$53.55$KG$20240906$N$HP$US$
242993841$24299384$1$I$$20240905$20240909$20240909$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144116$DAIICHI$$7$DEC$$M$Y$$$20240909$$HP$US$US
242993851$24299385$1$I$$20240904$20240909$20240909$EXP$$US-ABBVIE-5913825$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
242993861$24299386$1$I$20240814$20240814$20240909$20240909$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000813$PAREXEL$$$$$$Y$$$20240909$$HP$US$US
242993871$24299387$1$I$20240813$20240816$20240909$20240909$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000816$PAREXEL$$$$$$Y$$$20240909$$PH$US$US
242993881$24299388$1$I$$20240729$20240909$20240909$PER$$US-LUNDBECK-DKLU4003198$LUNDBECK$$$$$$Y$$$20240909$$CN$US$US
242993891$24299389$1$I$$20240903$20240909$20240909$EXP$$GB-JNJFOC-20240919495$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240909$$CN$GB$GB
242993901$24299390$1$I$20240830$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61882$$FDA-CTU$$73$YR$$M$N$$$20240909$N$$US$
242993921$24299392$1$I$20240727$20240905$20240909$20240909$EXP$$US-OTSUKA-2024_025041$OTSUKA$$84$YR$$$Y$$$20240909$$HP$US$US
242993931$24299393$1$I$$20240822$20240909$20240909$PER$$US-TPU-TPU-2024-00453$TEIKOKU$$$$$M$Y$$$20240909$$CN$US$US
242993941$24299394$1$I$20240801$20240821$20240909$20240909$PER$$US-TPU-TPU-2024-00450$TEIKOKU$$72$YR$E$M$Y$83.91$KG$20240909$$CN$US$US
242993961$24299396$1$I$20240704$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61883$$FDA-CTU$$69$YR$$F$N$$$20240909$N$$US$
242993991$24299399$1$I$$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024179425$AMGEN$$$$$F$Y$$$20240909$$PH$US$US
242994001$24299400$1$I$$20240902$20240909$20240909$EXP$$US-AMGEN-USASP2024176499$AMGEN$Haider A.; Taveras S.; Memushaj L. et al.. Myeloid Sarcoma and Lymphoid Sarcoma of the Brain: A Case Series. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S335-S336$59$YR$A$F$Y$$$20240909$$MD$US$US
242994011$24299401$1$I$20210322$20240823$20240909$20240909$EXP$$US-TPU-TPU-2024-00456$TEIKOKU$$$$$M$Y$119.5$KG$20240909$$CN$US$US
242994021$24299402$1$I$$20240906$20240909$20240909$EXP$$US-BAYER-2024A128515$BAYER$$$$$$Y$$$20240909$$CN$US$US
242994031$24299403$1$I$20240501$20240828$20240909$20240909$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17284$IPSEN$$44$YR$A$F$Y$$$20240909$$HP$US$US
242994041$24299404$1$I$$20240904$20240909$20240909$PER$$US-ALXN-202409USA000204US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242994052$24299405$2$F$$20240912$20240909$20240925$EXP$$US-UCBSA-2024044114$UCB$$$$$F$Y$$$20240926$$HP$US$US
242994061$24299406$1$I$20240808$20240903$20240909$20240909$EXP$$GR-TAKEDA-2024TUS089429$TAKEDA$$70$YR$$M$Y$$$20240909$$CN$GR$GR
242994071$24299407$1$I$$20240830$20240909$20240909$EXP$$US-SMPA-2024SPA000342$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
242994081$24299408$1$I$$20240904$20240909$20240909$EXP$$US-SMPA-2024SPA002298$SUNOVION$$$$$$Y$$$20240909$$PH$US$US
242994091$24299409$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003132$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240909$$CN$US$US
242994101$24299410$1$I$$20240905$20240909$20240909$30DAY$$US-SANDOZ INC.-SDZ2024US024201$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242994111$24299411$1$I$$20240830$20240909$20240909$EXP$$CA-TEVA-VS-3239062$TEVA$$65$YR$$F$Y$34$KG$20240909$$HP$CA$CA
242994121$24299412$1$I$20240814$20240905$20240909$20240909$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050274$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240909$$HP$CO$CO
242994132$24299413$2$F$$20240919$20240909$20240923$EXP$$LB-PFIZER INC-PV202400116085$PFIZER$Kharboutly, M.. CML-651 Challenges Navigating Therapies and Dosings in the Modern Era of Tyrosine Kinase Inhibitors (TKIs) in Low-Resource Countries. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(Supplement 1:S382$71$YR$$F$Y$$$20240923$$MD$LB$LB
242994321$24299432$1$I$$20240903$20240909$20240909$EXP$$FR-PFIZER INC-202400249117$PFIZER$Bottosso, M.. Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome.. JCO Precision Oncology. 2024;8:1-6$33$YR$$F$Y$$$20240909$$MD$FR$FR
242994351$24299435$1$I$20240709$20240816$20240909$20240909$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000894$PAREXEL$$$$$$Y$$$20240909$$PH$US$US
242994361$24299436$1$I$20240729$20240830$20240909$20240909$EXP$FR-AFSSAPS-NC2024000991$FR-TEVA-VS-3239271$TEVA$$53$YR$$F$Y$70$KG$20240909$$MD$FR$FR
242994371$24299437$1$I$20240827$20240828$20240909$20240909$PER$$US-ALKERMES INC.-ALK-2024-002263$ALKERMES$$34$YR$$M$Y$88.435$KG$20240909$$CN$US$US
242994381$24299438$1$I$20240715$20240905$20240909$20240909$EXP$IT-MINISAL02-1001155$IT-ABBVIE-5907984$ABBVIE$$74$YR$$M$Y$$$20240909$$MD$IT$IT
242994391$24299439$1$I$$20240902$20240909$20240909$EXP$$DE-VELOXIS PHARMACEUTICALS, INC.-2020-VEL-00877$VELOXIS PHARMACEUTICALS$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al.. Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant recipients: CERTAIN registry study. Transplantation. 2018;103(6):1-33$17$YR$$$Y$$$20240909$$MD$DE$DE
242994401$24299440$1$I$$20240905$20240909$20240909$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049735$BOEHRINGER INGELHEIM$$88$YR$E$F$Y$$$20240909$$MD$FR$FR
242994411$24299441$1$I$$20240903$20240909$20240909$EXP$$GB-AstraZeneca-2024A200214$ASTRAZENECA$$80$YR$$F$Y$68$KG$20240909$$MD$GB$
242994421$24299442$1$I$$20240827$20240909$20240909$EXP$$JP-AstraZeneca-2024A204468$ASTRAZENECA$$77$YR$$M$Y$$$20240909$$PH$JP$
242994431$24299443$1$I$$20240905$20240909$20240909$EXP$$BR-AstraZeneca-2024A178844$ASTRAZENECA$$$$$F$Y$$$20240909$$CN$BR$
242994441$24299444$1$I$$20240909$20240909$20240909$PER$$US-BAYER-2024A128804$BAYER$$$$$$Y$$$20240909$$CN$US$US
242994462$24299446$2$F$$20240909$20240909$20240911$30DAY$$US-SANDOZ INC.-SDZ2024US078491$SANDOZ$$$$$$Y$$$20240911$$CN$US$US
242994471$24299447$1$I$$20240902$20240909$20240909$EXP$$TR-OTSUKA-2024_024606$OTSUKA$Hasanzade U, Koruk K, Ahmed M, Tiryaki TO, Ozbalak M, Hindilerden IY et al.. CT-312 Secondary Solid Tumor After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report. Clin Lymphoma Myeloma Leuk. 2024;24:S601$56$YR$$M$Y$$$20240909$$MD$TR$TR
242994481$24299448$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142737$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240909$$CN$US$US
242994491$24299449$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141942$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240909$$CN$US$US
242994501$24299450$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141761$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240909$$HP$US$US
242994521$24299452$1$I$20240816$20240819$20240909$20240909$PER$$US-RDY-SPO/USA/24/0012381$DR REDDYS$$19$YR$A$F$Y$$$20240909$$MD$US$US
242994531$24299453$1$I$20240906$20240906$20240909$20240909$PER$$US-PFIZER INC-202400251932$PFIZER$$$$$$Y$$$20240909$$CN$US$US
242994541$24299454$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400252165$PFIZER$$57$YR$$F$Y$$$20240909$$MD$US$US
242994551$24299455$1$I$20230101$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142154$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$106.14$KG$20240909$$CN$US$US
242994561$24299456$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142711$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$82.65$KG$20240909$$PH$US$US
242994591$24299459$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400252026$PFIZER$$31$YR$$$Y$$$20240909$$CN$US$US
242994601$24299460$1$I$20240905$20240906$20240909$20240909$PER$$US-PFIZER INC-202400252262$PFIZER$$61$YR$$F$Y$$$20240909$$HP$US$US
242994621$24299462$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400251802$PFIZER$$75$YR$$F$Y$$$20240909$$CN$US$US
242994631$24299463$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400102075$PFIZER$$39$YR$$F$Y$$$20240909$$HP$US$US
242994651$24299465$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400117696$PFIZER$$91$YR$$F$Y$$$20240909$$HP$US$US
242994681$24299468$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400251472$PFIZER$$$$$$Y$$$20240909$$CN$US$US
242994702$24299470$2$F$20240825$20240924$20240909$20240927$PER$$US-PFIZER INC-202400252306$PFIZER$$49$YR$$F$Y$124.72$KG$20240927$$HP$US$US
242994711$24299471$1$I$$20240908$20240909$20240909$PER$$US-PFIZER INC-202400252450$PFIZER$$71$YR$$M$Y$$$20240909$$CN$US$US
242994721$24299472$1$I$20240824$20240906$20240909$20240909$PER$$US-PFIZER INC-202400251934$PFIZER$$37$YR$$F$Y$$$20240909$$CN$US$US
242994733$24299473$3$F$$20240913$20240909$20240917$PER$$US-PFIZER INC-PV202400117294$PFIZER$$24$YR$$F$Y$83.5$KG$20240917$$HP$US$US
242994741$24299474$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61884$$FDA-CTU$$36$YR$$F$N$$$20240909$N$$US$
242994751$24299475$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400251935$PFIZER$$67$YR$$M$Y$$$20240909$$CN$US$US
242994792$24299479$2$F$$20240912$20240909$20240918$PER$$US-PFIZER INC-PV202400117151$PFIZER$$59$YR$$F$Y$$$20240918$$HP$US$US
242994801$24299480$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400047539$PFIZER$$65$YR$$F$Y$$$20240909$$HP$US$US
242994821$24299482$1$I$20240701$20240906$20240909$20240909$PER$$US-PFIZER INC-202400230673$PFIZER$$34$YR$$M$Y$60.78$KG$20240909$$CN$US$US
242994872$24299487$2$F$20200101$20240910$20240909$20240912$EXP$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US001142$PAREXEL$$$$$F$Y$48.526$KG$20240912$$CN$US$US
242994882$24299488$2$F$20240802$20240910$20240909$20240913$EXP$GB-002147023-NVSC2024GB177326$GB-SANDOZ INC.-SDZ2024GB078320$SANDOZ$$56$YR$$$Y$$$20240913$$CN$GB$GB
242994892$24299489$2$F$20240625$20240919$20240909$20240923$EXP$$NVSC2024AU178791$NOVARTIS$$31$YR$$M$Y$$$20240923$$HP$AU$AU
242994901$24299490$1$I$20240719$20240904$20240909$20240909$EXP$$JP-OTSUKA-2024_024670$OTSUKA$$87$YR$$M$Y$68.5$KG$20240909$$MD$JP$JP
242994911$24299491$1$I$20240820$20240906$20240906$20240906$DIR$717444$$FDA-CTU$$67$YR$$F$N$54$KG$20240906$N$CN$US$
242994921$24299492$1$I$$20240827$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US078329$SANDOZ$$$$$F$Y$$$20240909$$MD$US$US
242994931$24299493$1$I$20240701$20240830$20240909$20240909$EXP$$US-ARDELYX-2024ARDX006701$ARDELYX$$64$YR$$M$Y$$$20240909$$CN$US$US
242994941$24299494$1$I$$20240906$20240909$20240909$EXP$$GB-SANDOZ INC.-NVSC2021GB258478$SANDOZ$$$$$M$Y$$$20240909$$MD$GB$GB
242994951$24299495$1$I$$20240829$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138704$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240909$$CN$US$US
242994961$24299496$1$I$20240708$20240904$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141203$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240909$$CN$US$US
242994971$24299497$1$I$20240701$20240904$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141555$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240909$$CN$US$US
242994982$24299498$2$F$20240905$20240910$20240909$20240911$PER$$US-AMGEN-USASP2024179122$AMGEN$$53$YR$A$F$Y$$$20240911$$CN$US$US
242994991$24299499$1$I$20240701$20240907$20240909$20240909$EXP$$US-KARYOPHARM-2024KPT001522$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240909$$CN$US$US
242995002$24299500$2$F$20240201$20240923$20240909$20240927$EXP$$NVSC2024US092671$NOVARTIS$$46$YR$$M$Y$$$20240927$$CN$US$US
242995011$24299501$1$I$20240802$20240829$20240909$20240909$EXP$$SE-JNJFOC-20240905807$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240909$$HP$SE$SE
242995021$24299502$1$I$$20240904$20240909$20240909$EXP$$US-JNJFOC-20240909247$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240909$$CN$US$US
242995041$24299504$1$I$20240901$20240905$20240909$20240909$EXP$$CN-PFIZER INC-PV202400116791$PFIZER$$54$YR$$F$Y$33$KG$20240909$$HP$CN$CN
242995051$24299505$1$I$$20240906$20240909$20240909$EXP$FR-AFSSAPS-AN2024001224$FR-PFIZER INC-202400251284$PFIZER$$54$YR$$M$Y$155$KG$20240909$$CN$FR$FR
242995061$24299506$1$I$20240701$20240906$20240909$20240909$EXP$$TW-PFIZER INC-PV202400117595$PFIZER$$46$YR$$M$Y$$$20240909$$HP$TW$TW
242995071$24299507$1$I$20240903$20240904$20240909$20240909$EXP$$JP-PFIZER INC-202400251245$PFIZER$$$$$$Y$$$20240909$$MD$JP$JP
242995083$24299508$3$F$20240908$20240919$20240909$20240923$EXP$$SE-PFIZER INC-202400252594$PFIZER$$18$YR$$F$Y$70$KG$20240923$$CN$SE$SE
242995091$24299509$1$I$20230711$20240905$20240909$20240909$EXP$$CA-PFIZER INC-2019445706$PFIZER$$71$YR$$F$Y$$$20240909$$MD$CA$CA
242995102$24299510$2$F$20240803$20240910$20240909$20240910$EXP$$US-PFIZER INC-202200277631$PFIZER$$72$YR$$M$Y$59.87$KG$20240910$$CN$US$US
242995111$24299511$1$I$20240610$20240902$20240909$20240909$EXP$$FR-PFIZER INC-202400251684$PFIZER$$61$YR$$F$Y$$$20240909$$MD$FR$FR
242995132$24299513$2$F$20240810$20240906$20240909$20240910$EXP$$JP-PFIZER INC-PV202400116819$PFIZER$$60$YR$$$Y$$$20240910$$MD$JP$JP
242995141$24299514$1$I$20240530$20240903$20240909$20240909$EXP$$RU-PFIZER INC-202400251529$PFIZER$$16$YR$$M$Y$48$KG$20240909$$HP$RU$RU
242995151$24299515$1$I$20240101$20240905$20240909$20240909$EXP$$US-PFIZER INC-202400251857$PFIZER$$74$YR$$M$Y$$$20240909$$HP$US$US
242995161$24299516$1$I$20240817$20240828$20240909$20240909$EXP$$IN-PFIZER INC-PV202400083833$PFIZER$$39$YR$$F$Y$$$20240909$$CN$IN$IN
242995171$24299517$1$I$$20240904$20240909$20240909$EXP$$FI-INCYTE CORPORATION-2024IN009390$INCYTE$$$$$$Y$$$20240909$$MD$FI$FI
242995181$24299518$1$I$$20240903$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141511$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240909$$CN$US$US
242995191$24299519$1$I$$20240829$20240909$20240909$EXP$817951$AU-LUPIN PHARMACEUTICALS INC.-2024-08646$LUPIN$$$$$$Y$$$20240909$$CN$AU$AU
242995201$24299520$1$I$20240814$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61885$$FDA-CTU$$77$YR$$M$N$$$20240909$Y$HP$US$
242995211$24299521$1$I$20140808$20240903$20240909$20240909$EXP$$FR-SANDOZ INC.-NVSC2017FR015913$SANDOZ$$83$YR$$M$Y$$$20240909$$MD$FR$FR
242995221$24299522$1$I$$20240901$20240909$20240909$EXP$$IL-PERRIGO-24IL008109$PERRIGO$$28$YR$$F$Y$$$20240909$$CN$IL$IL
242995231$24299523$1$I$$20240904$20240909$20240909$EXP$$US-JNJFOC-20240913716$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240909$$HP$US$US
242995241$24299524$1$I$$20240906$20240909$20240909$PER$$US-JNJFOC-20240916610$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$PH$US$US
242995251$24299525$1$I$$20240828$20240909$20240909$EXP$$IT-Accord-444063$ACCORD$Castelli M, Betelli M, Valenti A, Merelli B, Loglio A, Vigano M, Benetti A. A Case of Polyserositis, Chylous Ascites and Hepatitis Induced by Immune Checkpoint Inhibitors. Eur J Case Rep Intern Med. 2024 May 31;11(7):004237.$39$YR$A$M$Y$$$20240909$$HP$IT$IT
242995261$24299526$1$I$$20240904$20240909$20240909$EXP$$VN-INCYTE CORPORATION-2024IN009432$INCYTE$$$$$$Y$$$20240909$$MD$VN$VN
242995271$24299527$1$I$20240624$20240830$20240909$20240909$EXP$FR-AFSSAPS-NT2024001064$FR-TEVA-VS-3238841$TEVA$$60$YR$$M$Y$82$KG$20240909$$PH$FR$FR
242995301$24299530$1$I$$20240826$20240909$20240909$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467049$RANBAXY$Wathen C, Yang AI, Hitti FL, Henry L, Chaibainou H, Baltuch GH. Feasibility of Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Essential Tremor in the Setting of Prior Craniotomy. OPERATIVE NEUROSURGERY. 2022;22:61-65$55$YR$$M$Y$$$20240909$$MD$US$US
242995311$24299531$1$I$$20240826$20240909$20240909$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466675$RANBAXY$Johnson N, Solkar M, Sehgal R, Riyad K. Non-steroidal anti-inf lammatory drug induced intestinal stricturing: diaphragm disease. J Surg Case Rep. 2024;2024:1-4$$$$F$Y$$$20240909$$HP$GB$GB
242995322$24299532$2$F$$20240902$20240909$20240917$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466404$RANBAXY$Zhao Z-Y, Tang N, Lin L-E. A rare BCR-ABL1 transcript in chronic myeloid leukemia: Case report and literature review. Leuk Res. 2023;133:107369$21$YR$$M$Y$$$20240917$$HP$CN$CN
242995331$24299533$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466915$RANBAXY$Lu Y, Liao L, Du K, Mo J, Zou X, Liang J, et al.. Clinical activity and safety of sintilimab bevacizumab, and TMZ in patients with recurrent glioblastoma. BMC Can. 2024;24:133(1-10)$$$$F$Y$$$20240909$$HP$CN$CN
242995341$24299534$1$I$$20240826$20240909$20240909$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466681$RANBAXY$Johnson N, Solkar M, Sehgal R, Riyad K. Non-steroidal anti-inflammatory drug induced intestinal stricturing: diaphragm disease. J Surg Case Rep. 2024;2024 (1):1-4$41$YR$$M$Y$$$20240909$$HP$GB$GB
242995351$24299535$1$I$20240501$20240826$20240909$20240909$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465392$RANBAXY$$32$YR$$F$Y$97.506$KG$20240909$$CN$US$US
242995361$24299536$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466731$RANBAXY$Gao Z, Fan Z, Liu Z, Ye X, Zeng Y, Xuan L, et al. Vedolizumab plus basiliximab as second-line therapy for steroid refractory lower gastrointestinal acute graft-versus-host disease. Front Immunol. 2024;15 (0):1408211$$$A$$Y$$$20240909$$HP$CN$CN
242995371$24299537$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466911$RANBAXY$Lu Y, Liao L, Du K, Mo J, Zou X, Liang J, et al.. Clinical activity and safety of sintilimab bevacizumab, and TMZ in patients with recurrent glioblastoma. BMC Can. 2024;24:133(1-10)$$$$F$Y$$$20240909$$HP$CN$CN
242995381$24299538$1$I$20230101$20240826$20240909$20240909$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466782$RANBAXY$Palmer JP, Suriawinata AA, Yan S, Kerr DA, Afzal MZ, Shirai K. Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series. Am J Case Rep. 2023;24:e938537-1-e938537-16$51$YR$$M$Y$$$20240909$$HP$US$US
242995391$24299539$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466814$RANBAXY$Tao R, Liu C, Zhang W, Zhu Y, Ma Y, Hao S. Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade. Oncologist. 2024;29:E90-E96$44$YR$$M$Y$$$20240909$$HP$CN$CN
242995401$24299540$1$I$$20240826$20240909$20240909$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466622$RANBAXY$Krawczyk D, Dabrowski F, Kosinska-Kaczynska K. Preeclampsia is caused by impaired placenta -A case report. Eur J Obstet Gynecol Reprod Bio. 2024;293:170-300$$$N$M$Y$0.65$KG$20240909$$HP$PL$PL
242995411$24299541$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466732$RANBAXY$Zhang Q, Fu W, Bao W, Ling C, Jin Q, Chen B. ACUTE MYELOID LEUKEMIAS: BIOMARKERS, MOLECULAR MARKERS AND MINIMAL RESIDUAL DISEASE IN DIAGNOSIS AND PROGNOSIS. Blood. 2023;142:5983$70$YR$$M$Y$$$20240909$$HP$CN$CN
242995421$24299542$1$I$$20240826$20240909$20240909$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465371$RANBAXY$$$$E$M$Y$$$20240909$$CN$US$US
242995431$24299543$1$I$$20240826$20240909$20240909$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465000$RANBAXY$Carneiro Martins AL, Miguel Martins R, Oliveira RC, Correia JG, Angelo MD, Tomas AR. Dedifferentiated GIST after therapy with imatinib. Eur J Surg Oncol. 2024;50(2):107822/P427$72$YR$$M$Y$$$20240909$$HP$PT$PT
242995441$24299544$1$I$$20240826$20240909$20240909$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466615$RANBAXY$Krawczyk D, Dabrowski F, Kosinska-Krawczyk D, Dabrowski F, Kosinska. Preeclampsia is caused by impaired placenta -A case report. Eur J Obstet Gynecol Reprod Biol. 2024;293:170-300$30$YR$$F$Y$$$20240909$$HP$PL$PL
242995451$24299545$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466846$RANBAXY$Zhang J, Kang Y, Xia Z, Chong Y,. Case report: Macrophage activation syndrome in a patient with Kabuki syndrome. Front Immunol. 2024;15 (0)::1412084(1-7)$22$YR$$M$Y$$$20240909$$HP$CN$CN
242995461$24299546$1$I$$20240826$20240909$20240909$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466556$RANBAXY$Kostrzanowski M, Kosinska-Kaczynska K, Dabrowski F. Pregestational diabetes - the importance of pregestational counseling- case report. Eur J Obstet Gynecol Reprod Biol. 2024;293:210$36$YR$$F$Y$$$20240909$$HP$PL$PL
242995472$24299547$2$F$$20240902$20240909$20240917$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466810$RANBAXY$Tao R, Liu C, Zhang W, Zhu Y, Ma Y, Hao S. Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade. Oncologist. 2024;29:E90-E96$55$YR$$M$Y$$$20240917$$HP$CN$CN
242995481$24299548$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466910$RANBAXY$Lu Y, Liao L, Du K, Mo J, Zou X, Liang J, et al.. Clinical activity and safety of sintilimab bevacizumab, and TMZ in patients with recurrent glioblastoma. BMC Can. 2024;24:133(1-10)$$$$F$Y$$$20240909$$HP$CN$CN
242995491$24299549$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466821$RANBAXY$Tao R, Liu C, Zhang W, Zhu Y, Ma Y, Hao S. Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade. Oncologist. 2024;29:E90-E96$38$YR$$M$Y$$$20240909$$HP$CN$CN
242995501$24299550$1$I$$20240826$20240909$20240909$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466559$RANBAXY$Kostrzanowski M, Kosinska-Kaczynska K, Dabrowski F. Pregestational diabetes - the importance of pregestational counseling- case report. Eur J Obstet Gynecol Reprod Biol. 2024;293:210$$$N$F$Y$1.85$KG$20240909$$HP$PL$PL
242995511$24299551$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466728$RANBAXY$Sui Y, Zhao Y, Zhou N, Sun H, Sun Y, Liu J, et al. Case report: heart failure related to intravitreal injection of anti-VEGF. BMC Cardiovasc Disord. 2014;24 (1):418$80$YR$$M$Y$$$20240909$$HP$CN$CN
242995521$24299552$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459652$RANBAXY$Xingyu C, Yuxia J, Tongxin S, Caijie Q. Two cases of amlodipine-induced interstitial granulomatous drug reaction. Chin J Dermatol. 2021;Nov;54 (11):1005-1006$76$YR$$M$Y$$$20240909$$HP$CN$CN
242995531$24299553$1$I$$20240826$20240909$20240909$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466550$RANBAXY$Fecko M, Klimek M, Zielinski T, Gawrychowski J, Mackiewicz M, Nowosielski K. An unusual presentation of acute pancreatitis associated with primary hyperparathyroidism in pregnant woman. hEur J Obstet Gynecol Reprod Biol. 2024;293:254$30$YR$$F$Y$$$20240909$$HP$PL$PL
242995541$24299554$1$I$$20240826$20240909$20240909$EXP$$PE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466724$RANBAXY$Viru-Loza MA, Alvarado-Gamarra G Zapata-Sequeiros RI, Flores- Nakandakare HF. Life-threatening hypercalcemia in a child with vitamin D intoxication due to parental self-medication: A case report. SAGE Open Med Case Rep. 2024;12 (0):1-5$$$C$M$Y$$$20240909$$HP$PE$PE
242995552$24299555$2$F$20240418$20240829$20240909$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466557$RANBAXY$$73$YR$$F$Y$$$20240913$$HP$AU$AU
242995562$24299556$2$F$$20240903$20240909$20240918$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466729$RANBAXY$Tunc A, AkbaS AA, Bozkurt B, Once S. Beyond conventional therapies: IVIG in treating severe fingolimod-rebound in a postpartum patient with MS. BMJ Case Reports. 2024;17 (7):1-5$4$DEC$$F$Y$$$20240918$$HP$TR$TR
242995571$24299557$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466908$RANBAXY$Lu Y, Liao L, Du K, Mo J, Zou X, Liang J, et al.. Clinical activity and safety of sintilimab bevacizumab, and TMZ in patients with recurrent glioblastoma. BMC Can. 2024;24:133(1-10)$$$$M$Y$$$20240909$$HP$CN$CN
242995581$24299558$1$I$$20240826$20240909$20240909$EXP$$FI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465253$RANBAXY$Aaltio J, Euro L, Tynninen O, Vu HS, Ni M, DeBerardinis RJ, et al. Niacin supplementation in a child with novel MTTN variant m.5670A}G causing early onset mitochondrial myopathy and NAD+ deficiency. Neuromuscul Disord. 2024;Aug 43:14-19$8$YR$$$Y$$$20240909$$HP$FI$FI
242995591$24299559$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466909$RANBAXY$Lu Y, Liao L, Du K, Mo J, Zou X, Liang J, et al.. Clinical activity and safety of sintilimab bevacizumab, and TMZ in patients with recurrent glioblastoma. BMC Can. 2024;24:133(1-10)$$$$M$Y$$$20240909$$HP$CN$CN
242995601$24299560$1$I$$20240826$20240909$20240909$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467034$RANBAXY$Ali EA, Jain M, Pokhrel A, Mooppan U, Wang JC. Olaparib induced aplastic anemia in a patient with castrate resistant prostate cancer: A case report. Leukemia Research Rep. 2024;22(0):1-4$75$YR$$M$Y$$$20240909$$HP$US$US
242995611$24299561$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466725$RANBAXY$Yang Y, Ye Y, Wang H, Wu H, Zhang J, Lv Z,. Malignant hypertension in a patient with Turner syndrome: A case report. Medicine. 2024;103:31:e39128; 1-4$13$YR$$F$Y$29$KG$20240909$$MD$CN$CN
242995622$24299562$2$F$$20240903$20240909$20240918$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466730$RANBAXY$Sun M, Xu G, Cai L, He S. Misdiagnosis of severe and atypical oxaliplatin-related hypersensitivity reaction following chemotherapy combined with PD-1 inhibitor: A case report and literature review.. Oncol Lett. 2024;28 (4):1-7$67$YR$$M$Y$$$20240918$$HP$CN$CN
242995631$24299563$1$I$$20240826$20240909$20240909$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465085$RANBAXY$Neto VD, Fiuza J, Pires I, Santos JM, Correia M. Hydroxychloroquine-induced cardiomyopathy predominantly affecting the right ventricle. Eur Heart J Cardiovasc Imaging. 2024;April 25 (4):e141$73$YR$$F$Y$$$20240909$$HP$PT$PT
242995641$24299564$1$I$20240902$20240906$20240909$20240909$EXP$$US-AstraZeneca-2024A204068$ASTRAZENECA$$$$$M$Y$$$20240909$$CN$US$
242995651$24299565$1$I$$20240906$20240909$20240909$EXP$$US-AstraZeneca-2024A204633$ASTRAZENECA$$$$$M$Y$81.6$KG$20240909$$CN$US$
242995662$24299566$2$F$$20240903$20240909$20240910$EXP$$GB-AstraZeneca-2024A200311$ASTRAZENECA$$46$YR$$F$Y$$$20240910$$MD$GB$
242995671$24299567$1$I$$20240826$20240909$20240909$EXP$$MY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465775$RANBAXY$Hazwani I, Raja Abdul wafy RMR. Case report of a pregnant patient with peripartum cardiomyopathy, pulmonary embolism, and cardiac arrest: Lessons learned. -. -;-:8;P 015$34$YR$$F$Y$$$20240909$$HP$MY$MY
242995681$24299568$1$I$$20240826$20240909$20240909$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466767$RANBAXY$Ekladious F, Saul D. A case of severe anaphylactic reaction after administration of diagnostic?dose ferumoxytol in a pediatric patient. Pediatr Radiol. 2024;54 (9):1553-1555$4$YR$$F$Y$$$20240909$$HP$US$US
242995691$24299569$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003133$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240909$$CN$US$US
242995701$24299570$1$I$20240828$20240829$20240909$20240909$PER$$US-ALKERMES INC.-ALK-2024-002280$ALKERMES$$48$YR$$M$Y$$$20240909$$CN$US$US
242995711$24299571$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143228$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240909$$CN$US$US
242995721$24299572$1$I$20240807$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142324$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240909$$CN$US$US
242995731$24299573$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142718$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240909$$HP$US$US
242995741$24299574$1$I$20231207$20240903$20240909$20240909$EXP$$FR-009507513-2409FRA001241$MERCK$$73$YR$$M$Y$70$KG$20240909$$MD$FR$FR
242995751$24299575$1$I$20240823$20240830$20240909$20240909$PER$$US-ALKERMES INC.-ALK-2024-002294$ALKERMES$$$$$M$Y$$$20240909$$PH$US$US
242995761$24299576$1$I$20240101$20240906$20240909$20240909$EXP$$US-FERRINGPH-2024FE05062$FERRING$$$$$$Y$$$20240909$$CN$US$US
242995781$24299578$1$I$20240827$20240829$20240909$20240909$EXP$GB-MHRA-TPP62574424C4714927YC1724761156914$GB-PERRIGO-24GB008072$PERRIGO$$44$YR$$F$Y$69$KG$20240909$$MD$GB$GB
242995791$24299579$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61886$$FDA-CTU$$43$YR$$F$N$$$20240909$N$$US$
242995801$24299580$1$I$20240803$20240906$20240906$20240906$DIR$717472$$FDA-CTU$$21$YR$$F$N$48.5$KG$20240906$Y$HP$US$
242995811$24299581$1$I$20240621$20240901$20240909$20240909$EXP$$CA-FERRINGPH-2024FE03662$FERRING$$$$$$Y$$$20240909$$MD$CA$TT
242995821$24299582$1$I$20240828$20240829$20240909$20240909$EXP$GB-MHRA-MED-202408291643299370-HNZKY$GB-PERRIGO-24GB008102$PERRIGO$$93$YR$$F$Y$$$20240909$$HP$GB$GB
242995831$24299583$1$I$$20240826$20240909$20240909$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466771$RANBAXY$Pace JL, Hopstone MD, Conti PS, Tom C, Mohamed P, Gong Y, et al. Unresectable Metastatic Solid Pseudopapillary Pancreatic Neoplasm Treated With Liver Transplantation. ACG Case Rep J. 2024;11 (8):e01432$49$YR$$F$Y$$$20240909$$MD$US$US
242995841$24299584$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459653$RANBAXY$Xingyu C, Yuxia J, Tongxin S, Caijie Q. Two cases of amlodipine-induced interstitial granulomatous drug reaction. Chin J Dermatol. 2021;Nov;54 (11):1005-1006$68$YR$$F$Y$$$20240909$$HP$CN$CN
242995851$24299585$1$I$$20240826$20240909$20240909$EXP$$LB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466683$RANBAXY$Deep Morphea in an Immunosuppressed Patient With Anti-U1RNP Myositis: A Case Report. Int J Dermatol Venereol. 2024;7 (2):111-114$64$YR$$M$Y$$$20240909$$HP$LB$LB
242995862$24299586$2$F$$20240902$20240909$20240917$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466789$RANBAXY$Tao R, Liu C, Zhang W, Zhu Y, Ma Y, Hao S. Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade. Oncologist. 2024;29:E90-E96$53$YR$$M$Y$$$20240917$$HP$CN$CN
242995872$24299587$2$F$$20240902$20240909$20240917$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466802$RANBAXY$Tao R, Liu C, Zhang W, Zhu Y, Ma Y, Hao S. Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade. Oncologist. 2024;29:E90-E96$35$YR$$M$Y$$$20240917$$HP$CN$CN
242995881$24299588$1$I$$20240826$20240909$20240909$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466884$RANBAXY$Lu Y, Liao L, Du K, Mo J, Zou X, Liang J, et al.. Clinical activity and safety of sintilimab bevacizumab, and TMZ in patients with recurrent glioblastoma. BMC Can. 2024;24;133$$$$M$Y$$$20240909$$HP$CN$CN
242995891$24299589$1$I$$20240826$20240909$20240909$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466726$RANBAXY$Adachi K, Murata M, Inada A, Morimoto T, Shimizu M, Beppu S, et al. Interaction of a caffeine overdose with clinical doses of contraceptive ethinyl estradiol in a young woman. Acute Med Surg. 2024;11 (1):e985;1-4$23$YR$$F$Y$67$KG$20240909$$HP$JP$JP
242995911$24299591$1$I$20220112$20240903$20240909$20240909$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014180$JAZZ$$69$YR$$F$Y$$$20240909$$CN$US$US
242995921$24299592$1$I$$20240826$20240909$20240909$PER$$US-SA-2024SA256836$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240909$$HP$US$US
242995931$24299593$1$I$20240101$20240827$20240909$20240909$EXP$$US-SA-2024SA258364$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240909$$HP$US$US
242995941$24299594$1$I$20240101$20240903$20240909$20240909$PER$$US-SA-2024SA258564$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240909$$CN$US$US
242995952$24299595$2$F$20240826$20240830$20240909$20240913$PER$$US-SA-2024SA255076$SANOFI AVENTIS$$21$YR$A$M$Y$64$KG$20240913$$MD$US$US
242995961$24299596$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259778$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240909$$HP$US$US
242995971$24299597$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180401$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
242995981$24299598$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180321$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
242995991$24299599$1$I$20240808$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024176917$AMGEN$$$$$$Y$$$20240909$$PH$US$US
242996001$24299600$1$I$20240904$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024178563$AMGEN$$69$YR$E$M$Y$$$20240909$$CN$US$US
242996011$24299601$1$I$$20240830$20240909$20240909$PER$$US-TEVA-VS-3239624$TEVA$$66$YR$$F$Y$$$20240909$$MD$US$US
242996022$24299602$2$F$$20240920$20240909$20240927$EXP$$JP-AMGEN-JPNSP2024176318$AMGEN$Oda, R.. A case of incomplete Behcet^s disease that occurred during ixezumab treatment for psoriatic arthritis. Program/abstracts of the 39th Annual Meeting of the Japanese Society for Psorias. 2024;15$$$E$F$Y$$$20240927$$MD$JP$JP
242996031$24299603$1$I$$20240904$20240909$20240909$EXP$$US-JNJFOC-20240915423$JOHNSON AND JOHNSON$$$$$M$Y$$$20240909$$CN$US$US
242996041$24299604$1$I$$20240903$20240909$20240909$PER$$US-JNJFOC-20240908056$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$US$US
242996052$24299605$2$F$20231229$20240919$20240909$20240928$EXP$$CA-JNJFOC-20240845100$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240928$$CN$CA$CA
242996063$24299606$3$F$$20240924$20240909$20240926$EXP$$DE-SANDOZ INC.-PHHY2018DE090309$SANDOZ$$52$YR$$F$Y$$$20240926$$MD$DE$DE
242996071$24299607$1$I$20240906$20240906$20240906$20240906$DIR$717505$$FDA-CTU$$63$YR$$M$N$$$20240906$N$$US$
242996081$24299608$1$I$20240819$20240909$20240909$20240909$DIR$717640$$FDA-CTU$$43$YR$$F$N$75.15$KG$20240909$N$CN$US$
242996091$24299609$1$I$20240906$20240909$20240909$20240909$DIR$717655$$FDA-CTU$$77$YR$$M$N$$$20240909$N$$US$
242996101$24299610$1$I$20240905$20240909$20240909$20240909$DIR$717660$$FDA-CTU$$77$YR$$M$N$86.2$KG$20240909$N$CN$US$
242996111$24299611$1$I$$20240909$20240909$20240909$DIR$717668$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
242996121$24299612$1$I$20240816$20240903$20240909$20240909$EXP$$BR-TAKEDA-2024TUS085834$TAKEDA$$30$YR$$M$Y$$$20240909$$CN$BR$BR
242996131$24299613$1$I$$20240902$20240909$20240909$30DAY$$PA-PFIZER INC-PV202400115385$PFIZER$$12$YR$$F$Y$$$20240909$$CN$PA$PA
242996141$24299614$1$I$$20240904$20240909$20240909$EXP$$CA-TAKEDA-2023TUS016217$TAKEDA$$$$$M$Y$$$20240909$$CN$CA$CA
242996151$24299615$1$I$20240101$20240902$20240909$20240909$EXP$$JP-GENMAB-2024-01955AA$GENMAB$$50$YR$$F$Y$$$20240909$$PH$JP$JP
242996161$24299616$1$I$$20240909$20240909$20240909$DIR$717665$$FDA-CTU$$$$$UNK$N$$$20240909$$CN$US$
242996172$24299617$2$F$$20240828$20240909$20240910$EXP$$CR-PFIZER INC-PV202400113196$PFIZER$$44$YR$$F$Y$$$20240910$$CN$CR$CR
242996181$24299618$1$I$20240101$20240827$20240909$20240909$EXP$$US-SA-2024SA258723$SANOFI AVENTIS$$$$A$M$Y$90.77$KG$20240909$$MD$US$US
242996191$24299619$1$I$$20240904$20240909$20240909$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014352$JAZZ$$$$$M$Y$$$20240909$$HP$US$US
242996201$24299620$1$I$$20240830$20240909$20240909$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-17445$IPSEN$$$$$M$Y$$$20240909$$CN$GB$GB
242996211$24299621$1$I$20240809$20240830$20240909$20240909$EXP$$CN-SA-2024SA259315$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240909$$HP$CN$CN
242996221$24299622$1$I$$20240830$20240909$20240909$EXP$GB-MHRA-MIDB-e3ffbe2f-4c0f-47ec-9c6b-f968b73335b6$GB-TEVA-VS-3239077$TEVA$$81$YR$$F$Y$$$20240909$$PH$GB$GB
242996231$24299623$1$I$20240101$20240828$20240909$20240909$EXP$$HU-SA-2024SA256933$SANOFI AVENTIS$$51$YR$A$F$Y$90$KG$20240909$$CN$HU$HU
242996241$24299624$1$I$20211119$20240905$20240909$20240909$EXP$PL-URPL-DML-MLP.4401.1.5051.2021$PL-MYLANLABS-2024M1081531$MYLAN$$49$YR$$F$Y$100$KG$20240909$$MD$PL$PL
242996261$24299626$1$I$20240701$20240827$20240909$20240909$PER$$US-SA-2024SA259598$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240909$$HP$US$US
242996271$24299627$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259781$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240909$$HP$US$US
242996281$24299628$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA258963$SANOFI AVENTIS$$$$A$F$Y$$$20240909$$MD$US$US
242996291$24299629$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA258627$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240909$$HP$US$US
242996301$24299630$1$I$$20240829$20240909$20240909$PER$$US-IGSA-BIG0030518$GRIFOLS$$56$YR$$F$Y$$$20240909$$CN$US$US
242996311$24299631$1$I$20240827$20240830$20240909$20240909$EXP$$PY-TEVA-VS-3239873$TEVA$$28$YR$$F$Y$75$KG$20240909$$CN$PY$PY
242996321$24299632$1$I$20240801$20240907$20240909$20240909$PER$$US-PFIZER INC-202400251979$PFIZER$$60$YR$$F$Y$$$20240909$$CN$US$US
242996331$24299633$1$I$20240907$20240907$20240909$20240909$PER$$US-PFIZER INC-202400252393$PFIZER$$59$YR$$F$Y$$$20240909$$CN$US$US
242996341$24299634$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400252235$PFIZER$$63$YR$$F$Y$$$20240909$$CN$US$US
242996352$24299635$2$F$$20240924$20240909$20240930$EXP$$AT-MYLANLABS-2024M1080780$MYLAN$Gelbenegger G, Buchtele N,Schoergenhofer C, Grafeneder J,Schwameis M, Schellongowski P, et al. Disseminated Intravascular Coagulation in Anaphylaxis. Seminars in thrombosis and hemostasis. 2024;50(4):569-79$78$YR$$F$Y$$$20240930$$MD$AT$AT
242996371$24299637$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400118025$PFIZER$$59$YR$$F$Y$$$20240909$$HP$US$US
242996381$24299638$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400251795$PFIZER$$$$$F$Y$$$20240909$$CN$US$US
242996391$24299639$1$I$20240906$20240907$20240909$20240909$PER$$US-PFIZER INC-202400251940$PFIZER$$42$YR$$F$Y$$$20240909$$CN$US$US
242996401$24299640$1$I$20240801$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400117775$PFIZER$$42$YR$$F$Y$$$20240909$$HP$US$US
242996411$24299641$1$I$20240907$20240907$20240909$20240909$PER$$US-PFIZER INC-202400252367$PFIZER$$44$YR$$F$Y$$$20240909$$HP$US$US
242996421$24299642$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400117822$PFIZER$$49$YR$$F$Y$$$20240909$$HP$US$US
242996431$24299643$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400251813$PFIZER$$$$$F$Y$$$20240909$$CN$US$US
242996441$24299644$1$I$20240905$20240908$20240909$20240909$PER$$US-PFIZER INC-202400252042$PFIZER$$43$YR$$F$Y$$$20240909$$CN$US$US
242996461$24299646$1$I$20240903$20240906$20240909$20240909$PER$$US-PFIZER INC-202400252482$PFIZER$$77$YR$$M$Y$$$20240909$$CN$US$US
242996471$24299647$1$I$20240801$20240907$20240909$20240909$PER$$US-PFIZER INC-202400252059$PFIZER$$39$YR$$F$Y$$$20240909$$CN$US$US
242996491$24299649$1$I$20240906$20240907$20240909$20240909$PER$$US-PFIZER INC-202400252049$PFIZER$$$$E$F$Y$$$20240909$$CN$US$US
242996501$24299650$1$I$20240908$20240908$20240909$20240909$PER$$US-PFIZER INC-202400252444$PFIZER$$81$YR$$F$Y$$$20240909$$CN$US$US
242996511$24299651$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400252070$PFIZER$$15$YR$$F$Y$$$20240909$$HP$US$US
242996521$24299652$1$I$$20240908$20240909$20240909$PER$$US-PFIZER INC-PV202400117454$PFIZER$$$$$$Y$$$20240909$$CN$US$US
242996531$24299653$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400117898$PFIZER$$62$YR$$F$Y$$$20240909$$HP$US$US
242996542$24299654$2$F$$20240920$20240909$20240924$PER$$US-PFIZER INC-PV202400117763$PFIZER$$71$YR$$F$Y$$$20240924$$CN$US$US
242996551$24299655$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400117472$PFIZER$$80$YR$$M$Y$$$20240909$$CN$US$US
242996561$24299656$1$I$20240907$20240907$20240909$20240909$PER$$US-PFIZER INC-202400252000$PFIZER$$53$YR$$M$Y$$$20240909$$CN$US$US
242996571$24299657$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400117889$PFIZER$$17$YR$$M$Y$$$20240909$$HP$US$US
242996581$24299658$1$I$$20240908$20240909$20240909$PER$$US-PFIZER INC-202400251951$PFIZER$$52$YR$$F$Y$$$20240909$$CN$US$US
242996591$24299659$1$I$20240906$20240907$20240909$20240909$PER$$US-PFIZER INC-202400252090$PFIZER$$67$YR$$F$Y$$$20240909$$CN$US$US
242996601$24299660$1$I$20240101$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400117575$PFIZER$$41$YR$$F$Y$$$20240909$$HP$US$US
242996611$24299661$1$I$20240907$20240907$20240909$20240909$PER$$US-PFIZER INC-202400252092$PFIZER$$56$YR$$F$Y$$$20240909$$CN$US$US
242996622$24299662$2$F$20240101$20240912$20240909$20240913$PER$$US-PFIZER INC-202400252036$PFIZER$$38$YR$$F$Y$$$20240913$$HP$US$US
242996631$24299663$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400252455$PFIZER$$$$$$Y$$$20240909$$HP$US$US
242996642$24299664$2$F$20240101$20240912$20240909$20240913$PER$$US-PFIZER INC-202400252081$PFIZER$$71$YR$$M$Y$$$20240913$$CN$US$US
242996651$24299665$1$I$20240906$20240906$20240909$20240909$PER$$US-PFIZER INC-202400251941$PFIZER$$62$YR$$F$Y$$$20240909$$PH$US$US
242996661$24299666$1$I$20240907$20240908$20240909$20240909$PER$$US-PFIZER INC-202400252024$PFIZER$$52$YR$$F$Y$$$20240909$$CN$US$US
242996671$24299667$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400251800$PFIZER$$$$$F$Y$$$20240909$$CN$US$US
242996681$24299668$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400117794$PFIZER$$77$YR$$F$Y$$$20240909$$HP$US$US
242996702$24299670$2$F$20240906$20240924$20240909$20240925$PER$$US-PFIZER INC-202400252435$PFIZER$$71$YR$$M$Y$74.83$KG$20240925$$MD$US$US
242996711$24299671$1$I$20240101$20240903$20240909$20240909$EXP$$US-SA-2024SA258793$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240909$$MD$US$US
242996721$24299672$1$I$$20240829$20240909$20240909$EXP$$DK-AstraZeneca-2024A204604$ASTRAZENECA$Hoeck PR, Kessing LV, Pagsberg AK, Andersen MLM.. 15-year-old with bipolar affective disorder treated with ECT.. Ugeskr L?ger 2024;186:V02240137..$15$YR$$F$Y$$$20240909$$HP$DK$
242996731$24299673$1$I$20240201$20240904$20240909$20240909$PER$$US-AstraZeneca-2024A201648$ASTRAZENECA$$$$$M$Y$$$20240909$$MD$US$
242996741$24299674$1$I$$20240903$20240909$20240909$PER$$US-AstraZeneca-2024A200437$ASTRAZENECA$$$$$$Y$$$20240909$$CN$US$
242996751$24299675$1$I$$20240909$20240909$20240909$EXP$$NVSC2024ES179939$NOVARTIS$$$$$$Y$$$20240909$$HP$ES$ES
242996762$24299676$2$F$20240101$20240919$20240909$20240923$EXP$$US-SA-2024SA258845$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240923$$HP$US$US
242996771$24299677$1$I$20240101$20240824$20240909$20240909$PER$$US-SA-2024SA259165$SANOFI AVENTIS$$18$YR$A$F$Y$60$KG$20240909$$MD$US$US
242996781$24299678$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259784$SANOFI AVENTIS$$$$E$F$Y$$$20240909$$CN$US$US
242996792$24299679$2$F$20230313$20240909$20240909$20240920$EXP$$FR-DSJP-DSE-2024-143850$DAIICHI$$$$E$F$Y$70$KG$20240920$$MD$FR$FR
242996802$24299680$2$F$$20240917$20240909$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142971$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240919$$CN$US$US
242996831$24299683$1$I$$20240906$20240909$20240909$PER$$US-ALXN-202409USA000419US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242996841$24299684$1$I$$20240904$20240909$20240909$EXP$$US-AMGEN-USASP2024178219$AMGEN$Khadka S.; Dong N.; Chavez J. et.al.. Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CUP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Single-Center Experience. Clinical Lymphoma Clinical Lymphoma. 2024;24:S480$$$$$Y$$$20240909$$MD$US$US
242996851$24299685$1$I$$20240904$20240909$20240909$EXP$$US-AMGEN-USASP2024178220$AMGEN$Khadka S.; Dong N.; Chavez J. et.al.. Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CHP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Single-Center Experience. Clinical Lymphoma, Myeloma + Leukemia. 2024;24:S480$$$$$Y$$$20240909$$MD$US$US
242996861$24299686$1$I$20240806$20240906$20240909$20240909$EXP$$NVSC2024CN179354$NOVARTIS$$77$YR$$M$Y$60$KG$20240909$$HP$CN$CN
242996872$24299687$2$F$$20240906$20240909$20240910$PER$$NVSC2024US180260$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
242996881$24299688$1$I$20240801$20240827$20240909$20240909$PER$$US-SA-2024SA259619$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240909$$HP$US$US
242996891$24299689$1$I$$20240828$20240909$20240909$PER$$US-SA-2024SA259910$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240909$$HP$US$US
242996901$24299690$1$I$20240801$20240829$20240909$20240909$PER$$US-SA-2024SA256689$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240909$$HP$US$US
242996911$24299691$1$I$$20240903$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001863$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240909$$CN$US$US
242996921$24299692$1$I$20240101$20240830$20240909$20240909$EXP$$US-TEVA-VS-3239446$TEVA$$59$YR$$F$Y$$$20240909$$CN$US$US
242996931$24299693$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003292$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240909$$CN$US$US
242996941$24299694$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002961$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240909$$CN$US$US
242996951$24299695$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003880$ELI LILLY AND CO$$$$$F$Y$$$20240909$$PH$US$US
242996961$24299696$1$I$$20240829$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138676$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240909$$HP$US$US
242996971$24299697$1$I$20240826$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142350$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240909$$HP$US$US
242996981$24299698$1$I$$20240902$20240909$20240909$EXP$$US-BAYER-2024A126194$BAYER$$$$$$Y$$$20240909$$CN$US$US
242996991$24299699$1$I$$20240904$20240909$20240909$EXP$$CA-TAKEDA-2024TUS089032$TAKEDA$$$$$M$Y$$$20240909$$CN$CA$CA
242997001$24299700$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180395$NOVARTIS$$$$$M$Y$$$20240909$$HP$US$US
242997011$24299701$1$I$20240823$20240902$20240909$20240909$EXP$$FR-DSJP-DSE-2024-143639$DAIICHI$$$$A$F$Y$66$KG$20240909$$MD$FR$FR
242997021$24299702$1$I$20240501$20240906$20240909$20240909$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144118$DAIICHI$$60$YR$$F$Y$$$20240909$$CN$US$US
242997031$24299703$1$I$20240823$20240903$20240909$20240909$EXP$$CN-SANDOZ INC.-SDZ2024CN078472$SANDOZ$$60$YR$$M$Y$75$KG$20240909$$HP$CN$CN
242997041$24299704$1$I$20240601$20240903$20240909$20240909$PER$$US-ORGANON-O2409USA000327$ORGANON$$$$$F$Y$$$20240909$$CN$US$US
242997061$24299706$1$I$20240622$20240908$20240908$20240908$DIR$717582$$FDA-CTU$$33$YR$$F$N$51.75$KG$20240908$N$CN$US$
242997081$24299708$1$I$$20240906$20240909$20240909$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-127439$DAIICHI$$$$$F$Y$$$20240909$$MD$US$US
242997091$24299709$1$I$20240618$20240903$20240909$20240909$EXP$$NVSC2024IN179397$NOVARTIS$$79$YR$$M$Y$$$20240909$$CN$IN$IN
242997101$24299710$1$I$20240501$20240909$20240909$20240909$EXP$FR-AFSSAPS-AM2024000707$NVSC2024FR179980$NOVARTIS$$65$YR$$F$Y$$$20240909$$MD$FR$FR
242997111$24299711$1$I$20140101$20240905$20240909$20240909$PER$$US-BIOGEN-2024BI01281415$BIOGEN$$$$$F$Y$$$20240909$$CN$US$US
242997121$24299712$1$I$$20240905$20240909$20240909$EXP$$BR-GENMAB-2024-03254$GENMAB$$19$YR$$M$Y$$$20240909$$MD$BR$BR
242997131$24299713$1$I$$20240904$20240909$20240909$PER$$US-HALEON-2195384$Haleon PLC$$$$$F$Y$56.245$KG$20240909$$CN$US$US
242997141$24299714$1$I$$20240902$20240909$20240909$EXP$$PH-MAYNE PHARMA-2024MYN000401$MAYNE$Richelle Cunanan and Alma Calavera. AML-662 treatment of secondary acute myeloid leukemia With FLT3-ITD mutation in a 45-year-old woman: a case report. Clinical lymphoma, myeloma and leukemia. 2024;24 (Supp 1):S327-S328$$$$$Y$$$20240909$$HP$PH$PH
242997151$24299715$1$I$20240321$20240902$20240909$20240909$EXP$IT-MINISAL02-1000058$IT-TEVA-VS-3239532$TEVA$$81$YR$$F$Y$$$20240909$$PH$IT$IT
242997161$24299716$1$I$$20240830$20240909$20240909$PER$$US-ALXN-202408USA002116US$ALEXION PHARMACEUTICALS$$$$$F$Y$55$KG$20240909$$MD$US$US
242997171$24299717$1$I$20240801$20240830$20240909$20240909$EXP$$US-TEVA-VS-3238887$TEVA$$$$$F$Y$$$20240909$$CN$US$US
242997202$24299720$2$F$20240904$20240909$20240909$20240910$PER$$US-AMGEN-USASP2024179036$AMGEN$$71$YR$E$F$Y$$$20240910$$CN$US$US
242997211$24299721$1$I$20240801$20240830$20240909$20240909$EXP$$JP-ASTELLAS-2024-AER-000615$ASTELLAS$$81$YR$E$M$Y$$$20240909$$PH$JP$JP
242997222$24299722$2$F$20240819$20240830$20240909$20240927$EXP$CN-NMPACDR-5329001570801202400883$CN-BAXTER-2024BAX024163$BAXTER$$69$YR$$M$Y$52$KG$20240927$$MD$CN$CN
242997231$24299723$1$I$$20240830$20240909$20240909$EXP$$DE-BAXTER-2024BAX023976$BAXTER$$$$$M$Y$2.535$KG$20240909$$MD$DE$DE
242997241$24299724$1$I$20240820$20240830$20240909$20240909$EXP$CN-NMPACDR-3708281020400202400606$CN-BAXTER-2024BAX024153$BAXTER$$56$YR$$F$Y$60$KG$20240909$$MD$CN$CN
242997251$24299725$1$I$20240816$20240830$20240909$20240909$EXP$CN-NMPACDR-5329231011228202400418$CN-BAXTER-2024BAX024157$BAXTER$$66$YR$$F$Y$70$KG$20240909$$MD$CN$CN
242997261$24299726$1$I$$20240908$20240908$20240908$DIR$717618$$FDA-CTU$$5$YR$$M$N$15.75$KG$20240908$Y$CN$US$
242997271$24299727$1$I$20240902$20240908$20240908$20240908$DIR$717589$$FDA-CTU$$82$YR$$F$N$84.1$KG$20240908$N$MD$US$
242997281$24299728$1$I$20231201$20240830$20240909$20240909$30DAY$$US-GSK-US2024108448$GLAXOSMITHKLINE$$74$YR$$F$Y$$$20240909$$CN$US$US
242997291$24299729$1$I$20240831$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A201827$ASTRAZENECA$$26281$DY$$M$Y$$$20240909$$CN$US$
242997311$24299731$1$I$$20240902$20240909$20240909$EXP$$JP-AstraZeneca-2024A200996$ASTRAZENECA$$$$$F$Y$$$20240909$$PH$JP$
242997331$24299733$1$I$20230901$20240906$20240909$20240909$EXP$$BR-AstraZeneca-2024A176334$ASTRAZENECA$$786$MON$$F$Y$77$KG$20240909$$CN$BR$
242997341$24299734$1$I$$20231115$20240909$20240909$PER$$US-JAZZ PHARMACEUTICALS-2023-US-023249$JAZZ$$$$$$Y$$$20240909$$HP$US$US
242997351$24299735$1$I$$20231115$20240909$20240909$PER$$US-JAZZ PHARMACEUTICALS-2023-US-023248$JAZZ$$$$$$Y$$$20240909$$HP$US$US
242997361$24299736$1$I$$20231122$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2023-CA-023667$JAZZ$$$$$$Y$$$20240909$$MD$CA$CA
242997371$24299737$1$I$$20231219$20240909$20240909$PER$$US-JAZZ PHARMACEUTICALS-2023-US-025060$JAZZ$$$$$$Y$$$20240909$$MD$US$US
242997381$24299738$1$I$$20231212$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2023-CA-024670$JAZZ$$$$$$Y$$$20240909$$MD$CA$CA
242997391$24299739$1$I$20230616$20230921$20240909$20240909$PER$$US-JAZZ PHARMACEUTICALS-2023-US-021312$JAZZ$$10$YR$$F$Y$45.4$KG$20240909$$MD$US$US
242997412$24299741$2$F$$20240916$20240909$20240919$30DAY$$US-PFIZER INC-PV202400056248$PFIZER$$$$$$Y$$$20240919$$HP$US$US
242997421$24299742$1$I$20240806$20240830$20240909$20240909$EXP$FR-AFSSAPS-AVMA2024000360$FR-TEVA-VS-3239076$TEVA$$72$YR$$M$Y$$$20240909$$MD$FR$FR
242997441$24299744$1$I$$20240905$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US078306$SANDOZ$$$$$M$Y$$$20240909$$CN$US$US
242997451$24299745$1$I$$20240607$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-008911$JAZZ$$10$YR$$F$Y$$$20240909$$HP$CA$CA
242997461$24299746$1$I$20240304$20240906$20240909$20240909$EXP$$DE-SANDOZ INC.-NVSC2020DE156034$SANDOZ$$74$YR$$M$Y$$$20240909$$MD$DE$DE
242997471$24299747$1$I$$20240425$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-006723$JAZZ$$$$$$Y$$$20240909$$PH$CA$CA
242997481$24299748$1$I$$20240701$20240909$20240909$PER$$US-JAZZ PHARMACEUTICALS-2024-US-010100$JAZZ$$3$YR$$F$Y$$$20240909$$MD$US$US
242997491$24299749$1$I$$20240530$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-008555$JAZZ$$$$$$Y$$$20240909$$MD$CA$CA
242997501$24299750$1$I$$20240530$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-008384$JAZZ$$$$$F$Y$$$20240909$$HP$CA$CA
242997511$24299751$1$I$$20240222$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-003262$JAZZ$$$$$$Y$$$20240909$$MD$CA$CA
242997521$24299752$1$I$$20240325$20240909$20240909$PER$$MX-JAZZ PHARMACEUTICALS-2024-MX-005159$JAZZ$Jimenez K.C, Gonzalez-Diaz S, Ortega N.A, Henriquez R.L, Sauceda M.E. L-ASPARAGINASE DESENSITIZATION IN PEDIATRICS: A NECESSITY, NOT A LUXURY IN ACUTE LYMPHOBLASTIC LEUKEMIA- CASE REPORT. Annals of Allergy, Asthma and Immunology. 2023;Supplement 1$9$YR$$M$Y$$$20240909$$HP$MX$MX
242997531$24299753$1$I$$20240530$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-008553$JAZZ$$$$$$Y$$$20240909$$MD$CA$CA
242997541$24299754$1$I$$20240404$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-005670$JAZZ$$4$YR$$F$Y$$$20240909$$PH$CA$CA
242997551$24299755$1$I$$20240308$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-004197$JAZZ$$$$$M$Y$$$20240909$$MD$CA$CA
242997561$24299756$1$I$$20230523$20240909$20240909$EXP$$TR-Ipsen Biopharmaceuticals, Inc.-2024-16159$IPSEN$KUBILAY E, GOKMEN D, GOKCE MI, SUER E, GULPONAR O. EFFECTS OF INTRAVESICAL BOTULINUM TOXINTYPE-AINJECTION LOCATION ON SYMPTOM SCORES AND SEXUAL FUNCTIONS IN FEMALE PATIENTS WITH A DIAGNOSIS OF REFRACTORY BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS: A RANDOMIZED, PROSPECTIVE STUDY. Journal of Urology. 2023 Apr;E1113. doi:10.1097/JU.0000000000003352.06..$$$$F$Y$$$20240909$$MD$TR$TR
242997573$24299757$3$F$20240830$20240911$20240909$20240913$EXP$$CL-BIOMARINAP-CL-2024-160326$BIOMARIN$$$$$$Y$$$20240913$$CN$CL$CL
242997581$24299758$1$I$20240731$20240830$20240909$20240909$EXP$$AR-BIOMARINAP-AR-2024-160341$BIOMARIN$$$$$$Y$$$20240909$$CN$AR$AR
242997591$24299759$1$I$20240729$20240906$20240909$20240909$EXP$IS-IMA-8786$IS-DSJP-DSE-2024-144044$DAIICHI$$62$YR$$F$Y$$$20240909$$PH$IS$IS
242997601$24299760$1$I$$20240821$20240909$20240909$PER$$US-TEVA-VS-3237266$TEVA$$$$$$Y$$$20240909$$CN$US$US
242997611$24299761$1$I$20240727$20240830$20240909$20240909$EXP$FR-AFSSAPS-AVNT2024000648$FR-TEVA-VS-3239098$TEVA$$24$YR$$M$Y$$$20240909$$MD$FR$FR
242997621$24299762$1$I$$20240830$20240909$20240909$EXP$$US-MYLANLABS-2024M1081433$MYLAN$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$68$YR$$F$Y$$$20240909$$MD$US$US
242997631$24299763$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259614$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240909$$CN$US$US
242997641$24299764$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259604$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240909$$HP$US$US
242997651$24299765$1$I$20240101$20240829$20240909$20240909$PER$$US-SA-2024SA254758$SANOFI AVENTIS$$$$A$$Y$$$20240909$$HP$US$US
242997661$24299766$1$I$20240808$20240903$20240909$20240909$EXP$FR-AFSSAPS-RN2024000925$FR-MYLANLABS-2024M1080783$MYLAN$$36$YR$$F$Y$50$KG$20240909$$MD$FR$FR
242997681$24299768$1$I$$20240725$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-011313$JAZZ$$$$$$Y$$$20240909$$MD$CA$CA
242997691$24299769$1$I$$20240717$20240909$20240909$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011005$JAZZ$$3$YR$$F$Y$$$20240909$$HP$US$US
242997701$24299770$1$I$$20240702$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-010165$JAZZ$$$$A$$Y$$$20240909$$MD$CA$CA
242997711$24299771$1$I$$20240702$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-010164$JAZZ$$$$A$$Y$$$20240909$$MD$CA$CA
242997721$24299772$1$I$$20240715$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-010704$JAZZ$$6$YR$$M$Y$$$20240909$$HP$CA$CA
242997731$24299773$1$I$$20240702$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-010166$JAZZ$$$$A$$Y$$$20240909$$MD$CA$CA
242997741$24299774$1$I$$20240905$20240909$20240909$PER$$US-ABBVIE-5913796$ABBVIE$$$$$$Y$$$20240909$$CN$US$US
242997751$24299775$1$I$20240907$20240909$20240909$20240909$DIR$717638$$FDA-CTU$$69$YR$$M$N$77.1$KG$20240909$N$HP$US$
242997761$24299776$1$I$20220308$20240909$20240909$20240909$DIR$717663$$FDA-CTU$$42$YR$$M$N$72.9$KG$20240909$N$CN$US$
242997771$24299777$1$I$$20240731$20240909$20240909$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011616$JAZZ$$$$$M$Y$$$20240909$$HP$US$US
242997781$24299778$1$I$$20240801$20240909$20240909$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011059$JAZZ$$12$YR$$M$Y$$$20240909$$HP$US$US
242997791$24299779$1$I$$20240730$20240909$20240909$PER$$US-JAZZ PHARMACEUTICALS-2024-US-011576$JAZZ$$$$$$Y$$$20240909$$MD$US$US
242997801$24299780$1$I$$20240812$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-010317$JAZZ$$$$A$M$Y$$$20240909$$PH$CA$CA
242997811$24299781$1$I$20240818$20240830$20240909$20240909$EXP$SE-SEMPA-2024-006283$SE-TEVA-VS-3239107$TEVA$$88$YR$$F$Y$$$20240909$$MD$SE$SE
242997821$24299782$1$I$$20240814$20240909$20240909$PER$$US-JAZZ PHARMACEUTICALS-2024-US-012654$JAZZ$$18$YR$$M$Y$$$20240909$$MD$US$US
242997831$24299783$1$I$$20240814$20240909$20240909$PER$$US-JAZZ PHARMACEUTICALS-2024-US-012653$JAZZ$$8$YR$$M$Y$$$20240909$$MD$US$US
242997841$24299784$1$I$$20240829$20240909$20240909$PER$$US-JAZZ PHARMACEUTICALS-2024-US-013931$JAZZ$$55$YR$$M$Y$$$20240909$$PH$US$US
242997851$24299785$1$I$$20240815$20240909$20240909$PER$$CA-JAZZ PHARMACEUTICALS-2024-CA-012238$JAZZ$$$$$M$Y$$$20240909$$PH$CA$CA
242997862$24299786$2$F$20230701$20240910$20240909$20240917$EXP$FR-AFSSAPS-LY2024001250$FR-TEVA-VS-3239151$TEVA$$32$YR$$M$Y$78$KG$20240917$$CN$FR$FR
242997871$24299787$1$I$$20240909$20240909$20240909$DIR$717654$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
242997881$24299788$1$I$$20240902$20240909$20240909$EXP$$US-MYLANLABS-2024M1081804$MYLAN$Santistevan L, Lonergan D, Eyvazzadeh AD. First case report of serous otitis media as a complication of severe ovarian hyperstimulation syndrome: Case report and literature review. [Review]. Int-J-Gynaecol-Obstet 2024; 164 (3): 843-847.$30$YR$$F$Y$$$20240909$$HP$US$US
242997891$24299789$1$I$20240820$20240904$20240909$20240909$PER$$US-JNJFOC-20240909507$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240909$$CN$US$US
242997912$24299791$2$F$20240827$20240906$20240909$20240917$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000030$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240917$$MD$US$US
242997931$24299793$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003764$ELI LILLY AND CO$$$$$F$Y$$$20240909$$CN$US$US
242997941$24299794$1$I$20230801$20240828$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202408017740$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240909$$CN$US$US
242997951$24299795$1$I$20240101$20240903$20240909$20240909$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202409004638$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240909$$CN$CO$CO
242997961$24299796$1$I$$20240904$20240909$20240909$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003852$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240909$$HP$US$US
242997971$24299797$1$I$20240803$20240903$20240909$20240909$EXP$GB-MHRA-MED-202409030939117250-GZHJS$GB-ELI_LILLY_AND_COMPANY-GB202409001966$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240909$$CN$GB$GB
242997981$24299798$1$I$20240812$20240830$20240909$20240909$EXP$ES-AEMPS-1562562$ES-TEVA-VS-3239354$TEVA$$89$YR$$F$Y$$$20240909$$MD$ES$ES
242997991$24299799$1$I$20240801$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142321$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240909$$CN$US$US
242998002$24299800$2$F$20220101$20240909$20240909$20240911$EXP$$US-BIOMARINAP-US-2024-160332$BIOMARIN$$$$$$Y$$$20240911$$CN$US$US
242998011$24299801$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142838$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240909$$HP$US$US
242998021$24299802$1$I$20240605$20240906$20240909$20240909$EXP$IT-MINISAL02-1001395$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-142941$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$57$KG$20240909$$MD$IT$IT
242998031$24299803$1$I$20240701$20240906$20240909$20240909$EXP$$JP-AMERICAN REGENT INC-2024003420$AMERICAN REGENT$$93$YR$$F$Y$$$20240909$$MD$JP$JP
242998041$24299804$1$I$$20230523$20240909$20240909$EXP$$TR-Ipsen Biopharmaceuticals, Inc.-2024-16471$IPSEN$KUBILAY E, GOKMEN D, GOKCE MI, SUER E, GULPONAR O. EFFECTS OF INTRAVESICAL BOTULINUM TOXIN TYPE-A INJECTION LOCATION ON SYMPTOM SCORES AND SEXUAL FUNCTIONS IN FEMALE PATIENTS WITH A DIAGNOSIS OF REFRACTORY BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS: A RANDOMIZED, PROSPECTIVE STUDY. Journal of Urology. 2023 Apr;E113. doi:10.1097/JU.0000000000003352.06.$$$$F$Y$$$20240909$$MD$TR$TR
242998051$24299805$1$I$$20240905$20240909$20240909$EXP$$JP-DSJP-DSJ-2024-143779$DAIICHI$$$$$M$Y$$$20240909$$CN$JP$JP
242998061$24299806$1$I$20240728$20240830$20240909$20240909$EXP$FR-AFSSAPS-NC2024000990$FR-TEVA-VS-3239127$TEVA$$77$YR$$M$Y$80$KG$20240909$$MD$FR$FR
242998071$24299807$1$I$$20240830$20240909$20240909$EXP$$US-ABBVIE-5908735$ABBVIE$Eyerly-Webb SA, Howley L, Brock CO, Lillegard JB, Fisher J, Reynolds B, et al. Continuous fetal cardiac monitoring during fetoscopic myelomeningocele repair and relationship to spectral doppler changes. Fetal Diagn Ther. 2024;51(4):357-64.$$$$$Y$$$20240909$$HP$US$US
242998081$24299808$1$I$20240801$20240830$20240909$20240909$EXP$FR-AFSSAPS-SE2024000664$FR-TEVA-VS-3239138$TEVA$$65$YR$$F$Y$65$KG$20240909$$MD$FR$FR
242998092$24299809$2$F$$20240829$20240909$20240916$EXP$$AU-AstraZeneca-2024A204009$ASTRAZENECA$Reimann F, Whyte I. et. all. Chronic lithium toxicity. Aust Prescriber 2022;45(3):93-94.$66$YR$$M$Y$$$20240916$$MD$AU$
242998101$24299810$1$I$20210101$20240901$20240909$20240909$EXP$$BG-ANIPHARMA-2024-BG-000010$ANI$Tchernev G, Broshtilova V.Adverse drug events: lichen planus of the penis after intake of nebivolol- first reported case in the world literature..Georgian Medical News.2023;338(5):115-117.$48$YR$$M$Y$$$20240909$$HP$BG$BG
242998111$24299811$1$I$20240818$20240823$20240909$20240909$PER$$US-ANIPHARMA-2024-US-045632$ANI$$48$YR$$M$Y$$$20240909$$CN$US$US
242998121$24299812$1$I$$20240902$20240909$20240909$EXP$$GB-AstraZeneca-2024A204177$ASTRAZENECA$$81$YR$$F$Y$$$20240909$$MD$GB$
242998131$24299813$1$I$20240126$20240830$20240909$20240909$EXP$FR-AFSSAPS-TO2024001599$FR-TEVA-VS-3239285$TEVA$$57$YR$$M$Y$71$KG$20240909$$HP$FR$FR
242998141$24299814$1$I$$20240904$20240909$20240909$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050116$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240909$$CN$US$US
242998151$24299815$1$I$$20240903$20240909$20240909$EXP$$IN-PFIZER INC-202400250362$PFIZER$Kulkarni, A.. Emphysematous gastritis: An ominous condition masquerading as enterocolitis in immunocompromised host. Indian Journal of Critical Care Medicine. 2024;28(8):808-9$15$YR$$M$Y$$$20240909$$MD$IN$IN
242998161$24299816$1$I$20231201$20240909$20240909$20240909$EXP$$NVSC2024FR180011$NOVARTIS$$62$YR$$F$Y$$$20240909$$MD$FR$FR
242998184$24299818$4$F$$20240917$20240909$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US078307$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
242998191$24299819$1$I$$20240904$20240909$20240909$EXP$$BR-DSJP-DSE-2024-143833$DAIICHI$$$$$M$Y$$$20240909$$MD$BR$BR
242998202$24299820$2$F$20240901$20240906$20240909$20240910$EXP$$US-ABBVIE-5914269$ABBVIE$$81$YR$$F$Y$$$20240910$$CN$US$US
242998211$24299821$1$I$20240801$20240830$20240909$20240909$EXP$FR-AFSSAPS-AVLL2024000215$FR-TEVA-VS-3239346$TEVA$$21$YR$$F$Y$$$20240909$$CN$FR$FR
242998222$24299822$2$F$20140101$20240919$20240909$20240927$EXP$$FR-SANDOZ INC.-SDZ2024FR078559$SANDOZ$$22$YR$$F$Y$54$KG$20240927$$MD$FR$FR
242998231$24299823$1$I$20240801$20240904$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143114$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240909$$MD$US$US
242998241$24299824$1$I$20240401$20240904$20240909$20240909$EXP$$US-MYLANLABS-2024M1081935$MYLAN$$23$YR$$F$Y$$$20240909$$MD$US$US
242998251$24299825$1$I$$20240904$20240909$20240909$EXP$$DE-DSJP-DSE-2024-143931$DAIICHI$$$$$F$Y$$$20240909$$MD$DE$DE
242998261$24299826$1$I$20231101$20240904$20240909$20240909$EXP$$FR-DSJP-DSE-2024-143910$DAIICHI$$70$YR$$F$Y$$$20240909$$MD$FR$FR
242998272$24299827$2$F$$20240912$20240909$20240916$EXP$$US-ABBVIE-5914279$ABBVIE$$60$YR$$$Y$$$20240916$$MD$US$US
242998281$24299828$1$I$$20240905$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US078539$SANDOZ$$$$$F$Y$$$20240909$$MD$US$US
242998291$24299829$1$I$$20240907$20240909$20240909$PER$$US-AMGEN-USASP2024179535$AMGEN$$$$$$Y$$$20240909$$CN$US$US
242998302$24299830$2$F$20240824$20240903$20240909$20240916$EXP$$US-BEH-2024178239$CSL BEHRING$$68$YR$E$F$Y$100.6$KG$20240916$$CN$US$US
242998311$24299831$1$I$20240101$20240828$20240909$20240909$EXP$$US-SA-2024SA260049$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240909$$MD$US$US
242998321$24299832$1$I$$20240830$20240909$20240909$EXP$$US-SA-2024SA258642$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240909$$CN$US$US
242998341$24299834$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259334$SANOFI AVENTIS$$$$$F$Y$$$20240909$$MD$US$US
242998351$24299835$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA258044$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240909$$MD$US$US
242998361$24299836$1$I$20240801$20240830$20240909$20240909$EXP$$US-SA-2024SA260642$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240909$$MD$US$US
242998372$24299837$2$F$20231101$20240926$20240909$20240930$EXP$$US-SA-2024SA260829$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240930$$HP$US$US
242998381$24299838$1$I$20240801$20240903$20240909$20240909$30DAY$$US-MYLANLABS-2024M1081350$MYLAN$$10$YR$$M$Y$$$20240909$$CN$US$US
242998391$24299839$1$I$$20240905$20240909$20240909$EXP$$IT-MYLANLABS-2024M1081479$MYLAN$Biondo T, Baldino G, Burrascano G, Tarzia P, Indelicato M, Asmundo A et al.. Sudden Unexpected Death in Epilepsy (SUDEP). Full forensic approach in two cases and review of literature. Clinica Terapeutica. 2024;175(4):97-108$13$YR$$F$Y$$$20240909$$HP$IT$IT
242998401$24299840$1$I$$20240830$20240909$20240909$PER$$US-TRAVERE-2024TVT00876$TRAVERE THERAPEUTICS$$56$YR$A$F$Y$$$20240909$$CN$US$US
242998411$24299841$1$I$$20230107$20240909$20240909$PER$$US-RDY-SPO/USA/24/0012771$DR REDDYS$$$$$M$Y$$$20240909$$HP$US$US
242998425$24299842$5$F$20240728$20240918$20240909$20240925$EXP$$DE-Eisai-EC-2024-171398$EISAI$$71$YR$E$M$Y$73$KG$20240925$$MD$DE$DE
242998441$24299844$1$I$20240501$20240830$20240909$20240909$PER$$PR-JNJFOC-20240919524$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240909$$CN$PR$US
242998451$24299845$1$I$$20240829$20240909$20240909$PER$$US-JNJFOC-20240915935$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$US$US
242998461$24299846$1$I$20240802$20240905$20240909$20240909$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014498$JAZZ$$59$YR$$M$Y$77.6$KG$20240909$$CN$US$US
242998471$24299847$1$I$$20240829$20240909$20240909$EXP$$US-AstraZeneca-2024A204069$ASTRAZENECA$Mulroy M, Ghafouri S, Sisk A, Ribas A, Goshtaseb R, Cherry G et al. Acute interstitial nephritis and PR3-ANCA following reintroduction of pembrolizumab: a case report. Immunotherapy 2021;13(4):283-288.$79$YR$$F$Y$$$20240909$$HP$US$
242998481$24299848$1$I$$20240904$20240909$20240909$EXP$$US-AstraZeneca-2024A202025$ASTRAZENECA$Aguilera D.;  Janss A.;  Schniederjan M.;  Goldman-Yassen A.;  Velazquez J.; Mazewski C.;  Gray R.;  MacDonald T.;  Fangusaro J.;  Castellino R.C.. OTHR-25. ANAPLASTIC TRANSFORMATION OF DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMORS: TWO PEDIATRIC CASES. Neuro-Oncology 2024;26(Supplement 4):iv199-.$2$YR$$M$Y$$$20240909$$HP$US$
242998491$24299849$1$I$$20240820$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN008735$INCYTE$$$$$$Y$$$20240909$$MD$US$US
242998501$24299850$1$I$$20240907$20240909$20240909$EXP$$IR-AstraZeneca-2024A203756$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$M$Y$$$20240909$$MD$IR$
242998511$24299851$1$I$20240906$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004715$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240909$$CN$US$US
242998521$24299852$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003717$ELI LILLY AND CO$$$$A$F$Y$$$20240909$$CN$US$US
242998531$24299853$1$I$20240828$20240828$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001145$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$US$US
242998541$24299854$1$I$20240201$20240829$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009202$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242998551$24299855$1$I$20240813$20240908$20240908$20240908$DIR$717599$$FDA-CTU$$8$YR$$F$N$32.4$KG$20240908$N$CN$US$
242998561$24299856$1$I$$20240907$20240909$20240909$EXP$$IR-AstraZeneca-2024A203754$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$M$Y$$$20240909$$MD$IR$
242998571$24299857$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259637$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240909$$HP$US$US
242998581$24299858$1$I$20230901$20240902$20240909$20240909$PER$$US-SA-2024SA258445$SANOFI AVENTIS$$19$YR$A$M$Y$56.689$KG$20240909$$MD$US$US
242998591$24299859$1$I$20240101$20240827$20240909$20240909$PER$$US-SA-2024SA259358$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240909$$MD$US$US
242998601$24299860$1$I$20240101$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142603$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240909$$CN$US$US
242998611$24299861$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142564$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240909$$CN$US$US
242998632$24299863$2$F$20240830$20240909$20240909$20240910$PER$$US-AMGEN-USASP2024179060$AMGEN$$67$YR$E$M$Y$$$20240910$$CN$US$US
242998641$24299864$1$I$$20240905$20240909$20240909$EXP$$NVSC2024RU179525$NOVARTIS$$$$A$$Y$$$20240909$$MD$RU$RU
242998651$24299865$1$I$$20240829$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009168$INCYTE$$$$$$Y$$$20240909$$PH$US$US
242998661$24299866$1$I$$20240829$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009174$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242998681$24299868$1$I$20240803$20240806$20240909$20240909$PER$$US-KARYOPHARM-2024KPT001405$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240909$$CN$US$US
242998691$24299869$1$I$20240823$20240905$20240909$20240909$EXP$$US-ABBVIE-5908965$ABBVIE$$38$YR$$M$Y$$$20240909$$CN$US$US
242998702$24299870$2$F$20240101$20240909$20240909$20240910$PER$$US-AMGEN-USASP2024179410$AMGEN$$$$$M$Y$$$20240910$$HP$US$US
242998711$24299871$1$I$20240823$20240827$20240909$20240909$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17100$IPSEN$$20$YR$A$F$Y$57.6$KG$20240909$$CN$US$US
242998721$24299872$1$I$$20240906$20240909$20240909$PER$$US-HALEON-2195736$Haleon PLC$$$$$F$Y$$$20240909$$CN$US$US
242998741$24299874$1$I$$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251378$PFIZER$$25$YR$$F$Y$$$20240909$$CN$US$US
242998771$24299877$1$I$$20240901$20240909$20240909$EXP$$NVSC2024IL177172$NOVARTIS$$80$YR$$F$Y$$$20240909$$MD$IL$IL
242998781$24299878$1$I$20231110$20240902$20240909$20240909$EXP$$NVSC2024KR177859$NOVARTIS$$69$YR$$M$Y$$$20240909$$MD$KR$KR
242998791$24299879$1$I$20231130$20240902$20240909$20240909$EXP$$NVSC2023CO158256$NOVARTIS$$48$YR$$F$Y$90$KG$20240909$$CN$CO$CO
242998801$24299880$1$I$$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142872$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240909$$CN$US$US
242998811$24299881$1$I$20161118$20240829$20240909$20240909$EXP$$BE-ABBVIE-17K-013-3066287-00$ABBVIE$$77$YR$$M$Y$$$20240909$$HP$BE$BE
242998841$24299884$1$I$20240701$20240908$20240908$20240908$DIR$717616$$FDA-CTU$$52$YR$$F$N$39.15$KG$20240908$N$CN$US$
242998861$24299886$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180391$NOVARTIS$$$$$F$Y$$$20240909$$HP$US$US
242998871$24299887$1$I$$20240905$20240909$20240909$EXP$$NVSC2024SA179768$NOVARTIS$$$$$$Y$$$20240909$$MD$SA$SA
242998891$24299889$1$I$$20240820$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN008729$INCYTE$$$$$$Y$$$20240909$$CN$US$US
242998901$24299890$1$I$$20240906$20240909$20240909$PER$$US-HALEON-2195870$Haleon PLC$$$$$$Y$$$20240909$$CN$US$US
242998911$24299891$1$I$$20240909$20240909$20240909$EXP$FDA-CDER-CTU-2024-61888$C.G.$FDA-CTU$$78$YR$$F$N$$$20240909$$$US$
242998922$24299892$2$F$$20240904$20240909$20240913$EXP$$CA-MYLANLABS-2024M1082006$MYLAN$$68$YR$$F$Y$85$KG$20240913$$HP$CA$CA
242998931$24299893$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259671$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240909$$MD$US$US
242998941$24299894$1$I$$20240905$20240909$20240909$EXP$$IN-AstraZeneca-2024A202071$ASTRAZENECA$Patra KSL, Baskaran N, Chatterjee D, Mahajan R.. Flagellate-like presentation of Steven Johnson Syndrome-Toxic epidermal necrolysis after gefitinib therapy.. Indian Journal of Dermatology, Venereology and Leprology 2024;1-3.$64$YR$$F$Y$$$20240909$$MD$IN$
242998951$24299895$1$I$$20240908$20240909$20240909$PER$$NVSC2024US180088$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
242998961$24299896$1$I$20240906$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024178963$AMGEN$$66$YR$E$F$Y$$$20240909$$CN$US$US
242998982$24299898$2$F$$20240909$20240909$20240911$PER$$US-AMGEN-USASP2024179593$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
242998992$24299899$2$F$$20240909$20240909$20240910$PER$$US-AMGEN-USASP2024179571$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
242999001$24299900$1$I$$20240905$20240909$20240909$PER$$US-JNJFOC-20240914460$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240909$$CN$US$US
242999011$24299901$1$I$20240101$20240903$20240909$20240909$EXP$$AU-ABBVIE-5906927$ABBVIE$$$$$M$Y$$$20240909$$CN$AU$AU
242999021$24299902$1$I$20240823$20240906$20240906$20240906$DIR$717512$$FDA-CTU$$25$YR$$F$N$60.75$KG$20240906$N$HP$US$
242999031$24299903$1$I$20240501$20240828$20240909$20240909$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17263$IPSEN$$34$YR$A$F$Y$$$20240909$$HP$US$US
242999041$24299904$1$I$$20240902$20240909$20240909$EXP$$SE-ABBVIE-5908804$ABBVIE$$$$$M$Y$$$20240909$$HP$SE$SE
242999053$24299905$3$F$$20240926$20240909$20240928$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144089$DAIICHI$$$$$M$Y$$$20240928$$CN$US$US
242999061$24299906$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180449$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
242999071$24299907$1$I$20240101$20240830$20240909$20240909$EXP$$DE-TEVA-VS-3239953$TEVA$$$$$F$Y$$$20240909$$CN$DE$DE
242999091$24299909$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA260075$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240909$$HP$US$US
242999102$24299910$2$F$$20240912$20240909$20240917$30DAY$$GR-PFIZER INC-PV202400076398$PFIZER$$8$YR$$M$Y$23$KG$20240917$$CN$GR$GR
242999111$24299911$1$I$$20240903$20240909$20240909$30DAY$$GB-PFIZER INC-PV202400115941$PFIZER$$4$YR$$M$Y$$$20240909$$CN$GB$GB
242999123$24299912$3$F$20240101$20240913$20240909$20240918$EXP$$CA-PFIZER INC-202400250103$PFIZER$$76$YR$$F$Y$$$20240918$$HP$CA$CA
242999131$24299913$1$I$$20240906$20240909$20240909$EXP$$US-PFIZER INC-202400251796$PFIZER$$$$$F$Y$$$20240909$$CN$US$US
242999141$24299914$1$I$$20240906$20240909$20240909$PER$$US-JNJFOC-20240916760$JOHNSON AND JOHNSON$$$$$$Y$$$20240909$$HP$US$US
242999151$24299915$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142608$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240909$$CN$US$US
242999161$24299916$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004361$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240909$$CN$US$US
242999171$24299917$1$I$$20240830$20240909$20240909$30DAY$$KR-PFIZER INC-202400252111$PFIZER$$$$$$Y$$$20240909$$PH$KR$KR
242999181$24299918$1$I$20240313$20240829$20240909$20240909$EXP$$FR-DSJP-DSE-2024-142808$DAIICHI$$$$E$F$Y$66$KG$20240909$$MD$FR$FR
242999191$24299919$1$I$20240619$20240903$20240909$20240909$EXP$GB-MHRA-MED-202409031649162920-QMYVG$GB-ELI_LILLY_AND_COMPANY-GB202409002066$ELI LILLY AND CO$$58$YR$A$F$Y$90$KG$20240909$$CN$GB$GB
242999201$24299920$1$I$20240823$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004502$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240909$$CN$US$US
242999211$24299921$1$I$20240820$20240902$20240909$20240909$EXP$GB-MHRA-MED-202409022234579740-WNRKQ$GB-TEVA-VS-3239867$TEVA$$48$YR$$M$Y$85$KG$20240909$$CN$GB$GB
242999221$24299922$1$I$$20240830$20240909$20240909$EXP$$US-BAUSCHBL-2024BNL032667$BAUSCH AND LOMB$$95$YR$$F$Y$$$20240909$$MD$US$US
242999231$24299923$1$I$20240820$20240905$20240909$20240909$EXP$$US-ABBVIE-5909981$ABBVIE$$50$YR$$F$Y$$$20240909$$CN$US$US
242999271$24299927$1$I$20240907$20240908$20240908$20240908$DIR$717611$$FDA-CTU$$60$YR$$M$N$62.55$KG$20240908$N$CN$US$
242999281$24299928$1$I$20240907$20240908$20240908$20240908$DIR$717578$$FDA-CTU$$54$YR$$F$N$62.1$KG$20240908$Y$CN$US$
242999291$24299929$1$I$$20240829$20240909$20240909$EXP$$US-SA-2024SA259343$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240909$$CN$US$US
242999301$24299930$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180458$NOVARTIS$$$$$F$Y$$$20240909$$MD$US$US
242999312$24299931$2$F$$20240906$20240909$20240911$PER$$NVSC2024US180170$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
242999321$24299932$1$I$$20240905$20240909$20240909$EXP$$CA-PFIZER INC-202400250892$PFIZER$$53$YR$$M$Y$$$20240909$$HP$CA$CA
242999332$24299933$2$F$20240827$20240926$20240909$20240927$EXP$$US-PFIZER INC-202400252186$PFIZER$$57$YR$$F$Y$$$20240927$$HP$US$US
242999341$24299934$1$I$20230401$20240905$20240909$20240909$EXP$$CA-PFIZER INC-202400251804$PFIZER$$77$YR$$F$Y$$$20240909$$HP$CA$CA
242999361$24299936$1$I$$20240901$20240909$20240909$EXP$PL-URPL-1-2437-2020$PL-GE HEALTHCARE-2024CSU009966$GE HEALTHCARE$$49$YR$$F$Y$59$KG$20240909$$HP$PL$PL
242999371$24299937$1$I$$20240830$20240909$20240909$EXP$$AR-BIOMARINAP-AR-2024-160379$BIOMARIN$$$$$$Y$$$20240909$$CN$AR$AR
242999381$24299938$1$I$$20240905$20240909$20240909$PER$$US-BIOMARINAP-US-2024-160331$BIOMARIN$$$$$$Y$$$20240909$$CN$US$US
242999392$24299939$2$F$$20240912$20240909$20240921$EXP$$AU-TEVA-VS-3232479$TEVA$Kamsani S, Middeldorp M, Chiang G, Stefil M, Evans S, Nguyen M, et al.. Safety of outpatient commencement of sotalol. Heart Rhythm O2. 2024;5(6):341-50; Kamsani S, Middeldorp M, Chiang G, Stefil M, Evans S, Nguyen M, et al.. Safety of outpatient commencement of sotalol. Heart Rhythm O2. 2024;5(6):341-50$78$YR$$F$Y$$$20240921$$HP$AU$AU
242999401$24299940$1$I$20240801$20240828$20240909$20240909$PER$$US-BAUSCHBL-2024BNL011979$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240909$$CN$US$US
242999411$24299941$1$I$$20240902$20240909$20240909$EXP$$DE-SANDOZ INC.-SDZ2024DE077024$SANDOZ$$59$YR$$M$Y$$$20240909$$HP$DE$DE
242999424$24299942$4$F$$20240924$20240909$20240925$PER$$US-PFIZER INC-202400201558$PFIZER$$8$YR$$M$Y$$$20240925$$CN$US$US
242999431$24299943$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400117469$PFIZER$$91$YR$$F$Y$$$20240909$$CN$US$US
242999441$24299944$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400251794$PFIZER$$58$YR$$F$Y$$$20240909$$CN$US$US
242999451$24299945$1$I$20240901$20240905$20240909$20240909$PER$$US-PFIZER INC-202400251479$PFIZER$$65$YR$$F$Y$$$20240909$$CN$US$US
242999461$24299946$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-PV202400117955$PFIZER$$38$YR$$F$Y$$$20240909$$HP$US$US
242999472$24299947$2$F$$20240905$20240909$20240912$PER$$US-PFIZER INC-PV202400117227$PFIZER$$22$YR$$F$Y$$$20240912$$CN$US$US
242999481$24299948$1$I$$20240906$20240909$20240909$PER$$US-PFIZER INC-202400252252$PFIZER$$$$$$Y$$$20240909$$HP$US$US
242999492$24299949$2$F$$20240919$20240909$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141118$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$92.9$KG$20240925$$MD$US$US
242999502$24299950$2$F$20220909$20240913$20240909$20240924$EXP$$CA-TAKEDA-2024TUS089044$TAKEDA$$77$YR$$F$Y$$$20240924$$CN$CA$CA
242999511$24299951$1$I$20240129$20240903$20240909$20240909$EXP$FR-AFSSAPS-TO2024001644$FR-MYLANLABS-2024M1080761$MYLAN$$74$YR$$F$Y$$$20240909$$PH$FR$FR
242999521$24299952$1$I$$20240903$20240909$20240909$EXP$$PT-MYLANLABS-2024M1080792$MYLAN$Vicente B, Rodrigues C, Serrao C, Baptista M, Carvalho V, Antunes AP. C-05 -Headache secondary to inflammatory orbitopathy caused by zoledronic acid: a rare complication of frequent treatment. Synapse. 2023;Suppl 1:200$57$YR$$F$Y$$$20240909$$HP$PT$PT
242999531$24299953$1$I$20240511$20240902$20240909$20240909$EXP$$CN-PURDUE-USA-2024-0311837$PURDUE$$74$YR$$M$Y$60$KG$20240909$$HP$CN$CN
242999541$24299954$1$I$$20240903$20240909$20240909$EXP$$US-PURDUE-USA-2024-0311831$PURDUE$Joseph M, Batra S, Kamran W, Barrett K, Ebert B, Nassar A, Misselbeck T, Hawwa N.. Home inotrope therapy in chronic stimulant-induced cardiomyopathy: a case series. European Heart Journal - Case Reports. 2024;8(8):ytae406$49$YR$$M$Y$$$20240909$$HP$US$US
242999551$24299955$1$I$20190305$20240906$20240909$20240909$EXP$$US-PURDUE PHARMA-USA-2024-0311841$PURDUE$$48$YR$$F$Y$$$20240909$$CN$US$US
242999561$24299956$1$I$20240825$20240903$20240909$20240909$EXP$$CN-PURDUE-USA-2024-0311852$PURDUE$$70$YR$$M$Y$65$KG$20240909$$HP$CN$CN
242999571$24299957$1$I$20240814$20240903$20240909$20240909$EXP$$SE-PURDUE-USA-2024-0311851$PURDUE$$18$YR$$F$Y$$$20240909$$MD$SE$SE
242999581$24299958$1$I$20240626$20240908$20240908$20240908$DIR$717623$$FDA-CTU$$37$YR$$F$N$51.75$KG$20240908$N$CN$US$
242999611$24299961$1$I$20240905$20240908$20240908$20240908$DIR$717620$$FDA-CTU$$77$YR$$F$N$74.7$KG$20240908$N$CN$US$
242999621$24299962$1$I$20240401$20240828$20240909$20240909$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17278$IPSEN$$25$YR$A$F$Y$$$20240909$$HP$US$US
242999631$24299963$1$I$20240101$20240829$20240909$20240909$PER$$US-ALKERMES INC.-ALK-2024-002293$ALKERMES$$$$$F$Y$$$20240909$$MD$US$US
242999641$24299964$1$I$20240401$20240828$20240909$20240909$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17290$IPSEN$$34$YR$A$M$Y$$$20240909$$HP$US$US
242999651$24299965$1$I$$20240906$20240909$20240909$PER$$US-PURDUE PHARMA-USA-2024-0311840$PURDUE$$31$YR$$F$Y$$$20240909$$CN$US$US
242999661$24299966$1$I$$20240906$20240909$20240909$PER$$US-PURDUE PHARMA-USA-2024-0311857$PURDUE$$$$$$Y$$$20240909$$CN$US$US
242999671$24299967$1$I$$20240909$20240909$20240909$PER$$US-PURDUE PHARMA-USA-2024-0311843$PURDUE$$$$$$Y$$$20240909$$CN$US$US
242999681$24299968$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180452$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
242999691$24299969$1$I$20240801$20240904$20240909$20240909$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-017314$JAZZ$$29$YR$$F$Y$$$20240909$$HP$US$US
242999702$24299970$2$F$20240903$20240918$20240909$20240925$EXP$$JP-Eisai-EC-2024-173703$EISAI$$80$YR$E$$Y$53$KG$20240925$$MD$JP$JP
242999711$24299971$1$I$20240904$20240905$20240909$20240909$EXP$$ZA-ABBVIE-5907859$ABBVIE$$37$YR$$F$Y$$$20240909$$MD$ZA$ZA
242999721$24299972$1$I$$20240827$20240909$20240909$EXP$$US-HLS-202401094$HLS THERAPEUTICS$$22$YR$A$F$Y$$$20240909$$CN$US$US
242999741$24299974$1$I$20240801$20240826$20240909$20240909$PER$$US-SA-2024SA258868$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240909$$MD$US$US
242999751$24299975$1$I$$20240906$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142795$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240909$$CN$US$US
242999761$24299976$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142816$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240909$$CN$US$US
242999771$24299977$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142804$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240909$$CN$US$US
242999781$24299978$1$I$20240901$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142801$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240909$$CN$US$US
242999791$24299979$1$I$20240101$20240903$20240909$20240909$PER$$US-JNJFOC-20240907352$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240909$$CN$US$US
242999801$24299980$1$I$$20240909$20240909$20240909$PER$$US-JNJFOC-20240920517$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240909$$CN$US$US
242999811$24299981$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143156$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240909$$CN$US$US
242999821$24299982$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142785$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240909$$CN$US$US
242999832$24299983$2$F$20240626$20240911$20240909$20240923$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409003947$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240923$$CN$DE$BR
242999841$24299984$1$I$20240830$20240830$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001168$ELI LILLY AND CO$$$$$M$Y$295$KG$20240909$$CN$US$US
242999851$24299985$1$I$20240903$20240903$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002243$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$US$US
242999862$24299986$2$F$20240808$20240909$20240909$20240911$PER$$US-AMGEN-USASP2024179392$AMGEN$$75$YR$E$F$Y$$$20240911$$CN$US$US
242999871$24299987$1$I$20240905$20240905$20240909$20240909$PER$$US-AMGEN-USASL2024178568$AMGEN$$$$$M$Y$$$20240909$$CN$US$US
242999881$24299988$1$I$$20240905$20240909$20240909$EXP$$US-OTSUKA-2024_025043$OTSUKA$$$$$M$Y$$$20240909$$CN$US$US
242999921$24299992$1$I$$20240906$20240909$20240909$EXP$$US-SANDOZ INC.-SDZ2024US065964$SANDOZ$$$$$$Y$$$20240909$$CN$US$US
242999931$24299993$1$I$$20240906$20240909$20240909$PER$$US-ALXN-202409USA000414US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240909$$CN$US$US
242999941$24299994$1$I$$20240905$20240909$20240909$PER$$US-DSJP-DSU-2024-144111$DAIICHI$$$$$F$Y$$$20240909$$MD$US$US
242999951$24299995$1$I$$20240831$20240909$20240909$PER$$US-SA-2024SA260604$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240909$$HP$US$US
242999961$24299996$1$I$20130101$20240908$20240909$20240909$EXP$$JO-SANDOZ INC.-PHHY2019JO036715$SANDOZ$$36$YR$$F$Y$$$20240909$$MD$JO$JO
242999971$24299997$1$I$20240801$20240827$20240909$20240909$PER$$US-SA-2024SA259359$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240909$$CN$US$US
242999981$24299998$1$I$$20240827$20240909$20240909$PER$$US-JNJFOC-20240873989$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240909$$CN$US$US
242999991$24299999$1$I$$20240903$20240909$20240909$EXP$$US-MAYNE PHARMA-2024MYN000397$MAYNE$$$$$$Y$$$20240909$$MD$US$US
243000001$24300000$1$I$$20240903$20240909$20240909$EXP$$JP-DSJP-DSJ-2024-143519$DAIICHI$$8$DEC$$F$Y$$$20240909$$MD$JP$JP
243000012$24300001$2$F$$20240918$20240909$20240927$EXP$$US-DAIICHI SANKYO, INC.-DSU-2024-143675$DAIICHI$$$$$M$Y$$$20240927$$CN$US$US
243000021$24300002$1$I$$20240903$20240909$20240909$EXP$$JP-DSJP-DSJ-2024-143389$DAIICHI$Enomoto T, Fukatsu K, Emori T, Mori K, Ishihara T. VS1-11 A case of multiple perforations 82 days after ESD for early gastric cancer. The 112th Kinki Branch Meeting of Japan Gastroenterological Endoscopy Society. 2024;71$82$YR$$M$Y$$$20240909$$MD$JP$JP
243000033$24300003$3$F$20240718$20240917$20240909$20240926$EXP$$IT-DSJP-DSE-2024-143430$DAIICHI$$$$E$F$Y$$$20240926$$MD$IT$IT
243000051$24300005$1$I$20240908$20240908$20240908$20240908$DIR$717596$$FDA-CTU$$63$YR$$F$N$$$20240908$N$HP$US$
243000061$24300006$1$I$20240907$20240908$20240908$20240908$DIR$717595$$FDA-CTU$$65$YR$$F$N$$$20240908$N$HP$US$
243000071$24300007$1$I$20240313$20240908$20240908$20240908$DIR$717602$$FDA-CTU$$61$YR$$F$N$47.7$KG$20240908$Y$CN$US$
243000081$24300008$1$I$$20240908$20240908$20240908$DIR$717576$$FDA-CTU$$$$$M$N$68$KG$20240908$N$CN$ZM$
243000091$24300009$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA257934$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240909$$MD$US$US
243000101$24300010$1$I$$20240904$20240909$20240909$EXP$$GR-PFIZER INC-PV202400116349$PFIZER$Myoteri, D.. An overweight female with a history of allergies and drug-induced liver injury. Journal of Hepatology. 2024;81(3):e93-e95$42$YR$$F$Y$$$20240909$$HP$GR$GR
243000112$24300011$2$F$$20240905$20240909$20240909$EXP$$CH-PFIZER INC-PV202400116275$PFIZER$Corbisier, T.. Role of molecular adsorbent recirculating system in methotrexate-induced acute liver failure: a case report and literature review. Frontiers in Pediatrics. 2024;12:10.3389/fped.2024.1424919$14$YR$$F$Y$$$20240909$$HP$CH$CH
243000121$24300012$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259362$SANOFI AVENTIS$$$$$F$Y$$$20240909$$$US$US
243000131$24300013$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142956$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240909$$HP$US$US
243000141$24300014$1$I$20240801$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142808$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240909$$HP$US$US
243000151$24300015$1$I$$20240902$20240909$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-141404$BRISTOL MYERS SQUIBB$Terashima Y, Matsumoto M, Ozaki S, Nakagawa M, Nakagome S, Terasaki Y, et al. IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report. Frontiers in Immunology. 2024 Aug 14;15:1-6. doi:10.3389/fimmu.2024.1370972.$73$YR$E$M$Y$$$20240909$$HP$JP$JP
243000162$24300016$2$F$$20240909$20240909$20240911$PER$$US-AMGEN-USASP2024179134$AMGEN$$89$YR$E$$Y$$$20240910$$CN$US$US
243000171$24300017$1$I$20240827$20240906$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142738$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240909$$CN$US$US
243000182$24300018$2$F$20240101$20240913$20240909$20240919$EXP$HR-HALMEDAPP-202408081142121050-DNRCG$HR-TEVA-VS-3239975$TEVA$$53$YR$$F$Y$$$20240919$$PH$HR$HR
243000191$24300019$1$I$20240710$20240906$20240909$20240909$EXP$$FR-AMERICAN REGENT INC-2024003416$AMERICAN REGENT$$27$YR$$F$Y$50$KG$20240909$$CN$FR$FR
243000201$24300020$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180454$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
243000212$24300021$2$F$$20240903$20240909$20240909$PER$$US-ABBVIE-5908136$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
243000221$24300022$1$I$$20240902$20240909$20240909$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-141281$BRISTOL MYERS SQUIBB$Genc NI, Kalemoglu E, Moayedi NM, Copur S, Selcukbiricik F. Immunotherapy-related lung and dermatologic toxicity in a patient with gastric cancer. European Journal of Case Reports in Internal Medicine. 2024 Jan 01;11(Supplement 1):763-4. doi:10.12890/2024_V11Sup1.$$$$$Y$$$20240909$$HP$TR$TR
243000231$24300023$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002732$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240909$$CN$US$US
243000241$24300024$1$I$20210728$20240902$20240909$20240909$EXP$PL-URPL-DML-MLP.4401.1.5030.2021$PL-TEVA-VS-3239990$TEVA$$83$YR$$F$Y$52$KG$20240909$$MD$PL$PL
243000251$24300025$1$I$20240107$20240905$20240909$20240909$EXP$DE-CADRBFARM-2024330234$DE-INCYTE CORPORATION-2024IN009386$INCYTE$$$$$$Y$$$20240909$$MD$DE$DE
243000261$24300026$1$I$20240905$20240909$20240909$20240909$EXP$$DE-GILEAD-2024-0686822$GILEAD$$73$YR$E$M$Y$$$20240909$$HP$DE$DE
243000291$24300029$1$I$$20240909$20240909$20240909$DIR$717669$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
243000301$24300030$1$I$20240819$20240909$20240909$20240909$DIR$717674$$FDA-CTU$$58$YR$$F$N$110.7$KG$20240909$N$CN$US$
243000311$24300031$1$I$$20240909$20240909$20240909$DIR$717671$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
243000321$24300032$1$I$20240826$20240909$20240909$20240909$DIR$717661$$FDA-CTU$$61$YR$$F$N$76.5$KG$20240909$N$CN$US$
243000331$24300033$1$I$$20240827$20240909$20240909$EXP$$CA-EMERGENT BIOSOLUTIONS,-24000123$EMERGENT BIOSOLUTIONS$$57$YR$$M$Y$$$20240909$$HP$CA$CA
243000341$24300034$1$I$$20240905$20240909$20240909$EXP$$CA-009507513-2409CAN002885$MERCK$$44$YR$$M$Y$$$20240909$$HP$CA$CA
243000352$24300035$2$F$20240906$20240909$20240909$20240913$PER$$US-AMGEN-USASP2024179552$AMGEN$$70$YR$E$F$Y$$$20240913$$CN$US$US
243000361$24300036$1$I$$20240827$20240909$20240909$EXP$$CA-EMERGENT BIOSOLUTIONS,-24000124$EMERGENT BIOSOLUTIONS$$64$YR$$F$Y$$$20240909$$HP$CA$CA
243000371$24300037$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180476$NOVARTIS$$$$$F$Y$$$20240909$$CN$US$US
243000381$24300038$1$I$$20240827$20240909$20240909$EXP$$CA-EMERGENT BIOSOLUTIONS,-24000126$EMERGENT BIOSOLUTIONS$$46$YR$$M$Y$$$20240909$$HP$CA$CA
243000401$24300040$1$I$20240808$20240902$20240909$20240909$EXP$FR-AFSSAPS-MP2024001324$FR-TEVA-VS-3239268$TEVA$$70$YR$$M$Y$97$KG$20240909$$PH$FR$FR
243000421$24300042$1$I$$20240827$20240909$20240909$EXP$$CA-EMERGENT BIOSOLUTIONS,-24000125$EMERGENT BIOSOLUTIONS$$64$YR$$M$Y$$$20240909$$HP$CA$CA
243000431$24300043$1$I$$20240909$20240909$20240909$DIR$717672$$FDA-CTU$$$$$UNK$N$$$20240909$$CN$US$
243000441$24300044$1$I$20240903$20240909$20240909$20240909$DIR$717675$$FDA-CTU$$61$YR$$M$N$$$20240909$N$HP$US$
243000452$24300045$2$F$$20240904$20240909$20240911$PER$$US-MYLANLABS-2024M1081965$MYLAN$$$$$$Y$$$20240911$$CN$US$US
243000461$24300046$1$I$$20240904$20240909$20240909$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-142607$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$MD$FR$FR
243000471$24300047$1$I$20240703$20240906$20240909$20240909$EXP$GB-MHRA-MED-202409021808404380-JCBFH$GB-REGENERON PHARMACEUTICALS, INC.-2024-120410$REGENERON$$79$YR$$M$Y$$$20240909$$MD$GB$GB
243000481$24300048$1$I$20240825$20240903$20240909$20240909$EXP$$JP-BAUSCH-BL-2024-013320$BAUSCH AND LOMB$$67$YR$$M$Y$$$20240909$$MD$JP$JP
243000491$24300049$1$I$$20240826$20240909$20240909$EXP$$GB-NOVOPROD-1279663$NOVO NORDISK$A D MILNER. Managing suicidal insulin overdose. British medical journal. 1982;285:974$26$YR$$M$Y$$$20240909$$HP$GB$GB
243000501$24300050$1$I$$20240904$20240909$20240909$PER$$US-MYLANLABS-2024M1081948$MYLAN$$18$YR$$M$Y$$$20240909$$CN$US$US
243000511$24300051$1$I$$20240825$20240909$20240909$EXP$$CA-JUBILANT CADISTA PHARMACEUTICALS-2024JUB00068$JUBILANT$Cameron-Coffill K.M, Ondiveeran H.K, Walsh L.D. A Case of Delayed and Persistent Carbamazepine Overdose Treated With Hemodialysis, Plasmapheresis, and Neostigmine. Journal of Pharmacy Practice. 2024;1-6$61$YR$$F$Y$$$20240909$$PH$CA$CA
243000521$24300052$1$I$20240909$20240909$20240909$20240909$DIR$717676$$FDA-CTU$$82$YR$$F$N$63$KG$20240909$N$HP$US$
243000531$24300053$1$I$20240514$20240909$20240909$20240909$DIR$717666$$FDA-CTU$$40$YR$$M$N$69.75$KG$20240909$N$CN$US$
243000552$24300055$2$F$$20240921$20240909$20240924$PER$$NVSC2024US180141$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
243000562$24300056$2$F$20240807$20240909$20240909$20240910$PER$$US-AMGEN-USASP2024179010$AMGEN$$77$YR$E$F$Y$$$20240910$$CN$US$US
243000573$24300057$3$F$20240903$20240916$20240909$20240918$PER$$US-JAZZ PHARMACEUTICALS-2024-US-014275$JAZZ$$17$YR$$M$Y$181$KG$20240918$$CN$US$US
243000581$24300058$1$I$20231024$20240909$20240909$20240909$EXP$SE-SEMPA-2024-006369$SE-ABBVIE-5914253$ABBVIE$$53$YR$$F$Y$$$20240909$$MD$SE$SE
243000591$24300059$1$I$$20240903$20240909$20240909$EXP$$US-AstraZeneca-2024A200839$ASTRAZENECA$$$$T$F$Y$53.1$KG$20240909$$CN$US$
243000601$24300060$1$I$$20240828$20240909$20240909$PER$$US-SA-2024SA259426$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240909$$HP$US$US
243000611$24300061$1$I$20240617$20240902$20240909$20240909$EXP$FR-AFSSAPS-PO2024000928$FR-TEVA-VS-3239735$TEVA$$63$YR$$M$Y$71$KG$20240909$$MD$FR$FR
243000631$24300063$1$I$$20240827$20240909$20240909$EXP$$CA-EMERGENT BIOSOLUTIONS,-24000127$EMERGENT BIOSOLUTIONS$$38$YR$$M$Y$$$20240909$$HP$CA$CA
243000641$24300064$1$I$$20240903$20240909$20240909$PER$$US-RDY-SPO/USA/24/0012932$DR REDDYS$$$$$$Y$$$20240909$$CN$US$US
243000651$24300065$1$I$20240828$20240909$20240909$20240909$DIR$717657$$FDA-CTU$$69$YR$$F$N$85.5$KG$20240909$N$CN$US$
243000661$24300066$1$I$20240301$20240903$20240909$20240909$EXP$$US-ABBVIE-5906825$ABBVIE$$61$YR$$$Y$$$20240909$$CN$US$US
243000671$24300067$1$I$$20240903$20240909$20240909$PER$$US-MYLANLABS-2024M1081659$MYLAN$$$$$F$Y$53.98$KG$20240909$$CN$US$US
243000681$24300068$1$I$$20240827$20240909$20240909$EXP$$CA-EMERGENT BIOSOLUTIONS,-24000128$EMERGENT BIOSOLUTIONS$$51$YR$$M$Y$$$20240909$$HP$CA$CA
243000691$24300069$1$I$$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143138$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240909$$CN$US$US
243000701$24300070$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142957$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$55.79$KG$20240909$$CN$US$US
243000712$24300071$2$F$20230518$20240904$20240909$20240923$EXP$$NVSC2024BR171517$NOVARTIS$$61$YR$$M$Y$55$KG$20240923$$MD$BR$BR
243000721$24300072$1$I$20240727$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142045$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240909$$CN$US$US
243000731$24300073$1$I$$20240904$20240909$20240909$EXP$$NVSC2024DE179569$NOVARTIS$$$$A$M$Y$$$20240909$$MD$DE$DE
243000741$24300074$1$I$$20240830$20240909$20240909$EXP$$NVSC2024DE112863$NOVARTIS$$82$YR$$M$Y$82$KG$20240909$$PH$DE$DE
243000762$24300076$2$F$20150301$20240829$20240909$20240923$EXP$$BE-ABBVIE-17K-013-3068592-00$ABBVIE$$69$YR$$M$Y$$$20240923$$HP$BE$BE
243000771$24300077$1$I$20240801$20240830$20240909$20240909$PER$$US-MYLANLABS-2024M1080965$MYLAN$$$$$F$Y$$$20240909$$PH$US$US
243000791$24300079$1$I$$20240906$20240909$20240909$EXP$$NVSC2024PT179241$NOVARTIS$$$$E$$Y$$$20240909$$HP$PT$PT
243000811$24300081$1$I$20240501$20240905$20240909$20240909$EXP$$CA-LUNDBECK-DKLU4004021$LUNDBECK$$$$$$Y$$$20240909$$CN$CA$CA
243000821$24300082$1$I$$20240827$20240909$20240909$EXP$$CA-EMERGENT BIOSOLUTIONS,-24000129$EMERGENT BIOSOLUTIONS$$63$YR$$M$Y$$$20240909$$HP$CA$CA
243000831$24300083$1$I$20230101$20240905$20240909$20240909$EXP$$US-DSJP-DSU-2023-138146$DAIICHI$$$$$F$Y$82.54$KG$20240909$$HP$US$US
243000841$24300084$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180393$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
243000851$24300085$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142617$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240909$$CN$US$US
243000861$24300086$1$I$20240501$20240828$20240909$20240909$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17279$IPSEN$$44$YR$A$F$Y$$$20240909$$HP$US$US
243000871$24300087$1$I$20220101$20240903$20240909$20240909$PER$US-MLMSERVICE-20240827-PI173683-00125-1$US-RDY-SPO/USA/24/0012866$DR REDDYS$Tadros M, Rente Lavastida D, Hanna A. Therapeutic Potential of Intravenous Ketamine in Early-Onset Dementia: A Case Report. Cureus. 2024;16(7):e65261. DOI: 10.7759/cureus.65261.$6$DEC$A$F$Y$$$20240909$$HP$US$US
243000881$24300088$1$I$20220101$20240903$20240909$20240909$PER$US-MLMSERVICE-20240827-PI173683-00287-3$US-RDY-SPO/USA/24/0012868$DR REDDYS$Tadros M, Rente Lavastida D, Hanna A. Therapeutic Potential of Intravenous Ketamine in Early-Onset Dementia: A Case Report. Cureus. 2024;16(7):e65261. DOI: 10.7759/cureus.65261.$6$DEC$A$F$Y$$$20240909$$HP$US$US
243000891$24300089$1$I$$20240827$20240909$20240909$EXP$$CA-EMERGENT BIOSOLUTIONS,-24000130$EMERGENT BIOSOLUTIONS$$21$YR$$M$Y$$$20240909$$HP$CA$CA
243000901$24300090$1$I$$20240903$20240909$20240909$PER$US-MLMSERVICE-20240827-PI173986-00196-1$US-RDY-SPO/USA/24/0012869$DR REDDYS$Pan SD, Osborne JR, Chiang GC, Ramakrishna R, Tsiouris AJ, Fine HA, et al. Positron Emission Tomography and Magnetic Resonance Imaging Findings in the Diagnosis of Stroke-Like Migraine Attacks after Radiation Therapy Syndrome: A Case Report. Advances in Radiation Oncology. 2024;9(9). DOI: 10.1016/j.adro.2024.101567.$38$YR$A$F$Y$$$20240909$$MD$US$US
243000911$24300091$1$I$$20240828$20240909$20240909$PER$$US-SA-2024SA259451$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240909$$HP$US$US
243000921$24300092$1$I$20240801$20240821$20240909$20240909$PER$$US-SA-2024SA259073$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240909$$MD$US$US
243000931$24300093$1$I$$20240903$20240909$20240909$EXP$$US-BAUSCH-BL-2024-013232$BAUSCH AND LOMB$$82$YR$$M$Y$$$20240909$$CN$US$US
243000941$24300094$1$I$20240101$20240908$20240909$20240909$EXP$$PT-BAUSCH-BL-2024-013410$BAUSCH AND LOMB$$49$YR$$F$Y$$$20240909$$MD$PT$PT
243000951$24300095$1$I$$20240907$20240909$20240909$EXP$$DE-BAUSCH-BL-2024-013375$BAUSCH AND LOMB$$$$$M$Y$$$20240909$$CN$DE$DE
243000961$24300096$1$I$20240601$20240826$20240909$20240909$PER$$US-ALKERMES INC.-ALK-2024-002250$ALKERMES$$62$YR$$M$Y$$$20240909$$CN$US$US
243000971$24300097$1$I$20200817$20240908$20240909$20240909$EXP$$DE-BAUSCH-BL-2024-013400$BAUSCH AND LOMB$$$$$M$Y$$$20240909$$MD$DE$DE
243000981$24300098$1$I$$20240906$20240909$20240909$EXP$$US-ALXN-202409USA000404US$ALEXION PHARMACEUTICALS$$$$$F$Y$72.574$KG$20240909$$MD$US$US
243000991$24300099$1$I$20240101$20240903$20240909$20240909$EXP$$US-ABBVIE-5908331$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
243001001$24300100$1$I$20240809$20240905$20240909$20240909$EXP$$US-KYOWAKIRIN-2024KK020801$KYOWA$$$$$$Y$$$20240909$$MD$US$US
243001011$24300101$1$I$$20240905$20240909$20240909$EXP$$CA-009507513-2409CAN002904$MERCK$Unknown. Unknown. Unknown$64$YR$$M$Y$$$20240909$$HP$CA$CA
243001022$24300102$2$F$20230902$20240909$20240909$20240911$PER$$NVSC2024US180325$NOVARTIS$$62$YR$$M$Y$$$20240911$$PH$US$US
243001031$24300103$1$I$20240330$20240330$20240909$20240909$PER$$US-AMGEN-USASP2024179357$AMGEN$$66$YR$E$M$Y$$$20240909$$CN$US$US
243001041$24300104$1$I$$20240907$20240909$20240909$PER$$NVSC2024US180479$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
243001061$24300106$1$I$20220101$20240903$20240909$20240909$PER$US-MLMSERVICE-20240827-PI173683-00213-2$US-RDY-SPO/USA/24/0012867$DR REDDYS$Tadros M, Rente Lavastida D, Hanna A. Therapeutic Potential of Intravenous Ketamine in Early-Onset Dementia: A Case Report. Cureus. 2024;16(7):e65261. DOI: 10.7759/cureus.65261.$6$DEC$A$F$Y$$$20240909$$HP$US$US
243001071$24300107$1$I$20240824$20240903$20240909$20240909$EXP$$CN-Eisai-EC-2024-173658$EISAI$$29$YR$A$F$Y$$$20240909$$HP$CN$CN
243001081$24300108$1$I$$20240905$20240909$20240909$EXP$$JP-Eisai-EC-2024-173800$EISAI$Sumiyoshi Ai. Kumamoto Hospital Pharmaceutical Association; -; .$$$E$F$Y$$$20240909$$PH$JP$JP
243001091$24300109$1$I$$20240904$20240909$20240909$EXP$$JP-Eisai-EC-2024-173799$EISAI$Taro Kuwayama et al.. Recurrent intrauterine cancer treated with pembrolizumab and lenvatinib combination therapy. Japanese Journal of Gynecological Oncology, The 66th Annual Meeting of the Japanese Society of Gynecologic Oncology. 2024; 42(3): 365-365.$$$$F$Y$$$20240909$$MD$JP$JP
243001102$24300110$2$F$20230101$20240910$20240909$20240918$PER$$JP-Eisai-EC-2024-173694$EISAI$Tae Oike. A retrospective study of 16 cases of recurrent uterine body cancer treated with pembrolizumab and lenvatinib combination therapy in our hospital. Japanese Journal of Gynecological Oncology. 2024; 42(3): 040-.$62$YR$A$F$Y$$$20240918$$MD$JP$JP
243001111$24300111$1$I$20240721$20240904$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000312$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001121$24300112$1$I$$20240812$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000321$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001131$24300113$1$I$20240804$20240813$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000326$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001141$24300114$1$I$20240801$20240815$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000329$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001151$24300115$1$I$20240716$20240816$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000332$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001161$24300116$1$I$$20240816$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000337$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001171$24300117$1$I$20240714$20240814$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000327$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001181$24300118$1$I$$20240815$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000331$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001191$24300119$1$I$20240816$20240819$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000335$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001201$24300120$1$I$20240101$20240903$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000339$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001211$24300121$1$I$$20240815$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000328$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001221$24300122$1$I$20240801$20240829$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000333$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001231$24300123$1$I$$20240809$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000317$THERATECHNOLOGIES$$$$$$Y$$$20240909$$PH$US$US
243001251$24300125$1$I$20240723$20240809$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000273$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001261$24300126$1$I$20240723$20240809$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000289$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001271$24300127$1$I$20240802$20240822$20240909$20240909$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000311$THERATECHNOLOGIES$$$$$$Y$$$20240909$$CN$US$US
243001281$24300128$1$I$$20240902$20240909$20240909$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-140524$BRISTOL MYERS SQUIBB$Salomon-Perzy?ski A, Budziszewska BK. How do I manage the myelotoxicity of venetoclax and azacitidine in patients with newly diagnosed acute myeloid leukemia?. Hematology in Clinical Practice. 2023;14:6-10. doi:10.5603/HCP.2023.0002.$68$YR$E$F$Y$$$20240909$$HP$PL$PL
243001291$24300129$1$I$20240904$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024177874$AMGEN$$70$YR$E$M$Y$$$20240909$$CN$US$US
243001301$24300130$1$I$20240725$20240902$20240909$20240909$EXP$IT-MINISAL02-999871$IT-TEVA-VS-3239763$TEVA$$82$YR$$M$Y$$$20240909$$MD$IT$IT
243001311$24300131$1$I$20240909$20240909$20240909$20240909$DIR$717653$$FDA-CTU$$77$YR$$F$N$74.7$KG$20240909$N$HP$US$
243001321$24300132$1$I$20200804$20240902$20240909$20240909$EXP$PL-URPL-1-1715-2020$PL-TEVA-VS-3239909$TEVA$$38$YR$$F$Y$60$KG$20240909$$MD$PL$PL
243001331$24300133$1$I$$20240904$20240909$20240909$EXP$$KR-AstraZeneca-2024A202467$ASTRAZENECA$$$$T$F$Y$58$KG$20240909$$CN$KR$
243001341$24300134$1$I$20240616$20240902$20240909$20240909$EXP$ES-AEMPS-1563662$ES-TEVA-VS-3240003$TEVA$$72$YR$$M$Y$96.4$KG$20240909$$PH$ES$ES
243001351$24300135$1$I$$20240902$20240909$20240909$EXP$$JP-PFIZER INC-202400249912$PFIZER$Miura, R.. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine (United States). 2024;103(34):10.1097/MD.0000000000039289$$$E$$Y$$$20240909$$MD$JP$JP
243001362$24300136$2$F$$20240902$20240909$20240910$EXP$$JP-PFIZER INC-202400249911$PFIZER$Miura, R.. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine (United States). 2024;103(34):10.1097/MD.0000000000039289$$$E$$Y$$$20240910$$MD$JP$JP
243001371$24300137$1$I$$20240904$20240909$20240909$EXP$$US-PFIZER INC-PV202400116289$PFIZER$Montoya, L.. The emerging global threat of multidrug-resistant Candida auris- a case of deep fungal cutaneous infection. Journal of the American Academy of Dermatology. 2024;91(3 Suppl):AB90$78$YR$$M$Y$$$20240909$$MD$US$US
243001382$24300138$2$F$$20240910$20240909$20240913$EXP$$US-PFIZER INC-PV202400116927$PFIZER$Mena, S.. The annoyance of singultus: a case report of a rare adverse effect after epidural steroid injection. BMC Anesthesiology. 2024;24(1):10.1186/s12871-024-02682-8$49$YR$$M$Y$$$20240913$$HP$US$US
243001392$24300139$2$F$20190101$20240905$20240909$20240911$EXP$$CN-PFIZER INC-PV202400116564$PFIZER$Chen, Y.. PARP inhibitor and immune checkpoint inhibitor have synergism efficacy in gallbladder cancer. Genes and Immunity. 2024;25(4):307-316$56$YR$$F$Y$$$20240911$$HP$CN$CN
243001401$24300140$1$I$$20240903$20240909$20240909$EXP$$JP-PFIZER INC-202400249698$PFIZER$Liu, Y.. Fluid Overload-Associated Large B-Cell Lymphoma with Light Chain Restriction Type Plasma Cell Infiltration: A Case Report. American Journal of Case Reports. 2024;25:10.12659/AJCR.944268.$80$YR$$M$Y$$$20240909$$MD$JP$JP
243001421$24300142$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178252$AMGEN$$80$YR$E$F$Y$$$20240909$$CN$US$US
243001431$24300143$1$I$20240801$20240826$20240909$20240909$PER$$US-ALKERMES INC.-ALK-2024-002270$ALKERMES$$57$YR$$M$Y$$$20240909$$CN$US$US
243001441$24300144$1$I$20240401$20240829$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009161$INCYTE$$$$$$Y$$$20240909$$CN$US$US
243001451$24300145$1$I$20220301$20240829$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009160$INCYTE$$$$$$Y$$$20240909$$CN$US$US
243001461$24300146$1$I$$20240715$20240909$20240909$PER$$US-ALXN-202407USA002303US$ALEXION PHARMACEUTICALS$$$$$F$Y$62.6$KG$20240909$$CN$US$US
243001471$24300147$1$I$20240709$20240715$20240909$20240909$EXP$$US-ALXN-202407USA002302US$ALEXION PHARMACEUTICALS$$53$YR$$F$Y$62.6$KG$20240909$$CN$US$US
243001481$24300148$1$I$20240701$20240829$20240909$20240909$PER$$US-INCYTE CORPORATION-2024IN009142$INCYTE$$$$$$Y$$$20240909$$CN$US$US
243001491$24300149$1$I$20240701$20240902$20240909$20240909$EXP$DK-DKMA-30737732$DK-TEVA-VS-3239815$TEVA$$88$YR$$M$Y$$$20240909$$MD$DK$DK
243001502$24300150$2$F$20240801$20240910$20240909$20240916$EXP$$CA-OTSUKA-2024_024982$OTSUKA$$73$YR$$M$Y$$$20240916$$CN$CA$CA
243001511$24300151$1$I$20240901$20240905$20240909$20240909$EXP$$US-PFIZER INC-202400251118$PFIZER$$76$YR$$M$Y$$$20240909$$HP$US$US
243001521$24300152$1$I$20240101$20240720$20240909$20240909$PER$$US-KARYOPHARM-2024KPT001341$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240909$$CN$US$US
243001531$24300153$1$I$$20240830$20240909$20240909$30DAY$$KR-PFIZER INC-202400252107$PFIZER$$$$$$Y$$$20240909$$HP$KR$KR
243001541$24300154$1$I$$20240828$20240909$20240909$EXP$$IR-INSUD PHARMA-2408IR06900$INSUD PHARMA$Roshanzamiri S, Mousavizadeh SA, Razazzadeh S, Ziaie S. Acyclovir-induced psychiatric and renal adverse effects in a diabetic patient: A case report. Clin Case Rep.. 2024;12:e9310:1-4$$$$$Y$$$20240909$$HP$IR$IR
243001551$24300155$1$I$$20240830$20240909$20240909$EXP$$MY-INSUD PHARMA-2408MY06929$INSUD PHARMA$Weeraj C, Kannan B. Mesenteric Ischemia in a Patient on Levonorgestrel Containing Oral Contraception. J Obstet Gynaecol Can. 2024;46(10):102633:1-2$$$$$Y$$$20240909$$HP$MY$MY
243001561$24300156$1$I$$20240829$20240909$20240909$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01305$AIMMUNE$$$$$$Y$$$20240909$$HP$US$US
243001581$24300158$1$I$20230201$20240903$20240909$20240909$EXP$$BR-BIOGEN-2024BI01281220$BIOGEN$$40$YR$$F$Y$56$KG$20240909$$CN$BR$BR
243001591$24300159$1$I$$20240904$20240909$20240909$PER$$US-009507513-2409USA001880$MERCK$Tan D, Fujiwara RJT, Tan C, Isaacson B, Hunter JB.. Endolymphatic Sac Tumors Associated With von Hippel-Lindau: A Case Report Highlighting Opportunity for Novel Orphan Drug Therapy. Otology + neurotology : official publication of the American Otological Society,. 2024$23$YR$$F$Y$$$20240909$$HP$US$US
243001601$24300160$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180448$NOVARTIS$$$$$$Y$$$20240909$$CN$US$US
243001641$24300164$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142978$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240909$$CN$US$US
243001671$24300167$1$I$$20240902$20240909$20240909$EXP$$JP-009507513-2409JPN000746J$MERCK$$7$DEC$$F$Y$$$20240909$$HP$JP$JP
243001681$24300168$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143038$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240909$$CN$US$US
243001691$24300169$1$I$20151026$20240829$20240909$20240909$EXP$$BE-ABBVIE-17K-013-3064227-00$ABBVIE$$66$YR$$M$Y$$$20240909$$HP$BE$BE
243001701$24300170$1$I$$20240827$20240909$20240909$EXP$$GB-BEH-2024178010$CSL BEHRING$$$$N$$Y$$$20240909$$HP$GB$GB
243001711$24300171$1$I$$20240909$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143167$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240909$$HP$US$US
243001721$24300172$1$I$20240619$20240904$20240909$20240909$PER$$US-ALXN-202409USA000230US$ALEXION PHARMACEUTICALS$$61$YR$$F$Y$$$20240909$$CN$US$US
243001731$24300173$1$I$$20240901$20240909$20240909$EXP$$NVSC2024IL177173$NOVARTIS$$80$YR$$F$Y$$$20240909$$MD$IL$IL
243001741$24300174$1$I$20240807$20240903$20240909$20240909$EXP$$CN-009507513-2409CHN002170$MERCK$$73$YR$$M$Y$$$20240909$$HP$CN$CN
243001751$24300175$1$I$20240707$20240902$20240909$20240909$PER$$US-APELLIS-2024-APL-0000917$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240909$$HP$US$US
243001762$24300176$2$F$20240730$20240912$20240909$20240913$EXP$ES-AEMPS-1565395$ES-GILEAD-2024-0686857$GILEAD$$46$YR$A$F$Y$51$KG$20240913$$PH$ES$ES
243001771$24300177$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142745$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240909$$HP$US$US
243001782$24300178$2$F$20240831$20240923$20240909$20240927$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-143048$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$90$KG$20240927$$MD$DE$DE
243001791$24300179$1$I$20240820$20240903$20240909$20240909$EXP$$BR-BIOGEN-2024BI01281213$BIOGEN$$24$YR$$F$Y$105$KG$20240909$$CN$BR$BR
243001801$24300180$1$I$$20240903$20240909$20240909$EXP$$US-SMPA-2024SPA002248$SUNOVION$$$$$$Y$$$20240909$$CN$US$US
243001811$24300181$1$I$20240806$20240903$20240909$20240909$EXP$FR-AFSSAPS-PO2024000915$FR-009507513-2409FRA001263$MERCK$$65$YR$$M$Y$52$KG$20240909$$MD$FR$FR
243001821$24300182$1$I$20240101$20240827$20240909$20240909$PER$$US-SA-2024SA259250$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240909$$MD$US$US
243001831$24300183$1$I$$20240906$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142927$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240909$$CN$US$US
243001841$24300184$1$I$20240101$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178064$AMGEN$$$$$M$Y$$$20240909$$CN$US$US
243001852$24300185$2$F$20190101$20240911$20240909$20240917$EXP$$FR-PURDUE-USA-2022-0298708$PURDUE$Dufayet L, Deveaux M, Cheze M, Charuel L, Ludes B, Fortel I, et. al. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: Data from the ?le-de-France Toxic Death Surveillance System (DCTOX-IdF). Toxicologie Analytique et Clinique. 2022;438:1-6$$$$M$Y$$$20240917$$HP$FR$FR
243001862$24300186$2$F$$20240905$20240909$20240925$PER$$US-SMPA-2024SPA001335$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243001881$24300188$1$I$20101201$20240905$20240909$20240909$EXP$$IT-PURDUE-USA-2023-0304764$PURDUE$Barbera N, Paolo Busardo F, Indorato F, Romano G.. The pathogenetic role of adulterants in 5 cases of drug addicts with a fatal outcome. Forensic Science International. 2013;227 (1-3):74-76$33$YR$$M$Y$$$20240909$$HP$IT$IT
243001913$24300191$3$F$$20240920$20240909$20240926$PER$$US-BIOMARINAP-US-2024-160300$BIOMARIN$$$$$$Y$$$20240926$$CN$US$US
243001921$24300192$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024178902$AMGEN$$$$$$Y$$$20240909$$CN$US$US
243001931$24300193$1$I$$20240905$20240909$20240909$PER$$US-AMGEN-USASP2024179302$AMGEN$$$$$F$Y$$$20240909$$HP$US$US
243001942$24300194$2$F$20240829$20240906$20240909$20240911$EXP$$CO-BIOMARINAP-CO-2024-160357$BIOMARIN$$$$$$Y$$$20240911$$CN$CO$CO
243001951$24300195$1$I$20240826$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142187$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240909$$PH$US$US
243001961$24300196$1$I$20180630$20211013$20240909$20240909$EXP$$JP-GSK-JP2019JPN054832$GLAXOSMITHKLINE$$$$$$Y$$$20240909$$MD$JP$JP
243001971$24300197$1$I$20240101$20240903$20240909$20240909$EXP$$US-RIGEL-20240900020$RIGEL PHARMACEUTICALS$$$$$F$Y$62.596$KG$20240909$$CN$US$US
243001981$24300198$1$I$20240801$20240827$20240909$20240909$EXP$$CA-RIGEL-20240900025$RIGEL PHARMACEUTICALS$$80$YR$$M$Y$$$20240909$$CN$CA$CA
243001991$24300199$1$I$$20240903$20240909$20240909$PER$$US-009507513-2409USA001465$MERCK$Sherman N, Childers R V., Nisbet B, Knox A, Mahoney A. Bilateral aseptic loosening of glenoid and humeral components after anatomic shoulder arthroplasty: a case report. Seminars in Arthroplasty JSES. 2024;34 (3):755-61$69$YR$$F$Y$$$20240909$$HP$US$US
243002001$24300200$1$I$$20240904$20240909$20240909$PER$$US-ALXN-202409USA000356US$ALEXION PHARMACEUTICALS$$$$$F$Y$131.52$KG$20240909$$CN$US$US
243002011$24300201$1$I$20240712$20240815$20240909$20240909$PER$$US-AstraZeneca-2024A186944$ASTRAZENECA$$18524$DY$$F$Y$$$20240909$$MD$US$
243002021$24300202$1$I$$20240828$20240909$20240909$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08756$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240909$$CN$US$US
243002031$24300203$1$I$$20240906$20240909$20240909$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050252$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240909$$CN$US$US
243002041$24300204$1$I$$20240827$20240909$20240909$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08671$NEUROCRINE BIOSCIENCES$$$$A$M$Y$$$20240909$$HP$US$US
243002052$24300205$2$F$20240101$20240904$20240909$20240911$PER$$US-AMGEN-USASP2024177533$AMGEN$$$$$F$Y$$$20240911$$HP$US$US
243002071$24300207$1$I$$20240909$20240909$20240909$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050370$BOEHRINGER INGELHEIM$$55$YR$A$F$Y$$$20240909$$CN$US$US
243002081$24300208$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142803$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240909$$CN$US$US
243002091$24300209$1$I$20240805$20240828$20240909$20240909$EXP$$CA-HLS-202402190$HLS THERAPEUTICS$$68$YR$E$M$Y$$$20240909$$PH$CA$CA
243002101$24300210$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180471$NOVARTIS$$$$$M$Y$$$20240910$$MD$US$US
243002113$24300211$3$F$20240824$20240926$20240909$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142501$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$66.22$KG$20240927$$CN$US$US
243002121$24300212$1$I$$20240828$20240909$20240909$EXP$$US-HLS-202401117$HLS THERAPEUTICS$$$$A$F$Y$$$20240909$$HP$US$US
243002141$24300214$1$I$$20240828$20240909$20240909$EXP$$CA-HLS-202402179$HLS THERAPEUTICS$$$$A$M$Y$$$20240909$$MD$CA$CA
243002151$24300215$1$I$$20240904$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003541$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240909$$CN$US$US
243002161$24300216$1$I$$20240723$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409001171$ELI LILLY AND CO$$$$$$Y$$$20240909$$CN$US$US
243002191$24300219$1$I$20240101$20240902$20240909$20240909$EXP$$JP-009507513-2409JPN000396J$MERCK$$74$YR$$M$Y$$$20240909$$MD$JP$JP
243002202$24300220$2$F$20240709$20240912$20240909$20240913$EXP$ES-AEMPS-1565803$ES-GILEAD-2024-0686858$GILEAD$$52$YR$A$F$Y$93$KG$20240913$$PH$ES$ES
243002211$24300221$1$I$$20240828$20240909$20240909$EXP$$CA-HLS-202402177$HLS THERAPEUTICS$$$$E$F$Y$$$20240909$$HP$CA$CA
243002231$24300223$1$I$20240801$20240828$20240909$20240909$EXP$$CA-HLS-202402181$HLS THERAPEUTICS$$51$YR$A$M$Y$$$20240909$$HP$CA$CA
243002241$24300224$1$I$$20240828$20240909$20240909$EXP$$US-HLS-202401115$HLS THERAPEUTICS$$$$E$$Y$$$20240909$$HP$US$US
243002251$24300225$1$I$$20240828$20240909$20240909$EXP$$US-HLS-202401112$HLS THERAPEUTICS$$$$A$$Y$$$20240909$$PH$US$US
243002261$24300226$1$I$$20240903$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409002245$ELI LILLY AND CO$$$$$M$Y$$$20240909$$CN$US$US
243002271$24300227$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409003805$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240909$$CN$US$US
243002281$24300228$1$I$20200512$20240904$20240909$20240909$EXP$$CA-TAKEDA-2021TUS009924$TAKEDA$$51$YR$$F$Y$115$KG$20240909$$MD$CA$CA
243002291$24300229$1$I$$20240829$20240909$20240909$EXP$$US-HLS-202401139$HLS THERAPEUTICS$$$$A$$Y$$$20240909$$HP$US$US
243002301$24300230$1$I$$20240905$20240909$20240909$EXP$$PA-BRISTOL-MYERS SQUIBB COMPANY-2024-142560$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$97$KG$20240909$$CN$PA$PA
243002311$24300231$1$I$$20240904$20240909$20240909$EXP$$PT-JNJFOC-20240919843$JOHNSON AND JOHNSON$Joelma Mendes ; Liliia Savka ; Maria Jose Pires ; Catarina Lopes ; Milton Rosa ; Nuno Reis Carreira. POSA-065 - (2675) - THROMBOCYTOPENIA CEFEPIME-INDUCED IMMUNE. Santa Maria Local Health Unit. 1137$56$YR$A$M$Y$$$20240909$$HP$PT$PT
243002321$24300232$1$I$$20240904$20240909$20240909$EXP$$PT-JNJFOC-20240919721$JOHNSON AND JOHNSON$Joana Correia Nunes ; Carolina Saca ; Catarina Couto ; Maria Carolina Carvalho ; Ricardo Paquete Oliveira; Jose Delgado Alves. Cancerous Diseases. Congresso Nacional de Medicina Interna [National Congress of Internal Medicine]. NA;NA:833$67$YR$E$M$Y$$$20240909$$HP$PT$PT
243002341$24300234$1$I$20240905$20240905$20240909$20240909$PER$$US-JNJFOC-20240915023$JOHNSON AND JOHNSON$$$$$F$Y$$$20240909$$CN$US$US
243002351$24300235$1$I$$20240903$20240909$20240909$EXP$$JP-009507513-2405JPN000004J$MERCK$$$$$F$Y$$$20240909$$MD$JP$JP
243002362$24300236$2$F$20240820$20240913$20240909$20240918$EXP$$DE-BIOMARINAP-DE-2024-160066$BIOMARIN$$$$$$Y$$$20240918$$HP$DE$DE
243002371$24300237$1$I$$20240903$20240909$20240909$PER$$US-009507513-2409USA001512$MERCK$$$$$M$Y$$$20240909$$CN$US$US
243002381$24300238$1$I$20240818$20240904$20240909$20240909$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050265$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240910$$HP$CO$CO
243002391$24300239$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004781$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240909$$CN$US$US
243002401$24300240$1$I$$20240826$20240909$20240909$EXP$$GB-SMPA-2024SPA002376$SUNOVION$$$$$$Y$$$20240909$$PH$GB$GB
243002411$24300241$1$I$$20240906$20240909$20240909$EXP$$GB-SANDOZ INC.-SDZ2024GB078388$SANDOZ$$$$$F$Y$$$20240909$$CN$GB$GB
243002421$24300242$1$I$$20240903$20240909$20240909$EXP$$NVSJ2024JP010520$NOVARTIS$$$$$$Y$$$20240910$$MD$JP$JP
243002441$24300244$1$I$20240828$20240905$20240909$20240909$EXP$$US-ABBVIE-5910646$ABBVIE$$72$YR$$M$Y$$$20240909$$CN$US$US
243002451$24300245$1$I$$20240905$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004377$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240909$$CN$US$US
243002462$24300246$2$F$20240816$20240917$20240909$20240925$EXP$$CA-JNJFOC-20240906556$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240925$$PH$CA$CA
243002471$24300247$1$I$20211101$20240903$20240909$20240909$EXP$$BR-JNJFOC-20240913116$JOHNSON AND JOHNSON$$50$YR$$F$Y$$$20240910$$CN$BR$BR
243002482$24300248$2$F$$20240909$20240909$20240910$PER$$NVSC2024US180338$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
243002491$24300249$1$I$20210201$20240906$20240909$20240909$EXP$$DE-SANDOZ INC.-NVSC2022DE034669$SANDOZ$$67$YR$$M$Y$$$20240909$$HP$DE$DE
243002502$24300250$2$F$$20240905$20240909$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409004387$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240918$$CN$US$US
243002511$24300251$1$I$20240101$20240826$20240909$20240909$PER$$US-SA-2024SA258187$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240910$$MD$US$US
243002531$24300253$1$I$$20240903$20240909$20240909$PER$$US-SA-2024SA258563$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240910$$CN$US$US
243002551$24300255$1$I$$20240904$20240909$20240909$PER$$US-AMGEN-USASP2024177046$AMGEN$$$$$M$Y$$$20240909$$CN$US$US
243002561$24300256$1$I$20240715$20240903$20240909$20240909$EXP$$CN-AstraZeneca-2024A202477$ASTRAZENECA$$88$YR$$F$Y$$$20240910$$MD$CN$
243002571$24300257$1$I$$20240829$20240909$20240909$EXP$$US-Bion-013780$BIONPHARMA$$39$YR$A$M$Y$$$20240910$$CN$US$US
243002581$24300258$1$I$$20240905$20240909$20240909$EXP$$NVSJ2024JP010615$NOVARTIS$$$$E$F$Y$$$20240910$$MD$JP$JP
243002591$24300259$1$I$$20240829$20240909$20240909$EXP$$US-Bion-013781$BIONPHARMA$$$$$F$Y$$$20240910$$CN$US$US
243002601$24300260$1$I$$20240829$20240909$20240909$EXP$$US-Bion-013782$BIONPHARMA$$$$A$M$Y$$$20240910$$CN$US$US
243002611$24300261$1$I$20240101$20240903$20240909$20240909$EXP$$GB-JNJFOC-20240920137$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$GB$GB
243002621$24300262$1$I$$20240903$20240909$20240909$EXP$$US-Bion-013779$BIONPHARMA$$69$YR$E$M$Y$$$20240910$$HP$US$US
243002641$24300264$1$I$$20240829$20240909$20240909$PER$$US-ABBVIE-5902092$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
243002651$24300265$1$I$20240101$20240828$20240909$20240909$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139809$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240910$$PH$JP$JP
243002671$24300267$1$I$20240101$20240904$20240909$20240909$EXP$$CO-ABBVIE-5909121$ABBVIE$$$$$F$Y$60$KG$20240909$$CN$CO$CO
243002681$24300268$1$I$$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004584$ELI LILLY AND CO$$59$YR$A$$Y$$$20240909$$LW$US$US
243002691$24300269$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180297$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243002711$24300271$1$I$$20240828$20240909$20240909$30DAY$$AE-JNJFOC-20240901854$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$AE$AE
243002721$24300272$1$I$$20240904$20240909$20240909$PER$$US-JNJFOC-20240909595$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240910$$PH$US$US
243002731$24300273$1$I$20240612$20240903$20240909$20240909$PER$$US-AMGEN-USASP2024175817$AMGEN$$50$YR$A$F$Y$$$20240909$$CN$US$US
243002741$24300274$1$I$20240806$20240903$20240909$20240909$EXP$$DE-JNJFOC-20240914357$JOHNSON AND JOHNSON$$40$YR$A$F$Y$100$KG$20240910$$MD$DE$DE
243002751$24300275$1$I$20231019$20240906$20240909$20240909$EXP$$EU-BAUSCHBL-2024BNL003081$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240910$$HP$EU$EU
243002761$24300276$1$I$$20240904$20240909$20240909$EXP$$CA-ABBVIE-5908806$ABBVIE$$$$E$M$Y$$$20240909$$CN$CA$CA
243002781$24300278$1$I$$20240904$20240909$20240909$EXP$$CA-ABBVIE-5910112$ABBVIE$$$$E$F$Y$$$20240909$$MD$CA$CA
243002791$24300279$1$I$20230101$20240905$20240909$20240909$EXP$$CO-ABBVIE-5913626$ABBVIE$$60$YR$$F$Y$78$KG$20240909$$CN$CO$CO
243002801$24300280$1$I$20240722$20240831$20240909$20240909$EXP$$CN-BEIGENE-BGN-2024-013818$BEIGENE$$$$$$Y$$$20240909$$HP$CN$CN
243002811$24300281$1$I$20240320$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202935$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
243002821$24300282$1$I$20240801$20240820$20240909$20240909$PER$$US-009507513-2408USA007066$MERCK$$68$YR$$F$Y$$$20240909$$MD$US$US
243002831$24300283$1$I$20240601$20240902$20240909$20240909$EXP$$BR-JNJFOC-20240907647$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240910$$CN$BR$BR
243002841$24300284$1$I$$20240903$20240909$20240909$EXP$$US-AstraZeneca-2024A201045$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243002851$24300285$1$I$20240829$20240903$20240909$20240909$EXP$$US-JNJFOC-20240913646$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240910$$MD$US$US
243002861$24300286$1$I$$20240902$20240909$20240909$EXP$$JP-AstraZeneca-2024A201418$ASTRAZENECA$$$$$F$Y$$$20240910$$HP$JP$
243002872$24300287$2$F$$20240905$20240909$20240911$EXP$$US-AstraZeneca-2024A203294$ASTRAZENECA$$$$$F$Y$$$20240911$$MD$US$
243002881$24300288$1$I$$20240903$20240909$20240909$EXP$$US-AstraZeneca-2024A200429$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243002891$24300289$1$I$$20240830$20240909$20240909$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00327$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240909$$CN$US$US
243002911$24300291$1$I$$20240906$20240909$20240909$EXP$$JP-TAKEDA-2024TJP013250$TAKEDA$$$$$$Y$$$20240909$$MD$JP$JP
243002921$24300292$1$I$20240101$20240903$20240909$20240909$EXP$$US-JNJFOC-20240908404$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240910$$MD$US$US
243002931$24300293$1$I$$20240905$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142293$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240910$$HP$US$US
243002941$24300294$1$I$$20240904$20240909$20240909$PER$$US-ABBVIE-5907702$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
243002951$24300295$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141723$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240910$$HP$US$US
243002961$24300296$1$I$$20240902$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142932$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$$$$$Y$$$20240910$$HP$US$US
243002971$24300297$1$I$$20240830$20240909$20240909$PER$$US-BAUSCHBL-2024BNL032680$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240910$$CN$US$US
243002983$24300298$3$F$20240825$20240909$20240909$20240912$PER$$US-AMGEN-USASP2024179432$AMGEN$$68$YR$E$F$Y$$$20240912$$CN$US$US
243002991$24300299$1$I$20240826$20240830$20240909$20240909$PER$$US-BAUSCHBL-2024BNL032671$BAUSCH AND LOMB$$$$$F$Y$$$20240910$$CN$US$US
243003001$24300300$1$I$$20240829$20240909$20240909$PER$$US-BAUSCHBL-2024BNL032637$BAUSCH AND LOMB$$$$$F$Y$$$20240910$$CN$US$US
243003011$24300301$1$I$$20240829$20240909$20240909$PER$$US-BAUSCHBL-2024BNL032664$BAUSCH AND LOMB$$$$$M$Y$$$20240910$$HP$US$US
243003021$24300302$1$I$20240801$20240829$20240909$20240909$PER$$US-BAUSCHBL-2024BNL032677$BAUSCH AND LOMB$$79$YR$$F$Y$$$20240910$$CN$US$US
243003031$24300303$1$I$20240801$20240829$20240909$20240909$PER$$US-BAUSCHBL-2024BNL032639$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240910$$CN$US$US
243003041$24300304$1$I$20240724$20240905$20240909$20240909$EXP$$CO-ABBVIE-5913666$ABBVIE$$81$YR$$M$Y$$$20240909$$CN$CO$CO
243003051$24300305$1$I$20240903$20240903$20240909$20240909$EXP$$FR-ABBVIE-5909051$ABBVIE$$67$YR$$M$Y$$$20240909$$HP$FR$FR
243003061$24300306$1$I$$20240904$20240909$20240909$EXP$$BG-ABBVIE-5908931$ABBVIE$$69$YR$$F$Y$$$20240909$$MD$BG$BG
243003071$24300307$1$I$$20240905$20240909$20240909$EXP$$US-ABBVIE-5910544$ABBVIE$$$$$F$Y$$$20240909$$HP$US$US
243003081$24300308$1$I$20240101$20240904$20240909$20240909$EXP$$US-ABBVIE-5913693$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
243003091$24300309$1$I$$20240903$20240909$20240909$PER$$US-JNJFOC-20240906635$JOHNSON AND JOHNSON$$35$YR$A$$Y$$$20240910$$MD$US$US
243003101$24300310$1$I$20240101$20240906$20240909$20240909$EXP$$CA-ABBVIE-5913647$ABBVIE$$77$YR$$M$Y$$$20240909$$MD$CA$CA
243003111$24300311$1$I$20240901$20240902$20240909$20240909$EXP$$ES-ABBVIE-5905388$ABBVIE$$72$YR$$M$Y$$$20240909$$CN$ES$ES
243003121$24300312$1$I$20240101$20240904$20240909$20240909$EXP$$US-ABBVIE-5907628$ABBVIE$$$$$M$Y$$$20240909$$CN$US$US
243003131$24300313$1$I$20240115$20240904$20240909$20240909$EXP$$US-ABBVIE-5908829$ABBVIE$$80$YR$$F$Y$$$20240909$$CN$US$US
243003151$24300315$1$I$$20240902$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142931$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$49$YR$A$F$Y$$$20240910$$HP$US$US
243003162$24300316$2$F$$20240909$20240909$20240920$EXP$$HR-BRISTOL-MYERS SQUIBB COMPANY-2024-139691$BRISTOL MYERS SQUIBB$Krecak I, Supe M, Markov B, Skelin M, Lucijanic M. Fatal heart tamponade during induction treatment with azacitidine and venetoclax. Annals of Hematology. 2024 Aug 25;doi:10.1007/s00277-024-05957-9.$62$YR$A$M$Y$$$20240920$$HP$HR$HR
243003171$24300317$1$I$$20240819$20240909$20240909$PER$$US-BEIGENE-BGN-2024-013219$BEIGENE$$$$$$Y$$$20240909$$CN$US$US
243003182$24300318$2$F$$20240909$20240909$20240913$EXP$$CA-ROCHE-10000008916$ROCHE$$$$A$F$Y$$$20240913$$CN$CA$CA
243003191$24300319$1$I$20240903$20240906$20240909$20240909$PER$$US-AMGEN-USASP2024179381$AMGEN$$$$$$Y$$$20240909$$PH$US$US
243003201$24300320$1$I$$20240829$20240909$20240909$PER$$US-BEIGENE-BGN-2024-013855$BEIGENE$$$$$$Y$$$20240909$$CN$US$US
243003211$24300321$1$I$20220101$20240905$20240909$20240909$EXP$$US-ROCHE-10000075461$ROCHE$$44$YR$A$M$Y$75.29$KG$20240910$$CN$US$US
243003221$24300322$1$I$$20240830$20240909$20240909$30DAY$$US-JNJFOC-20240881393$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
243003231$24300323$1$I$20240101$20240903$20240909$20240909$EXP$$CA-ABBVIE-5837291$ABBVIE$$72$YR$$F$Y$$$20240909$$CN$CA$CA
243003241$24300324$1$I$20240813$20240904$20240909$20240909$EXP$$US-ABBVIE-5907940$ABBVIE$$67$YR$$M$Y$$$20240909$$CN$US$US
243003251$24300325$1$I$20240101$20240904$20240909$20240909$EXP$$CA-ABBVIE-5909256$ABBVIE$$72$YR$$F$Y$$$20240909$$CN$CA$CA
243003262$24300326$2$F$$20240911$20240909$20240916$EXP$$CA-ROCHE-2721802$ROCHE$$$$A$M$Y$$$20240916$$CN$CA$CA
243003271$24300327$1$I$20240101$20240904$20240909$20240909$EXP$$US-ABBVIE-5913570$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
243003281$24300328$1$I$$20240902$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142924$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$27$YR$A$M$Y$$$20240910$$HP$US$US
243003291$24300329$1$I$20240101$20240903$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140586$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240910$$CN$US$US
243003301$24300330$1$I$20240101$20240828$20240909$20240909$PER$$US-SA-2024SA258849$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240910$$HP$US$US
243003311$24300331$1$I$$20240905$20240909$20240909$EXP$$US-AstraZeneca-2024A202850$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
243003321$24300332$1$I$$20240906$20240909$20240909$PER$$US-ROCHE-10000076550$ROCHE$$$$$M$Y$$$20240910$$CN$US$US
243003331$24300333$1$I$20240601$20240903$20240909$20240909$EXP$$CA-TAKEDA-2024TUS077671$TAKEDA$$58$YR$$F$Y$$$20240909$$CN$CA$CA
243003341$24300334$1$I$$20240905$20240909$20240909$EXP$$JP-ABBVIE-5908848$ABBVIE$$$$$$Y$$$20240909$$MD$JP$JP
243003351$24300335$1$I$$20240905$20240909$20240909$EXP$$US-JNJFOC-20240912232$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240910$$HP$US$US
243003361$24300336$1$I$20240722$20240902$20240909$20240909$EXP$$CN-TAKEDA-2024TUS089704$TAKEDA$$69$YR$$M$Y$75$KG$20240909$$HP$CN$CN
243003371$24300337$1$I$$20240903$20240909$20240909$PER$$US-BEIGENE-BGN-2024-014042$BEIGENE$$$$$$Y$$$20240909$$PH$US$US
243003381$24300338$1$I$$20240905$20240909$20240909$EXP$$US-ABBVIE-5909879$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
243003391$24300339$1$I$$20240902$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142930$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$$$$$Y$$$20240910$$HP$US$US
243003401$24300340$1$I$20230625$20240904$20240909$20240909$EXP$$US-ABBVIE-5907881$ABBVIE$$62$YR$$F$Y$$$20240909$$CN$US$US
243003411$24300341$1$I$$20240906$20240909$20240909$EXP$$LB-BRISTOL-MYERS SQUIBB COMPANY-2024-142576$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240910$$HP$LB$LB
243003421$24300342$1$I$20240701$20240903$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140572$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240910$$PH$US$US
243003431$24300343$1$I$$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004830$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240909$$CN$US$US
243003441$24300344$1$I$$20240904$20240909$20240909$EXP$$US-JNJFOC-20240915001$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
243003451$24300345$1$I$$20240906$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409004734$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240909$$CN$US$US
243003472$24300347$2$F$$20240916$20240909$20240922$EXP$$US-TAKEDA-2024TUS072240$TAKEDA$$$$$F$Y$$$20240922$$CN$US$US
243003481$24300348$1$I$20240701$20240905$20240909$20240909$EXP$$CA-JNJFOC-20240611663$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240910$$HP$CA$CA
243003491$24300349$1$I$$20240905$20240909$20240909$PER$$US-JNJFOC-20240915723$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240910$$MD$US$US
243003511$24300351$1$I$20240101$20240902$20240909$20240909$EXP$$SK-JNJFOC-20240907008$JOHNSON AND JOHNSON$$64$YR$A$$Y$$$20240910$$MD$SK$SK
243003522$24300352$2$F$$20240923$20240909$20240927$EXP$$US-TAKEDA-2024TUS088668$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
243003531$24300353$1$I$$20240904$20240909$20240909$EXP$$US-ABBVIE-5908832$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
243003541$24300354$1$I$20240801$20240904$20240909$20240909$EXP$$GB-ABBVIE-5910675$ABBVIE$$63$YR$$M$Y$$$20240909$$CN$GB$GB
243003551$24300355$1$I$$20240902$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142921$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$$$$$Y$$$20240910$$HP$US$US
243003561$24300356$1$I$$20240829$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138733$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$PH$US$US
243003571$24300357$1$I$$20240902$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142922$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$55$YR$A$M$Y$$$20240910$$HP$US$US
243003581$24300358$1$I$$20240903$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140266$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240910$$CN$US$US
243003591$24300359$1$I$$20240903$20240909$20240909$EXP$$CA-ABBVIE-5907213$ABBVIE$$42$YR$$F$Y$$$20240909$$HP$CA$CA
243003603$24300360$3$F$20240809$20240918$20240909$20240925$30DAY$$FR-JNJFOC-20240831796$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240925$$PH$FR$FR
243003611$24300361$1$I$$20240906$20240909$20240909$PER$$US-JNJFOC-20240917754$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$LW$US$US
243003621$24300362$1$I$20240611$20240827$20240909$20240909$PER$$US-SA-2024SA259376$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240910$$MD$US$US
243003651$24300365$1$I$$20240904$20240909$20240909$EXP$$US-TAKEDA-2024TUS088933$TAKEDA$$$$$M$Y$$$20240909$$CN$US$US
243003661$24300366$1$I$$20240903$20240909$20240909$EXP$$GR-ABBVIE-5910451$ABBVIE$Kourti A, Kosmeri C, Chira A, Kanavaki I, Stefos E, Foukas P, et al. Renal manifestations in a cohort of pediatric patients with inflammatory bowel disease. Arab Journal of Gastroenterology. ?2024;25(3):284-7.$14$YR$$F$Y$$$20240909$$HP$GR$GR
243003681$24300368$1$I$$20240904$20240909$20240909$PER$$US-ALXN-202409USA000227US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243003691$24300369$1$I$20240601$20240903$20240909$20240909$EXP$$GB-ESPERIONTHERAPEUTICS-2024GBR01389$ESPERION THERAPEUTICS$$81$YR$$M$Y$82$KG$20240910$$CN$GB$GB
243003702$24300370$2$F$20240802$20240917$20240909$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141546$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240919$$PH$US$US
243003711$24300371$1$I$$20240902$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142918$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$$$$$Y$$$20240910$$HP$US$US
243003721$24300372$1$I$$20240904$20240909$20240909$EXP$$CA-AMGEN-CANSL2024147465$AMGEN$$69$YR$E$F$Y$$$20240909$$HP$CA$CA
243003731$24300373$1$I$20240829$20240904$20240909$20240909$EXP$$US-JNJFOC-20240915620$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240910$$MD$US$US
243003741$24300374$1$I$$20240903$20240909$20240909$PER$$US-SA-2024SA259344$SANOFI AVENTIS$$$$$M$Y$$$20240910$$MD$US$US
243003761$24300376$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180588$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243003771$24300377$1$I$20240827$20240907$20240909$20240909$EXP$$US-BEIGENE-BGN-2024-010144$BEIGENE$$$$$$Y$$$20240909$$CN$US$US
243003791$24300379$1$I$$20240829$20240909$20240909$PER$$US-SA-2024SA259477$SANOFI AVENTIS$$83$YR$E$$Y$$$20240910$$CN$US$US
243003801$24300380$1$I$$20240905$20240909$20240909$EXP$$GB-TAKEDA-2024TUS089767$TAKEDA$$$$$M$Y$$$20240909$$MD$GB$GB
243003811$24300381$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180591$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243003821$24300382$1$I$20240701$20240904$20240909$20240909$EXP$$CO-JNJFOC-20240917909$JOHNSON AND JOHNSON$$59$YR$A$F$Y$30$KG$20240910$$HP$CO$CO
243003831$24300383$1$I$20230701$20240909$20240909$20240909$EXP$GB-MHRA-MED-202409082049593860-LVBDS$GB-ORGANON-O2409GBR000533$ORGANON$$8$YR$$M$Y$28$KG$20240909$$CN$GB$GB
243003841$24300384$1$I$$20240830$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139923$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240910$$CN$US$US
243003851$24300385$1$I$$20240902$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140101$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$$$$$Y$$$20240910$$HP$US$US
243003861$24300386$1$I$$20240902$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142929$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$61$YR$$M$Y$$$20240910$$HP$US$US
243003871$24300387$1$I$20240902$20240903$20240909$20240909$EXP$$CO-BIOGEN-2024BI01281078$BIOGEN$$0$YR$$F$Y$5.8$KG$20240909$$CN$CO$CO
243003881$24300388$1$I$20240101$20240905$20240909$20240909$EXP$$US-ABBVIE-5909564$ABBVIE$$$$$F$Y$$$20240909$$CN$US$US
243003891$24300389$1$I$20240728$20240902$20240909$20240909$EXP$$HU-BIOGEN-2024BI01276275$BIOGEN$$6$YR$$M$Y$$$20240909$$MD$HU$HU
243003901$24300390$1$I$20240831$20240904$20240909$20240909$EXP$$US-ABBVIE-5908946$ABBVIE$$70$YR$$M$Y$$$20240909$$CN$US$US
243003911$24300391$1$I$$20240828$20240909$20240909$EXP$$CO-ABBVIE-5913622$ABBVIE$$$$$M$Y$67$KG$20240909$$HP$CO$CO
243003921$24300392$1$I$$20240830$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139607$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$PH$US$US
243003931$24300393$1$I$20240101$20240903$20240909$20240909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140550$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240910$$CN$US$US
243003941$24300394$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180546$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243003952$24300395$2$F$20240101$20240912$20240909$20240919$EXP$$US-ABBVIE-4714612$ABBVIE$$$$$F$Y$65$KG$20240919$$CN$US$US
243003961$24300396$1$I$$20240906$20240909$20240909$EXP$$US-JNJFOC-20240919800$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240910$$HP$US$US
243003971$24300397$1$I$$20240729$20240909$20240909$PER$$US-LUNDBECK-DKLU4002362$LUNDBECK$$$$$$Y$$$20240910$$HP$US$US
243003981$24300398$1$I$$20240902$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142926$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$$$$$Y$$$20240910$$HP$US$US
243003992$24300399$2$F$20240601$20240924$20240909$20240925$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050365$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240925$$CN$US$US
243004011$24300401$1$I$20240620$20240904$20240909$20240909$EXP$$CA-LUNDBECK-DKLU4003980$LUNDBECK$$$$$$Y$$$20240910$$CN$CA$CA
243004021$24300402$1$I$$20240905$20240909$20240909$EXP$$NVSJ2024JP010635$NOVARTIS$$$$E$F$Y$$$20240910$$MD$JP$JP
243004041$24300404$1$I$$20240905$20240909$20240909$PER$$US-ALXN-202409USA000386US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243004053$24300405$3$F$20240101$20240917$20240909$20240920$EXP$$US-ABBVIE-5908523$ABBVIE$$78$YR$$F$Y$61$KG$20240920$$CN$US$US
243004061$24300406$1$I$$20240729$20240909$20240909$PER$$US-LUNDBECK-DKLU4002363$LUNDBECK$$$$$$Y$$$20240910$$HP$US$US
243004071$24300407$1$I$20240301$20240905$20240909$20240909$PER$$US-ABBVIE-5910176$ABBVIE$$$$$$Y$$$20240909$$CN$US$US
243004081$24300408$1$I$$20240830$20240909$20240909$PER$$US-ELI_LILLY_AND_COMPANY-US202409000608$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240909$$CN$US$US
243004092$24300409$2$F$20240827$20240912$20240909$20240921$PER$$US-JNJFOC-20240911287$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240921$$CN$US$US
243004101$24300410$1$I$$20240904$20240909$20240909$PER$$US-ROCHE-10000074821$ROCHE$$$$$$Y$$$20240910$$CN$US$US
243004111$24300411$1$I$$20240905$20240909$20240909$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143174$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240910$$CN$US$US
243004121$24300412$1$I$$20240827$20240909$20240909$PER$$US-SA-2024SA259166$SANOFI AVENTIS$$$$A$F$Y$290$KG$20240910$$MD$US$US
243004132$24300413$2$F$$20240905$20240909$20240910$EXP$$US-LUNDBECK-DKLU4003975$LUNDBECK$$$$$$Y$$$20240910$$CN$US$US
243004141$24300414$1$I$$20240905$20240909$20240909$EXP$$US-ALXN-202409USA000387US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$PH$US$US
243004161$24300416$1$I$$20240729$20240909$20240909$PER$$US-LUNDBECK-DKLU4002444$LUNDBECK$$$$$$Y$$$20240910$$MD$US$US
243004171$24300417$1$I$20240213$20240903$20240909$20240909$EXP$$DE-AMGEN-DEUSP2024179265$AMGEN$$$$A$F$Y$$$20240909$$MD$DE$DE
243004181$24300418$1$I$$20240906$20240909$20240909$PER$$NVSC2024US180499$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243004191$24300419$1$I$$20240909$20240909$20240909$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050392$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240910$$CN$US$US
243004202$24300420$2$F$20240801$20240830$20240909$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138942$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240911$$HP$US$US
243004211$24300421$1$I$$20240903$20240909$20240909$EXP$$DE-BEIGENE-BGN-2024-013926$BEIGENE$$$$$$Y$$$20240909$$MD$DE$DE
243004221$24300422$1$I$$20240903$20240910$20240910$EXP$$ZA-AstraZeneca-2024A201019$ASTRAZENECA$$75$YR$$M$Y$$$20240910$$CN$ZA$
243004241$24300424$1$I$$20240827$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011028$STRIDES$Rink DE, Abramson RH, Johnson NJ, Lee RY. Diagnostic Confounders in Brain Death A Woman with Unexplained Coma and Brainstem Areflexia. Annals of the American Thoracic Society. 2024;21(8):1204-8$60$YR$$F$Y$$$20240910$$MD$US$US
243004251$24300425$1$I$20240826$20240905$20240910$20240910$EXP$$CN-PFIZER INC-PV202400116787$PFIZER$$83$YR$$M$Y$55$KG$20240909$$HP$CN$CN
243004291$24300429$1$I$20240101$20240904$20240910$20240910$EXP$$US-JNJFOC-20240911486$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240910$$HP$US$US
243004301$24300430$1$I$20240501$20240826$20240910$20240910$PER$$US-SA-2024SA259386$SANOFI AVENTIS$$$$E$F$Y$$$20240910$$MD$US$US
243004311$24300431$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141741$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240910$$HP$US$US
243004321$24300432$1$I$$20240904$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409002979$ELI LILLY AND CO$$$$$M$Y$$$20240909$$CN$US$US
243004331$24300433$1$I$20240820$20240909$20240910$20240910$EXP$IT-MINISAL02-1001621$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-143088$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240910$$PH$IT$IT
243004352$24300435$2$F$20240828$20240911$20240910$20240917$EXP$$US-AMGEN-USASP2024175585$AMGEN$$89$YR$E$M$Y$$$20240917$$MD$US$US
243004371$24300437$1$I$20240831$20240904$20240910$20240910$PER$$US-AMGEN-USASP2024178189$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
243004391$24300439$1$I$20240101$20240902$20240910$20240910$EXP$$JP-AstraZeneca-2024A201478$ASTRAZENECA$$$$$$Y$$$20240910$$MD$JP$
243004401$24300440$1$I$20240904$20240906$20240910$20240910$EXP$$US-AstraZeneca-2024A204390$ASTRAZENECA$$$$$F$Y$$$20240910$$MD$US$
243004411$24300441$1$I$$20240904$20240910$20240910$PER$$US-LEO Pharma-373313$LEO PHARM$$50$YR$$M$Y$$$20240910$$CN$US$US
243004421$24300442$1$I$$20240904$20240910$20240910$EXP$$CA-TAKEDA-2024TUS089319$TAKEDA$$$$$F$Y$$$20240910$$CN$CA$CA
243004441$24300444$1$I$20240717$20240827$20240910$20240910$PER$$US-SA-2024SA259188$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240910$$MD$US$US
243004451$24300445$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2024SA260620$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240910$$HP$US$US
243004461$24300446$1$I$$20240822$20240910$20240910$PER$$US-ASTELLAS-2024-AER-002494$ASTELLAS$$$$$F$Y$$$20240910$$MD$US$US
243004471$24300447$1$I$$20240905$20240910$20240910$EXP$$US-ABBVIE-5909873$ABBVIE$$$$$M$Y$$$20240910$$HP$US$US
243004481$24300448$1$I$20240822$20240826$20240910$20240910$PER$$US-JNJFOC-20240867074$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240910$$CN$US$US
243004511$24300451$1$I$$20240904$20240910$20240910$PER$$US-JNJFOC-20240916481$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$LW$US$US
243004521$24300452$1$I$20240823$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024178330$AMGEN$$67$YR$E$F$Y$$$20240909$$CN$US$US
243004531$24300453$1$I$$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024177977$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
243004541$24300454$1$I$20240101$20240905$20240910$20240910$EXP$$US-ABBVIE-5910335$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243004551$24300455$1$I$20240603$20240906$20240910$20240910$EXP$$US-ABBVIE-5914146$ABBVIE$$79$YR$$F$Y$39.916$KG$20240910$$CN$US$US
243004561$24300456$1$I$$20240829$20240910$20240910$EXP$IN-MLMSERVICE-20240823-PI168809-00163-1$IN-STRIDES ARCOLAB LIMITED-2024SP011062$STRIDES$Priya L, Alamanda VA, Javali M, Acharya P, Rangaiah P, Nagabushana D.. Gabapentin-induced Multifocal Myoclonus.. The Journal of the Association of Physicians of India.. 2024;72(8):78-9.$66$YR$$M$Y$$$20240910$$MD$IN$IN
243004571$24300457$1$I$20240905$20240906$20240910$20240910$30DAY$$US-SANDOZ INC.-SDZ2024US078485$SANDOZ$$10$YR$$M$Y$$$20240910$$CN$US$US
243004581$24300458$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004425$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243004592$24300459$2$F$$20240916$20240910$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409005151$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240918$$CN$US$US
243004601$24300460$1$I$$20240902$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142934$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$55$YR$A$M$Y$$$20240910$$HP$US$US
243004613$24300461$3$F$$20240913$20240910$20240927$PER$$US-AMGEN-USASP2024178258$AMGEN$$$$$$Y$$$20240927$$HP$US$US
243004621$24300462$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179487$AMGEN$$$$$$Y$$$20240909$$HP$US$US
243004631$24300463$1$I$$20240827$20240910$20240910$EXP$$ZA-CIPLA LTD.-2024ZA09601$CIPLA$$$$$$Y$$$20240910$$CN$ZA$ZA
243004641$24300464$1$I$$20240906$20240910$20240910$EXP$$US-AstraZeneca-2024A204367$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243004651$24300465$1$I$$20240903$20240910$20240910$PER$$US-AMGEN-USASP2024176951$AMGEN$Karabukayeva A.; Hearld L. R.;  Choi S.et.al. Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights and Future Considerations. Journal of rheumatology. 2024;51 (8):798-803$58$YR$A$F$Y$$$20240909$$MD$US$US
243004661$24300466$1$I$20240101$20240903$20240910$20240910$EXP$$US-ABBVIE-5817233$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243004671$24300467$1$I$20240901$20240902$20240910$20240910$EXP$$PT-ABBVIE-5907173$ABBVIE$$88$YR$$F$Y$$$20240910$$CN$PT$PT
243004681$24300468$1$I$$20240902$20240910$20240910$EXP$$DE-Indoco-000608$INDOCO$Gallinger A, Osei-Davies R, Hennersdorf F. Reversibilitat einer kritischen intraventrikularen Leitungsverzogerung unter Flecainid und Lacosamid durch Natriumbicarbonat (Reversibility of a critical intraventricular conduction delay under flecainide and lacosamide by sodium bicarbonate). Inn Med (Heidelb). 2024 Aug 21. German.$72$YR$E$F$Y$$$20240909$$MD$DE$DE
243004691$24300469$1$I$$20240904$20240910$20240910$PER$$US-ABBVIE-5913866$ABBVIE$$$$A$F$Y$$$20240910$$HP$US$US
243004701$24300470$1$I$$20240906$20240910$20240910$PER$$US-ABBVIE-5914844$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243004712$24300471$2$F$$20240912$20240910$20240916$PER$$US-ABBVIE-5909557$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243004721$24300472$1$I$$20240822$20240910$20240910$PER$$US-ASTELLAS-2024-AER-002449$ASTELLAS$$68$YR$E$F$Y$$$20240910$$CN$US$US
243004731$24300473$1$I$$20240904$20240910$20240910$EXP$$NVSC2024CO001533$NOVARTIS$$$$$F$Y$70$KG$20240910$$CN$CO$CO
243004741$24300474$1$I$$20240829$20240910$20240910$PER$$US-ABBVIE-5902925$ABBVIE$$$$$$Y$$$20240910$$CN$US$US
243004751$24300475$1$I$$20240902$20240910$20240910$EXP$$CA-HALEON-2195122$Haleon PLC$$43$YR$$F$Y$96$KG$20240909$$HP$CA$CA
243004761$24300476$1$I$$20240905$20240910$20240910$PER$$US-ROCHE-10000075835$ROCHE$$$$$$Y$$$20240910$$PH$US$US
243004771$24300477$1$I$$20240901$20240910$20240910$EXP$$JP-SKF-000139$ESKAYEF PHARMACEUTICALS$$50$YR$A$M$Y$107$KG$20240904$$HP$JP$JP
243004781$24300478$1$I$20240816$20240902$20240910$20240910$EXP$GB-MHRA-MED-202409021204518000-RTGMF$GB-GE HEALTHCARE-2024CSU010124$GE HEALTHCARE$$73$YR$$M$Y$$$20240910$$HP$GB$GB
243004793$24300479$3$F$$20240827$20240910$20240912$EXP$$FR-GE HEALTHCARE-2024CSU009848$GE HEALTHCARE$$$$$$Y$$$20240912$$HP$FR$FR
243004801$24300480$1$I$20240829$20240830$20240910$20240910$EXP$$IN-GE HEALTHCARE-2024CSU010045$GE HEALTHCARE$$25$YR$$M$Y$70$KG$20240910$$HP$IN$IN
243004811$24300481$1$I$20240906$20240906$20240910$20240910$EXP$$US-ABBVIE-5914156$ABBVIE$$77$YR$$F$Y$$$20240910$$CN$US$US
243004822$24300482$2$F$20240906$20240909$20240910$20240911$PER$$US-AMGEN-USASP2024178747$AMGEN$$68$YR$E$M$Y$$$20240910$$CN$US$US
243004831$24300483$1$I$20240905$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179433$AMGEN$$68$YR$E$F$Y$$$20240909$$HP$US$US
243004841$24300484$1$I$$20240904$20240910$20240910$EXP$$US-AMGEN-USASP2024177106$AMGEN$Shahid M.; Dinov D.; Brenton J. et al.. Clinical Response to Late-Stage Cyclophosphamide in a Child With Refractory N-Methyl-d-Aspartate Receptor Encephalitis. Pediatric Neurology. 2024;160:8-10$13$YR$T$F$Y$$$20240909$$MD$US$US
243004852$24300485$2$F$$20240827$20240910$20240910$PER$$US-ASTELLAS-2024-AER-003151$ASTELLAS$$7$DEC$E$M$Y$$$20240910$$HP$US$US
243004861$24300486$1$I$$20240909$20240910$20240910$EXP$$DE-SANDOZ INC.-SDZ2024DE078568$SANDOZ$$70$YR$$F$Y$$$20240910$$MD$DE$DE
243004871$24300487$1$I$$20240827$20240910$20240910$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011026$STRIDES$Kawamura H, Sobue S, Harada T, Yamamoto Y, Kumai D, Ikeuchi H, et al.. De novo hepatitis B in a patient with negative hepatitis B core antibody and high normal range hepatitis B surface antibody treated with R-CHOP therapy for Diffuse large B-cell lymphoma. Kanzo/Acta Hepatologica Japonica. 2024;65(7):336-42$8$DEC$$F$Y$51.5$KG$20240910$$MD$JP$JP
243004881$24300488$1$I$20240801$20240906$20240910$20240910$EXP$$NVSJ2024JP010673$NOVARTIS$$70$YR$$M$Y$$$20240910$$MD$JP$JP
243004891$24300489$1$I$$20240828$20240910$20240910$EXP$$US-Accord-444863$ACCORD$$53$YR$A$M$Y$$$20240909$$PH$US$US
243004901$24300490$1$I$$20240904$20240910$20240910$EXP$$US-JNJFOC-20240908291$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$MD$US$US
243004911$24300491$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000413US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243004921$24300492$1$I$20240101$20240905$20240910$20240910$EXP$$ZA-ABBVIE-5914838$ABBVIE$$79$YR$$F$Y$$$20240910$$HP$ZA$ZA
243004931$24300493$1$I$20240425$20240905$20240910$20240910$EXP$ES-AEMPS-1515834$ES-ABBVIE-5908688$ABBVIE$$10$YR$$M$Y$42$KG$20240910$$MD$ES$ES
243004941$24300494$1$I$20240813$20240903$20240910$20240910$EXP$$FR-AstraZeneca-2024A199933$ASTRAZENECA$$72$YR$$F$Y$63$KG$20240910$$MD$FR$
243004951$24300495$1$I$$20240905$20240910$20240910$EXP$$DE-ABBVIE-5908611$ABBVIE$$8$DEC$$$Y$$$20240910$$MD$DE$DE
243004961$24300496$1$I$$20240902$20240910$20240910$EXP$$JP-AstraZeneca-2024A201746$ASTRAZENECA$$74$YR$$F$Y$$$20240910$$MD$JP$
243004971$24300497$1$I$20240601$20240828$20240910$20240910$PER$$US-AstraZeneca-2024A197028$ASTRAZENECA$$49$YR$$F$Y$99.8$KG$20240910$$MD$US$
243004981$24300498$1$I$20240620$20240821$20240910$20240910$PER$$US-AstraZeneca-2024A145155$ASTRAZENECA$$21739$DY$$M$Y$$$20240910$$CN$US$
243004991$24300499$1$I$$20240903$20240910$20240910$EXP$$US-ABBVIE-5906997$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243005001$24300500$1$I$$20240904$20240910$20240910$PER$$US-AstraZeneca-2024A202755$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243005011$24300501$1$I$20240812$20240820$20240910$20240910$PER$$US-TOLMAR, INC.-24US051826$TOLMAR$$81$YR$$M$Y$$$20240910$$HP$US$US
243005031$24300503$1$I$$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024178923$AMGEN$$$$$$Y$$$20240909$$HP$US$US
243005041$24300504$1$I$$20240830$20240910$20240910$EXP$$CA-ABBVIE-5908671$ABBVIE$$58$YR$$M$Y$$$20240910$$HP$CA$CA
243005051$24300505$1$I$20240828$20240903$20240910$20240910$EXP$$EC-EMD Serono-2024048062$EMD SERONO INC$$4$YR$C$M$Y$$$20240910$$CN$EC$EC
243005061$24300506$1$I$$20240830$20240910$20240910$EXP$$JP-ASTELLAS-2024-AER-003489$ASTELLAS$$94$YR$E$F$Y$$$20240910$$PH$JP$JP
243005081$24300508$1$I$$20240902$20240910$20240910$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011363$STRIDES$Morikawa K, Otsuka T, Moriwaki S.. Two Cases of Advanced Stage Merkel Cell Carcinoma Treated with Avelumab Immunotherapy. [Japanese].. Skin-Res. 2023;22 (2):126-132$58$YR$$F$Y$$$20240910$$MD$JP$JP
243005091$24300509$1$I$$20240826$20240910$20240910$EXP$$CN-SUPERNUS Pharmaceuticals, Inc.-SUP202408-003240$SUPERNUS$$16$YR$$M$Y$$$20240910$$HP$CN$
243005101$24300510$1$I$$20240904$20240910$20240910$EXP$$US-TAKEDA-2024TUS089573$TAKEDA$$$$$F$Y$$$20240910$$HP$US$US
243005111$24300511$1$I$$20240904$20240910$20240910$EXP$$CA-LUNDBECK-DKLU4002930$LUNDBECK$$$$$$Y$$$20240910$$CN$CA$CA
243005121$24300512$1$I$$20240909$20240910$20240910$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050318$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240910$$MD$US$US
243005141$24300514$1$I$20240101$20240619$20240910$20240910$PER$$US-LUNDBECK-DKLU4004042$LUNDBECK$$$$$$Y$$$20240910$$CN$US$US
243005151$24300515$1$I$20240101$20240903$20240910$20240910$EXP$$JP-ABBVIE-5906538$ABBVIE$$77$YR$$F$Y$$$20240910$$CN$JP$JP
243005161$24300516$1$I$$20240902$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142938$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$28$YR$A$F$Y$$$20240910$$HP$US$US
243005171$24300517$1$I$$20240902$20240910$20240910$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011352$STRIDES$Tao R, Liu C, Zhang W, Zhu Y, Ma Y, Hao S.. Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade.. Oncologist. 2024;29:E90-E96$55$YR$$M$Y$$$20240910$$HP$CN$CN
243005181$24300518$1$I$$20240902$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142935$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$55$YR$A$F$Y$$$20240910$$HP$US$US
243005191$24300519$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142376$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240910$$HP$US$US
243005201$24300520$1$I$20240729$20240729$20240910$20240910$PER$$US-LUNDBECK-DKLU4002356$LUNDBECK$$$$$$Y$$$20240910$$MD$US$US
243005211$24300521$1$I$20240601$20240828$20240910$20240910$EXP$$US-NOVOPROD-1276968$NOVO NORDISK$$60$YR$$F$Y$$$20240910$$CN$US$US
243005221$24300522$1$I$20220101$20240827$20240910$20240910$EXP$$US-NOVOPROD-1276555$NOVO NORDISK$$53$YR$$F$Y$$$20240910$$CN$US$US
243005231$24300523$1$I$$20240729$20240910$20240910$PER$$US-LUNDBECK-DKLU4002360$LUNDBECK$$$$$$Y$$$20240910$$HP$US$US
243005243$24300524$3$F$20240905$20240920$20240910$20240921$PER$$US-AMGEN-USASP2024178332$AMGEN$$47$YR$A$F$Y$$$20240921$$HP$US$US
243005251$24300525$1$I$20240101$20240904$20240910$20240910$PER$$US-ABBVIE-5907759$ABBVIE$$$$A$F$Y$$$20240910$$MD$US$US
243005261$24300526$1$I$$20240812$20240910$20240910$PER$$US-009507513-2408USA005296$MERCK$$$$C$$Y$$$20240910$$HP$US$US
243005271$24300527$1$I$$20240903$20240910$20240910$EXP$$US-AstraZeneca-2024A202202$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
243005281$24300528$1$I$$20240904$20240910$20240910$PER$$US-AstraZeneca-2024A201484$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243005291$24300529$1$I$$20240830$20240910$20240910$EXP$$DK-ASTELLAS-2024EU004206$ASTELLAS$Loft J. Maribavir for the treatment of cytomegalovirus infection in a liver transplant patient. Ugeskr Laeger. 2024;186: 1457-1548.$49$YR$A$M$Y$$$20240910$$HP$DK$DK
243005301$24300530$1$I$$20240903$20240910$20240910$EXP$$US-AstraZeneca-2024A200971$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243005311$24300531$1$I$$20240828$20240910$20240910$EXP$$US-NOVOPROD-1278424$NOVO NORDISK$$$$A$$Y$$$20240910$$HP$US$US
243005321$24300532$1$I$20240816$20240828$20240910$20240910$EXP$$US-NOVOPROD-1277662$NOVO NORDISK$$73$YR$$F$Y$$$20240910$$CN$US$US
243005331$24300533$1$I$$20240828$20240910$20240910$EXP$$CO-NOVOPROD-1277575$NOVO NORDISK$$64$YR$$M$Y$100$KG$20240910$$CN$CO$CO
243005341$24300534$1$I$20240101$20240828$20240910$20240910$EXP$$CO-NOVOPROD-1277607$NOVO NORDISK$$64$YR$$M$Y$100$KG$20240910$$CN$CO$CO
243005351$24300535$1$I$20240206$20240828$20240910$20240910$EXP$$CO-NOVOPROD-1277615$NOVO NORDISK$$77$YR$$F$Y$70$KG$20240910$$CN$CO$CO
243005361$24300536$1$I$20210101$20240828$20240910$20240910$EXP$$US-NOVOPROD-1277664$NOVO NORDISK$$84$YR$$F$Y$$$20240910$$CN$US$US
243005371$24300537$1$I$20240501$20240829$20240910$20240910$EXP$CN-NMPA-4403051981222202400669$CN-NOVOPROD-1276909$NOVO NORDISK$$68$YR$$M$Y$76$KG$20240910$$HP$CN$CN
243005381$24300538$1$I$20120101$20240828$20240910$20240910$EXP$$US-NOVOPROD-1278136$NOVO NORDISK$$43$YR$$F$Y$$$20240910$$CN$US$US
243005402$24300540$2$F$20240818$20240906$20240910$20240913$PER$$US-AMGEN-USASP2024178909$AMGEN$$66$YR$E$F$Y$$$20240912$$CN$US$US
243005411$24300541$1$I$$20240904$20240910$20240910$EXP$$NVSC2024DE179866$NOVARTIS$$$$A$$Y$$$20240910$$CN$DE$DE
243005421$24300542$1$I$$20240904$20240910$20240910$PER$$US-AMGEN-USASP2024177489$AMGEN$$$$$F$Y$$$20240909$$CN$US$US
243005432$24300543$2$F$20240822$20240905$20240910$20240917$EXP$$US-NOVOPROD-1276448$NOVO NORDISK$$79$YR$$M$Y$$$20240917$$MD$US$US
243005441$24300544$1$I$20240405$20240829$20240910$20240910$EXP$$GB-NOVOPROD-1276248$NOVO NORDISK$$57$YR$$M$Y$125$KG$20240910$$PH$GB$GB
243005451$24300545$1$I$$20240829$20240910$20240910$EXP$$ES-NOVOPROD-1276977$NOVO NORDISK$$$$$F$Y$$$20240910$$CN$ES$ES
243005461$24300546$1$I$20240101$20240829$20240910$20240910$EXP$$CN-NOVOPROD-1276979$NOVO NORDISK$$$$$F$Y$$$20240910$$CN$CN$CN
243005471$24300547$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA258339$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$CN$US$US
243005481$24300548$1$I$20240101$20240828$20240910$20240910$PER$$US-SA-2024SA259453$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240910$$MD$US$US
243005491$24300549$1$I$$20240902$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142939$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$76$YR$E$M$Y$$$20240910$$HP$US$US
243005501$24300550$1$I$20240801$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004378$ELI LILLY AND CO$$32$YR$A$M$Y$$$20240910$$CN$US$US
243005512$24300551$2$F$20240801$20240905$20240910$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002864$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240917$$CN$US$US
243005521$24300552$1$I$$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408291020178410-JWKBL$GB-Accord-444201$ACCORD$$76$YR$E$M$Y$94$KG$20240910$$CN$GB$GB
243005531$24300553$1$I$20230101$20240829$20240910$20240910$EXP$$AU-NOVOPROD-1277005$NOVO NORDISK$$56$YR$$F$Y$$$20240910$$MD$AU$AU
243005541$24300554$1$I$20230801$20240829$20240910$20240910$EXP$SE-SEMPA-2024-006316$SE-NOVOPROD-1277433$NOVO NORDISK$$39$YR$$F$Y$59$KG$20240910$$CN$SE$SE
243005551$24300555$1$I$20240701$20240829$20240910$20240910$EXP$DE-BFARM-24006049$DE-NOVOPROD-1277438$NOVO NORDISK$$67$YR$$F$Y$78.8$KG$20240910$$MD$DE$DE
243005561$24300556$1$I$20240812$20240829$20240910$20240910$EXP$$US-NOVOPROD-1277260$NOVO NORDISK$$$$A$F$Y$$$20240910$$CN$US$US
243005571$24300557$1$I$20230807$20240829$20240910$20240910$EXP$FR-AFSSAPS-ST2024001333$FR-Accord-444442$ACCORD$$66$YR$E$M$Y$69.9$KG$20240910$$HP$FR$FR
243005581$24300558$1$I$20240801$20240829$20240910$20240910$EXP$$US-NOVOPROD-1277420$NOVO NORDISK$$$$A$F$Y$$$20240910$$CN$US$US
243005591$24300559$1$I$20240101$20240829$20240910$20240910$EXP$BE-FAMHP-DHH-N2024-122562$BE-NOVOPROD-1277404$NOVO NORDISK$$60$YR$$F$Y$75$KG$20240910$$MD$BE$BE
243005601$24300560$1$I$20240101$20240829$20240910$20240910$EXP$DK-DKMA-30738035$DK-NOVOPROD-1277409$NOVO NORDISK$$68$YR$$F$Y$$$20240910$$MD$DK$DK
243005611$24300561$1$I$$20240829$20240910$20240910$EXP$$ES-NOVOPROD-1276995$NOVO NORDISK$$$$$F$Y$$$20240910$$CN$ES$ES
243005621$24300562$1$I$$20240905$20240910$20240910$PER$$NVSC2024US179706$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
243005632$24300563$2$F$20240902$20240909$20240910$20240911$PER$$US-AMGEN-USASP2024178752$AMGEN$$65$YR$E$F$Y$$$20240910$$CN$US$US
243005641$24300564$1$I$20240822$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179569$AMGEN$$67$YR$E$M$Y$$$20240909$$CN$US$US
243005651$24300565$1$I$$20240821$20240910$20240910$PER$$US-TEVA-VS-3236289$TEVA$$$$$$Y$$$20240910$$CN$US$US
243005661$24300566$1$I$20200101$20240830$20240910$20240910$EXP$$JP-AMGEN-JPNSP2024034247$AMGEN$$60$YR$A$F$Y$$$20240909$$MD$JP$JP
243005671$24300567$1$I$$20240907$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2024US078519$SANDOZ$$$$$$Y$77$KG$20240910$$CN$US$US
243005681$24300568$1$I$20240801$20240826$20240910$20240910$PER$$US-SA-2024SA259646$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240910$$HP$US$US
243005691$24300569$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA259313$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240910$$MD$US$US
243005701$24300570$1$I$20240819$20240902$20240910$20240910$EXP$$CN-BEIGENE-BGN-2024-013877$BEIGENE$$$$$$Y$$$20240910$$HP$CN$CN
243005711$24300571$1$I$$20240905$20240910$20240910$30DAY$$US-SANDOZ INC.-SDZ2023US049938$SANDOZ$$$$$M$Y$$$20240910$$CN$US$US
243005721$24300572$1$I$$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408291146371510-GMSLN$GB-Accord-444378$ACCORD$$59$YR$A$M$Y$$$20240910$$HP$GB$GB
243005731$24300573$1$I$20240827$20240902$20240910$20240910$EXP$$CN-AstraZeneca-2024A201261$ASTRAZENECA$$52$YR$$M$Y$70.1$KG$20240910$$MD$CN$
243005741$24300574$1$I$20240806$20240904$20240910$20240910$EXP$$CN-JNJFOC-20240911646$JOHNSON AND JOHNSON$$68$YR$E$M$Y$58.5$KG$20240910$$HP$CN$CN
243005751$24300575$1$I$$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202820$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243005771$24300577$1$I$$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202882$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
243005783$24300578$3$F$20240904$20240925$20240910$20240926$EXP$$MY-BRISTOL-MYERS SQUIBB COMPANY-2024-142651$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240926$$MD$MY$MY
243005791$24300579$1$I$$20240902$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142940$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$48$YR$A$M$Y$$$20240910$$HP$US$US
243005801$24300580$1$I$$20240904$20240910$20240910$PER$$US-BEIGENE-BGN-2024-014157$BEIGENE$$$$$$Y$$$20240910$$CN$US$US
243005811$24300581$1$I$$20240826$20240910$20240910$PER$$US-ASTELLAS-2024-AER-003203$ASTELLAS$$$$$M$Y$$$20240910$$CN$US$US
243005821$24300582$1$I$$20240715$20240910$20240910$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-458838$RANBAXY$$$$C$M$Y$$$20240910$$CN$US$US
243005831$24300583$1$I$20240501$20240906$20240910$20240910$PER$$US-ALXN-202409USA000468US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243005841$24300584$1$I$20240831$20240904$20240910$20240910$EXP$$US-HALEON-2195430$Haleon PLC$$52$YR$$F$Y$$$20240909$$CN$US$US
243005851$24300585$1$I$$20240904$20240910$20240910$EXP$$JP-GSK-JP2024JPN077320$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$PH$JP$JP
243005862$24300586$2$F$20240828$20240901$20240910$20240911$EXP$$CN-JNJFOC-20240906804$JOHNSON AND JOHNSON$$6$YR$C$M$Y$18$KG$20240911$$HP$CN$CN
243005871$24300587$1$I$$20240905$20240910$20240910$EXP$$US-JNJFOC-20240911961$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$PH$US$US
243005881$24300588$1$I$20240824$20240902$20240910$20240910$EXP$$CN-BEIGENE-BGN-2024-013875$BEIGENE$$$$$$Y$$$20240910$$HP$CN$CN
243005893$24300589$3$F$20240902$20240904$20240910$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027560$UNITED THERAPEUTICS$$64$YR$$F$Y$68.481$KG$20240913$$$US$US
243005911$24300591$1$I$20240101$20240828$20240910$20240910$PER$$US-SA-2024SA258715$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240910$$HP$US$US
243005921$24300592$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259207$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240910$$HP$US$US
243005931$24300593$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA259520$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240910$$MD$US$US
243005941$24300594$1$I$20240704$20240903$20240910$20240910$EXP$$CN-BEIGENE-BGN-2024-013966$BEIGENE$$$$$$Y$$$20240910$$HP$CN$CN
243005951$24300595$1$I$$20240906$20240910$20240910$PER$$US-ABBVIE-5914035$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243005961$24300596$1$I$20240528$20240905$20240910$20240910$EXP$FR-AFSSAPS-DJ2024000934$FR-Alcon Laboratories-ALC2024FR004127$ALCON$$$$$$Y$$$20240910$$HP$FR$FR
243005971$24300597$1$I$20240101$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142379$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240910$$HP$US$US
243005982$24300598$2$F$20240826$20240827$20240910$20240917$30DAY$$US-JNJFOC-20240869953$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$HP$US$US
243005991$24300599$1$I$$20240904$20240910$20240910$EXP$$JP-SANDOZ INC.-SDZ2024JP077933$SANDOZ$Hayashi K, Tanaka H, Shibata T,  Kondo E, Sakai H, Kurita H. A case of asystole caused by trigeminocardiac reflex possibly due to the invasiveness of dental local anesthesia. Program of the 33rd General Meeting and Academic Conference of the Japanese Soci. 2024;O13-2$68$YR$$F$Y$$$20240910$$MD$JP$JP
243006002$24300600$2$F$20240902$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024179470$AMGEN$$52$YR$A$$Y$$$20240910$$CN$US$US
243006011$24300601$1$I$20240317$20240829$20240910$20240910$EXP$FR-AFSSAPS-PO2024000872$FR-Accord-444589$ACCORD$$1$DY$N$M$Y$2.26$KG$20240910$$HP$FR$FR
243006021$24300602$1$I$$20240827$20240910$20240910$EXP$$JP-UCBSA-2024044251$UCB$$$$$$Y$$$20240910$$PH$JP$JP
243006031$24300603$1$I$$20240902$20240910$20240910$EXP$$NVSC2024IN178537$NOVARTIS$$80$YR$$F$Y$$$20240910$$CN$IN$IN
243006042$24300604$2$F$$20240909$20240910$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004749$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243006051$24300605$1$I$20240801$20240823$20240910$20240910$PER$$US-SA-2024SA258882$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240910$$HP$US$US
243006061$24300606$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260696$SANOFI AVENTIS$$11$YR$C$M$Y$31.746$KG$20240910$$HP$US$US
243006071$24300607$1$I$20240701$20240828$20240910$20240910$PER$$US-SA-2023SA053621$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240910$$MD$US$US
243006081$24300608$1$I$20230101$20240905$20240910$20240910$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-258150$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$126$KG$20240910$$CN$CA$CA
243006091$24300609$1$I$$20240729$20240910$20240910$PER$$US-LUNDBECK-DKLU4002361$LUNDBECK$$$$$$Y$$$20240910$$HP$US$US
243006102$24300610$2$F$$20240909$20240910$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005073$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243006111$24300611$1$I$$20240826$20240910$20240910$PER$$US-SA-2024SA259623$SANOFI AVENTIS$$$$A$M$Y$$$20240910$$MD$US$US
243006121$24300612$1$I$20240830$20240830$20240910$20240910$EXP$$RU-ROCHE-10000072544$ROCHE$$35$YR$A$F$Y$$$20240910$$CN$RU$RU
243006131$24300613$1$I$$20240828$20240910$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-043389$AUROBINDO$Reinfeld S, Gill P. Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: A case series. CNS-Spectrums. 2023;28(5):587-591$15$YR$$M$Y$$$20240910$$HP$US$US
243006141$24300614$1$I$$20240829$20240910$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-044034$AUROBINDO$$78$YR$$M$Y$70.3$KG$20240910$$PH$CA$CA
243006151$24300615$1$I$$20240902$20240910$20240910$EXP$$US-AMGEN-USASP2024176964$AMGEN$Peshin S.; Modi S.; Kolagatla S. et al.. An Unusual Case of Renal Infiltration in Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S340-S341$67$YR$E$F$Y$$$20240909$$HP$US$US
243006161$24300616$1$I$$20240902$20240910$20240910$PER$$US-LEO Pharma-373280$LEO PHARM$$25$YR$$F$Y$$$20240910$$PH$US$US
243006171$24300617$1$I$$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408290747098060-WLRBT$GB-Accord-444371$ACCORD$$59$YR$A$$Y$$$20240910$$CN$GB$GB
243006181$24300618$1$I$20240701$20240828$20240910$20240910$EXP$$US-UCBSA-2024044105$UCB$$46$YR$$F$Y$$$20240910$$HP$US$US
243006191$24300619$1$I$$20240828$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137784$BRISTOL MYERS SQUIBB$$29$YR$A$M$Y$66.68$KG$20240910$$CN$US$US
243006202$24300620$2$F$20240831$20240909$20240910$20240911$PER$$US-AMGEN-USASP2024179093$AMGEN$$79$YR$E$F$Y$$$20240911$$CN$US$US
243006212$24300621$2$F$20240905$20240909$20240910$20240911$PER$$US-AMGEN-USASP2024179390$AMGEN$$62$YR$A$F$Y$$$20240910$$HP$US$US
243006231$24300623$1$I$20240726$20240828$20240910$20240910$PER$$US-SA-2024SA259351$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240910$$CN$US$US
243006241$24300624$1$I$20240801$20240827$20240910$20240910$PER$$US-SA-2024SA259798$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240910$$HP$US$US
243006251$24300625$1$I$$20240826$20240910$20240910$PER$$US-SA-2024SA259506$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$MD$US$US
243006262$24300626$2$F$$20240911$20240910$20240923$PER$$US-ASTELLAS-2024-AER-003587$ASTELLAS$$45$YR$A$F$Y$$$20240923$$HP$US$US
243006271$24300627$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009928$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243006282$24300628$2$F$$20240910$20240910$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003691$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243006291$24300629$1$I$20200101$20240906$20240910$20240910$EXP$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US001146$PAREXEL$$$$$F$Y$$$20240910$$CN$US$US
243006301$24300630$1$I$$20240831$20240910$20240910$EXP$$JP-AMGEN-JPNSP2024177676$AMGEN$$$$$F$Y$$$20240909$$MD$JP$JP
243006311$24300631$1$I$20130827$20240906$20240910$20240910$EXP$$US-ASTELLAS-2024-AER-005410$ASTELLAS$$$$$F$Y$$$20240910$$HP$US$US
243006332$24300633$2$F$20240101$20240903$20240910$20240911$EXP$$CA-CELLTRION INC.-2024CA021436$CELLTRION$$$$$$Y$$$20240911$$CN$CA$CA
243006341$24300634$1$I$$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202898$ASTRAZENECA$$$$$$Y$$$20240910$$MD$US$
243006362$24300636$2$F$$20240902$20240910$20240912$EXP$$GB-AMGEN-GBRSP2024175455$AMGEN$$$$$F$Y$$$20240912$$CN$GB$GB
243006371$24300637$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179386$AMGEN$$$$$$Y$$$20240909$$PH$US$US
243006382$24300638$2$F$20240828$20240907$20240910$20240912$PER$$US-AMGEN-USASP2024179308$AMGEN$$45$YR$A$F$Y$$$20240912$$CN$US$US
243006391$24300639$1$I$$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202541$ASTRAZENECA$$$$$F$Y$57$KG$20240910$$CN$US$
243006401$24300640$1$I$20240828$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202570$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
243006411$24300641$1$I$$20240903$20240910$20240910$EXP$$US-AstraZeneca-2024A201004$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243006422$24300642$2$F$$20240909$20240910$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004990$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
243006431$24300643$1$I$20240729$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004752$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240910$$CN$US$US
243006441$24300644$1$I$20240816$20240902$20240910$20240910$EXP$$CN-BEIGENE-BGN-2024-013883$BEIGENE$$$$$$Y$$$20240910$$HP$CN$CN
243006451$24300645$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142307$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240910$$HP$US$US
243006461$24300646$1$I$$20240905$20240910$20240910$EXP$$MY-BRISTOL-MYERS SQUIBB COMPANY-2024-142813$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240910$$MD$MY$MY
243006471$24300647$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004501$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240910$$CN$US$US
243006482$24300648$2$F$20240903$20240910$20240910$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202312007989$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240917$$CN$US$US
243006491$24300649$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004860$ELI LILLY AND CO$$21$YR$A$$Y$$$20240910$$CN$US$US
243006501$24300650$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004824$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240910$$CN$US$US
243006511$24300651$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004877$ELI LILLY AND CO$$$$$$Y$$$20240910$$CN$US$US
243006521$24300652$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004644$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240910$$CN$US$US
243006531$24300653$1$I$$20240902$20240910$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142885$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240910$$CN$JP$JP
243006541$24300654$1$I$$20240904$20240910$20240910$PER$$US-ABBVIE-5910069$ABBVIE$$$$$$Y$$$20240910$$CN$US$US
243006551$24300655$1$I$20240701$20240829$20240910$20240910$PER$$US-SA-2024SA259221$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240910$$CN$US$US
243006561$24300656$1$I$20240801$20240827$20240910$20240910$PER$$US-SA-2024SA259759$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240910$$HP$US$US
243006571$24300657$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA055895$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240910$$HP$US$US
243006582$24300658$2$F$20240101$20240918$20240910$20240928$PER$$US-SA-2024SA258944$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240928$$MD$US$US
243006591$24300659$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA259392$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240910$$MD$US$US
243006602$24300660$2$F$20240829$20240912$20240910$20240921$EXP$$US-AUROBINDO-AUR-APL-2024-044382$AUROBINDO$$24$YR$$M$Y$$$20240921$$HP$US$US
243006612$24300661$2$F$20240905$20240911$20240910$20240920$EXP$$ZA-CELLTRION INC.-2024ZA015776$CELLTRION$$$$$$Y$$$20240920$$CN$ZA$ZA
243006621$24300662$1$I$$20240828$20240910$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-043151$AUROBINDO$Tanas R, Shah V, Henderson C. The classic ?Rat-Bite? erosions in gouty arthritis with normal uric acid levels. American Journal of the Medical Sciences. 2024;368 (3):e27-8$82$YR$$M$Y$$$20240910$$MD$US$US
243006631$24300663$1$I$$20240830$20240910$20240910$PER$$US-CHATTEMPRD-2024OHG030913$CHATTEM$$$$$M$Y$$$20240910$$CN$US$US
243006641$24300664$1$I$$20240829$20240910$20240910$EXP$$CA-GSK-CA2023174602$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$CA$CA
243006651$24300665$1$I$20240101$20240903$20240910$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-027728$UNITED THERAPEUTICS$$$$$F$Y$62.132$KG$20240910$$$US$US
243006661$24300666$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004757$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243006671$24300667$1$I$$20240904$20240910$20240910$PER$$US-JNJFOC-20240915581$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$HP$US$US
243006691$24300669$1$I$$20240903$20240910$20240910$PER$$US-CHATTEMPRD-2024OHG030926$CHATTEM$$$$$F$Y$$$20240910$$CN$US$US
243006701$24300670$1$I$20240807$20240903$20240910$20240910$EXP$$CN-BEIGENE-BGN-2024-013965$BEIGENE$$$$$$Y$$$20240910$$HP$CN$CN
243006711$24300671$1$I$$20240828$20240910$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-043391$AUROBINDO$Tatari A, Moore P, Singh A.. NATIVE AORTIC VALVE THROMBUS CAUSING TRANSIENT ISCHEMIC ATTACKS AND SUDDEN CARDIAC ARREST. J-Am-Coll-Cardiol. 2019;73 (Suppl.1)(9):2376$48$YR$$F$Y$$$20240910$$HP$US$US
243006721$24300672$1$I$$20240903$20240910$20240910$EXP$$US-PIRAMAL CRITICAL CARE LIMITED-2024-PPL-000655$PIRAMAL$$$$$$Y$$$20240910$$HP$US$US
243006732$24300673$2$F$20240826$20240909$20240910$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004597$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240927$$CN$US$US
243006741$24300674$1$I$$20240903$20240910$20240910$PER$$US-CHATTEMPRD-2024OHG030718$CHATTEM$$90$YR$E$M$Y$$$20240910$$CN$US$US
243006753$24300675$3$F$20240901$20240920$20240910$20240927$PER$$US-CHATTEMPRD-2024OHG030871$CHATTEM$$$$$F$Y$$$20240927$$CN$US$US
243006762$24300676$2$F$$20240912$20240910$20240924$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004776$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243006771$24300677$1$I$20240125$20240830$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-043843$AUROBINDO$$61$YR$$M$Y$75$KG$20240910$$PH$FR$FR
243006782$24300678$2$F$$20240913$20240910$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004769$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243006792$24300679$2$F$20240207$20240904$20240910$20240913$EXP$$MX-NOVOPROD-1277660$NOVO NORDISK$$30$YR$$F$Y$108$KG$20240913$$CN$MX$MX
243006801$24300680$1$I$20240812$20240829$20240910$20240910$EXP$$US-NOVOPROD-1277679$NOVO NORDISK$$77$YR$$F$Y$$$20240910$$CN$US$US
243006811$24300681$1$I$$20240829$20240910$20240910$EXP$$JP-NOVOPROD-1277677$NOVO NORDISK$$$$$M$Y$$$20240910$$CN$JP$JP
243006821$24300682$1$I$$20240829$20240910$20240910$EXP$$ES-NOVOPROD-1277774$NOVO NORDISK$$$$$F$Y$$$20240910$$CN$ES$ES
243006831$24300683$1$I$$20240829$20240910$20240910$EXP$$US-NOVOPROD-1277709$NOVO NORDISK$$$$$M$Y$$$20240910$$CN$US$US
243006841$24300684$1$I$$20240829$20240910$20240910$EXP$$ES-NOVOPROD-1277674$NOVO NORDISK$$14$YR$$F$Y$$$20240910$$CN$ES$ES
243006851$24300685$1$I$20240825$20240829$20240910$20240910$EXP$$US-NOVOPROD-1277771$NOVO NORDISK$$72$YR$$F$Y$$$20240910$$CN$US$US
243006861$24300686$1$I$$20240829$20240910$20240910$EXP$$US-NOVOPROD-1277798$NOVO NORDISK$$$$$$Y$$$20240910$$CN$US$US
243006871$24300687$1$I$$20240829$20240910$20240910$EXP$$US-NOVOPROD-1277704$NOVO NORDISK$$$$$$Y$$$20240910$$CN$US$US
243006881$24300688$1$I$$20240829$20240910$20240910$EXP$$CA-NOVOPROD-1277746$NOVO NORDISK$$$$$M$Y$$$20240910$$MD$CA$CA
243006891$24300689$1$I$20240827$20240829$20240910$20240910$EXP$$US-NOVOPROD-1277718$NOVO NORDISK$$$$$M$Y$$$20240910$$CN$US$US
243006901$24300690$1$I$20240201$20240906$20240910$20240910$EXP$$CN-ROCHE-10000076474$ROCHE$$46$YR$A$F$Y$$$20240910$$HP$CN$CN
243006911$24300691$1$I$20240726$20240830$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-043860$AUROBINDO$$18$YR$$F$Y$$$20240910$$MD$FR$FR
243006931$24300693$1$I$$20240905$20240910$20240910$PER$$NVSC2024US179699$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243006941$24300694$1$I$20240309$20240909$20240910$20240910$EXP$FR-AFSSAPS-PA2024001385$FR-SANDOZ INC.-SDZ2024FR078748$SANDOZ$$43$YR$$M$Y$69$KG$20240910$$MD$FR$FR
243006961$24300696$1$I$$20240829$20240910$20240910$EXP$$US-NOVOPROD-1278309$NOVO NORDISK$$$$$F$Y$$$20240910$$CN$US$US
243006971$24300697$1$I$$20240829$20240910$20240910$EXP$$US-NOVOPROD-1278419$NOVO NORDISK$$$$$M$Y$$$20240910$$CN$US$US
243006981$24300698$1$I$$20240829$20240910$20240910$EXP$$US-NOVOPROD-1278434$NOVO NORDISK$$$$$F$Y$$$20240910$$CN$US$US
243007001$24300700$1$I$$20240905$20240910$20240910$PER$$NVSC2024US179489$NOVARTIS$$$$$F$Y$$$20240910$$CN$US$US
243007011$24300701$1$I$20240101$20240902$20240910$20240910$EXP$$JP-GENMAB-2024-03179$GENMAB$$61$YR$$M$Y$$$20240910$$MD$JP$JP
243007021$24300702$1$I$20240714$20240829$20240910$20240910$EXP$FR-AFSSAPS-PV2024000779$FR-Accord-444604$ACCORD$$69$YR$E$M$Y$100$KG$20240910$$MD$FR$FR
243007031$24300703$1$I$20240808$20240831$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044149$AUROBINDO$$46$YR$$F$Y$58$KG$20240910$$MD$FR$FR
243007041$24300704$1$I$$20240816$20240910$20240910$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004777$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243007051$24300705$1$I$20240801$20240904$20240910$20240910$EXP$$US-GSK-US2024AMR111029$GLAXOSMITHKLINE$$$$$F$Y$$$20240910$$CN$US$US
243007061$24300706$1$I$$20240903$20240910$20240910$EXP$$BR-JNJFOC-20240913003$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$MD$BR$BR
243007071$24300707$1$I$$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408291202511180-TJQBY$GB-Accord-444380$ACCORD$$73$YR$E$F$Y$$$20240910$$HP$GB$GB
243007081$24300708$1$I$20240808$20240909$20240910$20240910$EXP$FR-AFSSAPS-TS2024000948$FR-UCBSA-2024046025$UCB$$46$YR$$F$Y$58$KG$20240910$$MD$FR$FR
243007091$24300709$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004824$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240910$$HP$US$US
243007101$24300710$1$I$$20240905$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142312$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240910$$CN$US$US
243007111$24300711$1$I$20240829$20240831$20240910$20240910$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005209$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20240910$$CN$US$US
243007121$24300712$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004799$ELI LILLY AND CO$$$$A$F$Y$$$20240910$$CN$US$US
243007131$24300713$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA079456$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240910$$MD$US$US
243007141$24300714$1$I$20240801$20240829$20240910$20240910$PER$$US-SA-2024SA260713$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240910$$MD$US$US
243007151$24300715$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259333$SANOFI AVENTIS$$$$$F$Y$$$20240910$$CN$US$US
243007161$24300716$1$I$20240808$20240820$20240910$20240910$PER$$US-SA-2024SA257462$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240910$$CN$US$US
243007171$24300717$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004829$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243007181$24300718$1$I$20240821$20240829$20240910$20240910$EXP$GB-MHRA-TPP27978491C11252216YC1724832219074$GB-Accord-444190$ACCORD$$60$YR$A$M$Y$94$KG$20240910$$MD$GB$GB
243007191$24300719$1$I$20240305$20240906$20240910$20240910$EXP$$NVSJ2024JP008247$NOVARTIS$$87$YR$$M$Y$$$20240910$$MD$JP$JP
243007201$24300720$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004830$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243007211$24300721$1$I$20170401$20240903$20240910$20240910$EXP$$NL-JNJFOC-20240920417$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240910$$MD$NL$NL
243007221$24300722$1$I$20230420$20240904$20240910$20240910$EXP$DE-CADRBFARM-2024329788$DE-ABBVIE-5909401$ABBVIE$$$$$$Y$$$20240910$$CN$DE$DE
243007231$24300723$1$I$$20240903$20240910$20240910$PER$$US-AMGEN-USASP2024176539$AMGEN$$$$A$M$Y$$$20240909$$MD$US$US
243007241$24300724$1$I$20210712$20240829$20240910$20240910$EXP$PL-URPL-DML-MLP.4401.1.5025.2021$PL-Accord-444628$ACCORD$$60$YR$A$M$Y$40$KG$20240910$$HP$PL$PL
243007251$24300725$1$I$20240101$20240902$20240910$20240910$EXP$$JP-GENMAB-2024-03180$GENMAB$$63$YR$$M$Y$$$20240910$$MD$JP$JP
243007261$24300726$1$I$$20240823$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051835$TOLMAR$$$$$M$Y$$$20240910$$CN$CA$CA
243007271$24300727$1$I$$20240821$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA052065$TOLMAR$$$$$M$Y$$$20240910$$CN$CA$CA
243007281$24300728$1$I$20240821$20240821$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA052069$TOLMAR$$81$YR$$M$Y$$$20240910$$CN$CA$CA
243007291$24300729$1$I$$20240821$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA052071$TOLMAR$$$$$M$Y$$$20240910$$CN$CA$CA
243007301$24300730$1$I$20240822$20240822$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051895$TOLMAR$$68$YR$$M$Y$$$20240910$$CN$CA$CA
243007311$24300731$1$I$20240821$20240821$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA052095$TOLMAR$$81$YR$$M$Y$$$20240910$$CN$CA$CA
243007321$24300732$1$I$$20240821$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA052072$TOLMAR$$$$$M$Y$$$20240910$$CN$CA$CA
243007331$24300733$1$I$$20240822$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA052076$TOLMAR$$$$$M$Y$$$20240910$$CN$CA$CA
243007341$24300734$1$I$20240822$20240822$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA052096$TOLMAR$$70$YR$$M$Y$$$20240910$$CN$CA$CA
243007351$24300735$1$I$20240821$20240821$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA052097$TOLMAR$$61$YR$$M$Y$$$20240910$$CN$CA$CA
243007361$24300736$1$I$$20240822$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA052110$TOLMAR$$$$$M$Y$$$20240910$$CN$CA$CA
243007371$24300737$1$I$20240501$20240822$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA052111$TOLMAR$$88$YR$$M$Y$$$20240910$$CN$CA$CA
243007381$24300738$1$I$$20240904$20240910$20240910$PER$$US-009507513-2409USA002274$MERCK$Triantafillou V., Leahy K.. Pembrolizumab-Associated Bullous Pemphigoid with Laryngeal Involvement. Laryngoscope. 2024;00:1-4$69$YR$$M$Y$$$20240910$$MD$US$US
243007392$24300739$2$F$$20240910$20240910$20240913$EXP$$US-ROCHE-10000076650$ROCHE$$78$YR$E$M$Y$$$20240913$$CN$US$US
243007401$24300740$1$I$$20240906$20240910$20240910$PER$$US-JNJFOC-20240917436$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$HP$US$US
243007411$24300741$1$I$20240614$20240905$20240910$20240910$PER$$US-ABBVIE-5914597$ABBVIE$$76$YR$$$Y$52$KG$20240910$$CN$US$US
243007421$24300742$1$I$20240717$20240717$20240910$20240910$PER$$US-ABBVIE-5907321$ABBVIE$$38$YR$$F$Y$$$20240910$$MD$US$US
243007441$24300744$1$I$20240715$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202915$ASTRAZENECA$$26011$DY$$M$Y$$$20240910$$MD$US$
243007451$24300745$1$I$$20240901$20240910$20240910$EXP$GB-MHRA-MIDB-cce2cc13-d54d-40d3-945b-227feddcaf40$GB-DEXPHARM-2024-2991$DEXCEL$$81$YR$E$F$Y$$$20240910$$HP$GB$GB
243007461$24300746$1$I$$20240831$20240910$20240910$EXP$GB-MHRA-MIDB-e3ffbe2f-4c0f-47ec-9c6b-f968b73335b6$GB-DEXPHARM-2024-2982$DEXCEL$$81$YR$E$F$Y$$$20240908$$HP$GB$GB
243007471$24300747$1$I$20240905$20240905$20240910$20240910$EXP$$GB-AstraZeneca-2024A202073$ASTRAZENECA$$52$YR$$F$Y$87$KG$20240910$$MD$GB$
243007481$24300748$1$I$20240816$20240902$20240910$20240910$EXP$$CN-AstraZeneca-2024A201514$ASTRAZENECA$$18968$DY$$F$Y$56$KG$20240910$$MD$CN$
243007491$24300749$1$I$$20240520$20240910$20240910$PER$$US-TERSERA THERAPEUTICS LLC-2024TRS002546$TERSERA THERAPEUTICS$$$$$$Y$$$20240910$$PH$US$US
243007501$24300750$1$I$$20240905$20240910$20240910$EXP$$BE-AMGEN-BELSP2024178235$AMGEN$$$$$M$Y$$$20240909$$MD$BE$BE
243007511$24300751$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA258896$SANOFI AVENTIS$$$$E$M$Y$84.09$KG$20240910$$MD$US$US
243007521$24300752$1$I$$20240831$20240910$20240910$PER$$US-SA-2024SA260609$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240910$$CN$US$US
243007531$24300753$1$I$$20240903$20240910$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-027670$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240910$$$US$US
243007541$24300754$1$I$20240801$20240826$20240910$20240910$PER$$US-SA-2024SA258928$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240910$$HP$US$US
243007551$24300755$1$I$$20240826$20240910$20240910$PER$$US-SA-2024SA259672$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240910$$HP$US$US
243007561$24300756$1$I$$20240829$20240910$20240910$PER$$US-JNJFOC-20240880953$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
243007571$24300757$1$I$20240829$20240829$20240910$20240910$EXP$$US-NOVOPROD-1278529$NOVO NORDISK$$66$YR$$M$Y$$$20240910$$CN$US$US
243007581$24300758$1$I$20240101$20240903$20240910$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-027705$UNITED THERAPEUTICS$$$$$F$Y$140.59$KG$20240910$$$US$US
243007593$24300759$3$F$20240101$20240903$20240910$20240917$EXP$$GB-UCBSA-2024043655$UCB$$$$$F$Y$$$20240917$$CN$GB$GB
243007601$24300760$1$I$20240809$20240903$20240910$20240910$EXP$$CN-BEIGENE-BGN-2024-013962$BEIGENE$$$$$$Y$$$20240910$$HP$CN$CN
243007611$24300761$1$I$20240807$20240904$20240910$20240910$PER$$US-AMGEN-USASP2024177236$AMGEN$$$$$$Y$$$20240909$$HP$US$US
243007624$24300762$4$F$20240906$20240911$20240910$20240919$30DAY$$US-AMGEN-USASP2024179208$AMGEN$$67$YR$E$M$Y$84.5$KG$20240918$$PH$US$US
243007642$24300764$2$F$$20240910$20240910$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004894$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243007651$24300765$1$I$20190101$20240830$20240910$20240910$EXP$$US-NOVOPROD-1277374$NOVO NORDISK$$73$YR$$M$Y$$$20240910$$CN$US$US
243007671$24300767$1$I$20240515$20240830$20240910$20240910$EXP$$CH-NOVOPROD-1272337$NOVO NORDISK$$42$YR$$F$Y$102$KG$20240910$$MD$CH$CH
243007681$24300768$1$I$20240415$20240830$20240910$20240910$EXP$ES-AEMPS-1516831$ES-NOVOPROD-1277508$NOVO NORDISK$$74$YR$$M$Y$116$KG$20240910$$MD$ES$ES
243007691$24300769$1$I$$20240830$20240910$20240910$EXP$$US-NOVOPROD-1277023$NOVO NORDISK$Ernest Oji Kanu et al.. Euglycemic Ketoacidosis After the Addition of Glucagon-Like Peptide-1 Receptor Agonist: A Case Report. Annals of Internal Medicine Clinical cases. 2024;3:1-4$44$YR$$F$Y$$$20240910$$HP$US$US
243007701$24300770$1$I$$20240830$20240910$20240910$EXP$GB-MHRA-MED-202408301448054270-KCMRS$GB-NOVOPROD-1277082$NOVO NORDISK$$$$$F$Y$$$20240910$$CN$GB$GB
243007711$24300771$1$I$20240810$20240830$20240910$20240910$EXP$GB-MHRA-MED-202408301040322580-WFRCY$GB-NOVOPROD-1277172$NOVO NORDISK$$38$YR$$F$Y$71$KG$20240910$$CN$GB$GB
243007722$24300772$2$F$20240101$20240905$20240910$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-023085$UNITED THERAPEUTICS$$$$$M$Y$94.331$KG$20240914$$$US$US
243007731$24300773$1$I$20240426$20240830$20240910$20240910$EXP$SE-SEMPA-2024-006376$SE-NOVOPROD-1277517$NOVO NORDISK$$59$YR$$F$Y$88$KG$20240910$$CN$SE$SE
243007741$24300774$1$I$$20240905$20240910$20240910$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014371$JAZZ$$$$$M$Y$$$20240909$$CN$US$US
243007751$24300775$1$I$$20240903$20240910$20240910$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049168$BOEHRINGER INGELHEIM$MIDDLEDORP ME, CHIANG G, STEFIL M, EVANS S, NGUYEN MT, SHAHMOHAMADI E, et al. Safety of outpatient commencement of sotalol. heart rhythm o2. 2024;(5:6):$69$YR$E$F$Y$$$20240910$$CN$AU$AU
243007761$24300776$1$I$$20240905$20240910$20240910$EXP$$ZA-ROCHE-10000075965$ROCHE$$$$$F$Y$$$20240910$$HP$ZA$ZA
243007771$24300777$1$I$$20240828$20240910$20240910$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08165$HIKMA$Tanas R, Shah V, Henderson C.. Tanas R, Shah V, Henderson C. The classic ^Rat-Bite^ erosions in gouty arthritis with normal uric acid levels.. American Journal of the Medical Sciences.. 2024;368(3):27-28$82$YR$$M$Y$$$20240906$$MD$US$US
243007781$24300778$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000447US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243007791$24300779$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000454US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243007801$24300780$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005115$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243007811$24300781$1$I$20240826$20240826$20240910$20240910$PER$$US-SA-2024SA259732$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240910$$CN$US$US
243007821$24300782$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA259791$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240910$$HP$US$US
243007831$24300783$1$I$20240903$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003550$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240910$$CN$US$US
243007842$24300784$2$F$$20240912$20240910$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409004630$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243007851$24300785$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004822$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240910$$CN$US$US
243007861$24300786$1$I$20240905$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004424$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240910$$CN$US$US
243007881$24300788$1$I$20240905$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004718$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240910$$CN$US$US
243007891$24300789$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003891$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240910$$CN$US$US
243007901$24300790$1$I$$20240830$20240910$20240910$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08201$HIKMA$$$$$$Y$$$20240906$$CN$US$US
243007911$24300791$1$I$20240718$20240905$20240910$20240910$EXP$$GB-AstraZeneca-2024A202367$ASTRAZENECA$$61$YR$$F$Y$73$KG$20240910$$MD$GB$
243007921$24300792$1$I$20240901$20240902$20240910$20240910$EXP$$IL-TAKEDA-2024TUS089189$TAKEDA$$$$$F$Y$$$20240910$$CN$IL$IL
243007931$24300793$1$I$$20240816$20240910$20240910$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004340$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243007942$24300794$2$F$20240101$20240910$20240910$20240911$PER$$US-AMGEN-USASP2024179765$AMGEN$$66$YR$E$F$Y$$$20240910$$CN$US$US
243007951$24300795$1$I$20240301$20240903$20240910$20240910$PER$$US-AMGEN-USASP2024175703$AMGEN$$71$YR$E$F$Y$$$20240909$$CN$US$US
243007971$24300797$1$I$20240712$20240830$20240910$20240910$EXP$$CA-VANTIVE-2024VAN019200$Vantive US Healthcare$$$$$M$Y$$$20240910$$CN$CA$CA
243007981$24300798$1$I$$20240903$20240910$20240910$EXP$$IN-ROCHE-10000073694$ROCHE$$52$YR$A$M$Y$$$20240910$$CN$IN$IN
243007991$24300799$1$I$20240726$20240730$20240910$20240910$PER$$US-AMGEN-USASP2024177551$AMGEN$$$$$$Y$$$20240909$$MD$US$US
243008001$24300800$1$I$20240906$20240906$20240910$20240910$PER$$US-ALXN-202409USA000442US$ALEXION PHARMACEUTICALS$$63$YR$$F$Y$$$20240910$$CN$US$US
243008011$24300801$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000467US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243008022$24300802$2$F$20240101$20240904$20240910$20240918$EXP$$CA-UCBSA-2024043831$UCB$$$$$F$Y$$$20240918$$MD$CA$CA
243008041$24300804$1$I$20240822$20240903$20240910$20240910$EXP$$PK-ROCHE-10000072826$ROCHE$$41$YR$A$M$Y$$$20240910$$CN$PK$PK
243008051$24300805$1$I$20240702$20240906$20240910$20240910$EXP$$CN-JNJFOC-20240919829$JOHNSON AND JOHNSON$$66$YR$E$F$Y$65.5$KG$20240910$$HP$CN$CN
243008061$24300806$1$I$20240704$20240909$20240910$20240910$EXP$GB-MHRA-MED-202409071040229170-TKRFC$GB-SANDOZ INC.-SDZ2024GB078658$SANDOZ$$72$YR$$F$Y$90$KG$20240910$$CN$GB$GB
243008071$24300807$1$I$$20240909$20240910$20240910$EXP$$AT-SANDOZ INC.-SDZ2024AT078744$SANDOZ$$32$YR$$M$Y$$$20240910$$HP$AT$AT
243008081$24300808$1$I$$20240830$20240910$20240910$EXP$GB-MHRA-TPP3893001C22625977YC1724397768199$GB-DEXPHARM-2024-2975$DEXCEL$$67$YR$E$F$Y$52$KG$20240910$$HP$GB$GB
243008101$24300810$1$I$$20240529$20240910$20240910$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450113$RANBAXY$$$$$M$Y$$$20240910$$CN$US$US
243008121$24300812$1$I$20240704$20240903$20240910$20240910$EXP$$GB-009507513-2407GBR012552$MERCK$$27$YR$$F$Y$99$KG$20240910$$HP$GB$GB
243008131$24300813$1$I$$20240905$20240910$20240910$PER$$US-ABBVIE-5913868$ABBVIE$$65$YR$$M$Y$$$20240910$$MD$US$US
243008141$24300814$1$I$$20240829$20240910$20240910$EXP$$AT-Accord-444655$ACCORD$Spanberger T., Therapeutic success in the relapse of multiple myeloma (Therapieerfolg im Rezidiv des Multiplen Myeloms). Spectrum Onkologie, 2024 (Nr. 3): p. 99.$66$YR$E$F$Y$$$20240910$$MD$AT$AT
243008152$24300815$2$F$$20240911$20240910$20240919$30DAY$$US-GSK-US2024109566$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243008163$24300816$3$F$20240821$20240910$20240910$20240927$PER$$US-AMGEN-USASP2024179494$AMGEN$$73$YR$E$F$Y$$$20240927$$CN$US$US
243008171$24300817$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2024SA260613$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240910$$MD$US$US
243008181$24300818$1$I$20240801$20240829$20240910$20240910$PER$$US-SA-2024SA260711$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240910$$MD$US$US
243008191$24300819$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260601$SANOFI AVENTIS$$12$YR$T$M$Y$35.6$KG$20240910$$MD$US$US
243008211$24300821$1$I$$20240826$20240910$20240910$PER$$US-SA-2024SA259706$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240910$$HP$US$US
243008221$24300822$1$I$$20240904$20240910$20240910$PER$$US-ROCHE-10000073438$ROCHE$Ganesh D, Corradetti G, Sadda S. Macular neovascularization in a case of late-onset retinal degeneration treated with aflibercept. Retinal Cases and Brief Reports. 2024-Sep-01;18 (5):633-636. doi:10.1097/ICB.0000000000001439.$72$YR$E$F$Y$$$20240910$$HP$US$US
243008241$24300824$1$I$20220601$20240909$20240910$20240910$EXP$$AT-SANDOZ INC.-SDZ2024AT078540$SANDOZ$$63$YR$$M$Y$$$20240910$$HP$AT$AT
243008251$24300825$1$I$$20240829$20240910$20240910$PER$$US-JNJFOC-20240878107$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
243008262$24300826$2$F$$20240919$20240910$20240924$PER$$US-AMGEN-USASP2024179660$AMGEN$$69$YR$E$F$Y$$$20240923$$CN$US$US
243008271$24300827$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009929$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243008281$24300828$1$I$20240812$20240830$20240910$20240910$EXP$$CN-ROCHE-10000071347$ROCHE$$66$YR$E$M$Y$75$KG$20240910$$HP$CN$CN
243008291$24300829$1$I$$20240902$20240910$20240910$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006643$BIOCON$$$$$$Y$$$20240910$$CN$CA$CA
243008302$24300830$2$F$$20240903$20240910$20240916$PER$$US-CHATTEMPRD-2024OHG030922$CHATTEM$$$$$F$Y$$$20240916$$CN$US$US
243008311$24300831$1$I$$20240827$20240910$20240910$EXP$$CA-UCBSA-2024043974$UCB$$$$$F$Y$$$20240910$$HP$CA$CA
243008331$24300833$1$I$20240317$20240829$20240910$20240910$EXP$FR-AFSSAPS-DJ2024000930$FR-Accord-444584$ACCORD$$73$YR$E$M$Y$75$KG$20240910$$MD$FR$FR
243008341$24300834$1$I$20240903$20240904$20240910$20240910$PER$$US-ABBVIE-5909553$ABBVIE$$47$YR$$F$Y$$$20240910$$MD$US$US
243008351$24300835$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009930$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243008361$24300836$1$I$$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024178721$AMGEN$$$$$$Y$$$20240909$$HP$US$US
243008371$24300837$1$I$$20240904$20240910$20240910$EXP$$US-AMGEN-USASP2024177472$AMGEN$$$$$M$Y$$$20240909$$CN$US$US
243008381$24300838$1$I$$20240905$20240910$20240910$EXP$$CA-GSK-CA2024AMR008662$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$PH$CA$CA
243008391$24300839$1$I$$20240902$20240910$20240910$EXP$$US-ROCHE-10000075057$ROCHE$Tannous T, Hevroni G, Islam R, Pongas G. Successful treatment of a CLL associated IgM hyper-viscosity syndrome: A rare case. Leukemia Research Reports. 2024-Jan;22:1-4. doi:10.1016/j.lrr.2024.100479.$53$YR$A$M$Y$$$20240910$$HP$US$US
243008401$24300840$1$I$20240902$20240903$20240910$20240910$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-014501$JAZZ$$$$$$Y$$$20240909$$MD$JP$JP
243008411$24300841$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009931$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243008422$24300842$2$F$$20240916$20240910$20240918$EXP$$GB-ROCHE-10000073038$ROCHE$$$$$F$Y$$$20240918$$CN$GB$GB
243008431$24300843$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009932$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243008452$24300845$2$F$$20240909$20240910$20240912$PER$$US-HALEON-2195974$Haleon PLC$$$$$$Y$$$20240912$$CN$US$US
243008461$24300846$1$I$$20240830$20240910$20240910$EXP$$JP-ROCHE-10000073118$ROCHE$$$$A$M$Y$$$20240910$$MD$JP$JP
243008471$24300847$1$I$$20240829$20240910$20240910$PER$$US-ABBVIE-5902982$ABBVIE$$$$$$Y$$$20240910$$CN$US$US
243008481$24300848$1$I$20240101$20240904$20240910$20240910$EXP$$US-ABBVIE-5908104$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243008491$24300849$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142528$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$HP$US$US
243008501$24300850$1$I$20201201$20240909$20240910$20240910$EXP$$PL-SANDOZ INC.-SDZ2024PL078730$SANDOZ$$$$$$Y$$$20240910$$MD$PL$PL
243008512$24300851$2$F$20240819$20240910$20240910$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140023$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240912$$HP$US$US
243008521$24300852$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009933$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243008531$24300853$1$I$$20240909$20240910$20240910$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050385$BOEHRINGER INGELHEIM$$$$$$Y$$$20240910$$PH$JP$JP
243008541$24300854$1$I$20240829$20240829$20240910$20240910$PER$$US-ABBVIE-5903231$ABBVIE$$39$YR$$$Y$$$20240910$$CN$US$US
243008551$24300855$1$I$20240801$20240827$20240910$20240910$EXP$$CA-UCBSA-2024043981$UCB$$62$YR$$F$Y$$$20240910$$CN$CA$CA
243008561$24300856$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004741$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243008571$24300857$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004784$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243008581$24300858$1$I$$20240903$20240910$20240910$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049453$BOEHRINGER INGELHEIM$$$$$$Y$$$20240910$$CN$US$US
243008591$24300859$1$I$$20240904$20240910$20240910$EXP$$US-AstraZeneca-2024A201933$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
243008601$24300860$1$I$20240811$20240908$20240910$20240910$EXP$$US-TAKEDA-2024TUS083932$TAKEDA$$87$YR$$M$Y$$$20240910$$CN$US$US
243008611$24300861$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024109467$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243008621$24300862$1$I$20230801$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179424$AMGEN$$60$YR$A$$Y$$$20240910$$HP$US$US
243008631$24300863$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009934$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243008642$24300864$2$F$20240101$20240910$20240910$20240912$EXP$$US-ABBVIE-5908976$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243008651$24300865$1$I$$20240903$20240910$20240910$EXP$$BR-Accord-445258$ACCORD$Appenzeller S, Costallat LL, Ramos MC, Andrade SO, Reis F. Paracoccidioidomycosis: An uncommon cause of discitis in lupus. Revista da Sociedade Brasileira de Medicina Tropical. 2024;57:e00922-2024. DOI: 10.1590/0037-8682-0191-2024.$41$YR$A$F$Y$$$20240910$$MD$BR$BR
243008661$24300866$1$I$$20240905$20240910$20240910$PER$$US-BIOGEN-2024BI01281302$BIOGEN$$$$$M$Y$$$20240910$$CN$US$US
243008671$24300867$1$I$$20240827$20240910$20240910$PER$$US-ASTELLAS-2024-AER-003526$ASTELLAS$$56$YR$A$F$Y$$$20240910$$MD$US$US
243008681$24300868$1$I$$20240829$20240910$20240910$EXP$$PK-IPCA LABORATORIES LIMITED-IPC-2024-PK-002142$IPCA$Zehra Abdul Muhammad, Tashfeen Ahmad and Haroon Rashid. Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-A cohort study. Expert Opinion On Drug Safety. 2024;1-8$$$$$Y$$$20240910$$HP$PK$PK
243008702$24300870$2$F$20231107$20240912$20240910$20240918$EXP$$NVSJ2024JP010495$NOVARTIS$$65$YR$$M$Y$66.6$KG$20240918$$MD$JP$JP
243008711$24300871$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009935$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243008721$24300872$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259067$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240910$$MD$US$US
243008731$24300873$1$I$$20240822$20240910$20240910$PER$$US-SA-2024SA260328$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240910$$CN$US$US
243008741$24300874$1$I$20240101$20240902$20240910$20240910$PER$$US-SA-2024SA260660$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240910$$HP$US$US
243008751$24300875$1$I$20240101$20240906$20240910$20240910$EXP$$US-ABBVIE-5914425$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243008761$24300876$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143278$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$CN$US$US
243008771$24300877$1$I$20240822$20240823$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135745$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$74.84$KG$20240910$$CN$US$US
243008781$24300878$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005211$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243008791$24300879$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004674$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240910$$CN$US$US
243008801$24300880$1$I$20240905$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004429$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240910$$CN$US$US
243008811$24300881$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004611$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240910$$CN$US$US
243008821$24300882$1$I$20240710$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004578$ELI LILLY AND CO$$$$$$Y$$$20240910$$CN$US$US
243008831$24300883$1$I$$20240904$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409002939$ELI LILLY AND CO$$64$YR$A$$Y$$$20240910$$CN$US$US
243008841$24300884$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260608$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240910$$HP$US$US
243008851$24300885$1$I$20240301$20240830$20240910$20240910$PER$$US-SA-2024SA260796$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240910$$MD$US$US
243008861$24300886$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004554$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243008871$24300887$1$I$20240802$20240906$20240910$20240910$EXP$FR-AFSSAPS-TS2024000920$FR-ABBVIE-5915613$ABBVIE$$92$YR$$F$Y$$$20240910$$MD$FR$FR
243008882$24300888$2$F$20240902$20240910$20240910$20240912$PER$$US-AMGEN-USASP2024179484$AMGEN$$75$YR$E$F$Y$$$20240912$$CN$US$US
243008891$24300889$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009936$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243008901$24300890$1$I$$20240828$20240910$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-043431$AUROBINDO$Hussain U, Ratajczak T, Joffe CD.. ACUTE THROMBOEMBOLIC MYOCARDIAL INFARCTION AFTER BIOPROSTHETIC MITRAL VALVE REPLACEMENT AND INTRAOPERATIVE LEFT ATRIAL THROMBUS EVACUATION.. J-Am-Coll-Cardiol. 2019;73 (Suppl.)(9):2683$79$YR$$F$Y$$$20240910$$HP$US$US
243008911$24300891$1$I$$20240904$20240910$20240910$EXP$$JP-JNJFOC-20240922239$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$PH$JP$JP
243008921$24300892$1$I$$20240903$20240910$20240910$PER$$US-JNJFOC-20240904218$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$CN$US$US
243008931$24300893$1$I$$20240830$20240910$20240910$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-140056$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240910$$MD$PR$PR
243008941$24300894$1$I$$20240902$20240910$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142686$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$PH$JP$JP
243008951$24300895$1$I$$20240904$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142287$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240910$$CN$US$US
243008961$24300896$1$I$20240905$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024178431$AMGEN$$66$YR$E$M$Y$$$20240910$$CN$US$US
243008972$24300897$2$F$20240906$20240927$20240910$20240928$PER$$US-AMGEN-USASP2024179108$AMGEN$$53$YR$A$M$Y$$$20240928$$CN$US$US
243008981$24300898$1$I$$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024177789$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
243008992$24300899$2$F$20240902$20240911$20240910$20240913$PER$$US-AMGEN-USASP2024175721$AMGEN$$19$YR$A$F$Y$$$20240913$$MD$US$US
243009002$24300900$2$F$20240809$20240916$20240910$20240926$EXP$FR-AFSSAPS-AN2024001171$FR-TEVA-VS-3239744$TEVA$$77$YR$$F$Y$93$KG$20240926$$PH$FR$FR
243009011$24300901$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009945$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243009022$24300902$2$F$20240701$20240916$20240910$20240925$EXP$$US-UCBSA-2024044502$UCB$$48$YR$$F$Y$$$20240925$$HP$US$US
243009031$24300903$1$I$$20240902$20240910$20240910$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006588$BIOCON$$$$$$Y$$$20240910$$MD$CA$CA
243009041$24300904$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004788$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243009051$24300905$1$I$$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408291138337940-BJCHN$GB-ROCHE-10000069661$ROCHE$$85$YR$E$M$Y$$$20240910$$HP$GB$GB
243009061$24300906$1$I$20240601$20240902$20240910$20240910$EXP$$FR-AstraZeneca-2024A199166$ASTRAZENECA$$67$YR$$M$Y$74$KG$20240910$$MD$FR$
243009071$24300907$1$I$$20240908$20240910$20240910$EXP$$JP-SANDOZ INC.-SDZ2024JP078523$SANDOZ$$66$YR$$M$Y$$$20240910$$MD$JP$JP
243009082$24300908$2$F$20240725$20240916$20240910$20240918$EXP$$DE-SANDOZ INC.-SDZ2024DE078737$SANDOZ$$$$A$F$Y$130$KG$20240918$$MD$DE$DE
243009092$24300909$2$F$$20240909$20240910$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005111$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243009101$24300910$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004747$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243009111$24300911$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009946$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243009121$24300912$1$I$$20240904$20240910$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-023765$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240910$$$US$US
243009131$24300913$1$I$$20240830$20240910$20240910$EXP$$IN-ABBVIE-5914819$ABBVIE$Ramachandran S, Kriplani K, Khurana H, Rayapureddi K. Ibrutinib-Induced Uveitis: A Case of Rapid Ocular Toxicity in Mantle Cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2024:S518$41$YR$$M$Y$$$20240910$$MD$IN$IN
243009141$24300914$1$I$$20240830$20240910$20240910$30DAY$$US-JNJFOC-20240910795$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
243009152$24300915$2$F$20240802$20240905$20240910$20240918$EXP$$NVSC2024CN180275$NOVARTIS$$62$YR$$M$Y$76$KG$20240919$$HP$CN$CN
243009161$24300916$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009947$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243009171$24300917$1$I$$20240830$20240910$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-044666$AUROBINDO$$67$YR$$F$Y$$$20240910$$MD$CA$CA
243009181$24300918$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179499$AMGEN$$$$$$Y$$$20240910$$MD$US$US
243009191$24300919$1$I$$20240906$20240910$20240910$PER$$US-ROCHE-10000077083$ROCHE$$54$YR$A$M$Y$$$20240910$$CN$US$US
243009201$24300920$1$I$20240820$20240905$20240910$20240910$EXP$$US-ALXN-202409USA000333US$ALEXION PHARMACEUTICALS$$77$YR$$F$Y$$$20240910$$CN$US$US
243009221$24300922$1$I$$20240830$20240910$20240910$EXP$GB-MHRA-TPP5514855C21926203YC1724940670402$GB-Accord-444567$ACCORD$$61$YR$A$M$Y$94$KG$20240910$$HP$GB$GB
243009231$24300923$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004179$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243009241$24300924$1$I$$20240902$20240910$20240910$EXP$IN-MLMSERVICE-20240826-PI172107-00232-1$IN-ROCHE-10000071473$ROCHE$C S, P H, Jayanthi N. A Rare Lung Malignancy in a Case of Systemic Sclerosis. Cureus. 2024;16(7):e65146. DOI: 10.7759/cureus.65146.$55$YR$A$F$Y$$$20240910$$HP$IN$IN
243009251$24300925$1$I$$20240710$20240910$20240910$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00274$PRINSTON PHARMACEUTICAL$$$$$M$Y$106.59$KG$20240906$$CN$US$US
243009262$24300926$2$F$20220209$20240830$20240910$20240913$EXP$$CA-CELLTRION INC.-2021CA019484$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
243009271$24300927$1$I$$20240826$20240910$20240910$PER$$US-SA-2024SA258798$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240910$$HP$US$US
243009281$24300928$1$I$20240730$20240805$20240910$20240910$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00308$PRINSTON PHARMACEUTICAL$$51$YR$$M$Y$98.429$KG$20240906$$CN$US$US
243009291$24300929$1$I$$20240829$20240910$20240910$EXP$$PK-IPCA LABORATORIES LIMITED-IPC-2024-PK-002143$IPCA$Zehra Abdul Muhammad, Tashfeen Ahmad and Haroon Rashid. Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-A cohort study. Expert Opinion On Drug Safety. 2024;1-8$$$$$Y$$$20240910$$HP$PK$PK
243009301$24300930$1$I$20240825$20240826$20240910$20240910$PER$$US-SA-2024SA259064$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240910$$MD$US$US
243009311$24300931$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA255029$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240910$$MD$US$US
243009321$24300932$1$I$20240712$20240826$20240910$20240910$PER$$US-SA-2024SA259680$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240910$$CN$US$US
243009331$24300933$1$I$20240801$20240826$20240910$20240910$PER$$US-SA-2024SA257879$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240910$$MD$US$US
243009341$24300934$1$I$$20240827$20240910$20240910$PER$$US-SA-2023SA396686$SANOFI AVENTIS$$$$A$M$Y$$$20240910$$HP$US$US
243009351$24300935$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2024SA260138$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240910$$HP$US$US
243009361$24300936$1$I$20240801$20240901$20240910$20240910$PER$$US-SA-2024SA260715$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240910$$HP$US$US
243009371$24300937$1$I$$20240830$20240910$20240910$EXP$$US-TEVA-VS-3239139$TEVA$$71$YR$$F$Y$$$20240910$$CN$US$US
243009381$24300938$1$I$$20240830$20240910$20240910$PER$$US-SA-2024SA260810$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240910$$MD$US$US
243009391$24300939$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260675$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240910$$MD$US$US
243009401$24300940$1$I$$20240830$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043547$AUROBINDO$Lonsdale H, Sawant R, Kinshuck A, Fleming J.. Airway consequences of alendronic acid aspiration. BMJ case reports. 2024;17(8):e260930$8$DEC$$F$Y$$$20240910$$MD$GB$GB
243009411$24300941$1$I$$20240829$20240910$20240910$EXP$$JP-ROCHE-10000072212$ROCHE$$8$DEC$E$M$Y$$$20240910$$MD$JP$JP
243009421$24300942$1$I$20240825$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004797$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240910$$CN$US$US
243009431$24300943$1$I$$20240830$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043760$AUROBINDO$$53$YR$$$Y$$$20240910$$PH$GB$GB
243009441$24300944$1$I$$20240830$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043755$AUROBINDO$$78$YR$$$Y$$$20240910$$PH$GB$GB
243009452$24300945$2$F$20240301$20240911$20240910$20240919$EXP$$DE-SANDOZ INC.-SDZ2024DE078783$SANDOZ$$$$E$F$Y$60$KG$20240919$$HP$DE$DE
243009461$24300946$1$I$$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408291202511180-TJQBY$GB-ROCHE-10000069705$ROCHE$$73$YR$E$F$Y$$$20240910$$HP$GB$GB
243009471$24300947$1$I$$20240830$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043756$AUROBINDO$$83$YR$$$Y$$$20240910$$PH$GB$GB
243009481$24300948$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259098$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240910$$HP$US$US
243009491$24300949$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009937$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243009501$24300950$1$I$20240809$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202692$ASTRAZENECA$$28616$DY$$M$Y$$$20240910$$CN$US$
243009511$24300951$1$I$$20240902$20240910$20240910$EXP$$ZA-AstraZeneca-2024A200345$ASTRAZENECA$$79$YR$$F$Y$$$20240910$$CN$ZA$
243009521$24300952$1$I$$20240902$20240910$20240910$EXP$$ZA-AstraZeneca-2024A200053$ASTRAZENECA$$27759$DY$$M$Y$$$20240910$$CN$ZA$
243009531$24300953$1$I$$20240904$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2024US078106$SANDOZ$$$$$$Y$$$20240910$$HP$US$US
243009541$24300954$1$I$20240901$20240826$20240910$20240910$PER$$US-SA-2024SA259052$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240910$$HP$US$US
243009551$24300955$1$I$$20240902$20240910$20240910$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006581$BIOCON$$$$$$Y$$$20240910$$CN$CA$CA
243009561$24300956$1$I$$20240830$20240910$20240910$EXP$GB-MHRA-TPP18978005C7016075YC1724924261304$GB-Accord-444542$ACCORD$$60$YR$A$F$Y$88$KG$20240910$$MD$GB$GB
243009572$24300957$2$F$$20240912$20240910$20240926$PER$$US-RDY-SPO/USA/24/0012909$DR REDDYS$$43$YR$A$M$Y$$$20240926$$HP$US$US
243009581$24300958$1$I$$20240904$20240910$20240910$EXP$$US-RDY-SPO/USA/24/0012908$DR REDDYS$$54$YR$A$M$Y$$$20240910$$HP$US$US
243009591$24300959$1$I$$20240821$20240910$20240910$PER$$US-APOTEX-2024AP009938$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240910$$HP$US$US
243009601$24300960$1$I$$20240829$20240910$20240910$EXP$$US-ROCHE-10000070077$ROCHE$$91$YR$E$F$Y$$$20240910$$CN$US$US
243009611$24300961$1$I$$20240827$20240910$20240910$EXP$$JP-UCBSA-2024044354$UCB$Itazawa K, et al.. A 3-year-old boy with PMM2-CDG complicated by stroke-like episodes. Medical Journal Aomori. 2023;68(4):156-62$3$YR$$M$Y$$$20240910$$MD$JP$JP
243009621$24300962$1$I$20231101$20240903$20240910$20240910$EXP$IR-MLMSERVICE-20240821-PI168793-00077-1$IR-CHEPLA-2024011447$CHEPLAPHARM$Zonooz YA, Alizadehasl A, Davani DN, Jebelli SF, Aliabadi AY, Najdaghi S, et al. Cardiac interventricular septum hemangioma in a colon cancer patient treated with Capecitabine: A case report and review of literature. Clin Case Rep.2024;12(8):e9331.DOI:10.1002/ccr3.9331.$21$YR$$M$Y$$$20240910$$HP$COUNTRY NOT SPECIFIED$IR
243009632$24300963$2$F$$20240903$20240910$20240916$PER$$US-AMGEN-USASP2024179498$AMGEN$$$$$$Y$$$20240916$$PH$US$US
243009641$24300964$1$I$20240904$20240909$20240910$20240910$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050423$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240910$$CN$US$US
243009651$24300965$1$I$20240601$20240909$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143419$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240910$$CN$US$US
243009661$24300966$1$I$20240828$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142259$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$79.1$KG$20240910$$PH$US$US
243009672$24300967$2$F$$20240905$20240910$20240913$PER$$US-AMGEN-USASP2024178826$AMGEN$$$$$F$Y$$$20240913$$CN$US$US
243009681$24300968$1$I$20240906$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179391$AMGEN$$$$$$Y$$$20240910$$HP$US$US
243009701$24300970$1$I$20240209$20240909$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-085418-2024$RECKITT BENCKISER$$73$YR$$F$Y$70.45$KG$20240910$$CN$US$US
243009711$24300971$1$I$20240101$20240828$20240910$20240910$PER$$US-SA-2024SA257775$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240910$$HP$US$US
243009721$24300972$1$I$20240817$20240902$20240910$20240910$EXP$$NVSC2024CN179401$NOVARTIS$$10$YR$$F$Y$38$KG$20240910$$HP$CN$CN
243009731$24300973$1$I$20240621$20240905$20240910$20240910$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2024-120729$REGENERON$$$$$F$Y$$$20240910$$CN$CO$CO
243009741$24300974$1$I$20240717$20240830$20240910$20240910$EXP$$IT-AUROBINDO-AUR-APL-2024-043866$AUROBINDO$$62$YR$$F$Y$51$KG$20240910$$MD$IT$IT
243009751$24300975$1$I$$20240830$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043803$AUROBINDO$$77$YR$$F$Y$$$20240910$$PH$GB$GB
243009761$24300976$1$I$20240531$20240831$20240910$20240910$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005315$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240910$$CN$US$US
243009771$24300977$1$I$$20240906$20240910$20240910$EXP$$CA-ROCHE-10000075797$ROCHE$$1$YR$I$F$Y$6$KG$20240910$$HP$CA$CA
243009782$24300978$2$F$$20240925$20240910$20240927$PER$$NVSC2024US180805$NOVARTIS$$$$$M$Y$$$20240927$$HP$US$US
243009791$24300979$1$I$$20240903$20240910$20240910$EXP$$NVSC2024US177953$NOVARTIS$$$$$M$Y$$$20240910$$HP$US$US
243009801$24300980$1$I$$20240830$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043792$AUROBINDO$$72$YR$$M$Y$$$20240910$$PH$GB$GB
243009811$24300981$1$I$20240602$20240831$20240910$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-043972$AUROBINDO$$84$YR$$F$Y$$$20240910$$MD$DE$DE
243009821$24300982$1$I$$20240909$20240910$20240910$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050445$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240910$$HP$US$US
243009831$24300983$1$I$20240824$20240902$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043995$AUROBINDO$$66$YR$$F$Y$$$20240910$$PH$GB$GB
243009841$24300984$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004789$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243009851$24300985$1$I$20240831$20240831$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043894$AUROBINDO$$40$YR$$M$Y$82$KG$20240910$$MD$GB$GB
243009861$24300986$1$I$20230807$20240902$20240910$20240910$EXP$$ES-AUROBINDO-AUR-APL-2024-044306$AUROBINDO$$68$YR$$M$Y$$$20240910$$MD$ES$ES
243009881$24300988$1$I$20240507$20240903$20240910$20240910$EXP$$FR-AstraZeneca-2024A199921$ASTRAZENECA$$85$YR$$M$Y$$$20240910$$MD$FR$
243009891$24300989$1$I$20240815$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004791$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240910$$CN$US$US
243009901$24300990$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004555$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240910$$CN$US$US
243009911$24300991$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004666$ELI LILLY AND CO$$82$YR$E$$Y$$$20240910$$CN$US$US
243009921$24300992$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004466$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240910$$CN$US$US
243009931$24300993$1$I$$20240904$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409002901$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240910$$CN$US$US
243009941$24300994$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004557$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240910$$CN$US$US
243009961$24300996$1$I$20240903$20240903$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-044197$AUROBINDO$$39$YR$$F$Y$$$20240910$$CN$GB$GB
243009971$24300997$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259966$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240910$$HP$US$US
243009981$24300998$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA254055$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240910$$MD$US$US
243009991$24300999$1$I$20240101$20240826$20240910$20240910$PER$$US-SA-2024SA259050$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240910$$MD$US$US
243010002$24301000$2$F$20240101$20240828$20240910$20240913$PER$$US-SA-2024SA258433$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240913$$MD$US$US
243010011$24301001$1$I$$20240820$20240910$20240910$PER$$US-SA-2024SA259247$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240910$$CN$US$US
243010021$24301002$1$I$20240701$20240827$20240910$20240910$PER$$US-SA-2024SA259659$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240910$$MD$US$US
243010031$24301003$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA007067$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240910$$HP$US$US
243010041$24301004$1$I$$20240901$20240910$20240910$PER$$US-SA-2024SA260690$SANOFI AVENTIS$$$$T$M$Y$$$20240910$$MD$US$US
243010051$24301005$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259136$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240910$$HP$US$US
243010061$24301006$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004790$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243010071$24301007$1$I$$20240831$20240910$20240910$EXP$$NL-AUROBINDO-AUR-APL-2024-044181$AUROBINDO$$53$YR$$F$Y$63$KG$20240910$$CN$NL$NL
243010081$24301008$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179613$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243010091$24301009$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004793$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243010101$24301010$1$I$20200101$20240830$20240910$20240910$EXP$$US-NOVOPROD-1278005$NOVO NORDISK$$$$$F$Y$$$20240910$$CN$US$US
243010111$24301011$1$I$$20240830$20240910$20240910$EXP$$US-NOVOPROD-1278048$NOVO NORDISK$$$$$M$Y$$$20240910$$CN$US$US
243010121$24301012$1$I$20080101$20240830$20240910$20240910$EXP$$US-NOVOPROD-1278026$NOVO NORDISK$$53$YR$$F$Y$$$20240910$$CN$US$US
243010131$24301013$1$I$20230801$20240830$20240910$20240910$EXP$$CN-NOVOPROD-1277665$NOVO NORDISK$$85$YR$$M$Y$72.5$KG$20240910$$CN$CN$CN
243010141$24301014$1$I$$20240830$20240910$20240910$EXP$$JP-NOVOPROD-1278243$NOVO NORDISK$$$$$M$Y$$$20240910$$PH$JP$JP
243010151$24301015$1$I$20240101$20240830$20240910$20240910$EXP$$JP-NOVOPROD-1278224$NOVO NORDISK$$88$YR$$M$Y$$$20240910$$CN$JP$JP
243010161$24301016$1$I$20240726$20240830$20240910$20240910$EXP$CN-NMPA-3202061034119202400095$CN-NOVOPROD-1278144$NOVO NORDISK$$72$YR$$F$Y$85$KG$20240910$$HP$CN$CN
243010171$24301017$1$I$$20240830$20240910$20240910$EXP$$UA-NOVOPROD-1278228$NOVO NORDISK$$$$$F$Y$$$20240910$$HP$UA$UA
243010181$24301018$1$I$20240802$20240830$20240910$20240910$EXP$CN-NMPA-1503021056580202400140$CN-NOVOPROD-1278149$NOVO NORDISK$$53$YR$$F$Y$70$KG$20240910$$HP$CN$CN
243010191$24301019$1$I$20230104$20240830$20240910$20240910$EXP$$US-NOVOPROD-1277926$NOVO NORDISK$$59$YR$$F$Y$$$20240910$$CN$US$US
243010212$24301021$2$F$$20240903$20240910$20240916$EXP$$US-NOVOPROD-1278003$NOVO NORDISK$$$$$M$Y$$$20240916$$CN$US$US
243010221$24301022$1$I$$20240830$20240910$20240910$EXP$$BR-NOVOPROD-1277783$NOVO NORDISK$$$$$F$Y$$$20240910$$CN$BR$BR
243010231$24301023$1$I$$20240904$20240910$20240910$PER$$US-ABBVIE-5910495$ABBVIE$$$$$F$Y$$$20240910$$HP$US$US
243010242$24301024$2$F$20240820$20240916$20240910$20240924$EXP$$TW-ROCHE-10000075896$ROCHE$$90$YR$E$M$Y$63.1$KG$20240924$$MD$TW$TW
243010251$24301025$1$I$$20240829$20240910$20240910$EXP$$PT-Accord-444858$ACCORD$Quadrado F, Vieira AT, Jacinto M, Ribeirinho R. PO-0292 - (2710) - MENINGOENCEFALITE A VHS (MENINGOENCEPHALITIS AT VHS-7). Doencas infeciosas e parasitarias  Caso clinico (Infectious and parasitic disea. 657.)$20$YR$A$F$Y$$$20240910$$HP$PT$PT
243010261$24301026$1$I$$20240901$20240910$20240910$EXP$$US-AMGEN-USASP2024177508$AMGEN$Popat D.; Singh A.; Alfaraj A. et al.. Dramatically Decreased Transfusion Dependency With Luspatercept in a Case of High-Risk MDS. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S402$81$YR$E$M$Y$$$20240910$$MD$US$US
243010271$24301027$1$I$20240101$20240903$20240910$20240910$EXP$$US-AMGEN-USASP2024175718$AMGEN$$73$YR$E$F$Y$$$20240910$$HP$US$US
243010281$24301028$1$I$$20240909$20240910$20240910$EXP$$PH-UCBSA-2024044721$UCB$Ajon ARS, Camara PTA.. Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Due to Multiple Anti-Epileptic Drug Hypersensitivity. Cureus. 2024;16(7):1-5$41$YR$$F$Y$$$20240910$$HP$PH$PH
243010291$24301029$1$I$20240724$20240830$20240910$20240910$EXP$CN-NMPA-3310231059341202400289$CN-NOVOPROD-1278385$NOVO NORDISK$$32$YR$$M$Y$93.5$KG$20240910$$HP$CN$CN
243010311$24301031$1$I$$20240907$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142945$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$80.29$KG$20240910$$CN$US$US
243010321$24301032$1$I$20240201$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143504$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240910$$CN$US$US
243010331$24301033$1$I$$20240907$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142894$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$79.83$KG$20240910$$CN$US$US
243010341$24301034$1$I$20240101$20240906$20240910$20240910$PER$$US-ABBVIE-5913838$ABBVIE$$$$$F$Y$$$20240910$$HP$US$US
243010351$24301035$1$I$20240801$20240902$20240910$20240910$EXP$DK-DKMA-30737733$DK-TEVA-VS-3239730$TEVA$$85$YR$$F$Y$$$20240910$$MD$DK$DK
243010361$24301036$1$I$20240623$20240902$20240910$20240910$EXP$$IT-AUROBINDO-AUR-APL-2024-044248$AUROBINDO$$36$YR$$F$Y$$$20240910$$MD$IT$IT
243010372$24301037$2$F$20240904$20240923$20240910$20240924$PER$$US-AMGEN-USASP2024179073$AMGEN$$64$YR$A$F$Y$$$20240924$$CN$US$US
243010392$24301039$2$F$20240906$20240906$20240910$20240917$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004906$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240917$$CN$US$US
243010401$24301040$1$I$20240805$20240902$20240910$20240910$EXP$IT-MINISAL02-1000189$IT-TEVA-VS-3239497$TEVA$$71$YR$$F$Y$$$20240910$$MD$IT$IT
243010411$24301041$1$I$$20240909$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-082273-2024$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243010421$24301042$1$I$$20240906$20240910$20240910$PER$$US-ROCHE-10000077076$ROCHE$$81$YR$E$F$Y$$$20240910$$CN$US$US
243010431$24301043$1$I$$20240906$20240910$20240910$EXP$$CN-TAKEDA-2024TUS089724$TAKEDA$$$$$F$Y$$$20240910$$CN$CN$CN
243010441$24301044$1$I$20240806$20240903$20240910$20240910$EXP$$CN-ROCHE-10000073443$ROCHE$$46$YR$A$F$Y$63$KG$20240910$$HP$CN$CN
243010451$24301045$1$I$$20240905$20240910$20240910$PER$$US-AstraZeneca-2024A203478$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243010461$24301046$1$I$$20240903$20240910$20240910$EXP$$DE-AstraZeneca-2024A201470$ASTRAZENECA$$$$$$Y$$$20240910$$MD$DE$
243010472$24301047$2$F$20240101$20240904$20240910$20240925$EXP$$US-SA-2024SA258852$SANOFI AVENTIS$$61$YR$A$M$Y$129.55$KG$20240925$$MD$US$US
243010483$24301048$3$F$20240805$20240909$20240910$20240913$PER$$US-AMGEN-USASP2024179155$AMGEN$$77$YR$E$M$Y$$$20240912$$CN$US$US
243010491$24301049$1$I$$20240823$20240910$20240910$PER$$US-SA-2024SA260823$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240910$$MD$US$US
243010501$24301050$1$I$$20240826$20240910$20240910$PER$$US-SA-2024SA261083$SANOFI AVENTIS$$56$YR$A$$Y$$$20240910$$CN$US$US
243010511$24301051$1$I$20240801$20240826$20240910$20240910$PER$$US-SA-2024SA261177$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240910$$HP$US$US
243010521$24301052$1$I$20240903$20240903$20240910$20240910$EXP$$NL-BIOVITRUM-2024-NL-011790$BIOVITRUM$$139$DY$$F$Y$5$KG$20240910$$HP$NL$NL
243010532$24301053$2$F$$20240906$20240910$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005222$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243010541$24301054$1$I$$20240903$20240910$20240910$EXP$$BR-BIOVITRUM-2024-BR-011796$BIOVITRUM$$$$$M$Y$$$20240910$$CN$BR$BR
243010551$24301055$1$I$$20240905$20240910$20240910$EXP$$CA-ROCHE-10000075065$ROCHE$$67$YR$E$F$Y$$$20240910$$MD$CA$CA
243010562$24301056$2$F$20230101$20240909$20240910$20240912$EXP$$FR-SANDOZ INC.-SDZ2024FR078690$SANDOZ$$72$YR$$M$Y$$$20240912$$MD$FR$FR
243010571$24301057$1$I$$20240909$20240910$20240910$EXP$$SK-ABBVIE-5914090$ABBVIE$$50$YR$$M$Y$$$20240910$$MD$SK$SK
243010581$24301058$1$I$20240101$20240906$20240910$20240910$EXP$$US-ABBVIE-5914916$ABBVIE$$$$$$Y$$$20240910$$CN$US$US
243010591$24301059$1$I$20231201$20240830$20240910$20240910$EXP$DE-BFARM-24005943$DE-Accord-445066$ACCORD$$$$$F$Y$2.6$KG$20240910$$MD$DE$DE
243010601$24301060$1$I$20240801$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004447$ELI LILLY AND CO$$$$A$F$Y$$$20240910$$CN$US$US
243010611$24301061$1$I$20240527$20240904$20240910$20240910$EXP$$BR-BIOVITRUM-2024-BR-011797$BIOVITRUM$$125$DY$$F$Y$4$KG$20240910$$CN$BR$BR
243010621$24301062$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004453$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240910$$CN$US$US
243010631$24301063$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004446$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243010641$24301064$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003478$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240910$$CN$US$US
243010651$24301065$1$I$$20240904$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004732$ELI LILLY AND CO$$$$A$F$Y$$$20240910$$CN$US$US
243010661$24301066$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004552$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240910$$CN$US$US
243010671$24301067$1$I$20240401$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004488$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240910$$CN$US$US
243010681$24301068$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004338$ELI LILLY AND CO$$59$YR$A$$Y$$$20240910$$LW$US$US
243010691$24301069$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004523$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240910$$HP$US$US
243010712$24301071$2$F$20240906$20240909$20240910$20240911$PER$$US-AMGEN-USASP2024178979$AMGEN$$63$YR$A$M$Y$$$20240911$$CN$US$US
243010731$24301073$1$I$$20240909$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-089377-2024$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243010741$24301074$1$I$$20240822$20240910$20240910$EXP$$DE-UCBSA-2024045470$UCB$$$$$F$Y$$$20240910$$MD$DE$DE
243010751$24301075$1$I$$20240828$20240910$20240910$EXP$$US-PADAGIS-2024PAD01419$PADAGIS$$$$$$Y$$$20240910$$MD$US$US
243010761$24301076$1$I$$20240828$20240910$20240910$EXP$$US-PADAGIS-2024PAD01415$PADAGIS$$$$$$Y$$$20240910$$MD$US$US
243010771$24301077$1$I$$20240828$20240910$20240910$EXP$$US-PADAGIS-2024PAD01418$PADAGIS$$$$$$Y$$$20240910$$CN$US$US
243010781$24301078$1$I$$20240827$20240910$20240910$EXP$$US-PADAGIS-2024PAD01414$PADAGIS$$$$$$Y$$$20240910$$CN$US$US
243010792$24301079$2$F$20240101$20240916$20240910$20240919$EXP$$US-SA-2024SA260073$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240919$$CN$US$US
243010801$24301080$1$I$$20240902$20240910$20240910$EXP$$US-PADAGIS-2024PAD01441$PADAGIS$Riegel DC, Fonkem E, Connelly JM. Treatment of Extraneural Metastases of Myxopapillary Ependymomas With Dose-Dense Temozolomide and Lapatinib.. Cureus. 2024;16(8):e67928$$$$$Y$$$20240910$$HP$US$US
243010811$24301081$1$I$$20240901$20240910$20240910$PER$$US-009507513-2409USA001347$MERCK$$$$$$Y$$$20240910$$CN$US$US
243010821$24301082$1$I$20240801$20240829$20240910$20240910$PER$$US-SA-2024SA260263$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240910$$HP$US$US
243010831$24301083$1$I$20240101$20240826$20240910$20240910$PER$$US-SA-2024SA258932$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240910$$MD$US$US
243010841$24301084$1$I$20240801$20240827$20240910$20240910$PER$$US-SA-2024SA261125$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240910$$CN$US$US
243010851$24301085$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259573$SANOFI AVENTIS$$$$A$F$Y$54.55$KG$20240910$$HP$US$US
243010861$24301086$1$I$20240801$20240826$20240910$20240910$PER$$US-SA-2024SA259497$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240910$$PH$US$US
243010872$24301087$2$F$20240812$20240829$20240910$20240919$PER$$US-SA-2024SA259491$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240919$$PH$US$US
243010881$24301088$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA260775$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240910$$CN$US$US
243010891$24301089$1$I$20240722$20240904$20240910$20240910$EXP$$SG-ROCHE-10000073858$ROCHE$$71$YR$E$M$Y$$$20240910$$HP$SG$SG
243010911$24301091$1$I$20240716$20240904$20240910$20240910$EXP$$SG-ROCHE-10000073863$ROCHE$$44$YR$A$F$Y$$$20240910$$HP$SG$SG
243010921$24301092$1$I$$20240829$20240910$20240910$EXP$$US-Accord-445082$ACCORD$$65$YR$$M$Y$$$20240910$$PH$US$US
243010931$24301093$1$I$20220817$20240905$20240910$20240910$EXP$$FR-AstraZeneca-2024A202269$ASTRAZENECA$$65$YR$$M$Y$95$KG$20240910$$MD$FR$
243010941$24301094$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004753$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243010951$24301095$1$I$20240701$20240829$20240910$20240910$PER$$US-SA-2024SA260267$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240910$$HP$US$US
243010961$24301096$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180856$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243010971$24301097$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180858$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243010981$24301098$1$I$$20240904$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141244$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240910$$HP$US$US
243010991$24301099$1$I$$20231024$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2023US047843$SANDOZ$$$$$F$Y$$$20240910$$CN$US$US
243011001$24301100$1$I$$20240902$20240910$20240910$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08208$HIKMA$$$$$M$Y$$$20240910$$MD$CA$CA
243011011$24301101$1$I$20230901$20230922$20240910$20240910$PER$$US-ALVOGEN-2023092318$ALVOGEN$$$$$$Y$$$20240910$$CN$US$US
243011021$24301102$1$I$20240607$20240902$20240910$20240910$EXP$FR-AFSSAPS-LL2024001619$FR-TEVA-VS-3239751$TEVA$$73$YR$$F$Y$65$KG$20240910$$MD$FR$FR
243011031$24301103$1$I$$20240909$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-087563-2024$RECKITT BENCKISER$$86$YR$$F$Y$$$20240910$$CN$US$US
243011041$24301104$1$I$$20240827$20240910$20240910$EXP$$GB-RISINGPHARMA-GB-2024RISLIT00316$RISING PHARMACEUTICALS$Henry Lonsdale.Airway consequences of alendronic acid aspiration.BMJ Case Reports.19-JUL-2024;17(8):1-5$8$DEC$E$F$Y$$$20240910$$HP$GB$GB
243011051$24301105$1$I$$20240820$20240910$20240910$EXP$$US-PADAGIS-2024PAD01364$PADAGIS$$$$$$Y$$$20240910$$PH$US$US
243011061$24301106$1$I$$20240904$20240910$20240910$EXP$$US-ABBVIE-5908805$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243011071$24301107$1$I$20221026$20240909$20240910$20240910$EXP$$US-UCBSA-2024046051$UCB$$48$YR$$M$Y$$$20240910$$HP$US$US
243011081$24301108$1$I$$20240902$20240910$20240910$EXP$$US-RDY-SPO/USA/24/0012994$DR REDDYS$Dotson AD, Fingert JH, Boese EA. Unsuccessful transscleral cyclophotocoagulation in oculocutaneous albinism. American Journal of Ophthalmology Case Reports. 2024;34: doi:10.1016/j.ajoc.2024.102020.$35$YR$A$F$Y$$$20240910$$HP$US$US
243011091$24301109$1$I$$20240903$20240910$20240910$EXP$NL-LRB-00996734$NL-TEVA-VS-3240184$TEVA$$33$YR$$M$Y$85$KG$20240910$$CN$NL$NL
243011101$24301110$1$I$20231101$20240909$20240910$20240910$EXP$ES-AEMPS-1566919$NVSC2024ES180293$NOVARTIS$$73$YR$$F$Y$$$20240910$$MD$ES$ES
243011111$24301111$1$I$$20240903$20240910$20240910$EXP$$US-TERSERA THERAPEUTICS LLC-2024TRS004505$TERSERA THERAPEUTICS$$$$$$Y$$$20240910$$MD$US$US
243011121$24301112$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259942$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240910$$CN$US$US
243011131$24301113$1$I$20240401$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004010$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240910$$MD$US$US
243011141$24301114$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003964$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243011151$24301115$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260005$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240910$$HP$US$US
243011161$24301116$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259499$SANOFI AVENTIS$$45$YR$A$$Y$$$20240910$$CN$US$US
243011171$24301117$1$I$20240701$20240829$20240910$20240910$PER$$US-SA-2024SA260842$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240910$$MD$US$US
243011181$24301118$1$I$20240801$20240829$20240910$20240910$PER$$US-SA-2024SA260628$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240910$$MD$US$US
243011191$24301119$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2024SA260791$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240910$$MD$US$US
243011201$24301120$1$I$$20240906$20240910$20240910$EXP$$RO-ABBVIE-5915344$ABBVIE$$$$E$F$Y$$$20240910$$MD$RO$RO
243011211$24301121$1$I$$20240904$20240910$20240910$EXP$$FR-ABBVIE-5909974$ABBVIE$$$$E$F$Y$$$20240910$$MD$FR$FR
243011221$24301122$1$I$20240904$20240904$20240910$20240910$PER$$US-009507513-2409USA002000$MERCK$$70$YR$$M$Y$$$20240910$$PH$US$US
243011231$24301123$1$I$$20240903$20240910$20240910$EXP$$NVSC2024US177286$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243011241$24301124$1$I$20240101$20240904$20240910$20240910$EXP$$US-ABBVIE-5908877$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243011251$24301125$1$I$20240718$20240826$20240910$20240910$30DAY$$US-JNJFOC-20240910013$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$CN$US$US
243011261$24301126$1$I$20240505$20240909$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-089429-2024$RECKITT BENCKISER$$84$YR$$F$Y$$$20240910$$CN$US$US
243011281$24301128$1$I$$20240904$20240910$20240910$EXP$HU-EMA-DD-20240827-7482701-064009$HU-CHEPLA-2024011423$CHEPLAPHARM$Barczi G, Papp R, David DA, Fulop GA, Kulyassa PM. Sudden cardiac death of a patient who has basically low risk profile. Does psychiatric treatment modify risk. Cardiologia Hungarica Supplementum. 2024;3:309.$18$YR$$M$Y$$$20240910$$HP$COUNTRY NOT SPECIFIED$HU
243011291$24301129$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA261196$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240910$$HP$US$US
243011301$24301130$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA260433$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240910$$CN$US$US
243011311$24301131$1$I$$20240903$20240910$20240910$PER$$US-SA-2024SA261351$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$CN$US$US
243011321$24301132$1$I$$20240829$20240910$20240910$EXP$$US-RDY-SPO/USA/24/0012689$DR REDDYS$Bell AP, Custer MK, Presley S. Pyoderma Gangrenosum in a 75-Year-Old Male With Follicular Diffuse Large B-cell Lymphoma. Cureus. 2024;16(8):e67234. DOI: 10.7759/cureus.67234.$75$YR$E$M$Y$$$20240910$$MD$US$US
243011331$24301133$1$I$$20240830$20240910$20240910$EXP$GB-MHRA-MIDB-e3ffbe2f-4c0f-47ec-9c6b-f968b73335b6$GB-Accord-444555$ACCORD$$81$YR$E$F$Y$$$20240910$$PH$GB$GB
243011342$24301134$2$F$$20240906$20240910$20240917$EXP$$CN-JNJFOC-20240913879$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$MD$CN$CN
243011361$24301136$1$I$20240801$20240908$20240910$20240910$EXP$$DE-JNJFOC-20240902558$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240910$$CN$DE$DE
243011371$24301137$1$I$$20240908$20240910$20240910$PER$$US-AMGEN-USASP2024179556$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243011382$24301138$2$F$$20240903$20240910$20240912$PER$$US-AMGEN-USASP2024179349$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
243011391$24301139$1$I$$20240808$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2024US072987$SANDOZ$$$$$F$Y$$$20240910$$CN$US$US
243011401$24301140$1$I$20230101$20240902$20240910$20240910$EXP$DE-BFARM-24005942$DE-UCBSA-2024044625$UCB$$$$$$Y$$$20240910$$MD$DE$DE
243011411$24301141$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143343$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$96.16$KG$20240910$$CN$US$US
243011421$24301142$1$I$20230901$20231023$20240910$20240910$PER$$US-ALVOGEN-2023092464$ALVOGEN$$$$$F$Y$$$20240910$$CN$US$US
243011431$24301143$1$I$20240101$20240909$20240910$20240910$EXP$GB-MHRA-MED-202409081949044920-PLMFG$GB-ORGANON-O2409GBR000508$ORGANON$$82$YR$$F$Y$$$20240910$$CN$GB$GB
243011441$24301144$1$I$$20240909$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-089399-2024$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243011452$24301145$2$F$20240817$20240913$20240910$20240918$EXP$$FR-CHEPLA-2024008757$CHEPLAPHARM$$64$YR$$M$Y$80$KG$20240918$$MD$COUNTRY NOT SPECIFIED$FR
243011461$24301146$1$I$20240901$20240909$20240910$20240910$EXP$$US-ALXN-202409USA000513US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$MD$US$US
243011471$24301147$1$I$20240126$20240829$20240910$20240910$EXP$FR-AFSSAPS-TO2024001599$FR-Accord-444517$ACCORD$$57$YR$A$M$Y$71$KG$20240910$$HP$FR$FR
243011481$24301148$1$I$$20240906$20240910$20240910$PER$$US-ROCHE-10000076544$ROCHE$$79$YR$E$F$Y$$$20240910$$MD$US$US
243011491$24301149$1$I$$20240904$20240910$20240910$EXP$$CL-BRISTOL-MYERS SQUIBB COMPANY-2024-142580$BRISTOL MYERS SQUIBB$$75$YR$E$$Y$$$20240910$$MD$CL$CL
243011501$24301150$1$I$$20240829$20240910$20240910$EXP$$CN-GSK-CN2024APC092056$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$CN$CN
243011511$24301151$1$I$20180823$20240905$20240910$20240910$EXP$$JP-GSK-JP2024JPN110288$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$JP$JP
243011522$24301152$2$F$$20240906$20240910$20240925$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005319$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240925$$CN$US$US
243011531$24301153$1$I$$20240903$20240910$20240910$EXP$$CA-TAKEDA-2024TUS075016$TAKEDA$$$$$F$Y$$$20240910$$CN$CA$CA
243011551$24301155$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004806$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243011561$24301156$1$I$20240809$20240905$20240910$20240910$EXP$$ID-AstraZeneca-2024A204127$ASTRAZENECA$$26145$DY$$F$Y$$$20240910$$CN$ID$
243011571$24301157$1$I$$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A203408$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243011581$24301158$1$I$20240801$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004421$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240910$$CN$US$US
243011591$24301159$1$I$20240904$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004370$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240910$$CN$US$US
243011601$24301160$1$I$20240826$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004459$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240910$$CN$US$US
243011611$24301161$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005058$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240910$$CN$US$US
243011621$24301162$1$I$20240905$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004785$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240910$$CN$US$US
243011631$24301163$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004332$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240910$$CN$US$US
243011641$24301164$1$I$20240905$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004788$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240910$$CN$US$US
243011651$24301165$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004572$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243011661$24301166$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004582$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240910$$CN$US$US
243011671$24301167$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004606$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240910$$CN$US$US
243011681$24301168$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142858$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$136.53$KG$20240910$$CN$US$US
243011691$24301169$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143087$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240910$$CN$US$US
243011701$24301170$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004809$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243011711$24301171$1$I$$20240906$20240910$20240910$EXP$$US-GSK-US2024111288$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$HP$US$US
243011722$24301172$2$F$20240823$20240909$20240910$20240916$EXP$$DE-SANDOZ INC.-SDZ2024DE078664$SANDOZ$$72$YR$$F$Y$$$20240916$$MD$DE$DE
243011741$24301174$1$I$$20240828$20240910$20240910$PER$$US-009507513-2408USA010363$MERCK$$$$$F$Y$$$20240910$$HP$US$US
243011751$24301175$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180813$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243011761$24301176$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180868$NOVARTIS$$$$$F$Y$$$20240910$$HP$US$US
243011781$24301178$1$I$$20240904$20240910$20240910$PER$$US-JNJFOC-20240909122$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$PH$US$US
243011792$24301179$2$F$20220606$20240909$20240910$20240912$EXP$$NVSC2022GB202650$NOVARTIS$$45$YR$$F$Y$$$20240912$$CN$GB$GB
243011822$24301182$2$F$20240905$20240909$20240910$20240911$PER$$US-AMGEN-USASP2024179086$AMGEN$$67$YR$E$F$Y$$$20240910$$CN$US$US
243011831$24301183$1$I$20240816$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024178671$AMGEN$$70$YR$E$M$Y$$$20240910$$CN$US$US
243011841$24301184$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004815$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243011852$24301185$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686808$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243011871$24301187$1$I$20231201$20231227$20240910$20240910$PER$$US-TWI PHARMACEUTICAL, INC-2023SCTW000092$TWI PHARMACEUTICALS$$83$YR$$F$Y$$$20240903$$CN$US$US
243011881$24301188$1$I$20240701$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143031$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240910$$CN$US$US
243011891$24301189$1$I$20231030$20231030$20240910$20240910$PER$$US-TWI PHARMACEUTICAL, INC-2023SCTW000069$TWI PHARMACEUTICALS$$69$YR$$M$Y$$$20240903$$CN$US$US
243011911$24301191$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142420$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240910$$CN$US$US
243011921$24301192$1$I$$20240904$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141492$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240910$$HP$US$US
243011931$24301193$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142854$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$130.18$KG$20240910$$HP$US$US
243011941$24301194$1$I$20240901$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142445$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240910$$CN$US$US
243011951$24301195$1$I$20240801$20240903$20240910$20240910$PER$$US-ABBVIE-5908371$ABBVIE$$$$$$Y$$$20240910$$CN$US$US
243011961$24301196$1$I$$20240903$20240910$20240910$30DAY$$US-GSK-US2024AMR110294$GLAXOSMITHKLINE$$$$$F$Y$$$20240910$$CN$US$US
243011971$24301197$1$I$20240823$20240829$20240910$20240910$EXP$$US-Accord-444872$ACCORD$$52$YR$A$M$Y$$$20240910$$HP$US$US
243011981$24301198$1$I$$20240821$20240910$20240910$PER$$US-SA-2024SA259367$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240910$$MD$US$US
243012001$24301200$1$I$20240801$20240828$20240910$20240910$PER$$US-SA-2024SA062073$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240910$$MD$US$US
243012021$24301202$1$I$20220101$20240826$20240910$20240910$PER$$US-SA-2024SA259218$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240910$$HP$US$US
243012031$24301203$1$I$$20240830$20240910$20240910$PER$$US-SA-2024SA260142$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$MD$US$US
243012053$24301205$3$F$20240101$20240916$20240910$20240925$PER$$US-SA-2024SA260148$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240925$$MD$US$US
243012061$24301206$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2024SA260745$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240910$$MD$US$US
243012071$24301207$1$I$20240905$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179497$AMGEN$$82$YR$E$F$Y$$$20240910$$PH$US$US
243012081$24301208$1$I$$20240902$20240910$20240910$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-08213$HIKMA$$81$YR$$F$Y$86$KG$20240910$$HP$CA$CA
243012091$24301209$1$I$$20240904$20240910$20240910$PER$$US-ALXN-202409USA000287US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243012101$24301210$1$I$$20240829$20240910$20240910$EXP$$BE-CELLTRION INC.-2024BE021447$CELLTRION$Mustafovski, M.. WORKSHOP VAN DE BELGIAN CLUB OF DERMATOPATHOLOGY - The importance of Clinicopathological Correlation in Dermatology.. Skin. 2024;27(2):14-17$$$$$Y$$$20240910$$HP$BE$BE
243012111$24301211$1$I$$20240503$20240910$20240910$PER$$US-TWI PHARMACEUTICAL, INC-2024SCTW000082$TWI PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
243012121$24301212$1$I$$20240517$20240910$20240910$PER$$US-TWI PHARMACEUTICAL, INC-2024SCTW000095$TWI PHARMACEUTICALS$$$$$F$Y$$$20240903$$CN$US$US
243012131$24301213$1$I$$20240830$20240910$20240910$PER$$US-AstraZeneca-2024A198839$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243012141$24301214$1$I$20240901$20240909$20240910$20240910$PER$$US-ABBVIE-5916063$ABBVIE$$$$A$F$Y$$$20240910$$HP$US$US
243012151$24301215$1$I$20240801$20240828$20240910$20240910$EXP$$US-INSMED, INC.-2023-04736-US$INSMED$$75$YR$$F$Y$$$20240910$$CN$US$US
243012161$24301216$1$I$$20240816$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004820$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243012171$24301217$1$I$20240301$20240327$20240910$20240910$PER$$US-TWI PHARMACEUTICAL, INC-2024SCTW000061$TWI PHARMACEUTICALS$$78$YR$$M$Y$$$20240903$$PH$US$US
243012181$24301218$1$I$$20240830$20240910$20240910$PER$$US-RDY-SPO/USA/24/0012777$DR REDDYS$$89$YR$E$F$Y$$$20240910$$HP$US$US
243012191$24301219$1$I$20240414$20240903$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044040$AUROBINDO$$71$YR$$F$Y$$$20240910$$PH$FR$FR
243012211$24301221$1$I$$20240904$20240910$20240910$PER$$US-JNJFOC-20240914237$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$HP$US$US
243012221$24301222$1$I$$20240904$20240910$20240910$EXP$$JP-009507513-2409JPN000844J$MERCK$$75$YR$$$Y$$$20240910$$MD$JP$JP
243012231$24301223$1$I$$20240903$20240910$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-044364$AUROBINDO$$$$A$M$Y$$$20240910$$MD$DE$DE
243012241$24301224$1$I$$20240612$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202406008740$ELI LILLY AND CO$$$$$M$Y$$$20240910$$CN$US$US
243012251$24301225$1$I$20240430$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179280$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243012261$24301226$1$I$20240507$20240902$20240910$20240910$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-143093$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240910$$MD$DE$DE
243012271$24301227$1$I$$20240904$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-044359$AUROBINDO$$23$YR$$F$Y$$$20240910$$CN$GB$GB
243012281$24301228$1$I$$20240904$20240910$20240910$EXP$$US-TAKEDA-2024TUS089404$TAKEDA$Jones DT, Cruz G, Lugue MT, Heer MS, Sai M, Pace C, et al. Fruquintinib-induced cerebellar hemorrhage in left-sided descending metastatic colorectal adenocarcinoma: a case report and risk assessment. Cureus. 2024;16(8):e68203$46$YR$$M$Y$$$20240910$$MD$US$US
243012291$24301229$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2020187874$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243012301$24301230$1$I$$20240904$20240910$20240910$PER$$US-ALXN-202409USA000241US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240910$$CN$US$US
243012312$24301231$2$F$$20240909$20240910$20240917$PER$$US-ALXN-202409USA000207US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240917$$MD$US$US
243012321$24301232$1$I$$20240827$20240910$20240910$PER$$US-COSETTE-CP2024US000234$COSETTE PHARMACEUTICALS$$$$$F$Y$165$KG$20240910$$CN$US$US
243012331$24301233$1$I$$20240830$20240910$20240910$PER$$US-JNJFOC-20240900767$JOHNSON AND JOHNSON$$6$MON$I$F$Y$$$20240910$$CN$US$US
243012341$24301234$1$I$20200725$20240903$20240910$20240910$EXP$$CA-TAKEDA-2024TUS026108$TAKEDA$$65$YR$$F$Y$$$20240910$$CN$CA$CA
243012351$24301235$1$I$20240901$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024179827$AMGEN$$57$YR$A$M$Y$$$20240910$$CN$US$US
243012361$24301236$1$I$$20240903$20240910$20240910$EXP$$US-AMGEN-USASL2024176198$AMGEN$$$$E$$Y$$$20240910$$CN$US$US
243012382$24301238$2$F$$20240906$20240910$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004823$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243012391$24301239$1$I$$20240904$20240910$20240910$EXP$$IN-ROCHE-10000074954$ROCHE$$60$YR$A$F$Y$$$20240910$$CN$IN$IN
243012402$24301240$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686807$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243012411$24301241$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-140551-2023$RECKITT BENCKISER$$7$YR$$M$Y$$$20240910$$CN$US$US
243012421$24301242$1$I$20240624$20240903$20240910$20240910$EXP$$JP-EMD Serono-2024047355$EMD SERONO INC$$77$YR$E$F$Y$40$KG$20240910$$PH$JP$JP
243012431$24301243$1$I$$20240906$20240910$20240910$PER$$US-ROCHE-10000076536$ROCHE$$$$$F$Y$$$20240910$$MD$US$US
243012441$24301244$1$I$$20240903$20240910$20240910$EXP$NL-LRB-00999107$NL-TEVA-VS-3240050$TEVA$$47$YR$$F$Y$108$KG$20240910$$MD$NL$NL
243012451$24301245$1$I$$20240902$20240910$20240910$EXP$E2B_06994850; 5575516$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08284$HIKMA$$81$YR$$M$Y$$$20240910$$MD$CA$CA
243012461$24301246$1$I$20240827$20240904$20240910$20240910$EXP$$JP-ASTELLAS-2024-AER-004523$ASTELLAS$$7$DEC$E$M$Y$$$20240910$$MD$JP$JP
243012472$24301247$2$F$$20240919$20240910$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142158$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240920$$HP$US$US
243012481$24301248$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142163$BRISTOL MYERS SQUIBB$$27$YR$A$F$Y$$$20240910$$HP$US$US
243012491$24301249$1$I$$20240902$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142925$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$$$$$Y$$$20240910$$HP$US$US
243012501$24301250$1$I$$20240902$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142923$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$71$YR$E$M$Y$$$20240910$$HP$US$US
243012521$24301252$1$I$20240801$20240906$20240910$20240910$EXP$SE-SEMPA-2024-006424$SE-TAKEDA-2024TUS089199$TAKEDA$$20$YR$$M$Y$$$20240910$$HP$SE$SE
243012531$24301253$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141878$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240910$$CN$US$US
243012541$24301254$1$I$20240716$20240903$20240910$20240910$PER$$US-AMGEN-USASP2024176432$AMGEN$$70$YR$E$M$Y$$$20240910$$CN$US$US
243012551$24301255$1$I$$20240909$20240910$20240910$EXP$$DE-SANDOZ INC.-SDZ2024DE078671$SANDOZ$$46$YR$$F$Y$$$20240910$$MD$DE$DE
243012561$24301256$1$I$$20240907$20240910$20240910$EXP$$US-AMGEN-USASP2024179529$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
243012571$24301257$1$I$20240830$20240905$20240910$20240910$EXP$$CN-AMGEN-CHNSP2024179563$AMGEN$$68$YR$E$M$Y$$$20240910$$HP$CN$CN
243012581$24301258$1$I$20240908$20240909$20240910$20240910$PER$$US-HALEON-2195977$Haleon PLC$$74$YR$$M$Y$$$20240910$$CN$US$US
243012591$24301259$1$I$$20240904$20240910$20240910$EXP$$JP-GSK-JP2024JPN109721$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$PH$JP$JP
243012601$24301260$1$I$$20240322$20240910$20240910$EXP$$CA-TEVA-201904_00003082$TEVA$$61$YR$$F$Y$70$KG$20240910$$MD$CA$CA
243012611$24301261$1$I$$20240905$20240910$20240910$EXP$$IL-ALXN-202409ISR000270IL$ALEXION PHARMACEUTICALS$$67$YR$$F$Y$$$20240910$$MD$IL$IL
243012622$24301262$2$F$$20240910$20240910$20240921$EXP$$JP-UCBSA-2024044575$UCB$$6$DEC$$M$Y$$$20240921$$MD$JP$JP
243012631$24301263$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-136096-2023$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243012641$24301264$1$I$20240405$20240903$20240910$20240910$EXP$FR-AFSSAPS-PP2024000920$FR-TEVA-VS-3240133$TEVA$$50$YR$$F$Y$68$KG$20240910$$PH$FR$FR
243012651$24301265$1$I$$20240909$20240910$20240910$EXP$$CA-ADIENNEP-2024AD000724$ADIENNE PHARMA + BIOTECH$$51$YR$$F$Y$$$20240909$$HP$CA$
243012661$24301266$1$I$20240101$20240905$20240910$20240910$PER$$US-ABBVIE-5914276$ABBVIE$$$$$$Y$$$20240910$$CN$US$US
243012671$24301267$1$I$20240904$20240904$20240910$20240910$EXP$$DE-ABBVIE-5909040$ABBVIE$$$$A$M$Y$$$20240910$$CN$DE$DE
243012681$24301268$1$I$20240807$20240905$20240910$20240910$EXP$$US-ABBVIE-5910206$ABBVIE$$68$YR$$F$Y$$$20240910$$CN$US$US
243012691$24301269$1$I$20240517$20240904$20240910$20240910$EXP$$US-ABBVIE-5908201$ABBVIE$$35$YR$$F$Y$$$20240910$$CN$US$US
243012701$24301270$1$I$$20240903$20240910$20240910$EXP$$JP-ABBVIE-5906519$ABBVIE$$80$YR$$M$Y$$$20240910$$MD$JP$JP
243012711$24301271$1$I$$20240827$20240910$20240910$PER$$US-COSETTE-CP2024US000238$COSETTE PHARMACEUTICALS$$54$YR$A$F$Y$$$20240910$$MD$US$US
243012731$24301273$1$I$20240803$20240828$20240910$20240910$PER$$US-IGSA-BIG0030546$GRIFOLS$$70$YR$$F$Y$91.156$KG$20240910$$HP$US$US
243012741$24301274$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004492$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240910$$CN$US$US
243012751$24301275$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005139$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240910$$CN$US$US
243012761$24301276$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004671$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240910$$CN$US$US
243012771$24301277$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004649$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243012781$24301278$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004396$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240910$$MD$US$US
243012791$24301279$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004551$ELI LILLY AND CO$$$$$M$Y$$$20240910$$CN$US$US
243012801$24301280$1$I$20240827$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004333$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240910$$CN$US$US
243012811$24301281$1$I$20240902$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004636$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240910$$CN$US$US
243012821$24301282$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004747$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240910$$CN$US$US
243012831$24301283$1$I$20240906$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005444$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240910$$CN$US$US
243012841$24301284$1$I$20240716$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004787$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240910$$CN$US$US
243012851$24301285$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004409$ELI LILLY AND CO$$$$$F$Y$$$20240910$$HP$US$US
243012861$24301286$1$I$20240905$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004603$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240910$$CN$US$US
243012881$24301288$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142255$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240910$$CN$US$US
243012891$24301289$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142371$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240910$$CN$US$US
243012901$24301290$1$I$20240415$20240903$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140993$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240910$$HP$US$US
243012921$24301292$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143341$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240910$$CN$US$US
243012931$24301293$1$I$20240101$20240905$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142033$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$96$KG$20240910$$PH$US$US
243012941$24301294$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142257$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$51.26$KG$20240910$$CN$US$US
243012951$24301295$1$I$$20240815$20240910$20240910$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004724$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243012961$24301296$1$I$$20240905$20240910$20240910$PER$$US-BAUSCH-BL-2024-013318$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240910$$CN$US$US
243012972$24301297$2$F$20240817$20240906$20240910$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005264$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240916$$CN$US$US
243012981$24301298$1$I$20240906$20240906$20240910$20240910$EXP$$US-ALXN-202409USA000410US$ALEXION PHARMACEUTICALS$$28$YR$$F$Y$82.8$KG$20240910$$PH$US$US
243012991$24301299$1$I$$20240909$20240910$20240910$EXP$$CA-SANDOZ INC.-SDZ2024CA078790$SANDOZ$$69$YR$$M$Y$$$20240910$$PH$CA$CA
243013001$24301300$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-134220-2023$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243013011$24301301$1$I$$20240902$20240910$20240910$EXP$$KR-MSNLABS-2024MSNLIT01928$MSN LABORATORIES$Kim TM, Jo SJ.Short-term Safety of Dimethyl Fumarate for Psoriasis in Korea.Annals of Dermatology.23-FEB-2024;36(4):252-254$$$$$Y$$$20240910$$HP$KR$KR
243013021$24301302$1$I$20240906$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179013$AMGEN$$$$$$Y$$$20240910$$CN$US$US
243013031$24301303$1$I$20240101$20240903$20240910$20240910$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900022$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243013041$24301304$1$I$$20240905$20240910$20240910$EXP$$US-TAKEDA-2022TUS035691$TAKEDA$$$$$F$Y$77$KG$20240910$$CN$US$US
243013051$24301305$1$I$20240819$20240905$20240910$20240910$PER$$US-MSNLABS-2024MSNSPO01930$MSN LABORATORIES$$$$$$Y$$$20240910$$CN$US$US
243013061$24301306$1$I$20240701$20240830$20240910$20240910$EXP$$US-JNJFOC-20240902068$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240910$$CN$US$US
243013072$24301307$2$F$$20240924$20240910$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142367$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240926$$HP$US$US
243013081$24301308$1$I$20240826$20240903$20240910$20240910$EXP$$EG-BRISTOL-MYERS SQUIBB COMPANY-2024-141166$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240910$$MD$EG$EG
243013092$24301309$2$F$$20240905$20240910$20240919$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20689$ALKEM$Iannaccone R, Sue YJ, Avner JR. Suicidal psychosis secondary to isoniazid. Pediatr Emerg Care. 2002;18(1):25-27$14$YR$$F$Y$$$20240919$$HP$US$US
243013101$24301310$1$I$$20240826$20240910$20240910$EXP$$PT-ALKEM LABORATORIES LIMITED-PT-ALKEM-2024-19665$ALKEM$Gamelas V, Borges V, Santos S, Santos J, Silva MJ, Bernardes C, Ramos J.. Gastrointestinal: Olmesartan-induced enterocolopathy: A new presentation of a known entity. Journal of Gastroenterology and Hepatology. 2021;36:1150$64$YR$$M$Y$$$20240910$$HP$PT$PT
243013111$24301311$1$I$$20240826$20240910$20240910$EXP$$AE-ALKEM LABORATORIES LIMITED-AE-ALKEM-2024-20658$ALKEM$Alsaadi T, Kassie S, Farook F, Nasreddine W, Wani S, Saleh B. Antiseizure drugs use during pregnancy and congenital malformations: A retrospective review from the United Arab Emirates. Epilepsy Research. 2020;159:106259$$$N$$Y$$$20240910$$HP$AE$AE
243013121$24301312$1$I$$20240826$20240910$20240910$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-19446$ALKEM$Dixit R, Jakhmola P, Sharma S, et al. Recurrent haemoptysis following sildenafil administration. Indian J Chest Dis Allied Sci. 2009;51:119-20$38$YR$$M$Y$$$20240910$$HP$IN$IN
243013131$24301313$1$I$$20240826$20240910$20240910$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-19618$ALKEM$Sutar A, Venkategowda PM, Murthy A, Chikkaswamy SB.. Severe Amlodipine Toxicity: A Case Rescued with Extracorporeal Membrane Oxygenation. Indian J Crit Care Med. 2020;24(5):365-366$28$YR$$F$Y$$$20240910$$HP$IN$IN
243013141$24301314$1$I$20240905$20240905$20240910$20240910$EXP$$IN-ROCHE-10000075992$ROCHE$$40$YR$A$M$Y$$$20240910$$CN$IN$IN
243013161$24301316$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180702$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243013181$24301318$1$I$$20240828$20240910$20240910$30DAY$$US-NOVOPROD-1276690$NOVO NORDISK$$$$$F$Y$$$20240910$$HP$US$US
243013192$24301319$2$F$$20240909$20240910$20240924$EXP$$US-SANDOZ INC.-SDZ2024US078522$SANDOZ$$45$YR$$M$Y$85.1$KG$20240924$$HP$US$US
243013201$24301320$1$I$$20240830$20240910$20240910$EXP$$US-NOVOPROD-1278836$NOVO NORDISK$$$$$M$Y$$$20240910$$CN$US$US
243013211$24301321$1$I$20180101$20240830$20240910$20240910$EXP$$US-NOVOPROD-1278442$NOVO NORDISK$$$$$$Y$$$20240910$$CN$US$US
243013221$24301322$1$I$20230101$20240831$20240910$20240910$EXP$$TR-NOVOPROD-1278791$NOVO NORDISK$$$$$M$Y$$$20240910$$CN$TR$TR
243013231$24301323$1$I$$20240830$20240910$20240910$EXP$$US-NOVOPROD-1278920$NOVO NORDISK$$$$$$Y$$$20240910$$CN$US$US
243013241$24301324$1$I$$20240829$20240910$20240910$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08241$HIKMA$Bhopalwala H, Hussain A, Turab M, Dewaswala N.. Bhopalwala H, Hussain A, Turab M, Dewaswala N. Anabolic steroid-induced cardiomyopathy in middle age: a case report and literature review.. Journal of the American College of Cardiology. 2024;83(13):/$44$YR$$M$Y$$$20240910$$MD$US$US
243013252$24301325$2$F$20210101$20240912$20240910$20240914$EXP$$US-ABBVIE-5913912$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243013261$24301326$1$I$20240905$20240906$20240910$20240910$EXP$$NVSC2024US180334$NOVARTIS$$67$YR$$M$Y$$$20240910$$CN$US$US
243013271$24301327$1$I$$20231106$20240910$20240910$PER$$US-ALVOGEN-2023092262$ALVOGEN$$50$YR$$$Y$$$20240910$$CN$US$US
243013282$24301328$2$F$$20240905$20240910$20240916$PER$$US-AMGEN-USASP2024177997$AMGEN$$40$YR$A$M$Y$$$20240916$$CN$US$US
243013291$24301329$1$I$20240904$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179348$AMGEN$$90$YR$E$F$Y$$$20240910$$HP$US$US
243013301$24301330$1$I$$20240907$20240910$20240910$PER$$US-ABBVIE-5915188$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243013311$24301331$1$I$20240814$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179384$AMGEN$$65$YR$E$F$Y$$$20240910$$CN$US$US
243013321$24301332$1$I$$20240829$20240910$20240910$EXP$$US-Accord-445379$ACCORD$$40$YR$A$M$Y$$$20240910$$HP$US$US
243013331$24301333$1$I$20240828$20240829$20240910$20240910$EXP$$US-Accord-445190$ACCORD$$35$YR$A$F$Y$$$20240910$$HP$US$US
243013344$24301334$4$F$20240101$20240920$20240910$20240930$EXP$$CA-CELLTRION INC.-2024CA021496$CELLTRION$$$$$$Y$$$20240930$$CN$CA$CA
243013351$24301335$1$I$$20240909$20240910$20240910$EXP$$DE-SANDOZ INC.-SDZ2024DE078637$SANDOZ$$60$YR$$M$Y$$$20240910$$MD$DE$DE
243013361$24301336$1$I$$20240904$20240910$20240910$EXP$$EG-AMGEN-EGYSP2024177327$AMGEN$Eltelbanei,M. Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen before autologous hematopoietic cell transplantation. BMC Cancer. 2024;24(1)$$$$$Y$$$20240910$$HP$EG$EG
243013371$24301337$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141714$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240910$$CN$US$US
243013381$24301338$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142862$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$122.92$KG$20240910$$CN$US$US
243013401$24301340$1$I$20240101$20240903$20240910$20240910$EXP$$BR-JNJFOC-20240911360$JOHNSON AND JOHNSON$$60$YR$A$F$Y$70$KG$20240910$$CN$BR$BR
243013411$24301341$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004663$ELI LILLY AND CO$$46$YR$A$$Y$$$20240910$$CN$US$US
243013421$24301342$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004499$ELI LILLY AND CO$$54$YR$A$$Y$$$20240910$$CN$US$US
243013431$24301343$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004791$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240910$$CN$US$US
243013442$24301344$2$F$20240117$20240919$20240910$20240923$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-142444$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240923$$MD$DE$DE
243013451$24301345$1$I$20240822$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142942$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$68.04$KG$20240910$$CN$US$US
243013461$24301346$1$I$20240801$20240904$20240910$20240910$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900024$RIGEL PHARMACEUTICALS$$79$YR$$F$Y$46.266$KG$20240910$$CN$US$US
243013471$24301347$1$I$$20240902$20240910$20240910$EXP$$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-08303$HIKMA$Maia S, Xavier B, S? M, Antunes E, Morais D, Sampaio J. Maia S, Xavier B, S? M, Antunes E, Morais D, Sampaio J. Edema Pulmonar por Press?o Negativa : Uma Intercorr?ncia Inesperada. Revista da Sociedade Portuguesa de Anestesiologia. 2024;33(Supp. 1):49$19$YR$$M$Y$$$20240910$$MD$PT$PT
243013481$24301348$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004650$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240910$$CN$US$US
243013491$24301349$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004798$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240910$$CN$US$US
243013501$24301350$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004600$ELI LILLY AND CO$$$$$$Y$$$20240910$$CN$US$US
243013511$24301351$1$I$20240904$20240904$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003026$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240910$$CN$US$US
243013531$24301353$1$I$20240808$20240827$20240910$20240910$EXP$$CN-OCTA-ALB14824$OCTAPHARMA$$80$YR$E$M$Y$93$KG$20240909$$HP$CN$CN
243013551$24301355$1$I$20240820$20240829$20240910$20240910$EXP$$US-Accord-445384$ACCORD$$37$YR$A$M$Y$$$20240910$$PH$US$US
243013562$24301356$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686809$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243013571$24301357$1$I$20240830$20240902$20240910$20240910$EXP$$CA-CELLTRION INC.-2024CA021503$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
243013581$24301358$1$I$$20240116$20240910$20240910$PER$$US-ALVOGEN-2023092692$ALVOGEN$$$$$$Y$$$20240910$$CN$US$US
243013591$24301359$1$I$20240819$20240904$20240910$20240910$EXP$PT-INFARMED-R202408-544$PT-TEVA-VS-3240440$TEVA$$1$MON$$F$Y$80$KG$20240910$$MD$PT$PT
243013601$24301360$1$I$$20240829$20240910$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-044289$AUROBINDO$$50$YR$$F$Y$$$20240910$$MD$CA$CA
243013611$24301361$1$I$$20240906$20240910$20240910$PER$$NVSC2024US180660$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243013621$24301362$1$I$20240904$20240907$20240910$20240910$PER$$NVSC2024US180543$NOVARTIS$$7$YR$$$Y$$$20240910$$MD$US$US
243013631$24301363$1$I$20240822$20240830$20240910$20240910$EXP$$PL-ROCHE-10000072842$ROCHE$$$$$$Y$$$20240910$$MD$PL$PL
243013641$24301364$1$I$20220506$20240903$20240910$20240910$EXP$$CA-CELLTRION INC.-2021CA018438$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
243013651$24301365$1$I$20240819$20240902$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-044014$AUROBINDO$$73$YR$$M$Y$$$20240910$$HP$GB$GB
243013661$24301366$1$I$20231101$20240906$20240910$20240910$PER$$US-ROCHE-10000076306$ROCHE$$58$YR$A$F$Y$$$20240910$$CN$US$US
243013671$24301367$1$I$20240831$20240901$20240910$20240910$PER$$US-RDY-SPO/USA/24/0012882$DR REDDYS$$44$YR$A$M$Y$$$20240910$$PH$US$US
243013681$24301368$1$I$$20240829$20240910$20240910$EXP$$US-RDY-SPO/USA/24/0012834$DR REDDYS$$50$YR$A$M$Y$$$20240910$$HP$US$US
243013691$24301369$1$I$20220701$20240903$20240910$20240910$EXP$$DE-AMGEN-DEUSP2024157619$AMGEN$$70$YR$E$F$Y$$$20240910$$MD$DE$DE
243013701$24301370$1$I$$20240217$20240910$20240910$PER$$US-ALVOGEN-2024092842$ALVOGEN$$$$$$Y$$$20240910$$CN$US$US
243013711$24301371$1$I$$20240905$20240910$20240910$PER$$US-ROCHE-10000075105$ROCHE$Boppana L, Sluzevich J, Katsolis J, Narula T, Alvarez F, Sareyyupoglu B, et al. Chromoblastomycosis: a potential mimic of squamous cell carcinoma in transplant recipients. Transplantation Proceedings. 2024-Jul;56 (6):1454-56. doi:10.1016/j.transproceed.2024.05.023.$75$YR$E$M$Y$$$20240910$$HP$US$US
243013721$24301372$1$I$$20240905$20240910$20240910$EXP$$US-ABBVIE-5909383$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243013732$24301373$2$F$20240904$20240904$20240910$20240912$PER$$US-AMGEN-USASP2024176826$AMGEN$$61$YR$A$M$Y$$$20240912$$CN$US$US
243013741$24301374$1$I$$20240904$20240910$20240910$EXP$$CN-AMGEN-CHNSP2024177020$AMGEN$Hu Q.; Lu J.; Bao X. et al.. Safety and efficacy of blinatumomab as bridge-to transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease. Blood Cancer Journal. 2024;14 (1):1-5$$$$$Y$$$20240910$$HP$CN$CN
243013751$24301375$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-080948-2024$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243013761$24301376$1$I$$20240902$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142936$BRISTOL MYERS SQUIBB$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology Communications. 2024 Aug 26;8(9):1-12. doi:10.1097/HC9.0000000000000518.$61$YR$A$F$Y$$$20240910$$HP$US$US
243013771$24301377$1$I$$20240321$20240910$20240910$PER$$US-ALVOGEN-2024093014$ALVOGEN$$$$$M$Y$$$20240910$$CN$US$US
243013781$24301378$1$I$20240205$20240904$20240910$20240910$EXP$FR-AFSSAPS-MP2024001353$FR-AMGEN-FRASP2024176752$AMGEN$$46$YR$A$F$Y$59$KG$20240910$$PH$FR$FR
243013792$24301379$2$F$$20240917$20240910$20240919$EXP$$US-GILEAD-2024-0686840$GILEAD$$$$T$M$Y$$$20240919$$CN$US$US
243013801$24301380$1$I$20240824$20240904$20240910$20240910$EXP$IT-MINISAL02-1000685$IT-AMGEN-ITASP2024176753$AMGEN$$69$YR$E$M$Y$77$KG$20240910$$MD$IT$IT
243013811$24301381$1$I$$20240827$20240910$20240910$PER$$US-BEH-2024178357$CSL BEHRING$$$$$F$Y$$$20240910$$HP$US$US
243013821$24301382$1$I$$20240827$20240910$20240910$PER$$US-BEH-2024178360$CSL BEHRING$$$$$F$Y$$$20240910$$HP$US$US
243013831$24301383$1$I$$20240829$20240910$20240910$EXP$$CH-ROCHE-10000075275$ROCHE$$$$E$$Y$$$20240910$$MD$CH$CH
243013841$24301384$1$I$$20240829$20240910$20240910$EXP$$US-SPECGX-T202401829$SPECGX$Vergidis P, Sendi P, Alkhateeb HB, Nguyen MH. How do I manage refractory invasive pulmonary aspergillosis. Clinical Microbiology and Infection. 2024;30:755-61$77$YR$$M$Y$$$20240910$$HP$US$US
243013851$24301385$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241004$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$37$YR$$M$Y$$$20240910$$HP$ES$ES
243013861$24301386$1$I$20240801$20240903$20240910$20240910$EXP$$US-GSK-US2024109507$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240910$$CN$US$US
243013871$24301387$1$I$$20240904$20240910$20240910$30DAY$$US-GSK-US2024110244$GLAXOSMITHKLINE$$$$$F$Y$$$20240910$$MD$US$US
243013881$24301388$1$I$20200627$20240903$20240910$20240910$EXP$$PL-AUROBINDO-AUR-APL-2024-044363$AUROBINDO$$22$YR$$F$Y$57$KG$20240910$$MD$PL$PL
243013891$24301389$1$I$$20240830$20240910$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-044670$AUROBINDO$$32$YR$$F$Y$$$20240910$$HP$CA$CA
243013902$24301390$2$F$20200101$20240918$20240910$20240927$EXP$$FI-AUROBINDO-AUR-APL-2024-043852$AUROBINDO$Lindstr?m M. y?ik?isen laihduttajan k?velyvaikeus ? osa 1. L??K?RILEHTI. 2024;VSK 79:34-5$59$YR$$M$Y$$$20240927$$MD$FI$FI
243013911$24301391$1$I$$20240515$20240910$20240910$PER$$US-ALVOGEN-2024094081$ALVOGEN$$$$$M$Y$$$20240910$$CN$US$US
243013921$24301392$1$I$20240829$20240902$20240910$20240910$EXP$RU-RZN-2541096$RU-SERVIER-S24011090$SERVIER$$$$$$Y$$$20240910$$HP$RU$RU
243013931$24301393$1$I$20040101$20240904$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044606$AUROBINDO$$50$YR$$F$Y$72$KG$20240910$$HP$FR$FR
243013941$24301394$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143460$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240910$$HP$US$US
243013951$24301395$1$I$$20240903$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141018$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$109.32$KG$20240910$$CN$US$US
243013962$24301396$2$F$20240115$20240923$20240910$20240930$EXP$$CO-UCBSA-2024027535$UCB$$36$YR$$F$Y$72$KG$20240930$$CN$CO$CO
243013971$24301397$1$I$20240808$20240909$20240910$20240910$EXP$$CN-ROCHE-10000077394$ROCHE$$61$YR$A$F$Y$60$KG$20240910$$HP$CN$CN
243013981$24301398$1$I$20200527$20240905$20240910$20240910$EXP$PL-URPL-1-1597-2020$PL-TEVA-VS-3240956$TEVA$$81$YR$$F$Y$68$KG$20240910$$HP$PL$PL
243013991$24301399$1$I$20230520$20240905$20240910$20240910$EXP$FR-AFSSAPS-AM2024000710$FR-RDY-SPO/FRA/24/0013012$DR REDDYS$$71$YR$A$F$Y$62$KG$20240910$$MD$FR$FR
243014001$24301400$1$I$$20240830$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043767$AUROBINDO$$81$YR$$F$Y$$$20240910$$PH$GB$GB
243014011$24301401$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180759$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243014021$24301402$1$I$$20240521$20240910$20240910$PER$US-ALVOGEN-2024094427$US-ALVOGEN-2024094427$ALVOGEN$$$$$$Y$$$20240910$$CN$US$US
243014032$24301403$2$F$$20240830$20240910$20240924$PER$$US-ROCHE-10000072124$ROCHE$$$$E$F$Y$$$20240924$$CN$US$US
243014051$24301405$1$I$20240829$20240830$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043809$AUROBINDO$$74$YR$$F$Y$$$20240910$$HP$GB$GB
243014061$24301406$1$I$$20240829$20240910$20240910$EXP$$IN-CHIESI-2024CHF05523$CHIESI$$$$N$M$Y$$$20240910$$MD$IN$IN
243014071$24301407$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003987$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240910$$CN$US$US
243014081$24301408$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004412$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240910$$CN$US$US
243014091$24301409$1$I$20240603$20240904$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409002642$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240910$$HP$US$US
243014101$24301410$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004476$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240910$$CN$US$US
243014111$24301411$1$I$20240901$20240903$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409001391$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240910$$PH$US$US
243014122$24301412$2$F$20140101$20240910$20240910$20240921$EXP$$PL-AUROBINDO-AUR-APL-2019-093681$AUROBINDO$Turno-Krecicka A, Tomczyk-Socha M, Zimny A. Progressive outer retinal necrosis syndrome in the course of systemic lupus erythematosus. Lupus. 2016;25(14):1610-1614$44$YR$$F$Y$$$20240921$$MD$PL$PL
243014131$24301413$1$I$$20240903$20240910$20240910$EXP$$DE-ABBVIE-5913661$ABBVIE$$64$YR$$F$Y$$$20240910$$MD$DE$DE
243014142$24301414$2$F$20200101$20240909$20240910$20240916$EXP$$US-AMGEN-USASP2024178754$AMGEN$$72$YR$E$M$Y$$$20240916$$CN$US$US
243014151$24301415$1$I$20240801$20240906$20240910$20240910$PER$$US-ABBVIE-5914012$ABBVIE$$$$$$Y$$$20240910$$HP$US$US
243014171$24301417$1$I$$20240904$20240910$20240910$EXP$$NVSC2024US179314$NOVARTIS$$$$$F$Y$$$20240910$$CN$US$US
243014181$24301418$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179611$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243014191$24301419$1$I$$20240523$20240910$20240910$PER$US-ALVOGEN-2024094354$US-ALVOGEN-2024094354$ALVOGEN$$$$$$Y$$$20240910$$CN$US$US
243014201$24301420$1$I$20240301$20240904$20240910$20240910$EXP$$US-TAKEDA-2024TUS083426$TAKEDA$$25$YR$$M$Y$$$20240910$$CN$US$US
243014211$24301421$1$I$20220608$20240905$20240910$20240910$EXP$$ES-AMGEN-ESPSP2024177767$AMGEN$$76$YR$E$M$Y$85.6$KG$20240910$$MD$ES$ES
243014221$24301422$1$I$20240501$20240903$20240910$20240910$EXP$$BR-TAKEDA-2024TUS089716$TAKEDA$$52$YR$$F$Y$$$20240910$$CN$BR$BR
243014232$24301423$2$F$20240414$20240910$20240910$20240918$EXP$$PR-BIOGEN-2024BI01266256$BIOGEN$$32$YR$$F$Y$83.99$KG$20240918$$CN$PR$PR
243014241$24301424$1$I$$20240903$20240910$20240910$EXP$$US-BIOGEN-2024BI01281170$BIOGEN$$$$$F$Y$$$20240910$$HP$US$US
243014251$24301425$1$I$20240601$20240904$20240910$20240910$EXP$$US-BIOGEN-2024BI01281085$BIOGEN$$74$YR$$F$Y$$$20240910$$CN$US$US
243014261$24301426$1$I$$20240805$20240910$20240910$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461749$RANBAXY$$59$YR$$F$Y$$$20240910$$CN$US$US
243014271$24301427$1$I$$20240830$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044016$AUROBINDO$Ikic A, Chatelus E, Epailly E, Kremer H, Sibilia J, Gottenberg J, et al.. Heart transplantation in 6 patients with systemic sclerosis and a primary cardiac involvement.. Default Record. 2014;1$$$$M$Y$$$20240910$$HP$FR$FR
243014281$24301428$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241005$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$44$YR$$F$Y$$$20240910$$HP$ES$ES
243014291$24301429$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241006$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$56$YR$$M$Y$$$20240910$$HP$ES$ES
243014311$24301431$1$I$$20240831$20240910$20240910$EXP$$US-BEH-2024178140$CSL BEHRING$$$$$F$Y$$$20240910$$CN$US$US
243014321$24301432$1$I$20240625$20240903$20240910$20240910$EXP$$CN-BEIGENE-BGN-2024-013957$BEIGENE$$$$$$Y$$$20240910$$HP$CN$CN
243014331$24301433$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241007$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$70$YR$$F$Y$$$20240910$$HP$ES$ES
243014341$24301434$1$I$$20240523$20240910$20240910$PER$US-ALVOGEN-2024094436$US-ALVOGEN-2024094436$ALVOGEN$$$$$$Y$$$20240910$$CN$US$US
243014351$24301435$1$I$20240901$20240905$20240910$20240910$EXP$$CA-JNJFOC-20240915645$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240910$$PH$CA$CA
243014361$24301436$1$I$$20240820$20240910$20240910$PER$$US-JNJFOC-20240857342$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240910$$CN$US$US
243014371$24301437$1$I$$20240906$20240910$20240910$PER$$US-JNJFOC-20240915788$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$HP$US$US
243014381$24301438$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241008$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$51$YR$$M$Y$$$20240910$$HP$ES$ES
243014392$24301439$2$F$$20240924$20240910$20240930$EXP$$GR-TAKEDA-2024TUS078420$TAKEDA$$46$YR$$F$Y$$$20240930$$CN$GR$GR
243014402$24301440$2$F$$20240913$20240910$20240918$EXP$$US-TAKEDA-2024TUS088975$TAKEDA$$$$$M$Y$$$20240918$$CN$US$US
243014411$24301441$1$I$$20240820$20240910$20240910$PER$$US-009507513-2408USA007477$MERCK$Manjunath J, Liao V, Kambala A, Bao A, Kollhoff AL, Ma EZ et al.. Immune stimulus exposure as a trigger for the development of chronic pruritus and circulating blood type 2 inflammation. JAAD Int. 2024;16 ():97-102$62$YR$$M$Y$$$20240910$$HP$US$US
243014421$24301442$1$I$$20240830$20240910$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-044673$AUROBINDO$$54$YR$$F$Y$$$20240910$$HP$CA$CA
243014432$24301443$2$F$20240822$20240830$20240910$20240911$EXP$$US-UCBSA-2024044163$UCB$$23$YR$$M$Y$$$20240911$$MD$US$US
243014441$24301444$1$I$$20240906$20240910$20240910$EXP$$US-AstraZeneca-2024A204810$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243014451$24301445$1$I$$20240908$20240910$20240910$PER$$US-AstraZeneca-2024A204312$ASTRAZENECA$$48$YR$$F$Y$86.6$KG$20240910$$CN$US$
243014461$24301446$1$I$20240823$20240905$20240910$20240910$EXP$$GB-AstraZeneca-2024A202435$ASTRAZENECA$$29$YR$$F$Y$$$20240910$$MD$GB$
243014471$24301447$1$I$$20240905$20240910$20240910$EXP$$ZA-AstraZeneca-2024A204620$ASTRAZENECA$$78$YR$$F$Y$$$20240910$$CN$ZA$
243014481$24301448$1$I$20240827$20240829$20240910$20240910$PER$$US-ABBVIE-5903028$ABBVIE$$37$YR$$M$Y$$$20240910$$CN$US$US
243014491$24301449$1$I$$20240905$20240910$20240910$PER$$US-JNJFOC-20240917743$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240910$$CN$US$US
243014501$24301450$1$I$$20240902$20240910$20240910$EXP$FR-EMA-DD-20220121-veeravajhul_p-090605$FR-BIOCON BIOLOGICS LIMITED-BBL2024006509$BIOCON$Altwegg R, Combes R, Laharie D, De Ledinghen V, Radenne S, Conti F, et al.. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.. Dig-Liver-Dis.. 2018;50(7):668-674$$$$$Y$$$20240910$$HP$FR$FR
243014511$24301451$1$I$20240101$20240820$20240910$20240910$PER$$US-009507513-2408USA006900$MERCK$$$$$F$Y$$$20240910$$CN$US$US
243014521$24301452$1$I$20240801$20240906$20240910$20240910$PER$$US-ABBVIE-5913994$ABBVIE$$$$$$Y$$$20240910$$HP$US$US
243014541$24301454$1$I$$20240903$20240910$20240910$EXP$$US-TAKEDA-2024TUS088950$TAKEDA$$$$$M$Y$$$20240910$$CN$US$US
243014551$24301455$1$I$$20240523$20240910$20240910$PER$US-ALVOGEN-2024094426$US-ALVOGEN-2024094426$ALVOGEN$$$$$$Y$$$20240910$$CN$US$US
243014561$24301456$1$I$20240501$20240831$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043886$AUROBINDO$$$$$F$Y$$$20240910$$CN$GB$GB
243014571$24301457$1$I$$20240903$20240910$20240910$PER$$US-AMGEN-USASP2024178525$AMGEN$Walker N.; Beedupalli K.; Ramadas P.et.al. Acute Acquired Hemophilia A Following Snake Bite- A Case Report and Clinical Insights. American Journal of Case Reports. 2024;25:e943621 -1 to e943621-4$50$YR$A$M$Y$$$20240910$$HP$US$US
243014581$24301458$1$I$20240804$20240830$20240910$20240910$EXP$$US-BANNER LIFE SCIENCES-USBAN24000134$BANNER$$$$$$Y$$$20240910$$CN$US$US
243014591$24301459$1$I$20240818$20240831$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-043828$AUROBINDO$$77$YR$$F$Y$125$KG$20240910$$MD$FR$FR
243014601$24301460$1$I$$20240831$20240910$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-044090$AUROBINDO$$$$$M$Y$$$20240910$$CN$DE$DE
243014611$24301461$1$I$$20240905$20240910$20240910$EXP$$IN-ROCHE-10000076047$ROCHE$$52$YR$A$M$Y$$$20240910$$CN$IN$IN
243014621$24301462$1$I$20240822$20240829$20240910$20240910$EXP$$PK-ROCHE-10000069532$ROCHE$$65$YR$E$M$Y$$$20240910$$CN$PK$PK
243014631$24301463$1$I$$20240904$20240910$20240910$PER$$US-LEO Pharma-373329$LEO PHARM$$36$YR$$F$Y$$$20240910$$CN$US$US
243014641$24301464$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR109708$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243014651$24301465$1$I$20240801$20240902$20240910$20240910$EXP$$US-CHIESI-2024CHF05797$CHIESI$$59$YR$$M$Y$$$20240910$$PH$US$US
243014661$24301466$1$I$$20240521$20240910$20240910$PER$US-ALVOGEN-2024094330$US-ALVOGEN-2024094330$ALVOGEN$$$$$$Y$$$20240910$$CN$US$US
243014671$24301467$1$I$20240101$20240903$20240910$20240910$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-00978$CATALYST PHARMA$$$$$F$Y$$$20240910$$CN$US$US
243014681$24301468$1$I$$20240904$20240910$20240910$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-00982$CATALYST PHARMA$$$$$M$Y$$$20240910$$CN$US$US
243014691$24301469$1$I$20240901$20240903$20240910$20240910$EXP$$US-CATALYST PHARMACEUTICALS-US-CATA-24-00980$CATALYST PHARMA$$19$YR$$M$Y$81.633$KG$20240910$$CN$US$US
243014701$24301470$1$I$$20240906$20240910$20240910$EXP$$KR-GILEAD-2024-0686526$GILEAD$$$$$M$Y$$$20240910$$MD$KR$KR
243014712$24301471$2$F$20240901$20240910$20240910$20240911$PER$$US-AMGEN-USASP2024179846$AMGEN$$65$YR$E$F$Y$$$20240911$$CN$US$US
243014721$24301472$1$I$$20240905$20240910$20240910$PER$$US-JNJFOC-20240917791$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240910$$CN$US$US
243014731$24301473$1$I$20200911$20240831$20240910$20240910$EXP$$PL-AUROBINDO-AUR-APL-2024-044259$AUROBINDO$$87$YR$$M$Y$$$20240910$$CN$PL$PL
243014751$24301475$1$I$20200417$20240902$20240910$20240910$EXP$$CA-CELLTRION INC.-2020CA021304$CELLTRION$$$$$$Y$$$20240910$$MD$CA$CA
243014771$24301477$1$I$20240816$20240830$20240910$20240910$EXP$GB-MHRA-MED-202408301453410670-CYLWS$GB-ROCHE-10000071625$ROCHE$$7$YR$C$M$Y$19$KG$20240910$$MD$GB$GB
243014781$24301478$1$I$$20240820$20240910$20240910$PER$$US-HALEON-2196055$Haleon PLC$$65$YR$$F$Y$$$20240910$$CN$US$US
243014791$24301479$1$I$$20240902$20240910$20240910$EXP$$US-RDY-SPO/USA/24/0013066$DR REDDYS$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham III CO, Wigleya FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Seminars in Arthritis and Rheumatism. 2024;67: doi:10.1016/j.semarthrit.2024.152460.$54$YR$A$F$Y$$$20240910$$HP$US$US
243014801$24301480$1$I$20240820$20240902$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043985$AUROBINDO$$48$YR$$M$Y$85$KG$20240910$$CN$GB$GB
243014811$24301481$1$I$$20240905$20240910$20240910$EXP$$ZA-ABBVIE-5877081$ABBVIE$$78$YR$$F$Y$$$20240910$$CN$ZA$ZA
243014831$24301483$1$I$20240401$20240903$20240910$20240910$EXP$$US-GSK-US2024109399$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243014841$24301484$1$I$20230501$20240903$20240910$20240910$EXP$$AR-GSK-AR2023AMR102386$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$AR$AR
243014851$24301485$1$I$20240508$20240830$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-043941$AUROBINDO$$81$YR$$F$Y$$$20240910$$MD$FR$FR
243014861$24301486$1$I$20231101$20240905$20240910$20240910$EXP$$DE-TAKEDA-2024TUS088989$TAKEDA$$$$$F$Y$2.8$KG$20240910$$CN$DE$DE
243014871$24301487$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004176$ELI LILLY AND CO$$$$$M$Y$$$20240910$$MD$US$US
243014881$24301488$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004524$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240910$$CN$US$US
243014891$24301489$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005522$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240910$$CN$US$US
243014901$24301490$1$I$20240905$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004473$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243014911$24301491$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004465$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240910$$CN$US$US
243014921$24301492$1$I$20240901$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004490$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240910$$CN$US$US
243014931$24301493$1$I$$20240904$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004868$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240910$$CN$US$US
243014941$24301494$1$I$$20240903$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141136$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$MD$US$US
243014951$24301495$1$I$20240818$20240909$20240910$20240910$EXP$SE-SEMPA-2024-006569$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-143165$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240910$$MD$SE$SE
243014961$24301496$1$I$$20240829$20240910$20240910$PER$$US-JNJFOC-20240900859$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
243014971$24301497$1$I$$20240903$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141068$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$MD$US$US
243014981$24301498$1$I$$20240821$20240910$20240910$PER$$US-JNJFOC-20240856638$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
243014991$24301499$1$I$20240902$20240902$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043987$AUROBINDO$$54$YR$$F$Y$75$KG$20240910$$MD$GB$GB
243015001$24301500$1$I$$20240903$20240910$20240910$EXP$$AU-ALXN-202409OCE000020AU$ALEXION PHARMACEUTICALS$$34$YR$$F$Y$$$20240910$$MD$AU$AU
243015011$24301501$1$I$20240815$20240906$20240910$20240910$EXP$$CN-GILEAD-2024-0686766$GILEAD$$58$YR$A$M$Y$63$KG$20240910$$HP$CN$CN
243015021$24301502$1$I$$20240902$20240910$20240910$EXP$$CA-APOTEX-2024AP010241$APOTEX$$59$YR$$F$Y$$$20240910$$HP$CA$CA
243015031$24301503$1$I$20201025$20240903$20240910$20240910$EXP$$PL-AUROBINDO-AUR-APL-2024-044459$AUROBINDO$$44$YR$$M$Y$$$20240910$$MD$PL$PL
243015042$24301504$2$F$$20240911$20240910$20240917$EXP$$AU-TAKEDA-2023TUS101815$TAKEDA$$$$$M$Y$$$20240917$$CN$AU$AU
243015051$24301505$1$I$$20240822$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08506$LUPIN$$$$$$Y$$$20240910$$CN$US$US
243015061$24301506$1$I$20240729$20240905$20240910$20240910$EXP$$CN-ROCHE-10000075417$ROCHE$$45$YR$A$F$Y$56.7$KG$20240910$$HP$CN$CN
243015071$24301507$1$I$20240829$20240902$20240910$20240910$EXP$$IT-AUROBINDO-AUR-APL-2024-044318$AUROBINDO$$56$YR$$M$Y$$$20240910$$PH$IT$IT
243015081$24301508$1$I$20240828$20240902$20240910$20240910$EXP$$GB-VANTIVE-2024VAN019506$Vantive US Healthcare$$82$YR$$M$Y$$$20240910$$HP$GB$GB
243015092$24301509$2$F$$20240917$20240910$20240924$EXP$$IN-VANTIVE-2024VAN019552$Vantive US Healthcare$$65$YR$$F$Y$$$20240924$$CN$IN$IN
243015101$24301510$1$I$20240901$20240908$20240910$20240910$EXP$GB-MHRA-MED-202409082040096940-SKLCG$GB-ABBVIE-5913770$ABBVIE$$23$YR$$F$Y$70$KG$20240910$$CN$GB$GB
243015111$24301511$1$I$20240101$20240904$20240910$20240910$EXP$$US-AMGEN-USASP2024178078$AMGEN$$48$YR$A$F$Y$$$20240910$$CN$US$US
243015121$24301512$1$I$$20240904$20240910$20240910$EXP$$US-AMGEN-USASP2024177268$AMGEN$$56$YR$A$F$Y$$$20240910$$MD$US$US
243015131$24301513$1$I$20190202$20240831$20240910$20240910$EXP$$IT-AUROBINDO-AUR-APL-2024-044056$AUROBINDO$$47$YR$$F$Y$70$KG$20240910$$CN$IT$IT
243015141$24301514$1$I$$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024177981$AMGEN$$$$$M$Y$$$20240910$$CN$US$US
243015151$24301515$1$I$20240829$20240829$20240910$20240910$PER$$US-JNJFOC-20240878440$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240910$$CN$US$US
243015171$24301517$1$I$$20240828$20240910$20240910$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08800$LUPIN$$$$$$Y$$$20240910$$CN$US$US
243015181$24301518$1$I$$20240905$20240910$20240910$EXP$$IT-AMGEN-ITASP2024179053$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$60$YR$A$F$Y$$$20240910$$HP$IT$IT
243015192$24301519$2$F$$20240911$20240910$20240911$PER$$US-AMGEN-USASP2024177953$AMGEN$$$$$$Y$$$20240911$$CN$US$US
243015201$24301520$1$I$20240822$20240830$20240910$20240910$EXP$$US-UCBSA-2024044994$UCB$$19$YR$$F$Y$$$20240910$$CN$US$US
243015212$24301521$2$F$$20240912$20240910$20240920$EXP$$JP-TEVA-VS-3239753$TEVA$Takamiya R, Fukuda K, Katsurada N, Kawa Y, Satouchi M, Kaneshiro K, et al. EP14.05-022 The Drug Induced Interstitial Lung Disease in Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer. J-Thorac-Oncol 2022; 17 (Suppl.) (9): S553 abstr. EP14.05-022.; Takamiya R, Fukuda K, Katsurada N, Kawa Y, Satouchi M, Kaneshiro K, et al. EP14.05-022 The Drug Induced Interstitial Lung Disease in Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer. J-Thorac-Oncol 2022; 17 (Suppl.) (9): S55...$$$$$Y$$$20240920$$HP$JP$JP
243015223$24301522$3$F$20240101$20240915$20240910$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-027596$UNITED THERAPEUTICS$$$$$F$Y$82.993$KG$20240921$$$US$US
243015251$24301525$1$I$20220320$20240903$20240910$20240910$EXP$IT-MINISAL02-1000257$IT-BIOGEN-2024BI01281229$BIOGEN$$32$YR$$F$Y$$$20240910$$MD$IT$IT
243015261$24301526$1$I$20240401$20240904$20240910$20240910$EXP$$IE-BIOGEN-2024BI01281324$BIOGEN$$21$YR$$F$Y$$$20240910$$HP$IE$IE
243015273$24301527$3$F$$20240913$20240910$20240919$EXP$$IE-ABBVIE-5909459$ABBVIE$Tomkins E, Ruttledge M. Case study 2: Layering multiple migraine treatments-tales of the unexpected. Neurology.2024;30(7):26-28.; Tomkins E, Ruttledge M. Case study 2: Layering multiple migraine treatments - tales of the unexpected. Hosp Doct Irel. 2024;30:3-4.$50$YR$$F$Y$$$20240919$$HP$IE$IE
243015281$24301528$1$I$20131101$20240903$20240910$20240910$EXP$$BR-BIOGEN-2024BI01281230$BIOGEN$$36$YR$$M$Y$115$KG$20240910$$CN$BR$BR
243015291$24301529$1$I$$20240904$20240910$20240910$EXP$$PR-BIOGEN-2024BI01281359$BIOGEN$$$$$$Y$$$20240910$$CN$PR$PR
243015301$24301530$1$I$20240907$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143532$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240910$$CN$US$US
243015311$24301531$1$I$$20240905$20240910$20240910$EXP$$US-ABBVIE-5910107$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243015321$24301532$1$I$$20240906$20240910$20240910$EXP$$GB-ABBVIE-5913613$ABBVIE$$$$A$M$Y$$$20240910$$CN$GB$GB
243015331$24301533$1$I$20240101$20240905$20240910$20240910$EXP$$US-ABBVIE-5909567$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243015341$24301534$1$I$20240801$20240905$20240910$20240910$EXP$$GB-ABBVIE-5909245$ABBVIE$$23$YR$$F$Y$$$20240910$$CN$GB$GB
243015351$24301535$1$I$20240904$20240904$20240910$20240910$EXP$$AU-ABBVIE-5906537$ABBVIE$$67$YR$$M$Y$$$20240910$$HP$AU$AU
243015362$24301536$2$F$20240901$20240917$20240910$20240927$PER$$US-ABBVIE-5907941$ABBVIE$$$$$F$Y$90.265$KG$20240927$$PH$US$US
243015371$24301537$1$I$20240827$20240909$20240910$20240910$EXP$$SK-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050440$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240910$$MD$SK$SK
243015381$24301538$1$I$$20240905$20240910$20240910$EXP$$CN-ABBVIE-5909428$ABBVIE$$$$$$Y$$$20240910$$MD$CN$CN
243015391$24301539$1$I$$20240909$20240910$20240910$EXP$$FR-SANDOZ INC.-NVSC2019FR006062$SANDOZ$$41$YR$$M$Y$$$20240910$$MD$FR$FR
243015401$24301540$1$I$$20240827$20240910$20240910$EXP$$US-UCBSA-2024040241$UCB$$$$$M$Y$$$20240910$$HP$US$US
243015411$24301541$1$I$$20240909$20240910$20240910$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050460$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240910$$CN$US$US
243015432$24301543$2$F$$20240909$20240910$20240920$EXP$$PT-AUROBINDO-AUR-APL-2024-036222$AUROBINDO$Lopes B, Furtado D, Freitas J, Azevedo S, Caley L, Pedro F, et al. OLMESARTAN ENTEROPATHY ? A RARE CAUSE OF CHRONIC DIARROHEA. Medicina Interna. 2024;30 (Sup 1):340$72$YR$$F$Y$$$20240920$$MD$PT$PT
243015441$24301544$1$I$$20240905$20240910$20240910$EXP$$IT-AMGEN-ITASP2024179032$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$54$YR$A$M$Y$$$20240910$$HP$IT$IT
243015451$24301545$1$I$20240715$20240902$20240910$20240910$EXP$SE-SEMPA-2024-006117$SE-AMGEN-SWESP2024176832$AMGEN$$78$YR$E$F$Y$$$20240910$$HP$SE$SE
243015461$24301546$1$I$$20240904$20240910$20240910$PER$$US-AMGEN-USASP2024177555$AMGEN$$$$$M$Y$$$20240910$$CN$US$US
243015481$24301548$1$I$$20240904$20240910$20240910$EXP$$US-AMGEN-USASP2024178221$AMGEN$Khadka S.; Dong N.; Chavez J. et.al. Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CUP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Single-Center Experience. Clinical Lymphoma Clinical Lymphoma. 2024;24:S480$$$$$Y$$$20240910$$MD$US$US
243015491$24301549$1$I$$20240904$20240910$20240910$EXP$$IT-TAKEDA-2024TUS088885$TAKEDA$$$$$F$Y$$$20240910$$CN$IT$IT
243015501$24301550$1$I$$20240903$20240910$20240910$EXP$$FR-ADIENNEP-2024AD000720$ADIENNE PHARMA + BIOTECH$Franchi V, Labussiere-Wallet H, Chouik Y,Heiblig M, Larcher M. LAM UBTF-TD compliquee de MVO post-allogreffe traitee par transplantation hepatique [Liver transplantation for VOD/SOS after HSCT in a UBTF-TD AML]. Correspondances en Onco-Hematologie. 2023,XVIII(6):349-51. [Article in French]$$$A$M$Y$$$20240906$$MD$FR$
243015511$24301551$1$I$$20240821$20240910$20240910$PER$$US-TEVA-VS-3237185$TEVA$$55$YR$$F$Y$$$20240910$$MD$US$US
243015521$24301552$1$I$20240905$20240905$20240910$20240910$PER$$NVSC2024US179476$NOVARTIS$$21$YR$$F$Y$$$20240910$$HP$US$US
243015541$24301554$1$I$$20240906$20240910$20240910$EXP$$US-AMGEN-USASP2024178629$AMGEN$Kalangi H.; Boadla L.R.; Perlman D.C. et al.. A true challenge Disseminated tuberculosis with tuberculous meningitis in a patient with underlying chronic liver disease. IDCases. 2024;37:1-6$67$YR$E$F$Y$$$20240910$$HP$US$US
243015551$24301555$1$I$20240101$20240904$20240910$20240910$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027896$UNITED THERAPEUTICS$$$$$M$Y$79.365$KG$20240910$$PH$US$US
243015561$24301556$1$I$$20240904$20240910$20240910$EXP$PL-URPL-1-1711-2020$PL-TEVA-VS-3240371$TEVA$$30$YR$$F$Y$60$KG$20240910$$MD$PL$PL
243015571$24301557$1$I$$20240903$20240910$20240910$EXP$$CA-JNJFOC-20240911481$JOHNSON AND JOHNSON$$57$YR$A$M$Y$94$KG$20240910$$MD$CA$CA
243015581$24301558$1$I$$20240822$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08525$LUPIN$$$$$$Y$$$20240910$$CN$US$US
243015591$24301559$1$I$$20240905$20240910$20240910$EXP$$JP-GILEAD-2024-0686972$GILEAD$$$$A$$Y$$$20240910$$MD$JP$JP
243015601$24301560$1$I$$20240828$20240910$20240910$EXP$$GB-LUPIN PHARMACEUTICALS INC.-2024-08575$LUPIN$$$$$$Y$$$20240910$$PH$GB$GB
243015611$24301561$1$I$20240501$20240903$20240910$20240910$EXP$$PL-GSK-PL2024109350$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$PL$PL
243015621$24301562$1$I$$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202642$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
243015632$24301563$2$F$$20240912$20240910$20240917$EXP$$US-AstraZeneca-2024A204736$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243015641$24301564$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003800$ELI LILLY AND CO$$$$$$Y$$$20240910$$CN$US$US
243015652$24301565$2$F$$20240925$20240910$20240928$PER$$US-ELI_LILLY_AND_COMPANY-US202409004474$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240928$$CN$US$US
243015661$24301566$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003748$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243015671$24301567$1$I$$20240905$20240910$20240910$PER$$US-ALXN-202409USA000421US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243015681$24301568$1$I$20180101$20240903$20240910$20240910$EXP$$CN-JNJFOC-20240920289$JOHNSON AND JOHNSON$$2$DEC$A$F$Y$$$20240910$$HP$CN$CN
243015692$24301569$2$F$20240624$20240918$20240910$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-044251$AUROBINDO$$96$YR$$F$Y$51$KG$20240926$$PH$FR$FR
243015701$24301570$1$I$$20240831$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043896$AUROBINDO$$41$YR$$F$Y$$$20240910$$CN$GB$GB
243015711$24301571$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180921$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243015731$24301573$1$I$20240905$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024177837$AMGEN$$31$YR$A$F$Y$$$20240910$$CN$US$US
243015741$24301574$1$I$$20240905$20240910$20240910$EXP$$IT-AMGEN-ITASP2024179055$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$50$YR$A$M$Y$$$20240910$$HP$IT$IT
243015751$24301575$1$I$20240715$20240909$20240910$20240910$EXP$FR-AFSSAPS-SE2024000688$FR-TAKEDA-2024TUS089605$TAKEDA$$86$YR$$F$Y$$$20240910$$HP$FR$FR
243015762$24301576$2$F$20240520$20240916$20240910$20240923$EXP$$CA-GSK-CA2024065037$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$PH$CA$CA
243015771$24301577$1$I$$20240905$20240910$20240910$EXP$$IT-AMGEN-ITASP2024179054$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$53$YR$A$F$Y$$$20240910$$HP$IT$IT
243015781$24301578$1$I$$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024179336$AMGEN$$$$A$F$Y$$$20240910$$MD$US$US
243015791$24301579$1$I$$20240830$20240910$20240910$EXP$$CA-APOTEX-2024AP010197$APOTEX$$89$YR$$F$Y$$$20240910$$HP$CA$CA
243015801$24301580$1$I$$20240904$20240910$20240910$EXP$$BE-TAKEDA-2024TUS088958$TAKEDA$$7$YR$$M$Y$$$20240910$$CN$BE$BE
243015811$24301581$1$I$$20240903$20240910$20240910$EXP$$CA-ABBVIE-5906875$ABBVIE$$12$YR$$F$Y$$$20240910$$CN$CA$CA
243015821$24301582$1$I$$20240905$20240910$20240910$PER$$US-LEO Pharma-373357$LEO PHARM$$79$YR$$F$Y$$$20240910$$CN$US$US
243015841$24301584$1$I$$20240830$20240910$20240910$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111820$ZYDUS PHARM$Bajwa NA, Bajwa AA, Ghazala S, Masood U.. Dimethyl Fumarate-Associated Enterocolitis.. Am-J-Ther. 2024;31(4):e448-e450$$$$$Y$$$20240910$$MD$US$US
243015851$24301585$1$I$$20240611$20240910$20240910$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108620$ZYDUS PHARM$$$$$$Y$$$20240910$$CN$US$US
243015861$24301586$1$I$$20240828$20240910$20240910$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111823$ZYDUS PHARM$Al Aboud A, Huston J, Kim SH, O^Leary J.. Not your mama^s mi: chest pain in a postpartum woman.. J-Am-Coll-Cardiol. 2019;73 (Suppl. 1)(9:2978$$$$$Y$$$20240910$$HP$US$US
243015871$24301587$1$I$20240701$20240902$20240910$20240910$EXP$FR-AFSSAPS-TS2024000951$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111957$ZYDUS PHARM$$$$$$Y$$$20240910$$MD$FR$FR
243015891$24301589$1$I$$20240828$20240910$20240910$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111791$ZYDUS PHARM$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.. Cancer-Immunol-Immunother. 2024;73:200:1-9$$$$$Y$$$20240910$$HP$US$US
243015901$24301590$1$I$$20240823$20240910$20240910$PER$$US-ASTELLAS-2024-AER-003801$ASTELLAS$$$$E$M$Y$$$20240910$$MD$US$US
243015911$24301591$1$I$20240822$20240902$20240910$20240910$EXP$FR-AFSSAPS-BR2024000696$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111926$ZYDUS PHARM$$$$$$Y$$$20240910$$MD$FR$FR
243015921$24301592$1$I$20240323$20240902$20240910$20240910$EXP$FR-AFSSAPS-AN2024001185$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111856$ZYDUS PHARM$$$$$$Y$$$20240910$$MD$FR$FR
243015931$24301593$1$I$$20240827$20240910$20240910$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111712$ZYDUS PHARM$Schwartz AH, Sieminski S.. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event.. Am-J-Ophthalmol-Case-Rep. 2023;30:1-4$$$$$Y$$$20240910$$HP$US$US
243015941$24301594$1$I$$20240904$20240910$20240910$PER$$US-TAKEDA-2024TUS088855$TAKEDA$$29$YR$$F$Y$$$20240910$$CN$US$US
243015951$24301595$1$I$20240630$20240903$20240910$20240910$30DAY$$BR-AMGEN-BRASP2024176002$AMGEN$$$$$$Y$$$20240910$$PH$BR$BR
243015961$24301596$1$I$$20240905$20240910$20240910$EXP$$IT-AMGEN-ITASP2024179056$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$40$YR$A$M$Y$$$20240910$$HP$IT$IT
243015971$24301597$1$I$20240903$20240905$20240910$20240910$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024110707$VIIV$$30$YR$$M$Y$$$20240910$$HP$US$US
243015981$24301598$1$I$20240812$20240904$20240910$20240910$EXP$$US-GILEAD-2024-0686388$GILEAD$$73$YR$E$F$Y$$$20240910$$HP$US$US
243015991$24301599$1$I$20231031$20240904$20240910$20240910$EXP$$AU-TAKEDA-2023TUS106706$TAKEDA$$33$YR$$F$Y$$$20240910$$CN$AU$AU
243016011$24301601$1$I$20170417$20240904$20240910$20240910$EXP$$CA-TAKEDA-2017TUS011801$TAKEDA$$59$YR$$M$Y$$$20240910$$CN$CA$CA
243016021$24301602$1$I$20240826$20240904$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044611$AUROBINDO$$74$YR$$M$Y$88$KG$20240910$$MD$FR$FR
243016031$24301603$1$I$20230101$20240904$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143559$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240910$$HP$US$US
243016041$24301604$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142892$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240910$$CN$US$US
243016051$24301605$1$I$20240522$20240603$20240910$20240910$PER$$US-CELLTRION INC.-2024US012729$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243016061$24301606$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142899$BRISTOL MYERS SQUIBB$$27$YR$A$M$Y$$$20240910$$MD$US$US
243016071$24301607$1$I$$20240822$20240910$20240910$EXP$$US-SA-2024SA260518$SANOFI AVENTIS$$$$E$M$Y$86.18$KG$20240910$$MD$US$US
243016081$24301608$1$I$$20240902$20240910$20240910$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08340$HIKMA$$33$YR$$F$Y$$$20240910$$PH$CA$CA
243016091$24301609$1$I$$20240905$20240910$20240910$EXP$$IT-AMGEN-ITASP2024179079$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$28$YR$A$M$Y$$$20240910$$HP$IT$IT
243016101$24301610$1$I$20240901$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024179774$AMGEN$$67$YR$E$F$Y$$$20240910$$CN$US$US
243016111$24301611$1$I$20240109$20240906$20240910$20240910$EXP$$ES-AUROBINDO-AUR-APL-2024-044654$AUROBINDO$$83$YR$$M$Y$$$20240910$$MD$ES$ES
243016141$24301614$1$I$20240801$20240829$20240910$20240910$EXP$$US-Accord-445075$ACCORD$$44$YR$A$M$Y$$$20240910$$HP$US$US
243016152$24301615$2$F$$20240923$20240910$20240923$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050446$BOEHRINGER INGELHEIM$$83$YR$E$M$Y$$$20240924$$MD$RU$RU
243016161$24301616$1$I$$20240909$20240910$20240910$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050409$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240910$$HP$US$US
243016171$24301617$1$I$20240822$20240909$20240910$20240910$EXP$PT-INFARMED-F202408-784$PT-ROCHE-10000076541$ROCHE$$61$YR$A$F$Y$56$KG$20240910$$PH$PT$PT
243016181$24301618$1$I$$20240828$20240910$20240910$EXP$$US-SA-2024SA260801$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240910$$CN$US$US
243016191$24301619$1$I$$20240901$20240910$20240910$EXP$$CN-JNJFOC-20240919685$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240910$$HP$CN$CN
243016201$24301620$1$I$$20240829$20240910$20240910$EXP$$US-SA-2024SA260657$SANOFI AVENTIS$$$$A$M$Y$$$20240910$$HP$US$US
243016211$24301621$1$I$20240524$20240524$20240910$20240910$PER$$US-CELLTRION INC.-2024US012749$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243016232$24301623$2$F$20221229$20240919$20240910$20240926$EXP$$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-08308$HIKMA$Soares M, Rosa S, Bettencourt S, Ferreira R, Sardinha M, Dias M, et al.. Soares M, Rosa S, Bettencourt S, Ferreira R, Sardinha M, Dias M, et al. Cytotoxic lesions of the corpus callosum due to FOLFIRINOX chemotherapy. Brain Disorders. 2024;15:100157:/$47$YR$$F$Y$$$20240926$$MD$PT$PT
243016241$24301624$1$I$$20240830$20240910$20240910$PER$$US-ROCHE-10000071748$ROCHE$$$$$F$Y$$$20240910$$HP$US$US
243016251$24301625$1$I$$20240828$20240910$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-043407$AUROBINDO$Muddasani R, Talwar N, Mambetsariev I, Salgia R, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73:200$75$YR$$F$Y$$$20240910$$HP$US$US
243016261$24301626$1$I$$20240905$20240910$20240910$EXP$$IT-AMGEN-ITASP2024179081$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$32$YR$A$M$Y$$$20240910$$HP$IT$IT
243016271$24301627$1$I$20240905$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179449$AMGEN$$44$YR$A$M$Y$$$20240910$$CN$US$US
243016282$24301628$2$F$20240906$20240909$20240910$20240912$PER$$US-AMGEN-USASP2024179141$AMGEN$$52$YR$A$M$Y$$$20240912$$PH$US$US
243016301$24301630$1$I$20240827$20240828$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08679$LUPIN$$$$$$Y$$$20240910$$CN$US$US
243016311$24301631$1$I$$20240905$20240910$20240910$EXP$$IT-AMGEN-ITASP2024179080$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$46$YR$A$M$Y$$$20240910$$HP$IT$IT
243016321$24301632$1$I$$20240828$20240910$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-043404$AUROBINDO$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. CancerImmunol-Immunother. 2024;73 (200):1-9$55$YR$$F$Y$$$20240910$$HP$US$US
243016331$24301633$1$I$$20231215$20240910$20240910$PER$$US-HIKMA PHARMACEUTICALS-US-H14001-23-67855$HIKMA$$$$$F$Y$$$20240910$$HP$US$US
243016341$24301634$1$I$$20240831$20240910$20240910$EXP$$US-TEVA-VS-3239727$TEVA$$$$$M$Y$$$20240910$$CN$US$US
243016351$24301635$1$I$$20240301$20240910$20240910$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-01985$HIKMA$$$$$F$Y$$$20240910$$PH$US$US
243016361$24301636$1$I$$20240904$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409002948$ELI LILLY AND CO$$61$YR$A$$Y$$$20240910$$CN$US$US
243016371$24301637$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005267$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240910$$CN$US$US
243016381$24301638$1$I$$20240125$20240910$20240910$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00883$HIKMA$$$$$M$Y$$$20240910$$CN$US$US
243016391$24301639$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004493$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240910$$CN$US$US
243016401$24301640$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004451$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240910$$CN$US$US
243016411$24301641$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005617$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240910$$CN$US$US
243016421$24301642$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004242$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240910$$CN$US$US
243016431$24301643$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142736$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240910$$PH$US$US
243016441$24301644$1$I$$20240903$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141520$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240910$$CN$US$US
243016451$24301645$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143423$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240910$$CN$US$US
243016461$24301646$1$I$$20240902$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011366$STRIDES$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework.. J-Forens-Legal-Med. 2024;101$88$YR$$F$Y$$$20240910$$HP$US$US
243016471$24301647$1$I$$20240909$20240910$20240910$EXP$$RS-GILEAD-2024-0686827$GILEAD$$31$YR$A$M$Y$$$20240910$$HP$RS$RS
243016481$24301648$1$I$20240525$20240710$20240910$20240910$PER$$US-CELLTRION INC.-2024US012830$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243016491$24301649$1$I$20240810$20240828$20240910$20240910$EXP$FR-AFSSAPS-PA2024001472$FR-Accord-444304$ACCORD$$59$YR$A$M$Y$79$KG$20240909$$MD$FR$FR
243016501$24301650$1$I$20240905$20240905$20240910$20240910$EXP$$CA-JNJFOC-20240915338$JOHNSON AND JOHNSON$$69$YR$E$F$Y$89$KG$20240910$$HP$CA$CA
243016511$24301651$1$I$$20240906$20240910$20240910$EXP$$US-JNJFOC-20240917445$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$HP$US$US
243016521$24301652$1$I$20240822$20240905$20240910$20240910$PER$$US-JNJFOC-20240913066$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
243016531$24301653$1$I$20230101$20240829$20240910$20240910$EXP$$CN-Accord-445670$ACCORD$Huo K, Gao J, Wang Y, Qin X, Ma X. Short segment myelitis as a dominant manifestation of cryptococcal infection: a case report. BMC infectious diseases. 2024;24(1):863. DOI: 10.1186/s12879-024-09756-5.$38$YR$A$M$Y$$$20240910$$HP$CN$CN
243016541$24301654$1$I$20200101$20240822$20240910$20240910$PER$$US-JNJFOC-20240859565$JOHNSON AND JOHNSON$$8$DEC$$F$Y$$$20240910$$CN$US$US
243016551$24301655$1$I$$20240829$20240910$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-043569$AUROBINDO$Kistler EA, Clinebell K, Gannon JM, Nathaniel VI, Lupu AM, Chengappa KNR. Applying Shared Decision Making to the Process of Medication Deprescribing in Schizophrenia. Clin-Ther. 2023;45 (10):1008-1011$42$YR$$M$Y$$$20240910$$HP$US$US
243016561$24301656$1$I$$20240905$20240910$20240910$EXP$GB-MHRA-MIDB-05eb5954-9762-4004-9c3d-bcdfff55175c$GB-SA-2024SA261169$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240910$$PH$GB$GB
243016571$24301657$1$I$$20240902$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011367$STRIDES$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework.. J-Forens-Legal-Med. 2024;101.$95$YR$$$Y$$$20240910$$HP$US$US
243016591$24301659$1$I$$20240904$20240910$20240910$EXP$$IN-ROCHE-10000077365$ROCHE$$65$YR$E$$Y$$$20240910$$MD$IN$IN
243016601$24301660$1$I$20240801$20240829$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044387$AUROBINDO$$29$YR$$F$Y$$$20240910$$MD$FR$FR
243016611$24301661$1$I$$20240905$20240910$20240910$EXP$$US-TAKEDA-2023TUS010812$TAKEDA$$$$$M$Y$$$20240910$$CN$US$US
243016622$24301662$2$F$20240801$20240910$20240910$20240919$EXP$$US-GSK-US2024AMR110560$GLAXOSMITHKLINE$$84$YR$$F$Y$56.23$KG$20240919$$CN$US$US
243016631$24301663$1$I$20230102$20240909$20240909$20240909$DIR$717750$$FDA-CTU$$35$YR$$F$N$135$KG$20240909$N$CN$US$
243016641$24301664$1$I$20240906$20240906$20240910$20240910$PER$$NVSC2024US180331$NOVARTIS$$11$MON$$F$Y$$$20240910$$MD$US$US
243016661$24301666$1$I$20230901$20230907$20240910$20240910$EXP$$US-TEVA-VS-3225519$TEVA$$$$$F$Y$$$20240910$$MD$US$US
243016671$24301667$1$I$20240531$20240531$20240910$20240910$PER$$US-CELLTRION INC.-2024US013260$CELLTRION$$$$$$Y$$$20240910$$CN$US$US
243016681$24301668$1$I$20240731$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408291536152990-RTCPM$GB-UCBSA-2024044062$UCB$$58$YR$$F$Y$$$20240910$$CN$GB$GB
243016691$24301669$1$I$$20240904$20240910$20240910$PER$$US-LEO Pharma-373327$LEO PHARM$$55$YR$$F$Y$$$20240910$$CN$US$US
243016711$24301671$1$I$20240101$20240905$20240910$20240910$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-008545$UNITED THERAPEUTICS$$77$YR$$M$Y$$$20240910$$$JP$JP
243016721$24301672$1$I$20240531$20240531$20240910$20240910$PER$$US-CELLTRION INC.-2024US013310$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243016741$24301674$1$I$$20240905$20240910$20240910$EXP$$IT-AMGEN-ITASP2024179082$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$51$YR$A$M$Y$$$20240910$$HP$IT$IT
243016751$24301675$1$I$$20240905$20240910$20240910$EXP$$IT-AMGEN-ITASP2024179083$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$21$YR$A$F$Y$$$20240910$$HP$IT$IT
243016761$24301676$1$I$20240101$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179644$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243016771$24301677$1$I$20240801$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143162$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240910$$PH$US$US
243016781$24301678$1$I$$20240906$20240910$20240910$EXP$$US-AstraZeneca-2024A204925$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
243016791$24301679$1$I$$20240907$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142857$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$73.94$KG$20240910$$CN$US$US
243016801$24301680$1$I$$20240903$20240910$20240910$EXP$$BR-ROCHE-10000072891$ROCHE$$12$MON$I$F$Y$9.8$KG$20240910$$CN$BR$BR
243016812$24301681$2$F$$20240913$20240910$20240923$EXP$$NVSJ2024JP010617$NOVARTIS$Sakamoto R, Terashita Y, Orihata K, Ahimosato A, Okuda J.. INTRA-ABDOMINAL RUPTURE OF UNDIFFERENTIATED PLEOMORPHIC SARCOMA-A CASE REPORT-. Journal of Japan Surgical Association. 2024;85:278-283$42$YR$$M$Y$$$20240924$$HP$JP$JP
243016821$24301682$1$I$20240401$20240902$20240910$20240910$EXP$SE-SEMPA-2024-006375$SE-AMGEN-SWESP2024179710$AMGEN$$63$YR$A$F$Y$46$KG$20240910$$MD$SE$SE
243016831$24301683$1$I$$20240904$20240910$20240910$EXP$$RO-AMGEN-ROUSP2024178040$AMGEN$$$$$$Y$$$20240910$$MD$RO$RO
243016841$24301684$1$I$20240101$20240905$20240910$20240910$EXP$$US-ABBVIE-5909945$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243016851$24301685$1$I$$20240829$20240910$20240910$EXP$$US-BIOCODEX2-2024001230$BIOCODEX$$3$YR$$M$Y$18.2$KG$20240909$$CN$US$US
243016861$24301686$1$I$20240801$20240904$20240910$20240910$EXP$$GB-ABBVIE-5910499$ABBVIE$$58$YR$$F$Y$$$20240910$$CN$GB$GB
243016871$24301687$1$I$$20240830$20240910$20240910$EXP$$GB-ASTELLAS-2024-AER-004047$ASTELLAS$$88$YR$E$M$Y$108$KG$20240910$$MD$GB$GB
243016882$24301688$2$F$20181001$20240918$20240910$20240930$EXP$$US-Accord-434053$ACCORD$$62$YR$A$F$Y$$$20240930$$LW$US$US
243016892$24301689$2$F$$20240905$20240910$20240919$EXP$DE-EMA-DD-20240826-7482827-170511$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-20442$ALKEM$Kasper P, Gobel H, Michels G. MTOR-induced pneumonitis in a 72-year-old patient after heart transplan. DTSCH MED WOCHENSCHR. 2020;185:189-194$72$YR$$M$Y$57.8$KG$20240919$$MD$DE$DE
243016901$24301690$1$I$$20240826$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08595$LUPIN$$$$$$Y$$$20240910$$CN$US$US
243016911$24301691$1$I$20240815$20240902$20240910$20240910$EXP$$CN-ROCHE-10000072493$ROCHE$$50$YR$A$F$Y$70$KG$20240910$$HP$CN$CN
243016921$24301692$1$I$$20240830$20240910$20240910$EXP$$AU-ASTELLAS-2024-AER-003556$ASTELLAS$$$$$M$Y$$$20240910$$MD$AU$AU
243016931$24301693$1$I$$20240830$20240910$20240910$EXP$GB-MHRA-MIDB-f3fc2ddf-7714-46db-9048-8c21cba62f6f$GB-Accord-444536$ACCORD$$53$YR$A$$Y$$$20240910$$PH$GB$GB
243016961$24301696$1$I$$20240907$20240910$20240910$PER$$US-JNJFOC-20240920154$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
243016971$24301697$1$I$20230601$20240904$20240910$20240910$EXP$$US-ABBVIE-5909050$ABBVIE$$82$YR$$F$Y$$$20240910$$CN$US$US
243016981$24301698$1$I$$20240906$20240910$20240910$EXP$$US-VIIV HEALTHCARE LIMITED-US2024111283$VIIV$$$$$M$Y$$$20240910$$CN$US$US
243016991$24301699$1$I$$20240826$20240910$20240910$PER$$US-COSETTE-CP2024US000231$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243017002$24301700$2$F$$20240906$20240910$20240912$PER$$NVSC2024US180403$NOVARTIS$$$$$$Y$$$20240912$$CN$US$US
243017011$24301701$1$I$20240715$20240909$20240910$20240910$EXP$IT-MINISAL02-1001272$NVSC2024IT180067$NOVARTIS$$44$YR$$F$Y$60$KG$20240910$$MD$IT$IT
243017021$24301702$1$I$20240701$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005022$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240910$$CN$US$US
243017031$24301703$1$I$20240909$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005642$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240910$$CN$US$US
243017041$24301704$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004405$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240910$$CN$US$US
243017051$24301705$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004480$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240910$$CN$US$US
243017061$24301706$1$I$$20240826$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08622$LUPIN$$$$$$Y$$$20240910$$CN$US$US
243017072$24301707$2$F$20240817$20240910$20240910$20240912$PER$$US-AMGEN-USASP2024180007$AMGEN$$45$YR$A$F$Y$$$20240912$$CN$US$US
243017081$24301708$1$I$20240604$20240625$20240910$20240910$PER$$US-CELLTRION INC.-2024US013814$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243017091$24301709$1$I$20240101$20240903$20240910$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-027508$UNITED THERAPEUTICS$$$$$F$Y$$$20240910$$$US$US
243017112$24301711$2$F$20231001$20240913$20240910$20240918$EXP$$EU-BAUSCHBL-2024BNL026578$BAUSCH AND LOMB$$59$YR$$M$Y$$$20240918$$MD$EU$EU
243017121$24301712$1$I$20240901$20240903$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140279$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$90.72$KG$20240910$$PH$US$US
243017141$24301714$1$I$$20240905$20240910$20240910$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-119380$REGENERON$$$$$F$Y$$$20240910$$CN$US$US
243017151$24301715$1$I$$20240909$20240910$20240910$EXP$$ZA-ABBVIE-5915183$ABBVIE$$55$YR$$F$Y$$$20240910$$CN$ZA$ZA
243017161$24301716$1$I$$20240827$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08745$LUPIN$$$$$$Y$$$20240910$$MD$US$US
243017171$24301717$1$I$$20240819$20240910$20240910$EXP$$NL-ABBVIE-5913830$ABBVIE$$$$E$M$Y$81$KG$20240910$$HP$NL$NL
243017181$24301718$1$I$20240731$20240828$20240910$20240910$EXP$CN-HENLIUS-24CN016724$CN-Accord-445895$ACCORD$$50$YR$A$M$Y$70$KG$20240910$$MD$CN$CN
243017191$24301719$1$I$20240501$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179355$AMGEN$$$$A$F$Y$$$20240910$$CN$US$US
243017202$24301720$2$F$20240907$20240910$20240910$20240912$PER$$US-AMGEN-USASP2024179759$AMGEN$$49$YR$A$F$Y$$$20240912$$CN$US$US
243017212$24301721$2$F$20240904$20240906$20240910$20240913$PER$$US-AMGEN-USASP2024179388$AMGEN$$60$YR$A$F$Y$$$20240913$$CN$US$US
243017221$24301722$1$I$$20240830$20240910$20240910$EXP$GB-MHRA-MIDB-730a0f6d-d33e-4bb2-a941-4a8a6061f182$GB-Accord-444521$ACCORD$$15$YR$T$F$Y$$$20240910$$PH$GB$GB
243017231$24301723$1$I$20220325$20240902$20240910$20240910$EXP$$FR-AstraZeneca-2024A199176$ASTRAZENECA$$74$YR$$M$Y$77$KG$20240910$$MD$FR$
243017252$24301725$2$F$20240829$20240917$20240910$20240925$PER$$US-BAUSCHBL-2024BNL032670$BAUSCH AND LOMB$$61$YR$$M$Y$97.522$KG$20240926$$CN$US$US
243017261$24301726$1$I$20240801$20240830$20240910$20240910$PER$$US-BAUSCHBL-2024BNL032672$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240910$$CN$US$US
243017271$24301727$1$I$20240827$20240903$20240910$20240910$EXP$$US-CORIUM, LLC-2024COR000168$CORIUM$$13$YR$$M$Y$$$20240910$$$US$US
243017291$24301729$1$I$$20240904$20240910$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-027879$UNITED THERAPEUTICS$$$$$F$Y$70.748$KG$20240910$$$US$US
243017301$24301730$1$I$20240827$20240827$20240910$20240910$PER$$US-ABBVIE-5905620$ABBVIE$$62$YR$$F$Y$78$KG$20240910$$CN$US$US
243017311$24301731$1$I$$20240904$20240910$20240910$EXP$$NVSC2024US178066$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
243017321$24301732$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180872$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243017331$24301733$1$I$20240905$20240905$20240910$20240910$EXP$$NVSC2024US178895$NOVARTIS$$43$YR$$F$Y$$$20240910$$CN$US$US
243017341$24301734$1$I$20220101$20240906$20240910$20240910$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-120041$REGENERON$$$$$F$Y$$$20240910$$CN$US$US
243017351$24301735$1$I$$20240902$20240910$20240910$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006648$BIOCON$$$$$$Y$$$20240910$$CN$CA$CA
243017361$24301736$1$I$$20240826$20240910$20240910$EXP$$GB-EPICPHARMA-GB-2024EPCLIT01077$EPIC PHARM$Divya Khanna.A topical matter: iatrogenic adrenal crisis following excessive prescription corticosteroid use..British Journal of Dermatology .2024;192:i188$39$YR$A$M$Y$$$20240910$$HP$GB$GB
243017371$24301737$1$I$$20240830$20240910$20240910$EXP$$CA-APOTEX-2024AP010194$APOTEX$$78$YR$$F$Y$62$KG$20240910$$PH$CA$CA
243017412$24301741$2$F$$20240905$20240910$20240918$EXP$$JP-UCBSA-2024044848$UCB$$8$DEC$$F$Y$$$20240918$$PH$JP$JP
243017421$24301742$1$I$$20240830$20240910$20240910$EXP$$IN-ROCHE-3571960$ROCHE$$73$YR$E$M$Y$50$KG$20240910$$CN$IN$IN
243017431$24301743$1$I$$20240903$20240910$20240910$EXP$$NZ-GSK-NZ2024109105$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$HP$NZ$NZ
243017441$24301744$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR110097$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243017451$24301745$1$I$$20240905$20240910$20240910$EXP$$US-GSK-US2024110639$GLAXOSMITHKLINE$$$$$M$Y$$$20240910$$MD$US$US
243017461$24301746$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143577$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240910$$CN$US$US
243017471$24301747$1$I$$20240905$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143076$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240910$$CN$US$US
243017481$24301748$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143474$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240910$$CN$US$US
243017491$24301749$1$I$20240823$20240831$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139444$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240910$$PH$US$US
243017501$24301750$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142869$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240910$$CN$US$US
243017511$24301751$1$I$20240701$20240906$20240910$20240910$EXP$$HR-ASTELLAS-2024-AER-005307$ASTELLAS$$$$E$M$Y$$$20240910$$MD$HR$HR
243017522$24301752$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0687109$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243017531$24301753$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024178751$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
243017542$24301754$2$F$$20240924$20240910$20240930$EXP$$JP-AMGEN-JPNSP2024176383$AMGEN$Kawashima H.. A Case of Exacerbation of Psoriatic Arthritis after Syphilis. Japanese Society for Psoriasis Research. 2024;37$40$YR$A$M$Y$$$20240930$$MD$JP$JP
243017551$24301755$1$I$20150101$20240905$20240910$20240910$EXP$$CA-Orion Corporation ORION PHARMA-24_00031603$ORION$$14$YR$T$M$Y$$$20240910$$HP$CA$
243017561$24301756$1$I$$20240904$20240910$20240910$EXP$$JP-ABBVIE-5913644$ABBVIE$$$$$M$Y$$$20240910$$CN$JP$JP
243017573$24301757$3$F$$20240906$20240910$20240916$EXP$$CA-CELLTRION INC.-2024CA021173$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
243017581$24301758$1$I$20210601$20240902$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011368$STRIDES$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework.. J-Forens-Legal-Med. 2024;101.$85$YR$$$Y$$$20240910$$HP$US$US
243017591$24301759$1$I$$20240830$20240910$20240910$EXP$$US-TEVA-VS-3239297$TEVA$$$$$M$Y$$$20240910$$LW$US$US
243017601$24301760$1$I$$20240902$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011369$STRIDES$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework.. J-Forens-Legal-Med. 2024;101$63$YR$$F$Y$$$20240910$$HP$US$US
243017612$24301761$2$F$20240905$20240913$20240910$20240916$PER$$US-AMGEN-USASP2024178316$AMGEN$$22$YR$A$F$Y$$$20240916$$MD$US$US
243017621$24301762$1$I$20240703$20240902$20240910$20240910$EXP$FR-AFSSAPS-LY2024001332$FR-TEVA-VS-3239661$TEVA$$66$YR$$F$Y$$$20240910$$CN$FR$FR
243017631$24301763$1$I$$20240903$20240910$20240910$EXP$$BR-TAKEDA-2024TUS088492$TAKEDA$$$$$F$Y$$$20240910$$MD$BR$BR
243017641$24301764$1$I$$20240902$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011370$STRIDES$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework.. J-Forens-Legal-Med. 2024;101$65$YR$$$Y$$$20240910$$HP$US$US
243017651$24301765$1$I$$20240826$20240910$20240910$EXP$$US-PURACAP-US-2024EPCLIT01089$PURACAP$Robert A. Sorabella.Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal.2024;70:e92-e96$12$YR$T$F$Y$63$KG$20240910$$HP$US$US
243017661$24301766$1$I$$20240904$20240910$20240910$PER$$US-ALXN-202409USA000352US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243017671$24301767$1$I$$20240902$20240910$20240910$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14602$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$44$YR$$M$Y$$$20240910$$HP$DE$DE
243017681$24301768$1$I$$20240826$20240910$20240910$EXP$DE-EMA-DD-20240717-7482689-074104$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14612$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$40$YR$$M$Y$$$20240910$$HP$DE$DE
243017691$24301769$1$I$20230830$20240823$20240910$20240910$EXP$$NL-AMGEN-NLDNI2023213491$AMGEN$$68$YR$E$F$Y$$$20240910$$HP$NL$NL
243017701$24301770$1$I$$20240823$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08516$LUPIN$$$$$$Y$$$20240910$$CN$US$US
243017711$24301771$1$I$$20240905$20240910$20240910$EXP$$ES-AMGEN-ESPSP2024177973$AMGEN$De La Cruz-benito B.; Lazaro-del Campo P.; Ramirez-lopez A. et.al. Managing the front-line treatment for diffuse large B cell lymphoma and high-grade B cell lymphoma during the COVID-19 outbreak. British Journal of Haematology. 2020;191 (3):386-389$52$YR$A$F$Y$$$20240910$$HP$ES$ES
243017721$24301772$1$I$20240822$20240906$20240910$20240910$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050375$BOEHRINGER INGELHEIM$$89$YR$E$F$Y$$$20240910$$HP$CO$CO
243017731$24301773$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005366$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240910$$CN$US$US
243017741$24301774$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004885$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240910$$CN$US$US
243017751$24301775$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004760$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240910$$CN$US$US
243017771$24301777$1$I$20240101$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003842$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240910$$CN$US$US
243017781$24301778$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005268$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240910$$CN$US$US
243017791$24301779$1$I$20240905$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004803$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240910$$CN$US$US
243017801$24301780$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004691$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240910$$CN$US$US
243017811$24301781$1$I$$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142523$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$87.09$KG$20240910$$CN$US$US
243017831$24301783$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141754$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$76.2$KG$20240910$$CN$US$US
243017841$24301784$1$I$$20240904$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141266$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240910$$HP$US$US
243017851$24301785$1$I$$20240907$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143281$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$CN$US$US
243017861$24301786$1$I$20240831$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142581$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240910$$CN$US$US
243017871$24301787$1$I$$20240826$20240910$20240910$EXP$$US-PURACAP-US-2024EPCLIT01049$PURACAP$Robert A. Sorabella.Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children. ASAIO Journal.2024;70:e92-e96$14$YR$T$F$Y$129$KG$20240910$$HP$US$US
243017891$24301789$1$I$$20240902$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011373$STRIDES$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al.. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum. 2024;67 (0)$65$YR$$M$Y$$$20240910$$HP$US$US
243017901$24301790$1$I$$20240902$20240910$20240910$EXP$$CN-ROCHE-10000077312$ROCHE$Kou Z, Wang N, Li Y, Li Y, Wang Y, Yu X. Omalizumab in the treatment of asthma induced peripheral blood two-line cell decreased: a case report.. Journal of clinical pulmonary medicine. 2024;29 (9):1453-5. doi:10.3969/j.issn.1009-6663.2024.09.029.$56$YR$A$M$Y$76$KG$20240910$$HP$CN$CN
243017921$24301792$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180867$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243017931$24301793$1$I$$20240906$20240910$20240910$PER$$NVSC2024US180473$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243017941$24301794$1$I$20220101$20240903$20240910$20240910$EXP$$NVSC2024FR180651$NOVARTIS$$$$E$F$Y$$$20240910$$CN$FR$FR
243017951$24301795$1$I$20240903$20240904$20240910$20240910$EXP$$US-TAKEDA-2024TUS071218$TAKEDA$$42$YR$$M$Y$$$20240910$$CN$US$US
243017961$24301796$1$I$20240828$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024178021$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243017971$24301797$1$I$20240801$20240904$20240910$20240910$EXP$$US-AMGEN-USASP2024177374$AMGEN$$71$YR$E$F$Y$$$20240910$$CN$US$US
243017982$24301798$2$F$20240830$20240909$20240910$20240914$PER$$US-AMGEN-USASP2024179097$AMGEN$$58$YR$A$M$Y$$$20240913$$HP$US$US
243017991$24301799$1$I$$20240902$20240910$20240910$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08235$HIKMA$$76$YR$$M$Y$$$20240910$$MD$CA$CA
243018002$24301800$2$F$$20240909$20240910$20240911$EXP$$US-BIOVITRUM-2024-US-011772$BIOVITRUM$$80$YR$$M$Y$$$20240911$$CN$US$US
243018011$24301801$1$I$$20240827$20240910$20240910$PER$$US-BEH-2024178358$CSL BEHRING$$$$$F$Y$$$20240910$$HP$US$US
243018021$24301802$1$I$$20240902$20240910$20240910$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011376$STRIDES$Tao R, Liu C, Zhang W, Zhu Y, Ma Y, Hao S.. Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade.. Oncologist. 2024;29:E90-E96$35$YR$$M$Y$$$20240910$$HP$CN$CN
243018032$24301803$2$F$20240905$20240924$20240910$20240927$PER$$US-BIOVITRUM-2024-US-011782$BIOVITRUM$$90$YR$$F$Y$$$20240927$$CN$US$US
243018041$24301804$1$I$$20240826$20240910$20240910$EXP$$US-PURACAP-US-2024EPCLIT01085$PURACAP$Robert A. Sorabella.Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children.ASAIO Journal.JUL-2024;70 No. 7: e92-e96$15$YR$T$F$Y$49$KG$20240910$$HP$US$US
243018051$24301805$1$I$$20240902$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011343$STRIDES$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework.. J-Forens-Legal-Med. 2024;101$82$YR$$$Y$$$20240910$$HP$US$US
243018071$24301807$1$I$$20240830$20240910$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-044675$AUROBINDO$Farrell.B. Communicating adverse drug events: serotonin toxicity. Prescriber. 2023;34:11-12:19-24$$$$$Y$$$20240910$$PH$CA$CA
243018081$24301808$1$I$$20240829$20240910$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-043371$AUROBINDO$Bell AP, Custer MK, Presley S. Pyoderma Gangrenosum in a 75-Year-Old Male With Follicular Diffuse Large B-cell Lymphoma. Cureus. 2024;16 (8):e67234$75$YR$$M$Y$$$20240910$$MD$US$US
243018091$24301809$1$I$$20240828$20240910$20240910$EXP$$CN-AUROBINDO-AUR-APL-2024-043369$AUROBINDO$Tang J, Lu P, Yang H, Qian H, Xi J, Shen J. Death due to severe hypoglycemia caused by diclofenac sodium and lidocaine injection. [Chinese].. Advers-Drug-React-J. 2021;23(6):324-325$53$YR$$M$Y$$$20240910$$HP$CN$CN
243018101$24301810$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024109422$GLAXOSMITHKLINE$$$$$F$Y$$$20240910$$HP$US$US
243018111$24301811$1$I$$20240902$20240910$20240910$EXP$$KW-AMGEN-KWTSP2024175342$AMGEN$Hasaneen M.. Retrospective Analysis of a Group of Early Relapsed Multiple Myeloma (MM) Patients Treated by Daratumumab Carfilzomib Dexamethasone (DKD). Clinical Lymphoma Myeloma and Leukemia. 2024;24:S542-S543$$$$$Y$$$20240910$$MD$KW$KW
243018131$24301813$1$I$$20230829$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2023US021966$SANDOZ$$$$$M$Y$$$20240910$$CN$US$US
243018141$24301814$1$I$$20240823$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08518$LUPIN$$$$$M$Y$$$20240910$$PH$US$US
243018152$24301815$2$F$$20240910$20240910$20240911$PER$$US-AMGEN-USASP2024179669$AMGEN$$$$$M$Y$$$20240911$$CN$US$US
243018161$24301816$1$I$20240907$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024179693$AMGEN$$70$YR$E$M$Y$$$20240910$$CN$US$US
243018171$24301817$1$I$$20240903$20240910$20240910$EXP$$JP-AMGEN-JPNSP2024175397$AMGEN$$$$$$Y$$$20240910$$PH$JP$JP
243018181$24301818$1$I$$20240709$20240910$20240910$EXP$$ID-ROCHE-10000076894$ROCHE$$$$$F$Y$$$20240910$$CN$ID$ID
243018191$24301819$1$I$20220601$20240903$20240910$20240910$EXP$$RO-AMGEN-ROUSP2024176878$AMGEN$$70$YR$E$M$Y$$$20240910$$MD$RO$RO
243018202$24301820$2$F$$20240910$20240910$20240921$EXP$$PL-AUROBINDO-AUR-APL-2019-083593$AUROBINDO$Boratynska M, Obremska M, Malecki R, Gacka M, Magott M, Kaminska D, et al... Impact of immunosuppressive treatment on the cardiovascular system in patients after hand transplantation.. Transplantation Proceedings (F). 2014;46(8):2890-3$44$YR$$M$Y$$$20240921$$HP$PL$PL
243018211$24301821$1$I$$20240826$20240910$20240910$EXP$$DE-PURACAP-DE-2024EPCLIT01087$PURACAP$Raw Bingart.Suicide of minors Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock.Rechtsmedizin.30-JUN-2023;33:396-402$14$YR$T$F$Y$$$20240910$$MD$DE$DE
243018221$24301822$1$I$20240101$20240903$20240910$20240910$EXP$$US-ABBVIE-5905612$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243018231$24301823$1$I$$20240828$20240910$20240910$PER$$US-JNJFOC-20240903285$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$HP$US$US
243018241$24301824$1$I$$20240906$20240910$20240910$PER$$US-ROCHE-10000077018$ROCHE$$$$A$M$Y$$$20240910$$HP$US$US
243018251$24301825$1$I$$20240831$20240910$20240910$EXP$$DE-AUROBINDO-AUR-APL-2024-044170$AUROBINDO$$$YR$$M$Y$$$20240910$$MD$DE$DE
243018261$24301826$1$I$$20240830$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044025$AUROBINDO$Kanitakis J, Karayannopoulou G, Lanzetta M, P Petruzzo. Graft vasculopathy in the skin of a human hand allograft: implications for diagnosis of rejection of vascularized composite allografts.. Transplant international. 2014;1-6$$$$M$Y$$$20240910$$HP$FR$FR
243018271$24301827$1$I$$20240905$20240910$20240910$PER$$US-ALXN-202409USA000478US$ALEXION PHARMACEUTICALS$$$$$F$Y$108.84$KG$20240910$$CN$US$US
243018291$24301829$1$I$20240101$20240904$20240910$20240910$PER$$US-AMGEN-USASP2024180018$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
243018301$24301830$1$I$$20240905$20240910$20240910$EXP$$DE-AMGEN-DEUSP2024178669$AMGEN$Korge B.; Vanhooteghem O.; Lynde C.W. et al.. Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One year Results from the CIMREAL Study. Dermatology and Therapy. 2024;14 (8):2077-2092$$$$$Y$$$20240910$$HP$DE$DE
243018311$24301831$1$I$$20240830$20240910$20240910$EXP$$US-MYLANLABS-2024M1081434$MYLAN$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$59$YR$$F$Y$$$20240910$$MD$US$US
243018321$24301832$1$I$$20240902$20240910$20240910$EXP$$US-MYLANLABS-2024M1081855$MYLAN$Russe-Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwari A. Rousing drug-induced liver injury through cytochrome p450 isoenzyme overload leading to fulminant liver failure. J-Liver-Transplant 2024; 14.$40$YR$$F$Y$$$20240910$$HP$US$US
243018331$24301833$1$I$$20240902$20240910$20240910$EXP$$US-MYLANLABS-2024M1081909$MYLAN$Ordway S, Sadowski B, Driggers KE, Kwok R. Severe Drug-Induced Liver Injury in the Military: A Retrospective Review. Mil-Med 2023; 188 (5-6): e991-e996.$$$$M$Y$$$20240910$$MD$US$US
243018341$24301834$1$I$$20240828$20240910$20240910$EXP$$US-MYLANLABS-2024M1079898$MYLAN$Wang N. Neurologic Complications of Cancer Immunotherapy. Continuum-Minneap-Minn 2023; 29 1827-1843.$42$YR$$F$Y$$$20240910$$HP$US$US
243018351$24301835$1$I$$20240902$20240910$20240910$EXP$$US-MYLANLABS-2024M1081761$MYLAN$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024; 67 (0).$60$YR$$F$Y$$$20240910$$HP$US$US
243018361$24301836$1$I$$20240828$20240910$20240910$EXP$$US-MYLANLABS-2024M1080531$MYLAN$De Marsh SJ, Orr B, Willard N, Dahl N. A unique case of cns diffuse, non-systemic alk+ histiocytosis in a pediatric patient. Neuro-Oncol 2024; 26 (Suppl. 4) iv59 abstr. ETMR-31.$20$MON$$M$Y$$$20240910$$HP$US$US
243018371$24301837$1$I$$20240830$20240910$20240910$EXP$$US-MYLANLABS-2024M1081462$MYLAN$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$52$YR$$F$Y$$$20240910$$MD$US$US
243018381$24301838$1$I$$20240828$20240910$20240910$EXP$$US-MYLANLABS-2024M1080533$MYLAN$Barrison L, Park S, Decherney A. Spontaneous conception in a 40-year-old woman after allogeneic stem cell transplant with active graft-versus-host disease: A case report. Case-Rep-Women-Health 2024; 43 1-3.$40$YR$$F$Y$$$20240910$$HP$US$US
243018421$24301842$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143518$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240910$$CN$US$US
243018431$24301843$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142271$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240910$$PH$US$US
243018441$24301844$1$I$20240101$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142790$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240910$$HP$US$US
243018451$24301845$1$I$$20240830$20240910$20240910$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-140347$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$HP$NL$NL
243018461$24301846$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143380$BRISTOL MYERS SQUIBB$$23$YR$A$F$Y$$$20240910$$CN$US$US
243018471$24301847$1$I$20240101$20240827$20240910$20240910$EXP$$US-SA-2024SA261073$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240910$$CN$US$US
243018481$24301848$1$I$$20240903$20240910$20240910$EXP$$CA-TAKEDA-2024TUS088723$TAKEDA$$$$$F$Y$$$20240910$$CN$CA$CA
243018491$24301849$1$I$20240101$20240905$20240910$20240910$EXP$$US-ABBVIE-5735123$ABBVIE$$$$$F$Y$63$KG$20240910$$CN$US$US
243018501$24301850$1$I$$20240906$20240910$20240910$EXP$$NVSC2024JM180553$NOVARTIS$$$$$F$Y$$$20240910$$MD$JM$JM
243018511$24301851$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180918$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243018521$24301852$1$I$$20240830$20240910$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-044661$AUROBINDO$$54$YR$$F$Y$$$20240910$$HP$CA$CA
243018531$24301853$1$I$$20240828$20240910$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-043403$AUROBINDO$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Ravi Salgia et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. CancerImmunol-Immunother. 2024;73:200$60$YR$$F$Y$$$20240910$$HP$US$US
243018551$24301855$1$I$20240201$20240909$20240910$20240910$EXP$$US-TAKEDA-2024TUS089838$TAKEDA$$47$YR$$F$Y$$$20240910$$HP$US$US
243018571$24301857$1$I$20240701$20240831$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044120$AUROBINDO$$47$YR$$M$Y$83$KG$20240910$$MD$FR$FR
243018581$24301858$1$I$$20240829$20240910$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-043582$AUROBINDO$Meseha M, Qu D, Lykon J, Cofey D. Carflzomib?induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review. Annals of Hematology. 2024$77$YR$$M$Y$$$20240910$$HP$US$US
243018591$24301859$1$I$$20240826$20240910$20240910$EXP$$TR-PURACAP-TR-2024EPCLIT01083$PURACAP$Yazisma Adresi:.Clinicopathological analysis of patients diagnosed with  DRESS.Turkderm-Turkish Archives of Dermatology and Venereology .2023;57:101-107$$$$$Y$$$20240910$$HP$TR$TR
243018602$24301860$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0687117$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243018611$24301861$1$I$$20240902$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011344$STRIDES$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework.. J-Forens-Legal-Med. 2024;101$84$YR$$F$Y$$$20240910$$HP$US$US
243018621$24301862$1$I$$20240829$20240910$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-043935$AUROBINDO$$65$YR$$F$Y$49$KG$20240910$$MD$CA$CA
243018631$24301863$1$I$$20240903$20240910$20240910$EXP$$US-LUOXIN-LUX-2024-US-LIT-00050$LUOXIN AUROVITAS PHARMA(CHENGDU)$$19$YR$A$F$Y$$$20240910$$MD$US$US
243018641$24301864$1$I$20240101$20240904$20240910$20240910$PER$$US-ABBVIE-5910226$ABBVIE$$$$$$Y$$$20240910$$CN$US$US
243018651$24301865$1$I$$20240907$20240910$20240910$PER$$US-AMGEN-USASP2024179588$AMGEN$$$$$$Y$$$20240910$$HP$US$US
243018661$24301866$1$I$$20240902$20240910$20240910$EXP$$JP-AMGEN-JPNSP2024177337$AMGEN$Tachi H.; Takahashi Y.; Watanabe R. et al.. Drug-induced lung injury in a patient treated with prior atezolizuinab and subsequent sotorasib: A case report. Respirology Case Reports. 2024;12:1-4$62$YR$A$F$Y$$$20240910$$HP$JP$JP
243018671$24301867$1$I$$20240906$20240910$20240910$PER$$US-TAKEDA-2024TUS089855$TAKEDA$$$$$$Y$$$20240910$$PH$US$US
243018692$24301869$2$F$$20240912$20240910$20240924$EXP$$GB-AUROBINDO-AUR-APL-2021-038224$AUROBINDO$Sadik A, Jelley M, Ward R.. Depression with psychosis following pregabalin discontinuation.. Progress in Neurology and Psychiatry. 2021;25 (1):19-22$74$YR$$F$Y$$$20240924$$MD$GB$GB
243018701$24301870$1$I$$20240831$20240910$20240910$EXP$GB-CHEPLA-2024010962$GB-JUBILANT PHARMA LTD-2024GB001256$JUBILANT$$16$YR$$M$Y$$$20240910$$CN$GB$GB
243018711$24301871$1$I$$20240902$20240910$20240910$EXP$JP-MLMSERVICE-20240826-PI171437-00327-1$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP001260$JUBILANT$Kato T, Hiyama S, Sano M, Nakamura G, Sugiyama K.. Transient Arginine Vasopressin Deficiency Induced by Valproic Acid Intoxication: A Case Report.. Cureus. 2024;16(7)$42$YR$$F$Y$$$20240910$$MD$JP$JP
243018721$24301872$1$I$20240101$20240903$20240910$20240910$EXP$$JP-SANDOZ INC.-SDZ2024JP078761$SANDOZ$$77$YR$$F$Y$$$20240910$$CN$JP$JP
243018751$24301875$1$I$20240327$20240831$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044250$AUROBINDO$$88$YR$$F$Y$$$20240910$$MD$FR$FR
243018761$24301876$1$I$$20240830$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043780$AUROBINDO$$78$YR$$M$Y$$$20240910$$PH$GB$GB
243018771$24301877$1$I$$20240909$20240910$20240910$EXP$$PL-SANDOZ INC.-SDZ2024PL078636$SANDOZ$$64$YR$$M$Y$$$20240910$$HP$PL$PL
243018781$24301878$1$I$$20240910$20240910$20240910$PER$$US-ROCHE-10000077862$ROCHE$$68$YR$E$M$Y$$$20240910$$CN$US$US
243018791$24301879$1$I$20240901$20240901$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043915$AUROBINDO$$39$YR$$F$Y$$$20240910$$CN$GB$GB
243018801$24301880$1$I$$20240905$20240910$20240910$EXP$$SG-ROCHE-10000075045$ROCHE$Lee H, Lim E, Aslim E, Ng L. De Novo Urological Malignancies After Renal Transplantation: An Asian 30-Year Experience. Clinical Transplantation. 2024;38 (7):1-10. doi:10.1111/ctr.15415.$$$$$Y$$$20240910$$HP$SG$SG
243018811$24301881$1$I$20210101$20240902$20240910$20240910$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011349$STRIDES$Ueda Y, Sakai T, Yamada K, Arita K, Ishige Y, Hoshi D, et al.. Fatal hemophagocytic lymphohistiocytosis with intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case.. Immuno-Med. 2024;47 (3):192-199$61$YR$$F$Y$$$20240910$$HP$JP$JP
243018821$24301882$1$I$$20240909$20240910$20240910$PER$$US-HALEON-2196013$Haleon PLC$$89$YR$$$Y$$$20240910$$CN$US$US
243018831$24301883$1$I$$20230906$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2023US028481$SANDOZ$$88$YR$$F$Y$$$20240910$$CN$US$US
243018841$24301884$1$I$20230301$20240906$20240910$20240910$EXP$DE-BFARM-24006193$DE-SANDOZ INC.-SDZ2024DE078819$SANDOZ$$$$$$Y$$$20240910$$CN$DE$DE
243018852$24301885$2$F$20231201$20240926$20240910$20240927$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050464$BOEHRINGER INGELHEIM$Masuda T, Ishida M, Nakamura M, Nonaka T, Tanaka T, Takahama S. O2-2 A case of microscopic polyangiitis with optic nerve papillitis and exudative otitis media. 94-94.$70$YR$E$M$Y$$$20240927$$MD$JP$JP
243018862$24301886$2$F$$20240906$20240910$20240911$PER$$NVSC2024US180023$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243018871$24301887$1$I$$20240906$20240910$20240910$PER$$US-ABBVIE-5915594$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243018881$24301888$1$I$$20240903$20240910$20240910$EXP$$ID-STRIDES ARCOLAB LIMITED-2024SP011445$STRIDES$Ilmi N, Idrus I, Budhiani S.. A case of recurrent acute generalized exanthematous pustulosis mimicking generalized pustular psoriasis: a diagnostic challenge.. Gazz-Med-Ital-Arch-Sci-Med. 2024;183 (5):471-475.$40$YR$$F$Y$$$20240910$$HP$ID$ID
243018891$24301889$1$I$$20240903$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011434$STRIDES$Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N.. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.. Am-J-Gastroenterol. 2024;119:200-202$$$$$Y$$$20240910$$MD$US$US
243018901$24301890$1$I$$20240902$20240910$20240910$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08341$HIKMA$$$$$$Y$$$20240910$$CN$CA$CA
243018912$24301891$2$F$$20240920$20240910$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409005557$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240923$$CN$US$US
243018921$24301892$1$I$20240601$20240828$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202408018628$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240910$$CN$US$US
243018931$24301893$1$I$$20240903$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409002983$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240910$$CN$US$US
243018941$24301894$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004511$ELI LILLY AND CO$$$$$$Y$$$20240910$$PH$US$US
243018951$24301895$1$I$$20240829$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409000168$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240910$$MD$US$US
243018961$24301896$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005566$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240910$$CN$US$US
243018972$24301897$2$F$20240906$20240909$20240910$20240911$PER$$US-AMGEN-USASP2024179044$AMGEN$$$$$$Y$$$20240911$$CN$US$US
243018981$24301898$1$I$20240801$20240904$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141058$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240910$$HP$US$US
243018991$24301899$1$I$$20240621$20240910$20240910$PER$$US-CELLTRION INC.-2024US014056$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243019001$24301900$1$I$$20240827$20240910$20240910$EXP$$GB-UCBSA-2024043730$UCB$$$$$F$Y$$$20240910$$CN$GB$GB
243019011$24301901$1$I$20240410$20240902$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043959$AUROBINDO$$75$YR$$M$Y$$$20240910$$CN$GB$GB
243019021$24301902$1$I$$20240905$20240910$20240910$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144082$DAIICHI$$$$$F$Y$$$20240910$$CN$US$US
243019031$24301903$1$I$$20240826$20240910$20240910$EXP$$DE-EPICPHARMA-DE-2024EPCLIT01082$EPIC PHARM$Raw. Bingart.Suicide of minors-Retrospective 22-year analysis of the post-mortem and autopsy material of the Institute of Forensic Medicine Rostock .Rechtsmedizin.30-JUN-2023;33:396-402$17$YR$T$F$Y$$$20240910$$HP$DE$DE
243019041$24301904$1$I$20240829$20240902$20240910$20240910$EXP$GB-MHRA-MED-202409021157022960-DVJFR$GB-BAYER-2024A125801$BAYER$$10$YR$C$M$Y$$$20240910$$MD$GB$GB
243019051$24301905$1$I$20240903$20240906$20240910$20240910$EXP$GB-MHRA-MED-202409041029413460-WZBNG$GB-STRIDES ARCOLAB LIMITED-2024SP011461$STRIDES$$76$YR$$M$Y$$$20240910$$HP$GB$GB
243019071$24301907$1$I$$20240904$20240910$20240910$EXP$$IL-STRIDES ARCOLAB LIMITED-2024SP011455$STRIDES$Avidan Y, Aker A, Tabachnikov V.. Prolonged asystole following adenosine. Was it necessary?.. J-Geriatr-Cardiol. 2024;21 (6):686-688$77$YR$$F$Y$$$20240910$$HP$IL$IL
243019081$24301908$1$I$$20240903$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-044154$AUROBINDO$$$$$$Y$$$20240910$$CN$GB$GB
243019091$24301909$1$I$$20240902$20240910$20240910$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006650$BIOCON$$$$$$Y$$$20240910$$CN$CA$CA
243019101$24301910$1$I$$20240903$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-044117$AUROBINDO$$53$YR$$F$Y$104$KG$20240910$$MD$GB$GB
243019111$24301911$1$I$20230915$20230925$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2023US035364$SANDOZ$$68$YR$$F$Y$$$20240910$$MD$US$US
243019121$24301912$1$I$$20240903$20240910$20240910$EXP$$US-ABBVIE-5906449$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243019132$24301913$2$F$$20240906$20240910$20240911$PER$$NVSC2024US180455$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243019141$24301914$1$I$$20240906$20240910$20240910$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-120040$REGENERON$$$$$M$Y$$$20240910$$CN$US$US
243019151$24301915$1$I$$20240909$20240910$20240910$EXP$$IT-SANDOZ INC.-SDZ2024IT078538$SANDOZ$$$$$F$Y$$$20240910$$HP$IT$IT
243019161$24301916$1$I$$20240908$20240910$20240910$EXP$$CA-SPECGX-T202401856$SPECGX$$48$YR$$M$Y$$$20240910$$HP$CA$CA
243019171$24301917$1$I$20240514$20240903$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044326$AUROBINDO$$17$YR$$F$Y$$$20240910$$MD$FR$FR
243019181$24301918$1$I$$20240826$20240910$20240910$EXP$$US-EPICPHARMA-US-2024EPCLIT01050$EPIC PHARM$Cate Enstrom.Cardiogenic Shock Due to Concomitant Use of E-cigarettes and Amphetamine/Dextroamphetamine-associated Cardiomyopathy.US Cardiology.jun-2024;18 (Suppl.)$29$YR$A$M$Y$$$20240910$$HP$US$US
243019191$24301919$1$I$20240501$20240614$20240910$20240910$PER$$US-CELLTRION INC.-2024US014086$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243019211$24301921$1$I$$20240903$20240910$20240910$EXP$GB-MHRA-31738807$GB-862174955-ML2024-04760$Unknown Manufacturer$$$$$$Y$$$20240910$$CN$GB$GB
243019221$24301922$1$I$$20240904$20240910$20240910$PER$$US-ABBVIE-5909460$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243019231$24301923$1$I$$20240830$20240910$20240910$EXP$$DE-862174955-ML2024-04723$Unknown Manufacturer$$$$$$Y$$$20240910$$MD$DE$DE
243019241$24301924$1$I$$20240904$20240910$20240910$EXP$$US-ALXN-202409USA000330US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$HP$US$US
243019251$24301925$1$I$20240908$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024180196$AMGEN$$62$YR$A$F$Y$$$20240910$$CN$US$US
243019261$24301926$1$I$$20240902$20240910$20240910$EXP$PL-URPL-1-1921-2020$PL-TEVA-VS-3239816$TEVA$$84$YR$$F$Y$50$KG$20240910$$MD$PL$PL
243019271$24301927$1$I$20240904$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024178748$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
243019281$24301928$1$I$20240824$20240904$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044741$AUROBINDO$$42$YR$$F$Y$46.7$KG$20240910$$MD$FR$FR
243019311$24301931$1$I$$20240905$20240910$20240910$PER$$US-JNJFOC-20240911767$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$HP$US$US
243019321$24301932$1$I$$20240828$20240910$20240910$EXP$$JP-UCBSA-2024045395$UCB$$72$YR$$F$Y$$$20240910$$PH$JP$JP
243019331$24301933$1$I$$20240826$20240910$20240910$EXP$$IN-EPICPHARMA-IN-2024EPCLIT01081$EPIC PHARM$Kaur P.Carbamazepine-Triggered Hemophagocytic Lymphohistiocytosis: A Case Report and Review of Literature.Pediatric Neurology.MAR-2023;144:69-71$4$YR$C$F$Y$$$20240910$$HP$IN$IN
243019351$24301935$1$I$20220701$20240829$20240910$20240910$EXP$$CA-JNJFOC-20240915880$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$70$KG$20240910$$MD$CA$CA
243019361$24301936$1$I$$20240906$20240910$20240910$PER$$US-HALEON-2195739$Haleon PLC$$$$$$Y$$$20240910$$CN$US$US
243019371$24301937$1$I$$20240829$20240910$20240910$EXP$$UY-ROCHE-10000071000$ROCHE$$$$$F$Y$$$20240910$$HP$UY$UY
243019381$24301938$1$I$20240718$20240904$20240910$20240910$EXP$IT-MINISAL02-1000314$IT-TEVA-VS-3240484$TEVA$$65$YR$$F$Y$56$KG$20240910$$PH$IT$IT
243019391$24301939$1$I$$20240905$20240910$20240910$EXP$$ZA-AstraZeneca-2024A204348$ASTRAZENECA$$$$$F$Y$$$20240910$$MD$ZA$
243019401$24301940$1$I$$20240905$20240910$20240910$EXP$$ZA-AstraZeneca-2024A204370$ASTRAZENECA$$74$YR$$F$Y$$$20240910$$CN$ZA$
243019411$24301941$1$I$$20240903$20240910$20240910$EXP$$JP-AstraZeneca-2024A200991$ASTRAZENECA$$50$YR$$F$Y$$$20240910$$MD$JP$
243019422$24301942$2$F$$20240916$20240910$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142969$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$90.26$KG$20240925$$CN$US$US
243019431$24301943$1$I$20240801$20240904$20240910$20240910$EXP$$US-009507513-2409USA001657$MERCK$$82$YR$$M$Y$$$20240910$$CN$US$US
243019441$24301944$1$I$20240801$20240827$20240910$20240910$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-26569$SAMSUNG BIOEPIS$$39$YR$A$F$Y$$$20240909$$HP$CA$CA
243019451$24301945$1$I$$20240828$20240910$20240910$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24773$SAMSUNG BIOEPIS$$58$YR$A$M$Y$$$20240909$$CN$GB$GB
243019461$24301946$1$I$20220201$20240828$20240910$20240910$EXP$$ES-SAMSUNG BIOEPIS-SB-2024-26649$SAMSUNG BIOEPIS$GARBAYO-SALMONS P, MARTINEZ-LOSA MM, EXPOSITO-SERRANO V, RIBERA M, CALVET J. Insights into new-onset arthritis in patients with hidradenitis suppurativa Garbayo-Salmons. Acta Dermato-Venereologica. 2024 Jun 25;(104): doi:10.2340/actadv.v104.40145.$61$YR$A$M$Y$$$20240910$$HP$ES$ES
243019471$24301947$1$I$20240905$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024179711$AMGEN$$$$$$Y$$$20240910$$CN$US$US
243019481$24301948$1$I$20240905$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179003$AMGEN$$74$YR$E$M$Y$$$20240910$$CN$US$US
243019492$24301949$2$F$20240905$20240926$20240910$20240927$PER$$US-AMGEN-USASP2024179024$AMGEN$$67$YR$E$F$Y$$$20240927$$CN$US$US
243019501$24301950$1$I$$20240901$20240910$20240910$EXP$$US-AMGEN-USASP2024177909$AMGEN$Sawalha Y.;Fleming M.; Huang Y.et.al. Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas. Blood Advances. 2022;6 (2):460-472$$$$$Y$$$20240910$$HP$US$US
243019511$24301951$1$I$20230905$20240905$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-044592$AUROBINDO$$45$YR$$M$Y$69$KG$20240910$$MD$GB$GB
243019522$24301952$2$F$$20240906$20240910$20240912$PER$$NVSC2024US180008$NOVARTIS$$$$$$Y$$$20240912$$CN$US$US
243019532$24301953$2$F$20240101$20240923$20240910$20240928$EXP$$CA-ABBVIE-5908956$ABBVIE$$31$YR$$M$Y$69$KG$20240928$$MD$CA$CA
243019541$24301954$1$I$20240718$20240902$20240910$20240910$EXP$FR-AFSSAPS-LL2024001642$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111931$ZYDUS PHARM$$$$$$Y$$$20240910$$MD$FR$FR
243019551$24301955$1$I$20240809$20240902$20240910$20240910$EXP$FR-AFSSAPS-CN2024000789$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111925$ZYDUS PHARM$$$$$$Y$$$20240910$$PH$FR$FR
243019561$24301956$1$I$20240824$20240902$20240910$20240910$EXP$FR-AFSSAPS-TO2024001663$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111929$ZYDUS PHARM$$$$$$Y$$$20240910$$PH$FR$FR
243019572$24301957$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0687118$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243019581$24301958$1$I$$20240828$20240910$20240910$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111793$ZYDUS PHARM$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.. Cancer-Immunol-Immunother. 2024$$$$$Y$$$20240910$$HP$US$US
243019591$24301959$1$I$$20240828$20240910$20240910$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111794$ZYDUS PHARM$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.. Cancer-Immunol-Immunother. 2024$$$$$Y$$$20240910$$HP$US$US
243019611$24301961$1$I$20240314$20240829$20240909$20240909$DIR$FDA-CDER-CTU-2024-61893$$FDA-CTU$$76$YR$$F$N$$$20240829$Y$CN$US$
243019621$24301962$1$I$20240610$20240612$20240910$20240910$PER$$US-CELLTRION INC.-2024US014464$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243019631$24301963$1$I$$20240830$20240910$20240910$EXP$$DE-MYLANLABS-2024M1081431$MYLAN$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.$6$YR$$M$Y$$$20240910$$MD$DE$DE
243019641$24301964$1$I$$20240902$20240910$20240910$EXP$$AU-MYLANLABS-2024M1081800$MYLAN$Gardiner BJ, Ivulich SP, Snell GI. Voriconazole inhalation powder: A novel therapeutic alternative for invasive pulmonary fungal infections. Transpl-Infect-Dis 2024; 26 (3): no pagination.$54$YR$$F$Y$$$20240910$$HP$AU$AU
243019651$24301965$1$I$$20240902$20240910$20240910$EXP$$CA-MYLANLABS-2024M1082213$MYLAN$Purssell A, Leung K, Giguere P, Angel JB. Pritelivir for the treatment of nucleoside analogue-resistant orolabial herpes simplex virus 2 in a person living with HIV. JAMMI 2024; 9 (2): 108-112.$53$YR$$M$Y$$$20240910$$MD$CA$CA
243019674$24301967$4$F$20240908$20240919$20240910$20240923$PER$$US-AMGEN-USASP2024179625$AMGEN$$82$YR$E$M$Y$$$20240922$$CN$US$US
243019681$24301968$1$I$20240820$20240829$20240910$20240910$EXP$$US-Accord-444870$ACCORD$$44$YR$A$F$Y$$$20240910$$HP$US$US
243019691$24301969$1$I$$20240806$20240910$20240910$PER$$US-MankindUS-000221$MANKIND PHARMA$$10$MON$I$M$Y$8.07$KG$20240910$$CN$US$US
243019701$24301970$1$I$$20240903$20240910$20240910$EXP$$CA-JNJFOC-20240907137$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240910$$HP$CA$CA
243019711$24301971$1$I$$20240701$20240910$20240910$PER$$US-MankindUS-000211$MANKIND PHARMA$$$$$F$Y$53.07$KG$20240910$$CN$US$US
243019751$24301975$1$I$$20240830$20240909$20240909$DIR$FDA-CDER-CTU-2024-61892$$FDA-CTU$$$$$$N$$$20240830$N$CN$US$
243019791$24301979$1$I$$20240902$20240910$20240910$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-08232$HIKMA$$88$YR$$M$Y$$$20240910$$HP$CA$CA
243019801$24301980$1$I$$20240902$20240910$20240910$EXP$$CA-APOTEX-2024AP010231$APOTEX$$74$YR$$M$Y$$$20240910$$PH$CA$CA
243019811$24301981$1$I$20240819$20240905$20240910$20240910$EXP$$IN-ROCHE-10000021275$ROCHE$$77$YR$E$M$Y$$$20240910$$CN$IN$IN
243019821$24301982$1$I$$20240829$20240910$20240910$EXP$$US-Accord-445081$ACCORD$$38$YR$A$F$Y$$$20240910$$HP$US$US
243019832$24301983$2$F$20240501$20240911$20240910$20240916$EXP$$EG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050406$BOEHRINGER INGELHEIM$$28$YR$A$M$Y$150$KG$20240916$$CN$EG$EG
243019861$24301986$1$I$20240807$20240906$20240910$20240910$EXP$$JP-GILEAD-2024-0683347$GILEAD$$83$YR$E$F$Y$$$20240910$$PH$JP$JP
243019871$24301987$1$I$$20240830$20240910$20240910$EXP$$GB-AUROBINDO-AUR-APL-2024-043784$AUROBINDO$$60$YR$$F$Y$88$KG$20240910$$MD$GB$GB
243019881$24301988$1$I$$20240903$20240910$20240910$PER$$US-ROCHE-10000073158$ROCHE$$$$A$F$Y$$$20240910$$CN$US$US
243019891$24301989$1$I$$20240902$20240910$20240910$EXP$$CA-ROCHE-10000072932$ROCHE$$$$$$Y$$$20240910$$HP$CA$CA
243019901$24301990$1$I$$20240906$20240909$20240909$DIR$FDA-CDER-CTU-2024-62027$$FDA-CTU$$$$$F$N$$$20240906$N$HP$US$
243019911$24301991$1$I$$20240830$20240910$20240910$30DAY$$US-VEROBIOTECH-2024USVEROSPO00209$VERO BIOTECH$$$$$$Y$$$20240910$$CN$US$US
243019921$24301992$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005732$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240910$$CN$US$US
243019931$24301993$1$I$20240907$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005226$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240910$$CN$US$US
243019942$24301994$2$F$20240822$20240909$20240910$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004326$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240912$$CN$US$US
243019951$24301995$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142557$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$79.38$KG$20240910$$CN$US$US
243019961$24301996$1$I$$20240909$20240910$20240910$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050408$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240910$$CN$US$US
243019982$24301998$2$F$20240905$20240910$20240910$20240911$PER$$US-AMGEN-USASP2024179743$AMGEN$$53$YR$A$M$Y$$$20240911$$CN$US$US
243019991$24301999$1$I$20240909$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62047$$FDA-CTU$$79$YR$$F$N$$$20240909$N$HP$US$
243020001$24302000$1$I$$20240906$20240910$20240910$EXP$GB-MHRA-MIDB-a47b32e4-8c0c-4823-a14b-eb3256c1b16b$GB-BAYER-2024A128047$BAYER$$88$YR$E$$Y$$$20240910$$PH$GB$GB
243020012$24302001$2$F$$20240903$20240910$20240913$EXP$$RU-BAYER-2024A127078$BAYER$$24$YR$A$F$Y$$$20240913$$MD$RU$RU
243020021$24302002$1$I$20240531$20240904$20240910$20240910$EXP$FR-AFSSAPS-NC2024001026$FR-MYLANLABS-2024M1081126$MYLAN$$69$YR$$F$Y$77$KG$20240910$$MD$FR$FR
243020031$24302003$1$I$$20240904$20240910$20240910$EXP$$GB-MYLANLABS-2024M1077462$MYLAN$$$$$M$Y$$$20240910$$CN$GB$GB
243020041$24302004$1$I$$20240904$20240910$20240910$EXP$$GB-MYLANLABS-2024M1082078$MYLAN$$$$$F$Y$$$20240910$$MD$GB$GB
243020051$24302005$1$I$$20240829$20240910$20240910$EXP$$US-BRAEBURN-US-BRA-24-000798$BRAEBURN PHARMACEUTICALS$$30$YR$$F$Y$$$20240910$$HP$US$US
243020061$24302006$1$I$20240527$20240618$20240910$20240910$PER$$US-CELLTRION INC.-2024US014492$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243020071$24302007$1$I$20130326$20240904$20240910$20240910$EXP$$US-CHEPLA-2024011407$CHEPLAPHARM$$70$YR$$M$Y$103.59$KG$20240910$$MD$COUNTRY NOT SPECIFIED$US
243020081$24302008$1$I$$20240906$20240910$20240910$EXP$$US-BAYER-2024A128436$BAYER$$$$$F$Y$$$20240910$$CN$US$US
243020091$24302009$1$I$$20240909$20240910$20240910$EXP$$ES-SANDOZ INC.-SDZ2024ES078632$SANDOZ$$16$YR$$F$Y$$$20240910$$HP$ES$ES
243020111$24302011$1$I$20240829$20240905$20240910$20240910$EXP$$US-BAYER-2024A128259$BAYER$$85$YR$E$F$Y$61.224$KG$20240910$$HP$US$US
243020121$24302012$1$I$20240801$20240827$20240910$20240910$EXP$$US-UCBSA-2024044090$UCB$$76$YR$$F$Y$89.342$KG$20240910$$HP$US$US
243020131$24302013$1$I$$20240831$20240910$20240910$EXP$$ES-AUROBINDO-AUR-APL-2023-067670$AUROBINDO$Quintero V, Bueno-S?nchez D, Mozo-Del-Castillo Y, Urtasun-Erburu A, Sisinni L, L?pez-Duarte M et al.. Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow Failure.. Transplantation and Cellular Therapy. 2023;29(10):e1-621.e6$11$YR$$F$Y$$$20240910$$HP$ES$ES
243020151$24302015$1$I$20240827$20240827$20240827$20240827$DIR$716208$$FDA-CTU$$50$YR$$M$N$85.5$KG$20240827$N$CN$US$
243020171$24302017$1$I$20240708$20240827$20240827$20240827$DIR$716166$$FDA-CTU$$67$YR$$M$N$166.5$KG$20240827$N$CN$US$
243020181$24302018$1$I$20231102$20240828$20240828$20240828$DIR$716220$$FDA-CTU$$48$YR$$F$N$90$KG$20240828$N$CN$US$
243020201$24302020$1$I$20240804$20240906$20240910$20240910$EXP$$PK-ROCHE-10000075910$ROCHE$$52$YR$A$M$Y$$$20240910$$CN$PK$PK
243020211$24302021$1$I$20240826$20240904$20240910$20240910$EXP$$SG-JNJFOC-20240914832$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240910$$HP$SG$SG
243020221$24302022$1$I$$20240902$20240910$20240910$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006583$BIOCON$$$$$$Y$$$20240910$$CN$CA$CA
243020231$24302023$1$I$$20240904$20240910$20240910$PER$$US-ROCHE-10000074508$ROCHE$$$$$$Y$$$20240910$$CN$US$US
243020242$24302024$2$F$$20240912$20240910$20240912$PER$$US-HALEON-2195293$Haleon PLC$$$$$$Y$$$20240912$$CN$US$US
243020251$24302025$1$I$$20231018$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2023US045883$SANDOZ$$$$$F$Y$$$20240910$$CN$US$US
243020261$24302026$1$I$$20240904$20240910$20240910$EXP$$CA-ROCHE-10000075036$ROCHE$$41$YR$A$F$Y$$$20240910$$CN$CA$CA
243020283$24302028$3$F$$20240905$20240910$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-044071$AUROBINDO$Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoeman H, Ljungman P, Kobbe G, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. American journal of transplantation. 2015;15:705-714$39$YR$$M$Y$$$20240918$$HP$PL$PL
243020291$24302029$1$I$20240827$20240906$20240910$20240910$EXP$$US-BAYER-2024A128842$BAYER$$15$YR$T$M$Y$$$20240910$$CN$US$US
243020301$24302030$1$I$$20240904$20240910$20240910$PER$$US-BIOGEN-2024BI01281221$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
243020311$24302031$1$I$$20240827$20240910$20240910$EXP$$US-ENDO USA, INC.-2024-003362$ENDO$$$$$F$Y$$$20240910$$CN$US$US
243020321$24302032$1$I$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687122$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243020341$24302034$1$I$$20240905$20240910$20240910$EXP$$JP-BAYER-2024A129183$BAYER$$$$$$Y$$$20240910$$MD$JP$JP
243020351$24302035$1$I$$20240910$20240910$20240910$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050487$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240910$$PH$GB$GB
243020361$24302036$1$I$$20240909$20240910$20240910$EXP$$ES-ABBVIE-5915592$ABBVIE$$60$YR$$M$Y$$$20240910$$MD$ES$ES
243020371$24302037$1$I$$20240830$20240910$20240910$EXP$$JP-CHEPLA-2024011400$CHEPLAPHARM$$87$YR$$F$Y$$$20240910$$PH$COUNTRY NOT SPECIFIED$JP
243020382$24302038$2$F$20230401$20240912$20240910$20240917$EXP$$ES-ABBVIE-5914052$ABBVIE$$79$YR$$F$Y$55$KG$20240917$$MD$ES$ES
243020402$24302040$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686781$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243020411$24302041$1$I$20221108$20240905$20240910$20240910$EXP$$BE-PFIZER INC-2022SGN11500$PFIZER$$66$YR$$F$Y$42$KG$20240910$$MD$BE$BE
243020421$24302042$1$I$$20240905$20240910$20240910$EXP$$VN-PFIZER INC-202400237337$PFIZER$$54$YR$$M$Y$$$20240910$$CN$VN$VN
243020431$24302043$1$I$20221005$20240906$20240910$20240910$EXP$$FR-PFIZER INC-202400251288$PFIZER$$84$YR$$M$Y$82$KG$20240910$$MD$FR$FR
243020443$24302044$3$F$20240801$20240920$20240910$20240925$EXP$$US-PFIZER INC-202400247790$PFIZER$$46$YR$$F$Y$78.005$KG$20240925$$HP$US$US
243020451$24302045$1$I$20240624$20240903$20240910$20240910$EXP$$JP-GENMAB-2024-02746$GENMAB$$71$YR$$M$Y$$$20240910$$PH$JP$JP
243020461$24302046$1$I$20240826$20240904$20240910$20240910$EXP$$SG-JNJFOC-20240914829$JOHNSON AND JOHNSON$$24$YR$A$F$Y$$$20240910$$HP$SG$SG
243020471$24302047$1$I$20240820$20240904$20240910$20240910$EXP$SE-SEMPA-2024-006389$SE-MYLANLABS-2024M1081212$MYLAN$$9$YR$$F$Y$$$20240910$$MD$SE$SE
243020481$24302048$1$I$20240720$20240904$20240910$20240910$EXP$FR-AFSSAPS-PO2024000932$FR-MYLANLABS-2024M1081216$MYLAN$$34$YR$$M$Y$100$KG$20240910$$MD$FR$FR
243020491$24302049$1$I$$20240826$20240910$20240910$EXP$$US-EPICPHARMA-US-2024EPCLIT01051$EPIC PHARM$W Harmouch.A challenging case of eosinophilic myocarditis leading to heart failure and transplantation.Cardiovascular Pathology.2024;72$$$$M$Y$$$20240910$$HP$US$US
243020501$24302050$1$I$20150818$20240904$20240910$20240910$EXP$$CA-JNJFOC-20240911202$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240910$$HP$CA$CA
243020511$24302051$1$I$$20240906$20240910$20240910$EXP$$DE-GSK-DE2024EME111714$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$PH$DE$DE
243020522$24302052$2$F$20240903$20240923$20240910$20240930$EXP$$KW-CHIESI-2024CHF05624$CHIESI$$9$YR$$M$Y$$$20240930$$MD$KW$KW
243020531$24302053$1$I$$20240829$20240910$20240910$EXP$$US-AUROBINDO-AUR-APL-2024-043338$AUROBINDO$Nepal N, Okam N, Ahmed-Khan M, Vargas J.. WHEN WORKOUT GOES WRONG: SPONTANEOUS CORONARY ARTERY DISSECTION IN A BODYBUILDER ON ANABOLIC STEROIDS. Chest. 2023;164(4):A551$34$YR$$M$Y$$$20240910$$MD$US$US
243020542$24302054$2$F$20240905$20240912$20240910$20240912$EXP$$AT-BAYER-2024A128562$BAYER$$25$YR$A$F$Y$$$20240912$$MD$AT$AT
243020551$24302055$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180980$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243020571$24302057$1$I$$20240905$20240910$20240910$EXP$$JP-BAYER-2024A129191$BAYER$$$$$$Y$$$20240910$$MD$JP$JP
243020581$24302058$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-089864-2024$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243020591$24302059$1$I$20240814$20240903$20240910$20240910$EXP$SE-SEMPA-2024-006308$SE-TEVA-VS-3240257$TEVA$$18$YR$$F$Y$$$20240910$$MD$SE$SE
243020601$24302060$1$I$$20240904$20240910$20240910$EXP$$US-JAZZ-2017-US-010332$JAZZ$$$$$M$Y$$$20240910$$CN$US$US
243020611$24302061$1$I$20240728$20240827$20240827$20240827$DIR$716189$$FDA-CTU$$$$$UNK$N$$$20240827$N$PH$US$
243020621$24302062$1$I$20190101$20240826$20240910$20240910$EXP$$ES-EPICPHARMA-ES-2024EPCLIT01080$EPIC PHARM$Alvaro Lassaletta.Continuous response despite reduced dose of trametinib as single agent in an adolescent with a relapsed disseminated pediatric low-grade glioma KIAA1549-BRAF fusion positive: a case report and review of the literature..Frontiers in Oncology.23-MAY-2024;14:01-05$$$$M$Y$$$20240910$$HP$ES$ES
243020632$24302063$2$F$20240101$20240920$20240910$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027556$UNITED THERAPEUTICS$$$$$M$Y$92.063$KG$20240928$$$US$US
243020641$24302064$1$I$20240828$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202575$ASTRAZENECA$$31290$DY$$M$Y$$$20240910$$CN$US$
243020651$24302065$1$I$$20240902$20240910$20240910$PER$$US-AstraZeneca-2024A201679$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243020661$24302066$1$I$$20240904$20240910$20240910$EXP$$US-AstraZeneca-2024A201816$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
243020671$24302067$1$I$20240327$20240906$20240910$20240910$EXP$$NVSC2024US069224$NOVARTIS$$53$YR$$F$Y$77.11$KG$20240910$$HP$US$US
243020681$24302068$1$I$$20240902$20240910$20240910$EXP$001091323$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08215$HIKMA$$71$YR$$M$Y$60$KG$20240910$$HP$CA$CA
243020691$24302069$1$I$20240101$20240904$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003980$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240910$$CN$US$US
243020702$24302070$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686782$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243020711$24302071$1$I$$20240902$20240910$20240910$PER$$US-BEH-2024178227$CSL BEHRING$$$$A$F$Y$$$20240910$$HP$US$US
243020721$24302072$1$I$20121012$20240827$20240827$20240827$DIR$716197$$FDA-CTU$$50$YR$$F$N$99$KG$20240827$N$CN$US$
243020731$24302073$1$I$$20240905$20240910$20240910$EXP$$JP-BAYER-2024A129192$BAYER$$$$$$Y$$$20240910$$MD$JP$JP
243020741$24302074$1$I$$20240904$20240910$20240910$EXP$$ES-MYLANLABS-2024M1082333$MYLAN$Caro MG, Marti DL, Garcia PR. Drug-Induced Anaemia. Eur-J-Case-Rep-Intern-Med 2024; 11 (Suppl.) 757 abstr. 2065.$40$YR$$M$Y$$$20240910$$HP$ES$ES
243020751$24302075$1$I$$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143511$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240910$$MD$US$US
243020771$24302077$1$I$20240822$20240905$20240906$20240906$DIR$FDA-CDER-CTU-2024-62112$$FDA-CTU$$50$YR$$F$N$$$20240905$N$$US$
243020781$24302078$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61973$$FDA-CTU$$19$YR$$M$N$96.16$KG$20240909$N$$US$
243020792$24302079$2$F$20240101$20240912$20240910$20240919$EXP$$US-ABBVIE-5910133$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243020801$24302080$1$I$$20240830$20240910$20240910$EXP$$NL-AUROBINDO-AUR-APL-2024-044088$AUROBINDO$$$$$M$Y$$$20240910$$HP$NL$NL
243020811$24302081$1$I$$20240829$20240910$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-044036$AUROBINDO$Liu C, Zhou LL. Terbinafine-induced generalized pustular psoriasis (GPP) of von Zumbusch simulating toxic epidermal necrolysis (TEN).. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT: JDDG.. 2023;1-3$69$YR$$M$Y$$$20240910$$HP$CA$CA
243020821$24302082$1$I$$20240906$20240910$20240910$EXP$$JP-BAYER-2024A128587$BAYER$$$$$F$Y$$$20240910$$PH$JP$JP
243020831$24302083$1$I$$20240829$20240910$20240910$PER$$US-ABBVIE-5903352$ABBVIE$$$$$$Y$$$20240910$$CN$US$US
243020841$24302084$1$I$20240802$20240831$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044253$AUROBINDO$$73$YR$$M$Y$70$KG$20240910$$MD$FR$FR
243020851$24302085$1$I$20240904$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179464$AMGEN$$$$$$Y$$$20240910$$HP$US$US
243020862$24302086$2$F$20240101$20240908$20240910$20240915$PER$$US-AMGEN-USASP2024179554$AMGEN$$$$$$Y$$$20240915$$CN$US$US
243020871$24302087$1$I$$20240906$20240910$20240910$EXP$$GR-AMGEN-GRCSP2024178635$AMGEN$$69$YR$E$F$Y$$$20240910$$MD$GR$GR
243020881$24302088$1$I$$20240905$20240910$20240910$EXP$$CA-ROCHE-10000074898$ROCHE$$57$YR$A$F$Y$79$KG$20240910$$HP$CA$CA
243020891$24302089$1$I$20240522$20240904$20240910$20240910$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-137283$DAIICHI$$84$YR$$$Y$$$20240910$$PH$JP$JP
243020901$24302090$1$I$20240101$20240822$20240910$20240910$PER$$US-TEVA-VS-3236397$TEVA$$$$$$Y$$$20240910$$PH$US$US
243020911$24302091$1$I$$20240903$20240910$20240910$EXP$$CN-Umedica-000102$UMEDICA LABS$Zhang X, Huang D, Lou D, Si X, Mao J. Stevens-Johnson Syndrome/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review. BMC Endocr Disord. 2024 Sep 2;24(1):172. doi: 10.1186/s12902-024-01683-5.$73$YR$$F$Y$$$20240910$$HP$CN$
243020931$24302093$1$I$20231101$20240903$20240910$20240910$EXP$$JP-TAKEDA-2024TUS089781$TAKEDA$$26$YR$$M$Y$$$20240910$$PH$JP$JP
243020941$24302094$1$I$$20240905$20240910$20240910$PER$$US-JNJFOC-20240912887$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
243020951$24302095$1$I$20240614$20240621$20240910$20240910$PER$$US-CELLTRION INC.-2024US015423$CELLTRION$$$$$$Y$$$20240910$$CN$US$US
243020971$24302097$1$I$$20240907$20240910$20240910$EXP$GB-MHRA-MED-202409071842488450-NYLVB$GB-MYLANLABS-2024M1082257$MYLAN$$$$$F$Y$$$20240910$$CN$GB$GB
243020991$24302099$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61942$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243021001$24302100$1$I$$20240828$20240910$20240910$EXP$$US-STERISCIENCE B.V.-2024-ST-001371$Steriscience PTE$Barrison L, Park S, Decherney A.. Spontaneous conception in a 40-year-old woman after allogeneic stem cell transplant with active graft-versus-host disease: A case report. Case-Rep-Women-Health. 2024;43:1-3$$$N$M$Y$1.73$KG$20240910$$HP$US$US
243021021$24302102$1$I$20240824$20240906$20240910$20240910$EXP$$MM-ROCHE-10000076757$ROCHE$$79$YR$E$M$Y$$$20240910$$CN$MM$MM
243021041$24302104$1$I$20240905$20240908$20240910$20240910$EXP$$MX-BAYER-2024A128969$BAYER$$34$YR$A$M$Y$$$20240910$$CN$MX$MX
243021051$24302105$1$I$20240801$20240904$20240910$20240910$EXP$$US-ABBVIE-5908894$ABBVIE$$78$YR$$F$Y$$$20240910$$CN$US$US
243021061$24302106$1$I$20240818$20240905$20240910$20240910$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014375$JAZZ$$53$YR$$M$Y$$$20240910$$CN$US$US
243021071$24302107$1$I$20240908$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62057$$FDA-CTU$$68$YR$$M$N$116$KG$20240909$Y$PH$US$
243021081$24302108$1$I$20240905$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61905$$FDA-CTU$$65$YR$$F$N$$$20240906$N$HP$US$
243021091$24302109$1$I$$20240820$20240910$20240910$PER$$US-009507513-2409USA001728$MERCK$Manjunath J, Liao V, Kambala A, Bao A, Kollhoff AL, Ma EZ et al.. Immune stimulus exposure as a trigger for the development of chronic pruritus and circulating blood type 2 inflammation. JAAD Int. 2024;16 ():97-102$63$YR$$M$Y$$$20240910$$HP$US$US
243021101$24302110$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61944$$FDA-CTU$$73$YR$$F$N$$$20240909$N$$US$
243021112$24302111$2$F$$20240905$20240910$20240924$PER$$US-HALEON-2195354$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
243021121$24302112$1$I$20240710$20240902$20240910$20240910$EXP$SE-SEMPA-2024-006201$SE-TEVA-VS-3239780$TEVA$$55$YR$$F$Y$$$20240910$$MD$SE$SE
243021131$24302113$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61900$$FDA-CTU$$$$$$N$$$20240906$N$CN$US$
243021141$24302114$1$I$20240101$20240821$20240910$20240910$EXP$$US-SA-2024SA261072$SANOFI AVENTIS$$12$YR$T$M$Y$90$KG$20240910$$MD$US$US
243021162$24302116$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686783$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243021201$24302120$1$I$$20240906$20240910$20240910$EXP$$ES-BAYER-2024A128745$BAYER$$$$$F$Y$$$20240910$$CN$ES$ES
243021231$24302123$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000444US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243021251$24302125$1$I$$20240901$20240910$20240910$EXP$$TN-AMGEN-TUNSP2024178066$AMGEN$Fenniche I.; Somai M.; Imene R. et al.. CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY DURING SPONDYLARTERITIS: IATROGENESIS OR ASSOCIATION. European journal of case reports in internal medicine. 2024;11 (SUPPL_1):1025-1026$55$YR$A$M$Y$$$20240910$$HP$TN$TN
243021271$24302127$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143685$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240910$$HP$US$US
243021281$24302128$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR110096$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243021292$24302129$2$F$$20240910$20240910$20240913$PER$$US-ABBVIE-5913656$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243021301$24302130$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61949$$FDA-CTU$$36$YR$$F$N$63.5$KG$20240909$N$$US$
243021311$24302131$1$I$20240903$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61898$$FDA-CTU$$29$YR$$F$N$71.67$KG$20240906$Y$$US$
243021321$24302132$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61986$$FDA-CTU$$64$YR$$M$N$42.64$KG$20240909$N$$US$
243021331$24302133$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62036$$FDA-CTU$$$$$M$N$$$20240909$N$HP$US$
243021351$24302135$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62025$$FDA-CTU$$52$YR$$F$N$$$20240909$N$$US$
243021361$24302136$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62031$$FDA-CTU$$82$YR$$F$N$82.1$KG$20240909$N$$US$
243021371$24302137$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61933$$FDA-CTU$$$$$$N$$$20240906$N$CN$US$
243021381$24302138$1$I$20240801$20240906$20240909$20240909$DIR$FDA-CDER-CTU-2024-62068$$FDA-CTU$$$$$M$N$$$20240906$N$HP$US$
243021421$24302142$1$I$$20240827$20240910$20240910$EXP$$US-SA-2024SA259457$SANOFI AVENTIS$$$$A$F$Y$106$KG$20240910$$MD$US$US
243021431$24302143$1$I$$20240909$20240910$20240910$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050447$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$$$20240910$$CN$US$US
243021441$24302144$1$I$$20240903$20240910$20240910$EXP$$ES-MYLANLABS-2024M1081754$MYLAN$$$$$M$Y$$$20240910$$HP$ES$ES
243021451$24302145$1$I$$20240903$20240910$20240910$EXP$$US-MYLANLABS-2024M1080972$MYLAN$$$$$$Y$$$20240910$$LW$US$US
243021461$24302146$1$I$$20240830$20240910$20240910$EXP$$US-MYLANLABS-2024M1081415$MYLAN$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$50$YR$$F$Y$$$20240910$$MD$US$US
243021472$24302147$2$F$$20240911$20240910$20240916$EXP$$US-MYLANLABS-2024M1081706$MYLAN$$$$$F$Y$$$20240916$$MD$US$US
243021481$24302148$1$I$20240126$20240903$20240910$20240910$EXP$$KR-MYLANLABS-2024M1010964$MYLAN$$39$YR$$F$Y$$$20240910$$MD$KR$KR
243021491$24302149$1$I$$20240903$20240910$20240910$EXP$$US-MYLANLABS-2024M1081912$MYLAN$Medsinge A, Westbom C, Iyer S. Fatal coronary artery air embolism during CT guided percutaneous lung biopsy. J-Radiol-Case-Rep 2024; 18 (5): 55-60.$76$YR$$M$Y$$$20240910$$MD$US$US
243021501$24302150$1$I$$20240902$20240910$20240910$EXP$$US-MYLANLABS-2024M1081749$MYLAN$Wright B, Moore A, Becker-Weidman D, Joyce D. Primary B cell lymphoma of the patella presenting as anterior knee pain: A case report. J-Orthop 2024; 48 60-63.$76$YR$$F$Y$$$20240910$$HP$US$US
243021511$24302151$1$I$20240523$20240731$20240910$20240910$PER$$US-CELLTRION INC.-2024US015532$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243021531$24302153$1$I$$20240828$20240910$20240910$EXP$$PL-STERISCIENCE B.V.-2024-ST-001314$Steriscience PTE$Cheyne I, Hassan K, Dunkel T, et al.. Effective Treatment of Acinetobacter baumannii Ventriculitis With Interventricular Colistin: A Case Report. Cureus. 2024;16(6):e62169$22$YR$$M$Y$$$20240910$$HP$PL$PL
243021541$24302154$1$I$20100901$20240830$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044073$AUROBINDO$Petruzzo P, Testelin, S. Kanitakis, J. Badet, L. Lengele,B. Girbon,JP et al.. First Human Face Transplantation: 5 Years Outcomes. Transplantation. 2012;93 (2):236-240$38$YR$$F$Y$$$20240910$$MD$FR$FR
243021551$24302155$1$I$20240806$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179047$AMGEN$$74$YR$E$F$Y$$$20240910$$CN$US$US
243021562$24302156$2$F$20240826$20240905$20240910$20240911$EXP$$US-ABBVIE-5915309$ABBVIE$$77$YR$$M$Y$$$20240911$$MD$US$US
243021571$24302157$1$I$$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202902$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243021581$24302158$1$I$$20240905$20240910$20240910$EXP$$GB-AstraZeneca-2024A202280$ASTRAZENECA$$64$YR$$F$Y$69$KG$20240910$$MD$GB$
243021591$24302159$1$I$20240819$20240831$20240910$20240910$EXP$CN-NMPACDR-4401061573928202400221$CN-BAXTER-2024BAX024147$BAXTER$$62$YR$$M$Y$51.5$KG$20240910$$MD$CN$CN
243021601$24302160$1$I$20240828$20240905$20240910$20240910$EXP$$CN-DSJP-DSJ-2024-143945$DAIICHI$$29$YR$$F$Y$66$KG$20240910$$HP$CN$CN
243021611$24302161$1$I$20240508$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143705$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240910$$HP$US$US
243021621$24302162$1$I$$20240830$20240910$20240910$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-143304$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$HP$NL$NL
243021631$24302163$1$I$20240101$20240829$20240910$20240910$EXP$$US-SA-2024SA260729$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240910$$HP$US$US
243021642$24302164$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0687128$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243021651$24302165$1$I$$20240830$20240910$20240910$EXP$$CA-AUROBINDO-AUR-APL-2024-044672$AUROBINDO$$41$YR$$F$Y$$$20240910$$CN$CA$CA
243021661$24302166$1$I$$20240820$20240910$20240910$PER$$US-009507513-2409USA001729$MERCK$Manjunath J, Liao V, Kambala A, Bao A, Kollhoff AL, Ma EZ et al.. Immune stimulus exposure as a trigger for the development of chronic pruritus and circulating blood type 2 inflammation. JAAD Int. 2024;16 ():97-102$74$YR$$F$Y$$$20240910$$HP$US$US
243021671$24302167$1$I$$20240905$20240910$20240910$PER$$US-ABBVIE-5913761$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243021681$24302168$1$I$$20240903$20240910$20240910$30DAY$$US-GSK-US2024109367$GLAXOSMITHKLINE$$$$$F$Y$$$20240910$$CN$US$US
243021691$24302169$1$I$$20240831$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044330$AUROBINDO$Robin M, Meunier M, Manez AC, Latour RPD, Fontbrune FSD, Dhedin N et al. Late donor bone marrow failure after allogeneic hematopoietic stem cell transplantation. Transplantation. 2014;97:75-77$51$YR$$M$Y$$$20240910$$HP$FR$FR
243021701$24302170$1$I$20240801$20240903$20240910$20240910$EXP$$CN-VIIV HEALTHCARE LIMITED-CN2024APC109652$VIIV$$$$$$Y$$$20240910$$HP$CN$CN
243021711$24302171$1$I$20231210$20240904$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-081360-2024$RECKITT BENCKISER$$73$YR$$F$Y$78.18$KG$20240910$$CN$US$US
243021722$24302172$2$F$$20240903$20240910$20240912$EXP$GB-MHRA-MED-202409031839459090-DFGPZ$GB-SA-2024SA261388$SANOFI AVENTIS$$$$$M$Y$$$20240912$$HP$GB$GB
243021731$24302173$1$I$$20240902$20240910$20240910$EXP$$CO-SA-2024SA259790$SANOFI AVENTIS$$$$E$F$Y$30$KG$20240910$$CN$CO$CO
243021751$24302175$1$I$$20240907$20240910$20240910$PER$$US-AMGEN-USASP2024179578$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243021761$24302176$1$I$$20240828$20240910$20240910$EXP$$TR-STERISCIENCE B.V.-2024-ST-001316$Steriscience PTE$Dilmen S, Kilic S, Torun A. A Rare Case of Aggressive Infective Endocarditis Due to Corynebacterium striatum.. Cureus. 2023;15(9):e44903$91$YR$$F$Y$$$20240910$$HP$TR$CN
243021772$24302177$2$F$20240906$20240919$20240910$20240921$PER$$US-AMGEN-USASP2024180002$AMGEN$$52$YR$A$F$Y$$$20240921$$CN$US$US
243021781$24302178$1$I$20240903$20240904$20240910$20240910$EXP$GB-MHRA-MED-202409041029413460-WZBNG$GB-RDY-SPO/GBR/24/0013007$DR REDDYS$$76$YR$E$M$Y$$$20240910$$HP$GB$GB
243021791$24302179$1$I$$20240830$20240910$20240910$EXP$$FR-RDY-SPO/FRA/24/0012943$DR REDDYS$Dourthe ME, Yakouben K, David A, Thouvenin S, Chaillou D, Caillat- Zucman S, et al. Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia. British Journal of Haematology. 2024;205(1): doi:10.1111/bjh.19524.$4$YR$C$M$Y$$$20240910$$HP$FR$FR
243021801$24302180$1$I$$20240905$20240910$20240910$EXP$$CA-ROCHE-10000076196$ROCHE$$$$A$F$Y$$$20240910$$CN$CA$CA
243021811$24302181$1$I$$20240906$20240910$20240910$PER$$US-ROCHE-10000076888$ROCHE$$$$$$Y$$$20240910$$CN$US$US
243021821$24302182$1$I$$20240905$20240910$20240910$EXP$$US-ROCHE-10000075451$ROCHE$$27$YR$A$F$Y$$$20240910$$MD$US$US
243021831$24302183$1$I$$20240826$20240910$20240910$PER$$US-ASTELLAS-2024-AER-003364$ASTELLAS$$$$$M$Y$$$20240910$$PH$US$US
243021841$24302184$1$I$20230801$20240905$20240910$20240910$EXP$$DE-DSJP-DSE-2024-144096$DAIICHI$$64$YR$$M$Y$75$KG$20240910$$CN$DE$DE
243021852$24302185$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686784$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243021871$24302187$1$I$$20231211$20240910$20240910$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424294$RANBAXY$$64$YR$$M$Y$$$20240910$$HP$US$US
243021881$24302188$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005559$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240910$$CN$US$US
243021891$24302189$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005040$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240910$$HP$US$US
243021902$24302190$2$F$20231123$20240911$20240910$20240916$EXP$$GB-SA-2024SA258407$SANOFI AVENTIS$$67$YR$E$F$Y$89$KG$20240916$$MD$GB$GB
243021911$24302191$1$I$20240906$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005766$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240910$$CN$US$US
243021921$24302192$1$I$20240904$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004574$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240910$$HP$US$US
243021931$24302193$1$I$20240909$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005232$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240910$$CN$US$US
243021941$24302194$1$I$20230101$20240903$20240910$20240910$EXP$$CN-009507513-2409CHN002076$MERCK$Qian Y, Zhi Z Ai J, Kang L, Qiu G, Huang X, et al.. Immune-related intestinal pseudo-obstruction caused by immune checkpoint inhibitors: case report. Frontiers in Oncology. 2024;14:1-6$64$YR$$M$Y$$$20240910$$HP$CN$CN
243021971$24302197$1$I$20211119$20240831$20240910$20240910$EXP$$PL-AUROBINDO-AUR-APL-2024-044167$AUROBINDO$$49$YR$$$Y$100$KG$20240910$$MD$PL$PL
243021982$24302198$2$F$$20240906$20240910$20240913$PER$$US-AMGEN-USASP2024179549$AMGEN$$$$$$Y$$$20240913$$CN$US$US
243021992$24302199$2$F$$20240909$20240910$20240925$PER$$US-JNJFOC-20240908975$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243022001$24302200$1$I$$20240906$20240910$20240910$PER$$US-JNJFOC-20240917353$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
243022012$24302201$2$F$$20240904$20240910$20240912$EXP$$GB-MYLANLABS-2024M1081878$MYLAN$$$$$F$Y$$$20240912$$CN$GB$GB
243022021$24302202$1$I$$20240904$20240910$20240910$PER$$US-LEO Pharma-373305$LEO PHARM$$51$YR$$M$Y$$$20240910$$CN$US$US
243022031$24302203$1$I$$20240906$20240910$20240910$PER$$NVSC2024US180411$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243022051$24302205$1$I$$20240829$20240910$20240910$EXP$$US-UCBSA-2024044394$UCB$$$$$F$Y$$$20240910$$HP$US$US
243022061$24302206$1$I$$20240831$20240910$20240910$EXP$$PT-AUROBINDO-AUR-APL-2024-044234$AUROBINDO$Jorge Governa; Beatriz Marqu?s; Pedro Avelar; Manuel Ribeiro; Liliana Sim?es; S?rgio Borges et al.. PO-0116 - (4016) Intoxica??o medicamentosa por quetiapina - Al?m da anamnese (PO-0116 - (4016) Quetiapine drug poisoning - Beyond the anamnesis). ?ndice de autores - Medicina Interna - Congressos Nacionais. 30CNMI. 2024;486$61$YR$$F$Y$$$20240910$$MD$PT$PT
243022071$24302207$1$I$$20240902$20240910$20240910$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS004547$TERSERA THERAPEUTICS$$$$$$Y$$$20240910$$CN$AU$AU
243022081$24302208$1$I$20240827$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408281601191460-VRTND$GB-GLENMARK PHARMACEUTICALS-2024GMK093789$GLENMARK$$$$$$Y$$$20240910$$HP$GB$GB
243022091$24302209$1$I$20240101$20240906$20240910$20240910$PER$$US-ABBVIE-5913904$ABBVIE$$$$$F$Y$48$KG$20240910$$CN$US$US
243022101$24302210$1$I$$20240903$20240910$20240910$PER$$US-BAUSCHBL-2024BNL032763$BAUSCH AND LOMB$$$$$F$Y$$$20240910$$CN$US$US
243022111$24302211$1$I$20240501$20240831$20240910$20240910$EXP$GB-MHRA-MED-202408312202138740-VSRJQ$GB-TEVA-VS-3239211$TEVA$$$$$F$Y$$$20240910$$CN$GB$GB
243022121$24302212$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61934$$FDA-CTU$$$$$$N$$$20240906$N$CN$US$
243022131$24302213$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61935$$FDA-CTU$$$$$$N$$$20240906$$CN$US$
243022151$24302215$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241010$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$50$YR$$M$Y$$$20240910$$HP$ES$ES
243022161$24302216$1$I$$20240904$20240910$20240910$EXP$$FR-ASTELLAS-2024-AER-005195$ASTELLAS$$75$YR$E$M$Y$$$20240910$$MD$FR$FR
243022171$24302217$1$I$20240811$20240910$20240910$20240910$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050492$BOEHRINGER INGELHEIM$$67$YR$E$F$Y$83$KG$20240910$$MD$GB$GB
243022181$24302218$1$I$$20240826$20240910$20240910$EXP$$IT-EPICPHARMA-IT-2024EPCLIT01078$EPIC PHARM$Bennati E.Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy.Circulation: Genomic and Precision Medicine .APR-2024;17:E004353$1$YR$N$M$Y$$$20240910$$HP$IT$IT
243022191$24302219$1$I$$20240624$20240910$20240910$PER$$US-CELLTRION INC.-2024US015539$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243022201$24302220$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241012$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$43$YR$$M$Y$$$20240910$$HP$ES$ES
243022221$24302222$1$I$$20240906$20240906$20240906$DIR$FDA-CDER-CTU-2024-61901$$FDA-CTU$$$$$$N$$$20240906$N$CN$US$
243022241$24302224$1$I$$20240904$20240910$20240910$EXP$$NVSJ2024JP010619$NOVARTIS$Kodaka E, Sekine S, Higashida S, Nishimura K, Oyama N, Hasegawa M et al.. A case of psoriatic arthritis coexisting with rheumatoid arthritis, which was unresponsive to a series of biologics but showed a favorable effect with combined use of immunosuppressants and a TYK2 inhibitor deucravacitinib. Program and Abstracts of the 39th Annual Meeting of the Japanese Society for Pso. 2024;43$47$YR$$M$Y$$$20240910$$HP$JP$JP
243022251$24302225$1$I$20240811$20240909$20240910$20240910$EXP$PT-INFARMED-J202408-869$NVSC2024PT180423$NOVARTIS$$54$YR$$F$Y$$$20240910$$MD$PT$PT
243022261$24302226$1$I$20230722$20240904$20240910$20240910$EXP$$NVSC2024CN179394$NOVARTIS$$67$YR$$F$Y$68$KG$20240910$$HP$CN$CN
243022271$24302227$1$I$20240823$20240904$20240910$20240910$EXP$$RU-AMERICAN REGENT INC-2024003374$AMERICAN REGENT$$21$YR$$F$Y$54$KG$20240910$$HP$RU$RU
243022281$24302228$1$I$$20240906$20240910$20240910$EXP$$NVSJ2024JP010682$NOVARTIS$$89$YR$$M$Y$$$20240910$$PH$JP$JP
243022292$24302229$2$F$$20240910$20240910$20240916$EXP$$NVSC2024GB180631$NOVARTIS$$44$YR$$M$Y$$$20240916$$MD$GB$GB
243022301$24302230$1$I$$20240903$20240910$20240910$EXP$$NVSC2024GB178120$NOVARTIS$$21$YR$$$Y$$$20240910$$HP$GB$GB
243022322$24302232$2$F$$20240912$20240910$20240920$EXP$$ES-TEVA-VS-3241003$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$47$YR$$M$Y$$$20240920$$HP$ES$ES
243022331$24302233$1$I$$20240904$20240910$20240910$EXP$$SG-JNJFOC-20240913570$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$HP$SG$SG
243022341$24302234$1$I$$20240904$20240910$20240910$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000769$DECIPHERA PHARMACEUTICALS$$63$YR$A$M$Y$$$20240910$$CN$US$US
243022351$24302235$1$I$$20240904$20240910$20240910$PER$$US-ROCHE-10000075312$ROCHE$$$$T$M$Y$$$20240910$$CN$US$US
243022361$24302236$1$I$20240101$20240904$20240910$20240910$PER$$US-JNJFOC-20240913870$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240910$$CN$US$US
243022371$24302237$1$I$20240813$20240903$20240910$20240910$EXP$$JP-GENMAB-2024-03198$GENMAB$$$$$M$Y$$$20240910$$MD$JP$JP
243022381$24302238$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241011$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$59$YR$$F$Y$$$20240910$$HP$ES$ES
243022391$24302239$1$I$$20240828$20240910$20240910$EXP$$CN-STERISCIENCE B.V.-2024-ST-001370$Steriscience PTE$Wu Yuanxing, Liu Lin, Wu Yujiao, Wu Hua.. Characteristic of pancreatic involvement in melioidosis: Case report and literature review. Heliyon. 2024;10(9):e30299$$$$$Y$$$20240910$$HP$CN$CN
243022401$24302240$1$I$20230207$20240909$20240910$20240910$PER$FR-AFSSAPS-PA2024001298$FR-Eisai-EC-2024-173929$EISAI$$87$YR$E$M$Y$82$KG$20240910$$MD$FR$FR
243022411$24302241$1$I$20230316$20240610$20240910$20240910$EXP$$US-TEVA-VS-3217595$TEVA$$$$N$$Y$$$20240910$$CN$US$US
243022421$24302242$1$I$20240616$20240702$20240910$20240910$PER$$US-CELLTRION INC.-2024US015702$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243022431$24302243$1$I$$20240829$20240910$20240910$EXP$$JP-BIOGEN-2024BI01281377$BIOGEN$$$$$$Y$$$20240910$$MD$JP$JP
243022441$24302244$1$I$$20240831$20240910$20240910$EXP$$FR-AUROBINDO-AUR-APL-2024-044320$AUROBINDO$Bottosso M, Verret B, Caron O, Hamzaoui N, Pasmant E, Danlos FX, et al.. Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome.. JCO Precision Oncology.. 2024;8:1-6$$$A$F$Y$$$20240910$$MD$FR$FR
243022451$24302245$1$I$$20240831$20240910$20240910$EXP$$CN-REGENERON PHARMACEUTICALS, INC.-2024-120927$REGENERON$$$$$$Y$$$20240910$$CN$CN$CN
243022461$24302246$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024180157$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243022472$24302247$2$F$$20240910$20240910$20240912$EXP$$JP-009507513-2409JPN000980J$MERCK$$10$DEC$$$Y$$$20240912$$MD$JP$JP
243022492$24302249$2$F$20240904$20240906$20240910$20240921$EXP$$CN-ROCHE-10000076664$ROCHE$$71$YR$E$F$Y$49.4$KG$20240921$$HP$CN$CN
243022501$24302250$1$I$$20240905$20240910$20240910$EXP$$NVSC2024US180477$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
243022511$24302251$1$I$$20240828$20240910$20240910$EXP$$SA-STERISCIENCE B.V.-2024-ST-001335$Steriscience PTE$Alquaydheb H, Alharbi A, Badran A, Alshamsan B, Algwaiz G, Elshenawy MA, Ajarim D. Successful Recovery of COVID-19 Associated With Cardiomyopathy in Advanced Breast Cancer Patient With Pulmonary Lymphangitis Carcinomatosis. Clinical Medicine Insights: Case Reports. 2023;16:1-4$43$YR$$F$Y$$$20240910$$HP$SA$SA
243022522$24302252$2$F$20240807$20240912$20240910$20240917$EXP$$IN-PFIZER INC-PV202400088498$PFIZER$$50$YR$$M$Y$$$20240917$$CN$IN$IN
243022531$24302253$1$I$20240903$20240905$20240910$20240910$EXP$$IN-PFIZER INC-202101260258$PFIZER$$58$YR$$F$Y$$$20240910$$CN$IN$IN
243022541$24302254$1$I$20230901$20240905$20240910$20240910$EXP$$CA-PFIZER INC-202300128848$PFIZER$$51$YR$$M$Y$$$20240910$$CN$CA$CA
243022552$24302255$2$F$$20240910$20240910$20240911$EXP$$US-PFIZER INC-202400251821$PFIZER$$$$$$Y$$$20240911$$MD$US$US
243022571$24302257$1$I$20240719$20240905$20240910$20240910$EXP$$FI-PFIZER INC-202400252644$PFIZER$$$$$M$Y$91.6$KG$20240910$$HP$FI$FI
243022601$24302260$1$I$$20240906$20240910$20240910$EXP$$US-PFIZER INC-PV202400117793$PFIZER$$71$YR$$$Y$$$20240910$$CN$US$US
243022611$24302261$1$I$$20240905$20240910$20240910$EXP$$US-PFIZER INC-202400251946$PFIZER$$82$YR$$F$Y$68.95$KG$20240910$$CN$US$US
243022621$24302262$1$I$$20240906$20240910$20240910$EXP$$US-PFIZER INC-202400251734$PFIZER$$53$YR$$M$Y$$$20240910$$MD$US$US
243022631$24302263$1$I$20240827$20240906$20240910$20240910$EXP$$CN-PFIZER INC-PV202400117400$PFIZER$$4$YR$$M$Y$$$20240910$$HP$CN$CN
243022641$24302264$1$I$20240415$20240906$20240910$20240910$EXP$FR-AFSSAPS-LM2024000485$FR-PFIZER INC-202400251285$PFIZER$$81$YR$$M$Y$$$20240910$$MD$FR$FR
243022661$24302266$1$I$$20240905$20240910$20240910$EXP$$IE-PFIZER INC-202400252706$PFIZER$$31$YR$$M$Y$$$20240910$$HP$IE$IE
243022681$24302268$1$I$20230119$20240905$20240910$20240910$EXP$FR-AFSSAPS-PC2024000681$FR-PFIZER INC-202400250510$PFIZER$$52$YR$$F$Y$83$KG$20240910$$PH$FR$FR
243022692$24302269$2$F$20240823$20240918$20240910$20240919$EXP$$JP-PFIZER INC-PV202400116687$PFIZER$$80$YR$$F$Y$$$20240919$$PH$JP$JP
243022701$24302270$1$I$20240820$20240905$20240910$20240910$EXP$GR-GREOF-202400974$GR-PFIZER INC-202400250424$PFIZER$$73$YR$$M$Y$93$KG$20240910$$MD$GR$GR
243022711$24302271$1$I$20240904$20240906$20240910$20240910$EXP$$US-PFIZER INC-PV202400099665$PFIZER$$65$YR$$F$Y$$$20240910$$CN$US$US
243022721$24302272$1$I$$20240829$20240910$20240910$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-08715$LUPIN$$$$$$Y$$$20240910$$CN$AU$AU
243022731$24302273$1$I$$20240829$20240910$20240910$EXP$$US-UCBSA-2024044497$UCB$$$$$F$Y$$$20240910$$HP$US$US
243022741$24302274$1$I$$20240905$20240910$20240910$PER$$US-MYLANLABS-2024M1082146$MYLAN$$$$$$Y$$$20240910$$CN$US$US
243022761$24302276$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143502$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240910$$HP$US$US
243022771$24302277$1$I$$20240904$20240910$20240910$PER$$US-MYLANLABS-2024M1081946$MYLAN$$$$$M$Y$$$20240910$$CN$US$US
243022782$24302278$2$F$20231101$20240911$20240910$20240916$EXP$$GB-PFIZER INC-202400250624$PFIZER$$67$YR$$F$Y$89$KG$20240916$$MD$GB$GB
243022791$24302279$1$I$$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143517$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240910$$HP$US$US
243022801$24302280$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143246$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$81.19$KG$20240910$$CN$US$US
243022811$24302281$1$I$20240801$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143018$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$58.06$KG$20240910$$CN$US$US
243022821$24302282$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143164$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240910$$HP$US$US
243022831$24302283$1$I$20240101$20240802$20240910$20240910$EXP$$US-TEVA-VS-3230758$TEVA$$18$YR$$F$Y$$$20240910$$CN$US$US
243022841$24302284$1$I$20240801$20240909$20240910$20240910$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-143212$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$65.77$KG$20240910$$CN$PR$PR
243022851$24302285$1$I$$20240909$20240910$20240910$EXP$GB-MHRA-MIDB-b59af161-c598-4294-a73e-b12288a55d54$GB-Orion Corporation ORION PHARMA-24_00031606$ORION$$56$YR$A$F$Y$$$20240910$$HP$GB$
243022861$24302286$1$I$$20240824$20240910$20240910$PER$$US-JNJFOC-20240864447$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$MD$US$US
243022871$24302287$1$I$20240822$20240905$20240910$20240910$EXP$$CA-JNJFOC-20240917668$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240910$$HP$CA$CA
243022881$24302288$1$I$20240901$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024179804$AMGEN$$60$YR$A$M$Y$$$20240910$$CN$US$US
243022901$24302290$1$I$$20240830$20240910$20240910$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07084$HIKMA$$$$$$Y$$$20240910$$CN$US$US
243022911$24302291$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181085$NOVARTIS$$$$$F$Y$$$20240910$$MD$US$US
243022921$24302292$1$I$$20240627$20240910$20240910$PER$$US-CELLTRION INC.-2024US015978$CELLTRION$$$$$$Y$$$20240910$$HP$US$US
243022931$24302293$1$I$$20240906$20240910$20240910$EXP$$US-ABBVIE-5914502$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243022942$24302294$2$F$$20240912$20240910$20240920$EXP$$JP-TEVA-VS-3239823$TEVA$Yoshimura Y, Suwabe T, Miki K, Yokoyama T, Kono K, Kinowaki K, et al. Renal cell carcinoma preceded by a rheumatoid-like paraneoplastic syndrome: A case report. Oncol-Lett 2024; 28 (4):.; Yoshimura Y, Suwabe T, Miki K, Yokoyama T, Kono K, Kinowaki K, et al. Renal cell carcinoma preceded by a rheumatoid-like paraneoplastic syndrome: A case report. Oncol-Lett 2024; 28 (4):.$72$YR$$M$Y$54$KG$20240920$$HP$JP$JP
243022951$24302295$1$I$20231023$20240902$20240910$20240910$EXP$FR-AFSSAPS-MP2024001331$FR-009507513-2409FRA000940$MERCK$$50$YR$$M$Y$92$KG$20240910$$MD$FR$FR
243022961$24302296$1$I$$20240826$20240910$20240910$EXP$$ES-EPICPHARMA-ES-2024EPCLIT01079$EPIC PHARM$Luis Posado-Dominguez.Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review.Chinese Clinical Oncology.31-MAY-2024;13: No. 3:1-7$65$YR$E$M$Y$$$20240910$$MD$ES$ES
243022971$24302297$1$I$20240522$20240906$20240910$20240910$30DAY$$IT-SANDOZ INC.-SDZ2024IT052462$SANDOZ$$14$YR$$F$Y$45$KG$20240910$$CN$IT$IT
243022981$24302298$1$I$$20240902$20240910$20240910$EXP$$AU-MYLANLABS-2024M1081797$MYLAN$Gardiner BJ, Ivulich SP, Snell GI. Voriconazole inhalation powder: A novel therapeutic alternative for invasive pulmonary fungal infections. Transpl-Infect-Dis 2024; 26 (3).$50$YR$$M$Y$$$20240910$$HP$AU$AU
243022991$24302299$1$I$$20240902$20240910$20240910$EXP$$US-MYLANLABS-2024M1082200$MYLAN$Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J-Med-Toxicol 2024.$3$HR$$M$Y$$$20240910$$HP$US$US
243023001$24302300$1$I$20240901$20240904$20240910$20240910$EXP$$US-JNJFOC-20240911379$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240910$$CN$US$US
243023011$24302301$1$I$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686714$GILEAD$$$$A$F$Y$$$20240910$$CN$US$US
243023031$24302303$1$I$20210701$20240905$20240910$20240910$EXP$$NVSC2021GB186534$NOVARTIS$$54$YR$$F$Y$$$20240910$$CN$GB$GB
243023042$24302304$2$F$20220109$20240909$20240910$20240911$PER$$NVSC2024US180485$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
243023061$24302306$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62007$$FDA-CTU$$76$YR$$M$N$73.94$KG$20240909$N$$US$
243023071$24302307$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62022$$FDA-CTU$$49$YR$$F$N$$$20240909$N$$US$
243023081$24302308$1$I$20240904$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62094$$FDA-CTU$$73$YR$$F$N$$$20240909$N$$US$
243023091$24302309$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62080$$FDA-CTU$$62$YR$$F$N$61.23$KG$20240909$N$$US$
243023121$24302312$1$I$$20240903$20240910$20240910$PER$$US-MYLANLABS-2024M1082029$MYLAN$$$$$F$Y$$$20240910$$MD$US$US
243023131$24302313$1$I$20240731$20240830$20240910$20240910$PER$$US-CELLTRION INC.-2024US018803$CELLTRION$$$$$$Y$$$20240910$$CN$US$US
243023141$24302314$1$I$20231201$20240827$20240910$20240910$PER$$US-ASTELLAS-2024-AER-003548$ASTELLAS$$90$YR$E$M$Y$$$20240910$$MD$US$US
243023151$24302315$1$I$$20240903$20240910$20240910$PER$$US-RDY-SPO/USA/24/0013027$DR REDDYS$Jimenez-Kurlander L, DeRosa A, Bogardus K, Kostrzewa CE, Moskowitz CS, Antal Z, et al. Ovarian function in female survivors of high-risk neuroblastoma. Pediatric Blood and Cancer. 2024;71(9): e31181. doi:10.1002/pbc.31181.$$$$F$Y$$$20240910$$HP$US$US
243023162$24302316$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687064$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243023171$24302317$1$I$20200817$20240909$20240910$20240910$EXP$$DE-SANDOZ INC.-SDZ2024DE078738$SANDOZ$$$$$M$Y$$$20240910$$MD$DE$DE
243023181$24302318$1$I$20240829$20240904$20240910$20240910$PER$$US-ALXN-202409USA000357US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243023191$24302319$1$I$20240815$20240905$20240910$20240910$EXP$$JP-009507513-2409JPN001025J$MERCK$$48$YR$$$Y$$$20240910$$MD$JP$JP
243023201$24302320$1$I$$20240906$20240910$20240910$PER$$US-ROCHE-10000076802$ROCHE$$$$A$M$Y$$$20240910$$CN$US$US
243023211$24302321$1$I$$20240826$20240910$20240910$EXP$$CN-EPICPHARMA-CN-2024EPCLIT01090$EPIC PHARM$Qiang Zhu.Case Report: Amiodarone-induced multi-organ toxicity.Frontiers in Cardiovascular Medicine.17-JUL-2024;11:01-08$73$YR$E$F$Y$65$KG$20240910$$HP$CN$CN
243023221$24302322$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181042$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243023231$24302323$1$I$20230610$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466931$RANBAXY$$71$YR$$F$Y$$$20240910$$PH$FR$FR
243023241$24302324$1$I$20230101$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466950$RANBAXY$$15$YR$$M$Y$$$20240910$$MD$FR$FR
243023251$24302325$1$I$20240624$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466896$RANBAXY$$16$YR$$F$Y$58.3$KG$20240910$$PH$FR$FR
243023261$24302326$1$I$20240523$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466934$RANBAXY$$2$MON$$F$Y$$$20240910$$MD$FR$FR
243023281$24302328$1$I$$20240904$20240910$20240910$EXP$$SA-TAKEDA-2024TUS089144$TAKEDA$$$$$F$Y$$$20240910$$CN$SA$SA
243023291$24302329$1$I$$20240826$20240910$20240910$PER$$US-ASTELLAS-2024-AER-003136$ASTELLAS$$54$YR$A$F$Y$$$20240910$$MD$US$US
243023301$24302330$1$I$20240429$20240826$20240910$20240910$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466875$RANBAXY$$87$YR$$F$Y$$$20240910$$HP$ES$ES
243023311$24302331$1$I$20240605$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466964$RANBAXY$$86$YR$$M$Y$60$KG$20240910$$PH$FR$FR
243023321$24302332$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004385$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240910$$CN$US$US
243023331$24302333$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004410$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243023341$24302334$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004773$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240910$$CN$US$US
243023351$24302335$1$I$20240621$20240826$20240910$20240910$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466857$RANBAXY$$$$$M$Y$$$20240910$$MD$IT$IT
243023361$24302336$1$I$20240607$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466859$RANBAXY$$75$YR$$F$Y$74.5$KG$20240910$$PH$FR$FR
243023371$24302337$1$I$20240219$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466952$RANBAXY$$21$YR$$F$Y$$$20240910$$PH$FR$FR
243023381$24302338$1$I$20240611$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466953$RANBAXY$$73$YR$$M$Y$$$20240910$$MD$FR$FR
243023391$24302339$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143211$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240910$$CN$US$US
243023401$24302340$1$I$$20240826$20240910$20240910$PER$$US-ASTELLAS-2024-AER-003165$ASTELLAS$$$$A$F$Y$$$20240910$$CN$US$US
243023411$24302341$1$I$$20240906$20240910$20240910$EXP$$SK-JNJFOC-20240921060$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$MD$SK$SK
243023421$24302342$1$I$20240723$20240903$20240910$20240910$EXP$DE-AMK-278647$DE-TEVA-VS-3240177$TEVA$$46$YR$$F$Y$66$KG$20240910$$PH$DE$DE
243023431$24302343$1$I$$20240829$20240910$20240910$EXP$$US-UCBSA-2024044413$UCB$$$$$F$Y$$$20240910$$HP$US$US
243023441$24302344$1$I$20240828$20240904$20240910$20240910$PER$$US-MYLANLABS-2024M1081717$MYLAN$$55$YR$$M$Y$136.08$KG$20240910$$CN$US$US
243023451$24302345$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-088177-2024$RECKITT BENCKISER$$$$$M$Y$$$20240910$$CN$US$US
243023462$24302346$2$F$20240101$20240905$20240910$20240918$EXP$$US-ABBVIE-5913516$ABBVIE$$$$$F$Y$$$20240918$$HP$US$US
243023471$24302347$1$I$$20240826$20240910$20240910$EXP$$DE-EPICPHARMA-DE-2024EPCLIT01084$EPIC PHARM$Bienenstein E.Acute Yew-Intoxication (Taxus baccata): Lessons to Be Learned for Pediatric Cardiologists.Thoracic and Cardiovascular Surgeon.JAN-2024;72 (Suppl.)$16$YR$T$M$Y$$$20240910$$HP$DE$DE
243023481$24302348$1$I$20240703$20240901$20240910$20240910$EXP$$CN-BEIGENE-BGN-2024-013782$BEIGENE$$$$$$Y$$$20240910$$HP$CN$CN
243023491$24302349$1$I$20240902$20240909$20240910$20240910$EXP$$CN-BAYER-2024A129048$BAYER$$35$YR$A$F$Y$50$KG$20240910$$HP$CN$CN
243023501$24302350$1$I$$20240903$20240910$20240910$PER$$US-TAKEDA-2024TUS089272$TAKEDA$$$$$$Y$$$20240910$$CN$US$US
243023512$24302351$2$F$$20240905$20240910$20240914$EXP$GB-MHRA-MED-202409031839459090-DFGPZ$GB-TEVA-VS-3240193$TEVA$$$$$M$Y$$$20240914$$CN$GB$GB
243023521$24302352$1$I$$20240731$20240910$20240910$EXP$$JP-009507513-2409JPN003275$MERCK$Tonai K, Ohta-Ogo K, Kainuma S, Tadokoro N, Tsukamoto Y, Hatakeyama K et al.. Case series: successful salvage from refractory cardiogenic shock caused by COVID-19-associated myocardial injury with temporary ventricular assist devices. European Heart Journal - Case Reports. 2024;8:ytae308$43$YR$$F$Y$$$20240910$$HP$JP$JP
243023532$24302353$2$F$20240409$20240905$20240910$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014194$JAZZ$$61$YR$$M$Y$$$20240912$$HP$US$US
243023541$24302354$1$I$20240809$20240829$20240910$20240910$EXP$IT-MINISAL02-999683$IT-Accord-444601$ACCORD$$75$YR$E$F$Y$$$20240910$$MD$IT$IT
243023551$24302355$1$I$$20240909$20240910$20240910$PER$$US-HALEON-2196077$Haleon PLC$$$$$$Y$$$20240910$$CN$US$US
243023561$24302356$1$I$$20240909$20240910$20240910$PER$$US-TAKEDA-2024TUS089953$TAKEDA$$$$$$Y$$$20240910$$CN$US$US
243023571$24302357$1$I$$20240901$20240910$20240910$EXP$$CN-JNJFOC-20240919663$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240910$$HP$CN$CN
243023582$24302358$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686775$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243023591$24302359$1$I$20240801$20240830$20240910$20240910$EXP$$CO-GSK-CO2024AMR057059$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$CO$CO
243023601$24302360$1$I$20240830$20240901$20240910$20240910$PER$$US-RDY-SPO/USA/24/0012884$DR REDDYS$$61$YR$A$F$Y$$$20240910$$HP$US$US
243023611$24302361$1$I$20240801$20240904$20240910$20240910$PER$$US-Eisai-EC-2024-173934$EISAI$$72$YR$E$F$Y$$$20240910$$CN$US$US
243023621$24302362$1$I$$20240816$20240910$20240910$EXP$$NVSC2024US180535$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
243023631$24302363$1$I$$20240829$20240910$20240910$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000522$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243023641$24302364$1$I$20240515$20240909$20240910$20240910$EXP$FR-AFSSAPS-AVMA2024000391$FR-BAUSCH-BL-2024-013429$BAUSCH AND LOMB$$31$YR$$M$Y$$$20240910$$PH$FR$FR
243023651$24302365$1$I$$20240902$20240910$20240910$EXP$$US-RDY-SPO/USA/24/0013061$DR REDDYS$Wright B, Moore A, Becker-Weidman D, Joyce D. Primary B cell lymphoma of the patella presenting as anterior knee pain: A case report. Journal of Orthopaedics. 48: 60-63. doi:10.1016/j.jor.2023.11.022.$76$YR$E$F$Y$$$20240910$$HP$US$US
243023661$24302366$1$I$$20240829$20240910$20240910$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000526$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240910$$HP$US$US
243023671$24302367$1$I$$20240827$20240910$20240910$EXP$$JP-AZURITY PHARMACEUTICALS, INC.-AZR202408-000518$AZURITY PHARMACEUTICALS$Okazaki R, Arita S, Hoshio H, Uetani N, Inui G, Ishikawa H. et al.. Allergic bronchopulmonary mycosis caused by Scedosporium apiospermum: A case report. Respir. Med. Case Rep. 2024;51:102092$61$YR$$F$Y$$$20240910$$HP$JP$JP
243023711$24302371$1$I$$20240906$20240910$20240910$EXP$$CA-ROCHE-10000077248$ROCHE$$$$A$M$Y$$$20240910$$CN$CA$CA
243023721$24302372$1$I$20240814$20240826$20240910$20240910$PER$$US-PURACAP-US-2024EPCSPO01092$PURACAP$$66$YR$E$F$Y$150$KG$20240910$$CN$US$US
243023731$24302373$1$I$20240819$20240902$20240910$20240910$EXP$$CN-BEIGENE-BGN-2024-013878$BEIGENE$$$$$$Y$$$20240910$$HP$CN$CN
243023741$24302374$1$I$20240808$20240905$20240910$20240910$EXP$$FR-AMGEN-FRASP2024177707$AMGEN$$61$YR$A$F$Y$$$20240910$$MD$FR$FR
243023761$24302376$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142537$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240910$$CN$US$US
243023781$24302378$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142618$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$69.4$KG$20240910$$CN$US$US
243023791$24302379$1$I$20240101$20240822$20240910$20240910$PER$$US-TEVA-VS-3237269$TEVA$$64$YR$$F$Y$$$20240910$$HP$US$US
243023801$24302380$1$I$$20240904$20240910$20240910$EXP$FR-AFSSAPS-AVPA2024000671$FR-MYLANLABS-2024M1081707$MYLAN$$58$YR$$F$Y$47.8$KG$20240910$$HP$FR$FR
243023811$24302381$1$I$20240826$20240826$20240910$20240910$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00416$MELINTA THERAPEUTICS$$$$$$Y$$$20240910$$CN$BR$BR
243023821$24302382$1$I$$20240903$20240910$20240910$EXP$$US-MYLANLABS-2024M1082268$MYLAN$Hertz D, Scorza FA, Fiorini AC, Finsterer J. SARS-CoV-2 vaccination complicated by small fiber neuropathy, mast cell activation syndrome, and pericarditis. Clinics 2023; 78.$66$YR$$F$Y$$$20240910$$HP$US$US
243023831$24302383$1$I$20240801$20240829$20240910$20240910$PER$$US-MYLANLABS-2024M1080176$MYLAN$$67$YR$$F$Y$58.97$KG$20240910$$CN$US$US
243023841$24302384$1$I$$20240902$20240910$20240910$EXP$$US-APOTEX-2024AP010293$APOTEX$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101 (102625):1-6$61$YR$$$Y$$$20240910$$HP$US$US
243023851$24302385$1$I$20240901$20240905$20240910$20240910$EXP$$MX-ROCHE-10000077193$ROCHE$$44$YR$A$F$Y$$$20240910$$CN$MX$MX
243023861$24302386$1$I$20220718$20240909$20240910$20240910$EXP$$KR-ROCHE-10000076689$ROCHE$$56$YR$A$F$Y$46.5$KG$20240910$$HP$KR$KR
243023871$24302387$1$I$$20220813$20240910$20240910$EXP$$CA-VANTIVE-2022BAX017476$Vantive US Healthcare$$$$$F$Y$$$20240910$$CN$CA$CA
243023881$24302388$1$I$20240801$20240826$20240910$20240910$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00424$Unknown Manufacturer$$$$$$Y$$$20240910$$CN$BR$BR
243023891$24302389$1$I$20240802$20240905$20240910$20240910$EXP$GB-MHRA-MED-202409051939447860-RSGCW$GB-MYLANLABS-2024M1081839$MYLAN$$33$YR$$F$Y$94$KG$20240910$$CN$GB$GB
243023901$24302390$1$I$20231205$20240906$20240910$20240910$EXP$GB-MHRA-MED-202409070034259890-KJSFQ$GB-MYLANLABS-2024M1082154$MYLAN$$49$YR$$M$Y$$$20240910$$CN$GB$GB
243023911$24302391$1$I$$20240906$20240910$20240910$EXP$$GB-MYLANLABS-2024M1082235$MYLAN$$$$$F$Y$$$20240910$$CN$GB$GB
243023921$24302392$1$I$$20240906$20240910$20240910$EXP$$AU-MYLANLABS-2024M1082056$MYLAN$$$$$F$Y$$$20240910$$PH$AU$AU
243023932$24302393$2$F$$20240910$20240910$20240912$EXP$$GB-MYLANLABS-2024M1081842$MYLAN$$$$$M$Y$$$20240912$$CN$GB$GB
243023941$24302394$1$I$20240906$20240906$20240910$20240910$EXP$$US-MYLANLABS-2024M1082079$MYLAN$$34$YR$$F$Y$$$20240910$$PH$US$US
243023951$24302395$1$I$20240830$20240903$20240910$20240910$EXP$$US-VANTIVE-2024VAN019511$Vantive US Healthcare$$$$$M$Y$$$20240910$$CN$US$US
243023961$24302396$1$I$20100101$20240905$20240910$20240910$EXP$$CR-MYLANLABS-2024M1082143$MYLAN$$$$$F$Y$60$KG$20240910$$CN$CR$CR
243023971$24302397$1$I$20240523$20240906$20240910$20240910$EXP$FR-AFSSAPS-ST2024001387$FR-MYLANLABS-2024M1081822$MYLAN$$43$YR$$M$Y$60$KG$20240910$$MD$FR$FR
243023981$24302398$1$I$20240801$20240903$20240910$20240910$EXP$$CN-JNJFOC-20240910532$JOHNSON AND JOHNSON$$57$YR$A$F$Y$50$KG$20240910$$HP$CN$CN
243023991$24302399$1$I$$20240904$20240910$20240910$EXP$$US-JNJFOC-20240915057$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$CN$US$US
243024002$24302400$2$F$20240801$20240905$20240910$20240912$EXP$$US-JNJFOC-20240908895$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
243024011$24302401$1$I$$20240907$20240910$20240910$PER$$NVSC2024US180084$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243024021$24302402$1$I$20230301$20240910$20240910$20240910$EXP$DE-BFARM-24006193$DE-BAYER-2024A129264$BAYER$$$$$$Y$$$20240910$$CN$DE$DE
243024032$24302403$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686776$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243024061$24302406$1$I$20240131$20240909$20240910$20240910$EXP$FR-AFSSAPS-MA2024001299$FR-UCBSA-2024046003$UCB$$78$YR$$M$Y$69$KG$20240910$$PH$FR$FR
243024071$24302407$1$I$$20240828$20240910$20240910$EXP$$IT-MYLANLABS-2024M1080550$MYLAN$Signorini F, Puccini M, Materazzi G, Ugolini C. ^Incidental^ lipoadenoma of the parathyroid gland: A case report of a rare entity. J-Clin-Transl-Endocrinol-Case-Rep 2024; 33 (0):.$48$YR$$M$Y$$$20240910$$HP$IT$IT
243024082$24302408$2$F$20181226$20240906$20240910$20240913$EXP$$NVSC2024CR180511$NOVARTIS$$68$YR$$F$Y$$$20240913$$CN$CR$CR
243024091$24302409$1$I$20240823$20240826$20240910$20240910$PER$$US-GRANULES-US-2024GRASPO00389$GRANULES INDIA$$72$YR$E$F$Y$69.85$KG$20240910$$CN$US$US
243024101$24302410$1$I$20240813$20240902$20240910$20240910$EXP$$JP-AstraZeneca-2024A070108$ASTRAZENECA$$75$YR$$M$Y$$$20240910$$MD$JP$
243024111$24302411$1$I$20240801$20240903$20240910$20240910$EXP$$DE-AstraZeneca-2024A199934$ASTRAZENECA$$28$YR$$F$Y$$$20240910$$MD$DE$
243024121$24302412$1$I$$20240907$20240910$20240910$EXP$$DE-AstraZeneca-2024A205247$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$DE$
243024131$24302413$1$I$20240805$20240905$20240910$20240910$EXP$$ID-AstraZeneca-2024A204081$ASTRAZENECA$$29229$DY$$M$Y$$$20240910$$CN$ID$
243024141$24302414$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004669$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240910$$CN$US$US
243024151$24302415$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005385$ELI LILLY AND CO$$74$YR$E$$Y$$$20240910$$CN$US$US
243024161$24302416$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004941$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240910$$PH$US$US
243024171$24302417$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005469$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240910$$CN$US$US
243024191$24302419$1$I$20240907$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005228$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240910$$CN$US$US
243024201$24302420$1$I$20240905$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004513$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240910$$CN$US$US
243024211$24302421$1$I$$20240904$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004559$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243024221$24302422$1$I$20240902$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004435$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240910$$CN$US$US
243024241$24302424$1$I$$20190220$20240910$20240910$EXP$$US-SANDOZ INC.-NVSC2019US092360$SANDOZ$$$$$F$Y$$$20240910$$CN$US$US
243024251$24302425$1$I$$20240909$20240910$20240910$PER$$US-HALEON-2195995$Haleon PLC$$$$$F$Y$$$20240910$$CN$US$US
243024261$24302426$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62060$$FDA-CTU$$63$YR$$F$N$$$20240909$N$$US$
243024271$24302427$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62016$$FDA-CTU$$85$YR$$F$N$64.41$KG$20240909$N$$US$
243024281$24302428$1$I$20240426$20240902$20240910$20240910$EXP$$JP-009507513-2409JPN000174J$MERCK$$58$YR$$M$Y$$$20240910$$MD$JP$JP
243024291$24302429$1$I$$20240902$20240910$20240910$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006647$BIOCON$$$$$$Y$$$20240910$$CN$CA$CA
243024301$24302430$1$I$20240905$20240906$20240910$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143408$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240910$$PH$JP$JP
243024311$24302431$1$I$$20240907$20240910$20240910$EXP$$CA-ROCHE-10000077274$ROCHE$$$$A$F$Y$$$20240910$$CN$CA$CA
243024321$24302432$1$I$$20240905$20240910$20240910$EXP$$IN-ROCHE-10000074716$ROCHE$Pareeth F, Babu G, Mathew B. Trastuzumab emtansine induced hyponatremia in breast cancer - A case report. Journal of cancer research and therapeutics. 2024-Aug-16;1-3. doi:10.4103/jcrt.jcrt_1602_23.$49$YR$A$F$Y$$$20240910$$HP$IN$IN
243024342$24302434$2$F$$20240907$20240910$20240910$30DAY$$US-SANDOZ INC.-SDZ2024US078575$SANDOZ$$$$$M$Y$$$20240910$$CN$US$US
243024351$24302435$1$I$20240704$20240904$20240910$20240910$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001799$BLUEPRINT MEDICINES$$71$YR$E$F$Y$$$20240910$$HP$US$US
243024361$24302436$1$I$20240903$20240905$20240910$20240910$EXP$$US-JNJFOC-20240911932$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240910$$CN$US$US
243024371$24302437$1$I$$20240906$20240910$20240910$EXP$$US-JNJFOC-20240920380$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$CN$US$US
243024381$24302438$1$I$$20240909$20240910$20240910$EXP$$DE-SANDOZ INC.-SDZ2024DE078553$SANDOZ$$62$YR$$M$Y$$$20240910$$MD$DE$DE
243024391$24302439$1$I$20240717$20240909$20240910$20240910$EXP$GB-MHRA-MED-202409091821142190-TSHCV$GB-GILEAD-2024-0687081$GILEAD$$$$$M$Y$$$20240910$$HP$GB$GB
243024401$24302440$1$I$$20240829$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN009158$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243024411$24302441$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-087432-2024$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243024421$24302442$1$I$$20240829$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN009147$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243024431$24302443$1$I$20231201$20240827$20240910$20240910$PER$$US-ASTELLAS-2024-AER-003647$ASTELLAS$$60$YR$A$F$Y$$$20240910$$MD$US$US
243024441$24302444$1$I$20240101$20240618$20240910$20240910$PER$$US-KARYOPHARM-2024KPT001202$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240910$$CN$US$US
243024451$24302445$1$I$20240826$20240903$20240910$20240910$EXP$$CN-BEIGENE-BGN-2024-013944$BEIGENE$$$$$$Y$$$20240910$$HP$CN$CN
243024462$24302446$2$F$20240801$20240924$20240910$20240924$EXP$$JP-PFIZER INC-202400252135$PFIZER$$72$YR$$F$Y$$$20240924$$MD$JP$JP
243024471$24302447$1$I$20240813$20240906$20240910$20240910$EXP$$CN-PFIZER INC-PV202400117438$PFIZER$$69$YR$$M$Y$$$20240910$$HP$CN$CN
243024481$24302448$1$I$$20240830$20240910$20240910$EXP$$US-PFIZER INC-2003171010US$PFIZER$Punukollu, G.. Delayed Presentation of Calcium Channel Antagonist Overdose. American Journal of Therapeutics. 2003;10(2):132-134$63$YR$$F$Y$$$20240910$$HP$US$US
243024491$24302449$1$I$$20240906$20240910$20240910$EXP$$CA-PFIZER INC-202400251723$PFIZER$$18$MON$$M$Y$8$KG$20240910$$HP$CA$CA
243024501$24302450$1$I$$20240906$20240910$20240910$EXP$$US-PFIZER INC-PV202200087929$PFIZER$$76$YR$$F$Y$$$20240910$$CN$US$US
243024511$24302451$1$I$20221115$20240903$20240910$20240910$PER$$US-BAYER-2024A126862$BAYER$$32$YR$A$F$Y$$$20240910$$MD$US$US
243024521$24302452$1$I$$20240906$20240910$20240910$EXP$$GB-PFIZER INC-202400252375$PFIZER$$34$YR$$M$Y$$$20240910$$PH$GB$GB
243024531$24302453$1$I$20240807$20240905$20240910$20240910$EXP$$SG-VANTIVE-2024VAN019579$Vantive US Healthcare$$75$YR$$F$Y$$$20240910$$CN$SG$SG
243024541$24302454$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62052$$FDA-CTU$$72$YR$$F$N$104.33$KG$20240909$N$$US$
243024551$24302455$1$I$20240817$20240830$20240910$20240910$PER$$CN-IGSA-BIG0030519$GRIFOLS$$72$YR$$F$Y$$$20240910$$HP$CN$CN
243024561$24302456$1$I$20240101$20240829$20240910$20240910$EXP$$US-UCBSA-2024044529$UCB$$$$$F$Y$59.002$KG$20240910$$HP$US$US
243024572$24302457$2$F$20240801$20240909$20240910$20240917$EXP$$CL-JNJFOC-20240905084$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240917$$CN$CL$CL
243024592$24302459$2$F$$20240911$20240910$20240913$EXP$$US-TAKEDA-2024TUS089991$TAKEDA$$$$$M$Y$$$20240913$$CN$US$US
243024611$24302461$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR110090$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243024621$24302462$1$I$20240731$20240909$20240910$20240910$EXP$GB-MHRA-MED-202409031001335990-QZPML$GB-JNJFOC-20240922939$JOHNSON AND JOHNSON$$64$YR$A$M$Y$64$KG$20240910$$MD$GB$GB
243024631$24302463$1$I$$20240903$20240910$20240910$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17674$IPSEN$$$$$F$Y$$$20240910$$MD$US$US
243024643$24302464$3$F$20230101$20240909$20240910$20240918$PER$$US-AMGEN-USASP2024179276$AMGEN$$73$YR$E$F$Y$$$20240917$$CN$US$US
243024651$24302465$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61976$$FDA-CTU$$24$YR$$F$N$$$20240909$N$$US$
243024661$24302466$1$I$20240601$20240903$20240910$20240910$EXP$FI-FIMEA-202403078$FI-TEVA-VS-3240247$TEVA$$75$YR$$M$Y$$$20240910$$MD$FI$FI
243024671$24302467$1$I$$20240905$20240910$20240910$PER$$US-ROCHE-10000075374$ROCHE$$59$YR$A$F$Y$$$20240910$$CN$US$US
243024681$24302468$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR110086$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243024692$24302469$2$F$$20240904$20240910$20240917$EXP$$US-ADVANZ PHARMA-202408007208$ADVANZ PHARMA$$$$$$Y$$$20240917$$HP$US$US
243024701$24302470$1$I$20240825$20240903$20240910$20240910$EXP$$CN-BEIGENE-BGN-2024-013950$BEIGENE$$$$$$Y$$$20240910$$HP$CN$CN
243024711$24302471$1$I$$20240830$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN009243$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243024721$24302472$1$I$$20240829$20240910$20240910$EXP$$ES-ABBVIE-5902864$ABBVIE$$$$$F$Y$$$20240910$$HP$ES$ES
243024731$24302473$1$I$$20240906$20240910$20240910$PER$$US-HALEON-2195980$Haleon PLC$$$$$$Y$$$20240910$$CN$US$US
243024741$24302474$1$I$20210302$20240830$20240910$20240910$EXP$$GB-OTSUKA-2024_024706$OTSUKA$$68$YR$$M$Y$$$20240910$$MD$GB$GB
243024751$24302475$1$I$$20240829$20240910$20240910$EXP$$MX-SERVIER-S24010993$SERVIER$$$$$$Y$$$20240910$$MD$MX$MX
243024761$24302476$1$I$$20240909$20240910$20240910$EXP$$AT-GILEAD-2024-0686749$GILEAD$$$$$M$Y$$$20240910$$HP$AT$AT
243024771$24302477$1$I$20240609$20240703$20240910$20240910$EXP$$US-NIPPON SHINYAKU-NIP-2024-000033$NIPPON SHINYAKU$$22$YR$$M$Y$79.38$KG$20240910$$HP$US$US
243024781$24302478$1$I$$20240904$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143420$BRISTOL MYERS SQUIBB$$72$YR$E$$Y$$$20240910$$HP$US$US
243024791$24302479$1$I$$20240830$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN009240$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243024801$24302480$1$I$$20240902$20240910$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142133$BRISTOL MYERS SQUIBB$$26$YR$A$F$Y$$$20240910$$MD$JP$JP
243024811$24302481$1$I$20240827$20240903$20240910$20240910$EXP$$CN-BEIGENE-BGN-2024-013959$BEIGENE$$$$$$Y$$$20240910$$HP$CN$CN
243024821$24302482$1$I$$20240906$20240910$20240910$EXP$$JP-GILEAD-2024-0686460$GILEAD$$56$YR$A$M$Y$$$20240910$$MD$JP$JP
243024832$24302483$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687168$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243024841$24302484$1$I$$20240902$20240910$20240910$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-08328$HIKMA$$63$YR$$F$Y$58$KG$20240910$$HP$CA$CA
243024851$24302485$1$I$$20240830$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN009238$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243024861$24302486$1$I$20240909$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62084$$FDA-CTU$$57$YR$$M$N$83.9$KG$20240909$N$HP$US$
243024871$24302487$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61952$$FDA-CTU$$72$YR$$M$N$$$20240909$N$$US$
243024881$24302488$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62092$$FDA-CTU$$80$YR$$M$N$$$20240909$N$$US$
243024911$24302491$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62037$$FDA-CTU$$57$YR$$M$N$$$20240909$N$$US$
243024921$24302492$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62101$$FDA-CTU$$61$YR$$F$N$$$20240909$N$$US$
243024931$24302493$1$I$$20240909$20240909$20240909$DIR$717731$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
243024952$24302495$2$F$20240701$20240917$20240910$20240920$EXP$$TN-ABBVIE-5908807$ABBVIE$$65$YR$$M$Y$$$20240920$$CN$TN$TN
243024971$24302497$1$I$$20240907$20240910$20240910$EXP$$DE-ROCHE-10000077165$ROCHE$$$$$F$Y$$$20240910$$CN$DE$DE
243024981$24302498$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62033$$FDA-CTU$$87$YR$$F$N$$$20240909$N$$US$
243025001$24302500$1$I$$20240901$20240910$20240910$PER$$US-BAYER-2024A126460$BAYER$$$$$F$Y$$$20240910$$CN$US$US
243025011$24302501$1$I$$20240830$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN009216$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243025031$24302503$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61947$$FDA-CTU$$42$YR$$F$N$$$20240909$N$$US$
243025041$24302504$1$I$20200801$20240909$20240909$20240909$DIR$717716$$FDA-CTU$$35$YR$$F$N$74.25$KG$20240909$N$CN$US$
243025051$24302505$1$I$$20240829$20240910$20240910$PER$$US-IGSA-BIG0030594$GRIFOLS$$$$$M$Y$104$KG$20240910$$CN$US$US
243025061$24302506$1$I$20240101$20240829$20240910$20240910$EXP$$US-SA-2024SA261101$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240910$$MD$US$US
243025071$24302507$1$I$$20240828$20240910$20240910$30DAY$$US-PFIZER INC-202400246544$PFIZER$$6$YR$$M$Y$$$20240910$$HP$US$US
243025091$24302509$1$I$$20240823$20240910$20240910$30DAY$$CR-PFIZER INC-PV202400111172$PFIZER$$35$YR$$M$Y$$$20240910$$HP$CR$CR
243025112$24302511$2$F$$20240924$20240910$20240926$30DAY$$CA-PFIZER INC-202400252948$PFIZER$$$$$$Y$$$20240926$$HP$CA$CA
243025122$24302512$2$F$20240801$20240917$20240910$20240917$30DAY$$AR-PFIZER INC-202400247373$PFIZER$$62$YR$$F$Y$$$20240917$$HP$AR$AR
243025131$24302513$1$I$20240101$20240902$20240910$20240910$30DAY$$AU-PFIZER INC-202400248632$PFIZER$$56$YR$$F$Y$$$20240910$$CN$AU$AU
243025152$24302515$2$F$20240808$20240917$20240910$20240919$30DAY$$CO-PFIZER INC-PV202400113183$PFIZER$$8$YR$$F$Y$$$20240919$$CN$CO$CO
243025161$24302516$1$I$20240901$20240904$20240910$20240910$PER$$US-BAYER-2024A127397$BAYER$$37$YR$A$M$Y$$$20240910$$CN$US$US
243025191$24302519$1$I$$20240827$20240910$20240910$30DAY$$GB-PFIZER INC-202400247214$PFIZER$$53$YR$$F$Y$$$20240910$$CN$GB$GB
243025201$24302520$1$I$20240312$20240905$20240910$20240910$EXP$$DE-AstraZeneca-2024A202129$ASTRAZENECA$$$$E$F$Y$71$KG$20240910$$MD$DE$
243025211$24302521$1$I$20190925$20240830$20240910$20240910$EXP$$GB-SA-2019SA285926$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240910$$HP$FR$GB
243025221$24302522$1$I$20240101$20240815$20240910$20240910$PER$$US-TEVA-VS-3234408$TEVA$$45$YR$$M$Y$$$20240910$$CN$US$US
243025231$24302523$1$I$$20240904$20240910$20240910$EXP$$JP-AMGEN-JPNSP2024177451$AMGEN$$$$E$$Y$$$20240910$$CN$JP$JP
243025261$24302526$1$I$$20240904$20240910$20240910$PER$$US-BAYER-2024A128272$BAYER$$$$$$Y$$$20240910$$CN$US$US
243025271$24302527$1$I$20220524$20240909$20240910$20240910$EXP$$KR-ROCHE-10000076687$ROCHE$$77$YR$E$F$Y$$$20240910$$HP$KR$KR
243025281$24302528$1$I$$20240909$20240910$20240910$EXP$$US-GILEAD-2024-0687055$GILEAD$$66$YR$E$M$Y$$$20240910$$PH$US$US
243025291$24302529$1$I$$20240829$20240910$20240910$PER$$US-JNJFOC-20240900984$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
243025301$24302530$1$I$$20240830$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN009207$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243025311$24302531$1$I$$20240908$20240910$20240910$PER$$US-ALXN-202409USA000517US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243025321$24302532$1$I$$20240904$20240910$20240910$EXP$$US-SA-2024SA261584$SANOFI AVENTIS$$$$$F$Y$$$20240910$$HP$US$US
243025331$24302533$1$I$20240701$20240902$20240910$20240910$EXP$$AR-ROCHE-10000077311$ROCHE$$54$YR$A$F$Y$$$20240910$$CN$AR$AR
243025341$24302534$1$I$20240401$20240904$20240910$20240910$EXP$$DE-ABBVIE-5908926$ABBVIE$$62$YR$$F$Y$$$20240910$$MD$DE$DE
243025361$24302536$1$I$$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408291704064190-TYHMK$GB-NOVOPROD-1276249$NOVO NORDISK$$49$YR$$F$Y$$$20240910$$MD$GB$GB
243025372$24302537$2$F$20230101$20240918$20240910$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-026938$UNITED THERAPEUTICS$$$$$F$Y$96.599$KG$20240925$$$US$US
243025382$24302538$2$F$$20240830$20240910$20240917$EXP$$US-BEH-2024178172$CSL BEHRING$$17$YR$T$F$Y$49.433$KG$20240917$$CN$US$US
243025392$24302539$2$F$20240908$20240910$20240910$20240911$PER$$US-AMGEN-USASP2024180021$AMGEN$$64$YR$A$F$Y$$$20240911$$CN$US$US
243025402$24302540$2$F$20240904$20240911$20240910$20240913$PER$$US-AMGEN-USASP2024178340$AMGEN$$63$YR$A$F$Y$$$20240913$$HP$US$US
243025411$24302541$1$I$$20240905$20240910$20240910$EXP$$BE-AMGEN-BELSP2024177624$AMGEN$$$$$$Y$$$20240910$$PH$BE$BE
243025421$24302542$1$I$$20240903$20240910$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-025165$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240910$$$US$US
243025431$24302543$1$I$20240907$20240907$20240910$20240910$PER$$US-AMGEN-USASP2024179595$AMGEN$$62$YR$A$F$Y$$$20240910$$CN$US$US
243025441$24302544$1$I$20240601$20240826$20240910$20240910$PER$$US-GRANULES-US-2024GRASPO00394$GRANULES INDIA$$49$YR$A$F$Y$150$KG$20240910$$CN$US$US
243025451$24302545$1$I$$20240905$20240910$20240910$PER$$US-AMGEN-USASL2024178941$AMGEN$$$$A$F$Y$$$20240910$$HP$US$US
243025461$24302546$1$I$20240801$20240904$20240910$20240910$EXP$$US-PFIZER INC-202400250366$PFIZER$$37$YR$$F$Y$81.65$KG$20240910$$CN$US$US
243025481$24302548$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181141$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243025491$24302549$1$I$$20230202$20240910$20240910$EXP$$US-SANDOZ INC.-NVSC2022US276899$SANDOZ$$$$$M$Y$$$20240910$$CN$US$US
243025502$24302550$2$F$20240702$20240919$20240910$20240923$EXP$$SE-Hill Dermaceuticals, Inc.-2161400$HILL DERM$$67$YR$$M$Y$$$20240923$$MD$SE$SE
243025511$24302551$1$I$20240615$20240902$20240910$20240910$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161416$JIANGSU HANSOH PHARMACEUTICAL$$41$YR$$M$Y$76$KG$20240910$$MD$CN$CN
243025521$24302552$1$I$$20240905$20240910$20240910$EXP$$US-ABBVIE-5915340$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243025531$24302553$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143569$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240910$$HP$US$US
243025542$24302554$2$F$20240725$20240912$20240910$20240919$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409004024$ELI LILLY AND CO$$$$A$F$Y$130$KG$20240919$$CN$DE$DE
243025552$24302555$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687116$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243025561$24302556$1$I$20240101$20240624$20240910$20240910$PER$$US-LUNDBECK-DKLU4004052$LUNDBECK$$$$$$Y$$$20240910$$CN$US$US
243025571$24302557$1$I$$20240906$20240910$20240910$PER$$US-BAYER-2024A128319$BAYER$$$$$M$Y$$$20240910$$CN$US$US
243025581$24302558$1$I$20240727$20240805$20240910$20240910$PER$$US-ITALFARMACO SPA-2161422$ITALFARMACO$$75$YR$$F$Y$$$20240910$$$US$US
243025591$24302559$1$I$20240101$20240115$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000005$NIPPON SHINYAKU$$15$YR$$M$Y$$$20240910$$HP$US$US
243025601$24302560$1$I$20240809$20240823$20240910$20240910$EXP$$US-ITALFARMACO SPA-2161424$ITALFARMACO$$59$YR$$F$Y$$$20240910$$$US$US
243025611$24302561$1$I$20240814$20240815$20240910$20240910$PER$$US-ITALFARMACO SPA-2161420$ITALFARMACO$$69$YR$$M$Y$$$20240910$$$US$US
243025622$24302562$2$F$20240201$20240313$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000014$NIPPON SHINYAKU$$9$YR$$M$Y$$$20240910$$HP$US$US
243025631$24302563$1$I$20231025$20231102$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2023-000048$NIPPON SHINYAKU$$11$YR$$M$Y$$$20240910$$HP$US$US
243025641$24302564$1$I$20240222$20240314$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000010$NIPPON SHINYAKU$$8$YR$$M$Y$28.3$KG$20240910$$HP$US$US
243025651$24302565$1$I$20231101$20231101$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2023-000047$NIPPON SHINYAKU$$5$YR$$M$Y$$$20240910$$PH$US$US
243025661$24302566$1$I$20220801$20231017$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2023-000043$NIPPON SHINYAKU$$20$YR$$M$Y$$$20240910$$HP$US$US
243025671$24302567$1$I$20230921$20231220$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2023-000058$NIPPON SHINYAKU$$2$YR$$M$Y$$$20240910$$HP$US$US
243025681$24302568$1$I$$20240906$20240910$20240910$EXP$$US-ABBVIE-5914054$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243025691$24302569$1$I$$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408291138337940-BJCHN$GB-Accord-444374$ACCORD$$85$YR$E$M$Y$$$20240910$$HP$GB$GB
243025701$24302570$1$I$20230101$20231019$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2023-000044$NIPPON SHINYAKU$$$$$M$Y$78.005$KG$20240910$$HP$US$US
243025721$24302572$1$I$20240803$20240807$20240910$20240910$PER$$US-ITALFARMACO SPA-2161421$ITALFARMACO$$59$YR$$F$Y$$$20240910$$$US$US
243025732$24302573$2$F$$20240919$20240910$20240927$EXP$$US-VERTEX PHARMACEUTICALS-2024-014221$VERTEX$$$$$$Y$$$20240927$$CN$US$US
243025741$24302574$1$I$$20240904$20240910$20240910$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014160$VERTEX$$$$A$M$Y$$$20240910$$CN$GB$GB
243025751$24302575$1$I$$20240909$20240910$20240910$EXP$$GB-Karo Pharma-2161404$Karo Pharma$$36$YR$$F$Y$67$KG$20240910$$MD$GB$GB
243025761$24302576$1$I$$20240904$20240910$20240910$EXP$$US-VERTEX PHARMACEUTICALS-2024-014148$VERTEX$$19$YR$$$Y$$$20240910$$CN$US$US
243025771$24302577$1$I$$20240905$20240910$20240910$PER$$US-VERTEX PHARMACEUTICALS-2024-014207$VERTEX$$$$$M$Y$$$20240910$$CN$US$US
243025782$24302578$2$F$$20240917$20240910$20240923$EXP$$US-VERTEX PHARMACEUTICALS-2024-014159$VERTEX$$$$$F$Y$$$20240923$$MD$US$US
243025791$24302579$1$I$$20240905$20240910$20240910$PER$$US-VERTEX PHARMACEUTICALS-2024-009886$VERTEX$$$$$F$Y$$$20240910$$CN$US$US
243025811$24302581$1$I$20240101$20240905$20240910$20240910$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014171$VERTEX$$$$A$M$Y$$$20240910$$CN$GB$GB
243025821$24302582$1$I$20240801$20240905$20240910$20240910$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014214$VERTEX$$$$A$F$Y$$$20240910$$CN$GB$GB
243025831$24302583$1$I$20240101$20240904$20240910$20240910$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014112$VERTEX$$$$A$F$Y$$$20240910$$CN$GB$GB
243025842$24302584$2$F$$20240913$20240910$20240925$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161418$JIANGSU HENGRUI MEDICINE$20240913 275 H2024001205399 FU2 A CASE OF...$64$YR$$M$Y$$$20240925$$MD$US$CN
243025851$24302585$1$I$$20240827$20240910$20240910$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161417$JIANGSU HENGRUI MEDICINE$$58$YR$$F$Y$64$KG$20240910$$MD$CN$CN
243025861$24302586$1$I$$20240905$20240910$20240910$EXP$$US-VERTEX PHARMACEUTICALS-2024-013250$VERTEX$$$$$M$Y$$$20240910$$CN$US$US
243025871$24302587$1$I$20240806$20240830$20240910$20240910$EXP$$CN-Hisun Pharmaceuticals-2161414$HISUN PHARMACEUTICALS$$46$YR$$M$Y$100$KG$20240910$$$CN$CN
243025891$24302589$1$I$20240824$20240830$20240910$20240910$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161419$JIANGSU HANSOH PHARMACEUTICAL$$52$YR$$M$Y$65$KG$20240910$$MD$CN$CN
243025901$24302590$1$I$20240724$20240729$20240910$20240910$PER$$US-ITALFARMACO SPA-2161423$ITALFARMACO$$81$YR$$F$Y$$$20240910$$$US$US
243025911$24302591$1$I$$20240828$20240910$20240910$EXP$$US-Medline Industries, LP-2161430$MEDLINE INDUSTRIES$$$$$M$Y$$$20240910$$$US$US
243025921$24302592$1$I$20240101$20240828$20240910$20240910$EXP$$CA-UCBSA-2024044317$UCB$$$$$F$Y$$$20240910$$CN$CA$CA
243025931$24302593$1$I$$20240828$20240910$20240910$EXP$$IT-B.Braun Medical Inc.-2161427$B BRAUN$Literature Article$22$YR$$F$Y$$$20240910$$$IT$IT
243025941$24302594$1$I$$20240828$20240910$20240910$EXP$$US-B.Braun Medical Inc.-2161431$B BRAUN$Literature Article$70$YR$$F$Y$$$20240910$$$US$US
243025952$24302595$2$F$20240817$20240904$20240910$20240913$EXP$$JP-UCBSA-2024044587$UCB$$37$YR$$M$Y$$$20240913$$MD$JP$JP
243025961$24302596$1$I$$20240826$20240910$20240910$EXP$$US-CHEMI SPA-2161429$CHEMI SPA$$26$YR$$F$Y$$$20240910$$$US$US
243025971$24302597$1$I$$20240904$20240910$20240910$EXP$$JP-BEH-2024178218$CSL BEHRING$$$$$$Y$$$20240910$$PH$JP$JP
243025981$24302598$1$I$20240730$20240902$20240910$20240910$EXP$FR-AFSSAPS-TS2024000931$FR-TEVA-VS-3239552$TEVA$$61$YR$$M$Y$76$KG$20240910$$MD$FR$FR
243025991$24302599$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62095$$FDA-CTU$$67$YR$$F$N$$$20240909$N$$US$
243026001$24302600$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61983$$FDA-CTU$$90$YR$$F$N$$$20240909$N$$US$
243026021$24302602$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62039$$FDA-CTU$$69$YR$$F$N$$$20240909$N$$US$
243026031$24302603$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62065$$FDA-CTU$$79$YR$$F$N$$$20240909$N$$US$
243026041$24302604$1$I$$20240906$20240909$20240909$DIR$FDA-CDER-CTU-2024-62038$$FDA-CTU$$$$$M$N$$$20240906$N$HP$US$
243026051$24302605$1$I$20240815$20240903$20240910$20240910$PER$$US-Kiniksa Pharmaceuticals Ltd.-2024KPU001536$KINIKSA PHARMACEUTICALS$$61$YR$A$F$Y$$$20240909$$HP$US$US
243026061$24302606$1$I$20230101$20240906$20240910$20240910$EXP$FR-AFSSAPS-PO2024000032$FR-LUNDBECK-DKLU3073222$LUNDBECK$$$$$$Y$$$20240910$$PH$FR$FR
243026071$24302607$1$I$20240401$20240902$20240910$20240910$EXP$FR-AFSSAPS-DJ2024000887$FR-SERVIER-S24011044$SERVIER$$$$$$Y$$$20240910$$MD$FR$FR
243026081$24302608$1$I$$20240828$20240910$20240910$EXP$$GB-ADVANZ PHARMA-202408007212$ADVANZ PHARMA$$$$$$Y$$$20240910$$MD$GB$GB
243026091$24302609$1$I$20240101$20240904$20240910$20240910$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-119836$REGENERON$$76$YR$$F$Y$$$20240910$$MD$US$US
243026102$24302610$2$F$$20240912$20240910$20240920$EXP$$JP-TEVA-VS-3239813$TEVA$Adachi K, Murata M, Inada A, Morimoto T, Shimizu M, Beppu S, et al. Interaction of a caffeine overdose with clinical doses of contraceptive ethinyl estradiol in a young woman. Acute-Med-Surg 2024; 11 (1): 1-4.; Adachi K, Murata M, Inada A, Morimoto T, Shimizu M, Beppu S, et al. Interaction of a caffeine overdose with clinical doses of contraceptive ethinyl estradiol in a young woman. Acute-Med-Surg 2024; 11 (1): 1-4.; Adachi K, Murata M, Inada A, Morimoto T, Shimizu M, Beppu S, et al. Interac...$23$YR$$F$Y$$$20240920$$HP$JP$JP
243026111$24302611$1$I$$20240813$20240910$20240910$30DAY$$US-Kaleo, Inc.-2024KL000038$KALEO$$$$C$$Y$$$20240909$$CN$US$US
243026121$24302612$1$I$20240910$20240910$20240910$20240910$EXP$$RU-PFIZER INC-202400253276$PFIZER$$$$A$F$Y$$$20240910$$MD$RU$RU
243026132$24302613$2$F$20240801$20240904$20240910$20240911$EXP$FR-AFSSAPS-TS2024000954$FR-PFIZER INC-202400251287$PFIZER$$70$YR$$F$Y$45$KG$20240911$$MD$FR$FR
243026141$24302614$1$I$20240904$20240906$20240910$20240910$EXP$GB-MHRA-MED-202409051400377550-QNDRW$GB-PFIZER INC-202400251750$PFIZER$$53$YR$$F$Y$$$20240910$$HP$GB$GB
243026151$24302615$1$I$20240101$20240906$20240910$20240910$EXP$GB-MHRA-MED-202409061635586740-YFCKS$GB-PFIZER INC-202400251798$PFIZER$$76$YR$$F$Y$95$KG$20240910$$PH$GB$GB
243026161$24302616$1$I$20230719$20240906$20240910$20240910$EXP$$FR-PFIZER INC-202400251279$PFIZER$$52$YR$$F$Y$$$20240910$$HP$FR$FR
243026171$24302617$1$I$$20240909$20240910$20240910$EXP$GB-MHRA-MIDB-b59af161-c598-4294-a73e-b12288a55d54$GB-PFIZER INC-202400252679$PFIZER$$56$YR$$F$Y$$$20240910$$HP$GB$GB
243026181$24302618$1$I$$20240907$20240910$20240910$EXP$GB-MHRA-MED-202409071842488450-NYLVB$GB-PFIZER INC-202400251896$PFIZER$$$$$F$Y$$$20240910$$CN$GB$GB
243026191$24302619$1$I$20240826$20240909$20240910$20240910$EXP$$CN-PFIZER INC-PV202400118233$PFIZER$$62$YR$$F$Y$54$KG$20240910$$HP$CN$CN
243026201$24302620$1$I$$20240909$20240910$20240910$EXP$$CA-PFIZER INC-202400231663$PFIZER$$66$YR$$F$Y$$$20240910$$HP$CA$CA
243026211$24302621$1$I$20240606$20240909$20240910$20240910$EXP$NO-NOMAADVRE-RELISSO-2024-V8bmwq$NO-PFIZER INC-202400252431$PFIZER$$57$YR$$M$Y$$$20240910$$MD$NO$NO
243026221$24302622$1$I$$20240909$20240910$20240910$EXP$$US-PFIZER INC-202400253027$PFIZER$$65$YR$$$Y$$$20240910$$HP$US$US
243026241$24302624$1$I$$20240909$20240910$20240910$EXP$$JP-PFIZER INC-202400252178$PFIZER$$$$$$Y$$$20240910$$PH$JP$JP
243026262$24302626$2$F$$20240909$20240910$20240911$EXP$$US-PFIZER INC-202400253140$PFIZER$$77$YR$$F$Y$$$20240911$$CN$US$US
243026271$24302627$1$I$20240801$20240909$20240910$20240910$EXP$$TW-PFIZER INC-PV202400118281$PFIZER$$$$E$M$Y$$$20240910$$HP$TW$TW
243026281$24302628$1$I$20240628$20240906$20240910$20240910$EXP$$CN-PFIZER INC-PV202400117411$PFIZER$$57$YR$$M$Y$65$KG$20240910$$HP$CN$CN
243026302$24302630$2$F$$20240916$20240910$20240916$EXP$$DE-PFIZER INC-202400252462$PFIZER$$84$YR$$M$Y$$$20240916$$MD$DE$DE
243026311$24302631$1$I$$20240909$20240910$20240910$EXP$$EG-PFIZER INC-PV202400118564$PFIZER$$45$YR$$M$Y$$$20240910$$CN$EG$EG
243026321$24302632$1$I$20240702$20240906$20240910$20240910$EXP$$FR-PFIZER INC-202400251275$PFIZER$$49$YR$$F$Y$86$KG$20240910$$MD$FR$FR
243026331$24302633$1$I$$20240909$20240910$20240910$EXP$$CN-PFIZER INC-202400252300$PFIZER$$45$YR$$M$Y$$$20240910$$CN$CN$CN
243026341$24302634$1$I$20240902$20240906$20240910$20240910$EXP$$CN-PFIZER INC-PV202400117425$PFIZER$$33$YR$$F$Y$47.1$KG$20240910$$HP$CN$CN
243026352$24302635$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687169$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243026381$24302638$1$I$20240810$20240903$20240910$20240910$EXP$$US-RDY-SPO/USA/24/0012822$DR REDDYS$$75$YR$E$M$Y$$$20240910$$HP$US$US
243026391$24302639$1$I$20240903$20240903$20240910$20240910$PER$$US-RDY-SPO/USA/24/0012891$DR REDDYS$$69$YR$E$M$Y$$$20240910$$HP$US$US
243026401$24302640$1$I$20240906$20240903$20240910$20240910$PER$$US-RDY-SPO/USA/24/0013021$DR REDDYS$$22$YR$A$F$Y$$$20240910$$CN$US$US
243026411$24302641$1$I$20240830$20240903$20240910$20240910$PER$$US-RDY-SPO/USA/24/0012825$DR REDDYS$$27$YR$A$M$Y$$$20240910$$HP$US$US
243026431$24302643$1$I$20240829$20240903$20240910$20240910$PER$$US-RDY-SPO/USA/24/0013020$DR REDDYS$$23$YR$A$F$Y$$$20240910$$HP$US$US
243026441$24302644$1$I$20240827$20240903$20240910$20240910$PER$$US-RDY-SPO/USA/24/0012833$DR REDDYS$$45$YR$A$M$Y$$$20240910$$PH$US$US
243026451$24302645$1$I$$20240909$20240910$20240910$PER$$US-HALEON-2196090$Haleon PLC$$$$$$Y$$$20240910$$CN$US$US
243026461$24302646$1$I$20240831$20240902$20240910$20240910$EXP$$CN-FreseniusKabi-FK202413391$FRESENIUS KABI$$93$YR$E$F$Y$50$KG$20240910$$HP$CN$CN
243026471$24302647$1$I$$20240904$20240910$20240910$PER$$US-BAYER-2024A128883$BAYER$$$$$$Y$$$20240910$$CN$US$US
243026481$24302648$1$I$$20240830$20240910$20240910$EXP$$JP-UCBSA-2024045537$UCB$$$$$$Y$$$20240910$$PH$JP$JP
243026491$24302649$1$I$$20240904$20240910$20240910$30DAY$$DE-UCBSA-2024045997$UCB$$$$$F$Y$$$20240910$$PH$DE$DE
243026511$24302651$1$I$$20240903$20240910$20240910$30DAY$$US-PFIZER INC-202400249769$PFIZER$$4$YR$$M$Y$$$20240910$$CN$US$US
243026552$24302655$2$F$20240902$20240910$20240910$20240912$30DAY$$US-PFIZER INC-202400249449$PFIZER$$$$$M$Y$$$20240912$$CN$US$US
243026561$24302656$1$I$$20240315$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000015$NIPPON SHINYAKU$$$$$M$Y$$$20240910$$CN$US$US
243026571$24302657$1$I$20240823$20240823$20240910$20240910$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005029$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240910$$CN$US$US
243026581$24302658$1$I$$20240329$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000018$NIPPON SHINYAKU$$9$YR$$M$Y$$$20240910$$CN$US$US
243026591$24302659$1$I$20240403$20240507$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000019$NIPPON SHINYAKU$$12$YR$$M$Y$$$20240910$$CN$US$US
243026601$24302660$1$I$20240201$20240313$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000016$NIPPON SHINYAKU$$0$YR$$M$Y$$$20240910$$CN$US$US
243026611$24302661$1$I$$20240503$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000023$NIPPON SHINYAKU$$$$$M$Y$$$20240910$$CN$US$US
243026622$24302662$2$F$$20240911$20240910$20240917$EXP$$CN-AstraZeneca-2024A139221$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$CN$
243026631$24302663$1$I$$20240902$20240910$20240910$EXP$$SI-AstraZeneca-2024A199274$ASTRAZENECA$$80$YR$$F$Y$$$20240910$$MD$SI$
243026641$24302664$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179624$AMGEN$$$$$$Y$$$20240910$$MD$US$US
243026652$24302665$2$F$20240908$20240910$20240910$20240913$PER$$US-AMGEN-USASP2024180203$AMGEN$$59$YR$A$M$Y$$$20240912$$CN$US$US
243026662$24302666$2$F$$20240917$20240910$20240919$EXP$$UA-AMGEN-UKRSP2024178052$AMGEN$Lymanets T.. Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240919$$MD$UA$UA
243026671$24302667$1$I$20240824$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179545$AMGEN$$81$YR$E$F$Y$$$20240910$$CN$US$US
243026682$24302668$2$F$$20240910$20240910$20240910$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050525$BOEHRINGER INGELHEIM$$$$$$Y$$$20240910$$CN$US$US
243026691$24302669$1$I$20240824$20240909$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143582$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$62.14$KG$20240910$$HP$US$US
243026702$24302670$2$F$20240909$20240908$20240910$20240913$PER$$US-BAYER-2024A128853$BAYER$$47$YR$A$F$Y$$$20240913$$CN$US$US
243026711$24302671$1$I$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686711$GILEAD$$86$YR$E$M$Y$$$20240910$$PH$US$US
243026721$24302672$1$I$$20240909$20240910$20240910$EXP$$GB-Karo Pharma-2161432$Karo Pharma$$$$$F$Y$$$20240910$$$GB$GB
243026731$24302673$1$I$20240801$20240829$20240910$20240910$EXP$$US-UCBSA-2024044501$UCB$$41$YR$$F$Y$119.72$KG$20240910$$HP$US$US
243026741$24302674$1$I$20240815$20240828$20240910$20240910$EXP$$US-UCBSA-2024044093$UCB$$19$YR$$M$Y$$$20240910$$CN$US$US
243026751$24302675$1$I$$20240904$20240910$20240910$EXP$$CA-SANDOZ INC.-SDZ2024CA078184$SANDOZ$$$$$M$Y$74$KG$20240910$$CN$CA$CA
243026762$24302676$2$F$20240101$20240913$20240910$20240917$PER$$US-ABBVIE-5914396$ABBVIE$$$$A$F$Y$$$20240917$$HP$US$US
243026771$24302677$1$I$20240101$20240822$20240910$20240910$PER$$US-SA-2024SA259719$SANOFI AVENTIS$$$$C$M$Y$$$20240910$$HP$US$US
243026791$24302679$1$I$$20240821$20240910$20240910$PER$$US-SA-2024SA201533$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240910$$CN$US$US
243026801$24302680$1$I$20240801$20240820$20240910$20240910$PER$$US-SA-2024SA260150$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240910$$MD$US$US
243026811$24302681$1$I$$20240821$20240910$20240910$PER$$US-SA-2024SA260277$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240910$$CN$US$US
243026821$24302682$1$I$$20240823$20240910$20240910$PER$$US-SA-2024SA259945$SANOFI AVENTIS$$$$A$M$Y$$$20240910$$MD$US$US
243026831$24302683$1$I$$20240821$20240910$20240910$PER$$US-SA-2024SA259559$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240910$$MD$US$US
243026841$24302684$1$I$$20240821$20240910$20240910$PER$$US-SA-2024SA259285$SANOFI AVENTIS$$$$E$F$Y$$$20240910$$MD$US$US
243026851$24302685$1$I$$20240830$20240910$20240910$PER$$US-MYLANLABS-2024M1076710$MYLAN$$$$$F$Y$$$20240910$$CN$US$US
243026861$24302686$1$I$20240806$20240906$20240910$20240910$EXP$FR-AFSSAPS-MP2024001304$FR-LUNDBECK-DKLU4003982$LUNDBECK$$$$$$Y$$$20240910$$PH$FR$FR
243026871$24302687$1$I$$20240909$20240910$20240910$PER$$US-ABBVIE-5916050$ABBVIE$$30$YR$$F$Y$$$20240910$$HP$US$US
243026882$24302688$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687062$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243026891$24302689$1$I$20240701$20240828$20240910$20240910$PER$$US-SA-2024SA259404$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240910$$HP$US$US
243026901$24302690$1$I$20190101$20240828$20240910$20240910$PER$$US-SA-2024SA259190$SANOFI AVENTIS$$$$$$Y$$$20240910$$CN$US$US
243026911$24302691$1$I$20240801$20240828$20240910$20240910$PER$$US-SA-2024SA186985$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240910$$MD$US$US
243026921$24302692$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259727$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240910$$HP$US$US
243026931$24302693$1$I$20240827$20240828$20240910$20240910$PER$$US-SA-2024SA259969$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240910$$MD$US$US
243026941$24302694$1$I$20240101$20240826$20240910$20240910$PER$$US-SA-2024SA259555$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240910$$MD$US$US
243026951$24302695$1$I$20240824$20240828$20240910$20240910$PER$$US-SA-2024SA259802$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240910$$MD$US$US
243026961$24302696$1$I$$20240823$20240910$20240910$PER$$US-SA-2024SA259633$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240910$$MD$US$US
243026971$24302697$1$I$20240701$20240823$20240910$20240910$PER$$US-SA-2024SA259492$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240910$$CN$US$US
243026981$24302698$1$I$20240807$20240827$20240910$20240910$PER$$US-SA-2024SA243093$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240910$$CN$US$US
243026991$24302699$1$I$20231001$20240827$20240910$20240910$PER$$US-SA-2024SA259961$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240910$$CN$US$US
243027001$24302700$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA259209$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240910$$MD$US$US
243027011$24302701$1$I$20240801$20240828$20240910$20240910$PER$$US-SA-2024SA259141$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240910$$MD$US$US
243027021$24302702$1$I$20240801$20240826$20240910$20240910$PER$$US-SA-2024SA259405$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240910$$MD$US$US
243027031$24302703$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA151904$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240910$$PH$US$US
243027041$24302704$1$I$20240711$20240903$20240910$20240910$EXP$SE-SEMPA-2024-006317$SE-TEVA-VS-3240101$TEVA$$89$YR$$M$Y$$$20240910$$MD$SE$SE
243027051$24302705$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259654$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240910$$HP$US$US
243027061$24302706$1$I$20220901$20240828$20240910$20240910$PER$$US-SA-2024SA261378$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240910$$HP$US$US
243027071$24302707$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259068$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240910$$CN$US$US
243027081$24302708$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA261502$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240910$$HP$US$US
243027091$24302709$1$I$20240301$20240827$20240910$20240910$PER$$US-SA-2024SA259399$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240910$$CN$US$US
243027101$24302710$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA253855$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240910$$HP$US$US
243027112$24302711$2$F$$20240906$20240910$20240911$PER$$NVSC2024US180059$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243027131$24302713$1$I$$20240826$20240910$20240910$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467045$RANBAXY$Rajni E, Goel P, Sarna MK, Jorwal A, Sharma C, Rijhwani P.. The genus Ralstonia: the new kid on the block. J R Coll Physicians Edinb. 2023;53 (1):44-52$72$YR$$F$Y$$$20240910$$HP$IN$IN
243027141$24302714$1$I$$20240826$20240910$20240910$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467043$RANBAXY$BRUNO M, STROBER B, ROSSO JQD. TOPICAL MANAGEMENT OF PLAQUE PSORIASIS-A Review and Case Series Discussion with Focus on Aryl Hydrocarbon Receptor Modulation. JCAD. 2023;16(9 Suppl1)Sep:S3-S12$79$YR$$F$Y$$$20240910$$HP$US$US
243027151$24302715$1$I$$20240826$20240910$20240910$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467142$RANBAXY$Wang S, Liu A, Wang N, Wang Y, Zhang A, Wang L, et al. Use of blinatumomab and CAR T-cell therapy in children with relapsed/refractory leukemia: A case series study. Front-Pediatr. 2023;10:1100404$$$C$$Y$$$20240910$$HP$CN$CN
243027161$24302716$1$I$$20240826$20240910$20240910$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467048$RANBAXY$Gorham R, Posada J, Walker B. Positive Antibodies in Atypical Dementia: A Case Report Exploring the Intricacies of Diagnosing Rapid Cognitive Decline. JACLP. 2023;64:S:102$70$YR$$F$Y$$$20240910$$HP$US$US
243027171$24302717$1$I$$20240826$20240910$20240910$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466961$RANBAXY$Vincent MN, Jaggers J, Fiske C, Phillips EJ, Stollings JL. Amikacin symmetrical drug-related intertriginous and flexural exanthema on the basis of neomycin cross-reactivity managed with desensitization and treating through. Ann Allergy Asthma Immunol. 2024;133:215-217$70$YR$$F$Y$$$20240910$$HP$US$US
243027181$24302718$1$I$$20240826$20240910$20240910$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466889$RANBAXY$Wang S, Liu A, Wang N, Wang Y, Zhang A, Wang L, et al. Use of blinatumomab and CAR T-cell therapy in children with relapsed/refractory leukemia: A case series study. Front-Pediatr. 2023;10:1100404$33$MON$$$Y$$$20240910$$HP$CN$CN
243027191$24302719$1$I$$20240826$20240910$20240910$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467074$RANBAXY$Reinfeld S, Gill P. Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: A case series. CNS Spectrums. 2023;28(5):587-591$12$YR$$F$Y$$$20240910$$HP$US$US
243027201$24302720$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259927$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240910$$HP$US$US
243027211$24302721$1$I$20240801$20240828$20240910$20240910$PER$$US-SA-2024SA259909$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240910$$CN$US$US
243027221$24302722$1$I$$20240826$20240910$20240910$PER$$US-SA-2024SA260641$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240910$$CN$US$US
243027231$24302723$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259667$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240910$$HP$US$US
243027241$24302724$1$I$$20240826$20240910$20240910$PER$$US-SA-2024SA261081$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240910$$HP$US$US
243027251$24302725$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259498$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240910$$HP$US$US
243027262$24302726$2$F$$20240826$20240910$20240920$PER$$US-SA-2024SA261567$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240920$$CN$US$US
243027271$24302727$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA259034$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240910$$CN$US$US
243027281$24302728$1$I$20240101$20240828$20240910$20240910$PER$$US-SA-2024SA259251$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240910$$CN$US$US
243027291$24302729$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259917$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240910$$MD$US$US
243027311$24302731$1$I$$20240830$20240909$20240909$DIR$FDA-CDER-CTU-2024-62003$$FDA-CTU$$$$$M$N$$$20240830$N$HP$US$
243027321$24302732$1$I$20240318$20240908$20240908$20240908$DIR$717593$$FDA-CTU$$77$YR$$M$N$66$KG$20240908$N$CN$US$
243027331$24302733$1$I$$20240826$20240910$20240910$PER$$US-SA-2024SA261080$SANOFI AVENTIS$$65$YR$E$$Y$$$20240910$$HP$US$US
243027352$24302735$2$F$$20240827$20240910$20240913$PER$$US-SA-2024SA258191$SANOFI AVENTIS$$73$YR$E$$Y$$$20240913$$CN$US$US
243027361$24302736$1$I$20240909$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62087$$FDA-CTU$$73$YR$$F$N$$$20240909$Y$HP$US$
243027371$24302737$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA260268$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240910$$MD$US$US
243027391$24302739$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259420$SANOFI AVENTIS$$98$YR$E$F$Y$$$20240910$$HP$US$US
243027401$24302740$1$I$20240601$20240826$20240910$20240910$PER$$US-SA-2024SA254050$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240910$$MD$US$US
243027411$24302741$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA261648$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240910$$MD$US$US
243027422$24302742$2$F$20240801$20240826$20240910$20240917$PER$$US-SA-2024SA253246$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240918$$HP$US$US
243027431$24302743$1$I$20240824$20240830$20240910$20240910$PER$$US-SA-2024SA259976$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240910$$HP$US$US
243027441$24302744$1$I$20230101$20240829$20240910$20240910$PER$$US-SA-2024SA260886$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240910$$MD$US$US
243027451$24302745$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2024SA260481$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240910$$HP$US$US
243027471$24302747$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-087066-2024$RECKITT BENCKISER$$$$$M$Y$$$20240910$$CN$US$US
243027481$24302748$1$I$$20240826$20240910$20240910$PER$$US-SA-2024SA258523$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240910$$HP$US$US
243027491$24302749$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259960$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240910$$HP$US$US
243027501$24302750$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA260124$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240910$$MD$US$US
243027512$24302751$2$F$20240901$20240917$20240910$20240923$PER$$US-SA-2023SA106711$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240923$$MD$US$US
243027531$24302753$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA261141$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240910$$CN$US$US
243027541$24302754$1$I$20200220$20240827$20240910$20240910$PER$$US-SA-2024SA259407$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240910$$MD$US$US
243027551$24302755$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA261284$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240910$$CN$US$US
243027561$24302756$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259212$SANOFI AVENTIS$$$$T$F$Y$$$20240910$$MD$US$US
243027571$24302757$1$I$20240801$20240826$20240910$20240910$PER$$US-SA-2024SA259396$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240910$$HP$US$US
243027581$24302758$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259883$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240910$$MD$US$US
243027591$24302759$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259330$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240910$$CN$US$US
243027602$24302760$2$F$$20240904$20240910$20240912$PER$$US-SA-2024SA259793$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240912$$MD$US$US
243027611$24302761$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA261143$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240910$$CN$US$US
243027621$24302762$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA260587$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240910$$MD$US$US
243027632$24302763$2$F$20240101$20240905$20240910$20240914$EXP$$US-UCBSA-2024044965$UCB$$$$$M$Y$$$20240914$$MD$US$US
243027641$24302764$1$I$20240701$20240829$20240910$20240910$PER$$US-SA-2024SA260574$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240910$$HP$US$US
243027651$24302765$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA259878$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240910$$HP$US$US
243027662$24302766$2$F$$20240829$20240910$20240911$PER$$US-SA-2024SA260297$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240911$$HP$US$US
243027671$24302767$1$I$20231201$20240829$20240910$20240910$PER$$US-SA-2024SA260185$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240910$$HP$US$US
243027682$24302768$2$F$20240101$20240910$20240910$20240916$PER$$US-SA-2024SA260470$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240916$$HP$US$US
243027691$24302769$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2024SA260220$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240910$$HP$US$US
243027701$24302770$1$I$20200101$20240829$20240910$20240910$PER$$US-SA-2024SA260088$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240910$$HP$US$US
243027711$24302771$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260749$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240910$$HP$US$US
243027721$24302772$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260573$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240910$$MD$US$US
243027731$24302773$1$I$20240601$20240828$20240910$20240910$PER$$US-SA-2024SA172400$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240910$$MD$US$US
243027741$24302774$1$I$20240818$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62102$$FDA-CTU$$79$YR$$M$N$$$20240909$Y$HP$US$
243027751$24302775$1$I$20240101$20240828$20240910$20240910$PER$$US-SA-2024SA259949$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240910$$MD$US$US
243027761$24302776$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260585$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240910$$MD$US$US
243027771$24302777$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2024SA260188$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240910$$MD$US$US
243027781$24302778$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61992$$FDA-CTU$$57$YR$$F$N$$$20240909$N$$US$
243027791$24302779$1$I$20240712$20240908$20240908$20240908$DIR$717583$$FDA-CTU$$60$YR$$F$N$60.75$KG$20240908$N$CN$US$
243027801$24302780$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260588$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240910$$CN$US$US
243027811$24302781$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA258111$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240910$$MD$US$US
243027821$24302782$1$I$$20240906$20240909$20240909$DIR$FDA-CDER-CTU-2024-62040$$FDA-CTU$$$$$M$N$$$20240906$N$HP$US$
243027831$24302783$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA259408$SANOFI AVENTIS$$3$YR$C$F$Y$12.2$KG$20240910$$MD$US$US
243027841$24302784$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260693$SANOFI AVENTIS$$$$C$M$Y$$$20240910$$HP$US$US
243027851$24302785$1$I$20240701$20240829$20240910$20240910$PER$$US-SA-2024SA260059$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240910$$HP$US$US
243027861$24302786$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260166$SANOFI AVENTIS$$$$A$M$Y$$$20240910$$MD$US$US
243027881$24302788$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260356$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$MD$US$US
243027891$24302789$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2022SA518577$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240910$$HP$US$US
243027911$24302791$1$I$20240801$20240829$20240910$20240910$PER$$US-SA-2024SA260889$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240910$$MD$US$US
243027921$24302792$1$I$$20240903$20240910$20240910$PER$$US-MYLANLABS-2024M1081346$MYLAN$$$$$F$Y$85.28$KG$20240910$$CN$US$US
243027942$24302794$2$F$20240903$20240909$20240910$20240918$PER$$US-BAYER-2024A128921$BAYER$$23$YR$A$F$Y$$$20240918$$CN$US$US
243027951$24302795$1$I$20240825$20240830$20240910$20240910$PER$$US-SA-2024SA260670$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240910$$HP$US$US
243027971$24302797$1$I$20240708$20240813$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000036$NIPPON SHINYAKU$$9$YR$$M$Y$35.896$KG$20240910$$HP$US$US
243027981$24302798$1$I$$20240717$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000038$NIPPON SHINYAKU$$$$$M$Y$$$20240910$$HP$US$US
243027991$24302799$1$I$20240606$20240814$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000035$NIPPON SHINYAKU$$6$YR$$M$Y$$$20240910$$HP$US$US
243028001$24302800$1$I$20240710$20240718$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000037$NIPPON SHINYAKU$$$$$M$Y$$$20240910$$CN$US$US
243028011$24302801$1$I$20240801$20240829$20240910$20240910$PER$$US-SA-2024SA259641$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240910$$HP$US$US
243028022$24302802$2$F$20240829$20240916$20240910$20240924$PER$$US-SA-2024SA260885$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240924$$MD$US$US
243028031$24302803$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA259665$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240910$$MD$US$US
243028041$24302804$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260347$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240910$$CN$US$US
243028051$24302805$1$I$20240829$20240830$20240910$20240910$PER$$US-SA-2024SA258950$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240910$$CN$US$US
243028061$24302806$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA259647$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240910$$HP$US$US
243028071$24302807$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260528$SANOFI AVENTIS$$67$YR$E$$Y$$$20240910$$MD$US$US
243028081$24302808$1$I$20240101$20240830$20240910$20240910$PER$$US-SA-2024SA260156$SANOFI AVENTIS$$58$YR$A$F$Y$73$KG$20240910$$HP$US$US
243028101$24302810$1$I$20240810$20240830$20240910$20240910$PER$$US-SA-2024SA258996$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240910$$CN$US$US
243028111$24302811$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260718$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240910$$HP$US$US
243028121$24302812$1$I$20240801$20240829$20240910$20240910$PER$$US-SA-2024SA260290$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240910$$CN$US$US
243028131$24302813$1$I$$20240830$20240910$20240910$PER$$US-SA-2024SA260844$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240910$$MD$US$US
243028141$24302814$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260212$SANOFI AVENTIS$$$$A$M$Y$$$20240910$$HP$US$US
243028151$24302815$1$I$$20240830$20240910$20240910$PER$$US-SA-2024SA260646$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240910$$HP$US$US
243028161$24302816$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260155$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$MD$US$US
243028171$24302817$1$I$20230101$20240830$20240910$20240910$PER$$US-SA-2024SA260848$SANOFI AVENTIS$$$$E$M$Y$$$20240910$$CN$US$US
243028181$24302818$1$I$20240801$20240903$20240910$20240910$PER$$US-SA-2024SA260704$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240910$$HP$US$US
243028192$24302819$2$F$20240902$20240903$20240910$20240925$PER$$US-SA-2024SA259591$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240925$$CN$US$US
243028201$24302820$1$I$20240801$20240830$20240910$20240910$PER$$US-SA-2024SA260831$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240910$$HP$US$US
243028212$24302821$2$F$20240831$20240904$20240910$20240917$PER$$US-SA-2024SA259755$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240918$$CN$US$US
243028222$24302822$2$F$20240101$20240909$20240910$20240916$PER$$US-SA-2024SA260350$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240916$$MD$US$US
243028231$24302823$1$I$20240101$20240904$20240910$20240910$PER$$US-SA-2024SA261563$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240910$$HP$US$US
243028241$24302824$1$I$20240801$20240903$20240910$20240910$PER$$US-SA-2024SA260751$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240910$$HP$US$US
243028251$24302825$1$I$$20240830$20240910$20240910$PER$$US-SA-2024SA260636$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240910$$HP$US$US
243028261$24302826$1$I$20240801$20240830$20240910$20240910$PER$$US-SA-2024SA260730$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240910$$HP$US$US
243028281$24302828$1$I$$20240903$20240910$20240910$PER$$US-SA-2024SA261938$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240910$$HP$US$US
243028291$24302829$1$I$20240801$20240903$20240910$20240910$PER$$US-SA-2024SA260558$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240910$$MD$US$US
243028301$24302830$1$I$20240101$20240903$20240910$20240910$PER$$US-SA-2024SA260771$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240910$$HP$US$US
243028311$24302831$1$I$$20240903$20240910$20240910$PER$$US-SA-2024SA260535$SANOFI AVENTIS$$$$A$F$Y$$$20240910$$MD$US$US
243028321$24302832$1$I$$20240830$20240910$20240910$PER$$US-SA-2024SA260505$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240910$$HP$US$US
243028332$24302833$2$F$20240902$20240904$20240910$20240913$PER$$US-SA-2024SA258467$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240913$$MD$US$US
243028341$24302834$1$I$$20240730$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000043$NIPPON SHINYAKU$$$$$$Y$$$20240910$$CN$US$US
243028351$24302835$1$I$20240806$20240909$20240910$20240910$EXP$$GB-GILEAD-2024-0683671$GILEAD$$54$YR$A$M$Y$105$KG$20240910$$HP$GB$GB
243028361$24302836$1$I$20240701$20240820$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000042$NIPPON SHINYAKU$$26$YR$$M$Y$95.6$KG$20240910$$HP$US$US
243028371$24302837$1$I$20240101$20240223$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000006$NIPPON SHINYAKU$$6$YR$$M$Y$18.6$KG$20240910$$HP$US$US
243028381$24302838$1$I$20240717$20240821$20240910$20240910$PER$$US-NIPPON SHINYAKU-NIP-2024-000039$NIPPON SHINYAKU$$$$$M$Y$$$20240910$$HP$US$US
243028391$24302839$1$I$20240801$20240903$20240910$20240910$EXP$SE-SEMPA-2024-006126$SE-TEVA-VS-3240275$TEVA$$52$YR$$F$Y$$$20240910$$MD$SE$SE
243028422$24302842$2$F$$20240912$20240910$20240924$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202409001170$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$IT$IT
243028431$24302843$1$I$20240907$20240907$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005183$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243028441$24302844$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005447$ELI LILLY AND CO$$82$YR$E$$Y$$$20240910$$CN$US$US
243028451$24302845$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004654$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243028462$24302846$2$F$$20240910$20240910$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409004560$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240917$$CN$US$US
243028471$24302847$1$I$20240824$20240827$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409000310$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240910$$CN$US$US
243028481$24302848$1$I$20240602$20240826$20240910$20240910$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466882$RANBAXY$$76$YR$$F$Y$45$KG$20240910$$MD$IT$IT
243028491$24302849$1$I$20230522$20240826$20240910$20240910$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466793$RANBAXY$$58$YR$$M$Y$$$20240910$$MD$IT$IT
243028511$24302851$1$I$20240525$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466833$RANBAXY$$30$YR$$M$Y$75$KG$20240910$$CN$FR$FR
243028521$24302852$1$I$$20240826$20240910$20240910$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466651$RANBAXY$Brunoni B, Zadek F, Mulazzani F, Verza G, Marrazzo F, Spina S, et al.. Calcium-Citrate Anticoagulation during Continuous Renal Replacement Therapy in Patients with Metformin Intoxication: A Case Series, Mathematical Estimation of Citrate Accumulation, and Literature Review.. Blood Purif. 2023;52:802-811$66$YR$$M$Y$75$KG$20240910$$HP$IT$IT
243028531$24302853$1$I$$20240826$20240910$20240910$EXP$IT-EMA-DD-20240628-7482647-070528$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466774$RANBAXY$$11$YR$$M$Y$$$20240910$$HP$IT$IT
243028541$24302854$1$I$20240426$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466788$RANBAXY$$25$YR$$M$Y$$$20240910$$MD$FR$FR
243028551$24302855$1$I$$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466799$RANBAXY$Eid R, Zamparini E, Ouchrif Y, Snanoudj R, Ottolenghi C, Zaidan M. A case report of Paracetamol related pyroglutamic acidosis: mind the gap in a malnourished patient. BMC Nephrol. 2024;25 (1):1-4$67$YR$$M$Y$$$20240910$$HP$FR$FR
243028561$24302856$1$I$$20240826$20240910$20240910$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467146$RANBAXY$Wang S, Liu A, Wang N, Wang Y, Zhang A, Wang L, et al. Use of blinatumomab and CAR T-cell therapy in children with relapsed/refractory leukemia: A case series study. Front Pediatr. 2023;10:1100404$4$MON$$F$Y$$$20240910$$HP$CN$CN
243028571$24302857$1$I$20240603$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466785$RANBAXY$$84$YR$$M$Y$65.3$KG$20240910$$PH$FR$FR
243028581$24302858$1$I$20210101$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466722$RANBAXY$$55$YR$$F$Y$$$20240910$$PH$FR$FR
243028601$24302860$1$I$20240624$20240826$20240910$20240910$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466665$RANBAXY$$76$YR$$F$Y$$$20240910$$CN$GB$GB
243028611$24302861$1$I$$20240826$20240910$20240910$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466484$RANBAXY$$47$YR$$M$Y$95$KG$20240910$$CN$IT$IT
243028621$24302862$1$I$20230101$20240826$20240910$20240910$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466847$RANBAXY$$48$YR$$M$Y$94$KG$20240910$$MD$IT$IT
243028631$24302863$1$I$$20240905$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2024US078518$SANDOZ$$$$$F$Y$81.633$KG$20240910$$CN$US$US
243028641$24302864$1$I$20190401$20240826$20240910$20240910$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466713$RANBAXY$$67$YR$$M$Y$$$20240910$$LW$DE$DE
243028651$24302865$1$I$$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466827$RANBAXY$$54$YR$$M$Y$80$KG$20240910$$PH$FR$FR
243028661$24302866$1$I$20240521$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466824$RANBAXY$$68$YR$$M$Y$$$20240910$$MD$FR$FR
243028671$24302867$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179161$AMGEN$$$$$F$Y$$$20240910$$HP$US$US
243028681$24302868$1$I$20240905$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024178375$AMGEN$$41$YR$A$F$Y$$$20240910$$CN$US$US
243028691$24302869$1$I$20240620$20240826$20240910$20240910$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466720$RANBAXY$$59$YR$$M$Y$$$20240910$$PH$IT$IT
243028701$24302870$1$I$20240309$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466839$RANBAXY$$39$YR$$F$Y$$$20240910$$PH$FR$FR
243028711$24302871$1$I$$20240826$20240910$20240910$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466659$RANBAXY$Brunoni B, Zadek F, Mulazzani F, Verza G, Marrazzo F, Spina S, et al.. Calcium-Citrate Anticoagulation during Continuous Renal Replacement Therapy in Patients with Metformin Intoxication: A Case Series, Mathematical Estimation of Citrate Accumulation, and Literature Review.. Blood Purif. 2023;52:802-811$71$YR$$F$Y$75$KG$20240910$$HP$IT$IT
243028721$24302872$1$I$$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466829$RANBAXY$Thomas Diot, Stephane Mouchabac, Philippe Giraud, Florian Ferreri, Vladimir Adrien. Electroconvulsive Therapy for Major Depressive Disorder Induced by Androgen Deprivation Therapy Report of 2 Cases. ECT. 2024;Volume 40, Numb:e7-e8$76$YR$$M$Y$$$20240910$$MD$FR$FR
243028731$24302873$1$I$20240322$20240826$20240910$20240910$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466878$RANBAXY$$73$YR$$M$Y$$$20240910$$PH$ES$ES
243028741$24302874$1$I$$20240826$20240910$20240910$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466636$RANBAXY$Takahashi K, Kobayashi R, Morikawa K, Maeda M, Samura O, Okamoto A.. Overdose of angiotensin II receptor blocker in the third trimester of pregnancy: A case report.. J Obstet Gynaecol Res. 2024;0 (0):no pagination$$$N$$Y$$$20240910$$HP$JP$JP
243028751$24302875$1$I$$20240826$20240910$20240910$EXP$$JP-SUNPHARMA-2024RR-466486AA$RANBAXY$Kamitani R, Matsumoto K, Yokota K, Hirai S, Komori T, Kamisawa K, et al. Maintenance avelumab therapy for urothelial carcinoma in a hemodialysis patient: a case report. Int Canc Conf J. 2024;13:58-62$73$YR$$M$Y$$$20240910$$HP$JP$JP
243028762$24302876$2$F$20240513$20240909$20240910$20240924$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466786$RANBAXY$$69$YR$$F$Y$60$KG$20240924$$MD$IT$IT
243028771$24302877$1$I$$20240826$20240910$20240910$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466625$RANBAXY$Takahashi K, Kobayashi R, Morikawa K, Maeda M, Samura O, Okamoto A.. Overdose of angiotensin II receptor blocker in the third trimester of pregnancy: A case report.. J Obstet Gynaecol Res. 2024;0 (0):no pagination$23$YR$$F$Y$$$20240910$$HP$JP$JP
243028781$24302878$1$I$$20240826$20240910$20240910$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467148$RANBAXY$Wang S, Liu A, Wang N, Wang Y, Zhang A, Wang L, et al. Use of blinatumomab and CAR T-cell therapy in children with relapsed/refractory leukemia: A case series study. Front-Pediatr. 2023;10:1100404$50$MON$$M$Y$$$20240910$$HP$CN$CN
243028791$24302879$1$I$20240307$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466723$RANBAXY$$22$YR$$F$Y$$$20240910$$PH$FR$FR
243028801$24302880$1$I$$20240826$20240910$20240910$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466848$RANBAXY$Roch C, Para S, Brandhofer C, Seitz AK, Remi C, Berner J, et al.. Successful use of Rectal Pregabalin for the Treatment of Chemotherapy-Induced Neuropathic Pain-a Case Report. J Palliative Care. 2023;38 (4):412-415$65$YR$$F$Y$$$20240910$$MD$DE$DE
243028811$24302881$1$I$20240614$20240826$20240910$20240910$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466783$RANBAXY$$86$YR$$M$Y$75$KG$20240910$$MD$IT$IT
243028821$24302882$1$I$$20240826$20240910$20240910$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466648$RANBAXY$Brunoni B, Zadek F, Mulazzani F, Verza G, Marrazzo F, Spina S, et al.. Calcium-Citrate Anticoagulation during Continuous Renal Replacement Therapy in Patients with Metformin Intoxication: A Case Series, Mathematical Estimation of Citrate Accumulation, and Literature Review.. Blood Purif. 2023;52:802-811$66$YR$$F$Y$70$KG$20240910$$HP$IT$IT
243028831$24302883$1$I$20240501$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466711$RANBAXY$$79$YR$$M$Y$$$20240910$$PH$FR$FR
243028841$24302884$1$I$20240622$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466694$RANBAXY$$22$YR$$F$Y$76.5$KG$20240910$$MD$FR$FR
243028851$24302885$1$I$20240310$20240826$20240910$20240910$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466841$RANBAXY$$31$YR$$F$Y$$$20240910$$PH$FR$FR
243028871$24302887$1$I$20240506$20240826$20240910$20240910$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467126$RANBAXY$$67$YR$$F$Y$69.1$KG$20240910$$MD$ES$ES
243028881$24302888$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143034$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240910$$HP$US$US
243028891$24302889$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142818$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240910$$CN$US$US
243028901$24302890$1$I$$20240625$20240910$20240910$PER$$US-MAYNE PHARMA-2024MYN000251$MAYNE$$$$$$Y$$$20240910$$CN$US$US
243028911$24302891$1$I$20240801$20240826$20240910$20240910$PER$$US-SA-2024SA257845$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240910$$MD$US$US
243028921$24302892$1$I$$20240826$20240910$20240910$PER$$US-SA-2024SA259027$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240910$$HP$US$US
243028931$24302893$1$I$20240801$20240821$20240910$20240910$PER$$US-SA-2024SA259907$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240910$$CN$US$US
243028941$24302894$1$I$$20240905$20240910$20240910$EXP$$US-SERVIER-S24011298$SERVIER$$$$$$Y$$$20240910$$MD$US$US
243028951$24302895$1$I$$20240906$20240910$20240910$EXP$$GB-JNJFOC-20240920860$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240910$$CN$GB$GB
243028962$24302896$2$F$20240731$20240913$20240910$20240916$EXP$LU-ALMPS-202404305$LU-GILEAD-2024-0686861$GILEAD$$69$YR$E$M$Y$113$KG$20240916$$PH$LU$LU
243028971$24302897$1$I$$20240831$20240910$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-027583$UNITED THERAPEUTICS$$$$$F$Y$65.76$KG$20240910$$$US$US
243028991$24302899$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR110095$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243029002$24302900$2$F$20231205$20240912$20240910$20240913$EXP$ES-AEMPS-1488742$ES-GILEAD-2024-0686862$GILEAD$$66$YR$E$M$Y$75$KG$20240913$$PH$ES$ES
243029011$24302901$1$I$$20240822$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08583$LUPIN$$$$$$Y$$$20240910$$CN$US$US
243029021$24302902$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2024SA260905$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240910$$HP$US$US
243029031$24302903$1$I$20240820$20240823$20240910$20240910$PER$$US-SA-2024SA259521$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240910$$HP$US$US
243029041$24302904$1$I$$20240826$20240910$20240910$PER$$US-SA-2024SA261249$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240910$$HP$US$US
243029051$24302905$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259908$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240910$$MD$US$US
243029061$24302906$1$I$20240826$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024177992$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243029071$24302907$1$I$20240907$20240908$20240908$20240908$DIR$717598$$FDA-CTU$$9$YR$$M$N$29.7$KG$20240908$N$CN$CA$
243029091$24302909$1$I$$20240909$20240910$20240910$PER$$US-BAYER-2024A128923$BAYER$$$$$F$Y$$$20240910$$CN$US$US
243029121$24302912$1$I$$20240830$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN009205$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243029131$24302913$1$I$$20240830$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN009204$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243029152$24302915$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687167$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243029162$24302916$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687114$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243029171$24302917$1$I$20240614$20240909$20240910$20240910$EXP$$US-GILEAD-2024-0687127$GILEAD$$57$YR$A$M$Y$$$20240910$$CN$US$US
243029182$24302918$2$F$20240801$20240912$20240910$20240916$PER$$US-JNJFOC-20240876813$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240916$$CN$US$US
243029191$24302919$1$I$$20240909$20240910$20240910$PER$$US-BAYER-2024A128962$BAYER$$$$$F$Y$$$20240910$$CN$US$US
243029201$24302920$1$I$$20240902$20240910$20240910$EXP$$CH-TAKEDA-2024TUS087372$TAKEDA$$$$A$F$Y$$$20240910$$MD$CH$CH
243029212$24302921$2$F$20240825$20240906$20240910$20240910$EXP$$US-TRAVERE-2024TVT00846$TRAVERE THERAPEUTICS$$65$YR$E$M$Y$$$20240910$$CN$US$US
243029221$24302922$1$I$20240907$20240908$20240908$20240908$DIR$717609$$FDA-CTU$$67$YR$$M$N$112.5$KG$20240908$N$PH$US$
243029251$24302925$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62103$$FDA-CTU$$68$YR$$M$N$$$20240909$N$HP$US$
243029261$24302926$1$I$20240320$20240908$20240908$20240908$DIR$717600$$FDA-CTU$$71$YR$$F$N$90$KG$20240908$$CN$US$
243029291$24302929$1$I$$20240903$20240910$20240910$EXP$$CA-GSK-CA2024AMR110030$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$CA$CA
243029301$24302930$1$I$$20240903$20240910$20240910$EXP$$US-RDY-SPO/USA/24/0012926$DR REDDYS$$$$$F$Y$$$20240910$$HP$US$US
243029312$24302931$2$F$$20240920$20240910$20240927$EXP$$CA-GSK-CA2023155391$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$CA$CA
243029321$24302932$1$I$$20240822$20240910$20240910$PER$$US-RDY-CLI/USA/24/0012573$DR REDDYS$$10$YR$C$F$Y$$$20240910$$CN$US$US
243029331$24302933$1$I$$20240905$20240910$20240910$EXP$$NVSC2024CA180512$NOVARTIS$$$$$F$Y$$$20240910$$CN$CA$CA
243029342$24302934$2$F$$20240905$20240910$20240913$EXP$$NVSC2024AU178043$NOVARTIS$$$$$M$Y$$$20240913$$MD$AU$AU
243029362$24302936$2$F$20240801$20240829$20240910$20240912$EXP$$CA-UCBSA-2024043977$UCB$$83$YR$$F$Y$$$20240912$$CN$CA$CA
243029371$24302937$1$I$20240101$20240826$20240910$20240910$PER$$US-SA-2024SA261467$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240910$$MD$US$US
243029381$24302938$1$I$$20240830$20240910$20240910$PER$$US-SA-2024SA256568$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240910$$MD$US$US
243029391$24302939$1$I$20240101$20240826$20240910$20240910$PER$$US-SA-2024SA258912$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240910$$HP$US$US
243029401$24302940$1$I$20240101$20240828$20240910$20240910$PER$$US-SA-2024SA258993$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240910$$MD$US$US
243029411$24302941$1$I$20240822$20240903$20240910$20240910$PER$$US-SA-2024SA259580$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240910$$CN$US$US
243029421$24302942$1$I$20240801$20240828$20240910$20240910$PER$$US-SA-2024SA261078$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240910$$MD$US$US
243029431$24302943$1$I$20240904$20240904$20240910$20240910$PER$$US-BAYER-2024A127084$BAYER$$38$YR$A$F$Y$$$20240910$$MD$US$US
243029441$24302944$1$I$20240821$20240909$20240910$20240910$EXP$$US-INCYTE CORPORATION-2024IN009504$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243029451$24302945$1$I$20240907$20240909$20240910$20240910$PER$$US-BAYER-2024A128965$BAYER$$62$YR$A$F$Y$$$20240910$$CN$US$US
243029461$24302946$1$I$$20240828$20240910$20240910$EXP$$GB-ADVANZ PHARMA-202408007216$ADVANZ PHARMA$$$$$$Y$$$20240910$$MD$GB$GB
243029471$24302947$1$I$$20240829$20240910$20240910$PER$$US-PharmaLex US Corporation-2161433$PHARMALEX$$31$YR$$F$Y$$$20240910$$$US$US
243029481$24302948$1$I$$20240906$20240910$20240910$EXP$$CN-TAKEDA-2024TUS089749$TAKEDA$$$$$M$Y$$$20240910$$CN$CN$CN
243029491$24302949$1$I$20240901$20240906$20240910$20240910$EXP$$US-INCYTE CORPORATION-2024IN009438$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243029501$24302950$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143413$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$103.87$KG$20240910$$CN$US$US
243029511$24302951$1$I$20240830$20240909$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143558$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240910$$CN$US$US
243029521$24302952$1$I$$20240905$20240910$20240910$EXP$$US-INCYTE CORPORATION-2024IN009402$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243029531$24302953$1$I$$20240906$20240910$20240910$30DAY$$US-SANDOZ INC.-SDZ2024US078705$SANDOZ$$$$$M$Y$$$20240910$$CN$US$US
243029541$24302954$1$I$$20240903$20240910$20240910$EXP$$US-OTSUKA-2024_024719$OTSUKA$$$$$$Y$$$20240910$$CN$US$US
243029551$24302955$1$I$20240817$20240903$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140835$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$291$KG$20240910$$CN$US$US
243029561$24302956$1$I$20240906$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179473$AMGEN$$64$YR$A$M$Y$$$20240910$$CN$US$US
243029571$24302957$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-086627-2024$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243029581$24302958$1$I$20240117$20240903$20240910$20240910$EXP$PT-INFARMED-B202408-600$PT-TEVA-VS-3240042$TEVA$$38$YR$$F$Y$$$20240910$$MD$PT$PT
243029591$24302959$1$I$$20240826$20240910$20240910$PER$$US-TAKEDA-2024TUS086155$TAKEDA$$$$$F$Y$$$20240910$$CN$US$US
243029601$24302960$1$I$$20240813$20240910$20240910$30DAY$$US-VEROBIOTECH-2024USVEROSPO00211$VERO BIOTECH$$$$$$Y$$$20240910$$HP$US$US
243029621$24302962$1$I$20240101$20240827$20240910$20240910$EXP$$US-COOPERSURGICAL, INC.-2024CPS002642$COOPERSURGICAL$$$$$F$Y$94.785$KG$20240910$$CN$US$US
243029631$24302963$1$I$20240801$20240829$20240910$20240910$PER$$US-SA-2024SA260774$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240910$$HP$US$US
243029641$24302964$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260744$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240910$$HP$US$US
243029651$24302965$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260837$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240910$$HP$US$US
243029661$24302966$1$I$20240808$20240903$20240910$20240910$EXP$$NVSC2024AR170974$NOVARTIS$$54$YR$$F$Y$$$20240910$$CN$AR$AR
243029671$24302967$1$I$$20240909$20240910$20240910$PER$$US-BAYER-2024A129012$BAYER$$41$YR$A$M$Y$$$20240910$$MD$US$US
243029682$24302968$2$F$$20240924$20240910$20240926$EXP$$US-BIOVITRUM-2024-US-011813$BIOVITRUM$$80$YR$$F$Y$$$20240926$$CN$US$US
243029691$24302969$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000503US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243029701$24302970$1$I$20240904$20240905$20240910$20240910$EXP$$US-PROD-AS2-212756134-20-24-USA-RB-0006939$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243029711$24302971$1$I$$20240813$20240910$20240910$30DAY$$US-VEROBIOTECH-2024USVEROSPO00210$VERO BIOTECH$$$$$$Y$$$20240910$$HP$US$US
243029732$24302973$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0687171$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243029742$24302974$2$F$$20240905$20240910$20240917$PER$$US-ABBVIE-5910448$ABBVIE$$$$$$Y$$$20240917$$CN$US$US
243029752$24302975$2$F$20240814$20240920$20240910$20240926$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004931$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240926$$HP$US$US
243029761$24302976$1$I$20240101$20240830$20240910$20240910$PER$$US-TEVA-VS-3239163$TEVA$$77$YR$$M$Y$$$20240910$$PH$US$US
243029772$24302977$2$F$20240813$20240925$20240910$20240930$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004897$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240930$$CN$US$US
243029781$24302978$1$I$20240801$20240903$20240910$20240910$EXP$$US-ABBVIE-5908953$ABBVIE$$$$A$F$Y$$$20240910$$HP$US$US
243029791$24302979$1$I$$20240904$20240910$20240910$PER$$ZA-Eisai-EC-2024-173956$EISAI$$$$A$M$Y$$$20240910$$MD$ZA$ZA
243029801$24302980$1$I$$20240906$20240910$20240910$PER$$JP-Eisai-EC-2024-173909$EISAI$Akaishi, Y., et al.. Five Cases of Pseudocirrhosis during Eribulin Treatment for Breast Cancer. Cancer  chemotherapy. 2024; 51(7): 753-755.$45$YR$A$$Y$$$20240910$$MD$JP$JP
243029812$24302981$2$F$20240904$20240917$20240910$20240924$EXP$$NVSC2024ZA180149$NOVARTIS$$35$YR$$M$Y$$$20240924$$MD$ZA$ZA
243029821$24302982$1$I$$20240902$20240910$20240910$EXP$$SG-ROCHE-10000072357$ROCHE$$64$YR$A$F$Y$$$20240910$$CN$SG$SG
243029841$24302984$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR110099$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243029851$24302985$1$I$20240701$20240903$20240910$20240910$EXP$$TR-GSK-TR2024TRK109688$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$TR$TR
243029861$24302986$1$I$20240701$20240903$20240910$20240910$EXP$$TR-VIIV HEALTHCARE LIMITED-TR2024TRK109688$VIIV$$$$$$Y$$$20240910$$MD$TR$TR
243029871$24302987$1$I$$20240830$20240910$20240910$EXP$$BR-JNJFOC-20240902763$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$BR$BR
243029881$24302988$1$I$$20240904$20240910$20240910$EXP$$US-JNJFOC-20240909423$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$CN$US$US
243029891$24302989$1$I$20240827$20240909$20240910$20240910$EXP$GB-MHRA-MED-202409091414208770-DCQFK$GB-TEVA-VS-3241709$TEVA$$74$YR$$F$Y$$$20240910$$PH$GB$GB
243029901$24302990$1$I$$20240906$20240910$20240910$PER$$US-ABBVIE-5915978$ABBVIE$$$$A$F$Y$$$20240910$$MD$US$US
243029911$24302991$1$I$$20240904$20240910$20240910$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001801$BLUEPRINT MEDICINES$$$$$M$Y$$$20240910$$CN$US$US
243029931$24302993$1$I$20240826$20240828$20240910$20240910$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007384$AEGERION$$40$YR$$M$Y$$$20240910$$CN$US$US
243029941$24302994$1$I$20240201$20240906$20240910$20240910$EXP$ES-AEMPS-1559592$ES-TAKEDA-2024TUS089631$TAKEDA$$68$YR$$F$Y$$$20240910$$HP$ES$ES
243029951$24302995$1$I$20230101$20240905$20240910$20240910$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-119448$REGENERON$$$$$F$Y$$$20240910$$CN$US$US
243029961$24302996$1$I$$20240828$20240910$20240910$EXP$$GB-ADVANZ PHARMA-202408007217$ADVANZ PHARMA$$$$$$Y$$$20240910$$MD$GB$GB
243029981$24302998$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005553$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240910$$CN$US$US
243029991$24302999$1$I$$20240907$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143348$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$CN$US$US
243030001$24303000$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005753$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240910$$CN$US$US
243030011$24303001$1$I$20240101$20240904$20240910$20240910$PER$$US-BAYER-2024A127169$BAYER$$48$YR$A$F$Y$$$20240910$$CN$US$US
243030021$24303002$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143892$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240910$$CN$US$US
243030031$24303003$1$I$$20240905$20240910$20240910$EXP$$US-INCYTE CORPORATION-2024IN009397$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243030041$24303004$1$I$$20240904$20240910$20240910$PER$$US-BAYER-2024A127218$BAYER$$$$$F$Y$$$20240910$$CN$US$US
243030051$24303005$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR110085$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243030061$24303006$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR110088$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243030071$24303007$1$I$$20240909$20240909$20240909$DIR$717678$$FDA-CTU$$37$YR$$F$N$68.4$KG$20240909$N$CN$US$
243030081$24303008$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62019$$FDA-CTU$$54$YR$$F$N$102.06$KG$20240909$N$HP$US$
243030091$24303009$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61948$$FDA-CTU$$60$YR$$F$N$$$20240909$N$$US$
243030101$24303010$1$I$$20240909$20240910$20240910$EXP$$US-BIOVITRUM-2024-US-011810$BIOVITRUM$$$$I$F$Y$$$20240910$$CN$US$US
243030111$24303011$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000448US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243030121$24303012$1$I$20210801$20240905$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2024US078473$SANDOZ$$71$YR$$F$Y$$$20240910$$MD$US$US
243030131$24303013$1$I$20240828$20240830$20240910$20240910$PER$$US-AMGEN-USASP2024174563$AMGEN$$59$YR$A$F$Y$$$20240910$$CN$US$US
243030141$24303014$1$I$$20240902$20240910$20240910$EXP$$US-AMGEN-USASP2024175967$AMGEN$Meseha M.. Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review. Annals of Hematology. 2024;1-5$77$YR$E$M$Y$$$20240910$$HP$US$US
243030152$24303015$2$F$20200101$20240917$20240910$20240921$EXP$$US-AMGEN-USASP2024179271$AMGEN$$71$YR$E$F$Y$114$KG$20240921$$LW$US$US
243030162$24303016$2$F$20240826$20240904$20240910$20240911$30DAY$$US-PFIZER INC-202400250206$PFIZER$$8$YR$$M$Y$23.59$KG$20240909$$CN$US$US
243030171$24303017$1$I$20240218$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-086069-2024$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243030181$24303018$1$I$20240801$20240902$20240910$20240910$EXP$$CA-CELLTRION INC.-2024CA021534$CELLTRION$$$$$$Y$$$20240910$$HP$CA$CA
243030192$24303019$2$F$$20240926$20240910$20240930$EXP$$BR-JNJFOC-20240913172$JOHNSON AND JOHNSON$$91$YR$E$F$Y$54$KG$20240930$$CN$BR$BR
243030201$24303020$1$I$20240303$20240904$20240910$20240910$PER$$US-BAYER-2024A127221$BAYER$$37$YR$A$F$Y$$$20240910$$HP$US$US
243030211$24303021$1$I$20240908$20240908$20240910$20240910$PER$$US-HALEON-2196046$Haleon PLC$$77$YR$$M$Y$$$20240910$$CN$US$US
243030222$24303022$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687125$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243030231$24303023$1$I$$20240611$20240910$20240910$EXP$$CA-TEVA-VS-3209439$TEVA$$$$$F$Y$$$20240910$$CN$CA$CA
243030261$24303026$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62063$$FDA-CTU$$54$YR$$F$N$$$20240909$N$$US$
243030271$24303027$1$I$$20240906$20240909$20240909$DIR$FDA-CDER-CTU-2024-61960$$FDA-CTU$$$$$M$N$$$20240906$N$HP$US$
243030281$24303028$1$I$20240908$20240909$20240909$20240909$DIR$717662$$FDA-CTU$$49$YR$$F$N$$$20240909$N$PH$US$
243030291$24303029$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62050$$FDA-CTU$$72$YR$$F$N$85.28$KG$20240909$N$$US$
243030311$24303031$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61941$$FDA-CTU$$84$YR$$F$N$62.6$KG$20240909$N$$US$
243030331$24303033$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR110089$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243030341$24303034$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180864$NOVARTIS$$$$$$Y$$$20240910$$MD$US$US
243030351$24303035$1$I$$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001651$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030361$24303036$1$I$$20240815$20240910$20240910$PER$$US-SMPA-2024SPA001467$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030371$24303037$1$I$$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001643$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030382$24303038$2$F$$20240909$20240910$20240927$PER$$US-SMPA-2024SPA001663$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243030391$24303039$1$I$$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001688$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030401$24303040$1$I$20240708$20240814$20240910$20240910$PER$$US-SMPA-202407-URV-001005$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030412$24303041$2$F$$20240822$20240910$20240917$PER$$US-SMPA-2024SPA001344$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243030422$24303042$2$F$$20240916$20240910$20240925$PER$$US-SMPA-2024SPA001674$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243030431$24303043$1$I$$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001689$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030441$24303044$1$I$20240815$20240815$20240910$20240910$PER$$US-SMPA-2024SPA001455$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030463$24303046$3$F$$20240916$20240910$20240930$PER$$US-SMPA-2024SPA001654$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243030471$24303047$1$I$$20240814$20240910$20240910$PER$$US-SMPA-2024SPA001360$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030481$24303048$1$I$$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001629$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030491$24303049$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001299$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030502$24303050$2$F$$20240904$20240910$20240925$PER$$US-SMPA-2024SPA001532$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243030512$24303051$2$F$$20240912$20240910$20240923$PER$$US-SMPA-2024SPA001617$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243030521$24303052$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001323$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030531$24303053$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001449$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030541$24303054$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001390$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030551$24303055$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001395$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030571$24303057$1$I$$20240814$20240910$20240910$PER$$US-SMPA-2024SPA001469$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030581$24303058$1$I$20200713$20240909$20240909$20240909$DIR$717773$$FDA-CTU$$22$YR$$F$N$54$KG$20240909$N$CN$US$
243030602$24303060$2$F$$20240831$20240910$20240923$PER$$US-SMPA-2024SPA001564$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243030612$24303061$2$F$20240801$20240916$20240910$20240923$PER$$US-SMPA-2024SPA001632$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243030621$24303062$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001338$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030631$24303063$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61940$$FDA-CTU$$63$YR$$M$N$$$20240909$N$$US$
243030641$24303064$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61943$$FDA-CTU$$62$YR$$F$N$61.69$KG$20240909$N$$US$
243030651$24303065$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001463$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030661$24303066$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001337$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030671$24303067$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001370$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030681$24303068$1$I$$20240815$20240910$20240910$PER$$US-SMPA-2024SPA001462$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030692$24303069$2$F$20240815$20240815$20240910$20240916$PER$$US-SMPA-2024SPA001479$SUNOVION$$$$$$Y$$$20240916$$HP$US$US
243030711$24303071$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001304$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030723$24303072$3$F$$20240911$20240910$20240927$PER$$US-SMPA-2024SPA001411$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243030731$24303073$1$I$20240101$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001652$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030741$24303074$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001302$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030752$24303075$2$F$$20240825$20240910$20240920$PER$$US-SMPA-2024SPA001351$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243030761$24303076$1$I$$20240815$20240910$20240910$PER$$US-SMPA-2024SPA001473$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030771$24303077$1$I$$20240816$20240910$20240910$PER$$US-SMPA-2024SPA001574$SUNOVION$$$$$$Y$$$20240910$$HP$US$US
243030781$24303078$1$I$$20240815$20240910$20240910$PER$$US-SMPA-2024SPA001537$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030791$24303079$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001312$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030801$24303080$1$I$$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001627$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030811$24303081$1$I$20240101$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001683$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030821$24303082$1$I$$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001634$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030832$24303083$2$F$20240101$20240912$20240910$20240927$PER$$US-SMPA-2024SPA001355$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243030841$24303084$1$I$20240101$20240813$20240910$20240910$PER$$US-SMPA-2024SPA000768$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030852$24303085$2$F$$20240814$20240910$20240913$PER$$US-SMPA-2024SPA001491$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243030861$24303086$1$I$$20240814$20240910$20240910$PER$$US-SMPA-2024SPA001547$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030872$24303087$2$F$$20240906$20240910$20240927$PER$$US-SMPA-2024SPA000271$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243030891$24303089$1$I$$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001644$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030901$24303090$1$I$$20240816$20240910$20240910$PER$$US-SMPA-2024SPA001472$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030911$24303091$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001496$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030921$24303092$1$I$$20240814$20240910$20240910$PER$$US-SMPA-2024SPA001436$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030931$24303093$1$I$$20240813$20240910$20240910$PER$$US-SMPA-2024SPA001383$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030941$24303094$1$I$$20240816$20240910$20240910$PER$$US-SMPA-2024SPA000244$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030951$24303095$1$I$$20240904$20240910$20240910$PER$$US-BAYER-2024A127575$BAYER$$$$$F$Y$$$20240910$$CN$US$US
243030962$24303096$2$F$$20240910$20240910$20240923$PER$$US-SMPA-2024SPA001402$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243030981$24303098$1$I$$20240815$20240910$20240910$PER$$US-SMPA-2024SPA001512$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243030991$24303099$1$I$$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001648$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243031001$24303100$1$I$$20240904$20240910$20240910$EXP$$US-TAKEDA-2024TUS089281$TAKEDA$$$$$$Y$$$20240910$$MD$US$US
243031012$24303101$2$F$$20240909$20240910$20240930$PER$$US-SMPA-2024SPA000201$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243031022$24303102$2$F$$20240909$20240910$20240927$PER$$US-SMPA-2024SPA001646$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243031031$24303103$1$I$$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001682$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243031041$24303104$1$I$$20240819$20240910$20240910$PER$$US-SMPA-2024SPA001716$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243031051$24303105$1$I$20240821$20240822$20240910$20240910$PER$$US-TEVA-VS-3237715$TEVA$$24$YR$$M$Y$$$20240910$$PH$US$US
243031061$24303106$1$I$20240829$20240904$20240910$20240910$PER$$US-BAYER-2024A127721$BAYER$$34$YR$A$F$Y$$$20240910$$CN$US$US
243031071$24303107$1$I$$20240907$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142948$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$66.68$KG$20240910$$CN$US$US
243031081$24303108$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143074$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240910$$CN$US$US
243031091$24303109$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143756$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$$$20240910$$HP$US$US
243031101$24303110$1$I$20240805$20240827$20240910$20240910$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00429$MELINTA THERAPEUTICS$$$$$$Y$$$20240910$$CN$BR$BR
243031111$24303111$1$I$$20240826$20240910$20240910$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08603$NEUROCRINE BIOSCIENCES$$21$YR$$M$Y$$$20240910$$HP$US$US
243031121$24303112$1$I$20240501$20240822$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051655$TOLMAR$$76$YR$$M$Y$$$20240909$$CN$CA$CA
243031141$24303114$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-083704-2024$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243031151$24303115$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR110092$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243031161$24303116$1$I$$20240904$20240910$20240910$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027835$UNITED THERAPEUTICS$$$$$M$Y$$$20240910$$$US$US
243031171$24303117$1$I$$20240904$20240910$20240910$PER$$US-BAYER-2024A128016$BAYER$$$$$F$Y$$$20240910$$CN$US$US
243031181$24303118$1$I$$20240903$20240910$20240910$EXP$$ES-ABBVIE-5915114$ABBVIE$Jimenez-Vicente C, Guardia-Torrelles A, Perez-Valencia AI, Martinez-Roca A, Castano-Diez S, Guijarro F, et al. Clinical management of patients diagnosed with acute myeloid leukemia treated with Venetoclax in combination with hypomethylating agents after achieving a response: a real-life study. Ann Hematol. 2024.$$$A$$Y$$$20240910$$HP$ES$ES
243031192$24303119$2$F$$20240906$20240910$20240917$EXP$$AR-BIOVITRUM-2024-AR-011806$BIOVITRUM$$$$$F$Y$$$20240917$$CN$AR$AR
243031211$24303121$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259876$SANOFI AVENTIS$$$$E$M$Y$$$20240910$$MD$US$US
243031221$24303122$1$I$20240501$20240829$20240910$20240910$PER$$US-SA-2024SA259416$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240910$$MD$US$US
243031231$24303123$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259993$SANOFI AVENTIS$$$$E$M$Y$$$20240910$$HP$US$US
243031241$24303124$1$I$$20240903$20240910$20240910$EXP$$US-TAKEDA-2022TUS073224$TAKEDA$$$$$F$Y$$$20240910$$CN$US$US
243031251$24303125$1$I$$20240904$20240910$20240910$EXP$$US-OTSUKA-2024_025086$OTSUKA$$$$$M$Y$$$20240910$$MD$US$US
243031261$24303126$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259707$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240910$$HP$US$US
243031271$24303127$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2024SA259610$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240910$$MD$US$US
243031282$24303128$2$F$$20240909$20240910$20240920$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001298$AKEBIA THERAPEUTICS$$$$$$Y$$$20240920$$PH$JP$JP
243031291$24303129$1$I$20240611$20240827$20240910$20240910$EXP$$FR-HARMONY BIOSCIENCES-2024HMY01802$HARMONY BIOSCIENCES$$$$$$Y$$$20240910$$PH$FR$FR
243031301$24303130$1$I$$20240903$20240910$20240910$PER$$US-AstraZeneca-2024A201149$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
243031311$24303131$1$I$20240301$20240903$20240910$20240910$EXP$$NVSC2024GB016102$NOVARTIS$$34$YR$$F$Y$$$20240910$$CN$GB$GB
243031321$24303132$1$I$$20240906$20240910$20240910$EXP$$NVSC2024CA180183$NOVARTIS$$68$YR$$M$Y$$$20240910$$CN$CA$CA
243031331$24303133$1$I$$20240902$20240910$20240910$EXP$$ES-AMGEN-ESPSP2024177954$AMGEN$Oriol A.. Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Bortezomib (BORT) or Carfilzomib (CFZ) in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Results From the CC-92480-MM-002 Trial. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S566-S566$$$$$Y$$$20240910$$MD$ES$ES
243031341$24303134$1$I$$20240822$20240910$20240910$PER$$US-TEVA-VS-3237104$TEVA$$52$YR$$F$Y$$$20240910$$CN$US$US
243031362$24303136$2$F$$20240919$20240910$20240922$PER$$US-AMGEN-USASP2024179199$AMGEN$$47$YR$A$F$Y$$$20240922$$CN$US$US
243031371$24303137$1$I$$20240906$20240910$20240910$PER$$JP-Eisai-EC-2024-173908$EISAI$Akaishi, Y., et al.. Five Cases of Pseudocirrhosis during Eribulin Treatment for Breast Cancer. Cancer chemotherapy. 2024; 51(7): 753-755.$63$YR$A$$Y$$$20240910$$MD$JP$JP
243031382$24303138$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687159$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243031391$24303139$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA259291$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240910$$MD$US$US
243031401$24303140$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA256065$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240910$$MD$US$US
243031411$24303141$1$I$20240812$20240902$20240910$20240910$EXP$FR-AFSSAPS-NC2024001013$FR-FreseniusKabi-FK202413353$FRESENIUS KABI$$77$YR$E$M$Y$92$KG$20240910$$MD$FR$FR
243031431$24303143$1$I$$20240906$20240910$20240910$PER$$CH-Blueprint Medicines Corporation-SP-CH-2024-001812$BLUEPRINT MEDICINES$$$$$$Y$$$20240910$$HP$CH$FR
243031441$24303144$1$I$$20240908$20240910$20240910$PER$$US-BAYER-2024A129108$BAYER$$$$E$$Y$$$20240910$$MD$US$US
243031451$24303145$1$I$$20240902$20240910$20240910$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006644$BIOCON$$$$$$Y$$$20240910$$CN$CA$CA
243031461$24303146$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005734$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240910$$CN$US$US
243031471$24303147$1$I$20240830$20240830$20240910$20240910$EXP$$US-BIOCODEX2-2024001244$BIOCODEX$$$$$F$Y$22.1$KG$20240909$$CN$US$US
243031481$24303148$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142712$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240910$$HP$US$US
243031491$24303149$1$I$20240817$20240904$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141121$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240910$$HP$US$US
243031501$24303150$1$I$$20240905$20240910$20240910$EXP$$US-AMGEN-USASP2024178545$AMGEN$Schinstock C.A.; Agrawal A.; Balakrishnan S. et.al.. Highly Sensitized Candidates Remain at Risk for Microvascular Inflammation even When Donor-specific Antibody Is Avoided: A Matched Cohort Study. Transplantation. 2024;108 (9):1986-1993$$$$$Y$$$20240910$$MD$US$US
243031511$24303151$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143835$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240910$$HP$US$US
243031521$24303152$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142698$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240910$$HP$US$US
243031531$24303153$1$I$20240606$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62029$$FDA-CTU$$78$YR$$F$N$$$20240909$N$MD$US$
243031541$24303154$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143388$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240910$$CN$US$US
243031561$24303156$1$I$$20240909$20240910$20240910$EXP$$US-BAYER-2024A129185$BAYER$$96$YR$E$M$Y$$$20240910$$CN$US$US
243031571$24303157$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61957$$FDA-CTU$$62$YR$$M$N$$$20240909$N$$US$
243031581$24303158$1$I$20240715$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61945$$FDA-CTU$$97$YR$$F$N$$$20240909$N$$US$
243031591$24303159$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181133$NOVARTIS$$$$$F$Y$$$20240910$$MD$US$US
243031601$24303160$1$I$$20240907$20240910$20240910$PER$$US-BAYER-2024A129140$BAYER$$$$$F$Y$$$20240910$$CN$US$US
243031611$24303161$1$I$20240801$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142574$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240910$$PH$US$US
243031621$24303162$1$I$$20240909$20240910$20240910$PER$$US-HALEON-2196044$Haleon PLC$$$$$F$Y$$$20240910$$CN$US$US
243031631$24303163$1$I$$20240906$20240910$20240910$PER$$US-TAKEDA-2024TUS089902$TAKEDA$$$$$$Y$$$20240910$$PH$US$US
243031652$24303165$2$F$$20240903$20240910$20240924$EXP$$US-GSK-US2024AMR110070$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$US$US
243031661$24303166$1$I$$20240909$20240910$20240910$EXP$$US-UCBSA-2024046176$UCB$$$$$F$Y$$$20240910$$HP$US$US
243031671$24303167$1$I$20240722$20240909$20240909$20240909$DIR$717723$$FDA-CTU$$78$YR$$M$N$105.75$KG$20240909$N$CN$US$
243031691$24303169$1$I$$20240904$20240909$20240909$DIR$FDA-CDER-CTU-2024-61946$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
243031701$24303170$1$I$$20240828$20240910$20240910$EXP$$US-B.Braun Medical Inc.-2161434$B BRAUN$Literature Article$44$YR$$F$Y$$$20240910$$$US$US
243031711$24303171$1$I$20240816$20240828$20240910$20240910$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001288$AKEBIA THERAPEUTICS$$$$E$$Y$$$20240910$$MD$JP$JP
243031721$24303172$1$I$20240821$20240909$20240910$20240910$PER$$US-BAYER-2024A128836$BAYER$$43$YR$A$F$Y$$$20240910$$HP$US$US
243031731$24303173$1$I$20240825$20240903$20240910$20240910$EXP$$US-GSK-US2024109523$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243031741$24303174$1$I$20240826$20240826$20240910$20240910$PER$$US-JNJFOC-20240867823$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240910$$CN$US$US
243031751$24303175$1$I$$20240829$20240910$20240910$EXP$$US-SMPA-2024SPA002124$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243031761$24303176$1$I$20210301$20240903$20240910$20240910$EXP$$RO-AMGEN-ROUSP2024177421$AMGEN$$79$YR$E$M$Y$$$20240910$$MD$RO$RO
243031771$24303177$1$I$20240714$20240829$20240910$20240910$EXP$$US-SMPA-2024SPA002153$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243031781$24303178$1$I$$20240830$20240910$20240910$EXP$GB-MHRA-MED-202408252325301880-NKQDJ$GB-SMPA-2024SPA002217$SUNOVION$$$$$$Y$$$20240910$$CN$GB$GB
243031791$24303179$1$I$$20240829$20240910$20240910$EXP$$US-SMPA-2024SPA002206$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243031801$24303180$1$I$$20240904$20240910$20240910$EXP$$CA-TAKEDA-2024TUS086014$TAKEDA$$$$$M$Y$$$20240910$$CN$CA$CA
243031811$24303181$1$I$$20240909$20240910$20240910$PER$$US-BAYER-2024A128941$BAYER$$38$YR$A$F$Y$$$20240910$$MD$US$US
243031823$24303182$3$F$20240907$20240910$20240910$20240915$PER$$US-AMGEN-USASP2024180004$AMGEN$$58$YR$A$M$Y$$$20240915$$CN$US$US
243031841$24303184$1$I$$20240909$20240910$20240910$PER$$US-BAYER-2024A128944$BAYER$$22$YR$A$F$Y$$$20240910$$MD$US$US
243031851$24303185$1$I$$20240902$20240910$20240910$EXP$$US-RDY-SPO/USA/24/0013088$DR REDDYS$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 101: doi:10.1016/j.jflm.2023.102625.$95$YR$E$$Y$$$20240910$$HP$US$US
243031861$24303186$1$I$$20240902$20240910$20240910$EXP$$US-RDY-SPO/USA/24/0013091$DR REDDYS$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 101: doi:10.1016/j.jflm.2023.102625.$95$YR$E$$Y$$$20240910$$HP$US$US
243031871$24303187$1$I$20240809$20240901$20240910$20240910$PER$$US-SA-2024SA255237$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240910$$MD$US$US
243031901$24303190$1$I$20240618$20240903$20240910$20240910$30DAY$$US-PFIZER INC-PV202400115822$PFIZER$$$$$$Y$$$20240910$$HP$US$US
243031911$24303191$1$I$20240904$20240904$20240910$20240910$EXP$$US-OTSUKA-2024_024985$OTSUKA$$$$$M$Y$$$20240910$$CN$US$US
243031922$24303192$2$F$$20240904$20240910$20240917$EXP$$NL-MYLANLABS-2024M1081740$MYLAN$$$$$M$Y$$$20240917$$HP$NL$NL
243031931$24303193$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143747$BRISTOL MYERS SQUIBB$$65$YR$A$M$Y$$$20240910$$HP$US$US
243031941$24303194$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62098$$FDA-CTU$$74$YR$$F$N$$$20240909$N$$US$
243031951$24303195$1$I$20240907$20240907$20240907$20240907$DIR$FDA-CDER-CTU-2024-61914$$FDA-CTU$$27$YR$$M$N$64$KG$20240907$N$$BR$
243031961$24303196$1$I$20240830$20240830$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139339$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240910$$CN$US$US
243031971$24303197$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143733$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240910$$HP$US$US
243031981$24303198$1$I$$20240904$20240910$20240910$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-141583$BRISTOL MYERS SQUIBB$Boot M, Raz Y. Een complex hematologisch beeld. Medisch Contact. 2024 Aug 21;34/35.$69$YR$E$F$Y$$$20240910$$MD$NL$NL
243031991$24303199$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62099$$FDA-CTU$$57$YR$$F$N$$$20240909$N$$US$
243032001$24303200$1$I$20240905$20240907$20240907$20240907$DIR$FDA-CDER-CTU-2024-61937$$FDA-CTU$$48$YR$$F$N$84$KG$20240907$N$$US$
243032011$24303201$1$I$20240816$20240909$20240909$20240909$DIR$717754$$FDA-CTU$$74$YR$$F$N$$$20240909$N$HP$US$
243032021$24303202$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143758$BRISTOL MYERS SQUIBB$$31$YR$A$M$Y$$$20240910$$MD$US$US
243032031$24303203$1$I$$20240902$20240910$20240910$EXP$$JP-TEVA-VS-3239833$TEVA$Kamijo Y, Usuda M, Matsuno A, Katoh N, Morita Y, Tamaru F, et al. Successful Maintenance Therapy with Intravenous Immunoglobulin to Reduce Relapse Attacks and Steroid Dose in a Patient with Refractory Myelin Oligodendrocyte Glycoprotein Antibody-positive Optic Neuritis. Intern-Med 2024; 0 (0):.; Kamijo Y, Usuda M, Matsuno A, Katoh N, Morita Y, Tamaru F, et al. Successful Maintenance Therapy with Intravenous Immunoglobulin to Reduce Relapse Attacks and Steroid Dose in a Patient with Refractory...$25$YR$$M$Y$$$20240910$$HP$JP$JP
243032041$24303204$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62097$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243032051$24303205$1$I$$20240902$20240910$20240910$EXP$$NVSC2024IN179594$NOVARTIS$Chinnaswamy G, Gollamudi VRM, Choudhari A, Prasad M, Dasgupta A, Chatterji A et al. Mek Inhibitors in Pediatric Low-Grade Gliomas (PLGG)- Early Experience in a Resource Limited Setting. NEURO-ONCOLOGY. 2024;26 (Suppl. 4)$$$C$$Y$$$20240910$$HP$IN$IN
243032062$24303206$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687163$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243032071$24303207$1$I$$20240910$20240910$20240910$PER$$NVSC2024US181159$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243032081$24303208$1$I$$20240903$20240910$20240910$EXP$$NVSC2024KR178976$NOVARTIS$$17$YR$$M$Y$$$20240910$$MD$KR$KR
243032091$24303209$1$I$$20240902$20240910$20240910$EXP$$NVSC2024IN179595$NOVARTIS$Chinnaswamy G, Gollamudi VRM, Choudhari A, Prasad M, Dasgupta A, Chatterji A, et al.. Mek Inhibitors in Pediatric Low-Grade Gliomas (PLGG)- Early Experience in a Resource Limited Setting. NEURO-ONCOLOGY. 2024;26 (Suppl. 4)$$$C$$Y$$$20240910$$HP$IN$IN
243032101$24303210$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180643$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243032111$24303211$1$I$$20240902$20240910$20240910$EXP$NL-LRB-00996606$NL-TEVA-VS-3239939$TEVA$$80$YR$$F$Y$110$KG$20240910$$MD$NL$NL
243032121$24303212$1$I$$20240905$20240910$20240910$PER$$US-BAYER-2024A128652$BAYER$$73$YR$E$M$Y$$$20240910$$CN$US$US
243032131$24303213$1$I$$20240822$20240910$20240910$PER$$US-TEVA-VS-3236375$TEVA$$41$YR$$F$Y$60.33$KG$20240910$$CN$US$US
243032141$24303214$1$I$20240813$20240909$20240910$20240910$EXP$FR-AFSSAPS-MP2024001369$FR-SANDOZ INC.-SDZ2024FR078718$SANDOZ$$17$YR$$F$Y$$$20240910$$MD$FR$FR
243032151$24303215$1$I$20240101$20240909$20240910$20240910$PER$$US-BAYER-2024A129033$BAYER$$$$$F$Y$$$20240910$$CN$US$US
243032171$24303217$1$I$$20240826$20240910$20240910$EXP$$US-SA-2024SA261715$SANOFI AVENTIS$$$$A$F$Y$90$KG$20240910$$MD$US$US
243032191$24303219$1$I$20240801$20240901$20240910$20240910$PER$$US-SA-2024SA260293$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240910$$HP$US$US
243032201$24303220$1$I$20240712$20240902$20240910$20240910$EXP$$IT-TAKEDA-2024TUS073299$TAKEDA$$$$$M$Y$$$20240910$$CN$GB$IT
243032241$24303224$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62028$$FDA-CTU$$$$$M$N$$$20240909$N$HP$US$
243032251$24303225$1$I$20240821$20240909$20240909$20240909$DIR$717763$$FDA-CTU$$71$YR$$M$N$86.4$KG$20240909$Y$MD$US$
243032271$24303227$1$I$$20240909$20240909$20240909$DIR$717730$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
243032281$24303228$1$I$20240604$20240908$20240908$20240908$DIR$FDA-CDER-CTU-2024-61931$$FDA-CTU$$57$YR$$F$N$67.13$KG$20240908$N$PH$US$
243032291$24303229$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62045$$FDA-CTU$$60$YR$$M$N$$$20240909$N$$US$
243032301$24303230$1$I$$20240908$20240908$20240908$DIR$FDA-CDER-CTU-2024-61923$$FDA-CTU$$23$YR$$F$N$$$20240908$$CN$US$
243032311$24303231$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-083972-2024$RECKITT BENCKISER$$$$$M$Y$$$20240910$$CN$US$US
243032331$24303233$1$I$20240702$20240908$20240908$20240908$DIR$FDA-CDER-CTU-2024-61920$$FDA-CTU$$74$YR$$M$N$74$KG$20240908$Y$HP$US$
243032351$24303235$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259849$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240910$$CN$US$US
243032362$24303236$2$F$20220101$20240910$20240910$20240912$PER$$US-AMGEN-USASP2024179730$AMGEN$$74$YR$E$M$Y$$$20240911$$CN$US$US
243032371$24303237$1$I$$20240902$20240910$20240910$EXP$$BR-JNJFOC-20240913429$JOHNSON AND JOHNSON$$50$YR$A$F$Y$62$KG$20240910$$CN$BR$BR
243032382$24303238$2$F$$20240903$20240910$20240919$30DAY$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03264$AMNEAL$$$$$$Y$$$20240919$$CN$US$US
243032391$24303239$1$I$20240801$20240909$20240910$20240910$PER$$US-BAYER-2024A129229$BAYER$$$$$F$Y$$$20240910$$CN$US$US
243032401$24303240$1$I$20230601$20240903$20240910$20240910$EXP$$CA-GSK-CA2023079718$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$CA$CA
243032411$24303241$1$I$$20240909$20240910$20240910$EXP$$GB-SANDOZ INC.-SDZ2024GB078889$SANDOZ$$$$$M$Y$$$20240910$$CN$GB$GB
243032421$24303242$1$I$$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408291122397530-DQCJV$GB-ELI_LILLY_AND_COMPANY-GB202408019412$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$GB$GB
243032431$24303243$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005613$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240910$$CN$US$US
243032441$24303244$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005208$ELI LILLY AND CO$$54$YR$A$$Y$$$20240910$$LW$US$US
243032451$24303245$1$I$20240725$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408282044012520-FHVRM$GB-ELI_LILLY_AND_COMPANY-GB202408018494$ELI LILLY AND CO$$63$YR$A$F$Y$104$KG$20240910$$CN$GB$GB
243032461$24303246$1$I$$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018984$ELI LILLY AND CO$$89$YR$E$F$Y$$$20240910$$CN$US$US
243032471$24303247$1$I$20240730$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408291252131970-QPZRL$GB-ELI_LILLY_AND_COMPANY-GB202408019337$ELI LILLY AND CO$$$$$$Y$$$20240910$$CN$GB$GB
243032481$24303248$1$I$$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408019152$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240910$$CN$US$US
243032491$24303249$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004590$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240910$$CN$US$US
243032501$24303250$1$I$$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000199$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243032511$24303251$1$I$20240826$20240828$20240910$20240910$EXP$GB-MHRA-MED-202408280816403080-CKYTW$GB-ELI_LILLY_AND_COMPANY-GB202408018529$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$GB$GB
243032523$24303252$3$F$20240828$20240909$20240910$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409004536$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240920$$MD$US$US
243032531$24303253$1$I$20200803$20240829$20240910$20240910$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202408019279$ELI LILLY AND CO$$60$YR$A$F$Y$40$KG$20240910$$CN$CN$CN
243032541$24303254$1$I$$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408290601234340-QZKRD$GB-ELI_LILLY_AND_COMPANY-GB202408019251$ELI LILLY AND CO$$$$$F$Y$96$KG$20240910$$CN$GB$GB
243032551$24303255$1$I$$20240828$20240910$20240910$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202408018669$ELI LILLY AND CO$$$$$F$Y$$$20240910$$MD$AE$AE
243032561$24303256$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143124$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240910$$CN$US$US
243032572$24303257$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687164$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243032581$24303258$1$I$$20240828$20240910$20240910$EXP$$GB-ADVANZ PHARMA-202408007218$ADVANZ PHARMA$$$$$$Y$$$20240910$$MD$GB$GB
243032591$24303259$1$I$20231129$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-080494-2024$RECKITT BENCKISER$$$$$M$Y$$$20240910$$CN$US$US
243032601$24303260$1$I$$20240904$20240910$20240910$EXP$GB-MHRA-MED-202409041559277730-WVMTP$GB-LABORATORIOS LICONSA S.A.-2409GB06921$INSUD PHARMA$$31$YR$$M$Y$105$KG$20240910$$CN$GB$GB
243032611$24303261$1$I$$20240905$20240910$20240910$EXP$$HU-SANDOZ INC.-SDZ2024HU078646$SANDOZ$$$$A$M$Y$$$20240910$$MD$HU$HU
243032621$24303262$1$I$$20240903$20240910$20240910$EXP$NL-LRB-00999295$NL-TEVA-VS-3240175$TEVA$$61$YR$$M$Y$65$KG$20240910$$CN$NL$NL
243032632$24303263$2$F$$20240904$20240910$20240917$PER$$US-ALXN-202409USA000222US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$MD$US$US
243032641$24303264$1$I$$20240904$20240910$20240910$EXP$$ZA-ROCHE-10000015072$ROCHE$$$$C$M$Y$$$20240910$$MD$ZA$ZA
243032651$24303265$1$I$20240715$20240905$20240910$20240910$EXP$$ID-AstraZeneca-2024A204037$ASTRAZENECA$$15707$DY$$F$Y$$$20240910$$CN$ID$
243032661$24303266$1$I$$20240828$20240910$20240910$EXP$$GB-ADVANZ PHARMA-202408007221$ADVANZ PHARMA$$$$$$Y$$$20240910$$MD$GB$GB
243032671$24303267$1$I$$20240902$20240910$20240910$EXP$$BR-AstraZeneca-2024A202875$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$BR$
243032681$24303268$1$I$$20240827$20240910$20240910$EXP$$TW-SEBELA IRELAND LIMITED-2024SEB00066$SEBELA$Chen CF, Liang YC, Tsai MJ, et al.. Sheehan?s syndrome presenting with panhypopituitarism and central diabetes insipidus: a case report. BMC Endocrine Disorder. 2024;24(120)$39$YR$$F$Y$$$20240910$$HP$TW$TW
243032691$24303269$1$I$20240601$20240905$20240910$20240910$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001810$BLUEPRINT MEDICINES$$74$YR$E$M$Y$$$20240910$$HP$US$US
243032701$24303270$1$I$20240207$20240902$20240910$20240910$EXP$$ES-AstraZeneca-2024A205791$ASTRAZENECA$$73$YR$$M$Y$$$20240910$$MD$ES$
243032711$24303271$1$I$20240327$20240906$20240910$20240910$EXP$FR-AFSSAPS-AVMA2024000375$FR-MYLANLABS-2024M1081945$MYLAN$$60$YR$$F$Y$$$20240910$$PH$FR$FR
243032721$24303272$1$I$20240801$20240903$20240910$20240910$EXP$$ZA-Vifor (International) Inc.-VIT-2024-07993$VIFOR$$$$A$F$Y$$$20240910$$HP$ZA$ZA
243032731$24303273$1$I$$20240904$20240910$20240910$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001802$BLUEPRINT MEDICINES$$$$$M$Y$$$20240910$$CN$US$US
243032752$24303275$2$F$20240328$20240909$20240910$20240913$EXP$DE-CADRBFARM-2024330314$DE-RDY-SPO/DEU/24/0013018$DR REDDYS$$71$YR$E$M$Y$76$KG$20240913$$CN$DE$DE
243032771$24303277$1$I$20201201$20240907$20240910$20240910$EXP$$PL-BAUSCH-BL-2024-013378$BAUSCH AND LOMB$$49$YR$$M$Y$$$20240910$$HP$PL$PL
243032781$24303278$1$I$20240822$20240906$20240910$20240910$EXP$$NVSC2024CN180992$NOVARTIS$$87$YR$$F$Y$$$20240910$$HP$CN$CN
243032791$24303279$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA259751$SANOFI AVENTIS$$5$YR$C$F$Y$23.6$KG$20240910$$MD$US$US
243032802$24303280$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0687165$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243032821$24303282$1$I$20240801$20240903$20240910$20240910$EXP$$US-GSK-US2024109409$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243032862$24303286$2$F$20240905$20240910$20240910$20240912$PER$$US-AMGEN-USASP2024180132$AMGEN$$77$YR$E$F$Y$$$20240912$$CN$US$US
243032871$24303287$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024109481$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243032881$24303288$1$I$$20240821$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08359$LUPIN$$$$$$Y$$$20240910$$CN$US$US
243032892$24303289$2$F$$20240913$20240910$20240924$EXP$AT-EMA-2024821-AUTODUP-1724269719020$AT-Accord-445061$ACCORD$$66$YR$E$F$Y$$$20240924$$MD$AT$AT
243032901$24303290$1$I$20240712$20240905$20240910$20240910$EXP$IT-MINISAL02-1001159$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-141566$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$49$KG$20240910$$MD$IT$IT
243032911$24303291$1$I$20240801$20240906$20240910$20240910$EXP$$US-BAYER-2024A128832$BAYER$$64$YR$A$M$Y$$$20240910$$CN$US$US
243032921$24303292$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143178$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240910$$CN$US$US
243032931$24303293$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143682$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240910$$HP$US$US
243032941$24303294$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142563$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$82.55$KG$20240910$$CN$US$US
243032961$24303296$1$I$20240826$20240903$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140253$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$80.56$KG$20240910$$PH$US$US
243032971$24303297$1$I$$20240905$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143032$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240910$$CN$US$US
243032981$24303298$1$I$20240815$20240907$20240910$20240910$PER$$US-AMGEN-USASP2024179622$AMGEN$$76$YR$E$F$Y$$$20240910$$CN$US$US
243032991$24303299$1$I$$20240907$20240910$20240910$PER$$US-AMGEN-USASP2024179592$AMGEN$$$$$$Y$$$20240910$$CN$US$US
243033001$24303300$1$I$20240830$20240909$20240910$20240910$PER$$US-ALXN-202409USA000540US$ALEXION PHARMACEUTICALS$$34$YR$$F$Y$$$20240910$$CN$US$US
243033021$24303302$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62104$$FDA-CTU$$42$YR$$F$N$$$20240909$N$$US$
243033031$24303303$1$I$20240801$20240828$20240828$20240828$DIR$716303$$FDA-CTU$$67$YR$$M$N$87.75$KG$20240828$N$CN$US$
243033041$24303304$1$I$20231001$20240909$20240909$20240909$DIR$717733$$FDA-CTU$$70$YR$$F$N$$$20240909$N$MD$US$
243033051$24303305$1$I$20240906$20240909$20240909$20240909$DIR$717718$$FDA-CTU$$62$YR$$F$N$$$20240909$Y$HP$US$
243033061$24303306$1$I$$20240906$20240910$20240910$EXP$$AT-JNJFOC-20240917887$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$MD$AT$AT
243033071$24303307$1$I$$20240830$20240910$20240910$EXP$$CA-APOTEX-2024AP010205$APOTEX$$$$$$Y$$$20240910$$MD$CA$CA
243033081$24303308$1$I$$20240909$20240909$20240909$DIR$717680$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
243033101$24303310$1$I$20240829$20240905$20240910$20240910$EXP$SI-JAZMP-NCPHV-2024SI0893_0893$SI-INCYTE CORPORATION-2024IN009369$INCYTE$$$$$$Y$$$20240910$$HP$SI$SI
243033111$24303311$1$I$$20240820$20240910$20240910$EXP$$US-Vifor (International) Inc.-VIT-2024-07607$VIFOR$$$$$$Y$$$20240910$$HP$US$US
243033122$24303312$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687180$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243033132$24303313$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687166$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243033141$24303314$1$I$$20240903$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003537$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243033151$24303315$1$I$$20240905$20240910$20240910$EXP$$NVSC2024CA179562$NOVARTIS$$86$YR$$M$Y$70$KG$20240910$$PH$CA$CA
243033161$24303316$1$I$$20240906$20240910$20240910$PER$$US-HALEON-2195622$Haleon PLC$$17$YR$$M$Y$$$20240910$$HP$US$US
243033181$24303318$1$I$20240801$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004248$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240910$$CN$US$US
243033191$24303319$1$I$20240815$20240909$20240909$20240909$DIR$717747$$FDA-CTU$$78$YR$$M$N$$$20240909$N$PH$US$
243033201$24303320$1$I$20240909$20240909$20240909$20240909$DIR$717757$$FDA-CTU$$72$YR$$F$N$82.57$KG$20240909$N$HP$US$
243033211$24303321$1$I$20240830$20240906$20240910$20240910$DIR$FDA-CDER-CTU-2024-62107$$FDA-CTU$$67$YR$$M$N$68.49$KG$20240906$N$$US$
243033231$24303323$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143782$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240910$$CN$US$US
243033241$24303324$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143382$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240910$$CN$US$US
243033252$24303325$2$F$$20240924$20240910$20240927$EXP$$GR-ABBVIE-5913630$ABBVIE$$34$YR$$M$Y$$$20240927$$MD$GR$GR
243033261$24303326$1$I$$20240828$20240910$20240910$EXP$$US-CIPLA LTD.-2024US09754$CIPLA$Haddad TC, Suman VJ, Giridhar KV, Sideras K, Northfelt DW, Ernst BJ et al. Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early-stage breast cancer: A prospective trial. Clinical Cancer Research. 2024;30:3147 to 3156$$$$$Y$$$20240910$$HP$US$US
243033271$24303327$1$I$$20240828$20240910$20240910$EXP$$US-CIPLA LTD.-2024US09753$CIPLA$Haddad TC, Suman VJ, Giridhar KV, Sideras K, Northfelt DW, Ernst BJ et al. Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early-stage breast cancer: A prospective trial. Clinical Cancer Research. 2024;30:3147 to 3156$$$$$Y$$$20240910$$HP$US$US
243033281$24303328$1$I$$20240828$20240910$20240910$EXP$$US-CIPLA LTD.-2024US09755$CIPLA$Haddad TC, Suman VJ, Giridhar KV, Sideras K, Northfelt DW, Ernst BJ et al. Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early-stage breast cancer: A prospective trial. Clinical Cancer Research. 2024;30:3147 to 3156$$$$$Y$$$20240910$$HP$US$US
243033291$24303329$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA260790$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240910$$MD$US$US
243033301$24303330$1$I$$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024178607$AMGEN$$$$$$Y$$$20240910$$MD$US$US
243033321$24303332$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000529US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$HP$US$US
243033331$24303333$1$I$$20240905$20240910$20240910$EXP$$GB-BAYER-2024A128138$BAYER$Crocker-Buque T.; Lachenal N.; Narasimooloo C.; Abdrasuliev T.; Parpieva N.; Tigay Z.; Liverko I.; Usmanova R.; Butabekov I.; Moodliar R.; Mbenga M.; Rasool M.; Nyangwa B.-T.; Berry C.. Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL. Clinical Infectious Diseases. 2024;79:2:569-570$$$$F$Y$$$20240910$$HP$GB$GB
243033341$24303334$1$I$20240701$20240905$20240910$20240910$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-116661$REGENERON$$52$YR$$M$Y$$$20240910$$HP$US$US
243033351$24303335$1$I$20240801$20240829$20240910$20240910$EXP$$US-BAYER-2024A125023$BAYER$$64$YR$A$M$Y$$$20240910$$CN$US$US
243033361$24303336$1$I$20240826$20240905$20240910$20240910$EXP$$US-JNJFOC-20240917305$JOHNSON AND JOHNSON$$74$YR$E$F$Y$74.5$KG$20240910$$HP$US$US
243033381$24303338$1$I$$20240903$20240910$20240910$30DAY$$US-GSK-US2024109545$GLAXOSMITHKLINE$$$$$M$Y$$$20240910$$CN$US$US
243033391$24303339$1$I$$20240830$20240910$20240910$EXP$$CA-APOTEX-2024AP010199$APOTEX$$89$YR$$F$Y$$$20240910$$HP$CA$CA
243033402$24303340$2$F$20220101$20240912$20240910$20240917$EXP$$IT-PFIZER INC-PV202400115332$PFIZER$Sorella, S.. A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD. Leukemia + Lymphoma. 2024;27:1-4$71$YR$$M$Y$$$20240917$$HP$IT$IT
243033411$24303341$1$I$20200101$20240903$20240910$20240910$EXP$$TN-EMD Serono-2024047416$EMD SERONO INC$$50$YR$A$F$Y$$$20240910$$CN$TN$TN
243033422$24303342$2$F$$20240916$20240910$20240918$PER$$US-ROCHE-10000076333$ROCHE$$52$YR$A$F$Y$$$20240918$$CN$US$US
243033431$24303343$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143533$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240910$$CN$US$US
243033441$24303344$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143141$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240910$$CN$US$US
243033451$24303345$1$I$$20240821$20240910$20240910$PER$$US-009507513-2408USA007560$MERCK$Sandow L, Tsikitis L, Lopez CD, Brinkerhoff B, Kardosh A, Pegna G, et al. Neoadjuvant immunotherapy leads to complete pathologic response in locally advanced colon cancer. Clinical Case Reports. 2024;12:e9218:1-7$65$YR$$F$Y$$$20240910$$HP$US$US
243033461$24303346$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179383$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243033471$24303347$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-137511-2023$RECKITT BENCKISER$$$$$M$Y$$$20240910$$CN$US$US
243033481$24303348$1$I$20240801$20240909$20240910$20240910$EXP$$MA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050311$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240910$$HP$MA$MA
243033491$24303349$1$I$$20240821$20240910$20240910$PER$$US-SA-2024SA259213$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240910$$MD$US$US
243033501$24303350$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260723$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240910$$MD$US$US
243033521$24303352$1$I$$20240906$20240910$20240910$PER$$NVSC2024US179697$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243033532$24303353$2$F$$20240923$20240910$20240923$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050438$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240924$$MD$RU$RU
243033541$24303354$1$I$$20240828$20240910$20240910$EXP$$TW-B.Braun Medical Inc.-2161435$B BRAUN$Literature Article$56$YR$$F$Y$57$KG$20240910$$$TW$TW
243033551$24303355$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142616$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240910$$CN$US$US
243033571$24303357$1$I$20240828$20240909$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143708$BRISTOL MYERS SQUIBB$$97$YR$E$F$Y$$$20240910$$HP$US$US
243033581$24303358$1$I$20240511$20240909$20240910$20240910$EXP$$NVSC2024US180879$NOVARTIS$$60$YR$$M$Y$$$20240910$$CN$US$US
243033591$24303359$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241014$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$71$YR$$F$Y$$$20240910$$HP$ES$ES
243033601$24303360$1$I$$20240905$20240910$20240910$EXP$$CA-Covis Pharma GmbH-2024COV01104$COVIS PHARMA$$80$YR$E$M$Y$89$KG$20240910$$HP$CA$CA
243033611$24303361$1$I$20240701$20240906$20240910$20240910$PER$$US-BAYER-2024A128611$BAYER$$81$YR$E$M$Y$$$20240910$$CN$US$US
243033621$24303362$1$I$20240903$20240904$20240910$20240910$DIR$FDA-CDER-CTU-2024-62105$$FDA-CTU$$$$$F$N$84.5$KG$20240904$N$$US$
243033631$24303363$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61989$$FDA-CTU$$57$YR$$F$N$$$20240909$N$$US$
243033641$24303364$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61966$$FDA-CTU$$39$YR$$F$N$$$20240909$N$$US$
243033661$24303366$1$I$20240831$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62106$$FDA-CTU$$36$YR$$M$N$79.4$KG$20240909$N$$US$
243033671$24303367$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61963$$FDA-CTU$$48$YR$$F$N$$$20240909$N$$US$
243033681$24303368$1$I$20240822$20240909$20240909$20240909$DIR$717691$$FDA-CTU$$23$YR$$F$N$96.75$KG$20240909$N$CN$US$
243033691$24303369$1$I$20240414$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62110$$FDA-CTU$$$$$F$N$74.4$KG$20240909$N$$US$
243033701$24303370$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61970$$FDA-CTU$$61$YR$$F$N$$$20240909$N$$US$
243033721$24303372$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62090$$FDA-CTU$$89$YR$$M$N$$$20240909$N$$US$
243033731$24303373$1$I$20240301$20240909$20240909$20240909$DIR$717724$$FDA-CTU$$38$YR$$M$N$$$20240909$Y$MD$US$
243033741$24303374$1$I$20240829$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62109$$FDA-CTU$$68$YR$$F$N$69.9$KG$20240909$N$$US$
243033761$24303376$1$I$20240909$20240909$20240909$20240909$DIR$717689$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
243033771$24303377$1$I$$20240909$20240909$20240909$DIR$717725$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
243033781$24303378$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61996$$FDA-CTU$$19$YR$$M$N$$$20240909$N$$US$
243033791$24303379$1$I$20240830$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62108$$FDA-CTU$$$$$M$N$70.3$KG$20240909$N$$US$
243033801$24303380$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-61979$$FDA-CTU$$43$YR$$F$N$184$LBS$20240909$N$$US$
243033811$24303381$1$I$20240908$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024180160$AMGEN$$73$YR$E$F$Y$$$20240910$$CN$US$US
243033821$24303382$1$I$20240906$20240906$20240910$20240910$PER$$US-009507513-2409USA002847$MERCK$$3$YR$$$Y$$$20240910$$HP$US$US
243033831$24303383$1$I$$20240906$20240910$20240910$EXP$$FR-PFIZER INC-202400251621$PFIZER$$35$YR$$M$Y$$$20240910$$PH$FR$FR
243033841$24303384$1$I$20230601$20240906$20240910$20240910$EXP$$GB-PFIZER INC-202400251685$PFIZER$$34$YR$$M$Y$$$20240910$$PH$GB$GB
243033851$24303385$1$I$$20240906$20240910$20240910$EXP$$JP-PFIZER INC-202400251247$PFIZER$$$$$$Y$$$20240910$$PH$JP$JP
243033861$24303386$1$I$$20240906$20240910$20240910$EXP$$US-PFIZER INC-202400252129$PFIZER$$68$YR$$F$Y$$$20240910$$HP$US$US
243033881$24303388$1$I$$20240905$20240910$20240910$EXP$$JP-PFIZER INC-202400251161$PFIZER$$69$YR$$F$Y$$$20240910$$MD$JP$JP
243033891$24303389$1$I$20240805$20240906$20240910$20240910$EXP$$CN-PFIZER INC-PV202400117404$PFIZER$$62$YR$$M$Y$77$KG$20240910$$HP$CN$CN
243033901$24303390$1$I$20240819$20240904$20240910$20240910$EXP$$CN-JNJFOC-20240911435$JOHNSON AND JOHNSON$$79$YR$E$F$Y$46$KG$20240910$$HP$CN$CN
243033911$24303391$1$I$$20240827$20240910$20240910$PER$$US-JNJFOC-20240871495$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$CN$US$US
243033921$24303392$1$I$20240909$20240909$20240910$20240910$PER$$US-JNJFOC-20240920321$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240910$$CN$US$US
243033931$24303393$1$I$$20240904$20240910$20240910$PER$$US-JNJFOC-20240913737$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$CN$US$US
243033941$24303394$1$I$$20240904$20240910$20240910$PER$$US-BAYER-2024A127312$BAYER$$$$$F$Y$$$20240910$$CN$US$US
243033951$24303395$1$I$$20240902$20240910$20240910$EXP$$CA-APOTEX-2024AP010246$APOTEX$$$$$F$Y$$$20240910$$MD$CA$CA
243033961$24303396$1$I$$20240906$20240910$20240910$EXP$$JP-Eisai-EC-2024-173906$EISAI$Yuko Akaishi, et al.. Five Cases of Pseudocirrhosis during Eribulin Treatment for Breast Cancer. Cancer  chemotherapy. 2024; 51(7): 753-755.$64$YR$A$$Y$$$20240910$$MD$JP$JP
243033971$24303397$1$I$$20240827$20240910$20240910$EXP$$US-SAMSUNG BIOEPIS-SB-2024-26418$SAMSUNG BIOEPIS$$49$YR$A$M$Y$$$20240910$$CN$US$US
243033981$24303398$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241015$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$70$YR$$M$Y$$$20240910$$HP$ES$ES
243033991$24303399$1$I$$20240907$20240910$20240910$PER$$US-HALEON-2195840$Haleon PLC$$$$$$Y$$$20240910$$CN$US$US
243034001$24303400$1$I$20240602$20240909$20240910$20240910$PER$$US-BAYER-2024A128947$BAYER$$33$YR$A$F$Y$$$20240910$$HP$US$US
243034013$24303401$3$F$$20220926$20240910$20240917$EXP$$DE-SANDOZ INC.-NVSC2022DE180004$SANDOZ$$40$YR$$F$Y$$$20240917$$MD$DE$DE
243034021$24303402$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241016$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$68$YR$$M$Y$$$20240910$$HP$ES$ES
243034031$24303403$1$I$$20240903$20240910$20240910$EXP$$ES-GSK-ES2024EME109764$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$PH$ES$ES
243034041$24303404$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241017$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$77$YR$$M$Y$$$20240910$$HP$ES$ES
243034051$24303405$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR110093$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243034061$24303406$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR110091$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243034071$24303407$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004585$ELI LILLY AND CO$$29$YR$A$M$Y$$$20240910$$CN$US$US
243034081$24303408$1$I$20240601$20240904$20240910$20240910$EXP$CZ-CZSUKL-24002380$CZ-009507513-2409CZE001641$MERCK$$55$YR$$F$Y$57$KG$20240910$$PH$CZ$CZ
243034091$24303409$1$I$$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408019153$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240910$$CN$US$US
243034101$24303410$1$I$$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000122$ELI LILLY AND CO$$$$A$M$Y$$$20240910$$CN$US$US
243034112$24303411$2$F$20240825$20240903$20240910$20240913$EXP$GB-MHRA-MED-202408300034042660-KCBPD$GB-ELI_LILLY_AND_COMPANY-GB202408019313$ELI LILLY AND CO$$52$YR$A$F$Y$87$KG$20240913$$CN$GB$GB
243034121$24303412$1$I$$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018869$ELI LILLY AND CO$$49$YR$A$$Y$$$20240910$$LW$US$US
243034131$24303413$1$I$$20240829$20240910$20240910$EXP$GB-MHRA-TPP33376891C6932441YC1724835995284$GB-ELI_LILLY_AND_COMPANY-GB202408019312$ELI LILLY AND CO$$66$YR$E$F$Y$106$KG$20240910$$CN$GB$GB
243034141$24303414$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004812$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243034151$24303415$1$I$$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018874$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243034161$24303416$1$I$20240819$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000402$ELI LILLY AND CO$$$$A$F$Y$$$20240910$$CN$US$US
243034171$24303417$1$I$20240501$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408019065$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240910$$CN$US$US
243034181$24303418$1$I$20240705$20240829$20240910$20240910$EXP$GB-MHRA-MED-202408291357190510-NHGRQ$GB-ELI_LILLY_AND_COMPANY-GB202408019336$ELI LILLY AND CO$$46$YR$A$M$Y$86$KG$20240910$$CN$GB$GB
243034191$24303419$1$I$20230101$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408019118$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240910$$CN$US$US
243034201$24303420$1$I$$20240902$20240910$20240910$EXP$$ES-TEVA-VS-3241018$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$58$YR$$M$Y$$$20240910$$HP$ES$ES
243034211$24303421$1$I$$20240906$20240910$20240910$EXP$$US-BAYER-2024A128846$BAYER$$64$YR$A$M$Y$$$20240910$$MD$US$US
243034222$24303422$2$F$$20240920$20240910$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137038$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240923$$PH$US$US
243034231$24303423$1$I$$20240904$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140909$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240910$$CN$US$US
243034241$24303424$1$I$$20240828$20240910$20240910$EXP$$CA-Covis Pharma GmbH-2024COV01069$COVIS PHARMA$$$$$F$Y$$$20240910$$CN$CA$CA
243034251$24303425$1$I$20240907$20240907$20240910$20240910$PER$$US-ALXN-202409USA000491US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240910$$CN$US$US
243034261$24303426$1$I$$20240906$20240910$20240910$PER$$US-BAYER-2024A128324$BAYER$$$$$$Y$$$20240910$$CN$US$US
243034271$24303427$1$I$$20240905$20240910$20240910$EXP$$CA-Covis Pharma GmbH-2024COV01103$COVIS PHARMA$$45$YR$A$F$Y$$$20240910$$CN$CA$CA
243034292$24303429$2$F$$20240917$20240910$20240923$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144328$DAIICHI$$$$$F$Y$$$20240923$$MD$US$US
243034301$24303430$1$I$20240305$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-087169-2024$RECKITT BENCKISER$$39$YR$$M$Y$$$20240910$$CN$US$US
243034311$24303431$1$I$$20240909$20240910$20240910$EXP$$US-BAYER-2024A129437$BAYER$$86$YR$E$M$Y$$$20240910$$CN$US$US
243034321$24303432$1$I$20240801$20240829$20240910$20240910$PER$$US-SA-2024SA260757$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240910$$MD$US$US
243034331$24303433$1$I$$20240903$20240910$20240910$PER$$US-SA-2024SA261608$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240910$$HP$US$US
243034341$24303434$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA260320$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240910$$CN$US$US
243034351$24303435$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259750$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240910$$HP$US$US
243034371$24303437$1$I$20240904$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62111$$FDA-CTU$$85$YR$$F$N$$$20240909$N$HP$US$
243034381$24303438$1$I$20240904$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62123$$FDA-CTU$$8$YR$$M$N$$$20240909$N$HP$US$
243034391$24303439$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62012$$FDA-CTU$$79$YR$$M$N$$$20240909$N$$US$
243034401$24303440$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62127$$FDA-CTU$$63$YR$$F$N$148$LBS$20240910$N$HP$US$
243034411$24303441$1$I$$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62116$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243034421$24303442$1$I$20240904$20240909$20240909$20240909$DIR$717712$$FDA-CTU$$$$$M$N$$$20240909$N$CN$US$
243034431$24303443$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62129$$FDA-CTU$$85$YR$$UNK$N$126$LBS$20240910$N$$US$
243034441$24303444$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62117$$FDA-CTU$$63$YR$$F$N$$$20240910$N$$US$
243034451$24303445$1$I$20240830$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62118$$FDA-CTU$$47$YR$$F$N$$$20240909$Y$HP$US$
243034471$24303447$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62010$$FDA-CTU$$76$YR$$M$N$$$20240909$N$$US$
243034481$24303448$1$I$20240902$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62078$$FDA-CTU$$78$YR$$F$N$99$KG$20240909$Y$PH$US$
243034491$24303449$1$I$20240731$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62121$$FDA-CTU$$49$YR$$F$N$$$20240910$N$$US$
243034501$24303450$1$I$$20240906$20240909$20240909$DIR$FDA-CDER-CTU-2024-62030$$FDA-CTU$$$$$F$N$58.06$KG$20240906$N$$US$
243034511$24303451$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62132$$FDA-CTU$$72$YR$$M$N$197$LBS$20240910$N$$US$
243034521$24303452$1$I$20240907$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62032$$FDA-CTU$$53$YR$$F$N$$$20240909$N$$US$
243034531$24303453$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62133$$FDA-CTU$$47$YR$$F$N$96.16$KG$20240910$N$$US$
243034541$24303454$1$I$20240908$20240909$20240909$20240909$DIR$717698$$FDA-CTU$$62$YR$$F$N$50.4$KG$20240909$N$CN$US$
243034551$24303455$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62135$$FDA-CTU$$53$YR$$F$N$182$LBS$20240910$N$$US$
243034561$24303456$1$I$20240909$20240909$20240909$20240909$DIR$717708$$FDA-CTU$$44$YR$$M$N$164.25$KG$20240909$Y$CN$US$
243034571$24303457$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62136$$FDA-CTU$$42$YR$$M$N$$$20240910$N$$US$
243034581$24303458$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62134$$FDA-CTU$$60$YR$$F$N$180$LBS$20240910$N$$US$
243034591$24303459$1$I$$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62130$$FDA-CTU$$$$$M$N$$$20240909$N$HP$US$
243034601$24303460$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62131$$FDA-CTU$$58$YR$$M$N$$$20240910$N$$US$
243034611$24303461$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62137$$FDA-CTU$$51$YR$$F$N$$$20240910$N$$US$
243034621$24303462$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62119$$FDA-CTU$$60$YR$$F$N$$$20240910$N$$US$
243034631$24303463$1$I$20240907$20240909$20240909$20240909$DIR$717765$$FDA-CTU$$58$YR$$F$N$60.75$KG$20240909$N$CN$US$
243034641$24303464$1$I$20240908$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62120$$FDA-CTU$$39$YR$$F$N$$$20240910$Y$$US$
243034651$24303465$1$I$$20240909$20240909$20240909$DIR$717727$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
243034671$24303467$1$I$20240902$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62122$$FDA-CTU$$78$YR$$F$N$99$KG$20240909$Y$HP$US$
243034681$24303468$1$I$$20240909$20240909$20240909$DIR$717745$$FDA-CTU$$$$$F$N$$$20240909$$CN$US$
243034691$24303469$1$I$20240806$20240904$20240910$20240910$EXP$$CN-PURDUE-USA-2024-0311863$PURDUE$$72$YR$$F$Y$55$KG$20240910$$HP$CN$CN
243034701$24303470$1$I$$20240904$20240910$20240910$EXP$$ES-PURDUE-USA-2024-0311832$PURDUE$Mestres Catala C.. Improvement of adherence and health status of a young patientwith multiple pathologies through the follow-up service with SPD in a community pharmacy. Community Farms. 2024;16(3):43-48$36$YR$$F$Y$83.3$KG$20240910$$PH$ES$ES
243034711$24303471$1$I$20220101$20240907$20240910$20240910$EXP$$US-PURDUE PHARMA-USA-2024-0311876$PURDUE$$$$$M$Y$$$20240910$$CN$US$US
243034721$24303472$1$I$$20240903$20240910$20240910$EXP$$CA-GSK-CA2024109465$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$CA$CA
243034741$24303474$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181110$NOVARTIS$$2$YR$$F$Y$$$20240910$$HP$US$US
243034752$24303475$2$F$20240901$20240906$20240910$20240920$EXP$$DE-BAXTER-2024BAX024257$BAXTER$$37$YR$$F$Y$$$20240920$$HP$DE$DE
243034761$24303476$1$I$$20240903$20240910$20240910$EXP$$BR-TAKEDA-2024TUS089216$TAKEDA$$$$$M$Y$85$KG$20240910$$CN$BR$BR
243034771$24303477$1$I$20220210$20240830$20240910$20240910$EXP$$MY-BAXTER-2024BAX024050$BAXTER$$69$YR$$F$Y$$$20240910$$HP$MY$MY
243034782$24303478$2$F$20240901$20240922$20240910$20240924$EXP$$IL-BAYER-2024A128486$BAYER$$95$YR$E$M$Y$$$20240924$$CN$IL$IL
243034791$24303479$1$I$$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024179570$AMGEN$$$$$$Y$$$20240910$$MD$US$US
243034801$24303480$1$I$$20240902$20240910$20240910$EXP$$US-MYLANLABS-2024M1082262$MYLAN$Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J-Med-Toxicol 2024;.$41$YR$$F$Y$$$20240910$$HP$US$US
243034811$24303481$1$I$$20240902$20240910$20240910$EXP$$US-MYLANLABS-2024M1081782$MYLAN$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024; 67 (0).$65$YR$$M$Y$$$20240910$$HP$US$US
243034821$24303482$1$I$$20240902$20240910$20240910$EXP$$TW-MYLANLABS-2024M1082258$MYLAN$Chung B-S, Lin P-C, Chen S-H, Yeh Y-M. Combination of Anti-programmed Cell Death Protein 1 and Antiangiogenesis Displaying a Response Disparity between Pulmonary and Nonpulmonary Metastases. J-Cancer-Res-Pract 2023; 10 (4): 150-153.$55$YR$$M$Y$$$20240910$$MD$TW$TW
243034831$24303483$1$I$$20240903$20240910$20240910$EXP$$CH-MYLANLABS-2024M1082294$MYLAN$De Pieri M. Is Quetiapine the Best Option for Patients With Antipsychotic-Induced Disorders of Extrinsic Ocular Motricity?. Prim-Care-Comp-CNS-Disorders 2024; 26 (1):.$20$YR$$M$Y$$$20240910$$MD$CH$CH
243034841$24303484$1$I$20230101$20240903$20240910$20240910$EXP$FR-AFSSAPS-AVBX2024000463$FR-MYLANLABS-2024M1080908$MYLAN$$17$YR$$M$Y$$$20240910$$MD$FR$FR
243034851$24303485$1$I$$20231218$20240910$20240910$EXP$$US-TEVA-VS-3226896$TEVA$Jain S, Pynadath CT, Ajaimy M, Shi Y, Al Azzi Y, Graham JA, et al. Hemophagocytic Lymphohistiocytosis in Adult Renal Transplant Patients: A Case Series of Three Patients. J-Am-Soc-Nephrol 2023; 34 609.$34$YR$$M$Y$$$20240910$$HP$US$US
243034861$24303486$1$I$$20240903$20240910$20240910$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024EME109617$VIIV$$$$$$Y$$$20240910$$MD$GB$GB
243034871$24303487$1$I$$20240908$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2024US078673$SANDOZ$$57$YR$$M$Y$$$20240910$$MD$US$US
243034892$24303489$2$F$20240905$20240919$20240910$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142670$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240923$$CN$US$US
243034901$24303490$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143513$BRISTOL MYERS SQUIBB$$42$YR$A$$Y$$$20240910$$HP$US$US
243034911$24303491$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-133899-2023$RECKITT BENCKISER$$81$YR$$F$Y$$$20240910$$CN$US$US
243034921$24303492$1$I$20100702$20240827$20240910$20240910$EXP$$AU-KREUSSLER-2024-AU-000006$CHEMISCHE FABRIK KREUSSLER$frati M, Jackson M, Jindal R, Lim A, Lurie F, Marks L, Raymond-Martimbeau P, Paraskevas P, Ramelet AA, Rial R, Roberts S, Simkin C, Thibault PK, Whiteley MS. Guidelines for management of actual or sus.Parsi K, De Maeseneer M, van Rij AM, Rogan C, Bonython W, Devereux JA, Lekich CK, Amos M, Bozkurt AK, Connor DE, Davies AH, Gianesini S, Gibson K, Gloviczki P, Grabs A, Grillo L, Hafner F, Huber D, Ia..$46$YR$A$F$Y$$$20240910$$MD$AU$AU
243034932$24303493$2$F$20240826$20240910$20240910$20240917$EXP$$DE-BAXTER-2024BAX024193$BAXTER$$82$YR$$F$Y$$$20240917$$HP$DE$DE
243034941$24303494$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000506US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243034951$24303495$1$I$20240228$20240826$20240910$20240910$EXP$$FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2024-019383$VALIDUS$$$$$$Y$$$20240910$$MD$FR$FR
243034962$24303496$2$F$20240101$20240917$20240910$20240923$EXP$$ES-BIOGEN-2024BI01269435$BIOGEN$$63$YR$$F$Y$$$20240923$$MD$ES$ES
243034971$24303497$1$I$$20240822$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08553$LUPIN$$$$$$Y$$$20240910$$CN$US$US
243034991$24303499$1$I$$20240903$20240910$20240910$EXP$$CA-GSK-CA2023123151$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$CA$CA
243035001$24303500$1$I$20240501$20240909$20240910$20240910$EXP$GB-MHRA-MED-202409091717574630-PJNTZ$GB-MYLANLABS-2024M1082568$MYLAN$$$$$F$Y$$$20240910$$CN$GB$GB
243035011$24303501$1$I$20240717$20240906$20240910$20240910$EXP$$FR-AMGEN-FRASP2024178710$AMGEN$$74$YR$E$M$Y$$$20240910$$MD$FR$FR
243035021$24303502$1$I$20240101$20240905$20240910$20240910$EXP$$CA-PFIZER INC-202400023326$PFIZER$$64$YR$$M$Y$$$20240910$$MD$CA$CA
243035031$24303503$1$I$$20240909$20240909$20240909$DIR$717772$$FDA-CTU$$45$YR$$F$N$53.1$KG$20240909$N$CN$US$
243035041$24303504$1$I$20240516$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62125$$FDA-CTU$$69$YR$$M$N$85.18$KG$20240909$N$HP$US$
243035051$24303505$1$I$20240907$20240909$20240909$20240909$DIR$717696$$FDA-CTU$$88$YR$$F$N$66.15$KG$20240909$N$HP$US$
243035061$24303506$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62126$$FDA-CTU$$43$YR$$M$N$$$20240910$N$$US$
243035071$24303507$1$I$20240909$20240909$20240909$20240909$DIR$717762$$FDA-CTU$$50$YR$$F$N$63$KG$20240909$N$CN$CA$
243035081$24303508$1$I$20240831$20240903$20240910$20240910$PER$$US-Eisai-EC-2024-173722$EISAI$$69$YR$E$M$Y$$$20240910$$CN$US$US
243035093$24303509$3$F$20240901$20240920$20240910$20240926$EXP$$US-AMGEN-USASP2024177357$AMGEN$$86$YR$E$F$Y$$$20240926$$CN$US$US
243035101$24303510$1$I$20240101$20240909$20240910$20240910$EXP$$SG-JNJFOC-20240920021$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240910$$HP$SG$SG
243035111$24303511$1$I$$20240805$20240910$20240910$EXP$$CA-ABBVIE-5913675$ABBVIE$$82$YR$$F$Y$$$20240910$$HP$CA$CA
243035122$24303512$2$F$$20240910$20240910$20240919$30DAY$$GB-PFIZER INC-202400248292$PFIZER$$10$YR$$M$Y$$$20240919$$CN$GB$GB
243035142$24303514$2$F$$20240912$20240910$20240913$EXP$$AT-GILEAD-2024-0687185$GILEAD$$$$E$M$Y$$$20240913$$MD$AT$AT
243035152$24303515$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687178$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243035162$24303516$2$F$$20240906$20240910$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409004236$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$US$US
243035171$24303517$1$I$$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408019164$ELI LILLY AND CO$$61$YR$A$$Y$$$20240910$$LW$US$US
243035181$24303518$1$I$20221201$20240829$20240910$20240910$EXP$$CA-ELI_LILLY_AND_COMPANY-CA202408018722$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240910$$CN$CA$CA
243035192$24303519$2$F$$20240904$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002242$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240910$$CN$US$US
243035201$24303520$1$I$20231101$20240830$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000610$ELI LILLY AND CO$$$$$$Y$$$20240910$$CN$US$US
243035211$24303521$1$I$$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018793$ELI LILLY AND CO$$66$YR$E$$Y$$$20240910$$LW$US$US
243035221$24303522$1$I$20240301$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408019051$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240910$$CN$US$US
243035231$24303523$1$I$20240801$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004375$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240910$$CN$US$US
243035242$24303524$2$F$$20240911$20240910$20240919$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409002340AA$ELI LILLY AND CO$$$$$$Y$$$20240919$$CN$JP$JP
243035251$24303525$1$I$$20240902$20240910$20240910$30DAY$$GR-PFIZER INC-PV202400115259$PFIZER$$9$YR$$M$Y$20$KG$20240910$$CN$GR$GR
243035262$24303526$2$F$20240801$20240917$20240910$20240923$30DAY$$GT-PFIZER INC-PV202400109135$PFIZER$$15$YR$$M$Y$$$20240923$$HP$GT$GT
243035281$24303528$1$I$20240826$20240828$20240910$20240910$30DAY$$CO-PFIZER INC-202400246739$PFIZER$$$$$$Y$$$20240910$$CN$CO$CO
243035291$24303529$1$I$$20240909$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143604$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240910$$HP$US$US
243035301$24303530$1$I$20240905$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142647$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$74.39$KG$20240910$$HP$US$US
243035311$24303531$1$I$20240819$20240830$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139916$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240910$$CN$US$US
243035331$24303533$1$I$$20240822$20240910$20240910$PER$$US-SA-2024SA259584$SANOFI AVENTIS$$$$A$M$Y$$$20240910$$MD$US$US
243035341$24303534$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181184$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243035351$24303535$1$I$$20240909$20240910$20240910$PER$$US-ALXN-202409USA000557US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243035361$24303536$1$I$$20240903$20240910$20240910$PER$$US-009507513-2409USA001539$MERCK$Mooradian MJ, Fintelmann FJ, LaSalle TJ, Simon J, Graur A, Muzikansky A, et al.. Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial. Nature Communications. 2024;15:1-12$63$YR$$M$Y$$$20240910$$HP$US$US
243035371$24303537$1$I$$20240903$20240910$20240910$EXP$$PL-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00458$VELOXIS PHARMACEUTICALS$Muras Szwedziak K, Zawiasa-Bryszewska A, Bryszewski B, Strzelczyk J, Szwedziak K, Nowicki M et al.. The intervertebral disc apergillosis in patient in short term after kidney transplantation. Clinical cases. 2017;10(2):139-143$55$YR$$F$Y$$$20240910$$HP$PL$PL
243035391$24303539$1$I$$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202797$ASTRAZENECA$$$$$$Y$$$20240910$$CN$US$
243035402$24303540$2$F$$20240919$20240910$20240925$EXP$$US-PFIZER INC-PV202400116591$PFIZER$Rose, M.. Hypoxia following interscalene block. Regional Anesthesia + Pain Medicine. 2002;27(1):94-96$43$YR$$M$Y$$$20240925$$MD$US$US
243035411$24303541$1$I$$20240906$20240910$20240910$EXP$$CN-AstraZeneca-2024A205230$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$CN$
243035422$24303542$2$F$$20240903$20240910$20240917$PER$$US-JNJFOC-20240919702$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$US$US
243035431$24303543$1$I$$20240830$20240910$20240910$EXP$$US-JNJFOC-20240902849$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$MD$US$US
243035441$24303544$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024109382$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$HP$US$US
243035451$24303545$1$I$$20240906$20240910$20240910$EXP$$ZA-AstraZeneca-2024A204973$ASTRAZENECA$$88$YR$$M$Y$$$20240910$$CN$ZA$
243035461$24303546$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179150$AMGEN$$$$$M$Y$$$20240910$$HP$US$US
243035471$24303547$1$I$20240905$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179244$AMGEN$$$$$F$Y$$$20240910$$PH$US$US
243035491$24303549$1$I$20231017$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-135961-2023$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243035502$24303550$2$F$20240801$20240909$20240910$20240912$EXP$$NVSC2024IE180587$NOVARTIS$$31$YR$$F$Y$$$20240912$$CN$IE$IE
243035511$24303551$1$I$$20240907$20240910$20240910$PER$$NVSC2024US180657$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243035521$24303552$1$I$$20240910$20240910$20240910$EXP$$IT-GILEAD-2024-0686517$GILEAD$$$$$F$Y$$$20240910$$MD$IT$IT
243035532$24303553$2$F$$20240911$20240910$20240913$EXP$$GB-ANIPHARMA-2024-UK-000183$ANI$$68$YR$$M$Y$$$20240913$$CN$GB$GB
243035541$24303554$1$I$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687175$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243035551$24303555$1$I$$20240828$20240910$20240910$EXP$$KR-B.Braun Medical Inc.-2161437$B BRAUN$Literature Article$56$YR$$M$Y$$$20240910$$$KR$KR
243035561$24303556$1$I$$20240905$20240910$20240910$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00466$VELOXIS PHARMACEUTICALS$Shirini K, Gautam U, Ahmed H, Meier RP, Drachenberg C, Haririan A.. Masked kidney allograft failure after simultaneous liver and kidney transplantation: A case report.. Journal of Liver Transplantation.. 2024;16:100237$58$YR$$M$Y$$$20240910$$MD$US$US
243035571$24303557$1$I$20240907$20240909$20240909$20240909$DIR$717705$$FDA-CTU$$78$YR$$F$N$$$20240909$N$$US$
243035591$24303559$1$I$$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62138$$FDA-CTU$$$$$M$N$$$20240909$N$HP$US$
243035601$24303560$1$I$20240903$20240909$20240909$20240909$DIR$717726$$FDA-CTU$$67$YR$$F$N$90$KG$20240909$N$CN$US$
243035611$24303561$1$I$20240821$20240909$20240909$20240909$DIR$717776$$FDA-CTU$$42$YR$$F$N$68.4$KG$20240909$N$CN$US$
243035621$24303562$1$I$20240908$20240909$20240909$20240909$DIR$717707$$FDA-CTU$$$$$F$N$$$20240909$N$CN$US$
243035631$24303563$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142339$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240910$$CN$US$US
243035641$24303564$1$I$20240909$20240909$20240909$20240909$DIR$717681$$FDA-CTU$$50$YR$$M$N$$$20240909$N$HP$US$
243035652$24303565$2$F$$20240909$20240910$20240911$PER$$NVSC2024US181113$NOVARTIS$$74$YR$$F$Y$$$20240911$$MD$US$US
243035661$24303566$1$I$20240909$20240909$20240909$20240909$DIR$717711$$FDA-CTU$$28$YR$$M$N$$$20240909$Y$PH$US$
243035671$24303567$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144061$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240910$$CN$US$US
243035681$24303568$1$I$20240706$20240909$20240909$20240909$DIR$717710$$FDA-CTU$$45$YR$$M$N$60$KG$20240909$N$HP$US$
243035692$24303569$2$F$20240714$20240829$20240910$20240923$EXP$$CN-VALIDUS PHARMACEUTICALS LLC-CN-VDP-2024-019384$VALIDUS$$$$$$Y$$$20240923$$HP$CN$CN
243035702$24303570$2$F$20240908$20240910$20240910$20240911$PER$$US-AMGEN-USASP2024180256$AMGEN$$78$YR$E$F$Y$$$20240911$$CN$US$US
243035711$24303571$1$I$20240517$20240909$20240909$20240909$DIR$717682$$FDA-CTU$$73$YR$$F$N$$$20240909$N$HP$US$
243035731$24303573$1$I$$20240909$20240910$20240910$PER$$US-ALXN-202409USA000551US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243035751$24303575$1$I$20240101$20240903$20240910$20240910$PER$$US-009507513-2409USA001231$MERCK$$$$$M$Y$102$KG$20240910$$CN$US$US
243035771$24303577$1$I$20240901$20240903$20240910$20240910$EXP$$US-GSK-US2024109529$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243035781$24303578$1$I$$20240902$20240910$20240910$EXP$$BR-JNJFOC-20240912454$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240910$$CN$BR$BR
243035791$24303579$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-082189-2024$RECKITT BENCKISER$$$$$M$Y$$$20240910$$CN$US$US
243035801$24303580$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181182$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243035811$24303581$1$I$$20240816$20240910$20240910$PER$$US-AstraZeneca-2024A187573$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243035821$24303582$1$I$20240822$20240903$20240910$20240910$PER$$US-BRACCO-2024US05488$BRACCO$$52$YR$$F$Y$$$20240910$$CN$US$US
243035831$24303583$1$I$20240704$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A203087$ASTRAZENECA$$30291$DY$$F$Y$$$20240910$$CN$US$
243035841$24303584$1$I$20240820$20240905$20240910$20240910$EXP$$ID-AstraZeneca-2024A204036$ASTRAZENECA$$25904$DY$$F$Y$$$20240910$$CN$ID$
243035851$24303585$1$I$20210101$20240902$20240910$20240910$EXP$$BR-AstraZeneca-2024A202771$ASTRAZENECA$$91$YR$$F$Y$$$20240910$$CN$BR$
243035861$24303586$1$I$$20240831$20240910$20240910$EXP$$AU-ROCHE-10000072393$ROCHE$$$$$$Y$$$20240910$$HP$AU$AU
243035871$24303587$1$I$20240906$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005705$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240910$$CN$US$US
243035881$24303588$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144065$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240910$$CN$US$US
243035891$24303589$1$I$$20240903$20240910$20240910$EXP$$US-EMD Serono-2024047567$EMD SERONO INC$$59$YR$A$F$Y$$$20240910$$CN$US$US
243035911$24303591$1$I$20230101$20240829$20240910$20240910$PER$$US-SA-2024SA260625$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240910$$HP$US$US
243035921$24303592$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-083705-2024$RECKITT BENCKISER$$$$$F$Y$$$20240910$$CN$US$US
243035931$24303593$1$I$$20240903$20240910$20240910$EXP$NL-LRB-00999039$NL-TEVA-VS-3240222$TEVA$$56$YR$$M$Y$84$KG$20240910$$CN$NL$NL
243035941$24303594$1$I$$20240905$20240910$20240910$EXP$$NVSC2024DE167760$NOVARTIS$$79$YR$$F$Y$77$KG$20240910$$MD$DE$DE
243035951$24303595$1$I$$20240614$20240910$20240910$EXP$$GB-TEVA-VS-3219803$TEVA$$33$YR$$F$Y$$$20240910$$CN$GB$GB
243035961$24303596$1$I$$20240909$20240910$20240910$EXP$$US-TAKEDA-2024TUS001305$TAKEDA$$$$$M$Y$$$20240910$$CN$US$US
243035971$24303597$1$I$$20240906$20240910$20240910$PER$$US-TAKEDA-2024TUS089937$TAKEDA$$$$$M$Y$$$20240910$$HP$US$US
243035982$24303598$2$F$20240806$20240903$20240910$20240930$EXP$$SA-GSK-SA2024EME109728$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$SA$SA
243035991$24303599$1$I$20240904$20240905$20240910$20240910$EXP$$DE-BAYER-2024A128644$BAYER$$27$YR$A$F$Y$$$20240910$$MD$DE$DE
243036002$24303600$2$F$20240903$20240905$20240910$20240911$PER$$US-JNJFOC-20240908774$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240911$$CN$US$US
243036011$24303601$1$I$$20240823$20240910$20240910$PER$$US-JNJFOC-20240862894$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$MD$US$US
243036031$24303603$1$I$20240905$20240909$20240909$20240909$DIR$717700$$FDA-CTU$$78$YR$$M$N$$$20240909$Y$HP$US$
243036041$24303604$1$I$20240903$20240909$20240909$20240909$DIR$717701$$FDA-CTU$$82$YR$$M$N$63$KG$20240909$N$CN$US$
243036051$24303605$1$I$$20240829$20240910$20240910$EXP$$AU-Accord-444611$ACCORD$Skinner T, Liang S, Sanagapalli S. Budesonide Orodispersible Tablet for the Treatment of Refractory Esophageal Lichen Planus. ACG case reports journal. 2024;11(8):e01460. DOI: 10.14309/crj.0000000000001460.$61$YR$A$F$Y$$$20240910$$MD$AU$AU
243036061$24303606$1$I$20150419$20240904$20240910$20240910$EXP$BE-EMA-20160304-ashishvp-164444402$BE-MYLANLABS-2024M1081622$MYLAN$$71$YR$$M$Y$81.7$KG$20240910$$MD$BE$BE
243036071$24303607$1$I$20240823$20240906$20240910$20240910$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-120840$REGENERON$$$$$F$Y$$$20240910$$CN$CA$CA
243036081$24303608$1$I$$20240905$20240910$20240910$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00465$VELOXIS PHARMACEUTICALS$Ansari A, Dirani K, Malik A, Matthews S.. Silent manifestations of disseminated nocardia in a renal transplant patient. Cureus. 2024;16(7):e65523$45$YR$$M$Y$$$20240910$$MD$US$US
243036093$24303609$3$F$20240408$20240914$20240910$20240917$EXP$$ES-BIOVITRUM-2024-ES-011800$BIOVITRUM$$49$YR$$M$Y$$$20240917$$HP$ES$ES
243036111$24303611$1$I$$20240906$20240910$20240910$EXP$$US-PFIZER INC-PV202400117396$PFIZER$$70$YR$$M$Y$$$20240910$$CN$US$US
243036121$24303612$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62162$$FDA-CTU$$75$YR$$F$N$$$20240910$N$$US$
243036131$24303613$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62163$$FDA-CTU$$72$YR$$M$N$$$20240910$N$$US$
243036141$24303614$1$I$20240827$20240909$20240910$20240910$EXP$$CN-PFIZER INC-PV202400118234$PFIZER$$69$YR$$M$Y$70$KG$20240910$$HP$CN$CN
243036151$24303615$1$I$$20240909$20240910$20240910$EXP$$EG-PFIZER INC-PV202400118582$PFIZER$$48$YR$$M$Y$$$20240910$$CN$EG$EG
243036161$24303616$1$I$20240728$20240909$20240910$20240910$EXP$IT-MINISAL02-999731$IT-PFIZER INC-202400243539$PFIZER$$85$YR$$F$Y$55$KG$20240910$$MD$IT$IT
243036171$24303617$1$I$$20240909$20240910$20240910$EXP$$PL-PFIZER INC-202400252574$PFIZER$$71$YR$$M$Y$$$20240910$$HP$PL$PL
243036181$24303618$1$I$20240107$20240909$20240909$20240909$DIR$717697$$FDA-CTU$$36$YR$$F$N$63.9$KG$20240909$N$CN$US$
243036201$24303620$1$I$20240619$20240906$20240910$20240910$EXP$FR-AFSSAPS-PA2024001358$FR-PFIZER INC-202400251301$PFIZER$$36$YR$$M$Y$72.9$KG$20240910$$MD$FR$FR
243036211$24303621$1$I$$20240909$20240910$20240910$EXP$$JP-PFIZER INC-202400252471$PFIZER$$$$E$M$Y$$$20240910$$MD$JP$JP
243036221$24303622$1$I$20231001$20240907$20240910$20240910$EXP$$CR-PFIZER INC-PV202400077182$PFIZER$$82$YR$$M$Y$$$20240910$$CN$CR$CR
243036231$24303623$1$I$$20240906$20240910$20240910$EXP$$IN-PFIZER INC-PV202400117960$PFIZER$$32$YR$$M$Y$$$20240910$$CN$IN$IN
243036241$24303624$1$I$$20240909$20240910$20240910$EXP$$US-PFIZER INC-202400252792$PFIZER$$54$YR$$F$Y$$$20240910$$CN$US$US
243036251$24303625$1$I$$20240909$20240910$20240910$EXP$$JP-PFIZER INC-202400252625$PFIZER$$$$$$Y$$$20240910$$PH$JP$JP
243036261$24303626$1$I$20240905$20240907$20240910$20240910$EXP$$CN-PFIZER INC-PV202400117486$PFIZER$$73$YR$$M$Y$80$KG$20240910$$HP$CN$CN
243036271$24303627$1$I$20190101$20240909$20240910$20240910$EXP$$US-PFIZER INC-202400252946$PFIZER$$63$YR$$F$Y$$$20240910$$MD$US$US
243036281$24303628$1$I$20240822$20240909$20240910$20240910$EXP$$JP-PFIZER INC-PV202400112472$PFIZER$$70$YR$$M$Y$56$KG$20240910$$MD$JP$JP
243036291$24303629$1$I$20240813$20240815$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051927$TOLMAR$$90$YR$$M$Y$$$20240910$$CN$CA$CA
243036301$24303630$1$I$20240815$20240815$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051926$TOLMAR$$65$YR$$M$Y$$$20240910$$CN$CA$CA
243036311$24303631$1$I$20240815$20240815$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051929$TOLMAR$$95$YR$$M$Y$$$20240910$$CN$CA$CA
243036321$24303632$1$I$$20240814$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051935$TOLMAR$$$$$M$Y$$$20240910$$CN$CA$CA
243036331$24303633$1$I$20240816$20240816$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051949$TOLMAR$$74$YR$$M$Y$$$20240910$$CN$CA$CA
243036341$24303634$1$I$20240815$20240815$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051975$TOLMAR$$85$YR$$M$Y$$$20240910$$CN$CA$CA
243036351$24303635$1$I$20240809$20240816$20240910$20240910$PER$$CO-TOLMAR, INC.-24CO051983$TOLMAR$$72$YR$$M$Y$$$20240910$$CN$CO$CO
243036361$24303636$1$I$$20240816$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051951$TOLMAR$$$$$M$Y$$$20240910$$CN$CA$CA
243036371$24303637$1$I$20240815$20240815$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051974$TOLMAR$$80$YR$$M$Y$$$20240910$$CN$CA$CA
243036381$24303638$1$I$$20240815$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051976$TOLMAR$$$$$M$Y$$$20240910$$CN$CA$CA
243036391$24303639$1$I$20240816$20240816$20240910$20240910$PER$$CA-TOLMAR, INC.-24CA051977$TOLMAR$$68$YR$$M$Y$$$20240910$$CN$CA$CA
243036401$24303640$1$I$20240101$20240816$20240910$20240910$PER$$CO-TOLMAR, INC.-24CO052063$TOLMAR$$$$$M$Y$$$20240910$$CN$CO$CO
243036411$24303641$1$I$20240101$20240815$20240910$20240910$PER$$CO-TOLMAR, INC.-24CO052022$TOLMAR$$$$$M$Y$$$20240910$$CN$CO$CO
243036431$24303643$1$I$20240903$20240903$20240910$20240910$EXP$$CO-GSK-CO2023AMR155671$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$CO$CO
243036441$24303644$1$I$20240101$20240903$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141408$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240910$$CN$US$US
243036451$24303645$1$I$20240813$20240905$20240910$20240910$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-118403$REGENERON$$$$$F$Y$$$20240910$$HP$US$US
243036461$24303646$1$I$20231101$20240910$20240910$20240910$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-083734$REGENERON$$$$$M$Y$$$20240910$$CN$CA$CA
243036472$24303647$2$F$20240806$20240917$20240910$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US078495$SANDOZ$$12$YR$$F$Y$$$20240919$$CN$US$US
243036481$24303648$1$I$$20240531$20240910$20240910$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-081083$REGENERON$$$$$F$Y$$$20240910$$MD$US$US
243036492$24303649$2$F$$20240905$20240910$20240912$EXP$$PL-SANDOZ INC.-PHHY2015PL015567$SANDOZ$$39$YR$$M$Y$$$20240912$$MD$PL$PL
243036501$24303650$1$I$20240828$20240904$20240910$20240910$EXP$$CN-009507513-2409CHN002490$MERCK$$68$YR$$M$Y$47.5$KG$20240910$$HP$CN$CN
243036581$24303658$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62184$$FDA-CTU$$63$YR$$M$N$$$20240910$N$$US$
243036601$24303660$1$I$$20240906$20240910$20240910$PER$$US-BIOGEN-2024BI01280965$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
243036612$24303661$2$F$20230101$20240923$20240910$20240926$PER$$US-BIOGEN-2023BI01203008$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243036621$24303662$1$I$$20240906$20240910$20240910$PER$$US-BIOGEN-2024BI01281565$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
243036631$24303663$1$I$$20240906$20240910$20240910$PER$$US-BIOGEN-2024BI01281606$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
243036641$24303664$1$I$$20240910$20240910$20240910$PER$$US-PROD-AS2-212756134-RB-088021-2024$RECKITT BENCKISER$$84$YR$$F$Y$$$20240910$$CN$US$US
243036651$24303665$1$I$20240906$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179422$AMGEN$$68$YR$E$F$Y$$$20240910$$CN$US$US
243036661$24303666$1$I$$20240823$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08522$LUPIN$$$$$$Y$$$20240910$$CN$US$US
243036681$24303668$1$I$20240101$20240830$20240910$20240910$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-002055$SK LIFE SCIENCE$$$$$$Y$$$20240910$$CN$CA$CA
243036692$24303669$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686870$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243036702$24303670$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686819$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243036711$24303671$1$I$20240101$20240829$20240910$20240910$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-000566$SK LIFE SCIENCE$$$$$$Y$$$20240910$$HP$CA$CA
243036731$24303673$1$I$$20240823$20240910$20240910$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08543$LUPIN$$$$$$Y$$$20240910$$CN$US$US
243036741$24303674$1$I$20240804$20240905$20240910$20240910$EXP$$CA-LUNDBECK-DKLU4004029$LUNDBECK$$$$$$Y$$$20240910$$CN$CA$CA
243036752$24303675$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686794$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243036762$24303676$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686875$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243036771$24303677$1$I$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686866$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243036782$24303678$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686813$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243036791$24303679$1$I$$20240828$20240910$20240910$EXP$$BR-UCBSA-2024044719$UCB$$$$A$M$Y$$$20240910$$CN$BR$BR
243036802$24303680$2$F$$20240901$20240910$20240913$EXP$$US-BEH-2024178113$CSL BEHRING$$20$YR$A$M$Y$$$20240913$$HP$US$US
243036811$24303681$1$I$20240720$20240905$20240910$20240910$EXP$$ID-AstraZeneca-2024A204080$ASTRAZENECA$$27522$DY$$F$Y$$$20240910$$CN$ID$
243036821$24303682$1$I$$20240903$20240910$20240910$PER$$US-ROCHE-10000075356$ROCHE$$$$$M$Y$$$20240910$$CN$US$US
243036831$24303683$1$I$20240101$20240902$20240910$20240910$EXP$$JP-AstraZeneca-2024A201759$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$JP$
243036841$24303684$1$I$$20240902$20240910$20240910$EXP$$ZA-AstraZeneca-2024A200329$ASTRAZENECA$$77$YR$$F$Y$$$20240910$$CN$ZA$
243036851$24303685$1$I$$20240905$20240910$20240910$EXP$$GR-AstraZeneca-2024A204132$ASTRAZENECA$Chrysostomos, G; Christos, M; Konstantina, M; Evangeli, L; Georgios, G. DEVELOPMENT OF BULLOUS PEMPHIGOID DURING TREATMENT WITH BENRALIZUMAB FOR EOSINOPHILIC ASTHMA. 2024 International Meeting of the International Pemphigus and Pemphigoid Foundation (IPPF) 2024;$78$YR$$F$Y$$$20240910$$HP$GR$
243036861$24303686$1$I$$20240902$20240910$20240910$EXP$$BR-AstraZeneca-2024A202911$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$BR$
243036871$24303687$1$I$$20240902$20240910$20240910$EXP$$AU-AstraZeneca-2024A199796$ASTRAZENECA$$14610$DY$$F$Y$$$20240910$$MD$AU$
243036881$24303688$1$I$20190101$20240902$20240910$20240910$EXP$$RU-AstraZeneca-2024A203895$ASTRAZENECA$Chernikova N. A, Grigorieva M. A. Important about dyslipidaemia for patients with diabetes mellitus. Diabetes.Way of life 2024;22-26.$72$YR$$F$Y$$$20240910$$HP$RU$
243036891$24303689$1$I$$20240905$20240910$20240910$PER$$US-ROCHE-10000076702$ROCHE$$31$YR$A$M$Y$$$20240910$$CN$US$US
243036931$24303693$1$I$$20240905$20240910$20240910$PER$$US-ROCHE-10000076564$ROCHE$$20$YR$A$M$Y$$$20240910$$CN$US$US
243036941$24303694$1$I$20240304$20240826$20240910$20240910$EXP$$JP-GALDERMA-JP2024004282$GALDERMA$$$$$$Y$$$20240910$$MD$JP$JP
243036951$24303695$1$I$20240810$20240902$20240910$20240910$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000903$PAREXEL$$$$$$Y$$$20240910$$HP$CN$CN
243036961$24303696$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62188$$FDA-CTU$$70$YR$$F$N$155$LBS$20240910$N$$US$
243036971$24303697$1$I$$20240909$20240909$20240909$DIR$717699$$FDA-CTU$$$$$UNK$N$$$20240909$$CN$US$
243036982$24303698$2$F$20240421$20240912$20240910$20240918$30DAY$$GB-PFIZER INC-PV202400054433$PFIZER$$18$YR$$F$Y$$$20240918$$CN$GB$GB
243036991$24303699$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62185$$FDA-CTU$$30$YR$$M$N$$$20240910$N$$US$
243037001$24303700$1$I$$20240909$20240909$20240909$DIR$717706$$FDA-CTU$$$$$UNK$N$$$20240909$$CN$US$
243037011$24303701$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62186$$FDA-CTU$$76$YR$$F$N$231$LBS$20240910$N$$US$
243037021$24303702$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62187$$FDA-CTU$$48$YR$$F$N$$$20240910$N$$US$
243037032$24303703$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686815$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037041$24303704$1$I$20240101$20240906$20240910$20240910$PER$$US-ABBVIE-5915967$ABBVIE$$$$E$F$Y$$$20240910$$MD$US$US
243037052$24303705$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686758$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037061$24303706$1$I$$20240910$20240910$20240910$PER$$NVSC2024US181189$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243037071$24303707$1$I$20200101$20240830$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000309$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240910$$CN$US$US
243037081$24303708$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004622$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240910$$CN$US$US
243037091$24303709$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004862$ELI LILLY AND CO$$$$$M$Y$$$20240910$$CN$US$US
243037101$24303710$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004819$ELI LILLY AND CO$$$$$$Y$$$20240910$$CN$US$US
243037112$24303711$2$F$$20240906$20240910$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003832$ELI LILLY AND CO$$89$YR$E$M$Y$$$20240918$$CN$US$US
243037121$24303712$1$I$20240905$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004587$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240910$$CN$US$US
243037131$24303713$1$I$$20240909$20240910$20240910$PER$$US-ROCHE-10000077794$ROCHE$$$$A$M$Y$$$20240910$$CN$US$US
243037151$24303715$1$I$20240101$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142750$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$79.83$KG$20240910$$PH$US$US
243037161$24303716$1$I$$20240905$20240910$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142771$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$MD$JP$JP
243037171$24303717$1$I$$20240826$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136398$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$95.7$KG$20240910$$HP$US$US
243037181$24303718$1$I$$20240905$20240910$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142842$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240910$$PH$JP$JP
243037191$24303719$1$I$$20240904$20240910$20240910$EXP$$FR-DSJP-DSE-2024-144075$DAIICHI$$$$A$F$Y$68$KG$20240910$$MD$FR$FR
243037201$24303720$1$I$$20240909$20240910$20240910$EXP$$US-ROCHE-10000077404$ROCHE$$$$$$Y$$$20240910$$CN$US$US
243037211$24303721$1$I$$20240907$20240910$20240910$PER$$US-AMGEN-USASP2024179617$AMGEN$$$$$$Y$$$20240910$$CN$US$US
243037221$24303722$1$I$20190101$20240822$20240910$20240910$EXP$$JP-ABBVIE-19K-087-2935360-00$ABBVIE$$60$YR$$M$Y$66$KG$20240910$$CN$JP$JP
243037231$24303723$1$I$$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024180224$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
243037241$24303724$1$I$$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024180355$AMGEN$$41$YR$A$F$Y$$$20240910$$HP$US$US
243037252$24303725$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686761$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037262$24303726$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686759$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037282$24303728$2$F$20240814$20240912$20240910$20240913$EXP$FR-AFSSAPS-RN2024000961$FR-GILEAD-2024-0686865$GILEAD$$76$YR$E$M$Y$94$KG$20240913$$MD$FR$FR
243037291$24303729$1$I$$20240905$20240910$20240910$EXP$$US-BAYER-2024A128152$BAYER$$36$YR$A$M$Y$111.11$KG$20240910$$CN$US$US
243037302$24303730$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686760$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037312$24303731$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686762$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037321$24303732$1$I$20240827$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62189$$FDA-CTU$$52$YR$$F$N$$$20240910$N$$US$
243037351$24303735$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62190$$FDA-CTU$$61$YR$$F$N$102.51$KG$20240910$N$$US$
243037362$24303736$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686763$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037382$24303738$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687068$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037392$24303739$2$F$20240829$20240910$20240910$20240912$PER$$US-AMGEN-USASP2024180144$AMGEN$$64$YR$A$F$Y$$$20240912$$CN$US$US
243037401$24303740$1$I$20240812$20240905$20240910$20240910$EXP$FR-AFSSAPS-TS2024000953$FR-MYLANLABS-2024M1081510$MYLAN$$92$YR$$F$Y$55$KG$20240910$$MD$FR$FR
243037411$24303741$1$I$$20240905$20240910$20240910$EXP$$GB-MYLANLABS-2024M1021588$MYLAN$$27$YR$$M$Y$$$20240910$$CN$GB$GB
243037421$24303742$1$I$$20240906$20240910$20240910$EXP$$GB-MYLANLABS-2024M1073853$MYLAN$$$$$F$Y$$$20240910$$MD$GB$GB
243037441$24303744$1$I$20240909$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024180136$AMGEN$$57$YR$A$F$Y$$$20240910$$CN$US$US
243037451$24303745$1$I$$20240904$20240910$20240910$EXP$GB-MHRA-TPP63000036C11065230YC1724863232627$GB-GSK-GB2024109941$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$GB$GB
243037461$24303746$1$I$$20240903$20240910$20240910$EXP$$US-AMGEN-USASP2024177164$AMGEN$Lorenz E.C.; Smith B.H.; Mour G.et.al. Prospective Cohort Study Examining the Ability of Performance-Based and Self-Reported Frailty Measures to  Predict 30-Day Rehospitalizations After Kidney Transplantation. Clinical Transplantation. 2024;38 (8):1-8$$$$$Y$$$20240910$$HP$US$US
243037471$24303747$1$I$20240101$20240903$20240910$20240910$EXP$$US-AMGEN-HZN-2024-004404$AMGEN$$64$YR$A$F$Y$$$20240910$$CN$US$US
243037492$24303749$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0687070$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037501$24303750$1$I$$20240828$20240910$20240910$EXP$$US-B.Braun Medical Inc.-2161439$B BRAUN$Literature Article$60$YR$$F$Y$$$20240910$$$US$US
243037512$24303751$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687072$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037522$24303752$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687071$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037532$24303753$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687073$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037541$24303754$1$I$20240527$20240903$20240910$20240910$EXP$$CN-ROCHE-10000008448$ROCHE$$62$YR$A$M$Y$$$20240910$$MD$CN$CN
243037551$24303755$1$I$$20240904$20240910$20240910$EXP$$US-RDY-SPO/USA/24/0012910$DR REDDYS$$27$YR$A$M$Y$$$20240910$$HP$US$US
243037572$24303757$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0687074$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037582$24303758$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687075$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037591$24303759$1$I$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687076$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243037601$24303760$1$I$20240712$20240903$20240910$20240910$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000905$PAREXEL$$$$$$Y$$$20240910$$HP$CN$CN
243037611$24303761$1$I$20240829$20240904$20240910$20240910$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000912$PAREXEL$$$$$$Y$$$20240910$$HP$CN$CN
243037621$24303762$1$I$$20240909$20240910$20240910$PER$$US-ALXN-202409USA000556US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240910$$CN$US$US
243037631$24303763$1$I$$20240909$20240910$20240910$PER$$NVSC2024US180639$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243037641$24303764$1$I$20240825$20240906$20240910$20240910$EXP$$NVSC2024CN180985$NOVARTIS$$57$YR$$M$Y$60$KG$20240910$$HP$CN$CN
243037651$24303765$1$I$$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202682$ASTRAZENECA$$$$$M$Y$$$20240910$$CN$US$
243037662$24303766$2$F$$20240911$20240910$20240918$EXP$$AR-AstraZeneca-2024A204084$ASTRAZENECA$$69$YR$$F$Y$$$20240918$$CN$AR$
243037671$24303767$1$I$20240828$20240829$20240910$20240910$EXP$$CA-HLS-202402199$HLS THERAPEUTICS$$43$YR$A$F$Y$$$20240910$$HP$CA$CA
243037691$24303769$1$I$$20240909$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143872$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240910$$CN$US$US
243037701$24303770$1$I$$20240904$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141918$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240910$$HP$US$US
243037711$24303771$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2024SA260363$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240910$$HP$US$US
243037721$24303772$1$I$$20240906$20240910$20240910$EXP$$DE-ROCHE-10000076765$ROCHE$$$$$F$Y$$$20240910$$CN$DE$DE
243037731$24303773$1$I$20240812$20240905$20240910$20240910$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000913$PAREXEL$$$$$$Y$$$20240910$$HP$CN$CN
243037752$24303775$2$F$20240201$20240905$20240910$20240920$PER$$US-ABBVIE-5910150$ABBVIE$$38$YR$$F$Y$47$KG$20240920$$CN$US$US
243037761$24303776$1$I$$20240905$20240910$20240910$EXP$$FR-JNJFOC-20240911529$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240910$$PH$FR$FR
243037771$24303777$1$I$$20240902$20240910$20240910$EXP$$IE-JNJFOC-20240913283$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240910$$MD$IE$IE
243037781$24303778$1$I$$20240904$20240910$20240910$EXP$$US-MYLANLABS-2024M1081320$MYLAN$$68$YR$$F$Y$$$20240910$$CN$US$US
243037791$24303779$1$I$$20240904$20240910$20240910$EXP$$DE-MYLANLABS-2018M1029224$MYLAN$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al.. Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant recipients: CERTAIN registry study.. TRANSPLANTATION. 2018;103 (6):1-33$5$YR$$$Y$$$20240910$$HP$DE$DE
243037801$24303780$1$I$$20240909$20240910$20240910$EXP$$BE-SANDOZ INC.-SDZ2024BE078726$SANDOZ$$53$YR$$F$Y$$$20240910$$HP$BE$BE
243037811$24303781$1$I$$20240903$20240910$20240910$EXP$$JP-AMGEN-JPNSP2024124374$AMGEN$$$$$$Y$$$20240910$$PH$JP$JP
243037821$24303782$1$I$$20240903$20240910$20240910$EXP$$JP-AMGEN-JPNSP2024176433$AMGEN$$74$YR$E$M$Y$$$20240910$$PH$JP$JP
243037831$24303783$1$I$$20240903$20240910$20240910$EXP$$US-ROCHE-10000073206$ROCHE$$55$YR$A$M$Y$$$20240910$$CN$US$US
243037841$24303784$1$I$20230101$20240903$20240910$20240910$EXP$$US-ABBVIE-5689578$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243037852$24303785$2$F$$20240906$20240910$20240911$PER$$NVSC2024US180402$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243037861$24303786$1$I$20240101$20240830$20240910$20240910$PER$$US-SA-2024SA260084$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240910$$HP$US$US
243037871$24303787$1$I$20240101$20240904$20240910$20240910$EXP$$US-ABBVIE-5908218$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243037891$24303789$1$I$20240614$20240828$20240910$20240910$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000899$PAREXEL$$$$$$Y$$$20240910$$HP$CN$CN
243037901$24303790$1$I$$20240904$20240910$20240910$EXP$$GR-INCYTE CORPORATION-2024IN009442$INCYTE$Stafylidis C, Giannakopoulou N, Chatzidavid S, Viniou NA, Diamantopoulos P.. The skin hydroxyurea lives in: Confronting recurrent squamous Cell carcinomas in a hydroxyurea- Treated patient with polycythemia vera. ONCOLOGIC AND HEMATOLOGIC DISEASES. 2024;11:768$$$$$Y$$$20240910$$HP$GR$GR
243037912$24303791$2$F$$20240906$20240910$20240914$EXP$$FR-ABBVIE-5908774$ABBVIE$$71$YR$$M$Y$$$20240914$$MD$FR$FR
243037921$24303792$1$I$$20240906$20240910$20240910$EXP$$GB-ABBVIE-5915744$ABBVIE$$$$E$M$Y$$$20240910$$HP$GB$GB
243037931$24303793$1$I$20240904$20240905$20240910$20240910$EXP$$CA-ABBVIE-5915591$ABBVIE$$83$YR$$M$Y$$$20240910$$CN$CA$CA
243037941$24303794$1$I$20200101$20240827$20240910$20240910$PER$$US-ABBVIE-5914705$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243037951$24303795$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000482US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$HP$US$US
243037961$24303796$1$I$$20240906$20240910$20240910$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050278$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20240910$$MD$CA$CA
243037971$24303797$1$I$$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001328$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240910$$CN$US$US
243037981$24303798$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005318$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240910$$CN$US$US
243037991$24303799$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005524$ELI LILLY AND CO$$36$YR$A$$Y$$$20240910$$CN$US$US
243038001$24303800$1$I$$20240904$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003778$ELI LILLY AND CO$$$$A$F$Y$$$20240910$$CN$US$US
243038011$24303801$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004576$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240910$$CN$US$US
243038021$24303802$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004589$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240910$$CN$US$US
243038031$24303803$1$I$$20240815$20240910$20240910$PER$$US-009507513-2408USA006046$MERCK$$$$T$$Y$$$20240910$$MD$US$US
243038041$24303804$1$I$20240823$20240830$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139879$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$45.81$KG$20240910$$PH$US$US
243038051$24303805$1$I$$20240902$20240910$20240910$EXP$$DE-TEVA-VS-3239679$TEVA$$$$$$Y$$$20240910$$MD$DE$DE
243038061$24303806$1$I$20240101$20240830$20240910$20240910$PER$$US-SA-2024SA260736$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240910$$HP$US$US
243038071$24303807$1$I$20240101$20240829$20240910$20240910$PER$$US-SA-2024SA260554$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240910$$HP$US$US
243038091$24303809$1$I$20240814$20240904$20240910$20240910$EXP$$US-RDY-SPO/USA/24/0012905$DR REDDYS$$69$YR$E$F$Y$$$20240910$$HP$US$US
243038101$24303810$1$I$20240902$20240903$20240910$20240910$PER$$US-Eisai-EC-2024-173874$EISAI$$68$YR$E$M$Y$59.9$KG$20240910$$MD$US$US
243038111$24303811$1$I$$20240903$20240910$20240910$EXP$$GB-MYLANLABS-2024M1077504$MYLAN$$$$$M$Y$$$20240910$$CN$GB$GB
243038121$24303812$1$I$20240622$20240902$20240910$20240910$EXP$FR-AFSSAPS-PP2024000953$FR-FreseniusKabi-FK202413368$FRESENIUS KABI$$64$YR$A$F$Y$87$KG$20240910$$MD$FR$FR
243038131$24303813$1$I$20240409$20240902$20240910$20240910$EXP$$CN-FreseniusKabi-FK202413395$FRESENIUS KABI$$72$YR$E$F$Y$$$20240910$$HP$CN$CN
243038141$24303814$1$I$20240708$20240902$20240910$20240910$EXP$$CN-FreseniusKabi-FK202413410$FRESENIUS KABI$$1$MON$I$F$Y$1$KG$20240910$$HP$CN$CN
243038151$24303815$1$I$$20240830$20240910$20240910$PER$$US-FreseniusKabi-FK202413258$FRESENIUS KABI$$$$$$Y$$$20240910$$MD$US$US
243038161$24303816$1$I$20240816$20240902$20240910$20240910$EXP$$CN-FreseniusKabi-FK202413406$FRESENIUS KABI$$76$YR$E$M$Y$39$KG$20240910$$HP$CN$CN
243038171$24303817$1$I$20240601$20240902$20240910$20240910$EXP$CZ-CZSUKL-24002380$CZ-FreseniusKabi-FK202413365$FRESENIUS KABI$$55$YR$A$F$Y$57$KG$20240910$$PH$CZ$CZ
243038191$24303819$1$I$$20240830$20240910$20240910$PER$$US-FreseniusKabi-FK202413429$FRESENIUS KABI$$73$YR$E$M$Y$$$20240910$$MD$US$US
243038201$24303820$1$I$20240901$20240909$20240910$20240910$PER$$US-PFIZER INC-202400253295$PFIZER$$90$YR$$M$Y$$$20240910$$CN$US$US
243038211$24303821$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-202400253045$PFIZER$$38$YR$$F$Y$$$20240910$$HP$US$US
243038221$24303822$1$I$20240101$20240906$20240910$20240910$PER$$US-PFIZER INC-PV202400118058$PFIZER$$41$YR$$M$Y$$$20240910$$HP$US$US
243038231$24303823$1$I$20240801$20240905$20240910$20240910$PER$$US-PFIZER INC-202400251263$PFIZER$$49$YR$$F$Y$$$20240910$$MD$US$US
243038251$24303825$1$I$$20240909$20240910$20240910$PER$$US-PFIZER INC-202400252789$PFIZER$$71$YR$$F$Y$$$20240910$$CN$US$US
243038261$24303826$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-202400252027$PFIZER$$$$$F$Y$$$20240910$$CN$US$US
243038271$24303827$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-PV202400117901$PFIZER$$55$YR$$F$Y$$$20240910$$HP$US$US
243038281$24303828$1$I$20240830$20240907$20240910$20240910$PER$$US-PFIZER INC-PV202400118129$PFIZER$$32$YR$$F$Y$70.295$KG$20240910$$CN$US$US
243038292$24303829$2$F$$20240913$20240910$20240916$PER$$US-PFIZER INC-202400251441$PFIZER$$33$YR$$F$Y$$$20240916$$HP$US$US
243038311$24303831$1$I$20240906$20240908$20240910$20240910$PER$$US-PFIZER INC-202400253053$PFIZER$$54$YR$$F$Y$$$20240910$$CN$US$US
243038331$24303833$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-PV202400117458$PFIZER$$$$$F$Y$$$20240910$$CN$US$US
243038342$24303834$2$F$$20240912$20240910$20240919$PER$$US-PFIZER INC-202400251793$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243038361$24303836$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-202400251799$PFIZER$$84$YR$$F$Y$$$20240910$$CN$US$US
243038371$24303837$1$I$20240905$20240909$20240910$20240910$PER$$US-PFIZER INC-202400253211$PFIZER$$60$YR$$M$Y$$$20240910$$CN$US$US
243038382$24303838$2$F$20240101$20240906$20240910$20240913$PER$$US-PFIZER INC-202400251658$PFIZER$$60$YR$$M$Y$97.52$KG$20240913$$CN$US$US
243038391$24303839$1$I$20240907$20240909$20240910$20240910$PER$$US-PFIZER INC-202400253099$PFIZER$$44$YR$$F$Y$$$20240910$$CN$US$US
243038401$24303840$1$I$20240805$20240909$20240910$20240910$EXP$IT-MINISAL02-1001334$IT-PFIZER INC-202400252766$PFIZER$$3$YR$$M$Y$12.5$KG$20240910$$MD$IT$IT
243038411$24303841$1$I$20240906$20240907$20240910$20240910$PER$$US-PFIZER INC-202400252250$PFIZER$$$$$$Y$$$20240910$$CN$US$US
243038421$24303842$1$I$20240601$20240905$20240910$20240910$PER$$US-PFIZER INC-PV202400116869$PFIZER$$81$YR$$M$Y$$$20240910$$CN$US$US
243038431$24303843$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-202400251828$PFIZER$$$$$M$Y$$$20240910$$MD$US$US
243038451$24303845$1$I$20240909$20240909$20240910$20240910$PER$$US-PFIZER INC-202400253192$PFIZER$$34$YR$$M$Y$$$20240910$$CN$US$US
243038461$24303846$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-202400253029$PFIZER$$26$YR$$F$Y$$$20240910$$HP$US$US
243038471$24303847$1$I$20240906$20240906$20240910$20240910$PER$$US-PFIZER INC-202400252278$PFIZER$$55$YR$$F$Y$$$20240910$$CN$US$US
243038481$24303848$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-202400253164$PFIZER$$62$YR$$F$Y$$$20240910$$HP$US$US
243038493$24303849$3$F$$20240917$20240910$20240918$EXP$$GR-PFIZER INC-PV202400116619$PFIZER$Tartanis, G.. POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN THE CONTEXT OF A SUDDEN INCREASE IN CYCLOSPORIN LEVELS: CASE REPORT. 35th National Conference of the Hellenic Neurological Society. 2024;135$20$YR$$M$Y$$$20240918$$MD$GR$GR
243038501$24303850$1$I$$20240905$20240910$20240910$PER$$US-PFIZER INC-PV202400117123$PFIZER$$41$YR$$F$Y$$$20240910$$HP$US$US
243038511$24303851$1$I$$20240909$20240910$20240910$PER$$US-PFIZER INC-PV202400117858$PFIZER$$39$YR$$F$Y$$$20240910$$HP$US$US
243038522$24303852$2$F$$20240916$20240910$20240918$PER$$US-PFIZER INC-PV202400117724$PFIZER$$74$YR$$F$Y$$$20240918$$HP$US$US
243038531$24303853$1$I$20240905$20240905$20240910$20240910$PER$$JP-PFIZER INC-202400250433$PFIZER$$$$$$Y$$$20240910$$PH$JP$JP
243038541$24303854$1$I$20240909$20240909$20240910$20240910$PER$$US-PFIZER INC-202400253209$PFIZER$$51$YR$$F$Y$$$20240910$$CN$US$US
243038561$24303856$1$I$$20240909$20240910$20240910$PER$$US-PFIZER INC-PV202400118410$PFIZER$$$$$F$Y$$$20240910$$CN$US$US
243038571$24303857$1$I$20240822$20240909$20240910$20240910$PER$$US-PFIZER INC-PV202400118315$PFIZER$$50$YR$$F$Y$$$20240910$$CN$US$US
243038581$24303858$1$I$$20240909$20240910$20240910$PER$$US-PFIZER INC-PV202400118404$PFIZER$$$$$M$Y$$$20240910$$CN$US$US
243038611$24303861$1$I$20240904$20240905$20240910$20240910$PER$$US-PFIZER INC-202400251344$PFIZER$$72$YR$$F$Y$72.57$KG$20240910$$HP$US$US
243038621$24303862$1$I$20240906$20240908$20240910$20240910$PER$$US-PFIZER INC-202400252971$PFIZER$$61$YR$$F$Y$$$20240910$$HP$US$US
243038641$24303864$1$I$$20240909$20240910$20240910$PER$$US-PFIZER INC-PV202400118361$PFIZER$$79$YR$$F$Y$$$20240910$$CN$US$US
243038651$24303865$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-PV202400117789$PFIZER$$51$YR$$M$Y$$$20240910$$HP$US$US
243038661$24303866$1$I$$20240909$20240910$20240910$PER$$US-PFIZER INC-202400253011$PFIZER$$36$YR$$M$Y$$$20240910$$CN$US$US
243038671$24303867$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-PV202400118090$PFIZER$$38$YR$$F$Y$$$20240910$$CN$US$US
243038681$24303868$1$I$20240701$20240908$20240910$20240910$PER$$US-PFIZER INC-202400253075$PFIZER$$$$$$Y$$$20240910$$CN$US$US
243038691$24303869$1$I$$20240905$20240910$20240910$PER$$US-PFIZER INC-202400251810$PFIZER$$$$$F$Y$$$20240910$$MD$US$US
243038701$24303870$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-202400253040$PFIZER$$53$YR$$M$Y$$$20240910$$HP$US$US
243038712$24303871$2$F$$20240926$20240910$20240927$PER$$US-PFIZER INC-202400252289$PFIZER$$72$YR$$F$Y$72.12$KG$20240927$$CN$US$US
243038721$24303872$1$I$20240907$20240907$20240910$20240910$PER$$US-PFIZER INC-202400251969$PFIZER$$75$YR$$M$Y$$$20240910$$CN$US$US
243038731$24303873$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-202400253060$PFIZER$$74$YR$$F$Y$$$20240910$$CN$US$US
243038741$24303874$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-PV202400117841$PFIZER$$63$YR$$F$Y$$$20240910$$HP$US$US
243038752$24303875$2$F$20240901$20240924$20240910$20240926$PER$$US-PFIZER INC-202400253037$PFIZER$$58$YR$$M$Y$86.18$KG$20240926$$CN$US$US
243038761$24303876$1$I$20240907$20240908$20240910$20240910$PER$$US-PFIZER INC-202400252837$PFIZER$$50$YR$$F$Y$$$20240910$$CN$US$US
243038771$24303877$1$I$20240101$20240909$20240910$20240910$EXP$$US-PFIZER INC-202400252984$PFIZER$$65$YR$$F$Y$$$20240910$$CN$US$US
243038781$24303878$1$I$20240906$20240906$20240910$20240910$PER$$US-PFIZER INC-202400252305$PFIZER$$64$YR$$M$Y$$$20240910$$CN$US$US
243038791$24303879$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-202400251835$PFIZER$$$$E$F$Y$$$20240910$$CN$US$US
243038801$24303880$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-202400253061$PFIZER$$44$YR$$F$Y$$$20240910$$HP$US$US
243038812$24303881$2$F$20240801$20240906$20240910$20240911$PER$$US-PFIZER INC-202400251638$PFIZER$$73$YR$$F$Y$81.65$KG$20240911$$CN$US$US
243038841$24303884$1$I$$20240905$20240910$20240910$PER$$US-PFIZER INC-202400250776$PFIZER$$$$A$F$Y$$$20240910$$MD$US$US
243038851$24303885$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-202400251712$PFIZER$$$$$F$Y$$$20240910$$CN$US$US
243038871$24303887$1$I$20240101$20240906$20240910$20240910$PER$$US-PFIZER INC-PV202400118069$PFIZER$$53$YR$$F$Y$$$20240910$$HP$US$US
243038881$24303888$1$I$$20240907$20240910$20240910$PER$$US-PFIZER INC-PV202400118157$PFIZER$$$$$$Y$$$20240910$$CN$US$US
243038891$24303889$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-202400251803$PFIZER$$50$YR$$M$Y$$$20240910$$CN$US$US
243038911$24303891$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-PV202400117466$PFIZER$$$$$F$Y$$$20240910$$CN$US$US
243038921$24303892$1$I$20220101$20240907$20240910$20240910$PER$$US-PFIZER INC-PV202400118122$PFIZER$$31$YR$$F$Y$99.773$KG$20240910$$CN$US$US
243038932$24303893$2$F$20240826$20240923$20240910$20240926$PER$$US-PFIZER INC-202400252410$PFIZER$$72$YR$$M$Y$77.11$KG$20240926$$CN$US$US
243038941$24303894$1$I$20240907$20240907$20240910$20240910$PER$$US-PFIZER INC-202400251989$PFIZER$$75$YR$$M$Y$$$20240910$$CN$US$US
243038951$24303895$1$I$$20240904$20240910$20240910$PER$$US-PFIZER INC-PV202400116515$PFIZER$$52$YR$$M$Y$$$20240910$$HP$US$US
243038982$24303898$2$F$$20240906$20240910$20240911$PER$$US-PFIZER INC-202400251981$PFIZER$$80$YR$$F$Y$$$20240911$$CN$US$US
243038991$24303899$1$I$$20240906$20240910$20240910$PER$$US-PFIZER INC-PV202400117675$PFIZER$$55$YR$$F$Y$$$20240910$$CN$US$US
243039001$24303900$1$I$20240901$20240909$20240910$20240910$PER$$US-PFIZER INC-202400253142$PFIZER$$57$YR$$F$Y$$$20240910$$CN$US$US
243039011$24303901$1$I$20240102$20240906$20240910$20240910$PER$$US-PFIZER INC-PV202400118089$PFIZER$$54$YR$$M$Y$78.005$KG$20240910$$CN$US$US
243039022$24303902$2$F$$20240916$20240910$20240917$PER$$US-PFIZER INC-202400251766$PFIZER$$67$YR$$F$Y$59.87$KG$20240917$$CN$US$US
243039032$24303903$2$F$$20240912$20240910$20240916$EXP$$NVSC2024MX180638$NOVARTIS$$$$$F$Y$$$20240916$$CN$MX$MX
243039041$24303904$1$I$20240101$20240904$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140829$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240910$$HP$US$US
243039051$24303905$1$I$20240301$20240906$20240910$20240910$PER$$US-PFIZER INC-202400074314$PFIZER$$71$YR$$F$Y$59.864$KG$20240910$$CN$US$US
243039061$24303906$1$I$$20240905$20240910$20240910$PER$$US-PFIZER INC-202400251068$PFIZER$$53$YR$$F$Y$$$20240910$$CN$US$US
243039071$24303907$1$I$$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143535$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240910$$CN$US$US
243039081$24303908$1$I$20240807$20240906$20240910$20240910$EXP$$US-BAYER-2024A128335$BAYER$$14$YR$T$M$Y$$$20240910$$CN$US$US
243039103$24303910$3$F$20240101$20240916$20240910$20240919$30DAY$$TR-PFIZER INC-202400243747$PFIZER$$$$$$Y$$$20240919$$PH$TR$TR
243039111$24303911$1$I$20240831$20240909$20240910$20240910$EXP$$CN-ROCHE-10000077433$ROCHE$$74$YR$E$F$Y$85$KG$20240910$$HP$CN$CN
243039121$24303912$1$I$$20240909$20240910$20240910$PER$$US-JNJFOC-20240921883$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
243039131$24303913$1$I$$20240904$20240910$20240910$EXP$$US-ABBVIE-5907883$ABBVIE$$87$YR$$F$Y$$$20240910$$CN$US$US
243039141$24303914$1$I$20230101$20240903$20240910$20240910$EXP$$NVSC2024CN172083$NOVARTIS$$31$YR$$M$Y$80$KG$20240910$$CN$CN$CN
243039152$24303915$2$F$20240904$20240913$20240910$20240918$PER$$US-FreseniusKabi-FK202413464$FRESENIUS KABI$$79$YR$E$F$Y$75$KG$20240918$$PH$US$US
243039161$24303916$1$I$$20240905$20240910$20240910$EXP$$JP-009507513-2409JPN000829J$MERCK$$$$E$$Y$$$20240910$$PH$JP$JP
243039171$24303917$1$I$20230101$20240903$20240910$20240910$PER$$US-ABBVIE-5914158$ABBVIE$$$$$F$Y$48$KG$20240910$$CN$US$US
243039181$24303918$1$I$$20240902$20240910$20240910$EXP$$ZA-AstraZeneca-2024A200606$ASTRAZENECA$$25932$DY$$F$Y$$$20240910$$CN$ZA$
243039191$24303919$1$I$$20240902$20240910$20240910$EXP$$AU-AstraZeneca-2024A199798$ASTRAZENECA$$54$YR$$F$Y$$$20240910$$MD$AU$
243039202$24303920$2$F$20240801$20240912$20240910$20240926$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1443$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240926$$HP$US$US
243039211$24303921$1$I$$20240903$20240910$20240910$PER$$US-AstraZeneca-2024A200881$ASTRAZENECA$$$$$F$Y$$$20240910$$HP$US$
243039221$24303922$1$I$$20240906$20240910$20240910$EXP$$CA-PFIZER INC-202400251648$PFIZER$$$$$$Y$$$20240910$$HP$CA$CA
243039231$24303923$1$I$$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A203304$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243039241$24303924$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142110$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$53.98$KG$20240910$$HP$US$US
243039251$24303925$1$I$20230718$20240902$20240910$20240910$EXP$$JP-AstraZeneca-2023A238415$ASTRAZENECA$$75$YR$$F$Y$64$KG$20240910$$MD$JP$
243039261$24303926$1$I$$20240906$20240910$20240910$EXP$SE-SEMPA-2024-006563$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-143728$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240910$$MD$SE$SE
243039271$24303927$1$I$$20240906$20240910$20240910$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-142726$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$MD$FR$FR
243039281$24303928$1$I$$20240907$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142822$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$82.1$KG$20240910$$CN$US$US
243039291$24303929$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005402$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243039301$24303930$1$I$$20240905$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202409004225$ELI LILLY AND CO$$$$$M$Y$$$20240910$$CN$US$US
243039311$24303931$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004766$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240910$$CN$US$US
243039321$24303932$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004437$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240910$$CN$US$US
243039331$24303933$1$I$20240825$20240830$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409000299$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240910$$CN$US$US
243039341$24303934$1$I$20240607$20240906$20240910$20240910$EXP$$CN-PFIZER INC-PV202400117405$PFIZER$$44$YR$$F$Y$64$KG$20240910$$HP$CN$CN
243039361$24303936$1$I$$20240827$20240910$20240910$PER$$US-MYLANLABS-2024M1079454$MYLAN$$$$$F$Y$$$20240910$$CN$US$US
243039371$24303937$1$I$$20240909$20240910$20240910$EXP$$FR-SANDOZ INC.-SDZ2024FR078820$SANDOZ$$$$$F$Y$$$20240910$$HP$FR$FR
243039381$24303938$1$I$20231215$20240910$20240910$20240910$DIR$717787$$FDA-CTU$$43$YR$$M$N$100.8$KG$20240910$N$CN$US$
243039391$24303939$1$I$20240910$20240910$20240910$20240910$DIR$717784$$FDA-CTU$$29$YR$$F$N$90$KG$20240910$Y$CN$US$
243039411$24303941$1$I$$20240910$20240910$20240910$DIR$717798$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243039421$24303942$1$I$$20240909$20240909$20240909$DIR$717715$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
243039431$24303943$1$I$$20240910$20240910$20240910$PER$$NVSC2024US181177$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243039442$24303944$2$F$20240609$20240910$20240910$20240912$PER$$NVSC2024US180841$NOVARTIS$$46$YR$$F$Y$$$20240912$$CN$US$US
243039451$24303945$1$I$20240101$20240823$20240910$20240910$PER$$US-SA-2024SA258943$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240910$$MD$US$US
243039461$24303946$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260536$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240910$$HP$US$US
243039481$24303948$1$I$20240101$20240905$20240910$20240910$EXP$$US-ABBVIE-5913631$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243039491$24303949$1$I$$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024178139$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243039501$24303950$1$I$$20240828$20240910$20240910$EXP$$BH-STERISCIENCE B.V.-2024-ST-001326$Steriscience PTE$Saif H S, Al-Ansari B, Raza G, et al.. Approach to the Management of Hypertriglyceridemia Complicated With Acute Pancreatitis in Pregnancy: A Case Report.. Cureus. 2024;16(3):e56006$32$YR$$F$Y$$$20240910$$HP$BH$BH
243039512$24303951$2$F$20240904$20240924$20240910$20240926$EXP$$JP-PFIZER INC-PV202400117899$PFIZER$$73$YR$$M$Y$56.1$KG$20240926$$MD$JP$JP
243039521$24303952$1$I$$20240908$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143131$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$66.68$KG$20240910$$CN$US$US
243039531$24303953$1$I$$20240904$20240910$20240910$EXP$$CA-PFIZER INC-202400033866$PFIZER$$54$YR$$M$Y$$$20240910$$CN$CA$CA
243039541$24303954$1$I$$20240828$20240910$20240910$EXP$$MA-STERISCIENCE B.V.-2024-ST-001330$Steriscience PTE$Azelmat S, Baadi T, Benaissa E, et al.. Infective Endocarditis Caused by Carbapenemase-Producing Klebsiella pneumoniae on a Prosthetic Valve: A Case Report and Review of the Literature. Cureus. 2024;16(7):e64639$$$$$Y$$$20240910$$HP$MA$MA
243039561$24303956$1$I$$20240827$20240910$20240910$EXP$$US-BIOGEN-2024BI01281828$BIOGEN$$$$$M$Y$$$20240910$$CN$US$US
243039571$24303957$1$I$20240831$20240909$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143621$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240910$$CN$US$US
243039583$24303958$3$F$20240805$20240906$20240910$20240920$EXP$$IN-SANDOZ INC.-SDZ2024IN078807$SANDOZ$$53$YR$$M$Y$$$20240920$$CN$IN$IN
243039591$24303959$1$I$$20240906$20240910$20240910$PER$$US-JNJFOC-20240916079$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$CN$US$US
243039602$24303960$2$F$$20240906$20240910$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143925$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240916$$CN$US$US
243039611$24303961$1$I$20120101$20240828$20240910$20240910$EXP$$US-GE HEALTHCARE-2024CSU009850$GE HEALTHCARE$$67$YR$$F$Y$$$20240910$$HP$US$US
243039621$24303962$1$I$$20240828$20240910$20240910$EXP$$JP-STERISCIENCE B.V.-2024-ST-001332$Steriscience PTE$Yamada M, Shoji K, Fukuda T, et al.. Two Cases of Children With Black Hairy Tongue and Tooth Discoloration Caused by Antibacterial Agents.. Cureus. 2024;16(4):e58354$2$YR$$M$Y$$$20240910$$HP$JP$JP
243039631$24303963$1$I$20240806$20240910$20240910$20240910$DIR$717785$$FDA-CTU$$44$YR$$M$N$114.75$KG$20240910$N$CN$US$
243039641$24303964$1$I$20240610$20240910$20240910$20240910$DIR$717796$$FDA-CTU$$38$YR$$M$N$69$KG$20240910$N$MD$US$
243039651$24303965$1$I$$20240131$20240910$20240910$EXP$$CA-TEVA-VS-3231562$TEVA$$40$YR$$F$Y$$$20240910$$HP$CA$CA
243039661$24303966$1$I$$20240909$20240909$20240909$DIR$717742$$FDA-CTU$$$$$M$N$$$20240909$N$HP$US$
243039671$24303967$1$I$$20240831$20240910$20240910$PER$$US-SA-2024SA260804$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240910$$MD$US$US
243039681$24303968$1$I$$20240901$20240910$20240910$PER$$US-SA-2024SA260967$SANOFI AVENTIS$$$$A$M$Y$$$20240910$$HP$US$US
243039691$24303969$1$I$$20240906$20240910$20240910$PER$$US-BIOGEN-2024BI01281647$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
243039702$24303970$2$F$$20240916$20240910$20240919$EXP$$IT-ROCHE-10000075846$ROCHE$Caterina R, Sadeghipour P, Salehi M, Kohansal E, Mozafarybazargany M, Parsaee M. Ultraslow low-dose thrombolytic therapy in patients with acute mechanical prosthetic heart valve thrombosis - a prospective cohort study [Abstract: P24-06219]. International Journal of Cardiology. 2024; doi:10.1016/j.ijcard.2024.132507.$$$$$Y$$$20240919$$MD$IT$IT
243039712$24303971$2$F$$20240910$20240910$20240918$EXP$$CA-AstraZeneca-2024A199043$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$CA$
243039721$24303972$1$I$$20240909$20240910$20240910$30DAY$$IT-SANDOZ INC.-SDZ2024IT053532$SANDOZ$$$$$F$Y$$$20240910$$CN$IT$IT
243039731$24303973$1$I$20060406$20240829$20240910$20240910$EXP$$JP-AstraZeneca-2006AP02282$ASTRAZENECA$$75$YR$$F$Y$58$KG$20240910$$MD$JP$
243039741$24303974$1$I$20240901$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024179991$AMGEN$$78$YR$E$F$Y$$$20240910$$CN$US$US
243039751$24303975$1$I$$20240828$20240910$20240910$EXP$$JP-STERISCIENCE B.V.-2024-ST-001333$Steriscience PTE$Yoshiro Sakai, Seiji Karakawa, Takato Koutaki, Kyoko Higuchi, Aya Hashimoto, and Hiroshi Watanabe. Concomitant Administration of Vancomycin with a High Dose of Meropenem May Cause Acute Kidney Injury. Case Reports in Infectious Diseases. 2024;4$65$YR$$F$Y$58.3$KG$20240910$$HP$JP$JP
243039761$24303976$1$I$$20240826$20240910$20240910$EXP$$IN-CIPHER-2024-IN-000001$CIPHER$Saini B, Agarwal A, Singh G, Jayachandran S, Jain S..Tramadol-Induced Fatal Angioedema: A Rare Case..Cureus.2024;16(7):.$23$YR$A$F$Y$$$20240910$$HP$IN$IN
243039772$24303977$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687057$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243039781$24303978$1$I$$20240905$20240910$20240910$EXP$$CN-KYOWAKIRIN-2024KK020942$KYOWA$$$$$$Y$$$20240910$$HP$CN$CN
243039792$24303979$2$F$20240812$20240911$20240910$20240918$PER$$US-Calliditas-2024CAL01687$CALLIDITAS THERAPEUTICS$$76$YR$E$F$Y$82.1$KG$20240918$$CN$US$US
243039801$24303980$1$I$$20240828$20240910$20240910$EXP$$JP-STERISCIENCE B.V.-2024-ST-001337$Steriscience PTE$Satoki I, Takuya T, Yuji I, Haruka I, Tomoka N, Hiroki I. A case of recurrent Campylobacter fetus meningitis, occurring two months after the ?initial infection was successfully treated. Clinical Neurology. 2024;64(7):490-495$43$YR$$M$Y$$$20240910$$HP$JP$JP
243039811$24303981$1$I$20240713$20240827$20240910$20240910$EXP$$FR-CIPLA LTD.-2024FR09481$CIPLA$$$$$$Y$$$20240910$$MD$FR$FR
243039842$24303984$2$F$20240908$20240910$20240910$20240912$PER$$US-AMGEN-USASP2024180238$AMGEN$$69$YR$E$F$Y$$$20240912$$CN$US$US
243039852$24303985$2$F$20230101$20240912$20240910$20240920$EXP$$TR-TEVA-VS-3240662$TEVA$Tunc A, AkbaS AA, Bozkurt B, Oncel S. Beyond conventional therapies: IVIG in treating severe fingolimod-rebound in a postpartum patient with MS. BMJ-Case-Rep 2024; 17 (7):.; Tunc A, AkbaS AA, Bozkurt B, Oncel S. Beyond conventional therapies: IVIG in treating severe fingolimod-rebound in a postpartum patient with MS. BMJ-Case-Rep 2024; 17 (7):.$$$A$F$Y$$$20240920$$MD$TR$TR
243039861$24303986$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142874$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240910$$CN$US$US
243039871$24303987$1$I$$20240827$20240910$20240910$EXP$$US-CIPLA LTD.-2024US09592$CIPLA$Rink DE, Abramson RH, Johnson NJ, Lee RY. Diagnostic confounders in brain death a woman with unexplained coma and brainstem areflexia. Annals of the American Thoracic Society. 2024;21(8):1204 to 1208$$$$$Y$$$20240910$$MD$US$US
243039881$24303988$1$I$$20240904$20240910$20240910$EXP$$RU-BRISTOL-MYERS SQUIBB COMPANY-2024-142611$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240910$$HP$RU$RU
243039891$24303989$1$I$20240903$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143751$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240910$$CN$US$US
243039901$24303990$1$I$20240801$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018965$ELI LILLY AND CO$$$$$$Y$$$20240910$$CN$US$US
243039911$24303991$1$I$20240806$20240829$20240910$20240910$EXP$FR-AFSSAPS-PO2024000915$FR-ELI_LILLY_AND_COMPANY-FR202408018521$ELI LILLY AND CO$$65$YR$E$M$Y$52$KG$20240910$$CN$FR$FR
243039922$24303992$2$F$20240801$20240909$20240910$20240913$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000889$ELI LILLY AND CO$$32$YR$A$$Y$$$20240913$$CN$JP$JP
243039931$24303993$1$I$20240801$20240829$20240910$20240910$EXP$$PL-ELI_LILLY_AND_COMPANY-PL202409000368$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240910$$MD$PL$PL
243039941$24303994$1$I$20240401$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000597$ELI LILLY AND CO$$$$$$Y$$$20240910$$CN$US$US
243039951$24303995$1$I$20220520$20240830$20240910$20240910$EXP$FR-AFSSAPS-NC2024001028$FR-ELI_LILLY_AND_COMPANY-FR202409000642$ELI LILLY AND CO$$66$YR$E$M$Y$100$KG$20240910$$CN$FR$FR
243039961$24303996$1$I$20240905$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004793$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240910$$CN$US$US
243039971$24303997$1$I$20240520$20240830$20240910$20240910$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409001654$ELI LILLY AND CO$$62$YR$A$M$Y$51$KG$20240910$$CN$DE$CN
243039981$24303998$1$I$$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018976$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240910$$CN$US$US
243039991$24303999$1$I$$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202408018970$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240910$$CN$US$US
243040001$24304000$1$I$20240909$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005390$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240910$$CN$US$US
243040011$24304001$1$I$$20240904$20240910$20240910$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409003394$ELI LILLY AND CO$$75$YR$E$$Y$$$20240910$$CN$JP$JP
243040022$24304002$2$F$20211228$20240903$20240910$20240916$EXP$$KR-ELI_LILLY_AND_COMPANY-KR202409002268$ELI LILLY AND CO$$$$A$M$Y$$$20240916$$CN$KR$KR
243040031$24304003$1$I$20240722$20240829$20240910$20240910$EXP$FR-AFSSAPS-TO2024001622$FR-ELI_LILLY_AND_COMPANY-FR202408019281$ELI LILLY AND CO$$69$YR$E$M$Y$49.4$KG$20240910$$CN$FR$FR
243040051$24304005$1$I$20240711$20240829$20240910$20240910$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000003$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240910$$CN$US$US
243040061$24304006$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005760$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240910$$CN$US$US
243040071$24304007$1$I$$20240906$20240910$20240910$PER$$US-JNJFOC-20240916754$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$HP$US$US
243040081$24304008$1$I$$20240906$20240910$20240910$PER$$US-JNJFOC-20240916857$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$HP$US$US
243040091$24304009$1$I$$20240828$20240910$20240910$EXP$$JP-STERISCIENCE B.V.-2024-ST-001334$Steriscience PTE$Kaho Yamasaki, Seiko Ishikawa, Takefumi Suzuki, Yukiko Tanaka and Katsuyuki Oi. Refractory Peritonitis Related to Peritoneal Dialysis Caused by Enterococcus gallinarum. Intern Med. 2024;63:1907-1912$65$YR$$F$Y$$$20240910$$HP$JP$JP
243040101$24304010$1$I$$20240903$20240910$20240910$EXP$$US-GSK-US2024AMR109646$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$US$US
243040121$24304012$1$I$20240728$20240904$20240910$20240910$EXP$$EG-GSK-EG2024EME110524$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$EG$EG
243040131$24304013$1$I$$20240906$20240910$20240910$PER$$US-JNJFOC-20240916778$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$PH$US$US
243040141$24304014$1$I$$20240906$20240910$20240910$EXP$$US-KYOWAKIRIN-2024KK020944$KYOWA$$$$$$Y$$$20240910$$HP$US$US
243040161$24304016$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181220$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
243040171$24304017$1$I$20240203$20240830$20240910$20240910$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000909$PAREXEL$$$$$$Y$$$20240910$$HP$CN$CN
243040181$24304018$1$I$$20240828$20240910$20240910$EXP$$US-CIPLA LTD.-2024US09752$CIPLA$Haddad TC, Suman VJ, Giridhar KV, Sideras K, Northfelt DW, Ernst BJ et al. Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early-stage breast cancer: A prospective trial. Clinical Cancer Research. 2024;30:3147 to 3156$$$$$Y$$$20240910$$HP$US$US
243040191$24304019$1$I$$20240903$20240910$20240910$EXP$$ES-ABBVIE-5915113$ABBVIE$Jimenez-Vicente C, Guardia-Torrelles A, Perez-Valencia AI, Martinez-Roca A, Castano-Diez S, Guijarro F, et al. Clinical management of patients diagnosed with acute myeloid leukemia treated with Venetoclax in combination with hypomethylating agents after achieving a response: a real-life study. Ann Hematol. 2024.$$$A$$Y$$$20240910$$HP$ES$ES
243040201$24304020$1$I$$20240829$20240910$20240910$PER$$PR-ABBVIE-5903412$ABBVIE$$50$YR$$F$Y$$$20240910$$MD$PR$PR
243040211$24304021$1$I$$20240905$20240910$20240910$EXP$$FR-INCYTE CORPORATION-2024IN009453$INCYTE$$$$$$Y$$$20240910$$PH$FR$FR
243040221$24304022$1$I$$20240904$20240910$20240910$EXP$$ES-BAUSCH-BL-2024-013315$BAUSCH AND LOMB$Pozo I, Comesana M, Castillo A, Oliva M, Vazquez G. Putting pieces together to reach the diagnosis. European Journal of Case Reports in Internal Medicine. 2024;11 (1):791. doi:10.12890/2024_V11Sup1$66$YR$$M$Y$$$20240910$$HP$ES$ES
243040231$24304023$1$I$$20240905$20240910$20240910$EXP$$BR-BAUSCH-BL-2024-013263$BAUSCH AND LOMB$Gonzaga Y, Mattosinho C, Azulay D. Blastic Plasmacytoid Dendritic Cell Neoplasm with ocular infiltration. American journal of ophthalmology. 2024 JUN;E3-E4. doi:10.1016/j.ajo.2024.06.009$62$YR$$M$Y$$$20240910$$HP$BR$BR
243040241$24304024$1$I$20240907$20240909$20240909$20240909$DIR$717752$$FDA-CTU$$43$YR$$M$N$109.8$KG$20240909$N$CN$US$
243040251$24304025$1$I$20240725$20240909$20240909$20240909$DIR$717694$$FDA-CTU$$38$YR$$F$N$58.5$KG$20240909$N$CN$US$
243040261$24304026$1$I$$20240905$20240910$20240910$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049832$BOEHRINGER INGELHEIM$Rai O, Rai O. A jaw-dropping consequence: nintedanib^s role in osteonecrosis of the jaw. Cureus. 2024 Jul 29;16:7: e65689. doi:10.7759/cureu s.65689.$80$YR$E$F$Y$$$20240910$$HP$US$US
243040271$24304027$1$I$$20240909$20240910$20240910$EXP$$CA-BAUSCH-BL-2024-013471$BAUSCH AND LOMB$$$$$$Y$$$20240910$$MD$CA$CA
243040281$24304028$1$I$$20240909$20240910$20240910$EXP$$CA-BAUSCH-BL-2024-013460$BAUSCH AND LOMB$$4$YR$$F$Y$$$20240910$$PH$CA$CA
243040292$24304029$2$F$$20240828$20240910$20240911$EXP$US-MLMSERVICE-20240822-PI167757-00162-1$US-STRIDES ARCOLAB LIMITED-2024SP011030$STRIDES$Tanas R, Shah V, Henderson C.. The classic ^Rat-Bite^ erosions in gouty arthritis with normal uric acid levels.. American Journal of the Medical Sciences.. 2024;368(3):e27-8$82$YR$$M$Y$$$20240911$$MD$US$US
243040301$24304030$1$I$$20240904$20240910$20240910$PER$$US-UNITED THERAPEUTICS-UNT-2024-027754$UNITED THERAPEUTICS$$$$$F$Y$$$20240910$$$US$US
243040311$24304031$1$I$$20240828$20240910$20240910$EXP$TR-MLMSERVICE-20201201-2601578-1$TR-STRIDES ARCOLAB LIMITED-2020SP015446$STRIDES$Sonkurt HO, Altinoz AE.. Oxybutynin addiction: two case reports. Journal of Substance Use.. 2020$22$YR$$M$Y$$$20240910$$MD$TR$TR
243040321$24304032$1$I$$20240826$20240910$20240910$EXP$$US-PARI RESPIRATORY EQUIPMENT, INC.-2024PAR00056$PARI RESPIRATORY EQUIPMENT$$$$$F$Y$26.304$KG$20240910$$HP$US$US
243040331$24304033$1$I$$20240902$20240910$20240910$EXP$$PT-BAUSCH-BL-2024-013200$BAUSCH AND LOMB$$$$E$$Y$$$20240910$$HP$PT$PT
243040341$24304034$1$I$$20240906$20240910$20240910$PER$$US-JNJFOC-20240916967$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$PH$US$US
243040351$24304035$1$I$$20240906$20240910$20240910$EXP$$BE-JNJFOC-20240919972$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$MD$BE$BE
243040361$24304036$1$I$20240816$20240828$20240910$20240910$PER$$US-SA-2024SA259512$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240910$$CN$US$US
243040371$24304037$1$I$$20240904$20240910$20240910$EXP$$US-VERTEX PHARMACEUTICALS-2024-014127$VERTEX$$$$$M$Y$$$20240910$$CN$US$US
243040381$24304038$1$I$$20240904$20240910$20240910$PER$$US-ROCHE-10000074959$ROCHE$$$$$M$Y$$$20240910$$CN$US$US
243040412$24304041$2$F$20190101$20240910$20240910$20240912$EXP$$NVSC2024GB180542$NOVARTIS$$51$YR$$F$Y$$$20240912$$HP$GB$GB
243040421$24304042$1$I$$20240905$20240910$20240910$EXP$$GB-INCYTE CORPORATION-2024IN009510$INCYTE$$$$$$Y$$$20240910$$HP$GB$GB
243040441$24304044$1$I$20240822$20240906$20240910$20240910$EXP$$US-AstraZeneca-2024A204056$ASTRAZENECA$$30134$DY$$M$Y$$$20240910$$CN$US$
243040451$24304045$1$I$$20240907$20240910$20240910$EXP$$IR-AstraZeneca-2024A203767$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240910$$MD$IR$
243040461$24304046$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143573$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240910$$HP$US$US
243040471$24304047$1$I$$20240907$20240910$20240910$EXP$$IR-AstraZeneca-2024A203774$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240910$$MD$IR$
243040482$24304048$2$F$20200101$20240924$20240910$20240930$EXP$$FI-MYLANLABS-2024M1081310$MYLAN$Lindstr?m M. Working age dieter?s walking difficulty ? part 1. Medical Journal. 2024;79:34-5$59$YR$$M$Y$$$20240930$$MD$FI$FI
243040492$24304049$2$F$20240705$20240907$20240910$20240910$PER$$US-GILEAD-2024-0686745$GILEAD$$25$YR$A$F$Y$$$20240910$$CN$US$US
243040501$24304050$1$I$20240801$20240829$20240910$20240910$PER$$US-SA-2024SA260863$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240910$$HP$US$US
243040511$24304051$1$I$$20240905$20240910$20240910$PER$$US-JNJFOC-20240915988$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
243040521$24304052$1$I$$20240905$20240910$20240910$EXP$$MX-INCYTE CORPORATION-2024IN009509$INCYTE$$$$$$Y$$$20240910$$MD$MX$MX
243040532$24304053$2$F$20240907$20240910$20240910$20240911$PER$$US-AMGEN-USASP2024180225$AMGEN$$68$YR$E$M$Y$$$20240911$$CN$US$US
243040541$24304054$1$I$$20240830$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN009452$INCYTE$$$$$$Y$$$20240910$$MD$US$US
243040551$24304055$1$I$$20240830$20240910$20240910$EXP$$JP-HQ SPECIALTY-JP-2024INT000084$INTERCHEM$Gotoh T. A case of residual sodium zirconium cyclosilicate hydrate in the stomach after administration via a nasogastric tube. Journal of Japanese Society of Hospital Pharmacists. 2024;60(8):883-7$7$DEC$$F$Y$$$20240910$$HP$JP$JP
243040561$24304056$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142183$BRISTOL MYERS SQUIBB$$81$YR$E$$Y$$$20240910$$CN$US$US
243040571$24304057$1$I$20240801$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143364$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$79.83$KG$20240910$$CN$US$US
243040581$24304058$1$I$$20240901$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN009225$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243040601$24304060$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181206$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243040611$24304061$1$I$20240716$20240906$20240910$20240910$EXP$$NVSC2024KR180072$NOVARTIS$$78$YR$$M$Y$59$KG$20240910$$HP$KR$KR
243040622$24304062$2$F$20231218$20240913$20240910$20240920$EXP$$CN-VER-202400012$VERITY PHARMACEUTICALS$$58$YR$A$M$Y$70$KG$20240920$$HP$CN$CN
243040631$24304063$1$I$20240601$20240906$20240910$20240910$EXP$$CO-ABBVIE-5816909$ABBVIE$$83$YR$$M$Y$83$KG$20240910$$CN$CO$CO
243040641$24304064$1$I$20240905$20240905$20240910$20240910$EXP$$CA-LUNDBECK-DKLU4004040$LUNDBECK$$$$$$Y$$$20240910$$CN$CA$CA
243040651$24304065$1$I$20240906$20240909$20240909$20240909$DIR$717686$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
243040661$24304066$1$I$$20240909$20240909$20240909$DIR$717687$$FDA-CTU$$$$$F$N$69.3$KG$20240909$N$PH$US$
243040674$24304067$4$F$20240826$20240919$20240910$20240923$EXP$FR-AFSSAPS-PV2024000831$FR-EMD Serono-2024048052$EMD SERONO INC$$60$YR$A$M$Y$60$KG$20240923$$PH$FR$FR
243040681$24304068$1$I$$20240906$20240910$20240910$PER$$NVSC2024US180413$NOVARTIS$$$$$$Y$$$20240910$$CN$US$US
243040691$24304069$1$I$$20240901$20240910$20240910$EXP$$CN-JNJFOC-20240907377$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240910$$HP$CN$CN
243040711$24304071$1$I$20240401$20240902$20240910$20240910$EXP$$DE-TEVA-VS-3239721$TEVA$$$$$M$Y$2.44$KG$20240910$$MD$DE$DE
243040721$24304072$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142566$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240910$$HP$US$US
243040741$24304074$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143762$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240910$$CN$US$US
243040751$24304075$1$I$$20240909$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143946$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240910$$CN$US$US
243040761$24304076$1$I$20190301$20240829$20240910$20240910$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409004136$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240910$$CN$DE$GB
243040772$24304077$2$F$$20240917$20240910$20240930$EXP$$CA-LUNDBECK-DKLU4004032$LUNDBECK$$$$$$Y$$$20240930$$CN$CA$CA
243040781$24304078$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005482$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240910$$CN$US$US
243040791$24304079$1$I$$20240904$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003184$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240910$$CN$US$US
243040802$24304080$2$F$20240906$20240906$20240910$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004686$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240911$$CN$US$US
243040811$24304081$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005250$ELI LILLY AND CO$$65$YR$E$$Y$$$20240910$$CN$US$US
243040821$24304082$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005612$ELI LILLY AND CO$$$$$F$Y$$$20240910$$CN$US$US
243040831$24304083$1$I$$20240909$20240910$20240910$EXP$GB-MHRA-TPP5695104C581080YC1725638235203$GB-SANDOZ INC.-SDZ2024GB078798$SANDOZ$$62$YR$$F$Y$73$KG$20240910$$MD$GB$GB
243040841$24304084$1$I$20240706$20240907$20240910$20240910$PER$$US-HALEON-2195857$Haleon PLC$$60$YR$$F$Y$$$20240910$$CN$US$US
243040852$24304085$2$F$20240731$20240906$20240910$20240911$PER$$US-BAYER-2024A128159$BAYER$$20$YR$A$F$Y$$$20240911$$MD$US$US
243040861$24304086$1$I$20240801$20240829$20240910$20240910$PER$$US-SA-2024SA260568$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240910$$MD$US$US
243040872$24304087$2$F$20200301$20240919$20240910$20240924$EXP$$NVSC2024IT178692$NOVARTIS$$61$YR$$M$Y$$$20240924$$HP$IT$IT
243040881$24304088$1$I$$20240907$20240910$20240910$EXP$$IR-AstraZeneca-2024A203759$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$M$Y$$$20240910$$MD$IR$
243040891$24304089$1$I$$20240907$20240910$20240910$EXP$$IR-AstraZeneca-2024A203757$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$M$Y$$$20240910$$MD$IR$
243040911$24304091$1$I$20240430$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179174$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243040922$24304092$2$F$20240908$20240910$20240910$20240912$PER$$US-AMGEN-USASP2024180244$AMGEN$$76$YR$E$F$Y$$$20240912$$PH$US$US
243040981$24304098$1$I$20221018$20240905$20240910$20240910$EXP$FR-AFSSAPS-CF20221714$FR-Eisai-EC-2024-173690$EISAI$$60$YR$A$F$Y$$$20240910$$MD$FR$FR
243040991$24304099$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179615$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243041001$24304100$1$I$20240830$20240903$20240910$20240910$EXP$GB-MHRA-MED-202409031435598820-TYNLG$GB-Eisai-EC-2024-173639$EISAI$$65$YR$E$F$Y$$$20240910$$PH$GB$GB
243041011$24304101$1$I$20240807$20240903$20240910$20240910$EXP$FR-AFSSAPS-RN2024000888$FR-TEVA-VS-3240203$TEVA$$74$YR$$M$Y$$$20240910$$MD$FR$FR
243041021$24304102$1$I$20240714$20240902$20240910$20240910$EXP$IT-MINISAL02-1000056$IT-TEVA-VS-3239500$TEVA$$40$YR$$F$Y$$$20240910$$PH$IT$IT
243041031$24304103$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260498$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240910$$HP$US$US
243041051$24304105$1$I$$20240905$20240910$20240910$PER$$US-ABBVIE-5909840$ABBVIE$$$$$M$Y$$$20240910$$MD$US$US
243041062$24304106$2$F$20090101$20240906$20240910$20240912$EXP$$CO-LUNDBECK-DKLU4004096$LUNDBECK$$$$$$Y$$$20240912$$CN$CO$CO
243041071$24304107$1$I$$20240909$20240910$20240910$PER$$US-PFIZER INC-202400252918$PFIZER$$61$YR$$F$Y$$$20240910$$MD$US$US
243041081$24304108$1$I$20240909$20240909$20240909$20240909$DIR$717692$$FDA-CTU$$77$YR$$M$N$152.4$KG$20240909$N$PH$US$
243041091$24304109$1$I$$20240904$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141117$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240910$$CN$US$US
243041101$24304110$1$I$$20240909$20240910$20240910$PER$$US-PFIZER INC-202400253088$PFIZER$$71$YR$$F$Y$$$20240910$$MD$US$US
243041111$24304111$1$I$$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143592$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240910$$CN$US$US
243041122$24304112$2$F$$20240910$20240910$20240913$PER$$US-PFIZER INC-202400253182$PFIZER$$$$$F$Y$$$20240913$$CN$US$US
243041131$24304113$1$I$20240701$20240904$20240910$20240910$EXP$$NVSC2024KW179644$NOVARTIS$$59$YR$$M$Y$$$20240910$$CN$KW$KW
243041141$24304114$1$I$$20240910$20240910$20240910$PER$$NVSC2024US181237$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243041152$24304115$2$F$20240301$20240903$20240910$20240913$EXP$$CL-009507513-2409CHL003180$MERCK$$$$A$F$Y$$$20240913$$CN$CL$CL
243041161$24304116$1$I$$20240823$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008916$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243041172$24304117$2$F$$20240918$20240910$20240923$30DAY$$US-MYLANLABS-2024M1081285$MYLAN$$$$$F$Y$$$20240923$$CN$US$US
243041181$24304118$1$I$$20240823$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008913$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243041191$24304119$1$I$20240801$20240909$20240910$20240910$PER$$US-JNJFOC-20240921521$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$CN$US$US
243041201$24304120$1$I$$20240823$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008911$INCYTE$$$$$$Y$$$20240910$$MD$US$US
243041211$24304121$1$I$$20240903$20240910$20240910$PER$$US-SA-2024SA258358$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240910$$MD$US$US
243041221$24304122$1$I$20220101$20240829$20240910$20240910$EXP$$JP-009507513-2208JPN003559J$MERCK$$65$YR$$M$Y$$$20240910$$MD$JP$JP
243041231$24304123$1$I$$20240830$20240910$20240910$EXP$$CA-ROCHE-10000071052$ROCHE$$43$YR$A$F$Y$96$KG$20240910$$HP$CA$CA
243041241$24304124$1$I$20240830$20240906$20240910$20240910$EXP$$US-ABBVIE-5915596$ABBVIE$$72$YR$$M$Y$$$20240910$$HP$US$US
243041252$24304125$2$F$$20240906$20240910$20240912$EXP$$US-PFIZER INC-PV202400117205$PFIZER$Shnider, S.. High fetal blood levels of mepivacaine and fetal bradycardia. The New England Journal of Medicine. 1968;279(17):947-948$$$$$Y$$$20240912$$MD$US$US
243041261$24304126$1$I$$20240823$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008910$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243041271$24304127$1$I$20201022$20240903$20240910$20240910$EXP$PL-URPL-1-3588-2020$PL-TEVA-VS-3240036$TEVA$$77$YR$$M$Y$65$KG$20240910$$MD$PL$PL
243041291$24304129$1$I$20230601$20240904$20240910$20240910$EXP$$US-ABBVIE-5908987$ABBVIE$$63$YR$$F$Y$$$20240910$$CN$US$US
243041303$24304130$3$F$$20240916$20240910$20240920$EXP$$US-INCYTE CORPORATION-2024IN008888$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243041311$24304131$1$I$$20240905$20240910$20240910$EXP$$DE-ABBVIE-5914893$ABBVIE$$73$YR$$$Y$$$20240910$$MD$DE$DE
243041322$24304132$2$F$$20240905$20240910$20240927$PER$$US-Eisai-EC-2024-172125$EISAI$$58$YR$A$M$Y$$$20240927$$CN$US$US
243041341$24304134$1$I$$20240904$20240910$20240910$EXP$$US-BEH-2024178303$CSL BEHRING$$$$E$M$Y$99.773$KG$20240910$$CN$US$US
243041351$24304135$1$I$20240801$20240822$20240910$20240910$PER$$US-TEVA-VS-3237349$TEVA$$44$YR$$M$Y$$$20240910$$CN$US$US
243041361$24304136$1$I$$20240909$20240910$20240910$EXP$$PT-SANDOZ INC.-SDZ2024PT078536$SANDOZ$$23$YR$$F$Y$$$20240910$$HP$PT$PT
243041371$24304137$1$I$$20240822$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008842$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243041381$24304138$1$I$$20240909$20240910$20240910$EXP$$US-GILEAD-2024-0687100$GILEAD$$74$YR$E$$Y$$$20240910$$CN$US$US
243041391$24304139$1$I$$20240906$20240910$20240910$30DAY$$CO-PFIZER INC-202400252982$PFIZER$$$$$$Y$$$20240910$$CN$CO$CO
243041403$24304140$3$F$20240903$20240909$20240910$20240912$30DAY$$CO-PFIZER INC-PV202400116546$PFIZER$$14$YR$$M$Y$$$20240912$$CN$CO$CO
243041411$24304141$1$I$20240826$20240904$20240910$20240910$30DAY$$DE-PFIZER INC-202400249932$PFIZER$$$$$F$Y$$$20240910$$MD$DE$DE
243041423$24304142$3$F$$20240917$20240910$20240918$30DAY$$IT-PFIZER INC-PV202400113130$PFIZER$$$$$$Y$$$20240918$$PH$IT$IT
243041441$24304144$1$I$20240623$20240906$20240910$20240910$EXP$$US-AstraZeneca-2024A204571$ASTRAZENECA$$$$$F$Y$$$20240910$$CN$US$
243041451$24304145$1$I$$20240907$20240910$20240910$EXP$$IR-AstraZeneca-2024A203764$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$M$Y$$$20240910$$MD$IR$
243041461$24304146$1$I$20240822$20240822$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008838$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243041471$24304147$1$I$$20240828$20240910$20240910$30DAY$$CO-PFIZER INC-PV202400113832$PFIZER$$13$YR$$M$Y$$$20240910$$CN$CO$CO
243041481$24304148$1$I$$20240907$20240910$20240910$EXP$$GB-AstraZeneca-2024A203761$ASTRAZENECA$Katis G.;  Srinivasan S.;  Eleftheriou P.;  Walker M.;  Demetriades P.. Characterizing left ventricular systolic dysfunction in sickle cell disease: three contrasting case reports. European Heart Journal - Case Reports 2024;8(8):$52$YR$$M$Y$$$20240910$$HP$GB$
243041501$24304150$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143256$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240910$$CN$US$US
243041522$24304152$2$F$$20240912$20240910$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143818$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240916$$CN$US$US
243041531$24304153$1$I$20240908$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005552$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240910$$PH$US$US
243041541$24304154$1$I$20240701$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005432$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240910$$CN$US$US
243041551$24304155$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005408$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240910$$CN$US$US
243041561$24304156$1$I$$20240909$20240910$20240910$EXP$DE-EMA-DD-20240904-7482689-080928$DE-SANDOZ INC.-SDZ2024DE078842$SANDOZ$$11$YR$$M$Y$$$20240910$$HP$DE$DE
243041571$24304157$1$I$$20240822$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008834$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243041581$24304158$1$I$$20240823$20240910$20240910$PER$$US-BIOMARINAP-US-2024-160099$BIOMARIN$$$$$$Y$$$20240910$$CN$US$US
243041601$24304160$1$I$$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024180233$AMGEN$$$$$M$Y$$$20240910$$CN$US$US
243041611$24304161$1$I$$20240909$20240910$20240910$EXP$$NVSC2024ET181073$NOVARTIS$$$$$M$Y$$$20240910$$MD$ET$ET
243041621$24304162$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259683$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240910$$HP$US$US
243041631$24304163$1$I$$20240905$20240910$20240910$EXP$$CA-MYLANLABS-2024M1081880$MYLAN$$1$DY$$M$Y$3$KG$20240910$$HP$CA$CA
243041641$24304164$1$I$20240823$20240906$20240910$20240910$EXP$$US-BAYER-2024A128347$BAYER$$26$YR$A$M$Y$$$20240910$$CN$US$US
243041651$24304165$1$I$$20240906$20240910$20240910$EXP$GB-MHRA-MED-202409051523172920-TYMHB$GB-PFIZER INC-202400251581$PFIZER$$69$YR$$F$Y$78$KG$20240910$$CN$GB$GB
243041661$24304166$1$I$20230115$20240909$20240910$20240910$EXP$FR-AFSSAPS-PC2024000698$FR-PFIZER INC-202400252524$PFIZER$$74$YR$$M$Y$78$KG$20240910$$PH$FR$FR
243041671$24304167$1$I$20240816$20240906$20240910$20240910$EXP$$US-PFIZER INC-PV202400118255$PFIZER$$90$YR$$M$Y$$$20240910$$HP$US$US
243041691$24304169$1$I$20240819$20240909$20240910$20240910$EXP$FR-AFSSAPS-NC2024001059$FR-DSJP-DSE-2024-144268$DAIICHI$$77$YR$$F$Y$39.1$KG$20240910$$HP$FR$FR
243041701$24304170$1$I$$20240909$20240910$20240910$EXP$$ES-SANDOZ INC.-SDZ2024ES078754$SANDOZ$$32$YR$$M$Y$$$20240910$$HP$ES$ES
243041731$24304173$1$I$20240909$20240910$20240910$20240910$DIR$717803$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243041742$24304174$2$F$20240828$20240912$20240910$20240918$PER$$US-RDY-SPO/USA/24/0013004$DR REDDYS$$18$YR$A$F$Y$$$20240918$$CN$US$US
243041751$24304175$1$I$$20240909$20240909$20240909$DIR$717740$$FDA-CTU$$$$$UNK$N$$$20240909$$CN$US$
243041761$24304176$1$I$20240528$20240906$20240910$20240910$EXP$FR-AFSSAPS-DJ2024000934$FR-MYLANLABS-2024M1081851$MYLAN$$51$YR$$M$Y$65$KG$20240910$$MD$FR$FR
243041771$24304177$1$I$$20240905$20240910$20240910$EXP$$CA-MYLANLABS-202101565357$MYLAN$$59$YR$$F$Y$$$20240910$$HP$CA$CA
243041782$24304178$2$F$20240101$20240912$20240910$20240916$EXP$$US-ORGANON-O2409USA000558$ORGANON$$$$$F$Y$$$20240916$$MD$US$US
243041791$24304179$1$I$20240101$20240821$20240910$20240910$PER$$US-SA-2024SA259906$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240910$$MD$US$US
243041801$24304180$1$I$$20240906$20240910$20240910$PER$$US-JNJFOC-20240915710$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
243041811$24304181$1$I$$20240904$20240910$20240910$EXP$$BR-TAKEDA-2024TUS089568$TAKEDA$$$$$F$Y$65$KG$20240910$$CN$BR$BR
243041821$24304182$1$I$$20240906$20240910$20240910$EXP$$US-TAKEDA-2024TUS064724$TAKEDA$$$$$F$Y$$$20240910$$MD$US$US
243041831$24304183$1$I$$20240905$20240910$20240910$EXP$$AR-BIOMARINAP-AR-2024-160445$BIOMARIN$$$$$$Y$$$20240910$$CN$AR$AR
243041841$24304184$1$I$$20240909$20240910$20240910$PER$$US-PFIZER INC-PV202400118628$PFIZER$$47$YR$$F$Y$$$20240910$$CN$US$US
243041861$24304186$1$I$20240903$20240904$20240910$20240910$PER$$US-AMGEN-USASP2024177095$AMGEN$$$$$$Y$$$20240910$$PH$US$US
243041871$24304187$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143531$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240910$$CN$US$US
243041891$24304189$1$I$20240902$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143537$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240910$$HP$US$US
243041901$24304190$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143576$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240910$$CN$US$US
243041911$24304191$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143553$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240910$$CN$US$US
243041921$24304192$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143371$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240910$$CN$US$US
243041931$24304193$1$I$20240905$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142982$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$59.42$KG$20240910$$HP$US$US
243041941$24304194$1$I$20240906$20240906$20240910$20240910$PER$$US-ALXN-202409USA000532US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243041951$24304195$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181230$NOVARTIS$$$$$F$Y$58$KG$20240910$$CN$US$US
243041961$24304196$1$I$$20240907$20240910$20240910$EXP$$US-TAKEDA-2024TUS054137$TAKEDA$$$$$F$Y$102.07$KG$20240910$$MD$US$US
243041971$24304197$1$I$$20240906$20240910$20240910$PER$$US-JNJFOC-20240917983$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
243042001$24304200$1$I$20240701$20240711$20240910$20240910$EXP$$GB-TEVA-VS-3230263$TEVA$$37$YR$$M$Y$89$KG$20240910$$CN$GB$GB
243042011$24304201$1$I$20240901$20240904$20240910$20240910$PER$$US-ALKERMES INC.-ALK-2024-002311$ALKERMES$$34$YR$$F$Y$58.957$KG$20240910$$CN$US$US
243042023$24304202$3$F$20240101$20240916$20240910$20240923$PER$$US-ABBVIE-5914455$ABBVIE$$$$$F$Y$75$KG$20240923$$CN$US$US
243042031$24304203$1$I$$20240903$20240910$20240910$EXP$NL-LRB-00999240$NL-TEVA-VS-3240215$TEVA$$61$YR$$M$Y$78$KG$20240910$$MD$NL$NL
243042041$24304204$1$I$$20240907$20240910$20240910$EXP$$IR-AstraZeneca-2024A203765$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$M$Y$$$20240910$$MD$IR$
243042051$24304205$1$I$$20240906$20240910$20240910$EXP$$LB-PFIZER INC-PV202400117317$PFIZER$Al Jassem, O.. A rare case of systemic lupus erythematosus-associated neuromyelitis optica spectrum disorder with cystic lesions and dual seropositivity for anti-AQP4 and anti-MOG antibodies. Clinical Case Reports. 2024;12:10.1002/ccr3.9063$19$YR$$F$Y$$$20240910$$HP$LB$LB
243042061$24304206$1$I$20240809$20240904$20240910$20240910$EXP$IT-MINISAL02-1000254$IT-TEVA-VS-3240494$TEVA$$51$YR$$M$Y$$$20240910$$MD$IT$IT
243042071$24304207$1$I$$20240909$20240909$20240909$DIR$717729$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
243042081$24304208$1$I$20240901$20240901$20240910$20240910$EXP$GB-MHRA-MED-202409011154434140-JTGLQ$GB-TEVA-VS-3239223$TEVA$$39$YR$$F$Y$$$20240910$$CN$GB$GB
243042101$24304210$1$I$20240909$20240909$20240910$20240910$EXP$$AU-GILEAD-2024-0687107$GILEAD$$$$$F$Y$$$20240910$$MD$AU$AU
243042111$24304211$1$I$20240814$20240902$20240910$20240910$EXP$$GB-TEVA-VS-3239547$TEVA$$77$YR$$F$Y$74$KG$20240910$$MD$GB$GB
243042121$24304212$1$I$$20240829$20240910$20240910$PER$$US-ABBVIE-5905499$ABBVIE$$$$$$Y$$$20240910$$HP$US$US
243042131$24304213$1$I$20240901$20240902$20240910$20240910$EXP$GB-MHRA-MED-202409021438380780-JMKWT$GB-TEVA-VS-3239952$TEVA$$$$$$Y$$$20240910$$PH$GB$GB
243042151$24304215$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143791$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240910$$CN$US$US
243042161$24304216$1$I$$20240907$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142909$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$65.77$KG$20240910$$CN$US$US
243042171$24304217$1$I$20240810$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142056$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$90.72$KG$20240910$$HP$US$US
243042182$24304218$2$F$$20240913$20240910$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143911$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240920$$MD$JP$JP
243042191$24304219$1$I$$20240909$20240910$20240910$PER$$US-HALEON-2196088$Haleon PLC$$$$$$Y$$$20240910$$CN$US$US
243042201$24304220$1$I$20240801$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004737$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240910$$CN$US$US
243042211$24304221$1$I$$20240829$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409000703$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240910$$CN$US$US
243042235$24304223$5$F$20240906$20240918$20240910$20240924$EXP$$NVSC2024ZA179929$NOVARTIS$$56$YR$$F$Y$$$20240925$$HP$ZA$ZA
243042242$24304224$2$F$$20240909$20240910$20240912$EXP$$NVSC2024US180562$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
243042251$24304225$1$I$$20240901$20240910$20240910$EXP$$RU-JNJFOC-20240907625$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$HP$RU$RU
243042261$24304226$1$I$$20240906$20240910$20240910$PER$$US-JNJFOC-20240915514$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$MD$US$US
243042272$24304227$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686792$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042281$24304228$1$I$20230929$20240829$20240910$20240910$EXP$$DE-ROCHE-10000070540$ROCHE$$64$YR$A$F$Y$$$20240910$$MD$DE$DE
243042292$24304229$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686795$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042302$24304230$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686793$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042312$24304231$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686796$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042342$24304234$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686797$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042351$24304235$1$I$$20240830$20240910$20240910$PER$$US-SA-2024SA260374$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240910$$MD$US$US
243042361$24304236$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA259427$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240910$$HP$US$US
243042371$24304237$1$I$$20240906$20240910$20240910$30DAY$$CO-PFIZER INC-PV202400118088$PFIZER$$$$$$Y$$$20240910$$CN$CO$CO
243042381$24304238$1$I$20240701$20240905$20240910$20240910$EXP$$CN-KYOWAKIRIN-2024KK020945$KYOWA$$$$$$Y$$$20240910$$HP$FI$CN
243042391$24304239$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142057$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240910$$CN$US$US
243042401$24304240$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143068$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240910$$CN$US$US
243042411$24304241$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143464$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240910$$CN$US$US
243042421$24304242$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141789$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240910$$HP$US$US
243042431$24304243$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143817$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240910$$CN$US$US
243042441$24304244$1$I$$20240906$20240910$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143763$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240910$$MD$JP$JP
243042451$24304245$1$I$20240726$20240909$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143778$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240910$$HP$US$US
243042461$24304246$1$I$20240726$20240904$20240910$20240910$EXP$FR-AFSSAPS-MA2024001287$FR-MYLANLABS-2024M1081123$MYLAN$$18$YR$$F$Y$$$20240910$$MD$FR$FR
243042472$24304247$2$F$20240501$20240905$20240910$20240913$EXP$$CO-ABBVIE-5909374$ABBVIE$$82$YR$$M$Y$70$KG$20240913$$HP$CO$CO
243042482$24304248$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686798$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042491$24304249$1$I$20240908$20240908$20240910$20240910$EXP$GB-MHRA-MED-202409080943162840-KPYTM$GB-ABBVIE-5915695$ABBVIE$$54$YR$$M$Y$$$20240910$$MD$GB$GB
243042501$24304250$1$I$$20240905$20240910$20240910$EXP$$MY-FOUNDATIONCONSUMERHC-2024-MY-000019$FOUNDATION CONSUMER HEALTHCARE$Weeraj C, Kannan B..Mesenteric Ischemia in a Patient on Levonorgestrel Containing Oral Contraception..Journal of Obstetrical Gynecology of Canada.2024;46(10):01-02.$44$YR$$F$Y$$$20240910$$CN$MY$MY
243042511$24304251$1$I$20240626$20240905$20240910$20240910$EXP$$GB-KYOWA KIRIN , INC.-2024KK019303$KYOWA$$$$$$Y$$$20240910$$HP$GB$GB
243042521$24304252$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260547$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240910$$MD$US$US
243042531$24304253$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA259890$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240910$$HP$US$US
243042542$24304254$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686799$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042551$24304255$1$I$$20240906$20240910$20240910$PER$$US-ABBVIE-5915227$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243042561$24304256$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260513$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240910$$MD$US$US
243042571$24304257$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181215$NOVARTIS$$$$$$Y$$$20240910$$HP$US$US
243042582$24304258$2$F$$20240911$20240910$20240916$EXP$$TN-PFIZER INC-PV202400117641$PFIZER$Boussaa, H.. Tofacitinib-Induced Acute Pancreatitis in a Patient with Rheumatoid Arthritis: A Case Report and Review of the Literature. Current Drug Safety. 2024;10.2174/0115748863300565240819$58$YR$$F$Y$$$20240916$$HP$TN$TN
243042591$24304259$1$I$$20240906$20240910$20240910$EXP$$HR-PFIZER INC-PV202400117551$PFIZER$Kranjcec, I.. Pharmacogenetic profiling of paediatric oncology patients: a single-centre experience. Paediatria Croatica. 2024;68(2):55-64$41$MON$$F$Y$$$20240910$$HP$HR$HR
243042601$24304260$1$I$$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024179305$AMGEN$$$$$$Y$$$20240910$$CN$US$US
243042611$24304261$1$I$$20240909$20240910$20240910$PER$$US-AMGEN-USASP2024180205$AMGEN$$$$$$Y$$$20240910$$CN$US$US
243042621$24304262$1$I$20240816$20240905$20240910$20240910$EXP$$US-CHIESI USA, INC.-2024CHF05756$CHIESI$$14$YR$$M$Y$$$20240910$$CN$US$US
243042632$24304263$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686800$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042641$24304264$1$I$20240907$20240909$20240910$20240910$PER$$US-JNJFOC-20240920612$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
243042652$24304265$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686802$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042662$24304266$2$F$20240820$20240905$20240910$20240919$EXP$$MX-ROCHE-10000076147$ROCHE$$64$YR$A$M$Y$77$KG$20240919$$MD$MX$MX
243042672$24304267$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0686801$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042682$24304268$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686803$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042692$24304269$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686804$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042701$24304270$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143816$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240910$$CN$US$US
243042711$24304271$1$I$20240819$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143440$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240910$$PH$US$US
243042721$24304272$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143768$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240910$$HP$US$US
243042731$24304273$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143971$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240910$$CN$US$US
243042751$24304275$1$I$20220701$20240829$20240910$20240910$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409004993$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240910$$CN$DE$GB
243042762$24304276$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686805$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042772$24304277$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686806$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042781$24304278$1$I$$20240828$20240910$20240910$EXP$$US-SA-2024SA258781$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240910$$CN$US$US
243042791$24304279$1$I$20240101$20240909$20240910$20240910$EXP$$US-KYOWAKIRIN-2024KK021024$KYOWA$$$$$$Y$$$20240910$$HP$US$US
243042802$24304280$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0686811$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243042811$24304281$1$I$$20240530$20240910$20240910$EXP$$US-TEVA-VS-3205810$TEVA$$63$YR$$F$Y$$$20240910$$CN$US$US
243042821$24304282$1$I$20231113$20240909$20240910$20240910$EXP$$DE-BAUSCH-BL-2024-013425$BAUSCH AND LOMB$$$$A$M$Y$$$20240910$$MD$DE$DE
243042831$24304283$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000497US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243042841$24304284$1$I$$20240909$20240910$20240910$PER$$US-ALXN-202409USA000549US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240910$$CN$US$US
243042851$24304285$1$I$$20240821$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008828$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243042861$24304286$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA259425$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240910$$CN$US$US
243042871$24304287$1$I$$20240829$20240910$20240910$PER$$US-SA-2024SA260891$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240910$$HP$US$US
243042881$24304288$1$I$20240828$20240901$20240910$20240910$EXP$GB-MHRA-MED-202409012341419180-JYGZV$GB-TEVA-VS-3239599$TEVA$$27$YR$$F$Y$57$KG$20240910$$CN$GB$GB
243042891$24304289$1$I$20240601$20240909$20240909$20240909$DIR$717709$$FDA-CTU$$$$$F$N$$$20240909$N$CN$US$
243042901$24304290$1$I$20221214$20240902$20240910$20240910$EXP$GB-MHRA-MED-202409022337012260-DSBLJ$GB-TEVA-VS-3240038$TEVA$$29$YR$$M$Y$$$20240910$$CN$GB$GB
243042911$24304291$1$I$$20240821$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008827$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243042921$24304292$1$I$20240815$20240905$20240910$20240910$EXP$$US-ABBVIE-5902429$ABBVIE$$53$YR$$F$Y$$$20240910$$CN$US$US
243042931$24304293$1$I$20240601$20240909$20240909$20240909$DIR$717709$$FDA-CTU$$$$$F$N$$$20240909$N$CN$US$
243042941$24304294$1$I$20180216$20240328$20240910$20240910$EXP$$PHHY2018TR031814$NOVARTIS$$34$YR$$M$Y$$$20240910$$CN$TR$TR
243042951$24304295$1$I$20240101$20240830$20240910$20240910$PER$$US-ABBVIE-5903427$ABBVIE$$$$$M$Y$90.718$KG$20240910$$CN$US$US
243042961$24304296$1$I$20240801$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141984$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240910$$HP$US$US
243042971$24304297$1$I$20240801$20240903$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140877$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240910$$CN$US$US
243042981$24304298$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141756$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240910$$CN$US$US
243042991$24304299$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143590$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$81.19$KG$20240910$$CN$US$US
243043001$24304300$1$I$$20240821$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008780$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243043011$24304301$1$I$$20240821$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008778$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243043021$24304302$1$I$20240705$20240807$20240910$20240910$EXP$$NVSC2024CN162434$NOVARTIS$$71$YR$$M$Y$65$KG$20240910$$HP$CN$CN
243043031$24304303$1$I$$20240830$20240910$20240910$PER$$US-ABBVIE-5905918$ABBVIE$$$$$$Y$$$20240910$$HP$US$US
243043041$24304304$1$I$$20240830$20240910$20240910$PER$$US-ABBVIE-5906771$ABBVIE$$$$$$Y$$$20240910$$HP$US$US
243043062$24304306$2$F$20240601$20240910$20240910$20240913$EXP$$US-KYOWAKIRIN-2024KK021039$KYOWA$$$$$$Y$$$20240913$$HP$US$US
243043071$24304307$1$I$20220801$20240909$20240910$20240910$EXP$$ES-PFIZER INC-202400252541$PFIZER$$66$YR$$M$Y$$$20240910$$MD$ES$ES
243043081$24304308$1$I$$20240906$20240910$20240910$EXP$$HR-PFIZER INC-202400252085$PFIZER$Kranjcec, I.. Pharmacogenetic profiling of paediatric oncology patients: a single-centre experience. Paediatria Croatica. 2024;68(2):55-64$4$MON$$F$Y$$$20240910$$HP$HR$HR
243043091$24304309$1$I$$20240906$20240910$20240910$EXP$$GB-PFIZER INC-202400252631$PFIZER$Hall, R.. Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin^s lymphoma, complicated by anthracycline-induced cardiomyopathy.. BMJ-Case-Rep. 2024;17(8)$3$DEC$$F$Y$$$20240910$$HP$GB$GB
243043101$24304310$1$I$20240701$20240909$20240910$20240910$EXP$IT-MINISAL02-1001172$IT-PFIZER INC-202400252439$PFIZER$$77$YR$$M$Y$$$20240910$$MD$IT$IT
243043111$24304311$1$I$$20240909$20240910$20240910$EXP$GB-MHRA-MED-202409071112464930-LVPWQ$GB-PFIZER INC-202400252636$PFIZER$$62$YR$$F$Y$78$KG$20240910$$CN$GB$GB
243043131$24304313$1$I$$20240819$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144153$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$81.01$KG$20240910$$CN$US$US
243043141$24304314$1$I$$20240902$20240910$20240910$EXP$$NVSC2024DE181015$NOVARTIS$McMullen L, Khoo L, Anderson L, Strasser S, Gracey DM. BK viraemia as a cause of anaemia in after ABO-incompatible liver transplant: a case report.. BMC INFECTIOUS DISEASES. 2023;23(1):609$59$YR$$M$Y$$$20240910$$HP$DE$DE
243043151$24304315$1$I$20240801$20240831$20240910$20240910$PER$$US-SA-2024SA260563$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240910$$MD$US$US
243043161$24304316$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA260271$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240910$$MD$US$US
243043171$24304317$1$I$$20240905$20240910$20240910$PER$$NVSC2024US179269$NOVARTIS$$$$$M$Y$$$20240910$$CN$US$US
243043181$24304318$1$I$$20240904$20240910$20240910$PER$$US-AstraZeneca-2024A201576$ASTRAZENECA$$$$$$Y$$$20240910$$CN$US$
243043191$24304319$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143520$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240910$$CN$US$US
243043201$24304320$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004591$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240910$$CN$US$US
243043212$24304321$2$F$$20240904$20240910$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002952$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240916$$CN$US$US
243043222$24304322$2$F$20240903$20240905$20240910$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002970$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240917$$CN$US$US
243043231$24304323$1$I$20240906$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004573$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240910$$CN$US$US
243043242$24304324$2$F$20240701$20240913$20240910$20240925$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000524$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240925$$CN$US$US
243043251$24304325$1$I$$20240906$20240910$20240910$PER$$US-ROCHE-10000076832$ROCHE$$$$E$M$Y$$$20240910$$HP$US$US
243043261$24304326$1$I$$20240909$20240909$20240909$DIR$717736$$FDA-CTU$$$$$UNK$N$$$20240909$$CN$US$
243043271$24304327$1$I$$20240909$20240909$20240909$DIR$717744$$FDA-CTU$$$$$UNK$N$$$20240909$$CN$US$
243043281$24304328$1$I$20231223$20240906$20240910$20240910$EXP$$NVSC2024DE180598$NOVARTIS$$$$A$M$Y$$$20240910$$MD$DE$DE
243043291$24304329$1$I$$20240906$20240910$20240910$EXP$$SA-PFIZER INC-PV202400117520$PFIZER$Al-Shamrani, A.. A Niemann-Pick Disease Type C2 with Severe Pulmonary Involvement and Limited Therapeutic Options: A Case Report. Children-(Basel). 2022;9No.12$3$YR$$M$Y$$$20240910$$HP$SA$SA
243043301$24304330$1$I$$20240903$20240910$20240910$EXP$$IT-MYLANLABS-2024M1082209$MYLAN$De Zen L, Divisic A, Molinaro G, Solidoro S, Barbi E. Dexmedetomidine at Home for Intractable Dystonia and Insomnia in Children With Special Needs: A Case Series. J-Pain-Symptom-Manage 2023; 66 (6): e653-e657.$$$$F$Y$$$20240910$$HP$IT$IT
243043321$24304332$1$I$$20240909$20240910$20240910$PER$$US-ALXN-202409USA000536US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243043332$24304333$2$F$$20240917$20240910$20240926$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03258$AMNEAL$$$$$$Y$$$20240926$$CN$US$US
243043341$24304334$1$I$20240101$20240705$20240910$20240910$EXP$$US-LUNDBECK-DKLU4004045$LUNDBECK$$$$$$Y$$$20240910$$CN$US$US
243043352$24304335$2$F$20230101$20240826$20240910$20240910$EXP$$US-ASTELLAS-2024-AER-005521$ASTELLAS$$$$$M$Y$$$20240910$$CN$US$US
243043371$24304337$1$I$$20240905$20240910$20240910$EXP$$NL-MYLANLABS-2024M1082264$MYLAN$Klingenberg MG, Sinkeler SJ, Koopmans N, Plaat RE. Severe hypotension requiring resuscitation in tumour-related carotid sinus syndrome: a case report. Eur-Heart-J-Case-Rep 2024; 8 (8):.$57$YR$$F$Y$$$20240910$$HP$NL$NL
243043383$24304338$3$F$20240901$20240917$20240910$20240918$PER$$US-AMGEN-USASP2024180149$AMGEN$$83$YR$E$F$Y$$$20240918$$CN$US$US
243043391$24304339$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144164$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240910$$CN$US$US
243043471$24304347$1$I$$20240903$20240910$20240910$EXP$$IN-MYLANLABS-2024M1081795$MYLAN$Mukartihal R, Das R, Krishna B, Patil S. Aspergillus hip arthritis in COVID-19 era: Two case reports. J-Arthrosc-Joint-Surg 2023; 10 (1): 29-35.$74$YR$$M$Y$$$20240910$$MD$IN$IN
243043481$24304348$1$I$$20240828$20240910$20240910$EXP$$US-LNK INTERNATIONAL, INC.-2161445$LNK INTERNATIONAL$$$$$F$Y$$$20240910$$$US$US
243043491$24304349$1$I$$20240716$20240910$20240910$PER$$US-LUNDBECK-DKLU4004046$LUNDBECK$$$$$$Y$$$20240910$$CN$US$US
243043501$24304350$1$I$$20240828$20240910$20240910$EXP$$US-B.Braun Medical Inc.-2161446$B BRAUN$Literature Article$25$YR$$M$Y$$$20240910$$$US$US
243043511$24304351$1$I$$20240903$20240910$20240910$PER$$US-Mission Pharmacal Company-2161444$MISSION$$67$YR$$M$Y$$$20240910$$$US$US
243043521$24304352$1$I$$20240903$20240910$20240910$PER$$US-Mission Pharmacal Company-2161443$MISSION$$67$YR$$M$Y$$$20240910$$$US$US
243043531$24304353$1$I$$20240820$20240910$20240910$EXP$$US-CBFLEET-202408-US-002811$CB FLEET$$$$$F$Y$$$20240910$$CN$US$US
243043541$24304354$1$I$20240701$20240901$20240910$20240910$EXP$$GB-TEVA-VS-3239595$TEVA$$56$YR$$M$Y$12$KG$20240910$$CN$GB$GB
243043551$24304355$1$I$$20240902$20240910$20240910$EXP$GB-MHRA-MED-202409021643037420-RKBCQ$GB-TEVA-VS-3239403$TEVA$$$$$M$Y$$$20240910$$PH$GB$GB
243043561$24304356$1$I$20240819$20240902$20240910$20240910$EXP$GB-MHRA-MED-202409021357227910-DKPCY$GB-TEVA-VS-3239632$TEVA$$73$YR$$M$Y$$$20240910$$HP$GB$GB
243043581$24304358$1$I$20240823$20240902$20240910$20240910$EXP$GB-MHRA-MED-202409021025240390-QJSFV$GB-TEVA-VS-3239607$TEVA$$43$YR$$F$Y$54$KG$20240910$$CN$GB$GB
243043591$24304359$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000445US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240910$$CN$US$US
243043601$24304360$1$I$20240830$20240830$20240910$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-140977$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240910$$CN$JP$JP
243043611$24304361$1$I$$20240906$20240910$20240910$EXP$$PL-PURDUE-USA-2024-0311889$PURDUE$Klimaszyk D, Klimaszyk S. Fentanyl and other opioid poisoning. Medycyna Praktyczna. 2024;7-8:81-85,100$60$YR$$M$Y$$$20240910$$HP$PL$PL
243043621$24304362$1$I$20240901$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143642$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$48.99$KG$20240910$$CN$US$US
243043651$24304365$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004651$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240910$$CN$US$US
243043661$24304366$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004749$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240910$$CN$US$US
243043671$24304367$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004723$ELI LILLY AND CO$$15$YR$T$F$Y$$$20240910$$CN$US$US
243043681$24304368$1$I$$20240904$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2024US078963$SANDOZ$$$$$F$Y$$$20240910$$CN$US$US
243043691$24304369$1$I$20240830$20240909$20240910$20240910$EXP$$US-GILEAD-2024-0687094$GILEAD$$64$YR$A$M$Y$$$20240910$$MD$US$US
243043721$24304372$1$I$$20240903$20240910$20240910$PER$$US-PURDUE-USA-2024-0311869$PURDUE$$$$$$Y$$$20240910$$CN$US$US
243043731$24304373$1$I$20220101$20240907$20240910$20240910$PER$$US-PURDUE PHARMA-USA-2024-0311874$PURDUE$$$$$M$Y$$$20240910$$CN$US$US
243043742$24304374$2$F$20240815$20240924$20240910$20240925$PER$$US-PURDUE PHARMA-USA-2024-0311877$PURDUE$$$$$F$Y$$$20240925$$CN$US$US
243043751$24304375$1$I$$20240907$20240910$20240910$PER$$US-PURDUE PHARMA-USA-2024-0311873$PURDUE$$$$$M$Y$$$20240910$$CN$US$US
243043761$24304376$1$I$$20240908$20240910$20240910$PER$$US-PURDUE PHARMA-USA-2024-0311867$PURDUE$$71$YR$$M$Y$$$20240910$$MD$US$US
243043771$24304377$1$I$$20240908$20240910$20240910$PER$$US-PURDUE PHARMA-USA-2024-0311868$PURDUE$$50$YR$$M$Y$$$20240910$$MD$US$US
243043781$24304378$1$I$$20240907$20240910$20240910$PER$$US-PURDUE PHARMA-USA-2024-0311870$PURDUE$$63$YR$$M$Y$$$20240910$$CN$US$US
243043791$24304379$1$I$$20240907$20240910$20240910$PER$$US-PURDUE PHARMA-USA-2024-0311895$PURDUE$$16$YR$$M$Y$$$20240910$$MD$US$US
243043801$24304380$1$I$$20240906$20240910$20240910$EXP$$HR-PFIZER INC-202400252083$PFIZER$Kranjcec, I.. Pharmacogenetic profiling of paediatric oncology patients: a single-centre experience. Paediatria Croatica. 2024;68(2):55-64$6$YR$$M$Y$$$20240910$$HP$HR$HR
243043811$24304381$1$I$$20240906$20240910$20240910$EXP$$HR-PFIZER INC-202400252079$PFIZER$Kranjcec, I.. Pharmacogenetic profiling of paediatric oncology patients: a single-centre experience. Paediatria Croatica. 2024;68 (2):55-64$17$YR$$F$Y$$$20240910$$HP$HR$HR
243043821$24304382$1$I$20240906$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62206$$FDA-CTU$$75$YR$$M$N$$$20240909$N$HP$US$
243043831$24304383$1$I$$20240910$20240910$20240910$DIR$717834$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243043841$24304384$1$I$20240909$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62198$$FDA-CTU$$41$YR$$F$N$44$KG$20240909$N$MD$US$
243043851$24304385$1$I$$20240910$20240910$20240910$DIR$717852$$FDA-CTU$$53$YR$$M$N$$$20240910$N$$US$
243043871$24304387$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62213$$FDA-CTU$$74$YR$$F$N$$$20240909$Y$PH$US$
243043891$24304389$1$I$20240331$20240910$20240910$20240910$DIR$717837$$FDA-CTU$$74$YR$$F$N$69.75$KG$20240910$N$CN$US$
243043901$24304390$1$I$$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62191$$FDA-CTU$$$$$$N$$$20240909$Y$PH$US$
243043911$24304391$1$I$20240830$20240902$20240910$20240910$EXP$$IT-APELLIS-2024-APL-0000951$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240910$$MD$IT$IT
243043921$24304392$1$I$$20240828$20240910$20240910$EXP$$IE-AMNEAL PHARMACEUTICALS-2024-AMRX-03275$AMNEAL$$50$YR$$F$Y$$$20240910$$HP$IE$IE
243043931$24304393$1$I$$20240902$20240910$20240910$EXP$$GB-TEVA-VS-3239636$TEVA$$44$YR$$F$Y$70$KG$20240910$$MD$GB$GB
243043941$24304394$1$I$$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143806$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240910$$CN$US$US
243043952$24304395$2$F$$20240906$20240910$20240919$EXP$$CN-B.Braun Medical Inc.-2161448$B BRAUN$Literature Article$53$YR$$M$Y$$$20240919$$$CN$CN
243043961$24304396$1$I$20240101$20240726$20240910$20240910$PER$$US-LUNDBECK-DKLU4004058$LUNDBECK$$$$$$Y$$$20240910$$CN$US$US
243043972$24304397$2$F$$20240920$20240910$20240924$EXP$$US-PFIZER INC-PV202400117203$PFIZER$Hersh, E.. Local anesthetic mortality: report of case. Journal of Dentistry for Children. 1991;58(6):489-491$5$YR$$F$Y$16.4$KG$20240924$$MD$US$US
243043981$24304398$1$I$20240101$20240830$20240910$20240910$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005030$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240910$$HP$US$US
243043991$24304399$1$I$$20240730$20240910$20240910$PER$$US-LUNDBECK-DKLU4002521$LUNDBECK$$$$$$Y$$$20240910$$CN$US$US
243044001$24304400$1$I$$20240902$20240910$20240910$EXP$$GB-TEVA-VS-3239654$TEVA$$48$YR$$M$Y$105$KG$20240910$$HP$GB$GB
243044011$24304401$1$I$$20240830$20240910$20240910$PER$$US-JNJFOC-20240916377$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$PH$US$US
243044021$24304402$1$I$$20240904$20240910$20240910$PER$$US-JNJFOC-20240911513$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
243044031$24304403$1$I$20240907$20240909$20240909$20240909$DIR$FDA-CDER-CTU-2024-62205$$FDA-CTU$$64$YR$$F$N$204$LBS$20240909$N$$US$
243044112$24304411$2$F$20240101$20240913$20240910$20240923$EXP$$JP-Eisai-EC-2024-166433$EISAI$Nakayama S. My experience with and considerations on Pem+LEN therapy.. Renal cell carcinoma seminar in Higashi-Harima..$77$YR$E$M$Y$$$20240923$$MD$JP$JP
243044121$24304412$1$I$$20240826$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008978$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243044131$24304413$1$I$$20240826$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008977$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243044141$24304414$1$I$20240801$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0687261$GILEAD$$30$YR$A$M$Y$$$20240910$$CN$US$US
243044151$24304415$1$I$$20240905$20240910$20240910$EXP$$US-ABBVIE-5909563$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243044161$24304416$1$I$$20240909$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143915$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240910$$CN$US$US
243044171$24304417$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005512$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240910$$CN$US$US
243044181$24304418$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005260$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240910$$CN$US$US
243044191$24304419$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005224$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240910$$CN$US$US
243044201$24304420$1$I$$20240826$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008967$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243044211$24304421$1$I$20240503$20240506$20240910$20240910$PER$$US-Armstrong Pharmaceuticals, Inc.-2161449$ARMSTRONG$$$$$F$Y$$$20240910$$$US$US
243044221$24304422$1$I$20240701$20240827$20240910$20240910$EXP$$US-MALLINCKRODT-MNK202405453$MALLINCKRODT$$54$YR$A$M$Y$$$20240910$$CN$US$US
243044231$24304423$1$I$$20240905$20240910$20240910$PER$$US-JNJFOC-20240917485$JOHNSON AND JOHNSON$$$$$M$Y$$$20240910$$MD$US$US
243044241$24304424$1$I$$20240815$20240910$20240910$PER$$US-009507513-2409USA003000$MERCK$$$$T$$Y$$$20240910$$MD$US$US
243044251$24304425$1$I$$20240815$20240910$20240910$PER$$US-009507513-2409USA002999$MERCK$$$$T$$Y$$$20240910$$MD$US$US
243044261$24304426$1$I$$20240826$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008965$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243044271$24304427$1$I$20240801$20240826$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008960$INCYTE$$$$$$Y$$$20240910$$PH$US$US
243044281$24304428$1$I$$20240504$20240910$20240910$PER$$US-Armstrong Pharmaceuticals, Inc.-2161450$ARMSTRONG$$$$$F$Y$$$20240910$$$US$US
243044291$24304429$1$I$20231106$20240903$20240910$20240910$PER$$JP-Eisai-EC-2024-173687$EISAI$$51$YR$A$F$Y$57$KG$20240910$$MD$JP$JP
243044301$24304430$1$I$20240902$20240905$20240910$20240910$PER$$JP-Eisai-EC-2024-173782$EISAI$$$$E$M$Y$$$20240910$$MD$JP$JP
243044311$24304431$1$I$20240731$20240814$20240910$20240910$PER$$US-INCYTE CORPORATION-2024IN008575$INCYTE$$$$$$Y$$$20240910$$CN$US$US
243044321$24304432$1$I$$20240910$20240910$20240910$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050513$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240910$$CN$IT$IT
243044331$24304433$1$I$20240829$20240903$20240910$20240910$EXP$$CA-HLS-202402214$HLS THERAPEUTICS$$82$YR$E$M$Y$$$20240910$$PH$CA$CA
243044341$24304434$1$I$20240711$20240910$20240910$20240910$DIR$717816$$FDA-CTU$$60$YR$$F$N$87.9$KG$20240910$N$HP$US$
243044351$24304435$1$I$$20240910$20240910$20240910$DIR$717827$$FDA-CTU$$52$YR$$F$N$$$20240910$N$$US$
243044371$24304437$1$I$20240901$20240906$20240910$20240910$PER$$US-KARYOPHARM-2024KPT001518$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240910$$CN$US$US
243044381$24304438$1$I$20240101$20240906$20240910$20240910$PER$$US-KARYOPHARM-2024KPT001520$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240910$$CN$US$US
243044401$24304440$1$I$20240713$20240909$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143320$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240910$$CN$US$US
243044411$24304441$1$I$$20240910$20240910$20240910$DIR$717806$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243044421$24304442$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141589$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240910$$CN$US$US
243044431$24304443$1$I$20240826$20240903$20240910$20240910$EXP$GB-MHRA-MED-202409030643105750-YWLCV$GB-TEVA-VS-3240043$TEVA$$59$YR$$F$Y$$$20240910$$CN$GB$GB
243044441$24304444$1$I$20240909$20240910$20240910$20240910$DIR$717841$$FDA-CTU$$39$YR$$F$N$84.3$KG$20240910$N$PH$US$
243044451$24304445$1$I$$20240906$20240910$20240910$PER$$US-JNJFOC-20240919647$JOHNSON AND JOHNSON$$$$$$Y$$$20240910$$CN$US$US
243044461$24304446$1$I$$20240904$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141497$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240910$$HP$US$US
243044471$24304447$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143099$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240910$$CN$US$US
243044481$24304448$1$I$20240906$20240908$20240910$20240910$EXP$GB-MHRA-MED-202409082126159870-KCFVT$GB-GILEAD-2024-0686736$GILEAD$$40$YR$A$M$Y$80$KG$20240910$$CN$GB$GB
243044491$24304449$1$I$20240201$20240905$20240910$20240910$EXP$$US-AstraZeneca-2024A202731$ASTRAZENECA$$890$MON$$F$Y$$$20240910$$CN$US$
243044501$24304450$1$I$$20240815$20240910$20240910$PER$$US-009507513-2409USA003001$MERCK$$$$T$$Y$$$20240910$$MD$US$US
243044511$24304451$1$I$$20240826$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202408016478$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240910$$CN$US$US
243044521$24304452$1$I$$20240910$20240910$20240910$DIR$717844$$FDA-CTU$$30$YR$$M$N$$$20240910$N$PH$US$
243044551$24304455$1$I$$20240906$20240910$20240910$PER$$US-ALXN-202409USA000537US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240910$$CN$US$US
243044561$24304456$1$I$20240904$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143128$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240910$$CN$US$US
243044571$24304457$1$I$$20240906$20240910$20240910$PER$$US-Mission Pharmacal Company-2161451$MISSION$$$$$F$Y$$$20240910$$$US$US
243044581$24304458$1$I$20240831$20240910$20240910$20240910$DIR$717832$$FDA-CTU$$67$YR$$M$N$100.35$KG$20240910$N$PH$US$
243044591$24304459$1$I$20240909$20240910$20240910$20240910$DIR$717797$$FDA-CTU$$22$YR$$M$N$112.5$KG$20240910$N$CN$AF$
243044601$24304460$1$I$$20240910$20240910$20240910$DIR$717835$$FDA-CTU$$$$$UNK$N$$$20240910$$CN$US$
243044611$24304461$1$I$20170510$20240910$20240910$20240910$DIR$717822$$FDA-CTU$$$$$F$N$$$20240910$N$CN$US$
243044621$24304462$1$I$20240909$20240910$20240910$20240910$DIR$717825$$FDA-CTU$$71$YR$$F$N$$$20240910$Y$PH$US$
243044631$24304463$1$I$$20240830$20240910$20240910$EXP$$GB-AstraZeneca-2024A205046$ASTRAZENECA$$$$C$$Y$$$20240910$$MD$GB$
243044641$24304464$1$I$$20240828$20240910$20240910$EXP$$US-Time-Cap Labs, Inc.-2161452$TIME CAPS$$$$$$Y$$$20240910$$$US$US
243044651$24304465$1$I$$20240909$20240910$20240910$EXP$$US-GILEAD-2024-0686869$GILEAD$$60$YR$A$F$Y$$$20240910$$CN$US$US
243044661$24304466$1$I$$20240905$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409003596$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240910$$CN$US$US
243044672$24304467$2$F$20240909$20240913$20240910$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144022$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240918$$HP$US$US
243044681$24304468$1$I$$20240903$20240910$20240910$PER$$US-009507513-2409USA003416$MERCK$Mooradian MJ, Fintelmann FJ, LaSalle TJ, Simon J, Graur A, Muzikansky A, et al.. Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial. Nature Communications. 2024;15:1-12$67$YR$$F$Y$$$20240910$$HP$US$US
243044691$24304469$1$I$$20240910$20240910$20240910$DIR$717824$$FDA-CTU$$$$$UNK$N$$$20240910$$CN$US$
243044711$24304471$1$I$$20240910$20240910$20240910$DIR$717833$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243044731$24304473$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143102$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$61.23$KG$20240910$$CN$US$US
243044741$24304474$1$I$$20240903$20240910$20240910$PER$$US-009507513-2409USA003417$MERCK$Mooradian MJ, Fintelmann FJ, LaSalle TJ, Simon J, Graur A, Muzikansky A, et al.. Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial. Nature Communications. 2024;15:1-12$82$YR$$$Y$$$20240910$$HP$US$US
243044751$24304475$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181274$NOVARTIS$$$$$F$Y$$$20240910$$HP$US$US
243044761$24304476$1$I$$20240904$20240910$20240910$EXP$$JP-009507513-2409JPN000810J$MERCK$$54$YR$$$Y$$$20240910$$MD$JP$JP
243044771$24304477$1$I$20240719$20240910$20240910$20240910$DIR$717839$$FDA-CTU$$49$YR$$M$N$95.3$KG$20240910$N$HP$US$
243044781$24304478$1$I$$20240910$20240910$20240910$DIR$717840$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243044791$24304479$1$I$$20240827$20240910$20240910$EXP$$US-MALLINCKRODT-MNK202405455$MALLINCKRODT$$$$$M$Y$$$20240910$$HP$US$US
243044802$24304480$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0687189$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243044811$24304481$1$I$20220101$20240902$20240910$20240910$PER$$JP-Eisai-EC-2023-133241$EISAI$$63$YR$A$F$Y$$$20240910$$MD$JP$JP
243044831$24304483$1$I$20240909$20240910$20240910$20240910$DIR$717850$$FDA-CTU$$58$YR$$M$N$$$20240910$N$PH$US$
243044871$24304487$1$I$20240909$20240910$20240910$20240910$DIR$717848$$FDA-CTU$$81$YR$$M$N$$$20240910$N$PH$US$
243044881$24304488$1$I$20210101$20240906$20240910$20240910$PER$$US-JNJFOC-20240919646$JOHNSON AND JOHNSON$$$$$F$Y$$$20240910$$CN$US$US
243044892$24304489$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687179$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243044912$24304491$2$F$20240827$20240909$20240910$20240920$EXP$$US-BEH-2024178377$CSL BEHRING$$6$YR$C$F$Y$41.542$KG$20240920$$HP$US$US
243044921$24304492$1$I$20240910$20240910$20240910$20240910$DIR$717821$$FDA-CTU$$10$YR$$F$N$$$20240910$N$CN$US$
243044931$24304493$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181281$NOVARTIS$$$$$F$Y$75$KG$20240910$$CN$US$US
243044941$24304494$1$I$$20240829$20240910$20240910$EXP$$JP-009507513-2305JPN001399J$MERCK$$56$YR$$M$Y$$$20240910$$MD$JP$JP
243044951$24304495$1$I$20240903$20240910$20240910$20240910$DIR$717846$$FDA-CTU$$38$YR$$M$N$75.4$KG$20240910$Y$$US$
243044961$24304496$1$I$20240909$20240910$20240910$20240910$DIR$717831$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243044972$24304497$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687177$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243044981$24304498$1$I$20240101$20240903$20240910$20240910$PER$$US-009507513-2409USA001916$MERCK$$35$YR$$F$Y$$$20240910$$CN$US$US
243044991$24304499$1$I$$20240826$20240910$20240910$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08588$NEUROCRINE BIOSCIENCES$$65$YR$$M$Y$$$20240910$$MD$US$US
243045002$24304500$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687176$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243045011$24304501$1$I$$20240815$20240910$20240910$PER$$US-009507513-2409USA003002$MERCK$$$$T$$Y$$$20240910$$MD$US$US
243045021$24304502$1$I$$20240909$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409005384$ELI LILLY AND CO$$65$YR$E$$Y$$$20240910$$CN$US$US
243045031$24304503$1$I$$20240830$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409001127$ELI LILLY AND CO$$52$YR$A$$Y$$$20240910$$CN$US$US
243045041$24304504$1$I$$20240906$20240910$20240910$PER$$US-ELI_LILLY_AND_COMPANY-US202409004678$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240910$$CN$US$US
243045061$24304506$1$I$20240530$20240910$20240910$20240910$DIR$717842$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243045071$24304507$1$I$$20240829$20240910$20240910$EXP$$JP-009507513-2305JPN001406J$MERCK$$62$YR$$M$Y$$$20240910$$MD$JP$JP
243045082$24304508$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687174$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243045091$24304509$1$I$$20240815$20240910$20240910$PER$$US-009507513-2409USA003003$MERCK$$$$T$$Y$$$20240910$$MD$US$US
243045101$24304510$1$I$$20240903$20240910$20240910$PER$$US-BIOMARINAP-US-2024-160286$BIOMARIN$$$$$$Y$$$20240910$$CN$US$US
243045122$24304512$2$F$$20240906$20240910$20240910$EXP$$US-GILEAD-2024-0687173$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243045131$24304513$1$I$$20240903$20240910$20240910$EXP$$US-BIOGEN-2024BI01279980$BIOGEN$$$$$F$Y$$$20240910$$CN$US$US
243045141$24304514$1$I$$20240715$20240910$20240910$PER$$US-Amphastar Pharmaceuticals, Inc.-2161455$AMPHASTAR$$59$YR$$F$Y$$$20240910$$$US$US
243045151$24304515$1$I$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687170$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243045161$24304516$1$I$20231006$20240903$20240910$20240910$EXP$$NVSC2023IN280110$NOVARTIS$$78$YR$$F$Y$$$20240911$$CN$IN$IN
243045171$24304517$1$I$20060905$20240813$20240910$20240910$EXP$$BR-BIOMARINAP-BR-2024-160467$BIOMARIN$$$$$$Y$$$20240910$$CN$US$BR
243045181$24304518$1$I$$20230805$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000291$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045191$24304519$1$I$$20230728$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000286$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045201$24304520$1$I$$20230731$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000288$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045211$24304521$1$I$$20230810$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000294$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045221$24304522$1$I$$20230726$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000282$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045231$24304523$1$I$$20230724$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000280$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045241$24304524$1$I$$20230726$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000283$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045251$24304525$1$I$$20230727$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000284$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045261$24304526$1$I$$20230731$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000289$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045271$24304527$1$I$$20230809$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000293$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045291$24304529$1$I$20240731$20240807$20240910$20240910$PER$$US-FMCRTG-FMC-2408-000951$FRESENIUS MEDICAL CARE$$78$YR$E$M$Y$116.5$KG$20240910$$HP$US$US
243045301$24304530$1$I$$20240731$20240910$20240910$PER$$US-FMCRTG-FMC-2408-000946$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240910$$CN$US$US
243045311$24304531$1$I$$20240808$20240910$20240910$PER$$US-FMCRTG-FMC-2408-000984$FRESENIUS MEDICAL CARE$$$$$$Y$$$20240910$$HP$US$US
243045321$24304532$1$I$$20240806$20240910$20240910$PER$$US-FMCRTG-FMC-2408-000950$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240910$$CN$US$US
243045331$24304533$1$I$20240723$20240807$20240910$20240910$PER$$US-FMCRTG-FMC-2408-000961$FRESENIUS MEDICAL CARE$$84$YR$E$F$Y$80.9$KG$20240910$$HP$US$US
243045341$24304534$1$I$20240808$20240808$20240910$20240910$PER$$US-FMCRTG-FMC-2408-000983$FRESENIUS MEDICAL CARE$$75$YR$E$M$Y$81$KG$20240910$$HP$US$US
243045351$24304535$1$I$20240826$20240827$20240910$20240910$EXP$$US-FMCRTG-FMC-2409-001106$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240910$$HP$US$US
243045361$24304536$1$I$$20230828$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000319$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045371$24304537$1$I$$20230821$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000308$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045381$24304538$1$I$$20230810$20240910$20240910$PER$$US-LEADIANT GMBH-2023STPI000295$SIGMA TAU$$$$$M$Y$$$20240910$$MD$US$US
243045391$24304539$1$I$$20230823$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000311$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045401$24304540$1$I$$20230822$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000309$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045411$24304541$1$I$$20230824$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000315$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045421$24304542$1$I$$20230824$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000314$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045431$24304543$1$I$$20230811$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000297$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045441$24304544$1$I$20230825$20230915$20240910$20240910$EXP$$US-LEADIANT GMBH-2023STPI000325$SIGMA TAU$$26$YR$$M$Y$$$20240910$$MD$US$US
243045451$24304545$1$I$$20230811$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000312$SIGMA TAU$$$$$M$Y$$$20240910$$MD$US$US
243045461$24304546$1$I$$20230831$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000323$SIGMA TAU$$$$$F$Y$$$20240910$$HP$US$US
243045471$24304547$1$I$$20230824$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000316$SIGMA TAU$$$$$M$Y$$$20240910$$PH$US$US
243045481$24304548$1$I$20230801$20230822$20240910$20240910$EXP$$US-LEADIANT GMBH-2023STPI000317$SIGMA TAU$$76$YR$$F$Y$$$20240910$$MD$US$US
243045491$24304549$1$I$$20230810$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000296$SIGMA TAU$$$$$F$Y$$$20240910$$MD$US$US
243045501$24304550$1$I$$20230824$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000313$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045511$24304551$1$I$$20230815$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000318$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045521$24304552$1$I$$20230822$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000310$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045531$24304553$1$I$$20230814$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000299$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045541$24304554$1$I$$20230831$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000324$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045551$24304555$1$I$$20230831$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000322$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045561$24304556$1$I$$20230919$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000341$SIGMA TAU$$$$$F$Y$$$20240910$$MD$US$US
243045571$24304557$1$I$$20230913$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000337$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045581$24304558$1$I$$20230911$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000332$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045591$24304559$1$I$$20230911$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000333$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045601$24304560$1$I$$20230919$20240910$20240910$EXP$$US-LEADIANT GMBH-2023STPI000340$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045611$24304561$1$I$$20230912$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000335$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045621$24304562$1$I$$20230913$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000336$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045631$24304563$1$I$$20230902$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000329$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045641$24304564$1$I$$20230908$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000331$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045651$24304565$1$I$$20230901$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000327$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045661$24304566$1$I$$20230914$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000338$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045671$24304567$1$I$$20230927$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000350$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045681$24304568$1$I$$20230920$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000343$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045691$24304569$1$I$$20230926$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000348$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045701$24304570$1$I$$20230925$20240910$20240910$EXP$$US-LEADIANT GMBH-2023STPI000328$SIGMA TAU$$$$$M$Y$27.5$KG$20240910$$HP$US$US
243045711$24304571$1$I$$20230921$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000345$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045721$24304572$1$I$$20230920$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000342$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045731$24304573$1$I$$20230926$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000349$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045741$24304574$1$I$$20230922$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000346$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045751$24304575$1$I$$20230921$20240910$20240910$EXP$$US-LEADIANT GMBH-2023STPI000344$SIGMA TAU$$$$$F$Y$$$20240910$$HP$US$US
243045761$24304576$1$I$$20230929$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000356$SIGMA TAU$$$$$F$Y$$$20240910$$MD$US$US
243045771$24304577$1$I$$20230925$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000355$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045781$24304578$1$I$$20230928$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000357$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045791$24304579$1$I$$20231002$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000358$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045801$24304580$1$I$$20230928$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000354$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045811$24304581$1$I$$20230926$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000351$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045821$24304582$1$I$$20231003$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000360$SIGMA TAU$$$$$F$Y$$$20240910$$MD$US$US
243045831$24304583$1$I$$20231003$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000359$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045841$24304584$1$I$$20231004$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000365$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045851$24304585$1$I$$20230921$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000352$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045861$24304586$1$I$$20231004$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000371$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045871$24304587$1$I$$20231003$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000361$SIGMA TAU$$$$$F$Y$$$20240910$$HP$US$US
243045881$24304588$1$I$$20231011$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000374$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045891$24304589$1$I$$20231012$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000375$SIGMA TAU$$$$$F$Y$$$20240910$$HP$US$US
243045901$24304590$1$I$$20231003$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000363$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045911$24304591$1$I$$20231007$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000370$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045921$24304592$1$I$$20231004$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000366$SIGMA TAU$$$$$$Y$$$20240910$$CN$US$US
243045931$24304593$1$I$$20231004$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000364$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243045941$24304594$1$I$$20231003$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000362$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045951$24304595$1$I$$20231012$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000376$SIGMA TAU$$$$$M$Y$$$20240910$$MD$US$US
243045961$24304596$1$I$$20231017$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000381$SIGMA TAU$$$$$M$Y$$$20240910$$MD$US$US
243045971$24304597$1$I$$20231023$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000393$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045981$24304598$1$I$$20231024$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000398$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243045991$24304599$1$I$$20231024$20240910$20240910$PER$$US-LEADIANT GMBH-2023STPI000397$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243046001$24304600$1$I$$20231018$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000389$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243046011$24304601$1$I$$20231019$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000390$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243046021$24304602$1$I$$20231019$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000388$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243046031$24304603$1$I$$20231025$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000402$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243046041$24304604$1$I$$20231024$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000399$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243046051$24304605$1$I$$20231025$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000401$SIGMA TAU$$$$$M$Y$$$20240910$$MD$US$US
243046061$24304606$1$I$$20231020$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000391$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243046071$24304607$1$I$$20231017$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000382$SIGMA TAU$$$$$M$Y$$$20240910$$MD$US$US
243046081$24304608$1$I$$20231026$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000403$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243046091$24304609$1$I$$20231026$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000405$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243046101$24304610$1$I$$20231026$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000404$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243046111$24304611$1$I$$20231017$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000383$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243046121$24304612$1$I$$20231018$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000386$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243046131$24304613$1$I$$20231023$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000396$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243046141$24304614$1$I$$20231101$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000411$SIGMA TAU$$$$$M$Y$$$20240910$$MD$US$US
243046151$24304615$1$I$$20231031$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000407$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243046161$24304616$1$I$$20240829$20240910$20240910$EXP$$NVSC2024FR177779$NOVARTIS$Tardy C, Puszkiel A, Boudou-Rouquette P, De Percin S, Alexandre J, Berge M et al.. Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection.. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2024;93:169-75$55$YR$$M$Y$86$KG$20240911$$HP$FR$FR
243046171$24304617$1$I$$20231102$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000410$SIGMA TAU$$$$$F$Y$$$20240910$$CN$US$US
243046181$24304618$1$I$$20231030$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000406$SIGMA TAU$$$$$M$Y$$$20240910$$CN$US$US
243046191$24304619$1$I$$20231101$20240910$20240910$PER$$US-LEADIANT GMBH-2023STPI000412$SIGMA TAU$$$$$F$Y$$$20240910$$MD$US$US
243046201$24304620$1$I$$20231030$20240910$20240910$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000413$SIGMA TAU$$$$$F$Y$$$20240910$$HP$US$US
243046212$24304621$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687091$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243046221$24304622$1$I$$20240831$20240910$20240910$PER$$US-ABBVIE-5904827$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243046231$24304623$1$I$$20240910$20240910$20240910$EXP$$US-GILEAD-2024-0687213$GILEAD$$68$YR$E$M$Y$$$20240910$$MD$US$US
243046242$24304624$2$F$20240704$20240913$20240910$20240913$EXP$ES-AEMPS-1566818$ES-GILEAD-2024-0687263$GILEAD$$67$YR$E$F$Y$101$KG$20240913$$PH$ES$ES
243046251$24304625$1$I$20240710$20240902$20240910$20240910$EXP$SE-SEMPA-2024-005876$SE-ABBVIE-5906632$ABBVIE$$$$$$Y$$$20240910$$HP$SE$SE
243046272$24304627$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687078$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243046282$24304628$2$F$20240617$20240916$20240910$20240916$EXP$ES-AEMPS-1567358$ES-GILEAD-2024-0687274$GILEAD$$61$YR$A$F$Y$73$KG$20240916$$PH$ES$ES
243046291$24304629$1$I$$20240909$20240909$20240909$DIR$717693$$FDA-CTU$$$$$UNK$N$$$20240909$$CN$US$
243046301$24304630$1$I$20240909$20240909$20240909$20240909$DIR$717719$$FDA-CTU$$$$$UNK$N$$$20240909$N$CN$US$
243046312$24304631$2$F$$20240910$20240910$20240924$EXP$$CA-HLS-202402194$HLS THERAPEUTICS$$$$E$M$Y$$$20240924$$MD$CA$CA
243046331$24304633$1$I$$20240829$20240910$20240910$PER$$CA-HLS-202402192$HLS THERAPEUTICS$$$$A$M$Y$$$20240910$$HP$CA$CA
243046341$24304634$1$I$20240701$20240903$20240910$20240910$PER$$US-BIOGEN-2024BI01281087$BIOGEN$$54$YR$$F$Y$$$20240910$$CN$US$US
243046351$24304635$1$I$$20240830$20240910$20240910$EXP$$US-HLS-202401157$HLS THERAPEUTICS$$67$YR$E$M$Y$$$20240910$$CN$US$US
243046361$24304636$1$I$$20240829$20240910$20240910$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI03643$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240910$$CN$JP$JP
243046372$24304637$2$F$20240811$20240919$20240910$20240923$EXP$$JP-SETONPHARMA-2024SETSPO00005$SETON$$54$YR$A$M$Y$74.5$KG$20240923$$MD$JP$JP
243046391$24304639$1$I$20240821$20240823$20240910$20240910$PER$$US-APELLIS-2024-APL-0000862$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240904$$HP$US$US
243046402$24304640$2$F$$20240906$20240910$20240910$PER$$US-GILEAD-2024-0687172$GILEAD$$$$$$Y$$$20240910$$LW$US$US
243046411$24304641$1$I$$20240828$20240910$20240910$EXP$$US-HLS-202401121$HLS THERAPEUTICS$$71$YR$E$M$Y$$$20240910$$CN$US$US
243046421$24304642$1$I$$20240905$20240910$20240910$EXP$$AR-AMGEN-ARGSP2024179452$AMGEN$$60$YR$A$F$Y$$$20240910$$CN$AR$AR
243046431$24304643$1$I$20240101$20240903$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140213$BRISTOL MYERS SQUIBB$$34$YR$A$M$Y$$$20240910$$HP$US$US
243046441$24304644$1$I$$20240827$20240910$20240910$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08621$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240910$$CN$US$US
243046451$24304645$1$I$$20240907$20240910$20240910$PER$$US-AstraZeneca-2024A206094$ASTRAZENECA$$$$$$Y$$$20240911$$CN$US$
243046461$24304646$1$I$$20240908$20240910$20240910$PER$$US-AstraZeneca-2024A206103$ASTRAZENECA$$$$$$Y$$$20240911$$CN$US$
243046471$24304647$1$I$$20240829$20240910$20240910$EXP$$US-HLS-202401138$HLS THERAPEUTICS$$$$A$$Y$$$20240910$$HP$US$US
243046481$24304648$1$I$$20240829$20240910$20240910$EXP$$US-HLS-202401141$HLS THERAPEUTICS$$$$A$$Y$$$20240910$$MD$US$US
243046491$24304649$1$I$20240710$20240909$20240910$20240910$EXP$DE-DCGMA-24203776$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-143773$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$81$KG$20240911$$MD$DE$DE
243046501$24304650$1$I$$20240829$20240910$20240910$EXP$$US-HLS-202401144$HLS THERAPEUTICS$$58$YR$A$M$Y$$$20240910$$HP$US$US
243046511$24304651$1$I$$20240830$20240910$20240910$PER$$US-BIOMARINAP-US-2024-160292$BIOMARIN$$$$$$Y$$$20240910$$CN$US$US
243046521$24304652$1$I$$20240904$20240910$20240910$EXP$$TW-AMGEN-TWNSP2024178971$AMGEN$$$$E$F$Y$$$20240910$$HP$TW$TW
243046531$24304653$1$I$$20240904$20240910$20240910$EXP$$FR-Bion-013798$BIONPHARMA$$70$YR$E$M$Y$$$20240911$$HP$FR$FR
243046541$24304654$1$I$$20240904$20240910$20240910$EXP$$FR-Bion-013803$BIONPHARMA$$79$YR$E$M$Y$$$20240911$$HP$FR$FR
243046551$24304655$1$I$$20240829$20240910$20240910$EXP$$US-HLS-202401146$HLS THERAPEUTICS$$26$YR$A$M$Y$$$20240910$$PH$US$US
243046581$24304658$1$I$$20240816$20240910$20240910$EXP$$US-SMPA-2024MYSCI0700717$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243046591$24304659$1$I$$20240819$20240910$20240910$EXP$$US-SMPA-2024SPA001695$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243046611$24304661$1$I$20240820$20240830$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139793$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240911$$HP$US$US
243046621$24304662$1$I$$20240821$20240910$20240910$PER$$US-SA-2024SA259267$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240911$$MD$US$US
243046631$24304663$1$I$20240101$20240904$20240910$20240910$EXP$$US-ABBVIE-5907913$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243046641$24304664$1$I$$20240904$20240910$20240910$EXP$$US-ABBVIE-5908963$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243046651$24304665$1$I$$20240906$20240910$20240910$EXP$$US-ABBVIE-5915327$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243046661$24304666$1$I$$20240909$20240910$20240910$PER$$NVSC2024US181205$NOVARTIS$$$$A$F$Y$$$20240911$$CN$US$US
243046681$24304668$1$I$$20240904$20240910$20240910$EXP$$US-ABBVIE-5906856$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243046691$24304669$1$I$$20240906$20240910$20240910$EXP$$US-ABBVIE-5913972$ABBVIE$$$$$F$Y$$$20240910$$HP$US$US
243046701$24304670$1$I$20240101$20240827$20240910$20240910$PER$$US-SA-2024SA258158$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240911$$MD$US$US
243046711$24304671$1$I$$20240906$20240910$20240910$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050237$BOEHRINGER INGELHEIM$$86$YR$E$F$Y$$$20240911$$MD$US$US
243046721$24304672$1$I$20240101$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024178882$AMGEN$$45$YR$A$F$Y$$$20240910$$CN$US$US
243046731$24304673$1$I$20240903$20240904$20240910$20240910$PER$$US-BEH-2024178282$CSL BEHRING$$80$YR$E$M$Y$$$20240910$$HP$US$US
243046742$24304674$2$F$20240901$20240913$20240910$20240918$PER$$US-AMGEN-USASP2024179667$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243046761$24304676$1$I$20190622$20240905$20240910$20240910$EXP$$JP-GSK-JP2024JPN110374$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$MD$JP$JP
243046771$24304677$1$I$$20240824$20240910$20240910$PER$$US-SMPA-2024SPA001885$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243046781$24304678$1$I$$20240825$20240910$20240910$PER$$US-SMPA-2024SPA001898$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243046792$24304679$2$F$$20240904$20240910$20240925$PER$$US-SMPA-2024SPA001988$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243046821$24304682$1$I$$20240824$20240910$20240910$PER$$US-SMPA-2024SPA001931$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243046831$24304683$1$I$20240101$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143299$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240911$$CN$US$US
243046841$24304684$1$I$$20240909$20240910$20240910$PER$$US-AstraZeneca-2024A205833$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243046851$24304685$1$I$$20240909$20240910$20240910$EXP$$CA-SANDOZ INC.-PHHY2017CA163303$SANDOZ$$60$YR$$M$Y$$$20240910$$HP$CA$CA
243046861$24304686$1$I$$20240531$20240910$20240910$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00233$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240905$$CN$US$US
243046871$24304687$1$I$$20240822$20240910$20240910$PER$$US-SA-2024SA260355$SANOFI AVENTIS$$59$YR$A$$Y$$$20240911$$MD$US$US
243046881$24304688$1$I$$20240903$20240910$20240910$EXP$$US-JNJFOC-20240916211$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240911$$HP$US$US
243046892$24304689$2$F$20240901$20240905$20240910$20240911$EXP$$US-JNJFOC-20240905426$JOHNSON AND JOHNSON$$59$YR$A$F$Y$59.1$KG$20240912$$CN$US$US
243046911$24304691$1$I$20240314$20240905$20240910$20240910$PER$$US-AMGEN-HZN-2024-003350$AMGEN$$45$YR$A$M$Y$$$20240910$$HP$US$US
243046922$24304692$2$F$$20240925$20240910$20240930$EXP$$JP-SA-2024SA259983$SANOFI AVENTIS$$$$$$Y$$$20241001$$MD$JP$JP
243046931$24304693$1$I$$20240827$20240910$20240910$PER$$US-SA-2024SA259236$SANOFI AVENTIS$$$$A$M$Y$$$20240911$$MD$US$US
243046941$24304694$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142408$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240911$$CN$US$US
243046951$24304695$1$I$$20240831$20240910$20240910$EXP$$US-BIOGEN-2024BI01281916$BIOGEN$$$$$$Y$$$20240910$$HP$US$US
243046961$24304696$1$I$$20240824$20240910$20240910$PER$$US-BIOGEN-2024BI01281914$BIOGEN$$$$$$Y$$$20240910$$HP$US$US
243046971$24304697$1$I$20240906$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143424$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$51.6$KG$20240911$$PH$US$US
243046981$24304698$1$I$20240101$20240830$20240910$20240910$PER$$US-JNJFOC-20240903040$JOHNSON AND JOHNSON$$68$YR$E$M$Y$98$KG$20240911$$CN$US$US
243046991$24304699$1$I$$20240903$20240910$20240910$PER$$US-SMPA-2024SPA002265$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243047011$24304701$1$I$$20240905$20240910$20240910$PER$$US-SMPA-2024SPA002367$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243047021$24304702$1$I$$20240903$20240910$20240910$PER$$US-SMPA-2024SPA002258$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243047031$24304703$1$I$$20240903$20240910$20240910$PER$$US-SMPA-2024SPA002292$SUNOVION$$$$$$Y$$$20240910$$CN$US$US
243047062$24304706$2$F$$20240909$20240910$20240927$PER$$US-SMPA-2024SPA002242$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243047071$24304707$1$I$$20240906$20240910$20240910$EXP$$US-BEIGENE-BGN-2024-014299$BEIGENE$$$$$$Y$$$20240910$$CN$US$US
243047081$24304708$1$I$20240101$20240905$20240910$20240910$EXP$$DE-ABBVIE-5797553$ABBVIE$$$$$M$Y$$$20240910$$CN$DE$DE
243047091$24304709$1$I$20240101$20240904$20240910$20240910$EXP$$CA-ABBVIE-5910016$ABBVIE$$21$YR$$F$Y$$$20240910$$CN$CA$CA
243047101$24304710$1$I$$20240823$20240910$20240910$PER$$US-BIOMARINAP-US-2024-160334$BIOMARIN$$$$$$Y$$$20240910$$CN$US$US
243047112$24304711$2$F$$20240912$20240910$20240918$EXP$$JP-JNJFOC-20240923267$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$CN$JP$JP
243047133$24304713$3$F$$20240905$20240910$20240913$EXP$$US-ABBVIE-5914386$ABBVIE$$$$$$Y$$$20240913$$CN$US$US
243047141$24304714$1$I$20240901$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143884$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240911$$HP$US$US
243047151$24304715$1$I$$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143187$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240911$$CN$US$US
243047161$24304716$1$I$20240815$20240822$20240910$20240910$PER$$US-TEVA-VS-3237509$TEVA$$65$YR$$F$Y$$$20240910$$CN$US$US
243047171$24304717$1$I$$20240906$20240910$20240910$EXP$$US-JNJFOC-20240918239$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$CN$US$US
243047181$24304718$1$I$$20240903$20240910$20240910$PER$$US-AMGEN-USASP2024177049$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
243047191$24304719$1$I$$20240904$20240910$20240910$PER$$US-TAKEDA-2024TUS089532$TAKEDA$$$$$$Y$$$20240910$$CN$US$US
243047201$24304720$1$I$20240101$20240906$20240910$20240910$EXP$$US-ABBVIE-5915317$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243047211$24304721$1$I$$20240905$20240910$20240910$EXP$$US-ABBVIE-5909402$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243047221$24304722$1$I$20240701$20240909$20240910$20240910$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050347$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240911$$CN$US$US
243047231$24304723$1$I$$20240902$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011365$STRIDES$Wright B, Moore A, Becker-Weidman D, Joyce D.. Primary B cell lymphoma of the patella presenting as anterior knee pain: A case report.. J-Orthop. 2024;48:60-63$$$$$Y$$$20240911$$HP$US$US
243047241$24304724$1$I$$20240830$20240910$20240910$EXP$$US-HLS-202401154$HLS THERAPEUTICS$$$$T$$Y$$$20240910$$HP$US$US
243047251$24304725$1$I$$20240906$20240910$20240910$EXP$$NVSC2024US180548$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243047261$24304726$1$I$20240501$20240903$20240910$20240910$EXP$$US-ROCHE-10000073045$ROCHE$$41$YR$A$M$Y$79.37$KG$20240911$$CN$US$US
243047271$24304727$1$I$$20240902$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011347$STRIDES$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework.. J-Forens-Legal-Med. 2024;101$$$$$Y$$$20240911$$HP$US$US
243047281$24304728$1$I$$20240903$20240910$20240910$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011432$STRIDES$Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N.. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.. Am-J-Gastroenterol. 2024;119:200-202$$$$$Y$$$20240911$$MD$US$US
243047291$24304729$1$I$$20240828$20240910$20240910$PER$$US-ROCHE-10000069934$ROCHE$$$$$M$Y$$$20240911$$CN$US$US
243047301$24304730$1$I$20240101$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024177972$AMGEN$$79$YR$E$F$Y$$$20240910$$CN$US$US
243047311$24304731$1$I$$20240910$20240910$20240910$EXP$$JP-TAKEDA-2024TJP013363$TAKEDA$$7$DEC$$M$Y$$$20240910$$MD$JP$JP
243047321$24304732$1$I$$20240906$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143494$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$66.22$KG$20240911$$CN$US$US
243047342$24304734$2$F$20210801$20240912$20240910$20240918$EXP$$US-ABBVIE-5908892$ABBVIE$$64$YR$$F$Y$55.338$KG$20240918$$CN$US$US
243047351$24304735$1$I$20230425$20240909$20240910$20240910$EXP$$MY-TAKEDA-2023TUS043961$TAKEDA$$66$YR$$M$Y$$$20240910$$CN$MY$MY
243047361$24304736$1$I$$20240903$20240910$20240910$EXP$$FR-JNJFOC-20240907542$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$MD$FR$FR
243047371$24304737$1$I$$20240906$20240910$20240910$EXP$$US-TAKEDA-2024TUS089547$TAKEDA$$$$$M$Y$$$20240910$$CN$US$US
243047382$24304738$2$F$20240909$20240910$20240910$20240915$EXP$$CA-ABBVIE-5916716$ABBVIE$$53$YR$$F$Y$$$20240915$$CN$CA$CA
243047391$24304739$1$I$20240827$20240909$20240910$20240910$EXP$FR-AFSSAPS-AN2024001223$FR-ORGANON-O2409FRA000594$ORGANON$$58$YR$$M$Y$$$20240910$$MD$FR$FR
243047401$24304740$1$I$$20240906$20240910$20240910$EXP$$CN-TAKEDA-2024TUS089633$TAKEDA$$$$$F$Y$$$20240910$$CN$CN$CN
243047411$24304741$1$I$20240821$20240902$20240910$20240910$EXP$$AR-BIOGEN-2024BI01280112$BIOGEN$$7$YR$$F$Y$$$20240910$$CN$AR$AR
243047441$24304744$1$I$20200904$20240906$20240910$20240910$EXP$$US-ABBVIE-5914601$ABBVIE$$75$YR$$M$Y$$$20240910$$CN$US$US
243047451$24304745$1$I$$20240906$20240910$20240910$EXP$$US-AstraZeneca-2024A204566$ASTRAZENECA$$$$$F$Y$$$20240911$$MD$US$
243047461$24304746$1$I$$20240903$20240910$20240910$EXP$$JP-AstraZeneca-2024A201916$ASTRAZENECA$$70$YR$$F$Y$$$20240911$$MD$JP$
243047471$24304747$1$I$$20240902$20240910$20240910$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142667$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240911$$PH$JP$JP
243047481$24304748$1$I$$20240828$20240910$20240910$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-137854$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240911$$PH$GB$GB
243047491$24304749$1$I$$20240909$20240910$20240910$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-144071$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240911$$HP$GB$GB
243047501$24304750$1$I$20221014$20240909$20240910$20240910$EXP$FR-AFSSAPS-CF20221653$FR-ORGANON-O2409FRA000619$ORGANON$$82$YR$$M$Y$75$KG$20240910$$MD$FR$FR
243047511$24304751$1$I$$20240726$20240910$20240910$EXP$$US-TEVA-VS-3227083$TEVA$$62$YR$$F$Y$$$20240910$$CN$US$US
243047521$24304752$1$I$20240101$20240904$20240910$20240910$EXP$$US-ABBVIE-5908001$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243047531$24304753$1$I$20240808$20240909$20240910$20240910$EXP$$NVSJ2024JP010729$NOVARTIS$$54$YR$$M$Y$$$20240911$$MD$JP$JP
243047541$24304754$1$I$20240101$20240905$20240910$20240910$EXP$$US-ABBVIE-5909934$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243047551$24304755$1$I$20240101$20240905$20240910$20240910$EXP$$US-ABBVIE-5762567$ABBVIE$$$$$F$Y$83$KG$20240910$$CN$US$US
243047561$24304756$1$I$20240727$20240909$20240910$20240910$EXP$$CN-JNJFOC-20240923388$JOHNSON AND JOHNSON$$37$YR$A$M$Y$74$KG$20240911$$HP$CN$CN
243047572$24304757$2$F$20230101$20240913$20240910$20240918$EXP$$US-ABBVIE-5910540$ABBVIE$$$$$F$Y$92.079$KG$20240918$$CN$US$US
243047581$24304758$1$I$$20240909$20240910$20240910$EXP$$NVSJ2024JP010730$NOVARTIS$$$$E$$Y$$$20240911$$MD$JP$JP
243047591$24304759$1$I$20100101$20240909$20240910$20240910$EXP$FR-EMA-DD-20240903-7482677-181059$FR-SANDOZ INC.-SDZ2024FR078760$SANDOZ$$57$YR$$F$Y$$$20240910$$HP$FR$FR
243047601$24304760$1$I$$20240903$20240910$20240910$EXP$$GB-AstraZeneca-2024A201517$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$GB$
243047611$24304761$1$I$20240101$20240903$20240910$20240910$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-014626$JAZZ$$$$$M$Y$$$20240910$$MD$JP$JP
243047621$24304762$1$I$$20240903$20240910$20240910$EXP$$US-AstraZeneca-2024A200460$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
243047631$24304763$1$I$20240829$20240904$20240910$20240910$EXP$$FR-ABBVIE-5913597$ABBVIE$$70$YR$$M$Y$$$20240910$$CN$FR$FR
243047641$24304764$1$I$$20240901$20240910$20240910$PER$$US-AMGEN-USASP2024176024$AMGEN$Yosypiv I.V.; Tollaksen R.; Craver R.D.. Nephrotic Syndrome in a Child With NPHS2 Mutation. Pediatric and Developmental Pathology. 2024;27 (4):359-369$2$YR$C$M$Y$$$20240910$$HP$US$US
243047651$24304765$1$I$$20240904$20240910$20240910$EXP$$EG-TAKEDA-2024TUS089658$TAKEDA$Reda, Shereen M, Radwa, et al. Safety of intravenous immunoglobulin replacement therapy in a group of patients with primary immune deficiency. QJM: An International Journal Of Medicine. 116:i287$$$$$Y$$$20240910$$HP$EG$EG
243047661$24304766$1$I$20240903$20240909$20240910$20240910$EXP$$US-ABBVIE-5916317$ABBVIE$$90$YR$$M$Y$$$20240910$$CN$US$US
243047671$24304767$1$I$$20240903$20240910$20240910$EXP$$US-SANDOZ INC.-SDZ2024US079276$SANDOZ$$$$$F$Y$$$20240910$$HP$US$US
243047681$24304768$1$I$$20240909$20240910$20240910$EXP$$US-ABBVIE-5916267$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243047691$24304769$1$I$20240501$20240906$20240910$20240910$EXP$$US-ABBVIE-5916809$ABBVIE$$72$YR$$M$Y$$$20240910$$CN$US$US
243047701$24304770$1$I$20240805$20240903$20240910$20240910$EXP$$RU-TAKEDA-2024TUS089110$TAKEDA$$9$YR$$F$Y$50$KG$20240910$$HP$RU$RU
243047711$24304771$1$I$20240906$20240909$20240910$20240910$EXP$$US-ABBVIE-5916323$ABBVIE$$76$YR$$M$Y$$$20240910$$CN$US$US
243047722$24304772$2$F$20240101$20240912$20240910$20240917$EXP$$US-ABBVIE-5913645$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243047731$24304773$1$I$20240101$20240905$20240910$20240910$EXP$$US-ABBVIE-5910427$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243047741$24304774$1$I$20240401$20240905$20240910$20240910$EXP$$US-ABBVIE-5910294$ABBVIE$$51$YR$$M$Y$$$20240910$$CN$US$US
243047751$24304775$1$I$$20240909$20240910$20240910$EXP$$US-ABBVIE-5915940$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243047761$24304776$1$I$20240827$20240906$20240910$20240910$EXP$FR-AFSSAPS-SE2024000693$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-142430$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$63.2$KG$20240911$$MD$FR$FR
243047772$24304777$2$F$20240801$20240918$20240910$20240924$EXP$$US-ABBVIE-5910496$ABBVIE$$31$YR$$M$Y$$$20240924$$CN$US$US
243047781$24304778$1$I$20240901$20240905$20240910$20240910$EXP$$IT-ABBVIE-5910481$ABBVIE$$73$YR$$F$Y$$$20240910$$CN$IT$IT
243047791$24304779$1$I$$20240904$20240910$20240910$EXP$$US-ABBVIE-5908235$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243047812$24304781$2$F$20240907$20240910$20240910$20240912$PER$$US-AMGEN-USASP2024180011$AMGEN$$72$YR$E$F$Y$$$20240912$$CN$US$US
243047821$24304782$1$I$$20240901$20240910$20240910$EXP$$US-JNJFOC-20240906230$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$HP$US$US
243047831$24304783$1$I$$20240905$20240910$20240910$EXP$$US-ABBVIE-5913561$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243047842$24304784$2$F$20240101$20240911$20240910$20240917$EXP$$US-ABBVIE-5909619$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243047851$24304785$1$I$$20240828$20240910$20240910$PER$$US-SA-2024SA259282$SANOFI AVENTIS$$$$A$F$Y$$$20240911$$MD$US$US
243047861$24304786$1$I$20240822$20240905$20240910$20240910$EXP$$US-ABBVIE-5910672$ABBVIE$$59$YR$$F$Y$$$20240910$$CN$US$US
243047871$24304787$1$I$$20240906$20240910$20240910$PER$$NVSC2024US180163$NOVARTIS$$$$$M$Y$$$20240911$$CN$US$US
243047881$24304788$1$I$20240101$20240905$20240910$20240910$EXP$$CA-ABBVIE-5913679$ABBVIE$$57$YR$$F$Y$$$20240910$$CN$CA$CA
243047901$24304790$1$I$$20240904$20240910$20240910$EXP$$GB-ABBVIE-5909959$ABBVIE$$$$E$M$Y$$$20240910$$CN$GB$GB
243047911$24304791$1$I$20240101$20240905$20240910$20240910$EXP$$AU-ABBVIE-5909451$ABBVIE$$$$$F$Y$$$20240910$$CN$AU$AU
243047931$24304793$1$I$$20240904$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142036$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240911$$CN$US$US
243047941$24304794$1$I$$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143519$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240911$$HP$US$US
243047951$24304795$1$I$$20240906$20240910$20240910$EXP$$ZA-AstraZeneca-2024A204136$ASTRAZENECA$$72$YR$$F$Y$$$20240911$$CN$ZA$
243047962$24304796$2$F$$20240917$20240910$20240923$EXP$$JP-GSK-JP2024110541$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$PH$JP$JP
243047971$24304797$1$I$$20240903$20240910$20240910$EXP$$US-AstraZeneca-2024A201438$ASTRAZENECA$$$$$F$Y$101.2$KG$20240911$$CN$US$
243047981$24304798$1$I$20240905$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179020$AMGEN$$81$YR$E$F$Y$$$20240910$$CN$US$US
243047992$24304799$2$F$20240902$20240913$20240910$20240918$EXP$$ES-ABBVIE-5906826$ABBVIE$$84$YR$$F$Y$$$20240918$$CN$ES$ES
243048001$24304800$1$I$$20240905$20240910$20240910$EXP$$US-ABBVIE-5910629$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243048011$24304801$1$I$$20240830$20240910$20240910$PER$$US-ROCHE-10000071456$ROCHE$$$$A$F$Y$$$20240911$$CN$US$US
243048021$24304802$1$I$$20230912$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202309-001200$UNICHEM$$$$$F$Y$$$20240911$$CN$US$
243048031$24304803$1$I$$20231006$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202309-001204$UNICHEM$$$$$M$Y$$$20240910$$CN$US$
243048041$24304804$1$I$$20231127$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202312-001540$UNICHEM$$$$$$Y$$$20240910$$CN$US$
243048051$24304805$1$I$20240601$20240606$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202406-000708$UNICHEM$$$$$F$Y$$$20240910$$PH$US$
243048061$24304806$1$I$$20240614$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202406-000723$UNICHEM$$51$YR$A$F$Y$$$20240910$$CN$US$
243048071$24304807$1$I$$20240611$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202406-000731$UNICHEM$$$$$$Y$$$20240910$$CN$US$
243048081$24304808$1$I$$20240112$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202406-000740$UNICHEM$$$$$F$Y$$$20240910$$CN$US$
243048091$24304809$1$I$$20240507$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202404-000360$UNICHEM$$72$YR$E$F$Y$48.8$KG$20240911$$CN$US$
243048101$24304810$1$I$$20240830$20240910$20240910$EXP$$ES-Unichem Pharmaceuticals (USA) Inc-UCM202409-001111$UNICHEM$$69$YR$E$M$Y$$$20240911$$HP$ES$
243048121$24304812$1$I$20240614$20240617$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202406-000742$UNICHEM$$68$YR$E$F$Y$102.06$KG$20240910$$CN$US$
243048131$24304813$1$I$20240618$20240619$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202406-000754$UNICHEM$$$$$F$Y$$$20240911$$CN$US$
243048141$24304814$1$I$20240508$20240520$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202405-000527$UNICHEM$$68$YR$E$M$Y$$$20240910$$CN$US$
243048151$24304815$1$I$$20230913$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202309-001201$UNICHEM$$$$$M$Y$$$20240911$$CN$US$
243048161$24304816$1$I$$20240118$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202401-000042$UNICHEM$$83$YR$E$$Y$$$20240911$$CN$US$
243048172$24304817$2$F$$20240915$20240910$20240918$EXP$$US-ABBVIE-5910661$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243048191$24304819$1$I$$20240222$20240910$20240910$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202402-000155$UNICHEM$$65$YR$E$F$Y$46.7$KG$20240911$$CN$US$
243048201$24304820$1$I$$20240906$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144126$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240911$$CN$US$US
243048211$24304821$1$I$20240801$20240905$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142205$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240911$$PH$US$US
243048222$24304822$2$F$$20240912$20240910$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143461$BRISTOL MYERS SQUIBB$Miyake Y, et al. MDS-related intestinal disease in which azacitidine was markedly effective. The 112th Annual Meeting of the Japan Gastroenterological Endoscopy Society, Kinki Branch. 2024;100.$73$YR$E$M$Y$$$20240918$$HP$JP$JP
243048241$24304824$1$I$20240101$20240906$20240910$20240910$EXP$$CO-ABBVIE-5913686$ABBVIE$$$$$F$Y$78$KG$20240910$$CN$CO$CO
243048251$24304825$1$I$$20240905$20240910$20240910$EXP$$US-ABBVIE-5910679$ABBVIE$$$$$M$Y$$$20240910$$CN$US$US
243048261$24304826$1$I$20240711$20240902$20240910$20240910$EXP$$TW-TAKEDA-2024TUS088480$TAKEDA$$37$YR$$M$Y$$$20240910$$CN$TW$TW
243048271$24304827$1$I$20170101$20240903$20240910$20240910$PER$$US-SA-2024SA262122$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240911$$MD$US$US
243048281$24304828$1$I$20240819$20240905$20240910$20240910$EXP$$US-ABBVIE-5909009$ABBVIE$$54$YR$$M$Y$$$20240910$$CN$US$US
243048302$24304830$2$F$20240318$20240909$20240910$20240916$EXP$$US-TAKEDA-2023TUS109792$TAKEDA$$69$YR$$F$Y$68$KG$20240916$$CN$US$US
243048311$24304831$1$I$$20240905$20240910$20240910$EXP$$JP-009507513-2409JPN001466J$MERCK$$8$DEC$$F$Y$$$20240910$$MD$JP$JP
243048321$24304832$1$I$20240101$20240905$20240910$20240910$EXP$$CA-ABBVIE-5913674$ABBVIE$$31$YR$$M$Y$$$20240910$$MD$CA$CA
243048341$24304834$1$I$20240101$20240905$20240910$20240910$EXP$$US-ABBVIE-5913586$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243048351$24304835$1$I$20220101$20240905$20240910$20240910$EXP$$US-ABBVIE-5353668$ABBVIE$$67$YR$$F$Y$106.14$KG$20240910$$HP$US$US
243048361$24304836$1$I$$20240905$20240910$20240910$EXP$$US-ABBVIE-5913628$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243048371$24304837$1$I$$20240910$20240910$20240910$PER$$US-DSJP-DSJ-2024-144454$DAIICHI$Cyclophosphamide/Lenvatinib Various toxicities and lack of efficacy: case report. Drug Safety: ADR Case Report. 2024;1-4$67$YR$$F$Y$$$20240911$$HP$US$US
243048381$24304838$1$I$$20240906$20240910$20240910$EXP$$US-ABBVIE-5914019$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243048391$24304839$1$I$$20240906$20240910$20240910$EXP$$CN-TAKEDA-2024TUS089654$TAKEDA$$$$$M$Y$$$20240910$$CN$CN$CN
243048403$24304840$3$F$20240902$20240920$20240910$20240923$PER$$US-ROCHE-10000073639$ROCHE$$73$YR$E$F$Y$$$20240923$$CN$US$US
243048411$24304841$1$I$$20240903$20240910$20240910$PER$$US-ROCHE-10000074015$ROCHE$$$$$F$Y$$$20240911$$CN$US$US
243048421$24304842$1$I$$20240904$20240910$20240910$EXP$$JP-AstraZeneca-2024A198695$ASTRAZENECA$$64$YR$$F$Y$$$20240911$$MD$JP$
243048431$24304843$1$I$$20240906$20240910$20240910$EXP$$US-JNJFOC-20240919874$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243048441$24304844$1$I$20240713$20240906$20240910$20240910$EXP$$CA-ABBVIE-5916579$ABBVIE$$66$YR$$M$Y$$$20240910$$CN$CA$CA
243048451$24304845$1$I$$20240905$20240910$20240910$PER$$US-ABBVIE-5909965$ABBVIE$$$$$$Y$$$20240910$$CN$US$US
243048461$24304846$1$I$$20240830$20240910$20240910$EXP$$US-Noden Pharma DAC-NOD202409-000120$NODEN PHARMA$$$$$$Y$$$20240911$$HP$US$
243048471$24304847$1$I$$20240909$20240910$20240910$EXP$$US-ABBVIE-5916805$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243048481$24304848$1$I$$20240909$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143863$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240911$$CN$US$US
243048501$24304850$1$I$20240101$20240906$20240910$20240910$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-144110$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240911$$MD$FR$FR
243048511$24304851$1$I$20240812$20240829$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138891$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$81.5$KG$20240911$$PH$US$US
243048521$24304852$1$I$$20240905$20240910$20240910$PER$$US-009507513-2409USA002486$MERCK$$$$$F$Y$$$20240910$$CN$US$US
243048532$24304853$2$F$20240906$20240910$20240910$20240911$PER$$US-AMGEN-USASP2024180073$AMGEN$$72$YR$E$F$Y$$$20240911$$CN$US$US
243048541$24304854$1$I$$20240905$20240910$20240910$PER$$US-AMGEN-USASP2024177967$AMGEN$$$$$$Y$$$20240910$$CN$US$US
243048561$24304856$1$I$20240101$20240905$20240910$20240910$EXP$$US-ABBVIE-5915709$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243048571$24304857$1$I$$20240830$20240910$20240910$EXP$$PT-ABBVIE-5906965$ABBVIE$Ribeiro M, Oliveira J,  Meira J, Soares-dos-Reis R, Lu?s Silva M, Albuquerque L, et al. When a red eye is a red flag: a nontraumatic case of a direct carotid-cavernous fistula. journal of neuro-ophthalmology. 2024; 44(3) e311-e313.$67$YR$$F$Y$$$20240910$$MD$PT$PT
243048581$24304858$1$I$$20240904$20240910$20240910$EXP$$US-ABBVIE-5913762$ABBVIE$$$$$M$Y$$$20240910$$MD$US$US
243048591$24304859$1$I$20240723$20240903$20240910$20240910$EXP$$CN-AstraZeneca-2024A202413$ASTRAZENECA$$63$YR$$F$Y$$$20240911$$MD$CN$
243048601$24304860$1$I$$20240909$20240910$20240910$PER$$US-AstraZeneca-2024A205879$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243048611$24304861$1$I$$20240903$20240910$20240910$EXP$$US-AstraZeneca-2024A200641$ASTRAZENECA$$$$$$Y$$$20240911$$CN$US$
243048621$24304862$1$I$$20240904$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142668$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240911$$CN$US$US
243048631$24304863$1$I$$20240905$20240910$20240910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142288$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$86.18$KG$20240911$$HP$US$US
243048641$24304864$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179447$AMGEN$$$$$M$Y$$$20240910$$CN$US$US
243048651$24304865$1$I$$20240906$20240910$20240910$PER$$US-AMGEN-USASP2024179034$AMGEN$$$$$$Y$$$20240910$$HP$US$US
243048661$24304866$1$I$$20240904$20240910$20240910$PER$$US-AMGEN-USASP2024178419$AMGEN$$40$YR$A$M$Y$$$20240910$$CN$US$US
243048671$24304867$1$I$$20240828$20240910$20240910$PER$$US-Encube-001309$ENCUBE ETHICALS$$$$$$Y$$$20240910$$CN$US$
243048681$24304868$1$I$$20240903$20240910$20240910$EXP$$JP-JNJFOC-20240925554$JOHNSON AND JOHNSON$Sowa H, Minatsuki H, Hatano M, Komuro K, Komuro K. [The month^s case A case of pulmonary hypertension developed during administration of Qingdai for ulcerative colitis] The Journal of the Japanese Society of Internal Medicine. 2024.8.10;113:8:1428-1432$29$YR$A$F$Y$$$20240911$$MD$JP$JP
243048692$24304869$2$F$20240101$20240910$20240910$20240919$EXP$$IE-ABBVIE-5913696$ABBVIE$$70$YR$$M$Y$$$20240919$$CN$IE$IE
243048702$24304870$2$F$20240604$20240905$20240910$20240914$EXP$$JP-JNJFOC-20240770970$JOHNSON AND JOHNSON$$66$YR$E$M$Y$82$KG$20240914$$MD$JP$JP
243048711$24304871$1$I$$20240831$20240910$20240910$PER$$US-ABBVIE-5904552$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243048721$24304872$1$I$20220201$20240903$20240910$20240910$EXP$$HR-CELLTRION INC.-2023HR008535$CELLTRION$$$$$$Y$$$20240911$$CN$HR$HR
243048731$24304873$1$I$20240208$20240829$20240910$20240910$EXP$$CA-CELLTRION INC.-2022CA022461$CELLTRION$$$$$$Y$$$20240911$$MD$CA$CA
243048741$24304874$1$I$20240101$20240903$20240910$20240910$EXP$$US-ABBVIE-5905978$ABBVIE$$$$$F$Y$$$20240910$$CN$US$US
243048751$24304875$1$I$20240831$20240905$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142060$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240911$$CN$US$US
243048771$24304877$1$I$20240829$20240904$20240910$20240910$EXP$$CO-GSK-CO2024AMR111118$GLAXOSMITHKLINE$$$$$$Y$$$20240910$$CN$CO$CO
243048781$24304878$1$I$$20240905$20240910$20240910$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141595$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$80.74$KG$20240911$$CN$US$US
243048791$24304879$1$I$20240101$20240903$20240911$20240911$EXP$$IL-ABBVIE-5907076$ABBVIE$$60$YR$$M$Y$$$20240910$$MD$IL$IL
243048801$24304880$1$I$$20240910$20240911$20240911$EXP$$JP-TAKEDA-2024TJP013323$TAKEDA$$8$DEC$$F$Y$$$20240910$$HP$JP$JP
243048811$24304881$1$I$20240815$20240906$20240911$20240911$EXP$$CN-AstraZeneca-2024A204128$ASTRAZENECA$$52$YR$$F$Y$72$KG$20240911$$MD$CN$
243048821$24304882$1$I$20240101$20240905$20240911$20240911$EXP$$CA-PFIZER INC-202400021356$PFIZER$$26$YR$$M$Y$$$20240910$$MD$CA$CA
243048831$24304883$1$I$$20240905$20240911$20240911$EXP$$US-AstraZeneca-2024A204089$ASTRAZENECA$$$$$M$Y$88.5$KG$20240911$$CN$US$
243048841$24304884$1$I$$20240906$20240911$20240911$EXP$$AU-PFIZER INC-PV202400117320$PFIZER$$$$$F$Y$$$20240910$$CN$AU$AU
243048851$24304885$1$I$$20240906$20240911$20240911$EXP$$US-PFIZER INC-202400252226$PFIZER$$51$YR$$F$Y$$$20240910$$CN$US$US
243048861$24304886$1$I$$20240812$20240911$20240911$PER$$US-009507513-2409USA002981$MERCK$$$$C$$Y$$$20240911$$HP$US$US
243048871$24304887$1$I$20230101$20240909$20240911$20240911$EXP$$US-PFIZER INC-202400253510$PFIZER$$61$YR$$F$Y$$$20240910$$CN$US$US
243048881$24304888$1$I$$20240905$20240911$20240911$PER$$US-ROCHE-10000076129$ROCHE$$55$YR$A$M$Y$$$20240911$$CN$US$US
243048891$24304889$1$I$$20240821$20240911$20240911$PER$$US-SA-2024SA259288$SANOFI AVENTIS$$$$C$M$Y$$$20240911$$HP$US$US
243048901$24304890$1$I$20240401$20240902$20240911$20240911$PER$$US-SA-2024SA261933$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240911$$MD$US$US
243048921$24304892$1$I$20240101$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179791$AMGEN$$58$YR$A$F$Y$$$20240910$$CN$US$US
243048931$24304893$1$I$$20240903$20240911$20240911$PER$$US-AMGEN-USASP2024176275$AMGEN$$$$$$Y$$$20240910$$HP$US$US
243048941$24304894$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004599$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240910$$CN$US$US
243048971$24304897$1$I$$20240904$20240911$20240911$30DAY$$US-GSK-US2024110231$GLAXOSMITHKLINE$$$$$M$Y$$$20240911$$CN$US$US
243048981$24304898$1$I$20240801$20240909$20240911$20240911$EXP$$JP-TAKEDA-2024TJP013320$TAKEDA$$$$$$Y$$$20240911$$MD$JP$JP
243049011$24304901$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA258978$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240911$$CN$US$US
243049021$24304902$1$I$$20240829$20240911$20240911$EXP$$US-ASTELLAS-2024-AER-004154$ASTELLAS$Ansari A. Silent Manifestations of Disseminated Nocardia in a Renal Transplant Patient. Cureus Part Of Springer Nature. 2024;16(7): 1-4. doi:10.7759/cureus.65523.$45$YR$A$M$Y$$$20240911$$HP$US$US
243049031$24304903$1$I$20240701$20240803$20240911$20240911$PER$$US-009507513-2408USA002197$MERCK$$42$YR$$F$Y$$$20240911$$CN$US$US
243049041$24304904$1$I$$20240906$20240911$20240911$PER$$US-ROCHE-10000077064$ROCHE$$$$A$M$Y$$$20240911$$HP$US$US
243049051$24304905$1$I$20240801$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143794$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240911$$MD$US$US
243049061$24304906$1$I$20240715$20240906$20240911$20240911$EXP$FR-AFSSAPS-BX2024001742$FR-JNJFOC-20240923509$JOHNSON AND JOHNSON$$47$YR$A$M$Y$88$KG$20240911$$MD$FR$FR
243049071$24304907$1$I$$20240906$20240911$20240911$PER$$US-ROCHE-10000076547$ROCHE$$$$E$M$Y$$$20240911$$CN$US$US
243049081$24304908$1$I$$20240906$20240911$20240911$PER$$US-ROCHE-10000076546$ROCHE$$$$A$F$Y$$$20240911$$CN$US$US
243049091$24304909$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA259653$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240911$$HP$US$US
243049102$24304910$2$F$$20240910$20240911$20240916$PER$$US-ROCHE-10000077285$ROCHE$$$$E$F$Y$$$20240916$$MD$US$US
243049111$24304911$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA259193$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240911$$HP$US$US
243049121$24304912$1$I$20240801$20240828$20240911$20240911$PER$$US-SA-2024SA259716$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240911$$HP$US$US
243049131$24304913$1$I$$20240909$20240911$20240911$PER$$NVSC2024US181411$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243049141$24304914$1$I$20240903$20240904$20240911$20240911$PER$$US-ABBVIE-5909808$ABBVIE$$38$YR$$F$Y$$$20240911$$MD$US$US
243049151$24304915$1$I$$20240906$20240911$20240911$PER$$US-ROCHE-10000077103$ROCHE$$$$A$F$Y$$$20240911$$CN$US$US
243049161$24304916$1$I$$20240905$20240911$20240911$EXP$$US-ABBVIE-5909777$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243049181$24304918$1$I$$20240902$20240911$20240911$EXP$$US-ABBVIE-5906068$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243049191$24304919$1$I$$20240905$20240911$20240911$EXP$$CA-ABBVIE-5913678$ABBVIE$$$$A$F$Y$$$20240911$$MD$CA$CA
243049201$24304920$1$I$$20240905$20240911$20240911$EXP$$US-ABBVIE-5910102$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243049211$24304921$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA262101$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240911$$HP$US$US
243049221$24304922$1$I$$20240821$20240911$20240911$PER$$US-SA-2024SA259281$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240911$$MD$US$US
243049231$24304923$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA262094$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240911$$HP$US$US
243049241$24304924$1$I$$20240904$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003595$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240911$$CN$US$US
243049251$24304925$1$I$20240907$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005352$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240911$$CN$US$US
243049261$24304926$1$I$20240701$20240828$20240911$20240911$EXP$$US-UCBSA-2024044084$UCB$$31$YR$$M$Y$$$20240911$$HP$US$US
243049271$24304927$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144206$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240911$$CN$US$US
243049281$24304928$1$I$20211028$20240904$20240911$20240911$EXP$$CA-JNJFOC-20211124137$JOHNSON AND JOHNSON$$9$YR$C$F$Y$34.5$KG$20240911$$HP$CA$CA
243049291$24304929$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5914335$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243049301$24304930$1$I$$20240906$20240911$20240911$EXP$$US-ABBVIE-5915240$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243049311$24304931$1$I$$20240904$20240911$20240911$EXP$$AU-ABBVIE-5900954$ABBVIE$$$$$M$Y$$$20240911$$CN$AU$AU
243049321$24304932$1$I$$20240904$20240911$20240911$EXP$$US-ABBVIE-5908811$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243049332$24304933$2$F$20240701$20240923$20240911$20240928$EXP$$CA-ABBVIE-5906944$ABBVIE$$$$A$M$Y$$$20240928$$CN$CA$CA
243049341$24304934$1$I$$20240903$20240911$20240911$EXP$$ZA-AstraZeneca-2024A201559$ASTRAZENECA$$76$YR$$F$Y$$$20240911$$CN$ZA$
243049351$24304935$1$I$20240903$20240909$20240911$20240911$EXP$$CA-ABBVIE-5916574$ABBVIE$$79$YR$$M$Y$$$20240911$$CN$CA$CA
243049361$24304936$1$I$20240801$20240905$20240911$20240911$EXP$$US-ABBVIE-5914549$ABBVIE$$14$YR$$M$Y$$$20240911$$CN$US$US
243049371$24304937$1$I$$20240828$20240911$20240911$EXP$$CA-UCBSA-2024044279$UCB$$$$$M$Y$$$20240911$$CN$CA$CA
243049382$24304938$2$F$$20240905$20240911$20240918$PER$$US-ABBVIE-5913557$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243049391$24304939$1$I$$20240902$20240911$20240911$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP011393$STRIDES$Haritha S, Pavithra R, Rallabandi P, Lakshmanan S, Sowmini PR, Sakthi VS, et al.. Anticoagulant-induced Spinal Epidural Hematoma with Spontaneous Recovery.. J-Assoc-Physicians-India. 2024;72 (8):114$71$YR$$M$Y$$$20240911$$MD$IN$IN
243049401$24304940$1$I$20240901$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179954$AMGEN$$32$YR$A$F$Y$$$20240910$$CN$US$US
243049411$24304941$1$I$20230501$20240906$20240911$20240911$EXP$GB-MHRA-31414759$GB-GSK-GB2024GSK111447$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$GB$GB
243049421$24304942$1$I$$20240905$20240911$20240911$EXP$$PT-CHATTEMPRD-2024OHG008376$CHATTEM$$$$E$$Y$$$20240911$$HP$PT$PT
243049431$24304943$1$I$$20240903$20240911$20240911$EXP$$HR-CHATTEMPRD-2011SA056460$CHATTEM$Vrabec-Matkovic D, Budisin V, Pahic R.. Failure in long-term treatment of chronic pain in cervical spondylotic myelopathy.. Medicinski Glasnik. 2011 Aug 1;8 (2):309-11.$31$YR$A$F$Y$$$20240911$$HP$HR$HR
243049441$24304944$1$I$$20240909$20240911$20240911$EXP$$GB-HALEON-2195926$Haleon PLC$$29$YR$$M$Y$$$20240910$$HP$GB$GB
243049451$24304945$1$I$20240801$20240905$20240911$20240911$EXP$$CO-ABBVIE-5913699$ABBVIE$$69$YR$$F$Y$49$KG$20240911$$CN$CO$CO
243049461$24304946$1$I$20240816$20240906$20240911$20240911$EXP$$US-ABBVIE-5915595$ABBVIE$$81$YR$$F$Y$$$20240911$$HP$US$US
243049471$24304947$1$I$$20240903$20240911$20240911$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP011387$STRIDES$De Zen L, Divisic A, Molinaro G, Solidoro S, Barbi E.. Dexmedetomidine at Home for Intractable Dystonia and Insomnia in Children With Special Needs: A Case Series.. J-Pain-Symptom-Manage. 2023;66 (6):e653-e657$$$$F$Y$$$20240911$$HP$IT$IT
243049481$24304948$1$I$$20240904$20240911$20240911$EXP$$LB-STRIDES ARCOLAB LIMITED-2024SP011456$STRIDES$Salam K, El S, Tarhini H, Bazarbachi A, Moukalled N, El-Cheikh J, et al.. CT-694 Haplo-Identical Stem Cell Transplant Outcomes in Patients with Donor-Specific Antibodies Receiving Desensitization: Insights From A Single-Center Experience.. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S614-S615.$$$$$Y$$$20240911$$MD$LB$LB
243049491$24304949$1$I$$20240904$20240911$20240911$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011458$STRIDES$Ebong I L, Delgado A, Aranda S S, et al.. Idiopathic Intracranial Hypertension in an Adolescent With Recent Human Immunodeficiency Virus (HIV) Diagnosis: A Challenging Etiological Dilemma.. Cureus. 2024;16(5):e60001$15$YR$$F$Y$$$20240911$$HP$US$US
243049501$24304950$1$I$$20240904$20240911$20240911$EXP$$SI-STRIDES ARCOLAB LIMITED-2024SP011459$STRIDES$Bezeljak N, Jerman A, Grenc D, Zorman SK.. Inadvertent Intoxication with Salbutamol, Treated with Hemodialysis: A Case Report and Brief Review of the Literature.. Case-Rep-Nephrol-Dial. 2024;14 (1):88-96$69$YR$$M$Y$$$20240911$$HP$SI$SI
243049511$24304951$1$I$$20240904$20240911$20240911$EXP$$US-ABBVIE-5676908$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243049521$24304952$1$I$20240625$20240905$20240911$20240911$EXP$$US-ABBVIE-5909847$ABBVIE$$66$YR$$F$Y$$$20240911$$CN$US$US
243049531$24304953$1$I$$20240831$20240911$20240911$PER$$US-P+L Developments of Newyork Corporation-2161460$PL DEVELOPMENTS$$$$$F$Y$$$20240911$$$US$US
243049542$24304954$2$F$$20240910$20240911$20240921$EXP$$JP-UCBSA-2024044807$UCB$$8$DEC$$M$Y$$$20240921$$MD$JP$JP
243049552$24304955$2$F$20240513$20240916$20240911$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024110750$VIIV$$36$YR$$M$Y$$$20240926$$HP$US$US
243049561$24304956$1$I$$20240909$20240911$20240911$EXP$$NVSC2024ET181185$NOVARTIS$$$$$M$Y$$$20240911$$MD$ET$ET
243049571$24304957$1$I$$20240828$20240911$20240911$EXP$$CN-GE HEALTHCARE-2024CSU010121$GE HEALTHCARE$$53$YR$$F$Y$$$20240911$$HP$CN$CN
243049581$24304958$1$I$20240907$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180016$AMGEN$$78$YR$E$F$Y$$$20240910$$CN$US$US
243049591$24304959$1$I$$20240902$20240911$20240911$EXP$$EG-AMGEN-EGYSP2024175830$AMGEN$Abdelhalim A.. MPN-485 A Case of Primary Autoimmune Myelofibrosis Complicated by Mucormycosis Achieving Treatment Success. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S435-S436$42$YR$A$M$Y$$$20240910$$MD$EG$EG
243049602$24304960$2$F$20240101$20240911$20240911$20240930$PER$$US-009507513-2408USA005234$MERCK$$$$$F$Y$53.061$KG$20240930$$CN$US$US
243049611$24304961$1$I$$20240905$20240911$20240911$EXP$$US-AstraZeneca-2024A203035$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243049621$24304962$1$I$20240712$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A204462$ASTRAZENECA$$31178$DY$$F$Y$$$20240911$$CN$US$
243049631$24304963$1$I$$20240903$20240911$20240911$EXP$$CN-AstraZeneca-2024A202659$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$CN$
243049641$24304964$1$I$20240801$20240816$20240911$20240911$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004822$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240911$$CN$US$US
243049651$24304965$1$I$20240903$20240905$20240911$20240911$EXP$$US-ABBVIE-5909568$ABBVIE$$52$YR$$M$Y$$$20240911$$CN$US$US
243049661$24304966$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006134$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240911$$CN$US$US
243049671$24304967$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142331$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240911$$CN$US$US
243049681$24304968$1$I$$20240905$20240911$20240911$EXP$$US-ABBVIE-5913721$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243049691$24304969$1$I$$20240905$20240911$20240911$EXP$$CA-JNJFOC-20240915222$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$HP$CA$CA
243049701$24304970$1$I$20240601$20240904$20240911$20240911$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR111161$VIIV$$51$YR$$M$Y$$$20240911$$PH$US$US
243049711$24304971$1$I$$20240902$20240911$20240911$EXP$$IN-NOVITIUMPHARMA-2024INNVP01787$NOVITIUM PHARMA$Sanatkumar Bharamu Nyamagoud.Actinomycetoma of Left Foot-A Case Report of Neglected Tropical Disease and Medication Non-adherence.Archives of Pharmacy Practice.2023;14(3):21-25$27$YR$A$M$Y$$$20240911$$HP$IN$IN
243049721$24304972$1$I$$20240904$20240911$20240911$EXP$$CR-STRIDES ARCOLAB LIMITED-2024SP011395$STRIDES$Fernandoenez F.. CLL-457 T-Cell Prolymphocytic Leukemia: A Case Report.. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S354 abstr. CLL-457.$86$YR$$M$Y$$$20240911$$HP$CR$CR
243049733$24304973$3$F$20240728$20240910$20240911$20240919$PER$$US-AMGEN-USASP2024180511$AMGEN$$46$YR$A$F$Y$$$20240919$$CN$US$US
243049741$24304974$1$I$20140409$20240904$20240911$20240911$EXP$$US-CHEPLA-2024011406$CHEPLAPHARM$$63$YR$$M$Y$112.19$KG$20240910$$MD$COUNTRY NOT SPECIFIED$US
243049751$24304975$1$I$20230101$20240903$20240911$20240911$EXP$$US-ABBVIE-5907453$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243049761$24304976$1$I$$20240905$20240911$20240911$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011420$STRIDES$Takada N, Fukui T, Irie H, Funatsu Y, Koh H.. Immune Checkpoint Inhibitor-induced Sclerosing Cholangitis: Three Cases Reported from Our Hospital. [Japanese].. Haigan. 2024;64 (3):193-199$73$YR$$F$Y$$$20240911$$HP$JP$JP
243049771$24304977$1$I$$20240906$20240911$20240911$EXP$GB-MHRA-MED-202409040811487310-HNSRJ$GB-STRIDES ARCOLAB LIMITED-2024SP011379$STRIDES$$23$YR$$F$Y$$$20240911$$CN$GB$GB
243049784$24304978$4$F$20240717$20240926$20240911$20240927$EXP$$IL-ABBVIE-5914441$ABBVIE$$33$YR$$M$Y$71$KG$20240927$$MD$IL$IL
243049791$24304979$1$I$$20240909$20240911$20240911$EXP$$TR-ABBVIE-5915789$ABBVIE$$21$YR$$F$Y$$$20240911$$MD$TR$TR
243049802$24304980$2$F$$20240910$20240911$20240916$EXP$$US-ROCHE-10000077704$ROCHE$$89$YR$E$M$Y$$$20240916$$CN$US$US
243049811$24304981$1$I$$20240904$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US079204$SANDOZ$$$$$F$Y$$$20240911$$MD$US$US
243049823$24304982$3$F$20240828$20240917$20240911$20240924$EXP$$NVSC2024SA175648$NOVARTIS$$0$YR$$F$Y$5.1$KG$20240924$$HP$SA$SA
243049832$24304983$2$F$20240101$20240912$20240911$20240917$EXP$$US-ABBVIE-5909906$ABBVIE$$55$YR$$M$Y$113.4$KG$20240917$$CN$US$US
243049841$24304984$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180467$AMGEN$$$$$$Y$$$20240910$$CN$US$US
243049851$24304985$1$I$$20240907$20240911$20240911$PER$$US-AMGEN-USASP2024179935$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
243049861$24304986$1$I$20210201$20240903$20240911$20240911$EXP$$FR-AMGEN-FRANI2024176017$AMGEN$$50$YR$A$F$Y$80$KG$20240910$$MD$FR$FR
243049872$24304987$2$F$$20240909$20240911$20240917$EXP$$US-AstraZeneca-2024A202895$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$US$
243049881$24304988$1$I$20240802$20240905$20240911$20240911$EXP$$GB-AstraZeneca-2024A202512$ASTRAZENECA$$$$$$Y$$$20240911$$MD$GB$
243049891$24304989$1$I$$20240909$20240911$20240911$PER$$US-AstraZeneca-2024A205702$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243049901$24304990$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180101$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
243049911$24304991$1$I$$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A203455$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243049921$24304992$1$I$20240903$20240905$20240911$20240911$PER$$US-AMGEN-USASP2024178035$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
243049931$24304993$1$I$$20240906$20240911$20240911$EXP$GB-PHARMVIT-4556-3352-ER24-RN1169$GB-STRIDES ARCOLAB LIMITED-2024SP011470$STRIDES$$53$YR$$M$Y$$$20240911$$MD$GB$GB
243049941$24304994$1$I$20240801$20240827$20240911$20240911$PER$$US-SA-2024SA179109$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240911$$MD$US$US
243049951$24304995$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA259443$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240911$$MD$US$US
243049961$24304996$1$I$$20240812$20240911$20240911$PER$$US-009507513-2409USA002982$MERCK$$$$C$$Y$$$20240911$$HP$US$US
243049972$24304997$2$F$20240101$20240911$20240911$20240916$PER$$US-AMGEN-USASP2024179655$AMGEN$$$$E$F$Y$$$20240915$$CN$US$US
243049981$24304998$1$I$20240909$20240909$20240911$20240911$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050628$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240911$$HP$CO$CO
243049991$24304999$1$I$$20240828$20240911$20240911$EXP$$ES-SAMSUNG BIOEPIS-SB-2024-26651$SAMSUNG BIOEPIS$Salmons P G. Insights into new-onset arthritis in patients with hidradenitis suppurativa Garbayo-Salmons. Acta Derm Venereol 2024. 2024 Jun 25;1-2. doi:10.2340/actadv.v104.40145..$29$YR$A$F$Y$$$20240911$$HP$ES$ES
243050001$24305000$1$I$$20240822$20240911$20240911$PER$$US-TEVA-VS-3236281$TEVA$$$$$F$Y$$$20240911$$CN$US$US
243050011$24305001$1$I$$20240828$20240911$20240911$EXP$$GR-SAMSUNG BIOEPIS-SB-2024-26645$SAMSUNG BIOEPIS$Bolla E. Optimal management of ocular complications in axial spondyloarthritis: rethinking subcutaneous infliximab.. Rheumatology. 2024 Aug 21;1-5. doi:10.1093/rheumatology/keae457.$46$YR$A$F$Y$$$20240911$$HP$GR$GR
243050021$24305002$1$I$20240801$20240827$20240911$20240911$PER$$US-SA-2024SA262220$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240911$$MD$US$US
243050031$24305003$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260581$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240911$$CN$US$US
243050041$24305004$1$I$20240718$20240829$20240911$20240911$PER$$US-SA-2024SA260340$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240911$$HP$US$US
243050051$24305005$1$I$20240101$20240824$20240911$20240911$PER$$US-SA-2024SA258873$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240911$$MD$US$US
243050061$24305006$1$I$20240826$20240902$20240911$20240911$EXP$$CN-HALEON-2194822$Haleon PLC$$26$YR$$F$Y$$$20240911$$HP$CN$CN
243050071$24305007$1$I$20240801$20240829$20240911$20240911$PER$$US-SA-2024SA260800$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240911$$MD$US$US
243050081$24305008$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A204778$ASTRAZENECA$$$$$F$Y$68.5$KG$20240911$$CN$US$
243050091$24305009$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA259642$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240911$$MD$US$US
243050101$24305010$1$I$20240101$20240904$20240911$20240911$EXP$$CA-ABBVIE-5908064$ABBVIE$$$$$F$Y$$$20240911$$CN$CA$CA
243050111$24305011$1$I$$20240906$20240911$20240911$EXP$$TH-ROCHE-10000075820$ROCHE$$67$YR$E$F$Y$$$20240911$$HP$TH$TH
243050121$24305012$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141557$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240911$$HP$US$US
243050131$24305013$1$I$20240803$20240909$20240911$20240911$EXP$$US-ABBVIE-5916819$ABBVIE$$16$YR$$F$Y$$$20240911$$CN$US$US
243050142$24305014$2$F$$20240904$20240911$20240913$EXP$$PT-AUROBINDO-AUR-APL-2024-037283$AUROBINDO$Henriques C, Lima S, Costa RS, Gon?alves J, Maia H, Maciel R.. DRUG INDUCED LIVER INJURY POR UM CASO CL?NICO (DRUG INDUCED LIVER INJURY FOR A CLINICAL CASE). Doen?as gastrenterol?gicas e doen?as hep?ticas (Gastroenterological diseasesand. 2024;30(Sup 1:1030$88$YR$$F$Y$$$20240913$$MD$PT$PT
243050151$24305015$1$I$$20240904$20240911$20240911$EXP$$JP-SANDOZ INC.-SDZ2024JP078996$SANDOZ$Shinya T, Ishida S. A case of a rheumatoid arthritis patient who developed oral mucositis after accidentally taking methotrexate preparations every day. Program of the 33rd Annual Meeting of the Japanese Society of Dental Health Care. 2024;P2-6$80$YR$$F$Y$$$20240911$$MD$JP$JP
243050161$24305016$1$I$20240801$20240905$20240911$20240911$EXP$$IT-TAKEDA-2024TUS088986$TAKEDA$$58$YR$$M$Y$$$20240911$$MD$IT$IT
243050171$24305017$1$I$20240101$20240725$20240911$20240911$EXP$$US-SPECGX-T202401525$SPECGX$$$$$F$Y$73$KG$20240911$$CN$US$US
243050181$24305018$1$I$20240812$20240827$20240911$20240911$PER$$US-SA-2024SA259946$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240911$$MD$US$US
243050191$24305019$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260466$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240911$$HP$US$US
243050211$24305021$1$I$$20240822$20240911$20240911$PER$$US-SA-2024SA259768$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240911$$MD$US$US
243050221$24305022$1$I$20240906$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005708$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240911$$CN$US$US
243050232$24305023$2$F$$20240909$20240911$20240912$PER$$US-JNJFOC-20240880926$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$PH$US$US
243050241$24305024$1$I$20240820$20240829$20240911$20240911$EXP$$US-Accord-445382$ACCORD$$60$YR$A$M$Y$$$20240910$$HP$US$US
243050251$24305025$1$I$$20240829$20240911$20240911$EXP$$JP-Accord-444691$ACCORD$Sakai Y, Ikawa Y, Takenaka M, Noguchi K, Fujiki T, Ikeda H, et al. Histopathological maturation in juvenile xanthogranuloma: a blueberry muffin infant mimicking aleukemic leukemia cutis. International journal of hematology. 2024;119:93-8.$$$I$F$Y$$$20240910$$MD$JP$JP
243050261$24305026$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A204603$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
243050272$24305027$2$F$20240101$20240917$20240911$20240924$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027573$UNITED THERAPEUTICS$$$$$F$Y$$$20240924$$$US$US
243050281$24305028$1$I$$20240905$20240911$20240911$EXP$$JP-AstraZeneca-2024A203174$ASTRAZENECA$$$$$M$Y$$$20240911$$MD$JP$
243050291$24305029$1$I$$20240903$20240911$20240911$EXP$$ZA-AstraZeneca-2024A200826$ASTRAZENECA$$46$YR$$M$Y$$$20240911$$CN$ZA$
243050301$24305030$1$I$$20240812$20240911$20240911$PER$$US-009507513-2409USA002983$MERCK$$$$C$$Y$$$20240911$$HP$US$US
243050311$24305031$1$I$20240408$20240830$20240911$20240911$EXP$PT-INFARMED-A202408-377$PT-Accord-444706$ACCORD$$60$YR$A$F$Y$$$20240910$$HP$PT$PT
243050321$24305032$1$I$$20240905$20240911$20240911$PER$$US-AstraZeneca-2024A202811$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
243050334$24305033$4$F$20240905$20240918$20240911$20240923$30DAY$$US-AMGEN-USASP2024178041$AMGEN$$47$YR$A$M$Y$89.8$KG$20240923$$PH$US$US
243050341$24305034$1$I$20240831$20240904$20240911$20240911$EXP$$US-ROCHE-10000074522$ROCHE$$58$YR$A$F$Y$$$20240911$$CN$US$US
243050351$24305035$1$I$20090101$20240909$20240911$20240911$EXP$$PL-SANDOZ INC.-NVSC2020PL135262$SANDOZ$$9$YR$$M$Y$$$20240911$$MD$PL$PL
243050361$24305036$1$I$20240101$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179853$AMGEN$$48$YR$A$F$Y$$$20240910$$HP$US$US
243050371$24305037$1$I$20240831$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179945$AMGEN$$67$YR$E$M$Y$$$20240910$$MD$US$US
243050381$24305038$1$I$$20240905$20240911$20240911$EXP$$US-ABBVIE-5914835$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243050391$24305039$1$I$20240301$20240831$20240911$20240911$EXP$$IT-AUROBINDO-AUR-APL-2024-044054$AUROBINDO$$76$YR$$F$Y$60$KG$20240911$$MD$IT$IT
243050401$24305040$1$I$$20240909$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US078709$SANDOZ$$39$YR$$M$Y$$$20240911$$MD$US$US
243050412$24305041$2$F$$20240910$20240911$20240912$PER$$US-TAKEDA-2024TUS089847$TAKEDA$$$$$$Y$$$20240912$$PH$US$US
243050421$24305042$1$I$20240907$20240909$20240911$20240911$PER$$US-HALEON-2196023$Haleon PLC$$27$YR$$M$Y$$$20240911$$CN$US$US
243050432$24305043$2$F$$20240910$20240911$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005243$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243050441$24305044$1$I$20230220$20240902$20240911$20240911$EXP$$ES-AUROBINDO-AUR-APL-2024-044288$AUROBINDO$$69$YR$$F$Y$65$KG$20240911$$PH$ES$ES
243050451$24305045$1$I$20240830$20240830$20240911$20240911$EXP$$CA-AMGEN-CANNI2024179892$AMGEN$$83$YR$E$M$Y$$$20240910$$CN$CA$CA
243050461$24305046$1$I$20240909$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180146$AMGEN$$29$YR$A$F$Y$$$20240910$$CN$US$US
243050471$24305047$1$I$$20240906$20240911$20240911$PER$$NVSC2024US180941$NOVARTIS$$$$$$Y$$$20240911$$MD$US$US
243050481$24305048$1$I$$20240902$20240911$20240911$EXP$$GB-AUROBINDO-AUR-APL-2024-043958$AUROBINDO$$$$$M$Y$100$KG$20240911$$CN$GB$GB
243050491$24305049$1$I$$20240909$20240911$20240911$PER$$US-BIOVITRUM-2024-US-011827$BIOVITRUM$$77$YR$$M$Y$$$20240911$$CN$US$US
243050502$24305050$2$F$$20240920$20240911$20240923$PER$$US-ROCHE-10000073862$ROCHE$$$$A$M$Y$113.4$KG$20240923$$HP$US$US
243050521$24305052$1$I$$20240903$20240911$20240911$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01821$NOVITIUM PHARMA$Boris Sorin.Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study.American Journal of Hematology.06-JUL-2023;98(9):E259-E262$79$YR$E$M$Y$$$20240911$$HP$FR$FR
243050531$24305053$1$I$$20240812$20240911$20240911$PER$$US-009507513-2409USA002984$MERCK$$$$C$$Y$$$20240911$$HP$US$US
243050541$24305054$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181492$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243050561$24305056$1$I$$20240904$20240911$20240911$PER$$US-ROCHE-10000074588$ROCHE$$$$$$Y$$$20240911$$CN$US$US
243050572$24305057$2$F$$20240910$20240911$20240912$PER$$US-ROCHE-10000075436$ROCHE$$$$$$Y$$$20240912$$CN$US$US
243050581$24305058$1$I$$20240904$20240911$20240911$PER$$US-ROCHE-10000074533$ROCHE$$$$$$Y$$$20240911$$PH$US$US
243050601$24305060$1$I$20240725$20240903$20240911$20240911$EXP$$FR-AstraZeneca-2024A199899$ASTRAZENECA$$59$YR$$M$Y$110$KG$20240911$$MD$FR$
243050611$24305061$1$I$20240901$20240909$20240911$20240911$EXP$$US-AstraZeneca-2024A205207$ASTRAZENECA$$$$$M$Y$$$20240911$$MD$US$
243050622$24305062$2$F$20240906$20240911$20240911$20240914$PER$$US-AMGEN-USASP2024180147$AMGEN$$83$YR$E$F$Y$$$20240913$$CN$US$US
243050631$24305063$1$I$20240825$20240903$20240911$20240911$EXP$$GB-AUROBINDO-AUR-APL-2024-044227$AUROBINDO$$55$YR$$M$Y$$$20240911$$HP$GB$GB
243050641$24305064$1$I$$20240909$20240911$20240911$PER$$NVSC2024US181467$NOVARTIS$$$$$F$Y$53.07$KG$20240911$$CN$US$US
243050651$24305065$1$I$20240711$20240905$20240911$20240911$PER$$US-ROCHE-10000075521$ROCHE$$36$YR$A$F$Y$111.13$KG$20240911$$HP$US$US
243050661$24305066$1$I$20240804$20240905$20240911$20240911$EXP$FR-AFSSAPS-TO2024001687$FR-ROCHE-10000075320$ROCHE$$55$YR$A$M$Y$87.9$KG$20240911$$PH$FR$FR
243050671$24305067$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006138$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243050692$24305069$2$F$20231001$20240909$20240911$20240921$EXP$NO-EMA-2024820-AUTODUP-1724183459492$NO-Accord-445033$ACCORD$$59$YR$A$M$Y$$$20240921$$MD$NO$NO
243050701$24305070$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144098$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240911$$HP$US$US
243050711$24305071$1$I$$20240906$20240911$20240911$PER$$US-ROCHE-10000076349$ROCHE$$$$A$M$Y$$$20240911$$CN$US$US
243050721$24305072$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA262000$SANOFI AVENTIS$$$$A$M$Y$86.36$KG$20240911$$MD$US$US
243050731$24305073$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA261968$SANOFI AVENTIS$$$$T$F$Y$50.8$KG$20240911$$MD$US$US
243050741$24305074$1$I$$20240906$20240911$20240911$PER$$US-ROCHE-10000077016$ROCHE$$69$YR$E$F$Y$$$20240911$$CN$US$US
243050751$24305075$1$I$$20240823$20240911$20240911$PER$$US-SA-2024SA258991$SANOFI AVENTIS$$$$A$M$Y$$$20240911$$MD$US$US
243050761$24305076$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260532$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240911$$CN$US$US
243050771$24305077$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260104$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240911$$CN$US$US
243050781$24305078$1$I$$20240904$20240911$20240911$EXP$$FR-AUROBINDO-AUR-APL-2024-044607$AUROBINDO$$54$YR$$M$Y$155$KG$20240911$$CN$FR$FR
243050791$24305079$1$I$$20240909$20240911$20240911$PER$$US-ROCHE-10000077332$ROCHE$$93$YR$E$F$Y$$$20240911$$CN$US$US
243050801$24305080$1$I$20240509$20240822$20240911$20240911$PER$$GT-TOLMAR, INC.-24GT052113$TOLMAR$$73$YR$$M$Y$$$20240911$$CN$GT$GT
243050811$24305081$1$I$20240524$20240823$20240911$20240911$PER$$NL-TOLMAR, INC.-24NL052121$TOLMAR$$63$YR$$M$Y$$$20240911$$CN$NL$NL
243050821$24305082$1$I$20240708$20240822$20240911$20240911$PER$$US-TOLMAR, INC.-24US050912$TOLMAR$$73$YR$$M$Y$$$20240911$$HP$US$US
243050831$24305083$1$I$$20240821$20240911$20240911$PER$$TR-TOLMAR, INC.-24TR052091$TOLMAR$$75$YR$$$Y$$$20240911$$HP$TR$TR
243050842$24305084$2$F$20240806$20240821$20240911$20240927$PER$$TR-TOLMAR, INC.-24TR052118$TOLMAR$$74$YR$$M$Y$$$20240927$$HP$TR$TR
243050852$24305085$2$F$20240823$20240823$20240911$20240913$PER$$TR-TOLMAR, INC.-24TR052184$TOLMAR$$76$YR$$M$Y$$$20240913$$PH$TR$TR
243050861$24305086$1$I$$20240903$20240911$20240911$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01816$NOVITIUM PHARMA$Boris Sorin.Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study.American Journal of Hematology.06-JUL-2023;98(9):E259-E262$70$YR$E$M$Y$$$20240911$$HP$FR$FR
243050871$24305087$1$I$20240101$20240905$20240911$20240911$EXP$$PT-AMGEN-PRTSP2024179469$AMGEN$$60$YR$A$M$Y$$$20240910$$MD$PT$PT
243050881$24305088$1$I$$20240905$20240911$20240911$EXP$$GB-AUROBINDO-AUR-APL-2024-044548$AUROBINDO$$$$$F$Y$$$20240911$$CN$GB$GB
243050891$24305089$1$I$$20240902$20240911$20240911$EXP$$GB-CELLTRION INC.-2024GB021218$CELLTRION$$$$$$Y$$$20240911$$CN$GB$GB
243050901$24305090$1$I$$20240905$20240911$20240911$PER$$US-ROCHE-10000075465$ROCHE$$53$YR$A$F$Y$$$20240911$$CN$US$US
243050911$24305091$1$I$$20240905$20240911$20240911$PER$$US-ROCHE-10000076121$ROCHE$$$$E$M$Y$$$20240911$$CN$US$US
243050921$24305092$1$I$$20240906$20240911$20240911$PER$$US-ROCHE-10000076572$ROCHE$$$$A$F$Y$$$20240911$$CN$US$US
243050942$24305094$2$F$$20240909$20240911$20240912$PER$$US-ROCHE-10000076521$ROCHE$$$$E$F$Y$$$20240912$$CN$US$US
243050951$24305095$1$I$$20240906$20240911$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143421$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240911$$MD$JP$JP
243050961$24305096$1$I$$20240905$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141644$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$63.05$KG$20240911$$CN$US$US
243050971$24305097$1$I$20240819$20240829$20240911$20240911$EXP$$CN-ASTELLAS-2024-AER-005523$ASTELLAS$$62$YR$A$F$Y$$$20240911$$PH$CN$CN
243050981$24305098$1$I$20240501$20240904$20240911$20240911$EXP$$FR-JNJFOC-20240919977$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240911$$PH$FR$FR
243050991$24305099$1$I$20240907$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180141$AMGEN$$26$YR$A$F$Y$$$20240910$$CN$US$US
243051011$24305101$1$I$20240903$20240905$20240911$20240911$PER$$US-ROCHE-10000076614$ROCHE$$12$YR$T$M$Y$$$20240911$$HP$US$US
243051021$24305102$1$I$$20240909$20240911$20240911$EXP$$US-ABBVIE-5915597$ABBVIE$$$$$M$Y$$$20240911$$MD$US$US
243051031$24305103$1$I$20240718$20240902$20240911$20240911$EXP$$CN-ROCHE-10000072468$ROCHE$$59$YR$A$F$Y$72$KG$20240911$$HP$CN$CN
243051042$24305104$2$F$$20240910$20240911$20240912$PER$$US-ROCHE-10000078022$ROCHE$$65$YR$E$F$Y$$$20240912$$CN$US$US
243051051$24305105$1$I$$20240818$20240911$20240911$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004817$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243051061$24305106$1$I$$20240909$20240911$20240911$PER$$US-ROCHE-10000077727$ROCHE$$$$E$M$Y$$$20240911$$CN$US$US
243051071$24305107$1$I$$20240906$20240911$20240911$PER$$US-UNITED THERAPEUTICS-UNT-2024-028158$UNITED THERAPEUTICS$$$$$M$Y$$$20240911$$$US$US
243051081$24305108$1$I$20240907$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179715$AMGEN$$$$$F$Y$$$20240910$$CN$US$US
243051091$24305109$1$I$20240101$20240905$20240911$20240911$PER$$US-ABBVIE-5909853$ABBVIE$$$$$F$Y$$$20240911$$HP$US$US
243051101$24305110$1$I$20240810$20240830$20240911$20240911$EXP$CN-HENLIUS-24CN016804$CN-Accord-445921$ACCORD$$52$YR$A$M$Y$63$KG$20240911$$MD$CN$CN
243051111$24305111$1$I$20240909$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005849$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240911$$CN$US$US
243051121$24305112$1$I$20240801$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005778$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243051131$24305113$1$I$$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143785$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$107.5$KG$20240911$$HP$US$US
243051141$24305114$1$I$$20240906$20240911$20240911$EXP$$NVSJ2024JP009377$NOVARTIS$$75$YR$$F$Y$$$20240911$$MD$JP$JP
243051152$24305115$2$F$20240101$20240909$20240911$20240913$PER$$US-AMGEN-USASP2024179958$AMGEN$$52$YR$A$M$Y$$$20240913$$CN$US$US
243051161$24305116$1$I$$20240907$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005592$ELI LILLY AND CO$$$$A$F$Y$$$20240911$$CN$US$US
243051172$24305117$2$F$$20240913$20240911$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143668$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240924$$MD$JP$JP
243051181$24305118$1$I$20240101$20240904$20240911$20240911$PER$$US-UNITED THERAPEUTICS-UNT-2024-028073$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240911$$$US$US
243051192$24305119$2$F$20240101$20240912$20240911$20240924$EXP$$US-ROCHE-10000071215$ROCHE$$70$YR$E$F$Y$$$20240924$$CN$US$US
243051201$24305120$1$I$20240801$20240902$20240911$20240911$EXP$$TN-EMD Serono-2024047325$EMD SERONO INC$$30$YR$A$M$Y$$$20240911$$CN$TN$TN
243051211$24305121$1$I$20240801$20240909$20240911$20240911$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050631$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240911$$HP$CO$CO
243051222$24305122$2$F$20240801$20240910$20240911$20240920$30DAY$$US-GSK-US2024112009$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240920$$MD$US$US
243051241$24305124$1$I$$20240907$20240911$20240911$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014604$JAZZ$$$$$F$Y$$$20240910$$CN$US$US
243051261$24305126$1$I$20240814$20240903$20240911$20240911$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161461$JIANGSU HENGRUI MEDICINE$$48$YR$$M$Y$$$20240911$$MD$CN$CN
243051271$24305127$1$I$$20240812$20240911$20240911$PER$$US-009507513-2409USA002985$MERCK$$$$C$$Y$$$20240911$$HP$US$US
243051281$24305128$1$I$20240831$20240905$20240911$20240911$EXP$$JP-JNJFOC-20240923111$JOHNSON AND JOHNSON$$66$YR$E$M$Y$82$KG$20240911$$MD$JP$JP
243051291$24305129$1$I$$20240902$20240911$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143008$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240911$$PH$JP$JP
243051301$24305130$1$I$20240101$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144146$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240911$$HP$US$US
243051311$24305131$1$I$$20240830$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139617$BRISTOL MYERS SQUIBB$$29$YR$A$F$Y$$$20240911$$CN$US$US
243051321$24305132$1$I$20240808$20240829$20240911$20240911$EXP$$CN-OCTA-ALB14924$OCTAPHARMA$$$$E$F$Y$63$KG$20240910$$HP$CN$CN
243051331$24305133$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009939$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243051341$24305134$1$I$$20240903$20240911$20240911$PER$$US-AstraZeneca-2024A200404$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
243051351$24305135$1$I$$20240905$20240911$20240911$EXP$$CA-ROCHE-10000074629$ROCHE$$72$YR$E$F$Y$82$KG$20240911$$HP$CA$CA
243051361$24305136$1$I$$20240909$20240911$20240911$EXP$$ES-SANDOZ INC.-SDZ2024ES078877$SANDOZ$$31$YR$$M$Y$$$20240911$$HP$ES$ES
243051371$24305137$1$I$$20240905$20240911$20240911$EXP$$CA-AstraZeneca-2024A204501$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$CA$
243051381$24305138$1$I$$20240830$20240911$20240911$EXP$$CA-AUROBINDO-AUR-APL-2024-044662$AUROBINDO$$30$YR$$F$Y$90$KG$20240911$$HP$CA$CA
243051391$24305139$1$I$$20240829$20240911$20240911$PER$$US-ABBVIE-5915585$ABBVIE$$$$$$Y$$$20240911$$HP$US$US
243051402$24305140$2$F$$20240917$20240911$20240923$EXP$$US-TEVA-VS-3240296$TEVA$Zhang Y, Bangert M, Chun M, Mattingly T, Zheng C. ACUTE AND CHRONIC INFECTIOUS COMPLICATIONS FOLLOWING GUNSHOT INJURIES: A CASE COMPARISON. South-Med-J 2022; 115 561.; Zhang Y, Bangert M, Chun M, Mattingly T, Zheng C. ACUTE AND CHRONIC INFECTIOUS COMPLICATIONS FOLLOWING GUNSHOT INJURIES: A CASE COMPARISON. South-Med-J 2022; 115 561.$26$YR$$M$Y$$$20240923$$HP$US$US
243051411$24305141$1$I$20231114$20240906$20240911$20240911$EXP$$CO-UCBSA-2024046388$UCB$$66$YR$$F$Y$$$20240911$$CN$CO$CO
243051421$24305142$1$I$$20240903$20240911$20240911$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01800$NOVITIUM PHARMA$Yu-Ting Peng.Tumor necrosis factor-alpha inhibitor for successful treatment of toxic epidermal necrolysis with severe infection: a case series.Journal of International Medical Research.31-JAN-2024;52(1):1-9$30$YR$A$M$Y$$$20240911$$HP$CN$CN
243051431$24305143$1$I$$20240909$20240911$20240911$PER$$US-ROCHE-10000078106$ROCHE$$$$$$Y$$$20240911$$CN$US$US
243051441$24305144$1$I$$20240909$20240911$20240911$EXP$$CA-SANDOZ INC.-SDZ2024CA078984$SANDOZ$$$$$F$Y$$$20240911$$CN$CA$CA
243051451$24305145$1$I$$20240830$20240911$20240911$EXP$$CA-AUROBINDO-AUR-APL-2024-044664$AUROBINDO$$44$YR$$F$Y$$$20240911$$HP$CA$CA
243051461$24305146$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009940$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243051471$24305147$1$I$$20240908$20240911$20240911$PER$$US-JNJFOC-20240920296$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243051481$24305148$1$I$$20231010$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000373$SIGMA TAU$$$$$M$Y$$$20240911$$MD$US$US
243051491$24305149$1$I$$20240822$20240911$20240911$PER$$US-TEVA-VS-3237581$TEVA$$40$YR$$M$Y$$$20240911$$CN$US$US
243051511$24305151$1$I$$20240909$20240911$20240911$EXP$$JP-VANTIVE-2024VAN019383$Vantive US Healthcare$$83$YR$$F$Y$$$20240911$$HP$JP$JP
243051532$24305153$2$F$$20240923$20240911$20240930$EXP$$IN-VANTIVE-2024VAN019660$Vantive US Healthcare$$58$YR$$M$Y$$$20240930$$CN$IN$IN
243051542$24305154$2$F$$20240903$20240911$20240912$EXP$$JP-VANTIVE-2024VAN018973$Vantive US Healthcare$$7$DEC$$M$Y$$$20240912$$MD$JP$JP
243051552$24305155$2$F$$20240905$20240911$20240913$PER$$US-CHATTEMPRD-2024OHG031071$CHATTEM$$$$$F$Y$$$20240913$$CN$US$US
243051561$24305156$1$I$$20240905$20240911$20240911$PER$$US-CHATTEMPRD-2024OHG031095$CHATTEM$$$$$$Y$$$20240911$$CN$US$US
243051571$24305157$1$I$$20240905$20240911$20240911$PER$$US-CHATTEMPRD-2024OHG031026$CHATTEM$$$$$F$Y$$$20240911$$CN$US$US
243051581$24305158$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009941$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243051591$24305159$1$I$$20240828$20240911$20240911$EXP$$US-ASTELLAS-2024-AER-003814$ASTELLAS$$$$E$M$Y$$$20240911$$CN$US$US
243051601$24305160$1$I$$20240903$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005169$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243051611$24305161$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005203$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240911$$CN$US$US
243051621$24305162$1$I$20240830$20240903$20240911$20240911$EXP$$US-ARGENX-2024-ARGX-US007413$ARGENX BVBA$$$$$$Y$$$20240911$$CN$US$US
243051632$24305163$2$F$$20240910$20240911$20240916$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014598$JAZZ$$$$$M$Y$57.6$KG$20240916$$CN$US$US
243051641$24305164$1$I$20200801$20240905$20240911$20240911$EXP$$US-JNJFOC-20240919412$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240911$$LW$US$US
243051651$24305165$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009942$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243051662$24305166$2$F$20240910$20240911$20240911$20240913$PER$$US-AMGEN-USASP2024180724$AMGEN$$61$YR$A$F$Y$$$20240913$$CN$US$US
243051671$24305167$1$I$20240819$20240905$20240911$20240911$PER$$US-AMGEN-USASP2024177827$AMGEN$$69$YR$E$F$Y$$$20240910$$CN$US$US
243051681$24305168$1$I$$20240902$20240911$20240911$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011460$STRIDES$Mohammadzadeh N, Punsoni M, Alhusaini S, Friedman JH.. Autopsy-Proven ^Pure^ Parkinson^s Disease with Rapidly Progressive Dementia and Cognitive Fluctuations in a Patient with GBA Mutation.. R-I-Med-J. 2024;107 (8):50-53$$$$$Y$$$20240911$$MD$US$US
243051691$24305169$1$I$20240223$20240301$20240911$20240911$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-104384$ZYDUS PHARM$$$$$$Y$$$20240911$$CN$US$US
243051701$24305170$1$I$20230701$20230821$20240911$20240911$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-097575$ZYDUS PHARM$$$$$$Y$$$20240911$$CN$US$US
243051711$24305171$1$I$20230220$20240902$20240911$20240911$EXP$ES-AEMPS-1565829$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111877$ZYDUS PHARM$$$$$$Y$$$20240911$$PH$ES$ES
243051721$24305172$1$I$$20240905$20240911$20240911$PER$$US-ABBVIE-5913608$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243051731$24305173$1$I$$20240906$20240911$20240911$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014592$JAZZ$$$$$F$Y$$$20240910$$CN$US$US
243051741$24305174$1$I$$20240318$20240911$20240911$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438605$RANBAXY$$$$$F$Y$$$20240911$$HP$US$US
243051751$24305175$1$I$$20240129$20240911$20240911$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429968$RANBAXY$$$$$F$Y$$$20240911$$CN$US$US
243051761$24305176$1$I$$20240831$20240911$20240911$EXP$$NL-AUROBINDO-AUR-APL-2024-044137$AUROBINDO$$71$YR$$F$Y$86$KG$20240911$$CN$NL$NL
243051771$24305177$1$I$20230614$20240902$20240911$20240911$EXP$$IT-CELLTRION INC.-2023IT015104$CELLTRION$$$$$$Y$$$20240911$$MD$IT$IT
243051791$24305179$1$I$20240101$20240828$20240911$20240911$PER$$US-SA-2024SA259697$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240911$$HP$US$US
243051801$24305180$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA259947$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240911$$HP$US$US
243051811$24305181$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA259836$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240911$$MD$US$US
243051821$24305182$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA260334$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240911$$MD$US$US
243051831$24305183$1$I$20240501$20240828$20240911$20240911$PER$$US-SA-2024SA259260$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240911$$MD$US$US
243051841$24305184$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA208526$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240911$$MD$US$US
243051851$24305185$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA262112$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240911$$HP$US$US
243051861$24305186$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260445$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240911$$HP$US$US
243051871$24305187$1$I$$20240830$20240911$20240911$EXP$$US-NOVOPROD-1277969$NOVO NORDISK$$81$YR$$M$Y$$$20240911$$CN$US$US
243051881$24305188$1$I$20240708$20240830$20240911$20240911$EXP$$US-NOVOPROD-1279020$NOVO NORDISK$$77$YR$$M$Y$$$20240911$$MD$US$US
243051892$24305189$2$F$$20240906$20240911$20240918$EXP$$DK-NOVOPROD-1279374$NOVO NORDISK$$56$YR$$M$Y$$$20240918$$CN$DK$DK
243051901$24305190$1$I$$20240830$20240911$20240911$EXP$$US-NOVOPROD-1278520$NOVO NORDISK$$69$YR$$M$Y$$$20240911$$CN$US$US
243051911$24305191$1$I$$20240829$20240911$20240911$EXP$$AU-NOVOPROD-1276992$NOVO NORDISK$$$$$$Y$$$20240911$$CN$AU$AU
243051921$24305192$1$I$$20240830$20240911$20240911$EXP$$US-NOVOPROD-1278502$NOVO NORDISK$$$$$$Y$$$20240911$$CN$US$US
243051931$24305193$1$I$20220101$20240830$20240911$20240911$EXP$$US-NOVOPROD-1278537$NOVO NORDISK$$$$$$Y$$$20240911$$CN$US$US
243051941$24305194$1$I$$20240830$20240911$20240911$EXP$$US-NOVOPROD-1278840$NOVO NORDISK$$$$A$$Y$$$20240911$$CN$US$US
243051951$24305195$1$I$$20240830$20240911$20240911$EXP$$US-NOVOPROD-1279528$NOVO NORDISK$$$$$F$Y$$$20240911$$CN$US$US
243051962$24305196$2$F$$20240906$20240911$20240918$EXP$$US-NOVOPROD-1279150$NOVO NORDISK$$$$$F$Y$$$20240918$$CN$US$US
243051971$24305197$1$I$20240830$20240830$20240911$20240911$EXP$$US-NOVOPROD-1278436$NOVO NORDISK$$69$YR$$F$Y$$$20240911$$CN$US$US
243051981$24305198$1$I$$20240831$20240911$20240911$EXP$$FR-AUROBINDO-AUR-APL-2024-044462$AUROBINDO$Altwegg R, Combes R, Laharie D, De Ledinghen V, Radenne S, Conti F, et al.. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.. Dig-Liver-Dis. 2018;50(7):668-674$26$YR$$M$Y$$$20240911$$HP$FR$FR
243051991$24305199$1$I$$20240904$20240911$20240911$EXP$$US-ABBVIE-5909684$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243052002$24305200$2$F$20240823$20240925$20240911$20240930$PER$$US-ASTELLAS-2024-AER-003591$ASTELLAS$$$$$$Y$$$20240930$$MD$US$US
243052011$24305201$1$I$$20240901$20240911$20240911$EXP$$CN-NOVOPROD-1277690$NOVO NORDISK$$68$YR$$M$Y$$$20240911$$CN$CN$CN
243052022$24305202$2$F$20240726$20240904$20240911$20240916$EXP$$CN-NOVOPROD-1277671$NOVO NORDISK$$$$$M$Y$63$KG$20240916$$CN$CN$CN
243052031$24305203$1$I$20220101$20240830$20240911$20240911$EXP$$CO-NOVOPROD-1278117$NOVO NORDISK$$46$YR$$F$Y$88$KG$20240911$$CN$CO$CO
243052041$24305204$1$I$$20240830$20240911$20240911$EXP$$US-NOVOPROD-1278253$NOVO NORDISK$$$$A$F$Y$$$20240911$$CN$US$US
243052051$24305205$1$I$$20240829$20240911$20240911$EXP$$TR-NOVOPROD-1277685$NOVO NORDISK$$$$$M$Y$100$KG$20240911$$CN$TR$TR
243052061$24305206$1$I$20240808$20240830$20240911$20240911$EXP$CN-NMPA-5304011002322202400141$CN-NOVOPROD-1278115$NOVO NORDISK$$40$YR$$M$Y$90$KG$20240911$$HP$CN$CN
243052071$24305207$1$I$$20240830$20240911$20240911$EXP$$US-NOVOPROD-1277885$NOVO NORDISK$$$$$F$Y$$$20240911$$CN$US$US
243052081$24305208$1$I$20240817$20240830$20240911$20240911$EXP$RU-RZN-2537401$RU-NOVOPROD-1278239$NOVO NORDISK$$63$YR$$F$Y$98$KG$20240911$$MD$RU$RU
243052101$24305210$1$I$$20240901$20240911$20240911$EXP$$EG-NOVOPROD-1278792$NOVO NORDISK$$$$$M$Y$$$20240911$$CN$EG$EG
243052111$24305211$1$I$20240831$20240901$20240911$20240911$EXP$$CN-NOVOPROD-1277698$NOVO NORDISK$$63$YR$$M$Y$$$20240911$$CN$CN$CN
243052121$24305212$1$I$20240401$20240830$20240911$20240911$EXP$$US-NOVOPROD-1278432$NOVO NORDISK$$60$YR$$F$Y$$$20240911$$CN$US$US
243052131$24305213$1$I$$20240910$20240911$20240911$EXP$$CA-SANDOZ INC.-SDZ2024CA079208$SANDOZ$$86$YR$$F$Y$$$20240911$$PH$CA$CA
243052141$24305214$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009966$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243052151$24305215$1$I$$20240905$20240911$20240911$EXP$$ES-ABBVIE-5913975$ABBVIE$$$$C$F$Y$$$20240911$$MD$ES$ES
243052161$24305216$1$I$20240901$20240902$20240911$20240911$EXP$$GB-AUROBINDO-AUR-APL-2024-043998$AUROBINDO$$$$$$Y$$$20240911$$PH$GB$GB
243052171$24305217$1$I$20240906$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179965$AMGEN$$70$YR$E$F$Y$$$20240910$$CN$US$US
243052181$24305218$1$I$$20240314$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-009236$AUROBINDO$$$$$M$Y$$$20240911$$CN$US$US
243052191$24305219$1$I$$20240221$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-009667$AUROBINDO$$77$YR$$F$Y$$$20240911$$CN$US$US
243052201$24305220$1$I$$20231121$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2023-075785$AUROBINDO$$83$YR$$F$Y$93.44$KG$20240911$$CN$US$US
243052211$24305221$1$I$20231212$20240126$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2023-080138$AUROBINDO$$60$YR$$M$Y$81$KG$20240911$$CN$US$US
243052221$24305222$1$I$20230731$20230914$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2023-052729$AUROBINDO$$57$YR$$F$Y$91$KG$20240911$$CN$US$US
243052231$24305223$1$I$20231101$20240903$20240911$20240911$EXP$$US-ABBVIE-5907276$ABBVIE$$$$$$Y$$$20240911$$CN$US$US
243052241$24305224$1$I$$20240411$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-016649$AUROBINDO$$$$$$Y$$$20240911$$HP$US$US
243052251$24305225$1$I$20230802$20230905$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2023-053171$AUROBINDO$$57$YR$$F$Y$63.502$KG$20240911$$CN$US$US
243052261$24305226$1$I$$20240412$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-017133$AUROBINDO$$$$$$Y$$$20240911$$HP$US$US
243052271$24305227$1$I$$20240506$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-016414$AUROBINDO$$$$$$Y$$$20240911$$HP$US$US
243052281$24305228$1$I$$20240329$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-016671$AUROBINDO$$$$$$Y$$$20240911$$HP$US$US
243052291$24305229$1$I$$20240411$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-010845$AUROBINDO$$63$YR$$M$Y$$$20240911$$CN$US$US
243052301$24305230$1$I$$20240523$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-018673$AUROBINDO$$57$YR$$F$Y$70.3$KG$20240911$$CN$US$US
243052311$24305231$1$I$$20240412$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-016751$AUROBINDO$$$$$$Y$$$20240911$$HP$US$US
243052321$24305232$1$I$$20240411$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-016409$AUROBINDO$$$$$$Y$$$20240911$$HP$US$US
243052331$24305233$1$I$$20240411$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-016643$AUROBINDO$$$$$$Y$$$20240911$$HP$US$US
243052341$24305234$1$I$20240909$20240909$20240911$20240911$EXP$$GB-SANDOZ INC.-SDZ2024GB078980$SANDOZ$$72$YR$$F$Y$60$KG$20240911$$HP$GB$GB
243052351$24305235$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009972$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243052361$24305236$1$I$20231201$20240829$20240911$20240911$EXP$$CA-UCBSA-2024001108$UCB$$30$YR$$F$Y$$$20240911$$CN$CA$CA
243052371$24305237$1$I$$20240612$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-027857$AUROBINDO$$51$YR$$F$Y$76.65$KG$20240911$$HP$US$US
243052381$24305238$1$I$$20240706$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-027178$AUROBINDO$$$$A$M$Y$68.03$KG$20240911$$CN$US$US
243052391$24305239$1$I$$20240829$20240911$20240911$EXP$$JP-ASTELLAS-2024-AER-004327$ASTELLAS$Ono R, Iwahana T, Aoki K, Kato H, Tsutsui Y, Takaishi K, et al.SARS-CoV-2 infection-induced immune thrombocytopenia in a patient with orthotopic heart transplantation: A case report and literature review. Journal of Cardiology Cases. 2024;1-4.$46$YR$A$M$Y$$$20240911$$MD$JP$JP
243052401$24305240$1$I$$20240511$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-021910$AUROBINDO$$$$$$Y$$$20240911$$HP$US$US
243052411$24305241$1$I$$20240625$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-032523$AUROBINDO$$$$$F$Y$$$20240911$$CN$US$US
243052421$24305242$1$I$$20240830$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-036792$AUROBINDO$$48$YR$$M$Y$$$20240911$$CN$US$US
243052431$24305243$1$I$$20240617$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-027888$AUROBINDO$$$$$$Y$$$20240911$$HP$US$US
243052441$24305244$1$I$$20240814$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2024-036411$AUROBINDO$$69$YR$$F$Y$$$20240911$$PH$US$US
243052451$24305245$1$I$$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024179071$AMGEN$$$$$$Y$$$20240910$$HP$US$US
243052461$24305246$1$I$20231114$20240822$20240911$20240911$EXP$$JP-AMGEN-JPNSP2023234165$AMGEN$Fukui S, Uchida T, Iwamoto N, Umetsu A, Okamoto M, Fujikawa K. Absence of Glucocorticoids Concomitant With Avacopan and Subsequent Liver Injury in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. The Journal of Rheumatology 2024. 2024;1-3. doi:10.3899/jrheum.2024-0340$69$YR$E$F$Y$50.5$KG$20240910$$MD$JP$JP
243052471$24305247$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009973$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243052481$24305248$1$I$20200911$20240903$20240911$20240911$EXP$$PL-AUROBINDO-AUR-APL-2024-044397$AUROBINDO$$60$YR$$F$Y$$$20240911$$MD$PL$PL
243052491$24305249$1$I$$20240903$20240911$20240911$PER$$US-AstraZeneca-2024A200594$ASTRAZENECA$$$$$$Y$$$20240911$$CN$US$
243052501$24305250$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A203904$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243052511$24305251$1$I$$20240818$20240911$20240911$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004800$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243052521$24305252$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143710$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240911$$CN$US$US
243052531$24305253$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005866$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240911$$CN$US$US
243052541$24305254$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009999$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243052551$24305255$1$I$$20240906$20240911$20240911$PER$$NVSC2024US180317$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243052561$24305256$1$I$$20240116$20240911$20240911$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-00673$HIKMA$$$$$F$Y$$$20240910$$CN$US$US
243052571$24305257$1$I$$20240904$20240911$20240911$EXP$$CO-SANDOZ INC.-NVSC2021CO143317$SANDOZ$$$$$M$Y$52$KG$20240911$$CN$CO$CO
243052591$24305259$1$I$20240801$20240903$20240911$20240911$EXP$$US-JNJFOC-20240904621$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$CN$US$US
243052602$24305260$2$F$$20240905$20240911$20240916$PER$$US-CHATTEMPRD-2024OHG031017$CHATTEM$$$$$M$Y$$$20240916$$CN$US$US
243052612$24305261$2$F$$20240910$20240911$20240923$EXP$$AR-GSK-AR2024AMR111557$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$AR$AR
243052621$24305262$1$I$20240205$20240906$20240911$20240911$30DAY$$US-AMGEN-USASP2024179051$AMGEN$$74$YR$E$F$Y$117.9$KG$20240910$$PH$US$US
243052631$24305263$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179129$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$50$YR$A$F$Y$$$20240910$$HP$IT$IT
243052641$24305264$1$I$$20240822$20240911$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08582$LUPIN$$$$$$Y$$$20240911$$CN$US$US
243052651$24305265$1$I$20240812$20240831$20240911$20240911$EXP$$FR-AUROBINDO-AUR-APL-2024-044254$AUROBINDO$$64$YR$$M$Y$$$20240911$$MD$FR$FR
243052662$24305266$2$F$$20240909$20240911$20240913$PER$$US-ABBVIE-5917297$ABBVIE$$$$$$Y$$$20240913$$MD$US$US
243052671$24305267$1$I$$20240904$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US079221$SANDOZ$$55$YR$$F$Y$$$20240911$$CN$US$US
243052681$24305268$1$I$$20240903$20240911$20240911$PER$$US-RDY-SPO/USA/24/0013023$DR REDDYS$$19$YR$A$F$Y$$$20240911$$HP$US$US
243052691$24305269$1$I$$20240909$20240911$20240911$EXP$$JP-TAKEDA-2024TJP012435$TAKEDA$$14$YR$$M$Y$$$20240911$$MD$JP$JP
243052701$24305270$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP010000$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243052711$24305271$1$I$$20240903$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012821$DR REDDYS$$27$YR$A$M$Y$$$20240911$$HP$US$US
243052732$24305273$2$F$$20240906$20240911$20240919$PER$$US-ROCHE-10000076997$ROCHE$$$$A$$Y$$$20240919$$MD$US$US
243052741$24305274$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179145$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$33$YR$A$M$Y$$$20240910$$HP$IT$IT
243052751$24305275$1$I$20240801$20240903$20240911$20240911$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-014630$JAZZ$$$$$$Y$$$20240910$$PH$JP$JP
243052761$24305276$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP010003$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243052771$24305277$1$I$$20240903$20240911$20240911$PER$$US-ABBVIE-5906043$ABBVIE$$$$$$Y$$$20240911$$CN$US$US
243052781$24305278$1$I$20240822$20240909$20240911$20240911$EXP$IT-MINISAL02-1000742$IT-UCBSA-2024046041$UCB$$77$YR$$M$Y$$$20240911$$MD$IT$IT
243052791$24305279$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141248$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240911$$CN$US$US
243052802$24305280$2$F$$20240902$20240911$20240913$PER$$US-ABBVIE-5915296$ABBVIE$$$$$M$Y$$$20240913$$PH$US$US
243052811$24305281$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143176$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240911$$CN$US$US
243052821$24305282$1$I$$20240906$20240911$20240911$PER$$US-ROCHE-10000076995$ROCHE$$$$A$$Y$$$20240911$$MD$US$US
243052831$24305283$1$I$$20240903$20240911$20240911$EXP$$GB-AUROBINDO-AUR-APL-2024-044230$AUROBINDO$$50$YR$$F$Y$59$KG$20240911$$CN$GB$GB
243052841$24305284$1$I$20240815$20240817$20240911$20240911$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004740$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240911$$CN$US$US
243052862$24305286$2$F$$20240918$20240911$20240925$PER$$US-JNJFOC-20240881993$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$HP$US$US
243052873$24305287$3$F$$20240909$20240911$20240918$EXP$$US-JNJFOC-20240915840$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240918$$CN$US$US
243052881$24305288$1$I$$20240826$20240911$20240911$PER$$US-ASTELLAS-2024-AER-003471$ASTELLAS$$$$$F$Y$$$20240911$$MD$US$US
243052891$24305289$1$I$20240804$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A203783$ASTRAZENECA$$29517$DY$$F$Y$$$20240911$$CN$US$
243052901$24305290$1$I$$20240906$20240911$20240911$PER$$NVSC2024US180412$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243052911$24305291$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144149$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240911$$CN$US$US
243052922$24305292$2$F$$20240909$20240911$20240920$EXP$$SE-NOVOPROD-1274094$NOVO NORDISK$$36$YR$$F$Y$82$KG$20240920$$CN$SE$SE
243052931$24305293$1$I$20240802$20240902$20240911$20240911$EXP$$CN-ROCHE-10000072489$ROCHE$$63$YR$A$M$Y$$$20240911$$HP$CN$CN
243052941$24305294$1$I$20240701$20240901$20240911$20240911$EXP$$GB-AUROBINDO-AUR-APL-2024-043911$AUROBINDO$$56$YR$$M$Y$12$KG$20240911$$CN$GB$GB
243052951$24305295$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009982$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243052961$24305296$1$I$$20231215$20240911$20240911$PER$$US-AUROBINDO-AUR-APL-2023-079838$AUROBINDO$$$$$$Y$$$20240911$$CN$US$US
243052971$24305297$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP010004$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243052982$24305298$2$F$20240904$20240905$20240911$20240911$EXP$$US-AMGEN-USASP2024178387$AMGEN$$67$YR$E$F$Y$$$20240911$$PH$US$US
243053002$24305300$2$F$20240809$20240911$20240911$20240917$PER$$US-AMGEN-USASP2024179181$AMGEN$$85$YR$E$F$Y$54.5$KG$20240917$$PH$US$US
243053011$24305301$1$I$20240908$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180200$AMGEN$$47$YR$A$M$Y$$$20240911$$CN$US$US
243053021$24305302$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009989$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243053031$24305303$1$I$20240909$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005879$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240911$$CN$US$US
243053041$24305304$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005883$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240911$$CN$US$US
243053051$24305305$1$I$20220901$20240905$20240911$20240911$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012851$JAZZ$$68$YR$$F$Y$$$20240911$$CN$US$US
243053071$24305307$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005246$ELI LILLY AND CO$$$$$F$Y$$$20240911$$HP$US$US
243053081$24305308$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009998$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243053091$24305309$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144059$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240911$$CN$US$US
243053101$24305310$1$I$$20240901$20240911$20240911$EXP$$IL-ROCHE-10000072088$ROCHE$$$$A$M$Y$$$20240911$$MD$IL$IL
243053111$24305311$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP010010$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243053121$24305312$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009983$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243053131$24305313$1$I$20240901$20240906$20240911$20240911$PER$$US-ABBVIE-5915079$ABBVIE$$$$$$Y$$$20240911$$HP$US$US
243053141$24305314$1$I$20230901$20240902$20240911$20240911$EXP$$ES-AUROBINDO-AUR-APL-2024-044284$AUROBINDO$$57$YR$$M$Y$$$20240911$$MD$ES$ES
243053151$24305315$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009990$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243053161$24305316$1$I$20211117$20240829$20240911$20240911$EXP$$FR-SERVIER-S24011006$SERVIER$$$$$$Y$$$20240911$$MD$FR$FR
243053171$24305317$1$I$20240701$20240906$20240911$20240911$EXP$$US-ABBVIE-5914889$ABBVIE$$63$YR$$F$Y$$$20240911$$CN$US$US
243053181$24305318$1$I$$20240905$20240911$20240911$PER$$US-ABBVIE-5915509$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243053191$24305319$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009991$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243053202$24305320$2$F$$20240906$20240911$20240913$EXP$$US-ARGENX-2024-ARGX-US007373$ARGENX BVBA$$$$$$Y$$$20240913$$MD$US$US
243053211$24305321$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009997$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243053221$24305322$1$I$20240828$20240830$20240911$20240911$PER$$US-RDY-SPO/USA/24/0013005$DR REDDYS$$30$YR$A$F$Y$$$20240911$$CN$US$US
243053231$24305323$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP010001$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243053241$24305324$1$I$20240823$20240905$20240911$20240911$EXP$$GB-AUROBINDO-AUR-APL-2024-044546$AUROBINDO$$24$YR$$F$Y$$$20240911$$HP$GB$GB
243053251$24305325$1$I$$20240905$20240911$20240911$PER$$US-ABBVIE-5909713$ABBVIE$$$$$M$Y$$$20240911$$HP$US$US
243053261$24305326$1$I$$20240827$20240911$20240911$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-08728$LUPIN$Singh DP, Raghunathan V, Dhaliwal MS, Singh R, Kumar A. Acute Levalbuterol toxicity with use of metered dose inhaler. Clinical Pediatrics. 2024;63(3):297-299$8$YR$$M$Y$$$20240911$$MD$IN$IN
243053271$24305327$1$I$$20240909$20240911$20240911$PER$$US-JNJFOC-20240921823$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243053282$24305328$2$F$$20240913$20240911$20240921$EXP$$GB-TAKEDA-2024TUS088837$TAKEDA$$$$$F$Y$$$20240921$$CN$GB$GB
243053291$24305329$1$I$20240101$20240905$20240911$20240911$EXP$$FR-AstraZeneca-2024A202184$ASTRAZENECA$$70$YR$$F$Y$74$KG$20240911$$MD$FR$
243053301$24305330$1$I$20240701$20240829$20240911$20240911$EXP$$US-UCBSA-2024044390$UCB$$41$YR$$F$Y$$$20240911$$HP$US$US
243053311$24305331$1$I$$20240907$20240911$20240911$EXP$$IR-AstraZeneca-2024A203766$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240911$$MD$IR$
243053321$24305332$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144127$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240911$$HP$US$US
243053331$24305333$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144012$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240911$$HP$US$US
243053342$24305334$2$F$20240901$20240916$20240911$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144160$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240924$$HP$US$US
243053351$24305335$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP010002$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243053361$24305336$1$I$$20240907$20240911$20240911$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014593$JAZZ$$$$$F$Y$43.6$KG$20240911$$CN$US$US
243053371$24305337$1$I$$20240906$20240911$20240911$PER$$US-BIOGEN-2024BI01281514$BIOGEN$$$$$M$Y$$$20240911$$CN$US$US
243053381$24305338$1$I$$20240906$20240911$20240911$PER$$US-BIOGEN-2024BI01281579$BIOGEN$$$$$M$Y$$$20240911$$CN$US$US
243053391$24305339$1$I$$20240906$20240911$20240911$PER$$US-BIOGEN-2024BI01281609$BIOGEN$$$$$F$Y$$$20240911$$HP$US$US
243053401$24305340$1$I$$20240906$20240911$20240911$PER$$US-JNJFOC-20240919817$JOHNSON AND JOHNSON$$$$$M$Y$$$20240911$$CN$US$US
243053411$24305341$1$I$20240904$20240904$20240911$20240911$EXP$$GB-AUROBINDO-AUR-APL-2024-044356$AUROBINDO$$59$YR$$M$Y$76$KG$20240911$$CN$GB$GB
243053421$24305342$1$I$$20240904$20240911$20240911$EXP$$GB-JNJFOC-20240923263$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240911$$HP$GB$GB
243053431$24305343$1$I$20221114$20240903$20240911$20240911$EXP$$BE-BIOCON BIOLOGICS LIMITED-BBL2024006521$BIOCON$$$$$$Y$$$20240911$$MD$BE$BE
243053441$24305344$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009996$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243053451$24305345$1$I$$20240909$20240911$20240911$PER$$US-ROCHE-10000078038$ROCHE$$37$YR$A$F$Y$$$20240911$$HP$US$US
243053461$24305346$1$I$20240828$20240904$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012912$DR REDDYS$$30$YR$A$M$Y$$$20240911$$HP$US$US
243053472$24305347$2$F$20240704$20240910$20240911$20240924$EXP$$US-MDD US Operations-MDD202407-002477$MDD OPERATIONS$$68$YR$$F$Y$$$20240924$$HP$US$
243053482$24305348$2$F$$20240917$20240911$20240926$EXP$$GB-TEVA-VS-3241032$TEVA$Thurston L, Todd G, Parsapour S, Kong WM. The complexities of managing neuropathic pain. Br-J-Diabetes 2024; 24 (1): 114.; Thurston L, Todd G, Parsapour S, Kong WM. The complexities of managing neuropathic pain. Br-J-Diabetes 2024; 24 (1): 114.$75$YR$$M$Y$$$20240926$$HP$GB$GB
243053491$24305349$1$I$20240823$20240904$20240911$20240911$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000911$PAREXEL$$$$$$Y$$$20240911$$HP$CN$CN
243053501$24305350$1$I$$20240904$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004779$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243053511$24305351$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005752$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240911$$CN$US$US
243053521$24305352$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005882$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240911$$CN$US$US
243053531$24305353$1$I$20240801$20240830$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409002802$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240911$$CN$US$US
243053541$24305354$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004563$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240911$$CN$US$US
243053551$24305355$1$I$$20240904$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004109$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240911$$CN$US$US
243053561$24305356$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006384$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240911$$CN$US$US
243053571$24305357$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004706$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240911$$CN$US$US
243053581$24305358$1$I$$20240906$20240911$20240911$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014584$JAZZ$$$$$M$Y$112$KG$20240911$$CN$US$US
243053591$24305359$1$I$$20240905$20240911$20240911$EXP$$US-AMGEN-USASP2024178132$AMGEN$$$$$F$Y$$$20240911$$HP$US$US
243053611$24305361$1$I$$20240902$20240911$20240911$EXP$$JP-ROCHE-10000072404$ROCHE$Okamoto K, Hijioka S, Nagashio Y, Okada M, Ohba A, Maruki Y, et al. Immune-related adverse event-associated sclerosing cholangitis due to immune checkpoint inhibitors: imaging findings and treatments. Japanese Journal of Clinical Oncology. 2024-Aug-01;54 (8):887-94. doi:10.1093/jjco/hyae060.$58$YR$A$M$Y$$$20240911$$HP$JP$JP
243053621$24305362$1$I$$20240823$20240911$20240911$PER$$US-TEVA-VS-3236837$TEVA$$40$YR$$F$Y$74.84$KG$20240911$$CN$US$US
243053632$24305363$2$F$$20240916$20240911$20240923$EXP$$FR-TEVA-VS-3240983$TEVA$Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, et al. Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study. Am-J-Hematol 2023; 98 (9): E259-E262.; Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, et al. Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study. Am-J-Hematol 2023; 98 (9): E259-E262.; Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau ...$67$YR$$M$Y$$$20240923$$HP$FR$FR
243053641$24305364$1$I$20240101$20240827$20240911$20240911$PER$$US-SA-2024SA258966$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240911$$MD$US$US
243053651$24305365$1$I$$20240821$20240911$20240911$PER$$US-SA-2023SA046148$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240911$$MD$US$US
243053661$24305366$1$I$20240701$20240909$20240911$20240911$EXP$FR-AFSSAPS-TS2024000951$FR-UCBSA-2024046015$UCB$$47$YR$$M$Y$83$KG$20240911$$MD$FR$FR
243053671$24305367$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA262052$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240911$$MD$US$US
243053681$24305368$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260425$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240911$$HP$US$US
243053691$24305369$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA262041$SANOFI AVENTIS$$$$A$F$Y$$$20240911$$HP$US$US
243053701$24305370$1$I$20240801$20240827$20240911$20240911$PER$$US-SA-2024SA259317$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240911$$HP$US$US
243053711$24305371$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA261217$SANOFI AVENTIS$$11$YR$C$M$Y$28.3$KG$20240911$$HP$US$US
243053721$24305372$1$I$20240101$20240829$20240911$20240911$PER$$US-SA-2024SA261439$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240911$$HP$US$US
243053741$24305374$1$I$20240301$20240829$20240911$20240911$PER$$US-SA-2024SA260278$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240911$$HP$US$US
243053751$24305375$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260540$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240911$$MD$US$US
243053761$24305376$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260365$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240911$$HP$US$US
243053771$24305377$1$I$20240101$20240828$20240911$20240911$PER$$US-SA-2024SA261171$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240911$$HP$US$US
243053781$24305378$1$I$20231101$20240829$20240911$20240911$PER$$US-SA-2024SA260948$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240911$$HP$US$US
243053791$24305379$1$I$$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A200756$ASTRAZENECA$$74$YR$$M$Y$$$20240911$$MD$US$
243053801$24305380$1$I$$20240905$20240911$20240911$EXP$$IN-AstraZeneca-2024A204093$ASTRAZENECA$$18262$DY$$F$Y$$$20240911$$CN$IN$
243053811$24305381$1$I$$20240902$20240911$20240911$EXP$$JP-ROCHE-10000076663$ROCHE$Inoue T, Miyazaki J, Akahane M, Tonshiyo M. O04-8 A case in which lymphangiography was effective for lymphocele after renal transplant. The 39th Japanese Society of Renal Transplantation and Vascular Surgery. 2024;140$61$YR$A$F$Y$$$20240911$$MD$JP$JP
243053821$24305382$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A204030$ASTRAZENECA$$$$$$Y$$$20240911$$HP$US$
243053831$24305383$1$I$20070801$20240907$20240911$20240911$EXP$FR-EMA-20130418-mgevhumanwt-102307659$FR-BAUSCH-BL-2024-013382$BAUSCH AND LOMB$$47$YR$$F$Y$148$KG$20240911$$MD$FR$US
243053842$24305384$2$F$$20240909$20240911$20240913$PER$$US-BAUSCH-BL-2024-013432$BAUSCH AND LOMB$$85$YR$$F$Y$52.21$KG$20240913$$CN$US$US
243053851$24305385$1$I$$20240906$20240911$20240911$PER$$US-BAUSCH-BL-2024-013372$BAUSCH AND LOMB$$$$$F$Y$$$20240911$$CN$US$US
243053861$24305386$1$I$$20240909$20240911$20240911$EXP$$CA-BAUSCH-BL-2024-013450$BAUSCH AND LOMB$$52$YR$$M$Y$$$20240911$$PH$CA$CA
243053891$24305389$1$I$$20240905$20240911$20240911$PER$$US-ROCHE-10000075416$ROCHE$$$$$F$Y$$$20240911$$MD$US$US
243053901$24305390$1$I$$20240826$20240911$20240911$PER$$US-TEVA-VS-3237322$TEVA$$62$YR$$F$Y$$$20240911$$CN$US$US
243053911$24305391$1$I$20240822$20240830$20240911$20240911$EXP$CN-HENLIUS-24CN016768$CN-Accord-445920$ACCORD$$38$YR$A$F$Y$62$KG$20240911$$HP$CN$CN
243053922$24305392$2$F$20240730$20240911$20240911$20240915$EXP$$PT-AUROBINDO-AUR-APL-2024-044619$AUROBINDO$$60$YR$$F$Y$55$KG$20240915$$PH$PT$PT
243053931$24305393$1$I$20240729$20240906$20240911$20240911$EXP$$IT-AUROBINDO-AUR-APL-2024-044655$AUROBINDO$$18$YR$$F$Y$$$20240911$$MD$IT$IT
243053941$24305394$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143230$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240911$$CN$US$US
243053951$24305395$1$I$20230101$20240904$20240911$20240911$EXP$$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-142620$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240911$$CN$SE$SE
243053961$24305396$1$I$$20240903$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140971$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$109.32$KG$20240911$$CN$US$US
243053971$24305397$1$I$$20240831$20240911$20240911$EXP$$FR-AUROBINDO-AUR-APL-2024-044162$AUROBINDO$Bodeau S, Bennis Y, Abe E, Quinton M-C, Andrejak M, Bricca G, et al.. Colchicine: An unusual but potential life threatening poisoning - About 3 cases. [French]. Toxic-Analyt-Clinique. 2016;28(1):32-37$16$YR$$F$Y$$$20240911$$HP$FR$FR
243053982$24305398$2$F$$20240905$20240911$20240913$EXP$$IN-ROCHE-10000074718$ROCHE$$63$YR$A$M$Y$$$20240913$$CN$IN$IN
243053991$24305399$1$I$$20240905$20240911$20240911$EXP$$CA-TAKEDA-2024TUS003865$TAKEDA$$$$$M$Y$$$20240911$$CN$CA$CA
243054002$24305400$2$F$20240724$20240904$20240911$20240913$PER$$US-ABBVIE-5907517$ABBVIE$$71$YR$$M$Y$$$20240913$$CN$US$US
243054012$24305401$2$F$20240116$20240916$20240911$20240924$EXP$$IL-SA-2024SA258831$SANOFI AVENTIS$$$$E$M$Y$$$20240924$$MD$IL$IL
243054021$24305402$1$I$20240101$20240903$20240911$20240911$EXP$$US-SA-2024SA257895$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240911$$HP$US$US
243054031$24305403$1$I$20240818$20240905$20240911$20240911$EXP$$CN-ROCHE-10000075579$ROCHE$$37$YR$A$F$Y$45$KG$20240911$$HP$CN$CN
243054041$24305404$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009995$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243054051$24305405$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179797$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
243054062$24305406$2$F$20240825$20240916$20240911$20240917$PER$$US-AMGEN-USASP2024179814$AMGEN$$$$$M$Y$$$20240916$$CN$US$US
243054071$24305407$1$I$$20240905$20240911$20240911$PER$$US-JNJFOC-20240916213$JOHNSON AND JOHNSON$$$$$M$Y$$$20240911$$MD$US$US
243054082$24305408$2$F$20240904$20240905$20240911$20240912$PER$$US-JNJFOC-20240919732$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$HP$US$US
243054091$24305409$1$I$20240301$20240906$20240911$20240911$PER$$US-BEH-2024178392$CSL BEHRING$$78$YR$E$F$Y$76.19$KG$20240911$$CN$US$US
243054101$24305410$1$I$$20240906$20240911$20240911$PER$$US-JNJFOC-20240919668$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240911$$MD$US$US
243054111$24305411$1$I$$20240822$20240911$20240911$PER$$US-TEVA-VS-3236453$TEVA$$78$YR$$F$Y$67.13$KG$20240911$$CN$US$US
243054121$24305412$1$I$20220428$20240828$20240911$20240911$EXP$$DE-NORDICGR-057314$NORDIC PHARMA$$$$A$F$Y$$$20240910$$CN$DE$DE
243054132$24305413$2$F$20240827$20240906$20240911$20240911$EXP$$US-AMGEN-USASP2024179135$AMGEN$$$$E$$Y$$$20240911$$PH$US$US
243054141$24305414$1$I$20240902$20240903$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012823$DR REDDYS$$15$YR$T$M$Y$$$20240911$$CN$US$US
243054151$24305415$1$I$$20240903$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012886$DR REDDYS$$55$YR$A$F$Y$$$20240911$$HP$US$US
243054162$24305416$2$F$20240828$20240911$20240911$20240919$PER$$US-RDY-SPO/USA/24/0012827$DR REDDYS$$34$YR$A$M$Y$73.94$KG$20240919$$MD$US$US
243054171$24305417$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5909898$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243054182$24305418$2$F$$20240910$20240911$20240920$EXP$$PL-AUROBINDO-AUR-APL-2024-044466$AUROBINDO$Kaminska D, Koscielska-Kasprzak K, Myszka M, Banasik M, Chelmonski A, Boratynska M et al.. Significant infections after hand transplantation in a polish population. Transplantation Proceedings. 2014;46:2887-2889$$$A$M$Y$$$20240920$$HP$PL$PL
243054191$24305419$1$I$$20240905$20240911$20240911$EXP$$US-ABBVIE-5913614$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243054201$24305420$1$I$$20240906$20240911$20240911$PER$$US-ABBVIE-5913604$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243054211$24305421$1$I$20240801$20240905$20240911$20240911$EXP$$US-ABBVIE-5909615$ABBVIE$$79$YR$$F$Y$$$20240911$$CN$US$US
243054221$24305422$1$I$20240801$20240829$20240911$20240911$EXP$$US-RECORDATI RARE DISEASES-2024006313$RECORDATI$$$$$$Y$$$20240911$$CN$US$US
243054231$24305423$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009994$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243054241$24305424$1$I$$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A203046$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243054251$24305425$1$I$20240814$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144281$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240911$$HP$US$US
243054262$24305426$2$F$$20240911$20240911$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144066$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240912$$CN$US$US
243054272$24305427$2$F$$20240911$20240911$20240921$EXP$$PT-AUROBINDO-AUR-APL-2024-037286$AUROBINDO$Zanga AG, Duarte M, Monteiro M, Pereira BS, Aldomiro F. PO-(4282)- LES?O HEP?TICAINDUZIDA POR MEDICAMENTOS: APROP?SITO DE UM (PO - (4282) - MEDICATION-INDUCED  HEPATIC INJURY: THE PURPOSE OF A  CLINICAL CASE). Doen?as raras | Caso cl?nico (Rare diseases | Clinical case). 1068$63$YR$$M$Y$$$20240921$$MD$PT$PT
243054281$24305428$1$I$$20240906$20240911$20240911$PER$$NVSC2024US180666$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243054291$24305429$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005453$ELI LILLY AND CO$$29$YR$A$M$Y$$$20240911$$CN$US$US
243054301$24305430$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005513$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240911$$CN$US$US
243054311$24305431$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005496$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240911$$CN$US$US
243054321$24305432$1$I$20240908$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005586$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240911$$CN$US$US
243054331$24305433$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005825$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240911$$CN$US$US
243054341$24305434$1$I$$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005788$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240911$$CN$US$US
243054351$24305435$1$I$$20240830$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409000161$ELI LILLY AND CO$$63$YR$A$$Y$$$20240911$$LW$US$US
243054361$24305436$1$I$20240905$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005660$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240911$$CN$US$US
243054371$24305437$1$I$$20240830$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409000154$ELI LILLY AND CO$$63$YR$A$$Y$$$20240911$$LW$US$US
243054381$24305438$1$I$20140101$20240909$20240911$20240911$EXP$$SE-SANDOZ INC.-PHHY2018SE101195$SANDOZ$$69$YR$$M$Y$$$20240911$$HP$SE$SE
243054391$24305439$1$I$$20240830$20240911$20240911$EXP$$PK-ALVOGEN-2024095452$ALVOGEN$Muhammad ZA, Ahmad T, Rashid H. Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-a cohort study. Expert Opinion on Drug Safety. 2024 Aug 19; doi:https://doi.org/10.1080/14740338.2024.2392863$75$YR$$F$Y$$$20240911$$HP$PK$PK
243054401$24305440$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240135$TEVA$Bains S, Garmany R, Neves R, Giudicessi JR, Gao X, Tester DJ, et al. Temporal Association Between Vaping and Risk of Cardiac Events. Mayo-Clin-Proc 2024; 99 (2): 241-248.; Bains S, Garmany R, Neves R, Giudicessi JR, Gao X, Tester DJ, et al. Temporal Association Between Vaping and Risk of Cardiac Events. Mayo-Clin-Proc 2024; 99 (2): 241-248.$26$YR$$M$Y$$$20240911$$HP$US$US
243054411$24305441$1$I$20221101$20240905$20240911$20240911$PER$$US-AMGEN-USASP2024178050$AMGEN$$36$YR$A$F$Y$$$20240911$$CN$US$US
243054422$24305442$2$F$$20240918$20240911$20240927$EXP$$TR-TEVA-VS-3240656$TEVA$Emre F, Uluyardimci E, Tahta M, Isik C. Intraarticular TXA Administration with Appropriate Timing of Clamping and Appropriate Dose is More Effective Than IV Administration. Acta-Chir-Orthop-Traumatol-Cech 2024; 91 (3): 151-155.; Emre F, Uluyardimci E, Tahta M, Isik C. Intraarticular TXA Administration with Appropriate Timing of Clamping and Appropriate Dose is More Effective Than IV Administration. Acta-Chir-Orthop-Traumatol-Cech 2024; 91 (3): 151-155.$$$$$Y$$$20240927$$HP$TR$TR
243054431$24305443$1$I$20240907$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180082$AMGEN$$78$YR$E$F$Y$$$20240911$$CN$US$US
243054442$24305444$2$F$20240101$20240911$20240911$20240911$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050700$BOEHRINGER INGELHEIM$$55$YR$A$F$Y$97$KG$20240911$$MD$RU$RU
243054451$24305445$1$I$$20240906$20240911$20240911$EXP$$US-ABBVIE-5406236$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243054461$24305446$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000534US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243054471$24305447$1$I$$20240831$20240911$20240911$EXP$$IT-AUROBINDO-AUR-APL-2024-044223$AUROBINDO$Biondo T, Baldino G, Burrascano G, Tarzia P, Indelicato M, Asmundo A et al.. Sudden Unexpected Death in Epilepsy (SUDEP). Full forensic approach in two cases and review of literature.. Clinica Terapeutica. 2024;175(4):97-108$13$YR$$F$Y$$$20240911$$HP$IT$IT
243054481$24305448$1$I$20240101$20240822$20240911$20240911$PER$$US-SA-2024SA259019$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240911$$MD$US$US
243054491$24305449$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA259211$SANOFI AVENTIS$$$$A$F$Y$$$20240911$$CN$US$US
243054501$24305450$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA259829$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240911$$HP$US$US
243054511$24305451$1$I$20240101$20240826$20240911$20240911$PER$$US-SA-2024SA261876$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240911$$MD$US$US
243054521$24305452$1$I$20240101$20240821$20240911$20240911$PER$$US-SA-2024SA261267$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240911$$MD$US$US
243054531$24305453$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000527US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243054541$24305454$1$I$20240801$20240821$20240911$20240911$PER$$US-SA-2024SA259228$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240911$$MD$US$US
243054551$24305455$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA260866$SANOFI AVENTIS$$$$E$M$Y$$$20240911$$HP$US$US
243054562$24305456$2$F$20240101$20240904$20240911$20240916$PER$$US-SA-2024SA261805$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240916$$HP$US$US
243054571$24305457$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260995$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240911$$HP$US$US
243054581$24305458$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260874$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240911$$MD$US$US
243054591$24305459$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260491$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240911$$CN$US$US
243054601$24305460$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA262042$SANOFI AVENTIS$$$$E$F$Y$$$20240911$$MD$US$US
243054611$24305461$1$I$$20240902$20240911$20240911$PER$$US-SA-2024SA262053$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240911$$HP$US$US
243054621$24305462$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA025757$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240911$$MD$US$US
243054631$24305463$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA262223$SANOFI AVENTIS$$77$YR$E$$Y$$$20240911$$CN$US$US
243054641$24305464$1$I$20240101$20240902$20240911$20240911$PER$$US-SA-2024SA260504$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240911$$MD$US$US
243054653$24305465$3$F$20240726$20240923$20240911$20240925$EXP$$US-ABBVIE-5914403$ABBVIE$$50$YR$$F$Y$66$KG$20240925$$CN$US$US
243054671$24305467$1$I$20240701$20240827$20240911$20240911$PER$$US-SA-2024SA243288$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240911$$HP$US$US
243054681$24305468$1$I$20240801$20240830$20240911$20240911$PER$$US-SA-2024SA261789$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240911$$MD$US$US
243054691$24305469$1$I$20240101$20240827$20240911$20240911$PER$$US-SA-2024SA259970$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240911$$MD$US$US
243054701$24305470$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA262174$SANOFI AVENTIS$$$$T$M$Y$$$20240911$$CN$US$US
243054711$24305471$1$I$20240801$20240830$20240911$20240911$PER$$US-SA-2024SA261785$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240911$$MD$US$US
243054721$24305472$1$I$$20240821$20240911$20240911$PER$$US-SA-2024SA259304$SANOFI AVENTIS$$$$A$M$Y$$$20240911$$MD$US$US
243054731$24305473$1$I$20240830$20240905$20240911$20240911$EXP$$US-ABBVIE-5913629$ABBVIE$$62$YR$$M$Y$$$20240911$$CN$US$US
243054741$24305474$1$I$20240101$20240827$20240911$20240911$PER$$US-SA-2024SA229066$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240911$$MD$US$US
243054751$24305475$1$I$$20240621$20240911$20240911$EXP$$US-ROCHE-10000073088$ROCHE$Jeng M, Beng F, Julie B, Anita G, Arnold M, Adrienne H, et al. Malignant Transformation of Infantile Hemangioma to Angiosarcoma: Response to Chemotherapy With Bevacizumab. Pediatr Blood Cancer. 2014;61:2115-7. doi:10.1002/pbc.25067.$5$MON$I$M$Y$$$20240911$$MD$US$US
243054771$24305477$1$I$20231201$20240904$20240911$20240911$PER$$US-009507513-2409USA001515$MERCK$$60$YR$$F$Y$$$20240911$$CN$US$US
243054781$24305478$1$I$20240903$20240909$20240911$20240911$EXP$$JP-TAKEDA-2024TJP013299$TAKEDA$$7$DEC$$F$Y$$$20240911$$MD$JP$JP
243054791$24305479$1$I$$20240909$20240911$20240911$EXP$$CA-ABBVIE-5916750$ABBVIE$$$$E$F$Y$$$20240911$$CN$CA$CA
243054801$24305480$1$I$20230830$20240903$20240911$20240911$EXP$$GB-AUROBINDO-AUR-APL-2024-044302$AUROBINDO$$58$YR$$M$Y$72$KG$20240911$$MD$GB$GB
243054811$24305481$1$I$$20240831$20240911$20240911$EXP$$DE-AUROBINDO-AUR-APL-2024-044287$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul L D. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$44$YR$$M$Y$$$20240911$$HP$DE$DE
243054821$24305482$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009993$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243054831$24305483$1$I$$20240902$20240911$20240911$PER$$US-ROCHE-10000072348$ROCHE$Matar C, Yaghi O N. HL-450 Rare Cases of Hodgkin Lymphoma Transformation in Chronic Lymphocytic Leukemia: Challenges in Diagnosis and Management. Clinical Lymphoma, Myeloma and Leukemia. 2024-Sep;24:S448-S449. doi:10.1016/S2152-2650(24)01467-8.$92$YR$E$F$Y$$$20240911$$MD$US$US
243054842$24305484$2$F$$20240906$20240911$20240916$PER$$US-AMGEN-USASP2024179219$AMGEN$$$$$$Y$$$20240916$$MD$US$US
243054851$24305485$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA261336$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240911$$MD$US$US
243054862$24305486$2$F$20240905$20240909$20240911$20240913$PER$$US-JNJFOC-20240913355$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240913$$CN$US$US
243054882$24305488$2$F$20240728$20240920$20240911$20240930$EXP$$US-Y-MABS THERAPEUTICS, INC.-SPO2024-US-001735$Y-MABS THERAPEUTICS$$$$$$Y$$$20240930$$HP$US$US
243054891$24305489$1$I$20230921$20240902$20240911$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-170886$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240911$$MD$JP$JP
243054902$24305490$2$F$$20240909$20240911$20240913$EXP$$CH-ROCHE-10000077155$ROCHE$$$$$$Y$$$20240913$$MD$CH$CH
243054911$24305491$1$I$$20240905$20240911$20240911$EXP$$JP-GSK-JP2024110542$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$JP$JP
243054921$24305492$1$I$20240415$20240902$20240911$20240911$EXP$$GB-AUROBINDO-AUR-APL-2024-044003$AUROBINDO$$77$YR$$F$Y$59$KG$20240911$$PH$GB$GB
243054931$24305493$1$I$20240701$20240830$20240911$20240911$PER$$US-ABBVIE-5905310$ABBVIE$$54$YR$$$Y$$$20240911$$CN$US$US
243054941$24305494$1$I$20200101$20240830$20240911$20240911$EXP$$US-ALVOGEN-2024095437$ALVOGEN$$$$$F$Y$$$20240911$$CN$US$US
243054951$24305495$1$I$$20240903$20240911$20240911$EXP$$FR-AUROBINDO-AUR-APL-2024-044332$AUROBINDO$$26$YR$$F$Y$$$20240911$$MD$FR$FR
243054961$24305496$1$I$$20240909$20240911$20240911$PER$$US-ROCHE-10000077678$ROCHE$$32$YR$A$F$Y$$$20240911$$HP$US$US
243054971$24305497$1$I$$20240905$20240911$20240911$EXP$$US-AstraZeneca-2024A203029$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243054981$24305498$1$I$20240828$20240830$20240911$20240911$PER$$US-AstraZeneca-2024A206196$ASTRAZENECA$$$$$$Y$$$20240911$$CN$US$
243054991$24305499$1$I$20240601$20240829$20240911$20240911$PER$$US-SA-2024SA261223$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240911$$MD$US$US
243055001$24305500$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA258855$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240911$$MD$US$US
243055011$24305501$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA261139$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240911$$HP$US$US
243055021$24305502$1$I$$20240907$20240911$20240911$PER$$US-JNJFOC-20240919661$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243055031$24305503$1$I$20240823$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024178877$AMGEN$$82$YR$E$F$Y$$$20240911$$CN$US$US
243055051$24305505$1$I$20240904$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024180076$AMGEN$$$$$$Y$$$20240911$$PH$US$US
243055061$24305506$1$I$$20240831$20240911$20240911$EXP$$PL-AUROBINDO-AUR-APL-2023-081831$AUROBINDO$Salomon-Perzy?ski A, Budziszewska BK.. How do I manage the myelotoxicity of venetoclax and azacitidine in patients with newly diagnosed acute myeloid leukemia?.. Hematology in Clinical Practice. 2023;14:6-10$68$YR$$F$Y$$$20240911$$MD$PL$PL
243055081$24305508$1$I$20240829$20240909$20240911$20240911$EXP$$JP-TAKEDA-2024TJP013312$TAKEDA$$7$DEC$$F$Y$$$20240911$$PH$JP$JP
243055091$24305509$1$I$$20240905$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0012993$DR REDDYS$$64$YR$A$M$Y$$$20240911$$PH$US$US
243055101$24305510$1$I$$20240817$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051954$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
243055111$24305511$1$I$$20240817$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA052070$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
243055121$24305512$1$I$20240813$20240905$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012985$DR REDDYS$$21$YR$A$M$Y$$$20240911$$HP$US$US
243055141$24305514$1$I$20240818$20240818$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051950$TOLMAR$$80$YR$$M$Y$$$20240911$$CN$CA$CA
243055162$24305516$2$F$20240829$20240913$20240911$20240923$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-26735$SAMSUNG BIOEPIS$$59$YR$A$F$Y$$$20240923$$MD$CA$CA
243055171$24305517$1$I$20240607$20240710$20240911$20240911$PER$$US-CELLTRION INC.-2024US015984$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243055191$24305519$1$I$20240814$20240904$20240911$20240911$EXP$$US-TAKEDA-2024TUS088506$TAKEDA$$84$YR$$F$Y$$$20240911$$CN$US$US
243055201$24305520$1$I$$20240909$20240911$20240911$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050359$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240911$$CN$US$US
243055211$24305521$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181638$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243055221$24305522$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181620$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243055231$24305523$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180199$AMGEN$$$$$$Y$$$20240911$$CN$US$US
243055242$24305524$2$F$20240905$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024178722$AMGEN$$83$YR$E$F$Y$$$20240911$$CN$US$US
243055251$24305525$1$I$20240907$20240907$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005504$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240911$$CN$US$US
243055261$24305526$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004455$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240911$$CN$US$US
243055272$24305527$2$F$$20240909$20240911$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004901$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243055281$24305528$1$I$$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003617$ELI LILLY AND CO$$56$YR$A$$Y$$$20240911$$CN$US$US
243055291$24305529$1$I$$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003875$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240911$$CN$US$US
243055301$24305530$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005863$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240911$$CN$US$US
243055311$24305531$1$I$20240906$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006267$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240911$$CN$US$US
243055321$24305532$1$I$$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004581$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240911$$CN$US$US
243055331$24305533$1$I$$20240820$20240911$20240911$PER$$US-SA-2024SA262212$SANOFI AVENTIS$$$$$F$Y$$$20240911$$CN$US$US
243055351$24305535$1$I$$20240909$20240911$20240911$EXP$$NVSC2024VE181308$NOVARTIS$$$$A$F$Y$$$20240911$$CN$VE$VE
243055361$24305536$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181642$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243055371$24305537$1$I$20240801$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141668$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240911$$HP$US$US
243055381$24305538$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144139$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$92.99$KG$20240911$$HP$US$US
243055391$24305539$1$I$$20240827$20240911$20240911$EXP$$US-RISINGPHARMA-US-2024RISLIT00313$RISING PHARMACEUTICALS$Robert T. Sataloff.Bilateral Sensorineural Hearing Loss in the Setting of Acute Methamphetamine Overdose.Ear, Nose + Throat Journal.2021;103(8):NP491-NP493$28$YR$A$M$Y$$$20240911$$MD$US$US
243055401$24305540$1$I$$20220304$20240911$20240911$EXP$$US-SANDOZ INC.-NVSC2022US052936$SANDOZ$$$$$F$Y$$$20240911$$CN$US$US
243055412$24305541$2$F$20240823$20240909$20240911$20240916$PER$$US-AMGEN-USASP2024180232$AMGEN$$16$MON$I$M$Y$$$20240915$$PH$US$US
243055421$24305542$1$I$20221221$20240828$20240911$20240911$EXP$$CA-CELLTRION INC.-2020CA035367$CELLTRION$$$$$$Y$$$20240911$$CN$CA$CA
243055431$24305543$1$I$$20240905$20240911$20240911$EXP$GB-MHRA-MED-202409051142525450-WZVKS$GB-RDY-SPO/GBR/24/0013047$DR REDDYS$$$$$M$Y$$$20240911$$CN$GB$GB
243055442$24305544$2$F$$20240918$20240911$20240927$EXP$$US-TEVA-VS-3240324$TEVA$Kuo C, Carlini SV, Tiwari S. (012) Parkinsonism is a Red Herring: Broad Differential Diagnoses in a Case of Catatonia Secondary to Clozapine Withdrawal. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S6-S7 abstr. 012.; Kuo C, Carlini SV, Tiwari S. (012) Parkinsonism is a Red Herring: Broad Differential Diagnoses in a Case of Catatonia Secondary to Clozapine Withdrawal. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S6-S7 abstr. 012.$56$YR$$F$Y$$$20240927$$HP$US$US
243055451$24305545$1$I$$20240909$20240911$20240911$EXP$GB-MHRA-MED-202409071112464930-LVPWQ$GB-SANDOZ INC.-SDZ2024GB079023$SANDOZ$$62$YR$$F$Y$78$KG$20240911$$CN$GB$GB
243055461$24305546$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A204628$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243055471$24305547$1$I$$20240903$20240911$20240911$30DAY$$JP-SA-2024SA257855$SANOFI AVENTIS$$$$A$$Y$$$20240911$$PH$JP$JP
243055481$24305548$1$I$20240801$20240830$20240911$20240911$PER$$US-SA-2024SA260548$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240911$$HP$US$US
243055491$24305549$1$I$20240801$20240830$20240911$20240911$PER$$US-SA-2024SA261678$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240911$$HP$US$US
243055501$24305550$1$I$20240601$20240903$20240911$20240911$PER$$US-SA-2024SA262050$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240911$$MD$US$US
243055511$24305551$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA261988$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240911$$HP$US$US
243055521$24305552$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180221$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
243055532$24305553$2$F$$20240921$20240911$20240930$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-142747$BRISTOL MYERS SQUIBB$Hilser T, Darr C, Niegisch G, Schnabel MJ, Foller S, Hauser L, et al. Cabozantinib plus nivolumab in adult patients with advanced or metastatic renal cell carcinoma: a retrospective, non-interventional study in a real-world cohort/guardians project. Cancers. 2024 Aug 28;16(17):1-11. doi:10.3390/cancers16172998.$$$A$$Y$$$20240930$$MD$DE$DE
243055541$24305554$1$I$$20240909$20240911$20240911$PER$$NVSC2024US181436$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243055551$24305555$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181663$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243055572$24305557$2$F$$20240911$20240911$20240918$EXP$$BE-AMGEN-BELSP2024177887$AMGEN$$47$YR$A$F$Y$$$20240918$$MD$BE$BE
243055581$24305558$1$I$$20240905$20240911$20240911$EXP$$SK-BRISTOL-MYERS SQUIBB COMPANY-2024-141633$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240911$$MD$SK$SK
243055591$24305559$1$I$$20240906$20240911$20240911$PER$$US-BEH-2024178373$CSL BEHRING$$$$$$Y$$$20240911$$CN$US$US
243055601$24305560$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009992$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243055611$24305561$1$I$$20240909$20240911$20240911$PER$$NVSC2024US180923$NOVARTIS$$70$YR$$M$Y$$$20240911$$CN$US$US
243055621$24305562$1$I$$20240907$20240911$20240911$EXP$$IN-ROCHE-10000077022$ROCHE$$70$YR$E$M$Y$44$KG$20240911$$CN$IN$IN
243055631$24305563$1$I$20240702$20240910$20240911$20240911$EXP$$JP-TAKEDA-2024TJP010147$TAKEDA$$$$A$M$Y$$$20240911$$MD$JP$JP
243055641$24305564$1$I$20240828$20240830$20240911$20240911$EXP$$US-Accord-445373$ACCORD$$47$YR$A$F$Y$$$20240911$$PH$US$US
243055652$24305565$2$F$20240829$20240912$20240911$20240917$EXP$$US-STALCOR-2024-AER-01945$Unknown Manufacturer$$18$YR$A$F$Y$$$20240917$$HP$US$US
243055671$24305567$1$I$$20240905$20240911$20240911$EXP$GB-MHRA-MED-202409051047363520-LJFDC$GB-RDY-SPO/GBR/24/0013049$DR REDDYS$$$$$$Y$65$KG$20240911$$CN$GB$GB
243055681$24305568$1$I$$20240903$20240911$20240911$PER$$US-RDY-SPO/USA/24/0013024$DR REDDYS$$31$YR$A$F$Y$$$20240911$$HP$US$US
243055691$24305569$1$I$20240810$20240904$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012894$DR REDDYS$$65$YR$E$F$Y$$$20240911$$HP$US$US
243055701$24305570$1$I$20240101$20240904$20240911$20240911$EXP$$US-AMGEN-USASP2024176774$AMGEN$$12$YR$T$M$Y$$$20240911$$HP$US$US
243055711$24305571$1$I$20240831$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180220$AMGEN$$74$YR$E$$Y$$$20240911$$CN$US$US
243055721$24305572$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180088$AMGEN$$$$$$Y$$$20240911$$PH$US$US
243055731$24305573$1$I$20240801$20240827$20240911$20240911$PER$$US-APOTEX-2024AP010047$APOTEX$$$$$M$Y$$$20240911$$CN$US$US
243055742$24305574$2$F$20240822$20240913$20240911$20240918$EXP$$US-ABBVIE-5910222$ABBVIE$$65$YR$$F$Y$81.7$KG$20240918$$CN$US$US
243055752$24305575$2$F$$20240912$20240911$20240918$PER$$NVSC2024US180415$NOVARTIS$$$$$F$Y$$$20240918$$HP$US$US
243055762$24305576$2$F$$20240906$20240911$20240912$EXP$$FR-ROCHE-10000074973$ROCHE$$74$YR$E$M$Y$120$KG$20240912$$MD$FR$FR
243055772$24305577$2$F$20240601$20240912$20240911$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08651$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243055791$24305579$1$I$$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004253$ELI LILLY AND CO$$$$$F$Y$$$20240911$$HP$US$US
243055801$24305580$1$I$$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004850$ELI LILLY AND CO$$65$YR$E$$Y$$$20240911$$CN$US$US
243055811$24305581$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005652$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240911$$CN$US$US
243055821$24305582$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004388$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240911$$CN$US$US
243055831$24305583$1$I$20240801$20240829$20240911$20240911$PER$$US-SA-2024SA259652$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240911$$MD$US$US
243055843$24305584$3$F$20240201$20240918$20240911$20240927$EXP$$US-ABBVIE-5910479$ABBVIE$$53$YR$$F$Y$72$KG$20240927$$CN$US$US
243055851$24305585$1$I$$20240904$20240911$20240911$EXP$$BG-SA-2024SA258273$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240911$$MD$BG$BG
243055861$24305586$1$I$20240822$20240830$20240911$20240911$PER$$US-SA-2024SA261520$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240911$$CN$US$US
243055881$24305588$1$I$20240801$20240829$20240911$20240911$PER$$US-SA-2024SA261065$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240911$$HP$US$US
243055891$24305589$1$I$20240603$20240905$20240911$20240911$EXP$$DE-ABBVIE-5913685$ABBVIE$$73$YR$$M$Y$90$KG$20240911$$MD$DE$DE
243055911$24305591$1$I$$20231016$20240911$20240911$PER$$US-ALVOGEN-2023092406$ALVOGEN$$$$$F$Y$$$20240911$$CN$US$US
243055921$24305592$1$I$20240812$20240906$20240911$20240911$EXP$$FR-AstraZeneca-2024A205649$ASTRAZENECA$$92$YR$$F$Y$55$KG$20240911$$MD$FR$
243055931$24305593$1$I$20240101$20240906$20240911$20240911$EXP$$CL-UCBSA-2024046058$UCB$$$$$F$Y$$$20240911$$CN$CL$CL
243055941$24305594$1$I$$20240525$20240911$20240911$PER$$NVSC2024US181273$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243055952$24305595$2$F$$20240925$20240911$20240926$PER$$NVSC2024US181665$NOVARTIS$$$$$M$Y$$$20240926$$HP$US$US
243055961$24305596$1$I$$20240904$20240911$20240911$EXP$$US-ORPHANEU-2024006939$RECORDATI$$$$$$Y$$$20240911$$CN$US$US
243055971$24305597$1$I$$20231025$20240911$20240911$PER$$US-ALVOGEN-2023092473$ALVOGEN$$$$$M$Y$$$20240911$$CN$US$US
243055982$24305598$2$F$20240303$20240911$20240911$20240914$EXP$GB-009507513-2311GBR011281$GB-ROCHE-10000075123$ROCHE$$$$E$F$Y$89$KG$20240914$$MD$GB$GB
243055991$24305599$1$I$$20240902$20240911$20240911$EXP$$CA-CELLTRION INC.-2024CA021388$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
243056001$24305600$1$I$$20240903$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0013130$DR REDDYS$Diaz MJ, Liu VY, Motaparthi K. Noninflammatory extrafacial edema as a clue to the diagnosis of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. JAAD Case Reports. 2024;47: 96-98. doi:10.1016/j.jdcr.2024.02.016.$6$DEC$A$M$Y$$$20240911$$HP$US$US
243056011$24305601$1$I$20240801$20240903$20240911$20240911$EXP$$JP-AMGEN-JPNSP2024176150$AMGEN$$$$I$F$Y$$$20240911$$MD$JP$JP
243056031$24305603$1$I$$20240904$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141349$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$68.49$KG$20240911$$CN$US$US
243056041$24305604$1$I$$20240906$20240911$20240911$EXP$$US-EXELIXIS-CABO-24080667$EXELIXIS$$$$$F$Y$$$20240911$$CN$US$US
243056051$24305605$1$I$20240809$20240906$20240911$20240911$EXP$$JP-EXELIXIS-EXL-2024-000061$EXELIXIS$$6$DEC$$F$Y$$$20240911$$MD$JP$JP
243056061$24305606$1$I$$20240904$20240911$20240911$EXP$$CA-TAKEDA-2024TUS085008$TAKEDA$$$$$F$Y$79$KG$20240911$$CN$CA$CA
243056071$24305607$1$I$20240907$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180009$AMGEN$$83$YR$E$F$Y$$$20240911$$CN$US$US
243056081$24305608$1$I$$20240122$20240911$20240911$EXP$$GB-TEVA-VS-3237782$TEVA$$43$YR$$F$Y$$$20240911$$CN$GB$GB
243056091$24305609$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181652$NOVARTIS$$$$$F$Y$78$KG$20240911$$CN$US$US
243056101$24305610$1$I$$20231127$20240911$20240911$PER$$US-APOTEX-2023AP017473$APOTEX$Tran E, Ledbetter LE.. A retrospective evaluation of direct oral anticoagulant (DOAC) management strategies in patients with cancer on active chemotherapy. Journal of Thrombosis and Thrombolysis. 2023;55(4):721-728$59$YR$$M$Y$126.1$KG$20240911$$HP$US$US
243056111$24305611$1$I$20240715$20240905$20240911$20240911$EXP$$US-ABBVIE-5909897$ABBVIE$$24$YR$$F$Y$$$20240911$$CN$US$US
243056121$24305612$1$I$20230912$20230913$20240911$20240911$PER$$US-Tamarang, S.A.-2161463$TAMARANG PHARMACEUTICALS$$5$YR$$M$Y$16.8$KG$20240911$$PH$US$US
243056131$24305613$1$I$20240101$20240904$20240911$20240911$EXP$$US-ABBVIE-5903923$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243056141$24305614$1$I$20230720$20240905$20240911$20240911$EXP$$CO-UCBSA-2024046084$UCB$$79$YR$$F$Y$$$20240911$$CN$CO$CO
243056151$24305615$1$I$$20240821$20240911$20240911$PER$$US-SA-2024SA259414$SANOFI AVENTIS$$$$E$F$Y$$$20240911$$MD$US$US
243056171$24305617$1$I$$20240905$20240911$20240911$EXP$$IN-ROCHE-10000076003$ROCHE$$64$YR$A$F$Y$$$20240911$$CN$IN$IN
243056181$24305618$1$I$20240902$20240906$20240911$20240911$EXP$$PE-AMGEN-PERSL2024179491$AMGEN$$43$YR$A$F$Y$$$20240911$$CN$PE$PE
243056192$24305619$2$F$20240908$20240911$20240911$20240914$PER$$US-AMGEN-USASP2024180127$AMGEN$$70$YR$E$M$Y$$$20240913$$CN$US$US
243056201$24305620$1$I$20240614$20240905$20240911$20240911$EXP$$US-JNJFOC-20240915901$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$HP$US$US
243056211$24305621$1$I$20240826$20240905$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012970$DR REDDYS$$20$YR$A$F$Y$$$20240911$$HP$US$US
243056221$24305622$1$I$20240903$20240904$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012963$DR REDDYS$$58$YR$A$F$Y$$$20240911$$PH$US$US
243056231$24305623$1$I$$20240905$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0012971$DR REDDYS$$72$YR$E$F$Y$$$20240911$$HP$US$US
243056251$24305625$1$I$$20240906$20240911$20240911$EXP$$GB-ABBVIE-5913823$ABBVIE$$$$E$F$Y$$$20240911$$CN$GB$GB
243056261$24305626$1$I$20240528$20240909$20240911$20240911$EXP$$DE-SANDOZ INC.-SDZ2024DE078697$SANDOZ$$72$YR$$F$Y$$$20240911$$MD$DE$DE
243056271$24305627$1$I$$20240828$20240911$20240911$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111788$ZYDUS PHARM$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al.. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.. Cancer-Immunol-Immunother. 2024;73$$$$$Y$$$20240911$$HP$US$US
243056281$24305628$1$I$$20240906$20240911$20240911$EXP$$GB-ABBVIE-5913743$ABBVIE$$$$E$F$Y$$$20240911$$PH$GB$GB
243056291$24305629$1$I$20240601$20240716$20240911$20240911$EXP$$FR-AstraZeneca-2024A136956$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$FR$
243056301$24305630$1$I$$20240827$20240911$20240911$EXP$$US-SA-2024SA259202$SANOFI AVENTIS$$$$A$F$Y$$$20240911$$MD$US$US
243056311$24305631$1$I$$20240903$20240911$20240911$EXP$$CA-TOLMAR, INC.-24CA052398$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
243056321$24305632$1$I$$20240906$20240911$20240911$EXP$$US-TAKEDA-2024TUS050734$TAKEDA$$$$$M$Y$$$20240911$$CN$US$US
243056331$24305633$1$I$$20240903$20240911$20240911$EXP$$NL-TOLMAR, INC.-24NL052329$TOLMAR$$$$$M$Y$$$20240911$$HP$NL$NL
243056341$24305634$1$I$$20240903$20240911$20240911$EXP$$CA-TOLMAR, INC.-24CA052403$TOLMAR$$$$$M$Y$$$20240911$$PH$CA$CA
243056351$24305635$1$I$$20240903$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409002100$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240911$$CN$US$US
243056361$24305636$1$I$20240907$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005629$ELI LILLY AND CO$$63$YR$A$$Y$$$20240911$$CN$US$US
243056371$24305637$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004608$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243056381$24305638$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006009$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240911$$CN$US$US
243056392$24305639$2$F$20240905$20240909$20240911$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005132$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240916$$CN$US$US
243056401$24305640$1$I$20240909$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006047$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240911$$CN$US$US
243056411$24305641$1$I$20240909$20240909$20240911$20240911$PER$$US-ALXN-202409USA000561US$ALEXION PHARMACEUTICALS$$77$YR$$M$Y$$$20240911$$CN$US$US
243056421$24305642$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005755$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240911$$CN$US$US
243056431$24305643$1$I$$20240829$20240911$20240911$EXP$$US-AUROBINDO-AUR-APL-2024-043366$AUROBINDO$Soliman Y, Hatfield AA, McAllister RK, Fettiplace MR, Hofkamp MP.. Apparent local anesthetic systemic toxicity following activation of an epidural catheter for cesarean delivery: Diagnosis and management of an uncommon obstetric anesthesia complication. Proceedings (Baylor University. Medical Center). 2024;37(5):874-6$25$YR$$F$Y$92$KG$20240911$$MD$US$US
243056441$24305644$1$I$20240905$20240905$20240911$20240911$PER$$US-ROCHE-10000076052$ROCHE$$14$YR$T$M$Y$40.82$KG$20240911$$CN$US$US
243056451$24305645$1$I$20230119$20240905$20240911$20240911$EXP$$CN-ABBVIE-5914958$ABBVIE$$45$YR$$F$Y$60$KG$20240911$$HP$CN$CN
243056462$24305646$2$F$$20240904$20240911$20240911$PER$$US-BIOGEN-2024BI01281260$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243056471$24305647$1$I$20240903$20240904$20240911$20240911$EXP$$JP-009507513-2409JPN000768J$MERCK$$75$YR$$M$Y$$$20240911$$MD$JP$JP
243056481$24305648$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181718$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243056491$24305649$1$I$$20240910$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144265$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240911$$CN$US$US
243056501$24305650$1$I$20240801$20240828$20240911$20240911$PER$$US-JNJFOC-20240875328$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240911$$PH$US$US
243056511$24305651$1$I$$20240802$20240911$20240911$EXP$$US-Shanghai Hengrui Pharmaceutical Co., Ltd.-2161464$SHANGHAI HENGRUI PHARMACEUTICAL$Transient recurrence of chemotherapy-induced peripheral neuropathy in the immediate postoperative period following gynaecological surgery under general anaesthesia$57$YR$$F$Y$$$20240911$$MD$US$US
243056522$24305652$2$F$$20240910$20240911$20240913$PER$$NVSC2024US181679$NOVARTIS$$70$YR$$F$Y$$$20240913$$HP$US$US
243056532$24305653$2$F$20240909$20240910$20240911$20240912$PER$$US-AMGEN-USASP2024180182$AMGEN$$78$YR$E$M$Y$$$20240912$$CN$US$US
243056541$24305654$1$I$20240315$20240328$20240911$20240911$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-105322$ZYDUS PHARM$$$$$$Y$$$20240911$$CN$US$US
243056551$24305655$1$I$20240729$20240902$20240911$20240911$EXP$ES-AEMPS-1564836$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-111884$ZYDUS PHARM$$$$$$Y$$$20240911$$MD$ES$ES
243056561$24305656$1$I$$20240828$20240911$20240911$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111827$ZYDUS PHARM$Cooper J, Soneji D, Rieger K, Narala S, Kim Y.. Primary Cutaneous CD30+ Large T Cell Lymphoproliferative Disorder Associated With Prolonged Exposure to Fingolimod.. Mult-Scler-J. 2023;29 (Suppl. 3)(3:969 abstr. P1519/117$$$$$Y$$$20240911$$HP$US$US
243056571$24305657$1$I$$20240904$20240911$20240911$PER$$US-ABBVIE-5910497$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243056581$24305658$1$I$20230101$20240701$20240911$20240911$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109292$ZYDUS PHARM$$$$$$Y$$$20240911$$CN$US$US
243056591$24305659$1$I$20240812$20240830$20240911$20240911$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111913$ZYDUS PHARM$$$$$$Y$$$20240911$$MD$US$US
243056611$24305661$1$I$$20240903$20240911$20240911$EXP$GB-MHRA-MED-202409031351406570-NCSHQ$GB-862174955-ML2024-04768$MICRO LABS$$67$YR$E$$Y$$$20240911$$PH$GB$GB
243056621$24305662$1$I$$20240827$20240911$20240911$EXP$$US-SA-2024SA259657$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240911$$HP$US$US
243056631$24305663$1$I$$20240827$20240911$20240911$EXP$$DE-LEADINGPHARMA-DE-2024LEALIT00379$LEADING PHARMA$N Dyballa.A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting clinical, toxicological and forensic aspects. Forensic Science, Medicine and Pathology.AUG-2024$12$WK$I$M$Y$$$20240911$$HP$DE$DE
243056641$24305664$1$I$20211119$20240905$20240911$20240911$EXP$PL-URPL-DML-MLP.4401.1.5051.2021$PL-EMD Serono-2024047677$EMD SERONO INC$$49$YR$A$$Y$100$KG$20240911$$MD$PL$PL
243056651$24305665$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144172$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240911$$HP$US$US
243056661$24305666$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143619$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$75.75$KG$20240911$$CN$US$US
243056671$24305667$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240815$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240911$$HP$US$US
243056681$24305668$1$I$$20240910$20240911$20240911$PER$$US-HALEON-2196098$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243056692$24305669$2$F$20240101$20240905$20240911$20240918$PER$$US-ABBVIE-5909003$ABBVIE$$$$$F$Y$66$KG$20240918$$CN$US$US
243056701$24305670$1$I$20240101$20240904$20240911$20240911$EXP$$US-ABBVIE-5908170$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243056711$24305671$1$I$20240801$20240904$20240911$20240911$EXP$$US-ABBVIE-5898348$ABBVIE$$38$YR$$M$Y$$$20240911$$CN$US$US
243056721$24305672$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000568US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243056731$24305673$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3239630$TEVA$$59$YR$$F$Y$100$KG$20240911$$HP$CA$CA
243056741$24305674$1$I$$20240905$20240911$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001811$BLUEPRINT MEDICINES$$$$$F$Y$$$20240911$$CN$US$US
243056751$24305675$1$I$$20240902$20240911$20240911$EXP$$US-NOVITIUMPHARMA-2024USNVP01786$NOVITIUM PHARMA$Cecchini A.An Uncommon Cause of Immunosuppression: Fatal Pneumocystis Jiroveci Pneumonia in a Patient With Cushing^s Syndrome.American Journal of Respiratory and Critical Care Medicine.21-MAY-2023;207A:1341$61$YR$A$F$Y$$$20240911$$HP$US$US
243056761$24305676$1$I$20240701$20240909$20240911$20240911$PER$$US-ALXN-202409USA000509US$ALEXION PHARMACEUTICALS$$5$YR$$M$Y$$$20240911$$CN$US$US
243056781$24305678$1$I$20240601$20240814$20240911$20240911$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00753$BIOCRYST PHARMACEUTICALS$$74$YR$$F$Y$$$20240911$$MD$US$US
243056791$24305679$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240816$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240911$$HP$US$US
243056801$24305680$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240404$TEVA$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.; Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.$71$YR$$F$Y$$$20240911$$HP$US$US
243056811$24305681$1$I$$20240905$20240911$20240911$EXP$$US-AstraZeneca-2024A203333$ASTRAZENECA$$$$$$Y$$$20240911$$HP$US$
243056821$24305682$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A203863$ASTRAZENECA$$$$$$Y$$$20240911$$MD$US$
243056831$24305683$1$I$$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A201048$ASTRAZENECA$$$$C$M$Y$$$20240911$$CN$US$
243056841$24305684$1$I$$20240902$20240911$20240911$EXP$$GT-ROCHE-10000073952$ROCHE$$85$YR$E$M$Y$$$20240911$$MD$GT$GT
243056851$24305685$1$I$$20240614$20240911$20240911$PER$$US-Tamarang, S.A.-2161465$TAMARANG PHARMACEUTICALS$$$$$F$Y$$$20240911$$$US$US
243056861$24305686$1$I$20240722$20240909$20240911$20240911$EXP$FR-AFSSAPS-CN2024000792$FR-SANDOZ INC.-SDZ2024FR077294$SANDOZ$$64$YR$$M$Y$86.85$KG$20240911$$MD$FR$FR
243056872$24305687$2$F$20240731$20240909$20240911$20240916$EXP$FR-AFSSAPS-PO2024000948$FR-JNJFOC-20240924292$JOHNSON AND JOHNSON$$60$YR$A$M$Y$72$KG$20240916$$PH$FR$FR
243056881$24305688$1$I$$20240904$20240911$20240911$EXP$$VN-ROCHE-10000075583$ROCHE$$65$YR$E$F$Y$$$20240911$$MD$VN$VN
243056891$24305689$1$I$$20240830$20240911$20240911$EXP$$PL-ROCHE-10000072843$ROCHE$$$$$$Y$$$20240911$$MD$PL$PL
243056901$24305690$1$I$20240903$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180303$AMGEN$$64$YR$A$F$Y$$$20240911$$CN$US$US
243056922$24305692$2$F$20240101$20240920$20240911$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-027735$UNITED THERAPEUTICS$$$$$F$Y$78.912$KG$20240927$$$US$US
243056931$24305693$1$I$$20240904$20240911$20240911$EXP$$US-AMGEN-USASP2024178029$AMGEN$$77$YR$E$F$Y$$$20240911$$HP$US$US
243056941$24305694$1$I$$20240827$20240911$20240911$EXP$$US-LEADINGPHARMA-US-2024LEALIT00384$LEADING PHARMA$C Bulleit.Treating Malignant Catatonia With Liquid Amantadine: A Case Report and Literature Review..Journal of Psychiatric Practice.JUL-2024;30 No.4:308-310$51$YR$A$F$Y$$$20240911$$HP$US$US
243056951$24305695$1$I$$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004839$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240911$$CN$US$US
243056961$24305696$1$I$20240715$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005241$ELI LILLY AND CO$$$$A$M$Y$$$20240911$$CN$US$US
243056971$24305697$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005762$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240911$$CN$US$US
243056981$24305698$1$I$$20240910$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144293$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240911$$CN$US$US
243056991$24305699$1$I$$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144294$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240911$$CN$US$US
243057001$24305700$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143316$BRISTOL MYERS SQUIBB$Latif R, Aloqaily M, Rabadi A, Arshad K, Kurian AI, Obeidat I, et al. Apixaban-induced hemopericardium in a post-TAVR patient: a case report highlighting diagnostic and management challenges. The American Journal of Case Reports. 2024 Jul 26;25:e944173-1-5. doi:10.12659/AJCR.944173.$66$YR$E$M$Y$$$20240911$$HP$US$US
243057011$24305701$1$I$$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143734$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240911$$CN$US$US
243057032$24305703$2$F$20221229$20240919$20240911$20240928$EXP$$PT-AUROBINDO-AUR-APL-2024-043543$AUROBINDO$Soares M, Rosa S, Bettencourt S, Ferreira R, Sardinha M, Dias M, et al. Cytotoxic lesions of the corpus callosum due to FOLFIRINOX chemotherapy. Brain Disorders. 2024;15:100157$47$YR$$F$Y$$$20240928$$MD$PT$PT
243057041$24305704$1$I$$20240823$20240911$20240911$PER$$US-TEVA-VS-3236843$TEVA$$26$YR$$M$Y$$$20240911$$PH$US$US
243057051$24305705$1$I$20240101$20240906$20240911$20240911$EXP$$US-ABBVIE-5914128$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243057061$24305706$1$I$$20240906$20240911$20240911$EXP$$US-TAKEDA-2023TUS117277$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
243057071$24305707$1$I$20240906$20240906$20240911$20240911$EXP$$TW-ABBVIE-5914492$ABBVIE$$64$YR$$F$Y$$$20240911$$CN$TW$TW
243057081$24305708$1$I$$20240903$20240911$20240911$EXP$$US-ROCHE-10000073850$ROCHE$$66$YR$E$M$Y$$$20240911$$CN$US$US
243057091$24305709$1$I$20240801$20240906$20240911$20240911$EXP$$CN-SANDOZ INC.-SDZ2024CN078548$SANDOZ$$72$YR$$F$Y$60$KG$20240911$$HP$CN$CN
243057101$24305710$1$I$$20240830$20240911$20240911$EXP$$US-Accord-445085$ACCORD$$$$$M$Y$$$20240911$$PH$US$US
243057111$24305711$1$I$20240419$20240902$20240911$20240911$EXP$FR-AFSSAPS-AN2024001182$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111857$ZYDUS PHARM$$$$$$Y$$$20240911$$MD$FR$FR
243057122$24305712$2$F$20240904$20240912$20240911$20240918$EXP$$US-ALXN-202409USA000545US$ALEXION PHARMACEUTICALS$$17$YR$$M$Y$$$20240918$$MD$US$US
243057131$24305713$1$I$$20240906$20240911$20240911$EXP$$US-AMGEN-USASP2024179387$AMGEN$$$$A$F$Y$$$20240911$$HP$US$US
243057151$24305715$1$I$$20240906$20240911$20240911$PER$$NVSC2024US180652$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
243057171$24305717$1$I$20240801$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180134$AMGEN$$81$YR$E$F$Y$$$20240911$$CN$US$US
243057181$24305718$1$I$20240701$20240903$20240911$20240911$30DAY$$US-GSK-US2024109505$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240911$$CN$US$US
243057191$24305719$1$I$20240823$20240830$20240911$20240911$EXP$GB-MHRA-MED-202408302021193740-GLQSC$GB-GLENMARK PHARMACEUTICALS-2024GMK093806$GLENMARK$$$$$$Y$$$20240911$$CN$GB$GB
243057201$24305720$1$I$20240823$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024180037$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
243057211$24305721$1$I$20240801$20240822$20240911$20240911$PER$$US-TEVA-VS-3237232$TEVA$$41$YR$$F$Y$$$20240911$$CN$US$US
243057221$24305722$1$I$20240729$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009702$APOTEX$$$$$F$Y$$$20240911$$CN$US$US
243057231$24305723$1$I$$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A200781$ASTRAZENECA$$$$$F$Y$54$KG$20240911$$CN$US$
243057241$24305724$1$I$$20240903$20240911$20240911$PER$$US-AstraZeneca-2024A201974$ASTRAZENECA$$$$A$F$Y$$$20240911$$CN$US$
243057251$24305725$1$I$20240101$20240909$20240911$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-144231$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240911$$MD$JP$JP
243057261$24305726$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144249$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240911$$CN$US$US
243057271$24305727$1$I$$20240902$20240911$20240911$EXP$$CA-NOVITIUMPHARMA-2024CANVP01784$NOVITIUM PHARMA$Patrick Benoit.Brainstorm: A case of granulomatous encephalitis.Journal of the Association of Medical Microbiology and Infectious Disease.12-JUN-2024;9(2):113-120$74$YR$E$F$Y$$$20240911$$HP$CA$CA
243057282$24305728$2$F$20240814$20240912$20240911$20240914$EXP$$US-ABBVIE-5916862$ABBVIE$$68$YR$$M$Y$81.647$KG$20240914$$HP$US$US
243057291$24305729$1$I$20240831$20240902$20240911$20240911$EXP$$GB-CELLTRION INC.-2024GB021226$CELLTRION$$$$$$Y$$$20240911$$CN$GB$GB
243057301$24305730$1$I$20240702$20240905$20240911$20240911$EXP$$JP-GSK-JP2024JPN110281$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$PH$JP$JP
243057311$24305731$1$I$20240822$20240902$20240911$20240911$EXP$$US-ROCHE-10000072391$ROCHE$$72$YR$E$M$Y$79.38$KG$20240911$$CN$US$US
243057321$24305732$1$I$20240813$20240829$20240911$20240911$EXP$ES-AEMPS-1562695$ES-Accord-444534$ACCORD$$67$YR$E$M$Y$70$KG$20240911$$PH$ES$ES
243057331$24305733$1$I$$20240830$20240911$20240911$EXP$$SA-HALEON-2195589$Haleon PLC$Sharif AF, Almulhim MN, Almosabeh HM, Alshammasy ME, Aljeshi AM, Mufti TM et. al. Predictors of Serotonin Syndrome in Acute Poisoning with 5-Hydroxytryptamine Modulators. Toxics. 2024;12(8).$$$$$Y$$$20240910$$HP$SA$SA
243057341$24305734$1$I$$20240905$20240911$20240911$EXP$$CA-ROCHE-10000074943$ROCHE$$87$YR$E$M$Y$$$20240911$$PH$CA$CA
243057351$24305735$1$I$20240909$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180807$AMGEN$$73$YR$E$F$Y$$$20240911$$CN$US$US
243057361$24305736$1$I$20240830$20240902$20240911$20240911$EXP$$GB-EMD Serono-2024048133$EMD SERONO INC$$48$YR$A$M$Y$105$KG$20240911$$HP$GB$GB
243057371$24305737$1$I$$20240902$20240911$20240911$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006684$BIOCON$$$$$$Y$$$20240911$$CN$CA$CA
243057381$24305738$1$I$$20240902$20240911$20240911$EXP$$JP-ROCHE-10000074453$ROCHE$Saito N, Kakizaki S, Hiraoka A, Tada T, Kariyama K, et al. Factors affecting an increase in spleen volume and association of spleen volume variation with the clinical outcomes of atezolizumab and bevacizumab treatment for hepatocellular carcinoma: A retrospective analysis. Oncology. 2024-Aug-20; doi:10.1159/000541002.$$$$$Y$$$20240911$$HP$JP$JP
243057391$24305739$1$I$20240201$20240904$20240911$20240911$EXP$$IT-AMGEN-ITASP2024177009$AMGEN$$84$YR$E$M$Y$75$KG$20240911$$MD$IT$IT
243057401$24305740$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005262$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240911$$CN$US$US
243057412$24305741$2$F$20240906$20240919$20240911$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409005757$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240923$$CN$US$US
243057421$24305742$1$I$20240907$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005877$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240911$$CN$US$US
243057431$24305743$1$I$20230801$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005521$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240911$$CN$US$US
243057452$24305745$2$F$$20240910$20240911$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409005799$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240913$$CN$US$US
243057461$24305746$1$I$20240801$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005449$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240911$$CN$US$US
243057471$24305747$1$I$20240905$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003746$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240911$$CN$US$US
243057481$24305748$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005698$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240911$$CN$US$US
243057491$24305749$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006285$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243057501$24305750$1$I$$20240828$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202408018366$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243057511$24305751$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006018$ELI LILLY AND CO$$$$$$Y$$$20240911$$CN$US$US
243057521$24305752$1$I$20240905$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005435$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240911$$CN$US$US
243057531$24305753$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004777$ELI LILLY AND CO$$$$$$Y$$$20240911$$CN$US$US
243057551$24305755$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144333$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$94.8$KG$20240911$$CN$US$US
243057561$24305756$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144327$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240911$$HP$US$US
243057571$24305757$1$I$$20240908$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143065$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$70.31$KG$20240911$$CN$US$US
243057581$24305758$1$I$20240801$20240909$20240911$20240911$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-143613$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$86.64$KG$20240911$$CN$PR$PR
243057591$24305759$1$I$20240826$20240910$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144230$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$76.2$KG$20240911$$PH$US$US
243057601$24305760$1$I$20240708$20240906$20240911$20240911$EXP$$US-JNJFOC-20240919803$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240911$$HP$US$US
243057621$24305762$1$I$20240729$20240909$20240911$20240911$EXP$$US-AstraZeneca-2024A205459$ASTRAZENECA$$24062$DY$$F$Y$$$20240911$$CN$US$
243057631$24305763$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A203956$ASTRAZENECA$$$$$$Y$$$20240911$$CN$US$
243057641$24305764$1$I$$20240905$20240911$20240911$EXP$$US-AstraZeneca-2024A202538$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243057651$24305765$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240817$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$$$Y$$$20240911$$HP$US$US
243057661$24305766$1$I$$20240906$20240911$20240911$EXP$$US-ABBVIE-5917097$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243057671$24305767$1$I$$20240910$20240911$20240911$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050655$BOEHRINGER INGELHEIM$$$$$$Y$$$20240911$$MD$JP$JP
243057681$24305768$1$I$$20240906$20240911$20240911$PER$$US-ABBVIE-5916055$ABBVIE$$$$$$Y$$$20240911$$HP$US$US
243057691$24305769$1$I$$20240816$20240911$20240911$30DAY$$US-GSK-US2024AMR112213$GLAXOSMITHKLINE$$$$$M$Y$$$20240911$$CN$US$US
243057701$24305770$1$I$$20240904$20240911$20240911$EXP$$GB-EMD Serono-2024047786$EMD SERONO INC$$$$E$F$Y$$$20240911$$CN$GB$GB
243057711$24305771$1$I$$20240903$20240911$20240911$EXP$$US-ROCHE-10000073673$ROCHE$$88$YR$E$M$Y$$$20240911$$CN$US$US
243057722$24305772$2$F$$20240828$20240911$20240911$EXP$$US-ASTELLAS-2024-AER-003983$ASTELLAS$$$$A$M$Y$$$20240911$$MD$US$US
243057732$24305773$2$F$20240101$20240910$20240911$20240911$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050692$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240911$$MD$US$US
243057741$24305774$1$I$20240223$20240905$20240911$20240911$EXP$$NVSC2024FR059673$NOVARTIS$$$$E$F$Y$44$KG$20240911$$MD$FR$FR
243057751$24305775$1$I$20240215$20240903$20240911$20240911$EXP$$DE-BIOGEN-2024BI01280906$BIOGEN$$55$YR$$F$Y$60$KG$20240911$$MD$DE$DE
243057761$24305776$1$I$$20240909$20240911$20240911$PER$$US-ROCHE-10000078044$ROCHE$$$$$$Y$$$20240911$$CN$US$US
243057781$24305778$1$I$20180101$20240523$20240911$20240911$EXP$$SK-TEVA-VS-3208028$TEVA$Rusnakova, S. et al. Long QT syndrome and pregnancy. Gynekol. prax 2024; 22 (2): 124-127, ISSN: 1336-3425$$$A$F$Y$$$20240911$$MD$SK$SK
243057791$24305779$1$I$$20240902$20240911$20240911$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS004564$TERSERA THERAPEUTICS$$$$$$Y$$$20240911$$CN$CN$CN
243057801$24305780$1$I$$20240903$20240911$20240911$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS004563$TERSERA THERAPEUTICS$$$$$$Y$$$20240911$$MD$CN$CN
243057812$24305781$2$F$20240909$20240909$20240911$20240915$PER$$US-AMGEN-USASP2024180065$AMGEN$$$$$$Y$$$20240915$$PH$US$US
243057821$24305782$1$I$20240826$20240904$20240911$20240911$EXP$$GB-AMGEN-GBRSL2024178550$AMGEN$$76$YR$E$F$Y$$$20240911$$CN$GB$GB
243057832$24305783$2$F$$20240910$20240911$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005112$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243057841$24305784$1$I$$20240908$20240911$20240911$PER$$US-JNJFOC-20240919637$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243057851$24305785$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240818$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240911$$HP$US$US
243057861$24305786$1$I$$20240905$20240911$20240911$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS004565$TERSERA THERAPEUTICS$$$$$$Y$$$20240911$$CN$AU$AU
243057872$24305787$2$F$$20240828$20240911$20240916$EXP$$US-ASTELLAS-2024-AER-003298$ASTELLAS$$$$E$F$Y$$$20240916$$CN$US$US
243057881$24305788$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240405$TEVA$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.; Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.$60$YR$$F$Y$$$20240911$$HP$US$US
243057891$24305789$1$I$20240801$20240819$20240911$20240911$EXP$$CA-TEVA-VS-3219309$TEVA$$79$YR$$F$Y$$$20240911$$CN$CA$CA
243057901$24305790$1$I$20240608$20240610$20240911$20240911$PER$$US-AJANTA-2024AJA00113$AJANTA PHARMA$$73$YR$E$F$Y$160$KG$20240911$$CN$US$US
243057921$24305792$1$I$20230724$20240902$20240911$20240911$EXP$$CN-ROCHE-10000072929$ROCHE$$56$YR$A$F$Y$$$20240911$$MD$CN$CN
243057931$24305793$1$I$20240420$20240603$20240911$20240911$PER$$US-AJANTA-2024AJA00112$AJANTA PHARMA$$48$YR$A$M$Y$200$KG$20240910$$CN$US$US
243057941$24305794$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5909720$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243057961$24305796$1$I$$20240907$20240911$20240911$EXP$$JP-EXELIXIS-EXL-2024-000034$EXELIXIS$$$$$$Y$$$20240911$$MD$JP$JP
243057974$24305797$4$F$$20240914$20240911$20240925$PER$$US-RDY-SPO/USA/24/0012802$DR REDDYS$$68$YR$E$F$Y$$$20240925$$PH$US$US
243057981$24305798$1$I$$20240829$20240911$20240911$EXP$$CZ-SAMSUNG BIOEPIS-SB-2024-26720$SAMSUNG BIOEPIS$Smetanova A. Risk of squamous cell carcinoma in patients with hidradenitis  suppurativa treated with anti-TNF-alpha?Results from a 12-year  multicentric observational prospective study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY + VENEREOLOCY. doi:10.1111/jdv.19916.$60$YR$A$M$Y$$$20240911$$HP$CZ$CZ
243057991$24305799$1$I$20240815$20240903$20240911$20240911$EXP$CN-91110000556821568D-2024DRL001664$CN-RDY-SPO/CHN/24/0012955$DR REDDYS$$60$YR$A$M$Y$66$KG$20240911$$HP$CN$CN
243058001$24305800$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467315$RANBAXY$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Can J. 2023;13(1):91/1-4$$$$$Y$$$20240911$$HP$US$US
243058011$24305801$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467063$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. Journal of Drugs in Dermatology. 2023;22 (11):e12-e16$35$YR$$F$Y$$$20240911$$HP$US$US
243058021$24305802$1$I$20240710$20240830$20240911$20240911$EXP$SE-SEMPA-2024-006201$SE-Accord-445096$ACCORD$$55$YR$A$F$Y$$$20240911$$MD$SE$SE
243058031$24305803$1$I$20240731$20240909$20240911$20240911$EXP$$CA-TAKEDA-2024TUS090241$TAKEDA$$81$YR$$M$Y$$$20240911$$CN$CA$CA
243058041$24305804$1$I$$20240827$20240911$20240911$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466758$RANBAXY$Sitina M, Sramek V. Euglycemic ketoacidosis associated with SGLT2 inhibitors and DPP4 inhibitors discussion of case reports. Anesteziol Intenz Med. 2024;35 (2):116-121$70$YR$$F$Y$$$20240911$$MD$CZ$CZ
243058051$24305805$1$I$$20240827$20240911$20240911$EXP$$MY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465931$RANBAXY$Hanapi NA, Halim SA, Razak AA, Sapiai NA. Roles of arterial spin labelling in cognitive impairment: Case series. Radiol Case Rep. 2024;19 (11):4736-4740$74$YR$$F$Y$$$20240911$$HP$MY$MY
243058061$24305806$1$I$20230201$20240827$20240911$20240911$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466987$RANBAXY$Arnet I, Dietrich F, Ruegg S, Allemann SS. Non-adherence and epileptic emergency-reasons and solutions. Clin Epileptol. 2023;36:280-287$18$YR$$F$Y$$$20240911$$HP$CH$CH
243058071$24305807$1$I$$20240827$20240911$20240911$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466982$RANBAXY$Yang L, Lu L, Ma J, Xu Z, Li N. A case of high?grade non?intestinal paranasal sinus adenocarcinoma primary in the maxillary sinus: targeted therapy after postoperative immunocombination with chemotherapy. J Cancer Res Clin Oncol. 2024;150 (8):381, 1-7$65$YR$$M$Y$$$20240911$$HP$CN$CN
243058081$24305808$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467062$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;22:e12-e16$50$YR$$M$Y$$$20240911$$HP$US$US
243058091$24305809$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466584$RANBAXY$$$$$M$Y$97.506$KG$20240911$$CN$US$US
243058101$24305810$1$I$$20240827$20240911$20240911$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466871$RANBAXY$Benoit P,Wang S, Wang C, Chakravarti A, Villalba JA, Ali IKM, et al. Brainstorm: A case of granulomatous encephalitis. JAMMI. 2024;9 (2):113-120$74$YR$$F$Y$$$20240911$$MD$CA$CA
243058112$24305811$2$F$$20240903$20240911$20240918$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466772$RANBAXY$Princy R, Neethu R. Methotrexate-Induced Mucositis Due to Accidental Overdose; a Case Report. Afr J Bol Sci. 2024;6(3):700-703$71$YR$$F$Y$$$20240918$$HP$IN$IN
243058121$24305812$1$I$$20240827$20240911$20240911$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466924$RANBAXY$Yamaguchi J, Sadahiro R, Hirayama T, Wada S, Nakahara R, Matsuoka H. Severe behavioral and psychological symptoms of dementia successfully treated at home with a blonanserin transdermal patch: A case report. Neuropsychopharmacol Rep. 2024;44 (2):474-478$91$YR$$F$Y$$$20240911$$HP$JP$JP
243058132$24305813$2$F$20240904$20240906$20240911$20240925$30DAY$$US-JNJFOC-20240916699$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240925$$PH$US$US
243058141$24305814$1$I$20240909$20240909$20240911$20240911$PER$$US-JNJFOC-20240920405$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240911$$CN$US$US
243058151$24305815$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467327$RANBAXY$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Can J. 2023;13(1):91/1-4$$$$$Y$$$20240911$$HP$US$US
243058161$24305816$1$I$$20240827$20240911$20240911$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466936$RANBAXY$Mishra VV, Choudhary S, Dharaiya N, Gaddagi RA, Vyas B. Successful Term Pregnancy in Post Renal Transplant Patient. J SAFOG. 2015;May-Aug; 7(2):89-90$37$YR$$F$Y$$$20240911$$HP$IN$IN
243058171$24305817$1$I$$20240827$20240911$20240911$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467124$RANBAXY$Yokota H, Akamine Y, Kobayashi M, Kitabayashi T, Horie M, Endo T et al.. Naldemedine-induced perforation of a diverticulum in the sigmoid colon of a patient with opioid-related constipation: a case report. J Pharm Health Care Sci. 2024;10 (1):1-6$65$YR$$M$Y$$$20240911$$HP$JP$JP
243058181$24305818$1$I$$20240827$20240911$20240911$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466940$RANBAXY$Kamijo Y, Usuda M, Matsuno A, Katoh N, Morita Y, Tamaru F, et al. Successful Maintenance Therapy with Intravenous Immunoglobulin to Reduce Relapse Attacks and Steroid Dose in a Patient with Refractory Myelin Oligodendrocyte Glycoprotein Antibody-positive Optic Neuritis.. Intern Med. 2024;0 (0):1-5$25$YR$$M$Y$72.8$KG$20240911$$HP$JP$JP
243058191$24305819$1$I$$20240827$20240911$20240911$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467003$RANBAXY$Wang Q, Lin L, Zhen J, Jiang B, Liu G.. Case report: Effective treatment of rituximab-resistant minimal change disease with obinutuzumab in an adult. Front Immunol. 2024;15 (0):1407461(1-5)$37$YR$$F$Y$$$20240911$$HP$CN$CN
243058201$24305820$1$I$$20240827$20240911$20240911$EXP$$MY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465935$RANBAXY$Hanapi NA, Halim SA, Razak AA, Sapiai NA. Roles of arterial spin labelling in cognitive impairment: Case series. Radiol Case Rep. 2024;19(11):4736-4740$66$YR$$F$Y$$$20240911$$HP$MY$MY
243058211$24305821$1$I$$20240827$20240911$20240911$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466984$RANBAXY$Vidal H, Salgado V, Alves P, Fonsecal NM, Frochot V, Ferreira A.. Calcium polystyrene sulfonate?induced colitis: advanced characterization of crystal nature with infrared spectroscopy. Clinical Kidney Journal. 2024;17 (8):No pagination (sfae210)$82$YR$$M$Y$$$20240911$$HP$PT$PT
243058221$24305822$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467059$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;Nov; 22(11):e12-e16$50$YR$$F$Y$$$20240911$$MD$US$US
243058231$24305823$1$I$20230227$20240827$20240911$20240911$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466663$RANBAXY$$55$YR$$F$Y$98$KG$20240911$$HP$GB$GB
243058241$24305824$1$I$$20240827$20240911$20240911$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466985$RANBAXY$Guo Y, Zhang R, Meng Y, Wang L, Zheng L, You J.. Durable response of ensartinib targeting EML4-ALK. Front Pharmacol. 2024;15 (0):1-7$71$YR$$F$Y$$$20240911$$HP$CN$CN
243058252$24305825$2$F$$20240914$20240911$20240927$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466998$RANBAXY$Luscher D, Maeder MT, Scheler E.. A case report of reversible left ventricular dysfunction due to azathioprine hypersensitivity syndrome. Eur Heart J Case Rep. 2024;8 (8):$68$YR$$M$Y$$$20240927$$HP$CH$CH
243058261$24305826$1$I$$20240827$20240911$20240911$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466989$RANBAXY$Nagaki S, Osawa M, Nagata S. Epilepsy associated with Graves^s disease: Report of two cases. SAGE Open Med Case Rep. 2024;12 (0):1-5$9$YR$$F$Y$$$20240911$$HP$JP$JP
243058271$24305827$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467057$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;Nov;22(11):e12-e16$50$YR$$M$Y$$$20240911$$HP$US$US
243058281$24305828$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467061$RANBAXY$Baroudi B, Bashyam  AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;Nov; 22(11):e12-e16$57$YR$$F$Y$$$20240911$$HP$US$US
243058291$24305829$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466835$RANBAXY$Miklus V, Trout L, Even K. Levetiracetam Dosing Based on Glasgow Coma Scale Scores in Pediatric Traumatic Brain Injury Patients. Neuropediatrics. 2024;55(4):224-231$$$C$$Y$$$20240911$$HP$US$US
243058301$24305830$1$I$$20240827$20240911$20240911$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466943$RANBAXY$de Lima Xavier Andrade I, Asato MA, de Oliveira Nunes M, de Brito ECA, Chaves CEV. INVOLVEMENT OF THE CECAL APPENDIX IN PARACOCCIDIOIDOMYCOSIS: CASE REPORT. BRAZ J INFECT DIS. 2023;27(S1):239; 1028$20$YR$$M$Y$51$KG$20240911$$HP$BR$BR
243058311$24305831$1$I$$20240827$20240911$20240911$EXP$$BG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466992$RANBAXY$Drenovska K, Valeva E, Shahid M, Vassileva S. Case Report: Coexistence of bullous pemphigoid and psoriasis: Therapeutic challenge and IL17A-targeted parallel treatment strategy. Front Med. 2023;10:no pagination$65$YR$$M$Y$$$20240911$$HP$BG$BG
243058321$24305832$1$I$$20240827$20240911$20240911$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467016$RANBAXY$Wang W, Zhang Y, Tao L, Jiang TX, Wang N, Zhai WH.. Adrenaline intravenous therapy persistence grade. Medicine. 2024;103 (31):e39193(1-4)$20$YR$$M$Y$$$20240911$$HP$CN$CN
243058331$24305833$1$I$20240115$20240827$20240911$20240911$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466558$RANBAXY$$$$E$M$Y$107$KG$20240911$$HP$GB$GB
243058341$24305834$1$I$$20240827$20240911$20240911$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466988$RANBAXY$Nagaki S, Osawa M, Nagata S. Epilepsy associated with Graves^ disease: Report of two cases. SAGE Open Med Case Rep. 2024;12 (0):1-5$22$YR$$F$Y$$$20240911$$HP$JP$JP
243058351$24305835$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467058$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;Nov;22(11):e12-e16$58$YR$$F$Y$$$20240911$$HP$US$US
243058361$24305836$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467055$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;22:e12-e16$33$YR$$M$Y$$$20240911$$HP$US$US
243058371$24305837$1$I$$20240827$20240911$20240911$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466939$RANBAXY$Ishigaki S, Kondo Y, Ota Y, Chu PS, Hanaoka H, Takeuchi T, et al. Successful treatment of refractory enteritis and arthritis with combination of tumour necrosis factor and interleukin-6 inhibition in patients with ulcerative colitis. Mod Rheumatol Case Rep. 2024;29; 8:33-36$18$YR$$M$Y$$$20240911$$HP$JP$JP
243058381$24305838$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467067$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;22:e12-e16$33$YR$$F$Y$$$20240911$$HP$US$US
243058391$24305839$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467029$RANBAXY$Kark M, Gerwin R,Wolfrum L, Nilsson M, Bokat P, Perry E. Treatment of complex catatonia in an adolescent. J ECT. 2024;40 (2):E8-E9$17$YR$$M$Y$$$20240911$$MD$US$US
243058411$24305841$1$I$$20240827$20240911$20240911$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467024$RANBAXY$Siebert K, Jassem E, Porzezinska M, Jelitto M, Bernard W. Lipoid pneumonia induced by aspiration of liquid paraffin. Annals of Agricultural and Environmental Medicine. 2024;31 (1):144-146$83$YR$$F$Y$$$20240911$$HP$PL$PL
243058421$24305842$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467325$RANBAXY$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Can J. 2023;13(1):91/1-4$$$$$Y$$$20240911$$HP$US$US
243058441$24305844$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467322$RANBAXY$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Can J. 2023;13(1):91/1-4$$$$$Y$$$20240911$$HP$US$US
243058451$24305845$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467028$RANBAXY$Abdelmageed S, Dalmage M, Mossner JM, Trierweiler R, Krater T, Raskin JS. Cervicothoracic ventral?dorsal rhizotomy for treatment of brachial hypertonia in cerebral palsy. Childs Nerv Syst. 2024;Jul;40 (9):2835-2842$22$YR$$M$Y$$$20240911$$HP$US$US
243058461$24305846$1$I$$20240827$20240911$20240911$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467285$RANBAXY$$84$YR$$F$Y$124$KG$20240911$$PH$GB$GB
243058471$24305847$1$I$20240501$20240827$20240911$20240911$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467387$RANBAXY$$55$YR$$M$Y$$$20240911$$MD$GB$GB
243058481$24305848$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467334$RANBAXY$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Can J. 2023;13(1):91/1-4$$$$$Y$$$20240911$$HP$US$US
243058491$24305849$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467051$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;22:e12-e16$37$YR$$F$Y$$$20240911$$HP$US$US
243058501$24305850$1$I$$20240827$20240911$20240911$EXP$$BG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466990$RANBAXY$Drenovska K, Valeva E, Shahid M, Vassileva S. Case Report: Coexistence of bullous pemphigoid and psoriasis: Therapeutic challenge and IL17A-targeted parallel treatment strategy. Front Med. 2023;10:no pagination$70$YR$$F$Y$$$20240911$$HP$BG$BG
243058511$24305851$1$I$20240730$20240906$20240911$20240911$EXP$$CY-SERVIER-S24011357$SERVIER$$$$$$Y$$$20240911$$MD$CY$CY
243058521$24305852$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467064$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO.. Dapsone to treat moderate-to-severe hidradenitis suppurativa: A retrospective case-series. J Drugs Dermatol. 2023;22:e12-e16$41$YR$$F$Y$$$20240911$$HP$US$US
243058531$24305853$1$I$$20240827$20240911$20240911$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467004$RANBAXY$Bugia L, Jungbauer F, Zaubitzer L, Horner C, Merx K, Yasser AM, et al. Nivolumab as a Promising Treatment Option for Metastatic Salivary Duct Carcinoma. J Immunother. 2024;Sep;47 (7):258-262$65$YR$$M$Y$$$20240911$$HP$DE$DE
243058541$24305854$1$I$20240718$20240906$20240911$20240911$EXP$$AT-AstraZeneca-2024A205083$ASTRAZENECA$$67$YR$$M$Y$$$20240911$$MD$AT$
243058561$24305856$1$I$20240801$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A203906$ASTRAZENECA$$30260$DY$$$Y$$$20240911$$MD$US$
243058571$24305857$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143049$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240911$$CN$US$US
243058581$24305858$1$I$20240805$20240910$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144223$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240911$$HP$US$US
243058591$24305859$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005394$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240911$$CN$US$US
243058601$24305860$1$I$$20240905$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142274$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240911$$CN$US$US
243058611$24305861$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142919$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240911$$HP$US$US
243058622$24305862$2$F$20240908$20240909$20240911$20240916$PER$$US-AMGEN-USASP2024180030$AMGEN$$66$YR$E$F$Y$$$20240916$$CN$US$US
243058632$24305863$2$F$$20240910$20240911$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409005911$ELI LILLY AND CO$$31$YR$A$$Y$$$20240913$$CN$US$US
243058641$24305864$1$I$20240801$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005535$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240911$$CN$US$US
243058651$24305865$1$I$20240906$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005287$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240911$$CN$US$US
243058661$24305866$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005517$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243058671$24305867$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005578$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240911$$CN$US$US
243058681$24305868$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005531$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240911$$CN$US$US
243058691$24305869$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005163$ELI LILLY AND CO$$$$$M$Y$$$20240911$$CN$US$US
243058701$24305870$1$I$$20240906$20240911$20240911$PER$$US-JNJFOC-20240920663$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243058711$24305871$1$I$20231201$20231228$20240911$20240911$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00010$TARO$$$$$$Y$$$20240911$$CN$US$US
243058721$24305872$1$I$$20240112$20240911$20240911$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00080$TARO$$$$$$Y$$$20240911$$CN$US$US
243058731$24305873$1$I$20240203$20240205$20240911$20240911$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00157$TARO$$$$$$Y$$$20240911$$CN$US$US
243058741$24305874$1$I$$20240909$20240911$20240911$PER$$US-ROCHE-10000077476$ROCHE$$$$A$F$Y$$$20240911$$CN$US$US
243058751$24305875$1$I$$20240830$20240911$20240911$PER$$US-ROCHE-10000071117$ROCHE$$$$$F$Y$$$20240911$$CN$US$US
243058761$24305876$1$I$$20240827$20240911$20240911$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467434$RANBAXY$$21$YR$$F$Y$80$KG$20240911$$PH$GB$GB
243058771$24305877$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467056$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;Nov;22(11):e12-e16$26$YR$$F$Y$$$20240911$$HP$US$US
243058781$24305878$1$I$$20240827$20240911$20240911$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466927$RANBAXY$Suzani M, Benatti E, Ceola S, Coppola M. ISOLATED VITREOUS METASTASIS in A PATIENT with AN ANAPLASTIC LYMPHOMA KINASE-POSITIVE LUNG CANCER TREATED with LORLATINIB. Retin Cases Brief Rep. 2024;18 (2):194-198$47$YR$$F$Y$$$20240911$$MD$IT$IT
243058791$24305879$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467052$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;22:e12-e16$59$YR$$M$Y$$$20240911$$HP$US$US
243058801$24305880$1$I$$20240827$20240911$20240911$EXP$$ET-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467002$RANBAXY$Tafese AM, Adela AY, Kebede AG, Tegegn AS, Asare ET, Awol M. Acute brachial artery occlusion following cisplatin-based chemotherapy: case report. SAGE Open Med Case Rep. 2024;12 (0):1-5$50$YR$$M$Y$$$20240911$$HP$ET$ET
243058811$24305881$1$I$20230928$20240827$20240911$20240911$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466660$RANBAXY$$67$YR$$F$Y$52$KG$20240911$$CN$GB$GB
243058821$24305882$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467060$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;22:e12-e16$42$YR$$F$Y$$$20240911$$HP$US$US
243058831$24305883$1$I$$20240827$20240911$20240911$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466978$RANBAXY$Papetti L, Moltoni G, Longo D, Monte G, Dellepiane F, Pro S, et al. Isolated Intracranial Hypertensions as Onset of Myelin Oligodendrocyte Glycoprotein Antibody Disease. J Clin Med. 2024;13 (15):4468$8$YR$$M$Y$$$20240911$$HP$IT$IT
243058841$24305884$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467065$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;22:e12-e16$29$YR$$M$Y$$$20240911$$HP$US$US
243058851$24305885$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467042$RANBAXY$Drosu N, Bjornevik K, Bilodeau P, Levy M. Long-term MRI and clinical stability in an HIV-positive patient with multiple sclerosis on tenofovir: A case report. Mult Scler and Relat Dis. 2024;83:1-2$25$YR$$F$Y$$$20240911$$HP$US$US
243058861$24305886$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467053$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;22:e12-e16$36$YR$$F$Y$$$20240911$$HP$US$US
243058871$24305887$1$I$20211205$20240827$20240911$20240911$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-322190$RANBAXY$$65$YR$E$F$Y$$$20240911$$CN$CA$CA
243058881$24305888$1$I$$20240827$20240911$20240911$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467054$RANBAXY$Baroudi B, Bashyam AM, Feldman SR, Pichardo RO. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series. J Drugs Dermatol. 2023;22:e12-e16$58$YR$$F$Y$$$20240911$$HP$US$US
243058891$24305889$1$I$$20240827$20240911$20240911$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467021$RANBAXY$Peng Y-T, Xiong J-X, Wei B, Li H, Xu J, Chen A-J, et al. Tumor necrosis factor-alpha inhibitor for successful treatment of toxic epidermal necrolysis with severe infection: a case series. J Int Med Res. 2024;52(1):1-9$24$YR$$M$Y$$$20240911$$HP$CN$CN
243058901$24305890$1$I$$20240827$20240911$20240911$EXP$$ID-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467391$RANBAXY$Lestari PM, Andrina H, Herponi A. A Rare Case Report: Belly Dancer Dyskinesia and Symptomatic Epilepsy in Pregnancy Causing Incomplete Uterine Rupture.. J acad res med. 2024;16 (4):455-457$$$$$Y$$$20240911$$HP$ID$ID
243058911$24305891$1$I$20240831$20240903$20240911$20240911$EXP$$AR-BIOGEN-2024BI01281074$BIOGEN$$1$YR$$M$Y$$$20240911$$CN$AR$AR
243058921$24305892$1$I$$20240827$20240911$20240911$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466997$RANBAXY$Gunes M, Baytar A, Bulut M, Kaya CM. Is it a novel indication for antipsychotic drugs, or a coincidence? A report of a psoriasis case. Psychiatr Clin Psychopharmacolog. 2019;29:187$43$YR$$M$Y$$$20240911$$HP$TR$TR
243058931$24305893$1$I$$20240827$20240911$20240911$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467160$RANBAXY$Ueta A, Yamada A, Yoshioka M, Kanai M, Muto M, Okita N. Remarkable response to capmatinib in a patient with intrahepatic cholangiocarcinoma harboring TFG-MET fusion. Int Canc Conf. 2024;0(0):no pagination$46$YR$$M$Y$$$20240911$$HP$JP$JP
243058941$24305894$1$I$$20240905$20240911$20240911$EXP$$BR-TAKEDA-2024TUS089806$TAKEDA$$$$$$Y$$$20240911$$CN$BR$BR
243058951$24305895$1$I$20240601$20240903$20240911$20240911$EXP$$JP-ARDELYX-2024ARDX005136$ARDELYX$$$$$F$Y$$$20240911$$MD$JP$JP
243058961$24305896$1$I$20240906$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180170$AMGEN$$57$YR$A$F$Y$$$20240911$$CN$US$US
243058971$24305897$1$I$20240601$20240904$20240911$20240911$EXP$$US-BIOGEN-2024BI01281082$BIOGEN$$72$YR$$F$Y$$$20240911$$CN$US$US
243058981$24305898$1$I$20240716$20240902$20240911$20240911$EXP$$JP-ARDELYX-2024ARDX006786$ARDELYX$$74$YR$$M$Y$$$20240911$$HP$JP$JP
243058991$24305899$1$I$20211011$20240905$20240911$20240911$EXP$$JP-ABBVIE-22K-087-4264224-00$ABBVIE$$77$YR$$F$Y$51$KG$20240911$$MD$JP$JP
243059001$24305900$1$I$$20240904$20240911$20240911$EXP$$US-TAKEDA-2024TUS088993$TAKEDA$$72$YR$$$Y$$$20240911$$CN$US$US
243059011$24305901$1$I$$20240904$20240911$20240911$EXP$$US-ABBVIE-5908177$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243059021$24305902$1$I$$20240909$20240911$20240911$EXP$$GB-HALEON-2196142$Haleon PLC$$$$$F$Y$$$20240911$$CN$GB$GB
243059031$24305903$1$I$$20240909$20240911$20240911$EXP$$US-ABBVIE-5916865$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243059041$24305904$1$I$20230101$20240904$20240911$20240911$EXP$$US-ABBVIE-5910138$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243059051$24305905$1$I$20240902$20240902$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012878$DR REDDYS$$35$YR$A$M$Y$$$20240911$$HP$US$US
243059061$24305906$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240819$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$$$Y$$$20240911$$HP$US$US
243059071$24305907$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181737$NOVARTIS$$$$$M$Y$$$20240911$$CN$US$US
243059081$24305908$1$I$$20240904$20240911$20240911$EXP$$US-TAKEDA-2024TUS088729$TAKEDA$$28$YR$$F$Y$$$20240911$$PH$US$US
243059111$24305911$1$I$$20240902$20240911$20240911$EXP$$JP-JNJFOC-20240908012$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$HP$JP$JP
243059121$24305912$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000586US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243059131$24305913$1$I$20240829$20240905$20240911$20240911$EXP$$GB-EMD Serono-2024047862$EMD SERONO INC$$50$YR$A$F$Y$93$KG$20240911$$HP$GB$GB
243059141$24305914$1$I$$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024179631$AMGEN$$$$$$Y$$$20240911$$HP$US$US
243059152$24305915$2$F$$20240917$20240911$20240926$EXP$$US-TEVA-VS-3240321$TEVA$Dana IN, Austin E, Asrani F. Mucocutaneous ulcers in an immunocompromised patient. JAAD-Case-Rep 2024; 51 48-50.; Dana IN, Austin E, Asrani F. Mucocutaneous ulcers in an immunocompromised patient. JAAD-Case-Rep 2024; 51 48-50.$49$YR$$F$Y$$$20240926$$HP$US$US
243059161$24305916$1$I$20230502$20240905$20240911$20240911$EXP$IT-MINISAL02-1000884$IT-AMGEN-ITASP2024177785$AMGEN$$59$YR$A$F$Y$$$20240911$$HP$IT$IT
243059171$24305917$1$I$$20240830$20240911$20240911$EXP$$US-SA-2024SA262215$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240911$$MD$US$US
243059182$24305918$2$F$20220101$20240917$20240911$20240926$EXP$$US-TEVA-VS-3239888$TEVA$Cooper J, Soneji D, Rieger K, Narala S, Kim Y. Primary Cutaneous CD30+ Large T Cell Lymphoproliferative Disorder Associated With Prolonged Exposure to Fingolimod. Mult-Scler-J 2023; 29 (Suppl. 3) (3): 969 abstr. P1519/117.; Cooper J, Soneji D, Rieger K, Narala S, Kim Y. Primary Cutaneous CD30+ Large T Cell Lymphoproliferative Disorder Associated With Prolonged Exposure to Fingolimod. Mult-Scler-J 2023; 29 (Suppl. 3) (3): 969 abstr. P1519/117.$67$YR$$F$Y$$$20240926$$HP$US$US
243059191$24305919$1$I$$20240901$20240911$20240911$EXP$$TW-VKT-000588$VKT PHARMA PRIVATE LIMITED$$$$$M$Y$$$20240905$$MD$TW$TW
243059201$24305920$1$I$$20240901$20240911$20240911$EXP$$TW-VKT-000587$VKT PHARMA PRIVATE LIMITED$$$$$F$Y$$$20240904$$MD$TW$TW
243059211$24305921$1$I$$20240901$20240911$20240911$EXP$$TW-VKT-000586$VKT PHARMA PRIVATE LIMITED$$$$$F$Y$$$20240904$$MD$TW$TW
243059221$24305922$1$I$$20240828$20240911$20240911$EXP$$US-CIPLA LTD.-2024US09757$CIPLA$Haddad TC, Suman VJ, Giridhar KV, Sideras K, Northfelt DW, Ernst BJ et al. Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early-stage breast cancer: A prospective trial. Clinical Cancer Research. 2024;30:3147 to 3156$$$$$Y$$$20240911$$HP$US$US
243059231$24305923$1$I$$20240901$20240911$20240911$EXP$$TW-VKT-000589$VKT PHARMA PRIVATE LIMITED$$$$$F$Y$$$20240905$$MD$TW$TW
243059241$24305924$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240820$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240911$$HP$US$US
243059251$24305925$1$I$$20240909$20240911$20240911$EXP$$DE-GILEAD-2024-0686849$GILEAD$$$$$F$Y$$$20240911$$PH$DE$DE
243059261$24305926$1$I$20230915$20240909$20240911$20240911$EXP$$US-AstraZeneca-2024A205359$ASTRAZENECA$$$$$$Y$$$20240911$$CN$US$
243059271$24305927$1$I$$20240905$20240911$20240911$EXP$$FR-AstraZeneca-2024A205416$ASTRAZENECA$$84$YR$$M$Y$$$20240911$$MD$FR$
243059281$24305928$1$I$20240702$20240906$20240911$20240911$EXP$$FR-AMGEN-FRASP2024178724$AMGEN$$49$YR$A$F$Y$86$KG$20240911$$MD$FR$FR
243059291$24305929$1$I$20240905$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180995$AMGEN$$59$YR$A$F$Y$$$20240911$$CN$US$US
243059301$24305930$1$I$$20240903$20240911$20240911$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000775$DECIPHERA PHARMACEUTICALS$$72$YR$E$M$Y$89.977$KG$20240911$$CN$US$US
243059311$24305931$1$I$20240813$20240906$20240911$20240911$EXP$FR-AFSSAPS-RN2024000940$FR-AMGEN-FRASP2024178730$AMGEN$$34$YR$A$M$Y$$$20240911$$PH$FR$FR
243059321$24305932$1$I$$20240903$20240911$20240911$EXP$$US-LUOXIN-LUX-2024-US-LIT-00049$LUOXIN AUROVITAS PHARMA(CHENGDU)$Steinbacher D, Murray B, Devlin T, Carson SS, Ford HJ.Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy.Pulm-Circ.2024;14:2$33$YR$A$M$Y$$$20240911$$HP$US$US
243059331$24305933$1$I$$20240907$20240911$20240911$EXP$$US-JNJFOC-20240918103$JOHNSON AND JOHNSON$$$$$M$Y$$$20240911$$CN$US$US
243059341$24305934$1$I$20240101$20240905$20240911$20240911$EXP$$US-JNJFOC-20240915662$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$MD$US$US
243059351$24305935$1$I$$20240904$20240911$20240911$EXP$$US-BIOGEN-2024BI01281469$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243059361$24305936$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006456$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240911$$CN$US$US
243059371$24305937$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004731$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240911$$CN$US$US
243059381$24305938$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005640$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240911$$CN$US$US
243059391$24305939$1$I$$20240910$20240911$20240911$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050604$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$64$KG$20240911$$HP$CA$CA
243059411$24305941$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005889$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240911$$CN$US$US
243059421$24305942$1$I$20240201$20240904$20240911$20240911$EXP$$RU-BIOGEN-2024BI01281406$BIOGEN$$26$YR$$F$Y$65$KG$20240911$$MD$RU$RU
243059431$24305943$1$I$20240909$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005643$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240911$$CN$US$US
243059441$24305944$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005812$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240911$$CN$US$US
243059451$24305945$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005529$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240911$$CN$US$US
243059461$24305946$1$I$$20240905$20240911$20240911$PER$$US-ALXN-202409USA000409US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243059471$24305947$1$I$20240906$20240906$20240911$20240911$EXP$$TW-TAKEDA-2024TUS089634$TAKEDA$$19$YR$$F$Y$$$20240911$$CN$TW$TW
243059482$24305948$2$F$$20240916$20240911$20240922$EXP$$US-TAKEDA-2024TUS084959$TAKEDA$$$$$M$Y$$$20240922$$CN$US$US
243059491$24305949$1$I$20240612$20240910$20240911$20240911$EXP$$NVSC2024US127754$NOVARTIS$$87$YR$$F$Y$$$20240911$$CN$US$US
243059501$24305950$1$I$20240901$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024181062$AMGEN$$76$YR$E$F$Y$$$20240911$$PH$US$US
243059511$24305951$1$I$20240904$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024180316$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
243059521$24305952$1$I$$20240904$20240911$20240911$EXP$$US-TAKEDA-2024TUS086712$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
243059532$24305953$2$F$20240905$20240910$20240911$20240911$PER$$US-AMGEN-USASP2024180418$AMGEN$$47$YR$A$M$Y$$$20240911$$PH$US$US
243059541$24305954$1$I$$20240827$20240911$20240911$PER$$US-009507513-2408USA010521$MERCK$Shannon BA, Mehta R, Mok RS, Lauwers YG, Baldonado RAJJ, Fontaine J, et al.. Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers. Annals of Surgical Oncology. 2024;1-11$70$YR$$F$Y$$$20240911$$MD$US$US
243059551$24305955$1$I$20240808$20240910$20240911$20240911$EXP$$US-TAKEDA-2024TUS089431$TAKEDA$$69$YR$$M$Y$$$20240911$$CN$US$US
243059561$24305956$1$I$20240811$20240829$20240911$20240911$EXP$$ES-AMNEAL PHARMACEUTICALS-2024-AMRX-03273$AMNEAL$$$$$$Y$$$20240911$$MD$ES$ES
243059571$24305957$1$I$$20240830$20240911$20240911$EXP$$CA-AUROBINDO-AUR-APL-2024-044674$AUROBINDO$$19$YR$$F$Y$72$KG$20240911$$HP$CA$CA
243059581$24305958$1$I$$20240829$20240911$20240911$EXP$US-MLMSERVICE-20240822-PI169608-00128-1$US-STRIDES PHARMA UK LTD.-2024SP011091$STRIDES$Bell AP, Custer MK,. Presley S. Pyoderma Gangrenosum in a 75-Year-Old Male With Follicular Diffuse Large B-cell Lymphoma.. Cureus. 2024;16(8):e67234.$75$YR$$M$Y$$$20240911$$MD$US$US
243059591$24305959$1$I$$20240903$20240911$20240911$EXP$$US-BIOGEN-2024BI01281228$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243059601$24305960$1$I$20120921$20230803$20240911$20240911$PER$$US-ALVOGEN-2023092061$ALVOGEN$$$$$$Y$$$20240911$$MD$US$US
243059611$24305961$1$I$$20240905$20240911$20240911$PER$$US-ABBVIE-5914207$ABBVIE$$$$$$Y$$$20240911$$CN$US$US
243059624$24305962$4$F$20240901$20240923$20240911$20240924$PER$$US-AMGEN-USASP2024179133$AMGEN$$67$YR$E$F$Y$$$20240924$$CN$US$US
243059631$24305963$1$I$20240501$20240909$20240911$20240911$EXP$$DE-AMGEN-DEUSL2024179953$AMGEN$$66$YR$E$F$Y$$$20240911$$CN$DE$DE
243059641$24305964$1$I$$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-087982-2024$RECKITT BENCKISER$$$$$F$Y$$$20240911$$CN$US$US
243059651$24305965$1$I$20240627$20240905$20240911$20240911$EXP$$NVSC2024US179326$NOVARTIS$$89$YR$$M$Y$$$20240911$$CN$US$US
243059661$24305966$1$I$$20240902$20240911$20240911$EXP$$JP-ASTELLAS-2024-AER-004040$ASTELLAS$$8$DEC$E$M$Y$$$20240911$$PH$JP$JP
243059671$24305967$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240403$TEVA$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.; Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.$55$YR$$F$Y$$$20240911$$HP$US$US
243059681$24305968$1$I$$20231108$20240911$20240911$PER$$US-ALVOGEN-2023092545$ALVOGEN$$$$$F$Y$$$20240911$$CN$US$US
243059691$24305969$1$I$$20240903$20240911$20240911$EXP$$US-BIOGEN-2024BI01281069$BIOGEN$$$$$$Y$$$20240911$$CN$US$US
243059701$24305970$1$I$$20240904$20240911$20240911$EXP$$CA-TAKEDA-2024TUS089138$TAKEDA$$$$$F$Y$$$20240911$$CN$CA$CA
243059711$24305971$1$I$$20240904$20240911$20240911$EXP$$CA-TAKEDA-2024TUS089332$TAKEDA$$$$$$Y$$$20240911$$MD$CA$CA
243059722$24305972$2$F$20240909$20240911$20240911$20240912$PER$$US-AMGEN-USASP2024180635$AMGEN$$36$YR$A$M$Y$$$20240912$$CN$US$US
243059732$24305973$2$F$$20240910$20240911$20240912$EXP$$CA-ROCHE-10000078492$ROCHE$$$$A$F$Y$$$20240912$$CN$CA$CA
243059742$24305974$2$F$$20240904$20240911$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022816$UNITED THERAPEUTICS$$$$$F$Y$109.75$KG$20240914$$$US$US
243059751$24305975$1$I$$20240905$20240911$20240911$EXP$$US-TAKEDA-2024TUS038603$TAKEDA$$$$$M$Y$$$20240911$$HP$US$US
243059761$24305976$1$I$$20240907$20240911$20240911$EXP$$NVSC2024TW181145$NOVARTIS$$$$$$Y$$$20240911$$MD$TW$TW
243059771$24305977$1$I$$20240909$20240911$20240911$PER$$US-HALEON-2196241$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243059781$24305978$1$I$20240829$20240831$20240911$20240911$EXP$$GB-AUROBINDO-AUR-APL-2024-043900$AUROBINDO$$48$YR$$F$Y$$$20240911$$CN$GB$GB
243059791$24305979$1$I$$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144002$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240911$$MD$US$US
243059801$24305980$1$I$$20240831$20240911$20240911$EXP$$IN-ROCHE-10000072016$ROCHE$$53$YR$A$M$Y$$$20240911$$CN$IN$IN
243059822$24305982$2$F$$20240910$20240911$20240912$PER$$US-ALXN-202409USA000275US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243059831$24305983$1$I$$20231011$20240911$20240911$PER$$US-APOTEX-2023AP015489$APOTEX$Hajjar S, Alberto P, Levy D.. Oral and Dermatologic Manifestations of Imatinib Mesylate: A Case Report.. Journal of Oral and Maxillofacial Surgery. 2023;81 (9):S101-S102$75$YR$$M$Y$$$20240911$$HP$US$US
243059851$24305985$1$I$20240712$20240903$20240911$20240911$EXP$$CA-CELLTRION INC.-2024CA021435$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
243059861$24305986$1$I$$20240909$20240911$20240911$EXP$$NVSC2024US181118$NOVARTIS$$$$$F$Y$$$20240911$$HP$US$US
243059871$24305987$1$I$$20240904$20240911$20240911$EXP$$VN-ROCHE-10000075584$ROCHE$$49$YR$A$M$Y$$$20240911$$MD$VN$VN
243059891$24305989$1$I$$20240830$20240911$20240911$EXP$$CA-AUROBINDO-AUR-APL-2024-044663$AUROBINDO$$$$$F$Y$$$20240911$$MD$CA$CA
243059901$24305990$1$I$$20240828$20240911$20240911$EXP$$US-UCBSA-2024044234$UCB$$$$$$Y$$$20240911$$CN$US$US
243059921$24305992$1$I$20240501$20240831$20240911$20240911$EXP$$FR-AUROBINDO-AUR-APL-2024-044119$AUROBINDO$$21$YR$$M$Y$$$20240911$$PH$FR$FR
243059931$24305993$1$I$20240101$20240906$20240911$20240911$EXP$$US-ORGANON-O2409USA000511$ORGANON$$$$$F$Y$$$20240911$$HP$US$US
243059941$24305994$1$I$$20240417$20240911$20240911$PER$$US-ALVOGEN-2024093116$ALVOGEN$$$$$F$Y$$$20240911$$CN$US$US
243059961$24305996$1$I$$20240907$20240911$20240911$PER$$NVSC2024US180399$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243059971$24305997$1$I$20240829$20240904$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012893$DR REDDYS$$41$YR$A$M$Y$$$20240911$$HP$US$US
243059981$24305998$1$I$$20240903$20240911$20240911$PER$$US-RDY-SPO/USA/24/0013111$DR REDDYS$Jimenez-Kurlander L, DeRosa A, Bogardus K, Kostrzewa CE, Moskowitz CS, Antal Z, et al. Ovarian function in female survivors of high-risk neuroblastoma. Pediatric Blood and Cancer. 2024;71(9): e31181. doi:10.1002/pbc.31181.$$$$F$Y$$$20240911$$HP$US$US
243059991$24305999$1$I$20240828$20240904$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012892$DR REDDYS$$44$YR$A$F$Y$$$20240911$$MD$US$US
243060001$24306000$1$I$$20240903$20240911$20240911$PER$$US-RDY-SPO/USA/24/0013109$DR REDDYS$Jimenez-Kurlander L, DeRosa A, Bogardus K, Kostrzewa CE, Moskowitz CS, Antal Z, et al. Ovarian function in female survivors of high-risk neuroblastoma. Pediatric Blood and Cancer. 2024;71(9): e31181. doi:10.1002/pbc.31181.$$$$F$Y$$$20240911$$HP$US$US
243060011$24306001$1$I$$20240903$20240911$20240911$PER$$US-RDY-SPO/USA/24/0013108$DR REDDYS$Jimenez-Kurlander L, DeRosa A, Bogardus K, Kostrzewa CE, Moskowitz CS, Antal Z, et al. Ovarian function in female survivors of high-risk neuroblastoma. Pediatric Blood and Cancer. 2024;71(9): e31181. doi:10.1002/pbc.31181.$$$$F$Y$$$20240911$$HP$US$US
243060021$24306002$1$I$$20240903$20240911$20240911$PER$$US-RDY-SPO/USA/24/0013110$DR REDDYS$Jimenez-Kurlander L, DeRosa A, Bogardus K, Kostrzewa CE, Moskowitz CS, Antal Z, et al. Ovarian function in female survivors of high-risk neuroblastoma. Pediatric Blood and Cancer. 2024;71(9): e31181. doi:10.1002/pbc.31181.$$$$F$Y$$$20240911$$HP$US$US
243060031$24306003$1$I$$20240903$20240911$20240911$PER$$US-RDY-SPO/USA/24/0013113$DR REDDYS$Jimenez-Kurlander L, DeRosa A, Bogardus K, Kostrzewa CE, Moskowitz CS, Antal Z, et al. Ovarian function in female survivors of high-risk neuroblastoma. Pediatric Blood and Cancer. 2024;71(9): e31181. doi:10.1002/pbc.31181.$$$$F$Y$$$20240911$$HP$US$US
243060041$24306004$1$I$$20240905$20240911$20240911$EXP$US-MLMSERVICE-20160526-0296802-1$US-RDY-SPO/USA/24/0013075$DR REDDYS$Alhefzi M, Aycart MA, Bueno EM, Kueckelhaus M, Fischer S, Snook RJ et al. Guillain-Barre syndrome associated with resistant cytomegalovirus infection after face transplantation.Transplant Infectious Disease. 2016; 18(2):288-292$39$YR$A$M$Y$$$20240911$$MD$US$US
243060051$24306005$1$I$$20240904$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0012907$DR REDDYS$$51$YR$A$M$Y$$$20240911$$PH$US$US
243060061$24306006$1$I$$20240905$20240911$20240911$PER$$US-TAKEDA-2024TUS089933$TAKEDA$$$$$M$Y$$$20240911$$CN$US$US
243060071$24306007$1$I$20240806$20240902$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012881$DR REDDYS$$42$YR$A$M$Y$$$20240911$$HP$US$US
243060081$24306008$1$I$$20240904$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0012902$DR REDDYS$$53$YR$A$M$Y$$$20240911$$PH$US$US
243060093$24306009$3$F$20240904$20240919$20240911$20240927$EXP$$US-RDY-SPO/USA/23/0179848$DR REDDYS$$32$YR$A$M$Y$$$20240927$$MD$US$US
243060111$24306011$1$I$$20240906$20240911$20240911$EXP$$JP-GSK-JP2024JPN111504$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$PH$JP$JP
243060121$24306012$1$I$20240417$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-087704-2024$RECKITT BENCKISER$$$$$M$Y$$$20240911$$CN$US$US
243060131$24306013$1$I$$20240904$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0012901$DR REDDYS$$45$YR$A$M$Y$$$20240911$$HP$US$US
243060151$24306015$1$I$$20240813$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202408008284$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240911$$CN$US$US
243060161$24306016$1$I$20240909$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006246$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240911$$CN$US$US
243060171$24306017$1$I$20240903$20240904$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003293$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240911$$CN$US$US
243060181$24306018$1$I$$20240828$20240911$20240911$EXP$$US-CIPLA LTD.-2024US09756$CIPLA$Haddad TC, Suman VJ, Giridhar KV, Sideras K, Northfelt DW, Ernst BJ et al. Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early-stage breast cancer: A prospective trial. Clinical Cancer Research. 2024;30:3147 to 3156$$$$$Y$$$20240911$$HP$US$US
243060201$24306020$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004596$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240911$$CN$US$US
243060211$24306021$1$I$$20240905$20240911$20240911$PER$$US-ABBVIE-5915741$ABBVIE$$$$$$Y$$$20240911$$CN$US$US
243060221$24306022$1$I$20240830$20240906$20240911$20240911$EXP$GB-MHRA-MED-202409051257314720-LBYSZ$GB-REGENERON PHARMACEUTICALS, INC.-2024-121328$REGENERON$$$$$$Y$$$20240911$$MD$GB$GB
243060231$24306023$1$I$20240818$20240831$20240911$20240911$EXP$$IE-AUROBINDO-AUR-APL-2024-043882$AUROBINDO$$52$YR$$F$Y$$$20240911$$CN$IE$IE
243060241$24306024$1$I$$20240909$20240911$20240911$EXP$$FR-SANDOZ INC.-SDZ2024FR078863$SANDOZ$$70$YR$$M$Y$$$20240911$$HP$FR$FR
243060251$24306025$1$I$20240829$20240902$20240911$20240911$EXP$$IT-AUROBINDO-AUR-APL-2024-044415$AUROBINDO$$23$YR$$F$Y$$$20240911$$PH$IT$IT
243060262$24306026$2$F$$20240830$20240911$20240913$EXP$$CA-UCBSA-2024044292$UCB$$$$$F$Y$$$20240913$$CN$CA$CA
243060271$24306027$1$I$$20240905$20240911$20240911$PER$$US-TAKEDA-2024TUS089901$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
243060281$24306028$1$I$$20240906$20240911$20240911$PER$$US-ALXN-202409USA000428US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243060291$24306029$1$I$$20240905$20240911$20240911$PER$$US-TAKEDA-2024TUS089588$TAKEDA$$$$$$Y$$$20240911$$PH$US$US
243060301$24306030$1$I$$20240905$20240911$20240911$PER$$US-TAKEDA-2024TUS089470$TAKEDA$$$$$M$Y$68$KG$20240911$$CN$US$US
243060312$24306031$2$F$$20240918$20240911$20240926$EXP$$US-TEVA-VS-3240328$TEVA$Correa S, Berman A. Glue Embolism Following Variceal Sclerotherapy. Am-J-Respir-Crit-Care-Med 2023; 207 A5498.; Correa S, Berman A. Glue Embolism Following Variceal Sclerotherapy. Am-J-Respir-Crit-Care-Med 2023; 207 A5498.$34$YR$$M$Y$$$20240926$$HP$US$US
243060322$24306032$2$F$$20240910$20240911$20240920$PER$$US-TAKEDA-2024TUS089309$TAKEDA$$$$$$Y$$$20240920$$CN$US$US
243060332$24306033$2$F$20221113$20240909$20240911$20240920$EXP$$DE-AUROBINDO-AUR-APL-2024-044094$AUROBINDO$$63$YR$$F$Y$53$KG$20240920$$MD$DE$DE
243060341$24306034$1$I$$20240906$20240911$20240911$EXP$$US-JNJFOC-20240919808$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243060351$24306035$1$I$$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A202106$ASTRAZENECA$$$$$$Y$$$20240911$$MD$US$
243060361$24306036$1$I$20170101$20240905$20240911$20240911$EXP$$CA-TAKEDA-2017TUS024270$TAKEDA$$$$$M$Y$$$20240911$$HP$CA$CA
243060371$24306037$1$I$$20240830$20240911$20240911$EXP$$CA-Accord-444621$ACCORD$Veettil S, Khan O, Durocher DP. Takotsubo Cardiomyopathy After Oxaliplatin Chemotherapy Exposure: A Case Report. CJC Open. 2024:1-4.$69$YR$E$F$Y$$$20240911$$MD$CA$CA
243060381$24306038$1$I$20231201$20240902$20240911$20240911$EXP$$DE-TEVA-VS-3239778$TEVA$$$$$F$Y$2.6$KG$20240911$$MD$DE$DE
243060391$24306039$1$I$$20240904$20240911$20240911$PER$$US-BIOGEN-2024BI01281253$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243060401$24306040$1$I$$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A200558$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
243060411$24306041$1$I$20230701$20240906$20240911$20240911$EXP$$PT-AstraZeneca-2024A203676$ASTRAZENECA$$64$YR$$M$Y$$$20240911$$MD$PT$
243060421$24306042$1$I$20240517$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A204365$ASTRAZENECA$$88$YR$$F$Y$76.7$KG$20240911$$HP$US$
243060431$24306043$1$I$$20240904$20240911$20240911$EXP$$NL-AUROBINDO-AUR-APL-2024-044650$AUROBINDO$$62$YR$$F$Y$71$KG$20240911$$CN$NL$NL
243060441$24306044$1$I$$20240909$20240911$20240911$PER$$US-BIOGEN-2024BI01281737$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243060451$24306045$1$I$$20240905$20240911$20240911$EXP$$US-CHEPLA-2024011472$CHEPLAPHARM$$52$YR$$M$Y$102.9$KG$20240911$$MD$COUNTRY NOT SPECIFIED$US
243060462$24306046$2$F$20240802$20240904$20240911$20240911$EXP$$US-ROCHE-10000074598$ROCHE$$32$YR$A$F$Y$$$20240911$$CN$US$US
243060471$24306047$1$I$20240720$20240830$20240911$20240911$EXP$ES-AEMPS-1560913$ES-Accord-444668$ACCORD$$70$YR$E$F$Y$$$20240911$$MD$ES$ES
243060481$24306048$1$I$$20240905$20240911$20240911$PER$$US-TAKEDA-2024TUS089736$TAKEDA$$$$$$Y$$$20240911$$MD$US$US
243060491$24306049$1$I$20120427$20240831$20240911$20240911$EXP$$PL-AUROBINDO-AUR-APL-2024-044325$AUROBINDO$Muras Szwedziak K, Zawiasa-Bryszewska A, Bryszewski B, Strzelczyk J, Szwedziak K, Nowicki M et al.. The intervertebral disc apergillosis in patient in short term after kidney transplantation.. PRZYPADKI KLINICZNE.. 2017;10(2):139-143$55$YR$$F$Y$$$20240911$$HP$PL$PL
243060501$24306050$1$I$$20240909$20240911$20240911$PER$$US-TAKEDA-2024TUS089885$TAKEDA$$$$$$Y$$$20240911$$CN$US$US
243060511$24306051$1$I$20240828$20240903$20240911$20240911$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-014633$JAZZ$$66$YR$$$Y$$$20240911$$MD$JP$JP
243060521$24306052$1$I$$20240902$20240911$20240911$EXP$$AU-TEVA-VS-3239469$TEVA$$$$$$Y$$$20240911$$MD$AU$AU
243060531$24306053$1$I$20231201$20240906$20240911$20240911$PER$$US-ORGANON-O2409USA000543$ORGANON$$$$$F$Y$$$20240911$$CN$US$US
243060541$24306054$1$I$$20240906$20240911$20240911$EXP$$JP-Taiho Oncology Inc-2023-002000$TAIHO ONCOLOGY INC$$76$YR$E$M$Y$$$20240911$$MD$JP$JP
243060551$24306055$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240406$TEVA$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.; Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.$69$YR$$M$Y$$$20240911$$HP$US$US
243060561$24306056$1$I$20240308$20240902$20240911$20240911$EXP$$IT-AUROBINDO-AUR-APL-2024-044414$AUROBINDO$$64$YR$$F$Y$41$KG$20240911$$HP$IT$IT
243060581$24306058$1$I$20231103$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-139215-2023$RECKITT BENCKISER$$16$YR$$M$Y$$$20240911$$CN$US$US
243060592$24306059$2$F$20240907$20240911$20240911$20240913$PER$$US-AMGEN-USASP2024179997$AMGEN$$71$YR$E$F$Y$$$20240913$$CN$US$US
243060601$24306060$1$I$$20240905$20240911$20240911$EXP$$US-AMGEN-USASP2024178081$AMGEN$$$$$F$Y$$$20240911$$PH$US$US
243060611$24306061$1$I$20240904$20240905$20240911$20240911$EXP$$JP-GSK-JP2024JPN110399$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$MD$JP$JP
243060621$24306062$1$I$$20240909$20240911$20240911$EXP$GB-TEVA-VS-3241234$GB-GSK-GB2024111968$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$HP$GB$GB
243060631$24306063$1$I$$20240905$20240911$20240911$EXP$$US-GSK-US2024110653$GLAXOSMITHKLINE$$$$$F$Y$$$20240911$$HP$US$US
243060641$24306064$1$I$$20240909$20240911$20240911$PER$$US-ROCHE-10000078145$ROCHE$$33$YR$A$M$Y$$$20240911$$MD$US$US
243060652$24306065$2$F$$20240913$20240911$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143959$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240920$$MD$JP$JP
243060661$24306066$1$I$$20240903$20240911$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143367$BRISTOL MYERS SQUIBB$Hyakudo T, Fukubu T, Juuzou K, Yasuda Y, Itou S, Kawa R, et al. A case of what was considered to be cytokine release syndrome developing after administration of ipilimumab and nivolumab for malignant pleural mesothelioma. The 119th Kansai Regional Meeting of the Japan Lung Cancer Society (Programs and Abstracts). 2024;45.$77$YR$E$M$Y$$$20240911$$MD$JP$JP
243060672$24306067$2$F$20240801$20240910$20240911$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143667$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$66.22$KG$20240918$$CN$US$US
243060682$24306068$2$F$$20240912$20240911$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144091$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$96.62$KG$20240919$$CN$US$US
243060691$24306069$1$I$20230101$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141410$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240911$$CN$US$US
243060701$24306070$1$I$$20240905$20240911$20240911$EXP$$AU-AMGEN-AUSSP2024179476$AMGEN$$81$YR$E$F$Y$$$20240911$$MD$AU$AU
243060711$24306071$1$I$20240821$20240822$20240911$20240911$PER$$US-TEVA-VS-3237677$TEVA$$24$YR$$M$Y$$$20240911$$PH$US$US
243060721$24306072$1$I$20240724$20240822$20240911$20240911$PER$$US-CELLTRION INC.-2024US018210$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243060731$24306073$1$I$$20240910$20240911$20240911$EXP$$PT-AMGEN-PRTSP2024180514$AMGEN$$62$YR$A$M$Y$$$20240911$$HP$PT$PT
243060741$24306074$1$I$$20240829$20240911$20240911$EXP$$US-UCBSA-2024044865$UCB$$$$$F$Y$$$20240911$$MD$US$US
243060771$24306077$1$I$$20240909$20240911$20240911$EXP$$FR-CHEPLA-1000007411$CHEPLAPHARM$$71$YR$$M$Y$$$20240911$$MD$COUNTRY NOT SPECIFIED$FR
243060781$24306078$1$I$20240830$20240904$20240911$20240911$EXP$$GB-VANTIVE-2024VAN019541$Vantive US Healthcare$$67$YR$$F$Y$$$20240911$$HP$GB$GB
243060792$24306079$2$F$$20240910$20240911$20240916$EXP$$IN-VANTIVE-2024VAN019666$Vantive US Healthcare$$56$YR$$F$Y$$$20240916$$CN$IN$IN
243060801$24306080$1$I$20240904$20240904$20240911$20240911$EXP$$US-VANTIVE-2024VAN019543$Vantive US Healthcare$$$$$F$Y$$$20240911$$CN$US$US
243060812$24306081$2$F$20240816$20240904$20240911$20240913$EXP$$IN-VANTIVE-2024VAN019142$Vantive US Healthcare$$57$YR$$M$Y$$$20240913$$CN$IN$IN
243060821$24306082$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240407$TEVA$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.; Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.$61$YR$$F$Y$$$20240911$$HP$US$US
243060831$24306083$1$I$20240905$20240905$20240911$20240911$PER$$US-JNJFOC-20240915006$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$CN$US$US
243060841$24306084$1$I$20240801$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144162$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240911$$HP$US$US
243060861$24306086$1$I$20210418$20240902$20240911$20240911$EXP$FR-AFSSAPS-MA2024001149$FR-TEVA-VS-3239438$TEVA$$58$YR$$F$Y$$$20240911$$MD$FR$FR
243060871$24306087$1$I$20240101$20240905$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US079223$SANDOZ$$$$$F$Y$$$20240911$$CN$US$US
243060881$24306088$1$I$$20240828$20240911$20240911$EXP$$GB-Unichem Pharmaceuticals (USA) Inc-UCM202408-001085$UNICHEM$$$$$$Y$$$20240911$$HP$GB$
243060891$24306089$1$I$$20240906$20240911$20240911$PER$$US-ABBVIE-5915320$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243060901$24306090$1$I$$20240904$20240911$20240911$EXP$$IT-CHEPLA-2024011506$CHEPLAPHARM$$$$$F$Y$$$20240911$$CN$COUNTRY NOT SPECIFIED$IT
243060911$24306091$1$I$$20240909$20240911$20240911$EXP$$US-ABBVIE-5916802$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243060921$24306092$1$I$20240815$20240829$20240911$20240911$EXP$$BR-UCBSA-2024045416$UCB$$43$YR$$F$Y$62$KG$20240911$$CN$BR$BR
243060932$24306093$2$F$20240808$20240912$20240911$20240917$EXP$$US-ABBVIE-5910671$ABBVIE$$61$YR$$F$Y$82$KG$20240917$$CN$US$US
243060941$24306094$1$I$20240723$20240724$20240911$20240911$PER$$US-CELLTRION INC.-2024US018211$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243060951$24306095$1$I$$20240904$20240911$20240911$EXP$$US-ABBVIE-5908785$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243060961$24306096$1$I$20240827$20240905$20240911$20240911$PER$$US-AMGEN-USASP2024177943$AMGEN$$$$$$Y$$$20240911$$PH$US$US
243060971$24306097$1$I$$20240903$20240911$20240911$EXP$$CA-JNJFOC-20240910529$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240911$$HP$CA$CA
243060991$24306099$1$I$$20240903$20240911$20240911$EXP$$CA-JNJFOC-20240910825$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240911$$HP$CA$CA
243061001$24306100$1$I$$20240905$20240911$20240911$EXP$$FR-ABBVIE-5915672$ABBVIE$$39$YR$$M$Y$$$20240911$$HP$FR$FR
243061022$24306102$2$F$$20240913$20240911$20240923$PER$$US-GSK-US2024AMR111572$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243061031$24306103$1$I$$20240905$20240911$20240911$EXP$$US-AstraZeneca-2024A203347$ASTRAZENECA$$66$YR$$M$Y$93$KG$20240911$$CN$US$
243061041$24306104$1$I$$20240906$20240911$20240911$EXP$$JP-AstraZeneca-2024A204567$ASTRAZENECA$$$$$F$Y$$$20240911$$MD$JP$
243061051$24306105$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3239633$TEVA$$$$$M$Y$9$KG$20240911$$HP$CA$CA
243061061$24306106$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005606$ELI LILLY AND CO$$32$YR$A$M$Y$$$20240911$$CN$US$US
243061071$24306107$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202403008055$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240911$$CN$US$US
243061081$24306108$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005365$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240911$$CN$US$US
243061111$24306111$1$I$$20240910$20240911$20240911$PER$$US-HALEON-2196259$Haleon PLC$$$$$M$Y$$$20240911$$CN$US$US
243061121$24306112$1$I$20240729$20240905$20240911$20240911$EXP$$CN-CHEPLA-2024011570$CHEPLAPHARM$$70$YR$$M$Y$76$KG$20240911$$HP$COUNTRY NOT SPECIFIED$CN
243061131$24306113$1$I$$20240829$20240911$20240911$EXP$GB-MHRA-MED-202408291214599110-TRYQJ$GB-LUPIN PHARMACEUTICALS INC.-2024-08704$LUPIN$$$$$$Y$$$20240911$$CN$GB$GB
243061151$24306115$1$I$20240907$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179973$AMGEN$$66$YR$E$F$Y$$$20240911$$CN$US$US
243061161$24306116$1$I$20240909$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180380$AMGEN$$74$YR$E$F$Y$$$20240911$$CN$US$US
243061171$24306117$1$I$$20240909$20240911$20240911$PER$$US-JNJFOC-20240923478$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$CN$US$US
243061181$24306118$1$I$$20240906$20240911$20240911$EXP$$US-JNJFOC-20240920227$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$HP$US$US
243061191$24306119$1$I$$20240908$20240911$20240911$PER$$NVSC2024US180472$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
243061201$24306120$1$I$$20240904$20240911$20240911$EXP$$IN-ROCHE-10000077360$ROCHE$$61$YR$A$M$Y$70$KG$20240911$$MD$IN$IN
243061213$24306121$3$F$20240908$20240924$20240911$20240926$EXP$$JP-GILEAD-2024-0686695$GILEAD$$49$YR$A$M$Y$$$20240926$$PH$JP$JP
243061221$24306122$1$I$$20240820$20240911$20240911$EXP$CA-NEBO-667537$CA-NEBO-667537$PHARMACOSMOS$$83$YR$$M$Y$$$20240911$$CN$CA$CA
243061231$24306123$1$I$20240701$20240909$20240911$20240911$EXP$NO-NOMAADVRE-RELISSO-2024-V93g4x$NO-GSK-NO2024111659$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$MD$NO$NO
243061241$24306124$1$I$$20240828$20240911$20240911$EXP$$JP-UCBSA-2024044571$UCB$$$$$$Y$$$20240911$$MD$JP$JP
243061251$24306125$1$I$20230324$20240909$20240911$20240911$EXP$$CO-UCBSA-2024046390$UCB$$66$YR$$M$Y$$$20240911$$CN$CO$CO
243061262$24306126$2$F$$20240916$20240911$20240927$EXP$$CA-UCBSA-2024003949$UCB$$$$$F$Y$$$20240927$$CN$CA$CA
243061291$24306129$1$I$20240725$20240726$20240911$20240911$PER$$US-CELLTRION INC.-2024US018375$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243061301$24306130$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000533US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243061321$24306132$1$I$20240910$20240910$20240911$20240911$EXP$$SA-GILEAD-2024-0687265$GILEAD$$60$YR$A$F$Y$$$20240911$$MD$SA$SA
243061331$24306133$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000546US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243061341$24306134$1$I$$20240903$20240911$20240911$PER$$US-RDY-SPO/USA/24/0013107$DR REDDYS$Jimenez-Kurlander L, DeRosa A, Bogardus K, Kostrzewa CE, Moskowitz CS, Antal Z, et al. Ovarian function in female survivors of high-risk neuroblastoma. Pediatric Blood and Cancer. 2024;71(9): e31181. doi:10.1002/pbc.31181.$$$$F$Y$$$20240911$$HP$US$US
243061351$24306135$1$I$$20240903$20240911$20240911$PER$$US-RDY-SPO/USA/24/0013114$DR REDDYS$Jimenez-Kurlander L, DeRosa A, Bogardus K, Kostrzewa CE, Moskowitz CS, Antal Z, et al. Ovarian function in female survivors of high-risk neuroblastoma. Pediatric Blood and Cancer. 2024;71(9): e31181. doi:10.1002/pbc.31181.$$$$F$Y$$$20240911$$HP$US$US
243061361$24306136$1$I$$20240902$20240911$20240911$30DAY$$JP-JNJFOC-20240919980$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$PH$JP$JP
243061371$24306137$1$I$$20240904$20240911$20240911$EXP$$US-JNJFOC-20240909419$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$CN$US$US
243061391$24306139$1$I$$20240902$20240911$20240911$EXP$$US-AMGEN-USASP2024176947$AMGEN$Goteti S.; Johnson A.K.; Devald B. et al.. Pediatric TAFRO syndrome: A multi-institution case series illustrating clinical challenges and excellent outcomes. Pediatric Blood and Cancer. 2024;71 (10):1-5$15$YR$T$M$Y$$$20240911$$HP$US$US
243061401$24306140$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144135$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$49.9$KG$20240911$$CN$US$US
243061421$24306142$1$I$20240517$20240904$20240911$20240911$EXP$$US-ABBVIE-5908020$ABBVIE$$35$YR$$F$Y$$$20240911$$CN$US$US
243061441$24306144$1$I$$20240828$20240911$20240911$EXP$$MX-ASTELLAS-2024US012219$ASTELLAS$$65$YR$E$M$Y$$$20240911$$MD$MX$MX
243061451$24306145$1$I$$20240829$20240911$20240911$EXP$$ES-Accord-445267$ACCORD$Pena M, Montane C, Paviglianiti A, Hurtado L, Gonzalez S, Carro I, et al. Outcomes of allogeneic hematopoietic cell transplantation after bispecific antibodies in non-Hodgkin lymphomas.. Bone Marrow Transplantation. 2023;58 (11):1282-5.$57$YR$A$M$Y$$$20240911$$HP$ES$ES
243061463$24306146$3$F$$20240913$20240911$20240918$PER$$NVSC2024US181257$NOVARTIS$$$$$$Y$$$20240918$$MD$US$US
243061471$24306147$1$I$$20240822$20240911$20240911$EXP$$US-SA-2024SA261079$SANOFI AVENTIS$$$$A$F$Y$60.45$KG$20240911$$MD$US$US
243061552$24306155$2$F$20240101$20240909$20240911$20240917$EXP$$CA-JNJFOC-20240918019$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20240917$$CN$CA$CA
243061561$24306156$1$I$$20240909$20240911$20240911$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-17977$IPSEN$$$$$F$Y$$$20240911$$CN$GB$GB
243061571$24306157$1$I$$20240904$20240911$20240911$EXP$$US-AMGEN-USASP2024177434$AMGEN$Lapite A.; Sanchez L.; Altaffer A.L. et al.. Concomitant sickle cell disease and systemic lupus erythematosus: A single-center case series. Pediatric Blood and Cancer. 2024;71 (10):1-5$14$YR$T$F$Y$$$20240911$$HP$US$US
243061581$24306158$1$I$$20240902$20240911$20240911$EXP$$DE-AMGEN-DEUSP2024175347$AMGEN$Fleischmann,B. Teclistamab Success in CAR-T Refractory Multiple Myeloma: A Case Presentation. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S536-S536$53$YR$A$F$Y$$$20240911$$MD$DE$DE
243061591$24306159$1$I$$20240903$20240911$20240911$EXP$$BR-AstraZeneca-2024A204332$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$BR$
243061601$24306160$1$I$20240830$20240906$20240911$20240911$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-121301$REGENERON$$$$$M$Y$$$20240911$$CN$CA$CA
243061611$24306161$1$I$20240712$20240829$20240911$20240911$EXP$FR-AFSSAPS-TO2024001443$FR-Accord-444792$ACCORD$$76$YR$E$M$Y$71$KG$20240911$$PH$FR$FR
243061621$24306162$1$I$20240314$20240829$20240911$20240911$EXP$$GB-LUPIN PHARMACEUTICALS INC.-2024-08615$LUPIN$$$$$$Y$$$20240911$$CN$GB$GB
243061632$24306163$2$F$$20240910$20240911$20240913$PER$$NVSC2024US181287$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
243061642$24306164$2$F$$20240902$20240911$20240912$EXP$$DE-AUROBINDO-AUR-APL-2024-044411$AUROBINDO$$80$YR$$F$Y$$$20240912$$CN$DE$DE
243061651$24306165$1$I$$20240906$20240911$20240911$EXP$$US-AMGEN-USASL2024135143$AMGEN$$64$YR$A$M$Y$$$20240911$$CN$US$US
243061673$24306167$3$F$$20240919$20240911$20240923$EXP$$TH-ROCHE-10000073635$ROCHE$$$$A$M$Y$$$20240923$$MD$TH$TH
243061681$24306168$1$I$$20240904$20240911$20240911$EXP$$US-AMGEN-USASP2024178225$AMGEN$Khadka S.; Dong N.; Chavez J.. Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CUP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Single-Center Experience. Clinical Lymphoma Clinical Lymphoma. 2024;24:S480$$$$$Y$$$20240911$$MD$US$US
243061691$24306169$1$I$20240101$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024178972$AMGEN$$13$YR$T$M$Y$$$20240911$$CN$US$US
243061702$24306170$2$F$20220101$20240916$20240911$20240919$EXP$$US-AMGEN-USASL2024179274$AMGEN$$58$YR$A$F$Y$$$20240919$$HP$US$US
243061711$24306171$1$I$$20240910$20240911$20240911$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050651$BOEHRINGER INGELHEIM$$$$$$Y$$$20240911$$MD$JP$JP
243061721$24306172$1$I$$20240904$20240911$20240911$EXP$$US-AMGEN-USASP2024178222$AMGEN$Khadka S.; Dong N.; Chavez J.. Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CUP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Single-Center Experience. Clinical Lymphoma Clinical Lymphoma. 2024;24:S480$$$$$Y$$$20240911$$MD$US$US
243061731$24306173$1$I$20240801$20240906$20240911$20240911$PER$$US-ABBVIE-5914376$ABBVIE$$21$YR$$M$Y$77.11$KG$20240911$$CN$US$US
243061742$24306174$2$F$20240901$20240914$20240911$20240919$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043412$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240919$$MD$DE$DE
243061751$24306175$1$I$$20240827$20240911$20240911$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466937$RANBAXY$Mishra VV, Choudhary S, Dharaiya N, Gaddagi RA, Vyas B. Successful Term Pregnancy in Post Renal Transplant Patient. J SAFOG. 2015;May-Aug; 7(2):89-90$$$N$F$Y$2.3$KG$20240911$$HP$IN$IN
243061761$24306176$1$I$$20240828$20240911$20240911$EXP$$DE-UCBSA-2024044067$UCB$$$$$F$Y$$$20240911$$MD$DE$DE
243061771$24306177$1$I$20191201$20240904$20240911$20240911$EXP$$PL-GILEAD-2024-0686237$GILEAD$$62$YR$A$M$Y$$$20240911$$MD$PL$PL
243061781$24306178$1$I$$20240910$20240911$20240911$PER$$US-HALEON-2196279$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243061791$24306179$1$I$$20240906$20240911$20240911$EXP$$US-SA-2024SA261506$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240911$$MD$US$US
243061801$24306180$1$I$$20240830$20240911$20240911$EXP$DE-BFARM-24005942$DE-Accord-445035$ACCORD$$$$$$Y$$$20240911$$MD$DE$DE
243061831$24306183$1$I$20240801$20240903$20240911$20240911$EXP$$US-ABBVIE-5905442$ABBVIE$$42$YR$$F$Y$$$20240911$$CN$US$US
243061842$24306184$2$F$$20240904$20240911$20240913$EXP$$US-ABBVIE-5909846$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243061851$24306185$1$I$20230101$20240909$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US079109$SANDOZ$$67$YR$$F$Y$103.9$KG$20240911$$PH$US$US
243061861$24306186$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005729$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240911$$CN$US$US
243061871$24306187$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005377$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240911$$CN$US$US
243061881$24306188$1$I$20240902$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005579$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240911$$CN$US$US
243061891$24306189$1$I$$20240903$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003397$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243061901$24306190$1$I$20240907$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005235$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240911$$CN$US$US
243061911$24306191$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006274$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240911$$CN$US$US
243061921$24306192$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006474$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240911$$CN$US$US
243061931$24306193$1$I$20240902$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004506$ELI LILLY AND CO$$39$YR$A$$Y$$$20240911$$CN$US$US
243061942$24306194$2$F$20240612$20240911$20240911$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005485$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240916$$CN$US$US
243061951$24306195$1$I$20240530$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142300$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240911$$CN$US$US
243061961$24306196$1$I$20240830$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005823$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240911$$CN$US$US
243061971$24306197$1$I$20240101$20240906$20240911$20240911$EXP$$US-ABBVIE-5914650$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243061981$24306198$1$I$20210501$20240905$20240911$20240911$EXP$$US-ABBVIE-5915043$ABBVIE$$84$YR$$M$Y$$$20240911$$CN$US$US
243061991$24306199$1$I$20240801$20240906$20240911$20240911$EXP$$US-ABBVIE-5916033$ABBVIE$$43$YR$$M$Y$$$20240911$$CN$US$US
243062001$24306200$1$I$20240306$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-087305-2024$RECKITT BENCKISER$$81$YR$$F$Y$$$20240911$$CN$US$US
243062011$24306201$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240821$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240911$$HP$US$US
243062021$24306202$1$I$$20240906$20240911$20240911$EXP$$US-ABBVIE-5913627$ABBVIE$$35$YR$$F$Y$71$KG$20240911$$CN$US$US
243062031$24306203$1$I$$20240904$20240911$20240911$PER$$US-TAKEDA-2023TUS037968$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
243062041$24306204$1$I$$20240903$20240911$20240911$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03250$AMNEAL$$$$$F$Y$10.748$KG$20240911$$CN$US$US
243062051$24306205$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179130$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$30$YR$A$F$Y$$$20240911$$HP$IT$IT
243062071$24306207$1$I$$20240909$20240911$20240911$EXP$$FR-AMGEN-FRASP2024179648$AMGEN$$$$$M$Y$$$20240911$$PH$FR$FR
243062081$24306208$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179128$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$65$YR$E$F$Y$$$20240911$$HP$IT$IT
243062091$24306209$1$I$$20240903$20240911$20240911$PER$$US-APOTEX-2024AP010326$APOTEX$McCullough KB, Vege SS, Mangaonkar AA, Ferrer A, Patnaik MM.. Pancreatitis as a Potential Consequence of Danazol Therapy for Telomere Biology Disorders. Mayo Clinic Proceedings. 2024;99 (8):1339-1346$$$A$M$Y$$$20240911$$PH$US$US
243062121$24306212$1$I$$20240904$20240911$20240911$PER$$US-GRUNENTHAL-2024-124901$AVERITAS$$47$YR$$F$Y$72.562$KG$20240911$$HP$US$US
243062132$24306213$2$F$20231001$20240912$20240911$20240918$EXP$$US-ABBVIE-5915303$ABBVIE$$48$YR$$F$Y$61$KG$20240918$$CN$US$US
243062161$24306216$1$I$$20240829$20240911$20240911$EXP$$DE-Accord-444856$ACCORD$Holzer MT, Kotter I, Xiong T, Ruffer N, Feindt FC, Melderis S, et al. Daratumumab for refractory systemic rheumatic diseases: a single center experience. Annals of the Rheumatic Diseases. 83:2133-4.$31$YR$A$F$Y$$$20240911$$HP$DE$DE
243062171$24306217$1$I$20240616$20240902$20240911$20240911$EXP$FR-AFSSAPS-AM2024000693$FR-TEVA-VS-3239525$TEVA$$81$YR$$F$Y$63$KG$20240911$$MD$FR$FR
243062191$24306219$1$I$$20240827$20240911$20240911$EXP$$CH-ROCHE-10000068517$ROCHE$$$$$F$Y$$$20240911$$MD$CH$CH
243062201$24306220$1$I$$20240909$20240911$20240911$EXP$$US-GILEAD-2024-0687138$GILEAD$$$$A$M$Y$$$20240911$$CN$US$US
243062214$24306221$4$F$$20240923$20240911$20240926$EXP$$NVSC2024SK180596$NOVARTIS$$34$YR$$F$Y$$$20240926$$MD$SK$SK
243062221$24306222$1$I$$20240906$20240911$20240911$PER$$NVSC2024US180186$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
243062231$24306223$1$I$$20240909$20240911$20240911$PER$$NVSC2024US180886$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243062241$24306224$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179144$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$21$YR$A$M$Y$$$20240911$$HP$IT$IT
243062251$24306225$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179131$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$66$YR$E$F$Y$$$20240911$$HP$IT$IT
243062261$24306226$1$I$20240904$20240904$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0012896$DR REDDYS$$71$YR$E$M$Y$$$20240911$$PH$US$US
243062271$24306227$1$I$$20240904$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012913$DR REDDYS$$44$YR$A$M$Y$$$20240911$$MD$US$US
243062281$24306228$1$I$20240902$20240904$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012899$DR REDDYS$$49$YR$A$M$Y$$$20240911$$HP$US$US
243062291$24306229$1$I$20240902$20240904$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012916$DR REDDYS$$34$YR$A$M$Y$$$20240911$$HP$US$US
243062301$24306230$1$I$20240701$20240906$20240911$20240911$PER$$US-ORGANON-O2408USA000594$ORGANON$$36$YR$$F$Y$124.26$KG$20240911$$MD$US$US
243062311$24306231$1$I$$20240827$20240911$20240911$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467697$RANBAXY$$58$YR$$M$Y$$$20240911$$PH$GB$GB
243062321$24306232$1$I$$20240909$20240911$20240911$EXP$$US-GILEAD-2024-0687205$GILEAD$$$$A$F$Y$$$20240911$$CN$US$US
243062331$24306233$1$I$$20240904$20240911$20240911$PER$$US-JNJFOC-20240913901$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$CN$US$US
243062351$24306235$1$I$$20240904$20240911$20240911$EXP$$VN-ROCHE-10000075483$ROCHE$$50$YR$A$M$Y$$$20240911$$MD$VN$VN
243062361$24306236$1$I$20240909$20240910$20240911$20240911$30DAY$$US-SANDOZ INC.-SDZ2024US079361$SANDOZ$$38$YR$$F$Y$$$20240911$$HP$US$US
243062371$24306237$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240823$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240911$$HP$US$US
243062391$24306239$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240824$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240911$$HP$US$US
243062401$24306240$1$I$20240714$20240715$20240911$20240911$PER$$US-CELLTRION INC.-2024US017693$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243062411$24306241$1$I$$20240909$20240911$20240911$EXP$$US-ABBVIE-5916148$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243062421$24306242$1$I$$20240909$20240911$20240911$PER$$NVSC2024US181845$NOVARTIS$$$$$F$Y$$$20240911$$MD$US$US
243062431$24306243$1$I$20240101$20240905$20240911$20240911$PER$$US-ABBVIE-5909955$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243062442$24306244$2$F$20240615$20240916$20240911$20240919$EXP$$NVSC2024US178632$NOVARTIS$$24$YR$$F$Y$138$KG$20240919$$PH$US$US
243062451$24306245$1$I$20240401$20240903$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140834$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$61.23$KG$20240911$$CN$US$US
243062461$24306246$1$I$20240901$20240903$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140398$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$90.72$KG$20240911$$PH$US$US
243062481$24306248$1$I$20240823$20240902$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012836$DR REDDYS$$47$YR$A$M$Y$$$20240911$$HP$US$US
243062491$24306249$1$I$20240805$20240901$20240911$20240911$EXP$CN-NMPACDR-1305341527121202400109$CN-BAXTER-2024BAX024126$BAXTER$$49$YR$$F$Y$60$KG$20240911$$MD$CN$CN
243062501$24306250$1$I$$20240905$20240911$20240911$PER$$US-TAKEDA-2024TUS089217$TAKEDA$$60$YR$$M$Y$$$20240911$$MD$US$US
243062511$24306251$1$I$20240531$20240903$20240911$20240911$EXP$CN-91110000556821568D-2024DRL001679$CN-RDY-SPO/CHN/24/0012984$DR REDDYS$$53$YR$A$M$Y$$$20240911$$HP$CN$CN
243062521$24306252$1$I$20240616$20240830$20240911$20240911$EXP$FR-AFSSAPS-AM2024000693$FR-Accord-445040$ACCORD$$81$YR$E$F$Y$63$KG$20240911$$MD$FR$FR
243062531$24306253$1$I$20240820$20240904$20240911$20240911$EXP$CN-91110000556821568D-2024DRL001684$CN-RDY-SPO/CHN/24/0013080$DR REDDYS$$17$YR$T$F$Y$$$20240911$$HP$CN$CN
243062541$24306254$1$I$20240826$20240904$20240911$20240911$EXP$$GB-CHIESI-2024CHF05661$CHIESI$$47$YR$$M$Y$$$20240911$$CN$GB$GB
243062551$24306255$1$I$$20240910$20240911$20240911$PER$$US-HALEON-2196276$Haleon PLC$$$$$F$Y$$$20240911$$CN$US$US
243062561$24306256$1$I$$20240906$20240911$20240911$PER$$NVSC2024US180418$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243062571$24306257$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181886$NOVARTIS$$$$$M$Y$$$20240911$$HP$US$US
243062581$24306258$1$I$20230101$20240909$20240911$20240911$EXP$$IL-JNJFOC-20240922640$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240911$$CN$IL$IL
243062591$24306259$1$I$$20240906$20240911$20240911$PER$$NVSC2024US180617$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243062601$24306260$1$I$$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005487$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243062611$24306261$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005416$ELI LILLY AND CO$$52$YR$A$$Y$$$20240911$$CN$US$US
243062621$24306262$1$I$20240908$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005626$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240911$$CN$US$US
243062631$24306263$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006463$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240911$$CN$US$US
243062641$24306264$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005391$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243062651$24306265$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000600US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243062661$24306266$1$I$$20240906$20240911$20240911$PER$$US-ALXN-202409USA000516US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243062671$24306267$1$I$20240726$20240801$20240911$20240911$PER$$US-CELLTRION INC.-2024US018489$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243062681$24306268$1$I$$20240902$20240911$20240911$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08285$HIKMA$$11$YR$$M$Y$53$KG$20240911$$PH$CA$CA
243062691$24306269$1$I$$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A201626$ASTRAZENECA$$$$$F$Y$57$KG$20240911$$CN$US$
243062701$24306270$1$I$20240601$20240903$20240911$20240911$EXP$$JP-AstraZeneca-2024A201920$ASTRAZENECA$$80$YR$$F$Y$$$20240911$$MD$JP$
243062711$24306271$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009948$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243062721$24306272$1$I$$20240910$20240911$20240911$PER$$US-HALEON-2196273$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243062731$24306273$1$I$$20240906$20240911$20240911$EXP$$JP-009507513-2409JPN001281J$MERCK$$8$DEC$$$Y$$$20240911$$MD$JP$JP
243062741$24306274$1$I$$20240904$20240911$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024110523$VIIV$$30$YR$$M$Y$$$20240911$$MD$US$US
243062761$24306276$1$I$20240101$20240827$20240911$20240911$PER$$US-TEVA-VS-3238190$TEVA$$71$YR$$F$Y$$$20240911$$PH$US$US
243062771$24306277$1$I$$20240904$20240911$20240911$EXP$$US-AMGEN-USASP2024177512$AMGEN$$$$$$Y$$$20240911$$CN$US$US
243062781$24306278$1$I$$20240910$20240911$20240911$PER$$US-AMGEN-USASP2024180598$AMGEN$$$$$M$Y$$$20240911$$PH$US$US
243062791$24306279$1$I$20240815$20240829$20240911$20240911$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161468$JIANGSU HANSOH PHARMACEUTICAL$$65$YR$$M$Y$53$KG$20240911$$MD$CN$CN
243062801$24306280$1$I$$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-085646-2024$RECKITT BENCKISER$$$$$$Y$$$20240911$$CN$US$US
243062811$24306281$1$I$$20240908$20240911$20240911$EXP$$IL-AMGEN-ISRSP2024179609$AMGEN$Amer R.; Milstein Y.; Haiimov E. et al.. Increased Risk of Celiac Disease in Patients with Uveitis. Ocular Immunology and Inflammation. 2024;32 (7):1330-1334$34$YR$A$F$Y$$$20240911$$MD$IL$IL
243062821$24306282$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3240009$TEVA$$6$YR$$M$Y$22$KG$20240911$$HP$CA$CA
243062831$24306283$1$I$20240829$20240830$20240911$20240911$EXP$$US-Accord-445192$ACCORD$$48$YR$A$F$Y$$$20240911$$MD$US$US
243062842$24306284$2$F$$20240910$20240911$20240918$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050416$BOEHRINGER INGELHEIM$Takahashi Y, Yamasaki N, Kadokura R, Sekine N, Iwamoto T, Nomiyama T. C-30 A case of emphysematous renal abscess 1 month after initiation of SGLT-2 inhibitor. 105-105.$89$YR$E$F$Y$$$20240918$$MD$JP$JP
243062851$24306285$1$I$20240822$20240906$20240911$20240911$PER$$US-ABBVIE-5914696$ABBVIE$$19$YR$$F$Y$$$20240911$$MD$US$US
243062871$24306287$1$I$$20240903$20240911$20240911$EXP$$US-LUOXIN-LUX-2024-US-LIT-00051$LUOXIN AUROVITAS PHARMA(CHENGDU)$Raymond R Blush 3rd.B-Adrenergic Agonist-Induced  Lactic Acidosis: A Case Report..AACN Adv Crit Care.2024;35(3):222-227$54$YR$A$F$Y$$$20240911$$HP$US$US
243062891$24306289$1$I$$20240801$20240911$20240911$PER$$US-AMGEN-USASP2024181111$AMGEN$$$$$M$Y$$$20240911$$PH$US$US
243062911$24306291$1$I$$20240908$20240911$20240911$EXP$$IL-AMGEN-ISRSP2024179612$AMGEN$Amer R.; Milstein Y.; Haiimov E. et al.. Increased Risk of Celiac Disease in Patients with Uveitis. Ocular Immunology and Inflammation. 2024;32 (7):1330-1334$8$YR$C$F$Y$$$20240911$$MD$IL$IL
243062921$24306292$1$I$20230719$20240906$20240911$20240911$EXP$$FR-AMGEN-FRASP2024179202$AMGEN$$52$YR$A$F$Y$$$20240911$$HP$FR$FR
243062952$24306295$2$F$20240101$20240905$20240911$20240914$EXP$$US-TEVA-VS-3241203$TEVA$$33$YR$$F$Y$$$20240914$$HP$US$US
243062961$24306296$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009949$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243062971$24306297$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181900$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243062981$24306298$1$I$$20240823$20240911$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08517$LUPIN$$$$$$Y$$$20240911$$CN$US$US
243062991$24306299$1$I$$20240902$20240911$20240911$30DAY$$GR-JNJFOC-20240919539$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$GR$GR
243063021$24306302$1$I$$20240903$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141599$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240911$$CN$US$US
243063031$24306303$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143887$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240911$$HP$US$US
243063041$24306304$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143632$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240911$$CN$US$US
243063051$24306305$1$I$20240830$20240830$20240911$20240911$EXP$$US-Accord-446047$ACCORD$$17$YR$T$F$Y$$$20240911$$MD$US$US
243063061$24306306$1$I$$20240904$20240911$20240911$30DAY$$US-GSK-US2024110194$GLAXOSMITHKLINE$$$$$M$Y$$$20240911$$CN$US$US
243063071$24306307$1$I$$20240903$20240911$20240911$EXP$$CA-APOTEX-2024AP010281$APOTEX$Lagace-Thomassin F, Nateghi A, Kechichian E, Veilleux M. Topical imiquimod adverse event: Beyond the local skin reaction-A case report. JCMS Case Reports. 2024;12:1-3$82$YR$$M$Y$$$20240911$$HP$CA$CA
243063081$24306308$1$I$20230324$20240911$20240911$20240911$PER$$US-HALEON-USCH2023013196$Haleon PLC$$60$YR$$$Y$$$20240911$$CN$US$US
243063092$24306309$2$F$20240909$20240909$20240911$20240912$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-121345$REGENERON$$56$YR$$M$Y$$$20240912$$MD$JP$JP
243063102$24306310$2$F$$20240905$20240911$20240914$EXP$$GB-TEVA-VS-3239483$TEVA$$$$C$M$Y$$$20240914$$PH$GB$GB
243063121$24306312$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240822$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$E$$Y$$$20240911$$HP$US$US
243063131$24306313$1$I$20240624$20240830$20240911$20240911$EXP$$MA-AMNEAL PHARMACEUTICALS-2024-AMRX-02359$AMNEAL$$$$$F$Y$$$20240911$$MD$MA$MA
243063141$24306314$1$I$$20240903$20240911$20240911$EXP$$US-TEVA-VS-3241469$TEVA$$59$YR$$M$Y$$$20240911$$HP$US$US
243063153$24306315$3$F$20240907$20240918$20240911$20240920$PER$$US-AMGEN-USASP2024180017$AMGEN$$77$YR$E$F$Y$$$20240919$$MD$US$US
243063161$24306316$1$I$20240101$20240905$20240911$20240911$EXP$$CN-REGENERON PHARMACEUTICALS, INC.-2024-121198$REGENERON$$78$YR$$M$Y$$$20240911$$HP$CN$CN
243063181$24306318$1$I$20240101$20240903$20240911$20240911$EXP$$US-TEVA-VS-3240020$TEVA$$57$YR$$M$Y$$$20240911$$CN$US$US
243063191$24306319$1$I$$20240910$20240911$20240911$PER$$US-ROCHE-10000078651$ROCHE$$11$YR$C$M$Y$$$20240911$$MD$US$US
243063201$24306320$1$I$20240609$20240909$20240911$20240911$PER$$NVSC2024US181269$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
243063211$24306321$1$I$$20240905$20240911$20240911$EXP$$NVSC2024CN180168$NOVARTIS$$$$$F$Y$$$20240911$$CN$CN$CN
243063221$24306322$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181882$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243063231$24306323$1$I$20240529$20240904$20240911$20240911$EXP$$AU-Ipsen Biopharmaceuticals, Inc.-2024-17572$IPSEN$$32$YR$A$F$Y$$$20240911$$HP$AU$AU
243063241$24306324$1$I$$20240823$20240911$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08520$LUPIN$$$$$$Y$$$20240911$$CN$US$US
243063251$24306325$1$I$20220501$20240830$20240911$20240911$EXP$$CN-Accord-444644$ACCORD$Tang LL, Huang YD, Zhang XJ, Zhu L, Li ZP. Pharmaceutical Care for Tacrolimus-associated Posterior Reversible Encephalopathy Syndrome in A Pediatric Patient with Nephrotic Syndrome. Herald of Medicine-Yiyao Daobao. 2024;43(2):292-8. DOI: 10.3870/j.issn.1004-0781.2024.02.23.$2$YR$C$M$Y$16.6$KG$20240911$$PH$CN$CN
243063261$24306326$1$I$$20240715$20240911$20240911$PER$$US-CELLTRION INC.-2024US017701$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243063271$24306327$1$I$$20240902$20240911$20240911$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08287$HIKMA$$69$YR$$M$Y$78$KG$20240911$$HP$CA$CA
243063281$24306328$1$I$20240701$20240910$20240911$20240911$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050733$BOEHRINGER INGELHEIM$$85$YR$E$F$Y$$$20240911$$PH$US$US
243063291$24306329$1$I$20240802$20240819$20240911$20240911$PER$$US-CELLTRION INC.-2024US018805$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243063301$24306330$1$I$20240814$20240910$20240911$20240911$EXP$GB-MHRA-MED-202409091625193460-DPYVC$GB-Orion Corporation ORION PHARMA-24_00031628$ORION$$89$YR$E$F$Y$43$KG$20240911$$PH$GB$
243063311$24306331$1$I$20231013$20240903$20240911$20240911$EXP$$US-RDY-SPO/USA/23/0180339$DR REDDYS$$68$YR$E$M$Y$$$20240911$$MD$US$US
243063323$24306332$3$F$20240701$20240912$20240911$20240919$EXP$$NVSC2024US180363$NOVARTIS$$65$YR$$M$Y$63.039$KG$20240919$$CN$US$US
243063331$24306333$1$I$$20240903$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0012879$DR REDDYS$$33$YR$A$M$Y$$$20240911$$HP$US$US
243063341$24306334$1$I$20240904$20240905$20240911$20240911$PER$$US-ABBVIE-5910407$ABBVIE$$25$YR$$F$Y$$$20240911$$HP$US$US
243063351$24306335$1$I$20240827$20240909$20240911$20240911$EXP$$US-AstraZeneca-2024A205373$ASTRAZENECA$$31376$DY$$M$Y$$$20240911$$MD$US$
243063361$24306336$1$I$20240826$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A201883$ASTRAZENECA$$31586$DY$$F$Y$$$20240911$$CN$US$
243063371$24306337$1$I$$20240828$20240911$20240911$PER$$US-AstraZeneca-2024A196553$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243063381$24306338$1$I$$20240823$20240911$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08533$LUPIN$$$$$$Y$$$20240911$$CN$US$US
243063392$24306339$2$F$$20240912$20240911$20240926$30DAY$$IN-JNJFOC-20240917098$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$MD$IN$IN
243063411$24306341$1$I$20240801$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006299$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240911$$CN$US$US
243063421$24306342$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005506$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240911$$CN$US$US
243063431$24306343$1$I$20240907$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005441$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240911$$CN$US$US
243063441$24306344$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004508$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240911$$CN$US$US
243063451$24306345$1$I$20240907$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005692$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240911$$CN$US$US
243063461$24306346$1$I$$20240904$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004820$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240911$$CN$US$US
243063471$24306347$1$I$20190202$20240831$20240911$20240911$EXP$IT-MINISAL02-1000740$IT-MACLEODS PHARMA-MAC2024049229$MACLEODS$$$$$$Y$$$20240911$$CN$IT$IT
243063481$24306348$1$I$20240124$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-083690-2024$RECKITT BENCKISER$$67$YR$$F$Y$71.82$KG$20240911$$CN$US$US
243063501$24306350$1$I$$20240830$20240911$20240911$EXP$$ZA-MACLEODS PHARMA-MAC2024049191$MACLEODS$$$$$$Y$$$20240911$$CN$ZA$ZA
243063511$24306351$1$I$$20240829$20240911$20240911$EXP$$ZA-MACLEODS PHARMA-MAC2024049204$MACLEODS$Bishop MD, Korutaro V, Boyce CL, Beck IA, Styrchak SM, Knowles K, Ziemba L, Brummel SS, Coletti A, Jean-Philippe P, Chakhtoura N..Characterizing HIV Drug Resistance in Cases of Vertical Transmission in the VESTED Randomized Antiretroviral Treatment Trial.JAIDS Journal of Acquired Immune Deficiency Syndromes.2024;96(4):385-392$$$$$Y$$$20240911$$HP$ZA$ZA
243063531$24306353$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143628$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240911$$CN$US$US
243063541$24306354$1$I$20240731$20240905$20240911$20240911$EXP$$US-ABBVIE-5909888$ABBVIE$$12$YR$$F$Y$$$20240911$$CN$US$US
243063551$24306355$1$I$$20240909$20240911$20240911$PER$$US-LEO Pharma-373377$LEO PHARM$$29$YR$$F$Y$$$20240911$$PH$US$US
243063561$24306356$1$I$$20240821$20240911$20240911$PER$$US-SA-2024SA260009$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240911$$PH$US$US
243063571$24306357$1$I$20240101$20240828$20240911$20240911$PER$$US-SA-2024SA260514$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240911$$MD$US$US
243063581$24306358$1$I$$20240823$20240911$20240911$PER$$US-SA-2024SA258945$SANOFI AVENTIS$$$$E$M$Y$$$20240911$$MD$US$US
243063592$24306359$2$F$20240812$20240828$20240911$20240926$PER$$US-SA-2024SA260435$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240926$$MD$US$US
243063601$24306360$1$I$20240801$20240821$20240911$20240911$PER$$US-SA-2024SA259810$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240911$$MD$US$US
243063611$24306361$1$I$20240801$20240828$20240911$20240911$PER$$US-SA-2024SA262536$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240911$$MD$US$US
243063621$24306362$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA259936$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240911$$$US$US
243063631$24306363$1$I$20230801$20240828$20240911$20240911$PER$$US-SA-2024SA261950$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240911$$CN$US$US
243063641$24306364$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA260139$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240911$$MD$US$US
243063651$24306365$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA262272$SANOFI AVENTIS$$51$YR$A$$Y$$$20240911$$CN$US$US
243063661$24306366$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA259134$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240911$$HP$US$US
243063671$24306367$1$I$20240709$20240827$20240911$20240911$PER$$US-SA-2024SA259689$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240911$$CN$US$US
243063681$24306368$1$I$$20240904$20240911$20240911$EXP$$US-GILEAD-2024-0686148$GILEAD$$$$A$F$Y$$$20240911$$CN$US$US
243063691$24306369$1$I$20240801$20240829$20240911$20240911$PER$$US-SA-2024SA261122$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240911$$MD$US$US
243063701$24306370$1$I$20240101$20240829$20240911$20240911$PER$$US-SA-2024SA259214$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240911$$HP$US$US
243063711$24306371$1$I$20240801$20240830$20240911$20240911$PER$$US-SA-2024SA261952$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240911$$MD$US$US
243063721$24306372$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA259662$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240911$$HP$US$US
243063731$24306373$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA261111$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240911$$HP$US$US
243063741$24306374$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA261564$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240911$$MD$US$US
243063751$24306375$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA261192$SANOFI AVENTIS$$75$YR$E$$Y$$$20240911$$CN$US$US
243063761$24306376$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA259438$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240911$$CN$US$US
243063771$24306377$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA261758$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240911$$HP$US$US
243063781$24306378$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA261959$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240911$$HP$US$US
243063791$24306379$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA261035$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240911$$HP$US$US
243063801$24306380$1$I$20240801$20240829$20240911$20240911$PER$$US-SA-2024SA261957$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240911$$HP$US$US
243063811$24306381$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA207047$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240911$$CN$US$US
243063821$24306382$1$I$20240101$20240828$20240911$20240911$PER$$US-SA-2024SA262201$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240911$$MD$US$US
243063831$24306383$1$I$20240826$20240829$20240911$20240911$PER$$US-SA-2024SA260377$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240911$$MD$US$US
243063841$24306384$1$I$20240101$20240829$20240911$20240911$PER$$US-SA-2024SA259172$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240911$$CN$US$US
243063851$24306385$1$I$20240101$20240829$20240911$20240911$PER$$US-SA-2024SA260549$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240911$$MD$US$US
243063861$24306386$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA261009$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240911$$HP$US$US
243063871$24306387$1$I$20240801$20240829$20240911$20240911$PER$$US-SA-2024SA260755$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240911$$HP$US$US
243063881$24306388$1$I$20240401$20240829$20240911$20240911$PER$$US-SA-2024SA260464$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240911$$MD$US$US
243063891$24306389$1$I$20210701$20240830$20240911$20240911$PER$$US-SA-2024SA261757$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240911$$HP$US$US
243063901$24306390$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA259106$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240911$$CN$US$US
243063911$24306391$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA261524$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240911$$HP$US$US
243063921$24306392$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260816$SANOFI AVENTIS$$91$YR$E$M$Y$$$20240911$$MD$US$US
243063931$24306393$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA261138$SANOFI AVENTIS$$$$A$$Y$$$20240911$$CN$US$US
243063941$24306394$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA192106$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240911$$MD$US$US
243063951$24306395$1$I$20240801$20240829$20240911$20240911$PER$$US-SA-2024SA261144$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240911$$HP$US$US
243063961$24306396$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA261618$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240911$$HP$US$US
243063971$24306397$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA261323$SANOFI AVENTIS$$$$A$$Y$$$20240911$$CN$US$US
243063981$24306398$1$I$$20240909$20240911$20240911$PER$$US-ROCHE-10000078130$ROCHE$$63$YR$A$M$Y$$$20240911$$MD$US$US
243063992$24306399$2$F$20240101$20240912$20240911$20240923$PER$$US-SA-2024SA261468$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240923$$MD$US$US
243064001$24306400$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA262155$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240911$$CN$US$US
243064011$24306401$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA262195$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240911$$MD$US$US
243064021$24306402$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA261780$SANOFI AVENTIS$$$$A$M$Y$$$20240911$$HP$US$US
243064031$24306403$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA228061$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240911$$CN$US$US
243064041$24306404$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA262224$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240911$$MD$US$US
243064051$24306405$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA188439$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240911$$MD$US$US
243064061$24306406$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA260257$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240911$$CN$US$US
243064071$24306407$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA261645$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240911$$MD$US$US
243064091$24306409$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261976$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240911$$CN$US$US
243064101$24306410$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261794$SANOFI AVENTIS$$$$E$M$Y$$$20240911$$HP$US$US
243064111$24306411$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA261359$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240911$$HP$US$US
243064121$24306412$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA261051$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240911$$HP$US$US
243064131$24306413$1$I$20240903$20240903$20240911$20240911$PER$$US-SA-2024SA261428$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240911$$PH$US$US
243064141$24306414$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA256191$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240911$$MD$US$US
243064151$24306415$1$I$20240828$20240903$20240911$20240911$PER$$US-SA-2024SA109736$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240911$$MD$US$US
243064161$24306416$1$I$$20240905$20240911$20240911$PER$$US-MYLANLABS-2024M1082038$MYLAN$$$$$$Y$$$20240911$$CN$US$US
243064171$24306417$1$I$$20240904$20240911$20240911$EXP$$CN-CHIESI-2024CHF05713$CHIESI$$$$N$M$Y$$$20240911$$MD$CN$CN
243064181$24306418$1$I$20240501$20240903$20240911$20240911$PER$$US-SA-2024SA260794$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240911$$CN$US$US
243064191$24306419$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261939$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240911$$CN$US$US
243064211$24306421$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA262059$SANOFI AVENTIS$$102$YR$E$F$Y$$$20240911$$CN$US$US
243064231$24306423$1$I$20240901$20240903$20240911$20240911$PER$$US-SA-2024SA261935$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240911$$HP$US$US
243064241$24306424$1$I$20240801$20240903$20240911$20240911$PER$$US-SA-2024SA261802$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240911$$HP$US$US
243064251$24306425$1$I$20240801$20240902$20240911$20240911$PER$$US-SA-2024SA260343$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240911$$MD$US$US
243064261$24306426$1$I$20240608$20240807$20240911$20240911$PER$$US-CELLTRION INC.-2024US019149$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243064271$24306427$1$I$20240905$20240906$20240911$20240911$EXP$$US-AMGEN-USASP2024179062$AMGEN$$71$YR$E$F$Y$$$20240911$$CN$US$US
243064281$24306428$1$I$$20240905$20240911$20240911$EXP$$US-AMGEN-USASP2024179011$AMGEN$$$$$M$Y$$$20240911$$MD$US$US
243064291$24306429$1$I$$20240904$20240911$20240911$EXP$$CO-GSK-CO2024AMR089254$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$CO$CO
243064301$24306430$1$I$$20240902$20240911$20240911$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS004584$TERSERA THERAPEUTICS$$$$$$Y$$$20240911$$MD$AU$AU
243064311$24306431$1$I$$20240902$20240911$20240911$PER$$US-ROCHE-10000078092$ROCHE$Dana IN, Austin E, Asrani F. Mucocutaneous ulcers in an immunocompromised patient. JAAD Case Reports,2024;51:48-50.2352-5126.https://doi.org/10.1016/j.jdcr.2024.06.016.$49$YR$A$F$Y$$$20240911$$HP$US$US
243064321$24306432$1$I$$20240823$20240911$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08546$LUPIN$$$$$$Y$$$20240911$$CN$US$US
243064331$24306433$1$I$$20240826$20240911$20240911$PER$$US-JNJFOC-20240869537$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240911$$CN$US$US
243064341$24306434$1$I$20231201$20240908$20240911$20240911$PER$$US-JNJFOC-20240919913$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240911$$CN$US$US
243064351$24306435$1$I$20240101$20240829$20240911$20240911$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000544$DECIPHERA PHARMACEUTICALS$$58$YR$A$M$Y$$$20240911$$CN$US$US
243064361$24306436$1$I$$20240904$20240911$20240911$EXP$$CA-GSK-CA2024110709$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$CA$CA
243064371$24306437$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62274$$FDA-CTU$$86$YR$$M$N$$$20240910$N$$US$
243064392$24306439$2$F$20221201$20240912$20240911$20240919$EXP$$PT-MYLANLABS-2024M1082216$MYLAN$Soares M, Rosa S, Bettencourt S, Ferreira R, Sardinha M, Dias M, et al. Cytotoxic lesions of the corpus callosum due to FOLFIRINOX chemotherapy. Brain-Disord 2024; 15.$47$YR$$F$Y$$$20240919$$HP$PT$PT
243064401$24306440$1$I$$20240903$20240911$20240911$EXP$$PL-MYLANLABS-2024M1082239$MYLAN$Kachlik Z, Blazewicz I, Ciarka A, Nowicki RJ. Case report: Lichenoid eruption under immunotherapy with MK-4830 and pembrolizumab in a breast cancer patient. Front-Pharmacol 2024; 15 (0):.$41$YR$$F$Y$$$20240911$$HP$PL$PL
243064411$24306441$1$I$$20240903$20240911$20240911$EXP$$TN-MYLANLABS-2024M1082388$MYLAN$Laroussi S, Bouattour N, Daoud S, Moalla KS, Sakka S, Damak M, et al. Reversible dementia and seizures due to metformin-induced vitamin B12 deficiency. Encephale 2024; 50 (4): 474-477.$64$YR$$F$Y$$$20240911$$HP$TN$TN
243064421$24306442$1$I$$20240902$20240911$20240911$EXP$$US-MYLANLABS-2024M1081808$MYLAN$Haliyur R, Johnson TJ, Johnson MW. Poor response of solitary optic disc retinal capillary hemangioblastoma to intravitreal propranolol. Can-J-Ophthalmol 2024; 59 e92-e94.$56$YR$$M$Y$$$20240911$$HP$US$US
243064431$24306443$1$I$$20240830$20240911$20240911$EXP$$US-MYLANLABS-2024M1081432$MYLAN$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$61$YR$$F$Y$$$20240911$$MD$US$US
243064441$24306444$1$I$$20240903$20240911$20240911$EXP$$US-MYLANLABS-2024M1081866$MYLAN$Higgins E, Yuan J, Lange S, Boilson BA, Pritt BS, Rizza SA. Fever, Cough, and Pancytopenia in a Transplant Recipient. Clin-Infect-Dis 2023; 77 (7): 1065-1067.$19$YR$$M$Y$$$20240911$$HP$US$US
243064451$24306445$1$I$$20240903$20240911$20240911$EXP$$IT-MYLANLABS-2024M1082310$MYLAN$De Zen L, Divisic A, Molinaro G, Solidoro S, Barbi E. Dexmedetomidine at Home for Intractable Dystonia and Insomnia in Children With Special Needs: A Case Series. J-Pain-Symptom-Manage 2023; 66 (6): e653-e657.$$$$F$Y$$$20240911$$HP$IT$IT
243064461$24306446$1$I$20240717$20240802$20240911$20240911$PER$$US-CELLTRION INC.-2024US017994$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243064472$24306447$2$F$$20240916$20240911$20240928$EXP$$ES-Accord-444875$ACCORD$Sisinni L, Mozo Y, Bueno D, De Paz R, Lopez-Granados E, Perez-Martinez A. Hemophagocytic syndrome after ex-vivo lymphodepleted hematopoietic transplantation. Bone Marrow Transplant. 2020 55 (614-615). DOI: 10.1038/s41409-020-01120-w.$10$YR$C$$Y$$$20240928$$MD$ES$ES
243064482$24306448$2$F$$20240911$20240911$20240925$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08749$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243064491$24306449$1$I$$20240905$20240911$20240911$EXP$$FR-JNJFOC-20240915136$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$MD$FR$FR
243064501$24306450$1$I$$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-086191-2024$RECKITT BENCKISER$$$$$F$Y$$$20240911$$CN$US$US
243064514$24306451$4$F$$20240922$20240911$20240930$PER$$NVSC2024US180424$NOVARTIS$$$$$$Y$$$20240930$$CN$US$US
243064521$24306452$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00730$GLAND PHARMA$Daqi Li.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini  CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin  Lymphoma.Turkish Journal of Hematology.JAN-2023;40: 284-285$68$YR$E$M$Y$$$20240911$$MD$CN$CN
243064531$24306453$1$I$$20240830$20240911$20240911$PER$$US-JNJFOC-20240903786$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240911$$CN$US$US
243064541$24306454$1$I$20240909$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179800$AMGEN$$79$YR$E$M$Y$$$20240911$$CN$US$US
243064551$24306455$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142561$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240911$$CN$US$US
243064561$24306456$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62280$$FDA-CTU$$15$YR$$M$N$$$20240910$N$$US$
243064571$24306457$1$I$$20240823$20240911$20240911$PER$$US-TEVA-VS-3237757$TEVA$$$$$$Y$$$20240911$$HP$US$US
243064581$24306458$1$I$20240803$20240904$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142315$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240911$$HP$US$US
243064591$24306459$1$I$20240901$20240905$20240911$20240911$EXP$$US-GSK-US2024110633$GLAXOSMITHKLINE$$$$$F$Y$$$20240911$$MD$US$US
243064601$24306460$1$I$$20240903$20240911$20240911$30DAY$$US-GSK-US2024109459$GLAXOSMITHKLINE$$$$$F$Y$$$20240911$$CN$US$US
243064611$24306461$1$I$$20240903$20240911$20240911$EXP$$US-SA-2024SA261718$SANOFI AVENTIS$$$$$F$Y$$$20240911$$CN$US$US
243064621$24306462$1$I$20240829$20240830$20240911$20240911$EXP$$US-Accord-446046$ACCORD$$49$YR$A$M$Y$$$20240911$$HP$US$US
243064631$24306463$1$I$$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62247$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243064641$24306464$1$I$20180224$20240909$20240911$20240911$EXP$FR-AFSSAPS-CN20180719$FR-SANDOZ INC.-PHHY2018FR039410$SANDOZ$$84$YR$$M$Y$89$KG$20240911$$PH$FR$FR
243064651$24306465$1$I$20190101$20240905$20240911$20240911$EXP$$BR-TAKEDA-2024TUS089903$TAKEDA$$$$$F$Y$$$20240911$$CN$BR$BR
243064661$24306466$1$I$$20240902$20240911$20240911$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011345$STRIDES$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework.. J-Forens-Legal-Med. 2024;101$$$$$Y$$$20240911$$HP$US$US
243064672$24306467$2$F$$20240903$20240911$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08534$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243064681$24306468$1$I$20230801$20240903$20240911$20240911$EXP$$DE-TEVA-VS-3240273$TEVA$$$$$M$Y$2.535$KG$20240911$$MD$DE$DE
243064691$24306469$1$I$$20240905$20240911$20240911$PER$$US-ALXN-202409USA000393US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243064701$24306470$1$I$20240907$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180485$AMGEN$$68$YR$E$M$Y$$$20240911$$CN$US$US
243064711$24306471$1$I$$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62277$$FDA-CTU$$$$$M$N$$$20240909$N$HP$US$
243064721$24306472$1$I$20240801$20240905$20240911$20240911$EXP$$US-AMGEN-USASP2024177137$AMGEN$$85$YR$E$F$Y$$$20240911$$MD$US$US
243064731$24306473$1$I$20240814$20240902$20240911$20240911$EXP$$US-BAYER-2024A118119$BAYER$$54$YR$A$F$Y$155.1$KG$20240911$$CN$US$US
243064742$24306474$2$F$$20240918$20240911$20240928$PER$$US-SA-2024SA259542$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240928$$HP$US$US
243064751$24306475$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA262548$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240911$$HP$US$US
243064761$24306476$1$I$$20240821$20240911$20240911$PER$$US-SA-2024SA259651$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240911$$MD$US$US
243064771$24306477$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA253984$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240911$$HP$US$US
243064781$24306478$1$I$$20240821$20240911$20240911$PER$$US-SA-2024SA262007$SANOFI AVENTIS$$$$E$M$Y$70.45$KG$20240911$$MD$US$US
243064791$24306479$1$I$$20240821$20240911$20240911$PER$$US-SA-2024SA261456$SANOFI AVENTIS$$$$A$F$Y$$$20240911$$MD$US$US
243064805$24306480$5$F$$20240918$20240911$20240925$PER$$US-SA-2024SA255236$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240925$$PH$US$US
243064811$24306481$1$I$$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62273$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243064821$24306482$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA262291$SANOFI AVENTIS$$63$YR$A$F$Y$140$KG$20240911$$MD$US$US
243064841$24306484$1$I$20240101$20240822$20240911$20240911$PER$$US-SA-2024SA259398$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240911$$MD$US$US
243064851$24306485$1$I$$20240902$20240911$20240911$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP011408$STRIDES$Lakshmanan K, Khandpur S, Garg S, Bagga A, Sinha A.. Rapid Steroid Withdrawal Unveiling Tender Nodules: A Pediatric Panniculitis Puzzle and its Management.. Indian-J-Pediatr. 2024;91 (3):312$5$YR$$M$Y$$$20240911$$HP$IN$IN
243064861$24306486$1$I$$20240902$20240911$20240911$EXP$$IT-MYLANLABS-2024M1081552$MYLAN$Tedeschi A, Ianni U, Gentile P, Palazzini M, Masciocco G, Ammirati E, et al. Recurrent Coronary Artery Vasospasm Complicated by Cardiac Arrests in Heart Transplant Recipient: An Unusual Enemy. Transplantation 2024; 108 (6): E86-E87.$30$YR$$M$Y$$$20240911$$MD$IT$IT
243064872$24306487$2$F$$20240909$20240911$20240917$EXP$$PT-ASPEN-GLO2024PT006124$ASPEN$Chicharo AT, Rebelo M, Lopes AR, Saavedra MJ, Parames MF, Arauo AR.. Dual challenge inside the womb: a case report of concomitant fetal atrio-ventricular block associated with maternal anti-SSA antibodies and fetal tachyarrhythmia diagnosed as Wolff-Parkinson-White syndrome after birth.. Front. Immunol... 2024;15$$$$$Y$$$20240917$$HP$PT$PT
243064881$24306488$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00732$GLAND PHARMA$Daqi Li.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Hematology.JAN-2023;40: 284-285$61$YR$A$F$Y$$$20240911$$MD$CN$CN
243064891$24306489$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181268$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243064901$24306490$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA261066$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240911$$HP$US$US
243064911$24306491$1$I$20240819$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62291$$FDA-CTU$$75$YR$$M$N$$$20240910$N$HP$US$
243064921$24306492$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA261137$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240911$$HP$US$US
243064931$24306493$1$I$20240101$20240827$20240911$20240911$PER$$US-SA-2024SA262302$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240911$$MD$US$US
243064941$24306494$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260348$SANOFI AVENTIS$$$$A$F$Y$$$20240911$$CN$US$US
243064951$24306495$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260386$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240911$$MD$US$US
243064962$24306496$2$F$20230504$20240911$20240911$20240918$EXP$$US-GSK-US2023065559$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$US$US
243064971$24306497$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA262148$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240911$$HP$US$US
243064981$24306498$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA260688$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240911$$CN$US$US
243064991$24306499$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA261214$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240911$$MD$US$US
243065001$24306500$1$I$20240601$20240830$20240911$20240911$PER$$US-SA-2024SA260584$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240911$$HP$US$US
243065011$24306501$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA260697$SANOFI AVENTIS$$68$YR$E$$Y$$$20240911$$CN$US$US
243065021$24306502$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA262051$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240911$$MD$US$US
243065031$24306503$1$I$20240826$20240830$20240911$20240911$PER$$US-SA-2024SA262161$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240911$$HP$US$US
243065041$24306504$1$I$$20240904$20240911$20240911$EXP$$AU-TAKEDA-2024TUS089252$TAKEDA$$$$$M$Y$$$20240911$$CN$AU$AU
243065051$24306505$1$I$20240101$20240829$20240911$20240911$PER$$US-SA-2024SA260760$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240911$$HP$US$US
243065061$24306506$1$I$20120101$20240902$20240911$20240911$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011476$STRIDES$Gutierrez RA, Smith P, Kranyak A, Davis M, Koo J.. Pimozide-induced tardive dyskinesia in the treatment of delusions of infestation.. JAAD-Case-Rep. 2024;45:71-73$6$DEC$$F$Y$$$20240911$$HP$US$US
243065071$24306507$1$I$20240101$20240902$20240911$20240911$PER$$US-SA-2024SA262068$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240911$$HP$US$US
243065081$24306508$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261588$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240911$$CN$US$US
243065091$24306509$1$I$20240801$20240902$20240911$20240911$PER$$US-SA-2024SA261335$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240911$$MD$US$US
243065102$24306510$2$F$20240101$20240912$20240911$20240923$PER$$US-SA-2024SA260877$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240923$$HP$US$US
243065112$24306511$2$F$20240801$20240913$20240911$20240923$PER$$US-SA-2024SA260857$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240923$$MD$US$US
243065131$24306513$1$I$$20240901$20240911$20240911$PER$$US-SA-2024SA261925$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240911$$HP$US$US
243065141$24306514$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA261956$SANOFI AVENTIS$$$$A$M$Y$$$20240911$$HP$US$US
243065151$24306515$1$I$20240831$20240902$20240911$20240911$PER$$US-SA-2024SA261610$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240911$$HP$US$US
243065161$24306516$1$I$20240801$20240903$20240911$20240911$PER$$US-SA-2024SA260420$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240911$$HP$US$US
243065171$24306517$1$I$20240101$20240901$20240911$20240911$PER$$US-SA-2024SA261875$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240911$$MD$US$US
243065181$24306518$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA260964$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240911$$MD$US$US
243065191$24306519$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261994$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240911$$CN$US$US
243065201$24306520$1$I$20240902$20240903$20240911$20240911$PER$$US-SA-2024SA261737$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240911$$CN$US$US
243065211$24306521$1$I$20240801$20240903$20240911$20240911$PER$$US-SA-2024SA262163$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240911$$CN$US$US
243065222$24306522$2$F$20240101$20240906$20240911$20240917$PER$$US-SA-2024SA261263$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240918$$HP$US$US
243065231$24306523$1$I$20240101$20240831$20240911$20240911$PER$$US-SA-2024SA261612$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240911$$MD$US$US
243065241$24306524$1$I$20240501$20240902$20240911$20240911$PER$$US-SA-2024SA262141$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240911$$HP$US$US
243065251$24306525$1$I$20240101$20240831$20240911$20240911$PER$$US-SA-2024SA261629$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240911$$MD$US$US
243065261$24306526$1$I$20240801$20240903$20240911$20240911$PER$$US-SA-2024SA262145$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240911$$HP$US$US
243065271$24306527$1$I$20240830$20240903$20240911$20240911$PER$$US-SA-2024SA261905$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240911$$HP$US$US
243065281$24306528$1$I$20240801$20240903$20240911$20240911$PER$$US-SA-2024SA261900$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240911$$CN$US$US
243065291$24306529$1$I$20240501$20240830$20240911$20240911$PER$$US-SA-2024SA261016$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240911$$HP$US$US
243065301$24306530$1$I$20240801$20240831$20240911$20240911$PER$$US-SA-2024SA261902$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240911$$HP$US$US
243065311$24306531$1$I$20240101$20240902$20240911$20240911$PER$$US-SA-2024SA261037$SANOFI AVENTIS$$$$A$F$Y$$$20240911$$HP$US$US
243065321$24306532$1$I$20240822$20240831$20240911$20240911$PER$$US-SA-2024SA260764$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240911$$MD$US$US
243065331$24306533$1$I$20240830$20240903$20240911$20240911$PER$$US-SA-2024SA261528$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240911$$CN$US$US
243065341$24306534$1$I$20240820$20240903$20240911$20240911$PER$$US-SA-2024SA261022$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240911$$HP$US$US
243065351$24306535$1$I$20240101$20240902$20240911$20240911$PER$$US-SA-2024SA262113$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240911$$HP$US$US
243065362$24306536$2$F$20240101$20240904$20240911$20240918$PER$$US-SA-2024SA260947$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240918$$HP$US$US
243065371$24306537$1$I$20240726$20240905$20240911$20240911$EXP$$DE-JNJFOC-20240919548$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240911$$MD$DE$DE
243065391$24306539$1$I$20240806$20240812$20240911$20240911$PER$$US-CELLTRION INC.-2024US018687$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243065401$24306540$1$I$$20240902$20240911$20240911$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08348$HIKMA$$83$YR$$F$Y$87$KG$20240911$$HP$CA$CA
243065411$24306541$1$I$$20240829$20240911$20240911$EXP$$IN-AMNEAL PHARMACEUTICALS-2024-AMRX-03271$AMNEAL$Ancilla LC, Sundaram B, Pathak N, Raj A.. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy. J Nephropharmacol.. 2024;13(2):e11681$$$$$Y$$$20240911$$HP$IN$IN
243065421$24306542$1$I$$20240902$20240911$20240911$EXP$$GB-AUROBINDO-AUR-APL-2024-043951$AUROBINDO$$56$YR$$F$Y$68$KG$20240911$$PH$GB$GB
243065431$24306543$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00739$GLAND PHARMA$Daqi Li.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Hematology.JAN-2023;40:284-285$75$YR$E$F$Y$$$20240911$$MD$CN$CN
243065441$24306544$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005562$ELI LILLY AND CO$$$$$$Y$$$20240911$$CN$US$US
243065451$24306545$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005593$ELI LILLY AND CO$$70$YR$E$$Y$$$20240911$$CN$US$US
243065461$24306546$1$I$20240904$20240904$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004160$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243065471$24306547$1$I$20240906$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005715$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240911$$CN$US$US
243065481$24306548$1$I$20240905$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005654$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240911$$CN$US$US
243065491$24306549$1$I$$20240902$20240911$20240911$EXP$$DK-STRIDES ARCOLAB LIMITED-2024SP011484$STRIDES$Plaehn G, Fuglsang T, Hindersson P, Breindahl T.. Adverse effects from counterfeit and mislabeled medicine containing tapentadol and carisoprodol.. Clin-Case-Rep. 2024;12 (8):1-6$16$YR$$$Y$$$20240911$$HP$DK$DK
243065501$24306550$1$I$$20240906$20240911$20240911$30DAY$$FR-SANDOZ INC.-SDZ2024FR078869$SANDOZ$$$$$F$Y$$$20240911$$CN$FR$FR
243065511$24306551$1$I$$20240909$20240911$20240911$EXP$$US-TAKEDA-2024TUS089960$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
243065521$24306552$1$I$$20240904$20240911$20240911$30DAY$$US-GSK-US2024AMR109908$GLAXOSMITHKLINE$$$$$M$Y$$$20240911$$CN$US$US
243065531$24306553$1$I$20220101$20240909$20240911$20240911$PER$$US-ROCHE-10000077889$ROCHE$$17$YR$T$F$Y$65.77$KG$20240911$$CN$US$US
243065541$24306554$1$I$$20240903$20240911$20240911$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011403$STRIDES$Jiang W, Xu Y, Fu Z, Hu M, Wu Q, Ji Y, et al.. Genetic analysis and functional study of a novel ABCG5 mutation in sitosterolemia with hematologic disease.. Gene. 2023;879:1-8$3$DEC$$F$Y$$$20240911$$HP$CN$CN
243065551$24306555$1$I$$20240826$20240911$20240911$PER$$US-ALVOTECHPMS-2024-ALVOTECHPMS-002180$Alvotech$$12$YR$$F$Y$$$20240911$$CN$US$
243065561$24306556$1$I$$20240909$20240911$20240911$PER$$NVSC2024US181125$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243065571$24306557$1$I$$20240909$20240911$20240911$EXP$$DE-SANDOZ INC.-PHHY2019DE051660$SANDOZ$$4$DEC$$F$Y$$$20240911$$MD$DE$DE
243065581$24306558$1$I$$20240903$20240911$20240911$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP011410$STRIDES$De Zen L, Divisic A, Molinaro G, Solidoro S, Barbi E.. Dexmedetomidine at Home for Intractable Dystonia and Insomnia in Children With Special Needs: A Case Series.. J-Pain-Symptom-Manage. 2023;66 (6):e653-e657.$$$$F$Y$$$20240911$$HP$IT$IT
243065591$24306559$1$I$20240801$20240827$20240911$20240911$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467755$RANBAXY$$77$YR$$M$Y$$$20240911$$HP$GB$GB
243065601$24306560$1$I$$20240909$20240911$20240911$EXP$$NVSJ2024JP010721$NOVARTIS$$$$$$Y$$$20240911$$MD$JP$JP
243065611$24306561$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181934$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243065621$24306562$1$I$$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-085636-2024$RECKITT BENCKISER$$$$$M$Y$$$20240911$$CN$US$US
243065631$24306563$1$I$20201025$20240906$20240911$20240911$EXP$PL-URPL-1-3236-2020$PL-MYLANLABS-2024M1081944$MYLAN$$44$YR$$M$Y$$$20240911$$MD$PL$PL
243065643$24306564$3$F$20201101$20240906$20240911$20240926$EXP$$FI-MYLANLABS-2024M1082526$MYLAN$$26$YR$$M$Y$$$20240926$$CN$FI$FI
243065661$24306566$1$I$$20240906$20240911$20240911$EXP$DE-BFARM-24006127$DE-MYLANLABS-2024M1081950$MYLAN$$$$A$M$Y$$$20240911$$MD$DE$DE
243065681$24306568$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62287$$FDA-CTU$$68$YR$$F$N$$$20240910$N$$US$
243065691$24306569$1$I$$20240909$20240911$20240911$EXP$$DE-SANDOZ INC.-NVSC2021DE315861$SANDOZ$$77$YR$$F$Y$$$20240911$$HP$DE$DE
243065711$24306571$1$I$$20240905$20240911$20240911$PER$$US-ALXN-202409USA000391US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243065721$24306572$1$I$$20240903$20240911$20240911$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP011412$STRIDES$De Zen L, Divisic A, Molinaro G, Solidoro S, Barbi E.. Dexmedetomidine at Home for Intractable Dystonia and Insomnia in Children With Special Needs: A Case Series.. J-Pain-Symptom-Manage. 2023;66 (6):e653-e657.$$$$F$Y$$$20240911$$HP$IT$IT
243065731$24306573$1$I$$20240904$20240911$20240911$PER$$US-AMGEN-USASP2024177090$AMGEN$$$$A$F$Y$$$20240911$$PH$US$US
243065741$24306574$1$I$$20240903$20240911$20240911$EXP$$PK-STRIDES ARCOLAB LIMITED-2024SP011464$STRIDES$Rizwanullah, Khan M, Bassi R, Hamad SB, Eisa R, Patel H.. CHRONIC PROTON PUMP INHIBITOR USE LEADING TO REFRACTORY HYPOMAGNESAEMIA IN A PATIENT WITH RHEUMATOID ARTHRITIS: A CASE REPORT.. J-Populat-Therap-Clin-Pharmacol. 2024;31 (8):160-163$31$YR$$F$Y$$$20240911$$HP$PK$PK
243065761$24306576$1$I$20180730$20240905$20240911$20240911$EXP$$CA-TAKEDA-CA202034279$TAKEDA$$62$YR$$F$Y$$$20240911$$CN$CA$CA
243065771$24306577$1$I$$20240730$20240911$20240911$PER$$US-LUNDBECK-DKLU4002350$LUNDBECK$$$$$$Y$$$20240911$$HP$US$US
243065781$24306578$1$I$$20240905$20240911$20240911$EXP$$US-MYLANLABS-2024M1082753$MYLAN$$$$$M$Y$$$20240911$$CN$US$US
243065791$24306579$1$I$$20240902$20240911$20240911$EXP$$NVSC2024CN178711$NOVARTIS$Zhang Q, Hui Y, Yuan F, Ma Y, Dong M, Kong Q. Baricitinib successfully treat pyoderma gangrenosum: a case report. THE CHINESE JOURNAL OF DERMATOVENEREOLOGY. 2024$59$YR$$F$Y$$$20240911$$HP$CN$CN
243065801$24306580$1$I$$20240904$20240911$20240911$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000773$DECIPHERA PHARMACEUTICALS$$74$YR$E$F$Y$$$20240911$$CN$US$US
243065811$24306581$1$I$20240828$20240828$20240911$20240911$PER$$US-SA-2024SA261183$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240911$$CN$US$US
243065821$24306582$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA262146$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240911$$HP$US$US
243065831$24306583$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00736$GLAND PHARMA$Daqi Li.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Hematology.JAN-2023;40:284-285$61$YR$A$F$Y$$$20240911$$MD$CN$CN
243065841$24306584$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA253665$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240911$$HP$US$US
243065851$24306585$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA259952$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240911$$CN$US$US
243065862$24306586$2$F$20230401$20240923$20240911$20240927$EXP$IT-MINISAL02-1001153$IT-ORGANON-O2409ITA000609$ORGANON$$35$YR$$F$Y$89$KG$20240927$$CN$IT$IT
243065871$24306587$1$I$20130201$20240827$20240911$20240911$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467712$RANBAXY$$41$YR$$M$Y$92$KG$20240911$$CN$GB$GB
243065881$24306588$1$I$20230322$20240904$20240911$20240911$EXP$$US-CHIESI-2024CHF05806$CHIESI$$45$YR$$F$Y$85$KG$20240911$$CN$US$US
243065891$24306589$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240701$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$E$$Y$$$20240911$$HP$US$US
243065901$24306590$1$I$$20240903$20240911$20240911$EXP$$EG-AMGEN-EGYSP2024179278$AMGEN$$51$YR$A$F$Y$$$20240911$$CN$EG$EG
243065911$24306591$1$I$$20240903$20240911$20240911$EXP$$ZA-STRIDES ARCOLAB LIMITED-2024SP011474$STRIDES$Soni AJ, Rugbeer Y, Rozmiarek J, Manesh A, Marais S.. Tumor necrosis factor-alpha antagonists in patients with complicated spinal tuberculosis: A case series and literature review. Infect-Dis-Now. 2024;54 (6)$41$YR$$M$Y$$$20240911$$HP$ZA$ZA
243065931$24306593$1$I$$20240905$20240911$20240911$EXP$$GB-MYLANLABS-2024M1082256$MYLAN$$$$$M$Y$$$20240911$$CN$GB$GB
243065941$24306594$1$I$$20240906$20240911$20240911$PER$$US-AstraZeneca-2024A204580$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
243065951$24306595$1$I$$20240909$20240911$20240911$EXP$$NVSC2024AU180678$NOVARTIS$$$$$$Y$$$20240911$$MD$AU$AU
243065961$24306596$1$I$20240711$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62252$$FDA-CTU$$32$YR$$F$N$$$20240910$N$$US$
243065981$24306598$1$I$$20240903$20240911$20240911$PER$$US-ABBVIE-5906045$ABBVIE$$$$$F$Y$$$20240911$$HP$US$US
243065991$24306599$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62245$$FDA-CTU$$20$YR$$F$N$105$LBS$20240910$N$$US$
243066001$24306600$1$I$$20240830$20240911$20240911$EXP$$JP-ROCHE-10000073342$ROCHE$$8$DEC$E$M$Y$$$20240911$$PH$JP$JP
243066011$24306601$1$I$20240101$20240304$20240911$20240911$PER$$US-Lavipharm SA-2161470$LAVIPHARM$$$$$M$Y$$$20240911$$$US$US
243066021$24306602$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00733$GLAND PHARMA$Daqi Li.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Hematology.JAN-2023;40:284-285$62$YR$A$F$Y$$$20240911$$MD$CN$CN
243066031$24306603$1$I$$20240902$20240911$20240911$EXP$$US-MSNLABS-2024MSNLIT01921$MSN LABORATORIES$Bajwa NA, Bajwa AA, Ghazala S, Masood U.Dimethyl Fumarate-Associated Enterocolitis.American Journal of Therapeutics.2024;31(4):e448-e450$$$$$Y$$$20240911$$MD$US$US
243066041$24306604$1$I$$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62268$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243066052$24306605$2$F$20240101$20240916$20240911$20240925$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000770$DECIPHERA PHARMACEUTICALS$$61$YR$A$F$Y$172.7$KG$20240925$$CN$US$US
243066062$24306606$2$F$$20240923$20240911$20240924$PER$$US-BIOVITRUM-2024-US-011129$BIOVITRUM$$71$YR$$M$Y$$$20240924$$CN$US$US
243066071$24306607$1$I$20240816$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62278$$FDA-CTU$$80$YR$$M$N$$$20240910$N$PH$US$
243066092$24306609$2$F$20240101$20240912$20240911$20240917$PER$$US-ABBVIE-5913959$ABBVIE$$$$$F$Y$68.038$KG$20240917$$CN$US$US
243066101$24306610$1$I$20240905$20240905$20240911$20240911$PER$$US-JNJFOC-20240916497$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240911$$CN$US$US
243066111$24306611$1$I$20240801$20240830$20240911$20240911$PER$$US-MYLANLABS-2024M1082708$MYLAN$$$$$F$Y$$$20240911$$CN$US$US
243066121$24306612$1$I$$20240905$20240911$20240911$EXP$$CA-ROCHE-10000075422$ROCHE$$8$YR$C$M$Y$$$20240911$$HP$CA$CA
243066131$24306613$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180342$AMGEN$$$$A$$Y$$$20240911$$MD$US$US
243066141$24306614$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA260510$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240911$$MD$US$US
243066151$24306615$1$I$$20240902$20240911$20240911$PER$$US-SA-2024SA261560$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240911$$HP$US$US
243066161$24306616$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA255970$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240911$$MD$US$US
243066171$24306617$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240702$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$E$$Y$$$20240911$$HP$US$US
243066181$24306618$1$I$$20240829$20240911$20240911$EXP$$US-ADVANZ PHARMA-202408007148$ADVANZ PHARMA$$$$$$Y$$$20240911$$MD$US$US
243066202$24306620$2$F$$20240917$20240911$20240920$EXP$$CZ-SANDOZ INC.-SDZ2024CZ079082$SANDOZ$$52$YR$$M$Y$$$20240920$$HP$CZ$CZ
243066211$24306621$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00737$GLAND PHARMA$Daqi Li.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Hematology.JAN-2023;40:284-285$76$YR$E$F$Y$$$20240911$$MD$CN$CN
243066222$24306622$2$F$$20240912$20240911$20240915$PER$$US-ALXN-202409USA000518US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243066231$24306623$1$I$$20240906$20240911$20240911$PER$$US-ALXN-202409USA000407US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243066241$24306624$1$I$20240524$20240830$20240911$20240911$EXP$ES-AEMPS-1563598$ES-Accord-444674$ACCORD$$86$YR$E$F$Y$$$20240911$$PH$ES$ES
243066251$24306625$1$I$$20240904$20240911$20240911$EXP$$US-GSK-US2024AMR110609$GLAXOSMITHKLINE$$$$$F$Y$$$20240911$$CN$US$US
243066261$24306626$1$I$$20240905$20240911$20240911$30DAY$$US-GSK-US2024110688$GLAXOSMITHKLINE$$$$$M$Y$$$20240911$$CN$US$US
243066271$24306627$1$I$$20240909$20240911$20240911$PER$$US-HALEON-2196102$Haleon PLC$$15$MON$$F$Y$$$20240911$$HP$US$US
243066281$24306628$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62244$$FDA-CTU$$79$YR$$F$N$$$20240910$N$$US$
243066291$24306629$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62242$$FDA-CTU$$50$YR$$F$N$213$LBS$20240910$N$HP$US$
243066301$24306630$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62249$$FDA-CTU$$81$YR$$F$N$$$20240910$N$$US$
243066311$24306631$1$I$20240201$20240828$20240911$20240911$PER$$US-ABBVIE-5915947$ABBVIE$$41$YR$$$Y$$$20240911$$CN$US$US
243066321$24306632$1$I$$20240909$20240911$20240911$PER$$US-ROCHE-10000078085$ROCHE$$4$YR$C$M$Y$$$20240911$$CN$US$US
243066331$24306633$1$I$$20240903$20240911$20240911$EXP$$NL-CELLTRION INC.-2022NL005956$CELLTRION$Ottevanger R, Melchers RC, Quint KD. Remittance of primary cutaneous CD30+ lymphoproliferative disorder in a patient on adalimumab.. JAAD Case Reports. 2022;22:34-37$$$$$Y$$$20240911$$MD$NL$NL
243066341$24306634$1$I$$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-081376-2024$RECKITT BENCKISER$$$$$$Y$$$20240911$$CN$US$US
243066351$24306635$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006509$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240911$$CN$US$US
243066361$24306636$1$I$20240821$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005809$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240911$$CN$US$US
243066371$24306637$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62275$$FDA-CTU$$13$YR$$F$N$170$LBS$20240910$N$CN$US$
243066381$24306638$1$I$20150216$20240830$20240911$20240911$EXP$$CZ-Accord-445169$ACCORD$Z Donatova. Uplatneni eribulinu a vinorelbinu v lecbe karcinomu prsu - dve kazuistiky (The use of eribulin and vinorelbin in treating breast cancer - two case studies). ONKOLOGICKA REVUE. 2019;6(6):78-80.$66$YR$E$F$Y$$$20240911$$HP$CZ$CZ
243066401$24306640$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006228$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240911$$CN$US$US
243066411$24306641$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62270$$FDA-CTU$$61$YR$$F$N$$$20240910$N$$US$
243066421$24306642$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62293$$FDA-CTU$$55$YR$$F$N$$$20240910$N$$US$
243066431$24306643$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62257$$FDA-CTU$$21$YR$$M$N$$$20240910$N$$US$
243066442$24306644$2$F$$20240910$20240911$20240914$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014603$JAZZ$$$$$M$Y$$$20240914$$HP$US$US
243066452$24306645$2$F$20240822$20240911$20240911$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143665$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240919$$MD$JP$JP
243066461$24306646$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144261$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240911$$CN$US$US
243066471$24306647$1$I$20240901$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143255$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240911$$HP$US$US
243066481$24306648$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143908$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240911$$HP$US$US
243066491$24306649$1$I$20240904$20240906$20240911$20240911$EXP$GB-MHRA-MED-202409042021491910-PKMHL$GB-STRIDES ARCOLAB LIMITED-2024SP011473$STRIDES$$16$YR$$F$Y$50$KG$20240911$$CN$GB$GB
243066501$24306650$1$I$$20240904$20240911$20240911$EXP$$US-LUNDBECK-DKLU4004062$LUNDBECK$$$$$$Y$$$20240911$$CN$US$US
243066511$24306651$1$I$$20240904$20240911$20240911$EXP$$US-MYLANLABS-2024M1082501$MYLAN$Akhdar G. MM-388 Navigating the Nexus: Lenalidomide-Associated Thrombotic Thrombocytopenic Purpura (TTP). Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl.) S555.$56$YR$$M$Y$$$20240911$$MD$US$US
243066521$24306652$1$I$$20240904$20240911$20240911$EXP$$US-MYLANLABS-2024M1082525$MYLAN$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B, et al. AML-713 Hematological Malignancies and Pregnancy: A Single-Institution Experience. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl. 1) S333-S334.$$$$F$Y$$$20240911$$MD$US$US
243066531$24306653$1$I$$20240905$20240911$20240911$EXP$$DE-MYLANLABS-2024M1081760$MYLAN$$$$$M$Y$$$20240911$$CN$DE$DE
243066541$24306654$1$I$20240807$20240905$20240911$20240911$EXP$IT-MINISAL02-1000963$IT-MYLANLABS-2024M1081726$MYLAN$$14$YR$$M$Y$$$20240911$$PH$IT$IT
243066551$24306655$1$I$$20240904$20240911$20240911$EXP$$ES-MYLANLABS-2024M1082345$MYLAN$Ortega JAC, Gonzalez CA, Royon DA, Zumaquero VU, Cuberos EC. Dermatomyositis: sometimes immunosuppression may not be sufficient. Eur-J-Case-Rep-Intern-Med 2024; 11 (Suppl.) 1063 abstr. 2428.$73$YR$$F$Y$$$20240911$$HP$ES$ES
243066561$24306656$1$I$$20240904$20240911$20240911$EXP$$US-MYLANLABS-2024M1082512$MYLAN$Aifuwa E, Kandahari A, Steinberg A. HL-298 Concomitant Methotrexate Withdrawal and Brentuximab Vedotin Therapy for Treatment of Methotrexate Associated Hodgkin Lymphoma. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl. 1) S446-S447.$82$YR$$M$Y$$$20240911$$HP$US$US
243066571$24306657$1$I$$20240904$20240911$20240911$EXP$$US-MYLANLABS-2024M1082363$MYLAN$Khurshid A, Steinberg A. IBCL-483 First Reported Use of Polatuzumab-RCHP in Follicular Lymphoma, With Excellent Response. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl. 1) S499 abstr. IBCL-483.$70$YR$$M$Y$$$20240911$$MD$US$US
243066581$24306658$1$I$$20240904$20240911$20240911$EXP$$ES-MYLANLABS-2024M1082516$MYLAN$Laserna PA, Fajardo MC, De Victoria Carazo JM, Fidel MV, Raquel RF. Don ^t forget the drugs. An atypical case of renopulmonary syndrome in an adult male. Eur-J-Case-Rep-Intern-Med 2024; 11 (Suppl.) 1018.$69$YR$$M$Y$$$20240911$$HP$ES$ES
243066591$24306659$1$I$$20240904$20240911$20240911$EXP$$IN-MYLANLABS-2024M1082504$MYLAN$Kumar NM, Bhargava R, Rastogi N, Yadav C, Swaminathan A, Garg P, et al. ALL-766 Asciminib as a Bridge to Allogenic Transplant in 3 Patients With Relapsed/Refractory Philadelphia Chromosome-positive ALL or CML Lymphoid Blast Crisis Refractory/Intolerant to Ponatinib. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl. 1) S283-S284.$$$$F$Y$$$20240911$$MD$IN$IN
243066601$24306660$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009967$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243066611$24306661$1$I$$20240910$20240911$20240911$EXP$$CA-SANDOZ INC.-SDZ2024CA079202$SANDOZ$$80$YR$$M$Y$82$KG$20240911$$MD$CA$CA
243066621$24306662$1$I$20240101$20240822$20240911$20240911$PER$$US-TEVA-VS-3236275$TEVA$$63$YR$$F$Y$$$20240911$$CN$US$US
243066631$24306663$1$I$20240112$20240907$20240911$20240911$EXP$$US-PFIZER INC-202400251952$PFIZER$$42$YR$$F$Y$$$20240911$$HP$US$US
243066641$24306664$1$I$20240902$20240909$20240911$20240911$EXP$$CN-PFIZER INC-PV202400118226$PFIZER$$50$YR$$F$Y$49$KG$20240911$$HP$CN$CN
243066651$24306665$1$I$20240418$20240906$20240911$20240911$EXP$FR-AFSSAPS-PA2024001076$FR-PFIZER INC-202400251277$PFIZER$$59$YR$$F$Y$57.5$KG$20240911$$MD$FR$FR
243066661$24306666$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00742$GLAND PHARMA$Daqi Li.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Hematology.JAN-2023;40:284-285$72$YR$E$M$Y$$$20240911$$MD$CN$CN
243066671$24306667$1$I$20240805$20240909$20240911$20240911$EXP$IT-MINISAL02-1001327$IT-PFIZER INC-202400252765$PFIZER$$13$YR$$F$Y$60$KG$20240911$$MD$IT$IT
243066692$24306669$2$F$20240619$20240918$20240911$20240919$EXP$IT-MINISAL02-1001311$IT-PFIZER INC-202400252764$PFIZER$$4$YR$$M$Y$17$KG$20240919$$MD$IT$IT
243066701$24306670$1$I$20240101$20240906$20240911$20240911$EXP$$CA-PFIZER INC-202400252916$PFIZER$$77$YR$$M$Y$$$20240911$$MD$CA$CA
243066722$24306672$2$F$20240707$20240917$20240911$20240920$EXP$$JP-PFIZER INC-PV202400118854$PFIZER$$85$YR$$$Y$$$20240920$$PH$JP$JP
243066731$24306673$1$I$$20240907$20240911$20240911$EXP$$US-PFIZER INC-PV202400118075$PFIZER$$$$$$Y$$$20240911$$MD$US$US
243066741$24306674$1$I$20240717$20240905$20240911$20240911$EXP$$VE-PFIZER INC-PV202400117104$PFIZER$$66$YR$$F$Y$$$20240911$$CN$VE$VE
243066751$24306675$1$I$20240827$20240909$20240911$20240911$EXP$GB-MHRA-MED-202409091414208770-DCQFK$GB-PFIZER INC-202400252814$PFIZER$$74$YR$$F$Y$$$20240911$$PH$GB$GB
243066761$24306676$1$I$20240101$20240909$20240911$20240911$EXP$HR-HALMED-300086423$HR-PFIZER INC-202400252376$PFIZER$$31$YR$$M$Y$80$KG$20240911$$MD$HR$HR
243066771$24306677$1$I$20240307$20240906$20240911$20240911$EXP$$CN-PFIZER INC-PV202400117434$PFIZER$$66$YR$$M$Y$84$KG$20240911$$HP$CN$CN
243066781$24306678$1$I$$20240909$20240911$20240911$EXP$$FR-PFIZER INC-202400252539$PFIZER$$84$YR$$M$Y$$$20240911$$MD$FR$FR
243066791$24306679$1$I$20230127$20240909$20240911$20240911$EXP$ES-AEMPS-1512943$ES-PFIZER INC-202400252543$PFIZER$$54$YR$$F$Y$$$20240911$$MD$ES$ES
243066811$24306681$1$I$$20240909$20240911$20240911$EXP$$US-PFIZER INC-202400253442$PFIZER$$79$YR$$F$Y$$$20240911$$CN$US$US
243066821$24306682$1$I$$20240909$20240911$20240911$EXP$$DO-PFIZER INC-202400253738$PFIZER$$66$YR$$M$Y$$$20240911$$CN$DO$DO
243066831$24306683$1$I$20230403$20240909$20240911$20240911$EXP$FR-AFSSAPS-PA2024001511$FR-PFIZER INC-202400252504$PFIZER$$65$YR$$M$Y$65.5$KG$20240911$$MD$FR$FR
243066841$24306684$1$I$20240804$20240906$20240911$20240911$EXP$$CN-PFIZER INC-PV202400117443$PFIZER$$62$YR$$F$Y$60$KG$20240911$$HP$CN$CN
243066851$24306685$1$I$20240831$20240909$20240911$20240911$EXP$$CA-PFIZER INC-PV202400118701$PFIZER$$68$YR$$F$Y$$$20240911$$HP$CA$CA
243066861$24306686$1$I$$20240909$20240911$20240911$EXP$$NO-PFIZER INC-202400252409$PFIZER$$40$YR$$M$Y$$$20240911$$MD$NO$NO
243066871$24306687$1$I$$20240909$20240911$20240911$EXP$$NO-PFIZER INC-202400252365$PFIZER$$40$YR$$M$Y$$$20240911$$MD$NO$NO
243066881$24306688$1$I$$20240906$20240911$20240911$EXP$$DE-PFIZER INC-202400252795$PFIZER$$$$$$Y$$$20240911$$HP$DE$DE
243066902$24306690$2$F$20240826$20240911$20240911$20240926$EXP$$US-ITALFARMACO SPA-2161471$ITALFARMACO$$66$YR$$M$Y$$$20240926$$$US$US
243066911$24306691$1$I$$20240903$20240911$20240911$EXP$$JP-CHEPLA-2024011491$CHEPLAPHARM$$7$DEC$$M$Y$$$20240911$$PH$COUNTRY NOT SPECIFIED$JP
243066921$24306692$1$I$20240812$20240905$20240911$20240911$EXP$FR-AFSSAPS-TS2024000947$FR-MYLANLABS-2024M1081723$MYLAN$$64$YR$$M$Y$$$20240911$$MD$FR$FR
243066931$24306693$1$I$20240725$20240906$20240911$20240911$EXP$$CO-AstraZeneca-2024A205318$ASTRAZENECA$$30992$DY$$M$Y$$$20240911$$CN$CO$
243066941$24306694$1$I$20240821$20240830$20240911$20240911$EXP$IT-MINISAL02-1000062$IT-Accord-445069$ACCORD$$66$YR$E$M$Y$83$KG$20240911$$MD$IT$IT
243066951$24306695$1$I$$20240905$20240911$20240911$EXP$$RO-MYLANLABS-2024M1082677$MYLAN$Rusu CT, Postolea G, Gurghean AL, Fiedler IMS, Homentcovschi CS. What is hiding behind multiple osteolytic lesions?. Eur-J-Case-Rep-Intern-Med 2024; 11 (Suppl. 1) 704 abstr. 0779.$73$YR$$M$Y$$$20240911$$HP$RO$RO
243066961$24306696$1$I$$20240903$20240911$20240911$EXP$$NVSJ2024JP010521$NOVARTIS$$$$$$Y$$$20240911$$MD$JP$JP
243066971$24306697$1$I$20231201$20240909$20240911$20240911$EXP$$US-PFIZER INC-PV202400029966$PFIZER$$80$YR$$F$Y$$$20240911$$MD$US$US
243066991$24306699$1$I$20240101$20240909$20240911$20240911$EXP$$DE-PFIZER INC-202400252454$PFIZER$$51$YR$$M$Y$$$20240911$$CN$DE$DE
243067001$24306700$1$I$$20240909$20240911$20240911$EXP$$DE-PFIZER INC-202400252467$PFIZER$$$$$$Y$$$20240911$$CN$DE$DE
243067011$24306701$1$I$20240601$20240909$20240911$20240911$EXP$FR-AFSSAPS-AN2024001209$FR-PFIZER INC-202400252502$PFIZER$$34$YR$$F$Y$88$KG$20240911$$MD$FR$FR
243067021$24306702$1$I$20240823$20240909$20240911$20240911$EXP$$CN-PFIZER INC-PV202400118185$PFIZER$$61$YR$$F$Y$64$KG$20240911$$HP$CN$CN
243067031$24306703$1$I$$20240909$20240911$20240911$EXP$$DO-PFIZER INC-202400252917$PFIZER$$66$YR$$M$Y$$$20240911$$CN$DO$DO
243067041$24306704$1$I$20240314$20240909$20240911$20240911$EXP$GB-MHRA-MED-202409090625485510-WKVZJ$GB-PFIZER INC-202400252200$PFIZER$$42$YR$$F$Y$$$20240911$$HP$GB$GB
243067061$24306706$1$I$20240826$20240909$20240911$20240911$EXP$FR-AFSSAPS-AM2024000720$FR-PFIZER INC-202400252495$PFIZER$$62$YR$$M$Y$$$20240911$$MD$FR$FR
243067072$24306707$2$F$20240816$20240912$20240911$20240913$EXP$$CN-PFIZER INC-PV202400118221$PFIZER$$45$YR$$M$Y$55$KG$20240913$$HP$CN$CN
243067082$24306708$2$F$20240906$20240916$20240911$20240917$PER$$US-AMGEN-USASP2024180077$AMGEN$$76$YR$E$F$Y$$$20240917$$CN$US$US
243067091$24306709$1$I$$20240718$20240911$20240911$PER$$US-CELLTRION INC.-2024US017909$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243067101$24306710$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144188$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240911$$HP$US$US
243067111$24306711$1$I$$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-080944-2024$RECKITT BENCKISER$$$$$F$Y$$$20240911$$CN$US$US
243067121$24306712$1$I$$20240823$20240911$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08542$LUPIN$$$$$$Y$$$20240911$$CN$US$US
243067131$24306713$1$I$$20240910$20240911$20240911$PER$$US-HALEON-2196296$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243067141$24306714$1$I$$20240906$20240911$20240911$EXP$$CA-SANDOZ INC.-SDZ2024CA079107$SANDOZ$$$$$M$Y$$$20240911$$MD$CA$CA
243067151$24306715$1$I$20240322$20240909$20240911$20240911$EXP$$FR-SANDOZ INC.-SDZ2024FR078686$SANDOZ$$84$YR$$M$Y$70$KG$20240911$$MD$FR$FR
243067161$24306716$1$I$20240906$20240907$20240911$20240911$PER$$US-AMGEN-USASP2024179828$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
243067171$24306717$1$I$20240501$20240822$20240911$20240911$EXP$$US-SA-2024SA260960$SANOFI AVENTIS$$30$YR$A$F$Y$118.6$KG$20240911$$MD$US$US
243067182$24306718$2$F$20221231$20240913$20240911$20240913$EXP$$IT-PFIZER INC-202400252477$PFIZER$$17$YR$$F$Y$71$KG$20240913$$MD$IT$IT
243067191$24306719$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62284$$FDA-CTU$$69$YR$$F$N$$$20240910$N$$US$
243067201$24306720$1$I$$20240905$20240911$20240911$PER$$US-ABBVIE-5914870$ABBVIE$$$$$F$Y$$$20240911$$MD$US$US
243067211$24306721$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62262$$FDA-CTU$$65$YR$$F$N$$$20240910$N$$US$
243067221$24306722$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62246$$FDA-CTU$$42$YR$$M$N$$$20240910$N$$US$
243067231$24306723$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62290$$FDA-CTU$$91$YR$$F$N$$$20240910$N$$US$
243067241$24306724$1$I$20240904$20240909$20240911$20240911$PER$$US-Eisai-EC-2024-174025$EISAI$$72$YR$E$M$Y$$$20240911$$MD$US$US
243067251$24306725$1$I$$20231120$20240911$20240911$EXP$$US-RDY-LIT/USA/23/0187483$DR REDDYS$Vlachou E, Matoso a, McConkey D, Jing Y, Johnson AB, Hahn MN, et al. Enfortumab Vedotin-related Cutaneous Toxicity and Radiographic Response in Patients with Urothelial Cancer: A Single-center Experience and Review of the Literature. European Urology Open Science. 2023;49: 100-03. doi:http://doi.org/10.1016/j.euros.2023.01.002.$81$YR$E$M$Y$$$20240911$$HP$US$US
243067261$24306726$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00734$GLAND PHARMA$Daqi Li.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Hematology.JAN-2023;40:284-285$71$YR$E$F$Y$$$20240911$$MD$CN$CN
243067271$24306727$1$I$20240101$20240828$20240911$20240911$PER$$US-SA-2024SA259577$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240911$$MD$US$US
243067281$24306728$1$I$$20240822$20240911$20240911$PER$$US-SA-2024SA260200$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240911$$MD$US$US
243067291$24306729$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009968$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243067301$24306730$1$I$20210222$20240904$20240911$20240911$EXP$FR-EMA-DD-20240829-7482711-121727$FR-Accord-445380$ACCORD$$45$YR$A$F$Y$85$KG$20240911$$MD$FR$FR
243067311$24306731$1$I$$20240830$20240911$20240911$EXP$$US-Accord-444690$ACCORD$Lopez J, Hua H, Toy BC. A case of herpes simplex virus and cytomegalovirus retinitis coinfection. Retinal Cases and Brief Reports. 2024;18(4):451-4.$64$YR$A$M$Y$$$20240911$$MD$US$US
243067331$24306733$1$I$20240601$20240904$20240911$20240911$EXP$$MX-CHEPLA-2024011494$CHEPLAPHARM$$52$YR$$F$Y$101.19$KG$20240911$$CN$COUNTRY NOT SPECIFIED$MX
243067351$24306735$1$I$$20240830$20240911$20240911$PER$$US-MSNLABS-2024MSNSPO01917$MSN LABORATORIES$$$$$$Y$$$20240911$$PH$US$US
243067361$24306736$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62286$$FDA-CTU$$66$YR$$F$N$$$20240910$N$$US$
243067371$24306737$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62254$$FDA-CTU$$40$YR$$F$N$$$20240910$N$$US$
243067381$24306738$1$I$20211021$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62219$$FDA-CTU$$53$YR$$F$N$110$LBS$20240910$Y$HP$US$
243067391$24306739$1$I$20230101$20240903$20240911$20240911$PER$$US-SA-2024SA261559$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240911$$HP$US$US
243067411$24306741$1$I$20240903$20240903$20240911$20240911$PER$$US-SA-2024SA261986$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240911$$MD$US$US
243067421$24306742$1$I$20240101$20240902$20240911$20240911$PER$$US-SA-2024SA261256$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240911$$MD$US$US
243067431$24306743$1$I$$20240823$20240911$20240911$PER$$US-TEVA-VS-3237655$TEVA$$54$YR$$M$Y$$$20240911$$CN$US$US
243067441$24306744$1$I$$20240902$20240911$20240911$EXP$$NVSC2024CN180247$NOVARTIS$Zhang R, Tang J, He A. Glucocorticoid combined with dupilumab in the treatment of bullous pemphigoid complicated with verruca plana: a case report. CHIN J LEPR SKIN DIS. 2024;40(10):727-9$25$YR$$M$Y$$$20240911$$HP$CN$CN
243067451$24306745$1$I$$20240902$20240911$20240911$EXP$$NVSC2024TH176789$NOVARTIS$$50$YR$$F$Y$$$20240911$$MD$TH$TH
243067461$24306746$1$I$$20240902$20240911$20240911$EXP$$JP-ROCHE-10000076798$ROCHE$Tanaka R, Matsumura S, Fukae S, Nakazawa S, Yamanaka K, Kakuta Y. P3-4 A case in which thrombotic microangiopathy developed after renal transplant and improved with early diagnosis and multidisciplinary therapy. The 39th Japanese Society of Renal Transplantation and Vascular Surgery. 2024;181.$41$YR$A$M$Y$$$20240911$$MD$JP$JP
243067471$24306747$1$I$20240101$20240828$20240911$20240911$EXP$$US-UCBSA-2024044100$UCB$$$$$F$Y$$$20240911$$HP$US$US
243067481$24306748$1$I$20240907$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180476$AMGEN$$52$YR$A$M$Y$$$20240911$$CN$US$US
243067491$24306749$1$I$20240818$20240902$20240911$20240911$EXP$CN-NMPACDR-4304011031269202400358$CN-BAXTER-2024BAX024208$BAXTER$$47$YR$$F$Y$48$KG$20240911$$MD$CN$CN
243067501$24306750$1$I$20240101$20240610$20240911$20240911$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000145$LANNETT$$$$$M$Y$$$20240911$$CN$US$US
243067511$24306751$1$I$$20240904$20240911$20240911$EXP$$US-AMGEN-USASP2024176719$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
243067521$24306752$1$I$$20240906$20240911$20240911$EXP$$PL-SANDOZ INC.-SDZ2024PL078361$SANDOZ$$72$YR$$F$Y$$$20240911$$MD$PL$PL
243067531$24306753$1$I$20240827$20240907$20240911$20240911$EXP$GB-MHRA-MED-202409072133178320-CFMNQ$GB-Accord-445769$ACCORD$$59$YR$A$M$Y$75$KG$20240911$$CN$GB$GB
243067541$24306754$1$I$$20240823$20240911$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08540$LUPIN$$$$$$Y$$$20240911$$CN$US$US
243067551$24306755$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261833$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240911$$HP$US$US
243067561$24306756$1$I$20230101$20240904$20240911$20240911$EXP$$HU-GILEAD-2024-0686392$GILEAD$$51$YR$A$F$Y$$$20240911$$MD$HU$HU
243067571$24306757$1$I$$20240823$20240911$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08549$LUPIN$$$$$$Y$$$20240911$$CN$US$US
243067581$24306758$1$I$$20240902$20240911$20240911$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08373$HIKMA$$$$$$Y$$$20240911$$CN$CA$CA
243067601$24306760$1$I$$20240903$20240911$20240911$EXP$$IN-ASTELLAS-2024-AER-004713$ASTELLAS$Doke P. Unusual presentations of the usual typhoid fever: A case series. Infectious Diseases in Clinical Practice. 2024;32(5): 1-4.$33$YR$A$M$Y$$$20240911$$MD$IN$IN
243067611$24306761$1$I$20221014$20240909$20240911$20240911$EXP$$US-UCBSA-2024046201$UCB$$67$YR$$M$Y$$$20240911$$HP$US$US
243067621$24306762$1$I$$20240828$20240911$20240911$EXP$$MY-STERISCIENCE B.V.-2024-ST-001320$Steriscience PTE$Ding CH, Wahab WA, Saaid MS, Mokhtar MN, Abdullah FA, Azaharuddin I.. Septicaemia due to Vibrio vulnificus: A tropical infection not to be taken lightly. Trop-Biomed. 2024;41(2):157-159$67$YR$$M$Y$$$20240911$$HP$MY$MY
243067631$24306763$1$I$20240528$20240909$20240911$20240911$EXP$DK-DKMA-30738193$DK-ABBVIE-5914433$ABBVIE$$53$YR$$F$Y$$$20240911$$MD$DK$DK
243067642$24306764$2$F$20240101$20240909$20240911$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-027526$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240919$$$US$US
243067651$24306765$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009969$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243067661$24306766$1$I$$20240909$20240911$20240911$EXP$$US-PFIZER INC-PV202400118461$PFIZER$$$$$$Y$$$20240911$$MD$US$US
243067671$24306767$1$I$20240831$20240909$20240911$20240911$EXP$$CN-PFIZER INC-PV202400118182$PFIZER$$28$YR$$F$Y$$$20240911$$HP$CN$CN
243067682$24306768$2$F$20240801$20240919$20240911$20240925$EXP$$US-BAYER-2024A127664$BAYER$$63$YR$A$M$Y$81.633$KG$20240925$$CN$US$US
243067691$24306769$1$I$20230224$20240909$20240911$20240911$EXP$FR-AFSSAPS-PC2024000689$FR-PFIZER INC-202400252527$PFIZER$$28$YR$$F$Y$57$KG$20240911$$PH$FR$FR
243067701$24306770$1$I$$20240909$20240911$20240911$EXP$$DO-PFIZER INC-202400253733$PFIZER$$54$YR$$F$Y$$$20240911$$CN$DO$DO
243067711$24306771$1$I$20240827$20240909$20240911$20240911$EXP$FR-AFSSAPS-AN2024001223$FR-PFIZER INC-202400253613$PFIZER$$58$YR$$M$Y$$$20240911$$MD$FR$FR
243067721$24306772$1$I$$20240909$20240911$20240911$EXP$$NZ-PFIZER INC-202400253225$PFIZER$$8$DEC$$F$Y$$$20240911$$CN$NZ$NZ
243067735$24306773$5$F$20240726$20240920$20240911$20240926$EXP$FR-AFSSAPS-AM2024000712$FR-PFIZER INC-202400252489$PFIZER$$67$YR$$M$Y$125$KG$20240926$$MD$FR$FR
243067741$24306774$1$I$20240101$20240909$20240911$20240911$EXP$$US-PFIZER INC-202400252832$PFIZER$$9$YR$$F$Y$56.7$KG$20240911$$CN$US$US
243067751$24306775$1$I$20240827$20240909$20240911$20240911$EXP$$US-PFIZER INC-202400252877$PFIZER$$62$YR$$F$Y$69.4$KG$20240911$$CN$US$US
243067761$24306776$1$I$$20240909$20240911$20240911$EXP$$ES-PFIZER INC-202400252538$PFIZER$$16$YR$$F$Y$$$20240911$$HP$ES$ES
243067771$24306777$1$I$$20240909$20240911$20240911$EXP$$PH-PFIZER INC-PV202400117931$PFIZER$$79$YR$$F$Y$$$20240911$$CN$PH$PH
243067781$24306778$1$I$20220916$20240909$20240911$20240911$EXP$FR-AFSSAPS-CF20221585$FR-PFIZER INC-202400252405$PFIZER$$57$YR$$F$Y$$$20240911$$PH$FR$FR
243067791$24306779$1$I$$20240909$20240911$20240911$EXP$$DO-PFIZER INC-202400252931$PFIZER$$76$YR$$M$Y$$$20240911$$CN$DO$DO
243067802$24306780$2$F$20240902$20240918$20240911$20240919$EXP$$CN-PFIZER INC-PV202400118181$PFIZER$$7$YR$$F$Y$17$KG$20240919$$HP$CN$CN
243067811$24306781$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143215$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240911$$CN$US$US
243067831$24306783$1$I$20240905$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144552$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240911$$CN$US$US
243067841$24306784$1$I$$20240906$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143529$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240911$$CN$US$US
243067851$24306785$1$I$$20240902$20240911$20240911$EXP$$ES-CELLTRION INC.-2024ES021422$CELLTRION$$$$$$Y$$$20240911$$MD$ES$ES
243067861$24306786$1$I$20240814$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141815$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240911$$PH$US$US
243067871$24306787$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143387$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240911$$MD$US$US
243067881$24306788$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144143$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240911$$CN$US$US
243067892$24306789$2$F$20240907$20240913$20240911$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143490$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240918$$HP$US$US
243067901$24306790$1$I$20240910$20240910$20240910$20240910$DIR$717884$$FDA-CTU$$65$YR$$UNK$N$$$20240910$N$HP$US$
243067911$24306791$1$I$20240910$20240910$20240910$20240910$DIR$717910$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243067921$24306792$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62259$$FDA-CTU$$62$YR$$F$N$$$20240910$N$$US$
243067932$24306793$2$F$20240101$20240905$20240911$20240916$EXP$$JP-ABBVIE-5908153$ABBVIE$$45$YR$$F$Y$$$20240916$$MD$JP$JP
243067941$24306794$1$I$$20240816$20240911$20240911$PER$$US-CELLTRION INC.-2024US017266$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243067951$24306795$1$I$$20240909$20240911$20240911$PER$$US-JNJFOC-20240923697$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243067971$24306797$1$I$$20240830$20240911$20240911$EXP$$US-SA-2024SA003255$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240911$$HP$US$US
243067981$24306798$1$I$20240909$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180408$AMGEN$$45$YR$A$F$Y$$$20240911$$CN$US$US
243067991$24306799$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA260500$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240911$$HP$US$US
243068001$24306800$1$I$20240801$20240903$20240911$20240911$PER$$US-SA-2024SA260439$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240911$$HP$US$US
243068011$24306801$1$I$$20240801$20240911$20240911$PER$$US-ALXN-202408USA002255US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240911$$HP$US$US
243068021$24306802$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3240082$TEVA$$76$YR$$M$Y$$$20240911$$HP$CA$CA
243068031$24306803$1$I$$20240909$20240911$20240911$EXP$$CZ-SANDOZ INC.-SDZ2024CZ078847$SANDOZ$$35$YR$$F$Y$$$20240911$$MD$CZ$CZ
243068051$24306805$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009970$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243068061$24306806$1$I$$20240904$20240911$20240911$EXP$$IT-MYLANLABS-2024M1082236$MYLAN$Fassi E, Amoroso V, Cosentini D, Ferrari V, Lagana M, Berruti A, et al. Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report. Front-Oncol 2024; 14 (0):.$58$YR$$F$Y$$$20240911$$HP$IT$IT
243068071$24306807$1$I$$20240828$20240911$20240911$EXP$$IR-STERISCIENCE B.V.-2024-ST-001295$Steriscience PTE$Movahedi M, Goharian M, Kabiri A, Zamansaraei S.. Comorbidity of mitral valve stenosis with influenza in pregnancy, a case report.. Adv Biomed Res. 2023;12:252$44$YR$$F$Y$80.5$KG$20240911$$HP$IR$IR
243068081$24306808$1$I$20240903$20240904$20240911$20240911$EXP$$US-AstraZeneca-2024A201625$ASTRAZENECA$$17239$DY$$F$Y$$$20240911$$CN$US$
243068091$24306809$1$I$$20240819$20240911$20240911$PER$$US-IMP-2024000665$Harrow Health$$$$$$Y$$$20240911$$MD$US$US
243068101$24306810$1$I$$20240904$20240911$20240911$EXP$$TN-MYLANLABS-2024M1082339$MYLAN$Cherif A, Hamdi MS, Jebri M, El Hadj WB, Azzabi S, Cherif E, et al.Idiopathic multicentric castleman disease co-existing with adult onset still disease: case report. Eur-J-Case-Rep-Intern-Med 2024; 11 (Suppl. 1) 899-900 abstr. 2301.$16$YR$$F$Y$$$20240911$$HP$TN$TN
243068111$24306811$1$I$$20240904$20240911$20240911$EXP$$ES-MYLANLABS-2024M1082344$MYLAN$De Los Reyes Vazquez SM, Gamarro BG, Guerrero PP. Urticarial vasculitis at the onset of systemic lupus erythematosus: specific therapeutic considerations. Eur-J-Case-Rep-Intern-Med 2024; 11 (Suppl.) 1036.$21$YR$$F$Y$$$20240911$$HP$ES$ES
243068121$24306812$1$I$$20240904$20240911$20240911$EXP$$SI-MYLANLABS-2024M1082240$MYLAN$Bezeljak N, Jerman A, Grenc D, Zorman SK. Inadvertent Intoxication with Salbutamol, Treated with Hemodialysis: A Case Report and Brief Review of the Literature. Case-Rep-Nephrol-Dial 2024; 14 (1): 88-96.$69$YR$$M$Y$$$20240911$$HP$SI$SI
243068141$24306814$1$I$$20240828$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202408018383$ELI LILLY AND CO$$$$$$Y$$$20240911$$CN$US$US
243068151$24306815$1$I$20240829$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004628$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240911$$CN$US$US
243068161$24306816$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005588$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240911$$MD$US$US
243068171$24306817$1$I$$20240828$20240911$20240911$EXP$$IR-STERISCIENCE B.V.-2024-ST-001296$Steriscience PTE$Movahedi M, Goharian M, Kabiri A, Zamansaraei S.. Comorbidity of mitral valve stenosis with influenza in pregnancy, a case report.. Adv Biomed Res. 2023;12:252$$$$F$Y$$$20240911$$HP$IR$IR
243068181$24306818$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006565$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243068192$24306819$2$F$$20240920$20240911$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409005895$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240924$$CN$US$US
243068201$24306820$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006340$ELI LILLY AND CO$$45$YR$A$$Y$$$20240911$$CN$US$US
243068211$24306821$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005645$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240911$$CN$US$US
243068221$24306822$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240703$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240911$$HP$US$US
243068231$24306823$1$I$$20240806$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-124661$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240911$$CN$US$US
243068251$24306825$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181460$NOVARTIS$$$$$M$Y$$$20240911$$CN$US$US
243068271$24306827$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005591$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240911$$CN$US$US
243068281$24306828$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004382$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240911$$CN$US$US
243068291$24306829$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005611$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240911$$CN$US$US
243068301$24306830$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005230$ELI LILLY AND CO$$$$$M$Y$$$20240911$$CN$US$US
243068311$24306831$1$I$20240907$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005718$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240911$$CN$US$US
243068321$24306832$1$I$$20240908$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005540$ELI LILLY AND CO$$$$$F$Y$$$20240911$$PH$US$US
243068331$24306833$1$I$20240906$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005271$ELI LILLY AND CO$$$$$$Y$$$20240911$$CN$US$US
243068341$24306834$1$I$$20240907$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005754$ELI LILLY AND CO$$$$A$M$Y$$$20240911$$CN$US$US
243068351$24306835$1$I$$20240828$20240911$20240911$EXP$$US-STERISCIENCE B.V.-2024-ST-001299$Steriscience PTE$Louie NK, Champagne B. Diverticular Abscess Complicating Pregnancy at 18 Weeks^ Gestation in a 30-Year-Old Female: A Case Report.. Cureus. 2023;15(12):e50590$30$YR$$F$Y$$$20240911$$HP$US$US
243068361$24306836$1$I$20240703$20240801$20240911$20240911$PER$$US-CELLTRION INC.-2024US017280$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243068371$24306837$1$I$20230501$20240827$20240911$20240911$EXP$$BE-JNJFOC-20230819953$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$48.2$KG$20240911$$MD$BE$BE
243068382$24306838$2$F$20240830$20240905$20240911$20240912$EXP$$CN-JNJFOC-20240920256$JOHNSON AND JOHNSON$$$$I$F$Y$0.79$KG$20240912$$HP$CN$CN
243068391$24306839$1$I$20240910$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62267$$FDA-CTU$$72$YR$$F$N$$$20240910$Y$PH$US$
243068411$24306841$1$I$$20240910$20240910$20240910$DIR$717931$$FDA-CTU$$$$$F$N$94.5$KG$20240910$N$CN$US$
243068421$24306842$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62263$$FDA-CTU$$74$YR$$F$N$$$20240910$N$CN$US$
243068431$24306843$1$I$$20240902$20240911$20240911$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08343$HIKMA$$$$$$Y$$$20240911$$CN$CA$CA
243068441$24306844$1$I$$20240902$20240911$20240911$EXP$$JP-009507513-2409JPN000388J$MERCK$$67$YR$$$Y$$$20240911$$MD$JP$JP
243068451$24306845$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00740$GLAND PHARMA$Daqi Li.Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma.Turkish Journal of Hematology.JAN-2023;40:284-285$69$YR$E$F$Y$$$20240911$$MD$CN$CN
243068461$24306846$1$I$20220201$20240903$20240911$20240911$EXP$DE-002147023-NVSC2022DE283991$DE-TORRENT-00027283$TORRENT$$$$A$F$Y$$$20240911$$MD$DE$DE
243068471$24306847$1$I$20240901$20240902$20240911$20240911$EXP$GB-MHRA-MED-202409021438380780-JMKWT$GB-TORRENT-00037815$TORRENT$$$$$$Y$$$20240911$$PH$GB$GB
243068481$24306848$1$I$$20240903$20240911$20240911$EXP$GB-MHRA-MED-202409030938406780-SWYZQ$GB-TORRENT-00037829$TORRENT$$50$YR$A$F$Y$59$KG$20240911$$CN$GB$GB
243068491$24306849$1$I$20240824$20240902$20240911$20240911$EXP$GB-MHRA-MED-202409021420190550-KJMHY$GB-TORRENT-00037813$TORRENT$$66$YR$E$F$Y$$$20240911$$PH$GB$GB
243068501$24306850$1$I$20240712$20240802$20240911$20240911$PER$$US-CELLTRION INC.-2024US017352$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243068511$24306851$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009971$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243068522$24306852$2$F$20230101$20240917$20240911$20240926$EXP$$CA-CELLTRION INC.-2023CA019945$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243068531$24306853$1$I$$20240909$20240911$20240911$PER$$NVSC2024US181003$NOVARTIS$$$$$$Y$$$20240911$$CN$US$US
243068551$24306855$1$I$$20240823$20240911$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08578$LUPIN$$$$$$Y$$$20240911$$PH$US$US
243068571$24306857$1$I$20240728$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62288$$FDA-CTU$$68$YR$$M$N$$$20240909$N$PH$US$
243068581$24306858$1$I$$20240712$20240911$20240911$PER$$US-CELLTRION INC.-2024US017357$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243068591$24306859$1$I$$20240827$20240911$20240911$PER$$US-ASTELLAS-2024-AER-003522$ASTELLAS$$81$YR$E$M$Y$$$20240911$$CN$US$US
243068601$24306860$1$I$$20240816$20240911$20240911$30DAY$$US-VEROBIOTECH-2024USVEROSPO00212$VERO BIOTECH$$$$$$Y$$$20240911$$HP$US$US
243068612$24306861$2$F$$20240916$20240911$20240923$EXP$$ES-TEVA-VS-3240995$TEVA$Peralt JE, Gonzalez LF, San Roman KG, Astorga Burgo JC, Labarta AA. An acute coronary syndrome in an unusual patient: analysing cisplatin toxicity-a case report and review of the literature. Eur-Heart-J-Case-Rep 2024; 8 (8): ytae365.; Peralt JE, Gonzalez LF, San Roman KG, Astorga Burgo JC, Labarta AA. An acute coronary syndrome in an unusual patient: analysing cisplatin toxicity-a case report and review of the literature. Eur-Heart-J-Case-Rep 2024; 8 (8): ytae365.$23$YR$$M$Y$$$20240923$$HP$ES$ES
243068621$24306862$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144425$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240911$$MD$US$US
243068631$24306863$1$I$$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-109482-2023$RECKITT BENCKISER$$$$$M$Y$$$20240911$$CN$US$US
243068641$24306864$1$I$$20240902$20240911$20240911$EXP$$IN-ROCHE-10000072558$ROCHE$$63$YR$A$F$Y$50$KG$20240911$$CN$IN$IN
243068651$24306865$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180081$AMGEN$$$$$$Y$$$20240911$$HP$US$US
243068661$24306866$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5910686$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243068671$24306867$1$I$$20240828$20240911$20240911$EXP$$US-UCBSA-2024044081$UCB$$$$$F$Y$$$20240911$$HP$US$US
243068691$24306869$1$I$$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62269$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243068701$24306870$1$I$20240906$20240910$20240910$20240910$DIR$717907$$FDA-CTU$$47$YR$$M$N$84.8$KG$20240910$N$PH$US$
243068711$24306871$1$I$20240910$20240910$20240910$20240910$DIR$717908$$FDA-CTU$$59$YR$$M$N$$$20240910$N$CN$US$
243068731$24306873$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62248$$FDA-CTU$$30$YR$$F$N$$$20240910$N$$US$
243068741$24306874$1$I$$20240910$20240910$20240910$DIR$717801$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243068761$24306876$1$I$$20240826$20240911$20240911$PER$$US-JNJFOC-20240867483$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$CN$US$US
243068771$24306877$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240704$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$E$$Y$$$20240911$$HP$US$US
243068781$24306878$1$I$$20240905$20240911$20240911$EXP$$US-EMD Serono-2024048129$EMD SERONO INC$$74$YR$E$F$Y$$$20240911$$CN$US$US
243068791$24306879$1$I$$20240904$20240911$20240911$30DAY$$US-PFIZER INC-PV202400116442$PFIZER$$$$$F$Y$$$20240911$$CN$US$US
243068821$24306882$1$I$$20240827$20240911$20240911$PER$$US-GRANULES-US-2024GRASPO00400$GRANULES INDIA$$$$$$Y$$$20240911$$CN$US$US
243068831$24306883$1$I$20240801$20240910$20240911$20240911$EXP$GB-MHRA-MED-202409101058072820-JZDFG$GB-PFIZER INC-202400253587$PFIZER$$29$YR$$F$Y$64$KG$20240911$$CN$GB$GB
243068841$24306884$1$I$$20240904$20240911$20240911$EXP$$HK-BAYER-2024A123442$BAYER$$$$$F$Y$$$20240911$$MD$HK$HK
243068851$24306885$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009974$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243068861$24306886$1$I$$20240905$20240911$20240911$PER$$US-ABBVIE-5910628$ABBVIE$$$$$$Y$$$20240911$$MD$US$US
243068872$24306887$2$F$20240801$20240920$20240911$20240924$EXP$$SI-PFIZER INC-202400252618$PFIZER$$$$$$Y$$$20240924$$CN$SI$SI
243068881$24306888$1$I$$20240904$20240911$20240911$30DAY$$DE-PFIZER INC-202400251483$PFIZER$$$$$$Y$$$20240911$$HP$DE$DE
243068891$24306889$1$I$20240830$20240905$20240911$20240911$EXP$$FR-GILEAD-2024-0685946$GILEAD$$$$$F$Y$$$20240911$$PH$FR$FR
243068901$24306890$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261568$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240911$$HP$US$US
243068911$24306891$1$I$$20240827$20240911$20240911$PER$$US-COSETTE-CP2024US000232$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243068921$24306892$1$I$20201201$20240909$20240911$20240911$EXP$$NVSC2024PL180107$NOVARTIS$$49$YR$$M$Y$$$20240911$$HP$PL$PL
243068931$24306893$1$I$$20240902$20240911$20240911$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-08332$HIKMA$$69$YR$$F$Y$$$20240911$$HP$CA$CA
243068941$24306894$1$I$20240907$20240910$20240911$20240911$EXP$$AU-MYLANLABS-2024M1082835$MYLAN$$44$YR$$M$Y$$$20240911$$HP$AU$AU
243068952$24306895$2$F$$20240917$20240911$20240920$EXP$$UA-AMGEN-UKRSP2024178043$AMGEN$Lymanets T.. Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240919$$MD$UA$UA
243068961$24306896$1$I$$20240906$20240911$20240911$EXP$$RU-ORGANON-O2409RUS000704$ORGANON$$$$$F$Y$$$20240911$$MD$RU$RU
243068972$24306897$2$F$$20240918$20240911$20240927$EXP$$US-TEVA-VS-3240336$TEVA$Cecchini A, Stephenson E, Sill JM. An Uncommon Cause of Immunosuppression: Fatal Pneumocystis Jiroveci Pneumonia in a Patient With Cushing^s Syndrome. Am-J-Respir-Crit-Care-Med 2023; 207 A1341.; Cecchini A, Stephenson E, Sill JM. An Uncommon Cause of Immunosuppression: Fatal Pneumocystis Jiroveci Pneumonia in a Patient With Cushing^s Syndrome. Am-J-Respir-Crit-Care-Med 2023; 207 A1341.$61$YR$$F$Y$$$20240927$$HP$US$US
243068981$24306898$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179924$AMGEN$$$$$$Y$$$20240911$$CN$US$US
243068992$24306899$2$F$$20240917$20240911$20240920$EXP$$UA-AMGEN-UKRSP2024178166$AMGEN$Lymanets T.. AML-054 Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240919$$MD$UA$UA
243069002$24306900$2$F$$20240917$20240911$20240921$EXP$$UA-AMGEN-UKRSP2024178168$AMGEN$Lymanets T.. Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240920$$MD$UA$UA
243069012$24306901$2$F$$20240917$20240911$20240920$EXP$$UA-AMGEN-UKRSP2024178054$AMGEN$Lymanets T.. Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240919$$MD$UA$UA
243069022$24306902$2$F$$20240917$20240911$20240920$EXP$$UA-AMGEN-UKRSP2024178164$AMGEN$Lymanets T.. AML-054 Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240919$$MD$UA$UA
243069032$24306903$2$F$$20240917$20240911$20240921$EXP$$UA-AMGEN-UKRSP2024178167$AMGEN$Lymanets T.. AML-054 Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240920$$MD$UA$UA
243069042$24306904$2$F$$20240917$20240911$20240920$EXP$$UA-AMGEN-UKRSP2024178421$AMGEN$Lymanets T.. Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240920$$MD$UA$UA
243069052$24306905$2$F$$20240917$20240911$20240921$EXP$$UA-AMGEN-UKRSP2024178162$AMGEN$Lymanets T.. Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240920$$MD$UA$UA
243069062$24306906$2$F$$20240917$20240911$20240920$EXP$$UA-AMGEN-UKRSP2024178163$AMGEN$Lymanets T.. AML-054 Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240919$$MD$UA$UA
243069072$24306907$2$F$$20240917$20240911$20240920$EXP$$UA-AMGEN-UKRSP2024178053$AMGEN$Lymanets T.. Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240919$$MD$UA$UA
243069081$24306908$1$I$20240117$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-083553-2024$RECKITT BENCKISER$$$$$M$Y$72.73$KG$20240911$$CN$US$US
243069101$24306910$1$I$20240901$20240902$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012820$DR REDDYS$$39$YR$A$M$Y$$$20240911$$HP$US$US
243069111$24306911$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62282$$FDA-CTU$$$$$M$N$$$20240910$N$HP$US$
243069121$24306912$1$I$$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62251$$FDA-CTU$$$$$M$N$$$20240909$N$HP$US$
243069141$24306914$1$I$$20240904$20240911$20240911$PER$$US-RDY-SPO/USA/24/0012898$DR REDDYS$$55$YR$A$M$Y$$$20240911$$HP$US$US
243069151$24306915$1$I$$20240905$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0013030$DR REDDYS$$61$YR$A$F$Y$$$20240911$$HP$US$US
243069161$24306916$1$I$20210210$20240830$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009215$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243069171$24306917$1$I$$20240808$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202408005626$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240911$$CN$US$US
243069181$24306918$1$I$20240909$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005874$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240911$$CN$US$US
243069191$24306919$1$I$20240716$20240910$20240910$20240910$DIR$717811$$FDA-CTU$$74$YR$$M$N$$$20240910$N$CN$US$
243069201$24306920$1$I$20240826$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62264$$FDA-CTU$$68$YR$$F$N$$$20240909$N$HP$US$
243069211$24306921$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62253$$FDA-CTU$$35$YR$$F$N$$$20240910$N$$US$
243069221$24306922$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006218$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240911$$CN$US$US
243069231$24306923$1$I$20240909$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005855$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240911$$CN$US$US
243069241$24306924$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005355$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243069251$24306925$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009978$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243069261$24306926$1$I$$20230711$20240911$20240911$EXP$$NVSC2023CN281075$NOVARTIS$$$$$$Y$$$20240911$$CN$CN$CN
243069271$24306927$1$I$20240731$20240910$20240910$20240910$DIR$717815$$FDA-CTU$$54$YR$$M$N$$$20240910$N$CN$US$
243069281$24306928$1$I$20240901$20240910$20240910$20240910$DIR$717818$$FDA-CTU$$$$$F$N$$$20240910$N$CN$US$
243069291$24306929$1$I$20240901$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142976$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240911$$CN$US$US
243069301$24306930$1$I$$20240827$20240911$20240911$PER$$US-COSETTE-CP2024US000233$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243069312$24306931$2$F$$20240906$20240911$20240916$EXP$$NVSC2024AU179291$NOVARTIS$$$$$M$Y$$$20240916$$CN$AU$AU
243069321$24306932$1$I$20240701$20240909$20240911$20240911$EXP$FR-AFSSAPS-LL2024001662$FR-UCBSA-2024046009$UCB$$26$YR$$M$Y$$$20240911$$MD$FR$FR
243069331$24306933$1$I$$20230522$20240911$20240911$EXP$$NVSC2023SE281078$NOVARTIS$$$$$$Y$$$20240911$$MD$SE$SE
243069341$24306934$1$I$20230803$20230803$20240911$20240911$EXP$$NVSC2023CN281067$NOVARTIS$$$$$$Y$$$20240911$$MD$CN$CN
243069361$24306936$1$I$$20230205$20240911$20240911$EXP$$NVSC2023CA026318$NOVARTIS$$$$$M$Y$$$20240911$$CN$CA$CA
243069371$24306937$1$I$$20240830$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009214$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243069381$24306938$1$I$$20230712$20240911$20240911$EXP$$NVSC2022CA253181$NOVARTIS$$78$YR$$M$Y$$$20240911$$CN$CA$CA
243069391$24306939$1$I$20230615$20240904$20240911$20240911$EXP$$US-ABBVIE-5338200$ABBVIE$$61$YR$$M$Y$$$20240911$$CN$US$US
243069401$24306940$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179801$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
243069411$24306941$1$I$$20240904$20240911$20240911$EXP$$CA-ABBVIE-5907057$ABBVIE$$$$A$F$Y$$$20240911$$CN$CA$CA
243069422$24306942$2$F$$20240917$20240911$20240921$EXP$$UA-AMGEN-UKRSP2024178422$AMGEN$Lymanets T.. Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240920$$MD$UA$UA
243069432$24306943$2$F$$20240917$20240911$20240921$EXP$$UA-AMGEN-UKRSP2024178423$AMGEN$Lymanets T.. AML-054 Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240920$$MD$UA$UA
243069441$24306944$1$I$$20240904$20240911$20240911$EXP$$GB-AMGEN-GBRSL2023190038$AMGEN$$70$YR$E$M$Y$$$20240911$$CN$GB$GB
243069461$24306946$1$I$$20240829$20240911$20240911$EXP$$CN-B.Braun Medical Inc.-2161472$B BRAUN$$91$YR$$F$Y$50$KG$20240911$$$CN$CN
243069471$24306947$1$I$$20240906$20240911$20240911$PER$$US-BEH-2024178374$CSL BEHRING$$$$$M$Y$$$20240911$$CN$US$US
243069481$24306948$1$I$20240903$20240906$20240911$20240911$EXP$$IN-ROCHE-10000076247$ROCHE$$42$YR$A$F$Y$$$20240911$$CN$IN$IN
243069491$24306949$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA263006$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240911$$CN$US$US
243069501$24306950$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA262025$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240911$$HP$US$US
243069511$24306951$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261526$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240911$$MD$US$US
243069521$24306952$1$I$20220101$20240828$20240911$20240911$PER$$US-SA-2024SA262923$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240911$$MD$US$US
243069531$24306953$1$I$20240101$20240829$20240911$20240911$PER$$US-SA-2024SA261466$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240911$$HP$US$US
243069541$24306954$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261454$SANOFI AVENTIS$$$$E$F$Y$$$20240911$$MD$US$US
243069551$24306955$1$I$20240605$20240905$20240911$20240911$EXP$$US-BAYER-2024A105492$BAYER$$80$YR$E$F$Y$63.492$KG$20240911$$CN$US$US
243069561$24306956$1$I$20240811$20240903$20240911$20240911$PER$$US-SA-2024SA261813$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240911$$MD$US$US
243069572$24306957$2$F$20240101$20240905$20240911$20240912$EXP$$US-SA-2024SA262796$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240912$$HP$US$US
243069581$24306958$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA261539$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240911$$MD$US$US
243069591$24306959$1$I$20240101$20240909$20240911$20240911$30DAY$$US-SANDOZ INC.-SDZ2024US078574$SANDOZ$$$$$F$Y$47.73$KG$20240911$$CN$US$US
243069601$24306960$1$I$20240101$20240827$20240911$20240911$PER$$US-SA-2024SA262074$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240911$$MD$US$US
243069611$24306961$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA260403$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240911$$HP$US$US
243069621$24306962$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA259692$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240911$$HP$US$US
243069631$24306963$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA260958$SANOFI AVENTIS$$$$A$F$Y$$$20240911$$HP$US$US
243069641$24306964$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62260$$FDA-CTU$$57$YR$$F$N$68.49$KG$20240910$N$$US$
243069651$24306965$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62243$$FDA-CTU$$50$YR$$F$N$$$20240910$N$$US$
243069661$24306966$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62271$$FDA-CTU$$91$YR$$F$N$$$20240910$N$$US$
243069671$24306967$1$I$20240706$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62285$$FDA-CTU$$89$YR$$F$N$$$20240910$N$PH$US$
243069681$24306968$1$I$20240901$20240910$20240910$20240910$DIR$717817$$FDA-CTU$$42$YR$$M$N$$$20240910$N$CN$US$
243069691$24306969$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62289$$FDA-CTU$$78$YR$$F$N$$$20240910$N$$US$
243069701$24306970$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62276$$FDA-CTU$$57$YR$$M$N$$$20240910$N$$US$
243069711$24306971$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62255$$FDA-CTU$$56$YR$$M$N$112.04$KG$20240910$N$$US$
243069721$24306972$1$I$$20240910$20240910$20240910$DIR$717911$$FDA-CTU$$$$$UNK$N$$$20240910$$CN$US$
243069742$24306974$2$F$$20240829$20240911$20240911$EXP$$US-ASTELLAS-2024-AER-003645$ASTELLAS$$$$A$M$Y$$$20240911$$MD$US$US
243069751$24306975$1$I$$20240828$20240911$20240911$EXP$$US-STERISCIENCE B.V.-2024-ST-001300$Steriscience PTE$Louie NK, Champagne B. Diverticular Abscess Complicating Pregnancy at 18 Weeks^ Gestation in a 30-Year-Old Female: A Case Report.. Cureus. 2023;15(12):e50590$$$N$$Y$$$20240911$$HP$US$US
243069761$24306976$1$I$$20240828$20240911$20240911$EXP$$CN-STERISCIENCE B.V.-2024-ST-001317$Steriscience PTE$Liu T, Liu H and Jia Y. Streptococcus suis meningitis in China: a case report. Front. Public Health. 2024;12:1369703$57$YR$$M$Y$$$20240911$$HP$CN$CN
243069771$24306977$1$I$20240909$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180489$AMGEN$$65$YR$E$F$Y$$$20240911$$CN$US$US
243069781$24306978$1$I$20211201$20240830$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009210$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243069791$24306979$1$I$20240901$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024179418$AMGEN$$82$YR$E$M$Y$$$20240911$$CN$US$US
243069801$24306980$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009979$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243069811$24306981$1$I$$20240905$20240911$20240911$PER$$US-TAKEDA-2024TUS089330$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
243069821$24306982$1$I$20240601$20240904$20240911$20240911$EXP$$CN-BEIGENE-BGN-2024-014014$BEIGENE$$$$$$Y$$$20240911$$CN$CN$CN
243069831$24306983$1$I$$20240909$20240911$20240911$EXP$$US-TAKEDA-2024TUS089895$TAKEDA$$$$$M$Y$$$20240911$$CN$US$US
243069841$24306984$1$I$20240725$20240830$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009209$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243069851$24306985$1$I$20240805$20240830$20240911$20240911$EXP$IT-MINISAL02-1000189$IT-Accord-444607$ACCORD$$71$YR$E$F$Y$$$20240911$$MD$IT$IT
243069861$24306986$1$I$20240101$20240905$20240911$20240911$PER$$US-ABBVIE-5910170$ABBVIE$$43$YR$$$Y$$$20240911$$CN$US$US
243069881$24306988$1$I$20240818$20240905$20240911$20240911$EXP$FR-AFSSAPS-AN2024001161$FR-MYLANLABS-2024M1081685$MYLAN$$77$YR$$F$Y$125$KG$20240911$$MD$FR$FR
243069891$24306989$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5915675$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243069901$24306990$1$I$$20240905$20240911$20240911$EXP$GB-MHRA-MIDB-05eb5954-9762-4004-9c3d-bcdfff55175c$GB-RDY-SPO/GBR/24/0013076$DR REDDYS$$71$YR$E$M$Y$$$20240911$$PH$GB$GB
243069911$24306991$1$I$$20240903$20240911$20240911$PER$$US-ABBVIE-5905616$ABBVIE$$$$$$Y$$$20240911$$HP$US$US
243069921$24306992$1$I$20240801$20240829$20240911$20240911$PER$$US-SA-2024SA260993$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240911$$HP$US$US
243069931$24306993$1$I$20240801$20240829$20240911$20240911$PER$$US-SA-2024SA259442$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240911$$MD$US$US
243069941$24306994$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA261034$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240911$$HP$US$US
243069951$24306995$1$I$$20240829$20240911$20240911$30DAY$$CO-SA-2024SA261945$SANOFI AVENTIS$$$$A$$Y$$$20240911$$PH$CO$CO
243069961$24306996$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA259639$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240911$$HP$US$US
243069971$24306997$1$I$20240805$20240822$20240911$20240911$PER$$US-SA-2024SA260610$SANOFI AVENTIS$$63$YR$A$F$Y$62.73$KG$20240911$$MD$US$US
243069981$24306998$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261552$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240911$$HP$US$US
243069991$24306999$1$I$$20240909$20240911$20240911$EXP$$NVSC2024US181261$NOVARTIS$$63$YR$$F$Y$$$20240911$$HP$US$US
243070001$24307000$1$I$$20231129$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-23-000430$BECTON DICKINSON$$$$$M$Y$$$20240911$$CN$US$US
243070012$24307001$2$F$20240905$20240905$20240911$20240912$EXP$$US-CSL-2024-008244$CSL Plasma$$45$YR$$F$Y$$$20240912$$HP$US$US
243070021$24307002$1$I$$20240823$20240911$20240911$PER$$US-TEVA-VS-3238161$TEVA$$$$$$Y$$$20240911$$CN$US$US
243070031$24307003$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009980$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243070041$24307004$1$I$$20240910$20240911$20240911$PER$$US-BAYER-2024A129850$BAYER$$68$YR$E$F$Y$$$20240911$$CN$US$US
243070051$24307005$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62261$$FDA-CTU$$80$YR$$M$N$$$20240910$N$$US$
243070061$24307006$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62265$$FDA-CTU$$37$YR$$F$N$$$20240910$N$$US$
243070071$24307007$1$I$20240713$20240910$20240910$20240910$DIR$717812$$FDA-CTU$$60$YR$$F$N$$$20240910$N$CN$US$
243070081$24307008$1$I$20240501$20240831$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009211$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243070091$24307009$1$I$20240806$20240906$20240910$20240910$DIR$FDA-CDER-CTU-2024-62266$$FDA-CTU$$74$YR$$M$N$$$20240906$N$HP$US$
243070101$24307010$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62250$$FDA-CTU$$$$$M$N$$$20240910$N$HP$US$
243070111$24307011$1$I$$20240903$20240911$20240911$EXP$$AU-MYLANLABS-2024M1082284$MYLAN$Skinner T, Liang S, Sanagapalli S. Budesonide Orodispersible Tablet for the Treatment of Refractory Esophageal Lichen Planus. ACG-Case-Rep-J 2024; 11 (8).$59$YR$$F$Y$$$20240911$$MD$AU$AU
243070121$24307012$1$I$20240906$20240910$20240910$20240910$DIR$717820$$FDA-CTU$$49$YR$$M$N$$$20240910$N$CN$US$
243070131$24307013$1$I$$20240906$20240911$20240911$PER$$US-UNITED THERAPEUTICS-UNT-2024-028161$UNITED THERAPEUTICS$$$$$M$Y$94.331$KG$20240911$$$US$US
243070141$24307014$1$I$20240715$20240904$20240911$20240911$EXP$$CN-BEIGENE-BGN-2024-014016$BEIGENE$$$$$$Y$$$20240911$$HP$CN$CN
243070153$24307015$3$F$$20240927$20240911$20240927$EXP$$CA-BAYER-2024A127889$BAYER$$$$$F$Y$$$20240927$$HP$CA$CA
243070161$24307016$1$I$$20240910$20240911$20240911$PER$$US-BAYER-2024A129683$BAYER$$3$YR$C$F$Y$$$20240911$$CN$US$US
243070171$24307017$1$I$20240905$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143846$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240911$$PH$US$US
243070181$24307018$1$I$$20240909$20240911$20240911$EXP$$US-INCYTE CORPORATION-2024IN009565$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243070191$24307019$1$I$20240802$20240904$20240911$20240911$PER$$US-ABBVIE-5909552$ABBVIE$$21$YR$$F$Y$$$20240911$$MD$US$US
243070201$24307020$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240705$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$$$Y$$$20240911$$HP$US$US
243070211$24307021$1$I$20240904$20240905$20240911$20240911$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-027893$UNITED THERAPEUTICS$$48$YR$$F$Y$$$20240911$$$CA$CA
243070221$24307022$1$I$$20240902$20240911$20240911$EXP$$JP-ROCHE-10000069355$ROCHE$Okamoto K, Hijioka S, Nagashio Y, Okada M, Ohba A, Maruki Y, et al. Immune-related adverse event-associated sclerosing cholangitis due to immune checkpoint inhibitors: imaging findings and treatments. Japanese Journal of Clinical Oncology. 2024-Aug-01;54 (8):887-94. doi:10.1093/jjco/hyae060.$60$YR$A$M$Y$$$20240911$$HP$JP$JP
243070231$24307023$1$I$20240701$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143847$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$87.09$KG$20240911$$CN$US$US
243070241$24307024$1$I$20240812$20240910$20240911$20240911$EXP$$US-INCYTE CORPORATION-2024IN009554$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243070251$24307025$1$I$$20240909$20240911$20240911$PER$$US-BAYER-2024A129315$BAYER$$75$YR$E$F$Y$$$20240911$$HP$US$US
243070261$24307026$1$I$20240701$20240822$20240911$20240911$PER$$US-SA-2024SA259820$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240911$$HP$US$US
243070271$24307027$1$I$20210101$20240829$20240911$20240911$PER$$US-SA-2024SA260552$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240911$$MD$US$US
243070281$24307028$1$I$$20240910$20240911$20240911$EXP$$GB-MYLANLABS-2024M1082849$MYLAN$$$$$M$Y$$$20240911$$HP$GB$GB
243070291$24307029$1$I$20240819$20240904$20240911$20240911$EXP$$CN-BEIGENE-BGN-2024-014017$BEIGENE$$$$$$Y$$$20240911$$HP$CN$CN
243070301$24307030$1$I$$20240910$20240911$20240911$EXP$$NVSC2024CA181602$NOVARTIS$$43$YR$$M$Y$$$20240911$$HP$CA$CA
243070311$24307031$1$I$$20240902$20240911$20240911$EXP$$JP-ROCHE-10000075313$ROCHE$Hagihara M, Hayashi H, Nakashima S, Imai Y, Nakano H, Uchida T. Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies. Internal Medicine. 2024;63 (16):2283-7. doi:10.2169/internalmedicine.2900-23.$68$YR$E$M$Y$$$20240911$$MD$JP$JP
243070321$24307032$1$I$20240815$20240904$20240911$20240911$EXP$$CN-BEIGENE-BGN-2024-014022$BEIGENE$$$$$$Y$$$20240911$$HP$CN$CN
243070331$24307033$1$I$20240905$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024178980$AMGEN$$62$YR$A$F$Y$$$20240911$$CN$US$US
243070341$24307034$1$I$20240905$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024179016$AMGEN$$47$YR$A$F$Y$$$20240911$$CN$US$US
243070361$24307036$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180388$AMGEN$$$$$$Y$$$20240911$$PH$US$US
243070371$24307037$1$I$$20240902$20240911$20240911$EXP$$KR-KOWA-24JP002238AA$KOWA PHARM$$70$YR$$M$Y$73$KG$20240911$$HP$KR$KR
243070381$24307038$1$I$20230101$20240902$20240911$20240911$EXP$$KR-KOWA-24JP002236AA$KOWA PHARM$$47$YR$$M$Y$75$KG$20240911$$HP$KR$KR
243070391$24307039$1$I$$20240902$20240911$20240911$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-08339$HIKMA$$$$$F$Y$$$20240911$$HP$CA$CA
243070401$24307040$1$I$$20240902$20240911$20240911$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006501$BIOCON$$$$$$Y$$$20240911$$HP$CA$CA
243070421$24307042$1$I$$20240905$20240911$20240911$EXP$$US-TAKEDA-2024TUS089669$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
243070431$24307043$1$I$20240902$20240906$20240911$20240911$EXP$$CN-CHEPLA-2024011591$CHEPLAPHARM$$79$YR$E$F$Y$86$KG$20240911$$HP$COUNTRY NOT SPECIFIED$CN
243070451$24307045$1$I$$20240909$20240911$20240911$EXP$$US-MYLANLABS-2024M1082777$MYLAN$$$$$F$Y$$$20240911$$CN$US$US
243070461$24307046$1$I$20240819$20240909$20240911$20240911$EXP$$GB-MYLANLABS-2024M1079584$MYLAN$$61$YR$$F$Y$90$KG$20240911$$MD$GB$GB
243070471$24307047$1$I$20240909$20240909$20240911$20240911$EXP$GB-MHRA-TPP2245943C22576978YC1725887365955$GB-MYLANLABS-2024M1082537$MYLAN$$82$YR$$F$Y$74$KG$20240911$$MD$GB$GB
243070481$24307048$1$I$$20240909$20240911$20240911$EXP$$GB-MYLANLABS-2024M1082559$MYLAN$$90$YR$$F$Y$51$KG$20240911$$HP$GB$GB
243070491$24307049$1$I$$20240909$20240911$20240911$EXP$GB-MHRA-MED-202409091622566530-RCQKL$GB-MYLANLABS-2024M1082670$MYLAN$$$$$F$Y$$$20240911$$CN$GB$GB
243070501$24307050$1$I$$20240909$20240911$20240911$EXP$$GB-MYLANLABS-2024M1082446$MYLAN$$67$YR$$M$Y$120$KG$20240911$$MD$GB$GB
243070511$24307051$1$I$$20240909$20240911$20240911$EXP$GB-MHRA-MED-202409090928199270-VMSTZ$GB-MYLANLABS-2024M1082373$MYLAN$$$$$F$Y$101$KG$20240911$$MD$GB$GB
243070521$24307052$1$I$20240906$20240907$20240911$20240911$EXP$GB-MHRA-MED-202409072048193750-TZQFY$GB-MYLANLABS-2024M1082285$MYLAN$$21$YR$$F$Y$$$20240911$$CN$GB$GB
243070531$24307053$1$I$20240816$20240910$20240911$20240911$EXP$$NP-TAKEDA-2024TUS090086$TAKEDA$$49$YR$$M$Y$$$20240911$$CN$NP$NP
243070552$24307055$2$F$20240829$20240918$20240911$20240930$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409003327$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240930$$CN$JP$JP
243070561$24307056$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006716$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240911$$CN$US$US
243070571$24307057$1$I$20240824$20240830$20240911$20240911$EXP$GB-MHRA-MED-202408302304322430-SVRTD$GB-ELI_LILLY_AND_COMPANY-GB202409000748$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$GB$GB
243070581$24307058$1$I$20240824$20240829$20240911$20240911$EXP$GB-MHRA-MED-202408292042551270-ZVLBD$GB-ELI_LILLY_AND_COMPANY-GB202408019318$ELI LILLY AND CO$$$$$$Y$$$20240911$$CN$GB$GB
243070591$24307059$1$I$$20240904$20240911$20240911$EXP$PT-INFARMED-J202408-693$PT-ELI_LILLY_AND_COMPANY-PT202409003248$ELI LILLY AND CO$$66$YR$E$F$Y$52$KG$20240911$$CN$PT$PT
243070601$24307060$1$I$$20240830$20240911$20240911$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409000766$ELI LILLY AND CO$$79$YR$E$M$Y$120$KG$20240911$$CN$GB$GB
243070611$24307061$1$I$20240730$20240909$20240910$20240910$DIR$FDA-CDER-CTU-2024-62279$$FDA-CTU$$59$YR$$F$N$$$20240909$N$HP$US$
243070621$24307062$1$I$20240731$20240830$20240911$20240911$EXP$GB-MHRA-MED-202408300943352290-DNPKR$GB-ELI_LILLY_AND_COMPANY-GB202409000674$ELI LILLY AND CO$$58$YR$A$M$Y$107$KG$20240911$$CN$GB$GB
243070631$24307063$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62283$$FDA-CTU$$66$YR$$M$N$$$20240910$N$$US$
243070641$24307064$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62292$$FDA-CTU$$50$YR$$F$N$$$20240910$N$$US$
243070651$24307065$1$I$$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62256$$FDA-CTU$$$$$F$N$$$20240910$N$HP$US$
243070661$24307066$1$I$20240821$20240902$20240911$20240911$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408018164$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240911$$CN$JP$JP
243070671$24307067$1$I$$20240830$20240911$20240911$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408019332$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240911$$MD$DE$DE
243070681$24307068$1$I$20240824$20240910$20240910$20240910$DIR$717860$$FDA-CTU$$59$YR$$F$N$61.65$KG$20240910$N$PH$US$
243070691$24307069$1$I$20240903$20240906$20240911$20240911$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409004895$ELI LILLY AND CO$$66$YR$E$M$Y$57$KG$20240911$$CN$CN$CN
243070701$24307070$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005790$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240911$$CN$US$US
243070711$24307071$1$I$$20240830$20240911$20240911$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000248$ELI LILLY AND CO$$$$$M$Y$$$20240911$$CN$US$US
243070721$24307072$1$I$20240821$20240903$20240911$20240911$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409003930$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240911$$CN$DE$CN
243070731$24307073$1$I$20240713$20240830$20240911$20240911$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001123$ELI LILLY AND CO$$$$$$Y$$$20240911$$CN$US$US
243070741$24307074$1$I$$20240830$20240911$20240911$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000583$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240911$$CN$US$US
243070751$24307075$1$I$$20240905$20240911$20240911$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003816$ELI LILLY AND CO$$101$YR$E$M$Y$$$20240911$$CN$US$US
243070761$24307076$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005681$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240911$$CN$US$US
243070772$24307077$2$F$$20240916$20240911$20240925$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409004083$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$BR$BR
243070781$24307078$1$I$$20240830$20240911$20240911$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202409000605$ELI LILLY AND CO$$$$$F$Y$$$20240911$$MD$SA$SA
243070801$24307080$1$I$20240829$20240830$20240911$20240911$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000438$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240911$$CN$JP$JP
243070811$24307081$1$I$20240214$20240830$20240911$20240911$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408000692$ELI LILLY AND CO$$$$$F$Y$$$20240911$$MD$DE$DE
243070821$24307082$1$I$$20230729$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-23-000296$BECTON DICKINSON$$$$$M$Y$92.1$KG$20240911$$CN$US$US
243070832$24307083$2$F$$20240910$20240911$20240916$PER$$US-IMP-2024000688$Harrow Health$$$$E$F$Y$$$20240916$$CN$US$US
243070841$24307084$1$I$$20240903$20240911$20240911$EXP$$ES-TERSERA THERAPEUTICS LLC-2024TRS004538$TERSERA THERAPEUTICS$Rezqallah A., Torres-Esquius S., Llop-Guevara A., Cruellas M., Martinez M.T., Romey M., Denkert C., Serra V., Chirivella I., Balmana J... Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing.. JCO Precision Oncology. 2024;8$$$$$Y$$$20240911$$MD$ES$ES
243070851$24307085$1$I$$20240122$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-24-000009$BECTON DICKINSON$$41$YR$$M$Y$$$20240911$$HP$US$US
243070861$24307086$1$I$20230101$20231104$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-23-000395$BECTON DICKINSON$$$$$F$Y$43.9$KG$20240911$$CN$US$US
243070881$24307088$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5910666$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243070891$24307089$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5909699$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243070901$24307090$1$I$$20240902$20240911$20240911$EXP$$JP-ROCHE-10000072403$ROCHE$Okamoto K, Hijioka S, Nagashio Y, Okada M, Ohba A, Maruki Y, et al. Immune-related adverse event-associated sclerosing cholangitis due to immune checkpoint inhibitors: imaging findings and treatments. Japanese Journal of Clinical Oncology. 2024-Aug-01;54 (8):887-94. doi:10.1093/jjco/hyae060.$67$YR$E$F$Y$$$20240911$$HP$JP$JP
243070911$24307091$1$I$$20240905$20240911$20240911$30DAY$$CO-PFIZER INC-PV202400117119$PFIZER$$29$YR$$F$Y$$$20240911$$CN$CO$CO
243070921$24307092$1$I$20240711$20240809$20240911$20240911$EXP$$US-TEVA-VS-3234057$TEVA$$28$YR$$F$Y$$$20240911$$HP$US$US
243070932$24307093$2$F$20230101$20240911$20240911$20240919$EXP$$JP-009507513-2307JPN000696J$MERCK$$70$YR$$M$Y$$$20240919$$MD$JP$JP
243070941$24307094$1$I$20240101$20240903$20240911$20240911$EXP$$CA-ABBVIE-5905974$ABBVIE$$59$YR$$M$Y$$$20240911$$CN$CA$CA
243070951$24307095$1$I$$20240902$20240911$20240911$EXP$$JP-ROCHE-10000075234$ROCHE$Hagihara M, Hayashi H, Nakashima S, Imai Y, Nakano H, Uchida T. Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies. Internal Medicine. 2024;63 (16):2283-7. doi:10.2169/internalmedicine.2900-23.$63$YR$A$F$Y$$$20240911$$MD$JP$JP
243070962$24307096$2$F$$20240909$20240911$20240913$EXP$$NL-ABBVIE-5833113$ABBVIE$$$$A$F$Y$150$KG$20240913$$CN$NL$NL
243070971$24307097$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009981$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243070981$24307098$1$I$$20240904$20240911$20240911$PER$$US-HALEON-2195272$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243070991$24307099$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240707$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240911$$HP$US$US
243071001$24307100$1$I$$20240908$20240911$20240911$PER$$US-BAYER-2024A128307$BAYER$$$$$$Y$$$20240911$$CN$US$US
243071011$24307101$1$I$20240101$20240827$20240911$20240911$PER$$US-009507513-2408USA009423$MERCK$$$$A$$Y$$$20240911$$MD$US$US
243071021$24307102$1$I$20231101$20231212$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-23-000451$BECTON DICKINSON$$57$YR$$F$Y$41.6$KG$20240911$$CN$US$US
243071031$24307103$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179146$AMGEN$Scavo M. P.; De Luca M.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID-19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$39$YR$A$M$Y$$$20240911$$HP$IT$IT
243071041$24307104$1$I$$20240905$20240911$20240911$EXP$$US-SA-2024SA034945$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240911$$MD$US$US
243071051$24307105$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA262286$SANOFI AVENTIS$$$$C$F$Y$20.91$KG$20240911$$MD$US$US
243071061$24307106$1$I$$20240905$20240911$20240911$EXP$$US-TAKEDA-2021TUS071202$TAKEDA$$$$$F$Y$$$20240911$$HP$US$US
243071081$24307108$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179147$AMGEN$Scavo M. P.; De Luca M.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID-19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$27$YR$A$M$Y$$$20240911$$HP$IT$IT
243071092$24307109$2$F$$20240906$20240911$20240916$30DAY$$GB-PFIZER INC-PV202400117059$PFIZER$$2$YR$$M$Y$$$20240916$$CN$GB$GB
243071101$24307110$1$I$20240828$20240829$20240911$20240911$30DAY$$CO-PFIZER INC-202400248440$PFIZER$$9$YR$$M$Y$$$20240911$$CN$CO$CO
243071111$24307111$1$I$20240909$20240909$20240911$20240911$EXP$$US-ORGANON-O2409USA000636$ORGANON$$$$$F$Y$$$20240911$$CN$US$US
243071121$24307112$1$I$$20240906$20240911$20240911$PER$$US-BAYER-2024A128634$BAYER$$57$YR$A$F$Y$$$20240911$$CN$US$US
243071131$24307113$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA262235$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240911$$MD$US$US
243071141$24307114$1$I$$20240830$20240911$20240911$PER$$US-SA-2023SA216327$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240911$$MD$US$US
243071151$24307115$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA259311$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240911$$CN$US$US
243071161$24307116$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA260060$SANOFI AVENTIS$$$$A$F$Y$$$20240911$$HP$US$US
243071191$24307119$1$I$20200601$20240910$20240910$20240910$DIR$717851$$FDA-CTU$$67$YR$$F$N$79.2$KG$20240910$N$CN$US$
243071211$24307121$1$I$$20240823$20240911$20240911$PER$$US-TEVA-VS-3237657$TEVA$$$$$$Y$$$20240911$$HP$US$US
243071221$24307122$1$I$$20240823$20240911$20240911$PER$$US-TEVA-VS-3237666$TEVA$$44$YR$$F$Y$$$20240911$$MD$US$US
243071231$24307123$1$I$20240830$20240910$20240911$20240911$EXP$GB-MHRA-TPP30859095C16651190YC1725963319760$GB-SANDOZ INC.-SDZ2024GB079185$SANDOZ$$29$YR$$M$Y$65$KG$20240911$$PH$GB$GB
243071241$24307124$1$I$20240826$20240906$20240911$20240911$EXP$$VN-PFIZER INC-202400251447$PFIZER$$28$YR$$M$Y$$$20240911$$MD$VN$VN
243071251$24307125$1$I$$20240909$20240911$20240911$EXP$$US-PFIZER INC-PV202400118723$PFIZER$$85$YR$$F$Y$$$20240911$$HP$US$US
243071261$24307126$1$I$20240101$20240906$20240911$20240911$EXP$$CA-PFIZER INC-202400251777$PFIZER$$3$YR$$M$Y$$$20240911$$HP$CA$CA
243071271$24307127$1$I$$20240909$20240911$20240911$EXP$$US-PFIZER INC-202300455302$PFIZER$$79$YR$$F$Y$$$20240911$$HP$US$US
243071281$24307128$1$I$20240801$20240909$20240911$20240911$EXP$$US-PFIZER INC-PV202400118676$PFIZER$$50$YR$$F$Y$$$20240911$$HP$US$US
243071291$24307129$1$I$20181030$20240906$20240911$20240911$EXP$$DE-PFIZER INC-202400251278$PFIZER$$29$YR$$M$Y$$$20240911$$CN$DE$DE
243071304$24307130$4$F$$20240916$20240911$20240923$30DAY$$CO-PFIZER INC-PV202400113167$PFIZER$$$$$M$Y$$$20240923$$CN$CO$CO
243071322$24307132$2$F$20240703$20240828$20240911$20240911$PER$$US-CELLTRION INC.-2024US016892$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243071331$24307133$1$I$$20240906$20240911$20240911$PER$$US-ABBVIE-5914408$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243071352$24307135$2$F$$20240909$20240911$20240913$EXP$$NVSC2024HR181582$NOVARTIS$$$$$F$Y$$$20240913$$MD$HR$HR
243071361$24307136$1$I$$20240904$20240911$20240911$EXP$$IL-TAKEDA-2024TUS090025$TAKEDA$$$$$F$Y$$$20240911$$CN$IL$IL
243071391$24307139$1$I$$20240904$20240911$20240911$PER$$US-BAUSCHBL-2024BNL031457$BAUSCH AND LOMB$$$$$M$Y$$$20240911$$CN$US$US
243071401$24307140$1$I$$20240907$20240911$20240911$EXP$$EU-BAUSCHBL-2024BNL033015$BAUSCH AND LOMB$$8$DEC$$$Y$$$20240911$$MD$EU$EU
243071411$24307141$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00741$GLAND PHARMA$$73$YR$E$F$Y$65$KG$20240911$$HP$CN$CN
243071421$24307142$1$I$$20240907$20240911$20240911$EXP$$EU-BAUSCHBL-2024BNL033014$BAUSCH AND LOMB$$$$$M$Y$$$20240911$$CN$EU$EU
243071431$24307143$1$I$20230901$20240829$20240911$20240911$PER$$US-Nobelpharma America, LLC-NPA-2024-01504$NOBELPHARMA$$29$YR$A$F$Y$$$20240911$$PH$US$US
243071442$24307144$2$F$$20240923$20240911$20240927$EXP$$US-GILEAD-2024-0686731$GILEAD$$74$YR$E$F$Y$$$20240927$$CN$US$US
243071461$24307146$1$I$$20240903$20240911$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001789$BLUEPRINT MEDICINES$$$$$F$Y$$$20240911$$CN$US$US
243071471$24307147$1$I$20240814$20240909$20240911$20240911$EXP$$CN-MYLANLABS-2024M1082721$MYLAN$$79$YR$$F$Y$45$KG$20240911$$HP$CN$CN
243071481$24307148$1$I$20240801$20240906$20240911$20240911$EXP$$DE-ABBVIE-5913911$ABBVIE$$58$YR$$F$Y$$$20240911$$CN$DE$DE
243071492$24307149$2$F$20230302$20240924$20240911$20240926$EXP$$US-BAUSCH-BL-2023-003925$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240926$$CN$US$US
243071501$24307150$1$I$$20240906$20240911$20240911$EXP$$JP-ALXN-202409JPN000315JP$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240911$$PH$JP$JP
243071511$24307151$1$I$20240101$20240906$20240911$20240911$EXP$$US-ABBVIE-5913898$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243071521$24307152$1$I$$20240905$20240911$20240911$PER$$US-BAYER-2024A127903$BAYER$$76$YR$E$M$Y$$$20240911$$CN$US$US
243071531$24307153$1$I$$20240829$20240911$20240911$EXP$GB-MHRA-MED-202408291531588130-WZQJS$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-08155$HIKMA$$$$$M$Y$$$20240911$$CN$GB$GB
243071541$24307154$1$I$$20240903$20240911$20240911$EXP$$JP-009507513-2409JPN000542J$MERCK$$6$DEC$$F$Y$$$20240911$$MD$JP$JP
243071551$24307155$1$I$20200801$20240905$20240911$20240911$EXP$$US-TAKEDA-2024TUS089920$TAKEDA$$51$YR$$F$Y$$$20240911$$MD$US$US
243071561$24307156$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144379$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240911$$CN$US$US
243071571$24307157$1$I$20240822$20240903$20240911$20240911$EXP$$US-INCYTE CORPORATION-2024IN009412$INCYTE$$$$$$Y$$$20240911$$HP$US$US
243071581$24307158$1$I$20240801$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143743$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240911$$HP$US$US
243071591$24307159$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240709$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$$$Y$$$20240911$$HP$US$US
243071601$24307160$1$I$$20240904$20240911$20240911$EXP$$CA-ABBVIE-5910508$ABBVIE$$$$A$F$Y$$$20240911$$CN$CA$CA
243071611$24307161$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009984$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243071621$24307162$1$I$$20240901$20240911$20240911$EXP$$US-UCBSA-2024045454$UCB$$$$$$Y$$$20240911$$CN$US$US
243071631$24307163$1$I$20230724$20240831$20240911$20240911$30DAY$$IT-UCBSA-2024046391$UCB$$64$YR$$F$Y$$$20240911$$CN$IT$IT
243071642$24307164$2$F$$20240911$20240911$20240916$EXP$$US-ABBVIE-5909569$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243071651$24307165$1$I$$20240830$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0012944$DR REDDYS$Timothy LD, Healy CM, Quintanilla NM, Montgomery N, Okcu MF. Nocardiosis in an infant with spindle cell rhabdomyosarcoma treated with mild immunosuppressive chemotherapy. Pediatric Blood and Cancer. 2024;71(4): doi:10.1002/pbc.30873.$9$DY$N$F$Y$$$20240911$$HP$US$US
243071661$24307166$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179211$AMGEN$Scavo M. P.; De Luca M.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID-19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$34$YR$A$F$Y$$$20240911$$HP$IT$IT
243071671$24307167$1$I$20240101$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180085$AMGEN$$70$YR$E$M$Y$$$20240911$$CN$US$US
243071681$24307168$1$I$$20240905$20240911$20240911$EXP$$US-ABBVIE-5909385$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243071691$24307169$1$I$20240828$20240905$20240911$20240911$EXP$$US-ABBVIE-5910680$ABBVIE$$69$YR$$M$Y$$$20240911$$CN$US$US
243071701$24307170$1$I$20240101$20240909$20240911$20240911$EXP$$US-ABBVIE-5916845$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243071711$24307171$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5913636$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243071721$24307172$1$I$20240822$20240827$20240911$20240911$EXP$$NL-ABBVIE-5916895$ABBVIE$$82$YR$$M$Y$$$20240911$$CN$NL$NL
243071731$24307173$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179148$AMGEN$Scavo M. P.; De Luca M.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$45$YR$A$M$Y$$$20240911$$HP$IT$IT
243071742$24307174$2$F$20240829$20240919$20240911$20240922$PER$$US-AMGEN-USASP2024180649$AMGEN$$$$$$Y$$$20240922$$HP$US$US
243071751$24307175$1$I$20240909$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180551$AMGEN$$75$YR$E$M$Y$$$20240911$$PH$US$US
243071761$24307176$1$I$$20240906$20240911$20240911$PER$$US-JNJFOC-20240923549$JOHNSON AND JOHNSON$$$$$M$Y$$$20240911$$HP$US$US
243071771$24307177$1$I$$20240906$20240911$20240911$PER$$US-JNJFOC-20240922404$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20240911$$CN$US$US
243071781$24307178$1$I$20240709$20240720$20240911$20240911$PER$$US-CELLTRION INC.-2024US017101$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243071791$24307179$1$I$$20240904$20240911$20240911$PER$$US-BAYER-2024A127133$BAYER$$$$$F$Y$$$20240911$$CN$US$US
243071801$24307180$1$I$20240822$20240904$20240911$20240911$EXP$$CN-009507513-2409CHN002600$MERCK$$74$YR$$M$Y$87$KG$20240911$$HP$CN$CN
243071811$24307181$1$I$20240801$20240904$20240911$20240911$EXP$$GB-AstraZeneca-2024A201032$ASTRAZENECA$$62$YR$$M$Y$74$KG$20240911$$MD$GB$
243071821$24307182$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00746$GLAND PHARMA$Guoxin Cai.Neoadjuvant camrelizumab combined with chemotherapy for resectable stage IIIA-IIIb non-small cell lung cancer: Single arm phase II study.Journal of Clinical Oncology.JUN-2024;42$$$$$Y$$$20240911$$HP$CN$CN
243071841$24307184$1$I$20240806$20240903$20240911$20240911$EXP$$FR-AstraZeneca-2024A196840$ASTRAZENECA$$44$YR$$F$Y$$$20240911$$MD$FR$
243071851$24307185$1$I$$20240909$20240911$20240911$EXP$$ZA-AstraZeneca-2024A206356$ASTRAZENECA$$29220$DY$$M$Y$$$20240911$$CN$ZA$
243071861$24307186$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006234$ELI LILLY AND CO$$$$$M$Y$$$20240911$$CN$US$US
243071871$24307187$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006352$ELI LILLY AND CO$$34$YR$A$$Y$$$20240911$$CN$US$US
243071881$24307188$1$I$20240826$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005464$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240911$$CN$US$US
243071901$24307190$1$I$20240824$20240910$20240910$20240910$DIR$717799$$FDA-CTU$$73$YR$$M$N$78.5$KG$20240910$N$HP$US$
243071921$24307192$1$I$20240910$20240910$20240910$20240910$DIR$717876$$FDA-CTU$$65$YR$$F$N$$$20240910$N$HP$US$
243071932$24307193$2$F$$20240917$20240911$20240925$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004501$Unknown Manufacturer$$$$$$Y$$$20240924$$HP$US$US
243071941$24307194$1$I$20240901$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179938$AMGEN$$$$$M$Y$$$20240911$$PH$US$US
243071951$24307195$1$I$20240828$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024179561$AMGEN$$55$YR$A$F$Y$$$20240911$$CN$US$US
243071961$24307196$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179215$AMGEN$Scavo M. P.; De Luca M.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID-19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$44$YR$A$F$Y$$$20240911$$HP$IT$IT
243071971$24307197$1$I$20240819$20240904$20240911$20240911$EXP$$BR-AKCEA THERAPEUTICS, INC.-2024IS006353$AKCEA THERAPEUTICS$$$$$$Y$$$20240911$$CN$BR$BR
243071981$24307198$1$I$20240726$20240903$20240911$20240911$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004481$BLUEPRINT MEDICINES$$$$$$Y$$$20240911$$CN$US$US
243071991$24307199$1$I$$20240903$20240911$20240911$PER$$US-BAYER-2024A126654$BAYER$$15$YR$T$F$Y$$$20240911$$MD$US$US
243072011$24307201$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179213$AMGEN$Scavo M. P.; De Luca M.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID-19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$36$YR$A$M$Y$$$20240911$$HP$IT$IT
243072023$24307202$3$F$20240201$20240919$20240911$20240927$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004509$Unknown Manufacturer$$$$$$Y$$$20240926$$HP$CN$CN
243072031$24307203$1$I$$20240827$20240911$20240911$EXP$$US-GLANDPHARMA-US-2024GLNLIT00735$GLAND PHARMA$Shammas Bajwa .Venetoclax combined with hypomethylating agents for favorable risk acute myeloid leukemia: A single center experience.Journal of Clinical Oncology.JUN-2024;42 (Suppl.): No. 16$$$$$Y$$$20240911$$HP$US$US
243072041$24307204$1$I$20240808$20240909$20240911$20240911$EXP$FR-AFSSAPS-GR2024001040$FR-PFIZER INC-202400252523$PFIZER$$79$YR$$M$Y$$$20240911$$PH$FR$FR
243072051$24307205$1$I$20240312$20240909$20240911$20240911$EXP$FR-AFSSAPS-DJ2024001012$FR-PFIZER INC-202400252536$PFIZER$$59$YR$$F$Y$65$KG$20240911$$MD$FR$FR
243072061$24307206$1$I$$20240910$20240911$20240911$EXP$$CN-PFIZER INC-PV202400118430$PFIZER$$$$A$F$Y$$$20240911$$CN$CN$CN
243072071$24307207$1$I$20240101$20240909$20240911$20240911$EXP$$US-PFIZER INC-PV202400118714$PFIZER$$41$YR$$F$Y$$$20240911$$HP$US$US
243072082$24307208$2$F$$20240916$20240911$20240918$EXP$$AR-PFIZER INC-202400253880$PFIZER$$81$YR$$F$Y$$$20240918$$CN$AR$AR
243072091$24307209$1$I$20240717$20240910$20240911$20240911$EXP$$JP-PFIZER INC-PV202400118138$PFIZER$$72$YR$$F$Y$39.4$KG$20240911$$PH$JP$JP
243072101$24307210$1$I$20240901$20240909$20240911$20240911$EXP$$US-PFIZER INC-202400253086$PFIZER$$$$A$M$Y$$$20240911$$CN$US$US
243072112$24307211$2$F$20240823$20240912$20240911$20240916$EXP$$CN-PFIZER INC-PV202400118241$PFIZER$$29$YR$$F$Y$75$KG$20240916$$HP$CN$CN
243072121$24307212$1$I$20240902$20240910$20240911$20240911$EXP$$CN-PFIZER INC-PV202400118920$PFIZER$$73$YR$$M$Y$48$KG$20240911$$HP$CN$CN
243072131$24307213$1$I$$20240909$20240911$20240911$EXP$$US-PFIZER INC-PV202400118327$PFIZER$$77$YR$$M$Y$$$20240911$$CN$US$US
243072151$24307215$1$I$20140101$20240909$20240911$20240911$EXP$$FR-PFIZER INC-202400252486$PFIZER$$21$YR$$F$Y$52$KG$20240911$$MD$FR$FR
243072161$24307216$1$I$20240901$20240909$20240911$20240911$EXP$$SA-PFIZER INC-PV202400118576$PFIZER$$$$$$Y$$$20240911$$MD$SA$SA
243072171$24307217$1$I$20240817$20240909$20240911$20240911$EXP$FR-AFSSAPS-RN2024000956$FR-PFIZER INC-202400252534$PFIZER$$44$YR$$F$Y$$$20240911$$MD$FR$FR
243072181$24307218$1$I$$20240909$20240911$20240911$EXP$$FR-PFIZER INC-202400252640$PFIZER$$83$YR$$M$Y$$$20240911$$CN$FR$FR
243072191$24307219$1$I$20240727$20240909$20240911$20240911$EXP$FR-AFSSAPS-NT2024001115$FR-PFIZER INC-202400252533$PFIZER$$40$YR$$F$Y$$$20240911$$CN$FR$FR
243072201$24307220$1$I$20240827$20240909$20240911$20240911$EXP$$CN-PFIZER INC-PV202400118230$PFIZER$$56$YR$$F$Y$58$KG$20240911$$HP$CN$CN
243072211$24307221$1$I$$20240909$20240911$20240911$EXP$$ES-PFIZER INC-202400252553$PFIZER$$$$$$Y$$$20240911$$CN$ES$ES
243072231$24307223$1$I$20240816$20240826$20240911$20240911$PER$$US-CELLTRION INC.-2024US020060$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243072241$24307224$1$I$$20240822$20240911$20240911$PER$$US-CELLTRION INC.-2024US020037$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243072251$24307225$1$I$20240801$20240805$20240911$20240911$PER$$US-CELLTRION INC.-2024US018841$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243072271$24307227$1$I$20240604$20240627$20240911$20240911$PER$$US-CELLTRION INC.-2024US013620$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243072281$24307228$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA262651$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240911$$HP$US$US
243072291$24307229$1$I$20240101$20240828$20240911$20240911$PER$$US-SA-2024SA262802$SANOFI AVENTIS$$60$YR$A$M$Y$100$KG$20240911$$MD$US$US
243072301$24307230$1$I$20231201$20240903$20240911$20240911$PER$$US-SA-2024SA261853$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240911$$MD$US$US
243072311$24307231$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA259722$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240911$$HP$US$US
243072321$24307232$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA262159$SANOFI AVENTIS$$$$E$M$Y$$$20240911$$HP$US$US
243072341$24307234$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA260401$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240911$$HP$US$US
243072351$24307235$1$I$$20240905$20240911$20240911$EXP$$US-ABBVIE-5909833$ABBVIE$$$$$$Y$$$20240911$$CN$US$US
243072382$24307238$2$F$$20240917$20240911$20240923$EXP$$US-TEVA-VS-3240301$TEVA$Balashova O, Rosoph S, Buryk Y. Multiple Pneumothoraces Due to COVID-19 Related Interstitial Lung Disease in a Middle-aged Female with AIDS. South-Med-J 2022; 116.; Balashova O, Rosoph S, Buryk Y. Multiple Pneumothoraces Due to COVID-19 Related Interstitial Lung Disease in a Middle-aged Female with AIDS. South-Med-J 2022; 116.$59$YR$$F$Y$$$20240923$$HP$US$US
243072391$24307239$1$I$$20240905$20240911$20240911$PER$$US-VERTEX PHARMACEUTICALS-2024-014196$VERTEX$$$$$$Y$$$20240911$$CN$US$US
243072401$24307240$1$I$$20240906$20240911$20240911$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014332$VERTEX$$$$A$F$Y$$$20240911$$CN$GB$GB
243072411$24307241$1$I$$20240905$20240911$20240911$PER$$US-VERTEX PHARMACEUTICALS-2024-014190$VERTEX$$12$YR$$$Y$$$20240911$$PH$US$US
243072421$24307242$1$I$$20240905$20240911$20240911$PER$$US-VERTEX PHARMACEUTICALS-2024-014240$VERTEX$$2$YR$$F$Y$$$20240911$$CN$US$US
243072431$24307243$1$I$$20240905$20240911$20240911$PER$$US-VERTEX PHARMACEUTICALS-2024-014267$VERTEX$$12$YR$$F$Y$$$20240911$$HP$US$US
243072441$24307244$1$I$$20240905$20240911$20240911$PER$$US-VERTEX PHARMACEUTICALS-2024-014264$VERTEX$$6$YR$$M$Y$$$20240911$$HP$US$US
243072451$24307245$1$I$$20240903$20240911$20240911$PER$$US-VERTEX PHARMACEUTICALS-2024-014052$VERTEX$$$$$$Y$$$20240911$$CN$US$US
243072472$24307247$2$F$$20240917$20240911$20240923$EXP$$US-VERTEX PHARMACEUTICALS-2024-014164$VERTEX$$$$$$Y$$$20240923$$CN$US$US
243072481$24307248$1$I$$20240905$20240911$20240911$PER$$US-VERTEX PHARMACEUTICALS-2024-014248$VERTEX$$$$$$Y$$$20240911$$CN$US$US
243072491$24307249$1$I$$20240909$20240911$20240911$EXP$$GB-SANDOZ INC.-SDZ2024GB078883$SANDOZ$$$$$F$Y$$$20240911$$CN$GB$GB
243072501$24307250$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240708$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240911$$HP$US$US
243072511$24307251$1$I$20150701$20240909$20240911$20240911$EXP$$AT-SANDOZ INC.-PHHY2019AT030482$SANDOZ$$57$YR$$M$Y$70$KG$20240911$$MD$AT$AT
243072521$24307252$1$I$$20240830$20240911$20240911$PER$$US-MYLANLABS-2024M1080285$MYLAN$$$$$F$Y$$$20240911$$CN$US$US
243072532$24307253$2$F$$20240913$20240911$20240915$PER$$US-ALXN-202409USA000465US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243072542$24307254$2$F$$20240910$20240911$20240912$PER$$US-HALEON-2196230$Haleon PLC$$$$$F$Y$$$20240912$$CN$US$US
243072551$24307255$1$I$$20240902$20240911$20240911$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08250$HIKMA$$80$YR$$F$Y$$$20240911$$PH$CA$CA
243072562$24307256$2$F$$20240918$20240911$20240927$EXP$$US-TEVA-VS-3240409$TEVA$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.; Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer-Immunol-Immunother 2024; 73.; Muddasani R, Talwar N, Mambetsariev I, Fricke J, Li...$75$YR$$F$Y$$$20240927$$HP$US$US
243072571$24307257$1$I$$20240901$20240911$20240911$PER$$US-BAYER-2024A126175$BAYER$$$$$$Y$$$20240911$$CN$US$US
243072581$24307258$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00747$GLAND PHARMA$X fang.Efficacy and safety of pomalidomide combined with cyclophosphamide and dexamethasone in treatment of relapsed/refractory multiple myeloma.Cancer Research and Clinic.APR-2023;35(4):252-257$$$$$Y$$$20240911$$HP$CN$CN
243072591$24307259$1$I$20240601$20240910$20240910$20240910$DIR$717857$$FDA-CTU$$8$YR$$F$N$33.75$KG$20240910$N$CN$US$
243072601$24307260$1$I$$20240910$20240910$20240910$DIR$717853$$FDA-CTU$$$$$UNK$N$$$20240910$$CN$US$
243072612$24307261$2$F$$20240925$20240911$20240925$EXP$$JP-SA-2024SA258970$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240926$$MD$JP$JP
243072621$24307262$1$I$20240209$20240909$20240911$20240911$EXP$$NVSC2024CA145609$NOVARTIS$$35$YR$$M$Y$72.3$KG$20240911$$MD$CA$CA
243072631$24307263$1$I$20240601$20240906$20240911$20240911$EXP$$US-INCYTE CORPORATION-2024IN009434$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243072641$24307264$1$I$$20240831$20240910$20240910$DIR$FDA-CDER-CTU-2024-62241$$FDA-CTU$$$$$$N$$$20240831$N$CN$US$
243072651$24307265$1$I$20240811$20240909$20240911$20240911$EXP$$NVSC2024DE167474$NOVARTIS$$82$YR$$F$Y$60$KG$20240911$$MD$DE$DE
243072661$24307266$1$I$20240827$20240910$20240910$20240910$DIR$717855$$FDA-CTU$$13$YR$$F$N$$$20240910$Y$PH$US$
243072681$24307268$1$I$20240723$20240820$20240910$20240910$DIR$FDA-CDER-CTU-2024-62281$$FDA-CTU$$65$YR$$F$N$74.84$KG$20240820$N$CN$US$
243072691$24307269$1$I$$20240730$20240911$20240911$PER$$US-LUNDBECK-DKLU4002348$LUNDBECK$$$$$$Y$$$20240911$$CN$US$US
243072701$24307270$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009985$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243072712$24307271$2$F$20240903$20240911$20240911$20240912$PER$$US-AMGEN-USASP2024181114$AMGEN$$51$YR$A$F$Y$$$20240912$$CN$US$US
243072721$24307272$1$I$20240901$20240906$20240911$20240911$PER$$US-JNJFOC-20240917257$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240911$$CN$US$US
243072741$24307274$1$I$$20240903$20240911$20240911$PER$$US-JNJFOC-20240904796$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$HP$US$US
243072751$24307275$1$I$$20240902$20240911$20240911$EXP$$US-MYLANLABS-2024M1081845$MYLAN$Sasidharan Pillai S, Robilliard R, Fredette ME, Serrano-Gonzalez M, Scully KJ. Persistent hypercalcemia mimicking hypophosphatasia after discontinuation of a ketogenic diet: a case report. J-Pediatr-Endocrinol-Metab 2023; 36 1109-1113.$$$C$M$Y$$$20240911$$MD$US$US
243072762$24307276$2$F$20230520$20240909$20240911$20240912$EXP$FR-AFSSAPS-AM2024000710$FR-JNJFOC-20240926226$JOHNSON AND JOHNSON$$71$YR$E$F$Y$62$KG$20240913$$MD$FR$FR
243072771$24307277$1$I$20240801$20240826$20240911$20240911$PER$$US-009507513-2408USA008946$MERCK$$88$YR$$F$Y$$$20240911$$CN$US$US
243072781$24307278$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144490$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240911$$CN$US$US
243072791$24307279$1$I$20240826$20240909$20240911$20240911$EXP$EU-ADIENNEP-2024AD000730$EU-ADIENNEP-2024AD000730$ADIENNE PHARMA + BIOTECH$$12$YR$$F$Y$61$KG$20240910$$MD$EU$EU
243072801$24307280$1$I$20240809$20240904$20240911$20240911$EXP$$NVSC2024CN179380$NOVARTIS$$84$YR$$F$Y$55$KG$20240911$$HP$CN$CN
243072811$24307281$1$I$20240822$20240830$20240911$20240911$EXP$$PL-ROCHE-10000072845$ROCHE$$$$$$Y$$$20240911$$MD$PL$PL
243072821$24307282$1$I$20240828$20240830$20240911$20240911$EXP$$US-MYLANLABS-2024M1081333$MYLAN$$53$YR$$F$Y$56.7$KG$20240911$$CN$US$US
243072851$24307285$1$I$20240305$20240910$20240910$20240910$DIR$717859$$FDA-CTU$$73$YR$$F$N$92.25$KG$20240910$N$CN$US$
243072861$24307286$1$I$$20240910$20240910$20240910$DIR$717865$$FDA-CTU$$$$$UNK$N$$$20240910$$CN$US$
243072881$24307288$1$I$20240101$20240827$20240911$20240911$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01413$INTRA-CELLULAR THERAPIES$$52$YR$$M$Y$$$20240911$$HP$US$US
243072891$24307289$1$I$$20240827$20240911$20240911$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01411$INTRA-CELLULAR THERAPIES$$34$YR$$$Y$101.59$KG$20240911$$HP$US$US
243072901$24307290$1$I$20240909$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180108$AMGEN$$27$YR$A$F$Y$$$20240911$$CN$US$US
243072911$24307291$1$I$$20240905$20240911$20240911$EXP$$KR-AMGEN-KORSP2024179028$AMGEN$$$$$$Y$$$20240911$$MD$KR$KR
243072921$24307292$1$I$20240731$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024178771$AMGEN$$45$YR$A$M$Y$$$20240911$$CN$US$US
243072931$24307293$1$I$20240830$20240902$20240911$20240911$EXP$$CA-CELLTRION INC.-2024CA021486$CELLTRION$$$$$$Y$$$20240911$$HP$CA$CA
243072941$24307294$1$I$$20240827$20240911$20240911$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00728$GLAND PHARMA$Nakura M.Cases of Advanced Colorectal Cancer with Nephrotic Syndrome after FOLFIRI plus Ramucirumab Administration.Gan to Kagaku Ryoho.DEC-2022;49(13):1745-1747$54$YR$A$F$Y$$$20240911$$HP$JP$JP
243072951$24307295$1$I$$20240904$20240911$20240911$EXP$$US-ARGENX-2024-ARGX-US007426$ARGENX BVBA$$$$$$Y$$$20240911$$CN$US$US
243072961$24307296$1$I$20240903$20240904$20240911$20240911$PER$$US-JNJFOC-20240908268$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240911$$PH$US$US
243072971$24307297$1$I$20240822$20240909$20240911$20240911$EXP$FR-AFSSAPS-TS2024000963$NVSC2024FR180016$NOVARTIS$$40$YR$$M$Y$86$KG$20240911$$MD$FR$FR
243072981$24307298$1$I$20240722$20240730$20240911$20240911$PER$$US-LUNDBECK-DKLU4002433$LUNDBECK$$$$$$Y$$$20240911$$CN$US$US
243072991$24307299$1$I$$20240830$20240911$20240911$EXP$$GB-UCBSA-2024044755$UCB$$$$$M$Y$$$20240911$$MD$GB$GB
243073001$24307300$1$I$$20240906$20240911$20240911$EXP$$CA-009507513-2409CAN003653$MERCK$$$$$M$Y$$$20240911$$MD$CA$CA
243073011$24307301$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A204693$ASTRAZENECA$$$$$$Y$$$20240911$$MD$US$
243073021$24307302$1$I$$20230628$20240911$20240911$EXP$$US-AstraZeneca-2023A150826$ASTRAZENECA$$$$$F$Y$$$20240911$$MD$US$
243073031$24307303$1$I$$20240704$20240911$20240911$EXP$$CA-AstraZeneca-2021A883109$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$CA$
243073041$24307304$1$I$$20240910$20240911$20240911$EXP$$PL-SANDOZ INC.-SDZ2024PL079231$SANDOZ$$5$YR$$M$Y$$$20240911$$MD$PL$PL
243073051$24307305$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009986$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243073061$24307306$1$I$20230222$20240910$20240911$20240911$EXP$$CN-BAYER-2024A129721$BAYER$$54$YR$A$F$Y$70$KG$20240911$$HP$CN$CN
243073071$24307307$1$I$20240101$20240821$20240911$20240911$PER$$US-SA-2024SA259938$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240911$$CN$US$US
243073091$24307309$1$I$20240801$20240903$20240911$20240911$PER$$US-SA-2024SA261558$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240911$$HP$US$US
243073101$24307310$1$I$20240908$20240910$20240910$20240910$DIR$717866$$FDA-CTU$$63$YR$$F$N$67.5$KG$20240910$N$CN$CA$
243073131$24307313$1$I$20240905$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62389$$FDA-CTU$$79$YR$$M$N$$$20240910$N$HP$US$
243073141$24307314$1$I$$20240902$20240911$20240911$EXP$$JP-ROCHE-10000076782$ROCHE$Sakurabayashi K, Kawamura T, Maeda M, Oji A, Suzuki T, Yonekura T et al.. A case of encapsulating peritoneal sclerosis occurred due to second hit of intra-abdominal infection in the 17th year after renal transplant. The 39th Japanese Society of Renal Transplantation and Vascular Surgery. 2024;129$48$YR$A$F$Y$$$20240911$$MD$JP$JP
243073151$24307315$1$I$20240101$20240827$20240911$20240911$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1461$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240911$$CN$US$US
243073161$24307316$1$I$$20240903$20240911$20240911$30DAY$$US-GSK-US2024109434$GLAXOSMITHKLINE$$$$$F$Y$$$20240911$$CN$US$US
243073171$24307317$1$I$$20240903$20240911$20240911$EXP$$IT-ALXN-202409EEA000111IT$ALEXION PHARMACEUTICALS$$22$YR$$F$Y$$$20240911$$MD$IT$IT
243073181$24307318$1$I$20240703$20240729$20240911$20240911$PER$$US-CELLTRION INC.-2024US017176$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243073191$24307319$1$I$$20240910$20240911$20240911$PER$$NVSC2024US182047$NOVARTIS$$$$$$Y$$$20240911$$MD$US$US
243073201$24307320$1$I$20240101$20240828$20240911$20240911$EXP$$US-UCBSA-2024044432$UCB$$$$E$M$Y$$$20240911$$CN$US$US
243073211$24307321$1$I$20240101$20240829$20240911$20240911$EXP$$CA-UCBSA-2024044473$UCB$$$$$F$Y$$$20240911$$MD$CA$CA
243073222$24307322$2$F$$20240911$20240911$20240912$EXP$$US-Eisai-EC-2024-173954$EISAI$$61$YR$A$M$Y$106.8$KG$20240912$$CN$US$US
243073241$24307324$1$I$$20240904$20240911$20240911$EXP$$US-GSK-US2024AMR111515$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$US$US
243073251$24307325$1$I$20240905$20240905$20240911$20240911$EXP$$US-JNJFOC-20240921108$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240911$$HP$US$US
243073261$24307326$1$I$20230101$20240906$20240911$20240911$EXP$$US-TAKEDA-2024TUS089773$TAKEDA$$$$$$Y$$$20240911$$MD$US$US
243073271$24307327$1$I$$20240903$20240911$20240911$EXP$$VN-SANDOZ INC.-SDZ2024VN079393$SANDOZ$Do Thi MT, Nguyen TQ, Pham VQ. Ket qua hoa tri truoc phau thuat benh ung thu vu giai doan ii, iii bang phac do tch (Efficacy of neoadjuvant therapy with tch regimen in stage II and III breast cancer). VIETNAM MEDICAL JOURNAL. 2022;2:133-8$$$$$Y$$$20240911$$HP$VN$VN
243073281$24307328$1$I$20240826$20240905$20240911$20240911$EXP$$CN-JNJFOC-20240919436$JOHNSON AND JOHNSON$$62$YR$A$F$Y$60$KG$20240911$$HP$CN$CN
243073292$24307329$2$F$$20240918$20240911$20240923$EXP$$CO-AMGEN-COLSL2024089652$AMGEN$$55$YR$A$M$Y$$$20240923$$CN$CO$CO
243073301$24307330$1$I$20231101$20240911$20240911$20240911$EXP$$RU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050774$BOEHRINGER INGELHEIM$$50$YR$A$F$Y$54$KG$20240911$$MD$RU$RU
243073311$24307331$1$I$20240804$20240903$20240911$20240911$PER$$US-Eisai-EC-2024-174049$EISAI$$71$YR$E$F$Y$89.4$KG$20240911$$CN$US$US
243073321$24307332$1$I$$20240905$20240911$20240911$30DAY$$US-PFIZER INC-202400251944$PFIZER$$12$YR$$M$Y$41.3$KG$20240911$$MD$US$US
243073331$24307333$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006371$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240911$$CN$US$US
243073341$24307334$1$I$20240906$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005719$ELI LILLY AND CO$$73$YR$E$$Y$$$20240911$$CN$US$US
243073351$24307335$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006446$ELI LILLY AND CO$$$$$$Y$$$20240911$$CN$US$US
243073361$24307336$1$I$20240909$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006271$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240911$$CN$US$US
243073371$24307337$1$I$20240825$20240830$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409000570$ELI LILLY AND CO$$59$YR$A$$Y$$$20240911$$CN$US$US
243073381$24307338$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144117$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240911$$HP$US$US
243073391$24307339$1$I$$20240820$20240911$20240911$PER$$US-009507513-2408USA006847$MERCK$$$$$F$Y$$$20240911$$MD$US$US
243073401$24307340$1$I$$20240903$20240911$20240911$EXP$$IT-MYLANLABS-2024M1082287$MYLAN$De Zen L, Divisic A, Molinaro G, Solidoro S, Barbi E. Dexmedetomidine at Home for Intractable Dystonia and Insomnia in Children With Special Needs: A Case Series. J-Pain-Symptom-Manage 2023; 66 (6): e653-e657.$$$$M$Y$$$20240911$$HP$IT$IT
243073421$24307342$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009987$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243073431$24307343$1$I$20231120$20240910$20240911$20240911$EXP$$NO-ABBVIE-5917473$ABBVIE$$66$YR$$F$Y$$$20240911$$HP$NO$NO
243073451$24307345$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA259937$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240911$$CN$US$US
243073461$24307346$1$I$20220901$20240823$20240911$20240911$PER$$US-SA-2024SA259848$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240911$$MD$US$US
243073471$24307347$1$I$20220101$20240830$20240911$20240911$PER$$US-SA-2024SA260475$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240911$$CN$US$US
243073481$24307348$1$I$$20240909$20240911$20240911$EXP$$ES-SANDOZ INC.-NVSC2021ES048262$SANDOZ$$13$YR$$F$Y$$$20240911$$MD$ES$ES
243073491$24307349$1$I$20231201$20240904$20240911$20240911$EXP$$US-GSK-US2024110042$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$HP$US$US
243073501$24307350$1$I$20240908$20240910$20240911$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024112472$VIIV$$33$YR$$M$Y$$$20240911$$HP$US$US
243073512$24307351$2$F$$20240906$20240911$20240912$30DAY$$PR-PFIZER INC-202400252001$PFIZER$$13$YR$$M$Y$$$20240912$$CN$PR$PR
243073523$24307352$3$F$$20240909$20240911$20240916$30DAY$$US-PFIZER INC-202400253068$PFIZER$$15$YR$$M$Y$$$20240916$$CN$US$US
243073531$24307353$1$I$$20240902$20240911$20240911$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08252$HIKMA$$83$YR$$M$Y$77$KG$20240911$$PH$CA$CA
243073551$24307355$1$I$20240612$20240806$20240911$20240911$PER$$US-CELLTRION INC.-2024US017195$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243073561$24307356$1$I$20240619$20240828$20240911$20240911$EXP$EU-AFSSAPS-AVCN2024000653$EU-ETHYPHARM-2024002333$ETHYPHARM$$$$$$Y$$$20240911$$MD$EU$EU
243073571$24307357$1$I$20171214$20240906$20240911$20240911$EXP$$CA-TAKEDA-2023TUS088442$TAKEDA$$36$YR$$F$Y$$$20240911$$CN$CA$CA
243073591$24307359$1$I$20240909$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62295$$FDA-CTU$$$$$M$N$76.8$KG$20240910$N$$US$
243073601$24307360$1$I$20240822$20240826$20240911$20240911$DIR$FDA-CDER-CTU-2024-62297$$FDA-CTU$$$$$M$N$78.1$KG$20240826$N$$US$
243073631$24307363$1$I$20240902$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62296$$FDA-CTU$$$$$F$N$90.1$KG$20240910$N$$US$
243073641$24307364$1$I$20240905$20240906$20240911$20240911$EXP$$US-JNJFOC-20240916066$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240911$$PH$US$US
243073671$24307367$1$I$$20240830$20240911$20240911$30DAY$$US-PFIZER INC-202400247922$PFIZER$$15$YR$$F$Y$$$20240911$$HP$US$US
243073681$24307368$1$I$$20240906$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143547$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240911$$CN$US$US
243073702$24307370$2$F$20240823$20240911$20240911$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140693$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$83.01$KG$20240920$$HP$US$US
243073711$24307371$1$I$$20240830$20240911$20240911$PER$$US-JNJFOC-20240900812$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243073731$24307373$1$I$20240718$20240829$20240911$20240911$EXP$FR-AFSSAPS-LL2024001523$FR-Axellia-005346$XELLIA PHARMACEUTICALS$$62$YR$A$F$Y$76$KG$20240911$$MD$FR$FR
243073741$24307374$1$I$20240416$20240829$20240911$20240911$EXP$FR-AFSSAPS-PA2024001277$FR-Axellia-005350$XELLIA PHARMACEUTICALS$$79$YR$E$F$Y$75$KG$20240911$$PH$FR$FR
243073761$24307376$1$I$$20240906$20240911$20240911$EXP$$FR-009507513-2409FRA003093$MERCK$$$$$M$Y$$$20240911$$PH$FR$FR
243073771$24307377$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009988$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243073781$24307378$1$I$20240811$20240903$20240911$20240911$PER$$US-ABBVIE-5905588$ABBVIE$$50$YR$$F$Y$$$20240911$$CN$US$US
243073791$24307379$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA259926$SANOFI AVENTIS$$$$A$F$Y$$$20240911$$CN$US$US
243073801$24307380$1$I$20240801$20240903$20240911$20240911$PER$$US-SA-2024SA262240$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240911$$MD$US$US
243073811$24307381$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA261635$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240911$$HP$US$US
243073821$24307382$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA262169$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240911$$MD$US$US
243073831$24307383$1$I$20240101$20240829$20240911$20240911$PER$$US-SA-2024SA259911$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240911$$MD$US$US
243073842$24307384$2$F$$20240902$20240911$20240926$EXP$$CR-Ipsen Biopharmaceuticals, Inc.-2024-17669$IPSEN$$$$$F$Y$$$20240926$$MD$CR$CR
243073851$24307385$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261872$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240911$$CN$US$US
243073871$24307387$1$I$20240801$20240830$20240911$20240911$30DAY$$US-PFIZER INC-202400247760$PFIZER$$13$YR$$F$Y$44$KG$20240911$$PH$US$US
243073881$24307388$1$I$$20240906$20240911$20240911$30DAY$$US-PFIZER INC-202400252519$PFIZER$$23$YR$$M$Y$$$20240911$$CN$US$US
243073891$24307389$1$I$$20240906$20240911$20240911$PER$$US-ALXN-202409USA000490US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243073911$24307391$1$I$20240820$20240909$20240911$20240911$EXP$$US-BAYER-2024A129240$BAYER$$93$YR$E$M$Y$$$20240911$$HP$US$US
243073931$24307393$1$I$20240802$20240820$20240911$20240911$PER$$US-CELLTRION INC.-2024US019787$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243073941$24307394$1$I$$20240905$20240911$20240911$PER$$US-JNJFOC-20240915857$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$MD$US$US
243073951$24307395$1$I$20240906$20240906$20240911$20240911$PER$$US-JNJFOC-20240917095$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240911$$HP$US$US
243073961$24307396$1$I$20240822$20240909$20240911$20240911$EXP$CZ-CZSUKL-24002500$CZ-OTSUKA-2024_025261$OTSUKA$$54$YR$$F$Y$100$KG$20240911$$PH$CZ$CZ
243073971$24307397$1$I$20240401$20240903$20240911$20240911$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000088$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240911$$CN$US$US
243073991$24307399$1$I$$20240903$20240911$20240911$EXP$$CN-Merck Healthcare KGaA-2024047344$MERCK KGAA$$$$$F$Y$$$20240911$$CN$CN$CN
243074001$24307400$1$I$$20240906$20240911$20240911$30DAY$$US-PFIZER INC-202400251997$PFIZER$$15$YR$$M$Y$$$20240911$$CN$US$US
243074021$24307402$1$I$$20240906$20240911$20240911$EXP$$TW-AstraZeneca-2024A203374$ASTRAZENECA$Huang C.. Case report: Rare variants in the MTRR gene, 66GG and 524TT cause hyperhomocysteinemia and folic acid deficiency linked to schizophrenia. Frontiers in Psychiatry 2024;15(1353308):01-05.$39$YR$$M$Y$112.8$KG$20240911$$HP$TW$
243074031$24307403$1$I$$20240906$20240911$20240911$30DAY$$US-PFIZER INC-202400251973$PFIZER$$13$YR$$F$Y$$$20240911$$CN$US$US
243074041$24307404$1$I$$20240910$20240910$20240910$DIR$717872$$FDA-CTU$$$$$UNK$N$$$20240910$$CN$US$
243074052$24307405$2$F$$20240909$20240911$20240916$PER$$US-AMGEN-USASP2024180383$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243074061$24307406$1$I$$20240910$20240910$20240910$DIR$717877$$FDA-CTU$$$$$UNK$N$$$20240910$$CN$US$
243074071$24307407$1$I$$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144393$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240911$$CN$US$US
243074081$24307408$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144358$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240911$$HP$US$US
243074091$24307409$1$I$20240908$20240910$20240910$20240910$DIR$717874$$FDA-CTU$$44$YR$$M$N$106.5$KG$20240910$N$PH$US$
243074101$24307410$1$I$$20240910$20240910$20240910$DIR$717875$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243074111$24307411$1$I$$20240909$20240911$20240911$EXP$$NVSC2024US181389$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
243074121$24307412$1$I$$20240907$20240911$20240911$PER$$US-TAKEDA-2024TUS089763$TAKEDA$$$$$$Y$$$20240911$$CN$US$US
243074131$24307413$1$I$20240909$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143311$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240911$$HP$US$US
243074152$24307415$2$F$$20240906$20240911$20240916$PER$$US-SA-2024SA260985$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240916$$CN$US$US
243074161$24307416$1$I$$20240909$20240911$20240911$PER$$US-TAKEDA-2024TUS089880$TAKEDA$$$$$$Y$$$20240911$$CN$US$US
243074171$24307417$1$I$20240908$20240909$20240911$20240911$EXP$$US-ABBVIE-5915910$ABBVIE$$33$YR$$F$Y$$$20240911$$CN$US$US
243074182$24307418$2$F$20240515$20240918$20240911$20240923$30DAY$$US-PFIZER INC-PV202400049779$PFIZER$$10$YR$$M$Y$20.87$KG$20240923$$MD$US$US
243074191$24307419$1$I$$20240903$20240911$20240911$30DAY$$US-PFIZER INC-PV202400115738$PFIZER$$$$$M$Y$$$20240911$$HP$US$US
243074203$24307420$3$F$20240905$20240906$20240911$20240925$30DAY$$US-JNJFOC-20240915820$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240925$$HP$US$US
243074211$24307421$1$I$20230401$20240902$20240911$20240911$EXP$$JP-ROCHE-3524532$ROCHE$Yanase M, Kunishima Y, Muranaka T and Senda M A case of cytomegalovirus enterocolitis which occurred 17 years after living donor renal transplant. [abstract number: P9-1].. The 57th Annual Meeting of Japanese Society for Clinical Renal Transplantation 2024;:236-.$39$YR$A$M$Y$$$20240911$$MD$JP$JP
243074221$24307422$1$I$20240715$20240715$20240911$20240911$PER$$US-CELLTRION INC.-2024US017426$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243074232$24307423$2$F$20240703$20240916$20240911$20240919$EXP$$NVSC2024DE180214$NOVARTIS$$45$YR$$F$Y$110$KG$20240919$$MD$DE$DE
243074241$24307424$1$I$$20240827$20240911$20240911$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00731$GLAND PHARMA$Nakura M.Cases of Advanced Colorectal Cancer with Nephrotic Syndrome after FOLFIRI plus Ramucirumab Administration.Gan to Kagaku Ryoho.DEC-2022;49(13):1745-1747$72$YR$E$M$Y$$$20240911$$HP$JP$JP
243074252$24307425$2$F$20240905$20240909$20240911$20240913$30DAY$$MX-PFIZER INC-PV202400118106$PFIZER$$$$T$F$Y$$$20240913$$CN$MX$MX
243074261$24307426$1$I$$20240807$20240911$20240911$PER$$US-CELLTRION INC.-2024US019153$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243074272$24307427$2$F$20240819$20240916$20240911$20240919$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004946$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240919$$HP$US$US
243074281$24307428$1$I$20240614$20240909$20240911$20240911$EXP$$US-BAYER-2024A129003$BAYER$$31$YR$A$M$Y$$$20240911$$CN$US$US
243074291$24307429$1$I$$20240827$20240911$20240911$EXP$$US-SA-2024SA263024$SANOFI AVENTIS$$$$A$F$Y$$$20240911$$MD$US$US
243074301$24307430$1$I$$20240909$20240911$20240911$PER$$US-DSJP-DSU-2024-144481$DAIICHI$$$$$F$Y$$$20240911$$HP$US$US
243074312$24307431$2$F$20240101$20240912$20240911$20240926$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01448$AVADEL CNS PHARMA$$$$$F$Y$54.422$KG$20240926$$CN$US$US
243074321$24307432$1$I$20240610$20240904$20240911$20240911$EXP$IT-MINISAL02-1000459$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005020$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240911$$MD$IT$IT
243074331$24307433$1$I$20180807$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62300$$FDA-CTU$$$$$F$N$51.8$KG$20240910$N$$US$
243074361$24307436$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62396$$FDA-CTU$$88$YR$$F$N$$$20240911$N$$US$
243074371$24307437$1$I$$20240903$20240911$20240911$EXP$$US-SERVIER-S24011094$SERVIER$$$$$$Y$$$20240911$$CN$US$US
243074381$24307438$1$I$20240820$20240823$20240911$20240911$PER$$US-TEVA-VS-3237692$TEVA$$34$YR$$F$Y$$$20240911$$CN$US$US
243074391$24307439$1$I$$20240905$20240911$20240911$PER$$US-ABBVIE-5909591$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243074402$24307440$2$F$$20240923$20240911$20240926$EXP$$US-BAYER-2024A129570$BAYER$$54$YR$A$F$Y$$$20240926$$CN$US$US
243074411$24307441$1$I$20240715$20240715$20240911$20240911$PER$$US-CELLTRION INC.-2024US017492$CELLTRION$$$$$$Y$$$20240911$$PH$US$US
243074421$24307442$1$I$20240621$20240904$20240911$20240911$EXP$$CN-ROCHE-10000075303$ROCHE$$84$YR$E$F$Y$60$KG$20240911$$HP$CN$CN
243074441$24307444$1$I$$20240901$20240911$20240911$EXP$$US-ABBVIE-5917767$ABBVIE$Peshin S, Modi S, Kolagatla S, Moka N. An Unusual Case of Renal Infiltration in Chronic Lymphocytic Leukemia. Clin Lymphoma Myeloma Leuk. 2024:S340-S341.$67$YR$$F$Y$$$20240911$$MD$US$US
243074451$24307445$1$I$20240725$20240903$20240911$20240911$30DAY$$CA-JNJFOC-20240763757$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240911$$CN$CA$CA
243074462$24307446$2$F$20240821$20240909$20240911$20240913$EXP$SE-SEMPA-2024-006477$SE-JNJFOC-20240925904$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240913$$MD$SE$SE
243074471$24307447$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006232$ELI LILLY AND CO$$$$$$Y$$$20240911$$CN$US$US
243074481$24307448$1$I$20240301$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006500$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243074491$24307449$1$I$20240101$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005616$ELI LILLY AND CO$$$$$$Y$$$20240911$$CN$US$US
243074501$24307450$1$I$20240903$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005396$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240911$$CN$US$US
243074511$24307451$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006368$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240911$$CN$US$US
243074521$24307452$1$I$20210927$20240903$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144503$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240911$$HP$US$US
243074531$24307453$1$I$$20240122$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-24-000011$BECTON DICKINSON$$55$YR$$F$Y$$$20240911$$HP$US$US
243074541$24307454$1$I$$20240827$20240911$20240911$EXP$$KR-GLANDPHARMA-KR-2024GLNLIT00745$GLAND PHARMA$Mi-Hyang Jung.Genetic predisposition in chemotherapy-induced cardiomyopathy in a 65-year-old female with metastatic breast cancer.ESC heart failure.AUG-2024;11 (No. 4):2410-2414$65$YR$E$F$Y$$$20240911$$HP$KR$KR
243074551$24307455$1$I$20240123$20240130$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-24-000063$BECTON DICKINSON$$$$$M$Y$$$20240911$$CN$US$US
243074561$24307456$1$I$20050120$20240905$20240911$20240911$EXP$FR-GlaxoSmithKline-B0396408A$FR-MYLANLABS-2024M1081693$MYLAN$$44$YR$$M$Y$$$20240911$$MD$FR$FR
243074572$24307457$2$F$$20240912$20240911$20240919$EXP$$US-TAKEDA-2024TUS090175$TAKEDA$$$$$F$Y$68.027$KG$20240919$$CN$US$US
243074581$24307458$1$I$$20240122$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-24-000047$BECTON DICKINSON$$$$$$Y$$$20240911$$HP$US$US
243074591$24307459$1$I$$20240122$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-24-000046$BECTON DICKINSON$$$$$$Y$$$20240911$$HP$US$US
243074601$24307460$1$I$$20240122$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-24-000013$BECTON DICKINSON$$$$$$Y$$$20240911$$HP$US$US
243074611$24307461$1$I$$20240827$20240911$20240911$PER$$US-SERVIER-S24011046$SERVIER$$$$$$Y$$$20240911$$HP$US$US
243074621$24307462$1$I$20240820$20240906$20240911$20240911$DIR$FDA-CDER-CTU-2024-62298$$FDA-CTU$$$$$F$N$39.7$KG$20240906$N$$US$
243074651$24307465$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA259687$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240911$$MD$US$US
243074661$24307466$1$I$20240801$20240903$20240911$20240911$PER$$US-SA-2024SA262008$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240911$$HP$US$US
243074671$24307467$1$I$$20240122$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-24-000012$BECTON DICKINSON$$56$YR$$F$Y$$$20240911$$HP$US$US
243074681$24307468$1$I$$20240905$20240911$20240911$EXP$$US-GSK-US2024110652$GLAXOSMITHKLINE$$$$$M$Y$$$20240911$$CN$US$US
243074701$24307470$1$I$$20240122$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-24-000010$BECTON DICKINSON$$56$YR$$M$Y$$$20240911$$HP$US$US
243074711$24307471$1$I$20240719$20240813$20240911$20240911$PER$$US-CELLTRION INC.-2024US019398$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243074721$24307472$1$I$20240711$20240716$20240911$20240911$PER$$US-CELLTRION INC.-2024US017770$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243074731$24307473$1$I$$20240905$20240911$20240911$EXP$$CA-JNJFOC-20240908022$JOHNSON AND JOHNSON$$15$YR$T$M$Y$67$KG$20240911$$HP$CA$CA
243074741$24307474$1$I$$20240520$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-075386$REGENERON$$$$$M$Y$$$20240911$$CN$US$US
243074751$24307475$1$I$$20240529$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-079467$REGENERON$$$$$$Y$$$20240911$$HP$US$US
243074761$24307476$1$I$$20240529$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-080061$REGENERON$$$$$$Y$$$20240911$$MD$US$US
243074771$24307477$1$I$$20240627$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-080193$REGENERON$$$$$$Y$$$20240911$$HP$US$US
243074781$24307478$1$I$$20240613$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-081554$REGENERON$$$$$F$Y$$$20240911$$CN$US$US
243074791$24307479$1$I$$20240906$20240911$20240911$EXP$$US-OTSUKA-2024_025195$OTSUKA$$$$$M$Y$$$20240911$$CN$US$US
243074801$24307480$1$I$20240520$20240612$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-077553$REGENERON$$$$$M$Y$$$20240911$$CN$US$US
243074812$24307481$2$F$$20240909$20240911$20240916$PER$$US-AMGEN-USASP2024180366$AMGEN$$$$$$Y$$$20240916$$MD$US$US
243074821$24307482$1$I$20240808$20240905$20240911$20240911$EXP$FR-AFSSAPS-TS2024000948$FR-MYLANLABS-2024M1081550$MYLAN$$46$YR$$F$Y$58$KG$20240911$$MD$FR$FR
243074832$24307483$2$F$$20240910$20240911$20240916$EXP$$IN-VANTIVE-2024VAN019684$Vantive US Healthcare$$76$YR$$M$Y$$$20240916$$CN$IN$IN
243074841$24307484$1$I$$20240906$20240911$20240911$EXP$$US-ABBVIE-5916794$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243074851$24307485$1$I$20240101$20240906$20240911$20240911$30DAY$$GR-PFIZER INC-PV202400118012$PFIZER$$9$YR$$M$Y$30$KG$20240911$$CN$GR$GR
243074861$24307486$1$I$$20240601$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-081616$REGENERON$$$$$$Y$$$20240911$$MD$US$US
243074871$24307487$1$I$20240718$20240718$20240911$20240911$PER$$US-CELLTRION INC.-2024US017892$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243074881$24307488$1$I$$20240906$20240911$20240911$EXP$$CA-JNJFOC-20240774921$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240911$$HP$CA$CA
243074891$24307489$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA261647$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240911$$HP$US$US
243074901$24307490$1$I$20240101$20240902$20240911$20240911$EXP$$AU-UCBSA-2024044983$UCB$$$$$F$Y$$$20240911$$MD$AU$AU
243074911$24307491$1$I$$20240903$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0013131$DR REDDYS$Gangat N, Ajufo H, Abdelmagid M, Karrar O, McCullough K, Badar T, et al. IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience. British Journal of Haematology. 2023;203(3): e87-e92. doi:10.1111/bjh.19027.$81$YR$E$F$Y$$$20240911$$HP$US$US
243074921$24307492$1$I$$20240904$20240911$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001798$BLUEPRINT MEDICINES$$$$$F$Y$$$20240911$$CN$US$US
243074931$24307493$1$I$$20240905$20240911$20240911$EXP$$PT-MYLANLABS-2024M1072604$MYLAN$Beatriz Castro Silva, Maria Ana Flores, Gon?alo Jantarada Domingos, Sergio Paulo, Carla Mimoso Santos, Robert Badura. Umbilicated injuries in the monkeypox time. Congresses of the Portuguese Society of Internal Medicine:30th National Congress. 2024;1296$25$YR$$F$Y$$$20240911$$HP$PT$PT
243074941$24307494$1$I$20240801$20240911$20240911$20240911$EXP$$CZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050768$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240911$$MD$CZ$CZ
243074951$24307495$1$I$$20240909$20240911$20240911$EXP$$NVSC2024US181144$NOVARTIS$$$$$F$Y$$$20240911$$MD$US$US
243074961$24307496$1$I$$20240905$20240911$20240911$EXP$$TN-MYLANLABS-2024M1082680$MYLAN$Achour TB, Jridi M, Naceur I, Said F, Smiti M. Tocilizumab: a promising remission treatment in takayasu arteritis. Eur-J-Case-Rep-Intern-Med 2024; 11 (Suppl. 1) 1059-1060.$$$A$F$Y$$$20240911$$HP$TN$TN
243074971$24307497$1$I$$20240830$20240911$20240911$EXP$$US-MYLANLABS-2024M1081425$MYLAN$Angeli A, Blazek A, Stephenson C. 64-Year-Old Woman With Fevers and Abdominal Pain. Mayo-Clin-Proc 2024; 99 (8): 1312-1316.$64$YR$$F$Y$$$20240911$$MD$US$US
243074981$24307498$1$I$$20240904$20240911$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024110168$VIIV$$$$$M$Y$$$20240911$$MD$US$US
243074991$24307499$1$I$20240821$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024178845$AMGEN$$62$YR$A$F$Y$$$20240911$$PH$US$US
243075001$24307500$1$I$$20240827$20240911$20240911$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00743$GLAND PHARMA$S Murata.Bloodstream infection caused by Wickerhamiella pararugosa in a patient with intestinal obstruction: A case report.Journal of Infection and Chemotherapy.SEP-2024;30:942-945$9$DEC$E$F$Y$$$20240911$$HP$JP$JP
243075011$24307501$1$I$$20240830$20240911$20240911$DIR$FDA-CDER-CTU-2024-62391$$FDA-CTU$$$$$F$N$$$20240830$N$HP$US$
243075021$24307502$1$I$$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62399$$FDA-CTU$$$$$M$N$$$20240910$N$HP$US$
243075031$24307503$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62414$$FDA-CTU$$53$YR$$F$N$111.58$KG$20240911$N$$US$
243075041$24307504$1$I$$20240910$20240910$20240910$DIR$717887$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243075051$24307505$1$I$20240910$20240910$20240910$20240910$DIR$717883$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243075071$24307507$1$I$$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62394$$FDA-CTU$$$$$F$N$$$20240910$N$HP$US$
243075081$24307508$1$I$20240714$20240723$20240911$20240911$PER$$US-CELLTRION INC.-2024US018182$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243075101$24307510$1$I$$20240909$20240911$20240911$PER$$US-BEH-2024178439$CSL BEHRING$$$$$F$Y$$$20240911$$CN$US$US
243075111$24307511$1$I$20240101$20240906$20240911$20240911$PER$$US-BEH-2024178354$CSL BEHRING$$4$YR$C$M$Y$$$20240911$$HP$US$US
243075121$24307512$1$I$20240101$20240610$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-083808$REGENERON$$$$$$Y$$$20240911$$CN$US$US
243075131$24307513$1$I$20230101$20240903$20240911$20240911$EXP$$AU-JNJFOC-20240914810$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$HP$AU$AU
243075141$24307514$1$I$20240816$20240816$20240911$20240911$PER$$US-CELLTRION INC.-2024US019999$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243075151$24307515$1$I$$20240906$20240911$20240911$EXP$$US-MYLANLABS-2024M1082761$MYLAN$$99$YR$$M$Y$$$20240911$$CN$US$US
243075161$24307516$1$I$20240715$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143110$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$71.21$KG$20240911$$HP$US$US
243075171$24307517$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144782$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$92.99$KG$20240911$$CN$US$US
243075181$24307518$1$I$20230101$20240610$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-083838$REGENERON$$$$$$Y$$$20240911$$CN$US$US
243075191$24307519$1$I$20240319$20240902$20240911$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-144256$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$54.5$KG$20240911$$MD$JP$JP
243075201$24307520$1$I$20240419$20240618$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-086969$REGENERON$$$$$F$Y$$$20240911$$HP$US$US
243075221$24307522$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP010009$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243075231$24307523$1$I$$20240821$20240911$20240911$EXP$$US-SA-2024SA262150$SANOFI AVENTIS$$$$E$F$Y$68.18$KG$20240911$$CN$US$US
243075241$24307524$1$I$$20240904$20240911$20240911$EXP$$CA-ABBVIE-5910146$ABBVIE$$$$A$F$Y$$$20240911$$CN$CA$CA
243075251$24307525$1$I$20240101$20240618$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-087512$REGENERON$$$$$$Y$$$20240911$$HP$US$US
243075271$24307527$1$I$20231219$20240905$20240911$20240911$EXP$$US-OTSUKA-2024_020730$OTSUKA$$33$YR$$F$Y$109.3$KG$20240911$$MD$US$US
243075281$24307528$1$I$20240814$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62299$$FDA-CTU$$$$$F$N$65.3$KG$20240910$N$$US$
243075291$24307529$1$I$20240410$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687267$GILEAD$$54$YR$A$F$Y$$$20240911$$PH$US$US
243075301$24307530$1$I$$20240905$20240911$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024110807$VIIV$$$$A$M$Y$$$20240911$$HP$US$US
243075311$24307531$1$I$20240830$20240903$20240911$20240911$30DAY$$US-GSK-US2024109476$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240911$$CN$US$US
243075321$24307532$1$I$$20240910$20240910$20240910$DIR$717891$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243075331$24307533$1$I$20240906$20240910$20240910$20240910$DIR$717890$$FDA-CTU$$67$YR$$M$N$94.5$KG$20240910$N$CN$US$
243075341$24307534$1$I$$20240904$20240911$20240911$EXP$$CA-GSK-CA2024110159$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$CA$CA
243075351$24307535$1$I$20240630$20240819$20240911$20240911$PER$$US-CELLTRION INC.-2024US016699$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243075362$24307536$2$F$$20240911$20240911$20240918$PER$$US-SA-2024SA260990$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240918$$HP$US$US
243075371$24307537$1$I$20240101$20240904$20240911$20240911$EXP$$AR-SA-2024SA262939$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240911$$HP$AR$AR
243075381$24307538$1$I$$20240627$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-090839$REGENERON$$$$$$Y$$$20240911$$MD$US$US
243075391$24307539$1$I$20240702$20240703$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-093547$REGENERON$$$$$$Y$$$20240911$$CN$US$US
243075401$24307540$1$I$20240101$20240627$20240911$20240911$5DAY$$US-REGENERON PHARMACEUTICALS, INC.-2024-088228$REGENERON$$$$$F$Y$$$20240911$$CN$US$US
243075411$24307541$1$I$$20240827$20240911$20240911$EXP$$BD-GLANDPHARMA-BD-2024GLNLIT00725$GLAND PHARMA$Sabbir Hossain.A Case of Milk Alkali Syndrome: The Forgotten Diagnosis of Generalized Weakness and Altered Consciousness.Journal of Medicine.JUL-2024;25:184-186$76$YR$E$M$Y$$$20240911$$MD$BD$BD
243075421$24307542$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA261661$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240911$$HP$US$US
243075431$24307543$1$I$20240901$20240903$20240911$20240911$PER$$US-SA-2024SA261620$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240911$$HP$US$US
243075441$24307544$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA261099$SANOFI AVENTIS$$$$E$F$Y$$$20240911$$CN$US$US
243075461$24307546$1$I$20240123$20240821$20240911$20240911$PER$$US-SA-2024SA262471$SANOFI AVENTIS$$34$YR$A$M$Y$99.33$KG$20240911$$MD$US$US
243075471$24307547$1$I$20240101$20240821$20240911$20240911$PER$$US-SA-2024SA259900$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240911$$MD$US$US
243075481$24307548$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA259650$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240911$$HP$US$US
243075492$24307549$2$F$20240101$20240910$20240911$20240918$PER$$US-SA-2024SA262176$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240918$$HP$US$US
243075501$24307550$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA259181$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240911$$HP$US$US
243075511$24307551$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA261044$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240911$$HP$US$US
243075521$24307552$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA261140$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240911$$HP$US$US
243075531$24307553$1$I$$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-136217-2023$RECKITT BENCKISER$$84$YR$$F$Y$$$20240911$$CN$US$US
243075541$24307554$1$I$20240101$20240910$20240911$20240911$EXP$$EG-PFIZER INC-PV202400119221$PFIZER$$60$YR$$F$Y$$$20240911$$CN$EG$EG
243075551$24307555$1$I$20240903$20240910$20240911$20240911$EXP$$US-PFIZER INC-202400253471$PFIZER$$57$YR$$F$Y$$$20240911$$HP$US$US
243075561$24307556$1$I$20240704$20240910$20240911$20240911$EXP$SE-SEMPA-2024-006564$SE-PFIZER INC-202400253453$PFIZER$$70$YR$$F$Y$$$20240911$$MD$SE$SE
243075572$24307557$2$F$20240307$20240924$20240911$20240926$EXP$$US-PFIZER INC-202400253187$PFIZER$$61$YR$$F$Y$95.238$KG$20240926$$CN$US$US
243075581$24307558$1$I$20240821$20240909$20240911$20240911$EXP$$CN-PFIZER INC-PV202400118163$PFIZER$$43$YR$$F$Y$57$KG$20240911$$HP$CN$CN
243075591$24307559$1$I$20240601$20240904$20240911$20240911$EXP$$US-ABBVIE-5909908$ABBVIE$$55$YR$$M$Y$$$20240911$$CN$US$US
243075601$24307560$1$I$$20240906$20240911$20240911$EXP$$BR-PFIZER INC-202400253629$PFIZER$$$$$F$Y$$$20240911$$CN$BR$BR
243075611$24307561$1$I$20240801$20240910$20240911$20240911$EXP$$JP-PFIZER INC-PV202400118801$PFIZER$$49$YR$$M$Y$$$20240911$$MD$JP$JP
243075621$24307562$1$I$$20240909$20240911$20240911$EXP$$DE-PFIZER INC-202400252459$PFIZER$$$$E$F$Y$$$20240911$$MD$DE$DE
243075634$24307563$4$F$$20240925$20240911$20240930$EXP$$US-PFIZER INC-202400253826$PFIZER$$77$YR$$F$Y$49.9$KG$20240930$$HP$US$US
243075651$24307565$1$I$$20240909$20240911$20240911$EXP$$US-PFIZER INC-202400253158$PFIZER$$72$YR$$M$Y$$$20240911$$CN$US$US
243075661$24307566$1$I$$20240909$20240911$20240911$EXP$$DE-PFIZER INC-202400252456$PFIZER$$$$$$Y$$$20240911$$CN$DE$DE
243075681$24307568$1$I$20240819$20240910$20240911$20240911$EXP$DK-DKMA-30738284$DK-PFIZER INC-202400253377$PFIZER$$65$YR$$M$Y$70$KG$20240911$$MD$DK$DK
243075692$24307569$2$F$20240909$20240911$20240911$20240912$EXP$$JP-PFIZER INC-PV202400118834$PFIZER$$78$YR$$M$Y$$$20240912$$MD$JP$JP
243075711$24307571$1$I$20240908$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180566$AMGEN$$71$YR$E$F$Y$$$20240911$$CN$US$US
243075721$24307572$1$I$$20240823$20240911$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08535$LUPIN$$$$$$Y$$$20240911$$CN$US$US
243075731$24307573$1$I$$20240905$20240911$20240911$EXP$$US-ABBVIE-5910152$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243075741$24307574$1$I$$20240906$20240911$20240911$EXP$$GB-ABBVIE-5913753$ABBVIE$$$$E$M$Y$$$20240911$$CN$GB$GB
243075751$24307575$1$I$20240101$20240906$20240911$20240911$EXP$$US-ABBVIE-5913967$ABBVIE$$60$YR$$M$Y$$$20240911$$CN$US$US
243075761$24307576$1$I$20240304$20240904$20240911$20240911$EXP$PT-INFARMED-A202408-472$PT-TEVA-VS-3240477$TEVA$$21$YR$$F$Y$$$20240911$$CN$PT$PT
243075771$24307577$1$I$$20240827$20240911$20240911$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00729$GLAND PHARMA$Meng Liu.Efficacy and safety analysis of first-line tirelizumab combined with paclitaxelcontaining chemotherapy regimen in 30 cases of real-world advanced gastric cancer in China.Journal of Clinical Oncology.JUN-2024;42$$$$$Y$$$20240911$$HP$CN$CN
243075781$24307578$1$I$$20240905$20240911$20240911$EXP$$CO-AMGEN-COLSP2024179490$AMGEN$$45$YR$A$F$Y$$$20240911$$CN$CO$CO
243075791$24307579$1$I$20240711$20240905$20240911$20240911$EXP$GB-MHRA-MED-202409051602228240-CRTJQ$GB-RDY-SPO/GBR/24/0013057$DR REDDYS$$$$$$Y$$$20240911$$HP$GB$GB
243075803$24307580$3$F$$20240918$20240911$20240922$PER$$US-AMGEN-USASP2024178006$AMGEN$$$$E$F$Y$62.58$KG$20240922$$HP$US$US
243075811$24307581$1$I$20240301$20240909$20240911$20240911$EXP$FR-AFSSAPS-RN2024000965$FR-ORGANON-O2409FRA000638$ORGANON$$61$YR$$F$Y$$$20240911$$MD$FR$FR
243075821$24307582$1$I$$20240903$20240911$20240911$EXP$$JP-AstraZeneca-2024A200888$ASTRAZENECA$$60$YR$$F$Y$$$20240911$$MD$JP$
243075841$24307584$1$I$20240101$20240905$20240911$20240911$EXP$$NVSC2024FR131460$NOVARTIS$$64$YR$$M$Y$90$KG$20240911$$MD$FR$FR
243075851$24307585$1$I$$20240904$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004890$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243075861$24307586$1$I$20240902$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003710$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240911$$HP$US$US
243075871$24307587$1$I$20240903$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003542$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240911$$CN$US$US
243075882$24307588$2$F$$20240911$20240911$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141791$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240917$$CN$US$US
243075891$24307589$1$I$$20240903$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141844$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$90.72$KG$20240911$$CN$US$US
243075902$24307590$2$F$20240830$20240903$20240911$20240917$EXP$$CN-ROCHE-10000073046$ROCHE$$78$YR$E$F$Y$62$KG$20240917$$HP$CN$CN
243075912$24307591$2$F$$20240902$20240911$20240912$EXP$$MX-SANDOZ INC.-NVSC2023MX141025$SANDOZ$$$$$F$Y$64$KG$20240912$$CN$MX$MX
243075921$24307592$1$I$20240702$20240829$20240911$20240911$EXP$$CA-HLS-202401671$HLS THERAPEUTICS$$91$YR$E$M$Y$74$KG$20240911$$PH$CA$CA
243075931$24307593$1$I$$20240827$20240911$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08632$LUPIN$$$$$$Y$$$20240911$$CN$US$US
243075941$24307594$1$I$20240701$20240906$20240911$20240911$EXP$$FR-ANIPHARMA-2024-FR-000159$ANI$$83$YR$$F$Y$$$20240911$$PH$FR$FR
243075961$24307596$1$I$20240811$20240904$20240911$20240911$EXP$$JP-GENMAB-2024-02995$GENMAB$$70$YR$$$Y$$$20240911$$MD$JP$JP
243075971$24307597$1$I$20230801$20240820$20240911$20240911$PER$$US-CELLTRION INC.-2024US016433$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243075981$24307598$1$I$$20240905$20240911$20240911$EXP$$NL-VER-202400058$VERITY PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$NL$NL
243075991$24307599$1$I$20240701$20240812$20240911$20240911$PER$$US-CELLTRION INC.-2024US018458$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243076001$24307600$1$I$$20240907$20240911$20240911$PER$$US-JNJFOC-20240919614$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243076011$24307601$1$I$$20240907$20240911$20240911$PER$$US-TAKEDA-2024TUS090134$TAKEDA$$$$A$M$Y$$$20240911$$CN$US$US
243076021$24307602$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240710$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$$$Y$$$20240911$$HP$US$US
243076031$24307603$1$I$20240101$20240905$20240911$20240911$EXP$$JP-OTSUKA-2024_025149$OTSUKA$$$$$$Y$$$20240911$$MD$JP$JP
243076041$24307604$1$I$$20240827$20240911$20240911$EXP$$ES-GLANDPHARMA-ES-2024GLNLIT00738$GLAND PHARMA$Luis Posado-Dominguez.Paraneoplastic leukocytosis secondary to carcinosarcoma:  a report of two cases and literature review.Chinese Clinical Oncology.31-MAY-2024;13:1-7$65$YR$A$M$Y$$$20240911$$MD$ES$ES
243076051$24307605$1$I$$20240902$20240911$20240911$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08254$HIKMA$$77$YR$$M$Y$61$KG$20240911$$PH$CA$CA
243076061$24307606$1$I$20231009$20240908$20240911$20240911$EXP$$EG-SANDOZ INC.-SDZ2024EG079160$SANDOZ$$42$YR$$F$Y$$$20240911$$CN$EG$EG
243076091$24307609$1$I$$20240909$20240911$20240911$PER$$US-BIOGEN-2024BI01281861$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243076101$24307610$1$I$$20240909$20240911$20240911$PER$$US-BIOGEN-2024BI01281729$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243076111$24307611$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA262641$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240911$$HP$US$US
243076121$24307612$1$I$$20240821$20240911$20240911$PER$$US-SA-2024SA262011$SANOFI AVENTIS$$4$YR$C$$Y$$$20240911$$PH$US$US
243076131$24307613$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009965$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243076141$24307614$1$I$20231220$20240904$20240911$20240911$EXP$$US-OTSUKA-2023_033237$OTSUKA$$$$$M$Y$$$20240911$$CN$US$US
243076151$24307615$1$I$$20240823$20240911$20240911$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08539$LUPIN$$$$$$Y$$$20240911$$CN$US$US
243076161$24307616$1$I$$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-135727-2023$RECKITT BENCKISER$$$$$F$Y$$$20240911$$CN$US$US
243076181$24307618$1$I$20240701$20240730$20240911$20240911$PER$$US-CELLTRION INC.-2024US018157$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243076191$24307619$1$I$20240718$20240909$20240911$20240911$EXP$IE-HPRA-2024-115204$IE-ORGANON-O2409IRL000584$ORGANON$$23$YR$$F$Y$$$20240911$$MD$IE$IE
243076201$24307620$1$I$$20240904$20240911$20240911$EXP$DE-BFARM-24006022$DE-TEVA-VS-3241167$TEVA$$$$$F$Y$$$20240911$$CN$DE$DE
243076211$24307621$1$I$20200612$20240906$20240911$20240911$EXP$PL-URPL-1-1868-2020$PL-ABBVIE-5918309$ABBVIE$$42$YR$$F$Y$$$20240911$$MD$PL$PL
243076221$24307622$1$I$$20240903$20240911$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143676$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240911$$PH$JP$JP
243076231$24307623$1$I$$20240910$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144213$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$50$KG$20240911$$CN$US$US
243076241$24307624$1$I$$20240905$20240911$20240911$EXP$$FR-DSJP-DSE-2024-144311$DAIICHI$$$$E$F$Y$68$KG$20240911$$MD$FR$FR
243076251$24307625$1$I$20240801$20240909$20240911$20240911$PER$$US-BIOGEN-2024BI01281860$BIOGEN$$45$YR$$F$Y$$$20240911$$CN$US$US
243076262$24307626$2$F$$20240814$20240911$20240912$PER$$US-009507513-2408USA006398$MERCK$$$$E$M$Y$64$KG$20240912$$MD$US$US
243076272$24307627$2$F$$20240905$20240911$20240912$EXP$$BR-GENMAB-2024-03293$GENMAB$$56$YR$$M$Y$$$20240912$$MD$BR$BR
243076283$24307628$3$F$$20240913$20240911$20240918$EXP$$GB-SANDOZ INC.-SDZ2024GB079209$SANDOZ$$$$$F$Y$$$20240918$$CN$GB$GB
243076291$24307629$1$I$20231224$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62294$$FDA-CTU$$$$$F$N$76.9$KG$20240910$N$$US$
243076311$24307631$1$I$$20240910$20240910$20240910$DIR$717897$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243076321$24307632$1$I$20240910$20240910$20240910$20240910$DIR$717899$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243076331$24307633$1$I$20240910$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62395$$FDA-CTU$$86$YR$$F$N$$$20240911$N$$US$
243076341$24307634$1$I$20240904$20240910$20240910$20240910$DIR$717900$$FDA-CTU$$72$YR$$F$N$83.25$KG$20240910$N$CN$US$
243076351$24307635$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62390$$FDA-CTU$$63$YR$$M$N$$$20240911$N$$US$
243076361$24307636$1$I$$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62392$$FDA-CTU$$46$YR$$F$N$$$20240910$N$$US$
243076371$24307637$1$I$$20240910$20240910$20240910$DIR$717901$$FDA-CTU$$$$$UNK$N$$$20240910$$CN$US$
243076381$24307638$1$I$$20240911$20240911$20240911$DIR$717961$$FDA-CTU$$$$$UNK$N$$$20240911$N$CN$US$
243076391$24307639$1$I$20240910$20240910$20240910$20240910$DIR$717903$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243076402$24307640$2$F$$20240918$20240911$20240927$EXP$$US-TEVA-VS-3240594$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R,...$$$$$Y$$$20240927$$HP$US$US
243076411$24307641$1$I$20240629$20240906$20240911$20240911$EXP$$JP-SHIONOGI INC.-2024002459$SHIONOGI$$$$$$Y$$$20240911$$MD$JP$JP
243076421$24307642$1$I$$20240909$20240911$20240911$PER$$US-HALEON-2196103$Haleon PLC$$30$YR$$M$Y$$$20240911$$MD$US$US
243076431$24307643$1$I$20240728$20240730$20240911$20240911$PER$$US-CELLTRION INC.-2024US018578$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243076441$24307644$1$I$20240903$20240905$20240911$20240911$PER$$US-ALXN-202409USA000351US$ALEXION PHARMACEUTICALS$$78$YR$$F$Y$$$20240911$$CN$US$US
243076451$24307645$1$I$$20240904$20240911$20240911$EXP$$US-ABBVIE-5909071$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243076471$24307647$1$I$20240101$20240905$20240911$20240911$EXP$$FR-ABBVIE-5915291$ABBVIE$$20$YR$$F$Y$$$20240911$$MD$FR$FR
243076481$24307648$1$I$20240807$20240902$20240911$20240911$EXP$$GB-TEVA-VS-3239912$TEVA$$73$YR$$M$Y$84$KG$20240911$$MD$GB$GB
243076491$24307649$1$I$20230927$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-113410-2023$RECKITT BENCKISER$$$$$M$Y$$$20240911$$CN$US$US
243076501$24307650$1$I$20240822$20240902$20240911$20240911$EXP$GB-MHRA-MED-202409020839563320-DLCMP$GB-TEVA-VS-3239526$TEVA$$58$YR$$F$Y$56$KG$20240911$$CN$GB$GB
243076511$24307651$1$I$20240426$20240904$20240911$20240911$EXP$$IN-CIPLA LTD.-2024IN08234$CIPLA$$$$$$Y$$$20240911$$CN$IN$IN
243076531$24307653$1$I$$20240904$20240911$20240911$PER$$JP-Eisai-EC-2024-173790$EISAI$Yamada Koki. Treatment strategy based on experience with Scheduled LEN-TACE. Okinawa Prefecture HCC Treatment Seminar - Considering treatment strategies aimed at maximizing TACA treatment and drug treatment - CQ discussion; 2024 Sep 11-2024 Sep 11; .$$$E$M$Y$65$KG$20240911$$MD$JP$JP
243076541$24307654$1$I$20240520$20240904$20240911$20240911$EXP$$US-Eisai-EC-2024-161687$EISAI$$77$YR$E$F$Y$88.09$KG$20240911$$MD$US$US
243076551$24307655$1$I$20221024$20240902$20240911$20240911$PER$$JP-Eisai-EC-2023-133341$EISAI$$58$YR$A$F$Y$$$20240911$$MD$JP$JP
243076561$24307656$1$I$20240808$20240904$20240911$20240911$PER$$JP-Eisai-EC-2024-173781$EISAI$$$$E$F$Y$$$20240911$$MD$JP$JP
243076571$24307657$1$I$$20240906$20240911$20240911$EXP$$JP-Eisai-EC-2024-173872$EISAI$$$$E$F$Y$$$20240911$$MD$JP$JP
243076581$24307658$1$I$$20240906$20240911$20240911$PER$$JP-Eisai-EC-2024-173907$EISAI$Akaishi, Y., et al.. Five Cases of Pseudocirrhosis during Eribulin Treatment for Breast Cancer. Cancer  chemotherapy. 2024; 51(7): 753-755.$34$YR$A$$Y$$$20240911$$MD$JP$JP
243076592$24307659$2$F$20240101$20240913$20240911$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-025597$UNITED THERAPEUTICS$$$$$F$Y$117.91$KG$20240919$$$US$US
243076602$24307660$2$F$20231001$20240911$20240911$20240919$PER$$JP-Eisai-EC-2024-173682$EISAI$Tae Oike. A retrospective study of 16 cases of recurrent uterine body cancer treated with pembrolizumab and lenvatinib combination therapy in our hospital. Japanese Journal of Gynecological Oncology. 2024; 42(3): 040-.$$$A$F$Y$$$20240919$$MD$JP$JP
243076611$24307661$1$I$$20240905$20240911$20240911$PER$$JP-Eisai-EC-2024-173791$EISAI$$$$A$M$Y$$$20240911$$MD$JP$JP
243076621$24307662$1$I$$20240829$20240911$20240911$EXP$$GB-CIPLA LTD.-2024GB09625$CIPLA$$$$$$Y$$$20240911$$CN$GB$GB
243076652$24307665$2$F$$20240923$20240911$20240925$EXP$$CA-PFIZER INC-PV202400117993$PFIZER$Milnes, A.. Drug-Drug Interaction or a Local Anesthetic Overdose?. Anesthesia and Analgesia. 2007;104(5):1294$$$$$Y$$$20240925$$HP$CA$CA
243076661$24307666$1$I$20230101$20240909$20240911$20240911$EXP$$FR-PFIZER INC-202400252537$PFIZER$$81$YR$$F$Y$50.2$KG$20240911$$MD$FR$FR
243076671$24307667$1$I$$20240903$20240911$20240911$EXP$$PH-PFIZER INC-2024SGN04611$PFIZER$$28$YR$$F$Y$$$20240911$$CN$PH$PH
243076692$24307669$2$F$$20240920$20240911$20240924$EXP$$JP-PFIZER INC-PV202400117573$PFIZER$Niimoto, T.. Cytokine release syndrome following COVID-19 infection during treatment with nivolumab for cancer of esophagogastric junction carcinoma: a case report and review. International Journal of Emergency Medicine. 2024;17(1):106$60$YR$$M$Y$$$20240924$$HP$JP$JP
243076711$24307671$1$I$$20240910$20240911$20240911$EXP$$NVSC2024CL181323$NOVARTIS$$$$E$M$Y$$$20240911$$CN$CL$CL
243076722$24307672$2$F$20240701$20240915$20240911$20240924$EXP$$JP-ROCHE-10000035718$ROCHE$$83$YR$E$F$Y$$$20240924$$MD$JP$JP
243076731$24307673$1$I$$20240823$20240911$20240911$PER$$US-TEVA-VS-3237777$TEVA$$$$$$Y$$$20240911$$CN$US$US
243076741$24307674$1$I$$20240904$20240911$20240911$EXP$$US-GSK-US2024AMR111520$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$US$US
243076751$24307675$1$I$$20240904$20240911$20240911$EXP$$US-GSK-US2024110058$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$US$US
243076761$24307676$1$I$20240714$20240730$20240911$20240911$PER$$US-CELLTRION INC.-2024US018189$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243076771$24307677$1$I$$20240827$20240911$20240911$EXP$$AU-PHARMAAND GMBH-2024PHR00510$pharmaAND$$$$$$Y$$$20240911$$PH$AU$AU
243076781$24307678$1$I$$20240909$20240911$20240911$EXP$$BG-ABBVIE-5915553$ABBVIE$$74$YR$$F$Y$$$20240911$$CN$BG$BG
243076791$24307679$1$I$20240617$20240716$20240911$20240911$PER$$US-CELLTRION INC.-2024US014790$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243076801$24307680$1$I$$20240606$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202406004695$ELI LILLY AND CO$$$$$F$Y$$$20240911$$HP$US$US
243076811$24307681$1$I$$20240909$20240911$20240911$EXP$$GR-SANDOZ INC.-PHHY2019GR096061$SANDOZ$$63$YR$$M$Y$$$20240911$$MD$GR$GR
243076821$24307682$1$I$20230403$20240904$20240911$20240911$EXP$ES-AEMPS-1564682$ES-ROCHE-10000077426$ROCHE$$63$YR$A$F$Y$$$20240911$$MD$ES$ES
243076831$24307683$1$I$$20240904$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003868$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240911$$MD$US$US
243076841$24307684$1$I$$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003899$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240911$$CN$US$US
243076881$24307688$1$I$20240908$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180143$AMGEN$$60$YR$A$F$Y$$$20240911$$CN$US$US
243076892$24307689$2$F$$20240905$20240911$20240919$PER$$US-AMGEN-USASP2024178118$AMGEN$$$$$$Y$$$20240919$$HP$US$US
243076901$24307690$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144250$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240911$$MD$US$US
243076911$24307691$1$I$$20240908$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142996$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$95.25$KG$20240911$$CN$US$US
243076921$24307692$1$I$20240731$20240909$20240911$20240911$EXP$FR-AFSSAPS-AM2024000716$FR-SANDOZ INC.-SDZ2024FR078777$SANDOZ$$20$YR$$F$Y$80$KG$20240911$$MD$FR$FR
243076931$24307693$1$I$20240829$20240905$20240911$20240911$EXP$IT-MINISAL02-1000925$IT-MYLANLABS-2024M1081710$MYLAN$$23$YR$$F$Y$$$20240911$$PH$IT$IT
243076941$24307694$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143300$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$87.54$KG$20240911$$CN$US$US
243076951$24307695$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144640$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240911$$CN$US$US
243076971$24307697$1$I$20240828$20240906$20240911$20240911$EXP$$US-JNJFOC-20240922311$JOHNSON AND JOHNSON$$50$YR$A$F$Y$50$KG$20240911$$HP$US$US
243076981$24307698$1$I$20180601$20240904$20240911$20240911$EXP$$JP-ABBVIE-5915054$ABBVIE$$39$YR$$M$Y$75$KG$20240911$$MD$JP$JP
243076991$24307699$1$I$$20240829$20240911$20240911$30DAY$$DE-PFIZER INC-PV202400113813$PFIZER$$$$$F$Y$$$20240911$$CN$DE$DE
243077001$24307700$1$I$$20240906$20240911$20240911$EXP$$HR-PFIZER INC-202400252086$PFIZER$Kranjcec, I.. Pharmacogenetic profiling of paediatric oncology patients: a single-centre experience. Paediatria Croatica. 2024;68(2):55-64$2$YR$$M$Y$$$20240911$$HP$HR$HR
243077022$24307702$2$F$20240903$20240913$20240911$20240913$30DAY$$US-PFIZER INC-202400251352$PFIZER$$7$YR$$F$Y$19.048$KG$20240913$$CN$US$US
243077041$24307704$1$I$$20240906$20240911$20240911$EXP$$HR-PFIZER INC-202400252084$PFIZER$Kranjcec, I.. Pharmacogenetic profiling of paediatric oncology patients: a single-centre experience. Paediatria Croatica. 2024;68(2):55-64$2$YR$$F$Y$$$20240911$$HP$HR$HR
243077051$24307705$1$I$20240614$20240617$20240911$20240911$PER$$US-CELLTRION INC.-2024US015016$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243077061$24307706$1$I$$20240904$20240911$20240911$EXP$$HU-ROCHE-10000073962$ROCHE$$2$YR$C$M$Y$$$20240911$$MD$HU$HU
243077071$24307707$1$I$$20240910$20240910$20240910$DIR$717905$$FDA-CTU$$$$$UNK$N$$$20240910$$CN$US$
243077081$24307708$1$I$20240910$20240910$20240910$20240910$DIR$717906$$FDA-CTU$$$$$UNK$N$$$20240910$N$CN$US$
243077091$24307709$1$I$20240803$20240911$20240911$20240911$DIR$717954$$FDA-CTU$$66$YR$$F$N$81$KG$20240911$N$CN$US$
243077111$24307711$1$I$$20240911$20240911$20240911$DIR$717963$$FDA-CTU$$$$$UNK$N$$$20240911$N$CN$US$
243077121$24307712$1$I$20240714$20240911$20240911$20240911$DIR$717958$$FDA-CTU$$56$YR$$M$N$95.4$KG$20240911$N$CN$US$
243077131$24307713$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62404$$FDA-CTU$$51$YR$$F$N$9.98$KG$20240911$N$$US$
243077141$24307714$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62418$$FDA-CTU$$60$YR$$M$N$$$20240911$N$$US$
243077151$24307715$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62412$$FDA-CTU$$46$YR$$F$N$117.93$KG$20240911$N$$US$
243077161$24307716$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62407$$FDA-CTU$$62$YR$$F$N$$$20240911$N$$US$
243077171$24307717$1$I$20240909$20240911$20240911$20240911$DIR$717951$$FDA-CTU$$42$YR$$F$N$99$KG$20240911$N$CN$US$
243077181$24307718$1$I$20240903$20240910$20240910$20240910$DIR$717915$$FDA-CTU$$59$YR$$M$N$64.2$KG$20240910$N$PH$US$
243077191$24307719$1$I$$20240910$20240910$20240910$DIR$717913$$FDA-CTU$$$$$UNK$N$$$20240910$$CN$US$
243077201$24307720$1$I$$20240910$20240910$20240910$DIR$717912$$FDA-CTU$$$$$UNK$N$$$20240910$$CN$US$
243077211$24307721$1$I$$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62402$$FDA-CTU$$$$$M$N$65.77$KG$20240910$N$$US$
243077221$24307722$1$I$20240828$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62400$$FDA-CTU$$70$YR$$F$N$$$20240911$N$CN$US$
243077231$24307723$1$I$$20240902$20240911$20240911$EXP$$US-TEVA-VS-3240706$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240911$$HP$US$US
243077241$24307724$1$I$20240716$20240806$20240911$20240911$PER$$US-CELLTRION INC.-2024US018455$CELLTRION$$$$$$Y$$$20240911$$CN$US$US
243077253$24307725$3$F$20240801$20240917$20240911$20240927$EXP$$JP-JNJFOC-20240906287$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240927$$MD$JP$JP
243077261$24307726$1$I$$20240908$20240911$20240911$PER$$US-JNJFOC-20240920250$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243077271$24307727$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000603US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243077281$24307728$1$I$$20240903$20240911$20240911$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK093847$GLENMARK$$$$$$Y$$$20240911$$MD$GB$GB
243077291$24307729$1$I$$20240905$20240911$20240911$30DAY$$US-PFIZER INC-202400251846$PFIZER$$7$YR$$F$Y$$$20240911$$CN$US$US
243077311$24307731$1$I$20240831$20240903$20240911$20240911$30DAY$$AR-PFIZER INC-202400249925$PFIZER$$14$YR$$M$Y$$$20240911$$CN$AR$AR
243077331$24307733$1$I$$20240906$20240911$20240911$30DAY$$US-PFIZER INC-202400251974$PFIZER$$13$YR$$F$Y$$$20240911$$CN$US$US
243077342$24307734$2$F$20240809$20240920$20240911$20240924$EXP$SI-JAZMP-NCPHV-2024SI0892_0892$SI-PFIZER INC-202400252406$PFIZER$$35$YR$$F$Y$$$20240924$$CN$SI$SI
243077351$24307735$1$I$$20240905$20240911$20240911$30DAY$$GR-PFIZER INC-PV202400117107$PFIZER$$13$YR$$M$Y$55$KG$20240911$$CN$GR$GR
243077361$24307736$1$I$$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-110069-2023$RECKITT BENCKISER$$77$YR$$M$Y$104.55$KG$20240911$$CN$US$US
243077371$24307737$1$I$20230531$20240904$20240911$20240911$EXP$$JP-GILEAD-2023-0632296$GILEAD$$61$YR$A$M$Y$$$20240911$$MD$JP$JP
243077381$24307738$1$I$20240829$20240903$20240911$20240911$EXP$$CN-GE HEALTHCARE-2024CSU010197$GE HEALTHCARE$$66$YR$$F$Y$$$20240911$$HP$CN$CN
243077391$24307739$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP010008$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243077401$24307740$1$I$$20240909$20240911$20240911$PER$$US-BIOGEN-2022BI01085641$BIOGEN$$$$$F$Y$$$20240911$$HP$US$US
243077422$24307742$2$F$$20240911$20240911$20240912$PER$$US-TAKEDA-2024TUS090126$TAKEDA$$$$$M$Y$$$20240912$$CN$US$US
243077431$24307743$1$I$$20240910$20240911$20240911$EXP$$CA-SANDOZ INC.-SDZ2024CA079215$SANDOZ$$76$YR$$M$Y$67$KG$20240911$$PH$CA$CA
243077441$24307744$1$I$20240628$20240628$20240911$20240911$PER$$US-CELLTRION INC.-2024US016083$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243077451$24307745$1$I$20240430$20240905$20240911$20240911$EXP$$CN-009507513-2409CHN003071$MERCK$$52$YR$$F$Y$59$KG$20240911$$HP$CN$CN
243077461$24307746$1$I$$20240903$20240911$20240911$EXP$$CA-AstraZeneca-2024A201675$ASTRAZENECA$$$$A$M$Y$$$20240911$$CN$CA$
243077471$24307747$1$I$$20240910$20240911$20240911$EXP$$CA-VER-202400465$VERITY PHARMACEUTICALS$$87$YR$E$M$Y$$$20240911$$HP$CA$CA
243077482$24307748$2$F$$20240909$20240911$20240920$EXP$$NL-ORGANON-1904NLD010657$ORGANON$Raats-ten Cate IM, van der Maten J, Overbeek MJ, ten Holder JT. Organising pneumonia and non-specific interstitial pneumonia as a late consequence of treatment with imatinib in a patient with chronic myeloid leukemia.. Ned-Tijdschr-Voor-Allerg-Asthma. 2019;19(1):22-7$68$YR$$M$Y$$$20240920$$HP$NL$NL
243077491$24307749$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143655$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240911$$HP$US$US
243077501$24307750$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143673$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240911$$CN$US$US
243077511$24307751$1$I$20240101$20240904$20240911$20240911$EXP$$US-ABBVIE-5907385$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243077521$24307752$1$I$$20240906$20240911$20240911$PER$$US-JNJFOC-20240919741$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240911$$HP$US$US
243077542$24307754$2$F$20230701$20240916$20240911$20240920$EXP$$ES-AMGEN-ESPSP2024179250$AMGEN$$73$YR$E$F$Y$$$20240920$$MD$ES$ES
243077551$24307755$1$I$$20240829$20240911$20240911$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-002106$SK LIFE SCIENCE$$$$$$Y$$$20240911$$HP$CA$CA
243077561$24307756$1$I$$20240822$20240911$20240911$PER$$US-TEVA-VS-3236248$TEVA$$$$$$Y$$$20240911$$HP$US$US
243077571$24307757$1$I$20240710$20240808$20240911$20240911$PER$$US-CELLTRION INC.-2024US017360$CELLTRION$$$$$$Y$$$20240911$$HP$US$US
243077581$24307758$1$I$$20240905$20240911$20240911$30DAY$$CA-PFIZER INC-202400250826$PFIZER$$82$YR$$M$Y$$$20240911$$CN$CA$CA
243077591$24307759$1$I$$20240829$20240911$20240911$EXP$$CA-HLS-202402198$HLS THERAPEUTICS$$50$YR$A$M$Y$$$20240911$$MD$CA$CA
243077601$24307760$1$I$20240101$20240821$20240911$20240911$PER$$US-SA-2024SA262226$SANOFI AVENTIS$$3$YR$C$M$Y$15.1$KG$20240911$$MD$US$US
243077612$24307761$2$F$20240904$20240920$20240911$20240926$EXP$$AU-MYLANLABS-2024M1081821$MYLAN$$54$YR$$M$Y$110$KG$20240926$$HP$AU$AU
243077631$24307763$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA262228$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240911$$HP$US$US
243077641$24307764$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA262186$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240911$$HP$US$US
243077651$24307765$1$I$20240101$20240829$20240911$20240911$PER$$US-SA-2024SA261411$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240911$$MD$US$US
243077661$24307766$1$I$20240101$20240831$20240911$20240911$PER$$US-SA-2024SA260567$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240911$$MD$US$US
243077671$24307767$1$I$20240701$20240831$20240911$20240911$PER$$US-SA-2024SA260832$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240911$$HP$US$US
243077682$24307768$2$F$20240101$20240909$20240911$20240917$PER$$US-AMGEN-USASP2024180512$AMGEN$$65$YR$E$F$Y$$$20240917$$HP$US$US
243077691$24307769$1$I$20240801$20240903$20240911$20240911$PER$$US-SA-2024SA262233$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240911$$MD$US$US
243077701$24307770$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181266$NOVARTIS$$$$$F$Y$$$20240911$$HP$US$US
243077712$24307771$2$F$20240503$20240910$20240911$20240913$EXP$$NVSC2024US179673$NOVARTIS$$54$YR$$F$Y$49.9$KG$20240913$$MD$US$US
243077731$24307773$1$I$$20240903$20240911$20240911$EXP$$US-ABBVIE-5917055$ABBVIE$Lan N, Shen B. Efficacy and safety of risankizumab in the treatment of crohn^s disease of the pouch. ACG Case Rep J. 2024;11(9):e01476.$22$YR$$F$Y$$$20240911$$MD$US$US
243077751$24307775$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62420$$FDA-CTU$$30$YR$$M$N$63.05$KG$20240911$N$$US$
243077771$24307777$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62421$$FDA-CTU$$64$YR$$F$N$$$20240911$N$$US$
243077791$24307779$1$I$20240829$20240910$20240910$20240910$DIR$717917$$FDA-CTU$$71$YR$$F$N$63$KG$20240910$N$PH$US$
243077801$24307780$1$I$$20240911$20240911$20240911$DIR$717970$$FDA-CTU$$$$$UNK$N$$$20240911$N$$US$
243077811$24307781$1$I$20240911$20240911$20240911$20240911$DIR$717969$$FDA-CTU$$58$YR$$F$N$77.85$KG$20240911$N$PH$US$
243077821$24307782$1$I$20240827$20240911$20240911$20240911$DIR$717971$$FDA-CTU$$77$YR$$M$N$$$20240911$Y$PH$US$
243077841$24307784$1$I$20240301$20240911$20240911$20240911$DIR$717956$$FDA-CTU$$63$YR$$F$N$110.25$KG$20240911$N$CN$US$
243077851$24307785$1$I$20240726$20240910$20240910$20240910$DIR$717922$$FDA-CTU$$61$YR$$F$N$72$KG$20240910$N$CN$US$
243077861$24307786$1$I$20240101$20240827$20240911$20240911$EXP$$AR-SA-2024SA262880$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240911$$MD$AR$AR
243077871$24307787$1$I$$20240910$20240911$20240911$EXP$$US-TAKEDA-2024TUS052432$TAKEDA$$$$$M$Y$$$20240911$$CN$US$US
243077881$24307788$1$I$20240101$20240904$20240911$20240911$PER$$US-UNITED THERAPEUTICS-UNT-2024-028005$UNITED THERAPEUTICS$$$$$F$Y$$$20240911$$$US$US
243077891$24307789$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA262242$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240911$$HP$US$US
243077901$24307790$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA262735$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240911$$HP$US$US
243077911$24307791$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA258880$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240911$$MD$US$US
243077921$24307792$1$I$20240801$20240903$20240911$20240911$PER$$US-SA-2024SA262222$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240911$$MD$US$US
243077931$24307793$1$I$$20240906$20240911$20240911$30DAY$$US-GSK-US2024111382$GLAXOSMITHKLINE$$$$$F$Y$$$20240911$$CN$US$US
243077941$24307794$1$I$20230926$20240904$20240911$20240911$EXP$$JP-GILEAD-2024-0665039$GILEAD$$72$YR$E$M$Y$$$20240911$$MD$JP$JP
243077951$24307795$1$I$20120817$20240909$20240911$20240911$EXP$$DE-SANDOZ INC.-SDZ2024DE078630$SANDOZ$$46$YR$$M$Y$$$20240911$$MD$DE$DE
243077961$24307796$1$I$$20240911$20240911$20240911$PER$$US-PROD-AS2-212756134-RB-104304-2023$RECKITT BENCKISER$$$$$F$Y$$$20240911$$CN$US$US
243077972$24307797$2$F$$20240906$20240911$20240911$EXP$$US-GILEAD-2024-0686818$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243077981$24307798$1$I$20240822$20240909$20240911$20240911$EXP$FR-AFSSAPS-RN2024000960$FR-ORGANON-O2409FRA000646$ORGANON$$19$YR$$F$Y$$$20240911$$MD$FR$FR
243078002$24307800$2$F$$20240906$20240911$20240911$EXP$$US-GILEAD-2024-0686876$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243078012$24307801$2$F$$20240906$20240911$20240911$EXP$$US-GILEAD-2024-0686863$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243078021$24307802$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005532$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243078032$24307803$2$F$20240201$20240910$20240911$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409005299$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240918$$CN$US$US
243078043$24307804$3$F$20240801$20240918$20240911$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-027852$UNITED THERAPEUTICS$$69$YR$$M$Y$71.202$KG$20240926$$$US$US
243078061$24307806$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005666$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240911$$MD$US$US
243078071$24307807$1$I$20240902$20240902$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409002918$ELI LILLY AND CO$$58$YR$A$$Y$$$20240911$$CN$US$US
243078081$24307808$1$I$20240908$20240911$20240911$20240911$DIR$717968$$FDA-CTU$$52$YR$$F$N$$$20240911$N$PH$US$
243078091$24307809$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144316$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240911$$HP$US$US
243078101$24307810$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143098$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240911$$HP$US$US
243078111$24307811$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144373$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240911$$HP$US$US
243078121$24307812$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144571$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$82.55$KG$20240911$$HP$US$US
243078131$24307813$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA260583$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240911$$CN$US$US
243078141$24307814$1$I$$20240904$20240911$20240911$DIR$FDA-CDER-CTU-2024-62422$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
243078151$24307815$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62424$$FDA-CTU$$66$YR$$F$N$85.73$KG$20240911$N$$US$
243078161$24307816$1$I$20210101$20240904$20240911$20240911$EXP$$CN-SA-2024SA253830$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240911$$MD$CN$CN
243078171$24307817$1$I$20240101$20240821$20240911$20240911$PER$$US-SA-2024SA261093$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240911$$MD$US$US
243078181$24307818$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA261092$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240911$$HP$US$US
243078191$24307819$1$I$$20240909$20240911$20240911$PER$$NVSC2024US181285$NOVARTIS$$$$$F$Y$$$20240911$$HP$US$US
243078201$24307820$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62423$$FDA-CTU$$56$YR$$F$N$$$20240911$N$$US$
243078211$24307821$1$I$20240910$20240911$20240911$20240911$DIR$717959$$FDA-CTU$$70$YR$$F$N$$$20240911$N$$US$
243078221$24307822$1$I$20240907$20240911$20240911$20240911$DIR$717955$$FDA-CTU$$71$YR$$F$N$$$20240911$N$CN$US$
243078232$24307823$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687098$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243078241$24307824$1$I$20240412$20240910$20240910$20240910$DIR$717925$$FDA-CTU$$43$YR$$F$N$45$KG$20240910$N$CN$US$
243078251$24307825$1$I$$20240905$20240911$20240911$EXP$$US-ABBVIE-5910683$ABBVIE$$$$$F$Y$$$20240911$$HP$US$US
243078261$24307826$1$I$20240823$20240911$20240911$20240911$DIR$717966$$FDA-CTU$$72$YR$$F$N$50.4$KG$20240911$N$CN$US$
243078271$24307827$1$I$20240719$20240911$20240911$20240911$DIR$717965$$FDA-CTU$$68$YR$$M$N$93.8$KG$20240911$N$MD$US$
243078282$24307828$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687066$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243078291$24307829$1$I$$20240910$20240910$20240910$DIR$717929$$FDA-CTU$$$$$F$N$67.5$KG$20240910$N$CN$US$
243078301$24307830$1$I$$20240906$20240911$20240911$EXP$$ZA-AstraZeneca-2024A205005$ASTRAZENECA$$71$YR$$M$Y$$$20240911$$CN$ZA$
243078311$24307831$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A203830$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
243078321$24307832$1$I$$20240908$20240911$20240911$PER$$US-AstraZeneca-2024A206014$ASTRAZENECA$$$$$$Y$$$20240911$$CN$US$
243078331$24307833$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A204885$ASTRAZENECA$$$$$M$Y$$$20240911$$HP$US$
243078351$24307835$1$I$$20240906$20240911$20240911$EXP$$ZA-AstraZeneca-2024A203969$ASTRAZENECA$$89$YR$$M$Y$$$20240911$$CN$ZA$
243078371$24307837$1$I$$20240905$20240911$20240911$EXP$$RU-ROCHE-10000076935$ROCHE$$9$YR$C$F$Y$$$20240911$$MD$RU$RU
243078381$24307838$1$I$$20240902$20240911$20240911$EXP$$JP-009507513-2409JPN000753J$MERCK$$5$DEC$$F$Y$$$20240911$$HP$JP$JP
243078391$24307839$1$I$20240731$20240905$20240911$20240911$EXP$$ZA-AstraZeneca-2024A202849$ASTRAZENECA$$73$YR$$F$Y$$$20240911$$CN$ZA$
243078401$24307840$1$I$$20240903$20240911$20240911$EXP$$NL-AstraZeneca-2024A205965$ASTRAZENECA$$42$YR$$F$Y$110$KG$20240911$$MD$NL$
243078411$24307841$1$I$$20240906$20240911$20240911$PER$$US-ABBVIE-5915420$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243078421$24307842$1$I$$20240902$20240911$20240911$EXP$$JP-JNJFOC-20240924941$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240911$$MD$JP$JP
243078432$24307843$2$F$$20240909$20240911$20240914$EXP$$GB-ABBVIE-5913672$ABBVIE$$$$A$F$Y$$$20240914$$CN$GB$GB
243078441$24307844$1$I$$20240905$20240911$20240911$EXP$$JP-AMGEN-JPNSP2024178414$AMGEN$$$$$$Y$$$20240911$$CN$JP$JP
243078452$24307845$2$F$$20240906$20240911$20240911$EXP$$US-GILEAD-2024-0687086$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243078462$24307846$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687131$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243078472$24307847$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687111$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243078482$24307848$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687101$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243078493$24307849$3$F$20240809$20240920$20240911$20240926$EXP$FR-AFSSAPS-AN2024001234$FR-Waylis Therapeutics LLC-ATNAHS20240902532$Waylis$$43$YR$A$F$Y$152$KG$20240925$$PH$FR$FR
243078502$24307850$2$F$20240816$20240912$20240911$20240918$EXP$$PT-AMERICAN REGENT INC-2024003411$AMERICAN REGENT$$60$YR$$F$Y$$$20240918$$HP$PT$PT
243078511$24307851$1$I$20200615$20240906$20240911$20240911$EXP$PL-URPL-1-1867-2020$PL-ABBVIE-5917606$ABBVIE$$44$YR$$F$Y$$$20240911$$MD$PL$PL
243078531$24307853$1$I$20240601$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62426$$FDA-CTU$$35$YR$$M$N$$$20240910$N$HP$US$
243078541$24307854$1$I$20240910$20240910$20240910$20240910$DIR$717939$$FDA-CTU$$45$YR$$F$N$92.25$KG$20240910$N$CN$US$
243078571$24307857$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62453$$FDA-CTU$$80$YR$$M$N$$$20240911$N$$US$
243078581$24307858$1$I$20240718$20240829$20240911$20240911$EXP$$AU-CIPLA LTD.-2024AU09640$CIPLA$$$$$$Y$$$20240911$$MD$AU$AU
243078591$24307859$1$I$20240827$20240829$20240911$20240911$EXP$$GB-CIPLA LTD.-2024GB09596$CIPLA$$$$$$Y$$$20240911$$MD$GB$GB
243078601$24307860$1$I$20160101$20240909$20240911$20240911$EXP$$DE-ORGANON-O2409DEU000645$ORGANON$$80$YR$$F$Y$$$20240911$$CN$DE$DE
243078612$24307861$2$F$20240829$20240829$20240911$20240914$PER$$US-ABBVIE-5918126$ABBVIE$$28$YR$$F$Y$$$20240914$$MD$US$US
243078621$24307862$1$I$20240905$20240910$20240910$20240910$DIR$717934$$FDA-CTU$$46$YR$$F$N$70.2$KG$20240910$N$CN$US$
243078631$24307863$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62454$$FDA-CTU$$40$YR$$F$N$64.86$KG$20240911$N$$US$
243078641$24307864$1$I$$20240830$20240911$20240911$EXP$$GB-IMP-2024000708$Harrow Health$$$$$$Y$$$20240911$$CN$GB$GB
243078651$24307865$1$I$$20240829$20240911$20240911$EXP$$US-CIPLA LTD.-2024US09667$CIPLA$Bell AP, Custer MK, Presley S.. Pyoderma gangrenosum in a 75-year-old male with follicular diffuse large B-cell lymphoma. Cureus. 2024;16 (8):e67234$$$$$Y$$$20240911$$MD$US$US
243078671$24307867$1$I$$20240909$20240911$20240911$EXP$DE-EMA-DD-20240903-7482827-133848$DE-SANDOZ INC.-SDZ2024DE078550$SANDOZ$$$$$M$Y$$$20240911$$HP$DE$DE
243078681$24307868$1$I$$20240903$20240911$20240911$EXP$$PH-OTSUKA-2024_024700$OTSUKA$$$$$M$Y$$$20240911$$MD$PH$PH
243078691$24307869$1$I$20240815$20240827$20240911$20240911$EXP$$AR-MIRUM PHARMACEUTICALS, INC.-AR-MIR-24-00697$MIRUM PHARMACEUTICALS$$$$$$Y$$$20240911$$MD$AR$AR
243078701$24307870$1$I$$20240905$20240911$20240911$EXP$$US-BIOGEN-2024BI01281881$BIOGEN$$$$$F$Y$69.008$KG$20240911$$MD$US$US
243078712$24307871$2$F$20240909$20240911$20240911$20240916$PER$$US-AMGEN-USASP2024180790$AMGEN$$66$YR$E$F$Y$$$20240916$$CN$US$US
243078721$24307872$1$I$20240101$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024179088$AMGEN$$77$YR$E$F$Y$$$20240911$$CN$US$US
243078731$24307873$1$I$20240721$20240902$20240911$20240911$EXP$GB-MHRA-MED-202409021835483740-GCLHZ$GB-TEVA-VS-3240030$TEVA$$48$YR$$M$Y$95$KG$20240911$$CN$GB$GB
243078741$24307874$1$I$20240413$20240902$20240911$20240911$EXP$GB-MHRA-MED-202409021641253340-WVYSN$GB-TEVA-VS-3239399$TEVA$$34$YR$$F$Y$$$20240911$$HP$GB$GB
243078751$24307875$1$I$$20240905$20240911$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001807$BLUEPRINT MEDICINES$$$$$F$Y$$$20240911$$CN$US$US
243078771$24307877$1$I$20240308$20240903$20240911$20240911$EXP$GB-MHRA-MED-202409031151325570-MLGJC$GB-TEVA-VS-3240035$TEVA$$66$YR$$F$Y$48$KG$20240911$$PH$GB$GB
243078782$24307878$2$F$$20240911$20240911$20240912$PER$$NVSC2024US182103$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
243078792$24307879$2$F$20230630$20240904$20240911$20240919$EXP$$JP-GILEAD-2024-0686595$GILEAD$$73$YR$E$M$Y$$$20240919$$MD$JP$JP
243078801$24307880$1$I$20240801$20240904$20240911$20240911$30DAY$$US-GSK-US2024110056$GLAXOSMITHKLINE$$43$YR$$F$Y$$$20240911$$CN$US$US
243078811$24307881$1$I$20220801$20240905$20240911$20240911$EXP$$AT-ABBVIE-5826391$ABBVIE$$53$YR$$M$Y$$$20240911$$MD$AT$AT
243078821$24307882$1$I$20240909$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180479$AMGEN$$79$YR$E$F$Y$$$20240911$$CN$US$US
243078831$24307883$1$I$$20240910$20240911$20240911$EXP$$PL-GILEAD-2024-0687206$GILEAD$$50$YR$A$F$Y$$$20240911$$MD$PL$PL
243078841$24307884$1$I$$20240830$20240911$20240911$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093777$GLENMARK$Soliman Y, Hatfield AA, McAllister RK, Fettiplace MR, Hofkamp MP.. Apparent local anesthetic systemic toxicity following activation of an epidural catheter for cesarean delivery: Diagnosis and management of an uncommon obstetric anesthesia complication.. Proceedings (Baylor University. Medical Center).. 2024;37(5):874-6$$$$$Y$$$20240911$$MD$US$US
243078861$24307886$1$I$$20240909$20240911$20240911$EXP$$CA-SANDOZ INC.-SDZ2024CA078835$SANDOZ$$62$YR$$M$Y$$$20240911$$HP$CA$CA
243078872$24307887$2$F$$20240923$20240911$20240924$EXP$$CA-PFIZER INC-PV202400118535$PFIZER$Lecours, M.. Complications of single-injection ultrasound-guided infraclavicular block: A cohort study. Canadian Journal of Anesthesia. 2013;60(3):244-252$59$YR$$M$Y$$$20240924$$MD$CA$CA
243078881$24307888$1$I$$20240909$20240911$20240911$EXP$$PT-PFIZER INC-202400252904$PFIZER$Mendes, Raquel. Obinutuzumab-Induced Inflammatory Bowel Disease-Like Pancolitis A First Case Report. GE Port J Gastroenterol. 2024;31:278-282$47$YR$$F$Y$$$20240911$$MD$PT$PT
243078891$24307889$1$I$$20240906$20240911$20240911$EXP$$BE-PFIZER INC-PV202400117327$PFIZER$Bosteels, C. Respiratory failure in a tofacitinib treated patient with ulcerative colitis. Acta Gastro-Enterologica Belgica. 2024;87:10.51821/87.2.11812$55$YR$$M$Y$$$20240911$$HP$BE$BE
243078901$24307890$1$I$$20240904$20240911$20240911$EXP$$CA-OTSUKA-2024_019149$OTSUKA$$$$$M$Y$$$20240911$$MD$CA$CA
243078911$24307891$1$I$20240822$20240905$20240911$20240911$EXP$$US-ABBVIE-5909975$ABBVIE$$57$YR$$F$Y$$$20240911$$CN$US$US
243078921$24307892$1$I$20240802$20240904$20240911$20240911$EXP$$NVSC2024AR167685$NOVARTIS$$66$YR$$M$Y$$$20240911$$MD$AR$AR
243078931$24307893$1$I$$20240822$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN008844$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243078941$24307894$1$I$$20240909$20240911$20240911$EXP$$DE-HALEON-2196154$Haleon PLC$$$$$F$Y$$$20240911$$CN$DE$DE
243078951$24307895$1$I$$20240903$20240911$20240911$EXP$$IN-ROCHE-10000028062$ROCHE$$66$YR$E$F$Y$73.35$KG$20240911$$MD$IN$IN
243078961$24307896$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000591US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243078971$24307897$1$I$20240801$20240909$20240911$20240911$PER$$US-ALXN-202409USA000612US$ALEXION PHARMACEUTICALS$$54$YR$$M$Y$$$20240911$$CN$US$US
243078981$24307898$1$I$$20240910$20240911$20240911$PER$$US-HALEON-2196365$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243078991$24307899$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000616US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243079021$24307902$1$I$$20240910$20240910$20240910$DIR$717944$$FDA-CTU$$60$YR$$M$N$$$20240910$N$CN$US$
243079061$24307906$1$I$20230916$20240904$20240911$20240911$EXP$$JP-GILEAD-2024-0686596$GILEAD$$$$E$F$Y$$$20240911$$MD$JP$JP
243079071$24307907$1$I$$20240904$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005647$ELI LILLY AND CO$$49$YR$A$F$Y$60.78$KG$20240911$$CN$US$US
243079081$24307908$1$I$$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005913$ELI LILLY AND CO$$$$$$Y$$$20240911$$CN$US$US
243079091$24307909$1$I$20230101$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006253$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240911$$CN$US$US
243079111$24307911$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143916$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240911$$HP$US$US
243079131$24307913$1$I$20240829$20240829$20240911$20240911$30DAY$$CO-PFIZER INC-202400247535$PFIZER$$$$$F$Y$$$20240911$$CN$CO$CO
243079143$24307914$3$F$20240905$20240918$20240911$20240920$30DAY$$CO-PFIZER INC-PV202400117984$PFIZER$$4$YR$$F$Y$$$20240920$$CN$CO$CO
243079152$24307915$2$F$$20240920$20240911$20240924$30DAY$$PA-PFIZER INC-PV202400118111$PFIZER$$12$YR$$F$Y$$$20240924$$HP$PA$PA
243079161$24307916$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA260956$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240911$$HP$US$US
243079171$24307917$1$I$20240101$20240829$20240911$20240911$PER$$US-SA-2024SA261427$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240911$$HP$US$US
243079181$24307918$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA260861$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240911$$HP$US$US
243079191$24307919$1$I$$20240821$20240911$20240911$PER$$US-SA-2024SA261089$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240911$$CN$US$US
243079202$24307920$2$F$20240829$20240909$20240911$20240916$EXP$IT-MINISAL02-1000925$IT-OTSUKA-2024_024690$OTSUKA$$23$YR$$F$Y$$$20240916$$PH$IT$IT
243079211$24307921$1$I$20240629$20240701$20240911$20240911$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000015$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240911$$MD$US$US
243079231$24307923$1$I$$20240904$20240911$20240911$EXP$$US-OTSUKA-2024_024768$OTSUKA$$$$$M$Y$$$20240911$$CN$US$US
243079241$24307924$1$I$20240821$20240902$20240911$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024109478$VIIV$$37$YR$$M$Y$$$20240911$$CN$US$US
243079251$24307925$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5913599$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243079261$24307926$1$I$$20240903$20240911$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001793$BLUEPRINT MEDICINES$$$$$M$Y$$$20240911$$CN$US$US
243079271$24307927$1$I$$20240909$20240911$20240911$PER$$US-BIOGEN-2024BI01281755$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243079281$24307928$1$I$$20240909$20240911$20240911$PER$$US-BIOGEN-2024BI01278136$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243079291$24307929$1$I$$20240904$20240911$20240911$EXP$$US-GSK-US2024AMR111518$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$US$US
243079311$24307931$1$I$20240501$20240909$20240911$20240911$PER$$US-BIOGEN-2024BI01281731$BIOGEN$$52$YR$$M$Y$$$20240911$$CN$US$US
243079321$24307932$1$I$20240904$20240906$20240911$20240911$EXP$$US-IMMUNOCORE, LTD.-2024-IMC-003088$IMMUNOCORE$$80$YR$$F$Y$$$20240911$$CN$US$US
243079333$24307933$3$F$20240826$20240912$20240911$20240914$PER$$US-AMGEN-USASP2024181215$AMGEN$$77$YR$E$F$Y$$$20240914$$PH$US$US
243079341$24307934$1$I$$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024180492$AMGEN$$$$$$Y$$$20240911$$MD$US$US
243079351$24307935$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62456$$FDA-CTU$$47$YR$$F$N$$$20240911$N$$US$
243079361$24307936$1$I$20240801$20240903$20240911$20240911$EXP$$US-SA-2024SA262270$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240911$$CN$US$US
243079371$24307937$1$I$20240601$20240903$20240911$20240911$PER$$US-SA-2024SA261303$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240911$$MD$US$US
243079381$24307938$1$I$20240808$20240829$20240911$20240911$EXP$$CN-SA-2024SA262487$SANOFI AVENTIS$$57$YR$A$F$Y$57$KG$20240911$$HP$CN$CN
243079391$24307939$1$I$$20240902$20240911$20240911$EXP$$RU-ROCHE-10000072846$ROCHE$$75$YR$E$M$Y$$$20240911$$MD$RU$RU
243079401$24307940$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62457$$FDA-CTU$$30$YR$$F$N$57.15$KG$20240911$N$$US$
243079411$24307941$1$I$$20240908$20240911$20240911$PER$$US-HALEON-2195841$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243079421$24307942$1$I$$20240829$20240911$20240911$EXP$$US-IBSA PHARMA INC.-2024IBS000406$IBSA INSTITUT BIOCHIMIQUE$$$$$$Y$$$20240910$$CN$US$US
243079452$24307945$2$F$$20240909$20240911$20240916$30DAY$$US-MYLANLABS-2024M1082135$MYLAN$$$$$M$Y$$$20240916$$CN$US$US
243079461$24307946$1$I$$20240828$20240911$20240911$30DAY$$US-MYLANLABS-2024M1079723$MYLAN$$$$$F$Y$$$20240911$$PH$US$US
243079471$24307947$1$I$$20240906$20240911$20240911$EXP$$US-ABBVIE-5914891$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243079481$24307948$1$I$$20240828$20240911$20240911$30DAY$$US-MYLANLABS-2024M1082686$MYLAN$$$$$$Y$$$20240911$$PH$US$US
243079492$24307949$2$F$$20240905$20240911$20240927$PER$$US-SMPA-2024SPA001635$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243079501$24307950$1$I$20240808$20240904$20240911$20240911$EXP$$CN-REGENERON PHARMACEUTICALS, INC.-2024-120685$REGENERON$$79$YR$$M$Y$$$20240911$$HP$CN$CN
243079511$24307951$1$I$$20240905$20240911$20240911$PER$$US-ALXN-202409USA000390US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243079521$24307952$1$I$$20240910$20240911$20240911$PER$$US-AMGEN-USASP2024180522$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
243079531$24307953$1$I$20231128$20240904$20240911$20240911$EXP$$JP-GILEAD-2024-0686600$GILEAD$$56$YR$A$M$Y$$$20240911$$MD$JP$JP
243079541$24307954$1$I$20240829$20240904$20240911$20240911$PER$$US-ABBVIE-5907805$ABBVIE$$28$YR$$M$Y$$$20240911$$CN$US$US
243079551$24307955$1$I$$20240828$20240911$20240911$PER$$US-SMPA-2024SPA002107$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079561$24307956$1$I$$20240906$20240911$20240911$PER$$US-SMPA-2024SPA002417$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079571$24307957$1$I$$20240819$20240911$20240911$PER$$US-SMPA-2024SPA001622$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079581$24307958$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001586$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079591$24307959$1$I$$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001448$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079601$24307960$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001542$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079621$24307962$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001641$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079632$24307963$2$F$20230501$20240829$20240911$20240925$PER$$US-SMPA-2024SPA000228$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243079642$24307964$2$F$$20240904$20240911$20240924$PER$$US-SMPA-2024SPA002086$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243079651$24307965$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001415$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079661$24307966$1$I$20240801$20240821$20240911$20240911$PER$$US-SMPA-2024SPA001808$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079671$24307967$1$I$$20240829$20240911$20240911$PER$$US-SMPA-2024MYSCI0501206$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079681$24307968$1$I$$20240822$20240911$20240911$PER$$US-SMPA-2024SPA001818$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079691$24307969$1$I$$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001456$SUNOVION$$$$$$Y$$$20240911$$HP$US$US
243079701$24307970$1$I$$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001446$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079712$24307971$2$F$20240801$20240904$20240911$20240925$PER$$US-SMPA-2024SPA001857$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243079731$24307973$1$I$$20240826$20240911$20240911$PER$$US-SMPA-2024SPA001943$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079741$24307974$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001357$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079751$24307975$1$I$$20240827$20240911$20240911$PER$$US-SMPA-2024SPA001998$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079762$24307976$2$F$$20240918$20240911$20240925$PER$$US-SMPA-2024SPA001768$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243079771$24307977$1$I$$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001457$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079781$24307978$1$I$20240101$20240823$20240911$20240911$PER$$US-SMPA-2024SPA001909$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079791$24307979$1$I$$20240904$20240911$20240911$PER$$US-SMPA-2024SPA002343$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079811$24307981$1$I$20240101$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001552$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079831$24307983$1$I$$20240821$20240911$20240911$PER$$US-SMPA-2024SPA001797$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079841$24307984$1$I$$20240830$20240911$20240911$PER$$US-SMPA-2024SPA002171$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079853$24307985$3$F$$20240904$20240911$20240916$EXP$$US-SMPA-2024SPA002388$SUNOVION$$$$$$Y$$$20240916$$MD$US$US
243079862$24307986$2$F$$20240919$20240911$20240927$PER$$US-SMPA-2024SPA001486$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243079871$24307987$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001391$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079881$24307988$1$I$$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001498$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079891$24307989$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001494$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079901$24307990$1$I$$20240820$20240911$20240911$PER$$US-SMPA-2024SPA001657$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079912$24307991$2$F$20240101$20240831$20240911$20240924$PER$$US-SMPA-2024SPA001633$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243079921$24307992$1$I$$20240822$20240911$20240911$PER$$US-SMPA-2024SPA001867$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079931$24307993$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001441$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079951$24307995$1$I$$20240821$20240911$20240911$PER$$US-SMPA-2024SPA001773$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079963$24307996$3$F$$20240911$20240911$20240925$EXP$$US-SMPA-2024SPA001382$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243079972$24307997$2$F$$20240909$20240911$20240919$PER$$US-SMPA-2024SPA001731$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243079981$24307998$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001451$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243079991$24307999$1$I$$20240815$20240911$20240911$PER$$US-SMPA-2024SPA000224$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080001$24308000$1$I$$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001487$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080011$24308001$1$I$20240824$20240828$20240911$20240911$PER$$US-SMPA-2024SPA002077$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080021$24308002$1$I$$20240822$20240911$20240911$PER$$US-SMPA-2024SPA001872$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080031$24308003$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001500$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080041$24308004$1$I$$20240904$20240911$20240911$PER$$US-SMPA-2024MYSCI0200741$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080061$24308006$1$I$$20240820$20240911$20240911$PER$$US-SMPA-2024SPA001709$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080071$24308007$1$I$$20240821$20240911$20240911$PER$$US-SMPA-2024SPA000473$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080081$24308008$1$I$20240801$20240827$20240911$20240911$PER$$US-SMPA-2024SPA002034$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080091$24308009$1$I$$20240820$20240911$20240911$PER$$US-SMPA-2024SPA001749$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080101$24308010$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001600$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080111$24308011$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001519$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080121$24308012$1$I$$20240821$20240911$20240911$PER$$US-SMPA-2024SPA001793$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080131$24308013$1$I$$20240904$20240911$20240911$PER$$US-SMPA-2024SPA002313$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080141$24308014$1$I$$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001510$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080161$24308016$1$I$$20240827$20240911$20240911$PER$$US-SMPA-2024SPA002014$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080171$24308017$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001378$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080181$24308018$1$I$20240813$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001454$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080203$24308020$3$F$$20240919$20240911$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144348$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240923$$HP$US$US
243080211$24308021$1$I$$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001474$SUNOVION$$$$$$Y$$$20240911$$HP$US$US
243080221$24308022$1$I$$20240819$20240911$20240911$PER$$US-SMPA-2024SPA001623$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080231$24308023$1$I$$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001609$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080251$24308025$1$I$$20240822$20240911$20240911$PER$$US-SMPA-2024SPA001897$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080282$24308028$2$F$$20240909$20240911$20240927$PER$$US-SMPA-2024SPA001464$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243080301$24308030$1$I$$20240905$20240911$20240911$PER$$US-SMPA-2024SPA002416$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080311$24308031$1$I$$20240820$20240911$20240911$PER$$US-SMPA-2024SPA001684$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080321$24308032$1$I$$20240822$20240911$20240911$PER$$US-SMPA-2024SPA001834$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080331$24308033$1$I$$20240820$20240911$20240911$PER$$US-SMPA-2024SPA001704$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080341$24308034$1$I$$20240820$20240911$20240911$PER$$US-SMPA-2024SPA001713$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080351$24308035$1$I$$20240822$20240911$20240911$PER$$US-SMPA-2024SPA001802$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080361$24308036$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001331$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080371$24308037$1$I$$20231226$20240911$20240911$PER$$US-TEVA-VS-3236519$TEVA$$$$$$Y$$$20240911$$HP$US$US
243080381$24308038$1$I$$20240820$20240911$20240911$PER$$US-SMPA-2024SPA001735$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080391$24308039$1$I$$20240821$20240911$20240911$PER$$US-SMPA-2024SPA001741$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080401$24308040$1$I$$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001480$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080411$24308041$1$I$$20240822$20240911$20240911$PER$$US-SMPA-2024SPA001866$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080421$24308042$1$I$$20240830$20240911$20240911$PER$$US-SMPA-2024SPA002214$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080431$24308043$1$I$$20240820$20240911$20240911$PER$$US-SMPA-2024SPA001691$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080441$24308044$1$I$$20240823$20240911$20240911$PER$$US-SMPA-2024SPA001923$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080451$24308045$1$I$$20240816$20240911$20240911$PER$$US-SMPA-202406-URV-000963$SUNOVION$$$$$$Y$$$20240911$$HP$US$US
243080461$24308046$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001531$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080481$24308048$1$I$$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001481$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080491$24308049$1$I$$20240830$20240911$20240911$PER$$US-SMPA-2024SPA002183$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080501$24308050$1$I$20240101$20240822$20240911$20240911$PER$$US-SMPA-2024SPA001826$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243080521$24308052$1$I$20240807$20240828$20240911$20240911$EXP$$JP-AMICUS THERAPEUTICS, INC.-AMI_3344$AMICUS THERAPEUTICS$$77$YR$$F$Y$$$20240911$$MD$JP$JP
243080531$24308053$1$I$$20240909$20240911$20240911$EXP$$US-AstraZeneca-2024A205424$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243080541$24308054$1$I$$20201027$20240911$20240911$EXP$$NVSC2020FR371137$NOVARTIS$$$$$$Y$$$20240911$$MD$FR$FR
243080551$24308055$1$I$$20240902$20240911$20240911$EXP$$ES-ROCHE-10000074845$ROCHE$Garcia-Goni M, Guti?rrez B, Sanmamed M, Mart?n-Algarra S, P?rez-Gracia J, Olmedo M, et al. Thyroid dysfunction caused by immune checkpoint inhibitors improves cancer outcomes. Endocrine-Related Cancer. 2024-Oct;31 (10):1-8. doi:10.1530/ERC-24-0064.$$$$$Y$$$20240911$$HP$ES$ES
243080562$24308056$2$F$20240215$20240917$20240911$20240918$EXP$$NVSC2024ZA103666$NOVARTIS$$69$YR$$M$Y$92$KG$20240918$$HP$ZA$ZA
243080571$24308057$1$I$$20231103$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000415$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080581$24308058$1$I$$20231106$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000417$SIGMA TAU$$$$$M$Y$$$20240911$$MD$US$US
243080591$24308059$1$I$$20231106$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000419$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080601$24308060$1$I$$20231128$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000442$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243080611$24308061$1$I$$20231128$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000441$SIGMA TAU$$$$$$Y$$$20240911$$HP$US$US
243080621$24308062$1$I$$20231120$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000429$SIGMA TAU$$$$$M$Y$$$20240911$$HP$US$US
243080631$24308063$1$I$$20231107$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000418$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243080641$24308064$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62460$$FDA-CTU$$77$YR$$F$N$96.16$KG$20240911$N$$US$
243080661$24308066$1$I$$20231117$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000427$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243080671$24308067$1$I$$20231124$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000436$SIGMA TAU$$$$$M$Y$$$20240911$$MD$US$US
243080681$24308068$1$I$$20231122$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000433$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080691$24308069$1$I$$20231110$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000421$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080701$24308070$1$I$$20231120$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000428$SIGMA TAU$$$$$M$Y$$$20240911$$HP$US$US
243080711$24308071$1$I$$20231227$20240911$20240911$PER$$US-LEADIANT GMBH-2023STPI000435$SIGMA TAU$$$$$M$Y$114$KG$20240911$$CN$US$US
243080731$24308073$1$I$$20231127$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000438$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080741$24308074$1$I$$20231121$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000432$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080751$24308075$1$I$$20231109$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000420$SIGMA TAU$$$$$F$Y$$$20240911$$MD$US$US
243080761$24308076$1$I$$20231122$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000434$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080771$24308077$1$I$$20231115$20240911$20240911$EXP$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000425$SIGMA TAU$$$$$M$Y$$$20240911$$MD$US$US
243080781$24308078$1$I$$20231117$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000426$SIGMA TAU$$$$$F$Y$$$20240911$$MD$US$US
243080791$24308079$1$I$$20231120$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000430$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080801$24308080$1$I$20240830$20240903$20240911$20240911$PER$$CN-Eisai-EC-2024-173618$EISAI$$56$YR$A$M$Y$53$KG$20240911$$HP$CN$CN
243080811$24308081$1$I$20231120$20231205$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000448$SIGMA TAU$$52$YR$$M$Y$$$20240911$$CN$US$US
243080821$24308082$1$I$$20231201$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000447$SIGMA TAU$$$$$F$Y$$$20240911$$MD$US$US
243080831$24308083$1$I$$20231128$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000444$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243080841$24308084$1$I$$20231129$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000445$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080851$24308085$1$I$$20231201$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000446$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243080871$24308087$1$I$$20240909$20240911$20240911$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050548$BOEHRINGER INGELHEIM$$$$$$Y$$$20240911$$CN$CA$CA
243080881$24308088$1$I$$20231211$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000453$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080891$24308089$1$I$$20231220$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000465$SIGMA TAU$$$$$F$Y$$$20240911$$MD$US$US
243080901$24308090$1$I$$20231214$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000457$SIGMA TAU$$$$$$Y$$$20240911$$CN$US$US
243080913$24308091$3$F$$20240919$20240911$20240923$EXP$$JP-SA-2024SA262030$SANOFI AVENTIS$Shintani-Ishida K, Kawamoto M, Kondo H, Onoe T, Ikegaya H.. Fatal pregabalin poisoning in Japan: A case report.. Legal medicine.. 2024;71:1-4$50$YR$A$M$Y$107.4$KG$20240923$$MD$JP$JP
243080921$24308092$1$I$$20231212$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000455$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080931$24308093$1$I$$20231206$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000450$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243080941$24308094$1$I$$20231221$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000467$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080951$24308095$1$I$$20231207$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000451$SIGMA TAU$$$$$M$Y$$$20240911$$HP$US$US
243080961$24308096$1$I$$20240105$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000454$SIGMA TAU$$$$$F$Y$$$20240911$$MD$US$US
243080971$24308097$1$I$$20231219$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000463$SIGMA TAU$$$$$M$Y$$$20240911$$MD$US$US
243080981$24308098$1$I$$20231227$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000462$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243080991$24308099$1$I$$20231206$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000449$SIGMA TAU$$$$$M$Y$$$20240911$$MD$US$US
243081001$24308100$1$I$$20231215$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000459$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081011$24308101$1$I$$20231212$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000456$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081021$24308102$1$I$$20231220$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000464$SIGMA TAU$$$$$F$Y$$$20240911$$MD$US$US
243081031$24308103$1$I$$20231221$20240911$20240911$EXP$$US-LEADIANT GMBH-2023STPI000466$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081041$24308104$1$I$20240101$20240906$20240911$20240911$EXP$$DE-ABBVIE-5916681$ABBVIE$$64$YR$$F$Y$$$20240911$$CN$DE$DE
243081051$24308105$1$I$20240101$20240906$20240911$20240911$EXP$$DO-JNJFOC-20240520071$JOHNSON AND JOHNSON$$59$YR$A$F$Y$116$KG$20240911$$HP$DO$DO
243081061$24308106$1$I$$20240216$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000049$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081071$24308107$1$I$$20231230$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000475$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081081$24308108$1$I$$20231229$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000473$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081091$24308109$1$I$$20231226$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000469$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081101$24308110$1$I$$20240219$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000050$SIGMA TAU$$$$$M$Y$$$20240911$$HP$US$US
243081111$24308111$1$I$20231208$20231226$20240911$20240911$EXP$$US-LEADIANT GMBH-2023STPI000474$SIGMA TAU$$34$YR$$F$Y$$$20240911$$CN$US$US
243081121$24308112$1$I$$20231227$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000471$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081131$24308113$1$I$$20231221$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2023STPI000468$SIGMA TAU$$$$$F$Y$$$20240911$$MD$US$US
243081151$24308115$1$I$$20240301$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000068$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081171$24308117$1$I$20231225$20231228$20240911$20240911$EXP$$US-LEADIANT GMBH-2023STPI000472$SIGMA TAU$$38$YR$$F$Y$$$20240911$$CN$US$US
243081181$24308118$1$I$$20240220$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000053$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081191$24308119$1$I$$20240222$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000060$SIGMA TAU$$$$$M$Y$$$20240911$$MD$US$US
243081201$24308120$1$I$$20240219$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000054$SIGMA TAU$$$$$M$Y$$$20240911$$MD$US$US
243081211$24308121$1$I$$20240220$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000051$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081221$24308122$1$I$$20240227$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000061$SIGMA TAU$$$$$M$Y$$$20240911$$MD$US$US
243081231$24308123$1$I$$20240227$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000063$SIGMA TAU$$$$$F$Y$$$20240911$$MD$US$US
243081241$24308124$1$I$$20240220$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000055$SIGMA TAU$$$$$F$Y$$$20240911$$MD$US$US
243081251$24308125$1$I$$20240220$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000052$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081261$24308126$1$I$$20240229$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000065$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081271$24308127$1$I$$20240220$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000056$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081282$24308128$2$F$$20240910$20240911$20240919$EXP$$US-ROCHE-10000073364$ROCHE$$62$YR$A$M$Y$$$20240919$$CN$US$US
243081291$24308129$1$I$$20240903$20240911$20240911$EXP$$NVSC2024US181689$NOVARTIS$$$$$M$Y$$$20240911$$CN$US$US
243081301$24308130$1$I$20240908$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006399$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240911$$CN$US$US
243081311$24308131$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62462$$FDA-CTU$$42$YR$$M$N$122.47$KG$20240911$N$$US$
243081321$24308132$1$I$20240909$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006363$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240911$$CN$US$US
243081331$24308133$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004343$ELI LILLY AND CO$$50$YR$A$$Y$$$20240911$$LW$US$US
243081341$24308134$1$I$20240801$20240904$20240911$20240911$EXP$FR-AFSSAPS-TS2024000954$FR-ELI_LILLY_AND_COMPANY-FR202409003066$ELI LILLY AND CO$$70$YR$E$F$Y$45$KG$20240911$$CN$FR$FR
243081351$24308135$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005534$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240911$$CN$US$US
243081371$24308137$1$I$20240909$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005923$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240911$$CN$US$US
243081381$24308138$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62472$$FDA-CTU$$59$YR$$F$N$97.52$KG$20240911$N$$US$
243081391$24308139$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62465$$FDA-CTU$$79$YR$$F$N$$$20240911$N$$US$
243081401$24308140$1$I$$20240305$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000075$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081411$24308141$1$I$$20240301$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000070$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081421$24308142$1$I$$20240304$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000073$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081431$24308143$1$I$$20240304$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000071$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081441$24308144$1$I$$20240313$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000088$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081451$24308145$1$I$$20240304$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000079$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081461$24308146$1$I$20240906$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005740$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240911$$CN$US$US
243081471$24308147$1$I$$20240306$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000076$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081481$24308148$1$I$$20240304$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000074$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081491$24308149$1$I$$20240301$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000069$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081501$24308150$1$I$$20240311$20240911$20240911$PER$$US-LEADIANT GMBH-2024LBI000081$SIGMA TAU$$$$$F$Y$$$20240911$$MD$US$US
243081511$24308151$1$I$$20240301$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000072$SIGMA TAU$$$$$M$Y$$$20240911$$HP$US$US
243081531$24308153$1$I$$20240320$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000099$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081541$24308154$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP010007$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243081551$24308155$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000611US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243081561$24308156$1$I$$20240315$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000092$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081571$24308157$1$I$$20240315$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000093$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081581$24308158$1$I$$20240316$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000095$SIGMA TAU$$$$$F$Y$$$20240911$$MD$US$US
243081591$24308159$1$I$$20240314$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000091$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081601$24308160$1$I$$20240313$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000089$SIGMA TAU$$$$$F$Y$$$20240911$$HP$US$US
243081611$24308161$1$I$$20240315$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000094$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081621$24308162$1$I$$20240320$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000098$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081631$24308163$1$I$$20240327$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000102$SIGMA TAU$$$$$F$Y$$$20240911$$MD$US$US
243081641$24308164$1$I$20240401$20240904$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141585$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240911$$CN$US$US
243081651$24308165$1$I$$20240910$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144624$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240911$$CN$US$US
243081671$24308167$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144371$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240911$$HP$US$US
243081681$24308168$1$I$20240907$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143562$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240911$$HP$US$US
243081691$24308169$1$I$20240909$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143893$BRISTOL MYERS SQUIBB$$19$YR$A$F$Y$$$20240911$$CN$US$US
243081711$24308171$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA260659$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240911$$CN$US$US
243081721$24308172$1$I$20240823$20240903$20240911$20240911$PER$$US-SA-2024SA259971$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240911$$CN$US$US
243081731$24308173$1$I$$20240207$20240911$20240911$PER$$US-BECTON DICKINSON-US-BD-24-000094$BECTON DICKINSON$$$$$F$Y$57.1$KG$20240911$$CN$US$US
243081741$24308174$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA261300$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240911$$HP$US$US
243081751$24308175$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA262946$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240911$$MD$US$US
243081761$24308176$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA260937$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240911$$HP$US$US
243081771$24308177$1$I$20240701$20240830$20240911$20240911$PER$$US-SA-2024SA261948$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240911$$HP$US$US
243081781$24308178$1$I$$20240409$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000120$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081791$24308179$1$I$$20240325$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000105$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081801$24308180$1$I$$20240326$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000107$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081811$24308181$1$I$$20240418$20240911$20240911$EXP$$US-LEADIANT GMBH-2024LBI000132$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081821$24308182$1$I$$20240417$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000128$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081831$24308183$1$I$$20240327$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000116$SIGMA TAU$$$$$F$Y$$$20240911$$HP$US$US
243081841$24308184$1$I$$20240411$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000121$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081851$24308185$1$I$$20240417$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000129$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081861$24308186$1$I$$20240418$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000131$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081871$24308187$1$I$$20240403$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000117$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081881$24308188$1$I$$20240326$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000106$SIGMA TAU$$$$$F$Y$$$20240911$$CN$US$US
243081891$24308189$1$I$$20240322$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000103$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081901$24308190$1$I$$20240326$20240911$20240911$EXP$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000104$SIGMA TAU$$$$$F$Y$$$20240911$$HP$US$US
243081911$24308191$1$I$$20240405$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000118$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081933$24308193$3$F$20240702$20240912$20240911$20240913$EXP$$US-PURDUE PHARMA-USA-2024-0311866$PURDUE$$42$YR$$F$Y$$$20240913$$CN$US$US
243081941$24308194$1$I$$20240903$20240911$20240911$EXP$$US-PURDUE-USA-2024-0311902$PURDUE$Nilssen P K, Compton E, Stephan S, Andras L M, Chu J K, Illingworth K D, et al.. Incidental dural tears during pediatric posterior spinal fusions. Spine Deformity. 2024;12:5:1277-1282$$$$F$Y$$$20240911$$HP$US$US
243081951$24308195$1$I$20190101$20240903$20240911$20240911$EXP$$FR-PURDUE-USA-2024-0311904$PURDUE$Larabi I-A, Etting I, Alvarez J-C. The duration of ketamine detection in hair after treatment cessation: Case study and review of the literature in forensic and clinical casework. Drug Test Anal. 2023;15(9):971-979$22$YR$$F$Y$57$KG$20240911$$MD$FR$FR
243081961$24308196$1$I$20240821$20240910$20240911$20240911$EXP$$FR-TAKEDA-2024TUS090309$TAKEDA$$91$YR$$F$Y$$$20240911$$MD$FR$FR
243081971$24308197$1$I$$20240419$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000133$SIGMA TAU$$$$$M$Y$$$20240911$$MD$US$US
243081981$24308198$1$I$$20240423$20240911$20240911$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000135$SIGMA TAU$$$$$M$Y$$$20240911$$CN$US$US
243081991$24308199$1$I$$20240903$20240911$20240911$PER$$US-ABBVIE-5918496$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243082011$24308201$1$I$$20240905$20240911$20240911$EXP$$CA-PURDUE-USA-2024-0311896$PURDUE$$65$YR$$F$Y$34$KG$20240911$$HP$CA$CA
243082021$24308202$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62466$$FDA-CTU$$28$YR$$F$N$117.93$KG$20240911$N$$US$
243082031$24308203$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62467$$FDA-CTU$$61$YR$$M$N$$$20240911$N$$US$
243082041$24308204$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62469$$FDA-CTU$$56$YR$$M$N$$$20240911$N$HP$US$
243082051$24308205$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62470$$FDA-CTU$$46$YR$$M$N$113.4$KG$20240911$N$$US$
243082061$24308206$1$I$20230101$20240902$20240911$20240911$EXP$$US-BIOGEN-2024BI01280904$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243082072$24308207$2$F$20240809$20240906$20240911$20240927$PER$$US-Eisai-EC-2024-172332$EISAI$$77$YR$E$M$Y$$$20240927$$CN$US$US
243082082$24308208$2$F$20240101$20240909$20240911$20240930$PER$$US-Eisai-EC-2024-173483$EISAI$$79$YR$E$F$Y$62.5$KG$20240930$$HP$US$US
243082091$24308209$1$I$20240101$20240905$20240911$20240911$PER$$JP-Eisai-EC-2024-173797$EISAI$$$$E$F$Y$$$20240911$$MD$JP$JP
243082101$24308210$1$I$$20240903$20240911$20240911$PER$$AU-Eisai-EC-2024-173707$EISAI$$$$$F$Y$$$20240911$$MD$AU$AU
243082111$24308211$1$I$20240801$20240904$20240911$20240911$PER$$US-Eisai-EC-2024-173089$EISAI$$77$YR$E$F$Y$72.5$KG$20240911$$CN$US$US
243082121$24308212$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143427$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240911$$CN$US$US
243082132$24308213$2$F$20240909$20240911$20240911$20240912$PER$$US-AMGEN-USASP2024181095$AMGEN$$71$YR$E$F$Y$$$20240912$$CN$US$US
243082141$24308214$1$I$$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143945$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240911$$HP$US$US
243082151$24308215$1$I$20240909$20240910$20240911$20240911$PER$$US-AMGEN-USASP2024180980$AMGEN$$$$$$Y$$$20240911$$CN$US$US
243082161$24308216$1$I$20240101$20240906$20240911$20240911$EXP$$US-009507513-2409USA003048$MERCK$$$$$F$Y$$$20240911$$HP$US$US
243082182$24308218$2$F$$20240916$20240911$20240923$EXP$$FR-TEVA-VS-3241104$TEVA$Messekher M, Francois H, Denis MG, Ferrer-Lopez P, Bost-Bezeaud F, Mazieres J, et al. [Resistance to anti-EGFR through the successive and cumulative acquisition of two new oncogenic addictions: BRAF and ALK]. [French]. Rev-Mal-Respir 2024; 41 (6): 451-454.; Messekher M, Francois H, Denis MG, Ferrer-Lopez P, Bost-Bezeaud F, Mazieres J, et al. [Resistance to anti-EGFR through the successive and cumulative acquisition of two new oncogenic addictions: BRAF and ALK]. [French]. Rev-Mal-Respir 2024;...$52$YR$$F$Y$$$20240923$$HP$FR$FR
243082191$24308219$1$I$$20240906$20240911$20240911$PER$$US-TAKEDA-2024TUS089737$TAKEDA$$$$A$M$Y$$$20240911$$HP$US$US
243082201$24308220$1$I$$20240827$20240911$20240911$EXP$$US-TEVA-VS-3227528$TEVA$$71$YR$$F$Y$$$20240911$$CN$US$US
243082211$24308221$1$I$$20240906$20240911$20240911$EXP$$US-ROCHE-10000077067$ROCHE$$$$$$Y$$$20240911$$CN$US$US
243082221$24308222$1$I$$20240910$20240911$20240911$PER$$US-ALXN-202409USA000641US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243082231$24308223$1$I$$20240910$20240911$20240911$EXP$$ES-AMGEN-ESPSP2024180487$AMGEN$$16$YR$T$F$Y$$$20240911$$HP$ES$ES
243082241$24308224$1$I$$20240906$20240911$20240911$PER$$US-ALXN-202409USA000449US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243082251$24308225$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000615US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243082261$24308226$1$I$$20240903$20240911$20240911$EXP$$US-ROCHE-10000074932$ROCHE$$$$C$M$Y$$$20240911$$CN$US$US
243082271$24308227$1$I$20240903$20240905$20240911$20240911$EXP$$JP-009507513-2409JPN000950J$MERCK$$6$DEC$$M$Y$$$20240911$$MD$JP$JP
243082291$24308229$1$I$$20240904$20240911$20240911$EXP$$BR-TAKEDA-BR202032709$TAKEDA$$$$$M$Y$54$KG$20240911$$CN$BR$BR
243082301$24308230$1$I$$20240909$20240911$20240911$EXP$GB-MHRA-MIDB-b59af161-c598-4294-a73e-b12288a55d54$GB-SANDOZ INC.-SDZ2024GB078796$SANDOZ$$56$YR$$F$Y$$$20240911$$HP$GB$GB
243082311$24308231$1$I$$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62471$$FDA-CTU$$$$$F$N$$$20240910$N$HP$US$
243082321$24308232$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62473$$FDA-CTU$$33$YR$$F$N$113.4$KG$20240911$N$$US$
243082331$24308233$1$I$$20240903$20240911$20240911$EXP$$CN-ROCHE-10000077340$ROCHE$$77$YR$E$M$Y$$$20240911$$CN$CN$CN
243082341$24308234$1$I$$20240903$20240911$20240911$EXP$$JP-Eisai-EC-2024-173683$EISAI$Yuka Oi. A case of recurrent uterine cancer presenting with tumorigenic pancreatitis as an immune-related side effect. Journal of the Japanese Society of Gynecologic Oncology. 2024; 42(3): P-048-.$71$YR$E$F$Y$$$20240911$$MD$JP$JP
243082351$24308235$1$I$20240325$20240902$20240911$20240911$PER$$JP-Eisai-EC-2024-173577$EISAI$$51$YR$A$F$Y$41$KG$20240911$$PH$JP$JP
243082361$24308236$1$I$$20240830$20240911$20240911$EXP$$US-FARMAPROD-202409-3123$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240911$$CN$US$US
243082371$24308237$1$I$$20240910$20240911$20240911$EXP$GB-MHRA-MED-202409101118526150-PLFBG$GB-MYLANLABS-2024M1082730$MYLAN$$$$$M$Y$$$20240911$$PH$GB$GB
243082381$24308238$1$I$$20240909$20240911$20240911$EXP$$ES-SANDOZ INC.-SDZ2024ES079103$SANDOZ$$$$C$F$Y$$$20240911$$HP$ES$ES
243082391$24308239$1$I$$20240909$20240911$20240911$EXP$ES-EMA-DD-20240903-7482829-090613$ES-SANDOZ INC.-SDZ2024ES078745$SANDOZ$$6$YR$$F$Y$$$20240911$$MD$ES$ES
243082401$24308240$1$I$20240814$20240910$20240911$20240911$EXP$GB-MHRA-MED-202409091625193460-DPYVC$GB-SANDOZ INC.-SDZ2024GB079245$SANDOZ$$89$YR$$F$Y$43$KG$20240911$$PH$GB$GB
243082412$24308241$2$F$20240823$20240904$20240911$20240911$PER$$US-ROCHE-10000074605$ROCHE$$3$YR$C$M$Y$$$20240911$$CN$US$US
243082421$24308242$1$I$$20240910$20240911$20240911$PER$$NVSC2024US182107$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243082431$24308243$1$I$20240827$20240828$20240911$20240911$EXP$$US-ChurchDwight-2024-CDW-01423$CHURCH + DWIGHT$$3$YR$C$F$Y$$$20240911$$CN$US$US
243082441$24308244$1$I$20240801$20240910$20240911$20240911$PER$$US-AMGEN-USASP2024181222$AMGEN$$74$YR$E$M$Y$$$20240911$$CN$US$US
243082451$24308245$1$I$20240101$20240909$20240911$20240911$EXP$$US-KARYOPHARM-2024KPT001525$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240911$$CN$US$US
243082461$24308246$1$I$$20240910$20240911$20240911$EXP$$CA-SANDOZ INC.-SDZ2024CA079283$SANDOZ$$5$MON$$F$Y$$$20240911$$HP$CA$CA
243082471$24308247$1$I$$20240904$20240911$20240911$PER$$US-TAKEDA-2024TUS088915$TAKEDA$$18$YR$$F$Y$$$20240911$$CN$US$US
243082481$24308248$1$I$$20240820$20240911$20240911$30DAY$$FR-JNJFOC-20240852938$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240911$$PH$FR$FR
243082491$24308249$1$I$20240904$20240830$20240911$20240911$EXP$$US-FARMAPROD-202409-3131$DOMPE FARMACEUTICI$$72$YR$E$F$Y$$$20240911$$CN$US$US
243082501$24308250$1$I$20060320$20240905$20240911$20240911$EXP$$US-BAXTER-2006BH008105$TAKEDA$$35$YR$$F$Y$63.503$KG$20240911$$CN$US$US
243082521$24308252$1$I$20240909$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143435$BRISTOL MYERS SQUIBB$$76$YR$E$$Y$$$20240911$$PH$US$US
243082531$24308253$1$I$$20240910$20240911$20240911$PER$$NVSC2024US182018$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243082541$24308254$1$I$$20240910$20240911$20240911$PER$$NVSC2024US182140$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243082551$24308255$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143499$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240911$$CN$US$US
243082561$24308256$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143750$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$68.95$KG$20240911$$CN$US$US
243082571$24308257$1$I$20231222$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144863$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240911$$MD$US$US
243082582$24308258$2$F$$20240906$20240911$20240916$PER$$US-AMGEN-USASP2024179172$AMGEN$$$$$F$Y$$$20240916$$HP$US$US
243082591$24308259$1$I$20220401$20240904$20240911$20240911$EXP$$US-SA-2024SA263059$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240911$$MD$US$US
243082602$24308260$2$F$20240823$20240918$20240911$20240924$EXP$$CA-LUNDBECK-DKLU4004044$LUNDBECK$$$$$$Y$$$20240924$$CN$CA$CA
243082621$24308262$1$I$20240101$20240828$20240911$20240911$EXP$$US-Axsome Therapeutics, Inc.-AXS202408-001313$AXSOME THERAPEUTICS$$49$YR$A$F$Y$$$20240911$$$US$
243082631$24308263$1$I$20230816$20240904$20240911$20240911$EXP$$JP-GILEAD-2024-0686610$GILEAD$$68$YR$E$M$Y$$$20240911$$MD$JP$JP
243082641$24308264$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000614US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243082651$24308265$1$I$$20240910$20240911$20240911$PER$$US-ALXN-202409USA000622US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243082661$24308266$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000569US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243082671$24308267$1$I$$20240905$20240911$20240911$PER$$US-ALXN-202409USA000394US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243082681$24308268$1$I$$20240910$20240911$20240911$PER$$US-ALXN-202409USA000634US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243082691$24308269$1$I$$20240906$20240911$20240911$PER$$US-AstraZeneca-2024A206116$ASTRAZENECA$$$$$$Y$$$20240911$$CN$US$
243082701$24308270$1$I$20240903$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A204548$ASTRAZENECA$$25659$DY$$M$Y$$$20240911$$MD$US$
243082712$24308271$2$F$$20240918$20240911$20240920$EXP$$BR-TAKEDA-2024TUS090016$TAKEDA$$$$$$Y$$$20240920$$CN$BR$BR
243082721$24308272$1$I$20240819$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143185$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240911$$HP$US$US
243082742$24308274$2$F$$20240916$20240911$20240923$EXP$$FR-TEVA-VS-3241103$TEVA$Venet A, Vergier R, Cenac K, Inamo J, Mussigbrodt A. Axillary and subclavian venous spasm during pacemaker implantation - A case report and literature review. Clin-Case-Rep 2024; 12 (8):.; Venet A, Vergier R, Cenac K, Inamo J, Mussigbrodt A. Axillary and subclavian venous spasm during pacemaker implantation - A case report and literature review. Clin-Case-Rep 2024; 12 (8):.$66$YR$$F$Y$$$20240923$$HP$FR$FR
243082751$24308275$1$I$$20240814$20240911$20240911$PER$$US-LUNDBECK-DKLU4003007$LUNDBECK$$$$$$Y$$$20240911$$HP$US$US
243082771$24308277$1$I$20240101$20240815$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051652$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
243082781$24308278$1$I$20240814$20240814$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051868$TOLMAR$$78$YR$$M$Y$$$20240911$$CN$CA$CA
243082791$24308279$1$I$$20240815$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051699$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
243082801$24308280$1$I$20240815$20240815$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051899$TOLMAR$$85$YR$$M$Y$$$20240911$$CN$CA$CA
243082811$24308281$1$I$20240814$20240814$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051898$TOLMAR$$72$YR$$M$Y$$$20240911$$CN$CA$CA
243082821$24308282$1$I$20240815$20240815$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051900$TOLMAR$$64$YR$$M$Y$$$20240911$$CN$CA$CA
243082831$24308283$1$I$20240101$20240815$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051902$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
243082841$24308284$1$I$$20240814$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051903$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
243082861$24308286$1$I$$20240814$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051917$TOLMAR$$$$$F$Y$$$20240911$$CN$CA$CA
243082871$24308287$1$I$$20240815$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051924$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
243082881$24308288$1$I$$20240815$20240911$20240911$PER$$US-LUNDBECK-DKLU4003100$LUNDBECK$$$$$$Y$$$20240911$$CN$US$US
243082891$24308289$1$I$$20240815$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051925$TOLMAR$$$$$M$Y$$$20240911$$CN$CA$CA
243082901$24308290$1$I$$20240903$20240911$20240911$EXP$$US-Calliditas-2024CAL01749$CALLIDITAS THERAPEUTICS$$30$YR$A$F$Y$$$20240911$$CN$US$US
243082911$24308291$1$I$$20240904$20240911$20240911$EXP$$US-TEVA-VS-3241751$TEVA$$63$YR$$F$Y$$$20240911$$CN$US$US
243082921$24308292$1$I$20231031$20240904$20240911$20240911$EXP$$JP-GILEAD-2024-0686613$GILEAD$$65$YR$E$M$Y$$$20240911$$MD$JP$JP
243082953$24308295$3$F$$20240918$20240911$20240920$EXP$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US001151$PAREXEL$$77$YR$$F$Y$67.12$KG$20240920$$CN$US$US
243082961$24308296$1$I$$20240905$20240911$20240911$EXP$$US-TAKEDA-2024TUS089193$TAKEDA$$8$YR$$M$Y$47$KG$20240911$$PH$US$US
243082971$24308297$1$I$$20240906$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US078565$SANDOZ$$$$$F$Y$$$20240911$$CN$US$US
243082981$24308298$1$I$$20240909$20240911$20240911$EXP$$US-SANDOZ INC.-NVSC2020US105707$SANDOZ$$$$$F$Y$$$20240911$$CN$US$US
243082991$24308299$1$I$20230101$20240909$20240911$20240911$EXP$$HU-SANDOZ INC.-SDZ2024HU079078$SANDOZ$$7$YR$$M$Y$$$20240911$$MD$HU$HU
243083002$24308300$2$F$20240903$20240917$20240911$20240918$30DAY$$IT-SANDOZ INC.-SDZ2024IT078871$SANDOZ$$13$YR$$M$Y$46$KG$20240918$$CN$IT$IT
243083011$24308301$1$I$20240731$20240902$20240911$20240911$EXP$$TW-JNJFOC-20240920441$JOHNSON AND JOHNSON$$$$$M$Y$$$20240911$$MD$TW$TW
243083021$24308302$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62481$$FDA-CTU$$53$YR$$F$N$75.3$KG$20240911$N$$US$
243083031$24308303$1$I$20240901$20240909$20240911$20240911$PER$$US-ROCHE-10000077987$ROCHE$$40$YR$A$M$Y$$$20240911$$CN$US$US
243083041$24308304$1$I$$20240909$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US079434$SANDOZ$$$$$F$Y$45.91$KG$20240911$$CN$US$US
243083051$24308305$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA260927$SANOFI AVENTIS$$$$A$M$Y$$$20240911$$HP$US$US
243083061$24308306$1$I$20240801$20240826$20240911$20240911$PER$$US-SA-2024SA262382$SANOFI AVENTIS$$58$YR$A$F$Y$72.73$KG$20240911$$HP$US$US
243083071$24308307$1$I$$20240910$20240911$20240911$PER$$US-ROCHE-10000078141$ROCHE$$$$A$M$Y$$$20240911$$CN$US$US
243083081$24308308$1$I$20240130$20240904$20240911$20240911$EXP$$JP-GILEAD-2024-0686615$GILEAD$$68$YR$E$M$Y$$$20240911$$MD$JP$JP
243083101$24308310$1$I$20240801$20240905$20240911$20240911$PER$$US-BAYER-2024A127477$BAYER$$54$YR$A$F$Y$$$20240911$$CN$US$US
243083111$24308311$1$I$20240815$20240907$20240911$20240911$EXP$$US-BAYER-2024A117509$BAYER$$77$YR$E$F$Y$57.596$KG$20240911$$CN$US$US
243083121$24308312$1$I$20240601$20240906$20240911$20240911$EXP$$AR-AMGEN-ARGSP2024179510$AMGEN$$61$YR$A$F$Y$$$20240911$$CN$AR$AR
243083131$24308313$1$I$20231113$20240904$20240911$20240911$EXP$$JP-GILEAD-2024-0686618$GILEAD$$66$YR$E$M$Y$$$20240911$$MD$JP$JP
243083141$24308314$1$I$$20240905$20240911$20240911$PER$$US-BAYER-2024A127670$BAYER$$48$YR$A$F$Y$$$20240911$$HP$US$US
243083151$24308315$1$I$20210901$20240909$20240911$20240911$EXP$$SA-GSK-SA2022EME084230$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$CN$SA$SA
243083171$24308317$1$I$$20240910$20240911$20240911$PER$$US-ALXN-202409USA000642US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243083181$24308318$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000604US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243083191$24308319$1$I$$20240902$20240911$20240911$PER$$US-APELLIS-2024-APL-0000933$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240911$$MD$US$US
243083201$24308320$1$I$$20240909$20240911$20240911$PER$$JP-Eisai-EC-2024-174119$EISAI$Kazuyoshi Iijima. Metastatic Renal Cell Carcinoma Treatment by Age. Tohokushin Renal Cell Carcinoma Treatment Seminar.$$$$$Y$$$20240911$$MD$JP$JP
243083211$24308321$1$I$20240807$20240809$20240911$20240911$PER$$US-Eisai-EC-2024-171885$EISAI$$52$YR$A$F$Y$$$20240911$$CN$US$US
243083221$24308322$1$I$20240826$20240910$20240911$20240911$EXP$DE-BFARM-24006317$DE-Eisai-EC-2024-174011$EISAI$$79$YR$E$M$Y$85$KG$20240911$$MD$DE$DE
243083231$24308323$1$I$$20240903$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0013257$DR REDDYS$Gangat N, Ajufo H, Abdelmagid M, Karrar O, McCullough K, Badar T, et al. IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience. British Journal of Haematology. 2023;203(3): e87-e92. doi:10.1111/bjh.19027.$45$YR$A$F$Y$$$20240911$$HP$US$US
243083251$24308325$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144680$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240911$$HP$US$US
243083261$24308326$1$I$20240628$20240909$20240911$20240911$EXP$FR-AFSSAPS-PA2024001358$FR-009507513-2409FRA003281$MERCK$$36$YR$$M$Y$72.9$KG$20240911$$MD$FR$FR
243083271$24308327$1$I$20240814$20240906$20240911$20240911$EXP$$US-BAYER-2024A129181$BAYER$$59$YR$A$M$Y$$$20240911$$CN$US$US
243083281$24308328$1$I$$20240907$20240911$20240911$EXP$$CN-AstraZeneca-2024A203760$ASTRAZENECA$Ding K, Peng Z, Liu D, Xu Y.. Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation. Journal of Translational Medicine 2024;22(761):$43$YR$$M$Y$$$20240911$$HP$CN$
243083291$24308329$1$I$$20240905$20240911$20240911$EXP$$EG-AstraZeneca-2024A202309$ASTRAZENECA$Ibrahim A., Atef M.. MM-111 A Complex Journey of Multiple Myeloma, a Devastating Metastatic Breast Cancer, Then Multiple Myeloma Again: A Double Malignancy Case Report. Clinical Lymphoma, Myeloma and Leukemia 2024;24(Supplement 1):S536-S537.$71$YR$$F$Y$$$20240911$$HP$EG$
243083301$24308330$1$I$20240830$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A204663$ASTRAZENECA$$$$$$Y$$$20240911$$CN$US$
243083311$24308331$1$I$$20240905$20240911$20240911$EXP$$DE-AstraZeneca-2024A205475$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$DE$
243083321$24308332$1$I$20240301$20240906$20240911$20240911$EXP$$IT-AstraZeneca-2024A205523$ASTRAZENECA$$76$YR$$F$Y$60$KG$20240911$$MD$IT$
243083331$24308333$1$I$$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A200462$ASTRAZENECA$$$$$F$Y$$$20240911$$MD$US$
243083341$24308334$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A204616$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
243083351$24308335$1$I$$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A203200$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243083362$24308336$2$F$20230101$20240909$20240911$20240913$EXP$$DE-AstraZeneca-2024A203678$ASTRAZENECA$$65$YR$$F$Y$$$20240913$$MD$DE$
243083371$24308337$1$I$20240909$20240910$20240911$20240911$EXP$$US-AstraZeneca-2024A206561$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
243083381$24308338$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005412$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240911$$CN$US$US
243083392$24308339$2$F$$20240906$20240911$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409004545$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240913$$CN$US$US
243083401$24308340$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006346$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240911$$CN$US$US
243083411$24308341$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62482$$FDA-CTU$$60$YR$$F$N$66.68$KG$20240911$N$$US$
243083421$24308342$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62484$$FDA-CTU$$43$YR$$F$N$81.65$KG$20240911$N$$US$
243083431$24308343$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62485$$FDA-CTU$$63$YR$$F$N$74.39$KG$20240911$N$$US$
243083441$24308344$1$I$20240101$20240905$20240911$20240911$EXP$$GB-ORGANON-O2409GBR000730$ORGANON$$$$$F$Y$$$20240911$$HP$GB$GB
243083452$24308345$2$F$$20240917$20240911$20240920$EXP$$US-ABBVIE-5760525$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243083461$24308346$1$I$$20240904$20240911$20240911$EXP$$CA-JNJFOC-20240911771$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$MD$CA$CA
243083473$24308347$3$F$$20240923$20240911$20240926$PER$$US-BIOGEN-2024BI01281298$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243083481$24308348$1$I$$20240904$20240911$20240911$PER$$US-BAYER-2024A127744$BAYER$$47$YR$A$F$Y$$$20240911$$CN$US$US
243083491$24308349$1$I$20240101$20240909$20240911$20240911$PER$$US-BIOGEN-2024BI01279804$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243083502$24308350$2$F$20240123$20240912$20240911$20240919$EXP$$US-VIIV HEALTHCARE LIMITED-US2024110129$VIIV$$$$$$Y$$$20240919$$HP$US$US
243083511$24308351$1$I$20000101$20240906$20240911$20240911$EXP$FR-AFSSAPS-AVLY2024000165$FR-INDIVIOR UK LIMITED-INDV-156352-2024$RECKITT BENCKISER$$$$$$Y$$$20240911$$MD$FR$FR
243083521$24308352$1$I$$20240730$20240911$20240911$PER$$US-LUNDBECK-DKLU4002436$LUNDBECK$$$$$$Y$$$20240911$$PH$US$US
243083531$24308353$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA262157$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240911$$HP$US$US
243083541$24308354$1$I$20240903$20240903$20240911$20240911$EXP$GB-MHRA-MED-202409031353236340-ZCMTR$GB-TEVA-VS-3240317$TEVA$$39$YR$$F$Y$$$20240911$$CN$GB$GB
243083551$24308355$1$I$$20240903$20240911$20240911$EXP$GB-MHRA-31738807$GB-TEVA-VS-3240053$TEVA$$$$$$Y$$$20240911$$CN$GB$GB
243083561$24308356$1$I$$20240910$20240911$20240911$EXP$$NVSC2024US181402$NOVARTIS$$$$$F$Y$$$20240911$$CN$US$US
243083571$24308357$1$I$20240801$20240910$20240911$20240911$PER$$US-AMGEN-USASP2024180690$AMGEN$$$$$M$Y$$$20240911$$CN$US$US
243083581$24308358$1$I$20230318$20240909$20240911$20240911$EXP$FR-AFSSAPS-AN2023000511$FR-SANDOZ INC.-NVSC2023FR082524$SANDOZ$$36$YR$$M$Y$106$KG$20240911$$MD$FR$FR
243083591$24308359$1$I$20240101$20240903$20240911$20240911$EXP$$GB-TEVA-VS-3240256$TEVA$$41$YR$$F$Y$$$20240911$$MD$GB$GB
243083601$24308360$1$I$20240908$20240910$20240911$20240911$EXP$$US-BAYER-2024A129556$BAYER$$64$YR$A$F$Y$$$20240911$$CN$US$US
243083611$24308361$1$I$$20240903$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0013258$DR REDDYS$Gangat N, Ajufo H, Abdelmagid M, Karrar O, McCullough K, Badar T, et al. IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience. British Journal of Haematology. 2023;203(3): e87-e92. doi:10.1111/bjh.19027.$72$YR$E$M$Y$$$20240911$$HP$US$US
243083621$24308362$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP010006$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243083631$24308363$1$I$20240908$20240910$20240911$20240911$PER$$US-ALXN-202409USA000649US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243083641$24308364$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000577US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243083651$24308365$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000618US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243083661$24308366$1$I$$20240830$20240911$20240911$EXP$$US-FARMAPROD-202409-3135$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240911$$CN$US$US
243083671$24308367$1$I$20240101$20240906$20240911$20240911$PER$$US-PFIZER INC-PV202400117502$PFIZER$$38$YR$$F$Y$$$20240911$$HP$US$US
243083681$24308368$1$I$20240905$20240907$20240911$20240911$PER$$US-PFIZER INC-202400253119$PFIZER$$$$$M$Y$$$20240911$$CN$US$US
243083691$24308369$1$I$20240907$20240907$20240911$20240911$PER$$US-PFIZER INC-PV202400118125$PFIZER$$36$YR$$F$Y$95.2$KG$20240911$$CN$US$US
243083712$24308371$2$F$20240903$20240917$20240911$20240919$PER$$US-PFIZER INC-202400251660$PFIZER$$$$$M$Y$$$20240919$$CN$US$US
243083721$24308372$1$I$20240801$20240908$20240911$20240911$PER$$US-PFIZER INC-202400252053$PFIZER$$75$YR$$F$Y$$$20240911$$CN$US$US
243083731$24308373$1$I$20240101$20240906$20240911$20240911$PER$$US-PFIZER INC-202400251823$PFIZER$$71$YR$$M$Y$82.55$KG$20240911$$CN$US$US
243083741$24308374$1$I$$20240904$20240911$20240911$PER$$US-PFIZER INC-PV202400104120$PFIZER$$17$YR$$M$Y$$$20240911$$CN$US$US
243083751$24308375$1$I$20240101$20240906$20240911$20240911$PER$$US-PFIZER INC-PV202300158592$PFIZER$$78$YR$$F$Y$69.17$KG$20240911$$HP$US$US
243083771$24308377$1$I$20240904$20240906$20240911$20240911$PER$$US-PFIZER INC-202400252204$PFIZER$$60$YR$$F$Y$$$20240911$$CN$US$US
243083781$24308378$1$I$$20240908$20240911$20240911$PER$$US-PFIZER INC-202400253110$PFIZER$$$$$$Y$$$20240911$$CN$US$US
243083792$24308379$2$F$$20240912$20240911$20240916$PER$$US-PFIZER INC-PV202400116831$PFIZER$$79$YR$$M$Y$$$20240916$$HP$US$US
243083802$24308380$2$F$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400252037$PFIZER$$40$YR$$F$Y$$$20240911$$CN$US$US
243083811$24308381$1$I$$20240906$20240911$20240911$PER$$US-PFIZER INC-PV202400118057$PFIZER$$56$YR$$M$Y$$$20240911$$CN$US$US
243083821$24308382$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253165$PFIZER$$76$YR$$M$Y$$$20240911$$CN$US$US
243083831$24308383$1$I$20240101$20240906$20240911$20240911$PER$$US-PFIZER INC-202400252203$PFIZER$$80$YR$$M$Y$$$20240911$$CN$US$US
243083841$24308384$1$I$$20240906$20240911$20240911$PER$$US-PFIZER INC-202400251785$PFIZER$$$$E$M$Y$$$20240911$$CN$US$US
243083853$24308385$3$F$20240901$20240919$20240911$20240919$PER$$US-PFIZER INC-202400252173$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243083861$24308386$1$I$20240905$20240906$20240911$20240911$PER$$US-PFIZER INC-202400251662$PFIZER$$97$YR$$M$Y$63.5$KG$20240911$$CN$US$US
243083872$24308387$2$F$$20240906$20240911$20240912$PER$$US-PFIZER INC-202400251801$PFIZER$$$$$F$Y$$$20240912$$CN$US$US
243083881$24308388$1$I$$20240910$20240911$20240911$PER$$US-BAYER-2024A129759$BAYER$$$$$F$Y$$$20240911$$HP$US$US
243083891$24308389$1$I$$20240906$20240911$20240911$EXP$$US-GILEAD-2024-0686878$GILEAD$$$$E$M$Y$$$20240911$$CN$US$US
243083901$24308390$1$I$$20240906$20240911$20240911$30DAY$$US-SANDOZ INC.-SDZ2024US053831$SANDOZ$$$$$M$Y$$$20240911$$CN$US$US
243083911$24308391$1$I$20240101$20240903$20240911$20240911$PER$$US-SA-2024SA262076$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240911$$HP$US$US
243083921$24308392$1$I$$20240820$20240911$20240911$PER$$US-SA-2024SA262192$SANOFI AVENTIS$$$$E$F$Y$68.481$KG$20240911$$MD$US$US
243083931$24308393$1$I$20240830$20240911$20240911$20240911$DIR$717982$$FDA-CTU$$46$YR$$F$N$65.25$KG$20240911$N$CN$US$
243083941$24308394$1$I$20240909$20240911$20240911$20240911$DIR$717978$$FDA-CTU$$54$YR$$F$N$130.5$KG$20240911$N$CN$US$
243083961$24308396$1$I$20240813$20240910$20240910$20240910$DIR$717885$$FDA-CTU$$67$YR$$UNK$N$$$20240910$N$PH$US$
243083971$24308397$1$I$20240802$20240910$20240910$20240910$DIR$717813$$FDA-CTU$$25$YR$$M$N$$$20240910$N$CN$US$
243083981$24308398$1$I$20240510$20240909$20240911$20240911$EXP$$NVSC2024GB107389$NOVARTIS$$52$YR$$F$Y$$$20240911$$CN$GB$GB
243083991$24308399$1$I$$20240827$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009090$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243084001$24308400$1$I$20240906$20240909$20240911$20240911$PER$$US-BAYER-2024A129305$BAYER$$30$YR$A$F$Y$$$20240911$$CN$US$US
243084011$24308401$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP010005$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243084021$24308402$1$I$$20240905$20240911$20240911$PER$$US-BAYER-2024A128051$BAYER$$$$$F$Y$$$20240911$$CN$US$US
243084031$24308403$1$I$20240601$20240904$20240911$20240911$PER$$CA-TOLMAR, INC.-24CA051772$TOLMAR$$70$YR$$M$Y$$$20240911$$HP$CA$CA
243084041$24308404$1$I$$20240827$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009089$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243084052$24308405$2$F$20240101$20240909$20240911$20240927$PER$$US-TOLMAR, INC.-24US051456$TOLMAR$$$$$M$Y$$$20240927$$HP$US$US
243084071$24308407$1$I$$20240821$20240911$20240911$PER$$US-TOLMAR, INC.-24US051831$TOLMAR$$$$$M$Y$$$20240911$$HP$US$US
243084082$24308408$2$F$20240726$20240906$20240911$20240925$PER$$US-TOLMAR, INC.-24US051972$TOLMAR$$85$YR$$M$Y$$$20240925$$HP$US$US
243084091$24308409$1$I$20240808$20240821$20240911$20240911$PER$$US-TOLMAR, INC.-24US052018$TOLMAR$$75$YR$$M$Y$$$20240911$$PH$US$US
243084101$24308410$1$I$20240308$20240822$20240911$20240911$PER$$US-TOLMAR, INC.-24US052073$TOLMAR$$80$YR$$M$Y$$$20240911$$HP$US$US
243084111$24308411$1$I$20240716$20240821$20240911$20240911$PER$$US-TOLMAR, INC.-24US051747$TOLMAR$$76$YR$$M$Y$$$20240911$$HP$US$US
243084121$24308412$1$I$20240725$20240822$20240911$20240911$PER$$US-TOLMAR, INC.-24US052074$TOLMAR$$69$YR$$M$Y$$$20240911$$HP$US$US
243084131$24308413$1$I$20240820$20240821$20240911$20240911$PER$$US-TOLMAR, INC.-24US052080$TOLMAR$$$$$$Y$$$20240911$$PH$US$US
243084141$24308414$1$I$20240820$20240821$20240911$20240911$PER$$US-TOLMAR, INC.-24US052081$TOLMAR$$$$$$Y$$$20240911$$PH$US$US
243084151$24308415$1$I$$20240906$20240911$20240911$EXP$$PT-AstraZeneca-2024A206621$ASTRAZENECA$$$$A$F$Y$$$20240911$$MD$PT$
243084161$24308416$1$I$$20240903$20240911$20240911$EXP$$US-AstraZeneca-2024A200970$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
243084171$24308417$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A204090$ASTRAZENECA$$$$$M$Y$$$20240911$$CN$US$
243084181$24308418$1$I$$20240902$20240911$20240911$EXP$$JP-BIOCON BIOLOGICS LIMITED-BBL2017000002$BIOCON$Yamada M, Kubo M, Kai M, Yamamoto H, Nakamura M.. Efficacy of GC Therapy for the Patient of iTNBC with Resistance to TAC Therapy.. Gan to kagaku ryoho. Cancer + chemotherapy.. 2017;44(8):703-705$$$$$Y$$$20240911$$MD$JP$JP
243084191$24308419$1$I$$20240906$20240911$20240911$EXP$$FR-REGENERON PHARMACEUTICALS, INC.-2024-120787$REGENERON$$81$YR$$F$Y$$$20240911$$MD$FR$FR
243084201$24308420$1$I$$20240907$20240911$20240911$EXP$$IR-AstraZeneca-2024A203769$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240911$$MD$IR$
243084211$24308421$1$I$20240705$20240907$20240911$20240911$EXP$$US-VIIV HEALTHCARE LIMITED-US2024111478$VIIV$$$$$$Y$$$20240911$$CN$US$US
243084221$24308422$1$I$20240701$20240827$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009055$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243084241$24308424$1$I$$20240907$20240911$20240911$EXP$$IR-AstraZeneca-2024A203770$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240911$$MD$IR$
243084251$24308425$1$I$$20240822$20240911$20240911$EXP$$US-SA-2024SA262294$SANOFI AVENTIS$$60$YR$A$M$Y$84.09$KG$20240911$$MD$US$US
243084262$24308426$2$F$$20240827$20240911$20240919$PER$$US-INCYTE CORPORATION-2024IN009052$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243084271$24308427$1$I$20240831$20240910$20240911$20240911$EXP$$IN-PFIZER INC-PV202400119146$PFIZER$$67$YR$$M$Y$$$20240911$$CN$IN$IN
243084281$24308428$1$I$20240821$20240909$20240911$20240911$EXP$IT-MINISAL02-1001256$IT-PFIZER INC-202400252427$PFIZER$$69$YR$$M$Y$83$KG$20240911$$MD$IT$IT
243084291$24308429$1$I$20240827$20240910$20240911$20240911$EXP$$JP-PFIZER INC-202400254404$PFIZER$$63$YR$$M$Y$62.6$KG$20240911$$PH$JP$JP
243084301$24308430$1$I$20240101$20240906$20240911$20240911$EXP$$CA-PFIZER INC-202400253752$PFIZER$$63$YR$$F$Y$$$20240911$$MD$CA$CA
243084311$24308431$1$I$20231215$20240909$20240911$20240911$EXP$IT-MINISAL02-1001430$IT-PFIZER INC-202400252425$PFIZER$$61$YR$$M$Y$$$20240911$$MD$IT$IT
243084321$24308432$1$I$$20240911$20240911$20240911$EXP$$IE-PFIZER INC-202400254459$PFIZER$$$$$F$Y$$$20240911$$HP$IE$IE
243084331$24308433$1$I$$20240909$20240911$20240911$EXP$$US-PFIZER INC-202400253833$PFIZER$$72$YR$$M$Y$$$20240911$$CN$US$US
243084342$24308434$2$F$$20240912$20240911$20240917$EXP$$CA-PFIZER INC-202400253904$PFIZER$$75$YR$$F$Y$$$20240917$$MD$CA$CA
243084351$24308435$1$I$20230418$20240909$20240911$20240911$EXP$FR-AFSSAPS-PC2024000688$FR-PFIZER INC-202400252530$PFIZER$$62$YR$$F$Y$73$KG$20240911$$PH$FR$FR
243084361$24308436$1$I$20240619$20240910$20240911$20240911$EXP$DK-DKMA-30738130$DK-PFIZER INC-202400253386$PFIZER$$55$YR$$F$Y$$$20240911$$MD$DK$DK
243084371$24308437$1$I$20240101$20240906$20240911$20240911$PER$$US-BAYER-2024A128286$BAYER$$45$YR$A$F$Y$$$20240911$$HP$US$US
243084381$24308438$1$I$$20240910$20240911$20240911$PER$$US-BAYER-2024A129743$BAYER$$$$$$Y$$$20240911$$CN$US$US
243084401$24308440$1$I$20230905$20240909$20240911$20240911$EXP$$RO-PFIZER INC-202400252434$PFIZER$$32$YR$$M$Y$$$20240911$$CN$RO$RO
243084411$24308441$1$I$$20240906$20240911$20240911$EXP$$US-SA-2024SA262798$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240911$$MD$US$US
243084421$24308442$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA260454$SANOFI AVENTIS$$$$A$M$Y$$$20240911$$HP$US$US
243084432$24308443$2$F$20240801$20240913$20240911$20240923$EXP$$JP-SA-2024SA262983$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240923$$PH$JP$JP
243084441$24308444$1$I$$20240903$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0013259$DR REDDYS$Gangat N, Ajufo H, Abdelmagid M, Karrar O, McCullough K, Badar T, et al. IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience. British Journal of Haematology. 2023;203(3): e87-e92. doi:10.1111/bjh.19027.$57$YR$A$M$Y$$$20240911$$HP$US$US
243084451$24308445$1$I$20240828$20240906$20240911$20240911$EXP$$CN-PFIZER INC-PV202400117420$PFIZER$$71$YR$$F$Y$$$20240911$$HP$CN$CN
243084462$24308446$2$F$$20240924$20240911$20240927$EXP$$US-ASTELLAS-2024-AER-003463$ASTELLAS$$82$YR$E$M$Y$$$20240927$$CN$US$US
243084471$24308447$1$I$$20240827$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009049$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243084481$24308448$1$I$20201021$20240904$20240911$20240911$EXP$PL-URPL-1-2522-2020$PL-TEVA-VS-3240479$TEVA$$70$YR$$F$Y$70$KG$20240911$$HP$PL$PL
243084491$24308449$1$I$20240801$20240828$20240911$20240911$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004665$PAREXEL$$$$$$Y$$$20240911$$CN$US$US
243084501$24308450$1$I$20240101$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180447$AMGEN$$78$YR$E$F$Y$$$20240911$$CN$US$US
243084512$24308451$2$F$20170501$20240910$20240911$20240916$PER$$US-AMGEN-USASP2024181154$AMGEN$$79$YR$E$M$Y$$$20240916$$CN$US$US
243084521$24308452$1$I$20240101$20240821$20240911$20240911$PER$$US-SA-2024SA262172$SANOFI AVENTIS$$76$YR$E$M$Y$70.3$KG$20240911$$MD$US$US
243084531$24308453$1$I$20240909$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005725$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240911$$CN$US$US
243084541$24308454$1$I$$20240904$20240911$20240911$PER$$US-ABBVIE-5917443$ABBVIE$$$$$$Y$$$20240911$$HP$US$US
243084551$24308455$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006359$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240911$$CN$US$US
243084562$24308456$2$F$20240711$20240827$20240911$20240911$PER$$US-ASTELLAS-2024-AER-003542$ASTELLAS$$84$YR$E$M$Y$$$20240911$$CN$US$US
243084571$24308457$1$I$$20240906$20240911$20240911$PER$$US-BAYER-2024A128290$BAYER$$22$YR$A$F$Y$$$20240911$$MD$US$US
243084581$24308458$1$I$$20240827$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009035$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243084591$24308459$1$I$$20240827$20240911$20240911$EXP$$US-SA-2024SA262779$SANOFI AVENTIS$$$$$M$Y$77.27$KG$20240911$$MD$US$US
243084601$24308460$1$I$20240101$20240829$20240911$20240911$PER$$US-SA-2024SA260703$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240911$$MD$US$US
243084611$24308461$1$I$20230101$20240830$20240911$20240911$PER$$US-SA-2024SA262124$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240911$$HP$US$US
243084621$24308462$1$I$20240801$20240903$20240911$20240911$PER$$US-SA-2024SA262032$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240911$$HP$US$US
243084631$24308463$1$I$$20240909$20240911$20240911$PER$$US-TAKEDA-2024TUS089998$TAKEDA$$$$$F$Y$45$KG$20240911$$MD$US$US
243084641$24308464$1$I$20240810$20240904$20240911$20240911$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-144715$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240911$$HP$AU$AU
243084651$24308465$1$I$$20240905$20240911$20240911$EXP$$US-TAKEDA-2024TUS089198$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
243084661$24308466$1$I$$20240909$20240911$20240911$EXP$$US-TAKEDA-2024TUS089839$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
243084671$24308467$1$I$$20240906$20240911$20240911$PER$$US-BAYER-2024A129195$BAYER$$$$$F$Y$$$20240911$$CN$US$US
243084691$24308469$1$I$$20240910$20240911$20240911$DIR$FDA-CDER-CTU-2024-62492$$FDA-CTU$$$$$F$N$$$20240910$N$HP$US$
243084701$24308470$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62483$$FDA-CTU$$14$YR$$F$N$$$20240911$N$$US$
243084721$24308472$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62486$$FDA-CTU$$56$YR$$F$N$78.02$KG$20240911$N$$US$
243084731$24308473$1$I$20230401$20240905$20240911$20240911$EXP$$CA-TAKEDA-2023TUS048813$TAKEDA$$78$YR$$F$Y$$$20240911$$HP$CA$CA
243084751$24308475$1$I$$20240904$20240911$20240911$EXP$$CA-JNJFOC-20240820315$JOHNSON AND JOHNSON$$15$YR$T$M$Y$64$KG$20240911$$HP$CA$CA
243084762$24308476$2$F$$20240911$20240911$20240912$PER$$US-JNJFOC-20240927813$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243084771$24308477$1$I$20240731$20240906$20240911$20240911$PER$$US-BAYER-2024A129549$BAYER$$20$YR$A$F$Y$$$20240911$$MD$US$US
243084781$24308478$1$I$$20240905$20240911$20240911$EXP$$NVSC2024FR180531$NOVARTIS$$$$$$Y$$$20240911$$MD$FR$FR
243084791$24308479$1$I$$20240904$20240911$20240911$EXP$$NVSC2024FR181416$NOVARTIS$$$$A$F$Y$$$20240911$$HP$FR$FR
243084801$24308480$1$I$$20240903$20240911$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024109546$VIIV$$$$$M$Y$$$20240911$$CN$US$US
243084811$24308481$1$I$$20240910$20240911$20240911$PER$$US-BAYER-2024A130073$BAYER$$$$$$Y$$$20240911$$CN$US$US
243084821$24308482$1$I$20240904$20240909$20240911$20240911$EXP$GB-MHRA-MED-202409091003212070-FQVML$GB-MYLANLABS-2024M1082533$MYLAN$$71$YR$$$Y$77$KG$20240911$$CN$GB$GB
243084832$24308483$2$F$$20240918$20240911$20240919$EXP$$NZ-MYLANLABS-2024M1082909$MYLAN$$$$$M$Y$$$20240919$$HP$NZ$NZ
243084841$24308484$1$I$20230601$20240909$20240911$20240911$EXP$$US-MYLANLABS-2024M1083015$MYLAN$$53$YR$$M$Y$$$20240911$$CN$US$US
243084851$24308485$1$I$20240904$20240904$20240911$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024110117$VIIV$$33$YR$$$Y$$$20240911$$HP$US$US
243084861$24308486$1$I$20240908$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179978$AMGEN$$$$$M$Y$$$20240911$$CN$US$US
243084871$24308487$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62502$$FDA-CTU$$53$YR$$F$N$91.17$KG$20240911$N$$US$
243084883$24308488$3$F$20240910$20240912$20240911$20240913$PER$$US-AMGEN-USASP2024181087$AMGEN$$61$YR$A$M$Y$$$20240913$$CN$US$US
243084891$24308489$1$I$20240601$20240903$20240911$20240911$EXP$$CN-AMGEN-CHNSP2024177946$AMGEN$$63$YR$A$F$Y$$$20240911$$MD$CN$CN
243084901$24308490$1$I$20240718$20240909$20240911$20240911$PER$$US-BAYER-2024A129574$BAYER$$$$$F$Y$$$20240911$$HP$US$US
243084911$24308491$1$I$$20240904$20240911$20240911$EXP$NL-LRB-00999609$NL-TEVA-VS-3240476$TEVA$$84$YR$$M$Y$69$KG$20240911$$CN$NL$NL
243084921$24308492$1$I$20240906$20240906$20240911$20240911$PER$$US-JNJFOC-20240919997$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240911$$CN$US$US
243084931$24308493$1$I$20240717$20240830$20240911$20240911$EXP$$IT-EXELIXIS-EXL-2024-000019$EXELIXIS$$65$YR$$M$Y$$$20240911$$MD$IT$IT
243084941$24308494$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62498$$FDA-CTU$$62$YR$$F$N$$$20240911$N$$US$
243084951$24308495$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62500$$FDA-CTU$$67$YR$$F$N$94.35$KG$20240911$N$$US$
243084961$24308496$1$I$$20240905$20240911$20240911$PER$$US-ALXN-202409USA000435US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243084971$24308497$1$I$20240905$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A204075$ASTRAZENECA$$$$$$Y$$$20240911$$MD$US$
243084981$24308498$1$I$$20240907$20240911$20240911$EXP$$IR-AstraZeneca-2024A203758$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$M$Y$$$20240911$$MD$IR$
243084991$24308499$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62494$$FDA-CTU$$43$YR$$F$N$$$20240911$N$$US$
243085011$24308501$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62497$$FDA-CTU$$42$YR$$F$N$86.18$KG$20240911$N$$US$
243085021$24308502$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000652US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243085032$24308503$2$F$20240910$20240924$20240911$20240925$PER$$US-AMGEN-USASP2024181380$AMGEN$$96$YR$E$F$Y$$$20240925$$MD$US$US
243085041$24308504$1$I$$20240907$20240911$20240911$EXP$$IR-AstraZeneca-2024A203768$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240911$$MD$IR$
243085051$24308505$1$I$$20240906$20240911$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001814$BLUEPRINT MEDICINES$$$$$M$Y$$$20240911$$CN$US$US
243085061$24308506$1$I$20240821$20240902$20240911$20240911$EXP$CN-NMPACDR-4419001005628202400137$CN-BAXTER-2024BAX024219$BAXTER$$51$YR$$F$Y$52$KG$20240911$$MD$CN$CN
243085071$24308507$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62496$$FDA-CTU$$68$YR$$F$N$77.56$KG$20240911$N$$US$
243085081$24308508$1$I$$20240906$20240911$20240911$EXP$$US-AstraZeneca-2024A203899$ASTRAZENECA$$$$$M$Y$$$20240911$$MD$US$
243085101$24308510$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144522$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240911$$CN$US$US
243085111$24308511$1$I$$20240906$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143748$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240911$$CN$US$US
243085121$24308512$1$I$$20240903$20240911$20240911$EXP$$GB-Bion-013783$BIONPHARMA$$69$YR$E$F$Y$$$20240911$$HP$GB$GB
243085131$24308513$1$I$20240101$20240905$20240911$20240911$PER$$US-SA-2024SA262761$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240911$$MD$US$US
243085141$24308514$1$I$20240101$20240827$20240911$20240911$PER$$US-SA-2024SA262293$SANOFI AVENTIS$$58$YR$A$F$Y$68$KG$20240911$$MD$US$US
243085151$24308515$1$I$$20240903$20240911$20240911$EXP$$GB-Bion-013776$BIONPHARMA$$41$YR$A$M$Y$$$20240911$$HP$GB$GB
243085162$24308516$2$F$20240910$20240911$20240911$20240912$PER$$US-AMGEN-USASP2024181150$AMGEN$$81$YR$E$F$Y$$$20240912$$CN$US$US
243085171$24308517$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180377$AMGEN$$$$$$Y$$$20240911$$CN$US$US
243085181$24308518$1$I$20240601$20240909$20240911$20240911$PER$$US-JNJFOC-20240921988$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$CN$US$US
243085191$24308519$1$I$$20240903$20240911$20240911$EXP$$US-ROCHE-10000073835$ROCHE$$62$YR$A$M$Y$$$20240911$$CN$US$US
243085201$24308520$1$I$20240822$20240910$20240910$20240910$DIR$717909$$FDA-CTU$$46$YR$$M$N$139.5$KG$20240910$N$PH$US$
243085211$24308521$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62501$$FDA-CTU$$64$YR$$M$N$139.71$KG$20240911$N$$US$
243085231$24308523$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62499$$FDA-CTU$$78$YR$$F$N$93.89$KG$20240911$N$$US$
243085241$24308524$1$I$$20240904$20240911$20240911$EXP$$FR-DSJP-DSE-2024-144101$DAIICHI$$$$$F$Y$$$20240911$$MD$FR$FR
243085251$24308525$1$I$$20240909$20240911$20240911$EXP$DE-EMA-DD-20240903-7482645-140825$DE-SANDOZ INC.-SDZ2024DE079138$SANDOZ$$8$YR$$$Y$$$20240911$$MD$DE$DE
243085261$24308526$1$I$$20240902$20240911$20240911$EXP$$US-RDY-SPO/USA/24/0013098$DR REDDYS$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 101: doi:10.1016/j.jflm.2023.102625.$69$YR$E$$Y$$$20240911$$HP$US$US
243085271$24308527$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62503$$FDA-CTU$$60$YR$$F$N$$$20240911$N$$US$
243085281$24308528$1$I$$20240830$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144516$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240911$$HP$US$US
243085291$24308529$1$I$20240728$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62504$$FDA-CTU$$33$YR$$F$N$$$20240911$N$$US$
243085301$24308530$1$I$20240820$20240910$20240911$20240911$EXP$ES-AEMPS-1567709$ES-PFIZER INC-202400253461$PFIZER$$52$YR$$F$Y$$$20240911$$PH$ES$ES
243085311$24308531$1$I$20200701$20240909$20240911$20240911$EXP$PL-URPL-1-3099-2020$PL-FreseniusKabi-FK202413560$FRESENIUS KABI$$43$YR$A$F$Y$65$KG$20240911$$MD$PL$PL
243085321$24308532$1$I$$20240905$20240911$20240911$PER$$US-FreseniusKabi-FK202413490$FRESENIUS KABI$$35$YR$A$F$Y$$$20240911$$CN$US$US
243085331$24308533$1$I$20240101$20240906$20240911$20240911$PER$$US-TAKEDA-2024TUS089428$TAKEDA$$$$$$Y$$$20240911$$CN$US$US
243085342$24308534$2$F$$20240917$20240911$20240926$EXP$$US-TEVA-VS-3239904$TEVA$Ashinne B, Zablah G, Colombo R. THE USE OF IMPELLA FOR RIGHT VENTRICLE DECOMPRESSION: A LIFE SAVER. J-Am-Coll-Cardiol 2019; 73 (Suppl. 1) (9): 2505.; Ashinne B, Zablah G, Colombo R. THE USE OF IMPELLA FOR RIGHT VENTRICLE DECOMPRESSION: A LIFE SAVER. J-Am-Coll-Cardiol 2019; 73 (Suppl. 1) (9): 2505.$49$YR$$M$Y$$$20240926$$HP$US$US
243085351$24308535$1$I$20240701$20240905$20240911$20240911$EXP$FR-AFSSAPS-TS2024000951$FR-MYLANLABS-2024M1081544$MYLAN$$47$YR$$M$Y$83$KG$20240911$$MD$FR$FR
243085361$24308536$1$I$$20240909$20240911$20240911$EXP$$CA-SANDOZ INC.-SDZ2024CA079049$SANDOZ$$$$$F$Y$120$KG$20240911$$CN$CA$CA
243085371$24308537$1$I$$20240905$20240911$20240911$EXP$$DE-MYLANLABS-2024M1081570$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul L D.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. Journal of Analytical Toxicology. 2024;48(5):299-313$44$YR$$M$Y$$$20240911$$HP$DE$DE
243085381$24308538$1$I$20240101$20240909$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US079155$SANDOZ$$$$$F$Y$$$20240911$$CN$US$US
243085391$24308539$1$I$$20240830$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009239$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243085401$24308540$1$I$20240601$20240830$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009237$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243085411$24308541$1$I$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687077$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243085421$24308542$1$I$$20240830$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009231$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243085431$24308543$1$I$$20240909$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US079238$SANDOZ$$$$$F$Y$106$KG$20240911$$CN$US$US
243085442$24308544$2$F$$20240913$20240911$20240916$PER$$US-AMGEN-USASP2024180844$AMGEN$$$$$M$Y$$$20240916$$CN$US$US
243085451$24308545$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000563US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243085461$24308546$1$I$$20240906$20240911$20240911$EXP$$JP-BAYER-2024A121934$BAYER$$28$YR$A$F$Y$$$20240911$$PH$JP$JP
243085471$24308547$1$I$20240828$20240905$20240911$20240911$EXP$IT-MINISAL02-1000924$IT-MYLANLABS-2024M1081704$MYLAN$$56$YR$$M$Y$$$20240911$$PH$IT$IT
243085481$24308548$1$I$$20240830$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009224$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243085492$24308549$2$F$$20240917$20240911$20240926$EXP$$US-TEVA-VS-3240320$TEVA$Zahran NA, Zeller WP, Charnogursky GA. Hyperglycemia and multiple organ failure in a male adolescent. J-Clin-Transl-Endocrinol-Case-Rep 2023; 28 1-5.; Zahran NA, Zeller WP, Charnogursky GA. Hyperglycemia and multiple organ failure in a male adolescent. J-Clin-Transl-Endocrinol-Case-Rep 2023; 28 1-5.$14$YR$$M$Y$$$20240926$$HP$US$US
243085501$24308550$1$I$$20240830$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009221$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243085511$24308551$1$I$$20240830$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009220$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243085522$24308552$2$F$$20240917$20240911$20240926$EXP$$US-TEVA-VS-3239896$TEVA$Kotamarti V. Disentangling the Diagnoses of Psychotic Depression, Catatonia, Neurocognitive Disorders, and Delirium: A Multidisciplinary Approach. Am-J-Geriatr-Psychiatry 2024; 32 (Suppl.) (4): S35-S36.; Kotamarti V. Disentangling the Diagnoses of Psychotic Depression, Catatonia, Neurocognitive Disorders, and Delirium: A Multidisciplinary Approach. Am-J-Geriatr-Psychiatry 2024; 32 (Suppl.) (4): S35-S36.$77$YR$$M$Y$$$20240926$$MD$US$US
243085531$24308553$1$I$$20240903$20240911$20240911$EXP$$PL-BAUSCH-BL-2024-013445$BAUSCH AND LOMB$$35$YR$$F$Y$$$20240911$$MD$PL$PL
243085551$24308555$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5910325$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243085561$24308556$1$I$$20240911$20240911$20240911$PER$$US-BAYER-2024A130063$BAYER$$$$$$Y$$$20240911$$CN$US$US
243085571$24308557$1$I$$20240829$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009195$INCYTE$$$$$$Y$$$20240911$$PH$US$US
243085581$24308558$1$I$$20240830$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009218$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243085591$24308559$1$I$$20240909$20240911$20240911$EXP$$US-BAUSCH-BL-2024-013532$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240911$$CN$US$US
243085601$24308560$1$I$$20240904$20240911$20240911$PER$$US-AstraZeneca-2024A202647$ASTRAZENECA$$$$$$Y$$$20240911$$HP$US$
243085611$24308561$1$I$$20240909$20240911$20240911$PER$$US-BAYER-2024A129221$BAYER$$$$$F$Y$$$20240911$$CN$US$US
243085621$24308562$1$I$$20240907$20240911$20240911$EXP$$IR-AstraZeneca-2024A203778$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240911$$MD$IR$
243085631$24308563$1$I$$20240902$20240911$20240911$EXP$$US-JNJFOC-20240914033$JOHNSON AND JOHNSON$Philbrick S. Hands. Annals of Emergency Medicine. 2024;84:323--. doi:10.1016/j.annemergmed.2024.05.015$$$$F$Y$$$20240911$$HP$US$US
243085641$24308564$1$I$$20240906$20240911$20240911$EXP$$ZA-AstraZeneca-2024A204619$ASTRAZENECA$$78$YR$$M$Y$$$20240911$$CN$ZA$
243085651$24308565$1$I$$20240905$20240911$20240911$EXP$$NL-AstraZeneca-2024A207062$ASTRAZENECA$$25$YR$$M$Y$75$KG$20240911$$MD$NL$
243085661$24308566$1$I$$20240909$20240911$20240911$EXP$$IN-AstraZeneca-2024A205811$ASTRAZENECA$$71$YR$$F$Y$$$20240911$$CN$IN$
243085671$24308567$1$I$$20240829$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009164$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243085681$24308568$1$I$$20240829$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009169$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243085691$24308569$1$I$$20240907$20240911$20240911$EXP$$IR-AstraZeneca-2024A203771$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240911$$MD$IR$
243085701$24308570$1$I$$20240907$20240911$20240911$EXP$$IR-AstraZeneca-2024A203776$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240911$$MD$IR$
243085711$24308571$1$I$$20240907$20240911$20240911$EXP$$IR-AstraZeneca-2024A203772$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240911$$MD$IR$
243085721$24308572$1$I$$20240909$20240911$20240911$EXP$$CA-BAUSCH-BL-2024-013447$BAUSCH AND LOMB$$36$YR$$M$Y$$$20240911$$CN$CA$CA
243085731$24308573$1$I$$20240907$20240911$20240911$EXP$$IR-AstraZeneca-2024A203775$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240911$$MD$IR$
243085741$24308574$1$I$$20240907$20240911$20240911$EXP$$IR-AstraZeneca-2024A203773$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240911$$MD$IR$
243085751$24308575$1$I$20240814$20240904$20240911$20240911$EXP$IT-MINISAL02-1000320$IT-TEVA-VS-3241073$TEVA$$60$YR$$M$Y$63$KG$20240911$$MD$IT$IT
243085761$24308576$1$I$$20240909$20240911$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024111819$VIIV$$$$$M$Y$$$20240911$$HP$US$US
243085771$24308577$1$I$$20240905$20240911$20240911$PER$$US-BAUSCH-BL-2024-013341$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240911$$CN$US$US
243085781$24308578$1$I$$20240909$20240911$20240911$EXP$$CA-BAUSCH-BL-2024-013492$BAUSCH AND LOMB$$$$$M$Y$78$KG$20240911$$HP$CA$CA
243085791$24308579$1$I$$20240905$20240911$20240911$EXP$$US-BAUSCH-BL-2024-013333$BAUSCH AND LOMB$$$$$F$Y$$$20240911$$PH$US$US
243085801$24308580$1$I$$20240904$20240911$20240911$PER$$US-FreseniusKabi-FK202413462$FRESENIUS KABI$$47$YR$A$F$Y$$$20240911$$CN$US$US
243085812$24308581$2$F$20240101$20240923$20240911$20240930$EXP$$RO-FreseniusKabi-FK202413566$FRESENIUS KABI$$$$E$F$Y$$$20240930$$MD$RO$RO
243085821$24308582$1$I$$20240819$20240911$20240911$PER$$US-IMP-2024000712$Harrow Health$$$$$$Y$$$20240911$$CN$US$US
243085832$24308583$2$F$20240831$20240910$20240911$20240913$EXP$$US-BAUSCH-BL-2024-013547$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240913$$CN$US$US
243085841$24308584$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009950$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243085851$24308585$1$I$$20240909$20240911$20240911$EXP$$CA-BAUSCH-BL-2024-013503$BAUSCH AND LOMB$$7$DEC$$F$Y$$$20240911$$HP$CA$CA
243085862$24308586$2$F$20240906$20240910$20240911$20240917$EXP$$US-BAYER-2024A130030$BAYER$$73$YR$E$M$Y$72.562$KG$20240917$$CN$US$US
243085871$24308587$1$I$$20240909$20240911$20240911$EXP$$CA-BAUSCH-BL-2024-010441$BAUSCH AND LOMB$$61$YR$$F$Y$$$20240911$$PH$CA$CA
243085901$24308590$1$I$$20240828$20240911$20240911$EXP$$JP-NXDC-2024GLE00067$NX DEVELOPMENT CORPORATION$The safety of intraoperative photodynamic diagnosis using 5-aminolevulinic acid combined with talaporfin sodium photodynamic therapy in recurrent high-grade glioma. The 24th annual Meeting of the Japan Society of Intraoperative Imaging, Kohzuki H et al.. 25.?; The safety of intraoperative photodynamic diagnosis using 5-aminolevulinic acid combined with talaporfin sodium photodynamic therapy in recurrent high-grade glioma. World Neurosurgery, Kohzuki H et al.. 2024 Aug 06;$60$YR$A$M$Y$$$20240911$$MD$JP$JP
243085911$24308591$1$I$$20240904$20240911$20240911$EXP$$US-FreseniusKabi-FK202413630$FRESENIUS KABI$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B. Hematological Malignancies and Pregnancy: A Single-Institution Experience. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24(1): S333-S334. doi:https://dx.doi.org/10.1016/S2152-2650%2824%2901240-0.$$$$F$Y$$$20240911$$MD$US$US
243085921$24308592$1$I$20240101$20240905$20240911$20240911$EXP$$CA-BAUSCH-BL-2024-013402$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240911$$CN$CA$CA
243085931$24308593$1$I$$20240906$20240911$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001817$BLUEPRINT MEDICINES$$$$$F$Y$$$20240911$$CN$US$US
243085941$24308594$1$I$$20240909$20240911$20240911$EXP$$CA-BAUSCH-BL-2024-013438$BAUSCH AND LOMB$$3$YR$$$Y$$$20240911$$CN$CA$CA
243085951$24308595$1$I$$20240909$20240911$20240911$EXP$$JP-PFIZER INC-PV202400118313$PFIZER$Shimogawa, T.. Intracranial Subdural Empyema During Long-term Chemotherapy for Metastatic Colorectal Cancer: Case Report. In Vivo. 2024;38(5):2557-2561$69$YR$$F$Y$$$20240911$$HP$JP$JP
243085961$24308596$1$I$20240817$20240910$20240911$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024112601$VIIV$$37$YR$$M$Y$$$20240911$$HP$US$US
243085972$24308597$2$F$20240909$20240916$20240911$20240918$PER$$US-AMGEN-USASP2024180358$AMGEN$$77$YR$E$M$Y$$$20240918$$CN$US$US
243086011$24308601$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141307$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240911$$CN$US$US
243086022$24308602$2$F$20240101$20240923$20240911$20240925$PER$$US-JAZZ PHARMACEUTICALS-2024-US-013700$JAZZ$$$$$F$Y$$$20240925$$CN$US$US
243086041$24308604$1$I$20240901$20240909$20240911$20240911$PER$$US-ALXN-202409USA000547US$ALEXION PHARMACEUTICALS$$85$YR$$M$Y$$$20240911$$CN$US$US
243086051$24308605$1$I$$20240905$20240911$20240911$PER$$US-ALXN-202409USA000372US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243086061$24308606$1$I$$20240910$20240911$20240911$PER$$US-BAYER-2024A129553$BAYER$$$$$M$Y$$$20240911$$CN$US$US
243086071$24308607$1$I$20240822$20240822$20240911$20240911$PER$$US-TEVA-VS-3237118$TEVA$$46$YR$$F$Y$$$20240911$$CN$US$US
243086081$24308608$1$I$20240820$20240902$20240911$20240911$EXP$$GB-TEVA-VS-3239384$TEVA$$75$YR$$F$Y$84$KG$20240911$$MD$GB$GB
243086091$24308609$1$I$$20240910$20240911$20240911$PER$$US-BAYER-2024A129578$BAYER$$51$YR$A$F$Y$$$20240911$$HP$US$US
243086102$24308610$2$F$20240101$20240910$20240911$20240916$EXP$$US-ABBVIE-5816162$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243086111$24308611$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181728$NOVARTIS$$$$$$Y$$$20240911$$MD$US$US
243086121$24308612$1$I$20240726$20240910$20240910$20240910$DIR$717808$$FDA-CTU$$38$YR$$F$N$$$20240910$N$CN$US$
243086131$24308613$1$I$$20230417$20240911$20240911$EXP$$NVSC2023CA061324$NOVARTIS$$27$YR$$F$Y$$$20240911$$CN$CA$CA
243086141$24308614$1$I$$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144446$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240911$$CN$US$US
243086151$24308615$1$I$$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143637$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240911$$HP$US$US
243086161$24308616$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144762$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240911$$CN$US$US
243086171$24308617$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143570$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240911$$HP$US$US
243086181$24308618$1$I$20240101$20240909$20240911$20240911$EXP$SE-SEMPA-2024-006408$SE-FreseniusKabi-FK202413541$FRESENIUS KABI$$50$YR$A$M$Y$$$20240911$$MD$SE$SE
243086191$24308619$1$I$20240101$20240904$20240911$20240911$EXP$$CA-DSJP-DSJ-2024-144388$DAIICHI$$$$$F$Y$$$20240911$$MD$CA$CA
243086201$24308620$1$I$20240601$20240909$20240911$20240911$EXP$FR-AFSSAPS-CN2024000547$FR-FreseniusKabi-FK202413621$FRESENIUS KABI$$61$YR$A$F$Y$84.6$KG$20240911$$MD$FR$FR
243086211$24308621$1$I$20240822$20240909$20240911$20240911$EXP$DE-BFARM-24006240$DE-FreseniusKabi-FK202413552$FRESENIUS KABI$$88$YR$E$F$Y$81$KG$20240911$$MD$DE$DE
243086231$24308623$1$I$$20240830$20240911$20240911$30DAY$$JP-JNJFOC-20240915427$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$HP$JP$JP
243086242$24308624$2$F$$20240917$20240911$20240926$EXP$$US-TEVA-VS-3240318$TEVA$Tatari A, Moore P, Singh A. NATIVE AORTIC VALVE THROMBUS CAUSING TRANSIENT ISCHEMIC ATTACKS AND SUDDEN CARDIAC ARREST. J-Am-Coll-Cardiol 2019; 73 (Suppl. 1) (9): 2376.; Tatari A, Moore P, Singh A. NATIVE AORTIC VALVE THROMBUS CAUSING TRANSIENT ISCHEMIC ATTACKS AND SUDDEN CARDIAC ARREST. J-Am-Coll-Cardiol 2019; 73 (Suppl. 1) (9): 2376.$48$YR$$F$Y$$$20240926$$HP$US$US
243086251$24308625$1$I$$20240907$20240911$20240911$EXP$$IR-AstraZeneca-2024A203777$ASTRAZENECA$Farnaghi F, Eini P, Gachkar L.. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022. International Journal of Medical Toxicology and Forensic Medicine 2024;14(3):E44672..$$$C$F$Y$$$20240911$$MD$IR$
243086271$24308627$1$I$$20240903$20240911$20240911$EXP$$US-SMPA-2024SPA002278$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243086291$24308629$1$I$$20240904$20240911$20240911$EXP$$US-SMPA-2024SPA000418$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243086302$24308630$2$F$20240821$20240911$20240911$20240917$EXP$$TW-ABBVIE-5913560$ABBVIE$$71$YR$$M$Y$$$20240917$$CN$TW$TW
243086311$24308631$1$I$$20240909$20240911$20240911$EXP$$US-AstraZeneca-2024A205719$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243086321$24308632$1$I$20240910$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62438$$FDA-CTU$$61$YR$$F$N$122$KG$20240910$N$$US$
243086331$24308633$1$I$20240726$20240910$20240910$20240910$DIR$717808$$FDA-CTU$$38$YR$$F$N$$$20240910$N$CN$US$
243086341$24308634$1$I$20240905$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004717$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240911$$CN$US$US
243086351$24308635$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005704$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240911$$CN$US$US
243086361$24308636$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005747$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240911$$CN$US$US
243086371$24308637$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005776$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240911$$CN$US$US
243086381$24308638$1$I$20240904$20240904$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003051$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240911$$CN$US$US
243086391$24308639$1$I$20240905$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005363$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240911$$CN$US$US
243086412$24308641$2$F$$20240917$20240911$20240926$EXP$$US-TEVA-VS-3240322$TEVA$Haidry A, Kabra N, Bhinder J, Gass A. UTILIZING ECMO FOR RECURRENT IDIOPATHIC VENTRICULAR FIBRILLATION. J-Am-Coll-Cardiol 2019; 73 (Suppl.) (9): 2598.; Haidry A, Kabra N, Bhinder J, Gass A. UTILIZING ECMO FOR RECURRENT IDIOPATHIC VENTRICULAR FIBRILLATION. J-Am-Coll-Cardiol 2019; 73 (Suppl.) (9): 2598.$44$YR$$F$Y$$$20240926$$HP$US$US
243086421$24308642$1$I$20240823$20240909$20240911$20240911$EXP$$NVSC2024CN181901$NOVARTIS$$85$YR$$F$Y$46$KG$20240911$$HP$CN$CN
243086432$24308643$2$F$$20240918$20240911$20240925$EXP$$JP-AMGEN-JPNSP2024176360$AMGEN$$$$A$M$Y$$$20240925$$MD$JP$JP
243086441$24308644$1$I$20140101$20240905$20240911$20240911$EXP$$FR-AMGEN-FRANI2024177684$AMGEN$$29$YR$A$F$Y$52$KG$20240911$$MD$FR$FR
243086451$24308645$1$I$$20240904$20240911$20240911$EXP$$US-VERTEX PHARMACEUTICALS-2024-014275$VERTEX$McKinzie CJ, Duehlmeyer SR, Kam CW, Safirstein J.. Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy. Pediatr Pulmonol. 2024$6$YR$$M$Y$$$20240911$$PH$US$US
243086461$24308646$1$I$$20240904$20240911$20240911$EXP$$US-VERTEX PHARMACEUTICALS-2024-014276$VERTEX$McKinzie CJ, Duehlmeyer SR, Kam CW, Safirstein J.. Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy. Pediatr Pulmonol. 2024$14$YR$$F$Y$$$20240911$$PH$US$US
243086482$24308648$2$F$$20240919$20240911$20240930$30DAY$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03284$AMNEAL$$$$$$Y$$$20240930$$HP$US$US
243086491$24308649$1$I$20240906$20240910$20240911$20240911$PER$$US-BAYER-2024A129832$BAYER$$32$YR$A$F$Y$$$20240911$$HP$US$US
243086502$24308650$2$F$$20240917$20240911$20240920$EXP$$UA-AMGEN-UKRSP2024178055$AMGEN$Lymanets T.. Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240919$$MD$UA$UA
243086511$24308651$1$I$20240801$20240821$20240911$20240911$PER$$US-SA-2024SA262105$SANOFI AVENTIS$$31$YR$A$F$Y$69.03$KG$20240911$$MD$US$US
243086521$24308652$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA262104$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240911$$HP$US$US
243086531$24308653$1$I$20240101$20240904$20240911$20240911$PER$$US-SA-2024SA261975$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240911$$HP$US$US
243086541$24308654$1$I$$20240910$20240911$20240911$PER$$US-BAYER-2024A130086$BAYER$$$$$$Y$$$20240911$$CN$US$US
243086551$24308655$1$I$$20240906$20240911$20240911$EXP$$ES-ALXN-202409EEA000359ES$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$MD$ES$ES
243086561$24308656$1$I$20230609$20240614$20240911$20240911$PER$$US-GE HEALTHCARE-2024CSU007874$GE HEALTHCARE$$$$$$Y$$$20240911$$HP$US$US
243086571$24308657$1$I$20240213$20240614$20240911$20240911$PER$$US-GE HEALTHCARE-2024CSU007873$GE HEALTHCARE$$$$$$Y$$$20240911$$HP$US$US
243086581$24308658$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62509$$FDA-CTU$$72$YR$$F$N$100.24$KG$20240911$N$$US$
243086591$24308659$1$I$20191002$20240614$20240911$20240911$PER$$US-GE HEALTHCARE-2024CSU007875$GE HEALTHCARE$$$$$$Y$$$20240911$$HP$US$US
243086601$24308660$1$I$$20240910$20240911$20240911$PER$$US-ALXN-202408USA000858US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243086611$24308661$1$I$20240910$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62510$$FDA-CTU$$79$YR$$M$N$$$20240911$N$PH$US$
243086621$24308662$1$I$$20240903$20240911$20240911$EXP$$GB-JNJFOC-20240924488$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$MD$GB$GB
243086631$24308663$1$I$20240820$20240904$20240911$20240911$EXP$SE-SEMPA-2024-006363$SE-TEVA-VS-3240399$TEVA$$44$YR$$F$Y$$$20240911$$MD$SE$SE
243086641$24308664$1$I$20240101$20240909$20240911$20240911$PER$$JP-Eisai-EC-2024-171775$EISAI$$$$E$M$Y$$$20240911$$MD$JP$JP
243086651$24308665$1$I$$20240905$20240911$20240911$PER$$US-BIOGEN-2019BI00760478$BIOGEN$$$$$M$Y$$$20240911$$CN$US$US
243086661$24308666$1$I$$20240829$20240911$20240911$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17417$IPSEN$$60$YR$A$M$Y$$$20240911$$MD$US$US
243086671$24308667$1$I$20240719$20240905$20240911$20240911$EXP$$FI-MYLANLABS-2024M1081886$MYLAN$$$$$M$Y$91.6$KG$20240911$$HP$FI$FI
243086681$24308668$1$I$20200911$20240905$20240911$20240911$EXP$PL-URPL-2-1304-2020$PL-MYLANLABS-2024M1081602$MYLAN$$87$YR$$M$Y$$$20240911$$CN$PL$PL
243086691$24308669$1$I$$20240904$20240911$20240911$EXP$$FR-DSJP-DSE-2024-144068$DAIICHI$$$$A$F$Y$53$KG$20240911$$MD$FR$FR
243086701$24308670$1$I$$20240909$20240911$20240911$EXP$$CA-TAKEDA-2024TUS090454$TAKEDA$$$$$F$Y$$$20240911$$CN$CA$CA
243086721$24308672$1$I$20170517$20230202$20240911$20240911$EXP$$CA-SANDOZ INC.-PHHY2017CA075389$SANDOZ$$44$YR$$M$Y$$$20240911$$CN$CA$CA
243086731$24308673$1$I$20210302$20240910$20240911$20240911$EXP$$GB-ORGANON-O2409GBR000717$ORGANON$$68$YR$$M$Y$$$20240911$$MD$GB$GB
243086741$24308674$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3239598$TEVA$$$$C$F$Y$70$KG$20240911$$HP$CA$CA
243086751$24308675$1$I$$20240906$20240911$20240911$EXP$$US-BAUSCH-BL-2024-013351$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240911$$MD$US$US
243086762$24308676$2$F$$20240917$20240911$20240923$EXP$$NL-BAUSCH-BL-2024-013525$BAUSCH AND LOMB$Hermes N, Duivenvoorden R, Geerts P. C3-glomerulopathie bij een MGRS op basis van een monoklonaal IgA-kappa  waarvoor succesvolle onderdrukking met daratumumab. NED TIJDSCHR HEMATOL. 2024;21:277-282.$59$YR$$$Y$$$20240923$$MD$NL$NL
243086771$24308677$1$I$$20240909$20240911$20240911$EXP$$CA-BAUSCH-BL-2024-013534$BAUSCH AND LOMB$$86$YR$$F$Y$70$KG$20240911$$HP$CA$CA
243086781$24308678$1$I$$20240909$20240911$20240911$EXP$$CA-BAUSCH-BL-2024-013467$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240911$$HP$CA$CA
243086791$24308679$1$I$20240101$20240829$20240911$20240911$PER$$US-SA-2024SA254170$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240911$$MD$US$US
243086801$24308680$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62511$$FDA-CTU$$45$YR$$F$N$$$20240911$N$$US$
243086811$24308681$1$I$20240724$20240910$20240910$20240910$DIR$717882$$FDA-CTU$$44$YR$$F$N$137.25$KG$20240910$N$CN$US$
243086821$24308682$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62512$$FDA-CTU$$49$YR$$F$N$$$20240911$N$$US$
243086831$24308683$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62513$$FDA-CTU$$23$YR$$F$N$$$20240911$N$$US$
243086841$24308684$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62514$$FDA-CTU$$62$YR$$M$N$$$20240911$N$$US$
243086851$24308685$1$I$$20240910$20240910$20240910$DIR$717902$$FDA-CTU$$$$$UNK$N$$$20240910$$CN$US$
243086861$24308686$1$I$20240805$20240910$20240910$20240910$DIR$717889$$FDA-CTU$$22$YR$$F$N$90.09$KG$20240910$Y$PH$US$
243086871$24308687$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62515$$FDA-CTU$$90$YR$$F$N$$$20240911$N$$US$
243086891$24308689$1$I$$20240909$20240911$20240911$PER$$US-BIOGEN-2024BI01281762$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243086901$24308690$1$I$$20240903$20240911$20240911$PER$$US-BIOMARINAP-US-2024-160278$BIOMARIN$$$$$$Y$$$20240911$$CN$US$US
243086931$24308693$1$I$$20240904$20240911$20240911$EXP$$US-BIOMARINAP-US-2024-160417$BIOMARIN$Cooney E.,  Ammous Z., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240911$$MD$US$US
243086941$24308694$1$I$$20240904$20240911$20240911$EXP$$US-BIOMARINAP-US-2024-160414$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et.al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024$$$$$Y$$$20240911$$MD$US$US
243086952$24308695$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687124$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243086961$24308696$1$I$$20240904$20240911$20240911$EXP$$US-BIOMARINAP-US-2024-160418$BIOMARIN$Cooney E.,  Ammous Z., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240911$$MD$US$US
243086991$24308699$1$I$20240815$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024179564$AMGEN$$60$YR$A$F$Y$$$20240911$$CN$US$US
243087001$24308700$1$I$20240828$20240909$20240911$20240911$EXP$$IT-AMERICAN REGENT INC-2024003435$AMERICAN REGENT$$88$YR$$F$Y$$$20240911$$MD$IT$IT
243087011$24308701$1$I$$20240910$20240911$20240911$PER$$NVSC2024US182118$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243087021$24308702$1$I$$20240910$20240911$20240911$EXP$$AT-SANDOZ INC.-SDZ2024AT079157$SANDOZ$$71$YR$$F$Y$$$20240911$$HP$AT$AT
243087031$24308703$1$I$20240801$20240830$20240911$20240911$PER$$US-MYLANLABS-2024M1080948$MYLAN$$66$YR$$M$Y$$$20240911$$CN$US$US
243087051$24308705$1$I$$20240902$20240911$20240911$EXP$$US-JNJFOC-20240903787$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243087061$24308706$1$I$20240708$20240909$20240911$20240911$PER$$US-JNJFOC-20240922824$JOHNSON AND JOHNSON$$$$$M$Y$$$20240911$$HP$US$US
243087071$24308707$1$I$20240701$20240906$20240911$20240911$EXP$$CO-ABBVIE-5915507$ABBVIE$$82$YR$$M$Y$$$20240911$$CN$CO$CO
243087081$24308708$1$I$20240821$20240904$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US079190$SANDOZ$$$$$$Y$$$20240911$$CN$US$US
243087091$24308709$1$I$20240101$20240903$20240911$20240911$EXP$$FR-ABBVIE-5914917$ABBVIE$$75$YR$$M$Y$$$20240911$$CN$FR$FR
243087101$24308710$1$I$$20240909$20240911$20240911$EXP$$NL-SANDOZ INC.-SDZ2024NL079074$SANDOZ$$6$YR$$M$Y$$$20240911$$MD$NL$NL
243087111$24308711$1$I$$20240910$20240911$20240911$EXP$$US-ALXN-202409USA000679US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243087131$24308713$1$I$$20240906$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US079341$SANDOZ$$$$$M$Y$15.91$KG$20240911$$CN$US$US
243087141$24308714$1$I$$20240909$20240911$20240911$PER$$US-BAYER-2024A129776$BAYER$$27$YR$A$F$Y$$$20240911$$CN$US$US
243087151$24308715$1$I$20231201$20240822$20240911$20240911$EXP$$US-SA-2024SA262060$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240911$$CN$US$US
243087161$24308716$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143700$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240911$$CN$US$US
243087171$24308717$1$I$$20240909$20240911$20240911$EXP$$CA-SANDOZ INC.-PHHY2017CA117318$SANDOZ$$14$YR$$M$Y$35$KG$20240911$$HP$CA$CA
243087181$24308718$1$I$20240301$20240904$20240911$20240911$EXP$$US-ABBVIE-5908099$ABBVIE$$54$YR$$M$Y$$$20240911$$CN$US$US
243087191$24308719$1$I$20240822$20240902$20240911$20240911$EXP$ES-AEMPS-1564199$ES-GUERBET / LLC-ES-20240039$GUERBET$$35$YR$A$F$Y$$$20240911$$PH$ES$ES
243087201$24308720$1$I$20240624$20240905$20240911$20240911$EXP$FR-AFSSAPS-TO2024001262$FR-MYLANLABS-2024M1081680$MYLAN$$96$YR$$F$Y$51$KG$20240911$$PH$FR$FR
243087211$24308721$1$I$20240801$20240829$20240911$20240911$PER$$US-SA-2024SA260570$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240911$$HP$US$US
243087221$24308722$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA262117$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240911$$MD$US$US
243087232$24308723$2$F$$20240823$20240911$20240916$PER$$US-SA-2024SA262135$SANOFI AVENTIS$$$$T$F$Y$95.45$KG$20240916$$MD$US$US
243087241$24308724$1$I$20240822$20240906$20240911$20240911$EXP$$CN-SA-2024SA261500$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240911$$HP$CN$CN
243087251$24308725$1$I$$20240904$20240911$20240911$EXP$$US-ABBVIE-5909169$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243087261$24308726$1$I$20240907$20240909$20240911$20240911$PER$$US-JNJFOC-20240922305$JOHNSON AND JOHNSON$$$$$M$Y$$$20240911$$CN$US$US
243087281$24308728$1$I$20240821$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006555$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240911$$CN$US$US
243087291$24308729$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005619$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240911$$CN$US$US
243087301$24308730$1$I$20240801$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003734$ELI LILLY AND CO$$$$$M$Y$$$20240911$$CN$US$US
243087311$24308731$1$I$20240701$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005659$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240911$$CN$US$US
243087321$24308732$1$I$20100101$20240903$20240911$20240911$PER$$US-ABBVIE-5905443$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243087332$24308733$2$F$20240903$20240911$20240911$20240916$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024109411$VIIV$$72$YR$$F$Y$$$20240916$$HP$US$US
243087341$24308734$1$I$$20240903$20240911$20240911$EXP$GB-MHRA-MED-202409031344590130-HDSKC$GB-TEVA-VS-3240045$TEVA$$67$YR$$$Y$$$20240911$$PH$GB$GB
243087351$24308735$1$I$$20240827$20240911$20240911$PER$$US-SA-2024SA262736$SANOFI AVENTIS$$29$YR$A$M$Y$92$KG$20240911$$PH$US$US
243087361$24308736$1$I$20240801$20240830$20240911$20240911$PER$$US-SA-2024SA260957$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240911$$MD$US$US
243087371$24308737$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141448$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240911$$HP$US$US
243087381$24308738$1$I$20240617$20240905$20240911$20240911$EXP$$CN-SA-2024SA259736$SANOFI AVENTIS$$49$YR$A$F$Y$65$KG$20240911$$HP$CN$CN
243087392$24308739$2$F$$20240917$20240911$20240920$EXP$$UA-AMGEN-UKRSP2024178056$AMGEN$Lymanets T.. Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240919$$MD$UA$UA
243087401$24308740$1$I$$20240909$20240911$20240911$PER$$US-TAKEDA-2024TUS090477$TAKEDA$$$$$M$Y$$$20240911$$CN$US$US
243087411$24308741$1$I$$20240905$20240911$20240911$EXP$$GB-TAKEDA-2023TUS087607$TAKEDA$$$$$F$Y$$$20240911$$CN$GB$GB
243087421$24308742$1$I$$20240903$20240911$20240911$EXP$$GB-TEVA-VS-3240164$TEVA$$53$YR$$F$Y$104$KG$20240911$$MD$GB$GB
243087431$24308743$1$I$20240820$20240910$20240910$20240910$DIR$FDA-CDER-CTU-2024-62433$$FDA-CTU$$54$YR$$M$N$$$20240910$N$HP$US$
243087441$24308744$1$I$$20240904$20240911$20240911$EXP$NL-LRB-00999893$NL-TEVA-VS-3240533$TEVA$$54$YR$$M$Y$77$KG$20240911$$CN$NL$NL
243087451$24308745$1$I$$20240903$20240911$20240911$30DAY$$AR-PFIZER INC-202400250058$PFIZER$$13$YR$$M$Y$$$20240911$$CN$AR$AR
243087461$24308746$1$I$20240908$20240910$20240911$20240911$PER$$US-AMGEN-USASP2024181118$AMGEN$$71$YR$E$F$Y$$$20240911$$CN$US$US
243087472$24308747$2$F$20240910$20240911$20240911$20240912$PER$$US-AMGEN-USASP2024181160$AMGEN$$72$YR$E$F$Y$$$20240912$$PH$US$US
243087491$24308749$1$I$$20240905$20240911$20240911$EXP$$IT-AMGEN-ITASP2024179132$AMGEN$Scavo M. P.; Luca M. D.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID- 19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$28$YR$A$M$Y$$$20240911$$HP$IT$IT
243087501$24308750$1$I$20240201$20240831$20240911$20240911$30DAY$$CO-PFIZER INC-PV202400114784$PFIZER$$$$$M$Y$$$20240911$$CN$CO$CO
243087511$24308751$1$I$20240829$20240830$20240911$20240911$30DAY$$US-PFIZER INC-202400247783$PFIZER$$11$YR$$M$Y$$$20240911$$CN$US$US
243087521$24308752$1$I$20240801$20240909$20240911$20240911$EXP$$CA-PFIZER INC-202400233405$PFIZER$$51$YR$$F$Y$$$20240911$$HP$CA$CA
243087531$24308753$1$I$20240717$20240830$20240911$20240911$EXP$IE-HPRA-2024-115026$IE-GUERBET / LLC-IE-20240030$GUERBET$$41$YR$A$F$Y$70$KG$20240911$$CN$IE$IE
243087541$24308754$1$I$$20240910$20240911$20240911$EXP$$DE-SANDOZ INC.-SDZ2024DE079159$SANDOZ$$2$YR$$M$Y$$$20240911$$HP$DE$DE
243087552$24308755$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687123$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243087561$24308756$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3239631$TEVA$$$$$F$Y$7$KG$20240911$$HP$CA$CA
243087571$24308757$1$I$$20240904$20240911$20240911$EXP$$US-JNJFOC-20240915456$JOHNSON AND JOHNSON$$$$$F$Y$$$20240911$$CN$US$US
243087581$24308758$1$I$20240201$20240903$20240911$20240911$EXP$$BR-AstraZeneca-2024A204471$ASTRAZENECA$$24894$DY$$F$Y$$$20240911$$CN$BR$
243087591$24308759$1$I$$20240903$20240911$20240911$30DAY$$CO-PFIZER INC-PV202400115978$PFIZER$$7$YR$$M$Y$$$20240911$$CN$CO$CO
243087601$24308760$1$I$$20240829$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009162$INCYTE$$$$$$Y$$$20240911$$HP$US$US
243087611$24308761$1$I$20240901$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024181148$AMGEN$$65$YR$E$F$Y$$$20240911$$CN$US$US
243087621$24308762$1$I$$20240906$20240911$20240911$EXP$$GR-AMGEN-GRCSP2024180048$AMGEN$$68$YR$E$$Y$$$20240911$$MD$GR$GR
243087631$24308763$1$I$20240903$20240909$20240911$20240911$EXP$$NVSC2024CN182009$NOVARTIS$$82$YR$$F$Y$49$KG$20240911$$HP$CN$CN
243087641$24308764$1$I$20230901$20240905$20240911$20240911$EXP$$ES-AMGEN-ESPSP2024177932$AMGEN$Yaringano J.; Roca-herrera M.; Eremiev S. et al.. Sacituzumab govitecan response in extensive leptomeningeal carcinomatosis from triple-negative breast cancer: a case report. Frontiers in Oncology. 2024;14:1-6$62$YR$A$F$Y$$$20240911$$HP$ES$ES
243087651$24308765$1$I$$20240910$20240911$20240911$PER$$NVSC2024US181977$NOVARTIS$$$$$M$Y$$$20240911$$HP$US$US
243087671$24308767$1$I$$20240829$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009157$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243087681$24308768$1$I$20231022$20240909$20240911$20240911$EXP$$JP-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-003797$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240911$$MD$JP$JP
243087691$24308769$1$I$20160918$20240905$20240911$20240911$EXP$DE-EMA-DD-20190627-agrahari_p-134139$DE-MYLANLABS-2024M1081646$MYLAN$$20$YR$$F$Y$54$KG$20240911$$MD$DE$DE
243087701$24308770$1$I$20240901$20240902$20240911$20240911$EXP$$CL-JNJFOC-20240904950$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240911$$CN$CL$CL
243087711$24308771$1$I$20110401$20240904$20240911$20240911$EXP$$IT-PURDUE-USA-2023-0304827$PURDUE$Barbera N, Busardo FP, Indorato F, Romano G .. The pathogenetic role of adulterants in 5 cases of drug addicts with a fatal outcome. The 50th Annual Meeting of the International Association of Forensic Toxicologists; 2012 Jun 3-8; Homamatsu, Japan. Forensic Science International. 2013;227(1-3):74-76$23$YR$$F$Y$$$20240911$$HP$IT$IT
243087721$24308772$1$I$$20240903$20240911$20240911$EXP$$AU-PURDUE-USA-2024-0311880$PURDUE$$$$$M$Y$$$20240911$$HP$AU$AU
243087731$24308773$1$I$20240820$20240904$20240911$20240911$EXP$SE-SEMPA-2024-006363$SE-PURDUE-USA-2024-0311883$PURDUE$$44$YR$$F$Y$$$20240911$$MD$SE$SE
243087741$24308774$1$I$$20240905$20240911$20240911$PER$$US-MYLANLABS-2024M1082671$MYLAN$$$$$M$Y$$$20240911$$HP$US$US
243087761$24308776$1$I$$20231215$20240911$20240911$PER$$NVSC2023US275252$NOVARTIS$$$$$F$Y$$$20240911$$HP$US$US
243087771$24308777$1$I$20240308$20240905$20240911$20240911$EXP$$IT-MYLANLABS-2024M1081727$MYLAN$$64$YR$$F$Y$41$KG$20240911$$HP$IT$IT
243087781$24308778$1$I$20240906$20240911$20240911$20240911$DIR$717973$$FDA-CTU$$69$YR$$F$N$73.35$KG$20240911$N$CN$US$
243087791$24308779$1$I$20240726$20240911$20240911$20240911$DIR$717972$$FDA-CTU$$24$YR$$F$N$85.5$KG$20240911$N$CN$US$
243087811$24308781$1$I$20240911$20240911$20240911$20240911$DIR$717974$$FDA-CTU$$20$YR$$F$N$$$20240911$N$PH$US$
243087821$24308782$1$I$20240910$20240911$20240911$20240911$DIR$717977$$FDA-CTU$$77$YR$$M$N$$$20240911$N$$US$
243087831$24308783$1$I$$20240828$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009115$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243087844$24308784$4$F$20240910$20240917$20240911$20240927$EXP$$CA-BEH-2024177636$CSL BEHRING$$62$YR$A$F$Y$58.3$KG$20240927$$CN$CA$CA
243087851$24308785$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128661$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240911$$CN$US$US
243087861$24308786$1$I$20240101$20240904$20240911$20240911$EXP$$US-ABBVIE-5908566$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243087871$24308787$1$I$20240905$20240905$20240911$20240911$EXP$$IE-ROCHE-10000075077$ROCHE$$$$$F$Y$$$20240911$$CN$IE$IE
243087881$24308788$1$I$20240801$20240907$20240911$20240911$PER$$NVSC2024US180302$NOVARTIS$$11$YR$$F$Y$63.5$KG$20240911$$HP$US$US
243087891$24308789$1$I$20240801$20240904$20240911$20240911$EXP$$CO-ABBVIE-5917468$ABBVIE$$77$YR$$M$Y$54$KG$20240911$$HP$CO$CO
243087901$24308790$1$I$$20240909$20240911$20240911$EXP$$JP-OTSUKA-2024_025276$OTSUKA$$$$$M$Y$$$20240911$$MD$JP$JP
243087911$24308791$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005491$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240911$$CN$US$US
243087921$24308792$1$I$$20240903$20240911$20240911$EXP$$GB-TEVA-VS-3240062$TEVA$$55$YR$$F$Y$79$KG$20240911$$MD$GB$GB
243087931$24308793$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005348$ELI LILLY AND CO$$$$$M$Y$$$20240911$$CN$US$US
243087941$24308794$1$I$20240908$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005702$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240911$$CN$US$US
243087951$24308795$1$I$20240910$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006811$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240911$$HP$US$US
243087961$24308796$1$I$20240826$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005461$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240911$$CN$US$US
243087971$24308797$1$I$$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005031$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240911$$CN$US$US
243087981$24308798$1$I$20231102$20240904$20240911$20240911$EXP$$JP-GILEAD-2024-0686628$GILEAD$$59$YR$A$M$Y$$$20240911$$MD$JP$JP
243087991$24308799$1$I$20240814$20240828$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009114$INCYTE$$$$$$Y$$$20240911$$HP$US$US
243088002$24308800$2$F$20240101$20240911$20240911$20240916$EXP$$FR-ABBVIE-5913718$ABBVIE$$81$YR$$M$Y$$$20240916$$CN$FR$FR
243088011$24308801$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143740$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240911$$CN$US$US
243088021$24308802$1$I$20240101$20240903$20240911$20240911$EXP$$US-SA-2024SA258420$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240911$$CN$US$US
243088031$24308803$1$I$20240601$20240906$20240911$20240911$EXP$$US-OTSUKA-2024_025164$OTSUKA$$64$YR$$M$Y$$$20240911$$MD$US$US
243088041$24308804$1$I$20240823$20240903$20240911$20240911$EXP$GB-MHRA-MED-202409031426178480-JKPYZ$GB-TEVA-VS-3240051$TEVA$$83$YR$$F$Y$$$20240911$$PH$GB$GB
243088051$24308805$1$I$20240813$20240816$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN008617$INCYTE$$$$$$Y$$$20240911$$MD$US$US
243088061$24308806$1$I$$20240822$20240911$20240911$PER$$US-TEVA-VS-3237027$TEVA$$34$YR$$F$Y$$$20240911$$MD$US$US
243088072$24308807$2$F$20231104$20240910$20240911$20240917$EXP$$CO-GSK-CO2023AMR155078$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$CO$CO
243088082$24308808$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687121$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243088092$24308809$2$F$$20240916$20240911$20240923$EXP$$IT-TEVA-VS-3241772$TEVA$Ferini G, Zagardo V, Viola A, Aiello MM, Harikar MM, Venkataram T, et al. Considerations on surgery invasiveness and response and toxicity patterns in classic palliative radiotherapy for acrometastases of the hand: a hint for a potential role of stereotactic body radiation therapy? A case report and literature review. Front-Oncol 2023; 13.; Ferini G, Zagardo V, Viola A, Aiello MM, Harikar MM, Venkataram T, et al. Considerations on surgery invasiveness and response and toxicity patterns in cla...$57$YR$$F$Y$$$20240923$$HP$IT$IT
243088101$24308810$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3239570$TEVA$$4$MON$$F$Y$$$20240911$$HP$CA$CA
243088111$24308811$1$I$20240701$20240903$20240911$20240911$EXP$$US-UNITED THERAPEUTICS-UNT-2024-022826$UNITED THERAPEUTICS$$48$YR$$F$Y$$$20240911$$$US$US
243088121$24308812$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261705$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240911$$HP$US$US
243088131$24308813$1$I$20240701$20240830$20240911$20240911$EXP$$US-UCBSA-2024044722$UCB$$34$YR$$F$Y$$$20240911$$HP$US$US
243088141$24308814$1$I$$20240906$20240911$20240911$EXP$$US-AMGEN-USASP2024179127$AMGEN$$$$$$Y$$$20240911$$PH$US$US
243088151$24308815$1$I$$20240829$20240911$20240911$EXP$$IT-CIPLA LTD.-2024IT09633$CIPLA$Serrao A, Canichella M, De Luca ML, Tartaglia G, Annechini G, D^Elia GM.. Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma.. Annals of Hematology.. 2019;98 (6):1505 to 1506$$$$$Y$$$20240911$$HP$IT$IT
243088161$24308816$1$I$$20240911$20240911$20240911$DIR$717979$$FDA-CTU$$$$$UNK$N$$$20240911$$CN$US$
243088171$24308817$1$I$20240904$20240911$20240911$20240911$DIR$717980$$FDA-CTU$$81$YR$$F$N$52.5$KG$20240911$N$PH$US$
243088181$24308818$1$I$$20240911$20240911$20240911$DIR$717984$$FDA-CTU$$$$$UNK$N$$$20240911$N$$US$
243088191$24308819$1$I$$20240911$20240911$20240911$DIR$717983$$FDA-CTU$$$$$UNK$N$$$20240911$$CN$US$
243088202$24308820$2$F$20240905$20240912$20240911$20240916$EXP$$US-VIIV HEALTHCARE LIMITED-US2024110761$VIIV$$58$YR$$M$Y$$$20240916$$HP$US$US
243088211$24308821$1$I$$20240902$20240911$20240911$EXP$$TR-ROCHE-10000072567$ROCHE$$$$$$Y$$$20240911$$MD$TR$TR
243088231$24308823$1$I$$20240813$20240911$20240911$PER$$US-LUNDBECK-DKLU4003018$LUNDBECK$$$$$$Y$$$20240911$$MD$US$US
243088241$24308824$1$I$$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254162$PFIZER$$67$YR$$F$Y$$$20240911$$CN$US$US
243088252$24308825$2$F$$20240918$20240911$20240920$PER$$US-PFIZER INC-PV202400118790$PFIZER$$$$$M$Y$$$20240920$$CN$US$US
243088261$24308826$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253892$PFIZER$$$$$F$Y$$$20240911$$CN$US$US
243088271$24308827$1$I$$20240910$20240911$20240911$PER$$US-PFIZER INC-202400059769$PFIZER$$82$YR$$F$Y$$$20240911$$HP$US$US
243088282$24308828$2$F$$20240910$20240911$20240912$PER$$US-PFIZER INC-202400253885$PFIZER$$82$YR$$F$Y$59$KG$20240912$$CN$US$US
243088291$24308829$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253948$PFIZER$$56$YR$$F$Y$$$20240911$$HP$US$US
243088301$24308830$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-PV202400118849$PFIZER$$34$YR$$F$Y$$$20240911$$HP$US$US
243088311$24308831$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-PV202400118589$PFIZER$$40$YR$$F$Y$$$20240911$$CN$US$US
243088321$24308832$1$I$20240908$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254224$PFIZER$$74$YR$$F$Y$$$20240911$$CN$US$US
243088331$24308833$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400236027$PFIZER$$77$YR$$F$Y$$$20240911$$MD$US$US
243088341$24308834$1$I$20240906$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253217$PFIZER$$55$YR$$M$Y$$$20240911$$CN$US$US
243088351$24308835$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-PV202400118382$PFIZER$$$$$$Y$$$20240911$$CN$US$US
243088361$24308836$1$I$20240910$20240911$20240911$20240911$DIR$717985$$FDA-CTU$$77$YR$$F$N$71.1$KG$20240911$N$PH$US$
243088371$24308837$1$I$20240902$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62446$$FDA-CTU$$31$YR$$F$N$$$20240911$Y$$US$
243088391$24308839$1$I$20240101$20240910$20240911$20240911$PER$$US-PFIZER INC-PV202400118699$PFIZER$$39$YR$$M$Y$58.957$KG$20240911$$CN$US$US
243088401$24308840$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253346$PFIZER$$80$YR$$F$Y$$$20240911$$CN$US$US
243088411$24308841$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-PV202400119168$PFIZER$$58$YR$$M$Y$$$20240911$$HP$US$US
243088431$24308843$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-PV202400118608$PFIZER$$56$YR$$F$Y$$$20240911$$CN$US$US
243088441$24308844$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253089$PFIZER$$82$YR$$F$Y$$$20240911$$CN$US$US
243088451$24308845$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-PV202400118979$PFIZER$$30$YR$$F$Y$$$20240911$$HP$US$US
243088461$24308846$1$I$$20240909$20240911$20240911$PER$$PR-PFIZER INC-202400252993$PFIZER$$$$A$F$Y$$$20240911$$MD$PR$PR
243088471$24308847$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253929$PFIZER$$$$A$F$Y$$$20240911$$HP$US$US
243088481$24308848$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400254047$PFIZER$$$$$F$Y$$$20240911$$CN$US$US
243088491$24308849$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-PV202400118498$PFIZER$$$$$F$Y$$$20240911$$CN$US$US
243088501$24308850$1$I$$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254213$PFIZER$$$$$M$Y$$$20240911$$MD$US$US
243088511$24308851$1$I$$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254085$PFIZER$$65$YR$$F$Y$$$20240911$$MD$US$US
243088521$24308852$1$I$20240910$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254051$PFIZER$$57$YR$$F$Y$$$20240911$$CN$US$US
243088531$24308853$1$I$20240909$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253421$PFIZER$$40$YR$$M$Y$$$20240911$$CN$US$US
243088541$24308854$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400254039$PFIZER$$56$YR$$F$Y$$$20240911$$CN$US$US
243088561$24308856$1$I$20240910$20240910$20240911$20240911$PER$$US-PFIZER INC-202400253913$PFIZER$$45$YR$$F$Y$$$20240911$$MD$US$US
243088571$24308857$1$I$$20240910$20240911$20240911$PER$$US-PFIZER INC-202400213920$PFIZER$$52$YR$$F$Y$$$20240911$$HP$US$US
243088581$24308858$1$I$20240908$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253303$PFIZER$$68$YR$$F$Y$$$20240911$$CN$US$US
243088591$24308859$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253387$PFIZER$$73$YR$$F$Y$$$20240911$$CN$US$US
243088602$24308860$2$F$20240101$20240910$20240911$20240912$EXP$$US-PFIZER INC-202400253807$PFIZER$$$$$F$Y$$$20240912$$MD$US$US
243088613$24308861$3$F$20240907$20240920$20240911$20240923$PER$$US-PFIZER INC-202400254049$PFIZER$$71$YR$$M$Y$232$KG$20240923$$CN$US$US
243088621$24308862$1$I$$20240910$20240911$20240911$PER$$US-PFIZER INC-2020232080$PFIZER$$68$YR$$F$Y$$$20240911$$CN$US$US
243088631$24308863$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400252986$PFIZER$$72$YR$$F$Y$$$20240911$$CN$US$US
243088642$24308864$2$F$20240901$20240925$20240911$20240926$PER$$US-PFIZER INC-202400253212$PFIZER$$68$YR$$F$Y$121.1$KG$20240926$$CN$US$US
243088651$24308865$1$I$$20240910$20240911$20240911$PER$$NVSC2024US182132$NOVARTIS$$$$$$Y$106$KG$20240911$$CN$US$US
243088661$24308866$1$I$20231115$20240904$20240911$20240911$PER$$NVSC2024US178070$NOVARTIS$$48$YR$$F$Y$$$20240911$$CN$US$US
243088671$24308867$1$I$$20240829$20240911$20240911$30DAY$$US-GSK-US2024112007$GLAXOSMITHKLINE$$62$YR$$M$Y$$$20240911$$CN$US$US
243088681$24308868$1$I$$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254036$PFIZER$$10$YR$$M$Y$$$20240911$$MD$US$US
243088691$24308869$1$I$20240910$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254145$PFIZER$$$$$$Y$$$20240911$$MD$US$US
243088711$24308871$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-PV202400118773$PFIZER$$41$YR$$$Y$$$20240911$$HP$US$US
243088721$24308872$1$I$$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254326$PFIZER$$67$YR$$F$Y$$$20240911$$CN$US$US
243088731$24308873$1$I$20240910$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254139$PFIZER$$$$$$Y$$$20240911$$MD$US$US
243088741$24308874$1$I$20240906$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253404$PFIZER$$45$YR$$F$Y$$$20240911$$CN$US$US
243088751$24308875$1$I$$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254422$PFIZER$$74$YR$$M$Y$$$20240911$$CN$US$US
243088762$24308876$2$F$$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254042$PFIZER$$50$YR$$F$Y$$$20240911$$MD$US$US
243088771$24308877$1$I$20231001$20240909$20240911$20240911$PER$$US-PFIZER INC-202400252913$PFIZER$$84$YR$$F$Y$75.737$KG$20240911$$HP$US$US
243088781$24308878$1$I$20240101$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253283$PFIZER$$80$YR$$M$Y$114.31$KG$20240911$$CN$US$US
243088791$24308879$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253985$PFIZER$$63$YR$$F$Y$$$20240911$$HP$US$US
243088801$24308880$1$I$20240901$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254160$PFIZER$$$$$$Y$$$20240911$$CN$US$US
243088811$24308881$1$I$$20240907$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144220$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240911$$MD$US$US
243088821$24308882$1$I$20240906$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144426$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240911$$CN$US$US
243088831$24308883$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144519$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240911$$CN$US$US
243088841$24308884$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143772$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240911$$CN$US$US
243088851$24308885$1$I$$20240909$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144374$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240911$$CN$US$US
243088863$24308886$3$F$$20240916$20240911$20240923$EXP$$GB-TEVA-VS-3241000$TEVA$Reisz Z, Pereira R, Nevis S, Mackay A, Bhaw L, Grabovska Y, et al. AN EXCEPTIONALLY RARE CASE OF A DIFFUSE MIDLINE GLIOMA WITH CONCOMITANT H3.1 K27M AND G34R MUTATIONS IN THE HIST1H3C (H3C3) GENE. Neuro-Oncol 2024; 26 (Suppl.) iv30 abstr. DIPG-53.; Reisz Z, Pereira R, Nevis S, Mackay A, Bhaw L, Grabovska Y, et al. AN EXCEPTIONALLY RARE CASE OF A DIFFUSE MIDLINE GLIOMA WITH CONCOMITANT H3.1 K27M AND G34R MUTATIONS IN THE HIST1H3C (H3C3) GENE. Neuro-Oncol 2024; 26 (Suppl.) iv30 abstr. DIPG-53.$2$YR$$F$Y$$$20240923$$HP$GB$GB
243088871$24308887$1$I$$20240904$20240911$20240911$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001804$BLUEPRINT MEDICINES$$$$$F$Y$$$20240911$$CN$US$US
243088881$24308888$1$I$20240829$20240904$20240911$20240911$PER$$US-BAYER-2024A127976$BAYER$$29$YR$A$F$Y$70.748$KG$20240911$$MD$US$US
243088891$24308889$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142709$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$94.8$KG$20240911$$HP$US$US
243088901$24308890$1$I$$20240909$20240911$20240911$PER$$US-BAYER-2024A129480$BAYER$$62$YR$A$M$Y$$$20240911$$HP$US$US
243088911$24308891$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3239594$TEVA$$14$YR$$M$Y$19$KG$20240911$$HP$CA$CA
243088921$24308892$1$I$20240817$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62479$$FDA-CTU$$45$YR$$F$N$90$KG$20240911$N$PH$US$
243088931$24308893$1$I$20240826$20240911$20240911$20240911$DIR$717986$$FDA-CTU$$56$YR$$M$N$70.3$KG$20240911$N$PH$US$
243088941$24308894$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144642$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240911$$CN$US$US
243088951$24308895$1$I$20240611$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144347$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240911$$CN$US$US
243088961$24308896$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142848$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240911$$CN$US$US
243088972$24308897$2$F$20240719$20240919$20240911$20240925$EXP$$AU-GUERBET / LLC-AU-20240058$GUERBET$$31$YR$A$F$Y$64$KG$20240925$$HP$AU$AU
243088981$24308898$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144118$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240911$$HP$US$US
243088991$24308899$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143314$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240911$$HP$US$US
243089001$24308900$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142884$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240911$$CN$US$US
243089011$24308901$1$I$$20240902$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140737$BRISTOL MYERS SQUIBB$Wallace CE, Tam I, Beveridge MG. Cyclosporine for recalcitrant bullous pemphigoid induced by nivolumab therapy for malignant melanoma. Cutis. 2024 Jul 01;114(1):E21-3. doi:10.12788/cutis.1058.$41$YR$A$M$Y$$$20240911$$MD$US$US
243089021$24308902$1$I$20240904$20240904$20240911$20240911$EXP$$US-GUERBET / LLC-US-20240142$GUERBET$$42$YR$A$F$Y$$$20240911$$HP$US$US
243089031$24308903$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA261930$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240911$$HP$US$US
243089042$24308904$2$F$20240101$20240916$20240911$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027379$UNITED THERAPEUTICS$$$$$M$Y$105.22$KG$20240920$$PH$US$US
243089051$24308905$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA261711$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240911$$HP$US$US
243089062$24308906$2$F$20240101$20240905$20240911$20240913$PER$$US-SA-2024SA262297$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240913$$CN$US$US
243089071$24308907$1$I$$20240827$20240911$20240911$EXP$$JP-AstraZeneca-2024A205841$ASTRAZENECA$Ikeda Y, Wada Y, Yamaguchi Y, Kita A, Matsuura H, Kimoto S.. A case of botulinum therapy for the torticollis of tardive dystonia due to antipsychotic drugs.. Psychiatria et neurologia Japonica (The 132nd Kinki Society of Psychiatry and Neurology 2024;126(2):15.$40$YR$$M$Y$$$20240911$$MD$JP$
243089081$24308908$1$I$20240401$20240905$20240911$20240911$EXP$$PL-MYLANLABS-2024M1081520$MYLAN$$76$YR$$F$Y$$$20240911$$MD$PL$PL
243089091$24308909$1$I$20240623$20240905$20240911$20240911$EXP$IT-MINISAL02-1000812$IT-MYLANLABS-2024M1081701$MYLAN$$36$YR$$F$Y$$$20240911$$MD$IT$IT
243089101$24308910$1$I$$20240902$20240911$20240911$EXP$$NO-AstraZeneca-2024A205259$ASTRAZENECA$Frost J, Mikkelsen T, Andersen MN, Bjerke HA, Gundersen PM, Aamo TO.. Detoxification after using new drugs from the internet.. Journal of the Norwegian Medical Association. 2024;$30$YR$$M$Y$$$20240911$$MD$NO$
243089111$24308911$1$I$20240816$20240905$20240911$20240911$EXP$FR-AFSSAPS-PV2024000807$FR-MYLANLABS-2024M1081609$MYLAN$$76$YR$$M$Y$65$KG$20240911$$MD$FR$FR
243089121$24308912$1$I$20240801$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024179732$AMGEN$$74$YR$E$F$Y$$$20240911$$CN$US$US
243089131$24308913$1$I$20240910$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006724$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240911$$CN$US$US
243089141$24308914$1$I$$20240903$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005589$ELI LILLY AND CO$$61$YR$A$F$Y$99.773$KG$20240911$$CN$US$US
243089151$24308915$1$I$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687162$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089161$24308916$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006596$ELI LILLY AND CO$$61$YR$A$$Y$$$20240911$$LW$US$US
243089172$24308917$2$F$$20240906$20240911$20240911$EXP$$US-GILEAD-2024-0687161$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089182$24308918$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687154$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089192$24308919$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687120$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089201$24308920$1$I$20240905$20240906$20240911$20240911$EXP$$US-JNJFOC-20240918834$JOHNSON AND JOHNSON$$66$YR$E$M$Y$76.136$KG$20240911$$MD$US$US
243089211$24308921$1$I$$20240909$20240911$20240911$PER$$US-HALEON-2196368$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243089221$24308922$1$I$20240903$20240904$20240911$20240911$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024110146$VIIV$$36$YR$$M$Y$$$20240911$$HP$US$US
243089231$24308923$1$I$$20240904$20240911$20240911$30DAY$$US-GSK-US2024110249$GLAXOSMITHKLINE$$$$$F$Y$$$20240911$$CN$US$US
243089242$24308924$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687192$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089251$24308925$1$I$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687181$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089262$24308926$2$F$$20240906$20240911$20240911$EXP$$US-GILEAD-2024-0687182$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089272$24308927$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687183$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089281$24308928$1$I$$20240906$20240911$20240911$EXP$$US-TAKEDA-2024TUS040768$TAKEDA$$$$$F$Y$$$20240911$$CN$US$US
243089302$24308930$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687194$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089311$24308931$1$I$$20240911$20240911$20240911$DIR$717988$$FDA-CTU$$$$$UNK$N$$$20240911$$CN$US$
243089322$24308932$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687203$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089332$24308933$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687196$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089341$24308934$1$I$20240828$20240911$20240911$20240911$DIR$717990$$FDA-CTU$$38$YR$$M$N$$$20240911$N$$US$
243089351$24308935$1$I$20240911$20240911$20240911$20240911$DIR$717991$$FDA-CTU$$$$$UNK$N$$$20240911$N$PH$US$
243089361$24308936$1$I$$20240906$20240911$20240911$EXP$$US-GILEAD-2024-0687381$GILEAD$$75$YR$E$F$Y$$$20240911$$MD$US$US
243089371$24308937$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3239637$TEVA$$$$$M$Y$4$KG$20240911$$HP$CA$CA
243089382$24308938$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687201$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089391$24308939$1$I$$20240826$20240911$20240911$PER$$US-JNJFOC-20240873241$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$CN$US$US
243089402$24308940$2$F$$20240906$20240911$20240911$PER$$US-GILEAD-2024-0687119$GILEAD$$$$$$Y$$$20240911$$LW$US$US
243089411$24308941$1$I$$20240906$20240911$20240911$EXP$$US-GILEAD-2024-0687382$GILEAD$$67$YR$E$F$Y$$$20240911$$MD$US$US
243089431$24308943$1$I$$20240909$20240911$20240911$EXP$$IT-SANDOZ INC.-SDZ2024IT078953$SANDOZ$$69$YR$$F$Y$$$20240911$$HP$IT$IT
243089461$24308946$1$I$$20240911$20240911$20240911$DIR$717993$$FDA-CTU$$$$$M$N$$$20240911$N$HP$US$
243089471$24308947$1$I$20240911$20240911$20240911$20240911$DIR$717994$$FDA-CTU$$49$YR$$M$N$103.5$KG$20240911$Y$PH$US$
243089501$24308950$1$I$$20240906$20240911$20240911$EXP$$US-GILEAD-2024-0687383$GILEAD$$64$YR$A$F$Y$$$20240911$$MD$US$US
243089511$24308951$1$I$$20240909$20240911$20240911$PER$$US-JNJFOC-20240926135$JOHNSON AND JOHNSON$$$$$M$Y$$$20240911$$CN$US$US
243089521$24308952$1$I$20240401$20240909$20240911$20240911$EXP$NO-NOMAADVRE-PASRAPP-2024-V7zx5j$NO-FERRINGPH-2024FE05081$FERRING$$$$$$Y$$$20240911$$CN$NO$NO
243089531$24308953$1$I$$20240905$20240911$20240911$EXP$$CN-FERRINGPH-2024FE05053$FERRING$$$$$$Y$$$20240911$$CN$CN$CN
243089541$24308954$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3240061$TEVA$$76$YR$$M$Y$$$20240911$$MD$CA$CA
243089552$24308955$2$F$20240731$20240917$20240911$20240919$EXP$FR-AFSSAPS-PO2024000948$FR-FERRINGPH-2024FE05078$FERRING$$$$$$Y$$$20240919$$PH$FR$FR
243089561$24308956$1$I$20240701$20240907$20240911$20240911$EXP$$US-FERRINGPH-2024FE05094$FERRING$$$$$$Y$$$20240911$$HP$US$US
243089571$24308957$1$I$20240730$20240910$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144381$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240911$$CN$US$US
243089592$24308959$2$F$$20240917$20240911$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141694$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240926$$HP$US$US
243089601$24308960$1$I$$20240908$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143040$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$65.32$KG$20240911$$CN$US$US
243089611$24308961$1$I$20240909$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144703$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240911$$CN$US$US
243089621$24308962$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA260838$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240911$$MD$US$US
243089631$24308963$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA259323$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240911$$CN$US$US
243089641$24308964$1$I$$20240903$20240911$20240911$EXP$GB-MHRA-MED-202409031124062690-QGNDS$GB-TEVA-VS-3240186$TEVA$$57$YR$$F$Y$73$KG$20240911$$CN$GB$GB
243089651$24308965$1$I$20240412$20240910$20240911$20240911$PER$$NVSC2024US181871$NOVARTIS$$72$YR$$M$Y$$$20240911$$HP$US$US
243089661$24308966$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180152$AMGEN$$$$$M$Y$$$20240911$$CN$US$US
243089671$24308967$1$I$20220607$20240911$20240911$20240911$DIR$717998$$FDA-CTU$$85$YR$$F$N$$$20240911$N$PH$US$
243089681$24308968$1$I$$20240905$20240911$20240911$EXP$$CA-TAKEDA-2022TUS024089$TAKEDA$$$$$F$Y$$$20240911$$CN$CA$CA
243089691$24308969$1$I$$20240905$20240911$20240911$EXP$$PT-ANIPHARMA-2024-PT-000084$ANI$Campos ID, Moreira H, Portal F, Paiva JA.Unusual presentation of benzodiazepine withdrawal with Takotsubo syndrome: a case report..European Heart Journal Case Reports.2024;8(4):.$58$YR$$F$Y$$$20240911$$MD$PT$PT
243089701$24308970$1$I$$20240829$20240911$20240911$PER$$US-SA-2024SA261271$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240911$$MD$US$US
243089721$24308972$1$I$20240719$20240909$20240911$20240911$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050626$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240911$$HP$CO$CO
243089731$24308973$1$I$20240501$20240909$20240911$20240911$EXP$SE-SEMPA-2024-006464$SE-TAKEDA-2024TUS089691$TAKEDA$$25$YR$$F$Y$78$KG$20240911$$HP$SE$SE
243089741$24308974$1$I$20240829$20240905$20240911$20240911$EXP$$DE-GUERBET / LLC-DE-20240041$GUERBET$$76$YR$E$F$Y$64$KG$20240911$$MD$DE$DE
243089752$24308975$2$F$20240701$20240905$20240911$20240916$EXP$$US-UCBSA-2024044800$UCB$$63$YR$$F$Y$$$20240916$$HP$US$US
243089761$24308976$1$I$$20240828$20240911$20240911$EXP$$IN-ASTELLAS-2024-AER-004643$ASTELLAS$D JS, Annapureddy K, Poojary N, Balapanga S, Kumari B. Mucormycosis in an Immunocompetent Patient Recovering From Dengue Fever. Cureus. 2024;16(7):e65212. doi:10.7759/cureus.65212$42$YR$A$M$Y$$$20240911$$MD$IN$IN
243089771$24308977$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202405001825$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240911$$CN$US$US
243089781$24308978$1$I$$20240906$20240911$20240911$EXP$$US-GILEAD-2024-0687408$GILEAD$$41$YR$A$F$Y$$$20240911$$MD$US$US
243089791$24308979$1$I$$20240910$20240911$20240911$EXP$$NVSC2024TH096264$NOVARTIS$$$$$F$Y$$$20240911$$CN$TH$TH
243089801$24308980$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3239738$TEVA$$76$YR$$M$Y$$$20240911$$PH$CA$CA
243089811$24308981$1$I$20240910$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144646$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240911$$HP$US$US
243089821$24308982$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3240056$TEVA$$69$YR$$F$Y$$$20240911$$PH$CA$CA
243089831$24308983$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3240057$TEVA$$81$YR$$F$Y$$$20240911$$PH$CA$CA
243089841$24308984$1$I$$20240905$20240911$20240911$EXP$NL-LRB-00999756$NL-TEVA-VS-3241247$TEVA$$50$YR$$F$Y$68$KG$20240911$$CN$NL$NL
243089851$24308985$1$I$$20240905$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143079$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240911$$CN$US$US
243089861$24308986$1$I$$20240906$20240911$20240911$PER$$US-ABBVIE-5915953$ABBVIE$$$$$$Y$$$20240911$$CN$US$US
243089872$24308987$2$F$20240905$20240920$20240911$20240925$EXP$$US-BAYER-2024A129436$BAYER$$57$YR$A$M$Y$$$20240925$$CN$US$US
243089881$24308988$1$I$20240327$20240905$20240911$20240911$EXP$FR-AFSSAPS-TO2024001638$FR-MYLANLABS-2024M1081678$MYLAN$$88$YR$$F$Y$$$20240911$$MD$FR$FR
243089891$24308989$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001482$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243089901$24308990$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001558$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243089911$24308991$1$I$$20240814$20240911$20240911$PER$$US-SMPA-2024SPA001562$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243089921$24308992$1$I$20240501$20240905$20240911$20240911$EXP$FR-AFSSAPS-TO2024001685$FR-MYLANLABS-2024M1081667$MYLAN$$21$YR$$M$Y$$$20240911$$PH$FR$FR
243089932$24308993$2$F$$20240911$20240911$20240927$PER$$US-SMPA-2024SPA001508$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243089941$24308994$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001575$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243089951$24308995$1$I$20240801$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001583$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243089961$24308996$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001596$SUNOVION$$$$$$Y$$$20240911$$MD$US$US
243089981$24308998$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001489$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243089991$24308999$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001595$SUNOVION$$$$$$Y$$$20240911$$HP$US$US
243090001$24309000$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001599$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243090011$24309001$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001541$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243090021$24309002$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001584$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243090031$24309003$1$I$20240601$20240820$20240911$20240911$PER$$US-SMPA-2024MYSCI0600872$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243090041$24309004$1$I$$20240911$20240911$20240911$PER$$US-TAKEDA-2024TUS090407$TAKEDA$$$$A$$Y$$$20240911$$MD$US$US
243090051$24309005$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3240065$TEVA$$31$YR$$F$Y$71$KG$20240911$$MD$CA$CA
243090061$24309006$1$I$$20240902$20240911$20240911$EXP$$ES-TEVA-VS-3241013$TEVA$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol 2023; 89 (8): 2497-2507.; Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of...$30$YR$$M$Y$$$20240911$$HP$ES$ES
243090071$24309007$1$I$$20240911$20240911$20240911$DIR$717992$$FDA-CTU$$$$$F$N$$$20240911$N$PH$US$
243090081$24309008$1$I$20230601$20240909$20240911$20240911$EXP$$US-MYLANLABS-2024M1083030$MYLAN$$$$$M$Y$$$20240911$$CN$US$US
243090091$24309009$1$I$$20240905$20240911$20240911$EXP$$US-ABBVIE-5909980$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243090101$24309010$1$I$$20240903$20240911$20240911$EXP$$GB-TEVA-VS-3240311$TEVA$$42$YR$$F$Y$75$KG$20240911$$MD$GB$GB
243090111$24309011$1$I$$20240904$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141312$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240911$$CN$US$US
243090121$24309012$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144460$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240911$$CN$US$US
243090131$24309013$1$I$$20240910$20240911$20240911$PER$$NVSC2024US182180$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243090141$24309014$1$I$$20240827$20240911$20240911$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2161483$BRECKENRIDGE$$$$$M$Y$$$20240911$$$ES$A1
243090151$24309015$1$I$20240822$20240905$20240911$20240911$EXP$$US-ABBVIE-5910096$ABBVIE$$59$YR$$M$Y$$$20240911$$CN$US$US
243090161$24309016$1$I$20240827$20240910$20240911$20240911$EXP$$US-ABBVIE-5917747$ABBVIE$$60$YR$$F$Y$$$20240911$$HP$US$US
243090171$24309017$1$I$$20240906$20240911$20240911$EXP$$US-ABBVIE-5915279$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243090181$24309018$1$I$$20240907$20240911$20240911$PER$$US-ROCHE-10000077015$ROCHE$$$$$$Y$$$20240911$$CN$US$US
243090191$24309019$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5914514$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243090201$24309020$1$I$$20240906$20240911$20240911$PER$$US-ROCHE-10000077082$ROCHE$$$$$$Y$$$20240911$$CN$US$US
243090211$24309021$1$I$$20240908$20240911$20240911$EXP$$NZ-ABBVIE-5914856$ABBVIE$$55$YR$$F$Y$$$20240911$$MD$NZ$NZ
243090221$24309022$1$I$$20240903$20240911$20240911$PER$$US-ABBVIE-5905643$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243090231$24309023$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3239585$TEVA$$$$$F$Y$5$KG$20240911$$HP$CA$CA
243090241$24309024$1$I$$20240906$20240911$20240911$PER$$US-TAKEDA-2024TUS090428$TAKEDA$$$$$$Y$$$20240911$$CN$US$US
243090261$24309026$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3239628$TEVA$$$$$$Y$$$20240911$$HP$CA$CA
243090271$24309027$1$I$$20240906$20240911$20240911$EXP$NL-LRB-01000457$NL-MYLANLABS-2024M1082012$MYLAN$$31$YR$$F$Y$66$KG$20240911$$CN$NL$NL
243090281$24309028$1$I$20220101$20240906$20240911$20240911$EXP$$RO-MYLANLABS-2024M1081981$MYLAN$$69$YR$$M$Y$$$20240911$$MD$RO$RO
243090291$24309029$1$I$20230615$20240828$20240911$20240911$EXP$$KR-ASTELLAS-2024-AER-003098$ASTELLAS$$20$YR$A$F$Y$45$KG$20240911$$MD$KR$KR
243090301$24309030$1$I$20240717$20240905$20240911$20240911$EXP$$BR-GILEAD-2024-0682249$GILEAD$$22$YR$A$M$Y$$$20240911$$PH$BR$BR
243090311$24309031$1$I$$20240910$20240911$20240911$PER$$NVSC2024US182185$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243090321$24309032$1$I$$20240904$20240911$20240911$EXP$$JP-MTPC-MTPC2024-0018863$MITSUBISHI TANABE PHARMA$$$$A$$Y$$$20240911$$MD$JP$JP
243090331$24309033$1$I$$20240902$20240911$20240911$EXP$$CA-TEVA-VS-3239634$TEVA$$76$YR$$M$Y$$$20240911$$PH$CA$CA
243090341$24309034$1$I$$20240904$20240911$20240911$PER$$US-ALXN-202409USA000231US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243090351$24309035$1$I$$20240910$20240911$20240911$EXP$$JP-PFIZER INC-PV202400119063$PFIZER$$9$DEC$$$Y$$$20240911$$MD$JP$JP
243090371$24309037$1$I$$20240903$20240911$20240911$EXP$GB-MHRA-MED-202409032048169360-NLFMK$GB-TEVA-VS-3240098$TEVA$$46$YR$$F$Y$$$20240911$$CN$GB$GB
243090381$24309038$1$I$$20240903$20240911$20240911$EXP$GB-MHRA-MED-202409031351406570-NCSHQ$GB-TEVA-VS-3239840$TEVA$$67$YR$$$Y$$$20240911$$PH$GB$GB
243090391$24309039$1$I$$20240902$20240911$20240911$EXP$$US-GUERBET / LLC-US-20240143$GUERBET$Acute cor pulmonale following uterine artery embolization. Radiology Case Reports 2024; 19: 4978-4982.$38$YR$A$F$Y$$$20240911$$MD$US$US
243090401$24309040$1$I$20240815$20240828$20240911$20240911$PER$$US-009507513-2408USA010107$MERCK$$$$$F$Y$142.86$KG$20240911$$CN$US$US
243090411$24309041$1$I$20240401$20240902$20240911$20240911$EXP$FR-AFSSAPS-TS2024000936$FR-TEVA-VS-3239761$TEVA$$76$YR$$F$Y$$$20240911$$MD$FR$FR
243090421$24309042$1$I$20140101$20240903$20240911$20240911$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001176$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$US$US
243090431$24309043$1$I$20230101$20240830$20240911$20240911$EXP$$SK-ELI_LILLY_AND_COMPANY-SK202409004179$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240911$$CN$SK$SK
243090441$24309044$1$I$$20240905$20240911$20240911$EXP$$RU-ELI_LILLY_AND_COMPANY-RU202409004832$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$RU$RU
243090451$24309045$1$I$20240624$20240905$20240911$20240911$EXP$FR-AFSSAPS-AM2024000706$FR-ELI_LILLY_AND_COMPANY-FR202409004157$ELI LILLY AND CO$$57$YR$A$F$Y$74$KG$20240911$$CN$FR$FR
243090462$24309046$2$F$20240601$20240918$20240911$20240930$EXP$$SK-ELI_LILLY_AND_COMPANY-SK202409001358$ELI LILLY AND CO$$59$YR$A$M$Y$79$KG$20240930$$MD$SK$SK
243090471$24309047$1$I$$20240830$20240911$20240911$EXP$GB-MHRA-MED-202408301533008900-CJWTP$GB-ELI_LILLY_AND_COMPANY-GB202409000742$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240911$$CN$GB$GB
243090481$24309048$1$I$$20240902$20240911$20240911$EXP$$PT-ELI_LILLY_AND_COMPANY-PT202409005724$ELI LILLY AND CO$$$$$M$Y$$$20240911$$CN$DE$PT
243090492$24309049$2$F$$20240916$20240911$20240916$PER$$US-PFIZER INC-202400254623$PFIZER$$1$YR$$M$Y$$$20240916$$CN$US$US
243090501$24309050$1$I$20240901$20240906$20240911$20240911$PER$$US-PFIZER INC-202400251754$PFIZER$$69$YR$$F$Y$$$20240911$$CN$US$US
243090511$24309051$1$I$$20240905$20240911$20240911$PER$$US-PFIZER INC-202400251854$PFIZER$$64$YR$$F$Y$$$20240911$$HP$US$US
243090521$24309052$1$I$$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254120$PFIZER$$68$YR$$F$Y$$$20240911$$CN$US$US
243090531$24309053$1$I$$20240906$20240911$20240911$PER$$US-PFIZER INC-202400252048$PFIZER$$$$$F$Y$$$20240911$$CN$US$US
243090541$24309054$1$I$20240801$20240909$20240911$20240911$PER$$US-PFIZER INC-202400253639$PFIZER$$$$$M$Y$$$20240911$$MD$US$US
243090551$24309055$1$I$$20240909$20240911$20240911$PER$$US-PFIZER INC-202400254090$PFIZER$$27$YR$$F$Y$$$20240911$$CN$US$US
243090571$24309057$1$I$$20240909$20240911$20240911$PER$$US-ROCHE-10000077297$ROCHE$$14$YR$T$F$Y$$$20240911$$HP$US$US
243090582$24309058$2$F$$20240924$20240911$20240926$EXP$$CA-ROCHE-10000077267$ROCHE$$$$A$M$Y$$$20240926$$CN$CA$CA
243090592$24309059$2$F$20240726$20240919$20240911$20240926$EXP$IE-HPRA-2024-115086$IE-TEVA-VS-3240682$TEVA$$69$YR$$F$Y$56$KG$20240926$$CN$IE$IE
243090601$24309060$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA263049$SANOFI AVENTIS$$68$YR$E$$Y$$$20240911$$MD$US$US
243090611$24309061$1$I$$20240908$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142951$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$61.69$KG$20240911$$CN$US$US
243090621$24309062$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144748$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240911$$HP$US$US
243090631$24309063$1$I$20240801$20240910$20240911$20240911$PER$$PR-PFIZER INC-202400254019$PFIZER$$64$YR$$F$Y$$$20240911$$HP$PR$PR
243090641$24309064$1$I$$20240812$20240911$20240911$PER$$US-009507513-2408USA004685$MERCK$$$$$F$Y$$$20240911$$MD$US$US
243090651$24309065$1$I$$20240812$20240911$20240911$PER$$US-009507513-2408USA004817$MERCK$$$$$F$Y$$$20240911$$MD$US$US
243090662$24309066$2$F$$20240911$20240911$20240919$EXP$NL-LRB-00999073$NL-TEVA-VS-3240181$TEVA$$74$YR$$M$Y$79.5$KG$20240919$$CN$NL$NL
243090671$24309067$1$I$$20240906$20240911$20240911$EXP$$DE-MYLANLABS-2024M1081906$MYLAN$$10$YR$$F$Y$$$20240911$$MD$DE$DE
243090681$24309068$1$I$20240830$20240905$20240911$20240911$PER$$US-JNJFOC-20240912985$JOHNSON AND JOHNSON$$90$YR$E$F$Y$56.75$KG$20240911$$CN$US$US
243090691$24309069$1$I$20240706$20240828$20240911$20240911$30DAY$$BR-AMGEN-BRASP2024172303$AMGEN$$$$$$Y$$$20240911$$MD$BR$BR
243090703$24309070$3$F$20240904$20240918$20240911$20240920$PER$$BR-PFIZER INC-202400250804$PFIZER$$73$YR$$F$Y$54.8$KG$20240920$$CN$BR$BR
243090711$24309071$1$I$$20240821$20240911$20240911$PER$$US-SA-2024SA262179$SANOFI AVENTIS$$$$A$M$Y$77.27$KG$20240911$$MD$US$US
243090722$24309072$2$F$20240901$20240909$20240911$20240916$EXP$$CA-PFIZER INC-202400250853$PFIZER$$25$YR$$M$Y$$$20240916$$HP$CA$CA
243090732$24309073$2$F$$20240906$20240911$20240912$EXP$$US-PFIZER INC-0015572601PHAMED$PFIZER$Cimpello, L.. A CALCIUM CHANNEL BLOCKER AND IBUPROFEN OVERDOSE. CURRENT OPINION IN PEDIATRICS. 1998;10:303-307$17$YR$$F$Y$$$20240912$$MD$US$US
243090741$24309074$1$I$$20240905$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142364$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240911$$CN$US$US
243090751$24309075$1$I$20240101$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144354$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240911$$HP$US$US
243090761$24309076$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144484$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240911$$CN$US$US
243090771$24309077$1$I$20240509$20240805$20240911$20240911$PER$$US-Eisai-EC-2024-171548$EISAI$$79$YR$E$M$Y$$$20240911$$HP$US$US
243090791$24309079$1$I$20240805$20240812$20240911$20240911$PER$$US-Eisai-EC-2024-172045$EISAI$$72$YR$E$F$Y$$$20240911$$CN$US$US
243090801$24309080$1$I$$20240910$20240911$20240911$PER$$US-HALEON-2196330$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243090822$24309082$2$F$$20240917$20240911$20240920$EXP$$US-TAKEDA-2024TUS089791$TAKEDA$$$$$F$Y$$$20240920$$CN$US$US
243090841$24309084$1$I$$20240910$20240911$20240911$PER$$US-ROCHE-10000078702$ROCHE$$24$YR$A$F$Y$$$20240911$$CN$US$US
243090851$24309085$1$I$$20240812$20240911$20240911$PER$$US-009507513-2408USA004809$MERCK$$$$$F$Y$$$20240911$$CN$US$US
243090861$24309086$1$I$$20240823$20240911$20240911$PER$$US-TEVA-VS-3237773$TEVA$$67$YR$$F$Y$$$20240911$$CN$US$US
243090871$24309087$1$I$$20240910$20240911$20240911$PER$$US-ROCHE-10000078622$ROCHE$$29$YR$A$F$Y$105.23$KG$20240911$$CN$US$US
243090901$24309090$1$I$20240903$20240910$20240911$20240911$EXP$$US-KYOWAKIRIN-2024KK021123$KYOWA$$$$$$Y$$$20240911$$PH$US$US
243090911$24309091$1$I$$20240905$20240911$20240911$EXP$$CA-JAZZ PHARMACEUTICALS-2024-CA-014641$JAZZ$$$$$F$Y$$$20240911$$CN$CA$CA
243090921$24309092$1$I$$20240905$20240911$20240911$EXP$$PT-SA-2024SA262984$SANOFI AVENTIS$$$$E$$Y$$$20240911$$HP$PT$PT
243090933$24309093$3$F$20240801$20240906$20240911$20240924$30DAY$$US-JNJFOC-20240917022$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240924$$CN$US$US
243090941$24309094$1$I$$20240910$20240911$20240911$EXP$$NVSC2024CA181583$NOVARTIS$$52$YR$$M$Y$$$20240911$$HP$CA$CA
243090951$24309095$1$I$$20240905$20240911$20240911$EXP$GB-MHRA-MIDB-a7fa5f05-1b57-4111-b6d1-a6c254e70685$GB-ABBVIE-5909161$ABBVIE$$89$YR$$$Y$$$20240911$$PH$GB$GB
243090971$24309097$1$I$$20240902$20240911$20240911$PER$$US-SA-2024SA261910$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240911$$HP$US$US
243090982$24309098$2$F$20240801$20240911$20240911$20240919$EXP$$AR-VER-202400003$VERITY PHARMACEUTICALS$$11$YR$C$M$Y$$$20240919$$HP$AR$AR
243090991$24309099$1$I$20240910$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006402$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240911$$CN$US$US
243091001$24309100$1$I$20240829$20240909$20240911$20240911$EXP$$US-ELI_LILLY_AND_COMPANY-US202402015561$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240911$$CN$US$US
243091011$24309101$1$I$20240902$20240905$20240911$20240911$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409006928$ELI LILLY AND CO$$70$YR$E$M$Y$66$KG$20240911$$CN$DE$CN
243091022$24309102$2$F$$20240918$20240911$20240926$EXP$$US-TEVA-VS-3240334$TEVA$Palmer JP, Suriawinata AA, Yan S, Kerr DA, Afzal MZ, Shirai K. Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series. Am-J-Case-Rep 2023; 24.; Palmer JP, Suriawinata AA, Yan S, Kerr DA, Afzal MZ, Shirai K. Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series. Am-J-Case-Rep 2023; 24.$51$YR$$M$Y$$$20240926$$HP$US$US
243091031$24309103$1$I$$20240904$20240911$20240911$EXP$$NVSC2024TR181150$NOVARTIS$Uyaroglu OA, Kilic L. Keep in mind! Drug-associated vasculitis: zoledronic acid-induced large vessel vasculitis diagnosed by computerized tomography.. EUROPEAN JOURNAL OF CASE REPORT IN INTERNAL MEDICINE. 2024;11:1071-2$50$YR$$F$Y$$$20240911$$HP$TR$TR
243091041$24309104$1$I$20240319$20240904$20240911$20240911$EXP$$JP-009507513-2404JPN002572J$MERCK$$7$DEC$$F$Y$$$20240911$$MD$JP$JP
243091051$24309105$1$I$$20240909$20240911$20240911$PER$$US-GILEAD-2024-0687065$GILEAD$$70$YR$E$M$Y$$$20240911$$CN$US$US
243091061$24309106$1$I$$20240909$20240911$20240911$EXP$$JP-GILEAD-2024-0686646$GILEAD$$59$YR$A$F$Y$$$20240911$$MD$JP$JP
243091071$24309107$1$I$20240101$20240823$20240911$20240911$PER$$US-SA-2024SA262147$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240911$$MD$US$US
243091081$24309108$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA262811$SANOFI AVENTIS$$50$YR$A$$Y$$$20240911$$CN$US$US
243091091$24309109$1$I$$20240826$20240911$20240911$PER$$US-SA-2024SA262249$SANOFI AVENTIS$$$$A$F$Y$72.562$KG$20240911$$MD$US$US
243091102$24309110$2$F$$20240917$20240911$20240926$EXP$$US-TEVA-VS-3240100$TEVA$Mukherji S, Shoaib H, Jimenez X. Brief case report: A case of FOLFIRI-Induced psychosis. Psycho-Oncology 2023; 32 (10): 1625-1627.; Mukherji S, Shoaib H, Jimenez X. Brief case report: A case of FOLFIRI-Induced psychosis. Psycho-Oncology 2023; 32 (10): 1625-1627.$72$YR$$M$Y$$$20240926$$HP$US$US
243091121$24309112$1$I$$20240910$20240911$20240911$PER$$US-HALEON-2196305$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243091131$24309113$1$I$$20240909$20240911$20240911$PER$$US-HALEON-2196042$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243091142$24309114$2$F$20240101$20240917$20240911$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143200$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240918$$CN$US$US
243091151$24309115$1$I$$20240902$20240911$20240911$EXP$$US-SMPA-2024SPA002233$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243091162$24309116$2$F$$20240812$20240911$20240911$EXP$$US-EXELAPHARMA-2024EXLA00027$EXELA PHARMA SCIENCES$$$$$$Y$$$20240911$$HP$US$US
243091172$24309117$2$F$20240101$20240910$20240911$20240918$EXP$$US-ROCHE-10000078897$ROCHE$$41$YR$A$F$Y$68.04$KG$20240918$$CN$US$US
243091181$24309118$1$I$20240701$20240812$20240911$20240911$PER$$US-Eisai-EC-2024-171906$EISAI$$68$YR$E$M$Y$$$20240911$$CN$US$US
243091191$24309119$1$I$20240806$20240807$20240911$20240911$PER$$US-Eisai-EC-2024-171791$EISAI$$85$YR$E$M$Y$$$20240911$$CN$US$US
243091202$24309120$2$F$$20240909$20240911$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144037$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$CN$US$US
243091211$24309121$1$I$20240729$20240802$20240911$20240911$PER$$US-Eisai-EC-2024-171617$EISAI$$78$YR$E$M$Y$$$20240911$$HP$US$US
243091221$24309122$1$I$$20240903$20240911$20240911$PER$$US-ROCHE-10000073940$ROCHE$$$$$F$Y$$$20240911$$CN$US$US
243091231$24309123$1$I$$20240909$20240911$20240911$EXP$$CH-GILEAD-2024-0687149$GILEAD$$$$A$F$Y$$$20240911$$MD$CH$CH
243091241$24309124$1$I$$20240905$20240911$20240911$PER$$PR-ROCHE-10000075510$ROCHE$$$$$$Y$$$20240911$$MD$PR$PR
243091251$24309125$1$I$$20240902$20240911$20240911$30DAY$$US-GSK-US2024109394$GLAXOSMITHKLINE$$$$$M$Y$$$20240911$$HP$US$US
243091261$24309126$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000575US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243091281$24309128$1$I$$20240904$20240911$20240911$EXP$$NVSC2024ID179593$NOVARTIS$Yuniaswan AP, Retnan DP, Widasmara D, Ekasari DP, Sitaresmi A. Clinico-histopathological correlation in 3 patients with Lucio phenomenon: A serial case report. JOURNAL OF PAKISTAN ASSOCIATION OF DERMATOLOGISTS. 2023;33(4):1701-7$33$YR$$M$Y$$$20240911$$HP$ID$ID
243091291$24309129$1$I$$20240910$20240911$20240911$PER$$NVSC2024US182194$NOVARTIS$$$$$$Y$$$20240911$$HP$US$US
243091312$24309131$2$F$$20240918$20240911$20240927$EXP$$US-TEVA-VS-3240327$TEVA$Gaston FN, Chatterjee T. Spontaneous Iliac Artery Dissection in a 66-Year Old Male Complicated By Hemorrhage, GI Bleeding, and Bilateral DVT/PE. Blood 2023; 142 (Suppl. 1).; Gaston FN, Chatterjee T. Spontaneous Iliac Artery Dissection in a 66-Year Old Male Complicated By Hemorrhage, GI Bleeding, and Bilateral DVT/PE. Blood 2023; 142 (Suppl. 1).$66$YR$$M$Y$$$20240927$$HP$US$US
243091321$24309132$1$I$20240819$20240909$20240911$20240911$PER$$US-AstraZeneca-2024A206032$ASTRAZENECA$$$$$F$Y$$$20240911$$MD$US$
243091331$24309133$1$I$$20240910$20240911$20240911$EXP$$US-GILEAD-2024-0687224$GILEAD$$73$YR$E$F$Y$$$20240911$$CN$US$US
243091341$24309134$1$I$20220901$20240903$20240911$20240911$EXP$$US-ABBVIE-5905596$ABBVIE$$35$YR$$F$Y$$$20240911$$CN$US$US
243091351$24309135$1$I$20240822$20240909$20240911$20240911$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014705$JAZZ$$17$YR$$M$Y$44$KG$20240911$$CN$US$US
243091361$24309136$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143277$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240911$$CN$US$US
243091371$24309137$1$I$$20240826$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-122962$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240911$$CN$US$US
243091381$24309138$1$I$20240818$20240829$20240911$20240911$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-048706$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$52.5$KG$20240911$$HP$CN$CN
243091392$24309139$2$F$20230101$20240909$20240911$20240919$EXP$$JP-Eisai-EC-2024-173695$EISAI$Hisanori Kobara. Three Cases of Recurrent Uterine Carcinosarcoma Treated with Lenvatinib and Pembrolizumab Combination Therapy. Japanese Journal of Gynecological Oncology. 2024; 42(3): 405-405.$54$YR$A$F$Y$$$20240919$$MD$JP$JP
243091401$24309140$1$I$$20240902$20240911$20240911$PER$$JP-Eisai-EC-2024-173963$EISAI$$63$YR$A$M$Y$$$20240911$$MD$JP$JP
243091411$24309141$1$I$$20240905$20240911$20240911$EXP$NL-LRB-00999129$NL-TEVA-VS-3241252$TEVA$$25$YR$$M$Y$75$KG$20240911$$CN$NL$NL
243091421$24309142$1$I$$20240903$20240911$20240911$EXP$$JP-Eisai-EC-2024-173681$EISAI$Higashi Kenshi. One case of dementia with Lewy bodies who developed acute cardiac failure after administration of donepezil. Psychiatria et neurologia Japonica. 2024; 126(2): 146-146.$$$E$F$Y$$$20240911$$MD$JP$JP
243091452$24309145$2$F$$20240916$20240911$20240923$EXP$$ES-TEVA-VS-3241101$TEVA$Ruiz Sarrias O, Gonzalez Deza C, Rodriguez Rodriguez J, Arrizibita Iriarte O, Vizcay Atienza A, Zumarraga Lizundia T, et al. Predicting Severe Haematological Toxicity in Gastrointestinal Cancer Patients Undergoing 5-FU-Based Chemotherapy: A Bayesian Network Approach. Cancers 2023; 15 (17):.; Ruiz Sarrias O, Gonzalez Deza C, Rodriguez Rodriguez J, Arrizibita Iriarte O, Vizcay Atienza A, Zumarraga Lizundia T, et al. Predicting Severe Haematological Toxicity in Gastrointestinal Cancer Patients U...$$$$$Y$$$20240923$$HP$ES$ES
243091462$24309146$2$F$20240824$20240904$20240911$20240916$EXP$DE-BFARM-24006118$DE-BAUSCH-BL-2024-013504$BAUSCH AND LOMB$$54$YR$$F$Y$54$KG$20240916$$CN$DE$DE
243091472$24309147$2$F$$20240916$20240911$20240923$EXP$$ES-TEVA-VS-3241102$TEVA$Mansilla-Polo M, Escutia-Munoz B, Llavador-Ros M, Botella-Estrada R. Skin lesions in a lung transplant recipient. Enferm-Infecc-Microbiol-Clin 2024; 42 (3): 160-162.; Mansilla-Polo M, Escutia-Munoz B, Llavador-Ros M, Botella-Estrada R. Skin lesions in a lung transplant recipient. Enferm-Infecc-Microbiol-Clin 2024; 42 (3): 160-162.$31$YR$$M$Y$$$20240923$$HP$ES$ES
243091481$24309148$1$I$$20240910$20240911$20240911$PER$$US-ALXN-202409USA000667US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243091491$24309149$1$I$20240101$20240903$20240911$20240911$PER$$US-009507513-2409USA001401$MERCK$$$$$F$Y$$$20240911$$CN$US$US
243091501$24309150$1$I$20240723$20240904$20240911$20240911$EXP$$JP-009507513-2409JPN000618J$MERCK$$48$YR$$F$Y$47$KG$20240911$$PH$JP$JP
243091511$24309151$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA259963$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240911$$MD$US$US
243091531$24309153$1$I$20240812$20240909$20240911$20240911$EXP$GR-GREOF-202400984$GR-ABBVIE-5915280$ABBVIE$$46$YR$$F$Y$110$KG$20240911$$MD$GR$GR
243091541$24309154$1$I$20240906$20240906$20240911$20240911$PER$$NVSC2024US180592$NOVARTIS$$55$YR$$F$Y$$$20240911$$CN$US$US
243091552$24309155$2$F$20240801$20240910$20240911$20240913$EXP$$NVSC2024IE180568$NOVARTIS$$$$$F$Y$$$20240913$$HP$IE$IE
243091561$24309156$1$I$$20240703$20240911$20240911$EXP$$PT-GILEAD-2024-0687266$GILEAD$$$$$M$Y$$$20240911$$HP$PT$PT
243091571$24309157$1$I$$20240830$20240911$20240911$EXP$$JP-ASTELLAS-2024-AER-004513$ASTELLAS$Ueda Y, Sakai T, Yamada K, Arita K, Ishige Y, Hoshi D, et al. ^Fatal hemophagocytic lymphohistiocytosis with intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case^. Immunological Medicine. 47(3): 192-199.$61$YR$A$F$Y$$$20240911$$MD$JP$JP
243091581$24309158$1$I$20240101$20240906$20240911$20240911$EXP$$US-ABBVIE-5913833$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243091592$24309159$2$F$20240101$20240916$20240911$20240924$PER$$US-ABBVIE-5905869$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243091611$24309161$1$I$$20240904$20240911$20240911$PER$$MY-Eisai-EC-2024-173877$EISAI$$$$$F$Y$$$20240911$$MD$MY$MY
243091621$24309162$1$I$20240801$20240905$20240911$20240911$EXP$$JP-Eisai-EC-2024-173792$EISAI$$$$E$$Y$$$20240911$$MD$JP$JP
243091631$24309163$1$I$20240515$20240904$20240911$20240911$PER$$JP-Eisai-EC-2024-174153$EISAI$$73$YR$E$F$Y$55$KG$20240911$$MD$JP$JP
243091642$24309164$2$F$$20240905$20240911$20240912$PER$$US-009507513-2409USA002833$MERCK$$$$$F$Y$$$20240912$$MD$US$US
243091651$24309165$1$I$$20240904$20240911$20240911$EXP$$NL-ABBVIE-5672320$ABBVIE$$$$E$M$Y$$$20240911$$HP$NL$NL
243091662$24309166$2$F$$20240910$20240911$20240913$EXP$$CA-AstraZeneca-2024A204145$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$CA$
243091671$24309167$1$I$20240909$20240909$20240911$20240911$PER$$US-ALXN-202409USA000574US$ALEXION PHARMACEUTICALS$$75$YR$$$Y$$$20240911$$CN$US$US
243091681$24309168$1$I$20240801$20240904$20240911$20240911$EXP$$US-ABBVIE-5908773$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243091691$24309169$1$I$$20240909$20240911$20240911$EXP$CZ-EMA-DD-20240904-7482831-083716$CZ-SANDOZ INC.-SDZ2024CZ078966$SANDOZ$$40$YR$$M$Y$$$20240911$$HP$CZ$CZ
243091701$24309170$1$I$20240904$20240909$20240911$20240911$EXP$$NVSC2024US180929$NOVARTIS$$45$YR$$F$Y$$$20240911$$CN$US$US
243091721$24309172$1$I$$20240829$20240911$20240911$PER$$US-Calliditas-2024CAL01702$CALLIDITAS THERAPEUTICS$$59$YR$A$F$Y$$$20240911$$MD$US$US
243091731$24309173$1$I$$20240901$20240911$20240911$EXP$$JP-ASTELLAS-2024-AER-004584$ASTELLAS$$45$YR$A$M$Y$$$20240911$$MD$JP$JP
243091741$24309174$1$I$20220101$20240905$20240911$20240911$EXP$$US-ABBVIE-5913595$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243091752$24309175$2$F$20240904$20240911$20240911$20240913$30DAY$$FR-SANDOZ INC.-SDZ2024FR078876$SANDOZ$$12$YR$$M$Y$$$20240913$$CN$FR$FR
243091761$24309176$1$I$20240614$20240906$20240911$20240911$EXP$$US-ABBVIE-5915650$ABBVIE$$30$YR$$F$Y$74.8$KG$20240911$$MD$US$US
243091781$24309178$1$I$20240501$20240902$20240911$20240911$EXP$$JP-ASTELLAS-2024JP004338$ASTELLAS$$8$DEC$E$M$Y$$$20240911$$HP$JP$JP
243091801$24309180$1$I$$20240902$20240911$20240911$EXP$$JP-ASTELLAS-2024-AER-004218$ASTELLAS$$41$YR$A$F$Y$$$20240911$$PH$JP$JP
243091821$24309182$1$I$$20240910$20240911$20240911$PER$$US-ROCHE-10000078647$ROCHE$$$$A$F$Y$$$20240911$$CN$US$US
243091831$24309183$1$I$20240905$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004660$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240911$$CN$US$US
243091841$24309184$1$I$$20240827$20240911$20240911$PER$$US-INCYTE CORPORATION-2024IN009069$INCYTE$$$$$$Y$$$20240911$$CN$US$US
243091851$24309185$1$I$$20240909$20240911$20240911$EXP$$US-ALXN-202409USA000539US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$MD$US$US
243091862$24309186$2$F$$20240918$20240911$20240927$EXP$$DE-TEVA-VS-3240981$TEVA$Kaulen LD, Gumbinger C, Hinz F, Kessler T, Winkler F, Bendszus M, et al. Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma. Neurooncol-Adv 2022; 4 (1):.; Kaulen LD, Gumbinger C, Hinz F, Kessler T, Winkler F, Bendszus M, et al. Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma. Neurooncol-Adv 2022; 4 (1):.$77$YR$$F$Y$$$20240927$$MD$DE$DE
243091871$24309187$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141365$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240911$$CN$US$US
243091883$24309188$3$F$20240316$20240922$20240911$20240930$EXP$$US-FreseniusKabi-FK202413465$FRESENIUS KABI$$75$YR$E$F$Y$59$KG$20240930$$MD$US$US
243091903$24309190$3$F$20240904$20240912$20240911$20240916$EXP$$AR-BIOMARINAP-AR-2024-160492$BIOMARIN$$$$$$Y$$$20240916$$CN$AR$AR
243091911$24309191$1$I$$20240909$20240911$20240911$PER$$US-JNJFOC-20240920446$JOHNSON AND JOHNSON$$$$$$Y$$$20240911$$HP$US$US
243091921$24309192$1$I$$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005918$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240911$$CN$US$US
243091932$24309193$2$F$$20240916$20240911$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409006339$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240917$$CN$US$US
243091941$24309194$1$I$$20240906$20240911$20240911$30DAY$$US-PFIZER INC-202400251977$PFIZER$$16$YR$$M$Y$$$20240911$$CN$US$US
243091961$24309196$1$I$$20240830$20240911$20240911$PER$$US-009507513-2409USA000434$MERCK$$$$$F$Y$$$20240911$$PH$US$US
243091981$24309198$1$I$$20240910$20240911$20240911$PER$$US-PFIZER INC-202400254012$PFIZER$$30$YR$$F$Y$$$20240911$$HP$US$US
243091991$24309199$1$I$$20240827$20240911$20240911$PER$$US-BIOMARINAP-US-2024-160469$BIOMARIN$$$$$$Y$$$20240911$$CN$US$US
243092011$24309201$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142696$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240911$$PH$US$US
243092021$24309202$1$I$$20240903$20240911$20240911$EXP$$CA-009507513-2409CAN001761$MERCK$$82$YR$$M$Y$54$KG$20240911$$HP$CA$CA
243092031$24309203$1$I$$20240909$20240911$20240911$PER$$US-ALXN-202409USA000689US$ALEXION PHARMACEUTICALS$$$$$M$Y$114.29$KG$20240911$$CN$US$US
243092041$24309204$1$I$$20240910$20240911$20240911$PER$$US-ROCHE-10000078172$ROCHE$$$$$$Y$$$20240911$$CN$US$US
243092051$24309205$1$I$$20240901$20240911$20240911$EXP$$US-NPI-000037$NIVAGEN PHARMACEUTICALS$$48$YR$A$F$Y$110$KG$20240904$$MD$US$US
243092071$24309207$1$I$$20240909$20240911$20240911$EXP$$US-OTSUKA-2024_025366$OTSUKA$$$$$F$Y$$$20240911$$HP$US$US
243092081$24309208$1$I$$20240910$20240911$20240911$PER$$US-ALXN-202409USA000688US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240911$$CN$US$US
243092092$24309209$2$F$$20240917$20240911$20240924$EXP$$DK-PURDUE-USA-2024-0311915$PURDUE$Vorre MM, Lange P.. Metoclopramide-induced respiratory dyskinesia. Ugeskrift for laeger/ Ugeskr Laeg;. 2019;181(17):1-3$42$YR$$F$Y$$$20240924$$MD$DK$DK
243092101$24309210$1$I$$20240731$20240911$20240911$PER$$US-LUNDBECK-DKLU4002511$LUNDBECK$$$$$$Y$$$20240911$$HP$US$US
243092111$24309211$1$I$$20240731$20240911$20240911$PER$$US-LUNDBECK-DKLU4002510$LUNDBECK$$$$$$Y$$$20240911$$HP$US$US
243092121$24309212$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144669$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$58.06$KG$20240911$$CN$US$US
243092131$24309213$1$I$20230801$20240906$20240911$20240911$EXP$$US-ROCHE-10000076273$ROCHE$$57$YR$A$F$Y$$$20240911$$CN$US$US
243092141$24309214$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140906$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240911$$CN$US$US
243092151$24309215$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144420$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240911$$CN$US$US
243092161$24309216$1$I$$20240731$20240911$20240911$PER$$US-LUNDBECK-DKLU4002423$LUNDBECK$$$$$$Y$$$20240911$$HP$US$US
243092171$24309217$1$I$$20240909$20240911$20240911$EXP$CA-HEALTHCANVIG-E2B_07253473$CA-PURDUE-USA-2024-0311918$PURDUE$$44$YR$$F$Y$97$KG$20240911$$HP$CA$CA
243092181$24309218$1$I$20240319$20240904$20240911$20240911$PER$$US-BIOGEN-2024BI01257008$BIOGEN$$74$YR$$M$Y$$$20240911$$CN$US$US
243092201$24309220$1$I$20200612$20240904$20240911$20240911$EXP$$CA-009507513-2103CAN005921$MERCK$$65$YR$$F$Y$57$KG$20240911$$PH$CA$CA
243092211$24309221$1$I$$20240906$20240911$20240911$EXP$$US-RIGEL-20240900039$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240911$$CN$US$US
243092222$24309222$2$F$$20240909$20240911$20240911$EXP$$US-ROCHE-10000078069$ROCHE$$$$$$Y$$$20240911$$HP$US$US
243092231$24309223$1$I$20231001$20240909$20240911$20240911$EXP$$US-ROCHE-10000077410$ROCHE$$44$YR$A$F$Y$65.77$KG$20240911$$CN$US$US
243092261$24309226$1$I$20240601$20240829$20240911$20240911$PER$$US-SA-2024SA260539$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240911$$CN$US$US
243092271$24309227$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142597$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240911$$HP$US$US
243092282$24309228$2$F$20210601$20240916$20240911$20240930$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00443$Alora Pharma$$36$YR$$F$Y$80.726$KG$20240930$$CN$US$US
243092291$24309229$1$I$$20240909$20240911$20240911$EXP$$IE-ROCHE-10000077896$ROCHE$$$$$F$Y$$$20240911$$CN$IE$IE
243092311$24309231$1$I$$20240829$20240911$20240911$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00439$Alora Pharma$N. Chalasani, H. L. Bonkovsky, J. G. Stine. et.al.. Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study.. J Hepatol.. 2022;76(4): 832-840$46$YR$$F$Y$$$20240911$$MD$US$US
243092321$24309232$1$I$$20240829$20240911$20240911$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00438$Alora Pharma$N. Chalasani, H. L. Bonkovsky, J. G. Stine. et.al.. Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study.. J Hepatol.. 2022;76(4): 832-840$46$YR$$F$Y$$$20240911$$MD$US$US
243092331$24309233$1$I$$20240829$20240911$20240911$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00436$Alora Pharma$N. Chalasani, H. L. Bonkovsky, J. G. Stine. et.al.. Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study. J Hepatol. 2022;76(4): 832-840$63$YR$$M$Y$$$20240911$$MD$US$US
243092341$24309234$1$I$$20240909$20240911$20240911$PER$$US-AstraZeneca-2024A206019$ASTRAZENECA$$$$$F$Y$$$20240911$$CN$US$
243092351$24309235$1$I$$20240829$20240911$20240911$PER$$US-009507513-2409USA003013$MERCK$Lin FY, Stuckert A, Tat C, White M, Ruggieri L, Zhang H, et al.. Phase i Trial of GD2.CART Cells Augmented with Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors. Journal of Clinical Oncology. 2024;42(42):2769-79$11$YR$$$Y$$$20240911$$MD$US$US
243092361$24309236$1$I$20200612$20240904$20240911$20240911$EXP$$US-ROCHE-2626492$ROCHE$$59$YR$A$F$Y$$$20240911$$CN$US$US
243092371$24309237$1$I$$20240910$20240911$20240911$EXP$$CA-HLS-202402297$HLS THERAPEUTICS$$20$YR$A$M$Y$$$20240911$$HP$CA$CA
243092381$24309238$1$I$20240902$20240905$20240911$20240911$EXP$$CL-ROCHE-10000078429$ROCHE$$33$YR$A$F$Y$52$KG$20240911$$CN$CL$CL
243092391$24309239$1$I$$20240901$20240911$20240911$EXP$$PL-ROCHE-10000073851$ROCHE$$65$YR$E$F$Y$$$20240911$$MD$PL$PL
243092401$24309240$1$I$20240826$20240904$20240911$20240911$EXP$$CN-009507513-2409CHN002817$MERCK$$69$YR$$M$Y$56.2$KG$20240911$$HP$CN$CN
243092411$24309241$1$I$$20240910$20240911$20240911$EXP$$CA-HLS-202402296$HLS THERAPEUTICS$$$$$M$Y$$$20240911$$HP$CA$CA
243092421$24309242$1$I$$20240905$20240911$20240911$PER$$US-ABBVIE-5913512$ABBVIE$$$$$$Y$$$20240911$$MD$US$US
243092431$24309243$1$I$20240620$20240902$20240911$20240911$PER$FR-AFSSAPS-DJ2024000966$FR-Eisai-EC-2024-173466$EISAI$$66$YR$A$M$Y$68$KG$20240911$$MD$FR$FR
243092441$24309244$1$I$$20240908$20240911$20240911$PER$$US-AstraZeneca-2024A206099$ASTRAZENECA$$$$$$Y$$$20240911$$CN$US$
243092451$24309245$1$I$$20240910$20240911$20240911$EXP$$US-GILEAD-2024-0687256$GILEAD$$$$$M$Y$$$20240911$$CN$US$US
243092461$24309246$1$I$20240616$20240618$20240911$20240911$PER$$US-GE HEALTHCARE-2024CSU006856$GE HEALTHCARE$$59$YR$$F$Y$76.19$KG$20240911$$HP$US$US
243092471$24309247$1$I$$20240904$20240911$20240911$EXP$$AU-VIIV HEALTHCARE LIMITED-AU2024GSK111050$VIIV$$$$$$Y$$$20240911$$HP$AU$AU
243092481$24309248$1$I$20240822$20240902$20240911$20240911$PER$$CN-Eisai-EC-2024-173622$EISAI$$67$YR$E$F$Y$$$20240911$$HP$CN$CN
243092491$24309249$1$I$20220101$20240902$20240911$20240911$EXP$$ES-Eisai-EC-2024-173717$EISAI$$77$YR$E$F$Y$$$20240911$$MD$ES$ES
243092501$24309250$1$I$$20240903$20240911$20240911$PER$$JP-Eisai-EC-2024-173696$EISAI$Kohei Ogawa. 7 cases of Pembrolizumab + Lenvatinib Treatment in our department. RCC Seminar; -; .$$$E$M$Y$$$20240911$$MD$JP$JP
243092511$24309251$1$I$20220720$20240903$20240911$20240911$EXP$$JP-Eisai-EC-2022-125127$EISAI$$44$YR$A$F$Y$$$20240911$$MD$JP$JP
243092521$24309252$1$I$$20240905$20240911$20240911$PER$$JP-Eisai-EC-2024-173804$EISAI$Owa Shunsuke. Len+Pem cases at our hospital. ELM Internal Lecture; -; .$$$$$Y$$$20240911$$MD$JP$JP
243092531$24309253$1$I$$20240829$20240911$20240911$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408019168$ELI LILLY AND CO$$$$$F$Y$$$20240911$$CN$DE$DE
243092541$24309254$1$I$20220802$20240830$20240911$20240911$EXP$$US-COOPERSURGICAL, INC.-2024CPS002678$COOPERSURGICAL$$$$$F$Y$$$20240911$$LW$US$US
243092551$24309255$1$I$$20240903$20240911$20240911$EXP$$US-GILEAD-2024-0687438$GILEAD$$80$YR$E$F$Y$$$20240911$$MD$US$US
243092561$24309256$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA260452$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240912$$HP$US$US
243092571$24309257$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140817$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240911$$HP$US$US
243092581$24309258$1$I$20240903$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004525$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240911$$CN$US$US
243092591$24309259$1$I$20240824$20240903$20240911$20240911$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01314$AIMMUNE$$$$$$Y$$$20240911$$CN$US$US
243092601$24309260$1$I$20240705$20240909$20240911$20240911$PER$$US-009507513-2409USA003450$MERCK$$$$$F$Y$122.45$KG$20240911$$CN$US$US
243092611$24309261$1$I$$20240905$20240911$20240911$PER$$US-TAKEDA-2024TUS089344$TAKEDA$$$$$M$Y$$$20240911$$CN$US$US
243092621$24309262$1$I$20240817$20240903$20240911$20240911$EXP$$US-Eisai-EC-2024-173709$EISAI$$64$YR$A$M$Y$$$20240911$$CN$US$US
243092631$24309263$1$I$20240828$20240903$20240911$20240911$PER$$US-ABBVIE-5905929$ABBVIE$$18$YR$$M$Y$$$20240911$$CN$US$US
243092641$24309264$1$I$$20240828$20240911$20240911$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08845$NEUROCRINE BIOSCIENCES$$86$YR$$F$Y$$$20240911$$HP$US$US
243092651$24309265$1$I$20240821$20240821$20240911$20240911$PER$$US-AMGEN-USASP2024167458$AMGEN$$83$YR$E$M$Y$$$20240911$$CN$US$US
243092661$24309266$1$I$$20240910$20240911$20240911$PER$$US-HALEON-2196299$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243092676$24309267$6$F$20240907$20240920$20240911$20240923$PER$$US-PURDUE PHARMA-USA-2024-0311906$PURDUE$$61$YR$$M$Y$108.86$KG$20240923$$CN$US$US
243092681$24309268$1$I$$20240910$20240911$20240911$PER$$US-PURDUE PHARMA-USA-2024-0311907$PURDUE$$64$YR$$M$Y$$$20240911$$MD$US$US
243092691$24309269$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141293$BRISTOL MYERS SQUIBB$$31$YR$A$F$Y$$$20240911$$HP$US$US
243092701$24309270$1$I$20240820$20240903$20240911$20240911$PER$$CN-Eisai-EC-2024-173615$EISAI$$50$YR$A$F$Y$49$KG$20240911$$HP$CN$CN
243092711$24309271$1$I$$20240903$20240911$20240911$PER$$JP-Eisai-EC-2024-172300$EISAI$Shimamoto Kumi. OS-175 Monitoring of adrenal function during Lenvatinib plus Pembrolizumab therapy. Journal of the Japan Society of Gynecologic Oncology, the 66th Annual Meeting of the Japan Society of Gynecologic Oncology. 2024; 42(3): 301-301.$$$$F$Y$$$20240911$$MD$JP$JP
243092721$24309272$1$I$$20240828$20240911$20240911$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08734$NEUROCRINE BIOSCIENCES$$22$YR$$F$Y$$$20240911$$PH$US$US
243092731$24309273$1$I$$20240828$20240911$20240911$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08745$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240911$$HP$US$US
243092742$24309274$2$F$$20240910$20240911$20240917$PER$$US-BIOGEN-2024BI01281171$BIOGEN$$$$$M$Y$$$20240917$$CN$US$US
243092751$24309275$1$I$$20240829$20240911$20240911$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08770$NEUROCRINE BIOSCIENCES$$5$DEC$$M$Y$$$20240911$$HP$US$US
243092761$24309276$1$I$$20240906$20240911$20240911$PER$$US-AstraZeneca-2024A206028$ASTRAZENECA$$$$$$Y$$$20240912$$CN$US$
243092771$24309277$1$I$20230201$20240807$20240911$20240911$PER$$US-009507513-2409USA003903$MERCK$$58$YR$$M$Y$$$20240911$$CN$US$US
243092791$24309279$1$I$20240801$20240902$20240911$20240911$EXP$$KR-MALLINCKRODT-MNK202405496$MALLINCKRODT$$$$N$$Y$$$20240911$$HP$KR$KR
243092801$24309280$1$I$$20240903$20240911$20240911$EXP$$US-BIOGEN-2024BI01281234$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243092811$24309281$1$I$$20240905$20240911$20240911$EXP$$US-AstraZeneca-2024A203055$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243092821$24309282$1$I$$20240905$20240911$20240911$EXP$$US-AstraZeneca-2024A203045$ASTRAZENECA$$$$$M$Y$65.3$KG$20240912$$CN$US$
243092831$24309283$1$I$$20240904$20240911$20240911$EXP$$US-BIOGEN-2024BI01281244$BIOGEN$$$$$M$Y$$$20240911$$CN$US$US
243092841$24309284$1$I$20240821$20240905$20240911$20240911$PER$$US-AMGEN-USASP2024177986$AMGEN$$82$YR$E$M$Y$$$20240911$$CN$US$US
243092851$24309285$1$I$$20240909$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US077859$SANDOZ$$36$YR$$F$Y$$$20240911$$HP$US$US
243092861$24309286$1$I$$20240906$20240911$20240911$EXP$$IN-SANDOZ INC.-SDZ2024IN078840$SANDOZ$$$$$M$Y$$$20240911$$CN$IN$IN
243092872$24309287$2$F$$20240910$20240911$20240913$PER$$NVSC2024US181376$NOVARTIS$$$$$$Y$$$20240913$$HP$US$US
243092881$24309288$1$I$20240401$20240905$20240911$20240911$EXP$$US-SANDOZ INC.-SDZ2024US078598$SANDOZ$$$$$M$Y$$$20240911$$MD$US$US
243092892$24309289$2$F$20240821$20240917$20240911$20240918$30DAY$$IT-SANDOZ INC.-SDZ2024IT078853$SANDOZ$$17$YR$$F$Y$54$KG$20240918$$CN$IT$IT
243092901$24309290$1$I$20240801$20240909$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409005368$ELI LILLY AND CO$$28$YR$A$$Y$$$20240911$$CN$US$US
243092911$24309291$1$I$$20240906$20240911$20240911$PER$$NVSC2024US180583$NOVARTIS$$$$$$Y$$$20240912$$CN$US$US
243092921$24309292$1$I$$20240905$20240911$20240911$EXP$$US-BIOGEN-2024BI01281592$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243092931$24309293$1$I$20231001$20240903$20240911$20240911$EXP$$NL-BIOGEN-2024BI01281247$BIOGEN$$23$YR$$M$Y$$$20240911$$HP$NL$NL
243092941$24309294$1$I$$20240903$20240911$20240911$EXP$$US-BIOGEN-2024BI01281231$BIOGEN$$$$$F$Y$$$20240911$$HP$US$US
243092951$24309295$1$I$20240802$20240909$20240911$20240911$EXP$IE-HPRA-2024-115237$IE-ORGANON-O2409IRL000607$ORGANON$$45$YR$$F$Y$$$20240911$$CN$IE$IE
243092961$24309296$1$I$20240812$20240904$20240911$20240911$EXP$$CN-BEIGENE-BGN-2024-014032$BEIGENE$$$$$$Y$$$20240911$$HP$CN$CN
243092971$24309297$1$I$$20240911$20240911$20240911$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050912$BOEHRINGER INGELHEIM$$8$DEC$E$F$Y$$$20240912$$MD$US$US
243092992$24309299$2$F$20240101$20240910$20240911$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000108$MERZ$$$$$$Y$$$20240925$$HP$US$US
243093001$24309300$1$I$20240101$20240910$20240911$20240911$PER$$US-ORGANON-O2409USA000733$ORGANON$$$$$F$Y$78.458$KG$20240911$$HP$US$US
243093011$24309301$1$I$20240824$20240909$20240911$20240911$EXP$$US-AstraZeneca-2024A205234$ASTRAZENECA$$27432$DY$$M$Y$$$20240912$$CN$US$
243093021$24309302$1$I$20240905$20240906$20240911$20240911$EXP$$GR-ABBVIE-5825087$ABBVIE$$78$YR$$M$Y$$$20240911$$HP$GR$GR
243093031$24309303$1$I$$20240906$20240911$20240911$EXP$$AU-BAUSCHBL-2024BNL032915$BAUSCH AND LOMB$$30$YR$$M$Y$$$20240912$$CN$AU$AU
243093041$24309304$1$I$$20240906$20240911$20240911$EXP$$AU-BAUSCHBL-2024BNL032918$BAUSCH AND LOMB$$41$YR$$M$Y$$$20240912$$CN$AU$AU
243093051$24309305$1$I$$20240906$20240911$20240911$EXP$$AU-BAUSCHBL-2024BNL032909$BAUSCH AND LOMB$$51$YR$$F$Y$$$20240912$$CN$AU$AU
243093061$24309306$1$I$$20240906$20240911$20240911$EXP$$AU-BAUSCHBL-2024BNL032916$BAUSCH AND LOMB$$$$$F$Y$$$20240912$$CN$AU$AU
243093071$24309307$1$I$$20240906$20240911$20240911$EXP$$AU-BAUSCHBL-2024BNL032917$BAUSCH AND LOMB$$54$YR$$M$Y$$$20240912$$CN$AU$AU
243093081$24309308$1$I$$20240906$20240911$20240911$EXP$NL-LRB-01000599$EU-BAUSCHBL-2024BNL032987$BAUSCH AND LOMB$$62$YR$$F$Y$71$KG$20240912$$CN$EU$EU
243093091$24309309$1$I$$20240906$20240911$20240911$EXP$$GB-BAUSCHBL-BL-2020-026421$BAUSCH AND LOMB$Yaakub A, Htet Z, Ball R, Karim M, Shah S. Two simultaneous unusual complications after renal transplantation. British Association of Dermatologists. 2020;183 (1):140. doi:doi/epdf/10.1111/bjd.19092] at [04/11/2020]$47$YR$$M$Y$$$20240912$$MD$GB$GB
243093102$24309310$2$F$$20240918$20240911$20240920$PER$$US-ABBVIE-5915974$ABBVIE$$$$$$Y$$$20240920$$HP$US$US
243093111$24309311$1$I$$20240905$20240911$20240911$EXP$$MX-BIOGEN-2024BI01281693$BIOGEN$$35$YR$$F$Y$$$20240911$$CN$MX$MX
243093122$24309312$2$F$20240101$20240910$20240911$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000239$MERZ$$$$$$Y$$$20240925$$HP$US$US
243093131$24309313$1$I$20240901$20240903$20240911$20240911$PER$$US-BAUSCHBL-2024BNL032731$BAUSCH AND LOMB$$$$$F$Y$$$20240912$$CN$US$US
243093141$24309314$1$I$20240821$20240903$20240911$20240911$PER$$US-BAUSCHBL-2024BNL032740$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240912$$CN$US$US
243093151$24309315$1$I$20240731$20240904$20240911$20240911$EXP$$CN-BEIGENE-BGN-2024-014028$BEIGENE$$$$$$Y$$$20240911$$HP$CN$CN
243093161$24309316$1$I$$20240906$20240911$20240911$EXP$$US-ESPERIONTHERAPEUTICS-2024USA01402$ESPERION THERAPEUTICS$$$$$$Y$$$20240912$$MD$US$US
243093172$24309317$2$F$20240701$20240918$20240911$20240925$PER$$US-BAUSCHBL-2024BNL032723$BAUSCH AND LOMB$$$$$F$Y$$$20240926$$CN$US$US
243093181$24309318$1$I$20230601$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144818$BRISTOL MYERS SQUIBB$$40$YR$A$M$Y$$$20240912$$CN$US$US
243093201$24309320$1$I$$20240903$20240911$20240911$PER$$US-BAUSCHBL-2024BNL032745$BAUSCH AND LOMB$$$$$M$Y$$$20240912$$CN$US$US
243093211$24309321$1$I$$20240906$20240911$20240911$PER$$US-AstraZeneca-2024A203912$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243093221$24309322$1$I$20240905$20240910$20240911$20240911$EXP$$US-AstraZeneca-2024A206641$ASTRAZENECA$$32638$DY$$F$Y$$$20240912$$HP$US$
243093232$24309323$2$F$20240101$20240910$20240911$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000240$MERZ$$$$$$Y$$$20240925$$HP$US$US
243093241$24309324$1$I$20240901$20240904$20240911$20240911$EXP$$CN-BEIGENE-BGN-2024-014035$BEIGENE$$$$$$Y$$$20240911$$HP$CN$CN
243093251$24309325$1$I$$20240904$20240911$20240911$EXP$$US-BIOGEN-2024BI01281366$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243093261$24309326$1$I$20240101$20240906$20240911$20240911$EXP$$US-BIOGEN-2024BI01281682$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243093272$24309327$2$F$$20240924$20240911$20240926$EXP$$NVSJ2024JP010773$NOVARTIS$$83$YR$$F$Y$$$20240927$$PH$JP$JP
243093281$24309328$1$I$$20240822$20240911$20240911$PER$$US-JNJFOC-20240861387$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243093301$24309330$1$I$$20240823$20240911$20240911$PER$$US-SMPA-2024SPA001906$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093311$24309331$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001523$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093321$24309332$1$I$$20240822$20240911$20240911$PER$$US-SMPA-2024SPA001865$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093331$24309333$1$I$20240801$20240902$20240911$20240911$EXP$$CO-JNJFOC-20240881536$JOHNSON AND JOHNSON$$52$YR$A$M$Y$65$KG$20240912$$HP$CO$CO
243093341$24309334$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001581$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093351$24309335$1$I$$20240823$20240911$20240911$PER$$US-SMPA-2024SPA001899$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093361$24309336$1$I$$20240822$20240911$20240911$PER$$US-SMPA-2024SPA001775$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093371$24309337$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001518$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093381$24309338$1$I$$20240816$20240911$20240911$PER$$US-SMPA-2024SPA001604$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093391$24309339$1$I$$20240823$20240911$20240911$PER$$US-SMPA-2024SPA001835$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093401$24309340$1$I$20240101$20240815$20240911$20240911$PER$$US-SMPA-2024SPA001502$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093411$24309341$1$I$$20240822$20240911$20240911$PER$$US-SMPA-2024SPA001840$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093431$24309343$1$I$$20240823$20240911$20240911$PER$$US-SMPA-2024SPA001831$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093441$24309344$1$I$$20240910$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144954$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240912$$CN$US$US
243093452$24309345$2$F$$20240916$20240911$20240930$PER$$US-SMPA-2024SPA001820$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243093461$24309346$1$I$$20240822$20240911$20240911$PER$$US-SMPA-2024SPA001813$SUNOVION$$$$$$Y$$$20240911$$CN$US$US
243093471$24309347$1$I$20240829$20240904$20240911$20240911$EXP$$CN-BEIGENE-BGN-2024-014034$BEIGENE$$$$$$Y$$$20240911$$HP$CN$CN
243093481$24309348$1$I$$20240906$20240911$20240911$EXP$$JP-JNJFOC-20240925940$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240912$$MD$JP$JP
243093491$24309349$1$I$20240507$20240904$20240911$20240911$EXP$FR-AFSSAPS-TO2024001143$FR-BIOGEN-2024BI01281487$BIOGEN$$36$YR$$F$Y$$$20240911$$PH$FR$FR
243093501$24309350$1$I$$20240904$20240911$20240911$EXP$$US-BIOGEN-2024BI01281333$BIOGEN$$$$$F$Y$$$20240911$$CN$US$US
243093512$24309351$2$F$$20240918$20240911$20240927$EXP$$US-TEVA-VS-3240325$TEVA$Andries G, Yandrapalli S, Malik A, Shetty S, Aronow W. CLOZAPINE-ASSOCIATED MYOCARDITIS: A LESS KNOWN BUT FATAL COMPLICATION. J-Am-Coll-Cardiol 2019; 73 (Suppl.) (9): 2708.; Andries G, Yandrapalli S, Malik A, Shetty S, Aronow W. CLOZAPINE-ASSOCIATED MYOCARDITIS: A LESS KNOWN BUT FATAL COMPLICATION. J-Am-Coll-Cardiol 2019; 73 (Suppl.) (9): 2708.$19$YR$$M$Y$$$20240927$$HP$US$US
243093521$24309352$1$I$$20240830$20240911$20240911$PER$$US-SA-2024SA260955$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240912$$MD$US$US
243093531$24309353$1$I$20240101$20240821$20240911$20240911$PER$$US-SA-2024SA261374$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240912$$CN$US$US
243093541$24309354$1$I$20240909$20240910$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144950$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240912$$CN$US$US
243093561$24309356$1$I$$20240904$20240911$20240911$EXP$$KR-JNJFOC-20240912056$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$KR$KR
243093572$24309357$2$F$$20240909$20240911$20240915$EXP$$US-JNJFOC-20240876672$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$HP$US$US
243093581$24309358$1$I$$20240906$20240911$20240911$PER$$US-JNJFOC-20240916437$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$HP$US$US
243093591$24309359$1$I$$20240906$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409004475$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240911$$CN$US$US
243093601$24309360$1$I$20240906$20240911$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006955$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240911$$CN$US$US
243093611$24309361$1$I$$20240907$20240911$20240911$PER$$US-AMGEN-USASP2024179532$AMGEN$$$$A$F$Y$$$20240911$$CN$US$US
243093621$24309362$1$I$$20240903$20240911$20240911$PER$$US-SA-2024SA262193$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240912$$HP$US$US
243093632$24309363$2$F$$20240918$20240911$20240926$EXP$$US-TEVA-VS-3240333$TEVA$Edelbach BM, Gospodarev V, Raghavan R, Dye J. Primary intracranial sarcoma, DICER-1 mutant, with hemorrhagic presentation: A case report. Surg-Neurol-Int 2024; 15 (0): 1-6.; Edelbach BM, Gospodarev V, Raghavan R, Dye J. Primary intracranial sarcoma, DICER-1 mutant, with hemorrhagic presentation: A case report. Surg-Neurol-Int 2024; 15 (0): 1-6.; Edelbach BM, Gospodarev V, Raghavan R, Dye J. Primary intracranial sarcoma, DICER-1 mutant, with hemorrhagic presentation: A case report. Surg-Neurol...$26$YR$$M$Y$$$20240926$$HP$US$US
243093641$24309364$1$I$20240512$20240905$20240911$20240911$EXP$$EU-BAUSCHBL-2024BNL032988$BAUSCH AND LOMB$$80$YR$$M$Y$75$KG$20240912$$CN$EU$EU
243093651$24309365$1$I$$20240905$20240911$20240911$EXP$$US-BIOGEN-2024BI01281673$BIOGEN$$$$$F$Y$$$20240911$$MD$US$US
243093662$24309366$2$F$20240829$20240910$20240911$20240917$PER$$US-AMGEN-USASP2024177253$AMGEN$$86$YR$E$F$Y$$$20240917$$PH$US$US
243093671$24309367$1$I$20240701$20240906$20240911$20240911$EXP$$US-ABBVIE-5915626$ABBVIE$$32$YR$$F$Y$$$20240911$$CN$US$US
243093681$24309368$1$I$20240801$20240830$20240911$20240911$PER$$US-SA-2024SA262209$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240912$$HP$US$US
243093692$24309369$2$F$$20240905$20240911$20240918$EXP$$NL-ABBVIE-5905448$ABBVIE$$$$E$F$Y$$$20240918$$HP$NL$NL
243093703$24309370$3$F$$20240923$20240911$20240927$EXP$$BG-ORGANON-O2409BGR000126$ORGANON$Tchernev G.. Multiple keratinocytic cancers after enalapril/losartan intake: potential links to drug mediated nitrosogenesis/carcinogenesis: melolabial advanced flap and undermining surgery as optimal therapeutic approach.. Georgian Med News.. 2023;344:196-99$71$YR$$M$Y$$$20240927$$MD$BG$BG
243093711$24309371$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144738$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$HP$US$US
243093721$24309372$1$I$$20240901$20240911$20240911$EXP$$IN-JNJFOC-20240917434$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$HP$IN$IN
243093731$24309373$1$I$$20240903$20240911$20240911$EXP$$JP-009507513-2409JPN000570J$MERCK$$71$YR$$$Y$$$20240911$$MD$JP$JP
243093741$24309374$1$I$$20240902$20240911$20240911$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-142137$BRISTOL MYERS SQUIBB$$34$YR$A$F$Y$$$20240912$$MD$JP$JP
243093751$24309375$1$I$20240101$20240904$20240911$20240911$EXP$$JP-ABBVIE-5915131$ABBVIE$$$$$M$Y$$$20240911$$MD$JP$JP
243093761$24309376$1$I$20170101$20240906$20240911$20240911$EXP$$DE-ABBVIE-5914938$ABBVIE$$71$YR$$F$Y$$$20240911$$CN$DE$DE
243093771$24309377$1$I$20240911$20240911$20240911$20240911$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050924$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240912$$MD$US$US
243093781$24309378$1$I$20240901$20240911$20240911$20240911$EXP$$CZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050769$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240912$$MD$CZ$CZ
243093791$24309379$1$I$$20240905$20240911$20240911$EXP$$CA-PURDUE-USA-2024-0311901$PURDUE$$$$$F$Y$$$20240912$$HP$CA$CA
243093801$24309380$1$I$20240904$20240907$20240911$20240911$EXP$$AU-JNJFOC-20240926976$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$AU$AU
243093811$24309381$1$I$$20240905$20240911$20240911$EXP$$GB-EMD Serono-2024047745$EMD SERONO INC$$$$A$F$Y$$$20240912$$CN$GB$GB
243093831$24309383$1$I$20240116$20240904$20240911$20240911$EXP$$JP-GILEAD-2024-0686619$GILEAD$$73$YR$E$F$Y$$$20240911$$MD$JP$JP
243093841$24309384$1$I$$20240903$20240911$20240911$EXP$$BR-JNJFOC-20240913048$JOHNSON AND JOHNSON$$80$YR$E$M$Y$77$KG$20240912$$CN$BR$BR
243093851$24309385$1$I$20231116$20240904$20240911$20240911$EXP$$JP-GILEAD-2024-0686620$GILEAD$$72$YR$E$F$Y$$$20240911$$MD$JP$JP
243093862$24309386$2$F$20240101$20240910$20240911$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000241$MERZ$$$$$$Y$$$20240925$$HP$US$US
243093871$24309387$1$I$20240808$20240905$20240911$20240911$EXP$FR-AFSSAPS-NC2024001044$FR-GSK-FR2024110435$GLAXOSMITHKLINE$$$$$$Y$$$20240911$$PH$FR$FR
243093881$24309388$1$I$20240101$20240830$20240911$20240911$PER$$US-SA-2024SA261726$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240912$$HP$US$US
243093901$24309390$1$I$20240826$20240909$20240911$20240911$EXP$$CN-ABBVIE-5914962$ABBVIE$$$$$M$Y$$$20240911$$CN$CN$CN
243093911$24309391$1$I$$20240906$20240911$20240911$EXP$$US-ABBVIE-5915505$ABBVIE$$$$$F$Y$$$20240911$$HP$US$US
243093921$24309392$1$I$$20240910$20240911$20240911$EXP$$US-ABBVIE-5917744$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243093932$24309393$2$F$20240101$20240910$20240911$20240925$PER$$US-MRZWEB-2024080000242$MERZ$$$$$$Y$$$20240925$$HP$US$US
243093941$24309394$1$I$$20240903$20240911$20240911$EXP$$US-JNJFOC-20240905258$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243093951$24309395$1$I$20240821$20240906$20240911$20240911$EXP$$US-ORGANON-O2409USA000577$ORGANON$$$$$F$Y$53.968$KG$20240911$$CN$US$US
243093962$24309396$2$F$$20240917$20240911$20240926$EXP$$FR-TEVA-VS-3240989$TEVA$Baudriller A, Abbara C, Briet M, Jousset N, Malbranque S, Zabet D, et al. Deaths related to pharmacobezoars: A report on two cases. Toxic-Analyt-Clinique 2024;.; Baudriller A, Abbara C, Briet M, Jousset N, Malbranque S, Zabet D, et al. Deaths related to pharmacobezoars: A report on two cases. Toxic-Analyt-Clinique 2024;.; Baudriller A, Abbara C, Briet M, Jousset N, Malbranque S, Zabet D, et al. Deaths related to pharmacobezoars: A report on two cases. Toxic-Analyt-Clinique 2024;.$55$YR$$F$Y$$$20240926$$HP$FR$FR
243093971$24309397$1$I$20240819$20240830$20240911$20240911$PER$$US-SA-2024SA261237$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240912$$HP$US$US
243093981$24309398$1$I$20240101$20240828$20240911$20240911$PER$$US-SA-2024SA178453$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240912$$CN$US$US
243093992$24309399$2$F$20240101$20240910$20240911$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000243$MERZ$$$$$$Y$$$20240925$$HP$US$US
243094001$24309400$1$I$20240101$20240905$20240911$20240911$PER$$US-ABBVIE-5909592$ABBVIE$$$$$F$Y$$$20240911$$HP$US$US
243094011$24309401$1$I$$20240902$20240911$20240911$EXP$$AU-JNJFOC-20240903091$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240912$$HP$AU$AU
243094021$24309402$1$I$$20240905$20240911$20240911$EXP$$CA-ABBVIE-5913715$ABBVIE$$$$E$M$Y$$$20240911$$CN$CA$CA
243094032$24309403$2$F$20240101$20240910$20240911$20240925$PER$$US-MRZWEB-2024080000244$MERZ$$$$$$Y$$$20240925$$HP$US$US
243094041$24309404$1$I$20240730$20240904$20240911$20240911$EXP$$CN-BEIGENE-BGN-2024-014026$BEIGENE$$$$$$Y$$$20240911$$HP$CN$CN
243094052$24309405$2$F$$20240918$20240911$20240924$EXP$$BR-009507513-2409BRA002557$MERCK$$$$$F$Y$$$20240924$$MD$BR$BR
243094063$24309406$3$F$$20240909$20240911$20240920$EXP$$JP-JNJFOC-20240917545$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240920$$HP$JP$JP
243094071$24309407$1$I$20240905$20240906$20240911$20240911$PER$$US-AMGEN-USASP2024179008$AMGEN$$48$YR$A$F$Y$$$20240911$$CN$US$US
243094081$24309408$1$I$20240906$20240906$20240911$20240911$EXP$$JP-ABBVIE-5913877$ABBVIE$$25$YR$$F$Y$$$20240911$$PH$JP$JP
243094091$24309409$1$I$20240901$20240909$20240911$20240911$30DAY$$IT-SANDOZ INC.-SDZ2024IT078911$SANDOZ$$$$$F$Y$$$20240911$$CN$IT$IT
243094101$24309410$1$I$$20240905$20240911$20240911$EXP$$JP-ABBVIE-5874278$ABBVIE$$$$E$F$Y$$$20240911$$MD$JP$JP
243094112$24309411$2$F$20240101$20240910$20240911$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000245$MERZ$$$$$$Y$$$20240925$$HP$US$US
243094121$24309412$1$I$20240904$20240905$20240911$20240911$EXP$$US-ABBVIE-5910264$ABBVIE$$87$YR$$F$Y$$$20240911$$CN$US$US
243094131$24309413$1$I$$20240905$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409003679$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240911$$CN$US$US
243094141$24309414$1$I$$20240905$20240911$20240911$EXP$$US-ABBVIE-5910169$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243094151$24309415$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5909811$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243094161$24309416$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009951$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243094172$24309417$2$F$20240101$20240910$20240911$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000246$MERZ$$$$$$Y$$$20240925$$HP$US$US
243094181$24309418$1$I$$20240909$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144340$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240912$$CN$US$US
243094191$24309419$1$I$20240525$20240905$20240911$20240911$EXP$$US-ABBVIE-5886698$ABBVIE$$47$YR$$F$Y$98$KG$20240911$$CN$US$US
243094201$24309420$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009952$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243094211$24309421$1$I$$20240911$20240911$20240911$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050950$BOEHRINGER INGELHEIM$$8$DEC$E$F$Y$$$20240912$$MD$US$US
243094221$24309422$1$I$$20240906$20240911$20240911$EXP$$US-ABBVIE-5914864$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243094231$24309423$1$I$20231001$20240905$20240911$20240911$EXP$$US-ABBVIE-5915700$ABBVIE$$24$YR$$M$Y$$$20240911$$CN$US$US
243094241$24309424$1$I$20240729$20240909$20240911$20240911$EXP$$IL-ABBVIE-5917134$ABBVIE$$72$YR$$M$Y$$$20240911$$CN$IL$IL
243094251$24309425$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5915717$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243094261$24309426$1$I$20240101$20240905$20240911$20240911$EXP$$CA-ABBVIE-5915691$ABBVIE$$17$YR$$F$Y$$$20240911$$HP$CA$CA
243094271$24309427$1$I$$20240906$20240911$20240911$PER$$US-ABBVIE-5915643$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243094281$24309428$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009953$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243094291$24309429$1$I$$20240905$20240911$20240911$EXP$$CA-ABBVIE-5916701$ABBVIE$$$$$M$Y$$$20240911$$HP$CA$CA
243094301$24309430$1$I$$20240906$20240911$20240911$EXP$$NVSC2024DE181312$NOVARTIS$$57$YR$$F$Y$$$20240912$$HP$DE$DE
243094311$24309431$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009954$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243094322$24309432$2$F$20240101$20240910$20240911$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000247$MERZ$$$$$$Y$$$20240925$$HP$US$US
243094332$24309433$2$F$$20240828$20240911$20240924$PER$$US-SA-2024SA262360$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240924$$CN$US$US
243094341$24309434$1$I$$20240906$20240911$20240911$EXP$$US-ABBVIE-5914319$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243094351$24309435$1$I$$20240826$20240911$20240911$PER$$US-APOTEX-2024AP010046$APOTEX$Chang ALS, Brown R, Li S, Betancourt N, Teng J. Assessment of Mammalian Target of Rapamycin Pathway Activation in Basal Cell Carcinoma as a New Therapeutic Approach. The American Journal of Dermatopathology. 2024;46 (9):588-592$6$YR$$F$Y$$$20240911$$MD$US$US
243094361$24309436$1$I$20240101$20240906$20240911$20240911$EXP$$US-ABBVIE-5914085$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243094371$24309437$1$I$$20240909$20240911$20240911$EXP$$GB-ABBVIE-5915555$ABBVIE$$$$A$M$Y$$$20240911$$CN$GB$GB
243094381$24309438$1$I$$20240821$20240911$20240911$PER$$US-APOTEX-2024AP009955$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240911$$HP$US$US
243094391$24309439$1$I$20240904$20240904$20240911$20240911$EXP$$US-ABBVIE-5909758$ABBVIE$$82$YR$$M$Y$$$20240911$$CN$US$US
243094402$24309440$2$F$20240101$20240910$20240911$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000248$MERZ$$$$$$Y$$$20240925$$HP$US$US
243094411$24309441$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144134$BRISTOL MYERS SQUIBB$$24$YR$A$M$Y$$$20240912$$HP$US$US
243094421$24309442$1$I$$20240911$20240911$20240911$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050949$BOEHRINGER INGELHEIM$$8$DEC$E$F$Y$$$20240912$$MD$US$US
243094431$24309443$1$I$20240801$20240827$20240911$20240911$PER$$US-APOTEX-2024AP010133$APOTEX$$77$YR$E$F$Y$$$20240911$$CN$US$US
243094442$24309444$2$F$20211115$20240917$20240911$20240919$EXP$$US-ABBVIE-5915083$ABBVIE$$69$YR$$F$Y$54$KG$20240919$$CN$US$US
243094451$24309445$1$I$20240802$20240909$20240911$20240911$EXP$$US-ABBVIE-5915590$ABBVIE$$59$YR$$F$Y$$$20240911$$CN$US$US
243094462$24309446$2$F$20240904$20240917$20240911$20240920$EXP$$NVSC2024ZA181401$NOVARTIS$$77$YR$$M$Y$80$KG$20240920$$MD$ZA$ZA
243094482$24309448$2$F$20240801$20240910$20240911$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000249$MERZ$$$$$$Y$$$20240925$$HP$US$US
243094491$24309449$1$I$$20240910$20240911$20240911$PER$$US-ELI_LILLY_AND_COMPANY-US202409006959$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240911$$CN$US$US
243094501$24309450$1$I$$20240910$20240911$20240911$PER$$US-HALEON-2196234$Haleon PLC$$$$$$Y$$$20240911$$CN$US$US
243094511$24309451$1$I$20240907$20240909$20240911$20240911$EXP$$US-ABBVIE-5917511$ABBVIE$$65$YR$$F$Y$$$20240911$$CN$US$US
243094521$24309452$1$I$20240910$20240910$20240911$20240911$EXP$$US-ABBVIE-5917746$ABBVIE$$85$YR$$M$Y$$$20240911$$CN$US$US
243094531$24309453$1$I$$20240906$20240911$20240911$EXP$$CA-ABBVIE-5913710$ABBVIE$$$$A$F$Y$$$20240911$$CN$CA$CA
243094541$24309454$1$I$$20240909$20240911$20240911$EXP$$DE-ALXN-202409EEA000581DE$ALEXION PHARMACEUTICALS$$11$YR$$M$Y$52$KG$20240912$$PH$DE$DE
243094551$24309455$1$I$$20240904$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143651$BRISTOL MYERS SQUIBB$Matthia E, Matar R, Altshuler E, Kerensky RA, Arnaoutakis G, Shah S, et al. Massive tension hemothorax after pacemaker implantation. Cureus. 2021 Jul 30;13(7):1-5. doi:10.7759/cureus.16754.$85$YR$E$M$Y$$$20240912$$HP$US$US
243094561$24309456$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142807$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240912$$HP$US$US
243094571$24309457$1$I$$20240827$20240911$20240911$PER$$US-APOTEX-2024AP010138$APOTEX$$$$$F$Y$$$20240911$$CN$US$US
243094581$24309458$1$I$$20240905$20240911$20240911$EXP$$US-AstraZeneca-2024A202730$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243094592$24309459$2$F$20240801$20240910$20240911$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000250$MERZ$$$$$$Y$$$20240925$$HP$US$US
243094602$24309460$2$F$20240916$20240920$20240911$20240923$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-143811$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$64.41$KG$20240923$$CN$PR$PR
243094611$24309461$1$I$20220101$20240903$20240911$20240911$EXP$$US-JNJFOC-20240904405$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
243094621$24309462$1$I$20230901$20240906$20240911$20240911$EXP$$US-ABBVIE-5916328$ABBVIE$$55$YR$$F$Y$$$20240911$$CN$US$US
243094631$24309463$1$I$20240621$20240822$20240911$20240911$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036070$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$$$20240912$$CN$CA$CA
243094641$24309464$1$I$$20240910$20240911$20240911$PER$$US-AMGEN-USASP2024180949$AMGEN$$$$$M$Y$$$20240911$$CN$US$US
243094651$24309465$1$I$20240706$20240906$20240911$20240911$EXP$$NVSC2024AR181563$NOVARTIS$$76$YR$$F$Y$$$20240912$$CN$AR$AR
243094661$24309466$1$I$$20240907$20240911$20240911$PER$$NVSC2024US180417$NOVARTIS$$$$$$Y$$$20240912$$CN$US$US
243094672$24309467$2$F$20240801$20240910$20240911$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024080000251$MERZ$$$$$$Y$$$20240925$$HP$US$US
243094691$24309469$1$I$20240322$20240906$20240911$20240911$EXP$$CA-ABBVIE-5703650$ABBVIE$$70$YR$$M$Y$$$20240911$$CN$CA$CA
243094701$24309470$1$I$20220928$20240906$20240911$20240911$EXP$$US-ABBVIE-5915506$ABBVIE$$47$YR$$F$Y$$$20240911$$CN$US$US
243094712$24309471$2$F$20240701$20240913$20240911$20240920$EXP$$US-ABBVIE-5914730$ABBVIE$$79$YR$$F$Y$46.719$KG$20240920$$CN$US$US
243094721$24309472$1$I$$20240910$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144593$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240912$$CN$US$US
243094741$24309474$1$I$$20240910$20240911$20240911$EXP$$TW-ABBVIE-5917737$ABBVIE$$89$YR$$M$Y$$$20240911$$CN$TW$TW
243094752$24309475$2$F$20240322$20240904$20240911$20240916$EXP$$ES-ABBVIE-5915634$ABBVIE$$82$YR$$F$Y$$$20240916$$MD$ES$ES
243094761$24309476$1$I$20240828$20240828$20240911$20240911$PER$$US-APOTEX-2024AP010137$APOTEX$$$$$F$Y$$$20240911$$CN$US$US
243094771$24309477$1$I$20210101$20240904$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141814$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240912$$MD$US$US
243094781$24309478$1$I$$20240906$20240911$20240911$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142824$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240912$$CN$US$US
243094791$24309479$1$I$20240801$20240906$20240911$20240911$EXP$$US-ABBVIE-5915628$ABBVIE$$60$YR$$F$Y$$$20240911$$CN$US$US
243094801$24309480$1$I$$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180427$AMGEN$$$$$$Y$$$20240911$$CN$US$US
243094821$24309482$1$I$$20240904$20240911$20240911$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011550$STRIDES$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B, et al.. AML-713 Hematological Malignancies and Pregnancy: A Single-Institution Experience.. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S333-S334 abstr. AML-713$$$$$Y$$$20240912$$MD$US$US
243094831$24309483$1$I$$20240910$20240911$20240911$PER$$US-009507513-2409USA003556$MERCK$$$$$F$Y$64.853$KG$20240911$$CN$US$US
243094841$24309484$1$I$$20240910$20240911$20240911$PER$$US-AMGEN-USASP2024181066$AMGEN$$$$$F$Y$$$20240911$$CN$US$US
243094851$24309485$1$I$$20240905$20240911$20240911$EXP$$US-ABBVIE-5910463$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243094861$24309486$1$I$20240908$20240909$20240911$20240911$PER$$US-AMGEN-USASP2024180580$AMGEN$$80$YR$E$F$Y$$$20240911$$CN$US$US
243094871$24309487$1$I$$20240904$20240911$20240911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142120$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240912$$CN$US$US
243094881$24309488$1$I$20240802$20240909$20240911$20240911$EXP$IT-MINISAL02-1001548$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-143295$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240912$$PH$IT$IT
243094891$24309489$1$I$$20240828$20240911$20240911$PER$$US-SA-2024SA259882$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240912$$HP$US$US
243094901$24309490$1$I$20240101$20240829$20240911$20240911$PER$$US-SA-2024SA261714$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240912$$MD$US$US
243094911$24309491$1$I$$20240904$20240911$20240911$EXP$$US-ABBVIE-5909114$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243094921$24309492$1$I$$20240904$20240911$20240911$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011562$STRIDES$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B, et al.. AML-713 Hematological Malignancies and Pregnancy: A Single-Institution Experience.. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S333-S334 abstr. AML-713$$$$$Y$$$20240912$$MD$US$US
243094941$24309494$1$I$20240810$20240828$20240911$20240911$EXP$$CO-MDD US Operations-E2B_00006431$MDD OPERATIONS$$77$YR$$F$Y$65$KG$20240912$$CN$CO$CO
243094961$24309496$1$I$20240901$20240906$20240911$20240911$EXP$$US-ABBVIE-5914178$ABBVIE$$76$YR$$M$Y$$$20240911$$CN$US$US
243094971$24309497$1$I$20240101$20240906$20240911$20240911$EXP$$US-ABBVIE-5915786$ABBVIE$$$$$M$Y$$$20240911$$CN$US$US
243094981$24309498$1$I$$20240828$20240911$20240911$EXP$$AU-MDD US Operations-MDD202409-003304$MDD OPERATIONS$$83$YR$E$M$Y$$$20240912$$HP$AU$
243094991$24309499$1$I$20240101$20240905$20240911$20240911$EXP$$US-ABBVIE-5914203$ABBVIE$$$$$F$Y$$$20240911$$CN$US$US
243095001$24309500$1$I$$20240909$20240912$20240912$PER$$US-ABBVIE-5917942$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243095011$24309501$1$I$20240806$20240909$20240912$20240912$PER$$US-ABBVIE-5917971$ABBVIE$$31$YR$$$Y$$$20240912$$MD$US$US
243095021$24309502$1$I$20240901$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144610$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240912$$CN$US$US
243095051$24309505$1$I$$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144635$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240912$$CN$US$US
243095061$24309506$1$I$20240101$20240905$20240912$20240912$EXP$$US-ABBVIE-5781928$ABBVIE$$$$$F$Y$87$KG$20240912$$CN$US$US
243095072$24309507$2$F$$20240905$20240912$20240928$PER$$US-JNJFOC-20240903588$JOHNSON AND JOHNSON$$$$$F$Y$$$20240928$$CN$US$US
243095081$24309508$1$I$20240825$20240827$20240912$20240912$PER$$US-JNJFOC-20240870588$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240912$$CN$US$US
243095091$24309509$1$I$$20240903$20240912$20240912$EXP$$KR-JNJFOC-20240911227$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$MD$KR$KR
243095101$24309510$1$I$$20240909$20240912$20240912$EXP$$US-PFIZER INC-PV202400118303$PFIZER$$83$YR$$M$Y$$$20240911$$CN$US$US
243095111$24309511$1$I$$20240906$20240912$20240912$EXP$$DE-PFIZER INC-PV202400118015$PFIZER$$$$$$Y$$$20240911$$HP$DE$DE
243095131$24309513$1$I$$20240903$20240912$20240912$EXP$$AE-STRIDES ARCOLAB LIMITED-2024SP011447$STRIDES$Fatima N, Hamza LK, Almulla AAA, Salman A.. Favourable outcome in a primigravida with hydroxychloroquine (HCQ) induced (most likely) cardiomyopathy: a case report and literature review.. Ital-J-Gynaecol-Obstet. 2023;35 (4):488-492.$28$YR$$F$Y$$$20240912$$HP$AE$AE
243095141$24309514$1$I$$20240904$20240912$20240912$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011542$STRIDES$Darnell H, Brenner A, Kern C, Flomenhoft D, Lee E.. Sevelamer-Induced Ischemic Enteritis.. ACG-Case-Rep-J. 2024;11 (7)$35$YR$$M$Y$$$20240912$$MD$US$US
243095151$24309515$1$I$$20240903$20240912$20240912$EXP$$AE-STRIDES ARCOLAB LIMITED-2024SP011451$STRIDES$Fatima N, Hamza LK, Almulla AAA, Salman A.. Favourable outcome in a primigravida with hydroxychloroquine (HCQ) induced (most likely) cardiomyopathy: a case report and literature review.. Ital-J-Gynaecol-Obstet. 2023;35 (4):488-492.$$$$M$Y$$$20240912$$HP$AE$AE
243095161$24309516$1$I$$20240904$20240912$20240912$EXP$$PK-STRIDES ARCOLAB LIMITED-2024SP011545$STRIDES$Khan MWZ, Talha M, Khan A, Khan S.. FATAL CASE OF ALK-NEGATIVE INTRAVASCULAR ANAPLASTIC LARGE T-CELL LYMPHOMA IN A YOUNG ADULT: A RARE CASE PRESENTATION.. Eur-J-Case-Rep-Intern-Med. 2024;11 (Suppl. 1):780 abstr. 2704.$33$YR$$M$Y$$$20240912$$HP$PK$PK
243095171$24309517$1$I$$20240906$20240912$20240912$EXP$$CA-TAKEDA-2024TUS089906$TAKEDA$$$$$M$Y$113$KG$20240912$$CN$CA$CA
243095191$24309519$1$I$20240101$20240830$20240912$20240912$PER$$US-SA-2024SA262376$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240912$$HP$US$US
243095201$24309520$1$I$$20240904$20240912$20240912$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011508$STRIDES$Khadka S, Dong N, Chavez J.. ABCL-440 Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CHP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Single-Center Experience.. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl.):S480$$$$$Y$$$20240912$$MD$US$US
243095211$24309521$1$I$$20240904$20240912$20240912$EXP$$TN-STRIDES ARCOLAB LIMITED-2024SP011551$STRIDES$Cherif A, Hamdi MS, Jebri M, El Hadj WB, Azzabi S, Cherif E, et al.. TAFRO SYNDROME; A SEVERE TYPE OF IDIOPATHIC MULTICENTRIC CASTLEMAN ^S DISEASE; CASE REPORT.. Eur-J-Case-Rep-Intern-Med. 2024;11 (Suppl. 1):899 abstr. 2300$61$YR$$M$Y$$$20240912$$HP$TN$TN
243095221$24309522$1$I$$20240909$20240912$20240912$EXP$$BR-ROCHE-10000077195$ROCHE$$$$$M$Y$$$20240912$$CN$BR$BR
243095231$24309523$1$I$$20240909$20240912$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US078944$SANDOZ$$$$$$Y$$$20240912$$CN$US$US
243095241$24309524$1$I$20240801$20240830$20240912$20240912$PER$$US-APOTEX-2024AP010215$APOTEX$$71$YR$E$F$Y$$$20240912$$HP$US$US
243095251$24309525$1$I$$20240827$20240912$20240912$PER$$US-JNJFOC-20240871216$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
243095261$24309526$1$I$$20240906$20240912$20240912$EXP$$US-JNJFOC-20240922498$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240912$$HP$US$US
243095271$24309527$1$I$$20240905$20240912$20240912$PER$$US-JNJFOC-20240919460$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
243095282$24309528$2$F$20240101$20240913$20240912$20240916$PER$$US-AMGEN-USASP2024175663$AMGEN$$72$YR$E$F$Y$$$20240916$$CN$US$US
243095291$24309529$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144694$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240912$$CN$US$US
243095301$24309530$1$I$20240801$20240829$20240912$20240912$PER$$US-SA-2024SA255025$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240912$$CN$US$US
243095311$24309531$1$I$$20240909$20240912$20240912$PER$$US-ROCHE-10000078032$ROCHE$$6$YR$C$F$Y$$$20240912$$CN$US$US
243095321$24309532$1$I$20240830$20240903$20240912$20240912$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027647$UNITED THERAPEUTICS$$81$YR$$F$Y$43.084$KG$20240912$$$US$US
243095331$24309533$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004811$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243095341$24309534$1$I$$20240905$20240912$20240912$PER$$US-ABBVIE-5913727$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243095352$24309535$2$F$$20240919$20240912$20240924$EXP$$US-ROCHE-10000078950$ROCHE$$71$YR$E$M$Y$$$20240924$$CN$US$US
243095371$24309537$1$I$$20240909$20240912$20240912$EXP$$JP-PFIZER INC-PV202400118395$PFIZER$$$$$$Y$$$20240912$$MD$JP$JP
243095381$24309538$1$I$$20240910$20240912$20240912$EXP$$US-PFIZER INC-202400253812$PFIZER$$$$$F$Y$$$20240912$$CN$US$US
243095391$24309539$1$I$20240101$20240910$20240912$20240912$EXP$$CA-PFIZER INC-202300232924$PFIZER$$39$YR$$F$Y$$$20240912$$MD$CA$CA
243095401$24309540$1$I$$20240905$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142241$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240912$$HP$US$US
243095411$24309541$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144070$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240912$$CN$US$US
243095421$24309542$1$I$$20240911$20240912$20240912$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050843$BOEHRINGER INGELHEIM$$76$YR$E$F$Y$$$20240912$$PH$CA$CA
243095431$24309543$1$I$$20240911$20240912$20240912$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050968$BOEHRINGER INGELHEIM$$$$$$Y$$$20240912$$CN$US$US
243095451$24309545$1$I$$20240909$20240912$20240912$EXP$$PL-SANDOZ INC.-PHHY2012PL085151$SANDOZ$$1$YR$$F$Y$$$20240912$$MD$PL$PL
243095471$24309547$1$I$$20240821$20240912$20240912$EXP$GB-MHRA-MED-202408211331256540-HZWRL$GB-AMAROX PHARMA-AMR2024GB02804$HETERO$$82$YR$$F$Y$$$20240830$$HP$GB$GB
243095481$24309548$1$I$$20240818$20240912$20240912$EXP$$DE-AMAROX PHARMA-AMR2024DE02784$HETERO$N?gele H, Rosenkranz M, N?gele MP.. Hyponatremia-Induced Epileptic Seizure Provoked by Levetiracetam and Pain Medication Intake in a Patient with Central Diabetes Insipidus. Neurology. 2024;16(1):204-207$67$YR$$M$Y$$$20240826$$HP$DE$DE
243095492$24309549$2$F$20230701$20240916$20240912$20240924$EXP$$US-ABBVIE-5906444$ABBVIE$$79$YR$$F$Y$58.966$KG$20240924$$CN$US$US
243095501$24309550$1$I$$20240902$20240912$20240912$EXP$$US-TEVA-VS-3240595$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240912$$HP$US$US
243095511$24309551$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005682$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240912$$CN$US$US
243095521$24309552$1$I$20230501$20240906$20240912$20240912$EXP$$JP-ABBVIE-21K-087-3918816-00$ABBVIE$$42$YR$$F$Y$56$KG$20240912$$MD$JP$JP
243095531$24309553$1$I$20230917$20240910$20240912$20240912$30DAY$$US-SANDOZ INC.-SDZ2023US047710$SANDOZ$$5$YR$$M$Y$$$20240912$$CN$US$US
243095541$24309554$1$I$20160101$20240904$20240912$20240912$EXP$$US-ABBVIE-5833069$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243095551$24309555$1$I$20240625$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181327$AMGEN$$78$YR$E$F$Y$$$20240911$$CN$US$US
243095561$24309556$1$I$20240825$20240909$20240912$20240912$EXP$$GB-ABBVIE-5916863$ABBVIE$$89$YR$$M$Y$$$20240912$$CN$GB$GB
243095572$24309557$2$F$20240101$20240909$20240912$20240916$EXP$$US-ABBVIE-5910134$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243095581$24309558$1$I$$20240906$20240912$20240912$EXP$$CO-ABBVIE-5917179$ABBVIE$$$$$M$Y$70$KG$20240912$$HP$CO$CO
243095593$24309559$3$F$20240901$20240912$20240912$20240917$EXP$$US-ABBVIE-5910205$ABBVIE$$45$YR$$F$Y$$$20240917$$CN$US$US
243095601$24309560$1$I$$20240906$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007123$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240912$$CN$US$US
243095621$24309562$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5915958$ABBVIE$$$$$M$Y$$$20240912$$HP$US$US
243095631$24309563$1$I$20240101$20240905$20240912$20240912$EXP$$US-ABBVIE-5915084$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243095641$24309564$1$I$20240601$20240906$20240912$20240912$EXP$$US-ABBVIE-5875908$ABBVIE$$75$YR$$F$Y$$$20240912$$CN$US$US
243095651$24309565$1$I$20240801$20240909$20240912$20240912$EXP$$US-ABBVIE-5915677$ABBVIE$$71$YR$$F$Y$$$20240912$$CN$US$US
243095661$24309566$1$I$20240818$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004857$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240912$$CN$US$US
243095671$24309567$1$I$20240801$20240903$20240912$20240912$EXP$$CO-ABBVIE-5917488$ABBVIE$$50$YR$$M$Y$84$KG$20240912$$HP$CO$CO
243095691$24309569$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004821$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243095701$24309570$1$I$$20240909$20240912$20240912$EXP$$JP-TAKEDA-2024TJP013326$TAKEDA$$$$$M$Y$$$20240912$$MD$JP$JP
243095711$24309571$1$I$$20240910$20240912$20240912$EXP$$US-ABBVIE-5919114$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243095721$24309572$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5915285$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243095731$24309573$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA261331$SANOFI AVENTIS$$$$A$M$Y$$$20240912$$HP$US$US
243095741$24309574$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5917140$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243095751$24309575$1$I$$20240902$20240912$20240912$EXP$$US-TEVA-VS-3240596$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240912$$HP$US$US
243095762$24309576$2$F$20240801$20240923$20240912$20240927$EXP$$US-ABBVIE-5909748$ABBVIE$$59$YR$$F$Y$63.502$KG$20240927$$CN$US$US
243095771$24309577$1$I$20231026$20240903$20240912$20240912$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-000564$Alvotech$$18$YR$$M$Y$$$20240912$$CN$CA$CA
243095781$24309578$1$I$20240820$20240902$20240912$20240912$EXP$$CN-TAKEDA-2024TUS090390$TAKEDA$$61$YR$$M$Y$61$KG$20240912$$HP$CN$CN
243095792$24309579$2$F$$20240910$20240912$20240916$PER$$US-JNJFOC-20240915875$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$MD$US$US
243095801$24309580$1$I$$20240910$20240912$20240912$EXP$$US-ALXN-202409USA000626US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243095821$24309582$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA262851$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240912$$HP$US$US
243095831$24309583$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA260867$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240912$$HP$US$US
243095841$24309584$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA261628$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240912$$MD$US$US
243095851$24309585$1$I$20240801$20240830$20240912$20240912$PER$$US-SA-2024SA261924$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240912$$HP$US$US
243095861$24309586$1$I$20240910$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181257$AMGEN$$79$YR$E$M$Y$$$20240911$$CN$US$US
243095881$24309588$1$I$20240827$20240905$20240912$20240912$EXP$$US-ABBVIE-5910440$ABBVIE$$41$YR$$F$Y$$$20240912$$CN$US$US
243095901$24309590$1$I$$20240902$20240912$20240912$EXP$$US-TEVA-VS-3240598$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240912$$HP$US$US
243095911$24309591$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5914084$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243095921$24309592$1$I$20240301$20240904$20240912$20240912$EXP$FR-AFSSAPS-TO2024001637$FR-EMD Serono-2024047527$EMD SERONO INC$$77$YR$E$M$Y$$$20240912$$MD$FR$FR
243095931$24309593$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5914233$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243095941$24309594$1$I$$20240910$20240912$20240912$PER$$US-ROCHE-3557464$ROCHE$$74$YR$E$F$Y$$$20240912$$CN$US$US
243095951$24309595$1$I$$20240827$20240912$20240912$PER$$US-ASTELLAS-2024-AER-003412$ASTELLAS$$$$$M$Y$$$20240912$$HP$US$US
243095971$24309597$1$I$$20240902$20240912$20240912$EXP$$BE-ABBVIE-5839416$ABBVIE$$$$E$F$Y$$$20240912$$HP$BE$BE
243095981$24309598$1$I$20240901$20240903$20240912$20240912$PER$$US-SA-2024SA255570$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240912$$CN$US$US
243095991$24309599$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA261665$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240912$$MD$US$US
243096001$24309600$1$I$$20240907$20240912$20240912$EXP$$US-ABBVIE-5915125$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243096011$24309601$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5914752$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243096021$24309602$1$I$$20240905$20240912$20240912$30DAY$$US-GSK-US2024AMR110876$GLAXOSMITHKLINE$$$$$F$Y$$$20240912$$CN$US$US
243096031$24309603$1$I$20240517$20240605$20240912$20240912$PER$$US-AUROBINDO-AUR-APL-2024-029107$AUROBINDO$$63$YR$$F$Y$119.29$KG$20240912$$CN$US$US
243096041$24309604$1$I$$20240219$20240912$20240912$PER$$US-AUROBINDO-AUR-APL-2024-007694$AUROBINDO$$$$$$Y$$$20240912$$CN$US$US
243096051$24309605$1$I$20240710$20240711$20240912$20240912$EXP$$US-AstraZeneca-2024A161428$ASTRAZENECA$$2889$WK$$F$Y$$$20240912$$CN$US$
243096061$24309606$1$I$$20240205$20240912$20240912$PER$$US-AUROBINDO-AUR-APL-2023-078431$AUROBINDO$$$$$$Y$$$20240912$$CN$US$US
243096071$24309607$1$I$$20231016$20240912$20240912$PER$$US-AUROBINDO-AUR-APL-2023-064676$AUROBINDO$$$$A$M$Y$$$20240912$$HP$US$US
243096081$24309608$1$I$$20240625$20240912$20240912$PER$$US-AUROBINDO-AUR-APL-2024-032667$AUROBINDO$$54$YR$$F$Y$$$20240912$$HP$US$US
243096091$24309609$1$I$20240523$20240612$20240912$20240912$PER$$US-AUROBINDO-AUR-APL-2024-027576$AUROBINDO$$$$E$F$Y$74.8$KG$20240912$$PH$US$US
243096101$24309610$1$I$$20230920$20240912$20240912$PER$$US-AUROBINDO-AUR-APL-2023-064707$AUROBINDO$$3$YR$$F$Y$$$20240912$$CN$US$US
243096111$24309611$1$I$20240101$20240907$20240912$20240912$EXP$$JP-ABBVIE-5873426$ABBVIE$$$$$F$Y$$$20240912$$CN$JP$JP
243096121$24309612$1$I$$20240905$20240912$20240912$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003914$ELI LILLY AND CO$$$$$M$Y$$$20240912$$CN$US$US
243096131$24309613$1$I$20240301$20240905$20240912$20240912$EXP$$US-ABBVIE-5914020$ABBVIE$$50$YR$$F$Y$$$20240912$$CN$US$US
243096141$24309614$1$I$20240827$20240830$20240912$20240912$EXP$GB-MHRA-MED-202408301741285150-SWPNG$GB-ELI_LILLY_AND_COMPANY-GB202409000745$ELI LILLY AND CO$$51$YR$A$M$Y$76$KG$20240912$$CN$GB$GB
243096151$24309615$1$I$$20240830$20240912$20240912$EXP$GB-MHRA-MED-202408301154336020-GPRYK$GB-ELI_LILLY_AND_COMPANY-GB202409000686$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$GB$GB
243096161$24309616$1$I$20180101$20240904$20240912$20240912$EXP$$EG-ELI_LILLY_AND_COMPANY-EG202409002946$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240912$$CN$EG$EG
243096171$24309617$1$I$$20240830$20240912$20240912$EXP$GB-MHRA-MIDB-fe2c382f-85f9-4035-ba3b-a78654b0eca0$GB-ELI_LILLY_AND_COMPANY-GB202409000765$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240912$$CN$GB$GB
243096181$24309618$1$I$20240828$20240830$20240912$20240912$EXP$GB-MHRA-MED-202408301308128530-FKSBR$GB-ELI_LILLY_AND_COMPANY-GB202409000713$ELI LILLY AND CO$$27$YR$A$F$Y$92$KG$20240912$$CN$GB$GB
243096191$24309619$1$I$20240831$20240903$20240912$20240912$EXP$GB-MHRA-MED-202409032355510630-MHWVZ$GB-ELI_LILLY_AND_COMPANY-GB202409002037$ELI LILLY AND CO$$44$YR$A$F$Y$76$KG$20240912$$CN$GB$GB
243096201$24309620$1$I$$20240830$20240912$20240912$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000875$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240912$$CN$US$US
243096211$24309621$1$I$20240815$20240830$20240912$20240912$EXP$GB-MHRA-MED-202408301543469680-BMLFD$GB-ELI_LILLY_AND_COMPANY-GB202409000744$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240912$$CN$GB$GB
243096221$24309622$1$I$20240701$20240830$20240912$20240912$EXP$$US-ELI_LILLY_AND_COMPANY-US202409000514$ELI LILLY AND CO$$56$YR$A$$Y$$$20240912$$CN$US$US
243096231$24309623$1$I$$20240910$20240912$20240912$30DAY$$US-SANDOZ INC.-SDZ2023US047805$SANDOZ$$$$$F$Y$$$20240912$$HP$US$US
243096242$24309624$2$F$20240627$20240918$20240912$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003094$ELI LILLY AND CO$$70$YR$E$F$Y$104.5$KG$20240930$$MD$US$US
243096251$24309625$1$I$20240903$20240903$20240912$20240912$EXP$$AU-ROCHE-3311911$ROCHE$$49$YR$A$M$Y$$$20240912$$HP$AU$AU
243096261$24309626$1$I$$20240906$20240912$20240912$EXP$$US-ALXN-202409USA000489US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243096271$24309627$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5916068$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243096281$24309628$1$I$20240601$20240905$20240912$20240912$EXP$$US-ABBVIE-5887236$ABBVIE$$79$YR$$M$Y$$$20240912$$CN$US$US
243096291$24309629$1$I$20240515$20240906$20240912$20240912$EXP$$RU-ABBVIE-5913723$ABBVIE$$64$YR$$M$Y$$$20240912$$HP$RU$RU
243096301$24309630$1$I$20240826$20240902$20240912$20240912$EXP$$JP-NOVOPROD-1277736$NOVO NORDISK$$67$YR$$F$Y$$$20240912$$MD$JP$JP
243096311$24309631$1$I$20240101$20240902$20240912$20240912$EXP$$BR-NOVOPROD-1274390$NOVO NORDISK$$435$MON$$F$Y$78$KG$20240912$$CN$BR$BR
243096321$24309632$1$I$20200101$20240902$20240912$20240912$EXP$DE-CADRBFARM-2024330200$DE-NOVOPROD-1277556$NOVO NORDISK$$62$YR$$F$Y$95$KG$20240912$$CN$DE$DE
243096331$24309633$1$I$$20240830$20240912$20240912$EXP$$US-NOVOPROD-1281401$NOVO NORDISK$$$$$F$Y$$$20240912$$CN$US$US
243096341$24309634$1$I$20240810$20240902$20240912$20240912$EXP$DK-DKMA-30738018$DK-NOVOPROD-1277564$NOVO NORDISK$$29$YR$$F$Y$81$KG$20240912$$MD$DK$DK
243096351$24309635$1$I$$20240906$20240912$20240912$EXP$$AR-AMGEN-ARGSP2024180378$AMGEN$$$$$$Y$$$20240911$$MD$AR$AR
243096361$24309636$1$I$20240906$20240906$20240912$20240912$PER$$US-AMGEN-USASP2024179207$AMGEN$$42$YR$A$M$Y$$$20240911$$CN$US$US
243096371$24309637$1$I$20240828$20240903$20240912$20240912$EXP$$JP-ROCHE-10000075248$ROCHE$$80$YR$E$M$Y$$$20240912$$MD$JP$JP
243096381$24309638$1$I$$20240827$20240912$20240912$PER$$US-ASTELLAS-2024-AER-003476$ASTELLAS$$$$A$F$Y$$$20240912$$CN$US$US
243096391$24309639$1$I$20240501$20240905$20240912$20240912$EXP$$US-ABBVIE-5910196$ABBVIE$$60$YR$$M$Y$$$20240912$$CN$US$US
243096401$24309640$1$I$$20240909$20240912$20240912$EXP$$US-JNJFOC-20240923925$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240912$$HP$US$US
243096411$24309641$1$I$20240701$20240903$20240912$20240912$EXP$GB-MHRA-MED-202409031429356280-MDHJZ$GB-NOVOPROD-1278274$NOVO NORDISK$$65$YR$$F$Y$87$KG$20240912$$CN$GB$GB
243096421$24309642$1$I$$20240902$20240912$20240912$EXP$$TR-NOVOPROD-1279918$NOVO NORDISK$$$$$F$Y$$$20240912$$CN$TR$TR
243096431$24309643$1$I$$20240902$20240912$20240912$EXP$$CL-NOVOPROD-1280317$NOVO NORDISK$$$$$M$Y$$$20240912$$MD$CL$CL
243096441$24309644$1$I$$20240902$20240912$20240912$EXP$$JP-NOVOPROD-1278823$NOVO NORDISK$$80$YR$$M$Y$$$20240912$$PH$JP$JP
243096451$24309645$1$I$$20240903$20240912$20240912$EXP$$US-NOVOPROD-1278987$NOVO NORDISK$$66$YR$$$Y$$$20240912$$CN$US$US
243096461$24309646$1$I$20240820$20240903$20240912$20240912$EXP$$US-NOVOPROD-1278685$NOVO NORDISK$$70$YR$$M$Y$$$20240912$$CN$US$US
243096471$24309647$1$I$20080101$20240904$20240912$20240912$EXP$$AR-NOVOPROD-1279950$NOVO NORDISK$$62$YR$$F$Y$$$20240912$$CN$AR$AR
243096481$24309648$1$I$20240801$20240906$20240912$20240912$EXP$$US-ABBVIE-5915662$ABBVIE$$45$YR$$F$Y$$$20240912$$CN$US$US
243096491$24309649$1$I$20240327$20240902$20240912$20240912$EXP$$CO-NOVOPROD-1279767$NOVO NORDISK$$59$YR$$F$Y$78$KG$20240912$$CN$CO$CO
243096501$24309650$1$I$20240805$20240906$20240912$20240912$EXP$$US-ABBVIE-5915520$ABBVIE$$52$YR$$F$Y$$$20240912$$CN$US$US
243096511$24309651$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA260869$SANOFI AVENTIS$$$$$M$Y$$$20240912$$MD$US$US
243096523$24309652$3$F$20240101$20240924$20240912$20240930$EXP$$GB-ABBVIE-5913922$ABBVIE$$32$YR$$M$Y$$$20240930$$CN$GB$GB
243096531$24309653$1$I$20240701$20240903$20240912$20240912$PER$$US-ABBVIE-5906190$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243096541$24309654$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5914749$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243096551$24309655$1$I$$20240906$20240912$20240912$EXP$$US-TAKEDA-2024TUS056779$TAKEDA$$$$$F$Y$$$20240912$$MD$US$US
243096561$24309656$1$I$20240909$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180169$AMGEN$$70$YR$E$F$Y$$$20240911$$CN$US$US
243096571$24309657$1$I$$20240909$20240912$20240912$EXP$$RO-SANDOZ INC.-PHHY2018RO125528$SANDOZ$$84$YR$$F$Y$$$20240912$$MD$RO$RO
243096581$24309658$1$I$20240905$20240906$20240912$20240912$PER$$US-JNJFOC-20240920377$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240912$$HP$US$US
243096591$24309659$1$I$$20240828$20240912$20240912$EXP$$MY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466218$RANBAXY$Ding CH, Wahab WA, Saaid MS, Mokhtar MN, Abdullah FA, Azaharuddin I. Septicaemia due to Vibrio vulnificus: A tropical infection not to be taken lightly. Trop Biomed. 2024;41 (2):157-159$67$YR$$M$Y$$$20240912$$HP$MY$MY
243096601$24309660$1$I$20170717$20240828$20240912$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466589$RANBAXY$$69$YR$E$M$Y$$$20240912$$CN$US$US
243096611$24309661$1$I$20240801$20240904$20240912$20240912$EXP$$US-ABBVIE-5910251$ABBVIE$$72$YR$$M$Y$$$20240912$$CN$US$US
243096621$24309662$1$I$$20240828$20240912$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467037$RANBAXY$Hassan AM, Hill H, Donley C, Leonelli C.. Potential anaphylactoid reaction to nicardipine. J Am Coll Emerg Physicians Open. 2024;5 (4):e13271 (1-3)$52$YR$$M$Y$$$20240912$$MD$US$US
243096631$24309663$1$I$$20240828$20240912$20240912$EXP$$TZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466217$RANBAXY$Nganga ML, Mweya CN. Neglected massive multinodular goiter during pregnancy with dyspnea and successful normal delivery: A case report. Clin Case Rep. 2023;11:e8303/1-4$$$I$M$Y$2.1$KG$20240912$$HP$TZ$TZ
243096641$24309664$1$I$$20240828$20240912$20240912$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467079$RANBAXY$Ilieva K, Karnaukhova EY, Pobegalova OE, Lioznov DA. Clinical cases of pneumocystis pneumonia in patients with HIV infection and underlying COVID-19. Journal of Infectious Diseases. 2022;14 (4):126-131$38$YR$$$Y$$$20240912$$HP$RU$RU
243096651$24309665$1$I$$20240828$20240912$20240912$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467078$RANBAXY$Ilieva K, Karnaukhova EY, Pobegalova OE, Lioznov DA. Clinical cases of pneumocystis pneumonia in patients with HIV infection and underlying COVID-19. Journal of Infectious Diseases. 2022;14 (4):126-131$35$YR$$M$Y$$$20240912$$HP$RU$RU
243096661$24309666$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA262310$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240912$$HP$US$US
243096671$24309667$1$I$$20240828$20240912$20240912$EXP$$TZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466214$RANBAXY$Nganga ML, Mweya CN. Neglected massive multinodular goiter during pregnancy with dyspnea and successful normal delivery: A case report. Clin Case Rep. 2023;11:e8303/1-4$30$YR$$F$Y$$$20240912$$HP$TZ$TZ
243096681$24309668$1$I$$20240828$20240912$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467129$RANBAXY$Barrison L, Park S, Decherney A. Spontaneous conception in a 40-year-old woman after allogeneic stem cell transplant with active graft-versus-host disease: A case report. Case Rep Women Health. 2024;43 (0):e00636 (1-3)$41$YR$$F$Y$$$20240912$$HP$US$US
243096691$24309669$1$I$$20240828$20240912$20240912$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467080$RANBAXY$Babushkin AE, Matyukhina EN, Saitova GR, Israfilova GZ. Complicated COVID-19 conjunctivitis. A case report. Rossiiskii Oftal^mologicheskii Zhurnal. 2023;16 (2):130-134$26$YR$$M$Y$$$20240912$$HP$RU$RU
243096701$24309670$1$I$$20240828$20240912$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467116$RANBAXY$Tuan JJ, Ogbuagu O, Kumar D, Altice F,Fikrig M. Acute kidney injury due to myoglobin cast nephropathy in the setting of coronavirus disease 2019?mediated rhabdomyolysis: a case report. J Med Case Rep. 2022;16(1):491$67$YR$$M$Y$$$20240912$$HP$US$US
243096711$24309671$1$I$20240801$20240903$20240912$20240912$EXP$$US-ABBVIE-5906394$ABBVIE$$65$YR$$M$Y$$$20240912$$CN$US$US
243096721$24309672$1$I$$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467137$RANBAXY$Pessina E, Martini A, Raffone F, Martiadis V. Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series. Frontiers in Psychiatry. 2023;14:1299368 (1-5)$$$$$Y$$$20240912$$HP$IT$IT
243096731$24309673$1$I$$20240828$20240912$20240912$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467356$RANBAXY$Shamseldin M, Heers H, Steiner T, Puls R. Anatomic locations of ureterovascular fstulae: a review of 532 patients in the literature and a new series of 8 patients. CVIR Endovasc. 2024;Aug;7 (1):63(1-15)$79$YR$$F$Y$$$20240912$$HP$DE$DE
243096742$24309674$2$F$$20240906$20240912$20240920$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467110$RANBAXY$Chatzis G, Vlachopoulou M, Menemtsiadou G, Koliafas C, Ragazos N, Sarantakou M, et al. Metabolic acidosis in dyslipidemia with acute renal failure in pioglitazone/metformin treatment a case report. Atherosclerosis. 2024;395 (Suppl.):no pagination/117627/100/P308$50$YR$$F$Y$$$20240920$$HP$GR$GR
243096751$24309675$1$I$$20240828$20240912$20240912$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467321$RANBAXY$Al-Shamrani A, Al-Shamrani K, Mahfoudh AB, Mohamed AS, Mohamed S. A Niemann?Pick Disease Type C2 with Severe Pulmonary Involvement and Limited Therapeutic Options: A Case Report. Children-(Basel). 2022;9 (12):No pagination (1-7)$3$YR$$M$Y$$$20240912$$HP$SA$SA
243096761$24309676$1$I$$20240828$20240912$20240912$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467353$RANBAXY$Shamseldin M, Heers H, Steiner T, Puls R. Anatomic locations of ureterovascular fstulae: a review of 532 patients in the literature and a new series of 8 patients. CVIR Endovasc. 2024;Aug;7 (1):63(1-15)$71$YR$$M$Y$$$20240912$$HP$DE$DE
243096771$24309677$1$I$$20240828$20240912$20240912$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467132$RANBAXY$Hall R, Atmaja B, Sharma B, Cunningham D. Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin?s lymphoma, complicated by anthracycline-induced cardiomyopathy. BMJ Case Rep. 2024;17 (8):e257523.$20$YR$$F$Y$$$20240912$$MD$GB$GB
243096781$24309678$1$I$$20240828$20240912$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467036$RANBAXY$Babar S, Liu E, Kaur S, Hussain J, Danaher PJ, Anstead GM. Pseudopropionibacterium propionicum as a Cause of Empyema; A Diagnosis with Next-Generation Sequencing. Pathogens. 2024;13:165 (1-9)$77$YR$$M$Y$$$20240912$$HP$US$US
243096791$24309679$1$I$$20240828$20240912$20240912$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467309$RANBAXY$Mobark NA, Alotabi F, Balbaid AAO, Alshoumer A, Al-Dandan S. UNUSUAL NEUROFIBROMATOSIS TYPE 1-ASSOCIATED PILOCYTIC ASTROCYTOMAWITH MALIGNANT TRANSFORMATION IN A 7-YEAR-OLD GIRL. NEURO-ONCOLOGY. 2024;26 (Suppl.):iv165-iv166$7$YR$$F$Y$$$20240912$$HP$SA$SA
243096801$24309680$1$I$$20240828$20240912$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466032$RANBAXY$$$$E$F$Y$$$20240912$$CN$US$US
243096811$24309681$1$I$$20240828$20240912$20240912$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467358$RANBAXY$Shamseldin M, Heers H, Steiner T, Puls R. Anatomic locations of ureterovascular fstulae: a review of 532 patients in the literature and a new series of 8 patients. CVIR Endovascular. 2024;Aug;7 (1):63(1-15)$85$YR$$M$Y$$$20240912$$HP$DE$DE
243096821$24309682$1$I$$20240828$20240912$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467141$RANBAXY$Kendel N, Wilson Y, Wright EN. HIGH GRADE GLIOMA PRESENTING AS A SYNCHRONOUS CANCER IN A PATIENT WITH DIFFUSE LARGE B CELL LYMPHOMA: A UNIQUE TREATMENT DILEMMA. Neuro Oncol. 2024;Jun;26 (Suppl.):iv98/NOAE064.329/HGG-45$7$YR$$M$Y$$$20240912$$HP$US$US
243096832$24309683$2$F$$20240902$20240912$20240917$EXP$$DK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467628$RANBAXY$Plaehn G, Fuglsang T, Hindersson P, Breindahl T. Adverse effects from counterfeit and mislabeled medicine containing tapentadol and carisoprodol. Clin Case Rep. 2024;12 (8):e9241;1-6$16$YR$$M$Y$$$20240917$$HP$DK$DK
243096841$24309684$1$I$$20240828$20240912$20240912$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467168$RANBAXY$Vasilopoulou A, Spaho M, Theotokis P, Grekou A, Meditskou S, Manthou ME. Fatal misdiagnosis of progressive disseminated histoplasmosis. Med Mycol Case Reports. 2024;45 (0):10062(1-4)$39$YR$$M$Y$$$20240912$$HP$GR$GR
243096851$24309685$1$I$$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467143$RANBAXY$Pessina E, Martini A, Raffone F, Martiadis V. Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series. Front Psychiatry. 2023;14:1299368 (1-5)$$$$$Y$$$20240912$$HP$IT$IT
243096861$24309686$1$I$$20240828$20240912$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467120$RANBAXY$Long C, Mangum R, Keller L, Bristol RE, Ahmed SK, Kuwabara M, et al. INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMOR WITH MALIGNANT TRANSFORMATION TO EMBRYONAL RHABDOMYSARCOMA. Neuro Oncol. 2024;26 (Suppl.):iv83/NOAE064.281/GCT-26$13$YR$$M$Y$$$20240912$$HP$US$US
243096872$24309687$2$F$$20240912$20240912$20240927$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467195$RANBAXY$Jo HB, Kang JS, Choi S, Park SY. Intravenous Immunoglobulin as a Key to Treating Recurrent COVID-19 19 in Rituximab-Induced Immunodeficiency: A Clinical Case Insight. Infect-Chemotherap. 2024;56(Suppl.):S156/P2CC-007$47$YR$$F$Y$$$20240927$$HP$KR$KR
243096881$24309688$1$I$$20240828$20240912$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467130$RANBAXY$Barrison L, Park S, Decherney A. Spontaneous conception in a 40-year-old woman after allogeneic stem cell transplant with active graft-versus-host disease: A case report. Case Rep Women Health. 2024;43 (0):e00636 (1-3)$$$N$M$Y$1.73$KG$20240912$$HP$US$US
243096891$24309689$1$I$$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467140$RANBAXY$Pessina E, Martini A, Raffone F, Martiadis V. Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series. Frontiers in Psychiatry. 2023;14:1299368 (1-5)$$$$$Y$$$20240912$$HP$IT$IT
243096901$24309690$1$I$$20240828$20240912$20240912$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467357$RANBAXY$Shamseldin M, Heers H, Steiner T, Puls R. Anatomic locations of ureterovascular fstulae: a review of 532 patients in the literature and a new series of 8 patients. CVIR Endovas. 2024;Aug;7 (1):63(1-15)$76$YR$$M$Y$$$20240912$$HP$DE$DE
243096911$24309691$1$I$$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467150$RANBAXY$Castelli B, Fonte C, Guidi M, Di Nicola M, Giunti L, Buccoliero AM, et al. ROLES OF GEMCITABINE-OXALIPLATIN (GEMOX) ADD-ON THERAPY IN INFANT-TYPE BRAIN TUMORS: A SINGLE CENTER EXPERIENCE. Neuro Oncol. 2024;26 (Suppl.):iv194/OTHR-05/ (ID:NOAE064.67)$$$C$$Y$$$20240912$$HP$IT$IT
243096921$24309692$1$I$$20240828$20240912$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467109$RANBAXY$De Marsh SJ, Orr B, Willard N, Dahl N. A UNIQUE CASE OF CNS DIFFUSE, NON-SYSTEMIC ALK+ HISTIOCYTOSIS IN A PEDIATRIC PATIENT. Neuro Oncol. 2024;26 (Suppl.):iv59/ NOAE064.201/ETMR-31$20$MON$$M$Y$$$20240912$$HP$US$US
243096931$24309693$1$I$$20240828$20240912$20240912$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467269$RANBAXY$Shi S-M, Li Z-H, Xu J-R, Cai XX, Zhou X-X, Zheng R-C, et al. An adult with hemorrhagic varicella co-infects with cytomegalovirus: a case report. BMC Infect Dis. 2024;24 (1):691;1-6$25$YR$$M$Y$$$20240912$$HP$CN$CN
243096941$24309694$1$I$$20240828$20240912$20240912$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467270$RANBAXY$Nikkarinen A, Glimelius I. Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma - A case report. EJHaem. 2024;5 (4):820-824$79$YR$$M$Y$$$20240912$$HP$SE$SE
243096951$24309695$1$I$$20240906$20240912$20240912$EXP$$US-AstraZeneca-2024A204368$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243096961$24309696$1$I$$20240909$20240912$20240912$EXP$$US-AstraZeneca-2024A205391$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243096971$24309697$1$I$20240827$20240905$20240912$20240912$EXP$$US-AstraZeneca-2024A203038$ASTRAZENECA$$15359$DY$$F$Y$80.7$KG$20240912$$HP$US$
243096981$24309698$1$I$$20240909$20240912$20240912$EXP$$ZA-AstraZeneca-2024A205423$ASTRAZENECA$$74$YR$$M$Y$$$20240912$$CN$ZA$
243097001$24309700$1$I$$20240909$20240912$20240912$EXP$$GB-AstraZeneca-2024A205034$ASTRAZENECA$$$$C$$Y$$$20240912$$MD$GB$
243097013$24309701$3$F$$20240909$20240912$20240920$EXP$$SE-SANDOZ INC.-NVSC2021SE157237$SANDOZ$$65$YR$$M$Y$$$20240920$$MD$SE$SE
243097021$24309702$1$I$20240101$20240909$20240912$20240912$EXP$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US001152$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243097031$24309703$1$I$20240801$20240905$20240912$20240912$EXP$$US-ABBVIE-5913632$ABBVIE$$57$YR$$F$Y$$$20240912$$CN$US$US
243097041$24309704$1$I$20240101$20240905$20240912$20240912$EXP$$US-ABBVIE-5675583$ABBVIE$$$$$F$Y$88$KG$20240912$$CN$US$US
243097051$24309705$1$I$20240101$20240829$20240912$20240912$PER$$US-SA-2024SA261842$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240912$$HP$US$US
243097061$24309706$1$I$20221001$20240830$20240912$20240912$PER$$US-SA-2024SA262366$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240912$$HP$US$US
243097071$24309707$1$I$20230706$20240905$20240912$20240912$EXP$$NVSC2024US011186$NOVARTIS$$35$YR$$F$Y$$$20240912$$CN$US$US
243097081$24309708$1$I$$20231115$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017464$STRIDES$Gandhi A, Mortensen M, Alsayed M, Targovnik JH, Vinales KL, Correa RR.. Hypomagnesemia-Induced Hypocalcemia Successfully Treated With Sodium-Glucose Cotransport Inhibitor (SGLT-2i), a Case Report.. J-Endocr-Soc. 2021;5 (Suppl. 1):A201$74$YR$$M$Y$$$20240912$$MD$US$US
243097091$24309709$1$I$$20231009$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2023SP015573$STRIDES$Bharathidasan K, Evans A, Fernandez FMAO, Motes AT, Nugent K.. Mitochondrial Myopathy in a 21-Year-Old  Man Presenting With Bilateral Lower  Extremity Weakness and Swelling. Journal of Primary Care + Community Health. 2023;14:1-8$21$YR$$M$Y$$$20240912$$HP$US$US
243097101$24309710$1$I$$20240123$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP001124$STRIDES$Bigelow C, Campbell A, Poulose A, Sannes H, Longtin C, Lynch-Salamon D, et al.. Cardio-Obstetrics Team-Based Management of a Pregnant Patient With Severe Bioprosthetic Aortic Valve Disease.. JACC-Case-Rep. 2024;29 (3)$38$YR$$F$Y$$$20240912$$MD$US$US
243097111$24309711$1$I$$20240905$20240912$20240912$EXP$$CA-ABBVIE-5915027$ABBVIE$$$$E$M$Y$$$20240912$$CN$CA$CA
243097121$24309712$1$I$20240620$20240904$20240912$20240912$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002280$Alvotech$$84$YR$$M$Y$$$20240912$$CN$CA$CA
243097131$24309713$1$I$20240820$20240905$20240912$20240912$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001986$Alvotech$$50$YR$$M$Y$$$20240912$$CN$CA$CA
243097151$24309715$1$I$$20240424$20240912$20240912$PER$US-MLMSERVICE-20240417-PI029213-00162-1$US-STRIDES ARCOLAB LIMITED-2024SP005097$STRIDES$Bartkowiak J, Lebehn MA, Kodali SK, George I, Hahn RT, Vahl TP.. Transesophageal Echocardiographic Planning and Neo-Left Ventricular Outflow Tract Assessment for Transcatheter Mitral Valve Implantation Using Novel Software.. CASE: Cardiovascular Imaging Case Reports.. 2024;8(4):292-5.$85$YR$$F$Y$$$20240912$$MD$US$US
243097162$24309716$2$F$20240101$20240906$20240912$20240916$EXP$$CA-CELLTRION INC.-2024CA021656$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
243097182$24309718$2$F$$20240917$20240912$20240925$EXP$$NVSC2024ZA180830$NOVARTIS$$38$YR$$F$Y$$$20240925$$HP$ZA$ZA
243097191$24309719$1$I$20240829$20240831$20240912$20240912$EXP$$US-Accord-445376$ACCORD$$68$YR$E$F$Y$$$20240912$$PH$US$US
243097201$24309720$1$I$$20240810$20240912$20240912$EXP$$AU-ALXN-202408OCE002257AU$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$MD$AU$AU
243097211$24309721$1$I$$20240910$20240912$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US079450$SANDOZ$$$$$$Y$$$20240912$$CN$US$US
243097222$24309722$2$F$20240908$20240917$20240912$20240918$PER$$US-AMGEN-USASP2024181345$AMGEN$$78$YR$E$F$Y$$$20240918$$CN$US$US
243097231$24309723$1$I$$20240910$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US074085$SANDOZ$$$$$M$Y$$$20240912$$CN$US$US
243097241$24309724$1$I$$20240905$20240912$20240912$EXP$$FR-AFSSAPS-AM20200368$Haleon PLC$$66$YR$$F$Y$65$KG$20240912$$MD$FR$FR
243097261$24309726$1$I$$20240902$20240912$20240912$EXP$$US-TEVA-VS-3240597$TEVA$Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.; Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang YH, et al. Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO-Precis-Oncol 2023; 7.$$$A$$Y$$$20240912$$HP$US$US
243097271$24309727$1$I$$20240828$20240912$20240912$EXP$$US-CIPLA LTD.-2024US09751$CIPLA$Haddad TC, Suman VJ, Giridhar KV, Sideras K, Northfelt DW, Ernst BJ et al. Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early-stage breast cancer: A prospective trial. Clinical Cancer Research. 2024;30:3147 to 3156$$$$$Y$$$20240912$$HP$US$US
243097283$24309728$3$F$$20240918$20240912$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004886$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243097292$24309729$2$F$$20240906$20240912$20240919$EXP$NL-LRB-00999478$NL-Accord-444925$ACCORD$$60$YR$A$M$Y$70$KG$20240919$$MD$NL$NL
243097301$24309730$1$I$$20240409$20240912$20240912$PER$$US-ENDO PHARMACEUTICALS INC-2024-001730$ENDO$$$$$F$Y$$$20240912$$CN$US$US
243097311$24309731$1$I$20240101$20240422$20240912$20240912$PER$$US-ENDO USA, INC.-2024-001929$ENDO$$$$$F$Y$$$20240912$$CN$US$US
243097321$24309732$1$I$$20230919$20240912$20240912$PER$$US-ENDO PHARMACEUTICALS INC-2023-005099$ENDO$$$$$M$Y$$$20240912$$CN$US$US
243097331$24309733$1$I$$20231009$20240912$20240912$PER$$US-ENDO PHARMACEUTICALS INC-2023-005332$ENDO$$$$$F$Y$$$20240912$$CN$US$US
243097341$24309734$1$I$$20240326$20240912$20240912$PER$$US-ENDO PHARMACEUTICALS INC-2022-001116$ENDO$$$$$M$Y$$$20240912$$CN$US$US
243097351$24309735$1$I$$20240612$20240912$20240912$PER$$US-ENDO USA, INC.-2024-002651$ENDO$$$$$F$Y$$$20240912$$CN$US$US
243097361$24309736$1$I$$20240905$20240912$20240912$EXP$$IE-AMGEN-IRLSP2024179514$AMGEN$$$$$F$Y$$$20240911$$HP$IE$IE
243097371$24309737$1$I$20230101$20231005$20240912$20240912$PER$$US-ENDO PHARMACEUTICALS INC-2023-005313$ENDO$$$$$M$Y$$$20240912$$CN$US$US
243097381$24309738$1$I$$20240907$20240912$20240912$EXP$$US-AMGEN-USASP2024179536$AMGEN$$$$$M$Y$$$20240911$$MD$US$US
243097391$24309739$1$I$$20240906$20240912$20240912$EXP$$ZA-AstraZeneca-2024A204452$ASTRAZENECA$$74$YR$$M$Y$$$20240912$$CN$ZA$
243097402$24309740$2$F$$20240912$20240912$20240917$EXP$$US-AstraZeneca-2024A205209$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243097411$24309741$1$I$$20240903$20240912$20240912$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024109543$VIIV$$$$$$Y$$$20240912$$MD$US$US
243097421$24309742$1$I$$20240830$20240912$20240912$EXP$$CA-AUROBINDO-AUR-APL-2024-044668$AUROBINDO$$44$YR$$F$Y$70$KG$20240912$$HP$CA$CA
243097431$24309743$1$I$$20240827$20240912$20240912$PER$$US-SA-2024SA259217$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240912$$CN$US$US
243097441$24309744$1$I$20240815$20240829$20240912$20240912$PER$$US-SA-2024SA253354$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240912$$CN$US$US
243097451$24309745$1$I$$20240906$20240912$20240912$EXP$$US-BEIGENE-BGN-2024-014318$BEIGENE$$$$$$Y$$$20240912$$PH$US$US
243097462$24309746$2$F$20230101$20240911$20240912$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005035$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243097471$24309747$1$I$$20240905$20240912$20240912$PER$$US-ROCHE-10000074600$ROCHE$Macit B, Arora A, Reginato A, Qureshi A. Cerebral toxoplasmosis in a patient with systemic sclerosis under thalidomide treatment: A case report. JAAD Case Reports. 2024-Sep;51:100-3. doi:10.1016/j.jdcr.2024.03.009.$49$YR$A$F$Y$$$20240912$$MD$US$US
243097482$24309748$2$F$20240101$20240903$20240912$20240913$EXP$$US-UCBSA-2024032968$UCB$$$$$M$Y$$$20240913$$HP$US$US
243097501$24309750$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004871$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243097511$24309751$1$I$20240830$20240903$20240912$20240912$PER$$US-SA-2024SA103559$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240912$$MD$US$US
243097521$24309752$1$I$20240830$20240831$20240912$20240912$EXP$$US-Accord-445377$ACCORD$$23$YR$A$M$Y$$$20240912$$PH$US$US
243097531$24309753$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004873$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243097543$24309754$3$F$20240801$20240917$20240912$20240923$EXP$$CA-JNJFOC-20240918636$JOHNSON AND JOHNSON$$10$YR$C$M$Y$32$KG$20240923$$PH$CA$CA
243097551$24309755$1$I$$20240902$20240912$20240912$EXP$$US-MSNLABS-2024MSNLIT01920$MSN LABORATORIES$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D,Yue A,Rizvi A, Salgia R.Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.Cancer Immunology, Immunotherapy.2024;73:200$$$$$Y$$$20240912$$HP$US$US
243097562$24309756$2$F$20240827$20240920$20240912$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027800$UNITED THERAPEUTICS$$63$YR$$F$Y$79.819$KG$20240928$$$US$US
243097571$24309757$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004874$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243097591$24309759$1$I$20240818$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007202$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
243097601$24309760$1$I$20240801$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006629$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240912$$PH$US$US
243097621$24309762$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004878$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243097631$24309763$1$I$$20240909$20240912$20240912$EXP$$DE-AUROBINDO-AUR-APL-2024-044796$AUROBINDO$Heinig-Menhard, K. Tuberculosis in the intensive care unit: When to think about it - how to treat it?.. Intensivmedizin up2date. 2024;20(03):325 - 340$20$YR$$M$Y$$$20240912$$HP$DE$DE
243097641$24309764$1$I$20240101$20240823$20240912$20240912$PER$$US-SA-2024SA259042$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240912$$MD$US$US
243097651$24309765$1$I$20240101$20240828$20240912$20240912$PER$$US-SA-2024SA260019$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240912$$MD$US$US
243097662$24309766$2$F$20240101$20240904$20240912$20240917$EXP$$US-UCBSA-2024045354$UCB$$$$$F$Y$$$20240917$$HP$US$US
243097671$24309767$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA262031$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240912$$HP$US$US
243097692$24309769$2$F$$20240909$20240912$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US079355$SANDOZ$$$$$F$Y$$$20240912$$CN$US$US
243097701$24309770$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004854$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243097711$24309771$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004859$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243097721$24309772$1$I$$20240909$20240912$20240912$PER$$US-AstraZeneca-2024A205643$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243097731$24309773$1$I$$20240909$20240912$20240912$PER$$US-AstraZeneca-2024A205558$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243097741$24309774$1$I$$20240905$20240912$20240912$EXP$$US-AstraZeneca-2024A202991$ASTRAZENECA$$$$T$F$Y$71.7$KG$20240912$$CN$US$
243097751$24309775$1$I$$20240906$20240912$20240912$EXP$$US-AstraZeneca-2024A204436$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243097761$24309776$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA262281$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240912$$MD$US$US
243097771$24309777$1$I$20240101$20240902$20240912$20240912$PER$$US-SA-2024SA260453$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240912$$HP$US$US
243097781$24309778$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA262136$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240912$$HP$US$US
243097791$24309779$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004860$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243097802$24309780$2$F$20240101$20240909$20240912$20240916$PER$$US-AMGEN-USASP2024181026$AMGEN$$55$YR$A$F$Y$$$20240916$$HP$US$US
243097811$24309781$1$I$$20240906$20240912$20240912$PER$$US-ABBVIE-5916311$ABBVIE$$39$YR$$F$Y$$$20240912$$HP$US$US
243097821$24309782$1$I$$20240905$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142844$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$63.5$KG$20240912$$CN$US$US
243097831$24309783$1$I$20240829$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145019$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$84.82$KG$20240912$$PH$US$US
243097841$24309784$1$I$$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143395$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$75$KG$20240912$$PH$US$US
243097851$24309785$1$I$$20240909$20240912$20240912$EXP$$CA-SANDOZ INC.-NVSC2018CA020161$SANDOZ$$53$YR$$F$Y$$$20240912$$MD$CA$CA
243097861$24309786$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004852$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243097871$24309787$1$I$$20240909$20240912$20240912$EXP$$CA-JNJFOC-20240924004$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$HP$CA$CA
243097881$24309788$1$I$$20240902$20240912$20240912$EXP$$US-AUROBINDO-AUR-APL-2024-044310$AUROBINDO$Bains S, Garmany R, Neves R, Giudicessi JR, Gao X, Tester DJ, et al.. Temporal Association Between Vaping and Risk of Cardiac Events.. Mayo-Clin-Proc. 2024;99(2):241-248$21$YR$$F$Y$$$20240912$$HP$US$US
243097891$24309789$1$I$$20240903$20240912$20240912$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR113026$VIIV$$$$$$Y$$$20240912$$HP$US$US
243097901$24309790$1$I$20240819$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004827$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243097911$24309791$1$I$20240601$20240828$20240912$20240912$EXP$$US-MDD US Operations-MDD202406-002104$MDD OPERATIONS$$76$YR$$F$Y$$$20240912$$CN$US$
243097921$24309792$1$I$20240601$20240904$20240912$20240912$PER$$US-BIOGEN-2024BI01281291$BIOGEN$$66$YR$$F$Y$$$20240912$$CN$US$US
243097931$24309793$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004831$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243097941$24309794$1$I$$20240903$20240912$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143054$BRISTOL MYERS SQUIBB$Kuboi T, Nakajima D, Saito M, Sakane H, Tsukuda H. A case of lateral collateral ligament injury developing after multiple doses of local steroid injections for lateral humeral epicondylitis. Kanto Journal of Orthopedics and Traumatology. 2024;(55): 215.$49$YR$A$F$Y$$$20240912$$MD$JP$JP
243097952$24309795$2$F$$20240917$20240912$20240926$EXP$$US-TEVA-VS-3240299$TEVA$Blackwell JN, Estes NAM, Shalaby AA. Help from the little guy: Intramural ischemic ventricular tachycardia ablation leveraging a 2F multipolar catheter in a coronary vein. HeartRhythm-Case-Rep 2024; 10 (8): 595-599.; Blackwell JN, Estes NAM, Shalaby AA. Help from the little guy: Intramural ischemic ventricular tachycardia ablation leveraging a 2F multipolar catheter in a coronary vein. HeartRhythm-Case-Rep 2024; 10 (8): 595-599.; Blackwell JN, Estes NAM, Shalaby AA. Help from the little guy: ...$68$YR$$M$Y$$$20240926$$MD$US$US
243097961$24309796$1$I$20240823$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142855$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240912$$HP$US$US
243097971$24309797$1$I$$20240902$20240912$20240912$EXP$$US-AUROBINDO-AUR-APL-2024-044540$AUROBINDO$Haidry A, Kabra N, Bhinder J, Gass A. UTILIZING ECMO FOR RECURRENT IDIOPATHIC VENTRICULAR FIBRILLATION. J-Am-Coll-Cardiol. 2019;73 (Suppl.)(9):2598$44$YR$$F$Y$$$20240912$$HP$US$US
243097981$24309798$1$I$20240101$20240906$20240912$20240912$PER$$US-ABBVIE-5915973$ABBVIE$$29$YR$$$Y$$$20240912$$CN$US$US
243097991$24309799$1$I$$20240907$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US079079$SANDOZ$$$$$$Y$$$20240912$$CN$US$US
243098001$24309800$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144125$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$63.5$KG$20240912$$HP$US$US
243098011$24309801$1$I$$20240910$20240912$20240912$PER$$US-ROCHE-10000079238$ROCHE$$$$$M$Y$$$20240912$$CN$US$US
243098021$24309802$1$I$$20240906$20240912$20240912$PER$$US-AMGEN-USASP2024179352$AMGEN$Newman N.; Garcia M.; Ayele F. et al.. Cardiac sarcoidosis manifesting with atrioventricular block and intracardiac masses: case report and literature review. European Heart Journal - Case Reports. 2024;8 (8):1-6$45$YR$A$F$Y$$$20240911$$HP$US$US
243098031$24309803$1$I$20240909$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181287$AMGEN$$66$YR$E$F$Y$$$20240911$$CN$US$US
243098041$24309804$1$I$$20240902$20240912$20240912$EXP$$ES-AUROBINDO-AUR-APL-2024-044494$AUROBINDO$Ra?l J. Andrade, M. Isabel Lucena, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al.. Evaluation of diagnostic and prognostic candidate biomarkers in druginduced liver injury vs. other forms of acute liver damage. BrJ-Clin-Pharmacol. 2023;89 (8):2497-2507$58$YR$$M$Y$$$20240912$$HP$ES$ES
243098061$24309806$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004861$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243098081$24309808$1$I$20240601$20240906$20240912$20240912$EXP$$US-AstraZeneca-2024A203900$ASTRAZENECA$$925$MON$$F$Y$$$20240912$$MD$US$
243098091$24309809$1$I$$20240909$20240912$20240912$EXP$$US-AstraZeneca-2024A205819$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243098101$24309810$1$I$$20240906$20240912$20240912$EXP$$US-AstraZeneca-2024A204797$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243098111$24309811$1$I$$20240903$20240912$20240912$EXP$$NL-AUROBINDO-AUR-APL-2024-044374$AUROBINDO$$58$YR$$F$Y$74$KG$20240912$$CN$NL$NL
243098121$24309812$1$I$$20240909$20240912$20240912$PER$$US-AstraZeneca-2024A205380$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243098131$24309813$1$I$$20240907$20240912$20240912$EXP$$US-AstraZeneca-2024A205113$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243098141$24309814$1$I$$20240910$20240912$20240912$EXP$$US-AstraZeneca-2024A206588$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243098151$24309815$1$I$$20240905$20240912$20240912$EXP$$GB-AstraZeneca-2024A202434$ASTRAZENECA$$$$$F$Y$81$KG$20240912$$MD$GB$
243098161$24309816$1$I$$20240819$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004844$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243098171$24309817$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006315$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240912$$CN$US$US
243098181$24309818$1$I$20240501$20240904$20240912$20240912$EXP$$CA-APOTEX-2024AP010306$APOTEX$$52$YR$A$F$Y$$$20240912$$MD$CA$CA
243098191$24309819$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024179884$AMGEN$$$$$$Y$$$20240911$$CN$US$US
243098201$24309820$1$I$$20240904$20240912$20240912$EXP$$VN-SANDOZ INC.-SDZ2024VN079568$SANDOZ$Phan PD. Ket Qua Dieu Tri Sarcoma Xuong Giai Doan Ii Bang Hoa Chat Phac Do Map Bo Tro Truoc Phau Thuat Tai Benh Vien K [The efficacy of map neoadjuvant chemotherapy in patients with stage II osteosarcoma]. VIETNAM MEDICAL JOURNAL. 2022;519 (2):4-8$$$$$Y$$$20240912$$HP$VN$VN
243098211$24309821$1$I$20240422$20240830$20240912$20240912$EXP$$DE-AMGEN-DEUSP2024179664$AMGEN$$51$YR$A$M$Y$$$20240911$$HP$DE$DE
243098221$24309822$1$I$$20240903$20240912$20240912$EXP$$IN-ROCHE-3533989$ROCHE$$75$YR$E$M$Y$$$20240912$$CN$IN$IN
243098231$24309823$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004846$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243098241$24309824$1$I$$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144687$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240912$$CN$US$US
243098252$24309825$2$F$$20240911$20240912$20240917$30DAY$$US-SANDOZ INC.-SDZ2024US078962$SANDOZ$$$$$M$Y$$$20240917$$CN$US$US
243098261$24309826$1$I$20240829$20240903$20240912$20240912$PER$$US-JNJFOC-20240904186$JOHNSON AND JOHNSON$$26$YR$A$$Y$$$20240912$$CN$US$US
243098281$24309828$1$I$$20240903$20240912$20240912$PER$$US-ROCHE-10000073561$ROCHE$$86$YR$E$M$Y$$$20240912$$CN$US$US
243098291$24309829$1$I$$20240910$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA079271$SANDOZ$$$$$F$Y$$$20240912$$CN$CA$CA
243098302$24309830$2$F$$20240917$20240912$20240921$PER$$US-ROCHE-10000074877$ROCHE$$77$YR$E$M$Y$$$20240921$$CN$US$US
243098311$24309831$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004848$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243098321$24309832$1$I$20240101$20240906$20240912$20240912$PER$$US-BEH-2024178394$CSL BEHRING$$$$$F$Y$$$20240912$$CN$US$US
243098331$24309833$1$I$20230119$20240903$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044391$AUROBINDO$$52$YR$$F$Y$83$KG$20240912$$PH$FR$FR
243098341$24309834$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004863$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243098351$24309835$1$I$20240101$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024180960$AMGEN$$81$YR$E$F$Y$$$20240911$$CN$US$US
243098361$24309836$1$I$$20240903$20240912$20240912$PER$$US-PROD-AS2-212756134-RB-086451-2024$RECKITT BENCKISER$$75$YR$$F$Y$$$20240912$$CN$US$US
243098371$24309837$1$I$$20240904$20240912$20240912$PER$$US-ROCHE-10000074392$ROCHE$$$$$$Y$$$20240912$$CN$US$US
243098391$24309839$1$I$$20240905$20240912$20240912$PER$$US-ABBVIE-5918751$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243098401$24309840$1$I$20220601$20240905$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143179$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$CN$US$US
243098411$24309841$1$I$$20240903$20240912$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143512$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240912$$PH$JP$JP
243098421$24309842$1$I$20240101$20240903$20240912$20240912$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000767$DECIPHERA PHARMACEUTICALS$$68$YR$A$M$Y$$$20240912$$CN$US$US
243098431$24309843$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004864$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243098452$24309845$2$F$20240719$20240912$20240912$20240921$EXP$$BR-CELLTRION INC.-2024BR021425$CELLTRION$$$$$$Y$$$20240921$$CN$BR$BR
243098461$24309846$1$I$$20240909$20240912$20240912$PER$$US-TAKEDA-2024TUS090464$TAKEDA$$$$$F$Y$$$20240912$$PH$US$US
243098471$24309847$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004795$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243098481$24309848$1$I$$20240903$20240912$20240912$EXP$$GB-CELLTRION INC.-2024GB021384$CELLTRION$$$$$$Y$$$20240912$$HP$GB$GB
243098491$24309849$1$I$20240101$20240904$20240912$20240912$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000772$DECIPHERA PHARMACEUTICALS$$65$YR$A$F$Y$$$20240912$$CN$US$US
243098502$24309850$2$F$$20240901$20240912$20240912$EXP$$IN-HETERO-HET2024IN02993$HETERO$Kotla R, Borkar S,  Aloney S.. Late-Onset Angioedema with Olanzapine in a Tertiary Hospital. Cureus. 2024;16(7):1-5$25$YR$$F$Y$$$20240910$$HP$IN$IN
243098511$24309851$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004867$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243098521$24309852$1$I$$20240909$20240912$20240912$EXP$$US-JNJFOC-20240923126$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$LW$US$US
243098541$24309854$1$I$20240815$20240819$20240912$20240912$PER$$US-GLK-002373$GLAUKOS$$76$YR$$F$Y$$$20240912$$MD$US$US
243098551$24309855$1$I$20240829$20240909$20240912$20240912$PER$$US-ABBVIE-5918619$ABBVIE$$33$YR$$$Y$$$20240912$$MD$US$US
243098562$24309856$2$F$$20240904$20240912$20240913$PER$$US-AstraZeneca-2024A203344$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243098571$24309857$1$I$$20240903$20240912$20240912$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR113022$VIIV$$$$$$Y$$$20240912$$HP$US$US
243098583$24309858$3$F$20240101$20240911$20240912$20240917$PER$$US-AMGEN-USASP2024181249$AMGEN$$74$YR$E$F$Y$$$20240916$$CN$US$US
243098591$24309859$1$I$20240813$20240904$20240912$20240912$PER$$US-ROCHE-10000074349$ROCHE$$$$$$Y$$$20240912$$PH$US$US
243098601$24309860$1$I$20230204$20240907$20240912$20240912$EXP$$GB-AstraZeneca-2024A203755$ASTRAZENECA$$76$YR$$M$Y$68$KG$20240912$$MD$GB$
243098631$24309863$1$I$$20240906$20240912$20240912$PER$$US-AMGEN-USASP2024180391$AMGEN$$$$$$Y$$$20240911$$PH$US$US
243098641$24309864$1$I$20240828$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180098$AMGEN$$79$YR$E$M$Y$$$20240911$$CN$US$US
243098651$24309865$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004853$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243098661$24309866$1$I$$20240904$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044703$AUROBINDO$Gouillon L, Debarbieux S, Berruyer M, Fabien N, Lega JC, Thomas L. Chilblain lupus erythematosus treated successfully with mycophenolate mofetil. International Journal of Dermatology. 2017;56(8):158-159$22$YR$$F$Y$$$20240912$$MD$FR$FR
243098671$24309867$1$I$20240626$20240817$20240912$20240912$EXP$ES-AEMPS-1561567$ES-HETERO-AMR2024ES02753$HETERO$$52$YR$$M$Y$$$20240826$$MD$ES$ES
243098682$24309868$2$F$$20240910$20240912$20240921$EXP$$DE-AMAROX PHARMA-AMR2024DE02934$HETERO$Gallinger A, Osei-Davies R, Hennersdorf F. Reversibility of critical intra-ventricular conduction delay under flecainide and lacosamide by sodium bicarbonate. Innere Medizin. 2024;1-7$$$$F$Y$$$20240921$$HP$DE$DE
243098691$24309869$1$I$20231201$20240826$20240912$20240912$EXP$$DE-AMAROX PHARMA-AMR2024DE02848$HETERO$$$$$F$Y$2.6$KG$20240903$$MD$DE$DE
243098701$24309870$1$I$20240612$20240823$20240912$20240912$EXP$ES-AEMPS-1563194$ES-AMAROX PHARMA-AMR2024ES02830$HETERO$$91$YR$$F$Y$$$20240902$$MD$ES$ES
243098711$24309871$1$I$$20240826$20240912$20240912$EXP$$DE-AMAROX PHARMA-AMR2024DE02849$HETERO$$$$$$Y$$$20240906$$MD$DE$DE
243098721$24309872$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005735$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240912$$CN$US$US
243098731$24309873$1$I$20240907$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005417$ELI LILLY AND CO$$41$YR$A$$Y$$$20240912$$CN$US$US
243098741$24309874$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006675$ELI LILLY AND CO$$57$YR$A$$Y$$$20240912$$CN$US$US
243098752$24309875$2$F$20240910$20240913$20240912$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409006599$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240917$$CN$US$US
243098761$24309876$1$I$20240701$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006643$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240912$$CN$US$US
243098771$24309877$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006323$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240912$$CN$US$US
243098781$24309878$1$I$20240904$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006437$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240912$$CN$US$US
243098791$24309879$1$I$$20240906$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004570$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240912$$CN$US$US
243098801$24309880$1$I$$20240828$20240912$20240912$EXP$$ES-HETERO-AMR2024ES02868$HETERO$Sanchez EC. Elena Canadillas Sanchez.. Sindrome Rhupus: a proposito deun caso. Revista Electronica de PortalesMedicos. 2024;XIX (14):476$78$YR$$M$Y$$$20240909$$MD$ES$ES
243098811$24309881$1$I$20240601$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004797$ACADIA PHARMACEUTICALS$$86$YR$$F$Y$$$20240912$$CN$US$US
243098821$24309882$1$I$$20240909$20240912$20240912$PER$$US-ABBVIE-5916032$ABBVIE$$$$$M$Y$$$20240912$$HP$US$US
243098831$24309883$1$I$20240101$20240821$20240912$20240912$PER$$US-SA-2024SA262342$SANOFI AVENTIS$$58$YR$A$M$Y$86.36$KG$20240912$$MD$US$US
243098841$24309884$1$I$$20240827$20240912$20240912$PER$$US-ASTELLAS-2024-AER-003519$ASTELLAS$$$$$F$Y$$$20240912$$HP$US$US
243098851$24309885$1$I$$20240820$20240912$20240912$PER$$US-SA-2024SA261864$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$MD$US$US
243098861$24309886$1$I$20240101$20240823$20240912$20240912$PER$$US-SA-2024SA259412$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240912$$HP$US$US
243098872$24309887$2$F$$20240911$20240912$20240921$EXP$$US-HETERO-HET2024US02902$HETERO$$55$YR$$$Y$$$20240921$$CN$US$US
243098881$24309888$1$I$20240701$20240823$20240912$20240912$EXP$GB-MHRA-MED-202408231439294480-JKGRB$GB-AMAROX PHARMA-AMR2024GB02837$HETERO$$32$YR$$F$Y$$$20240831$$MD$GB$GB
243098891$24309889$1$I$20240624$20240826$20240912$20240912$EXP$GB-MHRA-MED-202408261330327800-LHBSQ$GB-HETERO-AMR2024GB02855$HETERO$$76$YR$$F$Y$$$20240906$$CN$GB$GB
243098901$24309890$1$I$20240101$20240828$20240912$20240912$PER$$US-SA-2024SA262843$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240912$$MD$US$US
243098911$24309891$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA260396$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240912$$HP$US$US
243098921$24309892$1$I$20240801$20240828$20240912$20240912$PER$$US-SA-2024SA258886$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240912$$MD$US$US
243098931$24309893$1$I$20240101$20240830$20240912$20240912$PER$$US-SA-2024SA261733$SANOFI AVENTIS$$$$A$M$Y$$$20240912$$MD$US$US
243098941$24309894$1$I$20240801$20240904$20240912$20240912$PER$$US-SA-2024SA261799$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240912$$MD$US$US
243098961$24309896$1$I$$20240828$20240912$20240912$EXP$$GB-AMAROX PHARMA-AMR2024GB02904$HETERO$$$$$$Y$$$20240909$$CN$GB$GB
243098972$24309897$2$F$$20240911$20240912$20240913$PER$$NVSC2024US182443$NOVARTIS$$$$$$Y$$$20240913$$HP$US$US
243098981$24309898$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004796$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243098991$24309899$1$I$20240813$20240813$20240912$20240912$PER$$US-ASTELLAS-2024-AER-000152$ASTELLAS$$$$$M$Y$$$20240912$$HP$US$US
243099001$24309900$1$I$$20240826$20240912$20240912$EXP$$US-HETERO-HET2024US02303$HETERO$$$$$$Y$$$20240902$$CN$US$US
243099012$24309901$2$F$$20240909$20240912$20240921$EXP$$IN-HETERO-HET2024IN02881$HETERO$Anandan S, Rajendran SS, Somarajan SA, Udayan A. A Very Rare Side Effect of a Very Commonly Used Drug: Pantoprazole-induced Seizure. The Journal of the Association of  Physicians of India. 2024;72(8):89$69$YR$$F$Y$$$20240921$$MD$IN$IN
243099021$24309902$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004799$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243099031$24309903$1$I$$20230921$20240912$20240912$PER$$US-AUROBINDO-AUR-APL-2023-051946$AUROBINDO$$$$$$Y$$$20240912$$CN$US$US
243099041$24309904$1$I$$20240616$20240912$20240912$PER$$US-AUROBINDO-AUR-APL-2024-030763$AUROBINDO$$$$$M$Y$$$20240912$$CN$US$US
243099051$24309905$1$I$$20240109$20240912$20240912$PER$$US-AUROBINDO-AUR-APL-2023-074603$AUROBINDO$$$$$$Y$$$20240912$$PH$US$US
243099061$24309906$1$I$$20240321$20240912$20240912$PER$$US-AUROBINDO-AUR-APL-2024-006686$AUROBINDO$$$$$F$Y$$$20240912$$CN$US$US
243099071$24309907$1$I$20230925$20231212$20240912$20240912$PER$$US-AUROBINDO-AUR-APL-2023-079290$AUROBINDO$$69$YR$$M$Y$62.5$KG$20240912$$CN$US$US
243099082$24309908$2$F$$20240919$20240912$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004798$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243099091$24309909$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024181098$AMGEN$$$$$$Y$$$20240911$$CN$US$US
243099101$24309910$1$I$$20240815$20240912$20240912$EXP$$US-HETERO-HET2024US02730$HETERO$$$$$F$Y$$$20240822$$CN$US$US
243099111$24309911$1$I$$20231121$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086830$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099121$24309912$1$I$$20240815$20240912$20240912$EXP$$US-HETERO-HET2024US02737$HETERO$$$$$M$Y$70.3$KG$20240823$$CN$US$US
243099131$24309913$1$I$$20240910$20240912$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US079364$SANDOZ$$$$$M$Y$$$20240912$$HP$US$US
243099141$24309914$1$I$$20240403$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089929$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099151$24309915$1$I$$20240701$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092105$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099161$24309916$1$I$$20240529$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090846$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099171$24309917$1$I$$20240408$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090245$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099181$24309918$1$I$$20240516$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090924$GLENMARK$$$$$$Y$$$20240910$$PH$US$US
243099191$24309919$1$I$$20240131$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088791$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099201$24309920$1$I$$20240212$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088378$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099211$24309921$1$I$$20231009$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK085967$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099221$24309922$1$I$$20231106$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK086367$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099231$24309923$1$I$20230701$20230724$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK083800$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099241$24309924$1$I$$20240221$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089102$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099251$24309925$1$I$$20240119$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088635$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099261$24309926$1$I$$20240307$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089327$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099271$24309927$1$I$$20240312$20240912$20240912$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089428$GLENMARK$$$$$$Y$$$20240910$$CN$US$US
243099281$24309928$1$I$$20240818$20240912$20240912$EXP$$US-HETERO-HET2024US02767$HETERO$$$$$M$Y$71.655$KG$20240826$$CN$US$US
243099291$24309929$1$I$20240101$20240829$20240912$20240912$EXP$$US-UCBSA-2024044429$UCB$$$$$M$Y$$$20240912$$CN$US$US
243099303$24309930$3$F$20240815$20240912$20240912$20240921$EXP$$US-HETERO-HET2024US02777$HETERO$$72$YR$$M$Y$92.2$KG$20240921$$PH$US$US
243099311$24309931$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004802$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243099321$24309932$1$I$20230412$20240909$20240912$20240912$EXP$SE-SEMPA-2024-006459$SE-ORGANON-O2409SWE000669$ORGANON$$78$YR$$F$Y$55$KG$20240912$$MD$SE$SE
243099331$24309933$1$I$$20240818$20240912$20240912$EXP$$US-HETERO-HET2024US02783$HETERO$Khachatryan A, Brilliant J, Batikyan A, Dickfeld T, Sargsyan M-et.al. Titin Cardiomyopathy Associated With Refractory Ventricular Tachycardia: A Case Report. Cureus. 2024;16(7):e64476$23$YR$$M$Y$$$20240827$$HP$US$US
243099341$24309934$1$I$$20240820$20240912$20240912$EXP$$US-HETERO-HET2024US02822$HETERO$$$$$$Y$$$20240829$$CN$US$US
243099351$24309935$1$I$20240805$20240819$20240912$20240912$EXP$$US-HETERO-HET2024US02780$HETERO$$73$YR$$F$Y$47.619$KG$20240828$$CN$US$US
243099361$24309936$1$I$20240823$20240904$20240912$20240912$EXP$$CN-BEIGENE-BGN-2024-014024$BEIGENE$$$$$$Y$$$20240912$$HP$CN$CN
243099371$24309937$1$I$$20240905$20240912$20240912$EXP$$JP-009507513-2409JPN000960J$MERCK$$8$DEC$$F$Y$$$20240912$$MD$JP$JP
243099381$24309938$1$I$20240817$20240831$20240912$20240912$EXP$FR-AFSSAPS-MA2024001415$FR-Accord-445208$ACCORD$$87$YR$E$F$Y$$$20240912$$MD$FR$FR
243099391$24309939$1$I$$20240820$20240912$20240912$EXP$$US-AMAROX PHARMA-HET2024US02829$HETERO$$$$$F$Y$$$20240829$$CN$US$US
243099402$24309940$2$F$$20240912$20240912$20240921$EXP$$US-HETERO-HET2024US02826$HETERO$$$$$$Y$$$20240921$$CN$US$US
243099411$24309941$1$I$$20240821$20240912$20240912$EXP$$US-HETERO-HET2024US02825$HETERO$$$$$M$Y$120$KG$20240830$$CN$US$US
243099433$24309943$3$F$20240820$20240909$20240912$20240918$EXP$$US-HETERO-HET2024US02844$HETERO$$86$YR$$M$Y$70.3$KG$20240918$$CN$US$US
243099441$24309944$1$I$20240823$20240826$20240912$20240912$EXP$$US-HETERO-HET2024US02860$HETERO$$73$YR$$F$Y$$$20240905$$CN$US$US
243099452$24309945$2$F$20240808$20240909$20240912$20240917$EXP$FR-AFSSAPS-BX2024001751$FR-JNJFOC-20240927749$JOHNSON AND JOHNSON$$75$YR$E$F$Y$55$KG$20240917$$MD$FR$FR
243099462$24309946$2$F$$20240829$20240912$20240913$EXP$$US-HETERO-HET2024US02861$HETERO$$$$$M$Y$$$20240913$$CN$US$US
243099471$24309947$1$I$20180606$20191023$20240912$20240912$EXP$$JP-GSK-JP2018JPN155408$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$JP$JP
243099481$24309948$1$I$$20240826$20240912$20240912$EXP$$US-HETERO-HET2024US02883$HETERO$Sterina E.. COGNITIVE DECLINE IN OLDER ADULTS WITH SCHIZOPHRENIA-BIPOLAR SPECTRUM DISORDER. The American Journal of Geriatric Psychiatry. 2024;32(4):S36-37$$$$M$Y$$$20240906$$MD$US$US
243099491$24309949$1$I$20240816$20240906$20240912$20240912$EXP$$CN-AstraZeneca-2024A204241$ASTRAZENECA$$74$YR$$F$Y$40$KG$20240912$$MD$CN$
243099501$24309950$1$I$$20240905$20240912$20240912$EXP$$US-AstraZeneca-2024A202679$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243099512$24309951$2$F$$20240919$20240912$20240927$EXP$$US-HETERO-HET2024US02901$HETERO$$$$$M$Y$$$20240927$$CN$US$US
243099521$24309952$1$I$$20240827$20240912$20240912$EXP$$US-AMAROX PHARMA-HET2024US02888$HETERO$Rink DE, Abramson RH, Johnson NJ, Lee RY.. Diagnostic Confounders in Brain Death A Woman  with Unexplained Coma and Brainstem Areflexia. Annals of the American Thoracic Society. 2024;21(8):1204-8$60$YR$$F$Y$$$20240906$$MD$US$US
243099542$24309954$2$F$20240828$20240911$20240912$20240921$EXP$$US-HETERO-HET2024US02905$HETERO$$83$YR$$M$Y$73.48$KG$20240921$$CN$US$US
243099552$24309955$2$F$$20240919$20240912$20240926$EXP$$US-HETERO-HET2024US02932$HETERO$$$$$M$Y$219$KG$20240926$$CN$US$US
243099561$24309956$1$I$$20240827$20240912$20240912$PER$$US-ASTELLAS-2024-AER-003329$ASTELLAS$$$$$F$Y$$$20240912$$MD$US$US
243099572$24309957$2$F$$20240919$20240912$20240927$EXP$$US-HETERO-HET2024US02940$HETERO$$$$$F$Y$$$20240927$$CN$US$US
243099581$24309958$1$I$$20240826$20240912$20240912$EXP$$US-HETERO-HET2024US02887$HETERO$Peshin S, Modi SK, Burwick N.. Lenalidomide and Dexamethasone in Scleromyxedema: A Case Report of Long-Term Efficacy and Challenges in a 54-Year-Old Patient.. cureus. 2024;16(6):1-15$$$A$M$Y$$$20240906$$MD$US$US
243099591$24309959$1$I$$20240819$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004810$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243099602$24309960$2$F$$20240913$20240912$20240923$EXP$$US-HETERO-HET2024US02952$HETERO$$$$$$Y$$$20240923$$HP$US$US
243099611$24309961$1$I$$20240829$20240912$20240912$EXP$$US-HETERO-HET2024US02941$HETERO$$$$$M$Y$$$20240909$$CN$US$US
243099622$24309962$2$F$$20240831$20240912$20240912$EXP$$US-HETERO-HET2024US02943$HETERO$$$$$F$Y$$$20240912$$CN$US$US
243099631$24309963$1$I$20230301$20240902$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044399$AUROBINDO$Roussot N, Thibaudin M, Fumet JD, Daumoine S, Hampe L, Rebe C, et al. Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC. Frontiers in Immunology. 2024;15$$$A$F$Y$$$20240912$$HP$FR$FR
243099642$24309964$2$F$20240801$20240914$20240912$20240924$EXP$$US-HETERO-HET2024US02959$HETERO$$14$YR$$M$Y$56.6$KG$20240924$$CN$US$US
243099651$24309965$1$I$20220101$20240829$20240912$20240912$EXP$$US-UCBSA-2024044414$UCB$$$$$M$Y$116.96$KG$20240912$$HP$US$US
243099661$24309966$1$I$$20240901$20240912$20240912$EXP$$US-AMAROX PHARMA-HET2024US03018$HETERO$Au-Yeung NM, Regennitter NS, Stepherson J, Seele J, Rosenblatt E, Carter W.. Folate Deficiency and Medication-Induced Severe Pancytopenia in a Bilateral Lung Transplantee. Cureus.. 2024;16(7):1-8$74$YR$$M$Y$$$20240910$$HP$US$US
243099671$24309967$1$I$$20240903$20240912$20240912$PER$$US-APOTEX-2024AP010262$APOTEX$$$$E$M$Y$$$20240912$$CN$US$US
243099682$24309968$2$F$20240827$20240906$20240912$20240912$EXP$$US-AMGEN-USASP2024179503$AMGEN$$$$E$$Y$$$20240912$$PH$US$US
243099691$24309969$1$I$$20240902$20240912$20240912$EXP$$US-AUROBINDO-AUR-APL-2024-044704$AUROBINDO$Sorunke A, Pinto C, Saleem MD, Tahir F. Mixed Cryoglobulinemia Syndrome Associated with Non-HCV B-Cell Lymphoproliferative Disorder Presenting with Gangrene and Peripheral Neuropathy. R I Med J. 2024$64$YR$$F$Y$$$20240912$$HP$US$US
243099701$24309970$1$I$20240805$20240910$20240912$20240912$EXP$$SE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050806$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240912$$MD$SE$SE
243099711$24309971$1$I$$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144566$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240912$$CN$US$US
243099721$24309972$1$I$$20240904$20240912$20240912$EXP$$ES-CELLTRION INC.-2024ES021424$CELLTRION$$$$$$Y$$$20240912$$MD$ES$ES
243099731$24309973$1$I$$20240905$20240912$20240912$EXP$$US-TAKEDA-2024TUS067790$TAKEDA$$$$$M$Y$$$20240912$$CN$US$US
243099741$24309974$1$I$$20230418$20240912$20240912$EXP$$IE-ROCHE-10000078548$ROCHE$$$$$$Y$$$20240912$$HP$IE$IE
243099751$24309975$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006391$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240912$$CN$US$US
243099761$24309976$1$I$20240801$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006583$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240912$$CN$US$US
243099771$24309977$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006502$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240912$$CN$US$US
243099781$24309978$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006590$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240912$$CN$US$US
243099791$24309979$1$I$$20240605$20240912$20240912$EXP$$GB-ROCHE-10000077203$ROCHE$$$$$F$Y$$$20240912$$CN$GB$GB
243099801$24309980$1$I$$20240902$20240912$20240912$EXP$$US-AUROBINDO-AUR-APL-2024-002531$AUROBINDO$Reinfeld S, Gill P. Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: A case series.. CNS Spectrums. 2023;28(5):587-91$15$YR$$M$Y$$$20240912$$MD$US$US
243099811$24309981$1$I$20240812$20240831$20240912$20240912$EXP$IE-HPRA-2024-114994$IE-Accord-444881$ACCORD$$90$YR$E$M$Y$$$20240912$$MD$IE$IE
243099821$24309982$1$I$$20240807$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010196$STRIDES$Robinson CL, Wahab S, Cai V.. Delayed Hypersensitivity Reaction to Iodinated-Contrast Following Lumbar Epidural Steroid Injection: Case Report.. Pain-Med-Case-Rep. 2023;7 (1):11-14$54$YR$$F$Y$$$20240912$$MD$US$US
243099831$24309983$1$I$$20240806$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010091$STRIDES$Mossner J, Saleh NB, Shahin MN, Rosenow JM, Raskin JS.. Occipital nerve stimulation in pediatric patients with refractory occipital neuralgia.. Childs-Nerv-Syst. 2024;40 (8):2465-2470.$17$YR$$F$Y$$$20240912$$HP$US$US
243099842$24309984$2$F$20240903$20240916$20240912$20240924$PER$$US-ABBVIE-5909232$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243099851$24309985$1$I$$20240822$20240912$20240912$PER$US-MLMSERVICE-20240815-PI163802-00030-1$US-STRIDES PHARMA UK LTD.-2024SP010739$STRIDES$Parikh SV, Madhavan S, Shapiro J, Knight R, Rosenberg AZ, Parikh CR, et al.. Characterization of Glomerular and Tubulointerstitial Proteomes in a Case of Nonsteroidal Anti-Inflammatory Drug-Attributed Acute Kidney Injury A Clinical Pathologic Molecular Correlation.. Clinical Journal of the American Society of Nephrology. 2023;18(3):402-10$38$YR$$F$Y$$$20240912$$MD$US$US
243099861$24309986$1$I$20210101$20240806$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010151$STRIDES$Adams L, Darabad RR.. Case Report on Chronic Shoulder Pain and Response to Peripheral Nerve Stimulation Twenty-Four Months After Placement.. Pain-Med-Case-Rep. 2024;8 (4):151-155$82$YR$$F$Y$$$20240912$$MD$US$US
243099871$24309987$1$I$$20240806$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009921$STRIDES$Robertson IJ, Mecham DK, Conte LM, Loncharich MF.. A Rare Case of Takayasu Arteritis Presenting as Pericarditis with Effusion. Case Reports in Rheumatology. 2023;2023:6044765$22$YR$$F$Y$$$20240912$$HP$US$US
243099881$24309988$1$I$$20240822$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010845$STRIDES$Majid M, Yaker ZS, Brands C, Unai S, Klein AL.. Not So Transient Effusive-Constrictive Pericarditis. JACC-Case-Rep. 2023;28$63$YR$$M$Y$$$20240912$$MD$US$US
243099891$24309989$1$I$$20240902$20240912$20240912$PER$$US-ABBVIE-5905662$ABBVIE$$$$A$$Y$$$20240912$$CN$US$US
243099901$24309990$1$I$$20240415$20240912$20240912$EXP$$US-GRAVITIPHARMA-GRA-2404-US-LIT-0108$GRAVITI PHARMACEUTICALS$Hilamber Subba.Vasopressin-Induced Hyponatremia in Patients With Aneurysmal Subarachnoid Hemorrhage: A Case Series and Literature Review.J-Pharm-Pract.2023;36(3):689-694$51$YR$A$F$Y$$$20240912$$HP$US$US
243099911$24309991$1$I$$20240906$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US079383$SANDOZ$$$$$F$Y$$$20240912$$MD$US$US
243099922$24309992$2$F$$20240913$20240912$20240920$EXP$$US-ABBVIE-5915843$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243099931$24309993$1$I$20240101$20240905$20240912$20240912$EXP$$NVSC2024US181363$NOVARTIS$$62$YR$$M$Y$$$20240912$$MD$US$US
243099951$24309995$1$I$$20240904$20240912$20240912$EXP$$AU-AstraZeneca-2024A201910$ASTRAZENECA$$62$YR$$F$Y$$$20240912$$MD$AU$
243099961$24309996$1$I$20240809$20240902$20240912$20240912$EXP$$ES-AUROBINDO-AUR-APL-2024-044269$AUROBINDO$$79$YR$$M$Y$$$20240912$$MD$ES$ES
243099981$24309998$1$I$$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144442$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240912$$CN$US$US
243099991$24309999$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180360$AMGEN$$$$$$Y$$$20240911$$CN$US$US
243100001$24310000$1$I$$20240907$20240912$20240912$EXP$$US-ABBVIE-5916298$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243100011$24310001$1$I$$20240906$20240912$20240912$EXP$$CA-ABBVIE-5917084$ABBVIE$$$$A$F$Y$$$20240912$$CN$CA$CA
243100021$24310002$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5917736$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243100031$24310003$1$I$20240323$20240831$20240912$20240912$EXP$FR-AFSSAPS-AN2024001185$FR-Accord-444892$ACCORD$$45$YR$A$M$Y$95$KG$20240912$$MD$FR$FR
243100041$24310004$1$I$20240826$20240906$20240912$20240912$EXP$$GB-AUROBINDO-AUR-APL-2024-044809$AUROBINDO$$68$YR$$M$Y$81$KG$20240912$$CN$GB$GB
243100051$24310005$1$I$$20240910$20240912$20240912$PER$$US-ROCHE-10000079016$ROCHE$$41$YR$A$F$Y$$$20240912$$HP$US$US
243100061$24310006$1$I$$20240828$20240912$20240912$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20704$ALKEM$Kazzaz F, O^Connell OJ, Vial MR, Stewart J, Grosu HB.. Everolimus-induced Chylous Effusion. Am J Respir Crit Care Med. 2018;198 (1):120-122$$$$$Y$$$20240912$$HP$US$US
243100071$24310007$1$I$$20240828$20240912$20240912$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20681$ALKEM$Sathy SJ, Martinu T, Youens K, et al.. Symptomatic pulmonary allograft Kaposi^s sarcoma in two lung transplant recipients. Am J Transplant. 2008;8(9):1951-1956$44$YR$$M$Y$$$20240912$$HP$US$US
243100082$24310008$2$F$$20240905$20240912$20240919$EXP$US-MLMSERVICE-20240821-PI166205-00275-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20712$ALKEM$Rink DE, Abramson RH, Johnson NJ, Lee RY.. Diagnostic Confounders in Brain Death A Woman with Unexplained Coma and Brainstem Areflexia. Annals of the American Thoracic Society. 2024;21(8):1204-1208$60$YR$$F$Y$$$20240919$$MD$US$US
243100091$24310009$1$I$$20240828$20240912$20240912$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20677$ALKEM$Martinez S, McAdams HP, Youens KE.. Kaposi sarcoma after bilateral lung transplantation. J Thorac Imaging. 2008;23(1):50-53$49$YR$$M$Y$$$20240912$$HP$US$US
243100101$24310010$1$I$$20240828$20240912$20240912$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20679$ALKEM$Sathy SJ, Martinu T, Youens K, et al.. Symptomatic pulmonary allograft Kaposi^s sarcoma in two lung transplant recipients. Am J Transplant.. 2008;8(9):1951-1956$48$YR$$M$Y$$$20240912$$HP$US$US
243100112$24310011$2$F$$20240904$20240912$20240918$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-20699$ALKEM$Van Gemert JP, Van Leer C, Akkerman OW, Landburg PP, Erasmus ME, Verschuuren EA.. Disseminated pulmonary Kaposi sarcoma after lung transplantation: the increased risk donor. The Journal of Heart and Lung Transplantation. 2022;41(4):S540- S541$66$YR$$M$Y$$$20240918$$HP$NL$NL
243100121$24310012$1$I$$20240828$20240912$20240912$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-20703$ALKEM$Sleiman C, Mal H, Roue C, et al.. Bronchial Kaposi^s sarcoma after single lung transplantation. Eur Respir J. 1997;10(5):1181-1183$56$YR$$M$Y$$$20240912$$HP$FR$FR
243100131$24310013$1$I$$20240828$20240912$20240912$EXP$$CH-ALKEM LABORATORIES LIMITED-CH-ALKEM-2024-20674$ALKEM$Sachsenberg-Studer EM, Dobrynski N, Sheldon J, et al.. Human herpes-virus 8 seropositive patient with skin and graft Kaposi^s sarcoma after lung transplantation. J Am Acad Dermatol. 1999;40(2 Pt 2):308-311$53$YR$$M$Y$$$20240912$$HP$CH$CH
243100141$24310014$1$I$$20240828$20240912$20240912$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-20764$ALKEM$Mendogni P, Henchi S, Morlacchi LC, Tosi D, Nosotti M, Tarsia P, Gregorini AI, Rosso L.. Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders in Cystic Fibrosis Lung Transplant Recipients: A Case Series. Transplantation Proceedings. 2019;51:194-197$21$YR$$F$Y$$$20240912$$MD$IT$IT
243100151$24310015$1$I$$20240828$20240912$20240912$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-20729$ALKEM$Koga T, Kaieda S, Okamoto M, Masuda K, Fujimoto K, Sakamoto S, Nakamura M, Tominaga M, Kawayama T, Fujimoto K, Hoshino T, Ida H.. Successful Treatment of Rapidly Progressive Unclassifiable Idiopathic Interstitial Pneumonia with Anti-melanoma Differentiation-associated Gene-5 Antibody by Intensive Immunosuppressive Therapy. International Medicine. 2018;57:1039-1043$61$YR$$F$Y$$$20240912$$HP$JP$JP
243100163$24310016$3$F$20220101$20240913$20240912$20240926$EXP$CN-MLMSERVICE-20240820-PI168397-00202-2$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-20528$ALKEM$Xiong YJ, Xiao Y, Xie L, Gao L, Han Y, Huang PF, Liu S, Liang YX, Wang H. Contezolid for the Treatment of Drug-Resistant Tuberculosis in China: A Clinical Case Series. Infection and drug  resistance. 2024;17:3491-3499$43$YR$$F$Y$$$20240926$$MD$CN$CN
243100171$24310017$1$I$$20240828$20240912$20240912$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20678$ALKEM$Martinez S, McAdams HP, Youens KE.. Kaposi sarcoma after bilateral lung transplantation. J Thorac Imaging. 2008;23(1):50-53$45$YR$$M$Y$$$20240912$$HP$US$US
243100182$24310018$2$F$20220101$20240905$20240912$20240919$EXP$US-MLMSERVICE-20240822-PI166551-00271-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20544$ALKEM$Mann I, Morado-Aramburo O, Hasbun R.. Emerging shadows: HHV-8-associated encephalitis unveiled in a solid organ transplant recipient. Transplant Infectious Disease. 2024;26(4):e14343$73$YR$$F$Y$$$20240919$$MD$US$US
243100202$24310020$2$F$$20240917$20240912$20240926$EXP$$US-TEVA-VS-3240326$TEVA$Koh S, Wu C, Cypro A, Castellanos L. HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-ASSOCIATED TAKOTSUBO CARDIOMYOPATHY AND SURVIVAL AFTER VENTRICULAR FIBRILLATION ARREST. J-Am-Coll-Cardiol 2019; 73 (Suppl.) (9): 2599.; Koh S, Wu C, Cypro A, Castellanos L. HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-ASSOCIATED TAKOTSUBO CARDIOMYOPATHY AND SURVIVAL AFTER VENTRICULAR FIBRILLATION ARREST. J-Am-Coll-Cardiol 2019; 73 (Suppl.) (9): 2599.$45$YR$$F$Y$$$20240926$$HP$US$US
243100211$24310021$1$I$20240819$20240819$20240912$20240912$PER$$CA-TOLMAR, INC.-24CA052008$TOLMAR$$83$YR$$M$Y$$$20240912$$CN$CA$CA
243100221$24310022$1$I$$20240819$20240912$20240912$PER$$CA-TOLMAR, INC.-24CA051990$TOLMAR$$$$$M$Y$$$20240912$$CN$CA$CA
243100231$24310023$1$I$$20240819$20240912$20240912$PER$$CA-TOLMAR, INC.-24CA051991$TOLMAR$$$$$M$Y$$$20240912$$CN$CA$CA
243100241$24310024$1$I$$20240819$20240912$20240912$PER$$DE-TOLMAR, INC.-24DE051580$TOLMAR$$$$A$M$Y$$$20240912$$MD$DE$DE
243100251$24310025$1$I$20240819$20240819$20240912$20240912$PER$$CA-TOLMAR, INC.-24CA052020$TOLMAR$$76$YR$$M$Y$$$20240912$$CN$CA$CA
243100261$24310026$1$I$$20240909$20240912$20240912$EXP$$NL-SANDOZ INC.-SDZ2024NL078758$SANDOZ$$$$A$$Y$$$20240912$$HP$NL$NL
243100271$24310027$1$I$20240905$20240907$20240912$20240912$EXP$$IN-ROCHE-10000077030$ROCHE$$76$YR$E$M$Y$$$20240912$$CN$IN$IN
243100281$24310028$1$I$$20240910$20240912$20240912$EXP$$US-ALXN-202407USA000577US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$HP$US$US
243100291$24310029$1$I$$20240906$20240912$20240912$PER$$US-ALXN-202409USA000424US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243100302$24310030$2$F$20240815$20240909$20240912$20240919$PER$$US-AMGEN-USASP2024181019$AMGEN$$68$YR$E$M$Y$$$20240918$$CN$US$US
243100311$24310031$1$I$20240908$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180394$AMGEN$$81$YR$E$M$Y$$$20240911$$CN$US$US
243100321$24310032$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024181580$AMGEN$$$$$$Y$$$20240911$$HP$US$US
243100331$24310033$1$I$$20240906$20240912$20240912$EXP$JP-MMM-XZKO42D5$JP-VIIV HEALTHCARE LIMITED-JP2024110949$VIIV$$$$$$Y$$$20240912$$MD$JP$JP
243100341$24310034$1$I$$20240903$20240912$20240912$EXP$$US-PADAGIS-2024PAD01442$PADAGIS$$$$$$Y$$$20240912$$CN$US$US
243100352$24310035$2$F$20240829$20240913$20240912$20240925$EXP$$US-PADAGIS-2024PAD01453$PADAGIS$$$$$$Y$$$20240925$$CN$US$US
243100361$24310036$1$I$$20240902$20240912$20240912$EXP$$US-PADAGIS-2024PAD01448$PADAGIS$$$$$$Y$$$20240912$$CN$US$US
243100371$24310037$1$I$$20240903$20240912$20240912$EXP$$US-PADAGIS-2024PAD01444$PADAGIS$$$$$$Y$$$20240912$$CN$US$US
243100381$24310038$1$I$20240501$20240903$20240912$20240912$EXP$$US-PADAGIS-2024PAD01447$PADAGIS$$$$$$Y$$$20240912$$CN$US$US
243100391$24310039$1$I$$20240904$20240912$20240912$EXP$$US-PADAGIS-2024PAD01456$PADAGIS$$$$$$Y$$$20240912$$PH$US$US
243100401$24310040$1$I$$20240905$20240912$20240912$EXP$$US-PADAGIS-2024PAD01445$PADAGIS$$$$$$Y$$$20240912$$CN$US$US
243100411$24310041$1$I$20240606$20240904$20240912$20240912$EXP$$US-PADAGIS-2024PAD01455$PADAGIS$$$$$$Y$$$20240912$$CN$US$US
243100422$24310042$2$F$$20240912$20240912$20240918$PER$$US-RDY-SPO/USA/24/0013119$DR REDDYS$$64$YR$A$M$Y$$$20240918$$HP$US$US
243100431$24310043$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013063$DR REDDYS$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 101: doi:10.1016/j.jflm.2023.102625.$88$YR$E$F$Y$$$20240912$$HP$US$US
243100441$24310044$1$I$$20240903$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141504$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240912$$CN$US$US
243100451$24310045$1$I$$20240827$20240912$20240912$PER$$US-ASTELLAS-2024-AER-003323$ASTELLAS$$$$A$$Y$$$20240912$$MD$US$US
243100461$24310046$1$I$20240814$20240906$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144166$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240912$$CN$US$US
243100471$24310047$1$I$$20240829$20240912$20240912$EXP$$JP-UCBSA-2024044854$UCB$$8$DEC$$M$Y$$$20240912$$MD$JP$JP
243100482$24310048$2$F$$20240918$20240912$20240924$EXP$$JP-ASTELLAS-2024-AER-004488$ASTELLAS$$$$E$M$Y$$$20240924$$PH$JP$JP
243100491$24310049$1$I$20240909$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180368$AMGEN$$77$YR$E$F$Y$$$20240911$$HP$US$US
243100501$24310050$1$I$20240906$20240906$20240912$20240912$EXP$$GB-AstraZeneca-2024A203707$ASTRAZENECA$$25$YR$$F$Y$$$20240912$$MD$GB$
243100511$24310051$1$I$$20240821$20240912$20240912$PER$$US-APOTEX-2024AP009943$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240912$$HP$US$US
243100522$24310052$2$F$$20240910$20240912$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409006438$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240918$$CN$US$US
243100531$24310053$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005563$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240912$$CN$US$US
243100541$24310054$1$I$$20240905$20240912$20240912$EXP$$US-AstraZeneca-2024A204509$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243100551$24310055$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006332$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240912$$CN$US$US
243100561$24310056$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006374$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240912$$CN$US$US
243100571$24310057$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006417$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240912$$CN$US$US
243100581$24310058$1$I$20240801$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006965$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240912$$CN$US$US
243100591$24310059$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005323$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240912$$CN$US$US
243100601$24310060$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006414$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240912$$CN$US$US
243100621$24310062$1$I$$20240905$20240912$20240912$EXP$$US-AstraZeneca-2024A204828$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243100631$24310063$1$I$$20240904$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409003030$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240912$$CN$US$US
243100641$24310064$1$I$$20240905$20240912$20240912$EXP$$US-ABBVIE-5915138$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243100652$24310065$2$F$$20240913$20240912$20240914$PER$$US-AMGEN-USASP2024179908$AMGEN$$73$YR$E$F$Y$$$20240914$$CN$US$US
243100661$24310066$1$I$$20240909$20240912$20240912$EXP$$JP-HALEON-2196218$Haleon PLC$Jinno A, Bunya N, Hagiwara J,?Takao K, Sawamoto K, Ishii A, et al. Trauma-related thyroid storm in adolescents: A case report. Acute Medicine + Surgery. 2024;11:e70004. DOI: 10.1002/ams2.70004$13$YR$$F$Y$$$20240912$$HP$JP$JP
243100671$24310067$1$I$$20240907$20240912$20240912$EXP$$BR-TAKEDA-2024TUS090427$TAKEDA$$$$$$Y$$$20240912$$CN$BR$BR
243100681$24310068$1$I$$20240829$20240912$20240912$PER$$US-JNJFOC-20240901638$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243100692$24310069$2$F$20240907$20240910$20240912$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028343$UNITED THERAPEUTICS$$81$YR$$F$Y$$$20240918$$$US$US
243100702$24310070$2$F$$20240917$20240912$20240919$EXP$$CA-ROCHE-10000060173$ROCHE$$$$A$M$Y$$$20240919$$HP$CA$CA
243100711$24310071$1$I$$20240903$20240912$20240912$EXP$$TH-ROCHE-10000073648$ROCHE$$64$YR$A$F$Y$$$20240912$$CN$TH$TH
243100721$24310072$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013031$DR REDDYS$Gutierrez RA, Smith P, Kranyak A, Davis M, Koo J. Pimozide-induced tardive dyskinesia in the treatment of delusions of infestation. JAAD Case Reports. 2024 Mar;45: 71-73. doi:10.1016/j.jdcr.2024.01.010.$52$YR$A$F$Y$$$20240912$$HP$US$US
243100731$24310073$1$I$$20240910$20240912$20240912$PER$$NVSC2024US181911$NOVARTIS$$$$$M$Y$92$KG$20240912$$CN$US$US
243100741$24310074$1$I$20240901$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144690$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240912$$CN$US$US
243100761$24310076$1$I$$20240904$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141842$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240912$$MD$US$US
243100771$24310077$1$I$$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142598$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240912$$CN$US$US
243100781$24310078$1$I$$20240905$20240912$20240912$EXP$$BR-TAKEDA-2024TUS090107$TAKEDA$$$$$$Y$$$20240912$$CN$BR$BR
243100791$24310079$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5914185$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243100802$24310080$2$F$20240101$20240909$20240912$20240916$PER$$US-AMGEN-USASP2024179931$AMGEN$$95$YR$E$F$Y$$$20240916$$CN$US$US
243100811$24310081$1$I$$20240903$20240912$20240912$EXP$$CA-AUROBINDO-AUR-APL-2024-044678$AUROBINDO$$65$YR$$F$Y$67$KG$20240912$$MD$CA$CA
243100831$24310083$1$I$$20240906$20240912$20240912$EXP$$TH-ROCHE-10000076407$ROCHE$$$$$$Y$$$20240912$$MD$TH$TH
243100841$24310084$1$I$$20240910$20240912$20240912$EXP$$IN-ROCHE-10000079343$ROCHE$$23$YR$A$M$Y$$$20240912$$CN$IN$IN
243100851$24310085$1$I$$20240910$20240912$20240912$PER$$US-ROCHE-10000078527$ROCHE$$$$$$Y$$$20240912$$HP$US$US
243100861$24310086$1$I$$20240903$20240912$20240912$EXP$$NL-AUROBINDO-AUR-APL-2024-044446$AUROBINDO$$60$YR$$M$Y$75$KG$20240912$$CN$NL$NL
243100871$24310087$1$I$20240909$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181155$AMGEN$$45$YR$A$F$Y$$$20240911$$PH$US$US
243100882$24310088$2$F$$20240912$20240912$20240916$PER$$US-BIOGEN-2024BI01281752$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
243100891$24310089$1$I$$20240910$20240912$20240912$PER$$US-BIOGEN-2023BI01232016$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
243100902$24310090$2$F$20240908$20240911$20240912$20240913$PER$$US-AMGEN-USASP2024181408$AMGEN$$71$YR$E$M$Y$$$20240912$$CN$US$US
243100911$24310091$1$I$20240501$20240903$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044384$AUROBINDO$$43$YR$$M$Y$60$KG$20240912$$MD$FR$FR
243100921$24310092$1$I$20240822$20240910$20240912$20240912$EXP$$US-AstraZeneca-2024A206434$ASTRAZENECA$$30677$DY$$F$Y$$$20240912$$MD$US$
243100931$24310093$1$I$$20240906$20240912$20240912$EXP$$US-AstraZeneca-2024A204850$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243100942$24310094$2$F$$20240911$20240912$20240913$PER$$US-ROCHE-10000079040$ROCHE$$65$YR$E$M$Y$$$20240913$$MD$US$US
243100951$24310095$1$I$$20240905$20240912$20240912$EXP$$ZA-AstraZeneca-2024A203983$ASTRAZENECA$$64$YR$$M$Y$$$20240912$$CN$ZA$
243100961$24310096$1$I$20201201$20240909$20240912$20240912$EXP$$PL-SANDOZ INC.-SDZ2024PL079068$SANDOZ$$49$YR$$M$Y$$$20240912$$MD$PL$PL
243100971$24310097$1$I$20240101$20240829$20240912$20240912$EXP$$CA-UCBSA-2024025874$UCB$$$$$F$Y$$$20240912$$CN$CA$CA
243100981$24310098$1$I$$20240827$20240912$20240912$PER$$US-ASTELLAS-2024-AER-003560$ASTELLAS$$65$YR$E$M$Y$$$20240912$$CN$US$US
243100991$24310099$1$I$20240610$20240830$20240912$20240912$EXP$$JP-ROCHE-3507667$ROCHE$$33$YR$A$F$Y$52.4$KG$20240912$$MD$JP$JP
243101001$24310100$1$I$$20240903$20240912$20240912$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08346$HIKMA$Umer M, Peters M, Dholiya H, Sagheer U, Bhandari S, Ghafghazi S. Umer M, Peters M, Dholiya H, Sagheer U, Bhandari S, Ghafghazi S, et al. Multiple recurrences of a left ventricular pseudoaneurysm: A case report.. European Heart Journal - Case Reports. 2024;8(8):ytae382$32$YR$$M$Y$$$20240912$$MD$US$US
243101021$24310102$1$I$$20240816$20240912$20240912$EXP$$CA-TEVA-VS-3202732$TEVA$$65$YR$$F$Y$$$20240912$$HP$CA$CA
243101041$24310104$1$I$$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142749$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$129$KG$20240912$$HP$US$US
243101051$24310105$1$I$$20240827$20240912$20240912$PER$$US-ASTELLAS-2024-AER-004346$ASTELLAS$$$$$F$Y$$$20240912$$MD$US$US
243101072$24310107$2$F$$20240926$20240912$20240927$PER$$US-BIOVITRUM-2024-US-011191$BIOVITRUM$$63$YR$$M$Y$$$20240927$$CN$US$US
243101081$24310108$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006387$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240912$$CN$US$US
243101091$24310109$1$I$20240908$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006434$ELI LILLY AND CO$$60$YR$A$$Y$$$20240912$$CN$US$US
243101101$24310110$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006642$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240912$$CN$US$US
243101111$24310111$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007310$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240912$$CN$US$US
243101121$24310112$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006598$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240912$$CN$US$US
243101131$24310113$1$I$20240901$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024180636$AMGEN$$$$$M$Y$$$20240912$$CN$US$US
243101141$24310114$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024181253$AMGEN$$$$$$Y$$$20240912$$CN$US$US
243101151$24310115$1$I$20240101$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005509$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240912$$CN$US$US
243101161$24310116$1$I$20240903$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024180863$AMGEN$$67$YR$E$F$Y$$$20240912$$CN$US$US
243101171$24310117$1$I$$20240905$20240912$20240912$EXP$$GB-TAKEDA-2023TUS074904$TAKEDA$$$$$F$Y$$$20240912$$CN$GB$GB
243101181$24310118$1$I$20240801$20240904$20240912$20240912$EXP$$JP-ASTELLAS-2024-AER-004813$ASTELLAS$$8$DEC$E$M$Y$$$20240912$$PH$JP$JP
243101191$24310119$1$I$$20240828$20240912$20240912$EXP$$SE-AMGEN-SWESP2024180400$AMGEN$$$$$F$Y$$$20240912$$MD$SE$SE
243101201$24310120$1$I$20240906$20240906$20240912$20240912$PER$$US-AMGEN-USASP2024179453$AMGEN$$63$YR$A$F$Y$$$20240912$$CN$US$US
243101211$24310121$1$I$20240823$20240905$20240912$20240912$PER$$US-AMGEN-USASP2024179077$AMGEN$$$$$$Y$$$20240912$$PH$US$US
243101221$24310122$1$I$20240101$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180137$AMGEN$$60$YR$A$M$Y$$$20240912$$CN$US$US
243101241$24310124$1$I$$20240902$20240912$20240912$EXP$$FR-MSNLABS-2024MSNLIT01924$MSN LABORATORIES$Baudriller A, Abbara C, Briet M, Jousset N, Malbranque S, Zabet D, Rossid L, Durfortd C, Fereca S, Drevina G.Deaths related to pharmacobezoars : a report on two cases.Toxicologie Analytique and Clinique.2024;547:1-9$$$$$Y$$$20240912$$HP$FR$FR
243101251$24310125$1$I$$20240910$20240912$20240912$EXP$$CH-BIOVITRUM-2024-CH-011906$BIOVITRUM$$$$E$F$Y$$$20240912$$MD$CH$CH
243101262$24310126$2$F$$20240918$20240912$20240927$EXP$$US-TEVA-VS-3240667$TEVA$Kinney RE, Nair S, Kim CH, Thomas MB, Delatorre M. Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer. Oncologist 2023; 28 (6): E478-E486.; Kinney RE, Nair S, Kim CH, Thomas MB, Delatorre M. Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer. Oncologist 2023; 28 (6): E478-E486.$51$YR$$F$Y$$$20240927$$MD$US$US
243101271$24310127$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180267$AMGEN$$55$YR$A$M$Y$$$20240912$$CN$US$US
243101281$24310128$1$I$20240910$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181304$AMGEN$$57$YR$A$F$Y$$$20240912$$CN$US$US
243101291$24310129$1$I$20240318$20240911$20240912$20240912$EXP$PT-INFARMED-E202409-103$PT-ROCHE-10000079117$ROCHE$$84$YR$E$F$Y$$$20240912$$PH$PT$PT
243101303$24310130$3$F$20240101$20240920$20240912$20240924$EXP$$US-AMGEN-USASP2024178250$AMGEN$$77$YR$E$M$Y$69.388$KG$20240924$$CN$US$US
243101311$24310131$1$I$$20240910$20240912$20240912$EXP$$US-AMGEN-USASP2024180518$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
243101321$24310132$1$I$$20240902$20240912$20240912$EXP$$JP-EMD Serono-2024047651$EMD SERONO INC$$81$YR$E$M$Y$69$KG$20240912$$MD$JP$JP
243101331$24310133$1$I$20240821$20240904$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044205$AUROBINDO$$79$YR$$M$Y$$$20240912$$PH$FR$FR
243101341$24310134$1$I$$20240823$20240912$20240912$PER$$US-TEVA-VS-3237977$TEVA$$57$YR$$$Y$$$20240912$$HP$US$US
243101351$24310135$1$I$20240909$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144724$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$CN$US$US
243101361$24310136$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144233$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240912$$CN$US$US
243101372$24310137$2$F$$20240917$20240912$20240921$EXP$$UA-AMGEN-UKRSP2024178425$AMGEN$Lymanets T.. AML-054 Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240920$$MD$UA$UA
243101381$24310138$1$I$$20240910$20240912$20240912$PER$$US-ALXN-202409USA000645US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243101391$24310139$1$I$$20240906$20240912$20240912$EXP$$US-AstraZeneca-2024A203901$ASTRAZENECA$$$$$F$Y$27.2$KG$20240912$$CN$US$
243101401$24310140$1$I$$20240906$20240912$20240912$PER$$US-AstraZeneca-2024A204867$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243101422$24310142$2$F$$20240917$20240912$20240921$EXP$$UA-AMGEN-UKRSP2024178427$AMGEN$Lymanets T.. AML-054 Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240920$$MD$UA$UA
243101431$24310143$1$I$20240909$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024180681$AMGEN$$77$YR$E$F$Y$$$20240912$$CN$US$US
243101441$24310144$1$I$20240815$20240909$20240912$20240912$EXP$DE-CADRBFARM-2024330319$DE-SANDOZ INC.-SDZ2024DE079099$SANDOZ$$17$YR$$M$Y$101$KG$20240912$$MD$DE$DE
243101451$24310145$1$I$20240623$20240902$20240912$20240912$EXP$PL-URPL-DML-MLP.4401.1.177.2024$PL-BEH-2024178244$CSL BEHRING$$15$MON$I$F$Y$10$KG$20240912$$PH$PL$PL
243101461$24310146$1$I$$20240909$20240912$20240912$PER$$NVSC2024US181105$NOVARTIS$$$$$F$Y$$$20240912$$PH$US$US
243101471$24310147$1$I$$20240903$20240912$20240912$PER$$US-APOTEX-2024AP010288$APOTEX$Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N.. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.. The American Journal of Gastroenterology. 2024;119:200-202$$$A$$Y$$$20240912$$MD$US$US
243101481$24310148$1$I$$20240909$20240912$20240912$PER$$US-JNJFOC-20240921640$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$US$US
243101491$24310149$1$I$20240828$20240905$20240912$20240912$PER$$US-AMGEN-USASP2024177858$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243101501$24310150$1$I$20240723$20240906$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044627$AUROBINDO$$93$YR$$M$Y$86$KG$20240912$$MD$FR$FR
243101511$24310151$1$I$20240903$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180536$AMGEN$$$$$$Y$$$20240912$$PH$US$US
243101521$24310152$1$I$20240814$20240831$20240912$20240912$EXP$FR-AFSSAPS-NY2024000996$FR-Accord-444903$ACCORD$$57$YR$A$M$Y$80$KG$20240912$$MD$FR$FR
243101532$24310153$2$F$$20240617$20240912$20240917$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091791$GLENMARK$$$$$$Y$$$20240917$$PH$US$US
243101541$24310154$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013093$DR REDDYS$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024 Jan;101: doi:10.1016/j.jflm.2023.102625.$63$YR$A$F$Y$$$20240912$$HP$US$US
243101551$24310155$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013095$DR REDDYS$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 101: doi:10.1016/j.jflm.2023.102625.$82$YR$E$$Y$$$20240912$$HP$US$US
243101564$24310156$4$F$20240909$20240916$20240912$20240923$PER$$US-ROCHE-10000078238$ROCHE$$34$YR$A$F$Y$83.91$KG$20240923$$CN$US$US
243101571$24310157$1$I$$20240911$20240912$20240912$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051010$BOEHRINGER INGELHEIM$$$$$$Y$$$20240912$$CN$US$US
243101581$24310158$1$I$$20240905$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142289$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240912$$HP$US$US
243101591$24310159$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180432$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243101601$24310160$1$I$$20240905$20240912$20240912$EXP$NL-LRB-00999830$NL-TEVA-VS-3241241$TEVA$$64$YR$$F$Y$82$KG$20240912$$CN$NL$NL
243101612$24310161$2$F$$20240910$20240912$20240922$EXP$$JP-AMGEN-JPNSP2024178892$AMGEN$$51$YR$A$F$Y$$$20240922$$PH$JP$JP
243101622$24310162$2$F$20230401$20240924$20240912$20240926$PER$$US-AMGEN-USASP2024176874$AMGEN$$54$YR$A$F$Y$$$20240926$$CN$US$US
243101631$24310163$1$I$$20240909$20240912$20240912$EXP$$US-AUROBINDO-AUR-APL-2024-044924$AUROBINDO$Al-Chalabi M, Martinez Salazar A, Bradshaw A.. Fluoroquinolone-Induced Demyelinating Polyneuropathy.. Journal of Clinical Neuromuscular Disease.. 2024;26(1):49-53$60$YR$$M$Y$$$20240912$$MD$US$US
243101641$24310164$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006495$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240912$$CN$US$US
243101651$24310165$1$I$20240801$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004041$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240912$$CN$US$US
243101661$24310166$1$I$20240908$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006582$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240912$$CN$US$US
243101671$24310167$1$I$20240501$20240827$20240912$20240912$PER$$US-SERVIER-S24010884$SERVIER$$$$$$Y$$$20240912$$MD$US$US
243101681$24310168$1$I$20240908$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006552$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240912$$CN$US$US
243101691$24310169$1$I$$20240909$20240912$20240912$EXP$$TR-SANDOZ INC.-SDZ2024TR079285$SANDOZ$$66$YR$$M$Y$$$20240912$$MD$TR$TR
243101701$24310170$1$I$$20240902$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044076$AUROBINDO$Gervais C, Auclin E, Saltel-Fulero A, Clair G, Oudard S, Mirghani H. Nivolumab immunotherapy rechallenge for progressive laryngeal squamous cell carcinoma after failure of conventional treatment: A CARE case report. Eur-Ann-Otorhinolaryngol-Head-Neck-Dis. 2024;141 (4):231-234$70$YR$$M$Y$$$20240912$$HP$FR$FR
243101711$24310171$1$I$$20240909$20240912$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014716$JAZZ$$$$$F$Y$$$20240912$$CN$US$US
243101721$24310172$1$I$$20240906$20240912$20240912$EXP$$US-AstraZeneca-2024A205464$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243101732$24310173$2$F$$20240906$20240912$20240913$EXP$$DE-AstraZeneca-2024A204238$ASTRAZENECA$$$$E$M$Y$$$20240913$$MD$DE$
243101751$24310175$1$I$20240908$20240909$20240912$20240912$EXP$$BR-ABBVIE-5917402$ABBVIE$$46$YR$$M$Y$$$20240912$$CN$BR$BR
243101781$24310178$1$I$$20240903$20240912$20240912$EXP$$US-APOTEX-2024AP010290$APOTEX$Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N.. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.. The American Journal of Gastroenterology. 2024;119:200-202$$$A$$Y$$$20240912$$MD$US$US
243101811$24310181$1$I$20240907$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181128$AMGEN$$$$$$Y$$$20240912$$PH$US$US
243101821$24310182$1$I$$20240828$20240912$20240912$EXP$$SE-AMGEN-SWESP2024180764$AMGEN$$$$$$Y$$$20240912$$MD$SE$SE
243101831$24310183$1$I$$20240905$20240912$20240912$EXP$$US-GSK-US2024110788$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$US$US
243101841$24310184$1$I$$20240905$20240912$20240912$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002299$Alvotech$$62$YR$$F$Y$$$20240912$$CN$CA$CA
243101851$24310185$1$I$$20240823$20240912$20240912$PER$$US-TEVA-VS-3237577$TEVA$$51$YR$$F$Y$$$20240912$$CN$US$US
243101861$24310186$1$I$20240701$20240910$20240912$20240912$EXP$GB-TEVA-VS-3230263$GB-SANDOZ INC.-SDZ2024GB079475$SANDOZ$$37$YR$$M$Y$89$KG$20240912$$CN$GB$GB
243101871$24310187$1$I$20240101$20240906$20240912$20240912$PER$$US-ABBVIE-5916593$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243101881$24310188$1$I$20240422$20240910$20240912$20240912$EXP$GB-MHRA-EMIS-8587-416054e5-83b0-4660-a9c2-896bac20a053$GB-SANDOZ INC.-SDZ2024GB079222$SANDOZ$$72$YR$$M$Y$77$KG$20240912$$PH$GB$GB
243101891$24310189$1$I$20240812$20240820$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004843$ACADIA PHARMACEUTICALS$$15$YR$$F$Y$$$20240912$$CN$US$US
243101901$24310190$1$I$20240815$20240820$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004834$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240912$$CN$US$US
243101911$24310191$1$I$20240717$20240820$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004837$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240912$$CN$US$US
243101921$24310192$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004835$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243101932$24310193$2$F$20240801$20240913$20240912$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004608$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240923$$CN$US$US
243101941$24310194$1$I$20240816$20240820$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004845$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240912$$CN$US$US
243101951$24310195$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004832$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243101961$24310196$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004840$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243101971$24310197$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004819$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243101981$24310198$1$I$20240801$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004842$ACADIA PHARMACEUTICALS$$84$YR$$F$Y$$$20240912$$CN$US$US
243101991$24310199$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004839$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243102001$24310200$1$I$$20240219$20240912$20240912$PER$$US-ALVOGEN-2023092261$ALVOGEN$$$$E$F$Y$$$20240912$$MD$US$US
243102011$24310201$1$I$$20240902$20240912$20240912$EXP$$US-TEVA-VS-3239860$TEVA$$$$$$Y$$$20240912$$CN$US$US
243102022$24310202$2$F$$20240917$20240912$20240923$EXP$$NVSC2024AU179685$NOVARTIS$$$$$F$Y$$$20240923$$MD$AU$AU
243102031$24310203$1$I$20240801$20240821$20240912$20240912$PER$$US-SA-2024SA260079$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240912$$CN$US$US
243102041$24310204$1$I$$20231127$20240912$20240912$PER$$US-ALVOGEN-2023092155$ALVOGEN$$79$YR$$F$Y$74.4$KG$20240912$$MD$US$US
243102051$24310205$1$I$20160101$20240320$20240912$20240912$PER$$US-ALVOGEN-2020085071$ALVOGEN$$59$YR$$F$Y$120.18$KG$20240912$$HP$US$US
243102061$24310206$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013163$DR REDDYS$Lee JZ, Karikalan S, Tan M, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC: Clinical Electrophysiology. 2023 Jun;9(6): 824-832. doi:10.1016/j.jacep.2022.10.024.$$$$$Y$$$20240912$$MD$US$US
243102071$24310207$1$I$$20240904$20240912$20240912$EXP$$DE-RDY-SPO/DEU/24/0013196$DR REDDYS$Berger M, Schumacher F, Wollsching-Strobel M, Kroppen D, Stanzel SB, Majorski DS, et al. A clinical phenotype of VEXAS syndrome with pleural effusion, infiltrates, and systemic inflammation in a 76-year-old patient: a case report. Journal of Medical Case Reports. 2024 Aug 24;18: doi:10.1186/s13256-024-04688-9.$76$YR$E$M$Y$$$20240912$$HP$DE$DE
243102081$24310208$1$I$20240101$20240830$20240912$20240912$PER$$US-SA-2024SA261550$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240912$$MD$US$US
243102092$24310209$2$F$20240101$20240916$20240912$20240922$PER$$US-SA-2024SA261095$SANOFI AVENTIS$$90$YR$E$F$Y$$$20240922$$MD$US$US
243102101$24310210$1$I$20240101$20240828$20240912$20240912$PER$$US-SA-2024SA262752$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$MD$US$US
243102121$24310212$1$I$20240801$20240830$20240912$20240912$PER$$US-SA-2024SA261898$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240912$$HP$US$US
243102131$24310213$1$I$20240808$20240829$20240912$20240912$PER$$US-SA-2024SA260785$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240912$$CN$US$US
243102141$24310214$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA260702$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$HP$US$US
243102151$24310215$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA259771$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240912$$CN$US$US
243102161$24310216$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA259017$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240912$$MD$US$US
243102171$24310217$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA258859$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240912$$HP$US$US
243102191$24310219$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA260072$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240912$$CN$US$US
243102201$24310220$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA258766$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240912$$CN$US$US
243102211$24310221$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA261562$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240912$$HP$US$US
243102221$24310222$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA259656$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240912$$MD$US$US
243102231$24310223$1$I$20240829$20240904$20240912$20240912$PER$$US-SA-2024SA261453$SANOFI AVENTIS$$44$YR$A$M$Y$70$KG$20240912$$HP$US$US
243102241$24310224$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA261787$SANOFI AVENTIS$$$$$F$Y$$$20240912$$PH$US$US
243102251$24310225$1$I$20240710$20240904$20240912$20240912$PER$$US-SA-2024SA262125$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240912$$HP$US$US
243102261$24310226$1$I$$20231129$20240912$20240912$PER$$US-ALVOGEN-2023092691$ALVOGEN$$69$YR$$F$Y$$$20240912$$CN$US$US
243102271$24310227$1$I$$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145043$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240912$$CN$US$US
243102281$24310228$1$I$$20231229$20240912$20240912$PER$$US-ALVOGEN-2023092848$ALVOGEN$$$$$F$Y$$$20240912$$MD$US$US
243102291$24310229$1$I$$20240108$20240912$20240912$PER$$US-ALVOGEN-2024092900$ALVOGEN$$$$$$Y$$$20240912$$HP$US$US
243102301$24310230$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004838$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243102311$24310231$1$I$$20240131$20240912$20240912$PER$$US-ALVOGEN-2024093018$ALVOGEN$$$$$F$Y$$$20240912$$MD$US$US
243102321$24310232$1$I$$20240219$20240912$20240912$PER$$US-ALVOGEN-2024093131$ALVOGEN$$26$YR$$F$Y$$$20240912$$MD$US$US
243102331$24310233$1$I$$20240401$20240912$20240912$PER$$US-ALVOGEN-2024094316$ALVOGEN$$74$YR$$F$Y$$$20240912$$HP$US$US
243102341$24310234$1$I$$20240402$20240912$20240912$PER$$US-ALVOGEN-2024094478$ALVOGEN$$87$YR$$F$Y$$$20240912$$CN$US$US
243102351$24310235$1$I$$20240904$20240912$20240912$EXP$$ZA-AstraZeneca-2024A202087$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$ZA$
243102361$24310236$1$I$$20240905$20240912$20240912$EXP$$US-AstraZeneca-2024A202921$ASTRAZENECA$$$$$M$Y$$$20240912$$HP$US$
243102371$24310237$1$I$$20240909$20240912$20240912$PER$$US-AstraZeneca-2024A205919$ASTRAZENECA$$$$$$Y$$$20240912$$MD$US$
243102381$24310238$1$I$$20240909$20240912$20240912$PER$$US-AstraZeneca-2024A205670$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243102391$24310239$1$I$$20240418$20240912$20240912$PER$$US-ALVOGEN-2024094514$ALVOGEN$$79$YR$$F$Y$$$20240912$$MD$US$US
243102401$24310240$1$I$20190801$20240906$20240912$20240912$EXP$$US-ABBVIE-5913638$ABBVIE$$28$YR$$F$Y$97$KG$20240912$$CN$US$US
243102411$24310241$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006529$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240912$$CN$US$US
243102421$24310242$1$I$20240909$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006580$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240912$$CN$US$US
243102431$24310243$1$I$20240801$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006327$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240912$$CN$US$US
243102441$24310244$1$I$20240905$20240905$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409003637$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240912$$CN$US$US
243102452$24310245$2$F$20240906$20240911$20240912$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409005998$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240917$$CN$US$US
243102461$24310246$1$I$20240902$20240906$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005451$ELI LILLY AND CO$$$$$$Y$$$20240912$$CN$US$US
243102471$24310247$1$I$$20240907$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006492$ELI LILLY AND CO$$$$$$Y$$$20240912$$CN$US$US
243102481$24310248$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006819$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240912$$CN$US$US
243102491$24310249$1$I$20240401$20240530$20240912$20240912$PER$$US-ALVOGEN-2024094801$ALVOGEN$$62$YR$$F$Y$74.84$KG$20240912$$CN$US$US
243102501$24310250$1$I$$20240902$20240912$20240912$EXP$$JP-JNJFOC-20240919542$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$JP$JP
243102513$24310251$3$F$20230612$20240923$20240912$20240925$EXP$IT-MINISAL02-1001233$IT-JNJFOC-20240927731$JOHNSON AND JOHNSON$$48$YR$A$M$Y$85$KG$20240926$$MD$IT$IT
243102521$24310252$1$I$20230203$20240903$20240912$20240912$EXP$$AU-ROCHE-3409064$ROCHE$$37$YR$A$M$Y$$$20240912$$HP$AU$AU
243102531$24310253$1$I$$20231211$20240912$20240912$PER$$US-ALVOGEN-2023092776$ALVOGEN$$83$YR$$F$Y$$$20240912$$MD$US$US
243102541$24310254$1$I$20240101$20240904$20240912$20240912$EXP$$US-ABBVIE-5855267$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243102551$24310255$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004862$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$HP$US$US
243102561$24310256$1$I$20240401$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145087$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240912$$CN$US$US
243102581$24310258$1$I$20240422$20240903$20240912$20240912$EXP$FR-AFSSAPS-RE2024000858$FR-TEVA-VS-3239998$TEVA$$91$YR$$F$Y$75$KG$20240912$$PH$FR$FR
243102591$24310259$1$I$20030101$20240902$20240912$20240912$EXP$FR-AFSSAPS-AVLY2024000167$FR-TEVA-VS-3239682$TEVA$$55$YR$$M$Y$80$KG$20240912$$MD$FR$FR
243102601$24310260$1$I$20240301$20240830$20240912$20240912$PER$$US-JNJFOC-20240881178$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
243102611$24310261$1$I$20240816$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004868$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240912$$CN$US$US
243102631$24310263$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004875$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243102641$24310264$1$I$$20240905$20240912$20240912$EXP$$CA-GSK-CA2024AMR111049$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$HP$CA$CA
243102651$24310265$1$I$20240101$20240829$20240912$20240912$EXP$$US-ENDO USA, INC.-2024-003379$ENDO$$$$$M$Y$$$20240912$$CN$US$US
243102661$24310266$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013172$DR REDDYS$Lee JZ, Karikalan S, Tan M, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC: Clinical Electrophysiology. 2023 Jun;9(6): 824-832. doi:10.1016/j.jacep.2022.10.024.$$$$$Y$$$20240912$$MD$US$US
243102671$24310267$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013173$DR REDDYS$Lee JZ, Karikalan S, Tan M, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC: Clinical Electrophysiology. 2023 Jun;9(6): 824-832. doi:10.1016/j.jacep.2022.10.024.$$$$$Y$$$20240912$$MD$US$US
243102681$24310268$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013174$DR REDDYS$Lee JZ, Karikalan S, Tan M, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC: Clinical Electrophysiology. 2023 Jun;9(6): 824-832. doi:10.1016/j.jacep.2022.10.024.$$$$$Y$$$20240912$$MD$US$US
243102691$24310269$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013183$DR REDDYS$Lee JZ, Karikalan S, Tan M, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC: Clinical Electrophysiology. 2023 Jun;9(6): 824-832. doi:10.1016/j.jacep.2022.10.024.$$$$$Y$$$20240912$$MD$US$US
243102701$24310270$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013097$DR REDDYS$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 101: doi:10.1016/j.jflm.2023.102625.$84$YR$E$$Y$$$20240912$$HP$US$US
243102711$24310271$1$I$20240218$20240910$20240912$20240912$EXP$$GB-ROCHE-3518486$ROCHE$$42$YR$A$F$Y$$$20240912$$HP$GB$GB
243102721$24310272$1$I$$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143703$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240912$$CN$US$US
243102731$24310273$1$I$20240821$20240906$20240912$20240912$EXP$$US-ABBVIE-5907449$ABBVIE$$39$YR$$F$Y$84$KG$20240912$$HP$US$US
243102741$24310274$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004880$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243102751$24310275$1$I$20240819$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004876$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240912$$CN$US$US
243102761$24310276$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004883$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243102771$24310277$1$I$20240827$20240909$20240912$20240912$EXP$$US-ABBVIE-5915826$ABBVIE$$64$YR$$M$Y$$$20240912$$CN$US$US
243102781$24310278$1$I$20240815$20240820$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004911$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240912$$CN$US$US
243102791$24310279$1$I$$20240903$20240912$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-025270$UNITED THERAPEUTICS$$$$$F$Y$86.168$KG$20240912$$$US$US
243102811$24310281$1$I$20240401$20240909$20240912$20240912$EXP$$US-ABBVIE-5916036$ABBVIE$$66$YR$$F$Y$$$20240912$$CN$US$US
243102841$24310284$1$I$20240829$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024180669$AMGEN$$65$YR$E$M$Y$$$20240912$$CN$US$US
243102851$24310285$1$I$$20240820$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004910$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243102861$24310286$1$I$20240101$20240905$20240912$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-027926$UNITED THERAPEUTICS$$$$$$Y$$$20240912$$$US$US
243102872$24310287$2$F$20240831$20240903$20240912$20240917$PER$$US-ABBVIE-5905494$ABBVIE$$18$YR$$M$Y$$$20240917$$CN$US$US
243102883$24310288$3$F$$20240918$20240912$20240923$EXP$$CA-ROCHE-10000076188$ROCHE$$$$A$M$Y$$$20240923$$CN$CA$CA
243102891$24310289$1$I$20240601$20240905$20240912$20240912$EXP$$US-SA-2024SA262812$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240912$$HP$US$US
243102901$24310290$1$I$$20240823$20240912$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08550$LUPIN$$$$$$Y$$$20240912$$CN$US$US
243102911$24310291$1$I$$20240820$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004912$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243102921$24310292$1$I$$20240911$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US079622$SANDOZ$Guleid Hussein Peter Krastev2 Arvin Junn P. Mallari3 |. Stone heart syndrome: A curious case of digoxin toxicityand calcium infusion. WILEY. 2024$78$YR$$F$Y$$$20240912$$HP$US$US
243102931$24310293$1$I$$20240906$20240912$20240912$EXP$$CO-SANDOZ INC.-SDZ2024CO079569$SANDOZ$$$$$$Y$$$20240912$$MD$CO$CO
243102941$24310294$1$I$$20240910$20240912$20240912$PER$$US-ALXN-202409USA000681US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243102952$24310295$2$F$20240101$20240919$20240912$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-028089$UNITED THERAPEUTICS$$$$$F$Y$90.703$KG$20240924$$$US$US
243102971$24310297$1$I$$20240910$20240912$20240912$PER$$US-ROCHE-10000079165$ROCHE$$$$A$M$Y$123.2$KG$20240912$$HP$US$US
243102981$24310298$1$I$$20240831$20240912$20240912$EXP$CA-MHPD-E2B_07224375$CA-Accord-444540$ACCORD$$27$YR$A$F$Y$$$20240912$$CN$CA$CA
243102991$24310299$1$I$20240614$20240820$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004889$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240912$$CN$US$US
243103001$24310300$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004915$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243103011$24310301$1$I$20240801$20240902$20240912$20240912$EXP$$TW-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050942$BOEHRINGER INGELHEIM$$72$YR$E$M$Y$66$KG$20240912$$PH$TW$TW
243103021$24310302$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144916$BRISTOL MYERS SQUIBB$$62$YR$A$$Y$$$20240912$$CN$US$US
243103031$24310303$1$I$20230101$20240905$20240912$20240912$EXP$$CA-GSK-CA2023122372$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$CA$CA
243103041$24310304$1$I$20240101$20240818$20240912$20240912$PER$$US-SA-2024SA263123$SANOFI AVENTIS$$43$YR$A$F$Y$72.73$KG$20240912$$MD$US$US
243103051$24310305$1$I$20240101$20240829$20240912$20240912$PER$$US-SA-2024SA261148$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240912$$HP$US$US
243103061$24310306$1$I$20240801$20240829$20240912$20240912$PER$$US-SA-2024SA260847$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240912$$HP$US$US
243103071$24310307$1$I$20240601$20240830$20240912$20240912$PER$$US-SA-2024SA260786$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240912$$MD$US$US
243103081$24310308$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA261984$SANOFI AVENTIS$$$$A$M$Y$$$20240912$$MD$US$US
243103091$24310309$1$I$$20240826$20240912$20240912$PER$$US-SA-2024SA262004$SANOFI AVENTIS$$$$A$F$Y$61.36$KG$20240912$$MD$US$US
243103101$24310310$1$I$20240101$20240821$20240912$20240912$PER$$US-SA-2024SA262369$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240912$$MD$US$US
243103111$24310311$1$I$20240701$20240830$20240912$20240912$PER$$US-SA-2024SA261555$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240912$$CN$US$US
243103121$24310312$1$I$$20240827$20240912$20240912$PER$$US-SA-2024SA260423$SANOFI AVENTIS$$$$$M$Y$$$20240912$$CN$US$US
243103131$24310313$1$I$20240801$20240828$20240912$20240912$PER$$US-SA-2024SA259430$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240912$$HP$US$US
243103141$24310314$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA260040$SANOFI AVENTIS$$$$A$$Y$$$20240912$$CN$US$US
243103151$24310315$1$I$20240801$20240830$20240912$20240912$PER$$US-SA-2024SA262077$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240912$$HP$US$US
243103161$24310316$1$I$$20240910$20240912$20240912$PER$$US-ROCHE-10000078991$ROCHE$$$$A$F$Y$$$20240912$$CN$US$US
243103171$24310317$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA262006$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240912$$MD$US$US
243103182$24310318$2$F$20240801$20240909$20240912$20240923$PER$$US-SA-2024SA262213$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240923$$MD$US$US
243103191$24310319$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA263029$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240912$$HP$US$US
243103201$24310320$1$I$20240601$20240904$20240912$20240912$PER$$US-SA-2024SA261357$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240912$$CN$US$US
243103211$24310321$1$I$20240806$20240904$20240912$20240912$PER$$US-SA-2024SA261458$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240912$$CN$US$US
243103221$24310322$1$I$20240501$20240909$20240912$20240912$EXP$$US-ABBVIE-5916297$ABBVIE$$50$YR$$M$Y$$$20240912$$CN$US$US
243103232$24310323$2$F$$20240917$20240912$20240925$EXP$$US-TEVA-VS-3240345$TEVA$Varney SM, Watkins S, Stuteville H, Winter ML, Gao HT, Martin TG, et al. An Analysis of Clinical Outcomes of Exploratory Pediatric Metformin Ingestions Reported to the Texas Poison Center Network From 2011 to 2021. Hosp-Pharm 2024; 59 (4): 465-470.; Varney SM, Watkins S, Stuteville H, Winter ML, Gao HT, Martin TG, et al. An Analysis of Clinical Outcomes of Exploratory Pediatric Metformin Ingestions Reported to the Texas Poison Center Network From 2011 to 2021. Hosp-Pharm 2024; 59 (4): 465-470.$$$C$$Y$$$20240925$$HP$US$US
243103241$24310324$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5914932$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243103251$24310325$1$I$20240101$20240904$20240912$20240912$EXP$$CA-RECORDATI RARE DISEASES-2024006951$RECORDATI$$$$$$Y$$$20240912$$CN$CA$CA
243103271$24310327$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006741$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
243103281$24310328$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006388$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240912$$CN$US$US
243103291$24310329$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006685$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
243103302$24310330$2$F$$20240918$20240912$20240927$EXP$$CZ-TEVA-VS-3241024$TEVA$Kabut T, Weinbergerova B, Folber F, Lengerova M, Mayer J. High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience. Bone-Marrow-Transplant 2023; 58 1229-1236.; Kabut T, Weinbergerova B, Folber F, Lengerova M, Mayer J. High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience. Bone-Marrow-Transplant 2023; 58 1229-1236.; Kabut T, Weinbergerova B, Folber F, Lengerova M, Mayer J. High-dose acicl...$59$YR$$F$Y$$$20240927$$HP$CZ$CZ
243103311$24310331$1$I$$20240903$20240912$20240912$EXP$$VN-SANDOZ INC.-SDZ2024VN079644$SANDOZ$Tran ATK, Trinh HL. Efficacy and safety of first-line modified docetaxel/cisplatin/5-fu as the systemic therapy for metastatic esophageal cancer at hanoi medical university hospitalv. VIETNAM MEDICAL JOURNAL. 2022;519(1)$$$$$Y$$$20240912$$HP$VN$VN
243103321$24310332$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007253$ELI LILLY AND CO$$78$YR$E$F$Y$56.689$KG$20240912$$CN$US$US
243103331$24310333$1$I$20240101$20240906$20240912$20240912$EXP$$CN-ABBVIE-5913567$ABBVIE$Guo Y, Li J, Hu R, Tan J, Luo H, Zhang Z, et al. Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis. BMC Psychiatry. 2024;24(1):1-4.$12$YR$$M$Y$$$20240912$$HP$CN$CN
243103341$24310334$1$I$20240101$20240904$20240912$20240912$EXP$$CA-CELLTRION INC.-2024CA021664$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
243103351$24310335$1$I$20240831$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181113$AMGEN$$67$YR$E$M$Y$$$20240912$$CN$US$US
243103361$24310336$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004918$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243103372$24310337$2$F$$20240905$20240912$20240916$EXP$$JP-UCBSA-2024045198$UCB$Yayoi Shite, et al. A Case of Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion Associated with Super Refractory Status Epilepticus during Late Seizure. Journal of Japanese Society of Emergency Pediatrics. 2024;23(2):O-044$2$YR$$F$Y$$$20240916$$MD$JP$JP
243103381$24310338$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004919$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243103391$24310339$1$I$20240501$20240831$20240912$20240912$EXP$GB-MHRA-MED-202408312202138740-VSRJQ$GB-Accord-444581$ACCORD$$$$$F$Y$$$20240912$$CN$GB$GB
243103401$24310340$1$I$20240717$20240831$20240912$20240912$EXP$FR-AFSSAPS-AM2024000696$FR-Accord-445200$ACCORD$$64$YR$A$M$Y$140$KG$20240912$$PH$FR$FR
243103422$24310342$2$F$$20240918$20240912$20240927$EXP$$US-TEVA-VS-3242325$TEVA$Reinfeld S, Gill P. Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: A case series. CNS-Spectrums 2023; 28 (5): 587-591.; Reinfeld S, Gill P. Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: A case series. CNS-Spectrums 2023; 28 (5): 587-591.$12$YR$$F$Y$$$20240927$$HP$US$US
243103431$24310343$1$I$$20240902$20240912$20240912$EXP$$US-TEVA-VS-3240745$TEVA$Reinfeld S, Gill P. Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: A case series. CNS-Spectrums 2023; 28 (5): 587-591.$15$YR$$M$Y$$$20240912$$HP$US$US
243103441$24310344$1$I$$20240906$20240912$20240912$EXP$$US-JNJFOC-20240922997$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
243103451$24310345$1$I$20240814$20240902$20240912$20240912$EXP$$GB-AUROBINDO-AUR-APL-2024-043939$AUROBINDO$$77$YR$$F$Y$74$KG$20240912$$MD$GB$GB
243103461$24310346$1$I$$20240909$20240912$20240912$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050251$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240912$$MD$DE$DE
243103471$24310347$1$I$20240101$20240903$20240912$20240912$PER$$US-TEVA-VS-3240015$TEVA$$26$YR$$F$Y$78.2$KG$20240912$$CN$US$US
243103481$24310348$1$I$20240908$20240910$20240912$20240912$EXP$$US-ABBVIE-5918354$ABBVIE$$73$YR$$F$Y$$$20240912$$HP$US$US
243103491$24310349$1$I$$20240910$20240912$20240912$EXP$$US-ABBVIE-5917745$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243103501$24310350$1$I$20240501$20240903$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044437$AUROBINDO$$78$YR$$M$Y$$$20240912$$MD$FR$FR
243103511$24310351$1$I$20240101$20240906$20240912$20240912$EXP$$CO-UCBSA-2024046639$UCB$$$$$F$Y$$$20240912$$CN$CO$CO
243103521$24310352$1$I$$20240909$20240912$20240912$30DAY$$US-UCBSA-2024045197$UCB$$$$$M$Y$$$20240912$$CN$US$US
243103532$24310353$2$F$20240816$20240912$20240912$20240918$EXP$$PL-AstraZeneca-2024A204446$ASTRAZENECA$$30610$DY$$M$Y$74$KG$20240918$$MD$PL$
243103541$24310354$1$I$$20240904$20240912$20240912$EXP$$JP-AstraZeneca-2024A201498$ASTRAZENECA$$51$YR$$F$Y$$$20240912$$PH$JP$
243103551$24310355$1$I$$20240910$20240912$20240912$PER$$US-AstraZeneca-2024A206701$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243103561$24310356$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182545$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
243103571$24310357$1$I$$20240910$20240912$20240912$EXP$$NVSC2024US182175$NOVARTIS$$$$$F$Y$94$KG$20240912$$CN$US$US
243103581$24310358$1$I$$20240909$20240912$20240912$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-120852$REGENERON$$$$$M$Y$$$20240912$$CN$US$US
243103591$24310359$1$I$20200101$20240909$20240912$20240912$EXP$$US-JNJFOC-20240921530$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
243103601$24310360$1$I$20240908$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180465$AMGEN$$84$YR$E$M$Y$$$20240912$$CN$US$US
243103611$24310361$1$I$20230111$20240831$20240912$20240912$EXP$FR-AFSSAPS-MA2024001243$FR-Accord-445203$ACCORD$$58$YR$A$F$Y$72$KG$20240912$$PH$FR$FR
243103621$24310362$1$I$20230104$20240904$20240912$20240912$EXP$$US-VIIV HEALTHCARE LIMITED-US2024110219$VIIV$$64$YR$$M$Y$$$20240912$$CN$US$US
243103642$24310364$2$F$$20240913$20240912$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004925$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243103651$24310365$1$I$20240807$20240831$20240912$20240912$EXP$IT-MINISAL02-1000242$IT-Accord-444898$ACCORD$$6$YR$C$M$Y$15$KG$20240912$$MD$IT$IT
243103661$24310366$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004923$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243103671$24310367$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5915205$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243103681$24310368$1$I$20181012$20240905$20240912$20240912$EXP$$JP-GSK-JP2023JPN056855$GLAXOSMITHKLINE$Sudo M, Ito S, Takamura S, Sakai S, Kobayashi D, Abe A, et al. P1-073 Therapeutic effect and safety of belimumab for systemic lupus erythematosus. The 67th Annual General Assembly and Scientific Meeting of Japan College of Rheu. 779$$$$$Y$$$20240912$$MD$JP$JP
243103691$24310369$1$I$20240720$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004922$ACADIA PHARMACEUTICALS$$68$YR$$F$Y$$$20240912$$CN$US$US
243103701$24310370$1$I$$20240831$20240912$20240912$EXP$NL-LRB-00999666$NL-Accord-445204$ACCORD$$33$YR$A$M$Y$85$KG$20240912$$CN$NL$NL
243103711$24310371$1$I$20240907$20240907$20240912$20240912$EXP$$EG-REGENERON PHARMACEUTICALS, INC.-2024-121888$REGENERON$$55$YR$$M$Y$$$20240912$$MD$EG$EG
243103721$24310372$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013099$DR REDDYS$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 101: doi:10.1016/j.jflm.2023.102625.$67$YR$E$$Y$$$20240912$$HP$US$US
243103731$24310373$1$I$$20240904$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013218$DR REDDYS$Peshin S, Kapadia C, Krishnadasan R. CML-401 Insights into Neulasta-Associated Splenic Infarction: Unveiling a Rare Complication in Chemotherapy for Chronic Myelomonocytic Leukemia. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(1): S372. doi:10.1016/S2152-2650%2824%2901314-4.$67$YR$E$M$Y$$$20240912$$MD$US$US
243103741$24310374$1$I$$20240904$20240912$20240912$PER$$US-RDY-SPO/USA/24/0013133$DR REDDYS$Popat D, Singh A, Alfaraj A. MDS-669 Dramatically Decreased Transfusion Dependency With Luspatercept in a Case of High-Risk MDS. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(1): S402. doi:10.1016/S2152-2650%2824%2901375-2.$81$YR$E$M$Y$$$20240912$$MD$US$US
243103751$24310375$1$I$20240101$20240909$20240912$20240912$EXP$$US-JNJFOC-20240923539$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240912$$HP$US$US
243103761$24310376$1$I$$20240910$20240912$20240912$PER$$US-ALXN-202409USA000690US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243103781$24310378$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144400$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$74.39$KG$20240912$$HP$US$US
243103792$24310379$2$F$$20240912$20240912$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144685$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240918$$CN$US$US
243103801$24310380$1$I$$20240905$20240912$20240912$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-142441$BRISTOL MYERS SQUIBB$Shamseldin M, Heers H, Steiner T, Puls R. Anatomic locations of ureterovascular fistulae: a review of 532 patients in the literature and a new series of 8 patients. CVIR-Endovasc. 2024 Aug 14;7(1):1-15. doi:10.1186/s42155-024-00475-1.$85$YR$E$M$Y$$$20240912$$HP$DE$DE
243103811$24310381$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006405$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240912$$CN$US$US
243103822$24310382$2$F$$20240911$20240912$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409006480$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240919$$CN$US$US
243103831$24310383$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006420$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240912$$CN$US$US
243103841$24310384$1$I$$20240908$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005533$ELI LILLY AND CO$$12$YR$C$M$Y$$$20240912$$CN$US$US
243103851$24310385$1$I$20240909$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006482$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240912$$CN$US$US
243103861$24310386$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006330$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240912$$CN$US$US
243103871$24310387$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006344$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240912$$CN$US$US
243103881$24310388$1$I$$20240906$20240912$20240912$EXP$$RU-ORGANON-O2409RUS000721$ORGANON$$$$$F$Y$$$20240912$$MD$RU$RU
243103891$24310389$1$I$$20240905$20240912$20240912$PER$$US-INDOCO-IND-2024-US-SPO-00081$INDOCO$$$$$F$Y$$$20240912$$CN$US$US
243103902$24310390$2$F$20240902$20240906$20240912$20240917$EXP$$JP-UCBSA-2024045400$UCB$$35$YR$$M$Y$$$20240917$$MD$JP$JP
243103912$24310391$2$F$$20240911$20240912$20240913$EXP$$CN-AstraZeneca-2024A206170$ASTRAZENECA$$75$YR$$M$Y$68$KG$20240913$$CN$CN$
243103921$24310392$1$I$$20240909$20240912$20240912$EXP$$FR-SANDOZ INC.-SDZ2024FR078834$SANDOZ$$10$MON$$M$Y$$$20240912$$MD$FR$FR
243103931$24310393$1$I$$20240903$20240912$20240912$EXP$$US-ROCHE-10000073761$ROCHE$$85$YR$E$F$Y$$$20240912$$CN$US$US
243103941$24310394$1$I$20240909$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024180696$AMGEN$$72$YR$E$F$Y$$$20240912$$CN$US$US
243103952$24310395$2$F$$20240918$20240912$20240927$EXP$$DE-TEVA-VS-3242037$TEVA$Mohring C, Graffe FJF, Bartels A, Sadeghlar F, Zhou T, Mahn R, et al. Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experience and review of literature. J-Gastrointest-Oncol 2023; 14 (1): 352-365.; Mohring C, Graffe FJF, Bartels A, Sadeghlar F, Zhou T, Mahn R, et al. Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experience and review of literature. J-Gastrointe...$$$$$Y$$$20240927$$HP$DE$DE
243103961$24310396$1$I$20231011$20240902$20240912$20240912$EXP$FR-AFSSAPS-LL2024001631$FR-TEVA-VS-3239801$TEVA$$2$MON$$M$Y$$$20240912$$MD$FR$FR
243103971$24310397$1$I$20240427$20240823$20240912$20240912$PER$$US-TEVA-VS-3237514$TEVA$$47$YR$$F$Y$$$20240912$$CN$US$US
243103981$24310398$1$I$$20240904$20240912$20240912$EXP$$US-GSK-US2024GSK111989$GLAXOSMITHKLINE$Li Y, Ang HS, Fatehi P, Htet N. The Roller Coaster of Lamotrigine Levels: Successful Treatment of Massive Lamotrigine Overdose With Continuous Veno-Venous Hemodiafiltration and Rifampin. Cureus. 2024;16 (7)$$$$$Y$$$20240912$$MD$US$US
243103991$24310399$1$I$20191201$20240831$20240912$20240912$EXP$BG-EMA-DD-20240826-7482827-083236$BG-Accord-444963$ACCORD$$53$YR$A$F$Y$54$KG$20240912$$MD$BG$BG
243104002$24310400$2$F$20240904$20240926$20240912$20240930$PER$$US-JNJFOC-20240915009$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240930$$CN$US$US
243104011$24310401$1$I$$20240909$20240912$20240912$EXP$$US-JNJFOC-20240926143$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243104021$24310402$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144630$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240912$$PH$US$US
243104031$24310403$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144331$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$67.59$KG$20240912$$HP$US$US
243104041$24310404$1$I$$20240904$20240912$20240912$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-032223$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240912$$CN$US$US
243104061$24310406$1$I$$20240910$20240912$20240912$EXP$$CN-ORGANON-O2404CHN000985$ORGANON$$$$$F$Y$$$20240912$$CN$CN$CN
243104071$24310407$1$I$20240806$20240831$20240912$20240912$EXP$CN-HENLIUS-24CN016824$CN-Accord-445923$ACCORD$$53$YR$$F$Y$$$20240912$$MD$CN$CN
243104082$24310408$2$F$20240717$20240906$20240912$20240917$EXP$$RU-ABBVIE-5909943$ABBVIE$$$$A$F$Y$50$KG$20240917$$HP$RU$RU
243104091$24310409$1$I$20240819$20240820$20240912$20240912$PER$$US-SA-2024SA262956$SANOFI AVENTIS$$18$YR$A$M$Y$54.55$KG$20240912$$MD$US$US
243104101$24310410$1$I$20240812$20240831$20240912$20240912$EXP$FR-AFSSAPS-BR2024000691$FR-Accord-444894$ACCORD$$17$YR$T$F$Y$45$KG$20240912$$MD$FR$FR
243104111$24310411$1$I$20230530$20240831$20240912$20240912$EXP$FR-AFSSAPS-AM2024000677$FR-Accord-444889$ACCORD$$91$YR$E$F$Y$48$KG$20240912$$MD$FR$FR
243104122$24310412$2$F$$20240911$20240912$20240923$EXP$$CA-APOTEX-2024AP010277$APOTEX$$$$E$M$Y$$$20240923$$PH$CA$CA
243104131$24310413$1$I$$20240903$20240912$20240912$EXP$$GB-CELLTRION INC.-2024GB021539$CELLTRION$$$$$$Y$$$20240912$$CN$GB$GB
243104141$24310414$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA260222$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240912$$MD$US$US
243104151$24310415$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2023SA342623$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240912$$HP$US$US
243104161$24310416$1$I$20240801$20240905$20240912$20240912$PER$$US-JNJFOC-20240915207$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240912$$CN$US$US
243104171$24310417$1$I$$20240909$20240912$20240912$EXP$$US-JNJFOC-20240923797$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240912$$HP$US$US
243104181$24310418$1$I$$20240905$20240912$20240912$PER$$US-JNJFOC-20240915408$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243104201$24310420$1$I$20240804$20240903$20240912$20240912$PER$$US-SA-2024SA261455$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240912$$HP$US$US
243104212$24310421$2$F$20240801$20240903$20240912$20240920$PER$$US-SA-2024SA259120$SANOFI AVENTIS$$74$YR$E$F$Y$107.73$KG$20240920$$MD$US$US
243104221$24310422$1$I$20240101$20240905$20240912$20240912$PER$$US-ABBVIE-5909543$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243104241$24310424$1$I$$20240910$20240912$20240912$PER$$US-HALEON-2196452$Haleon PLC$$79$YR$$M$Y$$$20240912$$CN$US$US
243104251$24310425$1$I$$20240905$20240912$20240912$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR111907$VIIV$$$$$M$Y$$$20240912$$MD$US$US
243104261$24310426$1$I$$20240904$20240912$20240912$PER$$NVSC2024US178574$NOVARTIS$$$$$M$Y$$$20240912$$CN$US$US
243104271$24310427$1$I$20240101$20240823$20240912$20240912$PER$$US-TEVA-VS-3238134$TEVA$$76$YR$$F$Y$$$20240912$$MD$US$US
243104281$24310428$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004927$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243104291$24310429$1$I$$20240906$20240912$20240912$PER$$US-AMGEN-USASP2024180838$AMGEN$$$$$$Y$$$20240912$$MD$US$US
243104301$24310430$1$I$20240823$20240911$20240912$20240912$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050750$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240912$$HP$SG$SG
243104311$24310431$1$I$20240903$20240910$20240912$20240912$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050895$BOEHRINGER INGELHEIM$$83$YR$E$F$Y$$$20240912$$HP$CO$CO
243104321$24310432$1$I$20240729$20240912$20240912$20240912$EXP$FR-AFSSAPS-TS2024000973$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051000$BOEHRINGER INGELHEIM$$56$YR$A$M$Y$$$20240912$$MD$FR$FR
243104331$24310433$1$I$20240101$20240905$20240912$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143143$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$82.1$KG$20240912$$MD$JP$JP
243104341$24310434$1$I$20240825$20240903$20240912$20240912$PER$$US-RDY-SPO/USA/24/0013011$DR REDDYS$$64$YR$E$M$Y$137$KG$20240912$$MD$US$US
243104351$24310435$1$I$20240714$20240905$20240912$20240912$EXP$FR-AFSSAPS-RN2024000935$FR-ROCHE-10000074802$ROCHE$$33$YR$A$F$Y$$$20240912$$MD$FR$FR
243104361$24310436$1$I$$20240904$20240912$20240912$PER$$US-ROCHE-10000075391$ROCHE$$$$E$F$Y$$$20240912$$MD$US$US
243104381$24310438$1$I$$20240909$20240912$20240912$EXP$$GB-AstraZeneca-2024A205049$ASTRAZENECA$$$$C$$Y$$$20240912$$MD$GB$
243104391$24310439$1$I$20240829$20240829$20240912$20240912$PER$$US-AstraZeneca-2024A197770$ASTRAZENECA$$31110$DY$$F$Y$$$20240912$$CN$US$
243104401$24310440$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A201794$ASTRAZENECA$$$$$F$Y$52.2$KG$20240912$$CN$US$
243104411$24310441$1$I$$20240614$20240912$20240912$EXP$$US-AUROBINDO-AUR-APL-2024-023962$AUROBINDO$Pankti P. Acharya, Joseph.C. An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report. Addiction Science + Clinical Practice. 2024;19 (1):34:1 to 5$41$YR$$M$Y$$$20240912$$MD$US$US
243104421$24310442$1$I$20240811$20240910$20240912$20240912$EXP$$PT-AstraZeneca-2024A205844$ASTRAZENECA$$82$YR$$F$Y$$$20240912$$MD$PT$
243104431$24310443$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006656$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240912$$CN$US$US
243104441$24310444$1$I$20210721$20240909$20240912$20240912$EXP$$ES-SANDOZ INC.-NVSC2021ES230761$SANDOZ$$69$YR$$M$Y$91$KG$20240912$$HP$ES$ES
243104451$24310445$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006400$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240912$$CN$US$US
243104461$24310446$1$I$20240701$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006048$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240912$$CN$US$US
243104471$24310447$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006350$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
243104481$24310448$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006586$ELI LILLY AND CO$$$$$M$Y$$$20240912$$CN$US$US
243104491$24310449$1$I$20240910$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006419$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240912$$CN$US$US
243104501$24310450$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006613$ELI LILLY AND CO$$$$$$Y$$$20240912$$CN$US$US
243104511$24310451$1$I$$20240906$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007016$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240912$$CN$US$US
243104521$24310452$1$I$20240902$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007192$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
243104531$24310453$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004929$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243104541$24310454$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5914125$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243104551$24310455$1$I$20240816$20240906$20240912$20240912$EXP$$CA-ABBVIE-5913776$ABBVIE$$78$YR$$M$Y$$$20240912$$CN$CA$CA
243104561$24310456$1$I$20240801$20240905$20240912$20240912$EXP$$JP-AMGEN-JPNSP2024180827$AMGEN$$$$$F$Y$$$20240912$$MD$JP$JP
243104571$24310457$1$I$20231027$20240905$20240912$20240912$EXP$$US-ABBVIE-5847224$ABBVIE$$51$YR$$F$Y$$$20240912$$CN$US$US
243104581$24310458$1$I$$20240902$20240912$20240912$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08262$HIKMA$$73$YR$$F$Y$57$KG$20240912$$HP$CA$CA
243104612$24310461$2$F$$20240923$20240912$20240928$EXP$$US-TAKEDA-2024TUS083975$TAKEDA$$$$$M$Y$$$20240928$$CN$US$US
243104621$24310462$1$I$$20240904$20240912$20240912$PER$$US-MTPC-MTDA2024-0018883$Unknown Manufacturer$$$$A$M$Y$$$20240912$$CN$US$US
243104631$24310463$1$I$20240728$20240910$20240912$20240912$EXP$$US-MTPC-MTDA2024-0019132$Unknown Manufacturer$$75$YR$$M$Y$$$20240912$$PH$US$US
243104641$24310464$1$I$20230101$20240905$20240912$20240912$EXP$$US-ABBVIE-5909667$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243104651$24310465$1$I$$20240906$20240912$20240912$PER$$US-MTPC-MTDA2024-0018952$Unknown Manufacturer$$$$E$M$Y$$$20240912$$CN$US$US
243104661$24310466$1$I$20160101$20240903$20240912$20240912$EXP$$US-JNJFOC-20240903930$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240912$$CN$US$US
243104681$24310468$1$I$20240502$20240906$20240912$20240912$EXP$$US-ABBVIE-5914507$ABBVIE$$75$YR$$M$Y$$$20240912$$CN$US$US
243104691$24310469$1$I$$20240902$20240912$20240912$EXP$$ES-AUROBINDO-AUR-APL-2024-044059$AUROBINDO$Ruiz Sarrias O, Gonzalez Deza C, Rodriguez Rodriguez J, Arrizibita Iriarte O, Sayar Beristain O, Aldaz Pastor A, et al.. Predicting Severe Haematological Toxicity in Gastrointestinal Cancer Patients Undergoing 5-FU-Based Chemotherapy: A Bayesian Network Approach.. Cancers. 2023;15 No 17:4206$$$$$Y$$$20240912$$HP$ES$ES
243104701$24310470$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5914114$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243104711$24310471$1$I$$20240826$20240912$20240912$PER$$US-APOTEX-2024AP009831$APOTEX$$$$$$Y$$$20240912$$PH$US$US
243104721$24310472$1$I$20240822$20240903$20240912$20240912$EXP$$BR-CELLTRION INC.-2024BR021484$CELLTRION$$$$$$Y$$$20240912$$CN$BR$BR
243104751$24310475$1$I$20240501$20240906$20240912$20240912$EXP$$US-ABBVIE-5914022$ABBVIE$$60$YR$$F$Y$$$20240912$$CN$US$US
243104761$24310476$1$I$20240901$20240910$20240912$20240912$EXP$$US-MTPC-MTDA2024-0019137$Unknown Manufacturer$$54$YR$$$Y$$$20240912$$CN$US$US
243104771$24310477$1$I$$20240828$20240912$20240912$PER$$US-ASTELLAS-2024-AER-003705$ASTELLAS$$$$$F$Y$$$20240912$$MD$US$US
243104781$24310478$1$I$20240127$20240831$20240912$20240912$EXP$FR-AFSSAPS-BX2024001703$FR-Accord-444899$ACCORD$$6$YR$C$M$Y$18$KG$20240912$$MD$FR$FR
243104791$24310479$1$I$20240528$20240903$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044331$AUROBINDO$$51$YR$$M$Y$65$KG$20240912$$MD$FR$FR
243104801$24310480$1$I$20240823$20240906$20240912$20240912$PER$$US-AMGEN-USASP2024181312$AMGEN$$$$$M$Y$$$20240912$$CN$US$US
243104811$24310481$1$I$$20230824$20240912$20240912$PER$US-MLMSERVICE-20230821-4489063-1$US-STRIDES ARCOLAB LIMITED-2023SP013817$STRIDES$Yang PG, Johnson CW, Hicken KH.. Suicidality in an older patient with chronic kidney disease.. Current Psychiatry.. 2023;22(1):44-48$72$YR$$M$Y$$$20240912$$HP$US$US
243104831$24310483$1$I$20240809$20240831$20240912$20240912$EXP$FR-AFSSAPS-ST2024001355$FR-Accord-445199$ACCORD$$84$YR$E$F$Y$60$KG$20240912$$MD$FR$FR
243104842$24310484$2$F$$20240906$20240912$20240919$EXP$$IT-AUROBINDO-AUR-APL-2024-044194$AUROBINDO$Fiorani C, Tchawa C, Cadoni A, Moro M, Porzio G, Giusti R. Letter to the Editor: Chlorpromazine as a Viable Alternative to Midazolam for Palliative Sedation in a Liver Transplant Recipient with HCC: A Brief Communication. J-Palliat-Med. 2024;27 (7)$51$YR$$F$Y$$$20240919$$HP$IT$IT
243104851$24310485$1$I$$20240108$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000554$STRIDES$Lane K, Kim S, Grock S, Freeby M.. Hypercalcemia After Placement of Antibiotic-Loaded Calcium Sulfate Beads.. J-Endocr-Soc. 2020;4 (Suppl.):A594-A595$$$$$Y$$$20240912$$MD$US$US
243104861$24310486$1$I$$20231115$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017447$STRIDES$Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clin-Diabet. 2022;40(2):253-256$14$YR$$F$Y$$$20240912$$HP$US$US
243104871$24310487$1$I$$20240117$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000904$STRIDES$Xi Q, Plaza Enriquez LJ, Tanni NU, Patsias I.. Underdiagnosed Roifman syndrome manifested as non-ischaemic cardiomyopathy: a case report. ESC-Heart-Fail. 2023;10 (5):3195-3198$20$YR$$M$Y$$$20240912$$HP$US$US
243104881$24310488$1$I$$20240417$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP004855$STRIDES$Patel D, Al-Jobory O, Dharmarpandi G, Naguib T.. A case of substantial acute kidney injury with resistance to hyperkalemia treatment induced by very low dose angiotensin converting enzyme inhibitors due to poor underlying mineralocorticoid function.. Am-J-Med-Sci. 2024;367 (Suppl. 1):S309-S310 abstr. 515$68$YR$$F$Y$$$20240912$$HP$US$US
243104891$24310489$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5916970$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243104902$24310490$2$F$20240819$20240923$20240912$20240926$EXP$$US-ABBVIE-5915278$ABBVIE$$34$YR$$F$Y$$$20240926$$CN$US$US
243104911$24310491$1$I$20200101$20240909$20240912$20240912$EXP$US-MLMSERVICE-20220531-3583040-1$US-SANDOZ INC.-SDZ2024US078645$SANDOZ$$63$YR$$M$Y$$$20240912$$MD$US$US
243104921$24310492$1$I$$20240902$20240912$20240912$EXP$$US-AUROBINDO-AUR-APL-2024-044164$AUROBINDO$Vincent MN, Jaggers J, Fiske C, Phillips EJ, Stollings JL. Amikacin symmetrical drug-related intertriginous and flexural exanthema on the basis of neomycin cross-reactivity managed with desensitization and treating through.. Ann-Allergy-Asthma-Immunol. 2024;133(2):215-217.$70$YR$$F$Y$$$20240912$$HP$US$US
243104931$24310493$1$I$$20240831$20240912$20240912$EXP$$HU-Accord-445104$ACCORD$Barczi Gy, Papp R, David DA, Fulop GA, Kulyassa PM, et al.Sudden cardiac death of a patient who has basically low risk profile. Does psychiatric treatment modify risk? Cardiologia Hungarica Supplementum. 2024/3: 309.$18$YR$A$M$Y$$$20240912$$MD$HU$HU
243104941$24310494$1$I$$20231107$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016961$STRIDES$Gruen D, Sanchez Di Sclafani M, Durdevic M, Spinelli C, Lakshmi K, Jesmajian S, et al.. Entering unusual territory: A rare case of enterococcal bacteremia-induced IgA nephropathy.. Chest. 2023;164 (Suppl.)(4):A209-A210$72$YR$$M$Y$$$20240912$$HP$US$US
243104951$24310495$1$I$$20240426$20240912$20240912$PER$US-MLMSERVICE-20240419-PI014591-00162-1$US-STRIDES ARCOLAB LIMITED-2024SP005222$STRIDES$DiBattista JV, Odenwald MA, Te H.. Successful Treatment of Refractory Chylous Ascites With Octreotide in a Patient With Decompensated Cirrhosis.. ACG Case Reports Journal. 2024;11(4):e01322$63$YR$$M$Y$$$20240912$$MD$US$US
243104961$24310496$1$I$$20240304$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002772$STRIDES$Hajmurad MF, Matthews D, Meyer A, et al.. Acute Hypoxic Respiratory Failure in Setting of Bronchiolitis Obliterans After COVID-19 Infection Complicated by Pulmonary Hypertension.. Am-J-Respir-Crit-Care-Med. 2023;207 (plus Poste$34$YR$$F$Y$$$20240912$$HP$US$US
243104971$24310497$1$I$$20240717$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009123$STRIDES$Migally K, Monge M, Wolfe B, Hammond N, Joong A.. Paracorporeal Ventricular Assist Device as Bridge to Transplant after Suspected SARS-CoV-2 Myocarditis in Child with Stage II Single Ventricle Palliation.. ASAIO-J. 2024;70 (Suppl.):149 abstr. P70.$10$MON$$M$Y$9.2$KG$20240912$$HP$US$US
243104981$24310498$1$I$$20231228$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000151$STRIDES$Zarei S, Kamali S, Narinyan W, Nasouri F, Hassani S, Ibrahim AM, et al.. Idiopathic intracranial hypertension associated with polycystic ovarian syndrome, sensorineural hearing loss, and elevated inflammatory markers that lead to bilateral blindness: A case report with literature review.. Surg-Neurol-Int. 2023;14 (399):1-7$32$YR$$F$Y$$$20240912$$HP$US$US
243104991$24310499$1$I$$20240112$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP000732$STRIDES$Simrampreet G, Funes IAG, Gomez D, Siddiqui S, Zahedi T, Zhang F.. SIADH In Acromegaly And Cerebrovascular Accident.. J-Endocr-Soc. 2023;7 (Suppl. 1):A688-A689$81$YR$$F$Y$$$20240912$$HP$US$US
243105001$24310500$1$I$20240301$20240906$20240912$20240912$EXP$$US-ABBVIE-5915270$ABBVIE$$68$YR$$F$Y$$$20240912$$CN$US$US
243105012$24310501$2$F$$20240913$20240912$20240925$EXP$$CN-ACS-20240335$ACS DOBFAR$Dai R, Niu Z, Yang Y, Liu X, Zhang B. Case report: Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by ceftazidime in a connective tissue disease (CTD) patient. Front Pharmacol. 2024 Aug 12;15:1403390. doi: 10.3389/fphar.2024.1403390.$58$YR$A$F$Y$41$KG$20240916$$MD$CN$
243105031$24310503$1$I$20240901$20240906$20240912$20240912$EXP$$CA-ABBVIE-5914448$ABBVIE$$$$E$F$Y$$$20240912$$CN$CA$CA
243105041$24310504$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004931$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243105051$24310505$1$I$20240802$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A202939$ASTRAZENECA$$23701$DY$$F$Y$59$KG$20240912$$CN$US$
243105061$24310506$1$I$$20240909$20240912$20240912$EXP$$US-AstraZeneca-2024A205164$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243105072$24310507$2$F$20240601$20240909$20240912$20240917$EXP$$DE-AstraZeneca-2024A202632$ASTRAZENECA$$64$YR$$M$Y$$$20240917$$MD$DE$
243105081$24310508$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A201890$ASTRAZENECA$$$$$F$Y$76$KG$20240912$$CN$US$
243105091$24310509$1$I$20240801$20240906$20240912$20240912$EXP$$US-RECORDATI-2024006911$RECORDATI$$$$$$Y$$$20240912$$CN$US$US
243105101$24310510$1$I$$20240909$20240912$20240912$EXP$$DE-SANDOZ INC.-SDZ2024DE079227$SANDOZ$$8$DEC$$$Y$$$20240912$$MD$DE$DE
243105111$24310511$1$I$$20240909$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US079399$SANDOZ$$$$$$Y$86.36$KG$20240912$$CN$US$US
243105121$24310512$1$I$$20240910$20240912$20240912$EXP$$CA-SANDOZ INC.-NVSC2022CA223879$SANDOZ$$80$YR$$M$Y$$$20240912$$HP$CA$CA
243105131$24310513$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004940$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$HP$US$US
243105141$24310514$1$I$$20240912$20240912$20240912$PER$$US-PROD-AS2-212756134-RB-089500-2024$RECKITT BENCKISER$$$$$F$Y$$$20240912$$CN$US$US
243105151$24310515$1$I$$20240903$20240912$20240912$EXP$$US-AUROBINDO-AUR-APL-2024-045168$AUROBINDO$$49$YR$$$Y$$$20240912$$PH$US$US
243105161$24310516$1$I$20240802$20240903$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044386$AUROBINDO$$70$YR$$F$Y$$$20240912$$PH$FR$FR
243105171$24310517$1$I$20190522$20240905$20240912$20240912$EXP$$JP-GSK-JP2024JPN110395$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$JP$JP
243105182$24310518$2$F$$20240923$20240912$20240930$EXP$$CA-GSK-CA2024AMR110944$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$CA$CA
243105191$24310519$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006626$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240912$$CN$US$US
243105202$24310520$2$F$$20240911$20240912$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005791$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240916$$CN$US$US
243105211$24310521$1$I$20240905$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006999$ELI LILLY AND CO$$65$YR$E$$Y$$$20240912$$CN$US$US
243105221$24310522$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006312$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240912$$CN$US$US
243105231$24310523$1$I$$20240903$20240912$20240912$EXP$$CA-AUROBINDO-AUR-APL-2024-044681$AUROBINDO$$31$YR$$F$Y$$$20240912$$HP$CA$CA
243105241$24310524$1$I$$20240909$20240912$20240912$EXP$$PT-BAUSCH-BL-2024-013526$BAUSCH AND LOMB$Marques A. EP-066 - CNS infection by varicella zoster. Sinapse. 2023;23(SUPPL 1):293-294.$$$E$$Y$$$20240912$$MD$PT$PT
243105261$24310526$1$I$20230123$20240903$20240912$20240912$EXP$$ES-CELLTRION INC.-2023ES003187$CELLTRION$$$$$$Y$$$20240912$$HP$ES$ES
243105271$24310527$1$I$$20240910$20240912$20240912$EXP$$US-BAUSCH-BL-2024-013589$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240912$$CN$US$US
243105281$24310528$1$I$20231218$20240909$20240912$20240912$EXP$$US-ABBVIE-5917127$ABBVIE$$23$YR$$M$Y$$$20240912$$CN$US$US
243105291$24310529$1$I$20240501$20240906$20240912$20240912$EXP$$CA-ABBVIE-5917631$ABBVIE$$$$E$F$Y$$$20240912$$CN$CA$CA
243105301$24310530$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004996$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243105311$24310531$1$I$$20240909$20240912$20240912$PER$$NVSC2024US182582$NOVARTIS$$$$$$Y$$$20240912$$CN$US$US
243105321$24310532$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5916830$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243105331$24310533$1$I$20240829$20240902$20240912$20240912$PER$$US-IGSA-BIG0030595$GRIFOLS$$77$YR$$M$Y$82.086$KG$20240912$$CN$US$US
243105341$24310534$1$I$20190709$20240909$20240912$20240912$EXP$$CO-UCBSA-2024046393$UCB$$46$YR$$F$Y$$$20240912$$CN$CO$CO
243105361$24310536$1$I$20240101$20240909$20240912$20240912$EXP$$US-ABBVIE-5916291$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243105381$24310538$1$I$20240901$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145015$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240912$$CN$US$US
243105391$24310539$1$I$$20240904$20240912$20240912$EXP$$US-ROCHE-10000066516$ROCHE$$73$YR$E$M$Y$147$KG$20240912$$CN$US$US
243105401$24310540$1$I$20230120$20240903$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044439$AUROBINDO$$50$YR$$F$Y$$$20240912$$PH$FR$FR
243105411$24310541$1$I$20240215$20240906$20240912$20240912$PER$$US-ROCHE-10000075286$ROCHE$$69$YR$E$F$Y$72.57$KG$20240912$$CN$US$US
243105421$24310542$1$I$$20240910$20240912$20240912$PER$$US-ALXN-202409USA000676US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243105431$24310543$1$I$$20240830$20240912$20240912$PER$$US-JNJFOC-20240900725$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243105441$24310544$1$I$$20240909$20240912$20240912$PER$$US-ALXN-202409USA000662US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243105451$24310545$1$I$$20240904$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044688$AUROBINDO$Schwarz C, Morel A Matignon M, Grimbert P, Rondeau E, Ouali N, et al. Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept. Kidney Int Rep. 2023;8 (8):1531-1541$77$YR$$$Y$$$20240912$$HP$FR$FR
243105461$24310546$1$I$$20240829$20240912$20240912$EXP$MY-MLMSERVICE-20240821-PI169360-00199-1$MY-NAARI PTE LIMITED-2024NP000088$NAARI PHARMA$Weeraj C, Kannan B.. Mesenteric Ischemia in a Patient on Levonorgestrel Containing Oral Contraception.. Journal of obstetrics and gynaecology Canada: JOGC. 2024;46 (10):01-02$44$YR$$F$Y$$$20240912$$MD$MY$MY
243105472$24310547$2$F$$20240913$20240912$20240920$EXP$$US-EMD Serono-2024047956$EMD SERONO INC$$55$YR$A$F$Y$$$20240920$$CN$US$US
243105481$24310548$1$I$20240101$20240909$20240912$20240912$EXP$$US-ABBVIE-5917233$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243105491$24310549$1$I$$20240910$20240912$20240912$EXP$$US-GILEAD-2024-0687372$GILEAD$$$$A$M$Y$$$20240912$$CN$US$US
243105501$24310550$1$I$20240828$20240909$20240912$20240912$EXP$$CN-ABBVIE-5916449$ABBVIE$$48$YR$$F$Y$44$KG$20240912$$MD$CN$CN
243105511$24310551$1$I$$20240831$20240912$20240912$EXP$CA-MHPD-E2B_07248238$CA-Accord-444593$ACCORD$$92$YR$E$M$Y$$$20240912$$HP$CA$CA
243105521$24310552$1$I$20240831$20240910$20240912$20240912$PER$$US-ROCHE-10000079301$ROCHE$$44$YR$A$F$Y$$$20240912$$CN$US$US
243105531$24310553$1$I$20240501$20240911$20240912$20240912$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050753$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240912$$HP$SG$SG
243105541$24310554$1$I$$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144809$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240912$$CN$US$US
243105551$24310555$1$I$$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143961$BRISTOL MYERS SQUIBB$$$$A$M$Y$$$20240912$$CN$US$US
243105561$24310556$1$I$20240909$20240911$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145070$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240912$$CN$US$US
243105571$24310557$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5914660$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243105581$24310558$1$I$20240701$20240906$20240912$20240912$EXP$$US-ABBVIE-5892431$ABBVIE$$82$YR$$M$Y$72.574$KG$20240912$$CN$US$US
243105591$24310559$1$I$20240612$20240904$20240912$20240912$EXP$$AR-AMGEN-ARGSP2024179301$AMGEN$$64$YR$A$F$Y$$$20240912$$CN$AR$AR
243105601$24310560$1$I$$20240912$20240912$20240912$PER$$US-PROD-AS2-212756134-RB-082107-2024$RECKITT BENCKISER$$$$$M$Y$$$20240912$$CN$US$US
243105622$24310562$2$F$20240908$20240909$20240912$20240917$PER$$US-AMGEN-USASP2024179919$AMGEN$$78$YR$E$M$Y$$$20240917$$CN$US$US
243105631$24310563$1$I$20240720$20240904$20240912$20240912$EXP$GB-MHRA-MED-202409041640318420-YWHLN$GB-PERRIGO-24GB008220$PERRIGO$$42$YR$$F$Y$$$20240912$$PH$GB$GB
243105641$24310564$1$I$$20240904$20240912$20240912$EXP$$BE-AstraZeneca-2024A202613$ASTRAZENECA$$$$$F$Y$$$20240912$$MD$BE$
243105651$24310565$1$I$20240715$20240820$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004891$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240912$$CN$US$US
243105661$24310566$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004869$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243105671$24310567$1$I$$20240909$20240912$20240912$PER$$US-ROCHE-10000078334$ROCHE$$67$YR$E$M$Y$$$20240912$$CN$US$US
243105681$24310568$1$I$$20240909$20240912$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014649$JAZZ$$$$$M$Y$$$20240912$$CN$US$US
243105701$24310570$1$I$20240910$20240910$20240912$20240912$PER$$US-ROCHE-10000078993$ROCHE$$76$YR$E$F$Y$$$20240912$$CN$US$US
243105712$24310571$2$F$20240807$20240919$20240912$20240927$EXP$PT-INFARMED-E202409-104$PT-GSK-PT2024112944$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$PH$PT$PT
243105722$24310572$2$F$20240819$20240906$20240912$20240913$EXP$$CN-JNJFOC-20240923663$JOHNSON AND JOHNSON$$62$YR$A$M$Y$65$KG$20240913$$HP$CN$CN
243105732$24310573$2$F$20220816$20240916$20240912$20240923$EXP$$CA-TAKEDA-2024TUS033100$TAKEDA$$25$YR$$F$Y$83$KG$20240923$$CN$CA$CA
243105741$24310574$1$I$20240601$20240904$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044749$AUROBINDO$$46$YR$$F$Y$$$20240912$$MD$FR$FR
243105751$24310575$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004892$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243105791$24310579$1$I$20240601$20240828$20240912$20240912$PER$$US-SA-2024SA262937$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240912$$MD$US$US
243105801$24310580$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262349$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240912$$HP$US$US
243105821$24310582$1$I$20240101$20240828$20240912$20240912$PER$$US-SA-2024SA260180$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240912$$MD$US$US
243105831$24310583$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262352$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240912$$HP$US$US
243105842$24310584$2$F$20240101$20240913$20240912$20240927$PER$$US-SA-2024SA259556$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240927$$MD$US$US
243105851$24310585$1$I$20240101$20240909$20240912$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014647$JAZZ$$$$$F$Y$$$20240912$$CN$US$US
243105861$24310586$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA263488$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240912$$HP$US$US
243105871$24310587$1$I$$20240902$20240912$20240912$EXP$$IE-TAKEDA-2024TUS090161$TAKEDA$$51$YR$$M$Y$$$20240912$$MD$IE$IE
243105881$24310588$1$I$$20240831$20240912$20240912$EXP$CA-MHPD-E2B_07251807$CA-Accord-444590$ACCORD$$74$YR$E$M$Y$$$20240912$$HP$CA$CA
243105891$24310589$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA247232$SANOFI AVENTIS$$$$$M$Y$$$20240912$$MD$US$US
243105901$24310590$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA023121$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240912$$MD$US$US
243105921$24310592$1$I$$20240821$20240912$20240912$PER$$US-SA-2024SA262676$SANOFI AVENTIS$$11$YR$C$$Y$$$20240912$$MD$US$US
243105931$24310593$1$I$20240819$20240830$20240912$20240912$PER$$US-SA-2024SA254548$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240912$$CN$US$US
243105941$24310594$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262420$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240912$$HP$US$US
243105952$24310595$2$F$20240101$20240912$20240912$20240923$PER$$US-SA-2024SA261385$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240923$$MD$US$US
243105961$24310596$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263493$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240912$$HP$US$US
243105971$24310597$1$I$20240821$20240821$20240912$20240912$PER$$US-SA-2024SA261990$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240912$$HP$US$US
243105981$24310598$1$I$20240101$20240830$20240912$20240912$PER$$US-SA-2024SA261435$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240912$$MD$US$US
243105992$24310599$2$F$20240828$20240912$20240912$20240919$EXP$$US-ABBVIE-5914890$ABBVIE$$73$YR$$M$Y$104.33$KG$20240919$$CN$US$US
243106001$24310600$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143580$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240912$$HP$US$US
243106011$24310601$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5914474$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243106021$24310602$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262377$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240912$$CN$US$US
243106031$24310603$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA261604$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240912$$MD$US$US
243106041$24310604$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262506$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240912$$HP$US$US
243106051$24310605$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA261382$SANOFI AVENTIS$$$$A$M$Y$$$20240912$$CN$US$US
243106061$24310606$1$I$20240902$20240903$20240912$20240912$PER$$US-SA-2024SA262530$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240912$$MD$US$US
243106071$24310607$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA262280$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240912$$HP$US$US
243106081$24310608$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA261497$SANOFI AVENTIS$$13$YR$T$M$Y$59.09$KG$20240912$$HP$US$US
243106091$24310609$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262365$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240912$$HP$US$US
243106102$24310610$2$F$$20240909$20240912$20240918$PER$$US-SA-2024SA262298$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240918$$CN$US$US
243106111$24310611$1$I$20240401$20240906$20240912$20240912$EXP$$US-ABBVIE-5914995$ABBVIE$$80$YR$$M$Y$$$20240912$$CN$US$US
243106121$24310612$1$I$20240823$20240909$20240912$20240912$PER$$US-SA-2024SA263345$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240912$$HP$US$US
243106131$24310613$1$I$20240101$20240909$20240912$20240912$PER$$US-SA-2024SA263657$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240912$$HP$US$US
243106141$24310614$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA263343$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240912$$MD$US$US
243106151$24310615$1$I$20240701$20240906$20240912$20240912$EXP$$US-ABBVIE-5914363$ABBVIE$$37$YR$$F$Y$$$20240912$$CN$US$US
243106161$24310616$1$I$$20240905$20240912$20240912$30DAY$$US-GSK-US2024110803$GLAXOSMITHKLINE$$$$E$F$Y$$$20240912$$CN$US$US
243106171$24310617$1$I$20240801$20240909$20240912$20240912$EXP$$US-ABBVIE-5915508$ABBVIE$$44$YR$$F$Y$$$20240912$$CN$US$US
243106181$24310618$1$I$$20240905$20240912$20240912$EXP$$IN-ROCHE-10000075936$ROCHE$$$$E$F$Y$$$20240912$$MD$IN$IN
243106191$24310619$1$I$20240818$20240905$20240912$20240912$EXP$$PT-AUROBINDO-AUR-APL-2024-044421$AUROBINDO$$84$YR$$M$Y$70$KG$20240912$$PH$PT$PT
243106201$24310620$1$I$20240910$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007321$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240912$$CN$US$US
243106211$24310621$1$I$$20240904$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004254$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240912$$CN$US$US
243106221$24310622$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006745$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
243106231$24310623$1$I$$20240902$20240912$20240912$EXP$$US-HETERO-HET2024US03005$HETERO$Ghezzi L, Levasseur VA, Perantie DC, Wu GF, Cross AH.. Extensive rebound MS activity following dimethyl fumarate discontinuation in a 63 year old ? A case report. Neuroimmunology Reports. 2023;3:100175$63$YR$$F$Y$$$20240912$$HP$US$US
243106241$24310624$1$I$$20240829$20240912$20240912$EXP$$AU-LUPIN HEALTHCARE (UK) LIMITED-2024-08726$LUPIN$$$$$$Y$$$20240912$$CN$AU$AU
243106251$24310625$1$I$$20240909$20240912$20240912$EXP$$US-TAKEDA-2024TUS089798$TAKEDA$$$$$M$Y$$$20240912$$CN$US$US
243106261$24310626$1$I$$20240904$20240912$20240912$EXP$$AU-TOLMAR, INC.-24AU052363$TOLMAR$$$$$M$Y$$$20240912$$CN$AU$AU
243106271$24310627$1$I$20240801$20240904$20240912$20240912$PER$$CA-TOLMAR, INC.-24CA052415$TOLMAR$$73$YR$$M$Y$$$20240912$$CN$CA$CA
243106281$24310628$1$I$$20240904$20240912$20240912$EXP$$CA-TOLMAR, INC.-24CA052431$TOLMAR$$$$$M$Y$$$20240912$$CN$CA$CA
243106291$24310629$1$I$$20240904$20240912$20240912$EXP$$CA-TOLMAR, INC.-24CA052445$TOLMAR$$$$$M$Y$$$20240912$$CN$CA$CA
243106301$24310630$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180230$AMGEN$$$$$$Y$$$20240912$$CN$US$US
243106311$24310631$1$I$$20240820$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003949$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243106321$24310632$1$I$$20240902$20240912$20240912$EXP$$JP-009507513-2409JPN000747J$MERCK$$6$DEC$$F$Y$$$20240912$$HP$JP$JP
243106332$24310633$2$F$20240101$20240923$20240912$20240926$EXP$$US-ABBVIE-5906795$ABBVIE$$$$$M$Y$129.27$KG$20240926$$CN$US$US
243106351$24310635$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A201608$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243106362$24310636$2$F$20240701$20240909$20240912$20240917$EXP$$CA-AstraZeneca-2024A201862$ASTRAZENECA$$722$MON$$F$Y$$$20240917$$HP$CA$
243106383$24310638$3$F$20240908$20240912$20240912$20240918$PER$$US-AMGEN-USASP2024180172$AMGEN$$85$YR$E$M$Y$$$20240917$$CN$US$US
243106391$24310639$1$I$20240725$20240909$20240912$20240912$EXP$$FR-AUROBINDO-AUR-APL-2024-044804$AUROBINDO$$77$YR$$M$Y$$$20240912$$MD$FR$FR
243106401$24310640$1$I$20221101$20231019$20240912$20240912$PER$$US-ADAREPHARM-2023-US-000042$ADARE PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243106411$24310641$1$I$$20230803$20240912$20240912$PER$$US-ADAREPHARM-2023-US-000022$ADARE PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243106421$24310642$1$I$$20240904$20240912$20240912$PER$$US-ABBVIE-5914236$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243106431$24310643$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143730$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$73.48$KG$20240912$$CN$US$US
243106451$24310645$1$I$20240101$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181147$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243106462$24310646$2$F$20240807$20240910$20240912$20240918$PER$$US-ABBVIE-5909657$ABBVIE$$37$YR$$F$Y$$$20240918$$HP$US$US
243106471$24310647$1$I$20240801$20240902$20240912$20240912$PER$$US-009507513-2409USA000587$MERCK$$39$YR$$F$Y$70.3$KG$20240912$$CN$US$US
243106481$24310648$1$I$$20240904$20240912$20240912$EXP$$BR-JNJFOC-20240917781$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240912$$CN$BR$BR
243106491$24310649$1$I$20230906$20240912$20240912$20240912$PER$$US-PROD-AS2-212756134-RB-081216-2024$RECKITT BENCKISER$$86$YR$$M$Y$$$20240912$$CN$US$US
243106501$24310650$1$I$20240101$20240906$20240912$20240912$EXP$$CA-ABBVIE-5913722$ABBVIE$$65$YR$$M$Y$$$20240912$$CN$CA$CA
243106511$24310651$1$I$$20240909$20240912$20240912$EXP$$CH-SANDOZ INC.-SDZ2024CH078667$SANDOZ$$14$YR$$F$Y$$$20240912$$MD$CH$CH
243106521$24310652$1$I$$20240826$20240912$20240912$PER$$US-APOTEX-2024AP010045$APOTEX$$$$$F$Y$$$20240912$$CN$US$US
243106541$24310654$1$I$20231211$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144705$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240912$$MD$US$US
243106551$24310655$1$I$$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144169$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240912$$CN$US$US
243106572$24310657$2$F$$20240918$20240912$20240927$EXP$$GB-TEVA-VS-3241130$TEVA$Johnson N, Solkar M, Sehgal R, Riyad K. Non-steroidal anti-inflammatory drug induced intestinal stricturing: diaphragm disease. J-Surg-Case-Rep 2024; 2024 (1):.; Johnson N, Solkar M, Sehgal R, Riyad K. Non-steroidal anti-inflammatory drug induced intestinal stricturing: diaphragm disease. J-Surg-Case-Rep 2024; 2024 (1):.; Johnson N, Solkar M, Sehgal R, Riyad K. Non-steroidal anti-inflammatory drug induced intestinal stricturing: diaphragm disease. J-Surg-Case-Rep 2024; 2024 (1):.$69$YR$$F$Y$$$20240927$$HP$GB$GB
243106581$24310658$1$I$20240712$20240906$20240912$20240912$EXP$$KR-TAKEDA-2024TUS090334$TAKEDA$$41$YR$$M$Y$92$KG$20240912$$MD$KR$KR
243106591$24310659$1$I$20181023$20240904$20240912$20240912$EXP$$BR-TAKEDA-2018TUS032351$TAKEDA$$24$YR$$F$Y$$$20240912$$CN$BR$BR
243106601$24310660$1$I$20230207$20240904$20240912$20240912$EXP$$SK-SPARK THERAPEUTICS INC.-SK-SPK-24-00086$SPARK THERAPEUTICS$$12$YR$$M$Y$$$20240912$$MD$SK$SK
243106611$24310661$1$I$20240801$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142584$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240912$$PH$US$US
243106632$24310663$2$F$20240101$20240911$20240912$20240917$EXP$$US-ABBVIE-5914915$ABBVIE$$64$YR$$F$Y$82$KG$20240917$$CN$US$US
243106641$24310664$1$I$20240824$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181309$AMGEN$$82$YR$E$F$Y$$$20240912$$CN$US$US
243106651$24310665$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143405$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240912$$PH$US$US
243106661$24310666$1$I$20230912$20240912$20240912$20240912$PER$$US-PROD-AS2-212756134-RB-109680-2023$RECKITT BENCKISER$$41$YR$$F$Y$$$20240912$$CN$US$US
243106671$24310667$1$I$$20240903$20240912$20240912$EXP$$DE-HETERO-AMR2024DE02955$HETERO$$9$YR$$M$Y$$$20240912$$MD$DE$DE
243106681$24310668$1$I$$20240903$20240912$20240912$EXP$$IT-ROCHE-10000073525$ROCHE$$$$$F$Y$$$20240912$$MD$IT$IT
243106691$24310669$1$I$20240410$20240424$20240912$20240912$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01448$AMNEAL$$41$YR$$F$Y$79.365$KG$20240912$$CN$US$US
243106701$24310670$1$I$$20230926$20240912$20240912$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03449$AMNEAL$$$$$F$Y$$$20240912$$CN$US$US
243106712$24310671$2$F$20240501$20240917$20240912$20240925$EXP$$BR-TAKEDA-2024TUS090054$TAKEDA$$46$YR$$F$Y$$$20240925$$CN$BR$BR
243106721$24310672$1$I$$20240910$20240912$20240912$PER$$US-HALEON-2196255$Haleon PLC$$$$$$Y$$$20240912$$CN$US$US
243106731$24310673$1$I$$20231211$20240912$20240912$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-04381$AMNEAL$$$$$F$Y$$$20240912$$CN$US$US
243106751$24310675$1$I$20240801$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006466$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240912$$CN$US$US
243106761$24310676$1$I$$20240906$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004694$ELI LILLY AND CO$$$$$F$Y$$$20240912$$PH$US$US
243106771$24310677$1$I$20240201$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006349$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240912$$CN$US$US
243106781$24310678$1$I$$20240905$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409003894$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240912$$CN$US$US
243106791$24310679$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007303$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240912$$CN$US$US
243106801$24310680$1$I$20240910$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006513$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240912$$CN$US$US
243106811$24310681$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005638$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240912$$CN$US$US
243106821$24310682$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006485$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240912$$CN$US$US
243106831$24310683$1$I$20240101$20240415$20240912$20240912$PER$$US-TEVA-VS-3221160$TEVA$$72$YR$$F$Y$$$20240912$$CN$US$US
243106841$24310684$1$I$20240101$20240524$20240912$20240912$PER$$US-ADAREPHARM-2024-US-000030$ADARE PHARMACEUTICALS$$65$YR$E$F$Y$77.11$KG$20240912$$CN$US$US
243106851$24310685$1$I$20240817$20240909$20240912$20240912$EXP$$NVSC2024CA169344$NOVARTIS$$80$YR$$F$Y$$$20240912$$PH$CA$CA
243106861$24310686$1$I$20240830$20240830$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139675$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240912$$CN$US$US
243106871$24310687$1$I$$20240902$20240912$20240912$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-08386$HIKMA$$81$YR$$M$Y$$$20240912$$HP$CA$CA
243106881$24310688$1$I$20240801$20240906$20240912$20240912$EXP$FR-AFSSAPS-BX2024001749$FR-RECORDATI RARE DISEASE INC.-2024006910$RECORDATI$$$$$$Y$$$20240912$$MD$FR$FR
243106891$24310689$1$I$20240101$20240904$20240912$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-027928$UNITED THERAPEUTICS$$$$$F$Y$100.23$KG$20240912$$$US$US
243106901$24310690$1$I$$20240902$20240912$20240912$EXP$$JP-ROCHE-10000075246$ROCHE$Hagihara M, Hayashi H, Nakashima S, Imai Y, Nakano H, Uchida T et al.. Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies. Internal Medicine. 2024;63(16):2283-2287. doi:10.2169/internalmedicine.2900-23$76$YR$E$F$Y$$$20240912$$MD$JP$JP
243106911$24310691$1$I$20240404$20240831$20240912$20240912$EXP$IT-MINISAL02-1000341$IT-Accord-444879$ACCORD$$49$YR$A$F$Y$$$20240912$$PH$IT$IT
243106921$24310692$1$I$$20240814$20240912$20240912$30DAY$$US-VEROBIOTECH-2024USVEROSPO00213$VERO BIOTECH$$$$$$Y$$$20240912$$HP$US$US
243106931$24310693$1$I$$20240903$20240912$20240912$EXP$$JP-ROCHE-10000076539$ROCHE$$$$E$M$Y$$$20240912$$HP$JP$JP
243106941$24310694$1$I$$20240909$20240912$20240912$PER$$US-LEO Pharma-373409$LEO PHARM$$$$$F$Y$$$20240912$$CN$US$US
243106951$24310695$1$I$20160707$20240909$20240912$20240912$EXP$$CO-UCBSA-2024046638$UCB$$78$YR$$F$Y$$$20240912$$CN$CO$CO
243106971$24310697$1$I$20240902$20240906$20240912$20240912$PER$$US-AMGEN-USASP2024179802$AMGEN$$52$YR$A$M$Y$$$20240912$$CN$US$US
243107001$24310700$1$I$$20240622$20240912$20240912$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02396$AMNEAL$$$$$$Y$$$20240912$$CN$US$US
243107012$24310701$2$F$$20240918$20240912$20240927$EXP$$US-TEVA-VS-3240628$TEVA$Kong S, Nagraj S, Cooper DL, Ferrick KJ, Zhang L. A case report of fludarabine associated ectopic atrial bradycardia and literature review of fludarabine induced bradycardia. Cardio-Oncol 2024; 10 (1):.; Kong S, Nagraj S, Cooper DL, Ferrick KJ, Zhang L. A case report of fludarabine associated ectopic atrial bradycardia and literature review of fludarabine induced bradycardia. Cardio-Oncol 2024; 10 (1):.$30$YR$$F$Y$$$20240927$$HP$US$US
243107021$24310702$1$I$$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144810$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240912$$CN$US$US
243107031$24310703$1$I$$20240907$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143646$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240912$$HP$US$US
243107041$24310704$1$I$20240801$20240905$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141899$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240912$$CN$US$US
243107051$24310705$1$I$$20240905$20240912$20240912$EXP$$CN-ROCHE-10000054510$ROCHE$Gao L, Miao Y, Shi W, Li J, Zhu H. Clinical efficacy and safety of single course CCR regimen in treatment of hairy cell leukemia: report of 4 cases. Journal of Leukemia and Lymphoma. 2024-Jul-25;33 (7):416-20. doi:10.3760/cma.j.cn115356-20231225-00117.$46$YR$A$F$Y$$$20240912$$HP$CN$CN
243107061$24310706$1$I$$20240902$20240912$20240912$EXP$$TN-BIOCON BIOLOGICS LIMITED-BBL2024006667$BIOCON$Fenniche I, Somai M, Rachdi I, Ibrahim A, Aydi Z, Dhaou BB et al.. Chronic inflammatory demyelinating polyradiculoneuropathy during spondylarthritis: iatrogenesis or association.. European Journal of Case Reports in Internal Medicine. 2024;11(1):1025-1026$$$$$Y$$$20240912$$HP$TN$TN
243107071$24310707$1$I$$20240822$20240912$20240912$PER$$CA-TOLMAR, INC.-24CA052152$TOLMAR$$$$$M$Y$$$20240912$$CN$CA$CA
243107081$24310708$1$I$$20240822$20240912$20240912$PER$$CA-TOLMAR, INC.-24CA052158$TOLMAR$$$$$M$Y$$$20240912$$CN$CA$CA
243107091$24310709$1$I$20240822$20240822$20240912$20240912$PER$$CA-TOLMAR, INC.-24CA052151$TOLMAR$$82$YR$$M$Y$$$20240912$$CN$CA$CA
243107101$24310710$1$I$$20240823$20240912$20240912$PER$$CA-TOLMAR, INC.-24CA052190$TOLMAR$$$$$M$Y$$$20240912$$CN$CA$CA
243107122$24310712$2$F$20240819$20240821$20240912$20240919$PER$$FR-TOLMAR, INC.-24FR052006$TOLMAR$$84$YR$$M$Y$$$20240918$$PH$FR$FR
243107131$24310713$1$I$20240301$20240909$20240911$20240911$DIR$FDA-CDER-CTU-2024-62516$$FDA-CTU$$71$YR$$$N$$$20240909$N$CN$US$
243107141$24310714$1$I$20240101$20240823$20240912$20240912$PER$$DO-TOLMAR, INC.-24DO052107$TOLMAR$$68$YR$$M$Y$$$20240912$$CN$DO$DO
243107161$24310716$1$I$20240821$20240821$20240912$20240912$PER$$FR-TOLMAR, INC.-24FR052061$TOLMAR$$82$YR$$M$Y$$$20240912$$PH$FR$FR
243107171$24310717$1$I$20240818$20240822$20240912$20240912$PER$$FR-TOLMAR, INC.-24FR052115$TOLMAR$$59$YR$$M$Y$$$20240912$$HP$FR$FR
243107181$24310718$1$I$20231218$20240912$20240912$20240912$PER$$US-PROD-AS2-212756134-RB-081503-2024$RECKITT BENCKISER$$50$YR$$F$Y$86.36$KG$20240912$$CN$US$US
243107191$24310719$1$I$$20240909$20240912$20240912$PER$$US-ALXN-202409USA000530US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243107221$24310722$1$I$20220101$20240829$20240912$20240912$EXP$$AU-UCBSA-2024044386$UCB$$68$YR$$M$Y$$$20240912$$CN$AU$AU
243107231$24310723$1$I$$20240905$20240912$20240912$EXP$$US-BIOGEN-2024BI01280673$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
243107241$24310724$1$I$$20240906$20240912$20240912$30DAY$$US-GSK-US2024111383$GLAXOSMITHKLINE$$$$$F$Y$$$20240912$$CN$US$US
243107251$24310725$1$I$20240909$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180458$AMGEN$$89$YR$E$F$Y$$$20240912$$CN$US$US
243107261$24310726$1$I$20240801$20240906$20240912$20240912$30DAY$$US-GSK-US2024111230$GLAXOSMITHKLINE$$24$YR$$M$Y$73.2$KG$20240912$$PH$US$US
243107271$24310727$1$I$$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181513$AMGEN$$$$$$Y$$$20240912$$PH$US$US
243107281$24310728$1$I$$20240909$20240912$20240912$EXP$$FR-AMGEN-FRASP2024181109$AMGEN$$$$$$Y$$$20240912$$PH$FR$FR
243107291$24310729$1$I$$20240828$20240912$20240912$EXP$$US-SA-2024SA262992$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240912$$MD$US$US
243107301$24310730$1$I$20230101$20240831$20240912$20240912$EXP$$IT-Accord-444888$ACCORD$Corcione S, Lupia T, Vita D, Sidoti F, Zanotto E, Solidoro P, et al. Maribavir treatment for resistant cytomegalovirus disseminated disease in kidney transplant recipients: A case-based scoping review of real-life data in literature. Transplantation Reviews. 2024:38(4).$54$YR$A$F$Y$$$20240912$$HP$IT$IT
243107311$24310731$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143745$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240912$$HP$US$US
243107321$24310732$1$I$20240101$20240904$20240912$20240912$EXP$$CA-CELLTRION INC.-2024CA021740$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
243107331$24310733$1$I$20240607$20240905$20240912$20240912$EXP$ES-AEMPS-1563951$ES-ROCHE-10000078794$ROCHE$$51$YR$A$F$Y$$$20240912$$MD$ES$ES
243107342$24310734$2$F$20240830$20240904$20240912$20240925$EXP$$CN-BEH-2024178366$CSL BEHRING$$61$YR$A$M$Y$57.3$KG$20240925$$CN$CN$CN
243107351$24310735$1$I$20231120$20240726$20240912$20240912$EXP$$JP-ROCHE-10000078707$ROCHE$$66$YR$E$F$Y$$$20240912$$MD$JP$JP
243107362$24310736$2$F$20240101$20240917$20240912$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014708$JAZZ$$$$$M$Y$$$20240924$$HP$US$US
243107371$24310737$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A201999$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243107381$24310738$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A201622$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243107391$24310739$1$I$$20240906$20240912$20240912$EXP$$AU-ROCHE-3579277$ROCHE$$57$YR$A$F$Y$$$20240912$$CN$AU$AU
243107401$24310740$1$I$20231003$20240909$20240912$20240912$EXP$$JP-EXELIXIS-EXL-2024-000110$EXELIXIS$$60$YR$$M$Y$72$KG$20240912$$MD$JP$JP
243107411$24310741$1$I$20240612$20240909$20240912$20240912$EXP$$JP-EXELIXIS-EXL-2024-000118$EXELIXIS$$59$YR$$F$Y$53$KG$20240912$$MD$JP$JP
243107421$24310742$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5916831$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243107431$24310743$1$I$20240910$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181296$AMGEN$$$$A$M$Y$$$20240912$$CN$US$US
243107441$24310744$1$I$20240909$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180678$AMGEN$$70$YR$E$F$Y$$$20240912$$CN$US$US
243107452$24310745$2$F$20240907$20240911$20240912$20240916$PER$$US-AMGEN-USASP2024181038$AMGEN$$79$YR$E$F$Y$$$20240916$$PH$US$US
243107461$24310746$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180422$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243107471$24310747$1$I$20240908$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143865$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$74.84$KG$20240912$$CN$US$US
243107481$24310748$1$I$20240829$20240905$20240912$20240912$PER$$US-RDY-SPO/USA/24/0013036$DR REDDYS$$30$YR$A$M$Y$$$20240912$$HP$US$US
243107501$24310750$1$I$$20240902$20240912$20240912$EXP$$US-BIOCON-BCN-2024-000184$BIOCON$Au-Yeung NM, Regennitter NS, Stepherson J, Seele J, Rosenblatt E and Carter W. Folate Deficiency and Medication-Induced Severe Pancytopenia in a Bilateral Lung Transplantee. Cureus. 16(7): e65780. doi:10.7759/cureus.65780.$74$YR$E$M$Y$$$20240912$$HP$US$US
243107512$24310751$2$F$20240816$20240926$20240912$20240930$EXP$$JP-ABBVIE-5888630$ABBVIE$$60$YR$$M$Y$$$20240930$$MD$JP$JP
243107521$24310752$1$I$$20240910$20240912$20240912$EXP$$BR-ROCHE-10000078459$ROCHE$$50$YR$A$$Y$$$20240912$$MD$BR$BR
243107531$24310753$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024181231$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243107542$24310754$2$F$20230101$20240918$20240912$20240927$EXP$$JP-ROCHE-10000077791$ROCHE$$59$YR$A$F$Y$$$20240927$$MD$JP$JP
243107551$24310755$1$I$$20240910$20240912$20240912$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050658$BOEHRINGER INGELHEIM$$$$$$Y$$$20240912$$MD$JP$JP
243107562$24310756$2$F$$20240913$20240912$20240914$PER$$US-JNJFOC-20240926394$JOHNSON AND JOHNSON$$$$$M$Y$$$20240914$$HP$US$US
243107571$24310757$1$I$$20240901$20240912$20240912$EXP$$PH-AMAROX PHARMA-HET2024PH03019$HETERO$Ajon ARS, Camara PT. Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Due to Multiple Anti-Epileptic Drug Hypersensitivity. Cureus. 2024;16(7):1-5$41$YR$$F$Y$$$20240912$$HP$PH$PH
243107581$24310758$1$I$20240901$20240906$20240912$20240912$EXP$$US-VIIV HEALTHCARE LIMITED-US2024111273$VIIV$$42$YR$$M$Y$$$20240912$$PH$US$US
243107591$24310759$1$I$20240101$20240909$20240912$20240912$EXP$$US-ABBVIE-5917007$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243107601$24310760$1$I$$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024180555$AMGEN$$$$$M$Y$$$20240912$$CN$US$US
243107611$24310761$1$I$20240101$20240904$20240912$20240912$PER$$US-009507513-2409USA002071$MERCK$$$$$F$Y$$$20240912$$CN$US$US
243107621$24310762$1$I$$20240909$20240912$20240912$PER$$US-ALXN-202409USA000578US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$HP$US$US
243107631$24310763$1$I$$20240907$20240912$20240912$EXP$$US-AMGEN-USASP2024179534$AMGEN$$$$$M$Y$$$20240912$$MD$US$US
243107641$24310764$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006560$ELI LILLY AND CO$$$$$$Y$$$20240912$$CN$US$US
243107651$24310765$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006439$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
243107661$24310766$1$I$20240909$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006589$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240912$$CN$US$US
243107671$24310767$1$I$$20240910$20240912$20240912$EXP$$US-GILEAD-2024-0687326$GILEAD$$68$YR$E$F$Y$$$20240912$$PH$US$US
243107681$24310768$1$I$$20240906$20240912$20240912$PER$$US-ABBVIE-5915839$ABBVIE$$26$YR$$M$Y$$$20240912$$HP$US$US
243107691$24310769$1$I$$20240903$20240912$20240912$EXP$$SG-ROCHE-10000073286$ROCHE$$57$YR$A$M$Y$$$20240912$$CN$SG$SG
243107701$24310770$1$I$$20240912$20240912$20240912$PER$$US-PROD-AS2-212756134-RB-140461-2023$RECKITT BENCKISER$$82$YR$$F$Y$45.45$KG$20240912$$CN$US$US
243107711$24310771$1$I$20240730$20240911$20240912$20240912$EXP$$US-GILEAD-2024-0687436$GILEAD$$68$YR$E$F$Y$$$20240912$$PH$US$US
243107721$24310772$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5917401$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243107732$24310773$2$F$20240618$20240913$20240912$20240923$EXP$$CA-TAKEDA-2024TUS054421$TAKEDA$$39$YR$$F$Y$$$20240923$$CN$CA$CA
243107741$24310774$1$I$$20240904$20240912$20240912$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00903$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240912$$CN$US$US
243107761$24310776$1$I$$20240911$20240912$20240912$EXP$GB-MHRA-MED-202409112158055820-SRTQY$GB-Orion Corporation ORION PHARMA-24_00031640$ORION$$$$$F$Y$$$20240912$$CN$GB$
243107782$24310778$2$F$$20240917$20240912$20240919$EXP$ES-SA-2024SA254849$ES-SANDOZ INC.-SDZ2024ES079081$SANDOZ$$10$YR$$$Y$$$20240919$$HP$ES$ES
243107791$24310779$1$I$$20240907$20240912$20240912$PER$$NVSC2024US180405$NOVARTIS$$$$$$Y$$$20240912$$CN$US$US
243107811$24310781$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144895$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$108$KG$20240912$$PH$US$US
243107832$24310783$2$F$$20240926$20240912$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144419$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$83.01$KG$20240927$$CN$US$US
243107842$24310784$2$F$$20240906$20240912$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-141376$BRISTOL MYERS SQUIBB$$72$YR$E$$Y$$$20240918$$MD$JP$JP
243107851$24310785$1$I$$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143660$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240912$$CN$US$US
243107861$24310786$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144494$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240912$$CN$US$US
243107871$24310787$1$I$$20240904$20240912$20240912$EXP$$US-ROCHE-10000075156$ROCHE$$83$YR$E$F$Y$$$20240912$$CN$US$US
243107891$24310789$1$I$$20240905$20240912$20240912$EXP$$CA-TAKEDA-2024TUS073182$TAKEDA$$$$$F$Y$$$20240912$$CN$CA$CA
243107901$24310790$1$I$20240831$20240831$20240912$20240912$EXP$GB-MHRA-MED-202408311227243100-VLNGH$GB-Accord-444528$ACCORD$$40$YR$A$M$Y$82$KG$20240912$$MD$GB$GB
243107911$24310791$1$I$20240601$20240905$20240912$20240912$PER$$US-JNJFOC-20240919511$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240912$$CN$US$US
243107931$24310793$1$I$20240801$20240904$20240912$20240912$EXP$$JP-EMD Serono-2024047454$EMD SERONO INC$$7$DEC$E$M$Y$$$20240912$$PH$JP$JP
243107951$24310795$1$I$20221003$20240905$20240912$20240912$EXP$$CO-TAKEDA-2022TUS071905$TAKEDA$$73$YR$$F$Y$46$KG$20240912$$CN$CO$CO
243107961$24310796$1$I$$20240904$20240912$20240912$EXP$$CA-TAKEDA-2023TUS016746$TAKEDA$$$$$F$Y$75$KG$20240912$$CN$CA$CA
243107971$24310797$1$I$20240820$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A204350$ASTRAZENECA$$24711$DY$$F$Y$$$20240912$$CN$US$
243107981$24310798$1$I$$20240909$20240912$20240912$EXP$$US-AstraZeneca-2024A205466$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243107991$24310799$1$I$20240825$20240904$20240912$20240912$EXP$$DE-AstraZeneca-2024A201036$ASTRAZENECA$$80$YR$$F$Y$70$KG$20240912$$MD$DE$
243108001$24310800$1$I$$20240904$20240912$20240912$EXP$$ZA-AstraZeneca-2024A201873$ASTRAZENECA$$70$YR$$M$Y$$$20240912$$CN$ZA$
243108011$24310801$1$I$$20240910$20240912$20240912$EXP$$CN-ROCHE-10000078798$ROCHE$Liang Z, Wu N, Meng F. Hypertension and nephrotic syndrome induced by bevacizumab and fuquitinib: one case report. Chinese Journal of Hospital Pharmacy. 2024-Aug;44 (15):1836-9. doi:10.13286/j.1001-5213.2024.15.19.$73$YR$E$M$Y$62$KG$20240912$$PH$CN$CN
243108021$24310802$1$I$$20240906$20240912$20240912$EXP$$US-BIOGEN-2024BI01281896$BIOGEN$$$$$M$Y$$$20240912$$CN$US$US
243108031$24310803$1$I$$20240906$20240912$20240912$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001816$BLUEPRINT MEDICINES$$$$$F$Y$$$20240912$$CN$US$US
243108061$24310806$1$I$20231001$20240829$20240912$20240912$PER$$US-SA-2024SA261646$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240912$$MD$US$US
243108071$24310807$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA259295$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240912$$CN$US$US
243108081$24310808$1$I$$20240820$20240912$20240912$PER$$US-SA-2024SA262299$SANOFI AVENTIS$$21$YR$A$F$Y$84.09$KG$20240912$$MD$US$US
243108091$24310809$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA259860$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240912$$HP$US$US
243108101$24310810$1$I$20240101$20240820$20240912$20240912$PER$$US-SA-2024SA262994$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240912$$CN$US$US
243108111$24310811$1$I$20240501$20240823$20240912$20240912$PER$$US-SA-2024SA262521$SANOFI AVENTIS$$39$YR$A$F$Y$48.8$KG$20240912$$MD$US$US
243108121$24310812$1$I$20240701$20240829$20240912$20240912$PER$$US-SA-2024SA260663$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240912$$HP$US$US
243108131$24310813$1$I$$20240824$20240912$20240912$PER$$US-SA-2024SA259648$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240912$$MD$US$US
243108142$24310814$2$F$20240101$20240821$20240912$20240917$PER$$US-SA-2024SA262359$SANOFI AVENTIS$$25$YR$A$F$Y$50$KG$20240918$$MD$US$US
243108151$24310815$1$I$20240101$20240830$20240912$20240912$PER$$US-SA-2024SA261013$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240912$$MD$US$US
243108161$24310816$1$I$20240818$20240821$20240912$20240912$PER$$US-SA-2024SA232269$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240912$$MD$US$US
243108171$24310817$1$I$20240827$20240828$20240912$20240912$PER$$US-SA-2024SA262904$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240912$$PH$US$US
243108181$24310818$1$I$20240801$20240830$20240912$20240912$PER$$US-SA-2024SA262423$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240912$$HP$US$US
243108191$24310819$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA262419$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240912$$HP$US$US
243108202$24310820$2$F$20240801$20240909$20240912$20240917$PER$$US-SA-2024SA261855$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240918$$HP$US$US
243108211$24310821$1$I$20240821$20240821$20240912$20240912$PER$$US-SA-2024SA263655$SANOFI AVENTIS$$1$YR$I$F$Y$11.34$KG$20240912$$HP$US$US
243108222$24310822$2$F$20240101$20240830$20240912$20240923$PER$$US-SA-2024SA262421$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240923$$HP$US$US
243108231$24310823$1$I$20240828$20240829$20240912$20240912$PER$$US-SA-2024SA259889$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240912$$CN$US$US
243108241$24310824$1$I$$20240906$20240912$20240912$EXP$$AE-TAKEDA-2024TUS090528$TAKEDA$$$$$F$Y$$$20240912$$CN$AE$AE
243108252$24310825$2$F$$20240918$20240912$20240923$EXP$$CA-TAKEDA-2024TUS089473$TAKEDA$$$$$M$Y$$$20240923$$CN$CA$CA
243108261$24310826$1$I$$20240906$20240912$20240912$EXP$$CA-TAKEDA-2024TUS075565$TAKEDA$$$$$F$Y$$$20240912$$MD$CA$CA
243108271$24310827$1$I$20230101$20240910$20240912$20240912$PER$$PR-ABBVIE-5918551$ABBVIE$$$$$F$Y$127$KG$20240912$$CN$PR$PR
243108281$24310828$1$I$$20240910$20240912$20240912$PER$$US-HALEON-2196366$Haleon PLC$$79$YR$$F$Y$$$20240912$$HP$US$US
243108292$24310829$2$F$20240601$20240905$20240912$20240925$EXP$$US-BEH-2024178408$CSL BEHRING$$78$YR$E$F$Y$$$20240925$$HP$US$US
243108301$24310830$1$I$$20240912$20240912$20240912$PER$$US-PROD-AS2-212756134-RB-140627-2023$RECKITT BENCKISER$$$$$$Y$$$20240912$$CN$US$US
243108311$24310831$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA261507$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240912$$CN$US$US
243108331$24310833$1$I$$20240901$20240912$20240912$PER$$US-SA-2024SA262048$SANOFI AVENTIS$$$$$M$Y$$$20240912$$CN$US$US
243108341$24310834$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262535$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240912$$HP$US$US
243108351$24310835$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263259$SANOFI AVENTIS$$$$A$M$Y$$$20240912$$MD$US$US
243108361$24310836$1$I$20240101$20240830$20240912$20240912$PER$$US-SA-2024SA262460$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240912$$HP$US$US
243108371$24310837$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA260639$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240912$$HP$US$US
243108381$24310838$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA262467$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240912$$HP$US$US
243108391$24310839$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263284$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240912$$MD$US$US
243108401$24310840$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA262579$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240912$$HP$US$US
243108411$24310841$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA263115$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240912$$MD$US$US
243108421$24310842$1$I$20240701$20240903$20240912$20240912$PER$$US-SA-2024SA263023$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240912$$MD$US$US
243108431$24310843$1$I$20240801$20240830$20240912$20240912$PER$$US-SA-2024SA262437$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240912$$HP$US$US
243108441$24310844$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263022$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240912$$HP$US$US
243108451$24310845$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA263097$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240912$$HP$US$US
243108461$24310846$1$I$20240822$20240903$20240912$20240912$PER$$US-SA-2024SA263034$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240912$$HP$US$US
243108471$24310847$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA262425$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240912$$HP$US$US
243108481$24310848$1$I$20240903$20240903$20240912$20240912$PER$$US-SA-2024SA261523$SANOFI AVENTIS$$2$YR$C$M$Y$11$KG$20240912$$CN$US$US
243108491$24310849$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA261759$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240912$$CN$US$US
243108501$24310850$1$I$20240101$20240905$20240912$20240912$PER$$US-SA-2024SA263249$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240912$$MD$US$US
243108511$24310851$1$I$20240601$20240903$20240912$20240912$PER$$US-SA-2024SA261380$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240912$$MD$US$US
243108521$24310852$1$I$$20240902$20240912$20240912$EXP$$CA-TEVA-VS-3239638$TEVA$$$$$F$Y$17$KG$20240912$$HP$CA$CA
243108541$24310854$1$I$$20240906$20240912$20240912$EXP$$US-TAKEDA-2024TUS089718$TAKEDA$$$$A$M$Y$$$20240912$$HP$US$US
243108551$24310855$1$I$20240904$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024181136$AMGEN$$83$YR$E$M$Y$$$20240912$$CN$US$US
243108561$24310856$1$I$$20240909$20240912$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US079627$SANDOZ$$$$$F$Y$$$20240912$$CN$US$US
243108572$24310857$2$F$20240101$20240822$20240912$20240917$PER$$US-SA-2024SA088164$SANOFI AVENTIS$$66$YR$E$M$Y$65.91$KG$20240918$$MD$US$US
243108581$24310858$1$I$$20240906$20240912$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014643$JAZZ$$$$$F$Y$$$20240912$$CN$US$US
243108591$24310859$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263563$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240912$$HP$US$US
243108601$24310860$1$I$$20240902$20240912$20240912$PER$$US-SA-2024SA262126$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240912$$CN$US$US
243108611$24310861$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263080$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240912$$CN$US$US
243108621$24310862$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA263523$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240912$$CN$US$US
243108631$24310863$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263340$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240912$$MD$US$US
243108652$24310865$2$F$20211104$20240912$20240912$20240923$EXP$$CA-TAKEDA-2024TUS085051$TAKEDA$$74$YR$$F$Y$$$20240923$$CN$CA$CA
243108661$24310866$1$I$$20240904$20240912$20240912$EXP$$CA-CELLTRION INC.-2024CA021730$CELLTRION$$$$$$Y$$$20240912$$HP$CA$CA
243108671$24310867$1$I$$20240906$20240912$20240912$EXP$$US-TAKEDA-2024TUS089731$TAKEDA$$$$A$F$Y$$$20240912$$HP$US$US
243108701$24310870$1$I$$20240903$20240912$20240912$EXP$$IR-862174955-ML2024-04796$Unknown Manufacturer$Ebrahimi P, Soleimani H, Nazari R, Senobari N, Mousavinezhad SM, Ghadimi DJ. Kounis syndrome type I induced by an intramuscular injection of diclofenac: A literature review based on a case report. Clinical Case Reports. 2024;12(e9198): 1-7. doi:10.1002/ccr3.9198.$51$YR$A$M$Y$$$20240912$$HP$IR$IR
243108711$24310871$1$I$$20240903$20240912$20240912$EXP$$GB-862174955-ML2024-04789$MICRO LABS$Johnson N, Solkar M, Sehgal R, Riyad K. Non-steroidal anti-inflammatory drug induced intestinal stricturing: diaphragm disease. Journal of Surgical Case Reports. 2023 Aug 13;1: 1-4. doi:10.1093/jscr/rjad489.$69$YR$E$F$Y$$$20240912$$HP$GB$GB
243108721$24310872$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144501$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240912$$CN$US$US
243108732$24310873$2$F$20240912$20240912$20240912$20240919$EXP$$CA-TAKEDA-2023TUS033359$TAKEDA$$37$YR$$F$Y$$$20240919$$CN$CA$CA
243108741$24310874$1$I$20210527$20240909$20240912$20240912$EXP$FR-AFSSAPS-NY2024001015$FR-TAKEDA-2024TUS089604$TAKEDA$$95$YR$$F$Y$56$KG$20240912$$HP$FR$FR
243108751$24310875$1$I$20240806$20240905$20240912$20240912$EXP$$CA-JNJFOC-20240819329$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240912$$HP$CA$CA
243108761$24310876$1$I$$20240905$20240912$20240912$PER$$US-JNJFOC-20240919983$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243108771$24310877$1$I$$20240821$20240912$20240912$PER$$US-SA-2024SA262693$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$MD$US$US
243108782$24310878$2$F$20240101$20240905$20240912$20240917$PER$$US-SA-2024SA261515$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240918$$MD$US$US
243108792$24310879$2$F$$20240806$20240912$20240930$EXP$$GB-BEH-2024176933$CSL BEHRING$$$$A$F$Y$$$20240930$$CN$GB$GB
243108801$24310880$1$I$$20240912$20240912$20240912$PER$$US-PROD-AS2-212756134-RB-140273-2023$RECKITT BENCKISER$$$$$$Y$$$20240912$$CN$US$US
243108811$24310881$1$I$$20240903$20240912$20240912$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR113023$VIIV$$$$$$Y$$$20240912$$HP$US$US
243108821$24310882$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006692$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240912$$CN$US$US
243108831$24310883$1$I$20240910$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007163$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
243108841$24310884$1$I$$20240905$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409003681$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240912$$CN$US$US
243108861$24310886$1$I$20240909$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006239$ELI LILLY AND CO$$$$$$Y$$$20240912$$CN$US$US
243108871$24310887$1$I$20240907$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005627$ELI LILLY AND CO$$72$YR$E$M$Y$122.45$KG$20240912$$CN$US$US
243108891$24310889$1$I$20240907$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006494$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240912$$CN$US$US
243108901$24310890$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007382$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240912$$CN$US$US
243108912$24310891$2$F$$20240909$20240912$20240912$EXP$$US-ABBVIE-5918374$ABBVIE$$$$$F$Y$$$20240912$$MD$US$US
243108921$24310892$1$I$20240801$20240906$20240912$20240912$EXP$$US-ABBVIE-5915250$ABBVIE$$75$YR$$F$Y$$$20240912$$CN$US$US
243108931$24310893$1$I$$20240909$20240912$20240912$PER$$US-TAKEDA-2023TUS035342$TAKEDA$$$$$F$Y$$$20240912$$CN$US$US
243108941$24310894$1$I$20210322$20240904$20240912$20240912$EXP$$CA-TAKEDA-2024TUS089153$TAKEDA$$78$YR$$F$Y$$$20240912$$CN$CA$CA
243108951$24310895$1$I$20240801$20240904$20240912$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-144447$BRISTOL MYERS SQUIBB$$$$E$M$Y$77$KG$20240912$$MD$JP$JP
243108961$24310896$1$I$$20240911$20240912$20240912$PER$$US-HALEON-2196500$Haleon PLC$$$$$$Y$$$20240912$$CN$US$US
243108971$24310897$1$I$$20240902$20240912$20240912$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-08233$HIKMA$$73$YR$$M$Y$$$20240912$$HP$CA$CA
243108982$24310898$2$F$20240910$20240912$20240912$20240913$PER$$US-AMGEN-USASP2024181626$AMGEN$$69$YR$E$F$Y$$$20240913$$CN$US$US
243108992$24310899$2$F$20240909$20240912$20240912$20240913$PER$$US-AMGEN-USASP2024180850$AMGEN$$61$YR$A$F$Y$$$20240913$$CN$US$US
243109001$24310900$1$I$20240906$20240906$20240912$20240912$PER$$US-AMGEN-USASP2024179194$AMGEN$$21$YR$A$F$Y$$$20240912$$CN$US$US
243109011$24310901$1$I$$20240909$20240912$20240912$PER$$US-ALXN-202409USA000651US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243109021$24310902$1$I$$20240911$20240912$20240912$PER$$US-HALEON-2196463$Haleon PLC$$$$$$Y$$$20240912$$CN$US$US
243109041$24310904$1$I$$20240910$20240912$20240912$PER$$US-ABBVIE-5919331$ABBVIE$$$$$F$Y$$$20240912$$HP$US$US
243109052$24310905$2$F$20240904$20240910$20240912$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014363$JAZZ$$25$YR$$F$Y$$$20240913$$HP$US$US
243109062$24310906$2$F$20240101$20240910$20240912$20240917$EXP$$CA-AstraZeneca-2024A184846$ASTRAZENECA$$38$YR$$M$Y$$$20240917$$CN$CA$
243109071$24310907$1$I$$20240903$20240912$20240912$EXP$$AU-CELLTRION INC.-2024AU021016$CELLTRION$Hii R, Bennett A. Acute haemostasis with bevacizumab for upper gastrointestinal bleeding secondary to lymphoma. Internal Medicine Journal. 2024;54:1418-1419$$$$$Y$$$20240912$$HP$AU$AU
243109081$24310908$1$I$$20240904$20240912$20240912$EXP$$CA-AstraZeneca-2024A203145$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$CA$
243109091$24310909$1$I$$20240909$20240912$20240912$PER$$US-ABBVIE-5915908$ABBVIE$$$$$$Y$$$20240912$$MD$US$US
243109101$24310910$1$I$$20240829$20240912$20240912$EXP$$AU-LUPIN EUROPE GMBH-2024-08716$LUPIN$$29$YR$$M$Y$$$20240912$$CN$AU$AU
243109111$24310911$1$I$$20240911$20240912$20240912$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050740$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240912$$HP$SG$SG
243109121$24310912$1$I$$20240904$20240912$20240912$EXP$$US-SPECGX-T202401855$SPECGX$Arjomand A, Myers A, Akella P. A case of Scedosporium prolificans pulmonary infection in a patient with acute myeloid leukemia. Respiratory Medicine Case Reports. 2024;51:1-4$63$YR$$F$Y$$$20240912$$HP$US$US
243109131$24310913$1$I$20240301$20240905$20240912$20240912$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-047538$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$77$KG$20240912$$CN$BR$BR
243109161$24310916$1$I$$20240905$20240912$20240912$PER$$US-ROCHE-10000076146$ROCHE$$55$YR$A$F$Y$$$20240912$$CN$US$US
243109171$24310917$1$I$20240601$20240820$20240912$20240912$PER$$US-SA-2024SA262364$SANOFI AVENTIS$$64$YR$A$M$Y$109.09$KG$20240912$$MD$US$US
243109181$24310918$1$I$20240801$20240905$20240912$20240912$EXP$$US-SA-2024SA262764$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240912$$MD$US$US
243109191$24310919$1$I$$20240910$20240912$20240912$PER$$US-ROCHE-10000078804$ROCHE$$$$$$Y$$$20240912$$CN$US$US
243109201$24310920$1$I$$20240910$20240912$20240912$PER$$US-ROCHE-10000079249$ROCHE$$62$YR$A$F$Y$$$20240912$$CN$US$US
243109221$24310922$1$I$$20240909$20240912$20240912$EXP$$NL-ADIENNEP-2024AD000727$ADIENNE PHARMA + BIOTECH$Berghuis D, Mehyar LS, Abu-Arja R, Albert MH, Barnum JL, von Bernuth H et al. Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study. J Clin Immunol. 2024;44(8):182. DOI: 10.1007/s10875-024-01786-7$$$T$F$Y$$$20240910$$MD$NL$
243109231$24310923$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263401$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240912$$HP$US$US
243109242$24310924$2$F$20240101$20240903$20240912$20240917$PER$$US-SA-2024SA259842$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240918$$CN$US$US
243109251$24310925$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA261504$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240912$$HP$US$US
243109261$24310926$1$I$20240901$20240905$20240912$20240912$EXP$$CN-TAKEDA-2024TUS089734$TAKEDA$$6$YR$$M$Y$$$20240912$$CN$CN$CN
243109271$24310927$1$I$$20240908$20240912$20240912$EXP$$CN-JNJFOC-20240921256$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$CN$CN
243109281$24310928$1$I$$20240831$20240912$20240912$EXP$CA-MHPD-E2B_07214663$CA-Accord-444597$ACCORD$$$$E$M$Y$$$20240912$$HP$CA$CA
243109291$24310929$1$I$20220701$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467293$RANBAXY$$75$YR$$F$Y$$$20240912$$PH$FR$FR
243109311$24310931$1$I$$20240829$20240912$20240912$EXP$$GB-CIPLA LTD.-2024GB09615$CIPLA$$$$$$Y$$$20240912$$CN$GB$GB
243109321$24310932$1$I$20200126$20240828$20240912$20240912$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467151$RANBAXY$$30$YR$$M$Y$$$20240912$$MD$PL$PL
243109331$24310933$1$I$20230915$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467290$RANBAXY$$44$YR$$M$Y$$$20240912$$MD$FR$FR
243109341$24310934$1$I$20230501$20240828$20240912$20240912$EXP$$AT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467305$RANBAXY$$68$YR$$M$Y$82$KG$20240912$$CN$AT$AT
243109351$24310935$1$I$20160101$20240828$20240912$20240912$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467102$RANBAXY$$57$YR$$M$Y$68$KG$20240912$$CN$DE$DE
243109361$24310936$1$I$$20240828$20240912$20240912$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467375$RANBAXY$$$$$$Y$$$20240912$$CN$GB$GB
243109371$24310937$1$I$$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467220$RANBAXY$$43$YR$$F$Y$$$20240912$$PH$FR$FR
243109381$24310938$1$I$20240601$20240828$20240912$20240912$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467188$RANBAXY$$59$YR$$M$Y$76$KG$20240912$$CN$DE$DE
243109391$24310939$1$I$20240309$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467354$RANBAXY$$14$YR$$F$Y$60$KG$20240912$$PH$FR$FR
243109401$24310940$1$I$20240612$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467287$RANBAXY$$65$YR$$M$Y$$$20240912$$PH$FR$FR
243109411$24310941$1$I$20181219$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467212$RANBAXY$$39$YR$$F$Y$$$20240912$$MD$FR$FR
243109421$24310942$1$I$20240619$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467343$RANBAXY$$24$YR$$M$Y$133$KG$20240912$$MD$FR$FR
243109431$24310943$1$I$$20240828$20240912$20240912$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467228$RANBAXY$$$$$F$Y$$$20240912$$CN$GB$GB
243109441$24310944$1$I$20240502$20240828$20240912$20240912$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467164$RANBAXY$$70$YR$$M$Y$$$20240912$$MD$ES$ES
243109451$24310945$1$I$20240411$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467297$RANBAXY$$23$YR$$F$Y$$$20240912$$MD$FR$FR
243109461$24310946$1$I$20231001$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467012$RANBAXY$$37$YR$$F$Y$57$KG$20240912$$MD$IT$IT
243109471$24310947$1$I$20240601$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467215$RANBAXY$$70$YR$$M$Y$63$KG$20240912$$MD$FR$FR
243109481$24310948$1$I$$20240828$20240912$20240912$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467279$RANBAXY$$78$YR$$M$Y$$$20240912$$PH$SE$SE
243109491$24310949$1$I$20240501$20240828$20240912$20240912$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467246$RANBAXY$$86$YR$$F$Y$66$KG$20240912$$CN$GB$GB
243109501$24310950$1$I$20240307$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467460$RANBAXY$$28$YR$$M$Y$$$20240912$$PH$FR$FR
243109511$24310951$1$I$20230701$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467349$RANBAXY$$66$YR$$M$Y$$$20240912$$MD$FR$FR
243109521$24310952$1$I$20231123$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467301$RANBAXY$$43$YR$$F$Y$92$KG$20240912$$MD$FR$FR
243109531$24310953$1$I$20230601$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467172$RANBAXY$$68$YR$$F$Y$$$20240912$$MD$FR$FR
243109541$24310954$1$I$20240319$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467214$RANBAXY$$84$YR$$M$Y$92$KG$20240912$$MD$FR$FR
243109561$24310956$1$I$$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467405$RANBAXY$Guerrieri S, Rubin M, Gattuso I, Zanetta C, Genchi A, Preziosa P. Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series. J Neurol. 2024;271(6):3678-3681$51$YR$$F$Y$$$20240912$$HP$IT$IT
243109571$24310957$1$I$$20240828$20240912$20240912$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467252$RANBAXY$Shamseldin M, Heers H, Steiner T, Puls R.. Anatomic locations of ureterovascular fistulae: a review of 532 patients in the literature and a new series of 8 patients.. CVIR Endovasc. 2024;7 (1):no pagination$80$YR$$F$Y$$$20240912$$HP$DE$DE
243109581$24310958$1$I$20240417$20240829$20240912$20240912$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467339$RANBAXY$$82$YR$$F$Y$$$20240912$$HP$AU$AU
243109591$24310959$1$I$$20240828$20240912$20240912$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467487$RANBAXY$A. Dunalska, A. Szulc. Internal medicine, neurology, psychiatry various faces of dissociation. Psychiatry after diploma. 2024$29$YR$$F$Y$$$20240912$$HP$PL$PL
243109601$24310960$1$I$$20240828$20240912$20240912$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467191$RANBAXY$$$$$M$Y$$$20240912$$PH$BE$BE
243109611$24310961$1$I$20240626$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467144$RANBAXY$$74$YR$$F$Y$$$20240912$$PH$IT$IT
243109631$24310963$1$I$20240908$20240909$20240912$20240912$EXP$$US-TAKEDA-2024TUS090138$TAKEDA$$6$YR$$M$Y$$$20240912$$MD$US$US
243109641$24310964$1$I$20231119$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467430$RANBAXY$$62$YR$$M$Y$64$KG$20240912$$MD$FR$FR
243109651$24310965$1$I$$20240828$20240912$20240912$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467257$RANBAXY$Shamseldin M, Heers H, Steiner T, Puls R.. Anatomic locations of ureterovascular fistulae: a review of 532 patients in the literature and a new series of 8 patients.. CVIR Endovasc. 2024;7 (1):no pagination$80$YR$$M$Y$$$20240912$$HP$DE$DE
243109661$24310966$1$I$$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467516$RANBAXY$Castelli B, Fonte C, Guidi M, Di Nicola M, Giunti L, Buccoliero AM. ROLES OF GEMCITABINEOXALIPLATIN (GEMOX) ADD-ON THERAPY IN INFANT-TYPE BRAIN TUMORS: A SINGLE CENTER EXPERIENCE. Neuro Oncol. 2024;26(1):194$$$C$$Y$$$20240912$$HP$IT$IT
243109671$24310967$1$I$$20240828$20240912$20240912$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467608$RANBAXY$Boal A, Millar C. Case series: Assessment of two anti-HMG-COA reductase antibody-associated immune-mediated necrotising myopathy patients in a Scottish Lipid Clinic. Atherosclerosis. 2024;395:117627$74$YR$$F$Y$$$20240912$$HP$GB$GB
243109681$24310968$1$I$20240207$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467444$RANBAXY$$61$YR$$F$Y$70$KG$20240912$$MD$FR$FR
243109691$24310969$1$I$$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467152$RANBAXY$Castelli B, Fonte C, Guidi M, Di Nicola M, Giunti L, Buccoliero AM, et al. ROLES OF GEMCITABINE-OXALIPLATIN (GEMOX) ADD-ON THERAPY IN INFANT-TYPE BRAIN TUMORS: A SINGLE CENTER EXPERIENCE. Neuro Oncol. 2024;26 (Suppl.):iv194/OTHR-05/ (ID:NOAE064.67)$$$C$$Y$$$20240912$$HP$IT$IT
243109701$24310970$1$I$20240201$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467105$RANBAXY$$68$YR$$F$Y$63$KG$20240912$$MD$FR$FR
243109711$24310971$1$I$20240413$20240828$20240912$20240912$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467573$RANBAXY$$95$YR$$M$Y$$$20240912$$MD$ES$ES
243109721$24310972$1$I$20240601$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467125$RANBAXY$$90$YR$$F$Y$74$KG$20240912$$PH$FR$FR
243109731$24310973$1$I$20240602$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466921$RANBAXY$$74$YR$$F$Y$$$20240912$$MD$IT$IT
243109741$24310974$1$I$$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467145$RANBAXY$Pessina E, Martini A, Raffone F, Martiadis V. Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series. Front Psychiatry. 2023;14:1299368 (1-5)$$$$$Y$$$20240912$$HP$IT$IT
243109751$24310975$1$I$20210317$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467615$RANBAXY$$70$YR$$F$Y$$$20240912$$PH$FR$FR
243109761$24310976$1$I$$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467610$RANBAXY$Garri F, Puthenparampil M, Simonato D, Rinaldi F, Gallo P. A rare case of Listeria rhombencephalitis with a sudden onset and unusual brain MRI features. Neurol Sci. 2024;45:353-355$66$YR$$F$Y$$$20240912$$HP$IT$IT
243109771$24310977$1$I$$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466763$RANBAXY$Jeantin L, Shor N, Pallix-Guyot M, Roos-Weil D, Bellanger A, Le G-T, et al. Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod. J Neurol. 2024;271:729-732$61$YR$$F$Y$$$20240912$$HP$FR$FR
243109781$24310978$1$I$20230201$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466960$RANBAXY$$72$YR$$M$Y$$$20240912$$MD$FR$FR
243109791$24310979$1$I$$20240828$20240912$20240912$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467581$RANBAXY$Boal A, Millar C. Case series: Assessment of two anti-HMG-COA reductase antibody-associated immune-mediated necrotising myopathy patients in a Scottish Lipid Clinic. Atherosclerosis. 2024;395:117627$65$YR$$F$Y$$$20240912$$HP$GB$GB
243109801$24310980$1$I$20240301$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467567$RANBAXY$$57$YR$$F$Y$$$20240912$$MD$FR$FR
243109811$24310981$1$I$20240627$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467291$RANBAXY$$50$YR$$M$Y$82$KG$20240912$$HP$FR$FR
243109821$24310982$1$I$20240524$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466928$RANBAXY$$37$YR$$M$Y$79.9$KG$20240912$$MD$FR$FR
243109831$24310983$1$I$$20240828$20240912$20240912$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467526$RANBAXY$Castelli B, Fonte C, Guidi M, Di Nicola M, Giunti L, Buccoliero AM. ROLES OF GEMCITABINEOXALIPLATIN (GEMOX) ADD-ON THERAPY IN INFANT-TYPE BRAIN TUMORS: A SINGLE CENTER EXPERIENCE. Neuro Oncol. 2024;26(1):194$$$C$$Y$$$20240912$$HP$IT$IT
243109841$24310984$1$I$20240522$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467565$RANBAXY$$87$YR$$F$Y$$$20240912$$MD$FR$FR
243109851$24310985$1$I$$20240828$20240912$20240912$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467261$RANBAXY$Wang J, Xiang Q. Successful treatment of relapsed and refractory CIDP with ofatumumab: a first case report. Front Immunol. 2024;15 (0):1437848;01-05$46$YR$$M$Y$$$20240912$$HP$CN$CN
243109861$24310986$1$I$20240627$20240828$20240912$20240912$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467578$RANBAXY$$52$YR$$F$Y$$$20240912$$MD$ES$ES
243109871$24310987$1$I$20240326$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467558$RANBAXY$$15$DY$$M$Y$4.4$KG$20240912$$MD$FR$FR
243109881$24310988$1$I$20240601$20240828$20240912$20240912$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467302$RANBAXY$$43$YR$$M$Y$$$20240912$$HP$SE$SE
243109891$24310989$1$I$20240801$20240828$20240912$20240912$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467217$RANBAXY$$70$YR$$F$Y$50.25$KG$20240912$$MD$KR$KR
243109901$24310990$1$I$$20240828$20240912$20240912$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467039$RANBAXY$Wang N. Neurologic Complications of Cancer Immunotherapy. Continuum Minneap Minn. 2023;29:1827-1843$42$YR$$F$Y$$$20240912$$MD$US$US
243109911$24310991$1$I$20240626$20240828$20240912$20240912$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467175$RANBAXY$$43$YR$$M$Y$$$20240912$$PH$ES$ES
243109921$24310992$1$I$20150505$20240909$20240912$20240912$EXP$$CO-UCBSA-2024046643$UCB$$67$YR$$F$Y$$$20240912$$CN$CO$CO
243109931$24310993$1$I$20240523$20240828$20240912$20240912$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466916$RANBAXY$$63$YR$$F$Y$32$KG$20240912$$HP$FR$FR
243109941$24310994$1$I$$20240905$20240912$20240912$PER$$US-AMGEN-USASP2024181847$AMGEN$$$$$M$Y$$$20240912$$CN$US$US
243109951$24310995$1$I$$20240910$20240912$20240912$PER$$US-ROCHE-10000079246$ROCHE$$49$YR$A$F$Y$$$20240912$$MD$US$US
243109961$24310996$1$I$$20240909$20240912$20240912$EXP$$NL-ADIENNEP-2024AD000728$ADIENNE PHARMA + BIOTECH$Berghuis D, Mehyar LS, Abu-Arja R, Albert MH, Barnum JL, von Bernuth H et al. Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study. J Clin Immunol. 2024;44(8):182. DOI: 10.1007/s10875-024-01786-7$$$T$M$Y$$$20240910$$MD$NL$
243109981$24310998$1$I$20230701$20240828$20240912$20240912$PER$$US-SA-2024SA262534$SANOFI AVENTIS$$59$YR$A$M$Y$70.45$KG$20240912$$MD$US$US
243109993$24310999$3$F$20240101$20240823$20240912$20240917$PER$$US-SA-2024SA263933$SANOFI AVENTIS$$74$YR$E$M$Y$79.55$KG$20240918$$HP$US$US
243110001$24311000$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA261517$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240912$$HP$US$US
243110011$24311001$1$I$$20240814$20240912$20240912$30DAY$$US-VEROBIOTECH-2024USVEROSPO00214$VERO BIOTECH$$$$$$Y$$$20240912$$HP$US$US
243110021$24311002$1$I$20240903$20240904$20240912$20240912$30DAY$$US-GSK-US2024110247$GLAXOSMITHKLINE$$69$YR$$M$Y$$$20240912$$CN$US$US
243110031$24311003$1$I$$20240824$20240912$20240912$PER$$US-JNJFOC-20240865869$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
243110041$24311004$1$I$$20240909$20240912$20240912$EXP$$NL-ADIENNEP-2024AD000729$ADIENNE PHARMA + BIOTECH$Berghuis D, Mehyar LS, Abu-Arja R, Albert MH, Barnum JL, von Bernuth H et al. Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study. J Clin Immunol. 2024;44(8):182. DOI: 10.1007/s10875-024-01786-7$$$C$M$Y$$$20240910$$MD$NL$
243110052$24311005$2$F$20230824$20240910$20240912$20240921$EXP$$CN-Accord-445415$ACCORD$Liao L, Zhang Z. Severe sepsis induced by zoledronic acid: A case report. Medicine (Baltimore). 2024 Aug 30;103(35):e39188. DOI:10.1097/MD.0000000000039188.$58$YR$A$F$Y$$$20240921$$HP$CN$CN
243110061$24311006$1$I$$20240830$20240912$20240912$EXP$$AE-GLENMARK PHARMACEUTICALS-2024GMK093776$GLENMARK$Jumani A, Ibrahim H, Purra H, Alkhazraji AK, AlNajjar MS. Metformin-Induced Hemolysis in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient:. Cureus. 2024;16(7):e65081$$$$$Y$$$20240912$$MD$AE$AE
243110071$24311007$1$I$$20240905$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013034$DR REDDYS$$16$YR$T$M$Y$$$20240912$$HP$US$US
243110081$24311008$1$I$20240801$20240911$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145135$BRISTOL MYERS SQUIBB$$33$YR$A$M$Y$$$20240912$$HP$US$US
243110091$24311009$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144858$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240912$$HP$US$US
243110101$24311010$1$I$20220610$20240904$20240912$20240912$EXP$$IN-ROCHE-10000078764$ROCHE$$63$YR$A$M$Y$$$20240912$$CN$IN$IN
243110111$24311011$1$I$$20240912$20240912$20240912$PER$$US-PROD-AS2-212756134-RB-104293-2023$RECKITT BENCKISER$$$$$M$Y$$$20240912$$CN$US$US
243110122$24311012$2$F$$20240905$20240912$20240917$EXP$$US-ROCHE-10000075368$ROCHE$$42$YR$A$F$Y$$$20240917$$CN$US$US
243110131$24311013$1$I$20240805$20240909$20240912$20240912$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-143882$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240912$$PH$IT$IT
243110143$24311014$3$F$20240823$20240917$20240912$20240923$PER$$US-AMGEN-USASP2024179092$AMGEN$$52$YR$A$F$Y$$$20240923$$PH$US$US
243110153$24311015$3$F$20240101$20240923$20240912$20240927$EXP$$US-009507513-2409USA003587$MERCK$$$$$M$Y$85.3$KG$20240927$$MD$US$US
243110161$24311016$1$I$$20240904$20240912$20240912$EXP$$ZA-AstraZeneca-2024A204630$ASTRAZENECA$$69$YR$$M$Y$$$20240912$$CN$ZA$
243110172$24311017$2$F$20240901$20240916$20240912$20240919$EXP$$US-ABBVIE-5910667$ABBVIE$$34$YR$$F$Y$140$KG$20240919$$CN$US$US
243110181$24311018$1$I$20240830$20240910$20240912$20240912$EXP$$US-KYOWAKIRIN-2024KK021134$KYOWA$$$$$$Y$$$20240912$$HP$US$US
243110191$24311019$1$I$$20240904$20240912$20240912$EXP$$AU-AstraZeneca-2024A201616$ASTRAZENECA$$$$$$Y$$$20240912$$MD$AU$
243110201$24311020$1$I$20240813$20240904$20240912$20240912$EXP$$GB-AstraZeneca-2024A201153$ASTRAZENECA$$75$YR$$M$Y$$$20240912$$MD$GB$
243110211$24311021$1$I$20240830$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006652$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240912$$CN$US$US
243110221$24311022$1$I$$20240901$20240912$20240912$EXP$$US-JNJFOC-20240903968$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$US$US
243110231$24311023$1$I$$20240906$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005220$ELI LILLY AND CO$$$$$M$Y$$$20240912$$CN$US$US
243110241$24311024$1$I$$20240814$20240912$20240912$30DAY$$US-VEROBIOTECH-2024USVEROSPO00215$VERO BIOTECH$$$$$$Y$$$20240912$$HP$US$US
243110261$24311026$1$I$20230101$20240905$20240912$20240912$PER$FR-AFSSAPS-AVBX2024000463$FR-CHEPLA-2024011468$CHEPLAPHARM$$17$YR$$M$Y$$$20240912$$MD$COUNTRY NOT SPECIFIED$FR
243110271$24311027$1$I$$20240903$20240912$20240912$EXP$DE-EMBRYOTOX-202300321$DE-TORRENT-00027287$TORRENT$$$$$M$Y$$$20240912$$MD$DE$DE
243110281$24311028$1$I$20240903$20240903$20240912$20240912$EXP$GB-MHRA-MED-202409031353236340-ZCMTR$GB-TORRENT-00037825$TORRENT$$39$YR$A$F$Y$$$20240912$$CN$GB$GB
243110291$24311029$1$I$$20240903$20240912$20240912$EXP$GB-MHRA-31738807$GB-TORRENT-00037831$TORRENT$$$$$$Y$$$20240912$$CN$GB$GB
243110301$24311030$1$I$20240904$20240904$20240912$20240912$EXP$GB-MHRA-MED-202409040717567780-ZLMDV$GB-TORRENT-00037850$TORRENT$$59$YR$A$M$Y$76$KG$20240912$$CN$GB$GB
243110311$24311031$1$I$$20240903$20240912$20240912$EXP$GB-MHRA-MED-202409032048169360-NLFMK$GB-TORRENT-00037856$TORRENT$$46$YR$A$F$Y$$$20240912$$CN$GB$GB
243110321$24311032$1$I$$20240902$20240912$20240912$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011397$STRIDES$Sasidharan Pillai S, Robilliard R, Fredette ME, Serrano-Gonzalez M, Scully KJ.. Persistent hypercalcemia mimicking hypophosphatasia after discontinuation of a ketogenic diet: a case report.. J-Pediatr-Endocrinol-Metab. 2023;36:1109-1113$1$DEC$$M$Y$12.9$KG$20240912$$MD$US$US
243110331$24311033$1$I$$20240902$20240912$20240912$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011346$STRIDES$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework.. J-Forens-Legal-Med. 2024;101$67$YR$$$Y$$$20240912$$HP$US$US
243110341$24311034$1$I$$20240904$20240912$20240912$EXP$$JP-ASTELLAS-2024JP005817$ASTELLAS$$61$YR$A$F$Y$$$20240912$$PH$JP$JP
243110351$24311035$1$I$$20231218$20240912$20240912$PER$$US-INGENUS PHARMACEUTICALS, LLC-2023INF000064$INGENUS$$$$$$Y$$$20240912$$CN$US$US
243110361$24311036$1$I$$20240430$20240912$20240912$PER$$US-INGENUS PHARMACEUTICALS, LLC-2024INF000021$INGENUS$$$$$$Y$$$20240912$$CN$US$US
243110381$24311038$1$I$20120403$20240830$20240912$20240912$EXP$GB-MHRA-MED-202407241045585120-DRSWJ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18271$ALKEM$$$$$M$Y$$$20240912$$MD$GB$GB
243110391$24311039$1$I$$20240904$20240912$20240912$EXP$GB-MHRA-TPP47231726C4678899YC1725384570438$GB-TORRENT-00037873$TORRENT$$69$YR$E$M$Y$109$KG$20240912$$MD$GB$GB
243110401$24311040$1$I$$20240902$20240912$20240912$PER$$US-ABBVIE-5905173$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243110411$24311041$1$I$$20240830$20240912$20240912$EXP$GB-MHRA-MIDB-696585cc-f7c3-4822-af83-2bb30f4a6440$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-20841$ALKEM$$56$YR$$$Y$$$20240912$$PH$GB$GB
243110421$24311042$1$I$20150601$20240830$20240912$20240912$EXP$GB-MHRA-EYC 00166049$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-20710$ALKEM$$52$YR$$M$Y$105$KG$20240912$$CN$GB$GB
243110431$24311043$1$I$20240813$20240830$20240912$20240912$EXP$GB-MHRA-TPP19467282C10252939YC1724430262941$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-20733$ALKEM$$65$YR$$M$Y$83$KG$20240912$$MD$GB$GB
243110441$24311044$1$I$$20240904$20240912$20240912$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP011518$STRIDES$Wallace B, Doran N, Vincent C.. Management of isopropyl nitrate-induced methaemoglobinaemia in pregnancy.. BMJ-Case-Rep. 2024;17 (7)$4$DEC$$F$Y$$$20240912$$MD$GB$GB
243110451$24311045$1$I$20240910$20240910$20240912$20240912$EXP$$JP-ALXN-202409JPN000636JP$ALEXION PHARMACEUTICALS$$83$YR$$F$Y$60$KG$20240912$$MD$JP$JP
243110461$24311046$1$I$$20240905$20240912$20240912$EXP$$CA-TAKEDA-2024TUS089646$TAKEDA$$$$$F$Y$$$20240912$$CN$CA$CA
243110472$24311047$2$F$20240907$20240917$20240912$20240920$PER$$US-AMGEN-USASP2024180078$AMGEN$$$$$F$Y$$$20240920$$CN$US$US
243110491$24311049$1$I$$20240904$20240912$20240912$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP011521$STRIDES$Wallace B, Doran N, Vincent C.. Management of isopropyl nitrate-induced methaemoglobinaemia in pregnancy.. BMJ-Case-Rep. 2024;17 (7)$$$$$Y$$$20240912$$MD$GB$GB
243110501$24311050$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145042$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$55.79$KG$20240912$$HP$US$US
243110511$24311051$1$I$$20240905$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142283$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240912$$CN$US$US
243110521$24311052$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144650$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240912$$HP$US$US
243110541$24311054$1$I$20240215$20240903$20240912$20240912$EXP$FR-AFSSAPS-TO2024001626$FR-TEVA-VS-3240240$TEVA$$52$YR$$M$Y$$$20240912$$MD$FR$FR
243110551$24311055$1$I$20240601$20240905$20240912$20240912$EXP$$US-ABBVIE-5802073$ABBVIE$$17$YR$$F$Y$$$20240912$$CN$US$US
243110561$24311056$1$I$$20240909$20240912$20240912$EXP$$US-TAKEDA-2024TUS090380$TAKEDA$$$$$M$Y$82.99$KG$20240912$$HP$US$US
243110571$24311057$1$I$20240904$20240904$20240912$20240912$PER$$US-BIOGEN-2024BI01281086$BIOGEN$$4$YR$$$Y$$$20240912$$CN$US$US
243110581$24311058$1$I$$20240904$20240912$20240912$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011572$STRIDES$Aifuwa E, Kandahari A, Steinberg A.. HL-298 Concomitant Methotrexate Withdrawal and Brentuximab Vedotin Therapy for Treatment of Methotrexate Associated Hodgkin Lymphoma.. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S446-S447.$82$YR$$M$Y$$$20240912$$HP$US$US
243110591$24311059$1$I$$20240904$20240912$20240912$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011533$STRIDES$Toutain J, Fares S, Cochereau I, Gargouri MA, Titah C.. Severe Vaso-Occlusive and Ocular Decompression Retinopathy Revealing a Sickle Cell Trait in a Patient with Herpetic Uveitis.. Ocular-Immunol-Inflamm. 2024;32 (6):1079-1082$24$YR$$M$Y$$$20240912$$MD$FR$FR
243110601$24311060$1$I$20240821$20240911$20240912$20240912$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050745$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240912$$HP$SG$SG
243110611$24311061$1$I$20240508$20240912$20240912$20240912$PER$$US-PROD-AS2-212756134-RB-089420-2024$RECKITT BENCKISER$$$$$M$Y$$$20240912$$CN$US$US
243110621$24311062$1$I$$20240909$20240912$20240912$EXP$$BR-ABBVIE-5917047$ABBVIE$$$$$M$Y$$$20240912$$CN$BR$BR
243110631$24311063$1$I$20240905$20240909$20240912$20240912$EXP$$US-ABBVIE-5917011$ABBVIE$$49$YR$$F$Y$$$20240912$$CN$US$US
243110651$24311065$1$I$20240401$20240905$20240912$20240912$EXP$FR-AFSSAPS-BX2024001717$FR-CHEPLA-2024011551$CHEPLAPHARM$$62$YR$$F$Y$49$KG$20240912$$MD$COUNTRY NOT SPECIFIED$FR
243110701$24311070$1$I$20181009$20240910$20240912$20240912$EXP$$CZ-ROCHE-2560093$ROCHE$Spisarova M. New horizons in the treatment of gastrointestinal tumours.. Current topics in oncology 2020 Jan;:56-.$56$YR$A$M$Y$$$20240912$$MD$CZ$CZ
243110711$24311071$1$I$$20240906$20240912$20240912$EXP$$RU-STRIDES ARCOLAB LIMITED-2024SP011575$STRIDES$Dukhin O, Bala D, Felker E, Golovina P, Tretyakova M, Haes B, et al.. Case report: Combination of veno-arterial extracorporeal membrane oxygenation and intra-aortic balloon pump in a young male patient with refractory cardiogenic shock due to aluminum phosphide poisoning.. Front-Cardiovasc-Med. 2023;10$20$YR$$M$Y$$$20240912$$HP$RU$RU
243110721$24311072$1$I$$20240906$20240912$20240912$EXP$$JP-AMGEN-JPNSP2024179688$AMGEN$$$$$$Y$$$20240912$$MD$JP$JP
243110731$24311073$1$I$20240906$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180407$AMGEN$$72$YR$E$F$Y$$$20240912$$CN$US$US
243110741$24311074$1$I$$20240903$20240912$20240912$EXP$$AU-JNJFOC-20240919733$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$HP$AU$AU
243110751$24311075$1$I$$20240905$20240912$20240912$EXP$$US-JNJFOC-20240917603$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
243110761$24311076$1$I$$20240910$20240912$20240912$EXP$$US-ABBVIE-5918965$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243110771$24311077$1$I$$20240906$20240912$20240912$EXP$$US-TAKEDA-2024TUS090102$TAKEDA$$$$$F$Y$$$20240912$$HP$US$US
243110782$24311078$2$F$20220201$20240918$20240912$20240927$EXP$$DE-TEVA-VS-3241100$TEVA$Roch C, Para S, Brandhofer C, Seitz AK, Remi C, Berner J, et al. Successful use of Rectal Pregabalin for the Treatment of Chemotherapy-Induced Neuropathic Pain-a Case Report. J-Palliative-Care 2023; 38 (4): 412-415.; Roch C, Para S, Brandhofer C, Seitz AK, Remi C, Berner J, et al. Successful use of Rectal Pregabalin for the Treatment of Chemotherapy-Induced Neuropathic Pain-a Case Report. J-Palliative-Care 2023; 38 (4): 412-415.$65$YR$$F$Y$$$20240927$$MD$DE$DE
243110791$24311079$1$I$20240907$20240909$20240912$20240912$EXP$GB-MHRA-MED-202409080153214700-MTCHY$GB-STRIDES ARCOLAB LIMITED-2024SP011526$STRIDES$$49$YR$$F$Y$82$KG$20240912$$CN$GB$GB
243110801$24311080$1$I$20240101$20240903$20240912$20240912$PER$$US-ABBVIE-5906201$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243110811$24311081$1$I$20231001$20240902$20240912$20240912$EXP$$BR-EMD Serono-2024047411$EMD SERONO INC$$33$YR$A$F$Y$$$20240912$$HP$BR$BR
243110821$24311082$1$I$$20240831$20240912$20240912$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001264$ALEMBIC$Tran J, Jackman R.P, Muench M.O, Hazegh K, Bean S.-W, Thomas K.A et.al.. Testosterone supplementation increases red blood cell susceptibility to oxidative stress, decreases membrane deformability, and decreases survival after cold storage and transfusion. Transfusion. 2024;64:1469-1480$$$$$Y$$$20240912$$HP$US$US
243110831$24311083$1$I$$20240906$20240912$20240912$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001826$BLUEPRINT MEDICINES$$$$$M$Y$$$20240912$$CN$US$US
243110841$24311084$1$I$20231228$20240906$20240912$20240912$PER$$US-AMGEN-USASP2024179279$AMGEN$$74$YR$E$F$Y$74.1$KG$20240912$$PH$US$US
243110861$24311086$1$I$20240404$20240904$20240912$20240912$EXP$IT-MINISAL02-1000341$IT-TEVA-VS-3241172$TEVA$$49$YR$$F$Y$$$20240912$$PH$IT$IT
243110881$24311088$1$I$$20240831$20240912$20240912$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001288$ALEMBIC$Tran J, Jackman R.P, Muench M.O, Hazegh K, Bean S.-W, Thomas K.A et.al.. Testosterone supplementation increases red blood cell susceptibility to oxidative stress, decreases membrane deformability, and decreases survival after cold storage and transfusion. Transfusion. 2024;64:1469-1480$$$$$Y$$$20240912$$HP$US$US
243110891$24311089$1$I$$20240831$20240912$20240912$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001292$ALEMBIC$Green K.D, Bianco L.M, McCleskey B.C, Scott K.S. The Emergence of Bromazolam in Jefferson County AL. A Case Series. Journal of analytical toxicology. 2024$$$$$Y$$$20240912$$MD$US$US
243110902$24311090$2$F$$20240911$20240912$20240919$30DAY$$CA-JNJFOC-20240927870$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$CA$CA
243110911$24311091$1$I$$20240906$20240912$20240912$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004998$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240912$$CN$IT$IT
243110921$24311092$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A202229$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243110932$24311093$2$F$$20240909$20240912$20240916$EXP$$CN-AstraZeneca-2024A193985$ASTRAZENECA$$22645$DY$$M$Y$$$20240917$$CN$CN$
243110941$24311094$1$I$$20240904$20240912$20240912$EXP$$GR-AstraZeneca-2024A203790$ASTRAZENECA$$65$YR$$M$Y$$$20240912$$MD$GR$
243110951$24311095$1$I$$20230912$20240912$20240912$PER$$US-ALVOGEN-2023092274$ALVOGEN$$$$$F$Y$$$20240912$$CN$US$US
243110961$24311096$1$I$$20230914$20240912$20240912$PER$$US-ALVOGEN-2023092267$ALVOGEN$$85$YR$$F$Y$123.4$KG$20240912$$MD$US$US
243110971$24311097$1$I$$20231023$20240912$20240912$PER$$US-ALVOGEN-2023092475$ALVOGEN$$15$YR$$F$Y$$$20240912$$HP$US$US
243110981$24311098$1$I$20231110$20231117$20240912$20240912$PER$$US-ALVOGEN-2023092647$ALVOGEN$$28$YR$$M$Y$$$20240912$$CN$US$US
243110991$24311099$1$I$$20240831$20240912$20240912$EXP$PT-INFARMED-J202408-492$PT-Accord-445460$ACCORD$$44$YR$A$F$Y$$$20240912$$HP$PT$PT
243111001$24311100$1$I$$20240830$20240912$20240912$EXP$$US-SA-2024SA262287$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240912$$MD$US$US
243111011$24311101$1$I$20180101$20240905$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US079118$SANDOZ$$60$YR$$F$Y$$$20240912$$HP$US$US
243111021$24311102$1$I$$20240909$20240912$20240912$PER$$US-ALXN-202409USA000617US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240912$$CN$US$US
243111031$24311103$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144755$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$88.45$KG$20240912$$CN$US$US
243111041$24311104$1$I$20240501$20240910$20240912$20240912$EXP$$NVSC2024IE182343$NOVARTIS$$55$YR$$F$Y$$$20240912$$HP$IE$IE
243111052$24311105$2$F$$20240911$20240912$20240919$PER$$US-BIOGEN-2024BI01281489$BIOGEN$$$$$M$Y$$$20240919$$MD$US$US
243111061$24311106$1$I$$20240911$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145073$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240912$$CN$US$US
243111081$24311108$1$I$20240822$20240911$20240912$20240912$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050748$BOEHRINGER INGELHEIM$$46$YR$A$F$Y$$$20240912$$HP$SG$SG
243111091$24311109$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA080770$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240912$$CN$US$US
243111101$24311110$1$I$$20240826$20240912$20240912$PER$$US-SA-2024SA262576$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240912$$HP$US$US
243111111$24311111$1$I$19990801$20240909$20240912$20240912$EXP$DE-EMA-DD-20240903-7482831-084148$DE-SANDOZ INC.-SDZ2024DE079124$SANDOZ$$47$YR$$F$Y$$$20240912$$MD$DE$DE
243111121$24311112$1$I$$20240831$20240912$20240912$EXP$$PL-Accord-445472$ACCORD$Szlauer-Stefanska A, Kaminska-Winciorek G. Patient with chronic cutaneous and mucosal form of graft versus host disease. POSTGRADUATE DERMATOLOGY (DERMATOLOGIA PO DYPLOMIE). 2024$30$YR$A$M$Y$$$20240912$$MD$PL$PL
243111131$24311113$1$I$20240821$20240909$20240912$20240912$EXP$$CO-UCBSA-2024046647$UCB$$52$YR$$F$Y$$$20240912$$CN$CO$CO
243111142$24311114$2$F$$20240912$20240912$20240919$PER$$US-ROCHE-10000078778$ROCHE$$75$YR$E$M$Y$$$20240919$$CN$US$US
243111151$24311115$1$I$$20240905$20240912$20240912$EXP$$JP-SPECGX-T202401866$SPECGX$$61$YR$$M$Y$$$20240912$$PH$JP$JP
243111161$24311116$1$I$$20240826$20240912$20240912$PER$$US-SA-2024SA262616$SANOFI AVENTIS$$3$YR$C$M$Y$15.91$KG$20240912$$MD$US$US
243111171$24311117$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263367$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240912$$HP$US$US
243111181$24311118$1$I$20240101$20240828$20240912$20240912$PER$$US-SA-2024SA263061$SANOFI AVENTIS$$54$YR$A$M$Y$92.18$KG$20240912$$MD$US$US
243111191$24311119$1$I$20240801$20240904$20240912$20240912$PER$$US-SA-2024SA261422$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240912$$MD$US$US
243111201$24311120$1$I$20240101$20240828$20240912$20240912$PER$$US-SA-2024SA259184$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240912$$HP$US$US
243111211$24311121$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA262198$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240912$$MD$US$US
243111221$24311122$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263051$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240912$$CN$US$US
243111231$24311123$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA262183$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240912$$MD$US$US
243111241$24311124$1$I$20240903$20240903$20240912$20240912$PER$$US-SA-2024SA261881$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240912$$CN$US$US
243111251$24311125$1$I$20240909$20240909$20240912$20240912$EXP$$MX-AMGEN-MEXSL2024180236$AMGEN$$20$YR$A$M$Y$$$20240912$$MD$MX$MX
243111261$24311126$1$I$20191028$20240909$20240912$20240912$EXP$$CA-GILEAD-2024-0687133$GILEAD$$37$YR$A$M$Y$$$20240912$$PH$CA$CA
243111271$24311127$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006520$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240912$$HP$US$US
243111281$24311128$1$I$$20240831$20240912$20240912$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0338$GRAVITI PHARMACEUTICALS$Dougherty JA.Atorvastatin-Associated Macroglossia in a Cardioembolic Stroke Patient.Ann Pharmacother.2018;52(12):1259-1260$54$YR$A$F$Y$$$20240912$$HP$US$US
243111291$24311129$1$I$$20240906$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006807$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240912$$CN$US$US
243111301$24311130$1$I$20240909$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006661$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240912$$CN$US$US
243111311$24311131$1$I$20240911$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007472$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240912$$CN$US$US
243111321$24311132$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006602$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240912$$CN$US$US
243111331$24311133$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006548$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240912$$CN$US$US
243111341$24311134$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005234$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240912$$CN$US$US
243111351$24311135$1$I$$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181723$AMGEN$$$$$$Y$$$20240912$$PH$US$US
243111361$24311136$1$I$20240101$20240903$20240912$20240912$EXP$$US-SA-2024SA263330$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240912$$HP$US$US
243111384$24311138$4$F$20240624$20240918$20240912$20240923$EXP$$AR-MYLANLABS-2024M1058277$MYLAN$$49$YR$$M$Y$$$20240923$$CN$AR$AR
243111391$24311139$1$I$$20240905$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142279$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$93$KG$20240912$$HP$US$US
243111401$24311140$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143952$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$91.63$KG$20240912$$CN$US$US
243111412$24311141$2$F$$20240821$20240912$20240916$PER$$US-SA-2024SA262531$SANOFI AVENTIS$$$$A$M$Y$88.64$KG$20240916$$MD$US$US
243111421$24311142$1$I$20240101$20240828$20240912$20240912$PER$$US-SA-2024SA260477$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240912$$MD$US$US
243111431$24311143$1$I$20240815$20240822$20240912$20240912$PER$$US-SA-2024SA263379$SANOFI AVENTIS$$52$YR$A$F$Y$148$KG$20240912$$MD$US$US
243111441$24311144$1$I$20240701$20240830$20240912$20240912$PER$$US-SA-2024SA261862$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240912$$MD$US$US
243111451$24311145$1$I$20240825$20240826$20240912$20240912$PER$$US-SA-2024SA262367$SANOFI AVENTIS$$46$YR$A$M$Y$62.73$KG$20240912$$MD$US$US
243111461$24311146$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA261706$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240912$$CN$US$US
243111471$24311147$1$I$20240501$20240903$20240912$20240912$PER$$US-SA-2024SA260798$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240912$$HP$US$US
243111491$24311149$1$I$$20230130$20240912$20240912$PER$$US-ALVOGEN-2023092290$ALVOGEN$$69$YR$$F$Y$$$20240912$$HP$US$US
243111501$24311150$1$I$20240531$20240828$20240912$20240912$EXP$FR-AFSSAPS-LL2024001538$FR-Accord-446338$ACCORD$$57$YR$A$F$Y$$$20240912$$MD$FR$FR
243111511$24311151$1$I$$20240901$20240912$20240912$EXP$$NL-Accord-445186$ACCORD$Klingenberg MG, Sinkeler SJ, Koopmans N, Plaat RE. Severe hypotension requiring resuscitation in tumour-related carotid sinus syndrome: a case report. Eur Heart J Case Rep. 2024 Aug 19;8(8):ytae393.$57$YR$A$F$Y$$$20240912$$HP$NL$NL
243111551$24311155$1$I$$20240902$20240912$20240912$EXP$$CA-TEVA-VS-3239587$TEVA$$$$$F$Y$47$KG$20240912$$HP$CA$CA
243111561$24311156$1$I$$20230727$20240912$20240912$PER$$US-ALVOGEN-2023092031$ALVOGEN$$71$YR$$F$Y$$$20240912$$MD$US$US
243111571$24311157$1$I$$20240902$20240912$20240912$EXP$$JP-ROCHE-10000076641$ROCHE$$$$$F$Y$$$20240912$$MD$JP$JP
243111581$24311158$1$I$$20230816$20240912$20240912$PER$$US-ALVOGEN-2023092149$ALVOGEN$$$$$F$Y$$$20240912$$MD$US$US
243111601$24311160$1$I$$20230817$20240912$20240912$PER$$US-ALVOGEN-2023092161$ALVOGEN$$$$$F$Y$$$20240912$$CN$US$US
243111611$24311161$1$I$$20240909$20240912$20240912$PER$$US-ABBVIE-5917087$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243111621$24311162$1$I$$20230808$20240912$20240912$PER$$US-ALVOGEN-2023092108$ALVOGEN$$70$YR$$F$Y$$$20240912$$HP$US$US
243111631$24311163$1$I$20230101$20230906$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US000862$PAREXEL$$71$YR$$F$Y$$$20240912$$CN$US$US
243111641$24311164$1$I$20230101$20230920$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US000897$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243111651$24311165$1$I$20230101$20230905$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US000887$PAREXEL$$60$YR$$F$Y$$$20240912$$CN$US$US
243111661$24311166$1$I$20230101$20230802$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US000848$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243111671$24311167$1$I$20230607$20230825$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US000939$PAREXEL$$53$YR$$F$Y$44.444$KG$20240912$$CN$US$US
243111691$24311169$1$I$$20230831$20240912$20240912$PER$$US-ALVOGEN-2023092228$ALVOGEN$$39$YR$$F$Y$$$20240912$$HP$US$US
243111701$24311170$1$I$$20230913$20240912$20240912$PER$$US-ALVOGEN-2023092275$ALVOGEN$$69$YR$$F$Y$$$20240912$$MD$US$US
243111711$24311171$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144591$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240912$$HP$US$US
243111731$24311173$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144551$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240912$$HP$US$US
243111741$24311174$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145079$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240912$$HP$US$US
243111751$24311175$1$I$20240101$20240830$20240912$20240912$EXP$$US-UCBSA-2024044782$UCB$$$$$F$Y$$$20240912$$HP$US$US
243111761$24311176$1$I$20240801$20240910$20240912$20240912$EXP$$GB-ABBVIE-5917415$ABBVIE$$70$YR$$F$Y$$$20240912$$MD$GB$GB
243111771$24311177$1$I$20240419$20240902$20240912$20240912$EXP$$ES-ADVANZ PHARMA-202409007469$ADVANZ PHARMA$$$$$$Y$$$20240912$$MD$ES$ES
243111782$24311178$2$F$20240907$20240912$20240912$20240914$PER$$US-AMGEN-USASP2024181914$AMGEN$$83$YR$E$F$Y$$$20240914$$CN$US$US
243111791$24311179$1$I$20240901$20240901$20240912$20240912$EXP$GB-MHRA-MED-202409011154434140-JTGLQ$GB-Accord-444585$ACCORD$$39$YR$A$F$Y$$$20240912$$CN$GB$GB
243111801$24311180$1$I$$20240911$20240912$20240912$PER$$US-HALEON-2196459$Haleon PLC$$92$YR$$F$Y$$$20240912$$CN$US$US
243111812$24311181$2$F$20240801$20240910$20240912$20240916$PER$$US-AMGEN-USASP2024181387$AMGEN$$92$YR$E$F$Y$$$20240916$$CN$US$US
243111831$24311183$1$I$$20240905$20240912$20240912$PER$$US-AMGEN-USASP2024178046$AMGEN$$$$$$Y$$$20240912$$MD$US$US
243111841$24311184$1$I$$20240905$20240912$20240912$PER$$US-AstraZeneca-2024A202933$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243111851$24311185$1$I$20240823$20240830$20240912$20240912$EXP$$BG-UCBSA-2024044991$UCB$$$$A$M$Y$$$20240912$$CN$BG$BG
243111861$24311186$1$I$20240101$20240830$20240912$20240912$EXP$$US-UCBSA-2024044750$UCB$$$$$F$Y$85.986$KG$20240912$$HP$US$US
243111871$24311187$1$I$$20240904$20240912$20240912$EXP$$VN-AstraZeneca-2024A205310$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$VN$
243111881$24311188$1$I$20240801$20240906$20240912$20240912$EXP$$BR-AstraZeneca-2024A206361$ASTRAZENECA$$39$YR$$F$Y$$$20240912$$CN$BR$
243111901$24311190$1$I$$20240906$20240912$20240912$EXP$$US-AstraZeneca-2024A204183$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243111911$24311191$1$I$$20240820$20240912$20240912$PER$$US-BAUSCHBL-2024BNL032031$BAUSCH AND LOMB$$$$$$Y$$$20240912$$MD$US$US
243111921$24311192$1$I$20240820$20240904$20240912$20240912$EXP$$GB-AstraZeneca-2024A201274$ASTRAZENECA$$$$$M$Y$70$KG$20240912$$MD$GB$
243111931$24311193$1$I$$20240905$20240912$20240912$PER$$US-JNJFOC-20240915199$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243111951$24311195$1$I$20240910$20240910$20240912$20240912$PER$$US-JNJFOC-20240924403$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240912$$CN$US$US
243111961$24311196$1$I$$20240906$20240912$20240912$EXP$$US-JNJFOC-20240919746$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$US$US
243111971$24311197$1$I$20240701$20240829$20240912$20240912$EXP$ES-AEMPS-1562658$ES-Accord-444606$ACCORD$$72$YR$E$M$Y$$$20240912$$MD$ES$ES
243111981$24311198$1$I$20240801$20240829$20240912$20240912$PER$$US-SA-2024SA259286$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240912$$MD$US$US
243111991$24311199$1$I$$20240828$20240912$20240912$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467230$RANBAXY$Kozaci N, Aydin IE, Ersahin T, Taskiran B. Diagnosis of Diffuse Pulmonary Hemorrhage by Ultrasonography: A Case Report. Respir Case Rep. 2024;13(2):95-99$72$YR$$M$Y$$$20240912$$HP$TR$TR
243112001$24311200$1$I$$20231025$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001060$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112011$24311201$1$I$20230101$20230921$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US000940$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112021$24311202$1$I$20230101$20231128$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001183$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112031$24311203$1$I$$20231109$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001231$PAREXEL$$$$$F$Y$68.481$KG$20240912$$CN$US$US
243112041$24311204$1$I$20230101$20231204$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001192$PAREXEL$$59$YR$$F$Y$77.197$KG$20240912$$CN$US$US
243112051$24311205$1$I$$20240205$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000142$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112061$24311206$1$I$$20231206$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001233$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112071$24311207$1$I$20230801$20230921$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US000937$PAREXEL$$54$YR$$F$Y$$$20240912$$CN$US$US
243112081$24311208$1$I$20230101$20240108$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001309$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112091$24311209$1$I$20231130$20231204$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001297$PAREXEL$$70$YR$$F$Y$$$20240912$$CN$US$US
243112101$24311210$1$I$20231004$20231108$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001229$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112111$24311211$1$I$20230101$20231025$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001084$PAREXEL$$$$$F$Y$70.748$KG$20240912$$CN$US$US
243112121$24311212$1$I$20231206$20240327$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000178$PAREXEL$$61$YR$$F$Y$46.259$KG$20240912$$CN$US$US
243112131$24311213$1$I$$20240301$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000152$PAREXEL$$$$$F$Y$74.83$KG$20240912$$CN$US$US
243112141$24311214$1$I$20231022$20231214$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001248$PAREXEL$$$$$F$Y$50.794$KG$20240912$$CN$US$US
243112151$24311215$1$I$20240104$20240105$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000017$PAREXEL$$$$$F$Y$$$20240912$$PH$US$US
243112161$24311216$1$I$20120101$20231113$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001143$PAREXEL$$66$YR$$F$Y$$$20240912$$CN$US$US
243112171$24311217$1$I$$20240215$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000045$PAREXEL$$$$$F$Y$63.492$KG$20240912$$CN$US$US
243112181$24311218$1$I$$20240312$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000168$PAREXEL$$$$$F$Y$$$20240912$$PH$US$US
243112191$24311219$1$I$20231001$20240102$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000003$PAREXEL$$53$YR$$F$Y$$$20240912$$CN$US$US
243112201$24311220$1$I$$20240222$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000183$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112211$24311221$1$I$20231118$20231222$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001263$PAREXEL$$55$YR$$F$Y$$$20240912$$CN$US$US
243112221$24311222$1$I$20230101$20240103$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000015$PAREXEL$$52$YR$$F$Y$89.796$KG$20240912$$CN$US$US
243112231$24311223$1$I$20190721$20240909$20240912$20240912$EXP$$CO-UCBSA-2024046655$UCB$$60$YR$$F$Y$$$20240912$$CN$CO$CO
243112243$24311224$3$F$$20240911$20240912$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144979$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$63$KG$20240916$$CN$US$US
243112251$24311225$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144874$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$122.92$KG$20240912$$CN$US$US
243112262$24311226$2$F$$20240911$20240912$20240913$EXP$$US-GILEAD-2024-0687137$GILEAD$$$$E$F$Y$$$20240913$$CN$US$US
243112271$24311227$1$I$$20240328$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000181$PAREXEL$$$$$F$Y$61.224$KG$20240912$$CN$US$US
243112281$24311228$1$I$$20240527$20240912$20240912$PER$US-ALVOGEN-2024094383$US-ALVOGEN-2024094383$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243112291$24311229$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180425$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243112301$24311230$1$I$$20240530$20240912$20240912$PER$US-ALVOGEN-2024094431$US-ALVOGEN-2024094431$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243112311$24311231$1$I$$20240530$20240912$20240912$PER$US-ALVOGEN-2024094429$US-ALVOGEN-2024094429$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243112321$24311232$1$I$$20240530$20240912$20240912$PER$US-ALVOGEN-2024094368$US-ALVOGEN-2024094368$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243112331$24311233$1$I$20240906$20240909$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US078919$SANDOZ$$42$YR$$F$Y$$$20240912$$HP$US$US
243112341$24311234$1$I$$20240613$20240912$20240912$PER$US-ALVOGEN-2024094370$US-ALVOGEN-2024094370$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243112351$24311235$1$I$$20240609$20240912$20240912$PER$US-ALVOGEN-2024094415$US-ALVOGEN-2024094415$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243112361$24311236$1$I$$20240906$20240912$20240912$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001821$BLUEPRINT MEDICINES$$$$$F$Y$$$20240912$$CN$US$US
243112371$24311237$1$I$$20240609$20240912$20240912$PER$US-ALVOGEN-2024094411$US-ALVOGEN-2024094411$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243112381$24311238$1$I$$20240902$20240912$20240912$EXP$$CH-ASTELLAS-2024-AER-005247$ASTELLAS$$$$$F$Y$$$20240912$$MD$CH$CH
243112391$24311239$1$I$$20240904$20240912$20240912$EXP$$US-INTERCEPT-PM2024001762$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243112401$24311240$1$I$$20240609$20240912$20240912$PER$US-ALVOGEN-2024094588$US-ALVOGEN-2024094588$ALVOGEN$$$$$M$Y$$$20240912$$CN$US$US
243112411$24311241$1$I$20240401$20240905$20240912$20240912$EXP$$US-INTERCEPT-PM2024001793$INTERCEPT PHARMACEUTICALS$$69$YR$$F$Y$$$20240912$$CN$US$US
243112461$24311246$1$I$$20240904$20240912$20240912$EXP$$EU-BAUSCHBL-2024BNL032799$BAUSCH AND LOMB$Ribeiro M, Oliveira J, Meira J, Soares-dos-Reis R, Silva M, Albuquerque L, Falcao-Reis F, Breda J. When a Red Eye Is a Red Flag: A Nontraumatic Case of a Direct Carotid-Cavernous Fistula. Journal of Neuro-Ophthalmology. 2024 SEP 01;44 (3):E311-E313. doi:10.1097/WNO.0000000000001847$67$YR$$F$Y$$$20240912$$MD$EU$EU
243112471$24311247$1$I$$20240903$20240912$20240912$PER$$US-BAUSCHBL-2024BNL032820$BAUSCH AND LOMB$$$$$F$Y$$$20240912$$CN$US$US
243112481$24311248$1$I$$20240609$20240912$20240912$PER$US-ALVOGEN-2024094424$US-ALVOGEN-2024094424$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243112491$24311249$1$I$$20240909$20240912$20240912$EXP$$DE-GILEAD-2024-0687375$GILEAD$$$$$F$Y$$$20240912$$MD$DE$DE
243112501$24311250$1$I$20240701$20240901$20240912$20240912$EXP$GB-MHRA-WEBRADR-202409012142599770-VQMDG$GB-Accord-444591$ACCORD$$56$YR$A$M$Y$12$KG$20240912$$CN$GB$GB
243112511$24311251$1$I$20240501$20240709$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000606$PAREXEL$$52$YR$$F$Y$$$20240912$$CN$US$US
243112521$24311252$1$I$20240601$20240717$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000889$PAREXEL$$55$YR$$F$Y$52.6$KG$20240912$$CN$US$US
243112531$24311253$1$I$20231020$20231219$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2023-NOV-US001253$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112541$24311254$1$I$20230101$20240517$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000393$PAREXEL$$$$$F$Y$70.748$KG$20240912$$CN$US$US
243112561$24311256$1$I$$20240716$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000653$PAREXEL$$74$YR$$F$Y$$$20240912$$CN$US$US
243112571$24311257$1$I$20230101$20240508$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000354$PAREXEL$$$$$F$Y$74.83$KG$20240912$$CN$US$US
243112581$24311258$1$I$20240101$20240620$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000537$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112591$24311259$1$I$20240101$20240521$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000291$PAREXEL$$$$$$Y$$$20240912$$CN$US$US
243112601$24311260$1$I$20240101$20240405$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000229$PAREXEL$$57$YR$$F$Y$54.422$KG$20240912$$CN$US$US
243112611$24311261$1$I$20240101$20240604$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000504$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112621$24311262$1$I$20240409$20240411$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000409$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112631$24311263$1$I$20240101$20240703$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000815$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112641$24311264$1$I$20240301$20240503$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000340$PAREXEL$$61$YR$$F$Y$48.98$KG$20240912$$CN$US$US
243112651$24311265$1$I$$20240611$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000594$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112661$24311266$1$I$20230101$20240627$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000559$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112671$24311267$1$I$20240101$20240621$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000691$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112681$24311268$1$I$20231222$20240607$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000679$PAREXEL$$47$YR$$F$Y$77.098$KG$20240912$$CN$US$US
243112691$24311269$1$I$$20240517$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000394$PAREXEL$$$$$F$Y$70.748$KG$20240912$$CN$US$US
243112701$24311270$1$I$$20240207$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000081$PAREXEL$$$$$F$Y$63.492$KG$20240912$$CN$US$US
243112711$24311271$1$I$20240101$20240627$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000567$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112721$24311272$1$I$20240101$20240604$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000629$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112731$24311273$1$I$20230601$20240514$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000560$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112741$24311274$1$I$20240501$20240620$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000543$PAREXEL$$51$YR$$F$Y$$$20240912$$CN$US$US
243112751$24311275$1$I$20231101$20240516$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000400$PAREXEL$$54$YR$$F$Y$52.154$KG$20240912$$CN$US$US
243112761$24311276$1$I$20170101$20240430$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000479$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112771$24311277$1$I$$20240705$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000827$PAREXEL$$$$$F$Y$$$20240912$$CN$US$US
243112781$24311278$1$I$20240101$20240425$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000484$PAREXEL$$$$$F$Y$52.154$KG$20240912$$CN$US$US
243112791$24311279$1$I$$20240606$20240912$20240912$PER$US-ALVOGEN-2024094365$US-ALVOGEN-2024094365$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243112801$24311280$1$I$20220101$20240405$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000255$PAREXEL$$$$$F$Y$78.005$KG$20240912$$CN$US$US
243112811$24311281$1$I$20240801$20240905$20240912$20240912$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-142090$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$77.11$KG$20240912$$CN$PR$PR
243112821$24311282$1$I$$20240609$20240912$20240912$PER$US-ALVOGEN-2024094579$US-ALVOGEN-2024094579$ALVOGEN$$$$$F$Y$$$20240912$$CN$US$US
243112841$24311284$1$I$$20240909$20240912$20240912$EXP$$TR-SANDOZ INC.-SDZ2024TR079200$SANDOZ$$50$YR$$F$Y$$$20240912$$MD$TR$TR
243112851$24311285$1$I$$20240609$20240912$20240912$PER$US-ALVOGEN-2024094421$US-ALVOGEN-2024094421$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243112871$24311287$1$I$$20240910$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA079297$SANDOZ$$77$YR$$F$Y$$$20240912$$HP$CA$CA
243112881$24311288$1$I$$20240905$20240912$20240912$PER$$US-LEO Pharma-373380$LEO PHARM$$86$YR$$F$Y$$$20240912$$PH$US$US
243112891$24311289$1$I$20240101$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024180825$AMGEN$$54$YR$A$F$Y$$$20240912$$CN$US$US
243112901$24311290$1$I$20230101$20240904$20240912$20240912$EXP$$US-ABBVIE-5908607$ABBVIE$$$$$M$Y$93$KG$20240912$$CN$US$US
243112911$24311291$1$I$20240222$20240905$20240912$20240912$EXP$$DE-ABBVIE-5910330$ABBVIE$$68$YR$$F$Y$$$20240912$$MD$DE$DE
243112921$24311292$1$I$$20240906$20240912$20240912$PER$$US-ALXN-202409USA000466US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$HP$US$US
243112931$24311293$1$I$20240510$20240902$20240912$20240912$EXP$FR-AFSSAPS-TS2024000944$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111860$ZYDUS PHARM$$$$$$Y$$$20240912$$MD$FR$FR
243112941$24311294$1$I$20240501$20240902$20240912$20240912$EXP$FR-AFSSAPS-TO2024001685$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111953$ZYDUS PHARM$$$$$$Y$$$20240912$$PH$FR$FR
243112951$24311295$1$I$$20240904$20240912$20240912$PER$$US-ALXN-202409USA000236US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243112961$24311296$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5914867$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243112972$24311297$2$F$$20240923$20240912$20240928$EXP$$US-ABBVIE-5914453$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243112981$24311298$1$I$$20240903$20240912$20240912$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112001$ZYDUS PHARM$Meyer AS, Cluster A, Ogle A, Brossier N, Beck M, Lampe A, et al.. Novel treatments for acneiform eruptions caused by targeted therapies in the pediatric population. Neuro-Oncology. 2024;26:iv186-iv187$$$$$Y$$$20240912$$HP$US$US
243112991$24311299$1$I$20230530$20240902$20240912$20240912$EXP$FR-AFSSAPS-AM2024000677$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-111927$ZYDUS PHARM$$$$$$Y$$$20240912$$MD$FR$FR
243113001$24311300$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180069$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
243113031$24311303$1$I$20240101$20240820$20240912$20240912$PER$$US-SA-2024SA262173$SANOFI AVENTIS$$43$YR$A$M$Y$60.78$KG$20240912$$MD$US$US
243113041$24311304$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA263069$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240912$$HP$US$US
243113051$24311305$1$I$20240101$20240827$20240912$20240912$PER$$US-SA-2024SA263766$SANOFI AVENTIS$$44$YR$A$F$Y$62.73$KG$20240912$$MD$US$US
243113061$24311306$1$I$$20240826$20240912$20240912$PER$$US-SA-2024SA262551$SANOFI AVENTIS$$18$YR$A$F$Y$54.55$KG$20240912$$MD$US$US
243113071$24311307$1$I$$20240831$20240912$20240912$PER$$US-SA-2024SA261685$SANOFI AVENTIS$$$$E$M$Y$$$20240912$$CN$US$US
243113083$24311308$3$F$20240101$20240917$20240912$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-027386$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240926$$$US$US
243113091$24311309$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262347$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$CN$US$US
243113101$24311310$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5915268$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243113111$24311311$1$I$20240809$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145178$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240912$$CN$US$US
243113121$24311312$1$I$$20240911$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144958$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$66.22$KG$20240912$$HP$US$US
243113131$24311313$1$I$20240101$20240903$20240912$20240912$PER$$US-ABBVIE-5906764$ABBVIE$$65$YR$$F$Y$$$20240912$$HP$US$US
243113141$24311314$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A204715$ASTRAZENECA$$498$MON$$F$Y$$$20240912$$CN$US$
243113151$24311315$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA261834$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240912$$CN$US$US
243113161$24311316$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263666$SANOFI AVENTIS$$$$E$F$Y$$$20240912$$MD$US$US
243113171$24311317$1$I$20240706$20240904$20240912$20240912$EXP$$AU-AstraZeneca-2024A207354$ASTRAZENECA$$$$A$F$Y$$$20240912$$MD$AU$
243113191$24311319$1$I$$20240904$20240912$20240912$30DAY$$BR-SA-2024SA262982$SANOFI AVENTIS$$$$$$Y$$$20240912$$CN$BR$BR
243113201$24311320$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A202626$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243113211$24311321$1$I$$20240910$20240912$20240912$EXP$$US-AstraZeneca-2024A206490$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243113221$24311322$1$I$20240911$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024181712$AMGEN$$62$YR$A$F$Y$$$20240912$$PH$US$US
243113232$24311323$2$F$20240812$20240822$20240912$20240912$EXP$$US-ROCHE-10000078983$ROCHE$$11$YR$C$M$Y$$$20240912$$MD$US$US
243113241$24311324$1$I$$20240903$20240912$20240912$PER$$US-ABBVIE-5906738$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243113261$24311326$1$I$20240901$20240905$20240912$20240912$PER$$US-JNJFOC-20240914807$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
243113271$24311327$1$I$$20240904$20240912$20240912$EXP$$GB-JNJFOC-20240920060$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240912$$HP$GB$GB
243113281$24311328$1$I$$20240904$20240912$20240912$EXP$$IN-RDY-SPO/IND/24/0013301$DR REDDYS$Ganju N, Panda T, Oberoi G, Agarwal M, Mahapatra M. AML-083 AML in Pregnancy: Case Series. Clinical Lymphoma, Myeloma and Leukemia. 2024;24: S293. doi:10.1016/S2152-2650%2824%2901157-1.$$$$F$Y$$$20240912$$MD$IN$IN
243113301$24311330$1$I$20240101$20240904$20240912$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-027938$UNITED THERAPEUTICS$$$$$F$Y$44.898$KG$20240912$$$US$US
243113311$24311331$1$I$20240826$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144940$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240912$$CN$US$US
243113321$24311332$1$I$$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145186$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240912$$CN$US$US
243113331$24311333$1$I$$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145147$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240912$$CN$US$US
243113341$24311334$1$I$$20240904$20240912$20240912$EXP$$PT-AstraZeneca-2024A201052$ASTRAZENECA$$$$E$$Y$$$20240912$$MD$PT$
243113351$24311335$1$I$$20240826$20240912$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08585$LUPIN$$$$$$Y$$$20240912$$CN$US$US
243113361$24311336$1$I$20240818$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144870$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$72.57$KG$20240912$$HP$US$US
243113371$24311337$1$I$20240101$20240904$20240912$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-023132$UNITED THERAPEUTICS$$$$$F$Y$77.551$KG$20240912$$$US$US
243113381$24311338$1$I$20240401$20240909$20240912$20240912$EXP$$DE-TAKEDA-2024TUS090176$TAKEDA$$$$A$M$Y$$$20240912$$CN$AT$DE
243113391$24311339$1$I$20210101$20240904$20240912$20240912$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2021-23008$IPSEN$$61$YR$A$F$Y$$$20240912$$HP$GB$GB
243113401$24311340$1$I$20240819$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144744$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240912$$PH$US$US
243113411$24311341$1$I$$20240910$20240912$20240912$PER$$US-BIOGEN-2024BI01280447$BIOGEN$$$$$M$Y$$$20240912$$CN$US$US
243113461$24311346$1$I$20240101$20240910$20240912$20240912$PER$$US-ALXN-202409USA000703US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243113471$24311347$1$I$20201021$20240831$20240912$20240912$EXP$PL-URPL-1-2522-2020$PL-Accord-444902$ACCORD$$70$YR$$F$Y$70$KG$20240912$$HP$PL$PL
243113481$24311348$1$I$20240112$20240906$20240912$20240912$PER$$US-ALXN-202409USA000400US$ALEXION PHARMACEUTICALS$$23$YR$$F$Y$$$20240912$$CN$US$US
243113491$24311349$1$I$$20240829$20240912$20240912$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111816$ZYDUS PHARM$Credo R, Kesey J, Bharadia D, Griswold J, Pang A.. Acute Intermittent Porphyria in a Burn Patient: Case Study and Review of the Literature. [Review].. Journal of Burn Care + Research. 2024;45(3):790-795$$$$$Y$$$20240912$$MD$US$US
243113501$24311350$1$I$$20240904$20240912$20240912$PER$$US-JNJFOC-20240911073$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
243113522$24311352$2$F$$20240920$20240912$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-028334$UNITED THERAPEUTICS$$$$$F$Y$128.8$KG$20240928$$$US$US
243113531$24311353$1$I$20240829$20240905$20240912$20240912$30DAY$$US-AMGEN-USASP2024178033$AMGEN$$39$YR$A$M$Y$92.5$KG$20240912$$PH$US$US
243113541$24311354$1$I$$20240903$20240912$20240912$30DAY$$US-JNJFOC-20240927854$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$US$US
243113551$24311355$1$I$$20240905$20240912$20240912$PER$$US-AMGEN-USASP2024180473$AMGEN$$$$$M$Y$$$20240912$$HP$US$US
243113561$24311356$1$I$$20240905$20240912$20240912$EXP$$US-AMGEN-USASP2024178664$AMGEN$Solomon, S.. Impact of Graft Versus-Host Disease on Relapse and Nonrelapse Mortality Following Posttransplant Cyclophosphamide Based Transplantation. Transplantation and Cellular Therapy. 2024;30 (9):903.e1-903.e9$$$$$Y$$$20240912$$HP$US$US
243113571$24311357$1$I$$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024181801$AMGEN$$$$A$M$Y$$$20240912$$MD$US$US
243113581$24311358$1$I$$20240909$20240912$20240912$EXP$$GB-ABBVIE-5917477$ABBVIE$$$$A$M$Y$$$20240912$$HP$GB$GB
243113592$24311359$2$F$$20240919$20240912$20240924$30DAY$$GB-PFIZER INC-PV202400119334$PFIZER$$72$YR$$F$Y$$$20240924$$CN$GB$GB
243113601$24311360$1$I$20240101$20240909$20240912$20240912$PER$$US-ORGANON-O2409USA000668$ORGANON$$$$$F$Y$$$20240912$$CN$US$US
243113611$24311361$1$I$$20240830$20240912$20240912$EXP$$GB-UCBSA-2024044730$UCB$$$$$M$Y$$$20240912$$PH$GB$GB
243113641$24311364$1$I$$20240902$20240912$20240912$EXP$$US-MYLANLABS-2024M1081809$MYLAN$Griffin J, Asel M. Diffuse eruptive squamous atypia, also known as eruptive keratoacanthoma: Unique case presentation. JAAD-Case-Rep 2024; 49 121-124.$64$YR$$M$Y$$$20240912$$MD$US$US
243113651$24311365$1$I$$20240904$20240912$20240912$EXP$$US-MYLANLABS-2024M1082365$MYLAN$Shafique N, Khatoon Z, Shafique A, Shafique I, Bajwa S, Shaukat Butt T, et al. MDS-337 Hemophagocytic Lymphohistiocytosis Co-Presenting With Non-Cirrhotic Portal Hypertensive Gastropathy: A Case Report. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl. 1) S393 abstr. MDS-337.$54$YR$$M$Y$$$20240912$$MD$US$US
243113661$24311366$1$I$$20240904$20240912$20240912$EXP$$US-MYLANLABS-2024M1082520$MYLAN$Haider A, Taveras S, Memushaj L, Esquenazi Y, Chen PR, Rios A. AML-738 Myeloid Sarcoma and Lymphoid Sarcoma of the Brain: A Case Series. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl.) S335-S336.$59$YR$$F$Y$$$20240912$$MD$US$US
243113671$24311367$1$I$$20240904$20240912$20240912$EXP$$FR-MYLANLABS-2024M1082490$MYLAN$Haidar NA, Vaillant W, Salignon K, Jounblat Y, Borel C. ABCL-159 Successful Treatment of a Gray Zone Lymphoma With Immunotherapy: A Case Report. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl.) S459.$66$YR$$F$Y$$$20240912$$MD$FR$FR
243113681$24311368$1$I$$20240904$20240912$20240912$EXP$$IN-MYLANLABS-2024M1082507$MYLAN$Kumar NM, Bhargava R, Rastogi N, Yadav C, Swaminathan A, Garg P, et al. ALL-766 Asciminib as a Bridge to Allogenic Transplant in 3 Patients With Relapsed/Refractory Philadelphia Chromosome-positive ALL or CML Lymphoid Blast Crisis Refractory/Intolerant to Ponatinib. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl. 1) S283-S284.$$$$F$Y$$$20240912$$MD$IN$IN
243113691$24311369$1$I$20240101$20240906$20240912$20240912$EXP$$CA-ABBVIE-5917764$ABBVIE$$$$A$F$Y$$$20240912$$CN$CA$CA
243113701$24311370$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143542$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240912$$CN$US$US
243113721$24311372$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143555$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240912$$HP$US$US
243113731$24311373$1$I$$20240903$20240912$20240912$PER$$US-CELLTRION INC.-2024US017900$CELLTRION$$$$$$Y$$$20240912$$CN$US$US
243113741$24311374$1$I$$20240829$20240912$20240912$PER$$US-ROCHE-10000069976$ROCHE$$$$A$F$Y$$$20240912$$PH$US$US
243113761$24311376$1$I$20240701$20240904$20240912$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-022256$UNITED THERAPEUTICS$$32$YR$$F$Y$86.168$KG$20240912$$PH$US$US
243113771$24311377$1$I$$20240905$20240912$20240912$EXP$$AR-AMGEN-ARGSP2024179777$AMGEN$$54$YR$A$F$Y$$$20240912$$CN$AR$AR
243113781$24311378$1$I$$20240906$20240912$20240912$EXP$$AU-AMGEN-AUSSP2024180372$AMGEN$$$$$$Y$$$20240912$$HP$AU$AU
243113801$24311380$1$I$$20240908$20240912$20240912$PER$$US-AMGEN-USASP2024179921$AMGEN$Balagani A.; Tariq F.; Zaheer M.. Adult-Onset PFAPA Syndrome: Successful Management with Colchicine. The American journal of case reports. 2024;25:e943658 -1 to e943658-3$22$YR$A$F$Y$$$20240912$$HP$US$US
243113811$24311381$1$I$$20240902$20240912$20240912$EXP$$US-MYLANLABS-2024M1081765$MYLAN$Dotson AD, Fingert JH, Boese EA. Unsuccessful transscleral cyclophotocoagulation in oculocutaneous albinism. Am-J-Ophthalmol-Case-Rep 2024; 34.$35$YR$$F$Y$$$20240912$$HP$US$US
243113821$24311382$1$I$20240101$20240904$20240912$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-024505$UNITED THERAPEUTICS$$$$$M$Y$87.075$KG$20240912$$$US$US
243113833$24311383$3$F$20240805$20240917$20240912$20240925$PER$$US-AMGEN-USASP2024181157$AMGEN$$58$YR$A$M$Y$$$20240925$$HP$US$US
243113841$24311384$1$I$$20240906$20240912$20240912$PER$$US-TAKEDA-2024TUS089596$TAKEDA$$$$$$Y$$$20240912$$PH$US$US
243113861$24311386$1$I$20231101$20240826$20240912$20240912$PER$$US-SA-2024SA262620$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240912$$MD$US$US
243113871$24311387$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA261885$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240912$$MD$US$US
243113881$24311388$1$I$20240826$20240830$20240912$20240912$PER$$US-SA-2024SA261345$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240912$$HP$US$US
243113891$24311389$1$I$20240716$20240808$20240912$20240912$PER$$US-CELLTRION INC.-2024US018152$CELLTRION$$$$$$Y$$$20240912$$CN$US$US
243113901$24311390$1$I$20240829$20240903$20240912$20240912$EXP$$EG-ROCHE-10000073845$ROCHE$$27$YR$A$M$Y$$$20240912$$CN$EG$EG
243113911$24311391$1$I$$20240904$20240912$20240912$30DAY$$TH-JNJFOC-20240927640$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$TH$TH
243113921$24311392$1$I$$20240831$20240912$20240912$PER$$US-JNJFOC-20240901349$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243113931$24311393$1$I$$20240826$20240912$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08584$LUPIN$$$$$$Y$$$20240912$$CN$US$US
243113941$24311394$1$I$20240902$20240905$20240912$20240912$EXP$$IN-ROCHE-10000075983$ROCHE$$73$YR$E$M$Y$$$20240912$$CN$IN$IN
243113951$24311395$1$I$$20240906$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143029$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$CN$US$US
243113961$24311396$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145002$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240912$$CN$US$US
243113971$24311397$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145286$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240912$$CN$US$US
243113982$24311398$2$F$$20240918$20240912$20240924$EXP$$UA-BRISTOL-MYERS SQUIBB COMPANY-2024-143157$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240924$$MD$UA$UA
243113992$24311399$2$F$20240731$20240911$20240912$20240919$EXP$$NVSC2024US182412$NOVARTIS$$60$YR$$F$Y$$$20240919$$CN$US$US
243114002$24311400$2$F$$20240918$20240912$20240927$EXP$$DE-TEVA-VS-3241096$TEVA$Dierks S, Buchholz SM, Konig A, Liersch T, Schanz J. Incomplete DPYD haplotype B3 in a patient with locally advanced gastric cancer: Reconsidering the 5-FU dosage strategy. Eur-J-Cancer 2024; 204 (0):.; Dierks S, Buchholz SM, Konig A, Liersch T, Schanz J. Incomplete DPYD haplotype B3 in a patient with locally advanced gastric cancer: Reconsidering the 5-FU dosage strategy. Eur-J-Cancer 2024; 204 (0):.$65$YR$$M$Y$$$20240927$$HP$DE$DE
243114011$24311401$1$I$$20240905$20240912$20240912$PER$$US-AMGEN-USASP2024178613$AMGEN$Bin Alamer O.; Taori S.; Tang A. et al.. Repeat stereotactic radiosurgery for progressive vestibular schwannomas after primary gamma knife radiosurgery. Journal of neuro Oncology. 2024;169:591-599$$$$$Y$$$20240912$$HP$US$US
243114021$24311402$1$I$20240801$20240814$20240912$20240912$PER$$US-CELLTRION INC.-2024US020068$CELLTRION$$$$$$Y$$$20240912$$CN$US$US
243114031$24311403$1$I$$20240902$20240912$20240912$EXP$$CA-TEVA-VS-3239590$TEVA$$4$YR$$F$Y$20$KG$20240912$$HP$CA$CA
243114041$24311404$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A201767$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243114052$24311405$2$F$$20240906$20240912$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08621$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243114061$24311406$1$I$20240101$20240904$20240912$20240912$EXP$$DE-AstraZeneca-2024A207518$ASTRAZENECA$$$$$M$Y$$$20240912$$MD$DE$
243114071$24311407$1$I$$20240910$20240912$20240912$EXP$$CN-AstraZeneca-2024A208180$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$CN$
243114091$24311409$1$I$$20240831$20240912$20240912$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0353$GRAVITI PHARMACEUTICALS$Brittany Vickery P, Hoots K.From sweet to belligerent in the blink of an eye.Current Psychiatry.2019;18 (6):E4-E10$87$YR$E$F$Y$$$20240912$$MD$US$US
243114111$24311411$1$I$$20240910$20240912$20240912$PER$$US-TAKEDA-2024TUS090704$TAKEDA$$$$$F$Y$$$20240912$$CN$US$US
243114122$24311412$2$F$20240503$20240913$20240912$20240924$EXP$$CA-TAKEDA-2024TUS043842$TAKEDA$$75$YR$$M$Y$$$20240924$$CN$CA$CA
243114141$24311414$1$I$20240101$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006662$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240912$$CN$US$US
243114151$24311415$1$I$$20240905$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004221$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240912$$CN$US$US
243114161$24311416$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007259$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240912$$CN$US$US
243114171$24311417$1$I$20240910$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007243$ELI LILLY AND CO$$$$$$Y$$$20240912$$CN$US$US
243114181$24311418$1$I$20240422$20240910$20240912$20240912$EXP$$GB-MYLANLABS-2024M1082759$MYLAN$$72$YR$$M$Y$77$KG$20240912$$PH$GB$GB
243114192$24311419$2$F$20191101$20240909$20240912$20240917$EXP$$DE-SANDOZ INC.-NVSC2021DE268596$SANDOZ$$42$YR$$F$Y$$$20240917$$MD$DE$DE
243114201$24311420$1$I$20191201$20240910$20240912$20240912$EXP$GB-MHRA-MED-202409101747487960-BRDYL$GB-MYLANLABS-2024M1082847$MYLAN$$25$YR$$F$Y$65$KG$20240912$$CN$GB$GB
243114211$24311421$1$I$$20240911$20240912$20240912$EXP$$GB-MYLANLABS-2024M1083184$MYLAN$$94$YR$$F$Y$$$20240912$$MD$GB$GB
243114222$24311422$2$F$20240824$20240910$20240912$20240917$30DAY$$US-AMGEN-USASL2024178238$AMGEN$$58$YR$A$F$Y$$$20240917$$HP$US$US
243114231$24311423$1$I$20240903$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181442$AMGEN$$78$YR$E$F$Y$$$20240912$$CN$US$US
243114241$24311424$1$I$$20240910$20240912$20240912$EXP$$AU-Orion Corporation ORION PHARMA-24_00030908$ORION$$$$$F$Y$$$20240912$$CN$AU$
243114262$24311426$2$F$20240101$20240612$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000699$PAREXEL$$$$$F$Y$47.619$KG$20240912$$CN$US$US
243114272$24311427$2$F$20240401$20240626$20240912$20240912$PER$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US000785$PAREXEL$$60$YR$$F$Y$108.84$KG$20240912$$CN$US$US
243114301$24311430$1$I$20240715$20240819$20240912$20240912$PER$$US-CELLTRION INC.-2024US020061$CELLTRION$$$$$$Y$$$20240912$$HP$US$US
243114311$24311431$1$I$20240826$20240905$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143261$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240912$$PH$US$US
243114321$24311432$1$I$$20240903$20240912$20240912$EXP$$CN-VANTIVE-2024VAN019536$Vantive US Healthcare$$$$$$Y$$$20240912$$HP$CN$CN
243114331$24311433$1$I$20240101$20240906$20240912$20240912$EXP$$NZ-AMGEN-NZLSP2024178600$AMGEN$$27$YR$A$M$Y$$$20240912$$CN$NZ$NZ
243114341$24311434$1$I$20240101$20240830$20240912$20240912$PER$$US-SA-2024SA260750$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240912$$HP$US$US
243114351$24311435$1$I$20240801$20240826$20240912$20240912$PER$$US-SA-2024SA262402$SANOFI AVENTIS$$52$YR$A$F$Y$104.09$KG$20240912$$MD$US$US
243114361$24311436$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA263347$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$HP$US$US
243114371$24311437$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA260914$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240912$$HP$US$US
243114381$24311438$1$I$$20240911$20240912$20240912$PER$$US-ROCHE-10000079937$ROCHE$$$$$$Y$$$20240912$$MD$US$US
243114421$24311442$1$I$$20240904$20240912$20240912$EXP$$IN-RDY-SPO/IND/24/0013305$DR REDDYS$Ganju N, Panda T, Oberoi G, Agarwal M, Mahapatra M. AML-083 AML in Pregnancy: Case Series. Clinical Lymphoma, Myeloma and Leukemia. 2024;24: S293. doi:10.1016/S2152-2650%2824%2901157-1.$$$N$$Y$$$20240912$$MD$IN$IN
243114431$24311443$1$I$20240101$20240827$20240912$20240912$PER$$US-JNJFOC-20240873098$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240912$$CN$US$US
243114441$24311444$1$I$20240101$20240909$20240912$20240912$EXP$DE-CADRBFARM-2024330333$DE-RDY-SPO/DEU/24/0013181$DR REDDYS$$43$YR$A$M$Y$84$KG$20240912$$MD$DE$DE
243114451$24311445$1$I$$20240902$20240912$20240912$30DAY$$BE-JNJFOC-20240926368$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$BE$BE
243114461$24311446$1$I$$20240902$20240912$20240912$EXP$$CN-ROCHE-10000076258$ROCHE$Qin S, Li J, Zhou A, Zhang Y, Yuan X, Zhu L, et al. SALIRI-based (raltitrexed plus irinotecan) therapy as a second-line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non-interventional, registry study. Cancer Communications. 2024-Aug;44 (8):910-914. doi:10.1002/cac2.12586.$$$$$Y$$$20240912$$HP$CN$CN
243114472$24311447$2$F$20240909$20240912$20240912$20240912$PER$$US-AMGEN-USASP2024181720$AMGEN$$79$YR$E$F$Y$$$20240912$$CN$US$US
243114481$24311448$1$I$20240910$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024180982$AMGEN$$75$YR$E$M$Y$$$20240912$$CN$US$US
243114501$24311450$1$I$$20240831$20240912$20240912$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0367$GRAVITI PHARMACEUTICALS$Qasim Agha O, Kaur S, Vijayavel N. .Statin-induced necrotising autoimmune myopathy and autoimmune hepatitis presenting with dysphagia.BMJ-Case-Rep.2020;13(2):e232391$7$DEC$$M$Y$$$20240912$$HP$US$US
243114511$24311451$1$I$20230510$20230608$20240912$20240912$EXP$$NVSC2023AE281083$NOVARTIS$$$$$$Y$$$20240912$$MD$AE$AE
243114521$24311452$1$I$$20240910$20240912$20240912$EXP$$RU-ABBVIE-5917603$ABBVIE$$60$YR$$M$Y$$$20240912$$MD$RU$RU
243114531$24311453$1$I$$20240903$20240912$20240912$30DAY$$AU-JNJFOC-20240925863$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$PH$AU$AU
243114541$24311454$1$I$$20240902$20240912$20240912$EXP$$BE-ROCHE-10000077489$ROCHE$Bosteels C, Truyens M, Vande Weygaerde Y, Malfait T, Libbrecht S, Ferdinande L, et al. Respiratory failure in a tofacitinib treated patient with ulcerative colitis. Acta Gastroenterol Belg. 2024;87 (2):336-9. doi:10.51821/87.2.11812. PMID: 39210768.$55$YR$A$M$Y$$$20240912$$MD$BE$BE
243114551$24311455$1$I$$20240831$20240912$20240912$EXP$$CZ-Accord-020042$ACCORD$Holubec L, Mrazkova P, Matejka VM, Fiala O, Finek J et, al. Polyneuropathic pain therapy with a patient suffering from generalized castrate-resistant prostate cancer - Clinical case report. Klinicka Onkologie. 2013;26 (5):354-7$65$YR$E$M$Y$$$20240912$$HP$CZ$CZ
243114562$24311456$2$F$20240829$20240905$20240912$20240926$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-118792$REGENERON$$$$$F$Y$$$20240926$$MD$DE$DE
243114581$24311458$1$I$$20240909$20240912$20240912$EXP$GB-MHRA-MED-202409091145056600-TNSBK$GB-CHATTEMPRD-2024OHG031365$CHATTEM$$74$YR$E$F$Y$$$20240912$$CN$GB$GB
243114641$24311464$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62527$$FDA-CTU$$66$YR$$M$N$$$20240911$N$$US$
243114661$24311466$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5914810$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243114671$24311467$1$I$$20240910$20240912$20240912$EXP$$NVSC2024CA181589$NOVARTIS$$$$$F$Y$$$20240912$$MD$CA$CA
243114691$24311469$1$I$$20240609$20240912$20240912$PER$US-ALVOGEN-2024094413$US-ALVOGEN-2024094413$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243114701$24311470$1$I$$20240609$20240912$20240912$PER$US-ALVOGEN-2024094417$US-ALVOGEN-2024094417$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243114711$24311471$1$I$$20240609$20240912$20240912$PER$US-ALVOGEN-2024094408$US-ALVOGEN-2024094408$ALVOGEN$$$$$$Y$$$20240912$$CN$US$US
243114722$24311472$2$F$20240830$20240911$20240912$20240916$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014264$JAZZ$$47$YR$$M$Y$$$20240916$$HP$US$US
243114731$24311473$1$I$20240601$20240823$20240912$20240912$PER$$US-TEVA-VS-3237312$TEVA$$26$YR$$F$Y$$$20240912$$CN$US$US
243114741$24311474$1$I$$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181926$AMGEN$$$$$$Y$$$20240912$$PH$US$US
243114751$24311475$1$I$$20240905$20240912$20240912$EXP$$IT-AMGEN-ITASP2024179212$AMGEN$Scavo M. P.; De Luca M.; Musio B. et al.. Role of Extracellular Vesicles in Crohn^s Patients on Adalimumab Who Received COVID-19 Vaccination. International Journal of Molecular Sciences. 2024;25 (16):1-23$40$YR$A$F$Y$$$20240912$$HP$IT$IT
243114771$24311477$1$I$$20240830$20240912$20240912$EXP$$US-STERISCIENCE B.V.-2024-ST-001362$Steriscience PTE$Blackmon J, Blackmon L, Goode C, Douthit N.. Systemic Cobalt Toxicity Secondary to Metal-on-Metal Prosthetic Hip Replacement: a Case Report.. J-Gen-Intern-Med. 2024;39:133-137$58$YR$$M$Y$$$20240912$$MD$US$US
243114781$24311478$1$I$20240811$20240909$20240912$20240912$EXP$$US-TAKEDA-2024TUS018081$TAKEDA$$63$YR$$F$Y$71.65$KG$20240912$$HP$US$US
243114791$24311479$1$I$$20240829$20240912$20240912$EXP$$CO-STERISCIENCE B.V.-2024-ST-001360$Steriscience PTE$Henao-Sierra JE, Alza-Arcila L, Echeverry E, Peralta Perez JJ, Tanaka Takegami M, Quiroz Alfaro AJ.. Pregnancy outcome in a patient with end-stage kidney disease treated with an intensive automated peritoneal dialysis regimen: A case report.. SAGE-Open-Med-Case-Rep. 2024;12$$$N$F$Y$0.938$KG$20240912$$HP$CO$CO
243114814$24311481$4$F$20220329$20240913$20240912$20240923$EXP$$CA-CELLTRION INC.-2022CA004218$CELLTRION$$$$$$Y$$$20240923$$MD$CA$CA
243114821$24311482$1$I$$20240831$20240912$20240912$PER$$US-ROCHE-10000077011$ROCHE$$$$$F$Y$$$20240912$$CN$US$US
243114831$24311483$1$I$$20240830$20240912$20240912$EXP$CN-MLMSERVICE-20240826-PI171126-00060-1$CN-STERISCIENCE B.V.-2024-ST-001344$Steriscience PTE$Long S, Tang P, Ouyang P, Liao X, Xie L.. A Case Report of a Rare Pulmonary Opportunistic Infection in an Infant Caused by Tsukamurella tyrosinosolvens.. International Medical Case Reports Journal. 2024;17:725-31$$$I$F$Y$$$20240912$$MD$CN$CN
243114841$24311484$1$I$$20240829$20240912$20240912$EXP$$CO-STERISCIENCE B.V.-2024-ST-001359$Steriscience PTE$Henao-Sierra JE, Alza-Arcila L, Echeverry E, Peralta Perez JJ, Tanaka Takegami M, Quiroz Alfaro AJ.. Pregnancy outcome in a patient with end-stage kidney disease treated with an intensive automated peritoneal dialysis regimen: A case report.. SAGE-Open-Med-Case-Rep. 2024;12$23$YR$$F$Y$$$20240912$$HP$CO$CO
243114851$24311485$1$I$$20240830$20240912$20240912$EXP$$JP-STERISCIENCE B.V.-2024-ST-001321$Steriscience PTE$Tsujino A, Nakajima A, Yabuta H, Sekioka J, Amano M, Fujimura S, et al.. An Autopsy Case of Streptococcus dysgalactiae subsp. equisimilis Infectious Endocarditis Accompanied by Streptococcal Toxic Shock Syndrome. Intern-Med. 2024;63 (15):2209-2214$66$YR$$F$Y$75$KG$20240912$$MD$JP$JP
243114861$24311486$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA263019$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240912$$MD$US$US
243114872$24311487$2$F$$20240918$20240912$20240927$EXP$$GR-TEVA-VS-3241026$TEVA$Dimitrakopoulos F-I, Goussia A, Koliou G-A, Dadouli K, Batistatou A, Kourea HP, et al. Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide + epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes. Breast 2024; 73.; Dimitrakopoulos F-I, Goussia A, Koliou G-A, Dadou...$$$$F$Y$$$20240927$$HP$GR$GR
243114881$24311488$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA184062$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240912$$CN$US$US
243114901$24311490$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA260969$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240912$$HP$US$US
243114911$24311491$1$I$$20240820$20240912$20240912$PER$$US-SA-2024SA262918$SANOFI AVENTIS$$24$YR$A$$Y$$$20240912$$PH$US$US
243114922$24311492$2$F$20240812$20240904$20240912$20240918$PER$$US-ROCHE-10000071380$ROCHE$$66$YR$E$F$Y$82.55$KG$20240918$$CN$US$US
243114931$24311493$1$I$20240513$20240828$20240912$20240912$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467525$RANBAXY$$75$YR$$M$Y$65$KG$20240912$$MD$DE$DE
243114951$24311495$1$I$20220201$20240831$20240912$20240912$EXP$$DE-MACLEODS PHARMA-MAC2024049230$MACLEODS$$$$$$Y$$$20240912$$MD$DE$DE
243114961$24311496$1$I$20230201$20240902$20240912$20240912$EXP$$JP-ASTELLAS-2024-AER-004037$ASTELLAS$$84$YR$E$M$Y$$$20240912$$CN$JP$JP
243114971$24311497$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA261643$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240912$$CN$US$US
243114981$24311498$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA260982$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240912$$HP$US$US
243114991$24311499$1$I$20240501$20240831$20240912$20240912$EXP$GB-MHRA-MED-202408312202138740-VSRJQ$GB-MACLEODS PHARMA-MAC2024049234$MACLEODS$$$$$$Y$$$20240912$$CN$GB$GB
243115001$24311500$1$I$20240831$20240831$20240912$20240912$EXP$GB-MHRA-MED-202408311227243100-VLNGH$GB-MACLEODS PHARMA-MAC2024049232$MACLEODS$$$$$$Y$$$20240912$$MD$GB$GB
243115021$24311502$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA259112$SANOFI AVENTIS$$$$A$$Y$$$20240912$$HP$US$US
243115041$24311504$1$I$20240101$20240908$20240912$20240912$PER$$US-SA-2024SA262750$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240912$$MD$US$US
243115051$24311505$1$I$20240617$20240322$20240912$20240912$PER$$US-TEVA-VS-3234404$TEVA$$76$YR$$M$Y$62.6$KG$20240912$$PH$US$US
243115061$24311506$1$I$$20240906$20240912$20240912$EXP$$US-JNJFOC-20240919858$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
243115071$24311507$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144530$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240912$$HP$US$US
243115081$24311508$1$I$20240101$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145099$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240912$$CN$US$US
243115091$24311509$1$I$$20240903$20240912$20240912$PER$$US-ABBVIE-5906188$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243115101$24311510$1$I$$20240902$20240912$20240912$EXP$$KR-ROCHE-10000077409$ROCHE$Jeong S. Cytomegalovirus retinitis with panretinal occlusive vasculopathy concealed by hypertensive uveitis: a case report. J Yeungnam Med Sci. 2024. doi:10.12701/jyms.2024.00584$72$YR$E$M$Y$$$20240912$$MD$KR$KR
243115111$24311511$1$I$$20240802$20240912$20240912$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009940$STRIDES$Singh AD, Kurin M.. An Unusual Case of Refractory Esophagitis and Esophageal Diverticulum.. Dig-Dis-Sci. 2024;69 (6):1913-1914.$76$YR$$F$Y$$$20240912$$HP$US$US
243115121$24311512$1$I$$20240312$20240912$20240912$EXP$$NVSC2024BR058501$NOVARTIS$$$$$F$Y$$$20240912$$CN$BR$BR
243115141$24311514$1$I$$20240909$20240912$20240912$EXP$$NL-ADIENNEP-2024AD000725$ADIENNE PHARMA + BIOTECH$Berghuis D, Mehyar LS, Abu-Arja R, Albert MH, Barnum JL, von Bernuth H et al. Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study. J Clin Immunol. 2024;44(8):182. DOI: 10.1007/s10875-024-01786-7$$$I$M$Y$$$20240910$$MD$NL$
243115151$24311515$1$I$20240806$20240909$20240912$20240912$EXP$$CO-UCBSA-2024046640$UCB$$67$YR$$M$Y$$$20240912$$CN$CO$CO
243115161$24311516$1$I$20240524$20240906$20240912$20240912$EXP$IT-MINISAL02-1001022$IT-AMGEN-ITASP2024179210$AMGEN$$43$YR$A$M$Y$$$20240912$$MD$IT$IT
243115171$24311517$1$I$20240101$20240726$20240912$20240912$PER$$US-IMP-2024000555$Harrow Health$$$$A$F$Y$$$20240912$$CN$US$US
243115182$24311518$2$F$20240819$20240822$20240912$20240916$PER$$US-SA-2024SA263320$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240916$$MD$US$US
243115191$24311519$1$I$20240901$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005403$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240912$$CN$US$US
243115201$24311520$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006263$ELI LILLY AND CO$$43$YR$A$$Y$$$20240912$$CN$US$US
243115211$24311521$1$I$20240910$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007452$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
243115221$24311522$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007228$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240912$$CN$US$US
243115231$24311523$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007223$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240912$$CN$US$US
243115241$24311524$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007200$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240912$$MD$US$US
243115261$24311526$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007334$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240912$$CN$US$US
243115282$24311528$2$F$20240911$20240925$20240912$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409005641$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240927$$CN$US$US
243115291$24311529$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005794$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240912$$CN$US$US
243115301$24311530$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007247$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240912$$CN$US$US
243115311$24311531$1$I$$20240906$20240912$20240912$EXP$$CN-TAKEDA-2024TUS090547$TAKEDA$$$$$$Y$$$20240912$$MD$CN$CN
243115321$24311532$1$I$20240804$20240909$20240912$20240912$EXP$FR-AFSSAPS-NC2024001032$FR-UCBSA-2024046021$UCB$$53$YR$$M$Y$60$KG$20240912$$MD$FR$FR
243115331$24311533$1$I$$20240905$20240912$20240912$EXP$$PT-MYLANLABS-2024M1082259$MYLAN$Pereira BS, Santos Z, Pereira TC, Penaforte R, Neves ML. Lymphangitic carcinomatosis: a challenging and uncommon diagnosis. Eur-J-Case-Rep-Intern-Med 2024; 11 (Suppl.) 896-897.$79$YR$$M$Y$$$20240912$$HP$PT$PT
243115341$24311534$1$I$$20240905$20240912$20240912$EXP$$US-MYLANLABS-2024M1082685$MYLAN$Popat D, Sanghavi N, Singh A, Sawhney R. MM-657 Parsonage Turner Syndrome Complicating Multiple Myeloma Therapy: ^Nothing to Shrug your Shoulders at^. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl.) S578.$66$YR$$M$Y$$$20240912$$HP$US$US
243115361$24311536$1$I$$20240910$20240912$20240912$EXP$$US-KYOWAKIRIN-2024KK021087$KYOWA$$$$$$Y$$$20240912$$HP$US$US
243115381$24311538$1$I$$20240906$20240912$20240912$EXP$$CN-TAKEDA-2024TUS090549$TAKEDA$Xie L, Wang X, He Q, Wang H, Ma J, Zhang H, et al. A multicenter, prospective, phase II, single-arm study of domestic bortezomib combined with lenalidomide and dexamethasone for the treatment of newly diagnosed multiple myeloma. Chin J Hematol. 2024;45(6):571-76$$$$$Y$$$20240912$$MD$CN$CN
243115412$24311541$2$F$$20240919$20240912$20240926$PER$$NVSC2024US180590$NOVARTIS$$$$$$Y$$$20240926$$CN$US$US
243115421$24311542$1$I$20240823$20240905$20240912$20240912$EXP$$US-CHATTEMPRD-2024OHG031102$CHATTEM$$$$$F$Y$$$20240912$$CN$US$US
243115431$24311543$1$I$20240101$20240905$20240912$20240912$EXP$$US-ABBVIE-5913616$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243115511$24311551$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62549$$FDA-CTU$$1$YR$$M$N$$$20240911$N$$US$
243115521$24311552$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62541$$FDA-CTU$$69$YR$$M$N$$$20240911$N$$US$
243115541$24311554$1$I$20240101$20240909$20240912$20240912$EXP$$CA-PFIZER INC-PV202400084147$PFIZER$$57$YR$$F$Y$97.506$KG$20240912$$MD$CA$CA
243115551$24311555$1$I$20240701$20240909$20240912$20240912$30DAY$$CA-PFIZER INC-202400247776$PFIZER$$29$YR$$F$Y$$$20240912$$PH$CA$CA
243115561$24311556$1$I$$20240908$20240912$20240912$PER$$US-ABBVIE-5918875$ABBVIE$$$$$$Y$$$20240912$$HP$US$US
243115571$24311557$1$I$20240909$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180411$AMGEN$$55$YR$A$F$Y$$$20240912$$CN$US$US
243115583$24311558$3$F$20240910$20240925$20240912$20240927$PER$$US-AMGEN-USASP2024181567$AMGEN$$79$YR$E$F$Y$$$20240927$$CN$US$US
243115591$24311559$1$I$$20240903$20240912$20240912$EXP$$AU-JNJFOC-20240919636$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$HP$AU$AU
243115601$24311560$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144875$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240912$$HP$US$US
243115611$24311561$1$I$$20240911$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA079516$SANDOZ$$43$YR$$M$Y$$$20240912$$HP$CA$CA
243115621$24311562$1$I$$20240828$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145363$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$HP$US$US
243115631$24311563$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143317$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$70.31$KG$20240912$$HP$US$US
243115641$24311564$1$I$20240821$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143951$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240912$$HP$US$US
243115651$24311565$1$I$20240831$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145097$BRISTOL MYERS SQUIBB$$83$YR$E$$Y$$$20240912$$PH$US$US
243115661$24311566$1$I$20240101$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143718$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240912$$CN$US$US
243115672$24311567$2$F$20240826$20240918$20240912$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141100$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240924$$CN$US$US
243115681$24311568$1$I$$20240906$20240912$20240912$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049960$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240912$$CN$US$US
243115691$24311569$1$I$20240821$20240911$20240912$20240912$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050964$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$$$20240912$$HP$SG$SG
243115701$24311570$1$I$$20240903$20240912$20240912$EXP$$CA-ROCHE-10000072613$ROCHE$$56$YR$A$F$Y$71$KG$20240912$$MD$CA$CA
243115712$24311571$2$F$20240301$20240912$20240912$20240916$EXP$$DE-SANDOZ INC.-SDZ2024DE038291$SANDOZ$$77$YR$$M$Y$68$KG$20240916$$HP$DE$DE
243115721$24311572$1$I$$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181391$AMGEN$$$$$$Y$$$20240912$$MD$US$US
243115733$24311573$3$F$20240101$20240916$20240912$20240921$EXP$$IE-ABBVIE-5917375$ABBVIE$$51$YR$$M$Y$$$20240921$$HP$IE$IE
243115741$24311574$1$I$$20240906$20240912$20240912$EXP$$ZA-AstraZeneca-2024A204131$ASTRAZENECA$$45$YR$$M$Y$$$20240912$$CN$ZA$
243115751$24311575$1$I$20240819$20240820$20240912$20240912$PER$$US-SA-2024SA262197$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240912$$MD$US$US
243115761$24311576$1$I$20210222$20240905$20240912$20240912$EXP$FR-EMA-DD-20240829-7482711-121727$FR-ROCHE-10000078590$ROCHE$$45$YR$A$F$Y$85$KG$20240912$$MD$FR$FR
243115771$24311577$1$I$$20240909$20240912$20240912$EXP$$NL-SANDOZ INC.-SDZ2024NL078826$SANDOZ$$52$YR$$M$Y$$$20240912$$HP$NL$NL
243115781$24311578$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA259718$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240912$$HP$US$US
243115791$24311579$1$I$20180101$20240828$20240912$20240912$PER$$US-SA-2024SA263219$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240912$$HP$US$US
243115801$24311580$1$I$$20240909$20240912$20240912$PER$$US-ABBVIE-5918240$ABBVIE$$$$$F$Y$$$20240912$$HP$US$US
243115811$24311581$1$I$20240826$20240830$20240912$20240912$PER$$US-SA-2024SA260752$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240912$$HP$US$US
243115821$24311582$1$I$$20240909$20240912$20240912$EXP$$CA-Orion Corporation ORION PHARMA-24_00031646$ORION$$75$YR$E$F$Y$$$20240912$$MD$CA$
243115831$24311583$1$I$20190916$20240909$20240912$20240912$EXP$$CO-UCBSA-2024046662$UCB$$63$YR$$M$Y$$$20240912$$CN$CO$CO
243115841$24311584$1$I$20240819$20240902$20240912$20240912$EXP$GB-MHRA-MED-202409021357227910-DKPCY$GB-GLENMARK PHARMACEUTICALS-2024GMK093838$GLENMARK$$$$$$Y$$$20240912$$HP$GB$GB
243115851$24311585$1$I$$20240903$20240912$20240912$EXP$$IN-ROCHE-10000073977$ROCHE$$37$YR$A$F$Y$$$20240912$$CN$IN$IN
243115861$24311586$1$I$$20240910$20240912$20240912$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144635$DAIICHI$$$$$M$Y$$$20240912$$CN$US$US
243115871$24311587$1$I$20240901$20240911$20240912$20240912$PER$$US-DSJP-DSU-2024-144645$DAIICHI$$$$$F$Y$$$20240912$$PH$US$US
243115882$24311588$2$F$$20240909$20240912$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US078974$SANDOZ$$$$$F$Y$$$20240912$$CN$US$US
243115891$24311589$1$I$$20240903$20240912$20240912$EXP$$US-JNJFOC-20240909880$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243115901$24311590$1$I$20231108$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62562$$FDA-CTU$$49$YR$$F$N$$$20240911$N$$US$
243115911$24311591$1$I$20240409$20240904$20240912$20240912$EXP$$US-BAYER-2024A055362$BAYER$$54$YR$A$F$Y$117.91$KG$20240912$$CN$US$US
243115921$24311592$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62528$$FDA-CTU$$49$YR$$M$N$$$20240911$N$$US$
243115931$24311593$1$I$$20240909$20240912$20240912$EXP$$CA-SANDOZ INC.-NVSC2020CA149260$SANDOZ$$$$$F$Y$$$20240912$$MD$CA$CA
243115941$24311594$1$I$20240901$20240907$20240912$20240912$EXP$GB-MHRA-MED-202409071002210420-KPQMS$GB-MYLANLABS-2024M1082883$MYLAN$$43$YR$$M$Y$74$KG$20240912$$CN$GB$GB
243115951$24311595$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5913977$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243115961$24311596$1$I$$20240905$20240912$20240912$EXP$$RU-ROCHE-3505678$ROCHE$$72$YR$E$M$Y$$$20240912$$HP$RU$RU
243115972$24311597$2$F$20240101$20240909$20240912$20240913$PER$$US-ABBVIE-5918494$ABBVIE$$$$$$Y$$$20240913$$HP$US$US
243115981$24311598$1$I$$20240906$20240911$20240911$DIR$FDA-CDER-CTU-2024-62544$$FDA-CTU$$$$$M$N$$$20240906$N$HP$US$
243115991$24311599$1$I$20240628$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62518$$FDA-CTU$$22$YR$$F$N$$$20240911$N$HP$US$
243116001$24311600$1$I$$20240903$20240912$20240912$PER$$US-ABBVIE-5906731$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243116012$24311601$2$F$20240901$20240923$20240912$20240926$EXP$$CO-UCBSA-2024046658$UCB$$27$YR$$M$Y$$$20240926$$CN$CO$CO
243116022$24311602$2$F$20240101$20240911$20240912$20240919$EXP$$CA-MIRUM PHARMACEUTICALS, INC.-CA-MIR-24-00832$Unknown Manufacturer$$$$$$Y$$$20240919$$HP$CA$CA
243116051$24311605$1$I$$20240610$20240912$20240912$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-452401$RANBAXY$$$$$$Y$$$20240912$$CN$US$US
243116061$24311606$1$I$$20240830$20240912$20240912$EXP$$JP-AZURITY PHARMACEUTICALS, INC.-AZR202408-000544$AZURITY PHARMACEUTICALS$Aiba M, Okada K, Funakoshi T, Nozu R, Takahashi T, Ozu S et al.. Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma. J Infect Chemother.. 2024;30(10):1065-8$$$$F$Y$$$20240912$$HP$JP$JP
243116071$24311607$1$I$$20240828$20240912$20240912$EXP$$IN-AZURITY PHARMACEUTICALS, INC.-AZR202408-000545$AZURITY PHARMACEUTICALS$Nanjappa H,  Rodrigues AJ.. Atrial Fibrillation Secondary to Levothyroxine Overdose with Underlying Secondary Infection.. J Assoc Physicians India. 2024;72(8):96-8$62$YR$$F$Y$$$20240912$$MD$IN$IN
243116081$24311608$1$I$$20240902$20240912$20240912$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202409-000551$AZURITY PHARMACEUTICALS$$$$$$Y$$$20240912$$CN$US$US
243116091$24311609$1$I$$20240829$20240912$20240912$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000566$AZURITY PHARMACEUTICALS$Hosseini R, Brooks SP, Gadelha E, Schaap R, Cook J, Husan A.. Effective treatment of Methotrexate induced oral mucositis with a Morphine mouthwash solution: A case report. J. Pharm. Pract.. 2024;0(0):1-5$67$YR$$F$Y$$$20240912$$PH$US$US
243116101$24311610$1$I$20240812$20240910$20240912$20240912$EXP$$UA-MYLANLABS-2024M1083098$MYLAN$$38$YR$$M$Y$$$20240912$$HP$UA$UA
243116111$24311611$1$I$20240819$20240910$20240912$20240912$EXP$$UA-MYLANLABS-2024M1083097$MYLAN$$38$YR$$M$Y$$$20240912$$HP$UA$UA
243116122$24311612$2$F$$20240918$20240912$20240919$EXP$$NZ-MYLANLABS-2024M1083158$MYLAN$$$$$M$Y$$$20240919$$PH$NZ$NZ
243116131$24311613$1$I$20240401$20240902$20240912$20240912$EXP$$US-AMGEN-USASP2024177422$AMGEN$Peshin S.. Insights into Neulasta-Associated Splenic Infarction: Unveiling a Rare Complication in Chemotherapy for Chronic Myelomonocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S372$67$YR$E$M$Y$$$20240912$$MD$US$US
243116141$24311614$1$I$20240703$20240910$20240912$20240912$EXP$$UA-MYLANLABS-2024M1083094$MYLAN$$53$YR$$M$Y$$$20240912$$HP$UA$UA
243116161$24311616$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180120$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
243116171$24311617$1$I$$20240906$20240912$20240912$EXP$$JP-AMGEN-JPNSP2024179436$AMGEN$$$$A$M$Y$$$20240912$$MD$JP$JP
243116181$24311618$1$I$$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181920$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243116191$24311619$1$I$20240528$20240909$20240912$20240912$EXP$FR-AFSSAPS-PC2024000668$FR-TAKEDA-2024TUS090296$TAKEDA$$62$YR$$F$Y$$$20240912$$HP$FR$FR
243116201$24311620$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144825$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240912$$CN$US$US
243116211$24311621$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145004$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$75.75$KG$20240912$$CN$US$US
243116221$24311622$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144360$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240912$$HP$US$US
243116231$24311623$1$I$20240101$20240909$20240912$20240912$PER$$US-ABBVIE-5917079$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243116241$24311624$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144999$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240912$$CN$US$US
243116261$24311626$1$I$$20240911$20240912$20240912$PER$$US-HALEON-2196316$Haleon PLC$$$$$$Y$$$20240912$$CN$US$US
243116271$24311627$1$I$20240815$20240911$20240912$20240912$EXP$ES-AEMPS-1568177$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050997$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$95$KG$20240912$$PH$ES$ES
243116281$24311628$1$I$20240829$20240906$20240912$20240912$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050135$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240912$$PH$JP$JP
243116291$24311629$1$I$$20240909$20240912$20240912$PER$$US-TAKEDA-2024TUS090546$TAKEDA$$$$$$Y$$$20240912$$CN$US$US
243116311$24311631$1$I$20221001$20240906$20240912$20240912$EXP$$US-AMGEN-USASP2024178782$AMGEN$$47$YR$A$F$Y$$$20240912$$CN$US$US
243116321$24311632$1$I$20240809$20240909$20240912$20240912$EXP$$US-BAYER-2024A129797$BAYER$$43$YR$A$F$Y$82.086$KG$20240912$$CN$US$US
243116331$24311633$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62535$$FDA-CTU$$44$YR$$F$N$$$20240911$N$$US$
243116341$24311634$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62536$$FDA-CTU$$63$YR$$F$N$$$20240911$N$$US$
243116352$24311635$2$F$20240101$20240916$20240912$20240924$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202409007121$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240924$$MD$IN$IN
243116361$24311636$1$I$20240501$20240903$20240912$20240912$PER$$US-SA-2024SA263670$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240912$$HP$US$US
243116371$24311637$1$I$20210601$20240903$20240912$20240912$PER$$US-SA-2024SA263173$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240912$$MD$US$US
243116382$24311638$2$F$20240826$20240913$20240912$20240917$EXP$$US-PFIZER INC-PV202400079689$PFIZER$$79$YR$$F$Y$58.06$KG$20240917$$CN$US$US
243116391$24311639$1$I$$20240910$20240912$20240912$EXP$GB-MHRA-MED-202408051436201010-PNQJC$GB-PFIZER INC-PV202400118703$PFIZER$$$$$$Y$$$20240912$$PH$GB$GB
243116401$24311640$1$I$20240814$20240910$20240912$20240912$EXP$GB-MHRA-MED-202409091625193460-DPYVC$GB-PFIZER INC-202400253590$PFIZER$$89$YR$$F$Y$43$KG$20240912$$PH$GB$GB
243116411$24311641$1$I$20240901$20240910$20240912$20240912$EXP$GB-MHRA-MED-202409101709335340-FTBPW$GB-PFIZER INC-202400253828$PFIZER$$90$YR$$F$Y$$$20240912$$MD$GB$GB
243116432$24311643$2$F$20240717$20240923$20240912$20240926$EXP$$FR-PFIZER INC-202400251276$PFIZER$$74$YR$$M$Y$$$20240926$$MD$FR$FR
243116441$24311644$1$I$20240908$20240910$20240912$20240912$EXP$$CA-PFIZER INC-PV202400118779$PFIZER$$61$YR$$F$Y$$$20240912$$CN$CA$CA
243116451$24311645$1$I$20240805$20240909$20240912$20240912$EXP$IT-MINISAL02-1001335$IT-PFIZER INC-202400252767$PFIZER$$37$YR$$M$Y$76$KG$20240912$$MD$IT$IT
243116461$24311646$1$I$$20240909$20240912$20240912$EXP$$US-PFIZER INC-PV202400118293$PFIZER$$65$YR$$F$Y$$$20240912$$MD$US$US
243116472$24311647$2$F$$20240922$20240912$20240925$EXP$$IL-BAYER-2024A129373$BAYER$$75$YR$E$F$Y$$$20240925$$HP$IL$IL
243116482$24311648$2$F$20240816$20240911$20240912$20240918$EXP$FR-AFSSAPS-MP2024001358$FR-PFIZER INC-202400252362$PFIZER$$39$YR$$M$Y$41$KG$20240918$$PH$FR$FR
243116501$24311650$1$I$20211015$20240501$20240912$20240912$PER$$US-LFBP-2024000153$LFB GROUP$$28$YR$$M$Y$69.1$KG$20240912$$MD$US$US
243116511$24311651$1$I$20240904$20240905$20240912$20240912$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-027914$UNITED THERAPEUTICS$$55$YR$$$Y$$$20240912$$$CA$CA
243116531$24311653$1$I$20240801$20240826$20240912$20240912$PER$$US-TEVA-VS-3238105$TEVA$$62$YR$$M$Y$$$20240912$$CN$US$US
243116541$24311654$1$I$$20240902$20240912$20240912$EXP$$US-AMAROX PHARMA-ASP2024US03006$ASPIRO PHARMA$Nanah A, Nair AS, Stoller J. Delayed Response to Glucocorticoids in Daptomycin Lung. American Journal of Therapeutics. 2024;31(4):e518-e521$75$YR$$M$Y$$$20240912$$MD$US$US
243116551$24311655$1$I$$20240910$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA079257$SANDOZ$$66$YR$$F$Y$$$20240912$$MD$CA$CA
243116561$24311656$1$I$$20240829$20240912$20240912$PER$$US-JNJFOC-20240880495$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240912$$CN$US$US
243116571$24311657$1$I$20240101$20240905$20240912$20240912$EXP$$US-ABBVIE-5910155$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243116581$24311658$1$I$$20240909$20240912$20240912$PER$$US-ROCHE-10000079159$ROCHE$Yu M, Bommakanti N, Yonekawa Y, Pulido J. Minocycline-induced retinal pigment epithelium hyperpigmentation masquerading as age-related macular degeneration: Case presentation and proposed mechanism. American Journal of Ophthalmology Case Reports. 2024;36: doi:10.1016/j.ajoc.2024.102154.$80$YR$E$M$Y$$$20240912$$HP$US$US
243116591$24311659$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A202264$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243116601$24311660$1$I$20240709$20240910$20240912$20240912$PER$$US-AstraZeneca-2024A206543$ASTRAZENECA$$$$$F$Y$$$20240912$$HP$US$
243116612$24311661$2$F$20240909$20240912$20240912$20240913$PER$$US-AMGEN-USASP2024181930$AMGEN$$70$YR$E$F$Y$$$20240913$$CN$US$US
243116622$24311662$2$F$20240101$20240924$20240912$20240925$EXP$$RO-SANDOZ INC.-SDZ2024RO079154$SANDOZ$$$$E$F$Y$$$20240925$$MD$RO$RO
243116631$24311663$1$I$$20240909$20240912$20240912$EXP$$GB-SANDOZ INC.-NVSC2020GB244113$SANDOZ$$47$YR$$M$Y$$$20240912$$MD$GB$GB
243116641$24311664$1$I$20240101$20240826$20240912$20240912$EXP$$US-SA-2024SA263126$SANOFI AVENTIS$$31$YR$A$M$Y$96.36$KG$20240912$$MD$US$US
243116651$24311665$1$I$20240908$20240909$20240912$20240912$EXP$$US-PFIZER INC-202400254112$PFIZER$$73$YR$$F$Y$$$20240912$$HP$US$US
243116662$24311666$2$F$20240830$20240920$20240912$20240926$EXP$$IN-PFIZER INC-PV202400017415$PFIZER$$58$YR$$F$Y$84$KG$20240926$$CN$IN$IN
243116671$24311667$1$I$20240906$20240910$20240912$20240912$EXP$$DE-PFIZER INC-PV202400118651$PFIZER$$81$YR$$M$Y$50$KG$20240912$$MD$DE$DE
243116681$24311668$1$I$$20240903$20240912$20240912$PER$$US-APOTEX-2024AP010287$APOTEX$Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N.. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.. The American Journal of Gastroenterology. 2024;119:200-202$$$A$$Y$$$20240912$$MD$US$US
243116692$24311669$2$F$$20240910$20240912$20240912$EXP$$EG-PFIZER INC-PV202400118592$PFIZER$$54$YR$$F$Y$90$KG$20240912$$PH$EG$EG
243116704$24311670$4$F$20220101$20240918$20240912$20240923$EXP$$US-PFIZER INC-202400022876$PFIZER$$56$YR$$F$Y$$$20240923$$CN$US$US
243116721$24311672$1$I$$20240910$20240912$20240912$EXP$$US-PFIZER INC-202400253708$PFIZER$$63$YR$$F$Y$104.33$KG$20240912$$CN$US$US
243116732$24311673$2$F$$20240910$20240912$20240912$EXP$$US-PFIZER INC-PV202400020651$PFIZER$$88$YR$$F$Y$$$20240912$$HP$US$US
243116751$24311675$1$I$$20240909$20240912$20240912$EXP$$ES-PFIZER INC-202400252529$PFIZER$$$$$$Y$$$20240912$$HP$ES$ES
243116761$24311676$1$I$20221101$20240906$20240912$20240912$EXP$$MY-PFIZER INC-PV202400118036$PFIZER$$59$YR$$M$Y$$$20240912$$MD$MY$MY
243116783$24311678$3$F$$20240918$20240912$20240924$EXP$$US-PFIZER INC-PV202400119001$PFIZER$$76$YR$$M$Y$$$20240924$$CN$US$US
243116791$24311679$1$I$20240101$20240910$20240912$20240912$EXP$$CN-PFIZER INC-PV202400118885$PFIZER$$64$YR$$M$Y$$$20240912$$HP$CN$CN
243116802$24311680$2$F$20240306$20240912$20240912$20240918$EXP$$US-PFIZER INC-PV202400118824$PFIZER$$66$YR$$M$Y$87.27$KG$20240918$$MD$US$US
243116812$24311681$2$F$$20240912$20240912$20240918$EXP$$CA-PFIZER INC-202400254592$PFIZER$$73$YR$$M$Y$$$20240918$$PH$CA$CA
243116821$24311682$1$I$20230819$20240909$20240912$20240912$EXP$$KR-009507513-2409KOR002628$MERCK$$$$$M$Y$$$20240912$$HP$KR$KR
243116831$24311683$1$I$20091001$20240909$20240912$20240912$EXP$$CA-PFIZER INC-202400254594$PFIZER$$51$YR$$F$Y$$$20240912$$MD$CA$CA
243116841$24311684$1$I$20240812$20240910$20240912$20240912$EXP$CH-SM-2024-15622$CH-PFIZER INC-202400253656$PFIZER$$$$$F$Y$55.3$KG$20240912$$PH$CH$CH
243116852$24311685$2$F$$20240910$20240912$20240916$EXP$$BR-MYLANLABS-2024M1082456$MYLAN$$$$$F$Y$68.7$KG$20240916$$CN$BR$BR
243116861$24311686$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA263256$SANOFI AVENTIS$$$$A$M$Y$140$KG$20240912$$MD$US$US
243116871$24311687$1$I$$20240823$20240912$20240912$PER$$US-SA-2024SA259801$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240912$$CN$US$US
243116881$24311688$1$I$$20240909$20240912$20240912$PER$$US-SA-2024SA263631$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240912$$MD$US$US
243116891$24311689$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA260330$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240912$$HP$US$US
243116901$24311690$1$I$$20240911$20240912$20240912$EXP$GB-MHRA-MED-202409112158055820-SRTQY$GB-PFIZER INC-202400254746$PFIZER$$$$$F$Y$$$20240912$$CN$GB$GB
243116911$24311691$1$I$20240701$20240911$20240912$20240912$EXP$$US-PFIZER INC-202400254840$PFIZER$$70$YR$$F$Y$77.11$KG$20240912$$CN$US$US
243116921$24311692$1$I$20240801$20240911$20240912$20240912$EXP$$CN-PFIZER INC-PV202400119472$PFIZER$$60$YR$$F$Y$$$20240912$$HP$CN$CN
243116931$24311693$1$I$20240803$20240910$20240912$20240912$EXP$$CN-PFIZER INC-PV202400118868$PFIZER$$67$YR$$M$Y$$$20240912$$HP$CN$CN
243116951$24311695$1$I$$20240910$20240912$20240912$EXP$$US-PFIZER INC-202400254340$PFIZER$$69$YR$$M$Y$$$20240912$$HP$US$US
243116961$24311696$1$I$$20240910$20240912$20240912$EXP$$CR-PFIZER INC-PV202400119369$PFIZER$$64$YR$$M$Y$$$20240912$$HP$CR$CR
243116981$24311698$1$I$$20240911$20240912$20240912$EXP$$JP-PFIZER INC-202400253964$PFIZER$$$$$$Y$$$20240912$$PH$JP$JP
243116991$24311699$1$I$$20240910$20240912$20240912$EXP$$US-PFIZER INC-PV202400118989$PFIZER$$$$$F$Y$$$20240912$$CN$US$US
243117001$24311700$1$I$20231101$20240911$20240912$20240912$EXP$$SE-PFIZER INC-PV202400119300$PFIZER$$30$YR$$F$Y$$$20240912$$CN$SE$SE
243117011$24311701$1$I$$20240911$20240912$20240912$EXP$$MA-PFIZER INC-PV202400119772$PFIZER$$$$$M$Y$$$20240912$$CN$MA$MA
243117021$24311702$1$I$$20240909$20240912$20240912$EXP$$PL-SANDOZ INC.-SDZ2024PL079163$SANDOZ$$37$YR$$M$Y$$$20240912$$MD$PL$PL
243117031$24311703$1$I$$20240906$20240912$20240912$EXP$$AU-INDIVIOR US-INDV-156363-2024$RECKITT BENCKISER$$$$$$Y$$$20240912$$HP$AU$AU
243117052$24311705$2$F$20230901$20240911$20240912$20240919$EXP$$NVSC2024BG181364$NOVARTIS$$51$YR$$F$Y$$$20240919$$MD$BG$BG
243117062$24311706$2$F$$20240910$20240912$20240913$EXP$$NVSC2024CA181632$NOVARTIS$$3$YR$$$Y$$$20240913$$CN$CA$CA
243117071$24311707$1$I$20211111$20240911$20240912$20240912$EXP$ES-AEMPS-1568222$NVSC2024ES181786$NOVARTIS$$37$YR$$F$Y$77$KG$20240912$$PH$ES$ES
243117081$24311708$1$I$$20240904$20240912$20240912$EXP$$NVSC2024JP181996$NOVARTIS$Kamemoto K, Morita N, Nakajima J, Yoneyama M, Honda K, Sekikawa S, et al. A Case of Chronic GVHD-Associated Tongue Cancer in a Patient After Allogeneic Peripheral Blood Stem Cell Transplantation.. PROGRAM OF THE 33RD GENERAL MEETING AND ACADEMIC CONFERENCE OF THE JAPANESE SOCI. 2024;O17:1$38$YR$$M$Y$$$20240912$$HP$JP$JP
243117091$24311709$1$I$$20240911$20240912$20240912$EXP$$NVSJ2024JP010821$NOVARTIS$$$$$$Y$$$20240912$$MD$JP$JP
243117101$24311710$1$I$$20240910$20240912$20240912$EXP$$NVSC2024CA181874$NOVARTIS$$14$YR$$F$Y$$$20240912$$HP$CA$CA
243117111$24311711$1$I$20240904$20240904$20240912$20240912$PER$$US-RDY-SPO/USA/24/0013106$DR REDDYS$$19$YR$A$F$Y$$$20240912$$CN$US$US
243117122$24311712$2$F$20231212$20240911$20240912$20240917$EXP$$NVSJ2024JP010645$NOVARTIS$$80$YR$$M$Y$62$KG$20240917$$MD$JP$JP
243117131$24311713$1$I$$20240904$20240912$20240912$PER$$US-RDY-SPO/USA/24/0013116$DR REDDYS$$20$YR$A$$Y$$$20240912$$MD$US$US
243117141$24311714$1$I$$20240831$20240912$20240912$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0370$GRAVITI PHARMACEUTICALS$Hang T-V, Taborda C, Barrett A, Xue Y, Vora R. .Not so safe for all: A case of statin-induced autoimmune hepatitis and primary biliary cholangitis overlap.The American Journal of GASTROENTEROLOGY.2019;114(Suppl. 2019):S1327-S1328$70$YR$E$F$Y$$$20240912$$MD$US$US
243117151$24311715$1$I$$20240902$20240912$20240912$EXP$$ES-ROCHE-10000073814$ROCHE$Juan-Carpena G, Martinez-Banaclocha N, Palazon-Cabanes J, Niveiro-De Jaime M, Betlloch-Mas I, Blanes-Martinez M. Cutaneous immune-related adverse events: incidence rates, risk factors and association with extracutaneous toxicity - a prospective study of 189 patients treated with checkpoint inhibitors at a Spanish tertiary care hospital. Clinical and Experimental Dermatology. 2024-Sep;49 (9):991-1001. doi:10.1093/ced/llae060.$$$$$Y$$$20240912$$HP$ES$ES
243117161$24311716$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004898$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243117171$24311717$1$I$$20240909$20240912$20240912$EXP$HU-PFIZER INC-2018088751$HU-CHIESI-2018CHF00778$CHIESI$$31$YR$$M$Y$$$20240912$$MD$HU$HU
243117181$24311718$1$I$$20240906$20240912$20240912$EXP$$AU-ABBVIE-5917039$ABBVIE$$$$$$Y$$$20240912$$MD$AU$AU
243117221$24311722$1$I$$20240903$20240912$20240912$EXP$IT-EMA-DD-20240830-7482643-142350$IT-BAXTER-2024BAX024178$BAXTER$$39$YR$$M$Y$$$20240912$$HP$IT$IT
243117241$24311724$1$I$$20240831$20240912$20240912$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0341$GRAVITI PHARMACEUTICALS$Xu J, Verga S, Stoll J, Pioppo L, Khan W.Nonspecific interstitial pneumonia: A rare adverse reaction of atorvastatin.Cardiology.2018;140 (suppl 1): 1-438$73$YR$E$F$Y$$$20240912$$HP$US$US
243117261$24311726$1$I$20240101$20240823$20240912$20240912$PER$$US-TEVA-VS-3236959$TEVA$$66$YR$$M$Y$$$20240912$$CN$US$US
243117272$24311727$2$F$$20240913$20240912$20240921$EXP$$JP-ROCHE-10000079288$ROCHE$$76$YR$E$M$Y$$$20240921$$PH$JP$JP
243117281$24311728$1$I$$20240828$20240912$20240912$EXP$$IR-GRANULES-IR-2024GRALIT00397$GRANULES INDIA$Majid Alikhani.Hypokalemic quadriplegia in Sjogren^s syndrome: A case report.Clinical Case Reports.03-JUL-2024;12 (No.8):1-5$38$YR$A$F$Y$$$20240912$$HP$IR$IR
243117291$24311729$1$I$$20240902$20240912$20240912$EXP$$US-TEVA-VS-3240668$TEVA$Kinney RE, Nair S, Kim CH, Thomas MB, Delatorre M. Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer. Oncologist 2023; 28 (6): E478-E486.$55$YR$$F$Y$$$20240912$$MD$US$US
243117301$24311730$1$I$20240908$20240909$20240912$20240912$EXP$$US-BAYER-2024A128922$BAYER$$$$E$F$Y$$$20240912$$CN$US$US
243117311$24311731$1$I$$20240902$20240912$20240912$EXP$$PT-ROCHE-10000072747$ROCHE$Antunes A, Guedes A, Salvado C, Carmo F, Soeiro B. Non-Cirrhotic Portal Hypertension After Trastuzumab Emtansine (Abstract no. PO-0248 - (2340)). Gastroenterological Diseases and Liver Diseases.613.$69$YR$E$F$Y$$$20240912$$HP$PT$PT
243117321$24311732$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144977$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240912$$HP$US$US
243117331$24311733$1$I$$20240828$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137814$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$HP$US$US
243117361$24311736$1$I$$20240903$20240912$20240912$30DAY$$CA-JNJFOC-20240925808$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$PH$CA$CA
243117371$24311737$1$I$$20240904$20240912$20240912$PER$$US-JNJFOC-20240915054$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243117381$24311738$1$I$20240905$20240905$20240912$20240912$PER$$US-JNJFOC-20240916820$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$MD$US$US
243117401$24311740$1$I$$20240828$20240912$20240912$PER$$US-ASTELLAS-2024-AER-003702$ASTELLAS$$90$YR$E$F$Y$$$20240912$$CN$US$US
243117411$24311741$1$I$20240501$20240902$20240912$20240912$EXP$$JP-ROCHE-10000074664$ROCHE$$87$YR$E$M$Y$55$KG$20240912$$PH$JP$JP
243117431$24311743$1$I$$20240903$20240912$20240912$EXP$$CA-ROCHE-10000072850$ROCHE$$43$YR$A$F$Y$$$20240912$$HP$CA$CA
243117441$24311744$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA261133$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240912$$MD$US$US
243117451$24311745$1$I$20240701$20240903$20240912$20240912$PER$$US-SA-2024SA261415$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240912$$HP$US$US
243117461$24311746$1$I$$20240903$20240912$20240912$EXP$$CA-ROCHE-10000072866$ROCHE$$$$$F$Y$$$20240912$$CN$CA$CA
243117471$24311747$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA263273$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$HP$US$US
243117481$24311748$1$I$$20240910$20240912$20240912$PER$$US-ABBVIE-5917888$ABBVIE$$$$$F$Y$$$20240912$$MD$US$US
243117501$24311750$1$I$$20240607$20240912$20240912$PER$$US-BIOCON-BCN-2024-000106$BIOCON$$$$$F$Y$$$20240912$$HP$US$US
243117511$24311751$1$I$$20240408$20240912$20240912$PER$$US-BIOCON-BCN-2024-000063$BIOCON$$$$$$Y$$$20240912$$HP$US$US
243117521$24311752$1$I$$20240902$20240912$20240912$EXP$$CA-TEVA-VS-3239554$TEVA$$10$YR$$M$Y$28$KG$20240912$$HP$CA$CA
243117531$24311753$1$I$20240701$20240702$20240912$20240912$PER$$US-FMCRTG-FMC-2407-000819$FRESENIUS MEDICAL CARE$$61$YR$A$F$Y$97$KG$20240912$$HP$US$US
243117541$24311754$1$I$$20240909$20240912$20240912$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024111959$VIIV$$$$$M$Y$$$20240912$$HP$US$US
243117551$24311755$1$I$20240610$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145127$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240912$$CN$US$US
243117571$24311757$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144706$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240912$$HP$US$US
243117581$24311758$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144817$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240912$$CN$US$US
243117591$24311759$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144747$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240912$$CN$US$US
243117601$24311760$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144588$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$89.36$KG$20240912$$CN$US$US
243117621$24311762$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144886$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240912$$HP$US$US
243117631$24311763$1$I$20240827$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144619$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$97.98$KG$20240912$$HP$US$US
243117641$24311764$1$I$$20240813$20240912$20240912$PER$$US-009507513-2408USA005525$MERCK$Enriquez Marulanda A, Young M, Shutran M, Taussky P, Kicielinski K, Ogilvy CS,. Acute Coiling With Delayed Flow Diversion for Posterior Communicating Segment Internal Carotid Artery Aneurysms: A Multicenter Case Series. Neurosurgery. 2024;94(4):729-35$$$A$$Y$$$20240912$$MD$US$US
243117651$24311765$1$I$$20240828$20240912$20240912$PER$$US-ASTELLAS-2024-AER-004312$ASTELLAS$$$$$M$Y$$$20240912$$MD$US$US
243117661$24311766$1$I$20240819$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144667$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240912$$HP$US$US
243117672$24311767$2$F$$20240918$20240912$20240927$EXP$$DE-TEVA-VS-3241216$TEVA$Schmidt F, Erlacher M, Niemeyer C, Reinhardt D, Klusmann J-H. Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML. Front-Pediatr 2022; 10 1-8.; Schmidt F, Erlacher M, Niemeyer C, Reinhardt D, Klusmann J-H. Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML. Front-Pediatr 2022; 10 1-8.; Schmidt F, Erlacher M, Niemeyer C, Reinhardt D, Klusmann ...$11$YR$$M$Y$$$20240927$$HP$DE$DE
243117691$24311769$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A202187$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243117701$24311770$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A203225$ASTRAZENECA$$$$$F$Y$65.8$KG$20240912$$CN$US$
243117711$24311771$1$I$$20240828$20240912$20240912$EXP$$TR-GRANULES-TR-2024GRALIT00398$GRANULES INDIA$Nurdan Tacyildiz.Multidisciplinary PAIN management features of pediatric oncology patients in a pediatric cancer center in Turkiye: A developing country experience.Journal of Clinical Oncology.JUN-2024;42$$$$$Y$$$20240912$$HP$TR$TR
243117721$24311772$1$I$$20240902$20240912$20240912$EXP$$PL-TEVA-VS-3239468$TEVA$Dzwilewski K. Drug-resistant epilepsy with focal seizures in the context of focal cortical dysplasia. POLSKI PRZEGL D NEUROLOGICZNY. 2024;20(2):109-114.$11$YR$$F$Y$$$20240912$$HP$PL$PL
243117731$24311773$1$I$$20240904$20240912$20240912$EXP$$AU-AstraZeneca-2024A201662$ASTRAZENECA$$78$YR$$F$Y$$$20240912$$MD$AU$
243117741$24311774$1$I$$20240828$20240912$20240912$EXP$$US-SHIELD THERAPEUTICS-US-STX-24-00236$IRON THERAPEUTICS$$77$YR$$M$Y$$$20240912$$CN$US$US
243117751$24311775$1$I$$20240829$20240912$20240912$EXP$$US-SHIELD THERAPEUTICS-US-STX-24-00238$IRON THERAPEUTICS$$42$YR$$F$Y$$$20240912$$CN$US$US
243117761$24311776$1$I$20240819$20240822$20240912$20240912$EXP$$US-SA-2024SA262516$SANOFI AVENTIS$$57$YR$A$F$Y$75.45$KG$20240912$$HP$US$US
243117771$24311777$1$I$$20240902$20240912$20240912$EXP$$CA-TEVA-VS-3239635$TEVA$$$$$F$Y$6$KG$20240912$$HP$CA$CA
243117791$24311779$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006361$ELI LILLY AND CO$$12$YR$C$M$Y$$$20240912$$PH$US$US
243117801$24311780$1$I$20240824$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006210$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240912$$MD$US$US
243117811$24311781$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005242$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240912$$CN$US$US
243117821$24311782$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007296$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240912$$CN$US$US
243117831$24311783$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006244$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240912$$CN$US$US
243117841$24311784$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006493$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
243117851$24311785$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006995$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240912$$MD$US$US
243117871$24311787$1$I$$20240906$20240912$20240912$EXP$$NVSC2024AR182126$NOVARTIS$$$$$F$Y$$$20240912$$MD$AR$AR
243117891$24311789$1$I$$20240910$20240912$20240912$EXP$$NVSC2024CA181677$NOVARTIS$$77$YR$$$Y$72$KG$20240912$$PH$CA$CA
243117901$24311790$1$I$$20240905$20240912$20240912$EXP$$US-ABBVIE-5910663$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243117912$24311791$2$F$$20240920$20240912$20240921$PER$$US-DSJP-DSU-2024-144652$DAIICHI$$$$$F$Y$$$20240921$$CN$US$US
243117931$24311793$1$I$20210101$20240904$20240912$20240912$PER$$US-SA-2024SA263252$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240912$$MD$US$US
243117941$24311794$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA264013$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240912$$HP$US$US
243117952$24311795$2$F$$20240905$20240912$20240919$PER$$US-SA-2024SA261863$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240919$$CN$US$US
243117961$24311796$1$I$20240101$20240826$20240912$20240912$PER$$US-SA-2024SA262774$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240912$$CN$US$US
243117971$24311797$1$I$20240818$20240903$20240912$20240912$PER$$US-SA-2024SA261430$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240912$$CN$US$US
243117981$24311798$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263733$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240912$$MD$US$US
243117991$24311799$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA263724$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240912$$HP$US$US
243118001$24311800$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA262002$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240912$$PH$US$US
243118011$24311801$1$I$$20240907$20240912$20240912$30DAY$$CO-PFIZER INC-PV202400118042$PFIZER$$$$$$Y$$$20240912$$CN$CO$CO
243118031$24311803$1$I$20240821$20240909$20240912$20240912$EXP$$US-BAYER-2024A129084$BAYER$$21$YR$A$M$Y$$$20240912$$CN$US$US
243118051$24311805$1$I$$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180848$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243118061$24311806$1$I$20240601$20240905$20240912$20240912$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024110802$VIIV$$50$YR$$F$Y$$$20240912$$HP$US$US
243118071$24311807$1$I$20240101$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024181818$AMGEN$$35$YR$A$F$Y$$$20240912$$HP$US$US
243118081$24311808$1$I$$20240910$20240912$20240912$EXP$$NVSC2024US181913$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
243118092$24311809$2$F$20240704$20240911$20240912$20240912$PER$$US-Calliditas-2024CAL01312$CALLIDITAS THERAPEUTICS$$65$YR$E$M$Y$165.2$KG$20240912$$HP$US$US
243118101$24311810$1$I$$20240911$20240911$20240911$DIR$718060$$FDA-CTU$$$$$F$N$$$20240911$Y$HP$US$
243118111$24311811$1$I$20240812$20240815$20240912$20240912$PER$$US-IMP-2024000639$Harrow Health$$78$YR$E$M$Y$$$20240912$$CN$US$US
243118121$24311812$1$I$$20240909$20240912$20240912$PER$$US-ABBVIE-5919073$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243118131$24311813$1$I$20240418$20240906$20240912$20240912$EXP$ES-AEMPS-1514945$ES-TEVA-VS-3241550$TEVA$$87$YR$$F$Y$$$20240912$$MD$ES$ES
243118141$24311814$1$I$$20240821$20240912$20240912$PER$$US-SA-2024SA262990$SANOFI AVENTIS$$$$E$M$Y$$$20240912$$MD$US$US
243118151$24311815$1$I$20240812$20240829$20240912$20240912$PER$$US-SA-2024SA263993$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240912$$MD$US$US
243118161$24311816$1$I$20240101$20240826$20240912$20240912$PER$$US-SA-2024SA262097$SANOFI AVENTIS$$8$YR$C$M$Y$50$KG$20240912$$CN$UM$US
243118171$24311817$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA264087$SANOFI AVENTIS$$$$E$F$Y$$$20240912$$MD$US$US
243118181$24311818$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62542$$FDA-CTU$$59$YR$$F$N$$$20240911$N$$US$
243118191$24311819$1$I$20240911$20240911$20240911$20240911$DIR$718069$$FDA-CTU$$15$YR$$M$N$78.75$KG$20240911$N$$US$
243118201$24311820$1$I$$20240828$20240912$20240912$EXP$$US-GRANULES-US-2024GRALIT00396$GRANULES INDIA$C. Fling.An Ophtha-MALA-gic Anomaly: Metformin Associated Lactic Acidosis Causing Transient Blindness.American Journal of Respiratory and Critical Care Medicine.2023;207:A3498$62$YR$A$M$Y$$$20240912$$HP$US$US
243118211$24311821$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA261094$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240912$$MD$US$US
243118221$24311822$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA263444$SANOFI AVENTIS$$$$E$F$Y$88.64$KG$20240912$$HP$US$US
243118231$24311823$1$I$20240801$20240826$20240912$20240912$PER$$US-SA-2024SA262329$SANOFI AVENTIS$$53$YR$A$F$Y$81.82$KG$20240912$$MD$US$US
243118241$24311824$1$I$20240904$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62568$$FDA-CTU$$80$YR$$F$N$$$20240911$N$PH$US$
243118251$24311825$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62529$$FDA-CTU$$59$YR$$F$N$98.43$KG$20240911$N$$US$
243118261$24311826$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62567$$FDA-CTU$$53$YR$$F$N$$$20240911$N$$US$
243118271$24311827$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA263149$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240912$$HP$US$US
243118281$24311828$1$I$$20240826$20240912$20240912$PER$$US-SA-2024SA262464$SANOFI AVENTIS$$74$YR$E$M$Y$83.9$KG$20240912$$HP$US$US
243118291$24311829$1$I$20240801$20240823$20240912$20240912$PER$$US-SA-2024SA262627$SANOFI AVENTIS$$5$YR$C$M$Y$17.78$KG$20240912$$MD$US$US
243118312$24311831$2$F$$20240916$20240912$20240920$30DAY$$TR-PFIZER INC-202400243714$PFIZER$$$$$$Y$$$20240920$$PH$TR$TR
243118321$24311832$1$I$$20240906$20240912$20240912$EXP$$US-PFIZER INC-202400251062$PFIZER$$6$YR$$M$Y$$$20240912$$HP$US$US
243118331$24311833$1$I$20240816$20240910$20240912$20240912$EXP$HR-HALMED-300086478$HR-PFIZER INC-202400253379$PFIZER$$62$YR$$F$Y$95$KG$20240912$$CN$HR$HR
243118352$24311835$2$F$$20240917$20240912$20240926$EXP$$US-TEVA-VS-3240381$TEVA$Bruno M, Strober B, Del Rosso JQ. TOPICAL MANAGEMENT OF PLAQUE PSORIASIS-A Review and Case Series Discussion with Focus on Aryl Hydrocarbon Receptor Modulation. J-Clin-Aesthet-Dermatol 2023; 16 (1) S3-S12.; Bruno M, Strober B, Del Rosso JQ. TOPICAL MANAGEMENT OF PLAQUE PSORIASIS-A Review and Case Series Discussion with Focus on Aryl Hydrocarbon Receptor Modulation. J-Clin-Aesthet-Dermatol 2023; 16 (1) S3-S12.$79$YR$$F$Y$$$20240926$$HP$US$US
243118361$24311836$1$I$20240804$20240820$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004903$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240912$$CN$US$US
243118371$24311837$1$I$$20240815$20240912$20240912$PER$$US-IMP-2024000641$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243118381$24311838$1$I$20240801$20240904$20240912$20240912$PER$$US-SA-2024SA263026$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240912$$MD$US$US
243118391$24311839$1$I$20240601$20240903$20240912$20240912$PER$$US-SA-2024SA263825$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240912$$HP$US$US
243118401$24311840$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA263246$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240912$$MD$US$US
243118411$24311841$1$I$$20240903$20240912$20240912$EXP$$US-862174955-ML2024-04785$MICRO LABS$Hassan AM, Hill H, Donley C, Leonelli C. Potential anaphylactoid reaction to nicardipine. Journal of the American College of Emergency Physicians Open. 2024;5(e13271): 1-3. doi:10.1002/emp2.13271.$52$YR$A$M$Y$$$20240912$$MD$US$US
243118421$24311842$1$I$$20240903$20240912$20240912$EXP$$US-862174955-ML2024-04831$MICRO LABS$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 06;73(200): 1-9. doi:10.1007/s00262-024-03775-6.$61$YR$E$F$Y$$$20240912$$HP$US$US
243118431$24311843$1$I$$20240903$20240912$20240912$EXP$$US-862174955-ML2024-04784$MICRO LABS$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 06;73(200): 1-9. doi:https://doi.org/10.1007/s00262-024-03775-6.$69$YR$E$M$Y$$$20240912$$HP$US$US
243118441$24311844$1$I$20240901$20240911$20240912$20240912$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050858$BOEHRINGER INGELHEIM$$$$A$$Y$$$20240912$$MD$US$US
243118451$24311845$1$I$$20240904$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143666$BRISTOL MYERS SQUIBB$Chela H, Mankoo R, Samiullah S, Daglilar E. Metastatic Gastric Lesions. The American Journal of Gastroenterology. 2020 Oct;115(Suppl):S1585-6. doi:10.14309/01.ajg.0000714080.99422.8e.$76$YR$E$M$Y$$$20240912$$MD$US$US
243118462$24311846$2$F$$20240925$20240912$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144888$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240926$$HP$US$US
243118471$24311847$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143635$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$PH$US$US
243118481$24311848$1$I$20240821$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144926$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240912$$CN$US$US
243118491$24311849$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182796$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
243118502$24311850$2$F$20231123$20240911$20240912$20240923$EXP$$GB-862174955-ML2024-04810$MICRO LABS$$$$E$F$Y$89$KG$20240923$$MD$GB$GB
243118511$24311851$1$I$$20240905$20240912$20240912$EXP$$US-TAKEDA-2024TUS089934$TAKEDA$$$$$M$Y$73.46$KG$20240912$$HP$US$US
243118531$24311853$1$I$$20240903$20240912$20240912$30DAY$$MY-JNJFOC-20240925729$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$MD$MY$MY
243118541$24311854$1$I$$20240906$20240912$20240912$EXP$$CN-TAKEDA-2024TUS090542$TAKEDA$Xie L N, Wang X, He Q, Wang H, Ma J, Zhang H Y, et.al. A multicenter, prospective, phase II, single-arm study on the treatment of newly diagnosed multiple myeloma with domestic bortezomib in combination with lenalidomide and dexamethasone. Chinese Journal of Hematology. 2024;45 (6):571-6$$$$$Y$$$20240912$$MD$CN$CN
243118552$24311855$2$F$$20240821$20240912$20240912$PER$$US-IMP-2024000660$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243118561$24311856$1$I$20240901$20240910$20240912$20240912$PER$$US-BIOGEN-2024BI01281971$BIOGEN$$42$YR$$F$Y$$$20240912$$CN$US$US
243118571$24311857$1$I$$20240910$20240912$20240912$PER$$US-BIOGEN-2024BI01281952$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
243118581$24311858$1$I$$20240911$20240911$20240911$DIR$718059$$FDA-CTU$$$$$UNK$N$$$20240911$$CN$US$
243118591$24311859$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62559$$FDA-CTU$$15$YR$$F$N$$$20240911$N$$US$
243118601$24311860$1$I$$20240911$20240911$20240911$DIR$718063$$FDA-CTU$$$$$UNK$N$$$20240911$$CN$US$
243118621$24311862$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62550$$FDA-CTU$$72$YR$$F$N$92.08$KG$20240911$N$$US$
243118641$24311864$1$I$$20240911$20240911$20240911$DIR$718038$$FDA-CTU$$$$$UNK$N$$$20240911$N$CN$US$
243118651$24311865$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62525$$FDA-CTU$$64$YR$$F$N$$$20240911$N$$US$
243118661$24311866$1$I$$20240905$20240912$20240912$DIR$FDA-CDER-CTU-2024-62635$$FDA-CTU$$$$$M$N$$$20240905$N$HP$US$
243118701$24311870$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62661$$FDA-CTU$$84$YR$$F$N$$$20240912$N$$US$
243118721$24311872$1$I$20240910$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62569$$FDA-CTU$$$$$M$N$74.7$KG$20240911$N$$US$
243118731$24311873$1$I$20240814$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62539$$FDA-CTU$$65$YR$$F$N$$$20240911$N$$US$
243118751$24311875$1$I$20240902$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62578$$FDA-CTU$$$$$F$N$49.4$KG$20240911$N$$US$
243118771$24311877$1$I$20240905$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62570$$FDA-CTU$$76$YR$$F$N$35.9$KG$20240911$N$$US$
243118781$24311878$1$I$20240816$20240906$20240912$20240912$DIR$FDA-CDER-CTU-2024-62580$$FDA-CTU$$$$$F$N$$$20240906$N$$US$
243118791$24311879$1$I$20240904$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62574$$FDA-CTU$$$$$F$N$80.1$KG$20240911$N$$US$
243118801$24311880$1$I$$20240903$20240912$20240912$DIR$FDA-CDER-CTU-2024-62664$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
243118821$24311882$1$I$$20240904$20240912$20240912$PER$$US-CHATTEMPRD-2024OHG030881$CHATTEM$$$$$F$Y$$$20240912$$CN$US$US
243118831$24311883$1$I$$20240905$20240912$20240912$PER$$US-CHATTEMPRD-2024OHG031046$CHATTEM$$$$A$$Y$$$20240912$$CN$US$US
243118841$24311884$1$I$$20240909$20240912$20240912$EXP$$US-MYLANLABS-2024M1082791$MYLAN$$$$$M$Y$$$20240912$$CN$US$US
243118851$24311885$1$I$20240119$20240902$20240912$20240912$EXP$FR-AFSSAPS-RE2024000187$FR-TEVA-VS-3170208$TEVA$$50$YR$$F$Y$62$KG$20240912$$MD$FR$FR
243118861$24311886$1$I$20240908$20240910$20240912$20240912$EXP$$US-TAKEDA-2024TUS090438$TAKEDA$$13$YR$$M$Y$$$20240912$$CN$US$US
243118871$24311887$1$I$$20240910$20240912$20240912$EXP$$PH-TAKEDA-2024TUS090351$TAKEDA$$$$$M$Y$$$20240912$$MD$PH$PH
243118881$24311888$1$I$$20240904$20240912$20240912$EXP$$GR-ROCHE-10000014466$ROCHE$$$$E$F$Y$$$20240912$$CN$GR$GR
243118891$24311889$1$I$$20240903$20240912$20240912$EXP$$CA-ROCHE-10000072632$ROCHE$$$$$F$Y$$$20240912$$MD$CA$CA
243118921$24311892$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62662$$FDA-CTU$$34$YR$$M$N$$$20240912$N$$US$
243118941$24311894$1$I$20240101$20240905$20240912$20240912$EXP$$US-ABBVIE-5910439$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243118951$24311895$1$I$20240420$20240903$20240912$20240912$EXP$$US-UCBSA-2024020841$UCB$$29$YR$$F$Y$$$20240912$$CN$US$US
243118961$24311896$1$I$20240404$20240829$20240912$20240912$EXP$$US-UCBSA-2024021326$UCB$$51$YR$$F$Y$$$20240912$$HP$US$US
243118991$24311899$1$I$20240426$20240911$20240912$20240912$EXP$FR-AFSSAPS-BX2024001763$FR-ORGANON-O2409FRA000732$ORGANON$$72$YR$$F$Y$$$20240912$$MD$FR$FR
243119001$24311900$1$I$$20240906$20240912$20240912$PER$$US-CHATTEMPRD-2024OHG031116$CHATTEM$$$$E$F$Y$$$20240912$$CN$US$US
243119011$24311901$1$I$$20240810$20240912$20240912$PER$$US-ASTELLAS-2024-AER-004867$ASTELLAS$$80$YR$E$M$Y$$$20240912$$CN$US$US
243119032$24311903$2$F$20240911$20240912$20240912$20240912$PER$$US-AMGEN-USASP2024181638$AMGEN$$62$YR$A$F$Y$$$20240912$$CN$US$US
243119042$24311904$2$F$$20240906$20240912$20240920$PER$$US-CHATTEMPRD-2024OHG031284$CHATTEM$$$$$M$Y$$$20240920$$CN$US$US
243119051$24311905$1$I$$20240905$20240912$20240912$PER$$US-CHATTEMPRD-2024OHG031225$CHATTEM$$$$$$Y$$$20240912$$CN$US$US
243119061$24311906$1$I$20240731$20240902$20240912$20240912$EXP$FR-AFSSAPS-PB2024000882$FR-TEVA-VS-3239374$TEVA$$58$YR$$F$Y$$$20240912$$MD$FR$FR
243119071$24311907$1$I$20240201$20240830$20240912$20240912$PER$$US-SA-2024SA262399$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240912$$HP$US$US
243119081$24311908$1$I$$20240902$20240912$20240912$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-08382$HIKMA$$79$YR$$F$Y$$$20240912$$HP$CA$CA
243119092$24311909$2$F$$20240917$20240912$20240926$EXP$$US-TEVA-VS-3240332$TEVA$Xia J, Ahmed R. Rapidly progressive locked-in syndrome secondary to atypical herpes simplex virus-1 rhombencephalitis in an immunocompromised individual. IDCases 2024; 37; Xia J, Ahmed R. Rapidly progressive locked-in syndrome secondary to atypical herpes simplex virus-1 rhombencephalitis in an immunocompromised individual. IDCases 2024; 37.$61$YR$$M$Y$$$20240926$$HP$US$US
243119101$24311910$1$I$$20240823$20240912$20240912$PER$$US-IMP-2024000670$Harrow Health$$$$E$M$Y$$$20240912$$CN$US$US
243119111$24311911$1$I$$20240906$20240912$20240912$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001823$BLUEPRINT MEDICINES$$$$$M$Y$$$20240912$$CN$US$US
243119121$24311912$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA263204$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240912$$HP$US$US
243119132$24311913$2$F$$20240917$20240912$20240926$EXP$$US-TEVA-VS-3240330$TEVA$Hennen M-A, Zhang V, Opler DJ. An unwelcome side-effect of trazodone use in a trans-male. Psychiatr-Clin-Neurosci 2024; 78 (6): 376.; Hennen M-A, Zhang V, Opler DJ. An unwelcome side-effect of trazodone use in a trans-male. Psychiatr-Clin-Neurosci 2024; 78 (6): 376.; Hennen M-A, Zhang V, Opler DJ. An unwelcome side-effect of trazodone use in a trans-male. Psychiatr-Clin-Neurosci 2024; 78 (6): 376.$24$YR$$F$Y$$$20240926$$MD$US$US
243119141$24311914$1$I$$20240823$20240912$20240912$PER$$US-TEVA-VS-3236715$TEVA$$$$$$Y$$$20240912$$HP$US$US
243119151$24311915$1$I$20240813$20240909$20240912$20240912$EXP$$FR-AstraZeneca-2024A206193$ASTRAZENECA$$68$YR$$M$Y$69$KG$20240912$$MD$FR$
243119171$24311917$1$I$$20240905$20240912$20240912$EXP$$CA-AstraZeneca-2024A206933$ASTRAZENECA$$$$$$Y$$$20240912$$HP$CA$
243119181$24311918$1$I$$20240828$20240912$20240912$PER$$US-IMP-2024000696$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243119191$24311919$1$I$$20240909$20240912$20240912$EXP$$AU-MYLANLABS-2024M1082640$MYLAN$$$$$M$Y$$$20240912$$PH$AU$AU
243119202$24311920$2$F$$20240911$20240912$20240926$PER$$US-GRANULES-US-2024GRASPO00399$GRANULES INDIA$$$$$M$Y$$$20240926$$CN$US$US
243119211$24311921$1$I$20240729$20240909$20240912$20240912$EXP$LU-ALMPS-202404298$LU-009507513-2409LUX003100$MERCK$$69$YR$$M$Y$77$KG$20240912$$PH$LU$LU
243119221$24311922$1$I$20240909$20240909$20240912$20240912$EXP$$GB-MYLANLABS-2024M1082540$MYLAN$$39$YR$$M$Y$68$KG$20240912$$PH$GB$GB
243119231$24311923$1$I$$20240909$20240912$20240912$EXP$GB-MHRA-MED-202409092038013930-WLYVF$GB-MYLANLABS-2024M1082951$MYLAN$$21$YR$$F$Y$58$KG$20240912$$CN$GB$GB
243119242$24311924$2$F$20240909$20240916$20240912$20240920$EXP$$NL-MYLANLABS-2024M1082769$MYLAN$$41$YR$$F$Y$$$20240920$$HP$NL$NL
243119251$24311925$1$I$20240226$20240909$20240912$20240912$EXP$$GB-MYLANLABS-2024M1018565$MYLAN$$55$YR$$M$Y$$$20240912$$MD$GB$GB
243119261$24311926$1$I$20240905$20240911$20240912$20240912$EXP$$GB-MYLANLABS-2024M1083163$MYLAN$$$$$M$Y$$$20240912$$HP$GB$GB
243119271$24311927$1$I$20240909$20240909$20240912$20240912$EXP$$GB-MYLANLABS-2024M1082684$MYLAN$$72$YR$$F$Y$60$KG$20240912$$HP$GB$GB
243119281$24311928$1$I$20240801$20240828$20240912$20240912$PER$$US-SA-2024SA259912$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240912$$HP$US$US
243119292$24311929$2$F$20240101$20240829$20240912$20240918$PER$$US-SA-2024SA263914$SANOFI AVENTIS$$46$YR$A$F$Y$89.705$KG$20240918$$MD$US$US
243119301$24311930$1$I$20240726$20240902$20240912$20240912$EXP$FR-AFSSAPS-TO2024001632$FR-TEVA-VS-3239664$TEVA$$86$YR$$M$Y$$$20240912$$MD$FR$FR
243119311$24311931$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA261974$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240912$$HP$US$US
243119321$24311932$1$I$20240801$20240904$20240912$20240912$PER$$US-SA-2024SA263142$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240912$$MD$US$US
243119331$24311933$1$I$20240801$20240904$20240912$20240912$PER$$US-SA-2024SA263309$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240912$$HP$US$US
243119351$24311935$1$I$$20240911$20240912$20240912$PER$$US-HALEON-2196488$Haleon PLC$$$$$$Y$$$20240912$$CN$US$US
243119361$24311936$1$I$$20240824$20240912$20240912$PER$$US-IMP-2024000672$Harrow Health$$$$E$M$Y$$$20240912$$CN$US$US
243119374$24311937$4$F$20240101$20240924$20240912$20240926$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050642$BOEHRINGER INGELHEIM$$49$YR$A$F$Y$75.66$KG$20240926$$HP$US$US
243119381$24311938$1$I$$20240826$20240912$20240912$PER$$US-IMP-2024000679$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243119401$24311940$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143589$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240912$$CN$US$US
243119411$24311941$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004907$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243119421$24311942$1$I$$20240903$20240912$20240912$EXP$$US-AMGEN-USASP2024177463$AMGEN$Shafique,N.;. Hemophagocytic Lymphohistiocytosis Co-Presenting With Non-Cirrhotic Portal Hypertensive Gastropathy: A Case Report. Clinical Lymphoma Myeloma + Leukemia. 2024;24(10):S393$54$YR$A$M$Y$$$20240912$$MD$US$US
243119431$24311943$1$I$$20240910$20240912$20240912$EXP$$US-JNJFOC-20240927436$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$HP$US$US
243119441$24311944$1$I$$20240826$20240912$20240912$PER$$US-IMP-2024000684$Harrow Health$$$$A$F$Y$$$20240912$$CN$US$US
243119451$24311945$1$I$20240801$20240827$20240912$20240912$PER$$US-IMP-2024000687$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243119461$24311946$1$I$20240819$20240909$20240912$20240912$EXP$$AR-ABBVIE-5915651$ABBVIE$$50$YR$$F$Y$$$20240912$$CN$AR$AR
243119471$24311947$1$I$20240101$20240826$20240912$20240912$PER$$US-IMP-2024000691$Harrow Health$$$$A$F$Y$$$20240912$$CN$US$US
243119482$24311948$2$F$20200101$20240906$20240912$20240926$EXP$$US-GILEAD-2024-0657397$GILEAD$$70$YR$E$F$Y$$$20240926$$HP$US$US
243119491$24311949$1$I$20240813$20240820$20240912$20240912$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004908$ACADIA PHARMACEUTICALS$$93$YR$$M$Y$$$20240912$$CN$US$US
243119501$24311950$1$I$$20240828$20240912$20240912$PER$$US-IMP-2024000697$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243119521$24311952$1$I$20240826$20240911$20240911$20240911$DIR$718047$$FDA-CTU$$10$YR$$F$N$39.7$KG$20240911$N$PH$US$
243119531$24311953$1$I$$20240909$20240912$20240912$EXP$$CA-BAYER-2024A129590$BAYER$$47$YR$A$F$Y$$$20240912$$HP$CA$CA
243119542$24311954$2$F$20240909$20240913$20240912$20240914$PER$$US-AMGEN-USASP2024181305$AMGEN$$81$YR$E$F$Y$$$20240914$$CN$US$US
243119552$24311955$2$F$20230630$20240919$20240912$20240927$EXP$FR-AFSSAPS-AM2024000691$FR-TEVA-VS-3239710$TEVA$$76$YR$$M$Y$95$KG$20240927$$HP$FR$FR
243119561$24311956$1$I$$20240911$20240911$20240911$DIR$718024$$FDA-CTU$$$$$F$N$$$20240911$N$PH$US$
243119571$24311957$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006442$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240912$$CN$US$US
243119581$24311958$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006609$ELI LILLY AND CO$$$$$$Y$$$20240912$$CN$US$US
243119591$24311959$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006746$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240912$$CN$US$US
243119601$24311960$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006217$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240912$$CN$US$US
243119611$24311961$1$I$$20240911$20240911$20240911$DIR$718062$$FDA-CTU$$$$$UNK$N$$$20240911$$CN$US$
243119621$24311962$1$I$20240910$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007354$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
243119631$24311963$1$I$20240903$20240903$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409001645$ELI LILLY AND CO$$35$YR$A$$Y$$$20240912$$CN$US$US
243119641$24311964$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006551$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$US$US
243119651$24311965$1$I$20240911$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007300$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240912$$HP$US$US
243119662$24311966$2$F$$20240917$20240912$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409005622$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240923$$CN$US$US
243119671$24311967$1$I$20240909$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007468$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240912$$CN$US$US
243119681$24311968$1$I$20240801$20240906$20240912$20240912$EXP$$US-ABBVIE-5916252$ABBVIE$$64$YR$$F$Y$$$20240912$$CN$US$US
243119691$24311969$1$I$20240821$20240911$20240912$20240912$EXP$$CN-BAYER-2024A130369$BAYER$$49$YR$A$F$Y$60$KG$20240912$$HP$CN$CN
243119701$24311970$1$I$$20240906$20240912$20240912$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001827$BLUEPRINT MEDICINES$$$$$F$Y$$$20240912$$CN$US$US
243119711$24311971$1$I$$20240906$20240912$20240912$PER$$US-AGIOS-2409US03878$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243119721$24311972$1$I$20240801$20240828$20240912$20240912$PER$$US-IMP-2024000695$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243119731$24311973$1$I$$20240820$20240912$20240912$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004909$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243119741$24311974$1$I$20190826$20240909$20240912$20240912$EXP$$CO-UCBSA-2024046651$UCB$$63$YR$$M$Y$$$20240912$$CN$CO$CO
243119751$24311975$1$I$$20240910$20240912$20240912$EXP$$AU-ABBVIE-5918212$ABBVIE$$$$$M$Y$$$20240912$$CN$AU$AU
243119761$24311976$1$I$$20240826$20240912$20240912$PER$$US-IMP-2024000678$Harrow Health$$$$E$M$Y$$$20240912$$CN$US$US
243119772$24311977$2$F$$20240912$20240912$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143583$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240913$$CN$US$US
243119782$24311978$2$F$20240615$20240917$20240912$20240922$EXP$$US-ABBVIE-5917228$ABBVIE$$69$YR$$M$Y$170$KG$20240922$$CN$US$US
243119791$24311979$1$I$$20240828$20240912$20240912$PER$$US-APOTEX-2024AP010149$APOTEX$$$$E$F$Y$$$20240912$$HP$US$US
243119801$24311980$1$I$20200501$20240829$20240912$20240912$EXP$$JP-Reliance-000416$RELIANCE GENEMEDIX$Horaguchi T, Tanaka Y, Sato Y, Yamamoto K, Fukada M, Yasufuku I, et.al. Successful direct oral anticoagulant management of asymptomatic superior mesenteric vein thrombosis after adjuvant chemotherapy for colorectal cancer patient: A case report. Exp Ther Med. 2024 Aug 8;28(4):396.$71$YR$E$F$Y$$$20240912$$HP$JP$JP
243119812$24311981$2$F$20240801$20240912$20240912$20240917$PER$$US-AMGEN-USASP2024181823$AMGEN$$77$YR$E$M$Y$$$20240917$$HP$US$US
243119821$24311982$1$I$20240821$20240906$20240912$20240912$EXP$$CA-ABBVIE-5914726$ABBVIE$$74$YR$$M$Y$$$20240912$$HP$CA$CA
243119831$24311983$1$I$20240715$20240829$20240912$20240912$EXP$FR-AFSSAPS-CF2024000417$FR-Axellia-005347$XELLIA PHARMACEUTICALS$$64$YR$A$M$Y$57$KG$20240912$$PH$FR$FR
243119841$24311984$1$I$$20240904$20240912$20240912$EXP$$US-VIIV HEALTHCARE LIMITED-US2024110171$VIIV$$$$$M$Y$$$20240912$$PH$US$US
243119871$24311987$1$I$20240903$20240906$20240912$20240912$EXP$$US-ABBVIE-5916039$ABBVIE$$92$YR$$M$Y$$$20240912$$CN$US$US
243119881$24311988$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5915932$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243119891$24311989$1$I$20240819$20240910$20240912$20240912$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005054$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240912$$CN$US$US
243119901$24311990$1$I$20240801$20240909$20240912$20240912$EXP$$CA-ABBVIE-5916713$ABBVIE$$$$A$M$Y$$$20240912$$CN$CA$CA
243119911$24311991$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5917252$ABBVIE$$$$$F$Y$$$20240912$$HP$US$US
243119921$24311992$1$I$$20240904$20240912$20240912$PER$$US-TAKEDA-2024TUS088597$TAKEDA$$$$$F$Y$$$20240912$$MD$US$US
243119941$24311994$1$I$$20240911$20240911$20240911$DIR$718008$$FDA-CTU$$$$$UNK$N$$$20240911$$CN$US$
243119951$24311995$1$I$$20240903$20240911$20240911$DIR$FDA-CDER-CTU-2024-62538$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
243119971$24311997$1$I$$20240906$20240912$20240912$EXP$$NVSC2024IN182113$NOVARTIS$Tewari P, Pande S, Arora D. Drug-Induced Acute Dystonia After Sacubitril/Valsartan Combination. ANNALS OF INTERNAL MEDICINE CLINICAL CASES. 2024;e230131:1-3$19$YR$$F$Y$$$20240912$$HP$IN$IN
243119982$24311998$2$F$20240906$20240913$20240912$20240917$PER$$US-HALEON-2196110$Haleon PLC$$63$YR$$F$Y$$$20240917$$CN$US$US
243119991$24311999$1$I$$20240910$20240912$20240912$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005074$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240912$$CN$US$US
243120011$24312001$1$I$$20240826$20240912$20240912$EXP$$US-CBFLEET-202409-US-002920$CB FLEET$$30$YR$A$F$Y$$$20240912$$CN$US$US
243120021$24312002$1$I$$20240905$20240912$20240912$PER$$US-RDY-SPO/USA/24/0013270$DR REDDYS$$49$YR$A$M$Y$$$20240912$$MD$US$US
243120031$24312003$1$I$20240905$20240905$20240912$20240912$PER$$US-RDY-SPO/USA/24/0013269$DR REDDYS$$17$YR$T$F$Y$$$20240912$$HP$US$US
243120041$24312004$1$I$$20240909$20240912$20240912$EXP$$CA-BAYER-2024A129994$BAYER$$58$YR$A$F$Y$$$20240912$$CN$CA$CA
243120051$24312005$1$I$20240908$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180962$AMGEN$$73$YR$E$F$Y$$$20240912$$CN$US$US
243120061$24312006$1$I$$20240911$20240912$20240912$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050921$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240912$$PH$JP$JP
243120071$24312007$1$I$20240701$20240909$20240912$20240912$EXP$$US-VIIV HEALTHCARE LIMITED-US2024111811$VIIV$$27$YR$$F$Y$$$20240912$$CN$US$US
243120081$24312008$1$I$$20240903$20240912$20240912$EXP$$CA-TEVA-VS-3240534$TEVA$$86$YR$$F$Y$$$20240912$$MD$CA$CA
243120091$24312009$1$I$$20240909$20240912$20240912$PER$$US-JNJFOC-20240926895$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240912$$HP$US$US
243120101$24312010$1$I$$20240911$20240912$20240912$PER$$US-JNJFOC-20240929188$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$US$US
243120111$24312011$1$I$20240101$20240903$20240912$20240912$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00829$MIRUM PHARMACEUTICALS$$$$$F$Y$32.66$KG$20240912$$CN$US$US
243120121$24312012$1$I$$20240902$20240912$20240912$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08255$HIKMA$$45$YR$$M$Y$84$KG$20240912$$HP$CA$CA
243120132$24312013$2$F$20190719$20240924$20240912$20240926$EXP$$CO-UCBSA-2024046637$UCB$$56$YR$$F$Y$60$KG$20240926$$CN$CO$CO
243120141$24312014$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62547$$FDA-CTU$$40$YR$$F$N$$$20240911$N$$US$
243120161$24312016$1$I$$20240903$20240912$20240912$EXP$$CA-ROCHE-10000072596$ROCHE$$$$$M$Y$$$20240912$$MD$CA$CA
243120171$24312017$1$I$$20240911$20240911$20240911$DIR$718053$$FDA-CTU$$$$$UNK$N$$$20240911$$CN$US$
243120181$24312018$1$I$20240910$20240911$20240911$20240911$DIR$718012$$FDA-CTU$$68$YR$$F$N$49$KG$20240911$N$PH$US$
243120191$24312019$1$I$$20240905$20240912$20240912$EXP$$US-JNJFOC-20240920072$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240912$$CN$US$US
243120211$24312021$1$I$20240809$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62560$$FDA-CTU$$64$YR$$F$N$$$20240911$N$$US$
243120222$24312022$2$F$20240829$20240829$20240912$20240913$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240800107$UPSHER SMITH LABORATORIES$$20$YR$$F$Y$$$20240913$$MD$US$US
243120231$24312023$1$I$$20240903$20240912$20240912$EXP$$CA-TEVA-VS-3240562$TEVA$$65$YR$$F$Y$$$20240912$$HP$CA$CA
243120241$24312024$1$I$20240904$20240905$20240912$20240912$PER$$KR-BRACCO-2024KR05632$BRACCO$$40$YR$$F$Y$$$20240912$$HP$KR$KR
243120251$24312025$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182816$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
243120261$24312026$1$I$20240910$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024181934$AMGEN$$65$YR$E$F$Y$$$20240912$$CN$US$US
243120281$24312028$1$I$20240821$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024180694$AMGEN$$72$YR$E$F$Y$$$20240912$$CN$US$US
243120292$24312029$2$F$20240908$20240909$20240912$20240916$PER$$US-AMGEN-USASP2024180000$AMGEN$$74$YR$E$F$Y$$$20240916$$CN$US$US
243120301$24312030$1$I$$20240903$20240912$20240912$EXP$$CA-TEVA-VS-3240278$TEVA$$35$YR$$F$Y$72$KG$20240912$$CN$CA$CA
243120311$24312031$1$I$$20240911$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145353$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240912$$CN$US$US
243120321$24312032$1$I$$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145322$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240912$$CN$US$US
243120331$24312033$1$I$20240905$20240906$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142513$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240912$$CN$US$US
243120341$24312034$1$I$$20240906$20240912$20240912$PER$$US-ABBVIE-5913954$ABBVIE$$$$$$Y$$$20240912$$HP$US$US
243120351$24312035$1$I$$20240902$20240912$20240912$EXP$$JP-ROCHE-10000076212$ROCHE$Miura R, Ono A, Yano S, Amioka K, Naruto K, Yamaoka K, et al. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine. 2024-Aug-23;103 (34):1-8. doi:10.1097/MD.0000000000039289.$$$$$Y$$$20240912$$MD$JP$JP
243120362$24312036$2$F$$20240917$20240912$20240926$EXP$$US-TEVA-VS-3240146$TEVA$Aamer S, Rajan A, Arora S. VASCULAR THREADS AND NEPHRON NESTS: EXPLORING THE ASSOCIATION BETWEEN TAKAYASU ARTERITIS AND MEMBRANOUS NEPHROPATHY. Eur-J-Case-Rep-Intern-Med 2024; 11 (8):.; Aamer S, Rajan A, Arora S. VASCULAR THREADS AND NEPHRON NESTS: EXPLORING THE ASSOCIATION BETWEEN TAKAYASU ARTERITIS AND MEMBRANOUS NEPHROPATHY. Eur-J-Case-Rep-Intern-Med 2024; 11 (8):.$$$A$F$Y$$$20240926$$HP$US$US
243120371$24312037$1$I$$20240910$20240912$20240912$PER$$US-JNJFOC-20240927726$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243120381$24312038$1$I$20240831$20240909$20240912$20240912$EXP$$CN-ROCHE-10000077576$ROCHE$$51$YR$A$F$Y$55$KG$20240912$$HP$CN$CN
243120391$24312039$1$I$20240101$20240902$20240912$20240912$EXP$$BR-TEVA-VS-3240516$TEVA$$$$$$Y$$$20240912$$PH$BR$BR
243120401$24312040$1$I$20231016$20231115$20240912$20240912$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2023-006001$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240912$$HP$US$US
243120411$24312041$1$I$20231001$20240904$20240912$20240912$EXP$IT-MINISAL02-1000119$IT-TEVA-VS-3241106$TEVA$$52$YR$$F$Y$100$KG$20240912$$PH$IT$IT
243120431$24312043$1$I$20240830$20240830$20240912$20240912$EXP$$PE-UCBSA-2024045534$UCB$$18$YR$$F$Y$$$20240912$$CN$PE$PE
243120442$24312044$2$F$20240101$20240903$20240912$20240913$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240900115$UPSHER SMITH LABORATORIES$$$$$$Y$$$20240913$$MD$US$US
243120451$24312045$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA261727$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240912$$HP$US$US
243120461$24312046$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA263045$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240912$$HP$US$US
243120471$24312047$1$I$$20240826$20240912$20240912$PER$$US-SA-2024SA263344$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$MD$US$US
243120491$24312049$1$I$20240712$20240905$20240912$20240912$PER$$US-BAYER-2024A127675$BAYER$$24$YR$A$F$Y$$$20240912$$HP$US$US
243120501$24312050$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62555$$FDA-CTU$$63$YR$$F$N$$$20240911$N$$US$
243120521$24312052$1$I$$20240911$20240911$20240911$DIR$718039$$FDA-CTU$$$$$UNK$N$$$20240911$N$CN$US$
243120531$24312053$1$I$$20240811$20240912$20240912$EXP$$US-CBFLEET-202409-US-002906$CB FLEET$$72$YR$E$F$Y$$$20240912$$CN$US$US
243120541$24312054$1$I$$20240911$20240912$20240912$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050860$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240912$$HP$CA$CA
243120551$24312055$1$I$$20240907$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143028$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$71.67$KG$20240912$$CN$US$US
243120562$24312056$2$F$20231207$20240914$20240912$20240920$EXP$$CA-GSK-CA2023174595$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$PH$CA$CA
243120572$24312057$2$F$$20240911$20240912$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144345$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240913$$CN$US$US
243120581$24312058$1$I$20240725$20240903$20240912$20240912$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-140491$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$80$KG$20240912$$MD$PL$PL
243120591$24312059$1$I$$20240906$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144314$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240912$$MD$US$US
243120602$24312060$2$F$$20240911$20240912$20240913$PER$$NVSC2024US182648$NOVARTIS$$$$$M$Y$$$20240913$$HP$US$US
243120611$24312061$1$I$$20240907$20240912$20240912$EXP$$AR-MYLANLABS-2024M1082592$MYLAN$$$$$M$Y$$$20240912$$MD$AR$AR
243120621$24312062$1$I$$20240820$20240912$20240912$PER$$US-SA-2023SA036279$SANOFI AVENTIS$$$$T$F$Y$$$20240912$$MD$US$US
243120641$24312064$1$I$$20240820$20240912$20240912$PER$$US-SA-2024SA263012$SANOFI AVENTIS$$$$C$M$Y$13.69$KG$20240912$$MD$US$US
243120661$24312066$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA260442$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240912$$MD$US$US
243120671$24312067$1$I$20240601$20240905$20240912$20240912$PER$$US-SA-2024SA262749$SANOFI AVENTIS$$$$$M$Y$$$20240912$$MD$US$US
243120681$24312068$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262170$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240912$$HP$US$US
243120691$24312069$1$I$20220920$20240911$20240911$20240911$DIR$718082$$FDA-CTU$$39$YR$$F$N$69.75$KG$20240911$N$CN$US$
243120701$24312070$1$I$$20240911$20240911$20240911$DIR$718041$$FDA-CTU$$$$$F$N$$$20240911$Y$HP$US$
243120711$24312071$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006693$ELI LILLY AND CO$$$$A$M$Y$$$20240912$$CN$US$US
243120721$24312072$1$I$$20240904$20240912$20240912$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08371$HIKMA$$$$$$Y$$$20240912$$CN$US$US
243120731$24312073$1$I$$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024181834$AMGEN$$$$$$Y$$$20240912$$CN$US$US
243120741$24312074$1$I$20240910$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181911$AMGEN$$44$YR$A$M$Y$$$20240912$$CN$US$US
243120751$24312075$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182808$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
243120761$24312076$1$I$$20240904$20240912$20240912$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08451$HIKMA$Ansari A, Dirani K, Malik A, Matthews S.. Ansari A, Dirani K, Malik A, Matthews S. Silent Manifestations of Disseminated Nocardia in a Renal Transplant Patient. Cureus. 2024;16(7):e65523$$$$$Y$$$20240912$$MD$US$US
243120781$24312078$1$I$20240831$20240908$20240912$20240912$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001822$BLUEPRINT MEDICINES$$20$YR$A$F$Y$$$20240912$$CN$US$US
243120791$24312079$1$I$20240727$20240910$20240912$20240912$EXP$$KR-AstraZeneca-2024A208159$ASTRAZENECA$$49$YR$$M$Y$$$20240912$$CN$KR$
243120801$24312080$1$I$$20240904$20240912$20240912$EXP$$BR-AstraZeneca-2024A204658$ASTRAZENECA$$86$YR$$M$Y$$$20240912$$MD$BR$
243120811$24312081$1$I$20171120$20240905$20240912$20240912$EXP$$DE-ROCHE-2264161$ROCHE$$$$A$M$Y$$$20240912$$MD$DE$DE
243120821$24312082$1$I$$20240905$20240912$20240912$EXP$$SI-ROCHE-10000075018$ROCHE$Janzic U, Rabinovich N, Shalata W, Kian W, Szymczak K, Dziadziuszko R, et al. Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study). Current Oncology. 2024-Aug;31 (8):4369-4381. doi:10.3390/curroncol31080326.$$$$$Y$$$20240912$$HP$SI$SI
243120831$24312083$1$I$$20240910$20240912$20240912$EXP$$CN-GILEAD-2024-0687239$GILEAD$$$$$$Y$$$20240912$$CN$CN$CN
243120851$24312085$1$I$$20240910$20240912$20240912$EXP$$GR-ALXN-202409EEA000685GR$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$MD$GR$GR
243120861$24312086$1$I$20240909$20240910$20240912$20240912$EXP$$JP-ALXN-202409JPN000550JP$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240912$$MD$JP$JP
243120871$24312087$1$I$20240501$20240906$20240912$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014528$JAZZ$$78$YR$$F$Y$$$20240912$$CN$US$US
243120882$24312088$2$F$20240919$20240924$20240912$20240926$EXP$$IE-ROCHE-10000030916$ROCHE$$$$$F$Y$$$20240926$$CN$IE$IE
243120891$24312089$1$I$20240101$20240909$20240912$20240912$PER$$US-009507513-2409USA003292$MERCK$$$$$F$Y$61.2$KG$20240912$$HP$US$US
243120901$24312090$1$I$$20240902$20240912$20240912$EXP$$US-MYLANLABS-2024M1081777$MYLAN$Karakus KE, Shah VN, Akturk HK. Tirzepatide-Induced Rapid Weight Loss-Related Thyrotoxicosis. JAMA-Intern-Med 2024;.$62$YR$$M$Y$93$KG$20240912$$MD$US$US
243120911$24312091$1$I$$20240904$20240912$20240912$EXP$$IT-MYLANLABS-2024M1082496$MYLAN$Ambrosecchia M, Miglio M, Di Francesco P, Furlan L, Montano N. A Rare Cause Of Lung Pseudotumor. Eur-J-Case-Rep-Intern-Med 2024; 11 (Suppl. 1) 877 abstr. 1411.$50$YR$$F$Y$$$20240912$$HP$IT$IT
243120921$24312092$1$I$$20240902$20240912$20240912$EXP$$CH-MYLANLABS-2024M1079869$MYLAN$$47$YR$$M$Y$87$KG$20240912$$CN$CH$CH
243120931$24312093$1$I$$20240908$20240912$20240912$EXP$$US-ABBVIE-5918064$ABBVIE$$56$YR$$F$Y$$$20240912$$CN$US$US
243120961$24312096$1$I$$20240906$20240912$20240912$PER$$US-AstraZeneca-2024A204346$ASTRAZENECA$$$$$$Y$$$20240912$$CN$US$
243120971$24312097$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-202400254117$PFIZER$$57$YR$$F$Y$$$20240912$$MD$US$US
243120981$24312098$1$I$$20240911$20240912$20240912$PER$$US-PFIZER INC-202400254752$PFIZER$$14$YR$$M$Y$$$20240912$$HP$US$US
243120991$24312099$1$I$$20240909$20240912$20240912$PER$$US-PFIZER INC-PV202400118848$PFIZER$$59$YR$$M$Y$$$20240912$$HP$US$US
243121001$24312100$1$I$$20240904$20240912$20240912$EXP$$IN-MYLANLABS-2024M1082494$MYLAN$Kumar NM, Bhargava R, Rastogi N, Yadav C, Swaminathan A, Garg P, et al. ALL-766 Asciminib as a Bridge to Allogenic Transplant in 3 Patients With Relapsed/Refractory Philadelphia Chromosome-positive ALL or CML Lymphoid Blast Crisis Refractory/Intolerant to Ponatinib. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl. 1) S283-S284.$$$$M$Y$$$20240912$$MD$IN$IN
243121011$24312101$1$I$20240501$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202300104496$PFIZER$$52$YR$$F$Y$$$20240912$$HP$US$US
243121021$24312102$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202400119566$PFIZER$$27$YR$$F$Y$$$20240912$$HP$US$US
243121041$24312104$1$I$20230701$20240910$20240912$20240912$PER$$US-PFIZER INC-202400254824$PFIZER$$76$YR$$F$Y$$$20240912$$MD$US$US
243121051$24312105$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202400119309$PFIZER$$63$YR$$M$Y$$$20240912$$HP$US$US
243121061$24312106$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-202400254868$PFIZER$$19$YR$$F$Y$$$20240912$$CN$US$US
243121071$24312107$1$I$$20240910$20240912$20240912$EXP$$NVSC2024GB182306$NOVARTIS$$$$$F$Y$$$20240912$$CN$GB$GB
243121081$24312108$1$I$$20240902$20240912$20240912$PER$$US-RDY-SPO/USA/24/0013094$DR REDDYS$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 101: doi:10.1016/j.jflm.2023.102625.$65$YR$E$$Y$$$20240912$$HP$US$US
243121091$24312109$1$I$$20240905$20240912$20240912$PER$US-MLMSERVICE-20240830-PI176469-00128-1$US-RDY-SPO/USA/24/0013070$DR REDDYS$Khurshid A, Steinberg A. IBCL-483 First Reported Use of Polatuzumab-RCHP in Follicular Lymphoma, With Excellent Response. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(Supplement 1):S499. DOI:10.1016/S2152-2650(24)01567-2.$70$YR$E$M$Y$$$20240912$$MD$US$US
243121101$24312110$1$I$$20240905$20240912$20240912$PER$$US-RDY-SPO/USA/24/0013033$DR REDDYS$$55$YR$A$F$Y$$$20240912$$HP$US$US
243121111$24312111$1$I$$20240910$20240912$20240912$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050690$BOEHRINGER INGELHEIM$$$$$$Y$$$20240912$$PH$US$US
243121121$24312112$1$I$$20240910$20240912$20240912$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050643$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240912$$HP$US$US
243121131$24312113$1$I$$20240906$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145166$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240912$$CN$US$US
243121151$24312115$1$I$$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144628$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240912$$CN$US$US
243121161$24312116$1$I$$20240904$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143826$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240912$$HP$US$US
243121171$24312117$1$I$$20240816$20240912$20240912$30DAY$$US-Kaleo, Inc.-2024KL000034$KALEO$$5$YR$C$F$Y$$$20240911$$CN$US$US
243121181$24312118$1$I$$20240905$20240912$20240912$EXP$$US-RIGEL-20240900035$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243121191$24312119$1$I$20240729$20240905$20240912$20240912$EXP$$US-RIGEL-20240900027$RIGEL PHARMACEUTICALS$$67$YR$$M$Y$$$20240912$$CN$US$US
243121201$24312120$1$I$20240828$20240906$20240912$20240912$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900034$RIGEL PHARMACEUTICALS$$83$YR$$F$Y$75.296$KG$20240912$$CN$US$US
243121211$24312121$1$I$$20240906$20240912$20240912$EXP$$DE-ALCON LABORATORIES-ALC2024DE004130$ALCON$$$$$$Y$$$20240912$$HP$DE$DE
243121222$24312122$2$F$20240903$20240906$20240912$20240917$PER$$US-AMGEN-USASP2024178529$AMGEN$$62$YR$A$M$Y$$$20240917$$CN$US$US
243121231$24312123$1$I$$20240828$20240912$20240912$PER$$US-APOTEX-2024AP010180$APOTEX$D^Netto M, Kuhn A, Ferdjallah A, Joshi A.. ALPS like: Trekking Sirolimus and its Fallouts. Clinical Immunology. 2023;250 (Suppl.):109547 (116-117)$3$YR$$M$Y$$$20240912$$HP$US$US
243121241$24312124$1$I$20240911$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62552$$FDA-CTU$$72$YR$$M$N$$$20240911$Y$PH$US$
243121271$24312127$1$I$$20240818$20240912$20240912$30DAY$$US-Kaleo, Inc.-2024KL000035$KALEO$$18$YR$A$M$Y$$$20240911$$CN$US$US
243121281$24312128$1$I$$20240910$20240912$20240912$PER$$US-ABBVIE-5919325$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243121291$24312129$1$I$$20240906$20240912$20240912$PER$$US-JNJFOC-20240922553$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
243121301$24312130$1$I$$20240829$20240912$20240912$30DAY$$SA-JNJFOC-20240911492$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$SA$SA
243121311$24312131$1$I$$20240908$20240912$20240912$PER$$US-JNJFOC-20240923650$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240912$$CN$US$US
243121321$24312132$1$I$$20240911$20240911$20240911$DIR$717989$$FDA-CTU$$$$$UNK$N$$$20240911$$CN$US$
243121331$24312133$1$I$$20240907$20240912$20240912$EXP$$PL-VELOXIS PHARMACEUTICALS, INC.-2020-VEL-00328$VELOXIS PHARMACEUTICALS$Witkowski G, MatejakG?rska M, Durlik M.. Severe infection with skin necrosis of the leg after simultaneous pancreas and kidney transplantation. Case report.. Transplantation reports. 2020;5(3)$37$YR$$M$Y$$$20240912$$MD$PL$PL
243121341$24312134$1$I$20240801$20240905$20240912$20240912$EXP$$JP-009507513-2409JPN000959J$MERCK$$$$E$$Y$$$20240912$$MD$JP$JP
243121351$24312135$1$I$$20240905$20240912$20240912$PER$$US-MYLANLABS-2024M1082722$MYLAN$$$$$F$Y$$$20240912$$CN$US$US
243121361$24312136$1$I$$20240906$20240912$20240912$PER$$US-ROCHE-10000077219$ROCHE$$78$YR$E$M$Y$$$20240912$$CN$US$US
243121372$24312137$2$F$20240902$20240916$20240912$20240925$EXP$$AR-AKCEA THERAPEUTICS, INC.-2024IS006449$AKCEA THERAPEUTICS$$$$$$Y$$$20240924$$CN$AR$AR
243121381$24312138$1$I$$20240904$20240912$20240912$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR112921$VIIV$$$$$$Y$$$20240912$$HP$US$US
243121392$24312139$2$F$20220101$20240914$20240912$20240919$PER$$US-ROCHE-10000076915$ROCHE$$90$YR$E$F$Y$$$20240919$$CN$US$US
243121411$24312141$1$I$$20240906$20240912$20240912$PER$$US-ABBVIE-5914731$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243121422$24312142$2$F$20240824$20240912$20240912$20240919$PER$GB-MHRA-MED-202409031136567470-QFDWM$GB-ALMUS-GB-2024-2363$ALMUS$$77$YR$E$M$Y$72$KG$20240919$$CN$GB$GB
243121431$24312143$1$I$20240821$20240822$20240912$20240912$PER$$US-LEX-000455$LEXICON PHARMACEUTICALS$$76$YR$$M$Y$$$20240912$$CN$US$US
243121441$24312144$1$I$$20240902$20240912$20240912$EXP$$SZ-CARNEGIE-000055$Carnegie Pharmaceuticals$$69$YR$E$F$Y$$$20240906$$HP$SZ$SZ
243121451$24312145$1$I$$20240902$20240912$20240912$EXP$$TR-CARNEGIE-000031$Carnegie Pharmaceuticals$$7$YR$C$F$Y$$$20240905$$MD$TR$TR
243121461$24312146$1$I$$20240902$20240912$20240912$EXP$$IT-CARNEGIE-000049$Carnegie Pharmaceuticals$$46$YR$A$F$Y$$$20240906$$MD$IT$IT
243121471$24312147$1$I$$20240902$20240912$20240912$EXP$$US-CARNEGIE-000039$Carnegie Pharmaceuticals$$14$YR$T$M$Y$47.1$KG$20240905$$HP$US$US
243121481$24312148$1$I$$20240902$20240912$20240912$EXP$$OM-CARNEGIE-000029$Carnegie Pharmaceuticals$$62$YR$A$F$Y$$$20240905$$MD$OM$OM
243121491$24312149$1$I$$20240902$20240912$20240912$EXP$$JP-CARNEGIE-000040$Carnegie Pharmaceuticals$$42$YR$A$F$Y$$$20240905$$MD$JP$JP
243121501$24312150$1$I$$20240902$20240912$20240912$EXP$$PT-CARNEGIE-000038$Carnegie Pharmaceuticals$$69$YR$E$F$Y$$$20240905$$MD$PT$PT
243121511$24312151$1$I$20240825$20240906$20240912$20240912$EXP$$US-BEH-2024178327$CSL BEHRING$$72$YR$E$F$Y$$$20240912$$HP$US$US
243121521$24312152$1$I$20220101$20240902$20240912$20240912$EXP$$PT-CARNEGIE-000043$Carnegie Pharmaceuticals$$51$YR$A$F$Y$$$20240906$$MD$PT$PT
243121531$24312153$1$I$$20240827$20240912$20240912$PER$$US-Covis Pharma GmbH-2024COV01065$COVIS PHARMA$$72$YR$E$F$Y$$$20240912$$CN$US$US
243121541$24312154$1$I$20240205$20240902$20240912$20240912$PER$$GR-Covis Pharma GmbH-2024COV01085$COVIS PHARMA$$72$YR$E$M$Y$78$KG$20240912$$HP$GR$GR
243121551$24312155$1$I$$20240902$20240912$20240912$EXP$$IN-MYLANLABS-2024M1081798$MYLAN$Nanjappa H, Rodrigues AJ. Atrial Fibrillation Secondary to Levothyroxine Overdose with Underlying Secondary Infection. J-Assoc-Physicians-India 2024; 72 (8): 96-98.$62$YR$$F$Y$$$20240912$$HP$IN$IN
243121561$24312156$1$I$$20240831$20240912$20240912$EXP$$IT-Accord-445131$ACCORD$Borotti E, Ronda E, Guidotti S, Scarpa A, Schiro A, Cortellazzi P, et al. Genetic molecular profile in Chronic Myelomonocytic leukemia (CMML) patient from onset to post-transplant relapse a case report. Haematologica 2024; 109 (Suppl.) 90 abstr. P067.$57$YR$A$F$Y$$$20240912$$HP$IT$IT
243121571$24312157$1$I$20240822$20240910$20240912$20240912$EXP$$UA-MYLANLABS-2024M1083142$MYLAN$$52$YR$$F$Y$$$20240912$$HP$UA$UA
243121581$24312158$1$I$$20240830$20240912$20240912$PER$$US-COSETTE-CP2024US000236$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243121591$24312159$1$I$$20240904$20240912$20240912$EXP$$US-MYLANLABS-2024M1082523$MYLAN$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B, et al. AML-713 Hematological Malignancies and Pregnancy: A Single-Institution Experience. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl. 1) S333-S334 abstr. AML-713.$$$$F$Y$$$20240912$$MD$US$US
243121601$24312160$1$I$20240521$20240830$20240912$20240912$EXP$FR-AFSSAPS-PV2024000806$FR-BEH-2024178176$CSL BEHRING$$67$YR$E$F$Y$50$KG$20240912$$MD$FR$FR
243121611$24312161$1$I$20240404$20240911$20240912$20240912$EXP$$NVSC2024IE073522$NOVARTIS$$62$YR$$F$Y$$$20240912$$HP$IE$IE
243121622$24312162$2$F$20240101$20240904$20240912$20240914$EXP$$US-UCBSA-2024012777$UCB$$$$$F$Y$$$20240914$$CN$US$US
243121641$24312164$1$I$$20240904$20240912$20240912$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-17751$IPSEN$$$$$F$Y$81.1$KG$20240912$$HP$US$US
243121651$24312165$1$I$$20240902$20240912$20240912$EXP$$GB-TEVA-VS-3239305$TEVA$$87$YR$$F$Y$77$KG$20240912$$MD$GB$GB
243121661$24312166$1$I$20121210$20240902$20240912$20240912$EXP$$US-CARNEGIE-000054$Carnegie Pharmaceuticals$$74$YR$E$F$Y$$$20240906$$MD$US$US
243121672$24312167$2$F$$20240917$20240912$20240918$EXP$$JP-BAYER-2024A130210$BAYER$$5$DEC$A$M$Y$$$20240918$$MD$JP$JP
243121681$24312168$1$I$$20240904$20240912$20240912$EXP$$IN-RDY-SPO/IND/24/0013217$DR REDDYS$Ganju N, Panda T, Oberoi G, Agarwal M, Mahapatra M. AML-083 AML in Pregnancy: Case Series. Clinical Lymphoma, Myeloma and Leukemia. 2024;24: S293. doi:10.1016/S2152-2650%2824%2901157-1.$$$$F$Y$$$20240912$$MD$IN$IN
243121691$24312169$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144508$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$85.73$KG$20240912$$CN$US$US
243121701$24312170$1$I$$20240905$20240912$20240912$EXP$$EG-MYLANLABS-2024M1082931$MYLAN$Atef M. HL-128 Simultaneous Hodgkin Lymphoma Diagnosis in 2 Sisters: Is This a Coincidence?. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl. 1) S445.$23$YR$$F$Y$$$20240912$$HP$EG$EG
243121711$24312171$1$I$20240101$20240829$20240912$20240912$EXP$$US-UCBSA-2024015334$UCB$$$$$F$Y$56.9$KG$20240912$$CN$US$US
243121721$24312172$1$I$$20240909$20240912$20240912$PER$$US-JNJFOC-20240924080$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243121731$24312173$1$I$20230826$20240901$20240912$20240912$EXP$$CN-INFO-20240269$INFORLIFE$Liao L, Zhang Z. Severe sepsis induced by zoledronic acid: A case report. Medicine (Baltimore). 2024 Aug 30;103(35):e39188. doi: 10.1097/MD.0000000000039188. PMID: 39213240; PMCID: PMC11365655.$58$YR$A$F$Y$$$20240903$$MD$CN$CN
243121741$24312174$1$I$$20240822$20240912$20240912$EXP$$US-SA-2024SA262800$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240912$$MD$US$US
243121751$24312175$1$I$$20240904$20240912$20240912$EXP$$US-TEVA-VS-3240244$TEVA$$$$$$Y$$$20240912$$CN$US$US
243121761$24312176$1$I$$20240823$20240912$20240912$PER$$US-TEVA-VS-3237725$TEVA$$22$YR$$F$Y$$$20240912$$CN$US$US
243121771$24312177$1$I$$20240809$20240912$20240912$EXP$$US-TEVA-VS-3238814$TEVA$$65$YR$$F$Y$$$20240912$$HP$US$US
243121791$24312179$1$I$20240908$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006237$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240912$$CN$US$US
243121801$24312180$1$I$$20240904$20240912$20240912$EXP$$IN-MYLANLABS-2024M1082500$MYLAN$Tripathi S, Balraam V, Ranjan Nayak A, Naranje P, Chauhan R, Dass J, et al. CML-754 Ischemic Stroke as a Presenting Feature of Promyelocytic Blast Phase in Chronic Myeloid Leukemia - an Uncommon Presentation of an Exceptionally Rare Blastic Transformation of Myeloproliferative Neoplasm. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl.) S384-S385.$45$YR$$F$Y$$$20240912$$MD$IN$IN
243121811$24312181$1$I$20240615$20240911$20240912$20240912$EXP$$CN-BAYER-2024A130294$BAYER$$51$YR$A$F$Y$62$KG$20240912$$HP$CN$CN
243121821$24312182$1$I$$20240903$20240912$20240912$PER$$US-APOTEX-2024AP010278$APOTEX$Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N.. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.. The American Journal of Gastroenterology. 2024;119:200-202$$$A$$Y$$$20240912$$MD$US$US
243121831$24312183$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA263188$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$HP$US$US
243121841$24312184$1$I$20180101$20240828$20240912$20240912$PER$$US-SA-2024SA262687$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240912$$MD$US$US
243121852$24312185$2$F$$20240912$20240912$20240927$PER$$US-SA-2024SA263477$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240927$$MD$US$US
243121861$24312186$1$I$20240201$20240904$20240912$20240912$PER$$US-SA-2024SA263281$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240912$$HP$US$US
243121871$24312187$1$I$$20240830$20240912$20240912$EXP$$US-UCBSA-2024044549$UCB$$$$$F$Y$$$20240912$$CN$US$US
243121881$24312188$1$I$$20240911$20240912$20240912$PER$$US-ROCHE-10000079970$ROCHE$$$$A$F$Y$$$20240912$$CN$US$US
243121891$24312189$1$I$$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181372$AMGEN$$73$YR$E$F$Y$$$20240912$$CN$US$US
243121901$24312190$1$I$$20240909$20240912$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014664$JAZZ$$$$$M$Y$$$20240912$$CN$US$US
243121911$24312191$1$I$$20240907$20240912$20240912$PER$$US-AMGEN-USASP2024180067$AMGEN$$$$$M$Y$$$20240912$$CN$US$US
243121921$24312192$1$I$$20240909$20240912$20240912$EXP$$CN-ROCHE-10000077230$ROCHE$$8$YR$C$M$Y$20$KG$20240912$$CN$CN$CN
243121931$24312193$1$I$$20240911$20240912$20240912$EXP$$US-BAYER-2024A130504$BAYER$$$$$$Y$$$20240912$$CN$US$US
243121941$24312194$1$I$20220101$20240905$20240912$20240912$EXP$$IT-009507513-2409ITA002972$MERCK$$$$$M$Y$$$20240912$$MD$IT$IT
243121951$24312195$1$I$$20240902$20240912$20240912$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-027984$UNITED THERAPEUTICS$Sowa H, et al.. A case of developing pulmonary hypertension during treatment of ulcerative colitis with Qing Dai. J. Jpn. Soc. Intern. Med.. 2024;113(8):1428-1432$29$YR$$F$Y$49.9$KG$20240912$$MD$JP$JP
243121961$24312196$1$I$20240701$20240909$20240912$20240912$EXP$$AR-JNJFOC-20240924658$JOHNSON AND JOHNSON$$81$YR$E$F$Y$60$KG$20240912$$CN$AR$AR
243121971$24312197$1$I$20240906$20240906$20240912$20240912$PER$$US-JNJFOC-20240918070$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$US$US
243121981$24312198$1$I$20240716$20240816$20240912$20240912$30DAY$$CA-JNJFOC-20240927730$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240912$$PH$CA$CA
243121991$24312199$1$I$20240902$20240903$20240912$20240912$EXP$$GB-TEVA-VS-3241467$TEVA$$42$YR$$F$Y$$$20240912$$HP$GB$GB
243122001$24312200$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA261489$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240912$$HP$US$US
243122011$24312201$1$I$20240801$20240904$20240912$20240912$PER$$US-SA-2024SA264003$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240912$$MD$US$US
243122021$24312202$1$I$20230801$20240828$20240912$20240912$PER$$US-SA-2024SA260206$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240912$$HP$US$US
243122031$24312203$1$I$$20240905$20240912$20240912$EXP$$IN-ROCHE-10000075987$ROCHE$$70$YR$E$M$Y$$$20240912$$CN$IN$IN
243122052$24312205$2$F$$20240913$20240912$20240917$PER$$US-PFIZER INC-PV202400119214$PFIZER$$$$$$Y$$$20240917$$CN$US$US
243122061$24312206$1$I$20240101$20240905$20240912$20240912$PER$$US-UNITED THERAPEUTICS-UNT-2024-028157$UNITED THERAPEUTICS$$$$$F$Y$60.771$KG$20240912$$$US$US
243122071$24312207$1$I$20240911$20240911$20240912$20240912$PER$$US-PFIZER INC-202400254786$PFIZER$$29$YR$$F$Y$$$20240912$$HP$US$US
243122081$24312208$1$I$20240910$20240911$20240912$20240912$PER$$US-PFIZER INC-202400255017$PFIZER$$48$YR$$F$Y$$$20240912$$CN$US$US
243122091$24312209$1$I$$20240911$20240912$20240912$PER$$US-PFIZER INC-202400255024$PFIZER$$36$YR$$F$Y$$$20240912$$CN$US$US
243122101$24312210$1$I$20240911$20240911$20240912$20240912$PER$$US-PFIZER INC-202400255025$PFIZER$$78$YR$$M$Y$$$20240912$$CN$US$US
243122111$24312211$1$I$20240829$20240911$20240912$20240912$PER$$US-PFIZER INC-202400212727$PFIZER$$39$YR$$F$Y$$$20240912$$CN$US$US
243122121$24312212$1$I$$20240909$20240912$20240912$PER$$US-PFIZER INC-202400253804$PFIZER$$79$YR$$F$Y$$$20240912$$MD$US$US
243122131$24312213$1$I$20240904$20240909$20240912$20240912$PER$$US-PFIZER INC-202400253435$PFIZER$$32$YR$$F$Y$$$20240912$$CN$US$US
243122141$24312214$1$I$$20240906$20240912$20240912$PER$$US-PFIZER INC-PV202400118074$PFIZER$$$$$$Y$$$20240912$$MD$US$US
243122152$24312215$2$F$$20240917$20240912$20240920$PER$$US-PFIZER INC-PV202400119186$PFIZER$$87$YR$$M$Y$$$20240920$$MD$US$US
243122161$24312216$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202400119342$PFIZER$$$$$M$Y$$$20240912$$CN$US$US
243122171$24312217$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202400119560$PFIZER$$62$YR$$F$Y$69.388$KG$20240912$$HP$US$US
243122181$24312218$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202400100387$PFIZER$$45$YR$$F$Y$$$20240912$$HP$US$US
243122192$24312219$2$F$$20240916$20240912$20240919$PER$$US-PFIZER INC-202400254830$PFIZER$$71$YR$$F$Y$$$20240919$$CN$US$US
243122201$24312220$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202400072343$PFIZER$$47$YR$$F$Y$$$20240912$$HP$US$US
243122211$24312221$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-202400253887$PFIZER$$$$$M$Y$$$20240912$$MD$US$US
243122232$24312223$2$F$20240910$20240911$20240912$20240913$PER$$US-PFIZER INC-202400254733$PFIZER$$84$YR$$M$Y$97.52$KG$20240913$$CN$US$US
243122241$24312224$1$I$$20240909$20240912$20240912$PER$$US-PFIZER INC-PV202400118386$PFIZER$$54$YR$$M$Y$$$20240912$$CN$US$US
243122262$24312226$2$F$20240901$20240910$20240912$20240919$PER$$US-MYLANLABS-2024M1082633$MYLAN$$68$YR$$M$Y$92.98$KG$20240919$$CN$US$US
243122271$24312227$1$I$$20240908$20240912$20240912$PER$$US-BAYER-2024A129302$BAYER$$$$$$Y$$$20240912$$CN$US$US
243122281$24312228$1$I$$20240904$20240912$20240912$EXP$$IN-RDY-SPO/IND/24/0013300$DR REDDYS$Ganju N, Panda T, Oberoi G, Agarwal M, Mahapatra M. AML-083 AML in Pregnancy: Case Series. Clinical Lymphoma, Myeloma and Leukemia. 2024;24: S293. doi:10.1016/S2152-2650%2824%2901157-1.$$$$F$Y$$$20240912$$MD$IN$IN
243122291$24312229$1$I$$20240909$20240912$20240912$EXP$$US-ALXN-202409USA000507US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243122301$24312230$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144395$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240912$$HP$US$US
243122311$24312231$1$I$20240901$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145327$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$69.85$KG$20240912$$CN$US$US
243122332$24312233$2$F$$20240910$20240912$20240913$PER$$NVSC2024US181498$NOVARTIS$$$$$$Y$$$20240913$$CN$US$US
243122341$24312234$1$I$$20240830$20240912$20240912$PER$$US-COSETTE-CP2024US000237$COSETTE PHARMACEUTICALS$$7$DEC$$$Y$50.34$KG$20240912$$CN$US$US
243122371$24312237$1$I$20231108$20240902$20240912$20240912$EXP$IT-MINISAL02-995646$IT-TEVA-VS-3227212$TEVA$$54$YR$$F$Y$$$20240912$$MD$IT$IT
243122382$24312238$2$F$20240818$20240905$20240912$20240924$EXP$FR-AFSSAPS-PV2024000833$FR-GSK-FR2024110984$GLAXOSMITHKLINE$$17$YR$$F$Y$40$KG$20240924$$MD$FR$FR
243122391$24312239$1$I$$20240903$20240912$20240912$EXP$$US-TEVA-VS-3240069$TEVA$$61$YR$$F$Y$$$20240912$$CN$US$US
243122401$24312240$1$I$$20240906$20240912$20240912$EXP$$KR-GILEAD-2024-0686184$GILEAD$$$$$M$Y$$$20240912$$MD$KR$KR
243122412$24312241$2$F$$20240911$20240912$20240918$EXP$$CA-TEVA-VS-3240524$TEVA$$44$YR$$M$Y$91$KG$20240918$$HP$CA$CA
243122421$24312242$1$I$$20240905$20240912$20240912$PER$$US-MYLANLABS-2024M1083062$MYLAN$$$$$F$Y$$$20240912$$HP$US$US
243122431$24312243$1$I$20240101$20240905$20240912$20240912$PER$$US-ABBVIE-5916650$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243122452$24312245$2$F$20240101$20240918$20240912$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-028223$UNITED THERAPEUTICS$$$$$M$Y$68.934$KG$20240925$$$US$US
243122462$24312246$2$F$$20240822$20240912$20240918$PER$$US-SA-2024SA263694$SANOFI AVENTIS$$$$A$F$Y$73$KG$20240918$$MD$US$US
243122472$24312247$2$F$$20240911$20240912$20240917$EXP$$CA-TEVA-VS-3240478$TEVA$$60$YR$$F$Y$$$20240917$$MD$CA$CA
243122481$24312248$1$I$$20240821$20240912$20240912$PER$$US-SA-2024SA262594$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240912$$CN$US$US
243122491$24312249$1$I$$20240909$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA078881$SANDOZ$$52$YR$$M$Y$$$20240912$$HP$CA$CA
243122501$24312250$1$I$20200301$20240904$20240912$20240912$PER$$US-SA-2024SA264030$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240912$$HP$US$US
243122511$24312251$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262708$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240912$$HP$US$US
243122521$24312252$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA263033$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240912$$CN$US$US
243122531$24312253$1$I$$20240905$20240912$20240912$PER$$US-SA-2024SA263135$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$HP$US$US
243122541$24312254$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62523$$FDA-CTU$$71$YR$$F$N$$$20240911$N$$US$
243122551$24312255$1$I$20240911$20240911$20240911$20240911$DIR$718096$$FDA-CTU$$42$YR$$F$N$52.65$KG$20240911$N$CN$US$
243122561$24312256$1$I$20240801$20240905$20240912$20240912$PER$$US-SA-2024SA263177$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240912$$MD$US$US
243122572$24312257$2$F$$20240909$20240912$20240918$PER$$US-SA-2024SA260114$SANOFI AVENTIS$$$$$F$Y$$$20240918$$CN$US$US
243122581$24312258$1$I$20240816$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62565$$FDA-CTU$$78$YR$$M$N$$$20240911$Y$PH$US$
243122591$24312259$1$I$20240815$20240906$20240912$20240912$EXP$$CN-009507513-2409CHN003367$MERCK$$75$YR$$F$Y$56$KG$20240912$$HP$CN$CN
243122601$24312260$1$I$20240101$20240826$20240912$20240912$PER$$US-SA-2024SA263119$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240912$$MD$US$US
243122611$24312261$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62566$$FDA-CTU$$$$$F$N$$$20240911$N$HP$US$
243122621$24312262$1$I$20240911$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62561$$FDA-CTU$$76$YR$$M$N$$$20240911$Y$PH$US$
243122631$24312263$1$I$20240808$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62531$$FDA-CTU$$9$YR$$F$N$$$20240911$N$PH$US$
243122641$24312264$1$I$$20240906$20240912$20240912$PER$$US-LEO Pharma-373397$LEO PHARM$$61$YR$$M$Y$$$20240912$$PH$US$US
243122652$24312265$2$F$20240901$20240909$20240912$20240917$EXP$$NVSC2024FR181370$NOVARTIS$$48$YR$$F$Y$$$20240917$$MD$FR$FR
243122661$24312266$1$I$$20240904$20240912$20240912$EXP$$NVSC2024US180429$NOVARTIS$Salk G, Mangala YO, Onukogu ID, Meleveedu K. Clonal competition between JAK2 and BCR-ABL in myeloproliferative neoplasm. CLINICAL LYMPHOMA, MYELOMA + LEUKEMIA. 2024;S238$67$YR$$M$Y$$$20240912$$HP$US$US
243122671$24312267$1$I$$20240903$20240912$20240912$EXP$$CA-TEVA-VS-3240232$TEVA$$31$YR$$F$Y$$$20240912$$HP$CA$CA
243122681$24312268$1$I$20240101$20240902$20240912$20240912$EXP$$BR-TEVA-VS-3240400$TEVA$$$$$$Y$$$20240912$$PH$BR$BR
243122691$24312269$1$I$$20240910$20240912$20240912$EXP$$NL-SANDOZ INC.-SDZ2024NL079498$SANDOZ$$72$YR$$M$Y$$$20240912$$HP$NL$NL
243122701$24312270$1$I$20240819$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62564$$FDA-CTU$$69$YR$$M$N$68.5$KG$20240911$N$PH$US$
243122721$24312272$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62548$$FDA-CTU$$$$$F$N$$$20240911$N$HP$US$
243122731$24312273$1$I$20240712$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62526$$FDA-CTU$$84$YR$$F$N$$$20240911$Y$PH$US$
243122751$24312275$1$I$$20240905$20240912$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-014198$VERTEX$$$$$$Y$$$20240912$$CN$US$US
243122762$24312276$2$F$$20240904$20240912$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR112926$VIIV$$$$$$Y$$$20240926$$HP$US$US
243122771$24312277$1$I$$20240905$20240912$20240912$EXP$$GB-VERTEX PHARMACEUTICALS-2023-012006$VERTEX$$$$$$Y$$$20240912$$CN$GB$GB
243122781$24312278$1$I$$20240906$20240912$20240912$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014345$VERTEX$$$$A$M$Y$$$20240912$$CN$GB$GB
243122791$24312279$1$I$$20240905$20240912$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-014192$VERTEX$$$$C$M$Y$$$20240912$$PH$US$US
243122801$24312280$1$I$$20240905$20240912$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-014347$VERTEX$$12$YR$$$Y$$$20240912$$PH$US$US
243122811$24312281$1$I$$20240905$20240912$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-014245$VERTEX$$$$$$Y$$$20240912$$CN$US$US
243122822$24312282$2$F$$20240917$20240912$20240924$PER$$US-VERTEX PHARMACEUTICALS-2024-014133$VERTEX$$$$$$Y$$$20240924$$MD$US$US
243122831$24312283$1$I$$20240905$20240912$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-014238$VERTEX$$$$$$Y$$$20240912$$CN$US$US
243122841$24312284$1$I$$20240905$20240912$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-014227$VERTEX$$28$YR$$M$Y$$$20240912$$CN$US$US
243122851$24312285$1$I$$20240905$20240912$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-014205$VERTEX$$$$$$Y$$$20240912$$CN$US$US
243122862$24312286$2$F$$20240919$20240912$20240924$EXP$$US-VERTEX PHARMACEUTICALS-2024-013599$VERTEX$$$$$$Y$$$20240924$$CN$US$US
243122871$24312287$1$I$$20240905$20240912$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-014191$VERTEX$$12$YR$$$Y$$$20240912$$PH$US$US
243122883$24312288$3$F$20240724$20240918$20240912$20240924$EXP$$JP-GILEAD-2024-0687293$GILEAD$$73$YR$E$F$Y$37.1$KG$20240924$$MD$JP$JP
243122901$24312290$1$I$$20240906$20240912$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-014336$VERTEX$$3$YR$$F$Y$$$20240912$$CN$US$US
243122911$24312291$1$I$$20240819$20240912$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-014504$VERTEX$$$$C$$Y$$$20240912$$CN$US$US
243122921$24312292$1$I$$20240905$20240912$20240912$PER$$US-BAYER-2024A127808$BAYER$$36$YR$A$F$Y$$$20240912$$HP$US$US
243122931$24312293$1$I$$20240905$20240912$20240912$EXP$$US-JNJFOC-20240919992$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243122941$24312294$1$I$$20240906$20240912$20240912$PER$$US-JNJFOC-20240919488$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
243122951$24312295$1$I$20240326$20240909$20240912$20240912$EXP$$IT-GILEAD-2024-0687340$GILEAD$$64$YR$A$F$Y$$$20240912$$CN$IT$IT
243122962$24312296$2$F$20240529$20240919$20240912$20240926$EXP$$US-BEH-2024176530$CSL BEHRING$$82$YR$E$F$Y$$$20240926$$CN$US$US
243122971$24312297$1$I$20240730$20240906$20240912$20240912$EXP$$ZA-AstraZeneca-2024A204258$ASTRAZENECA$$71$YR$$M$Y$$$20240912$$CN$ZA$
243122982$24312298$2$F$$20240917$20240912$20240923$EXP$$US-TEVA-VS-3240359$TEVA$Kistler EA, Clinebell K, Gannon JM, Nathaniel VI, Lupu AM, Chengappa KNR. Applying Shared Decision Making to the Process of Medication Deprescribing in Schizophrenia. Clin-Ther 2023; 45 (10): 1008-1011.; Kistler EA, Clinebell K, Gannon JM, Nathaniel VI, Lupu AM, Chengappa KNR. Applying Shared Decision Making to the Process of Medication Deprescribing in Schizophrenia. Clin-Ther 2023; 45 (10): 1008-1011.$42$YR$$M$Y$$$20240923$$MD$US$US
243122991$24312299$1$I$$20240904$20240912$20240912$EXP$$KR-AstraZeneca-2024A202694$ASTRAZENECA$$58$YR$$F$Y$$$20240912$$MD$KR$
243123001$24312300$1$I$$20240904$20240912$20240912$EXP$$GR-AstraZeneca-2024A203806$ASTRAZENECA$$$$$F$Y$$$20240912$$MD$GR$
243123011$24312301$1$I$$20240910$20240912$20240912$EXP$$US-AstraZeneca-2024A206378$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243123022$24312302$2$F$$20240917$20240912$20240926$EXP$$US-TEVA-VS-3240291$TEVA$Fatima R, Altorok N. Secukinumab-Induced Bullous Pemphigoid in a Patient with Psoriatic Arthritis. Am-J-Ther 2024; 31 (4): e434-e435.; Fatima R, Altorok N. Secukinumab-Induced Bullous Pemphigoid in a Patient with Psoriatic Arthritis. Am-J-Ther 2024; 31 (4): e434-e435.$62$YR$$M$Y$$$20240926$$MD$US$US
243123031$24312303$1$I$20240908$20240909$20240912$20240912$30DAY$$GR-PFIZER INC-PV202400118545$PFIZER$$43$YR$$F$Y$58$KG$20240912$$CN$GR$GR
243123043$24312304$3$F$20240906$20240917$20240912$20240919$30DAY$$FR-PFIZER INC-202400251554$PFIZER$$70$YR$$M$Y$77$KG$20240919$$PH$FR$FR
243123051$24312305$1$I$$20240906$20240912$20240912$EXP$$BR-TAKEDA-2024TUS090441$TAKEDA$$$$$$Y$$$20240912$$CN$BR$BR
243123061$24312306$1$I$20240101$20240905$20240912$20240912$PER$$US-SA-2024SA263223$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240912$$HP$US$US
243123071$24312307$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA263231$SANOFI AVENTIS$$8$YR$C$M$Y$53$KG$20240912$$HP$US$US
243123081$24312308$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA263861$SANOFI AVENTIS$$81$YR$E$$Y$$$20240912$$HP$US$US
243123091$24312309$1$I$20240901$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144623$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$108.41$KG$20240912$$CN$US$US
243123102$24312310$2$F$20220101$20240919$20240912$20240928$EXP$$CA-CELLTRION INC.-2022CA011032$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
243123111$24312311$1$I$20240624$20240902$20240912$20240912$EXP$FR-AFSSAPS-AVPO2024000159$FR-TEVA-VS-3239718$TEVA$$59$YR$$F$Y$$$20240912$$PH$FR$FR
243123122$24312312$2$F$20240911$20240912$20240912$20240914$PER$$US-AMGEN-USASP2024181710$AMGEN$$80$YR$E$F$Y$$$20240914$$CN$US$US
243123131$24312313$1$I$$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181909$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243123141$24312314$1$I$20240908$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024181656$AMGEN$$74$YR$E$$Y$$$20240912$$CN$US$US
243123151$24312315$1$I$$20240901$20240912$20240912$EXP$$TR-ABBVIE-5918034$ABBVIE$Sekuri A, Oguz B, Hacihasanoglu E, Atesoglu EB, Oven BB, Atalay F. A Rare Case of Kaposi ^S Sarcoma Concurrent with Chronic Lymphocytic Leukaemia in a patient receiving Ibrutinib. Eur J Case Rep Intern Med. 2024:750.$72$YR$$F$Y$$$20240912$$HP$TR$TR
243123161$24312316$1$I$$20240906$20240912$20240912$PER$$US-ALXN-202409USA000423US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240912$$CN$US$US
243123171$24312317$1$I$$20240906$20240912$20240912$PER$$US-ALXN-202409USA000426US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243123181$24312318$1$I$20160707$20240906$20240912$20240912$EXP$$CA-TAKEDA-2017TUS027300$TAKEDA$$54$YR$$F$Y$$$20240912$$MD$CA$CA
243123191$24312319$1$I$20240701$20240903$20240912$20240912$EXP$$US-UCBSA-2024045301$UCB$$29$YR$$F$Y$$$20240912$$HP$US$US
243123201$24312320$1$I$20240601$20240902$20240912$20240912$EXP$$BR-TEVA-VS-3240547$TEVA$$$$$$Y$$$20240912$$PH$BR$BR
243123211$24312321$1$I$20240801$20240906$20240912$20240912$EXP$$US-INTERCEPT-PM2024001785$INTERCEPT PHARMACEUTICALS$$72$YR$$F$Y$79.002$KG$20240912$$CN$US$US
243123231$24312323$1$I$20240824$20240903$20240912$20240912$EXP$$CN-JNJFOC-20240910140$JOHNSON AND JOHNSON$$25$YR$A$F$Y$49$KG$20240912$$HP$CN$CN
243123241$24312324$1$I$$20240909$20240912$20240912$EXP$$NL-PFIZER INC-202400252694$PFIZER$I.G. van der Sar. Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis. Annals of the American Thoracic Society. 2024;21 (6):989-998$$$A$$Y$$$20240912$$HP$NL$NL
243123251$24312325$1$I$$20240909$20240912$20240912$EXP$$NL-PFIZER INC-202400252696$PFIZER$I.G. van der Sar. Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis. Annals of the American Thoracic Society. 2024;21 (6):989-992$$$A$$Y$$$20240912$$HP$NL$NL
243123263$24312326$3$F$$20240910$20240912$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002162$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240920$$CN$US$US
243123271$24312327$1$I$$20240906$20240912$20240912$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409006540$ELI LILLY AND CO$$58$YR$A$F$Y$53$KG$20240912$$CN$CN$CN
243123281$24312328$1$I$20240909$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006747$ELI LILLY AND CO$$69$YR$E$$Y$$$20240912$$CN$US$US
243123291$24312329$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007466$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240912$$CN$US$US
243123301$24312330$1$I$20240830$20240904$20240912$20240912$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003907$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240912$$CN$US$US
243123311$24312331$1$I$20240101$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006703$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240912$$CN$US$US
243123321$24312332$1$I$20240911$20240911$20240911$20240911$DIR$718031$$FDA-CTU$$23$YR$$M$N$132.75$KG$20240911$N$CN$US$
243123331$24312333$1$I$20240905$20240909$20240912$20240912$EXP$$QA-ELI_LILLY_AND_COMPANY-QA202409006445$ELI LILLY AND CO$$$$$M$Y$$$20240912$$MD$QA$QA
243123341$24312334$1$I$$20240903$20240912$20240912$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002169$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240912$$CN$US$US
243123351$24312335$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62545$$FDA-CTU$$$$$M$N$$$20240911$N$HP$US$
243123361$24312336$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62557$$FDA-CTU$$81$YR$$F$N$$$20240911$N$$US$
243123371$24312337$1$I$20240825$20240831$20240912$20240912$EXP$GB-MHRA-MED-202408312046428410-KWCLP$GB-ELI_LILLY_AND_COMPANY-GB202409000753$ELI LILLY AND CO$$39$YR$A$F$Y$77$KG$20240912$$CN$GB$GB
243123381$24312338$1$I$$20240910$20240912$20240912$EXP$$US-ELI_LILLY_AND_COMPANY-US202409006481$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240912$$HP$US$US
243123391$24312339$1$I$$20240902$20240912$20240912$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202409001199$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$MX$MX
243123401$24312340$1$I$$20240904$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409003118$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240912$$CN$US$US
243123411$24312341$1$I$$20240906$20240912$20240912$EXP$$JP-009507513-2409JPN001170J$MERCK$$9$DEC$$M$Y$$$20240912$$MD$JP$JP
243123421$24312342$1$I$$20240910$20240912$20240912$30DAY$$US-UCBSA-2024045378$UCB$$$$$M$Y$$$20240912$$CN$US$US
243123431$24312343$1$I$$20240906$20240912$20240912$EXP$$NVSC2024CR181448$NOVARTIS$$$$$M$Y$$$20240912$$CN$CR$CR
243123442$24312344$2$F$20240701$20240916$20240912$20240917$PER$$US-BAYER-2024A128545$BAYER$$33$YR$A$F$Y$$$20240917$$HP$US$US
243123451$24312345$1$I$20240807$20240905$20240912$20240912$EXP$IT-MINISAL02-1000372$IT-TEVA-VS-3241314$TEVA$$71$YR$$M$Y$81$KG$20240912$$MD$IT$IT
243123461$24312346$1$I$20240729$20240905$20240912$20240912$EXP$ES-AEMPS-1564836$ES-TEVA-VS-3241364$TEVA$$86$YR$$F$Y$56.4$KG$20240912$$MD$ES$ES
243123471$24312347$1$I$20220329$20240906$20240912$20240912$EXP$PL-URPL-DML-MLP.4401.1.763.2022$PL-TEVA-VS-3241356$TEVA$$81$YR$$F$Y$61$KG$20240912$$MD$PL$PL
243123481$24312348$1$I$$20240904$20240912$20240912$EXP$$US-ABBVIE-5908583$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243123491$24312349$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687377$GILEAD$$58$YR$A$M$Y$$$20240912$$MD$US$US
243123501$24312350$1$I$$20240906$20240912$20240912$EXP$$US-SA-2024SA263920$SANOFI AVENTIS$$$$$$Y$$$20240912$$CN$US$US
243123512$24312351$2$F$20240601$20240904$20240912$20240926$PER$$US-GSK-US2024110189$GLAXOSMITHKLINE$$52$YR$$M$Y$$$20240926$$HP$US$US
243123521$24312352$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA263057$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240912$$MD$US$US
243123531$24312353$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA263300$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240912$$HP$US$US
243123541$24312354$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA263206$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240912$$MD$US$US
243123561$24312356$1$I$20240909$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024181924$AMGEN$$87$YR$E$F$Y$$$20240912$$CN$US$US
243123571$24312357$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA263092$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240912$$HP$US$US
243123581$24312358$1$I$$20240906$20240912$20240912$PER$$US-BAYER-2024A128575$BAYER$$$$$F$Y$$$20240912$$HP$US$US
243123592$24312359$2$F$20230101$20240913$20240912$20240923$PER$$US-SA-2024SA263650$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240923$$MD$US$US
243123601$24312360$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA261273$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240912$$MD$US$US
243123611$24312361$1$I$$20240910$20240912$20240912$EXP$GB-MHRA-MED-202409101408266480-TPVQN$GB-MYLANLABS-2024M1082889$MYLAN$$36$YR$$$Y$$$20240912$$PH$GB$GB
243123621$24312362$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687398$GILEAD$$55$YR$A$F$Y$$$20240912$$MD$US$US
243123631$24312363$1$I$20240813$20240822$20240912$20240912$PER$$US-SA-2024SA262740$SANOFI AVENTIS$$18$YR$A$M$Y$54.55$KG$20240912$$MD$US$US
243123641$24312364$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263272$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240912$$MD$US$US
243123651$24312365$1$I$20231001$20240910$20240912$20240912$EXP$$US-SA-2024SA263784$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240912$$MD$US$US
243123661$24312366$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA263040$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240912$$MD$US$US
243123671$24312367$1$I$$20240902$20240912$20240912$PER$$PR-ABBVIE-5906517$ABBVIE$$$$$M$Y$$$20240912$$CN$PR$PR
243123682$24312368$2$F$$20240903$20240912$20240925$PER$$US-SA-2024SA262028$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240925$$CN$US$US
243123691$24312369$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA263136$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240912$$MD$US$US
243123711$24312371$1$I$20240829$20240829$20240912$20240912$PER$$US-SA-2024SA261126$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240912$$MD$US$US
243123721$24312372$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA185983$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240912$$HP$US$US
243123731$24312373$1$I$20240829$20240903$20240912$20240912$PER$$US-SA-2024SA262928$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240912$$MD$US$US
243123741$24312374$1$I$$20240911$20240911$20240911$DIR$718054$$FDA-CTU$$$$$UNK$N$$$20240911$$CN$US$
243123751$24312375$1$I$20240831$20240911$20240911$20240911$DIR$718001$$FDA-CTU$$67$YR$$F$N$$$20240911$N$HP$US$
243123761$24312376$1$I$$20240829$20240912$20240912$EXP$$GB-COSETTE-CP2024GB000240$COSETTE PHARMACEUTICALS$$6$DEC$A$F$Y$$$20240912$$MD$GB$GB
243123772$24312377$2$F$$20240917$20240912$20240926$PER$$US-SA-2024SA263076$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240926$$CN$US$US
243123781$24312378$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA263100$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240912$$MD$US$US
243123791$24312379$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA261556$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240912$$CN$US$US
243123801$24312380$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA262522$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240912$$HP$US$US
243123811$24312381$1$I$20240801$20240904$20240912$20240912$PER$$US-SA-2024SA263301$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240912$$MD$US$US
243123821$24312382$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA262931$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240912$$HP$US$US
243123831$24312383$1$I$$20240905$20240912$20240912$EXP$$US-ABBVIE-5910149$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243123861$24312386$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62521$$FDA-CTU$$81$YR$$F$N$$$20240911$N$$US$
243123871$24312387$1$I$20240906$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62522$$FDA-CTU$$66$YR$$M$N$108$KG$20240911$N$PH$US$
243123881$24312388$1$I$20240904$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62532$$FDA-CTU$$74$YR$$M$N$$$20240911$N$HP$US$
243123891$24312389$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687403$GILEAD$$34$YR$A$F$Y$$$20240912$$MD$US$US
243123901$24312390$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62533$$FDA-CTU$$61$YR$$F$N$$$20240911$N$$US$
243123911$24312391$1$I$20240906$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62543$$FDA-CTU$$63$YR$$M$N$132$KG$20240911$N$$US$
243123921$24312392$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144944$BRISTOL MYERS SQUIBB$$$$A$M$Y$$$20240912$$HP$US$US
243123931$24312393$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144492$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240912$$CN$US$US
243123941$24312394$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144377$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240912$$HP$US$US
243123951$24312395$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144456$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240912$$CN$US$US
243123961$24312396$1$I$20240901$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143995$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240912$$PH$US$US
243123971$24312397$1$I$$20240904$20240912$20240912$PER$$US-AGIOS-2409US03875$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243123981$24312398$1$I$20240101$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181929$AMGEN$$$$$$Y$$$20240912$$PH$US$US
243123992$24312399$2$F$20190513$20240923$20240912$20240925$EXP$$GR-SANDOZ INC.-NVSC2020GR110694$SANDOZ$$$$A$F$Y$60$KG$20240925$$MD$GR$GR
243124001$24312400$1$I$$20240905$20240912$20240912$EXP$$US-LEO Pharma-373332$LEO PHARM$$60$YR$$M$Y$$$20240911$$PH$US$US
243124021$24312402$1$I$20240701$20240906$20240912$20240912$PER$$US-BAYER-2024A128937$BAYER$$44$YR$A$F$Y$$$20240912$$MD$US$US
243124031$24312403$1$I$20240519$20240906$20240912$20240912$EXP$FR-AFSSAPS-NC2024001041$FR-009507513-2409FRA002729$MERCK$$71$YR$$M$Y$82.5$KG$20240912$$MD$FR$FR
243124041$24312404$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687404$GILEAD$$53$YR$A$F$Y$$$20240912$$MD$US$US
243124053$24312405$3$F$20240202$20240924$20240912$20240930$EXP$BE-JNJFOC-20240482139$BE-GSK-BE2024110982$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$BE$BE
243124062$24312406$2$F$$20240904$20240912$20240913$PER$$NVSC2024US182568$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
243124071$24312407$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A203265$ASTRAZENECA$$$$$F$Y$57.6$KG$20240912$$CN$US$
243124081$24312408$1$I$$20240905$20240912$20240912$EXP$$CN-ROCHE-10000074841$ROCHE$Wu S, Bian L, Wang H, Zhang S, Wang T, Yu Z, et al. De-escalation of neoadjuvant taxane and carboplatin therapy in HER2-positive breast cancer with dual HER2 blockade: a multicenter real-world experience in China. World Journal of Surgical Oncology. 2024-Dec;22 (1):1-10. doi:10.1186/s12957-024-03468-5.$$$$$Y$$$20240912$$HP$CN$CN
243124091$24312409$1$I$$20240905$20240912$20240912$PER$$US-JNJFOC-20240920198$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243124101$24312410$1$I$$20240909$20240912$20240912$PER$$US-JNJFOC-20240921056$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$PH$US$US
243124111$24312411$1$I$20240819$20240907$20240912$20240912$PER$$US-BAYER-2024A128274$BAYER$$46$YR$A$F$Y$$$20240912$$CN$US$US
243124131$24312413$1$I$$20240829$20240912$20240912$EXP$$GB-JNJFOC-20240929638$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$GB$GB
243124141$24312414$1$I$$20240909$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA078908$SANDOZ$$65$YR$$F$Y$34$KG$20240912$$MD$CA$CA
243124151$24312415$1$I$$20240909$20240912$20240912$PER$$US-BAYER-2024A129922$BAYER$$$$$F$Y$$$20240912$$CN$US$US
243124171$24312417$1$I$$20240829$20240912$20240912$PER$$US-LEADINGPHARMA-US-2024LEASPO00385$LEADING PHARMA$$$$$$Y$$$20240912$$CN$US$US
243124181$24312418$1$I$20220101$20240830$20240912$20240912$EXP$$IN-CIPLA LTD.-2024IN09679$CIPLA$$$$$$Y$$$20240912$$CN$IN$IN
243124201$24312420$1$I$$20240910$20240912$20240912$PER$$US-GILEAD-2024-0687315$GILEAD$$33$YR$A$M$Y$$$20240912$$PH$US$US
243124211$24312421$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687485$GILEAD$$61$YR$A$F$Y$$$20240912$$MD$US$US
243124221$24312422$1$I$$20240910$20240912$20240912$PER$$US-BIOGEN-2022BI01126215$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
243124231$24312423$1$I$20240905$20240909$20240912$20240912$PER$$US-BAYER-2024A128841$BAYER$$38$YR$A$F$Y$$$20240912$$HP$US$US
243124242$24312424$2$F$20240813$20240918$20240912$20240925$EXP$$GB-MYLANLABS-2024M1075142$MYLAN$$47$YR$$M$Y$$$20240925$$MD$GB$GB
243124251$24312425$1$I$$20240905$20240912$20240912$PER$$US-JNJFOC-20240916006$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
243124261$24312426$1$I$$20240910$20240912$20240912$PER$$NVSC2024US182763$NOVARTIS$$$$$$Y$$$20240912$$MD$US$US
243124271$24312427$1$I$$20240910$20240912$20240912$EXP$$TR-ASTELLAS-2024US022791$ASTELLAS$$$$$M$Y$$$20240912$$MD$TR$TR
243124281$24312428$1$I$20240830$20240904$20240912$20240912$EXP$GB-MHRA-MED-202409041658565300-DTGVC$GB-TEVA-VS-3240660$TEVA$$63$YR$$F$Y$86$KG$20240912$$CN$GB$GB
243124291$24312429$1$I$20240101$20240909$20240912$20240912$PER$$US-BAYER-2024A128938$BAYER$$34$YR$A$F$Y$$$20240912$$CN$US$US
243124301$24312430$1$I$20240101$20240828$20240912$20240912$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0605$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240912$$CN$US$US
243124312$24312431$2$F$20240101$20240913$20240912$20240926$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1481$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240926$$MD$US$US
243124321$24312432$1$I$$20240829$20240912$20240912$EXP$$BE-OTSUKA-2024_024287$OTSUKA$$65$YR$$F$Y$$$20240912$$MD$BE$BE
243124331$24312433$1$I$20240701$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62551$$FDA-CTU$$75$YR$$F$N$$$20240911$N$HP$US$
243124341$24312434$1$I$$20240905$20240912$20240912$PER$$US-RDY-SPO/USA/24/0013194$DR REDDYS$$18$YR$A$F$Y$$$20240912$$MD$US$US
243124351$24312435$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62554$$FDA-CTU$$87$YR$$M$N$$$20240911$N$$US$
243124361$24312436$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62520$$FDA-CTU$$57$YR$$M$N$$$20240911$N$$US$
243124371$24312437$1$I$$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62537$$FDA-CTU$$62$YR$$F$N$$$20240911$N$$US$
243124381$24312438$1$I$20240316$20240911$20240911$20240911$DIR$718090$$FDA-CTU$$77$YR$$M$N$72$KG$20240911$N$CN$US$
243124401$24312440$1$I$$20240903$20240912$20240912$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00748$GLAND PHARMA$Masaru Matsumoto.IgA vasculitis induced by carboplatin + nabpaclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report.Frontiers in Immunology.14-AUG-2024;15:1-6$73$YR$E$M$Y$$$20240912$$HP$JP$JP
243124411$24312441$1$I$20240807$20240830$20240912$20240912$EXP$$FR-CIPLA LTD.-2024FR09637$CIPLA$$$$$$Y$$$20240912$$MD$FR$FR
243124421$24312442$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143810$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240912$$CN$US$US
243124431$24312443$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144245$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$73.03$KG$20240912$$CN$US$US
243124451$24312445$1$I$$20240909$20240912$20240912$PER$$US-BAYER-2024A129885$BAYER$$$$$F$Y$$$20240912$$CN$US$US
243124461$24312446$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144951$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$69.4$KG$20240912$$CN$US$US
243124481$24312448$1$I$$20240830$20240912$20240912$EXP$$US-CIPLA LTD.-2024US09767$CIPLA$Lopez J, Toy BC, Hua H.. A case of herpes simplex virus and cytomegalovirus retinitis coinfection. Retinal Cases and Brief Reports.. 2024;18 (4):451 to 454$$$$$Y$$$20240912$$HP$US$US
243124491$24312449$1$I$20240901$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024181075$AMGEN$$$$A$F$Y$$$20240912$$CN$US$US
243124501$24312450$1$I$$20240906$20240912$20240912$EXP$$IR-MYLANLABS-2024M1083319$MYLAN$Zargari O, Azimi SZ. Multiple COVID reinfections in a vaccinated psoriatic patient receiving adalimumab. J-Dermatolog-Treat 2022; 34.$26$YR$$M$Y$$$20240912$$HP$IR$IR
243124512$24312451$2$F$$20240925$20240912$20240930$EXP$$GB-MYLANLABS-2024M1082948$MYLAN$$$$$M$Y$$$20240930$$HP$GB$GB
243124522$24312452$2$F$20240816$20240920$20240912$20240925$EXP$$NZ-MYLANLABS-2024M1082954$MYLAN$$68$YR$$M$Y$$$20240925$$PH$NZ$NZ
243124541$24312454$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687486$GILEAD$$69$YR$E$F$Y$$$20240912$$MD$US$US
243124551$24312455$1$I$$20240903$20240912$20240912$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409002246$ELI LILLY AND CO$$61$YR$A$F$Y$62$KG$20240912$$CN$CN$CN
243124571$24312457$1$I$20240718$20240909$20240912$20240912$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408002733$ELI LILLY AND CO$$75$YR$E$F$Y$41$KG$20240912$$CN$JP$JP
243124582$24312458$2$F$20240826$20240904$20240912$20240916$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409002796$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240916$$CN$CN$CN
243124591$24312459$1$I$20240831$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005320$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240912$$CN$US$US
243124611$24312461$1$I$20240601$20240903$20240912$20240912$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409000934$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240912$$CN$DE$DE
243124621$24312462$1$I$$20240909$20240912$20240912$EXP$$US-ELI_LILLY_AND_COMPANY-US202409006219$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240912$$HP$US$US
243124631$24312463$1$I$$20240909$20240912$20240912$EXP$$US-ELI_LILLY_AND_COMPANY-US202409005803$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240912$$CN$US$US
243124642$24312464$2$F$$20240910$20240912$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409007239$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240918$$CN$US$US
243124651$24312465$1$I$20240901$20240909$20240912$20240912$DIR$FDA-CDER-CTU-2024-62671$$FDA-CTU$$73$YR$$F$N$$$20240909$N$HP$US$
243124661$24312466$1$I$$20240903$20240912$20240912$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001819$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240912$$CN$US$US
243124671$24312467$1$I$20240903$20240904$20240912$20240912$EXP$$CN-VANTIVE-2024VAN019580$Vantive US Healthcare$$$$E$M$Y$$$20240912$$HP$CN$CN
243124682$24312468$2$F$20240827$20240910$20240912$20240920$EXP$$US-VANTIVE-2024VAN019575$Vantive US Healthcare$$$$$M$Y$$$20240920$$CN$US$US
243124691$24312469$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687487$GILEAD$$63$YR$A$F$Y$$$20240912$$MD$US$US
243124701$24312470$1$I$$20240910$20240912$20240912$PER$$US-BAYER-2024A129559$BAYER$$$$$$Y$$$20240912$$CN$US$US
243124711$24312471$1$I$20240101$20240828$20240912$20240912$PER$$US-SA-2024SA263846$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240912$$MD$US$US
243124721$24312472$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA262719$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240912$$MD$US$US
243124731$24312473$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262889$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240912$$MD$US$US
243124741$24312474$1$I$$20240827$20240912$20240912$PER$$US-SA-2024SA144686$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240912$$MD$US$US
243124751$24312475$1$I$$20240823$20240912$20240912$PER$$US-SA-2024SA262229$SANOFI AVENTIS$$32$YR$A$$Y$$$20240912$$CN$US$US
243124761$24312476$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA264137$SANOFI AVENTIS$$$$A$M$Y$$$20240912$$CN$US$US
243124771$24312477$1$I$$20240909$20240912$20240912$EXP$$AR2024US00022290$SANDOZ$$$$$F$Y$$$20240912$$CN$US$US
243124781$24312478$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA262106$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240912$$HP$US$US
243124791$24312479$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA260777$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240912$$HP$US$US
243124801$24312480$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA262875$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240912$$CN$US$US
243124811$24312481$1$I$20240901$20240905$20240912$20240912$PER$$US-SA-2024SA263329$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240912$$MD$US$US
243124821$24312482$1$I$20240101$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024180633$AMGEN$$22$YR$A$F$Y$$$20240912$$HP$US$US
243124832$24312483$2$F$$20240917$20240912$20240925$EXP$$US-TEVA-VS-3240136$TEVA$Bains S, Garmany R, Neves R, Giudicessi JR, Gao X, Tester DJ, et al. Temporal Association Between Vaping and Risk of Cardiac Events. Mayo-Clin-Proc 2024; 99 (2): 241-248; Bains S, Garmany R, Neves R, Giudicessi JR, Gao X, Tester DJ, et al. Temporal Association Between Vaping and Risk of Cardiac Events. Mayo-Clin-Proc 2024; 99 (2): 241-248.; Bains S, Garmany R, Neves R, Giudicessi JR, Gao X, Tester DJ, et al. Temporal Association Between Vaping and Risk of Cardiac Events. Mayo-Clin-Proc 2024; ...$19$YR$$F$Y$$$20240925$$HP$US$US
243124841$24312484$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687399$GILEAD$$67$YR$E$M$Y$$$20240912$$MD$US$US
243124851$24312485$1$I$20240730$20240814$20240912$20240912$PER$$US-CELLTRION INC.-2024US018750$CELLTRION$$$$$$Y$$$20240912$$CN$US$US
243124861$24312486$1$I$20240101$20240910$20240912$20240912$PER$$US-BAYER-2024A129562$BAYER$$39$YR$A$F$Y$$$20240912$$MD$US$US
243124871$24312487$1$I$20231011$20240910$20240912$20240912$EXP$$US-AstraZeneca-2024A206576$ASTRAZENECA$$27920$DY$$M$Y$$$20240912$$CN$US$
243124881$24312488$1$I$20130321$20240909$20240912$20240912$EXP$PT-INFARMED-J202408-693$PT-ORGANON-O2409PRT000587$ORGANON$$66$YR$$F$Y$52$KG$20240912$$CN$PT$PT
243124891$24312489$1$I$$20240830$20240912$20240912$EXP$$US-CIPLA LTD.-2024US09689$CIPLA$$$$$$Y$$$20240912$$CN$US$US
243124901$24312490$1$I$20240908$20240910$20240912$20240912$EXP$$US-AstraZeneca-2024A206461$ASTRAZENECA$$25628$DY$$M$Y$$$20240912$$CN$US$
243124911$24312491$1$I$20240830$20240904$20240912$20240912$EXP$$GB-AstraZeneca-2024A201347$ASTRAZENECA$$63$YR$$F$Y$86$KG$20240912$$MD$GB$
243124922$24312492$2$F$20240908$20240923$20240912$20240925$PER$$US-BIOVITRUM-2024-US-011940$BIOVITRUM$$69$YR$$F$Y$$$20240925$$PH$US$US
243124932$24312493$2$F$20240828$20240924$20240912$20240927$EXP$$US-SA-2024SA264091$SANOFI AVENTIS$$89$YR$E$F$Y$60.91$KG$20240927$$MD$US$US
243124943$24312494$3$F$20240829$20240913$20240912$20240930$30DAY$$JP-JNJFOC-20240903243$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$JP$JP
243124951$24312495$1$I$20240829$20240829$20240912$20240912$PER$$US-PFIZER INC-202400254835$PFIZER$$54$YR$$F$Y$49.9$KG$20240912$$CN$US$US
243124961$24312496$1$I$$20240911$20240912$20240912$PER$$US-PFIZER INC-PV202400119564$PFIZER$$64$YR$$M$Y$$$20240912$$HP$US$US
243124971$24312497$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-2021083351$PFIZER$$63$YR$$F$Y$$$20240912$$CN$US$US
243124982$24312498$2$F$20200101$20240925$20240912$20240926$PER$$US-PFIZER INC-PV202400082538$PFIZER$$48$YR$$F$Y$$$20240926$$LW$US$US
243124992$24312499$2$F$$20240911$20240912$20240916$PER$$US-PFIZER INC-202400254883$PFIZER$$49$YR$$F$Y$$$20240916$$CN$US$US
243125001$24312500$1$I$$20240909$20240912$20240912$PER$$US-PFIZER INC-202400254003$PFIZER$$$$$$Y$$$20240912$$CN$US$US
243125011$24312501$1$I$20240101$20240910$20240912$20240912$PER$$US-PFIZER INC-202400254792$PFIZER$$82$YR$$F$Y$$$20240912$$HP$US$US
243125021$24312502$1$I$20240908$20240909$20240912$20240912$PER$$US-PFIZER INC-202400252939$PFIZER$$68$YR$$F$Y$97.506$KG$20240912$$CN$US$US
243125031$24312503$1$I$20240908$20240909$20240912$20240912$PER$$US-PFIZER INC-202400253253$PFIZER$$68$YR$$F$Y$72.12$KG$20240912$$CN$US$US
243125041$24312504$1$I$$20240909$20240912$20240912$PER$$US-PFIZER INC-202400253976$PFIZER$$72$YR$$M$Y$$$20240912$$CN$US$US
243125061$24312506$1$I$$20240910$20240912$20240912$EXP$$CA-PFIZER INC-202400254593$PFIZER$$79$YR$$F$Y$$$20240912$$HP$CA$CA
243125083$24312508$3$F$$20240925$20240912$20240927$PER$$US-PFIZER INC-202400241225$PFIZER$$46$YR$$F$Y$$$20240927$$MD$US$US
243125091$24312509$1$I$20170719$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202400119170$PFIZER$$60$YR$$F$Y$$$20240912$$MD$US$US
243125101$24312510$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202400119208$PFIZER$$$$$F$Y$$$20240912$$CN$US$US
243125111$24312511$1$I$20240101$20240909$20240912$20240912$PER$$US-PFIZER INC-PV202400118478$PFIZER$$$$$F$Y$$$20240912$$CN$US$US
243125121$24312512$1$I$20240901$20240910$20240912$20240912$PER$$US-PFIZER INC-202400253721$PFIZER$$29$YR$$F$Y$$$20240912$$CN$US$US
243125131$24312513$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202400119367$PFIZER$$56$YR$$M$Y$$$20240912$$HP$US$US
243125152$24312515$2$F$$20240912$20240912$20240913$PER$$US-PFIZER INC-202400254886$PFIZER$$49$YR$$F$Y$$$20240913$$CN$US$US
243125161$24312516$1$I$$20240911$20240912$20240912$EXP$$CA-PFIZER INC-202400254738$PFIZER$$13$YR$$F$Y$$$20240912$$HP$CA$CA
243125181$24312518$1$I$$20240906$20240912$20240912$PER$$US-PFIZER INC-PV202400118306$PFIZER$$45$YR$$F$Y$$$20240912$$MD$US$US
243125191$24312519$1$I$$20240909$20240912$20240912$PER$$US-PFIZER INC-202400252998$PFIZER$$77$YR$$M$Y$74.1$KG$20240912$$PH$US$US
243125201$24312520$1$I$20231001$20240910$20240912$20240912$PER$$US-PFIZER INC-202400254163$PFIZER$$66$YR$$F$Y$$$20240912$$HP$US$US
243125211$24312521$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202300063816$PFIZER$$67$YR$$F$Y$$$20240912$$CN$US$US
243125221$24312522$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-202400254082$PFIZER$$57$YR$$F$Y$65.77$KG$20240912$$CN$US$US
243125231$24312523$1$I$$20240909$20240912$20240912$PER$$US-PFIZER INC-202400253343$PFIZER$$66$YR$$F$Y$81.6$KG$20240912$$MD$US$US
243125242$24312524$2$F$$20240912$20240912$20240916$PER$$US-PFIZER INC-202400254783$PFIZER$$$$$F$Y$$$20240916$$MD$US$US
243125252$24312525$2$F$$20240915$20240912$20240918$PER$$US-PFIZER INC-202400254802$PFIZER$$71$YR$$F$Y$$$20240918$$CN$US$US
243125261$24312526$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-202400253718$PFIZER$$$$$F$Y$$$20240912$$CN$US$US
243125272$24312527$2$F$$20240912$20240912$20240919$EXP$$MX-PFIZER INC-202400254813$PFIZER$Ibarra, T.. Fatal invasive trichosporonosis in a patient with systemic lupus erythematosus: case report. Enfermedades Infecciosas y Microbiologia. 2024;44(2):75-7$52$YR$$F$Y$$$20240919$$MD$MX$MX
243125281$24312528$1$I$$20240910$20240912$20240912$PER$$US-BAYER-2024A130251$BAYER$$20$YR$A$F$Y$$$20240912$$HP$US$US
243125291$24312529$1$I$20240818$20240828$20240912$20240912$PER$$US-BEH-2024177981$CSL BEHRING$$60$YR$A$M$Y$$$20240912$$HP$US$US
243125301$24312530$1$I$20240909$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143500$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240912$$HP$US$US
243125321$24312532$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62665$$FDA-CTU$$35$YR$$M$N$$$20240912$N$$US$
243125361$24312536$1$I$$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62666$$FDA-CTU$$$$$F$N$$$20240911$N$HP$US$
243125421$24312542$1$I$$20240909$20240912$20240912$EXP$$US-GILEAD-2024-0687244$GILEAD$$$$A$M$Y$$$20240912$$MD$US$US
243125431$24312543$1$I$20230901$20240909$20240912$20240912$EXP$GB-MHRA-MED-202409091928410690-VLMKN$GB-SANDOZ INC.-SDZ2024GB079071$SANDOZ$$38$YR$$F$Y$91$KG$20240912$$CN$GB$GB
243125452$24312545$2$F$$20240917$20240912$20240926$EXP$$US-TEVA-VS-3240323$TEVA$Vincent MN, Jaggers J, Fiske C, Phillips EJ, Stollings JL. Amikacin symmetrical drug-related intertriginous and flexural exanthema on the basis of neomycin cross-reactivity managed with desensitization and treating through. Ann-Allergy-Asthma-Immunol 2024; 133 (2): 215-217.; Vincent MN, Jaggers J, Fiske C, Phillips EJ, Stollings JL. Amikacin symmetrical drug-related intertriginous and flexural exanthema on the basis of neomycin cross-reactivity managed with desensitization and treating throug...$70$YR$$F$Y$$$20240926$$HP$US$US
243125471$24312547$1$I$20240817$20240910$20240912$20240912$DIR$FDA-CDER-CTU-2024-62673$$FDA-CTU$$70$YR$$M$N$$$20240910$N$HP$US$
243125481$24312548$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62678$$FDA-CTU$$34$YR$$F$N$102.51$KG$20240912$N$$US$
243125491$24312549$1$I$$20240911$20240912$20240912$EXP$$US-PFIZER INC-PV202400119627$PFIZER$$34$YR$$M$Y$$$20240912$$HP$US$US
243125501$24312550$1$I$$20240905$20240912$20240912$30DAY$$US-PFIZER INC-PV202400116456$PFIZER$$10$YR$$M$Y$$$20240912$$MD$US$US
243125521$24312552$1$I$$20240904$20240912$20240912$30DAY$$US-PFIZER INC-202400249737$PFIZER$$10$YR$$M$Y$$$20240912$$CN$US$US
243125541$24312554$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62690$$FDA-CTU$$50$YR$$F$N$$$20240912$N$$US$
243125551$24312555$1$I$$20240906$20240912$20240912$DIR$FDA-CDER-CTU-2024-62672$$FDA-CTU$$$$$F$N$$$20240906$N$HP$US$
243125562$24312556$2$F$$20240919$20240912$20240926$30DAY$$US-PFIZER INC-PV202400056180$PFIZER$$$$$$Y$$$20240926$$HP$US$US
243125571$24312557$1$I$$20240906$20240912$20240912$30DAY$$JP-PFIZER INC-PV202400117310$PFIZER$$5$YR$$M$Y$$$20240912$$HP$JP$JP
243125581$24312558$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62675$$FDA-CTU$$63$YR$$F$N$97.52$KG$20240912$N$$US$
243125591$24312559$1$I$$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62680$$FDA-CTU$$$$$F$N$$$20240911$N$HP$US$
243125601$24312560$1$I$20240907$20240909$20240912$20240912$30DAY$$US-PFIZER INC-202400253091$PFIZER$$13$YR$$M$Y$41.27$KG$20240912$$CN$US$US
243125611$24312561$1$I$20240501$20240912$20240912$20240912$EXP$$MA-PFIZER INC-PV202400119827$PFIZER$$$$$F$Y$$$20240912$$CN$MA$MA
243125621$24312562$1$I$$20240906$20240912$20240912$30DAY$$US-PFIZER INC-202400252806$PFIZER$$12$YR$$F$Y$53.98$KG$20240912$$CN$US$US
243125631$24312563$1$I$$20240911$20240911$20240911$DIR$718028$$FDA-CTU$$24$YR$$F$N$56.25$KG$20240911$N$MD$US$
243125641$24312564$1$I$20240902$20240909$20240912$20240912$DIR$FDA-CDER-CTU-2024-62682$$FDA-CTU$$76$YR$$M$N$$$20240909$N$HP$US$
243125651$24312565$1$I$$20240909$20240912$20240912$DIR$FDA-CDER-CTU-2024-62688$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243125661$24312566$1$I$20240911$20240911$20240911$20240911$DIR$718099$$FDA-CTU$$37$YR$$F$N$73$KG$20240911$N$CN$US$
243125671$24312567$1$I$20231027$20240911$20240912$20240912$EXP$$JP-PFIZER INC-PV202300172327$PFIZER$$4$DEC$$F$Y$$$20240912$$MD$JP$JP
243125681$24312568$1$I$20240906$20240909$20240912$20240912$30DAY$$GR-PFIZER INC-PV202400118534$PFIZER$$12$YR$$F$Y$32$KG$20240912$$CN$GR$GR
243125692$24312569$2$F$$20240906$20240912$20240917$30DAY$$US-PFIZER INC-202400247883$PFIZER$$15$YR$$M$Y$$$20240917$$CN$US$US
243125701$24312570$1$I$20240725$20240910$20240912$20240912$EXP$FR-AFSSAPS-TS2024000964$FR-PFIZER INC-202400253447$PFIZER$$11$YR$$F$Y$50$KG$20240912$$MD$FR$FR
243125711$24312571$1$I$20240701$20240910$20240912$20240912$EXP$CH-SM-2024-15403$CH-PFIZER INC-202400253641$PFIZER$$64$YR$$F$Y$$$20240912$$MD$CH$CH
243125741$24312574$1$I$20240101$20240905$20240912$20240912$EXP$SE-SEMPA-2024-006397$SE-TEVA-VS-3240804$TEVA$$62$YR$$M$Y$$$20240912$$MD$SE$SE
243125752$24312575$2$F$$20240917$20240912$20240926$EXP$$US-TEVA-VS-3240315$TEVA$: Nakasone ES, Bustillos HC, Gui X, Konnick EQ, Sham JG, Cohen SA. Multidisciplinary Approach for the Management of Metastatic Poorly Differentiated Neuroendocrine Carcinoma of the Pancreas A Case Report of an Exceptional Responder. Pancreas 2024; 53 (6): e487-e491.; Nakasone ES, Bustillos HC, Gui X, Konnick EQ, Sham JG, Cohen SA. Multidisciplinary Approach for the Management of Metastatic Poorly Differentiated Neuroendocrine Carcinoma of the Pancreas A Case Report of an Exceptional Responder...$51$YR$$M$Y$$$20240926$$MD$US$US
243125771$24312577$1$I$$20240903$20240912$20240912$30DAY$$US-PFIZER INC-PV202400115774$PFIZER$$$$$$Y$$$20240912$$HP$US$US
243125781$24312578$1$I$$20240903$20240912$20240912$30DAY$$US-PFIZER INC-202400249436$PFIZER$$16$YR$$M$Y$$$20240912$$MD$US$US
243125801$24312580$1$I$20240101$20240905$20240912$20240912$EXP$$US-OTSUKA-2024_016115$OTSUKA$$$$$F$Y$70.8$KG$20240912$$CN$US$US
243125811$24312581$1$I$$20240910$20240912$20240912$PER$$US-BAYER-2024A129568$BAYER$$30$YR$A$F$Y$$$20240912$$HP$US$US
243125822$24312582$2$F$$20240918$20240912$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144495$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240923$$HP$US$US
243125831$24312583$1$I$20240601$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145155$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240912$$CN$US$US
243125841$24312584$1$I$$20240905$20240912$20240912$PER$$US-LEO Pharma-373383$LEO PHARM$$73$YR$$F$Y$63$KG$20240912$$CN$US$US
243125851$24312585$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144713$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240912$$CN$US$US
243125872$24312587$2$F$20240909$20240923$20240912$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US079502$SANDOZ$$49$YR$$F$Y$$$20240924$$CN$US$US
243125881$24312588$1$I$20240710$20240910$20240912$20240912$PER$$US-BAYER-2024A129898$BAYER$$44$YR$A$F$Y$$$20240912$$HP$US$US
243125891$24312589$1$I$$20240830$20240912$20240912$EXP$$IN-CIPLA LTD.-2024IN09686$CIPLA$$$$$$Y$$$20240912$$CN$IN$IN
243125901$24312590$1$I$$20240905$20240912$20240912$EXP$$US-OTSUKA-2024_019599$OTSUKA$$5$DEC$$M$Y$$$20240912$$HP$US$US
243125912$24312591$2$F$$20240917$20240912$20240923$EXP$$US-TEVA-VS-3240372$TEVA$Wang N. Neurologic Complications of Cancer Immunotherapy. Continuum-Minneap-Minn 2023; 29 1827-1843.; Wang N. Neurologic Complications of Cancer Immunotherapy. Continuum-Minneap-Minn 2023; 29 1827-1843.$42$YR$$F$Y$$$20240923$$HP$US$US
243125922$24312592$2$F$$20240916$20240912$20240923$30DAY$$US-PFIZER INC-PV202400056285$PFIZER$$$$$$Y$$$20240923$$CN$US$US
243125931$24312593$1$I$$20240905$20240912$20240912$EXP$$US-TG THERAPEUTICS INC.-TGT003973$TG THERAPEUTICS$$$$$$Y$$$20240912$$CN$US$US
243125951$24312595$1$I$$20240829$20240912$20240912$30DAY$$US-PFIZER INC-PV202400113827$PFIZER$$$$$$Y$$$20240912$$CN$US$US
243125961$24312596$1$I$$20240908$20240912$20240912$30DAY$$JP-PFIZER INC-202400253402$PFIZER$$$$$M$Y$$$20240912$$CN$JP$JP
243125971$24312597$1$I$20240504$20240909$20240912$20240912$30DAY$$US-PFIZER INC-PV202400072323$PFIZER$$$$$$Y$$$20240912$$HP$US$US
243125981$24312598$1$I$20240101$20240909$20240912$20240912$30DAY$$US-PFIZER INC-202400253058$PFIZER$$16$YR$$F$Y$$$20240912$$CN$US$US
243125991$24312599$1$I$20240101$20240910$20240912$20240912$30DAY$$JP-PFIZER INC-PV202400118250$PFIZER$$$$C$F$Y$$$20240912$$CN$JP$JP
243126021$24312602$1$I$$20240902$20240912$20240912$EXP$$PT-ABBVIE-5919880$ABBVIE$Baptista M, Jesus M, Nunes M, Ferreira C, Silva A. A complication emerging from uncommon cause. Hematological diseases | Clinical case.$66$YR$$F$Y$$$20240912$$HP$PT$PT
243126031$24312603$1$I$$20240909$20240912$20240912$EXP$$NVSC2024IT181461$NOVARTIS$$72$YR$$F$Y$$$20240912$$CN$IT$IT
243126041$24312604$1$I$$20240907$20240912$20240912$PER$$US-ROCHE-10000076457$ROCHE$$$$$$Y$$$20240912$$MD$US$US
243126051$24312605$1$I$$20240826$20240912$20240912$PER$$US-TEVA-VS-3238171$TEVA$$$$E$F$Y$$$20240912$$CN$US$US
243126071$24312607$1$I$$20240906$20240912$20240912$30DAY$$US-PFIZER INC-202400252123$PFIZER$$24$YR$$F$Y$$$20240912$$PH$US$US
243126081$24312608$1$I$20240806$20240807$20240912$20240912$PER$$US-CELLTRION INC.-2024US019064$CELLTRION$$$$$$Y$$$20240912$$CN$US$US
243126101$24312610$1$I$$20240903$20240912$20240912$EXP$$US-SA-2024SA261836$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240912$$CN$US$US
243126112$24312611$2$F$$20240829$20240912$20240917$30DAY$$DE-JNJFOC-20240900877$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$DE$DE
243126121$24312612$1$I$20240822$20240903$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409001715$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240912$$CN$US$US
243126132$24312613$2$F$$20240918$20240912$20240919$PER$$US-PFIZER INC-PV202400036257$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243126151$24312615$1$I$20240601$20240905$20240912$20240912$PER$$US-SA-2024SA263267$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240912$$MD$US$US
243126161$24312616$1$I$$20240905$20240912$20240912$30DAY$$JP-SA-2024SA263018$SANOFI AVENTIS$$$$A$$Y$$$20240912$$PH$JP$JP
243126171$24312617$1$I$20240614$20240829$20240912$20240912$PER$$US-SA-2024SA261130$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240912$$MD$US$US
243126181$24312618$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263634$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$HP$US$US
243126191$24312619$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA261572$SANOFI AVENTIS$$$$A$M$Y$$$20240912$$HP$US$US
243126201$24312620$1$I$20240906$20240907$20240912$20240912$EXP$$CN-SA-2024SA263875$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240912$$HP$CN$CN
243126211$24312621$1$I$$20230903$20240912$20240912$PER$$US-ANIPHARMA-2023-US-028201$ANI$$$$$UNK$Y$$$20240912$$CN$US$US
243126223$24312622$3$F$$20240906$20240912$20240917$EXP$$NVSC2024PL180398$NOVARTIS$Nizinska I, Gattner K. Lithium intoxication in patients using angiotensin II receptor antagonists and hydrochlorothiazide: two case reports.. FARMAKOTERAPIA W PSYCHIATRII I NEUROLOGII. 53-60$72$YR$$F$Y$$$20240917$$HP$PL$PL
243126231$24312623$1$I$$20240903$20240912$20240912$EXP$GB-MHRA-MED-202409030938406780-SWYZQ$GB-PERRIGO-24GB008166$PERRIGO$$50$YR$$F$Y$59$KG$20240912$$CN$GB$GB
243126242$24312624$2$F$20240826$20240913$20240912$20240924$EXP$GB-MHRA-MED-202409030643105750-YWLCV$GB-PERRIGO-24GB008164$PERRIGO$$59$YR$$F$Y$$$20240924$$CN$GB$GB
243126252$24312625$2$F$$20240913$20240912$20240924$EXP$GB-MHRA-TPP30846427C7796873YC1725266836838$GB-PERRIGO-24GB008165$PERRIGO$$25$YR$$F$Y$65$KG$20240924$$HP$GB$GB
243126261$24312626$1$I$20240801$20240910$20240912$20240912$PER$$US-BAYER-2024A130053$BAYER$$27$YR$A$F$Y$$$20240912$$CN$US$US
243126271$24312627$1$I$20240830$20240911$20240911$20240911$DIR$718019$$FDA-CTU$$81$YR$$F$N$$$20240911$N$PH$US$
243126281$24312628$1$I$20240911$20240911$20240911$20240911$DIR$718072$$FDA-CTU$$28$YR$$F$N$$$20240911$N$CN$US$
243126291$24312629$1$I$$20240910$20240912$20240912$PER$$US-BAYER-2024A130363$BAYER$$$$$$Y$$$20240912$$CN$US$US
243126301$24312630$1$I$20240911$20240911$20240911$20240911$DIR$718070$$FDA-CTU$$37$YR$$F$N$$$20240911$N$CN$US$
243126311$24312631$1$I$20240906$20240911$20240911$20240911$DIR$718067$$FDA-CTU$$53$YR$$F$N$$$20240911$N$CN$US$
243126321$24312632$1$I$$20240905$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141987$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240912$$CN$US$US
243126331$24312633$1$I$20240910$20240911$20240911$20240911$DIR$718084$$FDA-CTU$$57$YR$$F$N$89.1$KG$20240911$Y$CN$US$
243126341$24312634$1$I$$20240902$20240912$20240912$EXP$NL-LRB-00999843$NL-PERRIGO-24NL008110$PERRIGO$$70$YR$$M$Y$83$KG$20240912$$CN$NL$NL
243126351$24312635$1$I$$20240906$20240912$20240912$EXP$$CN-TAKEDA-2024TUS090548$TAKEDA$Xie LN, Wang X, He Q, Wang H, Ma J, Zhang H et. al. A multicenter, prospective, phase II, single-arm study of domestic bortezomib combined with lenalidomide and dexamethasone for the treatment of newly diagnosed multiple myeloma. China J Hematol. 2024;45(6):571-76$$$$$Y$$$20240912$$MD$CN$CN
243126361$24312636$1$I$$20240904$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141356$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$111.58$KG$20240912$$HP$US$US
243126371$24312637$1$I$20240820$20240906$20240912$20240912$EXP$$US-ABBVIE-5915823$ABBVIE$$57$YR$$F$Y$$$20240912$$CN$US$US
243126381$24312638$1$I$$20240906$20240912$20240912$PER$$US-AMGEN-USASP2024179546$AMGEN$$46$YR$A$F$Y$$$20240912$$HP$US$US
243126391$24312639$1$I$$20240904$20240912$20240912$EXP$$JP-PERRIGO-23JP015740$PERRIGO$$24$YR$$F$Y$54$KG$20240912$$CN$JP$JP
243126402$24312640$2$F$$20240917$20240912$20240926$EXP$$US-TEVA-VS-3240308$TEVA$Mansour MK, King JD, Chen ST, Fishman JA, Nazarian RM. Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes. N-Engl-J-Med 2023; 388 (10): 926-937.; Mansour MK, King JD, Chen ST, Fishman JA, Nazarian RM. Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes. N-Engl-J-Med 2023; 388 (10): 926-937.$70$YR$$M$Y$$$20240926$$HP$US$US
243126411$24312641$1$I$$20240911$20240912$20240912$PER$$US-BAYER-2024A130189$BAYER$$$$$$Y$$$20240912$$CN$US$US
243126421$24312642$1$I$20240729$20240911$20240912$20240912$PER$$US-BAYER-2024A130184$BAYER$$$$$F$Y$$$20240912$$MD$US$US
243126431$24312643$1$I$20240901$20240907$20240912$20240912$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005066$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240912$$CN$US$US
243126452$24312645$2$F$20240831$20240910$20240912$20240917$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-004918$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240917$$MD$CA$CA
243126461$24312646$1$I$20240830$20240906$20240912$20240912$PER$$US-ALXN-202409USA000460US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243126471$24312647$1$I$$20240904$20240912$20240912$EXP$$US-ROCHE-10000074477$ROCHE$$73$YR$E$F$Y$$$20240912$$CN$US$US
243126481$24312648$1$I$$20240808$20240912$20240912$PER$$US-CELLTRION INC.-2024US019354$CELLTRION$$$$$$Y$$$20240912$$CN$US$US
243126491$24312649$1$I$$20240907$20240912$20240912$EXP$$MX-JNJFOC-20240920885$JOHNSON AND JOHNSON$$28$YR$A$M$Y$90$KG$20240912$$CN$MX$MX
243126501$24312650$1$I$$20240909$20240912$20240912$EXP$$NL-PFIZER INC-202400252691$PFIZER$van der Sar I.G. Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis. Annals of the American Thoracic Society.. 2024;21 (6):989-992$$$A$$Y$$$20240912$$HP$NL$NL
243126511$24312651$1$I$$20240909$20240912$20240912$EXP$$NL-PFIZER INC-202400252690$PFIZER$I.G. van der Sar. Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis. Annals of the American Thoracic Society. 2024;21 (6):989-992$$$A$$Y$$$20240912$$HP$NL$NL
243126521$24312652$1$I$20240905$20240909$20240912$20240912$EXP$$US-TAKEDA-2024TUS090058$TAKEDA$$26$YR$$M$Y$$$20240912$$CN$US$US
243126531$24312653$1$I$20240911$20240911$20240912$20240912$PER$$US-BAYER-2024A130234$BAYER$$$$$F$Y$$$20240912$$HP$US$US
243126541$24312654$1$I$20240730$20240905$20240912$20240912$EXP$$US-ROCHE-10000075859$ROCHE$$17$YR$T$F$Y$$$20240912$$CN$US$US
243126551$24312655$1$I$20240101$20240830$20240912$20240912$PER$$US-009507513-2409USA000634$MERCK$$$$$F$Y$$$20240912$$CN$US$US
243126561$24312656$1$I$$20240904$20240912$20240912$EXP$GB-MHRA-TPP36172602C14742259YC1725376312361$GB-PERRIGO-24GB008217$PERRIGO$$9$YR$$M$Y$29$KG$20240912$$HP$GB$GB
243126572$24312657$2$F$$20240913$20240912$20240924$EXP$GB-MHRA-MED-202409032048169360-NLFMK$GB-PERRIGO-24GB008219$PERRIGO$$46$YR$$F$Y$$$20240924$$MD$GB$GB
243126581$24312658$1$I$20240709$20240906$20240912$20240912$EXP$$US-AMNEAL-2024-AMRX-03307$AMNEAL$$69$YR$$M$Y$$$20240912$$MD$US$US
243126592$24312659$2$F$$20240913$20240912$20240924$EXP$GB-MHRA-MED-202409040811487310-HNSRJ$GB-PERRIGO-24GB008218$PERRIGO$$23$YR$$F$Y$$$20240924$$CN$GB$GB
243126601$24312660$1$I$$20240911$20240911$20240911$DIR$718040$$FDA-CTU$$$$$UNK$N$$$20240911$N$CN$US$
243126611$24312661$1$I$$20240911$20240911$20240911$DIR$718091$$FDA-CTU$$29$YR$$M$N$90.45$KG$20240911$N$CN$US$
243126651$24312665$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5917223$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243126661$24312666$1$I$20240908$20240911$20240912$20240912$PER$$US-BAYER-2024A130194$BAYER$$$$$M$Y$$$20240912$$CN$US$US
243126671$24312667$1$I$$20240910$20240912$20240912$PER$$US-BIOVITRUM-2024-US-011920$BIOVITRUM$$18$YR$$F$Y$$$20240912$$CN$US$US
243126681$24312668$1$I$$20240826$20240912$20240912$EXP$$US-SA-2024SA263872$SANOFI AVENTIS$$$$E$F$Y$80.45$KG$20240912$$MD$US$US
243126691$24312669$1$I$$20240822$20240912$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08519$LUPIN$$$$$$Y$$$20240912$$CN$US$US
243126701$24312670$1$I$$20240731$20240912$20240912$PER$$US-LUNDBECK-DKLU4004098$LUNDBECK$$$$$$Y$$$20240912$$CN$US$US
243126711$24312671$1$I$20240904$20240909$20240912$20240912$EXP$$SA-AMGEN-SAUSP2024180379$AMGEN$$55$YR$A$M$Y$$$20240912$$CN$SA$SA
243126721$24312672$1$I$$20240909$20240912$20240912$EXP$$CN-PFIZER INC-PV202400118449$PFIZER$$35$YR$$M$Y$$$20240912$$CN$CN$CN
243126731$24312673$1$I$20240910$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024182011$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243126742$24312674$2$F$20240718$20240917$20240912$20240918$EXP$$NVSC2024FR182128$NOVARTIS$$$$A$F$Y$62$KG$20240918$$MD$FR$FR
243126751$24312675$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182908$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
243126761$24312676$1$I$20240419$20240911$20240912$20240912$EXP$$ES-TAKEDA-2024TUS090614$TAKEDA$$17$YR$$M$Y$$$20240912$$HP$ES$ES
243126771$24312677$1$I$20200403$20240906$20240912$20240912$EXP$PL-URPL-1-1480-2020$PL-TEVA-VS-3241547$TEVA$$66$YR$$F$Y$77$KG$20240912$$PH$PL$PL
243126781$24312678$1$I$20240728$20240829$20240912$20240912$EXP$$AR-Merck Healthcare KGaA-2024046779$MERCK KGAA$$4$YR$C$M$Y$$$20240905$$MD$AR$AR
243126802$24312680$2$F$$20240917$20240912$20240926$EXP$$US-TEVA-VS-3240319$TEVA$Jones H, Bhakta A, Jia L, Wojciechowski D, Torrealba J. An Unusual Presentation of Metastatic BK Virus-Associated Urothelial Carcinoma Arising in the Allograft, Persisting After Transplant Nephrectomy. Int-J-Surg-Pathol 2023; 31 (8): 1586-1592.; Jones H, Bhakta A, Jia L, Wojciechowski D, Torrealba J. An Unusual Presentation of Metastatic BK Virus-Associated Urothelial Carcinoma Arising in the Allograft, Persisting After Transplant Nephrectomy. Int-J-Surg-Pathol 2023; 31 (8): 1586-1592.; Jones...$32$YR$$M$Y$$$20240926$$MD$US$US
243126811$24312681$1$I$$20240903$20240912$20240912$PER$$US-AstraZeneca-2024A200815$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243126821$24312682$1$I$$20240911$20240912$20240912$PER$$US-BAYER-2024A130221$BAYER$$$$$$Y$$$20240912$$CN$US$US
243126831$24312683$1$I$$20240731$20240912$20240912$PER$$US-LUNDBECK-DKLU4002516$LUNDBECK$$$$$$Y$$$20240912$$PH$US$US
243126841$24312684$1$I$$20240830$20240912$20240912$EXP$$CN-HQ-20240061$HQ SPECIALTY$Long S, Tang P, Ouyang P, Liao X, Xie L. A Case Report of a Rare Pulmonary Opportunistic Infection in an Infant Caused by Tsukamurella tyrosinosolvens. International Medical Case Reports Journal. 2024;17:725-31. DOI:10.2147/IMCRJ.S471682.$$$I$F$Y$$$20240905$$MD$CN$
243126851$24312685$1$I$$20240820$20240912$20240912$PER$$US-LUNDBECK-DKLU4003305$LUNDBECK$$$$$$Y$$$20240912$$HP$US$US
243126861$24312686$1$I$20240101$20240907$20240912$20240912$EXP$$US-ABBVIE-5917510$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243126871$24312687$1$I$20240101$20240828$20240912$20240912$PER$$US-SA-2024SA262972$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240912$$HP$US$US
243126881$24312688$1$I$20240801$20240829$20240912$20240912$PER$$US-SA-2024SA260630$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240912$$MD$US$US
243126891$24312689$1$I$20220101$20240909$20240912$20240912$EXP$$CA-PFIZER INC-202201176175$PFIZER$$35$YR$$F$Y$75$KG$20240912$$HP$CA$CA
243126901$24312690$1$I$20230101$20240909$20240912$20240912$EXP$$CA-PFIZER INC-202300334760$PFIZER$$65$YR$$M$Y$$$20240912$$HP$CA$CA
243126911$24312691$1$I$$20240909$20240912$20240912$PER$$US-ROCHE-10000078193$ROCHE$$58$YR$A$F$Y$$$20240912$$HP$US$US
243126921$24312692$1$I$$20240908$20240912$20240912$PER$$US-ROCHE-10000077206$ROCHE$$$$$M$Y$$$20240912$$CN$US$US
243126931$24312693$1$I$$20240724$20240912$20240912$PER$$US-ANIPHARMA-2024-US-040437$ANI$$$$$M$Y$$$20240912$$CN$US$US
243126941$24312694$1$I$$20240909$20240912$20240912$EXP$$NVSC2024US181256$NOVARTIS$$$$$M$Y$$$20240912$$CN$US$US
243126951$24312695$1$I$$20240731$20240912$20240912$PER$$US-LUNDBECK-DKLU4002512$LUNDBECK$$$$$$Y$$$20240912$$CN$US$US
243126961$24312696$1$I$$20240904$20240912$20240912$EXP$$GB-TEVA-VS-3240674$TEVA$$31$YR$$M$Y$$$20240912$$CN$GB$GB
243126971$24312697$1$I$$20240904$20240912$20240912$EXP$$GB-TEVA-VS-3240624$TEVA$$55$YR$$F$Y$89$KG$20240912$$PH$GB$GB
243127011$24312701$1$I$20240903$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142708$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240912$$HP$US$US
243127021$24312702$1$I$20240801$20240904$20240912$20240912$EXP$GB-MHRA-MED-202409040830405940-DQVJB$GB-TEVA-VS-3240464$TEVA$$62$YR$$M$Y$74$KG$20240912$$CN$GB$GB
243127031$24312703$1$I$$20240911$20240912$20240912$PER$$US-ROCHE-10000080410$ROCHE$$$$E$F$Y$$$20240912$$CN$US$US
243127041$24312704$1$I$20231101$20240830$20240912$20240912$EXP$$IN-CIPLA LTD.-2024IN09681$CIPLA$$$$$$Y$$$20240912$$CN$IN$IN
243127051$24312705$1$I$20240827$20240903$20240912$20240912$EXP$CN-NMPACDR-3211001025543202400074$CN-BAXTER-2024BAX024288$BAXTER$$72$YR$$F$Y$70$KG$20240912$$MD$CN$CN
243127061$24312706$1$I$20240712$20240830$20240912$20240912$EXP$$IN-CIPLA LTD.-2024IN09684$CIPLA$$$$$$Y$$$20240912$$CN$IN$IN
243127071$24312707$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182813$NOVARTIS$$$$$F$Y$$$20240912$$HP$US$US
243127081$24312708$1$I$20240823$20240903$20240912$20240912$EXP$CN-NMPACDR-1403021020433202400255$CN-BAXTER-2024BAX024282$BAXTER$$52$YR$$F$Y$62$KG$20240912$$MD$CN$CN
243127091$24312709$1$I$20240826$20240902$20240912$20240912$EXP$CN-NMPACDR-1308011010306202400186$CN-BAXTER-2024BAX024214$BAXTER$$74$YR$$F$Y$51$KG$20240912$$MD$CN$CN
243127101$24312710$1$I$20240827$20240902$20240912$20240912$EXP$CN-NMPACDR-5201011979493202400092$CN-BAXTER-2024BAX024223$BAXTER$$51$YR$$F$Y$57.6$KG$20240912$$MD$CN$CN
243127111$24312711$1$I$$20240910$20240912$20240912$EXP$$NVSC2024CA181637$NOVARTIS$$$$$$Y$$$20240912$$CN$CA$CA
243127121$24312712$1$I$20231213$20240905$20240912$20240912$EXP$$NVSC2024AT144941$NOVARTIS$$64$YR$$M$Y$$$20240912$$MD$AT$AT
243127131$24312713$1$I$20240101$20240905$20240912$20240912$PER$$US-GILEAD-2024-0686487$GILEAD$$$$$F$Y$$$20240912$$CN$US$US
243127141$24312714$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5917129$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243127151$24312715$1$I$$20240828$20240912$20240912$EXP$$US-SA-2024SA263630$SANOFI AVENTIS$$$$$$Y$$$20240912$$CN$US$US
243127161$24312716$1$I$20240909$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007394$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240912$$CN$US$US
243127171$24312717$1$I$20240904$20240906$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004399$ELI LILLY AND CO$$54$YR$A$$Y$$$20240912$$CN$US$US
243127181$24312718$1$I$20240829$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007249$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240912$$CN$US$US
243127193$24312719$3$F$$20240927$20240912$20240927$30DAY$$TR-PFIZER INC-202400248823$PFIZER$$$$$$Y$$$20240927$$PH$TR$TR
243127201$24312720$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA263457$SANOFI AVENTIS$$42$YR$A$F$Y$69.09$KG$20240912$$MD$US$US
243127211$24312721$1$I$20240830$20240830$20240912$20240912$EXP$$IN-CIPLA LTD.-2024IN09726$CIPLA$$$$$$Y$$$20240912$$CN$IN$IN
243127241$24312724$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA262733$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240912$$MD$US$US
243127251$24312725$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA260830$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240912$$MD$US$US
243127261$24312726$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA260689$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240912$$MD$US$US
243127271$24312727$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA263220$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240912$$HP$US$US
243127281$24312728$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA261765$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240912$$HP$US$US
243127291$24312729$1$I$20240101$20240905$20240912$20240912$PER$$US-SA-2024SA263212$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240912$$MD$US$US
243127301$24312730$1$I$20240731$20240905$20240912$20240912$EXP$FR-AFSSAPS-AM2024000716$FR-Waylis Therapeutics LLC-ATNAHS20240902531$Waylis$$20$YR$A$F$Y$80$KG$20240912$$MD$FR$FR
243127311$24312731$1$I$20240826$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145264$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240912$$CN$US$US
243127321$24312732$1$I$$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144714$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240912$$CN$US$US
243127331$24312733$1$I$$20240828$20240912$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08772$LUPIN$$$$$$Y$$$20240912$$CN$US$US
243127341$24312734$1$I$20200819$20240906$20240912$20240912$EXP$PL-URPL-1-3371-2020$PL-TEVA-VS-3241404$TEVA$$63$YR$$M$Y$56$KG$20240912$$MD$PL$PL
243127351$24312735$1$I$$20240909$20240912$20240912$EXP$$BR-TAKEDA-2024TUS090759$TAKEDA$$$$$F$Y$$$20240912$$CN$BR$BR
243127361$24312736$1$I$20240910$20240911$20240911$20240911$DIR$718045$$FDA-CTU$$45$YR$$F$N$$$20240911$N$CN$US$
243127371$24312737$1$I$20240725$20240906$20240912$20240912$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024332$UNITED THERAPEUTICS$$63$YR$$F$Y$73.923$KG$20240912$$$US$US
243127381$24312738$1$I$20240911$20240911$20240911$20240911$DIR$718048$$FDA-CTU$$55$YR$$M$N$$$20240911$N$$US$
243127391$24312739$1$I$20240911$20240911$20240911$20240911$DIR$718018$$FDA-CTU$$48$YR$$F$N$$$20240911$N$$US$
243127401$24312740$1$I$$20240911$20240911$20240911$DIR$718042$$FDA-CTU$$$$$UNK$N$$$20240911$N$CN$US$
243127441$24312744$1$I$20240911$20240911$20240911$20240911$DIR$718015$$FDA-CTU$$68$YR$$F$N$$$20240911$N$PH$US$
243127451$24312745$1$I$$20240911$20240911$20240911$DIR$718006$$FDA-CTU$$$$$UNK$N$$$20240911$N$CN$US$
243127461$24312746$1$I$20240911$20240911$20240911$20240911$DIR$718046$$FDA-CTU$$30$YR$$F$N$$$20240911$Y$PH$US$
243127471$24312747$1$I$$20240909$20240912$20240912$PER$$US-ABBVIE-5918361$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243127482$24312748$2$F$20240910$20240912$20240912$20240914$PER$$US-AMGEN-USASP2024182361$AMGEN$$85$YR$E$F$Y$$$20240914$$CN$US$US
243127491$24312749$1$I$20220101$20240906$20240912$20240912$PER$$US-AMGEN-USASP2024178807$AMGEN$$63$YR$A$F$Y$$$20240912$$CN$US$US
243127511$24312751$1$I$20240910$20240910$20240912$20240912$EXP$$CA-PFIZER INC-202400254996$PFIZER$$47$YR$$F$Y$$$20240912$$HP$CA$CA
243127521$24312752$1$I$$20240902$20240912$20240912$EXP$$CZ-TEVA-VS-3241022$TEVA$Kabut T, Weinbergerova B, Folber F, Lengerova M, Mayer J. High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience. Bone-Marrow-Transplant 2023; 58 1229-1236.; Kabut T, Weinbergerova B, Folber F, Lengerova M, Mayer J. High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience. Bone-Marrow-Transplant 2023; 58 1229-1236.$58$YR$$M$Y$$$20240912$$HP$CZ$CZ
243127531$24312753$1$I$20240528$20240906$20240912$20240912$EXP$$US-ABBVIE-5885933$ABBVIE$$56$YR$$F$Y$57.606$KG$20240912$$CN$US$US
243127541$24312754$1$I$$20240906$20240912$20240912$EXP$$TR-SA-2024SA262504$SANOFI AVENTIS$Karakaya E, Acu N, Ozdemirkan A, Tak S, Unal Y.. Anticoagulation Management with Bivalirudin in a Case with Heparin Resistance Detected During Coronary Artery Bypass Surgery.. JARSS. 2024;32(3):182-6$75$YR$E$M$Y$68$KG$20240912$$HP$TR$TR
243127552$24312755$2$F$$20240901$20240912$20240912$EXP$$US-JNJFOC-20240914211$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$US$US
243127561$24312756$1$I$20240907$20240910$20240912$20240912$EXP$$US-PFIZER INC-PV202400092102$PFIZER$$84$YR$$M$Y$$$20240912$$HP$US$US
243127571$24312757$1$I$20240801$20240910$20240912$20240912$EXP$$US-PFIZER INC-PV202400110121$PFIZER$$61$YR$$F$Y$$$20240912$$HP$US$US
243127591$24312759$1$I$$20240911$20240912$20240912$EXP$$US-PFIZER INC-PV202400119775$PFIZER$$53$YR$$M$Y$$$20240912$$HP$US$US
243127601$24312760$1$I$$20240909$20240912$20240912$EXP$$CA-PFIZER INC-202400254512$PFIZER$$$$$$Y$$$20240912$$HP$CA$CA
243127611$24312761$1$I$$20240901$20240912$20240912$EXP$$US-Waylis Therapeutics LLC-ATNAHS20240902579$Waylis$Winzent-Oonk S.;  Vallejos C.;  Hemenway M.;  Lindsay H.B.;  Green A.L.. MEDICAL AID IN DYING: EXPERIENCE IN THE CENTER FOR CANCER AND BLOOD DISORDERS AT CHILDREN^S HOSPITAL COLORADO. Neuro-Oncology 2024; 26(Supplement 4):(iv201)..$24$YR$A$M$Y$$$20240911$$HP$US$US
243127621$24312762$1$I$$20240910$20240912$20240912$PER$$US-TAKEDA-2024TUS090742$TAKEDA$$$$$M$Y$$$20240912$$MD$US$US
243127631$24312763$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA260913$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240912$$HP$US$US
243127641$24312764$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262015$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240912$$CN$US$US
243127651$24312765$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA263130$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240912$$MD$US$US
243127661$24312766$1$I$20240101$20240826$20240912$20240912$PER$$US-SA-2024SA262818$SANOFI AVENTIS$$12$YR$T$M$Y$37$KG$20240912$$MD$US$US
243127671$24312767$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262564$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240912$$CN$US$US
243127681$24312768$1$I$20240101$20240823$20240912$20240912$PER$$US-SA-2024SA262771$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240912$$HP$US$US
243127701$24312770$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA264225$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240912$$CN$US$US
243127711$24312771$1$I$20240903$20240903$20240912$20240912$PER$$US-SA-2024SA262754$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240912$$MD$US$US
243127721$24312772$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA261319$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240912$$CN$US$US
243127731$24312773$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144877$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240912$$CN$US$US
243127741$24312774$1$I$20240828$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144943$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240912$$HP$US$US
243127751$24312775$1$I$$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143410$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240912$$HP$US$US
243127761$24312776$1$I$20240301$20240906$20240912$20240912$EXP$$US-ABBVIE-5811686$ABBVIE$$68$YR$$F$Y$$$20240912$$CN$US$US
243127771$24312777$1$I$$20240828$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145355$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$HP$US$US
243127781$24312778$1$I$20240903$20240904$20240912$20240912$EXP$$MX-BIOVITRUM-2024-MX-011860$BIOVITRUM$$240$DY$$M$Y$8.4$KG$20240912$$CN$MX$MX
243127791$24312779$1$I$20240101$20240828$20240912$20240912$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1464$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240912$$HP$US$US
243127801$24312780$1$I$20231215$20240906$20240912$20240912$EXP$$US-ABBVIE-5914480$ABBVIE$$68$YR$$M$Y$110$KG$20240912$$CN$US$US
243127811$24312781$1$I$$20240910$20240912$20240912$PER$$US-AstraZeneca-2024A206188$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243127821$24312782$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A202161$ASTRAZENECA$$$$$$Y$$$20240912$$CN$US$
243127832$24312783$2$F$$20240911$20240912$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08695$LUPIN$$$$$$Y$$$20240921$$MD$US$US
243127841$24312784$1$I$20230101$20240904$20240912$20240912$PER$$US-ABBVIE-5907263$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243127851$24312785$1$I$20240909$20240911$20240911$20240911$DIR$718044$$FDA-CTU$$39$YR$$F$N$$$20240911$Y$PH$US$
243127861$24312786$1$I$$20240902$20240912$20240912$EXP$$IE-ABBVIE-5919188$ABBVIE$$77$YR$$M$Y$$$20240912$$MD$IE$IE
243127871$24312787$1$I$20211017$20240911$20240911$20240911$DIR$718076$$FDA-CTU$$71$YR$$M$N$135$KG$20240911$N$CN$US$
243127881$24312788$1$I$20240823$20240911$20240911$20240911$DIR$718080$$FDA-CTU$$30$YR$$M$N$101.25$KG$20240911$N$CN$US$
243127891$24312789$1$I$$20240902$20240912$20240912$EXP$$GB-TEVA-VS-3239557$TEVA$$22$YR$$M$Y$$$20240912$$HP$GB$GB
243127901$24312790$1$I$20240827$20240903$20240912$20240912$PER$$US-SA-2024SA261781$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240912$$HP$US$US
243127911$24312791$1$I$$20240909$20240912$20240912$EXP$$US-GSK-US2024111913$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$US$US
243127921$24312792$1$I$$20240906$20240912$20240912$EXP$$BR-GSK-BR2024AMR005530$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$BR$BR
243127941$24312794$1$I$20240903$20240905$20240912$20240912$EXP$$CA-GSK-CA2024111268$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$CA$CA
243127951$24312795$1$I$20240904$20240910$20240912$20240912$EXP$$US-BIOVITRUM-2024-US-011893$BIOVITRUM$$7$MON$$F$Y$$$20240912$$CN$US$US
243127961$24312796$1$I$$20240901$20240912$20240912$EXP$$US-Waylis Therapeutics LLC-ATNAHS20240902580$Waylis$Winzent-Oonk S.;  Vallejos C.;  Hemenway M.;  Lindsay H.B.;  Green A.L.. MEDICAL AID IN DYING: EXPERIENCE IN THE CENTER FOR CANCER AND BLOOD DISORDERS AT CHILDREN^S HOSPITAL COLORADO. Neuro-Oncology 2024; 26(Supplement 4):(iv201).10.1093/neuonc/noae064.703?.$26$YR$A$M$Y$$$20240911$$HP$US$US
243127971$24312797$1$I$$20240910$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US079207$SANDOZ$$73$YR$$M$Y$$$20240912$$MD$US$US
243127981$24312798$1$I$20240511$20240905$20240912$20240912$EXP$IT-MINISAL02-1000367$IT-TEVA-VS-3241306$TEVA$$93$YR$$F$Y$55$KG$20240912$$CN$IT$IT
243127991$24312799$1$I$$20240902$20240912$20240912$EXP$$ES-CIPLA LTD.-2024ES09836$CIPLA$Albert-Lopez E, Villafranca CM, Acosta AR, Benayas IB, Montiel EDC.. Checkpoint inhibitors, a milestone. But what about complications?. European Journal of Case Reports in Internal Medicine. 2024;V11Sup1:988$$$$$Y$$$20240912$$HP$ES$ES
243128001$24312800$1$I$$20240906$20240912$20240912$EXP$GB-MHRA-MED-202409061710441640-KJSQG$GB-GSK-GB2024111345$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$GB$GB
243128011$24312801$1$I$20230601$20240904$20240912$20240912$PER$$US-SA-2024SA263313$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240912$$MD$US$US
243128021$24312802$1$I$20240831$20240905$20240912$20240912$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024110686$VIIV$$46$YR$$M$Y$$$20240912$$HP$US$US
243128031$24312803$1$I$$20240904$20240912$20240912$EXP$$US-BAYER-2024A127599$BAYER$$69$YR$E$M$Y$83.9$KG$20240912$$CN$US$US
243128092$24312809$2$F$$20240910$20240912$20240918$PER$$US-AMGEN-USASP2024181271$AMGEN$$$$$F$Y$$$20240917$$HP$US$US
243128101$24312810$1$I$20240907$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181233$AMGEN$$80$YR$E$F$Y$$$20240912$$CN$US$US
243128111$24312811$1$I$20240826$20240905$20240912$20240912$EXP$$US-BAYER-2024A128782$BAYER$$74$YR$E$F$Y$74.376$KG$20240912$$CN$US$US
243128121$24312812$1$I$$20240906$20240912$20240912$EXP$$US-PERRIGO-24US008445$PERRIGO$$$$A$$Y$$$20240912$$CN$US$US
243128131$24312813$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687396$GILEAD$$60$YR$A$M$Y$$$20240912$$MD$US$US
243128141$24312814$1$I$$20240902$20240912$20240912$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202407014686$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240912$$CN$CN$CN
243128151$24312815$1$I$20231101$20240903$20240912$20240912$EXP$FR-AFSSAPS-TS2024000941$FR-TEVA-VS-3240010$TEVA$$80$YR$$M$Y$68$KG$20240912$$MD$FR$FR
243128161$24312816$1$I$20240829$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006039$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240912$$CN$US$US
243128171$24312817$1$I$20240911$20240911$20240911$20240911$DIR$718016$$FDA-CTU$$82$YR$$F$N$$$20240911$N$$US$
243128181$24312818$1$I$20240602$20240911$20240911$20240911$DIR$718079$$FDA-CTU$$45$YR$$F$N$56.25$KG$20240911$N$CN$US$
243128191$24312819$1$I$20240826$20240903$20240912$20240912$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409005069$ELI LILLY AND CO$$61$YR$A$M$Y$70$KG$20240912$$CN$DE$CN
243128202$24312820$2$F$20240701$20240906$20240912$20240917$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409003014$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240917$$CN$FR$FR
243128221$24312822$1$I$20000101$20240903$20240912$20240912$30DAY$$US-GSK-US2024109477$GLAXOSMITHKLINE$$31$YR$$M$Y$$$20240912$$CN$US$US
243128231$24312823$1$I$20240814$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024182229$AMGEN$$83$YR$E$F$Y$$$20240912$$CN$US$US
243128241$24312824$1$I$$20240910$20240912$20240912$PER$$NVSC2024US182755$NOVARTIS$$$$$F$Y$$$20240912$$HP$US$US
243128251$24312825$1$I$20240903$20240904$20240912$20240912$EXP$$DE-JNJFOC-20240914313$JOHNSON AND JOHNSON$$42$YR$A$F$Y$78$KG$20240912$$MD$DE$DE
243128271$24312827$1$I$$20240910$20240912$20240912$EXP$$US-ABBVIE-5917579$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243128281$24312828$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687380$GILEAD$$67$YR$E$M$Y$$$20240912$$MD$US$US
243128291$24312829$1$I$$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143279$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240912$$HP$US$US
243128311$24312831$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182604$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
243128321$24312832$1$I$$20240903$20240912$20240912$PER$$US-INCYTE CORPORATION-2024IN009296$INCYTE$$$$$$Y$$$20240912$$CN$US$US
243128331$24312833$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A203343$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243128341$24312834$1$I$$20240904$20240912$20240912$EXP$$ZA-AstraZeneca-2024A201600$ASTRAZENECA$$23741$DY$$M$Y$$$20240912$$CN$ZA$
243128351$24312835$1$I$20240801$20240904$20240912$20240912$EXP$$CO-AstraZeneca-2024A204143$ASTRAZENECA$$793$MON$$M$Y$$$20240912$$CN$CO$
243128361$24312836$1$I$$20240910$20240912$20240912$EXP$$US-ALXN-202409USA000717US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243128381$24312838$1$I$$20240902$20240912$20240912$EXP$$AR-GSK-AR2023AMR130841$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$AR$AR
243128391$24312839$1$I$$20240903$20240912$20240912$PER$$US-INCYTE CORPORATION-2024IN009290$INCYTE$$$$$$Y$$$20240912$$CN$US$US
243128401$24312840$1$I$$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181984$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243128411$24312841$1$I$$20240905$20240912$20240912$EXP$$CA-GSK-CA2024111313$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$CA$CA
243128431$24312843$1$I$$20240831$20240912$20240912$EXP$$GB-CIPLA LTD.-2024GB09700$CIPLA$$$$$$Y$$$20240912$$PH$GB$GB
243128441$24312844$1$I$$20240909$20240912$20240912$PER$$US-JNJFOC-20240922381$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
243128451$24312845$1$I$$20240903$20240912$20240912$PER$$US-INCYTE CORPORATION-2024IN009287$INCYTE$$$$$$Y$$$20240912$$CN$US$US
243128462$24312846$2$F$$20240911$20240912$20240918$EXP$$NVSC2024US179522$NOVARTIS$$$$$F$Y$$$20240919$$MD$US$US
243128471$24312847$1$I$$20240822$20240912$20240912$PER$$US-009507513-2408USA008624$MERCK$$$$$F$Y$$$20240912$$HP$US$US
243128481$24312848$1$I$20240901$20240905$20240912$20240912$EXP$$DE-BIOGEN-2024BI01281692$BIOGEN$$44$YR$$F$Y$$$20240912$$MD$DE$DE
243128501$24312850$1$I$20220512$20240911$20240911$20240911$DIR$718027$$FDA-CTU$$4$YR$$F$N$18$KG$20240911$N$CN$US$
243128511$24312851$1$I$20240819$20240911$20240911$20240911$DIR$718030$$FDA-CTU$$70$YR$$M$N$83.25$KG$20240911$N$CN$US$
243128521$24312852$1$I$$20240903$20240912$20240912$PER$$US-INCYTE CORPORATION-2024IN009282$INCYTE$$$$$$Y$$$20240912$$CN$US$US
243128531$24312853$1$I$$20240906$20240912$20240912$EXP$$BE-BEH-2024178330$CSL BEHRING$$$$E$F$Y$$$20240912$$MD$BE$BE
243128541$24312854$1$I$$20240902$20240912$20240912$PER$$US-INCYTE CORPORATION-2024IN009260$INCYTE$$$$$$Y$$$20240912$$MD$US$US
243128551$24312855$1$I$$20240904$20240912$20240912$EXP$$US-SA-2024SA264051$SANOFI AVENTIS$$$$C$M$Y$$$20240912$$MD$US$US
243128591$24312859$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA261866$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240912$$HP$US$US
243128601$24312860$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA261576$SANOFI AVENTIS$$$$$F$Y$$$20240912$$HP$US$US
243128611$24312861$1$I$20240820$20240823$20240912$20240912$PER$$US-009507513-2408USA008612$MERCK$$$$$M$Y$$$20240912$$CN$US$US
243128621$24312862$1$I$$20240820$20240912$20240912$PER$$US-SA-2024SA262119$SANOFI AVENTIS$$$$E$F$Y$69.841$KG$20240912$$MD$US$US
243128631$24312863$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687385$GILEAD$$61$YR$A$F$Y$$$20240912$$MD$US$US
243128641$24312864$1$I$20240405$20240905$20240912$20240912$EXP$IT-MINISAL02-1000416$IT-TEVA-VS-3241311$TEVA$$86$YR$$F$Y$$$20240912$$PH$IT$IT
243128651$24312865$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202400119583$PFIZER$$15$YR$$M$Y$91.6$KG$20240912$$MD$US$US
243128661$24312866$1$I$20240824$20240906$20240912$20240912$EXP$$US-ABBVIE-5915287$ABBVIE$$22$YR$$F$Y$$$20240912$$CN$US$US
243128671$24312867$1$I$$20240910$20240912$20240912$DIR$FDA-CDER-CTU-2024-62699$$FDA-CTU$$$$$F$N$$$20240910$N$HP$US$
243128681$24312868$1$I$20240829$20240909$20240912$20240912$DIR$FDA-CDER-CTU-2024-62701$$FDA-CTU$$84$YR$$F$N$$$20240909$N$HP$US$
243128691$24312869$1$I$$20240905$20240912$20240912$EXP$$CA-ABBVIE-5916654$ABBVIE$$$$$F$Y$$$20240912$$HP$CA$CA
243128721$24312872$1$I$$20240904$20240912$20240912$DIR$FDA-CDER-CTU-2024-62698$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
243128731$24312873$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62700$$FDA-CTU$$53$YR$$F$N$$$20240912$N$HP$US$
243128741$24312874$1$I$$20240904$20240912$20240912$DIR$FDA-CDER-CTU-2024-62697$$FDA-CTU$$$$$F$N$$$20240904$N$HP$US$
243128751$24312875$1$I$20240831$20240911$20240911$20240911$DIR$718055$$FDA-CTU$$70$YR$$F$N$107.55$KG$20240911$Y$CN$US$
243128761$24312876$1$I$20240604$20240828$20240912$20240912$EXP$$JP-VISIOX-2024VSX00068$Visiox$$71$YR$$$Y$$$20240912$$MD$JP$JP
243128771$24312877$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687386$GILEAD$$60$YR$A$M$Y$$$20240912$$MD$US$US
243128781$24312878$1$I$$20240910$20240912$20240912$PER$$US-BIOGEN-2024BI01281982$BIOGEN$$$$$F$Y$$$20240912$$HP$US$US
243128791$24312879$1$I$20240101$20240909$20240912$20240912$PER$$US-PFIZER INC-PV202400118775$PFIZER$$64$YR$$F$Y$$$20240912$$HP$US$US
243128802$24312880$2$F$$20240912$20240912$20240916$PER$$US-PFIZER INC-PV202400082699$PFIZER$$71$YR$$F$Y$$$20240916$$CN$US$US
243128811$24312881$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-202101206500$PFIZER$$27$YR$$M$Y$$$20240912$$CN$US$US
243128821$24312882$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-202400251032$PFIZER$$71$YR$$F$Y$$$20240912$$CN$US$US
243128831$24312883$1$I$$20240909$20240912$20240912$EXP$$US-GILEAD-2024-0687332$GILEAD$$$$A$F$Y$$$20240912$$CN$US$US
243128841$24312884$1$I$$20240911$20240912$20240912$PER$$US-PFIZER INC-202400254977$PFIZER$$55$YR$$M$Y$$$20240912$$HP$US$US
243128851$24312885$1$I$$20240911$20240912$20240912$PER$$US-PFIZER INC-202400255154$PFIZER$$48$YR$$F$Y$127.01$KG$20240912$$HP$US$US
243128861$24312886$1$I$$20240909$20240912$20240912$PER$$US-PFIZER INC-202400253990$PFIZER$$$$$$Y$$$20240912$$MD$US$US
243128871$24312887$1$I$20240328$20240909$20240912$20240912$EXP$FR-AFSSAPS-TO2024001392$FR-BEH-2024176487$CSL BEHRING$$78$YR$E$F$Y$46$KG$20240912$$CN$FR$FR
243128891$24312889$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687387$GILEAD$$73$YR$E$M$Y$$$20240912$$MD$US$US
243128902$24312890$2$F$$20240910$20240912$20240913$PER$$NVSC2024US182189$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
243128911$24312891$1$I$20240711$20240907$20240912$20240912$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000918$PAREXEL$$$$$$Y$$$20240912$$CN$CN$CN
243128931$24312893$1$I$20231201$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181177$AMGEN$$50$YR$A$F$Y$$$20240912$$HP$US$US
243128942$24312894$2$F$20240822$20240916$20240912$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142305$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240918$$CN$US$US
243128951$24312895$1$I$$20240905$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142758$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240912$$MD$US$US
243128961$24312896$1$I$20230101$20240909$20240912$20240912$EXP$$US-ABBVIE-5915770$ABBVIE$$65$YR$$M$Y$$$20240912$$CN$US$US
243128972$24312897$2$F$20240101$20240916$20240912$20240919$EXP$$US-ABBVIE-5917227$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243128991$24312899$1$I$$20240906$20240912$20240912$EXP$$DE-MYLANLABS-2024M1081954$MYLAN$$9$YR$$M$Y$$$20240912$$MD$DE$DE
243129001$24312900$1$I$$20240909$20240912$20240912$EXP$$PL-SANDOZ INC.-PHHY2015PL015561$SANDOZ$$$$$M$Y$$$20240912$$HP$PL$PL
243129011$24312901$1$I$20240101$20240829$20240912$20240912$EXP$$CA-UCBSA-2024045520$UCB$$43$YR$$F$Y$$$20240912$$HP$CA$CA
243129021$24312902$1$I$20240101$20240909$20240912$20240912$EXP$$US-ABBVIE-5916274$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243129032$24312903$2$F$$20240918$20240912$20240927$EXP$$IT-TEVA-VS-3240994$TEVA$Conti EA, Chironi F, Petaccia A, Lanni S, Minoia F, Filocamo G. Safety and efficacy of concomitant use of anti IL17 and anti IL6 agents in a case of severe refractory systemic JIA: Report of the first 18 months of treatment. Pediatr-Rheumatol 2023; 21 (Suppl.).; Conti EA, Chironi F, Petaccia A, Lanni S, Minoia F, Filocamo G. Safety and efficacy of concomitant use of anti IL17 and anti IL6 agents in a case of severe refractory systemic JIA: Report of the first 18 months of treatment. Pediatr-R...$$$$F$Y$$$20240927$$HP$IT$IT
243129041$24312904$1$I$20240301$20240905$20240912$20240912$EXP$$US-ABBVIE-5689191$ABBVIE$$57$YR$$M$Y$$$20240912$$CN$US$US
243129071$24312907$1$I$20240905$20240905$20240912$20240912$EXP$$BR-GSK-BR2024AMR112143$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$BR$BR
243129081$24312908$1$I$20240717$20240813$20240912$20240912$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000183$LANNETT$$53$YR$$F$Y$$$20240912$$CN$US$US
243129091$24312909$1$I$$20240910$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA079244$SANDOZ$$90$YR$$F$Y$49$KG$20240912$$PH$CA$CA
243129111$24312911$1$I$$20240903$20240912$20240912$EXP$$US-TEVA-VS-3240680$TEVA$$$$$F$Y$$$20240912$$CN$US$US
243129122$24312912$2$F$$20240918$20240912$20240927$EXP$$PT-TEVA-VS-3240991$TEVA$Campos ID, Moreira H, Portal F, Paiva JA. Unusual presentation of benzodiazepine withdrawal with Takotsubo syndrome: a case report. Eur-Heart-J-Case-Rep 2024; 8 (4):.; Campos ID, Moreira H, Portal F, Paiva JA. Unusual presentation of benzodiazepine withdrawal with Takotsubo syndrome: a case report. Eur-Heart-J-Case-Rep 2024; 8 (4):.$58$YR$$F$Y$$$20240927$$HP$PT$PT
243129131$24312913$1$I$20240801$20240911$20240912$20240912$EXP$$US-BAYER-2024A130205$BAYER$$41$YR$A$F$Y$$$20240912$$CN$US$US
243129152$24312915$2$F$$20240917$20240912$20240919$EXP$$FR-SANDOZ INC.-SDZ2024FR079228$SANDOZ$$50$YR$$F$Y$135$KG$20240919$$HP$FR$FR
243129161$24312916$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145515$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240912$$CN$US$US
243129171$24312917$1$I$$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143633$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240912$$HP$US$US
243129182$24312918$2$F$$20240917$20240912$20240925$EXP$$US-TEVA-VS-3240111$TEVA$Greenman M, Bellone S, Demirkiran C, Max Philipp Hartwich T, Santin AD. Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer. Gynecol-Oncol-Rep 2024; 54 101459.; Greenman M, Bellone S, Demirkiran C, Max Philipp Hartwich T, Santin AD. Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer. Gynecol-Oncol-Rep 2024; 54 101459.; Greenman M, Bellone S, Demirkiran C, Max Philipp Hartwich T, Santin AD. Sacituzumab g...$69$YR$$F$Y$$$20240925$$HP$US$US
243129191$24312919$1$I$$20240906$20240912$20240912$EXP$$US-BIOGEN-2024BI01281683$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
243129212$24312921$2$F$20240126$20240917$20240912$20240924$EXP$$NVSC2024ZA179256$NOVARTIS$$20$YR$$F$Y$$$20240924$$HP$ZA$ZA
243129221$24312922$1$I$$20240906$20240912$20240912$EXP$$JP-ARGENX-2024-ARGX-JP007577$ARGENX BVBA$$$$$$Y$$$20240912$$PH$JP$JP
243129232$24312923$2$F$20240101$20240913$20240912$20240916$EXP$$US-ABBVIE-5919083$ABBVIE$$$$$F$Y$68$KG$20240916$$CN$US$US
243129241$24312924$1$I$$20240906$20240912$20240912$30DAY$$US-PFIZER INC-202400252961$PFIZER$$3$YR$$M$Y$$$20240912$$CN$US$US
243129251$24312925$1$I$20240911$20240911$20240912$20240912$EXP$$KR-BAYER-2024A130589$BAYER$$$$$F$Y$$$20240912$$HP$KR$KR
243129261$24312926$1$I$$20240905$20240912$20240912$30DAY$$US-GSK-US2024110787$GLAXOSMITHKLINE$$$$E$F$Y$$$20240912$$CN$US$US
243129271$24312927$1$I$$20240905$20240912$20240912$EXP$$CA-GSK-CA2024110683$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$CA$CA
243129281$24312928$1$I$20160101$20240909$20240912$20240912$EXP$$LV-SANDOZ INC.-NVSC2019LV078976$SANDOZ$$39$YR$$F$Y$$$20240912$$MD$LV$LV
243129291$24312929$1$I$20210101$20240909$20240912$20240912$EXP$$US-ABBVIE-5917329$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243129301$24312930$1$I$20240820$20240903$20240912$20240912$PER$$US-009507513-2409USA001114$MERCK$$74$YR$$F$Y$$$20240912$$CN$US$US
243129311$24312931$1$I$$20240905$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143584$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240912$$CN$US$US
243129321$24312932$1$I$20160301$20240904$20240912$20240912$EXP$DE-drreddys-GER/GER/18/0099860$DE-RDY-GER/GER/18/0099860$DR REDDYS$$82$YR$E$F$Y$56$KG$20240912$$MD$DE$DE
243129331$24312933$1$I$$20240910$20240912$20240912$EXP$$BG-ABBVIE-5919413$ABBVIE$$58$YR$$M$Y$$$20240912$$CN$BG$BG
243129341$24312934$1$I$20240909$20240910$20240912$20240912$EXP$$US-TAKEDA-2024TUS090531$TAKEDA$$65$YR$$F$Y$$$20240912$$HP$US$US
243129351$24312935$1$I$$20240905$20240912$20240912$EXP$$ZA-TAKEDA-2023TUS085304$TAKEDA$$$$$F$Y$$$20240912$$CN$ZA$ZA
243129371$24312937$1$I$$20240910$20240912$20240912$PER$$US-BAYER-2024A129552$BAYER$$43$YR$A$F$Y$$$20240912$$CN$US$US
243129381$24312938$1$I$$20240904$20240912$20240912$EXP$$US-MYLANLABS-2024M1082508$MYLAN$Wallace CE, Tam I, Beveridge MG. Cyclosporine for Recalcitrant Bullous Pemphigoid Induced by Nivolumab Therapy for Malignant Melanoma. Cutis 2024; 114 (1): E21-E23.$41$YR$$M$Y$$$20240912$$HP$US$US
243129391$24312939$1$I$20200327$20240905$20240912$20240912$EXP$PL-URPL-1-1602-2020$PL-TEVA-VS-3240813$TEVA$$75$YR$$F$Y$$$20240912$$MD$PL$PL
243129401$24312940$1$I$$20240905$20240912$20240912$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR112159$VIIV$$$$$$Y$$$20240912$$HP$US$US
243129421$24312942$1$I$20240830$20240903$20240912$20240912$PER$$US-ABBVIE-5907101$ABBVIE$$16$YR$$F$Y$$$20240912$$CN$US$US
243129431$24312943$1$I$20240827$20240830$20240912$20240912$PER$$US-JNJFOC-20240902905$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240912$$PH$US$US
243129441$24312944$1$I$$20240829$20240912$20240912$PER$$US-ROCHE-10000070302$ROCHE$$$$A$F$Y$$$20240912$$CN$US$US
243129451$24312945$1$I$20200420$20240830$20240912$20240912$EXP$$JP-EXELIXIS-EXL-2024-000123$EXELIXIS$$59$YR$$M$Y$69.6$KG$20240912$$MD$JP$JP
243129461$24312946$1$I$20240808$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62705$$FDA-CTU$$66$YR$$M$N$$$20240912$N$HP$US$
243129471$24312947$1$I$$20240909$20240912$20240912$DIR$FDA-CDER-CTU-2024-62707$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243129481$24312948$1$I$$20240909$20240912$20240912$DIR$FDA-CDER-CTU-2024-62708$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243129491$24312949$1$I$20240826$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62709$$FDA-CTU$$43$YR$$M$N$$$20240912$N$$US$
243129511$24312951$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62712$$FDA-CTU$$20$YR$$M$N$$$20240912$N$$US$
243129521$24312952$1$I$20240910$20240912$20240912$20240912$DIR$718107$$FDA-CTU$$25$YR$$F$N$56.25$KG$20240912$N$CN$US$
243129531$24312953$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62713$$FDA-CTU$$60$YR$$F$N$133$LBS$20240912$N$$US$
243129551$24312955$1$I$20240801$20240903$20240912$20240912$EXP$FR-AFSSAPS-TO2024001636$FR-TEVA-VS-3240176$TEVA$$62$YR$$F$Y$156$KG$20240912$$MD$FR$FR
243129561$24312956$1$I$20240907$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024181857$AMGEN$$78$YR$E$M$Y$$$20240912$$CN$US$US
243129572$24312957$2$F$20240907$20240912$20240912$20240913$PER$$US-AMGEN-USASP2024181940$AMGEN$$67$YR$E$F$Y$$$20240913$$CN$US$US
243129581$24312958$1$I$$20240905$20240912$20240912$EXP$$US-TAKEDA-2024TUS089936$TAKEDA$$$$$M$Y$$$20240912$$CN$US$US
243129591$24312959$1$I$20240420$20240905$20240912$20240912$EXP$$BR-BIOGEN-2024BI01281646$BIOGEN$$18$YR$$F$Y$55$KG$20240912$$CN$BR$BR
243129601$24312960$1$I$20230101$20240821$20240912$20240912$EXP$$FR-SA-2023SA348788$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240912$$MD$FR$FR
243129621$24312962$1$I$20240910$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024182020$AMGEN$$64$YR$A$F$Y$$$20240912$$CN$US$US
243129631$24312963$1$I$$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024182404$AMGEN$$$$$$Y$$$20240912$$PH$US$US
243129641$24312964$1$I$$20240413$20240912$20240912$30DAY$$HN-PFIZER INC-PV202400049951$PFIZER$$9$YR$$$Y$$$20240912$$HP$HN$HN
243129652$24312965$2$F$20240907$20240913$20240912$20240917$EXP$$GR-ABBVIE-5917583$ABBVIE$$49$YR$$F$Y$89$KG$20240917$$MD$GR$GR
243129661$24312966$1$I$20240101$20240904$20240912$20240912$EXP$$US-SA-2024SA262726$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240912$$HP$US$US
243129671$24312967$1$I$20240823$20240909$20240912$20240912$EXP$ES-AEMPS-1565724$ES-FreseniusKabi-FK202413606$FRESENIUS KABI$$79$YR$E$F$Y$$$20240912$$MD$ES$ES
243129681$24312968$1$I$20240826$20240909$20240912$20240912$EXP$$DE-FreseniusKabi-FK202413547$FRESENIUS KABI$$67$YR$E$M$Y$100.6$KG$20240912$$MD$DE$DE
243129691$24312969$1$I$20240801$20240826$20240912$20240912$EXP$$US-RADIUS HEALTH INC.-2024US006821$RADIUS PHARM$$61$YR$$F$Y$$$20240912$$CN$US$US
243129701$24312970$1$I$20240101$20240830$20240912$20240912$EXP$$US-UCBSA-2024044532$UCB$$$$$F$Y$$$20240912$$CN$US$US
243129711$24312971$1$I$20240101$20240821$20240912$20240912$PER$$US-SA-2024SA262816$SANOFI AVENTIS$$11$YR$C$F$Y$39.09$KG$20240912$$MD$US$US
243129721$24312972$1$I$$20240826$20240912$20240912$PER$$US-SA-2024SA262660$SANOFI AVENTIS$$$$A$M$Y$130$KG$20240912$$MD$US$US
243129731$24312973$1$I$20240301$20240904$20240912$20240912$PER$$US-SA-2024SA264046$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240912$$HP$US$US
243129741$24312974$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA264174$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240912$$CN$US$US
243129751$24312975$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687379$GILEAD$$58$YR$A$M$Y$$$20240912$$MD$US$US
243129761$24312976$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145570$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240912$$CN$US$US
243129771$24312977$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144821$BRISTOL MYERS SQUIBB$$27$YR$A$F$Y$$$20240912$$CN$US$US
243129781$24312978$1$I$20240201$20240911$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145317$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240912$$CN$US$US
243129791$24312979$1$I$20240901$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145297$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$65.77$KG$20240912$$CN$US$US
243129801$24312980$1$I$20240909$20240911$20240912$20240912$EXP$$NVSC2024US182456$NOVARTIS$$81$YR$$M$Y$$$20240912$$CN$US$US
243129811$24312981$1$I$20240619$20240910$20240912$20240912$EXP$SE-SEMPA-2024-006217$SE-SANDOZ INC.-SDZ2024SE079148$SANDOZ$$38$YR$$F$Y$$$20240912$$MD$SE$SE
243129821$24312982$1$I$20240821$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007403$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240912$$CN$US$US
243129831$24312983$1$I$20240101$20240830$20240912$20240912$PER$$US-SA-2024SA262063$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240912$$HP$US$US
243129842$24312984$2$F$$20240912$20240912$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007457$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240915$$CN$US$US
243129851$24312985$1$I$$20240820$20240912$20240912$PER$$US-SA-2024SA262045$SANOFI AVENTIS$$$$A$F$Y$88.64$KG$20240912$$MD$US$US
243129861$24312986$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA263155$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240912$$MD$US$US
243129871$24312987$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262410$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240912$$CN$US$US
243129881$24312988$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA263764$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240912$$HP$US$US
243129891$24312989$1$I$20231001$20240904$20240912$20240912$PER$$US-SA-2024SA263945$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240912$$MD$US$US
243129901$24312990$1$I$20240101$20240909$20240912$20240912$EXP$$FR-ABBVIE-5919687$ABBVIE$$56$YR$$F$Y$$$20240912$$MD$FR$FR
243129911$24312991$1$I$20240912$20240912$20240912$20240912$DIR$718109$$FDA-CTU$$65$YR$$F$N$54$KG$20240912$$CN$US$
243129931$24312993$1$I$20240904$20240905$20240912$20240912$EXP$$AU-BEH-2024178313$CSL BEHRING$$5$MON$I$M$Y$$$20240912$$MD$AU$AU
243129941$24312994$1$I$$20240905$20240912$20240912$EXP$$US-JNJFOC-20240919554$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243129961$24312996$1$I$20240902$20240912$20240912$20240912$DIR$718110$$FDA-CTU$$74$YR$$M$N$103.5$KG$20240912$N$CN$US$
243129981$24312998$1$I$$20240909$20240912$20240912$EXP$GB-MHRA-MED-202409071112464930-LVPWQ$GB-009507513-2409GBR003162$MERCK$$62$YR$$F$Y$78$KG$20240912$$CN$GB$GB
243129991$24312999$1$I$20240912$20240912$20240912$20240912$DIR$718111$$FDA-CTU$$64$YR$$F$N$108$KG$20240912$N$CN$US$
243130001$24313000$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143412$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$72.57$KG$20240912$$CN$US$US
243130021$24313002$1$I$$20240904$20240912$20240912$EXP$$NVSC2024JP180998$NOVARTIS$Yoshida Y, Motoyama R. A case of recurrent multiple cartilage inflammation and incomplete behcet^s disease in which oral steroids were ineffective. PROGRAM AND ABSTRACTS OF THE 35TH DIENCEPHALON-PITUITARY-ADRENAL SYSTEM RESEARCH. 2024$35$YR$$F$Y$30$KG$20240912$$HP$JP$JP
243130031$24313003$1$I$$20240823$20240912$20240912$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08609$LUPIN$$$$$$Y$$$20240912$$CN$US$US
243130041$24313004$1$I$20240831$20240910$20240912$20240912$PER$$US-ROCHE-10000079293$ROCHE$$42$YR$A$F$Y$$$20240912$$CN$US$US
243130051$24313005$1$I$20240401$20240911$20240912$20240912$EXP$$ES-TAKEDA-2024TUS050708$TAKEDA$$5$YR$$M$Y$$$20240912$$HP$ES$ES
243130072$24313007$2$F$$20240909$20240912$20240917$EXP$$HU-SANDOZ INC.-PHHY2019HU162992$SANDOZ$$38$YR$$M$Y$$$20240917$$MD$HU$HU
243130081$24313008$1$I$$20240905$20240912$20240912$EXP$$CA-GSK-CA2024048807$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$CA$CA
243130091$24313009$1$I$20200101$20240906$20240912$20240912$EXP$$FR-GILEAD-2020-0497386$GILEAD$Le MP, Le HQ, Jaquet P, Wicky PH, Bunel V, Massias L,etal. Removal of remdesivir^s metabolite GS-441524 by hemodialysis in a double lung transplant recipient with COVID-19.. Antimicrobial Agents + Chemotherapy.. 2020;64 (11):E01521-20. doi:10.1128/AAC.01521-20$5$DEC$A$M$Y$44$KG$20240912$$PH$FR$FR
243130101$24313010$1$I$20240822$20240911$20240912$20240912$PER$$US-ROCHE-10000080049$ROCHE$$11$YR$C$M$Y$$$20240912$$CN$US$US
243130111$24313011$1$I$$20240905$20240912$20240912$EXP$US-MLMSERVICE-20240829-PI176376-00307-1$US-RDY-SPO/USA/24/0013072$DR REDDYS$Zou H, Rau A, Thompson L, Henderson D. Pancytopenia Concurrent With Metabolic Encephalopathy. Cureus. 2024;16(8):e67963. DOI: 10.7759/cureus.67963.$81$YR$E$F$Y$$$20240912$$MD$US$US
243130131$24313013$1$I$$20240911$20240912$20240912$PER$$US-ROCHE-10000079766$ROCHE$$$$A$M$Y$$$20240912$$CN$US$US
243130141$24313014$1$I$20240601$20240911$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145030$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240912$$CN$US$US
243130151$24313015$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144368$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240912$$HP$US$US
243130161$24313016$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144787$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240912$$CN$US$US
243130171$24313017$1$I$20240815$20240905$20240912$20240912$EXP$$NZ-MYLANLABS-2024M1080395$MYLAN$$21$YR$$M$Y$$$20240912$$HP$NZ$NZ
243130181$24313018$1$I$$20240905$20240912$20240912$EXP$$IN-MYLANLABS-2024M1082846$MYLAN$Nayak S, Sharma H, Shah A. A rare case of Elizabethkingia meningoseptica bacteremia followed by meningitis in post-liver transplant patient. Transpl-Infect-Dis 2024; 26.$50$YR$$M$Y$$$20240912$$HP$IN$IN
243130191$24313019$1$I$$20240905$20240912$20240912$EXP$$ES-MYLANLABS-2024M1082857$MYLAN$Cantero AB, Nunez ML, Luis GR, Lucena CR, Rueda JR. Non-infectious fever. about a case. Eur-J-Case-Rep-Intern-Med 2024; 11 (Suppl. 1) 915 abstr. 2899.$62$YR$$F$Y$$$20240912$$HP$ES$ES
243130201$24313020$1$I$20240801$20240905$20240912$20240912$EXP$$UY-ABBVIE-5913621$ABBVIE$$41$YR$$F$Y$$$20240912$$CN$UY$UY
243130211$24313021$1$I$$20240909$20240912$20240912$EXP$$US-INCYTE CORPORATION-2024IN009537$INCYTE$$$$$$Y$$$20240912$$CN$US$US
243130221$24313022$1$I$20240101$20240903$20240912$20240912$EXP$$GB-TAKEDA-2024TUS090816$TAKEDA$$74$YR$$$Y$$$20240912$$MD$GB$GB
243130231$24313023$1$I$$20240910$20240912$20240912$EXP$$NVSC2024CA181557$NOVARTIS$$43$YR$$F$Y$$$20240912$$HP$CA$CA
243130242$24313024$2$F$20100101$20240917$20240912$20240919$EXP$$FR-SA-2024SA263622$SANOFI AVENTIS$Petruzzo P, Testelin S, Kanitakis J, Badet L, Lengel? B, Girbon JP et al.. First human face transplantation: 5 years outcomes.. Transplantation.. 2012;93(2):236-40.$$$A$F$Y$$$20240919$$MD$FR$FR
243130251$24313025$1$I$20240730$20240909$20240912$20240912$EXP$$US-INCYTE CORPORATION-2024IN009514$INCYTE$$$$$$Y$$$20240912$$CN$US$US
243130261$24313026$1$I$$20240821$20240912$20240912$PER$$AU-TOLMAR, INC.-24AU052054$TOLMAR$$$$$M$Y$$$20240912$$CN$AU$AU
243130271$24313027$1$I$$20240910$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA079219$SANDOZ$$3$YR$$$Y$$$20240912$$CN$CA$CA
243130291$24313029$1$I$20240802$20240808$20240912$20240912$PER$$US-ANIPHARMA-2024-US-042678$ANI$$78$YR$$F$Y$85.73$KG$20240912$$CN$US$US
243130301$24313030$1$I$$20240822$20240912$20240912$PER$$AU-TOLMAR, INC.-24AU051875$TOLMAR$$76$YR$$M$Y$$$20240912$$PH$AU$AU
243130311$24313031$1$I$$20240822$20240912$20240912$PER$$AU-TOLMAR, INC.-24AU052024$TOLMAR$$$$$M$Y$$$20240912$$CN$AU$AU
243130321$24313032$1$I$$20240822$20240912$20240912$PER$$AU-TOLMAR, INC.-24AU052088$TOLMAR$$$$$M$Y$$$20240912$$CN$AU$AU
243130331$24313033$1$I$20240822$20240823$20240912$20240912$PER$$AU-TOLMAR, INC.-24AU052094$TOLMAR$$$$$$Y$$$20240912$$HP$AU$AU
243130341$24313034$1$I$$20240821$20240912$20240912$PER$$AU-TOLMAR, INC.-24AU052089$TOLMAR$$$$$M$Y$$$20240912$$CN$AU$AU
243130351$24313035$1$I$20240604$20240821$20240912$20240912$PER$$BR-TOLMAR, INC.-24BR052099$TOLMAR$$10$YR$$F$Y$$$20240912$$CN$BR$BR
243130361$24313036$1$I$$20240823$20240912$20240912$PER$$AU-TOLMAR, INC.-24AU052191$TOLMAR$$$$$M$Y$$$20240912$$CN$AU$AU
243130371$24313037$1$I$$20240823$20240912$20240912$PER$$AU-TOLMAR, INC.-24AU052192$TOLMAR$$$$$M$Y$$$20240912$$CN$AU$AU
243130391$24313039$1$I$$20240822$20240912$20240912$PER$$BR-TOLMAR, INC.-24BR052125$TOLMAR$$$$$F$Y$$$20240912$$CN$BR$BR
243130411$24313041$1$I$20240723$20240822$20240912$20240912$PER$$BR-TOLMAR, INC.-24BR052141$TOLMAR$$11$YR$$F$Y$$$20240912$$CN$BR$BR
243130421$24313042$1$I$20240207$20240823$20240912$20240912$PER$$BR-TOLMAR, INC.-24BR052186$TOLMAR$$8$YR$$F$Y$$$20240912$$CN$BR$BR
243130521$24313052$1$I$20240901$20240909$20240912$20240912$EXP$$IT-ABBVIE-5916904$ABBVIE$$71$YR$$F$Y$$$20240912$$CN$IT$IT
243130531$24313053$1$I$20240421$20240911$20240912$20240912$EXP$$CA-PFIZER INC-PV202200077841$PFIZER$$64$YR$$F$Y$$$20240912$$HP$CA$CA
243130541$24313054$1$I$$20240910$20240912$20240912$EXP$$US-BAYER-2024A129927$BAYER$$51$YR$A$M$Y$$$20240912$$HP$US$US
243130551$24313055$1$I$20240701$20240909$20240912$20240912$EXP$$US-INCYTE CORPORATION-2024IN009512$INCYTE$$$$$$Y$$$20240912$$CN$US$US
243130561$24313056$1$I$20240801$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144676$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240912$$CN$US$US
243130571$24313057$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144829$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240912$$CN$US$US
243130581$24313058$1$I$20240610$20240903$20240912$20240912$EXP$FR-AFSSAPS-AVMA2024000364$FR-TEVA-VS-3239982$TEVA$$43$YR$$M$Y$$$20240912$$PH$FR$FR
243130601$24313060$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144409$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240912$$HP$US$US
243130611$24313061$1$I$20240801$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144832$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240912$$HP$US$US
243130621$24313062$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145062$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240912$$HP$US$US
243130631$24313063$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145057$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240912$$HP$US$US
243130641$24313064$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145052$BRISTOL MYERS SQUIBB$$9$YR$C$M$Y$$$20240912$$HP$US$US
243130651$24313065$1$I$20240801$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145315$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$119.29$KG$20240912$$CN$US$US
243130661$24313066$1$I$20240101$20240909$20240912$20240912$PER$$US-JNJFOC-20240922118$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$PH$US$US
243130671$24313067$1$I$$20240909$20240912$20240912$EXP$$US-INCYTE CORPORATION-2024IN009505$INCYTE$$$$$$Y$$$20240912$$CN$US$US
243130681$24313068$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144853$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240912$$PH$US$US
243130691$24313069$1$I$$20240909$20240912$20240912$EXP$$CN-SANDOZ INC.-SDZ2024CN079422$SANDOZ$Lankai Liao. Severe sepsis induced by zoledronic acid A case report. Medicine. 2024$58$YR$$F$Y$$$20240912$$HP$CN$CN
243130702$24313070$2$F$20240911$20240912$20240912$20240913$PER$$US-AMGEN-USASP2024182331$AMGEN$$71$YR$E$F$Y$$$20240913$$CN$US$US
243130711$24313071$1$I$$20240912$20240912$20240912$DIR$718116$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243130721$24313072$1$I$$20240909$20240912$20240912$EXP$$US-INCYTE CORPORATION-2024IN009506$INCYTE$$$$$$Y$$$20240912$$CN$US$US
243130731$24313073$1$I$$20240903$20240912$20240912$EXP$$TR-BIOMARINAP-TR-2024-160313$BIOMARIN$Yuksel, T., Yalcinkaya, E., Kasapoglu, U.S., Kasapoglu, U.S., Arikan, H., et al.. MUCOPOLYSACCHARIDOSIS TYPE IV: A CASE REPORT OF MORQUIO SYNDROME. European Journal of Case Reports in Internal Medicine. 2024;11:865-866$$$$$Y$$$20240912$$MD$TR$TR
243130742$24313074$2$F$$20240829$20240912$20240918$EXP$$US-SA-2024SA263431$SANOFI AVENTIS$$65$YR$E$F$Y$64.41$KG$20240918$$MD$US$US
243130761$24313076$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182831$NOVARTIS$$$$$M$Y$$$20240912$$HP$US$US
243130771$24313077$1$I$20240903$20240912$20240912$20240912$DIR$718114$$FDA-CTU$$50$YR$$F$N$94.95$KG$20240912$N$CN$US$
243130781$24313078$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62718$$FDA-CTU$$82$YR$$M$N$$$20240912$N$$US$
243130791$24313079$1$I$$20240912$20240912$20240912$DIR$718117$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243130801$24313080$1$I$$20240912$20240912$20240912$DIR$718118$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243130841$24313084$1$I$20220127$20240906$20240912$20240912$EXP$$CN-SA-2022SA233010$SANOFI AVENTIS$$52$YR$A$M$Y$56$KG$20240912$$HP$CN$CN
243130851$24313085$1$I$20240823$20240906$20240912$20240912$EXP$$US-ABBVIE-5914846$ABBVIE$$62$YR$$F$Y$$$20240912$$CN$US$US
243130871$24313087$1$I$20240722$20240822$20240912$20240912$PER$$US-SA-2024SA262383$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240912$$MD$US$US
243130893$24313089$3$F$20230731$20240920$20240912$20240927$EXP$DE-SANDOZ-SDZ2024DE075732$DE-RDY-SPO/DEU/24/0013082$DR REDDYS$Gallinger A, Osei-Davies R, Hennersdorf F. Reversibility of a critical intraventricular conduction delay under flecainide and lacosamide by sodium bicarbonate. Innere Medizin.2024;1-4. doi:10.1007/s00108-024-01768-2$72$YR$E$F$Y$$$20240927$$MD$DE$DE
243130901$24313090$1$I$20230701$20240908$20240912$20240912$EXP$GB-MHRA-MED-202409082049593860-LVBDS$GB-RDY-SPO/GBR/24/0013185$DR REDDYS$$8$YR$C$M$Y$28$KG$20240912$$CN$GB$US
243130911$24313091$1$I$20240821$20240904$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013105$DR REDDYS$$17$YR$T$$Y$$$20240912$$HP$US$US
243130922$24313092$2$F$$20240909$20240912$20240917$EXP$$US-JNJFOC-20240926279$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243130931$24313093$1$I$$20240909$20240912$20240912$PER$$US-JNJFOC-20240921246$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$PH$US$US
243130941$24313094$1$I$$20240827$20240912$20240912$30DAY$$FR-JNJFOC-20240872336$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240912$$PH$FR$FR
243130951$24313095$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA262284$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240912$$HP$US$US
243130961$24313096$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA262111$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240912$$CN$US$US
243130981$24313098$1$I$$20240912$20240912$20240912$DIR$718126$$FDA-CTU$$$$$UNK$N$$$20240912$$CN$US$
243130992$24313099$2$F$$20240918$20240912$20240927$EXP$$US-TEVA-VS-3240386$TEVA$Steinbacher D, Murray B, Devlin T, Carson SS, Ford HJ. Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy. Pulm-Circ 2024; 14 (2):.; Steinbacher D, Murray B, Devlin T, Carson SS, Ford HJ. Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy. Pulm-Circ 2024; 14 (2):.$33$YR$$M$Y$$$20240927$$HP$US$US
243131001$24313100$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62724$$FDA-CTU$$51$YR$$F$N$$$20240912$N$$US$
243131011$24313101$1$I$20240830$20240903$20240912$20240912$PER$$US-SA-2024SA261878$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240912$$HP$US$US
243131031$24313103$1$I$20240523$20240906$20240912$20240912$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-082117$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240912$$CN$GB$GB
243131051$24313105$1$I$20240912$20240912$20240912$20240912$DIR$718128$$FDA-CTU$$69$YR$$F$N$$$20240912$N$PH$US$
243131072$24313107$2$F$$20240918$20240912$20240927$EXP$$CA-TEVA-VS-3242730$TEVA$Brillant-Marquis F, Proulx E, Ratnarajah K, Lavoie A, Gauthier A, Gagnon R, Boursiquot J-N, Verreault N, Marois L, Bedard M-A, Boivin M, Bedard P-M, Ouakki M, De Serres G, Drolet J-P. Safety Of Direct Drug Provocation For The Evaluation Of Penicillin Allergy In Low-risk Adults. Journal of Allergy and Clinical Immunology 153 (Suppl.): AB227 abstr. 701.; Brillant-Marquis F, Proulx E, Ratnarajah K, Lavoie A, Gauthier A, Gagnon R, et al. Safety of Direct Drug Provocation for the Evaluation of Pen...$$$$$Y$$$20240927$$MD$CA$CA
243131081$24313108$1$I$20221101$20240903$20240912$20240912$PER$$US-SA-2024SA262246$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240912$$CN$US$US
243131091$24313109$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006281$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240912$$CN$US$US
243131101$24313110$1$I$$20240909$20240912$20240912$EXP$$BE-INCYTE CORPORATION-2024IN009479$INCYTE$$$$$$Y$$$20240912$$HP$BE$BE
243131111$24313111$1$I$$20240903$20240912$20240912$EXP$$US-BEH-2024178409$CSL BEHRING$$75$YR$E$M$Y$$$20240912$$HP$US$US
243131121$24313112$1$I$$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144560$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240912$$CN$US$US
243131131$24313113$1$I$$20240905$20240912$20240912$EXP$$NVSC2024PL181581$NOVARTIS$Miskiewicz-Bujna J, Miskiewicz-Migon I, Kozlowska M, Babol-Pokora K, Irga-Jaworska N, Mlynarski W et al.. Successful hematopoietic stem cell transplantation in MYH9-related congenital thrombocytopenia. PEDIATR BLOOD CANCER. 2024;71:e31005:1-2$$$I$M$Y$$$20240912$$HP$PL$PL
243131151$24313115$1$I$$20240910$20240912$20240912$EXP$$NVSC2024US181981$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
243131161$24313116$1$I$20240101$20240909$20240912$20240912$EXP$$US-ABBVIE-5916153$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243131171$24313117$1$I$20240701$20240904$20240912$20240912$EXP$NO-NOMAADVRE-PASRAPP-2024-V37458$NO-TEVA-VS-3240529$TEVA$$56$YR$$F$Y$$$20240912$$CN$NO$NO
243131181$24313118$1$I$$20240906$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143790$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240912$$CN$US$US
243131201$24313120$1$I$20240815$20240911$20240912$20240912$EXP$$US-BAYER-2024A130658$BAYER$$44$YR$A$M$Y$$$20240912$$CN$US$US
243131211$24313121$1$I$20240801$20240906$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142812$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240912$$HP$US$US
243131222$24313122$2$F$20240101$20240911$20240912$20240919$EXP$$US-BIOGEN-2024BI01281631$BIOGEN$$$$$M$Y$$$20240919$$CN$US$US
243131231$24313123$1$I$20240908$20240909$20240912$20240912$EXP$$ID-AstraZeneca-2024A207959$ASTRAZENECA$$18661$DY$$F$Y$$$20240912$$CN$ID$
243131241$24313124$1$I$$20240911$20240912$20240912$EXP$$NVSC2024AU062191$NOVARTIS$$$$$F$Y$$$20240912$$HP$AU$AU
243131252$24313125$2$F$$20240925$20240912$20240927$PER$$NVSC2024US182944$NOVARTIS$$$$$$Y$$$20240927$$MD$US$US
243131261$24313126$1$I$20240101$20240905$20240912$20240912$PER$$US-AMGEN-USASP2024178308$AMGEN$$60$YR$A$M$Y$$$20240912$$MD$US$US
243131271$24313127$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687378$GILEAD$$72$YR$E$M$Y$$$20240912$$MD$US$US
243131281$24313128$1$I$$20240906$20240912$20240912$PER$$US-ALXN-202409USA000427US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243131292$24313129$2$F$$20240903$20240912$20240916$PER$$PR-ABBVIE-5906556$ABBVIE$$$$A$F$Y$$$20240916$$MD$PR$PR
243131301$24313130$1$I$$20240907$20240912$20240912$EXP$$US-BAYER-2024A128330$BAYER$$$$$$Y$$$20240912$$CN$US$US
243131311$24313131$1$I$20240525$20240906$20240912$20240912$PER$$NL-Blueprint Medicines Corporation-SO-NL-2024-001813$BLUEPRINT MEDICINES$$80$YR$E$M$Y$$$20240912$$MD$NL$NL
243131321$24313132$1$I$20200721$20240904$20240912$20240912$EXP$PL-URPL-1-1830-2020$PL-TEVA-VS-3240432$TEVA$$67$YR$$F$Y$85$KG$20240912$$MD$PL$PL
243131331$24313133$1$I$20240810$20240906$20240912$20240912$EXP$GB-MHRA-MED-202408271048496410-JKFYS$GB-GSK-GB2024106587$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$MD$GB$GB
243131342$24313134$2$F$20240801$20240918$20240912$20240918$EXP$$JP-PFIZER INC-PV202400119396$PFIZER$$$$$F$Y$$$20240918$$MD$JP$JP
243131351$24313135$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145248$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240912$$CN$US$US
243131361$24313136$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144668$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240912$$CN$US$US
243131382$24313138$2$F$20240401$20240912$20240912$20240919$EXP$$US-RDY-SPO/USA/24/0013089$DR REDDYS$$$$$F$Y$$$20240919$$CN$US$US
243131391$24313139$1$I$$20240904$20240912$20240912$EXP$$US-BIOMARINAP-US-2024-160412$BIOMARIN$Cooney E.,  Ammous Z., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024$$$$$Y$$$20240912$$MD$US$US
243131401$24313140$1$I$$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024182283$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
243131431$24313143$1$I$20240911$20240912$20240912$20240912$DIR$718140$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243131441$24313144$1$I$20240712$20240912$20240912$20240912$DIR$718102$$FDA-CTU$$36$YR$$M$N$83.25$KG$20240912$Y$CN$US$
243131451$24313145$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62738$$FDA-CTU$$68$YR$$M$N$27.67$KG$20240912$N$$US$
243131461$24313146$1$I$20240908$20240912$20240912$20240912$DIR$718130$$FDA-CTU$$96$YR$$M$N$90$KG$20240912$N$CN$US$
243131481$24313148$1$I$20240912$20240912$20240912$20240912$DIR$718137$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243131491$24313149$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62740$$FDA-CTU$$36$YR$$M$N$$$20240912$N$$US$
243131502$24313150$2$F$$20240918$20240912$20240927$EXP$$IL-TEVA-VS-3241029$TEVA$Liran R, Garra W, Carmi O, Levy Y, Einbinder Y. A Severe Acute Kidney Injury Following Zoledronic Acid Therapy Leading to Chronic Hemodialysis Treatment: A Case Report. Isr-Med-Assoc-J 2023; 25 828-829.; Liran R, Garra W, Carmi O, Levy Y, Einbinder Y. A Severe Acute Kidney Injury Following Zoledronic Acid Therapy Leading to Chronic Hemodialysis Treatment: A Case Report. Isr-Med-Assoc-J 2023; 25 828-829.$78$YR$$F$Y$$$20240927$$MD$IL$IL
243131512$24313151$2$F$$20240906$20240912$20240925$EXP$$BE-BEH-2024178401$CSL BEHRING$$$$A$M$Y$$$20240925$$MD$BE$BE
243131521$24313152$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687395$GILEAD$$63$YR$A$M$Y$$$20240912$$MD$US$US
243131531$24313153$1$I$20240802$20240906$20240912$20240912$EXP$FR-AFSSAPS-CN2024000767$FR-MYLANLABS-2024M1081938$MYLAN$$70$YR$$F$Y$$$20240912$$PH$FR$FR
243131541$24313154$1$I$20230610$20240906$20240912$20240912$EXP$$DE-MYLANLABS-2024M1081890$MYLAN$$67$YR$$M$Y$$$20240912$$MD$DE$DE
243131551$24313155$1$I$$20240903$20240912$20240912$EXP$$DE-Calliditas-2024CAL01784$CALLIDITAS THERAPEUTICS$$59$YR$A$M$Y$$$20240912$$MD$DE$DE
243131561$24313156$1$I$20240812$20240908$20240912$20240912$EXP$$SE-MYLANLABS-2024M1082593$MYLAN$$71$YR$$F$Y$$$20240912$$CN$SE$SE
243131581$24313158$1$I$20240806$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62741$$FDA-CTU$$10$YR$$M$N$$$20240911$N$HP$US$
243131611$24313161$1$I$$20240821$20240912$20240912$PER$$US-SA-2024SA262046$SANOFI AVENTIS$$$$T$F$Y$61.36$KG$20240912$$MD$US$US
243131631$24313163$1$I$$20240912$20240912$20240912$DIR$718135$$FDA-CTU$$$$$UNK$N$$$20240912$$CN$US$
243131641$24313164$1$I$$20240912$20240912$20240912$DIR$718136$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243131651$24313165$1$I$$20240910$20240912$20240912$PER$$US-TAKEDA-2024TUS090682$TAKEDA$$16$YR$$F$Y$$$20240912$$CN$US$US
243131661$24313166$1$I$$20240909$20240912$20240912$DIR$FDA-CDER-CTU-2024-62742$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243131671$24313167$1$I$20240831$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62743$$FDA-CTU$$83$YR$$M$N$$$20240911$N$$US$
243131681$24313168$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144647$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240912$$CN$US$US
243131692$24313169$2$F$$20240918$20240912$20240927$EXP$$CA-TEVA-VS-3240990$TEVA$Benoit P, Wang S, Wang C, Chakravarti A, Villalba JA, Ali IKM, et al. Brainstorm: A case of granulomatous encephalitis. JAMMI 2024; 9 (2): 113-120.; Benoit P, Wang S, Wang C, Chakravarti A, Villalba JA, Ali IKM, et al. Brainstorm: A case of granulomatous encephalitis. JAMMI 2024; 9 (2): 113-120.$74$YR$$F$Y$$$20240927$$MD$CA$CA
243131701$24313170$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144229$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240912$$CN$US$US
243131721$24313172$1$I$20240813$20240905$20240912$20240912$EXP$$US-ABBVIE-5907954$ABBVIE$$75$YR$$F$Y$$$20240912$$CN$US$US
243131731$24313173$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687397$GILEAD$$73$YR$E$M$Y$$$20240912$$MD$US$US
243131741$24313174$1$I$$20240828$20240912$20240912$EXP$$US-CMP PHARMA-2024CMP00052$CMP PHARMA$Desai D, Nohria A, Alhanshali L et al.. Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases. . JAAD Case Rep.. 2024;51:86-91$58$YR$$F$Y$$$20240912$$HP$US$US
243131751$24313175$1$I$20220301$20240828$20240912$20240912$EXP$$US-CMP PHARMA-2024CMP00053$CMP PHARMA$Desai D, Nohria A, Alhanshali L et al.. Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases.. JAAD Case Rep.. 2024;51:86-91$34$YR$$M$Y$$$20240912$$HP$US$US
243131762$24313176$2$F$20231201$20240913$20240912$20240915$EXP$DE-EMBRYOTOX-202310245$DE-DEXPHARM-2024-3095$DEXCEL$$$$N$F$Y$2.6$KG$20240915$$HP$DE$DE
243131782$24313178$2$F$$20240910$20240912$20240923$EXP$$NVSC2024FR177775$NOVARTIS$Tardy C, Puszkiel A, Boudou-Rouquette P, De Percin S, Alexandre J, Berge M et al.. Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection.. CANCER-CHEMOTHER-PHARMACOL. 2024;93:169-75$50$YR$$F$Y$135$KG$20240924$$HP$FR$FR
243131791$24313179$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182942$NOVARTIS$$$$$$Y$$$20240912$$PH$US$US
243131801$24313180$1$I$$20240911$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA079591$SANDOZ$$44$YR$$F$Y$97$KG$20240912$$MD$CA$CA
243131811$24313181$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687402$GILEAD$$40$YR$A$M$Y$$$20240912$$MD$US$US
243131821$24313182$1$I$20240601$20240905$20240912$20240912$EXP$$BR-BIOGEN-2024BI01281643$BIOGEN$$56$YR$$F$Y$60$KG$20240912$$CN$BR$BR
243131831$24313183$1$I$$20240909$20240912$20240912$EXP$$CA-ROCHE-10000067058$ROCHE$$$$A$F$Y$$$20240912$$CN$CA$CA
243131842$24313184$2$F$20240911$20240916$20240912$20240917$PER$$US-AMGEN-USASP2024182315$AMGEN$$75$YR$E$F$Y$$$20240917$$CN$US$US
243131851$24313185$1$I$20240101$20240909$20240912$20240912$PER$$US-ALXN-202409USA000647US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243131861$24313186$1$I$$20240910$20240912$20240912$PER$$US-ALXN-202409USA000712US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243131871$24313187$1$I$$20240906$20240912$20240912$PER$$US-BEH-2024178426$CSL BEHRING$$6$DEC$A$F$Y$$$20240912$$CN$US$US
243131881$24313188$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144700$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240912$$CN$US$US
243131891$24313189$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013171$DR REDDYS$Lee JZ, Karikalan S, Tan M, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC: Clinical Electrophysiology. 2023 Jun;9(6): 824-832. doi:10.1016/j.jacep.2022.10.024.$$$$$Y$$$20240912$$MD$US$US
243131901$24313190$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013170$DR REDDYS$Lee JZ, Karikalan S, Tan M, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC: Clinical Electrophysiology. 2023 Jun;9(6): 824-832. doi:10.1016/j.jacep.2022.10.024.$$$$$Y$$$20240912$$MD$US$US
243131911$24313191$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013166$DR REDDYS$Lee JZ, Karikalan S, Tan M, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC: Clinical Electrophysiology. 2023 Jun;9(6): 824-832. doi:10.1016/j.jacep.2022.10.024.$$$$$Y$$$20240912$$MD$US$US
243131921$24313192$1$I$20141001$20240911$20240912$20240912$PER$$US-JNJFOC-20240931800$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20240912$$HP$US$US
243131931$24313193$1$I$$20240909$20240912$20240912$EXP$$US-JNJFOC-20240925956$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243131941$24313194$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013168$DR REDDYS$Lee JZ, Karikalan S, Tan M, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC: Clinical Electrophysiology. 2023 Jun;9(6): 824-832. doi:10.1016/j.jacep.2022.10.024.$$$$$Y$$$20240912$$MD$US$US
243131951$24313195$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013164$DR REDDYS$Lee JZ, Karikalan S, Tan M, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC: Clinical Electrophysiology. 2023 Jun;9(6): 824-832. doi:10.1016/j.jacep.2022.10.024.$$$$$Y$$$20240912$$MD$US$US
243131962$24313196$2$F$$20240911$20240912$20240920$EXP$$US-TAKEDA-2024TUS090605$TAKEDA$$$$$$Y$$$20240920$$CN$US$US
243131971$24313197$1$I$$20240911$20240912$20240912$EXP$$NVSC2024US182230$NOVARTIS$$$$$$Y$$$20240912$$CN$US$US
243131981$24313198$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0687407$GILEAD$$51$YR$A$M$Y$$$20240912$$MD$US$US
243131991$24313199$1$I$$20240905$20240912$20240912$PER$$US-BAUSCH-BL-2024-013556$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240912$$CN$US$US
243132011$24313201$1$I$$20240910$20240912$20240912$EXP$$CA-ROCHE-3205712$ROCHE$$$$A$F$Y$$$20240912$$CN$CA$CA
243132021$24313202$1$I$$20240909$20240912$20240912$EXP$$CA-BAUSCH-BL-2024-013496$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240912$$HP$CA$CA
243132031$24313203$1$I$$20240911$20240912$20240912$PER$$US-ROCHE-10000079949$ROCHE$$$$A$F$Y$$$20240912$$CN$US$US
243132041$24313204$1$I$$20240906$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA079129$SANDOZ$$$$$F$Y$$$20240912$$MD$CA$CA
243132051$24313205$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006729$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240912$$CN$US$US
243132061$24313206$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62744$$FDA-CTU$$36$YR$$F$N$$$20240912$N$$US$
243132072$24313207$2$F$$20240911$20240912$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409007329$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243132091$24313209$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007377$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240912$$CN$US$US
243132101$24313210$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007592$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240912$$CN$US$US
243132111$24313211$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007418$ELI LILLY AND CO$$46$YR$A$$Y$$$20240912$$LW$US$US
243132121$24313212$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005383$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240912$$PH$US$US
243132131$24313213$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0658192$GILEAD$$72$YR$E$M$Y$$$20240912$$MD$US$US
243132141$24313214$1$I$$20240909$20240912$20240912$DIR$FDA-CDER-CTU-2024-62756$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243132151$24313215$1$I$$20240909$20240912$20240912$EXP$$PT-BAUSCH-BL-2024-011762$BAUSCH AND LOMB$Carrilho M, Nobre M, Santos M, Silva R, Martins J. CO-0062 - (4147) - Myocarditis due to CMV. Doencas infeciosas e parasitarias. 2024;162.$72$YR$$F$Y$$$20240912$$HP$PT$PT
243132161$24313216$1$I$20240904$20240905$20240912$20240912$EXP$GB-MHRA-MED-202409050704131870-QSYHK$GB-BAUSCH-BL-2024-013597$BAUSCH AND LOMB$$44$YR$$M$Y$89$KG$20240912$$CN$GB$GB
243132171$24313217$1$I$$20240905$20240912$20240912$EXP$$PE-ANIPHARMA-2024-PE-000010$ANI$$$$$M$Y$$$20240912$$MD$PE$PE
243132202$24313220$2$F$$20240918$20240912$20240927$EXP$$SE-TEVA-VS-3240992$TEVA$Glimelius B, Khan T, Adolfsson K, Angenete E, Berglund A, Bonde K, et al. Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US). EClinicalMedicine 2024; 75.; Glimelius B, Khan T, Adolfsson K, Angenete E, Berglund A, Bonde K, et al. Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer wi...$61$YR$$M$Y$$$20240927$$HP$SE$SE
243132211$24313221$1$I$$20240910$20240912$20240912$EXP$$NVSC2024AU181415$NOVARTIS$$$$$F$Y$$$20240912$$CN$AU$AU
243132221$24313222$1$I$$20240723$20240912$20240912$EXP$$US-TEVA-VS-3238119$TEVA$$98$YR$$F$Y$$$20240912$$CN$US$US
243132231$24313223$1$I$20240901$20240901$20240912$20240912$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-002116$SK LIFE SCIENCE$$$$$$Y$$$20240912$$HP$CA$CA
243132241$24313224$1$I$20240911$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024182297$AMGEN$$72$YR$E$F$Y$$$20240912$$PH$US$US
243132252$24313225$2$F$20240904$20240910$20240912$20240916$EXP$$TW-TAKEDA-2024TUS089621$TAKEDA$$86$YR$$F$Y$$$20240916$$CN$TW$TW
243132261$24313226$1$I$$20240905$20240912$20240912$EXP$$US-TAKEDA-2024TUS090228$TAKEDA$$$$$M$Y$$$20240912$$CN$US$US
243132271$24313227$1$I$$20240912$20240912$20240912$PER$$US-BAYER-2024A130722$BAYER$$$$$$Y$$$20240912$$CN$US$US
243132281$24313228$1$I$$20240903$20240912$20240912$EXP$$DE-Calliditas-2024CAL01785$CALLIDITAS THERAPEUTICS$$$$$M$Y$$$20240912$$MD$DE$DE
243132292$24313229$2$F$$20240912$20240912$20240918$EXP$$NL-SANDOZ INC.-SDZ2024NL079563$SANDOZ$Brouwer, Medea, Offermans et al.. Effective Extracorporeal Treatment of Metformin - Associated Lactic Acidosis using Continuous Venovenous Hemodiafiltration. European journal of case reports in internal medicine. 2024;11(9):004784$57$YR$$F$Y$$$20240918$$MD$NL$NL
243132301$24313230$1$I$20240912$20240912$20240912$20240912$DIR$718145$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243132311$24313231$1$I$$20240911$20240912$20240912$EXP$$NVSC2024US182752$NOVARTIS$$$$$F$Y$$$20240912$$MD$US$US
243132321$24313232$1$I$$20240909$20240912$20240912$PER$$NVSC2024US182181$NOVARTIS$$$$$$Y$$$20240912$$CN$US$US
243132331$24313233$1$I$20240909$20240912$20240912$20240912$DIR$718124$$FDA-CTU$$73$YR$$M$N$103.05$KG$20240912$N$CN$US$
243132341$24313234$1$I$20240801$20240906$20240912$20240912$EXP$$NVSC2024AR181713$NOVARTIS$$68$YR$$F$Y$$$20240912$$MD$AR$AR
243132351$24313235$1$I$20220201$20240912$20240912$20240912$DIR$718143$$FDA-CTU$$65$YR$$F$N$99$KG$20240912$N$CN$US$
243132361$24313236$1$I$$20240906$20240912$20240912$EXP$$NVSC2024TW181161$NOVARTIS$$$$$$Y$$$20240912$$MD$TW$TW
243132371$24313237$1$I$20240814$20240904$20240912$20240912$PER$$US-SA-2024SA261664$SANOFI AVENTIS$$$$A$M$Y$$$20240912$$HP$US$US
243132381$24313238$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA261844$SANOFI AVENTIS$$66$YR$E$$Y$$$20240912$$MD$US$US
243132391$24313239$1$I$$20240910$20240912$20240912$PER$$US-ABBVIE-5917893$ABBVIE$$$$$F$Y$$$20240912$$MD$US$US
243132401$24313240$1$I$20240401$20240903$20240912$20240912$PER$$US-ABBVIE-5907684$ABBVIE$$32$YR$$M$Y$$$20240912$$CN$US$US
243132411$24313241$1$I$20240227$20240911$20240912$20240912$EXP$$US-TAKEDA-2024TUS036535$TAKEDA$$46$YR$$M$Y$$$20240912$$PH$US$US
243132421$24313242$1$I$$20240904$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143090$BRISTOL MYERS SQUIBB$$$$A$M$Y$$$20240912$$MD$US$US
243132431$24313243$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145377$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240912$$PH$US$US
243132441$24313244$1$I$20200901$20240904$20240912$20240912$EXP$PL-URPL-1-3427-2020$PL-TEVA-VS-3241183$TEVA$$31$YR$$M$Y$94$KG$20240912$$HP$PL$PL
243132451$24313245$1$I$$20240909$20240912$20240912$EXP$$US-JNJFOC-20240924024$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243132461$24313246$1$I$20240908$20240909$20240912$20240912$EXP$$IN-GSK-IN2024APC112764$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$IN$IN
243132471$24313247$1$I$20240801$20240906$20240912$20240912$EXP$$US-BEH-2024178387$CSL BEHRING$$47$YR$A$F$Y$$$20240912$$HP$US$US
243132481$24313248$1$I$$20240906$20240912$20240912$EXP$$US-JNJFOC-20240916167$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$MD$US$US
243132511$24313251$1$I$$20240808$20240912$20240912$PER$$US-TEVA-VS-3232772$TEVA$$$$$$Y$$$20240912$$MD$US$US
243132521$24313252$1$I$$20240906$20240912$20240912$PER$$US-HALEON-2195843$Haleon PLC$$$$$$Y$$$20240912$$CN$US$US
243132532$24313253$2$F$$20240905$20240912$20240914$EXP$$RU-ABBVIE-5910659$ABBVIE$$76$YR$$F$Y$$$20240914$$MD$RU$RU
243132551$24313255$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62777$$FDA-CTU$$57$YR$$F$N$$$20240912$N$$US$
243132561$24313256$1$I$20240819$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62781$$FDA-CTU$$33$YR$$F$N$$$20240911$N$HP$US$
243132571$24313257$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62782$$FDA-CTU$$18$YR$$F$N$$$20240912$N$$US$
243132591$24313259$1$I$20220421$20240910$20240912$20240912$EXP$$RU-ABBVIE-5917903$ABBVIE$$8$YR$$F$Y$21$KG$20240912$$MD$RU$RU
243132601$24313260$1$I$20240704$20240903$20240912$20240912$EXP$FR-AFSSAPS-TS2024000940$FR-TEVA-VS-3240142$TEVA$$68$YR$$M$Y$108$KG$20240912$$MD$FR$FR
243132611$24313261$1$I$$20240910$20240912$20240912$PER$$US-PFIZER INC-PV202400119318$PFIZER$$78$YR$$M$Y$$$20240912$$HP$US$US
243132622$24313262$2$F$20240910$20240916$20240912$20240918$PER$$US-PFIZER INC-PV202400119887$PFIZER$$63$YR$$M$Y$$$20240918$$CN$US$US
243132631$24313263$1$I$$20240829$20240912$20240912$PER$$US-PFIZER INC-202400247580$PFIZER$$44$YR$$F$Y$$$20240912$$CN$US$US
243132641$24313264$1$I$20240911$20240911$20240912$20240912$PER$$US-PFIZER INC-202400254776$PFIZER$$75$YR$$F$Y$$$20240912$$MD$US$US
243132651$24313265$1$I$$20240906$20240912$20240912$PER$$US-AstraZeneca-2024A204302$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243132661$24313266$1$I$$20240904$20240912$20240912$EXP$$VN-AstraZeneca-2024A204706$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$VN$
243132671$24313267$1$I$$20240909$20240912$20240912$PER$$US-AstraZeneca-2024A207852$ASTRAZENECA$$$$$$Y$$$20240912$$CN$US$
243132681$24313268$1$I$20240429$20240822$20240912$20240912$EXP$$RO-AstraZeneca-2024A195129$ASTRAZENECA$$81$YR$$F$Y$73$KG$20240912$$MD$RO$
243132691$24313269$1$I$$20240904$20240912$20240912$EXP$$PL-AstraZeneca-2024A204573$ASTRAZENECA$$$$$F$Y$$$20240912$$MD$PL$
243132701$24313270$1$I$$20240909$20240912$20240912$EXP$$GB-AstraZeneca-2024A208211$ASTRAZENECA$$$$$$Y$$$20240912$$HP$GB$
243132711$24313271$1$I$20240716$20240910$20240912$20240912$EXP$$US-AstraZeneca-2024A206295$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243132721$24313272$1$I$$20240904$20240912$20240912$EXP$$KR-AstraZeneca-2024A202937$ASTRAZENECA$$66$YR$$F$Y$$$20240912$$MD$KR$
243132731$24313273$1$I$$20240904$20240912$20240912$PER$$US-AstraZeneca-2024A202948$ASTRAZENECA$$$$$$Y$$$20240912$$CN$US$
243132742$24313274$2$F$$20240918$20240912$20240927$EXP$$HR-TEVA-VS-3241020$TEVA$Trajkovski AV, Reiner K, Dzaja N, Mamic G, Mazar M, Persec J, et al. Anesthetic management for cesarean section in two parturient with ascending aortic aneurysm: a case-based discussion. BMC-Anesthesiol 2024; 24.; Trajkovski AV, Reiner K, Dzaja N, Mamic G, Mazar M, Persec J, et al. Anesthetic management for cesarean section in two parturient with ascending aortic aneurysm: a case-based discussion. BMC-Anesthesiol 2024; 24.; Trajkovski AV, Reiner K, Dzaja N, Mamic G, Mazar M, Persec J, et al. ...$$$N$F$Y$1.59$KG$20240927$$HP$HR$HR
243132751$24313275$1$I$$20240902$20240912$20240912$EXP$$US-RDY-SPO/USA/24/0013193$DR REDDYS$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 101: doi:10.1016/j.jflm.2023.102625.$85$YR$E$$Y$$$20240912$$HP$US$US
243132761$24313276$1$I$$20240905$20240912$20240912$EXP$$NVSC2024US179271$NOVARTIS$$$$$M$Y$$$20240912$$CN$US$US
243132771$24313277$1$I$$20240902$20240912$20240912$EXP$$HR-TEVA-VS-3241021$TEVA$Trajkovski AV, Reiner K, Dzaja N, Mamic G, Mazar M, Persec J, et al. Anesthetic management for cesarean section in two parturient with ascending aortic aneurysm: a case-based discussion. BMC-Anesthesiol 2024; 24.; Trajkovski AV, Reiner K, Dzaja N, Mamic G, Mazar M, Persec J, et al. Anesthetic management for cesarean section in two parturient with ascending aortic aneurysm: a case-based discussion. BMC-Anesthesiol 2024; 24.$$$N$F$Y$1.78$KG$20240912$$HP$HR$HR
243132781$24313278$1$I$20240101$20240903$20240912$20240912$EXP$$US-TEVA-VS-3239970$TEVA$$60$YR$$F$Y$77.11$KG$20240912$$HP$US$US
243132802$24313280$2$F$20220101$20240918$20240912$20240927$EXP$$FR-TEVA-VS-3241027$TEVA$Terroir M, Lamesa C, Krim M, Vija L, Texier J-S, Cassou-Mounat T, et al. RadioLigand Therapy with [177Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France. Pharmaceuticals 2023; 16 (5).; Terroir M, Lamesa C, Krim M, Vija L, Texier J-S, Cassou-Mounat T, et al. RadioLigand Therapy with [177Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France. Pharmaceuticals 2023; 16 (5):.$56$YR$$M$Y$$$20240927$$HP$FR$FR
243132811$24313281$1$I$$20240909$20240912$20240912$DIR$FDA-CDER-CTU-2024-62783$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243132821$24313282$1$I$$20240829$20240912$20240912$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08758$NEUROCRINE BIOSCIENCES$$69$YR$$F$Y$$$20240912$$HP$US$US
243132831$24313283$1$I$$20240902$20240912$20240912$EXP$$HR-TEVA-VS-3241023$TEVA$Trajkovski AV, Reiner K, Dzaja N, Mamic G, Mazar M, Persec J, et al. Anesthetic management for cesarean section in two parturient with ascending aortic aneurysm: a case-based discussion. BMC-Anesthesiol 2024; 24.; Trajkovski AV, Reiner K, Dzaja N, Mamic G, Mazar M, Persec J, et al. Anesthetic management for cesarean section in two parturient with ascending aortic aneurysm: a case-based discussion. BMC-Anesthesiol 2024; 24.$$$N$M$Y$2.29$KG$20240912$$HP$HR$HR
243132852$24313285$2$F$$20240829$20240912$20240916$PER$$US-Calliditas-2024CAL01717$CALLIDITAS THERAPEUTICS$$$$$$Y$$$20240916$$MD$US$US
243132861$24313286$1$I$20240909$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006632$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240912$$CN$US$US
243132871$24313287$1$I$$20240906$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004505$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240912$$CN$US$US
243132881$24313288$1$I$20240910$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007420$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240912$$CN$US$US
243132891$24313289$1$I$20240722$20240909$20240912$20240912$EXP$FR-AFSSAPS-RN2024000950$FR-SANDOZ INC.-SDZ2024FR079046$SANDOZ$$52$YR$$M$Y$99$KG$20240912$$MD$FR$FR
243132901$24313290$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006682$ELI LILLY AND CO$$$$A$F$Y$$$20240912$$CN$US$US
243132911$24313291$1$I$20240829$20240830$20240912$20240912$PER$$US-SA-2024SA262066$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240912$$HP$US$US
243132921$24313292$1$I$20240101$20240828$20240912$20240912$PER$$US-SA-2024SA263845$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240912$$PH$US$US
243132931$24313293$1$I$$20240904$20240912$20240912$EXP$GB-MHRA-MED-202409031935018580-PJCTY$GB-TEVA-VS-3240561$TEVA$$$$$F$Y$$$20240912$$CN$GB$GB
243132951$24313295$1$I$20240901$20240910$20240912$20240912$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-144069$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$90.72$KG$20240912$$CN$PR$PR
243132961$24313296$1$I$20240818$20240904$20240912$20240912$EXP$GB-MHRA-MED-202409041050223420-MVLQT$GB-TEVA-VS-3240144$TEVA$$52$YR$$M$Y$$$20240912$$HP$GB$GB
243132981$24313298$1$I$20240101$20240819$20240912$20240912$PER$$US-IMP-2024000661$Harrow Health$$71$YR$E$F$Y$83.91$KG$20240912$$CN$US$US
243132991$24313299$1$I$20240904$20240904$20240912$20240912$EXP$GB-MHRA-MED-202409040717567780-ZLMDV$GB-TEVA-VS-3240302$TEVA$$59$YR$$M$Y$76$KG$20240912$$CN$GB$GB
243133002$24313300$2$F$20240907$20240912$20240912$20240916$EXP$$GT-BIOMARINAP-GT-2024-160466$BIOMARIN$$$$$$Y$$$20240916$$CN$GT$GT
243133011$24313301$1$I$$20240906$20240912$20240912$EXP$$US-TAKEDA-2024TUS089904$TAKEDA$$$$$M$Y$$$20240912$$CN$US$US
243133022$24313302$2$F$$20240911$20240912$20240918$PER$$US-HALEON-2196561$Haleon PLC$$$$$F$Y$$$20240918$$CN$US$US
243133031$24313303$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62784$$FDA-CTU$$65$YR$$M$N$113.85$KG$20240912$N$$US$
243133041$24313304$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62786$$FDA-CTU$$39$YR$$F$N$104.33$KG$20240912$N$$US$
243133051$24313305$1$I$20240801$20240905$20240912$20240912$DIR$FDA-CDER-CTU-2024-62788$$FDA-CTU$$64$YR$$F$N$$$20240905$N$HP$US$
243133061$24313306$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62789$$FDA-CTU$$47$YR$$F$N$183$LBS$20240912$N$$US$
243133071$24313307$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62790$$FDA-CTU$$77$YR$$F$N$153$LBS$20240912$N$$US$
243133081$24313308$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62792$$FDA-CTU$$61$YR$$F$N$$$20240912$N$$US$
243133091$24313309$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62794$$FDA-CTU$$62$YR$$M$N$$$20240912$N$$US$
243133101$24313310$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62795$$FDA-CTU$$73$YR$$F$N$$$20240912$N$HP$US$
243133111$24313311$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62793$$FDA-CTU$$79$YR$$M$N$$$20240912$N$HP$US$
243133131$24313313$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62796$$FDA-CTU$$54$YR$$F$N$89.81$KG$20240912$N$$US$
243133141$24313314$1$I$$20240904$20240912$20240912$DIR$FDA-CDER-CTU-2024-62797$$FDA-CTU$$$$$M$N$$$20240904$N$HP$US$
243133151$24313315$1$I$20240801$20240828$20240912$20240912$PER$$US-SA-2024SA263952$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240912$$MD$US$US
243133161$24313316$1$I$20200919$20240904$20240912$20240912$PER$$US-SA-2024SA261694$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240912$$CN$US$US
243133171$24313317$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA260900$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240912$$HP$US$US
243133181$24313318$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262613$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$HP$US$US
243133191$24313319$1$I$20230701$20240910$20240912$20240912$EXP$GB-MHRA-MED-202409100240277820-TNMLQ$GB-TAKEDA-2024TUS090164$TAKEDA$$57$YR$$F$Y$60$KG$20240912$$HP$GB$GB
243133201$24313320$1$I$$20240909$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA078851$SANDOZ$$40$YR$$F$Y$$$20240912$$HP$CA$CA
243133211$24313321$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145141$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240912$$HP$US$US
243133221$24313322$1$I$20240801$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143489$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240912$$CN$US$US
243133232$24313323$2$F$20240901$20240911$20240912$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144834$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$48.08$KG$20240917$$HP$US$US
243133251$24313325$1$I$$20240909$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA078897$SANDOZ$$88$YR$$M$Y$$$20240912$$PH$CA$CA
243133261$24313326$1$I$20240101$20240904$20240912$20240912$EXP$$JP-AstraZeneca-2024A199624$ASTRAZENECA$$90$YR$$F$Y$$$20240912$$MD$JP$
243133271$24313327$1$I$$20240909$20240912$20240912$EXP$$GB-AstraZeneca-2024A208218$ASTRAZENECA$$$$$$Y$$$20240912$$HP$GB$
243133281$24313328$1$I$$20240904$20240912$20240912$EXP$$CN-AstraZeneca-2024A187561$ASTRAZENECA$$58$YR$$F$Y$62$KG$20240912$$CN$CN$
243133291$24313329$1$I$20240510$20240904$20240912$20240912$EXP$$FR-AstraZeneca-2024A207814$ASTRAZENECA$$80$YR$$F$Y$65$KG$20240912$$MD$FR$
243133301$24313330$1$I$$20240911$20240912$20240912$EXP$$US-AstraZeneca-2024A207834$ASTRAZENECA$$$$$M$Y$$$20240912$$MD$US$
243133311$24313331$1$I$$20240909$20240912$20240912$EXP$$GB-AstraZeneca-2024A207352$ASTRAZENECA$$$$$$Y$$$20240912$$HP$GB$
243133321$24313332$1$I$20240101$20240904$20240912$20240912$EXP$$US-TEVA-VS-3240444$TEVA$$$$$M$Y$$$20240912$$HP$US$US
243133331$24313333$1$I$$20240909$20240912$20240912$EXP$$NO-SANDOZ INC.-PHHY2016NO004749$SANDOZ$$37$YR$$M$Y$$$20240912$$MD$NO$NO
243133341$24313334$1$I$$20240910$20240912$20240912$EXP$$NVSC2024CA181584$NOVARTIS$$$$$F$Y$$$20240912$$MD$CA$CA
243133351$24313335$1$I$20240801$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145237$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240912$$CN$US$US
243133361$24313336$1$I$$20240911$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145379$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240912$$HP$US$US
243133372$24313337$2$F$$20240906$20240912$20240913$EXP$$US-VANTIVE-2024VAN019613$Vantive US Healthcare$$$$$M$Y$$$20240913$$HP$US$US
243133401$24313340$1$I$$20240910$20240912$20240912$PER$$US-ABBVIE-5917413$ABBVIE$$76$YR$$M$Y$$$20240912$$MD$US$US
243133411$24313341$1$I$$20240904$20240912$20240912$EXP$$CA-TEVA-VS-3240694$TEVA$$69$YR$$M$Y$$$20240912$$PH$CA$CA
243133422$24313342$2$F$$20240923$20240912$20240930$30DAY$$US-AMGEN-USASP2024179699$AMGEN$$$$$$Y$$$20240930$$PH$US$US
243133431$24313343$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182950$NOVARTIS$$$$$M$Y$$$20240912$$HP$US$US
243133441$24313344$1$I$$20240909$20240912$20240912$PER$$NVSC2024US182830$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
243133451$24313345$1$I$$20240828$20240912$20240912$EXP$$US-ABBVIE-5917448$ABBVIE$$$$$$Y$$$20240912$$MD$US$US
243133471$24313347$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62801$$FDA-CTU$$70$YR$$F$N$131.09$KG$20240912$N$$US$
243133481$24313348$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62802$$FDA-CTU$$59$YR$$F$N$86.64$KG$20240912$N$$US$
243133491$24313349$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62799$$FDA-CTU$$58$YR$$F$N$$$20240912$N$$US$
243133501$24313350$1$I$$20240904$20240912$20240912$EXP$$CA-TEVA-VS-3240785$TEVA$$$$$M$Y$10$KG$20240912$$MD$CA$CA
243133521$24313352$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62804$$FDA-CTU$$60$YR$$F$N$$$20240912$N$$US$
243133531$24313353$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA263904$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240912$$MD$US$US
243133541$24313354$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA261886$SANOFI AVENTIS$$$$E$M$Y$$$20240912$$MD$US$US
243133551$24313355$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262573$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240912$$HP$US$US
243133561$24313356$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262558$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240912$$HP$US$US
243133571$24313357$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA262550$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240912$$MD$US$US
243133581$24313358$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143429$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240912$$CN$US$US
243133591$24313359$1$I$$20240904$20240912$20240912$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-142385$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240912$$PH$FR$FR
243133601$24313360$1$I$20160101$20240909$20240912$20240912$EXP$$DE-MYLANLABS-2024M1082372$MYLAN$$80$YR$$F$Y$$$20240912$$CN$DE$DE
243133621$24313362$1$I$$20240909$20240912$20240912$EXP$$ES-MYLANLABS-2024M1082309$MYLAN$$$$$M$Y$$$20240912$$CN$ES$ES
243133631$24313363$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62807$$FDA-CTU$$$$$F$N$$$20240912$N$HP$US$
243133641$24313364$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62803$$FDA-CTU$$61$YR$$F$N$$$20240912$N$$US$
243133651$24313365$1$I$$20240906$20240912$20240912$EXP$$US-JNJFOC-20240926380$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$MD$US$US
243133661$24313366$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62805$$FDA-CTU$$74$YR$$F$N$$$20240912$N$$US$
243133671$24313367$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62806$$FDA-CTU$$38$YR$$F$N$$$20240912$N$$US$
243133681$24313368$1$I$20240101$20240910$20240912$20240912$PER$$US-ABBVIE-5918157$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243133691$24313369$1$I$20240903$20240906$20240912$20240912$EXP$$US-ALXN-202409USA000731US$ALEXION PHARMACEUTICALS$$21$YR$$F$Y$$$20240912$$CN$US$US
243133701$24313370$1$I$20240717$20240903$20240912$20240912$EXP$FR-AFSSAPS-CN2024000819$FR-TEVA-VS-3240129$TEVA$$71$YR$$M$Y$$$20240912$$PH$FR$FR
243133711$24313371$1$I$$20240826$20240912$20240912$PER$$US-TEVA-VS-3237517$TEVA$$48$YR$$F$Y$73.7$KG$20240912$$PH$US$US
243133721$24313372$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A202707$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243133731$24313373$1$I$$20240910$20240912$20240912$PER$$US-BIOGEN-2018BI00611999$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
243133741$24313374$1$I$20240101$20240904$20240912$20240912$EXP$$CA-AstraZeneca-2024A198410$ASTRAZENECA$$883$MON$$F$Y$$$20240912$$CN$CA$
243133751$24313375$1$I$$20240904$20240912$20240912$EXP$$NVSC2024TR180880$NOVARTIS$Isiklar A, Basaran G. Hemophagocytic Histiocytosis like Syndrome After Initiation Of Ribociclib Therapy In Advanced Breast Cancer Patient. EUROPEAN JOURNAL OF CASE REPORTS IN INTERNAL MEDICINE. 2024;11 (Suppl. 1):729$44$YR$$F$Y$$$20240912$$HP$TR$TR
243133761$24313376$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA263873$SANOFI AVENTIS$$$$C$F$Y$24.86$KG$20240912$$MD$US$US
243133771$24313377$1$I$20240808$20240829$20240912$20240912$PER$$US-SA-2024SA263510$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240912$$CN$US$US
243133781$24313378$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA263191$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240912$$HP$US$US
243133791$24313379$1$I$$20240830$20240912$20240912$EXP$CN-MLMSERVICE-20240826-PI171126-00060-1$CN-STRIDES ARCOLAB LIMITED-2024SP011115$STRIDES$Long S, Tang P, Ouyang P, Liao X, Xie L. A Case Report of a Rare Pulmonary Opportunistic Infection in an Infant Caused by Tsukamurella tyrosinosolvens.. International Medical Case Reports Journal. 2024;17:725-31$$$I$F$Y$$$20240912$$MD$CN$CN
243133801$24313380$1$I$$20240903$20240912$20240912$EXP$$PL-BAYER-2024A129967$BAYER$$$$$M$Y$$$20240912$$CN$PL$PL
243133811$24313381$1$I$20240802$20240903$20240912$20240912$EXP$FR-AFSSAPS-NC2024001000$FR-TEVA-VS-3240213$TEVA$$78$YR$$F$Y$$$20240912$$MD$FR$FR
243133821$24313382$1$I$20240910$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181182$AMGEN$$64$YR$A$M$Y$$$20240912$$PH$US$US
243133831$24313383$1$I$20240101$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024181552$AMGEN$$40$YR$A$M$Y$$$20240912$$HP$US$US
243133842$24313384$2$F$$20240910$20240912$20240918$EXP$CN-MLMSERVICE-20240826-PI171202-00232-2$CN-STRIDES ARCOLAB LIMITED-2024SP011116$STRIDES$Wang D, Xue D, Chen X, Wu X, Gao W, Liang X, et al.. Mycobacterium marseillense bloodstream infection combined with skin fungal infection: a case report and literature review.. BMC infectious diseases. 2024;24(1):853$55$YR$$M$Y$$$20240918$$MD$CN$CN
243133851$24313385$1$I$20240910$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024181946$AMGEN$$63$YR$A$M$Y$$$20240912$$CN$US$US
243133871$24313387$1$I$$20240906$20240912$20240912$EXP$$US-PFIZER INC-PV202400117304$PFIZER$Chase D.. Ventricular tachycardia in a neonate with mepivacaine toxicity. Journal of Pediatrics. 1977;90(1):127-129$$$N$F$Y$3.5$KG$20240912$$MD$US$US
243133881$24313388$1$I$$20240906$20240912$20240912$EXP$$JP-PFIZER INC-PV202400117875$PFIZER$Koi, Y.. A dramatic response to an immune checkpoint inhibitor plus chemotherapy in a patient with metastatic metaplastic carcinoma of the breast: A case report. Thoracic Cancer. 2024;10.1111/1759-7714.15433$46$YR$$F$Y$$$20240912$$HP$JP$JP
243133891$24313389$1$I$20140101$20240905$20240912$20240912$EXP$$FR-PFIZER INC-202400250487$PFIZER$$29$YR$$F$Y$52$KG$20240912$$MD$FR$FR
243133901$24313390$1$I$$20240906$20240912$20240912$EXP$$US-PFIZER INC-202400254588$PFIZER$Shnider, S.. High fetal blood levels of mepivacaine and fetal bradycardia. The New England Journal of Medicine. 1968;279(17):947-948$$$$$Y$$$20240912$$MD$US$US
243133931$24313393$1$I$$20240829$20240912$20240912$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08783$NEUROCRINE BIOSCIENCES$$5$DEC$$F$Y$$$20240912$$HP$US$US
243133941$24313394$1$I$20240806$20240903$20240912$20240912$EXP$FR-AFSSAPS-NC2024000996$FR-TEVA-VS-3240018$TEVA$$44$YR$$F$Y$$$20240912$$MD$FR$FR
243133951$24313395$1$I$20240906$20240909$20240912$20240912$PER$$US-JNJFOC-20240920498$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240912$$HP$US$US
243133961$24313396$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62809$$FDA-CTU$$72$YR$$F$N$$$20240912$N$$US$
243133971$24313397$1$I$20240801$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62808$$FDA-CTU$$33$YR$$F$N$117.93$KG$20240912$N$$US$
243133981$24313398$1$I$20240501$20240907$20240912$20240912$DIR$FDA-CDER-CTU-2024-62787$$FDA-CTU$$46$YR$$F$N$207$LBS$20240907$N$CN$US$
243133991$24313399$1$I$20240909$20240911$20240912$20240912$PER$$US-AMGEN-USASP2024181504$AMGEN$$75$YR$E$M$Y$$$20240912$$HP$US$US
243134001$24313400$1$I$$20240830$20240912$20240912$EXP$IN-MLMSERVICE-20240826-PI172107-00232-1$IN-STRIDES ARCOLAB LIMITED-2024SP011118$STRIDES$C S, P H, Jayanthi N.. A Rare Lung Malignancy in a Case of Systemic Sclerosis.. Cureus. 2024;16(7):e65146$55$YR$$F$Y$$$20240912$$MD$IN$IN
243134011$24313401$1$I$$20240830$20240912$20240912$EXP$JP-MLMSERVICE-20240826-PI172097-00128-1$JP-STRIDES ARCOLAB LIMITED-2024SP011120$STRIDES$Imataki O, Uemura M.. Bifidobacterium Bloodstream Infection in a Lymphoma Patient Undergoing Chemotherapy: A Case Study and Implications for Probiotic Use. The American journal of case reports.. 2024;25:e944687$75$YR$$F$Y$$$20240912$$MD$JP$JP
243134021$24313402$1$I$20240801$20240904$20240912$20240912$EXP$$CA-BAYER-2024A128044$BAYER$$84$YR$E$M$Y$$$20240912$$CN$CA$CA
243134032$24313403$2$F$$20240912$20240912$20240918$PER$$NVSC2024US182894$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243134041$24313404$1$I$$20240908$20240912$20240912$PER$$NVSC2024US180172$NOVARTIS$$$$$$Y$$$20240912$$CN$US$US
243134052$24313405$2$F$$20240912$20240912$20240920$EXP$JP-MLMSERVICE-20240826-PI173357-00270-2$JP-STRIDES ARCOLAB LIMITED-2024SP011121$STRIDES$Ohara H, Kikutsuji N, Iguchi N, Kinoshita M.. Efgartigimod combined with steroids as a fast-acting therapy for myasthenic crisis: a case report. BMC Neurology.. 2024;24:1-7$70$YR$$F$Y$$$20240920$$MD$JP$JP
243134061$24313406$1$I$20240308$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144740$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240912$$CN$US$US
243134071$24313407$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145236$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240912$$CN$US$US
243134081$24313408$1$I$$20240911$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145148$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240912$$CN$US$US
243134091$24313409$1$I$$20240909$20240912$20240912$PER$$US-ALXN-202409USA000730US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240912$$MD$US$US
243134101$24313410$1$I$$20240906$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143037$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240912$$HP$US$US
243134111$24313411$1$I$$20240910$20240912$20240912$PER$$US-JNJFOC-20240926656$JOHNSON AND JOHNSON$$$$$M$Y$$$20240912$$CN$US$US
243134123$24313412$3$F$20230216$20240910$20240912$20240919$EXP$$BR-PFIZER INC-PV202300043947$PFIZER$$27$YR$$F$Y$75$KG$20240919$$CN$BR$BR
243134131$24313413$1$I$20240323$20240904$20240912$20240912$EXP$FR-AFSSAPS-AN2024001185$FR-TEVA-VS-3241152$TEVA$$45$YR$$M$Y$95$KG$20240912$$MD$FR$FR
243134141$24313414$1$I$$20240909$20240912$20240912$EXP$$GB-ABBVIE-5917595$ABBVIE$$$$$$Y$$$20240912$$HP$GB$GB
243134151$24313415$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262621$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240912$$HP$US$US
243134161$24313416$1$I$20240701$20240903$20240912$20240912$PER$$US-SA-2024SA261400$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240912$$CN$US$US
243134172$24313417$2$F$20240903$20240913$20240912$20240916$PER$$US-AMGEN-USASP2024179661$AMGEN$$$$$M$Y$$$20240916$$CN$US$US
243134181$24313418$1$I$20240101$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181202$AMGEN$$35$YR$A$F$Y$$$20240912$$HP$US$US
243134191$24313419$1$I$20200101$20240905$20240912$20240912$EXP$$US-AMGEN-USASP2024178438$AMGEN$Modi A.R.; Koval C.E.; Taege A.J. et.al.. Coronavirus disease 2019 in an orthotopic liver transplant recipient living with human immunodeficiency virus. Transplant Infectious Disease. 2020;22 (5):1-5$32$YR$A$M$Y$$$20240912$$HP$US$US
243134211$24313421$1$I$$20240905$20240912$20240912$EXP$$US-AMGEN-USASP2024178305$AMGEN$Chauhan A.; Lai C.; Kuhr F.et. al. Long-Term Follow-Up of Patients With Follicular Lymphoma Using Next Generation Sequencing to Detect Minimal Residual Disease. Clinical Lymphoma,Myeloma and Leukemia. 2024;24 (9):634-641$$$$$Y$$$20240912$$MD$US$US
243134221$24313422$1$I$20240826$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145187$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240912$$HP$US$US
243134231$24313423$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145621$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240912$$CN$US$US
243134241$24313424$1$I$20230203$20240909$20240912$20240912$EXP$FR-AFSSAPS-PC2024000682$FR-009507513-2409FRA003287$MERCK$$52$YR$$F$Y$83$KG$20240912$$PH$FR$FR
243134251$24313425$1$I$20240910$20240910$20240912$20240912$PER$$US-JNJFOC-20240924956$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240912$$CN$US$US
243134261$24313426$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2023-0617034$GILEAD$$71$YR$E$F$Y$$$20240912$$MD$US$US
243134271$24313427$1$I$20230101$20240906$20240912$20240912$EXP$FI-FIMEA-202402920$FI-ABBVIE-5915783$ABBVIE$$46$YR$$F$Y$$$20240912$$HP$FI$FI
243134283$24313428$3$F$$20240911$20240912$20240918$EXP$$CN-AstraZeneca-2024A206644$ASTRAZENECA$$44$YR$$M$Y$$$20240918$$MD$CN$
243134291$24313429$1$I$20170101$20240903$20240912$20240912$EXP$FR-AFSSAPS-NY2024000980$FR-TEVA-VS-3240207$TEVA$$90$YR$$M$Y$$$20240912$$MD$FR$FR
243134301$24313430$1$I$20240814$20240904$20240912$20240912$EXP$$CO-AstraZeneca-2024A204469$ASTRAZENECA$$17333$DY$$F$Y$$$20240912$$CN$CO$
243134311$24313431$1$I$$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181942$AMGEN$$$$$$Y$$$20240912$$CN$US$US
243134321$24313432$1$I$20240903$20240904$20240912$20240912$EXP$$GB-AstraZeneca-2024A207355$ASTRAZENECA$$39$YR$$F$Y$$$20240912$$MD$GB$
243134331$24313433$1$I$20240906$20240909$20240912$20240912$EXP$$US-AstraZeneca-2024A206029$ASTRAZENECA$$27583$DY$$F$Y$$$20240912$$MD$US$
243134341$24313434$1$I$$20240909$20240912$20240912$EXP$$GB-AstraZeneca-2024A208193$ASTRAZENECA$$$$$$Y$$$20240912$$HP$GB$
243134351$24313435$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006380$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240912$$CN$US$US
243134371$24313437$1$I$20240417$20240911$20240911$20240911$DIR$718068$$FDA-CTU$$56$YR$$F$N$64.8$KG$20240911$Y$CN$US$
243134382$24313438$2$F$$20240913$20240912$20240920$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006506$BIOCON$$$$$$Y$$$20240920$$CN$CA$CA
243134391$24313439$1$I$$20240904$20240912$20240912$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002806$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240912$$CN$US$US
243134401$24313440$1$I$20240101$20240903$20240912$20240912$EXP$$PT-ELI_LILLY_AND_COMPANY-PT202409001411$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$PT$PT
243134412$24313441$2$F$$20240916$20240912$20240926$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409000724$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$BR$BR
243134421$24313442$1$I$$20240909$20240912$20240912$EXP$$QA-ELI_LILLY_AND_COMPANY-QA202409006328$ELI LILLY AND CO$$19$YR$A$M$Y$$$20240912$$MD$QA$QA
243134431$24313443$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007431$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240912$$CN$US$US
243134451$24313445$1$I$$20240910$20240912$20240912$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409006324$ELI LILLY AND CO$$$$$M$Y$$$20240912$$CN$DE$DE
243134461$24313446$1$I$$20240906$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004828$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240912$$CN$US$US
243134472$24313447$2$F$20240601$20240909$20240912$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409004467$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240916$$CN$US$US
243134482$24313448$2$F$$20240917$20240912$20240925$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409003978$ELI LILLY AND CO$$$$$M$Y$$$20240925$$CN$BR$BR
243134491$24313449$1$I$$20240903$20240912$20240912$EXP$$AR-DSJP-DSJ-2024-144512$DAIICHI$$$$$F$Y$$$20240912$$CN$AR$AR
243134501$24313450$1$I$20240623$20240910$20240912$20240912$EXP$GB-MHRA-MED-202409101154050990-HLGMC$GB-SA-2024SA262667$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240912$$CN$GB$GB
243134511$24313451$1$I$20240830$20240909$20240912$20240912$EXP$$CN-SA-2024SA263746$SANOFI AVENTIS$$54$YR$A$F$Y$47.6$KG$20240912$$HP$CN$CN
243134522$24313452$2$F$$20240909$20240912$20240917$EXP$$US-SA-2024SA262828$SANOFI AVENTIS$$$$T$F$Y$$$20240917$$MD$US$US
243134531$24313453$1$I$$20240910$20240912$20240912$EXP$$CN-TAKEDA-2024TUS090059$TAKEDA$$$$$F$Y$$$20240912$$CN$CN$CN
243134541$24313454$1$I$20240620$20240905$20240912$20240912$EXP$$NVSC2024GB154827$NOVARTIS$$60$YR$$M$Y$85.8$KG$20240912$$HP$GB$GB
243134561$24313456$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA263260$SANOFI AVENTIS$$$$A$F$Y$$$20240912$$HP$US$US
243134571$24313457$1$I$20240101$20240830$20240912$20240912$PER$$US-SA-2024SA260963$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240912$$HP$US$US
243134591$24313459$1$I$$20240905$20240912$20240912$PER$$US-JNJFOC-20240915635$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$CN$US$US
243134601$24313460$1$I$$20240910$20240912$20240912$PER$$US-BIOGEN-2024BI01281977$BIOGEN$$$$$F$Y$$$20240912$$HP$US$US
243134611$24313461$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262619$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240912$$HP$US$US
243134621$24313462$1$I$$20231228$20240912$20240912$PER$$US-HALEON-2196592$Haleon PLC$$$$$F$Y$$$20240912$$HP$US$US
243134631$24313463$1$I$20240325$20240906$20240912$20240912$EXP$$NVSC2024US180737$NOVARTIS$$23$YR$$F$Y$63.492$KG$20240912$$PH$US$US
243134641$24313464$1$I$$20240828$20240912$20240912$EXP$$US-009507513-2409USA003356$MERCK$Fontana R,J, Li Y-Y, Chen V, Kleiner D, Stolz A, Odin J, et al.. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology communications. 2024;1-12 (6-7)$$$A$$Y$$$20240912$$HP$US$US
243134652$24313465$2$F$$20240911$20240912$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144067$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$72.57$KG$20240918$$CN$US$US
243134661$24313466$1$I$$20240801$20240912$20240912$PER$$US-LUNDBECK-DKLU4002672$LUNDBECK$$$$$$Y$$$20240912$$CN$US$US
243134671$24313467$1$I$$20240910$20240912$20240912$EXP$$NVSC2024CA181716$NOVARTIS$$$$$F$Y$$$20240912$$HP$CA$CA
243134681$24313468$1$I$20240126$20240902$20240912$20240912$EXP$$BE-ABBVIE-5917498$ABBVIE$$85$YR$$M$Y$$$20240912$$HP$BE$BE
243134691$24313469$1$I$$20240909$20240912$20240912$PER$$US-JNJFOC-20240928561$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
243134701$24313470$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5393399$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243134721$24313472$1$I$20240401$20240903$20240912$20240912$PER$$US-SA-2024SA261464$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240912$$MD$US$US
243134741$24313474$1$I$20240717$20240903$20240912$20240912$EXP$FR-AFSSAPS-AM2024000696$FR-TEVA-VS-3240196$TEVA$$64$YR$$M$Y$140$KG$20240912$$PH$FR$FR
243134751$24313475$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5915893$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243134761$24313476$1$I$20240101$20240903$20240912$20240912$EXP$$BE-ABBVIE-5783535$ABBVIE$$$$E$M$Y$91$KG$20240912$$HP$BE$BE
243134771$24313477$1$I$$20240909$20240912$20240912$EXP$$US-GILEAD-2024-0687254$GILEAD$$$$A$M$Y$$$20240912$$CN$US$US
243134781$24313478$1$I$$20240906$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143551$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240912$$CN$US$US
243134811$24313481$1$I$$20240911$20240911$20240911$DIR$718003$$FDA-CTU$$$$$UNK$N$$$20240911$$CN$US$
243134841$24313484$1$I$$20240808$20240912$20240912$DIR$FDA-CDER-CTU-2024-62811$$FDA-CTU$$$$$F$N$$$20240808$N$HP$US$
243134851$24313485$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62812$$FDA-CTU$$41$YR$$F$N$265$LBS$20240912$N$$US$
243134861$24313486$1$I$$20240909$20240912$20240912$EXP$FR-AFSSAPS-AN2024001224$FR-MYLANLABS-2024M1082415$MYLAN$$54$YR$$M$Y$155$KG$20240912$$CN$FR$FR
243134871$24313487$1$I$20240720$20240909$20240912$20240912$EXP$FR-AFSSAPS-RN2024000944$FR-MYLANLABS-2024M1082416$MYLAN$$49$YR$$M$Y$$$20240912$$MD$FR$FR
243134881$24313488$1$I$20170510$20240911$20240911$20240911$DIR$718004$$FDA-CTU$$39$YR$$F$N$$$20240911$N$CN$US$
243134901$24313490$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62813$$FDA-CTU$$76$YR$$F$N$194$LBS$20240912$N$$US$
243134911$24313491$1$I$$20240909$20240912$20240912$EXP$$GB-HALEON-2196148$Haleon PLC$$36$YR$$F$Y$67$KG$20240912$$MD$GB$GB
243134921$24313492$1$I$20240731$20240801$20240912$20240912$PER$$US-LUNDBECK-DKLU4002671$LUNDBECK$$$$$$Y$$$20240912$$CN$US$US
243134931$24313493$1$I$20240101$20240903$20240912$20240912$EXP$$US-TEVA-VS-3240541$TEVA$$67$YR$$F$Y$$$20240912$$CN$US$US
243134941$24313494$1$I$$20240909$20240912$20240912$EXP$$GB-AstraZeneca-2024A208208$ASTRAZENECA$$$$$$Y$$$20240912$$HP$GB$
243134951$24313495$1$I$20240907$20240909$20240912$20240912$EXP$$TH-AstraZeneca-2024A206089$ASTRAZENECA$$26839$DY$$F$Y$$$20240912$$CN$TH$
243134961$24313496$1$I$$20240910$20240912$20240912$PER$$US-ALXN-202409USA000722US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243134971$24313497$1$I$20240830$20240909$20240912$20240912$EXP$$US-AstraZeneca-2024A206058$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243134981$24313498$1$I$20240821$20240904$20240912$20240912$EXP$$IE-AstraZeneca-2024A161955$ASTRAZENECA$$7007$DY$$F$Y$$$20240912$$CN$IE$
243134992$24313499$2$F$$20240903$20240912$20240913$EXP$$ES-AstraZeneca-2024A204948$ASTRAZENECA$Navarro J. AM., Martinez AS. P., Matia M. A.. Voclosporina en nefropatIa lupica. Resultados en dos pacientes a los 3 meses de uso. Sociedad madrilena de nefrologia. SOMANE 2024;$44$YR$$F$Y$$$20240913$$MD$ES$
243135001$24313500$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA261888$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240912$$MD$US$US
243135021$24313502$1$I$20240909$20240911$20240912$20240912$PER$$CN-Eisai-EC-2024-174201$EISAI$$61$YR$A$F$Y$54$KG$20240912$$HP$CN$CN
243135031$24313503$1$I$$20240909$20240912$20240912$EXP$$US-INCYTE CORPORATION-2024IN009507$INCYTE$$$$$$Y$$$20240912$$CN$US$US
243135041$24313504$1$I$$20240910$20240912$20240912$EXP$$US-AMGEN-USASP2024180688$AMGEN$$$$$M$Y$$$20240912$$CN$US$US
243135052$24313505$2$F$$20240912$20240912$20240918$EXP$$US-KYOWAKIRIN-2024KK021124$KYOWA$$$$$$Y$$$20240918$$HP$US$US
243135061$24313506$1$I$$20240808$20240912$20240912$30DAY$$US-Amphastar Pharmaceuticals, Inc.-2161492$AMPHASTAR$$$$$$Y$$$20240912$$$US$US
243135071$24313507$1$I$$20240909$20240912$20240912$PER$$US-BIOGEN-2024BI01281814$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
243135091$24313509$1$I$20221201$20240903$20240912$20240912$EXP$$US-AGIOS-2409US03873$AGIOS PHARMACEUTICALS$Sara Tama-Shekan, Valeria Moreno, Ludovic Saba and Chakra P. Chaulagain. HowWe Treat Hemolytic Anemia Due to Pyruvate Kinase Deficiency. Hematology reports. 2024;559-567:16$52$YR$$M$Y$$$20240912$$MD$US$US
243135101$24313510$1$I$$20240904$20240912$20240912$EXP$$BE-GSK-BE2024GSK111973$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$HP$BE$BE
243135111$24313511$1$I$$20240906$20240912$20240912$EXP$$BG-GSK-BG2024GSK112212$GLAXOSMITHKLINE$Tchernev G, Ivanov L, Broshtilova V. Multiple keratinocytic cancers after intake of antihypertensives (lisinopril/bisoprolol/hct) and antiarrhytmics (propafenone): the important new links to the nitroso-contamination and the metabolic reprogramming of the future cancer cell. Georgian medical news. 2024;6 (351):65-71$$$$$Y$$$20240912$$HP$BG$BG
243135121$24313512$1$I$$20240906$20240912$20240912$EXP$$AU-GSK-AU2024GSK111786$GLAXOSMITHKLINE$Buckley NA, Whyte LM, Dawson AH. Self-poisoning with lamotrigine. The Lancet. 1993;342(8886-8887):1552-1553$$$$$Y$$$20240912$$HP$AU$AU
243135131$24313513$1$I$$20240904$20240912$20240912$EXP$$US-GSK-US2024GSK111987$GLAXOSMITHKLINE$Zachian RL, Sidhu BV, Liu P, Weimann R. Acute generalised exanthematous pustulosis and herpes simplex virus: a case of possible overlap. BMJ Case Reports. 2024;17 (8)$$$$$Y$$$20240912$$MD$US$US
243135141$24313514$1$I$$20240827$20240912$20240912$EXP$$US-Nostrum Laboratories, Inc.-2161490$NOSTRUM$$$$$$Y$$$20240912$$$US$US
243135151$24313515$1$I$$20240823$20240912$20240912$PER$$US-IMP-2024000674$Harrow Health$$$$A$F$Y$$$20240912$$CN$US$US
243135161$24313516$1$I$$20240829$20240912$20240912$EXP$$IR-Nuvo Pharmaceuticals Inc-2161514$NUVO PHARMACEUTICALS$Full text$38$YR$$F$Y$$$20240912$$$IR$IR
243135171$24313517$1$I$20240801$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006260$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240912$$CN$US$US
243135181$24313518$1$I$20240101$20240906$20240912$20240912$EXP$$JP-GENMAB-2024-03252$GENMAB$$$$$$Y$$$20240912$$MD$JP$JP
243135191$24313519$1$I$$20231219$20240912$20240912$PER$$ES-MC2 Therapeutics, Ltd-2161500$MC2 Therapeutics$$57$YR$$M$Y$$$20240912$$MD$ES$ES
243135211$24313521$1$I$$20240830$20240912$20240912$EXP$$ES-B.Braun Medical Inc.-2161508$B BRAUN$$$$$M$Y$$$20240912$$$ES$ES
243135221$24313522$1$I$20240801$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144450$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240912$$CN$US$US
243135231$24313523$1$I$$20240909$20240912$20240912$EXP$$PL-MYLANLABS-2024M1082435$MYLAN$Sternal, S... Clinical analysis of Klebsiella pneumoniae KPC infection in intensive care unit - series of 7 case reports. PRZEGLAD LEKARSKI. 2017;74 (9):445-449$40$YR$$M$Y$$$20240912$$HP$PL$PL
243135241$24313524$1$I$20240801$20240909$20240912$20240912$EXP$$IT-GENMAB-2024-03302$GENMAB$$$$$F$Y$$$20240912$$MD$IT$IT
243135251$24313525$1$I$$20240827$20240912$20240912$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2161487$BRECKENRIDGE$$$$$F$Y$$$20240912$$$ES$A1
243135261$24313526$1$I$$20240905$20240912$20240912$EXP$$US-GSK-US2024110664$GLAXOSMITHKLINE$$$$$$Y$$$20240912$$CN$US$US
243135271$24313527$1$I$$20240910$20240912$20240912$PER$$PR-ABBVIE-5919498$ABBVIE$$$$A$F$Y$$$20240912$$MD$PR$PR
243135281$24313528$1$I$20240806$20240909$20240912$20240912$EXP$FR-AFSSAPS-BX2024001727$FR-MYLANLABS-2024M1082418$MYLAN$$96$YR$$F$Y$54$KG$20240912$$MD$FR$FR
243135291$24313529$1$I$$20240909$20240912$20240912$EXP$$NL-PURDUE-USA-2024-0311939$PURDUE$$71$YR$$F$Y$86$KG$20240912$$CN$NL$NL
243135301$24313530$1$I$20240907$20240910$20240912$20240912$EXP$$GB-PURDUE-USA-2024-0311942$PURDUE$$47$YR$$F$Y$$$20240912$$MD$GB$GB
243135311$24313531$1$I$20240101$20240906$20240912$20240912$EXP$$CN-PURDUE-USA-2024-0311943$PURDUE$$56$YR$$F$Y$56$KG$20240912$$HP$CN$CN
243135321$24313532$1$I$$20240906$20240912$20240912$EXP$$GB-PURDUE-USA-2024-0311924$PURDUE$Coid F, Dima A, Livermore C, Das P, Kabra N. Buprenorphine-Associated Behavioral and Psychotic Side Effects: A Case Report. Journal of clinical psychopharmacology. 2024$56$YR$$F$Y$$$20240912$$MD$GB$GB
243135331$24313533$1$I$$20240910$20240912$20240912$EXP$$DE-TAKEDA-2024TUS090242$TAKEDA$$$$$F$Y$$$20240912$$CN$DE$DE
243135341$24313534$1$I$$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181162$AMGEN$$$$$M$Y$$$20240912$$CN$US$US
243135351$24313535$1$I$$20240830$20240912$20240912$EXP$$FR-B.Braun Medical Inc.-2161504$B BRAUN$$38$YR$$M$Y$$$20240912$$$FR$FR
243135371$24313537$1$I$$20240911$20240911$20240911$DIR$718007$$FDA-CTU$$$$$UNK$N$$$20240911$N$CN$US$
243135381$24313538$1$I$$20240911$20240911$20240911$DIR$718056$$FDA-CTU$$$$$UNK$N$$$20240911$N$PH$US$
243135391$24313539$1$I$$20240830$20240912$20240912$EXP$$TR-Zhejiang Yongtai pharmaceuticals Co..,Ltd.-2161515$ZHEJIANG YONGTAI$Full text$$$$$Y$$$20240912$$$TR$TR
243135401$24313540$1$I$$20240712$20240912$20240912$EXP$$US-Jiangsu Hengrui Medicine Co., Ltd.-2161494$JIANGSU HENGRUI MEDICINE$Durable Response to Programmed Death 1-Directed Antibodies in a Hypermutated Triple-Negative Breast Cancer: A Case Report$65$YR$$F$Y$$$20240912$$MD$US$US
243135411$24313541$1$I$$20240823$20240912$20240912$PER$$US-IMP-2024000675$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243135421$24313542$1$I$$20240827$20240912$20240912$PER$$US-009507513-2408USA009488$MERCK$$$$$F$Y$$$20240912$$CN$US$US
243135431$24313543$1$I$$20240830$20240912$20240912$EXP$$US-B.Braun Medical Inc.-2161502$B BRAUN$$38$YR$$M$Y$$$20240912$$$US$US
243135441$24313544$1$I$$20240830$20240912$20240912$EXP$$FR-B.Braun Medical Inc.-2161503$B BRAUN$$41$YR$$M$Y$$$20240912$$$FR$FR
243135451$24313545$1$I$$20240830$20240912$20240912$EXP$$ES-B.Braun Medical Inc.-2161509$B BRAUN$$$$$F$Y$$$20240912$$$ES$ES
243135461$24313546$1$I$$20240830$20240912$20240912$EXP$$FR-B.Braun Medical Inc.-2161507$B BRAUN$$52$YR$$F$Y$$$20240912$$$FR$FR
243135471$24313547$1$I$$20240807$20240912$20240912$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161496$JIANGSU HENGRUI MEDICINE$Literature title: A Rare Case of Bacterial Meningitis Caused by Hematogenous Spread of Vancomycin-Resistant Enterococcus faecium in an Immunocompromised Patient. ?Literature publication journal: Case Reports in Infectious Diseases 2024; 1-5.?Literature authors: Myeongji Kim, Christopher Graham, Ryan W. Stevens, Aditya Shah.$72$YR$$M$Y$$$20240912$$MD$US$CN
243135481$24313548$1$I$$20240830$20240912$20240912$EXP$$NL-B.Braun Medical Inc.-2161513$B BRAUN$$70$YR$$F$Y$80$KG$20240912$$$NL$NL
243135491$24313549$1$I$$20240906$20240912$20240912$EXP$$US-Fagron Sterile Services-2161523$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$34$YR$$F$Y$97.273$KG$20240912$$PH$US$US
243135502$24313550$2$F$20230901$20240913$20240912$20240917$EXP$$US-ABBVIE-5917279$ABBVIE$$64$YR$$M$Y$90.718$KG$20240917$$CN$US$US
243135511$24313551$1$I$$20240910$20240912$20240912$PER$$US-ALXN-202409USA000726US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243135521$24313552$1$I$20240902$20240903$20240912$20240912$PER$$US-ABBVIE-5908102$ABBVIE$$36$YR$$M$Y$$$20240912$$CN$US$US
243135531$24313553$1$I$$20240904$20240912$20240912$EXP$$US-ADC THERAPEUTICS SA-ADC-2024-000328$ADC THERAPEUTICS$$$$A$$Y$$$20240912$$PH$US$US
243135541$24313554$1$I$$20240904$20240912$20240912$EXP$$PL-AstraZeneca-2024A204374$ASTRAZENECA$$$$$F$Y$$$20240912$$MD$PL$
243135551$24313555$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263402$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240912$$HP$US$US
243135561$24313556$1$I$20240101$20240903$20240912$20240912$PER$$US-SA-2024SA262268$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240912$$HP$US$US
243135571$24313557$1$I$20240901$20240903$20240912$20240912$PER$$US-ABBVIE-5907667$ABBVIE$$11$YR$$F$Y$$$20240912$$CN$US$US
243135581$24313558$1$I$$20240827$20240912$20240912$PER$$US-IMP-2024000689$Harrow Health$$$$A$F$Y$$$20240912$$CN$US$US
243135591$24313559$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145298$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240912$$CN$US$US
243135601$24313560$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145292$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$61.23$KG$20240912$$CN$US$US
243135611$24313561$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145386$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$74.84$KG$20240912$$CN$US$US
243135621$24313562$1$I$20240905$20240904$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141634$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240912$$CN$US$US
243135631$24313563$1$I$20240807$20240904$20240912$20240912$EXP$$US-APELLIS-2024-APL-0000750$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240912$$MD$US$US
243135641$24313564$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144776$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240912$$CN$US$US
243135651$24313565$1$I$20240101$20240905$20240912$20240912$EXP$$US-ABBVIE-5916016$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243135681$24313568$1$I$20231120$20240911$20240911$20240911$DIR$718089$$FDA-CTU$$71$YR$$M$N$63$KG$20240911$N$CN$US$
243135691$24313569$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA260416$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240912$$MD$US$US
243135701$24313570$1$I$20240101$20240829$20240912$20240912$EXP$$US-NOVOPROD-1277763$NOVO NORDISK$$47$YR$$$Y$$$20240912$$CN$US$US
243135711$24313571$1$I$$20240904$20240912$20240912$EXP$$US-AMGEN-USASP2024178226$AMGEN$Khadka S.; Dong N.; Chavez J.. Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin, Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CUP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Single-Center Experience. Clinical Lymphoma Clinical Lymphoma. 2024;24:S480$$$$$Y$$$20240912$$MD$US$US
243135722$24313572$2$F$$20240909$20240912$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA079083$SANDOZ$$65$YR$$M$Y$$$20240919$$HP$CA$CA
243135731$24313573$1$I$20240903$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62750$$FDA-CTU$$57$YR$$F$N$$$20240911$N$PH$US$
243135751$24313575$1$I$20230830$20240903$20240912$20240912$EXP$$JP-AKEBIA THERAPEUTICS, INC.-JP-AKEB-23-001935$AKEBIA THERAPEUTICS$$87$YR$$M$Y$49.7$KG$20240912$$MD$JP$JP
243135761$24313576$1$I$$20240906$20240912$20240912$EXP$$US-GILEAD-2024-0686852$GILEAD$$$$A$M$Y$$$20240912$$CN$US$US
243135781$24313578$1$I$20230101$20240909$20240912$20240912$EXP$$DE-MYLANLABS-2024M1082531$MYLAN$$65$YR$$F$Y$$$20240912$$CN$DE$DE
243135791$24313579$1$I$$20240905$20240912$20240912$PER$$US-MYLANLABS-2024M1082414$MYLAN$$$$$$Y$$$20240912$$CN$US$US
243135802$24313580$2$F$$20240828$20240912$20240913$EXP$$US-009507513-2409USA004001$MERCK$Fontana RJ, Li Y-J, Chen V, Kleiner D, Stolz A, Odin J, et al.. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology communications. 2024;8(9):e0518$76$YR$$F$Y$$$20240913$$HP$US$US
243135811$24313581$1$I$20210101$20240909$20240912$20240912$EXP$$DE-FreseniusKabi-FK202413557$FRESENIUS KABI$$$$A$F$Y$$$20240912$$MD$DE$DE
243135821$24313582$1$I$$20240909$20240912$20240912$EXP$$US-OTSUKA-2024_025338$OTSUKA$$$$$F$Y$$$20240912$$PH$US$US
243135831$24313583$1$I$$20240904$20240912$20240912$EXP$$CA-TAKEDA-2024TUS089637$TAKEDA$$$$$F$Y$$$20240912$$MD$CA$CA
243135841$24313584$1$I$$20240906$20240912$20240912$EXP$$UA-ROCHE-10000077398$ROCHE$$$$$F$Y$$$20240912$$MD$UA$UA
243135851$24313585$1$I$20240801$20240905$20240912$20240912$PER$$US-SA-2024SA262744$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240912$$HP$US$US
243135861$24313586$1$I$$20240902$20240912$20240912$EXP$$BR-JNJFOC-20240910857$JOHNSON AND JOHNSON$$$$$F$Y$1.78$KG$20240912$$MD$BR$BR
243135871$24313587$1$I$20240907$20240910$20240912$20240912$EXP$$US-GILEAD-2024-0687471$GILEAD$$16$YR$T$F$Y$$$20240912$$CN$US$US
243135881$24313588$1$I$20231012$20240911$20240912$20240912$EXP$$CN-PFIZER INC-PV202300170148$PFIZER$$25$YR$$M$Y$$$20240912$$CN$CN$CN
243135891$24313589$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007434$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240912$$CN$US$US
243135901$24313590$1$I$20240908$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006778$ELI LILLY AND CO$$60$YR$A$$Y$$$20240912$$CN$US$US
243135911$24313591$1$I$$20240906$20240912$20240912$PER$$US-MYLANLABS-2024M1082621$MYLAN$$70$YR$$M$Y$$$20240912$$CN$US$US
243135931$24313593$1$I$$20240907$20240912$20240912$PER$$US-ROCHE-10000077085$ROCHE$$$$E$F$Y$$$20240912$$CN$US$US
243135941$24313594$1$I$20240910$20240912$20240912$20240912$PER$$US-BAYER-2024A130728$BAYER$$$$$F$Y$$$20240912$$MD$US$US
243135961$24313596$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144770$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240912$$HP$US$US
243135971$24313597$1$I$20240601$20240826$20240912$20240912$PER$$US-IMP-2024000682$Harrow Health$$$$A$F$Y$$$20240912$$CN$US$US
243135981$24313598$1$I$$20240910$20240912$20240912$EXP$$US-ROCHE-10000079058$ROCHE$$$$E$F$Y$$$20240912$$CN$US$US
243135991$24313599$1$I$$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181218$AMGEN$$74$YR$E$M$Y$$$20240912$$CN$US$US
243136001$24313600$1$I$20240101$20240906$20240912$20240912$EXP$$CA-KARYOPHARM-2024KPT001205$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240912$$PH$CA$CA
243136011$24313601$1$I$$20240906$20240912$20240912$EXP$$US-AMGEN-USASP2024178890$AMGEN$$$$$F$Y$$$20240912$$HP$US$US
243136021$24313602$1$I$20240817$20240829$20240912$20240912$PER$$US-IMP-2024000690$Harrow Health$$41$YR$A$M$Y$$$20240912$$CN$US$US
243136031$24313603$1$I$$20240906$20240912$20240912$PER$$US-AstraZeneca-2024A203946$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243136041$24313604$1$I$$20240909$20240912$20240912$EXP$$GB-AstraZeneca-2024A208186$ASTRAZENECA$$$$$$Y$$$20240912$$HP$GB$
243136051$24313605$1$I$$20240904$20240912$20240912$EXP$$CN-AstraZeneca-2024A202480$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$CN$
243136061$24313606$1$I$$20240910$20240912$20240912$EXP$$NVSC2024IT182323$NOVARTIS$$13$YR$$F$Y$$$20240912$$MD$IT$IT
243136071$24313607$1$I$20240801$20240906$20240912$20240912$EXP$$JP-009507513-2409JPN001167J$MERCK$$9$DEC$$F$Y$$$20240912$$MD$JP$JP
243136081$24313608$1$I$20240601$20240909$20240912$20240912$PER$$US-JNJFOC-20240921964$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240912$$HP$US$US
243136091$24313609$1$I$$20240909$20240912$20240912$30DAY$$AT-MYLANLABS-2024M1082635$MYLAN$$$$$M$Y$$$20240912$$PH$AT$AT
243136101$24313610$1$I$$20240911$20240912$20240912$PER$$US-HALEON-2196515$Haleon PLC$$$$$M$Y$$$20240912$$CN$US$US
243136111$24313611$1$I$$20240904$20240912$20240912$PER$$US-RDY-CLI/USA/24/0013026$DR REDDYS$$8$YR$C$M$Y$$$20240912$$CN$US$US
243136122$24313612$2$F$$20240918$20240912$20240920$EXP$$CA-SANDOZ INC.-SDZ2024CA078858$SANDOZ$$65$YR$$F$Y$$$20240920$$MD$CA$CA
243136131$24313613$1$I$$20240903$20240912$20240912$EXP$$CA-JNJFOC-20230764020$JOHNSON AND JOHNSON$$3$MON$I$M$Y$$$20240912$$HP$CA$CA
243136142$24313614$2$F$$20240903$20240912$20240924$PER$$US-RDY-CLI/USA/24/0013008$DR REDDYS$$18$YR$A$M$Y$87$KG$20240924$$CN$US$US
243136151$24313615$1$I$$20240903$20240912$20240912$PER$$US-ABBVIE-5907121$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243136162$24313616$2$F$20240505$20240912$20240912$20240916$EXP$$NVSC2024DE182653$NOVARTIS$$44$YR$$M$Y$115$KG$20240916$$MD$DE$DE
243136171$24313617$1$I$20240821$20240909$20240912$20240912$EXP$HR-HALMED-300086413$HR-FreseniusKabi-FK202413601$FRESENIUS KABI$$75$YR$E$M$Y$77$KG$20240912$$MD$HR$HR
243136181$24313618$1$I$20200911$20240909$20240912$20240912$EXP$PL-URPL-1-2051-2020$PL-FreseniusKabi-FK202413559$FRESENIUS KABI$$65$YR$E$$Y$87$KG$20240912$$MD$PL$PL
243136191$24313619$1$I$20240101$20240907$20240912$20240912$PER$$US-Eisai-EC-2024-172640$EISAI$$42$YR$A$F$Y$71.66$KG$20240912$$CN$US$US
243136201$24313620$1$I$20220101$20240909$20240912$20240912$EXP$$RO-FreseniusKabi-FK202413564$FRESENIUS KABI$$69$YR$E$M$Y$$$20240912$$MD$RO$RO
243136211$24313621$1$I$$20240912$20240912$20240912$DIR$718120$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243136221$24313622$1$I$20240912$20240912$20240912$20240912$DIR$718138$$FDA-CTU$$53$YR$$F$N$$$20240912$N$$US$
243136241$24313624$1$I$20150101$20240910$20240912$20240912$PER$$US-MYLANLABS-2024M1082783$MYLAN$$$$$F$Y$$$20240912$$CN$US$US
243136251$24313625$1$I$$20240828$20240912$20240912$PER$$US-IMP-2024000681$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243136261$24313626$1$I$$20240906$20240912$20240912$EXP$GB-MEN-2024-108492$GB-MEN-2024-108492$MENARINI$$87$YR$E$F$Y$$$20240912$$HP$GB$GB
243136271$24313627$1$I$20240331$20240911$20240912$20240912$EXP$$NVSC2024IN182891$NOVARTIS$$66$YR$$M$Y$$$20240912$$CN$IN$IN
243136281$24313628$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182990$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
243136291$24313629$1$I$$20240910$20240912$20240912$EXP$$GR-PFIZER INC-PV202400119325$PFIZER$Sachanas, S.. A Rapidly Developing Nodule in a Patient With Hairy Cell Leukemia in Remission: Merkel Cell Carcinoma: A Case Report. In Vivo. 2024;38(5):2540-2544$57$YR$$M$Y$$$20240912$$HP$GR$GR
243136303$24313630$3$F$$20240912$20240912$20240920$EXP$$JP-PFIZER INC-202400254048$PFIZER$Sumi, T.. A Case of Pleurisy as Immune-related Adverse Events of Neoadjuvant Nivolumab and Chemotherapy After Lobectomy. Japanese Journal of Lung Cancer. 2024;64(4):315-320$63$YR$$M$Y$73$KG$20240920$$MD$JP$JP
243136321$24313632$1$I$20240902$20240909$20240912$20240912$EXP$$US-PFIZER INC-202400252912$PFIZER$$$$$M$Y$$$20240912$$CN$US$US
243136332$24313633$2$F$$20240916$20240912$20240919$EXP$$PL-PFIZER INC-202400252671$PFIZER$Wach, A.. Therapeutic plasma exchange in catastrophic antiphospholipid syndrome: a rare case with concomitant systemic lupus erythematosus and infection. Polish Archives of Internal Medicine. 2024;134 (5):1-3$49$YR$$F$Y$$$20240919$$HP$PL$PL
243136341$24313634$1$I$20230814$20240909$20240912$20240912$EXP$$CA-PFIZER INC-202300274601$PFIZER$$47$YR$$F$Y$$$20240912$$MD$CA$CA
243136351$24313635$1$I$$20240906$20240912$20240912$EXP$$US-PFIZER INC-202400254952$PFIZER$Shnider, S.. High fetal blood levels of mepivacaine and fetal bradycardia. The New England Journal of Medicine. 1968;279(17):947-948$$$$$Y$$$20240912$$MD$US$US
243136361$24313636$1$I$$20240906$20240912$20240912$EXP$$US-PFIZER INC-202400254951$PFIZER$Shnider, S.. High fetal blood levels of mepivacaine and fetal bradycardia. The New England Journal of Medicine. 1968;279(17):947-948$$$$$Y$$$20240912$$MD$US$US
243136372$24313637$2$F$20240908$20240924$20240912$20240926$EXP$$JP-PFIZER INC-202400253415$PFIZER$$89$YR$$M$Y$$$20240926$$MD$JP$JP
243136382$24313638$2$F$$20240909$20240912$20240916$EXP$$GR-PFIZER INC-PV202400118007$PFIZER$Papantoniou, M.. ACUTE MOTOR AXIAL NEUROPATHY IN A PATIENT ON OXALIPLATIN CHEMOTHERAPY: CASE PRESENTATION. 35th National Conference of the Hellenic Neurological Society. 2024;266$69$YR$$M$Y$$$20240916$$MD$GR$GR
243136392$24313639$2$F$$20240911$20240912$20240916$EXP$$BG-PFIZER INC-202400252650$PFIZER$Kordeva, S.. Keratinocyte cancers, dysplastic nevi and cutaneous melanoma development after intake of potentially nitrosamine/NDSRIs contaminated drugs: new data. Important links to photo-(nitroso-) carcinogenesis and pharmaco-oncogenesis.. Medical Review. 2024;60(5):62-72$71$YR$$M$Y$$$20240916$$HP$BG$BG
243136401$24313640$1$I$20240904$20240909$20240912$20240912$EXP$$BR-PFIZER INC-202400252974$PFIZER$$62$YR$$M$Y$80.2$KG$20240912$$HP$BR$BR
243136412$24313641$2$F$$20240911$20240912$20240917$EXP$$JP-PFIZER INC-202400253459$PFIZER$Kimura, M.. Choroid plexitis caused by Burkholderia cepacia complex after COVID-19. International journal of infectious diseases : IJID. 2024;147:10.1016/j.ijid.2024.107201$67$YR$$F$Y$$$20240917$$MD$JP$JP
243136421$24313642$1$I$$20240904$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145068$BRISTOL MYERS SQUIBB$Kureshi A, Sunik A. From bulbar weakness to pea arrest: a unique case of lambert-eaton myasthenic syndrome. American Journal of Respiratory and Critical Care Medicine. 2024 May;209:A5622.$60$YR$A$M$Y$$$20240912$$HP$US$US
243136431$24313643$1$I$20240101$20240910$20240912$20240912$EXP$$ZA-ABBVIE-5918954$ABBVIE$$62$YR$$F$Y$$$20240912$$MD$ZA$ZA
243136441$24313644$1$I$20210101$20240906$20240912$20240912$PER$$US-ABBVIE-5913618$ABBVIE$$$$$F$Y$118$KG$20240912$$CN$US$US
243136452$24313645$2$F$20220701$20240910$20240912$20240915$EXP$$DE-ABBVIE-5916564$ABBVIE$$80$YR$$F$Y$$$20240915$$MD$DE$DE
243136461$24313646$1$I$20240903$20240904$20240912$20240912$EXP$$CN-ALCON LABORATORIES-ALC2024CN004108$ALCON$$$$$$Y$$$20240912$$CN$CN$CN
243136471$24313647$1$I$$20240911$20240912$20240912$PER$$US-HALEON-2196589$Haleon PLC$$$$$$Y$$$20240912$$CN$US$US
243136491$24313649$1$I$$20240911$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145077$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240912$$CN$US$US
243136501$24313650$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144918$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240912$$PH$US$US
243136511$24313651$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144968$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240912$$CN$US$US
243136521$24313652$1$I$20240910$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145224$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240912$$HP$US$US
243136531$24313653$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144794$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$73.94$KG$20240912$$CN$US$US
243136541$24313654$1$I$20240814$20240909$20240912$20240912$EXP$$DE-FreseniusKabi-FK202413549$FRESENIUS KABI$$67$YR$E$F$Y$50$KG$20240912$$MD$DE$DE
243136561$24313656$1$I$$20240828$20240912$20240912$EXP$$US-SA-2024SA263291$SANOFI AVENTIS$$$$E$F$Y$$$20240912$$MD$US$US
243136571$24313657$1$I$$20240910$20240912$20240912$EXP$$CA-TAKEDA-2024TUS090414$TAKEDA$$$$$F$Y$$$20240912$$CN$CA$CA
243136581$24313658$1$I$20230601$20240904$20240912$20240912$EXP$$PL-AstraZeneca-2024A205190$ASTRAZENECA$$$$$M$Y$$$20240912$$MD$PL$
243136601$24313660$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007328$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240912$$CN$US$US
243136611$24313661$1$I$$20240906$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004449$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240912$$CN$US$US
243136621$24313662$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007428$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240912$$CN$US$US
243136631$24313663$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007317$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240912$$CN$US$US
243136641$24313664$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007469$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240912$$CN$US$US
243136651$24313665$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007753$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240912$$CN$US$US
243136671$24313667$1$I$20240530$20240904$20240912$20240912$PER$$US-SA-2024SA262285$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240912$$PH$US$US
243136681$24313668$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA262514$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240912$$HP$US$US
243136691$24313669$1$I$$20240912$20240912$20240912$DIR$718119$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243136701$24313670$1$I$20240911$20240911$20240912$20240912$PER$$US-JNJFOC-20240927933$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240912$$PH$US$US
243136721$24313672$1$I$20240101$20240910$20240912$20240912$PER$$US-ALXN-202409USA000724US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243136731$24313673$1$I$$20240910$20240912$20240912$PER$$US-ALXN-202409USA000716US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$HP$US$US
243136741$24313674$1$I$20240909$20240910$20240912$20240912$PER$$US-ALXN-202409USA000723US$ALEXION PHARMACEUTICALS$$51$YR$$$Y$$$20240912$$CN$US$US
243136751$24313675$1$I$$20240909$20240912$20240912$EXP$$US-TAKEDA-2016BLT008143$TAKEDA$$$$$F$Y$$$20240912$$CN$US$US
243136761$24313676$1$I$20240904$20240909$20240912$20240912$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18036$IPSEN$$53$YR$A$F$Y$55.2$KG$20240912$$CN$US$US
243136771$24313677$1$I$$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142895$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240912$$HP$US$US
243136782$24313678$2$F$$20240911$20240912$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145067$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240924$$HP$US$US
243136791$24313679$1$I$$20240912$20240912$20240912$DIR$718152$$FDA-CTU$$78$YR$$M$N$72.1$KG$20240912$N$MD$US$
243136802$24313680$2$F$$20240909$20240912$20240912$PER$$US-ROCHE-10000077996$ROCHE$$$$$$Y$$$20240912$$CN$US$US
243136811$24313681$1$I$$20240903$20240912$20240912$PER$$US-ABBVIE-5907209$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243136831$24313683$1$I$20240911$20240911$20240911$20240911$DIR$FDA-CDER-CTU-2024-62753$$FDA-CTU$$84$YR$$F$N$$$20240911$N$PH$US$
243136841$24313684$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263418$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240912$$HP$US$US
243136851$24313685$1$I$20240718$20240912$20240912$20240912$DIR$718150$$FDA-CTU$$65$YR$$M$N$59.6$KG$20240912$N$HP$US$
243136871$24313687$1$I$$20240828$20240912$20240912$PER$$US-SA-2024SA249804$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240912$$CN$US$US
243136881$24313688$1$I$$20240910$20240912$20240912$EXP$$CA-TAKEDA-2024TUS090752$TAKEDA$$$$$F$Y$$$20240912$$MD$CA$CA
243136891$24313689$1$I$20240801$20240906$20240912$20240912$EXP$$NVSC2024FR181576$NOVARTIS$$27$YR$$M$Y$$$20240912$$MD$FR$FR
243136901$24313690$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA263217$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240912$$HP$US$US
243136911$24313691$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA168185$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240912$$MD$US$US
243136921$24313692$1$I$$20240909$20240912$20240912$PER$$US-FreseniusKabi-FK202413622$FRESENIUS KABI$$67$YR$E$F$Y$$$20240912$$CN$US$US
243136943$24313694$3$F$20220516$20240917$20240912$20240919$EXP$$FR-PFIZER INC-PV202400119900$PFIZER$$67$YR$$M$Y$$$20240919$$MD$FR$FR
243136951$24313695$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA261895$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240912$$HP$US$US
243136961$24313696$1$I$$20240911$20240911$20240911$DIR$718037$$FDA-CTU$$$$$UNK$N$$$20240911$N$CN$US$
243136971$24313697$1$I$20240909$20240911$20240911$20240911$DIR$718086$$FDA-CTU$$53$YR$$F$N$68.5$KG$20240911$N$$US$
243136981$24313698$1$I$20240910$20240912$20240912$20240912$DIR$718123$$FDA-CTU$$59$YR$$F$N$112$KG$20240912$N$PH$US$
243136991$24313699$1$I$$20240904$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141541$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240912$$MD$US$US
243137001$24313700$1$I$$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144686$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240912$$CN$US$US
243137011$24313701$1$I$20240817$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144111$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240912$$HP$US$US
243137021$24313702$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145419$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240912$$CN$US$US
243137031$24313703$1$I$$20240904$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142421$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240912$$CN$US$US
243137041$24313704$1$I$20240806$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144526$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$76.66$KG$20240912$$CN$US$US
243137051$24313705$1$I$$20240910$20240912$20240912$PER$$US-ALXN-202409USA000732US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243137061$24313706$1$I$$20230610$20240912$20240912$EXP$$NVSC2023CN281082$NOVARTIS$$$$$$Y$$$20240912$$MD$CN$CN
243137071$24313707$1$I$$20240909$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US078983$SANDOZ$$$$$F$Y$$$20240912$$CN$US$US
243137081$24313708$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263279$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240912$$HP$US$US
243137091$24313709$1$I$$20240823$20240912$20240912$PER$$US-SA-2024SA262305$SANOFI AVENTIS$$$$A$M$Y$62.73$KG$20240912$$MD$US$US
243137101$24313710$1$I$20240101$20240830$20240912$20240912$PER$$US-SA-2024SA110456$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240912$$MD$US$US
243137111$24313711$1$I$$20240904$20240912$20240912$EXP$$AU-AstraZeneca-2024A206909$ASTRAZENECA$Berling I, Isbister G.. Chlorpromazine overdose: a case series. Clin Toxicol 2024;1-6.$$$$$Y$$$20240912$$MD$AU$
243137121$24313712$1$I$$20240904$20240912$20240912$EXP$$US-AstraZeneca-2024A201978$ASTRAZENECA$Aguilera D.;  Janss A.;  Schniederjan M.;  Goldman-Yassen A.;  Velazquez J.; Mazewski C.;  Gray R.;  MacDonald T.;  Fangusaro J.;  Castellino R.C.. OTHR-25. ANAPLASTIC TRANSFORMATION OF DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMORS: TWO PEDIATRIC CASES. Neuro-Oncology 2024;26(Supplement 4):iv199-.$20$YR$$M$Y$$$20240912$$HP$US$
243137131$24313713$1$I$$20240909$20240912$20240912$EXP$$RU-AstraZeneca-2024A207926$ASTRAZENECA$Shekhovtsova E. V, Lukashik E. V, Bogochanova O. A, Kolonutov M. S, Kudinova M. A, Reznik E. V. et al.. Systemic amyloidosis in a patient with acute heart failure.. Klinitsist = The Clinician 2024;18((2)):30-7.$58$YR$$F$Y$$$20240912$$HP$RU$
243137141$24313714$1$I$20240903$20240903$20240912$20240912$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03255$AMNEAL$$$$$F$Y$$$20240912$$HP$US$US
243137152$24313715$2$F$$20240916$20240912$20240919$EXP$$GB-LABORATORIOS LICONSA S.A.-2409GB07049$INSUD PHARMA$$$$A$F$Y$$$20240919$$MD$GB$GB
243137161$24313716$1$I$20240101$20240830$20240912$20240912$PER$$US-INSUD PHARMA-2408US06902$INSUD PHARMA$$$$$$Y$$$20240912$$CN$US$US
243137171$24313717$1$I$$20240902$20240912$20240912$EXP$$DE-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2409DE06848$INSUD PHARMA$$54$YR$$F$Y$$$20240912$$CN$DE$DE
243137181$24313718$1$I$$20240806$20240912$20240912$EXP$$CA-RDY-CLI/CAN/24/0004580$DR REDDYS$$77$YR$E$M$Y$$$20240912$$HP$CA$CA
243137191$24313719$1$I$20240831$20240903$20240912$20240912$PER$$US-ABBVIE-5907246$ABBVIE$$25$YR$$F$Y$$$20240912$$CN$US$US
243137201$24313720$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145371$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240912$$CN$US$US
243137211$24313721$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145325$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$48.53$KG$20240912$$CN$US$US
243137221$24313722$1$I$20240910$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144326$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240912$$HP$US$US
243137231$24313723$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144836$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240912$$CN$US$US
243137241$24313724$1$I$$20240911$20240912$20240912$PER$$US-HALEON-2196585$Haleon PLC$$$$$$Y$$$20240912$$CN$US$US
243137251$24313725$1$I$$20240910$20240912$20240912$PER$$NVSC2024US182119$NOVARTIS$$$$$F$Y$$$20240912$$MD$US$US
243137262$24313726$2$F$$20240917$20240912$20240921$EXP$$UA-AMGEN-UKRSP2024178424$AMGEN$Lymanets T.. AML-054 Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240920$$MD$UA$UA
243137271$24313727$1$I$20240701$20240902$20240912$20240912$EXP$$AU-ASTELLAS-2024-AER-003910$ASTELLAS$$23$YR$A$M$Y$$$20240912$$HP$AU$AU
243137281$24313728$1$I$$20240906$20240912$20240912$EXP$$US-TAKEDA-2024TUS083344$TAKEDA$$$$$F$Y$$$20240912$$CN$US$US
243137291$24313729$1$I$20240101$20240904$20240912$20240912$EXP$$US-SA-2024SA263304$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240912$$HP$US$US
243137301$24313730$1$I$$20240823$20240912$20240912$PER$$US-SA-2024SA262435$SANOFI AVENTIS$$$$A$M$Y$88.64$KG$20240912$$MD$US$US
243137311$24313731$1$I$20240801$20240829$20240912$20240912$PER$$US-SA-2024SA264058$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240912$$CN$US$US
243137321$24313732$1$I$$20240904$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004826$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240912$$CN$US$US
243137331$24313733$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007347$ELI LILLY AND CO$$$$A$F$Y$$$20240912$$CN$US$US
243137341$24313734$1$I$20240901$20240903$20240912$20240912$PER$$US-SA-2024SA261731$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240912$$MD$US$US
243137351$24313735$1$I$$20210109$20240912$20240912$EXP$$NVSC2021IT318472$NOVARTIS$$$$$$Y$$$20240912$$HP$IT$IT
243137361$24313736$1$I$20240824$20240904$20240912$20240912$EXP$$CN-009507513-2409CHN002545$MERCK$$64$YR$$M$Y$$$20240912$$HP$CN$CN
243137371$24313737$1$I$20240729$20240910$20240912$20240912$PER$$US-ALXN-202409USA000719US$ALEXION PHARMACEUTICALS$$82$YR$$M$Y$$$20240912$$CN$US$US
243137381$24313738$1$I$$20240910$20240912$20240912$PER$$US-ALXN-202409USA000621US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$HP$US$US
243137391$24313739$1$I$$20240904$20240912$20240912$EXP$$US-ABBVIE-5919922$ABBVIE$Fakhri B, Wang V, Perez Burbano G, Wall A, Mandrekar S, Parikh SA, et al. Pericardial events associated with ibrutinib based therapies for chronic lymphocytic leukaemia in two landmark trials. Br J Haematol. 2024;1-4.$$$$$Y$$$20240912$$HP$US$US
243137401$24313740$1$I$$20240906$20240912$20240912$EXP$$US-ROCHE-10000076857$ROCHE$$$$E$M$Y$$$20240912$$CN$US$US
243137411$24313741$1$I$$20240905$20240912$20240912$PER$$US-JNJFOC-20240915731$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
243137421$24313742$1$I$20240815$20240907$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143109$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$68.95$KG$20240912$$CN$US$US
243137431$24313743$1$I$$20240909$20240912$20240912$EXP$$CA-TAKEDA-2024TUS090466$TAKEDA$$$$$F$Y$$$20240912$$CN$CA$CA
243137441$24313744$1$I$$20240911$20240912$20240912$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050936$BOEHRINGER INGELHEIM$$54$YR$A$M$Y$$$20240912$$MD$CA$CA
243137452$24313745$2$F$$20240904$20240912$20240924$PER$$US-SMPA-2024SPA002339$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243137462$24313746$2$F$$20240905$20240912$20240913$30DAY$$US-GSK-US2024110757$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243137471$24313747$1$I$20211014$20240909$20240912$20240912$EXP$SK-SUKLSK-202110077$SK-FreseniusKabi-FK202413588$FRESENIUS KABI$$58$YR$A$F$Y$65$KG$20240912$$MD$SK$SK
243137481$24313748$1$I$20240801$20240903$20240912$20240912$PER$$US-SA-2024SA262307$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240912$$CN$US$US
243137501$24313750$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182615$NOVARTIS$$$$A$F$Y$$$20240912$$MD$US$US
243137511$24313751$1$I$20240801$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144197$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240912$$HP$US$US
243137521$24313752$1$I$20240814$20240910$20240912$20240912$EXP$FR-AFSSAPS-CN2024000836$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-144855$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240912$$PH$FR$FR
243137531$24313753$1$I$20240701$20240909$20240912$20240912$EXP$GB-MHRA-MED-202409091727052100-JLPSR$GB-REGENERON PHARMACEUTICALS, INC.-2024-120931$REGENERON$$$$$M$Y$$$20240912$$MD$GB$GB
243137542$24313754$2$F$$20240911$20240912$20240916$PER$$US-TAKEDA-2024TUS090653$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
243137551$24313755$1$I$$20240910$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US079743$SANDOZ$$$$$F$Y$68.18$KG$20240912$$CN$US$US
243137561$24313756$1$I$20240819$20240909$20240912$20240912$EXP$FR-AFSSAPS-AN2024001210$FR-FreseniusKabi-FK202413673$FRESENIUS KABI$$71$YR$E$M$Y$72$KG$20240912$$MD$FR$FR
243137571$24313757$1$I$20240814$20240909$20240912$20240912$EXP$FR-AFSSAPS-AM2024000719$FR-FreseniusKabi-FK202413669$FRESENIUS KABI$$63$YR$A$F$Y$$$20240912$$PH$FR$FR
243137581$24313758$1$I$$20240910$20240912$20240912$PER$$US-FreseniusKabi-FK202413625$FRESENIUS KABI$$76$YR$E$F$Y$$$20240912$$CN$US$US
243137591$24313759$1$I$20240419$20240909$20240912$20240912$EXP$FR-AFSSAPS-PA2024001076$FR-FreseniusKabi-FK202413634$FRESENIUS KABI$$59$YR$A$F$Y$57.5$KG$20240912$$MD$FR$FR
243137601$24313760$1$I$$20240910$20240912$20240912$PER$$US-FreseniusKabi-FK202413623$FRESENIUS KABI$$55$YR$A$F$Y$$$20240912$$HP$US$US
243137611$24313761$1$I$$20240911$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145508$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240912$$CN$US$US
243137621$24313762$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145227$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240912$$PH$US$US
243137641$24313764$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182988$NOVARTIS$$$$$F$Y$$$20240912$$CN$US$US
243137651$24313765$1$I$$20240904$20240912$20240912$PER$$US-TAKEDA-2024TUS088984$TAKEDA$$$$$$Y$$$20240912$$CN$US$US
243137661$24313766$1$I$20240401$20240902$20240912$20240912$EXP$FR-AFSSAPS-BX2024001717$FR-ASTELLAS-2024-AER-004388$ASTELLAS$$62$YR$A$F$Y$49$KG$20240912$$MD$FR$FR
243137671$24313767$1$I$20240910$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007749$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240912$$CN$US$US
243137681$24313768$1$I$20040826$20240903$20240912$20240912$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409003983$ELI LILLY AND CO$$87$YR$E$M$Y$$$20240912$$CN$DE$BR
243137691$24313769$1$I$$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007395$ELI LILLY AND CO$$$$$M$Y$$$20240912$$CN$US$US
243137701$24313770$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005999$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240912$$CN$US$US
243137711$24313771$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145146$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240912$$HP$US$US
243137721$24313772$1$I$$20240910$20240912$20240912$EXP$$IN-SANDOZ INC.-SDZ2024IN079663$SANDOZ$$$$$M$Y$$$20240912$$CN$IN$IN
243137731$24313773$1$I$$20240910$20240912$20240912$EXP$$US-AstraZeneca-2024A207144$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243137741$24313774$1$I$$20240910$20240912$20240912$PER$$US-AstraZeneca-2024A207201$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243137761$24313776$1$I$$20240625$20240912$20240912$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00079$Krystal Biotech$$28$YR$$F$Y$$$20240904$$HP$US$US
243137771$24313777$1$I$$20240626$20240912$20240912$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00080$Krystal Biotech$$9$YR$$F$Y$$$20240904$$CN$US$US
243137781$24313778$1$I$$20240703$20240912$20240912$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00085$Krystal Biotech$$9$YR$$F$Y$$$20240904$$HP$US$US
243137791$24313779$1$I$$20240722$20240912$20240912$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00094$Krystal Biotech$$$$$$Y$$$20240904$$$US$US
243137801$24313780$1$I$$20240722$20240912$20240912$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00095$Krystal Biotech$$15$YR$$F$Y$$$20240904$$HP$US$US
243137811$24313781$1$I$$20240724$20240912$20240912$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00096$Krystal Biotech$$$$$$Y$$$20240904$$HP$US$US
243137821$24313782$1$I$$20240605$20240912$20240912$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00069$Krystal Biotech$$$$$$Y$$$20240904$$$US$US
243137831$24313783$1$I$$20240617$20240912$20240912$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00073$Krystal Biotech$$$$$F$Y$$$20240904$$HP$US$US
243137841$24313784$1$I$$20240713$20240912$20240912$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00091$Krystal Biotech$$$$$$Y$$$20240904$$MD$US$US
243137851$24313785$1$I$$20240717$20240912$20240912$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00093$Krystal Biotech$$10$YR$$$Y$$$20240904$$HP$US$US
243137861$24313786$1$I$$20240717$20240912$20240912$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00092$Krystal Biotech$$15$YR$$F$Y$$$20240904$$HP$US$US
243137871$24313787$1$I$$20240807$20240912$20240912$EXP$$US-KRYSTAL BIOTECH, INC.-2024KRYUS00104$Krystal Biotech$$1$YR$$F$Y$$$20240904$$HP$US$US
243137881$24313788$1$I$20240801$20240815$20240912$20240912$PER$$US-IMP-2024000640$Harrow Health$$$$E$M$Y$$$20240912$$CN$US$US
243137901$24313790$1$I$$20240909$20240912$20240912$EXP$$ES-MYLANLABS-2024M1082805$MYLAN$$41$YR$$F$Y$$$20240912$$PH$ES$ES
243137912$24313791$2$F$20240501$20240909$20240912$20240918$EXP$$US-MYLANLABS-2024M1082961$MYLAN$$38$YR$$F$Y$79.38$KG$20240918$$CN$US$US
243137931$24313793$1$I$$20240820$20240912$20240912$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051130$BOEHRINGER INGELHEIM$$$$$$Y$$$20240912$$MD$US$US
243137942$24313794$2$F$$20240917$20240912$20240920$EXP$$UA-AMGEN-UKRSP2024178426$AMGEN$Lymanets T.. AML-054 Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort. Clinical Lymphoma Myeloma and Leukemia. 2024;24 (Suppl 1):S290-S291$$$A$$Y$$$20240920$$MD$UA$UA
243137951$24313795$1$I$$20240909$20240912$20240912$PER$$US-JNJFOC-20240923467$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240912$$CN$US$US
243137961$24313796$1$I$$20240911$20240912$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US079733$SANDOZ$$$$$M$Y$$$20240912$$MD$US$US
243137971$24313797$1$I$$20240821$20240912$20240912$PER$$US-SA-2024SA262567$SANOFI AVENTIS$$$$$F$Y$53.18$KG$20240912$$MD$US$US
243137981$24313798$1$I$$20240909$20240912$20240912$EXP$$DE-PFIZER INC-202400252464$PFIZER$$$$A$F$Y$$$20240912$$MD$DE$DE
243137992$24313799$2$F$$20240910$20240912$20240927$PER$$US-SMPA-2024SPA001757$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243138001$24313800$1$I$20240731$20240815$20240912$20240912$PER$$US-IMP-2024000642$Harrow Health$$77$YR$E$F$Y$$$20240912$$CN$US$US
243138011$24313801$1$I$20220707$20240910$20240912$20240912$PER$$NVSC2024US183008$NOVARTIS$$76$YR$$M$Y$$$20240912$$HP$US$US
243138021$24313802$1$I$$20240908$20240912$20240912$PER$$NVSC2024US179930$NOVARTIS$$$$$M$Y$$$20240912$$CN$US$US
243138031$24313803$1$I$$20240905$20240912$20240912$PER$$US-JNJFOC-20240914421$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$CN$US$US
243138041$24313804$1$I$20191001$20240909$20240912$20240912$EXP$FR-AFSSAPS-AN20201156$FR-SANDOZ INC.-NVSC2020FR285930$SANDOZ$$43$YR$$F$Y$63$KG$20240912$$PH$FR$FR
243138051$24313805$1$I$$20240911$20240912$20240912$PER$$US-JNJFOC-20240929222$JOHNSON AND JOHNSON$$$$$F$Y$$$20240912$$HP$US$US
243138061$24313806$1$I$20240829$20240911$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145121$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240912$$CN$US$US
243138071$24313807$1$I$$20240905$20240912$20240912$PER$$US-EMD Serono-2024047919$EMD SERONO INC$$52$YR$A$F$Y$$$20240912$$CN$US$US
243138081$24313808$1$I$20240415$20240903$20240912$20240912$EXP$$US-PFIZER INC-PV202400115408$PFIZER$$68$YR$$F$Y$$$20240912$$HP$US$US
243138091$24313809$1$I$20231106$20240909$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143968$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$94.35$KG$20240912$$CN$US$US
243138101$24313810$1$I$$20240911$20240912$20240912$EXP$$CA-PFIZER INC-202400254712$PFIZER$$$$$F$Y$$$20240912$$CN$CA$CA
243138111$24313811$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA263426$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240912$$HP$US$US
243138121$24313812$1$I$$20240906$20240912$20240912$EXP$$US-ABBVIE-5916072$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243138131$24313813$1$I$20240601$20240903$20240912$20240912$PER$$JP-Eisai-EC-2024-173685$EISAI$$79$YR$E$M$Y$56$KG$20240912$$PH$JP$JP
243138141$24313814$1$I$$20240908$20240912$20240912$PER$$AU-Eisai-EC-2024-174016$EISAI$$$$$M$Y$$$20240912$$MD$AU$AU
243138151$24313815$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144889$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240912$$HP$US$US
243138161$24313816$1$I$20240906$20240906$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144020$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$97.52$KG$20240912$$CN$US$US
243138172$24313817$2$F$$20240923$20240912$20240924$EXP$GB-MHRA-MED-202409101642449390-TPHCK$GB-SANDOZ INC.-SDZ2024GB079473$SANDOZ$$85$YR$$F$Y$$$20240924$$CN$GB$GB
243138191$24313819$1$I$20240701$20240906$20240912$20240912$EXP$$US-ABBVIE-5914038$ABBVIE$$40$YR$$F$Y$$$20240912$$CN$US$US
243138201$24313820$1$I$20240830$20240910$20240912$20240912$EXP$$US-AstraZeneca-2024A207233$ASTRAZENECA$$14525$DY$$F$Y$$$20240912$$CN$US$
243138211$24313821$1$I$$20240910$20240912$20240912$EXP$$US-AstraZeneca-2024A207141$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243138221$24313822$1$I$$20240910$20240912$20240912$EXP$$US-AstraZeneca-2024A207155$ASTRAZENECA$$$$$F$Y$$$20240912$$CN$US$
243138231$24313823$1$I$20240101$20240904$20240912$20240912$PER$$US-009507513-2409USA001954$MERCK$$$$$F$Y$$$20240912$$HP$US$US
243138241$24313824$1$I$$20240827$20240912$20240912$PER$$US-009507513-2408USA009691$MERCK$$$$$F$Y$$$20240912$$CN$US$US
243138251$24313825$1$I$$20240905$20240912$20240912$EXP$$CA-Covis Pharma GmbH-2021COV22568$COVIS PHARMA$$63$YR$A$F$Y$$$20240912$$HP$CA$CA
243138262$24313826$2$F$$20240823$20240912$20240919$PER$$US-SMPA-2024SPA001918$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243138271$24313827$1$I$$20240904$20240912$20240912$EXP$GB-MHRA-MED-202409040749135630-QFRTV$GB-ELI_LILLY_AND_COMPANY-GB202409003125$ELI LILLY AND CO$$$$$F$Y$$$20240912$$CN$GB$GB
243138291$24313829$1$I$$20240911$20240912$20240912$EXP$GB-MHRA-MED-202409111139155900-NDJVR$GB-MYLANLABS-2024M1083189$MYLAN$$$$$F$Y$$$20240912$$CN$GB$GB
243138301$24313830$1$I$20240101$20240726$20240912$20240912$PER$$US-IMP-2024000551$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243138311$24313831$1$I$$20240906$20240912$20240912$PER$$US-PHARMING-PHAUS2024000780$PHARMING GROUP$$$$$$Y$$$20240912$$CN$US$US
243138321$24313832$1$I$$20240905$20240912$20240912$PER$$US-PHARMING-PHAUS2024000771$PHARMING GROUP$$$$$$Y$$$20240912$$MD$US$US
243138341$24313834$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA262666$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240912$$HP$US$US
243138351$24313835$1$I$$20240801$20240912$20240912$PER$$US-LUNDBECK-DKLU4002722$LUNDBECK$$$$$$Y$$$20240912$$CN$US$US
243138371$24313837$1$I$20240101$20240726$20240912$20240912$PER$$US-IMP-2024000554$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243138381$24313838$1$I$20240101$20240909$20240912$20240912$PER$$US-AMGEN-USASP2024180166$AMGEN$$57$YR$A$M$Y$$$20240912$$CN$US$US
243138391$24313839$1$I$$20240910$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA079296$SANDOZ$$68$YR$$M$Y$$$20240912$$CN$CA$CA
243138401$24313840$1$I$20240101$20240904$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141233$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240912$$CN$US$US
243138411$24313841$1$I$20240101$20240904$20240912$20240912$PER$$US-009507513-2408USA002104$MERCK$$$$$M$Y$76$KG$20240912$$HP$US$US
243138421$24313842$1$I$$20240903$20240912$20240912$PER$$US-JNJFOC-20240923733$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240912$$CN$US$US
243138431$24313843$1$I$20240819$20240822$20240912$20240912$PER$$US-IMP-2024000662$Harrow Health$$70$YR$E$F$Y$$$20240912$$CN$US$US
243138441$24313844$1$I$$20240906$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US079797$SANDOZ$$$$$F$Y$$$20240912$$CN$US$US
243138451$24313845$1$I$20231001$20240910$20240912$20240912$EXP$$SA-SANDOZ INC.-SDZ2024SA029024$SANDOZ$$53$YR$$M$Y$$$20240912$$CN$SA$SA
243138461$24313846$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA262463$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240912$$HP$US$US
243138471$24313847$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA261082$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240912$$MD$US$US
243138481$24313848$1$I$20240818$20240822$20240912$20240912$PER$$US-IMP-2024000664$Harrow Health$$70$YR$E$F$Y$$$20240912$$CN$US$US
243138491$24313849$1$I$20231223$20240909$20240912$20240912$EXP$PT-INFARMED-R202408-764$PT-BAYER-2024A130069$BAYER$$37$YR$A$F$Y$$$20240912$$HP$PT$PT
243138501$24313850$1$I$20240801$20240906$20240912$20240912$EXP$$JP-009507513-2409JPN000989J$MERCK$$66$YR$$M$Y$$$20240912$$MD$JP$JP
243138512$24313851$2$F$$20240907$20240912$20240918$PER$$US-JNJFOC-20240919919$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243138521$24313852$1$I$20240801$20240906$20240912$20240912$EXP$$JP-009507513-2409JPN000969J$MERCK$$6$DEC$$F$Y$$$20240912$$MD$JP$JP
243138531$24313853$1$I$$20240903$20240912$20240912$30DAY$$US-GSK-US2024AMR109927$GLAXOSMITHKLINE$$$$$F$Y$$$20240912$$CN$US$US
243138551$24313855$1$I$$20240827$20240912$20240912$PER$$US-IMP-2024000693$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243138561$24313856$1$I$$20240820$20240912$20240912$PER$$US-SA-2024SA262778$SANOFI AVENTIS$$$$A$F$Y$71.36$KG$20240912$$MD$US$US
243138571$24313857$1$I$$20240828$20240912$20240912$EXP$$US-009507513-2409USA003993$MERCK$Fontana R,J, Li Y-Y, Chen V, Kleiner D, Stolz A, Odin J, et al.. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology communications. 2024;1-12 (6-7)$$$A$$Y$$$20240912$$HP$US$US
243138581$24313858$1$I$$20240828$20240912$20240912$EXP$$US-009507513-2409USA003996$MERCK$Fontana R,J, Li Y-Y, Chen V, Kleiner D, Stolz A, Odin J, et al.. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology communications. 2024;1-12 (6-7)$$$A$$Y$$$20240912$$HP$US$US
243138591$24313859$1$I$$20240828$20240912$20240912$EXP$$US-009507513-2409USA003997$MERCK$Fontana R,J, Li Y-Y, Chen V, Kleiner D, Stolz A, Odin J, et al.. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology communications. 2024;1-12$$$A$$Y$$$20240912$$HP$US$US
243138601$24313860$1$I$$20240828$20240912$20240912$EXP$$US-009507513-2409USA003995$MERCK$Fontana R,J, Li Y-Y, Chen V, Kleiner D, Stolz A, Odin J, et al.. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology communications. 2024;1-12 (6-7)$$$A$$Y$$$20240912$$HP$US$US
243138611$24313861$1$I$$20240828$20240912$20240912$EXP$$US-009507513-2409USA003998$MERCK$Fontana R,J, Li Y-Y, Chen V, Kleiner D, Stolz A, Odin J, et al.. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology communications. 2024;1-12 (6-7)$$$A$$Y$$$20240912$$HP$US$US
243138621$24313862$1$I$$20240828$20240912$20240912$EXP$$US-009507513-2409USA003999$MERCK$Fontana R,J, Li Y-Y, Chen V, Kleiner D, Stolz A, Odin J, et al.. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology communications. 2024;1-12 (6-7)$76$YR$$M$Y$$$20240912$$HP$US$US
243138631$24313863$1$I$$20240828$20240912$20240912$EXP$$US-009507513-2409USA003994$MERCK$Fontana R,J, Li Y-Y, Chen V, Kleiner D, Stolz A, Odin J, et al.. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology communications. 2024;1-12 (6-7)$$$A$$Y$$$20240912$$HP$US$US
243138641$24313864$1$I$$20240828$20240912$20240912$EXP$$US-009507513-2409USA003992$MERCK$Fontana R,J, Li Y-Y, Chen V, Kleiner D, Stolz A, Odin J, et al.. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology communications. 2024;1-12 (6-7)$$$A$$Y$$$20240912$$HP$US$US
243138651$24313865$1$I$$20240826$20240912$20240912$PER$$US-IMP-2024000685$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243138671$24313867$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006300$ELI LILLY AND CO$$$$$$Y$$$20240912$$CN$US$US
243138681$24313868$1$I$$20240911$20240912$20240912$EXP$$US-PURDUE PHARMA-USA-2024-0311927$PURDUE$$$$$F$Y$$$20240912$$CN$US$US
243138691$24313869$1$I$$20240904$20240912$20240912$EXP$$BR-PURDUE-USA-2024-0311933$PURDUE$$$$$F$Y$$$20240912$$CN$BR$BR
243138701$24313870$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005649$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240912$$CN$US$US
243138711$24313871$1$I$20240901$20240906$20240912$20240912$EXP$$BR-PURDUE-USA-2024-0311935$PURDUE$$60$YR$$F$Y$80$KG$20240912$$CN$BR$BR
243138721$24313872$1$I$$20240909$20240912$20240912$EXP$$CA-PURDUE-USA-2024-0311941$PURDUE$$50$YR$$F$Y$68$KG$20240912$$HP$CA$CA
243138731$24313873$1$I$$20240904$20240912$20240912$EXP$$CA-PURDUE-USA-2024-0311934$PURDUE$$43$YR$$F$Y$97$KG$20240912$$HP$CA$CA
243138741$24313874$1$I$$20240911$20240912$20240912$PER$$US-PURDUE PHARMA-USA-2024-0311930$PURDUE$$49$YR$$M$Y$$$20240912$$CN$US$US
243138751$24313875$1$I$$20240911$20240912$20240912$PER$$US-PURDUE PHARMA-USA-2024-0311929$PURDUE$$$$$M$Y$$$20240912$$CN$US$US
243138761$24313876$1$I$$20240911$20240912$20240912$PER$$US-PURDUE PHARMA-USA-2024-0311926$PURDUE$$$$$M$Y$$$20240912$$CN$US$US
243138781$24313878$1$I$20240801$20240829$20240912$20240912$PER$$US-IMP-2024000700$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243138791$24313879$1$I$20240101$20240904$20240912$20240912$PER$$US-009507513-2409USA001953$MERCK$$$$$F$Y$52.5$KG$20240912$$HP$US$US
243138801$24313880$1$I$20230730$20240906$20240912$20240912$EXP$GB-MHRA-MED-202409061425441910-NPQTV$GB-RDY-SPO/GBR/24/0013122$DR REDDYS$$7$YR$C$F$Y$$$20240912$$CN$GB$GB
243138811$24313881$1$I$$20240911$20240912$20240912$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051127$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240912$$MD$CO$CO
243138821$24313882$1$I$$20240819$20240912$20240912$PER$$US-SMPA-2024SPA001645$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138851$24313885$1$I$$20240819$20240912$20240912$PER$$US-SMPA-2024SPA001658$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138861$24313886$1$I$$20240816$20240912$20240912$PER$$US-SMPA-2024SPA001569$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138871$24313887$1$I$20240801$20240818$20240912$20240912$PER$$US-SMPA-2024SPA001618$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138881$24313888$1$I$$20240817$20240912$20240912$PER$$US-SMPA-2024SPA001572$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138891$24313889$1$I$$20240819$20240912$20240912$PER$$US-SMPA-2024SPA001662$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138901$24313890$1$I$$20240817$20240912$20240912$PER$$US-SMPA-2024SPA001589$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138911$24313891$1$I$$20240819$20240912$20240912$PER$$US-SMPA-2024SPA000498$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138921$24313892$1$I$$20240816$20240912$20240912$PER$$US-SMPA-2024SPA001571$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138931$24313893$1$I$$20240819$20240912$20240912$PER$$US-SMPA-2024SPA001636$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138951$24313895$1$I$$20240819$20240912$20240912$PER$$US-SMPA-2024SPA001637$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138961$24313896$1$I$$20240819$20240912$20240912$PER$$US-SMPA-2024SPA001655$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138971$24313897$1$I$$20240818$20240912$20240912$PER$$US-SMPA-2024SPA001619$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243138982$24313898$2$F$$20240916$20240912$20240930$PER$$US-SMPA-2024SPA001620$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243139001$24313900$1$I$$20240813$20240912$20240912$PER$$US-UROVANT SCIENCES GMBH-202206-URV-000831$SUNOVION$$$$$$Y$$$20240912$$CN$US$US
243139011$24313901$1$I$$20240905$20240912$20240912$PER$$US-VERTEX PHARMACEUTICALS-2024-014268$VERTEX$$$$$F$Y$$$20240912$$HP$US$US
243139021$24313902$1$I$20240413$20240905$20240912$20240912$EXP$$RU-VERTEX PHARMACEUTICALS-2024-014188$VERTEX$$9$YR$$M$Y$24$KG$20240912$$MD$RU$RU
243139031$24313903$1$I$$20240904$20240912$20240912$EXP$$GB-VERTEX PHARMACEUTICALS-2024-013588$VERTEX$$$$$F$Y$$$20240912$$CN$GB$GB
243139041$24313904$1$I$$20240905$20240912$20240912$EXP$RU-RZN-2546329$RU-VERTEX PHARMACEUTICALS-2024-014311$VERTEX$$3$YR$$M$Y$14$KG$20240912$$MD$RU$RU
243139051$24313905$1$I$20211001$20240902$20240912$20240912$EXP$FR-AFSSAPS-RS2023000788$FR-VERTEX PHARMACEUTICALS-2023-016169$VERTEX$Blaisonneau E, Le Dare B, Mercerolle M, Bacle A, Triquet L, Osmont MN, et al.. Adverse effects of tezacaftor/ivacaftor/elexacaftor combination that may lead to treatment discontinuation: about a series of 10 cases (Effets ind?sirables de l?association tezacaftor/ivacaftor/elexacaftor pouvant mener ? un arr?t de traitement : ? propos d?une s?rie de 10 cas). Therapie. 2024$45$YR$$F$Y$63$KG$20240912$$PH$FR$FR
243139071$24313907$1$I$$20240831$20240912$20240912$30DAY$$DE-UCBSA-2024045026$UCB$$$$$F$Y$$$20240912$$CN$DE$DE
243139091$24313909$1$I$$20240907$20240912$20240912$PER$$US-ABBVIE-5914046$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243139101$24313910$1$I$$20240911$20240912$20240912$PER$$NVSC2024US182850$NOVARTIS$$$$$F$Y$$$20240912$$HP$US$US
243139111$24313911$1$I$$20240830$20240912$20240912$PER$$US-IMP-2024000703$Harrow Health$$$$A$F$Y$$$20240912$$CN$US$US
243139121$24313912$1$I$$20240910$20240912$20240912$PER$$US-ALXN-202409USA000683US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243139131$24313913$1$I$$20240909$20240912$20240912$EXP$$IN-SANDOZ INC.-SDZ2024IN079298$SANDOZ$$$$$F$Y$$$20240912$$CN$IN$IN
243139141$24313914$1$I$$20240830$20240912$20240912$PER$$US-IMP-2024000704$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243139151$24313915$1$I$20240328$20240909$20240912$20240912$EXP$FR-AFSSAPS-AM2024000715$FR-SANDOZ INC.-SDZ2024FR079310$SANDOZ$$20$YR$$F$Y$80$KG$20240912$$MD$FR$FR
243139161$24313916$1$I$20240101$20240830$20240912$20240912$PER$$US-IMP-2024000706$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243139172$24313917$2$F$$20240917$20240912$20240918$EXP$$US-SANDOZ INC.-SDZ2024US079701$SANDOZ$$$$$M$Y$$$20240918$$CN$US$US
243139181$24313918$1$I$$20240910$20240912$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US079366$SANDOZ$$$$$$Y$$$20240912$$CN$US$US
243139191$24313919$1$I$$20240830$20240912$20240912$PER$$US-Calliditas-2024CAL01710$CALLIDITAS THERAPEUTICS$$$$$M$Y$$$20240912$$HP$US$US
243139201$24313920$1$I$$20240909$20240912$20240912$EXP$PL-EMA-20170208-hksevhp-163654872$PL-SANDOZ INC.-SDZ2024PL079091$SANDOZ$$56$YR$$F$Y$$$20240912$$MD$PL$PL
243139211$24313921$1$I$$20240829$20240912$20240912$PER$$US-IMP-2024000701$Harrow Health$$$$E$F$Y$$$20240912$$CN$US$US
243139221$24313922$1$I$$20240911$20240912$20240912$PER$$US-JNJFOC-20240927823$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$US$US
243139241$24313924$1$I$$20240906$20240912$20240912$EXP$$CA-ABBVIE-5920790$ABBVIE$$$$$M$Y$$$20240912$$CN$CA$CA
243139251$24313925$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA262751$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240912$$CN$US$US
243139261$24313926$1$I$20240801$20240905$20240912$20240912$30DAY$$CO-PFIZER INC-202400250784$PFIZER$$11$YR$$F$Y$$$20240912$$CN$CO$CO
243139272$24313927$2$F$20240907$20240912$20240912$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006393$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240916$$CN$US$US
243139281$24313928$1$I$20240101$20240911$20240912$20240912$EXP$$US-ABBVIE-5920789$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243139291$24313929$1$I$$20240801$20240912$20240912$PER$$US-LUNDBECK-DKLU4003001$LUNDBECK$$$$$$Y$$$20240912$$CN$US$US
243139301$24313930$1$I$$20240909$20240912$20240912$PER$$US-JNJFOC-20240927561$JOHNSON AND JOHNSON$$$$$$Y$$$20240912$$HP$US$US
243139311$24313931$1$I$$20240910$20240912$20240912$PER$$US-ALXN-202409USA000733US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240912$$CN$US$US
243139321$24313932$1$I$20240101$20240902$20240912$20240912$EXP$$CN-009507513-2409CHN002313$MERCK$$78$YR$$M$Y$$$20240912$$HP$CN$CN
243139331$24313933$1$I$$20240831$20240912$20240912$EXP$$US-FMCRTG-FMC-2409-001093$FRESENIUS MEDICAL CARE$$$$$$Y$$$20240912$$HP$US$US
243139341$24313934$1$I$$20240906$20240912$20240912$EXP$NL-LRB-01000291$NL-MYLANLABS-2024M1082015$MYLAN$$60$YR$$M$Y$75$KG$20240912$$CN$NL$NL
243139351$24313935$1$I$$20240816$20240912$20240912$PER$$US-FMCRTG-FMC-2408-001035$FRESENIUS MEDICAL CARE$$57$YR$A$F$Y$81$KG$20240912$$HP$US$US
243139361$24313936$1$I$$20240816$20240912$20240912$PER$$US-FMCRTG-FMC-2408-000995$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240912$$HP$US$US
243139371$24313937$1$I$$20240717$20240912$20240912$PER$$US-FMCRTG-FMC-2407-000869$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240912$$HP$US$US
243139381$24313938$1$I$$20240806$20240912$20240912$PER$$US-FMCRTG-FMC-2408-000971$FRESENIUS MEDICAL CARE$$76$YR$E$M$Y$73$KG$20240912$$HP$US$US
243139391$24313939$1$I$20240819$20240901$20240912$20240912$EXP$$US-FMCRTG-FMC-2409-001096$FRESENIUS MEDICAL CARE$$70$YR$E$F$Y$86.5$KG$20240912$$HP$US$US
243139401$24313940$1$I$20240805$20240819$20240912$20240912$PER$$US-FMCRTG-FMC-2408-001024$FRESENIUS MEDICAL CARE$$68$YR$E$M$Y$$$20240912$$HP$US$US
243139411$24313941$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144133$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240912$$HP$US$US
243139421$24313942$1$I$$20240819$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-132781$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$61.69$KG$20240912$$CN$US$US
243139431$24313943$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145204$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240912$$HP$US$US
243139441$24313944$1$I$20240101$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143557$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240912$$HP$US$US
243139451$24313945$1$I$$20240909$20240912$20240912$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050254$BOEHRINGER INGELHEIM$$$$$$Y$$$20240912$$MD$DE$DE
243139461$24313946$1$I$$20240827$20240912$20240912$EXP$$US-Nostrum Laboratories, Inc.-2161525$NOSTRUM$$51$YR$$F$Y$$$20240912$$$US$US
243139471$24313947$1$I$20240101$20240909$20240912$20240912$30DAY$$FR-SANDOZ INC.-SDZ2024FR079188$SANDOZ$$8$YR$$M$Y$$$20240912$$CN$FR$FR
243139482$24313948$2$F$20240901$20240924$20240912$20240926$EXP$$US-KARYOPHARM-2024KPT001504$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240926$$CN$US$US
243139491$24313949$1$I$20240101$20240906$20240912$20240912$PER$$US-ABBVIE-5916375$ABBVIE$$$$$$Y$$$20240912$$CN$US$US
243139501$24313950$1$I$$20240117$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000021$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139511$24313951$1$I$$20240103$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000002$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139521$24313952$1$I$$20240119$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000022$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139531$24313953$1$I$$20240423$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000136$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139541$24313954$1$I$$20240117$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000020$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139551$24313955$1$I$$20240104$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000005$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243139561$24313956$1$I$$20240116$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000019$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139571$24313957$1$I$$20240104$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000006$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139581$24313958$1$I$$20240108$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000011$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139591$24313959$1$I$$20240112$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000015$SIGMA TAU$$$$$F$Y$$$20240912$$HP$US$US
243139601$24313960$1$I$$20240108$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000012$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139611$24313961$1$I$$20240109$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000013$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139621$24313962$1$I$$20240103$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000003$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243139631$24313963$1$I$$20240104$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000004$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139641$24313964$1$I$$20240111$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000014$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243139651$24313965$1$I$$20240112$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000016$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139661$24313966$1$I$$20240115$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000018$SIGMA TAU$$$$$M$Y$$$20240912$$HP$US$US
243139671$24313967$1$I$$20240123$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000024$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139681$24313968$1$I$$20240102$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000001$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243139691$24313969$1$I$$20240105$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000009$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139701$24313970$1$I$$20240801$20240912$20240912$PER$$US-LUNDBECK-DKLU4002569$LUNDBECK$$$$$$Y$$$20240912$$CN$US$US
243139711$24313971$1$I$$20240911$20240912$20240912$EXP$$CN-TAKEDA-2024TUS089796$TAKEDA$$$$$F$Y$$$20240912$$CN$CN$CN
243139721$24313972$1$I$$20240429$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000143$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139731$24313973$1$I$$20240507$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000158$SIGMA TAU$$$$$M$Y$$$20240912$$HP$US$US
243139741$24313974$1$I$$20240509$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000161$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243139751$24313975$1$I$$20240425$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000139$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139761$24313976$1$I$$20240424$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000137$SIGMA TAU$$$$$F$Y$$$20240912$$MD$US$US
243139771$24313977$1$I$$20240426$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000142$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139781$24313978$1$I$$20240502$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000150$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139791$24313979$1$I$$20240507$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000159$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139801$24313980$1$I$$20240430$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000148$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139811$24313981$1$I$$20240507$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000156$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139821$24313982$1$I$$20240507$20240912$20240912$EXP$$US-LEADIANT GMBH-2024LBI000157$SIGMA TAU$$$$$M$Y$$$20240912$$HP$US$US
243139831$24313983$1$I$$20240511$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000163$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139841$24313984$1$I$$20240503$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000152$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139851$24313985$1$I$$20240424$20240912$20240912$EXP$$US-LEADIANT GMBH-2024LBI000138$SIGMA TAU$$$$$M$Y$$$20240912$$HP$US$US
243139861$24313986$1$I$$20240426$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000141$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139871$24313987$1$I$$20240430$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000147$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139881$24313988$1$I$$20240429$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000144$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139891$24313989$1$I$$20240502$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000151$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139901$24313990$1$I$$20240506$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000154$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139911$24313991$1$I$$20240423$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000140$SIGMA TAU$$$$$M$Y$$$20240912$$HP$US$US
243139921$24313992$1$I$$20240522$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000173$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139931$24313993$1$I$$20240517$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000168$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243139941$24313994$1$I$$20240604$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000192$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139951$24313995$1$I$$20240517$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000169$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139961$24313996$1$I$$20240524$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000177$SIGMA TAU$$$$$F$Y$$$20240912$$MD$US$US
243139971$24313997$1$I$$20240521$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000172$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139981$24313998$1$I$$20240524$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000179$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243139991$24313999$1$I$$20240516$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000167$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243140001$24314000$1$I$$20240528$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000180$SIGMA TAU$$$$$F$Y$$$20240912$$MD$US$US
243140011$24314001$1$I$$20240604$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000190$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140021$24314002$1$I$$20240524$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000178$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140031$24314003$1$I$$20240529$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000184$SIGMA TAU$$$$$F$Y$$$20240912$$MD$US$US
243140041$24314004$1$I$$20240603$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000187$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140051$24314005$1$I$$20240523$20240912$20240912$EXP$$US-LEADIANT GMBH-2024LBI000174$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140061$24314006$1$I$$20240530$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000186$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243140071$24314007$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145439$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240912$$HP$US$US
243140081$24314008$1$I$20240728$20240904$20240912$20240912$EXP$PT-INFARMED-R202408-146$PT-ABBVIE-5920791$ABBVIE$$20$YR$$F$Y$$$20240912$$PH$PT$PT
243140091$24314009$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143657$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240912$$CN$US$US
243140111$24314011$1$I$$20240909$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143824$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240912$$CN$US$US
243140121$24314012$1$I$$20240610$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000205$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140131$24314013$1$I$$20240610$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000206$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243140141$24314014$1$I$$20240606$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000203$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140151$24314015$1$I$$20240604$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000191$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140161$24314016$1$I$$20240607$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000204$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243140181$24314018$1$I$$20240613$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000209$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140191$24314019$1$I$$20240618$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000219$SIGMA TAU$$$$$F$Y$$$20240912$$MD$US$US
243140201$24314020$1$I$$20240910$20240912$20240912$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050743$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$100$KG$20240912$$PH$CA$CA
243140211$24314021$1$I$20240618$20240618$20240912$20240912$PER$$US-LEADIANT GMBH-2024LBI000217$SIGMA TAU$$52$YR$$F$Y$$$20240912$$HP$US$US
243140221$24314022$1$I$$20240617$20240912$20240912$PER$$US-LEADIANT GMBH-2024LBI000215$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140231$24314023$1$I$$20240619$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000220$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140241$24314024$1$I$$20240611$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000207$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140251$24314025$1$I$$20240612$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000208$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243140261$24314026$1$I$$20240618$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000216$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140271$24314027$1$I$$20240619$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000221$SIGMA TAU$$$$$F$Y$$$20240912$$HP$US$US
243140281$24314028$1$I$$20240614$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000211$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140291$24314029$1$I$$20240624$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000229$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140301$24314030$1$I$$20240621$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000236$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140311$24314031$1$I$$20240625$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000235$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140321$24314032$1$I$$20240624$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000228$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140331$24314033$1$I$$20240620$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000222$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140341$24314034$1$I$$20240624$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000230$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140351$24314035$1$I$$20240625$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000233$SIGMA TAU$$$$$F$Y$$$20240912$$MD$US$US
243140361$24314036$1$I$$20240626$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000238$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140371$24314037$1$I$$20240625$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000234$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140381$24314038$1$I$$20240626$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000244$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140391$24314039$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006998$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240912$$CN$US$US
243140401$24314040$1$I$$20240701$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000240$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140411$24314041$1$I$$20240701$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000241$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140421$24314042$1$I$$20240627$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000239$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140431$24314043$1$I$20240901$20240905$20240912$20240912$PER$$US-ABBVIE-5915621$ABBVIE$$74$YR$$M$Y$$$20240912$$CN$US$US
243140441$24314044$1$I$$20240709$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000250$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243140451$24314045$1$I$$20240712$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000263$SIGMA TAU$$$$$F$Y$$$20240912$$MD$US$US
243140461$24314046$1$I$$20240715$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000262$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140471$24314047$1$I$$20240715$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000261$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140481$24314048$1$I$$20240701$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000242$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140491$24314049$1$I$$20240703$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000247$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140501$24314050$1$I$$20240710$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000252$SIGMA TAU$$$$$F$Y$$$20240912$$HP$US$US
243140511$24314051$1$I$$20240716$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000269$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140521$24314052$1$I$$20240716$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000266$SIGMA TAU$$$$$F$Y$$$20240912$$MD$US$US
243140531$24314053$1$I$$20240717$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000271$SIGMA TAU$$$$$F$Y$$$20240912$$MD$US$US
243140541$24314054$1$I$$20240722$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000277$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140551$24314055$1$I$$20240718$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024LBI000273$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140561$24314056$1$I$20240722$20240904$20240912$20240912$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-17089$IPSEN$$63$YR$A$F$Y$$$20240912$$HP$CA$CA
243140571$24314057$1$I$$20240903$20240912$20240912$30DAY$$US-GSK-US2024109531$GLAXOSMITHKLINE$$$$$M$Y$$$20240912$$CN$US$US
243140581$24314058$1$I$20180101$20240905$20240912$20240912$EXP$$NVSC2024US182864$NOVARTIS$$60$YR$$F$Y$$$20240912$$HP$US$US
243140601$24314060$1$I$$20240819$20240912$20240912$PER$$US-INCYTE CORPORATION-2024IN008687$INCYTE$$$$$$Y$$$20240912$$CN$US$US
243140611$24314061$1$I$$20240819$20240912$20240912$PER$$US-INCYTE CORPORATION-2024IN008676$INCYTE$$$$$$Y$$$20240912$$CN$US$US
243140621$24314062$1$I$$20240903$20240912$20240912$PER$$US-SA-2024SA261846$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240912$$MD$US$US
243140631$24314063$1$I$$20240905$20240912$20240912$EXP$$US-BIOGEN-2024BI01281510$BIOGEN$$$$$M$Y$$$20240912$$CN$US$US
243140641$24314064$1$I$20240101$20240904$20240912$20240912$PER$$US-SA-2024SA262819$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240912$$HP$US$US
243140651$24314065$1$I$$20240903$20240912$20240912$PER$$US-AstraZeneca-2024A201358$ASTRAZENECA$$$$$M$Y$$$20240912$$CN$US$
243140671$24314067$1$I$$20240903$20240912$20240912$EXP$$US-RADIUS HEALTH INC.-2024US006771$RADIUS PHARM$$$$$F$Y$$$20240912$$CN$US$US
243140691$24314069$1$I$$20240904$20240912$20240912$PER$$US-SA-2024SA262864$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240912$$MD$US$US
243140711$24314071$1$I$20240627$20240910$20240912$20240912$PER$$NVSC2024US183010$NOVARTIS$$$$$F$Y$$$20240912$$HP$US$US
243140723$24314072$3$F$$20240911$20240912$20240918$EXP$$NVSC2023LK193577$NOVARTIS$$$$$F$Y$$$20240918$$MD$LK$LK
243140731$24314073$1$I$$20240912$20240912$20240912$PER$$NVSC2024US183016$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
243140741$24314074$1$I$$20240828$20240912$20240912$EXP$$CA-PFIZER INC-202400255448$PFIZER$$32$YR$$F$Y$95$KG$20240912$$HP$CA$CA
243140751$24314075$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144707$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$72.57$KG$20240912$$CN$US$US
243140761$24314076$1$I$20220817$20240911$20240912$20240912$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-188122$BOEHRINGER INGELHEIM$$60$YR$A$M$Y$94.5$KG$20240912$$MD$DE$DE
243140771$24314077$1$I$$20240911$20240912$20240912$PER$$NVSC2024US183018$NOVARTIS$$$$$M$Y$$$20240912$$HP$US$US
243140781$24314078$1$I$$20240904$20240912$20240912$PER$$US-ABBVIE-5908161$ABBVIE$$$$$F$Y$$$20240912$$HP$US$US
243140791$24314079$1$I$20240815$20240907$20240912$20240912$EXP$$US-LUNDBECK-DKLU4004158$LUNDBECK$$$$$$Y$$$20240912$$HP$US$US
243140801$24314080$1$I$20240726$20240904$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141207$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$100.7$KG$20240912$$CN$US$US
243140811$24314081$1$I$20240101$20240909$20240912$20240912$PER$$US-ALXN-202409USA000644US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240912$$CN$US$US
243140821$24314082$1$I$$20240905$20240912$20240912$EXP$$NVSC2024IN179524$NOVARTIS$$$$$F$Y$62.04$KG$20240912$$CN$IN$IN
243140831$24314083$1$I$$20240801$20240912$20240912$PER$$US-LUNDBECK-DKLU4002673$LUNDBECK$$$$$$Y$$$20240912$$CN$US$US
243140841$24314084$1$I$$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144473$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240912$$CN$US$US
243140851$24314085$1$I$$20240903$20240912$20240912$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08869$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240912$$HP$US$US
243140861$24314086$1$I$$20240205$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000034$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140871$24314087$1$I$20240201$20240208$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000038$SIGMA TAU$$36$YR$$M$Y$87.5$KG$20240912$$$US$US
243140881$24314088$1$I$$20240202$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000033$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140891$24314089$1$I$$20240206$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000032$SIGMA TAU$$$$$F$Y$109$KG$20240912$$MD$US$US
243140901$24314090$1$I$$20240130$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000030$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140911$24314091$1$I$$20240124$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000025$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140921$24314092$1$I$$20240124$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000026$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140931$24314093$1$I$$20240125$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000027$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140941$24314094$1$I$20240103$20240125$20240912$20240912$EXP$$US-LEADIANT GMBH-2024STPI000028$SIGMA TAU$$53$YR$$F$Y$$$20240912$$MD$US$US
243140951$24314095$1$I$$20240131$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000035$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243140961$24314096$1$I$$20240214$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000044$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243140971$24314097$1$I$$20240214$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000045$SIGMA TAU$$$$$M$Y$$$20240912$$MD$US$US
243140981$24314098$1$I$$20240214$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000042$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243140991$24314099$1$I$$20240214$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000043$SIGMA TAU$$$$$M$Y$$$20240912$$HP$US$US
243141001$24314100$1$I$$20240208$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000039$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243141011$24314101$1$I$$20240214$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000046$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243141021$24314102$1$I$$20240209$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000040$SIGMA TAU$$$$$M$Y$$$20240912$$CN$US$US
243141031$24314103$1$I$$20240215$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000047$SIGMA TAU$$$$$F$Y$$$20240912$$MD$US$US
243141041$24314104$1$I$$20240209$20240912$20240912$PER$$US-LEADIANT BIOSCIENCES, INC.-2024STPI000041$SIGMA TAU$$$$$F$Y$$$20240912$$CN$US$US
243141051$24314105$1$I$$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143067$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240912$$CN$US$US
243141061$24314106$1$I$$20240909$20240912$20240912$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050161$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240912$$MD$JP$JP
243141071$24314107$1$I$$20240910$20240912$20240912$PER$$US-ABBVIE-5919724$ABBVIE$$$$A$M$Y$$$20240912$$MD$US$US
243141081$24314108$1$I$$20240906$20240912$20240912$PER$$US-BIOGEN-2024BI01281653$BIOGEN$$$$$$Y$$$20240912$$MD$US$US
243141091$24314109$1$I$$20240905$20240912$20240912$PER$$US-BIOGEN-2024BI01281434$BIOGEN$$$$$M$Y$$$20240912$$CN$US$US
243141101$24314110$1$I$$20240911$20240912$20240912$PER$$NVSC2024US183017$NOVARTIS$$$$$$Y$$$20240912$$HP$US$US
243141121$24314112$1$I$$20240903$20240912$20240912$EXP$$CA-GILEAD-2024-0687208$GILEAD$$$$$M$Y$$$20240912$$HP$CA$CA
243141131$24314113$1$I$20240801$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145266$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240912$$PH$US$US
243141141$24314114$1$I$20240801$20240829$20240912$20240912$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1575$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240912$$HP$US$US
243141151$24314115$1$I$$20240905$20240912$20240912$EXP$$CA-PURDUE-USA-2024-0311919$PURDUE$$40$YR$$F$Y$$$20240912$$HP$CA$CA
243141161$24314116$1$I$20240501$20240909$20240912$20240912$EXP$GB-MHRA-MED-202409091717574630-PJNTZ$GB-ABBVIE-5921186$ABBVIE$$$$$F$Y$$$20240912$$CN$GB$GB
243141191$24314119$1$I$20240601$20240910$20240912$20240912$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051096$BOEHRINGER INGELHEIM$$58$YR$A$F$Y$$$20240912$$HP$CO$CO
243141201$24314120$1$I$20240101$20240911$20240912$20240912$PER$$US-ABBVIE-5919965$ABBVIE$$$$$F$Y$$$20240912$$HP$US$US
243141221$24314122$1$I$20150101$20240903$20240912$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143390$BRISTOL MYERS SQUIBB$Oiwa K, Shin L, Fujita K, Ueda T, Yamauchi T, et al. Clinical Features of Clonal Cytogenetic Abnormalities in Philadelphia-negative Cells Developed During Tyrosine Kinase Inhibitor Treatment. Internal Medicine. 2024;63(5): 729-32.$73$YR$E$M$Y$$$20240912$$HP$JP$JP
243141231$24314123$1$I$20240101$20240905$20240912$20240912$EXP$$US-009507513-2409USA002441$MERCK$$56$YR$$M$Y$77.8$KG$20240912$$HP$US$US
243141241$24314124$1$I$$20240903$20240912$20240912$EXP$$CA-GILEAD-2024-0687215$GILEAD$$$$$F$Y$7$KG$20240912$$HP$CA$CA
243141251$24314125$1$I$$20240816$20240912$20240912$PER$$US-AstraZeneca-2024A189151$ASTRAZENECA$$$$$M$Y$$$20240912$$MD$US$
243141261$24314126$1$I$$20240910$20240912$20240912$EXP$$CA-HLS-202402295$HLS THERAPEUTICS$$56$YR$A$M$Y$$$20240912$$HP$CA$CA
243141271$24314127$1$I$$20240910$20240912$20240912$EXP$$CA-HLS-202402293$HLS THERAPEUTICS$$68$YR$E$M$Y$$$20240912$$HP$CA$CA
243141281$24314128$1$I$20240101$20240904$20240912$20240912$EXP$$US-IOVANCE BIOTHERAPEUTICS, INC-2024IOV000077$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240912$$CN$US$US
243141291$24314129$1$I$$20240911$20240912$20240912$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050982$BOEHRINGER INGELHEIM$$54$YR$A$M$Y$$$20240912$$PH$CA$CA
243141301$24314130$1$I$20240901$20240905$20240912$20240912$EXP$$US-BIOGEN-2024BI01281608$BIOGEN$$26$YR$$F$Y$$$20240912$$PH$US$US
243141311$24314131$1$I$$20240910$20240912$20240912$EXP$$CA-HLS-202402292$HLS THERAPEUTICS$$$$$M$Y$$$20240912$$HP$CA$CA
243141321$24314132$1$I$$20240828$20240912$20240912$EXP$$US-009507513-2409USA004000$MERCK$Fontana R,J, Li Y-Y, Chen V, Kleiner D, Stolz A, Odin J, et al.. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology communications. 2024;1-12 (6-7)$48$YR$$M$Y$$$20240912$$HP$US$US
243141331$24314133$1$I$$20240910$20240912$20240912$EXP$$CA-HLS-202402291$HLS THERAPEUTICS$$$$$M$Y$$$20240912$$HP$CA$CA
243141341$24314134$1$I$20240828$20240830$20240912$20240912$EXP$$US-HLS-202401147$HLS THERAPEUTICS$$67$YR$E$M$Y$$$20240912$$HP$US$US
243141351$24314135$1$I$$20240904$20240912$20240912$EXP$$US-BIOMARINAP-US-2024-160410$BIOMARIN$Cooney E.,  Ammous Z., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024$$$$$Y$$$20240912$$MD$US$US
243141361$24314136$1$I$$20240909$20240912$20240912$EXP$$CN-JNJFOC-20240930333$JOHNSON AND JOHNSON$Wan ZM; Liu XH.. Rivaroxaban-Associated Neutropenia. American Journal of Therapeutics. 2024;00(00)$63$YR$A$M$Y$65$KG$20240912$$MD$CN$CN
243141372$24314137$2$F$20240612$20240905$20240912$20240912$EXP$$US-BIOMARINAP-US-2024-160371$BIOMARIN$$$$$$Y$$$20240912$$CN$US$US
243141381$24314138$1$I$$20240905$20240912$20240912$EXP$$ES-009507513-2409ESP002480$MERCK$Pinacho MO, Carrillo JA, Cereza ML, Gonz?lez AM, Suarez AS.. PASH SYNDROME: PROLONGED IMMUNOSUPPRESSION AND CANCER. European Journal of Case Reports in Internal Medicine. 2024;11(Supplement1):723-24$41$YR$$M$Y$$$20240912$$HP$ES$ES
243141391$24314139$1$I$$20240830$20240912$20240912$EXP$$US-HLS-202401153$HLS THERAPEUTICS$$$$A$$Y$$$20240912$$MD$US$US
243141401$24314140$1$I$20240826$20240830$20240912$20240912$EXP$$US-HLS-202401155$HLS THERAPEUTICS$$29$YR$A$M$Y$$$20240912$$HP$US$US
243141411$24314141$1$I$20240701$20240911$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202408000861$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240912$$CN$US$US
243141421$24314142$1$I$20050901$20240813$20240912$20240912$EXP$$BR-BIOMARINAP-BR-2024-160540$BIOMARIN$$$$$$Y$$$20240912$$CN$US$BR
243141431$24314143$1$I$$20240830$20240912$20240912$EXP$$US-HLS-202401159$HLS THERAPEUTICS$$44$YR$A$M$Y$$$20240912$$PH$US$US
243141441$24314144$1$I$$20240830$20240912$20240912$EXP$$US-HLS-202401161$HLS THERAPEUTICS$$24$YR$A$F$Y$$$20240912$$PH$US$US
243141451$24314145$1$I$20240701$20240829$20240912$20240912$PER$$US-SA-2024SA261883$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240913$$MD$US$US
243141461$24314146$1$I$20240801$20240906$20240912$20240912$EXP$$JP-009507513-2409JPN000982J$MERCK$$77$YR$$M$Y$$$20240912$$PH$JP$JP
243141471$24314147$1$I$$20240903$20240912$20240912$EXP$$CA-GILEAD-2024-0687277$GILEAD$$6$YR$C$M$Y$$$20240912$$HP$CA$CA
243141481$24314148$1$I$$20240906$20240912$20240912$EXP$$US-BIOGEN-2024BI01281798$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
243141491$24314149$1$I$$20240911$20240912$20240912$PER$$US-ROCHE-10000079857$ROCHE$$$$$$Y$$$20240913$$CN$US$US
243141501$24314150$1$I$$20240904$20240912$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145034$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$PH$JP$JP
243141512$24314151$2$F$20240831$20240906$20240912$20240915$PER$$US-SA-2024SA262856$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240915$$MD$US$US
243141531$24314153$1$I$20240820$20240905$20240912$20240912$EXP$$US-ABBVIE-5910166$ABBVIE$$66$YR$$M$Y$$$20240912$$CN$US$US
243141541$24314154$1$I$$20240909$20240912$20240912$EXP$$IN-SANDOZ INC.-SDZ2024IN079430$SANDOZ$$$$$F$Y$$$20240912$$CN$IN$IN
243141561$24314156$1$I$20240426$20240905$20240912$20240912$EXP$$DE-ABBVIE-5910682$ABBVIE$$68$YR$$F$Y$$$20240912$$MD$DE$DE
243141572$24314157$2$F$20240301$20240912$20240912$20240919$EXP$$US-ABBVIE-5910184$ABBVIE$$71$YR$$F$Y$77$KG$20240919$$CN$US$US
243141581$24314158$1$I$$20240905$20240912$20240912$EXP$$US-BIOGEN-2024BI01281662$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
243141591$24314159$1$I$20240801$20240910$20240912$20240912$EXP$$US-ABBVIE-5919622$ABBVIE$$96$YR$$M$Y$$$20240912$$CN$US$US
243141601$24314160$1$I$$20240903$20240912$20240912$EXP$$CA-GILEAD-2024-0687279$GILEAD$$10$YR$C$M$Y$$$20240912$$HP$CA$CA
243141611$24314161$1$I$20240801$20240909$20240912$20240912$EXP$$US-ABBVIE-5916093$ABBVIE$$51$YR$$M$Y$$$20240912$$CN$US$US
243141631$24314163$1$I$20240701$20240906$20240912$20240912$EXP$$US-ABBVIE-5914657$ABBVIE$$49$YR$$F$Y$$$20240912$$CN$US$US
243141641$24314164$1$I$20240201$20240906$20240912$20240912$EXP$$US-ABBVIE-5914096$ABBVIE$$67$YR$$F$Y$$$20240912$$CN$US$US
243141651$24314165$1$I$20240831$20240909$20240912$20240912$EXP$$CN-ABBVIE-5916109$ABBVIE$$67$YR$$M$Y$62$KG$20240912$$MD$CN$CN
243141661$24314166$1$I$$20240830$20240912$20240912$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051164$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240913$$CN$CA$CA
243141671$24314167$1$I$$20240910$20240912$20240912$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-121924$REGENERON$$70$YR$$F$Y$$$20240913$$MD$JP$JP
243141681$24314168$1$I$20240701$20240911$20240912$20240912$EXP$$NVSJ2024JP010857$NOVARTIS$$91$YR$$M$Y$$$20240913$$MD$JP$JP
243141691$24314169$1$I$$20240903$20240912$20240912$EXP$$CA-GILEAD-2024-0687312$GILEAD$$6$YR$C$F$Y$$$20240912$$HP$CA$CA
243141701$24314170$1$I$$20240909$20240912$20240912$EXP$$IT-SANDOZ INC.-SDZ2024IT079088$SANDOZ$$10$YR$$F$Y$$$20240912$$HP$IT$IT
243141711$24314171$1$I$$20240906$20240912$20240912$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145194$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$MD$JP$JP
243141721$24314172$1$I$20050401$20240909$20240912$20240912$EXP$$NL-SANDOZ INC.-PHHY2018NL036669$SANDOZ$$47$YR$$F$Y$$$20240912$$MD$NL$NL
243141732$24314173$2$F$$20240910$20240912$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-144779$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$MD$JP$JP
243141742$24314174$2$F$$20240905$20240912$20240917$EXP$$JP-ALXN-202409JPN000339JP$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240917$$MD$JP$JP
243141751$24314175$1$I$20230401$20240909$20240912$20240912$PER$$US-ORGANON-O2409USA000612$ORGANON$$$$$F$Y$$$20240912$$CN$US$US
243141761$24314176$1$I$20240601$20240830$20240912$20240912$PER$$US-SA-2024SA261870$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240913$$HP$US$US
243141771$24314177$1$I$20240821$20240910$20240912$20240912$EXP$$US-AstraZeneca-2024A206443$ASTRAZENECA$$$$$$Y$$$20240913$$HP$US$
243141781$24314178$1$I$20240704$20240910$20240912$20240912$EXP$SE-SEMPA-2024-006564$SE-SANDOZ INC.-SDZ2024SE079294$SANDOZ$$70$YR$$F$Y$$$20240912$$MD$SE$SE
243141791$24314179$1$I$$20240909$20240912$20240912$EXP$$IT-SANDOZ INC.-PHHY2015IT015906$SANDOZ$$54$YR$$F$Y$$$20240912$$MD$IT$IT
243141801$24314180$1$I$$20240909$20240912$20240912$PER$$US-JNJFOC-20240920546$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$HP$US$US
243141811$24314181$1$I$$20240904$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US079756$SANDOZ$$$$$$Y$$$20240912$$PH$US$US
243141831$24314183$1$I$20240806$20240903$20240912$20240912$PER$$US-TEVA-VS-3240355$TEVA$$40$YR$$F$Y$59.8$KG$20240912$$MD$US$US
243141851$24314185$1$I$$20240911$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024CA079543$SANDOZ$$8$YR$$F$Y$$$20240912$$HP$CA$CA
243141861$24314186$1$I$20240903$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005406$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240912$$CN$US$US
243141871$24314187$1$I$20240101$20240906$20240912$20240912$EXP$$US-BIOGEN-2024BI01281901$BIOGEN$$$$$F$Y$$$20240912$$CN$US$US
243141881$24314188$1$I$20240301$20240906$20240912$20240912$EXP$$BR-BIOGEN-2024BI01281868$BIOGEN$$28$YR$$F$Y$83$KG$20240912$$CN$BR$BR
243141891$24314189$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5914894$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243141901$24314190$1$I$$20240911$20240912$20240912$EXP$$US-ABBVIE-5919676$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243141912$24314191$2$F$$20240902$20240912$20240916$EXP$$JP-JNJFOC-20240920291$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240916$$HP$JP$JP
243141921$24314192$1$I$$20240830$20240912$20240912$PER$$US-SA-2024SA261899$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240913$$MD$US$US
243141931$24314193$1$I$$20240909$20240912$20240912$PER$$US-GILEAD-2024-0687186$GILEAD$$$$$M$Y$$$20240912$$HP$US$US
243141941$24314194$1$I$$20240902$20240912$20240912$EXP$$GB-JNJFOC-20240906544$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240913$$HP$GB$GB
243141951$24314195$1$I$$20240911$20240912$20240912$EXP$$NVSJ2024JP010879$NOVARTIS$$$$$$Y$$$20240913$$MD$JP$JP
243141961$24314196$1$I$20240820$20240905$20240912$20240912$EXP$$US-009507513-2409USA002556$MERCK$$$$$M$Y$$$20240912$$CN$US$US
243141971$24314197$1$I$20180118$20240909$20240912$20240912$EXP$$IT-SANDOZ INC.-PHHY2018IT043214$SANDOZ$$58$YR$$M$Y$$$20240912$$HP$IT$IT
243141981$24314198$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5914103$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243141991$24314199$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5849824$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243142002$24314200$2$F$20231114$20240902$20240912$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-141112$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$52$KG$20240920$$MD$JP$JP
243142011$24314201$1$I$$20240903$20240912$20240912$EXP$$CA-GILEAD-2024-0687317$GILEAD$$4$YR$C$F$Y$$$20240912$$HP$CA$CA
243142021$24314202$1$I$20240101$20240909$20240912$20240912$EXP$$US-ABBVIE-5919618$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243142031$24314203$1$I$$20240908$20240912$20240912$PER$$US-AMGEN-USASP2024181782$AMGEN$Chen P.; Toker M.; Islam Z. et al.. Adalimumab dose escalation in patients with refractory hidradenitis suppurativa. Journal of the American Academy of Dermatology. 2024;91 (3):AB14$$$$$Y$$$20240912$$HP$US$US
243142041$24314204$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144966$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$HP$US$US
243142051$24314205$1$I$$20240904$20240912$20240912$PER$$US-BAUSCHBL-2024BNL032829$BAUSCH AND LOMB$$$$E$F$Y$$$20240913$$CN$US$US
243142061$24314206$1$I$20240801$20240903$20240912$20240912$PER$$US-BAUSCHBL-2024BNL032774$BAUSCH AND LOMB$$60$YR$$M$Y$$$20240913$$CN$US$US
243142071$24314207$1$I$$20240911$20240912$20240912$EXP$$NVSJ2024JP010867$NOVARTIS$$$$$$Y$$$20240913$$MD$JP$JP
243142081$24314208$1$I$$20240909$20240912$20240912$EXP$GB-MHRA-EMIS-4466-98ea284f-a476-4633-98b6-f958c5430d73$GB-ORGANON-O2409GBR000557$ORGANON$$84$YR$$F$Y$55$KG$20240912$$MD$GB$GB
243142091$24314209$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006706$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240912$$CN$US$US
243142101$24314210$1$I$20240910$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006545$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240912$$CN$US$US
243142111$24314211$1$I$$20240904$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409007260$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240912$$CN$US$US
243142121$24314212$1$I$$20240904$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004565$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240912$$CN$US$US
243142131$24314213$1$I$20240101$20240902$20240912$20240912$EXP$$GB-ABBVIE-5909067$ABBVIE$$37$YR$$F$Y$$$20240912$$CN$GB$GB
243142141$24314214$1$I$20240808$20240829$20240912$20240912$EXP$$NO-Ascend Therapeutics US, LLC-2161530$ASCEND$$53$YR$$F$Y$$$20240912$$PH$NO$NO
243142151$24314215$1$I$20240802$20240911$20240912$20240912$EXP$FR-AFSSAPS-MP2024001302$FR-JNJFOC-20240930378$JOHNSON AND JOHNSON$$89$YR$E$F$Y$58.5$KG$20240913$$PH$FR$FR
243142161$24314216$1$I$$20240903$20240912$20240912$EXP$$CA-GILEAD-2024-0687345$GILEAD$$1$YR$C$F$Y$$$20240912$$HP$CA$CA
243142171$24314217$1$I$20240101$20240905$20240912$20240912$EXP$$BR-BIOGEN-2024BI01281529$BIOGEN$$$$$M$Y$$$20240912$$CN$BR$BR
243142191$24314219$1$I$20240827$20240906$20240912$20240912$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161531$JIANGSU HANSOH PHARMACEUTICAL$$46$YR$$M$Y$50$KG$20240912$$MD$CN$CN
243142201$24314220$1$I$20240902$20240903$20240912$20240912$EXP$$FR-ABBVIE-5917733$ABBVIE$$86$YR$$M$Y$$$20240912$$HP$FR$FR
243142211$24314221$1$I$$20240907$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US078950$SANDOZ$$$$$$Y$$$20240912$$CN$US$US
243142221$24314222$1$I$20190101$20240911$20240912$20240912$EXP$$US-ABBVIE-5913601$ABBVIE$$$$$F$Y$39.008$KG$20240912$$CN$US$US
243142231$24314223$1$I$$20240906$20240912$20240912$PER$$US-ABBVIE-5913829$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243142241$24314224$1$I$20240731$20240909$20240912$20240912$EXP$PT-INFARMED-F202408-936$PT-ORGANON-O2409PRT000629$ORGANON$$79$YR$$F$Y$56$KG$20240912$$CN$PT$PT
243142251$24314225$1$I$$20240906$20240912$20240912$EXP$$GB-TAKEDA-2024TUS058201$TAKEDA$$$$$F$Y$$$20240912$$MD$GB$GB
243142261$24314226$1$I$$20240911$20240912$20240912$EXP$$US-ABBVIE-5920056$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243142271$24314227$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5917435$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243142281$24314228$1$I$$20240905$20240912$20240912$EXP$$US-TAKEDA-2022TUS020394$TAKEDA$$$$$F$Y$$$20240912$$CN$US$US
243142291$24314229$1$I$$20240910$20240912$20240912$EXP$$NVSJ2024JP010756$NOVARTIS$$46$YR$$M$Y$$$20240913$$MD$JP$JP
243142301$24314230$1$I$$20240905$20240912$20240912$EXP$$IT-BIOGEN-2024BI01281526$BIOGEN$$$$$$Y$$$20240912$$HP$IT$IT
243142311$24314231$1$I$20240816$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142720$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$55$KG$20240913$$PH$US$US
243142321$24314232$1$I$20240903$20240909$20240912$20240912$EXP$$US-ABBVIE-5917121$ABBVIE$$32$YR$$M$Y$$$20240912$$CN$US$US
243142331$24314233$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5915243$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243142341$24314234$1$I$20240605$20240909$20240912$20240912$EXP$$PH-BRISTOL-MYERS SQUIBB COMPANY-2024-138301$BRISTOL MYERS SQUIBB$$28$YR$A$M$Y$$$20240913$$MD$PH$PH
243142351$24314235$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5914828$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243142361$24314236$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5917023$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243142371$24314237$1$I$20240118$20240906$20240912$20240912$EXP$ES-AEMPS-1565597$ES-009507513-2409ESP003843$MERCK$$66$YR$$F$Y$63.6$KG$20240912$$PH$ES$ES
243142381$24314238$1$I$20240711$20240909$20240912$20240912$EXP$$US-ABBVIE-5916989$ABBVIE$$66$YR$$F$Y$$$20240912$$CN$US$US
243142391$24314239$1$I$$20240910$20240912$20240912$30DAY$$US-SANDOZ INC.-SDZ2024US079437$SANDOZ$$$$$$Y$$$20240912$$CN$US$US
243142401$24314240$1$I$20230929$20240907$20240912$20240912$EXP$$IN-PFIZER INC-PV202300167523$PFIZER$$57$YR$$F$Y$$$20240912$$CN$IN$IN
243142411$24314241$1$I$20240909$20240911$20240912$20240912$EXP$$CN-PFIZER INC-PV202400119441$PFIZER$$48$YR$$F$Y$58$KG$20240912$$HP$CN$CN
243142421$24314242$1$I$$20240910$20240912$20240912$EXP$$JP-PFIZER INC-202400254949$PFIZER$$66$YR$$F$Y$$$20240912$$MD$JP$JP
243142431$24314243$1$I$20240601$20240909$20240912$20240912$EXP$$US-ABBVIE-5917235$ABBVIE$$61$YR$$F$Y$$$20240912$$CN$US$US
243142442$24314244$2$F$$20240916$20240912$20240918$EXP$$PT-PFIZER INC-202400252597$PFIZER$$62$YR$$M$Y$$$20240918$$HP$PT$PT
243142451$24314245$1$I$$20240910$20240912$20240912$EXP$$JP-DSJP-DSJ-2024-144415$DAIICHI$$10$DEC$$F$Y$$$20240913$$PH$JP$JP
243142462$24314246$2$F$$20240905$20240912$20240918$PER$$US-AstraZeneca-2024A202576$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243142471$24314247$1$I$$20240906$20240912$20240912$PER$$US-AstraZeneca-2024A203805$ASTRAZENECA$$$$$M$Y$$$20240913$$HP$US$
243142481$24314248$1$I$$20240906$20240912$20240912$EXP$$US-AstraZeneca-2024A204490$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243142491$24314249$1$I$20240826$20240911$20240912$20240912$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-145090$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240913$$HP$PR$PR
243142501$24314250$1$I$$20240909$20240912$20240912$EXP$$DE-DSJP-DSE-2024-144459$DAIICHI$$$$$F$Y$$$20240913$$CN$DE$DE
243142511$24314251$1$I$$20240909$20240912$20240912$EXP$GB-MHRA-MIDB-50b441a6-3495-4062-92a1-6cfb8500ed5b$GB-DSJP-DSE-2024-144308$DAIICHI$$72$YR$$M$Y$$$20240913$$PH$GB$GB
243142521$24314252$1$I$$20240909$20240912$20240912$EXP$$DE-DSJP-DSE-2024-144277$DAIICHI$$69$YR$$M$Y$$$20240913$$CN$DE$DE
243142531$24314253$1$I$20200101$20240904$20240912$20240912$EXP$$US-ABBVIE-5900478$ABBVIE$$$$$F$Y$88.45$KG$20240912$$CN$US$US
243142541$24314254$1$I$20240906$20240911$20240912$20240912$EXP$$CA-ABBVIE-5920024$ABBVIE$$88$YR$$M$Y$$$20240912$$CN$CA$CA
243142551$24314255$1$I$$20240906$20240912$20240912$EXP$$ZA-ABBVIE-5915153$ABBVIE$$$$E$F$Y$$$20240912$$CN$ZA$ZA
243142561$24314256$1$I$$20240905$20240912$20240912$PER$$US-JNJFOC-20240913121$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$PH$US$US
243142581$24314258$1$I$20240824$20240905$20240912$20240912$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161532$JIANGSU HENGRUI MEDICINE$$38$YR$$F$Y$56$KG$20240912$$MD$CN$CN
243142591$24314259$1$I$20240828$20240906$20240912$20240912$EXP$GB-MHRA-MED-202409062018475000-BRFZH$GB-ABBVIE-5913847$ABBVIE$$43$YR$$M$Y$$$20240912$$CN$GB$GB
243142611$24314261$1$I$$20240909$20240912$20240912$PER$$US-JNJFOC-20240921228$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$PH$US$US
243142621$24314262$1$I$$20240912$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145586$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240913$$HP$US$US
243142632$24314263$2$F$20240812$20240902$20240912$20240923$EXP$$GB-SMPA-2024SPA002560$SUNOVION$$$$$$Y$$$20240923$$HP$RU$RU
243142641$24314264$1$I$$20240911$20240912$20240912$PER$$US-ALXN-202409USA000848US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$MD$US$US
243142651$24314265$1$I$20240101$20240906$20240912$20240912$EXP$$US-ABBVIE-5914132$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243142661$24314266$1$I$20240101$20240905$20240912$20240912$PER$$US-AMGEN-USASP2024177830$AMGEN$$10$YR$C$F$Y$$$20240912$$MD$US$US
243142671$24314267$1$I$20230529$20240909$20240912$20240912$EXP$$KR-009507513-2409KOR002625$MERCK$$$$E$M$Y$$$20240912$$HP$KR$KR
243142681$24314268$1$I$20240801$20240829$20240912$20240912$PER$$US-SA-2024SA250431$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240913$$HP$US$US
243142691$24314269$1$I$20240828$20240911$20240912$20240912$EXP$IT-MINISAL02-1001263$IT-JNJFOC-20240930332$JOHNSON AND JOHNSON$$73$YR$E$M$Y$106$KG$20240913$$MD$IT$IT
243142701$24314270$1$I$$20240911$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145124$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240913$$PH$US$US
243142711$24314271$1$I$$20240906$20240912$20240912$PER$$US-ABBVIE-5917013$ABBVIE$$$$$$Y$$$20240912$$HP$US$US
243142721$24314272$1$I$20240906$20240906$20240912$20240912$EXP$$US-JNJFOC-20240915961$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240913$$HP$US$US
243142731$24314273$1$I$$20240907$20240912$20240912$EXP$$US-ABBVIE-5915002$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243142751$24314275$1$I$20240801$20240905$20240912$20240912$EXP$$US-ABBVIE-5741110$ABBVIE$$49$YR$$M$Y$$$20240912$$CN$US$US
243142761$24314276$1$I$20240723$20240830$20240912$20240912$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161534$JIANGSU HANSOH PHARMACEUTICAL$$55$YR$$M$Y$60$KG$20240912$$MD$CN$CN
243142771$24314277$1$I$$20240911$20240912$20240912$PER$$US-ALXN-202409USA000845US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243142781$24314278$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5916184$ABBVIE$$$$$M$Y$$$20240912$$CN$US$US
243142791$24314279$1$I$20240108$20240906$20240912$20240912$EXP$$US-ABBVIE-5638489$ABBVIE$$70$YR$$M$Y$$$20240912$$CN$US$US
243142801$24314280$1$I$$20240909$20240912$20240912$EXP$$US-ABBVIE-5917582$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243142811$24314281$1$I$20240910$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181859$AMGEN$$75$YR$E$F$Y$$$20240912$$CN$US$US
243142821$24314282$1$I$20240908$20240910$20240912$20240912$PER$$US-AMGEN-USASP2024181283$AMGEN$$80$YR$E$F$Y$$$20240912$$CN$US$US
243142831$24314283$1$I$$20240910$20240912$20240912$PER$$US-ABBVIE-5920837$ABBVIE$$$$$$Y$$$20240912$$HP$US$US
243142841$24314284$1$I$$20240903$20240912$20240912$PER$$US-JNJFOC-20240904440$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$MD$US$US
243142861$24314286$1$I$$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142660$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240913$$CN$US$US
243142872$24314287$2$F$$20240915$20240912$20240918$EXP$$CA-ABBVIE-5919489$ABBVIE$$$$E$M$Y$$$20240918$$HP$CA$CA
243142881$24314288$1$I$20230701$20240906$20240912$20240912$EXP$$US-ABBVIE-5917568$ABBVIE$$53$YR$$M$Y$$$20240912$$CN$US$US
243142892$24314289$2$F$$20240911$20240912$20240917$EXP$$US-ABBVIE-5918217$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243142901$24314290$1$I$20240908$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409005687$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240912$$CN$US$US
243142911$24314291$1$I$$20240911$20240912$20240912$PER$$US-ALXN-202409USA000818US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$MD$US$US
243142921$24314292$1$I$$20240905$20240912$20240912$EXP$$NVSC2024HN180554$NOVARTIS$$$$$F$Y$$$20240913$$CN$HN$HN
243142931$24314293$1$I$20240301$20240906$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409004778$ELI LILLY AND CO$$$$$M$Y$$$20240912$$CN$US$US
243142941$24314294$1$I$20240801$20240828$20240912$20240912$PER$$US-SA-2024SA262745$SANOFI AVENTIS$$33$YR$A$F$Y$93.18$KG$20240913$$MD$US$US
243142951$24314295$1$I$$20240910$20240912$20240912$EXP$$US-ABBVIE-5919480$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243142961$24314296$1$I$$20240911$20240912$20240912$EXP$$US-ABBVIE-5920360$ABBVIE$$$$$F$Y$$$20240912$$CN$US$US
243142971$24314297$1$I$20240801$20240909$20240912$20240912$EXP$$CA-JNJFOC-20240907709$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240913$$HP$CA$CA
243142981$24314298$1$I$$20240909$20240912$20240912$PER$$US-009507513-2409USA003546$MERCK$$$$$M$Y$$$20240912$$CN$US$US
243143001$24314300$1$I$$20240910$20240912$20240912$EXP$$US-ABBVIE-5919417$ABBVIE$$$$$$Y$$$20240912$$MD$US$US
243143011$24314301$1$I$$20240909$20240912$20240912$EXP$$US-AstraZeneca-2024A205312$ASTRAZENECA$$$$$M$Y$$$20240913$$HP$US$
243143021$24314302$1$I$$20240909$20240912$20240912$EXP$$NVSC2024GB181352$NOVARTIS$$$$$F$Y$$$20240913$$CN$GB$GB
243143041$24314304$1$I$20230101$20240910$20240912$20240912$EXP$$CO-ABBVIE-5919495$ABBVIE$$$$$F$Y$$$20240912$$CN$CO$CO
243143051$24314305$1$I$$20240909$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006592$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240912$$CN$US$US
243143061$24314306$1$I$20240501$20240906$20240912$20240912$EXP$$US-ABBVIE-5641618$ABBVIE$$82$YR$$M$Y$$$20240912$$CN$US$US
243143071$24314307$1$I$20240801$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006720$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240912$$CN$US$US
243143081$24314308$1$I$$20240910$20240912$20240912$PER$$US-ELI_LILLY_AND_COMPANY-US202409006627$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240912$$CN$US$US
243143091$24314309$1$I$20240904$20240909$20240912$20240912$EXP$$CN-BEIGENE-BGN-2024-014298$BEIGENE$$$$$$Y$$$20240912$$HP$CN$CN
243143111$24314311$1$I$$20240909$20240912$20240912$PER$$US-009507513-2409USA004546$MERCK$$$$$F$Y$$$20240912$$HP$US$US
243143121$24314312$1$I$20240812$20240909$20240912$20240912$EXP$$US-ABBVIE-5917615$ABBVIE$$54$YR$$M$Y$$$20240912$$CN$US$US
243143131$24314313$1$I$$20240910$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144474$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240913$$CN$US$US
243143141$24314314$1$I$20230101$20240909$20240912$20240912$EXP$$CA-ABBVIE-5917470$ABBVIE$$$$E$F$Y$$$20240912$$CN$CA$CA
243143171$24314317$1$I$$20240911$20240912$20240912$PER$$NVSC2024US183084$NOVARTIS$$$$$F$Y$81$KG$20240913$$CN$US$US
243143181$24314318$1$I$20240627$20240903$20240912$20240912$EXP$FR-AFSSAPS-NC2024001012$FR-TEVA-VS-3240151$TEVA$$14$YR$$F$Y$86$KG$20240912$$MD$FR$FR
243143201$24314320$1$I$$20240911$20240912$20240912$PER$$US-ALXN-202409USA000802US$ALEXION PHARMACEUTICALS$$$$$F$Y$100.32$KG$20240913$$CN$US$US
243143211$24314321$1$I$$20240905$20240912$20240912$EXP$$GB-ABBVIE-5807502$ABBVIE$$$$$F$Y$$$20240912$$CN$GB$GB
243143221$24314322$1$I$20240422$20240903$20240912$20240912$EXP$$BE-ABBVIE-5919478$ABBVIE$$72$YR$$F$Y$58$KG$20240912$$MD$BE$BE
243143231$24314323$1$I$$20240905$20240912$20240912$EXP$$SI-BRISTOL-MYERS SQUIBB COMPANY-2024-143268$BRISTOL MYERS SQUIBB$$24$YR$A$F$Y$$$20240913$$MD$SI$SI
243143251$24314325$1$I$20240901$20240906$20240912$20240912$EXP$$JP-AstraZeneca-2024A205135$ASTRAZENECA$$70$YR$$$Y$$$20240913$$MD$JP$
243143261$24314326$1$I$20240709$20240903$20240912$20240912$EXP$FR-AFSSAPS-MA2024001203$FR-TEVA-VS-3239742$TEVA$$3$YR$$M$Y$$$20240912$$MD$FR$FR
243143271$24314327$1$I$$20240911$20240912$20240912$PER$$US-HALEON-2196464$Haleon PLC$$$$$$Y$$$20240912$$CN$US$US
243143281$24314328$1$I$$20240730$20240912$20240912$PER$$US-DSJP-DSU-2024-144804$DAIICHI$$$$$F$Y$$$20240913$$CN$US$US
243143291$24314329$1$I$$20240822$20240912$20240912$PER$$US-SA-2024SA263403$SANOFI AVENTIS$$33$YR$A$F$Y$61.36$KG$20240913$$HP$US$US
243143301$24314330$1$I$$20240909$20240912$20240912$EXP$$CA-SANDOZ INC.-SDZ2024US079047$SANDOZ$$$$$$Y$$$20240912$$CN$CA$US
243143311$24314331$1$I$$20240910$20240912$20240912$EXP$$JP-ABBVIE-5919469$ABBVIE$$60$YR$$M$Y$$$20240912$$MD$JP$JP
243143321$24314332$1$I$$20240826$20240912$20240912$PER$$US-SA-2024SA262370$SANOFI AVENTIS$$71$YR$E$F$Y$60.45$KG$20240913$$MD$US$US
243143331$24314333$1$I$20230111$20240903$20240912$20240912$EXP$FR-AFSSAPS-MA2024001243$FR-TEVA-VS-3240022$TEVA$$58$YR$$F$Y$72$KG$20240912$$PH$FR$FR
243143351$24314335$1$I$$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145611$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240913$$CN$US$US
243143361$24314336$1$I$20240601$20240910$20240912$20240912$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145552$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240913$$CN$US$US
243143371$24314337$1$I$$20240910$20240912$20240912$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014837$JAZZ$$$$$F$Y$$$20240912$$HP$US$US
243143381$24314338$1$I$$20240906$20240912$20240912$EXP$$US-SANDOZ INC.-SDZ2024US079043$SANDOZ$$$$$F$Y$107.48$KG$20240912$$CN$US$US
243143391$24314339$1$I$$20240829$20240912$20240912$PER$$US-SA-2024SA262143$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240913$$CN$US$US
243143401$24314340$1$I$20240806$20240906$20240912$20240912$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143975$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240913$$HP$US$US
243143411$24314341$1$I$$20240906$20240913$20240913$EXP$$PE-ABBVIE-5919095$ABBVIE$$$$$M$Y$$$20240913$$CN$PE$PE
243143421$24314342$1$I$$20240906$20240913$20240913$EXP$$RO-AstraZeneca-2024A206327$ASTRAZENECA$$$$$M$Y$$$20240913$$MD$RO$
243143431$24314343$1$I$$20240906$20240913$20240913$EXP$$US-AstraZeneca-2024A206620$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243143441$24314344$1$I$$20240909$20240913$20240913$EXP$$ZA-AstraZeneca-2024A206357$ASTRAZENECA$$83$YR$$M$Y$$$20240913$$CN$ZA$
243143451$24314345$1$I$$20240820$20240913$20240913$PER$$US-AstraZeneca-2024A193179$ASTRAZENECA$$69$YR$$F$Y$70.2$KG$20240913$$MD$US$
243143461$24314346$1$I$$20240909$20240913$20240913$EXP$$US-ABBVIE-5917236$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243143471$24314347$1$I$20240101$20240906$20240913$20240913$EXP$$CA-ABBVIE-5913777$ABBVIE$$$$A$M$Y$$$20240913$$HP$CA$CA
243143481$24314348$1$I$20240909$20240909$20240913$20240913$EXP$$US-JNJFOC-20240927895$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240913$$MD$US$US
243143491$24314349$1$I$$20240905$20240913$20240913$EXP$$JP-ASTELLAS-2024-AER-005073$ASTELLAS$$87$YR$E$M$Y$$$20240913$$MD$JP$JP
243143501$24314350$1$I$$20240904$20240913$20240913$PER$$US-ABBVIE-5908150$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243143511$24314351$1$I$20240101$20240906$20240913$20240913$EXP$$AR-AMGEN-ARGSP2024181073$AMGEN$$65$YR$E$F$Y$$$20240912$$CN$AR$AR
243143531$24314353$1$I$$20240822$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-134799$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240913$$HP$US$US
243143541$24314354$1$I$20231231$20240909$20240913$20240913$EXP$$TR-ABBVIE-5916922$ABBVIE$$$$E$F$Y$$$20240913$$MD$TR$TR
243143561$24314356$1$I$20240818$20240903$20240913$20240913$EXP$FR-AFSSAPS-MA2024001413$FR-TEVA-VS-3240139$TEVA$$13$YR$$F$Y$$$20240913$$MD$FR$FR
243143571$24314357$1$I$20240101$20240912$20240913$20240913$PER$$US-DSJP-DSU-2024-144825$DAIICHI$$$$$F$Y$$$20240913$$HP$US$US
243143581$24314358$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145476$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240913$$CN$US$US
243143591$24314359$1$I$$20240909$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144431$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240913$$CN$US$US
243143611$24314361$1$I$$20240912$20240913$20240913$PER$$NVSC2024US183122$NOVARTIS$$$$$$Y$$$20240913$$MD$US$US
243143621$24314362$1$I$$20240906$20240913$20240913$EXP$$JP-JNJFOC-20240930546$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240913$$PH$JP$JP
243143631$24314363$1$I$20240905$20240905$20240913$20240913$EXP$$FR-AstraZeneca-2024A205194$ASTRAZENECA$$$$A$M$Y$$$20240913$$PH$FR$
243143651$24314365$1$I$$20240904$20240913$20240913$PER$$US-ABBVIE-5908482$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243143661$24314366$1$I$20240529$20240906$20240913$20240913$EXP$GB-MHRA-MED-202409061122526010-QYTVG$GB-009507513-2409GBR002871$MERCK$$59$YR$$F$Y$$$20240913$$HP$GB$GB
243143671$24314367$1$I$20240905$20240909$20240913$20240913$EXP$$US-ABBVIE-5916127$ABBVIE$$44$YR$$F$Y$$$20240913$$CN$US$US
243143681$24314368$1$I$20240812$20240909$20240913$20240913$EXP$$US-ABBVIE-5917186$ABBVIE$$58$YR$$F$Y$$$20240913$$CN$US$US
243143701$24314370$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145699$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240913$$CN$US$US
243143711$24314371$1$I$20240814$20240903$20240913$20240913$EXP$FR-AFSSAPS-NY2024000996$FR-TEVA-VS-3240147$TEVA$$57$YR$$M$Y$80$KG$20240913$$MD$FR$FR
243143721$24314372$1$I$20240620$20240620$20240913$20240913$PER$$US-GE HEALTHCARE-2024CSU006941$GE HEALTHCARE$$65$YR$$M$Y$177$KG$20240913$$HP$US$US
243143731$24314373$1$I$20240903$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142866$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$79$KG$20240913$$PH$US$US
243143741$24314374$1$I$20240801$20240909$20240913$20240913$EXP$$CA-ABBVIE-5918698$ABBVIE$$31$YR$$M$Y$$$20240913$$CN$CA$CA
243143751$24314375$1$I$20240904$20240910$20240913$20240913$EXP$$RO-ABBVIE-5918889$ABBVIE$$73$YR$$M$Y$$$20240913$$CN$RO$RO
243143761$24314376$1$I$$20240909$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145600$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240913$$HP$US$US
243143782$24314378$2$F$20240904$20240917$20240913$20240921$PER$$US-AMGEN-USASP2024176965$AMGEN$$78$YR$E$M$Y$104.76$KG$20240921$$PH$US$US
243143791$24314379$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA262114$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240913$$PH$US$US
243143801$24314380$1$I$$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145723$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240913$$CN$US$US
243143811$24314381$1$I$20240801$20240829$20240913$20240913$PER$$US-PURACAP-US-2024EPCSPO01097$PURACAP$$68$YR$E$F$Y$58.05$KG$20240913$$CN$US$US
243143821$24314382$1$I$$20240905$20240913$20240913$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049663$BOEHRINGER INGELHEIM$$$$$$Y$$$20240913$$HP$JP$JP
243143831$24314383$1$I$20210101$20240905$20240913$20240913$EXP$$CA-AMGEN-CANSP2024179297$AMGEN$Lamb J.; Purdy K.; Sutherland A.. Use of dupilumab for recalcitrant bullous pemphigoid: A case report. SAGE Open Medical Case Reports. 2024;12:1-4$62$YR$A$F$Y$$$20240912$$HP$CA$CA
243143842$24314384$2$F$$20240919$20240913$20240930$EXP$$CO-JNJFOC-20240921494$JOHNSON AND JOHNSON$$89$YR$E$M$Y$75$KG$20240930$$HP$CO$CO
243143851$24314385$1$I$$20240902$20240913$20240913$EXP$$JP-ROCHE-10000076243$ROCHE$Miura R, Ono A, Yano S, Amioka K, Naruto K, Yamaoka K, et al. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine. 2024-Aug-23;103 (34):1-8. doi:10.1097/MD.0000000000039289.$$$$$Y$$$20240913$$MD$JP$JP
243143861$24314386$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5917569$ABBVIE$$$$$$Y$$$20240913$$HP$US$US
243143891$24314389$1$I$20240911$20240911$20240913$20240913$PER$$US-ALXN-202409USA000759US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243143901$24314390$1$I$20240527$20240911$20240913$20240913$EXP$FR-AFSSAPS-AVMA2024000395$FR-ORGANON-O2409FRA000764$ORGANON$$43$YR$$M$Y$$$20240913$$PH$FR$FR
243143911$24314391$1$I$20240101$20240905$20240913$20240913$PER$$US-ABBVIE-5914944$ABBVIE$$$$A$F$Y$$$20240913$$CN$US$US
243143921$24314392$1$I$20230101$20240906$20240913$20240913$EXP$$DE-ABBVIE-5916903$ABBVIE$$36$YR$$F$Y$65$KG$20240913$$CN$DE$DE
243143931$24314393$1$I$20230123$20240906$20240913$20240913$EXP$$US-ABBVIE-5914094$ABBVIE$$8$YR$$F$Y$$$20240913$$CN$US$US
243143941$24314394$1$I$$20240911$20240913$20240913$EXP$$US-ABBVIE-5920519$ABBVIE$$$$$M$Y$$$20240913$$HP$US$US
243143961$24314396$1$I$$20240909$20240913$20240913$EXP$$DE-ABBVIE-5917098$ABBVIE$$$$A$M$Y$64$KG$20240913$$MD$DE$DE
243143971$24314397$1$I$$20240904$20240913$20240913$EXP$$LY-STRIDES ARCOLAB LIMITED-2024SP011549$STRIDES$Hammad R, Grain M.. ALL-701 ALL in Pregnancy With Challenging Conditions + Side Effects.. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S281 abstr. ALL-701.$33$YR$$F$Y$$$20240913$$PH$LY$LY
243143981$24314398$1$I$20240911$20240912$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145664$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240913$$CN$US$US
243143991$24314399$1$I$20240822$20240822$20240913$20240913$PER$$US-SA-2024SA263423$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240913$$CN$US$US
243144001$24314400$1$I$20240101$20240829$20240913$20240913$PER$$US-SA-2024SA261514$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240913$$CN$US$US
243144011$24314401$1$I$$20240909$20240913$20240913$PER$$US-ABBVIE-5918286$ABBVIE$$$$$$Y$$$20240913$$MD$US$US
243144021$24314402$1$I$20240301$20240909$20240913$20240913$EXP$$JP-GSK-JP2024JPN033046$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$JP$JP
243144031$24314403$1$I$20240801$20240906$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144105$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240913$$PH$US$US
243144041$24314404$1$I$20240905$20240905$20240913$20240913$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03299$AMNEAL$$88$YR$$F$Y$$$20240913$$CN$US$US
243144051$24314405$1$I$20200101$20240905$20240913$20240913$EXP$$US-ABBVIE-5913574$ABBVIE$$28$YR$$F$Y$$$20240913$$CN$US$US
243144061$24314406$1$I$$20240904$20240913$20240913$EXP$$LY-STRIDES ARCOLAB LIMITED-2024SP011561$STRIDES$Hammad R, Grain M.. ALL-701 ALL in Pregnancy With Challenging Conditions + Side Effects.. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S281 abstr. ALL-701.$$$$$Y$$$20240913$$PH$LY$LY
243144071$24314407$1$I$20231101$20240906$20240913$20240913$EXP$$US-ABBVIE-5566340$ABBVIE$$80$YR$$F$Y$$$20240913$$CN$US$US
243144081$24314408$1$I$$20240906$20240913$20240913$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050064$BOEHRINGER INGELHEIM$Katori N, Kawada Y, Kaji K, Fujioka S, Yamaguchi T. Anticoagulation management for cardiopulmonary bypass using TEG 6 s in a patient receiving both heparin and dabigatran. JA Clinical Reports. 2024;10(1): 54. doi:10.1186/s40981-024-00739-8.$81$YR$E$F$Y$42$KG$20240913$$HP$JP$JP
243144091$24314409$1$I$20230101$20240906$20240913$20240913$EXP$$CA-ABBVIE-5749957$ABBVIE$$83$YR$$F$Y$$$20240913$$CN$CA$CA
243144101$24314410$1$I$20240808$20240906$20240913$20240913$EXP$$US-ABBVIE-5914343$ABBVIE$$85$YR$$F$Y$$$20240913$$CN$US$US
243144111$24314411$1$I$$20240906$20240913$20240913$EXP$$US-AstraZeneca-2024A205109$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243144121$24314412$1$I$$20240909$20240913$20240913$EXP$$US-ABBVIE-5917213$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243144131$24314413$1$I$$20240904$20240913$20240913$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP011569$STRIDES$Maksymowicz R, Straczek CN, Matysek JJ, Lech DM, Nosek K.. Case report: Comprehensive management of painful diabetic neuropathy-Addressing opioid-induced hyperalgesia through multimodal approaches.. Medicine. 2024;103 (31)$64$YR$$M$Y$$$20240913$$HP$PL$PL
243144141$24314414$1$I$$20240904$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141509$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240913$$CN$US$US
243144151$24314415$1$I$$20240824$20240913$20240913$PER$$US-SA-2024SA264193$SANOFI AVENTIS$$$$$F$Y$$$20240913$$CN$US$US
243144161$24314416$1$I$$20240908$20240913$20240913$PER$$NVSC2024US180714$NOVARTIS$$$$$$Y$$$20240913$$CN$US$US
243144171$24314417$1$I$20240101$20240830$20240913$20240913$PER$$US-SA-2024SA261679$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240913$$MD$US$US
243144181$24314418$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA260451$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240913$$CN$US$US
243144191$24314419$1$I$20240824$20240826$20240913$20240913$PER$$US-SA-2024SA262361$SANOFI AVENTIS$$44$YR$A$F$Y$63.64$KG$20240913$$MD$US$US
243144201$24314420$1$I$$20240901$20240913$20240913$PER$$US-Encube-001314$ENCUBE ETHICALS$$$$$F$Y$$$20240912$$CN$US$
243144211$24314421$1$I$$20240911$20240913$20240913$PER$$US-JNJFOC-20240929187$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$HP$US$US
243144221$24314422$1$I$20240101$20240909$20240913$20240913$EXP$$US-JNJFOC-20240926833$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20240913$$HP$US$US
243144233$24314423$3$F$20240701$20240923$20240913$20240930$EXP$$US-GSK-US2024111339$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$US$US
243144241$24314424$1$I$20221201$20240909$20240913$20240913$EXP$$US-TAKEDA-2023TUS009569$TAKEDA$$9$YR$$F$Y$$$20240913$$CN$US$US
243144251$24314425$1$I$20240807$20240904$20240913$20240913$EXP$IT-MINISAL02-1000235$IT-TEVA-VS-3240499$TEVA$$$$A$M$Y$$$20240913$$MD$IT$IT
243144261$24314426$1$I$20240816$20240902$20240913$20240913$EXP$CN-HENLIUS-24CN016924$CN-Accord-445493$ACCORD$$66$YR$E$F$Y$49$KG$20240913$$MD$CN$CN
243144271$24314427$1$I$$20240905$20240913$20240913$PER$$US-ROCHE-10000074736$ROCHE$O Connor W, Arshia A, Prabakar D, Sabesan V, Spindel J. Nuclear envelope lamin-related dilated cardiomyopathy: a case series including histopathology. European Heart Journal - Case Reports. 2024-Aug-01;8 (8):1-7. doi:10.1093/ehjcr/ytae412.$34$YR$A$M$Y$$$20240913$$HP$US$US
243144281$24314428$1$I$$20240904$20240913$20240913$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP011577$STRIDES$Akyol G, Unsal SE, Mandaci NS, Keklik M, Unal A.. CT-249 Treatment of Hematopoietic Stem Cell Transplant-Associated Microangiopathy with Eculizumab.. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S594.$62$YR$$F$Y$$$20240913$$MD$TR$TR
243144302$24314430$2$F$20240801$20240910$20240913$20240923$EXP$$AU-NOVOPROD-1279910$NOVO NORDISK$$74$YR$$F$Y$$$20240923$$MD$AU$AU
243144311$24314431$1$I$$20240902$20240913$20240913$EXP$$CA-NOVOPROD-1282096$NOVO NORDISK$$$$$$Y$$$20240913$$CN$CA$CA
243144321$24314432$1$I$$20240902$20240913$20240913$EXP$$AU-NOVOPROD-1278661$NOVO NORDISK$$72$YR$$M$Y$$$20240913$$CN$AU$AU
243144331$24314433$1$I$20240501$20240830$20240913$20240913$EXP$$US-NOVOPROD-1278597$NOVO NORDISK$$47$YR$$M$Y$$$20240913$$CN$US$US
243144341$24314434$1$I$$20240902$20240913$20240913$EXP$$BR-NOVOPROD-1279136$NOVO NORDISK$Nathaly de Oliveira Ciaramicolo et.al. Late Facial Edema After Lip Filling With Hyaluronic Acid: Possible Association With the Use of Ozempic. The Journal of Craniofacial Surgery. 2024;00:1-3$46$YR$$F$Y$$$20240913$$MD$BR$BR
243144351$24314435$1$I$$20240905$20240913$20240913$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011618$STRIDES$Yuan C-Y, Zhang Z-R, Guo M-F, Zhang N.. Recurrent multisystem Langerhans cell histiocytosis involving the female genitalia: A case report.. World-J-Clin-Cases. 2024;12 (28):6222-6229$52$YR$$F$Y$$$20240913$$MD$CN$CN
243144361$24314436$1$I$20240908$20240910$20240913$20240913$EXP$$GB-ABBVIE-5919460$ABBVIE$$72$YR$$M$Y$$$20240913$$HP$GB$GB
243144371$24314437$1$I$$20240911$20240913$20240913$EXP$$US-ABBVIE-5920882$ABBVIE$$$$$M$Y$$$20240913$$HP$US$US
243144381$24314438$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1278918$NOVO NORDISK$$69$YR$$$Y$$$20240913$$CN$US$US
243144391$24314439$1$I$20240903$20240903$20240913$20240913$EXP$$CN-NOVOPROD-1278841$NOVO NORDISK$$60$YR$$F$Y$81.5$KG$20240913$$CN$CN$CN
243144401$24314440$1$I$$20240903$20240913$20240913$EXP$$AR-NOVOPROD-1278796$NOVO NORDISK$$$$$F$Y$$$20240913$$MD$AR$AR
243144411$24314441$1$I$$20240901$20240913$20240913$EXP$$JP-Accord-445067$ACCORD$Terashima Y, Matsumoto M, Ozaki S, Nakagawa M, Nakagome S, Terasaki Y, et al. IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report. Front. Immunol. 2024;15:1370972.$73$YR$E$M$Y$$$20240913$$HP$JP$JP
243144422$24314442$2$F$$20240918$20240913$20240927$EXP$$MX-NOVOPROD-1278794$NOVO NORDISK$$56$YR$$M$Y$$$20240927$$CN$MX$MX
243144431$24314443$1$I$20240827$20240903$20240913$20240913$EXP$GB-MHRA-MED-202409031426346400-BFLJN$GB-NOVOPROD-1278275$NOVO NORDISK$$43$YR$$F$Y$$$20240913$$MD$GB$GB
243144441$24314444$1$I$20240626$20240903$20240913$20240913$EXP$$US-NOVOPROD-1279009$NOVO NORDISK$$$$$F$Y$$$20240913$$CN$US$US
243144461$24314446$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1278976$NOVO NORDISK$$$$$F$Y$$$20240913$$CN$US$US
243144471$24314447$1$I$20240726$20240903$20240913$20240913$EXP$$GB-NOVOPROD-1278803$NOVO NORDISK$$65$YR$$F$Y$$$20240913$$CN$GB$GB
243144481$24314448$1$I$$20240903$20240913$20240913$EXP$$LV-NOVOPROD-1278359$NOVO NORDISK$$68$YR$$$Y$$$20240913$$HP$LV$LV
243144491$24314449$1$I$$20240903$20240913$20240913$EXP$$CH-NOVOPROD-1278360$NOVO NORDISK$$20$YR$$F$Y$$$20240913$$MD$CH$CH
243144501$24314450$1$I$$20240905$20240913$20240913$EXP$$AR-STRIDES ARCOLAB LIMITED-2024SP011595$STRIDES$Soriano D, Santos Chocler G, Varela MA, Coronel MF.. Chemotherapy-induced neuropathy and pain in pediatric oncology patients: impact of combination therapies.. Eur-J-Pediatr. 2024;183 (9):3749-3756$$$C$F$Y$$$20240913$$HP$AR$AR
243144511$24314451$1$I$20240801$20240906$20240913$20240913$EXP$$US-ABBVIE-5916971$ABBVIE$$23$YR$$M$Y$$$20240913$$CN$US$US
243144522$24314452$2$F$20240907$20240917$20240913$20240920$EXP$$JP-ARGENX-2024-ARGX-JP007632AA$ARGENX BVBA$$$$$$Y$$$20240920$$PH$JP$JP
243144531$24314453$1$I$$20240905$20240913$20240913$EXP$$AR-STRIDES ARCOLAB LIMITED-2024SP011596$STRIDES$Soriano D, Santos Chocler G, Varela MA, Coronel MF.. Chemotherapy-induced neuropathy and pain in pediatric oncology patients: impact of combination therapies.. Eur-J-Pediatr. 2024;183 (9):3749-3756$$$C$M$Y$$$20240913$$HP$AR$AR
243144541$24314454$1$I$$20240911$20240913$20240913$EXP$$US-ROCHE-10000079990$ROCHE$$78$YR$E$F$Y$$$20240913$$CN$US$US
243144551$24314455$1$I$$20240906$20240913$20240913$EXP$$US-AstraZeneca-2024A203981$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243144561$24314456$1$I$20240718$20240911$20240913$20240913$EXP$$US-AstraZeneca-2024A207404$ASTRAZENECA$$28971$DY$$F$Y$$$20240913$$CN$US$
243144571$24314457$1$I$$20240905$20240913$20240913$EXP$$US-AstraZeneca-2024A202537$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243144581$24314458$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1279049$NOVO NORDISK$$$$$F$Y$$$20240913$$CN$US$US
243144591$24314459$1$I$$20240830$20240913$20240913$EXP$$CN-ACS-20240328$ACS DOBFAR$Long S, Tang P, Ouyang P, Liao X, Xie L. A Case Report of a Rare Pulmonary Opportunistic Infection in an Infant Caused by Tsukamurella tyrosinosolvens. International Medical Case Reports Journal. 2024;17:725-31. DOI:10.2147/IMCRJ.S471682.$$$I$F$Y$$$20240902$$MD$CN$
243144602$24314460$2$F$20240501$20240906$20240913$20240919$EXP$$US-NOVOPROD-1279048$NOVO NORDISK$$67$YR$$F$Y$$$20240919$$CN$US$US
243144621$24314462$1$I$20230101$20240905$20240913$20240913$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP011600$STRIDES$Burger D, Wttewaal E, Oosterhof P, Stalenhoef J.. Concomitant use of anabolic androgen steroids and cabotegravir/rilpivirine leading to virological failure and development of two-class resistance.. AIDS. 2024;38 (11):1728-1729$27$YR$$M$Y$$$20240913$$PH$NL$NL
243144631$24314463$1$I$$20240905$20240913$20240913$EXP$$FI-STRIDES ARCOLAB LIMITED-2024SP011603$STRIDES$Kaprio E, Prusila R, Tokola S, Kuusisto MEL, Jantunen E, Kuitunen H, et al.. Drug-induced pneumonitis risk in diffuse large B-cell/follicular lymphoma patients treated with R-CHOP-like regimen is associated with the use of granulocyte colony-stimulating growth factors.. Cancer-Med. 2024;13 (1):e6898$$$$$Y$$$20240913$$HP$FI$FI
243144641$24314464$1$I$20240101$20240823$20240913$20240913$PER$$US-SA-2024SA224557$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240913$$MD$US$US
243144651$24314465$1$I$20230701$20240903$20240913$20240913$EXP$$US-NOVOPROD-1093389$NOVO NORDISK$$53$YR$$F$Y$$$20240913$$CN$US$US
243144661$24314466$1$I$$20240911$20240913$20240913$EXP$$IL-ABBVIE-5919455$ABBVIE$$$$$M$Y$$$20240913$$CN$IL$IL
243144671$24314467$1$I$$20240905$20240913$20240913$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP011608$STRIDES$Nayak S, Sharma H, Shah A.. A rare case of Elizabethkingia meningoseptica bacteremia followed by meningitis in post-liver transplant patient.. Transpl-Infect-Dis. 2024;26$50$YR$$M$Y$$$20240913$$HP$IN$IN
243144681$24314468$1$I$$20240909$20240913$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US079527$SANDOZ$$$$$$Y$$$20240913$$HP$US$US
243144692$24314469$2$F$$20240918$20240913$20240928$EXP$CA-MHPD-E2B_07195072$CA-Accord-444768$ACCORD$$7$YR$C$M$Y$$$20240928$$MD$CA$CA
243144701$24314470$1$I$$20240906$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409004380$ELI LILLY AND CO$$62$YR$A$$Y$$$20240913$$CN$US$US
243144711$24314471$1$I$$20240909$20240913$20240913$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011613$STRIDES$Guo Y-J, Ma M-X, Tian T, Zhang J-N, Guo X-N, Qiao S.. Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement t(8;13)(p11;q12): A case report and literature review.. Oncol-Lett. 2024;28 (4):1-12.$62$YR$$F$Y$$$20240913$$HP$CN$CN
243144721$24314472$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5917237$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243144731$24314473$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5917409$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243144741$24314474$1$I$20240101$20240830$20240913$20240913$EXP$$KR-ASTELLAS-2024-AER-003849$ASTELLAS$$82$YR$E$M$Y$$$20240913$$CN$KR$KR
243144751$24314475$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA254455$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240913$$MD$US$US
243144761$24314476$1$I$20230101$20240826$20240913$20240913$PER$$US-SA-2024SA263438$SANOFI AVENTIS$$20$YR$A$F$Y$76.36$KG$20240913$$MD$US$US
243144771$24314477$1$I$20240816$20240902$20240913$20240913$EXP$$CN-ROCHE-10000072339$ROCHE$$62$YR$A$M$Y$68$KG$20240913$$HP$CN$CN
243144781$24314478$1$I$20240909$20240909$20240913$20240913$EXP$$GB-AMGEN-GBRSP2024181171$AMGEN$$75$YR$E$F$Y$$$20240912$$HP$GB$GB
243144791$24314479$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5877847$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243144801$24314480$1$I$20240909$20240911$20240913$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US079697$SANDOZ$$54$YR$$F$Y$$$20240913$$HP$US$US
243144831$24314483$1$I$$20240910$20240913$20240913$PER$$US-ROCHE-10000079603$ROCHE$$72$YR$E$F$Y$$$20240913$$CN$US$US
243144841$24314484$1$I$20240301$20240908$20240913$20240913$EXP$$EG-SANDOZ INC.-SDZ2024EG079115$SANDOZ$$23$YR$$F$Y$105$KG$20240913$$CN$EG$EG
243144851$24314485$1$I$20240808$20240902$20240913$20240913$EXP$IT-MINISAL02-1000421$IT-Accord-445129$ACCORD$$53$YR$A$F$Y$76$KG$20240913$$MD$IT$IT
243144861$24314486$1$I$20231118$20240903$20240913$20240913$EXP$FR-AFSSAPS-MA2024001289$FR-ASTELLAS-2024-AER-004542$ASTELLAS$$85$YR$E$F$Y$60$KG$20240913$$MD$FR$FR
243144871$24314487$1$I$$20240905$20240913$20240913$PER$$US-JNJFOC-20240912794$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$PH$US$US
243144882$24314488$2$F$$20240906$20240913$20240918$PER$$US-ROCHE-10000073460$ROCHE$Unknown -,  Obinutuzumab as debulking therapy for a successful delivered of fixed-duration venetoclaxobinutuzumab treatment in an elderly CLL patient with extremely high white blood count a case report [Abstract number: PB2568]. European Hematology Association (EHA). 2024;1-2.$77$YR$E$M$Y$$$20240918$$HP$US$US
243144891$24314489$1$I$$20240904$20240913$20240913$PER$$US-ABBVIE-5907785$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243144901$24314490$1$I$$20240910$20240913$20240913$PER$$US-ALXN-202409USA000735US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243144911$24314491$1$I$20240823$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014107$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243144921$24314492$1$I$$20240906$20240913$20240913$30DAY$$US-GSK-US2024AMR111607$GLAXOSMITHKLINE$$61$YR$$M$Y$$$20240913$$CN$US$US
243144941$24314494$1$I$$20240911$20240913$20240913$EXP$$US-AstraZeneca-2024A207782$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243144951$24314495$1$I$20240904$20240911$20240913$20240913$EXP$$US-ABBVIE-5920355$ABBVIE$$88$YR$$M$Y$$$20240913$$HP$US$US
243144961$24314496$1$I$20240910$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181958$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243144971$24314497$1$I$20240706$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024179792$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
243144981$24314498$1$I$20240118$20240910$20240913$20240913$EXP$$US-TAKEDA-2023TUS116359$TAKEDA$$70$YR$$F$Y$$$20240913$$CN$US$US
243144991$24314499$1$I$20200101$20240909$20240913$20240913$EXP$$US-SANDOZ INC.-NVSC2021US017119$SANDOZ$$$$$F$Y$$$20240913$$CN$US$US
243145001$24314500$1$I$$20240903$20240913$20240913$EXP$$MX-NOVOPROD-1279369$NOVO NORDISK$$55$YR$$F$Y$$$20240913$$MD$MX$MX
243145011$24314501$1$I$20240801$20240903$20240913$20240913$EXP$$US-NOVOPROD-1279103$NOVO NORDISK$$52$YR$$F$Y$$$20240913$$CN$US$US
243145021$24314502$1$I$20230531$20240902$20240913$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-047838$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$69.6$KG$20240913$$MD$JP$JP
243145031$24314503$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1279053$NOVO NORDISK$$70$YR$$$Y$$$20240913$$CN$US$US
243145041$24314504$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1279085$NOVO NORDISK$$$$A$F$Y$$$20240913$$CN$US$US
243145051$24314505$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1279180$NOVO NORDISK$$$$A$F$Y$$$20240913$$CN$US$US
243145071$24314507$1$I$$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181288$AMGEN$$$$$$Y$$$20240912$$HP$US$US
243145081$24314508$1$I$20240907$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024179677$AMGEN$$63$YR$A$M$Y$$$20240912$$CN$US$US
243145091$24314509$1$I$$20240909$20240913$20240913$EXP$$US-ABBVIE-5916259$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243145101$24314510$1$I$$20240909$20240913$20240913$EXP$$US-ABBVIE-5919619$ABBVIE$$$$$F$Y$$$20240913$$MD$US$US
243145111$24314511$1$I$20240827$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014120$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243145121$24314512$1$I$20240905$20240910$20240913$20240913$EXP$$RO-ABBVIE-5919473$ABBVIE$$70$YR$$M$Y$$$20240913$$CN$RO$RO
243145131$24314513$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-TPP18978005C7016075YC1724924261304$GB-MSNLABS-2024MSNSPO01951$MSN LABORATORIES$$$$$$Y$$$20240913$$MD$GB$GB
243145141$24314514$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1279662$NOVO NORDISK$$74$YR$$F$Y$$$20240913$$CN$US$US
243145151$24314515$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1279418$NOVO NORDISK$$$$A$$Y$$$20240913$$LW$US$US
243145161$24314516$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1279417$NOVO NORDISK$$$$$$Y$$$20240913$$CN$US$US
243145171$24314517$1$I$20230701$20240903$20240913$20240913$EXP$$US-NOVOPROD-1280092$NOVO NORDISK$$29$YR$$F$Y$$$20240913$$CN$US$US
243145181$24314518$1$I$20240830$20240903$20240913$20240913$EXP$$US-NOVOPROD-1279576$NOVO NORDISK$$77$YR$$M$Y$$$20240913$$CN$US$US
243145191$24314519$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1280139$NOVO NORDISK$$61$YR$$$Y$$$20240913$$CN$US$US
243145201$24314520$1$I$20231001$20240903$20240913$20240913$EXP$$JP-NOVOPROD-1279370$NOVO NORDISK$$4$DEC$$F$Y$$$20240913$$MD$JP$JP
243145211$24314521$1$I$20200101$20240903$20240913$20240913$EXP$$US-NOVOPROD-1279399$NOVO NORDISK$$57$YR$$M$Y$$$20240913$$CN$US$US
243145221$24314522$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1279450$NOVO NORDISK$$73$YR$$M$Y$$$20240913$$CN$US$US
243145231$24314523$1$I$20230906$20240903$20240913$20240913$EXP$$US-NOVOPROD-1280001$NOVO NORDISK$$53$YR$$$Y$$$20240913$$LW$US$US
243145241$24314524$1$I$20240101$20240823$20240913$20240913$PER$$US-SA-2024SA262633$SANOFI AVENTIS$$30$YR$A$F$Y$104.55$KG$20240913$$MD$US$US
243145251$24314525$1$I$20240902$20240903$20240913$20240913$PER$$US-SA-2024SA261761$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240913$$CN$US$US
243145261$24314526$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA259541$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240913$$MD$US$US
243145271$24314527$1$I$$20240902$20240913$20240913$EXP$CA-MHPD-001090209$CA-Accord-444711$ACCORD$$4$YR$C$M$Y$14$KG$20240913$$HP$CA$CA
243145281$24314528$1$I$20240827$20240830$20240913$20240913$EXP$$US-UCBSA-2024044598$UCB$$40$YR$$M$Y$$$20240913$$CN$US$US
243145291$24314529$1$I$$20240909$20240913$20240913$EXP$$CA-TAKEDA-2023TUS023940$TAKEDA$$$$$M$Y$$$20240913$$CN$CA$CA
243145301$24314530$1$I$$20240909$20240913$20240913$EXP$$JP-JNJFOC-20240930203$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$MD$JP$JP
243145311$24314531$1$I$$20240903$20240913$20240913$EXP$$US-ASTELLAS-2024-AER-005159$ASTELLAS$$$$E$M$Y$$$20240913$$CN$US$US
243145321$24314532$1$I$20240824$20240910$20240913$20240913$EXP$$MM-ASTELLAS-2024-AER-005988$ASTELLAS$$79$YR$E$M$Y$$$20240913$$CN$MM$MM
243145341$24314534$1$I$$20240826$20240913$20240913$PER$$US-SA-2024SA262251$SANOFI AVENTIS$$24$YR$A$F$Y$72.5$KG$20240913$$MD$US$US
243145351$24314535$1$I$$20240906$20240913$20240913$EXP$$US-ABBVIE-5914373$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243145361$24314536$1$I$20230907$20240909$20240913$20240913$EXP$$ES-JAZZ PHARMACEUTICALS-2024-ES-014661$JAZZ$$$$$$Y$$$20240912$$HP$ES$ES
243145381$24314538$1$I$20240101$20240830$20240913$20240913$PER$$US-SA-2024SA260894$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240913$$HP$US$US
243145401$24314540$1$I$$20240902$20240913$20240913$EXP$CA-MHPD-E2B_07197397$CA-Accord-444708$ACCORD$$19$YR$A$F$Y$$$20240913$$CN$CA$CA
243145411$24314541$1$I$20240826$20240909$20240913$20240913$EXP$$CA-AMGEN-CANSP2024180668$AMGEN$$84$YR$E$F$Y$$$20240912$$CN$CA$CA
243145421$24314542$1$I$$20240902$20240913$20240913$EXP$GB-MHRA-TPP23118379C10957521YC1725017844160$GB-Accord-444838$ACCORD$$56$YR$A$F$Y$68$KG$20240913$$PH$GB$GB
243145431$24314543$1$I$$20240905$20240913$20240913$EXP$$US-BEH-2024178400$CSL BEHRING$$$$C$F$Y$$$20240913$$HP$US$US
243145441$24314544$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145598$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$55.79$KG$20240913$$HP$US$US
243145451$24314545$1$I$20240806$20240902$20240913$20240913$EXP$FR-AFSSAPS-PO2024000915$FR-Accord-445334$ACCORD$$65$YR$E$M$Y$52$KG$20240913$$MD$FR$FR
243145461$24314546$1$I$$20240905$20240913$20240913$EXP$$US-APOTEX-2024AP010328$APOTEX$$$$$M$Y$$$20240913$$CN$US$US
243145471$24314547$1$I$$20240904$20240913$20240913$EXP$$CL-JNJFOC-20240912518$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240913$$CN$CL$CL
243145481$24314548$1$I$$20240910$20240913$20240913$EXP$$CA-TAKEDA-2023TUS106146$TAKEDA$$$$$F$Y$$$20240913$$MD$CA$CA
243145501$24314550$1$I$$20240909$20240913$20240913$PER$$US-ROCHE-10000078235$ROCHE$$$$A$F$Y$$$20240913$$CN$US$US
243145511$24314551$1$I$20240401$20240906$20240913$20240913$EXP$DE-LESVI-2024004822$DE-GSK-DE2024111187$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$DE$DE
243145521$24314552$1$I$$20240904$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR113025$VIIV$$$$$$Y$$$20240913$$HP$US$US
243145531$24314553$1$I$$20240902$20240913$20240913$EXP$CA-MHPD-E2B_07203161$CA-Accord-444793$ACCORD$$63$YR$A$F$Y$$$20240913$$HP$CA$CA
243145542$24314554$2$F$20240905$20240923$20240913$20240927$PER$$US-HALEON-2196602$Haleon PLC$$67$YR$$F$Y$$$20240927$$CN$US$US
243145552$24314555$2$F$20240909$20240919$20240913$20240920$PER$$US-AMGEN-USASP2024180228$AMGEN$$79$YR$E$M$Y$$$20240920$$PH$US$US
243145562$24314556$2$F$20240909$20240918$20240913$20240921$PER$$US-AMGEN-USASP2024180184$AMGEN$$77$YR$E$F$Y$$$20240921$$PH$US$US
243145571$24314557$1$I$$20240911$20240913$20240913$EXP$$US-ROCHE-10000079680$ROCHE$$80$YR$E$F$Y$$$20240913$$CN$US$US
243145581$24314558$1$I$$20240911$20240913$20240913$EXP$GB-MHRA-MED-202409112158055820-SRTQY$GB-SANDOZ INC.-SDZ2024GB079790$SANDOZ$$$$$F$Y$$$20240913$$CN$GB$GB
243145591$24314559$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1280296$NOVO NORDISK$$$$$F$Y$$$20240913$$CN$US$US
243145611$24314561$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1280251$NOVO NORDISK$$62$YR$$$Y$$$20240913$$CN$US$US
243145621$24314562$1$I$$20240903$20240913$20240913$EXP$$US-NOVOPROD-1280229$NOVO NORDISK$$$$$F$Y$$$20240913$$CN$US$US
243145631$24314563$1$I$20090601$20240903$20240913$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143392$BRISTOL MYERS SQUIBB$Kana Oiwa, Shin Lee, Kei Fujita, Takanori Ueda and Takahiro Yamauchi. Clinical Features of Clonal Cytogenetic Abnormalities in Philadelphia-negative Cells Developed During Tyrosine Kinase Inhibitor Treatment. Internal Medicine. 2024;63(5): 729-732. doi:10.2169/internalmedicine.2182-23.$85$YR$E$F$Y$$$20240913$$MD$JP$JP
243145641$24314564$1$I$20220801$20240904$20240913$20240913$EXP$NO-NOMAADVRE-PASRAPP-2024-Vmqbzn$NO-NOVOPROD-1278663$NOVO NORDISK$$$$$M$Y$92$KG$20240913$$CN$NO$NO
243145651$24314565$1$I$$20240910$20240913$20240913$EXP$$CA-TAKEDA-2023TUS012273$TAKEDA$$$$$F$Y$$$20240913$$MD$CA$CA
243145661$24314566$1$I$$20240909$20240913$20240913$EXP$$CA-ABBVIE-5917796$ABBVIE$$$$A$F$Y$$$20240913$$CN$CA$CA
243145672$24314567$2$F$$20240905$20240913$20240917$EXP$$US-AstraZeneca-2024A203118$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243145681$24314568$1$I$$20240906$20240913$20240913$EXP$$US-AstraZeneca-2024A204242$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243145691$24314569$1$I$$20240906$20240913$20240913$EXP$$US-JNJFOC-20240920313$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243145701$24314570$1$I$$20240906$20240913$20240913$PER$$US-JNJFOC-20240917350$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243145711$24314571$1$I$$20240906$20240913$20240913$EXP$$FR-ABBVIE-5919016$ABBVIE$$75$YR$$M$Y$$$20240913$$MD$FR$FR
243145721$24314572$1$I$$20240829$20240913$20240913$PER$$US-ASTELLAS-2024-AER-003588$ASTELLAS$$$$$M$Y$$$20240913$$CN$US$US
243145731$24314573$1$I$20230829$20240904$20240913$20240913$EXP$AU-TGA-0000786271$AU-NOVOPROD-1279363$NOVO NORDISK$$34$YR$$M$Y$$$20240913$$HP$AU$AU
243145741$24314574$1$I$20240830$20240904$20240913$20240913$EXP$GB-MHRA-MED-202409041343281120-CNDBF$GB-NOVOPROD-1278802$NOVO NORDISK$$68$YR$$$Y$$$20240913$$PH$GB$GB
243145751$24314575$1$I$20230701$20240904$20240913$20240913$EXP$AU-TGA-0000782136$AU-NOVOPROD-1279477$NOVO NORDISK$$68$YR$$F$Y$$$20240913$$CN$AU$AU
243145761$24314576$1$I$$20240904$20240913$20240913$EXP$AU-TGA-0000815836$AU-NOVOPROD-1279412$NOVO NORDISK$$81$YR$$F$Y$$$20240913$$HP$AU$AU
243145772$24314577$2$F$20240903$20240923$20240913$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-028134$UNITED THERAPEUTICS$$77$YR$$M$Y$82.54$KG$20240928$$$US$US
243145781$24314578$1$I$20240816$20240904$20240913$20240913$EXP$FI-FIMEA-202403205$FI-NOVOPROD-1278667$NOVO NORDISK$$37$YR$$F$Y$$$20240913$$CN$FI$FI
243145791$24314579$1$I$20240818$20240904$20240913$20240913$EXP$DE-AMK-279606$DE-NOVOPROD-1278700$NOVO NORDISK$$17$YR$$F$Y$126$KG$20240913$$PH$DE$DE
243145801$24314580$1$I$20210620$20240904$20240913$20240913$EXP$AU-TGA-0000695685$AU-NOVOPROD-1279429$NOVO NORDISK$$66$YR$$F$Y$$$20240913$$PH$AU$AU
243145811$24314581$1$I$20160928$20240906$20240913$20240913$EXP$$DE-002147023-PHHY2018DE061478$Haleon PLC$$82$YR$$F$Y$56$KG$20240913$$MD$DE$DE
243145821$24314582$1$I$$20240911$20240913$20240913$PER$$US-ROCHE-10000080038$ROCHE$$$$E$F$Y$$$20240913$$CN$US$US
243145831$24314583$1$I$$20240901$20240913$20240913$EXP$$RO-Accord-445961$ACCORD$Niculae CM, Gorea ME, Tirlescu LG, Matoru RM, Hristea A. Tigecycline-Based Regimens for Complicated Urinary Tract Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria: Case Series. Cureus. 2024 Jul 29;16(7):e65617.$63$YR$A$M$Y$$$20240913$$HP$RO$RO
243145851$24314585$1$I$20240706$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014104$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243145862$24314586$2$F$$20240906$20240913$20240913$PER$$US-ROCHE-10000076377$ROCHE$$$$A$F$Y$$$20240913$$HP$US$US
243145871$24314587$1$I$$20240909$20240913$20240913$EXP$$IT-ORGANON-O2409ITA000731$ORGANON$Levi V.. Bilateral Simultaneous Magnetic Resonance-Guided Focused Ultrasound Pallidotomy for Life-Threatening Status Dystonicus.. Movement Disorders.. 2024;39(8):1408-12$19$YR$$F$Y$$$20240913$$MD$IT$IT
243145881$24314588$1$I$20240501$20240905$20240913$20240913$EXP$$US-AMGEN-USASP2024178489$AMGEN$$66$YR$E$M$Y$$$20240912$$CN$US$US
243145891$24314589$1$I$20240829$20240905$20240913$20240913$EXP$CN-NMPA-3708831513250202400535$CN-NOVOPROD-1280598$NOVO NORDISK$$56$YR$$M$Y$88$KG$20240913$$HP$CN$CN
243145901$24314590$1$I$$20240831$20240913$20240913$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0350$GRAVITI PHARMACEUTICALS$Usman Ghani M, Guddati H, Hertan H..Atorvastatin-triggered autoimmune hepatitis.J-Gen-Intern-Med.2019;34:S488$65$YR$A$F$Y$$$20240913$$HP$US$US
243145911$24314591$1$I$$20240904$20240913$20240913$EXP$$CO-NOVOPROD-1281158$NOVO NORDISK$$38$YR$$$Y$$$20240913$$CN$CO$CO
243145921$24314592$1$I$$20240903$20240913$20240913$PER$$US-APOTEX-2024AP010289$APOTEX$Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N.. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.. The American Journal of Gastroenterology. 2024;119:200-202$$$A$$Y$$$20240913$$MD$US$US
243145931$24314593$1$I$$20240909$20240913$20240913$PER$$US-ABBVIE-5918638$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243145941$24314594$1$I$20240807$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014100$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243145951$24314595$1$I$20210103$20240902$20240913$20240913$EXP$GB-MHRA-MED-202409022344129800-WLJCQ$GB-Accord-444812$ACCORD$$48$YR$A$F$Y$60$KG$20240913$$CN$GB$GB
243145961$24314596$1$I$$20240831$20240913$20240913$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0369$GRAVITI PHARMACEUTICALS$Kagihara JE, Kalathil SC, Lopez KT.Drugs! a new mimicker of primary sclerosing cholangitis.Am-J-Gastroenterol.2019;114:S1697$63$YR$A$F$Y$$$20240913$$MD$US$US
243145971$24314597$1$I$20240101$20240906$20240913$20240913$EXP$$US-ABBVIE-5917593$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243145981$24314598$1$I$20231229$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014101$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243145991$24314599$1$I$$20240827$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08638$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243146001$24314600$1$I$20240601$20240910$20240913$20240913$EXP$$US-TAKEDA-2024TUS090573$TAKEDA$$$$$M$Y$$$20240913$$CN$US$US
243146011$24314601$1$I$20240101$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024180759$AMGEN$$19$YR$A$F$Y$$$20240912$$CN$US$US
243146022$24314602$2$F$20240901$20240923$20240913$20240930$30DAY$$US-AMGEN-USASP2024179998$AMGEN$$31$YR$A$F$Y$105$KG$20240930$$MD$US$US
243146032$24314603$2$F$20240908$20240916$20240913$20240918$PER$$US-AMGEN-USASP2024182421$AMGEN$$51$YR$A$F$Y$97.506$KG$20240918$$MD$US$US
243146042$24314604$2$F$20240908$20240918$20240913$20240919$PER$$US-AMGEN-USASP2024182418$AMGEN$$58$YR$A$F$Y$$$20240919$$MD$US$US
243146052$24314605$2$F$$20240912$20240913$20240925$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005017$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
243146071$24314607$1$I$$20240906$20240913$20240913$EXP$$CA-GSK-CA2024111340$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$CA$CA
243146081$24314608$1$I$20240812$20240906$20240913$20240913$EXP$FR-AFSSAPS-RN2024000951$FR-GSK-FR2024111216$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$FR$FR
243146091$24314609$1$I$20240527$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014103$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243146101$24314610$1$I$$20240905$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024110658$VIIV$$$$$M$Y$$$20240913$$MD$US$US
243146111$24314611$1$I$$20240906$20240913$20240913$PER$$NVSC2024US180450$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
243146121$24314612$1$I$$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181915$AMGEN$$$$$$Y$$$20240912$$MD$US$US
243146131$24314613$1$I$20240902$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014111$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243146141$24314614$1$I$$20240902$20240913$20240913$EXP$$BG-TAKEDA-2024TUS089406$TAKEDA$$52$YR$$F$Y$$$20240913$$CN$BG$BG
243146151$24314615$1$I$$20240905$20240913$20240913$EXP$$US-AstraZeneca-2024A203112$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243146161$24314616$1$I$20240902$20240911$20240913$20240913$EXP$$US-ABBVIE-5920366$ABBVIE$$79$YR$$F$Y$$$20240913$$CN$US$US
243146171$24314617$1$I$$20240905$20240913$20240913$EXP$$ZA-AstraZeneca-2024A202990$ASTRAZENECA$$59$YR$$F$Y$$$20240913$$CN$ZA$
243146181$24314618$1$I$20240822$20240905$20240913$20240913$EXP$$CL-AstraZeneca-2024A205725$ASTRAZENECA$$15703$DY$$F$Y$$$20240913$$CN$CL$
243146211$24314621$1$I$20230101$20240909$20240913$20240913$EXP$$US-ABBVIE-5917183$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243146231$24314623$1$I$$20240902$20240913$20240913$EXP$$JP-JNJFOC-20240926990$JOHNSON AND JOHNSON$Morinaga A. A case of SLE-PAH treated with combination therapy including continuous subcutaneous injection of treprostinil..$3$DEC$A$F$Y$$$20240913$$HP$JP$JP
243146241$24314624$1$I$20240823$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014116$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243146253$24314625$3$F$20240802$20240919$20240913$20240925$EXP$GB-002147023-NVSC2024GB177326$GB-RDY-SPO/GBR/24/0013051$DR REDDYS$$56$YR$A$$Y$$$20240925$$CN$GB$GB
243146262$24314626$2$F$20240910$20240912$20240913$20240915$PER$$US-AMGEN-USASP2024182375$AMGEN$$42$YR$A$F$Y$$$20240915$$CN$US$US
243146273$24314627$3$F$20240101$20240913$20240913$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026640$UNITED THERAPEUTICS$$$$$M$Y$61.224$KG$20240918$$$US$US
243146281$24314628$1$I$$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014102$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243146291$24314629$1$I$20240101$20240909$20240913$20240913$EXP$$JP-JNJFOC-20240930522$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$JP$JP
243146301$24314630$1$I$20230801$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409006379$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240913$$CN$US$US
243146311$24314631$1$I$20230716$20240830$20240913$20240913$EXP$$CA-CELLTRION INC.-2022CA022522$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
243146321$24314632$1$I$$20240905$20240913$20240913$EXP$$US-AMGEN-USASP2024179690$AMGEN$Barmettler A.; Zong A.M.. Effect of Cannabis Usage on Thyroid Eye Disease. Ophthalmic Plastic and Reconstructive Surgery. 2024;1-7$$$$$Y$$$20240912$$MD$US$US
243146331$24314633$1$I$20200527$20240902$20240913$20240913$EXP$PL-URPL-1-1597-2020$PL-Accord-445149$ACCORD$$81$YR$E$F$Y$68$KG$20240913$$HP$PL$PL
243146341$24314634$1$I$$20240903$20240913$20240913$30DAY$$US-GSK-US2024111320$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$HP$US$US
243146351$24314635$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5919012$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243146362$24314636$2$F$$20240912$20240913$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145260$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240916$$HP$US$US
243146371$24314637$1$I$$20240910$20240913$20240913$PER$$US-ALXN-202409USA000764US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243146381$24314638$1$I$20240901$20240911$20240913$20240913$EXP$$AT-ABBVIE-5919438$ABBVIE$$$$E$M$Y$$$20240913$$CN$AT$AT
243146392$24314639$2$F$$20240917$20240913$20240924$EXP$$JP-009507513-2409JPN000599J$MERCK$$61$YR$$M$Y$$$20240924$$PH$JP$JP
243146401$24314640$1$I$20240726$20240911$20240913$20240913$EXP$$CA-ABBVIE-5921140$ABBVIE$$67$YR$$M$Y$$$20240913$$MD$CA$CA
243146411$24314641$1$I$20240101$20240905$20240913$20240913$PER$$US-SA-2024SA264161$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240913$$MD$US$US
243146421$24314642$1$I$20240101$20240822$20240913$20240913$PER$$US-SA-2024SA263715$SANOFI AVENTIS$$$$T$F$Y$88.64$KG$20240913$$MD$US$US
243146431$24314643$1$I$20240101$20240905$20240913$20240913$PER$$US-SA-2024SA263251$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240913$$HP$US$US
243146441$24314644$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA101425$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240913$$MD$US$US
243146451$24314645$1$I$20240101$20240829$20240913$20240913$PER$$US-SA-2024SA260051$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240913$$HP$US$US
243146461$24314646$1$I$20240101$20240822$20240913$20240913$PER$$US-SA-2024SA263228$SANOFI AVENTIS$$$$$$Y$$$20240913$$MD$US$US
243146471$24314647$1$I$20240101$20240822$20240913$20240913$PER$$US-SA-2024SA262850$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240913$$MD$US$US
243146481$24314648$1$I$20240801$20240828$20240913$20240913$PER$$US-SA-2024SA263820$SANOFI AVENTIS$$20$YR$A$F$Y$65.91$KG$20240913$$CN$US$US
243146491$24314649$1$I$$20240902$20240913$20240913$EXP$$SK-TAKEDA-2024TUS090568$TAKEDA$$73$YR$$M$Y$96$KG$20240913$$MD$SK$SK
243146501$24314650$1$I$20240903$20240903$20240913$20240913$PER$$US-SA-2024SA261756$SANOFI AVENTIS$$1$YR$I$M$Y$11.34$KG$20240913$$CN$US$US
243146511$24314651$1$I$$20240912$20240913$20240913$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144809$DAIICHI$$$$$F$Y$$$20240913$$MD$US$US
243146521$24314652$1$I$$20240902$20240913$20240913$EXP$NL-LRB-00999830$NL-Accord-445430$ACCORD$$64$YR$A$F$Y$82$KG$20240913$$CN$NL$NL
243146541$24314654$1$I$$20240909$20240913$20240913$EXP$$AU-009507513-2409AUS003461$MERCK$$42$YR$$M$Y$$$20240913$$MD$AU$AU
243146561$24314656$1$I$$20240909$20240913$20240913$EXP$$US-AstraZeneca-2024A205699$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243146571$24314657$1$I$$20240906$20240913$20240913$EXP$$GB-AstraZeneca-2024A203949$ASTRAZENECA$$49$YR$$F$Y$$$20240913$$MD$GB$
243146581$24314658$1$I$$20240909$20240913$20240913$PER$$US-AstraZeneca-2024A207836$ASTRAZENECA$$$$$$Y$$$20240913$$CN$US$
243146591$24314659$1$I$$20240910$20240913$20240913$EXP$$NZ-ROCHE-10000079265$ROCHE$$$$$$Y$$$20240913$$HP$NZ$NZ
243146601$24314660$1$I$$20240905$20240913$20240913$EXP$$US-CHATTEMPRD-2024OHG031405$CHATTEM$$$$$$Y$$$20240913$$CN$US$US
243146622$24314662$2$F$$20240914$20240913$20240919$PER$$NVSC2024US180290$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
243146631$24314663$1$I$20240719$20240902$20240913$20240913$EXP$FR-AFSSAPS-NC2024001022$FR-Accord-445497$ACCORD$$73$YR$E$F$Y$60$KG$20240913$$HP$FR$FR
243146641$24314664$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145614$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240913$$HP$US$US
243146652$24314665$2$F$$20240904$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142240$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240913$$HP$US$US
243146661$24314666$1$I$$20240904$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142225$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240913$$HP$US$US
243146671$24314667$1$I$20240530$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024181970$AMGEN$$61$YR$A$M$Y$$$20240912$$CN$US$US
243146691$24314669$1$I$$20240911$20240913$20240913$PER$$US-HALEON-2196577$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
243146712$24314671$2$F$20240901$20240918$20240913$20240927$EXP$$GB-CELLTRION INC.-2024GB021381$CELLTRION$$$$$$Y$$$20240927$$CN$GB$GB
243146721$24314672$1$I$20240727$20240902$20240913$20240913$EXP$FR-AFSSAPS-LL2024001590$FR-Accord-445100$ACCORD$$19$YR$A$F$Y$71$KG$20240913$$PH$FR$FR
243146731$24314673$1$I$20240801$20240905$20240913$20240913$PER$$US-JNJFOC-20240919468$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20240913$$CN$US$US
243146741$24314674$1$I$20240903$20240906$20240913$20240913$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050713$BOEHRINGER INGELHEIM$$38$YR$A$M$Y$106$KG$20240913$$CN$GB$GB
243146761$24314676$1$I$$20240830$20240913$20240913$EXP$$US-Noden Pharma DAC-NOD202409-000121$NODEN PHARMA$$29$YR$A$M$Y$133.8$KG$20240913$$MD$US$
243146771$24314677$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145592$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240913$$HP$US$US
243146791$24314679$1$I$20240902$20240902$20240913$20240913$EXP$GB-MHRA-MED-202409020727012090-DHVRC$GB-Accord-444826$ACCORD$$54$YR$A$F$Y$75$KG$20240913$$MD$GB$GB
243146801$24314680$1$I$$20240911$20240913$20240913$EXP$$US-AMGEN-USASP2024181757$AMGEN$Rosenblatt T.R.; Chiou C.A.; Yoon M.K. et al.. Percent reduction in proptosis after teprotumumab treatment for thyroid eye disease. British Journal of Ophthalmology. 2024;1-3$$$$$Y$$$20240912$$MD$US$US
243146811$24314681$1$I$20240510$20240904$20240913$20240913$EXP$FR-AFSSAPS-TS2024000944$FR-TEVA-VS-3240446$TEVA$$80$YR$$F$Y$65$KG$20240913$$MD$FR$FR
243146831$24314683$1$I$$20240905$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409003446$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240913$$CN$US$US
243146841$24314684$1$I$20240828$20240828$20240913$20240913$30DAY$$US-JNJFOC-20240878486$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20240913$$CN$US$US
243146851$24314685$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409006367$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240913$$CN$US$US
243146871$24314687$1$I$$20240902$20240913$20240913$EXP$CA-MHPD-E2B_001101000$CA-Accord-444915$ACCORD$$26$YR$A$F$Y$$$20240913$$HP$CA$CA
243146881$24314688$1$I$20240829$20240903$20240913$20240913$EXP$$JP-CELLTRION INC.-2024JP021355$CELLTRION$$$$$$Y$$$20240913$$HP$JP$JP
243146891$24314689$1$I$$20240909$20240913$20240913$EXP$$US-009507513-2409USA003583$MERCK$$$$$F$Y$$$20240913$$CN$US$US
243146901$24314690$1$I$$20240827$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08747$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243146921$24314692$1$I$$20240905$20240913$20240913$EXP$$JP-AstraZeneca-2024A203330$ASTRAZENECA$$79$YR$$F$Y$$$20240913$$MD$JP$
243146931$24314693$1$I$20240813$20240911$20240913$20240913$EXP$$CN-ROCHE-10000079940$ROCHE$$45$YR$A$F$Y$47$KG$20240913$$HP$CN$CN
243146941$24314694$1$I$$20240905$20240913$20240913$EXP$$CA-AstraZeneca-2024A172723$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$CA$
243146961$24314696$1$I$$20240911$20240913$20240913$PER$$US-ROCHE-10000080596$ROCHE$$$$E$F$Y$$$20240913$$HP$US$US
243146981$24314698$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145631$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$123.38$KG$20240913$$CN$US$US
243146992$24314699$2$F$20240828$20240906$20240913$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027345$UNITED THERAPEUTICS$$58$YR$$F$Y$53.061$KG$20240914$$$US$US
243147001$24314700$1$I$$20240902$20240913$20240913$EXP$CA-MHPD-E2B_07207364$CA-Accord-444854$ACCORD$$2$YR$C$F$Y$$$20240913$$HP$CA$CA
243147011$24314701$1$I$$20240912$20240913$20240913$PER$$NVSC2024US183292$NOVARTIS$$$$$$Y$$$20240913$$PH$US$US
243147021$24314702$1$I$$20240906$20240913$20240913$PER$$US-ABBVIE-5916700$ABBVIE$$$$$$Y$$$20240913$$CN$US$US
243147031$24314703$1$I$$20240909$20240913$20240913$PER$$US-ROCHE-10000077843$ROCHE$$$$$$Y$$$20240913$$CN$US$US
243147042$24314704$2$F$$20240911$20240913$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005107$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243147051$24314705$1$I$20240901$20240911$20240913$20240913$EXP$$CA-ABBVIE-5921354$ABBVIE$$$$A$M$Y$$$20240913$$CN$CA$CA
243147071$24314707$1$I$$20240911$20240913$20240913$PER$$US-ROCHE-10000080732$ROCHE$$58$YR$A$F$Y$$$20240913$$CN$US$US
243147081$24314708$1$I$$20240826$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08579$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243147092$24314709$2$F$$20240910$20240913$20240919$PER$$US-AMGEN-USASP2024181436$AMGEN$$$$$M$Y$$$20240919$$CN$US$US
243147101$24314710$1$I$$20240911$20240913$20240913$PER$$NVSC2024US183223$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
243147111$24314711$1$I$20240801$20240819$20240913$20240913$PER$$FR-TOLMAR, INC.-24FR051794$TOLMAR$$78$YR$$M$Y$$$20240913$$PH$FR$FR
243147131$24314713$1$I$20240801$20240819$20240913$20240913$PER$$FR-TOLMAR, INC.-24FR051971$TOLMAR$$67$YR$$M$Y$$$20240913$$PH$FR$FR
243147141$24314714$1$I$20240816$20240819$20240913$20240913$PER$$FR-TOLMAR, INC.-24FR051980$TOLMAR$$82$YR$$M$Y$$$20240913$$PH$FR$FR
243147151$24314715$1$I$20240815$20240819$20240913$20240913$PER$$FR-TOLMAR, INC.-24FR051998$TOLMAR$$78$YR$$M$Y$$$20240913$$PH$FR$FR
243147161$24314716$1$I$20240817$20240819$20240913$20240913$PER$$FR-TOLMAR, INC.-24FR052003$TOLMAR$$73$YR$$M$Y$$$20240913$$PH$FR$FR
243147171$24314717$1$I$20240816$20240819$20240913$20240913$PER$$HN-TOLMAR, INC.-24HN052042$TOLMAR$$7$YR$$F$Y$$$20240913$$CN$HN$HN
243147181$24314718$1$I$20240814$20240819$20240913$20240913$PER$$FR-TOLMAR, INC.-24FR052012$TOLMAR$$79$YR$$M$Y$$$20240913$$PH$FR$FR
243147191$24314719$1$I$20240501$20240819$20240913$20240913$PER$$NL-TOLMAR, INC.-24NL051965$TOLMAR$$74$YR$$M$Y$$$20240913$$CN$NL$NL
243147201$24314720$1$I$20240819$20240819$20240913$20240913$PER$$TR-TOLMAR, INC.-24TR051999$TOLMAR$$71$YR$$$Y$$$20240913$$HP$TR$TR
243147211$24314721$1$I$$20240906$20240913$20240913$PER$$US-ALXN-202409USA000402US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243147221$24314722$1$I$$20240907$20240913$20240913$EXP$$JP-VANTIVE-2024VAN019278$Vantive US Healthcare$$92$YR$$F$Y$$$20240913$$MD$JP$JP
243147231$24314723$1$I$$20240903$20240913$20240913$EXP$$JP-VANTIVE-2024VAN019503$Vantive US Healthcare$$$$$$Y$$$20240913$$CN$JP$JP
243147251$24314725$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145543$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240913$$CN$US$US
243147261$24314726$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145651$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240913$$HP$US$US
243147271$24314727$1$I$20240905$20240905$20240913$20240913$EXP$$US-ORG100016242-2024000571$PACIRA$$32$YR$A$F$Y$$$20240913$$MD$US$US
243147281$24314728$1$I$$20240902$20240913$20240913$EXP$CA-MHPD-E2B_07250423$CA-Accord-444920$ACCORD$$31$YR$A$F$Y$71$KG$20240913$$MD$CA$CA
243147291$24314729$1$I$20240709$20240821$20240913$20240913$EXP$$US-SA-2024SA263156$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240913$$MD$US$US
243147302$24314730$2$F$20240619$20240926$20240913$20240927$EXP$$JP-TAKEDA-2024TJP013488$TAKEDA$$81$YR$$M$Y$$$20240927$$MD$JP$JP
243147311$24314731$1$I$$20240902$20240913$20240913$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03316$AMNEAL$Peshin S, Kapadia C, Krishnadasan R. CML-401 Insights into Neulasta-Associated Splenic Infarction: Unveiling a Rare Complication in Chemotherapy for Chronic Myelomonocytic Leukemia. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S372$67$YR$$M$Y$$$20240913$$HP$US$US
243147321$24314732$1$I$$20240909$20240913$20240913$EXP$$PT-GSK-PT2024GSK112277$GLAXOSMITHKLINE$Jesus F, Almeida E, Tavares A. Tracheal laceration following rapid sequence intubation. Jornal Brasileiro de Pneumologia. 2024;50(4)$$$$$Y$$$20240913$$HP$PT$PT
243147341$24314734$1$I$20240906$20240909$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409005910$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240913$$CN$US$US
243147351$24314735$1$I$$20240905$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409005651$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240913$$CN$US$US
243147361$24314736$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-045153$AUROBINDO$Mukherji S, Shoaib H, Jimenez X. Brief case report: A case of FOLFIRI-Induced psychosis.. Psycho-Oncology. 2023;32 (10):1625-1627$72$YR$$M$Y$$$20240913$$HP$US$US
243147371$24314737$1$I$20240908$20240909$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409005561$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240913$$CN$US$US
243147381$24314738$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409006425$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240913$$CN$US$US
243147391$24314739$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409006650$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240913$$CN$US$US
243147401$24314740$1$I$20240101$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007302$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240913$$CN$US$US
243147411$24314741$1$I$20210101$20240816$20240913$20240913$PER$$US-009507513-2408USA006257$MERCK$$74$YR$$F$Y$$$20240913$$CN$US$US
243147421$24314742$1$I$$20240903$20240913$20240913$EXP$$GB-AUROBINDO-AUR-APL-2024-044129$AUROBINDO$$55$YR$$F$Y$79$KG$20240912$$MD$GB$GB
243147431$24314743$1$I$20240808$20240903$20240913$20240913$EXP$$GB-AUROBINDO-AUR-APL-2024-044133$AUROBINDO$$53$YR$$M$Y$58$KG$20240913$$CN$GB$GB
243147441$24314744$1$I$$20240717$20240913$20240913$PER$$US-AUROBINDO-AUR-APL-2024-036881$AUROBINDO$$$$$F$Y$45.359$KG$20240913$$CN$US$US
243147451$24314745$1$I$$20240903$20240913$20240913$EXP$$CA-ROCHE-10000072865$ROCHE$$72$YR$E$F$Y$$$20240913$$HP$CA$CA
243147461$24314746$1$I$$20240904$20240913$20240913$EXP$$MX-HALEON-2195423$Haleon PLC$Torres-Guerrero E, Gutierrez-Palomares J, Tavizon-Ramos OE et al. Side effects of topical steroid abuse. A five-year observational clinical study (2018-2023). Salud publica de Mexico. 2024; 66(3): 322-323$$$$$Y$$$20240913$$HP$MX$MX
243147471$24314747$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044215$AUROBINDO$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience.. Blood Cancer Journal. 2023;13:91$$$$$Y$$$20240912$$HP$US$US
243147481$24314748$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044130$AUROBINDO$Ayan M, Salih M, Siraj A. ISOLATED PULMONARY NATIVE VALVE INFECTIVE ENDOCARDITIS DUE TO ENTEROCOCCUS FAECALIS: A PERSISTENT CHALLENGE. J-Am-Coll-Cardiol. 2019;73 (Suppl 1):2573$73$YR$$M$Y$$$20240912$$HP$US$US
243147492$24314749$2$F$20240906$20240910$20240913$20240921$30DAY$$US-UCBSA-2024046600$UCB$$63$YR$$F$Y$$$20240921$$CN$US$US
243147501$24314750$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044132$AUROBINDO$Cheney A, Krieger E, Dardas T, Vincent L. FROM MULTIPLE MYELOMA TO MYOCARDITIS.. JAm-Coll-Cardiol. 2019;73 (Suppl. 1)(9:2597 abstr. 1216-193$53$YR$$M$Y$$$20240912$$HP$US$US
243147511$24314751$1$I$20240728$20240905$20240913$20240913$EXP$$IT-AUROBINDO-AUR-APL-2024-042684$AUROBINDO$$85$YR$$F$Y$55$KG$20240912$$MD$IT$IT
243147521$24314752$1$I$$20240903$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044085$AUROBINDO$Umer M, Peters M, Dholiya H, Sagheer U, Bhandari S, Kalra DK, et al. Multiple recurrences of a left ventricular pseudoaneurysm: A case report. European Heart Journal - Case Reports. 2024;8(8):ytae382$32$YR$$M$Y$$$20240913$$MD$US$US
243147531$24314753$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044370$AUROBINDO$Mertz A, Fair C, Pol J. Geriatric Pharmacotherapy Case Series: Clotting and Gender-Affirming Care.. Sr Care Pharm. 2024$79$YR$$F$Y$$$20240912$$HP$US$US
243147541$24314754$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044292$AUROBINDO$Zhang Y, Bangert M, Chun M, Mattingly T, Zheng C. ACUTE AND CHRONIC INFECTIOUS COMPLICATIONS FOLLOWING GUNSHOT INJURIES: A CASE COMPARISON. South-Med-J. 2022;115:561$26$YR$$M$Y$$$20240912$$HP$US$US
243147553$24314755$3$F$20201201$20240919$20240913$20240923$EXP$$PL-AUROBINDO-AUR-APL-2021-028681$AUROBINDO$$49$YR$$M$Y$$$20240923$$MD$PL$PL
243147561$24314756$1$I$20240607$20240612$20240913$20240913$PER$$US-AUROBINDO-AUR-APL-2024-030212$AUROBINDO$$73$YR$$M$Y$98.88$KG$20240913$$PH$US$US
243147571$24314757$1$I$20240801$20240907$20240913$20240913$EXP$$IN-ROCHE-10000077159$ROCHE$$55$YR$A$M$Y$$$20240913$$CN$IN$IN
243147581$24314758$1$I$$20240903$20240913$20240913$EXP$$NL-AUROBINDO-AUR-APL-2024-044455$AUROBINDO$$77$YR$$M$Y$70$KG$20240913$$MD$NL$NL
243147591$24314759$1$I$20240822$20240904$20240913$20240913$EXP$FR-AFSSAPS-BR2024000696$FR-TEVA-VS-3240428$TEVA$$76$YR$$F$Y$45$KG$20240913$$MD$FR$FR
243147601$24314760$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-034374$AUROBINDO$Nakasone ES, Bustillos HC, Gui X, Konnick EQ, Sham JG, Cohen SA, et,al.. Multidisciplinary Approach for the Management of Metastatic Poorly Differentiated Neuroendocrine Carcinoma of the Pancreas A Case Report of an Exceptional Responder.. Pancreas. 2024;53(6):e487-91$51$YR$$M$Y$$$20240913$$MD$US$US
243147611$24314761$1$I$20240101$20240905$20240913$20240913$EXP$$US-DAY ONE BIOPHARMACEUTICALS, INC.-2024US000756$Day One Biopharmaceuticals$$14$MON$$M$Y$$$20240912$$HP$US$US
243147621$24314762$1$I$20230101$20240826$20240913$20240913$PER$$US-TEVA-VS-3238145$TEVA$$$$$F$Y$$$20240913$$PH$US$US
243147631$24314763$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182107$AMGEN$$$$$M$Y$$$20240912$$CN$US$US
243147641$24314764$1$I$20240701$20240903$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044410$AUROBINDO$$89$YR$$F$Y$62$KG$20240913$$PH$FR$FR
243147651$24314765$1$I$$20240912$20240913$20240913$PER$$US-ROCHE-10000080207$ROCHE$$72$YR$E$F$Y$$$20240913$$CN$US$US
243147671$24314767$1$I$20240904$20240907$20240913$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014588$JAZZ$$56$YR$$M$Y$$$20240912$$CN$US$US
243147681$24314768$1$I$$20240910$20240913$20240913$PER$$US-ROCHE-10000078642$ROCHE$$$$$F$Y$$$20240913$$CN$US$US
243147691$24314769$1$I$20180217$20240830$20240913$20240913$EXP$$FR-SERVIER-S24011085$SERVIER$$$$$$Y$$$20240913$$MD$FR$FR
243147711$24314771$1$I$$20240826$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08586$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243147722$24314772$2$F$20230501$20240924$20240913$20240926$EXP$$PL-SANDOZ INC.-SDZ2024PL079748$SANDOZ$$67$YR$$F$Y$$$20240926$$HP$PL$PL
243147732$24314773$2$F$$20240906$20240913$20240913$PER$$US-ROCHE-10000076268$ROCHE$$$$$$Y$$$20240913$$HP$US$US
243147751$24314775$1$I$$20240905$20240913$20240913$PER$$US-JNJFOC-20240917953$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$US$US
243147761$24314776$1$I$$20240907$20240913$20240913$EXP$$KR-JNJFOC-20240924183$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$HP$KR$KR
243147771$24314777$1$I$20240909$20240909$20240913$20240913$EXP$$JP-JNJFOC-20240930326$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240913$$MD$JP$JP
243147781$24314778$1$I$$20240910$20240913$20240913$PER$$US-ROCHE-10000079580$ROCHE$$$$A$M$Y$$$20240913$$CN$US$US
243147791$24314779$1$I$$20240906$20240913$20240913$EXP$$JP-ROCHE-10000077760$ROCHE$$$$$$Y$$$20240913$$MD$JP$JP
243147801$24314780$1$I$20240101$20240909$20240913$20240913$EXP$$US-SANDOZ INC.-SDZ2024US078957$SANDOZ$$$$$M$Y$$$20240913$$HP$US$US
243147812$24314781$2$F$20240911$20240926$20240913$20240927$PER$$US-AMGEN-USASP2024182087$AMGEN$$75$YR$E$F$Y$$$20240927$$CN$US$US
243147821$24314782$1$I$$20240902$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044139$AUROBINDO$Terroir M, Lamesa C, Krim M, Vija L, Texier J-S, Cassou-Mounat T, et al.. RadioLigand Therapy with [177Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France. Pharmaceuticals. 2023;16:No. 5$56$YR$$M$Y$$$20240913$$HP$FR$FR
243147831$24314783$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024181790$AMGEN$$$$$F$Y$$$20240912$$CN$US$US
243147842$24314784$2$F$20240831$20240925$20240913$20240930$PER$$US-ROCHE-10000078188$ROCHE$$26$YR$A$M$Y$$$20240930$$CN$US$US
243147851$24314785$1$I$$20240910$20240913$20240913$PER$$US-AstraZeneca-2024A206659$ASTRAZENECA$$27028$DY$$F$Y$$$20240913$$CN$US$
243147861$24314786$1$I$$20240830$20240913$20240913$PER$$US-AstraZeneca-2024A201544$ASTRAZENECA$$$$$$Y$$$20240913$$CN$US$
243147871$24314787$1$I$$20240908$20240913$20240913$PER$$NVSC2024US180204$NOVARTIS$$$$$$Y$$$20240913$$CN$US$US
243147881$24314788$1$I$$20240910$20240913$20240913$PER$$US-ROCHE-10000078748$ROCHE$$$$$$Y$$$20240913$$CN$US$US
243147891$24314789$1$I$20231101$20240907$20240913$20240913$EXP$$CA-GSK-CA2024108380$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$CA$CA
243147901$24314790$1$I$$20240904$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013203$DR REDDYS$Akhdar G, Akpan I. MM-388 Navigating the Nexus: Lenalidomide-Associated Thrombotic Thrombocytopenic Purpura (TTP). Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24: S555. doi:10.1016/S2152-2650%2824%2901677-X.$56$YR$A$M$Y$$$20240913$$MD$US$US
243147911$24314791$1$I$20240705$20240720$20240913$20240913$PER$$US-ROCHE-10000079670$ROCHE$$16$YR$T$M$Y$$$20240913$$CN$US$US
243147921$24314792$1$I$$20240902$20240913$20240913$EXP$$BE-AMGEN-BELSP2024182725$AMGEN$$$$$$Y$$$20240913$$MD$BE$BE
243147932$24314793$2$F$20240828$20240925$20240913$20240926$PER$$US-AMGEN-USASP2024181912$AMGEN$$83$YR$E$F$Y$$$20240926$$CN$US$US
243147941$24314794$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASL2024182440$AMGEN$$$$$M$Y$$$20240913$$CN$US$US
243147952$24314795$2$F$$20240909$20240913$20240913$EXP$$US-AMGEN-USASP2024181234$AMGEN$$$$$$Y$$$20240913$$HP$US$US
243147961$24314796$1$I$$20240910$20240913$20240913$PER$$US-ALXN-202409USA000699US$ALEXION PHARMACEUTICALS$$$$$M$Y$58$KG$20240913$$CN$US$US
243147971$24314797$1$I$20240301$20240909$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409006213$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240913$$CN$US$US
243147981$24314798$1$I$20240910$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007216$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240913$$CN$US$US
243148001$24314800$1$I$$20240903$20240913$20240913$EXP$$CA-AUROBINDO-AUR-APL-2024-044658$AUROBINDO$$58$YR$$F$Y$$$20240913$$HP$CA$CA
243148011$24314801$1$I$20240722$20240902$20240913$20240913$EXP$FR-AFSSAPS-TO2024001622$FR-Accord-445335$ACCORD$$69$YR$E$M$Y$49.4$KG$20240913$$PH$FR$FR
243148022$24314802$2$F$$20240910$20240913$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08620$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243148031$24314803$1$I$20160101$20240904$20240913$20240913$EXP$$DE-AUROBINDO-AUR-APL-2024-044566$AUROBINDO$$80$YR$$F$Y$$$20240913$$CN$DE$DE
243148051$24314805$1$I$$20240903$20240913$20240913$EXP$$CA-AUROBINDO-AUR-APL-2024-044682$AUROBINDO$Hutchinson KA, Peretz D, Darvish M, Talajic J, Choremis J.. Rare Case of Thygeson Superficial Punctate Keratitis after COVID-19 Vaccination.. Cornea. 2023;42(10):1306-1308$3$DEC$$F$Y$$$20240913$$HP$CA$CA
243148061$24314806$1$I$20240219$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014110$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243148081$24314808$1$I$$20240910$20240913$20240913$PER$$US-ROCHE-3491268$ROCHE$$22$YR$A$M$Y$$$20240913$$HP$US$US
243148091$24314809$1$I$20240816$20240903$20240913$20240913$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161535$JIANGSU HANSOH PHARMACEUTICAL$$66$YR$$M$Y$$$20240913$$MD$CN$CN
243148102$24314810$2$F$20240902$20240909$20240913$20240930$PER$$US-JNJFOC-20240916052$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240930$$MD$US$US
243148111$24314811$1$I$$20240831$20240913$20240913$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0363$GRAVITI PHARMACEUTICALS$Joury A, Alshehri M, Mahendra A, Anteet M, Yousef MA, Khan AM.Therapeutic approaches in hypertriglyceridemia-induced acute pancreatitis: A literature review of available therapies and case series.J-Clin-Apheresis.2020;35(2):131-137$28$YR$A$M$Y$$$20240913$$HP$US$US
243148121$24314812$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182254$AMGEN$$$$$$Y$$$20240913$$CN$US$US
243148131$24314813$1$I$$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181247$AMGEN$$$$$$Y$$$20240913$$MD$US$US
243148141$24314814$1$I$$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181374$AMGEN$$$$$$Y$$$20240913$$CN$US$US
243148152$24314815$2$F$$20240911$20240913$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004980$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243148161$24314816$1$I$$20240905$20240913$20240913$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024002727$BIOCON$$$$$$Y$$$20240913$$CN$CA$CA
243148171$24314817$1$I$20160101$20240906$20240913$20240913$EXP$$US-AMGEN-USASP2024178847$AMGEN$$37$YR$A$M$Y$$$20240913$$HP$US$US
243148181$24314818$1$I$20240726$20240911$20240913$20240913$EXP$$US-AstraZeneca-2024A207696$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243148191$24314819$1$I$$20240903$20240913$20240913$EXP$$NL-AUROBINDO-AUR-APL-2019-037978$AUROBINDO$Hovens M, Vaessen N, Sijpkens Y, de Fijter J.. Unusual presentation of central nervous system manifestations of Varicella zoster virus vasculopathy in renal transplant recipients.. Transplant Infectious Disease.. 2007;9(3):237-240$51$YR$$F$Y$$$20240913$$HP$NL$NL
243148201$24314820$1$I$$20240831$20240913$20240913$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0358$GRAVITI PHARMACEUTICALS$Troulakis J, Chhetry MG, Volodarskiy A.MYOCARDIAL INFARCTION AS A COMPLICATING FACTOR IN AORTIC DISSECTION DIAGNOSIS AND TREATMENT.Chest.2020;158(4):A142$66$YR$A$F$Y$$$20240913$$HP$US$US
243148211$24314821$1$I$$20240826$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08571$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243148222$24314822$2$F$20240918$20240920$20240913$20240930$EXP$$IN-VANTIVE-2024VAN019599$Vantive US Healthcare$$43$YR$$F$Y$$$20240930$$CN$IN$IN
243148231$24314823$1$I$20240830$20240903$20240913$20240913$PER$$US-ABBVIE-5907091$ABBVIE$$38$YR$$F$Y$$$20240913$$CN$US$US
243148251$24314825$1$I$$20240904$20240913$20240913$30DAY$$US-GSK-US2024110203$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243148262$24314826$2$F$$20240918$20240913$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR111196$VIIV$$$$A$M$Y$$$20240926$$CN$US$US
243148272$24314827$2$F$20240822$20240911$20240913$20240918$30DAY$$CA-JNJFOC-20240859319$JOHNSON AND JOHNSON$$58$YR$A$F$Y$86.26$KG$20240918$$HP$CA$CA
243148281$24314828$1$I$$20240905$20240913$20240913$EXP$$US-JNJFOC-20240916201$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240913$$CN$US$US
243148291$24314829$1$I$20240730$20240911$20240913$20240913$EXP$IT-MINISAL02-1001657$IT-JNJFOC-20240932106$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240913$$MD$IT$IT
243148302$24314830$2$F$$20240911$20240913$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005100$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243148311$24314831$1$I$20240327$20240903$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044335$AUROBINDO$$60$YR$$F$Y$$$20240913$$PH$FR$FR
243148321$24314832$1$I$$20240826$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08566$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243148341$24314834$1$I$20240823$20240909$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044811$AUROBINDO$$49$YR$$F$Y$$$20240913$$MD$FR$FR
243148351$24314835$1$I$$20240911$20240913$20240913$PER$$US-JNJFOC-20240931597$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243148361$24314836$1$I$20240911$20240912$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145809$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240913$$CN$US$US
243148381$24314838$1$I$$20240910$20240913$20240913$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-121914$REGENERON$$$$$M$Y$$$20240913$$CN$CA$CA
243148392$24314839$2$F$20240831$20240920$20240913$20240925$EXP$$GB-GSK-GB2024EME111619$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$GB$GB
243148401$24314840$1$I$20240801$20240910$20240913$20240913$30DAY$$GB-UCBSA-2024044697$UCB$$35$YR$$F$Y$$$20240913$$CN$GB$GB
243148411$24314841$1$I$20200912$20240903$20240913$20240913$EXP$$PL-AUROBINDO-AUR-APL-2024-044559$AUROBINDO$$38$YR$$M$Y$94$KG$20240913$$MD$PL$PL
243148421$24314842$1$I$20240911$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007352$ELI LILLY AND CO$$$$$$Y$$$20240913$$CN$US$US
243148431$24314843$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007511$ELI LILLY AND CO$$$$A$F$Y$$$20240913$$CN$US$US
243148442$24314844$2$F$20240908$20240910$20240913$20240919$PER$$US-AMGEN-USASP2024180661$AMGEN$$61$YR$A$F$Y$$$20240918$$CN$US$US
243148451$24314845$1$I$20240910$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181843$AMGEN$$58$YR$A$M$Y$$$20240913$$CN$US$US
243148461$24314846$1$I$$20240902$20240913$20240913$PER$$US-APOTEX-2024AP010269$APOTEX$Liu N, Prasad R, Iyer I, Sheikh S, Turka J, Dweik L, et al.. Cardioneuroablation can be an effective strategy to treat glossopharyngeal neuralgia-related sinus bradycardia and pauses. Journal of Cardiovascular Electrophysiology. 2024;1-5$59$YR$$F$Y$$$20240913$$MD$US$US
243148471$24314847$1$I$$20240910$20240913$20240913$EXP$$US-SANDOZ INC.-SDZ2024US079761$SANDOZ$$$$$F$Y$$$20240913$$CN$US$US
243148481$24314848$1$I$$20240826$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08569$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243148491$24314849$1$I$20240509$20240911$20240913$20240913$EXP$$IN-SANDOZ INC.-SDZ2024IN079850$SANDOZ$$51$YR$$M$Y$$$20240913$$CN$IN$IN
243148501$24314850$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004905$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243148511$24314851$1$I$20240829$20240829$20240913$20240913$EXP$$US-MDD US Operations-MDD202409-003271$MDD OPERATIONS$$$$$M$Y$$$20240913$$CN$US$
243148522$24314852$2$F$$20240919$20240913$20240926$EXP$$JP-JNJFOC-20240930593$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240927$$MD$JP$JP
243148532$24314853$2$F$$20240913$20240913$20240917$PER$$NVSC2024US183393$NOVARTIS$$$$$$Y$$$20240917$$HP$US$US
243148541$24314854$1$I$$20240903$20240913$20240913$EXP$$CA-AUROBINDO-AUR-APL-2024-044657$AUROBINDO$$56$YR$$F$Y$$$20240913$$CN$CA$CA
243148551$24314855$1$I$20230101$20240903$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044102$AUROBINDO$Hosseini R, Brooks SP, Gadelha E, Schaap R, Cook J, Husan A.. Effective Treatment of Methotrexate Induced Oral Mucositis With a Morphine Mouthwash Solution: A Case Report.. Journal of pharmacy practice. 2024;897190024127607$67$YR$$F$Y$103.9$KG$20240913$$PH$US$US
243148561$24314856$1$I$20240907$20240910$20240913$20240913$EXP$$IN-UNITED THERAPEUTICS-UNT-2024-028644$UNITED THERAPEUTICS$$$$$$Y$$$20240913$$$IN$IN
243148571$24314857$1$I$$20240903$20240913$20240913$EXP$$CA-AUROBINDO-AUR-APL-2024-044679$AUROBINDO$$58$YR$$F$Y$$$20240913$$MD$CA$CA
243148581$24314858$1$I$20240101$20240903$20240913$20240913$EXP$$IT-ROCHE-10000072832$ROCHE$$15$YR$T$F$Y$$$20240913$$CN$IT$IT
243148591$24314859$1$I$20240101$20240912$20240913$20240913$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051224$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$$$20240913$$PH$US$US
243148601$24314860$1$I$20220401$20240807$20240913$20240913$EXP$$PT-JNJFOC-20240827620$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240913$$HP$PT$PT
243148611$24314861$1$I$$20240830$20240913$20240913$PER$$US-JNJFOC-20240900906$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$US$US
243148621$24314862$1$I$20240301$20240911$20240913$20240913$EXP$FR-AFSSAPS-PB2024000970$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-144960$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240913$$MD$FR$FR
243148631$24314863$1$I$$20240905$20240913$20240913$EXP$$CA-CELLTRION INC.-2024CA021293$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
243148641$24314864$1$I$20240819$20240903$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044419$AUROBINDO$$55$YR$$F$Y$$$20240913$$HP$FR$FR
243148651$24314865$1$I$20240405$20240903$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044440$AUROBINDO$$46$YR$$M$Y$$$20240913$$PH$FR$FR
243148661$24314866$1$I$$20231110$20240913$20240913$EXP$$US-KHC-000099$Kilitch Healthcare$$$$$M$Y$$$20240913$$CN$US$US
243148671$24314867$1$I$20230101$20240305$20240913$20240913$EXP$$US-KHC-000138$Kilitch Healthcare$$64$YR$A$M$Y$$$20240913$$CN$US$US
243148681$24314868$1$I$20240802$20240903$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044041$AUROBINDO$$48$YR$$M$Y$$$20240913$$MD$FR$FR
243148691$24314869$1$I$20240907$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024180836$AMGEN$$62$YR$A$M$Y$$$20240913$$CN$US$US
243148701$24314870$1$I$20240825$20240903$20240913$20240913$EXP$$GB-AUROBINDO-AUR-APL-2024-044081$AUROBINDO$$$$$F$Y$65$KG$20240913$$CN$GB$GB
243148711$24314871$1$I$20161101$20240909$20240913$20240913$EXP$$DE-SANDOZ INC.-PHHY2019DE136720$SANDOZ$$29$YR$$F$Y$$$20240913$$MD$DE$DE
243148722$24314872$2$F$$20240923$20240913$20240927$PER$$US-HALEON-2196680$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243148731$24314873$1$I$$20240903$20240913$20240913$EXP$$JP-ROCHE-10000009450$ROCHE$$6$DEC$A$F$Y$$$20240913$$MD$JP$JP
243148741$24314874$1$I$$20240911$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA079624$SANDOZ$$61$YR$$F$Y$58$KG$20240913$$HP$CA$CA
243148751$24314875$1$I$$20240905$20240913$20240913$EXP$$GB-EMD Serono-2024048174$EMD SERONO INC$$$$A$F$Y$$$20240913$$CN$GB$GB
243148761$24314876$1$I$$20240909$20240913$20240913$EXP$$GB-GSK-GB2024EME112762$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$GB$GB
243148771$24314877$1$I$$20240901$20240913$20240913$EXP$$PL-ROCHE-10000072909$ROCHE$$65$YR$E$F$Y$$$20240913$$MD$PL$PL
243148782$24314878$2$F$20240101$20240910$20240913$20240917$EXP$$US-SANDOZ INC.-SDZ2024US079595$SANDOZ$$$$$F$Y$$$20240917$$CN$US$US
243148791$24314879$1$I$$20240910$20240913$20240913$EXP$$GB-HALEON-2196113$Haleon PLC$$84$YR$$F$Y$61$KG$20240913$$HP$GB$GB
243148801$24314880$1$I$20240910$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182480$AMGEN$$68$YR$E$F$Y$$$20240913$$CN$US$US
243148811$24314881$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182294$AMGEN$$$$$$Y$$$20240913$$CN$US$US
243148821$24314882$1$I$20240809$20240904$20240913$20240913$EXP$FR-AFSSAPS-CN2024000789$FR-TEVA-VS-3240385$TEVA$$68$YR$$F$Y$70$KG$20240913$$PH$FR$FR
243148831$24314883$1$I$$20240903$20240913$20240913$EXP$$CA-AUROBINDO-AUR-APL-2024-044680$AUROBINDO$$65$YR$$M$Y$$$20240913$$MD$CA$CA
243148841$24314884$1$I$20240802$20240905$20240913$20240913$EXP$$NVSJ2024JP010611$NOVARTIS$$0$YR$$M$Y$$$20240913$$MD$JP$JP
243148851$24314885$1$I$$20240905$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013100$DR REDDYS$$61$YR$A$F$Y$$$20240913$$MD$US$US
243148861$24314886$1$I$20240101$20240903$20240913$20240913$EXP$$GB-AUROBINDO-AUR-APL-2024-044126$AUROBINDO$$41$YR$$F$Y$$$20240913$$MD$GB$GB
243148871$24314887$1$I$20240301$20240904$20240913$20240913$EXP$$AU-ROCHE-3290932$ROCHE$$52$YR$A$F$Y$$$20240913$$HP$AU$AU
243148881$24314888$1$I$20210101$20240903$20240913$20240913$EXP$$NL-AUROBINDO-AUR-APL-2022-038185$AUROBINDO$Sogbein O, Gamilla-Crudo AKN, Mujtaba MA, Hussain SA.. Transplant Graft TMA Injury Post COVID-19 Vaccination.. American Journal of Kidney Diseases. 2022;79(4):31$48$YR$$M$Y$$$20240913$$HP$NL$NL
243148891$24314889$1$I$$20240905$20240913$20240913$PER$$US-JNJFOC-20240913093$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$PH$US$US
243148911$24314891$1$I$20231222$20240910$20240913$20240913$EXP$$US-AstraZeneca-2024A206495$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243148921$24314892$1$I$$20240910$20240913$20240913$EXP$$KR-AstraZeneca-2024A207286$ASTRAZENECA$$24408$DY$$F$Y$$$20240913$$CN$KR$
243148931$24314893$1$I$$20240901$20240913$20240913$EXP$$PH-Accord-445195$ACCORD$Ajon ARS, Camara PTA. Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Due to Multiple Anti-Epileptic Drug Hypersensitivity. Cureus. 2024 Jul 26;16(7):e65417. doi: 10.7759/cureus.65417.$41$YR$A$F$Y$$$20240913$$MD$PH$PH
243148952$24314895$2$F$20240906$20240912$20240913$20240917$PER$$US-AMGEN-USASP2024182736$AMGEN$$47$YR$A$F$Y$$$20240917$$CN$US$US
243148961$24314896$1$I$$20240903$20240913$20240913$EXP$$IN-ROCHE-10000073675$ROCHE$$64$YR$A$F$Y$56.2$KG$20240913$$CN$IN$IN
243148971$24314897$1$I$20220101$20240909$20240913$20240913$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-144315$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240913$$HP$AU$AU
243148981$24314898$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145782$BRISTOL MYERS SQUIBB$$28$YR$A$M$Y$$$20240913$$HP$US$US
243148991$24314899$1$I$20240101$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145832$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240913$$CN$US$US
243149031$24314903$1$I$$20240904$20240913$20240913$EXP$$JP-ROCHE-10000076347$ROCHE$$$$E$$Y$$$20240913$$PH$JP$JP
243149041$24314904$1$I$20240801$20240911$20240913$20240913$PER$$US-JNJFOC-20240928549$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$CN$US$US
243149051$24314905$1$I$20240911$20240911$20240913$20240913$PER$$US-JNJFOC-20240928425$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243149061$24314906$1$I$$20240904$20240913$20240913$PER$$US-ABBVIE-5907619$ABBVIE$$$$$M$Y$$$20240913$$HP$US$US
243149071$24314907$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044547$AUROBINDO$Mena S, Raj A, Caldwell W, Kaushal A. The annoyance of singultus: a case report of a rare adverse effect after epidural steroid injection. BMC Anesthesiology. 2024;24 (1):302$49$YR$$M$Y$$$20240913$$MD$US$US
243149081$24314908$1$I$20240708$20240905$20240913$20240913$EXP$$JP-ROCHE-10000078600$ROCHE$$76$YR$E$F$Y$58.9$KG$20240913$$MD$JP$JP
243149091$24314909$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044128$AUROBINDO$Jalili MH, Cornman-Homonoff J.. Suction thrombectomy for management of pulmonary tumor embolism in the setting of hepatocellular carcinoma with macrovascular invasion. Radiol-Case-Rep. 2024;19(10):4627-4630$83$YR$$M$Y$$$20240913$$MD$US$US
243149101$24314910$1$I$20240901$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024180761$AMGEN$$39$YR$A$$Y$$$20240913$$PH$US$US
243149111$24314911$1$I$$20240902$20240913$20240913$EXP$$CZ-AUROBINDO-AUR-APL-2024-044347$AUROBINDO$Kabut T, Weinbergerova B, Folber F, Lengerova M, Mayer J. High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience. Bone-Marrow-Transplant. 2023;58:1229-1236$58$YR$$M$Y$$$20240913$$HP$CZ$CZ
243149121$24314912$1$I$$20240906$20240913$20240913$PER$$US-CHATTEMPRD-2024OHG031320$CHATTEM$$95$YR$E$M$Y$$$20240913$$CN$US$US
243149131$24314913$1$I$$20240831$20240913$20240913$EXP$$JP-AMGEN-JPNSP2024180434$AMGEN$$$$$$Y$$$20240913$$MD$JP$JP
243149141$24314914$1$I$20240630$20240910$20240913$20240913$EXP$$JP-SANDOZ INC.-SDZ2024JP079810$SANDOZ$$83$YR$$F$Y$$$20240913$$CN$JP$JP
243149151$24314915$1$I$20240909$20240912$20240913$20240913$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051219$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240913$$CN$US$US
243149161$24314916$1$I$20240830$20240905$20240913$20240913$PER$$US-ROCHE-10000075562$ROCHE$$34$YR$A$M$Y$97.52$KG$20240913$$CN$US$US
243149171$24314917$1$I$20230420$20240909$20240913$20240913$EXP$$KR-ROCHE-10000076694$ROCHE$$65$YR$E$F$Y$53.3$KG$20240913$$HP$KR$KR
243149181$24314918$1$I$20240802$20240820$20240913$20240913$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000819$PAREXEL$$$$$$Y$$$20240913$$PH$US$US
243149201$24314920$1$I$20240803$20240820$20240913$20240913$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000821$PAREXEL$$$$$$Y$$$20240913$$PH$US$US
243149211$24314921$1$I$$20240905$20240913$20240913$PER$$US-CHATTEMPRD-2024OHG031413$CHATTEM$$$$A$$Y$$$20240913$$CN$US$US
243149221$24314922$1$I$$20240909$20240913$20240913$PER$$US-CHATTEMPRD-2024OHG031401$CHATTEM$$$$A$F$Y$$$20240913$$CN$US$US
243149231$24314923$1$I$20231001$20240903$20240913$20240913$EXP$$DE-AUROBINDO-AUR-APL-2024-044369$AUROBINDO$$54$YR$$F$Y$52$KG$20240913$$MD$DE$DE
243149241$24314924$1$I$$20240903$20240913$20240913$EXP$$CA-CELLTRION INC.-2024CA021250$CELLTRION$$$$$$Y$$$20240913$$MD$CA$CA
243149251$24314925$1$I$20240101$20240904$20240913$20240913$EXP$$CN-JNJFOC-20240913511$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240913$$MD$CN$CN
243149261$24314926$1$I$20240729$20240906$20240913$20240913$EXP$$JP-ROCHE-10000059890$ROCHE$$8$DEC$E$M$Y$$$20240913$$MD$JP$JP
243149271$24314927$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044537$AUROBINDO$Kinney RE, Nair S, Kim CH, Thomas MB, Delatorre M. Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer. Oncologist. 2023;28(6):E478-E486$55$YR$$F$Y$$$20240913$$HP$US$US
243149281$24314928$1$I$$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004941$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243149292$24314929$2$F$$20240906$20240913$20240917$PER$$US-CHATTEMPRD-2024OHG031352$CHATTEM$$$$$$Y$$$20240917$$CN$US$US
243149301$24314930$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044214$AUROBINDO$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience.. Blood Cancer Journal. 2023;13:91$$$$M$Y$$$20240913$$HP$US$US
243149311$24314931$1$I$20230101$20240903$20240913$20240913$EXP$$BR-UCBSA-2024045783$UCB$$$$$M$Y$$$20240913$$CN$BR$BR
243149321$24314932$1$I$20240519$20240906$20240913$20240913$EXP$$US-ABBVIE-5913639$ABBVIE$$0$YR$$M$Y$$$20240913$$HP$US$US
243149332$24314933$2$F$$20240905$20240913$20240913$PER$$US-ROCHE-10000078059$ROCHE$Fatmi SS, Kaur P, Bader F, Tangco E, Aliabadi D. A rare case of persistent ST-elevation  myocardial infarction post-tissue plasminogen  activator with white clot extraction in a middle aged woman on medroxyprogesterone acetate. Cureus. 2022 Jul 07;14:7: e26628. doi:10.7759/cureus.26628.$41$YR$A$F$Y$$$20240913$$HP$US$US
243149341$24314934$1$I$$20240828$20240913$20240913$PER$$US-CHATTEMPRD-2024OHG029971$CHATTEM$$$$$$Y$$$20240913$$CN$US$US
243149351$24314935$1$I$$20240910$20240913$20240913$PER$$US-ABBVIE-5920388$ABBVIE$$$$$$Y$$$20240913$$CN$US$US
243149361$24314936$1$I$20240101$20240912$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145863$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240913$$CN$US$US
243149372$24314937$2$F$$20240913$20240913$20240916$EXP$PL-EMA-20150318-AUTODUP-414269$PL-ROCHE-10000074282$ROCHE$Kaminska D, Koscielska-Kasprzak K, Myszka M, Banasik M, Chelmonski A, Boratynska M. Significant Infections after Hand Transplantation in a Polish Population. Transplantation proceedings. 2014;46:2887-9.$$$A$M$Y$$$20240916$$HP$PL$PL
243149381$24314938$1$I$20240805$20240910$20240913$20240913$EXP$FR-AFSSAPS-LY2024001382$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-144742$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$75$KG$20240913$$PH$FR$FR
243149391$24314939$1$I$$20240911$20240913$20240913$EXP$$BG-BRISTOL-MYERS SQUIBB COMPANY-2024-145361$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$96.8$KG$20240913$$HP$BG$BG
243149401$24314940$1$I$20240814$20240819$20240913$20240913$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000824$PAREXEL$$$$$$Y$$$20240913$$PH$US$US
243149411$24314941$1$I$20220101$20240909$20240913$20240913$EXP$$AR-JNJFOC-20240818075$JOHNSON AND JOHNSON$$55$YR$A$F$Y$68$KG$20240913$$CN$AR$AR
243149421$24314942$1$I$20240712$20240829$20240913$20240913$EXP$FR-AFSSAPS-BX2024001617$FR-Axellia-005349$XELLIA PHARMACEUTICALS$$77$YR$E$M$Y$$$20240912$$PH$FR$FR
243149441$24314944$1$I$$20240906$20240913$20240913$PER$$US-CHATTEMPRD-2024OHG031462$CHATTEM$$$$$$Y$$$20240913$$CN$US$US
243149451$24314945$1$I$$20240904$20240913$20240913$EXP$$US-EMD Serono-2024034820$EMD SERONO INC$$$$A$F$Y$$$20240913$$CN$US$US
243149461$24314946$1$I$$20240910$20240913$20240913$EXP$$NG-ROCHE-10000078011$ROCHE$$$$A$F$Y$$$20240913$$MD$NG$NG
243149471$24314947$1$I$20240910$20240911$20240913$20240913$EXP$$CN-REGENERON PHARMACEUTICALS, INC.-2024-122063$REGENERON$$82$YR$$M$Y$$$20240913$$MD$CN$CN
243149482$24314948$2$F$20240101$20240910$20240913$20240918$EXP$$CA-CELLTRION INC.-2024CA013350$CELLTRION$$$$$$Y$$$20240918$$CN$CA$CA
243149502$24314950$2$F$$20240920$20240913$20240930$PER$$US-BIOGEN-2024BI01281676$BIOGEN$$$$$M$Y$$$20240929$$PH$US$US
243149511$24314951$1$I$$20240903$20240913$20240913$EXP$$US-Accord-445911$ACCORD$$$$$M$Y$$$20240913$$HP$US$US
243149522$24314952$2$F$20240907$20240917$20240913$20240919$30DAY$$IT-SANDOZ INC.-SDZ2024IT079589$SANDOZ$$12$YR$$M$Y$40$KG$20240919$$CN$IT$IT
243149532$24314953$2$F$$20240911$20240913$20240920$EXP$$PT-AUROBINDO-AUR-APL-2024-044562$AUROBINDO$Coimbra M, De Sousa AS, Semedo E. S?ndrome de Horner e Simpatectomia do Membro  Superior Ipsilateral ap?s Bloqueio Epidural Lombar (Horner^s Syndrome and Ipsilateral Upper Limb Sympathectomy After Lumbar Epidural Block). REVISTA DA SOCIEDADE PORTUGUESA DE ANESTESIOLOGIA. 2024;33 (1):43$29$YR$$F$Y$$$20240920$$MD$PT$PT
243149541$24314954$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145368$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$85.28$KG$20240913$$PH$US$US
243149551$24314955$1$I$20240818$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004959$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240913$$CN$US$US
243149571$24314957$1$I$$20240910$20240913$20240913$EXP$$DE-ABBVIE-5916549$ABBVIE$$$$$M$Y$$$20240913$$MD$DE$DE
243149581$24314958$1$I$20230101$20240909$20240913$20240913$EXP$$US-ABBVIE-5917342$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243149592$24314959$2$F$20240802$20240910$20240913$20240918$PER$$US-AMGEN-USASP2024180756$AMGEN$$76$YR$E$F$Y$$$20240918$$CN$US$US
243149611$24314961$1$I$20240101$20240905$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409003539$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240913$$CN$US$US
243149621$24314962$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007289$ELI LILLY AND CO$$$$A$F$Y$$$20240913$$CN$US$US
243149631$24314963$1$I$$20240906$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409004909$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240913$$CN$US$US
243149641$24314964$1$I$$20240904$20240913$20240913$EXP$$PL-009507513-2409POL001556$MERCK$Maciag, E. Immune checkpoint inhibitors in clinical practice - case report of a patient with squamous cell lung cancer with PD-L1 expression less than 1% treated with pembrolizumab in combination with chemotherapy. ONKOLOGIA W PRAKTYCE KLINICZNEJ - EDUKACJA. 2024;10(Supl. C):C15-8$68$YR$$M$Y$$$20240913$$MD$PL$PL
243149651$24314965$1$I$20230101$20240903$20240913$20240913$EXP$$DE-ALK-ABELLO A/S-2024AA003407$ALK-ABELLO$$$$$$Y$$$20240913$$MD$DE$DE
243149661$24314966$1$I$$20240910$20240913$20240913$30DAY$$IT-SANDOZ INC.-SDZ2024IT079331$SANDOZ$$$$$F$Y$$$20240913$$CN$IT$IT
243149671$24314967$1$I$$20240905$20240913$20240913$EXP$$US-TAKEDA-2024TUS076362$TAKEDA$$$$$M$Y$$$20240913$$MD$US$US
243149681$24314968$1$I$$20240905$20240913$20240913$EXP$$US-BEIGENE-BGN-2024-014167$BEIGENE$$$$$$Y$$$20240913$$CN$US$US
243149691$24314969$1$I$20240826$20240902$20240913$20240913$EXP$CN-HENLIUS-24CN016898$CN-Accord-445480$ACCORD$$42$YR$A$F$Y$60$KG$20240913$$MD$CN$CN
243149702$24314970$2$F$$20240920$20240913$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139503$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240923$$MD$US$US
243149711$24314971$1$I$$20240912$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145738$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240913$$CN$US$US
243149721$24314972$1$I$20240815$20240820$20240913$20240913$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000852$PAREXEL$$$$$$Y$$$20240913$$HP$US$US
243149741$24314974$1$I$20240320$20240910$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145549$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240913$$HP$US$US
243149751$24314975$1$I$$20240903$20240913$20240913$EXP$$US-Accord-445791$ACCORD$$$$$M$Y$88$KG$20240913$$CN$US$US
243149761$24314976$1$I$$20240903$20240913$20240913$30DAY$$US-GSK-US2024109455$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243149771$24314977$1$I$$20240909$20240913$20240913$EXP$$JP-SA-2024SA261197$SANOFI AVENTIS$$$$A$$Y$$$20240913$$PH$JP$JP
243149781$24314978$1$I$$20240910$20240913$20240913$EXP$$IN-ROCHE-10000079416$ROCHE$$69$YR$E$M$Y$$$20240913$$CN$IN$IN
243149801$24314980$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004953$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243149811$24314981$1$I$20240801$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004914$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240913$$CN$US$US
243149821$24314982$1$I$$20240905$20240913$20240913$EXP$$CA-AMGEN-CANSP2024178108$AMGEN$$68$YR$E$F$Y$$$20240913$$CN$CA$CA
243149831$24314983$1$I$20240610$20240905$20240913$20240913$EXP$$US-AMGEN-USASP2024178121$AMGEN$$71$YR$E$M$Y$$$20240913$$CN$US$US
243149841$24314984$1$I$20240828$20240904$20240913$20240913$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001797$BLUEPRINT MEDICINES$$27$YR$A$F$Y$$$20240913$$CN$US$US
243149851$24314985$1$I$20240902$20240911$20240913$20240913$EXP$$US-ALXN-202409USA000865US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$HP$US$US
243149861$24314986$1$I$$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004967$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243149881$24314988$1$I$$20240906$20240913$20240913$EXP$$US-CHEPLA-2024011549$CHEPLAPHARM$$50$YR$$M$Y$84$KG$20240913$$MD$COUNTRY NOT SPECIFIED$US
243149891$24314989$1$I$$20240910$20240913$20240913$PER$$US-ABBVIE-5920225$ABBVIE$$$$$$Y$$$20240913$$HP$US$US
243149901$24314990$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004969$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243149911$24314991$1$I$20240828$20240902$20240913$20240913$EXP$$JP-ROCHE-10000074535$ROCHE$$$$E$$Y$$$20240913$$PH$JP$JP
243149922$24314992$2$F$$20240914$20240913$20240924$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004970$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
243149932$24314993$2$F$$20240924$20240913$20240930$EXP$$IT-AUROBINDO-AUR-APL-2024-044061$AUROBINDO$Garri F, Puthenparampil M, Simonato D, Rinaldi F, Gallo P. A rare case of Listeria rhombencephalitis with a sudden onset and unusual brain MRI features. Neurol-Sci. 2024;45:353-355$66$YR$$F$Y$$$20240930$$MD$IT$IT
243149941$24314994$1$I$$20240905$20240913$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-144985$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240913$$MD$JP$JP
243149951$24314995$1$I$$20240910$20240913$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-144398$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240913$$MD$JP$JP
243149961$24314996$1$I$$20240905$20240913$20240913$PER$$US-ABBVIE-5919582$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243149971$24314997$1$I$20240312$20240903$20240913$20240913$EXP$$DE-AUROBINDO-AUR-APL-2024-044281$AUROBINDO$$$$E$F$Y$71$KG$20240913$$HP$DE$DE
243149981$24314998$1$I$$20240902$20240913$20240913$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2024US001280$JUBILANT$Zachian RL, Sidhu BV, Liu P, Weimann R. Acute generalised exanthematous pustulosis and herpes simplex virus: a case of possible overlap. BMJ case Rep. 2024;17(8):e260873$$$A$F$Y$$$20240913$$MD$US$US
243149992$24314999$2$F$$20240917$20240913$20240924$EXP$$US-JNJFOC-20240928387$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243150001$24315000$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004961$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243150011$24315001$1$I$$20240905$20240913$20240913$PER$$US-BAUSCH-BL-2024-013339$BAUSCH AND LOMB$$$$$F$Y$$$20240913$$MD$US$US
243150022$24315002$2$F$20240201$20240910$20240913$20240921$EXP$$RO-Accord-445257$ACCORD$Rahnea-Nita RA, Toma RV, Grigorean VT, Coman IS, Coman VE, Plesea IE et al. Reinitiating Chemotherapy beyond Progression after Maintenance Immunotherapy in Extensive-Stage Small-Cell Lung Cancer. Medicina (Kaunas). 2024 Jul 28;60(8):1225.$51$YR$A$M$Y$$$20240921$$HP$RO$RO
243150031$24315003$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004963$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243150041$24315004$1$I$$20240906$20240913$20240913$EXP$$CN-BAUSCH-BL-2024-013368$BAUSCH AND LOMB$Feng M, Ji Q, Liu D, Xu W. Two cases of Leukemoid reaction in premature infants caused by fetal inflammatory response syndrome.. BMC Pediatrics. 2024 AUG 24;24:546:1-4. doi:10.1186/s12887-024-05006-4$$$N$F$Y$$$20240913$$HP$CN$CN
243150051$24315005$1$I$$20240906$20240913$20240913$EXP$$CN-BAUSCH-BL-2024-013365$BAUSCH AND LOMB$Feng M, Ji Q, Liu D, Xu W. Two cases of Leukemoid reaction in premature infants caused by fetal inflammatory response syndrome. BMC Pediatrics. 2024 AUG 24;24:546:1-4. doi:10.1186/s12887-024-05006-4$$$N$F$Y$$$20240913$$HP$CN$CN
243150061$24315006$1$I$20220101$20240908$20240913$20240913$EXP$$CA-BAUSCH-BL-2022-016228$BAUSCH AND LOMB$$59$YR$$M$Y$$$20240913$$CN$CA$CA
243150071$24315007$1$I$$20240912$20240913$20240913$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051270$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240913$$MD$US$US
243150081$24315008$1$I$$20240912$20240913$20240913$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051254$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240913$$MD$US$US
243150091$24315009$1$I$$20240902$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013144$DR REDDYS$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham III CO, Wigleya FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Seminars in Arthritis and Rheumatism. 2024;67: doi:10.1016/j.semarthrit.2024.152460.$60$YR$A$F$Y$$$20240913$$HP$US$US
243150101$24315010$1$I$20230322$20240906$20240913$20240913$EXP$$CN-CHEPLA-2024011596$CHEPLAPHARM$Cui P, Chen C, Li X, Chen J. Nivolumab induced severe chorea-like dyskinesia in a man with primary non-small cell lung cancer: one case report[J]. Chin J Hosp Pharm. 2024;(15):1839-1842.$66$YR$$F$Y$55$KG$20240913$$HP$COUNTRY NOT SPECIFIED$CN
243150111$24315011$1$I$$20240906$20240913$20240913$EXP$$US-AMGEN-USASP2024179022$AMGEN$$$$A$M$Y$$$20240913$$CN$US$US
243150121$24315012$1$I$$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181165$AMGEN$$$$$$Y$$$20240913$$PH$US$US
243150131$24315013$1$I$20240821$20240822$20240913$20240913$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000864$PAREXEL$$$$$$Y$$$20240913$$PH$US$US
243150141$24315014$1$I$20221005$20240904$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044635$AUROBINDO$$84$YR$$M$Y$82$KG$20240913$$MD$FR$FR
243150151$24315015$1$I$$20240907$20240913$20240913$EXP$$FR-BAUSCH-BL-2024-013376$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240913$$HP$FR$FR
243150171$24315017$1$I$20240801$20240910$20240913$20240913$EXP$$IL-UCBSA-2024043753$UCB$$8$YR$$M$Y$$$20240913$$MD$IL$IL
243150181$24315018$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465192$RANBAXY$$$$A$F$Y$$$20240913$$MD$US$US
243150191$24315019$1$I$$20240904$20240913$20240913$PER$$US-ABBVIE-5907450$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243150201$24315020$1$I$$20240910$20240913$20240913$PER$$US-ALXN-202409USA000775US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243150211$24315021$1$I$$20240829$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024113073$VIIV$$$$$M$Y$$$20240913$$HP$US$US
243150221$24315022$1$I$20240424$20240905$20240913$20240913$EXP$$US-ABBVIE-5797304$ABBVIE$$53$YR$$F$Y$$$20240913$$CN$US$US
243150231$24315023$1$I$20240824$20240910$20240913$20240913$EXP$$US-TAKEDA-2024TUS086624$TAKEDA$$69$YR$$F$Y$$$20240913$$MD$US$US
243150241$24315024$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007339$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240913$$CN$US$US
243150251$24315025$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409006974$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240913$$CN$US$US
243150261$24315026$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007290$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240913$$CN$US$US
243150271$24315027$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202408016147$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$US$US
243150281$24315028$1$I$$20240909$20240913$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014667$JAZZ$$$$$M$Y$$$20240913$$CN$US$US
243150302$24315030$2$F$20220318$20240916$20240913$20240930$EXP$$CO-UCBSA-2023018670$UCB$$43$YR$$F$Y$84$KG$20240930$$CN$CO$CO
243150311$24315031$1$I$$20240909$20240913$20240913$EXP$$EG-ROCHE-10000078328$ROCHE$$$$$F$Y$$$20240913$$MD$EG$EG
243150321$24315032$1$I$20240815$20240820$20240913$20240913$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000863$PAREXEL$$$$$$Y$$$20240913$$PH$US$US
243150331$24315033$1$I$20240831$20240906$20240913$20240913$EXP$$CA-JNJFOC-20240924926$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20240913$$HP$CA$CA
243150341$24315034$1$I$20240801$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004966$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240913$$CN$US$US
243150351$24315035$1$I$$20240829$20240913$20240913$PER$$US-ASTELLAS-2024-AER-004126$ASTELLAS$$$$$F$Y$$$20240913$$HP$US$US
243150361$24315036$1$I$$20240906$20240913$20240913$EXP$$JP-ASTELLAS-2024-AER-005175$ASTELLAS$$8$YR$C$$Y$$$20240913$$PH$JP$JP
243150371$24315037$1$I$20240731$20240909$20240913$20240913$EXP$$US-ABBVIE-5916357$ABBVIE$$71$YR$$F$Y$$$20240913$$CN$US$US
243150381$24315038$1$I$20240909$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024180375$AMGEN$$80$YR$E$F$Y$$$20240913$$CN$US$US
243150391$24315039$1$I$$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024182548$AMGEN$$$$$M$Y$$$20240913$$CN$US$US
243150401$24315040$1$I$20240830$20240903$20240913$20240913$30DAY$$US-GSK-US2024110228$GLAXOSMITHKLINE$$51$YR$$F$Y$$$20240913$$CN$US$US
243150411$24315041$1$I$20240601$20240909$20240913$20240913$EXP$$US-ABBVIE-5916899$ABBVIE$$69$YR$$F$Y$$$20240913$$CN$US$US
243150421$24315042$1$I$20240822$20240909$20240913$20240913$EXP$$DE-AstraZeneca-2024A204209$ASTRAZENECA$$$$E$F$Y$$$20240913$$MD$DE$
243150431$24315043$1$I$$20240909$20240913$20240913$EXP$$US-ABBVIE-5917243$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243150441$24315044$1$I$$20240905$20240913$20240913$EXP$$JP-ROCHE-10000077474$ROCHE$$$$E$M$Y$$$20240913$$MD$JP$JP
243150452$24315045$2$F$20240715$20240912$20240913$20240915$EXP$IT-MINISAL02-1001226$IT-ROCHE-10000078240$ROCHE$$62$YR$A$F$Y$$$20240915$$MD$IT$IT
243150461$24315046$1$I$$20240909$20240913$20240913$EXP$$US-ABBVIE-5917149$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243150481$24315048$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5916983$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243150491$24315049$1$I$$20240904$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013253$DR REDDYS$Darnell H, Brenner A, Kern C, Flomenhoft D, Lee E. Sevelamer-Induced Ischemic Enteritis. ACG Case Reports Journal. 2024;11: 7. doi:10.14309/crj.0000000000001451.$35$YR$A$M$Y$$$20240913$$MD$US$US
243150501$24315050$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145206$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240913$$CN$US$US
243150511$24315051$1$I$20240601$20240906$20240913$20240913$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049974$BOEHRINGER INGELHEIM$$58$YR$A$F$Y$$$20240913$$MD$DE$DE
243150531$24315053$1$I$$20240910$20240913$20240913$EXP$$NVSC2024CA182814$NOVARTIS$$65$YR$$F$Y$76$KG$20240913$$HP$CA$CA
243150541$24315054$1$I$20240711$20240820$20240913$20240913$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000855$PAREXEL$$$$$$Y$$$20240913$$HP$US$US
243150551$24315055$1$I$$20240911$20240913$20240913$PER$$US-ALXN-202409USA000776US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240913$$CN$US$US
243150561$24315056$1$I$$20240826$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08568$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243150572$24315057$2$F$20200101$20240910$20240913$20240916$EXP$$US-SANDOZ INC.-SDZ2024US079070$SANDOZ$$$$$F$Y$48.53$KG$20240916$$CN$US$US
243150581$24315058$1$I$20231228$20240909$20240913$20240913$EXP$$IE-ROCHE-RCA5206431$ROCHE$$75$YR$E$M$Y$$$20240913$$MD$IE$IE
243150591$24315059$1$I$$20240911$20240913$20240913$PER$$US-ALXN-202409USA000813US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243150601$24315060$1$I$$20240906$20240913$20240913$EXP$$KR-EMD Serono-2024048061$EMD SERONO INC$$$$A$F$Y$$$20240913$$CN$KR$KR
243150611$24315061$1$I$$20240905$20240913$20240913$EXP$$GB-AUROBINDO-AUR-APL-2024-044542$AUROBINDO$$$$$$Y$65$KG$20240913$$CN$GB$GB
243150621$24315062$1$I$20240801$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182374$AMGEN$$$$$M$Y$$$20240913$$CN$US$US
243150631$24315063$1$I$20240101$20240906$20240913$20240913$PER$$US-UNITED THERAPEUTICS-UNT-2024-028159$UNITED THERAPEUTICS$$$$$F$Y$51.247$KG$20240913$$$US$US
243150641$24315064$1$I$20240728$20240904$20240913$20240913$EXP$$CN-ROCHE-10000074446$ROCHE$$57$YR$A$F$Y$65$KG$20240913$$HP$CN$CN
243150651$24315065$1$I$$20240710$20240913$20240913$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001858$BLUEPRINT MEDICINES$$$$$F$Y$$$20240913$$HP$US$US
243150661$24315066$1$I$20240830$20240906$20240913$20240913$EXP$$US-TAKEDA-2024TUS089853$TAKEDA$$10$YR$$M$Y$$$20240913$$MD$US$US
243150703$24315070$3$F$20240101$20240918$20240913$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-028138$UNITED THERAPEUTICS$$$$$M$Y$93.878$KG$20240927$$$US$US
243150711$24315071$1$I$20240904$20240910$20240913$20240913$30DAY$$US-AMGEN-USASP2024181303$AMGEN$$44$YR$A$F$Y$149.66$KG$20240913$$HP$US$US
243150721$24315072$1$I$$20240906$20240913$20240913$EXP$$US-EMD Serono-2024048738$EMD SERONO INC$$40$YR$A$M$Y$$$20240913$$CN$US$US
243150731$24315073$1$I$$20240905$20240913$20240913$PER$$US-AMGEN-USASP2024178495$AMGEN$Matti M.; Sullivan B.; Cho gene. et.al.. Probable idiopathic hypereosinophilic syndrome: A case report of severe multi-organ eosinophilic involvement in a young male presenting with heart failure. SAGE Open Medical Case Reports. 2024;12:1-7$37$YR$A$M$Y$$$20240913$$HP$US$US
243150751$24315075$1$I$20240910$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145545$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240913$$CN$US$US
243150761$24315076$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145577$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240913$$CN$US$US
243150771$24315077$1$I$$20240905$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142275$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240913$$HP$US$US
243150781$24315078$1$I$$20240905$20240913$20240913$EXP$$IN-ROCHE-10000076002$ROCHE$$49$YR$A$F$Y$$$20240913$$CN$IN$IN
243150792$24315079$2$F$20240904$20240916$20240913$20240923$PER$$US-JNJFOC-20240926868$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240923$$MD$US$US
243150801$24315080$1$I$$20240903$20240913$20240913$EXP$$CA-CELLTRION INC.-2024CA021253$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
243150811$24315081$1$I$$20240902$20240913$20240913$EXP$$US-JNJFOC-20240906449$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$HP$US$US
243150822$24315082$2$F$20240101$20240904$20240913$20240913$PER$$US-ROCHE-10000074283$ROCHE$$18$YR$A$M$Y$$$20240913$$CN$US$US
243150831$24315083$1$I$$20240906$20240913$20240913$EXP$$AR-SANDOZ INC.-SDZ2024AR079921$SANDOZ$$$$$F$Y$$$20240913$$MD$AR$AR
243150841$24315084$1$I$$20240905$20240913$20240913$EXP$$US-AstraZeneca-2024A203274$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243150851$24315085$1$I$$20240827$20240913$20240913$PER$$US-009507513-2409USA000731$MERCK$Shannon Adrienne B., Mehta Rutika, Mok Shaffer R., Lauwers Gregory Y., Baldonado Jobelle J. A. R., Fontaine Jacques, Pimiento Jose M., Sinnamon Andrew J.,. Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers. Annals of Surgical Oncology. 2024;1-11$70$YR$$F$Y$$$20240913$$MD$US$US
243150861$24315086$1$I$20240901$20240904$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR110874$VIIV$$25$YR$$M$Y$$$20240913$$CN$US$US
243150871$24315087$1$I$20240911$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007690$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240913$$CN$US$US
243150881$24315088$1$I$20240911$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007474$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240913$$CN$US$US
243150901$24315090$1$I$20240801$20240906$20240913$20240913$EXP$$US-ABBVIE-5914201$ABBVIE$$58$YR$$M$Y$$$20240913$$CN$US$US
243150911$24315091$1$I$$20240906$20240913$20240913$EXP$$US-CHEPLA-2024011548$CHEPLAPHARM$$53$YR$$M$Y$$$20240913$$MD$COUNTRY NOT SPECIFIED$US
243150921$24315092$1$I$20240901$20240910$20240913$20240913$PER$$US-ALXN-202409USA000747US$ALEXION PHARMACEUTICALS$$62$YR$$F$Y$$$20240913$$CN$US$US
243150931$24315093$1$I$$20240911$20240913$20240913$PER$$US-ALXN-202409USA000790US$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240913$$CN$US$US
243150941$24315094$1$I$20240101$20240909$20240913$20240913$EXP$$CA-ABBVIE-5916723$ABBVIE$$57$YR$$F$Y$$$20240913$$CN$CA$CA
243150951$24315095$1$I$$20240909$20240913$20240913$EXP$$JP-ASTELLAS-2024-AER-005686$ASTELLAS$$$$$M$Y$$$20240913$$MD$JP$JP
243150961$24315096$1$I$20240906$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181169$AMGEN$$$$$$Y$$$20240913$$PH$US$US
243150971$24315097$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024181905$AMGEN$$$$$F$Y$$$20240913$$CN$US$US
243150981$24315098$1$I$$20240909$20240913$20240913$EXP$$GB-EMD Serono-2024048708$EMD SERONO INC$$$$E$F$Y$$$20240913$$CN$GB$GB
243150991$24315099$1$I$$20240910$20240913$20240913$PER$$US-GILEAD-2024-0687233$GILEAD$$$$$M$Y$$$20240913$$HP$US$US
243151001$24315100$1$I$$20240903$20240913$20240913$PER$$US-APOTEX-2024AP010268$APOTEX$$$$$F$Y$$$20240913$$CN$US$US
243151011$24315101$1$I$20240826$20240826$20240913$20240913$PER$$CA-TOLMAR, INC.-24CA052175$TOLMAR$$68$YR$$M$Y$$$20240913$$CN$CA$CA
243151021$24315102$1$I$$20240826$20240913$20240913$PER$$DO-TOLMAR, INC.-24DO052240$TOLMAR$$$$$M$Y$$$20240913$$CN$DO$DO
243151031$24315103$1$I$$20240826$20240913$20240913$PER$$CA-TOLMAR, INC.-24CA052189$TOLMAR$$$$$M$Y$$$20240913$$CN$CA$CA
243151041$24315104$1$I$20240725$20240826$20240913$20240913$PER$$FR-TOLMAR, INC.-24FR051789$TOLMAR$$75$YR$$M$Y$$$20240913$$PH$FR$FR
243151051$24315105$1$I$20240425$20240826$20240913$20240913$PER$$NL-TOLMAR, INC.-24NL052144$TOLMAR$$71$YR$$M$Y$$$20240913$$CN$NL$NL
243151071$24315107$1$I$20240826$20240826$20240913$20240913$PER$$US-TOLMAR, INC.-24US052160$TOLMAR$$74$YR$$M$Y$$$20240913$$HP$US$US
243151081$24315108$1$I$20240814$20240826$20240913$20240913$PER$$US-TOLMAR, INC.-24US052168$TOLMAR$$70$YR$$M$Y$$$20240913$$HP$US$US
243151091$24315109$1$I$20240705$20240826$20240913$20240913$PER$$US-TOLMAR, INC.-24US052197$TOLMAR$$$$$M$Y$$$20240913$$HP$US$US
243151101$24315110$1$I$20230101$20240826$20240913$20240913$PER$$US-TOLMAR, INC.-24US052242$TOLMAR$$66$YR$$M$Y$70.295$KG$20240913$$CN$US$US
243151111$24315111$1$I$$20240829$20240913$20240913$PER$$US-TEVA-VS-3239064$TEVA$$38$YR$$F$Y$$$20240913$$PH$US$US
243151121$24315112$1$I$$20240905$20240913$20240913$EXP$$CN-DECIPHERA PHARMACEUTICALS LLC-2024CN000790$DECIPHERA PHARMACEUTICALS$$65$YR$A$M$Y$60$KG$20240913$$CN$CN$CN
243151132$24315113$2$F$20240809$20240916$20240913$20240918$EXP$$US-ABBVIE-5916823$ABBVIE$$58$YR$$F$Y$$$20240918$$CN$US$US
243151141$24315114$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5917934$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243151151$24315115$1$I$20240809$20240904$20240913$20240913$EXP$ES-AEMPS-1565578$ES-JNJFOC-20240910161$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240913$$MD$ES$ES
243151172$24315117$2$F$$20240917$20240913$20240924$EXP$$AU-ROCHE-10000078601$ROCHE$$$$A$F$Y$$$20240924$$CN$AU$AU
243151191$24315119$1$I$20240129$20240902$20240913$20240913$EXP$FR-AFSSAPS-TO2024001644$FR-Accord-445102$ACCORD$$74$YR$E$F$Y$$$20240913$$PH$FR$FR
243151201$24315120$1$I$$20240830$20240913$20240913$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08204$HIKMA$$30$YR$$F$Y$$$20240913$$MD$US$US
243151212$24315121$2$F$$20240919$20240913$20240926$EXP$$US-BEH-2024178317$CSL BEHRING$$61$YR$A$M$Y$115.8$KG$20240926$$CN$US$US
243151221$24315122$1$I$$20240905$20240913$20240913$EXP$$AU-TOLMAR, INC.-24AU052402$TOLMAR$$$$$M$Y$$$20240913$$CN$AU$AU
243151231$24315123$1$I$20240801$20240905$20240913$20240913$EXP$$CA-TOLMAR, INC.-24CA051958$TOLMAR$$88$YR$$M$Y$$$20240913$$CN$CA$CA
243151251$24315125$1$I$$20240904$20240913$20240913$PER$$US-UNITED THERAPEUTICS-UNT-2024-006982$UNITED THERAPEUTICS$$$$$F$Y$55.329$KG$20240913$$MD$US$US
243151261$24315126$1$I$$20240907$20240913$20240913$EXP$$IT-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00470$VELOXIS PHARMACEUTICALS$Corcione S, Vita D.. Maribavir treatment for resistant cytomegalovirus disseminated disease in kidney transplant recipients: A case-based scoping review of real life data in literature. Transplantation reviews. 2024;38(4):1-8$54$YR$$F$Y$$$20240913$$HP$IT$IT
243151271$24315127$1$I$$20240904$20240913$20240913$EXP$$AU-ROCHE-10000074470$ROCHE$$$$A$M$Y$$$20240913$$MD$AU$AU
243151281$24315128$1$I$$20240906$20240913$20240913$PER$$US-ABBVIE-5916263$ABBVIE$$$$$$Y$$$20240913$$CN$US$US
243151291$24315129$1$I$20240818$20240820$20240913$20240913$EXP$$US-SA-2024SA264072$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240913$$CN$US$US
243151302$24315130$2$F$$20240913$20240913$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-022213$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240921$$$US$US
243151331$24315133$1$I$20220101$20240910$20240913$20240913$EXP$$DK-Orion Corporation ORION PHARMA-24_00031630$ORION$Petersen C, David M. Atypical fractures of the lower extremities in two patients with rheumatoid arthritis: clinical presentations of presumed methotrexate osteopathy. BMJ case reports. 2024;17(8):.$8$DEC$E$M$Y$$$20240913$$MD$DK$
243151341$24315134$1$I$20160101$20240910$20240913$20240913$EXP$$DK-Orion Corporation ORION PHARMA-24_00031650$ORION$Petersen C, David M. Atypical fractures of the lower extremities in two patients with rheumatoid arthritis: clinical presentations of presumed methotrexate osteopathy. BMJ case reports. 2024;17(8):E256567.$$$E$F$Y$$$20240913$$MD$DK$
243151351$24315135$1$I$$20240909$20240913$20240913$EXP$$DE-CHEPLA-9000024356$CHEPLAPHARM$Cicinnati V, Kabar I, Wolters H, Anthoni C, Schmidt H, Beckebaum S et.al. Small bowel transplantation complicated by cytomegalovirus tissue invasive disease without viremia. J. Clin. Virol.. 2014;60:177-180.$52$YR$$F$Y$$$20240913$$MD$COUNTRY NOT SPECIFIED$DE
243151362$24315136$2$F$20240101$20240920$20240913$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-024738$UNITED THERAPEUTICS$$$$$F$Y$71.202$KG$20240927$$$US$US
243151371$24315137$1$I$$20240906$20240913$20240913$EXP$$US-CHATTEMPRD-2024OHG031288$CHATTEM$$$$$M$Y$$$20240913$$LW$US$US
243151381$24315138$1$I$$20240903$20240913$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027809$UNITED THERAPEUTICS$$$$$F$Y$109.75$KG$20240913$$$US$US
243151391$24315139$1$I$$20240827$20240913$20240913$PER$$US-009507513-2409USA000732$MERCK$Shannon Adrienne B., Mehta Rutika, Mok Shaffer R., Lauwers Gregory Y., Baldonado Jobelle J. A. R., Fontaine Jacques, Pimiento Jose M., Sinnamon Andrew J.,. Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers. Annals of Surgical Oncology. 2024;1-11$71$YR$$M$Y$$$20240913$$MD$US$US
243151401$24315140$1$I$$20240816$20240913$20240913$PER$$US-009507513-2408USA006444$MERCK$$$$$F$Y$$$20240913$$CN$US$US
243151421$24315142$1$I$$20240908$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142993$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$81.19$KG$20240913$$CN$US$US
243151431$24315143$1$I$$20240820$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145660$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$99.79$KG$20240913$$CN$US$US
243151442$24315144$2$F$20240101$20240911$20240913$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-027832$UNITED THERAPEUTICS$$$$$M$Y$57.143$KG$20240917$$$US$US
243151451$24315145$1$I$$20240909$20240913$20240913$PER$$US-ROCHE-10000079444$ROCHE$Song D, Ginsberg C, Nudleman E, Borooah S, King A, Bousquet E, et al. Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis. American Journal of Ophthalmology Case Reports. 2024;36:1-4. doi:10.1016/j.ajoc.2024.102153.$32$YR$A$F$Y$$$20240913$$HP$US$US
243151461$24315146$1$I$20240301$20240909$20240913$20240913$EXP$$US-ABBVIE-5917556$ABBVIE$$31$YR$$M$Y$92.986$KG$20240913$$CN$US$US
243151471$24315147$1$I$20220101$20240901$20240913$20240913$EXP$$CN-Accord-445475$ACCORD$Ma YY, He XC, Gao Y, Ma TT, Cheng G, Yue CW. Treatment of nasopharyngeal carcinoma and prevention of non-alcoholic Wernicke^s disease: A case report and review of literature. World J Clin Cases. 2024 Aug 26;12(24):5628-5635.$33$YR$A$M$Y$96$KG$20240913$$HP$CN$CN
243151481$24315148$1$I$20240725$20240827$20240913$20240913$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000881$PAREXEL$$$$$$Y$$$20240913$$HP$US$US
243151491$24315149$1$I$20240901$20240909$20240913$20240913$EXP$$UY-AMGEN-URYSP2024181704$AMGEN$$69$YR$E$F$Y$$$20240913$$CN$UY$UY
243151501$24315150$1$I$20240101$20240905$20240913$20240913$EXP$$US-AMGEN-USASP2024178010$AMGEN$$36$YR$A$F$Y$$$20240913$$CN$US$US
243151523$24315152$3$F$$20240918$20240913$20240927$EXP$$EC-ROCHE-10000076150$ROCHE$$$$$$Y$$$20240927$$CN$EC$EC
243151531$24315153$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5917518$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243151541$24315154$1$I$$20240906$20240913$20240913$EXP$$US-CHATTEMPRD-2024OHG031300$CHATTEM$$$$$M$Y$$$20240913$$LW$US$US
243151551$24315155$1$I$20240805$20240910$20240913$20240913$EXP$CZ-CZSUKL-24002527$CZ-ABBVIE-5916349$ABBVIE$$48$YR$$M$Y$90$KG$20240913$$MD$CZ$CZ
243151561$24315156$1$I$20231201$20240906$20240913$20240913$EXP$$BR-UCBSA-2024046672$UCB$$56$YR$$M$Y$84$KG$20240913$$LW$BR$BR
243151571$24315157$1$I$$20240909$20240913$20240913$PER$$US-JNJFOC-20240923912$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$US$US
243151581$24315158$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004972$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243151591$24315159$1$I$$20240911$20240913$20240913$EXP$$AR-AstraZeneca-2024A207774$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$AR$
243151601$24315160$1$I$$20240909$20240913$20240913$EXP$$US-CHATTEMPRD-2024OHG031449$CHATTEM$$$$$M$Y$$$20240913$$LW$US$US
243151611$24315161$1$I$20240901$20240904$20240913$20240913$PER$$US-BAUSCHBL-2024BNL032886$BAUSCH AND LOMB$$$$$F$Y$$$20240913$$CN$US$US
243151621$24315162$1$I$$20240904$20240913$20240913$PER$$US-BAUSCHBL-2024BNL032973$BAUSCH AND LOMB$$$$$$Y$$$20240913$$HP$US$US
243151631$24315163$1$I$$20240906$20240913$20240913$PER$$US-ABBVIE-5915842$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243151641$24315164$1$I$20240801$20240906$20240913$20240913$EXP$$US-AMGEN-USASP2024178714$AMGEN$$$$$F$Y$$$20240913$$HP$US$US
243151651$24315165$1$I$$20240903$20240913$20240913$EXP$$GB-TEVA-VS-3240067$TEVA$$72$YR$$F$Y$78$KG$20240913$$HP$GB$GB
243151661$24315166$1$I$$20240903$20240913$20240913$PER$$US-BAUSCHBL-2024BNL032884$BAUSCH AND LOMB$$$$$F$Y$$$20240913$$CN$US$US
243151671$24315167$1$I$20240911$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182061$AMGEN$$75$YR$E$M$Y$$$20240913$$CN$US$US
243151681$24315168$1$I$20240908$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024181658$AMGEN$$72$YR$E$F$Y$$$20240913$$CN$US$US
243151691$24315169$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145740$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$CN$US$US
243151701$24315170$1$I$20240814$20240909$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144851$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$91$KG$20240913$$CN$US$US
243151711$24315171$1$I$$20240906$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142659$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240913$$CN$US$US
243151721$24315172$1$I$$20240904$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013210$DR REDDYS$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B, et al. AML-713 Hematological Malignancies and Pregnancy: A Single-Institution Experience. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(1): S333-S334. doi:10.1016/S2152-2650%2824%2901240-0.$$$$F$Y$$$20240913$$MD$US$US
243151731$24315173$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004974$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243151741$24315174$1$I$$20240906$20240913$20240913$EXP$$US-CHATTEMPRD-2024OHG031220$CHATTEM$$$$$F$Y$$$20240913$$LW$US$US
243151751$24315175$1$I$$20240909$20240913$20240913$PER$$US-JNJFOC-20240920864$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$CN$US$US
243151761$24315176$1$I$20240829$20240903$20240913$20240913$EXP$$US-GSK-US2024109497$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240913$$CN$US$US
243151771$24315177$1$I$$20240906$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024111381$VIIV$$$$$F$Y$$$20240913$$HP$US$US
243151781$24315178$1$I$20240427$20240902$20240913$20240913$EXP$CN-HENLIUS-24CN016900$CN-Accord-446439$ACCORD$$41$YR$A$F$Y$58$KG$20240913$$MD$CN$CN
243151791$24315179$1$I$20240403$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004964$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240913$$CN$US$US
243151811$24315181$1$I$20240814$20240815$20240913$20240913$PER$$US-009507513-2408USA005467$MERCK$$$$$F$Y$$$20240913$$CN$US$US
243151821$24315182$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409008310$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$US$US
243151831$24315183$1$I$20240905$20240905$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409005860$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$US$US
243151841$24315184$1$I$$20240907$20240913$20240913$EXP$$DE-VELOXIS PHARMACEUTICALS, INC.-2020-VEL-00876$VELOXIS PHARMACEUTICALS$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al.. Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: Certain registry study. Transplantation. 2018;103(6):1-33$14$YR$$$Y$$$20240913$$MD$DE$DE
243151851$24315185$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007345$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240913$$CN$US$US
243151861$24315186$1$I$$20240910$20240913$20240913$EXP$$AU-ROCHE-10000078891$ROCHE$$71$YR$E$M$Y$$$20240913$$MD$AU$AU
243151871$24315187$1$I$$20240910$20240913$20240913$PER$$US-ROCHE-10000080435$ROCHE$$$$$F$Y$$$20240913$$CN$US$US
243151881$24315188$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004899$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243151901$24315190$1$I$$20240910$20240913$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145474$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240913$$MD$JP$JP
243151911$24315191$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004900$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243151921$24315192$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004977$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243151932$24315193$2$F$20240901$20240909$20240913$20240917$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028309$UNITED THERAPEUTICS$$57$YR$$M$Y$112.93$KG$20240917$$PH$US$US
243151941$24315194$1$I$$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004897$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243151951$24315195$1$I$$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004580$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243151961$24315196$1$I$20240808$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004888$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240913$$CN$US$US
243151971$24315197$1$I$20240818$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004893$ACADIA PHARMACEUTICALS$$88$YR$$M$Y$$$20240913$$CN$US$US
243151981$24315198$1$I$20230101$20240902$20240913$20240913$EXP$$JP-ROCHE-10000076812$ROCHE$Mugita T, Kato Y, Samejima R, Yoshitake O, Suzuki T, Honda H. A report of intrinsic urothelial carcinoma which developed after renal transplant. The 39th Japanese Society of Renal Transplantation and Vascular Surgery. 2024;186.$65$YR$E$F$Y$$$20240913$$MD$JP$JP
243152002$24315200$2$F$20240713$20240916$20240913$20240920$PER$$FR-IDORSIA-008446-2024-FR$IDORSIA PHARMACEUTICALS$$74$YR$$M$Y$93$KG$20240920$$MD$FR$FR
243152011$24315201$1$I$20240901$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182068$AMGEN$$61$YR$A$F$Y$$$20240913$$CN$US$US
243152021$24315202$1$I$20240806$20240806$20240913$20240913$PER$$US-AMGEN-USASP2024182717$AMGEN$$$$$$Y$$$20240913$$PH$US$US
243152031$24315203$1$I$20240101$20240905$20240913$20240913$PER$$US-AMGEN-USASP2024178372$AMGEN$$84$YR$E$F$Y$$$20240913$$MD$US$US
243152041$24315204$1$I$$20240911$20240913$20240913$PER$$US-ROCHE-10000080623$ROCHE$$$$$$Y$$$20240913$$CN$US$US
243152051$24315205$1$I$$20240905$20240913$20240913$EXP$$US-ROCHE-10000075570$ROCHE$$50$YR$A$M$Y$$$20240913$$CN$US$US
243152061$24315206$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240933$TEVA$$61$YR$$M$Y$$$20240913$$HP$CA$CA
243152071$24315207$1$I$20240903$20240910$20240913$20240913$PER$$US-ROCHE-10000078586$ROCHE$$28$YR$A$M$Y$$$20240913$$HP$US$US
243152081$24315208$1$I$20230201$20240904$20240913$20240913$EXP$$CA-CELLTRION INC.-2024CA003068$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
243152091$24315209$1$I$$20240910$20240913$20240913$PER$$US-ABBVIE-5919327$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243152111$24315211$1$I$$20240904$20240913$20240913$EXP$$DE-MSNLABS-2024MSNLIT01939$MSN LABORATORIES$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha -PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.Journal of Analytical Toxicology.2024;48:299-313$$$$$Y$$$20240913$$HP$DE$DE
243152121$24315212$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004946$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243152131$24315213$1$I$20220401$20240905$20240913$20240913$EXP$$BR-BIOGEN-2024BI01281663$BIOGEN$$30$YR$$F$Y$63$KG$20240913$$CN$BR$BR
243152152$24315215$2$F$$20240913$20240913$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004939$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243152171$24315217$1$I$20240903$20240903$20240913$20240913$EXP$GB-MHRA-MED-202409031353236340-ZCMTR$GB-Accord-444962$ACCORD$$39$YR$A$F$Y$$$20240913$$CN$GB$GB
243152182$24315218$2$F$$20240916$20240913$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004935$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243152192$24315219$2$F$20230101$20240906$20240913$20240918$EXP$$US-009507513-2409USA003034$MERCK$$$$$F$Y$$$20240918$$CN$US$US
243152201$24315220$1$I$20240820$20240822$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004962$ACADIA PHARMACEUTICALS$$88$YR$$F$Y$$$20240913$$CN$US$US
243152211$24315221$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004933$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243152221$24315222$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004947$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243152231$24315223$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004975$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243152241$24315224$1$I$20240814$20240822$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004960$ACADIA PHARMACEUTICALS$$95$YR$$F$Y$$$20240913$$CN$US$US
243152251$24315225$1$I$$20240910$20240913$20240913$PER$$US-JNJFOC-20240925022$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243152271$24315227$1$I$$20240905$20240913$20240913$EXP$$US-ROCHE-10000076225$ROCHE$$91$YR$E$F$Y$$$20240913$$CN$US$US
243152281$24315228$1$I$20180601$20240905$20240913$20240913$EXP$$JP-GSK-JP2024JPN112202$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$JP$JP
243152291$24315229$1$I$$20240912$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA079819$SANDOZ$$73$YR$$M$Y$$$20240913$$HP$CA$CA
243152301$24315230$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182314$AMGEN$$$$$F$Y$$$20240913$$CN$US$US
243152321$24315232$1$I$20240905$20240905$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142332$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240913$$CN$US$US
243152333$24315233$3$F$20240825$20240913$20240913$20240918$30DAY$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136341$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$61.23$KG$20240919$$CN$US$US
243152341$24315234$1$I$20231001$20240906$20240913$20240913$EXP$$US-BIOGEN-2024BI01273643$BIOGEN$$33$YR$$F$Y$73.094$KG$20240913$$CN$US$US
243152351$24315235$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004976$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243152361$24315236$1$I$20240701$20240904$20240913$20240913$EXP$$JP-ROCHE-10000023099$ROCHE$$44$YR$A$M$Y$91$KG$20240913$$MD$JP$JP
243152372$24315237$2$F$20240911$20240913$20240913$20240916$PER$$US-AMGEN-USASP2024182692$AMGEN$$38$YR$A$F$Y$$$20240916$$CN$US$US
243152381$24315238$1$I$$20240905$20240913$20240913$PER$$US-JNJFOC-20240912997$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$MD$US$US
243152391$24315239$1$I$$20240901$20240913$20240913$EXP$$IT-Accord-445487$ACCORD$Ponta G, Ranzenigo M, Marzi A, Oltolini C, Tassan Din C, Uberti-Foppa C et al. Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience. Clin Ther. 2024 Aug 24:S0149-2918(24)00211-X.$$$$$Y$$$20240913$$HP$IT$IT
243152401$24315240$1$I$$20240901$20240913$20240913$30DAY$$IT-JNJFOC-20240926433$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$IT$IT
243152411$24315241$1$I$$20240829$20240913$20240913$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03344$AMNEAL$Taseer AR., Velez J.C.Q.. Midodrine-induced urinary retention as a cause of acute kidney injury in cirrhosis: not always hepatorenal but the failed therapy for it. Am J Kidney Dis.. 2024;83(4):S4-S5$66$YR$$M$Y$$$20240913$$HP$US$US
243152421$24315242$1$I$$20240910$20240913$20240913$EXP$$CA-JNJFOC-20240926303$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240913$$HP$CA$CA
243152431$24315243$1$I$$20240903$20240913$20240913$PER$$US-JNJFOC-20240907536$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$MD$US$US
243152441$24315244$1$I$$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004968$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243152461$24315246$1$I$$20240911$20240913$20240913$PER$$US-ALXN-202409USA000796US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243152481$24315248$1$I$$20240912$20240913$20240913$PER$$US-HALEON-2196677$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
243152491$24315249$1$I$20240701$20240830$20240913$20240913$EXP$$US-UCBSA-2024044779$UCB$$58$YR$$F$Y$$$20240913$$HP$US$US
243152501$24315250$1$I$$20240906$20240913$20240913$EXP$$US-BIOGEN-2024BI01281878$BIOGEN$$$$$F$Y$$$20240913$$CN$US$US
243152511$24315251$1$I$$20240816$20240913$20240913$PER$$US-009507513-2408USA006437$MERCK$Grant CR, Arter Z, Smith J, Seyedin SN, Nourbakhsh M, Lee B, et al. Pembrolizumab and radiation therapy for multifocal myxofibrosarcoma of the scalp: a case report. Therapeutic Advances in Medical Oncology. 2024;16:1-9$76$YR$$M$Y$$$20240913$$HP$US$US
243152522$24315252$2$F$20240314$20240829$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467258$RANBAXY$$45$YR$$M$Y$79$KG$20240913$$CN$GB$GB
243152531$24315253$1$I$$20240911$20240913$20240913$EXP$$US-SANDOZ INC.-SDZ2024US079879$SANDOZ$$$$$F$Y$$$20240913$$CN$US$US
243152541$24315254$1$I$$20240821$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202408013502$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240913$$CN$US$US
243152551$24315255$1$I$$20240909$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007445$ELI LILLY AND CO$$$$$$Y$$$20240913$$CN$US$US
243152561$24315256$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007293$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240913$$CN$US$US
243152571$24315257$1$I$20240907$20240909$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409005819$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240913$$CN$US$US
243152581$24315258$1$I$20240329$20240911$20240913$20240913$EXP$$AU-ROCHE-RCA5073436$ROCHE$$10$YR$C$M$Y$52$KG$20240913$$MD$AU$AU
243152591$24315259$1$I$20240101$20240907$20240913$20240913$EXP$$CA-ABBVIE-5917485$ABBVIE$$34$YR$$F$Y$$$20240913$$MD$CA$BW
243152603$24315260$3$F$20240816$20240924$20240913$20240930$EXP$$US-BIOGEN-2024BI01281535$BIOGEN$$74$YR$$F$Y$$$20240930$$CN$US$US
243152611$24315261$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007669$ELI LILLY AND CO$$$$$$Y$$$20240913$$CN$US$US
243152621$24315262$1$I$20240726$20240830$20240913$20240913$EXP$$TW-ASTELLAS-2024-AER-003913$ASTELLAS$$75$YR$E$M$Y$$$20240913$$MD$TW$TW
243152631$24315263$1$I$$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024182386$AMGEN$$$$$$Y$$$20240913$$MD$US$US
243152641$24315264$1$I$$20240910$20240913$20240913$PER$$US-BIOVITRUM-2024-US-011939$BIOVITRUM$$65$YR$$F$Y$$$20240913$$CN$US$US
243152653$24315265$3$F$20240906$20240919$20240913$20240924$PER$$US-AMGEN-USASP2024181104$AMGEN$$63$YR$A$F$Y$$$20240924$$MD$US$US
243152661$24315266$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145661$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240913$$HP$US$US
243152671$24315267$1$I$20190830$20240910$20240913$20240913$EXP$$CO-UCBSA-2024046915$UCB$$59$YR$$F$Y$$$20240913$$CN$CO$CO
243152682$24315268$2$F$$20240912$20240913$20240926$EXP$$TR-ALVOGEN-2024095444$ALVOGEN$Balan K, Aydin F, Akdogan N. Acute Localized Exanthematous Pustulosis in a 5-Year-Old Boy With Zosteriform Distrubiton. Cureus. 2024 Jul 26;16(7):e65402. doi:10.7759/cureus.65402$5$YR$$M$Y$$$20240926$$HP$TR$TR
243152691$24315269$1$I$$20240905$20240913$20240913$PER$$US-APOTEX-2024AP010297$APOTEX$$$$E$M$Y$$$20240913$$CN$US$US
243152701$24315270$1$I$20240801$20240830$20240913$20240913$EXP$$US-BRAINTREE LABORATORIES, INC.-2024BTE00573$BRAINTREE$$65$YR$$M$Y$$$20240913$$CN$US$US
243152711$24315271$1$I$$20240829$20240913$20240913$EXP$$US-BRAINTREE LABORATORIES, INC.-2024BTE00569$BRAINTREE$$$$$$Y$$$20240913$$CN$US$US
243152721$24315272$1$I$20240101$20240906$20240913$20240913$EXP$$JP-AstraZeneca-2024A164973$ASTRAZENECA$$$$$F$Y$$$20240913$$MD$JP$
243152732$24315273$2$F$$20240912$20240913$20240916$PER$$US-AstraZeneca-2024A204861$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243152741$24315274$1$I$$20240902$20240913$20240913$EXP$CA-MHPD-E2B_07203167$CA-Accord-444713$ACCORD$$47$YR$A$M$Y$$$20240913$$HP$CA$CA
243152751$24315275$1$I$$20240901$20240913$20240913$30DAY$$IT-JNJFOC-20240926662$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$IT$IT
243152761$24315276$1$I$$20240906$20240913$20240913$PER$$US-JNJFOC-20240916049$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$US$US
243152771$24315277$1$I$20240909$20240911$20240913$20240913$PER$$US-JNJFOC-20240928115$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243152781$24315278$1$I$$20240903$20240913$20240913$PER$$US-ROCHE-3538336$ROCHE$$12$YR$T$M$Y$$$20240913$$CN$US$US
243152791$24315279$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004995$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243152801$24315280$1$I$$20240906$20240913$20240913$EXP$$JP-AMGEN-JPNSP2024178406$AMGEN$$$$$$Y$$$20240913$$PH$JP$JP
243152811$24315281$1$I$20240909$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024180362$AMGEN$$63$YR$A$F$Y$$$20240913$$CN$US$US
243152841$24315284$1$I$20240815$20240906$20240913$20240913$EXP$$CO-AMGEN-COLSL2024170783$AMGEN$$61$YR$A$F$Y$$$20240913$$CN$CO$CO
243152861$24315286$1$I$$20240910$20240913$20240913$PER$$US-ROCHE-10000078932$ROCHE$$48$YR$A$M$Y$$$20240913$$CN$US$US
243152872$24315287$2$F$20230502$20240722$20240913$20240924$EXP$$US-TEVA-VS-3237647$TEVA$$71$YR$$M$Y$81.4$KG$20240924$$HP$US$US
243152881$24315288$1$I$$20240905$20240913$20240913$EXP$$CA-ROCHE-10000074521$ROCHE$$$$$F$Y$$$20240913$$HP$CA$CA
243152891$24315289$1$I$20130101$20240908$20240913$20240913$EXP$$IL-BRISTOL-MYERS SQUIBB COMPANY-2024-144860$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240913$$MD$IL$IL
243152903$24315290$3$F$20240306$20240919$20240913$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-009167$UNITED THERAPEUTICS$$47$YR$$F$Y$76.19$KG$20240926$$$US$US
243152911$24315291$1$I$$20240905$20240913$20240913$EXP$$AU-CELLTRION INC.-2024AU021830$CELLTRION$$$$$$Y$$$20240913$$MD$AU$AU
243152931$24315293$1$I$$20240904$20240913$20240913$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004765$PAREXEL$$$$$$Y$$$20240913$$CN$US$US
243152941$24315294$1$I$$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024180765$AMGEN$$$$$F$Y$$$20240913$$CN$US$US
243152951$24315295$1$I$$20240910$20240913$20240913$EXP$$US-AMGEN-USASP2024181102$AMGEN$$$$E$F$Y$$$20240913$$HP$US$US
243152982$24315298$2$F$$20240912$20240913$20240920$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240900052$RIGEL PHARMACEUTICALS$$8$DEC$$F$Y$$$20240920$$PH$JP$JP
243152991$24315299$1$I$$20240823$20240913$20240913$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900042$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243153002$24315300$2$F$20230601$20240920$20240913$20240927$EXP$$CA-GSK-CA2023AMR064199$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$PH$CA$CA
243153011$24315301$1$I$$20240903$20240913$20240913$30DAY$$US-GSK-US2024109390$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$CN$US$US
243153041$24315304$1$I$$20240606$20240913$20240913$PER$US-ALVOGEN-2024094398$US-ALVOGEN-2024094398$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153051$24315305$1$I$20010427$20240829$20240913$20240913$EXP$$NO-TEVA-2001B-00335$TEVA$$21810$DY$$M$Y$$$20240913$$HP$NO$NO
243153061$24315306$1$I$$20240606$20240913$20240913$PER$US-ALVOGEN-2024094592$US-ALVOGEN-2024094592$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153071$24315307$1$I$20240730$20240903$20240913$20240913$EXP$FR-AFSSAPS-TO2024001518$FR-TEVA-VS-3240028$TEVA$$69$YR$$M$Y$49$KG$20240913$$MD$FR$FR
243153081$24315308$1$I$$20240606$20240913$20240913$PER$$US-ALVOGEN-2024094635$ALVOGEN$$$$$F$Y$$$20240913$$HP$US$US
243153091$24315309$1$I$20240801$20240905$20240913$20240913$EXP$GB-MHRA-MED-202409040830405940-DQVJB$GB-MSNLABS-2024MSNSPO01964$MSN LABORATORIES$$$$$$Y$$$20240913$$CN$GB$GB
243153101$24315310$1$I$$20240605$20240913$20240913$PER$US-ALVOGEN-2024094395$US-ALVOGEN-2024094395$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153111$24315311$1$I$20240701$20240904$20240913$20240913$PER$$PR-ABBVIE-5908507$ABBVIE$$22$YR$$M$Y$$$20240913$$HP$PR$PR
243153121$24315312$1$I$$20240821$20240913$20240913$PER$$US-APOTEX-2024AP009944$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240913$$HP$US$US
243153131$24315313$1$I$$20240904$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013308$DR REDDYS$$$$$M$Y$$$20240913$$MD$US$US
243153141$24315314$1$I$$20240903$20240913$20240913$EXP$$CA-CELLTRION INC.-2024CA021256$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
243153151$24315315$1$I$$20240911$20240913$20240913$PER$$US-ROCHE-10000080627$ROCHE$$62$YR$A$F$Y$146$KG$20240913$$HP$US$US
243153161$24315316$1$I$$20240904$20240913$20240913$EXP$$CN-ROCHE-10000073599$ROCHE$Li Y, Li G, Zheng Z, Wen W, Zhao H, Liu X, et al. Benefits of osimertinib treat a lung adenocarcinoma patient with germline EGFR T790M, somatic EGFR 19-Del, TP53 and PIK3CA mutations. Hereditary Cancer in Clinical Practice. 2024-Dec;22 (1): doi:10.1186/s13053-024-00286-4.$52$YR$A$M$Y$$$20240913$$HP$CN$CN
243153171$24315317$1$I$$20240531$20240913$20240913$PER$US-ALVOGEN-2024094428$US-ALVOGEN-2024094428$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153182$24315318$2$F$20240904$20240905$20240913$20240923$PER$$US-ROCHE-10000076284$ROCHE$$39$YR$A$F$Y$$$20240923$$CN$US$US
243153191$24315319$1$I$20240110$20240829$20240913$20240913$EXP$$CA-CELLTRION INC.-2024CA002440$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
243153201$24315320$1$I$20240101$20240903$20240913$20240913$EXP$DK-DKMA-30737910$DK-GLENMARK PHARMACEUTICALS-2024GMK093875$GLENMARK$$$$$$Y$$$20240913$$MD$DK$DK
243153211$24315321$1$I$$20240609$20240913$20240913$PER$US-ALVOGEN-2024094378$US-ALVOGEN-2024094378$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153221$24315322$1$I$$20240911$20240913$20240913$PER$$US-ALXN-202409USA000853US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243153231$24315323$1$I$$20240609$20240913$20240913$PER$US-ALVOGEN-2024094361$US-ALVOGEN-2024094361$ALVOGEN$$$$$$Y$$$20240913$$HP$US$US
243153241$24315324$1$I$$20240609$20240913$20240913$PER$US-ALVOGEN-2024094407$US-ALVOGEN-2024094407$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153251$24315325$1$I$$20240905$20240913$20240913$PER$$US-ROCHE-10000076330$ROCHE$Mahtani R, Harpalani N, Yan F, Phiel K, Kovalenko L. Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series. Frontiers in Oncology. 2024-Jan;14:1-7. doi:10.3389/fonc.2024.1419246.$54$YR$A$F$Y$$$20240913$$HP$US$US
243153261$24315326$1$I$$20240909$20240913$20240913$EXP$$GB-AstraZeneca-2024A205033$ASTRAZENECA$$$$C$$Y$$$20240913$$MD$GB$
243153271$24315327$1$I$$20240609$20240913$20240913$PER$US-ALVOGEN-2024094402$US-ALVOGEN-2024094402$ALVOGEN$$$$$F$Y$$$20240913$$CN$US$US
243153281$24315328$1$I$$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024180246$AMGEN$$$$A$F$Y$$$20240913$$HP$US$US
243153291$24315329$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182466$AMGEN$$$$$$Y$$$20240913$$HP$US$US
243153301$24315330$1$I$$20240609$20240913$20240913$PER$US-ALVOGEN-2024094380$US-ALVOGEN-2024094380$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153312$24315331$2$F$$20240911$20240913$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409007374$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240918$$CN$US$US
243153321$24315332$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007614$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$US$US
243153331$24315333$1$I$$20240609$20240913$20240913$PER$US-ALVOGEN-2024094385$US-ALVOGEN-2024094385$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153341$24315334$1$I$$20240903$20240913$20240913$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112000$ZYDUS PHARM$Meyer AS, Cluster A, Ogle A, Brossier N, Beck M, Lampe A, et al.. Novel treatments for acneiform eruptions caused by targeted therapies in the pediatric population. Neuro-Oncology. 2024;26:iv186-iv187$$$$$Y$$$20240913$$HP$US$US
243153351$24315335$1$I$$20240905$20240913$20240913$EXP$$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-112031$ZYDUS PHARM$$$$$$Y$$$20240913$$PH$GB$GB
243153362$24315336$2$F$$20240912$20240913$20240918$PER$$US-LEO Pharma-373446$LEO PHARM$$33$YR$$M$Y$$$20240918$$PH$US$US
243153371$24315337$1$I$$20240609$20240913$20240913$PER$US-ALVOGEN-2024094386$US-ALVOGEN-2024094386$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153381$24315338$1$I$$20240609$20240913$20240913$PER$US-ALVOGEN-2024094388$US-ALVOGEN-2024094388$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153391$24315339$1$I$$20240902$20240913$20240913$EXP$$TW-Accord-445942$ACCORD$Wu H, Shih J-Y, Yang JC-H. Rapid Response to Sunitinib in a Patient with Lung Adenocarcinoma Harboring KIF5B-RET Fusion Gene. Journal of Thoracic Oncology. 2015; 10(9):e95-e96$63$YR$A$F$Y$$$20240913$$MD$TW$TW
243153401$24315340$1$I$20240814$20240819$20240913$20240913$PER$$US-TOLMAR, INC.-24US051956$TOLMAR$$82$YR$$M$Y$$$20240913$$HP$US$US
243153411$24315341$1$I$20240819$20240819$20240913$20240913$PER$$US-TOLMAR, INC.-24US052007$TOLMAR$$74$YR$$M$Y$$$20240913$$HP$US$US
243153421$24315342$1$I$20240819$20240819$20240913$20240913$PER$$US-TOLMAR, INC.-24US052029$TOLMAR$$73$YR$$M$Y$$$20240913$$HP$US$US
243153431$24315343$1$I$$20240830$20240913$20240913$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01441$INTRA-CELLULAR THERAPIES$$$$$$Y$$$20240913$$HP$US$US
243153441$24315344$1$I$$20240609$20240913$20240913$PER$US-ALVOGEN-2024094400$US-ALVOGEN-2024094400$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153451$24315345$1$I$$20240831$20240913$20240913$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0359$GRAVITI PHARMACEUTICALS$Barrons R, Woods JA, Humphries R.Stain Associated Autoimmune Myopathy: Case Report With Delayed Onset and Treatment Challenges.J-Pharm-Pract.2020$54$YR$A$M$Y$$$20240913$$HP$US$US
243153462$24315346$2$F$$20240910$20240913$20240924$EXP$$US-SINTETICA US LLC-US-SIN-2024-00012$Sintetica$Soliman Y, Hatfield AA, McAllister RK, Fettiplace MR, Hofkamp MP.. Apparent local anesthetic systemic toxicity following activation of an epidural catheter for cesarean delivery: Diagnosis and management of an uncommon obstetric anesthesia complication. Proceedings (Baylor University. Medical Center). 2024;37(5):874-876$25$YR$$F$Y$92$KG$20240923$$MD$US$US
243153471$24315347$1$I$$20240609$20240913$20240913$PER$US-ALVOGEN-2024094381$US-ALVOGEN-2024094381$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153481$24315348$1$I$$20240609$20240913$20240913$PER$US-ALVOGEN-2024094348$US-ALVOGEN-2024094348$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153491$24315349$1$I$$20240610$20240913$20240913$PER$US-ALVOGEN-2024094586$US-ALVOGEN-2024094586$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153501$24315350$1$I$20240830$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145343$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$85.7$KG$20240913$$PH$US$US
243153511$24315351$1$I$$20240912$20240913$20240913$PER$$US-HALEON-2196692$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
243153521$24315352$1$I$$20240611$20240913$20240913$PER$$US-ALVOGEN-2024094559$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153541$24315354$1$I$$20240612$20240913$20240913$PER$US-ALVOGEN-2024094371$US-ALVOGEN-2024094371$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153551$24315355$1$I$$20240612$20240913$20240913$PER$US-ALVOGEN-2024094580$US-ALVOGEN-2024094580$ALVOGEN$$$$$$Y$$$20240913$$MD$US$US
243153561$24315356$1$I$$20240611$20240913$20240913$PER$US-ALVOGEN-2024094583$US-ALVOGEN-2024094583$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153571$24315357$1$I$$20240906$20240913$20240913$EXP$$FI-GSK-FI2024111194$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$FI$FI
243153581$24315358$1$I$$20240612$20240913$20240913$PER$US-ALVOGEN-2024094591$US-ALVOGEN-2024094591$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153591$24315359$1$I$$20240612$20240913$20240913$PER$US-ALVOGEN-2024094390$US-ALVOGEN-2024094390$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153601$24315360$1$I$$20240831$20240913$20240913$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0371$GRAVITI PHARMACEUTICALS$Park BD, Hountras P.Diffuse Alveolar Hemorrhage in the Setting of an Acute Exacerbation of Chronic Hypersensitivity Pneumonitis Due to Drug Rash with Eosinophilia and Systemic Symptoms: A Case Report.Clin-Pulmon-Med.2019;26(6):181-183$62$YR$A$F$Y$$$20240913$$HP$US$US
243153611$24315361$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005000$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243153621$24315362$1$I$$20240612$20240913$20240913$PER$US-ALVOGEN-2024094376$US-ALVOGEN-2024094376$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153631$24315363$1$I$$20240902$20240913$20240913$EXP$$IT-STERISCIENCE B.V.-2024-ST-001341$Steriscience PTE$Esposito P, Cappadona F, Sangregorio F, Costa E, Mallia L, Zanetti V et al. Combined extracorporeal CO2 removal and renal replacement therapy in a pregnant patient with COVID-19: a case report. Giornale Italiano di Nefrologia. 2023;40(2)$$$N$F$Y$0.8$KG$20240913$$MD$IT$IT
243153641$24315364$1$I$$20240902$20240913$20240913$EXP$$IT-STERISCIENCE B.V.-2024-ST-001340$Steriscience PTE$Esposito P, Cappadona F, Sangregorio F, Costa E, Mallia L, Zanetti V et al.. Combined extracorporeal CO2 removal and renal replacement therapy in a pregnant patient with COVID-19: a case report.. Giornale Italiano di Nefrologia. 2023;40(2)$34$YR$$F$Y$$$20240913$$MD$IT$IT
243153651$24315365$1$I$20240818$20240903$20240913$20240913$EXP$$IE-STERISCIENCE B.V.-2024-ST-001343$Steriscience PTE$$52$YR$$F$Y$$$20240913$$CN$IE$IE
243153661$24315366$1$I$$20240902$20240913$20240913$EXP$$PT-STERISCIENCE B.V.-2024-ST-001342$Steriscience PTE$Lage G, Fernandes L, Fernandes I, Clerigo V, Ferrao A.. PO-0121 - (2093) - WHAT IS BEHIND THE PINK COAT?.. Respiratory Diseases I Clinical Case. 2024;unk:491$74$YR$$M$Y$$$20240913$$HP$PT$PT
243153671$24315367$1$I$$20240902$20240913$20240913$EXP$$US-STERISCIENCE B.V.-2024-ST-001364$Steriscience PTE$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework.. J-Forens-Legal-Med. 2024;101$82$YR$$$Y$$$20240913$$HP$US$US
243153681$24315368$1$I$$20240612$20240913$20240913$PER$US-ALVOGEN-2024094356$US-ALVOGEN-2024094356$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153691$24315369$1$I$$20240909$20240913$20240913$PER$$US-JNJFOC-20240922687$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243153701$24315370$1$I$20240801$20240906$20240913$20240913$PER$$US-JNJFOC-20240923040$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243153712$24315371$2$F$20240831$20240909$20240913$20240916$EXP$$JP-ROCHE-10000077813$ROCHE$$8$DEC$E$F$Y$$$20240916$$MD$JP$JP
243153722$24315372$2$F$$20240914$20240913$20240927$PER$$US-JNJFOC-20240915293$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240927$$CN$US$US
243153731$24315373$1$I$$20240613$20240913$20240913$PER$US-ALVOGEN-2024094372$US-ALVOGEN-2024094372$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153741$24315374$1$I$$20240728$20240913$20240913$PER$$US-ALVOGEN-2024094985$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243153751$24315375$1$I$$20240904$20240913$20240913$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08384$HIKMA$$$$$$Y$$$20240913$$CN$US$US
243153761$24315376$1$I$$20240807$20240913$20240913$PER$$US-ALVOGEN-2024095240$ALVOGEN$$$$$M$Y$$$20240913$$CN$US$US
243153771$24315377$1$I$$20240909$20240913$20240913$EXP$$CA-APOTEX-2024AP010374$APOTEX$$$$$M$Y$$$20240913$$HP$CA$CA
243153781$24315378$1$I$$20240903$20240913$20240913$EXP$$TR-ASTELLAS-2024-AER-005036$ASTELLAS$Sabanci M, Tasdemir M. Managing recurrent parvovirus B19-associated anemia after a pediatric kidney transplant. Pediatric Nephrology. 2024;39: 2923-25. doi:10.1007/s00467-024-06378-6.$13$YR$T$F$Y$40$KG$20240913$$HP$TR$TR
243153791$24315379$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004981$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243153801$24315380$1$I$$20240612$20240913$20240913$PER$US-ALVOGEN-2024094420$US-ALVOGEN-2024094420$ALVOGEN$$$$$M$Y$$$20240913$$CN$US$US
243153811$24315381$1$I$$20240902$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013126$DR REDDYS$Lee JZ, Karikalan S, Tan M, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC: Clinical Electrophysiology. 2023 Jun;9(6): 824-832. doi:10.1016/j.jacep.2022.10.024.$$$$$Y$$$20240913$$MD$US$US
243153821$24315382$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145546$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240913$$CN$US$US
243153831$24315383$1$I$20240607$20240909$20240913$20240913$EXP$$SE-REGENERON PHARMACEUTICALS, INC.-2024-122575$REGENERON$$$$$M$Y$$$20240913$$CN$SE$SE
243153841$24315384$1$I$$20240906$20240913$20240913$PER$$US-ROCHE-10000076026$ROCHE$$58$YR$A$F$Y$$$20240913$$CN$US$US
243153851$24315385$1$I$$20240831$20240913$20240913$EXP$$US-GRAVITIPHARMA-GRA-2408-US-LIT-0347$GRAVITI PHARMACEUTICALS$Qiu X, Tackett E, Khitan Z..A case of gabapentin overdose induced rhabdomyolysis requiring renal replacement therapy.Clinical Case Reports.2019;7 (8):1596-1599$39$YR$A$M$Y$$$20240913$$HP$US$US
243153861$24315386$1$I$$20240912$20240913$20240913$PER$$US-HALEON-2196694$Haleon PLC$$$$$F$Y$$$20240913$$CN$US$US
243153871$24315387$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005003$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243153881$24315388$1$I$$20240808$20240913$20240913$PER$$US-STRIDES PHARMA UK LTD.-2024SP010266$STRIDES$Shakoor HI, Farsakh D, Shewmake H, Maliakkal N, Hanks A, Funk K, et al.. Multiple Viral Infections With Elevated Cell-free DNA After Heart Transplantation.. J-Card-Fail. 2024;30 (1):210 abstr. 218$$$$$Y$$$20240913$$HP$US$US
243153891$24315389$1$I$$20240822$20240913$20240913$PER$$US-STRIDES PHARMA UK LTD.-2024SP010813$STRIDES$Dana IN, Austin E, Asrani F.. Mucocutaneous ulcers in an immunocompromised patient.. JAAD-Case-Rep. 2024;51:48-50$$$$$Y$$$20240913$$HP$US$US
243153901$24315390$1$I$$20240718$20240913$20240913$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009162$STRIDES$Lawson CT, Portz BJ.. A Case of Steroid Refractory Lupus Podocytopathy: Is Glucocorticoid Monotherapy Sufficient?. J-Am-Soc-Nephrol. 2023;34:1013$38$YR$$F$Y$$$20240913$$HP$US$US
243153911$24315391$1$I$$20240725$20240913$20240913$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009547$STRIDES$Patel G, Khan DA.. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria.. J-Allergy-Clin-Immunol-Pract. 2024;12 (6):1663-1665.$57$YR$$M$Y$$$20240913$$MD$US$US
243153921$24315392$1$I$$20240807$20240913$20240913$PER$$US-STRIDES PHARMA UK LTD.-2024SP010178$STRIDES$Schlatter MI, Yandamuri SS, O^Connor KC, Nowak RJ, Pham MC, Obaid AH, et al.. Remission of severe myasthenia gravis after autologous stem cell transplantation.. Ann-Clin-Transl-Neurol. 2023;10 (11):2105-2113$$$$$Y$$$20240913$$HP$US$US
243153931$24315393$1$I$$20240705$20240913$20240913$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008410$STRIDES$Baker M, Thakker S, Cardis M, DeSimone J, Larson A.. A Vexing Case of a Treatment-Refractory, Idiopathic Rash Resembling Histiocytoid Sweet Syndrome: Insights into the Diagnostic Challenge of Vexas Syndrome.. Am-J-Dermatopathol. 2024;46 (7):S1-S2$71$YR$$M$Y$$$20240913$$HP$US$US
243153941$24315394$1$I$$20240705$20240913$20240913$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008444$STRIDES$Kassels A, Edwards L, Kraus CN.. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series.. JAAD-Case-Rep. 2023;40:14-18.$$$$F$Y$$$20240913$$MD$US$US
243153951$24315395$1$I$$20240823$20240913$20240913$PER$$US-STRIDES PHARMA UK LTD.-2024SP010795$STRIDES$Mansour MK, King JD, Chen ST, Fishman JA, Nazarian RM.. Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes.. N-Engl-J-Med. 2023;388 (10):926-937$$$$$Y$$$20240913$$HP$US$US
243153961$24315396$1$I$20230807$20240829$20240913$20240913$EXP$FR-AFSSAPS-ST2024001333$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-08140$HIKMA$$$$$$Y$$$20240913$$HP$FR$FR
243153971$24315397$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044216$AUROBINDO$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience.. Blood Cancer Journal. 2023;13:91$$$$$Y$$$20240913$$HP$US$US
243153981$24315398$1$I$$20240910$20240913$20240913$PER$$US-ALXN-202409USA000756US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$MD$US$US
243153991$24315399$1$I$20240902$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182139$AMGEN$$33$YR$A$F$Y$$$20240913$$CN$US$US
243154001$24315400$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182399$AMGEN$$$$E$F$Y$$$20240913$$CN$US$US
243154011$24315401$1$I$$20240906$20240913$20240913$PER$$US-ALXN-202409USA000473US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243154021$24315402$1$I$$20240910$20240913$20240913$PER$$US-ALXN-202409USA000740US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243154031$24315403$1$I$20240527$20240904$20240913$20240913$EXP$FR-AFSSAPS-MP2024001016$FR-TEVA-VS-3240393$TEVA$$55$YR$$M$Y$59$KG$20240913$$MD$FR$FR
243154041$24315404$1$I$$20240902$20240913$20240913$EXP$CA-MHPD-E2B_07199052$CA-Accord-444791$ACCORD$$30$YR$A$F$Y$$$20240913$$CN$CA$CA
243154051$24315405$1$I$20240912$20240912$20240913$20240913$PER$$US-AMGEN-USASP2024182682$AMGEN$$57$YR$A$F$Y$$$20240913$$PH$US$US
243154061$24315406$1$I$$20240905$20240913$20240913$EXP$$CA-TAKEDA-2024TUS089551$TAKEDA$$$$$F$Y$$$20240913$$CN$CA$CA
243154071$24315407$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044452$AUROBINDO$Laura D, Garrity L, Poisson K, Broomall E. Enteral Ketamine for Status Epilepticus in Children with Epilepsy. Pediatr Neurol. 2024$$$C$$Y$$$20240913$$HP$US$US
243154081$24315408$1$I$20200714$20240905$20240913$20240913$EXP$PL-URPL-1-1224-2020$PL-TEVA-VS-3241238$TEVA$$19$YR$$F$Y$45$KG$20240913$$MD$PL$PL
243154093$24315409$3$F$$20240924$20240913$20240927$EXP$$CA-TAKEDA-2024TUS090664$TAKEDA$$$$$M$Y$$$20240927$$CN$CA$CA
243154101$24315410$1$I$$20240906$20240913$20240913$EXP$$FR-ABBVIE-5919040$ABBVIE$$76$YR$$M$Y$$$20240913$$CN$FR$FR
243154111$24315411$1$I$$20240904$20240913$20240913$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093890$GLENMARK$$$$$$Y$$$20240913$$PH$US$US
243154121$24315412$1$I$20240101$20240826$20240913$20240913$PER$$US-TEVA-VS-3237554$TEVA$$66$YR$$F$Y$$$20240913$$CN$US$US
243154131$24315413$1$I$20240903$20240910$20240913$20240913$PER$$US-AstraZeneca-2024A206656$ASTRAZENECA$$25808$DY$$F$Y$$$20240913$$CN$US$
243154142$24315414$2$F$$20240917$20240913$20240918$EXP$$IL-AstraZeneca-2024A205171$ASTRAZENECA$$$$$M$Y$$$20240918$$MD$IL$
243154151$24315415$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044800$AUROBINDO$Cho SJ, Magale H, Dimitrov K. Cemented in place: kyphoplasty-associated pulmonary cement embolism: a case report. Journal of Medical Case Reports. 2024;18:407$74$YR$$F$Y$$$20240913$$HP$US$US
243154161$24315416$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005004$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243154171$24315417$1$I$$20240910$20240913$20240913$EXP$$GB-AstraZeneca-2024A207544$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$GB$
243154181$24315418$1$I$$20240906$20240913$20240913$EXP$$CA-VIIV HEALTHCARE LIMITED-CA2024111430$VIIV$$$$$$Y$$$20240913$$PH$CA$CA
243154211$24315421$1$I$$20240816$20240913$20240913$PER$$US-ALVOGEN-2024095115$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243154221$24315422$1$I$20240101$20240905$20240913$20240913$EXP$$US-SA-2024SA262797$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240913$$MD$US$US
243154231$24315423$1$I$$20240612$20240913$20240913$PER$US-ALVOGEN-2024094419$US-ALVOGEN-2024094419$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243154241$24315424$1$I$$20240612$20240913$20240913$PER$US-ALVOGEN-2024094416$US-ALVOGEN-2024094416$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243154251$24315425$1$I$$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143695$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240913$$CN$US$US
243154261$24315426$1$I$20240101$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005014$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$HP$US$US
243154271$24315427$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145531$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240913$$CN$US$US
243154281$24315428$1$I$$20240905$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145947$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$81.19$KG$20240913$$CN$US$US
243154291$24315429$1$I$$20240612$20240913$20240913$PER$US-ALVOGEN-2024094360$US-ALVOGEN-2024094360$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243154301$24315430$1$I$20240902$20240903$20240913$20240913$EXP$$US-HETERO-HET2024US02989$HETERO$$$$$F$Y$$$20240913$$CN$US$US
243154311$24315431$1$I$20240903$20240903$20240913$20240913$PER$$US-ABBVIE-5907673$ABBVIE$$20$YR$$M$Y$$$20240913$$CN$US$US
243154321$24315432$1$I$20240101$20240801$20240913$20240913$PER$$US-ALVOGEN-2024095267$ALVOGEN$$$$$M$Y$$$20240913$$CN$US$US
243154331$24315433$1$I$$20240613$20240913$20240913$PER$US-ALVOGEN-2024094373$US-ALVOGEN-2024094373$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243154341$24315434$1$I$$20240612$20240913$20240913$PER$US-ALVOGEN-2024094396$US-ALVOGEN-2024094396$ALVOGEN$$$$$$Y$$$20240913$$CN$US$US
243154351$24315435$1$I$20220906$20240910$20240913$20240913$EXP$$CO-UCBSA-2024046903$UCB$$63$YR$$M$Y$$$20240913$$CN$CO$CO
243154361$24315436$1$I$20240101$20240908$20240913$20240913$EXP$$US-ABBVIE-5915531$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243154371$24315437$1$I$$20240903$20240913$20240913$EXP$$US-UCBSA-2024045582$UCB$$$$C$$Y$$$20240913$$MD$US$US
243154381$24315438$1$I$$20240904$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR113021$VIIV$$$$$$Y$$$20240913$$HP$US$US
243154391$24315439$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409006396$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240913$$CN$US$US
243154401$24315440$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007725$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240913$$CN$US$US
243154411$24315441$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007728$ELI LILLY AND CO$$26$YR$A$M$Y$$$20240913$$HP$US$US
243154421$24315442$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007455$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240913$$CN$US$US
243154431$24315443$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007381$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$US$US
243154441$24315444$1$I$20240910$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007385$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240913$$CN$US$US
243154451$24315445$1$I$$20240903$20240913$20240913$EXP$$US-Accord-445908$ACCORD$$$$$F$Y$$$20240913$$MD$US$US
243154461$24315446$1$I$20240910$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007716$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240913$$CN$US$US
243154471$24315447$1$I$$20240903$20240913$20240913$EXP$$US-HETERO-HET2024US03000$HETERO$$$$$F$Y$$$20240913$$CN$US$US
243154482$24315448$2$F$20240728$20240914$20240913$20240928$EXP$$CH-AMGEN-CHESP2024182716$AMGEN$$80$YR$E$F$Y$$$20240927$$MD$CH$CH
243154491$24315449$1$I$$20240911$20240913$20240913$PER$$US-HALEON-2196451$Haleon PLC$$$$$F$Y$$$20240913$$CN$US$US
243154511$24315451$1$I$$20240906$20240913$20240913$EXP$$US-BIOGEN-2024BI01281690$BIOGEN$$$$$F$Y$$$20240913$$HP$US$US
243154521$24315452$1$I$20240816$20240816$20240913$20240913$PER$$US-OrBion Pharmaceuticals Private Limited-2161537$ORBION PHARMACEUTICALS$$48$YR$$F$Y$$$20240913$$$US$US
243154531$24315453$1$I$20240905$20240906$20240913$20240913$EXP$$US-TAKEDA-2024TUS090101$TAKEDA$$78$YR$$F$Y$$$20240913$$CN$US$US
243154541$24315454$1$I$$20240909$20240913$20240913$PER$$US-HALEON-2196725$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
243154551$24315455$1$I$$20240909$20240913$20240913$PER$$US-ABBVIE-5916264$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243154571$24315457$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005007$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243154581$24315458$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182345$AMGEN$$$$A$M$Y$$$20240913$$MD$US$US
243154591$24315459$1$I$20240804$20240807$20240913$20240913$PER$$US-ALVOGEN-2024095308$ALVOGEN$$$$$F$Y$$$20240913$$CN$US$US
243154601$24315460$1$I$$20240903$20240913$20240913$EXP$$US-GSK-US2024109534$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243154611$24315461$1$I$20240815$20240820$20240913$20240913$PER$$US-OrBion Pharmaceuticals Private Limited-2161538$ORBION PHARMACEUTICALS$$50$YR$$F$Y$$$20240913$$$US$US
243154621$24315462$1$I$20240601$20240910$20240913$20240913$EXP$$US-TAKEDA-2024TUS090613$TAKEDA$$64$YR$$M$Y$$$20240913$$CN$US$US
243154631$24315463$1$I$20240910$20240910$20240913$20240913$PER$$US-JNJFOC-20240927293$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240913$$PH$US$US
243154642$24315464$2$F$20240826$20240912$20240913$20240922$EXP$$AU-JNJFOC-20240915771$JOHNSON AND JOHNSON$$74$YR$E$F$Y$68$KG$20240922$$MD$AU$AU
243154651$24315465$1$I$20210302$20240910$20240913$20240913$EXP$$GB-TAKEDA-2024TUS090654$TAKEDA$$68$YR$$M$Y$$$20240913$$MD$GB$GB
243154661$24315466$1$I$$20240902$20240913$20240913$EXP$CA-MHPD-E2B_07197388$CA-Accord-444773$ACCORD$$78$YR$E$F$Y$$$20240913$$HP$CA$CA
243154671$24315467$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182594$AMGEN$$$$$$Y$$$20240913$$HP$US$US
243154681$24315468$1$I$$20240909$20240913$20240913$EXP$$CH-AMGEN-CHESP2024180815$AMGEN$$$$$F$Y$$$20240913$$CN$CH$CH
243154691$24315469$1$I$20240911$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182477$AMGEN$$20$YR$A$M$Y$$$20240913$$CN$US$US
243154701$24315470$1$I$$20240904$20240913$20240913$EXP$$RU-OrBion Pharmaceuticals Private Limited-2161539$ORBION PHARMACEUTICALS$Gumeniuk OI, Yanin KR, Fisun AV, Chernenkov YV, Stepanov AA. Clinical case of rare mitochondrial disease in a child. Russian Open Med J 2024 June; Volume 13. Issue 2. Article CID e0209 doi: 10.15275/rusomj.2024.0209$9$YR$$M$Y$$$20240913$$MD$RU$RU
243154711$24315471$1$I$20240606$20240909$20240913$20240913$EXP$$US-ABBVIE-5916811$ABBVIE$$71$YR$$M$Y$$$20240913$$CN$US$US
243154721$24315472$1$I$$20240906$20240913$20240913$EXP$$US-AstraZeneca-2024A205580$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243154731$24315473$1$I$20070626$20240909$20240913$20240913$EXP$$GB-TEVA-VS-3241973$TEVA$$55$YR$$M$Y$$$20240913$$HP$GB$GB
243154741$24315474$1$I$$20240906$20240913$20240913$EXP$$US-AstraZeneca-2024A204105$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243154752$24315475$2$F$$20240910$20240913$20240917$EXP$$CA-AstraZeneca-2024A141146$ASTRAZENECA$$$$$M$Y$$$20240917$$HP$CA$
243154761$24315476$1$I$$20240910$20240913$20240913$EXP$$GB-AstraZeneca-2024A205946$ASTRAZENECA$$$$C$$Y$$$20240913$$MD$GB$
243154771$24315477$1$I$20240717$20240718$20240913$20240913$PER$$US-KVK-TECH, INC-20240700091$KVK-TECH$$$$$F$Y$$$20240913$$CN$US$US
243154781$24315478$1$I$$20240703$20240913$20240913$PER$$US-KVK-TECH, INC-20240700087$KVK-TECH$$$$$M$Y$$$20240913$$CN$US$US
243154791$24315479$1$I$$20240829$20240913$20240913$PER$$US-KVK-TECH, INC-20240900127$KVK-TECH$$5$YR$$$Y$$$20240913$$PH$US$US
243154801$24315480$1$I$$20240826$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08570$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243154811$24315481$1$I$$20240909$20240913$20240913$EXP$JP-MMM-VQF4NM1W$JP-GSK-JP2024111545$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$JP$JP
243154821$24315482$1$I$20240601$20240909$20240913$20240913$PER$$US-009507513-2409USA003580$MERCK$$$$$F$Y$$$20240913$$CN$US$US
243154831$24315483$1$I$20240730$20240905$20240913$20240913$EXP$$CA-CELLTRION INC.-2024CA019389$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
243154841$24315484$1$I$$20240909$20240913$20240913$PER$$US-LEO Pharma-373439$LEO PHARM$$31$YR$$F$Y$$$20240913$$PH$US$US
243154851$24315485$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144659$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$142.88$KG$20240913$$CN$US$US
243154861$24315486$1$I$$20240902$20240913$20240913$EXP$$IT-AUROBINDO-AUR-APL-2023-065758$AUROBINDO$Castelli B, Fonte C, Guidi M, Tellini M, Di Nicola M, Iacono A, et al.. Bevacizumab Irinotecan combination therapy in recurrent low grade glioma previously treated with chemo radiotherapy: a case report.. Frontiers in Oncology.. 2023;13:1-6$15$YR$$M$Y$$$20240913$$HP$IT$IT
243154871$24315487$1$I$20200101$20240903$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044400$AUROBINDO$Le MP, Le HQ, Jaquet P, Wicky PH, Bunel V, Massias L, Visseaux B, Messika J, Descamps D, Mal H, Timsit JF, Peytavin G.. Removal of remdesivir^s metabolite GS-441524 by hemodialysis in a double lung transplant recipient with COVID-19.. Antimicrobial Agents + Chemotherapy.. 2020;64 (11):E01521-20$5$DEC$$M$Y$44$KG$20240913$$HP$FR$FR
243154881$24315488$1$I$$20240909$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144957$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$72.57$KG$20240913$$HP$US$US
243154891$24315489$1$I$$20240902$20240913$20240913$EXP$$US-AUROBINDO-AUR-APL-2024-044241$AUROBINDO$Bruno M, Strober B, Del Rosso JQ. TOPICAL MANAGEMENT OF PLAQUE PSORIASIS-A Review and Case Series Discussion with Focus on Aryl Hydrocarbon Receptor Modulation.. J-ClinAesthet-Dermatol. 2023;16 (1):S3-S12$79$YR$$F$Y$$$20240913$$HP$US$US
243154901$24315490$1$I$$20240910$20240913$20240913$PER$$US-ALXN-202409USA000743US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243154911$24315491$1$I$$20240902$20240913$20240913$EXP$$DE-ROCHE-10000073885$ROCHE$$$$$$Y$$$20240913$$MD$DE$DE
243154921$24315492$1$I$$20240904$20240913$20240913$EXP$$US-OrBion Pharmaceuticals Private Limited-2161540$ORBION PHARMACEUTICALS$S. Correa, A. Berman., Glue Embolism Following Variceal Sclerotherapy. Am J Respir Crit Care Med 2023; 207: A5498. [Abstract]$34$YR$$M$Y$$$20240913$$MD$US$US
243154931$24315493$1$I$$20240902$20240913$20240913$EXP$$US-JNJFOC-20240923463$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$MD$US$US
243154941$24315494$1$I$20210317$20240903$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2021-017747$AUROBINDO$$50$YR$$F$Y$126$KG$20240913$$MD$FR$FR
243154951$24315495$1$I$$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024180204$AMGEN$$$$A$F$Y$$$20240913$$MD$US$US
243154961$24315496$1$I$$20240826$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08567$LUPIN$$$$$$Y$$$20240913$$PH$US$US
243154971$24315497$1$I$$20240903$20240913$20240913$EXP$GB-MHRA-TPP8647950C571455YC1725025248270$GB-Accord-444990$ACCORD$$55$YR$A$F$Y$79$KG$20240913$$MD$GB$GB
243154981$24315498$1$I$20240823$20240909$20240913$20240913$EXP$$CA-ABBVIE-5918932$ABBVIE$$84$YR$$M$Y$$$20240913$$HP$CA$CA
243155011$24315501$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145719$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240913$$HP$US$US
243155021$24315502$1$I$$20220217$20240913$20240913$EXP$$AU-SANDOZ INC.-NVSC2022AU039335$SANDOZ$$51$YR$$M$Y$$$20240913$$HP$AU$AU
243155031$24315503$1$I$$20240908$20240913$20240913$EXP$$US-BIOGEN-2024BI01281694$BIOGEN$$$$$F$Y$$$20240913$$CN$US$US
243155041$24315504$1$I$20230101$20240906$20240913$20240913$EXP$$US-BIOGEN-2024BI01281884$BIOGEN$$$$$M$Y$90.1$KG$20240913$$MD$US$US
243155051$24315505$1$I$20240724$20240909$20240913$20240913$EXP$$NL-BIOGEN-2024BI01281919$BIOGEN$$46$YR$$F$Y$$$20240913$$HP$NL$NL
243155061$24315506$1$I$$20240909$20240913$20240913$EXP$$GB-AUROBINDO-AUR-APL-2024-044904$AUROBINDO$$19$YR$$F$Y$$$20240913$$PH$GB$GB
243155071$24315507$1$I$20240806$20240905$20240913$20240913$EXP$IT-MINISAL02-999767$IT-TEVA-VS-3241345$TEVA$$83$YR$$F$Y$43$KG$20240913$$MD$IT$IT
243155081$24315508$1$I$$20240829$20240913$20240913$EXP$$GB-BEH-2024177603$CSL BEHRING$$77$YR$E$F$Y$64$KG$20240913$$HP$GB$GB
243155091$24315509$1$I$20220912$20240903$20240913$20240913$EXP$$DE-AUROBINDO-AUR-APL-2024-044273$AUROBINDO$$74$YR$$M$Y$$$20240913$$MD$DE$DE
243155111$24315511$1$I$20240326$20240903$20240913$20240913$EXP$$BR-AMGEN-BRASP2024177881$AMGEN$$68$YR$E$F$Y$$$20240913$$CN$BR$BR
243155121$24315512$1$I$$20240826$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08618$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243155131$24315513$1$I$$20240912$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409008084$ELI LILLY AND CO$$$$$$Y$$$20240913$$CN$US$US
243155142$24315514$2$F$20240701$20240916$20240913$20240920$EXP$$ES-AMGEN-ESPSP2024179459$AMGEN$$78$YR$E$F$Y$$$20240920$$MD$ES$ES
243155151$24315515$1$I$20240911$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007531$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$US$US
243155161$24315516$1$I$20240911$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007337$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240913$$CN$US$US
243155171$24315517$1$I$20240201$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007350$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240913$$CN$US$US
243155181$24315518$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007365$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240913$$CN$US$US
243155201$24315520$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144489$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240913$$CN$US$US
243155211$24315521$1$I$20240819$20240910$20240913$20240913$EXP$$DE-SANDOZ INC.-SDZ2024DE079501$SANDOZ$$$$$F$Y$$$20240913$$CN$DE$DE
243155222$24315522$2$F$20240904$20240919$20240913$20240925$EXP$$CA-ABBVIE-5917765$ABBVIE$$84$YR$$$Y$$$20240925$$MD$CA$CA
243155231$24315523$1$I$20220101$20240903$20240913$20240913$EXP$$CA-ASTELLAS-2023US025299$ASTELLAS$$7$YR$C$F$Y$19$KG$20240913$$HP$CA$CA
243155241$24315524$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145021$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240913$$HP$US$US
243155261$24315526$1$I$$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143752$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240913$$HP$US$US
243155281$24315528$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143998$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240913$$CN$US$US
243155292$24315529$2$F$20240902$20240909$20240913$20240915$EXP$$NL-BIOGEN-2024BI01282074$BIOGEN$$46$YR$$F$Y$$$20240915$$CN$NL$NL
243155301$24315530$1$I$$20240909$20240913$20240913$EXP$$US-ABBVIE-5915883$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243155311$24315531$1$I$20240801$20240911$20240913$20240913$EXP$FR-AFSSAPS-BX2024001761$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-145308$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$70$KG$20240913$$PH$FR$FR
243155322$24315532$2$F$$20240916$20240913$20240923$EXP$$US-EMD Serono-2024047881$EMD SERONO INC$$52$YR$A$F$Y$$$20240923$$CN$US$US
243155331$24315533$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5917182$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243155341$24315534$1$I$$20240905$20240913$20240913$PER$$US-AstraZeneca-2024A203037$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243155351$24315535$1$I$20240726$20240909$20240913$20240913$EXP$$US-AstraZeneca-2024A205597$ASTRAZENECA$$26256$DY$$M$Y$$$20240913$$HP$US$
243155361$24315536$1$I$20240909$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024180789$AMGEN$$79$YR$E$$Y$$$20240913$$CN$US$US
243155371$24315537$1$I$$20240826$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08605$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243155381$24315538$1$I$$20240912$20240913$20240913$PER$$US-ROCHE-10000081149$ROCHE$$$$A$M$Y$$$20240913$$CN$US$US
243155391$24315539$1$I$20240701$20240909$20240913$20240913$EXP$$US-GILEAD-2024-0687082$GILEAD$$58$YR$A$F$Y$$$20240913$$CN$US$US
243155402$24315540$2$F$20240801$20240911$20240913$20240918$PER$$US-AMGEN-USASP2024170463$AMGEN$$63$YR$A$M$Y$$$20240917$$CN$US$US
243155411$24315541$1$I$20240904$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142890$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$HP$US$US
243155421$24315542$1$I$$20240905$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142210$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240913$$CN$US$US
243155431$24315543$1$I$20230301$20240906$20240913$20240913$EXP$$BR-BIOGEN-2024BI01281883$BIOGEN$$39$YR$$F$Y$$$20240913$$CN$BR$BR
243155441$24315544$1$I$$20240906$20240913$20240913$EXP$$US-BIOGEN-2024BI01281887$BIOGEN$$$$$F$Y$$$20240913$$CN$US$US
243155461$24315546$1$I$$20240909$20240913$20240913$EXP$$CA-ROCHE-10000078128$ROCHE$$70$YR$E$M$Y$$$20240913$$HP$CA$CA
243155471$24315547$1$I$20240830$20240903$20240913$20240913$EXP$$US-ZPPROD-ZP24US000933$ZEALAND PHARMACEUTICALS$$$$$$Y$$$20240913$$HP$US$US
243155481$24315548$1$I$$20240909$20240913$20240913$EXP$$US-TAKEDA-2024TUS089908$TAKEDA$$34$YR$$M$Y$73$KG$20240913$$MD$US$US
243155501$24315550$1$I$20240731$20240904$20240913$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-144539$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$MD$JP$JP
243155511$24315551$1$I$$20240909$20240913$20240913$EXP$$CA-ROCHE-10000077653$ROCHE$$$$$$Y$$$20240913$$HP$CA$CA
243155521$24315552$1$I$20220113$20240905$20240913$20240913$EXP$$US-TAKEDA-2022TUS005470$TAKEDA$$50$YR$$F$Y$$$20240913$$MD$US$US
243155531$24315553$1$I$20191125$20240912$20240913$20240913$EXP$GB-MHRA-MED-202409120729514340-FMSJY$GB-SANDOZ INC.-SDZ2024GB079793$SANDOZ$$41$YR$$M$Y$144$KG$20240913$$CN$GB$GB
243155542$24315554$2$F$$20240920$20240913$20240926$EXP$$ES-TAKEDA-2024TUS090673$TAKEDA$$$$E$$Y$$$20240926$$CN$ES$ES
243155551$24315555$1$I$$20240911$20240913$20240913$PER$$US-ALXN-202409USA000887US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243155562$24315556$2$F$20240622$20240912$20240913$20240923$EXP$$FR-ROCHE-10000077830$ROCHE$$$$A$F$Y$$$20240923$$MD$FR$FR
243155571$24315557$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145445$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240913$$CN$US$US
243155581$24315558$1$I$$20240909$20240913$20240913$PER$$US-BEH-2024178593$CSL BEHRING$$$$A$$Y$$$20240913$$CN$US$US
243155591$24315559$1$I$$20240909$20240913$20240913$EXP$$JP-AstraZeneca-2024A206161$ASTRAZENECA$$79$YR$$M$Y$$$20240913$$MD$JP$
243155601$24315560$1$I$20240831$20240910$20240913$20240913$EXP$$ZA-AstraZeneca-2024A206370$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$ZA$
243155611$24315561$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409006800$ELI LILLY AND CO$$30$YR$A$M$Y$$$20240913$$CN$US$US
243155621$24315562$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007792$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240913$$CN$US$US
243155631$24315563$1$I$$20240909$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409005801$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240913$$CN$US$US
243155641$24315564$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007463$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240913$$CN$US$US
243155651$24315565$1$I$20240908$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409006798$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$US$US
243155661$24315566$1$I$$20240906$20240913$20240913$PER$$US-TAKEDA-2024TUS089611$TAKEDA$$$$$M$Y$$$20240913$$CN$US$US
243155681$24315568$1$I$20240908$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181213$AMGEN$$$$$$Y$$$20240913$$PH$US$US
243155692$24315569$2$F$20240501$20240926$20240913$20240927$PER$$US-AMGEN-USASP2024181161$AMGEN$$91$YR$E$F$Y$$$20240927$$CN$US$US
243155701$24315570$1$I$20240717$20240905$20240913$20240913$EXP$FR-AFSSAPS-RN2024000926$FR-TEVA-VS-3240895$TEVA$$58$YR$$F$Y$$$20240913$$MD$FR$FR
243155711$24315571$1$I$$20240821$20240913$20240913$PER$$US-ALVOGEN-2024095362$ALVOGEN$$$$$F$Y$$$20240913$$CN$US$US
243155721$24315572$1$I$$20240905$20240913$20240913$EXP$$BR-TAKEDA-2024TUS089899$TAKEDA$$$$$F$Y$$$20240913$$CN$BR$BR
243155732$24315573$2$F$20240813$20240926$20240913$20240927$EXP$$US-TAKEDA-2024TUS091156$TAKEDA$$51$YR$$M$Y$72$KG$20240927$$MD$US$US
243155743$24315574$3$F$20240101$20240917$20240913$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-027998$UNITED THERAPEUTICS$$$$$F$Y$97.506$KG$20240926$$$US$US
243155761$24315576$1$I$$20240902$20240913$20240913$EXP$CA-MHPD-E2B_07193408$CA-Accord-444775$ACCORD$$85$YR$E$F$Y$$$20240913$$HP$CA$CA
243155781$24315578$1$I$$20240830$20240913$20240913$PER$$US-ASTELLAS-2024-AER-004008$ASTELLAS$$56$YR$A$F$Y$$$20240913$$PH$US$US
243155791$24315579$1$I$$20240909$20240913$20240913$PER$$US-JNJFOC-20240922277$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243155802$24315580$2$F$$20240910$20240913$20240921$EXP$$JP-Accord-445058$ACCORD$Ebisawa K, Iwashita T, Uchiyama K, Kitayama Y, Takeuchi T. Epstein-Barr virus-positive mucocutaneous ulcer resulting in severe methotrexate intoxication: a case report. J Med Case Rep. 2024 Aug 30;18(1):409.$8$DEC$E$M$Y$$$20240921$$HP$JP$JP
243155811$24315581$1$I$20240722$20240904$20240913$20240913$EXP$FR-AFSSAPS-AN2024001173$FR-TEVA-VS-3240458$TEVA$$73$YR$$M$Y$68$KG$20240913$$PH$FR$FR
243155821$24315582$1$I$$20240911$20240913$20240913$EXP$$CN-TAKEDA-2024TUS090983$TAKEDA$$$$$M$Y$$$20240913$$CN$CN$CN
243155831$24315583$1$I$$20240910$20240913$20240913$EXP$$US-TAKEDA-US201829145$TAKEDA$$$$$M$Y$66$KG$20240913$$MD$US$US
243155841$24315584$1$I$20240801$20240905$20240913$20240913$EXP$$US-PARATEK PHARMACEUTICALS, INC.-2024PTK00801$PARATEK PHARMACEUTICALS$$78$YR$$F$Y$$$20240913$$CN$US$US
243155861$24315586$1$I$20240728$20240904$20240913$20240913$PER$$US-CELLTRION INC.-2024US018463$CELLTRION$$$$$$Y$$$20240913$$HP$US$US
243155871$24315587$1$I$$20240902$20240913$20240913$EXP$$TR-TEYRO-2024-TY-000592$Teyro Labs$Guren AK, Kocaaslan E, Agyol Y, Majidova N, Sever N, Erel P, et.al.HER2 exon 20 mutant non-small cell lung cancer with complete remission of intracranial metastases with trastuzumab deruxtecan: a case report..Anticancer Drugs.2024;35(8):769-773$58$YR$A$$Y$$$20240913$$HP$TR$TR
243155881$24315588$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144741$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240913$$HP$US$US
243155891$24315589$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145715$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$63.96$KG$20240913$$CN$US$US
243155901$24315590$1$I$$20240912$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145880$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240913$$CN$US$US
243155911$24315591$1$I$20240830$20240906$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143411$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$46.72$KG$20240913$$CN$US$US
243155921$24315592$1$I$$20240903$20240913$20240913$EXP$$CA-HALEON-2166541$Haleon PLC$$62$YR$$F$Y$$$20240913$$HP$CA$CA
243155941$24315594$1$I$20231227$20240912$20240912$20240912$DIR$718160$$FDA-CTU$$39$YR$$F$N$42.75$KG$20240912$N$CN$US$
243155961$24315596$1$I$$20240905$20240913$20240913$EXP$$JP-GALDERMA-JP2024013730$GALDERMA$$$$$$Y$$$20240913$$MD$JP$JP
243155971$24315597$1$I$20240807$20240904$20240913$20240913$PER$$US-CELLTRION INC.-2024US019741$CELLTRION$$$$$$Y$$$20240913$$HP$US$US
243155991$24315599$1$I$$20240909$20240913$20240913$PER$$US-ABBVIE-5919200$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243156011$24315601$1$I$20231116$20240905$20240913$20240913$EXP$IE-HPRA-2024-114578$IE-TEVA-VS-3233250$TEVA$$67$YR$$M$Y$$$20240913$$CN$IE$IE
243156021$24315602$1$I$20240501$20240904$20240913$20240913$EXP$$DE-SA-2024SA264247$SANOFI AVENTIS$$$$$M$Y$95$KG$20240913$$MD$DE$DE
243156031$24315603$1$I$20240806$20240905$20240913$20240913$EXP$$IT-AstraZeneca-2024A205206$ASTRAZENECA$$29881$DY$$M$Y$$$20240913$$MD$IT$
243156041$24315604$1$I$20240802$20240912$20240912$20240912$DIR$718179$$FDA-CTU$$46$YR$$F$N$61.65$KG$20240912$N$CN$US$
243156051$24315605$1$I$20240715$20240910$20240913$20240913$EXP$$KR-AstraZeneca-2024A207414$ASTRAZENECA$$26471$DY$$F$Y$$$20240913$$CN$KR$
243156061$24315606$1$I$20240829$20240906$20240913$20240913$EXP$$JP-AMGEN-JPNSP2024180070$AMGEN$$8$DEC$E$$Y$$$20240913$$MD$JP$JP
243156072$24315607$2$F$$20240917$20240913$20240919$PER$$US-AMGEN-USASP2024182258$AMGEN$$63$YR$A$M$Y$$$20240919$$PH$US$US
243156081$24315608$1$I$$20230817$20240913$20240913$PER$$US-ALVOGEN-2023092146$ALVOGEN$$$$$F$Y$$$20240913$$CN$US$US
243156091$24315609$1$I$20240822$20240905$20240913$20240913$EXP$$BR-CELLTRION INC.-2024BR021788$CELLTRION$$$$$$Y$$$20240913$$CN$BR$BR
243156101$24315610$1$I$$20240830$20240913$20240913$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093800$GLENMARK$$$$$$Y$$$20240913$$CN$US$US
243156132$24315613$2$F$$20240924$20240913$20240926$EXP$$CA-TAKEDA-2024TUS089531$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
243156141$24315614$1$I$20240702$20240815$20240913$20240913$PER$$US-CELLTRION INC.-2024US019891$CELLTRION$$$$$$Y$$$20240913$$HP$US$US
243156151$24315615$1$I$$20240911$20240913$20240913$PER$$US-HALEON-2196563$Haleon PLC$$$$$M$Y$$$20240913$$CN$US$US
243156161$24315616$1$I$$20240902$20240913$20240913$EXP$$IT-TEYRO-2024-TY-000600$Teyro Labs$Proto C, Ganzinelli M, Manglaviti S, Imbimbo M, Galli G, Marabese M, et.al.Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).Ann Oncol..2024;35(9):817-82$$$$$Y$$$20240913$$HP$IT$IT
243156171$24315617$1$I$20240807$20240905$20240913$20240913$PER$$US-CELLTRION INC.-2024US019096$CELLTRION$$$$$$Y$$$20240913$$CN$US$US
243156181$24315618$1$I$20240401$20240903$20240913$20240913$EXP$$CA-CELLTRION INC.-2024CA021286$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
243156191$24315619$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004926$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243156201$24315620$1$I$20240818$20240820$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004920$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240913$$CN$US$US
243156211$24315621$1$I$20240814$20240903$20240913$20240913$EXP$GB-MHRA-MED-202408240546063930-TJYKV$GB-AMAROX PHARMA-AMR2024GB02835$HETERO$$$$$$Y$$$20240913$$CN$GB$GB
243156221$24315622$1$I$$20240909$20240913$20240913$EXP$$DE-AUROBINDO-AUR-APL-2020-014911$AUROBINDO$Wobser M, Kneitz H, Brocker E-B, Becker JC.. Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - Diagnostic and therapeutic challenges. J-Dtsch-Dermatol-Ges. 2011;9(3}:204-210$70$YR$$M$Y$$$20240913$$MD$DE$DE
243156231$24315623$1$I$20240101$20240906$20240913$20240913$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240900117$UPSHER SMITH LABORATORIES$$$$$$Y$$$20240913$$HP$US$US
243156241$24315624$1$I$20240902$20240904$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409003060$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240913$$CN$US$US
243156251$24315625$1$I$20240909$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007577$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240913$$CN$US$US
243156261$24315626$1$I$$20240902$20240913$20240913$EXP$CA-MHPD-E2B_07252859$CA-Accord-444923$ACCORD$$87$YR$E$M$Y$$$20240913$$HP$CA$CA
243156272$24315627$2$F$$20240912$20240913$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005894$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$US$US
243156282$24315628$2$F$20240820$20240913$20240913$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409007851$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240924$$HP$US$US
243156291$24315629$1$I$20240910$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409008147$ELI LILLY AND CO$$$$$M$Y$$$20240913$$CN$US$US
243156301$24315630$1$I$20240906$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409006404$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240913$$CN$US$US
243156311$24315631$1$I$$20240909$20240913$20240913$EXP$$DE-TAKEDA-2024TUS090055$TAKEDA$$$$C$$Y$$$20240913$$PH$DE$DE
243156321$24315632$1$I$$20240819$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004882$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243156331$24315633$1$I$$20240905$20240913$20240913$EXP$$IE-CELLTRION INC.-2024IE021775$CELLTRION$$$$$$Y$$$20240913$$HP$IE$IE
243156341$24315634$1$I$$20240911$20240913$20240913$PER$$US-BIOGEN-2018BI00546025$BIOGEN$$$$$F$Y$$$20240913$$CN$US$US
243156351$24315635$1$I$$20240911$20240913$20240913$PER$$US-BIOGEN-2024BI01278506$BIOGEN$$$$$F$Y$$$20240913$$CN$US$US
243156361$24315636$1$I$20240626$20240906$20240913$20240913$EXP$$GB-ASTELLAS-2024-AER-005599$ASTELLAS$$73$YR$E$M$Y$$$20240913$$CN$GB$GB
243156381$24315638$1$I$20240502$20240909$20240913$20240913$EXP$$US-TAKEDA-2024TUS081502$TAKEDA$$84$YR$$M$Y$51$KG$20240913$$CN$US$US
243156391$24315639$1$I$$20240911$20240913$20240913$PER$$NVSC2024US183104$NOVARTIS$$$$$$Y$$$20240913$$MD$US$US
243156402$24315640$2$F$$20240912$20240913$20240917$PER$$NVSC2024US183401$NOVARTIS$$$$$M$Y$$$20240917$$MD$US$US
243156411$24315641$1$I$$20240910$20240913$20240913$EXP$$NVSC2024CA182454$NOVARTIS$$66$YR$$F$Y$$$20240913$$HP$CA$CA
243156421$24315642$1$I$$20240912$20240913$20240913$PER$$NVSC2024US183627$NOVARTIS$$$$$$Y$$$20240913$$HP$US$US
243156431$24315643$1$I$$20240909$20240913$20240913$EXP$$NVSJ2024JP010757$NOVARTIS$$$$$$Y$$$20240913$$MD$JP$JP
243156441$24315644$1$I$$20240912$20240913$20240913$PER$$NVSC2024US183572$NOVARTIS$$$$$$Y$$$20240913$$HP$US$US
243156451$24315645$1$I$$20240912$20240913$20240913$PER$$NVSC2024US183320$NOVARTIS$$$$$$Y$$$20240913$$CN$US$US
243156461$24315646$1$I$$20240912$20240913$20240913$PER$$NVSC2024US183526$NOVARTIS$$$$$$Y$$$20240913$$HP$US$US
243156471$24315647$1$I$$20240903$20240913$20240913$EXP$$GE-ASTELLAS-2024-AER-005324$ASTELLAS$Skalak HM, Mulloy LL. New Onset Diabetic Ketoacidosis in a Renal Transplant Recipient. The American Journal of the Medical Sciences. 2024;Unknown(Unknown): 1-18. doi:10.1016/j.amjms.2024.08.023.$38$YR$A$M$Y$$$20240913$$HP$GE$US
243156481$24315648$1$I$$20240911$20240913$20240913$PER$$NVSC2024US183616$NOVARTIS$$$$$$Y$$$20240913$$CN$US$US
243156491$24315649$1$I$20240115$20240912$20240912$20240912$DIR$718188$$FDA-CTU$$55$YR$$F$N$$$20240912$N$CN$US$
243156501$24315650$1$I$20240807$20240912$20240912$20240912$DIR$718199$$FDA-CTU$$80$YR$$F$N$51.75$KG$20240912$N$$US$
243156511$24315651$1$I$$20240910$20240913$20240913$EXP$$NVSC2024CA181662$NOVARTIS$$40$YR$$F$Y$$$20240913$$HP$CA$CA
243156531$24315653$1$I$$20240912$20240912$20240912$DIR$718154$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243156541$24315654$1$I$$20240912$20240912$20240912$DIR$718163$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243156551$24315655$1$I$20240912$20240912$20240912$20240912$DIR$718207$$FDA-CTU$$74$YR$$M$N$$$20240912$N$$US$
243156571$24315657$1$I$$20240905$20240913$20240913$EXP$$GB-TAKEDA-2023TUS029968$TAKEDA$$$$$M$Y$$$20240913$$CN$GB$GB
243156591$24315659$1$I$20240101$20240904$20240913$20240913$EXP$$US-JNJFOC-20240452533$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240913$$CN$US$US
243156601$24315660$1$I$$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004928$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243156612$24315661$2$F$$20240925$20240913$20240927$PER$$US-009507513-2408USA006412$MERCK$$$$$F$Y$63.492$KG$20240927$$HP$US$US
243156621$24315662$1$I$$20240909$20240913$20240913$EXP$$JP-AMGEN-JPNSP2024180423$AMGEN$$81$YR$E$F$Y$$$20240913$$PH$JP$JP
243156631$24315663$1$I$20240201$20240909$20240913$20240913$EXP$$JP-AMGEN-JPNSP2024180548$AMGEN$$$$$$Y$$$20240913$$MD$JP$JP
243156641$24315664$1$I$$20240904$20240913$20240913$30DAY$$US-GSK-US2024110223$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243156651$24315665$1$I$$20240904$20240913$20240913$EXP$$US-GSK-US2024110222$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$MD$US$US
243156661$24315666$1$I$$20240822$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005010$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243156671$24315667$1$I$$20240909$20240913$20240913$EXP$$US-AMGEN-USASL2024160665$AMGEN$$72$YR$E$F$Y$$$20240913$$CN$US$US
243156681$24315668$1$I$$20240906$20240913$20240913$EXP$$CO-AMGEN-COLSP2024180022$AMGEN$$$$$$Y$$$20240913$$CN$CO$CO
243156691$24315669$1$I$20240301$20240903$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0012824$DR REDDYS$$60$YR$A$M$Y$$$20240913$$HP$US$US
243156702$24315670$2$F$$20240916$20240913$20240926$PER$$US-RDY-SPO/USA/24/0012837$DR REDDYS$$53$YR$A$M$Y$$$20240926$$HP$US$US
243156721$24315672$1$I$$20240903$20240913$20240913$EXP$$CA-GILEAD-2024-0687255$GILEAD$$4$YR$C$F$Y$$$20240913$$HP$CA$CA
243156731$24315673$1$I$$20240903$20240913$20240913$EXP$$CA-GILEAD-2024-0687259$GILEAD$$17$YR$T$F$Y$$$20240913$$HP$CA$CA
243156741$24315674$1$I$20240909$20240909$20240913$20240913$PER$$US-JNJFOC-20240922065$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240913$$CN$US$US
243156751$24315675$1$I$20240901$20240903$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005291$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240913$$CN$US$US
243156761$24315676$1$I$$20240821$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004932$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243156771$24315677$1$I$20240815$20240906$20240913$20240913$EXP$$US-AstraZeneca-2024A206618$ASTRAZENECA$$17864$DY$$F$Y$$$20240913$$CN$US$
243156781$24315678$1$I$$20240909$20240913$20240913$PER$$US-AstraZeneca-2024A207835$ASTRAZENECA$$$$$$Y$$$20240913$$CN$US$
243156791$24315679$1$I$20240910$20240911$20240913$20240913$EXP$$US-AstraZeneca-2024A207602$ASTRAZENECA$$29543$DY$$F$Y$$$20240913$$CN$US$
243156801$24315680$1$I$20240101$20240906$20240913$20240913$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-EC-2024-164832$CATALYST PHARMA$$$$$M$Y$$$20240913$$CN$US$US
243156811$24315681$1$I$$20240905$20240913$20240913$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-00992$CATALYST PHARMA$$$$$M$Y$$$20240913$$CN$US$US
243156821$24315682$1$I$$20240906$20240913$20240913$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-01000$CATALYST PHARMA$$$$$M$Y$$$20240913$$CN$US$US
243156831$24315683$1$I$20240801$20240903$20240913$20240913$EXP$$US-UCBSA-2024045309$UCB$$33$YR$$F$Y$$$20240913$$HP$US$US
243156841$24315684$1$I$$20240902$20240913$20240913$EXP$$DE-Accord-445513$ACCORD$Foeldvari I, Anton J, Friswell M, Bica B, de Inocencio J, Aquilani A et al. Tocilizumab is a promising treatment option for therapy resistant juvenile localized scleroderma patients. Journal of Scleroderma and RelatedDisorders. 2017;2 (3):203-7.$$$$$Y$$$20240913$$MD$DE$DE
243156851$24315685$1$I$20240825$20240902$20240913$20240913$EXP$IT-MINISAL02-1000454$IT-Accord-445343$ACCORD$$85$YR$E$M$Y$$$20240913$$MD$IT$IT
243156861$24315686$1$I$$20240912$20240912$20240912$DIR$718158$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243156871$24315687$1$I$20240910$20240912$20240912$20240912$DIR$718161$$FDA-CTU$$38$YR$$F$N$76.5$KG$20240912$N$CN$US$
243156881$24315688$1$I$20240715$20240904$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044751$AUROBINDO$$86$YR$$F$Y$$$20240913$$MD$FR$FR
243156891$24315689$1$I$$20240903$20240913$20240913$EXP$$CA-GILEAD-2024-0687262$GILEAD$$$$$F$Y$$$20240913$$HP$CA$CA
243156901$24315690$1$I$$20240903$20240913$20240913$EXP$GB-MHRA-MED-202409032048169360-NLFMK$GB-Accord-444978$ACCORD$$46$YR$A$F$Y$$$20240913$$CN$GB$GB
243156921$24315692$1$I$$20240912$20240912$20240912$DIR$718169$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243156931$24315693$1$I$$20240912$20240912$20240912$DIR$718193$$FDA-CTU$$$$$UNK$N$$$20240912$$CN$US$
243156941$24315694$1$I$20240831$20240903$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005292$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240913$$CN$US$US
243156951$24315695$1$I$$20240909$20240913$20240913$EXP$$NVSC2024CA076281$NOVARTIS$$$$$F$Y$$$20240913$$MD$CA$CA
243156961$24315696$1$I$20240725$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145156$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240913$$HP$US$US
243156971$24315697$1$I$$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145686$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240913$$CN$US$US
243156981$24315698$1$I$20240827$20240909$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144862$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240913$$HP$US$US
243156991$24315699$1$I$$20240910$20240913$20240913$EXP$$JP-ABBVIE-22K-087-4440977-00$ABBVIE$$73$YR$$F$Y$$$20240913$$MD$JP$JP
243157011$24315701$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145323$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$107.96$KG$20240913$$PH$US$US
243157021$24315702$1$I$$20240703$20240913$20240913$PER$$US-ALVOGEN-2024094988$ALVOGEN$$$$$M$Y$$$20240913$$HP$US$US
243157031$24315703$1$I$$20240903$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005293$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243157042$24315704$2$F$$20240910$20240913$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08681$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243157051$24315705$1$I$$20240906$20240913$20240913$EXP$$CA-TAKEDA-2024TUS089926$TAKEDA$$$$$M$Y$$$20240913$$CN$CA$CA
243157061$24315706$1$I$$20240904$20240913$20240913$EXP$$TR-JNJFOC-20240923034$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$HP$TR$TR
243157071$24315707$1$I$$20240905$20240913$20240913$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011615$STRIDES$Goel AR, Sylvester C, Avidan OR, Gilvaz VJ.. Psoriasis and psoriatic arthritis following use of dostarlimab for endometrial cancer.. BMJ-Case-Rep. 2024;17 (8)$$$$$Y$$$20240913$$HP$US$US
243157081$24315708$1$I$$20240909$20240913$20240913$EXP$$JP-GSK-JP2024JPN112082$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$JP$JP
243157101$24315710$1$I$$20240903$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005300$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243157111$24315711$1$I$$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004936$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243157141$24315714$1$I$20240228$20240905$20240913$20240913$EXP$$CA-BEH-2024172758$CSL BEHRING$$74$YR$E$F$Y$109.75$KG$20240913$$CN$CA$CA
243157161$24315716$1$I$20240703$20240912$20240912$20240912$DIR$718166$$FDA-CTU$$65$YR$$F$N$85.95$KG$20240912$N$CN$US$
243157171$24315717$1$I$20240831$20240912$20240912$20240912$DIR$718206$$FDA-CTU$$66$YR$$F$N$65.7$KG$20240912$N$CN$US$
243157181$24315718$1$I$$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024180295$AMGEN$$$$E$F$Y$$$20240913$$HP$US$US
243157201$24315720$1$I$20240726$20240911$20240913$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028559$UNITED THERAPEUTICS$$65$YR$$M$Y$$$20240913$$$US$US
243157211$24315721$1$I$20240829$20240903$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005314$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240913$$CN$US$US
243157221$24315722$1$I$20240726$20240827$20240913$20240913$PER$$US-CELLTRION INC.-2024US018579$CELLTRION$$$$$$Y$$$20240913$$CN$US$US
243157232$24315723$2$F$20240611$20240912$20240913$20240920$EXP$$JP-GALDERMA-JP2024010788$GALDERMA$$$$$$Y$$$20240920$$MD$JP$JP
243157241$24315724$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240648$TEVA$$$$$$Y$$$20240913$$HP$CA$CA
243157251$24315725$1$I$20221114$20240906$20240913$20240913$EXP$BE-EMA-DD-20240902-7482677-073616$BE-Accord-446286$ACCORD$$66$YR$E$F$Y$42$KG$20240913$$MD$BE$BE
243157261$24315726$1$I$20240309$20240909$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409005454$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240913$$CN$US$US
243157271$24315727$1$I$$20240829$20240913$20240913$EXP$$BR-PHATHOM PHARMACEUTICALS INC.-2024PHT00834$Phathom Pharmaceuticals$$$$$F$Y$85$KG$20240913$$CN$BR$BR
243157281$24315728$1$I$$20240906$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409004834$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240913$$CN$US$US
243157291$24315729$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007299$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240913$$CN$US$US
243157301$24315730$1$I$$20240906$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409004444$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240913$$CN$US$US
243157312$24315731$2$F$$20240911$20240913$20240916$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014814$JAZZ$$$$$F$Y$$$20240916$$CN$US$US
243157321$24315732$1$I$$20240910$20240913$20240913$PER$$US-ROCHE-10000078927$ROCHE$$$$E$F$Y$$$20240913$$CN$US$US
243157331$24315733$1$I$20240619$20240904$20240913$20240913$EXP$$US-TEVA-VS-3240252$TEVA$$44$YR$$M$Y$89$KG$20240913$$PH$US$US
243157342$24315734$2$F$20240906$20240918$20240913$20240925$EXP$$CO-ROCHE-10000079717$ROCHE$$31$YR$A$F$Y$65$KG$20240925$$CN$CO$CO
243157351$24315735$1$I$20240727$20240905$20240913$20240913$EXP$FR-AFSSAPS-LL2024001590$FR-TEVA-VS-3240943$TEVA$$19$YR$$F$Y$71$KG$20240913$$PH$FR$FR
243157371$24315737$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144644$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240913$$CN$US$US
243157381$24315738$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144579$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240913$$HP$US$US
243157391$24315739$1$I$20240907$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144549$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240913$$CN$US$US
243157401$24315740$1$I$20240910$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145689$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240913$$CN$US$US
243157421$24315742$1$I$20240905$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145300$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240913$$CN$US$US
243157433$24315743$3$F$$20240919$20240913$20240927$EXP$GB-MLMSERVICE-20240807-PI154304-00117-3$GB-TEVA-VS-3240338$TEVA$Mohidin B, Needleman A, Fernando R, Lowe DM, Wechalekar A, Sheaff M, et al.. Renal transplant outcomes in plasma cell dyscrasias and AL amyloidosis after treatment with daratumuma. Journal of Clinical Medicine. 2024;13(14)_4109; Mohidin B, Needleman A, Fernando R, Lowe DM, Wechalekar A, Sheaff M, et al. Renal transplant outcomes in plasma cell dyscrasias and AL amyloidosis after treatment with daratumumab. Journal of Clinical Medicine. 2024;13(14):4109 on 07 Aug 2024$59$YR$$M$Y$$$20240927$$MD$GB$GB
243157441$24315744$1$I$$20240830$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140062$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240913$$CN$US$US
243157451$24315745$1$I$$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181196$AMGEN$$87$YR$E$F$Y$$$20240913$$CN$US$US
243157461$24315746$1$I$$20240909$20240913$20240913$EXP$$CA-AMGEN-CANSL2024180229$AMGEN$$88$YR$E$F$Y$$$20240913$$CN$CA$CA
243157471$24315747$1$I$20240906$20240906$20240913$20240913$PER$$US-AMGEN-USASP2024178949$AMGEN$$72$YR$E$F$Y$48.1$KG$20240913$$PH$US$US
243157481$24315748$1$I$$20240910$20240913$20240913$EXP$$CA-Orion Corporation ORION PHARMA-24_00031660$ORION$$40$YR$A$F$Y$$$20240913$$HP$CA$
243157491$24315749$1$I$20240627$20240905$20240913$20240913$EXP$FR-AFSSAPS-DJ2024000969$FR-TEVA-VS-3241120$TEVA$$84$YR$$F$Y$$$20240913$$PH$FR$FR
243157511$24315751$1$I$$20240907$20240913$20240913$PER$$US-BEH-2024178602$CSL BEHRING$$67$YR$E$M$Y$$$20240913$$CN$US$US
243157521$24315752$1$I$$20240906$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024111403$VIIV$$$$A$M$Y$$$20240913$$MD$US$US
243157531$24315753$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240758$TEVA$$42$YR$$F$Y$70$KG$20240913$$MD$CA$CA
243157541$24315754$1$I$$20240909$20240913$20240913$EXP$$JP-GSK-JP2024JPN112080$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$JP$JP
243157551$24315755$1$I$20240905$20240909$20240913$20240913$EXP$$US-GSK-US2024099726$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$US$US
243157561$24315756$1$I$$20240909$20240913$20240913$EXP$$JP-GSK-JP2024JPN112079$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$JP$JP
243157571$24315757$1$I$$20240909$20240913$20240913$EXP$$JP-GSK-JP2024JPN112078$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$JP$JP
243157581$24315758$1$I$$20240902$20240913$20240913$EXP$CA-MHPD-E2B_07202521$CA-Accord-444765$ACCORD$$66$YR$E$F$Y$$$20240913$$HP$CA$CA
243157591$24315759$1$I$20231223$20240902$20240913$20240913$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-26805$SAMSUNG BIOEPIS$$80$YR$E$M$Y$105$KG$20240913$$HP$GB$GB
243157601$24315760$1$I$20240620$20240906$20240913$20240913$EXP$$CN-JNJFOC-20240923436$JOHNSON AND JOHNSON$$7$DY$N$F$Y$1.4$KG$20240913$$HP$CN$CN
243157621$24315762$1$I$$20240901$20240913$20240913$EXP$$JP-Accord-446401$ACCORD$Toji Y, Takeuchi S, Ebihara Y, Kurashima Y, Harada K, Hayashi M, et al. Perioperative chemotherapy with nivolumab for HER2-negative locally advanced gastric cancer: a case series. Surg Case Rep. 2024 Aug 28;10(1):200. doi: 10.1186/s40792-024-02001-w.$60$YR$A$M$Y$$$20240913$$HP$JP$JP
243157631$24315763$1$I$20231008$20240913$20240913$20240913$PER$$US-PROD-AS2-212756134-RB-135367-2023$RECKITT BENCKISER$$74$YR$$F$Y$68.18$KG$20240913$$CN$US$US
243157641$24315764$1$I$$20240906$20240913$20240913$EXP$$JP-AMGEN-JPNSP2024178879$AMGEN$Yamaguchi Y.; Itogawa K.; Saito T. et al.. First Reported Case of Pure Red Cell Aplasia Related to Sotorasib. lnternal Medicine. 2024;1-4$63$YR$A$M$Y$$$20240913$$HP$JP$JP
243157651$24315765$1$I$20240221$20240830$20240913$20240913$EXP$$ES-MDD US Operations-E2B_00006433$MDD OPERATIONS$$78$YR$$M$Y$$$20240912$$MD$ES$ES
243157661$24315766$1$I$$20240903$20240913$20240913$EXP$$BR-TAKEDA-2024TUS089766$TAKEDA$$$$$F$Y$$$20240913$$CN$BR$BR
243157671$24315767$1$I$$20240910$20240913$20240913$EXP$$NVSC2024CA181725$NOVARTIS$$44$YR$$F$Y$$$20240913$$HP$CA$CA
243157692$24315769$2$F$$20240926$20240913$20240927$PER$$US-JNJFOC-20240934055$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240927$$CN$US$US
243157702$24315770$2$F$$20240911$20240913$20240918$EXP$$AU-ROCHE-10000078757$ROCHE$$43$YR$A$M$Y$$$20240918$$MD$AU$AU
243157711$24315771$1$I$20091214$20240905$20240913$20240913$EXP$$US-CHEPLA-2024011473$CHEPLAPHARM$$59$YR$$M$Y$93$KG$20240913$$MD$COUNTRY NOT SPECIFIED$US
243157721$24315772$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004978$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243157731$24315773$1$I$$20240911$20240913$20240913$PER$$NVSC2024US183152$NOVARTIS$$$$$$Y$$$20240913$$CN$US$US
243157741$24315774$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5917167$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243157751$24315775$1$I$$20240903$20240913$20240913$EXP$CA-MHPD-001094104$CA-Accord-445004$ACCORD$$3$YR$C$F$Y$15$KG$20240913$$HP$CA$CA
243157761$24315776$1$I$20240907$20240910$20240913$20240913$EXP$$JP-SANDOZ INC.-SDZ2024JP079997$SANDOZ$$71$YR$$M$Y$$$20240913$$CN$JP$JP
243157771$24315777$1$I$$20240826$20240913$20240913$EXP$$US-SANDOZ INC.-SDZ2024US079903$SANDOZ$$76$YR$$F$Y$$$20240913$$CN$US$US
243157781$24315778$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240782$TEVA$$$$$M$Y$12$KG$20240913$$MD$CA$CA
243157791$24315779$1$I$20240902$20240904$20240913$20240913$30DAY$$US-GSK-US2024110254$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240913$$CN$US$US
243157801$24315780$1$I$$20240905$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR110937$VIIV$$$$A$M$Y$$$20240913$$HP$US$US
243157811$24315781$1$I$$20240905$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR110938$VIIV$$$$A$M$Y$$$20240913$$HP$US$US
243157821$24315782$1$I$20240801$20240909$20240913$20240913$PER$$US-BAUSCH-BL-2024-013509$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240913$$CN$US$US
243157831$24315783$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145362$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240913$$CN$US$US
243157841$24315784$1$I$$20240903$20240913$20240913$EXP$$US-UCBSA-2024045379$UCB$$$$$F$Y$$$20240913$$HP$US$US
243157851$24315785$1$I$$20240903$20240913$20240913$EXP$$IT-MYLANLABS-2024M1082300$MYLAN$De Zen L, Divisic A, Molinaro G, Solidoro S, Barbi E. Dexmedetomidine at Home for Intractable Dystonia and Insomnia in Children With Special Needs: A Case Series. J-Pain-Symptom-Manage 2023; 66 (6): e653-e657.$$$$M$Y$$$20240913$$HP$IT$IT
243157861$24315786$1$I$$20240903$20240913$20240913$EXP$$IT-MYLANLABS-2024M1081900$MYLAN$De Zen L, Divisic A, Molinaro G, Solidoro S, Barbi E. Dexmedetomidine at Home for Intractable Dystonia and Insomnia in Children With Special Needs: A Case Series. J-Pain-Symptom-Manage 2023; 66 (6): e653-e657.$$$$F$Y$$$20240913$$HP$IT$IT
243157871$24315787$1$I$$20240902$20240913$20240913$EXP$$IN-MYLANLABS-2024M1082206$MYLAN$Haritha S, Pavithra R, Rallabandi P, Lakshmanan S, Sowmini PR, Sakthi VS, et al. Anticoagulant-induced Spinal Epidural Hematoma with Spontaneous Recovery. J-Assoc-Physicians-India 2024; 72 (8): 114.$71$YR$$M$Y$$$20240913$$MD$IN$IN
243157881$24315788$1$I$$20240904$20240913$20240913$EXP$$US-MYLANLABS-2024M1082362$MYLAN$Khadka S, Dong N, Chavez J. ABCL-440 Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CHP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Single-Center Experience. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl.) S480.$$$$$Y$$$20240913$$MD$US$US
243157901$24315790$1$I$$20240903$20240913$20240913$EXP$$IT-MYLANLABS-2024M1082234$MYLAN$De Zen L, Divisic A, Molinaro G, Solidoro S, Barbi E. Dexmedetomidine at Home for Intractable Dystonia and Insomnia in Children With Special Needs: A Case Series. J-Pain-Symptom-Manage 2023; 66 (6): e653-e657.$$$$F$Y$$$20240913$$HP$IT$IT
243157911$24315791$1$I$20240821$20240903$20240913$20240913$EXP$$CN-AUROBINDO-AUR-APL-2024-045139$AUROBINDO$$61$YR$$F$Y$$$20240913$$HP$CN$CN
243157921$24315792$1$I$$20240902$20240913$20240913$EXP$$US-MSNLABS-2024MSNLIT01923$MSN LABORATORIES$Ghezzi L, Levasseur VA, Perantie DC, Wu GF, Cross AH.Extensive rebound MS activity following dimethyl fumarate discontinuation in a 63 year old - A case report.Neuroimmunology Reports.2023;31-4$$$$$Y$$$20240913$$HP$US$US
243157932$24315793$2$F$$20240919$20240913$20240925$EXP$$JP-GSK-JP2024112335$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$PH$JP$JP
243157941$24315794$1$I$$20240911$20240913$20240913$PER$$US-TAKEDA-2024TUS090598$TAKEDA$$$$$$Y$$$20240913$$HP$US$US
243157952$24315795$2$F$20240815$20240923$20240913$20240927$PER$$ES-IDORSIA-008372-2024-ES$IDORSIA PHARMACEUTICALS$$93$YR$$M$Y$$$20240927$$CN$ES$ES
243157962$24315796$2$F$20240101$20240915$20240913$20240920$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-121423$REGENERON$$$$$F$Y$$$20240920$$MD$US$US
243157971$24315797$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004982$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243157981$24315798$1$I$$20240823$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08541$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243157991$24315799$1$I$$20240903$20240913$20240913$EXP$CA-MHPD-001092796$CA-Accord-445002$ACCORD$$29$YR$A$F$Y$$$20240913$$HP$CA$CA
243158001$24315800$1$I$20240101$20240910$20240913$20240913$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050708$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240913$$CN$US$US
243158031$24315803$1$I$20240806$20240913$20240913$20240913$EXP$IT-MINISAL02-1001928$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051264$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$$$20240913$$PH$IT$IT
243158041$24315804$1$I$20240701$20240830$20240913$20240913$EXP$$US-UCBSA-2024044757$UCB$$48$YR$$F$Y$$$20240913$$HP$US$US
243158051$24315805$1$I$$20240829$20240913$20240913$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467602$RANBAXY$Sung J, Lee D, Song JY, Kim JH, Lee J. The Value of High-Resolution Vessel Wall Magnetic Resonance Imaging in the Diagnosis and Management of Primary Angiitis of the Central Nervous System in Children. Ann Child Neurol. 2021;29 (4):159-167$6$YR$$M$Y$$$20240913$$MD$KR$KR
243158061$24315806$1$I$$20240829$20240913$20240913$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467601$RANBAXY$Sung J, Lee D, Song JY, Kim JH, Lee J. The Value of High-Resolution Vessel Wall Magnetic Resonance Imaging in the Diagnosis and Management of Primary Angiitis of the Central Nervous System in Children. Ann Child Neurol. 2021;29(4):159-167$11$YR$$F$Y$$$20240913$$MD$KR$KR
243158071$24315807$1$I$$20240829$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467593$RANBAXY$You C, Xu L, Zhu L, Qiu S, Xu N, Wang Y, et al. Clinical analysis of five CHD2 gene mutations in Chinese children with epilepsy. SEIZURE EUR J EPILEP. 2024;121 (0):38-44$$$C$F$Y$$$20240913$$HP$CN$CN
243158081$24315808$1$I$$20240829$20240913$20240913$EXP$$CL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467595$RANBAXY$You C, Xu L, Zhu L, Qiu S, Xu N, Wang Y, et al. Clinical analysis of five CHD2 gene mutations in Chinese children with epilepsy. SEIZURE EUR J EPILEP. 2024;121 (0):38-44$$$$M$Y$$$20240913$$HP$CL$CN
243158091$24315809$1$I$20231106$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466176$RANBAXY$$71$YR$$F$Y$$$20240913$$MD$AU$AU
243158101$24315810$1$I$$20240829$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467590$RANBAXY$Junyi C, Xiangmei K, Xinghuai S. Effect of selective laser trabeculoplasty on intraocular pressure in patients with glucocorticoid induced glaucoma. Chin J Exp Ophthalmol. 2014;32(2):168-171$43$YR$$M$Y$$$20240913$$HP$CN$CN
243158111$24315811$1$I$$20240829$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467591$RANBAXY$Junyi C, Xiangmei K, Xinghuai S. Effect of selective laser trabeculoplasty on intraocular pressure in patients with glucocorticoid induced glaucoma. Chin J Exp Opthalmol. 2014;Feb; 32(2):168-171$52$YR$$M$Y$$$20240913$$HP$CN$CN
243158121$24315812$1$I$$20240829$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467584$RANBAXY$Chen J, Kong X, Sun X. Effect of selective laser trabeculoplasty on intraocular pressure in patients with glucocorticoid induced glaucoma. Chin J Exp Ophthalmol. 2014;Feb;32(2):168-71$28$YR$$M$Y$$$20240913$$HP$CN$CN
243158131$24315813$1$I$$20240829$20240913$20240913$EXP$$LV-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467604$RANBAXY$Renemane L, Rancans E. Sertraline induced acute hepatocellular liver injury in patient with major depressive disorder: a case report. Frontiers in Psychiatry. 2024;15 (0):No pagination (1-7)$36$YR$$F$Y$$$20240913$$HP$LV$LV
243158142$24315814$2$F$$20240912$20240913$20240927$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467598$RANBAXY$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transpl Infect Dis. 2024;Apr; 26 (3):e14276$6$MON$$M$Y$$$20240927$$HP$ES$ES
243158151$24315815$1$I$$20240829$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467586$RANBAXY$Junyi C, Xiangmei K, Xinghuai S. Effect of selective laser trabeculoplasty on intraocular pressure in patients with glucocorticoid induced glaucoma. Chin J Exp Ophthalmol. 2024;Feb;32(2):168-71$22$YR$$M$Y$$$20240913$$HP$CN$CN
243158161$24315816$1$I$$20240829$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467585$RANBAXY$Junyi C, Xiangmei K, Xinghuai S. Effect of selective laser trabeculoplasty on intraocular pressure in patients with glucocorticoid induced glaucoma. Chin J Exp Ophthalmol. 2014;Feb;32(2):168-71$35$YR$$F$Y$$$20240913$$HP$CN$CN
243158171$24315817$1$I$$20240829$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467587$RANBAXY$Junyi C, Xiangmei K, Xinghuai S. Effect of selective laser trabeculoplasty on intraocular pressure in patients with glucocorticoid induced glaucoma. Chin J Exp Ophthalmol. 2014;Feb;32(2):168-71$28$YR$$M$Y$$$20240913$$HP$CN$CN
243158181$24315818$1$I$$20240829$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467611$RANBAXY$Dcunha NJ, Wei Q, Thakral B, Medeiros LJ. From the archives of MD Anderson Cancer Center: Monomorphic epitheliotropic intestinal T-cell lymphoma: A case with an unusual immunophenotype and discussion of differential diagnosis. Ann Diagn Pathol. 2024;70(0):No pagination$$$$$Y$$$20240913$$HP$US$US
243158191$24315819$1$I$$20240829$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467588$RANBAXY$Junyi C, Xiangmei K, Xinghuai S. Effect of selective laser trabeculoplasty on intraocular pressure in patients with glucocorticoid induced glaucoma. Chin J Exp Ophthalmol. 2014;Feb;32(2):168-71$45$YR$$M$Y$$$20240913$$HP$CN$CN
243158201$24315820$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467605$RANBAXY$$53$YR$$M$Y$$$20240913$$MD$AU$AU
243158211$24315821$1$I$20240708$20240903$20240913$20240913$EXP$$FR-JNJFOC-20240930657$JOHNSON AND JOHNSON$$54$YR$A$F$Y$115$KG$20240913$$MD$FR$FR
243158221$24315822$1$I$20171101$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466177$RANBAXY$$67$YR$$M$Y$$$20240913$$MD$AU$AU
243158231$24315823$1$I$$20240905$20240913$20240913$EXP$$RU-AstraZeneca-2024A205662$ASTRAZENECA$$$$$M$Y$$$20240913$$HP$RU$
243158241$24315824$1$I$$20240906$20240913$20240913$EXP$$ZA-AstraZeneca-2024A205449$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$ZA$
243158251$24315825$1$I$$20240829$20240913$20240913$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467476$RANBAXY$Schmidt F, Erlacher M, Niemeyer C, Reinhardt D, Klusmann J-H. Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML. Front Pediatr. 2022;10:1046586 (1-8)$17$YR$$F$Y$$$20240913$$HP$DE$DE
243158262$24315826$2$F$$20240912$20240913$20240927$EXP$$SG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467481$RANBAXY$Isais FS, Sadasiv MS, Ling DNH, Allen DM. Successful Treatment of Pulmonary Nocardia cyriacigeorgica in an Immunocompetent Patient with Oral Clarithromycin. Infect Chemotherap. 2024;Apr;56 (Suppl.1:S155;P2CC-005$70$YR$$F$Y$$$20240927$$HP$SG$SG
243158271$24315827$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467496$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243158281$24315828$1$I$20050501$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467400$RANBAXY$$$$$$Y$$$20240913$$MD$AU$AU
243158291$24315829$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467485$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243158301$24315830$1$I$$20240911$20240913$20240913$PER$$US-TAKEDA-2024TUS090699$TAKEDA$$$$$F$Y$$$20240913$$CN$US$US
243158311$24315831$1$I$20240415$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467518$RANBAXY$$70$YR$$F$Y$$$20240913$$CN$AU$AU
243158321$24315832$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467490$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243158331$24315833$1$I$$20240829$20240913$20240913$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467536$RANBAXY$Ladrach C, Wartenberg M, Zimmerli S, Anschuetz L, Bohlen S, Ebner J, et al. Survival from Rhino-Orbital-Cerebral Mucormycosis in SARS-CoV-2-Positive Diabetic Patients: Two Case Reports. Case Rep Neurol. 2024;16 (1):89-98$75$YR$$F$Y$$$20240913$$HP$CH$CH
243158341$24315834$1$I$$20240829$20240913$20240913$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467522$RANBAXY$Saxena M, Madabhavi IV, Patel A, Panchal H, Anand A. Treating low? and intermediate?risk acute promyelocytic leukemia with and without chemotherapy: A comparison in a tertiary care center. J Cancer Res Ther. 2023;19(5):1371-1378$$$A$$Y$$$20240913$$HP$IN$IN
243158351$24315835$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467551$RANBAXY$$$$$M$Y$$$20240913$$HP$AU$AU
243158361$24315836$1$I$20240604$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467503$RANBAXY$$7$WK$$$Y$$$20240913$$CN$AU$AU
243158371$24315837$1$I$$20240829$20240913$20240913$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467419$RANBAXY$Souza CC, Rigueto LG, Santiago HC, Seguro AC, Girardi ACC, Luchi WM. Multiple electrolyte disorders triggered by proton pump inhibitor-induced hypomagnesemia: Case reports with a mini-review of the literature. Clin Nephrol Case Stud. 2024;12:6-11$65$YR$$F$Y$$$20240913$$HP$BR$BR
243158381$24315838$1$I$$20240829$20240913$20240913$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467583$RANBAXY$Yamada S, Orisaka M, Kurokawa T, OnumaT, Shinagawa A, Yoshida Y. Combination therapy with paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive recurrent serous carcinoma of the uterine cervix: A case report. J Obstet Gynaecol. 2024;-:1-5$42$YR$$F$Y$$$20240913$$HP$JP$JP
243158391$24315839$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467466$RANBAXY$$30$YR$$M$Y$$$20240913$$HP$AU$AU
243158401$24315840$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467504$RANBAXY$$$$$F$Y$$$20240913$$CN$AU$AU
243158411$24315841$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467402$RANBAXY$$$$$$Y$$$20240913$$PH$AU$AU
243158421$24315842$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467470$RANBAXY$$49$YR$$F$Y$$$20240913$$HP$AU$AU
243158431$24315843$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467407$RANBAXY$$$$$$Y$$$20240913$$MD$AU$AU
243158441$24315844$1$I$20240604$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467517$RANBAXY$$32$YR$$F$Y$$$20240913$$CN$AU$AU
243158451$24315845$1$I$$20240829$20240913$20240913$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467539$RANBAXY$Ladrach C, Wartenberg M, Zimmerli S, Anschuetz L, Bohlen S, Ebner J, et al. Survival from Rhino-Orbital-Cerebral Mucormycosis in SARS-CoV-2-Positive Diabetic Patients: Two Case Reports. Case Rep Neurol. 2024;16 (1):89-98$39$YR$$M$Y$$$20240913$$HP$CH$CH
243158461$24315846$1$I$20240430$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467524$RANBAXY$$58$YR$$M$Y$$$20240913$$HP$AU$AU
243158471$24315847$1$I$20240407$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467529$RANBAXY$$42$YR$$F$Y$$$20240913$$HP$AU$AU
243158481$24315848$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467488$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243158491$24315849$1$I$$20240829$20240913$20240913$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467451$RANBAXY$Manju Bhargav BR, Radhakrishnan VV, Sivaprasad K. A CASE SERIES OF THROMBOLYSIS IN PROSTHETIC VALVE THROMBOSIS. Indian Heart J. 2023;75 (Suppl.):S91-S93;ABCSI2023268$41$YR$$F$Y$$$20240913$$HP$IN$IN
243158501$24315850$1$I$$20240829$20240913$20240913$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467454$RANBAXY$Campos ID, Moreira H, Portal F, Paiva JA. Unusual presentation of benzodiazepine withdrawal with Takotsubo syndrome: a case report. Eur Heart J Case Rep. 2024;8 (4):ytae136 (1-5)$58$YR$$F$Y$$$20240913$$HP$PT$PT
243158511$24315851$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467398$RANBAXY$$54$YR$$M$Y$$$20240913$$MD$AU$AU
243158521$24315852$1$I$20240713$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467554$RANBAXY$$79$YR$$F$Y$$$20240913$$CN$AU$AU
243158531$24315853$1$I$$20240829$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467443$RANBAXY$Ding K, Peng Z, Liu D, Xu Y. Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation. J Transl Med. 2024;22 (1):761$43$YR$$M$Y$$$20240913$$HP$CN$CN
243158541$24315854$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467508$RANBAXY$$6$DEC$$$Y$$$20240913$$MD$AU$AU
243158551$24315855$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467520$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243158561$24315856$1$I$20240419$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467561$RANBAXY$$72$YR$$M$Y$$$20240913$$CN$AU$AU
243158571$24315857$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467408$RANBAXY$$59$YR$$F$Y$$$20240913$$MD$AU$AU
243158581$24315858$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467446$RANBAXY$$77$YR$$$Y$$$20240913$$MD$AU$AU
243158591$24315859$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467461$RANBAXY$$83$YR$$F$Y$68$KG$20240913$$HP$AU$AU
243158601$24315860$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467412$RANBAXY$$$$$F$Y$$$20240913$$MD$AU$AU
243158611$24315861$1$I$20240201$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467403$RANBAXY$$47$YR$$F$Y$$$20240913$$MD$AU$AU
243158621$24315862$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467474$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243158631$24315863$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467464$RANBAXY$$52$YR$$M$Y$$$20240913$$MD$AU$AU
243158641$24315864$1$I$$20240829$20240913$20240913$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467569$RANBAXY$Anadure RK, Goel J, Saxena R, Mohimen A, Agrawal P. Refractory Immune?Mediated Cysticercal Meningitis and Role of B Cell Depleting Therapy. Neurol India. 2024;72:615-9$20$YR$$M$Y$$$20240913$$HP$IN$IN
243158651$24315865$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467404$RANBAXY$$44$YR$$F$Y$$$20240913$$MD$AU$AU
243158661$24315866$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467515$RANBAXY$$$$E$$Y$$$20240913$$HP$AU$AU
243158671$24315867$1$I$$20240829$20240913$20240913$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467416$RANBAXY$Souza CC, Rigueto LG, Santiago HC, Seguro AC, Girardi ACC, Luchi WM. Multiple electrolyte disorders triggered by proton pump inhibitor-induced hypomagnesemia: Case reports with a mini-review of the literature. Clin Nephrol Case Stud. 2024;12:6-11$35$YR$$M$Y$$$20240913$$HP$BR$BR
243158682$24315868$2$F$20240704$20240924$20240913$20240926$EXP$$NVSC2024GB143792$NOVARTIS$$70$YR$$F$Y$$$20240926$$CN$GB$GB
243158691$24315869$1$I$$20240903$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409002491$ELI LILLY AND CO$$54$YR$A$$Y$$$20240913$$LW$US$US
243158701$24315870$1$I$20240911$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007680$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240913$$CN$US$US
243158713$24315871$3$F$20240801$20240917$20240913$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409007674$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240923$$CN$US$US
243158721$24315872$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007131$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240913$$CN$US$US
243158731$24315873$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007367$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240913$$CN$US$US
243158741$24315874$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007522$ELI LILLY AND CO$$42$YR$A$$Y$$$20240913$$CN$US$US
243158751$24315875$1$I$20240701$20240903$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409001900$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240913$$CN$US$US
243158762$24315876$2$F$20240803$20240913$20240913$20240918$EXP$$US-BIOGEN-2024BI01281874$BIOGEN$$55$YR$$M$Y$$$20240918$$MD$US$US
243158771$24315877$1$I$$20240911$20240913$20240913$PER$$US-ABBVIE-5921690$ABBVIE$$72$YR$$M$Y$$$20240913$$MD$US$US
243158782$24315878$2$F$20240831$20240917$20240913$20240926$EXP$$TR-CELLTRION INC.-2024TR021782$CELLTRION$$$$$$Y$$$20240926$$HP$TR$TR
243158801$24315880$1$I$$20240910$20240913$20240913$EXP$$US-INTERCEPT-PM2024001798$INTERCEPT PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243158811$24315881$1$I$$20240910$20240913$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014853$JAZZ$$$$$F$Y$$$20240913$$HP$US$US
243158831$24315883$1$I$20240905$20240905$20240913$20240913$EXP$$DO-EMD Serono-2024047892$EMD SERONO INC$$41$YR$A$F$Y$$$20240913$$CN$DO$DO
243158841$24315884$1$I$$20240903$20240913$20240913$EXP$$NVSC2024AE182897$NOVARTIS$Fatima N, Hamza LK, Almulla AAA, Salman A. Favourable outcome in a primigravida with hydroxychloroquine (HCQ) induced (most likely) cardiomyopathy: a case report and literature review. ITALIAN JOURNAL OF GYNAECOLOGY AND OBSTETRICS. 2023;35 (4):488-92$$$N$M$Y$$$20240913$$HP$AE$AE
243158862$24315886$2$F$$20240916$20240913$20240924$EXP$$GB-AUROBINDO-AUR-APL-2024-045328$AUROBINDO$$$$A$F$Y$$$20240924$$MD$GB$GB
243158871$24315887$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467396$RANBAXY$$$$$M$Y$$$20240913$$HP$AU$AU
243158881$24315888$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467351$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243158891$24315889$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467383$RANBAXY$$$$$F$Y$$$20240913$$CN$AU$AU
243158901$24315890$1$I$20240220$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467392$RANBAXY$$30$YR$$M$Y$$$20240913$$MD$AU$AU
243158921$24315892$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467340$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243158931$24315893$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467237$RANBAXY$$$$N$$Y$$$20240913$$HP$AU$AU
243158941$24315894$1$I$20240418$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467312$RANBAXY$$61$YR$$M$Y$$$20240913$$HP$AU$AU
243158951$24315895$1$I$$20240829$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467397$RANBAXY$Bhatia SS, Malhotra PS, Poole K, Malaviya A. FGF23-secreting sinonasal tumour presenting with acute subdural haemorrhage and tumour induced osteomalacia. BMJ Case Rep. 2024;17 (8):e259439(1-7)$$$A$F$Y$$$20240913$$HP$GB$GB
243158961$24315896$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467344$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243158971$24315897$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467345$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243158981$24315898$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467239$RANBAXY$$$$N$$Y$$$20240913$$HP$AU$AU
243158991$24315899$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467362$RANBAXY$$73$YR$$M$Y$$$20240913$$HP$AU$AU
243159001$24315900$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467361$RANBAXY$$73$YR$$M$Y$$$20240913$$HP$AU$AU
243159011$24315901$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467355$RANBAXY$$$$$$Y$$$20240913$$MD$AU$AU
243159021$24315902$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467350$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159031$24315903$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467360$RANBAXY$$$$$M$Y$$$20240913$$MD$AU$AU
243159041$24315904$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467162$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159051$24315905$1$I$20240401$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467266$RANBAXY$$$$$F$Y$$$20240913$$CN$AU$AU
243159061$24315906$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467251$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159071$24315907$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467165$RANBAXY$$$$N$$Y$$$20240913$$HP$AU$AU
243159082$24315908$2$F$$20240906$20240913$20240920$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467320$RANBAXY$Gokten DB, Kavak FY, Mercan R. Bilateral hand dactylitis: An unusual presentation of the great imitator: Tuberculosis. Mod Rheumatol Case Rep. 2024;8 (2):365-367$42$YR$$M$Y$$$20240920$$HP$TR$TR
243159091$24315909$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467381$RANBAXY$$46$YR$$M$Y$$$20240913$$MD$AU$AU
243159101$24315910$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467394$RANBAXY$$30$YR$$M$Y$$$20240913$$HP$AU$AU
243159111$24315911$1$I$20230215$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467382$RANBAXY$$77$YR$$F$Y$$$20240913$$CN$AU$AU
243159121$24315912$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467255$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159131$24315913$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467245$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159141$24315914$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467232$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159151$24315915$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467196$RANBAXY$$$$$F$Y$$$20240913$$HP$AU$AU
243159161$24315916$1$I$20231122$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467307$RANBAXY$$58$YR$$M$Y$$$20240913$$HP$AU$AU
243159171$24315917$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467159$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159181$24315918$1$I$20240423$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467324$RANBAXY$$35$YR$$F$Y$$$20240913$$MD$AU$AU
243159191$24315919$1$I$20240401$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467326$RANBAXY$$80$YR$$M$Y$$$20240913$$HP$AU$AU
243159201$24315920$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467346$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159221$24315922$1$I$20240223$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467338$RANBAXY$$79$YR$$M$Y$$$20240913$$HP$AU$AU
243159231$24315923$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467263$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159241$24315924$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467248$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159251$24315925$1$I$20240129$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466699$RANBAXY$$75$YR$$F$Y$$$20240913$$HP$AU$AU
243159261$24315926$1$I$$20240905$20240913$20240913$EXP$$NZ-MYLANLABS-2024M1082850$MYLAN$Atkinson BS, Sandiford NA. Three Episodes of Presumed Culture-Negative Septic Arthritis Following Intramuscular Antipsychotic Injections: A Case Report. JBJS-Case-Connect 2023; 13.$43$YR$$M$Y$$$20240913$$HP$NZ$NZ
243159271$24315927$1$I$$20240905$20240913$20240913$EXP$$US-MYLANLABS-2024M1082875$MYLAN$Godin S-L, Pillai A, El Warrack S, Douglas^Andrea D. HL-446 From Hodgkin Lymphoma to Mycosis Fungiodes: A Quick Cascade. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl.) S448.$55$YR$$M$Y$$$20240913$$MD$US$US
243159281$24315928$1$I$$20240905$20240913$20240913$EXP$$US-MYLANLABS-2024M1082873$MYLAN$Ezetendu C, Jarden A, Hamzah M, Stewart R. Bivalirudin anticoagulation for an infant with hyperbilirubinemia and elevated plasma-free hemoglobin on ECMO. J-Extra-Corpor-Technol 2019; 51 26-28.$2$MON$$M$Y$$$20240913$$HP$US$US
243159291$24315929$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466646$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159301$24315930$1$I$$20240829$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467075$RANBAXY$Mukherji S, Shoaib H, Jimenez X. Brief case report: A case of FOLFIRI-Induced psychosis. Psycho Oncology. 2023;32 (10):1625-1627$72$YR$$M$Y$$$20240913$$HP$US$US
243159311$24315931$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466695$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159321$24315932$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466705$RANBAXY$$53$YR$$F$Y$$$20240913$$HP$AU$AU
243159331$24315933$1$I$20240210$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466718$RANBAXY$$$$$M$Y$88$KG$20240913$$CN$AU$AU
243159341$24315934$1$I$20240715$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466611$RANBAXY$$68$YR$$M$Y$$$20240913$$HP$AU$AU
243159351$24315935$1$I$20240109$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466613$RANBAXY$$29$YR$$F$Y$$$20240913$$PH$AU$AU
243159361$24315936$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466697$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159371$24315937$1$I$20240109$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466626$RANBAXY$$$$$$Y$$$20240913$$PH$AU$AU
243159381$24315938$1$I$20240706$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466596$RANBAXY$$21$YR$$F$Y$$$20240913$$PH$AU$AU
243159391$24315939$1$I$20240508$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466616$RANBAXY$$68$YR$$F$Y$$$20240913$$HP$AU$AU
243159401$24315940$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466643$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159411$24315941$1$I$20240529$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466669$RANBAXY$$80$YR$$M$Y$$$20240913$$HP$AU$AU
243159421$24315942$1$I$20240602$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466677$RANBAXY$$85$YR$$M$Y$$$20240913$$HP$AU$AU
243159431$24315943$1$I$$20240905$20240913$20240913$EXP$$IT-MYLANLABS-2024M1082848$MYLAN$Burgalassi A, Vigani G, Boccalini A, De Cesaris F, Mannaioni G, Chiarugi A, et al. Rimegepant as an acute treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations. Ceph-Rep 2024; 7 1-19.$$$A$F$Y$$$20240913$$HP$IT$IT
243159441$24315944$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466671$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159451$24315945$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466700$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159461$24315946$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466655$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159471$24315947$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466601$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159481$24315948$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466709$RANBAXY$$76$YR$$M$Y$$$20240913$$HP$AU$AU
243159491$24315949$1$I$20230823$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466632$RANBAXY$$63$YR$$M$Y$$$20240913$$HP$AU$AU
243159501$24315950$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466667$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159511$24315951$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466691$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159521$24315952$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466638$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159531$24315953$1$I$20240529$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466668$RANBAXY$$35$YR$$F$Y$$$20240913$$HP$AU$AU
243159541$24315954$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466587$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159551$24315955$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466608$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243159561$24315956$1$I$20240527$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466688$RANBAXY$$88$YR$$F$Y$$$20240913$$HP$AU$AU
243159571$24315957$1$I$20240512$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466704$RANBAXY$$71$YR$$F$Y$$$20240913$$HP$AU$AU
243159581$24315958$1$I$20240507$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466685$RANBAXY$$56$YR$$F$Y$$$20240913$$HP$AU$AU
243159591$24315959$1$I$$20240909$20240913$20240913$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001844$BLUEPRINT MEDICINES$$$$$M$Y$$$20240913$$CN$US$US
243159601$24315960$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466585$RANBAXY$$$$A$M$Y$$$20240913$$MD$AU$AU
243159611$24315961$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466698$RANBAXY$$53$YR$$F$Y$$$20240913$$HP$AU$AU
243159621$24315962$1$I$$20240903$20240913$20240913$EXP$CA-MHPD-E2B_07234708$CA-Accord-444999$ACCORD$$14$YR$T$M$Y$$$20240913$$HP$CA$CA
243159631$24315963$1$I$$20240912$20240913$20240913$EXP$$AR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051161$BOEHRINGER INGELHEIM$$84$YR$E$M$Y$$$20240913$$MD$AR$AR
243159641$24315964$1$I$20240910$20240910$20240913$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014787$JAZZ$$$$$M$Y$$$20240913$$CN$US$US
243159651$24315965$1$I$$20240902$20240913$20240913$EXP$$IT-TEYRO-2024-TY-000598$Teyro Labs$Proto C, Ganzinelli M, Manglaviti S, Imbimbo M, Galli G, Marabese M, et.al.Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).Ann Oncol..2024;35(9):817-826$$$$$Y$$$20240913$$HP$IT$IT
243159661$24315966$1$I$$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143070$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240913$$HP$US$US
243159671$24315967$1$I$$20240904$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141571$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240913$$HP$US$US
243159681$24315968$1$I$20240403$20240909$20240913$20240913$EXP$FR-AFSSAPS-AVMA2024000378$FR-CHEPLA-2024011618$CHEPLAPHARM$$29$YR$$M$Y$$$20240913$$PH$COUNTRY NOT SPECIFIED$FR
243159691$24315969$1$I$20240827$20240906$20240913$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028513$UNITED THERAPEUTICS$$66$YR$$F$Y$64.399$KG$20240913$$$US$US
243159721$24315972$1$I$$20240906$20240913$20240913$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-17836$IPSEN$$$$$M$Y$$$20240913$$CN$GB$GB
243159731$24315973$1$I$20240829$20240829$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467711$RANBAXY$$45$YR$$F$Y$$$20240913$$MD$GB$GB
243159741$24315974$1$I$$20240905$20240913$20240913$EXP$$CA-AMGEN-CANSP2024178315$AMGEN$Walkty A.; Jayasinghe H.; Lee S.J. et al.. Pantoea septica bacteremia in a 3-month-old infant with RAG2 severe combined immune deficiency: A case report. Diagnostic Microbiology + Infectious Disease. 2024;110:1-3$3$MON$I$M$Y$$$20240913$$HP$CA$CA
243159751$24315975$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467791$RANBAXY$$$$$M$Y$$$20240913$$HP$AU$AU
243159761$24315976$1$I$$20240829$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467612$RANBAXY$Miller K, McKean A, Hand J, Rackley S, Leung JG, LeMahieu A, et al. The occurrence of mental health symptoms in isotretinoin-treated adolescents. Pediatr Dermatol. 2024;41 (4):635-640$$$$$Y$$$20240913$$HP$US$US
243159771$24315977$1$I$20240820$20240829$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467716$RANBAXY$$73$YR$$M$Y$84$KG$20240913$$MD$GB$GB
243159781$24315978$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466532$RANBAXY$$$$$M$Y$$$20240913$$CN$AU$AU
243159791$24315979$1$I$20201023$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466521$RANBAXY$$34$YR$$F$Y$$$20240913$$HP$AU$AU
243159801$24315980$1$I$$20240829$20240913$20240913$EXP$$CO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467814$RANBAXY$Henao-Sierra JE, Alza-Arcila L, Echeverry E, Peralta Perez JJ, Tanaka Takegami M, Quiroz Alfaro AJ. Pregnancy outcome in a patient with end-stage kidney disease treated with an intensive automated peritoneal dialysis regimen: A case report. SAGE Open Med Case Rep. 2024;12 (0):1-5$$$N$F$Y$$$20240913$$HP$CO$CO
243159812$24315981$2$F$20240827$20240829$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467374$RANBAXY$$83$YR$$M$Y$$$20240913$$HP$GB$GB
243159822$24315982$2$F$20230701$20240829$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467384$RANBAXY$$$$$F$Y$$$20240913$$HP$GB$GB
243159831$24315983$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467801$RANBAXY$$47$YR$$M$Y$$$20240913$$HP$AU$AU
243159841$24315984$1$I$20240610$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466523$RANBAXY$$81$YR$$M$Y$$$20240913$$HP$AU$AU
243159851$24315985$1$I$$20240829$20240913$20240913$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467624$RANBAXY$Deshmukh AS, Hawkes C, Van Adel B, Algird A, Wang BH. Endovascular Treatment of Ruptured Blister Aneurysm. Canadian Journal of Neurological Sciences. 2024;51 (3):449-451$$$N$$Y$$$20240913$$HP$CA$CA
243159861$24315986$1$I$$20240829$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467620$RANBAXY$Steinbacher D, Murray B, Devlin T, Carson SS, Ford HJ.. Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy. Pulm Circ. 2024;14(2):e12396(1-4)$33$YR$$M$Y$$$20240913$$HP$US$US
243159871$24315987$1$I$$20240829$20240913$20240913$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467672$RANBAXY$K. Mozdzen, A. Murawska, J. Hypnar, E. Pedziwiatr, J. Pospiech, M. Bosak. Status epilepticus in pregnant patients two case reports and literature review. Polish Neurological Review. 2024;20(2):115-128$34$YR$$F$Y$$$20240913$$HP$PL$PL
243159881$24315988$1$I$$20240829$20240913$20240913$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466798$RANBAXY$Dzwilewski K, Zawadzka M, Zakrzewski D, et al. Drug-resistant epilepsy with focal seizures on a background of focal cortical dysplasia. NEUROLOGICAL CASE REPORTS. 2024;20(2):109-14$11$YR$$F$Y$$$20240913$$HP$PL$PL
243159891$24315989$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466508$RANBAXY$$19$YR$$M$Y$$$20240913$$HP$AU$AU
243159901$24315990$1$I$$20240829$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467836$RANBAXY$Mohan A, Quingalahua E, Gunchick V, Paul S, Kumar-Sinha C, Crysler O, et al. PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma. Oncologist. 2024;29:725-730$$$$F$Y$$$20240913$$HP$US$US
243159911$24315991$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466441$RANBAXY$$33$YR$$F$Y$$$20240913$$HP$AU$AU
243159921$24315992$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466579$RANBAXY$$$$T$M$Y$$$20240913$$MD$AU$AU
243159931$24315993$1$I$$20240829$20240913$20240913$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467493$RANBAXY$Woron J, Siwek M. Sore throat as an undesirable consequence of drug interactions used in the treatment of a female patient with depression and obesity. Psychiatria. 2024;(4):37-9$31$YR$$F$Y$$$20240913$$MD$PL$PL
243159941$24315994$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466541$RANBAXY$$$$N$$Y$$$20240913$$MD$AU$AU
243159951$24315995$1$I$$20240829$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467693$RANBAXY$$$$$M$Y$$$20240913$$CN$GB$GB
243159961$24315996$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467735$RANBAXY$$68$YR$$M$Y$$$20240913$$MD$AU$AU
243159971$24315997$1$I$20240101$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467700$RANBAXY$$58$YR$$M$Y$$$20240913$$MD$AU$AU
243159982$24315998$2$F$$20240829$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467264$RANBAXY$$44$YR$$F$Y$72$KG$20240913$$CN$GB$GB
243159991$24315999$1$I$$20240829$20240913$20240913$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467815$RANBAXY$Otsuka E, Kitamura M, Sawase K, Nakamura M, Inoue H, Yamaguchi K, et al. Hereditary Hemorrhagic Telangiectasia in a Patient Undergoing Hemodialysis with Anticoagulants and Antiplatelets. Intern Med. 2024;63 (11):1609-1614$61$YR$$F$Y$$$20240913$$HP$JP$JP
243160001$24316000$1$I$$20240829$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467868$RANBAXY$Bains S, Garmany R, Neves R, Giudicessi JR, Gao X, Tester DJ, et al. Temporal Association Between Vaping and Risk of Cardiac Events. Mayo Clin Proc. 2024;99:241-248$31$YR$$F$Y$$$20240913$$HP$US$US
243160011$24316001$1$I$20240521$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466534$RANBAXY$$70$YR$$M$Y$$$20240913$$MD$AU$AU
243160021$24316002$1$I$$20240829$20240913$20240913$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467665$RANBAXY$K. Mozdzen, A. Murawska, J. Hypnar, E. Pedziwiatr, J. Pospiech, M. Bosak. Status epilepticus in pregnant patients two case reports and literature review. Polish Neurological Review. 2024;20(2):115-128$28$YR$$F$Y$$$20240913$$HP$PL$PL
243160031$24316003$1$I$20240607$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466540$RANBAXY$$50$YR$$M$Y$$$20240913$$MD$AU$AU
243160041$24316004$1$I$$20240829$20240913$20240913$EXP$$CO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467813$RANBAXY$Henao-Sierra JE, Alza-Arcila L, Echeverry E, Peralta Perez JJ, Tanaka Takegami M, Quiroz Alfaro AJ. Pregnancy outcome in a patient with end-stage kidney disease treated with an intensive automated peritoneal dialysis regimen: A case report. SAGE Open Med Case Rep. 2024;12 (0):1-5$23$YR$$F$Y$$$20240913$$HP$CO$CO
243160051$24316005$1$I$$20240829$20240913$20240913$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467623$RANBAXY$Deshmukh AS, Hawkes C, Van Adel B, Algird A, Wang BH. Endovascular Treatment of Ruptured Blister Aneurysm. Canadian Journal of Neurological Sciences. 2024;51 (3):449-451$32$YR$$F$Y$$$20240913$$HP$CA$CA
243160061$24316006$1$I$20240606$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466445$RANBAXY$$67$YR$$M$Y$100.8$KG$20240913$$HP$AU$AU
243160071$24316007$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466444$RANBAXY$$$$A$F$Y$$$20240913$$CN$AU$AU
243160081$24316008$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466582$RANBAXY$$64$YR$$F$Y$$$20240913$$MD$AU$AU
243160091$24316009$1$I$20100506$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466491$RANBAXY$$48$YR$$M$Y$$$20240913$$MD$AU$AU
243160101$24316010$1$I$20240419$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466554$RANBAXY$$85$YR$$F$Y$$$20240913$$MD$AU$AU
243160111$24316011$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466446$RANBAXY$$64$YR$$F$Y$$$20240913$$HP$AU$AU
243160121$24316012$1$I$20240419$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467679$RANBAXY$$79$YR$$M$Y$$$20240913$$CN$AU$AU
243160132$24316013$2$F$$20240910$20240913$20240917$EXP$$US-JNJFOC-20240929795$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243160141$24316014$1$I$$20240911$20240913$20240913$PER$$US-ROCHE-10000081230$ROCHE$$22$YR$A$F$Y$$$20240913$$HP$US$US
243160151$24316015$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466449$RANBAXY$$81$YR$$M$Y$$$20240913$$MD$AU$AU
243160161$24316016$1$I$20211101$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466505$RANBAXY$$$$$M$Y$$$20240913$$MD$AU$AU
243160171$24316017$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466417$RANBAXY$$$$$F$Y$$$20240913$$HP$AU$AU
243160181$24316018$1$I$20240605$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466435$RANBAXY$$73$YR$$M$Y$$$20240913$$HP$AU$AU
243160191$24316019$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466434$RANBAXY$$33$YR$$F$Y$$$20240913$$MD$AU$AU
243160201$24316020$1$I$20240520$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466430$RANBAXY$$76$YR$$M$Y$$$20240913$$MD$AU$AU
243160211$24316021$1$I$20240630$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466418$RANBAXY$$88$YR$$F$Y$$$20240913$$HP$AU$AU
243160221$24316022$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466408$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243160231$24316023$1$I$20240626$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466422$RANBAXY$$42$YR$$M$Y$$$20240913$$MD$AU$AU
243160241$24316024$1$I$20220818$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466423$RANBAXY$$18$YR$$M$Y$$$20240913$$CN$AU$AU
243160251$24316025$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466385$RANBAXY$$19$YR$$M$Y$$$20240913$$CN$AU$AU
243160261$24316026$1$I$20240628$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466420$RANBAXY$$35$YR$$M$Y$$$20240913$$MD$AU$AU
243160271$24316027$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466413$RANBAXY$$73$YR$$F$Y$56.8$KG$20240913$$HP$AU$AU
243160281$24316028$1$I$20240527$20240906$20240913$20240913$EXP$$JP-009507513-2409JPN001026J$MERCK$$76$YR$$F$Y$$$20240913$$PH$JP$JP
243160291$24316029$1$I$20240702$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466407$RANBAXY$$73$YR$$M$Y$$$20240913$$MD$AU$AU
243160301$24316030$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466415$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243160311$24316031$1$I$20240603$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466405$RANBAXY$$35$YR$$F$Y$$$20240913$$HP$AU$AU
243160321$24316032$1$I$20240705$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466409$RANBAXY$$80$YR$$M$Y$$$20240913$$HP$AU$AU
243160331$24316033$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466412$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243160341$24316034$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466411$RANBAXY$$68$YR$$M$Y$$$20240913$$PH$AU$AU
243160361$24316036$1$I$20240603$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466427$RANBAXY$$70$YR$$M$Y$$$20240913$$HP$AU$AU
243160371$24316037$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466421$RANBAXY$$$$$M$Y$$$20240913$$CN$AU$AU
243160381$24316038$1$I$20240610$20240905$20240913$20240913$EXP$FR-AFSSAPS-LL2024001646$FR-TEVA-VS-3240947$TEVA$$55$YR$$F$Y$$$20240913$$MD$FR$FR
243160391$24316039$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466419$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243160401$24316040$1$I$20240825$20240903$20240913$20240913$30DAY$$US-GSK-US2024109401$GLAXOSMITHKLINE$$78$YR$$M$Y$$$20240913$$CN$US$US
243160421$24316042$1$I$$20240902$20240913$20240913$EXP$$DE-MSNLABS-2024MSNLIT01929$MSN LABORATORIES$Wagner C, Montecino A.Suicidal thoughts of a bipolar patient after ingestion of Pregabalin: a case report.Advances in neurology, psychiatry.2024$$$$$Y$$$20240913$$HP$DE$DE
243160441$24316044$1$I$$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145431$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240913$$CN$US$US
243160461$24316046$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62826$$FDA-CTU$$23$YR$$F$N$$$20240912$N$$US$
243160472$24316047$2$F$$20240919$20240913$20240919$EXP$$DK-BAYER-2024A130383$BAYER$$$$$F$Y$$$20240919$$CN$DK$DK
243160482$24316048$2$F$20240903$20240913$20240913$20240918$PER$$US-AMGEN-USASP2024181876$AMGEN$$73$YR$E$F$Y$$$20240918$$PH$US$US
243160491$24316049$1$I$20240901$20240902$20240913$20240913$EXP$GB-MHRA-MED-202409021438380780-JMKWT$GB-MACLEODS PHARMA-MAC2024049256$MACLEODS$$$$$$Y$$$20240913$$PH$GB$GB
243160501$24316050$1$I$20240824$20240902$20240913$20240913$EXP$GB-MHRA-MED-202409021420190550-KJMHY$GB-MACLEODS PHARMA-MAC2024049254$MACLEODS$$$$$$Y$$$20240913$$PH$GB$GB
243160511$24316051$1$I$20240820$20240902$20240913$20240913$EXP$GB-MHRA-MED-202409022234579740-WNRKQ$GB-MACLEODS PHARMA-MAC2024049260$MACLEODS$$$$$$Y$$$20240913$$CN$GB$GB
243160521$24316052$1$I$$20240902$20240913$20240913$EXP$$CA-CARNEGIE-000035$Carnegie Pharmaceuticals$$53$YR$A$F$Y$$$20240905$$MD$CA$CA
243160531$24316053$1$I$$20240902$20240913$20240913$EXP$$DE-CARNEGIE-000036$Carnegie Pharmaceuticals$$60$YR$A$F$Y$$$20240905$$MD$DE$DE
243160541$24316054$1$I$$20240902$20240913$20240913$EXP$$US-CARNEGIE-000037$Carnegie Pharmaceuticals$$78$YR$E$F$Y$$$20240905$$MD$US$US
243160551$24316055$1$I$$20240902$20240913$20240913$EXP$$IT-CARNEGIE-000048$Carnegie Pharmaceuticals$$67$YR$E$M$Y$$$20240906$$MD$IT$IT
243160561$24316056$1$I$$20240903$20240913$20240913$EXP$$TN-CARNEGIE-000052$Carnegie Pharmaceuticals$$66$YR$E$F$Y$$$20240906$$MD$TN$TN
243160571$24316057$1$I$$20240902$20240913$20240913$EXP$$GB-CARNEGIE-000050$Carnegie Pharmaceuticals$$72$YR$E$F$Y$$$20240906$$MD$GB$GB
243160581$24316058$1$I$$20240902$20240913$20240913$EXP$$IT-CARNEGIE-000047$Carnegie Pharmaceuticals$$66$YR$E$M$Y$$$20240906$$MD$IT$IT
243160591$24316059$1$I$20090101$20240902$20240913$20240913$EXP$$US-CARNEGIE-000051$Carnegie Pharmaceuticals$$61$YR$A$F$Y$$$20240906$$MD$US$US
243160601$24316060$1$I$$20240903$20240913$20240913$EXP$$US-CARNEGIE-000042$Carnegie Pharmaceuticals$$38$YR$A$F$Y$$$20240906$$MD$US$US
243160611$24316061$1$I$20200201$20240902$20240913$20240913$EXP$$CN-CARNEGIE-000030$Carnegie Pharmaceuticals$$46$YR$A$F$Y$$$20240905$$MD$CN$CN
243160621$24316062$1$I$$20240902$20240913$20240913$EXP$$JP-CARNEGIE-000041$Carnegie Pharmaceuticals$$65$YR$E$F$Y$$$20240906$$MD$JP$JP
243160631$24316063$1$I$$20240902$20240913$20240913$EXP$$GR-CARNEGIE-000044$Carnegie Pharmaceuticals$$63$YR$A$F$Y$$$20240906$$MD$GR$GR
243160641$24316064$1$I$$20240903$20240913$20240913$EXP$$GB-CARNEGIE-000032$Carnegie Pharmaceuticals$$59$YR$A$F$Y$$$20240905$$HP$GB$GB
243160651$24316065$1$I$20240101$20240903$20240913$20240913$EXP$$JP-AMGEN-JPNSP2024182731$AMGEN$$80$YR$E$F$Y$$$20240913$$PH$JP$JP
243160661$24316066$1$I$20150601$20240902$20240913$20240913$EXP$$GR-CARNEGIE-000046$Carnegie Pharmaceuticals$$42$YR$A$F$Y$$$20240906$$MD$GR$GR
243160671$24316067$1$I$$20240902$20240913$20240913$EXP$$JP-CARNEGIE-000034$Carnegie Pharmaceuticals$$29$YR$A$F$Y$48$KG$20240905$$MD$JP$JP
243160681$24316068$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466315$RANBAXY$$$$E$F$Y$$$20240913$$MD$AU$AU
243160691$24316069$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466359$RANBAXY$$$$$M$Y$$$20240913$$HP$AU$AU
243160701$24316070$1$I$20240803$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466299$RANBAXY$$78$YR$$F$Y$$$20240913$$HP$AU$AU
243160711$24316071$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466379$RANBAXY$$51$YR$$F$Y$$$20240913$$HP$AU$AU
243160721$24316072$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466313$RANBAXY$$19$YR$$M$Y$$$20240913$$CN$AU$AU
243160731$24316073$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466270$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243160741$24316074$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466336$RANBAXY$$$$A$$Y$$$20240913$$HP$AU$AU
243160751$24316075$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466344$RANBAXY$$$$A$$Y$$$20240913$$HP$AU$AU
243160761$24316076$1$I$20200301$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466376$RANBAXY$$43$YR$$F$Y$$$20240913$$CN$AU$AU
243160771$24316077$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466275$RANBAXY$$67$YR$$F$Y$$$20240913$$HP$AU$AU
243160781$24316078$1$I$20240730$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466307$RANBAXY$$52$YR$$M$Y$84.8$KG$20240913$$MD$AU$AU
243160791$24316079$1$I$20240802$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466303$RANBAXY$$74$YR$$M$Y$$$20240913$$MD$AU$AU
243160801$24316080$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466346$RANBAXY$$$$A$$Y$$$20240913$$HP$AU$AU
243160811$24316081$1$I$20240707$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466321$RANBAXY$$54$YR$$F$Y$$$20240913$$MD$AU$AU
243160821$24316082$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466353$RANBAXY$$56$YR$$M$Y$$$20240913$$HP$AU$AU
243160831$24316083$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466362$RANBAXY$$$$$F$Y$$$20240913$$HP$AU$AU
243160841$24316084$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466337$RANBAXY$$25$YR$$F$Y$$$20240913$$MD$AU$AU
243160851$24316085$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466366$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243160861$24316086$1$I$20240719$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466316$RANBAXY$$74$YR$$F$Y$$$20240913$$HP$AU$AU
243160871$24316087$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466285$RANBAXY$$52$YR$$F$Y$$$20240913$$MD$AU$AU
243160881$24316088$1$I$20140101$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466312$RANBAXY$$$$$M$Y$$$20240913$$CN$AU$AU
243160891$24316089$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466350$RANBAXY$$$$A$$Y$$$20240913$$HP$AU$AU
243160901$24316090$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466351$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243160911$24316091$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466341$RANBAXY$$$$A$$Y$$$20240913$$HP$AU$AU
243160921$24316092$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466253$RANBAXY$$85$YR$$M$Y$$$20240913$$HP$AU$AU
243160931$24316093$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466296$RANBAXY$$53$YR$$F$Y$$$20240913$$HP$AU$AU
243160941$24316094$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466249$RANBAXY$$67$YR$$F$Y$$$20240913$$HP$AU$AU
243160951$24316095$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466280$RANBAXY$$70$YR$$M$Y$$$20240913$$HP$AU$AU
243160961$24316096$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466246$RANBAXY$$54$YR$$M$Y$$$20240913$$HP$AU$AU
243160971$24316097$1$I$$20240829$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466319$RANBAXY$$$$E$F$Y$$$20240913$$MD$US$US
243160981$24316098$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466268$RANBAXY$$54$YR$$M$Y$$$20240913$$HP$AU$AU
243160991$24316099$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466349$RANBAXY$$$$A$$Y$$$20240913$$HP$AU$AU
243161001$24316100$1$I$20240415$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466276$RANBAXY$$59$YR$$M$Y$$$20240913$$MD$AU$AU
243161011$24316101$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466281$RANBAXY$$21$YR$$M$Y$$$20240913$$MD$AU$AU
243161021$24316102$1$I$20220801$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466335$RANBAXY$$$$$M$Y$$$20240913$$CN$AU$AU
243161033$24316103$3$F$$20240911$20240913$20240917$EXP$$US-AstraZeneca-2024A205555$ASTRAZENECA$$$$$F$Y$$$20240918$$HP$US$
243161041$24316104$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466328$RANBAXY$$62$YR$$M$Y$$$20240913$$HP$AU$AU
243161051$24316105$1$I$20230501$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466305$RANBAXY$$66$YR$$M$Y$$$20240913$$MD$AU$AU
243161061$24316106$1$I$20240501$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466320$RANBAXY$$58$YR$$M$Y$$$20240913$$CN$AU$AU
243161071$24316107$1$I$$20240902$20240913$20240913$EXP$$CO-TEYRO-2024-TY-000591$Teyro Labs$Nati-Castillo HA, Aristizabal-Colorado D, Lopez Ordonez C, Egas Proano D, Ortiz-Prado E, Izquierdo-Condoy JS., et.al.Takotsubo syndrome as an acute cardiac complication following combined chemotherapy.International Journal of Cardiology  Cardiovascular Risk and Prevention.2024;22:200292$61$YR$A$F$Y$$$20240913$$HP$CO$CO
243161081$24316108$1$I$20240630$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466354$RANBAXY$$67$YR$$M$Y$100.7$KG$20240913$$HP$AU$AU
243161091$24316109$1$I$$20240911$20240913$20240913$EXP$$US-AstraZeneca-2024A208300$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243161101$24316110$1$I$20240831$20240904$20240913$20240913$EXP$$US-EMD Serono-2024048015$EMD SERONO INC$$54$YR$A$F$Y$$$20240913$$MD$US$US
243161111$24316111$1$I$20220601$20240902$20240913$20240913$EXP$$FR-ORGANON-O2409FRA000489$ORGANON$$66$YR$$M$Y$$$20240913$$CN$FR$FR
243161121$24316112$1$I$$20240910$20240913$20240913$PER$$US-ALXN-202409USA000663US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243161131$24316113$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466144$RANBAXY$$$$$F$Y$$$20240913$$HP$AU$AU
243161141$24316114$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466171$RANBAXY$$70$YR$$M$Y$$$20240913$$MD$AU$AU
243161151$24316115$1$I$20240508$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466172$RANBAXY$$62$YR$$M$Y$$$20240913$$MD$AU$AU
243161161$24316116$1$I$20240503$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466174$RANBAXY$$75$YR$$F$Y$$$20240913$$MD$AU$AU
243161171$24316117$1$I$20240509$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466175$RANBAXY$$73$YR$$M$Y$$$20240913$$MD$AU$AU
243161181$24316118$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466226$RANBAXY$$$$$$Y$$$20240913$$HP$AU$AU
243161191$24316119$1$I$20240514$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466169$RANBAXY$$78$YR$$F$Y$$$20240913$$MD$AU$AU
243161201$24316120$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466205$RANBAXY$$$$$F$Y$$$20240913$$CN$AU$AU
243161211$24316121$1$I$20240527$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466167$RANBAXY$$77$YR$$F$Y$$$20240913$$MD$AU$AU
243161221$24316122$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466216$RANBAXY$$62$YR$$F$Y$$$20240913$$MD$AU$AU
243161231$24316123$1$I$20190417$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466158$RANBAXY$$69$YR$$F$Y$53.8$KG$20240913$$MD$AU$AU
243161241$24316124$1$I$20220901$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466304$RANBAXY$$4$YR$$F$Y$$$20240913$$MD$AU$AU
243161251$24316125$1$I$20240526$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466149$RANBAXY$$68$YR$$M$Y$$$20240913$$MD$AU$AU
243161261$24316126$1$I$20240608$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466165$RANBAXY$$78$YR$$F$Y$$$20240913$$MD$AU$AU
243161271$24316127$1$I$20240527$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466162$RANBAXY$$77$YR$$F$Y$$$20240913$$MD$AU$AU
243161281$24316128$1$I$20190323$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466154$RANBAXY$$38$YR$A$F$Y$75.5$KG$20240913$$MD$AU$AU
243161291$24316129$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466220$RANBAXY$$$$$F$Y$$$20240913$$CN$AU$AU
243161301$24316130$1$I$20240604$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466170$RANBAXY$$56$YR$$F$Y$$$20240913$$MD$AU$AU
243161311$24316131$1$I$20240608$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466168$RANBAXY$$78$YR$$F$Y$78.3$KG$20240913$$MD$AU$AU
243161321$24316132$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466213$RANBAXY$$78$YR$$F$Y$$$20240913$$MD$AU$AU
243161331$24316133$1$I$20240618$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466164$RANBAXY$$73$YR$$M$Y$$$20240913$$MD$AU$AU
243161351$24316135$1$I$20180718$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466208$RANBAXY$$52$YR$$F$Y$$$20240913$$MD$AU$AU
243161361$24316136$1$I$20180718$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466223$RANBAXY$$56$YR$$F$Y$$$20240913$$MD$AU$AU
243161371$24316137$1$I$$20240911$20240913$20240913$EXP$$US-BAYER-2024A130126$BAYER$$60$YR$A$F$Y$$$20240913$$CN$US$US
243161381$24316138$1$I$$20240911$20240913$20240913$PER$$US-ABBVIE-5921635$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243161391$24316139$1$I$20240815$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004983$ACADIA PHARMACEUTICALS$$90$YR$$F$Y$$$20240913$$CN$US$US
243161401$24316140$1$I$$20240903$20240913$20240913$30DAY$$US-GSK-US2024109525$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$CN$US$US
243161411$24316141$1$I$$20240905$20240913$20240913$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17993$IPSEN$$50$YR$A$M$Y$86.6$KG$20240913$$CN$US$US
243161421$24316142$1$I$20240101$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145551$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240913$$HP$US$US
243161431$24316143$1$I$20070627$20230915$20240913$20240913$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03289$AMNEAL$$$$$$Y$$$20240913$$HP$US$US
243161442$24316144$2$F$20240901$20240905$20240913$20240917$EXP$$JP-SA-2024SA264226$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240917$$PH$JP$JP
243161451$24316145$1$I$$20240911$20240913$20240913$PER$$US-BAYER-2024A130193$BAYER$$$$$$Y$$$20240913$$CN$US$US
243161461$24316146$1$I$$20240912$20240913$20240913$PER$$NVSC2024US183121$NOVARTIS$$$$$$Y$$$20240913$$CN$US$US
243161471$24316147$1$I$20240811$20240912$20240913$20240913$EXP$$NVSC2024US183182$NOVARTIS$$78$YR$$M$Y$$$20240913$$CN$US$US
243161491$24316149$1$I$20140101$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466130$RANBAXY$$68$YR$$M$Y$$$20240913$$HP$AU$AU
243161501$24316150$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466045$RANBAXY$$$$$$Y$$$20240913$$MD$AU$AU
243161511$24316151$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466040$RANBAXY$$$$E$$Y$$$20240913$$HP$AU$AU
243161521$24316152$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466126$RANBAXY$$58$YR$$M$Y$86.2$KG$20240913$$MD$AU$AU
243161531$24316153$1$I$20240902$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62882$$FDA-CTU$$48$YR$$F$N$$$20240912$N$HP$US$
243161541$24316154$1$I$$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62850$$FDA-CTU$$$$$M$N$$$20240911$N$HP$US$
243161551$24316155$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466031$RANBAXY$$$$E$$Y$$$20240913$$HP$AU$AU
243161561$24316156$1$I$20240603$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466133$RANBAXY$$68$YR$$M$Y$$$20240913$$MD$AU$AU
243161571$24316157$1$I$$20240909$20240913$20240913$EXP$$US-CHEPLA-2024011598$CHEPLAPHARM$$58$YR$$F$Y$$$20240913$$HP$COUNTRY NOT SPECIFIED$US
243161581$24316158$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466027$RANBAXY$$$$E$$Y$$$20240913$$HP$AU$AU
243161591$24316159$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466002$RANBAXY$$$$E$$Y$$$20240913$$HP$AU$AU
243161601$24316160$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466036$RANBAXY$$$$E$$Y$$$20240913$$HP$AU$AU
243161611$24316161$1$I$20240618$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466090$RANBAXY$$73$YR$$M$Y$$$20240913$$MD$AU$AU
243161621$24316162$1$I$20180830$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466049$RANBAXY$$22$YR$$F$Y$$$20240913$$MD$AU$AU
243161631$24316163$1$I$$20240910$20240912$20240912$DIR$FDA-CDER-CTU-2024-62830$$FDA-CTU$$$$$F$N$$$20240910$N$HP$US$
243161641$24316164$1$I$$20240911$20240913$20240913$PER$$US-JNJFOC-20240929484$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$HP$US$US
243161651$24316165$1$I$$20240910$20240913$20240913$PER$$US-009507513-2409USA003759$MERCK$Eakes J, Hatch L, Hennessy K, Ravichandran S, Ayoubi N, Fourzali K, et al. 50699 Pembrolizumab-Induced Lichenoid Drug Eruption Successfully Treated with Dupilumab - A Case Report. Journal of the American Academy of Dermatology. 2024;91 (3):AB70$85$YR$$M$Y$$$20240913$$HP$US$US
243161661$24316166$1$I$$20240904$20240913$20240913$EXP$$GB-CELLTRION INC.-2023GB023004$CELLTRION$$$$$$Y$$$20240913$$CN$GB$GB
243161671$24316167$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007248$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240913$$CN$US$US
243161681$24316168$1$I$$20240912$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409008248$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240913$$CN$US$US
243161691$24316169$1$I$$20240905$20240913$20240913$EXP$$CA-CELLTRION INC.-2024CA021794$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
243161701$24316170$1$I$$20240820$20240913$20240913$30DAY$$US-BAXTER-2024BAX024463$BAXTER$$$$$$Y$$$20240913$$HP$US$US
243161711$24316171$1$I$20240822$20240903$20240913$20240913$EXP$CN-NMPACDR-4403051004685202400163$CN-BAXTER-2024BAX024306$BAXTER$$61$YR$$M$Y$49$KG$20240913$$MD$CN$CN
243161731$24316173$1$I$$20240904$20240913$20240913$EXP$$GB-TEVA-VS-3240693$TEVA$$66$YR$$M$Y$$$20240913$$MD$GB$GB
243161741$24316174$1$I$$20240903$20240913$20240913$EXP$$ES-BAYER-2024A129919$BAYER$Cueto-Sanchez A; Niu H; alvarez-alvarez I; Lopez-Longarela B; Del Campo-Herrera E; Ortega-Alonso A; Garcia-Cortes M; Pinazo-Bandera J; Sanabria-Cabrera J; Diaz-Mochon JJ; Lucena MI; Andrade RJ; Stephe. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. British Journal of Clinical Pharmacology. 2023;89:8:2497-2507$51$YR$A$M$Y$$$20240913$$HP$ES$ES
243161761$24316176$1$I$$20240904$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146163$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$72.12$KG$20240913$$HP$US$US
243161771$24316177$1$I$$20240905$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141930$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240913$$CN$US$US
243161791$24316179$1$I$20240717$20240910$20240913$20240913$EXP$FI-FIMEA-202403242$FI-CHEPLA-2024011638$CHEPLAPHARM$$28$YR$$F$Y$$$20240913$$MD$COUNTRY NOT SPECIFIED$FI
243161801$24316180$1$I$$20240908$20240913$20240913$PER$$US-JNJFOC-20240927851$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243161811$24316181$1$I$$20240910$20240913$20240913$EXP$$CA-Novartis Pharma AG-NVSC2024CA108727$SANDOZ$$44$YR$$F$Y$$$20240913$$HP$CA$CA
243161823$24316182$3$F$$20240911$20240913$20240923$EXP$$NVSC2024CA181600$NOVARTIS$$43$YR$$F$Y$68$KG$20240923$$CN$CA$CA
243161832$24316183$2$F$$20240924$20240913$20240926$EXP$$CA-AUROBINDO-AUR-APL-2024-044665$AUROBINDO$$44$YR$$F$Y$$$20240926$$HP$CA$CA
243161851$24316185$1$I$$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62877$$FDA-CTU$$48$YR$$M$N$$$20240911$N$HP$US$
243161861$24316186$1$I$20240604$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62828$$FDA-CTU$$77$YR$$M$N$$$20240912$N$HP$US$
243161871$24316187$1$I$$20240910$20240913$20240913$EXP$$NVSC2024CA080623$NOVARTIS$$65$YR$$M$Y$$$20240913$$HP$CA$CA
243161881$24316188$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62822$$FDA-CTU$$61$YR$$F$N$$$20240912$N$$US$
243161891$24316189$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62914$$FDA-CTU$$$$$F$N$$$20240912$N$HP$US$
243161901$24316190$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62845$$FDA-CTU$$63$YR$$M$N$115.67$KG$20240912$N$$US$
243161911$24316191$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62821$$FDA-CTU$$40$YR$$F$N$$$20240912$N$$US$
243161921$24316192$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62824$$FDA-CTU$$53$YR$$F$N$200$LBS$20240912$N$$US$
243161941$24316194$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182415$AMGEN$$$$$$Y$$$20240913$$CN$US$US
243161951$24316195$1$I$20240101$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024179779$AMGEN$$78$YR$E$M$Y$$$20240913$$CN$US$US
243161963$24316196$3$F$20240823$20240924$20240913$20240925$PER$$US-AMGEN-USASP2024181709$AMGEN$$79$YR$E$F$Y$$$20240925$$CN$US$US
243161971$24316197$1$I$20240429$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465972$RANBAXY$$74$YR$$M$Y$74$KG$20240913$$HP$AU$AU
243161981$24316198$1$I$$20240829$20240913$20240913$EXP$$BG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460762$RANBAXY$Grigorov N, Grigorova B. METFORMIN INTOXICATION - THREE CLINICAL CASES WITH LETHAL OUTCOMES. RECOMMENDATIONS TO THE GENERAL PRACTITIONER. Gen Med. 2023;25(1):45-48$70$YR$$F$Y$$$20240913$$HP$BG$BG
243161991$24316199$1$I$$20240829$20240913$20240913$EXP$$BG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460765$RANBAXY$Grigorov N, Grigorova B. METFORMIN INTOXICATION - THREE CLINICAL CASES WITH LETHAL OUTCOMES. RECOMMENDATIONS TO THE GENERAL PRACTITIONER. Gen Med. 2023;25 (1):45-48$85$YR$$M$Y$$$20240913$$HP$BG$BG
243162001$24316200$1$I$$20240829$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465877$RANBAXY$Meseha M, Qu D, Lykon J, Coffey D. Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review. Ann Hematol. 2024;Aug 27:Online ahead of print$$$$M$Y$$$20240913$$HP$US$US
243162011$24316201$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459681$RANBAXY$Berling I, Isbister GK. Chlorpromazine overdose: a case series. Clin Toxicol (Phila). 2024;62 (6):372-377$$$$$Y$$$20240913$$HP$AU$AU
243162021$24316202$1$I$$20240829$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-461291$RANBAXY$Wu S, Jiang X-J, Jing L. Risperidone-associated venous thromboembolism in the treatment of schizophrenia:a case report and literature review. [Chinese]. Chin J New Drugs. 2023;32(12):1275-1280$53$YR$$M$Y$$$20240913$$HP$CN$CN
243162031$24316203$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465989$RANBAXY$$$$E$$Y$$$20240913$$HP$AU$AU
243162041$24316204$1$I$$20240829$20240913$20240913$EXP$$BG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460764$RANBAXY$Grigorov N, Grigorova B. METFORMIN INTOXICATION - THREE CLINICAL CASES WITH LETHAL OUTCOMES. RECOMMENDATIONS TO THE GENERAL PRACTITIONER. Gen Med. 2023;25(1):45-48$53$YR$$F$Y$$$20240913$$HP$BG$BG
243162061$24316206$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62926$$FDA-CTU$$38$YR$$M$N$155$LBS$20240913$N$HP$US$
243162081$24316208$1$I$$20240904$20240913$20240913$EXP$$US-ABBVIE-5920393$ABBVIE$Vojjala N, Roberson F, Yadav SK, Krishnamoorthy G. Ibrutinib-induced spinal haematoma in a patient with marginal zone lymphoma. BMJ Case Rep. 2024;17(8):e260598.$$$E$F$Y$$$20240913$$HP$US$US
243162091$24316209$1$I$$20240902$20240913$20240913$EXP$$US-Accord-445495$ACCORD$$$$$F$Y$$$20240913$$HP$US$US
243162101$24316210$1$I$20220529$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465969$RANBAXY$$$$$$Y$$$20240913$$MD$AU$AU
243162111$24316211$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465975$RANBAXY$$$$$$Y$$$20240913$$MD$AU$AU
243162121$24316212$1$I$$20240912$20240913$20240913$PER$$US-ALXN-202409USA000875US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243162131$24316213$1$I$20240909$20240909$20240913$20240913$PER$$US-ALXN-202409USA000531US$ALEXION PHARMACEUTICALS$$80$YR$$F$Y$$$20240913$$CN$US$US
243162141$24316214$1$I$$20240907$20240913$20240913$PER$$US-AMGEN-USASP2024179627$AMGEN$$$$$$Y$$$20240913$$CN$US$US
243162152$24316215$2$F$20240701$20240923$20240913$20240924$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051302$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240924$$MD$DE$DE
243162161$24316216$1$I$$20240909$20240913$20240913$EXP$$CA-CHEPLA-2024011676$CHEPLAPHARM$Page D, Sawler D, Brandwein J. Successful treatment of AML using non-intensive chemotherapy in Jehovah^s Witness patients. Leukemia Research Reports. 2024;22:100477. doi: 10.1016/j.lrr.2024.100477.$46$YR$$F$Y$$$20240913$$HP$COUNTRY NOT SPECIFIED$CA
243162181$24316218$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MED-202408291138337940-BJCHN$GB-MSNLABS-2024MSNSPO01946$MSN LABORATORIES$$$$$$Y$$$20240913$$HP$GB$GB
243162191$24316219$1$I$$20240909$20240913$20240913$PER$$US-ABBVIE-5918052$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243162201$24316220$1$I$20240816$20240904$20240913$20240913$EXP$$CN-ASTELLAS-2024-AER-004635$ASTELLAS$$64$YR$A$F$Y$60$KG$20240913$$HP$CN$CN
243162212$24316221$2$F$$20240913$20240913$20240914$PER$$US-BAYER-2024A130195$BAYER$$80$YR$E$F$Y$$$20240914$$CN$US$US
243162221$24316222$1$I$$20240901$20240913$20240913$EXP$$JP-Accord-445490$ACCORD$Tokunaga Y, Nakamura Y, Ando T, Katsuki K, Sakai K, Fujioka Y, et al. T-cell large granular lymphocytic leukemia with a STAT3 mutation successfully treated with cord blood transplantation. Intern Med. 2024 Aug 28. doi: 10.2169/internalmedicine.4076-24.$64$YR$A$F$Y$$$20240913$$HP$JP$JP
243162231$24316223$1$I$$20240909$20240913$20240913$EXP$$US-MYLANLABS-2024M1083284$MYLAN$Chunga N, Curtis K, Tomcik CB, Lizarraga KJ. Right putamen and claustrum infarction mimicking normal pressure hydrocephalus. BMJ-Case-Rep 2024; 17 (8): 1-6.$8$DEC$$F$Y$$$20240913$$HP$US$US
243162241$24316224$1$I$20240904$20240911$20240913$20240913$PER$$US-BAYER-2024A130370$BAYER$$$$$F$Y$$$20240913$$CN$US$US
243162251$24316225$1$I$$20240829$20240913$20240913$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467609$RANBAXY$$23$YR$$F$Y$$$20240913$$CN$AU$AU
243162261$24316226$1$I$20240911$20240911$20240913$20240913$PER$$US-JNJFOC-20240929390$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240913$$HP$US$US
243162272$24316227$2$F$$20240909$20240913$20240917$PER$$US-AstraZeneca-2024A194169$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243162281$24316228$1$I$$20240911$20240913$20240913$PER$$US-JNJFOC-20240927934$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$HP$US$US
243162291$24316229$1$I$20240418$20240906$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-045224$AUROBINDO$$37$YR$$F$Y$$$20240913$$PH$FR$FR
243162301$24316230$1$I$20240801$20240903$20240913$20240913$EXP$$US-TEVA-VS-3241546$TEVA$$57$YR$$M$Y$$$20240913$$CN$US$US
243162311$24316231$1$I$$20240906$20240913$20240913$EXP$$US-AstraZeneca-2024A208010$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243162321$24316232$1$I$20240801$20240909$20240913$20240913$EXP$$US-ABBVIE-5917988$ABBVIE$$77$YR$$F$Y$$$20240913$$CN$US$US
243162331$24316233$1$I$$20240905$20240913$20240913$EXP$$CN-AstraZeneca-2024A203712$ASTRAZENECA$$59$YR$$F$Y$$$20240913$$CN$CN$
243162341$24316234$1$I$$20240910$20240913$20240913$EXP$$US-AstraZeneca-2024A207462$ASTRAZENECA$$$$$$Y$$$20240913$$MD$US$
243162351$24316235$1$I$$20240909$20240913$20240913$EXP$$US-AstraZeneca-2024A206787$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243162361$24316236$1$I$$20240910$20240913$20240913$PER$$US-BAYER-2024A130437$BAYER$$51$YR$A$F$Y$$$20240913$$CN$US$US
243162371$24316237$1$I$$20240909$20240913$20240913$EXP$$TR-ASTELLAS-2024-AER-005906$ASTELLAS$$40$YR$A$F$Y$$$20240913$$MD$TR$TR
243162382$24316238$2$F$$20240924$20240913$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-044555$AUROBINDO$$$$$M$Y$$$20240927$$CN$GB$GB
243162391$24316239$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MED-202409041658254980-KTGCS$GB-TEVA-VS-3240665$TEVA$$$$$M$Y$$$20240913$$HP$GB$GB
243162401$24316240$1$I$20240515$20240911$20240913$20240913$EXP$$NVSC2024GB108468$NOVARTIS$$36$YR$$F$Y$$$20240913$$CN$GB$GB
243162411$24316241$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145620$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240913$$CN$US$US
243162421$24316242$1$I$$20240903$20240913$20240913$EXP$$US-Accord-445375$ACCORD$$$$$M$Y$63.96$KG$20240913$$MD$US$US
243162431$24316243$1$I$$20240911$20240913$20240913$EXP$$CA-SANDOZ INC.-NVSC2022CA110813$SANDOZ$$76$YR$$M$Y$$$20240913$$CN$CA$CA
243162442$24316244$2$F$$20240910$20240913$20240917$EXP$$CA-AstraZeneca-2024A147973$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$CA$
243162451$24316245$1$I$$20240905$20240913$20240913$EXP$$JP-ASTELLAS-2024-AER-005284$ASTELLAS$Kimura M, Fujiwara S, Kuroda H, Kanamori M, Kawamoto M, Kimura M. Choroid plexitis caused by Burkholderia cepacia complex after COVID-19. International Journal of Infectious Diseases. 2024;147: 1-4.$67$YR$E$F$Y$$$20240913$$MD$JP$JP
243162461$24316246$1$I$20240903$20240906$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142907$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$53.25$KG$20240913$$HP$US$US
243162471$24316247$1$I$$20240829$20240913$20240913$PER$$US-BAYER-2024A130478$BAYER$$$$$$Y$$$20240913$$CN$US$US
243162482$24316248$2$F$20240424$20240913$20240913$20240924$EXP$$BR-BAXTER-2024BAX019850$BAXTER$$68$YR$$F$Y$68.4$KG$20240924$$MD$BR$BR
243162491$24316249$1$I$20240808$20240903$20240913$20240913$EXP$GB-MHRA-MED-202408311917190870-SBCNL$GB-Accord-444987$ACCORD$$53$YR$A$M$Y$58$KG$20240913$$CN$GB$GB
243162501$24316250$1$I$$20240911$20240913$20240913$EXP$$GB-JNJFOC-20240932001$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240913$$CN$GB$GB
243162511$24316251$1$I$$20240903$20240913$20240913$30DAY$$JP-JNJFOC-20240927032$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$PH$JP$JP
243162522$24316252$2$F$$20240920$20240913$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005392$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243162531$24316253$1$I$20240817$20240905$20240913$20240913$EXP$FR-AFSSAPS-CN2024000825$FR-TEVA-VS-3240886$TEVA$$73$YR$$F$Y$54$KG$20240913$$MD$FR$FR
243162541$24316254$1$I$$20240907$20240913$20240913$EXP$$DE-VELOXIS PHARMACEUTICALS, INC.-2020-VEL-00879$VELOXIS PHARMACEUTICALS$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al.. Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant  recipients: CERTAIN registry study.. TRANSPLANTATION.. 2018;103(6):1-33$8$YR$$$Y$$$20240913$$MD$DE$DE
243162551$24316255$1$I$$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024179936$AMGEN$$$$$F$Y$$$20240913$$CN$US$US
243162561$24316256$1$I$$20240911$20240913$20240913$EXP$$US-ORGANON-O2409USA000837$ORGANON$$$$$F$Y$$$20240913$$HP$US$US
243162571$24316257$1$I$20240901$20240909$20240913$20240913$EXP$$US-ABBVIE-5916772$ABBVIE$$58$YR$$M$Y$$$20240913$$CN$US$US
243162581$24316258$1$I$20240101$20240909$20240913$20240913$EXP$$CA-Orion Corporation ORION PHARMA-24_00031652$ORION$$77$YR$E$M$Y$$$20240913$$MD$CA$
243162591$24316259$1$I$$20240902$20240913$20240913$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-26838$SAMSUNG BIOEPIS$$63$YR$A$F$Y$$$20240913$$CN$GB$GB
243162601$24316260$1$I$$20240910$20240913$20240913$EXP$$NVSC2024CA181822$NOVARTIS$$59$YR$$F$Y$$$20240913$$HP$CA$CA
243162611$24316261$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MED-202408291202511180-TJQBY$GB-MSNLABS-2024MSNSPO01949$MSN LABORATORIES$$$$$$Y$$$20240913$$HP$GB$GB
243162631$24316263$1$I$$20240912$20240913$20240913$PER$$US-ALXN-202409USA000902US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243162641$24316264$1$I$20240819$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181530$AMGEN$$68$YR$E$F$Y$$$20240913$$CN$US$US
243162651$24316265$1$I$20240821$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024179768$AMGEN$$72$YR$E$F$Y$$$20240913$$CN$US$US
243162661$24316266$1$I$$20240902$20240913$20240913$EXP$$BG-Accord-445518$ACCORD$Neykova L., Angelov I., Ivanova M., Notev A. INTRALIPIDS ADN THEIR ROLE IN THE MANAGEMENT OF ANTIPSYCHOTIC AND NEUROLEPTIC DRUG INTOXICATIONS Military Medicine, 2024, N 2, 29-33.$46$YR$A$F$Y$$$20240913$$HP$BG$BG
243162671$24316267$1$I$$20240904$20240913$20240913$EXP$$BE-Bion-013790$BIONPHARMA$$73$YR$E$M$Y$$$20240913$$HP$BE$BE
243162681$24316268$1$I$20240910$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182432$AMGEN$$$$$$Y$$$20240913$$HP$US$US
243162691$24316269$1$I$20240822$20240903$20240913$20240913$EXP$GB-MHRA-MED-202409031330368850-PSGWV$GB-TEVA-VS-3240041$TEVA$$80$YR$$F$Y$$$20240913$$HP$GB$GB
243162702$24316270$2$F$$20240920$20240913$20240925$30DAY$$FR-PFIZER INC-202400181668$PFIZER$$12$YR$$F$Y$$$20240925$$MD$FR$FR
243162711$24316271$1$I$$20240904$20240913$20240913$EXP$$ID-Bion-013797$BIONPHARMA$$33$YR$A$F$Y$$$20240913$$HP$ID$ID
243162721$24316272$1$I$20240904$20240905$20240913$20240913$EXP$$US-Bion-013825$BIONPHARMA$$70$YR$E$M$Y$$$20240913$$CN$US$US
243162731$24316273$1$I$$20240904$20240913$20240913$EXP$$CA-Bion-013784$BIONPHARMA$$74$YR$E$F$Y$$$20240913$$HP$CA$CA
243162741$24316274$1$I$20240801$20240909$20240913$20240913$EXP$$US-ABBVIE-5916680$ABBVIE$$55$YR$$F$Y$$$20240913$$CN$US$US
243162751$24316275$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007318$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240913$$CN$US$US
243162761$24316276$1$I$20240911$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007588$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240913$$CN$US$US
243162771$24316277$1$I$$20240910$20240913$20240913$EXP$$US-Bion-013835$BIONPHARMA$$61$YR$A$F$Y$$$20240913$$CN$US$US
243162781$24316278$1$I$20210101$20240910$20240913$20240913$EXP$NO-NOMAADVRE-PASRAPP-2024-Vjqrzn$NO-CHEPLA-2024011662$CHEPLAPHARM$$61$YR$$F$Y$82$KG$20240913$$CN$COUNTRY NOT SPECIFIED$NO
243162791$24316279$1$I$$20240907$20240913$20240913$EXP$$GB-VELOXIS PHARMACEUTICALS, INC.-2020-VEL-00906$VELOXIS PHARMACEUTICALS$Yaakub A, Htet ZM, Yardley Ball R, Karim M, Shah SN.. Two simultaneous unusual complications after renal transplantation. British journal of dermatology. 2020;183(1):140$47$YR$$M$Y$$$20240913$$MD$GB$GB
243162802$24316280$2$F$20211028$20240916$20240913$20240923$EXP$$CA-TAKEDA-2024TUS089883$TAKEDA$$58$YR$$F$Y$$$20240923$$MD$CA$CA
243162811$24316281$1$I$$20240902$20240913$20240913$EXP$$US-Accord-446080$ACCORD$$$$$$Y$$$20240913$$CN$US$US
243162821$24316282$1$I$20240827$20240904$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044612$AUROBINDO$$58$YR$$M$Y$$$20240913$$MD$FR$FR
243162832$24316283$2$F$20240701$20240919$20240913$20240924$EXP$$US-ROCHE-10000078876$ROCHE$$29$YR$A$F$Y$74.84$KG$20240924$$CN$US$US
243162842$24316284$2$F$$20240909$20240913$20240923$PER$$US-HALEON-2196062$Haleon PLC$$$$$$Y$$$20240923$$CN$US$US
243162851$24316285$1$I$20240801$20240905$20240913$20240913$EXP$GB-STEMLINE THERAPEUTICS B.V.-2024-STML-GB000426$GB-ASPEN-GLO2024GB006093$ASPEN$$$$$$Y$$$20240913$$HP$GB$GB
243162862$24316286$2$F$20240201$20240926$20240913$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145448$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240930$$HP$US$US
243162871$24316287$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144808$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240913$$HP$US$US
243162901$24316290$1$I$$20240903$20240913$20240913$PER$$US-TRIS PHARMA, INC.-24US011617$TRIS PHARM$$$$$$Y$$$20240913$$MD$US$US
243162921$24316292$1$I$$20240903$20240913$20240913$PER$$US-TRIS PHARMA, INC.-24US011618$TRIS PHARM$$$$$$Y$$$20240913$$MD$US$US
243162931$24316293$1$I$$20240903$20240913$20240913$PER$$US-TRIS PHARMA, INC.-24US011619$TRIS PHARM$$$$$$Y$$$20240913$$MD$US$US
243162941$24316294$1$I$$20240903$20240913$20240913$PER$$US-TRIS PHARMA, INC.-24US011620$TRIS PHARM$$$$$$Y$$$20240913$$CN$US$US
243162952$24316295$2$F$20240905$20240925$20240913$20240927$EXP$$GB-MYLANLABS-2024M1082659$MYLAN$$$$$F$Y$$$20240927$$PH$GB$GB
243162972$24316297$2$F$$20240916$20240913$20240919$EXP$$GB-MYLANLABS-2024M1083168$MYLAN$$$$$F$Y$$$20240919$$MD$GB$GB
243162981$24316298$1$I$$20240909$20240913$20240913$EXP$$HU-MYLANLABS-2024M1082459$MYLAN$$31$YR$$M$Y$$$20240913$$MD$HU$HU
243162991$24316299$1$I$$20240905$20240913$20240913$EXP$$US-AstraZeneca-2024A203241$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243163001$24316300$1$I$$20240907$20240913$20240913$EXP$$IN-AstraZeneca-2024A205335$ASTRAZENECA$$60$YR$$F$Y$42$KG$20240913$$CN$IN$
243163011$24316301$1$I$$20240903$20240913$20240913$PER$$US-AstraZeneca-2024A200560$ASTRAZENECA$$$$$$Y$$$20240913$$CN$US$
243163021$24316302$1$I$20230629$20240906$20240913$20240913$EXP$$DE-AstraZeneca-2024A203616$ASTRAZENECA$$57$YR$$F$Y$$$20240913$$MD$DE$
243163031$24316303$1$I$$20240911$20240913$20240913$PER$$US-HALEON-2196570$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
243163041$24316304$1$I$$20240910$20240913$20240913$PER$$US-AstraZeneca-2024A207938$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243163051$24316305$1$I$$20240911$20240913$20240913$PER$$US-ROCHE-10000080408$ROCHE$$54$YR$A$M$Y$$$20240913$$MD$US$US
243163061$24316306$1$I$$20240905$20240913$20240913$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001809$BLUEPRINT MEDICINES$$$$$F$Y$$$20240913$$CN$US$US
243163071$24316307$1$I$20240701$20240903$20240913$20240913$EXP$$JP-ASTELLAS-2024-AER-004315$ASTELLAS$$9$DEC$E$M$Y$$$20240913$$PH$JP$JP
243163081$24316308$1$I$20230910$20240912$20240913$20240913$EXP$GB-MHRA-MED-202409092211043050-VNYST$GB-ORGANON-O2409GBR000840$ORGANON$$62$YR$$M$Y$$$20240913$$MD$GB$GB
243163091$24316309$1$I$$20240903$20240913$20240913$EXP$$PT-Accord-445974$ACCORD$Flores R, Quintal J, Coelho RA, Goncalves S, Duarte T, Silvestre I, et al. PO-0395 - (4638) - Chemotherapy-Associated Cardiotoxicity: The Importance Of Differential Diagnosis In Therapeutic Optimization. 30 CNMI. Cardiovascular diseases, case report.$63$YR$A$M$Y$$$20240913$$HP$PT$PT
243163101$24316310$1$I$20230710$20240910$20240913$20240913$EXP$CZ-CZSUKL-24002475$CZ-CHEPLA-2024011663$CHEPLAPHARM$$34$YR$$M$Y$102$KG$20240913$$CN$COUNTRY NOT SPECIFIED$CZ
243163111$24316311$1$I$$20240903$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0012853$DR REDDYS$$45$YR$A$F$Y$$$20240913$$CN$US$US
243163121$24316312$1$I$$20240901$20240913$20240913$EXP$$JP-Accord-446398$ACCORD$Toji Y, Takeuchi S, Ebihara Y, Kurashima Y, Harada K, Hayashi M, et al. Perioperative chemotherapy with nivolumab for HER2-negative locally advanced gastric cancer: a case series. Surg Case Rep. 2024 Aug 28;10(1):200. doi: 10.1186/s40792-024-02001-w.$62$YR$A$M$Y$$$20240913$$HP$JP$JP
243163131$24316313$1$I$$20240908$20240913$20240913$EXP$$US-ROCHE-10000077431$ROCHE$$$$$M$Y$$$20240913$$CN$US$US
243163141$24316314$1$I$20240805$20240903$20240913$20240913$PER$$US-RDY-SPO/USA/24/0012838$DR REDDYS$$52$YR$A$M$Y$$$20240913$$HP$US$US
243163151$24316315$1$I$20240830$20240903$20240913$20240913$PER$$US-RDY-SPO/USA/24/0012839$DR REDDYS$$15$YR$T$F$Y$$$20240913$$HP$US$US
243163161$24316316$1$I$$20240903$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0012887$DR REDDYS$$63$YR$A$F$Y$$$20240913$$CN$US$US
243163171$24316317$1$I$$20240904$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0012965$DR REDDYS$$77$YR$E$F$Y$$$20240913$$MD$US$US
243163181$24316318$1$I$$20240904$20240913$20240913$EXP$$AT-TEVA-VS-3241591$TEVA$$50$YR$$M$Y$$$20240913$$MD$AT$AT
243163191$24316319$1$I$$20240903$20240913$20240913$EXP$$BR-TAKEDA-2024TUS090674$TAKEDA$$58$YR$$M$Y$$$20240913$$MD$BR$BR
243163211$24316321$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145793$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240913$$HP$US$US
243163221$24316322$1$I$20240802$20240912$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145859$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240913$$HP$US$US
243163231$24316323$1$I$20240801$20240902$20240913$20240913$EXP$$JP-ROCHE-10000076873$ROCHE$$70$YR$E$F$Y$47$KG$20240913$$MD$JP$JP
243163261$24316326$1$I$$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62911$$FDA-CTU$$$$$F$N$$$20240911$N$HP$US$
243163291$24316329$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62827$$FDA-CTU$$68$YR$$F$N$$$20240912$N$$US$
243163311$24316331$1$I$20240909$20240910$20240913$20240913$EXP$$US-ABBVIE-5917865$ABBVIE$$74$YR$$M$Y$$$20240913$$CN$US$US
243163321$24316332$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62833$$FDA-CTU$$58$YR$$F$N$177$LBS$20240912$N$$US$
243163341$24316334$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62836$$FDA-CTU$$61$YR$$F$N$$$20240912$N$HP$US$
243163351$24316335$1$I$20240807$20240904$20240913$20240913$EXP$$US-MSNLABS-2024MSNSPO01926$MSN LABORATORIES$$$$$$Y$$$20240913$$CN$US$US
243163361$24316336$1$I$20240717$20240910$20240913$20240913$EXP$FI-FIMEA-202403228$FI-CHEPLA-2024011708$CHEPLAPHARM$$39$YR$$M$Y$$$20240913$$MD$COUNTRY NOT SPECIFIED$FI
243163371$24316337$1$I$$20240906$20240913$20240913$PER$$US-ALXN-202409USA000931US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243163381$24316338$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62853$$FDA-CTU$$87$YR$$M$N$$$20240912$N$$US$
243163412$24316341$2$F$20240701$20240915$20240913$20240918$EXP$$US-ABBVIE-5330465$ABBVIE$$78$YR$$F$Y$$$20240918$$CN$US$US
243163421$24316342$1$I$20240909$20240910$20240913$20240913$EXP$$US-ABBVIE-5917908$ABBVIE$$53$YR$$F$Y$$$20240913$$CN$US$US
243163431$24316343$1$I$$20240912$20240913$20240913$PER$$US-HALEON-2196689$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
243163441$24316344$1$I$$20240910$20240913$20240913$PER$$US-ABBVIE-5919415$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243163451$24316345$1$I$20240701$20240904$20240913$20240913$EXP$$CL-JNJFOC-20240810998$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240913$$CN$CL$CL
243163461$24316346$1$I$$20240911$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA079639$SANDOZ$$43$YR$$F$Y$$$20240913$$HP$CA$CA
243163471$24316347$1$I$$20240903$20240913$20240913$30DAY$$ES-JNJFOC-20240925679$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$PH$ES$ES
243163481$24316348$1$I$20120901$20240909$20240913$20240913$PER$$US-JNJFOC-20240927333$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240913$$HP$US$US
243163491$24316349$1$I$20240228$20240905$20240913$20240913$EXP$$CO-PFIZER INC-2024SGN02597$PFIZER$$33$YR$$M$Y$54$KG$20240913$$CN$CO$CO
243163501$24316350$1$I$$20240911$20240913$20240913$EXP$$EG-PFIZER INC-202400255330$PFIZER$$47$YR$$F$Y$$$20240913$$CN$EG$EG
243163511$24316351$1$I$20240102$20240911$20240913$20240913$EXP$$US-PFIZER INC-202400004783$PFIZER$$23$YR$$M$Y$$$20240913$$CN$US$US
243163521$24316352$1$I$20240825$20240910$20240913$20240913$EXP$$PH-PFIZER INC-202400222004$PFIZER$$47$YR$$M$Y$$$20240913$$CN$PH$PH
243163531$24316353$1$I$20240701$20240903$20240913$20240913$EXP$$US-UCBSA-2024045310$UCB$$77$YR$$F$Y$$$20240913$$HP$US$US
243163541$24316354$1$I$$20240903$20240913$20240913$PER$$US-ABBVIE-5908186$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243163551$24316355$1$I$$20240911$20240913$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US055366$SANDOZ$$$$$M$Y$$$20240913$$CN$US$US
243163571$24316357$1$I$$20240901$20240913$20240913$EXP$$US-CBL-002765$CONCORD BIOTECH$Au-Yeung NM, Regennitter NS, Stepherson J, Seele J, Rosenblatt E, Carter W. Folate Deficiency and Medication-Induced Severe Pancytopenia in a Bilateral Lung Transplantee. Cureus. 2024 Jul 30;16(7):e65780. doi: 10.7759/cureus.65780.$74$YR$E$M$Y$$$20240913$$HP$US$US
243163582$24316358$2$F$20240809$20240916$20240913$20240923$EXP$FR-AFSSAPS-AN2024001234$FR-CHEPLA-2024011671$CHEPLAPHARM$$43$YR$$F$Y$152$KG$20240923$$PH$COUNTRY NOT SPECIFIED$FR
243163591$24316359$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145709$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$83.91$KG$20240913$$CN$US$US
243163601$24316360$1$I$20240101$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145640$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$86.18$KG$20240913$$CN$US$US
243163611$24316361$1$I$$20240910$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145571$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240913$$CN$US$US
243163621$24316362$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145666$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240913$$HP$US$US
243163631$24316363$1$I$20240101$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145677$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240913$$HP$US$US
243163641$24316364$1$I$20240811$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145862$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240913$$CN$US$US
243163651$24316365$1$I$20240820$20240906$20240913$20240913$EXP$FR-AFSSAPS-PO2024000947$FR-MYLANLABS-2024M1081871$MYLAN$$57$YR$$M$Y$85$KG$20240913$$MD$FR$FR
243163661$24316366$1$I$20240820$20240906$20240913$20240913$EXP$NL-LRB-00999635$NL-MYLANLABS-2024M1082020$MYLAN$$77$YR$$M$Y$70$KG$20240913$$MD$NL$NL
243163672$24316367$2$F$20240805$20240916$20240913$20240919$EXP$$GB-MYLANLABS-2024M1082198$MYLAN$$$$$F$Y$$$20240919$$MD$GB$GB
243163681$24316368$1$I$20240514$20240906$20240913$20240913$EXP$FR-AFSSAPS-NC2024001046$FR-MYLANLABS-2024M1081853$MYLAN$$17$YR$$F$Y$$$20240913$$MD$FR$FR
243163701$24316370$1$I$20240501$20240906$20240913$20240913$EXP$NL-LRB-00999589$NL-MYLANLABS-2024M1081991$MYLAN$$53$YR$$F$Y$67$KG$20240913$$CN$NL$NL
243163731$24316373$1$I$$20240910$20240913$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US079371$SANDOZ$$$$$M$Y$$$20240913$$CN$US$US
243163741$24316374$1$I$$20240906$20240913$20240913$EXP$$DE-MYLANLABS-2024M1081957$MYLAN$$7$MON$$F$Y$$$20240913$$MD$DE$DE
243163761$24316376$1$I$$20240814$20240912$20240912$DIR$FDA-CDER-CTU-2024-62825$$FDA-CTU$$$$$F$N$$$20240814$N$HP$US$
243163771$24316377$1$I$20240910$20240911$20240913$20240913$EXP$$US-INTERCEPT-PM2024001819$INTERCEPT PHARMACEUTICALS$$89$YR$$F$Y$$$20240913$$CN$US$US
243163781$24316378$1$I$20240827$20240910$20240913$20240913$EXP$$US-GILEAD-2024-0687334$GILEAD$$42$YR$A$M$Y$$$20240913$$CN$US$US
243163791$24316379$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004985$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243163811$24316381$1$I$$20240819$20240912$20240912$DIR$FDA-CDER-CTU-2024-62921$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
243163831$24316383$1$I$$20240907$20240913$20240913$EXP$$US-BAYER-2024A128371$BAYER$$$$$$Y$$$20240913$$CN$US$US
243163841$24316384$1$I$$20240903$20240913$20240913$EXP$$US-TEVA-VS-3239878$TEVA$$68$YR$$M$Y$68.49$KG$20240913$$CN$US$US
243163852$24316385$2$F$20240804$20240918$20240913$20240924$30DAY$$CO-PFIZER INC-202400253635$PFIZER$$11$YR$$F$Y$$$20240924$$CN$CO$CO
243163861$24316386$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62819$$FDA-CTU$$79$YR$$M$N$$$20240912$N$$US$
243163871$24316387$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62840$$FDA-CTU$$65$YR$$F$N$139$LBS$20240912$N$$US$
243163881$24316388$1$I$$20240906$20240912$20240912$DIR$FDA-CDER-CTU-2024-62915$$FDA-CTU$$$$$M$N$$$20240906$N$HP$US$
243163891$24316389$1$I$20240912$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62927$$FDA-CTU$$80$YR$$M$N$$$20240912$Y$PH$US$
243163901$24316390$1$I$$20240906$20240913$20240913$30DAY$$US-PFIZER INC-202400253047$PFIZER$$12$YR$$F$Y$$$20240913$$CN$US$US
243163914$24316391$4$F$$20240916$20240913$20240923$30DAY$$US-PFIZER INC-202400253642$PFIZER$$13$YR$$M$Y$44.91$KG$20240923$$CN$US$US
243163921$24316392$1$I$$20240909$20240913$20240913$30DAY$$US-PFIZER INC-202400253173$PFIZER$$17$YR$$M$Y$$$20240913$$CN$US$US
243163932$24316393$2$F$20240901$20240911$20240913$20240917$30DAY$$US-PFIZER INC-202400253269$PFIZER$$13$YR$$M$Y$$$20240917$$CN$US$US
243163941$24316394$1$I$20240101$20240904$20240913$20240913$30DAY$$CO-PFIZER INC-202400217249$PFIZER$$16$YR$$M$Y$$$20240913$$CN$CO$CO
243163952$24316395$2$F$20240902$20240913$20240913$20240919$30DAY$$US-PFIZER INC-202400253263$PFIZER$$44$YR$$F$Y$$$20240919$$CN$US$US
243163962$24316396$2$F$20240801$20240918$20240913$20240924$30DAY$$CO-PFIZER INC-PV202400115975$PFIZER$$11$YR$$M$Y$28$KG$20240924$$CN$CO$CO
243163972$24316397$2$F$$20240912$20240913$20240918$30DAY$$US-PFIZER INC-202400254245$PFIZER$$13$YR$$F$Y$$$20240918$$CN$US$US
243163981$24316398$1$I$$20240909$20240913$20240913$30DAY$$US-PFIZER INC-202400253315$PFIZER$$11$YR$$M$Y$$$20240913$$CN$US$US
243163992$24316399$2$F$$20240910$20240913$20240917$30DAY$$US-PFIZER INC-202400254095$PFIZER$$14$YR$$M$Y$$$20240917$$CN$US$US
243164001$24316400$1$I$$20240906$20240913$20240913$30DAY$$US-PFIZER INC-202400252997$PFIZER$$23$YR$$M$Y$90.72$KG$20240913$$CN$US$US
243164011$24316401$1$I$$20240909$20240913$20240913$30DAY$$US-PFIZER INC-202400253256$PFIZER$$14$YR$$M$Y$36.3$KG$20240913$$CN$US$US
243164021$24316402$1$I$$20240905$20240913$20240913$30DAY$$US-PFIZER INC-202400250801$PFIZER$$16$YR$$M$Y$54.43$KG$20240913$$CN$US$US
243164031$24316403$1$I$$20240903$20240913$20240913$30DAY$$US-PFIZER INC-202400249559$PFIZER$$12$YR$$M$Y$$$20240913$$CN$US$US
243164042$24316404$2$F$20240101$20240907$20240913$20240917$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028053$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240917$$$US$US
243164051$24316405$1$I$$20240823$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08547$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243164061$24316406$1$I$$20240909$20240913$20240913$EXP$$CA-MYLANLABS-2024M1069852$MYLAN$$$$$M$Y$66.2$KG$20240913$$PH$CA$CA
243164071$24316407$1$I$$20240909$20240913$20240913$EXP$$PT-AMGEN-PRTSP2024181000$AMGEN$$62$YR$A$M$Y$$$20240913$$MD$PT$PT
243164081$24316408$1$I$20240903$20240904$20240913$20240913$EXP$$KR-009507513-2409KOR002455$MERCK$$$$$F$Y$$$20240913$$CN$KR$KR
243164091$24316409$1$I$$20240912$20240913$20240913$PER$$NVSC2024US182993$NOVARTIS$$$$$$Y$$$20240913$$CN$US$US
243164101$24316410$1$I$20240808$20240906$20240913$20240913$EXP$$TW-ABBVIE-5914189$ABBVIE$$66$YR$$M$Y$72$KG$20240913$$HP$TW$TW
243164121$24316412$1$I$$20240912$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA079934$SANDOZ$$4$YR$$F$Y$$$20240913$$PH$CA$CA
243164131$24316413$1$I$$20240903$20240913$20240913$EXP$$FR-862174955-ML2024-04795$MICRO LABS$Baudriller A, Abbara C, Briet M, Jousset N, Malbranque S, Zabet D, et al. Deaths related to pharmacobezoars: A report on two cases. Toxic-Analyt-Clinique. 2024.$55$YR$A$F$Y$$$20240913$$HP$FR$FR
243164141$24316414$1$I$20240829$20240905$20240913$20240913$EXP$$GB-862174955-ML2024-04811$MICRO LABS$$50$YR$A$F$Y$93$KG$20240913$$HP$GB$GB
243164151$24316415$1$I$$20240902$20240913$20240913$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-17028$SAMSUNG BIOEPIS$$33$YR$A$F$Y$$$20240913$$CN$GB$GB
243164161$24316416$1$I$$20240909$20240913$20240913$EXP$GB-MHRA-MED-202409091415017530-BMRND$GB-ASTELLAS-2024-AER-005766$ASTELLAS$$63$YR$A$F$Y$$$20240913$$HP$GB$GB
243164171$24316417$1$I$20240909$20240910$20240913$20240913$EXP$$US-GILEAD-2024-0687368$GILEAD$$68$YR$E$M$Y$$$20240913$$CN$US$US
243164192$24316419$2$F$20240831$20240916$20240913$20240923$EXP$$GB-MYLANLABS-2024M1081059$MYLAN$$$$$F$Y$$$20240923$$CN$GB$GB
243164202$24316420$2$F$$20240923$20240913$20240926$EXP$GB-MHRA-MED-202409101642449390-TPHCK$GB-MYLANLABS-2024M1082856$MYLAN$$85$YR$$F$Y$$$20240926$$CN$GB$GB
243164211$24316421$1$I$20210302$20240910$20240913$20240913$EXP$$GB-MYLANLABS-2024M1083076$MYLAN$$68$YR$$M$Y$$$20240913$$MD$GB$GB
243164221$24316422$1$I$$20240910$20240913$20240913$EXP$$CA-MYLANLABS-2024M1082773$MYLAN$$91$YR$$F$Y$$$20240913$$MD$CA$CA
243164231$24316423$1$I$$20240910$20240913$20240913$EXP$$CA-MYLANLABS-2024M1082772$MYLAN$$$$$F$Y$$$20240913$$MD$CA$CA
243164241$24316424$1$I$$20240910$20240913$20240913$EXP$$GB-MYLANLABS-2024M1082738$MYLAN$$85$YR$$F$Y$67$KG$20240913$$MD$GB$GB
243164251$24316425$1$I$$20240910$20240913$20240913$EXP$$GB-MYLANLABS-2024M1077052$MYLAN$$$$$F$Y$$$20240913$$MD$GB$GB
243164261$24316426$1$I$$20240910$20240913$20240913$EXP$GB-MHRA-MED-202409102349253270-YZNMC$GB-MYLANLABS-2024M1082874$MYLAN$$$$$M$Y$$$20240913$$CN$GB$GB
243164271$24316427$1$I$$20240910$20240913$20240913$EXP$$GB-MYLANLABS-V-GB-2009-8219$MYLAN$Long S,et al.. The copetent novice: practising safety in the foundation years. BMJ. 2009;338 (7699):887-890$90$YR$$F$Y$$$20240913$$HP$GB$GB
243164281$24316428$1$I$$20240910$20240913$20240913$EXP$$NZ-MYLANLABS-2024M1082944$MYLAN$$$$$F$Y$$$20240913$$HP$NZ$NZ
243164291$24316429$1$I$20240720$20240910$20240913$20240913$EXP$$KR-MYLANLABS-2024M1078986$MYLAN$$51$YR$$M$Y$$$20240913$$MD$KR$KR
243164301$24316430$1$I$20240901$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181143$AMGEN$$64$YR$A$F$Y$$$20240913$$CN$US$US
243164311$24316431$1$I$$20240909$20240913$20240913$EXP$$DE-AMGEN-DEUSP2024181190$AMGEN$$72$YR$E$F$Y$$$20240913$$MD$DE$DE
243164321$24316432$1$I$20240709$20240903$20240913$20240913$EXP$$CN-GE HEALTHCARE-2024CSU010215$GE HEALTHCARE$$45$YR$$F$Y$59$KG$20240913$$HP$CN$CN
243164331$24316433$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007338$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240913$$CN$US$US
243164341$24316434$1$I$20240902$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007301$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240913$$CN$US$US
243164351$24316435$1$I$20240909$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007320$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240913$$CN$US$US
243164361$24316436$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007291$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240913$$CN$US$US
243164372$24316437$2$F$20240827$20240919$20240913$20240920$PER$$US-AMGEN-USASP2024182057$AMGEN$$83$YR$E$F$Y$$$20240920$$CN$US$US
243164381$24316438$1$I$20240524$20240906$20240913$20240913$EXP$IT-MINISAL02-1001019$IT-AMGEN-ITASP2024178738$AMGEN$$56$YR$A$F$Y$59$KG$20240913$$MD$IT$IT
243164391$24316439$1$I$20240829$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024180187$AMGEN$$76$YR$E$M$Y$$$20240913$$HP$US$US
243164401$24316440$1$I$$20240909$20240913$20240913$EXP$$CA-AMGEN-CANSL2024179702$AMGEN$$$$E$F$Y$$$20240913$$CN$CA$CA
243164411$24316441$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62937$$FDA-CTU$$63$YR$$M$N$267$LBS$20240912$N$$US$
243164421$24316442$1$I$$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62938$$FDA-CTU$$$$$F$N$$$20240911$N$HP$US$
243164431$24316443$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62913$$FDA-CTU$$53$YR$$F$N$$$20240913$N$$US$
243164441$24316444$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62816$$FDA-CTU$$$$$F$N$$$20240912$N$HP$US$
243164451$24316445$1$I$$20240909$20240912$20240912$DIR$FDA-CDER-CTU-2024-62916$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243164461$24316446$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62939$$FDA-CTU$$73$YR$$F$N$$$20240912$N$$US$
243164471$24316447$1$I$20240812$20240828$20240912$20240912$DIR$FDA-CDER-CTU-2024-62922$$FDA-CTU$$68$YR$$M$N$$$20240828$N$HP$US$
243164491$24316449$1$I$$20240815$20240912$20240912$DIR$FDA-CDER-CTU-2024-62820$$FDA-CTU$$$$$F$N$$$20240815$N$HP$US$
243164501$24316450$1$I$20240615$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62857$$FDA-CTU$$76$YR$$F$N$$$20240912$N$HP$US$
243164511$24316451$1$I$$20240827$20240912$20240912$DIR$FDA-CDER-CTU-2024-62928$$FDA-CTU$$$$$F$N$$$20240827$N$HP$US$
243164521$24316452$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010440$APOTEX$Ingole P, Morkas M, May R, Hinman B, Carrum G, Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$F$Y$$$20240913$$HP$US$US
243164551$24316455$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004987$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243164563$24316456$3$F$$20240917$20240913$20240919$EXP$$CA-ROCHE-10000080874$ROCHE$$$$A$F$Y$$$20240919$$CN$CA$CA
243164571$24316457$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5917656$ABBVIE$$$$$M$Y$$$20240913$$HP$US$US
243164581$24316458$1$I$20240830$20240909$20240913$20240913$EXP$$US-ABBVIE-5854611$ABBVIE$$55$YR$$F$Y$$$20240913$$CN$US$US
243164592$24316459$2$F$20240731$20240918$20240913$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145771$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240930$$PH$JP$JP
243164601$24316460$1$I$20240818$20240827$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-137593$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$70.31$KG$20240913$$CN$US$US
243164611$24316461$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146016$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240913$$CN$US$US
243164621$24316462$1$I$$20240912$20240913$20240913$PER$$NVSC2024US183752$NOVARTIS$$$$$M$Y$$$20240913$$MD$US$US
243164631$24316463$1$I$20231112$20240909$20240913$20240913$EXP$$MX-ROCHE-10000079392$ROCHE$$47$YR$A$F$Y$$$20240913$$CN$MX$MX
243164641$24316464$1$I$20240821$20240911$20240913$20240913$PER$$US-BAYER-2024A130135$BAYER$$38$YR$A$F$Y$$$20240913$$MD$US$US
243164652$24316465$2$F$20240101$20240909$20240913$20240913$PER$$US-ABBVIE-5918366$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243164662$24316466$2$F$20230825$20240910$20240913$20240920$EXP$$CN-USV-002875$USV PRIVATE$Liao L, Zhang Z. Severe sepsis induced by zoledronic acid: A case report. Medicine (Baltimore). 2024 Aug 30;103(35):e39188.$58$YR$A$F$Y$$$20240920$$HP$CN$CN
243164672$24316467$2$F$$20240911$20240913$20240923$EXP$$TR-Accord-445260$ACCORD$Balan K, Aydin F, Akdogan N. Acute Localized Exanthematous Pustulosis in a 5-Year-Old Boy With Zosteriform Distrubiton. Cureus. 2024 Jul 26;16(7):e65402.$5$YR$C$M$Y$$$20240923$$HP$TR$TR
243164681$24316468$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004989$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243164691$24316469$1$I$$20240911$20240913$20240913$PER$$US-BAYER-2024A130651$BAYER$$25$YR$A$F$Y$$$20240913$$HP$US$US
243164701$24316470$1$I$$20240903$20240913$20240913$PER$$US-IMP-2024000714$Harrow Health$$$$A$F$Y$$$20240913$$CN$US$US
243164711$24316471$1$I$$20240902$20240913$20240913$EXP$$US-MYLANLABS-2024M1081908$MYLAN$Mohammadzadeh N, Punsoni M, Alhusaini S, Friedman JH. Autopsy-Proven ^Pure^ Parkinson^s Disease with Rapidly Progressive Dementia and Cognitive Fluctuations in a Patient with GBA Mutation. R-I-Med-J 2024; 107 (8): 50-53.$75$YR$$F$Y$$$20240913$$MD$US$US
243164721$24316472$1$I$$20240825$20240913$20240913$30DAY$$US-VEROBIOTECH-2024USVEROSPO00216$VERO BIOTECH$$$$$$Y$$$20240913$$HP$US$US
243164731$24316473$1$I$$20240902$20240913$20240913$EXP$$NVSC2024DE179460$NOVARTIS$Kolsche T, Willison AG, Meuth SG, Pawlitzki M, Horbrugger M, Skripuletz T, et al.. Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL. 2024;30(8):1086-8$58$YR$$F$Y$$$20240913$$HP$DE$DE
243164751$24316475$1$I$$20240903$20240913$20240913$EXP$$US-862174955-ML2024-04832$MICRO LABS$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, Yue A, Rizvi A, Salgia R. Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy. 2024;73(200): 1-9. doi:https://doi.org/10.1007/s00262-024-03775-6.$75$YR$E$F$Y$$$20240913$$HP$US$US
243164761$24316476$1$I$20240910$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182066$AMGEN$$82$YR$E$M$Y$$$20240913$$CN$US$US
243164781$24316478$1$I$$20240904$20240913$20240913$EXP$$GB-AUROBINDO-AUR-APL-2024-044343$AUROBINDO$$79$YR$$F$Y$$$20240913$$PH$GB$GB
243164792$24316479$2$F$20240911$20240920$20240913$20240921$PER$$US-BAYER-2024A130653$BAYER$$26$YR$A$F$Y$$$20240921$$MD$US$US
243164801$24316480$1$I$$20240902$20240913$20240913$EXP$$CN-PBT-009682$PANACEA BIOTEC$Huo K, Gao J, Wang Y, Qin X, Ma X. Short segment myelitis as a dominant manifestation of cryptococcal infection: a case report. BMC Infect Dis. 2024 Aug 26;24(1):863. doi: 10.1186/s12879-024-09756-5.$38$YR$A$M$Y$$$20240913$$HP$CN$CN
243164811$24316481$1$I$20240803$20240912$20240913$20240913$PER$$US-BAYER-2024A130801$BAYER$$29$YR$A$F$Y$$$20240913$$MD$US$US
243164821$24316482$1$I$$20240905$20240913$20240913$EXP$$US-BAYER-2024A128569$BAYER$$$$$F$Y$$$20240913$$CN$US$US
243164831$24316483$1$I$$20240901$20240913$20240913$PER$$US-IMP-2024000702$Harrow Health$$$$E$F$Y$$$20240913$$CN$US$US
243164841$24316484$1$I$20070815$20231102$20240913$20240913$EXP$GB-EMA-DD-20190514-jain_h1-172903$NVSC2023GB239640$NOVARTIS$$36$YR$$M$Y$$$20240913$$MD$GB$GB
243164851$24316485$1$I$20200817$20240905$20240913$20240913$EXP$$BR-ALXN-202409SAM000378BR$ALEXION PHARMACEUTICALS$$$$A$F$Y$$$20240913$$MD$BR$BR
243164861$24316486$1$I$20240910$20240910$20240913$20240913$EXP$$NVSC2024US182236$NOVARTIS$$36$YR$$F$Y$$$20240913$$CN$US$US
243164871$24316487$1$I$20240810$20240814$20240913$20240913$PER$$US-CELLTRION INC.-2024US019798$CELLTRION$$$$$$Y$$$20240913$$CN$US$US
243164881$24316488$1$I$20240724$20240903$20240913$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024701$UNITED THERAPEUTICS$$50$YR$$F$Y$64.853$KG$20240913$$$US$US
243164891$24316489$1$I$20240905$20240911$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014466$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243164901$24316490$1$I$20240817$20240904$20240913$20240913$EXP$$PT-AUROBINDO-AUR-APL-2024-044189$AUROBINDO$$95$YR$$F$Y$60$KG$20240913$$PH$PT$PT
243164911$24316491$1$I$$20240829$20240913$20240913$PER$$US-JNJFOC-20240878521$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$CN$US$US
243164921$24316492$1$I$$20240906$20240913$20240913$EXP$$US-JNJFOC-20240927908$JOHNSON AND JOHNSON$$62$YR$A$$Y$$$20240913$$CN$US$US
243164931$24316493$1$I$$20240903$20240913$20240913$PER$$US-TRIS PHARMA, INC.-24US011628$TRIS PHARM$$$$$$Y$$$20240913$$CN$US$US
243164941$24316494$1$I$20240809$20240910$20240913$20240913$PER$$US-TRIS PHARMA, INC.-24US011635$TRIS PHARM$$$$$$Y$$$20240913$$CN$US$US
243164951$24316495$1$I$$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181803$AMGEN$$$$$$Y$$$20240913$$PH$US$US
243164981$24316498$1$I$20240801$20240830$20240913$20240913$EXP$$IT-SA-2024SA263459$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240913$$CN$IT$IT
243164991$24316499$1$I$$20240903$20240913$20240913$EXP$$IN-Accord-445270$ACCORD$Bhosale SJ, Joshi M, Dhakne P, Kulkarni AP. Emphysematous gastritis: An ominous condition masquerading as enterocolitis in immunocompromised host. Indian Journal of Critical Care Medicine. 2024;28(8):808-9.$15$YR$T$M$Y$$$20240913$$MD$IN$IN
243165011$24316501$1$I$20240904$20240911$20240913$20240913$PER$$US-BAYER-2024A130803$BAYER$$34$YR$A$F$Y$$$20240913$$MD$US$US
243165021$24316502$1$I$$20240902$20240913$20240913$EXP$$US-BEH-2024178196$CSL BEHRING$$$$E$F$Y$$$20240913$$HP$US$US
243165031$24316503$1$I$$20240904$20240913$20240913$EXP$$US-GSK-US2024110037$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$US$US
243165041$24316504$1$I$20240912$20240912$20240913$20240913$PER$$US-BAYER-2024A130807$BAYER$$19$YR$A$F$Y$$$20240913$$MD$US$US
243165081$24316508$1$I$$20240910$20240913$20240913$PER$$NVSC2024US181733$NOVARTIS$$$$$M$Y$$$20240913$$CN$US$US
243165091$24316509$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5917671$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243165101$24316510$1$I$$20240912$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145922$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240913$$CN$US$US
243165121$24316512$1$I$$20240909$20240913$20240913$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-145240$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240913$$PH$PR$PR
243165141$24316514$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145269$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240913$$CN$US$US
243165171$24316517$1$I$$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62940$$FDA-CTU$$$$$F$N$150$LBS$20240911$N$PH$US$
243165181$24316518$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62941$$FDA-CTU$$75$YR$$M$N$$$20240912$N$$US$
243165191$24316519$1$I$$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62866$$FDA-CTU$$$$$M$N$68.95$KG$20240911$N$PH$US$
243165221$24316522$1$I$$20240911$20240912$20240912$DIR$FDA-CDER-CTU-2024-62887$$FDA-CTU$$$$$F$N$111$LBS$20240911$N$$US$
243165231$24316523$1$I$20240812$20240828$20240912$20240912$DIR$FDA-CDER-CTU-2024-62919$$FDA-CTU$$68$YR$$M$N$$$20240828$N$HP$US$
243165241$24316524$1$I$20240830$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62942$$FDA-CTU$$67$YR$$M$N$$$20240912$N$PH$US$
243165251$24316525$1$I$20240712$20240909$20240912$20240912$DIR$FDA-CDER-CTU-2024-62924$$FDA-CTU$$53$YR$$M$N$$$20240909$N$HP$US$
243165272$24316527$2$F$20240101$20240904$20240913$20240914$EXP$$FR-ABBVIE-5918553$ABBVIE$$71$YR$$M$Y$$$20240914$$CN$FR$FR
243165281$24316528$1$I$20231201$20240910$20240913$20240913$EXP$$US-ABBVIE-5917629$ABBVIE$$73$YR$$F$Y$$$20240913$$CN$US$US
243165291$24316529$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5917845$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243165301$24316530$1$I$$20240909$20240913$20240913$EXP$$US-ABBVIE-5917577$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243165311$24316531$1$I$20240603$20240905$20240913$20240913$EXP$FR-AFSSAPS-DJ2024000970$FR-TEVA-VS-3240927$TEVA$$59$YR$$M$Y$59$KG$20240913$$CN$FR$FR
243165321$24316532$1$I$20210101$20240909$20240913$20240913$EXP$$CO-ABBVIE-5919567$ABBVIE$$$$$F$Y$71$KG$20240913$$CN$CO$CO
243165341$24316534$1$I$$20240911$20240913$20240913$PER$$US-BAYER-2024A130813$BAYER$$42$YR$A$F$Y$$$20240913$$HP$US$US
243165351$24316535$1$I$$20240909$20240913$20240913$EXP$$CA-ABBVIE-5917467$ABBVIE$$$$A$F$Y$$$20240913$$CN$CA$CA
243165361$24316536$1$I$$20240904$20240913$20240913$EXP$$CN-ROCHE-10000073449$ROCHE$Deng R, Li Y, Bai L, Zhou L, Wang Y. Case report: A case of Savolitinib in the treatment of MET amplification mutation advanced lung adenocarcinoma with rare bilateral breast metastasis. Frontiers in Oncology. 2024-Jan;14:1-6. doi:10.3389/fonc.2024.1450855.$63$YR$A$F$Y$$$20240913$$HP$CN$CN
243165371$24316537$1$I$$20240910$20240913$20240913$EXP$DE-BFARM-24006229$DE-ABBVIE-5921711$ABBVIE$$$$E$M$Y$103$KG$20240913$$PH$DE$DE
243165383$24316538$3$F$$20240913$20240913$20240920$30DAY$$US-PFIZER INC-202400250233$PFIZER$$11$YR$$M$Y$$$20240920$$CN$US$US
243165391$24316539$1$I$$20240909$20240913$20240913$EXP$$US-ROCHE-10000077641$ROCHE$$$$$F$Y$$$20240913$$CN$US$US
243165401$24316540$1$I$20240301$20240911$20240913$20240913$EXP$FR-AFSSAPS-TS2024000977$FR-ABBVIE-5917828$ABBVIE$$39$YR$$F$Y$$$20240913$$MD$FR$FR
243165421$24316542$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010443$APOTEX$Ingole P.; Morkas M.; May R.; Hinman B.; Carrum G.; Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$F$Y$$$20240913$$HP$US$US
243165431$24316543$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010455$APOTEX$Ingole P, Morkas M, May R, Hinman B, Carrum G, Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$M$Y$$$20240913$$HP$US$US
243165441$24316544$1$I$20240820$20240905$20240913$20240913$EXP$$US-PERRIGO-24US008400$PERRIGO$$65$YR$$M$Y$98.413$KG$20240913$$CN$US$US
243165461$24316546$1$I$$20240906$20240913$20240913$EXP$$US-SA-2024SA264878$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240913$$HP$US$US
243165481$24316548$1$I$20230501$20240902$20240913$20240913$EXP$$KR-KOWA-24JP002239AA$KOWA PHARM$$65$YR$$M$Y$80$KG$20240913$$HP$KR$KR
243165491$24316549$1$I$$20150617$20240913$20240913$EXP$$US-ROCHE-10000077343$ROCHE$Baxter KR, Robinson JE, Ruby AJ. Occlusive vasculitis due to hyperacute Streptococcus mitis endophthalmitis after intravitreal ranibizumab. RETINAL CASES AND  BRIEF REPORTS. 2015;9(3):201-4$83$YR$E$F$Y$$$20240913$$HP$US$US
243165501$24316550$1$I$$20240905$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013260$DR REDDYS$Popat D, Sanghavi N, Singh A, Sawhney R. MM-657 Parsonage Turner Syndrome Complicating Multiple Myeloma Therapy: Nothing to Shrug your Shoulders at. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24: S578-e92. doi:10.1016/S2152-2650%2824%2901720-8.$66$YR$E$M$Y$$$20240913$$MD$US$US
243165521$24316552$1$I$$20240912$20240913$20240913$PER$$US-BAYER-2024A130818$BAYER$$47$YR$A$F$Y$$$20240913$$MD$US$US
243165531$24316553$1$I$20240822$20240903$20240913$20240913$PER$$JP-Eisai-EC-2024-174271$EISAI$$79$YR$E$M$Y$56$KG$20240913$$PH$JP$JP
243165541$24316554$1$I$$20240903$20240913$20240913$EXP$$TR-ROCHE-10000076094$ROCHE$$55$YR$A$M$Y$$$20240913$$MD$TR$TR
243165551$24316555$1$I$$20240910$20240913$20240913$EXP$ES-EMA-DD-20240909-7483181-071949$ES-RDY-SPO/ESP/24/0013288$DR REDDYS$$82$YR$E$F$Y$$$20240913$$HP$ES$ES
243165561$24316556$1$I$$20240905$20240913$20240913$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR111555$VIIV$$$$$$Y$$$20240913$$MD$US$US
243165571$24316557$1$I$20240909$20240912$20240913$20240913$PER$$US-BAYER-2024A130821$BAYER$$48$YR$A$F$Y$$$20240913$$MD$US$US
243165581$24316558$1$I$20240509$20240905$20240913$20240913$EXP$$US-GSK-US2024110768$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240913$$CN$US$US
243165591$24316559$1$I$20240801$20240909$20240913$20240913$PER$$IL-Blueprint Medicines Corporation-SP-IL-2024-001824$BLUEPRINT MEDICINES$$52$YR$A$F$Y$$$20240913$$PH$IL$IL
243165601$24316560$1$I$20240125$20240903$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009293$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243165611$24316561$1$I$20240901$20240907$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143011$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240913$$PH$US$US
243165621$24316562$1$I$$20240904$20240913$20240913$EXP$$US-WOCKHARDT LIMITED-2024WLD000030$WOCKHARDT$Zachian RL, Sidhu BV, Liu P, Weimann R.. Acute generalised exanthematous pustulosis and herpes simplex virus: a case of possible overlap.. BMJ Case Rep.. 2024;17(8):e260873$60$YR$$F$Y$$$20240912$$MD$US$US
243165631$24316563$1$I$$20240906$20240913$20240913$PER$$US-UNITED THERAPEUTICS-UNT-2024-028222$UNITED THERAPEUTICS$$$$$F$Y$122.45$KG$20240913$$$US$US
243165641$24316564$1$I$$20240910$20240913$20240913$PER$$US-BAYER-2024A129714$BAYER$$23$YR$A$F$Y$$$20240913$$MD$US$US
243165651$24316565$1$I$20240831$20240911$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014473$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243165661$24316566$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409008289$ELI LILLY AND CO$$$$$$Y$$$20240913$$CN$US$US
243165681$24316568$1$I$$20240910$20240913$20240913$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409006278$ELI LILLY AND CO$Matsuoka A, et al..ORIGINAL ARTICLE Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series.The Journal of Obstetrics and Gynaecology Research 2024;50 (7):1148-1154.$62$YR$A$F$Y$$$20240913$$MD$JP$JP
243165693$24316569$3$F$20240801$20240913$20240913$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-024455$UNITED THERAPEUTICS$$69$YR$$F$Y$56.689$KG$20240921$$$US$US
243165711$24316571$1$I$$20240903$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009285$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243165721$24316572$1$I$20240830$20240905$20240913$20240913$EXP$$US-BEH-2024178406$CSL BEHRING$$$$$F$Y$$$20240913$$HP$US$US
243165731$24316573$1$I$$20240904$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044571$AUROBINDO$Schwarz C, Morel A Matignon M, Grimbert P, Rondeau E, Ouali N, et al. Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept. Kidney Int Rep. 2023;8 (8):1531-1541$25$YR$$$Y$$$20240913$$HP$FR$FR
243165741$24316574$1$I$$20240910$20240913$20240913$PER$$US-BAYER-2024A130726$BAYER$$31$YR$A$F$Y$$$20240913$$HP$US$US
243165751$24316575$1$I$$20240831$20240913$20240913$EXP$$PR-MELINTA THERAPEUTICS, LLC-PR-MLNT-24-00425$MELINTA THERAPEUTICS$Isidor-Pagan G., Fernandez-Vazquez D., Martinez-Martinez N., Jimenez R., Puig A., Puig G.. Calcium channel and beta blocker intoxication: A management challenge in an overmedicated psychiatric patient.. 2024 National Conference and Exhibition of the American Academy of Pediatrics. 2024$$$$$Y$$$20240913$$HP$PR$PR
243165761$24316576$1$I$$20240905$20240913$20240913$EXP$$IN-ROCHE-10000019091$ROCHE$$73$YR$E$M$Y$$$20240913$$MD$IN$IN
243165771$24316577$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010446$APOTEX$Ingole P.; Morkas M.; May R.; Hinman B.; Carrum G.; Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$F$Y$$$20240913$$HP$US$US
243165781$24316578$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145311$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240913$$HP$US$US
243165801$24316580$1$I$20240601$20240830$20240913$20240913$EXP$$US-UCBSA-2024044201$UCB$$35$YR$$M$Y$$$20240913$$MD$US$US
243165811$24316581$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145427$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240913$$CN$US$US
243165821$24316582$1$I$$20240903$20240913$20240913$30DAY$$US-GSK-US2024109516$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243165832$24316583$2$F$20240311$20240913$20240913$20240923$PER$$US-GSK-US2024110208$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240923$$CN$US$US
243165841$24316584$1$I$$20240904$20240913$20240913$EXP$$US-GSK-US2024110241$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$HP$US$US
243165851$24316585$1$I$20240101$20240906$20240913$20240913$PER$$US-UNITED THERAPEUTICS-UNT-2024-028515$UNITED THERAPEUTICS$$$$$M$Y$90.703$KG$20240913$$MD$US$US
243165861$24316586$1$I$20240905$20240906$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024111293$VIIV$$29$YR$$M$Y$$$20240913$$CN$US$US
243165871$24316587$1$I$$20240909$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024112044$VIIV$$$$$F$Y$$$20240913$$HP$US$US
243165881$24316588$1$I$$20240912$20240913$20240913$EXP$GB-MHRA-MED-202409120054073910-CTVMQ$GB-MYLANLABS-2024M1083197$MYLAN$$21$YR$$M$Y$84$KG$20240913$$CN$GB$GB
243165891$24316589$1$I$$20240912$20240913$20240913$EXP$$GB-MYLANLABS-2024M1046203$MYLAN$$$$$F$Y$$$20240913$$MD$GB$GB
243165901$24316590$1$I$$20240903$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009284$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243165911$24316591$1$I$$20240904$20240913$20240913$EXP$$PL-AUROBINDO-AUR-APL-2024-045285$AUROBINDO$Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoeman H, Ljungman P, Kobbe G, et al.,. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT.. American journal of transplantation. 2015;15:705-714 (1-10)$32$YR$$M$Y$$$20240913$$HP$PL$PL
243165921$24316592$1$I$$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181821$AMGEN$$$$$$Y$$$20240913$$HP$US$US
243165941$24316594$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62944$$FDA-CTU$$49$YR$$F$N$$$20240912$N$$US$
243165951$24316595$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62945$$FDA-CTU$$60$YR$$F$N$$$20240912$N$$US$
243165961$24316596$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62817$$FDA-CTU$$$$$M$N$$$20240912$N$HP$US$
243165971$24316597$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62933$$FDA-CTU$$79$YR$$M$N$$$20240912$N$$US$
243165981$24316598$1$I$20240905$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62943$$FDA-CTU$$64$YR$$F$N$$$20240912$N$HP$US$
243165991$24316599$1$I$20240716$20240819$20240912$20240912$DIR$FDA-CDER-CTU-2024-62842$$FDA-CTU$$4$MON$$M$N$$$20240819$N$HP$US$
243166001$24316600$1$I$20240719$20240912$20240912$20240912$DIR$718205$$FDA-CTU$$32$YR$$M$N$65$KG$20240912$N$CN$CA$
243166011$24316601$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010453$APOTEX$Ingole P.; Morkas M.; May R.; Hinman B.; Carrum G.; Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$M$Y$$$20240913$$HP$US$US
243166021$24316602$1$I$20230101$20240909$20240913$20240913$PER$$US-BAYER-2024A128951$BAYER$$50$YR$A$F$Y$$$20240913$$HP$US$US
243166031$24316603$1$I$$20240903$20240913$20240913$PER$DE-EMA-DD-20240829-7482707-105358$DE-PBT-001044$PANACEA BIOTEC$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al. Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant  recipients: CERTAIN registry study. TRANSPLANTATION. 2018;103(6):1-33.  doi:10.1097/TP.0000000000002414$17$YR$T$$Y$$$20240913$$HP$DE$DE
243166041$24316604$1$I$$20240903$20240913$20240913$PER$DE-EMA-DD-20240830-7482643-123914$DE-PBT-001049$PANACEA BIOTEC$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al. Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant recipients: CERTAIN registry study. TRANSPLANTATION. 2018;103(6):1-33. doi:10.1097/TP.0000000000002414.$1$YR$C$$Y$$$20240913$$HP$DE$DE
243166051$24316605$1$I$$20240911$20240913$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014860$JAZZ$$$$$M$Y$$$20240913$$CN$US$US
243166061$24316606$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004993$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243166081$24316608$1$I$$20240910$20240913$20240913$EXP$$CA-PFIZER INC-202200063496$MYLAN$$58$YR$$M$Y$$$20240913$$CN$CA$CA
243166092$24316609$2$F$20230608$20240921$20240913$20240925$EXP$$AR-MYLANLABS-2023M1062325$MYLAN$$23$YR$$M$Y$$$20240925$$CN$AR$AR
243166101$24316610$1$I$$20240903$20240913$20240913$EXP$$US-JNJFOC-20240909729$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243166111$24316611$1$I$20240805$20240906$20240913$20240913$EXP$$NVSC2024IN181654$NOVARTIS$$$$$M$Y$$$20240913$$CN$IN$IN
243166121$24316612$1$I$20240101$20240910$20240913$20240913$PER$$US-ABBVIE-5921951$ABBVIE$$$$$$Y$$$20240913$$CN$US$US
243166131$24316613$1$I$20240812$20240904$20240913$20240913$EXP$$FR-AUROBINDO-AUR-APL-2024-044731$AUROBINDO$$85$YR$$F$Y$$$20240913$$MD$FR$FR
243166141$24316614$1$I$$20240903$20240913$20240913$PER$$JP-Eisai-EC-2024-173893$EISAI$$75$YR$E$$Y$$$20240913$$MD$JP$JP
243166151$24316615$1$I$20240814$20240912$20240912$20240912$DIR$718183$$FDA-CTU$$43$YR$$F$N$54$KG$20240912$N$CN$US$
243166161$24316616$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010454$APOTEX$Ingole P.; Morkas M.; May R.; Hinman B.; Carrum G.; Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$M$Y$$$20240913$$HP$US$US
243166171$24316617$1$I$$20240904$20240913$20240913$PER$$US-ABBVIE-5907741$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243166181$24316618$1$I$$20240911$20240913$20240913$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-18254$IPSEN$$$$$F$Y$$$20240913$$PH$GB$GB
243166201$24316620$1$I$$20240902$20240913$20240913$EXP$$JP-ROCHE-10000076748$ROCHE$Miura R, Ono A, Yano S, Amioka K, Naruto K, Yamaoka K, et al. Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma. Medicine. 2024-Aug-23;103 (34):1-8. doi:10.1097/MD.0000000000039289.$$$$$Y$$$20240913$$MD$JP$JP
243166211$24316621$1$I$$20240908$20240913$20240913$PER$$US-JNJFOC-20240923803$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243166221$24316622$1$I$20130801$20240905$20240913$20240913$EXP$FR-AFSSAPS-RN2024000921$FR-TEVA-VS-3240889$TEVA$$27$YR$$F$Y$$$20240913$$MD$FR$FR
243166231$24316623$1$I$20231011$20240910$20240913$20240913$EXP$$US-PFIZER INC-PV202400119555$PFIZER$$61$YR$$$Y$$$20240913$$MD$US$US
243166241$24316624$1$I$$20240906$20240913$20240913$EXP$$JP-PFIZER INC-PV202400119622$PFIZER$$29$YR$$F$Y$$$20240913$$PH$JP$JP
243166261$24316626$1$I$$20240904$20240913$20240913$30DAY$$US-GSK-US2024110253$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243166271$24316627$1$I$$20240910$20240913$20240913$EXP$$JP-PFIZER INC-202400254779$PFIZER$$7$DEC$$F$Y$$$20240913$$MD$JP$JP
243166281$24316628$1$I$$20240910$20240913$20240913$EXP$$CA-PFIZER INC-202400254991$PFIZER$$80$YR$$M$Y$$$20240913$$MD$CA$CA
243166291$24316629$1$I$$20240910$20240913$20240913$EXP$$CA-PFIZER INC-202400254680$PFIZER$$71$YR$$$Y$$$20240913$$MD$CA$CA
243166301$24316630$1$I$$20240910$20240913$20240913$EXP$$US-PFIZER INC-PV202400119504$PFIZER$$40$YR$$F$Y$$$20240913$$HP$US$US
243166311$24316631$1$I$20210701$20240909$20240913$20240913$EXP$$US-PFIZER INC-202300260751$PFIZER$$58$YR$$F$Y$67.13$KG$20240913$$CN$US$US
243166331$24316633$1$I$20240828$20240903$20240913$20240913$PER$$US-ABBVIE-5907232$ABBVIE$$63$YR$$F$Y$$$20240913$$CN$US$US
243166341$24316634$1$I$$20240906$20240913$20240913$PER$$US-ROCHE-10000076620$ROCHE$$11$YR$C$$Y$$$20240913$$PH$US$US
243166351$24316635$1$I$20240911$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024182538$AMGEN$$$$$$Y$$$20240913$$CN$US$US
243166362$24316636$2$F$$20240911$20240913$20240917$PER$$US-AMGEN-USASP2024182019$AMGEN$$$$$$Y$$$20240917$$CN$US$US
243166381$24316638$1$I$$20240831$20240913$20240913$EXP$$US-UCBSA-2024045365$UCB$$$$$$Y$$$20240913$$CN$US$US
243166391$24316639$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146230$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240913$$CN$US$US
243166402$24316640$2$F$20240826$20240913$20240913$20240920$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000923$PAREXEL$$$$$$Y$$$20240920$$HP$CN$CN
243166411$24316641$1$I$20190101$20240912$20240913$20240913$EXP$$US-ABBVIE-5922115$ABBVIE$$64$YR$$F$Y$$$20240913$$CN$US$US
243166421$24316642$1$I$$20240905$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR112925$VIIV$$$$$$Y$$$20240913$$HP$US$US
243166431$24316643$1$I$20240827$20240904$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141406$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$95.71$KG$20240913$$CN$US$US
243166461$24316646$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010442$APOTEX$Ingole P.; Morkas M.; May R.; Hinman B.; Carrum G.; Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$F$Y$$$20240913$$HP$US$US
243166471$24316647$1$I$$20240903$20240913$20240913$EXP$$DE-AMAROX PHARMA-AMR2024DE02954$HETERO$$10$YR$$F$Y$$$20240913$$MD$DE$DE
243166481$24316648$1$I$20240812$20240905$20240913$20240913$EXP$FR-AFSSAPS-LL2024001641$FR-TEVA-VS-3241189$TEVA$$84$YR$$M$Y$$$20240913$$PH$FR$FR
243166492$24316649$2$F$$20240904$20240913$20240918$EXP$$CA-PFIZER INC-202400248451$PFIZER$$43$YR$$F$Y$96$KG$20240918$$HP$CA$CA
243166501$24316650$1$I$$20240909$20240913$20240913$EXP$$CA-BAYER-2024A129896$BAYER$$45$YR$A$F$Y$$$20240913$$MD$CA$CA
243166511$24316651$1$I$20240713$20240908$20240913$20240913$EXP$$US-CHIESI-2024CHF05945$CHIESI$$11$YR$$F$Y$$$20240913$$MD$US$US
243166531$24316653$1$I$$20240910$20240913$20240913$EXP$$US-PFIZER INC-PV202400119421$PFIZER$$62$YR$$$Y$$$20240913$$MD$US$US
243166542$24316654$2$F$20240101$20240913$20240913$20240918$EXP$$CA-PFIZER INC-202400228373$PFIZER$$91$YR$$F$Y$$$20240918$$HP$CA$CA
243166551$24316655$1$I$20240710$20240911$20240913$20240913$EXP$$EG-PFIZER INC-PV202400119231$PFIZER$$49$YR$$F$Y$55$KG$20240913$$PH$EG$EG
243166561$24316656$1$I$20240601$20240911$20240913$20240913$EXP$$US-PFIZER INC-PV202400119672$PFIZER$$88$YR$$F$Y$$$20240913$$CN$US$US
243166571$24316657$1$I$20240828$20240910$20240913$20240913$EXP$$JP-PFIZER INC-PV202400118813$PFIZER$$$$$$Y$$$20240913$$MD$JP$JP
243166581$24316658$1$I$20240328$20240910$20240913$20240913$EXP$DE-CADRBFARM-2024330314$DE-PFIZER INC-202400255363$PFIZER$$71$YR$$M$Y$76$KG$20240913$$CN$DE$DE
243166592$24316659$2$F$20240811$20240918$20240913$20240919$EXP$$CN-PFIZER INC-PV202400119439$PFIZER$$38$YR$$M$Y$$$20240919$$HP$CN$CN
243166601$24316660$1$I$20240904$20240911$20240913$20240913$EXP$$CN-PFIZER INC-PV202400119468$PFIZER$$73$YR$$M$Y$58$KG$20240913$$HP$CN$CN
243166611$24316661$1$I$$20240911$20240913$20240913$EXP$$JP-PFIZER INC-PV202400119413$PFIZER$$$$$$Y$$$20240913$$MD$JP$JP
243166621$24316662$1$I$20240901$20240910$20240913$20240913$EXP$$AU-PFIZER INC-PV202400119658$PFIZER$$40$YR$$M$Y$95$KG$20240913$$MD$AU$AU
243166631$24316663$1$I$$20240911$20240913$20240913$EXP$$US-PFIZER INC-PV202400046090$PFIZER$$93$YR$$F$Y$$$20240913$$CN$US$US
243166641$24316664$1$I$$20240910$20240913$20240913$EXP$$IT-PFIZER INC-PV202400119771$PFIZER$$$$E$M$Y$$$20240913$$MD$IT$IT
243166651$24316665$1$I$$20240909$20240913$20240913$EXP$$NVSC2024MT182776$NOVARTIS$$$$$M$Y$$$20240913$$PH$MT$MT
243166661$24316666$1$I$$20240911$20240913$20240913$EXP$$NVSC2024CA182712$NOVARTIS$$78$YR$$F$Y$54.422$KG$20240913$$MD$CA$CA
243166671$24316667$1$I$$20240911$20240913$20240913$PER$$US-ROCHE-10000081328$ROCHE$$64$YR$A$F$Y$$$20240913$$CN$US$US
243166681$24316668$1$I$$20240902$20240913$20240913$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08334$HIKMA$$$$$M$Y$$$20240913$$HP$CA$CA
243166691$24316669$1$I$$20240903$20240913$20240913$EXP$$US-UCBSA-2024046446$UCB$$$$$M$Y$$$20240913$$CN$US$US
243166711$24316671$1$I$$20240912$20240912$20240912$DIR$718157$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243166731$24316673$1$I$$20240905$20240913$20240913$EXP$$RO-RDY-SPO/ROU/24/0013307$DR REDDYS$Rusu CT, Postolea G, Gurghean AL, Fiedler IM, Homentcovschi CS. WHAT IS HIDING BEHIND MULTIPLE OSTEOLYTIC LESIONS?. European Journal of Case Reports in Internal Medicine. 2024;11(1):$73$YR$E$M$Y$$$20240913$$HP$RO$RO
243166741$24316674$1$I$20240912$20240912$20240913$20240913$PER$$US-ALXN-202409USA000862US$ALEXION PHARMACEUTICALS$$79$YR$$F$Y$$$20240913$$CN$US$US
243166751$24316675$1$I$$20240909$20240913$20240913$PER$$US-ALXN-202409USA000746US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243166761$24316676$1$I$$20240906$20240913$20240913$PER$$US-ALXN-202409USA000515US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243166771$24316677$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010313$APOTEX$Ingole P, Morkas M, May R, Hinman B, Carrum G, Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$F$Y$$$20240913$$HP$US$US
243166781$24316678$1$I$$20240909$20240913$20240913$EXP$$CR-MYLANLABS-2024M1083100$MYLAN$$$$$F$Y$$$20240913$$CN$CR$CR
243166791$24316679$1$I$20240715$20240909$20240913$20240913$EXP$FR-AFSSAPS-SE2024000688$FR-MYLANLABS-2024M1082439$MYLAN$$86$YR$$F$Y$$$20240913$$MD$FR$FR
243166801$24316680$1$I$20220101$20240909$20240913$20240913$EXP$$DE-MYLANLABS-2024M1082427$MYLAN$$95$YR$$M$Y$$$20240913$$MD$DE$DE
243166821$24316682$1$I$20240905$20240912$20240912$20240912$DIR$718162$$FDA-CTU$$55$YR$$M$N$78$KG$20240912$N$MD$US$
243166831$24316683$1$I$20240901$20240903$20240913$20240913$PER$$US-009507513-2409USA001681$MERCK$$$$$F$Y$$$20240913$$CN$US$US
243166842$24316684$2$F$20240910$20240910$20240913$20240917$EXP$$US-BEH-2024167038$CSL BEHRING$$59$YR$A$M$Y$90.7$KG$20240917$$CN$US$US
243166851$24316685$1$I$20210501$20240910$20240913$20240913$EXP$$US-TAKEDA-2024TUS090511$TAKEDA$$42$YR$$M$Y$$$20240913$$HP$US$US
243166861$24316686$1$I$20240729$20240909$20240913$20240913$EXP$$US-BAYER-2024A130034$BAYER$$58$YR$A$F$Y$58.957$KG$20240913$$HP$US$US
243166872$24316687$2$F$20240903$20240919$20240913$20240924$EXP$$JP-GILEAD-2024-0687327$GILEAD$$$$A$M$Y$$$20240924$$MD$JP$JP
243166882$24316688$2$F$$20240911$20240913$20240917$30DAY$$DO-PFIZER INC-PV202400118705$PFIZER$$13$YR$$M$Y$$$20240917$$HP$DO$DO
243166891$24316689$1$I$20240807$20240904$20240913$20240913$EXP$$CN-ROCHE-10000074693$ROCHE$$51$YR$A$F$Y$51$KG$20240913$$CN$CN$CN
243166901$24316690$1$I$$20240905$20240913$20240913$EXP$$GB-AstraZeneca-2024A203715$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$GB$
243166911$24316691$1$I$20221019$20240903$20240913$20240913$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08397$HIKMA$$80$YR$$M$Y$77$KG$20240913$$MD$US$US
243166921$24316692$1$I$$20240906$20240913$20240913$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001825$BLUEPRINT MEDICINES$$$$$M$Y$$$20240913$$CN$US$US
243166931$24316693$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010448$APOTEX$Ingole P.; Morkas M.; May R.; Hinman B.; Carrum G.; Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$M$Y$$$20240913$$HP$US$US
243166941$24316694$1$I$$20240820$20240913$20240913$PER$$US-GILEAD-2024-0684764$GILEAD$$$$E$F$Y$$$20240913$$PH$US$US
243166951$24316695$1$I$20230902$20240910$20240913$20240913$EXP$$JP-AstraZeneca-2024A208018$ASTRAZENECA$$$$$M$Y$$$20240913$$MD$JP$
243166961$24316696$1$I$20240523$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145726$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240913$$HP$US$US
243166971$24316697$1$I$$20240822$20240913$20240913$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004994$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243166982$24316698$2$F$$20240912$20240913$20240919$EXP$$CZ-AMGEN-CZESP2024180279$AMGEN$$71$YR$E$F$Y$$$20240919$$MD$CZ$CZ
243166991$24316699$1$I$$20240909$20240913$20240913$EXP$$SK-AMGEN-SVKSP2024181385$AMGEN$$$$$M$Y$$$20240913$$MD$SK$SK
243167001$24316700$1$I$$20240906$20240913$20240913$EXP$$JP-AstraZeneca-2024A204169$ASTRAZENECA$$$$$$Y$$$20240913$$MD$JP$
243167011$24316701$1$I$$20240903$20240913$20240913$30DAY$$US-GSK-US2024109537$GLAXOSMITHKLINE$$$$A$F$Y$$$20240913$$CN$US$US
243167021$24316702$1$I$$20240904$20240913$20240913$30DAY$$US-GSK-US2024AMR110389$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243167031$24316703$1$I$20230901$20240905$20240913$20240913$EXP$$DE-CELLTRION INC.-2023DE020831$CELLTRION$$$$$$Y$$$20240913$$MD$DE$DE
243167041$24316704$1$I$$20240905$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR113020$VIIV$$$$$$Y$$$20240913$$HP$US$US
243167051$24316705$1$I$20240706$20240909$20240913$20240913$PER$$US-AstraZeneca-2024A207047$ASTRAZENECA$$60$YR$$F$Y$$$20240913$$CN$US$
243167061$24316706$1$I$20240606$20240906$20240913$20240913$EXP$$SE-AstraZeneca-2024A203663$ASTRAZENECA$$73$YR$$F$Y$62$KG$20240913$$MD$SE$
243167072$24316707$2$F$20240801$20240918$20240913$20240920$30DAY$$UY-PFIZER INC-202400249144$PFIZER$$2$YR$$M$Y$14.5$KG$20240920$$CN$UY$UY
243167081$24316708$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62946$$FDA-CTU$$64$YR$$F$N$$$20240912$N$$US$
243167091$24316709$1$I$20240831$20240910$20240913$20240913$PER$$US-BEH-2024178596$CSL BEHRING$$42$YR$A$F$Y$$$20240913$$HP$US$US
243167101$24316710$1$I$20240101$20240910$20240913$20240913$EXP$$US-AMGEN-USASP2024181426$AMGEN$$60$YR$A$F$Y$$$20240913$$CN$US$US
243167111$24316711$1$I$20231120$20240904$20240913$20240913$EXP$$US-UCBSA-2023058107$UCB$$4$YR$$M$Y$$$20240913$$CN$US$US
243167122$24316712$2$F$$20240924$20240913$20240926$EXP$$NL-JNJFOC-20240934354$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240926$$HP$NL$NL
243167152$24316715$2$F$$20240912$20240913$20240917$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051293$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240917$$MD$US$US
243167171$24316717$1$I$20240101$20240903$20240913$20240913$EXP$$US-UCBSA-2024045311$UCB$$$$$M$Y$$$20240913$$HP$US$US
243167181$24316718$1$I$$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145580$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$56.7$KG$20240913$$CN$US$US
243167201$24316720$1$I$$20240910$20240913$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145583$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$MD$JP$JP
243167211$24316721$1$I$20240903$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62947$$FDA-CTU$$84$YR$$F$N$$$20240912$N$$US$
243167221$24316722$1$I$$20240902$20240913$20240913$EXP$$JP-ROCHE-10000076783$ROCHE$Yamakawa K, Kono H, Tonshiyo M, Iwado K, Matsui Z, Ohigashi T. P3-6 A case in which stenosis of the ureter graft occurred 13 years after renal transplant. The 39th Japanese Society of Renal Transplantation and Vascular Surgery. 2024;182$8$DEC$E$F$Y$$$20240913$$MD$JP$JP
243167231$24316723$1$I$$20240904$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR111033$VIIV$$$$$M$Y$$$20240913$$HP$US$US
243167241$24316724$1$I$$20240905$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR113024$VIIV$$$$$$Y$$$20240913$$HP$US$US
243167251$24316725$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010447$APOTEX$Ingole P, Morkas M, May R, Hinman B, Carrum G, Kamble RT. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$M$Y$$$20240913$$HP$US$US
243167261$24316726$1$I$$20240911$20240913$20240913$EXP$GB-MHRA-MED-202409111408560500-SGTCZ$GB-MYLANLABS-2024M1083166$MYLAN$$$$$M$Y$$$20240913$$PH$GB$GB
243167281$24316728$1$I$$20240911$20240913$20240913$EXP$GB-MHRA-MED-202409111600130520-LCVQZ$GB-MYLANLABS-2024M1083171$MYLAN$$$$$M$Y$72$KG$20240913$$HP$GB$GB
243167291$24316729$1$I$$20240911$20240913$20240913$EXP$$GB-MYLANLABS-2024M1083209$MYLAN$$$$$M$Y$$$20240913$$CN$GB$GB
243167301$24316730$1$I$$20240829$20240913$20240913$PER$$US-009507513-2408USA010519$MERCK$Kost Y, Mattis D, Muskat A, Amin B, Beth McLellan. Immune Checkpoint Inhibitor-Induced Psoriasiform, Spongiotic, and Lichenoid Dermatitis: A Novel Clinicopathological Pattern. Cureus. 2022;14 (8)$63$YR$$F$Y$$$20240913$$HP$US$US
243167311$24316731$1$I$$20240903$20240913$20240913$30DAY$$JP-PFIZER INC-202400248978$PFIZER$$$$$$Y$$$20240913$$PH$JP$JP
243167341$24316734$1$I$20190814$20240906$20240913$20240913$EXP$$CA-TAKEDA-2024TUS090033$TAKEDA$$86$YR$$M$Y$$$20240913$$MD$CA$CA
243167351$24316735$1$I$20180101$20240905$20240913$20240913$EXP$$AU-JNJFOC-20240914323$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240913$$HP$AU$AU
243167361$24316736$1$I$$20240906$20240913$20240913$EXP$$CO-JNJFOC-20240840088$JOHNSON AND JOHNSON$$65$YR$E$M$Y$81$KG$20240913$$HP$CO$CO
243167391$24316739$1$I$20240601$20240910$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144278$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240913$$CN$US$US
243167401$24316740$1$I$$20240906$20240913$20240913$EXP$$US-VIIV HEALTHCARE LIMITED-US2024111407$VIIV$$$$$$Y$$$20240913$$MD$US$US
243167411$24316741$1$I$$20240905$20240913$20240913$30DAY$$US-GSK-US2024110785$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243167421$24316742$1$I$$20240904$20240913$20240913$30DAY$$US-GSK-US2024AMR109914$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243167441$24316744$1$I$20240903$20240910$20240913$20240913$EXP$$NVSC2024MX183027$NOVARTIS$$60$YR$$M$Y$$$20240913$$MD$MX$MX
243167451$24316745$1$I$$20240830$20240913$20240913$EXP$$TR-Unichem Pharmaceuticals (USA) Inc-UCM202409-001147$UNICHEM$$$$$$Y$$$20240913$$HP$TR$
243167461$24316746$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5918384$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243167471$24316747$1$I$20240801$20240912$20240913$20240913$EXP$$JP-PFIZER INC-PV202400118820$PFIZER$$8$DEC$$M$Y$$$20240913$$PH$JP$JP
243167481$24316748$1$I$20240730$20240911$20240913$20240913$EXP$$US-PFIZER INC-202400255605$PFIZER$$70$YR$$M$Y$$$20240913$$HP$US$US
243167491$24316749$1$I$$20240912$20240913$20240913$EXP$$US-PFIZER INC-202400255881$PFIZER$$50$YR$$F$Y$$$20240913$$PH$US$US
243167501$24316750$1$I$20240901$20240912$20240913$20240913$EXP$$MA-PFIZER INC-PV202400120344$PFIZER$$$$$F$Y$$$20240913$$CN$MA$MA
243167511$24316751$1$I$$20240911$20240913$20240913$EXP$$US-PFIZER INC-202400255054$PFIZER$$$$$M$Y$$$20240913$$MD$US$US
243167522$24316752$2$F$$20240917$20240913$20240919$EXP$$US-PFIZER INC-PV202400119339$PFIZER$$87$YR$$M$Y$$$20240919$$HP$US$US
243167542$24316754$2$F$20240101$20240919$20240913$20240924$EXP$$AU-PFIZER INC-PV202400119503$PFIZER$$62$YR$$M$Y$105$KG$20240924$$MD$AU$AU
243167551$24316755$1$I$20171102$20240911$20240913$20240913$EXP$$GB-PFIZER INC-202400255199$PFIZER$$55$YR$$M$Y$$$20240913$$CN$GB$GB
243167561$24316756$1$I$$20240912$20240913$20240913$EXP$$US-PFIZER INC-202400255690$PFIZER$$62$YR$$F$Y$$$20240913$$PH$US$US
243167581$24316758$1$I$20240101$20240911$20240913$20240913$PER$$US-ABBVIE-5921688$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243167591$24316759$1$I$$20240905$20240913$20240913$EXP$$CA-CELLTRION INC.-2024CA021288$CELLTRION$$$$$$Y$$$20240913$$HP$CA$CA
243167601$24316760$1$I$20240401$20240909$20240913$20240913$PER$$US-JNJFOC-20240928739$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243167611$24316761$1$I$$20240905$20240913$20240913$EXP$$CA-APOTEX-2024AP010330$APOTEX$$$$E$M$Y$$$20240913$$CN$CA$CA
243167621$24316762$1$I$$20240911$20240913$20240913$EXP$$IT-ALXN-202409EEA000745IT$ALEXION PHARMACEUTICALS$$$$E$M$Y$$$20240913$$MD$IT$IT
243167631$24316763$1$I$$20240911$20240913$20240913$PER$$US-ALXN-202409USA000758US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$HP$US$US
243167651$24316765$1$I$20200101$20240905$20240913$20240913$EXP$$RO-ALXN-202409EEA000340RO$ALEXION PHARMACEUTICALS$$46$YR$$F$Y$$$20240913$$MD$RO$RO
243167661$24316766$1$I$$20240903$20240913$20240913$EXP$$US-ROCHE-10000073600$ROCHE$$73$YR$E$F$Y$$$20240913$$CN$US$US
243167671$24316767$1$I$20240101$20240910$20240913$20240913$EXP$$CA-TAKEDA-2024TUS059112$TAKEDA$$$$$M$Y$$$20240913$$HP$CA$CA
243167681$24316768$1$I$20240801$20240904$20240913$20240913$EXP$$US-ORPHANEU-2024006932$RECORDATI$$$$$$Y$$$20240913$$CN$US$US
243167691$24316769$1$I$20240101$20240910$20240913$20240913$EXP$FR-AFSSAPS-LL2024001720$FR-RDY-SPO/FRA/24/0013289$DR REDDYS$$33$YR$A$M$Y$$$20240913$$MD$FR$FR
243167701$24316770$1$I$20210101$20240906$20240913$20240913$EXP$$IN-ROCHE-10000076400$ROCHE$$$$$F$Y$$$20240913$$CN$IN$IN
243167711$24316771$1$I$$20240902$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013101$DR REDDYS$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 101: doi:10.1016/j.jflm.2023.102625.$61$YR$A$$Y$$$20240913$$HP$US$US
243167721$24316772$1$I$$20240906$20240913$20240913$EXP$$US-BEH-2024178385$CSL BEHRING$$$$A$M$Y$$$20240913$$HP$US$US
243167731$24316773$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146045$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240913$$HP$US$US
243167741$24316774$1$I$20240902$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145933$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240913$$CN$US$US
243167751$24316775$1$I$$20240904$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141093$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$113.4$KG$20240913$$CN$US$US
243167762$24316776$2$F$$20240912$20240913$20240922$PER$$US-GSK-US2024110812$GLAXOSMITHKLINE$$$$$F$Y$$$20240922$$CN$US$US
243167771$24316777$1$I$$20240904$20240913$20240913$EXP$$US-GSK-US2024110119$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$MD$US$US
243167781$24316778$1$I$20230530$20240904$20240913$20240913$EXP$FR-AFSSAPS-AM2024000677$FR-TEVA-VS-3240457$TEVA$$91$YR$$F$Y$48$KG$20240913$$MD$FR$FR
243167791$24316779$1$I$$20240909$20240913$20240913$EXP$$IT-MYLANLABS-2024M1082566$MYLAN$Valentini, P. An uncommon presentation for a severe invasive infection due to methicillin-resistant Staphylococcus aureus clone USA300 in Italy: a case report. Annals of Clinical Microbiology and Antimicrobials. 2008;7:11$15$YR$$M$Y$$$20240913$$HP$IT$IT
243167801$24316780$1$I$20240215$20240909$20240913$20240913$EXP$$CA-TAKEDA-2024TUS009065$TAKEDA$$35$YR$$M$Y$$$20240913$$MD$CA$CA
243167811$24316781$1$I$20240301$20240909$20240913$20240913$EXP$FR-AFSSAPS-AM2024000694$FR-MYLANLABS-2024M1082385$MYLAN$$74$YR$$M$Y$64$KG$20240913$$MD$FR$FR
243167821$24316782$1$I$20240724$20240911$20240913$20240913$EXP$$ES-TAKEDA-2024TUS090620$TAKEDA$$18$YR$$M$Y$$$20240913$$HP$ES$ES
243167831$24316783$1$I$$20240909$20240913$20240913$EXP$$PL-SANDOZ INC.-PHHY2019PL151220$SANDOZ$$56$YR$$M$Y$120$KG$20240913$$HP$PL$PL
243167841$24316784$1$I$20220101$20240912$20240913$20240913$EXP$$US-INCYTE CORPORATION-2024IN009648$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243167851$24316785$1$I$$20240909$20240913$20240913$EXP$$IN-AstraZeneca-2024A206402$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$IN$
243167861$24316786$1$I$20240101$20240909$20240913$20240913$EXP$$CA-AstraZeneca-2024A205477$ASTRAZENECA$$73$YR$$M$Y$$$20240913$$CN$CA$
243167871$24316787$1$I$20230301$20240909$20240913$20240913$EXP$$MX-ROCHE-10000079524$ROCHE$$59$YR$A$F$Y$57$KG$20240913$$CN$MX$MX
243167891$24316789$1$I$20240801$20240909$20240913$20240913$EXP$$JP-AstraZeneca-2024A205740$ASTRAZENECA$$$$E$F$Y$$$20240913$$PH$JP$
243167901$24316790$1$I$$20240909$20240913$20240913$EXP$$GB-AstraZeneca-2024A205051$ASTRAZENECA$$$$C$$Y$$$20240913$$MD$GB$
243167911$24316791$1$I$20240604$20240906$20240913$20240913$EXP$$JP-009507513-2409JPN001007J$MERCK$$63$YR$$F$Y$$$20240913$$MD$JP$JP
243167921$24316792$1$I$20240101$20240910$20240913$20240913$EXP$$US-ABBVIE-5918001$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243167931$24316793$1$I$20240301$20240909$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409006432$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240913$$CN$US$US
243167941$24316794$1$I$$20240907$20240913$20240913$30DAY$$JP-PFIZER INC-PV202400117566$PFIZER$$$$A$M$Y$$$20240913$$CN$JP$JP
243167951$24316795$1$I$$20240912$20240913$20240913$PER$$US-GILEAD-2024-0687572$GILEAD$$$$A$F$Y$$$20240913$$HP$US$US
243167971$24316797$1$I$20240912$20240912$20240912$20240912$DIR$718221$$FDA-CTU$$23$YR$$F$N$54$KG$20240912$N$CN$US$
243167981$24316798$1$I$20240909$20240912$20240912$20240912$DIR$718217$$FDA-CTU$$38$YR$$F$N$56$KG$20240912$N$CN$NZ$
243167992$24316799$2$F$20240101$20240911$20240913$20240917$EXP$$CA-PFIZER INC-202400103065$PFIZER$$56$YR$$F$Y$$$20240917$$HP$CA$CA
243168011$24316801$1$I$$20240911$20240913$20240913$EXP$$GB-PFIZER INC-PV202400119291$PFIZER$$77$YR$$F$Y$$$20240913$$CN$GB$GB
243168021$24316802$1$I$$20240903$20240913$20240913$30DAY$$JP-PFIZER INC-202400248979$PFIZER$$$$$$Y$$$20240913$$PH$JP$JP
243168031$24316803$1$I$$20240903$20240913$20240913$EXP$GB-MHRA-31738807$GB-HETERO-AMR2024GB02968$HETERO$$$$$$Y$$$20240913$$CN$GB$GB
243168041$24316804$1$I$$20240905$20240913$20240913$EXP$$GB-TEVA-VS-3241782$TEVA$$65$YR$$F$Y$$$20240913$$PH$GB$GB
243168051$24316805$1$I$$20240904$20240913$20240913$EXP$$JP-ASTELLAS-2024-AER-004790$ASTELLAS$$$$$M$Y$$$20240913$$MD$JP$JP
243168061$24316806$1$I$20240101$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024179772$AMGEN$$72$YR$E$F$Y$$$20240913$$CN$US$US
243168071$24316807$1$I$$20240909$20240913$20240913$EXP$$ES-ASTELLAS-2024-AER-005721$ASTELLAS$$32$YR$A$M$Y$$$20240913$$HP$ES$ES
243168081$24316808$1$I$20111111$20240909$20240913$20240913$EXP$$US-ASTELLAS-2024-AER-005661$ASTELLAS$$72$YR$E$M$Y$102$KG$20240913$$HP$US$US
243168091$24316809$1$I$$20240904$20240913$20240913$EXP$$CA-BAXTER-2024BAX024249$BAXTER$$73$YR$$F$Y$$$20240913$$CN$CA$CA
243168101$24316810$1$I$$20240820$20240913$20240913$PER$$US-SA-2024SA263415$SANOFI AVENTIS$$$$A$F$Y$56.6$KG$20240913$$MD$US$US
243168111$24316811$1$I$$20240820$20240913$20240913$PER$$US-SA-2024SA262081$SANOFI AVENTIS$$$$A$F$Y$77.27$KG$20240913$$MD$US$US
243168121$24316812$1$I$20230101$20240821$20240913$20240913$PER$$US-SA-2024SA264561$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240913$$PH$US$US
243168131$24316813$1$I$20230801$20240910$20240913$20240913$EXP$$CO-BAYER-2024A122091$BAYER$$80$YR$E$F$Y$$$20240913$$CN$CO$CO
243168141$24316814$1$I$20240101$20240820$20240913$20240913$PER$$US-SA-2024SA264250$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240913$$MD$US$US
243168161$24316816$1$I$20240101$20240820$20240913$20240913$PER$$US-SA-2024SA263836$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240913$$MD$US$US
243168171$24316817$1$I$$20240820$20240913$20240913$PER$$US-SA-2024SA262075$SANOFI AVENTIS$$52$YR$A$M$Y$165$KG$20240913$$MD$US$US
243168181$24316818$1$I$20240819$20240820$20240913$20240913$PER$$US-SA-2024SA264320$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240913$$MD$US$US
243168191$24316819$1$I$$20240820$20240913$20240913$PER$$US-SA-2024SA261998$SANOFI AVENTIS$$$$A$M$Y$92.98$KG$20240913$$MD$US$US
243168201$24316820$1$I$$20240822$20240913$20240913$PER$$US-SA-2024SA262884$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240913$$CN$US$US
243168211$24316821$1$I$20240801$20240823$20240913$20240913$PER$$US-SA-2024SA263334$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240913$$CN$US$US
243168221$24316822$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA263152$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240913$$MD$US$US
243168232$24316823$2$F$20240518$20240829$20240913$20240917$PER$$US-SA-2024SA263137$SANOFI AVENTIS$$54$YR$A$F$Y$121.36$KG$20240918$$MD$US$US
243168241$24316824$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA265056$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240913$$CN$US$US
243168251$24316825$1$I$20240101$20240823$20240913$20240913$PER$$US-SA-2024SA263447$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240913$$MD$US$US
243168261$24316826$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA263205$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240913$$CN$US$US
243168271$24316827$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA263010$SANOFI AVENTIS$$$$A$M$Y$118.64$KG$20240913$$MD$US$US
243168281$24316828$1$I$$20240822$20240913$20240913$PER$$US-SA-2024SA262611$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240913$$MD$US$US
243168291$24316829$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA263424$SANOFI AVENTIS$$44$YR$A$F$Y$69.55$KG$20240913$$MD$US$US
243168301$24316830$1$I$$20240822$20240913$20240913$PER$$US-SA-2024SA263778$SANOFI AVENTIS$$$$T$M$Y$56.82$KG$20240913$$MD$US$US
243168311$24316831$1$I$20240101$20240823$20240913$20240913$PER$$US-SA-2024SA263154$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240913$$CN$US$US
243168321$24316832$1$I$$20240822$20240913$20240913$PER$$US-SA-2024SA263763$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240913$$CN$US$US
243168331$24316833$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA263478$SANOFI AVENTIS$$$$A$F$Y$72.73$KG$20240913$$MD$US$US
243168341$24316834$1$I$$20240822$20240913$20240913$PER$$US-SA-2024SA262358$SANOFI AVENTIS$$48$YR$A$F$Y$94.09$KG$20240913$$MD$US$US
243168352$24316835$2$F$20240101$20240823$20240913$20240917$PER$$US-SA-2024SA263771$SANOFI AVENTIS$$8$YR$C$F$Y$52$KG$20240918$$MD$US$US
243168361$24316836$1$I$20240101$20240823$20240913$20240913$PER$$US-SA-2024SA263385$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240913$$MD$US$US
243168371$24316837$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62949$$FDA-CTU$$60$YR$$F$N$$$20240912$N$$US$
243168381$24316838$1$I$20240906$20240912$20240912$20240912$DIR$718173$$FDA-CTU$$31$YR$$F$N$$$20240912$N$HP$US$
243168391$24316839$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA263199$SANOFI AVENTIS$$$$A$M$Y$96.36$KG$20240913$$MD$US$US
243168401$24316840$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA262542$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$MD$US$US
243168411$24316841$1$I$20240101$20240823$20240913$20240913$PER$$US-SA-2024SA265058$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240913$$MD$US$US
243168421$24316842$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA263355$SANOFI AVENTIS$$$$E$F$Y$$$20240913$$CN$US$US
243168431$24316843$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA264316$SANOFI AVENTIS$$$$$$Y$$$20240913$$LW$US$US
243168441$24316844$1$I$$20240822$20240913$20240913$PER$$US-SA-2024SA263310$SANOFI AVENTIS$$$$A$M$Y$88.4$KG$20240913$$MD$US$US
243168451$24316845$1$I$20240912$20240912$20240912$20240912$DIR$718172$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243168461$24316846$1$I$$20240822$20240913$20240913$PER$$US-SA-2024SA259419$SANOFI AVENTIS$$$$E$F$Y$$$20240913$$MD$US$US
243168471$24316847$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA263445$SANOFI AVENTIS$$$$A$M$Y$106.82$KG$20240913$$MD$US$US
243168482$24316848$2$F$$20240822$20240913$20240918$PER$$US-SA-2024SA263323$SANOFI AVENTIS$$65$YR$E$M$Y$90.91$KG$20240918$$MD$US$US
243168491$24316849$1$I$20240801$20240823$20240913$20240913$PER$$US-SA-2024SA263044$SANOFI AVENTIS$$61$YR$A$M$Y$72.73$KG$20240913$$MD$US$US
243168501$24316850$1$I$$20240822$20240913$20240913$PER$$US-SA-2024SA262977$SANOFI AVENTIS$$61$YR$A$M$Y$100$KG$20240913$$MD$US$US
243168511$24316851$1$I$$20240912$20240913$20240913$EXP$$TW-ROCHE-10000063548$ROCHE$$55$YR$A$F$Y$$$20240913$$CN$TW$TW
243168521$24316852$1$I$$20240909$20240913$20240913$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005056$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240913$$CN$US$US
243168531$24316853$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA263127$SANOFI AVENTIS$$$$A$M$Y$$$20240913$$MD$US$US
243168541$24316854$1$I$20240801$20240823$20240913$20240913$PER$$US-SA-2024SA263101$SANOFI AVENTIS$$59$YR$A$M$Y$86.63$KG$20240913$$MD$US$US
243168551$24316855$1$I$20240709$20240912$20240913$20240913$EXP$FR-AFSSAPS-TO2024001716$FR-GRUNENTHAL-2024-125161$AVERITAS$$57$YR$$M$Y$$$20240913$$MD$FR$FR
243168561$24316856$1$I$$20240826$20240913$20240913$PER$$US-SA-2024SA263131$SANOFI AVENTIS$$$$E$F$Y$$$20240913$$MD$US$US
243168571$24316857$1$I$$20240911$20240913$20240913$PER$$US-GRUNENTHAL-2024-125126$AVERITAS$$69$YR$$F$Y$$$20240913$$CN$US$US
243168581$24316858$1$I$$20240826$20240913$20240913$PER$$US-SA-2024SA263186$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240913$$CN$US$US
243168591$24316859$1$I$$20240826$20240913$20240913$PER$$US-SA-2024SA263317$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240913$$HP$US$US
243168601$24316860$1$I$$20240903$20240913$20240913$EXP$$DE-009507513-2409DEU004628$MERCK$$$$$F$Y$$$20240913$$CN$DE$DE
243168611$24316861$1$I$20240101$20240906$20240913$20240913$EXP$$CN-009507513-2409CHN003690$MERCK$$92$YR$$M$Y$65$KG$20240913$$HP$CN$CN
243168621$24316862$1$I$$20240826$20240913$20240913$PER$$US-SA-2024SA263332$SANOFI AVENTIS$$$$A$F$Y$106.82$KG$20240913$$MD$US$US
243168631$24316863$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA260773$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240913$$MD$US$US
243168641$24316864$1$I$$20240826$20240913$20240913$PER$$US-SA-2024SA262379$SANOFI AVENTIS$$$$E$F$Y$54.55$KG$20240913$$HP$US$US
243168651$24316865$1$I$20240822$20240829$20240913$20240913$PER$$US-SA-2024SA264187$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240913$$MD$US$US
243168661$24316866$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA260950$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240913$$MD$US$US
243168671$24316867$1$I$20240801$20240829$20240913$20240913$PER$$US-SA-2024SA263802$SANOFI AVENTIS$$64$YR$A$M$Y$113.3$KG$20240913$$MD$US$US
243168681$24316868$1$I$20220101$20240829$20240913$20240913$PER$$US-SA-2024SA261695$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240913$$HP$US$US
243168691$24316869$1$I$20240801$20240826$20240913$20240913$PER$$US-SA-2024SA263404$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240913$$MD$US$US
243168701$24316870$1$I$$20240826$20240913$20240913$PER$$US-SA-2024SA263170$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$MD$US$US
243168711$24316871$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA262084$SANOFI AVENTIS$$$$$$Y$$$20240913$$PH$US$US
243168721$24316872$1$I$20230301$20240829$20240913$20240913$PER$$US-SA-2024SA262288$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240913$$HP$US$US
243168731$24316873$1$I$$20240826$20240913$20240913$PER$$US-SA-2024SA263241$SANOFI AVENTIS$$$$A$F$Y$58.41$KG$20240913$$MD$US$US
243168741$24316874$1$I$20240101$20240829$20240913$20240913$PER$$US-SA-2024SA262432$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240913$$HP$US$US
243168751$24316875$1$I$20240101$20240826$20240913$20240913$PER$$US-SA-2024SA263414$SANOFI AVENTIS$$28$YR$A$F$Y$48.64$KG$20240913$$MD$US$US
243168761$24316876$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA260728$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240913$$MD$US$US
243168771$24316877$1$I$20240101$20240826$20240913$20240913$PER$$US-SA-2024SA262304$SANOFI AVENTIS$$54$YR$A$F$Y$68.18$KG$20240913$$MD$US$US
243168781$24316878$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA261100$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240913$$MD$US$US
243168791$24316879$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA264154$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240913$$CN$US$US
243168801$24316880$1$I$20240801$20240829$20240913$20240913$PER$$US-SA-2024SA261292$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240913$$MD$US$US
243168811$24316881$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA260360$SANOFI AVENTIS$$$$A$M$Y$$$20240913$$HP$US$US
243168821$24316882$1$I$$20240911$20240913$20240913$EXP$$US-GSK-US2024113188$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$US$US
243168831$24316883$1$I$20240722$20240830$20240913$20240913$PER$$US-SA-2024SA261342$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240913$$MD$US$US
243168841$24316884$1$I$$20240829$20240913$20240913$PER$$US-SA-2022SA524483$SANOFI AVENTIS$$29$YR$A$F$Y$65.3$KG$20240913$$MD$US$US
243168851$24316885$1$I$20240101$20240830$20240913$20240913$PER$$US-SA-2024SA261465$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$HP$US$US
243168861$24316886$1$I$20240101$20240829$20240913$20240913$PER$$US-SA-2024SA262350$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240913$$HP$US$US
243168871$24316887$1$I$20240809$20240829$20240913$20240913$PER$$US-SA-2024SA264620$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240913$$MD$US$US
243168881$24316888$1$I$20240814$20240826$20240913$20240913$PER$$US-SA-2024SA262712$SANOFI AVENTIS$$59$YR$A$F$Y$97.73$KG$20240913$$MD$US$US
243168891$24316889$1$I$$20240906$20240913$20240913$PER$$US-MYLANLABS-2024M1082638$MYLAN$$81$YR$$F$Y$$$20240913$$CN$US$US
243168901$24316890$1$I$$20240905$20240913$20240913$PER$$US-MYLANLABS-2024M1082433$MYLAN$$$$$M$Y$$$20240913$$CN$US$US
243168911$24316891$1$I$20240801$20240830$20240913$20240913$PER$$US-SA-2024SA262391$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240913$$HP$US$US
243168921$24316892$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA263894$SANOFI AVENTIS$$73$YR$E$$Y$$$20240913$$CN$US$US
243168931$24316893$1$I$20240101$20240830$20240913$20240913$PER$$US-SA-2024SA260260$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240913$$MD$US$US
243168941$24316894$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA264606$SANOFI AVENTIS$$$$A$M$Y$82.576$KG$20240913$$MD$US$US
243168951$24316895$1$I$20240101$20240830$20240913$20240913$PER$$US-SA-2024SA260480$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240913$$MD$US$US
243168961$24316896$1$I$20240101$20240830$20240913$20240913$PER$$US-SA-2024SA260949$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240913$$MD$US$US
243168971$24316897$1$I$20240701$20240830$20240913$20240913$PER$$US-SA-2024SA263378$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240913$$HP$US$US
243168981$24316898$1$I$20240809$20240830$20240913$20240913$PER$$US-SA-2024SA262255$SANOFI AVENTIS$$$$I$$Y$$$20240913$$HP$US$US
243168991$24316899$1$I$20240717$20240830$20240913$20240913$PER$$US-SA-2024SA262265$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240913$$MD$US$US
243169001$24316900$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA265114$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240913$$CN$US$US
243169011$24316901$1$I$20240101$20240830$20240913$20240913$PER$$US-SA-2024SA261486$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240913$$MD$US$US
243169021$24316902$1$I$20240101$20240830$20240913$20240913$PER$$US-SA-2024SA261452$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240913$$MD$US$US
243169031$24316903$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA265255$SANOFI AVENTIS$$62$YR$A$$Y$$$20240913$$MD$US$US
243169051$24316905$1$I$20240801$20240830$20240913$20240913$PER$$US-SA-2024SA260394$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240913$$MD$US$US
243169061$24316906$1$I$20230401$20240830$20240913$20240913$PER$$US-SA-2024SA265000$SANOFI AVENTIS$$$$C$M$Y$$$20240913$$MD$US$US
243169072$24316907$2$F$20240829$20240903$20240913$20240917$PER$$US-SA-2024SA263055$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240918$$HP$US$US
243169081$24316908$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA263892$SANOFI AVENTIS$$52$YR$A$$Y$$$20240913$$CN$US$US
243169091$24316909$1$I$20240801$20240830$20240913$20240913$PER$$US-SA-2024SA137476$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240913$$HP$US$US
243169101$24316910$1$I$20240801$20240830$20240913$20240913$PER$$US-SA-2024SA259567$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240913$$CN$US$US
243169111$24316911$1$I$20240101$20240830$20240913$20240913$PER$$US-SA-2024SA262039$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240913$$HP$US$US
243169121$24316912$1$I$20240101$20240830$20240913$20240913$PER$$US-SA-2024SA261280$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240913$$HP$US$US
243169131$24316913$1$I$20240909$20240912$20240912$20240912$DIR$718216$$FDA-CTU$$37$YR$$F$N$83.25$KG$20240912$N$CN$US$
243169141$24316914$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62957$$FDA-CTU$$63$YR$$M$N$$$20240912$N$$US$
243169151$24316915$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA263086$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240913$$CN$US$US
243169171$24316917$1$I$20240603$20240905$20240913$20240913$EXP$FR-AFSSAPS-NC2024001018$FR-TEVA-VS-3240932$TEVA$$62$YR$$F$Y$$$20240913$$MD$FR$FR
243169181$24316918$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA261474$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240913$$MD$US$US
243169191$24316919$1$I$$20240831$20240913$20240913$PER$$US-SA-2024SA260769$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240913$$MD$US$US
243169201$24316920$1$I$20240911$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62958$$FDA-CTU$$83$YR$$F$N$$$20240912$Y$PH$US$
243169211$24316921$1$I$20240912$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62959$$FDA-CTU$$71$YR$$M$N$$$20240912$N$$US$
243169221$24316922$1$I$$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-62960$$FDA-CTU$$74$YR$$M$N$$$20240912$N$$US$
243169231$24316923$1$I$$20240831$20240913$20240913$PER$$US-SA-2024SA261287$SANOFI AVENTIS$$13$YR$T$M$Y$37$KG$20240913$$CN$US$US
243169241$24316924$1$I$20240801$20240903$20240913$20240913$PER$$US-SA-2024SA263437$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240913$$HP$US$US
243169251$24316925$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA261594$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240913$$CN$US$US
243169261$24316926$1$I$$20240831$20240913$20240913$PER$$US-SA-2024SA200350$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240913$$MD$US$US
243169271$24316927$1$I$20230615$20240912$20240912$20240912$DIR$718197$$FDA-CTU$$$$$M$N$$$20240912$$CN$US$
243169282$24316928$2$F$$20240918$20240913$20240925$PER$$US-SA-2024SA260783$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240925$$MD$US$US
243169291$24316929$1$I$20240901$20240912$20240913$20240913$PER$$US-GRUNENTHAL-2024-125206$AVERITAS$$77$YR$$F$Y$$$20240913$$MD$US$US
243169301$24316930$1$I$$20240904$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009339$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243169311$24316931$1$I$20240828$20240910$20240913$20240913$PER$$US-ALXN-202409USA000670US$ALEXION PHARMACEUTICALS$$48$YR$$F$Y$$$20240913$$HP$US$US
243169321$24316932$1$I$$20240909$20240913$20240913$EXP$$US-JNJFOC-20240927770$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243169331$24316933$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263351$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$HP$US$US
243169341$24316934$1$I$$20240903$20240913$20240913$PER$$US-SA-2024SA262602$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240913$$HP$US$US
243169351$24316935$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA243049$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240913$$HP$US$US
243169362$24316936$2$F$20240101$20240909$20240913$20240918$PER$$US-SA-2024SA264922$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240918$$CN$US$US
243169371$24316937$1$I$$20240903$20240913$20240913$PER$$US-SA-2024SA262997$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240913$$$US$US
243169381$24316938$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA264543$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240913$$HP$US$US
243169392$24316939$2$F$20240101$20240904$20240913$20240928$PER$$US-SA-2024SA264781$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240928$$CN$US$US
243169401$24316940$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA264102$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240913$$HP$US$US
243169411$24316941$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263662$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$MD$US$US
243169422$24316942$2$F$$20240905$20240913$20240920$PER$$US-SA-2024SA264274$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240920$$CN$US$US
243169431$24316943$1$I$20240908$20240911$20240913$20240913$EXP$$CA-JNJFOC-20240933585$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20240913$$PH$CA$CA
243169441$24316944$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA264536$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240913$$HP$US$US
243169451$24316945$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263858$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240913$$HP$US$US
243169461$24316946$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA264404$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240913$$CN$US$US
243169471$24316947$1$I$20230601$20240904$20240913$20240913$PER$$US-SA-2024SA263810$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240913$$MD$US$US
243169481$24316948$1$I$20240903$20240904$20240913$20240913$PER$$US-SA-2024SA264287$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240913$$CN$US$US
243169491$24316949$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA229777$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240913$$MD$US$US
243169501$24316950$1$I$$20240903$20240913$20240913$PER$$US-SA-2024SA265096$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240913$$CN$US$US
243169511$24316951$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA264604$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240913$$CN$US$US
243169521$24316952$1$I$$20240903$20240913$20240913$PER$$US-SA-2024SA263194$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$MD$US$US
243169531$24316953$1$I$$20240903$20240913$20240913$PER$$US-SA-2024SA263688$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240913$$HP$US$US
243169541$24316954$1$I$20180301$20240904$20240913$20240913$PER$$US-SA-2024SA263675$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240913$$HP$US$US
243169551$24316955$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263941$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240913$$HP$US$US
243169561$24316956$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA263148$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240913$$MD$US$US
243169571$24316957$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263762$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$HP$US$US
243169581$24316958$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA262801$SANOFI AVENTIS$$$$E$M$Y$$$20240913$$MD$US$US
243169591$24316959$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263568$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$HP$US$US
243169601$24316960$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263545$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240913$$MD$US$US
243169611$24316961$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA263612$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240913$$HP$US$US
243169621$24316962$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA264243$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240913$$HP$US$US
243169631$24316963$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA263937$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240913$$HP$US$US
243169641$24316964$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA262690$SANOFI AVENTIS$$$$I$$Y$$$20240913$$HP$US$US
243169651$24316965$1$I$$20240905$20240913$20240913$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-142170$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240913$$MD$PL$PL
243169661$24316966$1$I$$20240906$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013150$DR REDDYS$$61$YR$A$M$Y$$$20240913$$HP$US$US
243169681$24316968$1$I$20240829$20240907$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013167$DR REDDYS$$27$YR$A$M$Y$$$20240913$$PH$US$US
243169691$24316969$1$I$20211008$20240906$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013161$DR REDDYS$$65$YR$E$F$Y$$$20240913$$HP$US$US
243169701$24316970$1$I$20240806$20240906$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013157$DR REDDYS$$25$YR$A$M$Y$$$20240913$$MD$US$US
243169711$24316971$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA262920$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240913$$HP$US$US
243169721$24316972$1$I$$20240902$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013139$DR REDDYS$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham III CO, Wigleya FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Seminars in Arthritis and Rheumatism. 2024;67: doi:10.1016/j.semarthrit.2024.152460.$68$YR$E$M$Y$$$20240913$$HP$US$US
243169741$24316974$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263196$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240913$$MD$US$US
243169751$24316975$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263619$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240913$$HP$US$US
243169761$24316976$1$I$$20240903$20240913$20240913$PER$$US-SA-2024SA048244$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240913$$MD$US$US
243169771$24316977$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA264348$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240913$$HP$US$US
243169781$24316978$1$I$20230201$20240903$20240913$20240913$PER$$US-SA-2024SA260998$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240913$$HP$US$US
243169791$24316979$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263468$SANOFI AVENTIS$$$$E$F$Y$$$20240913$$MD$US$US
243169801$24316980$1$I$20240601$20240904$20240913$20240913$PER$$US-SA-2024SA154977$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240913$$HP$US$US
243169811$24316981$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA263226$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240913$$HP$US$US
243169821$24316982$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263066$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240913$$HP$US$US
243169831$24316983$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA263685$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240913$$MD$US$US
243169841$24316984$1$I$$20240904$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009335$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243169851$24316985$1$I$$20240910$20240913$20240913$PER$$US-HALEON-2196582$Haleon PLC$$$$$M$Y$$$20240913$$CN$US$US
243169861$24316986$1$I$20240901$20240903$20240913$20240913$PER$$US-SA-2024SA261193$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240913$$MD$US$US
243169871$24316987$1$I$$20240903$20240913$20240913$PER$$US-SA-2024SA262560$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240913$$HP$US$US
243169881$24316988$1$I$20240801$20240903$20240913$20240913$PER$$US-SA-2024SA263730$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240913$$MD$US$US
243169891$24316989$1$I$$20240906$20240913$20240913$EXP$$TH-ROCHE-10000075695$ROCHE$$63$YR$A$M$Y$$$20240913$$CN$TH$TH
243169901$24316990$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263522$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240913$$HP$US$US
243169911$24316991$1$I$20240101$20240902$20240913$20240913$PER$$CA-SA-2024SA257887$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240913$$CN$US$CA
243169921$24316992$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA264311$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240913$$HP$US$US
243169931$24316993$1$I$20240731$20240904$20240913$20240913$PER$$US-SA-2024SA263064$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240913$$HP$US$US
243169941$24316994$1$I$$20240903$20240913$20240913$PER$$US-SA-2024SA263430$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240913$$HP$US$US
243169951$24316995$1$I$20240815$20240904$20240913$20240913$PER$$US-SA-2024SA264400$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240913$$CN$US$US
243169961$24316996$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA264041$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240913$$HP$US$US
243169971$24316997$1$I$20240903$20240903$20240913$20240913$PER$$US-SA-2024SA263972$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240913$$CN$US$US
243169981$24316998$1$I$20240101$20240903$20240913$20240913$PER$$US-SA-2024SA260970$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240913$$MD$US$US
243169991$24316999$1$I$20240901$20240904$20240913$20240913$PER$$US-SA-2024SA263428$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240913$$CN$US$US
243170011$24317001$1$I$$20240903$20240913$20240913$PER$$US-SA-2024SA262087$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240913$$CN$US$US
243170031$24317003$1$I$20240821$20240904$20240913$20240913$PER$$US-SA-2024SA264238$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240913$$MD$US$US
243170041$24317004$1$I$$20240902$20240913$20240913$PER$$US-SA-2024SA260432$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240913$$HP$US$US
243170051$24317005$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263731$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$MD$US$US
243170061$24317006$1$I$20220301$20240903$20240913$20240913$PER$$US-SA-2024SA260471$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240913$$MD$US$US
243170071$24317007$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62967$$FDA-CTU$$75$YR$$M$N$$$20240913$N$$US$
243170081$24317008$1$I$$20240903$20240913$20240913$PER$$US-SA-2024SA263209$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240913$$MD$US$US
243170091$24317009$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62969$$FDA-CTU$$92$YR$$M$N$$$20240913$N$$US$
243170101$24317010$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA262922$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240913$$HP$US$US
243170111$24317011$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA264424$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240913$$HP$US$US
243170121$24317012$1$I$20240803$20240912$20240912$20240912$DIR$718184$$FDA-CTU$$44$YR$$F$N$$$20240912$Y$$US$
243170131$24317013$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263824$SANOFI AVENTIS$$$$E$F$Y$$$20240913$$MD$US$US
243170141$24317014$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264008$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240913$$MD$US$US
243170151$24317015$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264384$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240913$$HP$US$US
243170162$24317016$2$F$20240101$20240906$20240913$20240917$PER$$US-SA-2024SA263071$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240918$$MD$US$US
243170171$24317017$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA262637$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240913$$CN$US$US
243170181$24317018$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA264210$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240913$$HP$US$US
243170191$24317019$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA263640$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240913$$MD$US$US
243170201$24317020$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA264502$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240913$$CN$US$US
243170211$24317021$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA263368$SANOFI AVENTIS$$8$YR$C$F$Y$34.09$KG$20240913$$MD$US$US
243170231$24317023$1$I$20240901$20240906$20240913$20240913$EXP$$JP-009507513-2409JPN000967J$MERCK$$8$DEC$$M$Y$$$20240913$$PH$JP$JP
243170241$24317024$1$I$$20240904$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009333$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243170251$24317025$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264131$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240913$$MD$US$US
243170261$24317026$1$I$20240801$20240905$20240913$20240913$PER$$US-SA-2024SA262825$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240913$$HP$US$US
243170292$24317029$2$F$$20240919$20240913$20240925$EXP$$US-INCYTE CORPORATION-2024IN009331$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243170301$24317030$1$I$20240622$20240904$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009330$INCYTE$$$$$$Y$$$20240913$$HP$US$US
243170311$24317031$1$I$$20240906$20240913$20240913$PER$$US-MYLANLABS-2024M1082757$MYLAN$$$$$F$Y$63.05$KG$20240913$$CN$US$US
243170321$24317032$1$I$20180516$20240902$20240913$20240913$EXP$$EG-SA-2018SA139155$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240913$$CN$EG$EG
243170332$24317033$2$F$20240301$20240926$20240913$20240930$EXP$$US-OTSUKA-2024_020621$OTSUKA$$64$YR$$M$Y$$$20240930$$HP$US$US
243170341$24317034$1$I$$20240903$20240913$20240913$EXP$$JP-EMD Serono-2024048016$EMD SERONO INC$$79$YR$E$F$Y$53$KG$20240913$$MD$JP$JP
243170352$24317035$2$F$20210101$20240916$20240913$20240918$PER$$US-AMGEN-USASP2024181322$AMGEN$$59$YR$A$F$Y$$$20240917$$HP$US$US
243170361$24317036$1$I$$20240905$20240913$20240913$EXP$$US-JNJFOC-20240919998$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$US$US
243170371$24317037$1$I$$20240812$20240913$20240913$PER$$US-LUNDBECK-DKLU4002898$LUNDBECK$$$$$$Y$$$20240913$$CN$US$US
243170381$24317038$1$I$20240909$20240909$20240913$20240913$EXP$$US-OTSUKA-2024_025368$OTSUKA$$44$YR$$M$Y$$$20240913$$HP$US$US
243170391$24317039$1$I$20240812$20240904$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009327$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243170401$24317040$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144981$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240913$$CN$US$US
243170411$24317041$1$I$$20240829$20240913$20240913$PER$$US-ASTELLAS-2024-AER-003731$ASTELLAS$$$$$F$Y$$$20240913$$MD$US$US
243170422$24317042$2$F$20240701$20240917$20240913$20240924$EXP$$BR-ASTELLAS-2024-AER-004448$ASTELLAS$$74$YR$E$M$Y$$$20240924$$CN$BR$BR
243170431$24317043$1$I$$20240904$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009326$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243170441$24317044$1$I$$20240830$20240913$20240913$EXP$$IT-QUAGEN-2024QUALIT00254$QUAGEN PHARMACEUTICALS$Pier Aldo Canessa.Valproic acid-induced pleural effusion.Rassegna di Patologia dell^Apparato Respiratorio.2023;38 (No 1):53-56$53$YR$A$M$Y$$$20240913$$HP$IT$IT
243170461$24317046$1$I$$20240906$20240913$20240913$EXP$$IN-AstraZeneca-2024A204362$ASTRAZENECA$$12418$DY$$F$Y$72$KG$20240913$$CN$IN$
243170471$24317047$1$I$$20240909$20240913$20240913$EXP$FR-MLMSERVICE-20170808-0835269-1$FR-SANDOZ INC.-PHHY2017FR120450$SANDOZ$$22$YR$$F$Y$$$20240913$$MD$FR$FR
243170481$24317048$1$I$$20240831$20240913$20240913$EXP$$CA-UCBSA-2024045145$UCB$$$$$F$Y$$$20240913$$CN$CA$CA
243170492$24317049$2$F$$20240916$20240913$20240917$PER$$US-ALXN-202409USA000855US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243170501$24317050$1$I$20240827$20240828$20240913$20240913$PER$$US-009507513-2408USA009933$MERCK$$$$$F$Y$$$20240913$$CN$US$US
243170522$24317052$2$F$20240905$20240924$20240913$20240927$PER$$US-BIOGEN-2024BI01281442$BIOGEN$$75$YR$$F$Y$$$20240927$$CN$US$US
243170531$24317053$1$I$20180504$20240911$20240913$20240913$PER$$US-BIOGEN-2024BI01282251$BIOGEN$$18$YR$$F$Y$$$20240913$$CN$US$US
243170541$24317054$1$I$$20240911$20240913$20240913$PER$$US-BIOGEN-2024BI01282140$BIOGEN$$$$$M$Y$$$20240913$$HP$US$US
243170551$24317055$1$I$$20240906$20240913$20240913$EXP$$AU-TAKEDA-2024TUS091180$TAKEDA$$60$YR$$F$Y$$$20240913$$MD$AU$AU
243170562$24317056$2$F$20240904$20240916$20240913$20240918$PER$$US-BIOGEN-2024BI01282028$BIOGEN$$47$YR$$M$Y$$$20240918$$CN$US$US
243170581$24317058$1$I$20221004$20240904$20240913$20240913$EXP$$TW-ROCHE-10000077779$ROCHE$$39$YR$A$M$Y$$$20240913$$MD$TW$TW
243170591$24317059$1$I$$20230515$20240913$20240913$EXP$$NVSC2023CA026281$NOVARTIS$$56$YR$$M$Y$$$20240913$$CN$CA$CA
243170601$24317060$1$I$$20240911$20240913$20240913$EXP$$NVSC2024RW182951$NOVARTIS$$$$$M$Y$$$20240913$$MD$RW$RW
243170611$24317061$1$I$$20200804$20240913$20240913$EXP$$NVSC2020AU371141$NOVARTIS$$$$$$Y$$$20240913$$HP$AU$AU
243170622$24317062$2$F$20240630$20240912$20240913$20240920$EXP$FR-AFSSAPS-LL2024001670$FR-OTSUKA-2024_025032$OTSUKA$$45$YR$$M$Y$$$20240920$$MD$FR$FR
243170634$24317063$4$F$20240831$20240920$20240913$20240923$PER$$US-BAYER-2024A130855$BAYER$$53$YR$A$F$Y$$$20240923$$CN$US$US
243170641$24317064$1$I$$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181444$AMGEN$$$$$$Y$$$20240913$$MD$US$US
243170661$24317066$1$I$$20240830$20240913$20240913$EXP$$DE-QUAGEN-2024QUALIT00253$QUAGEN PHARMACEUTICALS$N Dyballa.A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting-clinical, toxicological and forensic aspects.Forensic Science, Medicine, and Pathology .AUG-2024$12$WK$I$M$Y$$$20240913$$HP$DE$DE
243170671$24317067$1$I$20220101$20240909$20240913$20240913$EXP$$US-AMERICAN REGENT INC-2024003457$AMERICAN REGENT$$$$E$F$Y$$$20240913$$CN$US$US
243170681$24317068$1$I$20150707$20240910$20240913$20240913$EXP$$FR-SANDOZ INC.-PHHY2016FR186033$SANDOZ$$44$YR$$M$Y$$$20240913$$MD$FR$FR
243170691$24317069$1$I$$20240905$20240913$20240913$EXP$$US-GSK-US2024AMR111128$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243170701$24317070$1$I$20240909$20240911$20240913$20240913$EXP$$US-VIIV HEALTHCARE LIMITED-US2024113050$VIIV$$35$YR$$M$Y$$$20240913$$CN$US$US
243170711$24317071$1$I$20240301$20240618$20240913$20240913$30DAY$$AR-PFIZER INC-202400196885$PFIZER$$10$YR$$M$Y$$$20240913$$CN$AR$AR
243170721$24317072$1$I$$20240909$20240913$20240913$EXP$$CA-ROCHE-10000076878$ROCHE$$27$YR$A$M$Y$$$20240913$$HP$CA$CA
243170741$24317074$1$I$20240909$20240912$20240912$20240912$DIR$718180$$FDA-CTU$$53$YR$$M$N$100.35$KG$20240912$N$MD$US$
243170751$24317075$1$I$$20240909$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143572$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$96.16$KG$20240913$$CN$US$US
243170761$24317076$1$I$$20240912$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145770$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240913$$PH$US$US
243170771$24317077$1$I$$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-62962$$FDA-CTU$$$$$F$N$$$20240912$N$HP$US$
243170782$24317078$2$F$20240817$20240916$20240913$20240925$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005017$SAREPTA THERAPEUTICS$$5$YR$$M$Y$20.3$KG$20240925$$CN$US$US
243170792$24317079$2$F$$20240903$20240913$20240914$EXP$$KR-ROCHE-10000079031$ROCHE$Kim J, Kim J. Short-term outcomes of faricimab for neovascular age-related macular degeneration with limited response to ranibizumab or aflibercept.. JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY. 2024;65 (8):515-24. doi:10.3341/jkos.2024.65.8.515..$83$YR$E$$Y$$$20240914$$HP$KR$KR
243170801$24317080$1$I$$20240910$20240913$20240913$PER$$US-JNJFOC-20240924823$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243170811$24317081$1$I$20240101$20240831$20240913$20240913$EXP$$GB-UCBSA-2024038757$UCB$$$$$F$Y$$$20240913$$CN$GB$GB
243170821$24317082$1$I$$20240830$20240913$20240913$EXP$$US-UCBSA-2024044612$UCB$$$$$M$Y$$$20240913$$CN$US$US
243170831$24317083$1$I$20240912$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-62966$$FDA-CTU$$65$YR$$F$N$$$20240912$N$HP$US$
243170841$24317084$1$I$20231225$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-62961$$FDA-CTU$$$$$M$N$99.8$KG$20240912$N$$US$
243170851$24317085$1$I$$20240906$20240913$20240913$EXP$$BG-SANDOZ INC.-SDZ2024BG079734$SANDOZ$$64$YR$$F$Y$$$20240913$$MD$BG$BG
243170861$24317086$1$I$$20240909$20240913$20240913$PER$$US-VERTEX PHARMACEUTICALS-2024-014382$VERTEX$$$$$$Y$$$20240913$$CN$US$US
243170881$24317088$1$I$$20240910$20240913$20240913$EXP$$US-VERTEX PHARMACEUTICALS-2024-014440$VERTEX$$$$$$Y$$$20240913$$CN$US$US
243170901$24317090$1$I$$20240903$20240913$20240913$EXP$$SE-TEVA-VS-3176362$TEVA$$46$YR$$F$Y$$$20240913$$CN$SE$SE
243170911$24317091$1$I$20240904$20240909$20240913$20240913$EXP$$CN-ROCHE-10000077746$ROCHE$$63$YR$A$F$Y$71.5$KG$20240913$$HP$CN$CN
243170951$24317095$1$I$$20240910$20240913$20240913$EXP$$US-BAYER-2024A130106$BAYER$$70$YR$E$F$Y$$$20240913$$CN$US$US
243170962$24317096$2$F$$20240919$20240913$20240919$30DAY$$US-PFIZER INC-PV202400116346$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243170972$24317097$2$F$$20240924$20240913$20240927$30DAY$$US-PFIZER INC-PV202400072410$PFIZER$$$$$F$Y$$$20240927$$HP$US$US
243170981$24317098$1$I$$20240909$20240913$20240913$30DAY$$US-PFIZER INC-202400253150$PFIZER$$8$YR$$M$Y$$$20240913$$HP$US$US
243170992$24317099$2$F$$20240920$20240913$20240925$30DAY$$TR-PFIZER INC-202400248824$PFIZER$$$$$$Y$$$20240925$$PH$TR$TR
243171001$24317100$1$I$20240101$20240910$20240913$20240913$EXP$$CA-PFIZER INC-202400255033$PFIZER$$41$YR$$F$Y$$$20240913$$HP$CA$CA
243171011$24317101$1$I$$20240903$20240913$20240913$30DAY$$US-PFIZER INC-PV202400115804$PFIZER$$$$$$Y$$$20240913$$CN$US$US
243171021$24317102$1$I$20240101$20240906$20240913$20240913$EXP$$CA-PFIZER INC-202400223488$PFIZER$$14$YR$$M$Y$$$20240913$$MD$CA$CA
243171031$24317103$1$I$20240906$20240909$20240913$20240913$30DAY$$KR-PFIZER INC-PV202400118821$PFIZER$$$$$$Y$$$20240913$$CN$KR$KR
243171041$24317104$1$I$$20240910$20240913$20240913$30DAY$$DE-PFIZER INC-202400253607$PFIZER$$8$YR$$M$Y$25$KG$20240913$$CN$DE$DE
243171051$24317105$1$I$$20240909$20240913$20240913$30DAY$$US-PFIZER INC-PV202400117578$PFIZER$$$$$F$Y$$$20240913$$CN$US$US
243171062$24317106$2$F$20240801$20240918$20240913$20240923$EXP$$BR-SANDOZ INC.-SDZ2024BR079906$SANDOZ$$49$YR$$F$Y$72$KG$20240923$$CN$BR$BR
243171071$24317107$1$I$$20240911$20240913$20240913$PER$$US-ALXN-202409USA000795US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243171081$24317108$1$I$$20240910$20240913$20240913$PER$$US-HALEON-2196483$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
243171091$24317109$1$I$$20240910$20240913$20240913$EXP$$IE-MYLANLABS-2024M1082914$MYLAN$$$$$M$Y$$$20240913$$HP$IE$IE
243171101$24317110$1$I$20240911$20240911$20240913$20240913$EXP$GB-MHRA-MED-202409110854139840-CSDQP$GB-MYLANLABS-2024M1082971$MYLAN$$65$YR$$M$Y$78$KG$20240913$$CN$GB$GB
243171121$24317112$1$I$20240801$20240911$20240913$20240913$PER$$US-BIOGEN-2024BI01282180$BIOGEN$$41$YR$$F$Y$$$20240913$$CN$US$US
243171131$24317113$1$I$$20240911$20240913$20240913$EXP$$SE-ORGANON-O2409SWE000871$ORGANON$$$$$F$Y$$$20240913$$MD$SE$SE
243171141$24317114$1$I$20240101$20240829$20240913$20240913$PER$$US-SA-2024SA261127$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240913$$MD$US$US
243171151$24317115$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA265345$SANOFI AVENTIS$$65$YR$E$$Y$$$20240913$$MD$US$US
243171171$24317117$1$I$20240101$20240820$20240913$20240913$PER$$US-SA-2024SA263440$SANOFI AVENTIS$$12$YR$T$F$Y$75$KG$20240913$$MD$US$US
243171181$24317118$1$I$$20240821$20240913$20240913$PER$$US-SA-2024SA264430$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$MD$US$US
243171191$24317119$1$I$20240801$20240831$20240913$20240913$PER$$US-SA-2023SA331622$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240913$$MD$US$US
243171201$24317120$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA260564$SANOFI AVENTIS$$56$YR$A$$Y$$$20240913$$CN$US$US
243171211$24317121$1$I$$20240821$20240913$20240913$PER$$US-SA-2024SA263384$SANOFI AVENTIS$$$$A$M$Y$$$20240913$$MD$US$US
243171221$24317122$1$I$$20240821$20240913$20240913$PER$$US-SA-2024SA264437$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240913$$HP$US$US
243171231$24317123$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263496$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240913$$HP$US$US
243171241$24317124$1$I$20240101$20240826$20240913$20240913$PER$$US-SA-2024SA262881$SANOFI AVENTIS$$84$YR$E$F$Y$66.64$KG$20240913$$MD$US$US
243171251$24317125$1$I$$20240822$20240913$20240913$PER$$US-SA-2024SA264378$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240913$$MD$US$US
243171262$24317126$2$F$20240101$20240914$20240913$20240921$EXP$$US-ABBVIE-5918178$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243171271$24317127$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62971$$FDA-CTU$$76$YR$$F$N$255$LBS$20240913$N$$US$
243171281$24317128$1$I$20240701$20240822$20240913$20240913$PER$$US-SA-2024SA263070$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240913$$MD$US$US
243171291$24317129$1$I$20240616$20240903$20240913$20240913$PER$$US-SA-2024SA263250$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240913$$MD$US$US
243171311$24317131$1$I$20240902$20240904$20240913$20240913$PER$$US-SA-2024SA262954$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240913$$CN$US$US
243171321$24317132$1$I$$20240913$20240913$20240913$DIR$718241$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243171331$24317133$1$I$20240701$20240904$20240913$20240913$PER$$US-SA-2024SA263660$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240913$$HP$US$US
243171341$24317134$1$I$20240101$20240903$20240913$20240913$EXP$$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-08444$HIKMA$$41$YR$$F$Y$$$20240913$$MD$GB$GB
243171351$24317135$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62974$$FDA-CTU$$79$YR$$M$N$$$20240913$N$$US$
243171361$24317136$1$I$20240912$20240913$20240913$20240913$DIR$718245$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243171371$24317137$1$I$20240101$20240905$20240913$20240913$PER$$US-SA-2024SA263463$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240913$$CN$US$US
243171381$24317138$1$I$20240823$20240904$20240913$20240913$PER$$US-SA-2024SA263553$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240913$$HP$US$US
243171391$24317139$1$I$20240701$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-62968$$FDA-CTU$$75$YR$$F$N$$$20240912$N$HP$US$
243171401$24317140$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA264477$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240913$$MD$US$US
243171411$24317141$1$I$20240912$20240913$20240913$20240913$DIR$718246$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243171421$24317142$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62975$$FDA-CTU$$68$YR$$F$N$$$20240913$N$$US$
243171431$24317143$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA265218$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240913$$CN$US$US
243171441$24317144$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA262942$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240913$$HP$US$US
243171451$24317145$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA263530$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240913$$HP$US$US
243171461$24317146$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62977$$FDA-CTU$$60$YR$$F$N$$$20240913$N$$US$
243171471$24317147$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263905$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240913$$HP$US$US
243171481$24317148$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA262932$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240913$$MD$US$US
243171491$24317149$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA263166$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$HP$US$US
243171501$24317150$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264212$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$MD$US$US
243171511$24317151$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263886$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240913$$HP$US$US
243171531$24317153$1$I$20240829$20240904$20240913$20240913$PER$$US-SA-2024SA264509$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240913$$CN$US$US
243171541$24317154$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA262934$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240913$$MD$US$US
243171551$24317155$1$I$$20240904$20240913$20240913$PER$$US-SA-2023SA370446$SANOFI AVENTIS$$10$YR$C$F$Y$34.014$KG$20240913$$MD$US$US
243171561$24317156$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA263658$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240913$$HP$US$US
243171571$24317157$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA265231$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240913$$CN$US$US
243171581$24317158$1$I$20240701$20240904$20240913$20240913$PER$$US-SA-2024SA263584$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240913$$HP$US$US
243171591$24317159$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA263088$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240913$$MD$US$US
243171601$24317160$1$I$20240901$20240905$20240913$20240913$PER$$US-SA-2024SA263610$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240913$$HP$US$US
243171611$24317161$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA263576$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240913$$HP$US$US
243171621$24317162$1$I$20240801$20240905$20240913$20240913$PER$$US-SA-2024SA084118$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240913$$HP$US$US
243171631$24317163$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264358$SANOFI AVENTIS$$$$C$M$Y$$$20240913$$MD$US$US
243171641$24317164$1$I$20240101$20240910$20240913$20240913$PER$$US-SA-2024SA264875$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$HP$US$US
243171651$24317165$1$I$$20240906$20240913$20240913$PER$$US-SA-2024SA265087$SANOFI AVENTIS$$$$E$F$Y$$$20240913$$MD$US$US
243171661$24317166$1$I$20240101$20240905$20240913$20240913$PER$$US-SA-2024SA191172$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240913$$MD$US$US
243171671$24317167$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264170$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240913$$HP$US$US
243171681$24317168$1$I$20240801$20240906$20240913$20240913$PER$$US-SA-2024SA264186$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240913$$MD$US$US
243171691$24317169$1$I$20240801$20240905$20240913$20240913$PER$$US-SA-2024SA253977$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240913$$HP$US$US
243171701$24317170$1$I$20240101$20240905$20240913$20240913$PER$$US-SA-2024SA263647$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240913$$MD$US$US
243171711$24317171$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264069$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240913$$HP$US$US
243171721$24317172$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA263232$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$MD$US$US
243171731$24317173$1$I$20240530$20240904$20240913$20240913$PER$$US-AstraZeneca-2024A185181$ASTRAZENECA$$23498$DY$$F$Y$88.5$KG$20240913$$MD$US$
243171741$24317174$1$I$$20240912$20240913$20240913$PER$$US-ABBVIE-5921739$ABBVIE$$$$$M$Y$$$20240913$$HP$US$US
243171751$24317175$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263103$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240913$$HP$US$US
243171762$24317176$2$F$$20240911$20240913$20240920$PER$$US-SA-2024SA263850$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240920$$MD$US$US
243171771$24317177$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA255238$SANOFI AVENTIS$$55$YR$A$$Y$$$20240913$$MD$US$US
243171781$24317178$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62973$$FDA-CTU$$38$YR$$F$N$66.68$KG$20240913$N$$US$
243171791$24317179$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263411$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240913$$HP$US$US
243171801$24317180$1$I$$20240903$20240913$20240913$30DAY$$US-PFIZER INC-PV202400115758$PFIZER$$$$$$Y$$$20240913$$HP$US$US
243171811$24317181$1$I$20240907$20240909$20240913$20240913$30DAY$$KR-PFIZER INC-PV202400118268$PFIZER$$12$YR$$F$Y$$$20240913$$CN$KR$KR
243171822$24317182$2$F$20240909$20240910$20240913$20240919$30DAY$$US-PFIZER INC-202400254018$PFIZER$$7$YR$$F$Y$$$20240919$$CN$US$US
243171832$24317183$2$F$$20240912$20240913$20240924$EXP$$JP-ROCHE-10000077729$ROCHE$$62$YR$A$M$Y$$$20240924$$PH$JP$JP
243171841$24317184$1$I$20240908$20240912$20240912$20240912$DIR$718211$$FDA-CTU$$41$YR$$M$N$124.2$KG$20240912$N$CN$US$
243171851$24317185$1$I$20240912$20240912$20240912$20240912$DIR$718213$$FDA-CTU$$$$$F$N$$$20240912$Y$CN$US$
243171861$24317186$1$I$20240101$20240528$20240913$20240913$PER$$US-SPECGX-T202401216$SPECGX$$$$$F$Y$$$20240913$$PH$US$US
243171871$24317187$1$I$20240902$20240910$20240913$20240913$EXP$$US-BAYER-2024A130373$BAYER$$13$YR$T$M$Y$$$20240913$$CN$US$US
243171881$24317188$1$I$20240501$20240617$20240913$20240913$PER$$US-SPECGX-T202401248$SPECGX$$34$YR$$F$Y$79$KG$20240913$$CN$US$US
243171891$24317189$1$I$$20240903$20240913$20240913$EXP$$DE-AMAROX PHARMA-AMR2024DE02956$HETERO$$7$MON$$F$Y$$$20240913$$MD$DE$DE
243171901$24317190$1$I$20240420$20240912$20240912$20240912$DIR$718159$$FDA-CTU$$60$YR$$F$N$78.75$KG$20240912$N$CN$US$
243171911$24317191$1$I$20240701$20240801$20240913$20240913$PER$$US-SPECGX-T202401695$SPECGX$$$$$F$Y$$$20240913$$HP$US$US
243171921$24317192$1$I$20240601$20240627$20240913$20240913$PER$$US-SPECGX-T202401471$SPECGX$$$$$F$Y$$$20240913$$CN$US$US
243171931$24317193$1$I$20240624$20240729$20240913$20240913$PER$$US-SPECGX-T202401640$SPECGX$$34$YR$$M$Y$$$20240913$$CN$US$US
243171941$24317194$1$I$20240601$20240717$20240913$20240913$EXP$$US-SPECGX-T202401557$SPECGX$$$$$F$Y$$$20240913$$PH$US$US
243171951$24317195$1$I$20240601$20240624$20240913$20240913$PER$$US-SPECGX-T202401412$SPECGX$$17$YR$$F$Y$48$KG$20240913$$CN$US$US
243171961$24317196$1$I$$20240805$20240913$20240913$PER$$US-SPECGX-T202401699$SPECGX$$$$$F$Y$$$20240913$$CN$US$US
243171971$24317197$1$I$20240701$20240719$20240913$20240913$PER$$US-SPECGX-T202401516$SPECGX$$30$YR$$M$Y$100$KG$20240913$$CN$US$US
243171981$24317198$1$I$$20240912$20240913$20240913$EXP$$CA-ACERUSPHRM-2024-CA-000741$ACERUS PHARMACEUTICALS$$33$YR$A$M$Y$$$20240913$$HP$CA$CA
243171991$24317199$1$I$$20240905$20240913$20240913$PER$$US-ROCHE-10000074654$ROCHE$Doumeth S, Petrinec E, Chaudhary H, Mattar M. Anti-PL-12 anti-synthetase syndrome manifesting with multiple digital ischemia: Case report + review of the literature. Clinical Case Reports. 2024-Sep;12 (9):1-9. doi:10.1002/ccr3.9408.$61$YR$A$M$Y$$$20240913$$HP$US$US
243172001$24317200$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MIDB-f9d1d433-ca26-4b1c-b9f6-259fb22fcece$GB-TEVA-VS-3240554$TEVA$$37$YR$$$Y$$$20240913$$PH$GB$GB
243172011$24317201$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144997$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$80.29$KG$20240913$$CN$US$US
243172021$24317202$1$I$$20240911$20240913$20240913$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-145161$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$53.98$KG$20240913$$CN$PR$PR
243172031$24317203$1$I$20240904$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145430$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240913$$HP$US$US
243172041$24317204$1$I$$20240905$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142316$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240913$$CN$US$US
243172051$24317205$1$I$$20240909$20240913$20240913$EXP$$US-ABBVIE-5917006$ABBVIE$$$$$$Y$$$20240913$$CN$US$US
243172061$24317206$1$I$20240821$20240911$20240913$20240913$EXP$GB-MHRA-MED-202409112330154860-CKLNB$GB-MYLANLABS-2024M1083228$MYLAN$$43$YR$$F$Y$120$KG$20240913$$CN$GB$GB
243172081$24317208$1$I$$20240912$20240913$20240913$EXP$$AU-MYLANLABS-2024M1083177$MYLAN$$$$$M$Y$$$20240913$$PH$AU$AU
243172091$24317209$1$I$$20240906$20240913$20240913$EXP$$US-JNJFOC-20240915590$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$PH$US$US
243172101$24317210$1$I$$20240909$20240913$20240913$EXP$$US-JNJFOC-20240926280$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243172111$24317211$1$I$20240810$20240905$20240913$20240913$EXP$$GB-OTSUKA-2024_025144$OTSUKA$$59$YR$$M$Y$$$20240913$$MD$GB$GB
243172122$24317212$2$F$$20240904$20240913$20240913$PER$$US-ROCHE-10000074731$ROCHE$$81$YR$E$F$Y$$$20240913$$CN$US$US
243172131$24317213$1$I$$20240903$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141523$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240913$$MD$US$US
243172151$24317215$1$I$$20240907$20240913$20240913$EXP$$IN-ROCHE-10000077545$ROCHE$$64$YR$A$M$Y$$$20240913$$CN$IN$IN
243172161$24317216$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MED-202409040947158170-NQVRW$GB-TEVA-VS-3240565$TEVA$$$$$F$Y$$$20240913$$PH$GB$GB
243172171$24317217$1$I$20240809$20240910$20240913$20240913$EXP$$US-BAYER-2024A130641$BAYER$$57$YR$A$F$Y$$$20240913$$CN$US$US
243172181$24317218$1$I$$20240905$20240913$20240913$EXP$$US-SA-2024SA265161$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240913$$MD$US$US
243172191$24317219$1$I$$20240912$20240913$20240913$EXP$$CN-PFIZER INC-202400256144$PFIZER$$$$$$Y$$$20240913$$MD$CN$CN
243172201$24317220$1$I$$20240912$20240913$20240913$EXP$$CN-PFIZER INC-202400255574$PFIZER$$$$$$Y$$$20240913$$MD$CN$CN
243172211$24317221$1$I$$20240903$20240913$20240913$30DAY$$US-GSK-US2024AMR110504$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$CN$US$US
243172222$24317222$2$F$$20240917$20240913$20240923$EXP$$US-BAYER-2024A130629$BAYER$$69$YR$E$F$Y$57.143$KG$20240923$$HP$US$US
243172231$24317223$1$I$20240802$20240912$20240913$20240913$EXP$$CN-PFIZER INC-PV202400120060$PFIZER$$72$YR$$F$Y$49.6$KG$20240913$$HP$CN$CN
243172241$24317224$1$I$20240601$20240913$20240913$20240913$EXP$$TH-PFIZER INC-PV202400120398$PFIZER$$$$$$Y$$$20240913$$CN$TH$TH
243172261$24317226$1$I$$20240911$20240913$20240913$EXP$$US-PFIZER INC-202400255554$PFIZER$$80$YR$$F$Y$$$20240913$$CN$US$US
243172271$24317227$1$I$$20240912$20240913$20240913$EXP$$CN-PFIZER INC-202400256149$PFIZER$$$$$$Y$$$20240913$$MD$CN$CN
243172282$24317228$2$F$20240422$20240925$20240913$20240930$EXP$$IQ-ROCHE-10000074682$ROCHE$$61$YR$A$M$Y$$$20240930$$MD$IQ$IQ
243172291$24317229$1$I$$20240909$20240913$20240913$EXP$$ME-ROCHE-10000077860$ROCHE$Roganovic M, Perunicic S, Erakovic J, Radulovic L, Milikic D, Vujovic B, et al. Efficacy and safety profile of ocrelizumab in primary progressive multiple sclerosis patients from Montenegro (Abstract no. EPO-192). 10th Congress of the European Academy of Neurology (EAN). 2024;118.$$$$$Y$$$20240913$$HP$ME$ME
243172301$24317230$1$I$$20240910$20240913$20240913$EXP$$US-JNJFOC-20240927642$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243172321$24317232$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145100$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240913$$CN$US$US
243172331$24317233$1$I$20240912$20240912$20240912$20240912$DIR$718194$$FDA-CTU$$29$YR$$F$N$$$20240912$Y$PH$US$
243172341$24317234$1$I$20240912$20240913$20240913$20240913$DIR$718248$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243172351$24317235$1$I$$20240904$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013191$DR REDDYS$$58$YR$E$$Y$$$20240913$$CN$US$US
243172361$24317236$1$I$$20240904$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0012973$DR REDDYS$$36$YR$A$M$Y$$$20240913$$HP$US$US
243172371$24317237$1$I$20240821$20240905$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013271$DR REDDYS$$26$YR$A$F$Y$$$20240913$$HP$US$US
243172381$24317238$1$I$20240829$20240912$20240912$20240912$DIR$718196$$FDA-CTU$$73$YR$$M$N$75$KG$20240912$N$PH$US$
243172391$24317239$1$I$20240904$20240912$20240912$20240912$DIR$718185$$FDA-CTU$$60$YR$$F$N$64$KG$20240912$N$PH$US$
243172401$24317240$1$I$$20240904$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013190$DR REDDYS$$20$YR$A$$Y$$$20240913$$HP$US$US
243172441$24317244$1$I$$20240909$20240913$20240913$EXP$$US-MYLANLABS-2024M1083583$MYLAN$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.$20$YR$$F$Y$$$20240913$$MD$US$US
243172451$24317245$1$I$$20240903$20240913$20240913$EXP$$PT-Accord-445979$ACCORD$Costa LF, Morgado C, Alves JN, Machado C, Ferreira C. EP-012-HEMOLYSIS AND THROMBOCYTOPENIA AFTER LEVETIRACETAM: WHEN THE PATIENT GIVES US A YELLOW CARD. Sinapse. 2023 Dec;23(Suppl 1).$82$YR$E$M$Y$$$20240913$$HP$PT$PT
243172461$24317246$1$I$$20240903$20240913$20240913$EXP$$US-RADIUS HEALTH INC.-2024US006748$RADIUS PHARM$$76$YR$$F$Y$$$20240913$$CN$US$US
243172471$24317247$1$I$$20240831$20240913$20240913$EXP$$GB-B.Braun Medical Inc.-2161546$B BRAUN$$48$YR$$F$Y$$$20240913$$$GB$GB
243172481$24317248$1$I$20240101$20240911$20240913$20240913$EXP$$NVSC2024ZA097922$NOVARTIS$$58$YR$$F$Y$$$20240913$$HP$ZA$ZA
243172492$24317249$2$F$20240820$20240919$20240913$20240920$PER$$US-AMGEN-USASP2024182848$AMGEN$$$$A$F$Y$$$20240920$$PH$US$US
243172502$24317250$2$F$20240910$20240924$20240913$20240925$PER$$US-AMGEN-USASP2024183211$AMGEN$$77$YR$E$F$Y$$$20240925$$CN$US$US
243172511$24317251$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409006573$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240913$$CN$US$US
243172521$24317252$1$I$20240627$20240903$20240913$20240913$30DAY$$US-PFIZER INC-PV202400115834$PFIZER$$$$$$Y$$$20240913$$HP$US$US
243172531$24317253$1$I$$20240903$20240913$20240913$30DAY$$US-PFIZER INC-PV202400115698$PFIZER$$$$$$Y$$$20240913$$CN$US$US
243172541$24317254$1$I$$20240910$20240913$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014723$JAZZ$$$$$M$Y$$$20240913$$CN$US$US
243172551$24317255$1$I$20240801$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144938$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240913$$CN$US$US
243172561$24317256$1$I$$20240905$20240913$20240913$30DAY$$US-GSK-US2024110819$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243172571$24317257$1$I$$20240903$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005263$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243172581$24317258$1$I$20240101$20240905$20240913$20240913$PER$$US-SA-2024SA264241$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240913$$CN$US$US
243172591$24317259$1$I$20240815$20240912$20240912$20240912$DIR$718214$$FDA-CTU$$77$YR$$M$N$$$20240912$Y$MD$US$
243172601$24317260$1$I$$20240910$20240913$20240913$EXP$$US-AstraZeneca-2024A206483$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243172611$24317261$1$I$$20240912$20240913$20240913$EXP$$US-AstraZeneca-2024A208804$ASTRAZENECA$$$$$M$Y$$$20240913$$MD$US$
243172622$24317262$2$F$$20240910$20240913$20240919$EXP$$GB-TEVA-VS-3241671$TEVA$$$$$$Y$$$20240919$$HP$GB$GB
243172631$24317263$1$I$20240811$20240910$20240913$20240913$EXP$FR-AFSSAPS-CN2024000839$FR-OTSUKA-2024_025361$OTSUKA$$16$YR$$M$Y$$$20240913$$MD$FR$FR
243172641$24317264$1$I$20240912$20240913$20240913$20240913$DIR$718255$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243172651$24317265$1$I$20240912$20240912$20240912$20240912$DIR$718186$$FDA-CTU$$83$YR$$M$N$$$20240912$N$PH$US$
243172661$24317266$1$I$$20240903$20240913$20240913$30DAY$$US-GSK-US2024109536$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$CN$US$US
243172671$24317267$1$I$20240801$20240903$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005272$ACADIA PHARMACEUTICALS$$65$YR$$F$Y$$$20240913$$CN$US$US
243172681$24317268$1$I$20240908$20240909$20240913$20240913$EXP$$VN-AstraZeneca-2024A207777$ASTRAZENECA$$25825$DY$$M$Y$$$20240913$$CN$VN$
243172691$24317269$1$I$$20240911$20240913$20240913$EXP$$KR-AstraZeneca-2024A208453$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$KR$
243172701$24317270$1$I$$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-62972$$FDA-CTU$$$$$F$N$$$20240912$N$HP$US$
243172711$24317271$1$I$20240502$20240911$20240913$20240913$EXP$$KR-AstraZeneca-2024A208385$ASTRAZENECA$$947$MON$$M$Y$$$20240913$$CN$KR$
243172721$24317272$1$I$$20240912$20240912$20240912$DIR$718190$$FDA-CTU$$$$$M$N$$$20240912$N$PH$US$
243172761$24317276$1$I$20240723$20240906$20240913$20240913$EXP$$US-PFIZER INC-202400075497$PFIZER$$48$YR$$F$Y$$$20240913$$MD$US$US
243172771$24317277$1$I$20231229$20240904$20240913$20240913$EXP$PT-INFARMED-R202408-666$PT-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-08356$HIKMA$$89$YR$$M$Y$$$20240913$$PH$PT$PT
243172781$24317278$1$I$20240801$20240830$20240913$20240913$PER$$US-SA-2024SA260935$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240913$$MD$US$US
243172791$24317279$1$I$20240601$20240904$20240913$20240913$PER$$US-SA-2024SA263117$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240913$$HP$US$US
243172801$24317280$1$I$20240701$20240904$20240913$20240913$PER$$US-SA-2024SA262960$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240913$$MD$US$US
243172811$24317281$1$I$20240101$20240905$20240913$20240913$EXP$FR-AFSSAPS-AVTO2024000124$FR-TEVA-VS-3240871$TEVA$$30$YR$$F$Y$$$20240913$$CN$FR$FR
243172833$24317283$3$F$20240911$20240919$20240913$20240920$PER$$US-AMGEN-USASP2024182125$AMGEN$$74$YR$E$F$Y$$$20240920$$HP$US$US
243172841$24317284$1$I$20240909$20240910$20240913$20240913$EXP$$MX-BAYER-2024A130989$BAYER$$32$YR$A$F$Y$76$KG$20240913$$HP$MX$MX
243172851$24317285$1$I$$20240904$20240913$20240913$EXP$$TR-MYLANLABS-2024M1081837$MYLAN$$61$YR$$M$Y$$$20240913$$CN$TR$TR
243172862$24317286$2$F$20240909$20240909$20240913$20240918$PER$$US-AMGEN-USASP2024180474$AMGEN$$79$YR$E$F$Y$$$20240917$$CN$US$US
243172872$24317287$2$F$20240516$20240916$20240913$20240927$EXP$$DE-ORG100014127-2024000250$HRA PHARMA$$40$YR$A$F$Y$$$20240927$$CN$DE$DE
243172881$24317288$1$I$$20240907$20240913$20240913$PER$$US-ROCHE-10000078561$ROCHE$$$$$F$Y$$$20240913$$CN$US$US
243172911$24317291$1$I$20240912$20240913$20240913$20240913$DIR$718252$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243172921$24317292$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA263180$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240913$$HP$US$US
243172931$24317293$1$I$20240904$20240904$20240913$20240913$PER$$US-SA-2024SA264296$SANOFI AVENTIS$$$$$F$Y$$$20240913$$CN$US$US
243172941$24317294$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264251$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240913$$HP$US$US
243172951$24317295$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA113186$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240913$$MD$US$US
243172961$24317296$1$I$$20240906$20240913$20240913$PER$$US-ROCHE-10000076928$ROCHE$$$$$$Y$$$20240913$$CN$US$US
243172972$24317297$2$F$$20240917$20240913$20240927$EXP$$CA-TEVA-VS-3240636$TEVA$$4$YR$$M$Y$$$20240927$$HP$CA$CA
243172981$24317298$1$I$$20240911$20240913$20240913$PER$$NVSC2024US182530$NOVARTIS$$$$$F$Y$$$20240913$$HP$US$US
243172991$24317299$1$I$$20240911$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA079535$SANDOZ$$50$YR$$M$Y$$$20240913$$CN$CA$CA
243173001$24317300$1$I$$20240908$20240913$20240913$EXP$$ES-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00473$VELOXIS PHARMACEUTICALS$$32$YR$$M$Y$$$20240913$$HP$ES$ES
243173011$24317301$1$I$$20240904$20240913$20240913$30DAY$$US-GSK-US2024110115$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$CN$US$US
243173031$24317303$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240683$TEVA$$46$YR$$M$Y$$$20240913$$PH$CA$CA
243173041$24317304$1$I$$20240903$20240913$20240913$PER$$US-ABBVIE-5909019$ABBVIE$$$$$$Y$$$20240913$$MD$US$US
243173051$24317305$1$I$$20240811$20240913$20240913$PER$$US-ROCHE-10000080407$ROCHE$$72$YR$E$F$Y$$$20240913$$MD$US$US
243173061$24317306$1$I$$20240912$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA079963$SANDOZ$$52$YR$$M$Y$$$20240913$$PH$CA$CA
243173071$24317307$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA263879$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240913$$CN$US$US
243173081$24317308$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240723$TEVA$$46$YR$$M$Y$$$20240913$$HP$CA$CA
243173091$24317309$1$I$20240101$20240906$20240913$20240913$EXP$$US-SA-2024SA265040$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240913$$HP$US$US
243173101$24317310$1$I$20240204$20240906$20240913$20240913$EXP$GB-MHRA-MED-202409060611077750-VQRYS$GB-SEPTODONT-2024018979$SEPTODONT$$61$YR$A$F$Y$$$20240913$$HP$GB$GB
243173111$24317311$1$I$$20240830$20240913$20240913$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467890$RANBAXY$$66$YR$$M$Y$80$KG$20240913$$MD$PL$PL
243173121$24317312$1$I$20220113$20240830$20240913$20240913$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467883$RANBAXY$$60$YR$$M$Y$$$20240913$$MD$IT$IT
243173131$24317313$1$I$20230426$20240830$20240913$20240913$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467893$RANBAXY$$67$YR$$M$Y$$$20240913$$MD$ES$ES
243173141$24317314$1$I$20240611$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467857$RANBAXY$$58$YR$$F$Y$60$KG$20240913$$MD$FR$FR
243173151$24317315$1$I$20230810$20240830$20240913$20240913$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467879$RANBAXY$$68$YR$$M$Y$$$20240913$$MD$IT$IT
243173171$24317317$1$I$20240219$20240830$20240913$20240913$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467891$RANBAXY$$61$YR$$F$Y$$$20240913$$MD$ES$ES
243173181$24317318$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62987$$FDA-CTU$$64$YR$$F$N$$$20240913$N$$US$
243173191$24317319$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62988$$FDA-CTU$$85$YR$$F$N$$$20240913$N$$US$
243173201$24317320$1$I$20200506$20240830$20240913$20240913$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467904$RANBAXY$$40$YR$$M$Y$80$KG$20240913$$MD$PL$PL
243173211$24317321$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240678$TEVA$$67$YR$$M$Y$$$20240913$$PH$CA$CA
243173221$24317322$1$I$$20240909$20240913$20240913$EXP$$US-ABBVIE-5917492$ABBVIE$$$$A$F$Y$71$KG$20240913$$CN$US$US
243173251$24317325$1$I$20240601$20240904$20240913$20240913$PER$$US-BEH-2024178299$CSL BEHRING$$69$YR$E$F$Y$59.864$KG$20240913$$CN$US$US
243173261$24317326$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240684$TEVA$$61$YR$$M$Y$$$20240913$$PH$CA$CA
243173271$24317327$1$I$20240801$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143123$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240913$$CN$US$US
243173281$24317328$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146057$BRISTOL MYERS SQUIBB$$27$YR$A$M$Y$$$20240913$$HP$US$US
243173291$24317329$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145948$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240913$$CN$US$US
243173301$24317330$1$I$20240715$20240910$20240913$20240913$EXP$CH-SM-2024-15795$CH-BAYER-2024A129818$BAYER$$66$YR$E$M$Y$$$20240913$$MD$CH$CH
243173311$24317331$1$I$$20240828$20240913$20240913$PER$$US-JNJFOC-20240876600$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$CN$US$US
243173321$24317332$1$I$20240825$20240905$20240913$20240913$EXP$$VN-SEPTODONT-2024018974$SEPTODONT$$49$YR$A$M$Y$70$KG$20240913$$PH$VN$VN
243173331$24317333$1$I$$20240903$20240913$20240913$EXP$$IR-MEITHEAL-2024MPLIT00279$MEITHEAL PHARMACEUTICALS$Abuotorabi-Zarchi M, et al. L.Late Onset MS and Challenging in Diagnosis and Treatment.Multiple Sclerosis and Related Disorders.DEC-2023;80 (1):09$77$YR$E$F$Y$$$20240912$$HP$IR$IR
243173341$24317334$1$I$$20240902$20240913$20240913$EXP$$CN-MEITHEAL-2024MPLIT00278$MEITHEAL PHARMACEUTICALS$Liao and Zhang.Severe sepsis induced by zoledronic acid A case report.Medicine.2024;103 (35):1-5$58$YR$A$F$Y$$$20240912$$HP$CN$CN
243173351$24317335$1$I$20240819$20240905$20240913$20240913$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08554$HIKMA$$16$YR$$M$Y$93.6$KG$20240913$$HP$US$US
243173361$24317336$1$I$20240905$20240911$20240913$20240913$EXP$$US-BAYER-2024A130744$BAYER$$78$YR$E$F$Y$$$20240913$$HP$US$US
243173372$24317337$2$F$20240816$20240920$20240913$20240925$EXP$$NVSC2024CH169537$NOVARTIS$$$$A$M$Y$$$20240925$$MD$CH$CH
243173381$24317338$1$I$20240820$20240906$20240913$20240913$EXP$$JP-009507513-2409JPN001180J$MERCK$$79$YR$$F$Y$$$20240913$$MD$JP$JP
243173391$24317339$1$I$$20240911$20240913$20240913$PER$$US-ALXN-202409USA000814US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243173401$24317340$1$I$20240912$20240912$20240913$20240913$PER$$US-HALEON-2196726$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
243173411$24317341$1$I$20240101$20240829$20240913$20240913$PER$$US-SA-2024SA260691$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240913$$MD$US$US
243173421$24317342$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA262348$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240913$$MD$US$US
243173431$24317343$1$I$20240429$20240830$20240913$20240913$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467537$RANBAXY$$70$YR$$F$Y$85$KG$20240913$$MD$GR$GR
243173441$24317344$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467785$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$22$YR$$M$Y$$$20240913$$MD$US$US
243173451$24317345$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467770$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$43$YR$$M$Y$$$20240913$$MD$US$US
243173461$24317346$1$I$20231130$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467840$RANBAXY$$71$YR$$M$Y$$$20240913$$PH$FR$FR
243173471$24317347$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467784$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$53$YR$$F$Y$$$20240913$$MD$US$US
243173481$24317348$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467754$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$61$YR$$F$Y$$$20240913$$MD$US$US
243173491$24317349$1$I$$20240910$20240913$20240913$EXP$$CA-ROCHE-10000079655$ROCHE$$$$A$F$Y$$$20240913$$CN$CA$CA
243173501$24317350$1$I$$20240830$20240913$20240913$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467821$RANBAXY$Gazit I, Wussuki-Lior O, Tauber T, Morad Y. Systemic Treatment With Cyclosporine A in Children. Cornea. 2024;0 (0):1-4$4$YR$$M$Y$$$20240913$$MD$IL$IL
243173511$24317351$1$I$$20240830$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467896$RANBAXY$Veligratli F, Alexandrou D, Shah S, Amin R, Dattani M, Gan H-W et al. Tolvaptan and urea in paediatric hyponatraemia. Pediatr Nephrol. 2024;39:177-183$5$MON$$F$Y$$$20240913$$HP$GB$GB
243173521$24317352$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467771$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$50$YR$$F$Y$$$20240913$$MD$US$US
243173531$24317353$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467961$RANBAXY$Patel AV, Morgan SL, Green R, Danila MI, Merriman TR, Wanzeck K, et al. Vitamin B12 status and hyperhomocysteinemia in patients with Rheumatoid arthritis treated with methotrexate and folic acid. Am J Med Sci. 2024;368 (1):33-39$$$$$Y$$$20240913$$HP$US$US
243173541$24317354$1$I$$20240830$20240913$20240913$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466956$RANBAXY$Pilotto C, Coassin E, Borsatti E, Tuniz F, Pegolo E, D^Agostini S, et al.. USING [18F]FET-PET/CT SCAN TO DIFFERENTIATE RADIONECROSIS FROM RECURRENCE/NEW TUMOURS: THE CASE OF A CNS SARCOMA. Neuro Oncology. 2024;26 (Sup.4):iv 107$5$YR$$F$Y$73.5$KG$20240913$$HP$IT$IT
243173551$24317355$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467767$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$57$YR$$F$Y$$$20240913$$MD$US$US
243173561$24317356$1$I$20240618$20240830$20240913$20240913$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467851$RANBAXY$$85$YR$$F$Y$$$20240913$$MD$SE$SE
243173571$24317357$1$I$20240512$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467644$RANBAXY$$18$YR$$F$Y$59.5$KG$20240913$$MD$FR$FR
243173582$24317358$2$F$$20240906$20240913$20240920$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467739$RANBAXY$Chelushkin DM, Sergeev AV, Malevanaya NV, Kurnosov AB, Arefiev AM, Shchubelko RV. The course of chronic cluster headache patient during virus-suppressive therapy of chronic recurrent herpes virus infection (Herpes simplex) with valacyclovir: case report. Rus J Pain. 2023;21 (2):33-37$27$YR$$M$Y$$$20240920$$HP$RU$RU
243173591$24317359$1$I$20240618$20240830$20240913$20240913$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467531$RANBAXY$$28$YR$$M$Y$82$KG$20240913$$MD$IT$IT
243173602$24317360$2$F$20231101$20240830$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467510$RANBAXY$$47$YR$$F$Y$80$KG$20240913$$CN$GB$GB
243173611$24317361$1$I$$20240830$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467678$RANBAXY$Jiajia J, Jia L, Wanlong W, Shuhui S, Xiaodong W, Shuang Y. Tocilizumab Treatment in a Patient of Refractory Anti-EJ Positive ASyS: A Case Report. J Investig Med High Impact Case Rep. 2024;12:1-3$39$YR$$F$Y$$$20240913$$HP$CN$CN
243173621$24317362$1$I$$20240830$20240913$20240913$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467640$RANBAXY$$41$YR$$F$Y$$$20240913$$MD$ES$ES
243173631$24317363$1$I$$20240830$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467804$RANBAXY$$16$YR$$M$Y$$$20240913$$CN$GB$GB
243173641$24317364$1$I$$20240830$20240913$20240913$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467704$RANBAXY$Sayed J, Nasir A, Sayed AG, Alghamdi OA, Alsharif EJ. A case report of MoCD etiology in a neonate A novel homozygous MoCS2 variant. Clin Case Rep. 2024;12 (7)$$$N$M$Y$$$20240913$$HP$SA$SA
243173651$24317365$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467776$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$57$YR$$F$Y$$$20240913$$MD$US$US
243173661$24317366$1$I$20240907$20240910$20240913$20240913$PER$$US-AMGEN-USASP2024181173$AMGEN$$82$YR$E$F$Y$$$20240913$$PH$US$US
243173671$24317367$1$I$$20240906$20240913$20240913$PER$$US-AMGEN-USASP2024182758$AMGEN$$$$$M$Y$$$20240913$$CN$US$US
243173681$24317368$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467769$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$55$YR$$F$Y$$$20240913$$MD$US$US
243173691$24317369$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62970$$FDA-CTU$$26$YR$$F$N$$$20240913$N$HP$US$
243173701$24317370$1$I$20230101$20240904$20240913$20240913$EXP$$CA-ABBVIE-5909843$ABBVIE$$73$YR$$F$Y$$$20240913$$CN$CA$CA
243173711$24317371$1$I$20240912$20240912$20240912$20240912$DIR$718174$$FDA-CTU$$39$YR$$F$N$99$KG$20240912$N$PH$US$
243173721$24317372$1$I$$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467823$RANBAXY$Reviron R, Joly E, Bertolotti A. Vitiligo treated with oral baricitinib and heliotherapy: A case series. Ann Dermatol Venereol. 2024;151:103300;1-3$53$YR$$F$Y$$$20240913$$HP$FR$FR
243173731$24317373$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62978$$FDA-CTU$$65$YR$$F$N$$$20240913$N$$US$
243173741$24317374$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467756$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$52$YR$$F$Y$$$20240913$$MD$US$US
243173751$24317375$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62989$$FDA-CTU$$54$YR$$F$N$$$20240913$N$$US$
243173761$24317376$1$I$$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-62964$$FDA-CTU$$$$$M$N$$$20240912$N$HP$US$
243173781$24317378$1$I$$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-62965$$FDA-CTU$$$$$F$N$$$20240912$N$HP$US$
243173791$24317379$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467789$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$26$YR$$M$Y$$$20240913$$MD$US$US
243173801$24317380$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467772$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$84$YR$$F$Y$$$20240913$$MD$US$US
243173811$24317381$1$I$$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-62976$$FDA-CTU$$$$$F$N$$$20240912$N$HP$US$
243173821$24317382$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467747$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$52$YR$$F$Y$$$20240913$$MD$US$US
243173831$24317383$1$I$$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467805$RANBAXY$Cohen E, Bozonnat A, Battistella M, Calvani J, Pennamen MDV, Rivet J, et al. Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib. J Eur Acad Dermatol Venereol. 2024;38:e32-e34$36$YR$$F$Y$$$20240913$$HP$FR$FR
243173841$24317384$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467790$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$76$YR$$F$Y$$$20240913$$MD$US$US
243173851$24317385$1$I$$20240830$20240913$20240913$PER$$US-ASTELLAS-2024-AER-004143$ASTELLAS$$$$$M$Y$$$20240913$$MD$US$US
243173861$24317386$1$I$$20240830$20240913$20240913$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467652$RANBAXY$Guney S, Durgunlu M, Sari S. Congenital malformation due to antiepileptic polytherapy: a case report. Psychopharmacology$$$$$Y$$$20240913$$HP$TR$TR
243173871$24317387$1$I$$20240830$20240913$20240913$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467568$RANBAXY$$33$YR$$F$Y$72$KG$20240913$$MD$PL$PL
243173881$24317388$1$I$20240826$20240830$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467690$RANBAXY$$$$$F$Y$$$20240913$$MD$GB$GB
243173891$24317389$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467783$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$62$YR$$F$Y$$$20240913$$MD$US$US
243173901$24317390$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467750$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$28$YR$$M$Y$$$20240913$$MD$US$US
243173911$24317391$1$I$$20240830$20240913$20240913$EXP$$MY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466947$RANBAXY$Weeraj C, Kannan B. Mesenteric Ischemia in a Patient on Levonorgestrel Containing Oral Contraception. J Obstet Gynaecol Can. 2024;46(10):102633, 1-2$44$YR$$F$Y$$$20240913$$MD$MY$MY
243173921$24317392$1$I$$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467827$RANBAXY$Reviron R, Joly E, Bertolotti A. Vitiligo treated with oral baricitinib and heliotherapy: A case series. Ann Dermatol Venereol. 2024;151:103300;1-3$39$YR$$M$Y$$$20240913$$HP$FR$FR
243173931$24317393$1$I$$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467824$RANBAXY$Reviron R, Joly E, Bertolotti A. Vitiligo treated with oral baricitinib and heliotherapy: A case series. Ann Dermatol Venereol. 2024;151:103300;1-3$66$YR$$M$Y$$$20240913$$HP$FR$FR
243173941$24317394$1$I$$20240830$20240913$20240913$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467744$RANBAXY$Demirok ZN. EROTOMANIC DELUSIONS AND TACTILE HALLUCINATIONS IN A LATE ADOLESCENT GIRL WITH SCHIZENCEPHALY. Psychiatr Danub. 2024;36(2):259-261$19$YR$$F$Y$$$20240913$$HP$TR$TR
243173951$24317395$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467763$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$44$YR$$M$Y$$$20240913$$MD$US$US
243173961$24317396$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467723$RANBAXY$Eakes J, Moore S, Hennessy K, Lin A. Naltrexone-induced acute generalized exanthematous pustulosis. JAAD Case Rep. 2023;Sep; 39:115-117$55$YR$$F$Y$$$20240913$$HP$US$US
243173971$24317397$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467773$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$60$YR$$F$Y$$$20240913$$MD$US$US
243173981$24317398$1$I$$20240830$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467645$RANBAXY$Long S, Tang P, Ouyang P, Liao X, Xie L. A Case Report of a Rare Pulmonary Opportunistic Infection in an Infant Caused by Tsukamurella tyrosinosolvens. Int Med Case Rep J. 2024;17 (0):725-731$2$MON$$F$Y$$$20240913$$HP$CN$CN
243173991$24317399$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467759$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$28$YR$$F$Y$$$20240913$$MD$US$US
243174001$24317400$1$I$$20240830$20240913$20240913$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465457$RANBAXY$Garcia M, Albizua Madariaga I, Sainz-Gil M, Lertxundi U. Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database. Br J Clin Pharmacol. 2024;90 (7):1751-1755$$$$$Y$$$20240913$$HP$ES$ES
243174011$24317401$1$I$$20240830$20240913$20240913$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467734$RANBAXY$Heimann AF, Gautier E, Schwab JM, Wahl P, Tannast M, Levrat E, et al. Metallosis-Induced Warm Antibody Auto-Immune  Hemolytic Anemia After Bilateral, Large-Diameter Metal-on-Metal Total Hip Arthroplasty With Complete Remission After Revision. Arthroplast Today. 2024;29:101471 (1-6)$36$YR$$F$Y$$$20240913$$MD$CH$CH
243174021$24317402$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467757$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$35$YR$$F$Y$$$20240913$$MD$US$US
243174031$24317403$1$I$$20240830$20240913$20240913$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467724$RANBAXY$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD Open. 2024;10 (3):e004381$9$YR$$M$Y$$$20240913$$HP$DE$DE
243174041$24317404$1$I$$20240830$20240913$20240913$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467717$RANBAXY$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD Open. 2024;10 (3):e004381$7$YR$$F$Y$$$20240913$$HP$DE$DE
243174051$24317405$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467703$RANBAXY$Asadi LK, Goldberg LH,Jih MH. Paradoxical Reaction to TNF-alpha Inhibitor Therapy in a Patient With Hidradenitis Suppurativa. CUTIS. 2023;112:E23-E25$38$YR$$F$Y$$$20240913$$HP$US$US
243174061$24317406$1$I$$20240830$20240913$20240913$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467733$RANBAXY$Yildirim R, Shikhaliyeva A, Icer H, Deveci H, Entok E, Uskudar Cansu D, et al. An underrecognized association: immune checkpoint inhibitor-related aortitis, a case report with the review of the literature. Int Canc Conf J. 2024;13:235-239$69$YR$$F$Y$$$20240913$$HP$TR$TR
243174071$24317407$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467768$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$59$YR$$F$Y$$$20240913$$MD$US$US
243174081$24317408$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466480$RANBAXY$$$$A$F$Y$$$20240913$$HP$US$US
243174091$24317409$1$I$$20240830$20240913$20240913$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467686$RANBAXY$Tsujino A, Nakajima A, Yabuta H, Sekioka J, Amano M, Fujimura S, et al. An Autopsy Case of Streptococcus dysgalactiae subsp. equisimilis Infectious Endocarditis Accompanied by Streptococcal Toxic Shock Syndrome. Intern Med. 2024;63:2209-2214$66$YR$$F$Y$75$KG$20240913$$HP$JP$JP
243174101$24317410$1$I$$20240903$20240913$20240913$EXP$$US-MYLANLABS-2024M1081856$MYLAN$Diaz MJ, Liu VY, Motaparthi K. Noninflammatory extrafacial edema as a clue to the diagnosis of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. JAAD-Case-Rep 2024; 47 96-98.$6$DEC$$M$Y$$$20240913$$MD$US$US
243174111$24317411$1$I$$20240902$20240913$20240913$EXP$$AE-GLENMARK PHARMACEUTICALS-2024GMK093934$GLENMARK$Al Naqbi AR, Yousuf K, Al Nuaimi N, Mehmood T, Kashiwagi D.. WHEN A RASH TAKES YOUR BREATH AWAY: A CASE OF ANTI-MDA5 DERMATOMYOSITIS.. European Journal of Case Reports in Internal Medicine.. 2024;11 Supplement 1:1064$$$$$Y$$$20240913$$HP$AE$AE
243174121$24317412$1$I$$20240902$20240913$20240913$EXP$$AU-RDY-SPO/AUS/24/0013028$DR REDDYS$Gardiner BJ, Ivulich SP, Snell GI. Voriconazole inhalation powder: A novel therapeutic alternative for invasive pulmonary fungal infections. Transplant Infectious Disease. 2024;26(3): doi:10.1111/tid.14264.$50$YR$A$M$Y$$$20240913$$HP$AU$AU
243174131$24317413$1$I$20240101$20240906$20240913$20240913$PER$$US-AMGEN-USASP2024178755$AMGEN$$62$YR$A$F$Y$$$20240913$$CN$US$US
243174151$24317415$1$I$20240903$20240912$20240913$20240913$EXP$$CN-BAYER-2024A130902$BAYER$$78$YR$E$F$Y$40$KG$20240913$$HP$CN$CN
243174161$24317416$1$I$$20240908$20240913$20240913$EXP$$CN-UNITED THERAPEUTICS-UNT-2024-028110$UNITED THERAPEUTICS$$29$YR$$F$Y$$$20240913$$$CN$CN
243174181$24317418$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010441$APOTEX$Ingole P, Morkas M, May R, Hinman B, Carrum G, Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$F$Y$$$20240913$$HP$US$US
243174192$24317419$2$F$20220801$20240911$20240913$20240913$PER$$US-ROCHE-10000080103$ROCHE$$74$YR$E$F$Y$76.2$KG$20240913$$CN$US$US
243174201$24317420$1$I$$20240823$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08551$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243174211$24317421$1$I$$20240716$20240913$20240913$PER$$US-KARYOPHARM-2024KPT001324$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240913$$CN$US$US
243174221$24317422$1$I$$20240717$20240913$20240913$PER$$US-KARYOPHARM-2024KPT001334$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240913$$HP$US$US
243174231$24317423$1$I$$20240829$20240913$20240913$PER$$US-ASTELLAS-2024-AER-003725$ASTELLAS$$$$$F$Y$$$20240913$$HP$US$US
243174241$24317424$1$I$$20240910$20240913$20240913$EXP$$GB-AstraZeneca-2024A205944$ASTRAZENECA$$$$C$$Y$$$20240913$$MD$GB$
243174251$24317425$1$I$20240201$20240820$20240913$20240913$EXP$$US-SA-2024SA264415$SANOFI AVENTIS$$$$E$F$Y$74.3$KG$20240913$$MD$US$US
243174271$24317427$1$I$20240515$20240913$20240913$20240913$DIR$718243$$FDA-CTU$$72$YR$$F$N$69.3$KG$20240913$N$CN$US$
243174281$24317428$1$I$$20240913$20240913$20240913$DIR$718253$$FDA-CTU$$$$$M$N$$$20240913$N$PH$US$
243174301$24317430$1$I$$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-62991$$FDA-CTU$$$$$F$N$$$20240912$N$HP$US$
243174321$24317432$1$I$$20240910$20240913$20240913$DIR$FDA-CDER-CTU-2024-62990$$FDA-CTU$$$$$F$N$$$20240910$N$HP$US$
243174331$24317433$1$I$20240719$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62992$$FDA-CTU$$86$YR$$F$N$$$20240913$N$$US$
243174341$24317434$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264248$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240913$$HP$US$US
243174351$24317435$1$I$$20240904$20240913$20240913$EXP$$SO-ROCHE-10000075075$ROCHE$$64$YR$A$F$Y$$$20240913$$CN$SO$SO
243174361$24317436$1$I$20240101$20240906$20240913$20240913$EXP$$US-SERVIER-S24011149$SERVIER$$$$$$Y$$$20240913$$CN$US$US
243174371$24317437$1$I$20240506$20240830$20240913$20240913$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467994$RANBAXY$$73$YR$$M$Y$$$20240913$$HP$ES$ES
243174381$24317438$1$I$20240326$20240830$20240913$20240913$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467929$RANBAXY$$88$YR$$M$Y$62.4$KG$20240913$$MD$ES$ES
243174391$24317439$1$I$20240610$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467956$RANBAXY$$42$YR$$F$Y$62$KG$20240913$$PH$FR$FR
243174401$24317440$1$I$$20240830$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467965$RANBAXY$$60$YR$$F$Y$88$KG$20240913$$MD$GB$GB
243174411$24317441$1$I$20240423$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467963$RANBAXY$$76$YR$$F$Y$$$20240913$$PH$FR$FR
243174421$24317442$1$I$$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467992$RANBAXY$$24$YR$$F$Y$$$20240913$$HP$FR$FR
243174431$24317443$1$I$20240101$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467985$RANBAXY$$67$YR$$F$Y$54$KG$20240913$$MD$FR$FR
243174441$24317444$1$I$$20240830$20240913$20240913$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-373379$RANBAXY$Rivolta F, Chiei Gallo A, Sangalli A, Pravettoni V. Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman post-vascular scaffolds implantation. Eur Ann Allergy Clin Immunol. 2024;56 (2):86-88$$$N$$Y$$$20240913$$HP$IT$IT
243174461$24317446$1$I$$20240830$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468112$RANBAXY$$19$YR$$F$Y$70$KG$20240913$$MD$GB$GB
243174471$24317447$1$I$$20240830$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468108$RANBAXY$$15$YR$$F$Y$$$20240913$$PH$GB$GB
243174481$24317448$1$I$20240609$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467990$RANBAXY$$80$YR$$M$Y$58$KG$20240913$$MD$FR$FR
243174491$24317449$1$I$$20240830$20240913$20240913$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467968$RANBAXY$$81$YR$$F$Y$$$20240913$$PH$GB$GB
243174501$24317450$1$I$$20240830$20240913$20240913$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464663$RANBAXY$Bulkowsteina Y, Nitzan?Luques A, Schnapp A, Barnoy A, Reif S, Gilboa T, et al.. The manifestations of metabolic acidosis during acetazolamide treatment in a cohort of pediatric idiopathic intracranial hypertension. Pediatr Nephrol. 2024;39:185-191$$$C$$Y$$$20240913$$HP$IL$IL
243174521$24317452$1$I$20230101$20240830$20240913$20240913$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467973$RANBAXY$$72$YR$$F$Y$94$KG$20240913$$CN$ES$ES
243174531$24317453$1$I$20240507$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467996$RANBAXY$$49$YR$$F$Y$51$KG$20240913$$CN$FR$FR
243174541$24317454$1$I$20240401$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467987$RANBAXY$$75$YR$$M$Y$64.5$KG$20240913$$MD$FR$FR
243174551$24317455$1$I$$20240830$20240913$20240913$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-410147$RANBAXY$Rodrigues LV, Roriz D, Seixas FS, Marinho S, Ferreira PR. A nephrogenic mechanism underlies dexmedetomidine-induced polyuria.A case report. Rev Esp Anestesiol Reanim. 2023;Online ahead of print$38$YR$$M$Y$98$KG$20240913$$HP$PT$PT
243174561$24317456$1$I$$20240830$20240913$20240913$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468036$RANBAXY$Masuda Y, Yamazaki S, Honda A, Masamoto Y, Kurokawa M. Isolated massive pleural effusion as a manifestation of chronic graft versus host disease successfully treated with corticosteroid. Ann Hematol. 2024;103(4):1403-1407$58$YR$$F$Y$$$20240913$$HP$JP$JP
243174571$24317457$1$I$$20240830$20240913$20240913$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468045$RANBAXY$Azumi H, Kubo M, Otani A, Ochi S, Kobayashi S, Miyataka Y. Patient with Adult T-cell Leukemia and Lung Infection Caused by Mycobacterium abscessus: Successful Treatment with Intensive Chemotherapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation. Intern Med. 2024;63(14):2069-2076$63$YR$$F$Y$$$20240913$$HP$JP$JP
243174581$24317458$1$I$20240614$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467911$RANBAXY$$93$YR$$M$Y$64.4$KG$20240913$$PH$FR$FR
243174591$24317459$1$I$20240626$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467849$RANBAXY$$72$YR$$F$Y$52$KG$20240913$$MD$FR$FR
243174601$24317460$1$I$$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467825$RANBAXY$Reviron R, Joly E, Bertolotti A. Vitiligo treated with oral baricitinib and heliotherapy: A case series. Ann Dermatol Venereol. 2024;151:103300;1-3$79$YR$$F$Y$$$20240913$$HP$FR$FR
243174611$24317461$1$I$$20240830$20240913$20240913$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467917$RANBAXY$Garcia M, Albizua Madariaga I, Sainz-Gil M, Lertxundi U. Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database. Br J Clin Pharmacol. 2024;90 (7):1751-1755$$$$$Y$$$20240913$$HP$ES$ES
243174621$24317462$1$I$$20240830$20240913$20240913$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-370661$RANBAXY$Rivolta F, Chiei Gallo A, Sangalli A, Pravettoni V. Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman post-vascular scaffolds implantation. Eur Ann Allergy Clin Immunol. 2024;Dec; 56(2):86-88$42$YR$$F$Y$$$20240913$$HP$IT$IT
243174631$24317463$1$I$$20240830$20240913$20240913$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467673$RANBAXY$Hsu JY, Lin YS, Huang LH, Wen WC Gao HW, Hsu CY, et al. A case report on the atypical metastatic pathway of prostate cancer to the kidney and stomach. Urol Case Rep. 2024;56 (0):102816(1-5)$73$YR$$M$Y$$$20240913$$HP$TW$TW
243174641$24317464$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467753$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$50$YR$$F$Y$$$20240913$$MD$US$US
243174651$24317465$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467780$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$56$YR$$F$Y$$$20240913$$MD$US$US
243174661$24317466$1$I$$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467728$RANBAXY$Pinana M, Rapoport C, Champtiaux N, Lescaille G, Allenbach Y, Rochefort J. Cytomegalovirus-induced oral ulcers: A case report and literature review. Clin Case Rep. 2023;11 (6):e7459/1-5$62$YR$$F$Y$$$20240913$$HP$FR$FR
243174671$24317467$1$I$$20240830$20240913$20240913$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467713$RANBAXY$Chandwani A, Sankar J, Dwivedi A, Sivasami K, Jain H, Goel N et al. Azathioprine-related alopecia totalis due to NUDT 15 mutation in a pregnant systemic lupus erythematosus patient with successful obstetric outcome. Rheumatology. 2024;00:1-2$28$YR$$F$Y$$$20240913$$HP$IN$IN
243174681$24317468$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467788$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$62$YR$$F$Y$$$20240913$$MD$US$US
243174691$24317469$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467777$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$77$YR$$M$Y$$$20240913$$MD$US$US
243174701$24317470$1$I$$20240830$20240913$20240913$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467797$RANBAXY$Binesh S L, Sukaash A J, Uvarajan T, Mathew K C. Functional Outcome of Steroid Injection in Plantar Fascitis: A Prospectiev Study. Res J Med Sci. 2024;18 (7):459?463$$$A$$Y$$$20240913$$HP$IN$IN
243174711$24317471$1$I$$20240830$20240913$20240913$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467799$RANBAXY$Binesh S L, Sukaash A J, Uvarajan T, Mathew K C. Functional Outcome of Steroid Injection in Plantar Fascitis: A Prospectiev Study. Res  J  Med Sci. 2024;18 (7):459?463$$$A$$Y$$$20240913$$HP$IN$IN
243174721$24317472$1$I$$20240830$20240913$20240913$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467721$RANBAXY$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD Open. 2024;10 (3):e004381$17$YR$$F$Y$$$20240913$$HP$DE$DE
243174731$24317473$1$I$$20240830$20240913$20240913$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467642$RANBAXY$Anandan S, Rajendran SS, Somarajan SA, Udayan A. A Very Rare Side Effect of a Very Commonly Used Drug: Pantoprazole-induced Seizure. J Assoc Physicians India. 2024;Aug;72 (8):89$69$YR$$F$Y$$$20240913$$HP$IN$IN
243174741$24317474$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467782$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$51$YR$$M$Y$$$20240913$$MD$US$US
243174751$24317475$1$I$$20240830$20240913$20240913$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465336$RANBAXY$Nagaoka M, Murata T, Nagamine T, Fujise N. Methylphenidate-Associated Creatine Kinase Level Elevation. Am J Ther. 2024;Jul/Aug, 31 (4):e498-e502$25$YR$$M$Y$$$20240913$$MD$JP$JP
243174761$24317476$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467786$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$64$YR$$F$Y$$$20240913$$MD$US$US
243174771$24317477$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467762$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$68$YR$$F$Y$$$20240913$$MD$US$US
243174781$24317478$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467730$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$45$YR$$F$Y$$$20240913$$MD$US$US
243174801$24317480$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467787$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$66$YR$$F$Y$$$20240913$$MD$US$US
243174811$24317481$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465918$RANBAXY$$$$$M$Y$$$20240913$$CN$US$US
243174821$24317482$1$I$20240822$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467694$RANBAXY$$82$YR$$M$Y$61.2$KG$20240913$$CN$US$KR
243174831$24317483$1$I$$20240830$20240913$20240913$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467725$RANBAXY$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD Open. 2024;10 (3):e004381$10$YR$$M$Y$$$20240913$$HP$DE$DE
243174841$24317484$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467779$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$80$YR$$F$Y$$$20240913$$MD$US$US
243174851$24317485$1$I$$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467803$RANBAXY$Cohen E, Bozonnat A, Battistella M, Calvani J, Pennamen MDV, Rivet J, et al. Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib. J Eur Acad Dermatol Venereol. 2024;38:e32?e34$47$YR$$M$Y$$$20240913$$HP$FR$FR
243174861$24317486$1$I$20240909$20240912$20240913$20240913$EXP$$JP-BAYER-2024A130929$BAYER$$57$YR$A$M$Y$$$20240913$$CN$JP$JP
243174871$24317487$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467745$RANBAXY$Ansari AN, Johnson EF, Wang KL, Koster MJ, Cantwell HM. SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing. JAAD Case Rep. 2024;Jan;43:57-5$50$YR$$M$Y$$$20240913$$MD$US$US
243174881$24317488$1$I$$20240830$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467764$RANBAXY$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J Am Acad Dermatol. 2024;Mar; 90(3):642-644$26$YR$$M$Y$$$20240913$$MD$US$US
243174891$24317489$1$I$20240822$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146013$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240913$$CN$US$US
243174901$24317490$1$I$20240812$20240909$20240913$20240913$EXP$FR-AFSSAPS-BS2024000603$FR-009507513-2409FRA003213$MERCK$$7$YR$$F$Y$27$KG$20240913$$MD$FR$FR
243174911$24317491$1$I$20240729$20240904$20240913$20240913$EXP$FR-AFSSAPS-RN2024000913$FR-TEVA-VS-3240460$TEVA$$50$YR$$F$Y$$$20240913$$MD$FR$FR
243174921$24317492$1$I$20201101$20240819$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004884$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240913$$CN$US$US
243174931$24317493$1$I$20240201$20240911$20240913$20240913$EXP$$US-ROCHE-10000080575$ROCHE$$59$YR$A$F$Y$99.79$KG$20240913$$CN$US$US
243174941$24317494$1$I$$20240911$20240913$20240913$EXP$$US-ROCHE-10000080361$ROCHE$$57$YR$A$F$Y$$$20240913$$CN$US$US
243174951$24317495$1$I$20240101$20240912$20240913$20240913$PER$$US-AMGEN-USASP2024182784$AMGEN$$$$$$Y$$$20240913$$CN$US$US
243174972$24317497$2$F$$20240918$20240913$20240925$PER$$US-ROCHE-10000069301$ROCHE$$$$A$F$Y$78.47$KG$20240925$$CN$US$US
243174981$24317498$1$I$20240907$20240911$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024113102$VIIV$$71$YR$$M$Y$$$20240913$$CN$US$US
243174991$24317499$1$I$$20240223$20240913$20240913$PER$$US-IDORSIA-007654-2024-US$IDORSIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243175001$24317500$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62994$$FDA-CTU$$6$YR$$M$N$$$20240913$N$$US$
243175011$24317501$1$I$20240911$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-62993$$FDA-CTU$$58$YR$$F$N$$$20240912$N$HP$US$
243175021$24317502$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA260381$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240913$$HP$US$US
243175031$24317503$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA181541$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240913$$MD$US$US
243175041$24317504$1$I$$20240909$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA079073$SANDOZ$$45$YR$$F$Y$95$KG$20240913$$HP$CA$CA
243175051$24317505$1$I$$20240905$20240913$20240913$DIR$FDA-CDER-CTU-2024-62995$$FDA-CTU$$$$$F$N$$$20240905$N$HP$US$
243175061$24317506$1$I$$20240819$20240913$20240913$DIR$FDA-CDER-CTU-2024-62996$$FDA-CTU$$$$$M$N$$$20240819$N$HP$US$
243175071$24317507$1$I$20240911$20240912$20240913$20240913$EXP$$TW-PFIZER INC-PV202400120157$PFIZER$$73$YR$$F$Y$$$20240913$$HP$TW$TW
243175081$24317508$1$I$20240904$20240912$20240913$20240913$EXP$$CN-PFIZER INC-PV202400120039$PFIZER$$4$YR$$F$Y$5.8$KG$20240913$$HP$CN$CN
243175091$24317509$1$I$20111101$20240911$20240913$20240913$EXP$$US-PFIZER INC-2011SGN00291$PFIZER$$38$YR$$F$Y$57.596$KG$20240913$$MD$US$US
243175101$24317510$1$I$$20240831$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467954$RANBAXY$Hennen M-A, Zhang V, Opler DJ. An unwelcome side-effect of trazodone use in a trans-male. Psychiatr Clin Neurosci. 2024;78 (6):376-378$24$YR$$M$Y$$$20240913$$MD$US$US
243175111$24317511$1$I$20240819$20240831$20240913$20240913$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466599$RANBAXY$$30$YR$$F$Y$62$KG$20240913$$HP$CN$CN
243175121$24317512$1$I$$20240831$20240913$20240913$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467856$RANBAXY$Andrade JA, Viana Junior AB, Holanda Moura SB, Gurgel Alves JA, Araujo Junior E, Carvalho FH. Using the algorithm of the Fetal Medicine Foundation to determine the cutoff point for prediction of pre-eclampsia in a Brazilian population. Minerva Obstet Gynecol. 2023;DEC; 75(6):503-11$$$$F$Y$$$20240913$$HP$BR$BR
243175131$24317513$1$I$20240323$20240830$20240913$20240913$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467418$RANBAXY$$52$YR$$M$Y$84$KG$20240913$$PH$FR$FR
243175141$24317514$1$I$$20240901$20240913$20240913$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466750$RANBAXY$$$$A$M$Y$$$20240913$$CN$US$US
243175151$24317515$1$I$$20240831$20240913$20240913$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467858$RANBAXY$Andrade JA, Viana Junior AB, Holanda Moura SB, Gurgel Alves JA, Araujo Junior E, Carvalho FH. Using the algorithm of the Fetal Medicine Foundation to determine the cutoff point for prediction of pre-eclampsia in a Brazilian population. Minerva Obstet Gynecol. 2023;75(6):503-11$$$$F$Y$$$20240913$$HP$BR$BR
243175161$24317516$1$I$$20240831$20240913$20240913$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467859$RANBAXY$Andrade JA, Viana Junior AB, Holanda Moura SB, Gurgel Alves JA, Araujo Junior E, Carvalho FH. Using the algorithm of the Fetal Medicine Foundation to determine the cutoff point for prediction of pre-eclampsia in a Brazilian population. Minerva Obstet Gynecol. 2023;75(6):503-11$$$$F$Y$$$20240913$$HP$BR$BR
243175171$24317517$1$I$$20240807$20240913$20240913$PER$$US-CSPC Ouyi Pharmaceutical Co., Ltd.-2161548$CSPC OUYI PHARMACEUTICAL$$41$YR$$M$Y$78.636$KG$20240913$$$US$US
243175181$24317518$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146075$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240913$$CN$US$US
243175191$24317519$1$I$20240701$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145299$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$94.5$KG$20240913$$HP$US$US
243175211$24317521$1$I$$20240904$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141428$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240913$$CN$US$US
243175221$24317522$1$I$$20240905$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142281$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240913$$CN$US$US
243175241$24317524$1$I$20240501$20240906$20240913$20240913$EXP$$US-ALKERMES INC.-ALK-2024-002346$ALKERMES$$59$YR$$M$Y$92.063$KG$20240913$$CN$US$US
243175251$24317525$1$I$20240101$20240902$20240913$20240913$EXP$$GB-UCBSA-2024045081$UCB$$$$$M$Y$$$20240913$$CN$GB$GB
243175262$24317526$2$F$$20240912$20240913$20240930$PER$$US-MYLANLABS-2024M1082774$MYLAN$$$$$M$Y$$$20240930$$CN$US$US
243175271$24317527$1$I$$20240902$20240913$20240913$EXP$$AU-RDY-SPO/AUS/24/0013140$DR REDDYS$Gardiner BJ, Ivulich SP, Snell GI. Voriconazole inhalation powder: A novel therapeutic alternative for invasive pulmonary fungal infections. Transplant Infectious Disease. 2024;26(3): doi:10.1111/tid.14264.$54$YR$A$F$Y$$$20240913$$HP$AU$AU
243175281$24317528$1$I$$20240911$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA079966$SANDOZ$$$$$M$Y$$$20240913$$MD$CA$CA
243175291$24317529$1$I$$20240909$20240913$20240913$EXP$$KR-ROCHE-10000078143$ROCHE$$$$$F$Y$$$20240913$$CN$KR$KR
243175301$24317530$1$I$$20240908$20240913$20240913$PER$$NVSC2024US182525$NOVARTIS$$70$YR$$F$Y$$$20240913$$MD$US$US
243175311$24317531$1$I$20240701$20240902$20240913$20240913$EXP$$GB-UCBSA-2024044880$UCB$$39$YR$$F$Y$$$20240913$$CN$GB$GB
243175321$24317532$1$I$$20240906$20240913$20240913$EXP$$US-GSK-US2024111295$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$US$US
243175332$24317533$2$F$20240201$20240918$20240913$20240927$PER$$US-GSK-US2024110143$GLAXOSMITHKLINE$$64$YR$$M$Y$$$20240927$$CN$US$US
243175341$24317534$1$I$20240908$20240909$20240913$20240913$EXP$$CA-ABBVIE-5917646$ABBVIE$$39$YR$$F$Y$$$20240913$$CN$CA$CA
243175351$24317535$1$I$20240701$20240911$20240913$20240913$PER$$GB-IDORSIA-008463-2024-GB$IDORSIA PHARMACEUTICALS$$69$YR$$F$Y$72$KG$20240913$$MD$GB$GB
243175361$24317536$1$I$20240902$20240909$20240913$20240913$EXP$$US-ABBVIE-5917459$ABBVIE$$56$YR$$F$Y$$$20240913$$CN$US$US
243175371$24317537$1$I$20240626$20240906$20240913$20240913$EXP$$JP-009507513-2409JPN001475J$MERCK$$75$YR$$M$Y$$$20240913$$MD$JP$JP
243175391$24317539$1$I$$20240828$20240913$20240913$30DAY$$BR-PFIZER INC-202400245742$PFIZER$$$$$F$Y$$$20240913$$CN$BR$BR
243175401$24317540$1$I$$20240912$20240913$20240913$EXP$$US-PFIZER INC-PV202400120338$PFIZER$$71$YR$$M$Y$$$20240913$$HP$US$US
243175411$24317541$1$I$$20240904$20240913$20240913$PER$$US-ABBVIE-5907279$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243175421$24317542$1$I$20240501$20240910$20240913$20240913$EXP$$US-ABBVIE-5917608$ABBVIE$$65$YR$$F$Y$$$20240913$$CN$US$US
243175431$24317543$1$I$$20240903$20240913$20240913$EXP$$US-RADIUS HEALTH INC.-2024US006754$RADIUS PHARM$$$$$F$Y$$$20240913$$CN$US$US
243175441$24317544$1$I$20240901$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144788$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240913$$CN$US$US
243175451$24317545$1$I$$20240819$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004885$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243175461$24317546$1$I$20240906$20240909$20240913$20240913$EXP$$US-ABBVIE-5917611$ABBVIE$$67$YR$$F$Y$$$20240913$$CN$US$US
243175471$24317547$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145873$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240913$$CN$US$US
243175481$24317548$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145853$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$58.97$KG$20240913$$CN$US$US
243175491$24317549$1$I$$20240909$20240913$20240913$PER$$US-ABBVIE-5916416$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243175501$24317550$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5918844$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243175511$24317551$1$I$20240905$20240910$20240913$20240913$EXP$$US-ABBVIE-5918504$ABBVIE$$71$YR$$F$Y$$$20240913$$CN$US$US
243175522$24317552$2$F$$20240909$20240913$20240916$EXP$$US-ROCHE-10000078112$ROCHE$$$$$$Y$$$20240916$$CN$US$US
243175531$24317553$1$I$20240616$20240909$20240913$20240913$EXP$$US-ABBVIE-5919652$ABBVIE$$53$YR$$F$Y$$$20240913$$CN$US$US
243175541$24317554$1$I$20240825$20240826$20240913$20240913$EXP$$US-ABBVIE-5896677$ABBVIE$$67$YR$$F$Y$$$20240913$$CN$US$US
243175551$24317555$1$I$20240603$20240905$20240913$20240913$EXP$$SG-JNJFOC-20240932057$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240913$$HP$SG$SG
243175581$24317558$1$I$20240908$20240908$20240913$20240913$EXP$GB-MHRA-MED-202409081853290820-GQDWT$GB-GSK-GB2024111499$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$GB$GB
243175591$24317559$1$I$$20240910$20240913$20240913$EXP$$US-AstraZeneca-2024A206362$ASTRAZENECA$$$$$$Y$$$20240913$$HP$US$
243175601$24317560$1$I$$20240905$20240913$20240913$EXP$$JP-AstraZeneca-2024A158435$ASTRAZENECA$Shinbu K, et al.. Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six-Case Series.. OncoTargets and Therapy 2024;17:717-726.$78$YR$$F$Y$$$20240913$$MD$JP$
243175611$24317561$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146283$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240913$$CN$US$US
243175621$24317562$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145841$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240913$$CN$US$US
243175631$24317563$1$I$$20240906$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013428$DR REDDYS$Terashita M, Selamet U, Midha S, Nadeem O, Laubach J, Rennke HG, et al. Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones. Kidney International Reports. 2023;8: 2765-2777. doi:10.1016/j.ekir.2023.09.022.$$$$$Y$$$20240913$$HP$US$US
243175651$24317565$1$I$$20240904$20240913$20240913$PER$$US-KARYOPHARM-2024KPT001513$KARYOPHARM THERAPEUTICS$$$$$F$Y$81.6$KG$20240913$$CN$US$US
243175661$24317566$1$I$$20240905$20240913$20240913$EXP$FR-009507513-2408FRA010193$FR-ROCHE-10000074901$ROCHE$Bottosso M, Verret B, Caron O, Hamzaoui N, Pasmant E, Danlos F. Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome. JCO Precision Oncology. 2024;8:1-6. doi:10.1200/PO.24.00139.$$$A$F$Y$$$20240913$$MD$FR$FR
243175671$24317567$1$I$20240723$20240906$20240913$20240913$EXP$$US-ABBVIE-5901681$ABBVIE$$86$YR$$F$Y$68.945$KG$20240913$$CN$US$US
243175691$24317569$1$I$$20240909$20240913$20240913$PER$$US-ROCHE-10000081222$ROCHE$Huang L, Flaxel C, Suhler E, Lin P. Two Cases of Chronic Central Serous Chorioretinopathy Successfully Treated with Systemic Interferon Alpha. Ocular Immunology and Inflammation. 2024-Jan;32 (7):1465-74. doi:10.1080/09273948.2023.2226206.$48$YR$A$M$Y$$$20240913$$HP$US$US
243175722$24317572$2$F$$20240905$20240913$20240916$EXP$$BR-JNJFOC-20240916525$JOHNSON AND JOHNSON$$56$YR$A$M$Y$79$KG$20240916$$CN$BR$BR
243175731$24317573$1$I$$20240905$20240913$20240913$30DAY$$US-GSK-US2024110813$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243175741$24317574$1$I$20240819$20240821$20240913$20240913$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004984$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240913$$HP$US$US
243175761$24317576$1$I$20240601$20240905$20240913$20240913$PER$$US-SA-2024SA264365$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240913$$HP$US$US
243175771$24317577$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007649$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240913$$CN$US$US
243175781$24317578$1$I$$20240912$20240912$20240912$DIR$718156$$FDA-CTU$$$$$UNK$N$$$20240912$N$CN$US$
243175791$24317579$1$I$$20240902$20240913$20240913$EXP$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01476$TARO$Abdelal Q, Isern S, Najjar N. Azith and the Myth. Am J Respir Crit Care Med. 2024;209$$$$$Y$$$20240913$$HP$US$US
243175801$24317580$1$I$20240808$20240906$20240913$20240913$EXP$$CN-AMGEN-CHNSP2024181117$AMGEN$$53$YR$A$F$Y$$$20240913$$HP$CN$CN
243175811$24317581$1$I$$20240910$20240913$20240913$PER$$US-TAKEDA-2024TUS090541$TAKEDA$$$$$F$Y$68$KG$20240913$$MD$US$US
243175821$24317582$1$I$$20240910$20240913$20240913$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000089$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240913$$CN$US$US
243175831$24317583$1$I$$20240903$20240913$20240913$PER$$US-ABBVIE-5908629$ABBVIE$$$$$F$Y$$$20240913$$MD$US$US
243175841$24317584$1$I$20240822$20240904$20240913$20240913$EXP$CN-NMPACDR-6540001535476202400310$CN-BAXTER-2024BAX024339$BAXTER$$65$YR$$F$Y$65$KG$20240913$$MD$CN$CN
243175851$24317585$1$I$20240301$20240910$20240913$20240913$EXP$$US-AMGEN-USASP2024180955$AMGEN$$$$E$F$Y$$$20240913$$HP$US$US
243175861$24317586$1$I$$20240903$20240913$20240913$EXP$$AU-JNJFOC-20240914696$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$HP$AU$AU
243175871$24317587$1$I$20240819$20240906$20240913$20240913$EXP$$KR-JNJFOC-20240919526$JOHNSON AND JOHNSON$$36$YR$A$F$Y$51$KG$20240913$$MD$KR$KR
243175881$24317588$1$I$$20240904$20240913$20240913$EXP$$GB-TEVA-VS-3240627$TEVA$$53$YR$$M$Y$$$20240913$$MD$GB$GB
243175891$24317589$1$I$20240908$20240909$20240913$20240913$PER$$US-ABBVIE-5916618$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243175901$24317590$1$I$$20240906$20240913$20240913$EXP$$DE-SANDOZ INC.-NVSC2021DE126218$SANDOZ$$77$YR$$F$Y$$$20240913$$HP$DE$DE
243175911$24317591$1$I$20240909$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-62997$$FDA-CTU$$74$YR$$M$N$$$20240913$N$$US$
243175931$24317593$1$I$20240901$20240904$20240913$20240913$EXP$CN-NMPACDR-4404021008474202400374$CN-BAXTER-2024BAX024333$BAXTER$$62$YR$$F$Y$60$KG$20240913$$MD$CN$CN
243175942$24317594$2$F$$20240906$20240913$20240918$EXP$$NL-SANDOZ INC.-PHHY2019NL147337$SANDOZ$$51$YR$$F$Y$$$20240918$$MD$NL$NL
243175951$24317595$1$I$$20240913$20240913$20240913$DIR$718261$$FDA-CTU$$$$$UNK$N$$$20240913$$CN$US$
243175961$24317596$1$I$20240913$20240913$20240913$20240913$DIR$718256$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243175971$24317597$1$I$$20240903$20240913$20240913$EXP$$US-FARMAPROD-202408-2972$DOMPE FARMACEUTICI$$$$A$F$Y$$$20240913$$CN$US$US
243175981$24317598$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5916911$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243175991$24317599$1$I$$20240814$20240913$20240913$PER$$US-Eisai-EC-2024-172121$EISAI$$10$YR$C$F$Y$$$20240913$$CN$US$US
243176001$24317600$1$I$$20240823$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08588$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243176011$24317601$1$I$20240104$20240904$20240913$20240913$EXP$GB-MHRA-MED-202409041052410330-PLBJN$GB-TEVA-VS-3240814$TEVA$$56$YR$$M$Y$120$KG$20240913$$CN$GB$GB
243176021$24317602$1$I$20240302$20240911$20240913$20240913$EXP$$US-TAKEDA-2024TUS091292$TAKEDA$$74$YR$$M$Y$$$20240913$$MD$US$US
243176031$24317603$1$I$20240722$20240904$20240913$20240913$EXP$FR-AFSSAPS-TO2024001622$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08360$HIKMA$$69$YR$$M$Y$49.4$KG$20240913$$PH$FR$FR
243176051$24317605$1$I$$20240902$20240913$20240913$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08393$HIKMA$$$$$$Y$$$20240913$$CN$CA$CA
243176061$24317606$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA263871$SANOFI AVENTIS$$66$YR$E$$Y$$$20240913$$CN$US$US
243176071$24317607$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA262866$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240913$$HP$US$US
243176081$24317608$1$I$20231101$20240904$20240913$20240913$PER$$US-SA-2024SA014805$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240913$$HP$US$US
243176091$24317609$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA264608$SANOFI AVENTIS$$$$A$F$Y$$$20240913$$CN$US$US
243176101$24317610$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA264548$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240913$$HP$US$US
243176111$24317611$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA253386$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240913$$CN$US$US
243176121$24317612$1$I$20240524$20240905$20240913$20240913$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08370$HIKMA$$76$YR$$M$Y$$$20240913$$CN$US$US
243176131$24317613$1$I$$20240809$20240913$20240913$EXP$$GB-UCBSA-2024040674$UCB$$$$$M$Y$$$20240913$$CN$GB$GB
243176141$24317614$1$I$$20240829$20240913$20240913$EXP$$US-TRIGEN LABORATORIES-2024ALO00440$Alora Pharma$S. H. Nasr, S. M. Said and A. Flickinger.. Nitrofurantoin-associated crystalline and granulomatous interstitial nephritis.. Kidney Int.. 2024;106(3):542$76$YR$$F$Y$$$20240913$$HP$US$US
243176151$24317615$1$I$$20240906$20240913$20240913$EXP$$US-AstraZeneca-2024A204681$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243176161$24317616$1$I$$20240906$20240913$20240913$EXP$$BR-AstraZeneca-2024A206353$ASTRAZENECA$$74$YR$$F$Y$$$20240913$$MD$BR$
243176171$24317617$1$I$$20240906$20240913$20240913$EXP$$ZA-AstraZeneca-2024A204319$ASTRAZENECA$$55$YR$$M$Y$$$20240913$$CN$ZA$
243176181$24317618$1$I$$20240905$20240913$20240913$EXP$$US-AstraZeneca-2024A205674$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243176191$24317619$1$I$$20240903$20240913$20240913$PER$$US-PFIZER INC-202400254575$PFIZER$$66$YR$$F$Y$90.72$KG$20240913$$CN$US$US
243176202$24317620$2$F$$20240912$20240913$20240913$PER$$US-PFIZER INC-PV202400024369$PFIZER$$61$YR$$F$Y$$$20240913$$CN$US$US
243176211$24317621$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202400119647$PFIZER$$66$YR$$F$Y$$$20240913$$HP$US$US
243176221$24317622$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-202400255617$PFIZER$$61$YR$$M$Y$$$20240913$$HP$US$US
243176231$24317623$1$I$$20240909$20240913$20240913$PER$$US-PFIZER INC-202400253344$PFIZER$$66$YR$$F$Y$81.6$KG$20240913$$MD$US$US
243176241$24317624$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-PV202400119130$PFIZER$$38$YR$$F$Y$$$20240913$$CN$US$US
243176251$24317625$1$I$20240909$20240909$20240913$20240913$PER$$US-PFIZER INC-202400253184$PFIZER$$61$YR$$M$Y$$$20240913$$CN$US$US
243176261$24317626$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-PV202400119008$PFIZER$$56$YR$$F$Y$$$20240913$$CN$US$US
243176271$24317627$1$I$$20240912$20240913$20240913$PER$$US-PFIZER INC-PV202300025001$PFIZER$$73$YR$$F$Y$$$20240913$$CN$US$US
243176281$24317628$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-202400254848$PFIZER$$68$YR$$F$Y$$$20240913$$CN$US$US
243176291$24317629$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-202400254461$PFIZER$$$$$F$Y$$$20240913$$CN$US$US
243176301$24317630$1$I$$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255259$PFIZER$$$$$F$Y$$$20240913$$CN$US$US
243176311$24317631$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-202400254271$PFIZER$$57$YR$$F$Y$$$20240913$$MD$US$US
243176332$24317633$2$F$$20240911$20240913$20240916$PER$$US-PFIZER INC-202400254737$PFIZER$$$$C$F$Y$$$20240916$$MD$US$US
243176341$24317634$1$I$20240101$20240911$20240913$20240913$PER$$US-PFIZER INC-202400255003$PFIZER$$62$YR$$F$Y$51.71$KG$20240913$$CN$US$US
243176351$24317635$1$I$$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255858$PFIZER$$77$YR$$F$Y$$$20240913$$CN$US$US
243176362$24317636$2$F$$20240917$20240913$20240919$PER$$US-PFIZER INC-PV202400119195$PFIZER$$54$YR$$F$Y$$$20240919$$HP$US$US
243176371$24317637$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-202400254159$PFIZER$$$$$M$Y$$$20240913$$MD$US$US
243176381$24317638$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-202400034265$PFIZER$$14$YR$$F$Y$$$20240913$$MD$US$US
243176392$24317639$2$F$$20240919$20240913$20240924$PER$$US-PFIZER INC-PV202400119651$PFIZER$$$$$$Y$$$20240924$$MD$US$US
243176401$24317640$1$I$$20240909$20240913$20240913$PER$$US-PFIZER INC-202400252978$PFIZER$$$$A$M$Y$$$20240913$$HP$US$US
243176411$24317641$1$I$20240910$20240910$20240913$20240913$PER$$US-PFIZER INC-202400253893$PFIZER$$59$YR$$F$Y$$$20240913$$CN$US$US
243176421$24317642$1$I$$20240909$20240913$20240913$PER$$US-PFIZER INC-202400253960$PFIZER$$81$YR$$F$Y$$$20240913$$HP$US$US
243176431$24317643$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-PV202400119540$PFIZER$$72$YR$$F$Y$$$20240913$$MD$US$US
243176442$24317644$2$F$$20240916$20240913$20240916$PER$$US-PFIZER INC-202400255262$PFIZER$$76$YR$$F$Y$$$20240916$$CN$US$US
243176452$24317645$2$F$$20240913$20240913$20240918$PER$$US-PFIZER INC-202400253020$PFIZER$$$$A$F$Y$$$20240918$$CN$US$US
243176462$24317646$2$F$$20240912$20240913$20240916$EXP$$ID-PFIZER INC-PV202400117584$PFIZER$Leman, Y.. Undetected intraabdominal sepsis due to prolonged corticosteroid therapy in systemic lupus erythematosus: a case report and literature review. Anaesthesia, Pain and Intensive Care. 2024;28(4):765-771$47$YR$$F$Y$$$20240916$$HP$ID$ID
243176471$24317647$1$I$20220919$20240909$20240913$20240913$PER$$US-PFIZER INC-202400253341$PFIZER$$64$YR$$F$Y$81.6$KG$20240913$$MD$US$US
243176481$24317648$1$I$$20240903$20240913$20240913$EXP$GB-MHRA-MED-202409020906128010-ZDPHQ$GB-AMAROX PHARMA-AMR2024GB02960$HETERO$$$$$M$Y$$$20240913$$HP$GB$GB
243176491$24317649$1$I$20240907$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144122$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240913$$HP$US$US
243176501$24317650$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145729$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$67.59$KG$20240913$$CN$US$US
243176511$24317651$1$I$20240829$20240909$20240913$20240913$EXP$$US-ABBVIE-5917226$ABBVIE$$61$YR$$M$Y$$$20240913$$CN$US$US
243176541$24317654$1$I$20160418$20240902$20240913$20240913$EXP$DE-BFARM-16166912$DE-TORRENT-00004882$TORRENT$$45$YR$A$M$Y$99$KG$20240913$$MD$DE$DE
243176551$24317655$1$I$20240711$20240905$20240913$20240913$EXP$GB-MHRA-MED-202409051602228240-CRTJQ$GB-TORRENT-00037869$TORRENT$$$$$$Y$$$20240913$$HP$GB$GB
243176561$24317656$1$I$$20240903$20240913$20240913$EXP$$GB-TORRENT-00037863$TORRENT$$66$YR$E$M$Y$$$20240913$$MD$GB$GB
243176571$24317657$1$I$$20240905$20240913$20240913$EXP$GB-MHRA-MED-202409051515367150-DZBPM$GB-TORRENT-00037868$TORRENT$$$$$M$Y$$$20240913$$HP$GB$GB
243176581$24317658$1$I$$20240905$20240913$20240913$EXP$GB-MHRA-MIDB-05eb5954-9762-4004-9c3d-bcdfff55175c$GB-TORRENT-00037871$TORRENT$$71$YR$E$M$Y$$$20240913$$PH$GB$GB
243176591$24317659$1$I$$20240905$20240913$20240913$EXP$GB-MHRA-TPP19127017C5148996YC1725462909287$GB-TORRENT-00037876$TORRENT$$64$YR$A$F$Y$69$KG$20240913$$PH$GB$GB
243176601$24317660$1$I$$20240903$20240913$20240913$EXP$$US-TORRENT-00013740$TORRENT$$$$$F$Y$$$20240913$$CN$US$US
243176611$24317661$1$I$$20240829$20240913$20240913$PER$$US-ASTELLAS-2024-AER-004155$ASTELLAS$$61$YR$A$M$Y$77.8$KG$20240913$$HP$US$US
243176621$24317662$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010450$APOTEX$Ingole P, Morkas M, May R, Hinman B, Carrum G, Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$M$Y$$$20240913$$HP$US$US
243176631$24317663$1$I$$20240906$20240913$20240913$EXP$$CA-TAKEDA-2024TUS089894$TAKEDA$$$$$F$Y$$$20240913$$CN$CA$CA
243176642$24317664$2$F$$20240917$20240913$20240925$EXP$$IN-TAKEDA-2022TUS094280$TAKEDA$$$$$F$Y$$$20240925$$MD$IN$IN
243176651$24317665$1$I$20240827$20240909$20240913$20240913$EXP$FR-AFSSAPS-AN2024001223$FR-MYLANLABS-2024M1082450$MYLAN$$58$YR$$M$Y$$$20240913$$MD$FR$FR
243176661$24317666$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-202400255573$PFIZER$$59$YR$$F$Y$$$20240913$$CN$US$US
243176672$24317667$2$F$$20240912$20240913$20240916$PER$$US-PFIZER INC-202400255499$PFIZER$$74$YR$$F$Y$65.32$KG$20240916$$CN$US$US
243176681$24317668$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-202400255604$PFIZER$$48$YR$$F$Y$$$20240913$$HP$US$US
243176691$24317669$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-202400237785$PFIZER$$29$YR$$M$Y$$$20240913$$CN$US$US
243176701$24317670$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-202400254708$PFIZER$$$$$F$Y$$$20240913$$MD$US$US
243176721$24317672$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-202400254849$PFIZER$$69$YR$$F$Y$$$20240913$$CN$US$US
243176731$24317673$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-202400254874$PFIZER$$57$YR$$M$Y$$$20240913$$CN$US$US
243176741$24317674$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202400120135$PFIZER$$54$YR$$F$Y$$$20240913$$CN$US$US
243176751$24317675$1$I$$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255376$PFIZER$$16$YR$$$Y$$$20240913$$MD$US$US
243176761$24317676$1$I$20240901$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202400109821$PFIZER$$80$YR$$F$Y$$$20240913$$CN$US$US
243176771$24317677$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-PV202400119123$PFIZER$$56$YR$$F$Y$$$20240913$$HP$US$US
243176781$24317678$1$I$20210101$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202400119941$PFIZER$$47$YR$$F$Y$$$20240913$$HP$US$US
243176791$24317679$1$I$20240301$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202400119944$PFIZER$$65$YR$$M$Y$$$20240913$$HP$US$US
243176801$24317680$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-202400255575$PFIZER$$47$YR$$M$Y$$$20240913$$HP$US$US
243176811$24317681$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-PV202400119164$PFIZER$$75$YR$$F$Y$$$20240913$$HP$US$US
243176821$24317682$1$I$$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255528$PFIZER$$$$$M$Y$$$20240913$$MD$US$US
243176831$24317683$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202400119720$PFIZER$$57$YR$$F$Y$$$20240913$$HP$US$US
243176841$24317684$1$I$20240601$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202400119966$PFIZER$$57$YR$$M$Y$$$20240913$$HP$US$US
243176851$24317685$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202400119706$PFIZER$$43$YR$$F$Y$$$20240913$$CN$US$US
243176861$24317686$1$I$20240911$20240911$20240913$20240913$PER$$US-PFIZER INC-202400255254$PFIZER$$45$YR$$M$Y$$$20240913$$CN$US$US
243176871$24317687$1$I$20240801$20240912$20240913$20240913$PER$$US-PFIZER INC-PV202400120171$PFIZER$$39$YR$$F$Y$$$20240913$$HP$US$US
243176881$24317688$1$I$20240801$20240911$20240913$20240913$PER$$US-PFIZER INC-202400254730$PFIZER$$81$YR$$F$Y$$$20240913$$CN$US$US
243176891$24317689$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-202400254990$PFIZER$$65$YR$$F$Y$$$20240913$$CN$US$US
243176901$24317690$1$I$20240910$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202400119790$PFIZER$$$$$$Y$$$20240913$$CN$US$US
243176911$24317691$1$I$$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255398$PFIZER$$13$YR$$M$Y$$$20240913$$HP$US$US
243176921$24317692$1$I$20240912$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255468$PFIZER$$83$YR$$F$Y$$$20240913$$CN$US$US
243176931$24317693$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202400119746$PFIZER$$67$YR$$F$Y$$$20240913$$HP$US$US
243176941$24317694$1$I$$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255261$PFIZER$$$$$F$Y$$$20240913$$CN$US$US
243176951$24317695$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202300070138$PFIZER$$73$YR$$F$Y$$$20240913$$MD$US$US
243176971$24317697$1$I$$20240912$20240913$20240913$PER$$US-PFIZER INC-PV202400120153$PFIZER$$53$YR$$F$Y$$$20240913$$HP$US$US
243176981$24317698$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-202400255703$PFIZER$$36$YR$$M$Y$$$20240913$$HP$US$US
243176991$24317699$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-202400255672$PFIZER$$$$$$Y$$$20240913$$MD$US$US
243177001$24317700$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202400119798$PFIZER$$71$YR$$F$Y$$$20240913$$CN$US$US
243177021$24317702$1$I$20240901$20240911$20240913$20240913$PER$$US-PFIZER INC-202400255564$PFIZER$$44$YR$$F$Y$$$20240913$$HP$US$US
243177031$24317703$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202200062173$PFIZER$$54$YR$$F$Y$$$20240913$$CN$US$US
243177051$24317705$1$I$20240701$20240912$20240913$20240913$PER$$US-BAYER-2024A131062$BAYER$$78$YR$E$F$Y$$$20240913$$CN$US$US
243177061$24317706$1$I$20240101$20240822$20240913$20240913$PER$$US-SA-2024SA262414$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240913$$MD$US$US
243177071$24317707$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA264607$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240913$$HP$US$US
243177082$24317708$2$F$20240801$20240914$20240913$20240923$PER$$US-SA-2024SA263346$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240923$$HP$US$US
243177091$24317709$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264434$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240913$$HP$US$US
243177101$24317710$1$I$$20240826$20240913$20240913$PER$$US-SA-2024SA262731$SANOFI AVENTIS$$$$A$F$Y$59.09$KG$20240913$$MD$US$US
243177111$24317711$1$I$$20240826$20240913$20240913$PER$$US-SA-2024SA262091$SANOFI AVENTIS$$$$$F$Y$63.64$KG$20240913$$MD$US$US
243177121$24317712$1$I$$20240903$20240913$20240913$EXP$$AT-ROCHE-10000074893$ROCHE$$95$YR$E$F$Y$$$20240913$$MD$AT$AT
243177131$24317713$1$I$20240809$20240813$20240913$20240913$PER$$US-Eisai-EC-2024-172087$EISAI$$73$YR$E$M$Y$$$20240913$$CN$US$US
243177141$24317714$1$I$$20240903$20240913$20240913$EXP$$TR-ADMA BIOLOGICS INC.-TR-2024ADM000115$ADMA BIOLOGICS$Senturk M, Oygur CS, Bitik B, Kibaroglu S, Yildirim T, Zeyneloglu P et al.. Rescue treatment with intravenous  Anakinra infusion in Still^s disease: a case report. European Journal of Case Reports in Internal Medicine. 2024;11 (Suppl 1):1038-1039$32$YR$$M$Y$$$20240913$$HP$TR$TR
243177151$24317715$1$I$$20240903$20240913$20240913$EXP$$TR-ADMA BIOLOGICS INC.-TR-2024ADM000114$ADMA BIOLOGICS$Senturk M, Oygur CS, Bitik B, Kibaroglu S, Yildirim T, Zeyneloglu P et al.. Rescue treatment with intravenous  Anakinra infusion in Still^s disease: a case report. European Journal of Case Reports in Internal Medicine. 2024;11 (Suppl 1):1038-1039$32$YR$$M$Y$$$20240913$$HP$TR$TR
243177161$24317716$1$I$$20240912$20240913$20240913$PER$$US-BAYER-2024A131069$BAYER$$$$$F$Y$$$20240913$$HP$US$US
243177181$24317718$1$I$$20240911$20240913$20240913$EXP$$DE-MYLANLABS-2024M1083057$MYLAN$$60$YR$$M$Y$$$20240913$$MD$DE$DE
243177191$24317719$1$I$$20240909$20240913$20240913$EXP$$CA-TAKEDA-2024TUS090218$TAKEDA$$$$$M$Y$$$20240913$$CN$CA$CA
243177201$24317720$1$I$$20240904$20240913$20240913$EXP$$US-ASTELLAS-2024-AER-005273$ASTELLAS$$$$E$M$Y$80.29$KG$20240913$$CN$US$US
243177211$24317721$1$I$$20240903$20240913$20240913$EXP$$JP-ROCHE-10000076427$ROCHE$$$$A$$Y$$$20240913$$PH$JP$JP
243177231$24317723$1$I$$20240911$20240913$20240913$PER$$US-JNJFOC-20240932668$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$HP$US$US
243177241$24317724$1$I$$20240904$20240913$20240913$30DAY$$US-GSK-US2024110236$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243177252$24317725$2$F$$20240913$20240913$20240917$PER$$US-PFIZER INC-202400255547$PFIZER$$74$YR$$F$Y$$$20240917$$CN$US$US
243177261$24317726$1$I$20240101$20240912$20240913$20240913$PER$$US-PFIZER INC-PV202400120256$PFIZER$$66$YR$$F$Y$$$20240913$$CN$US$US
243177271$24317727$1$I$20240909$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255816$PFIZER$$60$YR$$F$Y$$$20240913$$CN$US$US
243177281$24317728$1$I$20240911$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255846$PFIZER$$74$YR$$F$Y$$$20240913$$CN$US$US
243177291$24317729$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2022-0591120$GILEAD$$74$YR$E$F$Y$$$20240913$$HP$US$US
243177301$24317730$1$I$$20240905$20240913$20240913$EXP$$US-BAYER-2024A128815$BAYER$$81$YR$E$M$Y$81.633$KG$20240913$$HP$US$US
243177311$24317731$1$I$$20240912$20240913$20240913$PER$$US-PFIZER INC-PV202400120156$PFIZER$$49$YR$$F$Y$$$20240913$$HP$US$US
243177321$24317732$1$I$20240911$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255817$PFIZER$$34$YR$$F$Y$$$20240913$$CN$US$US
243177332$24317733$2$F$20240905$20240916$20240913$20240919$PER$$US-PFIZER INC-PV202400120167$PFIZER$$73$YR$$M$Y$$$20240919$$CN$US$US
243177341$24317734$1$I$$20240912$20240913$20240913$PER$$US-PFIZER INC-PV202400120132$PFIZER$$16$YR$$M$Y$$$20240913$$HP$US$US
243177352$24317735$2$F$20240829$20240912$20240913$20240916$PER$$US-PFIZER INC-202400255456$PFIZER$$79$YR$$M$Y$$$20240916$$CN$US$US
243177361$24317736$1$I$20240911$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255843$PFIZER$$67$YR$$F$Y$$$20240913$$CN$US$US
243177371$24317737$1$I$$20240905$20240913$20240913$EXP$$CA-Covis Pharma GmbH-2024COV01107$COVIS PHARMA$$80$YR$E$M$Y$89$KG$20240913$$HP$CA$CA
243177381$24317738$1$I$20240908$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255912$PFIZER$$49$YR$$F$Y$$$20240913$$HP$US$US
243177391$24317739$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007555$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240913$$CN$US$US
243177401$24317740$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007226$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240913$$CN$US$US
243177411$24317741$1$I$$20240903$20240913$20240913$EXP$$AU-Covis Pharma GmbH-2024COV01077$COVIS PHARMA$$57$YR$A$F$Y$$$20240913$$PH$AU$AU
243177421$24317742$1$I$20240826$20240904$20240913$20240913$EXP$$FI-MYLANLABS-2024M1081610$MYLAN$$55$YR$$M$Y$$$20240913$$MD$FI$FI
243177431$24317743$1$I$$20240906$20240913$20240913$30DAY$$CA-MYLANLABS-2024M1083045$MYLAN$$$$$$Y$$$20240913$$PH$CA$CA
243177441$24317744$1$I$$20240909$20240913$20240913$30DAY$$US-MYLANLABS-2024M1082755$MYLAN$$$$$F$Y$$$20240913$$CN$US$US
243177451$24317745$1$I$$20240909$20240913$20240913$EXP$$ES-AMGEN-ESPSP2024180983$AMGEN$$$$$$Y$$$20240913$$HP$ES$ES
243177461$24317746$1$I$20230101$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145663$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240913$$CN$US$US
243177471$24317747$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145788$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$78.02$KG$20240913$$CN$US$US
243177481$24317748$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145352$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240913$$CN$US$US
243177491$24317749$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145358$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240913$$MD$US$US
243177501$24317750$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145350$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240913$$CN$US$US
243177511$24317751$1$I$20240901$20240909$20240913$20240913$EXP$$US-LEX-000474$LEXICON PHARMACEUTICALS$$83$YR$$M$Y$$$20240913$$CN$US$US
243177521$24317752$1$I$20240826$20240910$20240913$20240913$EXP$$US-ABBVIE-5920561$ABBVIE$$61$YR$$F$Y$$$20240913$$CN$US$US
243177531$24317753$1$I$$20240903$20240913$20240913$EXP$$US-FARMAPROD-202409-3150$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240913$$CN$US$US
243177541$24317754$1$I$20240417$20240906$20240913$20240913$EXP$FR-AFSSAPS-AVMA2024000383$FR-Waylis Therapeutics LLC-ATNAHS20240902552$Waylis$$41$YR$A$M$Y$$$20240913$$PH$FR$FR
243177551$24317755$1$I$20240101$20240910$20240913$20240913$PER$$US-JNJFOC-20240924195$JOHNSON AND JOHNSON$$24$YR$A$$Y$$$20240913$$PH$US$US
243177562$24317756$2$F$20240820$20240913$20240913$20240918$EXP$$MX-AstraZeneca-2024A206400$ASTRAZENECA$$21142$DY$$M$Y$$$20240918$$CN$MX$
243177571$24317757$1$I$20240812$20240911$20240913$20240913$EXP$$US-AstraZeneca-2024A207417$ASTRAZENECA$$23694$DY$$M$Y$$$20240913$$CN$US$
243177581$24317758$1$I$$20240909$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024112589$VIIV$$3$DEC$$M$Y$$$20240913$$MD$US$US
243177591$24317759$1$I$20240905$20240905$20240913$20240913$PER$$US-AstraZeneca-2024A204890$ASTRAZENECA$$22$YR$$F$Y$68$KG$20240913$$CN$US$
243177601$24317760$1$I$$20240909$20240913$20240913$EXP$$US-AstraZeneca-2024A205709$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243177611$24317761$1$I$$20240904$20240913$20240913$PER$$US-ROCHE-10000074427$ROCHE$$$$A$F$Y$$$20240913$$CN$US$US
243177623$24317762$3$F$20240910$20240917$20240913$20240918$PER$$US-AMGEN-USASP2024182688$AMGEN$$84$YR$E$F$Y$$$20240918$$CN$US$US
243177631$24317763$1$I$20230101$20240906$20240913$20240913$EXP$$GB-AMGEN-GBRSL2024179707$AMGEN$$83$YR$E$F$Y$$$20240913$$CN$GB$GB
243177641$24317764$1$I$$20240826$20240913$20240913$PER$$US-TEVA-VS-3237494$TEVA$$$$$$Y$$$20240913$$HP$US$US
243177651$24317765$1$I$20180812$20240909$20240913$20240913$EXP$$ES-FreseniusKabi-FK202010891$FRESENIUS KABI$$67$YR$E$F$Y$48$KG$20240913$$HP$ES$ES
243177661$24317766$1$I$20240101$20240912$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145727$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240913$$CN$US$US
243177671$24317767$1$I$20240910$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145888$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240913$$HP$US$US
243177681$24317768$1$I$$20240814$20240913$20240913$PER$$US-Eisai-EC-2024-172139$EISAI$$52$YR$A$F$Y$$$20240913$$HP$US$US
243177691$24317769$1$I$20240731$20240906$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143645$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$62.3$KG$20240913$$PH$US$US
243177701$24317770$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2022-0595847$GILEAD$$68$YR$E$M$Y$$$20240913$$MD$US$US
243177721$24317772$1$I$$20240911$20240913$20240913$PER$$US-ROCHE-10000080477$ROCHE$$$$E$F$Y$$$20240913$$CN$US$US
243177731$24317773$1$I$20240601$20240906$20240913$20240913$EXP$$US-BIOGEN-2024BI01281836$BIOGEN$$25$YR$$F$Y$$$20240913$$CN$US$US
243177742$24317774$2$F$20201201$20240924$20240913$20240930$EXP$$PL-SANDOZ INC.-NVSC2021PL142238$SANDOZ$$49$YR$$M$Y$$$20240930$$MD$PL$PL
243177751$24317775$1$I$$20240911$20240913$20240913$EXP$$CA-ABBVIE-5921335$ABBVIE$$$$E$M$Y$$$20240913$$CN$CA$CA
243177771$24317777$1$I$$20240904$20240913$20240913$EXP$$US-RADIUS HEALTH INC.-2024US006899$RADIUS PHARM$$$$$F$Y$$$20240913$$CN$US$US
243177782$24317778$2$F$20240819$20240923$20240913$20240924$EXP$$ES-PFIZER INC-202400255135$PFIZER$$63$YR$$F$Y$$$20240924$$MD$ES$ES
243177791$24317779$1$I$$20240912$20240913$20240913$PER$$US-PFIZER INC-202400255629$PFIZER$$64$YR$$F$Y$$$20240913$$CN$US$US
243177831$24317783$1$I$20230719$20240909$20240913$20240913$EXP$$FR-SANDOZ INC.-SDZ2024FR078757$SANDOZ$$52$YR$$F$Y$$$20240913$$HP$FR$FR
243177841$24317784$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144453$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240913$$CN$US$US
243177851$24317785$1$I$20240907$20240912$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145898$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$136.98$KG$20240913$$CN$US$US
243177861$24317786$1$I$$20240906$20240913$20240913$EXP$$US-ABBVIE-5914997$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243177871$24317787$1$I$$20240902$20240913$20240913$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-002069$SK LIFE SCIENCE$$$$$$Y$$$20240913$$CN$US$US
243177882$24317788$2$F$20240101$20240917$20240913$20240918$PER$$US-ALXN-202409USA000415US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243177891$24317789$1$I$20240101$20240906$20240913$20240913$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-002097$SK LIFE SCIENCE$$$$$$Y$$$20240913$$MD$US$US
243177911$24317791$1$I$$20240906$20240913$20240913$PER$$US-ABBVIE-5916229$ABBVIE$$$$$$Y$$$20240913$$CN$US$US
243177941$24317794$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA263854$SANOFI AVENTIS$$81$YR$E$$Y$$$20240913$$CN$US$US
243177952$24317795$2$F$20210101$20240913$20240913$20240918$EXP$$US-ABBVIE-5919457$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243177961$24317796$1$I$20240622$20240905$20240913$20240913$EXP$$BR-BIOVITRUM-2024-BR-012001$BIOVITRUM$$$$I$M$Y$$$20240913$$CN$BR$BR
243177971$24317797$1$I$$20240829$20240913$20240913$EXP$$GB-BAXTER-2024BAX023964$BAXTER$$$$A$F$Y$$$20240913$$CN$GB$GB
243177981$24317798$1$I$$20240912$20240913$20240913$EXP$$US-BAYER-2024A130835$BAYER$$$$$F$Y$$$20240913$$CN$US$US
243177991$24317799$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA263717$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240913$$HP$US$US
243178002$24317800$2$F$$20240919$20240913$20240924$PER$$US-ROCHE-10000080419$ROCHE$$62$YR$A$F$Y$$$20240924$$CN$US$US
243178011$24317801$1$I$20240101$20240826$20240913$20240913$PER$$US-MRZWEB-2024080000257$MERZ$$$$$F$Y$$$20240913$$HP$US$US
243178021$24317802$1$I$$20240907$20240913$20240913$EXP$$IN-VANTIVE-2024VAN019692$Vantive US Healthcare$$58$YR$$M$Y$$$20240913$$CN$IN$IN
243178031$24317803$1$I$$20240905$20240913$20240913$EXP$$US-VANTIVE-2024VAN019583$Vantive US Healthcare$$$$$F$Y$$$20240913$$HP$US$US
243178061$24317806$1$I$$20240905$20240913$20240913$EXP$$US-VANTIVE-2024VAN019581$Vantive US Healthcare$$$$$M$Y$$$20240913$$CN$US$US
243178072$24317807$2$F$$20240910$20240913$20240918$EXP$$IN-VANTIVE-2024VAN019655$Vantive US Healthcare$$27$YR$$M$Y$$$20240918$$CN$IN$IN
243178092$24317809$2$F$$20240910$20240913$20240919$EXP$$IN-VANTIVE-2024VAN019678$Vantive US Healthcare$$43$YR$$F$Y$$$20240919$$CN$IN$IN
243178101$24317810$1$I$20240704$20240909$20240913$20240913$EXP$SE-SEMPA-2024-006564$SE-FreseniusKabi-FK202413540$FRESENIUS KABI$$70$YR$E$F$Y$$$20240913$$MD$SE$SE
243178111$24317811$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144731$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240913$$CN$US$US
243178121$24317812$1$I$20240711$20240815$20240913$20240913$PER$$US-Eisai-EC-2024-172208$EISAI$$62$YR$A$F$Y$$$20240913$$CN$US$US
243178131$24317813$1$I$$20240826$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000258$MERZ$$$$$$Y$$$20240913$$HP$US$US
243178141$24317814$1$I$$20240911$20240913$20240913$EXP$$US-TAKEDA-2024TUS091232$TAKEDA$$$$$M$Y$$$20240913$$CN$US$US
243178151$24317815$1$I$$20240904$20240913$20240913$EXP$$CA-TAKEDA-2023TUS080589$TAKEDA$$$$$F$Y$$$20240913$$CN$CA$CA
243178161$24317816$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2024-0658182$GILEAD$$78$YR$E$M$Y$$$20240913$$MD$US$US
243178171$24317817$1$I$$20240903$20240913$20240913$EXP$$CA-ROCHE-10000072949$ROCHE$$66$YR$E$F$Y$$$20240913$$MD$CA$CA
243178181$24317818$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010451$APOTEX$Ingole P, Morkas M, May R, Hinman B, Carrum G, Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$M$Y$$$20240913$$HP$US$US
243178201$24317820$1$I$$20240828$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000273$MERZ$$52$YR$$M$Y$$$20240913$$HP$US$US
243178221$24317822$1$I$20240428$20240905$20240913$20240913$EXP$FR-AFSSAPS-PA2024001444$FR-TEVA-VS-3240940$TEVA$$53$YR$$F$Y$85$KG$20240913$$PH$FR$FR
243178232$24317823$2$F$20240904$20240918$20240913$20240923$PER$$US-ROCHE-10000081375$ROCHE$$6$YR$C$F$Y$$$20240923$$HP$US$US
243178241$24317824$1$I$$20240827$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000275$MERZ$$$$$$Y$$$20240913$$HP$US$US
243178251$24317825$1$I$20240626$20240906$20240913$20240913$EXP$$GB-AMERICAN REGENT INC-2024003417$AMERICAN REGENT$$66$YR$$F$Y$91$KG$20240913$$MD$GB$GB
243178261$24317826$1$I$$20240801$20240913$20240913$EXP$$IL-AMGEN-ISRNI2024176196$AMGEN$$$$$$Y$$$20240908$$MD$IL$IL
243178271$24317827$1$I$$20240911$20240913$20240913$EXP$$US-TAKEDA-2024TUS090836$TAKEDA$$$$$F$Y$$$20240913$$CN$US$US
243178281$24317828$1$I$$20240903$20240913$20240913$EXP$$IT-BEH-2024178403$CSL BEHRING$$40$YR$A$M$Y$$$20240913$$HP$IT$IT
243178291$24317829$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MED-202409041301200300-DKHQN$GB-TEVA-VS-3240661$TEVA$$79$YR$$F$Y$$$20240913$$PH$GB$GB
243178301$24317830$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2023-0626802$GILEAD$$73$YR$E$M$Y$$$20240913$$MD$US$US
243178311$24317831$1$I$20240810$20240910$20240913$20240913$EXP$$US-AstraZeneca-2024A209233$ASTRAZENECA$$24008$DY$$F$Y$$$20240913$$CN$US$
243178321$24317832$1$I$$20240904$20240913$20240913$EXP$$US-AstraZeneca-2024A203256$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243178331$24317833$1$I$$20240905$20240913$20240913$EXP$$FR-AstraZeneca-2024A205189$ASTRAZENECA$$72$YR$$M$Y$$$20240913$$MD$FR$
243178341$24317834$1$I$20231201$20240903$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409001944$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240913$$CN$US$US
243178351$24317835$1$I$20240701$20240830$20240913$20240913$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000052$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240913$$CN$JP$JP
243178361$24317836$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007380$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240913$$CN$US$US
243178371$24317837$1$I$$20240904$20240913$20240913$30DAY$$US-GSK-US2024110226$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$CN$US$US
243178381$24317838$1$I$20240911$20240912$20240913$20240913$PER$$US-ALXN-202409USA000932US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243178391$24317839$1$I$$20240906$20240913$20240913$PER$$US-ALXN-202409USA000401US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243178401$24317840$1$I$$20240911$20240913$20240913$PER$$US-BIOVITRUM-2024-US-011970$BIOVITRUM$$71$YR$$M$Y$$$20240913$$CN$US$US
243178411$24317841$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263363$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240913$$MD$US$US
243178422$24317842$2$F$$20240917$20240913$20240923$PER$$US-SA-2024SA263951$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240923$$HP$US$US
243178431$24317843$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264364$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240913$$HP$US$US
243178441$24317844$1$I$20240304$20240906$20240913$20240913$EXP$$US-GSK-US2024111227$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$US$US
243178451$24317845$1$I$20240906$20240906$20240913$20240913$PER$$US-JNJFOC-20240924465$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$MD$US$US
243178461$24317846$1$I$$20240909$20240913$20240913$EXP$$RO-ROCHE-10000079500$ROCHE$$66$YR$E$F$Y$$$20240913$$MD$RO$RO
243178471$24317847$1$I$$20240906$20240913$20240913$EXP$$CL-JNJFOC-20240921375$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240913$$CN$CL$CL
243178501$24317850$1$I$20240512$20240723$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003132$PAREXEL$$77$YR$$F$Y$$$20240913$$CN$US$US
243178511$24317851$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263725$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240913$$MD$US$US
243178521$24317852$1$I$20200426$20240912$20240913$20240913$EXP$$US-SA-2024SA264883$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240913$$CN$US$US
243178542$24317854$2$F$20230101$20240909$20240913$20240916$PER$$US-PFIZER INC-202400252909$PFIZER$$67$YR$$M$Y$77.11$KG$20240916$$CN$US$US
243178551$24317855$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-PV202300116798$PFIZER$$47$YR$$M$Y$$$20240913$$MD$US$US
243178571$24317857$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2024-0658195$GILEAD$$74$YR$E$M$Y$$$20240913$$MD$US$US
243178581$24317858$1$I$$20240906$20240913$20240913$EXP$$US-TAKEDA-2020TUS001040$TAKEDA$$$$$M$Y$$$20240913$$CN$US$US
243178591$24317859$1$I$$20240902$20240913$20240913$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08907$LUPIN$Bierly JJ, Peterson BL. Distribution of Donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:1-6$69$YR$$$Y$$$20240913$$HP$US$US
243178602$24317860$2$F$$20240918$20240913$20240926$EXP$GB-MHRA-MIDB-5cc4d599-e189-497e-af68-6caf3191e77b$GB-TEVA-VS-3241411$TEVA$$16$YR$$F$Y$$$20240926$$PH$GB$GB
243178611$24317861$1$I$$20240903$20240913$20240913$30DAY$$US-GSK-US2024109519$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243178621$24317862$1$I$20240904$20240906$20240913$20240913$EXP$$CA-GSK-CA2023AMR098900$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$CA$CA
243178632$24317863$2$F$$20240916$20240913$20240918$EXP$$TW-009507513-2408TWN005967$MERCK$$65$YR$$M$Y$$$20240918$$MD$TW$TW
243178651$24317865$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2024-0658198$GILEAD$$73$YR$E$M$Y$$$20240913$$MD$US$US
243178661$24317866$1$I$$20240909$20240913$20240913$PER$$US-Karo Pharma-2161550$Karo Pharma$$30$YR$$M$Y$$$20240913$$MD$US$US
243178671$24317867$1$I$20240312$20240909$20240913$20240913$EXP$FR-AFSSAPS-DJ2024001012$FR-FreseniusKabi-FK202413655$FRESENIUS KABI$$59$YR$A$F$Y$65$KG$20240913$$MD$FR$FR
243178681$24317868$1$I$20240621$20240909$20240913$20240913$EXP$FR-AFSSAPS-AN2024001206$FR-FreseniusKabi-FK202413674$FRESENIUS KABI$$43$YR$A$F$Y$$$20240913$$MD$FR$FR
243178691$24317869$1$I$$20240909$20240913$20240913$EXP$$AT-FreseniusKabi-FK202413614$FRESENIUS KABI$$$$E$M$Y$55.7$KG$20240913$$HP$AT$AT
243178701$24317870$1$I$$20240910$20240913$20240913$EXP$$CO-BAYER-2024A130473$BAYER$$64$YR$A$M$Y$$$20240913$$MD$CO$CO
243178711$24317871$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240911$TEVA$$82$YR$$M$Y$102$KG$20240913$$MD$CA$CA
243178721$24317872$1$I$20240808$20240911$20240913$20240913$EXP$$DE-ORGANON-O2409DEU000778$ORGANON$$67$YR$$M$Y$$$20240913$$MD$DE$DE
243178731$24317873$1$I$20210310$20240909$20240913$20240913$EXP$$JP-009507513-2404JPN000034J$MERCK$$65$YR$$M$Y$$$20240913$$MD$JP$JP
243178741$24317874$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240929$TEVA$$72$YR$$F$Y$$$20240913$$HP$CA$CA
243178761$24317876$1$I$20240228$20240913$20240913$20240913$DIR$718263$$FDA-CTU$$72$YR$$F$N$70$KG$20240913$N$HP$US$
243178781$24317878$1$I$20240913$20240913$20240913$20240913$DIR$718264$$FDA-CTU$$59$YR$$F$N$$$20240913$N$PH$US$
243178791$24317879$1$I$20240912$20240913$20240913$20240913$DIR$718266$$FDA-CTU$$73$YR$$M$N$$$20240913$N$$US$
243178801$24317880$1$I$$20240913$20240913$20240913$DIR$718267$$FDA-CTU$$$$$UNK$N$$$20240913$$CN$US$
243178811$24317881$1$I$20240306$20240913$20240913$20240913$DIR$718268$$FDA-CTU$$59$YR$$F$N$63$KG$20240913$N$HP$US$
243178821$24317882$1$I$$20240617$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003323$PAREXEL$$47$YR$$F$Y$$$20240913$$CN$US$US
243178831$24317883$1$I$20240615$20240617$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002673$PAREXEL$$70$YR$$F$Y$$$20240913$$CN$US$US
243178841$24317884$1$I$20240906$20240906$20240913$20240913$EXP$$US-JNJFOC-20240924528$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$MD$US$US
243178851$24317885$1$I$20240101$20240911$20240913$20240913$PER$$US-PFIZER INC-202400254734$PFIZER$$$$$F$Y$$$20240913$$CN$US$US
243178861$24317886$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-2019237761$PFIZER$$14$YR$$M$Y$$$20240913$$CN$US$US
243178871$24317887$1$I$$20240725$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003597$PAREXEL$$85$YR$$F$Y$$$20240913$$CN$US$US
243178881$24317888$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-PV202400109823$PFIZER$$13$YR$$M$Y$$$20240913$$CN$US$US
243178892$24317889$2$F$$20240916$20240913$20240916$30DAY$$CO-PFIZER INC-202400097720$PFIZER$$8$YR$$M$Y$$$20240916$$CN$CO$CO
243178912$24317891$2$F$$20240911$20240913$20240918$PER$$US-PFIZER INC-202400254762$PFIZER$$20$YR$$F$Y$$$20240918$$MD$US$US
243178921$24317892$1$I$$20240911$20240913$20240913$PER$$US-PFIZER INC-202400255634$PFIZER$$$$A$F$Y$$$20240913$$HP$US$US
243178931$24317893$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-PV202400118812$PFIZER$$37$YR$$F$Y$$$20240913$$CN$US$US
243178941$24317894$1$I$$20240909$20240913$20240913$PER$$US-PFIZER INC-202400254084$PFIZER$$10$YR$$M$Y$$$20240913$$CN$US$US
243178951$24317895$1$I$$20240904$20240913$20240913$EXP$$US-APOTEX-2024AP010452$APOTEX$Ingole P, Morkas M, May R, Hinman B, Carrum G, Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$M$Y$$$20240913$$HP$US$US
243178961$24317896$1$I$20240906$20240912$20240913$20240913$EXP$$JP-BAYER-2024A130804$BAYER$$$$$M$Y$$$20240913$$MD$JP$JP
243178971$24317897$1$I$$20240905$20240913$20240913$PER$$US-ROCHE-10000076041$ROCHE$$31$YR$A$F$Y$$$20240913$$CN$US$US
243178981$24317898$1$I$$20240912$20240913$20240913$PER$$US-ALXN-202409USA000913US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243178991$24317899$1$I$$20240906$20240913$20240913$EXP$$JP-ROCHE-10000080102$ROCHE$Nishimoto Y, Itoi N, Miki H, Sasaki E, Komai M, Oohashi M. EP-1334 A case of enteritis pseudomembranous developed during preoperative chemotherapy. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 2024;511.$$$E$F$Y$39$KG$20240913$$MD$JP$JP
243179001$24317900$1$I$$20240910$20240913$20240913$EXP$$NVSC2024MY182972$NOVARTIS$$57$YR$$M$Y$$$20240913$$MD$MY$MY
243179021$24317902$1$I$$20240912$20240913$20240913$PER$$US-TAKEDA-2024TUS091147$TAKEDA$$$$$F$Y$37$KG$20240913$$MD$US$US
243179031$24317903$1$I$20240911$20240911$20240913$20240913$EXP$$US-TAKEDA-2023TUS111797$TAKEDA$$61$YR$$F$Y$$$20240913$$CN$US$US
243179041$24317904$1$I$$20240903$20240913$20240913$EXP$$CA-GILEAD-2024-0687212$GILEAD$$$$$F$Y$$$20240913$$HP$CA$CA
243179051$24317905$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264257$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240913$$MD$US$US
243179061$24317906$1$I$$20240910$20240913$20240913$PER$$US-AstraZeneca-2024A206726$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243179072$24317907$2$F$$20240912$20240913$20240913$PER$$NVSC2024US182958$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
243179081$24317908$1$I$$20240911$20240913$20240913$EXP$$US-SANDOZ INC.-SDZ2024US053720$SANDOZ$$$$$M$Y$77.551$KG$20240913$$PH$US$US
243179091$24317909$1$I$20210101$20240904$20240913$20240913$EXP$$US-PFIZER INC-PV202400116046$PFIZER$$83$YR$$M$Y$$$20240913$$MD$US$US
243179101$24317910$1$I$$20240903$20240913$20240913$EXP$$IN-BIOCON BIOLOGICS LIMITED-BBL2024006666$BIOCON$Mahdi RA, Krishnaraju VS, Mittal BR, Singh H, Kumar R, Prakash G. et.al.. Large Vessel Vasculitis in a Patient Receiving G-CSF: A Possible Differential for Fever of Unknown Origin.. Indian Journal of Nuclear Medicine.. 2024;39(3):224-6$$$$$Y$$$20240913$$MD$IN$IN
243179111$24317911$1$I$$20240904$20240913$20240913$30DAY$$US-GSK-US2024110178$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$CN$US$US
243179122$24317912$2$F$$20240920$20240913$20240927$EXP$$AR-GSK-AR2023AMR064839$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$PH$AR$AR
243179131$24317913$1$I$20230706$20240904$20240913$20240913$EXP$$CA-GSK-CA2023087383$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$CA$CA
243179141$24317914$1$I$$20240910$20240913$20240913$PER$$US-TAKEDA-2024TUS090570$TAKEDA$$$$$F$Y$$$20240913$$CN$US$US
243179151$24317915$1$I$$20240905$20240913$20240913$EXP$$US-Eisai-EC-2024-174280$EISAI$$61$YR$A$M$Y$$$20240913$$CN$US$US
243179161$24317916$1$I$$20240906$20240913$20240913$EXP$$CA-GSK-CA2023AMR093984$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$CA$CA
243179171$24317917$1$I$$20240902$20240913$20240913$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08905$LUPIN$Bierly JJ, Peterson BL. Distribution of Donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:1-6$82$YR$$$Y$$$20240913$$HP$US$US
243179182$24317918$2$F$$20240909$20240913$20240923$PER$$US-ROCHE-10000077649$ROCHE$$61$YR$A$M$Y$$$20240923$$CN$US$US
243179191$24317919$1$I$$20240905$20240913$20240913$EXP$GB-MHRA-MED-202409051036517840-DLRZS$GB-TEVA-VS-3240903$TEVA$$$$$F$Y$$$20240913$$CN$GB$GB
243179201$24317920$1$I$20240101$20240909$20240913$20240913$EXP$$CA-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005061$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240913$$HP$CA$CA
243179211$24317921$1$I$20190209$20240909$20240913$20240913$EXP$$FR-FreseniusKabi-FK202413598$FRESENIUS KABI$$36$YR$A$F$Y$47$KG$20240913$$HP$FR$FR
243179221$24317922$1$I$20190710$20240909$20240913$20240913$EXP$PT-INFARMED-B202408-640$PT-FreseniusKabi-FK202413690$FRESENIUS KABI$$41$YR$A$F$Y$$$20240913$$MD$PT$PT
243179231$24317923$1$I$20240524$20240909$20240913$20240913$EXP$FR-AFSSAPS-AN2024001202$FR-FreseniusKabi-FK202413675$FRESENIUS KABI$$41$YR$A$F$Y$88$KG$20240913$$MD$FR$FR
243179242$24317924$2$F$$20240829$20240913$20240916$PER$$US-SA-2024SA254444$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240916$$CN$US$US
243179251$24317925$1$I$$20240827$20240913$20240913$PER$$US-TEVA-VS-3238185$TEVA$$58$YR$$F$Y$65.77$KG$20240913$$CN$US$US
243179282$24317928$2$F$20230101$20240916$20240913$20240918$PER$$US-PFIZER INC-202400254429$PFIZER$$66$YR$$M$Y$77.11$KG$20240918$$CN$US$US
243179291$24317929$1$I$20240820$20240909$20240913$20240913$PER$$US-ROCHE-10000077593$ROCHE$$25$YR$A$F$Y$92.98$KG$20240913$$CN$US$US
243179301$24317930$1$I$$20240911$20240913$20240913$EXP$$US-GSK-US2024113077$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$US$US
243179311$24317931$1$I$$20240912$20240913$20240913$PER$$US-ALXN-202409USA000908US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240913$$CN$US$US
243179321$24317932$1$I$$20240912$20240913$20240913$PER$$US-ALXN-202409USA000867US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243179331$24317933$1$I$$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143172$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240913$$MD$US$US
243179341$24317934$1$I$20240101$20240910$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144728$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$65.77$KG$20240913$$PH$US$US
243179361$24317936$1$I$$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144285$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240913$$CN$US$US
243179371$24317937$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2024-0658194$GILEAD$$74$YR$E$F$Y$$$20240913$$MD$US$US
243179381$24317938$1$I$$20240907$20240913$20240913$PER$$US-JNJFOC-20240924352$JOHNSON AND JOHNSON$$76$YR$E$F$Y$59$KG$20240913$$HP$US$US
243179391$24317939$1$I$20240101$20240904$20240913$20240913$EXP$$US-RADIUS HEALTH INC.-2024US006447$RADIUS PHARM$$$$$F$Y$$$20240913$$CN$US$US
243179401$24317940$1$I$20240826$20240904$20240913$20240913$PER$$US-ABBVIE-5906796$ABBVIE$$50$YR$$F$Y$$$20240913$$CN$US$US
243179412$24317941$2$F$20240711$20240912$20240913$20240917$EXP$$NVSC2024GB151293$NOVARTIS$$34$YR$$M$Y$$$20240917$$CN$GB$GB
243179423$24317942$3$F$$20240913$20240913$20240920$EXP$$GB-ABBVIE-5917675$ABBVIE$$$$E$F$Y$$$20240920$$CN$GB$GB
243179432$24317943$2$F$20160101$20240909$20240913$20240917$EXP$$NVSC2024MX182238$NOVARTIS$$$$$M$Y$69$KG$20240918$$CN$MX$MX
243179441$24317944$1$I$20240801$20240823$20240913$20240913$EXP$$US-SA-2024SA263533$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240913$$MD$US$US
243179451$24317945$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63012$$FDA-CTU$$43$YR$$F$N$$$20240913$N$$US$
243179461$24317946$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63011$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243179481$24317948$1$I$$20240905$20240913$20240913$EXP$$RU-JNJFOC-20240930083$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240913$$HP$RU$RU
243179491$24317949$1$I$$20240906$20240913$20240913$EXP$$GB-SA-2024SA265102$SANOFI AVENTIS$$$$$$Y$$$20240913$$MD$GB$GB
243179501$24317950$1$I$20240406$20240905$20240913$20240913$EXP$$US-SA-2024SA211978$SANOFI AVENTIS$$89$YR$E$M$Y$217$KG$20240913$$MD$US$US
243179511$24317951$1$I$20240801$20240906$20240913$20240913$EXP$$CO-JNJFOC-20240921428$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$70$KG$20240913$$HP$CO$CO
243179521$24317952$1$I$$20240902$20240913$20240913$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08908$LUPIN$Bierly JJ, Peterson BL. Distribution of Donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:1-6$67$YR$$$Y$$$20240913$$HP$US$US
243179531$24317953$1$I$$20240909$20240913$20240913$PER$$US-BAYER-2024A129541$BAYER$Plante M.M.; Wang J.; Alhaj Moustafa M.. 73-Year-Old Man With Worsening Hematuria. Mayo Clinic Proceedings ()). 2024;99:9:1494-1499$73$YR$E$M$Y$$$20240913$$MD$US$US
243179541$24317954$1$I$$20240911$20240913$20240913$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024113103$VIIV$$$$$M$Y$$$20240913$$MD$US$US
243179551$24317955$1$I$$20240905$20240913$20240913$EXP$GB-MHRA-MIDB-a7fa5f05-1b57-4111-b6d1-a6c254e70685$GB-TEVA-VS-3241226$TEVA$$89$YR$$$Y$$$20240913$$PH$GB$GB
243179561$24317956$1$I$20240614$20240909$20240913$20240913$EXP$ES-AEMPS-1566611$ES-FreseniusKabi-FK202413608$FRESENIUS KABI$$75$YR$E$M$Y$$$20240913$$MD$ES$ES
243179571$24317957$1$I$20240729$20240909$20240913$20240913$EXP$LU-ALMPS-202404298$LU-FreseniusKabi-FK202413671$FRESENIUS KABI$$69$YR$E$M$Y$77$KG$20240913$$PH$LU$LU
243179581$24317958$1$I$20240801$20240909$20240913$20240913$EXP$FR-AFSSAPS-TS2024000954$FR-FreseniusKabi-FK202413635$FRESENIUS KABI$$70$YR$E$F$Y$45$KG$20240913$$MD$FR$FR
243179591$24317959$1$I$20240101$20240910$20240913$20240913$EXP$$US-ABBVIE-5918704$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243179601$24317960$1$I$20240805$20240906$20240913$20240913$EXP$$US-AMGEN-USASP2024178512$AMGEN$$71$YR$E$F$Y$$$20240913$$CN$US$US
243179611$24317961$1$I$20240903$20240912$20240913$20240913$PER$$US-AMGEN-USASP2024183227$AMGEN$$78$YR$E$F$Y$$$20240913$$CN$US$US
243179621$24317962$1$I$20201201$20240908$20240913$20240913$EXP$$PL-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00474$VELOXIS PHARMACEUTICALS$$49$YR$$M$Y$$$20240913$$HP$PL$PL
243179631$24317963$1$I$20240101$20240911$20240913$20240913$EXP$DE-BFARM-24006280$DE-ORGANON-O2409DEU000816$ORGANON$$35$YR$$F$Y$$$20240913$$MD$DE$DE
243179641$24317964$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263314$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240913$$MD$US$US
243179651$24317965$1$I$$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003736$PAREXEL$$58$YR$$F$Y$$$20240913$$CN$US$US
243179661$24317966$1$I$$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003743$PAREXEL$$81$YR$$F$Y$$$20240913$$CN$US$US
243179671$24317967$1$I$$20240909$20240913$20240913$DIR$FDA-CDER-CTU-2024-63013$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243179681$24317968$1$I$$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003739$PAREXEL$$62$YR$$F$Y$$$20240913$$CN$US$US
243179691$24317969$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63014$$FDA-CTU$$62$YR$$F$N$$$20240913$N$$US$
243179701$24317970$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63016$$FDA-CTU$$54$YR$$F$N$$$20240913$N$$US$
243179711$24317971$1$I$$20240617$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003699$PAREXEL$$34$YR$$F$Y$$$20240913$$CN$US$US
243179721$24317972$1$I$$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003760$PAREXEL$$78$YR$$F$Y$$$20240913$$CN$US$US
243179731$24317973$1$I$20240514$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003741$PAREXEL$$65$YR$$F$Y$$$20240913$$CN$US$US
243179741$24317974$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63015$$FDA-CTU$$17$YR$$F$N$105.69$KG$20240913$N$$US$
243179751$24317975$1$I$$20240909$20240913$20240913$EXP$$PT-009507513-2409PRT004158$MERCK$$6$DEC$$F$Y$$$20240913$$MD$PT$PT
243179761$24317976$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5919532$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243179771$24317977$1$I$$20240902$20240913$20240913$EXP$IN-MLMSERVICE-20240826-PI173251-00271-1$IN-STRIDES ARCOLAB LIMITED-2024SP011382$STRIDES$Ponnusamy R, Dasgupta P, Pai A. Intestinal Perforation in a Case of Peripheral T Cell Lymphoma after Initiation of Chemotherapy.. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi. 2024;84(2):90-4$59$YR$$M$Y$$$20240913$$MD$IN$IN
243179781$24317978$1$I$$20240911$20240913$20240913$PER$$US-JNJFOC-20240934146$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$HP$US$US
243179813$24317981$3$F$20190201$20240909$20240913$20240920$EXP$CN-MLMSERVICE-20240828-PI173177-00218-1$CN-STRIDES ARCOLAB LIMITED-2024SP011378$STRIDES$Gan H, Ren X, Zou Y, Li L, Ding J, Peng L, et al.. Rheumatoid arthritis complicated with cervical actinomycosis and ureteral obstruction: A case report and literature review.. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Med. 2024;49(5):818-24$60$YR$$F$Y$$$20240920$$MD$CN$CN
243179821$24317982$1$I$$20240910$20240913$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-042350$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240913$$MD$JP$JP
243179831$24317983$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145794$BRISTOL MYERS SQUIBB$$24$YR$A$F$Y$$$20240913$$MD$US$US
243179861$24317986$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2024-0658193$GILEAD$$72$YR$E$M$Y$$$20240913$$MD$US$US
243179871$24317987$1$I$$20240911$20240913$20240913$PER$$US-BIOVITRUM-2024-US-011943$BIOVITRUM$$63$YR$$M$Y$$$20240913$$CN$US$US
243179881$24317988$1$I$20240808$20240905$20240913$20240913$EXP$FR-AFSSAPS-RN2024000925$FR-TEVA-VS-3240909$TEVA$$36$YR$$F$Y$50$KG$20240913$$MD$FR$FR
243179891$24317989$1$I$20220101$20240902$20240913$20240913$EXP$IT-MLMSERVICE-20240826-PI172319-00097-1$IT-STRIDES ARCOLAB LIMITED-2024SP011417$STRIDES$Caorsi R, Bertoni A, Matucci-Cerinic C, Natoli V, Palmeri S, Rosina S, et al.. Long-term efficacy of MAS825, a bispecific anti-IL1? and IL-18 monoclonal antibody, in two patients with sJIA and recurrent episodes of MAS.. Rheumatology (Oxford, England).. 2024$20$YR$$M$Y$$$20240913$$MD$IT$IT
243179911$24317991$1$I$20240801$20240905$20240913$20240913$PER$$US-SA-2024SA264383$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240913$$HP$US$US
243179921$24317992$1$I$20240722$20240905$20240913$20240913$EXP$FR-AFSSAPS-TO2024001622$FR-TEVA-VS-3240944$TEVA$$69$YR$$M$Y$49.4$KG$20240913$$PH$FR$FR
243179931$24317993$1$I$$20240912$20240913$20240913$PER$$US-HALEON-2196715$Haleon PLC$$38$YR$$F$Y$$$20240913$$CN$US$US
243179951$24317995$1$I$20240101$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003707$PAREXEL$$73$YR$$F$Y$$$20240913$$CN$US$US
243179961$24317996$1$I$$20240617$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003693$PAREXEL$$61$YR$$F$Y$$$20240913$$CN$US$US
243179971$24317997$1$I$$20240617$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003843$PAREXEL$$58$YR$$F$Y$$$20240913$$CN$US$US
243179981$24317998$1$I$$20240908$20240913$20240913$PER$$US-TAKEDA-2024TUS090014$TAKEDA$$$$$$Y$$$20240913$$CN$US$US
243179991$24317999$1$I$20240911$20240911$20240913$20240913$PER$$US-JNJFOC-20240928175$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$US$US
243180002$24318000$2$F$20240811$20240913$20240913$20240917$EXP$$US-GSK-US2024113600$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$US$US
243180011$24318001$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240965$TEVA$$71$YR$$F$Y$$$20240913$$HP$CA$CA
243180021$24318002$1$I$$20240903$20240913$20240913$EXP$$CA-ROCHE-10000072875$ROCHE$$$$$F$Y$$$20240913$$HP$CA$CA
243180031$24318003$1$I$20240912$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63017$$FDA-CTU$$82$YR$$F$N$$$20240913$N$HP$US$
243180051$24318005$1$I$20211119$20240903$20240913$20240913$EXP$PL-URPL-DML-MLP.4401.1.5051.2021$PL-STRIDES ARCOLAB LIMITED-2024SP011268$STRIDES$$49$YR$$$Y$100$KG$20240913$$MD$PL$PL
243180061$24318006$1$I$20240809$20240910$20240913$20240913$EXP$$CN-FreseniusKabi-FK202413739$FRESENIUS KABI$$3$MON$I$F$Y$1.66$KG$20240913$$HP$CN$CN
243180071$24318007$1$I$20240729$20240911$20240913$20240913$EXP$IT-MINISAL02-1001344$IT-FreseniusKabi-FK202413718$FRESENIUS KABI$$18$YR$A$F$Y$$$20240913$$MD$IT$IT
243180081$24318008$1$I$20240827$20240911$20240913$20240913$EXP$IT-MINISAL02-1001359$IT-FreseniusKabi-FK202413727$FRESENIUS KABI$$23$YR$A$F$Y$$$20240913$$MD$IT$IT
243180091$24318009$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63018$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243180101$24318010$1$I$20240215$20240904$20240913$20240913$EXP$$US-SA-2024SA264824$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240913$$CN$US$US
243180121$24318012$1$I$20240821$20240911$20240913$20240913$EXP$$NVSC2024AU173926$NOVARTIS$$75$YR$$M$Y$$$20240913$$HP$AU$AU
243180131$24318013$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264269$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240913$$HP$US$US
243180141$24318014$1$I$$20240823$20240913$20240913$PER$$US-SA-2024SA264166$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240913$$MD$US$US
243180152$24318015$2$F$20240822$20240827$20240913$20240919$PER$$US-SA-2024SA264215$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240919$$CN$US$US
243180161$24318016$1$I$20240901$20240904$20240913$20240913$PER$$US-SA-2024SA263218$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240913$$MD$US$US
243180181$24318018$1$I$20220329$20240905$20240913$20240913$PER$$US-SA-2024SA264291$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240913$$HP$US$US
243180191$24318019$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264275$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240913$$HP$US$US
243180201$24318020$1$I$$20240902$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409002233$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240913$$CN$US$US
243180211$24318021$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007478$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240913$$CN$US$US
243180221$24318022$1$I$$20240903$20240913$20240913$30DAY$$US-GSK-US2024109542$GLAXOSMITHKLINE$$$$A$F$Y$$$20240913$$CN$US$US
243180231$24318023$1$I$$20240911$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007282$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240913$$CN$US$US
243180241$24318024$1$I$20240911$20240912$20240913$20240913$PER$$US-AMGEN-USASP2024183366$AMGEN$$$$$M$Y$$$20240913$$CN$US$US
243180251$24318025$1$I$20240601$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145241$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240913$$CN$US$US
243180261$24318026$1$I$$20240912$20240913$20240913$PER$$US-HALEON-2196733$Haleon PLC$$$$$M$Y$$$20240913$$CN$US$US
243180271$24318027$1$I$20240701$20240911$20240913$20240913$PER$$US-ALXN-202409USA000774US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243180281$24318028$1$I$$20240912$20240913$20240913$PER$$US-ALXN-202409USA000923US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243180291$24318029$1$I$20231001$20240909$20240913$20240913$EXP$$TR-NOVEN PHARMACEUTICALS, INC.-2024-NOV-TR001175$PAREXEL$Buyukkal U., Temelturk R.D., Tekin D. Acute Dystonic Reaction Following Methylphenidate Discontinuation During Combination Therapy with Risperidone: A Case Study. J Ankara Univ Fac Med. 2024;77(2):222-226$6$YR$$M$Y$$$20240913$$MD$TR$TR
243180301$24318030$1$I$20240901$20240906$20240913$20240913$EXP$GB-MHRA-MED-202409060855364380-WBSKM$GB-DUCHESNAY-2024GB000366$DUCHESNAY$$$$$$Y$$$20240913$$CN$GB$GB
243180311$24318031$1$I$$20240823$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000255$MERZ$$$$$M$Y$$$20240913$$CN$US$US
243180321$24318032$1$I$20220904$20240906$20240913$20240913$EXP$$HK-AstraZeneca-2024A206144$ASTRAZENECA$Yin C.. Therapeutic Management of Unresectable Stage III Non-small Cell Lung Cancer with DurvalumabTherapeutic Management of Unresectable Stage III Non-small Cell Lung Cancer with Durvalumab.$51$YR$$M$Y$$$20240913$$MD$HK$
243180331$24318033$1$I$$20240910$20240913$20240913$EXP$$US-AstraZeneca-2024A206202$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243180341$24318034$1$I$$20240905$20240913$20240913$EXP$$GB-AstraZeneca-2024A203752$ASTRAZENECA$Nana M, Gregori M, Chandler E, Powell H, Goulden B, Watts T, Dhanjal M, Nelson-Piercy C.. Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study. Lancet Rheumatol 2024;6:e625?35.$$$N$$Y$$$20240913$$HP$GB$
243180351$24318035$1$I$$20240823$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000256$MERZ$$91$YR$$F$Y$$$20240913$$HP$US$US
243180361$24318036$1$I$20240831$20240906$20240913$20240913$EXP$$US-Vifor (International) Inc.-VIT-2024-08116$VIFOR$$65$YR$$F$Y$113.9$KG$20240913$$HP$US$US
243180372$24318037$2$F$20240522$20240918$20240913$20240925$EXP$$NVSC2024GR112852$NOVARTIS$$52$YR$$F$Y$$$20240925$$CN$GR$GR
243180381$24318038$1$I$$20240912$20240913$20240913$PER$$US-ROCHE-10000081080$ROCHE$$46$YR$A$F$Y$$$20240913$$MD$US$US
243180391$24318039$1$I$$20240904$20240913$20240913$EXP$$US-ALKERMES INC.-ALK-2024-002376$ALKERMES$$$$$M$Y$$$20240913$$HP$US$US
243180401$24318040$1$I$20240810$20240911$20240913$20240913$EXP$IT-MINISAL02-1001206$IT-FreseniusKabi-FK202413681$FRESENIUS KABI$$38$YR$A$F$Y$$$20240913$$MD$IT$IT
243180411$24318041$1$I$$20240913$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146274$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240913$$CN$US$US
243180421$24318042$1$I$$20240905$20240913$20240913$EXP$GB-MHRA-MED-202409051119214520-ZNMFS$GB-TEVA-VS-3241119$TEVA$$82$YR$$F$Y$63$KG$20240913$$PH$GB$GB
243180431$24318043$1$I$$20240911$20240913$20240913$EXP$GB-MHRA-MED-202409111600130520-LCVQZ$GB-ORGANON-O2409GBR000802$ORGANON$$$$$M$Y$72$KG$20240913$$HP$GB$GB
243180441$24318044$1$I$20240401$20240905$20240913$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013391$UNITED THERAPEUTICS$$76$YR$$F$Y$63.492$KG$20240913$$$US$US
243180451$24318045$1$I$20240522$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63024$$FDA-CTU$$36$YR$$F$N$$$20240913$N$CN$US$
243180471$24318047$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63026$$FDA-CTU$$64$YR$$F$N$0$KG$20240913$N$$US$
243180481$24318048$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63025$$FDA-CTU$$61$YR$$F$N$95.25$KG$20240913$N$$US$
243180511$24318051$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA263158$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240913$$HP$US$US
243180521$24318052$1$I$$20240905$20240913$20240913$EXP$$US-ORGANON-O2409USA000376$ORGANON$$$$$M$Y$$$20240913$$CN$US$US
243180531$24318053$1$I$$20240912$20240913$20240913$PER$$NVSC2024US183776$NOVARTIS$$$$$F$Y$$$20240913$$HP$US$US
243180541$24318054$1$I$20240808$20240905$20240913$20240913$EXP$$CN-009507513-2409CHN003223$MERCK$$81$YR$$M$Y$50$KG$20240913$$HP$CN$CN
243180551$24318055$1$I$$20240902$20240913$20240913$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000295$NOVAST$$$$$$Y$$$20240913$$HP$CN$CN
243180581$24318058$1$I$$20240823$20240913$20240913$PER$$DO-TOLMAR, INC.-24DO052159$TOLMAR$$$$$M$Y$$$20240913$$CN$DO$DO
243180591$24318059$1$I$$20240824$20240913$20240913$PER$$CA-TOLMAR, INC.-24CA052150$TOLMAR$$$$$M$Y$$$20240913$$CN$CA$CA
243180601$24318060$1$I$$20240824$20240913$20240913$PER$$CA-TOLMAR, INC.-24CA052162$TOLMAR$$$$$M$Y$$$20240913$$CN$CA$CA
243180621$24318062$1$I$$20240827$20240913$20240913$PER$$DO-TOLMAR, INC.-24DO052200$TOLMAR$$$$$M$Y$$$20240913$$CN$DO$DO
243180631$24318063$1$I$20240822$20240823$20240913$20240913$PER$$US-TOLMAR, INC.-24US052114$TOLMAR$$$$$$Y$$$20240913$$HP$US$US
243180641$24318064$1$I$$20240815$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000142$MERZ$$58$YR$$M$Y$$$20240913$$HP$US$US
243180651$24318065$1$I$20240823$20240823$20240913$20240913$PER$$US-TOLMAR, INC.-24US052104$TOLMAR$$39$YR$$F$Y$$$20240913$$MD$US$US
243180661$24318066$1$I$$20240823$20240913$20240913$PER$$US-TOLMAR, INC.-24US052154$TOLMAR$$$$$M$Y$$$20240913$$HP$US$US
243180681$24318068$1$I$20231201$20240823$20240913$20240913$PER$$US-TOLMAR, INC.-24US052188$TOLMAR$$38$YR$$F$Y$$$20240913$$PH$US$US
243180691$24318069$1$I$$20240906$20240913$20240913$EXP$$US-GSK-US2022044589$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$US$US
243180701$24318070$1$I$20240801$20240819$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000204$MERZ$$70$YR$$F$Y$$$20240913$$CN$US$US
243180711$24318071$1$I$20240909$20240909$20240913$20240913$PER$$US-JNJFOC-20240923967$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240913$$CN$US$US
243180721$24318072$1$I$$20240814$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000126$MERZ$$$$$$Y$$$20240913$$HP$US$US
243180731$24318073$1$I$20220901$20240910$20240913$20240913$EXP$$RU-SANDOZ INC.-SDZ2024RU079136$SANDOZ$$$$$F$Y$$$20240913$$MD$RU$RU
243180741$24318074$1$I$$20240821$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000216$MERZ$$28$YR$$M$Y$$$20240913$$HP$US$US
243180751$24318075$1$I$$20240814$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000127$MERZ$$$$$$Y$$$20240913$$HP$US$US
243180761$24318076$1$I$$20240822$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000218$MERZ$$$$$$Y$$$20240913$$HP$US$US
243180771$24318077$1$I$$20200921$20240913$20240913$EXP$$NVSC2020AU371142$NOVARTIS$$$$$$Y$$$20240913$$HP$AU$AU
243180781$24318078$1$I$$20211027$20240913$20240913$EXP$$NVSC2021CZ318477$NOVARTIS$$$$$$Y$$$20240913$$MD$CZ$CZ
243180791$24318079$1$I$20210624$20210624$20240913$20240913$EXP$$NVSC2021ES318478$NOVARTIS$$$$$$Y$$$20240913$$MD$ES$ES
243180801$24318080$1$I$$20210624$20240913$20240913$EXP$$NVSC2021ES318479$NOVARTIS$$$$$$Y$$$20240913$$MD$ES$ES
243180811$24318081$1$I$$20240821$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000215$MERZ$$35$YR$$F$Y$$$20240913$$HP$US$US
243180821$24318082$1$I$$20240819$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000188$MERZ$$$$A$F$Y$$$20240913$$HP$US$US
243180831$24318083$1$I$$20240912$20240913$20240913$EXP$GB-MHRA-TPP4393410C122126YC1726041685798$GB-ABBVIE-5922396$ABBVIE$$34$YR$$F$Y$$$20240913$$MD$GB$GB
243180841$24318084$1$I$20240910$20240911$20240913$20240913$30DAY$$IT-SANDOZ INC.-SDZ2024IT079880$SANDOZ$$12$YR$$F$Y$33$KG$20240913$$CN$IT$IT
243180871$24318087$1$I$20240831$20240906$20240913$20240913$EXP$$CN-SA-2024SA261709$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240913$$HP$CN$CN
243180881$24318088$1$I$$20240814$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000125$MERZ$$$$$$Y$$$20240913$$HP$US$US
243180891$24318089$1$I$20240101$20240830$20240913$20240913$EXP$$US-UCBSA-2024044996$UCB$$$$$F$Y$101.13$KG$20240913$$HP$US$US
243180905$24318090$5$F$20240724$20240926$20240913$20240927$EXP$AT-BASGAGES-2024-006661$AT-BIOVITRUM-2024-AT-011980$BIOVITRUM$$61$YR$$F$Y$$$20240927$$MD$AT$AT
243180911$24318091$1$I$20231207$20240911$20240913$20240913$PER$$US-BIOVITRUM-2024-US-011952$BIOVITRUM$$80$YR$$F$Y$$$20240913$$CN$US$US
243180921$24318092$1$I$20240101$20240813$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000117$MERZ$$63$YR$$F$Y$$$20240913$$CN$US$US
243180931$24318093$1$I$$20240619$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003702$PAREXEL$$75$YR$$F$Y$$$20240913$$CN$US$US
243180941$24318094$1$I$$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003705$PAREXEL$$60$YR$$F$Y$$$20240913$$CN$US$US
243180951$24318095$1$I$$20240619$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003704$PAREXEL$$52$YR$$F$Y$$$20240913$$CN$US$US
243180961$24318096$1$I$$20240620$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003869$PAREXEL$$72$YR$$F$Y$$$20240913$$CN$US$US
243180971$24318097$1$I$$20240621$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003709$PAREXEL$$76$YR$$F$Y$$$20240913$$CN$US$US
243180981$24318098$1$I$$20240619$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003874$PAREXEL$$$$A$F$Y$$$20240913$$MD$US$US
243180991$24318099$1$I$$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003714$PAREXEL$$62$YR$$F$Y$$$20240913$$CN$US$US
243181001$24318100$1$I$$20240619$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003687$PAREXEL$$62$YR$$F$Y$$$20240913$$HP$US$US
243181011$24318101$1$I$20240616$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003713$PAREXEL$$58$YR$$F$Y$$$20240913$$CN$US$US
243181021$24318102$1$I$20240615$20240619$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003873$PAREXEL$$71$YR$$F$Y$$$20240913$$CN$US$US
243181031$24318103$1$I$$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003752$PAREXEL$$64$YR$$F$Y$$$20240913$$CN$US$US
243181041$24318104$1$I$$20240620$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003876$PAREXEL$$71$YR$$F$Y$$$20240913$$CN$US$US
243181051$24318105$1$I$$20240621$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003729$PAREXEL$$70$YR$$F$Y$$$20240913$$CN$US$US
243181061$24318106$1$I$$20240906$20240913$20240913$EXP$$US-BAYER-2024A128374$BAYER$$70$YR$E$M$Y$$$20240913$$CN$US$US
243181071$24318107$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63028$$FDA-CTU$$54$YR$$F$N$93.89$KG$20240913$N$HP$US$
243181081$24318108$1$I$20240609$20240904$20240912$20240912$DIR$FDA-CDER-CTU-2024-62785$$FDA-CTU$$33$YR$$F$N$247$LBS$20240904$N$CN$US$
243181091$24318109$1$I$$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003726$PAREXEL$$60$YR$$F$Y$$$20240913$$CN$US$US
243181101$24318110$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145752$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$55.79$KG$20240913$$CN$US$US
243181111$24318111$1$I$20240101$20240906$20240913$20240913$PER$$CA-Eisai-EC-2024-174338$EISAI$$71$YR$E$M$Y$$$20240913$$CN$CA$CA
243181121$24318112$1$I$$20240824$20240913$20240913$PER$$CA-TOLMAR, INC.-24CA052163$TOLMAR$$$$$M$Y$$$20240913$$CN$CA$CA
243181141$24318114$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024181874$AMGEN$$$$$F$Y$$$20240913$$CN$US$US
243181162$24318116$2$F$20240909$20240913$20240913$20240917$PER$$US-AMGEN-USASP2024183217$AMGEN$$$$A$$Y$$$20240917$$PH$US$US
243181171$24318117$1$I$$20240910$20240913$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US079521$SANDOZ$$$$$$Y$$$20240913$$CN$US$US
243181191$24318119$1$I$20210820$20240904$20240913$20240913$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2021-30511$IPSEN$$81$YR$E$F$Y$$$20240913$$MD$JP$JP
243181201$24318120$1$I$20201101$20240830$20240913$20240913$PER$$US-SA-2024SA260640$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240913$$HP$US$US
243181211$24318121$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA264522$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240913$$HP$US$US
243181221$24318122$1$I$$20240906$20240913$20240913$EXP$$US-AstraZeneca-2024A205412$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243181231$24318123$1$I$$20240910$20240913$20240913$EXP$$US-AstraZeneca-2024A206550$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243181241$24318124$1$I$$20240909$20240913$20240913$EXP$$US-AstraZeneca-2024A205140$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243181251$24318125$1$I$$20240910$20240913$20240913$EXP$$US-AstraZeneca-2024A206869$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243181261$24318126$1$I$$20240909$20240913$20240913$EXP$$CH-SANDOZ INC.-SDZ2024CH079214$SANDOZ$Corbisier T, Von Bueren AO, Breunis WB and Grazioli S. Role of molecular adsorbent recirculating system in methotrexate-induced acute liver failure: a case report and literaturereview.. Frontiers in pediatrics. 2024$14$YR$$F$Y$$$20240913$$HP$CH$CH
243181281$24318128$1$I$$20240910$20240913$20240913$PER$$NVSC2024US182191$NOVARTIS$$$$$F$Y$$$20240913$$CN$US$US
243181291$24318129$1$I$$20240911$20240913$20240913$EXP$$NVSC2024CA183300$NOVARTIS$$73$YR$$F$Y$66$KG$20240913$$HP$CA$CA
243181301$24318130$1$I$20230820$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014113$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243181311$24318131$1$I$$20240911$20240913$20240913$EXP$$NVSC2024CA182946$NOVARTIS$$43$YR$$M$Y$$$20240913$$HP$CA$CA
243181321$24318132$1$I$$20240910$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144718$BRISTOL MYERS SQUIBB$$42$YR$A$M$Y$$$20240913$$CN$US$US
243181331$24318133$1$I$$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142713$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240913$$PH$US$US
243181341$24318134$1$I$20240101$20240910$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144764$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$57.61$KG$20240913$$CN$US$US
243181351$24318135$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145180$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240913$$CN$US$US
243181361$24318136$1$I$$20240903$20240913$20240913$EXP$$KR-CORZA MEDICAL GMBH-2024-KR-002263$Unknown Manufacturer$Chun YM, Lee SH, Moon KS, and Chang MC.. Treatment of dural tear with nerve root herniation after unilateral biportal endoscopic decompression using an epidural blood patch: a case report. Journal of International Medical Research. 2022;Vol. 50(12):1-5$60$YR$$M$Y$$$20240913$$HP$KR$KR
243181371$24318137$1$I$20240501$20240912$20240913$20240913$EXP$FR-AFSSAPS-LY2024001372$FR-BIOVITRUM-2024-FR-011973$BIOVITRUM$$72$YR$$F$Y$73$KG$20240913$$PH$FR$FR
243181381$24318138$1$I$20240910$20240910$20240913$20240913$EXP$$AU-ABBVIE-5917801$ABBVIE$$79$YR$$M$Y$$$20240913$$CN$AU$AU
243181391$24318139$1$I$20240816$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014114$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243181401$24318140$1$I$$20240912$20240913$20240913$PER$$US-ALXN-202409USA000896US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240913$$CN$US$US
243181421$24318142$1$I$$20240830$20240913$20240913$PER$$US-Calliditas-2024CAL01711$CALLIDITAS THERAPEUTICS$$$$$F$Y$$$20240913$$MD$US$US
243181431$24318143$1$I$$20240912$20240913$20240913$PER$$US-AMGEN-USASP2024182861$AMGEN$$$$$F$Y$$$20240913$$CN$US$US
243181441$24318144$1$I$20240822$20240905$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014122$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243181451$24318145$1$I$$20240906$20240913$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145917$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240913$$MD$JP$JP
243181461$24318146$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145908$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$95.71$KG$20240913$$CN$US$US
243181471$24318147$1$I$20240709$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145535$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240913$$CN$US$US
243181481$24318148$1$I$20240903$20240904$20240913$20240913$EXP$$US-GSK-US2024110150$GLAXOSMITHKLINE$$42$YR$$M$Y$$$20240913$$CN$US$US
243181492$24318149$2$F$$20240917$20240913$20240923$PER$$US-LEO Pharma-373440$LEO PHARM$$35$YR$$F$Y$$$20240923$$HP$US$US
243181501$24318150$1$I$$20240909$20240913$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US078989$SANDOZ$$$$$$Y$$$20240913$$CN$US$US
243181511$24318151$1$I$$20240905$20240913$20240913$30DAY$$US-GSK-US2024110781$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$CN$US$US
243181521$24318152$1$I$20240831$20240906$20240913$20240913$EXP$$CN-SA-2024SA261958$SANOFI AVENTIS$$59$YR$A$M$Y$61.3$KG$20240913$$HP$CN$CN
243181531$24318153$1$I$20231101$20240904$20240913$20240913$PER$$US-SA-2024SA264292$SANOFI AVENTIS$$7$MON$I$F$Y$$$20240913$$MD$US$US
243181541$24318154$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA263263$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240913$$MD$US$US
243181561$24318156$1$I$20200901$20240911$20240913$20240913$EXP$$AT-PFIZER INC-202400254329$PFIZER$$71$YR$$M$Y$57$KG$20240913$$MD$AT$AT
243181571$24318157$1$I$20240701$20240912$20240913$20240913$EXP$$JP-PFIZER INC-PV202400119687$PFIZER$$$$E$F$Y$$$20240913$$MD$JP$JP
243181581$24318158$1$I$$20240907$20240913$20240913$EXP$$US-SANDOZ INC.-SDZ2024US078674$SANDOZ$$$$$$Y$$$20240913$$CN$US$US
243181591$24318159$1$I$20230120$20240909$20240913$20240913$EXP$FR-AFSSAPS-PC2024000680$FR-009507513-2409FRA003076$MERCK$$50$YR$$F$Y$$$20240913$$PH$FR$FR
243181601$24318160$1$I$$20240912$20240913$20240913$EXP$$CA-SANDOZ INC.-NVSC2021CA225307$SANDOZ$$49$YR$$F$Y$$$20240913$$HP$CA$CA
243181611$24318161$1$I$20240901$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63032$$FDA-CTU$$81$YR$$M$N$$$20240913$N$HP$US$
243181621$24318162$1$I$$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-63020$$FDA-CTU$$$$$M$N$$$20240912$N$HP$US$
243181631$24318163$1$I$20240808$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63029$$FDA-CTU$$82$YR$$F$N$$$20240913$Y$PH$US$
243181641$24318164$1$I$20231201$20240912$20240912$20240912$DIR$718215$$FDA-CTU$$40$YR$$F$N$88.65$KG$20240912$N$CN$US$
243181651$24318165$1$I$20240826$20240909$20240913$20240913$PER$$US-BRACCO-2024US05671$BRACCO$$75$YR$$F$Y$$$20240913$$HP$US$US
243181661$24318166$1$I$20220705$20240905$20240913$20240913$EXP$$US-SA-2024SA264552$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240913$$HP$US$US
243181671$24318167$1$I$20240830$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024179692$AMGEN$$70$YR$E$M$Y$$$20240913$$CN$US$US
243181691$24318169$1$I$20240601$20240910$20240913$20240913$EXP$FR-AFSSAPS-AN2024001209$FR-AMGEN-FRASP2024180685$AMGEN$$34$YR$A$F$Y$88$KG$20240913$$MD$FR$FR
243181711$24318171$1$I$$20240906$20240913$20240913$EXP$$JP-AstraZeneca-2024A206214$ASTRAZENECA$$$$$$Y$$$20240913$$PH$JP$
243181721$24318172$1$I$$20240829$20240913$20240913$EXP$$KR-AstraZeneca-2024A199071$ASTRAZENECA$$58$YR$$F$Y$$$20240913$$CN$KR$
243181731$24318173$1$I$20190806$20240910$20240913$20240913$EXP$$AU-TAKEDA-2024TUS090894$TAKEDA$$62$YR$$M$Y$$$20240913$$MD$AU$AU
243181751$24318175$1$I$20240101$20240905$20240913$20240913$PER$$US-SA-2024SA263425$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240913$$HP$US$US
243181761$24318176$1$I$20240801$20240904$20240913$20240913$PER$$US-SA-2024SA167431$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240913$$HP$US$US
243181771$24318177$1$I$20240101$20240905$20240913$20240913$PER$$US-SA-2024SA262783$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240913$$MD$US$US
243181781$24318178$1$I$$20240821$20240913$20240913$PER$$US-SA-2024SA263373$SANOFI AVENTIS$$$$$F$Y$$$20240913$$MD$US$US
243181791$24318179$1$I$20240902$20240905$20240913$20240913$EXP$$US-SA-2024SA265277$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240913$$MD$US$US
243181801$24318180$1$I$$20240830$20240913$20240913$PER$$US-SA-2024SA263840$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240913$$CN$US$US
243181811$24318181$1$I$$20240910$20240913$20240913$EXP$$US-AstraZeneca-2024A206568$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243181831$24318183$1$I$$20240909$20240913$20240913$EXP$$GB-AstraZeneca-2024A205050$ASTRAZENECA$$$$C$$Y$$$20240913$$MD$GB$
243181851$24318185$1$I$20240701$20240911$20240913$20240913$EXP$$CA-TAKEDA-2024TUS041778$TAKEDA$$69$YR$$M$Y$$$20240913$$CN$CA$CA
243181861$24318186$1$I$$20240910$20240913$20240913$EXP$$ME-JNJFOC-20240931480$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$MD$ME$ME
243181871$24318187$1$I$$20240912$20240913$20240913$PER$$US-ALXN-202409USA000876US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243181881$24318188$1$I$$20240829$20240913$20240913$PER$$US-ALXN-202408USA002043US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240913$$HP$US$US
243181892$24318189$2$F$20240805$20240912$20240913$20240916$PER$$US-ALXN-202409USA000883US$ALEXION PHARMACEUTICALS$$38$YR$$M$Y$$$20240916$$MD$US$US
243181901$24318190$1$I$20240706$20240906$20240913$20240913$PER$$IT-KARYOPHARM-2024KPT001435$KARYOPHARM THERAPEUTICS$$85$YR$$F$Y$$$20240913$$MD$IT$IT
243181911$24318191$1$I$$20240909$20240913$20240913$PER$$US-HALEON-2196100$Haleon PLC$$$$$$Y$$$20240913$$CN$US$US
243181921$24318192$1$I$20240818$20240906$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014135$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243181931$24318193$1$I$20221019$20240903$20240913$20240913$EXP$$IT-BAXTER-2024BAX024179$BAXTER$$80$YR$$M$Y$77$KG$20240913$$MD$IT$IT
243181941$24318194$1$I$$20240904$20240913$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2022-US-027239$JAZZ$$$$$F$Y$88.435$KG$20240913$$MD$US$US
243181961$24318196$1$I$$20240904$20240913$20240913$30DAY$$US-GSK-US2024110257$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$CN$US$US
243181971$24318197$1$I$20240906$20240906$20240913$20240913$30DAY$$US-GSK-US2024111415$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243181981$24318198$1$I$$20240911$20240913$20240913$PER$$US-Millicent Holdings Ltd.-MILL20241146$MILLICENT HOLDINGS$$$$$F$Y$$$20240913$$CN$US$US
243181991$24318199$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5917829$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243182001$24318200$1$I$20240601$20240910$20240913$20240913$PER$$US-ORGANON-O2409USA000750$ORGANON$$21$YR$$F$Y$65$KG$20240913$$CN$US$US
243182011$24318201$1$I$20240816$20240907$20240913$20240913$PER$HR-HALMED-300086415$HR-LEO Pharma-373338$LEO PHARM$$1$YR$$F$Y$$$20240912$$MD$HR$HR
243182021$24318202$1$I$20240501$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007737$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240913$$CN$US$US
243182041$24318204$1$I$20240907$20240912$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409008445$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240913$$CN$US$US
243182052$24318205$2$F$20220501$20240905$20240913$20240920$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390009$RANBAXY$$50$YR$A$M$Y$$$20240920$$MD$AU$AU
243182061$24318206$1$I$20240101$20240905$20240913$20240913$EXP$$US-UNITED THERAPEUTICS-UNT-2024-014593$UNITED THERAPEUTICS$$$$$M$Y$86.621$KG$20240913$$$US$US
243182081$24318208$1$I$$20240909$20240913$20240913$EXP$$CA-TAKEDA-2024TUS090315$TAKEDA$$$$$F$Y$$$20240913$$CN$CA$CA
243182091$24318209$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MED-202409041405391010-BPMQY$GB-AMAROX PHARMA-AMR2024GB02984$HETERO$$73$YR$$F$Y$52$KG$20240913$$CN$GB$GB
243182101$24318210$1$I$$20240910$20240913$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-146111$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240913$$MD$JP$JP
243182111$24318211$1$I$$20240829$20240913$20240913$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00437$Alora Pharma$N. Chalasani, H. L. Bonkovsky, J. G. Stine. et.al.. Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study.. J Hepatol.. 2022;76(4): 832-840$75$YR$$M$Y$$$20240913$$MD$US$US
243182121$24318212$1$I$20221215$20240903$20240913$20240913$EXP$FR-AFSSAPS-MP2024001335$FR-TEVA-VS-3240024$TEVA$$0$DY$$F$Y$2.92$KG$20240913$$MD$FR$PF
243182131$24318213$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63019$$FDA-CTU$$75$YR$$F$N$$$20240913$N$$US$
243182151$24318215$1$I$$20240910$20240913$20240913$EXP$$US-JNJFOC-20240929872$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243182161$24318216$1$I$20240907$20240913$20240913$20240913$DIR$718238$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243182172$24318217$2$F$20240101$20240918$20240913$20240927$EXP$$JP-GALDERMA-JP2024013697$GALDERMA$$$$$$Y$$$20240927$$MD$JP$JP
243182181$24318218$1$I$$20240826$20240913$20240913$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08572$LUPIN$$$$$$Y$$$20240913$$CN$US$US
243182191$24318219$1$I$$20240911$20240913$20240913$EXP$$US-TAKEDA-2024TUS091095$TAKEDA$$$$$F$Y$$$20240913$$MD$US$US
243182201$24318220$1$I$20240907$20240913$20240913$20240913$DIR$718238$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243182221$24318222$1$I$20240912$20240913$20240913$20240913$DIR$718249$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243182241$24318224$1$I$$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-63056$$FDA-CTU$$$$$F$N$$$20240912$N$HP$US$
243182251$24318225$1$I$20240913$20240913$20240913$20240913$DIR$718251$$FDA-CTU$$80$YR$$F$N$$$20240913$Y$$US$
243182261$24318226$1$I$20240912$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63057$$FDA-CTU$$55$YR$$M$N$$$20240913$N$$US$
243182271$24318227$1$I$20240830$20240912$20240912$20240912$DIR$718146$$FDA-CTU$$56$YR$$M$N$75.15$KG$20240912$N$MD$US$
243182281$24318228$1$I$$20240913$20240913$20240913$DIR$718262$$FDA-CTU$$$$$UNK$N$$$20240913$$CN$US$
243182291$24318229$1$I$$20240912$20240913$20240913$EXP$$US-BAYER-2024A130824$BAYER$$64$YR$A$M$Y$$$20240913$$MD$US$US
243182301$24318230$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA262824$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240913$$MD$US$US
243182311$24318231$1$I$20240901$20240904$20240913$20240913$PER$$US-SA-2024SA263598$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240913$$HP$US$US
243182321$24318232$1$I$20240101$20240906$20240913$20240913$EXP$$US-ABBVIE-5906095$ABBVIE$$$$$F$Y$82$KG$20240913$$CN$US$US
243182331$24318233$1$I$$20240906$20240913$20240913$PER$$US-JNJFOC-20240919820$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$HP$US$US
243182341$24318234$1$I$$20240910$20240913$20240913$EXP$$US-FreseniusKabi-FK202413695$FRESENIUS KABI$$76$YR$E$F$Y$$$20240913$$MD$US$US
243182351$24318235$1$I$$20240905$20240913$20240913$EXP$$GB-TEVA-VS-3241218$TEVA$$75$YR$$F$Y$$$20240913$$HP$GB$GB
243182361$24318236$1$I$$20240904$20240913$20240913$EXP$$US-ABBVIE-5907987$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243182371$24318237$1$I$$20240904$20240913$20240913$EXP$$GB-BAUSCH-BL-2024-013669$BAUSCH AND LOMB$$70$YR$$M$Y$125$KG$20240913$$MD$GB$GB
243182382$24318238$2$F$$20240903$20240913$20240919$EXP$$JP-BAUSCH-BL-2024-013643$BAUSCH AND LOMB$$81$YR$$F$Y$$$20240919$$HP$JP$JP
243182391$24318239$1$I$20240501$20240910$20240913$20240913$EXP$$US-ABBVIE-5918848$ABBVIE$$25$YR$$M$Y$$$20240913$$CN$US$US
243182401$24318240$1$I$$20240905$20240913$20240913$EXP$$FR-TAKEDA-2024TUS090990$TAKEDA$$48$YR$$F$Y$$$20240913$$CN$FR$FR
243182411$24318241$1$I$20230911$20240905$20240913$20240913$EXP$$GB-TAKEDA-2023TUS104891$TAKEDA$$$$E$M$Y$$$20240913$$CN$GB$GB
243182421$24318242$1$I$20240101$20240906$20240913$20240913$EXP$$US-ABBVIE-5915527$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243182431$24318243$1$I$$20240909$20240913$20240913$EXP$$IT-BAUSCH-BL-2024-013594$BAUSCH AND LOMB$Trave I, Salvi I, Micalizzi C, Castelli R, Parodi A, Cozzani E. Stevens-Johnson induced by imiquimod 5% cream: A case report. Dermatology Reports. 2024;. doi:10.4081/dr.2024.9930$79$YR$$M$Y$$$20240913$$HP$IT$IT
243182443$24318244$3$F$20240519$20240905$20240913$20240920$EXP$$US-ABBVIE-5919640$ABBVIE$$$$N$M$Y$3.45$KG$20240920$$HP$US$US
243182451$24318245$1$I$$20240904$20240913$20240913$EXP$$GR-EMD Serono-2024047926$EMD SERONO INC$Xanthopoulos, A.. Decongestion in heart failure with normal blood pressure. Panhellenic Congress of Cardiology. 2018$68$YR$E$F$Y$$$20240913$$MD$GR$GR
243182461$24318246$1$I$20240523$20240911$20240913$20240913$EXP$$US-ABBVIE-5921914$ABBVIE$$73$YR$$M$Y$$$20240913$$CN$US$US
243182471$24318247$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA264929$SANOFI AVENTIS$$$$$F$Y$$$20240913$$PH$US$US
243182483$24318248$3$F$20240904$20240909$20240913$20240918$PER$$US-SA-2024SA263406$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240918$$HP$US$US
243182491$24318249$1$I$$20240910$20240913$20240913$EXP$$GB-AstraZeneca-2024A205945$ASTRAZENECA$$$$C$$Y$$$20240913$$MD$GB$
243182501$24318250$1$I$$20240906$20240913$20240913$DIR$FDA-CDER-CTU-2024-63059$$FDA-CTU$$$$$F$N$$$20240906$N$HP$US$
243182511$24318251$1$I$$20240904$20240913$20240913$EXP$$PK-AMGEN-PAKSP2024179952$AMGEN$$35$YR$A$F$Y$$$20240913$$CN$PK$PK
243182521$24318252$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63060$$FDA-CTU$$50$YR$$F$N$$$20240913$N$$US$
243182531$24318253$1$I$$20240911$20240913$20240913$EXP$$US-AstraZeneca-2024A207976$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243182541$24318254$1$I$20240730$20240911$20240913$20240913$EXP$$US-AstraZeneca-2024A207798$ASTRAZENECA$$26681$DY$$M$Y$$$20240913$$HP$US$
243182551$24318255$1$I$$20240905$20240913$20240913$EXP$$US-AstraZeneca-2024A203109$ASTRAZENECA$$$$$$Y$$$20240913$$CN$US$
243182561$24318256$1$I$$20240905$20240913$20240913$EXP$$US-AstraZeneca-2024A205697$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243182571$24318257$1$I$$20240910$20240913$20240913$EXP$$JP-AstraZeneca-2024A207931$ASTRAZENECA$$72$YR$$M$Y$$$20240913$$MD$JP$
243182581$24318258$1$I$$20240905$20240913$20240913$EXP$$ZA-AstraZeneca-2024A205068$ASTRAZENECA$$58$YR$$F$Y$$$20240913$$CN$ZA$
243182591$24318259$1$I$$20240910$20240913$20240913$EXP$$CO-AstraZeneca-2024A208800$ASTRAZENECA$$$$$F$Y$58$KG$20240913$$CN$CO$
243182601$24318260$1$I$$20240909$20240913$20240913$EXP$$CA-BAUSCH-BL-2024-013516$BAUSCH AND LOMB$$$$$F$Y$$$20240913$$HP$CA$CA
243182611$24318261$1$I$20240828$20240905$20240913$20240913$EXP$$IT-BAUSCH-BL-2024-013654$BAUSCH AND LOMB$$56$YR$$M$Y$$$20240913$$PH$IT$IT
243182621$24318262$1$I$$20240906$20240913$20240913$EXP$$KR-AstraZeneca-2024A207051$ASTRAZENECA$$59$YR$$M$Y$$$20240913$$MD$KR$
243182631$24318263$1$I$$20240813$20240913$20240913$PER$$US-MRZWEB-2024080000115$MERZ$$53$YR$$M$Y$$$20240913$$HP$US$US
243182641$24318264$1$I$$20240813$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000116$MERZ$$36$YR$$F$Y$$$20240913$$HP$US$US
243182651$24318265$1$I$$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001680$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182661$24318266$1$I$$20240910$20240913$20240913$EXP$$IT-TAKEDA-2024TUS090136$TAKEDA$$24$YR$$F$Y$$$20240913$$HP$IT$IT
243182671$24318267$1$I$20240829$20240906$20240913$20240913$PER$$US-ABBVIE-5913548$ABBVIE$$78$YR$$F$Y$$$20240913$$PH$US$US
243182681$24318268$1$I$20240301$20240910$20240913$20240913$EXP$$US-ABBVIE-5920711$ABBVIE$$53$YR$$F$Y$$$20240913$$CN$US$US
243182691$24318269$1$I$$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001737$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182701$24318270$1$I$$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001640$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182711$24318271$1$I$$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001647$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182722$24318272$2$F$$20240911$20240913$20240927$PER$$US-SMPA-2024SPA001413$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243182731$24318273$1$I$$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001693$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182741$24318274$1$I$$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001681$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182751$24318275$1$I$$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001665$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182761$24318276$1$I$$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001666$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182771$24318277$1$I$20240718$20240905$20240913$20240913$EXP$FR-AFSSAPS-LL2024001642$FR-TEVA-VS-3241123$TEVA$$69$YR$$F$Y$$$20240913$$MD$FR$FR
243182781$24318278$1$I$$20240911$20240913$20240913$EXP$$SK-BAUSCH-BL-2024-013696$BAUSCH AND LOMB$$6$DEC$$M$Y$$$20240913$$MD$SK$SK
243182791$24318279$1$I$20240101$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001671$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182801$24318280$1$I$20240801$20240903$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141516$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240913$$CN$US$US
243182811$24318281$1$I$20240701$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146137$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$113.4$KG$20240913$$CN$US$US
243182821$24318282$1$I$$20240909$20240913$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014701$JAZZ$$$$$F$Y$$$20240913$$CN$US$US
243182831$24318283$1$I$20240807$20240904$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141512$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$72.12$KG$20240913$$HP$US$US
243182841$24318284$1$I$$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001650$SUNOVION$$$$$$Y$$$20240913$$HP$US$US
243182851$24318285$1$I$20240701$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001630$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182861$24318286$1$I$20240801$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001653$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182871$24318287$1$I$$20240906$20240913$20240913$EXP$$US-BAUSCH-BL-2024-013373$BAUSCH AND LOMB$Defayette A, Anibaldi E, Abad A, Ibegbu C, Silvestri N, Doobay R. A case report of elevated bromide levels from pyridostigmine bromide for treatment of myasthenia gravis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2024 AUG 22;. doi:10.1093/ajhp/zxae241$37$YR$$M$Y$70$KG$20240913$$HP$US$US
243182881$24318288$1$I$$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001742$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182891$24318289$1$I$$20240819$20240913$20240913$PER$$US-SMPA-2024SPA001687$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182902$24318290$2$F$$20240909$20240913$20240925$PER$$US-SMPA-2024SPA001625$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243182911$24318291$1$I$$20240912$20240913$20240913$PER$$US-AMGEN-USASP2024182870$AMGEN$$$$$$Y$$$20240913$$PH$US$US
243182921$24318292$1$I$$20240904$20240913$20240913$30DAY$$US-GSK-US2024AMR110397$GLAXOSMITHKLINE$$$$$F$Y$$$20240913$$CN$US$US
243182931$24318293$1$I$20240903$20240903$20240913$20240913$30DAY$$US-GSK-US2024109518$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240913$$CN$US$US
243182941$24318294$1$I$20230201$20240812$20240913$20240913$PER$$US-SMPA-2024SPA002556$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182951$24318295$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2022-0600730$GILEAD$$73$YR$E$M$Y$$$20240913$$MD$US$US
243182971$24318297$1$I$$20240821$20240913$20240913$PER$$US-SMPA-2024SPA001799$SUNOVION$$$$$$Y$$$20240913$$CN$US$US
243182981$24318298$1$I$20240101$20240812$20240913$20240913$PER$$US-MRZWEB-2024080000123$MERZ$$57$YR$$$Y$$$20240913$$HP$US$US
243182991$24318299$1$I$$20240904$20240913$20240913$PER$$US-ABBVIE-5909244$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243183001$24318300$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63061$$FDA-CTU$$79$YR$$F$N$56.7$KG$20240913$N$$US$
243183011$24318301$1$I$20240814$20240913$20240913$20240913$DIR$718280$$FDA-CTU$$43$YR$$M$N$$$20240913$N$$US$
243183021$24318302$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5917822$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243183031$24318303$1$I$$20240909$20240913$20240913$EXP$$NVSC2024IN056351$NOVARTIS$$31$YR$$F$Y$$$20240913$$CN$IN$IN
243183043$24318304$3$F$20230318$20240917$20240913$20240923$EXP$$DE-JNJFOC-20240922603$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240923$$HP$DE$DE
243183051$24318305$1$I$20240730$20240904$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0012900$DR REDDYS$$33$YR$A$$Y$$$20240913$$HP$US$US
243183061$24318306$1$I$$20240904$20240913$20240913$PER$$US-RDY-SPO/USA/24/0012962$DR REDDYS$$36$YR$A$F$Y$$$20240913$$HP$US$US
243183071$24318307$1$I$20240913$20240913$20240913$20240913$DIR$718271$$FDA-CTU$$58$YR$$M$N$102.15$KG$20240913$N$$US$
243183081$24318308$1$I$20240904$20240905$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013120$DR REDDYS$$43$YR$A$M$Y$$$20240913$$PH$US$US
243183101$24318310$1$I$$20240903$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0012889$DR REDDYS$$47$YR$A$M$Y$$$20240913$$HP$US$US
243183111$24318311$1$I$$20240905$20240913$20240913$EXP$$US-RDY-SPO/USA/24/0013029$DR REDDYS$$38$YR$A$M$Y$$$20240913$$HP$US$US
243183131$24318313$1$I$20240830$20240905$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013041$DR REDDYS$$64$YR$A$F$Y$$$20240913$$HP$US$US
243183141$24318314$1$I$20240823$20240910$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145040$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240913$$HP$US$US
243183151$24318315$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63062$$FDA-CTU$$35$YR$$F$N$$$20240913$N$$US$
243183161$24318316$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63063$$FDA-CTU$$47$YR$$M$N$$$20240913$N$$US$
243183171$24318317$1$I$$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143057$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$93$KG$20240913$$PH$US$US
243183191$24318319$1$I$$20240903$20240913$20240913$EXP$$US-BAYER-2024A127935$BAYER$$$$$F$Y$$$20240913$$CN$US$US
243183201$24318320$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63064$$FDA-CTU$$46$YR$$F$N$86.18$KG$20240913$N$$US$
243183211$24318321$1$I$$20240910$20240913$20240913$EXP$$US-SANDOZ INC.-SDZ2024US045188$SANDOZ$$$$$$Y$$$20240913$$CN$US$US
243183221$24318322$1$I$20231018$20240906$20240913$20240913$PER$$US-RDY-SPO/USA/23/0181952$DR REDDYS$$67$YR$E$F$Y$$$20240913$$MD$US$US
243183231$24318323$1$I$$20240912$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA079992$SANDOZ$$86$YR$$F$Y$70$KG$20240913$$HP$CA$CA
243183241$24318324$1$I$$20240903$20240913$20240913$PER$$US-RDY-SPO/USA/24/0012842$DR REDDYS$$52$YR$A$F$Y$$$20240913$$MD$US$US
243183261$24318326$1$I$20240901$20240903$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013092$DR REDDYS$$15$YR$T$F$Y$$$20240913$$CN$US$US
243183271$24318327$1$I$20230725$20240903$20240913$20240913$PER$$US-RDY-SPO/USA/23/0179534$DR REDDYS$$71$YR$E$M$Y$$$20240913$$HP$US$US
243183281$24318328$1$I$$20240903$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013022$DR REDDYS$$29$YR$A$F$Y$$$20240913$$MD$US$US
243183291$24318329$1$I$20240911$20240912$20240913$20240913$PER$$US-AMGEN-USASP2024182863$AMGEN$$82$YR$E$F$Y$$$20240913$$CN$US$US
243183301$24318330$1$I$$20240912$20240913$20240913$PER$$US-ALXN-202409USA000884US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240913$$CN$US$US
243183311$24318331$1$I$$20240903$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013096$DR REDDYS$$17$YR$T$$Y$$$20240913$$CN$US$US
243183321$24318332$1$I$$20240911$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA079532$SANDOZ$$42$YR$$M$Y$$$20240913$$HP$CA$CA
243183331$24318333$1$I$20230810$20240909$20240913$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409005187$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240913$$MD$US$US
243183342$24318334$2$F$$20240924$20240913$20240930$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202409006087$ELI LILLY AND CO$$64$YR$A$M$Y$85$KG$20240930$$CN$ES$ES
243183351$24318335$1$I$$20240906$20240913$20240913$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409004001$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240913$$CN$DE$DE
243183361$24318336$1$I$$20240903$20240913$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002515$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240913$$CN$US$US
243183371$24318337$1$I$$20240912$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409008384$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240913$$CN$US$US
243183381$24318338$1$I$20240826$20240902$20240913$20240913$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409000957$ELI LILLY AND CO$$66$YR$E$F$Y$65$KG$20240913$$CN$CN$CN
243183391$24318339$1$I$20240627$20240903$20240913$20240913$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409002472$ELI LILLY AND CO$$60$YR$A$F$Y$63.2$KG$20240913$$CN$JP$JP
243183401$24318340$1$I$20240701$20240903$20240913$20240913$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409001548$ELI LILLY AND CO$$$$$$Y$$$20240913$$CN$JP$JP
243183411$24318341$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007241$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240913$$CN$US$US
243183421$24318342$1$I$20240411$20240902$20240913$20240913$EXP$FR-AFSSAPS-PA2024001499$FR-ELI_LILLY_AND_COMPANY-FR202409001027$ELI LILLY AND CO$$42$YR$A$M$Y$95$KG$20240913$$CN$FR$FR
243183441$24318344$1$I$$20240902$20240913$20240913$EXP$$TR-ELI_LILLY_AND_COMPANY-TR202409001896$ELI LILLY AND CO$$$$$M$Y$$$20240913$$CN$TR$TR
243183451$24318345$1$I$20231101$20240903$20240913$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002636$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240913$$CN$US$US
243183461$24318346$1$I$20230301$20240902$20240913$20240913$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409001112$ELI LILLY AND CO$$$$A$F$Y$$$20240913$$HP$FR$FR
243183471$24318347$1$I$20240101$20240903$20240913$20240913$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202409003381$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$AE$AE
243183481$24318348$1$I$$20240906$20240913$20240913$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409004970$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240913$$CN$BR$BR
243183501$24318350$1$I$$20240909$20240913$20240913$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202409007068$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$CO$CO
243183511$24318351$1$I$$20240903$20240913$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001312$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240913$$MD$US$US
243183522$24318352$2$F$20240801$20240925$20240913$20240930$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409005106$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240930$$CN$JP$JP
243183531$24318353$1$I$$20240910$20240913$20240913$PER$$US-JNJFOC-20240927331$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243183551$24318355$1$I$$20240903$20240913$20240913$EXP$$IT-UCBSA-2024045552$UCB$$27$YR$$F$Y$$$20240913$$MD$IT$IT
243183561$24318356$1$I$20240830$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145084$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240913$$CN$US$US
243183571$24318357$1$I$$20240910$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145655$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240913$$MD$US$US
243183581$24318358$1$I$$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142832$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$84.37$KG$20240913$$CN$US$US
243183591$24318359$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146079$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240913$$HP$US$US
243183601$24318360$1$I$20240816$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143821$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240913$$CN$US$US
243183611$24318361$1$I$$20240910$20240913$20240913$EXP$$US-GSK-US2024112595$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$MD$US$US
243183621$24318362$1$I$20240903$20240903$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141536$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240913$$CN$US$US
243183631$24318363$1$I$$20240910$20240913$20240913$EXP$$IN-GSK-IN2024APC113460$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$IN$IN
243183651$24318365$1$I$$20240912$20240913$20240913$PER$$US-ROCHE-10000081092$ROCHE$$$$C$M$Y$$$20240913$$CN$US$US
243183661$24318366$1$I$$20240911$20240913$20240913$EXP$$CA-TAKEDA-2024TUS091273$TAKEDA$$$$$M$Y$$$20240913$$CN$CA$CA
243183671$24318367$1$I$$20240910$20240913$20240913$EXP$$US-BAYER-2024A122473$BAYER$$70$YR$E$M$Y$$$20240913$$CN$US$US
243183681$24318368$1$I$$20240912$20240913$20240913$PER$$US-ROCHE-10000081286$ROCHE$$$$A$M$Y$$$20240913$$CN$US$US
243183691$24318369$1$I$$20240909$20240913$20240913$EXP$$US-AMGEN-USASP2024181852$AMGEN$Forbess L.; Desai R.; Barr B. et. al. STEMI Following In-Stent Restenosis in Coronary Takayasu Arteritis With Pyoderma Gangrenosum in a Teenaged Athlete. JACC: Case Reports. 2024;29 (17):1-5$16$YR$T$F$Y$$$20240913$$MD$US$US
243183701$24318370$1$I$20240826$20240911$20240913$20240913$EXP$$US-AstraZeneca-2024A207743$ASTRAZENECA$$27553$DY$$M$Y$$$20240913$$MD$US$
243183711$24318371$1$I$20240904$20240910$20240913$20240913$EXP$$US-AstraZeneca-2024A208855$ASTRAZENECA$$27082$DY$$M$Y$$$20240913$$HP$US$
243183721$24318372$1$I$20240713$20240906$20240913$20240913$EXP$$JP-AstraZeneca-2024A205742$ASTRAZENECA$$50$YR$$F$Y$$$20240913$$MD$JP$
243183731$24318373$1$I$20240904$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63067$$FDA-CTU$$63$YR$$F$N$$$20240913$N$$US$
243183741$24318374$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63068$$FDA-CTU$$78$YR$$F$N$73.03$KG$20240913$N$$US$
243183751$24318375$1$I$20240904$20240912$20240913$20240913$PER$$US-ROCHE-10000081489$ROCHE$$37$YR$A$M$Y$$$20240913$$CN$US$US
243183761$24318376$1$I$$20240913$20240913$20240913$PER$$NVSC2024US184023$NOVARTIS$$$$$$Y$$$20240913$$HP$US$US
243183772$24318377$2$F$$20240906$20240913$20240913$EXP$$NVSC2022US191763$NOVARTIS$Sogbein O, Rizvi A, Mujtaba M, Hussain S. Transplant Graft TMA Injury Post COVID-19 Vaccination. AJT. 2020;22(3)$48$YR$$M$Y$$$20240913$$HP$US$US
243183801$24318380$1$I$$20240901$20240913$20240913$EXP$$JP-Accord-446667$ACCORD$Kitaya S, Nakano M, Katori Y, Yasuda S, Kanamori H. QTc Interval Prolongation as an Adverse Event of Azole Antifungal Drugs: Case Report and Literature Review. Microorganisms. 2024 Aug 8;12(8):1619. doi: 10.3390/microorganisms12081619.$77$YR$E$M$Y$$$20240913$$MD$JP$JP
243183811$24318381$1$I$20240301$20240820$20240913$20240913$PER$$US-009507513-2408USA006945$MERCK$$75$YR$$F$Y$$$20240913$$CN$US$US
243183821$24318382$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2024-0658200$GILEAD$$71$YR$E$M$Y$$$20240913$$MD$US$US
243183831$24318383$1$I$20240314$20240913$20240913$20240913$DIR$718285$$FDA-CTU$$81$YR$$F$N$68$KG$20240913$N$HP$US$
243183842$24318384$2$F$20240101$20240910$20240913$20240917$EXP$$CA-FERRINGPH-2024FE05113$FERRING$$$$$$Y$$$20240917$$CN$CA$CA
243183851$24318385$1$I$$20240911$20240913$20240913$EXP$$JP-JNJFOC-20240934632$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$MD$JP$JP
243183861$24318386$1$I$$20240910$20240913$20240913$PER$$US-ABBVIE-5919159$ABBVIE$$$$E$$Y$$$20240913$$MD$US$US
243183871$24318387$1$I$$20240911$20240913$20240913$PER$$US-ROCHE-3543936$ROCHE$$41$YR$A$M$Y$$$20240913$$CN$US$US
243183882$24318388$2$F$$20240917$20240913$20240924$EXP$$BR-TAKEDA-2024TUS090725$TAKEDA$$$$$$Y$$$20240924$$CN$BR$BR
243183891$24318389$1$I$$20240906$20240913$20240913$EXP$$US-GSK-US2024111331$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$CN$US$US
243183901$24318390$1$I$$20240808$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000100$MERZ$$$$$F$Y$$$20240913$$HP$US$US
243183912$24318391$2$F$$20240916$20240913$20240919$EXP$$GR-SANDOZ INC.-NVSC2022GR240789$SANDOZ$$12$YR$$M$Y$$$20240919$$MD$GR$GR
243183921$24318392$1$I$$20240913$20240913$20240913$DIR$718277$$FDA-CTU$$$$$UNK$N$$$20240913$$CN$US$
243183931$24318393$1$I$20240425$20240913$20240913$20240913$DIR$718296$$FDA-CTU$$66$YR$$F$N$68$KG$20240913$N$HP$US$
243183941$24318394$1$I$20240906$20240913$20240913$20240913$DIR$718286$$FDA-CTU$$59$YR$$F$N$$$20240913$N$PH$US$
243183951$24318395$1$I$20240321$20240913$20240913$20240913$DIR$718289$$FDA-CTU$$54$YR$$M$N$97$KG$20240913$N$HP$US$
243183961$24318396$1$I$20240101$20240812$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000122$MERZ$$38$YR$$F$Y$$$20240913$$HP$US$US
243183971$24318397$1$I$20240101$20240812$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000121$MERZ$$38$YR$$F$Y$$$20240913$$HP$US$US
243183991$24318399$1$I$$20240910$20240913$20240913$EXP$$US-SANDOZ INC.-SDZ2024US079744$SANDOZ$Hamdan A, Chou C, Rust D, et al. Epstein-Barr Virus-Associated Aggressive Natural Killer Cell Leukemia: Challenges and Emerging Therapies. Cureus. 2024;16(8):e66338$24$YR$$F$Y$$$20240913$$MD$US$US
243184011$24318401$1$I$20240101$20240812$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000119$MERZ$$26$YR$$$Y$$$20240913$$HP$US$US
243184021$24318402$1$I$20240101$20240731$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000388$AMARIN$$75$YR$E$M$Y$$$20240913$$CN$US$US
243184031$24318403$1$I$20240501$20240729$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000380$AMARIN$$77$YR$E$F$Y$$$20240913$$CN$US$US
243184041$24318404$1$I$20240601$20240726$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000378$AMARIN$$72$YR$E$F$Y$$$20240913$$CN$US$US
243184051$24318405$1$I$20210101$20240808$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000383$AMARIN$$74$YR$E$M$Y$$$20240913$$CN$US$US
243184061$24318406$1$I$20240101$20240730$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000386$AMARIN$$57$YR$A$F$Y$$$20240913$$CN$US$US
243184071$24318407$1$I$20240101$20240802$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000396$AMARIN$$75$YR$E$M$Y$$$20240913$$CN$US$US
243184081$24318408$1$I$20240806$20240806$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000406$AMARIN$$73$YR$E$M$Y$$$20240912$$CN$US$US
243184091$24318409$1$I$20240701$20240805$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000405$AMARIN$$68$YR$E$M$Y$$$20240913$$CN$US$US
243184111$24318411$1$I$20240101$20240812$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000120$MERZ$$55$YR$$$Y$$$20240913$$HP$US$US
243184121$24318412$1$I$20240701$20240806$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000403$AMARIN$$81$YR$E$F$Y$$$20240913$$CN$US$US
243184131$24318413$1$I$$20240912$20240913$20240913$PER$$US-ALXN-202409USA000898US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243184141$24318414$1$I$20240601$20240910$20240913$20240913$EXP$$US-ABBVIE-5907917$ABBVIE$$21$YR$$M$Y$$$20240913$$CN$US$US
243184151$24318415$1$I$20240901$20240912$20240913$20240913$PER$$US-ALXN-202409USA000890US$ALEXION PHARMACEUTICALS$$73$YR$$F$Y$$$20240913$$CN$US$US
243184162$24318416$2$F$20240801$20240917$20240913$20240926$EXP$$BR-BAYER-2024A127792$BAYER$$63$YR$A$F$Y$$$20240926$$CN$BR$BR
243184171$24318417$1$I$$20240816$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000408$AMARIN$$76$YR$E$M$Y$$$20240913$$CN$US$US
243184181$24318418$1$I$20240101$20240813$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000430$AMARIN$$68$YR$E$M$Y$$$20240912$$CN$US$US
243184191$24318419$1$I$$20240812$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000421$AMARIN$$71$YR$E$F$Y$$$20240913$$CN$US$US
243184202$24318420$2$F$20240805$20240906$20240913$20240918$EXP$$NVSC2024IN181298$NOVARTIS$$53$YR$$M$Y$$$20240919$$CN$IN$IN
243184211$24318421$1$I$$20240811$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000418$AMARIN$$$$$$Y$$$20240912$$CN$US$US
243184221$24318422$1$I$$20240812$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000419$AMARIN$$$$$F$Y$$$20240912$$CN$US$US
243184231$24318423$1$I$20240101$20240826$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000449$AMARIN$$$$$M$Y$$$20240913$$PH$US$US
243184241$24318424$1$I$20240101$20240823$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000443$AMARIN$$78$YR$E$M$Y$$$20240913$$CN$US$US
243184251$24318425$1$I$20240101$20240826$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000448$AMARIN$$50$YR$A$M$Y$$$20240913$$CN$US$US
243184261$24318426$1$I$$20240824$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000444$AMARIN$$$$$$Y$$$20240913$$CN$US$US
243184271$24318427$1$I$20240101$20240826$20240913$20240913$EXP$$US-Amarin Pharma, Inc-2024AMR000450$AMARIN$$71$YR$E$F$Y$$$20240913$$CN$US$US
243184281$24318428$1$I$$20240909$20240913$20240913$EXP$$US-JNJFOC-20240924008$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243184291$24318429$1$I$$20240910$20240913$20240913$EXP$$US-JNJFOC-20240808416$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$HP$US$US
243184302$24318430$2$F$20240801$20240912$20240913$20240926$30DAY$$CH-JNJFOC-20240860476$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$PH$CH$CH
243184311$24318431$1$I$$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145429$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240913$$CN$US$US
243184321$24318432$1$I$20240826$20240906$20240913$20240913$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-142399$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240913$$MD$IT$IT
243184331$24318433$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2024-0658196$GILEAD$$81$YR$E$F$Y$$$20240913$$MD$US$US
243184351$24318435$1$I$$20240906$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142567$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240913$$CN$US$US
243184361$24318436$1$I$$20240910$20240913$20240913$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-121472$REGENERON$$$$$F$Y$$$20240913$$MD$US$US
243184371$24318437$1$I$$20240904$20240913$20240913$30DAY$$US-GSK-US2024110162$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$CN$US$US
243184401$24318440$1$I$20240909$20240913$20240913$20240913$DIR$718295$$FDA-CTU$$64$YR$$M$N$69.75$KG$20240913$N$PH$US$
243184411$24318441$1$I$$20240906$20240913$20240913$EXP$$US-GSK-US2024111344$GLAXOSMITHKLINE$$$$$$Y$$$20240913$$HP$US$US
243184421$24318442$1$I$$20240802$20240913$20240913$PER$$US-MRZWEB-2024080000044$MERZ$$$$$$Y$$$20240913$$HP$US$US
243184431$24318443$1$I$$20240805$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000099$MERZ$$$$$$Y$$$20240913$$MD$US$US
243184441$24318444$1$I$20221001$20240904$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009325$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243184471$24318447$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2024-0658173$GILEAD$$73$YR$E$M$Y$$$20240913$$MD$US$US
243184491$24318449$1$I$$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024181986$AMGEN$$$$$M$Y$69.388$KG$20240913$$CN$US$US
243184501$24318450$1$I$$20240805$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000042$MERZ$$$$$F$Y$$$20240913$$CN$US$US
243184511$24318451$1$I$$20240903$20240913$20240913$EXP$$IE-EXELIXIS-CABO-24079661$EXELIXIS$$$$$M$Y$$$20240913$$HP$IE$IE
243184521$24318452$1$I$$20240911$20240913$20240913$EXP$$CA-PFIZER INC-202400255295$PFIZER$$17$YR$$M$Y$$$20240913$$HP$CA$CA
243184531$24318453$1$I$$20240911$20240913$20240913$EXP$$CN-PFIZER INC-202400255618$PFIZER$$20$YR$$F$Y$$$20240913$$CN$CN$CN
243184541$24318454$1$I$20240101$20240911$20240913$20240913$EXP$$CA-PFIZER INC-202400254912$PFIZER$$82$YR$$M$Y$$$20240913$$HP$CA$CA
243184551$24318455$1$I$$20240908$20240913$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014500$JAZZ$$$$$F$Y$$$20240913$$CN$US$US
243184561$24318456$1$I$20240901$20240911$20240913$20240913$EXP$$CA-PFIZER INC-202400255494$PFIZER$$91$YR$$M$Y$$$20240913$$PH$CA$CA
243184571$24318457$1$I$$20240909$20240913$20240913$EXP$$US-SANDOZ INC.-SDZ2024US079235$SANDOZ$$$$$F$Y$$$20240913$$CN$US$US
243184581$24318458$1$I$$20240909$20240913$20240913$EXP$$CA-ABBVIE-5920844$ABBVIE$$$$$M$Y$$$20240913$$HP$CA$CA
243184591$24318459$1$I$$20240802$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000028$MERZ$$$$$$Y$$$20240913$$HP$US$US
243184601$24318460$1$I$$20240802$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000254$MERZ$$$$$$Y$$$20240913$$HP$US$US
243184611$24318461$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2024-0658185$GILEAD$$66$YR$E$F$Y$$$20240913$$MD$US$US
243184621$24318462$1$I$$20240805$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000043$MERZ$$$$$F$Y$$$20240913$$CN$US$US
243184631$24318463$1$I$$20240805$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000040$MERZ$$40$YR$$F$Y$$$20240913$$HP$US$US
243184641$24318464$1$I$20240101$20240805$20240913$20240913$PER$$US-MRZWEB-2024080000041$MERZ$$$$$$Y$$$20240913$$HP$US$US
243184661$24318466$1$I$20240726$20240904$20240913$20240913$EXP$$US-TEVA-VS-3240805$TEVA$$$$$F$Y$$$20240913$$MD$US$US
243184671$24318467$1$I$20240501$20240911$20240913$20240913$EXP$$US-GILEAD-2024-0687629$GILEAD$$87$YR$E$F$Y$$$20240913$$CN$US$US
243184681$24318468$1$I$$20240808$20240913$20240913$PER$$US-MRZWEB-2024080000096$MERZ$$$$$F$Y$$$20240913$$CN$US$US
243184692$24318469$2$F$$20240916$20240913$20240930$EXP$$CA-JNJFOC-20230316787$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240929$$HP$CA$CA
243184701$24318470$1$I$$20240904$20240913$20240913$EXP$$AU-JNJFOC-20240917980$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240913$$MD$AU$AU
243184711$24318471$1$I$$20240806$20240913$20240913$PER$$US-MRZWEB-2024080000101$MERZ$$$$$$Y$$$20240913$$HP$US$US
243184721$24318472$1$I$$20240807$20240913$20240913$PER$$US-MRZWEB-2024080000073$MERZ$$47$YR$$F$Y$$$20240913$$HP$US$US
243184731$24318473$1$I$$20240807$20240913$20240913$PER$$US-MRZWEB-2024080000069$MERZ$$61$YR$$M$Y$$$20240913$$HP$US$US
243184741$24318474$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MED-202409031429539670-ZJPQL$GB-HETERO-AMR2024GB02991$HETERO$$$$$M$Y$$$20240913$$HP$GB$GB
243184761$24318476$1$I$20240529$20240905$20240913$20240913$EXP$$JP-AstraZeneca-2024A203880$ASTRAZENECA$$90$YR$$M$Y$51$KG$20240913$$MD$JP$
243184771$24318477$1$I$$20240910$20240913$20240913$EXP$$GB-AstraZeneca-2024A205943$ASTRAZENECA$$$$C$$Y$$$20240913$$MD$GB$
243184781$24318478$1$I$$20240905$20240913$20240913$PER$$US-AstraZeneca-2024A203482$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243184801$24318480$1$I$$20240911$20240913$20240913$PER$$US-AstraZeneca-2024A208464$ASTRAZENECA$$$$$$Y$$$20240913$$CN$US$
243184811$24318481$1$I$$20240730$20240913$20240913$PER$$US-MRZWEB-2024080000006$MERZ$$$$$F$Y$$$20240913$$HP$US$US
243184821$24318482$1$I$20240701$20240910$20240913$20240913$EXP$$NVSC2024US147078$NOVARTIS$$54$YR$$M$Y$$$20240913$$CN$US$US
243184831$24318483$1$I$20240801$20240911$20240913$20240913$EXP$$ES-ABBVIE-5921449$ABBVIE$$87$YR$$M$Y$$$20240913$$CN$ES$ES
243184841$24318484$1$I$$20240910$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409007812$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240913$$CN$US$US
243184851$24318485$1$I$20240101$20240730$20240913$20240913$PER$$US-MRZWEB-2024070000220$MERZ$$$$$$Y$$$20240913$$HP$US$US
243184861$24318486$1$I$20230111$20240904$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009358$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243184871$24318487$1$I$20240905$20240911$20240913$20240913$EXP$$US-AMGEN-USASP2024181639$AMGEN$$38$YR$A$M$Y$$$20240913$$CN$US$US
243184881$24318488$1$I$20240910$20240910$20240913$20240913$EXP$$US-AMGEN-USASP2024181291$AMGEN$$64$YR$A$M$Y$$$20240913$$HP$US$US
243184912$24318491$2$F$$20240910$20240913$20240919$EXP$$ES-JNJFOC-20240926958$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$MD$ES$ES
243184921$24318492$1$I$$20240911$20240913$20240913$PER$$US-ALXN-202409USA000851US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243184961$24318496$1$I$$20240913$20240913$20240913$DIR$718303$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243184971$24318497$1$I$$20240913$20240913$20240913$DIR$718300$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243185001$24318500$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145444$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$85.1$KG$20240913$$PH$US$US
243185021$24318502$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5920512$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243185061$24318506$1$I$$20240910$20240913$20240913$EXP$$US-KYOWAKIRIN-2024KK021137$KYOWA$$$$$$Y$$$20240913$$CN$US$US
243185072$24318507$2$F$$20240916$20240913$20240923$EXP$$IN-ROCHE-10000052173$ROCHE$$68$YR$E$M$Y$$$20240923$$CN$IN$IN
243185081$24318508$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000212$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185091$24318509$1$I$$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003679$PAREXEL$$43$YR$$F$Y$$$20240912$$CN$US$US
243185101$24318510$1$I$$20240618$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003683$PAREXEL$$45$YR$$F$Y$$$20240912$$HP$US$US
243185111$24318511$1$I$$20240617$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003674$PAREXEL$$69$YR$$F$Y$$$20240912$$HP$US$US
243185121$24318512$1$I$20240520$20240821$20240913$20240913$PER$$US-009507513-2408USA006988$MERCK$$$$A$F$Y$$$20240913$$MD$US$US
243185132$24318513$2$F$$20240913$20240913$20240921$EXP$FR-EMA-20150320-AUTODUP-420098$FR-ROCHE-10000073886$ROCHE$Kanitakis J, Karayannopoulou G, Petruzzo P, Lanzetta M. Graft vasculopathy may affect the skin of vascularized composite allografts undergoing rejection. American journal of transplantation. 2014;1.$35$YR$A$M$Y$$$20240921$$HP$FR$FR
243185141$24318514$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000224$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185152$24318515$2$F$20240801$20240919$20240913$20240926$EXP$$US-Calliditas-2024CAL01762$CALLIDITAS THERAPEUTICS$$36$YR$A$M$Y$58.3$KG$20240926$$CN$US$US
243185161$24318516$1$I$$20240801$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000027$MERZ$$$$$$Y$$$20240913$$MD$US$US
243185171$24318517$1$I$$20240910$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145547$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240913$$CN$US$US
243185181$24318518$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146266$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240913$$CN$US$US
243185191$24318519$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000216$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185201$24318520$1$I$$20240904$20240913$20240913$EXP$$US-RADIUS HEALTH INC.-2024US006903$RADIUS PHARM$$$$$M$Y$$$20240913$$CN$US$US
243185211$24318521$1$I$$20240910$20240913$20240913$EXP$$US-MYLANLABS-2024M1083710$MYLAN$$$$$F$Y$$$20240913$$CN$US$US
243185221$24318522$1$I$$20240910$20240913$20240913$EXP$$US-MYLANLABS-2024M1083032$MYLAN$$$$$$Y$$$20240913$$CN$US$US
243185231$24318523$1$I$$20240913$20240913$20240913$DIR$718311$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243185251$24318525$1$I$20240508$20240913$20240913$20240913$DIR$718302$$FDA-CTU$$36$YR$$M$N$90$KG$20240913$N$HP$US$
243185261$24318526$1$I$20240912$20240913$20240913$20240913$DIR$718310$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243185271$24318527$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000228$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185281$24318528$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000225$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185291$24318529$1$I$20240418$20240909$20240913$20240913$EXP$FR-AFSSAPS-AVMA2024000384$FR-ORGANON-O2409FRA000687$ORGANON$$37$YR$$F$Y$$$20240913$$PH$FR$FR
243185301$24318530$1$I$$20240911$20240913$20240913$EXP$$NVSC2024CA183101$NOVARTIS$$46$YR$$F$Y$$$20240913$$HP$CA$CA
243185311$24318531$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000214$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185321$24318532$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000217$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185341$24318534$1$I$$20240731$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000124$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185351$24318535$1$I$$20240911$20240913$20240913$EXP$$US-SANDOZ INC.-SDZ2024US079822$SANDOZ$$$$$F$Y$$$20240913$$CN$US$US
243185361$24318536$1$I$$20240617$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003684$PAREXEL$$87$YR$$F$Y$$$20240912$$CN$US$US
243185371$24318537$1$I$$20240620$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003643$PAREXEL$$58$YR$$F$Y$$$20240912$$HP$US$US
243185381$24318538$1$I$$20240617$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003672$PAREXEL$$72$YR$$F$Y$$$20240912$$CN$US$US
243185391$24318539$1$I$$20240617$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003682$PAREXEL$$76$YR$$F$Y$$$20240912$$CN$US$US
243185401$24318540$1$I$$20240621$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003661$PAREXEL$$66$YR$$F$Y$$$20240912$$CN$US$US
243185411$24318541$1$I$$20240620$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003667$PAREXEL$$58$YR$$F$Y$$$20240912$$MD$US$US
243185421$24318542$1$I$$20240620$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003645$PAREXEL$$42$YR$$F$Y$$$20240912$$CN$US$US
243185431$24318543$1$I$$20240621$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003673$PAREXEL$$44$YR$$F$Y$$$20240912$$CN$US$US
243185441$24318544$1$I$$20240616$20240913$20240913$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003648$PAREXEL$$71$YR$$F$Y$$$20240912$$CN$US$US
243185461$24318546$1$I$$20240802$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000045$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185471$24318547$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2024-0658217$GILEAD$$64$YR$A$M$Y$$$20240913$$MD$US$US
243185481$24318548$1$I$$20240911$20240913$20240913$EXP$$BR-JNJFOC-20240932433$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$BR$BR
243185501$24318550$1$I$$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142897$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240913$$MD$US$US
243185511$24318551$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000221$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185521$24318552$1$I$$20240911$20240913$20240913$EXP$$NVSC2024CA183102$NOVARTIS$$35$YR$$F$Y$$$20240913$$PH$CA$CA
243185531$24318553$1$I$20240907$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024180023$AMGEN$$75$YR$E$M$Y$$$20240913$$CN$US$US
243185541$24318554$1$I$20240912$20240912$20240913$20240913$PER$$US-AMGEN-USASP2024183236$AMGEN$$73$YR$E$M$Y$$$20240913$$CN$US$US
243185552$24318555$2$F$$20240916$20240913$20240917$PER$$US-ALXN-202409USA000682US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243185562$24318556$2$F$20240905$20240912$20240913$20240919$EXP$$US-GSK-US2024111419$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$US$US
243185572$24318557$2$F$20240824$20240906$20240913$20240913$EXP$$US-Vifor (International) Inc.-VIT-2024-08117$VIFOR$$52$YR$$M$Y$66.5$KG$20240913$$HP$US$US
243185581$24318558$1$I$$20240701$20240913$20240913$PER$$US-AstraZeneca-2024A209527$ASTRAZENECA$$$$$M$Y$$$20240913$$MD$US$
243185591$24318559$1$I$$20240905$20240913$20240913$EXP$$GB-AstraZeneca-2024A203731$ASTRAZENECA$Nana M, Gregori M, Chandler E, Powell H, Goulden B, Watts T, Dhanjal M, Nelson-Piercy C.. Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study. Lancet Rheumatol 2024;6:e625?35.$$$N$$Y$$$20240913$$HP$GB$
243185601$24318560$1$I$20240520$20240909$20240913$20240913$EXP$$DE-ABBVIE-5917478$ABBVIE$$85$YR$$M$Y$$$20240913$$MD$DE$DE
243185611$24318561$1$I$$20240905$20240913$20240913$PER$$US-TAKEDA-2024TUS089981$TAKEDA$$$$$F$Y$$$20240913$$HP$US$US
243185621$24318562$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000215$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185631$24318563$1$I$$20240911$20240913$20240913$EXP$$US-Taiho Oncology Inc-2024-008692$TAIHO ONCOLOGY INC$$70$YR$E$M$Y$$$20240913$$CN$US$US
243185641$24318564$1$I$$20240906$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013274$DR REDDYS$$46$YR$A$F$Y$$$20240913$$PH$US$US
243185651$24318565$1$I$$20240902$20240913$20240913$EXP$$ES-ABBVIE-5920797$ABBVIE$Sanchez Garrote PL, Rodriguez Gomez MA, Fernandez-Reyes Luis MJ. Spontaneous renal hemorrhage or Wunderlich syndrome associated with ibrutinib treatment: a case report. NefroPlus. 2023;15(2):88-89.$77$YR$$M$Y$$$20240913$$HP$ES$ES
243185661$24318566$1$I$20240201$20240910$20240913$20240913$EXP$RO-EMA-DD-20240909-7482715-083613$RO-RDY-SPO/ROU/24/0013287$DR REDDYS$Vazar-Tripon DA, Muntean MM, Filimon RA, Jimbu IL. A rare case of acute myeloid leukemia with central nervous system involvement. Acta Medica Marisiensis.2024;70(Suppl.3):216-217.$73$YR$E$F$Y$$$20240913$$HP$RO$RO
243185671$24318567$1$I$$20240904$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009350$INCYTE$$$$$$Y$$$20240913$$PH$US$US
243185681$24318568$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000210$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185691$24318569$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000213$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185701$24318570$1$I$$20240906$20240913$20240913$PER$$US-RDY-SPO/USA/24/0013195$DR REDDYS$$63$YR$A$M$Y$$$20240913$$CN$US$US
243185711$24318571$1$I$$20240904$20240913$20240913$PER$$US-TAKEDA-2024TUS090544$TAKEDA$$$$$F$Y$$$20240913$$HP$US$US
243185721$24318572$1$I$20240826$20240911$20240913$20240913$EXP$FR-AFSSAPS-AM2024000720$FR-009507513-2409FRA004409$MERCK$$62$YR$$M$Y$$$20240913$$MD$FR$FR
243185731$24318573$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000226$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185751$24318575$1$I$20240101$20240910$20240913$20240913$EXP$$JP-JNJFOC-20240934490$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240913$$PH$JP$JP
243185761$24318576$1$I$20240520$20240906$20240913$20240913$EXP$GB-MHRA-MED-202409061114454530-PRQHZ$GB-OTSUKA-2024_025143$OTSUKA$$35$YR$$M$Y$$$20240913$$MD$GB$GB
243185771$24318577$1$I$$20240827$20240913$20240913$PER$$US-SA-2024SA263948$SANOFI AVENTIS$$$$E$M$Y$$$20240913$$CN$US$US
243185781$24318578$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000211$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185791$24318579$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024080000007$MERZ$$$$$F$Y$$$20240913$$HP$US$US
243185801$24318580$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000223$MERZ$$$$$$Y$$$20240913$$HP$US$US
243185822$24318582$2$F$$20240910$20240913$20240921$EXP$$JP-Accord-445387$ACCORD$Hara K, Miura E, Umeda Y, Umeda M, Oyake M, Fujita N. (A case of Parkinson^s disease with marked head drop after administration of donepezil hydrochloride). Rinsho Shinkeigaku (Clinical neurology). 2024 Aug 24.$76$YR$E$F$Y$39$KG$20240921$$HP$JP$JP
243185831$24318583$1$I$20190901$20230804$20240913$20240913$EXP$$GB-SANDOZ INC.-NVSC2019GB010527$SANDOZ$$62$YR$$M$Y$$$20240913$$HP$GB$GB
243185841$24318584$1$I$$20240903$20240913$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001603$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240913$$CN$US$US
243185851$24318585$1$I$$20240903$20240913$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001551$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240913$$CN$US$US
243185861$24318586$1$I$$20240903$20240913$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001711$ELI LILLY AND CO$$$$$$Y$$$20240913$$CN$US$US
243185871$24318587$1$I$20240820$20240901$20240913$20240913$EXP$GB-MHRA-MED-202409012308387720-SMQYT$GB-ELI_LILLY_AND_COMPANY-GB202409000764$ELI LILLY AND CO$$34$YR$A$F$Y$144$KG$20240913$$CN$GB$GB
243185881$24318588$1$I$$20240902$20240913$20240913$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409001028$ELI LILLY AND CO$$$$$$Y$$$20240913$$CN$BR$BR
243185891$24318589$1$I$$20240903$20240913$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003266$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240913$$CN$US$US
243185901$24318590$1$I$20240902$20240903$20240913$20240913$EXP$GB-MHRA-MED-202409031427187260-DZJQS$GB-ELI_LILLY_AND_COMPANY-GB202409002276$ELI LILLY AND CO$$$$$M$Y$$$20240913$$CN$GB$GB
243185911$24318591$1$I$$20240903$20240913$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003040$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240913$$CN$US$US
243185921$24318592$1$I$$20240903$20240913$20240913$EXP$GB-MHRA-MED-202409031148390770-VMBYK$GB-ELI_LILLY_AND_COMPANY-GB202409002024$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$GB$GB
243185932$24318593$2$F$$20240912$20240913$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409006826$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240917$$PH$US$US
243185941$24318594$1$I$$20240903$20240913$20240913$EXP$GB-MHRA-MED-202409031132584050-TLZKV$GB-ELI_LILLY_AND_COMPANY-GB202409001990$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$GB$GB
243185951$24318595$1$I$$20240903$20240913$20240913$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202409001887$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240913$$MD$SA$SA
243185961$24318596$1$I$20191201$20240903$20240913$20240913$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202409002689$ELI LILLY AND CO$$88$YR$E$F$Y$42.5$KG$20240913$$CN$MX$MX
243185971$24318597$1$I$$20240903$20240913$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001924$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240913$$CN$US$US
243185981$24318598$1$I$$20240903$20240913$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001855$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240913$$HP$US$US
243185991$24318599$1$I$20240822$20240903$20240913$20240913$EXP$GB-MHRA-MED-202409031330368850-PSGWV$GB-ELI_LILLY_AND_COMPANY-GB202409002216$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240913$$CN$GB$GB
243186001$24318600$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000227$MERZ$$$$$$Y$$$20240913$$HP$US$US
243186021$24318602$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000218$MERZ$$$$$$Y$$$20240913$$HP$US$US
243186031$24318603$1$I$20240307$20240913$20240913$20240913$DIR$718279$$FDA-CTU$$50$YR$$F$N$68$KG$20240913$N$HP$US$
243186041$24318604$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000219$MERZ$$$$$$Y$$$20240913$$HP$US$US
243186051$24318605$1$I$20240903$20240904$20240913$20240913$EXP$GB-MHRA-MED-202409041156478010-VWJZD$GB-BAXTER-2024BAX024233$BAXTER$$79$YR$$F$Y$$$20240913$$MD$GB$GB
243186061$24318606$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145499$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240913$$CN$US$US
243186071$24318607$1$I$$20240906$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143127$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240913$$CN$US$US
243186081$24318608$1$I$20240101$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000222$MERZ$$$$$$Y$$$20240913$$HP$US$US
243186091$24318609$1$I$$20240730$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000229$MERZ$$$$$$Y$$$20240913$$MD$US$US
243186101$24318610$1$I$20240101$20240905$20240913$20240913$PER$$US-SA-2024SA263349$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240913$$HP$US$US
243186111$24318611$1$I$$20240904$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009348$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243186121$24318612$1$I$$20240827$20240913$20240913$PER$$US-TEVA-VS-3238863$TEVA$$64$YR$$F$Y$$$20240913$$HP$US$US
243186131$24318613$1$I$20240101$20240723$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000183$MERZ$$$$$$Y$$$20240913$$HP$US$US
243186141$24318614$1$I$$20240725$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000186$MERZ$$$$A$F$Y$$$20240913$$HP$US$US
243186151$24318615$1$I$20240101$20240725$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000188$MERZ$$$$$$Y$$$20240913$$MD$US$US
243186161$24318616$1$I$20240701$20240725$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000187$MERZ$$$$$F$Y$$$20240913$$HP$US$US
243186171$24318617$1$I$$20240911$20240913$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US079709$SANDOZ$$$$$$Y$$$20240913$$PH$US$US
243186181$24318618$1$I$$20240909$20240913$20240913$EXP$$US-SANDOZ INC.-SDZ2024US078959$SANDOZ$$$$$$Y$$$20240913$$CN$US$US
243186191$24318619$1$I$$20240909$20240913$20240913$EXP$$US-MYLANLABS-2024M1083346$MYLAN$$$$$M$Y$$$20240913$$MD$US$US
243186201$24318620$1$I$$20240909$20240913$20240913$EXP$$ES-MYLANLABS-2024M1083159$MYLAN$$87$YR$$F$Y$$$20240913$$MD$ES$ES
243186211$24318621$1$I$$20240909$20240913$20240913$EXP$$ES-MYLANLABS-2024M1083114$MYLAN$Borrego Dominguez, R. Brain Abscess in Children.. Anales de Pediatria. 2005;63 (3):253-258$12$YR$$M$Y$$$20240913$$MD$ES$ES
243186222$24318622$2$F$20240601$20240918$20240913$20240919$EXP$$NZ-MYLANLABS-2024M1082943$MYLAN$$86$YR$$F$Y$$$20240919$$CN$NZ$NZ
243186231$24318623$1$I$20231101$20240729$20240913$20240913$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-23500$SAMSUNG BIOEPIS$$65$YR$E$F$Y$$$20240913$$CN$AU$AU
243186241$24318624$1$I$$20240827$20240913$20240913$EXP$$IN-Merck Healthcare KGaA-2024048542$MERCK KGAA$Nanjappa H, Rodrigues AJ. Atrial Fibrillation Secondary to Levothyroxine Overdose with Underlying Secondary Infection.. The Journal of the Association of Physicians of India. 2024 Aug 01;72(8): 96-98.$62$YR$A$F$Y$$$20240911$$MD$IN$IN
243186251$24318625$1$I$20240503$20240904$20240913$20240913$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006471$AURINIA PHARMACEUTICALS$$21$YR$$F$Y$81.179$KG$20240913$$CN$US$US
243186261$24318626$1$I$20240530$20240905$20240913$20240913$EXP$CN-NMPA-3501021025896202400551$CN-Ipsen Biopharmaceuticals, Inc.-2024-18317$IPSEN$$69$YR$E$M$Y$$$20240913$$HP$CN$CN
243186271$24318627$1$I$$20240722$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000182$MERZ$$75$YR$$F$Y$$$20240913$$CN$US$US
243186281$24318628$1$I$$20240904$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009345$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243186291$24318629$1$I$$20240911$20240913$20240913$PER$$US-ROCHE-10000080121$ROCHE$$$$$$Y$$$20240913$$CN$US$US
243186301$24318630$1$I$$20240719$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000181$MERZ$$64$YR$$M$Y$$$20240913$$CN$US$US
243186311$24318631$1$I$20240701$20240729$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000184$MERZ$$$$$F$Y$$$20240913$$HP$US$US
243186321$24318632$1$I$20240101$20240906$20240913$20240913$EXP$$CA-JNJFOC-20240918706$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240913$$HP$CA$CA
243186331$24318633$1$I$$20240911$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA045642$SANDOZ$$$$$M$Y$$$20240913$$MD$CA$CA
243186341$24318634$1$I$20240627$20240719$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000180$MERZ$$$$$F$Y$$$20240913$$HP$US$US
243186351$24318635$1$I$20240701$20240729$20240913$20240913$PER$$US-Merz Pharmaceuticals GmbH-2024070000185$MERZ$$66$YR$$F$Y$$$20240913$$CN$US$US
243186361$24318636$1$I$20240824$20240909$20240913$20240913$EXP$IT-MINISAL02-1001027$IT-MYLANLABS-2024M1082612$MYLAN$$72$YR$$F$Y$$$20240913$$PH$IT$IT
243186371$24318637$1$I$20210527$20240909$20240913$20240913$EXP$FR-AFSSAPS-NY2024001015$FR-MYLANLABS-2024M1082815$MYLAN$$95$YR$$F$Y$56$KG$20240913$$MD$FR$FR
243186381$24318638$1$I$20240725$20240909$20240913$20240913$EXP$FR-AFSSAPS-SE2024000684$FR-MYLANLABS-2024M1082798$MYLAN$$49$YR$$M$Y$63.2$KG$20240913$$MD$FR$FR
243186391$24318639$1$I$$20240909$20240913$20240913$EXP$$ES-MYLANLABS-2024M1082803$MYLAN$$48$YR$$F$Y$$$20240913$$MD$ES$ES
243186401$24318640$1$I$20240301$20240904$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN009342$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243186412$24318641$2$F$$20240916$20240913$20240923$EXP$$US-PHARMING-PHAUS2024000792$PHARMING GROUP$$$$$$Y$$$20240923$$HP$US$US
243186421$24318642$1$I$$20240904$20240913$20240913$PER$$US-PHARMING-PHAUS2024000774$PHARMING GROUP$$$$$$Y$$$20240913$$CN$US$US
243186431$24318643$1$I$20240911$20240911$20240913$20240913$PER$$US-AMGEN-USASP2024181835$AMGEN$$53$YR$A$M$Y$$$20240913$$HP$US$US
243186441$24318644$1$I$$20240909$20240913$20240913$EXP$$US-AstraZeneca-2024A205569$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$US$
243186452$24318645$2$F$$20240904$20240913$20240916$EXP$$US-PHARMING-PHAUS2024000749$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
243186471$24318647$1$I$$20240912$20240913$20240913$EXP$$IN-AstraZeneca-2024A209089$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$IN$
243186481$24318648$1$I$20240401$20240905$20240913$20240913$EXP$$US-AstraZeneca-2024A205882$ASTRAZENECA$$75$YR$$M$Y$80.7$KG$20240913$$MD$US$
243186492$24318649$2$F$20240710$20240910$20240913$20240918$EXP$$NVSC2024AR183113$NOVARTIS$$79$YR$$M$Y$$$20240918$$CN$AR$AR
243186501$24318650$1$I$20240827$20240905$20240913$20240913$PER$$US-PHARMING-PHAUS2024000781$PHARMING GROUP$$$$$$Y$$$20240913$$CN$US$US
243186511$24318651$1$I$$20240912$20240913$20240913$PER$$US-ABBVIE-5922604$ABBVIE$$$$$$Y$$$20240913$$CN$US$US
243186521$24318652$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146183$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240913$$CN$US$US
243186541$24318654$1$I$$20240905$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141993$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240913$$CN$US$US
243186551$24318655$1$I$20240905$20240905$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142042$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240913$$CN$US$US
243186561$24318656$1$I$$20240826$20240913$20240913$PER$$US-009507513-2408USA008998$MERCK$$$$$F$Y$$$20240913$$CN$US$US
243186571$24318657$1$I$20240828$20240904$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142192$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240913$$HP$US$US
243186581$24318658$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146290$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240913$$CN$US$US
243186591$24318659$1$I$$20240910$20240913$20240913$EXP$$US-INCYTE CORPORATION-2024IN009588$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243186601$24318660$1$I$$20240905$20240913$20240913$PER$$US-EMD Serono-2024047965$EMD SERONO INC$$30$YR$A$F$Y$$$20240913$$CN$US$US
243186611$24318661$1$I$20240201$20240911$20240913$20240913$EXP$$US-OTSUKA-2024_025595$OTSUKA$$87$YR$$F$Y$$$20240913$$HP$US$US
243186621$24318662$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA265160$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240913$$PH$US$US
243186641$24318664$1$I$20240701$20240904$20240913$20240913$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17825$IPSEN$$$$$F$Y$$$20240913$$HP$US$US
243186651$24318665$1$I$20240831$20240905$20240913$20240913$EXP$$US-Eisai-EC-2024-173501$EISAI$$70$YR$E$F$Y$$$20240913$$CN$US$US
243186661$24318666$1$I$20240101$20240910$20240913$20240913$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050405$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240913$$CN$AU$AU
243186672$24318667$2$F$$20240909$20240913$20240916$EXP$$CN-ASTELLAS-2024-AER-000650$ASTELLAS$Jianping Z, Zhongxia Y, Rongrong Z, Boxia L. Retrospective analysis of the efficacy and safety of antimony sodium gluconate and liposomal amphotericin B in the treatment of black fever. ADRJ. 2024;26 (7):399-404. doi:10.3760/cma.j.cn114015-20240109-00019$5$YR$C$F$Y$17$KG$20240916$$HP$CN$CN
243186681$24318668$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5917873$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243186691$24318669$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264399$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240913$$HP$US$US
243186701$24318670$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA263690$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240913$$MD$US$US
243186711$24318671$1$I$$20240904$20240913$20240913$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409003329$ELI LILLY AND CO$$85$YR$E$$Y$$$20240913$$CN$JP$JP
243186721$24318672$1$I$$20240905$20240913$20240913$EXP$GB-MHRA-MED-202409051032288470-PLVQR$GB-ELI_LILLY_AND_COMPANY-GB202409004144$ELI LILLY AND CO$$$$$M$Y$$$20240913$$CN$GB$GB
243186731$24318673$1$I$20240601$20240903$20240913$20240913$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409001537$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$DE$DE
243186741$24318674$1$I$$20240903$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409002346$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240913$$CN$US$US
243186751$24318675$1$I$20240730$20240906$20240913$20240913$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202409004107$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240913$$CN$ES$ES
243186761$24318676$1$I$$20240829$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409000704$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240913$$CN$US$US
243186772$24318677$2$F$$20240906$20240913$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003569$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240918$$CN$US$US
243186781$24318678$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MED-202409041955528000-CMLJZ$GB-ELI_LILLY_AND_COMPANY-GB202409003203$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$GB$GB
243186801$24318680$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MED-202409041143040960-JFHLD$GB-ELI_LILLY_AND_COMPANY-GB202409003221$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$GB$GB
243186821$24318682$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MED-202409041439225560-KLNHS$GB-ELI_LILLY_AND_COMPANY-GB202409003259$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$GB$GB
243186831$24318683$1$I$20240912$20240912$20240913$20240913$PER$$US-AMGEN-USASP2024182690$AMGEN$$72$YR$E$F$Y$$$20240913$$CN$US$US
243186841$24318684$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146041$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240913$$CN$US$US
243186851$24318685$1$I$20230810$20240821$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133541$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240913$$CN$US$US
243186861$24318686$1$I$20240101$20240904$20240913$20240913$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000190$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240913$$CN$US$US
243186871$24318687$1$I$20240907$20240909$20240913$20240913$EXP$$US-OTSUKA-2024_025303$OTSUKA$$59$YR$$M$Y$$$20240913$$CN$US$US
243186881$24318688$1$I$20240521$20240903$20240913$20240913$EXP$FR-AFSSAPS-PP2024000909$FR-BIOGEN-2024BI01281464$BIOGEN$$34$YR$$F$Y$$$20240913$$MD$FR$FR
243186891$24318689$1$I$$20240905$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142265$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240913$$HP$US$US
243186901$24318690$1$I$$20240912$20240913$20240913$EXP$$AU-AstraZeneca-2024A208794$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$AU$
243186911$24318691$1$I$$20240909$20240913$20240913$EXP$$CN-AstraZeneca-2024A200050$ASTRAZENECA$$40$YR$$M$Y$$$20240913$$CN$CN$
243186921$24318692$1$I$$20240907$20240913$20240913$EXP$$HR-REGENERON PHARMACEUTICALS, INC.-2024-122305$REGENERON$$70$YR$$F$Y$$$20240913$$MD$HR$HR
243186931$24318693$1$I$20240101$20240905$20240913$20240913$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000191$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240913$$CN$US$US
243186941$24318694$1$I$20240101$20240906$20240913$20240913$EXP$$US-SANDOZ INC.-SDZ2024US080115$SANDOZ$$$$$F$Y$$$20240913$$CN$US$US
243186951$24318695$1$I$20240101$20240830$20240913$20240913$EXP$$DE-TEVA-VS-3239609$TEVA$$82$YR$$M$Y$$$20240913$$PH$DE$DE
243186961$24318696$1$I$$20240910$20240913$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US079507$SANDOZ$$$$$M$Y$$$20240913$$CN$US$US
243186971$24318697$1$I$$20240828$20240913$20240913$PER$$US-009507513-2408USA010813$MERCK$Tvrdik T, Gjeorgjievski SG, Wong P, Oskouei S, Read Wi, Bahrami A.. Genomic Insights Into High-Grade Infarct-Associated Bone Sarcomas. Modern Pathology. 2024;37$58$YR$$F$Y$$$20240913$$HP$US$US
243186981$24318698$1$I$20240101$20240903$20240913$20240913$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000189$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240913$$CN$US$US
243186991$24318699$1$I$20240911$20240912$20240913$20240913$PER$$US-AMGEN-USASP2024182601$AMGEN$$74$YR$E$F$Y$$$20240913$$CN$US$US
243187001$24318700$1$I$$20240910$20240913$20240913$EXP$$CA-SANDOZ INC.-NVSC2019CA100797$SANDOZ$$53$YR$$F$Y$$$20240913$$HP$CA$CA
243187031$24318703$1$I$20240820$20240913$20240913$20240913$DIR$718282$$FDA-CTU$$12$MON$$F$N$9.09$KG$20240913$N$CN$US$
243187041$24318704$1$I$20240820$20240913$20240913$20240913$DIR$718273$$FDA-CTU$$5$MON$$M$N$5.445$KG$20240913$N$CN$US$
243187052$24318705$2$F$20230101$20240911$20240913$20240930$EXP$$US-ORGANON-O2409USA000874$ORGANON$$$$$F$Y$$$20240930$$HP$US$US
243187071$24318707$1$I$$20240907$20240913$20240913$EXP$$US-ABBVIE-5914852$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243187091$24318709$1$I$20240101$20240903$20240913$20240913$PER$$US-ABBVIE-5907678$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243187101$24318710$1$I$$20240910$20240913$20240913$EXP$$JP-PFIZER INC-202400254948$PFIZER$$76$YR$$F$Y$$$20240913$$MD$JP$JP
243187111$24318711$1$I$20240101$20240910$20240913$20240913$EXP$$JP-PFIZER INC-PV202400102086$PFIZER$$50$YR$$F$Y$$$20240913$$MD$JP$JP
243187121$24318712$1$I$20240101$20240911$20240913$20240913$EXP$$US-PFIZER INC-PV202400119683$PFIZER$$64$YR$$F$Y$$$20240913$$HP$US$US
243187132$24318713$2$F$20240630$20240925$20240913$20240927$EXP$$US-Calliditas-2024CAL01248$CALLIDITAS THERAPEUTICS$$54$YR$A$M$Y$$$20240927$$CN$US$US
243187142$24318714$2$F$$20240918$20240913$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141538$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240920$$PH$US$US
243187152$24318715$2$F$$20240920$20240913$20240930$EXP$$JP-MALLINCKRODT-MNK202405560$MALLINCKRODT$$54$YR$A$M$Y$120$KG$20240930$$HP$JP$JP
243187161$24318716$1$I$$20240910$20240913$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145164$BRISTOL MYERS SQUIBB$Kohnoh A, Shimada T, Hamano S, Bando K, Takahata A, Toyoda S, et al. Cytomegalovirus retinitis developing during DRd therapy for plasma cell leukemia. The 20th Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology (Programs and Abstracts). 2024;59.$71$YR$E$M$Y$$$20240913$$MD$JP$JP
243187171$24318717$1$I$20240513$20240910$20240913$20240913$EXP$FR-AFSSAPS-BX2024001085$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-144582$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$44$KG$20240913$$MD$FR$FR
243187181$24318718$1$I$$20240903$20240913$20240913$30DAY$$US-GSK-US2024109527$GLAXOSMITHKLINE$$$$$M$Y$$$20240913$$CN$US$US
243187191$24318719$1$I$$20240821$20240913$20240913$PER$$US-SA-2024SA262978$SANOFI AVENTIS$$$$C$M$Y$66$KG$20240913$$MD$US$US
243187201$24318720$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA263288$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240913$$HP$US$US
243187211$24318721$1$I$$20240903$20240913$20240913$EXP$$IN-ROCHE-10000070142$ROCHE$$67$YR$E$M$Y$$$20240913$$CN$IN$IN
243187221$24318722$1$I$20231207$20240910$20240913$20240913$EXP$$US-OTSUKA-2024_025453$OTSUKA$$64$YR$$M$Y$$$20240913$$HP$US$US
243187231$24318723$1$I$$20240904$20240913$20240913$PER$$US-ABBVIE-5908871$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243187241$24318724$1$I$$20240910$20240913$20240913$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050736$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240913$$CN$US$US
243187251$24318725$1$I$$20240904$20240913$20240913$PER$$US-BIOGEN-2024BI01281111$BIOGEN$$$$$$Y$$$20240913$$CN$US$US
243187261$24318726$1$I$$20240905$20240913$20240913$EXP$$US-SA-2024SA264912$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240913$$HP$US$US
243187271$24318727$1$I$$20240909$20240913$20240913$EXP$$ES-MYLANLABS-2024M1082570$MYLAN$$57$YR$$M$Y$$$20240913$$MD$ES$ES
243187292$24318729$2$F$$20240911$20240913$20240917$EXP$$PL-MYLANLABS-2024M1082358$MYLAN$Fajkis M.. Long-term immunotherapy using pembrolizumab in combination with chemotherapy in a patient with metastatic lung cancer and low PD-L1 expression.. ONCOLOGY IN CLINICAL PRACTICE - EDU. 2024;10(Suppl C):C3-C5$61$YR$$F$Y$$$20240917$$HP$PL$PL
243187301$24318730$1$I$20240830$20240913$20240913$20240913$DIR$718272$$FDA-CTU$$3$MON$$F$N$4.95$KG$20240913$N$CN$US$
243187311$24318731$1$I$20240911$20240913$20240913$20240913$DIR$718275$$FDA-CTU$$4$WK$$F$N$$$20240913$N$CN$US$
243187321$24318732$1$I$$20240905$20240913$20240913$EXP$$CA-AstraZeneca-2024A206858$ASTRAZENECA$$80$YR$$M$Y$89$KG$20240913$$MD$CA$
243187331$24318733$1$I$$20240910$20240913$20240913$EXP$$NVSC2024CA181722$NOVARTIS$$65$YR$$F$Y$$$20240913$$HP$CA$CA
243187341$24318734$1$I$20240911$20240913$20240913$20240913$DIR$718276$$FDA-CTU$$4$MON$$UNK$N$$$20240913$N$CN$US$
243187352$24318735$2$F$$20240910$20240913$20240919$EXP$$CA-SANDOZ INC.-NVSC2022CA090083$SANDOZ$$75$YR$$F$Y$70$KG$20240919$$HP$CA$CA
243187381$24318738$1$I$$20240912$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA079991$SANDOZ$$$$$$Y$$$20240913$$MD$CA$CA
243187391$24318739$1$I$20240830$20240906$20240913$20240913$EXP$$CO-BIOMARINAP-CO-2024-160356$BIOMARIN$$$$$$Y$$$20240913$$CN$CO$CO
243187402$24318740$2$F$20231204$20240905$20240913$20240923$EXP$$JP-BIOMARINAP-JP-2024-160468$BIOMARIN$$$$$$Y$$$20240923$$MD$JP$JP
243187411$24318741$1$I$$20240903$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140685$BRISTOL MYERS SQUIBB$Bowden A, Zambito J, El-Feghaly J, Andolina JR. Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series. Pediatric Hematology and Oncology. 2024 May 07;41(6):389-98. doi:10.1080/08880018.2024.2350455.$9$YR$C$M$Y$$$20240913$$HP$US$US
243187421$24318742$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145282$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$56.7$KG$20240913$$CN$US$US
243187431$24318743$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145930$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240913$$CN$US$US
243187441$24318744$1$I$20240712$20240912$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146014$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240913$$CN$US$US
243187451$24318745$1$I$$20240910$20240913$20240913$EXP$$US-MYLANLABS-2024M1083099$MYLAN$$72$YR$$M$Y$$$20240913$$CN$US$US
243187461$24318746$1$I$$20240910$20240913$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US079368$SANDOZ$$$$$M$Y$$$20240913$$CN$US$US
243187471$24318747$1$I$$20240909$20240913$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US071990$SANDOZ$$$$$M$Y$$$20240913$$CN$US$US
243187481$24318748$1$I$20240904$20240906$20240913$20240913$EXP$$US-TAKEDA-2024TUS070006$TAKEDA$$59$YR$$F$Y$$$20240913$$CN$US$US
243187491$24318749$1$I$20240806$20240909$20240913$20240913$EXP$PT-INFARMED-B202408-340$PT-ABBVIE-5920775$ABBVIE$$69$YR$$F$Y$$$20240913$$PH$PT$PT
243187501$24318750$1$I$20211123$20240909$20240913$20240913$EXP$$CA-SANDOZ INC.-NVSC2019CA065392$SANDOZ$$55$YR$$F$Y$$$20240913$$MD$CA$CA
243187521$24318752$1$I$20240826$20240826$20240913$20240913$PER$$US-SA-2024SA262727$SANOFI AVENTIS$$$$A$$Y$$$20240913$$CN$US$US
243187531$24318753$1$I$20240801$20240822$20240913$20240913$PER$$US-SA-2024SA262845$SANOFI AVENTIS$$36$YR$A$M$Y$122.73$KG$20240913$$MD$US$US
243187541$24318754$1$I$$20240903$20240913$20240913$EXP$$BG-TAKEDA-2024TUS090618$TAKEDA$$62$YR$$M$Y$$$20240913$$MD$BG$BG
243187551$24318755$1$I$$20240905$20240913$20240913$EXP$$CA-TAKEDA-2022TUS064226$TAKEDA$$$$$F$Y$$$20240913$$CN$CA$CA
243187561$24318756$1$I$20240905$20240910$20240913$20240913$EXP$$JP-ABBVIE-5918809$ABBVIE$$21$YR$$M$Y$52.7$KG$20240913$$MD$JP$JP
243187571$24318757$1$I$$20240831$20240913$20240913$EXP$$CA-HLS-202402211$HLS THERAPEUTICS$$$$A$F$Y$$$20240913$$HP$CA$CA
243187582$24318758$2$F$20240828$20240917$20240913$20240924$PER$$US-AMGEN-USASP2024174409$AMGEN$$78$YR$E$F$Y$79$KG$20240924$$PH$US$US
243187591$24318759$1$I$$20240903$20240913$20240913$EXP$$JP-Eisai-EC-2024-173912$EISAI$Hara K, Miura E, Umeda Y, Umeda M, Oyake M, Fujita N. A case of Parkinson^s disease with severe head droop after administration of donepezil hydrochloride. Clinical neurology. 2024 Aug 24;1-4. doi:10.5692/clinicalneurol.cn-001983.$76$YR$E$F$Y$39.2$KG$20240913$$MD$JP$JP
243187602$24318760$2$F$20210101$20240916$20240913$20240919$EXP$$US-ABBVIE-5917715$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243187621$24318762$1$I$20240701$20240906$20240913$20240913$PER$$US-ABBVIE-5913510$ABBVIE$$56$YR$$F$Y$$$20240913$$PH$US$US
243187641$24318764$1$I$20240812$20240911$20240913$20240913$EXP$$MM-ASTELLAS-2024-AER-006458$ASTELLAS$$57$YR$A$F$Y$$$20240913$$CN$MM$MM
243187651$24318765$1$I$20240101$20240820$20240913$20240913$PER$$US-SA-2024SA263548$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240913$$PH$US$US
243187661$24318766$1$I$$20240829$20240913$20240913$PER$$US-SA-2024SA261116$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240913$$MD$US$US
243187671$24318767$1$I$$20240902$20240913$20240913$PER$$US-SA-2024SA264097$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240913$$MD$US$US
243187681$24318768$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263109$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240913$$HP$US$US
243187692$24318769$2$F$$20240909$20240913$20240920$EXP$$ES-009507513-2409ESP004318$MERCK$$80$YR$$F$Y$$$20240920$$MD$ES$ES
243187711$24318771$1$I$20240101$20240829$20240913$20240913$PER$$US-SA-2024SA264204$SANOFI AVENTIS$$58$YR$A$M$Y$125.45$KG$20240913$$MD$US$US
243187731$24318773$1$I$$20240911$20240913$20240913$EXP$$ES-MYLANLABS-2024M1083118$MYLAN$$32$YR$$M$Y$$$20240913$$HP$ES$ES
243187741$24318774$1$I$20240515$20240911$20240913$20240913$EXP$$AR-MYLANLABS-2024M1081802$MYLAN$$18$YR$$M$Y$$$20240913$$CN$AR$AR
243187751$24318775$1$I$20230910$20240912$20240913$20240913$EXP$GB-MHRA-MED-202409092211043050-VNYST$GB-MYLANLABS-2024M1083368$MYLAN$$62$YR$$M$Y$$$20240913$$MD$GB$GB
243187762$24318776$2$F$20240809$20240912$20240913$20240924$EXP$GB-MHRA-MED-202409120752144000-TSFRN$GB-MYLANLABS-2024M1083305$MYLAN$$77$YR$$F$Y$100$KG$20240924$$CN$GB$GB
243187771$24318777$1$I$20240818$20240911$20240913$20240913$EXP$FR-AFSSAPS-AN2024001208$FR-MYLANLABS-2024M1083121$MYLAN$$34$YR$$F$Y$88$KG$20240913$$MD$FR$FR
243187781$24318778$1$I$$20240909$20240913$20240913$EXP$$CA-BAUSCH-BL-2024-013517$BAUSCH AND LOMB$$$$$F$Y$$$20240913$$HP$CA$CA
243187792$24318779$2$F$$20240916$20240913$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142353$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240923$$CN$US$US
243187801$24318780$1$I$$20240903$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146270$BRISTOL MYERS SQUIBB$Bowden A, Zambito J, El-Feghaly J, Andolina JR. Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series. Pediatric Hematology and Oncology. 2024 May 07;41(6):389-98. doi:10.1080/08880018.2024.2350455.$10$YR$C$F$Y$$$20240913$$HP$US$US
243187811$24318781$1$I$$20240903$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146269$BRISTOL MYERS SQUIBB$Bowden A, Zambito J, El-Feghaly J, Andolina JR. Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series. Pediatric Hematology and Oncology. 2024 May 07;41(6):389-98. doi:10.1080/08880018.2024.2350455.$12$YR$T$M$Y$$$20240913$$HP$US$US
243187821$24318782$1$I$$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145365$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$89.36$KG$20240913$$CN$US$US
243187841$24318784$1$I$$20240909$20240913$20240913$EXP$$US-ABBVIE-5917341$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243187861$24318786$1$I$$20240909$20240913$20240913$PER$$US-AMGEN-USASP2024179760$AMGEN$$$$$M$Y$$$20240913$$CN$US$US
243187871$24318787$1$I$20240805$20240904$20240913$20240913$EXP$$JP-RADIUS HEALTH INC.-2024JP006733$RADIUS PHARM$$63$YR$$F$Y$$$20240913$$MD$JP$JP
243187881$24318788$1$I$$20240910$20240913$20240913$PER$$US-PFIZER INC-PV202400118997$PFIZER$$$$A$F$Y$$$20240913$$CN$US$US
243187891$24318789$1$I$$20240909$20240913$20240913$PER$$US-PFIZER INC-202400254056$PFIZER$$$$$$Y$$$20240913$$CN$US$US
243187911$24318791$1$I$$20240827$20240913$20240913$PER$$US-TEVA-VS-3238989$TEVA$$65$YR$$M$Y$$$20240913$$MD$US$US
243187931$24318793$1$I$$20240903$20240913$20240913$PER$$JP-Eisai-EC-2024-174363$EISAI$Kumi Shimamoto. Monitoring of adrenal function during lenvatinib/pembrolizumab therapy. Journal of the Japanese Society of Gynecologic Oncology. 2024; 42(3): OS-175-.$$$$F$Y$$$20240913$$MD$JP$JP
243187941$24318794$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146364$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240913$$CN$US$US
243187951$24318795$1$I$$20240909$20240913$20240913$EXP$US-MLMSERVICE-20240903-PI177112-00198-1$US-RDY-SPO/USA/24/0013265$DR REDDYS$Al-Chalabi M, Martinez Salazar A, Bradshaw A. Fluoroquinolone-Induced Demyelinating Polyneuropathy. Journal of Clinical Neuromuscular Disease. 2024;26(1):49-53. DOI: 1097/CND.0000000000000496.$60$YR$A$M$Y$$$20240913$$MD$US$US
243187961$24318796$1$I$$20240905$20240913$20240913$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17907$IPSEN$$1$YR$I$F$Y$$$20240913$$CN$US$US
243187971$24318797$1$I$20220901$20240905$20240913$20240913$EXP$AT-BASGAGES-2024-006572$AT-ASTELLAS-2024-AER-005148$ASTELLAS$$81$YR$E$M$Y$78$KG$20240913$$CN$AT$AT
243187981$24318798$1$I$$20240905$20240913$20240913$PER$$US-SA-2024SA264421$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240913$$HP$US$US
243187992$24318799$2$F$20240801$20240823$20240913$20240920$PER$$US-SA-2024SA262814$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240920$$MD$US$US
243188001$24318800$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240969$TEVA$$$$$$Y$$$20240913$$HP$CA$CA
243188021$24318802$1$I$$20240910$20240913$20240913$EXP$$NVSC2024CA182394$NOVARTIS$$$$$M$Y$$$20240913$$MD$CA$CA
243188031$24318803$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263396$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240913$$MD$US$US
243188041$24318804$1$I$$20240909$20240913$20240913$EXP$$PT-JNJFOC-20240927991$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240913$$HP$PT$PT
243188061$24318806$1$I$20240101$20240909$20240913$20240913$EXP$$CA-PFIZER INC-202400253927$PFIZER$$91$YR$$M$Y$$$20240913$$HP$CA$CA
243188072$24318807$2$F$$20240912$20240913$20240917$EXP$$JP-PFIZER INC-202400254402$PFIZER$Fujii, M.. Refractory vasospastic angina in a patient with autoimmune hepatitis managed by using combined non-invasive provocation tests: A case report. Journal of Cardiology Cases. 2024;10.1016/j.jccase.2024.08.002$49$YR$$M$Y$61$KG$20240917$$MD$JP$JP
243188082$24318808$2$F$$20240912$20240913$20240917$EXP$$JP-PFIZER INC-202400254850$PFIZER$Kitaya, S.. QTc Interval Prolongation as an Adverse Event of Azole Antifungal Drugs: Case Report and Literature Review. Microorganisms. 2024;12(8):1619$77$YR$$M$Y$$$20240917$$MD$JP$JP
243188091$24318809$1$I$$20240904$20240913$20240913$EXP$$CA-TEVA-VS-3240756$TEVA$$80$YR$$M$Y$69$KG$20240913$$HP$CA$CA
243188101$24318810$1$I$20240403$20240902$20240913$20240913$EXP$GB-MHRA-MED-202409020649014160-JYKQS$GB-ELI_LILLY_AND_COMPANY-GB202409001094$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240913$$CN$GB$GB
243188111$24318811$1$I$20240801$20240903$20240913$20240913$EXP$GB-MHRA-MED-202409031745413500-JPKDN$GB-ELI_LILLY_AND_COMPANY-GB202409002050$ELI LILLY AND CO$$10$YR$C$F$Y$138$KG$20240913$$CN$GB$GB
243188121$24318812$1$I$20240822$20240903$20240913$20240913$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409002260$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240913$$CN$CN$CN
243188131$24318813$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MED-202409040942357570-YSQTH$GB-ELI_LILLY_AND_COMPANY-GB202409003128$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240913$$CN$GB$GB
243188152$24318815$2$F$$20240912$20240913$20240916$EXP$$TR-PFIZER INC-202400254935$PFIZER$Tasdemir, M.. Managing recurrent parvovirus B19-associated anemia after a pediatric kidney transplant. Pediatric Nephrology. 2024;39(10):2923-2925$13$YR$$F$Y$40$KG$20240916$$MD$TR$TR
243188161$24318816$1$I$$20240911$20240913$20240913$PER$$US-ALXN-202409USA000857US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243188171$24318817$1$I$20240401$20240911$20240913$20240913$PER$$US-ALXN-202409USA000800US$ALEXION PHARMACEUTICALS$$47$YR$$F$Y$$$20240913$$CN$US$US
243188181$24318818$1$I$$20240905$20240913$20240913$EXP$$ES-TAKEDA-2024TUS090989$TAKEDA$$$$$$Y$$$20240913$$CN$ES$ES
243188192$24318819$2$F$20230701$20240920$20240913$20240924$EXP$FR-AFSSAPS-LY2024001250$FR-ABBVIE-5919540$ABBVIE$$32$YR$$M$Y$$$20240924$$CN$FR$FR
243188201$24318820$1$I$20240818$20240904$20240913$20240913$PER$$US-TAKEDA-2024TUS089268$TAKEDA$$$$E$M$Y$$$20240913$$CN$US$US
243188211$24318821$1$I$20240909$20240910$20240913$20240913$30DAY$$IT-SANDOZ INC.-SDZ2024IT079555$SANDOZ$$15$YR$$F$Y$45$KG$20240913$$CN$IT$IT
243188221$24318822$1$I$20240701$20240910$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144298$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$97.52$KG$20240913$$CN$US$US
243188231$24318823$1$I$20231214$20240910$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145529$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240913$$MD$US$US
243188241$24318824$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146316$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$89.36$KG$20240913$$CN$US$US
243188251$24318825$1$I$20240101$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145559$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240913$$CN$US$US
243188261$24318826$1$I$20221228$20240905$20240913$20240913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145541$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240913$$MD$JP$JP
243188271$24318827$1$I$$20240912$20240913$20240913$EXP$$DE-UNITED THERAPEUTICS-UNT-2024-028745$UNITED THERAPEUTICS$$$$A$$Y$$$20240913$$MD$DE$DE
243188292$24318829$2$F$$20240911$20240913$20240923$PER$$US-SA-2024SA257062$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240923$$HP$US$US
243188311$24318831$1$I$$20240820$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN008773$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243188321$24318832$1$I$20230101$20240911$20240913$20240913$EXP$$PR-ABBVIE-5920845$ABBVIE$$$$$F$Y$65$KG$20240913$$CN$PR$PR
243188331$24318833$1$I$$20240906$20240913$20240913$EXP$$US-GILEAD-2024-0659757$GILEAD$$79$YR$E$M$Y$$$20240913$$MD$US$US
243188341$24318834$1$I$$20240909$20240913$20240913$30DAY$$CO-PFIZER INC-202400254633$PFIZER$$$$$M$Y$$$20240913$$CN$CO$CO
243188352$24318835$2$F$$20240912$20240913$20240917$EXP$$AL-PFIZER INC-202400254400$PFIZER$Domi, R.. Intraoperative Takotsubo Syndrome. J Med Cases. 2024;15(9):242-49$22$YR$$F$Y$$$20240917$$MD$AL$AL
243188361$24318836$1$I$$20240910$20240913$20240913$30DAY$$CO-PFIZER INC-PV202400031546$PFIZER$$10$YR$$F$Y$$$20240913$$CN$CO$CO
243188372$24318837$2$F$$20240924$20240913$20240926$30DAY$$PA-PFIZER INC-PV202400119882$PFIZER$$14$YR$$F$Y$$$20240926$$CN$PA$PA
243188383$24318838$3$F$$20240913$20240913$20240923$30DAY$$US-PFIZER INC-202400253248$PFIZER$$6$YR$$M$Y$$$20240923$$MD$US$US
243188391$24318839$1$I$$20240910$20240913$20240913$PER$$US-MYLANLABS-2024M1082789$MYLAN$$71$YR$$F$Y$$$20240913$$CN$US$US
243188401$24318840$1$I$20240812$20240905$20240913$20240913$EXP$$US-TAKEDA-2024TUS066874$TAKEDA$$79$YR$$F$Y$$$20240913$$CN$US$US
243188412$24318841$2$F$20230101$20240905$20240913$20240916$PER$$US-Eisai-EC-2024-173910$EISAI$$81$YR$E$M$Y$$$20240916$$CN$US$US
243188421$24318842$1$I$20240101$20240912$20240913$20240913$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051235$BOEHRINGER INGELHEIM$$6$DEC$A$M$Y$$$20240913$$MD$US$US
243188432$24318843$2$F$$20240927$20240913$20240927$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050944$BOEHRINGER INGELHEIM$$7$DEC$E$M$Y$$$20240927$$MD$JP$JP
243188441$24318844$1$I$20240904$20240909$20240913$20240913$EXP$$US-009507513-2409USA004307$MERCK$$64$YR$$F$Y$$$20240913$$CN$US$US
243188451$24318845$1$I$20240713$20240904$20240913$20240913$EXP$$DE-RADIUS HEALTH INC.-2024DE006798$RADIUS PHARM$$$$$F$Y$$$20240913$$MD$DE$DE
243188461$24318846$1$I$20240101$20240906$20240913$20240913$EXP$$US-ABBVIE-5916946$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243188471$24318847$1$I$20240801$20240903$20240913$20240913$EXP$$CA-Vifor (International) Inc.-VIT-2024-08066$VIFOR$$72$YR$$M$Y$$$20240913$$CN$CA$CA
243188482$24318848$2$F$$20240913$20240913$20240918$EXP$$US-PFIZER INC-202400255057$PFIZER$Schwetye, K.. Histopathologic correlates of opioid-associated injury in CHANTER syndrome: first report of a post-mortem examination. Acta Neuropathologica. 2024;148(1):33$45$YR$$M$Y$$$20240918$$MD$US$US
243188491$24318849$1$I$$20240908$20240913$20240913$30DAY$$JP-PFIZER INC-PV202400117576$PFIZER$$$$$$Y$$$20240913$$CN$JP$JP
243188501$24318850$1$I$$20240821$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135374$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240913$$CN$US$US
243188511$24318851$1$I$20240101$20240911$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145627$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240913$$CN$US$US
243188522$24318852$2$F$$20240909$20240913$20240920$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-144605$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240920$$CN$TW$TW
243188531$24318853$1$I$20240425$20240906$20240913$20240913$PER$$US-ALXN-202409USA000443US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240913$$CN$US$US
243188541$24318854$1$I$20240812$20240906$20240913$20240913$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143661$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$56.2$KG$20240913$$PH$US$US
243188551$24318855$1$I$20240911$20240624$20240913$20240913$PER$$US-SA-2024SA264491$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240913$$CN$US$US
243188561$24318856$1$I$20240801$20240822$20240913$20240913$PER$$US-SA-2024SA263354$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240913$$MD$US$US
243188571$24318857$1$I$20240713$20240905$20240913$20240913$EXP$IT-MINISAL02-999177$IT-BAYER-2024A120297$BAYER$$29$MON$C$M$Y$16$KG$20240913$$MD$IT$IT
243188581$24318858$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263552$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240913$$MD$US$US
243188591$24318859$1$I$20240701$20240820$20240913$20240913$PER$$US-SA-2024SA264453$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240913$$HP$US$US
243188601$24318860$1$I$20240101$20240904$20240913$20240913$PER$$US-ABBVIE-5909157$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243188611$24318861$1$I$20150101$20240909$20240913$20240913$EXP$$JP-PFIZER INC-202400254907$PFIZER$Nakamura, T.. MTX-LPD as an iatrogenicity: a case of RA complicated with low grade B-cell lymphoma having a specific clinical course. The 68th Meeting of Kyushu College of Rheumatology. 2024;68th:71$$$A$M$Y$$$20240913$$HP$JP$JP
243188621$24318862$1$I$20220419$20240910$20240913$20240913$EXP$$KR-PFIZER INC-202400253332$PFIZER$$740$MON$$M$Y$62$KG$20240913$$MD$KR$KR
243188631$24318863$1$I$$20240903$20240913$20240913$PER$$US-IMP-2024000715$Harrow Health$$$$E$F$Y$$$20240913$$CN$US$US
243188641$24318864$1$I$$20240905$20240913$20240913$EXP$$SA-TAKEDA-2024TUS089962$TAKEDA$$$$$F$Y$$$20240913$$CN$SA$SA
243188651$24318865$1$I$20220320$20240905$20240913$20240913$PER$$JP-Eisai-EC-2023-142167$EISAI$Sumiyoshi A. Kumamoto Hospital Pharmaceutical Association.$72$YR$E$F$Y$$$20240913$$PH$JP$JP
243188661$24318866$1$I$$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146264$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240913$$CN$US$US
243188671$24318867$1$I$$20240913$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146355$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240913$$CN$US$US
243188681$24318868$1$I$$20240904$20240913$20240913$EXP$$US-VERTEX PHARMACEUTICALS-2024-014279$VERTEX$McKinzie CJ, Duehlmeyer SR, Kam CW, Safirstein J.. Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy. Pediatr Pulmonol. 2024$18$YR$$F$Y$$$20240913$$PH$US$US
243188691$24318869$1$I$$20240904$20240913$20240913$EXP$$US-VERTEX PHARMACEUTICALS-2024-014261$VERTEX$McKinzie CJ, Duehlmeyer SR, Kam CW, Safirstein J.. Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy. Pediatr Pulmonol. 2024;1-2$$$A$F$Y$$$20240913$$PH$US$US
243188701$24318870$1$I$$20240904$20240913$20240913$EXP$$US-VERTEX PHARMACEUTICALS-2024-014258$VERTEX$McKinzie CJ, Duehlmeyer SR, Kam CW, Safirstein J.. Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy. Pediatr Pulmonol. 2024$48$YR$$F$Y$$$20240913$$PH$US$US
243188712$24318871$2$F$$20240923$20240913$20240927$EXP$$US-VERTEX PHARMACEUTICALS-2024-014195$VERTEX$$$$$$Y$$$20240927$$CN$US$US
243188721$24318872$1$I$$20240904$20240913$20240913$EXP$$US-VERTEX PHARMACEUTICALS-2024-014306$VERTEX$Solomon GM, Linnemann RW, Rich R, Streby A, Buehler B, Hunter E, et al.. Evaluation of elexacaftor-tezacaftor-ivacaftor treatment in individuals with cystic fibrosis and CFTR N1303K in the USA: a prospective, multicentre, open-label, single-arm trial. Lancet Respir Med. 2024$$$$$Y$$$20240913$$MD$US$US
243188731$24318873$1$I$$20240904$20240913$20240913$EXP$$US-VERTEX PHARMACEUTICALS-2024-014273$VERTEX$McKinzie CJ, Duehlmeyer SR, Kam CW, Safirstein J.. Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy. Pediatr Pulmonol. 2024$14$YR$$M$Y$$$20240913$$PH$US$US
243188742$24318874$2$F$20240918$20240927$20240913$20240930$EXP$$GB-MYLANLABS-2024M1083181$MYLAN$$$$$M$Y$$$20240930$$PH$GB$GB
243188761$24318876$1$I$$20240912$20240913$20240913$PER$$US-BAUSCH-BL-2024-013684$BAUSCH AND LOMB$$47$YR$$$Y$$$20240913$$MD$US$US
243188771$24318877$1$I$20230101$20240906$20240913$20240913$EXP$$BR-BIOGEN-2024BI01281882$BIOGEN$$$$$M$Y$1.88$KG$20240913$$CN$BR$BR
243188781$24318878$1$I$20240501$20240903$20240913$20240913$EXP$GB-MHRA-MED-202409031726122210-NLPSJ$GB-ELI_LILLY_AND_COMPANY-GB202409002053$ELI LILLY AND CO$$28$YR$A$F$Y$86$KG$20240913$$CN$GB$GB
243188791$24318879$1$I$20240910$20240911$20240913$20240913$PER$$US-ALXN-202409USA000791US$ALEXION PHARMACEUTICALS$$17$YR$$F$Y$$$20240913$$CN$US$US
243188812$24318881$2$F$20240909$20240910$20240913$20240913$PER$$NVSC2024US181879$NOVARTIS$$48$YR$$M$Y$$$20240913$$PH$US$US
243188821$24318882$1$I$$20240913$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146348$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$58.97$KG$20240913$$CN$US$US
243188831$24318883$1$I$$20240911$20240913$20240913$PER$$US-ABBVIE-5921743$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243188851$24318885$1$I$20210101$20240906$20240913$20240913$EXP$$US-BIOGEN-2024BI01281255$BIOGEN$$$$$F$Y$$$20240913$$CN$US$US
243188861$24318886$1$I$20240101$20240905$20240913$20240913$EXP$$US-SPECGX-T202401864$SPECGX$$$$$M$Y$$$20240913$$CN$US$US
243188871$24318887$1$I$$20240912$20240913$20240913$EXP$$US-PURDUE PHARMA-USA-2024-0311949$PURDUE$$21$YR$$F$Y$$$20240913$$CN$US$US
243188882$24318888$2$F$20190806$20240920$20240913$20240923$EXP$$US-PURDUE PHARMA-USA-2024-0311947$PURDUE$$34$YR$$M$Y$$$20240923$$CN$US$US
243188891$24318889$1$I$20230907$20240906$20240913$20240913$EXP$$BR-BIOGEN-2023BI01240677$BIOGEN$$40$YR$$F$Y$74$KG$20240913$$CN$BR$BR
243188901$24318890$1$I$$20240906$20240913$20240913$EXP$$US-ALXN-202409USA000470US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243188911$24318891$1$I$$20240910$20240913$20240913$EXP$$RO-ALXN-202409EEA000608RO$ALEXION PHARMACEUTICALS$$4$YR$$F$Y$$$20240913$$MD$RO$RO
243188921$24318892$1$I$20240911$20240912$20240913$20240913$PER$$US-JNJFOC-20240931831$JOHNSON AND JOHNSON$$$$$$Y$$$20240913$$CN$US$US
243188932$24318893$2$F$20240904$20240919$20240913$20240927$PER$$US-ABBVIE-5909604$ABBVIE$$70$YR$$F$Y$57.606$KG$20240927$$CN$US$US
243188941$24318894$1$I$$20240910$20240913$20240913$EXP$$CN-PFIZER INC-PV202400119327$PFIZER$Zhang, X.. Sunitinib-induced endocapillary proliferative glomerulonephritis with IgA2 deposit in addition to thrombotic microangiopathy: a case report. BMC Nephrology. 2024;25(1):10.1186/s12882-024-03732-6$59$YR$$M$Y$$$20240913$$HP$CN$CN
243188951$24318895$1$I$$20240912$20240913$20240913$EXP$$US-PFIZER INC-PV202400079753$PFIZER$$70$YR$$F$Y$$$20240913$$CN$US$US
243188961$24318896$1$I$$20240912$20240913$20240913$EXP$$US-PFIZER INC-PV202400120328$PFIZER$$86$YR$$M$Y$$$20240913$$HP$US$US
243188971$24318897$1$I$$20240910$20240913$20240913$EXP$$PL-TAKEDA-2024TUS090147$TAKEDA$$47$YR$$M$Y$90$KG$20240913$$HP$PL$PL
243188981$24318898$1$I$$20240906$20240913$20240913$EXP$$US-SANDOZ INC.-PHEH2015US013971$SANDOZ$$$$$F$Y$$$20240913$$HP$US$US
243188991$24318899$1$I$$20240905$20240913$20240913$PER$$US-IMP-2024000722$Harrow Health$$$$E$F$Y$$$20240913$$CN$US$US
243189001$24318900$1$I$$20240906$20240913$20240913$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-144730$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240913$$MD$DE$DE
243189011$24318901$1$I$20240801$20240904$20240913$20240913$EXP$$CL-TEVA-VS-3243190$TEVA$$22$YR$$F$Y$$$20240913$$CN$CL$CL
243189022$24318902$2$F$$20240916$20240913$20240924$EXP$GB-MHRA-MED-202409041405391010-BPMQY$GB-TEVA-VS-3240647$TEVA$$73$YR$$F$Y$52$KG$20240924$$CN$GB$GB
243189032$24318903$2$F$20240831$20240911$20240913$20240923$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17684$IPSEN$$60$YR$A$F$Y$$$20240923$$CN$US$US
243189051$24318905$1$I$$20240911$20240913$20240913$EXP$$CA-SANDOZ INC.-SDZ2024CA079576$SANDOZ$$44$YR$$F$Y$78$KG$20240913$$HP$CA$CA
243189061$24318906$1$I$$20240903$20240913$20240913$PER$$US-009507513-2409USA002081$MERCK$Sykora D, Crowley PD., Abu Saleh, OM.. 79-Year-Old Man With Dysuria, Fever, and Back Pain. Mayo Clinic Proceedings. 2024;99(9):1482-87$79$YR$$M$Y$$$20240913$$MD$US$US
243189071$24318907$1$I$$20240910$20240913$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014826$JAZZ$$$$$F$Y$$$20240913$$CN$US$US
243189081$24318908$1$I$20240614$20240904$20240913$20240913$EXP$IT-MINISAL02-993953$IT-ELI_LILLY_AND_COMPANY-IT202407005798$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240913$$CN$IT$IT
243189091$24318909$1$I$20240730$20240903$20240913$20240913$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409001928$ELI LILLY AND CO$$63$YR$A$F$Y$61$KG$20240913$$CN$CN$CN
243189101$24318910$1$I$20240808$20240903$20240913$20240913$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409001882$ELI LILLY AND CO$$60$YR$A$F$Y$51$KG$20240913$$CN$CN$CN
243189111$24318911$1$I$$20240902$20240913$20240913$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002521$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$US$US
243189122$24318912$2$F$$20240912$20240913$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409005052$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243189131$24318913$1$I$20240502$20240902$20240913$20240913$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202407003873$ELI LILLY AND CO$$52$YR$A$F$Y$104$KG$20240913$$CN$FR$FR
243189141$24318914$1$I$$20240909$20240913$20240913$EXP$$JP-INCYTE CORPORATION-2024IN009644$INCYTE$$$$$$Y$$$20240913$$MD$JP$JP
243189151$24318915$1$I$$20240912$20240913$20240913$EXP$$US-MYLANLABS-2024M1083741$MYLAN$$$$$M$Y$$$20240913$$HP$US$US
243189161$24318916$1$I$20230520$20240911$20240913$20240913$EXP$FR-AFSSAPS-AM2024000710$FR-MYLANLABS-2024M1083120$MYLAN$$71$YR$$F$Y$62$KG$20240913$$MD$FR$FR
243189171$24318917$1$I$$20240911$20240913$20240913$EXP$$DE-MYLANLABS-2024M1083047$MYLAN$$68$YR$$F$Y$$$20240913$$MD$DE$DE
243189181$24318918$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA264467$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240913$$MD$US$US
243189191$24318919$1$I$20240901$20240910$20240913$20240913$PER$$US-JNJFOC-20240927722$JOHNSON AND JOHNSON$$$$$F$Y$$$20240913$$CN$US$US
243189201$24318920$1$I$$20240812$20240913$20240913$PER$$US-009507513-2409USA004864$MERCK$$$$$M$Y$$$20240913$$MD$US$US
243189211$24318921$1$I$$20240826$20240913$20240913$PER$$US-RDY-SPO/USA/24/0012604$DR REDDYS$$$$$M$Y$$$20240913$$CN$US$US
243189221$24318922$1$I$20240101$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146284$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240913$$CN$US$US
243189232$24318923$2$F$20240821$20240909$20240913$20240923$EXP$$CH-OPKO PHARMACEUTICALS, LLC.-2024OPK00236$OPKO HEALTH$$19$YR$$M$Y$60$KG$20240920$$CN$CH$DE
243189252$24318925$2$F$20240803$20240917$20240913$20240918$EXP$$DE-ABBVIE-5918561$ABBVIE$$76$YR$$M$Y$71$KG$20240918$$MD$DE$DE
243189261$24318926$1$I$$20240909$20240913$20240913$EXP$$DE-MYLANLABS-2018M1029242$MYLAN$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B, et al.. Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant recipients: CERTAIN registry study.. TRANSPLANTATION.. 2018;103 (6):1-33$14$YR$$$Y$$$20240913$$HP$DE$DE
243189281$24318928$1$I$20240813$20240910$20240913$20240913$EXP$$US-009507513-2409USA003867$MERCK$$60$YR$$F$Y$$$20240913$$CN$US$US
243189291$24318929$1$I$$20240910$20240913$20240913$EXP$$GB-AstraZeneca-2024A197613$ASTRAZENECA$$$$$M$Y$$$20240913$$CN$GB$
243189301$24318930$1$I$$20240814$20240913$20240913$PER$$US-AstraZeneca-2024A186603$ASTRAZENECA$$$$$$Y$$$20240913$$MD$US$
243189311$24318931$1$I$$20240820$20240913$20240913$PER$$US-SA-2024SA262831$SANOFI AVENTIS$$$$A$M$Y$$$20240913$$MD$US$US
243189321$24318932$1$I$$20240903$20240913$20240913$PER$$US-AstraZeneca-2024A201464$ASTRAZENECA$$$$$F$Y$$$20240913$$HP$US$
243189331$24318933$1$I$$20240905$20240913$20240913$PER$$US-AstraZeneca-2024A203342$ASTRAZENECA$$$$$F$Y$$$20240913$$HP$US$
243189341$24318934$1$I$$20240906$20240913$20240913$PER$$US-AstraZeneca-2024A204014$ASTRAZENECA$$$$$F$Y$$$20240913$$HP$US$
243189352$24318935$2$F$20221124$20240911$20240913$20240918$EXP$$NVSC2024IN183047$NOVARTIS$$67$YR$$F$Y$$$20240918$$CN$IN$IN
243189361$24318936$1$I$20240101$20240912$20240913$20240913$PER$$US-JNJFOC-20240931954$JOHNSON AND JOHNSON$$$$$M$Y$$$20240913$$HP$US$US
243189371$24318937$1$I$$20240830$20240913$20240913$PER$$US-RDY-SPO/USA/24/0012770$DR REDDYS$$78$YR$E$M$Y$$$20240913$$MD$US$US
243189381$24318938$1$I$20240731$20240813$20240913$20240913$PER$$US-Eisai-EC-2024-172063$EISAI$$64$YR$A$M$Y$$$20240913$$CN$US$US
243189391$24318939$1$I$$20240813$20240913$20240913$PER$$US-Eisai-EC-2024-172032$EISAI$$$$$$Y$$$20240913$$MD$US$US
243189401$24318940$1$I$20240801$20240904$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144773$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240913$$CN$US$US
243189412$24318941$2$F$20240716$20240917$20240913$20240920$EXP$$CA-ABBVIE-5917650$ABBVIE$$25$YR$$F$Y$$$20240920$$MD$CA$CA
243189421$24318942$1$I$20240101$20240905$20240913$20240913$EXP$$JP-BAUSCH-BL-2024-013790$BAUSCH AND LOMB$$5$DEC$$M$Y$$$20240913$$MD$JP$JP
243189431$24318943$1$I$$20240904$20240913$20240913$PER$$US-BAUSCHBL-2024BNL032938$BAUSCH AND LOMB$$$$$F$Y$$$20240913$$CN$US$US
243189441$24318944$1$I$20230120$20240904$20240913$20240913$EXP$IT-MINISAL02-994017$IT-ELI_LILLY_AND_COMPANY-IT202407005837$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240913$$CN$IT$IT
243189451$24318945$1$I$$20240906$20240913$20240913$EXP$$CA-TEVA-VS-3241522$TEVA$$$$$M$Y$$$20240913$$HP$CA$CA
243189462$24318946$2$F$$20240904$20240913$20240918$EXP$$CA-MYLANLABS-2024M1008756$MYLAN$$$$$F$Y$$$20240918$$CN$CA$CA
243189471$24318947$1$I$20240829$20240909$20240913$20240913$PER$$US-ALKERMES INC.-ALK-2024-002356$ALKERMES$$$$$F$Y$$$20240913$$MD$US$US
243189482$24318948$2$F$20240816$20240912$20240913$20240919$EXP$$US-KYOWAKIRIN-2024KK021263$KYOWA$$$$$$Y$$$20240919$$HP$US$US
243189491$24318949$1$I$$20240903$20240913$20240913$PER$$US-SA-2024SA264387$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240913$$CN$US$US
243189501$24318950$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA264462$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240913$$HP$US$US
243189511$24318951$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA264158$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240913$$MD$US$US
243189531$24318953$1$I$20240101$20240830$20240913$20240913$EXP$$DE-TEVA-VS-3243269$TEVA$$82$YR$$M$Y$$$20240913$$PH$DE$DE
243189541$24318954$1$I$$20240909$20240913$20240913$EXP$$PT-009507513-2409PRT004315$MERCK$$$$$F$Y$$$20240913$$MD$PT$PT
243189551$24318955$1$I$20240101$20240905$20240913$20240913$EXP$$CA-TEVA-VS-3220824$TEVA$$47$YR$$F$Y$$$20240913$$CN$CA$CA
243189561$24318956$1$I$20240101$20240909$20240913$20240913$EXP$$US-009507513-2409USA003462$MERCK$$75$YR$$M$Y$$$20240913$$CN$US$US
243189571$24318957$1$I$$20240911$20240913$20240913$EXP$$DE-MYLANLABS-2024M1083065$MYLAN$$46$YR$$F$Y$$$20240913$$MD$DE$DE
243189581$24318958$1$I$20240814$20240814$20240913$20240913$PER$$US-Eisai-EC-2024-172243$EISAI$$$$$$Y$$$20240913$$HP$US$US
243189591$24318959$1$I$20240813$20240814$20240913$20240913$PER$$US-Eisai-EC-2024-172250$EISAI$$73$YR$E$M$Y$$$20240913$$CN$US$US
243189602$24318960$2$F$20240814$20240913$20240913$20240930$PER$$US-Eisai-EC-2024-172244$EISAI$$$$$M$Y$$$20240930$$MD$US$US
243189611$24318961$1$I$20240720$20240911$20240913$20240913$EXP$FR-AFSSAPS-AN2024001217$FR-Eisai-EC-2024-174125$EISAI$$80$YR$E$F$Y$70.5$KG$20240913$$MD$FR$FR
243189621$24318962$1$I$20240801$20240912$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146233$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240913$$HP$US$US
243189631$24318963$1$I$$20240904$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142199$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$71.7$KG$20240913$$HP$US$US
243189641$24318964$1$I$$20240910$20240913$20240913$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050735$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240913$$CN$US$US
243189661$24318966$1$I$$20240909$20240913$20240913$EXP$$DE-ABBVIE-5919541$ABBVIE$$$$$$Y$$$20240913$$MD$DE$DE
243189671$24318967$1$I$20240101$20240906$20240913$20240913$PER$$US-ABBVIE-5915980$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243189681$24318968$1$I$$20240909$20240913$20240913$EXP$$JP-PFIZER INC-PV202400118383$PFIZER$Tsuji, M.. A case in which Kamikihito contributed to the improvement of an extradural/subdural haematoma associated with meningeal infiltration of acute leukaemia, against which platelet transfusion was ineffective. Kampo Medicine. 2024;75(3):217-224$44$YR$$F$Y$53$KG$20240913$$HP$JP$JP
243189691$24318969$1$I$$20240912$20240913$20240913$PER$$US-PURDUE PHARMA-USA-2024-0311972$PURDUE$$$$$F$Y$$$20240913$$HP$US$US
243189701$24318970$1$I$20220101$20240909$20240913$20240913$EXP$$JP-PFIZER INC-PV202400118312$PFIZER$Nakamura, T.. MTX-LPD as an iatrogenicity: a case of RA complicated with low grade B-cell lymphoma having a specific clinical course. The 68th Meeting of Kyushu College of Rheumatology. 2024;68th:71$63$YR$$M$Y$$$20240913$$HP$JP$JP
243189711$24318971$1$I$$20240912$20240913$20240913$PER$$US-PURDUE PHARMA-USA-2024-0311948$PURDUE$$57$YR$$M$Y$$$20240913$$CN$US$US
243189721$24318972$1$I$20240828$20240909$20240913$20240913$EXP$$US-ALKERMES INC.-ALK-2024-002365$ALKERMES$$27$YR$$M$Y$$$20240913$$CN$US$US
243189731$24318973$1$I$20240101$20240906$20240913$20240913$EXP$$US-ALKERMES INC.-ALK-2024-002375$ALKERMES$$$$$F$Y$$$20240913$$CN$US$US
243189762$24318976$2$F$20240830$20240925$20240913$20240926$EXP$$US-KYOWAKIRIN-2024KK021400$KYOWA$$$$$$Y$$$20240926$$HP$US$US
243189771$24318977$1$I$20240808$20240815$20240913$20240913$PER$$US-Eisai-EC-2024-172265$EISAI$$71$YR$E$M$Y$$$20240913$$CN$US$US
243189781$24318978$1$I$$20240830$20240913$20240913$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17546$IPSEN$$8$YR$C$M$Y$39.9$KG$20240913$$CN$US$US
243189791$24318979$1$I$$20240909$20240913$20240913$EXP$$FR-ABBVIE-5917483$ABBVIE$$$$E$F$Y$$$20240913$$PH$FR$FR
243189801$24318980$1$I$$20240906$20240913$20240913$PER$$US-ALXN-202409USA000398US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$MD$US$US
243189811$24318981$1$I$$20240911$20240913$20240913$30DAY$$US-SANDOZ INC.-SDZ2024US079710$SANDOZ$$$$$$Y$$$20240913$$HP$US$US
243189822$24318982$2$F$$20240910$20240913$20240919$PER$$JP-JAZZ PHARMACEUTICALS-2024-JP-014986$JAZZ$$$$A$$Y$$$20240919$$MD$JP$JP
243189841$24318984$1$I$$20240903$20240913$20240913$30DAY$$CL-PFIZER INC-202400256185$PFIZER$$$$$M$Y$$$20240913$$CN$CL$CL
243189851$24318985$1$I$20240906$20240912$20240913$20240913$EXP$$TH-PFIZER INC-PV202400120271$PFIZER$$80$YR$$M$Y$$$20240913$$CN$TH$TH
243189861$24318986$1$I$$20240911$20240913$20240913$EXP$$CA-PFIZER INC-PV202400119965$PFIZER$$$$$$Y$$$20240913$$HP$CA$CA
243189871$24318987$1$I$$20240904$20240913$20240913$EXP$GB-MHRA-MIDB-d90df364-b871-4beb-a0cd-1ba28245cffe$GB-TEVA-VS-3240677$TEVA$$84$YR$$$Y$$$20240913$$PH$GB$GB
243189881$24318988$1$I$$20240911$20240913$20240913$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146339$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240913$$CN$US$US
243189892$24318989$2$F$20230501$20240910$20240913$20240916$EXP$$PT-009507513-2409PRT003341$MERCK$$70$YR$$F$Y$$$20240916$$MD$PT$PT
243189902$24318990$2$F$20240804$20240912$20240913$20240919$PER$$US-Eisai-EC-2024-173265$EISAI$$$$$$Y$$$20240919$$MD$US$US
243189911$24318991$1$I$20240820$20240903$20240913$20240913$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17603$IPSEN$$43$YR$A$F$Y$$$20240913$$MD$US$US
243189922$24318992$2$F$20240101$20240918$20240913$20240924$PER$$US-Eisai-EC-2024-174296$EISAI$$77$YR$E$F$Y$59$KG$20240924$$CN$US$US
243189932$24318993$2$F$$20240916$20240913$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-096903$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240916$$MD$JP$JP
243189941$24318994$1$I$20240908$20240911$20240913$20240913$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014967$JAZZ$$14$YR$$M$Y$$$20240913$$CN$US$US
243189961$24318996$1$I$20240801$20240821$20240913$20240913$PER$$US-SA-2024SA264455$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240913$$CN$US$US
243189971$24318997$1$I$20221201$20240904$20240913$20240913$PER$$US-SA-2024SA263672$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240913$$MD$US$US
243189981$24318998$1$I$20240904$20240904$20240913$20240913$EXP$$GB-TEVA-VS-3240644$TEVA$$74$YR$$M$Y$65$KG$20240913$$MD$GB$GB
243189991$24318999$1$I$$20240904$20240913$20240913$30DAY$$CL-PFIZER INC-202400256187$PFIZER$$$$$M$Y$$$20240913$$CN$CL$CL
243190001$24319000$1$I$$20240802$20240913$20240913$PER$$US-LUNDBECK-DKLU4002631$LUNDBECK$$$$$$Y$$$20240913$$HP$US$US
243190011$24319001$1$I$$20240913$20240913$20240913$PER$$US-HALEON-2196789$Haleon PLC$$82$YR$$M$Y$$$20240913$$CN$US$US
243190021$24319002$1$I$$20240909$20240913$20240913$EXP$$NVSC2024CA182949$NOVARTIS$$52$YR$$M$Y$$$20240913$$HP$CA$CA
243190031$24319003$1$I$20240801$20240906$20240913$20240913$PER$$US-BIOGEN-2024BI01281691$BIOGEN$$25$YR$$$Y$$$20240913$$MD$US$US
243190041$24319004$1$I$20240101$20240910$20240913$20240913$PER$$US-JNJFOC-20240925033$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240913$$HP$US$US
243190051$24319005$1$I$20240906$20240909$20240913$20240913$EXP$$US-AMGEN-USASP2024180133$AMGEN$$78$YR$E$F$Y$$$20240913$$CN$US$US
243190111$24319011$1$I$20240606$20240909$20240913$20240913$EXP$$US-AMGEN-USASP2024179803$AMGEN$$62$YR$A$F$Y$$$20240913$$CN$US$US
243190121$24319012$1$I$$20240905$20240913$20240913$EXP$$GB-ALCON LABORATORIES-ALC2024GB004199$ALCON$$$$E$M$Y$$$20240913$$CN$COUNTRY NOT SPECIFIED$GB
243190131$24319013$1$I$20240101$20240909$20240913$20240913$EXP$$SE-Alcon Laboratories-ALC2024SE004054$ALCON$$$$$$Y$$$20240913$$CN$SE$SE
243190141$24319014$1$I$$20240909$20240913$20240913$EXP$$JP-INCYTE CORPORATION-2024IN009664$INCYTE$$$$$$Y$$$20240913$$MD$JP$JP
243190151$24319015$1$I$$20240820$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN008740$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243190161$24319016$1$I$20240811$20240820$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN008738$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243190171$24319017$1$I$$20240904$20240913$20240913$PER$$US-BAUSCHBL-2024BNL032980$BAUSCH AND LOMB$$$$$$Y$$$20240913$$CN$US$US
243190181$24319018$1$I$20240805$20240820$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN008728$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243190201$24319020$1$I$$20240907$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409005981$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240913$$CN$US$US
243190211$24319021$1$I$20240801$20240903$20240913$20240913$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409003058$ELI LILLY AND CO$$$$$F$Y$$$20240913$$CN$BR$BR
243190221$24319022$1$I$$20240908$20240913$20240913$PER$$US-ELI_LILLY_AND_COMPANY-US202409005997$ELI LILLY AND CO$$$$$$Y$$$20240913$$CN$US$US
243190231$24319023$1$I$$20240904$20240913$20240913$EXP$$GB-TEVA-VS-3240913$TEVA$$69$YR$$M$Y$109$KG$20240913$$MD$GB$GB
243190241$24319024$1$I$$20240906$20240913$20240913$EXP$$US-TEVA-VS-3241451$TEVA$$83$YR$$F$Y$$$20240913$$PH$US$US
243190251$24319025$1$I$20240101$20240904$20240913$20240913$PER$$US-SA-2024SA263728$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240913$$MD$US$US
243190291$24319029$1$I$$20240911$20240913$20240913$PER$$US-ALXN-202409USA000933US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240913$$CN$US$US
243190301$24319030$1$I$20240626$20240906$20240913$20240913$EXP$$JP-Eisai-EC-2024-173922$EISAI$$75$YR$E$M$Y$$$20240913$$MD$JP$JP
243190311$24319031$1$I$$20240906$20240913$20240913$PER$$US-Eisai-EC-2024-174040$EISAI$$$$$F$Y$$$20240913$$CN$US$US
243190331$24319033$1$I$$20240822$20240913$20240913$PER$$US-INCYTE CORPORATION-2024IN008845$INCYTE$$$$$$Y$$$20240913$$CN$US$US
243190342$24319034$2$F$20240829$20240906$20240913$20240923$EXP$$NVSC2024CN180990$NOVARTIS$$75$YR$$F$Y$71$KG$20240923$$HP$CN$CN
243190351$24319035$1$I$20240225$20240905$20240913$20240913$EXP$GB-MHRA-MED-202409051030070470-RSPCJ$GB-TEVA-VS-3240872$TEVA$$52$YR$$F$Y$53$KG$20240913$$MD$GB$GB
243190361$24319036$1$I$20240801$20240905$20240913$20240913$PER$$US-SA-2024SA264189$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240913$$MD$US$US
243190371$24319037$1$I$20240801$20240905$20240913$20240913$PER$$US-SA-2024SA263998$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240913$$HP$US$US
243190401$24319040$1$I$20240101$20240909$20240913$20240913$PER$$US-Eisai-EC-2024-174295$EISAI$$71$YR$E$F$Y$$$20240913$$CN$US$US
243190411$24319041$1$I$$20240903$20240913$20240913$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08893$NEUROCRINE BIOSCIENCES$$14$YR$$M$Y$$$20240913$$PH$US$US
243190421$24319042$1$I$$20240905$20240913$20240913$EXP$$GB-TEVA-VS-3240843$TEVA$$64$YR$$F$Y$69$KG$20240913$$PH$GB$GB
243190451$24319045$1$I$20240812$20240905$20240913$20240913$PER$$US-SA-2024SA264095$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240913$$MD$US$US
243190461$24319046$1$I$$20240906$20240913$20240913$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001819$BLUEPRINT MEDICINES$$$$$M$Y$$$20240913$$CN$US$US
243190473$24319047$3$F$20240911$20240926$20240913$20240930$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-145815$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$88.45$KG$20240930$$CN$PR$PR
243190481$24319048$1$I$$20240911$20240913$20240913$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-146151$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240913$$MD$CH$CH
243190501$24319050$1$I$$20240905$20240913$20240913$EXP$GB-MHRA-MED-202409051119214520-ZNMFS$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-08455$HIKMA$$82$YR$$F$Y$63$KG$20240913$$PH$GB$GB
243190521$24319052$1$I$20240910$20240910$20240913$20240913$EXP$$ES-GILEAD-2024-0687270$GILEAD$$65$YR$E$M$Y$$$20240913$$PH$ES$ES
243190531$24319053$1$I$$20240911$20240913$20240913$PER$$US-GILEAD-2024-0687422$GILEAD$$32$YR$A$F$Y$$$20240913$$CN$US$US
243190542$24319054$2$F$20240420$20240918$20240913$20240919$EXP$FR-AFSSAPS-RN2024000977$FR-GILEAD-2024-0687685$GILEAD$$58$YR$A$F$Y$$$20240919$$MD$FR$FR
243190571$24319057$1$I$20240829$20240905$20240913$20240913$EXP$GB-MHRA-MED-202409051033451690-HQZVL$GB-TEVA-VS-3241324$TEVA$$48$YR$$F$Y$99$KG$20240913$$HP$GB$GB
243190581$24319058$1$I$$20240829$20240913$20240913$PER$$US-ASTELLAS-2024-AER-004548$ASTELLAS$$$$$M$Y$$$20240913$$MD$US$US
243190591$24319059$1$I$$20240905$20240913$20240913$EXP$$GB-TEVA-VS-3241344$TEVA$$$$E$F$Y$$$20240913$$HP$GB$GB
243190601$24319060$1$I$20240816$20240816$20240913$20240913$PER$$US-PFIZER INC-PV202400120123$PFIZER$$75$YR$$M$Y$$$20240913$$CN$US$US
243190631$24319063$1$I$$20240912$20240913$20240913$EXP$$CA-009507513-2409CAN005054$MERCK$$76$YR$$M$Y$84.807$KG$20240913$$MD$CA$CA
243190641$24319064$1$I$20240816$20240908$20240913$20240913$EXP$$KR-009507513-2409KOR004351$MERCK$$64$YR$$F$Y$$$20240913$$MD$KR$KR
243190651$24319065$1$I$$20240906$20240913$20240913$EXP$$US-AstraZeneca-2024A204595$ASTRAZENECA$$$$$F$Y$$$20240913$$CN$US$
243190661$24319066$1$I$$20240822$20240913$20240913$PER$$US-009507513-2408USA008042$MERCK$Kong B, Stommel J, Keck J,Kilburn D, Streblow A, Egger J, et al.. Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 Expression. American Society of Clinical Oncology. 2024;8:1-7$67$YR$$F$Y$$$20240913$$PH$US$US
243190671$24319067$1$I$20240906$20240912$20240913$20240913$EXP$$CN-ROCHE-10000081103$ROCHE$$30$YR$A$M$Y$90$KG$20240913$$HP$CN$CN
243190681$24319068$1$I$$20240820$20240913$20240913$PER$$US-SA-2024SA262154$SANOFI AVENTIS$$$$E$F$Y$124.7$KG$20240914$$MD$US$US
243190691$24319069$1$I$$20240905$20240913$20240913$EXP$GB-MHRA-MED-202409051515367150-DZBPM$GB-TEVA-VS-3241373$TEVA$$$$$M$Y$$$20240913$$HP$GB$GB
243190701$24319070$1$I$$20240822$20240913$20240913$PER$$US-009507513-2408USA008223$MERCK$Park JJ, Chu A, Li J, Ali A, McKay AA, Hwang C, et al. Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations. JCO Precision Oncology. 2024;8:e2300567$$$$M$Y$$$20240913$$HP$US$US
243190721$24319072$1$I$20240904$20240905$20240913$20240913$EXP$$US-009507513-2409USA002293$MERCK$$$$A$F$Y$99.773$KG$20240913$$HP$US$US
243190741$24319074$1$I$$20240903$20240913$20240913$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08870$NEUROCRINE BIOSCIENCES$$6$DEC$$F$Y$$$20240913$$HP$US$US
243190751$24319075$1$I$$20240911$20240913$20240913$PER$$US-TAKEDA-2024TUS091307$TAKEDA$$$$$M$Y$$$20240913$$CN$US$US
243190761$24319076$1$I$$20240911$20240913$20240913$EXP$$CA-TAKEDA-2024TUS091318$TAKEDA$$$$$M$Y$$$20240913$$CN$CA$CA
243190771$24319077$1$I$20240701$20240905$20240913$20240913$EXP$$US-RADIUS HEALTH INC.-2024US006965$RADIUS PHARM$$90$YR$$F$Y$$$20240913$$MD$US$US
243190782$24319078$2$F$$20240917$20240913$20240923$EXP$$PL-009507513-2409POL003512$MERCK$Jankowski, T.. Long-term response of a patient with metastatic lung squamous cell carcinoma with PD-L1 expression below 1% to pembrolizumab therapy.. W PRAKTYCE KLINICZNEJ - EDUKACJA.. 2024;10 (Supl. C):55-58$69$YR$$M$Y$$$20240923$$MD$PL$PL
243190802$24319080$2$F$20240101$20240913$20240913$20240918$EXP$$US-ABBVIE-5916046$ABBVIE$$$$$F$Y$79.378$KG$20240918$$CN$US$US
243190811$24319081$1$I$20230101$20240909$20240913$20240913$EXP$$US-ABBVIE-5889964$ABBVIE$$$$$F$Y$86$KG$20240913$$CN$US$US
243190821$24319082$1$I$20240821$20240909$20240913$20240913$EXP$$CN-ABBVIE-5915951$ABBVIE$$56$YR$$M$Y$95$KG$20240913$$MD$CN$CN
243190831$24319083$1$I$$20240906$20240913$20240913$EXP$$CA-ABBVIE-5913711$ABBVIE$$$$A$M$Y$78$KG$20240913$$CN$CA$CA
243190841$24319084$1$I$20240101$20240906$20240913$20240913$EXP$$US-ABBVIE-5914359$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243190851$24319085$1$I$20210101$20240909$20240913$20240913$EXP$$US-ABBVIE-5900320$ABBVIE$$$$$M$Y$107.04$KG$20240913$$CN$US$US
243190863$24319086$3$F$20191201$20240918$20240913$20240925$EXP$$US-ABBVIE-5880117$ABBVIE$$76$YR$$F$Y$68.946$KG$20240925$$CN$US$US
243190871$24319087$1$I$$20240906$20240913$20240913$EXP$$ES-APELLIS-2024-APL-0000985$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240914$$MD$ES$ES
243190881$24319088$1$I$$20240910$20240913$20240913$EXP$$CA-ABBVIE-5919487$ABBVIE$$$$A$M$Y$$$20240913$$CN$CA$CA
243190891$24319089$1$I$20240910$20240910$20240913$20240913$EXP$$AU-ABBVIE-5919020$ABBVIE$$70$YR$$M$Y$$$20240913$$CN$AU$AU
243190903$24319090$3$F$20240101$20240926$20240913$20240930$EXP$$US-ABBVIE-5917229$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243190911$24319091$1$I$20231030$20240910$20240913$20240913$EXP$$US-ABBVIE-5918763$ABBVIE$$56$YR$$F$Y$$$20240913$$CN$US$US
243190921$24319092$1$I$20240704$20240909$20240913$20240913$EXP$$US-ABBVIE-5917274$ABBVIE$$62$YR$$F$Y$$$20240913$$CN$US$US
243190932$24319093$2$F$20240725$20240916$20240913$20240921$EXP$$US-ABBVIE-5917020$ABBVIE$$36$YR$$M$Y$61.234$KG$20240921$$CN$US$US
243190941$24319094$1$I$20240906$20240910$20240913$20240913$EXP$$US-ABBVIE-5919852$ABBVIE$$65$YR$$F$Y$$$20240913$$CN$US$US
243190952$24319095$2$F$20240405$20240913$20240913$20240923$EXP$$CA-ROCHE-10000033048$ROCHE$$47$YR$A$F$Y$50$KG$20240923$$MD$CA$CA
243190963$24319096$3$F$20240912$20240916$20240913$20240924$EXP$$US-ABBVIE-5917476$ABBVIE$$44$YR$$F$Y$$$20240924$$CN$US$US
243190971$24319097$1$I$20240101$20240910$20240913$20240913$EXP$$US-ABBVIE-5917594$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243190981$24319098$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5917836$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243190991$24319099$1$I$20240601$20240911$20240913$20240913$EXP$$AR-ABBVIE-5919581$ABBVIE$$57$YR$$F$Y$$$20240913$$CN$AR$AR
243191012$24319101$2$F$$20240919$20240913$20240924$EXP$PL-ROCHE-10000079096$PL-ROCHE-10000079096$ROCHE$Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoeman H, Ljungman P, Kobbe G, et al.,. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. American journal of transplantation. 2015;1-10$$$$M$Y$$$20240924$$HP$PL$PL
243191021$24319102$1$I$$20240912$20240913$20240913$EXP$$US-ABBVIE-5922618$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243191031$24319103$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5918692$ABBVIE$$$$$$Y$$$20240913$$HP$US$US
243191041$24319104$1$I$$20240903$20240913$20240913$EXP$$NL-ABBVIE-5921446$ABBVIE$$$$A$M$Y$$$20240913$$CN$NL$NL
243191051$24319105$1$I$$20240912$20240913$20240913$EXP$$US-ABBVIE-5922548$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243191061$24319106$1$I$20240906$20240911$20240913$20240913$EXP$$US-ABBVIE-5921705$ABBVIE$$88$YR$$M$Y$$$20240913$$MD$US$US
243191071$24319107$1$I$20240101$20240911$20240913$20240913$EXP$$US-ABBVIE-5920079$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243191081$24319108$1$I$$20240911$20240913$20240913$EXP$$BR-ABBVIE-5921637$ABBVIE$$$$$F$Y$$$20240913$$CN$BR$BR
243191091$24319109$1$I$20240101$20240910$20240913$20240913$EXP$$US-ABBVIE-5918926$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243191101$24319110$1$I$$20240904$20240913$20240913$PER$$US-ROCHE-10000074405$ROCHE$$14$YR$T$M$Y$$$20240914$$CN$US$US
243191131$24319113$1$I$20240819$20240910$20240913$20240913$EXP$$US-ABBVIE-5917830$ABBVIE$$85$YR$$F$Y$$$20240913$$CN$US$US
243191141$24319114$1$I$$20240903$20240913$20240913$PER$$US-LNK INTERNATIONAL, INC.-2161571$LNK INTERNATIONAL$$$$$F$Y$$$20240913$$$US$US
243191151$24319115$1$I$$20240823$20240913$20240913$PER$$US-B.Braun Medical Inc.-2161569$B BRAUN$$72$YR$$F$Y$81$KG$20240913$$$US$US
243191161$24319116$1$I$$20240902$20240913$20240913$EXP$$US-Pharmascience Inc.-2161581$PHARMASCIENCE$Conference abstract$$$$$Y$$$20240913$$$US$US
243191171$24319117$1$I$$20240902$20240913$20240913$EXP$$DE-B.Braun Medical Inc.-2161567$B BRAUN$$$$$$Y$$$20240913$$$DE$DE
243191181$24319118$1$I$$20240903$20240913$20240913$EXP$$US-LNK INTERNATIONAL, INC.-2161572$LNK INTERNATIONAL$$$$$M$Y$$$20240913$$$US$US
243191191$24319119$1$I$$20240830$20240913$20240913$EXP$$A1-Breckenridge Pharmaceutical, Inc.-2161574$BRECKENRIDGE$$$$$F$Y$$$20240913$$$ES$A1
243191221$24319122$1$I$$20240902$20240913$20240913$EXP$$US-Pharmascience Inc.-2161580$PHARMASCIENCE$Conference abstract$$$$$Y$$$20240913$$$US$US
243191232$24319123$2$F$20240711$20240829$20240913$20240913$EXP$$US-Leiters-2159683$LEITERS COMPOUNDING PHARMACY$$51$YR$$M$Y$128.64$KG$20240913$$$US$US
243191241$24319124$1$I$$20240830$20240913$20240913$EXP$$GB-Ascend Therapeutics US, LLC-2161586$ASCEND$$$$$F$Y$$$20240913$$$GB$GB
243191251$24319125$1$I$$20240902$20240913$20240913$EXP$$US-Pharmascience Inc.-2161579$PHARMASCIENCE$Literature$66$YR$$M$Y$$$20240913$$$US$US
243191282$24319128$2$F$$20240914$20240913$20240920$EXP$$JP-MALLINCKRODT-MNK202405681$MALLINCKRODT$$$$C$$Y$$$20240920$$MD$JP$JP
243191292$24319129$2$F$$20240914$20240913$20240920$EXP$$JP-MALLINCKRODT-MNK202405677$MALLINCKRODT$$$$C$$Y$$$20240920$$MD$JP$JP
243191302$24319130$2$F$$20240914$20240913$20240920$EXP$$JP-MALLINCKRODT-MNK202405679$MALLINCKRODT$$$$C$$Y$$$20240920$$MD$JP$JP
243191312$24319131$2$F$$20240914$20240913$20240920$EXP$$JP-MALLINCKRODT-MNK202405678$MALLINCKRODT$$$$C$$Y$$$20240920$$MD$JP$JP
243191321$24319132$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263280$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240914$$MD$US$US
243191331$24319133$1$I$20240829$20240903$20240913$20240913$EXP$$BR-BIOMARINAP-BR-2024-160565$BIOMARIN$$$$$$Y$$$20240913$$CN$US$BR
243191342$24319134$2$F$$20240914$20240913$20240920$EXP$$JP-MALLINCKRODT-MNK202405680$MALLINCKRODT$$$$C$$Y$$$20240920$$MD$JP$JP
243191351$24319135$1$I$20240906$20240906$20240913$20240913$EXP$$BR-BIOMARINAP-BR-2024-160535$BIOMARIN$$$$$$Y$$$20240913$$CN$BR$BR
243191361$24319136$1$I$$20240903$20240913$20240913$PER$$US-SA-2024SA264178$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240914$$CN$US$US
243191373$24319137$3$F$20240909$20240920$20240913$20240926$EXP$$AR-BIOMARINAP-AR-2024-160554$BIOMARIN$$$$$$Y$$$20240926$$CN$AR$AR
243191381$24319138$1$I$$20240909$20240913$20240913$EXP$$US-BIOMARINAP-US-2024-160502$BIOMARIN$$$$$$Y$$$20240913$$CN$US$US
243191391$24319139$1$I$$20240829$20240913$20240913$PER$$US-009507513-2408USA010793$MERCK$$$$$M$Y$$$20240913$$CN$US$US
243191401$24319140$1$I$20240701$20240904$20240913$20240913$EXP$$SG-ROCHE-10000077063$ROCHE$$$$$M$Y$$$20240914$$CN$SG$SG
243191411$24319141$1$I$20240101$20240830$20240913$20240913$EXP$$US-MALLINCKRODT-MNK202403193$MALLINCKRODT$$54$YR$A$F$Y$$$20240914$$HP$US$US
243191421$24319142$1$I$20240903$20240911$20240913$20240913$EXP$$CO-BIOMARINAP-CO-2024-160557$BIOMARIN$$$$$$Y$$$20240913$$CN$CO$CO
243191441$24319144$1$I$20240901$20240910$20240913$20240913$EXP$$US-BIOMARINAP-US-2024-160508$BIOMARIN$$$$$$Y$$$20240913$$CN$US$US
243191451$24319145$1$I$20240815$20240911$20240913$20240913$EXP$$MX-BIOMARINAP-MX-2024-160548$BIOMARIN$$$$$$Y$$$20240913$$CN$MX$MX
243191461$24319146$1$I$$20240903$20240913$20240913$PER$$US-BIOMARINAP-US-2024-160532$BIOMARIN$$$$$$Y$$$20240913$$CN$US$US
243191472$24319147$2$F$$20240909$20240913$20240925$PER$$US-SMPA-2024SPA001725$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243191481$24319148$1$I$20240819$20240903$20240913$20240913$EXP$$FR-ABBVIE-5921778$ABBVIE$$51$YR$$F$Y$97$KG$20240913$$MD$FR$FR
243191492$24319149$2$F$20220101$20240916$20240913$20240918$EXP$$US-ABBVIE-5922494$ABBVIE$$$$$M$Y$72$KG$20240918$$CN$US$US
243191501$24319150$1$I$$20240906$20240913$20240913$EXP$$US-ABBVIE-5914698$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243191511$24319151$1$I$$20240911$20240913$20240913$EXP$$US-MTPC-MTDA2024-0019324$MITSUBISHI TANABE PHARMA$$$$A$M$Y$$$20240913$$CN$US$US
243191521$24319152$1$I$20230101$20240909$20240913$20240913$EXP$$US-ABBVIE-5502743$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243191531$24319153$1$I$20240902$20240903$20240913$20240913$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00333$PRINSTON PHARMACEUTICAL$$92$YR$$M$Y$70.307$KG$20240913$$CN$US$US
243191541$24319154$1$I$20240813$20240911$20240913$20240913$EXP$$US-ABBVIE-5921410$ABBVIE$$89$YR$$F$Y$$$20240913$$HP$US$US
243191551$24319155$1$I$20240801$20240820$20240913$20240913$PER$$US-SA-2024SA263637$SANOFI AVENTIS$$26$YR$A$F$Y$59.09$KG$20240914$$MD$US$US
243191561$24319156$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA264110$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240914$$CN$US$US
243191581$24319158$1$I$20240801$20240829$20240913$20240913$PER$$US-INSUD PHARMA-2408US06867$INSUD PHARMA$$$$$$Y$$$20240914$$CN$US$US
243191591$24319159$1$I$20240101$20240830$20240913$20240913$PER$$US-INSUD PHARMA-2408US06869$INSUD PHARMA$$$$$$Y$$$20240914$$CN$US$US
243191601$24319160$1$I$20240101$20240830$20240913$20240913$PER$$US-INSUD PHARMA-2408US06870$INSUD PHARMA$$$$$$Y$$$20240914$$CN$US$US
243191611$24319161$1$I$20240801$20240830$20240913$20240913$PER$$US-INSUD PHARMA-2408US06872$INSUD PHARMA$$$$$$Y$$$20240914$$CN$US$US
243191621$24319162$1$I$20240101$20240828$20240913$20240913$PER$$US-INSUD PHARMA-2408US06860$INSUD PHARMA$$$$$$Y$$$20240914$$CN$US$US
243191631$24319163$1$I$$20240910$20240913$20240913$PER$$US-MTPC-MTDA2024-0019111$MITSUBISHI TANABE PHARMA$$$$A$M$Y$$$20240913$$CN$US$US
243191642$24319164$2$F$20240101$20240912$20240913$20240917$EXP$$US-ABBVIE-5917604$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243191651$24319165$1$I$20240101$20240906$20240913$20240913$EXP$$US-ABBVIE-5916445$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243191671$24319167$1$I$20231124$20240910$20240913$20240913$EXP$$ES-AMGEN-ESPSP2024180406$AMGEN$$54$YR$A$F$Y$$$20240913$$MD$ES$ES
243191681$24319168$1$I$20240101$20240906$20240913$20240913$EXP$$US-ABBVIE-5842428$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243191691$24319169$1$I$$20240906$20240913$20240913$EXP$$US-ABBVIE-5915215$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243191701$24319170$1$I$20240101$20240905$20240913$20240913$EXP$$US-ABBVIE-5870211$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243191711$24319171$1$I$20240903$20240906$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014201$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243191721$24319172$1$I$$20240904$20240913$20240913$EXP$$RS-STRIDES ARCOLAB LIMITED-2024SP011665$STRIDES$Nikolajevic N, Nikolajevic M, Pantic I, Korica B, Kotseva M, Alempijevic T et al.. Drug-Induced Liver Injury Due to Doxycycline: A Case Report and Review of Literature. Cureus. 2024;16(5):e59687$28$YR$$M$Y$$$20240914$$HP$RS$RS
243191731$24319173$1$I$20240101$20240910$20240913$20240913$EXP$$US-ABBVIE-5918944$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243191741$24319174$1$I$20240910$20240911$20240913$20240913$EXP$$DE-ABBVIE-5921900$ABBVIE$$75$YR$$F$Y$$$20240913$$CN$DE$DE
243191752$24319175$2$F$20240801$20240917$20240913$20240920$EXP$$CO-ABBVIE-5921802$ABBVIE$$63$YR$$M$Y$80$KG$20240920$$CN$CO$CO
243191761$24319176$1$I$$20240905$20240913$20240913$EXP$$AU-ABBVIE-5917340$ABBVIE$$$$$$Y$$$20240913$$MD$AU$AU
243191771$24319177$1$I$20240828$20240903$20240913$20240913$EXP$$US-Jiangsu Hengrui Medicine Co., Ltd.-2161593$JIANGSU HENGRUI MEDICINE$$67$YR$$F$Y$61.7$KG$20240913$$MD$US$US
243191781$24319178$1$I$$20240904$20240913$20240913$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011666$STRIDES$Varma S, Nathanson J, Dowlatshahi M, Del Portillo A, Ramirez I, Garcia-Carrasquillo R.. Doxycycline-induced cholestatic liver injury. Clinical journal of gastroenterology. 2021;14(5):1503-1510$43$YR$$F$Y$$$20240914$$HP$US$US
243191791$24319179$1$I$20240828$20240911$20240913$20240913$EXP$$DE-ABBVIE-5921990$ABBVIE$$72$YR$$M$Y$$$20240913$$HP$DE$DE
243191801$24319180$1$I$$20240910$20240913$20240913$EXP$$FR-ABBVIE-5921883$ABBVIE$$84$YR$$M$Y$$$20240913$$HP$FR$FR
243191811$24319181$1$I$20240819$20240907$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014204$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243191821$24319182$1$I$$20240904$20240913$20240913$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP011668$STRIDES$Lienart F, Morissens F, Jacobs P, Ducob, J. Doxycycline and Hepatotoxicity. Acta Clinica Belgica. 1992;47(3):205-208$42$YR$$F$Y$$$20240914$$HP$IT$IT
243191831$24319183$1$I$$20240906$20240913$20240913$PER$$US-JNJFOC-20240919695$JOHNSON AND JOHNSON$$$$$F$Y$$$20240914$$MD$US$US
243191841$24319184$1$I$20240903$20240904$20240913$20240913$PER$$US-SA-2024SA263465$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240914$$HP$US$US
243191851$24319185$1$I$20240501$20240823$20240913$20240913$PER$$US-SA-2024SA262396$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240914$$CN$US$US
243191861$24319186$1$I$$20240904$20240913$20240913$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP011669$STRIDES$Westermann GW, B?hm M, Bonsmann G, Rahn KH, Kisters K.. Chronic intoxication by doxycycline use for more than 12 years. Journal of internal medicine. 1999;246(6):591-592$38$YR$$M$Y$$$20240914$$HP$DE$DE
243191871$24319187$1$I$$20240904$20240913$20240913$PER$$US-SA-2024SA263603$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240914$$HP$US$US
243191882$24319188$2$F$20240901$20240922$20240913$20240930$PER$$US-SA-2024SA263547$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240930$$CN$US$US
243191891$24319189$1$I$$20240910$20240913$20240913$EXP$$US-JNJFOC-20240926621$JOHNSON AND JOHNSON$$$$$M$Y$$$20240914$$CN$US$US
243191901$24319190$1$I$$20240910$20240913$20240913$EXP$$US-JNJFOC-20240927559$JOHNSON AND JOHNSON$$$$$$Y$$$20240914$$HP$US$US
243191911$24319191$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5918754$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243191921$24319192$1$I$$20240910$20240913$20240913$PER$$US-ABBVIE-5919685$ABBVIE$$$$$$Y$$$20240913$$CN$US$US
243191931$24319193$1$I$20240908$20240912$20240913$20240913$EXP$$CA-ABBVIE-5922358$ABBVIE$$74$YR$$M$Y$$$20240913$$CN$CA$CA
243191941$24319194$1$I$20240831$20240906$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014203$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243191951$24319195$1$I$20240908$20240909$20240913$20240913$EXP$$CA-ABBVIE-5917910$ABBVIE$$62$YR$$F$Y$$$20240913$$CN$CA$CA
243191981$24319198$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5916335$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243191991$24319199$1$I$20240101$20240909$20240913$20240913$EXP$$US-ABBVIE-5915835$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243192001$24319200$1$I$$20240906$20240913$20240913$EXP$$US-ABBVIE-5871018$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243192011$24319201$1$I$20210601$20240905$20240913$20240913$EXP$$CN-ROCHE-10000074837$ROCHE$Zhang Q, Yan X, Tian T, Wu X. Case report: outcome of anlotinib treatment in breast cancer patient with brain metastases. Frontiers in Pharmacology. 2024-Aug-19;15:1-8. doi:10.3389/fphar.2024.1381478.$57$YR$A$F$Y$$$20240914$$HP$CN$CN
243192021$24319202$1$I$20240829$20240906$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014139$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243192031$24319203$1$I$20240601$20240905$20240913$20240913$EXP$$JP-ROCHE-10000078996$ROCHE$$61$YR$A$M$Y$$$20240914$$PH$JP$JP
243192041$24319204$1$I$20240819$20240906$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014137$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243192051$24319205$1$I$$20240905$20240913$20240913$EXP$$AT-ROCHE-10000076020$ROCHE$Scheiner B, M. Pinter. Cases from the tumour board. JATROS Hamatologie and Onkologie. 2024-May;1-2.$66$YR$E$F$Y$$$20240914$$MD$AT$AT
243192061$24319206$1$I$$20240904$20240913$20240913$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011677$STRIDES$Glenn, Candace, and Steven R Feldman.. Letter: Tetracycline-induced hepatotoxicity. Dermatology online journal. 2011;17(12):14$49$YR$$F$Y$$$20240914$$HP$US$US
243192071$24319207$1$I$20240910$20240912$20240913$20240913$EXP$$US-ABBVIE-5922535$ABBVIE$$65$YR$$F$Y$$$20240913$$CN$US$US
243192082$24319208$2$F$20240907$20240911$20240913$20240916$EXP$$US-ABBVIE-5922161$ABBVIE$$82$YR$$M$Y$$$20240916$$CN$US$US
243192091$24319209$1$I$20240101$20240906$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014138$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243192101$24319210$1$I$$20240912$20240913$20240913$EXP$$US-ABBVIE-5921932$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243192111$24319211$1$I$$20240904$20240913$20240913$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP011671$STRIDES$Shankar S, Oliver MR.. Primum non nocere: Minocycline-induced liver injury in a teenager.. Journal of paediatrics and child health. 2018;54(9):1031-1033$15$YR$$F$Y$$$20240914$$HP$AU$AU
243192121$24319212$1$I$$20240904$20240913$20240913$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP011670$STRIDES$Parker M, McGill NW.. Minocycline-associated polyarteritis nodosa and self-limiting hepatitis: a reminder of a potentially re-emerging culprit in drug-induced autoimmune syndromes.. Scandinavian journal of rheumatology. 2018;47(6):507-508$32$YR$$M$Y$$$20240914$$HP$AU$AU
243192131$24319213$1$I$20240904$20240906$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014180$BEIGENE$$$$$$Y$$$20240913$$HP$CN$CN
243192141$24319214$1$I$$20240904$20240913$20240913$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP011672$STRIDES$Rikken NE, Klinkhamer PJ, Haak HR.. Interstitial pneumonia and hepatitis caused by minocycline.. The Netherlands journal of medicine. 2004;62(2):62-64$28$YR$$M$Y$$$20240914$$HP$NL$NL
243192151$24319215$1$I$$20240912$20240913$20240913$EXP$$CA-ACERUSPHRM-2024-CA-000744$ACERUS PHARMACEUTICALS$$56$YR$A$M$Y$$$20240913$$HP$CA$CA
243192161$24319216$1$I$20240801$20240906$20240913$20240913$EXP$$CN-BEIGENE-BGN-2024-014313$BEIGENE$$$$$$Y$$$20240913$$MD$CN$CN
243192181$24319218$1$I$20240101$20240910$20240913$20240913$EXP$$US-ABBVIE-5918939$ABBVIE$$77$YR$$F$Y$$$20240913$$CN$US$US
243192191$24319219$1$I$20240101$20240910$20240913$20240913$EXP$$US-ABBVIE-5918010$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243192201$24319220$1$I$20240601$20240911$20240913$20240913$EXP$$AT-ABBVIE-5919034$ABBVIE$$65$YR$$M$Y$$$20240913$$CN$AT$AT
243192211$24319221$1$I$$20240903$20240913$20240913$EXP$$TR-ADMA BIOLOGICS INC.-TR-2024ADM000112$ADMA BIOLOGICS$Bulbul MC, Celebi O, Gulbezer EE.. Anti-glomerular basal membrane (anti-GBM) disease presenting with prolonged constitutional symptoms and positive anti-myeloperoxidase (anti-MPO): a case report.. European Journal of Case Reports in Internal Medicine. 2024;11 (Suppl 1):1051$71$YR$$F$Y$$$20240914$$HP$TR$TR
243192221$24319222$1$I$20240909$20240911$20240913$20240913$EXP$$BR-ABBVIE-5919544$ABBVIE$$63$YR$$M$Y$130$KG$20240913$$CN$BR$BR
243192231$24319223$1$I$$20240903$20240913$20240913$EXP$$TR-ADMA BIOLOGICS INC.-TR-2024ADM000113$ADMA BIOLOGICS$Bulbul MC, Celebi O, Gulbezer EE.. Anti-glomerular basal membrane (anti-GBM) disease presenting with prolonged constitutional symptoms and positive anti-myeloperoxidase (anti-MPO): a case report.. European Journal of Case Reports in Internal Medicine. 2024;11 (Suppl 1):1051$71$YR$$F$Y$$$20240914$$HP$TR$TR
243192241$24319224$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5919150$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243192251$24319225$1$I$20240907$20240910$20240913$20240913$EXP$$US-ABBVIE-5918981$ABBVIE$$74$YR$$M$Y$$$20240913$$CN$US$US
243192261$24319226$1$I$$20240831$20240913$20240913$PER$$US-SA-2024SA261603$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240914$$CN$US$US
243192271$24319227$1$I$20240825$20240905$20240913$20240913$PER$$US-SA-2024SA264062$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240914$$HP$US$US
243192282$24319228$2$F$20240101$20240904$20240913$20240918$PER$$US-SA-2024SA263472$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240918$$HP$US$US
243192291$24319229$1$I$$20240821$20240913$20240913$PER$$US-SA-2024SA262835$SANOFI AVENTIS$$$$C$M$Y$$$20240914$$MD$US$US
243192301$24319230$1$I$20230101$20240904$20240913$20240913$EXP$$US-ABBVIE-5616119$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243192322$24319232$2$F$20240815$20240916$20240913$20240920$EXP$$US-ABBVIE-5919600$ABBVIE$$24$YR$$M$Y$99.79$KG$20240920$$CN$US$US
243192331$24319233$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5918045$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243192341$24319234$1$I$$20240911$20240913$20240913$EXP$$US-ABBVIE-5919798$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243192351$24319235$1$I$$20240911$20240913$20240913$EXP$$IL-ABBVIE-5919587$ABBVIE$$$$$F$Y$$$20240913$$CN$IL$IL
243192362$24319236$2$F$20221201$20240916$20240913$20240923$EXP$$US-ABBVIE-5879257$ABBVIE$$73$YR$$M$Y$86$KG$20240923$$CN$US$US
243192371$24319237$1$I$$20240911$20240913$20240913$EXP$$US-ABBVIE-5922588$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243192381$24319238$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5919813$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243192391$24319239$1$I$20240823$20240906$20240913$20240913$EXP$$US-ABBVIE-5876385$ABBVIE$$70$YR$$F$Y$$$20240913$$CN$US$US
243192411$24319241$1$I$20240601$20240903$20240913$20240913$PER$$PR-ABBVIE-5909707$ABBVIE$$$$A$F$Y$$$20240913$$MD$PR$PR
243192421$24319242$1$I$20240101$20240909$20240913$20240913$EXP$$CA-ABBVIE-5916625$ABBVIE$$39$YR$$F$Y$$$20240913$$MD$CA$CA
243192431$24319243$1$I$$20240905$20240913$20240913$PER$$US-ABBVIE-5909654$ABBVIE$$$$$$Y$$$20240913$$CN$US$US
243192441$24319244$1$I$$20240910$20240913$20240913$EXP$$US-ABBVIE-5920760$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243192452$24319245$2$F$$20240910$20240913$20240916$EXP$$US-ROCHE-10000077373$ROCHE$$72$YR$E$M$Y$$$20240916$$HP$US$US
243192461$24319246$1$I$20240101$20240912$20240913$20240913$PER$$US-ABBVIE-5923094$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243192471$24319247$1$I$20231216$20240904$20240913$20240913$EXP$$TR-ROCHE-10000075742$ROCHE$$64$YR$A$M$Y$$$20240914$$MD$TR$TR
243192481$24319248$1$I$20240801$20240911$20240913$20240913$EXP$$PT-ABBVIE-5889378$ABBVIE$$51$YR$$F$Y$$$20240913$$CN$PT$PT
243192491$24319249$1$I$20240101$20240904$20240913$20240913$EXP$$US-ABBVIE-5913511$ABBVIE$$53$YR$$F$Y$51$KG$20240913$$CN$US$US
243192501$24319250$1$I$$20240909$20240913$20240913$EXP$$US-ABBVIE-5917474$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243192511$24319251$1$I$20240101$20240910$20240913$20240913$EXP$$US-ABBVIE-5918967$ABBVIE$$$$$M$Y$$$20240913$$CN$US$US
243192521$24319252$1$I$$20240912$20240913$20240913$EXP$$GB-ABBVIE-5921960$ABBVIE$$$$E$F$Y$$$20240913$$HP$GB$GB
243192531$24319253$1$I$20240101$20240819$20240913$20240913$PER$$US-ABBVIE-5916053$ABBVIE$$$$$F$Y$$$20240913$$CN$US$US
243192541$24319254$1$I$20240827$20240904$20240913$20240913$EXP$$CN-ROCHE-10000074679$ROCHE$$53$YR$A$F$Y$45$KG$20240914$$HP$CN$CN
243192551$24319255$1$I$$20240907$20240913$20240913$EXP$$AU-ROCHE-10000076487$ROCHE$$$$A$F$Y$$$20240914$$MD$AU$AU
243192561$24319256$1$I$20240911$20240912$20240913$20240913$EXP$$FR-ABBVIE-5922813$ABBVIE$$81$YR$$M$Y$$$20240913$$CN$FR$FR
243192571$24319257$1$I$20240101$20240910$20240913$20240913$EXP$$US-ABBVIE-5920428$ABBVIE$$$$$F$Y$$$20240913$$HP$US$US
243192592$24319259$2$F$20240815$20240917$20240913$20240919$EXP$$SG-ABBVIE-5921062$ABBVIE$$35$YR$$M$Y$$$20240919$$MD$SG$SG
243192611$24319261$1$I$$20240904$20240914$20240914$PER$$US-SA-2024SA263529$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240914$$HP$US$US
243192621$24319262$1$I$20230101$20240830$20240914$20240914$PER$$US-SA-2024SA259957$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240914$$CN$US$US
243192631$24319263$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264195$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240914$$MD$US$US
243192641$24319264$1$I$20240320$20240909$20240914$20240914$EXP$IT-MINISAL02-1001271$IT-ABBVIE-5919635$ABBVIE$$73$YR$$F$Y$70$KG$20240914$$MD$IT$IT
243192651$24319265$1$I$$20240910$20240914$20240914$PER$$US-ABBVIE-5919343$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243192661$24319266$1$I$20240101$20240904$20240914$20240914$EXP$$US-ABBVIE-5908243$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243192671$24319267$1$I$20240823$20240906$20240914$20240914$EXP$$CN-BEIGENE-BGN-2024-014185$BEIGENE$$$$$$Y$$$20240914$$HP$CN$CN
243192691$24319269$1$I$20240101$20240910$20240914$20240914$EXP$$US-ABBVIE-5861989$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243192701$24319270$1$I$20240101$20240830$20240914$20240914$EXP$$US-MALLINCKRODT-MNK202405472$MALLINCKRODT$$63$YR$A$F$Y$$$20240914$$HP$US$US
243192711$24319271$1$I$$20240830$20240914$20240914$EXP$$US-MALLINCKRODT-MNK202405466$MALLINCKRODT$$42$YR$A$F$Y$$$20240914$$HP$US$US
243192721$24319272$1$I$$20240830$20240914$20240914$EXP$$US-MALLINCKRODT-MNK202405464$MALLINCKRODT$$59$YR$A$F$Y$169$KG$20240914$$HP$US$US
243192731$24319273$1$I$$20240909$20240914$20240914$EXP$$US-ROCHE-10000077999$ROCHE$$61$YR$A$M$Y$$$20240914$$CN$US$US
243192741$24319274$1$I$$20240905$20240914$20240914$PER$$US-AstraZeneca-2024A202928$ASTRAZENECA$$$$$M$Y$$$20240914$$CN$US$
243192751$24319275$1$I$$20240911$20240914$20240914$EXP$$MX-ABBVIE-5921837$ABBVIE$$$$$F$Y$$$20240914$$CN$MX$MX
243192771$24319277$1$I$$20240904$20240914$20240914$EXP$$JP-ROCHE-10000079002$ROCHE$$7$DEC$E$M$Y$$$20240914$$MD$JP$JP
243192791$24319279$1$I$20240101$20240905$20240914$20240914$EXP$$CA-CELLTRION INC.-2024CA019848$CELLTRION$$$$$$Y$$$20240914$$CN$CA$CA
243192801$24319280$1$I$20231101$20240830$20240914$20240914$EXP$$US-MALLINCKRODT-MNK202405470$MALLINCKRODT$$66$YR$E$F$Y$153$KG$20240914$$HP$US$US
243192811$24319281$1$I$$20240903$20240914$20240914$PER$$US-ABBVIE-5909152$ABBVIE$$$$$M$Y$$$20240914$$MD$US$US
243192821$24319282$1$I$$20240903$20240914$20240914$EXP$$US-MALLINCKRODT-MNK202405535$MALLINCKRODT$$$$$M$Y$$$20240914$$HP$US$US
243192841$24319284$1$I$$20240903$20240914$20240914$EXP$$US-MALLINCKRODT-MNK202405505$MALLINCKRODT$$$$E$M$Y$$$20240914$$MD$US$US
243192851$24319285$1$I$20240726$20240911$20240914$20240914$EXP$$IN-ROCHE-10000080687$ROCHE$$69$YR$E$M$Y$$$20240914$$CN$IN$IN
243192861$24319286$1$I$$20240904$20240914$20240914$PER$$US-ABBVIE-5909747$ABBVIE$$$$$F$Y$$$20240914$$MD$US$US
243192871$24319287$1$I$$20240909$20240914$20240914$PER$$US-ROCHE-10000077916$ROCHE$$$$E$F$Y$$$20240914$$CN$US$US
243192881$24319288$1$I$20240801$20240822$20240914$20240914$PER$$US-SA-2024SA264066$SANOFI AVENTIS$$50$YR$A$F$Y$62.27$KG$20240914$$MD$US$US
243192891$24319289$1$I$20240101$20240821$20240914$20240914$PER$$US-SA-2024SA263808$SANOFI AVENTIS$$29$YR$A$F$Y$81.82$KG$20240914$$MD$US$US
243192901$24319290$1$I$$20240904$20240914$20240914$EXP$$IN-ROCHE-3553060$ROCHE$$66$YR$E$M$Y$$$20240914$$MD$IN$IN
243192911$24319291$1$I$$20240911$20240914$20240914$PER$$US-AMGEN-USASP2024182472$AMGEN$$$$$$Y$$$20240913$$MD$US$US
243192921$24319292$1$I$20240809$20240911$20240914$20240914$EXP$$US-ABBVIE-5922025$ABBVIE$$67$YR$$M$Y$$$20240914$$HP$US$US
243192931$24319293$1$I$20240906$20240909$20240914$20240914$EXP$$UY-ABBVIE-5917718$ABBVIE$$62$YR$$F$Y$$$20240914$$CN$UY$UY
243192942$24319294$2$F$$20240912$20240914$20240917$EXP$$US-ABBVIE-5921457$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243192951$24319295$1$I$20240101$20240904$20240914$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-021974$UNITED THERAPEUTICS$$$$$F$Y$$$20240914$$$US$US
243192961$24319296$1$I$20240816$20240905$20240914$20240914$EXP$$JP-ROCHE-10000078714$ROCHE$$80$YR$E$M$Y$56.4$KG$20240914$$PH$JP$JP
243192971$24319297$1$I$20240601$20240904$20240914$20240914$PER$$US-SA-2024SA263703$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240914$$MD$US$US
243192981$24319298$1$I$20240902$20240905$20240914$20240914$PER$$US-SA-2024SA264441$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240914$$HP$US$US
243192991$24319299$1$I$20240826$20240904$20240914$20240914$PER$$US-SA-2024SA264626$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240914$$CN$US$US
243193001$24319300$1$I$20240101$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024182352$AMGEN$$$$$F$Y$$$20240913$$CN$US$US
243193011$24319301$1$I$$20240904$20240914$20240914$PER$$US-SA-2024SA263580$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240914$$MD$US$US
243193021$24319302$1$I$20240401$20240905$20240914$20240914$PER$$US-SA-2024SA264433$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240914$$HP$US$US
243193031$24319303$1$I$20230101$20240821$20240914$20240914$PER$$US-SA-2024SA263681$SANOFI AVENTIS$$45$YR$A$F$Y$49$KG$20240914$$MD$US$US
243193041$24319304$1$I$$20240905$20240914$20240914$PER$$US-ABBVIE-5909523$ABBVIE$$$$$$Y$$$20240914$$CN$US$US
243193052$24319305$2$F$20230708$20240916$20240914$20240919$EXP$$US-ABBVIE-5920006$ABBVIE$$46$YR$$F$Y$95.25$KG$20240919$$CN$US$US
243193061$24319306$1$I$$20240905$20240914$20240914$EXP$$US-ROCHE-10000075619$ROCHE$$$$A$M$Y$$$20240914$$CN$US$US
243193072$24319307$2$F$$20240909$20240914$20240918$PER$$US-SA-2024SA259943$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240918$$CN$US$US
243193081$24319308$1$I$$20240912$20240914$20240914$EXP$$US-ABBVIE-5922693$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243193091$24319309$1$I$20240902$20240912$20240914$20240914$EXP$$CA-ABBVIE-5922062$ABBVIE$$74$YR$$F$Y$$$20240914$$CN$CA$CA
243193101$24319310$1$I$20240810$20240910$20240914$20240914$EXP$$CN-ROCHE-10000078539$ROCHE$$59$YR$A$F$Y$65$KG$20240914$$HP$CN$CN
243193111$24319311$1$I$20231213$20240905$20240914$20240914$EXP$$IN-ROCHE-10000028080$ROCHE$$45$YR$A$M$Y$$$20240914$$MD$IN$IN
243193121$24319312$1$I$20240901$20240905$20240914$20240914$EXP$$US-MALLINCKRODT-MNK202405575$MALLINCKRODT$$56$YR$A$F$Y$173$KG$20240914$$HP$US$US
243193131$24319313$1$I$$20240905$20240914$20240914$EXP$$US-MALLINCKRODT-MNK202405565$MALLINCKRODT$$$$$F$Y$248$KG$20240914$$HP$US$US
243193141$24319314$1$I$20240101$20240905$20240914$20240914$EXP$$US-MALLINCKRODT-MNK202405577$MALLINCKRODT$$36$YR$A$M$Y$$$20240914$$HP$US$US
243193151$24319315$1$I$20240101$20240905$20240914$20240914$EXP$$US-MALLINCKRODT-MNK202405568$MALLINCKRODT$$51$YR$A$F$Y$$$20240914$$HP$US$US
243193166$24319316$6$F$20240401$20240918$20240914$20240926$PER$$US-ROCHE-3552405$ROCHE$$44$YR$A$F$Y$88$KG$20240926$$CN$US$US
243193171$24319317$1$I$20240101$20240906$20240914$20240914$EXP$$CA-ABBVIE-5882582$ABBVIE$$81$YR$$F$Y$$$20240914$$CN$CA$CA
243193201$24319320$1$I$$20240904$20240914$20240914$PER$$US-ABBVIE-5909626$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243193221$24319322$1$I$$20240904$20240914$20240914$PER$$US-SA-2024SA263654$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240914$$HP$US$US
243193231$24319323$1$I$$20240823$20240914$20240914$PER$$US-SA-2024SA264067$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$MD$US$US
243193241$24319324$1$I$$20240831$20240914$20240914$PER$$US-SA-2024SA260756$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240914$$HP$US$US
243193251$24319325$1$I$20240101$20240904$20240914$20240914$PER$$US-ABBVIE-5909211$ABBVIE$$$$$$Y$$$20240914$$HP$US$US
243193261$24319326$1$I$$20240910$20240914$20240914$EXP$$US-ABBVIE-5919992$ABBVIE$$$$$$Y$$$20240914$$MD$US$US
243193271$24319327$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264442$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240914$$HP$US$US
243193281$24319328$1$I$20240801$20240822$20240914$20240914$PER$$US-SA-2024SA264546$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240914$$CN$US$US
243193291$24319329$1$I$$20240904$20240914$20240914$PER$$US-SA-2024SA262777$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240914$$MD$US$US
243193301$24319330$1$I$$20240821$20240914$20240914$PER$$US-SA-2024SA264463$SANOFI AVENTIS$$$$C$F$Y$$$20240914$$MD$US$US
243193321$24319332$1$I$20240909$20240911$20240914$20240914$EXP$$EG-ROCHE-10000078974$ROCHE$$37$YR$A$F$Y$$$20240914$$CN$EG$EG
243193331$24319333$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264897$SANOFI AVENTIS$$$$E$M$Y$$$20240914$$HP$US$US
243193341$24319334$1$I$$20240904$20240914$20240914$PER$$US-SA-2024SA263782$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240914$$MD$US$US
243193351$24319335$1$I$20240814$20240823$20240914$20240914$PER$$US-SA-2024SA264501$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240914$$HP$US$US
243193361$24319336$1$I$20240902$20240906$20240914$20240914$PER$$US-SA-2024SA264908$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240914$$HP$US$US
243193371$24319337$1$I$20240101$20240904$20240914$20240914$PER$$US-SA-2024SA263885$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240914$$MD$US$US
243193381$24319338$1$I$20240101$20240904$20240914$20240914$PER$$US-SA-2019SA351121$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240914$$CN$US$US
243193391$24319339$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264915$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240914$$MD$US$US
243193402$24319340$2$F$20240101$20240821$20240914$20240917$PER$$US-SA-2024SA264549$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240918$$MD$US$US
243193411$24319341$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA262879$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240914$$HP$US$US
243193421$24319342$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264900$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240914$$MD$US$US
243193432$24319343$2$F$20240912$20240912$20240914$20240918$PER$$US-AMGEN-USASP2024183246$AMGEN$$83$YR$E$M$Y$$$20240918$$CN$US$US
243193441$24319344$1$I$20240101$20240909$20240914$20240914$EXP$$US-ABBVIE-5786251$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243193451$24319345$1$I$20230101$20240909$20240914$20240914$EXP$$ZA-ABBVIE-5917035$ABBVIE$$63$YR$$M$Y$$$20240914$$CN$ZA$ZA
243193461$24319346$1$I$20240401$20240906$20240914$20240914$EXP$$US-ABBVIE-5892494$ABBVIE$$35$YR$$F$Y$99.79$KG$20240914$$CN$US$US
243193471$24319347$1$I$$20240904$20240914$20240914$PER$$PR-ABBVIE-5909386$ABBVIE$$$$A$M$Y$$$20240914$$MD$PR$PR
243193481$24319348$1$I$$20240909$20240914$20240914$EXP$$CA-ABBVIE-5919483$ABBVIE$$$$$$Y$$$20240914$$HP$CA$CA
243193491$24319349$1$I$$20240903$20240914$20240914$PER$$US-ABBVIE-5908666$ABBVIE$$$$$$Y$$$20240914$$HP$US$US
243193501$24319350$1$I$20240904$20240911$20240914$20240914$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP011656$STRIDES$$71$YR$$$Y$77$KG$20240914$$CN$GB$GB
243193511$24319351$1$I$20240906$20240911$20240914$20240914$EXP$GB-MHRA-TPP47303509C9397588YC1725631006096$GB-STRIDES ARCOLAB LIMITED-2024SP011657$STRIDES$$55$YR$$M$Y$65$KG$20240914$$MD$GB$GB
243193521$24319352$1$I$$20240904$20240914$20240914$PER$$US-SA-2024SA263727$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240914$$HP$US$US
243193531$24319353$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264927$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240914$$MD$US$US
243193541$24319354$1$I$$20240830$20240914$20240914$PER$$US-SA-2024SA262466$SANOFI AVENTIS$$$$A$M$Y$$$20240914$$HP$US$US
243193551$24319355$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264888$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240914$$HP$US$US
243193571$24319357$1$I$20240813$20240905$20240914$20240914$EXP$$GB-CELLTRION INC.-2024GB021419$CELLTRION$$$$$$Y$$$20240914$$CN$GB$GB
243193591$24319359$1$I$20240501$20240906$20240914$20240914$PER$$US-SA-2024SA264916$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240914$$MD$US$US
243193602$24319360$2$F$20240101$20240906$20240914$20240923$PER$$US-SA-2024SA262882$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240923$$MD$US$US
243193621$24319362$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264184$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240914$$HP$US$US
243193631$24319363$1$I$$20240904$20240914$20240914$EXP$$US-GSK-US2024AMR110386$GLAXOSMITHKLINE$$$$$F$Y$$$20240914$$CN$US$US
243193641$24319364$1$I$20240101$20240910$20240914$20240914$PER$$PR-ABBVIE-5919010$ABBVIE$$$$$F$Y$$$20240914$$CN$PR$PR
243193651$24319365$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264853$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240914$$MD$US$US
243193661$24319366$1$I$20240604$20240905$20240914$20240914$PER$$US-SA-2024SA265259$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240914$$CN$US$US
243193681$24319368$1$I$20240904$20240904$20240914$20240914$PER$$US-SA-2024SA264700$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240914$$HP$US$US
243193691$24319369$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA262883$SANOFI AVENTIS$$$$A$M$Y$$$20240914$$HP$US$US
243193701$24319370$1$I$$20240906$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-025456$UNITED THERAPEUTICS$$$$$F$Y$94.785$KG$20240914$$$US$US
243193711$24319371$1$I$20240823$20240904$20240914$20240914$PER$$US-ABBVIE-5919208$ABBVIE$$41$YR$$M$Y$$$20240914$$CN$US$US
243193721$24319372$1$I$$20240905$20240914$20240914$EXP$$IL-ASTELLAS-2024-AER-004971$ASTELLAS$$$$E$F$Y$$$20240914$$MD$IL$IL
243193741$24319374$1$I$20231201$20240913$20240914$20240914$PER$$US-ABBVIE-5923276$ABBVIE$$59$YR$$F$Y$$$20240914$$HP$US$US
243193751$24319375$1$I$20240825$20240911$20240914$20240914$EXP$$US-AstraZeneca-2024A207274$ASTRAZENECA$$24619$DY$$F$Y$$$20240914$$CN$US$
243193761$24319376$1$I$20240730$20240911$20240914$20240914$EXP$$GB-AstraZeneca-2024A207245$ASTRAZENECA$$29397$DY$$M$Y$$$20240914$$CN$GB$
243193771$24319377$1$I$$20240912$20240914$20240914$EXP$$DE-AstraZeneca-2024A208896$ASTRAZENECA$$$$$M$Y$$$20240914$$MD$DE$
243193782$24319378$2$F$20240801$20240919$20240914$20240927$PER$$US-ABBVIE-5909783$ABBVIE$$43$YR$$M$Y$79$KG$20240927$$CN$US$US
243193791$24319379$1$I$$20240907$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-028153$UNITED THERAPEUTICS$$$$$M$Y$87.528$KG$20240914$$$US$US
243193811$24319381$1$I$20230301$20240906$20240914$20240914$EXP$$US-GSK-US2024111334$GLAXOSMITHKLINE$$$$$$Y$$$20240914$$CN$US$US
243193823$24319382$3$F$20240530$20240919$20240914$20240928$EXP$$JP-ROCHE-3576829$ROCHE$$71$YR$E$M$Y$$$20240928$$MD$JP$JP
243193831$24319383$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264942$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240914$$HP$US$US
243193841$24319384$1$I$20240101$20240907$20240914$20240914$PER$$US-SA-2024SA264933$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240914$$MD$US$US
243193851$24319385$1$I$20240801$20240907$20240914$20240914$PER$$US-SA-2024SA264928$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240914$$MD$US$US
243193861$24319386$1$I$$20240912$20240914$20240914$PER$$US-ABBVIE-5923337$ABBVIE$$$$$$Y$$$20240914$$MD$US$US
243193872$24319387$2$F$20240910$20240915$20240914$20240918$PER$$US-AMGEN-USASP2024181621$AMGEN$$68$YR$E$F$Y$84.354$KG$20240917$$HP$US$US
243193881$24319388$1$I$20240903$20240906$20240914$20240914$EXP$$CN-BEIGENE-BGN-2024-014188$BEIGENE$$$$$$Y$$$20240914$$HP$CN$CN
243193891$24319389$1$I$20240101$20240906$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-027541$UNITED THERAPEUTICS$$$$$F$Y$45.351$KG$20240914$$$US$US
243193901$24319390$1$I$20240827$20240907$20240914$20240914$EXP$$CN-BEIGENE-BGN-2024-014189$BEIGENE$$$$$$Y$$$20240914$$HP$CN$CN
243193911$24319391$1$I$$20240906$20240914$20240914$EXP$$US-ABBVIE-5914842$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243193921$24319392$1$I$20240831$20240909$20240914$20240914$EXP$$TH-ROCHE-10000078351$ROCHE$$77$YR$E$F$Y$$$20240914$$CN$TH$TH
243193931$24319393$1$I$$20240911$20240914$20240914$PER$$US-ABBVIE-5922888$ABBVIE$$$$$$Y$$$20240914$$MD$US$US
243193941$24319394$1$I$$20240909$20240914$20240914$EXP$$US-ABBVIE-5917475$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243193951$24319395$1$I$$20240621$20240914$20240914$EXP$$US-ROCHE-10000072605$ROCHE$Viswanathan C, Truong M, Sagebiel T, Garg N, Bhosale P. Imaging of chemotherapy-related iatrogenic abdominal and pelvic conditions. Radiologic clinics of North America. 2014-Sep-01;52 (5):1029-40. doi:10.1016/j.rcl.2014.05.008.$47$YR$A$F$Y$$$20240914$$MD$US$US
243193961$24319396$1$I$20240903$20240909$20240914$20240914$EXP$$IT-ABBVIE-5917541$ABBVIE$$80$YR$$M$Y$$$20240914$$CN$IT$IT
243193971$24319397$1$I$20240101$20240903$20240914$20240914$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111889$ZYDUS PHARM$$$$$$Y$$$20240914$$HP$US$US
243193982$24319398$2$F$20240817$20240919$20240914$20240927$EXP$FR-AFSSAPS-CN2024000820$FR-TEVA-VS-3240438$TEVA$$86$YR$$F$Y$60$KG$20240927$$MD$FR$FR
243193991$24319399$1$I$20240101$20240904$20240914$20240914$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111922$ZYDUS PHARM$$$$$$Y$$$20240914$$PH$US$US
243194001$24319400$1$I$20240101$20240904$20240914$20240914$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111890$ZYDUS PHARM$$$$$$Y$$$20240914$$CN$US$US
243194011$24319401$1$I$20240802$20240909$20240914$20240914$EXP$FR-AFSSAPS-CN2024000767$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112084$ZYDUS PHARM$$$$$$Y$$$20240914$$PH$FR$FR
243194021$24319402$1$I$20240418$20240909$20240914$20240914$EXP$FR-AFSSAPS-PO2024000428$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112123$ZYDUS PHARM$$$$$$Y$$$20240914$$MD$FR$FR
243194031$24319403$1$I$20240101$20240904$20240914$20240914$PER$$US-AstraZeneca-2024A202262$ASTRAZENECA$$$$$M$Y$$$20240914$$CN$US$
243194051$24319405$1$I$20240715$20240904$20240914$20240914$EXP$FR-AFSSAPS-AVCF2024000538$FR-TEVA-VS-3240452$TEVA$$21$YR$$F$Y$$$20240914$$MD$FR$FR
243194061$24319406$1$I$20240824$20240906$20240914$20240914$EXP$$CN-BEIGENE-BGN-2024-014197$BEIGENE$$$$$$Y$$$20240914$$HP$CN$CN
243194071$24319407$1$I$20240830$20240906$20240914$20240914$EXP$$CN-BEIGENE-BGN-2024-014190$BEIGENE$$$$$$Y$$$20240914$$HP$CN$CN
243194081$24319408$1$I$20240824$20240905$20240914$20240914$PER$$US-ABBVIE-5910163$ABBVIE$$60$YR$$F$Y$55.791$KG$20240914$$CN$US$US
243194091$24319409$1$I$20240823$20240907$20240914$20240914$EXP$$CN-BEIGENE-BGN-2024-014191$BEIGENE$$$$$$Y$$$20240914$$HP$CN$CN
243194101$24319410$1$I$20240720$20240904$20240914$20240914$EXP$FR-AFSSAPS-AN2024001162$FR-TEVA-VS-3240463$TEVA$$37$YR$$M$Y$68.1$KG$20240914$$MD$FR$FR
243194111$24319411$1$I$$20240909$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-028487$UNITED THERAPEUTICS$$$$$M$Y$73.469$KG$20240914$$$US$US
243194121$24319412$1$I$$20240829$20240914$20240914$PER$$US-JNJFOC-20240907581$JOHNSON AND JOHNSON$$$$$F$Y$$$20240914$$CN$US$US
243194131$24319413$1$I$$20240903$20240914$20240914$PER$$US-JNJFOC-20240908575$JOHNSON AND JOHNSON$$$$$$Y$$$20240914$$CN$US$US
243194141$24319414$1$I$20240101$20240909$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-028599$UNITED THERAPEUTICS$$$$$F$Y$$$20240914$$$US$US
243194151$24319415$1$I$20240814$20240821$20240914$20240914$PER$$US-SA-2024SA264209$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240914$$CN$US$US
243194161$24319416$1$I$$20240905$20240914$20240914$EXP$$GB-TEVA-VS-3241282$TEVA$$94$YR$$F$Y$$$20240914$$HP$GB$GB
243194171$24319417$1$I$$20240905$20240914$20240914$PER$$US-ABBVIE-5914355$ABBVIE$$$$A$F$Y$$$20240914$$MD$US$US
243194181$24319418$1$I$$20240906$20240914$20240914$EXP$$CA-JNJFOC-20240869707$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240914$$PH$CA$CA
243194191$24319419$1$I$$20240911$20240914$20240914$PER$$US-AstraZeneca-2024A208133$ASTRAZENECA$$$$$F$Y$$$20240914$$CN$US$
243194201$24319420$1$I$20240808$20240905$20240914$20240914$EXP$FR-AFSSAPS-RN2024000928$FR-TEVA-VS-3240919$TEVA$$58$YR$$M$Y$$$20240914$$PH$FR$FR
243194221$24319422$1$I$20220701$20240905$20240914$20240914$EXP$$CA-CELLTRION INC.-2022CA014075$CELLTRION$$$$$$Y$$$20240914$$CN$CA$CA
243194231$24319423$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264020$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240914$$HP$US$US
243194241$24319424$1$I$20240101$20240821$20240914$20240914$PER$$US-SA-2024SA264629$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240914$$MD$US$US
243194261$24319426$1$I$20240430$20240905$20240914$20240914$EXP$FR-AFSSAPS-PA2024001446$FR-TEVA-VS-3240941$TEVA$$62$YR$$F$Y$47$KG$20240914$$PH$FR$FR
243194271$24319427$1$I$20240422$20240905$20240914$20240914$EXP$FR-AFSSAPS-NT2024001071$FR-TEVA-VS-3240937$TEVA$$63$YR$$F$Y$67$KG$20240914$$PH$FR$FR
243194281$24319428$1$I$$20240910$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-028621$UNITED THERAPEUTICS$$$$$M$Y$113.38$KG$20240914$$$US$US
243194291$24319429$1$I$20220101$20240905$20240914$20240914$EXP$$US-ROCHE-10000075223$ROCHE$$42$YR$A$F$Y$$$20240914$$CN$US$US
243194301$24319430$1$I$$20240905$20240914$20240914$PER$$US-ABBVIE-5916500$ABBVIE$$$$$F$Y$62$KG$20240914$$CN$US$US
243194311$24319431$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA179075$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240914$$MD$US$US
243194321$24319432$1$I$$20240911$20240914$20240914$PER$$PR-ABBVIE-5920690$ABBVIE$$$$$M$Y$$$20240914$$MD$PR$PR
243194331$24319433$1$I$20240501$20240910$20240914$20240914$EXP$$US-ABBVIE-5917574$ABBVIE$$70$YR$$F$Y$$$20240914$$CN$US$US
243194342$24319434$2$F$20220101$20240916$20240914$20240918$EXP$$US-ABBVIE-5917651$ABBVIE$$$$$F$Y$72.574$KG$20240918$$CN$US$US
243194351$24319435$1$I$$20240909$20240914$20240914$EXP$$ES-SANDOZ INC.-SDZ2024ES078571$SANDOZ$$$$$F$Y$$$20240914$$MD$ES$ES
243194361$24319436$1$I$20240129$20240905$20240914$20240914$EXP$FR-AFSSAPS-TO2024001644$FR-TEVA-VS-3240946$TEVA$$74$YR$$F$Y$$$20240914$$PH$FR$FR
243194371$24319437$1$I$20240903$20240904$20240914$20240914$EXP$GB-MHRA-MED-202409041029413460-WZBNG$GB-TEVA-VS-3240577$TEVA$$76$YR$$M$Y$$$20240914$$HP$GB$GB
243194382$24319438$2$F$20240701$20240919$20240914$20240924$EXP$$US-ABBVIE-5917919$ABBVIE$$63$YR$$M$Y$$$20240924$$CN$US$US
243194391$24319439$1$I$20240101$20240906$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-015427$UNITED THERAPEUTICS$$$$$M$Y$63.492$KG$20240914$$$US$US
243194401$24319440$1$I$20240101$20240908$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-028091$UNITED THERAPEUTICS$$$$$M$Y$87.075$KG$20240914$$$US$US
243194412$24319441$2$F$$20240916$20240914$20240923$PER$$US-SA-2024SA263114$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240923$$MD$US$US
243194421$24319442$1$I$$20240911$20240914$20240914$PER$$US-ROCHE-10000080296$ROCHE$$$$E$F$Y$$$20240914$$CN$US$US
243194431$24319443$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264196$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240914$$HP$US$US
243194441$24319444$1$I$$20240904$20240914$20240914$30DAY$$US-GSK-US2024110245$GLAXOSMITHKLINE$$$$$F$Y$$$20240914$$CN$US$US
243194451$24319445$1$I$20240904$20240912$20240914$20240914$PER$$US-ABBVIE-5922846$ABBVIE$$76$YR$$F$Y$59$KG$20240914$$CN$US$US
243194461$24319446$1$I$20240911$20240911$20240914$20240914$PER$$US-ABBVIE-5922963$ABBVIE$$$$$$Y$$$20240914$$CN$US$US
243194472$24319447$2$F$20240701$20240912$20240914$20240921$EXP$$CA-CELLTRION INC.-2024CA021821$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
243194481$24319448$1$I$20240822$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024182676$AMGEN$$71$YR$E$F$Y$$$20240913$$CN$US$US
243194491$24319449$1$I$$20240905$20240914$20240914$PER$$US-ABBVIE-5909803$ABBVIE$$$$$$Y$$$20240914$$HP$US$US
243194501$24319450$1$I$$20240910$20240914$20240914$PER$$US-ABBVIE-5920096$ABBVIE$$$$$$Y$$$20240914$$HP$US$US
243194511$24319451$1$I$$20240910$20240914$20240914$EXP$$BR-ROCHE-10000079583$ROCHE$$27$YR$A$F$Y$$$20240914$$MD$BR$BR
243194521$24319452$1$I$20230101$20240905$20240914$20240914$PER$$US-SA-2024SA262895$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240914$$HP$US$US
243194531$24319453$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264147$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240914$$MD$US$US
243194541$24319454$1$I$20240101$20240828$20240914$20240914$PER$$US-SA-2024SA264837$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240914$$MD$US$US
243194551$24319455$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA170294$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240914$$MD$US$US
243194561$24319456$1$I$20240829$20240905$20240914$20240914$EXP$$GB-TEVA-VS-3240897$TEVA$$50$YR$$F$Y$93$KG$20240914$$HP$GB$GB
243194571$24319457$1$I$$20240909$20240914$20240914$EXP$$DE-ABBVIE-5918784$ABBVIE$$$$A$F$Y$$$20240914$$MD$DE$DE
243194581$24319458$1$I$$20240903$20240914$20240914$PER$$US-ABBVIE-5920395$ABBVIE$$$$A$F$Y$$$20240914$$HP$US$US
243194591$24319459$1$I$$20240906$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-028524$UNITED THERAPEUTICS$$$$$M$Y$107.94$KG$20240914$$$US$US
243194602$24319460$2$F$$20240916$20240914$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-028232$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240924$$$US$US
243194621$24319462$1$I$20240801$20240909$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-028522$UNITED THERAPEUTICS$$64$YR$$F$Y$74.83$KG$20240914$$$US$US
243194631$24319463$1$I$$20240910$20240914$20240914$PER$$US-ABBVIE-5920021$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243194641$24319464$1$I$$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183446$AMGEN$$$$$$Y$$$20240914$$PH$US$US
243194651$24319465$1$I$20240814$20240910$20240914$20240914$EXP$$US-ABBVIE-5917853$ABBVIE$$57$YR$$F$Y$$$20240914$$CN$US$US
243194661$24319466$1$I$20240101$20240910$20240914$20240914$EXP$$US-ABBVIE-5918316$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243194671$24319467$1$I$$20240905$20240914$20240914$30DAY$$US-GSK-US2024110783$GLAXOSMITHKLINE$$$$$F$Y$$$20240914$$CN$US$US
243194681$24319468$1$I$$20240911$20240914$20240914$EXP$$US-ABBVIE-5921501$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243194691$24319469$1$I$$20240908$20240914$20240914$PER$$US-SA-2024SA264514$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240914$$HP$US$US
243194701$24319470$1$I$20240830$20240903$20240914$20240914$PER$$US-SA-2024SA264325$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240914$$MD$US$US
243194711$24319471$1$I$20240101$20240821$20240914$20240914$PER$$US-SA-2024SA263697$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240914$$MD$US$US
243194721$24319472$1$I$20240101$20240908$20240914$20240914$PER$$US-SA-2024SA264206$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240914$$HP$US$US
243194731$24319473$1$I$20240901$20240902$20240914$20240914$PER$$US-SA-2024SA263370$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240914$$HP$US$US
243194741$24319474$1$I$$20240910$20240914$20240914$PER$$US-AMGEN-USASP2024182059$AMGEN$$$$$$Y$$$20240914$$CN$US$US
243194751$24319475$1$I$$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183476$AMGEN$$$$$$Y$$$20240914$$HP$US$US
243194761$24319476$1$I$20240808$20240905$20240914$20240914$EXP$$CA-CELLTRION INC.-2024CA021787$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
243194771$24319477$1$I$20240801$20240905$20240914$20240914$PER$$US-SA-2024SA264297$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240914$$MD$US$US
243194781$24319478$1$I$$20240909$20240914$20240914$PER$$US-AMGEN-USASP2024179799$AMGEN$$$$$F$Y$$$20240914$$CN$US$US
243194801$24319480$1$I$$20240905$20240914$20240914$EXP$$CH-JNJFOC-20240919389$JOHNSON AND JOHNSON$$$$$F$Y$$$20240914$$MD$CH$CH
243194811$24319481$1$I$$20240904$20240914$20240914$EXP$$BR-CELLTRION INC.-2024BR021428$CELLTRION$$$$$$Y$$$20240914$$CN$BR$BR
243194821$24319482$1$I$20240711$20240905$20240914$20240914$EXP$GB-MHRA-MED-202409051602228240-CRTJQ$GB-TEVA-VS-3241423$TEVA$$$$$$Y$$$20240914$$HP$GB$GB
243194831$24319483$1$I$20240405$20240904$20240914$20240914$EXP$$JP-ROCHE-10000077481$ROCHE$$74$YR$E$M$Y$72.2$KG$20240914$$MD$JP$JP
243194841$24319484$1$I$$20240911$20240914$20240914$PER$$US-AMGEN-USASP2024183032$AMGEN$$$$$$Y$$$20240914$$CN$US$US
243194861$24319486$1$I$$20240909$20240914$20240914$EXP$$TR-ROCHE-10000080983$ROCHE$Ugurluer G, Dincer N, Danyeli A, Celik L, Guner A, Corapcioglu F, et al. Nuclear protein in testis (NUT) midline carcinoma of the larynx: A rare case report of a paediatric patient and literature review. Cancer/Radiotherapie. 2024-Aug;28 (4):385-389. doi:10.1016/j.canrad.2024.02.004.$17$YR$T$M$Y$$$20240914$$HP$TR$TR
243194871$24319487$1$I$$20240826$20240914$20240914$PER$$US-AstraZeneca-2024A194800$ASTRAZENECA$$$$$F$Y$$$20240914$$CN$US$
243194881$24319488$1$I$$20240905$20240914$20240914$PER$$US-JNJFOC-20240912379$JOHNSON AND JOHNSON$$$$$$Y$$$20240914$$MD$US$US
243194891$24319489$1$I$$20240905$20240914$20240914$PER$$US-SA-2023SA056715$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240914$$MD$US$US
243194903$24319490$3$F$$20240904$20240914$20240924$PER$$US-SA-2024SA265127$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240924$$CN$US$US
243194911$24319491$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264527$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$HP$US$US
243194921$24319492$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265556$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240914$$HP$US$US
243194931$24319493$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA262826$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240914$$HP$US$US
243194941$24319494$1$I$20240501$20240908$20240914$20240914$PER$$US-SA-2024SA264688$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240914$$MD$US$US
243194951$24319495$1$I$20240101$20240907$20240914$20240914$PER$$US-SA-2024SA265185$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$HP$US$US
243194961$24319496$1$I$20240906$20240906$20240914$20240914$PER$$US-AMGEN-USASP2024183179$AMGEN$$66$YR$E$F$Y$$$20240914$$CN$US$US
243194972$24319497$2$F$20240101$20240913$20240914$20240923$EXP$$CA-CELLTRION INC.-2024CA021810$CELLTRION$$$$$$Y$$$20240923$$CN$CA$CA
243194981$24319498$1$I$20240301$20240912$20240914$20240914$EXP$$JP-ALXN-202409JPN000788JP$ALEXION PHARMACEUTICALS$$72$YR$$M$Y$$$20240914$$MD$JP$JP
243194991$24319499$1$I$$20240909$20240914$20240914$PER$$US-JNJFOC-20240927136$JOHNSON AND JOHNSON$$$$$F$Y$$$20240914$$CN$US$US
243195001$24319500$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265490$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240914$$HP$US$US
243195011$24319501$1$I$$20240909$20240914$20240914$PER$$US-ABBVIE-5918132$ABBVIE$$$$$$Y$$$20240914$$CN$US$US
243195021$24319502$1$I$20240910$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024182877$AMGEN$$69$YR$E$F$Y$$$20240914$$CN$US$US
243195031$24319503$1$I$$20240905$20240914$20240914$EXP$$TR-AMGEN-TURSP2024178073$AMGEN$$$$A$F$Y$$$20240914$$MD$TR$TR
243195041$24319504$1$I$20240820$20240820$20240914$20240914$PER$$US-SA-2024SA263592$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240914$$MD$US$US
243195051$24319505$1$I$$20240823$20240914$20240914$PER$$US-SA-2024SA262900$SANOFI AVENTIS$$$$A$M$Y$115.91$KG$20240914$$MD$US$US
243195061$24319506$1$I$$20240905$20240914$20240914$EXP$$GB-TEVA-VS-3240733$TEVA$$45$YR$$F$Y$73$KG$20240914$$MD$GB$GB
243195071$24319507$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264907$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240914$$HP$US$US
243195082$24319508$2$F$20240101$20240916$20240914$20240925$PER$$US-SA-2024SA264958$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240925$$MD$US$US
243195091$24319509$1$I$20240701$20240823$20240914$20240914$PER$$US-SA-2024SA263874$SANOFI AVENTIS$$54$YR$A$F$Y$121.54$KG$20240914$$HP$US$US
243195101$24319510$1$I$20240101$20240905$20240914$20240914$EXP$$CA-CELLTRION INC.-2024CA019005$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
243195121$24319512$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265502$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240914$$MD$US$US
243195131$24319513$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA230407$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240914$$HP$US$US
243195141$24319514$1$I$$20240822$20240914$20240914$PER$$US-SA-2024SA262502$SANOFI AVENTIS$$$$E$F$Y$$$20240914$$MD$US$US
243195151$24319515$1$I$20240801$20240827$20240914$20240914$PER$$US-SA-2024SA263397$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240914$$MD$US$US
243195161$24319516$1$I$$20240909$20240914$20240914$PER$$US-AMGEN-USASP2024179778$AMGEN$$$$A$M$Y$$$20240914$$CN$US$US
243195171$24319517$1$I$$20240820$20240914$20240914$PER$$US-SA-2024SA263839$SANOFI AVENTIS$$$$A$M$Y$104.55$KG$20240914$$MD$US$US
243195181$24319518$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265560$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240914$$HP$US$US
243195191$24319519$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264302$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240914$$CN$US$US
243195201$24319520$1$I$20240905$20240906$20240914$20240914$PER$$US-SA-2024SA264865$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240914$$HP$US$US
243195211$24319521$1$I$$20240904$20240914$20240914$PER$$US-ABBVIE-5908796$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243195221$24319522$1$I$$20240907$20240914$20240914$PER$$US-SA-2024SA265588$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$HP$US$US
243195232$24319523$2$F$$20240918$20240914$20240926$EXP$$JP-ROCHE-10000077317$ROCHE$$$$E$$Y$$$20240926$$MD$JP$JP
243195241$24319524$1$I$$20240910$20240914$20240914$PER$$US-ABBVIE-5920723$ABBVIE$$$$$$Y$$$20240914$$CN$US$US
243195252$24319525$2$F$20240912$20240913$20240914$20240918$PER$$US-AMGEN-USASP2024183146$AMGEN$$76$YR$E$F$Y$$$20240918$$CN$US$US
243195261$24319526$1$I$$20240909$20240914$20240914$PER$$US-ABBVIE-5917306$ABBVIE$$$$$$Y$$$20240914$$CN$US$US
243195271$24319527$1$I$$20240909$20240914$20240914$PER$$US-ROCHE-10000077919$ROCHE$$$$$$Y$$$20240914$$HP$US$US
243195281$24319528$1$I$$20240911$20240914$20240914$EXP$$CA-SANDOZ INC.-SDZ2024CA079546$SANDOZ$$65$YR$$F$Y$$$20240914$$HP$CA$CA
243195291$24319529$1$I$20240826$20240910$20240914$20240914$PER$$US-JNJFOC-20240925146$JOHNSON AND JOHNSON$$$$$$Y$$$20240914$$HP$US$US
243195301$24319530$1$I$20231219$20240905$20240914$20240914$EXP$$CA-CELLTRION INC.-2024CA010744$CELLTRION$$$$$$Y$$$20240914$$MD$CA$CA
243195311$24319531$1$I$$20240904$20240914$20240914$PER$$US-SA-2024SA265249$SANOFI AVENTIS$$$$A$M$Y$$$20240914$$CN$US$US
243195321$24319532$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265432$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240914$$HP$US$US
243195331$24319533$1$I$$20240904$20240914$20240914$PER$$US-SA-2024SA264800$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240914$$MD$US$US
243195341$24319534$1$I$20240813$20240821$20240914$20240914$PER$$US-SA-2024SA264052$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240914$$MD$US$US
243195351$24319535$1$I$$20240827$20240914$20240914$PER$$US-SA-2024SA263419$SANOFI AVENTIS$$$$A$M$Y$$$20240914$$MD$US$US
243195361$24319536$1$I$20240409$20240905$20240914$20240914$EXP$$US-GSK-US2024110740$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240914$$HP$US$US
243195371$24319537$1$I$20240804$20240909$20240914$20240914$PER$$US-AMGEN-USASP2024180089$AMGEN$$76$YR$E$F$Y$$$20240914$$CN$US$US
243195381$24319538$1$I$$20240820$20240914$20240914$PER$$US-SA-2024SA263709$SANOFI AVENTIS$$$$A$F$Y$58$KG$20240914$$MD$US$US
243195392$24319539$2$F$20240801$20240912$20240914$20240919$PER$$US-ABBVIE-5922929$ABBVIE$$46$YR$$F$Y$76$KG$20240919$$CN$US$US
243195401$24319540$1$I$20240701$20240912$20240914$20240914$EXP$$JP-ALXN-202409JPN000789JP$ALEXION PHARMACEUTICALS$$54$YR$$F$Y$$$20240914$$MD$JP$JP
243195411$24319541$1$I$$20240826$20240914$20240914$PER$$US-SA-2024SA265142$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$MD$US$US
243195421$24319542$1$I$20240101$20240821$20240914$20240914$PER$$US-SA-2024SA263469$SANOFI AVENTIS$$33$YR$A$F$Y$96.145$KG$20240914$$MD$US$US
243195431$24319543$1$I$20240101$20240910$20240914$20240914$PER$$US-AMGEN-USASP2024180634$AMGEN$$83$YR$E$M$Y$$$20240914$$CN$US$US
243195441$24319544$1$I$$20240910$20240914$20240914$PER$$US-AMGEN-USASP2024181461$AMGEN$$$$$F$Y$$$20240914$$CN$US$US
243195451$24319545$1$I$20240101$20240910$20240914$20240914$PER$$US-AMGEN-USASP2024181457$AMGEN$$75$YR$E$F$Y$$$20240914$$CN$US$US
243195461$24319546$1$I$20240911$20240911$20240914$20240914$PER$$US-AMGEN-USASP2024183028$AMGEN$$65$YR$E$F$Y$$$20240914$$PH$US$US
243195472$24319547$2$F$20231123$20240911$20240914$20240921$EXP$$GB-TEVA-VS-3240834$TEVA$$$$E$F$Y$89$KG$20240921$$MD$GB$GB
243195482$24319548$2$F$$20240909$20240914$20240917$EXP$$GB-ABBVIE-5898215$ABBVIE$Teoh YP, Gold A, Yesudian PD. Fats and figures: how abnormal lipids unravel the truth. Br-J-Dermatol 2024;191(Suppl. 1):i127-i128.$22$YR$$M$Y$$$20240917$$HP$GB$GB
243195491$24319549$1$I$20200520$20240911$20240914$20240914$EXP$$BR-ABBVIE-5922876$ABBVIE$$87$YR$$M$Y$$$20240914$$MD$BR$BR
243195501$24319550$1$I$20211119$20240911$20240914$20240914$EXP$PL-URPL-DML-MLP.4401.1.5051.2021$PL-ABBVIE-5922425$ABBVIE$$49$YR$$$Y$$$20240914$$MD$PL$PL
243195511$24319551$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA264326$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240914$$HP$US$US
243195521$24319552$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264977$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240914$$MD$US$US
243195532$24319553$2$F$20240101$20240917$20240914$20240919$EXP$$US-ABBVIE-5917678$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243195541$24319554$1$I$$20240909$20240914$20240914$EXP$$CA-ABBVIE-5916278$ABBVIE$$$$A$M$Y$$$20240914$$CN$CA$CA
243195551$24319555$1$I$$20240905$20240914$20240914$PER$$PR-ABBVIE-5914246$ABBVIE$$$$E$M$Y$$$20240914$$MD$PR$PR
243195561$24319556$1$I$20230410$20240905$20240914$20240914$EXP$$GB-TEVA-VS-3241150$TEVA$$68$YR$$F$Y$69$KG$20240914$$HP$GB$GB
243195571$24319557$1$I$$20240905$20240914$20240914$30DAY$$US-GSK-US2024110810$GLAXOSMITHKLINE$$$$$M$Y$$$20240914$$CN$US$US
243195581$24319558$1$I$20240901$20240911$20240914$20240914$PER$$US-AMGEN-USASP2024182022$AMGEN$$$$$$Y$$$20240914$$HP$US$US
243195592$24319559$2$F$$20240918$20240914$20240924$EXP$$HU-ROCHE-3394359$ROCHE$Berzy K, Hermina S, Sashalmi S, Gulyas A, Batai B, Bedics G et al. Primary cardiac DLBCL, case presentation. ;:-.$82$YR$E$F$Y$$$20240924$$HP$HU$HU
243195601$24319560$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264329$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240914$$MD$US$US
243195611$24319561$1$I$20240101$20240904$20240914$20240914$PER$$US-SA-2024SA263083$SANOFI AVENTIS$$$$C$M$Y$$$20240914$$HP$US$US
243195621$24319562$1$I$$20240820$20240914$20240914$PER$$US-SA-2024SA264598$SANOFI AVENTIS$$$$A$$Y$$$20240914$$CN$US$US
243195631$24319563$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA262829$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240914$$HP$US$US
243195642$24319564$2$F$20240801$20240913$20240914$20240916$PER$$US-AMGEN-USASP2024183141$AMGEN$$75$YR$E$M$Y$$$20240916$$CN$US$US
243195651$24319565$1$I$20240422$20240903$20240914$20240914$EXP$$BE-ABBVIE-5919843$ABBVIE$$72$YR$$F$Y$$$20240914$$HP$BE$BE
243195671$24319567$1$I$20240703$20240911$20240914$20240914$EXP$$CA-ABBVIE-5921852$ABBVIE$$72$YR$$M$Y$$$20240914$$MD$CA$CA
243195681$24319568$1$I$20240829$20240909$20240914$20240914$EXP$$US-ABBVIE-5917166$ABBVIE$$80$YR$$M$Y$$$20240914$$CN$US$US
243195691$24319569$1$I$20240101$20240911$20240914$20240914$EXP$$US-ABBVIE-5921032$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243195701$24319570$1$I$$20240820$20240914$20240914$EXP$$NL-ABBVIE-5921586$ABBVIE$$72$YR$$M$Y$$$20240914$$CN$NL$NL
243195711$24319571$1$I$$20240910$20240914$20240914$EXP$$US-ROCHE-10000078867$ROCHE$$$$A$M$Y$$$20240914$$MD$US$US
243195721$24319572$1$I$20240831$20240905$20240914$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028092$UNITED THERAPEUTICS$$79$YR$$M$Y$87.982$KG$20240914$$$US$US
243195731$24319573$1$I$20240101$20240910$20240914$20240914$EXP$$CA-ABBVIE-5919486$ABBVIE$$39$YR$$M$Y$$$20240914$$CN$CA$CA
243195741$24319574$1$I$$20230317$20240914$20240914$EXP$$CN-ROCHE-10000079682$ROCHE$$$$$$Y$$$20240914$$MD$CN$CN
243195751$24319575$1$I$$20240904$20240914$20240914$EXP$$BG-TEVA-VS-3241565$TEVA$Viktoria B MD, Ivan K MD?Clinic of Hematology, Military Medical Academy, MHAT Sofia, Bulgaria$62$YR$$M$Y$$$20240914$$HP$BG$BG
243195761$24319576$1$I$$20240905$20240914$20240914$30DAY$$US-GSK-US2024111235$GLAXOSMITHKLINE$$2$DEC$$M$Y$$$20240914$$MD$US$US
243195771$24319577$1$I$20240101$20240905$20240914$20240914$EXP$$CA-CELLTRION INC.-2024CA017023$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
243195781$24319578$1$I$$20240908$20240914$20240914$EXP$$AU-ROCHE-10000076871$ROCHE$$67$YR$E$M$Y$$$20240914$$MD$AU$AU
243195791$24319579$1$I$$20240904$20240914$20240914$PER$$US-SA-2024SA264729$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240914$$HP$US$US
243195801$24319580$1$I$20240801$20240821$20240914$20240914$PER$$US-SA-2024SA263181$SANOFI AVENTIS$$55$YR$A$F$Y$102.73$KG$20240914$$MD$US$US
243195821$24319582$1$I$$20240905$20240914$20240914$EXP$$RU-ROCHE-10000076892$ROCHE$$73$YR$E$F$Y$$$20240914$$MD$RU$RU
243195831$24319583$1$I$$20240912$20240914$20240914$PER$$US-ABBVIE-5923151$ABBVIE$$$$$$Y$$$20240914$$CN$US$US
243195841$24319584$1$I$20240101$20240910$20240914$20240914$EXP$$US-ABBVIE-5917834$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243195851$24319585$1$I$$20240910$20240914$20240914$EXP$$US-ABBVIE-5918983$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243195861$24319586$1$I$20240801$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183123$AMGEN$$64$YR$A$M$Y$$$20240914$$CN$US$US
243195871$24319587$1$I$$20240905$20240914$20240914$EXP$$CN-Chengdu Suncadia Medicine Co., Ltd.-2161606$Chengdu Suncadia Medicine$Short segment myelitis as a dominant  manifestation of cryptococcal infection: a case  report$38$YR$$M$Y$$$20240914$$MD$CN$CN
243195881$24319588$1$I$20240801$20240831$20240914$20240914$PER$$US-SA-2024SA261747$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240914$$HP$US$US
243195891$24319589$1$I$20240101$20240904$20240914$20240914$PER$$US-SA-2023SA305387$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240914$$MD$US$US
243195911$24319591$1$I$20240701$20240911$20240914$20240914$EXP$$US-ABBVIE-5919809$ABBVIE$$65$YR$$F$Y$$$20240914$$CN$US$US
243195921$24319592$1$I$20240717$20240909$20240914$20240914$EXP$ES-AEMPS-1567334$ES-ABBVIE-5914452$ABBVIE$$47$YR$$M$Y$$$20240914$$PH$ES$ES
243195933$24319593$3$F$20240802$20240919$20240914$20240927$EXP$$GB-TEVA-VS-3241321$TEVA$$56$YR$$$Y$$$20240927$$CN$GB$GB
243195941$24319594$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264336$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240914$$CN$US$US
243195961$24319596$1$I$$20240820$20240914$20240914$PER$$US-SA-2024SA262999$SANOFI AVENTIS$$12$YR$T$$Y$$$20240914$$PH$US$US
243195971$24319597$1$I$20240101$20240909$20240914$20240914$PER$$US-SA-2024SA264570$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240914$$HP$US$US
243195991$24319599$1$I$$20240905$20240914$20240914$PER$$US-JNJFOC-20240917615$JOHNSON AND JOHNSON$$$$$F$Y$$$20240914$$MD$US$US
243196011$24319601$1$I$20240801$20240904$20240914$20240914$EXP$$US-UCBSA-2024045589$UCB$$42$YR$$F$Y$$$20240914$$HP$US$US
243196021$24319602$1$I$$20240910$20240914$20240914$EXP$$US-ABBVIE-5920467$ABBVIE$$$$$F$Y$$$20240914$$MD$US$US
243196031$24319603$1$I$$20240908$20240914$20240914$PER$$US-JNJFOC-20240922366$JOHNSON AND JOHNSON$$$$$$Y$$$20240914$$CN$US$US
243196041$24319604$1$I$20240221$20240910$20240914$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028611$UNITED THERAPEUTICS$$73$YR$$F$Y$49.887$KG$20240914$$$US$US
243196051$24319605$1$I$20220701$20240905$20240914$20240914$PER$$US-SA-2024SA264334$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240914$$HP$US$US
243196061$24319606$1$I$$20240910$20240914$20240914$PER$$US-AMGEN-USASP2024180726$AMGEN$$$$$M$Y$$$20240914$$MD$US$US
243196072$24319607$2$F$20240701$20240910$20240914$20240923$EXP$$BE-UCBSA-2024045858$UCB$$58$YR$$M$Y$$$20240923$$MD$BE$BE
243196081$24319608$1$I$20240821$20240908$20240914$20240914$PER$$US-SA-2024SA264983$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240914$$HP$US$US
243196091$24319609$1$I$$20240822$20240914$20240914$PER$$US-SA-2024SA263791$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240914$$HP$US$US
243196101$24319610$1$I$$20240823$20240914$20240914$PER$$US-SA-2024SA263943$SANOFI AVENTIS$$49$YR$A$M$Y$102.27$KG$20240914$$MD$US$US
243196111$24319611$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264950$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240914$$HP$US$US
243196121$24319612$1$I$$20240908$20240914$20240914$PER$$US-SA-2024SA265536$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$HP$US$US
243196131$24319613$1$I$20240701$20240905$20240914$20240914$PER$$US-SA-2024SA264331$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240914$$MD$US$US
243196141$24319614$1$I$20240514$20240909$20240914$20240914$EXP$FR-AFSSAPS-NC2024001046$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112082$ZYDUS PHARM$$$$$$Y$$$20240914$$MD$FR$FR
243196151$24319615$1$I$$20240904$20240914$20240914$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-112008$ZYDUS PHARM$Rupakumar T, Sankar A, Vijayasekharan K, VarikkattuRajendran P, ChellapanSojamani G, Rajeswari B, et al.. Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India.. Br-J-Haematol. 2024;220-228$$$$$Y$$$20240914$$HP$IN$IN
243196161$24319616$1$I$20240301$20240909$20240914$20240914$EXP$FR-AFSSAPS-AM2024000694$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112100$ZYDUS PHARM$$$$$$Y$$$20240914$$MD$FR$FR
243196171$24319617$1$I$20240101$20240909$20240914$20240914$PER$$US-SA-2024SA264563$SANOFI AVENTIS$$$$E$M$Y$$$20240914$$HP$US$US
243196181$24319618$1$I$$20240904$20240914$20240914$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-112007$ZYDUS PHARM$Rupakumar T, Sankar A, Vijayasekharan K, VarikkattuRajendran P, ChellapanSojamani G, Rajeswari B, et al.. Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India.. Br-J-Haematol. 2024;220-228$$$$$Y$$$20240914$$HP$IN$IN
243196191$24319619$1$I$20240528$20240909$20240914$20240914$EXP$FR-AFSSAPS-DJ2024000934$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112083$ZYDUS PHARM$$$$$$Y$$$20240914$$MD$FR$FR
243196211$24319621$1$I$20230401$20240906$20240914$20240914$EXP$$US-ABBVIE-5914676$ABBVIE$$75$YR$$F$Y$$$20240914$$CN$US$US
243196221$24319622$1$I$$20240903$20240914$20240914$EXP$$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-112025$ZYDUS PHARM$$$$$$Y$$$20240914$$HP$GB$GB
243196231$24319623$1$I$20240101$20240911$20240914$20240914$EXP$$US-ABBVIE-5920035$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243196241$24319624$1$I$$20240906$20240914$20240914$30DAY$$US-GSK-US2024111389$GLAXOSMITHKLINE$$$$$M$Y$$$20240914$$CN$US$US
243196251$24319625$1$I$$20240830$20240914$20240914$PER$$US-SA-2024SA265483$SANOFI AVENTIS$$$$E$$Y$$$20240914$$MD$US$US
243196261$24319626$1$I$20220201$20240910$20240914$20240914$EXP$$US-ABBVIE-5399268$ABBVIE$$70$YR$$F$Y$93$KG$20240914$$CN$US$US
243196271$24319627$1$I$$20240830$20240914$20240914$PER$$US-SA-2024SA265251$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240914$$CN$US$US
243196281$24319628$1$I$20231101$20240907$20240914$20240914$PER$$US-SA-2024SA264761$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240914$$MD$US$US
243196291$24319629$1$I$$20240904$20240914$20240914$PER$$US-ABBVIE-5909704$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243196301$24319630$1$I$20240701$20240910$20240914$20240914$EXP$$US-ABBVIE-5919439$ABBVIE$$81$YR$$F$Y$$$20240914$$CN$US$US
243196311$24319631$1$I$20240415$20240912$20240914$20240914$EXP$$JP-ALXN-202409JPN000803JP$ALEXION PHARMACEUTICALS$$59$YR$$F$Y$$$20240914$$MD$JP$JP
243196321$24319632$1$I$$20240910$20240914$20240914$EXP$$US-ABBVIE-5918065$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243196331$24319633$1$I$$20240903$20240914$20240914$EXP$$JP-UCBSA-2022058710$UCB$Ito Y, et al.. A case in which neurogenic stunned myocardium after abusive head trauma was suspected in a patient with decreased cardiac function and convulsive seizure.. Journal of Japanese Society of Emergency Pediatrics. 2022;21(2):283$4$MON$$M$Y$$$20240914$$MD$JP$JP
243196341$24319634$1$I$$20240907$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-028700$UNITED THERAPEUTICS$$$$$F$Y$68.027$KG$20240914$$$US$US
243196352$24319635$2$F$20240101$20240913$20240914$20240916$PER$$US-AMGEN-USASP2024183137$AMGEN$$64$YR$A$F$Y$$$20240916$$CN$US$US
243196361$24319636$1$I$20240901$20240905$20240914$20240914$30DAY$$US-GSK-US2024110777$GLAXOSMITHKLINE$$30$YR$$F$Y$$$20240914$$CN$US$US
243196371$24319637$1$I$20240806$20240906$20240914$20240914$EXP$$DE-ROCHE-10000077163$ROCHE$$33$YR$A$F$Y$$$20240914$$MD$DE$DE
243196381$24319638$1$I$20230720$20240905$20240914$20240914$EXP$$BR-CELLTRION INC.-2023BR015289$CELLTRION$$$$$$Y$$$20240914$$CN$BR$BR
243196391$24319639$1$I$$20240911$20240914$20240914$EXP$$ES-ABBVIE-5919682$ABBVIE$$$$$M$Y$$$20240914$$MD$ES$ES
243196401$24319640$1$I$$20240904$20240914$20240914$EXP$$AU-JNJFOC-20240916296$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240914$$MD$AU$AU
243196411$24319641$1$I$$20240910$20240914$20240914$EXP$$US-TAKEDA-2024TUS083873$TAKEDA$$$$$M$Y$$$20240914$$CN$US$US
243196421$24319642$1$I$20240804$20240829$20240914$20240914$PER$$US-AstraZeneca-2024A177760$ASTRAZENECA$$77$YR$$F$Y$$$20240914$$CN$US$
243196432$24319643$2$F$20240101$20240920$20240914$20240926$EXP$$US-ABBVIE-5919172$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243196441$24319644$1$I$$20240910$20240914$20240914$EXP$$US-ABBVIE-5918828$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243196451$24319645$1$I$$20240904$20240914$20240914$PER$$US-ABBVIE-5917411$ABBVIE$$$$$$Y$$$20240914$$HP$US$US
243196462$24319646$2$F$20240701$20240909$20240914$20240918$EXP$FR-AFSSAPS-TS2024000951$FR-TEVA-VS-3241556$TEVA$$47$YR$$M$Y$83$KG$20240918$$MD$FR$FR
243196471$24319647$1$I$$20240909$20240914$20240914$EXP$PL-EMA-20150317-AUTODUP-409963$PL-SANDOZ INC.-SDZ2024PL079020$SANDOZ$$$$$M$Y$$$20240914$$HP$PL$PL
243196491$24319649$1$I$$20240905$20240914$20240914$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161607$JIANGSU HENGRUI MEDICINE$A case of suspected Kounis syndrome induced by high dose of cisatracurium anesthesia$58$YR$$M$Y$68$KG$20240914$$MD$CN$CN
243196501$24319650$1$I$$20240905$20240914$20240914$EXP$$DE-TEVA-VS-3241651$TEVA$$$$$F$Y$$$20240914$$CN$DE$DE
243196511$24319651$1$I$20240811$20240905$20240914$20240914$PER$$US-SA-2024SA263383$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240914$$HP$US$US
243196521$24319652$1$I$20240101$20240826$20240914$20240914$PER$$US-SA-2024SA262262$SANOFI AVENTIS$$15$YR$T$M$Y$64.4$KG$20240914$$MD$US$US
243196531$24319653$1$I$$20240912$20240914$20240914$EXP$$US-TAKEDA-2024TUS091419$TAKEDA$$$$$M$Y$$$20240914$$MD$US$US
243196541$24319654$1$I$$20240911$20240914$20240914$PER$$US-JNJFOC-20240931225$JOHNSON AND JOHNSON$$$$$$Y$$$20240914$$CN$US$US
243196551$24319655$1$I$$20240910$20240914$20240914$EXP$$JP-AMGEN-JPNSP2024181487$AMGEN$$$$$$Y$$$20240914$$MD$JP$JP
243196582$24319658$2$F$20240905$20240912$20240914$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028294$UNITED THERAPEUTICS$$77$YR$$F$Y$94.331$KG$20240921$$$US$US
243196592$24319659$2$F$20240101$20240919$20240914$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027653$UNITED THERAPEUTICS$$$$$M$Y$92.063$KG$20240928$$$US$US
243196601$24319660$1$I$20240101$20240909$20240914$20240914$PER$$US-SA-2024SA264638$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240914$$CN$US$US
243196611$24319661$1$I$20240716$20240905$20240914$20240914$PER$$US-SA-2024SA263389$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240914$$MD$US$US
243196621$24319662$1$I$20240801$20240905$20240914$20240914$PER$$US-SA-2024SA262839$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240914$$HP$US$US
243196631$24319663$1$I$20240101$20240904$20240914$20240914$PER$$US-SA-2024SA263907$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240914$$MD$US$US
243196641$24319664$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264483$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240914$$MD$US$US
243196653$24319665$3$F$$20240917$20240914$20240919$EXP$$US-ABBVIE-5922323$ABBVIE$$$$$M$Y$105$KG$20240919$$CN$US$US
243196661$24319666$1$I$20230601$20240906$20240914$20240914$PER$$US-SA-2024SA264505$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240914$$MD$US$US
243196671$24319667$1$I$20240801$20240910$20240914$20240914$EXP$$DE-ABBVIE-5920449$ABBVIE$$28$YR$$M$Y$$$20240914$$CN$DE$DE
243196682$24319668$2$F$$20240912$20240914$20240919$PER$$US-AMGEN-USASP2024183067$AMGEN$$$$$$Y$$$20240918$$MD$US$US
243196691$24319669$1$I$$20240912$20240914$20240914$PER$$US-ROCHE-10000081284$ROCHE$$$$E$F$Y$$$20240914$$CN$US$US
243196701$24319670$1$I$20240820$20240902$20240914$20240914$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161608$JIANGSU HENGRUI MEDICINE$$75$YR$$M$Y$55$KG$20240914$$MD$CN$CN
243196711$24319671$1$I$$20240826$20240914$20240914$PER$$US-SA-2024SA262849$SANOFI AVENTIS$$$$T$F$Y$111.36$KG$20240914$$MD$US$US
243196721$24319672$1$I$$20240912$20240914$20240914$EXP$$CN-TAKEDA-2024TUS091391$TAKEDA$$$$$F$Y$$$20240914$$CN$CN$CN
243196731$24319673$1$I$$20240911$20240914$20240914$PER$$US-AMGEN-USASP2024181956$AMGEN$$65$YR$E$F$Y$$$20240914$$HP$US$US
243196741$24319674$1$I$20240101$20240907$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-028281$UNITED THERAPEUTICS$$$$$M$Y$84.807$KG$20240914$$$US$US
243196761$24319676$1$I$$20240904$20240914$20240914$PER$$US-ABBVIE-5909673$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243196771$24319677$1$I$20240911$20240911$20240914$20240914$PER$$US-AstraZeneca-2024A208098$ASTRAZENECA$$23741$DY$$F$Y$$$20240914$$CN$US$
243196781$24319678$1$I$$20240912$20240914$20240914$PER$$US-AstraZeneca-2024A209277$ASTRAZENECA$$$$$F$Y$$$20240914$$CN$US$
243196791$24319679$1$I$20240105$20240905$20240914$20240914$EXP$$BR-TAKEDA-2024TUS009529$TAKEDA$$42$YR$$M$Y$$$20240914$$CN$BR$BR
243196811$24319681$1$I$$20240826$20240914$20240914$PER$$US-ABBVIE-5923053$ABBVIE$$$$A$F$Y$$$20240914$$PH$US$US
243196821$24319682$1$I$$20240904$20240914$20240914$PER$$US-SA-2024SA263578$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240914$$HP$US$US
243196831$24319683$1$I$$20240826$20240914$20240914$PER$$US-SA-2024SA262362$SANOFI AVENTIS$$16$YR$T$M$Y$68.18$KG$20240914$$MD$US$US
243196842$24319684$2$F$$20240909$20240914$20240914$PER$$US-SA-2024SA264576$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$HP$US$US
243196851$24319685$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264504$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240914$$HP$US$US
243196861$24319686$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA264356$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240914$$HP$US$US
243196871$24319687$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264338$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240914$$HP$US$US
243196881$24319688$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA264426$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240914$$HP$US$US
243196891$24319689$1$I$20240301$20240830$20240914$20240914$PER$$US-SA-2024SA262526$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240914$$MD$US$US
243196901$24319690$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264846$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240914$$MD$US$US
243196911$24319691$1$I$20240801$20240905$20240914$20240914$PER$$US-SA-2024SA264027$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240914$$MD$US$US
243196921$24319692$1$I$$20240826$20240914$20240914$PER$$US-SA-2024SA262830$SANOFI AVENTIS$$$$E$M$Y$$$20240914$$CN$US$US
243196931$24319693$1$I$20240801$20240911$20240914$20240914$EXP$$AR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050814$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240914$$MD$AR$AR
243196964$24319696$4$F$$20240924$20240914$20240930$EXP$$PL-ROCHE-10000080880$ROCHE$$38$YR$A$F$Y$$$20240930$$MD$PL$PL
243196971$24319697$1$I$$20240911$20240914$20240914$EXP$$US-SHIRE-US201926937$TAKEDA$$$$$F$Y$$$20240914$$MD$US$US
243196991$24319699$1$I$$20240904$20240914$20240914$EXP$$CA-TAKEDA-2024TUS089179$TAKEDA$$$$$F$Y$$$20240914$$MD$CA$CA
243197001$24319700$1$I$20240901$20240911$20240914$20240914$PER$$US-ABBVIE-5922001$ABBVIE$$56$YR$$$Y$$$20240914$$HP$US$US
243197011$24319701$1$I$20240101$20240828$20240914$20240914$PER$$US-SA-2024SA264791$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240914$$MD$US$US
243197021$24319702$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264744$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240914$$MD$US$US
243197031$24319703$1$I$20240801$20240905$20240914$20240914$PER$$US-SA-2024SA263753$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240914$$HP$US$US
243197041$24319704$1$I$20230101$20240906$20240914$20240914$PER$$US-SA-2024SA264145$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240914$$MD$US$US
243197051$24319705$1$I$$20240911$20240914$20240914$EXP$$US-ABBVIE-5899747$ABBVIE$$$$$M$Y$92$KG$20240914$$CN$US$US
243197061$24319706$1$I$20200101$20240910$20240914$20240914$EXP$$US-ABBVIE-5176274$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243197071$24319707$1$I$20231219$20240905$20240914$20240914$EXP$GB-MHRA-MED-202409031803112940-JYWLM$GB-TEVA-VS-3241249$TEVA$$84$YR$$F$Y$76$KG$20240914$$MD$GB$GB
243197081$24319708$1$I$$20240906$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-024291$UNITED THERAPEUTICS$$$$$F$Y$94.785$KG$20240914$$$US$US
243197091$24319709$1$I$20240825$20240904$20240914$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027306$UNITED THERAPEUTICS$$77$YR$$F$Y$53.968$KG$20240914$$$US$US
243197101$24319710$1$I$20240827$20240906$20240914$20240914$PER$$US-ABBVIE-5917369$ABBVIE$$30$YR$$$Y$$$20240914$$HP$US$US
243197111$24319711$1$I$$20240905$20240914$20240914$EXP$GB-MHRA-MED-202409051453393970-JDWLQ$GB-TEVA-VS-3241429$TEVA$$$$$F$Y$$$20240914$$PH$GB$GB
243197121$24319712$1$I$$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183228$AMGEN$$$$$$Y$$$20240914$$HP$US$US
243197131$24319713$1$I$20240101$20240910$20240914$20240914$EXP$$US-ABBVIE-5918357$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243197141$24319714$1$I$$20240910$20240914$20240914$EXP$$CN-CHIESI-2024CHF05967$CHIESI$$$$N$M$Y$$$20240914$$MD$CN$CN
243197151$24319715$1$I$20240909$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183151$AMGEN$$52$YR$A$F$Y$$$20240914$$CN$US$US
243197161$24319716$1$I$20231001$20240905$20240914$20240914$EXP$$JP-AMGEN-HZN-2022-007617$AMGEN$$52$YR$A$F$Y$62.8$KG$20240914$$HP$JP$JP
243197171$24319717$1$I$20240812$20240820$20240914$20240914$PER$$US-SA-2024SA263090$SANOFI AVENTIS$$53$YR$A$F$Y$96.18$KG$20240914$$MD$US$US
243197181$24319718$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264771$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240914$$HP$US$US
243197191$24319719$1$I$20240901$20240905$20240914$20240914$PER$$US-SA-2024SA264849$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240914$$HP$US$US
243197201$24319720$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA263838$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$MD$US$US
243197212$24319721$2$F$20240828$20240905$20240914$20240919$PER$$US-SA-2024SA265663$SANOFI AVENTIS$$48$YR$A$F$Y$106.82$KG$20240919$$MD$US$US
243197221$24319722$1$I$$20240823$20240914$20240914$PER$$US-SA-2024SA264101$SANOFI AVENTIS$$$$T$M$Y$40.91$KG$20240914$$HP$US$US
243197231$24319723$1$I$20240101$20240910$20240914$20240914$EXP$$US-ABBVIE-5917680$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243197241$24319724$1$I$$20240912$20240914$20240914$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014963$JAZZ$$$$$M$Y$$$20240914$$CN$US$US
243197251$24319725$1$I$$20240905$20240914$20240914$PER$$US-ABBVIE-5913524$ABBVIE$$$$$$Y$$$20240914$$MD$US$US
243197261$24319726$1$I$20240601$20240826$20240914$20240914$PER$$US-SA-2024SA263082$SANOFI AVENTIS$$42$YR$A$F$Y$123.64$KG$20240914$$MD$US$US
243197272$24319727$2$F$$20240905$20240914$20240928$PER$$US-SA-2024SA265454$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240928$$MD$US$US
243197281$24319728$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA265644$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$MD$US$US
243197291$24319729$1$I$20160101$20240909$20240914$20240914$EXP$FR-AFSSAPS-TS2024000961$FR-ABBVIE-5915290$ABBVIE$$31$YR$$M$Y$87$KG$20240914$$MD$FR$FR
243197301$24319730$1$I$$20240906$20240914$20240914$EXP$$FI-TAKEDA-2024TUS090898$TAKEDA$$70$YR$$M$Y$$$20240914$$CN$FI$FI
243197311$24319731$1$I$$20240911$20240914$20240914$PER$$US-ROCHE-10000080062$ROCHE$$$$$$Y$$$20240914$$HP$US$US
243197321$24319732$1$I$20240101$20240904$20240914$20240914$EXP$$US-TEVA-VS-3240730$TEVA$$54$YR$$F$Y$$$20240914$$HP$US$US
243197331$24319733$1$I$20240617$20240906$20240914$20240914$EXP$$CN-ROCHE-10000076441$ROCHE$$49$YR$A$F$Y$65$KG$20240914$$HP$CN$CN
243197351$24319735$1$I$$20240905$20240914$20240914$PER$$US-ABBVIE-5914026$ABBVIE$$60$YR$$M$Y$$$20240914$$HP$US$US
243197361$24319736$1$I$20240909$20240910$20240914$20240914$EXP$$US-ABBVIE-5920392$ABBVIE$$70$YR$$M$Y$$$20240914$$CN$US$US
243197371$24319737$1$I$$20240911$20240914$20240914$EXP$$US-ABBVIE-5920356$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243197381$24319738$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA265829$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240914$$CN$US$US
243197391$24319739$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA264089$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240914$$HP$US$US
243197401$24319740$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA263793$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240914$$HP$US$US
243197411$24319741$1$I$$20240910$20240914$20240914$PER$$US-AMGEN-USASP2024181448$AMGEN$$$$$F$Y$$$20240914$$MD$US$US
243197421$24319742$1$I$20240801$20240910$20240914$20240914$PER$$US-ROCHE-10000078655$ROCHE$$33$YR$A$F$Y$$$20240914$$CN$US$US
243197431$24319743$1$I$$20240909$20240914$20240914$PER$$US-JNJFOC-20240924140$JOHNSON AND JOHNSON$$$$$$Y$$$20240914$$CN$US$US
243197441$24319744$1$I$20240722$20240905$20240914$20240914$EXP$$CA-CELLTRION INC.-2024CA021808$CELLTRION$$$$$$Y$$$20240914$$HP$CA$CA
243197451$24319745$1$I$20230101$20240911$20240914$20240914$EXP$$US-ABBVIE-5915715$ABBVIE$$$$$M$Y$90$KG$20240914$$CN$US$US
243197461$24319746$1$I$$20240905$20240914$20240914$PER$$US-ABBVIE-5910449$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243197472$24319747$2$F$20240912$20240912$20240914$20240923$EXP$$CA-TAKEDA-2024TUS090222$TAKEDA$$31$YR$$F$Y$$$20240923$$CN$CA$CA
243197491$24319749$1$I$$20240911$20240914$20240914$EXP$$US-AMGEN-USASP2024182821$AMGEN$$$$$F$Y$$$20240914$$HP$US$US
243197501$24319750$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA177808$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240914$$HP$US$US
243197511$24319751$1$I$$20240830$20240914$20240914$PER$$US-SA-2024SA262099$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240914$$HP$US$US
243197521$24319752$1$I$$20240903$20240914$20240914$EXP$$US-KOANAAP-SML-US-2024-00911$SHILPA MEDICARE$Palmer JP, Suriawinata AA, Yan S, Kerr DA, Afzal MZ, Shirai K. Oligometastatic MelanomaTreated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: ACase Series.. Am-J-Case-Rep. 2023 Nov 18;938537-938553. doi:10.12659/AJCR.938537.$51$YR$A$M$Y$$$20240914$$MD$US$US
243197531$24319753$1$I$$20240910$20240914$20240914$PER$$US-ROCHE-10000081181$ROCHE$$$$T$M$Y$$$20240914$$CN$US$US
243197541$24319754$1$I$$20240909$20240914$20240914$EXP$$FR-ABBVIE-5918510$ABBVIE$$85$YR$$F$Y$$$20240914$$MD$FR$FR
243197551$24319755$1$I$$20240903$20240914$20240914$EXP$$US-KOANAAP-SML-US-2024-00913$SHILPA MEDICARE$Rawish F, Nezam A. Secukinumab-Induced Bullous Pemphigoid in a Patient with Psoriatic Arthritis.. American Journal of Therapeutics. 2024 Aug;e434-e435. doi:10.1097/MJT.0000000000001642.$62$YR$A$M$Y$$$20240914$$MD$US$US
243197561$24319756$1$I$$20240903$20240914$20240914$EXP$$US-KOANAAP-SML-US-2024-00912$SHILPA MEDICARE$Mukherji S, Shoaib H, Jimenez X. Brief case report: A case of FOLFIRI-Induced psychosis.. Psycho-Oncology. 2023;1625-1627. doi:10.1002/pon.6206.$72$YR$E$M$Y$$$20240914$$MD$US$US
243197571$24319757$1$I$$20240903$20240914$20240914$EXP$$IN-KOANAAP-SML-IN-2024-00910$Unknown Manufacturer$Mahajan DS, Kalnawat NR, Paliwal V, Tongaonkar HB. Immunotherapy in Chemorefractory Endometrial Cancer: Ray of Hope. Indian Journal of Gynecologic Oncology. 2023;1-5.$52$YR$A$F$Y$$$20240914$$MD$IN$IN
243197581$24319758$1$I$$20240903$20240914$20240914$EXP$$US-KOANAAP-SML-US-2024-00916$SHILPA MEDICARE$Kinney RE, Nair S, Kim CH, Thomas MB, Torre MD. Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer. The Oncologist. 2023 Apr 07;(28): e478-e486. doi:10.1093/oncolo/oyad079.$55$YR$A$F$Y$$$20240914$$MD$US$US
243197591$24319759$1$I$$20240909$20240914$20240914$PER$$US-SA-2024SA265339$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240914$$HP$US$US
243197601$24319760$1$I$20240824$20240827$20240914$20240914$PER$$US-SA-2024SA263358$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240914$$MD$US$US
243197611$24319761$1$I$$20240822$20240914$20240914$PER$$US-SA-2024SA263807$SANOFI AVENTIS$$$$A$M$Y$88.4$KG$20240914$$MD$US$US
243197621$24319762$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA265035$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240914$$HP$US$US
243197631$24319763$1$I$20240801$20240822$20240914$20240914$PER$$US-SA-2024SA264149$SANOFI AVENTIS$$64$YR$A$F$Y$59.09$KG$20240914$$MD$US$US
243197641$24319764$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264181$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240914$$HP$US$US
243197651$24319765$1$I$$20240912$20240914$20240914$EXP$$PK-ROCHE-10000080660$ROCHE$$72$YR$E$M$Y$$$20240914$$CN$PK$PK
243197662$24319766$2$F$20240911$20240927$20240914$20240930$PER$$US-AMGEN-USASP2024182405$AMGEN$$83$YR$E$F$Y$$$20240930$$CN$US$US
243197671$24319767$1$I$20240907$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183196$AMGEN$$59$YR$A$F$Y$$$20240914$$CN$US$US
243197681$24319768$1$I$20240907$20240909$20240914$20240914$PER$$US-AMGEN-USASP2024179858$AMGEN$$66$YR$E$F$Y$$$20240914$$CN$US$US
243197691$24319769$1$I$$20240912$20240914$20240914$PER$$US-ROCHE-10000081444$ROCHE$$$$$$Y$$$20240914$$CN$US$US
243197701$24319770$1$I$20211101$20240911$20240914$20240914$EXP$$US-ABBVIE-5919954$ABBVIE$$57$YR$$M$Y$113$KG$20240914$$CN$US$US
243197711$24319771$1$I$$20240903$20240914$20240914$PER$$US-SA-2024SA265564$SANOFI AVENTIS$$56$YR$A$$Y$$$20240914$$CN$US$US
243197721$24319772$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264772$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240914$$MD$US$US
243197731$24319773$1$I$$20240904$20240914$20240914$PER$$US-SA-2024SA170138$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240914$$HP$US$US
243197741$24319774$1$I$20240830$20240905$20240914$20240914$PER$$US-SA-2024SA265300$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240914$$CN$US$US
243197752$24319775$2$F$$20240910$20240914$20240917$EXP$$TH-ROCHE-10000078019$ROCHE$$$$A$M$Y$$$20240917$$MD$TH$TH
243197761$24319776$1$I$$20240906$20240914$20240914$EXP$$CA-UNITED THERAPEUTICS-UNT-2023-012990$UNITED THERAPEUTICS$$52$YR$$F$Y$$$20240914$$$CA$CA
243197771$24319777$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA264864$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240914$$MD$US$US
243197781$24319778$1$I$$20240904$20240914$20240914$PER$$US-ABBVIE-5909312$ABBVIE$$$$$$Y$$$20240914$$CN$US$US
243197791$24319779$1$I$$20240823$20240914$20240914$PER$$US-SA-2024SA264037$SANOFI AVENTIS$$$$C$F$Y$41$KG$20240914$$MD$US$US
243197801$24319780$1$I$20240101$20240904$20240914$20240914$EXP$$US-TEVA-VS-3241427$TEVA$$75$YR$$F$Y$$$20240914$$CN$US$US
243197811$24319781$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA263869$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240914$$MD$US$US
243197821$24319782$1$I$$20240903$20240914$20240914$PER$$US-SA-2024SA264658$SANOFI AVENTIS$$63$YR$A$$Y$$$20240914$$CN$US$US
243197831$24319783$1$I$$20240910$20240914$20240914$EXP$$TH-ROCHE-10000078175$ROCHE$$$$A$M$Y$$$20240914$$MD$TH$TH
243197841$24319784$1$I$20240908$20240910$20240914$20240914$EXP$$CA-ABBVIE-5920515$ABBVIE$$68$YR$$M$Y$$$20240914$$HP$CA$CA
243197851$24319785$1$I$$20240905$20240914$20240914$EXP$$GB-CELLTRION INC.-2024GB021670$CELLTRION$$$$$$Y$$$20240914$$CN$GB$GB
243197861$24319786$1$I$20240816$20240905$20240914$20240914$PER$$US-SA-2024SA265606$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240914$$CN$US$US
243197871$24319787$1$I$$20240904$20240914$20240914$EXP$$US-GSK-US2024110251$GLAXOSMITHKLINE$$$$$F$Y$$$20240914$$CN$US$US
243197881$24319788$1$I$$20240906$20240914$20240914$EXP$$US-ROCHE-10000076506$ROCHE$$$$E$M$Y$$$20240914$$CN$US$US
243197892$24319789$2$F$20240601$20240919$20240914$20240927$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-021719$UNITED THERAPEUTICS$$7$YR$$M$Y$$$20240927$$$CA$CA
243197901$24319790$1$I$$20240903$20240914$20240914$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17666$IPSEN$$$$$F$Y$$$20240914$$HP$US$US
243197911$24319791$1$I$20240101$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183212$AMGEN$$80$YR$E$F$Y$$$20240914$$CN$US$US
243197922$24319792$2$F$20230101$20240917$20240914$20240924$EXP$$US-ROCHE-10000078789$ROCHE$$73$YR$E$M$Y$113.4$KG$20240924$$CN$US$US
243197931$24319793$1$I$$20240903$20240914$20240914$EXP$$US-KOANAAP-SML-US-2024-00917$SHILPA MEDICARE$Kinney RE, Nair S, Kim CH, Thomas MB, Torre MD. Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer. The Oncologist. 2023 Apr 07;e478-e486. doi:10.1093/oncolo/oyad079.$51$YR$A$F$Y$$$20240914$$MD$US$US
243197941$24319794$1$I$$20240910$20240914$20240914$PER$$US-AMGEN-USASP2024181524$AMGEN$$$$$$Y$$$20240914$$MD$US$US
243197951$24319795$1$I$20240908$20240912$20240914$20240914$EXP$$US-ABBVIE-5923439$ABBVIE$$91$YR$$M$Y$$$20240914$$CN$US$US
243197961$24319796$1$I$20240901$20240910$20240914$20240914$EXP$$ES-ABBVIE-5905222$ABBVIE$$61$YR$$M$Y$64$KG$20240914$$CN$ES$ES
243197971$24319797$1$I$$20240910$20240914$20240914$EXP$$US-ABBVIE-5918746$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243197981$24319798$1$I$20240904$20240910$20240914$20240914$EXP$$CA-ABBVIE-5918732$ABBVIE$$59$YR$$F$Y$$$20240914$$CN$CA$CA
243197991$24319799$1$I$$20240911$20240914$20240914$PER$$US-AMGEN-USASP2024182589$AMGEN$$$$$$Y$$$20240914$$CN$US$US
243198011$24319801$1$I$20230522$20240905$20240914$20240914$EXP$$NL-TEVA-VS-3240791$TEVA$$9$YR$$M$Y$$$20240914$$CN$NL$NL
243198021$24319802$1$I$20240101$20240906$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-028311$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240914$$$US$US
243198031$24319803$1$I$20240801$20240912$20240914$20240914$PER$$US-JNJFOC-20240933285$JOHNSON AND JOHNSON$$$$$$Y$$$20240914$$CN$US$US
243198041$24319804$1$I$$20240828$20240914$20240914$PER$$US-AstraZeneca-2024A196952$ASTRAZENECA$$$$$M$Y$$$20240914$$MD$US$
243198051$24319805$1$I$20240910$20240911$20240914$20240914$EXP$$FR-ABBVIE-5922801$ABBVIE$$59$YR$$M$Y$$$20240914$$CN$FR$FR
243198061$24319806$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA265692$SANOFI AVENTIS$$$$$F$Y$$$20240914$$CN$US$US
243198081$24319808$1$I$20240519$20240906$20240914$20240914$EXP$$US-ABBVIE-5919562$ABBVIE$$35$YR$$F$Y$99.79$KG$20240914$$CN$US$US
243198091$24319809$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264674$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240914$$HP$US$US
243198102$24319810$2$F$20240101$20240916$20240914$20240921$EXP$$US-ABBVIE-5919584$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243198111$24319811$1$I$$20240912$20240914$20240914$EXP$$IT-ROCHE-10000072740$ROCHE$Capecchi R, Linsalata G F. Drug- induced trombocytopenia and adverse reaction to rituximab: an unusual case. [Abstract: 0205]. European Journal of Case Reports in Internal Medicine. 2024-Jan;11:956. doi:10.12890/2024_V11Sup1.$66$YR$E$F$Y$$$20240914$$HP$IT$IT
243198121$24319812$1$I$$20240911$20240914$20240914$PER$$US-JNJFOC-20240931314$JOHNSON AND JOHNSON$$19$YR$A$$Y$$$20240914$$CN$US$US
243198131$24319813$1$I$20240908$20240909$20240914$20240914$PER$$US-JNJFOC-20240920460$JOHNSON AND JOHNSON$$$$$$Y$$$20240914$$CN$US$US
243198141$24319814$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA179080$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240914$$HP$US$US
243198151$24319815$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA263663$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240914$$CN$US$US
243198161$24319816$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265356$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240914$$HP$US$US
243198171$24319817$1$I$20240101$20240823$20240914$20240914$PER$$US-SA-2024SA264070$SANOFI AVENTIS$$62$YR$A$M$Y$69.09$KG$20240914$$MD$US$US
243198182$24319818$2$F$20240101$20240912$20240914$20240925$PER$$US-SA-2024SA264649$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240925$$MD$US$US
243198191$24319819$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264727$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240914$$MD$US$US
243198201$24319820$1$I$$20240822$20240914$20240914$PER$$US-SA-2024SA263898$SANOFI AVENTIS$$$$T$F$Y$40.91$KG$20240914$$MD$US$US
243198211$24319821$1$I$20240910$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183247$AMGEN$$68$YR$E$M$Y$$$20240914$$CN$US$US
243198221$24319822$1$I$$20240827$20240914$20240914$PER$$US-SA-2024SA263308$SANOFI AVENTIS$$$$E$$Y$$$20240914$$MD$US$US
243198231$24319823$1$I$$20240909$20240914$20240914$EXP$$US-ROCHE-10000072818$ROCHE$Cohen D, Ryan T, Moskovits T, Cazeau N, Newman E, Pachter H, et al. Safety and tolerability of combined gemcitabine (G) and erlotinib (E) plus sorafenib (S) in the first-line treatment of metastatic pancreatic cancer (Abstract number :e15594). Journal of Clinical Oncology. 2009-May-20; doi:10.1200/jco.2009.27.15_suppl.e15594.$$$$$Y$$$20240914$$MD$US$US
243198241$24319824$1$I$$20240904$20240914$20240914$EXP$$US-APOTEX-2024AP010314$APOTEX$Akhdar G.. MM-388 Navigating the Nexus: Lenalidomide-Associated Thrombotic Thrombocytopenic Purpura (TTP). Clinical Lymphoma, Myeloma and Leukemia. 2024;24 (Supp.1):S555-S558$56$YR$$M$Y$$$20240914$$HP$US$US
243198251$24319825$1$I$$20240905$20240914$20240914$EXP$$US-AMGEN-USASP2024179257$AMGEN$Davis A.A.; Morecroft R.; Logothetics C.N. et.al.. Chemotherapy-induced neutropenia management in a patient with metastatic breast cancer and Shwachman-Diamond syndrome (SDS): a case report. Translational Breast Cancer Research. 2024;5 (26):1-10$41$YR$A$F$Y$$$20240914$$HP$US$US
243198261$24319826$1$I$$20240822$20240914$20240914$PER$$US-SA-2024SA263818$SANOFI AVENTIS$$4$YR$C$$Y$$$20240914$$PH$US$US
243198271$24319827$1$I$20240801$20240906$20240914$20240914$PER$$US-SA-2024SA264662$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240914$$HP$US$US
243198281$24319828$1$I$20240201$20240911$20240914$20240914$PER$$US-AMGEN-USASP2024183185$AMGEN$$63$YR$A$F$Y$$$20240914$$MD$US$US
243198291$24319829$1$I$20240826$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024182867$AMGEN$$61$YR$A$M$Y$$$20240914$$CN$US$US
243198301$24319830$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264526$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240914$$HP$US$US
243198321$24319832$1$I$$20240910$20240914$20240914$PER$$US-ABBVIE-5920461$ABBVIE$$$$$$Y$$$20240914$$CN$US$US
243198331$24319833$1$I$20240710$20240912$20240914$20240914$EXP$$US-TAKEDA-2024TUS071133$TAKEDA$$11$YR$$M$Y$$$20240914$$CN$US$US
243198341$24319834$1$I$20240322$20240904$20240914$20240914$EXP$IT-MINISAL02-999566$IT-TEVA-VS-3240472$TEVA$$56$YR$$M$Y$72$KG$20240914$$CN$IT$IT
243198351$24319835$1$I$20240827$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183020$AMGEN$$61$YR$A$F$Y$$$20240914$$HP$US$US
243198361$24319836$1$I$20230112$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183207$AMGEN$$63$YR$A$M$Y$$$20240914$$CN$US$US
243198371$24319837$1$I$20231210$20240910$20240914$20240914$EXP$$US-ABBVIE-5917652$ABBVIE$$23$YR$$F$Y$$$20240914$$CN$US$US
243198381$24319838$1$I$20240101$20240905$20240914$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027990$UNITED THERAPEUTICS$$$$$F$Y$73.016$KG$20240914$$$US$US
243198392$24319839$2$F$$20240905$20240914$20240918$EXP$$US-ABBVIE-5914745$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243198401$24319840$1$I$$20240905$20240914$20240914$EXP$$GB-CELLTRION INC.-2024GB021632$CELLTRION$$$$$$Y$$$20240914$$CN$GB$GB
243198411$24319841$1$I$20240814$20240816$20240914$20240914$PER$$US-ABBVIE-5920367$ABBVIE$$18$YR$$F$Y$$$20240914$$HP$US$US
243198421$24319842$1$I$20240906$20240910$20240914$20240914$EXP$$CN-ABBVIE-5917687$ABBVIE$$43$YR$$F$Y$48$KG$20240914$$MD$CN$CN
243198431$24319843$1$I$$20240911$20240914$20240914$EXP$$JP-AstraZeneca-2024A206491$ASTRAZENECA$Shimbu K., Hisakane K., Kadoma N., Nishima S., Atsumi K., Seike M., Hirose T.. Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six- Case Series. OncoTargets and Therapy 2024;17:717-726.$62$YR$$F$Y$$$20240914$$HP$JP$
243198441$24319844$1$I$$20240910$20240914$20240914$EXP$$DK-AstraZeneca-2024A206306$ASTRAZENECA$Larsen M. L., Skouboe M. K., Mogensen T. H., Laursen A. L., Deleuran B., Troldborg A., Rasch M. N. B.. Dangers of herpesvirus infection in sle patients under anifrolumab treatment: case reports and clinical implications. American journal of case reports 2024;25(e-ISSN 1941-5923):e944505.$32$YR$$F$Y$$$20240914$$HP$DK$
243198451$24319845$1$I$20240911$20240912$20240914$20240914$EXP$$US-ABBVIE-5923461$ABBVIE$$80$YR$$F$Y$$$20240914$$CN$US$US
243198461$24319846$1$I$$20240910$20240914$20240914$EXP$$CA-ABBVIE-5919001$ABBVIE$$$$A$M$Y$$$20240914$$CN$CA$CA
243198471$24319847$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA263891$SANOFI AVENTIS$$$$C$F$Y$$$20240914$$MD$US$US
243198481$24319848$1$I$$20240830$20240914$20240914$EXP$$US-SA-2024SA231600$SANOFI AVENTIS$$$$E$F$Y$$$20240914$$MD$US$US
243198492$24319849$2$F$$20240916$20240914$20240918$PER$$US-AMGEN-USASP2024178936$AMGEN$$38$YR$A$M$Y$$$20240917$$HP$US$US
243198511$24319851$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA265607$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240914$$CN$US$US
243198521$24319852$1$I$$20240910$20240914$20240914$EXP$$PL-SANDOZ INC.-SDZ2024PL079249$SANDOZ$$31$YR$$F$Y$$$20240914$$MD$PL$PL
243198541$24319854$1$I$20240701$20240827$20240914$20240914$PER$$US-SA-2024SA263079$SANOFI AVENTIS$$57$YR$A$F$Y$48.98$KG$20240914$$MD$US$US
243198551$24319855$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264232$SANOFI AVENTIS$$9$MON$I$M$Y$$$20240914$$HP$US$US
243198561$24319856$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264056$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240914$$HP$US$US
243198571$24319857$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264677$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240914$$HP$US$US
243198591$24319859$1$I$20240801$20240906$20240914$20240914$PER$$US-SA-2024SA264510$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240914$$HP$US$US
243198601$24319860$1$I$20240801$20240906$20240914$20240914$PER$$US-SA-2024SA264517$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240914$$HP$US$US
243198611$24319861$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA265722$SANOFI AVENTIS$$$$E$M$Y$$$20240914$$CN$US$US
243198621$24319862$1$I$$20240904$20240914$20240914$EXP$$US-APOTEX-2024AP010315$APOTEX$McKnight M, Nnamani I, Volberding K, Cutshall BT, Wells DA.. Non-ST elevation myocardial ischemia in a patient on modafinil. The Nurse Practitioner. 2024;49 (8):9-12$35$YR$$M$Y$$$20240914$$PH$US$US
243198631$24319863$1$I$20240610$20240910$20240914$20240914$EXP$$US-ABBVIE-5918789$ABBVIE$$71$YR$$M$Y$$$20240914$$CN$US$US
243198641$24319864$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA263919$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240914$$MD$US$US
243198651$24319865$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA265818$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240914$$MD$US$US
243198661$24319866$1$I$20240101$20240909$20240914$20240914$PER$$US-SA-2024SA264655$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240914$$MD$US$US
243198671$24319867$1$I$20240701$20240823$20240914$20240914$PER$$US-SA-2024SA263559$SANOFI AVENTIS$$$$C$M$Y$81.09$KG$20240914$$MD$US$US
243198682$24319868$2$F$20231123$20240911$20240914$20240921$EXP$$GB-CELLTRION INC.-2024GB021784$CELLTRION$$$$$$Y$$$20240921$$MD$GB$GB
243198691$24319869$1$I$$20240904$20240914$20240914$PER$$US-RDY-SPO/USA/24/0013112$DR REDDYS$$21$YR$A$M$Y$$$20240914$$MD$US$US
243198701$24319870$1$I$$20240909$20240914$20240914$PER$$US-ROCHE-10000077869$ROCHE$$$$$$Y$$$20240914$$CN$US$US
243198711$24319871$1$I$20230101$20240905$20240914$20240914$EXP$$DE-TEVA-VS-3234724$TEVA$$64$YR$$M$Y$$$20240914$$CN$DE$DE
243198721$24319872$1$I$20240831$20240909$20240914$20240914$PER$$US-AMGEN-USASP2024181600$AMGEN$$78$YR$E$F$Y$$$20240914$$CN$US$US
243198731$24319873$1$I$20240719$20240905$20240914$20240914$EXP$$TR-TAKEDA-2024TUS091157$TAKEDA$$74$YR$$F$Y$76$KG$20240914$$MD$TR$TR
243198741$24319874$1$I$$20240911$20240914$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028938$UNITED THERAPEUTICS$$$$$M$Y$$$20240914$$MD$US$US
243198751$24319875$1$I$20240911$20240911$20240914$20240914$PER$$US-AMGEN-USASP2024181628$AMGEN$$72$YR$E$F$Y$$$20240914$$CN$US$US
243198761$24319876$1$I$20240905$20240909$20240914$20240914$PER$$US-ABBVIE-5917180$ABBVIE$$34$YR$$F$Y$$$20240914$$MD$US$US
243198771$24319877$1$I$$20240911$20240914$20240914$EXP$$GB-AstraZeneca-2024A209597$ASTRAZENECA$Grice S.;  Hammond S.;  Hampson L.;  Wagner A.;  Naisbitt D.J.. Omeprazole-Associated Atypical Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in a Patient with Positive In Vitro Diagnostic Testing to Multiple Proton Pump Inhibitors. Chemical Research in Toxicology 2024;$$$$$Y$$$20240914$$HP$GB$
243198801$24319880$1$I$$20240904$20240914$20240914$EXP$$US-APOTEX-2024AP010316$APOTEX$Fernandez JG, Farhoud M, Brake M. Coronary Artery Disease in a Young Patient Taking Modafinil. Kansas Journal of Medicine. 2014;7 (2):68-70$37$YR$$M$Y$$$20240914$$MD$US$US
243198812$24319881$2$F$$20240919$20240914$20240927$EXP$$CA-TAKEDA-2024TUS091230$TAKEDA$$35$YR$$M$Y$$$20240927$$HP$CA$CA
243198821$24319882$1$I$$20240905$20240914$20240914$EXP$$US-TEVA-VS-3242304$TEVA$$79$YR$$M$Y$$$20240914$$CN$US$US
243198831$24319883$1$I$$20240911$20240914$20240914$EXP$$JP-ROCHE-3565717$ROCHE$$80$YR$E$F$Y$$$20240914$$MD$JP$JP
243198841$24319884$1$I$$20240905$20240914$20240914$PER$$US-ABBVIE-5913939$ABBVIE$$$$$$Y$$$20240914$$CN$US$US
243198851$24319885$1$I$$20240902$20240914$20240914$EXP$$PT-Accord-445889$ACCORD$Quelhas MB, Silva DN, Bravo JB, Mozzer R, Gomes DM, Jaime LB et al. PO-0478-(4533)-ACUTE CONFUSIONAL SYNDROME AND GAIT IMBALANCE AS A PRESENTATION OF LUNG NEOPLASIA. Congresso Nacional de Medicina Interna.$68$YR$E$M$Y$$$20240914$$HP$PT$PT
243198862$24319886$2$F$20240201$20240917$20240914$20240926$EXP$$CA-CELLTRION INC.-2024CA007979$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243198871$24319887$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264684$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240914$$HP$US$US
243198882$24319888$2$F$20240101$20240918$20240914$20240930$EXP$$DE-SA-2024SA265084$SANOFI AVENTIS$$44$YR$A$M$Y$84$KG$20240929$$MD$DE$DE
243198891$24319889$1$I$20240808$20240820$20240914$20240914$PER$$US-SA-2024SA263809$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240914$$MD$US$US
243198911$24319891$1$I$20240911$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183286$AMGEN$$73$YR$E$M$Y$$$20240914$$CN$US$US
243198931$24319893$1$I$$20240909$20240914$20240914$EXP$$US-TAKEDA-2024TUS090341$TAKEDA$$$$$M$Y$$$20240914$$CN$US$US
243198941$24319894$1$I$$20240911$20240914$20240914$EXP$$SE-ROCHE-10000003684$ROCHE$$$$E$F$Y$$$20240914$$CN$SE$SE
243198961$24319896$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA263849$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240914$$MD$US$US
243198981$24319898$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265365$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240914$$HP$US$US
243198991$24319899$1$I$20240801$20240905$20240914$20240914$PER$$US-SA-2024SA263761$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$MD$US$US
243199001$24319900$1$I$$20240909$20240914$20240914$PER$$US-SA-2024SA264760$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240914$$HP$US$US
243199011$24319901$1$I$$20240911$20240914$20240914$EXP$$US-TAKEDA-2024TUS060435$TAKEDA$$$$$F$Y$$$20240914$$CN$US$US
243199021$24319902$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264989$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240914$$HP$US$US
243199031$24319903$1$I$$20240827$20240914$20240914$PER$$US-SA-2024SA263052$SANOFI AVENTIS$$$$C$M$Y$$$20240914$$MD$US$US
243199041$24319904$1$I$$20240912$20240914$20240914$PER$$US-ABBVIE-5923523$ABBVIE$$$$$F$Y$$$20240914$$MD$US$US
243199051$24319905$1$I$20210505$20240910$20240914$20240914$30DAY$$GR-SANDOZ INC.-SDZ2024GR025567$SANDOZ$$9$YR$$M$Y$$$20240914$$CN$GR$GR
243199061$24319906$1$I$20240101$20240910$20240914$20240914$PER$$US-UNITED THERAPEUTICS-UNT-2024-025764$UNITED THERAPEUTICS$$$$$F$Y$83.447$KG$20240914$$$US$US
243199081$24319908$1$I$20240906$20240906$20240914$20240914$PER$$US-SA-2024SA172586$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240914$$MD$US$US
243199091$24319909$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA265140$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240914$$HP$US$US
243199101$24319910$1$I$20190101$20240910$20240914$20240914$EXP$$US-ABBVIE-5917516$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243199111$24319911$1$I$20240401$20240904$20240914$20240914$PER$$US-SA-2024SA263901$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240914$$MD$US$US
243199121$24319912$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264599$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240914$$HP$US$US
243199131$24319913$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA264728$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240914$$HP$US$US
243199141$24319914$1$I$$20240830$20240914$20240914$PER$$US-SA-2024SA262373$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240914$$MD$US$US
243199151$24319915$1$I$20240903$20240905$20240914$20240914$PER$$US-SA-2024SA265246$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240914$$HP$US$US
243199161$24319916$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA167947$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240914$$HP$US$US
243199171$24319917$1$I$20240703$20240905$20240914$20240914$PER$$US-SA-2024SA263881$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240914$$MD$US$US
243199181$24319918$1$I$20240905$20240906$20240914$20240914$PER$$US-SA-2024SA264544$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240914$$MD$US$US
243199191$24319919$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA263976$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240914$$MD$US$US
243199201$24319920$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264496$SANOFI AVENTIS$$$$A$M$Y$$$20240914$$MD$US$US
243199212$24319921$2$F$20240820$20240911$20240914$20240919$EXP$$IN-ROCHE-10000078978$ROCHE$$65$YR$E$M$Y$84$KG$20240919$$CN$IN$IN
243199221$24319922$1$I$$20240904$20240914$20240914$PER$$US-RDY-SPO/USA/24/0013115$DR REDDYS$$14$YR$T$M$Y$$$20240914$$MD$US$US
243199231$24319923$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264159$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240914$$HP$US$US
243199241$24319924$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA264562$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240914$$HP$US$US
243199251$24319925$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA264475$SANOFI AVENTIS$$$$A$M$Y$$$20240914$$HP$US$US
243199261$24319926$1$I$20240902$20240904$20240914$20240914$PER$$US-RDY-SPO/USA/24/0013102$DR REDDYS$$15$YR$T$F$Y$$$20240914$$CN$US$US
243199271$24319927$1$I$20240801$20240906$20240914$20240914$PER$$US-SA-2024SA263897$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240914$$MD$US$US
243199281$24319928$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264047$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240914$$MD$US$US
243199291$24319929$1$I$20240905$20240905$20240914$20240914$PER$$US-SA-2024SA265568$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240914$$CN$US$US
243199301$24319930$1$I$20240905$20240905$20240914$20240914$PER$$US-RDY-SPO/USA/24/0013085$DR REDDYS$$67$YR$E$M$Y$$$20240914$$CN$US$US
243199311$24319931$1$I$20240608$20240910$20240914$20240914$EXP$$AU-ROCHE-10000015349$ROCHE$$89$YR$E$F$Y$$$20240914$$MD$AU$AU
243199321$24319932$1$I$20240822$20240830$20240914$20240914$PER$$US-SA-2024SA262492$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240914$$MD$US$US
243199331$24319933$1$I$20220101$20240906$20240914$20240914$PER$$US-SA-2024SA265182$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240914$$HP$US$US
243199341$24319934$1$I$20240101$20240909$20240914$20240914$PER$$US-SA-2024SA264755$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240914$$HP$US$US
243199361$24319936$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA265363$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240914$$MD$US$US
243199371$24319937$1$I$$20240905$20240914$20240914$PER$$US-TEVA-VS-3242348$TEVA$$$$A$M$Y$$$20240914$$MD$US$US
243199381$24319938$1$I$$20240904$20240914$20240914$PER$$US-RDY-SPO/USA/24/0013025$DR REDDYS$$73$YR$E$F$Y$98$KG$20240914$$CN$US$US
243199391$24319939$1$I$20240101$20240909$20240914$20240914$EXP$$US-AMGEN-USASP2024179637$AMGEN$$74$YR$E$F$Y$$$20240914$$CN$US$US
243199401$24319940$1$I$$20240909$20240914$20240914$PER$$US-AstraZeneca-2024A205557$ASTRAZENECA$$63$YR$$$Y$$$20240914$$CN$US$
243199411$24319941$1$I$20240903$20240904$20240914$20240914$PER$$US-ABBVIE-5909676$ABBVIE$$29$YR$$F$Y$$$20240914$$CN$US$US
243199421$24319942$1$I$20240909$20240909$20240914$20240914$PER$$US-ELI_LILLY_AND_COMPANY-US202409005543$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240914$$CN$US$US
243199431$24319943$1$I$$20240906$20240914$20240914$PER$$US-AstraZeneca-2024A204044$ASTRAZENECA$$$$$M$Y$$$20240914$$HP$US$
243199441$24319944$1$I$$20240911$20240914$20240914$EXP$$US-AMGEN-USASP2024182013$AMGEN$$$$$$Y$$$20240914$$HP$US$US
243199451$24319945$1$I$$20240909$20240914$20240914$EXP$$US-AMGEN-USASP2024181989$AMGEN$$$$$F$Y$$$20240914$$MD$US$US
243199461$24319946$1$I$20240904$20240904$20240914$20240914$PER$$US-SA-2024SA264572$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240914$$HP$US$US
243199471$24319947$1$I$20240801$20240905$20240914$20240914$PER$$US-SA-2024SA264690$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240914$$HP$US$US
243199511$24319951$1$I$$20240913$20240914$20240914$PER$$US-AMGEN-USASP2024183835$AMGEN$$$$$F$Y$$$20240914$$MD$US$US
243199521$24319952$1$I$$20240904$20240914$20240914$EXP$$US-ABBVIE-5908685$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243199541$24319954$1$I$$20240812$20240914$20240914$EXP$$NL-TEVA-VS-3243096$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$25$YR$$M$Y$$$20240914$$HP$NL$NL
243199551$24319955$1$I$$20240903$20240914$20240914$EXP$$US-KOANAAP-SML-US-2024-00918$SHILPA MEDICARE$Michelle D H, Jordan L P, Peter S C, Passant M, Yuna G, Vidyadhari K. Unresectable Metastatic Solid Pseudopapillary Pancreatic Neoplasm Treated with Liver Transplantation. ACG Case Reports Journal. 2024;8(11): e01432. doi:10.14309/crj.0000000000001432.$49$YR$A$F$Y$$$20240914$$MD$US$US
243199561$24319956$1$I$20240903$20240905$20240914$20240914$PER$$US-ABBVIE-5910358$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243199571$24319957$1$I$$20240812$20240914$20240914$EXP$$NL-TEVA-VS-3243206$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$43$YR$$M$Y$$$20240914$$HP$NL$NL
243199581$24319958$1$I$20231214$20240909$20240914$20240914$EXP$$US-ABBVIE-5916379$ABBVIE$$68$YR$$F$Y$76$KG$20240914$$HP$US$US
243199641$24319964$1$I$20240730$20240821$20240914$20240914$PER$$US-SA-2024SA264172$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240914$$MD$US$US
243199651$24319965$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264645$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240914$$HP$US$US
243199661$24319966$1$I$$20240912$20240914$20240914$PER$$US-BAYER-2024A130792$BAYER$$$$$F$Y$$$20240914$$CN$US$US
243199671$24319967$1$I$20240912$20240912$20240914$20240914$PER$$US-BAYER-2024A130873$BAYER$$$$$$Y$$$20240914$$CN$US$US
243199701$24319970$1$I$$20240912$20240914$20240914$PER$$US-ABBVIE-5923817$ABBVIE$$$$$$Y$$$20240914$$MD$US$US
243199711$24319971$1$I$$20240903$20240914$20240914$EXP$$US-KOANAAP-SML-US-2024-00919$SHILPA MEDICARE$Jones H, Bhakta A, Jia L, Wojciechowski D, Torrealba J. An Unusual Presentation of Metastatic BK Virus-Associated Urothelial Carcinoma Arising in the Allograft, Persisting After Transplant Nephrectomy. International Journal of Surgical Pathology. 2023;31(8): 1586-1592. doi:10.1177/10668969231160258.$32$YR$A$M$Y$$$20240914$$MD$US$US
243199721$24319972$1$I$$20240912$20240914$20240914$PER$$US-BAYER-2024A130879$BAYER$$$$$$Y$$$20240914$$CN$US$US
243199731$24319973$1$I$$20240911$20240914$20240914$PER$$US-BAYER-2024A131025$BAYER$$$$$$Y$$$20240914$$CN$US$US
243199741$24319974$1$I$20240101$20240823$20240914$20240914$PER$$US-009507513-2408USA009093$MERCK$$$$$M$Y$73.5$KG$20240914$$HP$US$US
243199791$24319979$1$I$20240901$20240909$20240914$20240914$PER$$US-SA-2024SA265227$SANOFI AVENTIS$$10$MON$I$F$Y$$$20240914$$HP$US$US
243199801$24319980$1$I$20240912$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183293$AMGEN$$64$YR$A$F$Y$$$20240914$$CN$US$US
243199811$24319981$1$I$20240829$20240906$20240914$20240914$PER$$US-SA-2024SA264545$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240914$$HP$US$US
243199821$24319982$1$I$20180101$20240910$20240914$20240914$EXP$$US-TAKEDA-2024TUS090408$TAKEDA$$$$$F$Y$$$20240914$$CN$US$US
243199831$24319983$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA265542$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240914$$HP$US$US
243199842$24319984$2$F$20240101$20240910$20240914$20240918$PER$$US-AMGEN-USASP2024180997$AMGEN$$75$YR$E$F$Y$$$20240918$$CN$US$US
243199851$24319985$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA264535$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240914$$HP$US$US
243199861$24319986$1$I$20240101$20240909$20240914$20240914$PER$$US-SA-2024SA264795$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240914$$HP$US$US
243199871$24319987$1$I$20240801$20240905$20240914$20240914$PER$$US-SA-2024SA264808$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240914$$HP$US$US
243199882$24319988$2$F$20240101$20240905$20240914$20240919$PER$$US-SA-2024SA265610$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240919$$MD$US$US
243199891$24319989$1$I$20240801$20240905$20240914$20240914$PER$$US-SA-2024SA262248$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240914$$MD$US$US
243199901$24319990$1$I$$20240826$20240914$20240914$PER$$US-SA-2024SA262318$SANOFI AVENTIS$$$$A$M$Y$147$KG$20240914$$MD$US$US
243199911$24319991$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA265400$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240914$$MD$US$US
243199921$24319992$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265406$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240914$$HP$US$US
243199941$24319994$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265013$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240914$$HP$US$US
243199951$24319995$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264998$SANOFI AVENTIS$$$$C$F$Y$$$20240914$$HP$US$US
243199961$24319996$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA265557$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240914$$MD$US$US
243200021$24320002$1$I$$20240910$20240914$20240914$PER$$US-ABBVIE-5920284$ABBVIE$$$$$$Y$$$20240914$$HP$US$US
243200032$24320003$2$F$20240824$20240916$20240914$20240917$PER$$US-AMGEN-USASP2024183992$AMGEN$$76$YR$E$F$Y$$$20240917$$CN$US$US
243200041$24320004$1$I$$20240812$20240914$20240914$EXP$$NL-TEVA-VS-3243140$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$40$YR$$M$Y$$$20240914$$HP$NL$NL
243200051$24320005$1$I$$20240911$20240914$20240914$EXP$$FR-AstraZeneca-2024A208850$ASTRAZENECA$$70$YR$$M$Y$$$20240914$$MD$FR$
243200061$24320006$1$I$$20240812$20240914$20240914$EXP$$NL-TEVA-VS-3243045$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$47$YR$$M$Y$$$20240914$$HP$NL$NL
243200071$24320007$1$I$20240819$20240905$20240914$20240914$EXP$$US-TEVA-VS-3242463$TEVA$$16$YR$$M$Y$93.6$KG$20240914$$HP$US$US
243200082$24320008$2$F$20240905$20240911$20240914$20240918$PER$$US-AMGEN-USASP2024182257$AMGEN$$80$YR$E$F$Y$$$20240917$$HP$US$US
243200091$24320009$1$I$$20240909$20240914$20240914$EXP$$US-TAKEDA-2024TUS089984$TAKEDA$$$$$M$Y$$$20240914$$MD$US$US
243200103$24320010$3$F$20240101$20240920$20240914$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-028162$UNITED THERAPEUTICS$$$$$F$Y$50.34$KG$20240928$$$US$US
243200131$24320013$1$I$$20240812$20240914$20240914$EXP$$NL-TEVA-VS-3243155$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$45$YR$$M$Y$$$20240914$$HP$NL$NL
243200151$24320015$1$I$$20240909$20240914$20240914$EXP$$US-TAKEDA-2024TUS080968$TAKEDA$$$$$F$Y$$$20240914$$CN$US$US
243200161$24320016$1$I$20230101$20240906$20240914$20240914$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-002168$UNITED THERAPEUTICS$$27$YR$$F$Y$$$20240914$$$JP$JP
243200171$24320017$1$I$$20240911$20240914$20240914$PER$$US-ELI_LILLY_AND_COMPANY-US202409007275$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240914$$HP$US$US
243200181$24320018$1$I$20240830$20240830$20240914$20240914$PER$$US-009507513-2409USA000423$MERCK$$$$$M$Y$$$20240914$$CN$US$US
243200191$24320019$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264551$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240914$$HP$US$US
243200201$24320020$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264652$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240914$$HP$US$US
243200211$24320021$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265402$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240914$$HP$US$US
243200221$24320022$1$I$20240903$20240904$20240914$20240914$PER$$US-SA-2024SA263913$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240914$$HP$US$US
243200231$24320023$1$I$$20240826$20240914$20240914$PER$$US-SA-2024SA113772$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240914$$HP$US$US
243200241$24320024$1$I$20240701$20240905$20240914$20240914$PER$$US-SA-2024SA262261$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240914$$MD$US$US
243200252$24320025$2$F$20240911$20240924$20240914$20240926$PER$$US-AMGEN-USASP2024182989$AMGEN$$78$YR$E$M$Y$$$20240926$$PH$US$US
243200261$24320026$1$I$20240819$20240906$20240914$20240914$EXP$$CN-SA-2024SA263145$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240914$$HP$CN$CN
243200271$24320027$1$I$20220101$20240907$20240914$20240914$PER$$US-JNJFOC-20240919737$JOHNSON AND JOHNSON$$$$$$Y$$$20240914$$CN$US$US
243200281$24320028$1$I$20240801$20240906$20240914$20240914$PER$$US-SA-2024SA265018$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240914$$HP$US$US
243200291$24320029$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265028$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240914$$HP$US$US
243200301$24320030$1$I$20240903$20240906$20240914$20240914$PER$$US-SA-2024SA264619$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240914$$HP$US$US
243200321$24320032$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265487$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240914$$MD$US$US
243200331$24320033$1$I$$20240905$20240914$20240914$PER$$US-ABBVIE-5914356$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243200341$24320034$1$I$$20240909$20240914$20240914$EXP$$ZA-AstraZeneca-2024A205425$ASTRAZENECA$$64$YR$$F$Y$$$20240914$$CN$ZA$
243200351$24320035$1$I$$20240911$20240914$20240914$PER$$US-ELI_LILLY_AND_COMPANY-US202409007344$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240914$$CN$US$US
243200361$24320036$1$I$$20240909$20240914$20240914$PER$$US-SA-2024SA265213$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240914$$MD$US$US
243200371$24320037$1$I$$20240903$20240914$20240914$PER$$US-SA-2024SA264061$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$HP$US$US
243200381$24320038$1$I$20240726$20240903$20240914$20240914$PER$$US-SA-2024SA264258$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240914$$HP$US$US
243200391$24320039$1$I$$20240903$20240914$20240914$PER$$US-SA-2024SA263990$SANOFI AVENTIS$$$$$F$Y$$$20240914$$CN$US$US
243200401$24320040$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA264584$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240914$$HP$US$US
243200411$24320041$1$I$20240523$20240905$20240914$20240914$PER$$US-SA-2024SA265541$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240914$$MD$US$US
243200441$24320044$1$I$20240912$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183193$AMGEN$$59$YR$A$M$Y$$$20240914$$CN$US$US
243200451$24320045$1$I$20240912$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024182596$AMGEN$$57$YR$A$M$Y$$$20240914$$CN$US$US
243200461$24320046$1$I$20230901$20240907$20240914$20240914$EXP$$CA-TAKEDA-2023TUS079523$TAKEDA$$32$YR$$F$Y$80$KG$20240914$$CN$CA$CA
243200471$24320047$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264127$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240914$$HP$US$US
243200501$24320050$1$I$20240910$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183276$AMGEN$$71$YR$E$F$Y$$$20240914$$CN$US$US
243200513$24320051$3$F$$20240918$20240914$20240920$PER$$US-AMGEN-USASP2024183997$AMGEN$$$$$F$Y$$$20240919$$CN$US$US
243200521$24320052$1$I$20240823$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183328$AMGEN$$87$YR$E$F$Y$$$20240914$$CN$US$US
243200531$24320053$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA265476$SANOFI AVENTIS$$$$$$Y$$$20240914$$MD$US$US
243200541$24320054$1$I$$20240910$20240914$20240914$EXP$$US-ABBVIE-5917911$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243200551$24320055$1$I$20240911$20240911$20240914$20240914$PER$$US-AMGEN-USASP2024182042$AMGEN$$58$YR$A$F$Y$$$20240914$$CN$US$US
243200563$24320056$3$F$20240912$20240920$20240914$20240923$PER$$US-AMGEN-USASP2024183637$AMGEN$$86$YR$E$M$Y$$$20240923$$CN$US$US
243200571$24320057$1$I$$20240906$20240914$20240914$PER$$US-AMGEN-USASP2024179860$AMGEN$$60$YR$A$F$Y$$$20240914$$PH$US$US
243200581$24320058$1$I$20240826$20240905$20240914$20240914$EXP$$US-ABBVIE-5910379$ABBVIE$$67$YR$$F$Y$$$20240914$$CN$US$US
243200591$24320059$1$I$$20240904$20240914$20240914$PER$$US-ABBVIE-5910409$ABBVIE$$$$$$Y$$$20240914$$HP$US$US
243200601$24320060$1$I$$20240908$20240914$20240914$EXP$$BE-JNJFOC-20240930698$JOHNSON AND JOHNSON$$$$I$$Y$$$20240914$$HP$BE$BE
243200611$24320061$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA265352$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240914$$HP$US$US
243200621$24320062$1$I$20240829$20240905$20240914$20240914$PER$$US-SA-2024SA265405$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240914$$HP$US$US
243200631$24320063$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA265299$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240914$$HP$US$US
243200641$24320064$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264345$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240914$$HP$US$US
243200671$24320067$1$I$20240608$20240905$20240914$20240914$PER$$US-SA-2024SA265657$SANOFI AVENTIS$$$$A$M$Y$$$20240914$$CN$US$US
243200681$24320068$1$I$20240601$20240910$20240914$20240914$EXP$$US-ABBVIE-5917802$ABBVIE$$82$YR$$F$Y$$$20240914$$CN$US$US
243200691$24320069$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA265388$SANOFI AVENTIS$$$$$F$Y$$$20240914$$MD$US$US
243200712$24320071$2$F$20240710$20240905$20240914$20240924$PER$$US-SA-2024SA265434$SANOFI AVENTIS$$$$$$Y$$$20240924$$CN$US$US
243200721$24320072$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA265438$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240914$$CN$US$US
243200732$24320073$2$F$20240904$20240909$20240914$20240923$PER$$US-SA-2024SA265469$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240923$$CN$US$US
243200741$24320074$1$I$20240905$20240909$20240914$20240914$PER$$US-SA-2024SA265212$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240914$$HP$US$US
243200761$24320076$1$I$20240529$20240910$20240914$20240914$EXP$$US-ABBVIE-5918151$ABBVIE$$65$YR$$M$Y$$$20240914$$CN$US$US
243200771$24320077$1$I$$20240911$20240914$20240914$EXP$$ZA-ABBVIE-5923421$ABBVIE$$$$$M$Y$$$20240914$$CN$ZA$ZA
243200781$24320078$1$I$$20240910$20240914$20240914$PER$$US-ALXN-202409USA000684US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240914$$MD$US$US
243200791$24320079$1$I$20240901$20240912$20240914$20240914$EXP$$AU-ABBVIE-5922747$ABBVIE$$86$YR$$M$Y$$$20240914$$CN$AU$AU
243200801$24320080$1$I$20240101$20240827$20240914$20240914$PER$$US-009507513-2408USA009679$MERCK$$$$$M$Y$$$20240914$$PH$US$US
243200812$24320081$2$F$20240912$20240916$20240914$20240917$PER$$US-AMGEN-USASP2024183979$AMGEN$$65$YR$E$M$Y$$$20240917$$CN$US$US
243200821$24320082$1$I$$20240909$20240914$20240914$PER$$US-AMGEN-USASP2024179880$AMGEN$$$$E$F$Y$$$20240914$$CN$US$US
243200831$24320083$1$I$20240626$20240905$20240914$20240914$PER$$US-SA-2024SA265499$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240914$$CN$US$US
243200841$24320084$1$I$20240101$20240909$20240914$20240914$PER$$US-SA-2024SA264104$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240914$$MD$US$US
243200851$24320085$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA263867$SANOFI AVENTIS$$$$E$M$Y$$$20240914$$MD$US$US
243200861$24320086$1$I$20240101$20240905$20240914$20240914$PER$$US-SA-2024SA264787$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240914$$HP$US$US
243200881$24320088$1$I$$20240913$20240914$20240914$EXP$$US-ABBVIE-5923475$ABBVIE$$$$$M$Y$$$20240914$$HP$US$US
243200891$24320089$1$I$$20240905$20240914$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028394$UNITED THERAPEUTICS$$$$$F$Y$66.667$KG$20240914$$$US$US
243200911$24320091$1$I$20240819$20240903$20240914$20240914$PER$$US-JNJFOC-20240909662$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240914$$CN$US$US
243200921$24320092$1$I$20240301$20240826$20240914$20240914$PER$$US-TEVA-VS-3238124$TEVA$$65$YR$$F$Y$$$20240914$$CN$US$US
243200931$24320093$1$I$20240910$20240911$20240914$20240914$EXP$$CN-ABBVIE-5919829$ABBVIE$$61$YR$$F$Y$69$KG$20240914$$MD$CN$CN
243200941$24320094$1$I$$20240905$20240914$20240914$EXP$$US-TEVA-VS-3242484$TEVA$$63$YR$$F$Y$$$20240914$$HP$US$US
243200951$24320095$1$I$20240909$20240911$20240914$20240914$EXP$$CA-ABBVIE-5923452$ABBVIE$$68$YR$$M$Y$$$20240914$$CN$CA$CA
243200962$24320096$2$F$$20240909$20240914$20240926$EXP$$JP-009507513-2409JPN001423J$MERCK$Yoshihara K, Nakamoto K, Shibamura N, Noda N, Nishimoto Y, Ohara R, et al.. 153 Two cases of gastrointestinal perforation during combination drug therapy with lenvatinib and pembrolizumab. Modern trends in obstetrics + gynecology The 76th Annual Meeting and Academic Sy. 2024;73(S):S69$69$YR$$F$Y$$$20240926$$HP$JP$JP
243200971$24320097$1$I$$20240911$20240914$20240914$EXP$$US-ABBVIE-5919968$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243200982$24320098$2$F$$20240916$20240914$20240917$PER$$US-AMGEN-USASP2024183976$AMGEN$$$$$$Y$$$20240917$$CN$US$US
243200992$24320099$2$F$20240903$20240906$20240914$20240919$PER$$US-SA-2024SA265508$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240919$$MD$US$US
243201001$24320100$1$I$20240801$20240906$20240914$20240914$PER$$US-SA-2024SA265282$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240914$$HP$US$US
243201011$24320101$1$I$20240101$20240904$20240914$20240914$PER$$US-SA-2024SA263132$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240914$$HP$US$US
243201021$24320102$1$I$20240731$20240909$20240914$20240914$PER$$US-SA-2024SA264335$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240914$$MD$US$US
243201031$24320103$1$I$20240904$20240913$20240914$20240914$PER$$US-AMGEN-USASP2024182970$AMGEN$$53$YR$A$F$Y$$$20240914$$CN$US$US
243201041$24320104$1$I$20240801$20240911$20240914$20240914$EXP$FI-FIMEA-202403085$FI-TAKEDA-2024TUS091445$TAKEDA$$43$YR$$F$Y$$$20240914$$HP$FI$FI
243201051$24320105$1$I$20240910$20240911$20240914$20240914$PER$$US-ELI_LILLY_AND_COMPANY-US202409007430$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240914$$CN$US$US
243201061$24320106$1$I$$20240830$20240914$20240914$PER$$US-SA-2024SA261402$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$HP$US$US
243201071$24320107$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA265497$SANOFI AVENTIS$$$$$M$Y$$$20240914$$HP$US$US
243201081$24320108$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA265528$SANOFI AVENTIS$$$$$F$Y$$$20240914$$CN$US$US
243201091$24320109$1$I$20240801$20240906$20240914$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028494$UNITED THERAPEUTICS$$82$YR$$F$Y$59.864$KG$20240914$$$US$US
243201121$24320112$1$I$20240720$20240903$20240914$20240914$EXP$$HU-UCBSA-2024043949$UCB$$73$YR$$F$Y$$$20240914$$HP$HU$HU
243201131$24320113$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265268$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240914$$HP$US$US
243201151$24320115$1$I$$20240906$20240914$20240914$EXP$$HU-TAKEDA-2024TUS090655$TAKEDA$$$$$$Y$$$20240914$$CN$HU$HU
243201171$24320117$1$I$$20240905$20240914$20240914$PER$$US-ABBVIE-5909854$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243201181$24320118$1$I$20240101$20240905$20240914$20240914$EXP$$US-TEVA-VS-3241993$TEVA$$77$YR$$F$Y$$$20240914$$CN$US$US
243201191$24320119$1$I$$20240904$20240914$20240914$PER$$US-JNJFOC-20240911286$JOHNSON AND JOHNSON$$$$$F$Y$$$20240914$$CN$US$US
243201203$24320120$3$F$20240912$20240917$20240914$20240921$PER$$US-AMGEN-USASP2024183900$AMGEN$$84$YR$E$F$Y$$$20240920$$CN$US$US
243201231$24320123$1$I$$20240913$20240914$20240914$PER$$US-AMGEN-USASP2024183901$AMGEN$$$$$F$Y$$$20240914$$PH$US$US
243201241$24320124$1$I$20240910$20240910$20240914$20240914$EXP$$JP-AMGEN-JPNSP2024182265$AMGEN$$$$$M$Y$$$20240914$$HP$JP$JP
243201251$24320125$1$I$$20240905$20240914$20240914$EXP$$US-AMGEN-USASP2024179343$AMGEN$Thayer E.G.; Weirich M.L.; Roecker Z.A. et.al.. Induction chemotherapy with cemiplimab in a patient with coexistent vulvar cancer and autoimmune disease: A case report. Gynecologic Oncology Reports. 2024;55:1-3$61$YR$A$F$Y$$$20240914$$HP$US$US
243201271$24320127$1$I$$20240904$20240914$20240914$PER$$US-JNJFOC-20240911171$JOHNSON AND JOHNSON$$$$$M$Y$$$20240914$$CN$US$US
243201281$24320128$1$I$$20240912$20240914$20240914$PER$$US-ABBVIE-5923988$ABBVIE$$$$$F$Y$$$20240914$$MD$US$US
243201291$24320129$1$I$20240101$20240909$20240914$20240914$PER$$US-SA-2024SA264488$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240914$$MD$US$US
243201301$24320130$1$I$$20240909$20240914$20240914$EXP$$JP-009507513-2409JPN001675J$MERCK$$6$DEC$$F$Y$$$20240914$$MD$JP$JP
243201311$24320131$1$I$20240608$20240909$20240914$20240914$EXP$$JP-AMGEN-JPNSP2024178368$AMGEN$$65$YR$E$M$Y$78$KG$20240914$$PH$JP$JP
243201321$24320132$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265150$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$MD$US$US
243201333$24320133$3$F$$20240917$20240914$20240918$PER$$US-AMGEN-USASP2024182719$AMGEN$$$$$M$Y$$$20240918$$PH$US$US
243201352$24320135$2$F$20240911$20240918$20240914$20240920$PER$$US-AMGEN-USASP2024183324$AMGEN$$46$YR$A$F$Y$$$20240920$$CN$US$US
243201361$24320136$1$I$$20240830$20240914$20240914$PER$$US-SA-2024SA261028$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240914$$HP$US$US
243201371$24320137$1$I$$20240903$20240914$20240914$PER$$US-SA-2024SA262341$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240914$$HP$US$US
243201381$24320138$1$I$20240101$20240904$20240914$20240914$PER$$US-SA-2024SA263215$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240914$$HP$US$US
243201391$24320139$1$I$$20240909$20240914$20240914$EXP$$CA-TAKEDA-2024TUS090344$TAKEDA$$$$$F$Y$$$20240914$$CN$CA$CA
243201401$24320140$1$I$$20240812$20240914$20240914$EXP$$NL-TEVA-VS-3243170$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$38$YR$$M$Y$$$20240914$$HP$NL$NL
243201411$24320141$1$I$$20240812$20240914$20240914$EXP$$NL-TEVA-VS-3243186$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$49$YR$$M$Y$$$20240914$$HP$NL$NL
243201421$24320142$1$I$$20240909$20240914$20240914$EXP$$CA-TAKEDA-2024TUS090287$TAKEDA$$$$$F$Y$$$20240914$$MD$CA$CA
243201431$24320143$1$I$$20240913$20240914$20240914$PER$$US-ALXN-202409USA001055US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240914$$CN$US$US
243201441$24320144$1$I$$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024182959$AMGEN$$$$$F$Y$$$20240914$$CN$US$US
243201451$24320145$1$I$$20240911$20240914$20240914$PER$$US-AMGEN-USASP2024181601$AMGEN$$$$$M$Y$$$20240914$$CN$US$US
243201461$24320146$1$I$$20240906$20240914$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-020863$UNITED THERAPEUTICS$$$$$M$Y$90.703$KG$20240914$$$US$US
243201482$24320148$2$F$20240913$20240916$20240914$20240917$PER$$US-AMGEN-USASP2024183527$AMGEN$$82$YR$E$F$Y$$$20240916$$CN$US$US
243201491$24320149$1$I$20240912$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024182823$AMGEN$$71$YR$E$F$Y$78$KG$20240914$$PH$US$US
243201501$24320150$1$I$$20240822$20240914$20240914$PER$$US-SA-2024SA262276$SANOFI AVENTIS$$$$$M$Y$$$20240914$$MD$US$US
243201541$24320154$1$I$$20240902$20240914$20240914$PER$$US-SA-2024SA263760$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240914$$HP$US$US
243201551$24320155$1$I$20240801$20240906$20240914$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026240$UNITED THERAPEUTICS$$73$YR$$F$Y$$$20240914$$$US$US
243201562$24320156$2$F$20240912$20240913$20240914$20240914$PER$$US-AMGEN-USASP2024183370$AMGEN$$74$YR$E$M$Y$$$20240914$$CN$US$US
243201571$24320157$1$I$20240101$20240910$20240914$20240914$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028764$UNITED THERAPEUTICS$$$$$M$Y$70.295$KG$20240914$$$US$US
243201621$24320162$1$I$20240101$20240904$20240914$20240914$PER$$US-SA-2024SA263221$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240914$$HP$US$US
243201631$24320163$1$I$20240816$20240820$20240914$20240914$PER$$US-009507513-2408USA007090$MERCK$$81$YR$$M$Y$$$20240914$$CN$US$US
243201641$24320164$1$I$$20240904$20240914$20240914$EXP$GB-MHRA-MED-202409041405391010-BPMQY$GB-UCBSA-2024045423$UCB$$73$YR$$F$Y$52$KG$20240914$$CN$GB$GB
243201661$24320166$1$I$$20240912$20240914$20240914$EXP$$US-ABBVIE-5922057$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243201681$24320168$1$I$20240701$20240906$20240914$20240914$PER$$US-SA-2024SA265162$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240914$$MD$US$US
243201691$24320169$1$I$20240101$20240903$20240914$20240914$PER$$US-SA-2024SA262339$SANOFI AVENTIS$$$$A$F$Y$$$20240914$$HP$US$US
243201701$24320170$1$I$$20240830$20240914$20240914$PER$$US-SA-2024SA260184$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240914$$CN$US$US
243201711$24320171$1$I$20240101$20240901$20240914$20240914$PER$$US-SA-2024SA262507$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240914$$HP$US$US
243201721$24320172$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265158$SANOFI AVENTIS$$$$A$M$Y$$$20240914$$HP$US$US
243201731$24320173$1$I$$20240906$20240914$20240914$EXP$$CN-TAKEDA-2024TUS085429$TAKEDA$$$$$$Y$$$20240914$$HP$CN$CN
243201741$24320174$1$I$20240907$20240910$20240914$20240914$EXP$$US-TAKEDA-2024TUS086536$TAKEDA$$36$YR$$M$Y$$$20240914$$CN$US$US
243201751$24320175$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265258$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240914$$HP$US$US
243201761$24320176$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264391$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240914$$CN$US$US
243201811$24320181$1$I$20210915$20240906$20240914$20240914$EXP$$CA-TAKEDA-2024TUS089857$TAKEDA$$39$YR$$M$Y$$$20240914$$CN$CA$CA
243201821$24320182$1$I$$20240913$20240914$20240914$PER$$US-ALXN-202409USA001044US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240914$$CN$US$US
243201831$24320183$1$I$$20240906$20240914$20240914$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-028326$UNITED THERAPEUTICS$$85$YR$$F$Y$$$20240914$$PH$JP$JP
243201841$24320184$1$I$20240101$20240830$20240914$20240914$EXP$$US-UCBSA-2024039163$UCB$$$$$M$Y$$$20240914$$CN$US$US
243201851$24320185$1$I$$20240812$20240914$20240914$EXP$$NL-TEVA-VS-3243224$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$50$YR$$M$Y$$$20240914$$HP$NL$NL
243201861$24320186$1$I$$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024182978$AMGEN$$$$$$Y$$$20240914$$PH$US$US
243201871$24320187$1$I$$20240812$20240914$20240914$EXP$$NL-TEVA-VS-3243238$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$22$YR$$M$Y$$$20240914$$HP$NL$NL
243201901$24320190$1$I$$20240812$20240914$20240914$EXP$$NL-TEVA-VS-3243255$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$42$YR$$M$Y$$$20240914$$HP$NL$NL
243201921$24320192$1$I$$20240906$20240914$20240914$PER$$IT-IGSA-BIG0029802$GRIFOLS$$$$$F$Y$$$20240914$$HP$IT$IT
243201931$24320193$1$I$$20240812$20240914$20240914$EXP$$NL-TEVA-VS-3243276$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$45$YR$$M$Y$$$20240914$$HP$NL$NL
243201941$24320194$1$I$$20240906$20240914$20240914$EXP$$AU-SCIEGENP-2024SCLIT00365$SCIEGEN$Xian et al..Hyperacute in-Stent Thrombosis Causing Large Vessel Occlusion after Stent-Assisted Aneurysm Coiling Secondary to Complete Clopidogrel and Prasugrel Resistance: a Case Report.Journal of Neurological Surgery Part A: Central European Neurosurgery.05-DEC-2022;85 (1):531-3$5$DEC$$M$Y$$$20240914$$MD$AU$AU
243201951$24320195$1$I$$20240906$20240914$20240914$EXP$$US-SCIEGENP-2024SCLIT00364$SCIEGEN$Zachian RL, et al..Acute generalised exanthematous pustulosis and  herpes simplex virus: a case of possible overlap.BMJ Case Reports.30-AUG-2024;17 (8):1-5$7$DEC$E$F$Y$$$20240914$$MD$US$US
243201961$24320196$1$I$$20240826$20240914$20240914$PER$$US-SA-2024SA263501$SANOFI AVENTIS$$$$E$F$Y$$$20240914$$HP$US$US
243201971$24320197$1$I$20240723$20240909$20240914$20240914$EXP$$CA-ABBVIE-5922731$ABBVIE$$84$YR$$M$Y$$$20240914$$CN$CA$CA
243201981$24320198$1$I$$20240909$20240914$20240914$EXP$$US-ABBVIE-5917416$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243201991$24320199$1$I$20240101$20240909$20240914$20240914$EXP$$US-ABBVIE-5917605$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243202001$24320200$1$I$$20240829$20240914$20240914$PER$$US-009507513-2408USA010713$MERCK$File B, Hari A.. Discrepancy in PD-L1 expression between primary and metastatic tumors in two patients with recurrent cervical cancer. Gynecologic Oncology Reports. 2024;55$36$YR$$F$Y$$$20240914$$HP$US$US
243202012$24320201$2$F$$20240823$20240914$20240917$PER$$US-SA-2024SA262592$SANOFI AVENTIS$$$$$M$Y$$$20240918$$MD$US$US
243202021$24320202$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265097$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240914$$MD$US$US
243202031$24320203$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264409$SANOFI AVENTIS$$$$C$M$Y$$$20240914$$HP$US$US
243202041$24320204$1$I$$20240910$20240914$20240914$PER$$US-JNJFOC-20240927700$JOHNSON AND JOHNSON$$$$$F$Y$$$20240914$$CN$US$US
243202051$24320205$1$I$20240301$20240905$20240914$20240914$PER$$US-SA-2024SA264982$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240914$$HP$US$US
243202071$24320207$1$I$20240101$20240909$20240914$20240914$EXP$$US-ABBVIE-5916620$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243202081$24320208$1$I$$20240909$20240914$20240914$EXP$$US-ABBVIE-5916736$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243202091$24320209$1$I$$20240911$20240914$20240914$EXP$$US-ABBVIE-5922590$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243202101$24320210$1$I$20240912$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024183332$AMGEN$$59$YR$A$F$Y$$$20240914$$CN$US$US
243202111$24320211$1$I$$20240910$20240914$20240914$PER$$US-JNJFOC-20240926966$JOHNSON AND JOHNSON$$$$$F$Y$$$20240914$$CN$US$US
243202121$24320212$1$I$$20240906$20240914$20240914$EXP$$DE-ABBVIE-5908780$ABBVIE$$83$YR$$M$Y$$$20240914$$CN$DE$DE
243202131$24320213$1$I$$20240910$20240914$20240914$EXP$$ZA-ABBVIE-5917570$ABBVIE$$55$YR$$F$Y$$$20240914$$MD$ZA$ZA
243202141$24320214$1$I$20240701$20240909$20240914$20240914$EXP$$US-ABBVIE-5917573$ABBVIE$$27$YR$$F$Y$$$20240914$$CN$US$US
243202151$24320215$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265117$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240914$$HP$US$US
243202161$24320216$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264412$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240914$$HP$US$US
243202171$24320217$1$I$$20240911$20240914$20240914$EXP$$US-ABBVIE-5919778$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243202181$24320218$1$I$20240101$20240909$20240914$20240914$EXP$$CA-ABBVIE-5917633$ABBVIE$$51$YR$$M$Y$$$20240914$$CN$CA$CA
243202191$24320219$1$I$20240908$20240910$20240914$20240914$EXP$$US-ABBVIE-5917537$ABBVIE$$38$YR$$M$Y$$$20240914$$CN$US$US
243202201$24320220$1$I$$20240910$20240914$20240914$EXP$$US-ABBVIE-5917545$ABBVIE$$$$$M$Y$$$20240914$$CN$US$US
243202211$24320221$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA264957$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240914$$HP$US$US
243202221$24320222$1$I$20240701$20240906$20240914$20240914$PER$$US-SA-2024SA265198$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240914$$MD$US$US
243202231$24320223$1$I$$20240909$20240914$20240914$PER$$US-SA-2024SA265199$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240914$$HP$US$US
243202241$24320224$1$I$20240101$20240904$20240914$20240914$PER$$US-SA-2024SA264136$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240914$$HP$US$US
243202261$24320226$1$I$20240801$20240906$20240914$20240914$PER$$US-SA-2024SA264962$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240914$$HP$US$US
243202271$24320227$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265081$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240914$$MD$US$US
243202281$24320228$1$I$20240701$20240906$20240914$20240914$PER$$US-SA-2024SA264431$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240914$$HP$US$US
243202291$24320229$1$I$20240821$20240902$20240914$20240914$PER$$US-JNJFOC-20240928159$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240914$$CN$US$US
243202302$24320230$2$F$20240902$20240916$20240914$20240926$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17683$IPSEN$$46$YR$A$F$Y$$$20240926$$HP$US$US
243202311$24320231$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA265175$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240914$$HP$US$US
243202321$24320232$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA265493$SANOFI AVENTIS$$$$E$M$Y$$$20240914$$CN$US$US
243202331$24320233$1$I$20240801$20240906$20240914$20240914$PER$$US-SA-2024SA265053$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240914$$MD$US$US
243202341$24320234$1$I$$20240905$20240914$20240914$PER$$US-SA-2024SA263302$SANOFI AVENTIS$$$$C$M$Y$$$20240914$$MD$US$US
243202352$24320235$2$F$20240903$20240911$20240914$20240921$PER$$US-JNJFOC-20240928752$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240921$$HP$US$US
243202362$24320236$2$F$$20240916$20240914$20240930$PER$$US-JNJFOC-20240926064$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
243202371$24320237$1$I$$20240909$20240914$20240914$PER$$US-JNJFOC-20240928413$JOHNSON AND JOHNSON$$$$$M$Y$$$20240914$$HP$US$US
243202381$24320238$1$I$$20240903$20240914$20240914$PER$$US-JNJFOC-20240930301$JOHNSON AND JOHNSON$$$$$$Y$$$20240914$$MD$US$US
243202391$24320239$1$I$$20240909$20240914$20240914$PER$$US-SA-2024SA265169$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240914$$HP$US$US
243202401$24320240$1$I$20230101$20240906$20240914$20240914$PER$$US-SA-2024SA265237$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240914$$CN$US$US
243202411$24320241$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264987$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240914$$HP$US$US
243202421$24320242$1$I$20240101$20240903$20240914$20240914$PER$$US-SA-2024SA264039$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240914$$MD$US$US
243202431$24320243$1$I$20240801$20240906$20240914$20240914$PER$$US-SA-2024SA265090$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240914$$HP$US$US
243202441$24320244$1$I$$20240912$20240914$20240914$EXP$$US-ABBVIE-5922924$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243202451$24320245$1$I$20240827$20240912$20240914$20240914$PER$$US-AMGEN-USASP2024182938$AMGEN$$66$YR$E$F$Y$$$20240914$$CN$US$US
243202461$24320246$1$I$$20240904$20240914$20240914$EXP$$US-UCBSA-2024045855$UCB$$$$$$Y$$$20240914$$CN$US$US
243202471$24320247$1$I$$20240912$20240914$20240914$PER$$US-ELI_LILLY_AND_COMPANY-US202409008513$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240914$$CN$US$US
243202481$24320248$1$I$20240830$20240904$20240914$20240914$EXP$$US-UCBSA-2024046479$UCB$$5$YR$$M$Y$$$20240914$$CN$US$US
243202501$24320250$1$I$$20240909$20240914$20240914$PER$$US-SA-2024SA265148$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240914$$MD$US$US
243202511$24320251$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA265243$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240914$$HP$US$US
243202521$24320252$1$I$20240801$20240904$20240914$20240914$PER$$US-SA-2024SA263526$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240914$$MD$US$US
243202531$24320253$1$I$20240717$20240903$20240914$20240914$EXP$$GB-UCBSA-2024045558$UCB$$70$YR$$F$Y$73.5$KG$20240914$$HP$GB$GB
243202541$24320254$1$I$20240801$20240906$20240914$20240914$PER$$US-SA-2024SA264566$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240914$$HP$US$US
243202551$24320255$1$I$20240828$20240907$20240914$20240914$EXP$$US-JNJFOC-20240920481$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240914$$HP$US$US
243202561$24320256$1$I$$20240905$20240914$20240914$PER$$US-ABBVIE-5916083$ABBVIE$$$$$F$Y$$$20240914$$CN$US$US
243202571$24320257$1$I$20240801$20240826$20240914$20240914$PER$$US-SA-2024SA262282$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240914$$MD$US$US
243202581$24320258$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264578$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240914$$HP$US$US
243202591$24320259$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264213$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240914$$HP$US$US
243202601$24320260$1$I$$20240906$20240914$20240914$PER$$US-SA-2024SA264579$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240914$$HP$US$US
243202611$24320261$1$I$$20240820$20240914$20240914$PER$$US-SA-2024SA262945$SANOFI AVENTIS$$12$YR$T$$Y$$$20240914$$PH$US$US
243202621$24320262$1$I$$20240904$20240914$20240914$PER$$US-SA-2024SA264845$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240914$$CN$US$US
243202631$24320263$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264580$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240914$$HP$US$US
243202642$24320264$2$F$$20240906$20240914$20240923$PER$$US-SA-2024SA264605$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240923$$HP$US$US
243202651$24320265$1$I$$20240821$20240914$20240914$PER$$US-SA-2024SA265250$SANOFI AVENTIS$$$$A$M$Y$92$KG$20240914$$MD$US$US
243202661$24320266$1$I$$20240912$20240914$20240914$PER$$US-ALXN-202409USA000915US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240914$$MD$US$US
243202681$24320268$1$I$20240101$20240906$20240914$20240914$PER$$US-SA-2024SA264521$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240915$$HP$US$US
243202691$24320269$1$I$$20240912$20240914$20240914$PER$$US-ELI_LILLY_AND_COMPANY-US202409008120$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240914$$CN$US$US
243202702$24320270$2$F$$20240912$20240914$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008129$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240916$$CN$US$US
243202712$24320271$2$F$20240101$20240923$20240914$20240928$EXP$$US-ABBVIE-5916756$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243202721$24320272$1$I$20240801$20240904$20240914$20240914$PER$$US-009507513-2409USA002864$MERCK$$38$YR$$M$Y$$$20240914$$CN$US$US
243202731$24320273$1$I$20240423$20240827$20240914$20240914$PER$$US-AstraZeneca-2024A175050$ASTRAZENECA$$8104$DY$$F$Y$$$20240915$$CN$US$
243202741$24320274$1$I$$20240909$20240914$20240914$EXP$$US-AstraZeneca-2024A205472$ASTRAZENECA$$$$$F$Y$$$20240915$$CN$US$
243202764$24320276$4$F$20240911$20240926$20240914$20240927$PER$$US-AMGEN-USASP2024183888$AMGEN$$71$YR$E$F$Y$$$20240927$$CN$US$US
243202771$24320277$1$I$$20240912$20240914$20240914$PER$$US-ALXN-202409USA001035US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243202791$24320279$1$I$$20240912$20240914$20240914$PER$$US-ALXN-202409USA001031US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243202801$24320280$1$I$20240912$20240912$20240914$20240914$PER$$US-ALXN-202409USA001025US$ALEXION PHARMACEUTICALS$$48$YR$$F$Y$$$20240915$$CN$US$US
243202811$24320281$1$I$20240101$20240909$20240914$20240914$EXP$$US-JNJFOC-20240924240$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240915$$CN$US$US
243202821$24320282$1$I$$20240909$20240914$20240914$PER$$US-JNJFOC-20240924585$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$HP$US$US
243202831$24320283$1$I$20240911$20240912$20240914$20240914$PER$$US-ALXN-202409USA001022US$ALEXION PHARMACEUTICALS$$76$YR$$F$Y$$$20240915$$CN$US$US
243202841$24320284$1$I$20240901$20240909$20240914$20240914$PER$$US-SA-2024SA265421$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240915$$MD$US$US
243202871$24320287$1$I$20240101$20240909$20240914$20240914$EXP$$GB-ABBVIE-5919491$ABBVIE$$$$A$M$Y$$$20240914$$CN$GB$GB
243202891$24320289$1$I$20240901$20240909$20240914$20240914$PER$$US-SA-2024SA265441$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240915$$MD$US$US
243202901$24320290$1$I$$20240912$20240914$20240914$PER$$US-ALXN-202409USA001036US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243202911$24320291$1$I$20240801$20240905$20240914$20240914$PER$$US-SA-2024SA264114$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240915$$HP$US$US
243202921$24320292$1$I$20240801$20240906$20240914$20240914$PER$$US-SA-2024SA265091$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240915$$HP$US$US
243202961$24320296$1$I$$20240912$20240914$20240914$PER$$US-ALXN-202409USA001061US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240915$$HP$US$US
243202981$24320298$1$I$$20240912$20240914$20240914$PER$$US-ALXN-202409USA000961US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243202991$24320299$1$I$20240101$20240909$20240914$20240914$PER$$US-SA-2024SA265455$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240915$$MD$US$US
243203001$24320300$1$I$20240910$20240912$20240914$20240914$PER$$US-ALXN-202409USA000945US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240915$$HP$US$US
243203011$24320301$1$I$$20240912$20240914$20240914$PER$$US-ALXN-202409USA000953US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243203021$24320302$1$I$$20240909$20240914$20240914$PER$$US-SA-2024SA265430$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240915$$HP$US$US
243203031$24320303$1$I$$20240904$20240914$20240914$EXP$$AE-BAUSCH-BL-2024-013781$BAUSCH AND LOMB$R A, S A, M A, T M. RIFAXIMIN INDUCED STEVEN JOHNSON SYNDROME - FIRST CASE IN MIDDLE EAST. European journal of Case Report in Internal Medicine. 2024;11:. doi:10.12890/2024$55$YR$$F$Y$$$20240915$$HP$AE$AE
243203061$24320306$1$I$20230101$20240909$20240914$20240914$PER$$US-SA-2024SA265461$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240915$$HP$US$US
243203072$24320307$2$F$20240401$20240916$20240914$20240916$PER$$US-AMGEN-USASP2024183875$AMGEN$$65$YR$E$M$Y$$$20240916$$CN$US$US
243203091$24320309$1$I$20240801$20240906$20240914$20240914$PER$$US-SA-2024SA265094$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240915$$HP$US$US
243203101$24320310$1$I$20240824$20240909$20240914$20240914$PER$$US-SA-2024SA265456$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240915$$HP$US$US
243203111$24320311$1$I$20240101$20240909$20240914$20240914$PER$$US-SA-2024SA265429$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240915$$MD$US$US
243203151$24320315$1$I$$20240826$20240914$20240914$PER$$US-SA-2024SA263141$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240915$$CN$US$US
243203162$24320316$2$F$20240913$20240916$20240914$20240917$PER$$US-AMGEN-USASP2024183515$AMGEN$$66$YR$E$M$Y$$$20240917$$CN$US$US
243203171$24320317$1$I$$20240913$20240914$20240914$PER$$US-ALXN-202409USA001048US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243203181$24320318$1$I$$20240913$20240914$20240914$PER$$US-ALXN-202409USA001045US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243203191$24320319$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001040US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243203201$24320320$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001043US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243203211$24320321$1$I$$20240909$20240915$20240915$PER$$US-SA-2024SA265459$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240915$$HP$US$US
243203221$24320322$1$I$$20240820$20240915$20240915$PER$$US-SA-2024SA263458$SANOFI AVENTIS$$$$A$M$Y$$$20240915$$MD$US$US
243203232$24320323$2$F$$20240911$20240915$20240917$EXP$$US-ROCHE-10000079496$ROCHE$$$$E$F$Y$$$20240917$$HP$US$US
243203241$24320324$1$I$$20240912$20240915$20240915$EXP$$US-ALXN-202409USA000893US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243203251$24320325$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA263882$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240915$$HP$US$US
243203261$24320326$1$I$20240801$20240904$20240915$20240915$EXP$$US-UCBSA-2024045586$UCB$$42$YR$$F$Y$$$20240915$$HP$US$US
243203271$24320327$1$I$$20240909$20240915$20240915$EXP$$US-JNJFOC-20240926738$JOHNSON AND JOHNSON$$$$$F$Y$$$20240915$$CN$US$US
243203281$24320328$1$I$20200822$20240903$20240915$20240915$EXP$$US-CHIESI-2024CHF05799$CHIESI$$52$YR$$F$Y$85$KG$20240915$$CN$US$US
243203291$24320329$1$I$$20240912$20240915$20240915$PER$$US-ALXN-202409USA000897US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243203301$24320330$1$I$$20240912$20240915$20240915$PER$$US-ALXN-202409USA000899US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243203311$24320331$1$I$$20240812$20240915$20240915$EXP$$NL-TEVA-VS-3243283$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$39$YR$$M$Y$$$20240915$$HP$NL$NL
243203321$24320332$1$I$20240101$20240904$20240915$20240915$EXP$$US-UCBSA-2024045632$UCB$$$$A$F$Y$$$20240915$$CN$US$US
243203332$24320333$2$F$$20240916$20240915$20240918$PER$$US-ALXN-202409USA000905US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243203351$24320335$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001066US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243203361$24320336$1$I$$20240812$20240915$20240915$EXP$$NL-TEVA-VS-3243293$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$24$YR$$M$Y$$$20240915$$HP$NL$NL
243203371$24320337$1$I$$20240812$20240915$20240915$EXP$$NL-TEVA-VS-3243297$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$24$YR$$M$Y$$$20240915$$HP$NL$NL
243203381$24320338$1$I$$20240905$20240915$20240915$PER$$US-AstraZeneca-2024A202758$ASTRAZENECA$$$$$M$Y$$$20240915$$CN$US$
243203391$24320339$1$I$$20240909$20240915$20240915$PER$$US-AstraZeneca-2024A205436$ASTRAZENECA$$$$$F$Y$$$20240915$$CN$US$
243203401$24320340$1$I$$20240904$20240915$20240915$EXP$$JP-UCBSA-2024046468$UCB$$$$$$Y$$$20240915$$MD$JP$JP
243203411$24320341$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001026US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243203421$24320342$1$I$$20240912$20240915$20240915$PER$$US-ALXN-202409USA001030US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243203431$24320343$1$I$$20240912$20240915$20240915$PER$$US-ALXN-202409USA000919US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243203441$24320344$1$I$$20240812$20240915$20240915$EXP$$NL-TEVA-VS-3243308$TEVA$Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO-Open 2024; 9 (7): 1-8.; Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, et al. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular even...$38$YR$$M$Y$$$20240915$$HP$NL$NL
243203451$24320345$1$I$20240701$20240905$20240915$20240915$PER$$US-ABBVIE-5910123$ABBVIE$$29$YR$$F$Y$72.574$KG$20240915$$CN$US$US
243203461$24320346$1$I$20240910$20240910$20240915$20240915$PER$$US-ABBVIE-5924229$ABBVIE$$32$YR$$F$Y$$$20240915$$MD$US$US
243203471$24320347$1$I$$20240912$20240915$20240915$PER$$US-ALXN-202409USA001023US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243203481$24320348$1$I$20240101$20240910$20240915$20240915$EXP$$US-ABBVIE-5734423$ABBVIE$$$$$M$Y$$$20240915$$CN$US$US
243203491$24320349$1$I$$20240912$20240915$20240915$PER$$US-ALXN-202409USA000967US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240915$$HP$US$US
243203501$24320350$1$I$20240101$20240905$20240915$20240915$PER$$US-SA-2024SA263852$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240915$$HP$US$US
243203511$24320351$1$I$$20240821$20240915$20240915$PER$$US-SA-2024SA262709$SANOFI AVENTIS$$$$T$M$Y$100$KG$20240915$$MD$US$US
243203521$24320352$1$I$20240101$20240905$20240915$20240915$EXP$$US-UCBSA-2024026438$UCB$$$$$F$Y$$$20240915$$HP$US$US
243203531$24320353$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001032US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243203542$24320354$2$F$20240701$20240904$20240915$20240917$EXP$$US-UCBSA-2024045315$UCB$$52$YR$$F$Y$$$20240917$$HP$US$US
243203551$24320355$1$I$$20240912$20240915$20240915$EXP$$CA-ROCHE-3571421$ROCHE$$$$A$F$Y$$$20240915$$HP$CA$CA
243203561$24320356$1$I$20240801$20240904$20240915$20240915$EXP$$US-UCBSA-2024045554$UCB$$49$YR$$F$Y$$$20240915$$HP$US$US
243203571$24320357$1$I$$20240909$20240915$20240915$EXP$$BE-AstraZeneca-2024A208626$ASTRAZENECA$$68$YR$$M$Y$$$20240915$$MD$BE$
243203581$24320358$1$I$$20240910$20240915$20240915$EXP$$US-AstraZeneca-2024A206424$ASTRAZENECA$$$$$F$Y$$$20240915$$CN$US$
243203591$24320359$1$I$$20240912$20240915$20240915$EXP$$US-ALXN-202409USA000925US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243203601$24320360$1$I$$20240904$20240915$20240915$EXP$$US-UCBSA-2024045592$UCB$$$$$$Y$$$20240915$$CN$US$US
243203611$24320361$1$I$$20240909$20240915$20240915$EXP$$US-AstraZeneca-2024A206648$ASTRAZENECA$$$$$M$Y$$$20240915$$CN$US$
243203621$24320362$1$I$$20240909$20240915$20240915$EXP$$US-AstraZeneca-2024A206638$ASTRAZENECA$$$$$F$Y$$$20240915$$CN$US$
243203631$24320363$1$I$$20240909$20240915$20240915$EXP$$ZA-AstraZeneca-2024A206335$ASTRAZENECA$$68$YR$$F$Y$$$20240915$$CN$ZA$
243203642$24320364$2$F$$20240916$20240915$20240918$PER$$US-ALXN-202409USA000929US$ALEXION PHARMACEUTICALS$$$$$M$Y$103.4$KG$20240918$$CN$US$US
243203651$24320365$1$I$$20240902$20240915$20240915$EXP$$US-LUPIN HEALTHCARE (UK) LIMITED-2024-08975$LUPIN$Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and maternal ichthyosiform dermopathy in association with kava use during pregnancy. Journal of Medical Toxicology. 2024;20:308-313$$$N$M$Y$$$20240915$$HP$US$US
243203661$24320366$1$I$20240801$20240904$20240915$20240915$EXP$$US-UCBSA-2024045678$UCB$$56$YR$$M$Y$$$20240915$$HP$US$US
243203681$24320368$1$I$$20240902$20240915$20240915$EXP$$US-LUPIN HEALTHCARE (UK) LIMITED-2024-08974$LUPIN$Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and maternal ichthyosiform dermopathy in association with kava use during pregnancy. Journal of Medical Toxicology. 2024;20:308-313$41$YR$$F$Y$$$20240915$$HP$US$US
243203691$24320369$1$I$20240905$20240911$20240915$20240915$EXP$$US-AstraZeneca-2024A207441$ASTRAZENECA$$$$$F$Y$$$20240915$$MD$US$
243203701$24320370$1$I$$20240911$20240915$20240915$PER$$US-AstraZeneca-2024A208160$ASTRAZENECA$$$$$F$Y$$$20240915$$HP$US$
243203711$24320371$1$I$$20240904$20240915$20240915$EXP$$JP-UCBSA-2024045916$UCB$$$$$$Y$$$20240915$$MD$JP$JP
243203721$24320372$1$I$20240701$20240906$20240915$20240915$PER$$US-SA-2024SA264099$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240915$$MD$US$US
243203731$24320373$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA264739$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240915$$HP$US$US
243203741$24320374$1$I$20240101$20240906$20240915$20240915$PER$$US-SA-2024SA264113$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240915$$MD$US$US
243203751$24320375$1$I$$20240910$20240915$20240915$PER$$US-AstraZeneca-2024A206885$ASTRAZENECA$$$$$F$Y$$$20240915$$CN$US$
243203761$24320376$1$I$20210101$20240910$20240915$20240915$EXP$$US-AstraZeneca-2024A206771$ASTRAZENECA$$72$YR$$M$Y$$$20240915$$CN$US$
243203771$24320377$1$I$20230101$20240909$20240915$20240915$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014697$JAZZ$$$$$F$Y$$$20240914$$CN$US$US
243203791$24320379$1$I$20240101$20240906$20240915$20240915$PER$$US-SA-2024SA263925$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240915$$MD$US$US
243203801$24320380$1$I$20240101$20240905$20240915$20240915$PER$$US-SA-2024SA263705$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240915$$MD$US$US
243203813$24320381$3$F$$20240827$20240915$20240923$PER$$US-SA-2024SA263716$SANOFI AVENTIS$$$$A$F$Y$116.55$KG$20240923$$MD$US$US
243203821$24320382$1$I$$20240909$20240915$20240915$PER$$US-SA-2024SA265420$SANOFI AVENTIS$$$$A$F$Y$$$20240915$$MD$US$US
243203841$24320384$1$I$$20240911$20240915$20240915$EXP$$US-ALXN-202409USA000834US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243203851$24320385$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001077US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$MD$US$US
243203861$24320386$1$I$$20240906$20240915$20240915$PER$$US-ABBVIE-5914314$ABBVIE$$$$$M$Y$$$20240915$$HP$US$US
243203872$24320387$2$F$20240902$20240916$20240915$20240930$EXP$$CA-UCBSA-2024045202$UCB$$36$YR$$F$Y$$$20240930$$CN$CA$CA
243203881$24320388$1$I$$20240902$20240915$20240915$EXP$$US-UCBSA-2024045312$UCB$$$$$$Y$$$20240915$$CN$US$US
243203891$24320389$1$I$20240801$20240902$20240915$20240915$EXP$$US-UCBSA-2024045661$UCB$$61$YR$$F$Y$$$20240915$$HP$US$US
243203901$24320390$1$I$$20240909$20240915$20240915$PER$$US-SA-2024SA265419$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240915$$HP$US$US
243203921$24320392$1$I$20240101$20240909$20240915$20240915$PER$$US-SA-2024SA265141$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240915$$HP$US$US
243203931$24320393$1$I$$20240905$20240915$20240915$PER$$US-JNJFOC-20240911963$JOHNSON AND JOHNSON$$$$$M$Y$$$20240915$$CN$US$US
243203951$24320395$1$I$$20240911$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007793$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240915$$CN$US$US
243203961$24320396$1$I$20240101$20240904$20240915$20240915$PER$$US-SA-2024SA264884$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240915$$MD$US$US
243203971$24320397$1$I$$20240823$20240915$20240915$PER$$US-SA-2024SA263781$SANOFI AVENTIS$$8$YR$C$M$Y$39.41$KG$20240915$$HP$US$US
243203981$24320398$1$I$$20240912$20240915$20240915$PER$$US-ALXN-202409USA000873US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243203991$24320399$1$I$20240801$20240909$20240915$20240915$PER$$US-SA-2024SA264799$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240915$$HP$US$US
243204001$24320400$1$I$20240907$20240907$20240915$20240915$PER$$US-SA-2024SA264124$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240915$$HP$US$US
243204021$24320402$1$I$$20240913$20240915$20240915$EXP$$US-ALXN-202409USA001042US$ALEXION PHARMACEUTICALS$$$$E$F$Y$$$20240915$$MD$US$US
243204031$24320403$1$I$$20240912$20240915$20240915$PER$$US-ALXN-202409USA000936US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243204041$24320404$1$I$$20240906$20240915$20240915$PER$$US-ROCHE-10000079105$ROCHE$$17$YR$T$M$Y$$$20240915$$HP$US$US
243204051$24320405$1$I$20240904$20240910$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013343$DR REDDYS$$57$YR$A$F$Y$$$20240915$$HP$US$US
243204061$24320406$1$I$20240906$20240910$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013344$DR REDDYS$$23$YR$A$M$Y$$$20240915$$HP$US$US
243204071$24320407$1$I$$20240910$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013336$DR REDDYS$$31$YR$A$M$Y$$$20240915$$HP$US$US
243204081$24320408$1$I$20240910$20240909$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013330$DR REDDYS$$34$YR$A$F$Y$$$20240915$$MD$US$US
243204092$24320409$2$F$20240904$20240916$20240915$20240923$EXP$$US-RDY-SPO/USA/24/0013345$DR REDDYS$$51$YR$A$F$Y$$$20240923$$MD$US$US
243204101$24320410$1$I$20240907$20240909$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013328$DR REDDYS$$27$YR$A$F$Y$$$20240915$$HP$US$US
243204111$24320411$1$I$20240909$20240910$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013360$DR REDDYS$$29$YR$A$M$Y$$$20240915$$HP$US$US
243204121$24320412$1$I$20240903$20240908$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013243$DR REDDYS$$18$YR$A$M$Y$$$20240915$$HP$US$US
243204131$24320413$1$I$20240907$20240909$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013318$DR REDDYS$$35$YR$A$F$Y$$$20240915$$HP$US$US
243204141$24320414$1$I$20240701$20240910$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013342$DR REDDYS$$44$YR$A$M$Y$$$20240915$$HP$US$US
243204151$24320415$1$I$20240729$20240908$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013283$DR REDDYS$$56$YR$A$M$Y$$$20240915$$HP$US$US
243204161$24320416$1$I$20240829$20240910$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013322$DR REDDYS$$51$YR$A$M$Y$$$20240915$$MD$US$US
243204171$24320417$1$I$20240819$20240910$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013339$DR REDDYS$$65$YR$E$F$Y$$$20240915$$HP$US$US
243204181$24320418$1$I$20240906$20240908$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013244$DR REDDYS$$42$YR$A$M$Y$$$20240915$$HP$US$US
243204191$24320419$1$I$$20240910$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013329$DR REDDYS$$24$YR$A$M$Y$$$20240915$$HP$US$US
243204201$24320420$1$I$20240821$20240910$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013331$DR REDDYS$$14$YR$T$M$Y$$$20240915$$MD$US$US
243204211$24320421$1$I$$20240910$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013341$DR REDDYS$$56$YR$A$M$Y$$$20240915$$CN$US$US
243204221$24320422$1$I$20240801$20240913$20240915$20240915$PER$$US-AMGEN-USASP2024183648$AMGEN$$$$$F$Y$$$20240915$$CN$US$US
243204231$24320423$1$I$20240101$20240909$20240915$20240915$PER$$US-SA-2024SA265410$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240915$$HP$US$US
243204241$24320424$1$I$$20240909$20240915$20240915$PER$$US-AMGEN-USASP2024180901$AMGEN$$$$$F$Y$$$20240915$$HP$US$US
243204261$24320426$1$I$$20240912$20240915$20240915$PER$$US-ALXN-202409USA001074US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$HP$US$US
243204271$24320427$1$I$$20240910$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013377$DR REDDYS$$24$YR$A$M$Y$$$20240915$$MD$US$US
243204281$24320428$1$I$$20240910$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013361$DR REDDYS$$65$YR$E$M$Y$$$20240915$$HP$US$US
243204291$24320429$1$I$20240816$20240910$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013368$DR REDDYS$$50$YR$A$F$Y$$$20240915$$MD$US$US
243204301$24320430$1$I$$20240820$20240915$20240915$PER$$US-SA-2024SA265533$SANOFI AVENTIS$$$$A$F$Y$130$KG$20240915$$MD$US$US
243204311$24320431$1$I$20220623$20240904$20240915$20240915$PER$$US-SA-2024SA264894$SANOFI AVENTIS$$93$YR$E$F$Y$$$20240915$$CN$US$US
243204321$24320432$1$I$$20240823$20240915$20240915$PER$$US-SA-2024SA265308$SANOFI AVENTIS$$$$A$$Y$$$20240915$$CN$US$US
243204331$24320433$1$I$$20240909$20240915$20240915$EXP$$US-AstraZeneca-2024A205102$ASTRAZENECA$$$$$M$Y$$$20240915$$CN$US$
243204341$24320434$1$I$20240904$20240906$20240915$20240915$PER$$US-GE HEALTHCARE-2024CSU010263$GE HEALTHCARE$$62$YR$$M$Y$$$20240915$$HP$US$US
243204351$24320435$1$I$$20240909$20240915$20240915$PER$$US-SA-2024SA265407$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240915$$HP$US$US
243204362$24320436$2$F$$20240916$20240915$20240917$PER$$US-ALXN-202409USA001079US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$MD$US$US
243204371$24320437$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001098US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243204381$24320438$1$I$$20240909$20240915$20240915$EXP$$JP-AstraZeneca-2024A206837$ASTRAZENECA$$60$YR$$F$Y$$$20240915$$MD$JP$
243204391$24320439$1$I$$20240903$20240915$20240915$EXP$IR-DEXPHARM-2024-3041$IR-DEXPHARM-2024-3041$DEXCEL$Basiri, R.; Ziaei Moghaddam, A.; Rikhtegar, A.; Jafarian, A. H. Primary Pulmonary Angiosarcoma Found Incidentally in a Complicated Patient: A Rare Case Report. Clinical Respiratory Journal 2024, V18, PNo. 8$$$A$F$Y$$$20240912$$HP$IR$IR
243204401$24320440$1$I$$20240909$20240915$20240915$EXP$$US-AstraZeneca-2024A205345$ASTRAZENECA$$$$$F$Y$$$20240915$$CN$US$
243204411$24320441$1$I$20240101$20240823$20240915$20240915$PER$$US-SA-2024SA265370$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240915$$MD$US$US
243204421$24320442$1$I$20240101$20240904$20240915$20240915$PER$$US-SA-2024SA264321$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240915$$HP$US$US
243204431$24320443$1$I$20240701$20240909$20240915$20240915$PER$$US-SA-2024SA265403$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240915$$HP$US$US
243204441$24320444$1$I$20240601$20240913$20240915$20240915$PER$$US-ALXN-202409USA001097US$ALEXION PHARMACEUTICALS$$82$YR$$F$Y$$$20240915$$CN$US$US
243204451$24320445$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001091US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243204461$24320446$1$I$$20240905$20240915$20240915$30DAY$$US-GSK-US2024110801$GLAXOSMITHKLINE$$$$$F$Y$$$20240915$$CN$US$US
243204471$24320447$1$I$20240826$20240906$20240915$20240915$EXP$$JP-ROCHE-10000078973$ROCHE$$60$YR$A$M$Y$$$20240915$$MD$JP$JP
243204481$24320448$1$I$20240801$20240909$20240915$20240915$PER$$US-SA-2024SA264814$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240915$$MD$US$US
243204491$24320449$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA165373$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240915$$MD$US$US
243204501$24320450$1$I$$20240905$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013351$DR REDDYS$Heyman HM, Alberts NM, Rees M, Puri L, Frett MJ, Anghelescu DL. COVID-19 infection and pain in adolescents with sickle cell disease: A case series. eJHaem. 2022 Nov;3(4): 1310-1315. doi:10.1002/jha2.587.$17$YR$T$M$Y$$$20240915$$HP$US$US
243204511$24320451$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001099US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243204521$24320452$1$I$$20240824$20240915$20240915$PER$$US-SA-2024SA265371$SANOFI AVENTIS$$$$A$M$Y$$$20240915$$MD$US$US
243204531$24320453$1$I$$20240911$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007486$ELI LILLY AND CO$$$$$M$Y$$$20240915$$CN$US$US
243204541$24320454$1$I$$20240911$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007397$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240915$$CN$US$US
243204551$24320455$1$I$$20240903$20240915$20240915$EXP$$KR-JNJFOC-20240938339$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240915$$HP$KR$KR
243204561$24320456$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA265338$SANOFI AVENTIS$$$$A$F$Y$$$20240915$$MD$US$US
243204571$24320457$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001089US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240915$$CN$US$US
243204581$24320458$1$I$$20240911$20240915$20240915$PER$$US-AstraZeneca-2024A207927$ASTRAZENECA$$$$$M$Y$$$20240915$$CN$US$
243204591$24320459$1$I$$20240910$20240915$20240915$PER$$US-AstraZeneca-2024A206394$ASTRAZENECA$$$$$$Y$$$20240915$$CN$US$
243204601$24320460$1$I$20230601$20240909$20240915$20240915$PER$$US-SA-2024SA265121$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240915$$HP$US$US
243204611$24320461$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA265278$SANOFI AVENTIS$$$$A$F$Y$$$20240915$$HP$US$US
243204621$24320462$1$I$$20240906$20240915$20240915$EXP$$JP-ROCHE-10000078646$ROCHE$$$$A$$Y$$$20240915$$MD$JP$JP
243204641$24320464$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA265064$SANOFI AVENTIS$$$$A$F$Y$$$20240915$$MD$US$US
243204651$24320465$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA265348$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240915$$CN$US$US
243204671$24320467$1$I$$20240909$20240915$20240915$PER$$US-SA-2024SA265373$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240915$$HP$US$US
243204681$24320468$1$I$$20240909$20240915$20240915$EXP$$IT-JNJFOC-20240927619$JOHNSON AND JOHNSON$$$$$M$Y$$$20240915$$MD$IT$IT
243204691$24320469$1$I$20240820$20240912$20240915$20240915$EXP$$CN-ROCHE-10000081060$ROCHE$$66$YR$E$F$Y$48.75$KG$20240915$$HP$CN$CN
243204701$24320470$1$I$$20240902$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013143$DR REDDYS$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham III CO, Wigleya FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Seminars in Arthritis and Rheumatism. 2024;67: doi:10.1016/j.semarthrit.2024.152460.$49$YR$A$F$Y$$$20240915$$HP$US$US
243204711$24320471$1$I$$20240910$20240915$20240915$EXP$$GB-ROCHE-3528673$ROCHE$$$$A$F$Y$$$20240915$$HP$GB$GB
243204721$24320472$1$I$$20240907$20240915$20240915$PER$$US-JNJFOC-20240919586$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$CN$US$US
243204731$24320473$1$I$$20240902$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013142$DR REDDYS$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham III CO, Wigleya FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Seminars in Arthritis and Rheumatism. 2024;67: doi:10.1016/j.semarthrit.2024.152460.$64$YR$A$F$Y$$$20240915$$HP$US$US
243204741$24320474$1$I$$20240912$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409008206$ELI LILLY AND CO$$$$$M$Y$$$20240915$$CN$US$US
243204761$24320476$1$I$$20240910$20240915$20240915$PER$$US-AstraZeneca-2024A206868$ASTRAZENECA$$$$$$Y$$$20240915$$MD$US$
243204771$24320477$1$I$20240801$20240912$20240915$20240915$PER$$US-ABBVIE-5922930$ABBVIE$$$$A$F$Y$$$20240915$$CN$US$US
243204781$24320478$1$I$20240816$20240909$20240915$20240915$PER$$US-SA-2024SA264866$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240915$$MD$US$US
243204791$24320479$1$I$$20240821$20240915$20240915$PER$$US-SA-2024SA264231$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240915$$HP$US$US
243204801$24320480$1$I$$20240906$20240915$20240915$PER$$US-SA-2024SA264691$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240915$$MD$US$US
243204811$24320481$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001102US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243204821$24320482$1$I$$20240911$20240915$20240915$EXP$$PE-ROCHE-10000080916$ROCHE$$59$YR$A$F$Y$$$20240915$$HP$PE$PE
243204831$24320483$1$I$$20240910$20240915$20240915$EXP$$PE-ROCHE-10000079489$ROCHE$$$$$F$Y$$$20240915$$CN$PE$PE
243204841$24320484$1$I$$20240911$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007616$ELI LILLY AND CO$$$$$F$Y$$$20240915$$CN$US$US
243204851$24320485$1$I$$20240912$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409008219$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240915$$CN$US$US
243204861$24320486$1$I$20240101$20240905$20240915$20240915$PER$$US-SA-2024SA262692$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240915$$HP$US$US
243204871$24320487$1$I$20240817$20240910$20240915$20240915$EXP$FR-AFSSAPS-RN2024000956$FR-ROCHE-10000077907$ROCHE$$44$YR$A$F$Y$$$20240915$$MD$FR$FR
243204881$24320488$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA264705$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240915$$HP$US$US
243204891$24320489$1$I$$20240827$20240915$20240915$PER$$US-SA-2024SA264555$SANOFI AVENTIS$$48$YR$A$M$Y$200$KG$20240915$$MD$US$US
243204901$24320490$1$I$$20240912$20240915$20240915$PER$$US-ABBVIE-5923762$ABBVIE$$$$$F$Y$$$20240915$$CN$US$US
243204911$24320491$1$I$20240828$20240913$20240915$20240915$PER$$US-ALXN-202409USA001082US$ALEXION PHARMACEUTICALS$$67$YR$$M$Y$113.38$KG$20240915$$CN$US$US
243204922$24320492$2$F$20240801$20240912$20240915$20240920$PER$$US-SA-2024SA265351$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240920$$MD$US$US
243204931$24320493$1$I$$20240906$20240915$20240915$PER$$US-SA-2024SA264686$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240915$$MD$US$US
243204941$24320494$1$I$20240801$20240904$20240915$20240915$PER$$US-SA-2024SA264679$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240915$$MD$US$US
243204951$24320495$1$I$20240907$20240909$20240915$20240915$EXP$$US-ROCHE-10000077504$ROCHE$$62$YR$A$M$Y$$$20240915$$HP$US$US
243204961$24320496$1$I$20230601$20240911$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007713$ELI LILLY AND CO$$$$$F$Y$$$20240915$$MD$US$US
243204971$24320497$1$I$20240911$20240911$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007371$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240915$$CN$US$US
243204981$24320498$1$I$$20240909$20240915$20240915$EXP$$GB-JNJFOC-20240938943$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240915$$CN$GB$GB
243204991$24320499$1$I$$20240912$20240915$20240915$PER$$US-ALXN-202409USA000914US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243205001$24320500$1$I$$20240906$20240915$20240915$PER$$US-SA-2024SA263813$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240915$$MD$US$US
243205011$24320501$1$I$20230101$20240912$20240915$20240915$EXP$$US-ABBVIE-5922136$ABBVIE$$$$$F$Y$$$20240915$$HP$US$US
243205021$24320502$1$I$20230101$20240912$20240915$20240915$EXP$$US-ABBVIE-5922915$ABBVIE$$$$$F$Y$$$20240915$$CN$US$US
243205031$24320503$1$I$$20240909$20240915$20240915$EXP$$US-JNJFOC-20240929974$JOHNSON AND JOHNSON$$$$$F$Y$$$20240915$$HP$US$US
243205041$24320504$1$I$$20240912$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409008218$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240915$$CN$US$US
243205051$24320505$1$I$$20240909$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409005947$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240915$$CN$US$US
243205061$24320506$1$I$20240101$20240906$20240915$20240915$PER$$US-SA-2024SA263551$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240915$$MD$US$US
243205071$24320507$1$I$$20240902$20240915$20240915$EXP$$CN-JNJFOC-20240911614$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$MD$CN$CN
243205081$24320508$1$I$$20240909$20240915$20240915$EXP$$GB-JNJFOC-20240937652$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240915$$CN$GB$GB
243205091$24320509$1$I$$20240902$20240915$20240915$EXP$$CZ-AUROBINDO-AUR-APL-2024-044346$AUROBINDO$Kabut T, Weinbergerova B, Folber F, Lengerova M, Mayer J.. High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience.. Bone-Marrow-Transplant. 2023;58:1229-1236$59$YR$$F$Y$$$20240915$$HP$CZ$CZ
243205101$24320510$1$I$$20240902$20240915$20240915$EXP$$US-AUROBINDO-AUR-APL-2024-044217$AUROBINDO$Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hayman S, et al. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Cancer Journal. 2023;13:91$$$$$Y$$$20240915$$HP$US$US
243205111$24320511$1$I$$20240902$20240915$20240915$EXP$$US-AUROBINDO-AUR-APL-2024-044430$AUROBINDO$Jeffrey a Kahn, Hopstone MD, Conti PS, Tom C, Mohamed P, Gong Y at all. Unresectable Metastatic Solid Pseudopapillary Pancreatic Neoplasm Treated with Liver Transplantation. ACG-Case-Rep-J. 2024;11:8$49$YR$$F$Y$$$20240915$$HP$US$US
243205121$24320512$1$I$$20240902$20240915$20240915$EXP$$US-AUROBINDO-AUR-APL-2024-044538$AUROBINDO$Kinney RE, Nair S, Kim CH, Thomas MB, Delatorre M. Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer. Oncologist. 2023;28(6):E478-E486$51$YR$$F$Y$$$20240915$$HP$US$US
243205131$24320513$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA264216$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240915$$HP$US$US
243205141$24320514$1$I$20191001$20240906$20240915$20240915$PER$$US-SA-2024SA264696$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240915$$HP$US$US
243205151$24320515$1$I$$20240905$20240915$20240915$EXP$$US-GSK-US2024AMR111719$GLAXOSMITHKLINE$$$$$F$Y$$$20240915$$CN$US$US
243205161$24320516$1$I$$20240903$20240915$20240915$EXP$$US-AUROBINDO-AUR-APL-2024-044518$AUROBINDO$Meyer AS, Cluster A, Ogle A, Brossier N, Beck M, Lampe A, et al.. NOVEL TREATMENTS FOR ACNEIFORM ERUPTIONS CAUSED BYTARGETED THERAPIES IN THE PEDIATRIC POPULATION. NEURO-ONCOLOGY. 2024;26 (Suppl.):iv186-iv187$$$T$F$Y$$$20240915$$HP$US$US
243205171$24320517$1$I$$20240903$20240915$20240915$EXP$$GB-AUROBINDO-AUR-APL-2024-044135$AUROBINDO$$72$YR$$F$Y$78$KG$20240915$$HP$GB$GB
243205191$24320519$1$I$20240101$20240905$20240915$20240915$PER$$US-SA-2024SA264168$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240915$$HP$US$US
243205201$24320520$1$I$20230824$20240827$20240915$20240915$PER$$US-SA-2024SA265522$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240915$$PH$US$US
243205271$24320527$1$I$20240101$20240905$20240915$20240915$PER$$US-SA-2024SA263847$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240915$$MD$US$US
243205281$24320528$1$I$$20240906$20240915$20240915$PER$$US-SA-2024SA264710$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240915$$HP$US$US
243205291$24320529$1$I$$20240827$20240915$20240915$PER$$US-SA-2024SA264388$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240915$$MD$US$US
243205301$24320530$1$I$$20240909$20240915$20240915$PER$$US-SA-2024SA265327$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240915$$HP$US$US
243205311$24320531$1$I$20240701$20240822$20240915$20240915$PER$$US-SA-2024SA263413$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240915$$MD$US$US
243205331$24320533$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001086US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243205381$24320538$1$I$$20240912$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409008203$ELI LILLY AND CO$$$$$M$Y$$$20240915$$CN$US$US
243205391$24320539$1$I$20240909$20240911$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007561$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240915$$CN$US$US
243205401$24320540$1$I$20240909$20240910$20240915$20240915$EXP$$GB-AstraZeneca-2024A206066$ASTRAZENECA$$67$YR$$F$Y$$$20240915$$MD$GB$
243205411$24320541$1$I$20240901$20240912$20240915$20240915$PER$$US-AstraZeneca-2024A209422$ASTRAZENECA$$651$MON$$F$Y$134.3$KG$20240915$$HP$US$
243205421$24320542$1$I$$20240913$20240915$20240915$PER$$US-ALXN-202409USA001100US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243205431$24320543$1$I$$20240910$20240915$20240915$PER$$US-ALXN-202409USA000705US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243205461$24320546$1$I$$20240905$20240915$20240915$30DAY$$US-GSK-US2024110806$GLAXOSMITHKLINE$$$$$M$Y$$$20240915$$CN$US$US
243205471$24320547$1$I$$20240905$20240915$20240915$EXP$$US-GSK-US2024110679$GLAXOSMITHKLINE$$$$$F$Y$$$20240915$$HP$US$US
243205481$24320548$1$I$20240101$20240827$20240915$20240915$PER$$US-SA-2024SA263903$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240915$$MD$US$US
243205491$24320549$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA263543$SANOFI AVENTIS$$$$A$F$Y$$$20240915$$HP$US$US
243205501$24320550$1$I$20240101$20240909$20240915$20240915$PER$$US-SA-2024SA265545$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240915$$HP$US$US
243205511$24320551$1$I$$20240827$20240915$20240915$PER$$US-SA-2024SA265506$SANOFI AVENTIS$$$$$F$Y$$$20240915$$HP$US$US
243205521$24320552$1$I$20240101$20240822$20240915$20240915$PER$$US-SA-2024SA259925$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240915$$MD$US$US
243205531$24320553$1$I$20240101$20240909$20240915$20240915$PER$$US-SA-2024SA265546$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240915$$HP$US$US
243205541$24320554$1$I$20240901$20240909$20240915$20240915$PER$$US-SA-2024SA265313$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240915$$HP$US$US
243205551$24320555$1$I$$20240909$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409005388$ELI LILLY AND CO$$$$$F$Y$$$20240915$$CN$US$US
243205561$24320556$1$I$20240601$20240909$20240915$20240915$PER$$US-SA-2024SA265301$SANOFI AVENTIS$$$$T$F$Y$$$20240915$$HP$US$US
243205571$24320557$1$I$$20240822$20240915$20240915$PER$$US-SA-2024SA263471$SANOFI AVENTIS$$$$A$F$Y$50.34$KG$20240915$$MD$US$US
243205581$24320558$1$I$$20240909$20240915$20240915$PER$$US-SA-2024SA265558$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240915$$HP$US$US
243205592$24320559$2$F$20240910$20240912$20240915$20240918$PER$$US-AMGEN-USASP2024182995$AMGEN$$58$YR$A$$Y$$$20240918$$CN$US$US
243205601$24320560$1$I$20240910$20240912$20240915$20240915$EXP$$US-ABBVIE-5922133$ABBVIE$$65$YR$$M$Y$$$20240915$$CN$US$US
243205611$24320561$1$I$20240815$20240909$20240915$20240915$EXP$$CN-ABBVIE-5916214$ABBVIE$$50$YR$$F$Y$42$KG$20240915$$MD$CN$CN
243205621$24320562$1$I$$20240910$20240915$20240915$PER$$US-JNJFOC-20240927371$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$HP$US$US
243205631$24320563$1$I$20240101$20240906$20240915$20240915$PER$$US-SA-2024SA264219$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240915$$HP$US$US
243205641$24320564$1$I$$20240904$20240915$20240915$EXP$$CA-AUROBINDO-AUR-APL-2024-045166$AUROBINDO$$59$YR$$M$Y$$$20240915$$PH$CA$CA
243205651$24320565$1$I$$20240904$20240915$20240915$EXP$$CA-AUROBINDO-AUR-APL-2024-045095$AUROBINDO$$56$YR$$F$Y$$$20240915$$HP$CA$CA
243205661$24320566$1$I$20220101$20240909$20240915$20240915$EXP$$US-JNJFOC-20240921716$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240915$$CN$US$US
243205671$24320567$1$I$$20240913$20240915$20240915$EXP$$GB-ABBVIE-5923621$ABBVIE$$$$A$$Y$$$20240915$$PH$GB$GB
243205681$24320568$1$I$20240909$20240909$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409006674$ELI LILLY AND CO$$$$A$F$Y$$$20240915$$CN$US$US
243205691$24320569$1$I$$20240904$20240915$20240915$EXP$$NL-ABBVIE-5923484$ABBVIE$$75$YR$$F$Y$$$20240915$$CN$NL$NL
243205701$24320570$1$I$20240101$20240911$20240915$20240915$EXP$$US-ABBVIE-5920568$ABBVIE$$$$$F$Y$$$20240915$$CN$US$US
243205711$24320571$1$I$20240101$20240910$20240915$20240915$EXP$$CA-ABBVIE-5921331$ABBVIE$$36$YR$$M$Y$$$20240915$$CN$CA$CA
243205721$24320572$1$I$$20240904$20240915$20240915$EXP$$CA-AUROBINDO-AUR-APL-2024-045261$AUROBINDO$$20$YR$$$Y$$$20240915$$HP$CA$CA
243205731$24320573$1$I$$20240910$20240915$20240915$EXP$$US-ABBVIE-5920916$ABBVIE$$$$$F$Y$$$20240915$$CN$US$US
243205741$24320574$1$I$20240904$20240911$20240915$20240915$EXP$$US-ABBVIE-5920233$ABBVIE$$55$YR$$F$Y$$$20240915$$CN$US$US
243205751$24320575$1$I$20240101$20240910$20240915$20240915$EXP$$CA-ABBVIE-5921958$ABBVIE$$$$A$F$Y$$$20240915$$CN$CA$CA
243205761$24320576$1$I$20240701$20240911$20240915$20240915$EXP$$US-ABBVIE-5921052$ABBVIE$$48$YR$$M$Y$$$20240915$$CN$US$US
243205771$24320577$1$I$20240101$20240911$20240915$20240915$EXP$$US-ABBVIE-5920344$ABBVIE$$$$$M$Y$$$20240915$$CN$US$US
243205781$24320578$1$I$$20240906$20240915$20240915$PER$$US-JNJFOC-20240917383$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240915$$PH$US$US
243205802$24320580$2$F$20240906$20240906$20240915$20240918$30DAY$$US-JNJFOC-20240917213$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$HP$US$US
243205811$24320581$1$I$20240801$20240909$20240915$20240915$EXP$$US-ABBVIE-5916952$ABBVIE$$64$YR$$F$Y$$$20240915$$CN$US$US
243205821$24320582$1$I$$20240902$20240915$20240915$EXP$$IT-AUROBINDO-AUR-APL-2024-044298$AUROBINDO$Tellini M, Di Nicola M, Fonte C, Castelli B, Guidi M, Giordano F, et al. LOW DOSE CARBOPLATIN - ETOPOSIDE REGIMEN IN PEDIATRIC PATIENTS WITH LOW GRADE GLIOMA. Neuro-Oncol. 2024;26:v128$$$C$$Y$$$20240915$$HP$IT$IT
243205831$24320583$1$I$$20240902$20240915$20240915$EXP$$US-AUROBINDO-AUR-APL-2024-044185$AUROBINDO$Steinbacher D, Murray B, Devlin T, Carson SS, Ford HJ. Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy.. Pulm-Circ. 2024;14:No. 2$33$YR$$M$Y$$$20240915$$HP$US$US
243205841$24320584$1$I$$20240904$20240915$20240915$EXP$$GB-AUROBINDO-AUR-APL-2024-044352$AUROBINDO$$73$YR$$F$Y$52$KG$20240915$$CN$GB$GB
243205851$24320585$1$I$$20240902$20240915$20240915$EXP$$US-AUROBINDO-AUR-APL-2024-044486$AUROBINDO$Palmer JP, Suriawinata AA, Yan S, Kerr DA, Afzal MZ, Shirai K. Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series.. Am-J-Case-Rep. 2023;24:e938537$51$YR$$M$Y$$$20240915$$HP$US$US
243205861$24320586$1$I$$20240903$20240915$20240915$EXP$$US-AUROBINDO-AUR-APL-2024-044457$AUROBINDO$Janopaul-Naylor JR, Patel JS, Rupji M, Qian DC, Hoang KB, McCall NS, et al.. Patterns of Treatment Failure in Primary Central Nervous System Lymphoma.. Am-J-Clin-Oncol. 2024;47(7):333-338$$$$$Y$$$20240915$$HP$US$US
243205881$24320588$1$I$20240901$20240910$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409006490$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240915$$CN$US$US
243205891$24320589$1$I$$20240821$20240915$20240915$PER$$US-SA-2024SA264786$SANOFI AVENTIS$$38$YR$A$F$Y$88.64$KG$20240915$$MD$US$US
243205901$24320590$1$I$20240101$20240906$20240915$20240915$PER$$US-SA-2024SA264282$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240915$$MD$US$US
243205911$24320591$1$I$20240827$20240903$20240915$20240915$EXP$$GB-AUROBINDO-AUR-APL-2024-044184$AUROBINDO$$75$YR$$F$Y$61$KG$20240915$$PH$GB$GB
243205921$24320592$1$I$20240823$20240910$20240915$20240915$PER$$US-JNJFOC-20240926959$JOHNSON AND JOHNSON$$$$$F$Y$$$20240915$$HP$US$US
243205931$24320593$1$I$$20240905$20240915$20240915$PER$$US-AstraZeneca-2024A203300$ASTRAZENECA$$$$$M$Y$$$20240915$$CN$US$
243205941$24320594$1$I$20240101$20240909$20240915$20240915$PER$$US-SA-2024SA265559$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240915$$MD$US$US
243205951$24320595$1$I$20240101$20240909$20240915$20240915$PER$$US-SA-2024SA265293$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240915$$MD$US$US
243205961$24320596$1$I$$20240829$20240915$20240915$PER$$US-SA-2024SA265382$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240915$$HP$US$US
243205981$24320598$1$I$$20240904$20240915$20240915$EXP$$US-ASTELLAS-2024-AER-004891$ASTELLAS$$53$YR$A$M$Y$$$20240915$$CN$US$US
243206001$24320600$1$I$20240801$20240904$20240915$20240915$EXP$$FR-AUROBINDO-AUR-APL-2024-044698$AUROBINDO$$70$YR$$F$Y$45$KG$20240915$$MD$FR$FR
243206011$24320601$1$I$$20240907$20240915$20240915$PER$$US-SA-2024SA264281$SANOFI AVENTIS$$3$YR$C$M$Y$16.3$KG$20240915$$MD$US$US
243206021$24320602$1$I$$20240822$20240915$20240915$PER$$US-SA-2024SA263503$SANOFI AVENTIS$$$$A$F$Y$129.55$KG$20240915$$HP$US$US
243206031$24320603$1$I$$20240906$20240915$20240915$PER$$US-SA-2024SA264711$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240915$$MD$US$US
243206041$24320604$1$I$20240101$20240906$20240915$20240915$PER$$US-SA-2024SA264389$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240915$$MD$US$US
243206052$24320605$2$F$$20240913$20240915$20240918$PER$$US-ALXN-202409USA000541US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243206061$24320606$1$I$$20240904$20240915$20240915$EXP$$CA-AUROBINDO-AUR-APL-2024-045253$AUROBINDO$$20$YR$$$Y$$$20240915$$HP$CA$CA
243206071$24320607$1$I$$20240904$20240915$20240915$EXP$$CA-AUROBINDO-AUR-APL-2024-045141$AUROBINDO$$66$YR$$F$Y$48$KG$20240915$$HP$CA$CA
243206081$24320608$1$I$20240830$20240904$20240915$20240915$EXP$GB-MHRA-MED-202409041658565300-DTGVC$GB-GLENMARK PHARMACEUTICALS-2024GMK093856$GLENMARK$$$$$$Y$$$20240915$$CN$GB$GB
243206091$24320609$1$I$$20240828$20240915$20240915$PER$$US-SA-2024SA264585$SANOFI AVENTIS$$50$YR$A$$Y$$$20240915$$HP$US$US
243206101$24320610$1$I$20240906$20240906$20240915$20240915$PER$$US-SA-2024SA264372$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240915$$HP$US$US
243206111$24320611$1$I$$20240903$20240915$20240915$EXP$$PT-Accord-445992$ACCORD$Fernandes C, Gomes F, Lima M, Santos N, Batista S, Pereira M. EP-200-SECONDARY TO METHOTREXATE CHRONIC HEPATIC ENCEPHALOPATHY. Sinapse. 2023 Dec;23(Suppl 1).$61$YR$A$F$Y$$$20240915$$HP$PT$PT
243206121$24320612$1$I$20240720$20240904$20240915$20240915$EXP$$FR-AUROBINDO-AUR-APL-2024-044763$AUROBINDO$$49$YR$$M$Y$$$20240915$$MD$FR$FR
243206131$24320613$1$I$20240801$20240904$20240915$20240915$EXP$GB-MHRA-MED-202409040830405940-DQVJB$GB-GLENMARK PHARMACEUTICALS-2024GMK093860$GLENMARK$$$$$$Y$$$20240915$$CN$GB$GB
243206141$24320614$1$I$20130321$20240904$20240915$20240915$EXP$$PT-AUROBINDO-AUR-APL-2024-044543$AUROBINDO$$66$YR$$F$Y$52$KG$20240915$$CN$PT$PT
243206151$24320615$1$I$$20240910$20240915$20240915$PER$$US-JNJFOC-20240928081$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$CN$US$US
243206161$24320616$1$I$20240614$20240904$20240915$20240915$EXP$$ES-AUROBINDO-AUR-APL-2024-044646$AUROBINDO$$75$YR$$M$Y$$$20240915$$MD$ES$ES
243206171$24320617$1$I$$20240904$20240915$20240915$EXP$$ES-RDY-SPO/ESP/24/0013134$DR REDDYS$Pozo IB, Comesana MS, Castillo AC, Oliva MP, Vazquez GP. PUTTING PIECES TOGETHER TO REACH THE DIAGNOSIS. European Journal of Case Reports in Internal Medicine. 2024;791(11): doi:10.12890/2024_V11Sup1.$66$YR$E$M$Y$$$20240915$$HP$ES$ES
243206182$24320618$2$F$$20240909$20240915$20240917$PER$$US-ALXN-202409USA000665US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243206191$24320619$1$I$$20240905$20240915$20240915$30DAY$$US-GSK-US2024AMR110886$GLAXOSMITHKLINE$$$$$F$Y$$$20240915$$HP$US$US
243206201$24320620$1$I$20210101$20240904$20240915$20240915$EXP$$FR-AUROBINDO-AUR-APL-2024-044736$AUROBINDO$$30$YR$$M$Y$$$20240915$$PH$FR$FR
243206211$24320621$1$I$20240817$20240904$20240915$20240915$EXP$$FR-AUROBINDO-AUR-APL-2024-044728$AUROBINDO$$49$YR$$M$Y$$$20240915$$MD$FR$FR
243206221$24320622$1$I$20240824$20240904$20240915$20240915$EXP$$IT-AUROBINDO-AUR-APL-2024-044431$AUROBINDO$$72$YR$$F$Y$$$20240915$$PH$IT$IT
243206231$24320623$1$I$20221001$20240903$20240915$20240915$EXP$$PT-Accord-446002$ACCORD$Pinto R., Nogueira J., Braga M, Mesquita P., Andrade J., Vilela F., PO-0441 - (4962) - CEREBRAL NOCARDIOSIS AS A COMPLICATION OF IMMUNOSUPPRESSION: ABOUT A CASE REPORT, 30 CNMI Infectious and parasitic diseases / Case report.$60$YR$A$M$Y$$$20240915$$HP$PT$PT
243206241$24320624$1$I$20240415$20240904$20240915$20240915$EXP$$FR-AUROBINDO-AUR-APL-2024-044701$AUROBINDO$$89$YR$$M$Y$62$KG$20240915$$MD$FR$FR
243206251$24320625$1$I$$20240904$20240915$20240915$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093871$GLENMARK$Ansari A, Dirani K, Malik A, Matthews S.. Silent Manifestations of Disseminated Nocardia in a Renal Transplant Patient.. Cureus.. 2024;16(7):e65523$$$$$Y$$$20240915$$MD$US$US
243206261$24320626$1$I$$20240822$20240915$20240915$PER$$US-SA-2024SA264663$SANOFI AVENTIS$$$$E$F$Y$$$20240915$$MD$US$US
243206271$24320627$1$I$$20240826$20240915$20240915$PER$$US-SA-2024SA262355$SANOFI AVENTIS$$30$YR$A$M$Y$77.45$KG$20240915$$MD$US$US
243206281$24320628$1$I$20240101$20240904$20240915$20240915$EXP$$SE-AUROBINDO-AUR-APL-2024-044550$AUROBINDO$$76$YR$$M$Y$$$20240915$$MD$SE$SE
243206291$24320629$1$I$$20240903$20240915$20240915$PER$$US-SA-2024SA265195$SANOFI AVENTIS$$55$YR$A$$Y$$$20240915$$CN$US$US
243206301$24320630$1$I$20240813$20240905$20240915$20240915$EXP$$FR-AUROBINDO-AUR-APL-2024-044985$AUROBINDO$$17$YR$$F$Y$$$20240915$$MD$FR$FR
243206311$24320631$1$I$$20240906$20240915$20240915$PER$$US-SA-2024SA264716$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240915$$MD$US$US
243206321$24320632$1$I$20240901$20240909$20240915$20240915$PER$$US-SA-2024SA265292$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240915$$HP$US$US
243206331$24320633$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA265330$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240915$$HP$US$US
243206342$24320634$2$F$20240913$20240916$20240915$20240916$PER$$US-AMGEN-USASP2024183568$AMGEN$$76$YR$E$F$Y$$$20240916$$CN$US$US
243206351$24320635$1$I$$20240821$20240915$20240915$PER$$US-SA-2024SA264822$SANOFI AVENTIS$$$$A$F$Y$$$20240915$$MD$US$US
243206361$24320636$1$I$$20240906$20240915$20240915$PER$$US-SA-2024SA264718$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240915$$HP$US$US
243206371$24320637$1$I$20240828$20240829$20240915$20240915$PER$$US-SA-2024SA265503$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240915$$CN$US$US
243206381$24320638$1$I$$20240902$20240915$20240915$EXP$$BE-AUROBINDO-AUR-APL-2014-08061$AUROBINDO$Dewilde K, George C, Alaerts H, D^heygere F. A patient with jaundice and onychomycosis. Journal of Medicine. 2014;70 (13):756-760$55$YR$$F$Y$$$20240915$$HP$BE$BE
243206391$24320639$1$I$$20240823$20240915$20240915$PER$$US-SA-2024SA264371$SANOFI AVENTIS$$$$A$F$Y$61.36$KG$20240915$$MD$US$US
243206401$24320640$1$I$20240520$20240906$20240915$20240915$EXP$$GB-AUROBINDO-AUR-APL-2024-044738$AUROBINDO$$35$YR$$M$Y$$$20240915$$MD$GB$GB
243206411$24320641$1$I$$20240909$20240915$20240915$EXP$$US-AUROBINDO-AUR-APL-2024-044957$AUROBINDO$Khajuria B, Khajuria M, Agrawal Y.. Mycophenolate-induced posterior reversible encephalopathy syndrome.. American Journal of Therapeutics.. 2016;23(4)::e1072-e1073$29$YR$$F$Y$$$20240915$$MD$US$US
243206421$24320642$1$I$$20240829$20240915$20240915$PER$$US-SA-2024SA265586$SANOFI AVENTIS$$$$E$F$Y$70$KG$20240915$$MD$US$US
243206431$24320643$1$I$$20240910$20240915$20240915$EXP$$FR-JNJFOC-20240928523$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240915$$MD$FR$FR
243206441$24320644$1$I$$20240909$20240915$20240915$EXP$$GB-AUROBINDO-AUR-APL-2024-044912$AUROBINDO$$62$YR$$F$Y$73$KG$20240915$$MD$GB$GB
243206451$24320645$1$I$$20240911$20240915$20240915$PER$$US-ALXN-202409USA000761US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243206461$24320646$1$I$$20240911$20240915$20240915$PER$$NVSC2024US182493$NOVARTIS$$$$$M$Y$70$KG$20240915$$CN$US$US
243206471$24320647$1$I$$20240906$20240915$20240915$EXP$$DE-AUROBINDO-AUR-APL-2024-045335$AUROBINDO$$$$$M$Y$87$KG$20240915$$CN$DE$DE
243206481$24320648$1$I$$20240909$20240915$20240915$EXP$$GB-AUROBINDO-AUR-APL-2024-044916$AUROBINDO$$73$YR$$F$Y$97$KG$20240915$$MD$GB$GB
243206492$24320649$2$F$20220101$20240913$20240915$20240924$EXP$$FR-AUROBINDO-AUR-APL-2024-045218$AUROBINDO$$56$YR$$M$Y$$$20240924$$MD$FR$FR
243206521$24320652$1$I$$20240909$20240915$20240915$PER$$US-SA-2024SA265241$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240915$$HP$US$US
243206531$24320653$1$I$20240801$20240822$20240915$20240915$PER$$US-SA-2024SA264734$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240915$$MD$US$US
243206541$24320654$1$I$$20240911$20240915$20240915$PER$$US-ALXN-202409USA000816US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243206551$24320655$1$I$$20240905$20240915$20240915$EXP$$BR-ROCHE-10000079464$ROCHE$$$$$$Y$$$20240915$$MD$BR$BR
243206561$24320656$1$I$$20240911$20240915$20240915$PER$$US-AstraZeneca-2024A208829$ASTRAZENECA$$$$$F$Y$$$20240915$$MD$US$
243206571$24320657$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA265029$SANOFI AVENTIS$$52$YR$A$$Y$$$20240915$$HP$US$US
243206581$24320658$1$I$$20240911$20240915$20240915$PER$$US-ALXN-202409USA000762US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$MD$US$US
243206591$24320659$1$I$$20240911$20240915$20240915$PER$$US-ALXN-202409USA000763US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243206601$24320660$1$I$$20240911$20240915$20240915$PER$$US-ALXN-202409USA000844US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240915$$CN$US$US
243206611$24320661$1$I$20240509$20240910$20240915$20240915$EXP$$CA-JNJFOC-20240918052$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240915$$CN$CA$CA
243206641$24320664$1$I$$20240906$20240915$20240915$PER$$US-SA-2024SA264741$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240915$$HP$US$US
243206651$24320665$1$I$$20240910$20240915$20240915$PER$$US-ALXN-202409USA001071US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243206661$24320666$1$I$$20240903$20240915$20240915$EXP$$ZA-AUROBINDO-AUR-APL-2024-044782$AUROBINDO$$61$YR$$M$Y$$$20240915$$PH$ZA$ZA
243206671$24320667$1$I$$20240911$20240915$20240915$PER$$US-AstraZeneca-2024A207748$ASTRAZENECA$$$$$F$Y$$$20240915$$CN$US$
243206681$24320668$1$I$20240101$20240827$20240915$20240915$PER$$US-SA-2024SA263629$SANOFI AVENTIS$$8$YR$C$F$Y$20.45$KG$20240915$$MD$US$US
243206722$24320672$2$F$$20240912$20240915$20240923$EXP$$US-JNJFOC-20240924344$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$CN$US$US
243206731$24320673$1$I$20240830$20240910$20240915$20240915$EXP$$JP-ROCHE-10000081156$ROCHE$$6$DEC$A$M$Y$$$20240915$$MD$JP$JP
243206751$24320675$1$I$$20240904$20240915$20240915$EXP$$IT-RDY-SPO/ITA/24/0013132$DR REDDYS$Fassi E, Amoroso V, Cosentini D, Ferrari V, Lagana M, Berruti A, et al. Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report. Frontiers in Oncology. 2024;14(0): doi:10.3389/fonc.2024.1398055.$52$YR$A$F$Y$$$20240915$$HP$IT$IT
243206761$24320676$1$I$$20240902$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013032$DR REDDYS$Pillai SS, Robilliard R, Fredette ME, Serrano-Gonzalez M, Scully KJ. Persistent hypercalcemia mimicking hypophosphatasia after discontinuation of a ketogenic diet: a case report. Journal of pediatric endocrinology and metabolism : JPEM. 2023;36: 1109-1113. doi:10.1515/jpem-2023-0304.$35$MON$C$M$Y$12.9$KG$20240915$$HP$US$US
243206771$24320677$1$I$$20240830$20240915$20240915$PER$$US-SA-2024SA265153$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240915$$MD$US$US
243206782$24320678$2$F$20240910$20240917$20240915$20240919$EXP$$US-ROCHE-10000079196$ROCHE$$51$YR$A$M$Y$96.8$KG$20240919$$PH$US$US
243206801$24320680$1$I$20240811$20240821$20240915$20240915$PER$$US-SA-2024SA263475$SANOFI AVENTIS$$52$YR$A$M$Y$93.18$KG$20240915$$MD$US$US
243206811$24320681$1$I$$20240821$20240915$20240915$PER$$US-SA-2024SA262863$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240915$$CN$US$US
243206821$24320682$1$I$20240601$20240821$20240915$20240915$PER$$US-SA-2024SA263719$SANOFI AVENTIS$$56$YR$A$F$Y$75.14$KG$20240915$$MD$US$US
243206851$24320685$1$I$20240901$20240909$20240915$20240915$PER$$US-SA-2024SA265281$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240915$$HP$US$US
243206861$24320686$1$I$20240711$20240909$20240915$20240915$EXP$$CN-ROCHE-10000077853$ROCHE$$61$YR$A$M$Y$57$KG$20240915$$HP$CN$CN
243206871$24320687$1$I$20240101$20240822$20240915$20240915$PER$$US-SA-2024SA264141$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240915$$MD$US$US
243206921$24320692$1$I$20240101$20240906$20240915$20240915$PER$$US-SA-2024SA264373$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240915$$MD$US$US
243206961$24320696$1$I$$20240911$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007208$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240915$$CN$US$US
243206971$24320697$1$I$20240909$20240909$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409005802$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240915$$CN$US$US
243206981$24320698$1$I$$20240910$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007261$ELI LILLY AND CO$$$$A$F$Y$$$20240915$$MD$US$US
243206991$24320699$1$I$$20240904$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013204$DR REDDYS$Olivo-Freites C, Hill W, Patel R, Haider A, Memushaj L, Schruniger J, et al. ABCL-709 Primary Mediastinal B-Cell Lymphoma: Experience at a General Hospital in Houston, Texas. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24: S490. doi:10.1016/S2152-2650%2824%2901550-7.$$$$F$Y$$$20240915$$MD$US$US
243207001$24320700$1$I$20240801$20240911$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007462$ELI LILLY AND CO$$85$YR$E$$Y$$$20240915$$CN$US$US
243207011$24320701$1$I$$20240909$20240915$20240915$PER$$US-SA-2024SA265286$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240915$$MD$US$US
243207021$24320702$1$I$$20240912$20240915$20240915$PER$$NVSC2024US183814$NOVARTIS$$$$$$Y$$$20240915$$HP$US$US
243207072$24320707$2$F$20240901$20240911$20240915$20240921$EXP$$IL-ROCHE-10000077129$ROCHE$$31$YR$A$F$Y$$$20240921$$CN$IL$IL
243207081$24320708$1$I$$20240905$20240915$20240915$PER$$US-AstraZeneca-2024A206690$ASTRAZENECA$$$$$M$Y$$$20240915$$CN$US$
243207091$24320709$1$I$20240101$20240909$20240915$20240915$PER$$US-SA-2024SA265215$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240915$$HP$US$US
243207101$24320710$1$I$20240801$20240904$20240915$20240915$PER$$US-SA-2024SA263718$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240915$$HP$US$US
243207121$24320712$1$I$$20240826$20240915$20240915$PER$$US-JNJFOC-20240873462$JOHNSON AND JOHNSON$$$$$F$Y$$$20240915$$CN$US$US
243207132$24320713$2$F$$20240918$20240915$20240924$PER$$US-GSK-US2024110791$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243207141$24320714$1$I$$20240904$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013211$DR REDDYS$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B, et al. AML-713 Hematological Malignancies and Pregnancy: A Single-Institution Experience. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(1): S333-S334. doi:10.1016/S2152-2650%2824%2901240-0.$$$$F$Y$$$20240915$$MD$US$US
243207151$24320715$1$I$$20240826$20240915$20240915$PER$$US-SA-2024SA264278$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240915$$HP$US$US
243207161$24320716$1$I$$20240821$20240915$20240915$PER$$US-SA-2024SA263786$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240915$$MD$US$US
243207171$24320717$1$I$$20240912$20240915$20240915$PER$$NVSC2024US184019$NOVARTIS$$$$$$Y$$$20240915$$HP$US$US
243207181$24320718$1$I$$20240909$20240915$20240915$PER$$US-JNJFOC-20240921683$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$MD$US$US
243207191$24320719$1$I$20240101$20240821$20240915$20240915$PER$$US-SA-2024SA263089$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240915$$MD$US$US
243207201$24320720$1$I$$20240911$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007549$ELI LILLY AND CO$$$$A$M$Y$$$20240915$$CN$US$US
243207212$24320721$2$F$$20240918$20240915$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409007276$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240923$$CN$US$US
243207221$24320722$1$I$20240101$20240906$20240915$20240915$PER$$US-SA-2024SA264367$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240915$$HP$US$US
243207231$24320723$1$I$20240101$20240906$20240915$20240915$PER$$US-SA-2024SA265357$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240915$$MD$US$US
243207241$24320724$1$I$20240801$20240905$20240915$20240915$30DAY$$US-GSK-US2024110799$GLAXOSMITHKLINE$$44$YR$$F$Y$$$20240915$$CN$US$US
243207251$24320725$1$I$$20240912$20240915$20240915$PER$$NVSC2024US183936$NOVARTIS$$$$$M$Y$$$20240915$$CN$US$US
243207261$24320726$1$I$$20240903$20240915$20240915$PER$$US-SA-2024SA264753$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240915$$HP$US$US
243207271$24320727$1$I$20240801$20240905$20240915$20240915$PER$$US-SA-2024SA264621$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240915$$HP$US$US
243207281$24320728$1$I$20240101$20240906$20240915$20240915$EXP$$US-SA-2024SA150029$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240915$$MD$US$US
243207291$24320729$1$I$$20240912$20240915$20240915$PER$$NVSC2024US183724$NOVARTIS$$$$$M$Y$$$20240915$$HP$US$US
243207301$24320730$1$I$20240901$20240910$20240915$20240915$PER$$US-JNJFOC-20240933274$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240915$$CN$US$US
243207311$24320731$1$I$$20240904$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013222$DR REDDYS$Ingole P, Morkas M, May R, Hinman B. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24: S587. doi:10.1016/S2152-2650%2824%2901739-7.$$$$M$Y$$$20240915$$HP$US$US
243207321$24320732$1$I$20240828$20240906$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013154$DR REDDYS$$56$YR$A$F$Y$$$20240915$$HP$US$US
243207331$24320733$1$I$20240903$20240906$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013276$DR REDDYS$$32$YR$A$M$Y$$$20240915$$MD$US$US
243207341$24320734$1$I$$20240905$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013038$DR REDDYS$$48$YR$A$F$Y$$$20240915$$HP$US$US
243207351$24320735$1$I$20240907$20240907$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013238$DR REDDYS$$62$YR$A$M$Y$$$20240915$$HP$US$US
243207361$24320736$1$I$$20240906$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013175$DR REDDYS$$49$YR$A$F$Y$$$20240915$$HP$US$US
243207371$24320737$1$I$$20240905$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013037$DR REDDYS$$58$YR$A$M$Y$$$20240915$$HP$US$US
243207381$24320738$1$I$$20240902$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013192$DR REDDYS$Russe-Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwai A. Rousing drug-induced liver injury through cytochrome p450 isoenzyme overload leading to fulminant liver failure. Journal of Liver Transplantation. 2024 May;14: doi:10.1016/j.liver.2024.100207.$40$YR$A$F$Y$$$20240915$$HP$US$US
243207391$24320739$1$I$20240830$20240906$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013178$DR REDDYS$$77$YR$E$F$Y$$$20240915$$HP$US$US
243207401$24320740$1$I$20240909$20240909$20240915$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144421$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240915$$CN$US$US
243207411$24320741$1$I$$20240905$20240915$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142258$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240915$$PH$US$US
243207421$24320742$1$I$$20240904$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013221$DR REDDYS$Ingole P, Morkas M, May R, Hinman B, Carrum G, Kamble RT. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24: S587. doi:10.1016/S2152-2650%2824%2901739-7.$$$$$Y$$$20240915$$HP$US$US
243207431$24320743$1$I$$20240906$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013151$DR REDDYS$$67$YR$E$M$Y$$$20240915$$HP$US$US
243207441$24320744$1$I$20240821$20240905$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013043$DR REDDYS$$36$YR$A$M$Y$$$20240915$$HP$US$US
243207451$24320745$1$I$$20240906$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013177$DR REDDYS$$67$YR$E$M$Y$$$20240915$$MD$US$US
243207461$24320746$1$I$$20240906$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013179$DR REDDYS$$61$YR$A$$Y$$$20240915$$HP$US$US
243207471$24320747$1$I$20240903$20240905$20240915$20240915$PER$$US-RDY-SPO/USA/24/0013044$DR REDDYS$$27$YR$A$M$Y$$$20240915$$HP$US$US
243207482$24320748$2$F$$20240916$20240915$20240924$EXP$$US-RDY-SPO/USA/24/0013232$DR REDDYS$$28$YR$A$M$Y$$$20240924$$HP$US$US
243207491$24320749$1$I$$20240905$20240915$20240915$30DAY$$US-GSK-US2024110713$GLAXOSMITHKLINE$$$$$M$Y$$$20240915$$CN$US$US
243207501$24320750$1$I$$20240906$20240915$20240915$PER$$US-JNJFOC-20240916096$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240915$$CN$US$US
243207511$24320751$1$I$$20240822$20240915$20240915$PER$$US-SA-2024SA262578$SANOFI AVENTIS$$48$YR$A$M$Y$86$KG$20240915$$MD$US$US
243207521$24320752$1$I$20240101$20240823$20240915$20240915$PER$$US-SA-2024SA263562$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240915$$MD$US$US
243207531$24320753$1$I$$20240909$20240915$20240915$PER$$US-JNJFOC-20240921357$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$CN$US$US
243207541$24320754$1$I$$20240903$20240915$20240915$EXP$$FR-RDY-SPO/FRA/24/0013129$DR REDDYS$Diallo AO, Lorenzo-Villalba N, Marcou A, Cordoba- Sosa Z, Lespinasse J, Andres E, et al. Malignant hypercalcemia revealing a diffuse large B-cell lymphoma in a patient with a previous diagnosis of chronic myelomonocytic leukemia: An uncommon hematological coexistence. Clinical Case Reports. 2023 Sep 01;11(9): doi:10.1002/ccr3.7885.$76$YR$E$M$Y$$$20240915$$HP$FR$FR
243207551$24320755$1$I$$20240904$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013208$DR REDDYS$Khadka S, Dong N, Chavez J. ABCL-440 Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CHP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Singl. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24: S480. doi:10.1016/S2152-2650%2824%2901530-1.$$$$$Y$$$20240915$$MD$US$US
243207561$24320756$1$I$$20240911$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007503$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240915$$CN$US$US
243207571$24320757$1$I$$20240912$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409008846$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240915$$CN$US$US
243207581$24320758$1$I$$20240912$20240915$20240915$PER$$US-ALXN-202409USA001021US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240915$$CN$US$US
243207591$24320759$1$I$$20240905$20240915$20240915$EXP$$US-RDY-SPO/USA/24/0013350$DR REDDYS$Heyman HM, Alberts NM, Rees M, Puri L, Frett MJ, Anghelescu DL. COVID-19 infection and pain in adolescents with sickle cell disease: A case series. eJHaem. 2022 Nov;3(4): 1310-1315. doi:10.1002/jha2.587.$17$YR$T$F$Y$$$20240915$$HP$US$US
243207611$24320761$1$I$20240909$20240911$20240915$20240915$PER$$US-JNJFOC-20240929561$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$CN$US$US
243207621$24320762$1$I$$20240905$20240915$20240915$PER$$US-ROCHE-10000076250$ROCHE$Mahtani R, Harpalani N, Yan F, Phiel K, Kovalenko L. Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series. Frontiers in Oncology. 2024-Jan;14:1-7. doi:10.3389/fonc.2024.1419246.$45$YR$A$F$Y$$$20240915$$HP$US$US
243207631$24320763$1$I$$20240906$20240915$20240915$EXP$$JP-ROCHE-10000005166$ROCHE$$8$DEC$E$M$Y$$$20240915$$MD$JP$JP
243207701$24320770$1$I$20240816$20240906$20240915$20240915$EXP$$JP-ROCHE-10000077327$ROCHE$$73$YR$E$M$Y$$$20240915$$MD$JP$JP
243207721$24320772$1$I$$20240910$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409006486$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240915$$CN$US$US
243207731$24320773$1$I$20240910$20240910$20240915$20240915$PER$$US-ROCHE-10000079127$ROCHE$$44$YR$A$M$Y$87.27$KG$20240915$$PH$US$US
243207742$24320774$2$F$$20240822$20240915$20240918$PER$$US-SA-2024SA264032$SANOFI AVENTIS$$$$C$M$Y$32$KG$20240918$$MD$US$US
243207751$24320775$1$I$$20240912$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409008403$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240915$$CN$US$US
243207761$24320776$1$I$$20240909$20240915$20240915$EXP$$US-JNJFOC-20240930186$JOHNSON AND JOHNSON$$$$$M$Y$$$20240915$$MD$US$US
243207771$24320777$1$I$$20240912$20240915$20240915$PER$$US-ALXN-202409USA000941US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240915$$HP$US$US
243207781$24320778$1$I$$20240909$20240915$20240915$EXP$$US-JNJFOC-20240929960$JOHNSON AND JOHNSON$$$$$M$Y$$$20240915$$CN$US$US
243207841$24320784$1$I$$20240822$20240915$20240915$PER$$US-SA-2024SA264142$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240915$$MD$US$US
243207851$24320785$1$I$20240501$20240905$20240915$20240915$PER$$US-SA-2024SA264194$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240915$$MD$US$US
243207861$24320786$1$I$20240902$20240909$20240915$20240915$EXP$$CO-JNJFOC-20240928416$JOHNSON AND JOHNSON$$76$YR$E$M$Y$100$KG$20240915$$HP$CO$CO
243207871$24320787$1$I$20240601$20240904$20240915$20240915$PER$$US-SA-2024SA262738$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240915$$MD$US$US
243207881$24320788$1$I$$20240909$20240915$20240915$EXP$$CA-JNJFOC-20240928344$JOHNSON AND JOHNSON$$4$MON$I$F$Y$$$20240915$$HP$CA$CA
243207941$24320794$1$I$$20240912$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409008190$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240915$$CN$US$US
243208021$24320802$1$I$20240821$20240821$20240915$20240915$PER$$US-SA-2024SA263583$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240915$$MD$US$US
243208031$24320803$1$I$$20240911$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007601$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240915$$CN$US$US
243208041$24320804$1$I$$20240906$20240915$20240915$PER$$US-JNJFOC-20240917978$JOHNSON AND JOHNSON$$$$$F$Y$$$20240915$$CN$US$US
243208051$24320805$1$I$20240909$20240910$20240915$20240915$PER$$US-JNJFOC-20240934287$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240915$$PH$US$US
243208071$24320807$1$I$$20240912$20240915$20240915$PER$$US-JNJFOC-20240931834$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$CN$US$US
243208091$24320809$1$I$20240911$20240912$20240915$20240915$PER$$US-JNJFOC-20240932482$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$HP$US$US
243208181$24320818$1$I$$20240905$20240915$20240915$EXP$$US-ARDELYX-2024ARDX006761$ARDELYX$$$$$M$Y$$$20240916$$HP$US$US
243208192$24320819$2$F$20240816$20240913$20240915$20240923$EXP$$US-ARDELYX-2024ARDX006777$ARDELYX$$68$YR$$F$Y$$$20240923$$HP$US$US
243208201$24320820$1$I$$20240821$20240915$20240915$PER$$US-SA-2024SA263788$SANOFI AVENTIS$$66$YR$E$F$Y$102.73$KG$20240915$$MD$US$US
243208211$24320821$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA263646$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240915$$MD$US$US
243208221$24320822$1$I$$20240906$20240915$20240915$PER$$US-SA-2024SA264955$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240915$$HP$US$US
243208231$24320823$1$I$$20240906$20240915$20240915$PER$$US-SA-2024SA265426$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240915$$HP$US$US
243208241$24320824$1$I$$20240906$20240915$20240915$PER$$US-JNJFOC-20240917982$JOHNSON AND JOHNSON$$$$$M$Y$$$20240915$$CN$US$US
243208251$24320825$1$I$$20240827$20240915$20240915$PER$$US-SA-2024SA264627$SANOFI AVENTIS$$$$A$F$Y$79.55$KG$20240915$$MD$US$US
243208261$24320826$1$I$$20240903$20240915$20240915$PER$$US-SA-2024SA264967$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240915$$HP$US$US
243208271$24320827$1$I$20240801$20240821$20240915$20240915$PER$$US-SA-2024SA263648$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240915$$MD$US$US
243208351$24320835$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA263572$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240915$$MD$US$US
243208361$24320836$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA263955$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240915$$HP$US$US
243208401$24320840$1$I$20240301$20240904$20240915$20240915$PER$$US-SA-2024SA263689$SANOFI AVENTIS$$$$$F$Y$$$20240915$$MD$US$US
243208511$24320851$1$I$20240101$20240904$20240915$20240915$PER$$US-SA-2024SA263939$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240915$$HP$US$US
243208521$24320852$1$I$20220501$20240911$20240915$20240915$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-172716$BOEHRINGER INGELHEIM$$73$YR$E$F$Y$$$20240915$$CN$CA$CA
243208531$24320853$1$I$$20240907$20240915$20240915$PER$$US-JNJFOC-20240923696$JOHNSON AND JOHNSON$$$$$F$Y$$$20240915$$CN$US$US
243208541$24320854$1$I$20240620$20240909$20240915$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145176$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240915$$MD$US$US
243208551$24320855$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA263946$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240915$$MD$US$US
243208561$24320856$1$I$20240701$20240912$20240915$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146273$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240915$$HP$US$US
243208571$24320857$1$I$$20240911$20240915$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145588$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240915$$CN$US$US
243208581$24320858$1$I$$20240912$20240915$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146082$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240915$$HP$US$US
243208591$24320859$1$I$20240827$20240913$20240915$20240915$EXP$DK-DKMA-30738341$DK-JNJFOC-20240936510$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20240915$$MD$DK$DK
243208611$24320861$1$I$20240901$20240905$20240915$20240915$PER$$US-SA-2024SA264476$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240915$$MD$US$US
243208621$24320862$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA264065$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240915$$HP$US$US
243208631$24320863$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA264965$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240915$$HP$US$US
243208641$24320864$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA263899$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240915$$HP$US$US
243208651$24320865$1$I$$20240823$20240915$20240915$PER$$US-SA-2024SA264660$SANOFI AVENTIS$$$$C$F$Y$14.5$KG$20240915$$HP$US$US
243208661$24320866$1$I$20240801$20240904$20240915$20240915$PER$$US-SA-2024SA263863$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240915$$MD$US$US
243208671$24320867$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA264081$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240915$$MD$US$US
243208681$24320868$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA264594$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240915$$HP$US$US
243208694$24320869$4$F$$20240923$20240915$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145755$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240924$$PH$US$US
243208702$24320870$2$F$20231120$20240913$20240915$20240917$EXP$ES-AEMPS-1567706$ES-JNJFOC-20240935322$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240917$$MD$ES$ES
243208711$24320871$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA263823$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240915$$HP$US$US
243208721$24320872$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA263751$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240915$$HP$US$US
243208731$24320873$1$I$20240801$20240905$20240915$20240915$PER$$US-SA-2024SA264539$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240915$$MD$US$US
243208751$24320875$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA263830$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240915$$HP$US$US
243208761$24320876$1$I$$20240906$20240915$20240915$PER$$US-JNJFOC-20240929664$JOHNSON AND JOHNSON$$$$$M$Y$$$20240915$$CN$US$US
243208771$24320877$1$I$$20240906$20240915$20240915$PER$$US-JNJFOC-20240917334$JOHNSON AND JOHNSON$$$$$M$Y$$$20240915$$PH$US$US
243208781$24320878$1$I$$20240909$20240915$20240915$PER$$US-JNJFOC-20240922285$JOHNSON AND JOHNSON$$$$$M$Y$$$20240915$$CN$US$US
243208791$24320879$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA263558$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240915$$HP$US$US
243208801$24320880$1$I$$20240801$20240915$20240915$EXP$$JP-009507513-2409JPN002925$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$81$YR$$F$Y$$$20240915$$HP$JP$JP
243208811$24320881$1$I$20240801$20240823$20240915$20240915$PER$$US-SA-2024SA262449$SANOFI AVENTIS$$62$YR$A$F$Y$45.45$KG$20240916$$MD$US$US
243208821$24320882$1$I$$20240908$20240915$20240915$PER$$US-JNJFOC-20240927531$JOHNSON AND JOHNSON$$$$$$Y$$$20240915$$CN$US$US
243208831$24320883$1$I$$20240830$20240915$20240915$PER$$US-JNJFOC-20240901326$JOHNSON AND JOHNSON$$$$$F$Y$$$20240915$$CN$US$US
243208841$24320884$1$I$20240101$20240820$20240915$20240915$PER$$US-SA-2024SA263644$SANOFI AVENTIS$$59$YR$A$M$Y$111.36$KG$20240916$$MD$US$US
243208851$24320885$1$I$20240101$20240904$20240915$20240915$PER$$US-SA-2024SA262905$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240916$$MD$US$US
243208861$24320886$1$I$20240101$20240820$20240915$20240915$PER$$US-SA-2024SA264128$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
243208871$24320887$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA263366$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240916$$HP$US$US
243208881$24320888$1$I$20240101$20240826$20240915$20240915$PER$$US-SMPA-2024SPA002019$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243208891$24320889$1$I$$20240826$20240915$20240915$PER$$US-SMPA-2024SPA001958$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243208901$24320890$1$I$20240801$20240830$20240915$20240915$PER$$US-SMPA-2024SPA002204$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243208911$24320891$1$I$$20240822$20240915$20240915$PER$$US-SMPA-2024SPA001825$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243208921$24320892$1$I$20240101$20240902$20240915$20240915$PER$$US-SMPA-2024SPA002234$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243208932$24320893$2$F$$20240819$20240915$20240917$PER$$US-SMPA-2024SPA001639$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243208951$24320895$1$I$$20240822$20240915$20240915$PER$$US-SMPA-2024SPA001879$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243208982$24320898$2$F$20240801$20240821$20240915$20240926$PER$$JP-SMPA-2024SPA002154$SUNOVION$$$$$$Y$$$20240926$$CN$US$US
243208992$24320899$2$F$$20240918$20240915$20240930$PER$$US-SMPA-2024SPA002029$SUNOVION$$$$$$Y$$$20240929$$HP$US$US
243209001$24320900$1$I$$20240824$20240915$20240915$PER$$US-SMPA-2024SPA001925$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209011$24320901$1$I$$20240828$20240915$20240915$PER$$US-SMPA-2024SPA002083$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209021$24320902$1$I$$20240822$20240915$20240915$PER$$US-SMPA-2024SPA001837$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209041$24320904$1$I$$20240821$20240915$20240915$PER$$US-SMPA-2024SPA001766$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209072$24320907$2$F$$20240910$20240915$20240927$PER$$US-SMPA-2024SPA002530$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243209081$24320908$1$I$$20240828$20240915$20240915$PER$$US-SMPA-2024SPA002106$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209091$24320909$1$I$$20240828$20240915$20240915$PER$$US-SMPA-2024SPA002115$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209101$24320910$1$I$$20240828$20240915$20240915$PER$$US-SMPA-2024SPA002109$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209111$24320911$1$I$$20240823$20240915$20240915$PER$$US-SMPA-2024SPA001850$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209122$24320912$2$F$$20240904$20240915$20240925$PER$$US-SMPA-2024SPA002081$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243209131$24320913$1$I$$20240826$20240915$20240915$PER$$US-SMPA-2024SPA001962$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209141$24320914$1$I$$20240828$20240915$20240915$PER$$US-SMPA-2024SPA002098$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209151$24320915$1$I$$20240823$20240915$20240915$PER$$US-SMPA-2024SPA001900$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209161$24320916$1$I$$20240826$20240915$20240915$PER$$US-SMPA-2024SPA001981$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209171$24320917$1$I$$20240823$20240915$20240915$PER$$US-SMPA-2024SPA001878$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209181$24320918$1$I$$20240827$20240915$20240915$PER$$US-SMPA-2024SPA002039$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209191$24320919$1$I$$20240826$20240915$20240915$PER$$US-SMPA-2024SPA001951$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209202$24320920$2$F$$20240913$20240915$20240924$PER$$US-SMPA-2024SPA002177$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243209211$24320921$1$I$$20240905$20240915$20240915$PER$$US-SMPA-2024SPA002395$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209221$24320922$1$I$$20240826$20240915$20240915$PER$$US-SMPA-2024SPA001979$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209231$24320923$1$I$$20240822$20240915$20240915$PER$$US-SMPA-2024SPA001821$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209242$24320924$2$F$$20240903$20240915$20240924$PER$$US-SMPA-2024SPA002013$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243209251$24320925$1$I$$20240905$20240915$20240915$PER$$US-SMPA-2024SPA002394$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209272$24320927$2$F$$20240916$20240915$20240924$PER$$US-SMPA-2024SPA002185$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243209291$24320929$1$I$$20240911$20240915$20240915$PER$$US-SMPA-2024SPA002587$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209301$24320930$1$I$$20240827$20240915$20240915$PER$$US-SMPA-2024SPA002018$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209311$24320931$1$I$$20240909$20240915$20240915$PER$$US-SMPA-2024SPA001980$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209322$24320932$2$F$$20240911$20240915$20240930$PER$$US-SMPA-2024SPA002490$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243209331$24320933$1$I$$20240823$20240915$20240915$PER$$US-SMPA-2024SPA001915$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209341$24320934$1$I$$20240826$20240915$20240915$PER$$US-SMPA-2024SPA002052$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209353$24320935$3$F$20240701$20240910$20240915$20240930$PER$$US-SMPA-2024SPA002156$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243209361$24320936$1$I$$20240823$20240915$20240915$PER$$US-SMPA-2024SPA001894$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209371$24320937$1$I$$20240826$20240915$20240915$PER$$US-SMPA-2024SPA001992$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209391$24320939$1$I$$20240825$20240915$20240915$PER$$US-SMPA-2024SPA001913$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209421$24320942$1$I$$20240823$20240915$20240915$PER$$US-SMPA-2024SPA001903$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209432$24320943$2$F$$20240923$20240915$20240930$PER$$US-SMPA-2024SPA001862$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243209441$24320944$1$I$$20240908$20240915$20240915$PER$$US-SMPA-2024SPA002496$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209451$24320945$1$I$$20240902$20240915$20240915$PER$$US-SMPA-2024SPA002219$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209461$24320946$1$I$$20240905$20240915$20240915$PER$$US-SMPA-2024SPA002435$SUNOVION$$$$$$Y$$$20240915$$CN$US$US
243209471$24320947$1$I$20240101$20240822$20240915$20240915$PER$$US-SA-2024SA263710$SANOFI AVENTIS$$88$YR$E$F$Y$73.9$KG$20240916$$MD$US$US
243209481$24320948$1$I$20240101$20240905$20240915$20240915$PER$$US-SA-2024SA262915$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
243209501$24320950$1$I$$20240909$20240915$20240915$EXP$$US-JNJFOC-20240925932$JOHNSON AND JOHNSON$$91$YR$E$M$Y$$$20240916$$CN$US$US
243209511$24320951$1$I$$20240912$20240915$20240915$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051396$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240916$$CN$US$US
243209521$24320952$1$I$20240901$20240909$20240915$20240915$EXP$$US-Bion-013826$BIONPHARMA$$72$YR$E$F$Y$$$20240916$$CN$US$US
243209531$24320953$1$I$$20240909$20240915$20240915$30DAY$$IT-SANDOZ INC.-SDZ2024IT079184$SANDOZ$$$$$M$Y$$$20240915$$CN$IT$IT
243209541$24320954$1$I$$20240905$20240915$20240915$EXP$$US-Bion-013834$BIONPHARMA$$$$$F$Y$$$20240916$$CN$US$US
243209551$24320955$1$I$$20240909$20240915$20240915$EXP$$US-Bion-013830$BIONPHARMA$$82$YR$E$$Y$$$20240916$$HP$US$US
243209561$24320956$1$I$20240901$20240910$20240915$20240915$PER$$US-AMGEN-USASP2024180944$AMGEN$$$$$$Y$$$20240915$$CN$US$US
243209571$24320957$1$I$20210622$20240911$20240915$20240915$PER$$US-AMGEN-USASP2024181957$AMGEN$$59$YR$A$F$Y$$$20240915$$CN$US$US
243209591$24320959$1$I$20240801$20240909$20240915$20240915$EXP$$US-SANDOZ INC.-SDZ2024US080258$SANDOZ$$$$$F$Y$$$20240915$$CN$US$US
243209601$24320960$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA262949$SANOFI AVENTIS$$$$$F$Y$$$20240916$$HP$US$US
243209611$24320961$1$I$$20240909$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409007197$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240915$$CN$US$US
243209622$24320962$2$F$20240101$20240909$20240915$20240923$PER$$US-SA-2024SA262926$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240923$$MD$US$US
243209631$24320963$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA263981$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$MD$US$US
243209641$24320964$1$I$$20240910$20240915$20240915$EXP$$US-JNJFOC-20240925183$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240916$$CN$US$US
243209661$24320966$1$I$$20240911$20240915$20240915$EXP$$FR-JNJFOC-20240931654$JOHNSON AND JOHNSON$$84$YR$E$M$Y$78$KG$20240916$$MD$FR$FR
243209671$24320967$1$I$$20240911$20240915$20240915$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145879$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240916$$MD$US$US
243209681$24320968$1$I$$20240909$20240915$20240915$EXP$$ZA-AstraZeneca-2024A207356$ASTRAZENECA$$76$YR$$F$Y$$$20240916$$CN$ZA$
243209691$24320969$1$I$$20240909$20240915$20240915$EXP$$CA-ABBVIE-5883447$ABBVIE$$$$$M$Y$$$20240915$$HP$CA$CA
243209711$24320971$1$I$$20240910$20240915$20240915$EXP$$US-JNJFOC-20240927090$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$US$US
243209721$24320972$1$I$$20240911$20240915$20240915$EXP$$US-ABBVIE-5919845$ABBVIE$$$$$M$Y$$$20240915$$CN$US$US
243209742$24320974$2$F$20240901$20240919$20240915$20240926$PER$$US-AMGEN-USASP2024183294$AMGEN$$74$YR$E$F$Y$$$20240926$$CN$US$US
243209751$24320975$1$I$20240906$20240909$20240915$20240915$EXP$$US-ABBVIE-5917544$ABBVIE$$50$YR$$F$Y$$$20240915$$CN$US$US
243209761$24320976$1$I$20240904$20240913$20240915$20240915$EXP$$CN-JNJFOC-20240937547$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240916$$HP$CN$CN
243209771$24320977$1$I$20211223$20240909$20240915$20240915$EXP$$US-ABBVIE-5905812$ABBVIE$$60$YR$$F$Y$100$KG$20240915$$CN$US$US
243209781$24320978$1$I$$20240906$20240915$20240915$EXP$$BR-TAKEDA-2024TUS090256$TAKEDA$$$$A$M$Y$$$20240915$$MD$BR$BR
243209801$24320980$1$I$$20240910$20240915$20240915$EXP$$US-ABBVIE-5918512$ABBVIE$$$$$F$Y$$$20240915$$CN$US$US
243209811$24320981$1$I$$20240910$20240915$20240915$EXP$$US-ABBVIE-5917610$ABBVIE$$$$$F$Y$$$20240915$$CN$US$US
243209821$24320982$1$I$$20240910$20240915$20240915$EXP$$CA-JNJFOC-20240929583$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$HP$CA$CA
243209841$24320984$1$I$$20240910$20240915$20240915$EXP$$BG-ABBVIE-5919579$ABBVIE$$65$YR$$M$Y$$$20240915$$CN$BG$BG
243209851$24320985$1$I$20240101$20240909$20240915$20240915$EXP$$ES-ABBVIE-5845966$ABBVIE$$$$$F$Y$$$20240915$$MD$ES$ES
243209861$24320986$1$I$20240101$20240909$20240915$20240915$EXP$$US-ABBVIE-5918039$ABBVIE$$$$$M$Y$$$20240915$$CN$US$US
243209881$24320988$1$I$20240101$20240910$20240915$20240915$EXP$$CA-ABBVIE-5917920$ABBVIE$$$$E$$Y$$$20240915$$PH$CA$CA
243209891$24320989$1$I$20240822$20240822$20240915$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-135187$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240916$$CN$US$US
243209911$24320991$1$I$$20240911$20240915$20240915$PER$$US-AMGEN-USASP2024181701$AMGEN$$77$YR$E$F$Y$$$20240915$$CN$US$US
243209931$24320993$1$I$$20240909$20240915$20240915$EXP$$ZA-AstraZeneca-2024A206336$ASTRAZENECA$$77$YR$$M$Y$$$20240916$$CN$ZA$
243209941$24320994$1$I$20240701$20240909$20240915$20240915$PER$$US-SA-2024SA265543$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240916$$HP$US$US
243209951$24320995$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA263912$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240916$$MD$US$US
243209962$24320996$2$F$$20240910$20240915$20240919$EXP$$US-ABBVIE-5870789$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243209971$24320997$1$I$$20240910$20240915$20240915$PER$$US-AMGEN-USASP2024181563$AMGEN$$$$$$Y$$$20240915$$CN$US$US
243209981$24320998$1$I$20240101$20240911$20240915$20240915$EXP$$US-ABBVIE-5920250$ABBVIE$$$$$M$Y$$$20240915$$CN$US$US
243209991$24320999$1$I$20240101$20240911$20240915$20240915$EXP$$US-ABBVIE-5919932$ABBVIE$$65$YR$$M$Y$$$20240915$$CN$US$US
243210001$24321000$1$I$20240501$20240620$20240915$20240915$PER$$US-BEIGENE-BGN-2024-009671$BEIGENE$$$$$$Y$$$20240915$$CN$US$US
243210011$24321001$1$I$$20240910$20240915$20240915$PER$$US-ABBVIE-5918691$ABBVIE$$$$$$Y$$$20240915$$CN$US$US
243210021$24321002$1$I$20240827$20240909$20240915$20240915$EXP$$CN-BEIGENE-BGN-2024-014286$BEIGENE$$$$$$Y$$$20240915$$HP$CN$CN
243210032$24321003$2$F$20240701$20240924$20240915$20240926$EXP$IT-MINISAL02-1001400$IT-JNJFOC-20240935176$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240927$$MD$IT$IT
243210041$24321004$1$I$$20240904$20240915$20240915$PER$$US-SA-2024SA264952$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240916$$CN$US$US
243210051$24321005$1$I$20240831$20240909$20240915$20240915$EXP$$CN-BEIGENE-BGN-2024-014287$BEIGENE$$$$$$Y$$$20240915$$HP$CN$CN
243210061$24321006$1$I$$20240910$20240915$20240915$PER$$US-AMGEN-USASP2024182275$AMGEN$$$$A$F$Y$$$20240915$$CN$US$US
243210071$24321007$1$I$$20240911$20240915$20240915$PER$$US-AMGEN-USASP2024182785$AMGEN$$$$$$Y$$$20240915$$PH$US$US
243210081$24321008$1$I$20240912$20240913$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409008861$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240915$$CN$US$US
243210091$24321009$1$I$$20240911$20240915$20240915$EXP$GB-MHRA-MED-202409102349253270-YZNMC$GB-ORGANON-O2409GBR000790$ORGANON$$$$$M$Y$$$20240915$$CN$GB$GB
243210101$24321010$1$I$20240810$20240909$20240915$20240915$EXP$$CN-BEIGENE-BGN-2024-014283$BEIGENE$$$$$$Y$$$20240915$$HP$CN$CN
243210111$24321011$1$I$20240910$20240912$20240915$20240915$PER$$US-ABBVIE-5922946$ABBVIE$$38$YR$$F$Y$$$20240915$$MD$US$US
243210121$24321012$1$I$$20240910$20240915$20240915$EXP$$US-JNJFOC-20240926864$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$CN$US$US
243210131$24321013$1$I$20240728$20240912$20240915$20240915$EXP$SE-SEMPA-2024-006534$SE-JNJFOC-20240939482$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240916$$MD$SE$SE
243210151$24321015$1$I$$20240913$20240915$20240915$EXP$BE-FAMHP-DHH-N2024-122583$BE-JNJFOC-20240938424$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240916$$PH$BE$BE
243210161$24321016$1$I$20240906$20240906$20240915$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142893$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240916$$HP$US$US
243210171$24321017$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA264497$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240916$$HP$US$US
243210181$24321018$1$I$$20240909$20240915$20240915$PER$$US-SA-2024SA265519$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240916$$HP$US$US
243210191$24321019$1$I$20240731$20240909$20240915$20240915$EXP$$CN-BEIGENE-BGN-2024-014284$BEIGENE$$$$$$Y$$$20240915$$HP$CN$CN
243210201$24321020$1$I$20240905$20240909$20240915$20240915$EXP$$CN-BEIGENE-BGN-2024-014292$BEIGENE$$$$$$Y$$$20240915$$HP$CN$CN
243210211$24321021$1$I$20240819$20240911$20240915$20240915$EXP$$NVSC2024CA148802$NOVARTIS$$$$$F$Y$$$20240916$$HP$CA$CA
243210221$24321022$1$I$20240906$20240909$20240915$20240915$EXP$$CN-BEIGENE-BGN-2024-014285$BEIGENE$$$$$$Y$$$20240915$$HP$CN$CN
243210231$24321023$1$I$$20240909$20240915$20240915$EXP$$US-AstraZeneca-2024A205766$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243210241$24321024$1$I$$20240911$20240915$20240915$EXP$$US-AstraZeneca-2024A207669$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243210251$24321025$1$I$$20240908$20240915$20240915$EXP$$TR-JNJFOC-20240931905$JOHNSON AND JOHNSON$$16$YR$T$$Y$$$20240916$$HP$TR$TR
243210261$24321026$1$I$20240706$20240909$20240915$20240915$EXP$$CN-BEIGENE-BGN-2024-014295$BEIGENE$$$$$$Y$$$20240915$$HP$CN$CN
243210271$24321027$1$I$$20240910$20240915$20240915$EXP$$US-JNJFOC-20240925090$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$US$US
243210281$24321028$1$I$$20240912$20240915$20240915$EXP$$IL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051421$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240916$$MD$IL$IL
243210291$24321029$1$I$20240101$20240909$20240915$20240915$PER$$US-SA-2024SA265538$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240916$$HP$US$US
243210301$24321030$1$I$20240830$20240909$20240915$20240915$EXP$$CN-ABBVIE-5921060$ABBVIE$$43$YR$$M$Y$96$KG$20240915$$HP$CN$CN
243210311$24321031$1$I$20240828$20240909$20240915$20240915$EXP$$CN-BEIGENE-BGN-2024-014296$BEIGENE$$$$$$Y$$$20240915$$HP$CN$CN
243210321$24321032$1$I$20240101$20240909$20240915$20240915$PER$$US-SA-2024SA265513$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240916$$MD$US$US
243210331$24321033$1$I$20240116$20240912$20240915$20240915$EXP$$DE-TAKEDA-2024TUS091178$TAKEDA$$$$A$M$Y$$$20240915$$HP$DE$DE
243210341$24321034$1$I$$20240911$20240915$20240915$PER$$US-AMGEN-USASP2024182787$AMGEN$$$$$$Y$$$20240915$$CN$US$US
243210351$24321035$1$I$20240906$20240909$20240915$20240915$EXP$$CN-BEIGENE-BGN-2024-014297$BEIGENE$$$$$$Y$$$20240915$$HP$CN$CN
243210361$24321036$1$I$$20240906$20240915$20240915$PER$$US-SA-2024SA263803$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$HP$US$US
243210371$24321037$1$I$20230101$20240909$20240915$20240915$EXP$$US-TAKEDA-2023TUS010672$TAKEDA$$72$YR$$F$Y$52.43$KG$20240915$$CN$US$US
243210381$24321038$1$I$20240101$20240904$20240915$20240915$PER$$US-ABBVIE-5913758$ABBVIE$$$$$F$Y$$$20240915$$HP$US$US
243210391$24321039$1$I$20240910$20240911$20240915$20240915$EXP$$US-ABBVIE-5920742$ABBVIE$$$$$F$Y$$$20240915$$CN$US$US
243210402$24321040$2$F$$20240920$20240915$20240926$EXP$$US-ESPERIONTHERAPEUTICS-2024USA01435$ESPERION THERAPEUTICS$$$$$M$Y$$$20240926$$CN$US$US
243210411$24321041$1$I$$20240822$20240915$20240915$PER$$US-SA-2024SA264614$SANOFI AVENTIS$$$$A$M$Y$93.44$KG$20240916$$MD$US$US
243210421$24321042$1$I$20240604$20240909$20240915$20240915$PER$$US-SA-2024SA265509$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240916$$MD$US$US
243210431$24321043$1$I$20240815$20240826$20240915$20240915$PER$$US-SA-2024SA264090$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240916$$MD$US$US
243210441$24321044$1$I$$20240906$20240915$20240915$EXP$BE-FAMHP-DHH-N2024-122557$BE-ESPERIONTHERAPEUTICS-2024BEL01430$ESPERION THERAPEUTICS$$$$E$M$Y$80$KG$20240916$$CN$BE$BE
243210451$24321045$1$I$$20240906$20240915$20240915$EXP$DE-BFARM-24006129$DE-ESPERIONTHERAPEUTICS-2024DEU01422$ESPERION THERAPEUTICS$$$$A$M$Y$$$20240916$$MD$DE$DE
243210461$24321046$1$I$20240827$20240906$20240915$20240915$EXP$GB-MHRA-MED-202409060952300170-YKJDB$GB-ESPERIONTHERAPEUTICS-2024GBR01416$ESPERION THERAPEUTICS$$58$YR$$F$Y$75$KG$20240916$$MD$GB$GB
243210471$24321047$1$I$20240830$20240906$20240915$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145417$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$114.79$KG$20240916$$HP$US$US
243210481$24321048$1$I$20240101$20240909$20240915$20240915$PER$$US-SA-2024SA265525$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240916$$MD$US$US
243210491$24321049$1$I$20240101$20240826$20240915$20240915$PER$$US-SA-2024SA263408$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240916$$MD$US$US
243210512$24321051$2$F$$20240910$20240915$20240917$EXP$$CA-BIOGEN-2024BI01282083$BIOGEN$$$$$F$Y$$$20240917$$CN$CA$CA
243210521$24321052$1$I$20240815$20240909$20240915$20240915$EXP$$CN-TAKEDA-2024TUS090397$TAKEDA$$85$YR$$F$Y$45$KG$20240915$$HP$CN$CN
243210533$24321053$3$F$20240713$20240923$20240915$20240927$EXP$$US-ABBVIE-5846485$ABBVIE$$78$YR$$F$Y$$$20240927$$CN$US$US
243210541$24321054$1$I$20240903$20240909$20240915$20240915$EXP$$AR-BIOGEN-2024BI01281931$BIOGEN$$1$YR$$F$Y$$$20240915$$CN$AR$AR
243210551$24321055$1$I$$20240912$20240915$20240915$EXP$$CA-PFIZER INC-202400256227$PFIZER$$6$YR$$F$Y$$$20240915$$HP$CA$CA
243210571$24321057$1$I$$20240821$20240915$20240915$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004938$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243210581$24321058$1$I$$20240909$20240915$20240915$PER$$US-AMGEN-USASP2024180177$AMGEN$$$$$M$Y$$$20240915$$MD$US$US
243210601$24321060$1$I$20240909$20240909$20240915$20240915$PER$$US-AMGEN-USASP2024180162$AMGEN$$$$$M$Y$$$20240915$$MD$US$US
243210611$24321061$1$I$20240614$20240903$20240915$20240915$EXP$$FR-JNJFOC-20240939278$JOHNSON AND JOHNSON$$51$YR$A$M$Y$66$KG$20240916$$HP$FR$FR
243210622$24321062$2$F$20240101$20240913$20240915$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145382$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240918$$HP$US$US
243210641$24321064$1$I$$20240827$20240915$20240915$PER$$US-SA-2024SA264523$SANOFI AVENTIS$$$$C$F$Y$36.09$KG$20240916$$MD$US$US
243210651$24321065$1$I$20240905$20240906$20240915$20240915$PER$$US-SA-2024SA263911$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240916$$HP$US$US
243210661$24321066$1$I$$20240905$20240915$20240915$PER$$US-SA-2024SA263982$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240916$$MD$US$US
243210671$24321067$1$I$20240901$20240912$20240915$20240915$PER$$US-ELI_LILLY_AND_COMPANY-US202409008048$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240915$$CN$US$US
243210681$24321068$1$I$$20240912$20240915$20240915$EXP$$CA-PFIZER INC-202400256239$PFIZER$$2$YR$$M$Y$$$20240915$$HP$CA$CA
243210691$24321069$1$I$$20240912$20240915$20240915$EXP$$CA-PFIZER INC-202400256229$PFIZER$$4$YR$$M$Y$$$20240915$$HP$CA$CA
243210701$24321070$1$I$20240805$20240906$20240915$20240915$PER$$US-AMGEN-USASP2024179939$AMGEN$$54$YR$A$M$Y$71.1$KG$20240915$$PH$US$US
243210711$24321071$1$I$$20240906$20240915$20240915$PER$$NVSC2024US180602$NOVARTIS$$$$E$F$Y$$$20240916$$CN$US$US
243210721$24321072$1$I$$20240912$20240915$20240915$PER$$NVSC2024US183932$NOVARTIS$$$$$$Y$$$20240916$$MD$US$US
243210741$24321074$1$I$$20240910$20240915$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145454$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240916$$CN$US$US
243210751$24321075$1$I$20240825$20240912$20240915$20240915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146178$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240916$$HP$US$US
243210771$24321077$1$I$$20240821$20240915$20240915$PER$$US-SA-2024SA263738$SANOFI AVENTIS$$$$E$F$Y$$$20240916$$MD$US$US
243210781$24321078$1$I$$20240912$20240915$20240915$EXP$$RO-JNJFOC-20240931829$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$MD$RO$RO
243210791$24321079$1$I$20240704$20240912$20240915$20240915$EXP$FR-AFSSAPS-LL2024001713$FR-JNJFOC-20240937685$JOHNSON AND JOHNSON$$25$YR$A$F$Y$81$KG$20240916$$MD$FR$FR
243210801$24321080$1$I$$20240904$20240915$20240915$EXP$$JP-AMGEN-JPNSP2024181528$AMGEN$$$$$$Y$$$20240915$$MD$JP$JP
243210811$24321081$1$I$$20240903$20240915$20240915$EXP$$JP-AMGEN-JPNCT2024182060$AMGEN$Toda Y, Ogura K, Iwata S, Kobayashi E, Osaki S, Fukushima S,et al.. The diagnostic and prognostic value of tartrate-resistant acid phosphatase isoform 5b for giant cell tumor of bone. International Journal of Clinical Oncology. 2024;29:1391-7$16$YR$T$M$Y$$$20240915$$MD$JP$JP
243210821$24321082$1$I$$20240910$20240915$20240915$EXP$$US-ABBVIE-5918199$ABBVIE$$$$$F$Y$$$20240915$$CN$US$US
243210831$24321083$1$I$$20240902$20240915$20240915$EXP$$US-Techdow-2024Techdow000189$SHENZHEN TECHDOW PHARMACEUTICAL$Weigle DP, Nielsen A, Braunecker S. Uncommon and Unfavorable: Heparin-Induced Hyperkalemia. Journal of Cardiothoracic and Vascular Anesthesia. 2024 Sep;38(9):2024-2027.$56$YR$A$M$Y$$$20240916$$MD$US$US
243210841$24321084$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205807$ASTRAZENECA$$$$$F$Y$$$20240916$$PH$US$
243210851$24321085$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205867$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243210861$24321086$1$I$20240801$20240912$20240916$20240916$EXP$FR-AFSSAPS-PV2024000844$FR-JNJFOC-20240937716$JOHNSON AND JOHNSON$$34$YR$A$M$Y$93$KG$20240916$$MD$FR$FR
243210872$24321087$2$F$20230522$20240902$20240916$20240916$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP011264$STRIDES$$9$YR$$M$Y$$$20240916$$CN$NL$NL
243210881$24321088$1$I$20240422$20240902$20240916$20240916$EXP$FR-AFSSAPS-NT2024001071$FR-STRIDES ARCOLAB LIMITED-2024SP011123$STRIDES$$63$YR$$F$Y$67$KG$20240916$$PH$FR$FR
243210891$24321089$1$I$20240822$20240822$20240916$20240916$PER$$US-SA-2024SA264769$SANOFI AVENTIS$$$$$M$Y$$$20240916$$HP$US$US
243210901$24321090$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265504$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$HP$US$US
243210911$24321091$1$I$20240821$20240910$20240916$20240916$EXP$$CA-ABBVIE-5902537$ABBVIE$$67$YR$$M$Y$$$20240916$$CN$CA$CA
243210922$24321092$2$F$20240101$20240924$20240916$20240930$PER$$US-ABBVIE-5917065$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243210931$24321093$1$I$20240101$20240911$20240916$20240916$PER$$US-SA-2024SA265877$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240916$$HP$US$US
243210951$24321095$1$I$20240620$20240911$20240916$20240916$EXP$$US-ABBVIE-5920580$ABBVIE$$71$YR$$M$Y$$$20240916$$CN$US$US
243210961$24321096$1$I$$20240906$20240916$20240916$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002308$Alvotech$$$$$F$Y$$$20240916$$CN$CA$CA
243210971$24321097$1$I$$20240904$20240916$20240916$EXP$$CN-ALVOTECHPMS-2024-ALVOTECHPMS-002288$Alvotech$Literature Citation: Wei Y, Ruan G, Qin Y, Bai X, Yang H. Renal Dysfunction in a Patient With Crohn^s Disease During Ustekinumab Treatment: A Case Report and Review of the Literature. Curr Ther Res Clin Exp. 2024 Jul 5;101:100753. doi: 10.1016/j.curtheres.2024.100753. PMID: 39224707; PMCID: PMC11367552$42$YR$$M$Y$$$20240916$$HP$CN$
243210982$24321098$2$F$20240913$20240916$20240916$20240919$PER$$US-AMGEN-USASP2024183551$AMGEN$$34$YR$A$F$Y$$$20240919$$CN$US$US
243210992$24321099$2$F$20240101$20240910$20240916$20240919$PER$$US-AMGEN-USASP2024182029$AMGEN$$50$YR$A$F$Y$$$20240918$$HP$US$US
243211001$24321100$1$I$$20240904$20240916$20240916$EXP$$JP-AMGEN-JPNSP2024182089$AMGEN$$$$$$Y$$$20240915$$HP$JP$JP
243211011$24321101$1$I$$20240909$20240916$20240916$PER$$US-LEO Pharma-373451$LEO PHARM$$26$YR$$F$Y$$$20240916$$HP$US$US
243211021$24321102$1$I$20240501$20240903$20240916$20240916$EXP$FR-AFSSAPS-TO2024001685$FR-STRIDES ARCOLAB LIMITED-2024SP011267$STRIDES$$21$YR$$M$Y$$$20240916$$PH$FR$FR
243211031$24321103$1$I$$20240906$20240916$20240916$PER$$US-SA-2024SA264108$SANOFI AVENTIS$$$$E$F$Y$$$20240916$$MD$US$US
243211041$24321104$1$I$$20240906$20240916$20240916$EXP$$JP-AMGEN-JPNSP2024182789$AMGEN$$$$$$Y$$$20240915$$HP$JP$JP
243211051$24321105$1$I$20240901$20240910$20240916$20240916$EXP$$GB-AMGEN-GBRSP2024181901$AMGEN$$58$YR$A$F$Y$$$20240915$$CN$GB$GB
243211061$24321106$1$I$$20240910$20240916$20240916$EXP$$ES-AstraZeneca-2024A209081$ASTRAZENECA$$56$YR$$F$Y$$$20240916$$CN$ES$
243211071$24321107$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265479$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240916$$HP$US$US
243211081$24321108$1$I$20240101$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145006$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240916$$CN$US$US
243211091$24321109$1$I$$20240911$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146422$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240916$$CN$US$US
243211101$24321110$1$I$20240501$20240909$20240916$20240916$EXP$$FR-AstraZeneca-2024A204213$ASTRAZENECA$$65$YR$$F$Y$$$20240916$$MD$FR$
243211111$24321111$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205915$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243211121$24321112$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A208130$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243211131$24321113$1$I$$20240830$20240916$20240916$PER$$US-AstraZeneca-2024A198945$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243211141$24321114$1$I$20240812$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A209033$ASTRAZENECA$$31865$DY$$F$Y$$$20240916$$MD$US$
243211151$24321115$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184222$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243211161$24321116$1$I$$20240909$20240916$20240916$EXP$$US-HALEON-2196346$Haleon PLC$$59$YR$$M$Y$$$20240913$$MD$US$US
243211171$24321117$1$I$20230101$20240911$20240916$20240916$EXP$$US-ABBVIE-5919531$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243211182$24321118$2$F$$20240919$20240916$20240930$EXP$$CA-TAKEDA-2024TUS090367$TAKEDA$$35$YR$$M$Y$$$20240930$$HP$CA$CA
243211191$24321119$1$I$$20240904$20240916$20240916$EXP$$JP-JNJFOC-A-CH2019-186584$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$MD$JP$JP
243211202$24321120$2$F$20240101$20240909$20240916$20240918$EXP$$US-ABBVIE-5918002$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243211211$24321121$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA263676$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240916$$MD$US$US
243211221$24321122$1$I$$20240826$20240916$20240916$PER$$US-SA-2024SA263811$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240916$$MD$US$US
243211231$24321123$1$I$20240101$20240910$20240916$20240916$EXP$$GR-ABBVIE-5919025$ABBVIE$$76$YR$$M$Y$$$20240916$$CN$GR$GR
243211241$24321124$1$I$20240908$20240908$20240916$20240916$EXP$$AU-ABBVIE-5918243$ABBVIE$$78$YR$$M$Y$$$20240916$$HP$AU$AU
243211251$24321125$1$I$$20240902$20240916$20240916$EXP$$TR-STERISCIENCE B.V.-2024-ST-001373$Steriscience PTE$Akbas T, Unlu N, Karahan F, Balbay EG, Ogul H, Onec B, et al.. A Case of Pulmonary and Central Nervous System Invasive Aspergillosis With Characteristic Radiological Findings.. J-Crit-Intensive-Care. 2024;15 (1):44-48$56$YR$$M$Y$$$20240916$$MD$TR$TR
243211261$24321126$1$I$$20240910$20240916$20240916$EXP$$IN-AstraZeneca-2024A207452$ASTRAZENECA$$18993$DY$$F$Y$70$KG$20240916$$CN$IN$
243211271$24321127$1$I$$20240909$20240916$20240916$EXP$$CA-AstraZeneca-2024A207067$ASTRAZENECA$$$$$$Y$$$20240916$$MD$CA$
243211281$24321128$1$I$20240827$20240908$20240916$20240916$EXP$$US-AstraZeneca-2024A204046$ASTRAZENECA$$29606$DY$$F$Y$83.9$KG$20240916$$CN$US$
243211291$24321129$1$I$20221020$20240902$20240916$20240916$EXP$$CN-STERISCIENCE B.V.-2024-ST-001367$Steriscience PTE$Zou J, Wang H, Nan Y, Jin X.. Stubborn hypoxemia after mild to moderate sedation and analgesia: A case report.. Medicine. 2024;103 (7)$62$YR$$$Y$$$20240916$$HP$CN$CN
243211301$24321130$1$I$$20240821$20240916$20240916$PER$$US-SA-2024SA264993$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240916$$MD$US$US
243211311$24321131$1$I$$20240902$20240916$20240916$EXP$$TR-STERISCIENCE B.V.-2024-ST-001365$Steriscience PTE$Gayretli Aydin ZG, Akturk Acar F, Ozgul Postuk G, Ozkaya E, Mutlu M, Arslan Y.. A Case of Pan-resistant Burkholderia cepacia Complex Sepsis in a Newborn Successfully Treated With a Combination Therapy.. Pediatr-Infect-Dis-J. 2024;43 (9):e334-e336$$$N$F$Y$1.24$KG$20240916$$MD$TR$TR
243211321$24321132$1$I$20240814$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207706$ASTRAZENECA$$28101$DY$$F$Y$$$20240916$$CN$US$
243211331$24321133$1$I$20240801$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A208998$ASTRAZENECA$$$$$$Y$$$20240916$$CN$US$
243211341$24321134$1$I$$20240910$20240916$20240916$EXP$$ZA-AstraZeneca-2024A207451$ASTRAZENECA$$57$YR$$F$Y$$$20240916$$CN$ZA$
243211361$24321136$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146550$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240916$$CN$US$US
243211392$24321139$2$F$$20240910$20240916$20240925$EXP$$US-CHATTEMPRD-2024OHG031568$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243211401$24321140$1$I$20240910$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183279$AMGEN$$47$YR$A$F$Y$$$20240915$$CN$US$US
243211411$24321141$1$I$$20240906$20240916$20240916$EXP$$JP-AMGEN-JPNSP2024182815$AMGEN$$$$$$Y$$$20240915$$HP$JP$JP
243211421$24321142$1$I$20240101$20240909$20240916$20240916$EXP$$US-ABBVIE-5917939$ABBVIE$$$$$F$Y$$$20240916$$HP$US$US
243211431$24321143$1$I$$20240909$20240916$20240916$EXP$$US-AMGEN-USASP2024181454$AMGEN$Fleischli A.; Pierog O.; Rozati S. et al.. Clinical presentation and outcomes of Cutaneous T-cell Lymphoma patients following the use of biologic therapies retrospective review at a single tertiary referral center. Journal of the American Academy of Dermatology. 2024;91 (3):AB26$$$$$Y$$$20240915$$HP$US$US
243211441$24321144$1$I$20240101$20240910$20240916$20240916$EXP$$JP-AMGEN-JPNSP2024136803$AMGEN$$$$E$F$Y$$$20240915$$MD$JP$JP
243211451$24321145$1$I$20240101$20240910$20240916$20240916$EXP$$US-ABBVIE-5919085$ABBVIE$$$$$$Y$$$20240916$$HP$US$US
243211471$24321147$1$I$$20240910$20240916$20240916$EXP$$US-ABBVIE-5918951$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243211481$24321148$1$I$20240905$20240910$20240916$20240916$EXP$$US-ABBVIE-5918696$ABBVIE$$63$YR$$M$Y$$$20240916$$CN$US$US
243211491$24321149$1$I$20240831$20240909$20240916$20240916$EXP$SE-SEMPA-2024-006481$SE-AMGEN-SWESP2024180131$AMGEN$$49$YR$A$F$Y$69$KG$20240915$$MD$SE$SE
243211501$24321150$1$I$$20240912$20240916$20240916$EXP$GB-MEN-2024-108570$GB-MEN-2024-108570$MENARINI$$$$$F$Y$$$20240916$$PH$GB$GB
243211511$24321151$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA263856$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240916$$MD$US$US
243211521$24321152$1$I$$20240904$20240916$20240916$EXP$$US-Harman-000067$HARMAN FINOCHEM$Sahyouni MJ, Acevedo LA, Rodriguez SC, Chiles JA, Pennings NJ. Neuropathy of diabetes following initiation of a low-carbohydrate diet: Case report. Obes Pillars. 2024 Jun 14;11:100115. doi: 10.1016/j.obpill.2024.100115.$50$YR$$M$Y$$$20240912$$MD$US$
243211541$24321154$1$I$$20240912$20240916$20240916$EXP$$US-ABBVIE-5922226$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243211551$24321155$1$I$20240901$20240912$20240916$20240916$PER$$US-ABBVIE-5924193$ABBVIE$$$$$M$Y$$$20240916$$MD$US$US
243211561$24321156$1$I$$20240910$20240916$20240916$EXP$$US-ABBVIE-5919135$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243211571$24321157$1$I$20240909$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145220$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$76$KG$20240916$$PH$US$US
243211581$24321158$1$I$20240719$20240911$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145654$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240916$$CN$US$US
243211591$24321159$1$I$20240910$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183283$AMGEN$$$$$F$Y$$$20240915$$CN$US$US
243211601$24321160$1$I$20240101$20240905$20240916$20240916$PER$$US-SA-2024SA263826$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240916$$MD$US$US
243211611$24321161$1$I$$20240911$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US079974$SANDOZ$$$$$F$Y$71.36$KG$20240916$$CN$US$US
243211621$24321162$1$I$$20240909$20240916$20240916$EXP$$IN-AstraZeneca-2024A206365$ASTRAZENECA$$79$YR$$F$Y$$$20240916$$CN$IN$
243211631$24321163$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A206861$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243211641$24321164$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A206750$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243211651$24321165$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A206587$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243211661$24321166$1$I$20240910$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207616$ASTRAZENECA$$29543$DY$$F$Y$$$20240916$$CN$US$
243211671$24321167$1$I$$20240906$20240916$20240916$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001830$BLUEPRINT MEDICINES$$$$$F$Y$$$20240916$$CN$US$US
243211691$24321169$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265648$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240916$$HP$US$US
243211701$24321170$1$I$$20240824$20240916$20240916$PER$$US-BEIGENE-BGN-2024-013485$BEIGENE$$$$$$Y$$$20240916$$MD$US$US
243211711$24321171$1$I$$20240910$20240916$20240916$EXP$$US-ABBVIE-5919780$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243211721$24321172$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265496$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240916$$MD$US$US
243211731$24321173$1$I$$20240908$20240916$20240916$EXP$$US-AMGEN-USASP2024181230$AMGEN$Law R. J.; Janssens  L.P.; Yamparala A.et.al. Incidence of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin vs. Compounded Rectal Diclofenac Prophylaxis. Digestive Diseases and Sciences. 2024;1-9$$$$$Y$$$20240915$$HP$US$US
243211741$24321174$1$I$$20240911$20240916$20240916$PER$$US-TAKEDA-2024TUS091300$TAKEDA$$$$$F$Y$$$20240916$$HP$US$US
243211751$24321175$1$I$20240401$20240903$20240916$20240916$EXP$$FR-AUROBINDO-AUR-APL-2024-044413$AUROBINDO$$52$YR$$M$Y$$$20240916$$PH$FR$FR
243211761$24321176$1$I$$20240910$20240916$20240916$PER$$US-TAKEDA-2024TUS090956$TAKEDA$$$$$M$Y$$$20240916$$CN$US$US
243211771$24321177$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265264$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240916$$HP$US$US
243211781$24321178$1$I$$20240911$20240916$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA079520$SANDOZ$$43$YR$$F$Y$68$KG$20240916$$CN$CA$CA
243211792$24321179$2$F$$20240912$20240916$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005257$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$HP$US$US
243211811$24321181$1$I$20240829$20240909$20240916$20240916$EXP$$US-JNJFOC-20240927799$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240916$$CN$US$US
243211821$24321182$1$I$20240401$20240911$20240916$20240916$EXP$IT-MINISAL02-1001778$IT-JNJFOC-20240938426$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240916$$MD$IT$IT
243211831$24321183$1$I$$20240910$20240916$20240916$EXP$GB-MHRA-31814689$GB-GSK-GB2024112336$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$GB$GB
243211841$24321184$1$I$20240701$20240903$20240916$20240916$EXP$$EG-NOVOPROD-1278974$NOVO NORDISK$$376$MON$$F$Y$65$KG$20240916$$CN$EG$EG
243211861$24321186$1$I$20240710$20240902$20240916$20240916$EXP$$CN-ROCHE-10000072334$ROCHE$$55$YR$A$F$Y$63$KG$20240916$$HP$CN$CN
243211871$24321187$1$I$20240627$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207500$ASTRAZENECA$$31925$DY$$F$Y$$$20240916$$CN$US$
243211881$24321188$1$I$$20240909$20240916$20240916$EXP$$ES-AstraZeneca-2024A204200$ASTRAZENECA$$$$$$Y$$$20240916$$MD$ES$
243211891$24321189$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A207608$ASTRAZENECA$$95$YR$$M$Y$$$20240916$$CN$US$
243211901$24321190$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A206846$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243211911$24321191$1$I$$20240911$20240916$20240916$EXP$$FR-AstraZeneca-2024A209175$ASTRAZENECA$$$$$M$Y$$$20240916$$MD$FR$
243211931$24321193$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205852$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243211941$24321194$1$I$$20240903$20240916$20240916$EXP$$US-NOVOPROD-1282208$NOVO NORDISK$$$$$F$Y$$$20240916$$CN$US$US
243211951$24321195$1$I$20240903$20240903$20240916$20240916$EXP$$CN-NOVOPROD-1278969$NOVO NORDISK$$$$$F$Y$$$20240916$$CN$CN$CN
243211961$24321196$1$I$20221027$20240903$20240916$20240916$EXP$$US-NOVOPROD-1279082$NOVO NORDISK$$81$YR$$M$Y$$$20240916$$CN$US$US
243211972$24321197$2$F$$20240911$20240916$20240923$EXP$$US-NOVOPROD-1279393$NOVO NORDISK$$$$$M$Y$$$20240923$$CN$US$US
243211981$24321198$1$I$$20240903$20240916$20240916$EXP$$CA-NOVOPROD-1280172$NOVO NORDISK$$$$A$F$Y$$$20240916$$CN$CA$CA
243211991$24321199$1$I$$20240903$20240916$20240916$EXP$$US-NOVOPROD-1279087$NOVO NORDISK$$$$$$Y$$$20240916$$CN$US$US
243212001$24321200$1$I$20240801$20240903$20240916$20240916$EXP$$US-NOVOPROD-1279502$NOVO NORDISK$$$$$F$Y$$$20240916$$CN$US$US
243212012$24321201$2$F$20230701$20240911$20240916$20240923$EXP$$MX-NOVOPROD-1273059$NOVO NORDISK$$57$YR$$F$Y$62$KG$20240923$$CN$MX$MX
243212021$24321202$1$I$$20240903$20240916$20240916$EXP$$US-NOVOPROD-1279461$NOVO NORDISK$$49$YR$$$Y$$$20240916$$CN$US$US
243212031$24321203$1$I$$20240903$20240916$20240916$EXP$$CO-NOVOPROD-1280414$NOVO NORDISK$$53$YR$$F$Y$62$KG$20240916$$CN$CO$CO
243212041$24321204$1$I$20240601$20240903$20240916$20240916$EXP$$US-NOVOPROD-1279572$NOVO NORDISK$$73$YR$$F$Y$$$20240916$$CN$US$US
243212051$24321205$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207718$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243212061$24321206$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205419$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243212071$24321207$1$I$20180101$20240903$20240916$20240916$EXP$$US-NOVOPROD-1279216$NOVO NORDISK$$82$YR$$M$Y$$$20240916$$CN$US$US
243212081$24321208$1$I$20240827$20240910$20240916$20240916$EXP$$CA-JNJFOC-20240931260$JOHNSON AND JOHNSON$$11$YR$C$F$Y$$$20240916$$HP$CA$CA
243212091$24321209$1$I$20240531$20240904$20240916$20240916$EXP$FR-AFSSAPS-NC2024001026$FR-Accord-445810$ACCORD$$69$YR$E$F$Y$77$KG$20240916$$MD$FR$FR
243212101$24321210$1$I$20210313$20240904$20240916$20240916$EXP$AU-TGA-0000523722$AU-NOVOPROD-1279388$NOVO NORDISK$$50$YR$$M$Y$$$20240916$$HP$AU$AU
243212111$24321211$1$I$20240823$20240904$20240916$20240916$EXP$$US-NOVOPROD-1279105$NOVO NORDISK$$66$YR$$F$Y$$$20240916$$CN$US$US
243212121$24321212$1$I$20240802$20240904$20240916$20240916$EXP$$MX-NOVOPROD-1279422$NOVO NORDISK$$48$YR$$F$Y$72.2$KG$20240916$$CN$MX$MX
243212131$24321213$1$I$20230601$20240904$20240916$20240916$EXP$$US-NOVOPROD-1279196$NOVO NORDISK$$34$YR$$F$Y$$$20240916$$CN$US$US
243212143$24321214$3$F$$20240912$20240916$20240919$EXP$$US-ROCHE-10000077579$ROCHE$Au-Yeung N, Regennitter N, Stepherson J. Folate Deficiency and Medication-Induced Severe Pancytopenia in a Bilateral Lung Transplantee. Cureus. 2024;16 (7):e65780. doi:10.7759/cureus.65780.$74$YR$E$M$Y$$$20240919$$HP$US$US
243212151$24321215$1$I$$20240911$20240916$20240916$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051384$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240916$$HP$US$US
243212161$24321216$1$I$20230101$20230905$20240916$20240916$PER$$US-BIOGEN-2023BI01242740$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
243212171$24321217$1$I$20240903$20240910$20240916$20240916$EXP$$CA-JNJFOC-20240935174$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240916$$HP$CA$CA
243212181$24321218$1$I$20240808$20240912$20240916$20240916$PER$$US-BIOVITRUM-2024-US-012014$BIOVITRUM$$77$YR$$F$Y$$$20240916$$CN$US$US
243212191$24321219$1$I$20240801$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008196$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240916$$CN$US$US
243212201$24321220$1$I$20210620$20240904$20240916$20240916$EXP$AU-TGA-0000753304$AU-NOVOPROD-1279364$NOVO NORDISK$$66$YR$$F$Y$$$20240916$$PH$AU$AU
243212211$24321221$1$I$20240101$20240826$20240916$20240916$PER$$US-SA-2024SA264031$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240916$$CN$US$US
243212221$24321222$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265138$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240916$$HP$US$US
243212231$24321223$1$I$$20240904$20240916$20240916$PER$$US-SA-2024SA265124$SANOFI AVENTIS$$$$E$F$Y$$$20240916$$MD$US$US
243212241$24321224$1$I$20240101$20240822$20240916$20240916$PER$$US-SA-2024SA264840$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240916$$CN$US$US
243212251$24321225$1$I$$20240904$20240916$20240916$PER$$US-SA-2024SA263183$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240916$$MD$US$US
243212271$24321227$1$I$20231227$20240906$20240916$20240916$EXP$$CN-ROCHE-10000076679$ROCHE$$58$YR$A$F$Y$$$20240916$$HP$CN$CN
243212282$24321228$2$F$$20240916$20240916$20240918$EXP$$US-NOVEN PHARMACEUTICALS, INC.-2024-NOV-US001185$PAREXEL$$73$YR$$F$Y$47.63$KG$20240918$$CN$US$US
243212291$24321229$1$I$20240903$20240904$20240916$20240916$EXP$$GB-AUROBINDO-AUR-APL-2024-044378$AUROBINDO$$79$YR$$F$Y$$$20240916$$MD$GB$GB
243212311$24321231$1$I$$20240909$20240916$20240916$EXP$$JP-009507513-2409JPN001672J$MERCK$$7$DEC$$F$Y$$$20240916$$MD$JP$JP
243212321$24321232$1$I$20240903$20240909$20240916$20240916$EXP$$CO-TAKEDA-2024TUS031643$TAKEDA$$51$YR$$F$Y$59$KG$20240916$$CN$CO$CO
243212331$24321233$1$I$20240501$20240907$20240916$20240916$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001831$BLUEPRINT MEDICINES$$$$C$F$Y$$$20240916$$MD$US$US
243212341$24321234$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183335$AMGEN$$$$$$Y$$$20240915$$CN$US$US
243212351$24321235$1$I$20240902$20240909$20240916$20240916$EXP$$CN-BEIGENE-BGN-2024-014294$BEIGENE$$$$$$Y$$$20240916$$HP$CN$CN
243212361$24321236$1$I$$20240904$20240916$20240916$EXP$$GB-AUROBINDO-AUR-APL-2024-044329$AUROBINDO$$53$YR$$F$Y$$$20240916$$PH$GB$GB
243212371$24321237$1$I$20230731$20240910$20240916$20240916$EXP$$GB-ROCHE-3417730$ROCHE$$49$YR$A$M$Y$$$20240916$$HP$GB$GB
243212381$24321238$1$I$$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146200$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240916$$CN$US$US
243212391$24321239$1$I$$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146127$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240916$$CN$US$US
243212401$24321240$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207659$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243212411$24321241$1$I$20230801$20240910$20240916$20240916$EXP$$FR-AstraZeneca-2024A205762$ASTRAZENECA$$55$YR$$M$Y$102$KG$20240916$$MD$FR$
243212421$24321242$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A206477$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243212431$24321243$1$I$$20240911$20240916$20240916$PER$$US-AstraZeneca-2024A207942$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243212441$24321244$1$I$$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A208802$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243212451$24321245$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205940$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243212461$24321246$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205111$ASTRAZENECA$$75$YR$$F$Y$$$20240916$$CN$US$
243212471$24321247$1$I$$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A208914$ASTRAZENECA$$82$YR$$F$Y$$$20240916$$CN$US$
243212481$24321248$1$I$$20240909$20240916$20240916$EXP$$ZA-AstraZeneca-2024A206157$ASTRAZENECA$$84$YR$$M$Y$$$20240916$$CN$ZA$
243212491$24321249$1$I$20240801$20240909$20240916$20240916$EXP$$NL-BIOVITRUM-2024-NL-012035$BIOVITRUM$$7$MON$$M$Y$9.3$KG$20240916$$HP$NL$NL
243212501$24321250$1$I$$20240905$20240916$20240916$PER$$US-ABBVIE-5915941$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243212511$24321251$1$I$20240904$20240904$20240916$20240916$EXP$GB-MHRA-MED-202409040717567780-ZLMDV$GB-Accord-445259$ACCORD$$59$YR$A$M$Y$76$KG$20240916$$CN$GB$GB
243212521$24321252$1$I$$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144798$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240916$$HP$US$US
243212531$24321253$1$I$$20240904$20240916$20240916$PER$$US-SA-2024SA263337$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240916$$HP$US$US
243212541$24321254$1$I$20240525$20240911$20240916$20240916$30DAY$$US-AMGEN-USASP2024182165$AMGEN$$56$YR$A$F$Y$$$20240915$$HP$US$US
243212551$24321255$1$I$20240616$20240617$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002693$ENDO$$57$YR$$F$Y$$$20240916$$CN$US$US
243212561$24321256$1$I$$20240719$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002578$ENDO$$$$$F$Y$$$20240916$$CN$US$US
243212571$24321257$1$I$$20240909$20240916$20240916$EXP$$MX-EMD Serono-2024048763$EMD SERONO INC$$$$T$F$Y$$$20240916$$CN$MX$MX
243212581$24321258$1$I$$20240909$20240916$20240916$EXP$$NL-WT-2024-37658804P1$Waylis$Crouwel F. et al. The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naive Inflammatory Bowel Disease Patients. Inflamm Bowel Dis. 2024 Sep 3;30(9):1492-1499. doi: 10.1093/ibd/izad197.$35$YR$$$Y$$$20240916$$MD$NL$NL
243212591$24321259$1$I$$20240912$20240916$20240916$PER$$US-JNJFOC-20240935055$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$US$US
243212601$24321260$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146220$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240916$$HP$US$US
243212611$24321261$1$I$20240601$20240911$20240916$20240916$PER$$US-SA-2024SA265872$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240916$$HP$US$US
243212621$24321262$1$I$$20240821$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010687$STRIDES$Ocon A, Avalos Sugastti E, Duffy N. Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab. BMJ Case Rep. 2024;17(6):e258487$7$DEC$$M$Y$$$20240916$$HP$US$US
243212631$24321263$1$I$$20240715$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009019$STRIDES$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al.. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.. J-Ophthalmic-Inflamm-Infect. 2024;14.$76$YR$$F$Y$$$20240916$$HP$US$US
243212641$24321264$1$I$$20240627$20240916$20240916$PER$$US-STRIDES PHARMA UK LTD.-2024SP007915$STRIDES$Razia D, Moin A, Arjuna A, Evans S.. VASCULOPATHY AND DEMYELINATING COMPLICATIONS OF VARICELLA IN AN IMMUNOCOMPROMISED PATIENT.. Crit-Care-Med. 2024;52 (Suppl.) (1):S228 abstr. 508$$$$$Y$$$20240916$$HP$US$US
243212651$24321265$1$I$$20240808$20240916$20240916$PER$$US-STRIDES PHARMA UK LTD.-2024SP010270$STRIDES$Essink J, Niebur H.. DELAYED DIAGNOSIS OF COMMON VARIABLE IMMUNODEFICIENCY AND IMPORTANCE OF MULTI-SPECIALTY COLLABORATION.. Ann-Allergy-Asthma-Immunol. 2023;131(Suppl.)(5):S158-S159$$$$$Y$$$20240916$$HP$US$US
243212661$24321266$1$I$$20240705$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008421$STRIDES$Kassels A, Edwards L, Kraus CN.. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series.. JAAD-Case-Rep. 2023;40:14-18$$$A$F$Y$$$20240916$$MD$US$US
243212671$24321267$1$I$$20240701$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008038$STRIDES$Celli S, Nash R, McMenamin C, Garza M, Von Geldern G, Georges G, et al.. Successful Autologous Hematopoietic Stem Cell Transplant in a Case of Stiff Person Spectrum Disorder with a positive Glycine Receptor antibody.. Neurology. 2023;100 (17)$59$YR$$M$Y$$$20240916$$HP$US$US
243212681$24321268$1$I$20240101$20240905$20240916$20240916$EXP$$US-ROCHE-10000075219$ROCHE$$43$YR$A$F$Y$$$20240916$$CN$US$US
243212691$24321269$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409003821$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$US$US
243212701$24321270$1$I$$20240807$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010220$STRIDES$Rios IP, Nguyen CHL, Misra SS, Ryan MS, Nair SS, Khamash HA.. Foscarnet-induced nephropathy in a kidney transplant recipient.. Kidney-Int. 2024;106 (1):156$53$YR$$M$Y$$$20240916$$HP$US$US
243212711$24321271$1$I$$20240712$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008942$STRIDES$G?l S, Siraj I, Meyer J A.. Idiopathic Intracranial Hypertension Secondary to Chronic Inflammatory Demyelinating Polyradiculoneuropathy.. Cureus. 2023;15(8):e43648$50$YR$$F$Y$$$20240916$$HP$US$US
243212721$24321272$1$I$$20240911$20240916$20240916$PER$$US-JNJFOC-20240929260$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$US$US
243212731$24321273$1$I$20240901$20240909$20240916$20240916$PER$$US-SA-2024SA265462$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240916$$HP$US$US
243212741$24321274$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265624$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240916$$HP$US$US
243212751$24321275$1$I$$20240912$20240916$20240916$PER$$US-AstraZeneca-2024A208688$ASTRAZENECA$$$$$$Y$$$20240916$$CN$US$
243212761$24321276$1$I$$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A208657$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243212771$24321277$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A206743$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243212781$24321278$1$I$$20240912$20240916$20240916$PER$$US-AstraZeneca-2024A209273$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243212791$24321279$1$I$20240910$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024184210$AMGEN$$57$YR$A$M$Y$$$20240915$$CN$US$US
243212802$24321280$2$F$$20240911$20240916$20240920$EXP$$US-GSK-US2024111335$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$HP$US$US
243212811$24321281$1$I$$20240912$20240916$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA065963$SANDOZ$$61$YR$$F$Y$$$20240916$$PH$CA$CA
243212831$24321283$1$I$$20240904$20240916$20240916$PER$$US-SA-2024SA263283$SANOFI AVENTIS$$$$C$F$Y$$$20240916$$MD$US$US
243212841$24321284$1$I$20240801$20240823$20240916$20240916$PER$$US-SA-2021SA077324$SANOFI AVENTIS$$30$YR$A$F$Y$97.52$KG$20240916$$MD$US$US
243212852$24321285$2$F$$20240911$20240916$20240918$EXP$$BR-JNJFOC-20240932299$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240918$$MD$BR$BR
243212861$24321286$1$I$$20240903$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146271$BRISTOL MYERS SQUIBB$Bowden A, Zambito J, El-Feghaly J, Andolina JR. Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series. Pediatric Hematology and Oncology. 2024 May 07;41(6):389-98. doi:10.1080/08880018.2024.2350455.$9$YR$C$M$Y$$$20240916$$HP$US$US
243212871$24321287$1$I$20240730$20240912$20240916$20240916$EXP$GB-MHRA-MED-202409121738305820-FBWNG$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-146011$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240916$$MD$GB$GB
243212881$24321288$1$I$$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144665$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240916$$CN$US$US
243212891$24321289$1$I$20240619$20240912$20240916$20240916$EXP$FR-AFSSAPS-RN2024000901$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-145634$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240916$$PH$FR$FR
243212901$24321290$1$I$$20230913$20240916$20240916$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408756$RANBAXY$$$$$F$Y$$$20240916$$CN$US$US
243212911$24321291$1$I$$20240126$20240916$20240916$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430068$RANBAXY$$$$$$Y$$$20240916$$HP$US$US
243212931$24321293$1$I$$20240405$20240916$20240916$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440816$RANBAXY$$$$$M$Y$$$20240916$$CN$US$US
243212941$24321294$1$I$$20240125$20240916$20240916$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429606$RANBAXY$$$$$F$Y$$$20240916$$CN$US$US
243212951$24321295$1$I$$20240315$20240916$20240916$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-438105$RANBAXY$$$$E$F$Y$$$20240916$$CN$US$US
243212961$24321296$1$I$20240122$20240122$20240916$20240916$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429972$RANBAXY$$3$YR$$F$Y$$$20240916$$CN$US$US
243212971$24321297$1$I$$20240116$20240916$20240916$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428998$RANBAXY$$$$$M$Y$$$20240916$$CN$US$US
243212981$24321298$1$I$$20231212$20240916$20240916$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425360$RANBAXY$$$$$F$Y$$$20240916$$CN$US$US
243212991$24321299$1$I$$20240403$20240916$20240916$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-440963$RANBAXY$$$$E$M$Y$$$20240916$$CN$US$US
243213001$24321300$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265095$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240916$$HP$US$US
243213011$24321301$1$I$20240809$20240909$20240916$20240916$EXP$$JP-009507513-2408JPN001358J$MERCK$$5$DEC$$F$Y$$$20240916$$MD$JP$JP
243213032$24321303$2$F$$20240910$20240916$20240925$EXP$$JP-AMGEN-JPNSP2024183576$AMGEN$$83$YR$E$F$Y$$$20240925$$PH$JP$JP
243213042$24321304$2$F$20240912$20240913$20240916$20240918$PER$$US-AMGEN-USASP2024183967$AMGEN$$37$YR$A$F$Y$$$20240918$$PH$US$US
243213051$24321305$1$I$$20240909$20240916$20240916$PER$$US-ROCHE-10000081503$ROCHE$Song D, Ginsberg C, Nudleman E, Borooah S, King A, Bousquet E, et al. Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis. American Journal of Ophthalmology Case Reports. 2024;36:1-4. doi:10.1016/j.ajoc.2024.102153.$57$YR$A$M$Y$$$20240916$$HP$US$US
243213061$24321306$1$I$20240813$20240903$20240916$20240916$EXP$$CZ-SAMSUNG BIOEPIS-SB-2024-26963$SAMSUNG BIOEPIS$$78$YR$E$F$Y$$$20240916$$HP$CZ$CZ
243213072$24321307$2$F$$20240910$20240916$20240917$EXP$$NVSC2024CA181570$NOVARTIS$$40$YR$$F$Y$$$20240917$$HP$CA$CA
243213081$24321308$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A208245$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243213091$24321309$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207458$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243213101$24321310$1$I$$20240909$20240916$20240916$EXP$$IT-ROCHE-10000081511$ROCHE$Gamba A, Depascale R, Zanatta E, Ienna L, Cruciani C, Gatto M. Effectiveness and safety of low dose Rituximab as remission-maintenance treatment for patients with refractory idiopathic inflammatory myopathies: results of a retrospective study from a monocentric cohort. Clinical Rheumatology. 2024; doi:10.1007/s10067-024-07079-z.$$$$F$Y$$$20240916$$HP$IT$IT
243213112$24321311$2$F$$20240916$20240916$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409008195$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240919$$CN$US$US
243213121$24321312$1$I$20240912$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008162$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240916$$CN$US$US
243213131$24321313$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008514$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$US$US
243213141$24321314$1$I$20240805$20240909$20240916$20240916$EXP$$NVSC2024MX167688$NOVARTIS$$50$YR$$M$Y$$$20240916$$CN$MX$MX
243213151$24321315$1$I$20240904$20240904$20240916$20240916$PER$$US-SA-2024SA265592$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240916$$HP$US$US
243213161$24321316$1$I$$20240911$20240916$20240916$EXP$$CA-HALEON-2196763$Haleon PLC$$$$$M$Y$$$20240916$$HP$CA$CA
243213171$24321317$1$I$$20240618$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003770$PAREXEL$$39$YR$$F$Y$$$20240914$$CN$US$US
243213181$24321318$1$I$$20240912$20240916$20240916$PER$$US-GILEAD-2024-0687576$GILEAD$$$$$M$Y$$$20240915$$PH$US$US
243213191$24321319$1$I$20240101$20240907$20240916$20240916$PER$$US-SA-2024SA263794$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240916$$HP$US$US
243213202$24321320$2$F$20240830$20240912$20240916$20240917$EXP$$UA-ROCHE-10000081361$ROCHE$$60$YR$A$M$Y$69$KG$20240917$$MD$UA$UA
243213211$24321321$1$I$20240902$20240906$20240916$20240916$EXP$$CN-EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD.-EVI-CN-2024-000032$Evive Biotechnology$$51$YR$$F$Y$57$KG$20240913$$MD$CN$CN
243213221$24321322$1$I$$20240903$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146272$BRISTOL MYERS SQUIBB$Bowden A, Zambito J, El-Feghaly J, Andolina JR. Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series. Pediatric Hematology and Oncology. 2024 May 07;41(6):389-98. doi:10.1080/08880018.2024.2350455.$20$YR$A$M$Y$$$20240916$$HP$US$US
243213232$24321323$2$F$20240413$20240918$20240916$20240928$EXP$$BR-CELLTRION INC.-2024BR009233$CELLTRION$$$$$$Y$$$20240928$$HP$BR$BR
243213242$24321324$2$F$20240101$20240911$20240916$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012539$JAZZ$$$$$F$Y$$$20240920$$HP$US$US
243213252$24321325$2$F$$20240913$20240916$20240918$PER$$NVSC2024US184311$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243213261$24321326$1$I$$20240913$20240916$20240916$EXP$$DE-SANDOZ INC.-SDZ2024DE080072$SANDOZ$$6$YR$$M$Y$$$20240916$$HP$DE$DE
243213271$24321327$1$I$$20240909$20240916$20240916$EXP$$CO-AMGEN-COLSP2024183170$AMGEN$$40$YR$A$F$Y$$$20240915$$CN$CO$CO
243213281$24321328$1$I$$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024181735$AMGEN$$$$$F$Y$$$20240915$$CN$US$US
243213291$24321329$1$I$20240904$20240904$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142299$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240916$$HP$US$US
243213301$24321330$1$I$20240829$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146051$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240916$$CN$US$US
243213321$24321332$1$I$20190724$20240904$20240916$20240916$EXP$AU-TGA-0000744510$AU-NOVOPROD-1279916$NOVO NORDISK$$80$YR$$M$Y$$$20240916$$HP$AU$AU
243213331$24321333$1$I$$20240904$20240916$20240916$EXP$$CA-NOVOPROD-1279898$NOVO NORDISK$$71$YR$$F$Y$$$20240916$$HP$CA$CA
243213341$24321334$1$I$20240101$20240911$20240916$20240916$EXP$$CA-ABBVIE-5920474$ABBVIE$$$$$F$Y$$$20240916$$CN$CA$CA
243213351$24321335$1$I$$20240904$20240916$20240916$EXP$$CA-NOVOPROD-1279494$NOVO NORDISK$$39$YR$$F$Y$$$20240916$$MD$CA$CA
243213361$24321336$1$I$$20240904$20240916$20240916$EXP$$CA-NOVOPROD-1279480$NOVO NORDISK$$$$$F$Y$$$20240916$$MD$CA$CA
243213371$24321337$1$I$$20240904$20240916$20240916$EXP$$CA-NOVOPROD-1279895$NOVO NORDISK$$$$$M$Y$$$20240916$$HP$CA$CA
243213381$24321338$1$I$$20240904$20240916$20240916$EXP$$US-NOVOPROD-1279546$NOVO NORDISK$$$$$M$Y$$$20240916$$CN$US$US
243213392$24321339$2$F$20240801$20240918$20240916$20240927$EXP$$BR-NOVOPROD-1279912$NOVO NORDISK$$77$YR$$F$Y$75$KG$20240927$$CN$BR$BR
243213401$24321340$1$I$20230917$20240904$20240916$20240916$EXP$AU-TGA-0000790624$AU-NOVOPROD-1279514$NOVO NORDISK$$78$YR$$F$Y$$$20240916$$CN$AU$AU
243213411$24321341$1$I$20240826$20240913$20240916$20240916$EXP$$CN-BEIGENE-BGN-2024-014614$BEIGENE$$$$$$Y$$$20240916$$HP$CN$CN
243213421$24321342$1$I$$20240903$20240916$20240916$EXP$$BR-ASTELLAS-2024-AER-004720$ASTELLAS$$80$YR$E$M$Y$$$20240916$$MD$BR$BR
243213431$24321343$1$I$$20240909$20240916$20240916$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001829$BLUEPRINT MEDICINES$$$$$F$Y$$$20240916$$CN$US$US
243213441$24321344$1$I$$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024182303$AMGEN$$$$$M$Y$$$20240915$$PH$US$US
243213451$24321345$1$I$$20240909$20240916$20240916$EXP$$ZA-AstraZeneca-2024A205422$ASTRAZENECA$$57$YR$$M$Y$$$20240916$$CN$ZA$
243213461$24321346$1$I$$20240904$20240916$20240916$EXP$$US-NOVOPROD-1280050$NOVO NORDISK$$$$A$F$Y$$$20240916$$CN$US$US
243213471$24321347$1$I$$20240904$20240916$20240916$EXP$$US-NOVOPROD-1280216$NOVO NORDISK$$$$$F$Y$$$20240916$$CN$US$US
243213481$24321348$1$I$$20240904$20240916$20240916$EXP$$US-NOVOPROD-1280168$NOVO NORDISK$$$$A$M$Y$$$20240916$$CN$US$US
243213491$24321349$1$I$$20240904$20240916$20240916$EXP$$US-NOVOPROD-1280059$NOVO NORDISK$$$$$$Y$$$20240916$$CN$US$US
243213501$24321350$1$I$20240828$20240904$20240916$20240916$EXP$$US-NOVOPROD-1280215$NOVO NORDISK$$34$YR$$F$Y$$$20240916$$CN$US$US
243213511$24321351$1$I$$20240904$20240916$20240916$EXP$$US-NOVOPROD-1280052$NOVO NORDISK$$$$$F$Y$$$20240916$$CN$US$US
243213522$24321352$2$F$$20240910$20240916$20240923$EXP$$CA-NOVOPROD-1279959$NOVO NORDISK$$63$YR$$$Y$129.3$KG$20240923$$CN$CA$CA
243213531$24321353$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146528$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$86.18$KG$20240916$$CN$US$US
243213541$24321354$1$I$20240901$20240909$20240916$20240916$EXP$$JP-009507513-2409JPN001232J$MERCK$$$$$F$Y$$$20240916$$MD$JP$JP
243213551$24321355$1$I$$20240914$20240916$20240916$EXP$$CN-JNJFOC-20240937783$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$MD$CN$CN
243213563$24321356$3$F$20240821$20240912$20240916$20240926$PER$$US-SA-2024SA262821$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240926$$CN$US$US
243213571$24321357$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA263779$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240916$$MD$US$US
243213581$24321358$1$I$20240901$20240909$20240916$20240916$PER$$US-CHATTEMPRD-2024OHG031524$CHATTEM$$$$$$Y$$$20240916$$CN$US$US
243213591$24321359$1$I$$20240909$20240916$20240916$PER$$US-CHATTEMPRD-2024OHG031393$CHATTEM$$$$$F$Y$$$20240916$$CN$US$US
243213601$24321360$1$I$20240101$20240906$20240916$20240916$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000783$DECIPHERA PHARMACEUTICALS$$92$YR$E$M$Y$$$20240916$$CN$US$US
243213611$24321361$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA265152$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240916$$MD$US$US
243213621$24321362$1$I$$20240821$20240916$20240916$PER$$US-SA-2024SA263376$SANOFI AVENTIS$$$$$F$Y$$$20240916$$MD$US$US
243213631$24321363$1$I$$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145891$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240916$$CN$US$US
243213642$24321364$2$F$20240713$20240917$20240916$20240925$EXP$$PE-ROCHE-10000079606$ROCHE$$$$$M$Y$$$20240925$$CN$PE$PE
243213651$24321365$1$I$$20240904$20240916$20240916$EXP$$CA-AUROBINDO-AUR-APL-2023-032759$AUROBINDO$$81$YR$$F$Y$$$20240916$$HP$CA$CA
243213671$24321367$1$I$20240613$20240906$20240916$20240916$EXP$IT-MINISAL02-1001030$IT-AMGEN-ITASP2024179531$AMGEN$$38$YR$A$F$Y$$$20240915$$MD$IT$IT
243213681$24321368$1$I$20240601$20240904$20240916$20240916$EXP$$FR-AUROBINDO-AUR-APL-2024-044702$AUROBINDO$$81$YR$$M$Y$$$20240916$$MD$FR$FR
243213691$24321369$1$I$20240907$20240910$20240916$20240916$EXP$$JP-SANDOZ INC.-SDZ2024JP080087$SANDOZ$$71$YR$$M$Y$$$20240916$$CN$JP$JP
243213702$24321370$2$F$$20240912$20240916$20240917$PER$$US-BIOGEN-2024BI01282429$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
243213711$24321371$1$I$$20240905$20240916$20240916$EXP$$CA-ROCHE-10000074889$ROCHE$$72$YR$E$F$Y$82$KG$20240916$$HP$CA$CA
243213721$24321372$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146534$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240916$$HP$US$US
243213741$24321374$1$I$$20240911$20240916$20240916$EXP$$BR-JNJFOC-20240937032$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$BR$BR
243213751$24321375$1$I$$20240906$20240916$20240916$EXP$$RO-AUROBINDO-AUR-APL-2024-045250$AUROBINDO$A M Oprean, D A Epure, R S Perjoc, A C Paslaru, R I Teleanu. Neurodevelopmental disorder related to TANC2 gene. Revista de Neurologie si Psihiatrie a Copilului si Adolescentului din Romania. 2024;30:65-69$12$YR$$F$Y$$$20240916$$HP$RO$RO
243213761$24321376$1$I$$20240904$20240916$20240916$EXP$$ES-RDY-SPO/ESP/24/0013251$DR REDDYS$Romero FL, Martin GR, Diaz De Guerenu LB, Esteban LL, Sanchez CC, Saiz EP, et al. A CASE OF GOODPASTURE ^S SYNDROME, CYTOMEGALOVIRUS AND ALVEOLAR HAEMORRHAGES: WHEN VASCULITIS IS NOT EVERYTHING. European Journal of Case Reports in Internal Medicine 11. 2024;965: 0396. doi:10.12890/2024_V11Sup1.$18$YR$A$M$Y$$$20240916$$HP$ES$ES
243213771$24321377$1$I$$20240904$20240916$20240916$EXP$US-MLMSERVICE-20240828-PI175862-00271-1$US-RDY-SPO/USA/24/0013009$DR REDDYS$Ansari A, Dirani K, Malik A, Matthews S. Silent Manifestations of Disseminated Nocardia in a Renal Transplant Patient. Cureus. 2024;16(7):e65523. DOI: 10.7759/cureus.65523.$45$YR$A$M$Y$$$20240916$$MD$US$US
243213781$24321378$1$I$$20240904$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013201$DR REDDYS$Wallace CE, Tam I, Beveridge MG. Cyclosporine for Recalcitrant Bullous Pemphigoid Induced by Nivolumab Therapy for Malignant Melanoma. Cutis. 2024 Jul;114(1): E21-E23. doi:10.12788/cutis.1058.$41$YR$A$M$Y$$$20240916$$MD$US$US
243213791$24321379$1$I$$20240905$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013303$DR REDDYS$Heyman HM, Alberts NM, Rees M, Puri L, Frett MJ, Anghelescu DL. COVID-19 infection and pain in adolescents with sickle cell disease: A case series. eJHaem. 2022 Nov;3(4): 1310-1315. doi:10.1002/jha2.587.$17$YR$T$F$Y$$$20240916$$HP$US$US
243213802$24321380$2$F$20240901$20240917$20240916$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145670$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240924$$CN$US$US
243213812$24321381$2$F$$20240926$20240916$20240930$PER$$NVSC2024US184318$NOVARTIS$$$$$M$Y$$$20240929$$HP$US$US
243213821$24321382$1$I$$20240913$20240916$20240916$EXP$$CN-AstraZeneca-2024A210153$ASTRAZENECA$$$$$F$Y$$$20240916$$HP$CN$
243213831$24321383$1$I$$20240904$20240916$20240916$PER$$US-SA-2024SA263589$SANOFI AVENTIS$$$$$M$Y$$$20240916$$PH$US$US
243213841$24321384$1$I$$20240911$20240916$20240916$PER$$US-BIOGEN-2024BI01282280$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
243213852$24321385$2$F$$20240912$20240916$20240920$PER$$US-AMGEN-USASP2024183450$AMGEN$$$$E$F$Y$$$20240919$$MD$US$US
243213861$24321386$1$I$20240911$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183285$AMGEN$$75$YR$E$M$Y$$$20240915$$CN$US$US
243213872$24321387$2$F$$20240923$20240916$20240924$PER$$US-AMGEN-USASP2024181268$AMGEN$$29$YR$A$M$Y$99.773$KG$20240924$$HP$US$US
243213881$24321388$1$I$$20240905$20240916$20240916$EXP$$US-ENDO USA, INC.-2024-003400$ENDO$$$$$F$Y$$$20240916$$CN$US$US
243213891$24321389$1$I$$20240905$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013353$DR REDDYS$Heyman HM, Alberts NM, Rees M, Puri L, Frett MJ, Anghelescu DL. COVID-19 infection and pain in adolescents with sickle cell disease: A case series. eJHaem. 2022 Nov;3(4): 1310-1315. doi:10.1002/jha2.587.$14$YR$T$F$Y$$$20240916$$HP$US$US
243213902$24321390$2$F$20240101$20240913$20240916$20240919$EXP$$US-ORGANON-O2409USA000927$ORGANON$$$$A$F$Y$$$20240919$$MD$US$US
243213911$24321391$1$I$20230101$20240904$20240916$20240916$EXP$$US-NOVOPROD-1281007$NOVO NORDISK$$77$YR$$F$Y$$$20240916$$HP$US$US
243213921$24321392$1$I$20190101$20240904$20240916$20240916$EXP$$US-NOVOPROD-1280438$NOVO NORDISK$$$$$F$Y$$$20240916$$MD$US$US
243213931$24321393$1$I$20240601$20240904$20240916$20240916$EXP$$US-NOVOPROD-1280915$NOVO NORDISK$$62$YR$$F$Y$$$20240916$$CN$US$US
243213941$24321394$1$I$20190919$20240904$20240916$20240916$EXP$$US-NOVOPROD-1280637$NOVO NORDISK$$71$YR$$M$Y$$$20240916$$CN$US$US
243213951$24321395$1$I$20240101$20240904$20240916$20240916$EXP$$US-NOVOPROD-1280576$NOVO NORDISK$$76$YR$$M$Y$$$20240916$$CN$US$US
243213961$24321396$1$I$$20240911$20240916$20240916$EXP$GB-MHRA-MED-202409111139155900-NDJVR$GB-VIIV HEALTHCARE LIMITED-GB2024112952$VIIV$$$$$$Y$$$20240916$$CN$GB$GB
243213971$24321397$1$I$$20240909$20240916$20240916$EXP$$CA-CHEPLA-2024011720$CHEPLAPHARM$Alenezi AF, Alnuaimi A, Liberman D. SIADH and mixed delirium following the abrupt cessation of long-acting benzodiazepines: a case report. Oxford Medical Case Reports. 2024;(9):381?383. doi: 10.1093/omcr/omae098. .$85$YR$$F$Y$$$20240913$$MD$COUNTRY NOT SPECIFIED$CA
243213981$24321398$1$I$$20240911$20240916$20240916$EXP$GB-MHRA-MED-202409111139155900-NDJVR$GB-GSK-GB2024112952$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$GB$GB
243213992$24321399$2$F$20240827$20240912$20240916$20240924$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18246$IPSEN$$63$YR$A$F$Y$$$20240924$$HP$US$US
243214001$24321400$1$I$20240721$20240906$20240916$20240916$PER$$US-SA-2024SA264465$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240916$$HP$US$US
243214012$24321401$2$F$20240909$20240916$20240916$20240919$30DAY$$US-AMGEN-USASL2024180024$AMGEN$$54$YR$A$M$Y$$$20240919$$CN$US$US
243214021$24321402$1$I$$20240830$20240916$20240916$PER$$US-SA-2024SA265919$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240916$$CN$US$US
243214031$24321403$1$I$$20240904$20240916$20240916$30DAY$$US-NOVOPROD-1281586$NOVO NORDISK$$$$$$Y$$$20240916$$CN$US$US
243214041$24321404$1$I$$20240904$20240916$20240916$EXP$$US-NOVOPROD-1281010$NOVO NORDISK$$$$$F$Y$$$20240916$$HP$US$US
243214051$24321405$1$I$20220101$20240904$20240916$20240916$EXP$$US-NOVOPROD-1281380$NOVO NORDISK$$78$YR$$M$Y$$$20240916$$MD$US$US
243214061$24321406$1$I$$20240904$20240916$20240916$EXP$$US-NOVOPROD-1281449$NOVO NORDISK$$$$$F$Y$$$20240916$$CN$US$US
243214071$24321407$1$I$$20240904$20240916$20240916$EXP$$US-NOVOPROD-1281068$NOVO NORDISK$Diego Anazco. Low incidence of Pulmonary Aspiration During Upper Endoscopy in patient prescribed a Glucagon Like peptide 1 Receptor Agonist. Clinical Gastroenterology and Hepatology 2024. 2024;22:1333?1335$$$E$F$Y$$$20240916$$HP$US$US
243214082$24321408$2$F$$20240916$20240916$20240926$EXP$$DE-NOVOPROD-1281339$NOVO NORDISK$$$$$M$Y$$$20240926$$CN$DE$DE
243214091$24321409$1$I$20240729$20240904$20240916$20240916$EXP$$US-NOVOPROD-1281451$NOVO NORDISK$$68$YR$$M$Y$$$20240916$$CN$US$US
243214101$24321410$1$I$$20240904$20240916$20240916$EXP$$US-NOVOPROD-1281954$NOVO NORDISK$$$$A$F$Y$$$20240916$$MD$US$US
243214111$24321411$1$I$$20240910$20240916$20240916$EXP$$CN-TAKEDA-2024TUS090423$TAKEDA$$$$$F$Y$$$20240916$$CN$CN$CN
243214131$24321413$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008502$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243214141$24321414$1$I$$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008455$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240916$$CN$US$US
243214151$24321415$1$I$$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005818$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240916$$CN$US$US
243214161$24321416$1$I$20240906$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007409$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240916$$CN$US$US
243214171$24321417$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008209$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240916$$CN$US$US
243214181$24321418$1$I$20240904$20240911$20240916$20240916$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-18232$IPSEN$$68$YR$E$M$Y$$$20240916$$CN$GB$GB
243214191$24321419$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008239$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243214201$24321420$1$I$20240907$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005992$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240916$$CN$US$US
243214211$24321421$1$I$20240601$20240903$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409001586$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240916$$CN$US$US
243214221$24321422$1$I$$20240912$20240916$20240916$EXP$$GB-SANDOZ INC.-SDZ2024GB080197$SANDOZ$$$$$M$Y$$$20240916$$CN$GB$GB
243214231$24321423$1$I$20240817$20240906$20240916$20240916$EXP$FR-AFSSAPS-NC2024001033$FR-TEVA-VS-3241369$TEVA$$50$YR$$M$Y$110$KG$20240916$$MD$FR$FR
243214241$24321424$1$I$$20240911$20240916$20240916$EXP$GB-MHRA-31829428$GB-GSK-GB2024GSK114219$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$GB$GB
243214261$24321426$1$I$$20240911$20240916$20240916$PER$$US-ABBVIE-5923102$ABBVIE$$$$A$F$Y$$$20240916$$HP$US$US
243214271$24321427$1$I$20240910$20240910$20240916$20240916$EXP$$US-ABBVIE-5919148$ABBVIE$$78$YR$$F$Y$$$20240916$$CN$US$US
243214281$24321428$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A206704$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243214291$24321429$1$I$$20240906$20240916$20240916$EXP$$US-AstraZeneca-2024A205401$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243214301$24321430$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205262$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243214311$24321431$1$I$20240910$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024182591$AMGEN$$79$YR$E$F$Y$$$20240915$$CN$US$US
243214321$24321432$1$I$$20240902$20240916$20240916$PER$$US-P+L Developments of Newyork Corporation-2161653$PL DEVELOPMENTS$$$$$$Y$$$20240916$$$US$US
243214331$24321433$1$I$$20240904$20240916$20240916$EXP$$ES-MSNLABS-2024MSNLIT01938$MSN LABORATORIES$Sisinni L, Mozo Y, Bueno D, De Paz R, Lopez-Granados E, Perez-Martinez A.Hemophagocytic syndrome after ex-vivo lymphodepleted hematopoietic transplantation.Bone Marrow Transplant.2020;55:614-615$$$$$Y$$$20240916$$MD$ES$ES
243214341$24321434$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146605$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240916$$CN$US$US
243214351$24321435$1$I$$20240904$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013404$DR REDDYS$Khadka S, Dong N, Chavez J. ABCL-440 Preliminary Safety and Efficacy Data of Combination Polatuzumab Vedotin Rituximab, Cyclophosphamide Adriamycin, Prednisone (Pola-R-CHP) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) in the Standard-of-Care Setting: A Singl. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24: S480. doi:10.1016/S2152-2650%2824%2901530-1.$$$$$Y$$$20240916$$MD$US$US
243214361$24321436$1$I$$20240904$20240916$20240916$EXP$$CA-AUROBINDO-AUR-APL-2024-045140$AUROBINDO$$67$YR$$F$Y$$$20240916$$HP$CA$CA
243214372$24321437$2$F$20230801$20240909$20240916$20240918$EXP$$CA-CELLTRION INC.-2023CA008607$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
243214381$24321438$1$I$$20240911$20240916$20240916$PER$$US-JNJFOC-20240929060$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$US$US
243214391$24321439$1$I$20240101$20240823$20240916$20240916$PER$$US-SA-2024SA264273$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240916$$MD$US$US
243214401$24321440$1$I$20240904$20240904$20240916$20240916$PER$$US-SA-2024SA264986$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240916$$MD$US$US
243214411$24321441$1$I$20240625$20240911$20240916$20240916$PER$$US-BIOGEN-2024BI01282250$BIOGEN$$74$YR$$F$Y$$$20240916$$CN$US$US
243214421$24321442$1$I$20240801$20240823$20240916$20240916$PER$$US-SA-2024SA264239$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240916$$MD$US$US
243214442$24321444$2$F$20240206$20240926$20240916$20240928$EXP$IT-MINISAL02-1002240$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-146202$BRISTOL MYERS SQUIBB$$23$YR$A$M$Y$64$KG$20240928$$MD$IT$IT
243214452$24321445$2$F$$20240912$20240916$20240925$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005152$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240925$$CN$US$US
243214461$24321446$1$I$$20240909$20240916$20240916$EXP$$GB-ASTELLAS-2024-AER-005891$ASTELLAS$$62$YR$A$M$Y$$$20240916$$MD$GB$GB
243214471$24321447$1$I$20240716$20240911$20240916$20240916$EXP$FR-AFSSAPS-TS2024000966$FR-ORGANON-O2409FRA000780$ORGANON$$72$YR$$M$Y$50$KG$20240916$$CN$FR$FR
243214481$24321448$1$I$$20240910$20240916$20240916$EXP$$CN-TAKEDA-2023TUS052779$TAKEDA$$$$$M$Y$$$20240916$$CN$CN$CN
243214492$24321449$2$F$20240101$20240912$20240916$20240920$PER$$US-AMGEN-USASP2024183367$AMGEN$$36$YR$A$F$Y$$$20240920$$HP$US$US
243214501$24321450$1$I$$20240904$20240916$20240916$EXP$$US-TAKEDA-2024TUS089131$TAKEDA$$$$$M$Y$83$KG$20240916$$MD$US$US
243214511$24321451$1$I$20231213$20240906$20240916$20240916$EXP$$CA-CELLTRION INC.-2023CA015618$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
243214521$24321452$1$I$$20240711$20240916$20240916$PER$$US-STRIDES PHARMA UK LTD.-2024SP008797$STRIDES$Mak J, Gandhi R, Zaidan MF, Murthy V.. Rituximab for Rapidly Progressive MDA5 Dermatomyositis-Associated Interstitial Lung Disease.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$$$$$Y$$$20240916$$HP$US$US
243214531$24321453$1$I$20240401$20240912$20240916$20240916$EXP$$JP-SANDOZ INC.-SDZ2024JP080091$SANDOZ$$88$YR$$F$Y$$$20240916$$CN$JP$JP
243214541$24321454$1$I$20240101$20240906$20240916$20240916$PER$$US-SA-2024SA264312$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240916$$MD$US$US
243214551$24321455$1$I$$20240829$20240916$20240916$PER$$US-SA-2024SA264490$SANOFI AVENTIS$$$$A$$Y$$$20240916$$CN$US$US
243214561$24321456$1$I$$20240820$20240916$20240916$PER$$US-SA-2024SA263621$SANOFI AVENTIS$$$$A$F$Y$100$KG$20240916$$MD$US$US
243214571$24321457$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA266102$SANOFI AVENTIS$$67$YR$E$$Y$$$20240916$$HP$US$US
243214581$24321458$1$I$20240101$20240906$20240916$20240916$PER$$US-SA-2024SA264479$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240916$$HP$US$US
243214591$24321459$1$I$20220801$20240823$20240916$20240916$PER$$US-SA-2024SA264493$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240916$$CN$US$US
243214611$24321461$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205275$ASTRAZENECA$$$$$M$Y$$$20240916$$MD$US$
243214621$24321462$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A208008$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243214631$24321463$1$I$$20240903$20240916$20240916$PER$$US-AstraZeneca-2024A200631$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243214641$24321464$1$I$$20240711$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008799$STRIDES$Wireko FW, Ryu JH.. Lung Transplant for Acute Exacerbation in Interstitial Pneumonia With Autoimmune Features (IPAF). Am-J-Respir-Crit-Care-Med. 2024;209.$63$YR$$M$Y$$$20240916$$HP$US$US
243214651$24321465$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205452$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243214661$24321466$1$I$20240816$20240911$20240916$20240916$EXP$$PT-AstraZeneca-2024A206890$ASTRAZENECA$$49$YR$$M$Y$$$20240916$$MD$PT$
243214671$24321467$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207895$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243214681$24321468$1$I$$20240905$20240916$20240916$PER$$US-AstraZeneca-2024A202872$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243214691$24321469$1$I$20240701$20240911$20240916$20240916$EXP$$IT-AstraZeneca-2024A207006$ASTRAZENECA$$56$YR$$F$Y$$$20240916$$MD$IT$
243214701$24321470$1$I$20240101$20240911$20240916$20240916$PER$$US-BIOGEN-2024BI01282256$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
243214711$24321471$1$I$20240912$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008133$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240916$$CN$US$US
243214721$24321472$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008383$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240916$$CN$US$US
243214731$24321473$1$I$20240830$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008518$ELI LILLY AND CO$$56$YR$A$$Y$$$20240916$$CN$US$US
243214741$24321474$1$I$20240912$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008469$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240916$$CN$US$US
243214751$24321475$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008322$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240916$$CN$US$US
243214761$24321476$1$I$20240911$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008837$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243214771$24321477$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008482$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240916$$PH$US$US
243214781$24321478$1$I$$20240619$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007488$STRIDES$Peters AT, Case R, Kim SJ, McGregor M, Shifren A, Schroeder G, et al.. Single-Agent Oral Therapy of Granulomatous-Lymphocytic Interstitial Lung Disease: A Case Series.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$$$$$Y$$$20240916$$HP$US$US
243214801$24321480$1$I$$20240910$20240916$20240916$PER$$US-JNJFOC-20240935396$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$HP$US$US
243214821$24321482$1$I$$20240821$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010719$STRIDES$Acob T, Jumaah O, Kakhktsyan T, et al.. Unmasking Focal Segmental Glomerulosclerosis in a Patient With Lupus Nephritis.. Cureus. 2024;16(6):e63008$28$YR$$M$Y$$$20240916$$HP$US$US
243214831$24321483$1$I$$20240902$20240916$20240916$PER$$US-P+L Developments of Newyork Corporation-2161654$PL DEVELOPMENTS$$$$$$Y$$$20240916$$$US$US
243214841$24321484$1$I$$20240822$20240916$20240916$PER$$US-SA-2024SA263190$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240916$$CN$US$US
243214851$24321485$1$I$20240901$20240906$20240916$20240916$PER$$US-SA-2024SA263721$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240916$$CN$US$US
243214861$24321486$1$I$$20240911$20240916$20240916$EXP$$GB-SANDOZ INC.-SDZ2023GB014270$SANDOZ$$$$$M$Y$$$20240916$$CN$GB$GB
243214871$24321487$1$I$20240101$20240906$20240916$20240916$PER$$US-SA-2024SA264456$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240916$$HP$US$US
243214881$24321488$1$I$$20240821$20240916$20240916$PER$$US-SA-2024SA263056$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240916$$CN$US$US
243214891$24321489$1$I$$20240718$20240916$20240916$PER$$US-STRIDES PHARMA UK LTD.-2024SP009204$STRIDES$Marvin JE, McSweeney T, Cohen E, Davis MW, Belfield K, Do V, et al.. Nocardiosis in Kidney Transplant Recipients and Possible Association With Decreased Utilization of Trimethoprim/Sulfamethoxazole During COVID-19.. Transplantation. 2024;108 (7):e150-e151$$$$$Y$$$20240916$$MD$US$US
243214901$24321490$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004988$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$HP$US$US
243214911$24321491$1$I$$20240904$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146387$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$85.73$KG$20240916$$HP$US$US
243214921$24321492$1$I$$20240909$20240916$20240916$EXP$$US-AMGEN-USASP2024182162$AMGEN$Lecompte M. C.; Vuppala N.; Reyes J. M. et al.. Conventionally Fractionated Reirradiation of Recurrent High-Grade Gliomas: A Look at Dose Escalation and Safety. International Journal of Radiation Oncology, Biology, Physics. 2024;120 (2):e248-e249$$$$$Y$$$20240915$$HP$US$US
243214931$24321493$1$I$$20240725$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009560$STRIDES$Patel G, Khan DA.. Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria.. J-Allergy-Clin-Immunol-Pract. 2024;12 (6):1663-1665$43$YR$$F$Y$$$20240916$$MD$US$US
243214941$24321494$1$I$20240624$20240823$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005005$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20240916$$CN$US$US
243214951$24321495$1$I$20240101$20240911$20240916$20240916$EXP$$US-JNJFOC-20240934352$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240916$$HP$US$US
243214962$24321496$2$F$$20240909$20240916$20240926$EXP$$JP-009507513-2409JPN001422J$MERCK$Yoshihara K, Nakamoto K, Shibamura N, Noda N, Nishimoto Y, Ohara R, et al.. 153 Two cases of gastrointestinal perforation during combination drug therapy with lenvatinib and pembrolizumab. Modern trends in obstetrics + gynecology The 76th Annual Meeting and Academic Sy. 2024;73(S):S69$59$YR$$F$Y$$$20240926$$HP$JP$JP
243214971$24321497$1$I$$20240906$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US079948$SANDOZ$$$$$F$Y$$$20240916$$CN$US$US
243214981$24321498$1$I$20230930$20240906$20240916$20240916$EXP$$CA-CELLTRION INC.-2023CA019833$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
243214991$24321499$1$I$20240101$20240906$20240916$20240916$EXP$$CA-CELLTRION INC.-2024CA018129$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
243215001$24321500$1$I$$20240715$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009102$STRIDES$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al.. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.. J-Ophthalmic-Inflamm-Infect. 2024;14$43$YR$$M$Y$$$20240916$$HP$US$US
243215011$24321501$1$I$20240901$20240909$20240916$20240916$EXP$$US-AMGEN-USASP2024181082$AMGEN$$74$YR$E$$Y$$$20240915$$CN$US$US
243215021$24321502$1$I$$20240905$20240916$20240916$EXP$$GB-MSNLABS-2024MSNSPO01969$MSN LABORATORIES$$$$$$Y$$$20240916$$PH$GB$GB
243215031$24321503$1$I$$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146245$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240916$$CN$US$US
243215041$24321504$1$I$$20240904$20240916$20240916$EXP$$NVSC2024CA183422$NOVARTIS$$43$YR$$F$Y$96$KG$20240916$$HP$CA$CA
243215051$24321505$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004991$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243215061$24321506$1$I$20190101$20240905$20240916$20240916$EXP$$CO-NOVOPROD-1282452$NOVO NORDISK$$$$$F$Y$78$KG$20240916$$CN$CO$CO
243215071$24321507$1$I$20240717$20240905$20240916$20240916$EXP$$US-NOVOPROD-1279508$NOVO NORDISK$$71$YR$$F$Y$$$20240916$$CN$US$US
243215081$24321508$1$I$20240101$20240905$20240916$20240916$EXP$SE-SEMPA-2024-006521$SE-NOVOPROD-1279225$NOVO NORDISK$$39$YR$$F$Y$86$KG$20240916$$CN$SE$SE
243215091$24321509$1$I$20240501$20240905$20240916$20240916$EXP$$CO-NOVOPROD-1282469$NOVO NORDISK$$$$$F$Y$$$20240916$$CN$CO$CO
243215111$24321511$1$I$20240101$20240905$20240916$20240916$EXP$SE-SEMPA-2024-006511$SE-NOVOPROD-1279206$NOVO NORDISK$$62$YR$$M$Y$$$20240916$$MD$SE$SE
243215121$24321512$1$I$$20240905$20240916$20240916$EXP$GB-MHRA-MED-202409051357273780-MRPFZ$GB-NOVOPROD-1279356$NOVO NORDISK$$$$$F$Y$$$20240916$$PH$GB$GB
243215131$24321513$1$I$$20240905$20240916$20240916$EXP$$US-NOVOPROD-1279050$NOVO NORDISK$Nikhil Sood et al.,. Euglycemic Ketoacidosis From Semaglutide in a Patient Without Diabetes. The Journal of Clinical Endocrinology + Metabolism Case Reports. 2024;156$40$YR$$F$Y$78$KG$20240916$$MD$US$US
243215141$24321514$1$I$$20240905$20240916$20240916$EXP$GB-MHRA-MIDB-7965040d-74a2-4267-b84d-9b2228274fc4$GB-NOVOPROD-1279353$NOVO NORDISK$$22$YR$$$Y$$$20240916$$PH$GB$GB
243215151$24321515$1$I$$20240826$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08591$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243215161$24321516$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265725$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240916$$MD$US$US
243215171$24321517$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265636$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240916$$HP$US$US
243215182$24321518$2$F$20210101$20240904$20240916$20240928$PER$$US-SA-2024SA266492$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240928$$CN$US$US
243215191$24321519$1$I$20240718$20240903$20240916$20240916$EXP$$US-UCBSA-2024038821$UCB$$63$YR$$F$Y$$$20240916$$CN$US$US
243215201$24321520$1$I$20240814$20240823$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004992$ACADIA PHARMACEUTICALS$$9$YR$$F$Y$$$20240916$$CN$US$US
243215211$24321521$1$I$$20240910$20240916$20240916$EXP$$ZA-AstraZeneca-2024A207347$ASTRAZENECA$$41$YR$$M$Y$$$20240916$$CN$ZA$
243215231$24321523$1$I$20240813$20240815$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010500$STRIDES$$75$YR$$$Y$$$20240916$$PH$US$US
243215241$24321524$1$I$20240101$20240909$20240916$20240916$EXP$$US-SA-2024SA263649$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240916$$MD$US$US
243215251$24321525$1$I$$20240904$20240916$20240916$PER$$US-JNJFOC-20240908794$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$PH$US$US
243215261$24321526$1$I$20240801$20240901$20240916$20240916$PER$$US-SA-2024SA263928$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240916$$MD$US$US
243215271$24321527$1$I$$20240909$20240916$20240916$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001833$BLUEPRINT MEDICINES$$$$$M$Y$$$20240916$$CN$US$US
243215281$24321528$1$I$$20240904$20240916$20240916$PER$$US-SA-2024SA265574$SANOFI AVENTIS$$$$A$$Y$$$20240916$$MD$US$US
243215291$24321529$1$I$20230101$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008974$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240916$$CN$US$US
243215301$24321530$1$I$$20240905$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409004050$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240916$$CN$US$US
243215311$24321531$1$I$$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005908$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240916$$CN$US$US
243215321$24321532$1$I$20240901$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007042$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240916$$CN$US$US
243215331$24321533$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008498$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240916$$CN$US$US
243215341$24321534$1$I$20240706$20240911$20240916$20240916$EXP$NO-NOMAADVRE-RELISSO-2024-V8bmwq$NO-Orion Corporation ORION PHARMA-24_00031654$ORION$$57$YR$A$M$Y$$$20240916$$MD$NO$
243215351$24321535$1$I$20240125$20240904$20240916$20240916$EXP$FR-AFSSAPS-TO2024001641$FR-Accord-445644$ACCORD$$61$YR$A$M$Y$75$KG$20240916$$PH$FR$FR
243215361$24321536$1$I$$20240911$20240916$20240916$EXP$$AU-ROCHE-10000080728$ROCHE$$$$A$F$Y$69$KG$20240916$$MD$AU$AU
243215371$24321537$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184404$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243215381$24321538$1$I$$20240906$20240916$20240916$PER$$US-CHATTEMPRD-2024OHG031705$CHATTEM$$$$$F$Y$$$20240916$$CN$US$US
243215391$24321539$1$I$20240812$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005001$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240916$$CN$US$US
243215411$24321541$1$I$20240901$20240909$20240916$20240916$30DAY$$US-GSK-US2024AMR110321$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$US$US
243215421$24321542$1$I$$20240823$20240916$20240916$PER$$US-SA-2024SA200012$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240916$$MD$US$US
243215431$24321543$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA263507$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240916$$MD$US$US
243215441$24321544$1$I$$20240829$20240916$20240916$PER$$US-SA-2024SA265907$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$PH$US$US
243215451$24321545$1$I$20240819$20240826$20240916$20240916$PER$$US-SA-2024SA263096$SANOFI AVENTIS$$$$$M$Y$$$20240916$$CN$US$US
243215461$24321546$1$I$20240101$20240904$20240916$20240916$PER$$US-SA-2024SA263240$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240916$$HP$US$US
243215471$24321547$1$I$20240101$20240906$20240916$20240916$PER$$US-SA-2024SA264007$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240916$$HP$US$US
243215481$24321548$1$I$20240101$20240906$20240916$20240916$PER$$US-SA-2024SA263878$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240916$$MD$US$US
243215491$24321549$1$I$20240813$20240813$20240916$20240916$PER$$US-SERVIER-S24010418$SERVIER$$$$$$Y$$$20240916$$HP$US$US
243215501$24321550$1$I$$20240905$20240916$20240916$EXP$$DE-JNJFOC-20240919236$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$MD$DE$DE
243215512$24321551$2$F$20240904$20240910$20240916$20240917$30DAY$$JP-JNJFOC-20240914243$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$PH$JP$JP
243215521$24321552$1$I$$20240827$20240916$20240916$PER$$US-TEVA-VS-3238196$TEVA$$68$YR$$M$Y$$$20240916$$CN$US$US
243215531$24321553$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004999$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243215541$24321554$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005002$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243215551$24321555$1$I$20240912$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024182866$AMGEN$$52$YR$A$M$Y$$$20240916$$CN$US$US
243215561$24321556$1$I$$20240912$20240916$20240916$PER$$US-ALXN-202409USA000930US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240916$$MD$US$US
243215571$24321557$1$I$20240731$20240910$20240916$20240916$EXP$FI-FIMEA-202403060$FI-CHEPLA-2024011683$CHEPLAPHARM$$63$YR$$M$Y$$$20240916$$MD$COUNTRY NOT SPECIFIED$FI
243215581$24321558$1$I$20240704$20240910$20240916$20240916$EXP$CZ-CZSUKL-24002477$CZ-CHEPLA-2024011645$CHEPLAPHARM$$57$YR$$M$Y$75$KG$20240916$$MD$COUNTRY NOT SPECIFIED$CZ
243215591$24321559$1$I$20240808$20240823$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005059$ACADIA PHARMACEUTICALS$$88$YR$$M$Y$$$20240916$$CN$US$US
243215601$24321560$1$I$20240909$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145874$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$117.93$KG$20240916$$CN$US$US
243215611$24321561$1$I$$20240830$20240916$20240916$PER$$US-SA-2024SA265937$SANOFI AVENTIS$$41$YR$A$$Y$$$20240916$$CN$US$US
243215621$24321562$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA264214$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240916$$MD$US$US
243215632$24321563$2$F$20240801$20240918$20240916$20240925$PER$$US-SA-2024SA263893$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240926$$HP$US$US
243215641$24321564$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A206797$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243215651$24321565$1$I$20240824$20240904$20240916$20240916$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS004632$TERSERA THERAPEUTICS$$$$$$Y$$$20240916$$MD$CN$CN
243215661$24321566$1$I$$20240912$20240916$20240916$EXP$$CN-AstraZeneca-2024A210050$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$CN$
243215671$24321567$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207704$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243215681$24321568$1$I$20240909$20240910$20240916$20240916$PER$$US-AstraZeneca-2024A207005$ASTRAZENECA$$61$YR$$M$Y$$$20240916$$CN$US$
243215691$24321569$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005048$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243215711$24321571$1$I$20240613$20240715$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009708$STRIDES$$24$YR$$F$Y$$$20240916$$HP$US$US
243215721$24321572$1$I$$20240711$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008809$STRIDES$Hebert BJ, Gallegos MA, Hartman E, Bradley J, Shelley P, Ng A, et al.. Severe Pre-capillary Pulmonary Arterial Hypertension in a Patient With Common Variable Immunodeficiency With Granulomatous Lymphocytic Interstitial Lung Disease.. Am-J-Respir-Crit-Care-Med. 2024;209:abstr. C52.$45$YR$$F$Y$$$20240916$$HP$US$US
243215731$24321573$1$I$$20240715$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009039$STRIDES$Ozer S, Farabi B, Kann R, Atak MF, Shulman K, Marmon S.. Refractory antimelanoma differentiation-associated gene 5 antibody negative ulcerative dermatomyositis responsive to mycophenolate mofetil.. JAAD-Case-Rep. 2024;50:1-3$52$YR$$F$Y$$$20240916$$MD$US$US
243215741$24321574$1$I$$20240723$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009421$STRIDES$Lopez A, Chen KP, Gundogdu B, Orr JE, Joshua J.. Shrinking Lung Syndrome With Diaphragm Myopathy and Phrenic Neuropathy.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$43$YR$$M$Y$$$20240916$$HP$US$US
243215751$24321575$1$I$$20240624$20240916$20240916$PER$$US-STRIDES PHARMA UK LTD.-2024SP007693$STRIDES$Patel P, Turbin RE, Husain S, Wang S. . Neurosyphilis Mimicking Connective Tissue Disease.. BMJ-Case-Rep. 2023;16 (9)$$$$$Y$$$20240916$$HP$US$US
243215761$24321576$1$I$$20240619$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007528$STRIDES$Wazirali M, Georg M, Malik M.. Relapsing Cryptogenic Organizing Pneumonia: What Comes After Steroids?.. Am-J-Respir-Crit-Care-Med. 2024;209:A2066$71$YR$$M$Y$$$20240916$$HP$US$US
243215772$24321577$2$F$$20240913$20240916$20240919$PER$$US-AMGEN-USASP2024183984$AMGEN$$$$$F$Y$$$20240919$$MD$US$US
243215791$24321579$1$I$$20240827$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08766$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243215801$24321580$1$I$$20240619$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007518$STRIDES$Lodh A, Blankenship S, Minish-Pron JM, Solomon GM.. Cyclophosphamide in the Treatment of Shrinking Lung Syndrome.. Am-J-Respir-Crit-Care-Med. 2024;209 abstr.:A1985$46$YR$$F$Y$$$20240916$$HP$US$US
243215811$24321581$1$I$$20240910$20240916$20240916$EXP$$CA-AMGEN-CANSP2024183422$AMGEN$$43$YR$A$F$Y$$$20240916$$HP$CA$CA
243215821$24321582$1$I$$20240910$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143943$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$MD$US$US
243215831$24321583$1$I$$20240726$20240916$20240916$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009591$STRIDES$Chumsky J, Kahn PJ, Carroll WL, Pierce KA, Hillier K.. Lupus anti-coagulant hypoprothrombinemia syndrome across different ages: a case report and review of the literature.. Clin-Rheumatol. 2023;42 (8):2231-2236$$$$F$Y$$$20240916$$HP$US$US
243215841$24321584$1$I$$20240827$20240916$20240916$PER$$US-TEVA-VS-3241251$TEVA$$$$$F$Y$$$20240916$$MD$US$US
243215851$24321585$1$I$20240621$20240906$20240916$20240916$EXP$FR-AFSSAPS-PO2024000942$FR-TEVA-VS-3241350$TEVA$$64$YR$$M$Y$88$KG$20240916$$MD$FR$FR
243215881$24321588$1$I$$20240909$20240916$20240916$EXP$$JP-009507513-2409JPN001673J$MERCK$$8$DEC$$F$Y$$$20240916$$MD$JP$JP
243215891$24321589$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008208$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240916$$CN$US$US
243215901$24321590$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008389$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243215912$24321591$2$F$$20240916$20240916$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008391$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240918$$CN$US$US
243215931$24321593$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008850$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243215941$24321594$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008233$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243215951$24321595$1$I$20240912$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008121$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243215961$24321596$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008487$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240916$$CN$US$US
243215971$24321597$1$I$$20240906$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409004861$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240916$$CN$US$US
243215981$24321598$1$I$$20240904$20240916$20240916$EXP$$US-ROCHE-10000069009$ROCHE$$$$A$F$Y$$$20240916$$MD$US$US
243215991$24321599$1$I$20240809$20240903$20240916$20240916$EXP$$US-UCBSA-2024040742$UCB$$72$YR$$M$Y$$$20240916$$CN$US$US
243216002$24321600$2$F$20240101$20240826$20240916$20240923$PER$$US-SA-2024SA263857$SANOFI AVENTIS$$66$YR$E$F$Y$54$KG$20240923$$MD$US$US
243216011$24321601$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA266307$SANOFI AVENTIS$$$$$F$Y$$$20240916$$CN$US$US
243216021$24321602$1$I$20240101$20240906$20240916$20240916$PER$$US-SA-2024SA264339$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240916$$MD$US$US
243216031$24321603$1$I$20240821$20240910$20240916$20240916$PER$$US-SA-2024SA264820$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240916$$MD$US$US
243216041$24321604$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA266234$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240916$$CN$US$US
243216051$24321605$1$I$20240501$20240904$20240916$20240916$PER$$US-SA-2024SA263365$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$HP$US$US
243216061$24321606$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265767$SANOFI AVENTIS$$$$E$M$Y$$$20240916$$HP$US$US
243216071$24321607$1$I$20240801$20240827$20240916$20240916$PER$$US-SA-2024SA265616$SANOFI AVENTIS$$96$YR$E$F$Y$60.32$KG$20240916$$MD$US$US
243216091$24321609$1$I$$20240906$20240916$20240916$EXP$$TH-ROCHE-10000076901$ROCHE$$48$YR$A$$Y$$$20240916$$MD$TH$TH
243216101$24321610$1$I$$20240904$20240916$20240916$EXP$$US-ROCHE-10000074367$ROCHE$$$$$M$Y$$$20240916$$MD$US$US
243216111$24321611$1$I$$20240905$20240916$20240916$EXP$$IN-ROCHE-10000076007$ROCHE$$50$YR$A$M$Y$$$20240916$$CN$IN$IN
243216121$24321612$1$I$$20240906$20240916$20240916$PER$$US-ROCHE-10000076626$ROCHE$$23$YR$A$F$Y$$$20240916$$CN$US$US
243216131$24321613$1$I$$20240507$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002143$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243216141$24321614$1$I$$20240514$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002227$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243216151$24321615$1$I$$20240514$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002234$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243216161$24321616$1$I$20141114$20240906$20240916$20240916$EXP$FR-EMA-20150311-AUTODUP-368343$FR-TEVA-VS-3241413$TEVA$$$$$$Y$$$20240916$$MD$FR$FR
243216171$24321617$1$I$$20240902$20240916$20240916$EXP$$HR-NATCOUSA-2024-NATCOUSA-000224$NATCO PHARMA$Krecak I, Supe M, Markov B, Skelin M, Lucijanic M. Fatal heart tamponade during induction treatment with azacitidine and venetoclax. Ann Hematol. 2024 Aug 25. doi: 10.1007/s00277-024-05957-9. Epub ahead of print. PMID: 39182200.$62$YR$$M$Y$$$20240916$$HP$HR$
243216181$24321618$1$I$$20240911$20240916$20240916$EXP$$FI-JNJFOC-20240934189$JOHNSON AND JOHNSON$$$$$M$Y$140$KG$20240916$$MD$FI$FI
243216192$24321619$2$F$$20240911$20240916$20240919$EXP$$US-JNJFOC-20240935290$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$HP$US$US
243216201$24321620$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005012$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243216211$24321621$1$I$$20240911$20240916$20240916$EXP$$TH-ROCHE-10000079189$ROCHE$$73$YR$E$F$Y$$$20240916$$CN$TH$TH
243216221$24321622$1$I$20240808$20240906$20240916$20240916$EXP$FR-ROCHE-10000061089$FR-ROCHE-10000075767$ROCHE$$61$YR$A$F$Y$$$20240916$$MD$FR$FR
243216231$24321623$1$I$$20240902$20240916$20240916$EXP$$AU-GENERIC HEALTH PTY. LTD.-2024-08966$LUPIN$Gardiner BJ, Ivulich SP, Snell GI. Voriconazole inhalation powder: A novel therapeutic alternative for invasive pulmonary fungal infections. Transplant Infectious Disease. 2024;26 (e14264):1-4$54$YR$$F$Y$$$20240916$$MD$AU$AU
243216241$24321624$1$I$20200204$20240906$20240916$20240916$EXP$PL-URPL-2-1226-2020$PL-TEVA-VS-3241397$TEVA$$27$YR$$M$Y$58.5$KG$20240916$$CN$PL$PL
243216251$24321625$1$I$20240101$20240910$20240916$20240916$EXP$$US-AMGEN-USASL2024180937$AMGEN$$79$YR$E$F$Y$$$20240916$$CN$US$US
243216261$24321626$1$I$20240101$20240905$20240916$20240916$EXP$IE-PFIZER INC-PV202400111749$IE-AMGEN-IRLSP2024182753$AMGEN$Tomkins E. Neurology. Module 368, Clinical Focus: Chronic migraine - layering treatment. HOSPITAL DOCTOR OF IRELAND. 2024;30:26$50$YR$A$F$Y$$$20240916$$HP$IE$IE
243216271$24321627$1$I$$20240908$20240916$20240916$EXP$$US-AMGEN-USASP2024181242$AMGEN$Taritsa I.; Fay C.; Cho S. et.al.. History Does Not Always Repeat Itself: Nonrecurrence of ICI induced Bullous Pemphigoid after Restarting Anti-PD-1 Therapy. Journal of the American Academy of Dermatology. 2024;91 (3):AB50$77$YR$E$M$Y$$$20240916$$HP$US$US
243216282$24321628$2$F$$20231219$20240916$20240916$PER$$US-ENDO USA, INC.-2024-000004$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243216291$24321629$1$I$$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024181093$AMGEN$$$$$F$Y$$$20240916$$CN$US$US
243216302$24321630$2$F$$20231218$20240916$20240916$PER$$US-ENDO USA, INC.-2024-000061$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243216311$24321631$1$I$$20240905$20240916$20240916$30DAY$$JP-JNJFOC-20240935356$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$PH$JP$JP
243216321$24321632$1$I$$20240909$20240916$20240916$EXP$$JP-009507513-2409JPN001407J$MERCK$$$$$F$Y$$$20240916$$MD$JP$JP
243216332$24321633$2$F$20140101$20231219$20240916$20240916$PER$$US-ENDO USA, INC.-2024-000176$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243216341$24321634$1$I$$20240805$20240916$20240916$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK093174$GLENMARK$$$$$$Y$$$20240916$$CN$US$US
243216351$24321635$1$I$$20240502$20240916$20240916$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089285$GLENMARK$$$$$$Y$$$20240916$$CN$US$US
243216361$24321636$1$I$20240901$20240903$20240916$20240916$EXP$GB-MHRA-MED-202409021438380780-JMKWT$GB-LUPIN PHARMACEUTICALS INC.-2024-08792$LUPIN$$$$$$Y$$$20240916$$PH$GB$GB
243216371$24321637$1$I$$20240821$20240916$20240916$PER$$US-AstraZeneca-2024A190796$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243216381$24321638$1$I$$20240912$20240916$20240916$PER$$US-AstraZeneca-2024A208501$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243216391$24321639$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008367$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240916$$CN$US$US
243216401$24321640$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006691$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240916$$CN$US$US
243216411$24321641$1$I$20240801$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006600$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240916$$CN$US$US
243216421$24321642$1$I$20240714$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006920$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240916$$CN$US$US
243216431$24321643$1$I$$20240908$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006433$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243216441$24321644$1$I$$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006020$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240916$$CN$US$US
243216451$24321645$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146066$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240916$$CN$US$US
243216461$24321646$1$I$$20240910$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144594$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240916$$HP$US$US
243216471$24321647$1$I$20240101$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145728$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240916$$CN$US$US
243216481$24321648$1$I$20240906$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024182996$AMGEN$$27$YR$A$M$Y$$$20240916$$CN$US$US
243216491$24321649$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146429$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$129.27$KG$20240916$$CN$US$US
243216501$24321650$1$I$20240814$20240904$20240916$20240916$EXP$GB-MHRA-MED-202409041446370210-DYFHT$GB-Accord-445185$ACCORD$$14$YR$T$F$Y$100$KG$20240916$$MD$GB$GB
243216511$24321651$1$I$20240823$20240911$20240916$20240916$EXP$FR-AFSSAPS-LM2024000496$FR-AMGEN-FRASP2024181642$AMGEN$$49$YR$A$F$Y$$$20240916$$MD$FR$FR
243216521$24321652$1$I$20240811$20240904$20240916$20240916$EXP$$ES-AUROBINDO-AUR-APL-2024-044632$AUROBINDO$$78$YR$$F$Y$83$KG$20240916$$HP$ES$ES
243216531$24321653$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000082241$ROCHE$$17$YR$T$F$Y$$$20240916$$MD$US$US
243216542$24321654$2$F$$20240918$20240916$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR111715$VIIV$$$$A$$Y$$$20240927$$CN$US$US
243216551$24321655$1$I$20240909$20240910$20240916$20240916$EXP$$CN-TAKEDA-2024TUS091392$TAKEDA$$8$YR$$M$Y$$$20240916$$HP$CN$CN
243216561$24321656$1$I$20240911$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024182379$AMGEN$$79$YR$E$F$Y$$$20240916$$CN$US$US
243216571$24321657$1$I$$20240908$20240916$20240916$PER$$US-AMGEN-USASP2024181251$AMGEN$Eakes J.; Hatch L.; Hennessy K. et al.. Pembrolizumab-Induced Lichenoid Drug Eruption Successfully Treated with Dupilumab - A Case Report. Journal of the American Academy of Dermatology. 2024;91 (3):AB70$85$YR$E$M$Y$$$20240916$$HP$US$US
243216581$24321658$1$I$20230101$20240912$20240916$20240916$EXP$$BR-AMGEN-BRASP2024183008$AMGEN$$$$$F$Y$$$20240916$$MD$BR$BR
243216591$24321659$1$I$20240821$20240821$20240916$20240916$PER$$US-SA-2024SA263600$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240916$$MD$US$US
243216601$24321660$1$I$$20240907$20240916$20240916$PER$$US-BEH-2024178530$CSL BEHRING$$$$$$Y$$$20240916$$HP$US$US
243216611$24321661$1$I$20240820$20240826$20240916$20240916$PER$$US-SA-2024SA264059$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240916$$MD$US$US
243216621$24321662$1$I$20240701$20240909$20240916$20240916$PER$$US-SA-2024SA264541$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240916$$HP$US$US
243216631$24321663$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265442$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240916$$MD$US$US
243216641$24321664$1$I$20240101$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144689$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240916$$CN$US$US
243216651$24321665$1$I$$20240912$20240916$20240916$PER$$NVSC2024US184450$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
243216661$24321666$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184293$NOVARTIS$$$$$M$Y$$$20240916$$CN$US$US
243216672$24321667$2$F$20240701$20240916$20240916$20240917$PER$$US-AMGEN-USASP2024184235$AMGEN$$76$YR$E$M$Y$$$20240917$$CN$US$US
243216681$24321668$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024182245$AMGEN$$67$YR$E$F$Y$$$20240916$$CN$US$US
243216691$24321669$1$I$$20240904$20240916$20240916$EXP$GB-MHRA-TPP47231726C4678899YC1725384570438$GB-Accord-445285$ACCORD$$69$YR$E$M$Y$109$KG$20240916$$MD$GB$GB
243216701$24321670$1$I$20240827$20240910$20240916$20240916$EXP$FR-AFSSAPS-SE2024000693$FR-JNJFOC-20240935832$JOHNSON AND JOHNSON$$80$YR$E$M$Y$63.2$KG$20240916$$MD$FR$FR
243216711$24321671$1$I$$20240912$20240916$20240916$EXP$$FR-JNJFOC-20240931737$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$MD$FR$FR
243216721$24321672$1$I$20240101$20240911$20240916$20240916$EXP$$US-ABBVIE-5920840$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243216731$24321673$1$I$20240720$20240903$20240916$20240916$EXP$FR-AFSSAPS-CN2024000838$FR-SA-2024SA265036$SANOFI AVENTIS$$75$YR$E$M$Y$72.3$KG$20240916$$PH$FR$FR
243216741$24321674$1$I$$20240911$20240916$20240916$EXP$$BG-ABBVIE-5921963$ABBVIE$$66$YR$$M$Y$$$20240916$$CN$BG$BG
243216761$24321676$1$I$20240101$20240911$20240916$20240916$EXP$$US-ABBVIE-5922061$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243216781$24321678$1$I$$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143931$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240916$$MD$US$US
243216791$24321679$1$I$20240101$20240827$20240916$20240916$PER$$CA-TOLMAR, INC.-24CA051526$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
243216801$24321680$1$I$$20240827$20240916$20240916$PER$$CA-TOLMAR, INC.-24CA051577$TOLMAR$$$$$M$Y$$$20240916$$HP$CA$CA
243216821$24321682$1$I$20240801$20240820$20240916$20240916$PER$$AU-TOLMAR, INC.-24AU052087$TOLMAR$$76$YR$$M$Y$$$20240916$$CN$AU$AU
243216831$24321683$1$I$$20240622$20240916$20240916$EXP$$US-ROCHE-10000009145$ROCHE$$$$$$Y$$$20240916$$CN$US$US
243216841$24321684$1$I$20220901$20240912$20240916$20240916$EXP$$JP-ASTELLAS-2024-AER-006636$ASTELLAS$$78$YR$E$F$Y$$$20240916$$MD$JP$JP
243216851$24321685$1$I$$20240905$20240916$20240916$PER$$US-AstraZeneca-2024A203400$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243216861$24321686$1$I$20240801$20240911$20240916$20240916$EXP$$US-GSK-US2024112992$GLAXOSMITHKLINE$$14$YR$$M$Y$$$20240916$$CN$US$US
243216871$24321687$1$I$20240310$20240912$20240916$20240916$EXP$$CN-JNJFOC-20240920667$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20240916$$CN$CN$CN
243216881$24321688$1$I$20240828$20240916$20240916$20240916$EXP$DE-CADRBFARM-2024330430$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051478$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$110$KG$20240916$$MD$DE$DE
243216891$24321689$1$I$$20240903$20240916$20240916$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27286$SAMSUNG BIOEPIS$$50$YR$A$F$Y$$$20240916$$CN$CA$CA
243216901$24321690$1$I$$20240904$20240916$20240916$EXP$$AU-TERSERA THERAPEUTICS LLC-2024TRS004633$TERSERA THERAPEUTICS$$$$$$Y$$$20240916$$CN$AU$AU
243216911$24321691$1$I$20240601$20240910$20240916$20240916$EXP$$CO-AMGEN-COLSP2024182667$AMGEN$$$$$F$Y$$$20240916$$CN$CO$CO
243216921$24321692$1$I$20240911$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008406$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240916$$CN$US$US
243216931$24321693$1$I$20240911$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008503$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240916$$CN$US$US
243216941$24321694$1$I$20240823$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005046$ACADIA PHARMACEUTICALS$$63$YR$$M$Y$$$20240916$$CN$US$US
243216951$24321695$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008227$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240916$$CN$US$US
243216962$24321696$2$F$$20240912$20240916$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008069$ELI LILLY AND CO$$43$YR$A$$Y$$$20240918$$CN$US$US
243216972$24321697$2$F$20240909$20240912$20240916$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008435$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240917$$CN$US$US
243216981$24321698$1$I$20240904$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008358$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240916$$CN$US$US
243216991$24321699$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008388$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240916$$CN$US$US
243217001$24321700$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007641$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$US$US
243217011$24321701$1$I$$20240912$20240916$20240916$PER$$NVSC2024US184224$NOVARTIS$$$$$M$Y$$$20240916$$HP$US$US
243217031$24321703$1$I$20240101$20240904$20240916$20240916$PER$$US-SA-2024SA264531$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240916$$MD$US$US
243217041$24321704$1$I$$20240826$20240916$20240916$PER$$US-SA-2023SA284639$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$MD$US$US
243217051$24321705$1$I$$20240910$20240916$20240916$PER$$US-JNJFOC-20240929880$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$HP$US$US
243217061$24321706$1$I$20240902$20240911$20240916$20240916$EXP$$CO-UCBSA-2024047177$UCB$$12$YR$$M$Y$$$20240916$$CN$CO$CO
243217072$24321707$2$F$20240831$20240916$20240916$20240924$PER$$US-SA-2024SA264129$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240924$$MD$US$US
243217081$24321708$1$I$20240701$20240910$20240916$20240916$EXP$HR-HALMED-300086459$HR-CHEPLA-2024011649$CHEPLAPHARM$$59$YR$$M$Y$70$KG$20240916$$MD$COUNTRY NOT SPECIFIED$HR
243217091$24321709$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265726$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240916$$MD$US$US
243217101$24321710$1$I$20240912$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183213$AMGEN$$72$YR$E$F$Y$$$20240916$$CN$US$US
243217112$24321711$2$F$$20240918$20240916$20240925$EXP$$US-AMGEN-USASP2024182928$AMGEN$$72$YR$E$F$Y$$$20240925$$MD$US$US
243217121$24321712$1$I$$20240911$20240916$20240916$PER$$US-ABBVIE-5922209$ABBVIE$$$$$$Y$$$20240916$$MD$US$US
243217131$24321713$1$I$20240826$20240906$20240916$20240916$EXP$$CN-ROCHE-10000076294$ROCHE$$38$YR$A$F$Y$74$KG$20240916$$HP$CN$CN
243217141$24321714$1$I$20240828$20240914$20240916$20240916$EXP$$CN-BEIGENE-BGN-2024-014661$BEIGENE$$$$$$Y$$$20240916$$HP$CN$CN
243217151$24321715$1$I$$20240902$20240916$20240916$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-08322$HIKMA$Caorsi R, Bertoni A, Matucci-Cerinic C, Natoli V, Palmeri S, Rosina S et al. Caorsi R, Bertoni A, Matucci-Cerinic C, Natoli V, Palmeri S, Rosina S, et al. Long-term efficacy of MAS825, a bispecific anti-IL1? and IL-18 monoclonal antibody, in two patients with sJIA and recurrent episodes of MAS. Rheumatology. 2024;/:/$$$C$F$Y$$$20240916$$MD$IT$IT
243217161$24321716$1$I$20240817$20240909$20240916$20240916$EXP$IT-MINISAL02-1001147$IT-VIIV HEALTHCARE LIMITED-IT2024112187$VIIV$$$$$$Y$$$20240916$$MD$IT$IT
243217171$24321717$1$I$20240801$20240829$20240916$20240916$EXP$$US-SA-2024SA265867$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240916$$MD$US$US
243217181$24321718$1$I$20240301$20240909$20240916$20240916$EXP$$CA-JNJFOC-20240360402$JOHNSON AND JOHNSON$$15$YR$T$M$Y$69$KG$20240916$$PH$CA$CA
243217191$24321719$1$I$20240829$20240904$20240916$20240916$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004502$BLUEPRINT MEDICINES$$$$$$Y$$$20240912$$CN$US$US
243217201$24321720$1$I$20240901$20240914$20240916$20240916$EXP$$CN-BEIGENE-BGN-2024-014668$BEIGENE$$$$$$Y$$$20240916$$HP$CN$CN
243217211$24321721$1$I$20240903$20240906$20240916$20240916$EXP$$US-ROCHE-10000076411$ROCHE$$54$YR$A$M$Y$$$20240916$$CN$US$US
243217221$24321722$1$I$$20240905$20240916$20240916$EXP$CA-MHPD-E2B_07211730$CA-Accord-445848$ACCORD$$86$YR$E$$Y$$$20240916$$MD$CA$CA
243217231$24321723$1$I$$20240903$20240916$20240916$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27147$SAMSUNG BIOEPIS$$52$YR$A$F$Y$$$20240916$$CN$CA$CA
243217241$24321724$1$I$$20240903$20240916$20240916$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27185$SAMSUNG BIOEPIS$$$$$M$Y$$$20240916$$HP$CA$CA
243217251$24321725$1$I$20231201$20240904$20240916$20240916$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004488$BLUEPRINT MEDICINES$$$$$$Y$$$20240912$$CN$US$US
243217261$24321726$1$I$$20240903$20240916$20240916$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27087$SAMSUNG BIOEPIS$$68$YR$E$F$Y$$$20240916$$HP$CA$CA
243217272$24321727$2$F$20240612$20240919$20240916$20240930$EXP$$GB-UCBSA-2024036947$UCB$$58$YR$$M$Y$88.4$KG$20240930$$HP$GB$GB
243217281$24321728$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005026$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243217292$24321729$2$F$$20240911$20240916$20240919$PER$$US-AMGEN-USASP2024182261$AMGEN$$$$$M$Y$$$20240919$$HP$US$US
243217301$24321730$1$I$$20240827$20240916$20240916$PER$$US-SA-2024SA263494$SANOFI AVENTIS$$$$$$Y$$$20240916$$CN$US$US
243217311$24321731$1$I$20240301$20240904$20240916$20240916$EXP$$SG-ROCHE-10000074376$ROCHE$$68$YR$E$M$Y$$$20240916$$CN$SG$SG
243217321$24321732$1$I$20211123$20240911$20240916$20240916$EXP$GB-MHRA-EYC 00270618$GB-GSK-GB2022001948$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$PH$GB$GB
243217331$24321733$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184447$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243217351$24321735$1$I$$20240905$20240916$20240916$30DAY$$GB-JNJFOC-20240937559$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$PH$GB$GB
243217361$24321736$1$I$$20240820$20240916$20240916$30DAY$$US-Kaleo, Inc.-2024KL000036$KALEO$$14$YR$T$F$Y$$$20240912$$CN$US$US
243217371$24321737$1$I$$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024182484$AMGEN$$$$$$Y$$$20240916$$PH$US$US
243217381$24321738$1$I$$20240906$20240916$20240916$EXP$$JP-AMGEN-JPNSP2024182853$AMGEN$$$$$$Y$$$20240916$$HP$JP$JP
243217391$24321739$1$I$$20240820$20240916$20240916$30DAY$$US-Kaleo, Inc.-2024KL000037$KALEO$$50$YR$A$F$Y$$$20240912$$CN$US$US
243217401$24321740$1$I$20240801$20240820$20240916$20240916$PER$$US-SA-2024SA263433$SANOFI AVENTIS$$12$YR$T$F$Y$75.95$KG$20240916$$MD$US$US
243217411$24321741$1$I$$20240909$20240916$20240916$EXP$$GB-GSK-GB2024EME078743$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$GB$GB
243217421$24321742$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA265310$SANOFI AVENTIS$$20$YR$A$$Y$$$20240916$$HP$US$US
243217431$24321743$1$I$20240801$20240905$20240916$20240916$PER$$US-SA-2024SA264177$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240916$$MD$US$US
243217441$24321744$1$I$$20240902$20240916$20240916$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08366$HIKMA$$78$YR$$F$Y$$$20240916$$HP$CA$CA
243217451$24321745$1$I$20230911$20240903$20240916$20240916$EXP$$DE-UCBSA-2023049232$UCB$$45$YR$$M$Y$$$20240916$$MD$DE$DE
243217461$24321746$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005037$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243217472$24321747$2$F$$20240911$20240916$20240918$EXP$$CA-ABBVIE-5921064$ABBVIE$$$$$F$Y$$$20240918$$HP$CA$CA
243217481$24321748$1$I$20240601$20240912$20240916$20240916$EXP$$US-ABBVIE-5922938$ABBVIE$$64$YR$$M$Y$$$20240916$$CN$US$US
243217491$24321749$1$I$20240101$20240912$20240916$20240916$EXP$$US-ABBVIE-5922171$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243217501$24321750$1$I$$20240910$20240916$20240916$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014844$JAZZ$$$$$F$Y$43.3$KG$20240916$$CN$US$US
243217511$24321751$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184443$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243217531$24321753$1$I$20240801$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005038$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240916$$CN$US$US
243217541$24321754$1$I$$20240910$20240916$20240916$EXP$$US-ABBVIE-5920040$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243217551$24321755$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008842$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240916$$CN$US$US
243217561$24321756$1$I$$20240906$20240916$20240916$EXP$$JP-ROCHE-10000078906$ROCHE$$7$DEC$E$$Y$$$20240916$$PH$JP$JP
243217571$24321757$1$I$$20240906$20240916$20240916$EXP$$CA-TEVA-VS-3241607$TEVA$$66$YR$$M$Y$$$20240916$$HP$CA$CA
243217581$24321758$1$I$20240101$20240904$20240916$20240916$PER$$US-ABBVIE-5913884$ABBVIE$$$$$$Y$$$20240916$$CN$US$US
243217591$24321759$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007668$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240916$$CN$US$US
243217602$24321760$2$F$20240911$20240913$20240916$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409008587$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240919$$CN$US$US
243217611$24321761$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008143$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240916$$CN$US$US
243217621$24321762$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008181$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240916$$CN$US$US
243217631$24321763$1$I$20240910$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009046$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240916$$CN$US$US
243217641$24321764$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008447$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243217651$24321765$1$I$$20240903$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409001850$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240916$$CN$US$US
243217661$24321766$1$I$20240909$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008151$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240916$$CN$US$US
243217671$24321767$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005044$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243217691$24321769$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183672$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243217701$24321770$1$I$$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024181944$AMGEN$$$$$$Y$$$20240916$$MD$US$US
243217711$24321771$1$I$$20240911$20240916$20240916$PER$$US-JNJFOC-20240928396$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240916$$MD$US$US
243217721$24321772$1$I$$20240909$20240916$20240916$EXP$$CH-ROCHE-10000076657$ROCHE$Degtiarova G, Conen A, Klarer A, Arifi T, Guldimann G, Finkener S, et al. Transfusion-related acute lung injury (TRALI) following intravenous immunoglobulin infusion in a rituximab immunosuppressed patient with long-shedding SARS-CoV-2. BMC infectious diseases. 2024-Sep-04;24 (1):1-5. doi:10.1186/s12879-024-09809-9.$63$YR$A$M$Y$$$20240916$$HP$CH$CH
243217731$24321773$1$I$$20240910$20240916$20240916$PER$$US-ABBVIE-5919319$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243217742$24321774$2$F$$20240604$20240916$20240917$PER$$US-ENDO USA, INC.-2024-002561$ENDO$$$$$$Y$$$20240917$$CN$US$US
243217751$24321775$1$I$$20240902$20240916$20240916$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08367$HIKMA$$74$YR$$M$Y$$$20240916$$CN$CA$CA
243217762$24321776$2$F$$20231219$20240916$20240918$PER$$US-ENDO USA, INC.-2024-000006$ENDO$$$$$F$Y$$$20240918$$CN$US$US
243217772$24321777$2$F$$20231218$20240916$20240916$PER$$US-ENDO USA, INC.-2023-006392$ENDO$$$$$F$Y$$$20240916$$CN$US$US
243217781$24321778$1$I$$20231218$20240916$20240916$PER$$US-ENDO USA, INC.-2024-000039$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243217791$24321779$1$I$$20240912$20240916$20240916$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014965$JAZZ$$$$$M$Y$$$20240916$$CN$US$US
243217802$24321780$2$F$$20240912$20240916$20240925$PER$$US-SA-2024SA264672$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240925$$HP$US$US
243217811$24321781$1$I$20240401$20240823$20240916$20240916$PER$$US-SA-2024SA264642$SANOFI AVENTIS$$54$YR$A$F$Y$85.73$KG$20240916$$HP$US$US
243217821$24321782$1$I$$20240904$20240916$20240916$PER$$US-SA-2024SA263442$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240916$$HP$US$US
243217831$24321783$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024182915$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243217841$24321784$1$I$$20240909$20240916$20240916$EXP$$ES-ABBVIE-5920777$ABBVIE$$$$$$Y$$$20240916$$CN$ES$ES
243217851$24321785$1$I$20240101$20240906$20240916$20240916$EXP$$CA-CELLTRION INC.-2024CA019019$CELLTRION$$$$$$Y$$$20240916$$MD$CA$CA
243217862$24321786$2$F$20240101$20240919$20240916$20240930$EXP$FR-AFSSAPS-RN2024000891$FR-JNJFOC-20240938303$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240930$$MD$FR$FR
243217872$24321787$2$F$20240822$20240912$20240916$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005054$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240923$$CN$US$US
243217881$24321788$1$I$$20240909$20240916$20240916$EXP$$US-GSK-US2024111916$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$US$US
243217891$24321789$1$I$$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146474$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240916$$CN$US$US
243217901$24321790$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005055$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243217911$24321791$1$I$$20240911$20240916$20240916$EXP$$US-TEVA-VS-3243243$TEVA$$$$$$Y$$$20240916$$LW$US$US
243217921$24321792$1$I$20240809$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005056$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240916$$CN$US$US
243217932$24321793$2$F$$20240919$20240916$20240927$EXP$$JP-TEVA-VS-3242276$TEVA$Dote S, Inose R, Goto R, Kobayashi Y, Muraki Y. Risk of a second cancer and infection in patients with indolent B-cell lymphoma exposed to first-line bendamustine plus rituximab: A retrospective analysis of an administrative claims database. Hematol-Oncol 2023; 41 (3): 354-362.; Dote S, Inose R, Goto R, Kobayashi Y, Muraki Y. Risk of a second cancer and infection in patients with indolent B-cell lymphoma exposed to first-line bendamustine plus rituximab: A retrospective analysis of an adminis...$$$$F$Y$$$20240927$$HP$JP$JP
243217951$24321795$1$I$$20240909$20240916$20240916$EXP$$JP-TEVA-VS-3242277$TEVA$Dote S, Inose R, Goto R, Kobayashi Y, Muraki Y. Risk of a second cancer and infection in patients with indolent B-cell lymphoma exposed to first-line bendamustine plus rituximab: A retrospective analysis of an administrative claims database. Hematol-Oncol 2023; 41 (3): 354-362.; Dote S, Inose R, Goto R, Kobayashi Y, Muraki Y. Risk of a second cancer and infection in patients with indolent B-cell lymphoma exposed to first-line bendamustine plus rituximab: A retrospective analysis of an adminis...$$$$$Y$$$20240916$$HP$JP$JP
243217961$24321796$1$I$20240823$20240823$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005057$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240916$$HP$US$US
243217971$24321797$1$I$$20240909$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US079461$SANDOZ$$13$YR$$M$Y$22.1$KG$20240916$$HP$US$US
243217982$24321798$2$F$$20240911$20240916$20240917$PER$$US-BAUSCH-BL-2024-013552$BAUSCH AND LOMB$$35$YR$$F$Y$$$20240917$$CN$US$US
243217991$24321799$1$I$$20240913$20240916$20240916$EXP$$US-BAUSCH-BL-2024-013832$BAUSCH AND LOMB$$36$YR$$F$Y$$$20240916$$PH$US$US
243218001$24321800$1$I$$20240911$20240916$20240916$EXP$$US-BAUSCH-BL-2024-013675$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240916$$CN$US$US
243218011$24321801$1$I$$20240905$20240916$20240916$PER$$US-ROCHE-10000074685$ROCHE$Liu A, Nayak L, Wong W, Ahn I, Murakami N. Masked Arginine Vasopressin Deficiency in a Kidney Transplant Recipient With Posttransplant Lymphoproliferative Disorder. Kidney International Reports. 2024-Sep;9 (9):2832-4. doi:10.1016/j.ekir.2024.06.029.$62$YR$A$M$Y$$$20240916$$HP$US$US
243218021$24321802$1$I$$20240830$20240916$20240916$30DAY$$TW-JNJFOC-20240910228$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$TW$TW
243218032$24321803$2$F$$20240918$20240916$20240923$EXP$$JP-009507513-2409JPN001283J$MERCK$$79$YR$$M$Y$$$20240923$$MD$JP$JP
243218041$24321804$1$I$$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143342$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240916$$PH$US$US
243218051$24321805$1$I$$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146468$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$$$20240916$$CN$US$US
243218061$24321806$1$I$20240912$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146004$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240916$$CN$US$US
243218071$24321807$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145349$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$89.36$KG$20240916$$CN$US$US
243218081$24321808$1$I$$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146473$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240916$$CN$US$US
243218091$24321809$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146396$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240916$$CN$US$US
243218101$24321810$1$I$20240823$20240823$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005058$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240916$$CN$US$US
243218111$24321811$1$I$$20240912$20240916$20240916$EXP$$US-GILEAD-2024-0687573$GILEAD$$66$YR$E$F$Y$$$20240916$$PH$US$US
243218121$24321812$1$I$20240101$20240820$20240916$20240916$PER$$US-SA-2024SA263855$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240916$$CN$US$US
243218131$24321813$1$I$20240905$20240910$20240916$20240916$PER$$US-SA-2024SA265780$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240916$$HP$US$US
243218141$24321814$1$I$$20240904$20240916$20240916$PER$$US-SA-2024SA263095$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240916$$MD$US$US
243218151$24321815$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA215194$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240916$$HP$US$US
243218161$24321816$1$I$$20240902$20240916$20240916$PER$$US-SA-2024SA263957$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240916$$MD$US$US
243218171$24321817$1$I$20240101$20240826$20240916$20240916$PER$$US-SA-2024SA264460$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240916$$MD$US$US
243218181$24321818$1$I$20240401$20240910$20240916$20240916$PER$$US-SA-2024SA265589$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240916$$HP$US$US
243218191$24321819$1$I$20170310$20240906$20240916$20240916$EXP$$BR-EMD Serono-2024048165$EMD SERONO INC$$24$YR$A$F$Y$$$20240916$$HP$BR$BR
243218202$24321820$2$F$20240901$20240916$20240916$20240917$PER$$US-AMGEN-USASP2024183665$AMGEN$$55$YR$A$F$Y$$$20240917$$CN$US$US
243218221$24321822$1$I$20240812$20240912$20240916$20240916$EXP$$US-GILEAD-2024-0687668$GILEAD$$61$YR$A$F$Y$$$20240916$$HP$US$US
243218231$24321823$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146648$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240916$$CN$US$US
243218241$24321824$1$I$$20240906$20240916$20240916$EXP$$CA-TEVA-VS-3241568$TEVA$$50$YR$$M$Y$$$20240916$$HP$CA$CA
243218251$24321825$1$I$20240101$20240909$20240916$20240916$PER$$US-ABBVIE-5919306$ABBVIE$$81$YR$$F$Y$$$20240916$$HP$US$US
243218271$24321827$1$I$20240101$20240909$20240916$20240916$PER$$US-ROCHE-10000078342$ROCHE$$64$YR$A$F$Y$95.25$KG$20240916$$CN$US$US
243218281$24321828$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184503$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243218291$24321829$1$I$$20240910$20240916$20240916$EXP$$HU-ASTELLAS-2024-AER-006116$ASTELLAS$$$$$M$Y$$$20240916$$MD$HU$HU
243218311$24321831$1$I$$20240904$20240916$20240916$EXP$$DE-Merck Healthcare KGaA-2024047813$MERCK KGAA$$$$E$F$Y$50$KG$20240912$$CN$DE$DE
243218321$24321832$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A206835$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243218331$24321833$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A208059$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243218341$24321834$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A206671$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243218361$24321836$1$I$$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A209015$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243218371$24321837$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A206601$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243218381$24321838$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007449$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240916$$CN$US$US
243218391$24321839$1$I$$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008982$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240916$$CN$US$US
243218401$24321840$1$I$20240901$20240910$20240916$20240916$EXP$$CA-GILEAD-2024-0687287$GILEAD$$69$YR$E$F$Y$$$20240916$$CN$CA$CA
243218411$24321841$1$I$20240907$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005903$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240916$$MD$US$US
243218421$24321842$1$I$$20240903$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409003298$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240916$$CN$US$US
243218432$24321843$2$F$$20240822$20240916$20240918$PER$$US-SA-2024SA264631$SANOFI AVENTIS$$$$A$F$Y$70$KG$20240918$$MD$US$US
243218441$24321844$1$I$$20240905$20240916$20240916$EXP$$KW-JNJFOC-20240919267$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$MD$KW$KW
243218451$24321845$1$I$$20240909$20240916$20240916$EXP$$US-ABBVIE-5917420$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243218461$24321846$1$I$$20240912$20240916$20240916$PER$$US-JNJFOC-20240932696$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$MD$US$US
243218471$24321847$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024111396$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
243218482$24321848$2$F$$20240913$20240916$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145979$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240918$$CN$US$US
243218491$24321849$1$I$20240909$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146417$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240916$$CN$US$US
243218501$24321850$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000081368$ROCHE$$$$A$F$Y$$$20240916$$CN$US$US
243218511$24321851$1$I$$20240521$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002379$ENDO$$$$$M$Y$$$20240916$$$US$US
243218521$24321852$1$I$20150101$20240528$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002459$ENDO$$$$$F$Y$$$20240916$$CN$US$US
243218531$24321853$1$I$20240618$20240618$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002699$ENDO$$32$YR$$F$Y$$$20240916$$CN$US$US
243218542$24321854$2$F$20240906$20240917$20240916$20240927$PER$$US-GSK-US2024111375$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20240927$$CN$US$US
243218551$24321855$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005039$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243218561$24321856$1$I$$20240912$20240916$20240916$EXP$$FR-JNJFOC-20240934075$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$MD$FR$FR
243218571$24321857$1$I$$20240911$20240916$20240916$EXP$$US-GILEAD-2024-0687606$GILEAD$$49$YR$A$F$Y$$$20240916$$PH$US$US
243218581$24321858$1$I$$20240213$20240916$20240916$PER$$US-ENDO USA, INC.-2024-001046$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243218592$24321859$2$F$$20240312$20240916$20240916$PER$$US-ENDO USA, INC.-2024-001391$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243218601$24321860$1$I$20240101$20240909$20240916$20240916$EXP$$JP-009507513-2409JPN001406J$MERCK$$61$YR$$F$Y$$$20240916$$MD$JP$JP
243218612$24321861$2$F$$20240412$20240916$20240917$PER$$US-ENDO USA, INC.-2024-001839$ENDO$$$$$F$Y$$$20240917$$CN$US$US
243218621$24321862$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004879$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243218631$24321863$1$I$20240304$20240911$20240916$20240916$EXP$$CO-UCBSA-2024047178$UCB$$67$YR$$M$Y$$$20240916$$CN$CO$CO
243218641$24321864$1$I$$20240906$20240916$20240916$EXP$$US-GSK-US2024AMR111588$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
243218651$24321865$1$I$20240801$20240912$20240916$20240916$EXP$$BR-JNJFOC-20240936767$JOHNSON AND JOHNSON$$86$YR$E$M$Y$67$KG$20240916$$CN$BR$BR
243218671$24321867$1$I$$20240904$20240916$20240916$EXP$$US-UCBSA-2024045609$UCB$$$$$$Y$$$20240916$$CN$US$US
243218681$24321868$1$I$20240727$20240909$20240916$20240916$EXP$IT-MINISAL02-1000908$IT-UCBSA-2024046016$UCB$$51$YR$$F$Y$70$KG$20240916$$MD$IT$IT
243218691$24321869$1$I$$20240906$20240916$20240916$EXP$$ES-CELLTRION INC.-2024ES021824$CELLTRION$Legaza ES, Sanchez AP.. Complicated oropharyngeal actinomycosis secondary to pharmacotherapy. Salud(i)Ciencia. 2023;25 (6):345-349$$$$$Y$$$20240916$$HP$ES$ES
243218701$24321870$1$I$20240901$20240911$20240916$20240916$EXP$$CA-ABBVIE-5921854$ABBVIE$$$$A$F$Y$$$20240916$$HP$CA$CA
243218711$24321871$1$I$$20240902$20240916$20240916$EXP$$JP-ROCHE-10000079731$ROCHE$Kato K, Kato K, Kimura M, Hotta K, Kasahara Y. P1-6 A Case of Metastatic Breast Cancer With Meningeal Seeding That has Achieved Long-term Survival. The 21st Chubu Regional Meeting of the Japanese Breast Cancer Society. 2024;74.$4$DEC$A$F$Y$$$20240916$$MD$JP$JP
243218721$24321872$1$I$20240101$20240911$20240916$20240916$EXP$$US-ABBVIE-5866886$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243218731$24321873$1$I$20240801$20240911$20240916$20240916$EXP$$US-ABBVIE-5922317$ABBVIE$$61$YR$$M$Y$$$20240916$$CN$US$US
243218741$24321874$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5922848$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243218751$24321875$1$I$20230824$20230824$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2023-056680$AUROBINDO$$15$YR$$F$Y$63.502$KG$20240916$$CN$US$US
243218761$24321876$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000082044$ROCHE$$77$YR$E$F$Y$$$20240916$$MD$US$US
243218771$24321877$1$I$$20231024$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2023-066342$AUROBINDO$$$$$F$Y$$$20240916$$CN$US$US
243218781$24321878$1$I$$20231119$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2023-074833$AUROBINDO$$16$YR$$F$Y$$$20240916$$CN$US$US
243218791$24321879$1$I$20230908$20230909$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2023-058738$AUROBINDO$$85$YR$$F$Y$63.5$KG$20240916$$CN$US$US
243218804$24321880$4$F$20240814$20240919$20240916$20240926$EXP$$US-ROCHE-10000078308$ROCHE$$40$YR$A$F$Y$65.77$KG$20240926$$CN$US$US
243218811$24321881$1$I$20190308$20240910$20240916$20240916$EXP$$CO-UCBSA-2024046910$UCB$$56$YR$$F$Y$$$20240916$$CN$CO$CO
243218821$24321882$1$I$$20231106$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2023-068539$AUROBINDO$$$$$M$Y$$$20240916$$CN$US$US
243218831$24321883$1$I$$20230923$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2023-061253$AUROBINDO$$$$$M$Y$$$20240916$$CN$US$US
243218841$24321884$1$I$$20240201$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-006110$AUROBINDO$$$$$M$Y$$$20240916$$CN$US$US
243218851$24321885$1$I$$20240206$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-006825$AUROBINDO$$70$YR$$F$Y$$$20240916$$CN$US$US
243218861$24321886$1$I$$20231207$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2023-078433$AUROBINDO$$$$$M$Y$$$20240916$$CN$US$US
243218871$24321887$1$I$$20240218$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-009246$AUROBINDO$$$$$F$Y$$$20240916$$CN$US$US
243218881$24321888$1$I$20240220$20240221$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-009749$AUROBINDO$$$$$F$Y$$$20240916$$CN$US$US
243218891$24321889$1$I$$20231011$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2023-059340$AUROBINDO$$$$$F$Y$$$20240916$$CN$US$US
243218901$24321890$1$I$$20231102$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2023-067504$AUROBINDO$$52$YR$$M$Y$90$KG$20240916$$CN$US$US
243218911$24321891$1$I$$20240209$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-007610$AUROBINDO$$79$YR$$M$Y$88.5$KG$20240916$$CN$US$US
243218921$24321892$1$I$20231003$20231003$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2023-062752$AUROBINDO$$$$$M$Y$$$20240916$$CN$US$US
243218931$24321893$1$I$$20240119$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2023-078434$AUROBINDO$$$$$M$Y$$$20240916$$CN$US$US
243218941$24321894$1$I$$20231006$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2023-063578$AUROBINDO$$$$E$M$Y$$$20240916$$CN$US$US
243218952$24321895$2$F$$20240911$20240916$20240919$EXP$$US-GSK-US2024AMR112364$GLAXOSMITHKLINE$$$$$F$Y$62.59$KG$20240919$$CN$US$US
243218961$24321896$1$I$$20240530$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-022938$AUROBINDO$$86$YR$$F$Y$$$20240916$$CN$US$US
243218971$24321897$1$I$$20240307$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-012208$AUROBINDO$$$$$F$Y$$$20240916$$CN$US$US
243218981$24321898$1$I$$20240522$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-026561$AUROBINDO$$90$YR$$M$Y$70.3$KG$20240916$$CN$US$US
243218991$24321899$1$I$20240515$20240516$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-025137$AUROBINDO$$53$YR$$F$Y$$$20240916$$CN$US$US
243219001$24321900$1$I$$20240528$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-027689$AUROBINDO$$$$$F$Y$$$20240916$$CN$US$US
243219011$24321901$1$I$20240221$20240527$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-010048$AUROBINDO$$53$YR$$F$Y$99.79$KG$20240916$$CN$US$US
243219021$24321902$1$I$20240101$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143428$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240916$$HP$US$US
243219031$24321903$1$I$20240223$20240223$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-010282$AUROBINDO$$73$YR$$F$Y$81.6$KG$20240916$$CN$US$US
243219041$24321904$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145986$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240916$$HP$US$US
243219051$24321905$1$I$20240903$20240904$20240916$20240916$EXP$GB-MHRA-MED-202409041156478010-VWJZD$GB-Accord-445290$ACCORD$$79$YR$E$F$Y$$$20240916$$MD$GB$GB
243219061$24321906$1$I$20240822$20240902$20240916$20240916$EXP$CN-HENLIUS-24CN016930$CN-Accord-446700$ACCORD$$47$YR$A$F$Y$56$KG$20240916$$MD$CN$CN
243219071$24321907$1$I$$20240904$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013209$DR REDDYS$Haider A, Taveras S, Memushaj L, Esquenazi Y, Chen PR, Rios A. AML-738 Myeloid Sarcoma and Lymphoid Sarcoma of the Brain: A Case Series. Clinical Lymphoma, Myeloma and Leukemia. 2024;24: S335-S336. doi:10.1016/S2152-2650%2824%2901244-8.$59$YR$A$F$Y$$$20240916$$MD$US$US
243219081$24321908$1$I$$20240621$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-031951$AUROBINDO$$$$$F$Y$$$20240916$$CN$US$US
243219091$24321909$1$I$$20240614$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-030894$AUROBINDO$$28$YR$$F$Y$86.636$KG$20240916$$CN$US$US
243219101$24321910$1$I$$20240704$20240916$20240916$PER$$US-AUROBINDO-AUR-APL-2024-034234$AUROBINDO$$$$$F$Y$$$20240916$$CN$US$US
243219111$24321911$1$I$$20240902$20240916$20240916$EXP$$CA-HIKMA PHARMACEUTICALS-CA-H14001-24-08385$HIKMA$$68$YR$$F$Y$$$20240916$$HP$CA$CA
243219121$24321912$1$I$20240910$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008838$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240916$$CN$US$US
243219131$24321913$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008311$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243219151$24321915$1$I$20240912$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183019$AMGEN$$66$YR$E$M$Y$$$20240916$$CN$US$US
243219161$24321916$1$I$$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024184052$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243219172$24321917$2$F$$20240911$20240916$20240918$PER$$US-AMGEN-USASP2024182801$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243219181$24321918$1$I$$20240908$20240916$20240916$EXP$$BD-ROCHE-10000077017$ROCHE$$72$YR$E$F$Y$$$20240916$$MD$BD$BD
243219191$24321919$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146302$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240916$$HP$US$US
243219201$24321920$1$I$$20240904$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146138$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$73.98$KG$20240916$$HP$US$US
243219211$24321921$1$I$20240709$20240912$20240916$20240916$EXP$FR-AFSSAPS-GR2024001073$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-146262$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240916$$PH$FR$FR
243219222$24321922$2$F$$20240919$20240916$20240926$EXP$$US-ROCHE-10000074466$ROCHE$$65$YR$E$M$Y$$$20240926$$CN$US$US
243219231$24321923$1$I$20240801$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146346$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240916$$HP$US$US
243219241$24321924$1$I$$20240910$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146428$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240916$$MD$US$US
243219251$24321925$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146288$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240916$$HP$US$US
243219261$24321926$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146433$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240916$$HP$US$US
243219272$24321927$2$F$20240901$20240924$20240916$20240926$EXP$$US-ROCHE-10000074171$ROCHE$$59$YR$A$F$Y$70.76$KG$20240926$$MD$US$US
243219281$24321928$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005020$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243219292$24321929$2$F$$20240909$20240916$20240916$PER$$US-GILEAD-2024-0687054$GILEAD$$70$YR$E$M$Y$$$20240916$$MD$US$US
243219321$24321932$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000081199$ROCHE$$73$YR$E$M$Y$$$20240916$$HP$US$US
243219331$24321933$1$I$$20240903$20240916$20240916$PER$$US-SA-2024SA264015$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240916$$MD$US$US
243219341$24321934$1$I$$20240911$20240916$20240916$EXP$$RU-ABBVIE-5919496$ABBVIE$$50$YR$$M$Y$$$20240916$$MD$RU$RU
243219352$24321935$2$F$20240101$20240911$20240916$20240919$EXP$$CA-CELLTRION INC.-2024CA019190$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
243219363$24321936$3$F$20240101$20240912$20240916$20240920$PER$$US-SA-2024SA263122$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240920$$MD$US$US
243219371$24321937$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146325$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240916$$HP$US$US
243219391$24321939$1$I$$20240910$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US079429$SANDOZ$$$$$F$Y$$$20240916$$CN$US$US
243219404$24321940$4$F$20240326$20240909$20240916$20240926$PER$$US-GILEAD-2024-0687157$GILEAD$$$$A$M$Y$$$20240926$$MD$US$US
243219411$24321941$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5920398$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243219422$24321942$2$F$$20240319$20240916$20240916$PER$$US-ENDO USA, INC.-2024-001475$ENDO$$$$A$F$Y$$$20240916$$CN$US$US
243219432$24321943$2$F$20240821$20240904$20240916$20240917$EXP$$JP-UCBSA-2024045969$UCB$$4$YR$$$Y$$$20240917$$MD$JP$JP
243219441$24321944$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005022$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243219461$24321946$1$I$$20240908$20240916$20240916$EXP$$ID-ROCHE-10000078284$ROCHE$$$$$$Y$$$20240916$$CN$ID$ID
243219471$24321947$1$I$$20240906$20240916$20240916$PER$$US-ROCHE-10000076436$ROCHE$$$$$$Y$$$20240916$$PH$US$US
243219481$24321948$1$I$$20240906$20240916$20240916$PER$$US-AstraZeneca-2024A205409$ASTRAZENECA$$$$$$Y$$$20240916$$MD$US$
243219501$24321950$1$I$$20240910$20240916$20240916$EXP$$GB-AstraZeneca-2024A207397$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$GB$
243219511$24321951$1$I$20240101$20240906$20240916$20240916$EXP$$US-SA-2024SA265433$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240916$$MD$US$US
243219521$24321952$1$I$20240101$20240904$20240916$20240916$PER$$US-SA-2024SA264768$SANOFI AVENTIS$$20$YR$A$$Y$$$20240916$$MD$US$US
243219531$24321953$1$I$20240101$20240905$20240916$20240916$PER$$US-SA-2024SA263988$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240916$$MD$US$US
243219541$24321954$1$I$20240806$20240826$20240916$20240916$PER$$US-SA-2024SA263732$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240916$$MD$US$US
243219551$24321955$1$I$$20240911$20240916$20240916$EXP$$US-JNJFOC-20240929474$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$US$US
243219561$24321956$1$I$$20240909$20240916$20240916$EXP$$PL-ROCHE-10000078341$ROCHE$$37$YR$A$M$Y$$$20240916$$MD$PL$PL
243219571$24321957$1$I$$20240910$20240916$20240916$PER$$US-ROCHE-10000079149$ROCHE$$$$$F$Y$$$20240916$$CN$US$US
243219582$24321958$2$F$$20240919$20240916$20240930$EXP$$US-ACORDA-ACO_177895_2024$MERZ$$$$$M$Y$$$20240930$$MD$US$US
243219591$24321959$1$I$$20240902$20240916$20240916$EXP$$US-CIPLA LTD.-2024US09791$CIPLA$Akhdar G, Akpan I.. MM-388 Navigating the Nexus: Lenalidomide-associated thrombotic thrombocytopenic purpura (TTP). Multiple Myeloma. 2024;24(1):S555$$$$$Y$$$20240916$$MD$US$US
243219601$24321960$1$I$$20240909$20240916$20240916$EXP$$JP-009507513-2409JPN001674J$MERCK$$6$DEC$$F$Y$$$20240916$$MD$JP$JP
243219611$24321961$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024182705$AMGEN$$$$$F$Y$$$20240916$$CN$US$US
243219621$24321962$1$I$20240910$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024182115$AMGEN$$58$YR$A$F$Y$$$20240916$$CN$US$US
243219631$24321963$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA266149$SANOFI AVENTIS$$$$T$M$Y$$$20240916$$MD$US$US
243219641$24321964$1$I$20240101$20240902$20240916$20240916$PER$$US-SA-2024SA263980$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240916$$HP$US$US
243219661$24321966$1$I$$20240910$20240916$20240916$EXP$$SY-ABBVIE-5920649$ABBVIE$Bisher O, Hamdy J, Al Najjar M, Khalil A. Severe fascial space infection following botulinum toxin treatment - A rare and critical case report. Oral and Maxillofacial Surgery Cases. 2024;10(4):100372.$52$YR$$F$Y$$$20240916$$HP$SY$SY
243219671$24321967$1$I$20240802$20240902$20240916$20240916$EXP$$DK-CIPLA LTD.-2024DK09759$CIPLA$$$$$$Y$$$20240916$$MD$DK$DK
243219681$24321968$1$I$$20240902$20240916$20240916$EXP$$PT-CIPLA LTD.-2024PT09564$CIPLA$$$$$$Y$$$20240916$$HP$PT$PT
243219691$24321969$1$I$$20240910$20240916$20240916$EXP$$CH-GILEAD-2024-0687466$GILEAD$$42$YR$A$F$Y$$$20240916$$MD$CH$CH
243219701$24321970$1$I$$20240911$20240916$20240916$PER$$US-ROCHE-10000079779$ROCHE$$$$$$Y$$$20240916$$CN$US$US
243219711$24321971$1$I$$20240906$20240916$20240916$EXP$$AU-BAUSCHBL-2024BNL032912$BAUSCH AND LOMB$$38$YR$$F$Y$$$20240916$$CN$AU$AU
243219721$24321972$1$I$$20240906$20240916$20240916$PER$$US-BIOGEN-2024BI01281511$BIOGEN$$$$$F$Y$$$20240916$$MD$US$US
243219731$24321973$1$I$20240601$20240909$20240916$20240916$EXP$FR-AFSSAPS-AN2024001209$FR-GSK-FR2024111806$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$FR$FR
243219741$24321974$1$I$20240810$20240904$20240916$20240916$EXP$$US-Accord-445909$ACCORD$$65$YR$E$F$Y$$$20240916$$HP$US$US
243219751$24321975$1$I$20240911$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008841$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240916$$CN$US$US
243219761$24321976$1$I$$20240906$20240916$20240916$EXP$$AU-BAUSCHBL-2024BNL032914$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240916$$CN$AU$AU
243219771$24321977$1$I$$20240905$20240916$20240916$EXP$$US-HIKMA PHARMACEUTICALS US-H14001-23-60319$HIKMA$Bharath SP, Pang H, Kaderi T, Rampolla R, Chen T, Gezalian M, Lahiri S, Toossi S, Ayodele M.. Bharath SP, Pang H, Kaderi T, Rampolla R, Chen T, Gezalian M, Lahiri S, Toossi S, Ayodele M. Pearls and Oy-sters: Status Epilepticus and Cerebral Edema From Hyperammonemia Due to Disseminated Ureaplasma and Mycoplasma Species. Neurology. 2022;100(15):727-731$57$YR$$M$Y$$$20240916$$MD$US$US
243219781$24321978$1$I$20240910$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007723$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240916$$CN$US$US
243219791$24321979$1$I$20240909$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008427$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240916$$CN$US$US
243219801$24321980$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008387$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$US$US
243219811$24321981$1$I$20230701$20240910$20240916$20240916$PER$$US-SA-2024SA265157$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240916$$HP$US$US
243219831$24321983$1$I$$20240906$20240916$20240916$EXP$$ES-AUROBINDO-AUR-APL-2024-044721$AUROBINDO$Caro MG, Marti DL, Garcia PR, Garcia PR.. Drug-induced anaemia.. European Journal of Case Reports in Internal Medicine.. 2024;11(Suppl 1):757$40$YR$$M$Y$$$20240916$$MD$ES$ES
243219841$24321984$1$I$$20240906$20240916$20240916$EXP$$AU-BAUSCHBL-2024BNL032953$BAUSCH AND LOMB$$42$YR$$F$Y$$$20240916$$CN$AU$AU
243219851$24321985$1$I$$20240903$20240916$20240916$EXP$$US-UCBSA-2024044844$UCB$$$$$M$Y$91.88$KG$20240916$$HP$US$US
243219861$24321986$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145812$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240916$$CN$US$US
243219871$24321987$1$I$20240910$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146298$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240916$$CN$US$US
243219882$24321988$2$F$$20240912$20240916$20240919$PER$$US-AMGEN-USASP2024183320$AMGEN$$$$E$F$Y$$$20240918$$MD$US$US
243219891$24321989$1$I$$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024182825$AMGEN$$$$$F$Y$$$20240916$$CN$US$US
243219901$24321990$1$I$$20240906$20240916$20240916$PER$$US-ROCHE-10000076437$ROCHE$$$$A$M$Y$63.5$KG$20240916$$CN$US$US
243219911$24321991$1$I$$20240911$20240916$20240916$EXP$$AE-Bion-013845$BIONPHARMA$$6$YR$C$F$Y$$$20240916$$HP$AE$AE
243219921$24321992$1$I$$20240911$20240916$20240916$EXP$$CN-Bion-013841$BIONPHARMA$$52$YR$A$F$Y$$$20240916$$HP$CN$CN
243219931$24321993$1$I$$20240909$20240916$20240916$EXP$$US-Bion-013829$BIONPHARMA$$$$$$Y$$$20240916$$HP$US$US
243219941$24321994$1$I$$20240904$20240916$20240916$PER$$US-ASTELLAS-2024-AER-006430$ASTELLAS$$88$YR$E$F$Y$$$20240916$$CN$US$US
243219952$24321995$2$F$20240815$20240919$20240916$20240925$EXP$$KR-ROCHE-10000060181$ROCHE$$60$YR$A$M$Y$48.7$KG$20240925$$MD$KR$KR
243219961$24321996$1$I$$20240911$20240916$20240916$EXP$$US-Bion-013842$BIONPHARMA$$66$YR$E$M$Y$$$20240916$$HP$US$US
243219971$24321997$1$I$$20240904$20240916$20240916$EXP$$FR-AUROBINDO-AUR-APL-2024-044572$AUROBINDO$Desaint, P. Perivalvular Mitral Abscess Fistulised to the Pericardial Cavity Revealing Staphylococcal Endocarditis. Heart Lung and Circulation. 2018;27 (3):e34-e37$66$YR$$F$Y$$$20240916$$MD$FR$FR
243219981$24321998$1$I$20240101$20240911$20240916$20240916$EXP$$ES-AMGEN-ESPSP2024181636$AMGEN$$57$YR$A$M$Y$$$20240916$$MD$ES$ES
243219991$24321999$1$I$$20240910$20240916$20240916$EXP$$GB-AUROBINDO-AUR-APL-2024-045396$AUROBINDO$$$$$M$Y$$$20240916$$CN$GB$GB
243220001$24322000$1$I$20240906$20240906$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005355$ACADIA PHARMACEUTICALS$$92$YR$$M$Y$$$20240916$$CN$US$US
243220011$24322001$1$I$$20240912$20240916$20240916$PER$$US-ABBVIE-5924180$ABBVIE$$$$$$Y$$$20240916$$MD$US$US
243220022$24322002$2$F$20240819$20240918$20240916$20240927$EXP$$CA-CELLTRION INC.-2024CA020709$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
243220031$24322003$1$I$$20240906$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005381$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$HP$US$US
243220041$24322004$1$I$20161101$20240904$20240916$20240916$EXP$$DE-AUROBINDO-AUR-APL-2019-036028$AUROBINDO$$29$YR$$F$Y$$$20240916$$MD$DE$DE
243220051$24322005$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005024$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243220062$24322006$2$F$20240328$20240905$20240916$20240916$EXP$DE-CADRBFARM-2024330314$DE-AMAROX PHARMA-AMR2024DE03010$HETERO$$71$YR$$M$Y$76$KG$20240916$$CN$DE$DE
243220072$24322007$2$F$20240819$20240823$20240916$20240918$PER$$US-SA-2024SA262258$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240918$$CN$US$US
243220091$24322009$1$I$20230101$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146541$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240916$$CN$US$US
243220101$24322010$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145693$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240916$$HP$US$US
243220111$24322011$1$I$20240624$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146225$BRISTOL MYERS SQUIBB$$4$MON$I$M$Y$$$20240916$$MD$US$US
243220121$24322012$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146184$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240916$$CN$US$US
243220131$24322013$1$I$20240622$20240904$20240916$20240916$EXP$FR-AFSSAPS-PP2024000953$FR-Accord-445652$ACCORD$$64$YR$A$F$Y$87$KG$20240916$$MD$FR$FR
243220141$24322014$1$I$$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146502$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240916$$CN$US$US
243220151$24322015$1$I$$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146426$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$69.4$KG$20240916$$CN$US$US
243220161$24322016$1$I$20240101$20240906$20240916$20240916$EXP$$RO-TEVA-VS-3241978$TEVA$$94$YR$$M$Y$$$20240916$$CN$RO$RO
243220172$24322017$2$F$20240827$20240916$20240916$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005391$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240926$$CN$US$US
243220181$24322018$1$I$$20240906$20240916$20240916$EXP$$CA-Amarin Pharma, Inc-2024AMR000469$AMARIN$$85$YR$E$$Y$$$20240913$$PH$CA$CA
243220191$24322019$1$I$20240101$20240906$20240916$20240916$EXP$$CA-CELLTRION INC.-2024CA012069$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
243220201$24322020$1$I$$20240828$20240916$20240916$PER$$AU-TOLMAR, INC.-24AU052292$TOLMAR$$$$$M$Y$$$20240916$$CN$AU$AU
243220211$24322021$1$I$$20240828$20240916$20240916$PER$$AU-TOLMAR, INC.-24AU052295$TOLMAR$$$$$M$Y$$$20240916$$CN$AU$AU
243220221$24322022$1$I$$20240828$20240916$20240916$PER$$BR-TOLMAR, INC.-24BR052307$TOLMAR$$$$$F$Y$$$20240916$$CN$BR$BR
243220231$24322023$1$I$20240828$20240829$20240916$20240916$PER$$BR-TOLMAR, INC.-24BR052323$TOLMAR$$$$$$Y$$$20240916$$HP$BR$BR
243220241$24322024$1$I$20240325$20240829$20240916$20240916$PER$$BR-TOLMAR, INC.-24BR052326$TOLMAR$$7$YR$$F$Y$$$20240916$$CN$BR$BR
243220251$24322025$1$I$$20240911$20240916$20240916$PER$$US-BIOGEN-2024BI01282242$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
243220261$24322026$1$I$20240101$20240903$20240916$20240916$PER$$US-APOTEX-2024AP010263$APOTEX$$$$E$F$Y$$$20240916$$HP$US$US
243220271$24322027$1$I$20240801$20240903$20240916$20240916$PER$$US-ASTELLAS-2024-AER-004495$ASTELLAS$$$$$F$Y$$$20240916$$MD$US$US
243220281$24322028$1$I$$20240910$20240916$20240916$PER$$US-TAKEDA-2024TUS090386$TAKEDA$$$$$$Y$$$20240916$$CN$US$US
243220291$24322029$1$I$$20240909$20240916$20240916$EXP$$CA-APOTEX-2024AP010431$APOTEX$$$$$M$Y$$$20240916$$HP$CA$CA
243220301$24322030$1$I$20240101$20240904$20240916$20240916$EXP$$US-UCBSA-2024034574$UCB$$$$$M$Y$118.1$KG$20240916$$PH$US$US
243220321$24322032$1$I$$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024181575$AMGEN$$$$$M$Y$$$20240916$$CN$US$US
243220331$24322033$1$I$$20240916$20240916$20240916$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051498$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240916$$HP$ES$ES
243220341$24322034$1$I$20220101$20240902$20240916$20240916$EXP$$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-08323$HIKMA$Caorsi R, Bertoni A, Matucci-Cerinic C, Natoli V, Palmeri S, Rosina S, et al. Caorsi R, Bertoni A, Matucci-Cerinic C, Natoli V, Palmeri S, Rosina S, et al. Long-term efficacy of MAS825, a bispecific anti-IL1? and IL-18 monoclonal antibody, in two patients with sJIA and recurrent episodes of MAS. Rheumatology. 2024;/:1-12$20$YR$$M$Y$$$20240916$$MD$IT$IT
243220352$24322035$2$F$20240718$20240917$20240916$20240924$PER$$US-AMGEN-USASP2024180496$AMGEN$$81$YR$E$M$Y$90$KG$20240924$$HP$US$US
243220361$24322036$1$I$$20240820$20240916$20240916$PER$$US-SA-2024SA265838$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$MD$US$US
243220371$24322037$1$I$$20240903$20240916$20240916$PER$$US-JNJFOC-20240904637$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$US$US
243220381$24322038$1$I$$20240827$20240916$20240916$PER$$US-SA-2024SA263617$SANOFI AVENTIS$$$$A$M$Y$91.89$KG$20240916$$MD$US$US
243220391$24322039$1$I$20240101$20240820$20240916$20240916$PER$$US-SA-2024SA263099$SANOFI AVENTIS$$53$YR$A$M$Y$81.82$KG$20240916$$MD$US$US
243220401$24322040$1$I$$20240906$20240916$20240916$PER$$US-SA-2024SA260069$SANOFI AVENTIS$$16$YR$T$F$Y$55.79$KG$20240916$$MD$US$US
243220411$24322041$1$I$$20240821$20240916$20240916$PER$$US-SA-2024SA264516$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240916$$MD$US$US
243220421$24322042$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265620$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240916$$MD$US$US
243220431$24322043$1$I$$20240903$20240916$20240916$PER$$US-ASTELLAS-2024-AER-004681$ASTELLAS$$48$YR$A$F$Y$$$20240916$$HP$US$US
243220441$24322044$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA265702$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240916$$HP$US$US
243220451$24322045$1$I$$20240909$20240916$20240916$EXP$$GB-AUROBINDO-AUR-APL-2024-044918$AUROBINDO$$89$YR$$F$Y$$$20240916$$PH$GB$GB
243220461$24322046$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205746$ASTRAZENECA$$$$A$M$Y$116$KG$20240916$$CN$US$
243220471$24322047$1$I$$20240909$20240916$20240916$PER$$US-AstraZeneca-2024A205880$ASTRAZENECA$$$$$$Y$$$20240916$$HP$US$
243220481$24322048$1$I$20240909$20240909$20240916$20240916$EXP$$ES-AstraZeneca-2024A207376$ASTRAZENECA$$$$E$M$Y$$$20240916$$PH$ES$
243220491$24322049$1$I$$20240906$20240916$20240916$EXP$$CA-TEVA-VS-3241729$TEVA$$55$YR$$M$Y$$$20240916$$HP$CA$CA
243220501$24322050$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A208606$ASTRAZENECA$$$$C$M$Y$$$20240916$$CN$US$
243220511$24322051$1$I$$20240909$20240916$20240916$EXP$$ZA-AstraZeneca-2024A206312$ASTRAZENECA$$20$YR$$M$Y$$$20240916$$CN$ZA$
243220521$24322052$1$I$$20240904$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409002828$ELI LILLY AND CO$$$$A$F$Y$$$20240916$$CN$US$US
243220531$24322053$1$I$$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005771$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240916$$CN$US$US
243220541$24322054$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007441$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240916$$CN$US$US
243220551$24322055$1$I$$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009204$ELI LILLY AND CO$$85$YR$E$M$Y$$$20240916$$CN$US$US
243220561$24322056$1$I$20181123$20181126$20240916$20240916$EXP$$ES-SA-2018SA324377$SANOFI AVENTIS$$68$YR$E$F$Y$89$KG$20240916$$CN$ES$ES
243220571$24322057$1$I$20240821$20240911$20240916$20240916$EXP$$GB-AUROBINDO-AUR-APL-2024-045426$AUROBINDO$$43$YR$$F$Y$120$KG$20240916$$CN$GB$GB
243220581$24322058$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA265590$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240916$$MD$US$US
243220591$24322059$1$I$20240801$20240910$20240916$20240916$PER$$US-SA-2024SA265743$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240916$$MD$US$US
243220602$24322060$2$F$$20240917$20240916$20240918$EXP$$NVSC2024US184274$NOVARTIS$$$$$M$Y$$$20240918$$HP$US$US
243220611$24322061$1$I$20220101$20240906$20240916$20240916$EXP$$CH-ROCHE-10000075805$ROCHE$$$$$$Y$$$20240916$$HP$CH$CH
243220621$24322062$1$I$$20231218$20240916$20240916$PER$$US-ENDO USA, INC.-2023-006384$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243220631$24322063$1$I$$20231218$20240916$20240916$PER$$US-ENDO USA, INC.-2023-006344$ENDO$$$$$F$Y$$$20240916$$LW$US$US
243220641$24322064$1$I$$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146496$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240916$$CN$US$US
243220651$24322065$1$I$20240911$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146287$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240916$$CN$US$US
243220661$24322066$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146631$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240916$$PH$US$US
243220671$24322067$1$I$20240101$20240906$20240916$20240916$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-143352$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240916$$CN$PR$PR
243220681$24322068$1$I$20240601$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146427$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240916$$CN$US$US
243220701$24322070$1$I$$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145008$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240916$$CN$US$US
243220711$24322071$1$I$20231201$20240909$20240916$20240916$EXP$$US-VIIV HEALTHCARE LIMITED-US2024112399$VIIV$$$$$M$Y$$$20240916$$PH$US$US
243220721$24322072$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024111413$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
243220731$24322073$1$I$$20240905$20240916$20240916$EXP$CA-MHPD-E2B_07210659$CA-Accord-445866$ACCORD$$3$DEC$A$M$Y$$$20240916$$MD$CA$CA
243220751$24322075$1$I$$20240912$20240916$20240916$PER$$US-HALEON-2196772$Haleon PLC$$$$$$Y$$$20240916$$CN$US$US
243220761$24322076$1$I$$20240911$20240916$20240916$EXP$$NVSC2024CA183148$NOVARTIS$$40$YR$$F$Y$$$20240916$$HP$CA$CA
243220771$24322077$1$I$20240801$20240908$20240916$20240916$EXP$$JP-ROCHE-10000081450$ROCHE$$13$YR$T$M$Y$$$20240916$$MD$JP$JP
243220781$24322078$1$I$20240828$20240828$20240916$20240916$PER$$US-SA-2024SA266091$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240916$$PH$US$US
243220791$24322079$1$I$$20240823$20240916$20240916$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005025$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243220801$24322080$1$I$$20240514$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002243$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243220811$24322081$1$I$$20240514$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002240$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243220821$24322082$1$I$20240801$20240904$20240916$20240916$PER$$US-JNJFOC-20240937857$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20240916$$CN$US$US
243220832$24322083$2$F$$20240918$20240916$20240925$PER$$US-VIIV HEALTHCARE LIMITED-US2024112004$VIIV$$$$$M$Y$$$20240925$$CN$US$US
243220841$24322084$1$I$$20240911$20240916$20240916$PER$$US-TAKEDA-2024TUS091106$TAKEDA$$$$$F$Y$82$KG$20240916$$HP$US$US
243220851$24322085$1$I$20240827$20240904$20240916$20240916$EXP$$CN-ROCHE-10000074576$ROCHE$$57$YR$A$F$Y$49$KG$20240916$$HP$CN$CN
243220861$24322086$1$I$20240701$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146335$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240916$$HP$US$US
243220871$24322087$1$I$20240829$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145814$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$78.93$KG$20240916$$HP$US$US
243220881$24322088$1$I$$20240906$20240916$20240916$PER$$US-JNJFOC-20240919763$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$HP$US$US
243220891$24322089$1$I$$20240909$20240916$20240916$EXP$$JP-TEVA-VS-3242278$TEVA$Dote S, Inose R, Goto R, Kobayashi Y, Muraki Y. Risk of a second cancer and infection in patients with indolent B-cell lymphoma exposed to first-line bendamustine plus rituximab: A retrospective analysis of an administrative claims database. Hematol-Oncol 2023; 41 (3): 354-362.; Dote S, Inose R, Goto R, Kobayashi Y, Muraki Y. Risk of a second cancer and infection in patients with indolent B-cell lymphoma exposed to first-line bendamustine plus rituximab: A retrospective analysis of an adminis...$$$$$Y$$$20240916$$HP$JP$JP
243220911$24322091$1$I$20240711$20240905$20240916$20240916$EXP$GB-MHRA-MED-202409051602228240-CRTJQ$GB-AMAROX PHARMA-AMR2024GB03025$HETERO$$$$$$Y$$$20240916$$HP$GB$GB
243220921$24322092$1$I$$20240906$20240916$20240916$PER$$US-TEVA-VS-3241557$TEVA$$62$YR$$F$Y$$$20240916$$PH$US$US
243220931$24322093$1$I$$20240904$20240916$20240916$PER$$US-SA-2024SA264796$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240916$$CN$US$US
243220941$24322094$1$I$20180525$20180606$20240916$20240916$EXP$$TR-SAKK-2018SA156072AA$SANOFI AVENTIS$$57$YR$A$F$Y$62$KG$20240916$$CN$TR$TR
243220951$24322095$1$I$20240101$20240822$20240916$20240916$PER$$US-SA-2024SA264205$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240916$$MD$US$US
243220971$24322097$1$I$$20240907$20240916$20240916$EXP$$TR-ROCHE-10000077187$ROCHE$$70$YR$E$M$Y$$$20240916$$MD$TR$TR
243220981$24322098$1$I$$20240910$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146415$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240916$$PH$US$US
243220991$24322099$1$I$$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146329$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240916$$CN$US$US
243221041$24322104$1$I$$20240826$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08627$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243221071$24322107$1$I$$20240910$20240916$20240916$EXP$$CN-AstraZeneca-2024A207855$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$CN$
243221081$24322108$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A208085$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243221091$24322109$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207291$ASTRAZENECA$$$$$M$Y$$$20240916$$MD$US$
243221101$24322110$1$I$20240101$20240910$20240916$20240916$EXP$$BE-ABBVIE-5920793$ABBVIE$$53$YR$$$Y$105$KG$20240916$$MD$BE$BE
243221121$24322112$1$I$$20240909$20240916$20240916$PER$$NVSC2024US183931$NOVARTIS$$$$$M$Y$$$20240916$$CN$US$US
243221131$24322113$1$I$20240712$20240912$20240916$20240916$EXP$$US-GILEAD-2024-0687583$GILEAD$$28$YR$A$F$Y$$$20240916$$HP$US$US
243221141$24322114$1$I$$20240904$20240916$20240916$EXP$$NG-ROCHE-10000075006$ROCHE$$$$A$M$Y$$$20240916$$MD$NG$NG
243221151$24322115$1$I$20240909$20240910$20240916$20240916$EXP$$US-GILEAD-2024-0687483$GILEAD$$69$YR$E$F$Y$$$20240916$$CN$US$US
243221161$24322116$1$I$20240904$20240904$20240916$20240916$EXP$GB-MHRA-MED-202409042021491910-PKMHL$GB-Accord-445318$ACCORD$$16$YR$T$F$Y$50$KG$20240916$$CN$GB$GB
243221171$24322117$1$I$20240101$20240904$20240916$20240916$PER$$US-APOTEX-2024AP010283$APOTEX$$$$$F$Y$$$20240916$$CN$US$US
243221182$24322118$2$F$20240912$20240916$20240916$20240916$PER$$US-AMGEN-USASP2024184187$AMGEN$$78$YR$E$F$Y$$$20240916$$CN$US$US
243221201$24322120$1$I$20240820$20240905$20240916$20240916$EXP$IT-MINISAL02-1000699$IT-Accord-445751$ACCORD$$72$YR$E$F$Y$72$KG$20240916$$HP$IT$IT
243221211$24322121$1$I$20240911$20240911$20240916$20240916$EXP$$NVSC2024CN183559$NOVARTIS$$67$YR$$F$Y$60$KG$20240916$$HP$CN$CN
243221221$24322122$1$I$$20240913$20240916$20240916$EXP$$NVSC2024RW183998$NOVARTIS$$$$$M$Y$$$20240916$$MD$RW$RW
243221241$24322124$1$I$20230901$20240702$20240916$20240916$PER$$US-AJANTA-2024AJA00125$AJANTA PHARMA$$84$YR$E$F$Y$210$KG$20240913$$CN$US$US
243221252$24322125$2$F$20240801$20240920$20240916$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409008569$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240923$$CN$US$US
243221261$24322126$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008489$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240916$$CN$US$US
243221271$24322127$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006917$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240916$$CN$US$US
243221281$24322128$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009259$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240916$$CN$US$US
243221291$24322129$1$I$20240820$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009140$ELI LILLY AND CO$$$$A$M$Y$$$20240916$$CN$US$US
243221301$24322130$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA265319$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$HP$US$US
243221311$24322131$1$I$20240821$20240906$20240916$20240916$EXP$$CA-CELLTRION INC.-2024CA021804$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
243221321$24322132$1$I$20240101$20240611$20240916$20240916$PER$$US-AJANTA-2024AJA00115$AJANTA PHARMA$$$$$$Y$$$20240916$$CN$US$US
243221331$24322133$1$I$20231101$20240823$20240916$20240916$PER$$US-SA-2024SA265750$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240916$$CN$US$US
243221342$24322134$2$F$20240910$20240916$20240916$20240918$PER$$US-AMGEN-USASP2024184072$AMGEN$$81$YR$E$F$Y$$$20240918$$CN$US$US
243221351$24322135$1$I$$20240912$20240916$20240916$EXP$$US-TAKEDA-2024TUS091051$TAKEDA$$$$$M$Y$$$20240916$$CN$US$US
243221391$24322139$1$I$$20240916$20240916$20240916$PER$$US-PROD-AS2-212756134-RB-081049-2024$RECKITT BENCKISER$$74$YR$$F$Y$$$20240916$$CN$US$US
243221401$24322140$1$I$$20240828$20240916$20240916$PER$$US-APOTEX-2024AP010230$APOTEX$Barrison L, Park S, Decherney A.. Spontaneous conception in a 40-year-old woman after allogeneic stem cell transplant with active graft-versus-host disease: A case report. Case Reports in Women^s Health. 2024;43:e00636 (1-3)$38$YR$$F$Y$$$20240916$$HP$US$US
243221411$24322141$1$I$$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143689$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240916$$HP$US$US
243221421$24322142$1$I$20240831$20240909$20240916$20240916$EXP$CN-91110000556821568D-2024DRL001722$CN-RDY-SPO/CHN/24/0013362$DR REDDYS$$50$YR$A$M$Y$$$20240916$$HP$CN$CN
243221431$24322143$1$I$20240419$20240916$20240916$20240916$EXP$FR-AFSSAPS-LY2024001371$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051486$BOEHRINGER INGELHEIM$$85$YR$E$F$Y$51$KG$20240916$$PH$FR$FR
243221441$24322144$1$I$20240906$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024181250$AMGEN$$61$YR$A$F$Y$$$20240916$$CN$US$US
243221451$24322145$1$I$20240819$20240820$20240916$20240916$EXP$$US-SA-2024SA262107$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240916$$HP$US$US
243221461$24322146$1$I$20240912$20240913$20240916$20240916$EXP$$CN-AstraZeneca-2024A209877$ASTRAZENECA$$19655$DY$$F$Y$43$KG$20240916$$MD$CN$
243221471$24322147$1$I$20240817$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A208883$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243221481$24322148$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205673$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243221491$24322149$1$I$20191201$20240905$20240916$20240916$EXP$$BR-TEVA-VS-3242588$TEVA$$84$YR$$F$Y$$$20240916$$CN$BR$BR
243221501$24322150$1$I$20230929$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A209035$ASTRAZENECA$$28374$DY$$F$Y$$$20240916$$HP$US$
243221511$24322151$1$I$20240801$20240905$20240916$20240916$EXP$$JP-ROCHE-10000080097$ROCHE$$8$DEC$E$M$Y$$$20240916$$MD$JP$JP
243221521$24322152$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A207068$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243221541$24322154$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184562$NOVARTIS$$$$$$Y$$$20240916$$MD$US$US
243221551$24322155$1$I$$20240905$20240916$20240916$EXP$GB-MHRA-MED-202409051142525450-WZVKS$GB-AMAROX PHARMA-AMR2024GB03021$HETERO$$$$$M$Y$$$20240916$$CN$GB$GB
243221561$24322156$1$I$20240101$20240826$20240916$20240916$PER$$US-SA-2024SA266454$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240916$$CN$US$US
243221571$24322157$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265622$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240916$$CN$US$US
243221581$24322158$1$I$20240903$20240906$20240916$20240916$EXP$$CA-CELLTRION INC.-2024CA021812$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
243221591$24322159$1$I$20240427$20240904$20240916$20240916$EXP$$US-UCBSA-2024045775$UCB$$$$A$F$Y$$$20240916$$CN$US$US
243221612$24322161$2$F$20240918$20240918$20240916$20240924$EXP$$CA-TAKEDA-2024TUS046885$TAKEDA$$67$YR$$F$Y$$$20240924$$CN$CA$CA
243221622$24322162$2$F$$20240918$20240916$20240920$EXP$$CA-SANDOZ INC.-SDZ2024CA080102$SANDOZ$$50$YR$$F$Y$$$20240920$$HP$CA$CA
243221641$24322164$1$I$20240905$20240905$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142296$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$PH$US$US
243221651$24322165$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146443$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240916$$CN$US$US
243221661$24322166$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145921$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240916$$CN$US$US
243221671$24322167$1$I$20240902$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145840$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240916$$HP$US$US
243221681$24322168$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146294$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240916$$CN$US$US
243221691$24322169$1$I$20240101$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024180079$AMGEN$$79$YR$E$F$Y$$$20240916$$CN$US$US
243221701$24322170$1$I$20240912$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024184139$AMGEN$$54$YR$A$F$Y$$$20240916$$CN$US$US
243221721$24322172$1$I$20240908$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183058$AMGEN$$76$YR$E$M$Y$$$20240916$$CN$US$US
243221732$24322173$2$F$20240909$20240909$20240916$20240917$EXP$$US-CSL-2024-008326$CSL Plasma$$34$YR$$F$Y$$$20240917$$HP$US$US
243221742$24322174$2$F$$20240910$20240916$20240917$PER$$US-ROCHE-10000078945$ROCHE$$9$YR$C$M$Y$$$20240917$$CN$US$US
243221751$24322175$1$I$$20240905$20240916$20240916$PER$$US-JNJFOC-20240917685$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240916$$CN$US$US
243221761$24322176$1$I$$20240903$20240916$20240916$EXP$$US-TEVA-VS-3242373$TEVA$$$$$F$Y$$$20240916$$LW$US$US
243221781$24322178$1$I$20240801$20240903$20240916$20240916$EXP$$US-UCBSA-2024045296$UCB$$49$YR$$F$Y$$$20240916$$HP$US$US
243221792$24322179$2$F$$20240917$20240916$20240919$EXP$$CA-TAKEDA-2024TUS090669$TAKEDA$$$$$M$Y$$$20240919$$CN$CA$CA
243221801$24322180$1$I$$20240909$20240916$20240916$EXP$$CA-TAKEDA-2024TUS090400$TAKEDA$$$$$F$Y$$$20240916$$CN$CA$CA
243221811$24322181$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5921564$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243221821$24322182$1$I$$20240904$20240916$20240916$PER$$US-SA-2024SA261696$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240916$$HP$US$US
243221831$24322183$1$I$$20240826$20240916$20240916$PER$$US-SA-2024SA265711$SANOFI AVENTIS$$77$YR$E$F$Y$80.2$KG$20240916$$MD$US$US
243221841$24322184$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA055925$SANOFI AVENTIS$$$$C$M$Y$$$20240916$$HP$US$US
243221861$24322186$1$I$$20240909$20240916$20240916$EXP$$GB-BIOGEN-2024BI01282065$BIOGEN$$$$$F$Y$$$20240916$$CN$GB$GB
243221881$24322188$1$I$$20240904$20240916$20240916$PER$$US-APOTEX-2024AP010308$APOTEX$Orsagova D, Mohamed Ramzy Hasan F, Sayed S, Sharma A, Khillan R. Beyond the Surface: A Case Study of Cutaneous Involvement in Multiple Myeloma. Clinical Lymphoma, Myeloma and Leukemia. 2024;24 (Suppl.1):S563-S566$47$YR$$F$Y$$$20240916$$HP$US$US
243221891$24322189$1$I$20210101$20240902$20240916$20240916$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00437$Unknown Manufacturer$$$$$$Y$$$20240916$$CN$BR$BR
243221901$24322190$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146755$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240916$$CN$US$US
243221913$24322191$3$F$20240101$20240920$20240916$20240924$EXP$$IN-SANDOZ INC.-SDZ2024IN079855$SANDOZ$$$$$M$Y$82.2$KG$20240924$$CN$IN$IN
243221921$24322192$1$I$20240201$20240903$20240916$20240916$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00439$Unknown Manufacturer$$$$$$Y$$$20240916$$CN$BR$BR
243221931$24322193$1$I$20180101$20240903$20240916$20240916$EXP$$RU-MELINTA THERAPEUTICS, LLC-RU-MLNT-24-00430$Unknown Manufacturer$$$$$$Y$$$20240916$$MD$RU$RU
243221941$24322194$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5920012$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243221951$24322195$1$I$$20240910$20240916$20240916$EXP$$CA-TAKEDA-2024TUS089871$TAKEDA$$$$$F$Y$$$20240916$$CN$CA$CA
243221961$24322196$1$I$$20240906$20240916$20240916$EXP$$ES-AMAROX PHARMA-AMR2024ES03054$HETERO$Cantero AB, Nunez ML, Luis GR, Lucena CR, Rueda JR. NON-INFECTIOUS FEVER. ABOUT A  CASE. European Journal of Case Reports in Internal Medicine. 2024;11 (1):915$62$YR$$F$Y$$$20240916$$MD$ES$ES
243221971$24322197$1$I$$20240904$20240916$20240916$EXP$$FR-RDY-SPO/FRA/24/0013205$DR REDDYS$Haidar NA, Vaillant W, Salignon K, Jounblat Y, Borel C. ABCL-159 Successful Treatment of a Gray Zone Lymphoma With Immunotherapy: A Case Report. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24: S459. doi:10.1016/S2152-2650%2824%2901490-3.$66$YR$E$F$Y$$$20240916$$MD$FR$FR
243221981$24322198$1$I$$20240906$20240916$20240916$EXP$$ZA-Vifor (International) Inc.-VIT-2024-08113$VIFOR$$83$YR$$M$Y$$$20240916$$HP$ZA$ZA
243221991$24322199$1$I$20240909$20240909$20240916$20240916$EXP$$CA-TAKEDA-2024TUS090231$TAKEDA$$70$YR$$F$Y$$$20240916$$MD$CA$CA
243222001$24322200$1$I$20240701$20240906$20240916$20240916$EXP$$ZA-Vifor (International) Inc.-VIT-2024-08108$VIFOR$$$$E$M$Y$$$20240916$$HP$ZA$ZA
243222012$24322201$2$F$$20240919$20240916$20240927$EXP$$JP-TEVA-VS-3242192$TEVA$Okazaki R, Arita S, Hoshio H, Uetani N, Inui G, Ishikawa H, et al. Allergic bronchopulmonary mycosis caused by Scedosporium apiospermum: A case report. Respirat-Med-Case-Report 2024; 51.; Okazaki R, Arita S, Hoshio H, Uetani N, Inui G, Ishikawa H, et al. Allergic bronchopulmonary mycosis caused by Scedosporium apiospermum: A case report. Respirat-Med-Case-Report 2024; 51.$58$YR$$F$Y$33.8$KG$20240927$$HP$JP$JP
243222031$24322203$1$I$$20240906$20240916$20240916$EXP$$US-JNJFOC-20240917435$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240916$$HP$US$US
243222041$24322204$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007529$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240916$$CN$US$US
243222051$24322205$1$I$20240912$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008854$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240916$$CN$US$US
243222061$24322206$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006526$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240916$$CN$US$US
243222072$24322207$2$F$$20240913$20240916$20240921$PER$$US-ELI_LILLY_AND_COMPANY-US202409009135$ELI LILLY AND CO$$$$$F$Y$$$20240921$$CN$US$US
243222081$24322208$1$I$$20240911$20240916$20240916$EXP$$CA-PUMA BIOTECHNOLOGY, LTD.-2024-PUM-CA001229$PUMA$$$$$$Y$$$20240916$$CN$CA$CA
243222091$24322209$1$I$20240101$20240906$20240916$20240916$EXP$$CA-CELLTRION INC.-2024CA021822$CELLTRION$$$$$$Y$$$20240916$$HP$CA$CA
243222101$24322210$1$I$$20240909$20240916$20240916$EXP$$GB-BIOGEN-2024BI01282062$BIOGEN$$$$A$F$Y$$$20240916$$CN$GB$GB
243222112$24322211$2$F$$20240912$20240916$20240922$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08513$HIKMA$Hall J, Edmundowicz D, Cronin E.. Hall J, Edmundowicz D, Cronin E. Advanced Interatrial block induced by flecainide.. Journal of Electrocardiology.. 2024;86:153767$$$$$Y$$$20240922$$MD$US$US
243222132$24322213$2$F$$20240913$20240916$20240919$30DAY$$US-GSK-US2024111275$GLAXOSMITHKLINE$$$$$M$Y$$$20240919$$CN$US$US
243222141$24322214$1$I$$20240909$20240916$20240916$EXP$$CL-GSK-CL2024AMR112908$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$CL$CL
243222151$24322215$1$I$$20240904$20240916$20240916$EXP$$DE-Accord-445940$ACCORD$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al. Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant recipients: CERTAIN registry study. TRANSPLANTATION. 2018;103(6):1-33.$8$YR$C$$Y$$$20240916$$MD$DE$DE
243222162$24322216$2$F$$20240912$20240916$20240920$EXP$$GB-CELLTRION INC.-2024GB021793$CELLTRION$$$$$$Y$$$20240920$$CN$GB$GB
243222171$24322217$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5919923$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243222181$24322218$1$I$20240823$20240903$20240916$20240916$EXP$$US-UCBSA-2024045306$UCB$$59$YR$$M$Y$$$20240916$$HP$US$US
243222191$24322219$1$I$20230101$20240910$20240916$20240916$EXP$$US-AMGEN-USASP2024183233$AMGEN$$$$$M$Y$$$20240916$$CN$US$US
243222211$24322221$1$I$$20240910$20240916$20240916$PER$$US-AstraZeneca-2024A207351$ASTRAZENECA$$$$$$Y$$$20240916$$HP$US$
243222221$24322222$1$I$20240821$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A208720$ASTRAZENECA$$33340$DY$$F$Y$$$20240916$$CN$US$
243222231$24322223$1$I$$20240911$20240916$20240916$PER$$US-AstraZeneca-2024A207802$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243222241$24322224$1$I$$20240908$20240916$20240916$EXP$$US-AMGEN-USASP2024182360$AMGEN$Leiphart P.; Naro G.. 54114 Severe cutaneous lupus mimicking SJS/TEN with no identifiable trigger. Journal of the American Academy of Dermatology. 2024;91 (3):AB85$31$YR$A$F$Y$$$20240916$$MD$US$US
243222251$24322225$1$I$$20240911$20240916$20240916$EXP$$FR-AstraZeneca-2024A209018$ASTRAZENECA$$70$YR$$F$Y$$$20240916$$MD$FR$
243222261$24322226$1$I$$20240909$20240916$20240916$EXP$$TW-ROCHE-10000079263$ROCHE$Chang J, Hsieh J, Tsai C, Chiu H, Lin Y, Wu C, et al. Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer. Biomedical Journal. 2024-Jan-25;47 (5):1-8. doi:10.1016/j.bj.2024.100698.$$$$$Y$$$20240916$$HP$TW$TW
243222271$24322227$1$I$$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A208986$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243222281$24322228$1$I$$20240905$20240916$20240916$EXP$$US-AMGEN-USASP2024178007$AMGEN$Kalra D. K.; Umer M. Peters M. et.al. Multiple recurrences of a left ventricular pseudoaneurysm: a case report. European Heart Journal - Case Reports. 2024;8 (8):1-8$32$YR$A$M$Y$$$20240916$$HP$US$US
243222291$24322229$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205193$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243222311$24322231$1$I$20240801$20240906$20240916$20240916$EXP$$JP-ROCHE-10000081391$ROCHE$$7$MON$I$M$Y$$$20240916$$MD$JP$JP
243222321$24322232$1$I$$20240906$20240916$20240916$EXP$$US-TEVA-VS-3242279$TEVA$$$$$M$Y$$$20240916$$HP$US$US
243222331$24322233$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000082125$ROCHE$$$$A$M$Y$$$20240916$$CN$US$US
243222341$24322234$1$I$$20240904$20240916$20240916$EXP$US-MLMSERVICE-20240828-PI175628-00306-1$US-RDY-SPO/USA/24/0013010$DR REDDYS$Shirini K, Gautam U, Ahmed H, Meier RP, Drachenberg C, Haririan A. Masked kidney allograft failure after simultaneous liver and kidney transplantation: A case report. Journal of Liver Transplantation. 2024;16:100237. DOI:10.1016/j.liver.2024.100237.$58$YR$A$M$Y$$$20240916$$MD$US$US
243222351$24322235$1$I$$20240909$20240916$20240916$EXP$$CA-ROCHE-10000079692$ROCHE$$39$YR$A$F$Y$$$20240916$$CN$CA$CA
243222361$24322236$1$I$20240501$20240916$20240916$20240916$EXP$FR-AFSSAPS-NY2024001057$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051491$BOEHRINGER INGELHEIM$$58$YR$A$M$Y$86.25$KG$20240916$$MD$FR$FR
243222371$24322237$1$I$$20240911$20240916$20240916$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050974$BOEHRINGER INGELHEIM$$52$YR$A$F$Y$$$20240916$$HP$CA$CA
243222382$24322238$2$F$$20240910$20240916$20240918$EXP$$CA-JNJFOC-20240930156$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$HP$CA$CA
243222392$24322239$2$F$$20240923$20240916$20240926$EXP$$CA-GSK-CA2024113621$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$CA$CA
243222401$24322240$1$I$$20240906$20240916$20240916$EXP$$US-GSK-US2024111311$GLAXOSMITHKLINE$$$$$M$Y$$$20240916$$MD$US$US
243222411$24322241$1$I$$20240909$20240916$20240916$EXP$$GB-TAKEDA-2024TUS090348$TAKEDA$$$$$F$Y$$$20240916$$CN$GB$GB
243222421$24322242$1$I$$20240903$20240916$20240916$EXP$DE-EMA-DD-20240829-7482655-122936$DE-PBT-001043$PANACEA BIOTEC$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al.. Epidemiology of and risk ?factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant ?recipients: CERTAIN registry study. TRANSPLANTATION. 2018;103(6):1-33. ?doi:10.1097/TP.0000000000002414$8$YR$C$$Y$$$20240916$$HP$DE$DE
243222431$24322243$1$I$$20240903$20240916$20240916$EXP$DE-EMA-DD-20240829-7482650-105702$DE-PBT-001046$PANACEA BIOTEC$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al.. Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant recipients: CERTAIN registry study. TRANSPLANTATION. 2019;103(6):1224-33. doi:10.1097/TP.0000000000002414$2$YR$C$$Y$$$20240916$$HP$DE$DE
243222451$24322245$1$I$20231220$20240723$20240916$20240916$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07081$HIKMA$$59$YR$$F$Y$109.3$KG$20240916$$HP$US$US
243222461$24322246$1$I$$20240906$20240916$20240916$EXP$$CA-TEVA-VS-3241634$TEVA$$55$YR$$M$Y$$$20240916$$MD$CA$CA
243222471$24322247$1$I$$20240911$20240916$20240916$EXP$$CA-009507513-2409CAN004665$MERCK$Unknown. Unknown. Unknown$44$YR$$M$Y$$$20240916$$HP$CA$CA
243222481$24322248$1$I$$20240905$20240916$20240916$PER$$US-JNJFOC-20240915433$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$MD$US$US
243222492$24322249$2$F$$20240916$20240916$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005400$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243222502$24322250$2$F$20240301$20240909$20240916$20240920$EXP$$DE-AUROBINDO-AUR-APL-2024-017651$AUROBINDO$$77$YR$$M$Y$68$KG$20240920$$HP$DE$DE
243222511$24322251$1$I$$20240909$20240916$20240916$EXP$$JP-AMGEN-JPNSP2024180940$AMGEN$Hitomi K. Clinical review on 14 cases of Hailey-Hailey disease over 34 years in our department. The 76th Annual Meeting of the Western Division of the Japane se Dermatological. 2024;96$$$$$Y$$$20240916$$HP$JP$JP
243222521$24322252$1$I$$20240910$20240916$20240916$EXP$$GB-TAKEDA-2024TUS091243$TAKEDA$$$$$F$Y$$$20240916$$CN$GB$GB
243222541$24322254$1$I$20240912$20240912$20240916$20240916$PER$$US-ROCHE-10000081518$ROCHE$$37$YR$A$F$Y$$$20240916$$CN$US$US
243222551$24322255$1$I$$20240909$20240916$20240916$EXP$$US-BIOGEN-2024BI01281925$BIOGEN$$$$$M$Y$$$20240916$$CN$US$US
243222561$24322256$1$I$$20240906$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142741$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$PH$US$US
243222571$24322257$1$I$20240101$20240909$20240916$20240916$PER$$US-ABBVIE-5916374$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243222581$24322258$1$I$20240621$20240905$20240916$20240916$EXP$$DE-KOANAAP-SML-DE-2024-00746$Unknown Manufacturer$$69$YR$E$M$Y$125$KG$20240916$$MD$DE$DE
243222591$24322259$1$I$20240801$20240906$20240916$20240916$PER$$US-TEVA-VS-3242740$TEVA$$$$A$F$Y$$$20240916$$HP$US$US
243222602$24322260$2$F$20240903$20240917$20240916$20240919$PER$$US-AMGEN-USASP2024182710$AMGEN$$49$YR$A$F$Y$$$20240919$$PH$US$US
243222623$24322262$3$F$20240825$20240923$20240916$20240930$EXP$$US-TAKEDA-2024TUS090382$TAKEDA$$64$YR$$F$Y$$$20240930$$MD$US$US
243222641$24322264$1$I$$20240909$20240916$20240916$EXP$$US-TAKEDA-2024TUS090554$TAKEDA$$$$$F$Y$58$KG$20240916$$MD$US$US
243222651$24322265$1$I$$20240913$20240916$20240916$PER$$US-ROCHE-10000082473$ROCHE$$$$$$Y$$$20240916$$MD$US$US
243222661$24322266$1$I$20240820$20240904$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005346$ACADIA PHARMACEUTICALS$$86$YR$$F$Y$$$20240916$$CN$US$US
243222672$24322267$2$F$20240819$20240919$20240916$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005414$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240927$$HP$US$US
243222681$24322268$1$I$20240101$20240913$20240916$20240916$EXP$$US-ABBVIE-5924103$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243222692$24322269$2$F$20000101$20240917$20240916$20240920$EXP$$US-ABBVIE-5923730$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243222721$24322272$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183330$AMGEN$$$$$$Y$$$20240916$$CN$US$US
243222731$24322273$1$I$$20240913$20240916$20240916$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051479$BOEHRINGER INGELHEIM$$$$$$Y$$$20240916$$MD$US$US
243222741$24322274$1$I$$20240906$20240916$20240916$EXP$GB-MHRA-MED-202409061107100170-VGBDS$GB-AMAROX PHARMA-AMR2024GB03035$HETERO$$37$YR$$F$Y$$$20240916$$HP$GB$GB
243222752$24322275$2$F$20240508$20240916$20240916$20240924$EXP$$AU-TAKEDA-2024TUS047057$TAKEDA$$22$YR$$F$Y$$$20240924$$HP$AU$AU
243222761$24322276$1$I$$20240905$20240916$20240916$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08984$LUPIN$$$$$$Y$$$20240916$$HP$US$US
243222771$24322277$1$I$$20240901$20240916$20240916$EXP$$RO-Nexus Pharma-000307$NEXUS PHARMACEUTICALS$Niculae CM, Gorea ME, Tirlescu LG, Matoru RM, Hristea A. Tigecycline-Based Regimens for Complicated Urinary Tract Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria: Case Series. Cureus. 2024 Jul 29;16(7):e65617.$63$YR$A$M$Y$$$20240916$$HP$RO$RO
243222781$24322278$1$I$$20240901$20240916$20240916$EXP$$RO-Axellia-005357$XELLIA PHARMACEUTICALS$Niculae CM, Gorea ME, Tirlescu LG, Matoru RM, Hristea A. Tigecycline-Based Regimens for Complicated Urinary Tract Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria: Case Series. Cureus. 2024 Jul 29;16(7):e65617.$63$YR$A$M$Y$$$20240916$$HP$RO$RO
243222791$24322279$1$I$$20240905$20240916$20240916$EXP$$US-Indoco-000611$INDOCO$Zhang RV, Carr BR. Reducing Respiratory Complications During Electroconvulsive Therapy (ECT) With Smaller Doses of Succinylcholine in a Morbidly Obese Patient: A Case Report. Cureus. 2024 Jul 29;16(7):e65654$48$YR$A$F$Y$110$KG$20240916$$HP$US$US
243222801$24322280$1$I$$20240901$20240916$20240916$EXP$$RO-Axellia-005356$XELLIA PHARMACEUTICALS$Niculae CM, Gorea ME, Tirlescu LG, Matoru RM, Hristea A. Tigecycline-Based Regimens for Complicated Urinary Tract Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria: Case Series. Cureus. 2024 Jul 29;16(7):e65617.$63$YR$A$M$Y$$$20240916$$HP$RO$RO
243222811$24322281$1$I$20240905$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A208163$ASTRAZENECA$$75$YR$$F$Y$$$20240916$$CN$US$
243222821$24322282$1$I$$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A209425$ASTRAZENECA$$$$$F$Y$52.2$KG$20240916$$CN$US$
243222831$24322283$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008113$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240916$$CN$US$US
243222841$24322284$1$I$$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009158$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243222851$24322285$1$I$20240911$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008161$ELI LILLY AND CO$$$$$M$Y$$$20240916$$CN$US$US
243222861$24322286$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007488$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240916$$CN$US$US
243222871$24322287$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008309$ELI LILLY AND CO$$69$YR$E$$Y$$$20240916$$PH$US$US
243222881$24322288$1$I$20240912$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008245$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240916$$CN$US$US
243222901$24322290$1$I$$20240905$20240916$20240916$PER$$US-ABBVIE-5916433$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243222911$24322291$1$I$20240818$20240909$20240916$20240916$EXP$FR-AFSSAPS-PV2024000833$FR-CHEPLA-2024011572$CHEPLAPHARM$$17$YR$$F$Y$40$KG$20240916$$MD$COUNTRY NOT SPECIFIED$FR
243222921$24322292$1$I$$20240912$20240916$20240916$EXP$$UY-ALXN-202409SAM001116UY$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240916$$MD$UY$UY
243222931$24322293$1$I$$20240910$20240916$20240916$EXP$$CN-ROCHE-10000078552$ROCHE$He Y, Yini W. Characteristics of Adverse Drug Reactions Induced by Bevacizumab Injection. Evaluation and Analysis of Drug-Use in Hospitals of China. 2024;24 (7):889-96. doi:10.14009/j.issn .1672-2124.2024.07.026.$$$$$Y$$$20240916$$MD$CN$CN
243222941$24322294$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146315$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240916$$HP$US$US
243222951$24322295$1$I$$20240906$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142524$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$70.31$KG$20240916$$CN$US$US
243222961$24322296$1$I$20240909$20240909$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143833$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240916$$MD$US$US
243222971$24322297$1$I$20240828$20240910$20240916$20240916$EXP$DK-DKMA-30738116$DK-CHEPLA-2024011633$CHEPLAPHARM$$53$YR$$M$Y$93.5$KG$20240916$$MD$COUNTRY NOT SPECIFIED$DK
243222981$24322298$1$I$$20231219$20240916$20240916$PER$$US-ENDO USA, INC.-2024-000090$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243222991$24322299$1$I$20210101$20240827$20240916$20240916$EXP$$SE-TEVA-VS-3237708$TEVA$$25$YR$$M$Y$$$20240916$$CN$SE$SE
243223001$24322300$1$I$20240101$20240905$20240916$20240916$PER$$US-APOTEX-2024AP010307$APOTEX$$$$$M$Y$$$20240916$$CN$US$US
243223011$24322301$1$I$20240905$20240906$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005427$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240916$$CN$US$US
243223021$24322302$1$I$$20240913$20240916$20240916$EXP$$GB-MHRA-MIDB-3680e06d-3bd5-4cec-831b-6a0725ef2c61$Haleon PLC$$75$YR$$$Y$$$20240916$$PH$GB$GB
243223031$24322303$1$I$$20240911$20240916$20240916$EXP$PT-CELLTRION INC.-2024PT020989$PT-ROCHE-10000079212$ROCHE$Lima MJ, Rocha R, Calejo M, Ferreira R, Martins da Silva A, Cruto C. EP-004 - Postherpetic Autoimmune Encephalitis with Epilepsy Immunemediated In JC Positive Patient: A Difficult Balance. Journal of the Portuguese Society of Neurology. 2023;23:271$62$YR$A$M$Y$$$20240916$$HP$PT$PT
243223041$24322304$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183163$AMGEN$$70$YR$E$$Y$$$20240916$$HP$US$US
243223051$24322305$1$I$$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024182882$AMGEN$$$$$$Y$$$20240916$$PH$US$US
243223061$24322306$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183302$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243223071$24322307$1$I$$20240906$20240916$20240916$EXP$$US-HETERO-HET2024US03091$HETERO$$$$$M$Y$$$20240916$$CN$US$US
243223081$24322308$1$I$$20240903$20240916$20240916$EXP$$CA-AUROBINDO-AUR-APL-2024-044159$AUROBINDO$Gilbert-Falardeau A, Drolet A. Remission of necrobiotic xanthogranuloma after intravenous immunoglobulin interruption: A case report. SAGE Open Medical Case Reports. 2024;12:1?3$92$YR$$F$Y$$$20240916$$MD$CA$CA
243223091$24322309$1$I$20240101$20240913$20240916$20240916$EXP$$US-ABBVIE-5923870$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243223101$24322310$1$I$$20240906$20240916$20240916$EXP$$US-TAKEDA-2024TUS089723$TAKEDA$$$$A$F$Y$$$20240916$$HP$US$US
243223111$24322311$1$I$20240830$20240911$20240916$20240916$EXP$$AU-ABBVIE-5906356$ABBVIE$$55$YR$$M$Y$77$KG$20240916$$PH$AU$AU
243223122$24322312$2$F$20240819$20240917$20240916$20240919$EXP$$US-ABBVIE-5920750$ABBVIE$$69$YR$$M$Y$88$KG$20240919$$MD$US$US
243223141$24322314$1$I$$20240912$20240916$20240916$EXP$$US-TAKEDA-2024TUS091373$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
243223152$24322315$2$F$20240701$20240913$20240916$20240924$EXP$$US-HETERO-HET2024US03080$HETERO$$42$YR$$$Y$$$20240924$$CN$US$US
243223161$24322316$1$I$$20240906$20240916$20240916$EXP$$CA-TEVA-VS-3241599$TEVA$$66$YR$$M$Y$$$20240916$$HP$CA$CA
243223171$24322317$1$I$$20240906$20240916$20240916$EXP$$US-TAKEDA-2024TUS090468$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
243223193$24322319$3$F$20230316$20240918$20240916$20240927$EXP$$DE-CELLTRION INC.-2024DE021973$CELLTRION$$$$$$Y$$$20240927$$HP$DE$DE
243223202$24322320$2$F$$20240912$20240916$20240918$EXP$$PH-ROCHE-10000076858$ROCHE$$$$E$F$Y$$$20240918$$MD$PH$PH
243223211$24322321$1$I$20230905$20240905$20240916$20240916$EXP$GB-MHRA-MED-202409050707446380-QNDPF$GB-LUPIN PHARMACEUTICALS INC.-2024-08913$LUPIN$$$$$$Y$$$20240916$$MD$GB$GB
243223233$24322323$3$F$20240831$20240905$20240916$20240930$PER$$US-JNJFOC-20240905805$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20241001$$CN$US$US
243223241$24322324$1$I$$20240904$20240916$20240916$EXP$$JP-Accord-445669$ACCORD$Ono R, Iwahana T, Aoki K, Kato H, Tsutsui Y, Takaishi K, et al. SARS-CoV-2 infection-induced immune thrombocytopenia in a patient with orthotopic heart transplantation: A case report and literature review. Journal of Cardiology Cases. 2024.$46$YR$A$M$Y$$$20240916$$MD$JP$JP
243223251$24322325$1$I$20240419$20240904$20240916$20240916$EXP$$FR-AUROBINDO-AUR-APL-2024-044744$AUROBINDO$$59$YR$$F$Y$57.5$KG$20240916$$MD$FR$FR
243223261$24322326$1$I$$20240903$20240916$20240916$EXP$$IT-AUROBINDO-AUR-APL-2024-044552$AUROBINDO$Castelli B, Fonte C, Guidi M, Di Nicola M, Giunti L, Buccoliero AM, et al. ROLES OF GEMCITABINE-OXALIPLATIN (GEMOX) ADD-ON THERAPYIN INFANT-TYPE BRAIN TUMORS: A SINGLE CENTER EXPERIENCE. NEURO-ONCOLOGY. 2024;26 (Suppl.):iv194$$$I$$Y$$$20240916$$HP$IT$IT
243223271$24322327$1$I$$20240911$20240916$20240916$EXP$$US-TAKEDA-2024TUS091304$TAKEDA$$$$$M$Y$$$20240916$$MD$US$US
243223291$24322329$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA265475$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
243223311$24322331$1$I$20240901$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145136$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240916$$PH$US$US
243223321$24322332$1$I$20240912$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146144$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240916$$CN$US$US
243223331$24322333$1$I$$20240906$20240916$20240916$EXP$$US-GSK-US2024111385$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$HP$US$US
243223352$24322335$2$F$20240912$20240913$20240916$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145792$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240918$$HP$US$US
243223371$24322337$1$I$20201103$20240904$20240916$20240916$EXP$$DE-AUROBINDO-AUR-APL-2024-044965$AUROBINDO$$$$$F$Y$$$20240916$$PH$DE$DE
243223381$24322338$1$I$20240813$20240909$20240916$20240916$EXP$$CO-TAKEDA-2024TUS072624$TAKEDA$$44$YR$$M$Y$65$KG$20240916$$CN$CO$CO
243223391$24322339$1$I$20240830$20240912$20240916$20240916$EXP$$IN-TAKEDA-2024TUS091588$TAKEDA$$8$YR$$M$Y$$$20240916$$CN$IN$IN
243223411$24322341$1$I$20240101$20240910$20240916$20240916$EXP$$US-ABBVIE-5900934$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243223421$24322342$1$I$20240731$20240905$20240916$20240916$EXP$$US-PHARMING-PHAUS2024000777$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
243223431$24322343$1$I$$20240912$20240916$20240916$EXP$$CA-SANDOZ INC.-NVSC2022CA251220$SANDOZ$$80$YR$$M$Y$$$20240916$$HP$CA$CA
243223441$24322344$1$I$$20240903$20240916$20240916$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08934$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243223451$24322345$1$I$$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A209423$ASTRAZENECA$$$$$M$Y$$$20240916$$HP$US$
243223461$24322346$1$I$$20240909$20240916$20240916$EXP$$JP-AstraZeneca-2024A207741$ASTRAZENECA$$91$YR$$F$Y$$$20240916$$MD$JP$
243223471$24322347$1$I$$20240912$20240916$20240916$PER$$US-AstraZeneca-2024A209399$ASTRAZENECA$$40$YR$$F$Y$$$20240916$$HP$US$
243223491$24322349$1$I$$20240906$20240916$20240916$EXP$$US-TEVA-VS-3242370$TEVA$$64$YR$$M$Y$$$20240916$$CN$US$US
243223501$24322350$1$I$20240801$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183083$AMGEN$$85$YR$E$F$Y$$$20240916$$CN$US$US
243223511$24322351$1$I$$20240906$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005437$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243223521$24322352$1$I$20240613$20240902$20240916$20240916$EXP$CN-HENLIUS-24CN016897$CN-Accord-446698$ACCORD$$36$YR$A$F$Y$59$KG$20240916$$MD$CN$CN
243223531$24322353$1$I$20240520$20240906$20240916$20240916$EXP$GB-MHRA-MED-202409061114454530-PRQHZ$GB-AMAROX PHARMA-AMR2024GB03040$HETERO$$35$YR$$M$Y$$$20240916$$MD$GB$GB
243223541$24322354$1$I$$20240901$20240916$20240916$EXP$$IT-Axellia-005358$XELLIA PHARMACEUTICALS$Ponta G, Ranzenigo M, Marzi A, Oltolini C, Tassan Din C, Uberti-Foppa C, et.al. Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience. Clin Ther. 2024 Aug 24:S0149-2918(24)00211-X.$$$$$Y$$$20240916$$HP$IT$IT
243223551$24322355$1$I$$20240909$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013295$DR REDDYS$$31$YR$A$M$Y$$$20240916$$HP$US$US
243223561$24322356$1$I$20240905$20240909$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013284$DR REDDYS$$37$YR$A$F$Y$$$20240916$$HP$US$US
243223571$24322357$1$I$$20240901$20240916$20240916$EXP$$US-Long Grove-000072$Long Grove Pharmaceuticals$Purt B, Nugent A, Wu PS, Paulus YM. Sub-Tenon Triamcinolone and Anti-HIV Medication-Induced Cushing Syndrome. JAMA Ophthalmol. 2024 Aug 29$82$YR$E$M$Y$$$20240916$$MD$US$US
243223591$24322359$1$I$$20240909$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013293$DR REDDYS$$47$YR$A$M$Y$$$20240916$$HP$US$US
243223602$24322360$2$F$20240906$20240916$20240916$20240924$PER$$US-RDY-SPO/USA/24/0013292$DR REDDYS$$29$YR$A$M$Y$$$20240924$$HP$US$US
243223611$24322361$1$I$$20240909$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013246$DR REDDYS$$62$YR$A$M$Y$$$20240916$$CN$US$US
243223621$24322362$1$I$20240830$20240909$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013285$DR REDDYS$$55$YR$A$F$Y$$$20240916$$HP$US$US
243223631$24322363$1$I$$20240908$20240916$20240916$EXP$$GB-TAKEDA-2023TUS107180$TAKEDA$$$$$M$Y$$$20240916$$CN$GB$GB
243223641$24322364$1$I$$20240906$20240916$20240916$EXP$$US-BIOCODEX2-2024001268$BIOCODEX$$10$YR$$M$Y$36.2$KG$20240912$$CN$US$US
243223661$24322366$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA266688$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240916$$CN$US$US
243223671$24322367$1$I$20240101$20240822$20240916$20240916$PER$$US-SA-2024SA264402$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240916$$MD$US$US
243223681$24322368$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265344$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240916$$MD$US$US
243223691$24322369$1$I$$20240826$20240916$20240916$PER$$US-SA-2024SA264004$SANOFI AVENTIS$$$$$F$Y$$$20240916$$MD$US$US
243223701$24322370$1$I$$20240904$20240916$20240916$PER$$US-ROCHE-10000075281$ROCHE$$$$E$M$Y$$$20240916$$PH$US$US
243223711$24322371$1$I$$20240906$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005438$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243223721$24322372$1$I$20220701$20240906$20240916$20240916$EXP$GB-MHRA-MED-202409061234337290-BCLYV$GB-TEVA-VS-3241624$TEVA$$29$YR$$F$Y$82$KG$20240916$$CN$GB$GB
243223731$24322373$1$I$$20240905$20240916$20240916$PER$$US-ADVANZ PHARMA-202409007554$ADVANZ PHARMA$$$$$$Y$$$20240916$$CN$US$US
243223741$24322374$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5919677$ABBVIE$$$$$F$Y$$$20240916$$MD$US$US
243223771$24322377$1$I$20240801$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008345$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240916$$CN$US$US
243223781$24322378$1$I$$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006064$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240916$$HP$US$US
243223791$24322379$1$I$20240908$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008158$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240916$$CN$US$US
243223801$24322380$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008168$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243223811$24322381$1$I$20240801$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006004$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240916$$CN$US$US
243223821$24322382$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008283$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240916$$CN$US$US
243223831$24322383$1$I$$20240910$20240916$20240916$EXP$$US-TAKEDA-US201614902$TAKEDA$$$$$F$Y$83.9$KG$20240916$$CN$US$US
243223841$24322384$1$I$20240904$20240906$20240916$20240916$EXP$GB-MHRA-MED-202409061635586740-YFCKS$GB-TEVA-VS-3241846$TEVA$$76$YR$$F$Y$95$KG$20240916$$PH$GB$GB
243223861$24322386$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145732$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$96.62$KG$20240916$$CN$US$US
243223872$24322387$2$F$20240829$20240917$20240916$20240926$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-143771$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$55.79$KG$20240926$$CN$PR$PR
243223881$24322388$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145679$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240916$$HP$US$US
243223891$24322389$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146100$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$106.59$KG$20240916$$MD$US$US
243223901$24322390$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146659$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240916$$CN$US$US
243223911$24322391$1$I$$20240827$20240916$20240916$PER$$US-SA-2024SA263495$SANOFI AVENTIS$$$$E$F$Y$$$20240916$$HP$US$US
243223921$24322392$1$I$$20240826$20240916$20240916$PER$$US-SA-2024SA266967$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240916$$MD$US$US
243223931$24322393$1$I$$20240821$20240916$20240916$PER$$US-SA-2024SA263058$SANOFI AVENTIS$$32$YR$A$F$Y$65$KG$20240916$$HP$US$US
243223941$24322394$1$I$20240817$20240906$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005440$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240916$$CN$US$US
243223951$24322395$1$I$$20240821$20240916$20240916$PER$$US-SA-2024SA262705$SANOFI AVENTIS$$$$C$$Y$$$20240916$$CN$US$US
243223961$24322396$1$I$$20240827$20240916$20240916$PER$$US-SA-2024SA266024$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240916$$MD$US$US
243223971$24322397$1$I$$20240905$20240916$20240916$EXP$$GB-ABBVIE-5916176$ABBVIE$$$$$$Y$$$20240916$$MD$GB$GB
243223981$24322398$1$I$20240825$20240903$20240916$20240916$EXP$CN-HENLIUS-24CN017035$CN-Accord-446694$ACCORD$$64$YR$A$F$Y$$$20240916$$MD$CN$CN
243223991$24322399$1$I$20231011$20240909$20240916$20240916$EXP$$BR-UCBSA-2024046985$UCB$$53$YR$$F$Y$60$KG$20240916$$CN$BR$BR
243224001$24322400$1$I$20240828$20240902$20240916$20240916$EXP$$IT-ROCHE-10000072405$ROCHE$$52$YR$A$M$Y$65$KG$20240916$$MD$IT$IT
243224012$24322401$2$F$$20240906$20240916$20240920$EXP$$US-UCBSA-2024046093$UCB$$$$$M$Y$$$20240920$$CN$US$US
243224021$24322402$1$I$$20240908$20240916$20240916$PER$$US-AMGEN-USASP2024182137$AMGEN$Herrera H.; Thomas K.; Cullison C. R. et al.. Impact of TNF-alpha Inhibitors on Emergency Department Visits in Hidradenitis Suppurativa Patients: A Retrospective Cohort Study. Journal of the american academy of Dermatology. 2024;91 (3):AB53$$$$$Y$$$20240916$$HP$US$US
243224031$24322403$1$I$20240904$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024183049$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243224041$24322404$1$I$$20240909$20240916$20240916$EXP$$JP-AMGEN-JPNSP2024182636$AMGEN$$79$YR$E$M$Y$$$20240916$$PH$JP$JP
243224051$24322405$1$I$$20240902$20240916$20240916$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08294$HIKMA$$53$YR$$M$Y$$$20240916$$HP$CA$CA
243224061$24322406$1$I$20090716$20240909$20240916$20240916$EXP$$US-CHEPLA-2024011601$CHEPLAPHARM$$68$YR$$F$Y$$$20240916$$CN$COUNTRY NOT SPECIFIED$US
243224081$24322408$1$I$$20240822$20240916$20240916$PER$$US-SA-2023SA263918$SANOFI AVENTIS$$58$YR$A$M$Y$89.3$KG$20240916$$MD$US$US
243224091$24322409$1$I$$20240906$20240916$20240916$EXP$$GB-CELLTRION INC.-2024GB021853$CELLTRION$$$$$$Y$$$20240916$$CN$GB$GB
243224102$24322410$2$F$20240805$20240918$20240916$20240920$EXP$$NVSC2024ZA181666$NOVARTIS$$59$YR$$F$Y$$$20240920$$HP$ZA$ZA
243224121$24322412$1$I$20240829$20240904$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005299$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240916$$CN$US$US
243224131$24322413$1$I$$20240912$20240916$20240916$EXP$$MG-ROCHE-10000081855$ROCHE$$74$YR$E$F$Y$$$20240916$$CN$MG$MG
243224141$24322414$1$I$20240720$20240902$20240916$20240916$EXP$FR-AFSSAPS-CN2024000838$FR-BAXTER-2024BAX024046$BAXTER$$75$YR$$M$Y$72.3$KG$20240916$$PH$FR$FR
243224151$24322415$1$I$20240713$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A209113$ASTRAZENECA$$78$YR$$M$Y$$$20240916$$CN$US$
243224161$24322416$1$I$20240830$20240909$20240916$20240916$EXP$$CN-AstraZeneca-2024A207985$ASTRAZENECA$$21621$DY$$M$Y$69.4$KG$20240916$$MD$CN$
243224172$24322417$2$F$20240101$20240911$20240916$20240920$EXP$$BE-TEVA-VS-3242155$TEVA$$72$YR$$F$Y$$$20240920$$PH$BE$BE
243224181$24322418$1$I$20240827$20240909$20240916$20240916$EXP$GB-MHRA-MED-202409091414208770-DCQFK$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-002193$IPCA$$$$$$Y$$$20240916$$PH$GB$GB
243224191$24322419$1$I$20231001$20240911$20240916$20240916$EXP$$DE-AstraZeneca-2024A206931$ASTRAZENECA$$$$$F$Y$$$20240916$$MD$DE$
243224201$24322420$1$I$$20240911$20240916$20240916$EXP$$ZA-AstraZeneca-2024A208862$ASTRAZENECA$$68$YR$$M$Y$$$20240916$$CN$ZA$
243224211$24322421$1$I$20240809$20240912$20240916$20240916$EXP$NO-NOMAADVRE-RELISSO-2024-Vnz69e$NO-ROCHE-10000079859$ROCHE$$32$YR$A$F$Y$$$20240916$$MD$NO$NO
243224221$24322422$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184352$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243224231$24322423$1$I$20240817$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A208653$ASTRAZENECA$$31576$DY$$F$Y$$$20240916$$CN$US$
243224241$24322424$1$I$20240904$20240910$20240916$20240916$EXP$$US-AMGEN-USASP2024181337$AMGEN$$67$YR$E$F$Y$$$20240916$$CN$US$US
243224261$24322426$1$I$$20240913$20240916$20240916$PER$$US-AstraZeneca-2024A210250$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243224271$24322427$1$I$20240901$20240910$20240916$20240916$PER$$US-AstraZeneca-2024A206253$ASTRAZENECA$$959$MON$$F$Y$66.7$KG$20240916$$HP$US$
243224281$24322428$1$I$$20240329$20240916$20240916$30DAY$$US-GSK-US2024AMR113407$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$PH$US$US
243224291$24322429$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183030$AMGEN$$$$$M$Y$$$20240916$$CN$US$US
243224301$24322430$1$I$20240727$20240904$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005328$ACADIA PHARMACEUTICALS$$60$YR$$M$Y$$$20240916$$CN$US$US
243224312$24322431$2$F$20240912$20240916$20240916$20240918$PER$$US-AMGEN-USASP2024184234$AMGEN$$75$YR$E$F$Y$$$20240918$$CN$US$US
243224321$24322432$1$I$20240801$20240823$20240916$20240916$PER$$US-SA-2024SA264812$SANOFI AVENTIS$$60$YR$A$M$Y$80.28$KG$20240916$$MD$US$US
243224331$24322433$1$I$20240101$20240821$20240916$20240916$PER$$US-SA-2024SA265815$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240916$$CN$US$US
243224341$24322434$1$I$$20240903$20240916$20240916$EXP$$US-ASTELLAS-2024-AER-004690$ASTELLAS$$$$$M$Y$$$20240916$$CN$US$US
243224351$24322435$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146521$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240916$$HP$US$US
243224361$24322436$1$I$$20240910$20240916$20240916$EXP$$MX-ROCHE-10000080746$ROCHE$$$$A$F$Y$58$KG$20240916$$CN$MX$MX
243224371$24322437$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024111417$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
243224381$24322438$1$I$$20240906$20240916$20240916$EXP$$NL-CELLTRION INC.-2024NL021842$CELLTRION$Borgers J, Van S, Van T, Klobuch S, Seijkens T.T.P, Tobin R.P, et. al.. Clinical presentation of cardiac symptoms following treatment with tumor-infiltrating lymphocytes: diagnostic challenges and lessons learned.. ESMO Open. 2024;9 (2):1-12$$$$$Y$$$20240916$$HP$NL$NL
243224392$24322439$2$F$$20240916$20240916$20240917$30DAY$$CO-UCBSA-2024047212$UCB$$$$$$Y$$$20240917$$CN$CO$CO
243224401$24322440$1$I$$20240904$20240916$20240916$EXP$$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-112030$ZYDUS PHARM$$$$$$Y$$$20240916$$CN$GB$GB
243224411$24322441$1$I$20230902$20240909$20240916$20240916$EXP$ES-AEMPS-1568369$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-112184$ZYDUS PHARM$$$$$$Y$$$20240916$$MD$ES$ES
243224421$24322442$1$I$20240423$20240909$20240916$20240916$EXP$FR-AFSSAPS-DJ2024000935$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112130$ZYDUS PHARM$$$$$$Y$$$20240916$$MD$FR$FR
243224431$24322443$1$I$$20240911$20240916$20240916$EXP$$CA-TAKEDA-2024TUS091158$TAKEDA$$$$$M$Y$$$20240916$$CN$CA$CA
243224443$24322444$3$F$20240901$20240924$20240916$20240927$EXP$$US-ABBVIE-5921592$ABBVIE$$71$YR$$F$Y$90.718$KG$20240927$$CN$US$US
243224451$24322445$1$I$20231223$20240906$20240916$20240916$EXP$$AU-IMMUNOCORE, LTD-2024-IMC-003084$IMMUNOCORE$$$$$$Y$$$20240916$$CN$AU$AU
243224461$24322446$1$I$20240601$20240913$20240916$20240916$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051493$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240916$$CN$US$US
243224471$24322447$1$I$20240827$20240904$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005345$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240916$$CN$US$US
243224481$24322448$1$I$$20240902$20240916$20240916$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08267$HIKMA$$25$YR$$M$Y$72$KG$20240916$$HP$CA$CA
243224491$24322449$1$I$$20240904$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005330$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243224501$24322450$1$I$$20240906$20240916$20240916$EXP$$CA-TOLMAR, INC.-24CA052452$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
243224511$24322451$1$I$$20240906$20240916$20240916$EXP$$CA-TOLMAR, INC.-24CA048268$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
243224521$24322452$1$I$$20240906$20240916$20240916$EXP$$CA-TOLMAR, INC.-24CA052482$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
243224531$24322453$1$I$$20240906$20240916$20240916$EXP$$CA-TOLMAR, INC.-24CA052481$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
243224541$24322454$1$I$$20240907$20240916$20240916$EXP$$CA-TOLMAR, INC.-24CA052485$TOLMAR$$$$$M$Y$$$20240916$$CN$CA$CA
243224551$24322455$1$I$$20240906$20240916$20240916$EXP$$NL-TOLMAR, INC.-24NL052426$TOLMAR$$$$$M$Y$$$20240916$$CN$NL$NL
243224561$24322456$1$I$20230905$20240909$20240916$20240916$EXP$$KR-ROCHE-10000076692$ROCHE$$52$YR$A$F$Y$$$20240916$$HP$KR$KR
243224571$24322457$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183098$AMGEN$$$$$$Y$$$20240916$$PH$US$US
243224581$24322458$1$I$20240815$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008386$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240916$$CN$US$US
243224591$24322459$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007602$ELI LILLY AND CO$$$$A$F$Y$$$20240916$$CN$US$US
243224601$24322460$1$I$20240912$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008235$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240916$$CN$US$US
243224611$24322461$1$I$20240901$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008506$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240916$$CN$US$US
243224621$24322462$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008241$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243224631$24322463$1$I$20240911$20240911$20240916$20240916$PER$$US-JNJFOC-20240934264$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240916$$CN$US$US
243224641$24322464$1$I$$20240911$20240916$20240916$PER$$US-JNJFOC-20240935017$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$US$US
243224651$24322465$1$I$$20240910$20240916$20240916$EXP$$US-JNJFOC-20240925941$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$MD$US$US
243224661$24322466$1$I$20240820$20240826$20240916$20240916$PER$$US-SA-2024SA262234$SANOFI AVENTIS$$26$YR$A$F$Y$111.36$KG$20240916$$HP$US$US
243224671$24322467$1$I$20240101$20240828$20240916$20240916$PER$$US-SA-2024SA265927$SANOFI AVENTIS$$69$YR$E$M$Y$47.27$KG$20240916$$MD$US$US
243224681$24322468$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265670$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240916$$MD$US$US
243224691$24322469$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265759$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240916$$MD$US$US
243224701$24322470$1$I$$20240823$20240916$20240916$PER$$US-SA-2024SA265903$SANOFI AVENTIS$$$$E$F$Y$$$20240916$$MD$US$US
243224711$24322471$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA264092$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240916$$MD$US$US
243224721$24322472$1$I$$20240823$20240916$20240916$PER$$US-SA-2024SA264261$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240916$$MD$US$US
243224731$24322473$1$I$$20240910$20240916$20240916$EXP$$US-AMGEN-USASP2024180913$AMGEN$$77$YR$E$M$Y$$$20240916$$HP$US$US
243224741$24322474$1$I$$20240912$20240916$20240916$EXP$$NVSC2024BR184082$NOVARTIS$$$$$F$Y$$$20240916$$CN$BR$BR
243224751$24322475$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265716$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240916$$HP$US$US
243224761$24322476$1$I$$20240904$20240916$20240916$EXP$$US-Accord-445667$ACCORD$Shirini K, Gautam U, Ahmed H, Meier RP, Drachenberg C, Haririan A. Masked kidney allograft failure after simultaneous liver and kidney transplantation: A case report. Journal of Liver Transplantation. 2024;16:100237$58$YR$A$M$Y$$$20240916$$MD$US$US
243224772$24322477$2$F$20240101$20240911$20240916$20240917$EXP$$JP-ASTELLAS-2024US022943$ASTELLAS$$9$DEC$E$M$Y$$$20240917$$MD$JP$JP
243224781$24322478$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146599$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240916$$MD$US$US
243224791$24322479$1$I$$20240904$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005297$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243224801$24322480$1$I$20240725$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145394$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$63.5$KG$20240916$$CN$US$US
243224831$24322483$1$I$20240508$20240906$20240916$20240916$EXP$$ZA-Vifor (International) Inc.-VIT-2024-08112$VIFOR$$$$$M$Y$$$20240916$$CN$ZA$ZA
243224842$24322484$2$F$$20240913$20240916$20240927$EXP$$ES-ALVOGEN-2024095443$ALVOGEN$Chovi-Trull M, Ballesta-Lopez O, Navarro Buendia GA, Sivera-Mascaro R, Albert- Mari A, Ruiz Caldes MJ, Garcia-Pellicer J, Poveda-Andres JL. Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die. European Journal of Hospital Pharmacy Science + Practice. 2024 Aug 22;0:1-5. doi:10.1136/ejhpharm-2024-004184$53$YR$$M$Y$$$20240927$$MD$ES$ES
243224851$24322485$1$I$20240724$20240904$20240916$20240916$PER$$US-ASTELLAS-2024-AER-004873$ASTELLAS$$55$YR$A$F$Y$$$20240916$$HP$US$US
243224861$24322486$1$I$20240621$20240911$20240916$20240916$EXP$$ID-AstraZeneca-2024A209780$ASTRAZENECA$$20633$DY$$F$Y$$$20240916$$CN$ID$
243224871$24322487$1$I$$20240701$20240916$20240916$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06277$HIKMA$$$$$$Y$$$20240916$$HP$US$US
243224881$24322488$1$I$20240910$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183351$AMGEN$$66$YR$E$F$Y$$$20240916$$CN$US$US
243224891$24322489$1$I$$20240908$20240916$20240916$PER$$US-AMGEN-USASP2024181778$AMGEN$Barve R.; Youssef I.; Kollmeier M.A. et.al.. Node Positive Prostate Cancer Treated with Brachytherapy Boost. International Journal of Radiation Oncology, Biology, Physics. 2024;120 (2):e513$$$$$Y$$$20240916$$HP$US$US
243224901$24322490$1$I$20240701$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024180350$AMGEN$$74$YR$E$M$Y$$$20240916$$MD$US$US
243224911$24322491$1$I$$20240904$20240916$20240916$EXP$$US-Accord-445798$ACCORD$$51$YR$$M$Y$$$20240916$$PH$US$US
243224921$24322492$1$I$20230815$20230913$20240916$20240916$PER$$US-ALVOGEN-2023092136$ALVOGEN$$$$$F$Y$$$20240916$$CN$US$US
243224931$24322493$1$I$$20240821$20240916$20240916$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08043$HIKMA$$$$$$Y$$$20240916$$HP$US$US
243224941$24322494$1$I$$20240903$20240916$20240916$EXP$$US-JNJFOC-20240907508$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$US$US
243224951$24322495$1$I$$20230930$20240916$20240916$PER$$US-ALVOGEN-2023092351$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243224961$24322496$1$I$$20240902$20240916$20240916$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08220$HIKMA$$75$YR$$M$Y$$$20240913$$CN$CA$CA
243224972$24322497$2$F$20240906$20240913$20240916$20240917$EXP$$AU-MYLANLABS-2024M1083179$MYLAN$$66$YR$$F$Y$$$20240917$$HP$AU$AU
243224983$24322498$3$F$20230501$20240924$20240916$20240926$EXP$$AR-MYLANLABS-2024M1061219$MYLAN$$16$YR$$F$Y$$$20240926$$MD$AR$AR
243224991$24322499$1$I$$20240903$20240916$20240916$EXP$$US-AUROBINDO-AUR-APL-2024-044402$AUROBINDO$Hassan AM, Hill H, Donley C, Leonelli C. Potential anaphylactoid reaction to nicardipine. J-Am Coll-Emerg-Physicians-Open. 2024;5:No. 4$52$YR$$M$Y$$$20240916$$HP$US$US
243225003$24322500$3$F$$20240913$20240916$20240925$EXP$$GB-MYLANLABS-2024M1083513$MYLAN$$$$$F$Y$$$20240925$$HP$GB$GB
243225011$24322501$1$I$$20240913$20240916$20240916$PER$$US-HALEON-2196930$Haleon PLC$$$$$$Y$$$20240916$$CN$US$US
243225021$24322502$1$I$$20240823$20240916$20240916$PER$$US-SA-2024SA265920$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240916$$HP$US$US
243225031$24322503$1$I$$20240823$20240916$20240916$PER$$US-SA-2024SA265740$SANOFI AVENTIS$$$$E$F$Y$$$20240916$$MD$US$US
243225041$24322504$1$I$20231001$20231120$20240916$20240916$PER$$US-ALVOGEN-2023092366$ALVOGEN$$$$$F$Y$$$20240916$$CN$US$US
243225051$24322505$1$I$$20231217$20240916$20240916$PER$$US-ALVOGEN-2023092505$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225061$24322506$1$I$20240101$20240213$20240916$20240916$PER$$US-ALVOGEN-2024092866$ALVOGEN$$$$$M$Y$$$20240916$$CN$US$US
243225071$24322507$1$I$$20240905$20240916$20240916$EXP$$US-AMAROX PHARMA-HET2024US03047$HETERO$Zou H, Rau A, Thompson L, Henderson D.. Pancytopenia Concurrent With Metabolic  Encephalopathy. Cureus. 2024;16(8):e67963$81$YR$$F$Y$$$20240916$$MD$US$US
243225081$24322508$1$I$$20240910$20240916$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA079241$SANDOZ$$66$YR$$M$Y$$$20240916$$HP$CA$CA
243225091$24322509$1$I$$20240502$20240916$20240916$PER$$US-ALVOGEN-2024093274$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225111$24322511$1$I$$20240522$20240916$20240916$PER$US-ALVOGEN-2024094412$US-ALVOGEN-2024094412$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225121$24322512$1$I$$20240522$20240916$20240916$PER$US-ALVOGEN-2024094404$US-ALVOGEN-2024094404$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225132$24322513$2$F$$20240923$20240916$20240930$EXP$$US-AUROBINDO-AUR-APL-2024-044596$AUROBINDO$Barkhordarian M, Grijalva M, Lee A, Jarri A, Belyayeva A, Weissman S. Statin-Induced Autoimmune Myopathy: A Diagnostic Challenge in Muscle Weakness. American Journal of Case Reports.. 2024;25:e944261$69$YR$$M$Y$$$20240930$$MD$US$US
243225141$24322514$1$I$20240903$20240909$20240916$20240916$EXP$GB-MHRA-MED-202409091514475910-SNZJF$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-002194$IPCA$$$$$$Y$$$20240916$$PH$GB$GB
243225151$24322515$1$I$$20240522$20240916$20240916$PER$US-ALVOGEN-2024094391$US-ALVOGEN-2024094391$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225161$24322516$1$I$$20240521$20240916$20240916$PER$US-ALVOGEN-2024094333$US-ALVOGEN-2024094333$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225171$24322517$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024111402$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
243225181$24322518$1$I$$20240521$20240916$20240916$PER$US-ALVOGEN-2024094326$US-ALVOGEN-2024094326$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225191$24322519$1$I$$20240522$20240916$20240916$PER$US-ALVOGEN-2024094363$US-ALVOGEN-2024094363$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225201$24322520$1$I$20240801$20240906$20240916$20240916$EXP$$AU-TAKEDA-2024TUS091153$TAKEDA$$83$YR$$M$Y$$$20240916$$MD$AU$AU
243225221$24322522$1$I$20240830$20240905$20240916$20240916$PER$$US-ABBVIE-5916382$ABBVIE$$64$YR$$M$Y$$$20240916$$CN$US$US
243225231$24322523$1$I$20240825$20240912$20240916$20240916$EXP$$US-ROCHE-10000081874$ROCHE$$61$YR$A$F$Y$$$20240916$$CN$US$US
243225241$24322524$1$I$20220101$20240522$20240916$20240916$PER$US-ALVOGEN-2024094349$US-ALVOGEN-2024094349$ALVOGEN$$$$$F$Y$$$20240916$$CN$US$US
243225251$24322525$1$I$20240904$20240905$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005388$ACADIA PHARMACEUTICALS$$87$YR$$M$Y$$$20240916$$CN$US$US
243225261$24322526$1$I$$20240522$20240916$20240916$PER$US-ALVOGEN-2024094344$US-ALVOGEN-2024094344$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225271$24322527$1$I$$20240904$20240916$20240916$EXP$$PL-Accord-445885$ACCORD$Sawosz M, Cieciura T, Perkowska-Ptasinska A, Sikora P, Beck B, Chmura A, et al. Late diagnosis of hyperoxaluria transplantation - case report. Progress Medical Sciences. 2014$65$YR$$F$Y$$$20240916$$HP$PL$PL
243225281$24322528$1$I$$20240521$20240916$20240916$PER$US-ALVOGEN-2024094336$US-ALVOGEN-2024094336$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225291$24322529$1$I$$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146560$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240916$$CN$US$US
243225301$24322530$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145507$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$CN$US$US
243225311$24322531$1$I$$20240523$20240916$20240916$PER$US-ALVOGEN-2024094394$US-ALVOGEN-2024094394$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225321$24322532$1$I$$20240522$20240916$20240916$PER$US-ALVOGEN-2024094341$US-ALVOGEN-2024094341$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225331$24322533$1$I$20240806$20240912$20240916$20240916$EXP$$US-ROCHE-10000081346$ROCHE$$37$YR$A$F$Y$83.91$KG$20240916$$CN$US$US
243225341$24322534$1$I$$20240524$20240916$20240916$PER$US-ALVOGEN-2024094350$US-ALVOGEN-2024094350$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225361$24322536$1$I$$20240610$20240916$20240916$PER$$US-ALVOGEN-2024094777$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225371$24322537$1$I$20220101$20240716$20240916$20240916$PER$$US-ALVOGEN-2024094880$ALVOGEN$$$$$F$Y$$$20240916$$CN$US$US
243225381$24322538$1$I$$20240910$20240916$20240916$PER$$US-ROCHE-10000079190$ROCHE$$$$A$F$Y$$$20240916$$CN$US$US
243225391$24322539$1$I$20240904$20240910$20240916$20240916$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024112581$VIIV$$53$YR$$F$Y$$$20240916$$CN$US$US
243225401$24322540$1$I$$20240719$20240916$20240916$PER$US-ALVOGEN-2024094861$US-ALVOGEN-2024094861$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225411$24322541$1$I$$20240415$20240916$20240916$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01283$AMNEAL$$$$$F$Y$$$20240916$$CN$US$US
243225421$24322542$1$I$20230908$20230915$20240916$20240916$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03297$AMNEAL$$61$YR$$M$Y$$$20240916$$CN$US$US
243225431$24322543$1$I$$20230914$20240916$20240916$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03270$AMNEAL$$$$$F$Y$$$20240916$$PH$US$US
243225441$24322544$1$I$$20240610$20240916$20240916$PER$US-ALVOGEN-2024094585$US-ALVOGEN-2024094585$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225451$24322545$1$I$$20240912$20240916$20240916$EXP$$CA-GILEAD-2024-0686482$GILEAD$$$$A$M$Y$$$20240916$$CN$CA$CA
243225461$24322546$1$I$$20240823$20240916$20240916$PER$$US-ALVOGEN-2024095159$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225471$24322547$1$I$$20240911$20240916$20240916$PER$$NVSC2024US184001$NOVARTIS$$$$$$Y$$$20240916$$CN$US$US
243225482$24322548$2$F$$20240912$20240916$20240920$PER$$US-AMGEN-USASP2024183400$AMGEN$$$$$$Y$$$20240919$$MD$US$US
243225491$24322549$1$I$20240911$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183229$AMGEN$$20$YR$A$F$Y$$$20240916$$CN$US$US
243225501$24322550$1$I$$20240826$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07829$LUPIN$$19$YR$$F$Y$61.224$KG$20240916$$CN$US$US
243225511$24322551$1$I$$20240824$20240916$20240916$PER$$US-ALVOGEN-2024095185$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225531$24322553$1$I$20190601$20240908$20240916$20240916$EXP$PL-URPL-2-600-2019$PL-LEO Pharma-373351$LEO PHARM$$33$YR$$M$Y$$$20240916$$CN$PL$PL
243225541$24322554$1$I$$20240726$20240916$20240916$PER$$US-ALVOGEN-2024095220$ALVOGEN$$$$$F$Y$$$20240916$$CN$US$US
243225551$24322555$1$I$$20240726$20240916$20240916$PER$US-ALVOGEN-2024094851$US-ALVOGEN-2024094851$ALVOGEN$$$$$$Y$$$20240916$$CN$US$US
243225561$24322556$1$I$20240101$20240729$20240916$20240916$PER$$US-ALVOGEN-2024094941$ALVOGEN$$$$$M$Y$$$20240916$$CN$US$US
243225571$24322557$1$I$$20240910$20240916$20240916$PER$$US-ROCHE-10000078616$ROCHE$$70$YR$E$F$Y$$$20240916$$HP$US$US
243225581$24322558$1$I$20240101$20240730$20240916$20240916$PER$$US-ALVOGEN-2024095007$ALVOGEN$$13$YR$$F$Y$$$20240916$$CN$US$US
243225591$24322559$1$I$$20240904$20240916$20240916$EXP$$CA-AUROBINDO-AUR-APL-2024-045234$AUROBINDO$$51$YR$$F$Y$$$20240916$$CN$CA$CA
243225601$24322560$1$I$20240909$20240910$20240916$20240916$EXP$$CA-ABBVIE-5917900$ABBVIE$$54$YR$$M$Y$$$20240916$$CN$CA$CA
243225612$24322561$2$F$20240830$20240919$20240916$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005377$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240927$$CN$US$US
243225621$24322562$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5922132$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243225631$24322563$1$I$$20240904$20240916$20240916$EXP$GB-MHRA-MED-202409040947158170-NQVRW$GB-Accord-445177$ACCORD$$$$$F$Y$$$20240916$$PH$GB$GB
243225641$24322564$1$I$20240828$20240911$20240916$20240916$EXP$$GB-ABBVIE-5921733$ABBVIE$$$$A$F$Y$$$20240916$$CN$GB$GB
243225651$24322565$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5920332$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243225661$24322566$1$I$$20240906$20240916$20240916$EXP$$ES-AMAROX PHARMA-AMR2024ES03059$HETERO$Laserna PA, Fajardo MC, De Victoria Carazo JM, Fidel MV, Raquel RF. Don^t forget the drugs. An  atypical case of renopulmonary syndrome in an adult male. European Journal of Case Reports  in Internal Medicine. 2024;11(1):1018$69$YR$$M$Y$$$20240916$$HP$ES$ES
243225671$24322567$1$I$$20240904$20240916$20240916$EXP$$PL-AUROBINDO-AUR-APL-2024-044569$AUROBINDO$Nizinska. Lithium intoxication in patients using angiotensin II receptor antagonists and hydrochlorothiazide: two case reports. FARMAKOTERAPIA W PSYCHIATRII I NEUROLOGII.$69$YR$$F$Y$$$20240916$$MD$PL$PL
243225681$24322568$1$I$$20240911$20240916$20240916$EXP$$CA-AstraZeneca-2024A209861$ASTRAZENECA$$47$YR$$F$Y$$$20240916$$MD$CA$
243225701$24322570$1$I$$20240910$20240916$20240916$EXP$$US-JNJFOC-20240924773$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$CN$US$US
243225711$24322571$1$I$$20240906$20240916$20240916$EXP$$CA-CELLTRION INC.-2024CA019075$CELLTRION$$$$$$Y$$$20240916$$CN$CA$CA
243225721$24322572$1$I$$20240828$20240916$20240916$PER$$US-SA-2024SA266391$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240916$$HP$US$US
243225731$24322573$1$I$$20240904$20240916$20240916$EXP$$CA-AUROBINDO-AUR-APL-2019-044256$AUROBINDO$Wu G, Chan M, Sugar L. PEMETREXED INDUCED INTERSTITIAL NEPHRITIS AMONG PATIENTS WITH METASTATIC NON-SMALL CELL ADENOCARCINOMA OF THE LUNGS (NSCLC). Kidney International Reports. 2019;4 (Suppl 7):S403$63$YR$$F$Y$$$20240916$$HP$CA$CA
243225741$24322574$1$I$$20240904$20240916$20240916$EXP$$ES-AUROBINDO-AUR-APL-2017-44075$AUROBINDO$Sanchez VG, Pedregosa LE, Martos ML, Cano VR, Gonzalez ER, Mendoza AE, et al.. Subacute polyneuropathy by pharmacological toxicity. 12th European Paediatric Neurology Society Congress. Eur J Paediatr Neurol. 2017;21 (Suppl 1):e232-e233$6$YR$$F$Y$$$20240916$$MD$ES$ES
243225751$24322575$1$I$$20240902$20240916$20240916$EXP$$US-PBT-009683$PANACEA BIOTEC$Au-Yeung NM, Regennitter NS, Stepherson J, Seele J, Rosenblatt E, Carter W. Folate Deficiency and Medication-Induced Severe Pancytopenia in a Bilateral Lung Transplantee. Cureus. 2024 Jul 30;16(7):e65780. doi: 10.7759/cureus.65780.$74$YR$E$M$Y$$$20240916$$HP$US$US
243225762$24322576$2$F$20240801$20240903$20240916$20240924$PER$$US-SA-2024SA266004$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240925$$CN$US$US
243225771$24322577$1$I$20240101$20240904$20240916$20240916$PER$$US-SA-2024SA263211$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240916$$MD$US$US
243225781$24322578$1$I$$20240821$20240916$20240916$PER$$US-SA-2024SA266692$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240916$$CN$US$US
243225791$24322579$1$I$20240904$20240905$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005356$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20240916$$CN$US$US
243225801$24322580$1$I$$20240823$20240916$20240916$PER$$US-SA-2024SA265853$SANOFI AVENTIS$$$$E$F$Y$$$20240916$$MD$US$US
243225811$24322581$1$I$20100101$20240904$20240916$20240916$EXP$$FR-AUROBINDO-AUR-APL-2024-044781$AUROBINDO$Zehou O, Leibler C, Arnault J, Sayegh J, Montaudie H, Remy P et al.. Ipilimumab for the treatment of advanced melanoma in six kidney transplant patients. American journal of transplantation.. 2018;18 (12):3065-71$57$YR$$F$Y$$$20240916$$HP$FR$FR
243225821$24322582$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA264937$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240916$$MD$US$US
243225832$24322583$2$F$20230727$20240920$20240916$20240924$PER$$US-SA-2024SA264819$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240924$$HP$US$US
243225841$24322584$1$I$20240101$20240911$20240916$20240916$PER$$US-SA-2024SA265715$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240916$$MD$US$US
243225851$24322585$1$I$20240820$20240903$20240916$20240916$PER$$US-SA-2024SA266988$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240916$$CN$US$US
243225862$24322586$2$F$20240403$20240916$20240916$20240926$EXP$$DE-ROCHE-10000081770$ROCHE$$42$YR$A$F$Y$$$20240926$$MD$DE$DE
243225871$24322587$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146591$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240916$$HP$US$US
243225881$24322588$1$I$20240101$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146551$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240916$$MD$US$US
243225891$24322589$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146833$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240916$$CN$US$US
243225901$24322590$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146261$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240916$$CN$US$US
243225911$24322591$1$I$$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145081$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$87.5$KG$20240916$$MD$US$US
243225921$24322592$1$I$20240801$20240905$20240916$20240916$EXP$$US-UCBSA-2024045808$UCB$$57$YR$$M$Y$$$20240916$$HP$US$US
243225931$24322593$1$I$$20240904$20240916$20240916$EXP$$US-Accord-446304$ACCORD$$45$YR$A$M$Y$$$20240916$$MD$US$US
243225941$24322594$1$I$$20240909$20240916$20240916$EXP$$JP-AMGEN-JPNSP2024180395$AMGEN$Kashida R.; Watanebe S.; Nakajima S. et al.. A case of suspected immune related adverse event (irAE) - associated primary adrenal insufficiency one year or more after the end of administration of an immune checkpoint inhibitor. Japan Lung Cancer society. 2024;18$81$YR$E$M$Y$$$20240916$$HP$JP$JP
243225951$24322595$1$I$20240501$20240909$20240916$20240916$EXP$DK-DKMA-30737895$DK-TEVA-VS-3241907$TEVA$$61$YR$$M$Y$$$20240916$$MD$DK$DK
243225961$24322596$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5920061$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243225971$24322597$1$I$$20240902$20240916$20240916$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08297$HIKMA$$71$YR$$M$Y$$$20240916$$HP$CA$CA
243225981$24322598$1$I$$20240903$20240916$20240916$PER$$US-ASTELLAS-2024-AER-004801$ASTELLAS$$$$$F$Y$$$20240916$$MD$US$US
243225991$24322599$1$I$20210710$20240906$20240916$20240916$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011643$STRIDES$Zheng L, Zhang F-J.. Adult rhabdomyosarcoma combined with acute myeloid leukemia: A case report.. World-J-Clin-Cases. 2024;12 (3):582-586$36$YR$$F$Y$$$20240916$$MD$CN$CN
243226001$24322600$1$I$$20240826$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08849$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243226011$24322601$1$I$$20240909$20240916$20240916$EXP$$US-GSK-US2024111975$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$US$US
243226021$24322602$1$I$$20240909$20240916$20240916$PER$$US-JNJFOC-20240924133$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$US$US
243226042$24322604$2$F$20240909$20240918$20240916$20240924$PER$$US-JNJFOC-20240921815$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$MD$US$US
243226061$24322606$1$I$$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024181325$AMGEN$$$$$$Y$$$20240916$$CN$US$US
243226071$24322607$1$I$$20240904$20240916$20240916$EXP$$NL-AUROBINDO-AUR-APL-2024-044589$AUROBINDO$$59$YR$$M$Y$118$KG$20240916$$CN$NL$NL
243226081$24322608$1$I$$20240909$20240916$20240916$EXP$$RO-AMGEN-ROUSP2024180431$AMGEN$Brusnic O.; Onisor D.; Mocan S. et al.. Cytomegalovirus in Ulcerative Colitis: An Unwanted Guest. Pathogens. 2024;13 (8):1-15$41$YR$A$M$Y$$$20240916$$HP$RO$RO
243226101$24322610$1$I$20230101$20240906$20240916$20240916$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011652$STRIDES$Zhang F-J, Fang W-J, Zhang C-J.. Monomorphic epitheliotropic intestinal T-cell lymphoma with bone marrow involved: A case report.. World-J-Clin-Cases. 2024;12:814-819$52$YR$$F$Y$$$20240916$$HP$CN$CN
243226131$24322613$1$I$20240829$20240909$20240916$20240916$EXP$IT-MINISAL02-1000924$IT-TEVA-VS-3241854$TEVA$$56$YR$$M$Y$$$20240916$$PH$IT$IT
243226141$24322614$1$I$20240831$20240904$20240916$20240916$EXP$$DE-AUROBINDO-AUR-APL-2024-044506$AUROBINDO$$73$YR$$F$Y$85$KG$20240916$$MD$DE$DE
243226151$24322615$1$I$$20240910$20240916$20240916$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024113107$VIIV$$4$DEC$$$Y$$$20240916$$HP$US$US
243226162$24322616$2$F$$20240916$20240916$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-045020$AUROBINDO$Charbit-Henrion F, Lacaille F, McKiernan P, Girard M, de Lonlay P, Valayannopoulos V et al. Early and late complications after liver transplantation for Propionic acidemia in children: a two centers study. American journal of transplantation.. 2015;1-6$6$YR$$F$Y$$$20240926$$HP$FR$FR
243226171$24322617$1$I$20240909$20240912$20240916$20240916$EXP$$JP-PHARMAESSENTIA CORPORATION-JP-2024-PEC-004522$PHARMAESSENTIA$$78$YR$$M$Y$$$20240916$$HP$JP$JP
243226182$24322618$2$F$$20240920$20240916$20240926$EXP$$US-HETERO-HET2024US03110$HETERO$$$$$M$Y$117.93$KG$20240926$$CN$US$US
243226191$24322619$1$I$$20240906$20240916$20240916$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011661$STRIDES$Desbuissons G, Ngango L, Baudeau C, Fournier P.. Successful twin pregnancy in a woman undergoing alternate diurnal and nocturnal hemodialysis.. Hemodial-Int. 2024;28 (2):233-235$31$YR$$F$Y$$$20240916$$HP$FR$FR
243226201$24322620$1$I$$20240909$20240916$20240916$PER$$US-ABBVIE-5918798$ABBVIE$$$$$$Y$$$20240916$$CN$US$US
243226211$24322621$1$I$$20240826$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08590$LUPIN$$$$$F$Y$$$20240916$$CN$US$US
243226231$24322623$1$I$$20240813$20240911$20240911$DIR$FDA-CDER-CTU-2024-62401$$FDA-CTU$$$$$M$N$70$KG$20240813$Y$$US$
243226251$24322625$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145257$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$PH$US$US
243226261$24322626$1$I$20240912$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146822$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240916$$CN$US$US
243226271$24322627$1$I$$20240902$20240916$20240916$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08217$HIKMA$$72$YR$$M$Y$171$KG$20240909$$HP$CA$CA
243226281$24322628$1$I$$20240910$20240916$20240916$EXP$$US-SA-2024SA265964$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240916$$MD$US$US
243226291$24322629$1$I$20240801$20240906$20240916$20240916$EXP$$CO-JNJFOC-20240922034$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240916$$HP$CO$CO
243226301$24322630$1$I$20240801$20240911$20240916$20240916$EXP$$US-SA-2024SA266300$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240916$$HP$US$US
243226311$24322631$1$I$20240819$20240905$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005348$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240916$$CN$US$US
243226321$24322632$1$I$20240911$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024183904$AMGEN$$73$YR$E$F$Y$$$20240916$$CN$US$US
243226331$24322633$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183012$AMGEN$$$$$F$Y$$$20240916$$CN$US$US
243226353$24322635$3$F$20240101$20240917$20240916$20240925$EXP$$US-AMGEN-USASP2024180402$AMGEN$$76$YR$E$F$Y$$$20240924$$CN$US$US
243226361$24322636$1$I$$20240906$20240916$20240916$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011662$STRIDES$Desbuissons G, Ngango L, Baudeau C, Fournier P.. Successful twin pregnancy in a woman undergoing alternate diurnal and nocturnal hemodialysis.. Hemodial-Int. 2024;28 (2):233-235$$$$F$Y$$$20240916$$HP$FR$FR
243226371$24322637$1$I$$20240910$20240916$20240916$EXP$$RE-AstraZeneca-2024A209794$ASTRAZENECA$$67$YR$$M$Y$$$20240916$$MD$FR$
243226381$24322638$1$I$$20240906$20240916$20240916$EXP$$US-GSK-US2024111401$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$US$US
243226411$24322641$1$I$$20240906$20240916$20240916$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011663$STRIDES$Desbuissons G, Ngango L, Baudeau C, Fournier P.. Successful twin pregnancy in a woman undergoing alternate diurnal and nocturnal hemodialysis.. Hemodial-Int. 2024;28 (2):233-235$$$$M$Y$$$20240916$$HP$FR$FR
243226421$24322642$1$I$$20240826$20240916$20240916$PER$$US-SA-2024SA263674$SANOFI AVENTIS$$$$A$M$Y$108.86$KG$20240916$$MD$US$US
243226431$24322643$1$I$$20240823$20240916$20240916$PER$$US-SA-2024SA266402$SANOFI AVENTIS$$4$YR$C$M$Y$13.3$KG$20240916$$MD$US$US
243226441$24322644$1$I$20240101$20240906$20240916$20240916$PER$$US-SA-2024SA265655$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240916$$MD$US$US
243226451$24322645$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA264882$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240916$$MD$US$US
243226461$24322646$1$I$$20240826$20240916$20240916$PER$$US-SA-2024SA266068$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
243226482$24322648$2$F$$20240924$20240916$20240925$EXP$$PT-SANDOZ INC.-PHHY2018PT187175$SANDOZ$$39$YR$$F$Y$$$20240925$$MD$PT$PT
243226492$24322649$2$F$20240129$20240913$20240916$20240917$EXP$$US-ROCHE-10000082417$ROCHE$$62$YR$A$F$Y$$$20240917$$CN$US$US
243226501$24322650$1$I$$20240820$20240916$20240916$PER$$US-SA-2024SA266834$SANOFI AVENTIS$$$$A$M$Y$70.5$KG$20240916$$MD$US$US
243226511$24322651$1$I$20240814$20240825$20240916$20240916$PER$$US-SA-2024SA265439$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240916$$MD$US$US
243226521$24322652$1$I$20240101$20240820$20240916$20240916$PER$$US-SA-2024SA264164$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240916$$MD$US$US
243226531$24322653$1$I$20240801$20240910$20240916$20240916$PER$$US-SA-2024SA265659$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240916$$HP$US$US
243226541$24322654$1$I$20240701$20240910$20240916$20240916$PER$$US-SA-2024SA265732$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240916$$MD$US$US
243226551$24322655$1$I$$20240904$20240916$20240916$EXP$$US-ASTELLAS-2024-AER-005296$ASTELLAS$$$$$M$Y$$$20240916$$MD$US$US
243226571$24322657$1$I$$20240910$20240916$20240916$EXP$$GB-AMGEN-GBRSP2024181092$AMGEN$$$$$M$Y$$$20240916$$CN$GB$GB
243226581$24322658$1$I$20240905$20240909$20240916$20240916$EXP$$CN-AMGEN-CHNSP2024181793$AMGEN$$62$YR$A$M$Y$$$20240916$$HP$CN$CN
243226591$24322659$1$I$$20240908$20240916$20240916$EXP$$TR-AMGEN-TURSP2024180459$AMGEN$Demir O.; Yondem O. Z.; Doganay M. et al.. A Neglected Disease: Hidradenitis Suppurativa a Rare Cause of Amyloidosis Complicated With Sepsis and Renal Failure: A Case Report. Case Reports in Critical Care. 2024;1-3$53$YR$A$M$Y$$$20240916$$HP$TR$TR
243226601$24322660$1$I$20240901$20240901$20240916$20240916$PER$$US-JNJFOC-20240907218$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20240916$$CN$US$US
243226611$24322661$1$I$$20240904$20240916$20240916$EXP$$PT-Accord-446253$ACCORD$Ferreira D, Neves AL, Martins A, Guimaraes A, Xu J, Ferreira-Pinto MJ, et al. EP-059 - Infiltrative Lesion Of The CNS In A Renal Transplant Patient: The Diagnostic Journey To Nocardiosis. Sinapse. Dec 2023;23(Supplement 1).$30$YR$A$M$Y$$$20240916$$HP$PT$PT
243226621$24322662$1$I$20240819$20240910$20240916$20240916$EXP$FR-AFSSAPS-LY2024001350$FR-CHEPLA-2024011715$CHEPLAPHARM$$55$YR$$F$Y$$$20240916$$HP$COUNTRY NOT SPECIFIED$FR
243226631$24322663$1$I$$20240902$20240916$20240916$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08268$HIKMA$$56$YR$$M$Y$109$KG$20240911$$HP$CA$CA
243226641$24322664$1$I$$20240906$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143697$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240916$$HP$US$US
243226651$24322665$1$I$20240819$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024181676$AMGEN$$66$YR$E$F$Y$$$20240916$$HP$US$US
243226661$24322666$1$I$$20240904$20240916$20240916$EXP$$DE-AUROBINDO-AUR-APL-2024-044629$AUROBINDO$$75$YR$$F$Y$$$20240916$$CN$DE$DE
243226671$24322667$1$I$20240701$20240905$20240916$20240916$EXP$$IT-AUROBINDO-AUR-APL-2024-044799$AUROBINDO$$77$YR$$M$Y$$$20240916$$MD$IT$IT
243226681$24322668$1$I$20240815$20240905$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005333$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240916$$CN$US$US
243226691$24322669$1$I$$20240906$20240916$20240916$PER$$US-TAKEDA-2024TUS090001$TAKEDA$$$$$F$Y$88$KG$20240916$$MD$US$US
243226702$24322670$2$F$$20240925$20240916$20240930$EXP$$IN-VANTIVE-2024VAN019667$Vantive US Healthcare$$69$YR$$F$Y$$$20240930$$CN$IN$IN
243226711$24322671$1$I$20240909$20240909$20240916$20240916$EXP$$US-VANTIVE-2024VAN019624$Vantive US Healthcare$$$$$F$Y$$$20240916$$CN$US$US
243226721$24322672$1$I$20240907$20240907$20240916$20240916$EXP$$CN-VANTIVE-2024VAN019647$Vantive US Healthcare$$53$YR$$F$Y$$$20240916$$CN$CN$CN
243226731$24322673$1$I$$20240909$20240916$20240916$EXP$$KR-VANTIVE-2024VAN019650$Vantive US Healthcare$$$$$M$Y$$$20240916$$HP$KR$KR
243226741$24322674$1$I$20240908$20240908$20240916$20240916$EXP$$KR-VANTIVE-2024VAN019683$Vantive US Healthcare$$22$YR$$F$Y$$$20240916$$CN$KR$KR
243226751$24322675$1$I$$20240909$20240916$20240916$EXP$$IN-VANTIVE-2024BAX011193$Vantive US Healthcare$$58$YR$$M$Y$$$20240916$$CN$IN$IN
243226761$24322676$1$I$20240826$20240906$20240916$20240916$EXP$$CL-VANTIVE-2024VAN019451$Vantive US Healthcare$$33$YR$$F$Y$58$KG$20240916$$HP$CL$CL
243226771$24322677$1$I$20240801$20240906$20240916$20240916$EXP$$US-GSK-US2024111229$GLAXOSMITHKLINE$$29$YR$$F$Y$$$20240916$$CN$US$US
243226781$24322678$1$I$$20240904$20240916$20240916$EXP$$GB-MYLANLABS-2024M1082352$MYLAN$Hong L, Witton LD, Jolly EC. Pneumocystis jirovecii pneumonia presenting with severe, refractory hypercalcaemia in an immunosuppressed renal transplant patient: Review of the literature and novel biochemical insights. Clin-Med-London 2024; 24 (1): 1-3.$48$YR$$F$Y$$$20240916$$HP$GB$GB
243226791$24322679$1$I$$20240904$20240916$20240916$EXP$$US-MYLANLABS-2024M1082519$MYLAN$Thaliath L, Berg H, Edmund J. AML-101 Bone Marrow Necrosis in APML. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl. 1) S293-S294 abstr. AML-101.$49$YR$$M$Y$$$20240916$$MD$US$US
243226801$24322680$1$I$$20240902$20240916$20240916$EXP$$DK-MYLANLABS-2024M1082291$MYLAN$Plaehn G, Fuglsang T, Hindersson P, Breindahl T. Adverse effects from counterfeit and mislabeled medicine containing tapentadol and carisoprodol. Clin-Case-Rep 2024; 12 (8): 1-6.$16$YR$$$Y$$$20240916$$HP$DK$DK
243226811$24322681$1$I$$20240912$20240916$20240916$EXP$$IN-ROCHE-10000081901$ROCHE$$80$YR$E$M$Y$$$20240916$$CN$IN$IN
243226821$24322682$1$I$$20240908$20240916$20240916$EXP$$IL-EMD Serono-2024048607$EMD SERONO INC$$77$YR$E$F$Y$$$20240916$$CN$IL$IL
243226831$24322683$1$I$$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005658$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240916$$CN$US$US
243226841$24322684$1$I$20240912$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008303$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240916$$CN$US$US
243226851$24322685$1$I$$20240905$20240916$20240916$EXP$$US-MYLANLABS-2024M1082871$MYLAN$Goel AR, Sylvester C, Avidan OR, Gilvaz VJ. Psoriasis and psoriatic arthritis following use of dostarlimab for endometrial cancer. BMJ-Case-Rep 2024; 17 (8).$6$DEC$$F$Y$$$20240916$$HP$US$US
243226861$24322686$1$I$$20240905$20240916$20240916$EXP$$PL-MYLANLABS-2024M1082534$MYLAN$Kamil Mozdzen , Agnieszka Murawska , Julia Hypnar, Edward P?dziwiatr, Jakub Pospiech , Magdalena Bosak. Status epilepticus in pregnant patients - two case reports and  literature review.. POLISH NEUROLOGY REVIEW. 2024;20(2):115-128$28$YR$$F$Y$$$20240916$$MD$PL$PL
243226871$24322687$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008426$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240916$$CN$US$US
243226881$24322688$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008315$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240916$$CN$US$US
243226891$24322689$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008436$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240916$$CN$US$US
243226901$24322690$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008231$ELI LILLY AND CO$$18$YR$A$F$Y$$$20240916$$CN$US$US
243226911$24322691$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202408016669$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240916$$CN$US$US
243226921$24322692$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008418$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240916$$CN$US$US
243226941$24322694$1$I$20240801$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008456$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240916$$CN$US$US
243226951$24322695$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007435$ELI LILLY AND CO$$$$$M$Y$$$20240916$$CN$US$US
243226962$24322696$2$F$$20240910$20240916$20240917$PER$$US-JNJFOC-20240922365$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243226971$24322697$1$I$20240905$20240905$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005329$ACADIA PHARMACEUTICALS$$3$YR$$F$Y$$$20240916$$CN$US$US
243226981$24322698$1$I$20201201$20240909$20240916$20240916$EXP$$RO-AMGEN-ROUSP2024181400$AMGEN$$48$YR$A$$Y$$$20240916$$MD$RO$RO
243226991$24322699$1$I$20240831$20240911$20240916$20240916$EXP$$BE-AUROBINDO-AUR-APL-2024-045542$AUROBINDO$$22$YR$$F$Y$$$20240916$$PH$BE$BE
243227001$24322700$1$I$$20210827$20240916$20240916$PER$$NVSC2021US318488$NOVARTIS$$$$$$Y$$$20240916$$PH$US$US
243227011$24322701$1$I$20240705$20240905$20240916$20240916$EXP$$US-ASTELLAS-2024-AER-005280$ASTELLAS$$83$YR$E$$Y$$$20240916$$MD$US$US
243227021$24322702$1$I$$20240904$20240916$20240916$EXP$$SE-Accord-446112$ACCORD$Toporski J, Krol L, Dykes J, Hakansson Y, Pronk C, Turkiewicz D. The combination of clofarabine, etoposide, and cyclophosphamide shows limited efficacy as a bridge to transplant for children with refractory acute leukemia: results of a monitored prospective study. Pediatric Hematology and Oncology. 2020;1-11.$10$YR$C$M$Y$$$20240916$$MD$SE$SE
243227031$24322703$1$I$20240808$20240909$20240916$20240916$30DAY$$IT-SANDOZ INC.-SDZ2024IT079603$SANDOZ$$14$YR$$F$Y$54$KG$20240916$$CN$IT$IT
243227041$24322704$1$I$$20240903$20240916$20240916$EXP$$US-MACLEODS PHARMA-MAC2024049264$MACLEODS$$$$$$Y$$$20240916$$CN$US$US
243227051$24322705$1$I$$20240913$20240916$20240916$EXP$FR-AFSSAPS-AVPO2024000178$FR-SANDOZ INC.-SDZ2024FR080113$SANDOZ$$55$YR$$F$Y$$$20240916$$PH$FR$FR
243227061$24322706$1$I$$20240904$20240916$20240916$EXP$$ZA-MACLEODS PHARMA-MAC2024049284$MACLEODS$$$$$$Y$$$20240916$$CN$ZA$ZA
243227072$24322707$2$F$$20240919$20240916$20240927$EXP$$JP-TEVA-VS-3242181$TEVA$Oguni K, Fukushima S, Hagiya H, Kato A, Suyama A, Iwata T, et al. Cryptococcal prostatitis in an immunocompromised patient with tocilizumab and glucocorticoid therapy: A case report. J-Infect-Chemother 2024;.; Oguni K, Fukushima S, Hagiya H, Kato A, Suyama A, Iwata T, et al. Cryptococcal prostatitis in an immunocompromised patient with tocilizumab and glucocorticoid therapy: A case report. J-Infect-Chemother 2024;.; Oguni K, Fukushima S, Hagiya H, Kato A, Suyama A, Iwata T, et al. Cryptococca...$72$YR$$M$Y$$$20240927$$HP$JP$JP
243227081$24322708$1$I$$20240903$20240916$20240916$EXP$GB-MHRA-MED-202409031839459090-DFGPZ$GB-MACLEODS PHARMA-MAC2024049276$MACLEODS$$$$$$Y$$$20240916$$CN$GB$GB
243227091$24322709$1$I$$20240903$20240916$20240916$EXP$GB-MHRA-MED-202409020906128010-ZDPHQ$GB-MACLEODS PHARMA-MAC2024049273$MACLEODS$$$$$$Y$$$20240916$$HP$GB$GB
243227101$24322710$1$I$20231201$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63231$$FDA-CTU$$66$YR$$M$N$$$20240913$N$HP$US$
243227111$24322711$1$I$$20240208$20240916$20240916$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00456$AMNEAL$$$$$F$Y$$$20240916$$HP$US$US
243227121$24322712$1$I$20240812$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63133$$FDA-CTU$$50$YR$$M$N$$$20240913$N$HP$US$
243227131$24322713$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63205$$FDA-CTU$$43$YR$$F$N$$$20240913$N$$US$
243227141$24322714$1$I$20240501$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63204$$FDA-CTU$$77$YR$$F$N$$$20240913$N$HP$US$
243227151$24322715$1$I$$20230925$20240916$20240916$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03579$AMNEAL$$$$$M$Y$$$20240916$$CN$US$US
243227161$24322716$1$I$$20240131$20240916$20240916$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00364$AMNEAL$$$$$M$Y$$$20240916$$CN$US$US
243227172$24322717$2$F$20240910$20240920$20240916$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005423$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240927$$CN$US$US
243227181$24322718$1$I$20240806$20240906$20240916$20240916$30DAY$$US-GSK-US2024111270$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240916$$CN$US$US
243227201$24322720$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63224$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243227211$24322721$1$I$20240907$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024179840$AMGEN$$42$YR$A$F$Y$$$20240916$$CN$US$US
243227221$24322722$1$I$$20240903$20240916$20240916$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07752$HIKMA$$57$YR$$M$Y$$$20240916$$CN$US$US
243227231$24322723$1$I$20220520$20240904$20240916$20240916$EXP$FR-AFSSAPS-NC2024001028$FR-Accord-445720$ACCORD$$66$YR$E$M$Y$100$KG$20240916$$MD$FR$FR
243227241$24322724$1$I$$20240905$20240913$20240913$DIR$FDA-CDER-CTU-2024-63186$$FDA-CTU$$$$$F$N$$$20240905$N$HP$US$
243227251$24322725$1$I$$20210716$20240916$20240916$PER$$NVSC2021US318486$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243227261$24322726$1$I$$20240909$20240916$20240916$EXP$$CN-ROCHE-10000077359$ROCHE$$74$YR$E$F$Y$$$20240916$$MD$CN$CN
243227271$24322727$1$I$$20240911$20240916$20240916$PER$$US-ABBVIE-5921904$ABBVIE$$$$$$Y$$$20240916$$CN$US$US
243227282$24322728$2$F$$20240909$20240916$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08598$LUPIN$$$$$F$Y$63.492$KG$20240924$$CN$US$US
243227291$24322729$1$I$20210915$20240910$20240916$20240916$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011659$STRIDES$Whitledge JD, Watson CJ, Burns MM.. Chronic Doxepin Toxicity Masquerading as Epilepsy in a 10-Year-Old Boy.. Journal of Medical Toxicology. 2023;19:405-410$10$YR$$M$Y$68$KG$20240916$$HP$US$US
243227311$24322731$1$I$$20240827$20240916$20240916$PER$$US-SERVIER-S24011045$SERVIER$$$$$$Y$$$20240916$$HP$US$US
243227341$24322734$1$I$20240101$20240910$20240916$20240916$EXP$SE-SEMPA-2024-006460$SE-TEVA-VS-3242642$TEVA$$70$YR$$F$Y$60$KG$20240916$$MD$SE$SE
243227351$24322735$1$I$$20240911$20240916$20240916$EXP$$NVSC2024US133876$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
243227361$24322736$1$I$20240418$20240827$20240916$20240916$PER$$US-009507513-2408USA009433$MERCK$$$$A$M$Y$$$20240916$$CN$US$US
243227381$24322738$1$I$$20240911$20240916$20240916$PER$$NVSC2024US184326$NOVARTIS$$$$$$Y$$$20240916$$CN$US$US
243227391$24322739$1$I$$20240905$20240916$20240916$EXP$$FR-AUROBINDO-AUR-APL-2024-045039$AUROBINDO$$27$YR$$M$Y$$$20240916$$CN$FR$FR
243227401$24322740$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63146$$FDA-CTU$$33$YR$$M$N$127.01$KG$20240913$N$$US$
243227413$24322741$3$F$$20240917$20240916$20240919$EXP$$CA-JNJFOC-20240927268$JOHNSON AND JOHNSON$$43$YR$A$F$Y$96$KG$20240919$$HP$CA$CA
243227421$24322742$1$I$20240907$20240907$20240916$20240916$EXP$$US-ABBVIE-5923413$ABBVIE$$81$YR$$F$Y$$$20240916$$CN$US$US
243227432$24322743$2$F$20240905$20240906$20240916$20240925$30DAY$$US-JNJFOC-20240917140$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240925$$CN$US$US
243227441$24322744$1$I$$20240909$20240913$20240913$DIR$FDA-CDER-CTU-2024-63171$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243227451$24322745$1$I$20240301$20240909$20240916$20240916$EXP$FR-AFSSAPS-RN2024000965$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112126$ZYDUS PHARM$$$$$$Y$$$20240916$$MD$FR$FR
243227461$24322746$1$I$20240601$20240909$20240916$20240916$EXP$FR-AFSSAPS-LM2024000485$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112101$ZYDUS PHARM$$$$$$Y$$$20240916$$MD$FR$FR
243227471$24322747$1$I$20231001$20240909$20240916$20240916$EXP$FR-AFSSAPS-TS2024000962$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112128$ZYDUS PHARM$$$$$$Y$$$20240916$$MD$FR$FR
243227481$24322748$1$I$20240527$20240909$20240916$20240916$EXP$FR-AFSSAPS-AVMA2024000395$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112145$ZYDUS PHARM$$$$$$Y$$$20240916$$PH$FR$FR
243227491$24322749$1$I$$20240904$20240916$20240916$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-112009$ZYDUS PHARM$Rupakumar T, Sankar A, Vijayasekharan K, Varikkattu Rajendran P, Chellapan Sojamani G, Rajeswari B, et al.. Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India.. British Journal of Haematology. 2024;220-228$$$$$Y$$$20240916$$HP$IN$IN
243227501$24322750$1$I$$20240904$20240916$20240916$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-112010$ZYDUS PHARM$Rupakumar T, Sankar A, Vijayasekharan K, VarikkattuRajendran P, ChellapanSojamani G, Rajeswari B, et al.. Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India.. British Journal of Haematology. 2024;220-228$$$$$Y$$$20240916$$HP$IN$IN
243227511$24322751$1$I$20231004$20240902$20240916$20240916$EXP$ES-AEMPS-1564528$ES-BAXTER-2024BAX024049$BAXTER$$25$YR$$F$Y$$$20240916$$MD$ES$ES
243227521$24322752$1$I$$20240909$20240916$20240916$EXP$$US-HETERO-HET2024US02763$HETERO$$$$$$Y$$$20240916$$CN$US$US
243227531$24322753$1$I$20240911$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024182595$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243227541$24322754$1$I$$20240905$20240916$20240916$EXP$CA-MHPD-E2B_07211827$CA-Accord-445717$ACCORD$$23$YR$A$F$Y$$$20240916$$HP$CA$CA
243227553$24322755$3$F$20240902$20240920$20240916$20240927$PER$$US-AMGEN-USASP2024182324$AMGEN$$55$YR$A$F$Y$85$KG$20240927$$PH$US$US
243227561$24322756$1$I$$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024180420$AMGEN$$$$$$Y$$$20240916$$MD$US$US
243227571$24322757$1$I$20240101$20240909$20240916$20240916$EXP$$US-ABBVIE-5916239$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243227581$24322758$1$I$$20240903$20240916$20240916$EXP$$US-SA-2024SA266398$SANOFI AVENTIS$$$$$F$Y$$$20240916$$CN$US$US
243227591$24322759$1$I$20240809$20240909$20240916$20240916$EXP$$JP-ROCHE-10000080072$ROCHE$$7$DEC$E$M$Y$$$20240916$$MD$JP$JP
243227601$24322760$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145704$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$67.59$KG$20240916$$CN$US$US
243227611$24322761$1$I$20240806$20240827$20240916$20240916$PER$$US-SA-2024SA264617$SANOFI AVENTIS$$61$YR$A$M$Y$79.55$KG$20240916$$MD$US$US
243227621$24322762$1$I$20240101$20240911$20240916$20240916$PER$$US-SA-2024SA265660$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240916$$MD$US$US
243227631$24322763$1$I$$20240910$20240916$20240916$EXP$$US-ABBVIE-5920202$ABBVIE$$$$$M$Y$$$20240916$$HP$US$US
243227651$24322765$1$I$$20240904$20240916$20240916$PER$$US-ROCHE-10000075093$ROCHE$$17$YR$T$M$Y$$$20240916$$CN$US$US
243227661$24322766$1$I$$20240906$20240916$20240916$PER$$US-ROCHE-10000076317$ROCHE$$$$$F$Y$$$20240916$$PH$US$US
243227671$24322767$1$I$$20240911$20240916$20240916$EXP$$IL-Ipsen Biopharmaceuticals, Inc.-2024-18361$IPSEN$$$$$M$Y$$$20240916$$CN$IL$IL
243227681$24322768$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024111291$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$MD$US$US
243227691$24322769$1$I$$20240906$20240916$20240916$EXP$$US-BAYER-2024A129205$BAYER$$82$YR$E$F$Y$$$20240916$$CN$US$US
243227701$24322770$1$I$20240629$20240906$20240916$20240916$EXP$IE-HPRA-2024-114424$IE-EMD Serono-2024042275$EMD SERONO INC$$40$YR$A$F$Y$$$20240916$$HP$IE$IE
243227711$24322771$1$I$20230902$20240909$20240916$20240916$EXP$$ES-AUROBINDO-AUR-APL-2024-044821$AUROBINDO$$58$YR$$M$Y$$$20240916$$MD$ES$ES
243227721$24322772$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63180$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243227731$24322773$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63148$$FDA-CTU$$54$YR$$F$N$65.32$KG$20240913$N$CN$US$
243227741$24322774$1$I$20210906$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63153$$FDA-CTU$$26$YR$$F$N$$$20240913$N$PH$US$
243227751$24322775$1$I$20080301$20240911$20240916$20240916$PER$$US-JNJFOC-20240934870$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20240916$$HP$US$US
243227761$24322776$1$I$$20240903$20240916$20240916$EXP$$JP-SA-2024SA266119$SANOFI AVENTIS$Fumiya O et al.. Two cases of small intestinal lipoma successfully treated by endoscopic unroofing.. The 112th Conference of the Japan Gastroenterological Endoscopy Society Kinki C. 2024;unk:unk$70$YR$E$M$Y$$$20240916$$HP$JP$JP
243227771$24322777$1$I$$20240913$20240916$20240916$PER$$US-HALEON-2196924$Haleon PLC$$$$$$Y$$$20240916$$CN$US$US
243227781$24322778$1$I$20240903$20240905$20240916$20240916$EXP$$US-JNJFOC-20240919871$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240916$$MD$US$US
243227791$24322779$1$I$$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143933$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240916$$CN$US$US
243227801$24322780$1$I$20240830$20240904$20240916$20240916$PER$$US-SA-2024SA263371$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240916$$MD$US$US
243227811$24322781$1$I$20210101$20240911$20240916$20240916$PER$$US-SA-2024SA266504$SANOFI AVENTIS$$$$$M$Y$$$20240916$$CN$US$US
243227822$24322782$2$F$20240801$20240912$20240916$20240920$PER$$US-SA-2024SA265745$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240920$$MD$US$US
243227831$24322783$1$I$$20240903$20240916$20240916$PER$$US-SA-2024SA267075$SANOFI AVENTIS$$64$YR$A$$Y$$$20240916$$MD$US$US
243227842$24322784$2$F$20240101$20240909$20240916$20240925$PER$$US-SA-2024SA264182$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240925$$CN$US$US
243227861$24322786$1$I$$20240823$20240916$20240916$PER$$US-SA-2024SA265831$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240916$$MD$US$US
243227871$24322787$1$I$$20240911$20240916$20240916$PER$$NVSC2024US184037$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243227881$24322788$1$I$$20240830$20240916$20240916$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07124$HIKMA$$$$$F$Y$$$20240911$$CN$US$US
243227891$24322789$1$I$$20240905$20240916$20240916$EXP$$US-BAYER-2024A131212$BAYER$Arif TB; Alabbas B; Vinayek R. Upper Gastrointestinal Bleeding Due to Metastatic Lung Adenocarcinoma in the Stomach and Duodenum. ACG Case Reports Journal. 2024;11:8:(e01474)$79$YR$E$M$Y$$$20240916$$MD$US$US
243227901$24322790$1$I$$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024184049$AMGEN$$$$$M$Y$$$20240916$$CN$US$US
243227911$24322791$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63227$$FDA-CTU$$51$YR$$F$N$$$20240913$N$$US$
243227921$24322792$1$I$20240826$20240910$20240916$20240916$EXP$$CN-EMD Serono-2024048719$EMD SERONO INC$$59$YR$A$F$Y$$$20240916$$HP$CN$CN
243227931$24322793$1$I$$20240912$20240916$20240916$PER$$US-ABBVIE-5923934$ABBVIE$$$$A$F$Y$$$20240916$$HP$US$US
243227941$24322794$1$I$$20240826$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08573$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243227951$24322795$1$I$$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009394$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240916$$CN$US$US
243227961$24322796$1$I$20240911$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007735$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240916$$CN$US$US
243227971$24322797$1$I$20240912$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008398$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240916$$CN$US$US
243227981$24322798$1$I$$20240905$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409004831$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240916$$CN$US$US
243227991$24322799$1$I$$20240830$20240916$20240916$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07085$HIKMA$$$$$F$Y$$$20240912$$CN$US$US
243228001$24322800$1$I$20240820$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024180093$AMGEN$$86$YR$E$M$Y$$$20240916$$CN$US$US
243228011$24322801$1$I$$20240912$20240916$20240916$EXP$$US-AMGEN-USASP2024183048$AMGEN$$$$$F$Y$$$20240916$$CN$US$US
243228021$24322802$1$I$$20240906$20240916$20240916$EXP$$US-CELLTRION INC.-2024US018690$CELLTRION$$$$$$Y$$$20240916$$HP$US$US
243228031$24322803$1$I$20230325$20230501$20240916$20240916$EXP$ES-AEMPS-1361565$ES-TEVA-VS-3237541$TEVA$$96$YR$$F$Y$76$KG$20240916$$MD$ES$ES
243228041$24322804$1$I$$20240910$20240916$20240916$EXP$$NVSC2024CA155429$NOVARTIS$$72$YR$$F$Y$$$20240916$$MD$CA$CA
243228051$24322805$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146680$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$76.66$KG$20240916$$CN$US$US
243228061$24322806$1$I$20240901$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146596$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240916$$PH$US$US
243228071$24322807$1$I$$20240906$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142962$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240916$$MD$US$US
243228081$24322808$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146529$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240916$$CN$US$US
243228091$24322809$1$I$$20240909$20240916$20240916$PER$$US-JNJFOC-20240935877$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$HP$US$US
243228101$24322810$1$I$$20240828$20240916$20240916$PER$$US-SA-2024SA266244$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$HP$US$US
243228111$24322811$1$I$$20240911$20240916$20240916$PER$$US-JNJFOC-20240929305$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$US$US
243228121$24322812$1$I$20200901$20240909$20240916$20240916$PER$$US-SA-2024SA265554$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240916$$HP$US$US
243228131$24322813$1$I$$20240829$20240916$20240916$PER$$US-SA-2024SA267059$SANOFI AVENTIS$$65$YR$E$$Y$$$20240916$$MD$US$US
243228141$24322814$1$I$20240701$20240905$20240916$20240916$EXP$$US-JNJFOC-20240920755$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240916$$HP$US$US
243228161$24322816$1$I$20240712$20240830$20240916$20240916$EXP$FR-AFSSAPS-MA2024001216$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08192$HIKMA$$7$YR$$M$Y$$$20240911$$MD$FR$FR
243228171$24322817$1$I$$20240905$20240916$20240916$PER$$US-ASTELLAS-2024-AER-005289$ASTELLAS$$96$YR$E$$Y$$$20240916$$MD$US$US
243228181$24322818$1$I$$20240909$20240916$20240916$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP011724$STRIDES$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al.. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.. Liver-Int. 2024;44 (2):286-292$$$$$Y$$$20240916$$HP$ES$ES
243228191$24322819$1$I$20230901$20240911$20240916$20240916$EXP$GB-MHRA-MED-202409091928410690-VLMKN$GB-STRIDES ARCOLAB LIMITED-2024SP011639$STRIDES$$38$YR$$F$Y$91$KG$20240916$$CN$GB$GB
243228201$24322820$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024111378$GLAXOSMITHKLINE$$$$A$M$Y$$$20240916$$CN$US$US
243228211$24322821$1$I$$20240909$20240916$20240916$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP011725$STRIDES$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al.. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.. Liver-Int. 2024;44 (2):286-292$$$$$Y$$$20240916$$HP$ES$ES
243228222$24322822$2$F$20230409$20230804$20240916$20240918$EXP$$IL-INCYTE CORPORATION-2023IN013845$INCYTE$$$$$$Y$$$20240918$$HP$IL$IL
243228231$24322823$1$I$20240701$20240904$20240916$20240916$PER$$US-ASTELLAS-2024-AER-005155$ASTELLAS$$54$YR$A$F$Y$$$20240916$$HP$US$US
243228241$24322824$1$I$20240101$20240822$20240916$20240916$EXP$$US-SA-2024SA266634$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240916$$CN$US$US
243228251$24322825$1$I$20240909$20240911$20240916$20240916$EXP$GB-MHRA-TPP2245943C22576978YC1725887365955$GB-STRIDES ARCOLAB LIMITED-2024SP011635$STRIDES$$82$YR$$F$Y$74$KG$20240916$$MD$GB$GB
243228261$24322826$1$I$20240912$20240912$20240916$20240916$PER$$NVSC2024US183717$NOVARTIS$$23$YR$$M$Y$$$20240916$$CN$US$US
243228272$24322827$2$F$20240810$20240926$20240916$20240926$EXP$$PL-BAYER-2024A130067$BAYER$$$$$F$Y$$$20240926$$MD$PL$PL
243228281$24322828$1$I$$20240908$20240916$20240916$EXP$$US-BAYER-2024A128357$BAYER$$$$$$Y$$$20240916$$CN$US$US
243228291$24322829$1$I$20240907$20240912$20240916$20240916$EXP$$US-GSK-US2024113591$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$US$US
243228302$24322830$2$F$20240903$20240906$20240916$20240919$PER$$US-SA-2024SA267069$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240919$$HP$US$US
243228311$24322831$1$I$$20240909$20240916$20240916$PER$$NVSC2024US181265$NOVARTIS$$$$$M$Y$85.261$KG$20240916$$CN$US$US
243228321$24322832$1$I$20240901$20240910$20240916$20240916$EXP$$AU-Orion Corporation ORION PHARMA-24_00031679$ORION$$40$YR$A$M$Y$95$KG$20240916$$MD$AU$
243228331$24322833$1$I$$20240828$20240916$20240916$PER$$US-SA-2024SA266399$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240916$$HP$US$US
243228341$24322834$1$I$20240828$20240828$20240916$20240916$PER$$US-JNJFOC-20240903374$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$MD$US$US
243228351$24322835$1$I$$20240910$20240916$20240916$PER$$US-JNJFOC-20240929682$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$US$US
243228361$24322836$1$I$$20240827$20240916$20240916$PER$$US-SA-2024SA266309$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$MD$US$US
243228371$24322837$1$I$$20240912$20240916$20240916$PER$$US-TAKEDA-2024TUS091359$TAKEDA$$$$$F$Y$136$KG$20240916$$MD$US$US
243228383$24322838$3$F$$20240913$20240916$20240920$PER$$US-SA-2024SA259177$SANOFI AVENTIS$$$$A$F$Y$79.05$KG$20240920$$MD$US$US
243228391$24322839$1$I$$20240904$20240916$20240916$EXP$$US-Accord-444810$ACCORD$Ansari A, Dirani K, Malik A, Matthews S. Silent Manifestations of Disseminated Nocardia in a Renal Transplant Patient. Cureus. 2024 Jul 27;16(7):e65523.$45$YR$A$M$Y$$$20240916$$MD$US$US
243228401$24322840$1$I$20240101$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146549$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240916$$CN$US$US
243228411$24322841$1$I$20240101$20240911$20240916$20240916$PER$$US-SA-2024SA265734$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240916$$MD$US$US
243228421$24322842$1$I$20230415$20240906$20240916$20240916$EXP$FR-AFSSAPS-CF2023000207$FR-CELLTRION INC.-2024FR022066$CELLTRION$$$$$$Y$$$20240916$$MD$FR$FR
243228431$24322843$1$I$$20240909$20240916$20240916$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011712$STRIDES$Ye P, Wu M, Cao J, Pei R, Yuan J, Zhuang H, et al.. Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients.. Ann-Hematol. 2024;103 (8):3135-3143$$$$$Y$$$20240916$$HP$CN$CN
243228441$24322844$1$I$$20240618$20240916$20240916$EXP$$US-EMD Serono-2024048562$EMD SERONO INC$Ouyang J, Salifu M, Sasidharan S, Jatoi T. How High Can Anion Gaps Be in Patients With Metabolic Acidosis. A Case Report. American Journal of Respiratory and Critical Care Medicine. 2024 May 01;209.$61$YR$A$F$Y$$$20240916$$HP$US$US
243228461$24322846$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63201$$FDA-CTU$$40$YR$$M$N$$$20240913$N$$US$
243228512$24322851$2$F$20240912$20240919$20240916$20240923$EXP$$CA-GSK-CA2024113214$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$CA$CA
243228532$24322853$2$F$$20240923$20240916$20240926$EXP$$IT-AUROBINDO-AUR-APL-2024-045245$AUROBINDO$Levi V, Stanziano M, Pinto C, Zibordi F, Fedeli D, Caldiera V, et al.. Bilateral Simultaneous Magnetic Resonance-Guided Focused Ultrasound Pallidotomy for Life-Threatening Status Dystonicus. Movement Disorders. 2024;39(8):1408-1412$19$YR$$F$Y$$$20240926$$MD$IT$IT
243228541$24322854$1$I$$20240912$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US079732$SANDOZ$$$$$F$Y$$$20240916$$MD$US$US
243228562$24322856$2$F$20240907$20240916$20240916$20240916$PER$$US-AMGEN-USASP2024183934$AMGEN$$79$YR$E$M$Y$$$20240916$$HP$US$US
243228571$24322857$1$I$20240529$20240909$20240916$20240916$EXP$$JP-AMGEN-JPNSP2024110536$AMGEN$$$$A$$Y$$$20240916$$MD$JP$JP
243228582$24322858$2$F$20240903$20240913$20240916$20240919$EXP$$JP-009507513-2409JPN001000J$MERCK$$82$YR$$M$Y$$$20240919$$MD$JP$JP
243228591$24322859$1$I$$20240912$20240916$20240916$EXP$$US-AMGEN-USASP2024183068$AMGEN$$$$$M$Y$$$20240916$$CN$US$US
243228601$24322860$1$I$20240720$20240902$20240916$20240916$EXP$FR-AFSSAPS-AN2024001162$FR-STRIDES ARCOLAB LIMITED-2024SP011129$STRIDES$$37$YR$$M$Y$68.1$KG$20240916$$MD$FR$FR
243228611$24322861$1$I$$20240909$20240916$20240916$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP011686$STRIDES$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al.. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.. Liver-Int. 2024;44 (2):286-292$$$$$Y$$$20240916$$HP$ES$ES
243228621$24322862$1$I$$20240910$20240916$20240916$EXP$$IN-ROCHE-10000079403$ROCHE$$64$YR$A$F$Y$$$20240916$$CN$IN$IN
243228631$24322863$1$I$$20240912$20240916$20240916$PER$$US-TAKEDA-2024TUS091393$TAKEDA$$59$YR$$F$Y$$$20240916$$CN$US$US
243228641$24322864$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146837$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240916$$CN$US$US
243228653$24322865$3$F$20240801$20240918$20240916$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146312$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240920$$HP$US$US
243228671$24322867$1$I$$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024179587$AMGEN$Biousse V.; Boyko M.; Aung A. B. et al.. Paracentral Acute Middle Maculopathy Secondary to Branch Retinal Artery Occlusion in Susac Syndrome. Journal of Neuro-Ophthalmology. 2024;44 (3):e323-e325$24$YR$A$F$Y$$$20240916$$MD$US$US
243228681$24322868$1$I$$20240904$20240916$20240916$EXP$$LB-STERISCIENCE B.V.-2024-ST-001385$Steriscience PTE$Salam K, El S, Tarhini H, Bazarbachi A, Moukalled N, El-Cheikh J, et al.. CT-694 Haplo-Identical Stem Cell Transplant Outcomes in Patients with Donor-Specific Antibodies Receiving Desensitization: Insights From A Single-Center Experience.. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S614-S615.$$$$$Y$$$20240916$$MD$LB$LB
243228691$24322869$1$I$$20240906$20240916$20240916$EXP$$GB-CELLTRION INC.-2024GB021766$CELLTRION$$$$$$Y$$$20240916$$HP$GB$GB
243228701$24322870$1$I$$20240913$20240916$20240916$PER$$US-GILEAD-2024-0687661$GILEAD$$$$$F$Y$$$20240916$$PH$US$US
243228711$24322871$1$I$$20240902$20240916$20240916$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08245$HIKMA$$7$YR$$M$Y$30$KG$20240916$$HP$CA$CA
243228721$24322872$1$I$$20240912$20240916$20240916$EXP$$KE-PFIZER INC-2024SGN01462$PFIZER$$36$YR$$M$Y$$$20240916$$CN$KE$KE
243228731$24322873$1$I$$20240909$20240916$20240916$EXP$$US-BAYER-2024A129834$BAYER$$67$YR$E$F$Y$87.982$KG$20240916$$CN$US$US
243228771$24322877$1$I$20240904$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-63089$$FDA-CTU$$61$YR$$M$N$$$20240912$N$PH$US$
243228782$24322878$2$F$$20240916$20240916$20240923$EXP$$GB-GSK-GB2024EME113540$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$PH$GB$GB
243228791$24322879$1$I$$20240909$20240916$20240916$EXP$$IT-GSK-IT2024EME112468$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$IT$IT
243228802$24322880$2$F$$20240916$20240916$20240923$EXP$$GB-VIIV HEALTHCARE LIMITED-GB2024EME113540$VIIV$$$$$$Y$$$20240923$$PH$GB$GB
243228811$24322881$1$I$$20240903$20240916$20240916$EXP$$US-ZPPROD-ZP24US000934$ZEALAND PHARMACEUTICALS$$$$$$Y$$$20240916$$CN$US$US
243228831$24322883$1$I$$20240911$20240916$20240916$EXP$$CR-ABBVIE-5921884$ABBVIE$$27$YR$$M$Y$$$20240916$$MD$CR$CR
243228851$24322885$1$I$$20240912$20240916$20240916$PER$$US-TAKEDA-2024TUS091414$TAKEDA$$21$YR$$F$Y$$$20240916$$MD$US$US
243228861$24322886$1$I$$20240904$20240916$20240916$EXP$$BR-TAKEDA-2023TUS061755$TAKEDA$$$$$M$Y$$$20240916$$CN$BR$BR
243228872$24322887$2$F$20240101$20240911$20240916$20240926$PER$$US-SA-2024SA265957$SANOFI AVENTIS$$55$YR$A$F$Y$90.91$KG$20240926$$HP$US$US
243228891$24322889$1$I$20240101$20240821$20240916$20240916$PER$$US-SA-2024SA263985$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240916$$MD$US$US
243228901$24322890$1$I$$20240903$20240916$20240916$PER$$US-SA-2024SA264554$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
243228911$24322891$1$I$$20240903$20240916$20240916$PER$$US-SA-2024SA229166$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240916$$MD$US$US
243228921$24322892$1$I$20240101$20240904$20240916$20240916$PER$$US-SA-2024SA264559$SANOFI AVENTIS$$$$$F$Y$$$20240916$$CN$US$US
243228931$24322893$1$I$$20240827$20240916$20240916$PER$$US-SA-2024SA266445$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$MD$US$US
243228941$24322894$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146349$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240916$$CN$US$US
243228951$24322895$1$I$20240226$20240911$20240916$20240916$EXP$IT-MINISAL02-1001702$IT-SANDOZ INC.-SDZ2024IT079683$SANDOZ$$42$YR$$M$Y$$$20240916$$MD$IT$IT
243228971$24322897$1$I$20240101$20240827$20240916$20240916$PER$$US-TEVA-VS-3238497$TEVA$$10$YR$$F$Y$$$20240916$$CN$US$US
243228981$24322898$1$I$$20240906$20240916$20240916$EXP$$US-MYLANLABS-2024M1082978$MYLAN$Lau A, Nguyen N, Hui A, Ong J, Salehpour M. Fournier^s gangrene with Streptococcus Anginosus in the setting of hidrandenitis suppurativa perineal abscess: A case report. Int-J-Surg-Case-Rep 2024; 116 1-4.$58$YR$$M$Y$$$20240916$$HP$US$US
243229002$24322900$2$F$20220418$20240920$20240916$20240925$EXP$$AU-MYLANLABS-2024M1082116$MYLAN$$66$YR$$M$Y$$$20240925$$HP$AU$AU
243229011$24322901$1$I$$20240906$20240916$20240916$EXP$$US-MYLANLABS-2024M1083162$MYLAN$Liao A, Fajoles-Vasseneix C, Rali A, Ward L, Fernandes A, Patel PS, et al. Visual Morbidity and Outcomes of Scleritis Associated with Intraocular Inflammation Compared to Isolated Scleritis. Ocular-Immunol-Inflamm 2024; 32 (6): 947-954.$45$YR$$M$Y$$$20240916$$MD$US$US
243229021$24322902$1$I$$20240906$20240916$20240916$EXP$$US-MYLANLABS-2024M1083156$MYLAN$Valido K, Murphy MJ, Leventhal JS, Damsky W. Successful treatment of pityriasis rubra pilaris with brodalumab after nonresponse to IL-17A inhibition: A role for the innate cytokine IL-17C. JAAD-Case-Rep 2024; 48 85-87.$80$YR$$M$Y$$$20240916$$MD$US$US
243229031$24322903$1$I$$20240906$20240916$20240916$EXP$$US-MYLANLABS-2024M1083160$MYLAN$Liao A, Fajoles-Vasseneix C, Rali A, Ward L, Fernandes A, Patel PS, et al. Visual Morbidity and Outcomes of Scleritis Associated with Intraocular Inflammation Compared to Isolated Scleritis. Ocular-Immunol-Inflamm 2024; 32 (6): 947-954.$$$$F$Y$$$20240916$$MD$US$US
243229041$24322904$1$I$$20240910$20240916$20240916$EXP$$JP-AstraZeneca-2024A207008$ASTRAZENECA$$$$$F$Y$$$20240916$$MD$JP$
243229051$24322905$1$I$$20240909$20240916$20240916$EXP$$PT-AstraZeneca-2024A209658$ASTRAZENECA$$$$$F$Y$$$20240916$$HP$PT$
243229061$24322906$1$I$20240908$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A209085$ASTRAZENECA$$28837$DY$$M$Y$$$20240916$$MD$US$
243229071$24322907$1$I$$20240909$20240916$20240916$PER$$US-ROCHE-10000077749$ROCHE$$$$$$Y$$$20240916$$CN$US$US
243229081$24322908$1$I$$20240826$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08628$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243229091$24322909$1$I$20220620$20240905$20240916$20240916$EXP$AU-TGA-0000747654$AU-NOVOPROD-1280978$NOVO NORDISK$$64$YR$$F$Y$$$20240916$$PH$AU$AU
243229101$24322910$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008272$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$US$US
243229111$24322911$1$I$20240912$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008146$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240916$$MD$US$US
243229122$24322912$2$F$$20240919$20240916$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409008413$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240923$$CN$US$US
243229131$24322913$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006810$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240916$$CN$US$US
243229141$24322914$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006640$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240916$$CN$US$US
243229151$24322915$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009288$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240916$$CN$US$US
243229161$24322916$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008329$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$US$US
243229171$24322917$1$I$20240901$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008370$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240916$$CN$US$US
243229181$24322918$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007783$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243229191$24322919$1$I$$20240912$20240916$20240916$EXP$$US-GILEAD-2024-0687711$GILEAD$$$$A$M$Y$$$20240916$$PH$US$US
243229201$24322920$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006464$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240916$$CN$US$US
243229211$24322921$1$I$20240812$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024184110$AMGEN$$82$YR$E$F$Y$$$20240916$$CN$US$US
243229241$24322924$1$I$20240524$20240906$20240916$20240916$EXP$GB-MHRA-MED-202409061305576320-QLSDY$GB-CELLTRION INC.-2024GB021820$CELLTRION$$$$$$Y$$$20240916$$MD$GB$GB
243229251$24322925$1$I$20240912$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-63090$$FDA-CTU$$63$YR$$F$N$$$20240912$N$PH$US$
243229262$24322926$2$F$$20240909$20240916$20240919$EXP$JP-MLMSERVICE-20240828-PI172230-00306-2$JP-STRIDES ARCOLAB LIMITED-2024SP011494$STRIDES$Aiba M, Okada K, Funakoshi T, Nozu R, Takahashi T, Ozu S, et al.. Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma.. Journal of Infection and Chemotherapy.. 2024;30(10):1065-1068$6$DEC$$F$Y$$$20240919$$MD$JP$JP
243229271$24322927$1$I$$20240909$20240916$20240916$PER$$US-ROCHE-10000078062$ROCHE$$$$$F$Y$$$20240916$$CN$US$US
243229281$24322928$1$I$$20210716$20240916$20240916$PER$$NVSC2021US318485$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243229301$24322930$1$I$20240829$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63136$$FDA-CTU$$2$YR$$M$N$$$20240913$Y$PH$US$
243229311$24322931$1$I$20240912$20240912$20240912$20240912$DIR$FDA-CDER-CTU-2024-63092$$FDA-CTU$$55$YR$$F$N$184$LBS$20240912$Y$HP$US$
243229321$24322932$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63195$$FDA-CTU$$66$YR$$F$N$240$LBS$20240913$N$$US$
243229351$24322935$1$I$20240101$20240913$20240916$20240916$EXP$GB-MHRA-MED-202409131500219810-DRBJF$GB-ABBVIE-5923539$ABBVIE$$38$YR$$F$Y$$$20240916$$HP$GB$GB
243229361$24322936$1$I$$20240903$20240916$20240916$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP011493$STRIDES$Appenzeller S, Costallat LL, Ramos MC, Andrade SO, Reis F.. Paracoccidioidomycosis: An uncommon cause of discitis in lupus. Revista da Sociedade Brasileira de Medicina Tropical.. 2024;57:e00922-2024$41$YR$$F$Y$$$20240916$$MD$BR$BR
243229391$24322939$1$I$20240913$20240913$20240913$20240913$DIR$718357$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243229401$24322940$1$I$$20240910$20240916$20240916$PER$$US-ROCHE-10000080280$ROCHE$$$$$F$Y$$$20240916$$CN$US$US
243229411$24322941$1$I$$20240903$20240916$20240916$EXP$PH-MLMSERVICE-20240827-PI173858-00079-1$PH-STRIDES ARCOLAB LIMITED-2024SP011497$STRIDES$Ajon ARS, Camara PT.. Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Due to Multiple Anti-Epileptic Drug Hypersensitivity. Cureus. 2024;16(7):e65417$41$YR$$F$Y$$$20240916$$MD$PH$PH
243229422$24322942$2$F$$20240911$20240916$20240918$PER$$US-ROCHE-10000080540$ROCHE$$58$YR$A$F$Y$$$20240918$$CN$US$US
243229431$24322943$1$I$$20240911$20240916$20240916$PER$$US-ROCHE-10000080749$ROCHE$$58$YR$A$F$Y$$$20240916$$MD$US$US
243229441$24322944$1$I$$20240911$20240916$20240916$PER$$US-ROCHE-10000081764$ROCHE$$$$$$Y$$$20240916$$HP$US$US
243229461$24322946$1$I$$20211126$20240916$20240916$EXP$$NVSC2021GB318481$NOVARTIS$$$$$$Y$$$20240916$$MD$GB$GB
243229471$24322947$1$I$20211230$20211231$20240916$20240916$EXP$$NVSC2021US318489$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243229491$24322949$1$I$$20240911$20240916$20240916$PER$$US-ROCHE-3500958$ROCHE$$$$A$F$Y$$$20240916$$CN$US$US
243229501$24322950$1$I$$20240912$20240916$20240916$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051228$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240916$$CN$US$US
243229512$24322951$2$F$20240825$20240924$20240916$20240930$PER$$US-ROCHE-10000080034$ROCHE$$47$YR$A$M$Y$103.42$KG$20240930$$CN$US$US
243229521$24322952$1$I$20240101$20240905$20240916$20240916$PER$$US-009507513-2409USA002704$MERCK$$55$YR$$F$Y$$$20240916$$CN$US$US
243229531$24322953$1$I$$20240906$20240916$20240916$EXP$$GB-AMGEN-GBRSP2024180188$AMGEN$$$$$F$Y$$$20240916$$CN$GB$GB
243229541$24322954$1$I$20240701$20240906$20240916$20240916$EXP$$US-Vifor (International) Inc.-VIT-2024-08199$VIFOR$$84$YR$$F$Y$$$20240916$$CN$US$US
243229551$24322955$1$I$$20240909$20240916$20240916$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001828$BLUEPRINT MEDICINES$$$$$M$Y$$$20240916$$CN$US$US
243229561$24322956$1$I$20240711$20240905$20240916$20240916$EXP$GB-MHRA-MED-202409051602228240-CRTJQ$GB-GLENMARK PHARMACEUTICALS-2024GMK093898$GLENMARK$$$$$$Y$$$20240916$$HP$GB$GB
243229571$24322957$1$I$20200627$20240910$20240916$20240916$EXP$PL-URPL-1-2134-2020$PL-TEVA-VS-3242382$TEVA$$22$YR$$F$Y$57$KG$20240916$$MD$PL$PL
243229591$24322959$1$I$$20240904$20240916$20240916$PER$$US-BAUSCHBL-2024BNL032999$BAUSCH AND LOMB$$$$$M$Y$$$20240916$$CN$US$US
243229601$24322960$1$I$$20240905$20240916$20240916$PER$$US-BAUSCHBL-2024BNL033021$BAUSCH AND LOMB$$$$$F$Y$$$20240916$$CN$US$US
243229611$24322961$1$I$$20240910$20240916$20240916$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001841$BLUEPRINT MEDICINES$$$$$F$Y$$$20240916$$CN$US$US
243229621$24322962$1$I$$20240906$20240916$20240916$PER$$US-BAUSCHBL-2024BNL033051$BAUSCH AND LOMB$$$$$F$Y$$$20240916$$CN$US$US
243229631$24322963$1$I$$20240905$20240916$20240916$PER$$US-BAUSCHBL-2024BNL033069$BAUSCH AND LOMB$$$$$M$Y$$$20240916$$CN$US$US
243229641$24322964$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63139$$FDA-CTU$$$$$M$N$$$20240913$N$HP$US$
243229661$24322966$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63138$$FDA-CTU$$74$YR$$F$N$$$20240913$N$$US$
243229691$24322969$1$I$20240828$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63137$$FDA-CTU$$77$YR$$F$N$$$20240913$Y$PH$US$
243229711$24322971$1$I$$20240909$20240913$20240913$DIR$FDA-CDER-CTU-2024-63169$$FDA-CTU$$$$$M$N$$$20240909$N$HP$US$
243229721$24322972$1$I$$20240905$20240913$20240913$DIR$FDA-CDER-CTU-2024-63229$$FDA-CTU$$$$$F$N$$$20240905$N$HP$US$
243229751$24322975$1$I$20240913$20240913$20240913$20240913$DIR$718347$$FDA-CTU$$46$YR$$F$N$$$20240913$N$$US$
243229761$24322976$1$I$$20240913$20240913$20240913$DIR$718355$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243229771$24322977$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63184$$FDA-CTU$$76$YR$$M$N$$$20240913$N$HP$US$
243229781$24322978$1$I$20240826$20240911$20240914$20240914$DIR$FDA-CDER-CTU-2024-63124$$FDA-CTU$$64$YR$$M$N$88$KG$20240911$N$$US$
243229791$24322979$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63150$$FDA-CTU$$75$YR$$M$N$$$20240913$N$$US$
243229801$24322980$1$I$20240823$20240913$20240914$20240914$DIR$FDA-CDER-CTU-2024-63125$$FDA-CTU$$61$YR$$M$N$115$KG$20240913$N$$US$
243229811$24322981$1$I$20240827$20240913$20240914$20240914$DIR$FDA-CDER-CTU-2024-63123$$FDA-CTU$$71$YR$$M$N$58$KG$20240913$N$$US$
243229821$24322982$1$I$20240909$20240913$20240914$20240914$DIR$FDA-CDER-CTU-2024-63120$$FDA-CTU$$$$$M$N$76.8$KG$20240913$N$$US$
243229831$24322983$1$I$20240312$20240913$20240913$20240913$DIR$718358$$FDA-CTU$$8$YR$$F$N$16.8$KG$20240913$N$HP$US$
243229841$24322984$1$I$20240901$20240904$20240914$20240914$DIR$FDA-CDER-CTU-2024-63121$$FDA-CTU$$$$$F$N$63.5$KG$20240904$N$$US$
243229851$24322985$1$I$20240901$20240913$20240914$20240914$DIR$FDA-CDER-CTU-2024-63122$$FDA-CTU$$50$YR$$F$N$103.4$KG$20240913$N$$US$
243229861$24322986$1$I$$20240914$20240914$20240914$DIR$FDA-CDER-CTU-2024-63127$$FDA-CTU$$45$YR$$M$N$$$20240914$N$$US$
243229871$24322987$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63144$$FDA-CTU$$24$YR$$F$N$179$LBS$20240913$N$$US$
243229881$24322988$1$I$$20240914$20240914$20240914$DIR$FDA-CDER-CTU-2024-63126$$FDA-CTU$$96$YR$$F$N$$$20240914$N$$US$
243229891$24322989$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63155$$FDA-CTU$$55$YR$$F$N$$$20240913$N$$US$
243229901$24322990$1$I$20240814$20240914$20240914$20240914$DIR$FDA-CDER-CTU-2024-63128$$FDA-CTU$$78$YR$$M$N$$$20240914$N$HP$US$
243229911$24322991$1$I$$20240914$20240914$20240914$DIR$FDA-CDER-CTU-2024-63129$$FDA-CTU$$80$YR$$M$N$$$20240914$N$$US$
243229921$24322992$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63168$$FDA-CTU$$42$YR$$F$N$$$20240913$N$$US$
243229961$24322996$1$I$20240101$20240912$20240916$20240916$EXP$NL-LRB-01000777$NL-GSK-NL2024113964$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$NL$NL
243229971$24322997$1$I$20240101$20240827$20240916$20240916$PER$$US-TEVA-VS-3237701$TEVA$$65$YR$$F$Y$$$20240916$$CN$US$US
243229981$24322998$1$I$20240701$20240821$20240916$20240916$PER$$US-009507513-2408USA007213$MERCK$$59$YR$$M$Y$$$20240916$$HP$US$US
243229991$24322999$1$I$20240910$20240910$20240916$20240916$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-123066$REGENERON$$$$$M$Y$$$20240916$$CN$CA$CA
243230001$24323000$1$I$$20240912$20240916$20240916$PER$$US-TAKEDA-2024TUS091476$TAKEDA$$$$$M$Y$73$KG$20240916$$CN$US$US
243230012$24323001$2$F$$20240911$20240916$20240916$30DAY$$US-SANDOZ INC.-SDZ2024US080005$SANDOZ$$$$$F$Y$$$20240916$$CN$US$US
243230052$24323005$2$F$$20240903$20240916$20240916$EXP$$CA-JNJFOC-20240915407$JOHNSON AND JOHNSON$$3$YR$C$M$Y$$$20240916$$HP$CA$CA
243230061$24323006$1$I$$20240903$20240916$20240916$EXP$$CA-JNJFOC-20240916244$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20240916$$CN$CA$CA
243230071$24323007$1$I$$20240912$20240916$20240916$PER$$US-BIOGEN-2024BI01282424$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
243230081$24323008$1$I$$20240902$20240916$20240916$EXP$$FR-AstraZeneca-2024A209841$ASTRAZENECA$$$$A$M$Y$$$20240916$$MD$FR$
243230091$24323009$1$I$$20240912$20240916$20240916$EXP$$JP-AstraZeneca-2024A209094$ASTRAZENECA$$84$YR$$F$Y$$$20240916$$MD$JP$
243230101$24323010$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000081491$ROCHE$$60$YR$A$F$Y$$$20240916$$CN$US$US
243230111$24323011$1$I$20240904$20240909$20240916$20240916$PER$$JP-REGENERON PHARMACEUTICALS, INC.-2024-123776$REGENERON$$55$YR$$M$Y$$$20240916$$CN$JP$JP
243230122$24323012$2$F$20240906$20240906$20240916$20240916$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024111287$VIIV$$40$YR$$M$Y$$$20240916$$HP$US$US
243230132$24323013$2$F$$20240909$20240916$20240919$EXP$$CA-GSK-CA2024111944$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$CA$CA
243230151$24323015$1$I$$20240911$20240916$20240916$PER$$US-ROCHE-10000081788$ROCHE$$$$$$Y$$$20240916$$HP$US$US
243230161$24323016$1$I$$20240913$20240916$20240916$PER$$US-ROCHE-10000082245$ROCHE$$$$$$Y$$$20240916$$MD$US$US
243230171$24323017$1$I$20240214$20240903$20240916$20240916$EXP$$BR-ASTELLAS-2024-AER-005711$ASTELLAS$$83$YR$E$M$Y$$$20240916$$MD$BR$BR
243230181$24323018$1$I$$20240828$20240916$20240916$PER$$US-SA-2024SA263075$SANOFI AVENTIS$$$$T$M$Y$55.41$KG$20240916$$MD$US$US
243230191$24323019$1$I$20240806$20240812$20240916$20240916$PER$$US-AMGEN-USASP2024183567$AMGEN$$$$A$F$Y$$$20240916$$PH$US$US
243230201$24323020$1$I$20240912$20240913$20240916$20240916$EXP$$US-INCYTE CORPORATION-2024IN009721$INCYTE$$$$$$Y$$$20240916$$HP$US$US
243230211$24323021$1$I$20240821$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024183943$AMGEN$$52$YR$A$F$Y$$$20240916$$CN$US$US
243230222$24323022$2$F$$20240919$20240916$20240920$PER$$US-AMGEN-USASP2024183385$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243230241$24323024$1$I$20231001$20240909$20240916$20240916$EXP$$DE-BIOGEN-2024BI01282093$BIOGEN$$43$YR$$F$Y$$$20240916$$CN$DE$DE
243230261$24323026$1$I$$20240116$20240916$20240916$PER$$US-ENDO USA, INC.-2024-000358$ENDO$$$$$$Y$$$20240916$$CN$US$US
243230271$24323027$1$I$$20240116$20240916$20240916$PER$$US-ENDO USA, INC.-2024-000355$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243230281$24323028$1$I$20240101$20240905$20240916$20240916$EXP$$GB-UCBSA-2024045845$UCB$$$$$F$Y$$$20240916$$MD$GB$GB
243230291$24323029$1$I$20240121$20240903$20240916$20240916$EXP$$CA-ASTELLAS-2024US017431$ASTELLAS$$58$YR$A$M$Y$$$20240916$$HP$CA$CA
243230301$24323030$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008298$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240916$$CN$US$US
243230311$24323031$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008154$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240916$$CN$US$US
243230321$24323032$1$I$20240726$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007790$ELI LILLY AND CO$$19$YR$A$F$Y$$$20240916$$CN$US$US
243230331$24323033$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024111411$GLAXOSMITHKLINE$$$$$M$Y$$$20240916$$CN$US$US
243230341$24323034$1$I$$20240821$20240916$20240916$EXP$$US-SA-2024SA263450$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240916$$MD$US$US
243230352$24323035$2$F$$20240909$20240916$20240916$PER$$US-ROCHE-10000077043$ROCHE$$62$YR$A$F$Y$$$20240916$$CN$US$US
243230361$24323036$1$I$20230101$20240910$20240916$20240916$EXP$$US-ABBVIE-5918349$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243230371$24323037$1$I$20240901$20240909$20240916$20240916$PER$$US-SA-2024SA266172$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240916$$MD$US$US
243230381$24323038$1$I$20230701$20240909$20240916$20240916$PER$$US-SA-2024SA265369$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240916$$MD$US$US
243230391$24323039$1$I$20240101$20240826$20240916$20240916$PER$$US-SA-2024SA266198$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240916$$MD$US$US
243230401$24323040$1$I$20240101$20240822$20240916$20240916$PER$$US-SA-2024SA265895$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240916$$CN$US$US
243230411$24323041$1$I$20240101$20240823$20240916$20240916$PER$$US-SA-2023SA360747$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240916$$CN$US$US
243230421$24323042$1$I$$20240828$20240916$20240916$PER$$US-SA-2024SA265978$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$CN$US$US
243230431$24323043$1$I$20240605$20240823$20240916$20240916$PER$$US-SA-2024SA265393$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240916$$MD$US$US
243230441$24323044$1$I$$20240823$20240916$20240916$PER$$US-SA-2024SA265809$SANOFI AVENTIS$$90$YR$E$F$Y$80.7$KG$20240916$$MD$US$US
243230451$24323045$1$I$$20240902$20240916$20240916$PER$$US-SA-2024SA267124$SANOFI AVENTIS$$$$$$Y$$$20240916$$HP$US$US
243230461$24323046$1$I$20240719$20240823$20240916$20240916$PER$$US-SA-2024SA262675$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240916$$MD$US$US
243230471$24323047$1$I$$20240828$20240916$20240916$PER$$US-SA-2024SA266341$SANOFI AVENTIS$$$$E$F$Y$$$20240916$$MD$US$US
243230481$24323048$1$I$$20240912$20240916$20240916$PER$$US-SA-2024SA265909$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$MD$US$US
243230491$24323049$1$I$$20240913$20240916$20240916$EXP$$NVSC2024RW184002$NOVARTIS$$$$$M$Y$$$20240916$$MD$RW$RW
243230511$24323051$1$I$$20240905$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009411$INCYTE$$$$$$Y$$$20240916$$MD$US$US
243230521$24323052$1$I$$20240910$20240916$20240916$EXP$$US-BAYER-2024A129388$BAYER$$$$$$Y$$$20240916$$CN$US$US
243230531$24323053$1$I$$20240904$20240916$20240916$PER$$US-JNJFOC-20240913986$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$CN$US$US
243230591$24323059$1$I$20240828$20240909$20240916$20240916$EXP$$CN-BEH-2024178553$CSL BEHRING$$62$YR$A$M$Y$75$KG$20240916$$HP$CN$CN
243230601$24323060$1$I$20240801$20240905$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009396$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243230611$24323061$1$I$$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024184148$AMGEN$$$$$F$Y$$$20240916$$HP$US$US
243230621$24323062$1$I$$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024184150$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243230633$24323063$3$F$20240913$20240923$20240916$20240924$PER$$US-AMGEN-USASP2024184317$AMGEN$$65$YR$E$F$Y$100.43$KG$20240924$$HP$US$US
243230641$24323064$1$I$20240101$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024180680$AMGEN$$74$YR$E$M$Y$$$20240916$$CN$US$US
243230651$24323065$1$I$$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024182509$AMGEN$$$$E$F$Y$$$20240916$$CN$US$US
243230661$24323066$1$I$20240701$20240905$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009393$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243230671$24323067$1$I$20240907$20240911$20240916$20240916$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024113008$VIIV$$34$YR$$M$Y$$$20240916$$PH$US$US
243230681$24323068$1$I$$20240909$20240916$20240916$EXP$$IT-ROCHE-10000081515$ROCHE$Gamba A, Depascale R, Zanatta E, Ienna L, Cruciani C, Gatto M. Effectiveness and safety of low dose Rituximab as remission-maintenance treatment for patients with refractory idiopathic inflammatory myopathies: results of a retrospective study from a monocentric cohort. Clinical Rheumatology. 2024; doi:10.1007/s10067-024-07079-z.$$$$$Y$$$20240916$$HP$IT$IT
243230691$24323069$1$I$$20240909$20240916$20240916$EXP$$AU-ABBVIE-5922607$ABBVIE$$$$$$Y$$$20240916$$MD$AU$AU
243230701$24323070$1$I$$20240914$20240916$20240916$EXP$$US-INCYTE CORPORATION-2024IN009723$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243230712$24323071$2$F$20240829$20240919$20240916$20240923$PER$$NVSC2024US183962$NOVARTIS$$39$YR$$M$Y$87$KG$20240923$$CN$US$US
243230721$24323072$1$I$20230311$20240903$20240916$20240916$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08383$HIKMA$$52$YR$$M$Y$64.9$KG$20240916$$MD$US$US
243230731$24323073$1$I$20240830$20240913$20240916$20240916$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051504$BOEHRINGER INGELHEIM$$60$YR$A$M$Y$99$KG$20240916$$HP$GB$GB
243230741$24323074$1$I$20240515$20240910$20240916$20240916$EXP$$NVSC2024CA062322$NOVARTIS$$63$YR$$F$Y$$$20240916$$CN$CA$CA
243230772$24323077$2$F$20190101$20240919$20240916$20240924$PER$$US-AMGEN-USASP2024182208$AMGEN$$73$YR$E$F$Y$$$20240924$$HP$US$US
243230781$24323078$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63182$$FDA-CTU$$54$YR$$M$N$194$LBS$20240913$N$$US$
243230791$24323079$1$I$$20240911$20240913$20240913$DIR$FDA-CDER-CTU-2024-63152$$FDA-CTU$$$$$F$N$$$20240911$N$HP$US$
243230811$24323081$1$I$$20240913$20240916$20240916$EXP$$NVSC2024RW183995$NOVARTIS$$$$$F$Y$$$20240916$$MD$RW$RW
243230821$24323082$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63226$$FDA-CTU$$71$YR$$F$N$72.12$KG$20240913$N$HP$US$
243230831$24323083$1$I$20240914$20240914$20240914$20240914$DIR$718414$$FDA-CTU$$29$YR$$F$N$81$KG$20240914$N$CN$CA$
243230841$24323084$1$I$$20240912$20240916$20240916$EXP$FR-AFSSAPS-AVNT2024000679$FR-JNJFOC-20240935207$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240916$$PH$FR$FR
243230851$24323085$1$I$20240802$20240913$20240913$20240913$DIR$718364$$FDA-CTU$$62$YR$$F$N$51.9$KG$20240913$N$HP$US$
243230861$24323086$1$I$$20240911$20240913$20240913$DIR$FDA-CDER-CTU-2024-63197$$FDA-CTU$$$$$F$N$$$20240911$N$HP$US$
243230871$24323087$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63200$$FDA-CTU$$$$$M$N$$$20240913$N$HP$US$
243230881$24323088$1$I$20240906$20240911$20240916$20240916$EXP$$NVSC2024US183103$NOVARTIS$$24$YR$$M$Y$$$20240916$$HP$US$US
243230891$24323089$1$I$$20240909$20240916$20240916$PER$$US-ROCHE-10000077644$ROCHE$$$$A$F$Y$63.5$KG$20240916$$CN$US$US
243230911$24323091$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63202$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243230921$24323092$1$I$$20240909$20240916$20240916$EXP$$NVSC2024ES180200$NOVARTIS$$$$$$Y$$$20240916$$CN$ES$ES
243230931$24323093$1$I$$20240910$20240916$20240916$30DAY$$US-PFIZER INC-202400254763$PFIZER$$42$YR$$F$Y$$$20240916$$CN$US$US
243230941$24323094$1$I$$20240906$20240916$20240916$30DAY$$US-PFIZER INC-202400253114$PFIZER$$8$YR$$F$Y$$$20240916$$CN$US$US
243230951$24323095$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63135$$FDA-CTU$$89$YR$$M$N$$$20240913$N$$US$
243230971$24323097$1$I$20240801$20240913$20240913$20240913$DIR$718373$$FDA-CTU$$63$YR$$M$N$$$20240913$N$HP$US$
243230982$24323098$2$F$$20240916$20240916$20240917$30DAY$$BE-PFIZER INC-202400249116$PFIZER$$65$YR$$F$Y$$$20240917$$PH$BE$BE
243230991$24323099$1$I$20240101$20240910$20240916$20240916$30DAY$$US-PFIZER INC-202400254204$PFIZER$$9$YR$$M$Y$21.769$KG$20240916$$CN$US$US
243231011$24323101$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63130$$FDA-CTU$$58$YR$$M$N$$$20240913$N$$US$
243231021$24323102$1$I$$20240910$20240916$20240916$EXP$$US-BAYER-2024A130531$BAYER$$38$YR$A$M$Y$68.027$KG$20240916$$CN$US$US
243231041$24323104$1$I$20240906$20240914$20240914$20240914$DIR$718409$$FDA-CTU$$41$YR$$F$N$70.65$KG$20240914$N$CN$US$
243231051$24323105$1$I$$20240911$20240916$20240916$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024113162$VIIV$$$$$$Y$$$20240916$$PH$US$US
243231061$24323106$1$I$$20240911$20240916$20240916$PER$$US-SA-2024SA166384$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$HP$US$US
243231081$24323108$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265602$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240916$$HP$US$US
243231091$24323109$1$I$20240101$20240904$20240916$20240916$PER$$US-SA-2024SA263661$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240916$$HP$US$US
243231101$24323110$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145562$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240916$$CN$US$US
243231111$24323111$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146730$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$70.31$KG$20240916$$CN$US$US
243231131$24323113$1$I$$20240909$20240913$20240913$DIR$FDA-CDER-CTU-2024-63228$$FDA-CTU$$$$$M$N$$$20240909$N$HP$US$
243231141$24323114$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63194$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243231151$24323115$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146892$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240916$$CN$US$US
243231162$24323116$2$F$20240101$20240913$20240916$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144077$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240917$$CN$US$US
243231171$24323117$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146769$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240916$$CN$US$US
243231181$24323118$1$I$$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146061$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240916$$CN$US$US
243231191$24323119$1$I$20230921$20240905$20240916$20240916$EXP$$JP-JNJFOC-20240934901$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240916$$MD$JP$JP
243231201$24323120$1$I$$20240903$20240916$20240916$EXP$$US-CIPLA LTD.-2024US09831$CIPLA$$$$$$Y$$$20240916$$PH$US$US
243231221$24323122$1$I$20240802$20240914$20240914$20240914$DIR$718386$$FDA-CTU$$32$YR$$M$N$121.5$KG$20240914$N$CN$US$
243231242$24323124$2$F$20240911$20240912$20240916$20240919$30DAY$$US-PFIZER INC-202400255578$PFIZER$$38$YR$$F$Y$$$20240919$$CN$US$US
243231251$24323125$1$I$20240101$20240829$20240916$20240916$30DAY$$CA-PFIZER INC-202400053035$PFIZER$$12$YR$$F$Y$$$20240916$$HP$CA$CA
243231262$24323126$2$F$$20240913$20240916$20240920$30DAY$$GB-PFIZER INC-PV202400119233$PFIZER$$12$YR$$F$Y$$$20240920$$CN$GB$GB
243231282$24323128$2$F$20240910$20240916$20240916$20240919$EXP$$CA-PFIZER INC-202400253894$PFIZER$$77$YR$$F$Y$$$20240919$$HP$CA$CA
243231291$24323129$1$I$$20240903$20240916$20240916$30DAY$$US-PFIZER INC-202400249745$PFIZER$$14$YR$$M$Y$$$20240916$$CN$US$US
243231301$24323130$1$I$$20240903$20240916$20240916$30DAY$$US-PFIZER INC-PV202400115813$PFIZER$$$$$$Y$$$20240916$$HP$US$US
243231311$24323131$1$I$$20240902$20240916$20240916$30DAY$$GB-PFIZER INC-202400249861$PFIZER$$14$YR$$M$Y$$$20240916$$CN$GB$GB
243231322$24323132$2$F$20240905$20240919$20240916$20240924$30DAY$$US-PFIZER INC-202400254043$PFIZER$$57$YR$$M$Y$91.63$KG$20240924$$CN$US$US
243231333$24323133$3$F$$20240924$20240916$20240926$30DAY$$BE-PFIZER INC-202400250695$PFIZER$$51$YR$$M$Y$$$20240926$$PH$BE$BE
243231341$24323134$1$I$20240906$20240909$20240916$20240916$30DAY$$US-PFIZER INC-202400253297$PFIZER$$7$YR$$M$Y$$$20240916$$CN$US$US
243231371$24323137$1$I$20170907$20240914$20240914$20240914$DIR$718406$$FDA-CTU$$45$YR$$F$N$$$20240914$N$HP$US$
243231381$24323138$1$I$20240903$20240913$20240913$20240913$DIR$718376$$FDA-CTU$$9$YR$$M$N$54$KG$20240913$N$CN$US$
243231401$24323140$1$I$20240910$20240914$20240914$20240914$DIR$718426$$FDA-CTU$$31$YR$$F$N$132.75$KG$20240914$N$CN$US$
243231431$24323143$1$I$$20240911$20240913$20240913$DIR$FDA-CDER-CTU-2024-63209$$FDA-CTU$$$$$F$N$$$20240911$N$HP$US$
243231451$24323145$1$I$$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144565$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240916$$HP$US$US
243231462$24323146$2$F$20240101$20240913$20240916$20240926$EXP$$CA-GILEAD-2024-0687718$GILEAD$$$$A$M$Y$$$20240926$$CN$CA$CA
243231471$24323147$1$I$$20240911$20240916$20240916$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-145307$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240916$$MD$FR$FR
243231481$24323148$1$I$$20240905$20240916$20240916$EXP$$NL-KOANAAP-SML-NL-2024-00932$KUMAR ORGANIC PRODUCTS$van der Sar I.G.,Wijsenbeek M.S.,Dumoulin D.W.,Jager A.,van der Veldt A.A.M.,Rossius M.J.P.,Dingemans A.-M.C.,Moor C.C.. Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis. Annals of the American Thoracic Society. 2024;21(6):989-992. doi:10.1513/AnnalsATS.202401-112RL$$$A$$Y$$$20240916$$HP$NL$NL
243231491$24323149$1$I$$20240911$20240916$20240916$EXP$$ZA-AstraZeneca-2024A207459$ASTRAZENECA$$78$YR$$F$Y$$$20240916$$CN$ZA$
243231501$24323150$1$I$20240824$20240913$20240916$20240916$EXP$$US-TAKEDA-2024TUS064116$TAKEDA$$64$YR$$M$Y$$$20240916$$CN$US$US
243231511$24323151$1$I$$20240911$20240916$20240916$PER$$US-BAYER-2024A130649$BAYER$$23$YR$A$F$Y$$$20240916$$CN$US$US
243231521$24323152$1$I$$20240911$20240916$20240916$EXP$$RU-AstraZeneca-2024A208544$ASTRAZENECA$$63$YR$$M$Y$$$20240916$$MD$RU$
243231531$24323153$1$I$20240713$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007795$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240916$$CN$US$US
243231541$24323154$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008292$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240916$$CN$US$US
243231551$24323155$1$I$20230101$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005857$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240916$$CN$US$US
243231562$24323156$2$F$$20240912$20240916$20240920$EXP$$US-BIOCON BIOLOGICS LIMITED-BBL2024006714$BIOCON$$$$$$Y$$$20240920$$PH$US$US
243231571$24323157$1$I$20240831$20240906$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005410$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240916$$CN$US$US
243231581$24323158$1$I$$20240904$20240916$20240916$EXP$$DO-TAKEDA-2024TUS091082$TAKEDA$$$$$F$Y$70$KG$20240916$$CN$DO$DO
243231591$24323159$1$I$20240901$20240909$20240916$20240916$PER$$US-ABBVIE-5916135$ABBVIE$$39$YR$$F$Y$$$20240916$$CN$US$US
243231601$24323160$1$I$$20240913$20240916$20240916$EXP$$US-GILEAD-2024-0663420$GILEAD$$88$YR$E$F$Y$$$20240916$$CN$US$US
243231611$24323161$1$I$$20240912$20240916$20240916$EXP$$US-GILEAD-2024-0687713$GILEAD$$66$YR$E$F$Y$$$20240916$$HP$US$US
243231621$24323162$1$I$20240701$20240820$20240916$20240916$PER$$US-SA-2024SA267086$SANOFI AVENTIS$$13$YR$T$M$Y$47.27$KG$20240916$$MD$US$US
243231631$24323163$1$I$20240101$20240828$20240916$20240916$PER$$US-SA-2024SA266421$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240916$$MD$US$US
243231641$24323164$1$I$$20240827$20240916$20240916$PER$$US-SA-2024SA263742$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
243231661$24323166$1$I$20240801$20240827$20240916$20240916$PER$$US-SA-2024SA266258$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240916$$CN$US$US
243231671$24323167$1$I$$20240827$20240916$20240916$PER$$US-TEVA-VS-3239232$TEVA$$$$A$M$Y$$$20240916$$HP$US$US
243231681$24323168$1$I$$20240906$20240916$20240916$EXP$$GB-TEVA-VS-3241563$TEVA$$85$YR$$M$Y$95$KG$20240916$$MD$GB$GB
243231692$24323169$2$F$$20240916$20240916$20240920$EXP$$US-MYLANLABS-2024M1083759$MYLAN$$$$$F$Y$$$20240920$$CN$US$US
243231701$24323170$1$I$$20240910$20240916$20240916$EXP$$US-MYLANLABS-2024M1083113$MYLAN$$$$$F$Y$$$20240916$$CN$US$US
243231712$24323171$2$F$20240828$20240919$20240916$20240926$EXP$$AU-BEH-2024178023$CSL BEHRING$$69$YR$E$F$Y$80$KG$20240926$$HP$AU$AU
243231721$24323172$1$I$$20240905$20240916$20240916$EXP$$AT-ROCHE-10000078377$ROCHE$$$$I$F$Y$3.46$KG$20240916$$HP$AT$AT
243231731$24323173$1$I$$20240909$20240916$20240916$EXP$$DE-BAXTER-2024BAX024484$BAXTER$$$$$F$Y$$$20240916$$HP$DE$DE
243231751$24323175$1$I$$20240910$20240916$20240916$EXP$$US-MYLANLABS-2024M1083010$MYLAN$$$$$M$Y$$$20240916$$CN$US$US
243231761$24323176$1$I$$20240910$20240916$20240916$EXP$$CA-MYLANLABS-2024M1083288$MYLAN$$74$YR$$F$Y$$$20240916$$CN$CA$CA
243231781$24323178$1$I$$20240903$20240916$20240916$30DAY$$US-PFIZER INC-202400249733$PFIZER$$23$YR$$F$Y$$$20240916$$CN$US$US
243231791$24323179$1$I$20240101$20240909$20240916$20240916$EXP$$CA-PFIZER INC-202400255627$PFIZER$$44$YR$$F$Y$$$20240916$$HP$CA$CA
243231801$24323180$1$I$20240908$20240909$20240916$20240916$30DAY$$US-PFIZER INC-202400253285$PFIZER$$12$YR$$F$Y$$$20240916$$CN$US$US
243231811$24323181$1$I$$20240906$20240913$20240913$DIR$FDA-CDER-CTU-2024-63167$$FDA-CTU$$$$$M$N$$$20240906$N$HP$US$
243231821$24323182$1$I$20240909$20240910$20240916$20240916$30DAY$$US-PFIZER INC-202400254186$PFIZER$$13$YR$$M$Y$$$20240916$$CN$US$US
243231831$24323183$1$I$$20240905$20240916$20240916$30DAY$$US-PFIZER INC-202400251215$PFIZER$$8$YR$$F$Y$$$20240916$$CN$US$US
243231844$24323184$4$F$$20240912$20240916$20240925$30DAY$$US-PFIZER INC-202400253334$PFIZER$$57$YR$$M$Y$$$20240925$$CN$US$US
243231851$24323185$1$I$$20240904$20240916$20240916$30DAY$$US-PFIZER INC-202400250298$PFIZER$$6$YR$$M$Y$$$20240916$$CN$US$US
243231862$24323186$2$F$$20240923$20240916$20240930$30DAY$$CA-PFIZER INC-PV202400118738$PFIZER$$66$YR$$F$Y$$$20240930$$PH$CA$CA
243231871$24323187$1$I$$20240912$20240916$20240916$EXP$$US-PFIZER INC-PV202400118853$PFIZER$$66$YR$$F$Y$$$20240916$$HP$US$US
243231881$24323188$1$I$20211201$20240913$20240913$20240913$DIR$718369$$FDA-CTU$$31$YR$$M$N$72$KG$20240913$N$CN$US$
243231901$24323190$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63170$$FDA-CTU$$56$YR$$F$N$$$20240913$N$$US$
243231911$24323191$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63190$$FDA-CTU$$53$YR$$F$N$$$20240913$N$$US$
243231921$24323192$1$I$$20240905$20240916$20240916$30DAY$$US-PFIZER INC-PV202400117251$PFIZER$$7$YR$$M$Y$$$20240916$$HP$US$US
243231931$24323193$1$I$$20240909$20240916$20240916$30DAY$$US-PFIZER INC-202400253275$PFIZER$$12$YR$$F$Y$$$20240916$$CN$US$US
243231941$24323194$1$I$20161021$20180711$20240916$20240916$EXP$$BR-SA-2024SA264593$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240916$$CN$BR$BR
243231951$24323195$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184704$NOVARTIS$$$$$$Y$$$20240916$$MD$US$US
243231961$24323196$1$I$20240710$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-63157$$FDA-CTU$$32$YR$$F$N$$$20240912$N$HP$US$
243231971$24323197$1$I$20240814$20240909$20240913$20240913$DIR$FDA-CDER-CTU-2024-63156$$FDA-CTU$$17$YR$$M$N$$$20240909$N$HP$US$
243231981$24323198$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63220$$FDA-CTU$$58$YR$$F$N$$$20240913$N$$US$
243231991$24323199$1$I$20240906$20240908$20240913$20240913$DIR$FDA-CDER-CTU-2024-63166$$FDA-CTU$$42$YR$$M$N$$$20240908$N$HP$US$
243232001$24323200$1$I$20240808$20240827$20240913$20240913$DIR$FDA-CDER-CTU-2024-63159$$FDA-CTU$$27$YR$$F$N$$$20240827$N$HP$US$
243232011$24323201$1$I$20240823$20240909$20240913$20240913$DIR$FDA-CDER-CTU-2024-63215$$FDA-CTU$$39$YR$$F$N$$$20240909$N$HP$US$
243232021$24323202$1$I$20240902$20240909$20240913$20240913$DIR$FDA-CDER-CTU-2024-63162$$FDA-CTU$$62$YR$$M$N$$$20240909$N$HP$US$
243232031$24323203$1$I$$20240821$20240913$20240913$DIR$FDA-CDER-CTU-2024-63158$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
243232041$24323204$1$I$20240705$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63147$$FDA-CTU$$72$YR$$F$N$$$20240913$N$HP$US$
243232051$24323205$1$I$20240806$20240823$20240913$20240913$DIR$FDA-CDER-CTU-2024-63163$$FDA-CTU$$47$YR$$M$N$$$20240823$N$HP$US$
243232081$24323208$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63222$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243232101$24323210$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63188$$FDA-CTU$$57$YR$$F$N$$$20240913$N$$US$
243232121$24323212$1$I$$20240913$20240913$20240913$DIR$718334$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243232131$24323213$1$I$20240913$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63131$$FDA-CTU$$63$YR$$F$N$$$20240913$N$$US$
243232141$24323214$1$I$20240904$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63213$$FDA-CTU$$73$YR$$F$N$$$20240913$N$$US$
243232151$24323215$1$I$20240903$20240907$20240913$20240913$DIR$FDA-CDER-CTU-2024-63140$$FDA-CTU$$50$YR$$M$N$$$20240907$N$$US$
243232161$24323216$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63164$$FDA-CTU$$48$YR$$F$N$$$20240913$N$$US$
243232171$24323217$1$I$20240913$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63203$$FDA-CTU$$81$YR$$M$N$$$20240913$N$CN$US$
243232181$24323218$1$I$$20240910$20240913$20240913$DIR$FDA-CDER-CTU-2024-63192$$FDA-CTU$$$$$F$N$$$20240910$N$HP$US$
243232191$24323219$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63199$$FDA-CTU$$64$YR$$F$N$83.91$KG$20240913$N$$US$
243232201$24323220$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63172$$FDA-CTU$$52$YR$$M$N$$$20240913$N$$US$
243232211$24323221$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63151$$FDA-CTU$$76$YR$$M$N$$$20240913$N$$US$
243232222$24323222$2$F$20240903$20240924$20240916$20240926$EXP$$US-BAYER-2024A121363$BAYER$$64$YR$A$M$Y$$$20240926$$HP$US$US
243232231$24323223$1$I$$20240912$20240916$20240916$PER$$US-HALEON-2196747$Haleon PLC$$$$$F$Y$$$20240916$$CN$US$US
243232241$24323224$1$I$20220101$20240910$20240916$20240916$EXP$$US-BIOGEN-2024BI01282058$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
243232251$24323225$1$I$20240402$20240909$20240916$20240916$EXP$$JP-EXELIXIS-EXL-2024-000195$EXELIXIS$$65$YR$$F$Y$54.1$KG$20240916$$MD$JP$JP
243232261$24323226$1$I$20231028$20240909$20240916$20240916$EXP$$JP-EXELIXIS-CABO-24073382$EXELIXIS$$53$YR$$M$Y$78.8$KG$20240916$$MD$JP$JP
243232271$24323227$1$I$$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024182078$AMGEN$Look-why S.; Otto T. S.; Chen S. X. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91 (3):AB354$$$$$Y$$$20240916$$MD$US$US
243232281$24323228$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024111390$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
243232291$24323229$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024111234$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
243232301$24323230$1$I$20240909$20240910$20240916$20240916$EXP$$CN-BAYER-2024A131440$BAYER$$30$YR$A$F$Y$$$20240916$$MD$CN$CN
243232311$24323231$1$I$20200609$20240910$20240916$20240916$EXP$PL-URPL-1-1987-2020$PL-TEVA-VS-3242648$TEVA$$24$YR$$F$Y$60$KG$20240916$$MD$PL$PL
243232321$24323232$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146662$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240916$$CN$US$US
243232341$24323234$1$I$20240801$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63176$$FDA-CTU$$77$YR$$F$N$$$20240913$N$HP$US$
243232351$24323235$1$I$20240522$20240913$20240913$20240913$DIR$718319$$FDA-CTU$$49$YR$$F$N$117$KG$20240913$N$HP$US$
243232361$24323236$1$I$$20240827$20240916$20240916$PER$$US-TEVA-VS-3238491$TEVA$$36$YR$$$Y$$$20240916$$CN$US$US
243232371$24323237$1$I$$20240903$20240916$20240916$EXP$$CA-UCBSA-2024045755$UCB$$$$$F$Y$$$20240916$$CN$CA$CA
243232391$24323239$1$I$$20240912$20240913$20240913$DIR$FDA-CDER-CTU-2024-63174$$FDA-CTU$$$$$F$N$$$20240912$N$HP$US$
243232401$24323240$1$I$20240911$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63161$$FDA-CTU$$44$YR$$F$N$$$20240913$N$$US$
243232411$24323241$1$I$$20240913$20240916$20240916$PER$$US-BAYER-2024A131539$BAYER$$$$$$Y$$$20240916$$CN$US$US
243232431$24323243$1$I$20240716$20240912$20240916$20240916$EXP$$PR-ABBVIE-5922105$ABBVIE$$66$YR$$F$Y$90$KG$20240916$$CN$PR$PR
243232441$24323244$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63178$$FDA-CTU$$77$YR$$M$N$$$20240913$N$$US$
243232451$24323245$1$I$$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024182206$AMGEN$Look-why S.; Otto T. S.; Chen S. X. et al.. 54512 Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91 (3):AB354$$$$$Y$$$20240916$$MD$US$US
243232461$24323246$1$I$$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024182514$AMGEN$Look-why S.; Otto T. S.; Chen S. X. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91(3):AB354$$$$$Y$$$20240916$$MD$US$US
243232471$24323247$1$I$$20240911$20240916$20240916$EXP$$NVSC2024CA183268$NOVARTIS$$39$YR$$F$Y$$$20240916$$PH$CA$CA
243232481$24323248$1$I$$20240911$20240913$20240913$DIR$FDA-CDER-CTU-2024-63225$$FDA-CTU$$$$$F$N$$$20240911$N$HP$US$
243232491$24323249$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63207$$FDA-CTU$$70$YR$$F$N$$$20240913$N$$US$
243232503$24323250$3$F$$20240923$20240916$20240927$30DAY$$US-PFIZER INC-202400253154$PFIZER$$10$YR$$M$Y$$$20240927$$CN$US$US
243232512$24323251$2$F$20240802$20240926$20240916$20240927$30DAY$$CA-PFIZER INC-202400251686$PFIZER$$18$YR$$F$Y$54.422$KG$20240927$$HP$CA$CA
243232522$24323252$2$F$20240901$20240911$20240916$20240920$30DAY$$US-PFIZER INC-202400253956$PFIZER$$14$YR$$M$Y$$$20240920$$HP$US$US
243232531$24323253$1$I$$20240909$20240916$20240916$30DAY$$US-PFIZER INC-202400253286$PFIZER$$12$YR$$F$Y$$$20240916$$CN$US$US
243232541$24323254$1$I$$20240909$20240916$20240916$30DAY$$US-PFIZER INC-202400253524$PFIZER$$15$YR$$F$Y$$$20240916$$CN$US$US
243232561$24323256$1$I$20240912$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63165$$FDA-CTU$$59$YR$$F$N$$$20240913$N$HP$US$
243232571$24323257$1$I$20240403$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63160$$FDA-CTU$$72$YR$$F$N$$$20240913$N$$US$
243232601$24323260$1$I$$20240910$20240916$20240916$30DAY$$US-PFIZER INC-202400254217$PFIZER$$16$YR$$M$Y$49.9$KG$20240916$$HP$US$US
243232611$24323261$1$I$$20240906$20240916$20240916$30DAY$$GB-PFIZER INC-202400254424$PFIZER$$15$YR$$M$Y$$$20240916$$CN$GB$GB
243232622$24323262$2$F$$20240917$20240916$20240920$30DAY$$US-PFIZER INC-202400253147$PFIZER$$10$YR$$M$Y$$$20240920$$CN$US$US
243232631$24323263$1$I$20240101$20240905$20240916$20240916$30DAY$$CO-PFIZER INC-PV202400118008$PFIZER$$9$YR$$F$Y$$$20240916$$CN$CO$CO
243232641$24323264$1$I$$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63149$$FDA-CTU$$88$YR$$F$N$$$20240913$N$$US$
243232653$24323265$3$F$$20240923$20240916$20240924$30DAY$$KR-PFIZER INC-PV202400119517$PFIZER$$14$YR$$M$Y$$$20240924$$CN$KR$KR
243232661$24323266$1$I$20240101$20240822$20240916$20240916$EXP$$US-SA-2024SA263128$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240916$$MD$US$US
243232671$24323267$1$I$20240801$20240911$20240916$20240916$EXP$$CA-BAYER-2024A131020$BAYER$$81$YR$E$F$Y$$$20240916$$HP$CA$CA
243232681$24323268$1$I$$20240909$20240916$20240916$EXP$$US-GSK-US2024111945$GLAXOSMITHKLINE$$$$$M$Y$$$20240916$$MD$US$US
243232691$24323269$1$I$$20240906$20240916$20240916$PER$$US-ABBVIE-5915446$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243232703$24323270$3$F$20240202$20240916$20240916$20240923$PER$$US-AMGEN-USASP2024184271$AMGEN$$72$YR$E$F$Y$$$20240923$$HP$US$US
243232711$24323271$1$I$$20240913$20240916$20240916$EXP$GB-MHRA-MED-202409131643302590-WMCZV$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051477$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240916$$PH$GB$GB
243232721$24323272$1$I$$20240909$20240916$20240916$EXP$$GB-GSK-GB2024EME112198$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$GB$GB
243232731$24323273$1$I$$20240909$20240916$20240916$EXP$AU-MMM-PMU12EDH$AU-GSK-AU2024111590$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$AU$AU
243232741$24323274$1$I$$20240909$20240916$20240916$EXP$$IT-TAKEDA-2024TUS090338$TAKEDA$$$$$F$Y$$$20240916$$CN$IT$IT
243232751$24323275$1$I$20200605$20240910$20240916$20240916$EXP$$US-TAKEDA-US202006717$TAKEDA$$54$YR$$M$Y$68$KG$20240916$$MD$US$US
243232761$24323276$1$I$$20240909$20240916$20240916$EXP$$CN-GSK-CN2024APC112120$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$CN$CN
243232781$24323278$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A206608$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243232791$24323279$1$I$20240908$20240911$20240916$20240916$PER$$US-AstraZeneca-2024A208045$ASTRAZENECA$$30421$DY$$F$Y$$$20240916$$CN$US$
243232801$24323280$1$I$$20240912$20240916$20240916$PER$$NVSC2024US183221$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
243232821$24323282$1$I$$20240905$20240916$20240916$EXP$$US-UCBSA-2024045814$UCB$$$$$F$Y$$$20240916$$HP$US$US
243232831$24323283$1$I$$20240909$20240916$20240916$EXP$$IT-ROCHE-10000081509$ROCHE$Gamba A, Depascale R, Zanatta E, Ienna L, Cruciani C, Gatto M. Effectiveness and safety of low dose Rituximab as remission-maintenance treatment for patients with refractory idiopathic inflammatory myopathies: results of a retrospective study from a monocentric cohort. Clinical Rheumatology. 2024; doi:10.1007/s10067-024-07079-z.$$$$M$Y$$$20240916$$HP$IT$IT
243232841$24323284$1$I$20240701$20240910$20240916$20240916$PER$$US-SA-2024SA265494$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240916$$MD$US$US
243232851$24323285$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265633$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240916$$CN$US$US
243232861$24323286$1$I$$20240822$20240916$20240916$EXP$$JP-AstraZeneca-2024A193837$ASTRAZENECA$$86$YR$$M$Y$$$20240916$$MD$JP$
243232871$24323287$1$I$$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024182517$AMGEN$Look-why S.; Otto T.S.; Chen X.S. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91 (3):AB354$$$$$Y$$$20240916$$MD$US$US
243232881$24323288$1$I$20240101$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024183790$AMGEN$$63$YR$A$M$Y$$$20240916$$CN$US$US
243232891$24323289$1$I$$20240904$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409003795$ELI LILLY AND CO$$$$$F$Y$$$20240916$$HP$US$US
243232901$24323290$1$I$20240911$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008300$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$US$US
243232911$24323291$1$I$20240829$20240911$20240916$20240916$EXP$$US-BAYER-2024A131226$BAYER$$74$YR$E$F$Y$43.084$KG$20240916$$CN$US$US
243232921$24323292$1$I$$20240914$20240916$20240916$DIR$FDA-CDER-CTU-2024-63369$$FDA-CTU$$$$$F$N$$$20240914$N$HP$US$
243232961$24323296$1$I$$20240903$20240916$20240916$EXP$$DE-SA-2024SA248914$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240916$$CN$DE$DE
243232971$24323297$1$I$$20240902$20240916$20240916$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08307$HIKMA$$67$YR$$F$Y$48$KG$20240916$$HP$CA$CA
243232981$24323298$1$I$20240903$20240910$20240916$20240916$EXP$$US-SA-2024SA265144$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240916$$MD$US$US
243232991$24323299$1$I$$20240910$20240916$20240916$EXP$$US-AMGEN-USASP2024181208$AMGEN$$$$$$Y$$$20240916$$LW$US$US
243233001$24323300$1$I$20240708$20240909$20240916$20240916$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-123922$REGENERON$$77$YR$$M$Y$$$20240916$$HP$CO$CO
243233011$24323301$1$I$$20240912$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US079885$SANDOZ$$$$$F$Y$$$20240916$$MD$US$US
243233021$24323302$1$I$$20240910$20240916$20240916$PER$$US-TAKEDA-2024TUS066374$TAKEDA$$$$$$Y$$$20240916$$HP$US$US
243233031$24323303$1$I$20230501$20240904$20240916$20240916$PER$$US-SA-2024SA263429$SANOFI AVENTIS$$$$C$F$Y$$$20240916$$MD$US$US
243233041$24323304$1$I$$20240821$20240916$20240916$PER$$US-SA-2024SA267262$SANOFI AVENTIS$$$$E$M$Y$73.016$KG$20240916$$MD$US$US
243233051$24323305$1$I$20240823$20240824$20240916$20240916$PER$$US-SA-2024SA262219$SANOFI AVENTIS$$41$YR$A$F$Y$120$KG$20240916$$MD$US$US
243233061$24323306$1$I$20230101$20240909$20240916$20240916$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-122869$REGENERON$$59$YR$$F$Y$$$20240916$$CN$CO$CO
243233071$24323307$1$I$$20240911$20240916$20240916$PER$$US-SA-2024SA265649$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240916$$MD$US$US
243233081$24323308$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145563$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240916$$CN$US$US
243233091$24323309$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146682$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240916$$CN$US$US
243233101$24323310$1$I$$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144239$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240916$$CN$US$US
243233111$24323311$1$I$$20240913$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146790$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240916$$CN$US$US
243233121$24323312$1$I$$20240909$20240916$20240916$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-144469$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240916$$HP$AU$AU
243233131$24323313$1$I$20240905$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145817$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$78.47$KG$20240916$$CN$US$US
243233141$24323314$1$I$20240822$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146010$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$116.12$KG$20240916$$PH$US$US
243233151$24323315$1$I$20240812$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146374$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240916$$CN$US$US
243233162$24323316$2$F$$20240905$20240916$20240918$EXP$$US-UCBSA-2024042690$UCB$$$$$F$Y$45.7$KG$20240918$$CN$US$US
243233171$24323317$1$I$$20240912$20240916$20240916$PER$$US-BIOGEN-2024BI01282358$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
243233181$24323318$1$I$$20240905$20240916$20240916$PER$$US-PHARMING-PHAUS2024000794$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
243233201$24323320$1$I$$20240905$20240916$20240916$PER$$US-PHARMING-PHAUS2024000779$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
243233211$24323321$1$I$20240831$20240909$20240916$20240916$PER$$US-PHARMING-PHAUS2024000788$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
243233222$24323322$2$F$$20240913$20240916$20240923$PER$$US-PHARMING-PHAUS2024000785$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243233241$24323324$1$I$$20240909$20240916$20240916$PER$$US-PHARMING-PHAUS2024000787$PHARMING GROUP$$$$$$Y$$$20240916$$CN$US$US
243233251$24323325$1$I$20240801$20240905$20240916$20240916$EXP$$US-UCBSA-2024045825$UCB$$34$YR$$F$Y$$$20240916$$HP$US$US
243233261$24323326$1$I$$20240828$20240916$20240916$PER$$US-009507513-2408USA010021$MERCK$$$$$F$Y$$$20240916$$CN$US$US
243233271$24323327$1$I$$20240906$20240916$20240916$PER$$US-PHARMING-PHAUS2024000784$PHARMING GROUP$$$$$$Y$$$20240916$$HP$US$US
243233281$24323328$1$I$$20240903$20240916$20240916$PER$$US-ASTELLAS-2024-AER-004860$ASTELLAS$$88$YR$E$M$Y$$$20240916$$CN$US$US
243233292$24323329$2$F$20240301$20240909$20240916$20240926$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-122813$REGENERON$$66$YR$$F$Y$$$20240926$$HP$CO$CO
243233301$24323330$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265092$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240916$$HP$US$US
243233312$24323331$2$F$20240829$20240913$20240916$20240920$EXP$$US-GSK-US2024112027$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243233341$24323334$1$I$20240101$20240906$20240916$20240916$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-122719$REGENERON$$76$YR$$F$Y$$$20240916$$HP$CO$CO
243233351$24323335$1$I$$20240913$20240913$20240913$DIR$718329$$FDA-CTU$$46$YR$$F$N$54$KG$20240913$N$CN$US$
243233371$24323337$1$I$$20240902$20240916$20240916$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08258$HIKMA$$$$$$Y$$$20240916$$CN$US$US
243233401$24323340$1$I$$20240909$20240916$20240916$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001837$BLUEPRINT MEDICINES$$$$$F$Y$$$20240916$$CN$US$US
243233411$24323341$1$I$$20240913$20240913$20240913$DIR$718312$$FDA-CTU$$$$$UNK$N$$$20240913$N$$US$
243233421$24323342$1$I$$20240914$20240916$20240916$DIR$FDA-CDER-CTU-2024-63370$$FDA-CTU$$$$$F$N$$$20240914$N$HP$US$
243233431$24323343$1$I$20240912$20240913$20240913$20240913$DIR$718384$$FDA-CTU$$76$YR$$M$N$58$KG$20240913$Y$HP$US$
243233441$24323344$1$I$$20240911$20240916$20240916$PER$$US-BAYER-2024A131129$BAYER$$25$YR$A$F$Y$$$20240916$$HP$US$US
243233452$24323345$2$F$20240801$20240917$20240916$20240925$EXP$$JP-SA-2024SA266598$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240925$$PH$JP$JP
243233462$24323346$2$F$20240905$20240912$20240916$20240918$EXP$$JP-009507513-2409JPN001035J$MERCK$$61$YR$$M$Y$$$20240918$$PH$JP$JP
243233471$24323347$1$I$$20240913$20240916$20240916$EXP$$NVSC2024ET184356$NOVARTIS$$$$$M$Y$$$20240916$$MD$ET$ET
243233481$24323348$1$I$$20240912$20240916$20240916$PER$$US-ABBVIE-5924575$ABBVIE$$$$$$Y$$$20240916$$HP$US$US
243233493$24323349$3$F$20240903$20240926$20240916$20240928$PER$$US-AMGEN-USASP2024181644$AMGEN$$64$YR$A$M$Y$$$20240928$$MD$US$US
243233501$24323350$1$I$20240701$20240910$20240916$20240916$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005064$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240916$$CN$US$US
243233511$24323351$1$I$20231124$20240910$20240916$20240916$EXP$ES-AEMPS-1512943$ES-ROCHE-10000078277$ROCHE$$54$YR$A$F$Y$$$20240916$$MD$ES$ES
243233531$24323353$1$I$20240614$20240913$20240913$20240913$DIR$718323$$FDA-CTU$$46$YR$$F$N$138$KG$20240913$N$HP$US$
243233551$24323355$1$I$$20240913$20240913$20240913$DIR$718377$$FDA-CTU$$74$YR$$F$N$$$20240913$Y$HP$US$
243233571$24323357$1$I$$20240914$20240914$20240914$DIR$718398$$FDA-CTU$$78$YR$$F$N$$$20240914$N$PH$US$
243233591$24323359$1$I$20240726$20240913$20240913$20240913$DIR$718362$$FDA-CTU$$74$YR$$F$N$59.8$KG$20240913$N$HP$US$
243233601$24323360$1$I$20240913$20240913$20240913$20240913$DIR$718354$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243233621$24323362$1$I$$20240909$20240916$20240916$EXP$$DE-MYLANLABS-2024M1083603$MYLAN$$$$$F$Y$$$20240916$$MD$DE$DE
243233632$24323363$2$F$20030101$20240924$20240916$20240927$EXP$$FR-MYLANLABS-2024M1082518$MYLAN$$74$YR$$M$Y$$$20240927$$CN$FR$FR
243233642$24323364$2$F$$20240918$20240916$20240924$EXP$$GR-MYLANLABS-2024M1083034$MYLAN$$73$YR$$F$Y$$$20240924$$CN$GR$GR
243233652$24323365$2$F$$20240916$20240916$20240923$EXP$$US-MYLANLABS-2024M1083035$MYLAN$$$$$M$Y$$$20240923$$CN$US$US
243233661$24323366$1$I$$20240909$20240916$20240916$EXP$$IT-MYLANLABS-2024M1083485$MYLAN$Dasara M, Dono F, Evangelista G, Quintieri P, Liviello D, Cipollone S, et al. Status epilepticus as a complication of SARS-CoV-2 vaccination: Two case reports and systematic review with individual patients^ data analysis. Seizure 2024; 121 (0): 8-16.$80$YR$$F$Y$$$20240916$$HP$IT$IT
243233671$24323367$1$I$$20240909$20240916$20240916$EXP$$ES-MYLANLABS-2024M1083593$MYLAN$Mansilla-Polo M, Escutia-Munoz B, Llavador-Ros M, Botella-Estrada R.. Skin lesions in a lung transplant recipient.. ENFERMEDADES INFECCIOSAS Y MICROBIOLOG?A CL?NIC. 2024;42 (3):160-2$31$YR$$M$Y$$$20240916$$HP$ES$ES
243233681$24323368$1$I$20240905$20240909$20240916$20240916$EXP$$GB-MYLANLABS-2024M1081229$MYLAN$$$$$F$Y$$$20240916$$CN$GB$GB
243233691$24323369$1$I$20240501$20240909$20240916$20240916$EXP$DK-DKMA-30737903$DK-TEVA-VS-3242034$TEVA$$75$YR$$F$Y$$$20240916$$HP$DK$DK
243233701$24323370$1$I$$20240909$20240916$20240916$EXP$$CA-MYLANLABS-2024M1083543$MYLAN$Neves Briard J, Duquette A, Cayrol R, Lapalme-Remis S. Refractory Status Epilepticus in a Patient With Aducanumab-Induced Amyloid-Related Imaging Abnormalities. Neurology 2024; 103 (5).$75$YR$$F$Y$$$20240916$$MD$CA$CA
243233711$24323371$1$I$$20240910$20240916$20240916$EXP$$US-TAKEDA-2024TUS090484$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
243233722$24323372$2$F$20240901$20240917$20240916$20240925$PER$$US-ABBVIE-5924078$ABBVIE$$$$$F$Y$$$20240925$$HP$US$US
243233732$24323373$2$F$20240611$20240912$20240916$20240916$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006694$AURINIA PHARMACEUTICALS$$51$YR$$F$Y$$$20240916$$HP$US$US
243233761$24323376$1$I$20231101$20240912$20240916$20240916$EXP$$CA-PFIZER INC-2020450851$PFIZER$$75$YR$$F$Y$$$20240916$$MD$CA$CA
243233771$24323377$1$I$$20240912$20240916$20240916$EXP$$US-PFIZER INC-PV202300192116$PFIZER$$69$YR$$F$Y$$$20240916$$CN$US$US
243233783$24323378$3$F$20240401$20240919$20240916$20240925$EXP$$PL-PFIZER INC-202400252585$PFIZER$$84$YR$$F$Y$$$20240925$$CN$PL$PL
243233791$24323379$1$I$20240901$20240912$20240916$20240916$EXP$$CN-PFIZER INC-PV202400120024$PFIZER$$$$$M$Y$0.79$KG$20240916$$HP$CN$CN
243233801$24323380$1$I$20240101$20240911$20240916$20240916$EXP$$CA-PFIZER INC-202400022470$PFIZER$$41$YR$$M$Y$$$20240916$$MD$CA$CA
243233811$24323381$1$I$$20240913$20240916$20240916$EXP$$CA-PFIZER INC-202400256248$PFIZER$$61$YR$$F$Y$43$KG$20240916$$MD$CA$CA
243233841$24323384$1$I$$20240912$20240916$20240916$EXP$$ZA-PFIZER INC-PV202400119870$PFIZER$$$$A$F$Y$60.5$KG$20240916$$MD$ZA$ZA
243233851$24323385$1$I$$20240909$20240916$20240916$EXP$$US-PFIZER INC-202400253342$PFIZER$$65$YR$$F$Y$81.6$KG$20240916$$MD$US$US
243233871$24323387$1$I$$20240910$20240916$20240916$EXP$$AU-PFIZER INC-PV202400119611$PFIZER$$37$YR$$M$Y$73$KG$20240916$$MD$AU$AU
243233881$24323388$1$I$$20240911$20240916$20240916$EXP$$US-PFIZER INC-PV202400120147$PFIZER$$62$YR$$M$Y$$$20240916$$CN$US$US
243233892$24323389$2$F$20240621$20240923$20240916$20240923$EXP$$CN-PFIZER INC-PV202400120062$PFIZER$$69$YR$$F$Y$47$KG$20240923$$HP$CN$CN
243233901$24323390$1$I$$20240911$20240916$20240916$EXP$$US-PFIZER INC-PV202400119970$PFIZER$$$$$$Y$$$20240916$$CN$US$US
243233911$24323391$1$I$20240805$20240906$20240916$20240916$EXP$GB-MHRA-MED-202409061549233240-QYHJB$GB-TEVA-VS-3241834$TEVA$$69$YR$$F$Y$$$20240916$$HP$GB$GB
243233921$24323392$1$I$20240101$20240911$20240916$20240916$EXP$$US-ABBVIE-5920952$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243233941$24323394$1$I$20240904$20240906$20240916$20240916$EXP$GB-MHRA-MED-202409051400377550-QNDRW$GB-TEVA-VS-3241645$TEVA$$53$YR$$F$Y$$$20240916$$HP$GB$GB
243233951$24323395$1$I$$20240912$20240916$20240916$EXP$$US-GILEAD-2024-0687681$GILEAD$$$$A$M$Y$$$20240916$$CN$US$US
243233962$24323396$2$F$$20240918$20240916$20240926$EXP$$JP-UCBSA-2024046250$UCB$$37$YR$$M$Y$$$20240926$$MD$JP$JP
243233971$24323397$1$I$$20240912$20240916$20240916$PER$$NVSC2024US183397$NOVARTIS$$$$$$Y$$$20240916$$CN$US$US
243233981$24323398$1$I$20240909$20240909$20240916$20240916$PER$$US-AstraZeneca-2024A206795$ASTRAZENECA$$32369$DY$$F$Y$$$20240916$$CN$US$
243233992$24323399$2$F$20240909$20240917$20240916$20240918$EXP$$US-AstraZeneca-2024A208579$ASTRAZENECA$$28962$DY$$F$Y$$$20240918$$CN$US$
243234001$24323400$1$I$20240913$20240913$20240913$20240913$DIR$718385$$FDA-CTU$$47$YR$$F$N$71.55$KG$20240913$N$CN$US$
243234011$24323401$1$I$$20240902$20240916$20240916$EXP$$US-SAMSUNG BIOEPIS-SB-2024-27032$SAMSUNG BIOEPIS$Morecroft R, Davis AA. Chemotherapy-induced neutropenia management in a patient with metastatic breast cancer and Shwachman- Diamond syndrome (SDS): a case report. Translational breast cancer research : a journal focusing on translational research in breast cancer. 2024 Jul 22;doi:https://dx.doi.org/10.21037/tbcr-24-13.$41$YR$A$F$Y$$$20240916$$HP$US$US
243234031$24323403$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146160$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240916$$CN$US$US
243234041$24323404$1$I$$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144592$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240916$$MD$US$US
243234051$24323405$1$I$20231001$20240912$20240916$20240916$EXP$PT-AMGEN-PRTSP2024175267$PT-ROCHE-10000079977$ROCHE$Lopes N.; Neves D.; Brito U.. OCULAR METASTASIS, A RARE MANIFESTATION. Pulmonology. 2024;30:S67$63$YR$A$F$Y$$$20240916$$HP$PT$PT
243234061$24323406$1$I$20240101$20240828$20240916$20240916$PER$$US-SA-2024SA266301$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240916$$CN$US$US
243234071$24323407$1$I$20240905$20240913$20240916$20240916$EXP$GB-MHRA-MED-202409131541484030-WHKQC$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051508$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$87$KG$20240916$$HP$GB$GB
243234081$24323408$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265080$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240916$$MD$US$US
243234101$24323410$1$I$20231201$20240906$20240916$20240916$PER$$US-SA-2024SA264751$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240916$$HP$US$US
243234111$24323411$1$I$20240101$20240828$20240916$20240916$PER$$US-SA-2024SA266438$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240916$$CN$US$US
243234121$24323412$1$I$20240903$20240909$20240916$20240916$PER$$US-SA-2024SA265650$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240916$$MD$US$US
243234131$24323413$1$I$20240101$20240822$20240916$20240916$PER$$US-SA-2024SA201459$SANOFI AVENTIS$$33$YR$A$F$Y$62.596$KG$20240916$$MD$US$US
243234142$24323414$2$F$20240501$20240911$20240916$20240919$EXP$$US-BAYER-2024A130424$BAYER$$76$YR$E$M$Y$$$20240919$$CN$US$US
243234151$24323415$1$I$$20240909$20240916$20240916$EXP$NL-LRB-00999255$NL-TEVA-VS-3242022$TEVA$$53$YR$$F$Y$63$KG$20240916$$CN$NL$NL
243234161$24323416$1$I$20240901$20240912$20240916$20240916$EXP$$NVSC2024CA183907$NOVARTIS$$43$YR$$F$Y$$$20240916$$CN$CA$CA
243234171$24323417$1$I$20240911$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008002$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240916$$HP$US$US
243234181$24323418$1$I$20240913$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008923$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240916$$CN$US$US
243234191$24323419$1$I$20240909$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005834$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240916$$CN$US$US
243234201$24323420$1$I$$20240909$20240916$20240916$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001845$BLUEPRINT MEDICINES$$$$$M$Y$$$20240916$$CN$US$US
243234211$24323421$1$I$20240901$20240912$20240916$20240916$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005098$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240916$$CN$US$US
243234221$24323422$1$I$$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009309$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240916$$CN$US$US
243234231$24323423$1$I$20240101$20240827$20240916$20240916$PER$$US-SA-2024SA266371$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240916$$MD$US$US
243234241$24323424$1$I$$20240913$20240916$20240916$EXP$$NVSC2024US184265$NOVARTIS$$$$$M$Y$$$20240916$$CN$US$US
243234252$24323425$2$F$20240801$20240918$20240916$20240919$EXP$FR-AFSSAPS-AN2024001263$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-145680$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240919$$PH$FR$FR
243234261$24323426$1$I$20240101$20240821$20240916$20240916$PER$$US-SA-2024SA265661$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240916$$HP$US$US
243234271$24323427$1$I$20240101$20240827$20240916$20240916$PER$$US-SA-2024SA263678$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240916$$MD$US$US
243234282$24323428$2$F$$20240923$20240916$20240926$EXP$$NVSC2024CN182567$NOVARTIS$$$$A$F$Y$$$20240926$$CN$CN$CN
243234293$24323429$3$F$20240816$20240920$20240916$20240925$EXP$$NVSC2024CN183943$NOVARTIS$$76$YR$$M$Y$74$KG$20240925$$CN$CN$CN
243234301$24323430$1$I$$20240905$20240916$20240916$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005379$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243234311$24323431$1$I$$20240905$20240916$20240916$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17908$IPSEN$$2$YR$C$F$Y$$$20240916$$CN$US$US
243234321$24323432$1$I$$20240913$20240916$20240916$DIR$FDA-CDER-CTU-2024-63372$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243234331$24323433$1$I$$20240913$20240916$20240916$DIR$FDA-CDER-CTU-2024-63365$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243234341$24323434$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63368$$FDA-CTU$$83$YR$$M$N$$$20240916$N$$US$
243234361$24323436$1$I$$20240913$20240916$20240916$DIR$FDA-CDER-CTU-2024-63366$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243234381$24323438$1$I$$20240906$20240916$20240916$DIR$FDA-CDER-CTU-2024-63363$$FDA-CTU$$$$$M$N$$$20240906$N$HP$US$
243234391$24323439$1$I$$20240830$20240916$20240916$DIR$FDA-CDER-CTU-2024-63349$$FDA-CTU$$$$$F$N$$$20240830$N$HP$US$
243234411$24323441$1$I$$20240913$20240916$20240916$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005126$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240916$$CN$US$US
243234422$24323442$2$F$$20240913$20240916$20240919$PER$$US-AMGEN-USASP2024184414$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243234431$24323443$1$I$20240901$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024181960$AMGEN$$$$$F$Y$$$20240916$$MD$US$US
243234441$24323444$1$I$20240901$20240912$20240916$20240916$EXP$$PL-GSK-PL2024114091$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$PL$PL
243234461$24323446$1$I$20230829$20240910$20240916$20240916$EXP$$GB-GSK-GB2024GSK112351$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$GB$GB
243234471$24323447$1$I$$20240912$20240916$20240916$PER$$US-HALEON-2196771$Haleon PLC$$$$$$Y$$$20240916$$CN$US$US
243234491$24323449$1$I$20240904$20240914$20240914$20240914$DIR$718403$$FDA-CTU$$73$YR$$F$N$90$KG$20240914$N$CN$US$
243234501$24323450$1$I$20240206$20240916$20240916$20240916$EXP$$US-PROD-AS2-212756134-RB-083225-2024$RECKITT BENCKISER$$71$YR$$M$Y$156.92$KG$20240916$$CN$US$US
243234511$24323451$1$I$$20240916$20240916$20240916$EXP$$US-PROD-AS2-212756134-RB-083959-2024$RECKITT BENCKISER$$$$$F$Y$$$20240916$$CN$US$US
243234521$24323452$1$I$20240913$20240913$20240913$20240913$DIR$718325$$FDA-CTU$$62$YR$$F$N$117.45$KG$20240913$N$CN$US$
243234531$24323453$1$I$$20240902$20240916$20240916$EXP$$TR-PURACAP-TR-2024EPCLIT01102$PURACAP$A Calim.Risk of Hypercalcemia in the Elderly Patients with Hypervitaminosis D and Vitamin D Intoxication.Clinical Laboratory: Journal for Clinical Laboratories and Laboratories Related to Blood Transfusion.MAR-2023;69 (No.3):523-529$$$E$$Y$$$20240916$$HP$TR$TR
243234542$24323454$2$F$20240101$20240919$20240916$20240923$EXP$$FR-GILEAD-2024-0687695$GILEAD$$57$YR$A$M$Y$$$20240923$$MD$FR$FR
243234571$24323457$1$I$20240101$20240911$20240916$20240916$PER$$US-SA-2024SA265598$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$HP$US$US
243234581$24323458$1$I$20240824$20240829$20240916$20240916$PER$$US-SA-2024SA259314$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240916$$MD$US$US
243234591$24323459$1$I$20240101$20240828$20240916$20240916$PER$$US-SA-2024SA266326$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240916$$MD$US$US
243234601$24323460$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA265749$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240916$$PH$US$US
243234611$24323461$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265727$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240916$$HP$US$US
243234621$24323462$1$I$$20240903$20240916$20240916$PER$$US-SA-2024SA267074$SANOFI AVENTIS$$65$YR$E$$Y$$$20240916$$CN$US$US
243234631$24323463$1$I$$20240910$20240916$20240916$PER$$US-GILEAD-2024-0687433$GILEAD$$83$YR$E$$Y$$$20240916$$MD$US$US
243234641$24323464$1$I$20240723$20240909$20240916$20240916$EXP$$US-Vifor (International) Inc.-VIT-2024-08197$VIFOR$$69$YR$$M$Y$88$KG$20240916$$HP$US$US
243234651$24323465$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146157$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240916$$HP$US$US
243234661$24323466$1$I$20240101$20240906$20240916$20240916$PER$CN-CMS-2024CMS001199$CN-Vifor (International) Inc.-VIT-2024-08206$VIFOR$$58$YR$$$Y$$$20240916$$MD$CN$CN
243234671$24323467$1$I$$20240913$20240916$20240916$EXP$NL-EMA-DD-20201105-kumarvn_p-112409$NL-SANDOZ INC.-GXKR2008NL09483$SANDOZ$$44$YR$$M$Y$$$20240916$$MD$NL$NL
243234681$24323468$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146684$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$49.9$KG$20240916$$CN$US$US
243234691$24323469$1$I$$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145942$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240916$$HP$US$US
243234701$24323470$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146091$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240916$$CN$US$US
243234711$24323471$1$I$$20240911$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146040$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240916$$HP$US$US
243234722$24323472$2$F$$20240916$20240916$20240930$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08874$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243234731$24323473$1$I$20240801$20240905$20240916$20240916$EXP$$US-UCBSA-2024046121$UCB$$63$YR$$F$Y$$$20240916$$HP$US$US
243234741$24323474$1$I$20240101$20240909$20240916$20240916$EXP$$US-TAKEDA-2023TUS119801$TAKEDA$$13$YR$$M$Y$67.42$KG$20240916$$MD$US$US
243234751$24323475$1$I$$20240912$20240916$20240916$EXP$$BR-AMGEN-BRASP2024183017$AMGEN$$$$$F$Y$$$20240916$$MD$BR$BR
243234761$24323476$1$I$$20240912$20240916$20240916$EXP$$BR-AMGEN-BRASP2024183027$AMGEN$$$$$F$Y$$$20240916$$MD$BR$BR
243234772$24323477$2$F$$20240918$20240916$20240923$EXP$$US-SANDOZ INC.-SDZ2024US080114$SANDOZ$$77$YR$$F$Y$67.12$KG$20240923$$CN$US$US
243234781$24323478$1$I$$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024182395$AMGEN$$$$A$F$Y$$$20240916$$MD$US$US
243234791$24323479$1$I$20240701$20240911$20240916$20240916$EXP$$NVSC2024RU183022$NOVARTIS$$$$A$M$Y$$$20240916$$MD$RU$RU
243234801$24323480$1$I$20240826$20240906$20240916$20240916$EXP$$CN-009507513-2409CHN003842$MERCK$$76$YR$$M$Y$50$KG$20240916$$HP$CN$CN
243234821$24323482$1$I$$20240911$20240916$20240916$EXP$$US-INCYTE CORPORATION-2024IN009677$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243234831$24323483$1$I$$20240906$20240916$20240916$EXP$$CA-TEVA-VS-3241579$TEVA$$67$YR$$F$Y$$$20240916$$PH$CA$CA
243234841$24323484$1$I$$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024180957$AMGEN$$$$$$Y$$$20240916$$MD$US$US
243234851$24323485$1$I$20240801$20240906$20240916$20240916$EXP$$FR-EXELIXIS-EXL-2024-000217$EXELIXIS$$62$YR$$M$Y$74$KG$20240916$$PH$FR$FR
243234861$24323486$1$I$20240329$20240913$20240913$20240913$DIR$718330$$FDA-CTU$$54$YR$$F$N$65.25$KG$20240913$N$CN$US$
243234881$24323488$1$I$20240825$20240914$20240914$20240914$DIR$718402$$FDA-CTU$$83$YR$$M$N$67.5$KG$20240914$N$CN$US$
243234891$24323489$1$I$20240810$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63376$$FDA-CTU$$65$YR$$F$N$$$20240916$N$$US$
243234911$24323491$1$I$20240814$20240914$20240914$20240914$DIR$718420$$FDA-CTU$$42$YR$$M$N$95.85$KG$20240914$N$CN$US$
243234921$24323492$1$I$$20240915$20240916$20240916$DIR$FDA-CDER-CTU-2024-63377$$FDA-CTU$$$$$F$N$$$20240915$N$HP$US$
243234941$24323494$1$I$$20240909$20240916$20240916$EXP$$RU-ROCHE-10000078232$ROCHE$$$$$F$Y$$$20240916$$MD$RU$RU
243234951$24323495$1$I$$20240827$20240916$20240916$PER$$US-SA-2024SA266006$SANOFI AVENTIS$$$$C$M$Y$13.15$KG$20240916$$MD$US$US
243234961$24323496$1$I$20240426$20240906$20240916$20240916$PER$$US-SA-2024SA265675$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240916$$HP$US$US
243234971$24323497$1$I$20240901$20240906$20240916$20240916$PER$$US-SA-2024SA264836$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240916$$MD$US$US
243234981$24323498$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265594$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240916$$MD$US$US
243234991$24323499$1$I$20240801$20240910$20240916$20240916$PER$$US-SA-2024SA264931$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240916$$MD$US$US
243235021$24323502$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146437$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240916$$HP$US$US
243235031$24323503$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145720$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240916$$CN$US$US
243235061$24323506$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146313$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240916$$CN$US$US
243235071$24323507$1$I$$20240902$20240916$20240916$EXP$$TR-PURACAP-TR-2024EPCLIT01099$PURACAP$A Calim.Risk of Hypercalcemia in the Elderly Patients with Hypervitaminosis D and Vitamin D Intoxication.Clinical Laboratory: Journal for Clinical Laboratories and Laboratories Related to Blood Transfusion.MAR-2023;69 (No.3):523-529$$$$$Y$$$20240916$$HP$TR$TR
243235081$24323508$1$I$20240101$20240904$20240916$20240916$EXP$$US-UCBSA-2024018501$UCB$$$$$F$Y$106.12$KG$20240916$$HP$US$US
243235091$24323509$1$I$20240901$20240910$20240916$20240916$EXP$$JP-009507513-2409JPN001462J$MERCK$$7$DEC$$F$Y$$$20240916$$PH$JP$JP
243235101$24323510$1$I$$20240909$20240916$20240916$EXP$$ES-ASTELLAS-2024-AER-006717$ASTELLAS$$$$A$M$Y$$$20240916$$MD$ES$ES
243235111$24323511$1$I$$20240912$20240916$20240916$PER$$NVSC2024US183619$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243235131$24323513$1$I$20240715$20240910$20240916$20240916$EXP$$US-JNJFOC-20240934427$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240916$$HP$US$US
243235141$24323514$1$I$20240101$20240910$20240916$20240916$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-01014$CATALYST PHARMA$$$$$M$Y$78.912$KG$20240916$$CN$US$US
243235161$24323516$1$I$20240901$20240910$20240916$20240916$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-01009$CATALYST PHARMA$$54$YR$$F$Y$81.633$KG$20240916$$CN$US$US
243235172$24323517$2$F$20240905$20240917$20240916$20240919$PER$$US-AMGEN-USASP2024183387$AMGEN$$70$YR$E$M$Y$$$20240919$$CN$US$US
243235181$24323518$1$I$$20240910$20240916$20240916$EXP$$US-AMGEN-USASL2024181221$AMGEN$$82$YR$E$F$Y$$$20240916$$CN$US$US
243235191$24323519$1$I$$20240911$20240916$20240916$EXP$$US-MYLANLABS-2024M1083431$MYLAN$$$$$F$Y$111$KG$20240916$$CN$US$US
243235201$24323520$1$I$$20240911$20240916$20240916$EXP$$GB-MYLANLABS-2024M1083198$MYLAN$$$$$F$Y$$$20240916$$MD$GB$GB
243235211$24323521$1$I$$20240911$20240916$20240916$EXP$$CA-MYLANLABS-2024M1083959$MYLAN$$$$$F$Y$$$20240916$$PH$CA$CA
243235221$24323522$1$I$20240101$20240911$20240916$20240916$EXP$$GB-MYLANLABS-2024M1083294$MYLAN$$$$$F$Y$$$20240916$$HP$GB$GB
243235241$24323524$1$I$$20240912$20240916$20240916$EXP$$DE-SANDOZ INC.-SDZ2024DE079869$SANDOZ$$25$YR$$F$Y$$$20240916$$CN$DE$DE
243235251$24323525$1$I$$20240902$20240916$20240916$EXP$$TR-PURACAP-TR-2024EPCLIT01103$PURACAP$A Calim.Risk of Hypercalcemia in the Elderly Patients with Hypervitaminosis D and Vitamin D Intoxication.Clinical Laboratory: Journal for Clinical Laboratories and Laboratories Related to Blood Transfusion.MAR-2023;69 (No.3):523-529$$$E$$Y$$$20240916$$HP$TR$TR
243235261$24323526$1$I$$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144076$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240916$$CN$US$US
243235271$24323527$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145974$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240916$$HP$US$US
243235291$24323529$1$I$20240724$20240913$20240913$20240913$DIR$718327$$FDA-CTU$$63$YR$$M$N$107$KG$20240913$N$HP$US$
243235301$24323530$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145985$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240916$$CN$US$US
243235311$24323531$1$I$20240630$20240911$20240916$20240916$PER$$NVSC2024US184014$NOVARTIS$$56$YR$$F$Y$$$20240916$$HP$US$US
243235331$24323533$1$I$20200915$20240910$20240916$20240916$EXP$PL-URPL-1-2018-2020$PL-TEVA-VS-3242724$TEVA$$82$MON$$F$Y$$$20240916$$MD$PL$PL
243235341$24323534$1$I$$20240909$20240916$20240916$EXP$$ES-Integrated Therapeutic Solutions Inc.-2161659$Integrated Therapeutic Solutions$Literature Article$38$YR$$F$Y$$$20240916$$$ES$ES
243235351$24323535$1$I$$20240911$20240916$20240916$EXP$$US-ROCHE-10000080648$ROCHE$$29$YR$A$F$Y$$$20240916$$CN$US$US
243235361$24323536$1$I$20240418$20240914$20240914$20240914$DIR$718407$$FDA-CTU$$62$YR$$F$N$48.15$KG$20240914$Y$CN$US$
243235371$24323537$1$I$$20240827$20240916$20240916$PER$$US-TEVA-VS-3238912$TEVA$$41$YR$$F$Y$$$20240916$$HP$US$US
243235381$24323538$1$I$$20240910$20240916$20240916$PER$$US-AstraZeneca-2024A209937$ASTRAZENECA$$$$A$F$Y$$$20240916$$HP$US$
243235391$24323539$1$I$$20240903$20240916$20240916$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08970$LUPIN$Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N. HLA-B*53:01 is a significant risk factor of liver injury due to phenytoin and other antiepileptic drugs in african americans. The American Journal of Gastroenterology. 2024;119:200-202$$$$$Y$$$20240916$$MD$US$US
243235401$24323540$1$I$$20240902$20240916$20240916$EXP$$IR-PURACAP-IR-2024EPCLIT01101$PURACAP$Majid Alikhani.Hypokalemic quadriplegia in Sjogren^s syndrome: A case report.Clinical Case Reports.03-JUL-2024;12:1-5$38$YR$A$F$Y$$$20240916$$HP$IR$IR
243235412$24323541$2$F$20230401$20240918$20240916$20240920$EXP$$US-BAYER-2024A131028$BAYER$$$$$F$Y$$$20240920$$CN$US$US
243235431$24323543$1$I$$20240826$20240916$20240916$PER$$US-SA-2024SA266130$SANOFI AVENTIS$$$$$F$Y$$$20240916$$CN$US$US
243235441$24323544$1$I$$20240822$20240916$20240916$PER$$US-SA-2024SA265924$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240916$$CN$US$US
243235451$24323545$1$I$20240905$20240909$20240916$20240916$EXP$$GB-MYLANLABS-2024M1083605$MYLAN$$$$$F$Y$$$20240916$$MD$GB$GB
243235461$24323546$1$I$20200101$20240909$20240916$20240916$EXP$$FI-PFIZER INC-202101884305$MYLAN$$25$YR$$M$Y$$$20240916$$CN$FI$FI
243235471$24323547$1$I$20240905$20240906$20240916$20240916$EXP$$US-GSK-US2024111247$GLAXOSMITHKLINE$$37$YR$$F$Y$$$20240916$$CN$US$US
243235481$24323548$1$I$$20240906$20240916$20240916$30DAY$$US-VIIV HEALTHCARE LIMITED-US1994000012$VIIV$$$$$M$Y$$$20240916$$CN$US$US
243235491$24323549$1$I$$20240910$20240916$20240916$PER$$US-ABBVIE-5920217$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243235501$24323550$1$I$20240701$20240909$20240916$20240916$EXP$$CA-GSK-CA2023AMR079899$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$PH$CA$CA
243235512$24323551$2$F$$20240910$20240916$20240925$EXP$$ES-009507513-2409ESP005062$MERCK$Ruiz D F, Garcia M E, Goncalves G, Ruiz C, Sanchez L, Bellmunt S.. Arterial Pseudoaneurysms, a Rare Complication of BCG Treatment: Three Case Reports. European Journal of Vascular and Endovascular Surgery. 2024;67(3):e61$81$YR$$M$Y$$$20240925$$MD$ES$ES
243235531$24323553$1$I$20240812$20240913$20240913$20240913$DIR$718344$$FDA-CTU$$75$YR$$M$N$62.55$KG$20240913$N$MD$US$
243235551$24323555$1$I$20191210$20240902$20240916$20240916$EXP$$PL-Key Therapeutics, Inc.-2161661$Key Therapeutics, Inc$$45$YR$$F$Y$$$20240916$$$US$PL
243235571$24323557$1$I$$20240910$20240916$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA079236$SANDOZ$$32$YR$$F$Y$109$KG$20240916$$HP$CA$CA
243235581$24323558$1$I$20240818$20240905$20240916$20240916$EXP$$US-ZENPEP LLC-2024AIMT01323$AIMMUNE$$$$$$Y$$$20240916$$CN$US$US
243235591$24323559$1$I$$20240909$20240916$20240916$PER$$US-ROCHE-10000082704$ROCHE$Ramo J, Kim L, Stryjewski T, Shah P, Bejjani R, Brodie F, et al. Targeting the Tie-2 Receptor with Faricimab in Central Serous Chorioretinopathy: A Case Series Motivated by a Genetic Finding. American journal of ophthalmology. 2024-Sep-02;1-11. doi:10.1016/j.ajo.2024.08.040.$$$$$Y$$$20240916$$MD$US$US
243235601$24323560$1$I$20170701$20240906$20240916$20240916$EXP$HU-EMA-DD-20240829-7482827-105016$HU-TEVA-VS-3241303$TEVA$$51$YR$$F$Y$$$20240916$$HP$HU$HU
243235611$24323561$1$I$$20240913$20240916$20240916$EXP$$US-PFIZER INC-202400256556$PFIZER$$63$YR$$F$Y$$$20240916$$CN$US$US
243235622$24323562$2$F$$20240918$20240916$20240920$EXP$$US-PFIZER INC-202400256518$PFIZER$$50$YR$$M$Y$$$20240920$$CN$US$US
243235631$24323563$1$I$$20240902$20240916$20240916$EXP$$US-EPICPHARMA-US-2024EPCLIT01093$EPIC PHARM$C Fling.An Ophtha-MALA-gic Anomaly: Metformin Associated Lactic Acidosis Causing Transient Blindness..American Journal of Respiratory and Critical Care Medicine.2023;207:A3498$62$YR$A$M$Y$$$20240916$$HP$US$US
243235641$24323564$1$I$$20240909$20240916$20240916$EXP$$AU-PFIZER INC-PV202400118117$PFIZER$$72$YR$$M$Y$$$20240916$$PH$AU$AU
243235651$24323565$1$I$$20240912$20240916$20240916$EXP$$US-PFIZER INC-202400255686$PFIZER$$75$YR$$F$Y$$$20240916$$CN$US$US
243235662$24323566$2$F$20240311$20240911$20240916$20240918$EXP$$CA-PFIZER INC-202400062532$PFIZER$$90$YR$$M$Y$$$20240918$$HP$CA$CA
243235672$24323567$2$F$20240101$20240912$20240916$20240917$EXP$$US-PFIZER INC-202400255667$PFIZER$$35$YR$$M$Y$79.38$KG$20240917$$CN$US$US
243235681$24323568$1$I$$20240910$20240916$20240916$EXP$$LT-PFIZER INC-PV202400119278$PFIZER$$18$YR$$M$Y$$$20240916$$MD$LT$LT
243235691$24323569$1$I$20240901$20240913$20240916$20240916$EXP$$US-PFIZER INC-PV202400120645$PFIZER$$61$YR$$F$Y$$$20240916$$HP$US$US
243235702$24323570$2$F$$20240909$20240916$20240917$EXP$$CA-JNJFOC-20240926517$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240917$$HP$CA$CA
243235711$24323571$1$I$20240614$20240912$20240916$20240916$EXP$$US-PFIZER INC-202400256068$PFIZER$$67$YR$$F$Y$$$20240916$$MD$US$US
243235722$24323572$2$F$$20240913$20240916$20240918$EXP$$BR-PFIZER INC-PV202400120493$PFIZER$$$$$M$Y$$$20240918$$MD$BR$BR
243235731$24323573$1$I$20240801$20240912$20240916$20240916$EXP$$US-PFIZER INC-PV202400120491$PFIZER$$56$YR$$F$Y$$$20240916$$HP$US$US
243235741$24323574$1$I$20240801$20240912$20240916$20240916$EXP$$CN-PFIZER INC-PV202400120056$PFIZER$$20$YR$$M$Y$63$KG$20240916$$HP$CN$CN
243235751$24323575$1$I$$20240912$20240916$20240916$EXP$$US-PFIZER INC-PV202200125007$PFIZER$$72$YR$$F$Y$$$20240916$$MD$US$US
243235762$24323576$2$F$20230419$20240920$20240916$20240924$EXP$$ES-PFIZER INC-202400255137$PFIZER$$55$YR$$F$Y$64.6$KG$20240924$$MD$ES$ES
243235771$24323577$1$I$20240812$20240913$20240916$20240916$EXP$$US-PFIZER INC-202400256501$PFIZER$$29$YR$$M$Y$65.77$KG$20240916$$MD$US$US
243235781$24323578$1$I$$20240913$20240916$20240916$EXP$$US-PFIZER INC-PV202400057806$PFIZER$$62$YR$$M$Y$$$20240916$$CN$US$US
243235791$24323579$1$I$$20240914$20240916$20240916$EXP$$SA-PFIZER INC-PV202400120706$PFIZER$$35$YR$$M$Y$$$20240916$$MD$SA$SA
243235801$24323580$1$I$$20240912$20240916$20240916$EXP$$CA-PFIZER INC-202400255444$PFIZER$$$$A$M$Y$$$20240916$$MD$CA$CA
243235811$24323581$1$I$20240904$20240913$20240913$20240913$DIR$718338$$FDA-CTU$$68$YR$$F$N$69.3$KG$20240913$N$CN$US$
243235821$24323582$1$I$20240828$20240913$20240913$20240913$DIR$718349$$FDA-CTU$$73$YR$$F$N$$$20240913$N$HP$US$
243235831$24323583$1$I$20240801$20240905$20240916$20240916$EXP$$US-PROCTER_AND_GAMBLE-GS24114979$PROCTER AND GAMBLE$$65$YR$$F$Y$$$20240916$$CN$US$US
243235842$24323584$2$F$$20240917$20240916$20240917$EXP$$CA-BAYER-2024A131549$BAYER$$$$$F$Y$$$20240917$$MD$CA$CA
243235851$24323585$1$I$20240901$20240913$20240913$20240913$DIR$718381$$FDA-CTU$$7$YR$$M$N$21.15$KG$20240913$N$CN$US$
243235861$24323586$1$I$$20240913$20240916$20240916$EXP$$US-PFIZER INC-202400256450$PFIZER$$53$YR$$M$Y$$$20240916$$CN$US$US
243235871$24323587$1$I$$20240912$20240916$20240916$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005090$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240916$$HP$US$US
243235881$24323588$1$I$$20240913$20240916$20240916$PER$$US-ALXN-202409USA001105US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243235891$24323589$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184510$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243235903$24323590$3$F$$20240919$20240916$20240924$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18420$IPSEN$$52$YR$A$M$Y$$$20240924$$HP$US$US
243235911$24323591$1$I$$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024182088$AMGEN$Look-why S.; Otto T. S.; Chen S. X. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91 (3):AB354$$$$$Y$$$20240916$$MD$US$US
243235921$24323592$1$I$20240826$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024183425$AMGEN$$80$YR$E$F$Y$$$20240916$$CN$US$US
243235931$24323593$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146092$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240916$$CN$US$US
243235941$24323594$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146463$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240916$$CN$US$US
243235951$24323595$1$I$$20240828$20240916$20240916$EXP$$US-SA-2024SA265911$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
243235961$24323596$1$I$$20240905$20240916$20240916$EXP$$US-MYLANLABS-2024M1082867$MYLAN$Doliner B, Gaddar H, Kalil R, Postalian A. Modern Perspectives on Hypertrophic Cardiomyopathy-No One Size Fits All. Tex-Heart-Inst-J 2024; 51 (2):.$61$YR$$M$Y$$$20240916$$MD$US$US
243235971$24323597$1$I$20240125$20240906$20240916$20240916$EXP$FR-AFSSAPS-TO2024001641$FR-TEVA-VS-3241396$TEVA$$61$YR$$M$Y$75$KG$20240916$$PH$FR$FR
243235981$24323598$1$I$20240720$20240906$20240916$20240916$EXP$FR-AFSSAPS-PO2024000932$FR-TEVA-VS-3241442$TEVA$$34$YR$$M$Y$100$KG$20240916$$MD$FR$FR
243235991$24323599$1$I$20240822$20240911$20240916$20240916$PER$GB-MHRA-MED-202408291010264410-ZPBSJ$GB-IDORSIA-008471-2024-GB$IDORSIA PHARMACEUTICALS$$56$YR$$F$Y$$$20240916$$HP$GB$GB
243236001$24323600$1$I$$20240910$20240916$20240916$EXP$$NVSC2024CA182450$NOVARTIS$$$$$M$Y$$$20240916$$CN$CA$CA
243236011$24323601$1$I$$20210407$20240916$20240916$EXP$$NVSC2021US318484$NOVARTIS$$$$$$Y$$$20240916$$MD$US$US
243236021$24323602$1$I$$20240910$20240916$20240916$EXP$GB-MHRA-MED-202409102349253270-YZNMC$GB-RDY-SPO/GBR/24/0013311$DR REDDYS$$$$$M$Y$$$20240916$$CN$GB$GB
243236031$24323603$1$I$$20240910$20240916$20240916$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050762$BOEHRINGER INGELHEIM$$92$YR$E$F$Y$$$20240916$$HP$GB$GB
243236041$24323604$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183136$AMGEN$$$$$M$Y$$$20240916$$CN$US$US
243236051$24323605$1$I$20240720$20240912$20240916$20240916$PER$$US-BAYER-2024A131607$BAYER$$$$$F$Y$$$20240916$$CN$US$US
243236061$24323606$1$I$20240911$20240912$20240916$20240916$EXP$$US-BAYER-2024A131072$BAYER$$51$YR$A$F$Y$$$20240916$$CN$US$US
243236071$24323607$1$I$$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024182233$AMGEN$Look-why S.; Otto T. S.; Chen S. X. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91 (3):AB354$$$$$Y$$$20240916$$MD$US$US
243236081$24323608$1$I$$20240909$20240916$20240916$EXP$$GB-SANDOZ INC.-SDZ2024GB079911$SANDOZ$Sophie Grace, Sean Hammond, Lucy Hampson, Annette Wagner and Dean J. Naisbitt. Omeprazole-associated atypical drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient with positive in vitro diagnostic testing to multiple proton pump inhibitors. Chemical Research in Toxicology. 2024$62$YR$$M$Y$$$20240916$$HP$GB$GB
243236091$24323609$1$I$$20240904$20240916$20240916$EXP$$US-APOTEX-2024AP010444$APOTEX$Ingole P.; Morkas M.; May R.; Hinman B.; Carrum G.; Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$F$Y$$$20240916$$HP$US$US
243236101$24323610$1$I$$20240910$20240916$20240916$PER$$US-AstraZeneca-2024A207984$ASTRAZENECA$$$$$F$Y$$$20240916$$HP$US$
243236111$24323611$1$I$20240512$20240912$20240916$20240916$EXP$$NVSC2024US183797$NOVARTIS$$32$YR$$F$Y$$$20240916$$CN$US$US
243236121$24323612$1$I$20240731$20240906$20240916$20240916$EXP$FR-AFSSAPS-CN2024000775$FR-TEVA-VS-3241476$TEVA$$43$YR$$M$Y$86.3$KG$20240916$$MD$FR$FR
243236131$24323613$1$I$20070101$20240903$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409001673$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240916$$CN$US$US
243236141$24323614$1$I$$20240910$20240916$20240916$EXP$$IT-ELI_LILLY_AND_COMPANY-IT202409006882$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$IT$IT
243236151$24323615$1$I$20240816$20240908$20240916$20240916$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409007579$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240916$$CN$DE$CN
243236161$24323616$1$I$20240701$20240904$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003902$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240916$$CN$US$US
243236171$24323617$1$I$20240827$20240907$20240916$20240916$EXP$GB-MHRA-MED-202409072133178320-CFMNQ$GB-ELI_LILLY_AND_COMPANY-GB202409005008$ELI LILLY AND CO$$59$YR$A$M$Y$75$KG$20240916$$CN$GB$GB
243236191$24323619$1$I$20240101$20240910$20240916$20240916$EXP$$TW-ELI_LILLY_AND_COMPANY-TW202409009225$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$TW$TW
243236201$24323620$1$I$20240906$20240906$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409004330$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243236211$24323621$1$I$20240811$20240904$20240916$20240916$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409002997$ELI LILLY AND CO$$62$YR$A$M$Y$58$KG$20240916$$CN$CN$CN
243236222$24323622$2$F$20240101$20240906$20240916$20240918$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409004961$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240918$$CN$BR$BR
243236232$24323623$2$F$20240101$20240918$20240916$20240920$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409008280$ELI LILLY AND CO$$35$YR$A$$Y$$$20240920$$MD$CN$CN
243236241$24323624$1$I$$20240904$20240916$20240916$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409007696$ELI LILLY AND CO$$$$A$F$Y$$$20240916$$CN$DE$FR
243236251$24323625$1$I$$20240909$20240916$20240916$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409006001$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240916$$PH$FR$FR
243236261$24323626$1$I$$20240911$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409008598$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240916$$MD$US$US
243236271$24323627$1$I$20231114$20240903$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002707$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240916$$CN$US$US
243236281$24323628$1$I$$20240913$20240913$20240913$DIR$718320$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243236291$24323629$1$I$20240913$20240913$20240913$20240913$DIR$718339$$FDA-CTU$$75$YR$$F$N$$$20240913$N$$US$
243236301$24323630$1$I$$20240913$20240913$20240913$DIR$718352$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243236311$24323631$1$I$20240813$20240913$20240913$20240913$DIR$718315$$FDA-CTU$$60$YR$$F$N$96.75$KG$20240913$N$CN$US$
243236321$24323632$1$I$20240905$20240906$20240916$20240916$EXP$$US-GSK-US2024AMR112214$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
243236331$24323633$1$I$$20240905$20240916$20240916$EXP$$VN-ROCHE-10000078242$ROCHE$$60$YR$A$M$Y$$$20240916$$MD$VN$VN
243236341$24323634$1$I$$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024182562$AMGEN$Look-why S.; Otto T. S.; Chen S. X. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91(3):AB354$$$$$Y$$$20240916$$MD$US$US
243236351$24323635$1$I$$20240902$20240916$20240916$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00852$Phathom Pharmaceuticals$$$$$$Y$$$20240916$$CN$JP$JP
243236361$24323636$1$I$$20240909$20240916$20240916$EXP$$US-GSK-US2024112526$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$US$US
243236371$24323637$1$I$20240101$20240905$20240916$20240916$EXP$$US-MALLINCKRODT-MNK202405572$MALLINCKRODT$$49$YR$A$M$Y$$$20240916$$HP$US$US
243236381$24323638$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184640$NOVARTIS$$$$$$Y$$$20240916$$MD$US$US
243236391$24323639$1$I$20240815$20240912$20240916$20240916$EXP$$CN-BAYER-2024A131158$BAYER$$50$YR$A$F$Y$50$KG$20240916$$HP$CN$CN
243236411$24323641$1$I$$20240904$20240916$20240916$30DAY$$CN-PFIZER INC-PV202400115627$PFIZER$$10$YR$$M$Y$$$20240916$$CN$CN$CN
243236422$24323642$2$F$20240717$20240920$20240916$20240925$EXP$$US-BEH-2024175902$CSL BEHRING$$43$YR$A$F$Y$106.6$KG$20240925$$CN$US$US
243236431$24323643$1$I$20240301$20240822$20240916$20240916$PER$$US-SA-2024SA266318$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240916$$MD$US$US
243236441$24323644$1$I$$20240909$20240916$20240916$EXP$$US-SA-2024SA263752$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240916$$MD$US$US
243236462$24323646$2$F$$20240911$20240916$20240921$EXP$$CA-JNJFOC-20240873857$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240921$$HP$CA$CA
243236471$24323647$1$I$$20240906$20240916$20240916$EXP$$US-ROCHE-10000076405$ROCHE$$83$YR$E$M$Y$$$20240916$$CN$US$US
243236491$24323649$1$I$$20240913$20240913$20240913$DIR$718335$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243236501$24323650$1$I$20240308$20240913$20240916$20240916$EXP$FR-AFSSAPS-DJ2024001037$NVSC2024FR183970$NOVARTIS$$69$YR$$M$Y$69$KG$20240916$$MD$FR$FR
243236511$24323651$1$I$20240801$20240828$20240916$20240916$PER$$US-SA-2024SA265826$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240916$$MD$US$US
243236521$24323652$1$I$20240101$20240827$20240916$20240916$PER$$US-SA-2024SA266122$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240916$$CN$US$US
243236531$24323653$1$I$20240101$20240826$20240916$20240916$PER$$US-SA-2024SA266262$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240916$$CN$US$US
243236541$24323654$1$I$20240901$20240909$20240916$20240916$PER$$US-SA-2024SA265603$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240916$$HP$US$US
243236551$24323655$1$I$$20240826$20240916$20240916$PER$$US-SA-2024SA266126$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240916$$HP$US$US
243236561$24323656$1$I$20240911$20240911$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013039$DR REDDYS$$61$YR$A$F$Y$$$20240916$$MD$US$US
243236571$24323657$1$I$20240907$20240909$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013248$DR REDDYS$$51$YR$A$F$Y$$$20240916$$MD$US$US
243236581$24323658$1$I$20240909$20240911$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013277$DR REDDYS$$65$YR$E$M$Y$$$20240916$$MD$US$US
243236591$24323659$1$I$$20240911$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013278$DR REDDYS$$40$YR$A$M$Y$$$20240916$$MD$US$US
243236601$24323660$1$I$20240909$20240909$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013314$DR REDDYS$$61$YR$A$M$Y$$$20240916$$HP$US$US
243236611$24323661$1$I$$20240910$20240916$20240916$EXP$$NVSC2024CA183801$NOVARTIS$$$$$F$Y$$$20240916$$MD$CA$CA
243236631$24323663$1$I$20240703$20240909$20240916$20240916$PER$$US-BAYER-2024A128866$BAYER$$34$YR$A$F$Y$$$20240916$$HP$US$US
243236652$24323665$2$F$20240916$20240920$20240916$20240920$EXP$$UA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051550$BOEHRINGER INGELHEIM$$87$YR$E$M$Y$88$KG$20240920$$CN$UA$UA
243236661$24323666$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146791$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$101.6$KG$20240916$$CN$US$US
243236671$24323667$1$I$20240829$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145914$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240916$$CN$US$US
243236681$24323668$1$I$$20240910$20240916$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-146149$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240916$$MD$JP$JP
243236701$24323670$1$I$$20240911$20240916$20240916$EXP$$ES-MYLANLABS-2024M1083117$MYLAN$$$$$$Y$$$20240916$$HP$ES$ES
243236711$24323671$1$I$20240418$20240911$20240916$20240916$EXP$FR-AFSSAPS-PO2024000428$FR-MYLANLABS-2024M1083013$MYLAN$$75$YR$$M$Y$$$20240916$$MD$FR$FR
243236721$24323672$1$I$$20240911$20240916$20240916$EXP$$ES-MYLANLABS-2024M1082964$MYLAN$$16$YR$$F$Y$$$20240916$$HP$ES$ES
243236751$24323675$1$I$20240703$20240913$20240913$20240913$DIR$718348$$FDA-CTU$$$$$UNK$N$$$20240913$N$HP$US$
243236761$24323676$1$I$$20240913$20240913$20240913$DIR$718353$$FDA-CTU$$$$$UNK$N$$$20240913$N$CN$US$
243236771$24323677$1$I$20240912$20240913$20240913$20240913$DIR$718331$$FDA-CTU$$$$$UNK$N$$$20240913$N$PH$US$
243236801$24323680$1$I$20240822$20240914$20240916$20240916$DIR$FDA-CDER-CTU-2024-63408$$FDA-CTU$$45$YR$$F$N$$$20240914$N$HP$US$
243236812$24323681$2$F$$20240917$20240916$20240922$EXP$$NVSC2024CA183947$NOVARTIS$Cameron-Coffill KM, Ondiveeran HK, Walsh LD. A case of delayed and persistent carbamazepine overdose treated with hemodialysis, plasmapheresis, and neostigmine. JOURNAL OF PHARMACY PRACTICE. 2024;0(0):1?6$61$YR$$F$Y$$$20240923$$HP$CA$CA
243236821$24323682$1$I$20240904$20240910$20240916$20240916$PER$$US-BAYER-2024A130161$BAYER$$22$YR$A$F$Y$$$20240916$$HP$US$US
243236832$24323683$2$F$20240909$20240913$20240916$20240924$EXP$$CN-BAYER-2024A131394$BAYER$$42$YR$A$F$Y$52$KG$20240924$$HP$CN$CN
243236842$24323684$2$F$20230101$20240917$20240916$20240924$PER$$US-AMGEN-USASP2024182410$AMGEN$$78$YR$E$F$Y$$$20240923$$CN$US$US
243236852$24323685$2$F$$20240918$20240916$20240930$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03300$AMNEAL$$$$$F$Y$$$20240930$$CN$US$US
243236861$24323686$1$I$$20240909$20240916$20240916$EXP$$GB-TAKEDA-2024TUS090350$TAKEDA$$$$$M$Y$$$20240916$$CN$GB$GB
243236871$24323687$1$I$20240609$20240903$20240916$20240916$EXP$$US-ASTELLAS-2024US020089$ASTELLAS$$67$YR$E$M$Y$$$20240916$$CN$US$US
243236881$24323688$1$I$$20240902$20240916$20240916$EXP$$JP-EPICPHARMA-JP-2024EPCLIT01096$EPIC PHARM$M Nakura.Cases of Advanced Colorectal Cancer with Nephrotic Syndrome after FOLFIRI plus Ramucirumab Administration.Gan to Kagaku Ryoho.DEC-2022;49:1745-1747$54$YR$A$F$Y$$$20240916$$HP$JP$JP
243236891$24323689$1$I$$20240910$20240916$20240916$EXP$$JP-SANDOZ INC.-SDZ2024JP079829$SANDOZ$$94$YR$$F$Y$$$20240916$$CN$JP$JP
243236901$24323690$1$I$$20240906$20240916$20240916$EXP$$CA-TEVA-VS-3241731$TEVA$$51$YR$$M$Y$102$KG$20240916$$PH$CA$CA
243236911$24323691$1$I$20240101$20240913$20240916$20240916$EXP$$GR-BAUSCH-BL-2024-013850$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240916$$MD$GR$GR
243236941$24323694$1$I$20240101$20240908$20240916$20240916$PER$$US-SA-2024SA265686$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$HP$US$US
243236951$24323695$1$I$$20240906$20240916$20240916$PER$$US-SA-2024SA264582$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240916$$HP$US$US
243236961$24323696$1$I$20240101$20240822$20240916$20240916$PER$$US-SA-2024SA265886$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240916$$CN$US$US
243236971$24323697$1$I$20240910$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024182528$AMGEN$$45$YR$A$F$Y$$$20240916$$CN$US$US
243236981$24323698$1$I$20240901$20240910$20240916$20240916$PER$$US-SA-2024SA265284$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240916$$MD$US$US
243236991$24323699$1$I$$20240827$20240916$20240916$PER$$US-SA-2024SA264368$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240916$$CN$US$US
243237001$24323700$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA265704$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240916$$MD$US$US
243237013$24323701$3$F$20240831$20240912$20240916$20240918$EXP$$US-ALKERMES INC.-ALK-2024-002298$ALKERMES$$41$YR$$M$Y$74.83$KG$20240918$$CN$US$US
243237021$24323702$1$I$$20240826$20240916$20240916$PER$$US-SA-2023SA193290$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
243237032$24323703$2$F$$20240927$20240916$20240930$EXP$GB-MHRA-MED-202409131505556900-GHJDY$GB-SANDOZ INC.-SDZ2024GB080182$SANDOZ$$$$$$Y$$$20240930$$HP$GB$GB
243237041$24323704$1$I$20240910$20240911$20240916$20240916$PER$$US-BAYER-2024A130148$BAYER$$15$YR$T$F$Y$$$20240916$$MD$US$US
243237051$24323705$1$I$20240829$20240904$20240916$20240916$EXP$$US-FARMAPROD-202409-3161$DOMPE FARMACEUTICI$$85$YR$E$F$Y$$$20240916$$CN$US$US
243237061$24323706$1$I$20230101$20240911$20240916$20240916$EXP$$US-INCYTE CORPORATION-2023IN002766$INCYTE$$$$$$Y$$$20240916$$MD$US$US
243237071$24323707$1$I$$20240910$20240916$20240916$EXP$$GB-INFO-20240281$INFORLIFE$Chean CS, Ali AIAH, Malick H. Bilateral simultaneous acute angle closure glaucoma triggered by an over-the-counter cold and influenza medication. BMJ case reports. 2024;17(8):e260950. DOI: 10.1136/bcr-2024-260950.$7$DEC$E$F$Y$$$20240911$$MD$GB$
243237081$24323708$1$I$20220401$20240908$20240916$20240916$EXP$$JP-INFO-20240283$INFORLIFE$Mathis AT, Pietrowski JF, Ahn DY. Foreign Language Syndrome Following Extraction of Wisdom Teeth Under General Anesthesia: A Case Report. J Oral Maxillofac Surg. 2024 Aug 10:S0278-2391(24)00696-7. doi: 10.1016/j.joms.2024.08.009. Epub ahead of print. PMID: 39216510.$21$YR$A$F$Y$57$KG$20240911$$MD$JP$
243237091$24323709$1$I$$20240909$20240916$20240916$EXP$$US-ACS-20240346$ACS DOBFAR$Sulaiman ZI, Sharma D, Salva JR, Rast J, Samra H, Askar G. A Rare Case of Cerebral Abscess due to Fusobacterium nucleatum with Native Aortic Valve Infective Endocarditis and Pyogenic Liver Abscess. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-6. DOI: 10.1177/23247096241272014.$62$YR$A$M$Y$$$20240910$$MD$US$
243237101$24323710$1$I$$20240908$20240916$20240916$EXP$$US-INFO-20240282$INFORLIFE$VanDolah H, Crossley JR, Kim HJ. Three cases of uncommon medication-associated osteonecrosis of temporal bone. World J Otorhinolaryngol Head Neck Surg. 2023 Dec 3;10(3):237-240. doi: 10.1002/wjo2.146.$69$YR$E$M$Y$$$20240911$$MD$US$
243237111$24323711$1$I$$20240910$20240916$20240916$EXP$$GB-TAKEDA-2024TUS091161$TAKEDA$$$$$M$Y$$$20240916$$CN$GB$GB
243237121$24323712$1$I$$20240902$20240916$20240916$EXP$$JP-EPICPHARMA-JP-2024EPCLIT01091$EPIC PHARM$M Nakura.Cases of Advanced Colorectal Cancer with Nephrotic Syndrome after FOLFIRI plus Ramucirumab Administration.Gan to Kagaku Ryoho.DEC-2022;49 No. 13:1745-1747$72$YR$E$M$Y$$$20240916$$HP$JP$JP
243237132$24323713$2$F$20240826$20240917$20240916$20240917$PER$$US-BAYER-2024A130434$BAYER$$42$YR$A$F$Y$$$20240917$$CN$US$US
243237142$24323714$2$F$$20240913$20240916$20240925$EXP$$AU-MYLANLABS-2024M1083724$MYLAN$$$$$M$Y$$$20240925$$PH$AU$AU
243237151$24323715$1$I$20240911$20240913$20240916$20240916$EXP$$AU-MYLANLABS-2024M1083653$MYLAN$$31$YR$$M$Y$$$20240916$$PH$AU$AU
243237161$24323716$1$I$$20240904$20240916$20240916$EXP$$US-APOTEX-2024AP010445$APOTEX$Ingole P.; Morkas M.; May R.; Hinman B.; Carrum G.; Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$F$Y$$$20240916$$HP$US$US
243237171$24323717$1$I$$20240911$20240916$20240916$PER$$US-BAYER-2024A130468$BAYER$$45$YR$A$F$Y$$$20240916$$HP$US$US
243237181$24323718$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63411$$FDA-CTU$$56$YR$$F$N$$$20240916$N$$US$
243237191$24323719$1$I$20240915$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63413$$FDA-CTU$$56$YR$$M$N$$$20240916$N$PH$US$
243237201$24323720$1$I$20240828$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146204$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240916$$HP$US$US
243237211$24323721$1$I$20240912$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024184325$AMGEN$$63$YR$A$M$Y$$$20240916$$CN$US$US
243237221$24323722$1$I$$20240904$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013207$DR REDDYS$Orsagova D, Mohamed FR, Sayed S, Sharma A, Khillan R. MM-494 Beyond the Surface: A Case Study of Cutaneous Involvement in Multiple Myeloma. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24: S563. doi:10.1016/S2152-2650%2824%2901691-4.$47$YR$A$F$Y$$$20240916$$MD$US$US
243237231$24323723$1$I$20240417$20240906$20240916$20240916$PER$$JP-Eisai-EC-2024-173892$EISAI$$$$A$F$Y$$$20240916$$MD$JP$JP
243237241$24323724$1$I$$20240909$20240916$20240916$EXP$$US-GSK-US2024111868$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$US$US
243237252$24323725$2$F$20240915$20240918$20240916$20240925$EXP$$CO-TAKEDA-2024TUS091904$TAKEDA$$47$YR$$F$Y$57$KG$20240925$$CN$CO$CO
243237261$24323726$1$I$20240812$20240902$20240916$20240916$EXP$$FR-CIPLA LTD.-2024FR09713$CIPLA$$$$$$Y$$$20240916$$MD$FR$FR
243237281$24323728$1$I$$20240528$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002501$ENDO$$$$$$Y$$$20240916$$CN$US$US
243237291$24323729$1$I$$20240521$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002389$ENDO$$$$$F$Y$$$20240916$$CN$US$US
243237301$24323730$1$I$$20240702$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002870$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243237311$24323731$1$I$$20240521$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002367$ENDO$$$$$F$Y$$$20240916$$CN$US$US
243237321$24323732$1$I$20240101$20240910$20240916$20240916$EXP$$BR-AMGEN-BRASP2024181212$AMGEN$$76$YR$E$F$Y$$$20240916$$CN$BR$BR
243237331$24323733$1$I$$20240528$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002488$ENDO$$$$$$Y$$$20240916$$CN$US$US
243237341$24323734$1$I$$20240528$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002453$ENDO$$$$$F$Y$$$20240916$$CN$US$US
243237351$24323735$1$I$$20240430$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002072$ENDO$$$$$F$Y$$$20240916$$CN$US$US
243237361$24323736$1$I$$20240412$20240916$20240916$PER$$US-ENDO USA, INC.-2024-001838$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243237371$24323737$1$I$$20240907$20240916$20240916$PER$$US-BAYER-2024A128303$BAYER$$54$YR$A$$Y$$$20240916$$CN$US$US
243237381$24323738$1$I$20220321$20220404$20240916$20240916$EXP$ES-AEMPS-1156129$ES-TEVA-VS-3237352$TEVA$$20$YR$$F$Y$$$20240916$$PH$ES$ES
243237391$24323739$1$I$$20240910$20240916$20240916$PER$$US-TAKEDA-2024TUS091383$TAKEDA$$$$$$Y$$$20240916$$CN$US$US
243237401$24323740$1$I$$20240910$20240916$20240916$EXP$$CA-TAKEDA-2023TUS124319$TAKEDA$$$$$M$Y$$$20240916$$CN$CA$CA
243237411$24323741$1$I$$20240514$20240916$20240916$PER$$US-ENDO USA, INC.-2024-002237$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243237421$24323742$1$I$$20240912$20240916$20240916$PER$$US-BAYER-2024A130861$BAYER$$$$$F$Y$$$20240916$$HP$US$US
243237431$24323743$1$I$20240912$20240912$20240916$20240916$EXP$$IN-ROCHE-10000081905$ROCHE$$59$YR$A$M$Y$$$20240916$$CN$IN$IN
243237441$24323744$1$I$$20240909$20240916$20240916$EXP$$CA-ROCHE-10000082440$ROCHE$$65$YR$E$F$Y$$$20240916$$MD$CA$CA
243237451$24323745$1$I$$20240909$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US079343$SANDOZ$Maryam Barkhordarian, Mark Grijalva, Albert Lee, AAnna Belyayeva, Simcha Weissmanmer Jarri. Statin-Induced Autoimmune Myopathy: A Diagnostic Challenge in Muscle Weakness. American Journal of case report. 2024$69$YR$$M$Y$$$20240916$$HP$US$US
243237471$24323747$1$I$$20240902$20240916$20240916$EXP$$DE-EPICPHARMA-DE-2024EPCLIT01094$EPIC PHARM$N Dyballa.A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting - clinical, toxicological and forensic aspects.Forensic Science, Medicine and Pathology.AUG-2024$12$WK$I$M$Y$$$20240916$$HP$DE$DE
243237481$24323748$1$I$$20240912$20240916$20240916$PER$$US-BAYER-2024A130981$BAYER$$$$$F$Y$$$20240916$$CN$US$US
243237491$24323749$1$I$$20240911$20240916$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA080201$SANDOZ$$66$YR$$F$Y$$$20240916$$CN$CA$CA
243237501$24323750$1$I$20240806$20240913$20240916$20240916$EXP$$US-GILEAD-2024-0687714$GILEAD$$79$YR$E$M$Y$$$20240916$$CN$US$US
243237511$24323751$1$I$$20240909$20240916$20240916$EXP$$SE-TAKEDA-2024TUS057635$TAKEDA$$$$$M$Y$$$20240916$$CN$SE$SE
243237521$24323752$1$I$20240807$20240906$20240916$20240916$EXP$$CA-TAKEDA-2024TUS089830$TAKEDA$$27$YR$$M$Y$$$20240916$$MD$CA$CA
243237562$24323756$2$F$$20240924$20240916$20240927$30DAY$$HK-PFIZER INC-202400255360$PFIZER$$$$$$Y$$$20240927$$HP$HK$HK
243237571$24323757$1$I$$20240912$20240916$20240916$30DAY$$FR-PFIZER INC-202400249805$PFIZER$$12$MON$$F$Y$$$20240916$$PH$FR$FR
243237581$24323758$1$I$$20240906$20240916$20240916$30DAY$$US-PFIZER INC-202400252276$PFIZER$$15$YR$$M$Y$$$20240916$$CN$US$US
243237592$24323759$2$F$20240909$20240912$20240916$20240918$30DAY$$CO-PFIZER INC-202400254743$PFIZER$$13$YR$$F$Y$$$20240918$$CN$CO$CO
243237601$24323760$1$I$$20240911$20240916$20240916$PER$$US-BAYER-2024A130997$BAYER$$$$$F$Y$$$20240916$$CN$US$US
243237611$24323761$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63409$$FDA-CTU$$85$YR$$M$N$$$20240916$N$$US$
243237621$24323762$1$I$$20240913$20240916$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA080130$SANDOZ$$46$YR$$M$Y$$$20240916$$MD$CA$CA
243237631$24323763$1$I$20240801$20240822$20240916$20240916$EXP$$US-SA-2024SA206068$SANOFI AVENTIS$$69$YR$E$F$Y$93.18$KG$20240916$$MD$US$US
243237642$24323764$2$F$20220802$20240910$20240916$20240920$EXP$$CO-TAKEDA-2022TUS053290$TAKEDA$$36$YR$$F$Y$60$KG$20240920$$HP$CO$CO
243237651$24323765$1$I$$20240902$20240916$20240916$EXP$$CN-EPICPHARMA-CN-2024EPCLIT01095$EPIC PHARM$X Zhao.Efficacy of neoadjuvant CapeOX/mFOLFOX6 without radiation for patients with baseline resectable mid-low locally advanced rectal cancer.Journal of Digestive Diseases.DEC-2022;23 No:12:695-704$$$$$Y$$$20240916$$HP$CN$CN
243237662$24323766$2$F$20240911$20240912$20240916$20240919$PER$$US-BAYER-2024A131091$BAYER$$16$YR$T$F$Y$$$20240919$$MD$US$US
243237671$24323767$1$I$20240601$20240909$20240916$20240916$EXP$$US-BEH-2024175028$CSL BEHRING$$71$YR$E$F$Y$70.748$KG$20240916$$CN$US$US
243237681$24323768$1$I$20240905$20240906$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013159$DR REDDYS$$49$YR$A$M$Y$$$20240916$$MD$US$US
243237691$24323769$1$I$$20240906$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013375$DR REDDYS$$15$YR$T$$Y$$$20240916$$MD$US$US
243237701$24323770$1$I$20240904$20240904$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013189$DR REDDYS$$28$YR$A$F$Y$$$20240916$$PH$US$US
243237711$24323771$1$I$20240216$20240916$20240916$20240916$EXP$$US-PROD-AS2-212756134-RB-084659-2024$RECKITT BENCKISER$$73$YR$$F$Y$$$20240916$$CN$US$US
243237721$24323772$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146867$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$100.24$KG$20240916$$CN$US$US
243237731$24323773$1$I$20230730$20240906$20240916$20240916$EXP$GB-MHRA-MED-202409061425441910-NPQTV$GB-TEVA-VS-3241945$TEVA$$7$YR$$F$Y$$$20240916$$CN$GB$GB
243237741$24323774$1$I$20240804$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024183812$AMGEN$$77$YR$E$F$Y$$$20240916$$CN$US$US
243237771$24323777$1$I$20240901$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024182209$AMGEN$$71$YR$E$F$Y$$$20240916$$CN$US$US
243237781$24323778$1$I$20240912$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024182994$AMGEN$$72$YR$E$$Y$$$20240916$$CN$US$US
243237791$24323779$1$I$$20240910$20240916$20240916$EXP$$JP-ROCHE-10000081383$ROCHE$$$$E$M$Y$$$20240916$$MD$JP$JP
243237801$24323780$1$I$20240912$20240912$20240916$20240916$PER$$US-BAYER-2024A131114$BAYER$$30$YR$A$F$Y$$$20240916$$MD$US$US
243237821$24323782$1$I$$20240911$20240916$20240916$EXP$$JP-AstraZeneca-2024A208577$ASTRAZENECA$$78$YR$$M$Y$$$20240916$$MD$JP$
243237831$24323783$1$I$20240520$20240906$20240916$20240916$EXP$GB-MHRA-MED-202409061114454530-PRQHZ$GB-TEVA-VS-3241603$TEVA$$35$YR$$M$Y$$$20240916$$MD$GB$GB
243237841$24323784$1$I$$20240911$20240916$20240916$EXP$$JP-AstraZeneca-2024A208678$ASTRAZENECA$$59$YR$$M$Y$$$20240916$$MD$JP$
243237851$24323785$1$I$20240906$20240906$20240916$20240916$EXP$$GB-TEVA-VS-3241685$TEVA$$75$YR$$F$Y$72$KG$20240916$$HP$GB$GB
243237871$24323787$1$I$$20240902$20240916$20240916$EXP$$US-EPICPHARMA-US-2024EPCLIT01105$EPIC PHARM$C Bulleit.Treating Malignant Catatonia With Liquid Amantadine: A Case Report and Literature Review..Journal of Psychiatric Practice.JUL-2024;30:308-310$51$YR$A$F$Y$$$20240916$$HP$US$US
243237881$24323788$1$I$$20240912$20240916$20240916$PER$$US-BAYER-2024A131181$BAYER$$$$C$$Y$$$20240916$$CN$US$US
243237891$24323789$1$I$$20240906$20240916$20240916$EXP$$US-JNJFOC-20240919914$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$US$US
243237901$24323790$1$I$20240101$20240826$20240916$20240916$PER$$US-SA-2024SA226536$SANOFI AVENTIS$$68$YR$E$F$Y$55.7$KG$20240916$$MD$US$US
243237911$24323791$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265707$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240916$$HP$US$US
243237921$24323792$1$I$20240723$20240910$20240916$20240916$PER$$US-SA-2024SA265514$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240916$$MD$US$US
243237931$24323793$1$I$$20240910$20240916$20240916$EXP$$CA-TAKEDA-2022TUS035147$TAKEDA$$$$$F$Y$$$20240916$$MD$CA$CA
243237941$24323794$1$I$20240528$20240909$20240916$20240916$EXP$$GR-TAKEDA-2024TUS091084$TAKEDA$$67$YR$$M$Y$$$20240916$$CN$GR$GR
243237961$24323796$1$I$$20240904$20240916$20240916$EXP$$US-APOTEX-2024AP010449$APOTEX$Ingole P.; Morkas M.; May R.; Hinman B.; Carrum G.; Kamble R.T. CT-130 Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:S587$$$A$M$Y$$$20240916$$HP$US$US
243237971$24323797$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146849$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240916$$CN$US$US
243237981$24323798$1$I$20240820$20240906$20240916$20240916$EXP$FR-AFSSAPS-NC2024001031$FR-TEVA-VS-3241388$TEVA$$71$YR$$M$Y$$$20240916$$MD$FR$FR
243237991$24323799$1$I$$20240910$20240916$20240916$EXP$$US-TAKEDA-2024TUS090767$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
243238001$24323800$1$I$$20240906$20240916$20240916$EXP$$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-094104$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240916$$MD$CZ$CZ
243238021$24323802$1$I$20240911$20240912$20240916$20240916$PER$$US-BAYER-2024A131265$BAYER$$22$YR$A$F$Y$$$20240916$$MD$US$US
243238031$24323803$1$I$$20240912$20240916$20240916$PER$$US-BIOGEN-2024BI01282408$BIOGEN$$$$$M$Y$$$20240916$$HP$US$US
243238051$24323805$1$I$$20240912$20240916$20240916$EXP$$GB-MYLANLABS-2024M1083510$MYLAN$$$$$F$Y$$$20240916$$HP$GB$GB
243238061$24323806$1$I$$20240912$20240916$20240916$EXP$$GB-MYLANLABS-2024M1083541$MYLAN$$$$$M$Y$$$20240916$$PH$GB$GB
243238071$24323807$1$I$$20240912$20240916$20240916$EXP$$GB-MYLANLABS-2024M1083519$MYLAN$$$$$M$Y$$$20240916$$HP$GB$GB
243238082$24323808$2$F$$20240913$20240916$20240918$PER$$US-BIOGEN-2024BI01282500$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
243238091$24323809$1$I$20230901$20240914$20240914$20240914$DIR$718424$$FDA-CTU$$48$YR$$F$N$70.65$KG$20240914$$CN$US$
243238101$24323810$1$I$20240825$20240912$20240916$20240916$EXP$GB-MHRA-MED-202409121121152550-GYRMC$GB-MYLANLABS-2024M1083584$MYLAN$$74$YR$$M$Y$$$20240916$$PH$GB$GB
243238111$24323811$1$I$20240806$20240912$20240916$20240916$EXP$FR-AFSSAPS-CN2024000797$FR-MYLANLABS-2024M1083254$MYLAN$$70$YR$$F$Y$56.6$KG$20240916$$PH$FR$FR
243238121$24323812$1$I$$20240912$20240916$20240916$EXP$$GB-MYLANLABS-2024M1083784$MYLAN$$$$$M$Y$$$20240916$$CN$GB$GB
243238131$24323813$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63412$$FDA-CTU$$72$YR$$F$N$$$20240916$N$$US$
243238141$24323814$1$I$20240911$20240914$20240914$20240914$DIR$718422$$FDA-CTU$$20$YR$$F$N$67.5$KG$20240914$N$CN$US$
243238151$24323815$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183478$AMGEN$$$$$$Y$$$20240916$$CN$US$US
243238161$24323816$1$I$$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024182797$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243238171$24323817$1$I$20240501$20240821$20240916$20240916$EXP$$FI-SA-2024SA262517$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240916$$MD$FI$FI
243238182$24323818$2$F$20240911$20240912$20240916$20240919$PER$$US-AMGEN-USASP2024182553$AMGEN$$81$YR$E$F$Y$$$20240918$$CN$US$US
243238191$24323819$1$I$20240101$20240909$20240916$20240916$EXP$$JP-009507513-2407JPN005307J$MERCK$$7$DEC$$M$Y$$$20240916$$MD$JP$JP
243238201$24323820$1$I$$20240822$20240916$20240916$EXP$$US-SA-2024SA265802$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240916$$MD$US$US
243238211$24323821$1$I$20240829$20240914$20240914$20240914$DIR$718410$$FDA-CTU$$61$YR$$F$N$68$KG$20240914$N$PH$US$
243238221$24323822$1$I$20240724$20240911$20240916$20240916$EXP$$JP-ROCHE-10000063143$ROCHE$$8$DEC$E$$Y$$$20240916$$MD$JP$JP
243238234$24323823$4$F$$20240917$20240916$20240919$30DAY$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03285$AMNEAL$$$$$$Y$$$20240919$$CN$US$US
243238241$24323824$1$I$$20240911$20240916$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA079628$SANDOZ$$48$YR$$F$Y$68$KG$20240916$$HP$CA$CA
243238261$24323826$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63410$$FDA-CTU$$47$YR$$F$N$$$20240916$N$HP$US$
243238281$24323828$1$I$20240101$20240910$20240916$20240916$EXP$$US-JNJFOC-20240934357$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240916$$HP$US$US
243238291$24323829$1$I$$20240909$20240916$20240916$EXP$$CO-JNJFOC-20240932994$JOHNSON AND JOHNSON$$30$YR$A$M$Y$68$KG$20240916$$HP$CO$CO
243238311$24323831$1$I$$20240902$20240916$20240916$EXP$$US-EPICPHARMA-US-2024EPCLIT01100$EPIC PHARM$P Davis.Emergency Department Buprenorphine and Naloxone Prescribing Disparities Among Racial and Ethnic Minorities Presenting With an Opioid Overdose.Advanced Emergency Nursing Journal.JUL-2024;46(3):187-194$50$YR$A$M$Y$$$20240916$$HP$US$US
243238321$24323832$1$I$20240629$20240911$20240916$20240916$EXP$$JP-ROCHE-10000081269$ROCHE$$58$YR$A$F$Y$52.1$KG$20240916$$PH$JP$JP
243238331$24323833$1$I$20240901$20240905$20240916$20240916$EXP$$US-OTSUKA-2024_025213$OTSUKA$$51$YR$$M$Y$$$20240916$$HP$US$US
243238341$24323834$1$I$$20240820$20240916$20240916$PER$$US-SA-2024SA263671$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240916$$MD$US$US
243238351$24323835$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265107$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240916$$MD$US$US
243238361$24323836$1$I$20240601$20240705$20240916$20240916$EXP$SE-SEMPA-2024-005346$SE-Atnahs Limited-ATNAHS20240701931$Atnahs Healthcare$$71$YR$E$M$Y$$$20240916$$MD$SE$SE
243238371$24323837$1$I$$20240906$20240916$20240916$EXP$$GB-TEVA-VS-3241626$TEVA$$91$YR$$M$Y$61$KG$20240916$$HP$GB$GB
243238381$24323838$1$I$20211001$20240912$20240916$20240916$EXP$$US-PFIZER INC-PV202400120316$PFIZER$$72$YR$$F$Y$$$20240916$$HP$US$US
243238391$24323839$1$I$$20240913$20240916$20240916$EXP$$IN-PFIZER INC-PV202400121106$PFIZER$$49$YR$$F$Y$$$20240916$$CN$IN$IN
243238401$24323840$1$I$$20240913$20240916$20240916$EXP$$CA-PFIZER INC-202400256255$PFIZER$$$$$F$Y$$$20240916$$MD$CA$CA
243238411$24323841$1$I$$20240911$20240916$20240916$EXP$$CA-PFIZER INC-202400091176$PFIZER$$67$YR$$M$Y$$$20240916$$MD$CA$CA
243238421$24323842$1$I$20240201$20240912$20240916$20240916$EXP$$US-PFIZER INC-202400256395$PFIZER$$64$YR$$F$Y$$$20240916$$HP$US$US
243238431$24323843$1$I$20240912$20240913$20240916$20240916$EXP$$US-PFIZER INC-202400256523$PFIZER$$87$YR$$F$Y$$$20240916$$PH$US$US
243238451$24323845$1$I$20240828$20240913$20240916$20240916$EXP$PT-INFARMED-J202408-881$PT-PFIZER INC-202400255768$PFIZER$$46$YR$$M$Y$$$20240916$$PH$PT$PT
243238461$24323846$1$I$$20240913$20240916$20240916$PER$$US-BAYER-2024A131331$BAYER$$$$$$Y$$$20240916$$CN$US$US
243238471$24323847$1$I$20240701$20240913$20240916$20240916$EXP$IT-MINISAL02-1001827$IT-PFIZER INC-202400255909$PFIZER$$74$YR$$F$Y$65$KG$20240916$$MD$IT$IT
243238502$24323850$2$F$20240822$20240917$20240916$20240919$EXP$$JP-PFIZER INC-PV202400119417$PFIZER$$52$YR$$F$Y$64.2$KG$20240919$$PH$JP$JP
243238511$24323851$1$I$$20240904$20240916$20240916$EXP$$US-FARMAPROD-202409-3177$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240916$$CN$US$US
243238522$24323852$2$F$$20240913$20240916$20240924$EXP$$IT-ROVI-20240924$ROVIPHARM SAS$$$$A$M$Y$$$20240923$$MD$IT$IT
243238531$24323853$1$I$$20240910$20240916$20240916$30DAY$$US-SANDOZ INC.-SDZ2024US078619$SANDOZ$$$$$F$Y$$$20240916$$CN$US$US
243238551$24323855$1$I$$20240904$20240916$20240916$EXP$GB-MHRA-MED-202409041359162950-CFKJD$GB-ELI_LILLY_AND_COMPANY-GB202409003258$ELI LILLY AND CO$$$$$M$Y$$$20240916$$CN$GB$GB
243238561$24323856$1$I$$20240904$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003906$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243238571$24323857$1$I$$20240904$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409004761$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240916$$CN$US$US
243238581$24323858$1$I$20240415$20240904$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409004239$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240916$$CN$US$US
243238611$24323861$1$I$$20240903$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002175$ELI LILLY AND CO$$$$$M$Y$$$20240916$$CN$US$US
243238621$24323862$1$I$$20240904$20240916$20240916$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202409001727$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240916$$CN$AU$AU
243238631$24323863$1$I$20240903$20240904$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002845$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240916$$CN$US$US
243238651$24323865$1$I$$20240910$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409006422$ELI LILLY AND CO$$$$$$Y$$$20240916$$CN$US$US
243238661$24323866$1$I$$20240903$20240916$20240916$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409002094$ELI LILLY AND CO$$$$$M$Y$$$20240916$$CN$BR$BR
243238672$24323867$2$F$$20240927$20240916$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409006467$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240930$$PH$US$US
243238681$24323868$1$I$$20240902$20240916$20240916$EXP$$CN-EPICPHARMA-CN-2024EPCLIT01098$EPIC PHARM$X Zhao.Efficacy of neoadjuvant CapeOX/mFOLFOX6 without radiation for patients with baseline resectable mid-low locally advanced rectal cancer. Journal of Digestive Diseases.DEC-2022;23(12):695-704$$$$$Y$$$20240916$$HP$CN$CN
243238691$24323869$1$I$20240101$20240910$20240916$20240916$EXP$$US-JNJFOC-20240934263$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240916$$HP$US$US
243238701$24323870$1$I$$20240912$20240916$20240916$EXP$$DE-JNJFOC-20240934347$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240916$$MD$DE$DE
243238711$24323871$1$I$$20240906$20240916$20240916$PER$$US-SA-2024SA265632$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240916$$MD$US$US
243238721$24323872$1$I$20240101$20240911$20240916$20240916$PER$$US-SA-2024SA265599$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240916$$MD$US$US
243238741$24323874$1$I$$20240912$20240916$20240916$PER$$US-BAYER-2024A131454$BAYER$$33$YR$A$F$Y$$$20240916$$MD$US$US
243238761$24323876$1$I$20240515$20240909$20240916$20240916$EXP$FR-AFSSAPS-AVMA2024000391$FR-Waylis Therapeutics LLC-ATNAHS20240902564$Waylis$$31$YR$A$M$Y$$$20240916$$PH$FR$FR
243238772$24323877$2$F$$20240913$20240916$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145403$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$73.94$KG$20240919$$CN$US$US
243238781$24323878$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145480$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240916$$HP$US$US
243238791$24323879$1$I$20240911$20240913$20240916$20240916$EXP$$CN-BAYER-2024A131430$BAYER$$60$YR$A$F$Y$36.3$KG$20240916$$HP$CN$CN
243238801$24323880$1$I$20240117$20240909$20240916$20240916$EXP$$RO-ROCHE-3508316$ROCHE$$56$YR$A$F$Y$$$20240916$$MD$RO$RO
243238811$24323881$1$I$20240101$20240912$20240916$20240916$PER$$US-BAYER-2024A131462$BAYER$$15$YR$T$F$Y$$$20240916$$MD$US$US
243238821$24323882$1$I$20240904$20240904$20240916$20240916$PER$$US-AstraZeneca-2024A201871$ASTRAZENECA$$26040$DY$$M$Y$$$20240916$$CN$US$
243238831$24323883$1$I$20240125$20240911$20240916$20240916$EXP$$IT-AstraZeneca-2024A206973$ASTRAZENECA$$58$YR$$F$Y$$$20240916$$MD$IT$
243238841$24323884$1$I$20231123$20240911$20240916$20240916$EXP$$GB-PERRIGO-24GB008287$PERRIGO$$$$E$F$Y$89$KG$20240916$$CN$GB$GB
243238851$24323885$1$I$$20240909$20240916$20240916$EXP$$TR-PFIZER INC-PV202400118757$PFIZER$Tellioglu, A.. Clinical Features, Treatment, and Visual Outcomes of Posterior Scleritis from Tertiary Eye Care Center. Ocular Immunology and Inflammation. 2024;32(7):1323-1329$$$A$$Y$$$20240916$$MD$TR$TR
243238862$24323886$2$F$$20240911$20240916$20240919$EXP$$ES-PFIZER INC-202400252714$PFIZER$Garcia, J.. Lipodistrophy In Dermatomyositis. European Journal of Case Reports in Internal Medicine. 2024;11:977-978$47$YR$$F$Y$$$20240919$$HP$ES$ES
243238871$24323887$1$I$20231109$20240906$20240916$20240916$EXP$GB-MHRA-TPP2093429C10878650YC1724843913446$GB-PERRIGO-24GB008348$PERRIGO$$64$YR$$M$Y$98$KG$20240916$$MD$GB$GB
243238881$24323888$1$I$$20240912$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US079785$SANDOZ$$$$$F$Y$118.36$KG$20240916$$MD$US$US
243238891$24323889$1$I$20230115$20240911$20240916$20240916$EXP$FR-AFSSAPS-PC2024000698$FR-009507513-2409FRA004151$MERCK$$74$YR$$M$Y$78$KG$20240916$$PH$FR$FR
243238901$24323890$1$I$$20240913$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US080375$SANDOZ$$$$$F$Y$$$20240916$$CN$US$US
243238911$24323891$1$I$20150301$20240910$20240916$20240916$PER$$US-FreseniusKabi-FK202413693$FRESENIUS KABI$$56$YR$A$M$Y$$$20240916$$CN$US$US
243238921$24323892$1$I$20240502$20240910$20240916$20240916$EXP$$JP-009507513-2405JPN003977J$MERCK$$7$DEC$$F$Y$$$20240916$$MD$JP$JP
243238931$24323893$1$I$20240313$20240906$20240916$20240916$EXP$ES-AEMPS-1565154$ES-TEVA-VS-3241432$TEVA$$88$YR$$M$Y$$$20240916$$MD$ES$ES
243238941$24323894$1$I$$20240912$20240916$20240916$PER$$US-BAYER-2024A131471$BAYER$$45$YR$A$F$Y$$$20240916$$CN$US$US
243238951$24323895$1$I$20240605$20240909$20240916$20240916$EXP$$DE-GSK-DE2024EME112760$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$DE$DE
243238961$24323896$1$I$$20240822$20240916$20240916$PER$$US-SA-2024SA266123$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240916$$CN$US$US
243238982$24323898$2$F$$20240917$20240916$20240923$EXP$$US-KYOWAKIRIN-2024KK021364$KYOWA$$$$$$Y$$$20240923$$HP$US$US
243238992$24323899$2$F$20240904$20240916$20240916$20240917$PER$$US-AMGEN-USASP2024184201$AMGEN$$75$YR$E$M$Y$$$20240917$$CN$US$US
243239001$24323900$1$I$20240823$20240906$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142873$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$141$KG$20240916$$PH$US$US
243239012$24323901$2$F$20240101$20240829$20240916$20240923$PER$$US-SA-2024SA265731$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240923$$MD$US$US
243239021$24323902$1$I$20240401$20240912$20240916$20240916$PER$$US-BAYER-2024A131474$BAYER$$19$YR$A$F$Y$$$20240916$$MD$US$US
243239031$24323903$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265078$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240916$$MD$US$US
243239041$24323904$1$I$$20240911$20240916$20240916$EXP$$JP-EXELIXIS-EXL-2024-000158$EXELIXIS$$82$YR$$F$Y$$$20240916$$MD$JP$JP
243239051$24323905$1$I$$20240910$20240916$20240916$EXP$$IN-SANDOZ INC.-SDZ2024IN079661$SANDOZ$$$$$F$Y$$$20240916$$CN$IN$IN
243239061$24323906$1$I$20230701$20240910$20240916$20240916$EXP$$US-EXELIXIS-EXL-2024-000136$EXELIXIS$$74$YR$$M$Y$81.179$KG$20240916$$CN$US$US
243239072$24323907$2$F$$20240917$20240916$20240926$EXP$GB-MHRA-MED-202409101408266480-TPVQN$GB-PERRIGO-24GB008460$PERRIGO$$36$YR$$$Y$$$20240926$$PH$GB$GB
243239081$24323908$1$I$20240908$20240910$20240916$20240916$EXP$GB-MHRA-MED-202409101624124940-DHJVC$GB-PERRIGO-24GB008466$PERRIGO$$80$YR$$F$Y$$$20240916$$PH$GB$GB
243239091$24323909$1$I$$20240910$20240916$20240916$EXP$$GB-PERRIGO-24GB008462$PERRIGO$$84$YR$$F$Y$61$KG$20240916$$HP$GB$GB
243239101$24323910$1$I$$20240913$20240916$20240916$PER$$US-ALXN-202409USA001096US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243239121$24323912$1$I$$20240913$20240916$20240916$PER$$US-BAYER-2024A131532$BAYER$$53$YR$A$F$Y$$$20240916$$CN$US$US
243239131$24323913$1$I$$20240912$20240916$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA080029$SANDOZ$$$$$M$Y$$$20240916$$CN$CA$CA
243239141$24323914$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA264858$SANOFI AVENTIS$$$$T$F$Y$$$20240916$$MD$US$US
243239151$24323915$1$I$20240801$20240829$20240916$20240916$PER$$US-SA-2024SA265477$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240916$$MD$US$US
243239161$24323916$1$I$$20240906$20240916$20240916$PER$$US-AMGEN-USASP2024182911$AMGEN$$$$$$Y$$$20240916$$CN$US$US
243239171$24323917$1$I$$20240822$20240916$20240916$PER$$US-SA-2024SA264999$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240916$$HP$US$US
243239181$24323918$1$I$20240903$20240903$20240916$20240916$PER$$US-SA-2024SA267015$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240916$$MD$US$US
243239191$24323919$1$I$20240101$20240822$20240916$20240916$PER$$US-SA-2024SA265022$SANOFI AVENTIS$$61$YR$A$M$Y$100$KG$20240916$$MD$US$US
243239202$24323920$2$F$$20240912$20240916$20240916$EXP$$US-ROCHE-10000080582$ROCHE$$52$YR$A$M$Y$$$20240916$$CN$US$US
243239211$24323921$1$I$$20240910$20240916$20240916$EXP$$NL-VIIV HEALTHCARE LIMITED-NL2024EME111787$VIIV$$$$$$Y$$$20240916$$HP$NL$NL
243239222$24323922$2$F$20210101$20240918$20240916$20240920$EXP$$US-ABBVIE-5924015$ABBVIE$$$$$M$Y$136.08$KG$20240920$$CN$US$US
243239231$24323923$1$I$20240828$20240912$20240916$20240916$EXP$$CN-AMERICAN REGENT INC-2024003505$AMERICAN REGENT$$18$YR$$F$Y$50$KG$20240916$$HP$CN$CN
243239241$24323924$1$I$$20240912$20240916$20240916$EXP$$US-BAYER-2024A131622$BAYER$$56$YR$A$F$Y$$$20240916$$CN$US$US
243239251$24323925$1$I$$20240913$20240916$20240916$EXP$$PL-SANDOZ INC.-SDZ2024PL080041$SANDOZ$$52$YR$$M$Y$$$20240916$$HP$PL$PL
243239261$24323926$1$I$20240913$20240913$20240916$20240916$PER$$US-BAYER-2024A131599$BAYER$$31$YR$A$F$Y$$$20240916$$MD$US$US
243239271$24323927$1$I$20240726$20240905$20240916$20240916$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-122364$REGENERON$$72$YR$$M$Y$$$20240916$$HP$CO$CO
243239281$24323928$1$I$$20240913$20240916$20240916$EXP$$US-BAYER-2024A131784$BAYER$$$$$$Y$$$20240916$$CN$US$US
243239291$24323929$1$I$20240801$20240910$20240916$20240916$PER$$US-FreseniusKabi-FK202413698$FRESENIUS KABI$$45$YR$A$M$Y$$$20240916$$HP$US$US
243239301$24323930$1$I$$20240912$20240916$20240916$PER$$US-TAKEDA-2024TUS091280$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
243239311$24323931$1$I$$20240911$20240916$20240916$PER$$US-JNJFOC-20240931545$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$US$US
243239321$24323932$1$I$$20240913$20240916$20240916$PER$$US-BAYER-2024A131618$BAYER$$$$$M$Y$$$20240916$$CN$US$US
243239331$24323933$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146879$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240916$$CN$US$US
243239341$24323934$1$I$$20240911$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146635$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$HP$US$US
243239351$24323935$1$I$20240829$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145775$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$80.74$KG$20240916$$HP$US$US
243239361$24323936$1$I$$20240907$20240916$20240916$PER$$US-ROCHE-10000076615$ROCHE$$59$YR$A$F$Y$$$20240916$$CN$US$US
243239371$24323937$1$I$$20240911$20240916$20240916$PER$$US-ROCHE-10000080857$ROCHE$$$$E$F$Y$$$20240916$$CN$US$US
243239382$24323938$2$F$$20240923$20240916$20240924$PER$$US-ROCHE-10000081582$ROCHE$$$$E$F$Y$$$20240924$$CN$US$US
243239391$24323939$1$I$$20240826$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08625$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243239401$24323940$1$I$$20240911$20240916$20240916$PER$$US-GILEAD-2024-0687420$GILEAD$$62$YR$A$F$Y$$$20240916$$CN$US$US
243239411$24323941$1$I$$20240905$20240916$20240916$PER$$US-AstraZeneca-2024A203885$ASTRAZENECA$$$$$F$Y$$$20240916$$HP$US$
243239421$24323942$1$I$20231102$20240912$20240916$20240916$EXP$$SG-AstraZeneca-2024A209171$ASTRAZENECA$$$$$F$Y$$$20240916$$MD$SG$
243239431$24323943$1$I$20240713$20240912$20240916$20240916$EXP$$SE-AstraZeneca-2024A208562$ASTRAZENECA$$$$$F$Y$$$20240916$$MD$SE$
243239441$24323944$1$I$$20240910$20240916$20240916$PER$$US-AstraZeneca-2024A208136$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243239451$24323945$1$I$20240501$20240911$20240916$20240916$PER$$US-ROCHE-10000079965$ROCHE$$81$YR$E$F$Y$55.33$KG$20240916$$CN$US$US
243239481$24323948$1$I$20240915$20240915$20240915$20240915$DIR$718455$$FDA-CTU$$74$YR$$M$N$100.8$KG$20240915$Y$HP$US$
243239491$24323949$1$I$$20240912$20240916$20240916$EXP$$CA-AstraZeneca-2024A210143$ASTRAZENECA$$78$YR$$F$Y$$$20240916$$MD$CA$
243239511$24323951$1$I$$20240829$20240916$20240916$PER$$US-009507513-2408USA010518$MERCK$$$$$F$Y$$$20240916$$PH$US$US
243239521$24323952$1$I$20240831$20240911$20240916$20240916$EXP$$IT-AstraZeneca-2024A207114$ASTRAZENECA$$67$YR$$M$Y$94$KG$20240916$$MD$IT$
243239531$24323953$1$I$$20240913$20240916$20240916$EXP$$DE-SANDOZ INC.-SDZ2024DE080078$SANDOZ$$6$YR$$F$Y$$$20240916$$HP$DE$DE
243239541$24323954$1$I$$20240911$20240916$20240916$PER$$US-PFIZER INC-PV202400120118$PFIZER$$70$YR$$M$Y$$$20240916$$MD$US$US
243239551$24323955$1$I$20240909$20240910$20240916$20240916$PER$$US-PFIZER INC-202400254083$PFIZER$$13$YR$$M$Y$$$20240916$$HP$US$US
243239561$24323956$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400120003$PFIZER$$64$YR$$F$Y$$$20240916$$MD$US$US
243239572$24323957$2$F$$20240920$20240916$20240924$PER$$US-PFIZER INC-PV202400120614$PFIZER$$14$YR$$F$Y$$$20240924$$CN$US$US
243239591$24323959$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400120497$PFIZER$$23$YR$$F$Y$$$20240916$$CN$US$US
243239601$24323960$1$I$$20240909$20240916$20240916$EXP$$PT-PFIZER INC-202400252642$PFIZER$Freitas. Composite mantle cell and Burkitt lymphoma: a rare case report (Letter to the Editor).. Porto Biomedical Journal.. 2024;9(3):1-2$68$YR$$M$Y$$$20240916$$HP$PT$PT
243239611$24323961$1$I$20240620$20240911$20240916$20240916$EXP$$FR-WAYLIS-2024-FR-000161$Waylis$$66$YR$$M$Y$$$20240916$$MD$FR$FR
243239621$24323962$1$I$$20240911$20240916$20240916$PER$$US-PFIZER INC-PV202300025755$PFIZER$$26$YR$$$Y$$$20240916$$MD$US$US
243239632$24323963$2$F$20240125$20240923$20240916$20240926$EXP$$AR-MYLANLABS-2024M1024185$MYLAN$$31$YR$$M$Y$$$20240926$$CN$AR$AR
243239641$24323964$1$I$20240910$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024182327$AMGEN$$76$YR$E$F$Y$$$20240916$$CN$US$US
243239651$24323965$1$I$$20240913$20240916$20240916$EXP$$CA-SANDOZ INC.-NVSC2023CA030372$SANDOZ$$29$YR$$M$Y$89$KG$20240916$$HP$CA$CA
243239661$24323966$1$I$20240101$20240904$20240916$20240916$EXP$$US-SA-2024SA265165$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240916$$CN$US$US
243239671$24323967$1$I$20220101$20240910$20240916$20240916$PER$$US-JNJFOC-20240929744$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240916$$CN$US$US
243239681$24323968$1$I$$20240904$20240916$20240916$PER$$US-BAYER-2024A122059$BAYER$$$$$M$Y$$$20240916$$CN$US$US
243239691$24323969$1$I$$20240909$20240916$20240916$EXP$$US-AMGEN-USASP2024181851$AMGEN$$$$$$Y$$$20240916$$CN$US$US
243239713$24323971$3$F$$20240917$20240916$20240925$PER$$US-Calliditas-2024CAL01731$CALLIDITAS THERAPEUTICS$$54$YR$A$M$Y$103.6$KG$20240924$$CN$US$US
243239722$24323972$2$F$$20240924$20240916$20240928$PER$$US-ROCHE-10000080691$ROCHE$$$$A$M$Y$$$20240928$$CN$US$US
243239731$24323973$1$I$$20240904$20240916$20240916$EXP$$JP-INSUD PHARMA-2409JP06996$INSUD PHARMA$Kuzume D, Ohturu S, Yosida T, Morimoto Y, Yamasaki M, Hosomi N. A case of a young woman with bilateral medial medullary infarcts caused by varicella-zoster virus vasculopathy without skin rash. Rinsho Shinkeigaku (Clin Neurol). 2024;64:583-588$$$$$Y$$$20240916$$MD$JP$JP
243239741$24323974$1$I$$20240912$20240916$20240916$PER$$US-BIOVITRUM-2024-US-012041$BIOVITRUM$$69$YR$$F$Y$$$20240916$$CN$US$US
243239751$24323975$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000080821$ROCHE$$$$A$M$Y$$$20240916$$CN$US$US
243239761$24323976$1$I$20240101$20240827$20240916$20240916$PER$$US-SA-2024SA265323$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240916$$MD$US$US
243239771$24323977$1$I$$20240906$20240916$20240916$PER$$US-SA-2024SA264827$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240916$$MD$US$US
243239781$24323978$1$I$$20240828$20240916$20240916$PER$$US-SA-2024SA266323$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240916$$CN$US$US
243239791$24323979$1$I$20240912$20240913$20240916$20240916$PER$$US-BAYER-2024A131728$BAYER$$45$YR$A$F$Y$$$20240916$$HP$US$US
243239801$24323980$1$I$$20240913$20240916$20240916$PER$$US-BAYER-2024A131621$BAYER$$76$YR$E$F$Y$$$20240916$$CN$US$US
243239811$24323981$1$I$20240724$20240909$20240916$20240916$EXP$FR-AFSSAPS-AN2024001211$FR-FreseniusKabi-FK202413672$FRESENIUS KABI$$75$YR$E$M$Y$59.6$KG$20240916$$PH$FR$FR
243239821$24323982$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000081069$ROCHE$$$$A$M$Y$$$20240916$$CN$US$US
243239861$24323986$1$I$$20240913$20240916$20240916$EXP$$US-ROCHE-10000082388$ROCHE$$$$$$Y$$$20240916$$MD$US$US
243239871$24323987$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000081610$ROCHE$$$$A$M$Y$$$20240916$$CN$US$US
243239891$24323989$1$I$$20240909$20240916$20240916$EXP$$FR-MYLANLABS-2024M1083528$MYLAN$Nevez G, Guillerm G, Talarmin J-P, Quinio D, Iriart X, Lissillour P-L, et al. Hormographiella aspergillata pulmonary infections: Detection and identification of the fungus using pan-fungal PCR assays and DNA sequencing. J-Mycol-Med 2024; 34 (1):.$30$YR$$F$Y$$$20240916$$HP$FR$FR
243239911$24323991$1$I$20230717$20240915$20240915$20240915$DIR$718471$$FDA-CTU$$81$YR$$F$N$137.25$KG$20240915$N$CN$US$
243239921$24323992$1$I$20240912$20240915$20240915$20240915$DIR$718470$$FDA-CTU$$72$YR$$F$N$$$20240915$N$$US$
243239941$24323994$1$I$$20240909$20240916$20240916$PER$$US-JNJFOC-20240926169$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$US$US
243239951$24323995$1$I$20240830$20240913$20240916$20240916$PER$$US-BAYER-2024A131772$BAYER$$42$YR$A$F$Y$$$20240916$$CN$US$US
243239961$24323996$1$I$$20240909$20240916$20240916$PER$$US-ROCHE-10000077570$ROCHE$$$$E$F$Y$$$20240916$$CN$US$US
243239981$24323998$1$I$20240401$20240909$20240916$20240916$PER$$US-ROCHE-10000077585$ROCHE$$$$$$Y$$$20240916$$CN$US$US
243239991$24323999$1$I$$20240909$20240916$20240916$PER$$US-ROCHE-10000078170$ROCHE$$$$$F$Y$$$20240916$$CN$US$US
243240001$24324000$1$I$20240101$20240911$20240916$20240916$PER$$US-009507513-2409USA004044$MERCK$$$$A$M$Y$$$20240916$$MD$US$US
243240021$24324002$1$I$20240912$20240913$20240916$20240916$30DAY$$FR-PFIZER INC-PV202400120511$PFIZER$$9$YR$$F$Y$$$20240916$$CN$FR$FR
243240031$24324003$1$I$$20240913$20240916$20240916$PER$$US-BAYER-2024A131880$BAYER$$39$YR$A$F$Y$$$20240916$$MD$US$US
243240041$24324004$1$I$20240101$20240910$20240916$20240916$EXP$$MY-ORGANON-O2409MYS000947$ORGANON$$$$$F$Y$$$20240916$$MD$MY$MY
243240051$24324005$1$I$$20240906$20240916$20240916$EXP$$CN-BAYER-2024A131237$BAYER$Huang X, Chen XY, Li YP, Liang XK, Zhang GY, Zhou Y, Zhan Y, Luo SHT, Liao JY, Xiao R, Long H. Efficacy and safety of dupilumab in the treatment of 123 cases of atopic dermatitis. Chinese Journal of Dermatology. 2022;55(6):486-493$4$YR$C$F$Y$$$20240916$$MD$CN$CN
243240061$24324006$1$I$$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146678$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240916$$MD$US$US
243240071$24324007$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000081761$ROCHE$$$$A$$Y$$$20240916$$CN$US$US
243240081$24324008$1$I$$20240913$20240916$20240916$PER$$US-ROCHE-10000082390$ROCHE$$$$A$M$Y$$$20240916$$CN$US$US
243240091$24324009$1$I$$20240905$20240916$20240916$30DAY$$US-JNJFOC-20240931133$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$US$US
243240101$24324010$1$I$$20240913$20240916$20240916$PER$$US-ROCHE-10000082370$ROCHE$$$$T$M$Y$$$20240916$$CN$US$US
243240111$24324011$1$I$20240906$20240906$20240916$20240916$EXP$$US-GSK-US2024111316$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240916$$CN$US$US
243240121$24324012$1$I$$20240909$20240916$20240916$30DAY$$US-MYLANLABS-2024M1082793$MYLAN$$$$$$Y$$$20240916$$PH$US$US
243240131$24324013$1$I$20240830$20240903$20240916$20240916$30DAY$$CA-MYLANLABS-2024M1081920$MYLAN$$$$$F$Y$$$20240916$$CN$CA$CA
243240141$24324014$1$I$$20240913$20240916$20240916$PER$$US-ROCHE-10000082588$ROCHE$$$$A$M$Y$$$20240916$$CN$US$US
243240151$24324015$1$I$$20240911$20240916$20240916$EXP$$JP-AstraZeneca-2024A206827$ASTRAZENECA$Shimbu K., Hisakane K., Kadoma N., Nishima S., Atsumi K., Seike M., Hirose T.. Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six- Case Series. OncoTargets and Therapy 2024;17:717-726.$57$YR$$F$Y$$$20240916$$HP$JP$
243240161$24324016$1$I$$20240907$20240916$20240916$EXP$$JP-ARGENX-2024-ARGX-JP000923AA$ARGENX BVBA$$$$$$Y$$$20240916$$MD$JP$JP
243240171$24324017$1$I$$20240911$20240916$20240916$EXP$$US-GILEAD-2024-0687601$GILEAD$$$$E$F$Y$$$20240916$$CN$US$US
243240181$24324018$1$I$$20240913$20240916$20240916$PER$$US-ROCHE-10000082524$ROCHE$$29$YR$A$M$Y$$$20240916$$CN$US$US
243240192$24324019$2$F$20240828$20240913$20240916$20240918$PER$$US-BAYER-2024A131609$BAYER$$$$$F$Y$$$20240918$$HP$US$US
243240201$24324020$1$I$$20240906$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013371$DR REDDYS$$18$YR$A$F$Y$$$20240916$$MD$US$US
243240231$24324023$1$I$$20240909$20240916$20240916$EXP$$GB-TAKEDA-2024TUS090721$TAKEDA$$$$$M$Y$$$20240916$$CN$GB$GB
243240241$24324024$1$I$20240101$20240910$20240916$20240916$PER$$US-JNJFOC-20240927507$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240916$$CN$US$US
243240251$24324025$1$I$20240805$20240915$20240915$20240915$DIR$718467$$FDA-CTU$$40$YR$$F$N$126$KG$20240915$N$CN$US$
243240261$24324026$1$I$20240824$20240913$20240913$20240913$DIR$718332$$FDA-CTU$$71$YR$$M$N$83$KG$20240913$N$HP$US$
243240271$24324027$1$I$20240910$20240912$20240916$20240916$EXP$$US-VIIV HEALTHCARE LIMITED-US2024113592$VIIV$$60$YR$$M$Y$$$20240916$$CN$US$US
243240281$24324028$1$I$20231001$20240828$20240916$20240916$PER$$US-TEVA-VS-3239241$TEVA$$56$YR$$M$Y$$$20240916$$CN$US$US
243240291$24324029$1$I$20150909$20240913$20240913$20240913$DIR$718316$$FDA-CTU$$53$YR$$M$N$65.25$KG$20240913$N$CN$US$
243240301$24324030$1$I$$20240901$20240916$20240916$EXP$$CN-JNJFOC-20240938280$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20240916$$MD$CN$CN
243240311$24324031$1$I$20240912$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024184315$AMGEN$$77$YR$E$M$Y$$$20240916$$CN$US$US
243240321$24324032$1$I$$20240906$20240916$20240916$EXP$$US-GSK-US2024111322$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$MD$US$US
243240331$24324033$1$I$20240524$20240910$20240916$20240916$EXP$FR-AFSSAPS-AVCN2024000682$FR-INDIVIOR US-INDV-156385-2024$RECKITT BENCKISER$$$$$$Y$$$20240916$$MD$FR$FR
243240351$24324035$1$I$20240715$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146663$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240916$$HP$US$US
243240361$24324036$1$I$20231230$20240906$20240916$20240916$EXP$$US-ARGENX-2024-ARGX-US007556$ARGENX BVBA$$$$$$Y$$$20240916$$CN$US$US
243240371$24324037$1$I$20240906$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024183003$AMGEN$$24$YR$A$F$Y$$$20240916$$CN$US$US
243240381$24324038$1$I$$20240831$20240916$20240916$PER$$US-INSUD PHARMA-2408US06909$INSUD PHARMA$$$$$$Y$$$20240916$$CN$US$US
243240391$24324039$1$I$20111017$20240909$20240916$20240916$EXP$$FR-SANDOZ INC.-PHHY2019FR002228$SANDOZ$$41$YR$$F$Y$$$20240916$$CN$FR$FR
243240401$24324040$1$I$$20240913$20240913$20240913$DIR$718326$$FDA-CTU$$$$$UNK$N$$$20240913$$CN$US$
243240411$24324041$1$I$20240501$20240915$20240915$20240915$DIR$718443$$FDA-CTU$$70$YR$$F$N$72$KG$20240915$Y$CN$US$
243240421$24324042$1$I$20240906$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024182274$AMGEN$$$$$M$Y$$$20240916$$CN$US$US
243240431$24324043$1$I$20240912$20240913$20240916$20240916$PER$$US-HALEON-2196931$Haleon PLC$$$$$$Y$$$20240916$$CN$US$US
243240441$24324044$1$I$20240808$20240909$20240916$20240916$EXP$$CA-GSK-CA2024023173$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$CA$CA
243240451$24324045$1$I$20240523$20240909$20240916$20240916$EXP$FR-AFSSAPS-ST2024001387$FR-FreseniusKabi-FK202413618$FRESENIUS KABI$$43$YR$A$M$Y$60$KG$20240916$$MD$FR$FR
243240461$24324046$1$I$20220401$20240906$20240916$20240916$EXP$FR-AFSSAPS-PP2024000915$FR-TEVA-VS-3241367$TEVA$$46$YR$$M$Y$69$KG$20240916$$MD$FR$FR
243240471$24324047$1$I$$20240904$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013104$DR REDDYS$$$$$F$Y$$$20240916$$CN$US$US
243240481$24324048$1$I$20240817$20240909$20240916$20240916$EXP$FR-AFSSAPS-RN2024000956$FR-FreseniusKabi-FK202413663$FRESENIUS KABI$$44$YR$A$F$Y$$$20240916$$MD$FR$FR
243240491$24324049$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63426$$FDA-CTU$$71$YR$$M$N$95.25$KG$20240916$N$HP$US$
243240501$24324050$1$I$20240622$20240913$20240913$20240913$DIR$718382$$FDA-CTU$$42$MON$$M$N$$$20240913$N$CN$US$
243240511$24324051$1$I$$20240909$20240916$20240916$PER$$US-ABBVIE-5916045$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243240521$24324052$1$I$$20240910$20240916$20240916$EXP$$KR-INCYTE CORPORATION-2024IN009722$INCYTE$$$$$$Y$$$20240916$$CN$KR$KR
243240531$24324053$1$I$20240801$20240830$20240916$20240916$PER$$US-INSUD PHARMA-2408US06898$INSUD PHARMA$$$$$$Y$$$20240916$$CN$US$US
243240541$24324054$1$I$$20240910$20240916$20240916$EXP$$FR-INCYTE CORPORATION-2024IN009720$INCYTE$$$$$$Y$$$20240916$$PH$FR$FR
243240551$24324055$1$I$20240602$20240913$20240916$20240916$EXP$$US-AstraZeneca-2024A209919$ASTRAZENECA$$$$$F$Y$$$20240916$$HP$US$
243240571$24324057$1$I$$20240823$20240916$20240916$30DAY$$US-BECTON DICKINSON-US-BD-24-000536$BECTON DICKINSON$$$$$$Y$$$20240916$$CN$US$US
243240601$24324060$1$I$$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144212$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$67.13$KG$20240916$$CN$US$US
243240611$24324061$1$I$$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144063$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$$$20240916$$CN$US$US
243240621$24324062$1$I$$20240912$20240916$20240916$EXP$$PL-SANDOZ INC.-SDZ2024PL080045$SANDOZ$$$$$$Y$$$20240916$$HP$PL$PL
243240631$24324063$1$I$$20240913$20240916$20240916$EXP$$FI-SANDOZ INC.-NVSC2020FI137139$SANDOZ$$64$YR$$M$Y$$$20240916$$MD$FI$FI
243240641$24324064$1$I$$20240909$20240916$20240916$EXP$$JP-TEVA-VS-3242221$TEVA$Takada N, Fukui T, Irie H, Funatsu Y, Koh H. Immune Checkpoint Inhibitor-induced Sclerosing Cholangitis: Three Cases Reported from Our Hospital. [Japanese]. Haigan 2024; 64 (3): 193-199.$69$YR$$M$Y$$$20240916$$HP$JP$JP
243240651$24324065$1$I$20240101$20240906$20240916$20240916$EXP$$US-TEVA-VS-3243645$TEVA$$56$YR$$F$Y$$$20240916$$CN$US$US
243240661$24324066$1$I$$20240909$20240916$20240916$EXP$$JP-TEVA-VS-3242220$TEVA$Takada N, Fukui T, Irie H, Funatsu Y, Koh H. Immune Checkpoint Inhibitor-induced Sclerosing Cholangitis: Three Cases Reported from Our Hospital. [Japanese]. Haigan 2024; 64 (3): 193-199.$73$YR$$F$Y$$$20240916$$HP$JP$JP
243240671$24324067$1$I$20240101$20240909$20240916$20240916$EXP$$US-AMGEN-USASL2024177962$AMGEN$$81$YR$E$F$Y$$$20240916$$CN$US$US
243240683$24324068$3$F$20240905$20240920$20240916$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014928$JAZZ$$53$YR$$M$Y$$$20240926$$CN$US$US
243240691$24324069$1$I$20240717$20240915$20240915$20240915$DIR$718437$$FDA-CTU$$38$YR$$F$N$93.6$KG$20240915$N$CN$US$
243240711$24324071$1$I$$20240909$20240916$20240916$EXP$$JP-TEVA-VS-3242222$TEVA$Takada N, Fukui T, Irie H, Funatsu Y, Koh H. Immune Checkpoint Inhibitor-induced Sclerosing Cholangitis: Three Cases Reported from Our Hospital. [Japanese]. Haigan 2024; 64 (3): 193-199.$68$YR$$M$Y$$$20240916$$HP$JP$JP
243240731$24324073$1$I$20240903$20240904$20240916$20240916$PER$$US-SA-2024SA265652$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240916$$MD$US$US
243240741$24324074$1$I$$20240903$20240916$20240916$PER$$US-SA-2024SA264403$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240916$$CN$US$US
243240751$24324075$1$I$20240828$20240911$20240916$20240916$EXP$$US-OTSUKA-2024_023943$OTSUKA$$$$$M$Y$97.5$KG$20240916$$HP$US$US
243240761$24324076$1$I$20240907$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024181719$AMGEN$$71$YR$E$F$Y$$$20240916$$CN$US$US
243240772$24324077$2$F$20240912$20240916$20240916$20240917$PER$$US-AMGEN-USASP2024183613$AMGEN$$76$YR$E$M$Y$$$20240916$$CN$US$US
243240781$24324078$1$I$20240901$20240912$20240916$20240916$EXP$$PH-OTSUKA-2024_025775$OTSUKA$$67$YR$$M$Y$$$20240916$$CN$PH$PH
243240791$24324079$1$I$20240902$20240912$20240916$20240916$EXP$$US-GSK-US2024113470$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$US$US
243240802$24324080$2$F$$20240926$20240916$20240927$PER$$US-PFIZER INC-202400255474$PFIZER$$67$YR$$F$Y$$$20240927$$CN$US$US
243240811$24324081$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400120429$PFIZER$$$$$F$Y$$$20240916$$HP$US$US
243240821$24324082$1$I$20240910$20240912$20240916$20240916$PER$$US-PFIZER INC-202400255938$PFIZER$$80$YR$$F$Y$$$20240916$$MD$US$US
243240831$24324083$1$I$20240101$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256414$PFIZER$$73$YR$$F$Y$$$20240916$$HP$US$US
243240843$24324084$3$F$20240901$20240916$20240916$20240920$PER$$US-PFIZER INC-202400256264$PFIZER$$77$YR$$M$Y$$$20240920$$CN$US$US
243240852$24324085$2$F$$20240912$20240916$20240918$PER$$US-PFIZER INC-202400255498$PFIZER$$$$$F$Y$$$20240918$$CN$US$US
243240861$24324086$1$I$20240801$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256411$PFIZER$$$$$F$Y$$$20240916$$CN$US$US
243240871$24324087$1$I$20240801$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256443$PFIZER$$71$YR$$M$Y$$$20240916$$HP$US$US
243240881$24324088$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256063$PFIZER$$31$YR$$F$Y$$$20240916$$HP$US$US
243240891$24324089$1$I$20230901$20240906$20240916$20240916$EXP$$US-ABBVIE-5917503$ABBVIE$$55$YR$$F$Y$$$20240916$$CN$US$US
243240901$24324090$1$I$20240805$20240912$20240916$20240916$PER$$US-PFIZER INC-202400255963$PFIZER$$$$$F$Y$$$20240916$$CN$US$US
243240911$24324091$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400120545$PFIZER$$25$YR$$F$Y$$$20240916$$CN$US$US
243240921$24324092$1$I$20240908$20240912$20240916$20240916$PER$$US-PFIZER INC-202400255812$PFIZER$$77$YR$$F$Y$$$20240916$$CN$US$US
243240931$24324093$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400255939$PFIZER$$75$YR$$F$Y$$$20240916$$HP$US$US
243240941$24324094$1$I$20240913$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256528$PFIZER$$52$YR$$$Y$$$20240916$$CN$US$US
243240952$24324095$2$F$$20240918$20240916$20240923$EXP$$IN-PFIZER INC-PV202400121209$PFIZER$$76$YR$$F$Y$$$20240923$$CN$IN$IN
243240961$24324096$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400119922$PFIZER$$$$$$Y$$$20240916$$CN$US$US
243240971$24324097$1$I$$20240911$20240916$20240916$PER$$US-PFIZER INC-PV202400119730$PFIZER$$$$$$Y$$$20240916$$CN$US$US
243240981$24324098$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256109$PFIZER$$68$YR$$F$Y$$$20240916$$MD$US$US
243240991$24324099$1$I$20240801$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256243$PFIZER$$$$A$F$Y$$$20240916$$MD$US$US
243241001$24324100$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400120594$PFIZER$$55$YR$$F$Y$$$20240916$$HP$US$US
243241011$24324101$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256461$PFIZER$$77$YR$$F$Y$$$20240916$$HP$US$US
243241021$24324102$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256190$PFIZER$$30$YR$$M$Y$$$20240916$$HP$US$US
243241031$24324103$1$I$20240901$20240912$20240916$20240916$PER$$US-PFIZER INC-202400255391$PFIZER$$81$YR$$F$Y$$$20240916$$CN$US$US
243241041$24324104$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256449$PFIZER$$27$YR$$M$Y$$$20240916$$HP$US$US
243241051$24324105$1$I$20240912$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256502$PFIZER$$45$YR$$M$Y$$$20240916$$CN$US$US
243241061$24324106$1$I$$20240911$20240916$20240916$PER$$US-PFIZER INC-202400255587$PFIZER$$11$YR$$M$Y$$$20240916$$CN$US$US
243241071$24324107$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400120325$PFIZER$$87$YR$$M$Y$$$20240916$$HP$US$US
243241081$24324108$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400255591$PFIZER$$72$YR$$F$Y$$$20240916$$CN$US$US
243241091$24324109$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256444$PFIZER$$62$YR$$F$Y$$$20240916$$HP$US$US
243241101$24324110$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400255927$PFIZER$$60$YR$$M$Y$$$20240916$$CN$US$US
243241111$24324111$1$I$20240820$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256394$PFIZER$$$$$F$Y$$$20240916$$HP$US$US
243241121$24324112$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256403$PFIZER$$$$$$Y$$$20240916$$CN$US$US
243241141$24324114$1$I$20240909$20240912$20240916$20240916$PER$$US-PFIZER INC-202400255916$PFIZER$$52$YR$$M$Y$$$20240916$$CN$US$US
243241152$24324115$2$F$$20240919$20240916$20240925$PER$$US-PFIZER INC-202400255720$PFIZER$$9$YR$$M$Y$20.5$KG$20240925$$CN$US$US
243241161$24324116$1$I$20240101$20240911$20240916$20240916$PER$$US-PFIZER INC-202400255864$PFIZER$$20$YR$$M$Y$$$20240916$$HP$US$US
243241171$24324117$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400120441$PFIZER$$$$$$Y$$$20240916$$MD$US$US
243241181$24324118$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202300091214$PFIZER$$74$YR$$F$Y$$$20240916$$CN$US$US
243241191$24324119$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400118144$PFIZER$$$$$M$Y$$$20240916$$CN$US$US
243241202$24324120$2$F$$20240916$20240916$20240918$PER$$US-PFIZER INC-PV202400120640$PFIZER$$53$YR$$F$Y$$$20240918$$HP$US$US
243241211$24324121$1$I$20240101$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400120168$PFIZER$$72$YR$$F$Y$$$20240916$$HP$US$US
243241222$24324122$2$F$$20240923$20240916$20240925$EXP$$US-PFIZER INC-PV202400120690$PFIZER$$80$YR$$F$Y$$$20240925$$HP$US$US
243241231$24324123$1$I$$20240911$20240916$20240916$PER$$US-PFIZER INC-202400256215$PFIZER$$$$C$$Y$$$20240916$$MD$US$US
243241241$24324124$1$I$20240912$20240912$20240916$20240916$PER$$US-PFIZER INC-202400255836$PFIZER$$69$YR$$M$Y$$$20240916$$CN$US$US
243241251$24324125$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400235076$PFIZER$$$$A$F$Y$$$20240916$$HP$US$US
243241261$24324126$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400120393$PFIZER$$31$YR$$F$Y$$$20240916$$HP$US$US
243241272$24324127$2$F$$20240918$20240916$20240920$PER$$US-PFIZER INC-202400256031$PFIZER$$$$$$Y$$$20240920$$CN$US$US
243241281$24324128$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256396$PFIZER$$$$A$F$Y$$$20240916$$CN$US$US
243241292$24324129$2$F$20240911$20240913$20240916$20240918$EXP$$US-PFIZER INC-202400256365$PFIZER$$56$YR$$F$Y$65.77$KG$20240918$$CN$US$US
243241311$24324131$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400255753$PFIZER$$79$YR$$F$Y$$$20240916$$MD$US$US
243241321$24324132$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400120305$PFIZER$$61$YR$$F$Y$$$20240916$$HP$US$US
243241331$24324133$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256017$PFIZER$$74$YR$$M$Y$$$20240916$$CN$US$US
243241341$24324134$1$I$20240209$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400120433$PFIZER$$37$YR$$F$Y$92.063$KG$20240916$$CN$US$US
243241351$24324135$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400255777$PFIZER$$$$A$M$Y$$$20240916$$CN$US$US
243241361$24324136$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256516$PFIZER$$72$YR$$F$Y$$$20240916$$CN$US$US
243241381$24324138$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202200568933$PFIZER$$25$YR$$F$Y$$$20240916$$HP$US$US
243241411$24324141$1$I$20230902$20240911$20240916$20240916$EXP$ES-AEMPS-1568369$ES-ORGANON-O2409ESP000753$ORGANON$$58$YR$$M$Y$$$20240916$$MD$ES$ES
243241421$24324142$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007039$ELI LILLY AND CO$$66$YR$E$$Y$$$20240916$$CN$US$US
243241431$24324143$1$I$$20240904$20240916$20240916$PER$$US-SA-2023SA004534$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240916$$HP$US$US
243241441$24324144$1$I$20240101$20240822$20240916$20240916$PER$$US-SA-2024SA265789$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240916$$CN$US$US
243241451$24324145$1$I$$20240906$20240916$20240916$PER$$US-SA-2024SA264758$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240916$$HP$US$US
243241461$24324146$1$I$$20240913$20240916$20240916$PER$$US-HALEON-2196918$Haleon PLC$$79$YR$$F$Y$$$20240916$$CN$US$US
243241471$24324147$1$I$20240911$20240911$20240916$20240916$PER$$US-JNJFOC-20240928795$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240916$$CN$US$US
243241481$24324148$1$I$$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143982$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240916$$HP$US$US
243241491$24324149$1$I$20240911$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146167$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240916$$CN$US$US
243241511$24324151$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146688$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$59.42$KG$20240916$$CN$US$US
243241531$24324153$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000081234$ROCHE$$$$$$Y$$$20240916$$CN$US$US
243241541$24324154$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000081480$ROCHE$$$$$$Y$$$20240916$$CN$US$US
243241561$24324156$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63431$$FDA-CTU$$52$YR$$F$N$$$20240916$N$$US$
243241571$24324157$1$I$$20240912$20240916$20240916$PER$$US-JNJFOC-20240932974$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$US$US
243241581$24324158$1$I$$20240911$20240916$20240916$EXP$$GT-AstraZeneca-2024A208531$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$GT$
243241591$24324159$1$I$20240831$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A208909$ASTRAZENECA$$26951$DY$$M$Y$$$20240916$$CN$US$
243241601$24324160$1$I$$20240911$20240916$20240916$EXP$$ZA-AstraZeneca-2024A208701$ASTRAZENECA$$54$YR$$M$Y$$$20240916$$CN$ZA$
243241621$24324162$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-PV202400120605$PFIZER$$$$$$Y$$$20240916$$CN$US$US
243241631$24324163$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63432$$FDA-CTU$$70$YR$$F$N$221$LBS$20240916$Y$$US$
243241641$24324164$1$I$20240912$20240915$20240915$20240915$DIR$718449$$FDA-CTU$$37$YR$$F$N$$$20240915$N$CN$US$
243241651$24324165$1$I$$20240910$20240916$20240916$EXP$$US-TAKEDA-2023TUS042870$TAKEDA$$$$$F$Y$83$KG$20240916$$HP$US$US
243241661$24324166$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-PV202300085228$PFIZER$$59$YR$$M$Y$$$20240916$$HP$US$US
243241671$24324167$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-PV202400120656$PFIZER$$68$YR$$F$Y$$$20240916$$HP$US$US
243241681$24324168$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-PV202400120653$PFIZER$$70$YR$$M$Y$$$20240916$$HP$US$US
243241711$24324171$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400044361$PFIZER$$25$YR$$F$Y$$$20240916$$HP$US$US
243241721$24324172$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-PV202400120647$PFIZER$$$$$$Y$$$20240916$$CN$US$US
243241731$24324173$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-PV202400085078$PFIZER$$58$YR$$M$Y$$$20240916$$HP$US$US
243241741$24324174$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-PV202400120620$PFIZER$$51$YR$$F$Y$$$20240916$$CN$US$US
243241751$24324175$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256543$PFIZER$$83$YR$$F$Y$$$20240916$$CN$US$US
243241761$24324176$1$I$$20240906$20240916$20240916$EXP$$JP-TAKEDA-2024TUS091869$TAKEDA$$13$YR$$F$Y$$$20240916$$PH$JP$JP
243241772$24324177$2$F$$20240919$20240916$20240925$EXP$$US-BIOVITRUM-2024-US-011990$BIOVITRUM$$16$YR$$M$Y$$$20240925$$MD$US$US
243241781$24324178$1$I$20240819$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024180711$AMGEN$$67$YR$E$M$Y$$$20240916$$CN$US$US
243241791$24324179$1$I$20240101$20240910$20240916$20240916$EXP$$US-SA-2024SA266603$SANOFI AVENTIS$$$$A$M$Y$100.23$KG$20240916$$MD$US$US
243241801$24324180$1$I$20240904$20240911$20240916$20240916$30DAY$$GB-MYLANLABS-2024M1083582$MYLAN$$$$$$Y$$$20240916$$HP$GB$GB
243241812$24324181$2$F$20240906$20240916$20240916$20240917$PER$$US-AMGEN-USASP2024183996$AMGEN$$65$YR$E$F$Y$$$20240917$$CN$US$US
243241821$24324182$1$I$20240101$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183113$AMGEN$$41$YR$A$M$Y$$$20240916$$CN$US$US
243241831$24324183$1$I$20240826$20240909$20240916$20240916$EXP$PT-INFARMED-J202408-779$PT-FreseniusKabi-FK202413694$FRESENIUS KABI$$72$YR$E$F$Y$$$20240916$$PH$PT$PT
243241841$24324184$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146646$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240916$$CN$US$US
243241851$24324185$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146859$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$52.62$KG$20240916$$CN$US$US
243241861$24324186$1$I$$20240826$20240916$20240916$PER$$US-SA-2024SA266112$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240916$$HP$US$US
243241872$24324187$2$F$20240415$20240918$20240916$20240927$EXP$$DE-EXELIXIS-CABO-24079585$EXELIXIS$$53$YR$$M$Y$$$20240927$$MD$DE$DE
243241881$24324188$1$I$$20240905$20240916$20240916$EXP$$US-JNJFOC-20240917486$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240916$$CN$US$US
243241892$24324189$2$F$20240912$20240912$20240916$20240919$PER$$US-AMGEN-USASP2024183073$AMGEN$$65$YR$E$F$Y$$$20240919$$CN$US$US
243241901$24324190$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63433$$FDA-CTU$$42$YR$$F$N$$$20240916$N$HP$US$
243241911$24324191$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63434$$FDA-CTU$$52$YR$$F$N$$$20240916$N$$US$
243241921$24324192$1$I$$20240909$20240916$20240916$EXP$$NVSC2024IT182564$NOVARTIS$Abete R, Iacovoni A, Vittori C, Candiago E, Gianatti A, Terzi A, et al.. Navigating the uncharted waters: managing concurrent cytomegalovirus myocarditis and allograft rejection in a patient with heart transplantation. EUROPEAN HEART JOURNAL. 2024;26 (SUPP (2)):ii39$49$YR$$F$Y$$$20240916$$HP$IT$IT
243241931$24324193$1$I$$20240912$20240916$20240916$PER$$US-TAKEDA-2024TUS091401$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
243241942$24324194$2$F$20240419$20240909$20240916$20240916$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-143678$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240917$$HP$AU$AU
243241951$24324195$1$I$$20240830$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-140108$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$88.45$KG$20240916$$CN$US$US
243241961$24324196$1$I$20240801$20240827$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08773$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243241971$24324197$1$I$$20240911$20240916$20240916$EXP$$IN-VANTIVE-2024VAN019741$Vantive US Healthcare$$62$YR$$M$Y$$$20240916$$CN$IN$IN
243241981$24324198$1$I$$20240722$20240916$20240916$EXP$$US-TEVA-VS-3236865$TEVA$Song JJ, Eyabi JC, Awatramani PD, Mitchell BG, Nene SY. Sudden Reduction in Caffeine Intake Increases Serum Lithium Concentration to Supratherapeutic Level: A Case Report. Prim-Care-Comp-CNS-Disorders 2024; 26 (2):.; Song JJ, Eyabi JC, Awatramani PD, Mitchell BG, Nene SY. Sudden Reduction in Caffeine Intake Increases Serum Lithium Concentration to Supratherapeutic Level: A Case Report. Prim-Care-Comp-CNS-Disorders 2024; 26 (2):.$59$YR$$M$Y$$$20240916$$HP$US$US
243242001$24324200$1$I$20240907$20240909$20240916$20240916$EXP$$US-VANTIVE-2024VAN019649$Vantive US Healthcare$$$$$F$Y$$$20240916$$CN$US$US
243242021$24324202$1$I$20240828$20240911$20240916$20240916$EXP$$SG-VANTIVE-2024VAN019693$Vantive US Healthcare$$63$YR$$M$Y$$$20240916$$CN$SG$SG
243242041$24324204$1$I$20240911$20240911$20240916$20240916$EXP$$KR-VANTIVE-2024VAN019757$Vantive US Healthcare$$44$YR$$M$Y$$$20240916$$CN$KR$KR
243242051$24324205$1$I$20240829$20240912$20240916$20240916$EXP$$SG-VANTIVE-2024VAN019729$Vantive US Healthcare$$56$YR$$M$Y$$$20240916$$CN$SG$SG
243242061$24324206$1$I$$20240904$20240916$20240916$EXP$$DK-Accord-445862$ACCORD$Schmiegelow A, Klein M. Small bowel obstruction caused by immunosuppressive therapy after a liver transplant. Ugeskr Laeger. 2014;176 (44).$53$YR$A$F$Y$$$20240916$$HP$DK$DK
243242071$24324207$1$I$20240808$20240902$20240916$20240916$EXP$FR-AFSSAPS-CN2024000798$FR-BAXTER-2024BAX024044$BAXTER$$54$YR$$F$Y$89$KG$20240916$$MD$FR$FR
243242081$24324208$1$I$20240826$20240905$20240916$20240916$EXP$CN-NMPACDR-2102011010991202400100$CN-BAXTER-2024BAX024420$BAXTER$$75$YR$$M$Y$80$KG$20240916$$MD$CN$CN
243242091$24324209$1$I$20090101$20240913$20240916$20240916$EXP$BG-SA-2024SA257810$BG-SANDOZ INC.-SDZ2024BG080126$SANDOZ$$74$YR$$F$Y$$$20240916$$MD$BG$BG
243242101$24324210$1$I$$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024183034$AMGEN$$$$$$Y$$$20240916$$CN$US$US
243242111$24324211$1$I$$20240911$20240916$20240916$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-123067$REGENERON$$$$$M$Y$$$20240916$$CN$CA$CA
243242121$24324212$1$I$20240904$20240909$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013296$DR REDDYS$$71$YR$E$M$Y$$$20240916$$PH$US$US
243242141$24324214$1$I$$20240909$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013310$DR REDDYS$$67$YR$E$F$Y$$$20240916$$MD$US$US
243242151$24324215$1$I$20240905$20240905$20240916$20240916$PER$$US-ABBVIE-5914470$ABBVIE$$19$YR$$M$Y$$$20240916$$HP$US$US
243242161$24324216$1$I$20230519$20240910$20240916$20240916$PER$$US-Eisai-EC-2023-140991$EISAI$$53$YR$A$F$Y$57.15$KG$20240916$$CN$US$US
243242171$24324217$1$I$$20240903$20240916$20240916$EXP$$US-NOVITIUMPHARMA-2024USNVP01813$NOVITIUM PHARMA$Ramya Muddasani.Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy.06-AUG-24;73:1-9$61$YR$A$F$Y$$$20240912$$HP$US$US
243242181$24324218$1$I$$20240828$20240916$20240916$PER$$US-009507513-2408USA010760$MERCK$Monsour EP, Pothen J, Balaraman R. A Novel Approach to the Treatment of Pembrolizumab induced Psoriasis Exacerbation. Cureus. 2019;11(10):e5824:1-5$63$YR$$F$Y$$$20240916$$HP$US$US
243242191$24324219$1$I$$20240827$20240916$20240916$PER$$US-TEVA-VS-3238893$TEVA$$$$$M$Y$$$20240916$$CN$US$US
243242201$24324220$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207296$ASTRAZENECA$$$$$F$Y$$$20240916$$MD$US$
243242211$24324221$1$I$$20240903$20240916$20240916$EXP$$US-NOVITIUMPHARMA-2024USNVP01812$NOVITIUM PHARMA$Ramya Muddasani.Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series. Cancer Immunology, Immunotherapy.06-AUG-24;73:1-9$69$YR$A$M$Y$$$20240912$$HP$US$US
243242221$24324222$1$I$$20240911$20240916$20240916$EXP$$JP-AstraZeneca-2024A208665$ASTRAZENECA$$81$YR$$M$Y$$$20240916$$MD$JP$
243242231$24324223$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A207684$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243242241$24324224$1$I$$20240911$20240916$20240916$EXP$$JP-AstraZeneca-2024A208561$ASTRAZENECA$$71$YR$$M$Y$$$20240916$$MD$JP$
243242251$24324225$1$I$$20240909$20240916$20240916$EXP$$IR-AstraZeneca-2024A206033$ASTRAZENECA$Atapour A,  Momenzadeh M,  Panahishokouh M,  Badri S. Rosuvastatin-Induced Rhabdomyolysis as a Result of Drug Interaction With Sitagliptin: A Case Report. Clinical Medicine Insights: Case Reports 2024;17:1-4.$64$YR$$F$Y$65$KG$20240916$$HP$IR$
243242261$24324226$1$I$20210615$20240915$20240915$20240915$DIR$718436$$FDA-CTU$$23$YR$$M$N$81$KG$20240915$N$CN$US$
243242271$24324227$1$I$$20240904$20240916$20240916$EXP$$SE-NOVITIUMPHARMA-2024SENVP01826$NOVITIUM PHARMA$Anna Nikkarinen.Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma - A case report.eJHaem.16-JUN-2024;5(4):820-824$79$YR$E$M$Y$$$20240912$$HP$SE$SE
243242281$24324228$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183477$AMGEN$$$$$$Y$$$20240916$$CN$US$US
243242291$24324229$1$I$20240909$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008438$ELI LILLY AND CO$$55$YR$A$$Y$$$20240916$$CN$US$US
243242301$24324230$1$I$$20240911$20240916$20240916$PER$$US-AMGEN-USASP2024182388$AMGEN$$$$$M$Y$$$20240916$$CN$US$US
243242311$24324231$1$I$$20240904$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003405$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240916$$CN$US$US
243242321$24324232$1$I$20240906$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008263$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240916$$CN$US$US
243242332$24324233$2$F$20240401$20240912$20240916$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409008262$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240930$$CN$US$US
243242341$24324234$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007373$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240916$$CN$US$US
243242351$24324235$1$I$20240909$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005636$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240916$$CN$US$US
243242361$24324236$1$I$20230101$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008844$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240916$$CN$US$US
243242381$24324238$1$I$20240701$20240910$20240916$20240916$EXP$$US-MYLANLABS-2024M1083432$MYLAN$$39$YR$$M$Y$58.97$KG$20240916$$CN$US$US
243242391$24324239$1$I$$20240905$20240916$20240916$EXP$$MW-NOVITIUMPHARMA-2024MWNVP01849$NOVITIUM PHARMA$Yohane, M.Conjugated hyperbilirubinemia associated with accidental rifapentine overdose.The International Journal of Tuberculosis and Lung Disease.01-JUL-2024;28(7):354-356$22$YR$A$F$Y$33$KG$20240913$$HP$MW$MW
243242401$24324240$1$I$20240328$20240911$20240916$20240916$EXP$FR-AFSSAPS-AM2024000715$FR-MYLANLABS-2024M1083470$MYLAN$$20$YR$$F$Y$80$KG$20240916$$MD$FR$FR
243242411$24324241$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145590$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240916$$CN$US$US
243242421$24324242$1$I$$20240909$20240916$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA078859$SANDOZ$$65$YR$$F$Y$34$KG$20240916$$HP$CA$CA
243242432$24324243$2$F$20240926$20240926$20240916$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146759$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240927$$HP$US$US
243242441$24324244$1$I$$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144094$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240916$$CN$US$US
243242451$24324245$1$I$$20240905$20240916$20240916$EXP$$IR-NOVITIUMPHARMA-2024IRNVP01838$NOVITIUM PHARMA$Soheil Roshanzamiri.Acyclovir-induced psychiatric and renal adverse effects in a diabetic patient: A case report.Clinical Case Reports.19-AUG-2024;12(8):1-4$52$YR$A$F$Y$$$20240912$$HP$IR$IR
243242461$24324246$1$I$$20240911$20240916$20240916$PER$$US-BIOVITRUM-2024-US-012024$BIOVITRUM$$88$YR$$F$Y$$$20240916$$CN$US$US
243242471$24324247$1$I$20240723$20240907$20240916$20240916$EXP$$CN-GE HEALTHCARE-2024CSU010365$GE HEALTHCARE$$37$YR$$F$Y$56$KG$20240916$$HP$CN$CN
243242481$24324248$1$I$$20240905$20240916$20240916$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18056$IPSEN$$$$$F$Y$$$20240916$$HP$US$US
243242491$24324249$1$I$20220101$20240905$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142599$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$79.83$KG$20240916$$PH$US$US
243242502$24324250$2$F$$20240910$20240916$20240926$PER$$US-ABBVIE-5922044$ABBVIE$$14$YR$$$Y$$$20240926$$PH$US$US
243242511$24324251$1$I$$20240909$20240916$20240916$PER$$US-JNJFOC-20240921893$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$US$US
243242522$24324252$2$F$20240101$20240916$20240916$20240923$EXP$$US-JNJFOC-20240934888$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240923$$HP$US$US
243242531$24324253$1$I$$20240904$20240916$20240916$PER$$US-JNJFOC-20240927542$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240916$$MD$US$US
243242541$24324254$1$I$$20240903$20240916$20240916$EXP$$ID-NOVITIUMPHARMA-2024IDNVP01799$NOVITIUM PHARMA$Peby M Lestari.A Rare Case Report: Belly Dancer Dyskinesia and Symptomatic Epilepsy in Pregnancy Causing Incomplete Uterine Rupture.Journal of South Asian Federation of Obstetrics and Gynaecology.09-JUL-2024;16(4):455-457$33$YR$A$F$Y$$$20240912$$HP$ID$ID
243242551$24324255$1$I$20240301$20240906$20240916$20240916$EXP$$AR-JNJFOC-20240921152$JOHNSON AND JOHNSON$$54$YR$A$M$Y$78$KG$20240916$$CN$AR$AR
243242561$24324256$1$I$$20240909$20240916$20240916$EXP$$FR-SANDOZ INC.-PHHY2018FR156450$SANDOZ$$13$YR$$F$Y$$$20240916$$MD$FR$FR
243242571$24324257$1$I$$20240911$20240916$20240916$PER$$US-PFIZER INC-202400255586$PFIZER$$71$YR$$M$Y$$$20240916$$HP$US$US
243242581$24324258$1$I$$20240904$20240916$20240916$EXP$DE-EMA-DD-20240829-7482707-105358$DE-Accord-445888$ACCORD$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al.. Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant recipients: CERTAIN registry study. TRANSPLANTATION. 2018;103(6):1-33. doi:10.1097/TP.0000000000002414$17$YR$T$$Y$$$20240916$$MD$DE$DE
243242592$24324259$2$F$$20240923$20240916$20240925$PER$$US-PFIZER INC-2019457430$PFIZER$$$$A$F$Y$56.7$KG$20240925$$CN$US$US
243242601$24324260$1$I$$20240905$20240916$20240916$EXP$$DE-NOVITIUMPHARMA-2024DENVP01844$NOVITIUM PHARMA$Ozlem Satirer.Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.RMD Open.14-JUL-2024;10:e004381$$$$F$Y$$$20240912$$HP$DE$DE
243242611$24324261$1$I$$20240911$20240916$20240916$PER$$US-PFIZER INC-202400254989$PFIZER$$15$YR$$M$Y$$$20240916$$CN$US$US
243242621$24324262$1$I$20240901$20240911$20240916$20240916$PER$$US-PFIZER INC-202400255433$PFIZER$$56$YR$$F$Y$62.6$KG$20240916$$CN$US$US
243242632$24324263$2$F$$20240915$20240916$20240920$PER$$US-PFIZER INC-202400254066$PFIZER$$$$$$Y$$$20240920$$CN$US$US
243242641$24324264$1$I$$20240911$20240916$20240916$PER$$US-PFIZER INC-202400255177$PFIZER$$43$YR$$M$Y$$$20240916$$CN$US$US
243242651$24324265$1$I$20240701$20240911$20240916$20240916$PER$$US-PFIZER INC-202300235192$PFIZER$$60$YR$$F$Y$$$20240916$$HP$US$US
243242661$24324266$1$I$20240828$20240910$20240916$20240916$PER$$US-ABBVIE-5920369$ABBVIE$$38$YR$$F$Y$$$20240916$$MD$US$US
243242671$24324267$1$I$$20240909$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013312$DR REDDYS$$29$YR$A$M$Y$$$20240916$$CN$US$US
243242681$24324268$1$I$20240101$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146161$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240916$$HP$US$US
243242692$24324269$2$F$$20240909$20240916$20240927$EXP$$JP-009507513-2409JPN001427J$MERCK$Nakashima S, Sasaki A, Motomura Y, Okamoto R, Yoshioka T, Matsuda K, et al.. 46 A case of TMB-high large intestine carcinoma complicated by hyperprogressive disease after pembrolizumab administration.. The 381st Regular Meeting of the Japanese Society of Gastroenterology Kanto Bran. 37$60$YR$$F$Y$$$20240927$$MD$JP$JP
243242701$24324270$1$I$20240913$20240915$20240915$20240915$DIR$718469$$FDA-CTU$$34$YR$$F$N$93.6$KG$20240915$N$CN$US$
243242722$24324272$2$F$$20240913$20240916$20240918$EXP$$CA-SANDOZ INC.-NVSC2020CA083044$SANDOZ$$48$YR$$M$Y$$$20240918$$HP$CA$CA
243242741$24324274$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63435$$FDA-CTU$$65$YR$$F$N$$$20240916$N$$US$
243242751$24324275$1$I$$20240913$20240916$20240916$PER$$US-ALXN-202409USA001059US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243242761$24324276$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63436$$FDA-CTU$$55$YR$$F$N$$$20240916$N$$US$
243242771$24324277$1$I$20220511$20240906$20240916$20240916$EXP$$BR-JNJFOC-20240920871$JOHNSON AND JOHNSON$$16$YR$T$M$Y$56$KG$20240916$$CN$BR$BR
243242781$24324278$1$I$20240101$20240906$20240916$20240916$EXP$$US-ZENPEP LLC-2024AIMT01329$AIMMUNE$$$$$$Y$$$20240916$$CN$US$US
243242791$24324279$1$I$$20240909$20240916$20240916$EXP$$CA-GSK-CA2024AMR112144$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$CA$CA
243242802$24324280$2$F$20200501$20240913$20240916$20240919$EXP$$US-PFIZER INC-202400255058$PFIZER$Safdar, Z.. Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension. Pulmonary circulation. 2024;14(3):10.1002/pul2.12426$52$YR$$F$Y$$$20240919$$MD$US$US
243242811$24324281$1$I$$20240911$20240916$20240916$EXP$$US-PFIZER INC-PV202400119815$PFIZER$Harper, K.. Leukemia cutis and anterior uveitis associated with chronic myelomonocytic leukemia. JAAD Case Reports. 2024;52:21-24$76$YR$$F$Y$$$20240916$$MD$US$US
243242831$24324283$1$I$$20240911$20240916$20240916$PER$$US-GILEAD-2024-0687480$GILEAD$$$$$$Y$$$20240916$$CN$US$US
243242841$24324284$1$I$$20240906$20240916$20240916$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01846$NOVITIUM PHARMA$Koichiro Adachi.Interaction of a caffeine overdose with clinical doses of contraceptive ethinyl estradiol in a young woman.Acute Medicine + Surgery.12-AUG-2024;11(1):1-4$23$YR$A$F$Y$$$20240916$$HP$JP$JP
243242851$24324285$1$I$$20240909$20240916$20240916$EXP$$NVSC2024US121151$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
243242861$24324286$1$I$$20240910$20240916$20240916$EXP$$NVSC2024IT183611$NOVARTIS$Reale ML, Passiglia F, Cappuzzo F, Minuti G, Occhipinti M, Bulotta A, et al.. Met exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the italian biomarker atlas database. ESMO-OPEN. 2024;9(9):1-9$76$YR$$M$Y$$$20240916$$HP$IT$IT
243242871$24324287$1$I$$20240911$20240916$20240916$30DAY$$US-SANDOZ INC.-SDZ2024US079716$SANDOZ$$$$$M$Y$$$20240916$$CN$US$US
243242881$24324288$1$I$20240901$20240905$20240916$20240916$EXP$$US-SA-2024SA254026$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240916$$HP$US$US
243242892$24324289$2$F$20240101$20240919$20240916$20240926$EXP$$US-SA-2024SA265245$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240926$$CN$US$US
243242901$24324290$1$I$20240701$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183186$AMGEN$$65$YR$E$F$Y$$$20240916$$MD$US$US
243242911$24324291$1$I$20220916$20240910$20240916$20240916$EXP$FR-AFSSAPS-CF20221585$FR-AMGEN-FRASP2024180766$AMGEN$$57$YR$A$F$Y$$$20240916$$PH$FR$FR
243242921$24324292$1$I$20240420$20240910$20240916$20240916$EXP$IT-MINISAL02-1001298$IT-AMGEN-ITASP2024180900$AMGEN$$55$YR$A$F$Y$57$KG$20240916$$MD$IT$IT
243242933$24324293$3$F$20240101$20240917$20240916$20240923$PER$$US-AMGEN-USASP2024181886$AMGEN$$71$YR$E$F$Y$76.6$KG$20240923$$HP$US$US
243242941$24324294$1$I$$20240910$20240916$20240916$EXP$$PL-AMGEN-POLSP2024180758$AMGEN$$73$YR$E$F$Y$$$20240916$$MD$PL$PL
243242951$24324295$1$I$20240814$20240903$20240916$20240916$EXP$$CA-HLS-202402215$HLS THERAPEUTICS$$87$YR$E$M$Y$$$20240916$$HP$CA$CA
243242961$24324296$1$I$20240801$20240910$20240916$20240916$EXP$$PH-OTSUKA-2024_025548$OTSUKA$$41$YR$$M$Y$$$20240916$$CN$PH$PH
243242971$24324297$1$I$$20240905$20240916$20240916$EXP$$US-SA-2024SA267298$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
243242981$24324298$1$I$$20240904$20240916$20240916$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01854$NOVITIUM PHARMA$Haotian Shi.Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications.Frontiers in Oncology.22-MAY-2023;13:1-8$73$YR$E$F$Y$$$20240912$$HP$CN$CN
243242991$24324299$1$I$$20240904$20240916$20240916$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01853$NOVITIUM PHARMA$Haotian Shi.Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications.Frontiers in Oncology.22-MAY-2023;13:1-8$74$YR$E$M$Y$$$20240912$$HP$CN$CN
243243001$24324300$1$I$$20240910$20240916$20240916$DIR$FDA-CDER-CTU-2024-63437$$FDA-CTU$$$$$M$N$$$20240910$N$HP$US$
243243011$24324301$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63438$$FDA-CTU$$46$YR$$F$N$$$20240916$N$$US$
243243041$24324304$1$I$$20240819$20240916$20240916$DIR$FDA-CDER-CTU-2024-63442$$FDA-CTU$$$$$M$N$$$20240819$N$HP$US$
243243051$24324305$1$I$20240911$20240909$20240916$20240916$EXP$$CA-TAKEDA-2024TUS090238$TAKEDA$$77$YR$$F$Y$$$20240916$$CN$CA$CA
243243071$24324307$1$I$$20240904$20240916$20240916$30DAY$$CH-JNJFOC-20240931299$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$CH$CH
243243081$24324308$1$I$$20240903$20240916$20240916$EXP$$GB-CIPLA LTD.-2024GB09800$CIPLA$$$$$$Y$$$20240916$$HP$GB$GB
243243091$24324309$1$I$$20240903$20240916$20240916$EXP$$GB-CIPLA (EU) LIMITED-2024GB09803$CIPLA$$$$$$Y$$$20240916$$CN$GB$GB
243243101$24324310$1$I$$20240904$20240916$20240916$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01851$NOVITIUM PHARMA$Haotian Shi.Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications.Frontiers in Oncology.22-MAY-2023;13:1-8$84$YR$E$F$Y$$$20240912$$HP$CN$CN
243243111$24324311$1$I$20240902$20240906$20240916$20240916$EXP$RU-RZN-2546708$NVSC2024RU184564$NOVARTIS$$32$YR$$M$Y$$$20240916$$HP$RU$RU
243243121$24324312$1$I$20170701$20240904$20240916$20240916$EXP$HU-EMA-DD-20240829-7482827-105016$HU-Accord-445762$ACCORD$$51$YR$A$F$Y$$$20240916$$HP$HU$HU
243243131$24324313$1$I$20240721$20240916$20240916$20240916$EXP$$US-BAYER-2024A131971$BAYER$$75$YR$E$F$Y$$$20240916$$HP$US$US
243243141$24324314$1$I$$20240916$20240916$20240916$EXP$GB-MHRA-MED-202409160005066000-CKVML$GB-BAYER-2024A131938$BAYER$$32$YR$A$M$Y$65$KG$20240916$$CN$GB$GB
243243151$24324315$1$I$$20240906$20240916$20240916$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01837$NOVITIUM PHARMA$Jiayun Zou.Stubborn hypoxemia after mild to moderate sedation and analgesia: A case report.Medicine .16-FEB-2024;103(7):e37059$62$YR$A$$Y$$$20240916$$HP$CN$CN
243243161$24324316$1$I$$20240911$20240916$20240916$EXP$$JP-AstraZeneca-2024A208679$ASTRAZENECA$$93$YR$$M$Y$$$20240916$$MD$JP$
243243171$24324317$1$I$$20240806$20240916$20240916$EXP$$US-AstraZeneca-2024A179608$ASTRAZENECA$Grichnik JM, Kucharik A, Curcovic N, Chavez J, Tsai K, Brohl A. Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton?s tyrosine kinase inhibitor. JAAD Case Reports 2024;51:17-21.$87$YR$$M$Y$$$20240916$$MD$US$
243243181$24324318$1$I$$20240904$20240916$20240916$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01832$NOVITIUM PHARMA$Si Man Shi.An adult with hemorrhagic varicella co-infects with cytomegalovirus: a case report.BMC Infectious Diseases.11-JUL-2024;691:1-6$25$YR$A$M$Y$$$20240912$$HP$CN$CN
243243191$24324319$1$I$$20240911$20240916$20240916$EXP$$ES-AstraZeneca-2024A206893$ASTRAZENECA$$50$YR$$M$Y$$$20240916$$MD$ES$
243243201$24324320$1$I$20240909$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A210857$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243243211$24324321$1$I$$20240905$20240916$20240916$EXP$$GB-AstraZeneca-2024A210776$ASTRAZENECA$$64$YR$$M$Y$$$20240916$$CN$GB$
243243221$24324322$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A208607$ASTRAZENECA$$$$$F$Y$$$20240916$$HP$US$
243243231$24324323$1$I$$20240904$20240916$20240916$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01830$NOVITIUM PHARMA$Chunyan Zhao.Diffuse lymphoma involvement of the spinal cord showed on [18F]FDG PET/MRI.Nuclear medicine review. Central + Eastern Europe.24-JUL-2024;27:24-27$61$YR$A$F$Y$$$20240912$$HP$CN$CN
243243241$24324324$1$I$20240501$20240912$20240916$20240916$EXP$$FR-AMERICAN REGENT INC-2024003509$AMERICAN REGENT$$37$YR$$F$Y$50$KG$20240916$$MD$FR$FR
243243251$24324325$1$I$20240904$20240909$20240916$20240916$EXP$$US-ANIPHARMA-2024-US-048974$ANI$$40$YR$$F$Y$$$20240916$$HP$US$US
243243261$24324326$1$I$20240801$20240910$20240916$20240916$PER$$US-BAYER-2024A129571$BAYER$$32$YR$A$F$Y$$$20240916$$MD$US$US
243243271$24324327$1$I$$20240904$20240916$20240916$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01825$NOVITIUM PHARMA$Haotian Shi.Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications.Frontiers in Oncology.22-MAY-2023;13:1-8$68$YR$A$M$Y$$$20240912$$HP$CN$CN
243243281$24324328$1$I$20240908$20240911$20240916$20240916$EXP$$CA-Eisai-EC-2024-174356$EISAI$$$$$F$Y$$$20240916$$CN$CA$CA
243243311$24324331$1$I$$20240903$20240916$20240916$EXP$$BE-NOVITIUMPHARMA-2024BENVP01804$NOVITIUM PHARMA$T. DEKOCK.Immunotherapy-induced diabetes mellitus: A case study.Nederlands Tijdschrift voor Geneeskunde.23-FEB-2024;7:585-593$73$YR$E$M$Y$$$20240912$$HP$BE$BE
243243321$24324332$1$I$20240711$20240910$20240916$20240916$PER$$US-SA-2024SA265550$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240916$$MD$US$US
243243331$24324333$1$I$20240501$20240827$20240916$20240916$PER$$US-SA-2024SA265271$SANOFI AVENTIS$$61$YR$A$F$Y$63.64$KG$20240916$$MD$US$US
243243341$24324334$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA265839$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240916$$MD$US$US
243243351$24324335$1$I$$20240904$20240916$20240916$PER$$US-SA-2024SA263528$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240916$$MD$US$US
243243361$24324336$1$I$20240701$20240828$20240916$20240916$PER$$US-SA-2024SA266340$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240916$$MD$US$US
243243371$24324337$1$I$$20240829$20240916$20240916$PER$$US-SA-2024SA266345$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$CN$US$US
243243381$24324338$1$I$20240315$20240907$20240916$20240916$EXP$$BR-TAKEDA-2024TUS091208$TAKEDA$$37$YR$$M$Y$$$20240916$$CN$BR$BR
243243392$24324339$2$F$20240911$20240917$20240916$20240918$PER$$US-AMGEN-USASP2024183761$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243243401$24324340$1$I$20240820$20240904$20240916$20240916$EXP$CN-NMPA-4403041004565202400621$CN-Ipsen Biopharmaceuticals, Inc.-2024-18287$IPSEN$$55$YR$A$M$Y$50$KG$20240916$$HP$CN$CN
243243411$24324341$1$I$$20240910$20240916$20240916$PER$$US-BAYER-2024A129582$BAYER$$32$YR$A$F$Y$$$20240916$$CN$US$US
243243421$24324342$1$I$$20240911$20240916$20240916$PER$$US-BAYER-2024A131046$BAYER$$$$$F$Y$$$20240916$$CN$US$US
243243431$24324343$1$I$$20240911$20240916$20240916$EXP$$US-TAKEDA-2023TUS110125$TAKEDA$$$$$F$Y$$$20240916$$CN$US$US
243243441$24324344$1$I$20240908$20240912$20240916$20240916$PER$$US-BAYER-2024A130805$BAYER$$32$YR$A$F$Y$$$20240916$$CN$US$US
243243461$24324346$1$I$$20240911$20240916$20240916$EXP$$PL-SA-2024SA264093$SANOFI AVENTIS$Miszewska-Szyszkowska D, Mikolajczyk N, Komuda-Leszek E, Wieczorek-Godlewska R, Swider R, Deborska-Materkowska D et al.. Severe cytomegalovirus infection in a second kidney transplant recipient treated with ganciclovir, leflunomide, and immunoglobulins, with complications including seizures, acute HCV infection, drug-induced pancytopenia, diabetes, cholangitis, and multi-organ failure with fatal outcome: A case report.. Ann Transplant.. 2015;20:169-74$32$YR$A$F$Y$$$20240916$$HP$PL$PL
243243471$24324347$1$I$20240901$20240908$20240916$20240916$EXP$$DZ-AMGEN-DZASP2024179369$AMGEN$$$$E$M$Y$$$20240916$$HP$DZ$DZ
243243481$24324348$1$I$20240903$20240912$20240916$20240916$EXP$$CN-HALEON-2196669$Haleon PLC$$74$YR$$M$Y$57$KG$20240916$$HP$CN$CN
243243501$24324350$1$I$20240617$20240909$20240916$20240916$EXP$$US-TAKEDA-2024TUS089862$TAKEDA$$36$YR$$F$Y$67$KG$20240916$$MD$US$US
243243521$24324352$1$I$20240625$20240906$20240916$20240916$EXP$$US-JNJFOC-20240920213$JOHNSON AND JOHNSON$$59$YR$A$F$Y$68.7$KG$20240916$$HP$US$US
243243531$24324353$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63444$$FDA-CTU$$70$YR$$M$N$$$20240916$N$$US$
243243551$24324355$1$I$20240810$20240915$20240915$20240915$DIR$718448$$FDA-CTU$$79$YR$$F$N$49.05$KG$20240915$N$CN$US$
243243561$24324356$1$I$20160901$20240915$20240915$20240915$DIR$718459$$FDA-CTU$$36$YR$$F$N$85.5$KG$20240915$N$CN$US$
243243571$24324357$1$I$$20231219$20240916$20240916$PER$$US-ENDO USA, INC.-2024-000122$ENDO$$$$$$Y$$$20240916$$CN$US$US
243243581$24324358$1$I$20240906$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63108$$FDA-CTU$$74$YR$$M$N$$$20240913$N$$US$
243243591$24324359$1$I$20240903$20240915$20240915$20240915$DIR$718460$$FDA-CTU$$18$YR$$F$N$$$20240915$N$CN$US$
243243601$24324360$1$I$$20231219$20240916$20240916$PER$$US-ENDO USA, INC.-2024-000164$ENDO$$$$$$Y$$$20240916$$CN$US$US
243243611$24324361$1$I$20160726$20231219$20240916$20240916$PER$$US-ENDO USA, INC.-2024-000086$ENDO$$$$A$M$Y$$$20240916$$CN$US$US
243243621$24324362$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024111277$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240916$$HP$US$US
243243631$24324363$1$I$20180801$20240909$20240916$20240916$EXP$NO-NOMAADVRE-PASRAPP-2024-V9z7db$NO-GSK-NO2024111651$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$NO$NO
243243641$24324364$1$I$$20240912$20240916$20240916$EXP$$JP-PFIZER INC-PV202400120017$PFIZER$$74$YR$$M$Y$$$20240916$$MD$JP$JP
243243651$24324365$1$I$20231201$20240909$20240916$20240916$EXP$$CA-GSK-CA2023AMR053186$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$CA$CA
243243662$24324366$2$F$20240501$20240919$20240916$20240923$EXP$$AR-PFIZER INC-202400257255$PFIZER$$36$YR$$F$Y$$$20240923$$CN$AR$AR
243243671$24324367$1$I$$20240911$20240916$20240916$PER$$US-BAYER-2024A131328$BAYER$$19$YR$A$F$Y$$$20240916$$MD$US$US
243243681$24324368$1$I$$20240913$20240916$20240916$PER$$US-BAYER-2024A131557$BAYER$$$$$$Y$$$20240916$$CN$US$US
243243691$24324369$1$I$$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024181464$AMGEN$$$$$$Y$$$20240916$$CN$US$US
243243701$24324370$1$I$20240101$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183031$AMGEN$$63$YR$A$F$Y$$$20240916$$CN$US$US
243243711$24324371$1$I$20240801$20240911$20240916$20240916$EXP$$JP-009507513-2409JPN001666J$MERCK$$9$DEC$$F$Y$$$20240916$$MD$JP$JP
243243721$24324372$1$I$$20240911$20240916$20240916$PER$$US-HALEON-2197061$Haleon PLC$$$$$F$Y$$$20240916$$CN$US$US
243243731$24324373$1$I$$20240910$20240916$20240916$EXP$$CZ-Ipsen Biopharmaceuticals, Inc.-2024-18070$IPSEN$$1$YR$I$$Y$14$KG$20240916$$MD$CZ$CZ
243243742$24324374$2$F$20240307$20240923$20240916$20240926$EXP$PT-INFARMED-R202408-724$PT-FreseniusKabi-FK202413703$FRESENIUS KABI$$54$YR$A$F$Y$$$20240926$$MD$PT$PT
243243751$24324375$1$I$$20240826$20240916$20240916$PER$$US-SA-2024SA266510$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240916$$HP$US$US
243243761$24324376$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265537$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240916$$MD$US$US
243243771$24324377$1$I$20240101$20240827$20240916$20240916$EXP$$US-SA-2024SA263159$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240916$$MD$US$US
243243791$24324379$1$I$$20240822$20240916$20240916$PER$$US-SA-2024SA266322$SANOFI AVENTIS$$$$T$F$Y$$$20240916$$MD$US$US
243243801$24324380$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146928$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240916$$CN$US$US
243243811$24324381$1$I$$20240828$20240916$20240916$PER$$US-SA-2024SA266519$SANOFI AVENTIS$$14$YR$T$$Y$$$20240916$$PH$US$US
243243821$24324382$1$I$$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144621$BRISTOL MYERS SQUIBB$Abugrin M, Panchal A, Aboulqassim B, Bilal M, Virk J. Timely transesophageal echocardiography after left atrial appendage occlusion mayavoid delayed detection of device-related thrombus. Case. 2024 Sep 01;8(9):1-5. doi:10.1016/j.case.2024.05.007.$72$YR$E$M$Y$$$20240916$$MD$US$US
243243841$24324384$1$I$20240912$20240913$20240916$20240916$EXP$$BR-AstraZeneca-2024A210500$ASTRAZENECA$$13$YR$$F$Y$$$20240916$$CN$BR$
243243852$24324385$2$F$$20240912$20240916$20240918$30DAY$$GT-PFIZER INC-PV202400117152$PFIZER$$6$YR$$F$Y$$$20240918$$CN$GT$GT
243243861$24324386$1$I$20230101$20240909$20240916$20240916$EXP$$CA-PFIZER INC-202300118965$PFIZER$$48$YR$$M$Y$$$20240916$$MD$CA$CA
243243871$24324387$1$I$$20240911$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US080315$SANDOZ$$$$$$Y$$$20240916$$CN$US$US
243243881$24324388$1$I$20240101$20240905$20240916$20240916$EXP$$US-BIOGEN-2024BI01281664$BIOGEN$$39$YR$$F$Y$$$20240916$$CN$US$US
243243892$24324389$2$F$20240813$20240918$20240916$20240925$EXP$$NVSC2024ZA183949$NOVARTIS$$51$YR$$F$Y$68$KG$20240925$$MD$ZA$ZA
243243901$24324390$1$I$$20240913$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146630$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240916$$HP$US$US
243243911$24324391$1$I$20240907$20240909$20240916$20240916$PER$$US-JNJFOC-20240931031$JOHNSON AND JOHNSON$$93$YR$E$M$Y$$$20240916$$CN$US$US
243243921$24324392$1$I$20240425$20240910$20240916$20240916$EXP$ES-AEMPS-1515834$ES-TAKEDA-2024TUS090057$TAKEDA$$10$YR$$M$Y$42$KG$20240916$$HP$ES$ES
243243941$24324394$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146242$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240916$$CN$US$US
243243951$24324395$1$I$20121101$20240909$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US078648$SANDOZ$$15$YR$$M$Y$46.4$KG$20240916$$HP$US$US
243243961$24324396$1$I$20220401$20240906$20240916$20240916$EXP$$IT-009507513-2409ITA003642$MERCK$Vignani F. Clinical Case 5-Clinical Benefit of Pembrolizumab Therapy in Frail Patients with Squamous Carcinoma of the Cervicocephalic Region. Impact Factor News. 2024;3:26-31$$$E$F$Y$$$20240916$$MD$IT$IT
243243971$24324397$1$I$$20240913$20240916$20240916$PER$$US-HALEON-2196935$Haleon PLC$$$$$$Y$$$20240916$$CN$US$US
243243981$24324398$1$I$$20240909$20240916$20240916$EXP$$CA-GSK-CA2022AMR136944$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$MD$CA$CA
243244012$24324401$2$F$20240601$20240913$20240916$20240918$PER$$US-PFIZER INC-202400255599$PFIZER$$51$YR$$F$Y$$$20240918$$HP$US$US
243244021$24324402$1$I$$20240909$20240916$20240916$EXP$$US-SA-2024SA265398$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240916$$HP$US$US
243244031$24324403$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146693$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240916$$HP$US$US
243244041$24324404$1$I$20240901$20240909$20240916$20240916$PER$$US-SA-2024SA265077$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240916$$HP$US$US
243244081$24324408$1$I$20240823$20240913$20240913$20240913$DIR$FDA-CDER-CTU-2024-63107$$FDA-CTU$$23$YR$$F$N$63.5$KG$20240913$N$$US$
243244091$24324409$1$I$$20240906$20240916$20240916$PER$$US-ABBVIE-5917433$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243244101$24324410$1$I$20231213$20240906$20240916$20240916$EXP$$CA-ROCHE-3309729$ROCHE$$54$YR$A$F$Y$$$20240916$$MD$CA$CA
243244111$24324411$1$I$$20240904$20240916$20240916$EXP$$IT-RDY-SPO/ITA/24/0013495$DR REDDYS$Abruzzese E, Trawinska MM, Canichella M, de Fabritiis P. The Pregnant or Want-to-Be Pregnant CML Patient. Clinical Lymphoma, Myeloma and Leukemia. 2024;24: 16-18. doi:10.1016/S2152-2650%2824%2900329-X.$$$$F$Y$$$20240916$$HP$IT$IT
243244122$24324412$2$F$$20240910$20240916$20240917$EXP$$NVSC2024IN183427$NOVARTIS$$$$$M$Y$$$20240918$$CN$IN$IN
243244131$24324413$1$I$$20240910$20240916$20240916$EXP$$PL-AMGEN-POLSP2024182348$AMGEN$$52$YR$A$M$Y$$$20240916$$MD$PL$PL
243244141$24324414$1$I$$20240910$20240916$20240916$EXP$$NVSC2024AU184006$NOVARTIS$Harris K, Dalton B, Learmont BG, Isoardi KZ. Rationalising the dose threshold for severe carbamazepine toxicity: a retrospective series. CLINICAL TOXICOLOGY. 2024;62(8):533-5$15$YR$$$Y$$$20240916$$HP$AU$AU
243244151$24324415$1$I$$20240912$20240916$20240916$EXP$$CA-SANDOZ INC.-NVSC2023CA023064$SANDOZ$$$$A$F$Y$$$20240916$$HP$CA$CA
243244171$24324417$1$I$20240903$20240904$20240916$20240916$PER$$US-JNJFOC-20240908062$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240916$$CN$US$US
243244181$24324418$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256400$PFIZER$$48$YR$$F$Y$$$20240916$$HP$US$US
243244191$24324419$1$I$$20240906$20240916$20240916$PER$$US-ABBVIE-5917367$ABBVIE$$$$$$Y$$$20240916$$HP$US$US
243244201$24324420$1$I$$20240904$20240916$20240916$EXP$IL-DEXPHARM-2024-3048$IL-DEXPHARM-2024-3048$DEXCEL$$73$YR$E$F$Y$$$20240916$$HP$IL$IL
243244211$24324421$1$I$$20240903$20240916$20240916$EXP$$US-DEXPHARM-2024-3060$DEXCEL$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: A single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 6;73(10). doi:10.1007/s00262-024-03775-6$60$YR$A$F$Y$$$20240916$$HP$US$US
243244221$24324422$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265062$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$HP$US$US
243244232$24324423$2$F$20240620$20240905$20240916$20240925$EXP$$AT-EXELIXIS-EXL-2024-000216$EXELIXIS$$64$YR$$F$Y$$$20240925$$MD$AT$AT
243244241$24324424$1$I$20240705$20240909$20240916$20240916$EXP$$CN-SPECGX-T202401870$SPECGX$$62$YR$$F$Y$65$KG$20240916$$CN$CN$CN
243244261$24324426$1$I$20240905$20240909$20240916$20240916$EXP$$CN-SPECGX-T202401871$SPECGX$$54$YR$$F$Y$60$KG$20240916$$CN$CN$CN
243244271$24324427$1$I$$20240911$20240916$20240916$EXP$$ID-AstraZeneca-2024A209693$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$ID$
243244282$24324428$2$F$$20240910$20240916$20240916$PER$$US-AstraZeneca-2024A207806$ASTRAZENECA$$$$$$Y$$$20240916$$HP$US$
243244291$24324429$1$I$20240815$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207422$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243244301$24324430$1$I$$20240903$20240916$20240916$EXP$$US-DEXPHARM-2024-3062$DEXCEL$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: A single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 6;73(10). doi:10.1007/s00262-024-03775-6$61$YR$A$F$Y$$$20240916$$HP$US$US
243244311$24324431$1$I$$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024183210$AMGEN$Young A.; Lu K.; Dai A. et al.. Predictors of drug survival in patients with hidradenitis suppurativa treated with TNF-alpha-inhibitors. Journal of the American Academy of Dermatology. 2024;91 (3):AB72$$$$$Y$$$20240916$$MD$US$US
243244321$24324432$1$I$$20240903$20240916$20240916$EXP$$US-DEXPHARM-2024-3063$DEXCEL$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: A single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 6;73(10). doi:10.1007/s00262-024-03775-6$55$YR$A$F$Y$$$20240916$$HP$US$US
243244331$24324433$1$I$$20240903$20240916$20240916$EXP$$US-DEXPHARM-2024-3061$DEXCEL$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, et al. Clinical features associated with immune checkpoint inhibitor nephritis: A single-center clinical case series. Cancer Immunology, Immunotherapy. 2024 Aug 6;73(10). doi:10.1007/s00262-024-03775-6$69$YR$E$M$Y$$$20240916$$HP$US$US
243244341$24324434$1$I$20240905$20240911$20240916$20240916$EXP$$ID-AstraZeneca-2024A210106$ASTRAZENECA$$31654$DY$$M$Y$$$20240916$$CN$ID$
243244351$24324435$1$I$$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A209328$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243244361$24324436$1$I$20240911$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A208868$ASTRAZENECA$$32664$DY$$M$Y$$$20240916$$CN$US$
243244371$24324437$1$I$$20240909$20240916$20240916$EXP$$GR-SANDOZ INC.-PHHY2018GR152785$SANDOZ$$68$YR$$F$Y$$$20240916$$MD$GR$GR
243244381$24324438$1$I$20240101$20240823$20240916$20240916$PER$$US-SA-2024SA264197$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240916$$CN$US$US
243244391$24324439$1$I$20240415$20240915$20240915$20240915$DIR$FDA-CDER-CTU-2024-63398$$FDA-CTU$$74$YR$$M$N$84$KG$20240915$Y$CN$US$
243244401$24324440$1$I$20240901$20240910$20240916$20240916$PER$$CN-BRACCO-2024CN05699$BRACCO$$71$YR$$M$Y$$$20240916$$HP$CN$CN
243244411$24324441$1$I$20240705$20240913$20240916$20240916$EXP$IT-MINISAL02-1001788$IT-SANDOZ INC.-SDZ2024IT080019$SANDOZ$$53$YR$$F$Y$$$20240916$$PH$IT$IT
243244422$24324442$2$F$20240913$20240917$20240916$20240919$PER$$US-AMGEN-USASP2024183500$AMGEN$$55$YR$A$F$Y$$$20240919$$HP$US$US
243244431$24324443$1$I$$20240903$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009283$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243244441$24324444$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024AMR113408$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$CN$US$US
243244451$24324445$1$I$$20240903$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009360$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243244461$24324446$1$I$$20240909$20240916$20240916$EXP$GB-MHRA-MED-202409091145056600-TNSBK$GB-RDY-SPO/GBR/24/0013247$DR REDDYS$$74$YR$E$F$Y$$$20240916$$CN$GB$GB
243244471$24324447$1$I$20210302$20240910$20240916$20240916$EXP$GB-OTSUKA-2024_024706$GB-RDY-SPO/GBR/24/0013326$DR REDDYS$$68$YR$E$M$Y$$$20240916$$MD$GB$GB
243244481$24324448$1$I$$20240913$20240916$20240916$EXP$$NVSC2024CN183899$NOVARTIS$$78$YR$$F$Y$$$20240916$$CN$CN$CN
243244491$24324449$1$I$$20240911$20240916$20240916$EXP$$NVSC2024KR183985$NOVARTIS$Kim HM, Lee J, Kim S, Lee JW, Kim H-J, Cho Y-S.. Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease. BLOOD RESEARCH. 2023;58(3):145-48$52$YR$$F$Y$$$20240916$$HP$KR$KR
243244501$24324450$1$I$20180628$20240915$20240915$20240915$DIR$FDA-CDER-CTU-2024-63395$$FDA-CTU$$55$YR$$F$N$68.04$KG$20240915$N$CN$US$
243244511$24324451$1$I$$20240816$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN008610$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243244521$24324452$1$I$20240806$20240911$20240916$20240916$EXP$$US-BAYER-2024A115362$BAYER$$65$YR$E$M$Y$90.703$KG$20240916$$CN$US$US
243244531$24324453$1$I$$20240909$20240916$20240916$EXP$$US-GSK-US2024112052$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240916$$CN$US$US
243244542$24324454$2$F$20240101$20240916$20240916$20240918$PER$$US-BIOGEN-2024BI01282430$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
243244551$24324455$1$I$$20240909$20240916$20240916$EXP$$US-BIOGEN-2024BI01281922$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
243244561$24324456$1$I$$20240911$20240916$20240916$EXP$$ID-INCYTE CORPORATION-2024IN009662$INCYTE$$$$$$Y$$$20240916$$MD$ID$ID
243244571$24324457$1$I$$20240905$20240916$20240916$PER$$US-JNJFOC-20240916021$JOHNSON AND JOHNSON$$30$YR$A$M$Y$109$KG$20240916$$CN$US$US
243244581$24324458$1$I$20240101$20240912$20240916$20240916$EXP$$US-INDIVIOR US-INDV-156439-2024$RECKITT BENCKISER$$$$$$Y$$$20240916$$CN$US$US
243244591$24324459$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146737$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$63.5$KG$20240916$$CN$US$US
243244601$24324460$1$I$20230830$20240903$20240916$20240916$EXP$GB-MHRA-MED-202409031126036020-BWPVM$GB-LUPIN PHARMACEUTICALS INC.-2024-08832$LUPIN$$$$$$Y$$$20240916$$MD$GB$GB
243244621$24324462$1$I$$20240904$20240916$20240916$30DAY$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03320$AMNEAL$$$$$$Y$$$20240916$$PH$US$US
243244631$24324463$1$I$20240101$20240906$20240916$20240916$PER$$US-TEVA-VS-3241748$TEVA$$38$YR$$M$Y$$$20240916$$PH$US$US
243244641$24324464$1$I$20240810$20240908$20240916$20240916$EXP$GB-MHRA-MED-202409071037442310-YKHDV$GB-DEXPHARM-2024-3161$DEXCEL$$50$YR$$F$Y$133$KG$20240916$$HP$GB$GB
243244663$24324466$3$F$20240607$20240916$20240916$20240925$EXP$FR-AFSSAPS-PV2024000839$FR-ASTELLAS-2024-AER-006904$ASTELLAS$$10$YR$C$F$Y$28$KG$20240925$$PH$FR$FR
243244671$24324467$1$I$$20240906$20240916$20240916$PER$$NVSC2024US180478$NOVARTIS$$91$YR$$F$Y$64$KG$20240916$$CN$US$US
243244681$24324468$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024112018$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$HP$US$US
243244691$24324469$1$I$$20240906$20240916$20240916$30DAY$$US-GSK-US2024111261$GLAXOSMITHKLINE$$$$$F$Y$$$20240916$$MD$US$US
243244701$24324470$1$I$20240901$20240912$20240916$20240916$PER$$US-BIOGEN-2024BI01282433$BIOGEN$$52$YR$$F$Y$$$20240916$$CN$US$US
243244711$24324471$1$I$$20240903$20240916$20240916$30DAY$$DE-JNJFOC-20240926087$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$PH$DE$DE
243244721$24324472$1$I$$20240912$20240916$20240916$PER$$US-BIOGEN-2024BI01282442$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
243244731$24324473$1$I$$20240909$20240916$20240916$EXP$$CZ-OTSUKA-2024_025383$OTSUKA$$$$$F$Y$$$20240916$$MD$CZ$CZ
243244751$24324475$1$I$$20240912$20240916$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA079836$SANDOZ$$28$YR$$F$Y$$$20240916$$HP$CA$CA
243244761$24324476$1$I$20240905$20240911$20240916$20240916$EXP$$CN-SA-2024SA265265$SANOFI AVENTIS$$79$YR$E$M$Y$52.5$KG$20240916$$HP$CN$CN
243244771$24324477$1$I$$20240913$20240916$20240916$PER$$US-HALEON-2196949$Haleon PLC$$83$YR$$$Y$$$20240916$$CN$US$US
243244781$24324478$1$I$20240805$20240906$20240916$20240916$EXP$GB-MHRA-MED-202409061549233240-QYHJB$GB-GILEAD-2024-0687533$GILEAD$$69$YR$E$F$Y$$$20240916$$HP$GB$GB
243244791$24324479$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265746$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240916$$HP$US$US
243244802$24324480$2$F$$20240828$20240916$20240924$PER$$US-SA-2024SA266254$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$MD$US$US
243244811$24324481$1$I$20240514$20240912$20240916$20240916$EXP$DE-002147023-NVSC2024DE109070$DE-RDY-SPO/DEU/24/0013424$DR REDDYS$$$$A$F$Y$108$KG$20240916$$CN$DE$DE
243244822$24324482$2$F$$20240909$20240916$20240916$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-18061$IPSEN$$64$YR$A$M$Y$$$20240916$$CN$US$US
243244831$24324483$1$I$20240912$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183167$AMGEN$$$$$$Y$$$20240916$$CN$US$US
243244841$24324484$1$I$$20240911$20240916$20240916$EXP$PL-URPL-2-1639-2019$PL-AMGEN-POLSP2024181588$AMGEN$$82$YR$E$F$Y$$$20240916$$CN$PL$PL
243244851$24324485$1$I$20240318$20240910$20240916$20240916$EXP$$ES-AMGEN-ESPSP2024180409$AMGEN$$76$YR$E$F$Y$$$20240916$$PH$ES$ES
243244861$24324486$1$I$$20240902$20240916$20240916$EXP$$TR-MEDEXUS PHARMA, INC.-2024MED00390$MEDEXUS PHARMA$Ozalp Y.C, Saygin B, Eren E et al. BONE MARROW HYPOPLASIA DUE TO IRREGULAR METHOTREXATE TREATMENT FOR PSORIASIS. Eur. J. Case Rep. Intern. Med.. 2024;(11)779$66$YR$$M$Y$$$20240916$$HP$TR$TR
243244872$24324487$2$F$20160101$20240913$20240916$20240924$EXP$$US-MEDEXUS PHARMA, INC.-2024MED00395$MEDEXUS PHARMA$$$$$F$Y$$$20240924$$CN$US$US
243244881$24324488$1$I$$20240911$20240916$20240916$EXP$$ZA-AstraZeneca-2024A208110$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$ZA$
243244891$24324489$1$I$20221101$20240910$20240916$20240916$EXP$$ES-AMGEN-ESPSP2024180430$AMGEN$$65$YR$E$M$Y$$$20240916$$MD$ES$ES
243244901$24324490$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207525$ASTRAZENECA$$$$$M$Y$$$20240916$$CN$US$
243244911$24324491$1$I$20240817$20240914$20240916$20240916$EXP$$CN-ROCHE-10000082190$ROCHE$$79$YR$E$M$Y$$$20240916$$HP$CN$CN
243244922$24324492$2$F$20230201$20240917$20240916$20240918$EXP$$US-PFIZER INC-202400255651$PFIZER$$81$YR$$F$Y$$$20240918$$HP$US$US
243244961$24324496$1$I$$20240906$20240916$20240916$PER$$US-JNJFOC-20240920731$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$US$US
243244971$24324497$1$I$20240901$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146819$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240916$$HP$US$US
243244981$24324498$1$I$20240902$20240910$20240916$20240916$PER$$US-ORGANON-O2409USA000851$ORGANON$$$$$F$Y$$$20240916$$HP$US$US
243244991$24324499$1$I$20240101$20240906$20240916$20240916$EXP$$US-TEVA-VS-3242549$TEVA$$53$YR$$M$Y$$$20240916$$CN$US$US
243245002$24324500$2$F$$20240906$20240916$20240920$EXP$$JP-JNJFOC-20240927695$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$60$KG$20240920$$MD$JP$JP
243245012$24324501$2$F$$20240913$20240916$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145724$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240918$$HP$US$US
243245021$24324502$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265605$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240916$$HP$US$US
243245031$24324503$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183430$AMGEN$$$$$$Y$$$20240916$$MD$US$US
243245042$24324504$2$F$20240812$20240916$20240916$20240930$EXP$$ALC2024ES004136$ALCON$$$$$$Y$$$20240930$$CN$ES$ES
243245051$24324505$1$I$$20240914$20240916$20240916$PER$$US-JNJFOC-20240938889$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$US$US
243245061$24324506$1$I$$20240903$20240916$20240916$EXP$$CN-DEXPHARM-2024-3059$DEXCEL$Tang, J.; Lu, P.; Yang, H.; Qian, H.; Xi, J.; Shen, J.  Death due to severe hypoglycemia caused by diclofenac sodium and lidocaine injection. [Chinese]. Adverse drug reactions journal 2021, V23, P324-325$53$YR$A$M$Y$$$20240916$$HP$CN$CN
243245071$24324507$1$I$20240825$20240910$20240916$20240916$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000927$PAREXEL$$$$$$Y$$$20240916$$HP$CN$CN
243245081$24324508$1$I$20240101$20240828$20240916$20240916$EXP$$US-SA-2024SA266397$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240916$$MD$US$US
243245091$24324509$1$I$20160301$20240906$20240916$20240916$EXP$$DE-SANDOZ INC.-PHHY2018DE061478$SANDOZ$$82$YR$$F$Y$56$KG$20240916$$MD$DE$DE
243245101$24324510$1$I$$20240913$20240916$20240916$EXP$$FR-SANDOZ INC.-PHHY2014FR081767$SANDOZ$$35$YR$$M$Y$$$20240916$$MD$FR$FR
243245111$24324511$1$I$20240101$20240909$20240916$20240916$EXP$$IL-SA-2024SA267316$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240916$$CN$IL$IL
243245121$24324512$1$I$$20240906$20240916$20240916$PER$$US-SA-2024SA264471$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240916$$HP$US$US
243245131$24324513$1$I$20240915$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63401$$FDA-CTU$$2$YR$$M$N$13.61$KG$20240916$N$$US$
243245141$24324514$1$I$$20240912$20240916$20240916$EXP$$NVSC2024DZ184054$NOVARTIS$Nadjat S. Place of romiplostim in the treatment of bone marrow aplasia?experience of the sidi bel abbes hematology department, Algeria. CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2024;S585$$$$$Y$$$20240916$$HP$DZ$DZ
243245151$24324515$1$I$$20240827$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08624$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243245161$24324516$1$I$$20240910$20240916$20240916$EXP$$CA-OTSUKA-2024_025544$OTSUKA$$24$YR$$M$Y$$$20240916$$HP$CA$CA
243245171$24324517$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146898$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240916$$CN$US$US
243245181$24324518$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265570$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240916$$HP$US$US
243245191$24324519$1$I$20240101$20240826$20240916$20240916$PER$$US-SA-2024SA263991$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240916$$MD$US$US
243245202$24324520$2$F$$20240913$20240916$20240923$PER$$US-SA-2024SA265843$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240923$$CN$US$US
243245221$24324522$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA264763$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240916$$MD$US$US
243245231$24324523$1$I$20240916$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63405$$FDA-CTU$$$$$$N$$$20240916$N$CN$US$
243245241$24324524$1$I$20240913$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63404$$FDA-CTU$$19$MON$$F$N$9.07$KG$20240916$N$$US$
243245251$24324525$1$I$20240913$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63403$$FDA-CTU$$$$$$N$$$20240916$N$CN$US$
243245261$24324526$1$I$$20240827$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08647$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243245271$24324527$1$I$20240101$20240906$20240916$20240916$EXP$GB-MHRA-MED-202409060814270460-MWQVD$GB-TEVA-VS-3241606$TEVA$$45$YR$$F$Y$47$KG$20240916$$CN$GB$GB
243245281$24324528$1$I$20240501$20240909$20240916$20240916$EXP$$US-TAKEDA-2024TUS089975$TAKEDA$$79$YR$$M$Y$63.492$KG$20240916$$MD$US$US
243245291$24324529$1$I$$20231219$20240916$20240916$PER$$US-ENDO USA, INC.-2024-000169$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243245301$24324530$1$I$$20231219$20240916$20240916$PER$$US-ENDO USA, INC.-2024-000173$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243245311$24324531$1$I$20240701$20240911$20240916$20240916$EXP$$JP-SPECGX-T202401875$SPECGX$$9$DEC$$M$Y$$$20240916$$PH$JP$JP
243245321$24324532$1$I$20240101$20240901$20240916$20240916$PER$$US-JNJFOC-20240909698$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$US$US
243245331$24324533$1$I$20240828$20240830$20240916$20240916$PER$$US-JNJFOC-20240900809$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240916$$CN$US$US
243245341$24324534$1$I$$20240909$20240916$20240916$PER$$US-JNJFOC-20240927203$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$US$US
243245351$24324535$1$I$20240801$20240830$20240916$20240916$PER$$US-JNJFOC-20240900601$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240916$$CN$US$US
243245361$24324536$1$I$20231101$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A205822$ASTRAZENECA$$841$MON$$M$Y$$$20240916$$CN$US$
243245372$24324537$2$F$$20240909$20240916$20240917$EXP$$US-AstraZeneca-2024A205317$ASTRAZENECA$$77$YR$$M$Y$$$20240917$$HP$US$
243245381$24324538$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256670$PFIZER$$$$$$Y$$$20240916$$CN$US$US
243245391$24324539$1$I$20240701$20240913$20240916$20240916$PER$$US-PFIZER INC-PV202400120650$PFIZER$$41$YR$$F$Y$$$20240916$$HP$US$US
243245401$24324540$1$I$$20240914$20240916$20240916$PER$$US-PFIZER INC-202400256684$PFIZER$$$$$$Y$$$20240916$$CN$US$US
243245411$24324541$1$I$20240912$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256517$PFIZER$$46$YR$$M$Y$$$20240916$$CN$US$US
243245421$24324542$1$I$20240913$20240914$20240916$20240916$PER$$US-PFIZER INC-202400257089$PFIZER$$57$YR$$F$Y$$$20240916$$CN$US$US
243245431$24324543$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400250191$PFIZER$$40$YR$$M$Y$$$20240916$$HP$US$US
243245441$24324544$1$I$20240912$20240914$20240916$20240916$PER$$US-PFIZER INC-202400257112$PFIZER$$60$YR$$F$Y$$$20240916$$CN$US$US
243245451$24324545$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256535$PFIZER$$$$$$Y$$$20240916$$CN$US$US
243245473$24324547$3$F$$20240917$20240916$20240919$EXP$$JP-PFIZER INC-202400254399$PFIZER$Ebisawa, K.. Epstein-Barr virus-positive mucocutaneous ulcer resulting in severe methotrexate intoxication: a case report.. Journal of medical case reports. 2024;18(1):409$9$DEC$$M$Y$$$20240919$$MD$JP$JP
243245481$24324548$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-PV202400120629$PFIZER$$73$YR$$F$Y$$$20240916$$MD$US$US
243245491$24324549$1$I$$20240909$20240916$20240916$EXP$$JP-PFIZER INC-PV202400118269$PFIZER$Osawa, K.. A case of suspected cutaneous aspergillosis. The Japanese Journal of Dermatology. 2024;134(9):2318-2319$8$DEC$$M$Y$$$20240916$$HP$JP$JP
243245511$24324551$1$I$$20240909$20240916$20240916$EXP$$NL-AstraZeneca-2024A211053$ASTRAZENECA$$31$YR$$F$Y$67$KG$20240916$$CN$NL$
243245521$24324552$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256499$PFIZER$$$$$F$Y$$$20240916$$CN$US$US
243245531$24324553$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-PV202400120666$PFIZER$$59$YR$$F$Y$$$20240916$$HP$US$US
243245541$24324554$1$I$20240914$20240914$20240916$20240916$PER$$US-PFIZER INC-202400257099$PFIZER$$87$YR$$F$Y$$$20240916$$CN$US$US
243245551$24324555$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-2020113226$PFIZER$$68$YR$$F$Y$$$20240916$$CN$US$US
243245562$24324556$2$F$$20240910$20240916$20240917$EXP$$DK-PFIZER INC-202400254382$PFIZER$Petersen, C.. Atypical fractures of the lower extremities in two patients with rheumatoid arthritis: clinical presentations of presumed methotrexate osteopathy. BMJ. 2024;10.1136/bcr-2023-256567$8$DEC$$F$Y$$$20240917$$HP$DK$DK
243245571$24324557$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256550$PFIZER$$55$YR$$M$Y$$$20240916$$CN$US$US
243245591$24324559$1$I$$20240914$20240916$20240916$PER$$US-PFIZER INC-202400256581$PFIZER$$$$A$$Y$$$20240916$$CN$US$US
243245601$24324560$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256451$PFIZER$$$$$$Y$$$20240916$$CN$US$US
243245621$24324562$1$I$20240914$20240914$20240916$20240916$PER$$US-PFIZER INC-202400256699$PFIZER$$85$YR$$M$Y$108.41$KG$20240916$$CN$US$US
243245631$24324563$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-PV202400120668$PFIZER$$$$$$Y$$$20240916$$CN$US$US
243245641$24324564$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256446$PFIZER$$72$YR$$F$Y$$$20240916$$CN$US$US
243245661$24324566$1$I$20230801$20240910$20240916$20240916$EXP$$CO-PFIZER INC-PV202400118980$PFIZER$Burbano, M.. Fatal nephrobronchial fistula arising from xanthogranulomatous pyelonephritis: a case report.. Frontiers in Medicine. 2024;11:10.3389/fmed.2024.1374043$63$YR$$F$Y$$$20240916$$HP$CO$CO
243245671$24324567$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256266$PFIZER$$$$$F$Y$$$20240916$$MD$US$US
243245682$24324568$2$F$20210401$20240910$20240916$20240917$EXP$$DK-PFIZER INC-202400254381$PFIZER$Petersen CL, David M, Stilgren L, Ennis ZN.. Atypical fractures of the lower extremities in two patients with rheumatoid arthritis: clinical presentations of presumed methotrexate osteopathy. BMJ Case Rep. 2024 Aug 31;17(8):e256567. BMJ. 2024$8$DEC$$M$Y$$$20240917$$HP$DK$DK
243245691$24324569$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207584$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243245701$24324570$1$I$$20240909$20240916$20240916$PER$$US-AstraZeneca-2024A206911$ASTRAZENECA$$$$$$Y$$$20240916$$MD$US$
243245711$24324571$1$I$$20240911$20240916$20240916$EXP$$RO-AstraZeneca-2024A207425$ASTRAZENECA$Tapirdea A. O., Vancea T. M., Venter B. C., Tertan O. B., Patka A., Burz C. C.. Multiple-Focused Analysis of Breast Cancer Late Recurrence -A Case Report and Literature Review. Journal of Medical and Radiation Oncology 2024;IV(1):45-50.$76$YR$$F$Y$$$20240916$$HP$RO$
243245731$24324573$1$I$20240814$20240911$20240916$20240916$EXP$FR-AFSSAPS-AM2024000719$FR-009507513-2409FRA004131$MERCK$$63$YR$$F$Y$$$20240916$$PH$FR$FR
243245741$24324574$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146763$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$133.81$KG$20240916$$CN$US$US
243245751$24324575$1$I$20240824$20240911$20240916$20240916$EXP$GB-MHRA-TPP20903326C19580434YC1726059952450$GB-RDY-SPO/GBR/24/0013411$DR REDDYS$$68$YR$E$F$Y$100$KG$20240916$$HP$GB$GB
243245761$24324576$1$I$$20240901$20240916$20240916$EXP$$CH-ROCHE-10000083017$ROCHE$Soomann M, Prader S, Carlomagno R, Schmid J, Truck J. Delayed B-cell maturation and attenuated vaccine responses in infants exposed to B-cell depleting therapies in utero. The Journal of Allergy and Clinical Immunology: In Practice. 2024;1-4. doi:10.1016/j.jaip.2024.08.007.$$$I$F$Y$$$20240916$$MD$CH$CH
243245771$24324577$1$I$20240720$20240903$20240916$20240916$EXP$$BR-BAXTER-2024BAX024371$BAXTER$$17$YR$$F$Y$79.3$KG$20240916$$CN$BR$BR
243245782$24324578$2$F$20240913$20240916$20240916$20240917$PER$$US-AMGEN-USASP2024183893$AMGEN$$64$YR$A$F$Y$$$20240917$$HP$US$US
243245791$24324579$1$I$20240814$20240905$20240916$20240916$EXP$$CN-BAXTER-2024BAX024381$BAXTER$$44$YR$$M$Y$57.5$KG$20240916$$MD$CN$CN
243245801$24324580$1$I$20240724$20240904$20240916$20240916$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI09134$NEUROCRINE BIOSCIENCES$$5$DEC$$F$Y$$$20240916$$MD$JP$JP
243245812$24324581$2$F$20240101$20240905$20240916$20240918$EXP$$US-SA-2024SA266738$SANOFI AVENTIS$$61$YR$A$M$Y$64.55$KG$20240918$$MD$US$US
243245821$24324582$1$I$$20240909$20240916$20240916$EXP$$US-MYLANLABS-2024M1083522$MYLAN$Rice D, Yoshida H. Opioid-Induced Adrenal Insufficiency. JAMA-Intern-Med 2024; 184 (7): 830-831.$5$DEC$$F$Y$$$20240916$$MD$US$US
243245831$24324583$1$I$20191125$20240912$20240916$20240916$EXP$GB-MHRA-MED-202409120729514340-FMSJY$GB-MYLANLABS-2024M1083317$MYLAN$$41$YR$$M$Y$144$KG$20240916$$CN$GB$GB
243245841$24324584$1$I$$20240909$20240916$20240916$EXP$$US-MYLANLABS-2024M1083520$MYLAN$Wang M, Reynolds KL, Montazeri K, Schaefer EA, Sullivan RJ, Dougan M. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clin-Gastroenterol-Hepatol 2024; 22 (7): 1539-1541.e2.$63$YR$$M$Y$$$20240916$$MD$US$US
243245851$24324585$1$I$20240501$20240912$20240916$20240916$EXP$FR-AFSSAPS-AVNT2024000669$FR-MYLANLABS-2024M1083240$MYLAN$$40$YR$$M$Y$$$20240916$$PH$FR$FR
243245861$24324586$1$I$$20240909$20240916$20240916$EXP$$ES-MYLANLABS-2024M1083255$MYLAN$$58$YR$$F$Y$$$20240916$$MD$ES$ES
243245872$24324587$2$F$$20240923$20240916$20240925$EXP$$JP-PFIZER INC-PV202400119874$PFIZER$Miyazaki, O.. Rapidly progressive mucus plugs in allergic bronchopulmonary mycosis. Journal of Asthma. 2024;61(9):1103-1108$52$YR$$F$Y$$$20240925$$MD$JP$JP
243245882$24324588$2$F$$20240912$20240916$20240918$EXP$$JP-PFIZER INC-PV202400119602$PFIZER$Iida, T.. A Rupture of a Lung Metastatic Lesion of Colon Cancer, Leading to Pneumothorax Caused by Bevacizumab. Internal Medicine. 2016;55:3125-3129$57$YR$$M$Y$$$20240918$$HP$JP$JP
243245891$24324589$1$I$$20240906$20240916$20240916$EXP$$US-MYLANLABS-2024M1083157$MYLAN$Liao A, Fajoles-Vasseneix C, Rali A, Ward L, Fernandes A, Patel PS, et al. Visual Morbidity and Outcomes of Scleritis Associated with Intraocular Inflammation Compared to Isolated Scleritis. Ocular-Immunol-Inflamm 2024; 32 (6): 947-954.$63$YR$$F$Y$$$20240916$$MD$US$US
243245911$24324591$1$I$$20240827$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08645$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243245921$24324592$1$I$$20240911$20240916$20240916$EXP$$JP-PFIZER INC-PV202400119425$PFIZER$Nishino, S.. Secondary spontaneous pneumothorax during chemotherapy with bevacizumab for cervical cancer: a case report and literature review. International Cancer Conference Journal. 2024;10.1007/s13691-024-00696-0$57$YR$$F$Y$46$KG$20240916$$HP$JP$JP
243245931$24324593$1$I$$20240911$20240916$20240916$EXP$$NVSC2024CA183099$NOVARTIS$$53$YR$$F$Y$$$20240916$$HP$CA$CA
243245941$24324594$1$I$$20210716$20240916$20240916$EXP$$NVSC2021US318487$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243245971$24324597$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146884$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$51.26$KG$20240916$$CN$US$US
243245981$24324598$1$I$20240101$20240911$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145119$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240916$$HP$US$US
243245991$24324599$1$I$$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143864$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240916$$CN$US$US
243246021$24324602$1$I$$20240827$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08650$LUPIN$$$$$$Y$$$20240916$$PH$US$US
243246031$24324603$1$I$20240522$20240906$20240916$20240916$EXP$FR-AFSSAPS-LL2024001567$FR-ABBVIE-5915563$ABBVIE$$2$MON$$M$Y$$$20240916$$PH$FR$FR
243246041$24324604$1$I$20240731$20240911$20240916$20240916$EXP$FR-AFSSAPS-AM2024000716$FR-MYLANLABS-2024M1083469$MYLAN$$20$YR$$F$Y$80$KG$20240916$$MD$FR$FR
243246053$24324605$3$F$$20240916$20240916$20240925$EXP$$DE-AURINIA PHARMACEUTICALS INC.-AUR-006661$AURINIA PHARMACEUTICALS$Tobias Alexander et al.. Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus. New England Journal of Medicine - 2024. 2024$$$$$Y$$$20240925$$MD$DE$DE
243246061$24324606$1$I$20240807$20240912$20240916$20240916$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024113534$VIIV$$38$YR$$M$Y$$$20240916$$HP$US$US
243246071$24324607$1$I$20240901$20240913$20240916$20240916$EXP$$NVSC2024CN183886$NOVARTIS$$38$YR$$F$Y$$$20240916$$HP$CN$CN
243246081$24324608$1$I$20240801$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145168$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$94.2$KG$20240916$$PH$US$US
243246091$24324609$1$I$$20240914$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146922$BRISTOL MYERS SQUIBB$$78$YR$A$F$Y$73.03$KG$20240916$$CN$US$US
243246111$24324611$1$I$$20240914$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146723$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$62.14$KG$20240916$$CN$US$US
243246122$24324612$2$F$20240101$20240920$20240916$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000788$DECIPHERA PHARMACEUTICALS$$56$YR$A$M$Y$62.54$KG$20240927$$CN$US$US
243246131$24324613$1$I$$20240912$20240916$20240916$EXP$FR-AFSSAPS-AVPO2024000174$FR-MYLANLABS-2024M1083193$MYLAN$$42$YR$$F$Y$$$20240916$$PH$FR$FR
243246141$24324614$1$I$$20240827$20240916$20240916$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08617$LUPIN$$$$$$Y$$$20240916$$CN$US$US
243246151$24324615$1$I$20240803$20240805$20240916$20240916$EXP$$AT-GILEAD-2024-0683010$GILEAD$$$$$$Y$$$20240916$$MD$AT$AT
243246161$24324616$1$I$$20240909$20240916$20240916$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000780$DECIPHERA PHARMACEUTICALS$$74$YR$E$M$Y$$$20240916$$CN$US$US
243246181$24324618$1$I$20240906$20240911$20240916$20240916$EXP$$ID-AstraZeneca-2024A209673$ASTRAZENECA$$24362$DY$$F$Y$$$20240916$$CN$ID$
243246191$24324619$1$I$20240909$20240912$20240916$20240916$PER$$US-AstraZeneca-2024A210589$ASTRAZENECA$$54$YR$$F$Y$$$20240916$$MD$US$
243246211$24324621$1$I$20240828$20240909$20240916$20240916$EXP$$US-The Proactiv LLC-2161674$PROACTIV$$31$YR$$F$Y$$$20240916$$$US$US
243246221$24324622$1$I$$20240911$20240916$20240916$PER$$US-Karo Pharma-2161676$Karo Pharma$$$$$F$Y$$$20240916$$$US$US
243246242$24324624$2$F$20240830$20240923$20240916$20240930$30DAY$$US-AMGEN-USASP2024182055$AMGEN$$71$YR$E$F$Y$53.9$KG$20240930$$PH$US$US
243246251$24324625$1$I$20240906$20240906$20240916$20240916$30DAY$$US-GSK-US2024111372$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240916$$CN$US$US
243246261$24324626$1$I$$20240904$20240916$20240916$EXP$$IT-ABBVIE-5925423$ABBVIE$Torre DE, Stecco C, Porzionato A, Mangino D, Macchi V, De Caro R, et al. Ibrutinib-induced ventricular electrical storm successfully managed with veno-arterial ecmo and intralipid administration: a rare case report. Annals of Cardiac Anaesthesia. 2024.$55$YR$$M$Y$$$20240916$$HP$IT$IT
243246271$24324627$1$I$$20240913$20240916$20240916$EXP$FR-AFSSAPS-AVPO2024000177$FR-MYLANLABS-2024M1083637$MYLAN$$40$YR$$M$Y$$$20240916$$PH$FR$FR
243246282$24324628$2$F$$20240910$20240916$20240923$EXP$$US-MYLANLABS-2024M1083352$MYLAN$$$$$F$Y$3.1$KG$20240923$$CN$US$US
243246291$24324629$1$I$$20240910$20240916$20240916$EXP$$NVSC2024AU184020$NOVARTIS$Harris K, Dalton B, Learmont BG, Isoardi KZ. Rationalising the dose threshold for severe carbamazepine toxicity: a retrospective series. CLINICAL TOXICOLOGY. 2024;62(8):533-5$25$YR$$$Y$$$20240916$$HP$AU$AU
243246301$24324630$1$I$$20240910$20240916$20240916$EXP$$NVSC2024AU184005$NOVARTIS$Harris K, Dalton B, Learmont BG, Isoardi KZ. Rationalising the dose threshold for severe carbamazepine toxicity: a retrospective series. CLINICAL TOXICOLOGY. 2024;62(8):533-35$24$YR$$$Y$$$20240916$$HP$AU$AU
243246311$24324631$1$I$20240901$20240913$20240916$20240916$EXP$$JP-ALXN-202409JPN001118JP$ALEXION PHARMACEUTICALS$$$$A$M$Y$$$20240916$$MD$JP$JP
243246321$24324632$1$I$20240101$20240911$20240916$20240916$EXP$$CL-ORGANON-O2409CHL000886$ORGANON$$36$YR$$F$Y$$$20240916$$CN$CL$CL
243246331$24324633$1$I$20240701$20240828$20240916$20240916$PER$$US-SA-2024SA266335$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240916$$MD$US$US
243246341$24324634$1$I$20230809$20240911$20240916$20240916$PER$$US-SA-2024SA267301$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240916$$MD$US$US
243246351$24324635$1$I$20240101$20240909$20240916$20240916$EXP$$US-SA-2024SA265713$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240916$$MD$US$US
243246361$24324636$1$I$$20240913$20240916$20240916$EXP$$US-ABBVIE-5924098$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243246371$24324637$1$I$$20240906$20240916$20240916$30DAY$$AR-PFIZER INC-202400244822$PFIZER$$$$$F$Y$$$20240916$$CN$AR$AR
243246381$24324638$1$I$$20240911$20240916$20240916$EXP$$US-BAYER-2024A130252$BAYER$$99$YR$E$M$Y$$$20240916$$CN$US$US
243246391$24324639$1$I$$20240820$20240916$20240916$PER$$US-SA-2024SA263399$SANOFI AVENTIS$$$$C$M$Y$40.1$KG$20240916$$MD$US$US
243246401$24324640$1$I$$20240911$20240916$20240916$EXP$$IT-PFIZER INC-PV202400118763$PFIZER$Manzon, L.. Bisphosphonate therapy and osteonecrosis of the jaw complicated with a temporal abscess in an elderly woman with rheumatoid arthritis: a case report. Clinical interventions in aging. 2014;9:1409-1413$68$YR$$F$Y$$$20240916$$HP$IT$IT
243246421$24324642$1$I$20240813$20240907$20240916$20240916$EXP$$US-ROCHE-10000076822$ROCHE$$65$YR$E$F$Y$$$20240916$$CN$US$US
243246431$24324643$1$I$$20240906$20240916$20240916$PER$$US-JNJFOC-20240917154$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240916$$MD$US$US
243246441$24324644$1$I$20240522$20240906$20240916$20240916$EXP$FR-ABBVIE-5925919$FR-ABBVIE-5925919$ABBVIE$$37$YR$$F$Y$$$20240916$$PH$FR$FR
243246451$24324645$1$I$$20240910$20240916$20240916$EXP$$NVSC2024AU184013$NOVARTIS$Harris K, Dalton B, Learmont BG, Isoardi KZ. Rationalising the dose threshold for severe carbamazepine toxicity: a retrospective series. CLINICAL TOXICOLOGY. 2024;62(8):533-5$34$YR$$$Y$$$20240916$$HP$AU$AU
243246462$24324646$2$F$20220101$20240913$20240916$20240919$EXP$$NVSC2024IE184229$NOVARTIS$$40$YR$$F$Y$$$20240919$$HP$IE$IE
243246482$24324648$2$F$$20240912$20240916$20240918$30DAY$$NL-SANDOZ INC.-SDZ2024NL080134$SANDOZ$$$$$F$Y$$$20240918$$CN$NL$NL
243246491$24324649$1$I$$20240911$20240916$20240916$30DAY$$US-SANDOZ INC.-SDZ2024US079694$SANDOZ$$$$$M$Y$$$20240916$$HP$US$US
243246501$24324650$1$I$$20240916$20240916$20240916$EXP$$RU-SANDOZ INC.-SDZ2024RU080391$SANDOZ$$$$$F$Y$$$20240916$$MD$RU$RU
243246511$24324651$1$I$20240913$20240916$20240916$20240916$DIR$718487$$FDA-CTU$$$$$UNK$N$$$20240916$N$CN$US$
243246521$24324652$1$I$20240826$20240910$20240916$20240916$EXP$PT-INFARMED-R202408-831$PT-GUERBET / LLC-PT-20240018$GUERBET$$90$YR$E$F$Y$77$KG$20240916$$HP$PT$PT
243246531$24324653$1$I$20240812$20240905$20240916$20240916$EXP$$AU-GUERBET / LLC-AU-20240052$GUERBET$$65$YR$E$M$Y$95$KG$20240916$$HP$AU$AU
243246541$24324654$1$I$20240101$20240816$20240916$20240916$PER$$US-Eisai-EC-2024-172325$EISAI$$72$YR$E$F$Y$$$20240916$$CN$US$US
243246551$24324655$1$I$$20240624$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003700$PAREXEL$$74$YR$$F$Y$$$20240916$$CN$US$US
243246561$24324656$1$I$$20240624$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003764$PAREXEL$$54$YR$$F$Y$$$20240916$$CN$US$US
243246571$24324657$1$I$$20240624$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003735$PAREXEL$$60$YR$$F$Y$$$20240916$$HP$US$US
243246581$24324658$1$I$$20240624$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003750$PAREXEL$$47$YR$$F$Y$$$20240916$$HP$US$US
243246591$24324659$1$I$$20240624$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003694$PAREXEL$$58$YR$$F$Y$$$20240916$$HP$US$US
243246601$24324660$1$I$$20240624$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003744$PAREXEL$$77$YR$$M$Y$$$20240916$$CN$US$US
243246611$24324661$1$I$$20240624$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003737$PAREXEL$$70$YR$$F$Y$$$20240916$$CN$US$US
243246621$24324662$1$I$$20240624$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003710$PAREXEL$$50$YR$$F$Y$$$20240916$$CN$US$US
243246631$24324663$1$I$$20240624$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003690$PAREXEL$$61$YR$$F$Y$$$20240916$$CN$US$US
243246641$24324664$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265733$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240916$$MD$US$US
243246651$24324665$1$I$$20240901$20240916$20240916$EXP$$MA-JUBILANT CADISTA PHARMACEUTICALS-2024JUB00070$JUBILANT$Habchane A, Bentabet F, Khatem S, Aliouaa A, Adali I, Manoudi F, et al.. Carbamazepine-induced bullous fixed drug eruption: A case report.. Therapies. 2024;79 (4):477-479$40$YR$$M$Y$$$20240916$$HP$MA$MA
243246661$24324666$1$I$20240101$20240913$20240916$20240916$EXP$$CN-BAYER-2024A131384$BAYER$$$$$M$Y$$$20240916$$CN$CN$CN
243246671$24324667$1$I$$20240906$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US078704$SANDOZ$$$$$$Y$$$20240916$$CN$US$US
243246681$24324668$1$I$20200101$20240905$20240916$20240916$EXP$$FR-TAKEDA-2024TUS091460$TAKEDA$$50$YR$$F$Y$$$20240916$$CN$FR$FR
243246691$24324669$1$I$$20240904$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-141043$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240916$$CN$US$US
243246701$24324670$1$I$$20240822$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN008837$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243246711$24324671$1$I$$20240910$20240916$20240916$EXP$$US-ABBVIE-5919429$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243246721$24324672$1$I$$20240912$20240916$20240916$PER$$US-ALXN-202409USA000904US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243246731$24324673$1$I$20240822$20240909$20240916$20240916$PER$$US-JNJFOC-20240921698$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$US$US
243246741$24324674$1$I$$20240911$20240916$20240916$EXP$$US-AMGEN-USASP2024182420$AMGEN$Slade M.J.; Goldsmith S.R.; Fiala M. et.al. A phase lb trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma. Annals of Hematology. 2024;1-9$$$$$Y$$$20240916$$HP$US$US
243246751$24324675$1$I$$20240913$20240916$20240916$PER$$US-ABBVIE-5925066$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243246761$24324676$1$I$$20240909$20240916$20240916$PER$$US-SMPA-2024SPA002511$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243246771$24324677$1$I$$20240829$20240916$20240916$PER$$US-SMPA-2024SPA002169$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243246801$24324680$1$I$$20240829$20240916$20240916$PER$$US-SMPA-2024SPA002197$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243246811$24324681$1$I$$20240829$20240916$20240916$PER$$US-SMPA-2024SPA002144$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243246821$24324682$1$I$$20240827$20240916$20240916$PER$$US-SMPA-2024SPA002066$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243246831$24324683$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA264881$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240916$$MD$US$US
243246841$24324684$1$I$$20240913$20240916$20240916$EXP$$US-PURDUE PHARMA-USA-2024-0311978$PURDUE$$27$YR$$M$Y$$$20240916$$CN$US$US
243246851$24324685$1$I$$20240911$20240916$20240916$EXP$$AU-BAYER-2024A130455$BAYER$$$$$M$Y$$$20240916$$MD$AU$AU
243246871$24324687$1$I$$20240820$20240916$20240916$PER$$US-SMPA-2024SPA001748$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243246891$24324689$1$I$$20240828$20240916$20240916$PER$$US-SMPA-2024SPA002074$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243246901$24324690$1$I$$20240820$20240916$20240916$PER$$US-SMPA-2024SPA001703$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243246911$24324691$1$I$$20240820$20240916$20240916$PER$$US-SMPA-2024SPA001723$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243246921$24324692$1$I$$20240828$20240916$20240916$PER$$US-SMPA-2024SPA002073$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243246931$24324693$1$I$$20240830$20240916$20240916$PER$$US-SMPA-2024SPA002192$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243246952$24324695$2$F$$20240920$20240916$20240930$PER$$US-SMPA-2024SPA001800$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243246961$24324696$1$I$20240101$20240820$20240916$20240916$PER$$US-SMPA-2024SPA001729$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243246981$24324698$1$I$$20240828$20240916$20240916$PER$$US-SMPA-2024SPA002075$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243247001$24324700$1$I$$20240903$20240916$20240916$PER$$US-SMPA-2024SPA002243$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243247012$24324701$2$F$$20240916$20240916$20240930$PER$$US-SMPA-2024SPA001807$SUNOVION$$$$$$Y$$$20240930$$HP$US$US
243247021$24324702$1$I$$20240820$20240916$20240916$PER$$US-SMPA-2024SPA001728$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243247031$24324703$1$I$$20240829$20240916$20240916$PER$$US-SMPA-2024SPA002200$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243247041$24324704$1$I$$20240913$20240916$20240916$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-18451$IPSEN$$$$$F$Y$$$20240916$$CN$GB$GB
243247051$24324705$1$I$20240101$20240911$20240916$20240916$PER$$US-SA-2024SA265529$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240916$$MD$US$US
243247061$24324706$1$I$20240913$20240916$20240916$20240916$DIR$718479$$FDA-CTU$$64$YR$$M$N$$$20240916$N$$US$
243247071$24324707$1$I$$20240911$20240916$20240916$EXP$$GB-TAKEDA-2023TUS115163$TAKEDA$$$$$M$Y$$$20240916$$CN$GB$GB
243247081$24324708$1$I$$20240913$20240916$20240916$EXP$$MX-AstraZeneca-2024A210305$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$MX$
243247091$24324709$1$I$$20240909$20240916$20240916$EXP$$US-AstraZeneca-2024A206003$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243247101$24324710$1$I$20240620$20240913$20240916$20240916$EXP$FR-AFSSAPS-AN2024001221$FR-PFIZER INC-202400255819$PFIZER$$63$YR$$M$Y$74$KG$20240916$$MD$FR$FR
243247111$24324711$1$I$20240901$20240912$20240916$20240916$EXP$$US-PFIZER INC-202400247560$PFIZER$$58$YR$$F$Y$$$20240916$$HP$US$US
243247121$24324712$1$I$20100101$20240912$20240916$20240916$EXP$$BG-PFIZER INC-202400255195$PFIZER$Tchernev G.. MUSTARDE ROTATION FLAP AS ADEQUATE OPTION FOR HIGH-RISK BCC NEAR THE LOWER EYE LID: THE ADDITIONAL INTAKE OF N-NITROSO-FOLIC-ACID AND N-NITROSO-RIVOROXABAN AS COFACTORS/ TRIGGERS OF THE METABOLIC REPROGRAMMING OF THE FUTURE CANCER CELL.. Georgian Medical News. 2024;6(351):131-7$74$YR$$F$Y$$$20240916$$MD$BG$BG
243247131$24324713$1$I$$20240911$20240916$20240916$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024113041$VIIV$$$$$M$Y$$$20240916$$MD$US$US
243247141$24324714$1$I$20240911$20240911$20240916$20240916$PER$$DE-BRACCO-2024DE05704$BRACCO$$52$YR$$M$Y$$$20240916$$MD$DE$DE
243247151$24324715$1$I$20240911$20240913$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146676$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$65.77$KG$20240916$$PH$US$US
243247162$24324716$2$F$20240903$20240913$20240916$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145984$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240920$$PH$US$US
243247171$24324717$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146752$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240916$$HP$US$US
243247192$24324719$2$F$20240814$20240920$20240916$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147048$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240926$$CN$US$US
243247201$24324720$1$I$20240809$20240913$20240916$20240916$EXP$FR-AFSSAPS-BX2024001802$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-146445$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$79$KG$20240916$$MD$FR$FR
243247211$24324721$1$I$20240819$20240909$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013255$DR REDDYS$$22$YR$A$F$Y$$$20240916$$HP$US$US
243247221$24324722$1$I$20240823$20240911$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013279$DR REDDYS$$31$YR$A$M$Y$$$20240916$$PH$US$US
243247231$24324723$1$I$$20240911$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013281$DR REDDYS$$22$YR$A$M$Y$$$20240916$$MD$US$US
243247241$24324724$1$I$20240806$20240816$20240916$20240916$PER$$US-Eisai-EC-2024-172328$EISAI$$$$$F$Y$$$20240916$$CN$US$US
243247251$24324725$1$I$$20240903$20240916$20240916$PER$$US-NOVITIUMPHARMA-2024USNVP01858$NOVITIUM PHARMA$$$$A$F$Y$$$20240916$$CN$US$US
243247261$24324726$1$I$$20240903$20240916$20240916$EXP$$US-NEURELIS-USNEU24000650$NEURELIS$$$$$$Y$$$20240916$$CN$US$US
243247271$24324727$1$I$20190201$20240910$20240916$20240916$EXP$US-MLMSERVICE-20201221-2637683-1$US-RDY-SPO/USA/24/0013370$DR REDDYS$Gooden T, Harriss P. Tacrolimus-induced remission of autoimmune enteropathy. American Journal of Gastroenterology. 2020;115:S1484. DOI: 10.14309/01.ajg.0000713400.72462.50.$28$YR$A$M$Y$$$20240916$$HP$US$US
243247281$24324728$1$I$20240913$20240916$20240916$20240916$DIR$718480$$FDA-CTU$$54$YR$$F$N$$$20240916$N$$US$
243247291$24324729$1$I$$20240831$20240916$20240916$PER$$US-SMPA-2024SPA002199$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243247301$24324730$1$I$$20240911$20240916$20240916$EXP$$US-BAYER-2024A130256$BAYER$$78$YR$E$M$Y$$$20240916$$CN$US$US
243247311$24324731$1$I$20240101$20240911$20240916$20240916$EXP$$US-SA-2024SA266889$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240916$$MD$US$US
243247321$24324732$1$I$20240801$20240911$20240916$20240916$EXP$$US-SA-2024SA266774$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240916$$MD$US$US
243247351$24324735$1$I$20240101$20240904$20240916$20240916$EXP$$US-SMPA-2024SPA002345$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243247361$24324736$1$I$$20240903$20240916$20240916$EXP$$HU-SMPA-2024SPA002494$SUNOVION$$$$$$Y$$$20240916$$MD$GB$GB
243247371$24324737$1$I$$20240904$20240916$20240916$EXP$$US-SMPA-2024SPA002304$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243247381$24324738$1$I$$20240903$20240916$20240916$EXP$$US-SMPA-2024SPA002606$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243247391$24324739$1$I$$20240904$20240916$20240916$EXP$$US-SMPA-2024SPA002332$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243247401$24324740$1$I$$20240903$20240916$20240916$EXP$$US-SMPA-2024SPA002245$SUNOVION$$$$$$Y$$$20240916$$CN$US$US
243247411$24324741$1$I$$20240904$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009353$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243247421$24324742$1$I$20240913$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146816$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240916$$CN$US$US
243247431$24324743$1$I$$20240904$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009349$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243247441$24324744$1$I$$20240906$20240916$20240916$PER$$US-ABBVIE-5915649$ABBVIE$$$$$$Y$$$20240916$$MD$US$US
243247451$24324745$1$I$20240903$20240904$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009346$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243247461$24324746$1$I$20240903$20240904$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009341$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243247471$24324747$1$I$$20240906$20240916$20240916$PER$$US-MYLANLABS-2024M1082801$MYLAN$$$$$F$Y$$$20240916$$CN$US$US
243247481$24324748$1$I$$20240909$20240916$20240916$EXP$$US-INDIVIOR UK LIMITED-INDV-156410-2024$RECKITT BENCKISER$Carolyn Salafia, Olivia Van Benschoten, Martin Olsen, et al.. Buprenorphine and the placenta: does MAT in pregnancy impact placental efficiency?. Placenta. 2024;154:e50$$$$$Y$$$20240916$$MD$US$US
243247491$24324749$1$I$$20240227$20240916$20240916$PER$$US-ENDO USA, INC.-2024-001226$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243247501$24324750$1$I$$20240305$20240916$20240916$PER$$US-ENDO USA, INC.-2024-001302$ENDO$$$$$M$Y$$$20240916$$CN$US$US
243247511$24324751$1$I$20240911$20240912$20240916$20240916$30DAY$$US-SANDOZ INC.-SDZ2024US080030$SANDOZ$$11$YR$$$Y$$$20240916$$CN$US$US
243247521$24324752$1$I$$20240823$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN008923$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243247531$24324753$1$I$20240801$20240816$20240916$20240916$PER$$US-Eisai-EC-2024-172375$EISAI$$76$YR$E$F$Y$$$20240916$$CN$US$US
243247541$24324754$1$I$$20240826$20240916$20240916$EXP$$US-SA-2024SA265724$SANOFI AVENTIS$$$$$F$Y$$$20240916$$CN$US$US
243247551$24324755$1$I$$20240618$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003126$PAREXEL$$53$YR$$F$Y$$$20240916$$CN$US$US
243247561$24324756$1$I$$20240621$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003405$PAREXEL$$59$YR$$F$Y$$$20240916$$CN$US$US
243247571$24324757$1$I$20240101$20240620$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003114$PAREXEL$$78$YR$$F$Y$$$20240916$$CN$US$US
243247581$24324758$1$I$$20240618$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003507$PAREXEL$$38$YR$$F$Y$$$20240916$$CN$US$US
243247591$24324759$1$I$20240401$20240618$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003145$PAREXEL$$67$YR$$F$Y$$$20240916$$CN$US$US
243247601$24324760$1$I$$20240619$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003142$PAREXEL$$51$YR$$F$Y$$$20240916$$HP$US$US
243247611$24324761$1$I$$20240725$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002115$PAREXEL$$$$$$Y$$$20240916$$HP$US$US
243247621$24324762$1$I$$20240624$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002846$PAREXEL$$50$YR$$F$Y$$$20240916$$CN$US$US
243247631$24324763$1$I$$20240618$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003269$PAREXEL$$64$YR$$F$Y$$$20240916$$CN$US$US
243247641$24324764$1$I$$20240621$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003325$PAREXEL$$73$YR$$F$Y$$$20240916$$CN$US$US
243247651$24324765$1$I$20240501$20240618$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003499$PAREXEL$$55$YR$$F$Y$$$20240916$$CN$US$US
243247661$24324766$1$I$$20240621$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003351$PAREXEL$$76$YR$$F$Y$$$20240916$$CN$US$US
243247671$24324767$1$I$20240501$20240717$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002864$PAREXEL$$64$YR$$F$Y$$$20240916$$CN$US$US
243247681$24324768$1$I$$20240910$20240916$20240916$EXP$$US-BAYER-2024A113240$BAYER$$56$YR$A$F$Y$$$20240916$$CN$US$US
243247691$24324769$1$I$$20240913$20240916$20240916$EXP$$DE-AstraZeneca-2024A210136$ASTRAZENECA$Crodel C. C.; Yomade O.; Hochhaus A.; Schnetzke U.. Aplastic anemia after treatment with the Bruton^s tyrosine kinase inhibitor acalabrutinib in a patient with chronic lymphocytic leukemia. 2024 Annual Meeting of the German, Austrian, Swiss Societies for Haematology and Medical Oncology (DGHO) 2024;$67$YR$$M$Y$$$20240916$$HP$DE$
243247701$24324770$1$I$$20240910$20240916$20240916$EXP$$US-AstraZeneca-2024A207270$ASTRAZENECA$$$$$F$Y$$$20240916$$CN$US$
243247711$24324771$1$I$20240901$20240912$20240916$20240916$EXP$RU-RZN-2556494$RU-SANDOZ INC.-SDZ2024RU080009$SANDOZ$$$$$F$Y$87$KG$20240916$$MD$RU$RU
243247721$24324772$1$I$$20240913$20240916$20240916$PER$$US-ABBVIE-5925390$ABBVIE$$$$$$Y$$$20240916$$MD$US$US
243247731$24324773$1$I$20240101$20240619$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002108$PAREXEL$$$$$$Y$$$20240916$$CN$US$US
243247741$24324774$1$I$$20240619$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US001886$PAREXEL$$$$$$Y$$$20240916$$CN$US$US
243247751$24324775$1$I$$20240618$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003292$PAREXEL$$57$YR$$F$Y$$$20240916$$CN$US$US
243247761$24324776$1$I$$20240722$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003489$PAREXEL$$86$YR$$F$Y$$$20240916$$CN$US$US
243247771$24324777$1$I$20240913$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009000$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240916$$CN$US$US
243247781$24324778$1$I$20240101$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007419$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240916$$CN$US$US
243247791$24324779$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006631$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$US$US
243247801$24324780$1$I$20240904$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005841$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240916$$CN$US$US
243247811$24324781$1$I$$20240914$20240916$20240916$PER$$US-ALXN-202409USA001132US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243247821$24324782$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146931$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$74.93$KG$20240916$$PH$US$US
243247831$24324783$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA264959$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240916$$MD$US$US
243247851$24324785$1$I$$20240906$20240916$20240916$EXP$GB-MHRA-MIDB-72bf831b-6da4-4c93-8234-d11678f88bd4$GB-TEVA-VS-3241621$TEVA$$84$YR$$F$Y$$$20240916$$PH$GB$GB
243247862$24324786$2$F$$20240916$20240916$20240918$EXP$$CN-PFIZER INC-PV202400120161$PFIZER$Yang, Y.. Acute Retinal Necrosis Possibly Triggered by Contra-Lateral Penetrating Trauma. Ocular Immunology and Inflammation. 2024;32(7):1475-1478$61$YR$$M$Y$$$20240918$$MD$CN$CN
243247882$24324788$2$F$20240903$20240917$20240916$20240919$EXP$$US-ABBVIE-5924084$ABBVIE$$81$YR$$F$Y$39$KG$20240919$$CN$US$US
243247891$24324789$1$I$$20240910$20240916$20240916$30DAY$$US-SANDOZ INC.-SDZ2024US079983$SANDOZ$$$$$M$Y$$$20240916$$CN$US$US
243247901$24324790$1$I$$20240912$20240916$20240916$EXP$$EG-TAKEDA-2024TUS091395$TAKEDA$$$$$F$Y$$$20240916$$MD$EG$EG
243247911$24324791$1$I$20240828$20240911$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013282$DR REDDYS$$75$YR$E$F$Y$$$20240916$$MD$US$US
243247921$24324792$1$I$20240806$20240819$20240916$20240916$PER$$US-Eisai-EC-2024-172576$EISAI$$78$YR$E$F$Y$$$20240916$$HP$US$US
243247931$24324793$1$I$20240801$20240910$20240916$20240916$PER$$US-SA-2024SA265582$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240916$$MD$US$US
243247941$24324794$1$I$$20240912$20240916$20240916$EXP$$BR-TAKEDA-2024TUS091892$TAKEDA$$$$$F$Y$$$20240916$$CN$BR$BR
243247951$24324795$1$I$$20240913$20240916$20240916$PER$$US-PFIZER INC-202400256484$PFIZER$$60$YR$$$Y$$$20240916$$CN$US$US
243247961$24324796$1$I$20240101$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143958$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240916$$CN$US$US
243247971$24324797$1$I$$20240906$20240916$20240916$PER$$US-ABBVIE-5917363$ABBVIE$$$$$$Y$$$20240916$$HP$US$US
243247981$24324798$1$I$$20240909$20240916$20240916$PER$$US-JNJFOC-20240922193$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$HP$US$US
243247991$24324799$1$I$20240912$20240912$20240916$20240916$PER$$US-JNJFOC-20240932262$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$US$US
243248012$24324801$2$F$20240825$20240919$20240916$20240924$EXP$$US-ANIPHARMA-2024-US-048380$ANI$$81$YR$$M$Y$73.48$KG$20240924$$CN$US$US
243248022$24324802$2$F$20240905$20240909$20240916$20240926$30DAY$$US-JNJFOC-20240922454$JOHNSON AND JOHNSON$$24$YR$A$F$Y$$$20240926$$CN$US$US
243248031$24324803$1$I$20240814$20240906$20240916$20240916$EXP$$CN-JNJFOC-20240919971$JOHNSON AND JOHNSON$$57$YR$A$F$Y$48$KG$20240916$$HP$CN$CN
243248041$24324804$1$I$$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146877$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240916$$CN$US$US
243248051$24324805$1$I$$20240913$20240916$20240916$PER$$US-BAYER-2024A131690$BAYER$$$$$$Y$$$20240916$$CN$US$US
243248061$24324806$1$I$20240828$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146215$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240916$$PH$US$US
243248071$24324807$1$I$20240818$20240911$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146208$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240916$$PH$US$US
243248082$24324808$2$F$20240825$20240910$20240916$20240919$EXP$$US-OTSUKA-2024_025021$OTSUKA$$54$YR$$M$Y$74.07$KG$20240919$$MD$US$US
243248092$24324809$2$F$$20240913$20240916$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142235$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240917$$HP$US$US
243248102$24324810$2$F$$20240919$20240916$20240924$EXP$$IT-MYLANLABS-2024M1083232$MYLAN$Levi, V., Stanziano, M., Pinto, C., Zibordi, F., Fedeli, D., Caldiera, V. et al.. Bilateral Simultaneous Magnetic Resonance-Guided Focused Ultrasound Pallidotomy for Life-Threatening Status Dystonicus. Movement Disorders. 2024;39(8):1408-1412$19$YR$$F$Y$$$20240924$$MD$IT$IT
243248111$24324811$1$I$20240814$20240912$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145945$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240916$$CN$US$US
243248121$24324812$1$I$20240901$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144781$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$HP$US$US
243248131$24324813$1$I$$20240910$20240916$20240916$PER$$US-GILEAD-2024-0687214$GILEAD$$$$$$Y$$$20240916$$CN$US$US
243248141$24324814$1$I$$20240907$20240916$20240916$EXP$$US-JNJFOC-20240920079$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$CN$US$US
243248151$24324815$1$I$20240101$20240620$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003552$PAREXEL$$55$YR$$F$Y$$$20240916$$CN$US$US
243248161$24324816$1$I$$20240619$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003723$PAREXEL$$55$YR$$F$Y$$$20240916$$HP$US$US
243248171$24324817$1$I$20240531$20240724$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003576$PAREXEL$$53$YR$$F$Y$72.64$KG$20240916$$CN$US$US
243248191$24324819$1$I$$20240621$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003603$PAREXEL$$67$YR$$F$Y$$$20240916$$CN$US$US
243248201$24324820$1$I$20240501$20240619$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003513$PAREXEL$$68$YR$$F$Y$$$20240916$$CN$US$US
243248231$24324823$1$I$$20240916$20240916$20240916$DIR$718500$$FDA-CTU$$$$$UNK$N$$$20240916$$CN$US$
243248241$24324824$1$I$20240912$20240916$20240916$20240916$DIR$718498$$FDA-CTU$$76$YR$$F$N$$$20240916$N$HP$US$
243248251$24324825$1$I$$20240910$20240916$20240916$PER$$US-ABBVIE-5920974$ABBVIE$$46$YR$$M$Y$$$20240916$$CN$US$US
243248261$24324826$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146670$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240916$$HP$US$US
243248272$24324827$2$F$$20240919$20240916$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146874$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$72.57$KG$20240920$$CN$US$US
243248281$24324828$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146820$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240916$$CN$US$US
243248291$24324829$1$I$$20240910$20240916$20240916$PER$$US-ABBVIE-5919819$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243248301$24324830$1$I$$20240912$20240916$20240916$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-146217$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240916$$MD$DE$DE
243248311$24324831$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184851$NOVARTIS$$$$$$Y$$$20240916$$HP$US$US
243248321$24324832$1$I$20240901$20240904$20240916$20240916$EXP$$US-RIGEL-20240900032$RIGEL PHARMACEUTICALS$$50$YR$$F$Y$$$20240916$$CN$US$US
243248332$24324833$2$F$20240101$20240925$20240916$20240930$EXP$$US-RIGEL-20240900049$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243248351$24324835$1$I$$20240906$20240916$20240916$PER$$US-ABBVIE-5916051$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243248371$24324837$1$I$$20240904$20240916$20240916$EXP$$US-INCYTE CORPORATION-2024IN009651$INCYTE$Salk G, Mangala YO, Onukogu ID, Meleveedu K.. Clonal competition between JAK2 and BCR-ABL in myeloproliferative neoplasm.. CLINICAL LYMPHOMA, MYELOMA + LEUKEMIA. 2024;S238$$$$$Y$$$20240916$$HP$US$US
243248391$24324839$1$I$20240914$20240914$20240916$20240916$PER$$US-ALXN-202409USA001122US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243248401$24324840$1$I$20240827$20240907$20240916$20240916$EXP$GB-MHRA-MED-202409072133178320-CFMNQ$GB-TEVA-VS-3241895$TEVA$$59$YR$$M$Y$75$KG$20240916$$CN$GB$GB
243248411$24324841$1$I$20221001$20240913$20240916$20240916$30DAY$$CA-SANDOZ INC.-NVSC2022CA260680$SANDOZ$$29$YR$$M$Y$$$20240916$$CN$CA$CA
243248421$24324842$1$I$20070801$20240911$20240916$20240916$EXP$$FR-MYLANLABS-07P-056-0420714-00$MYLAN$$47$YR$$F$Y$$$20240916$$HP$FR$FR
243248441$24324844$1$I$20240101$20240905$20240916$20240916$PER$$US-SA-2024SA263833$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240916$$MD$US$US
243248451$24324845$1$I$20240901$20240910$20240916$20240916$PER$$US-SA-2024SA264984$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240916$$MD$US$US
243248461$24324846$1$I$20240501$20240904$20240916$20240916$PER$$US-SA-2024SA263775$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240916$$MD$US$US
243248471$24324847$1$I$20240801$20240906$20240916$20240916$PER$$US-SA-2024SA265703$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$HP$US$US
243248481$24324848$1$I$20240101$20240909$20240916$20240916$PER$$US-SA-2024SA265549$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240916$$MD$US$US
243248491$24324849$1$I$20230511$20240903$20240916$20240916$EXP$$AU-Hill Dermaceuticals, Inc.-2161681$HILL DERM$$54$YR$$F$Y$$$20240916$$MD$AU$AU
243248501$24324850$1$I$$20240912$20240916$20240916$EXP$$US-KYOWAKIRIN-2024KK021357$KYOWA$$$$$$Y$$$20240916$$HP$US$US
243248511$24324851$1$I$20240823$20240912$20240916$20240916$EXP$$CN-PFIZER INC-PV202400120044$PFIZER$$36$YR$$F$Y$$$20240916$$HP$CN$CN
243248541$24324854$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146732$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240916$$PH$US$US
243248551$24324855$1$I$20240911$20240912$20240916$20240916$EXP$$AR-BAYER-2024A131755$BAYER$$71$YR$E$F$Y$$$20240916$$HP$AR$AR
243248561$24324856$1$I$20240825$20240905$20240916$20240916$EXP$ES-AEMPS-1565935$ES-TAKEDA-2024TUS088990$TAKEDA$$12$YR$$F$Y$35$KG$20240916$$HP$ES$ES
243248571$24324857$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA265719$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240916$$MD$US$US
243248581$24324858$1$I$20200701$20240906$20240916$20240916$PER$$US-SA-2024SA265697$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240916$$HP$US$US
243248591$24324859$1$I$$20240827$20240916$20240916$PER$$US-SA-2024SA264530$SANOFI AVENTIS$$$$A$M$Y$$$20240916$$MD$US$US
243248601$24324860$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA265736$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240916$$HP$US$US
243248611$24324861$1$I$20240801$20240905$20240916$20240916$PER$$US-SA-2024SA264235$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240916$$HP$US$US
243248621$24324862$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA263884$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240916$$MD$US$US
243248631$24324863$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA264825$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240916$$MD$US$US
243248651$24324865$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007729$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240916$$CN$US$US
243248661$24324866$1$I$$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009127$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240916$$CN$US$US
243248671$24324867$1$I$20220101$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006459$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240916$$CN$US$US
243248681$24324868$1$I$$20240909$20240916$20240916$PER$$US-MYLANLABS-2024M1082792$MYLAN$$$$$M$Y$88.45$KG$20240916$$CN$US$US
243248691$24324869$1$I$20240911$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024182582$AMGEN$$33$YR$A$M$Y$$$20240916$$HP$US$US
243248701$24324870$1$I$20240101$20240828$20240916$20240916$PER$$US-SA-2024SA265847$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240916$$MD$US$US
243248711$24324871$1$I$20240901$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007479$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240916$$CN$US$US
243248721$24324872$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA263918$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240916$$MD$US$US
243248731$24324873$1$I$20220101$20240827$20240916$20240916$PER$$US-SA-2024SA264461$SANOFI AVENTIS$$71$YR$E$F$Y$55$KG$20240916$$MD$US$US
243248741$24324874$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265680$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240916$$MD$US$US
243248751$24324875$1$I$20240820$20240908$20240916$20240916$EXP$$CN-AstraZeneca-2024A204963$ASTRAZENECA$$55$YR$$F$Y$47$KG$20240916$$MD$CN$
243248761$24324876$1$I$$20240909$20240916$20240916$EXP$$CA-GSK-CA2024AMR112359$GLAXOSMITHKLINE$$$$$$Y$$$20240916$$CN$CA$CA
243248781$24324878$1$I$20240101$20240911$20240916$20240916$PER$$US-JNJFOC-20240931136$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$CN$US$US
243248821$24324882$1$I$20240701$20240916$20240916$20240916$DIR$718474$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243248831$24324883$1$I$20240830$20240916$20240916$20240916$DIR$718481$$FDA-CTU$$64$YR$$F$N$63.9$KG$20240916$N$HP$US$
243248841$24324884$1$I$$20240906$20240916$20240916$EXP$$US-RADIUS HEALTH INC.-2024US006968$RADIUS PHARM$$$$$F$Y$$$20240916$$CN$US$US
243248851$24324885$1$I$20240827$20240909$20240916$20240916$EXP$$US-TAKEDA-2024TUS086731$TAKEDA$$75$YR$$F$Y$$$20240916$$CN$US$US
243248861$24324886$1$I$$20240826$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN008982$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243248873$24324887$3$F$$20240924$20240916$20240925$PER$$US-Prasco Laboratories-PRAS20241152$PRASCO$$$$$F$Y$$$20240925$$CN$US$US
243248881$24324888$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA264575$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240916$$MD$US$US
243248891$24324889$1$I$20240817$20240911$20240916$20240916$EXP$$CN-SA-2024SA267205$SANOFI AVENTIS$$52$YR$A$M$Y$57$KG$20240916$$HP$CN$CN
243248901$24324890$1$I$20240101$20240910$20240916$20240916$PER$$US-SA-2024SA265085$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240916$$MD$US$US
243248911$24324891$1$I$20240801$20240828$20240916$20240916$PER$$US-SA-2024SA265844$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240916$$CN$US$US
243248921$24324892$1$I$$20240910$20240916$20240916$EXP$$CA-PFIZER INC-202400256740$PFIZER$$48$YR$$F$Y$68$KG$20240916$$HP$CA$CA
243248931$24324893$1$I$$20240827$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009063$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243248943$24324894$3$F$$20240805$20240916$20240916$PER$$US-AstraZeneca-2024A177545$ASTRAZENECA$$$$$$Y$$$20240916$$PH$US$
243248951$24324895$1$I$$20240827$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009034$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243248961$24324896$1$I$20240916$20240916$20240916$20240916$DIR$718483$$FDA-CTU$$67$YR$$M$N$99.45$KG$20240916$N$HP$US$
243248971$24324897$1$I$$20240916$20240916$20240916$DIR$718493$$FDA-CTU$$$$$UNK$N$$$20240916$$CN$US$
243248981$24324898$1$I$20240912$20240916$20240916$20240916$DIR$718494$$FDA-CTU$$53$YR$$F$N$81$KG$20240916$N$HP$US$
243248991$24324899$1$I$20240829$20240916$20240916$20240916$DIR$718484$$FDA-CTU$$56$YR$$F$N$75.15$KG$20240916$N$CN$US$
243249001$24324900$1$I$$20240916$20240916$20240916$DIR$718497$$FDA-CTU$$$$$UNK$N$$$20240916$$CN$US$
243249011$24324901$1$I$$20240828$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009125$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243249021$24324902$1$I$$20240913$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146548$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240916$$PH$US$US
243249031$24324903$1$I$20240801$20240828$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009120$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243249041$24324904$1$I$$20240913$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146947$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240916$$CN$US$US
243249051$24324905$1$I$20221226$20240911$20240916$20240916$EXP$FR-AFSSAPS-PC2024000691$FR-009507513-2409FRA004168$MERCK$$78$YR$$F$Y$74$KG$20240916$$PH$FR$FR
243249062$24324906$2$F$20240801$20240917$20240916$20240918$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-17628$IPSEN$$62$YR$A$M$Y$$$20240918$$CN$CA$CA
243249071$24324907$1$I$$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024184420$AMGEN$$$$$$Y$$$20240916$$CN$US$US
243249081$24324908$1$I$20220101$20240912$20240916$20240916$EXP$$CH-AMERICAN REGENT INC-2024003516$AMERICAN REGENT$$20$YR$$F$Y$70$KG$20240916$$MD$CH$CH
243249091$24324909$1$I$$20240912$20240916$20240916$30DAY$$CO-PFIZER INC-PV202400120501$PFIZER$$11$YR$$M$Y$$$20240916$$CN$CO$CO
243249102$24324910$2$F$$20240910$20240916$20240923$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17890$IPSEN$$$$$F$Y$$$20240923$$CN$US$US
243249111$24324911$1$I$20240329$20240905$20240916$20240916$EXP$$RS-BRISTOL-MYERS SQUIBB COMPANY-2024-146925$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240916$$MD$RS$RS
243249121$24324912$1$I$$20240910$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013380$DR REDDYS$$50$YR$A$M$Y$$$20240916$$HP$US$US
243249141$24324914$1$I$$20240910$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013317$DR REDDYS$$69$YR$E$F$Y$$$20240916$$MD$US$US
243249151$24324915$1$I$20240907$20240909$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013319$DR REDDYS$$44$YR$A$F$Y$$$20240916$$HP$US$US
243249161$24324916$1$I$$20240829$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138407$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240916$$HP$US$US
243249171$24324917$1$I$$20240826$20240916$20240916$PER$$US-SA-2024SA266227$SANOFI AVENTIS$$$$$F$Y$$$20240916$$CN$US$US
243249181$24324918$1$I$$20240916$20240916$20240916$EXP$$US-PROD-AS2-212756134-RB-085596-2024$RECKITT BENCKISER$$$$$M$Y$$$20240916$$CN$US$US
243249191$24324919$1$I$$20240830$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009236$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243249201$24324920$1$I$$20240830$20240916$20240916$PER$$US-INCYTE CORPORATION-2024IN009232$INCYTE$$$$$$Y$$$20240916$$CN$US$US
243249211$24324921$1$I$20240831$20240916$20240916$20240916$DIR$718501$$FDA-CTU$$8$YR$$M$N$20.7$KG$20240916$N$MD$US$
243249221$24324922$1$I$20240913$20240916$20240916$20240916$DIR$718502$$FDA-CTU$$47$YR$$F$N$96.75$KG$20240916$N$CN$US$
243249231$24324923$1$I$20240909$20240916$20240916$20240916$DIR$718506$$FDA-CTU$$32$YR$$F$N$65.25$KG$20240916$N$CN$US$
243249241$24324924$1$I$$20240916$20240916$20240916$DIR$718504$$FDA-CTU$$$$$UNK$N$$$20240916$$CN$US$
243249251$24324925$1$I$20240815$20240916$20240916$20240916$DIR$718507$$FDA-CTU$$62$YR$$F$N$$$20240916$N$HP$US$
243249261$24324926$1$I$$20240916$20240916$20240916$DIR$718509$$FDA-CTU$$$$$UNK$N$$$20240916$N$$US$
243249291$24324929$1$I$20240910$20240916$20240916$20240916$DIR$718513$$FDA-CTU$$46$YR$$F$N$$$20240916$N$HP$US$
243249301$24324930$1$I$$20240916$20240916$20240916$DIR$718514$$FDA-CTU$$61$YR$$M$N$115$KG$20240916$N$$US$
243249311$24324931$1$I$20240913$20240916$20240916$20240916$DIR$718525$$FDA-CTU$$30$YR$$M$N$72$KG$20240916$N$CN$US$
243249322$24324932$2$F$20240101$20240916$20240916$20240919$EXP$$US-KYOWAKIRIN-2024KK021444$KYOWA$$$$$$Y$$$20240919$$HP$US$US
243249331$24324933$1$I$20240101$20240911$20240916$20240916$PER$$US-SA-2024SA265548$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240916$$MD$US$US
243249341$24324934$1$I$$20240725$20240916$20240916$PER$$US-AstraZeneca-2024A171345$ASTRAZENECA$$$$$F$Y$$$20240916$$PH$US$
243249351$24324935$1$I$$20240822$20240916$20240916$PER$$US-AstraZeneca-2024A193418$ASTRAZENECA$$$$$F$Y$$$20240916$$MD$US$
243249361$24324936$1$I$20240101$20240904$20240916$20240916$PER$$US-AstraZeneca-2024A202003$ASTRAZENECA$$$$A$F$Y$$$20240916$$PH$US$
243249371$24324937$1$I$$20240904$20240916$20240916$PER$$US-AstraZeneca-2024A204324$ASTRAZENECA$$$$$F$Y$$$20240916$$HP$US$
243249381$24324938$1$I$$20240905$20240916$20240916$PER$$US-AstraZeneca-2024A205240$ASTRAZENECA$$$$$F$Y$$$20240916$$MD$US$
243249391$24324939$1$I$$20240911$20240916$20240916$PER$$US-AstraZeneca-2024A208091$ASTRAZENECA$$$$$F$Y$$$20240916$$HP$US$
243249401$24324940$1$I$$20240911$20240916$20240916$EXP$$US-MYLANLABS-2024M1071377$MYLAN$$$$$F$Y$$$20240916$$CN$US$US
243249411$24324941$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265721$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240916$$HP$US$US
243249421$24324942$1$I$$20240910$20240916$20240916$EXP$$NVSC2024IN182975$NOVARTIS$$$$$M$Y$$$20240916$$MD$IN$IN
243249433$24324943$3$F$$20240912$20240916$20240924$EXP$$NVSC2024DE184144$NOVARTIS$$$$$$Y$$$20240924$$PH$DE$DE
243249441$24324944$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265630$SANOFI AVENTIS$$$$A$F$Y$$$20240916$$MD$US$US
243249452$24324945$2$F$$20240916$20240916$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409007742$ELI LILLY AND CO$$$$$$Y$$$20240918$$MD$US$US
243249471$24324947$1$I$$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009121$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240916$$CN$US$US
243249481$24324948$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009003$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240916$$CN$US$US
243249491$24324949$1$I$20240601$20240828$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202408018469$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240916$$CN$US$US
243249501$24324950$1$I$20240701$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006689$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240916$$CN$US$US
243249512$24324951$2$F$$20240917$20240916$20240925$PER$$US-Calliditas-2024CAL01856$CALLIDITAS THERAPEUTICS$$$$$M$Y$$$20240924$$MD$US$US
243249521$24324952$1$I$20240909$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007366$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240916$$CN$US$US
243249532$24324953$2$F$$20240918$20240916$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409008351$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240924$$CN$US$US
243249541$24324954$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008008$ELI LILLY AND CO$$$$$F$Y$$$20240916$$CN$US$US
243249551$24324955$1$I$$20240912$20240916$20240916$EXP$$US-PFIZER INC-202400256428$PFIZER$$61$YR$$F$Y$$$20240916$$HP$US$US
243249561$24324956$1$I$$20240913$20240916$20240916$PER$$US-AMGEN-USASP2024184481$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243249571$24324957$1$I$$20240821$20240916$20240916$PER$$US-SA-2024SA263390$SANOFI AVENTIS$$$$T$F$Y$$$20240916$$MD$US$US
243249591$24324959$1$I$20221201$20240903$20240916$20240916$EXP$$CA-BAUSCHBL-2024BNL032857$BAUSCH AND LOMB$$67$YR$$F$Y$79$KG$20240916$$CN$CA$CA
243249602$24324960$2$F$$20240925$20240916$20240926$EXP$$US-GILEAD-2024-0684803$GILEAD$$68$YR$E$F$Y$$$20240926$$HP$US$US
243249611$24324961$1$I$20240916$20240916$20240916$20240916$DIR$718519$$FDA-CTU$$68$YR$$F$N$$$20240916$N$$US$
243249621$24324962$1$I$20240915$20240916$20240916$20240916$DIR$718521$$FDA-CTU$$70$YR$$F$N$$$20240916$N$$US$
243249631$24324963$1$I$20240714$20240916$20240916$20240916$DIR$718523$$FDA-CTU$$27$YR$$F$N$85.5$KG$20240916$N$CN$US$
243249641$24324964$1$I$$20240916$20240916$20240916$DIR$718530$$FDA-CTU$$$$$UNK$N$$$20240916$N$CN$US$
243249651$24324965$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184779$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
243249671$24324967$1$I$20240901$20240911$20240916$20240916$EXP$$US-BAUSCH-BL-2024-013616$BAUSCH AND LOMB$$57$YR$$F$Y$$$20240916$$CN$US$US
243249681$24324968$1$I$$20240912$20240916$20240916$EXP$$US-BAUSCH-BL-2024-013750$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240916$$CN$US$US
243249691$24324969$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146637$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$PH$US$US
243249701$24324970$1$I$$20240909$20240916$20240916$EXP$$CA-BAUSCH-BL-2024-013533$BAUSCH AND LOMB$$$$$F$Y$$$20240916$$HP$CA$CA
243249711$24324971$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146766$BRISTOL MYERS SQUIBB$$27$YR$A$M$Y$$$20240916$$HP$US$US
243249721$24324972$1$I$20240824$20240911$20240916$20240916$EXP$$DE-AstraZeneca-2024A195478$ASTRAZENECA$$28360$DY$$F$Y$66$KG$20240916$$MD$DE$
243249731$24324973$1$I$20220901$20240914$20240916$20240916$EXP$$ES-BAUSCH-BL-2024-013858$BAUSCH AND LOMB$$77$YR$$F$Y$77$KG$20240916$$MD$ES$ES
243249742$24324974$2$F$$20240919$20240916$20240927$EXP$$FR-TEVA-VS-3243086$TEVA$Diallo AO, Marcou A, Lespinasse J, Cordoba-Sosa Z, Andres E, Docquier L, et al. Malignant hypercalcemia revealing a diffuse large B-cell lymphoma in a patient with a previous diagnosis of chronic myelomonocytic leukemia: An uncommon hematological coexistence. Clin-Case-Rep 2023; 11 (9):.; Diallo AO, Marcou A, Lespinasse J, Cordoba-Sosa Z, Andres E, Docquier L, et al. Malignant hypercalcemia revealing a diffuse large B-cell lymphoma in a patient with a previous diagnosis of chronic myelomonocy...$76$YR$$M$Y$$$20240927$$HP$FR$FR
243249751$24324975$1$I$20231224$20240911$20240916$20240916$PER$$US-GILEAD-2024-0687417$GILEAD$$61$YR$A$F$Y$79.8$KG$20240916$$HP$US$US
243249761$24324976$1$I$20230101$20240910$20240916$20240916$PER$$US-SA-2024SA265350$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240916$$MD$US$US
243249771$24324977$1$I$20240101$20240903$20240916$20240916$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002587$CORCEPT$$$$$$Y$$$20240916$$MD$US$US
243249781$24324978$1$I$20240101$20240911$20240916$20240916$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014512$VERTEX$$$$A$F$Y$$$20240916$$CN$GB$GB
243249791$24324979$1$I$$20240907$20240916$20240916$EXP$NL-EMA-DD-20201105-kumarvn_p-112409$EU-BAUSCHBL-2024BNL033075$BAUSCH AND LOMB$Bakker N, Dijk J, Slart R, Coppes M, Imhoff V, Verschuuren E. Extradural Thoracic spinal cord compression: unusual initial presentation of post-transplant lymphoproliferative disorder. The Journal of Heart and Lung Transplantation. 2008 OCT;27:1165-1168. doi:10.1016/ j.healun.2008.06.008$44$YR$$M$Y$$$20240916$$MD$EU$EU
243249801$24324980$1$I$$20240909$20240916$20240916$EXP$$CA-BAUSCH-BL-2024-013508$BAUSCH AND LOMB$$$$$F$Y$$$20240916$$HP$CA$CA
243249811$24324981$1$I$$20240911$20240916$20240916$EXP$$CA-BAUSCH-BL-2024-013639$BAUSCH AND LOMB$$43$YR$$F$Y$$$20240916$$HP$CA$CA
243249821$24324982$1$I$20240906$20240916$20240916$20240916$DIR$718554$$FDA-CTU$$45$YR$$F$N$103.5$KG$20240916$N$CN$US$
243249851$24324985$1$I$$20240909$20240916$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143805$BRISTOL MYERS SQUIBB$Kitano M, Yomota M, Ito K, Hosomi Y. Immune checkpoint inhibitor-associated sick sinus syndrome and cardiogenic shock. International Cancer Conference Journal. 2024 Aug 30;doi:10.1007/s13691-024-00718-x.$67$YR$E$M$Y$$$20240916$$HP$JP$JP
243249861$24324986$1$I$20240905$20240916$20240916$20240916$DIR$718562$$FDA-CTU$$58$YR$$M$N$113.3$KG$20240916$N$PH$US$
243249871$24324987$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184785$NOVARTIS$$$$$$Y$$$20240916$$CN$US$US
243249881$24324988$1$I$20240911$20240913$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146460$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$67$KG$20240916$$CN$US$US
243249891$24324989$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184860$NOVARTIS$$63$YR$$M$Y$$$20240916$$HP$US$US
243249901$24324990$1$I$$20240913$20240916$20240916$EXP$$NVSC2024US184709$NOVARTIS$$$$$F$Y$48.53$KG$20240916$$CN$US$US
243249911$24324991$1$I$$20240916$20240916$20240916$DIR$718559$$FDA-CTU$$$$$UNK$N$$$20240916$N$CN$US$
243249921$24324992$1$I$$20240912$20240916$20240916$PER$$NVSC2024US184653$NOVARTIS$$$$$M$Y$$$20240916$$CN$US$US
243249931$24324993$1$I$20240401$20240908$20240916$20240916$EXP$$NVSC2024MX182291$NOVARTIS$$53$YR$$F$Y$$$20240916$$CN$MX$MX
243249942$24324994$2$F$20161130$20240916$20240916$20240918$PER$$US-ABBVIE-5925974$ABBVIE$$50$YR$$M$Y$$$20240918$$CN$US$US
243249952$24324995$2$F$20221222$20240923$20240916$20240923$EXP$$NVSC2024EE184603$NOVARTIS$$71$YR$$M$Y$80.4$KG$20240923$$MD$EE$EE
243249961$24324996$1$I$$20240911$20240916$20240916$PER$$NVSC2024US184801$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
243249972$24324997$2$F$20240911$20240917$20240916$20240918$PER$$PR-PFIZER INC-202400256433$PFIZER$$69$YR$$F$Y$$$20240918$$HP$PR$PR
243249991$24324999$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-202400256398$PFIZER$$61$YR$$M$Y$$$20240916$$HP$US$US
243250001$24325000$1$I$$20240912$20240916$20240916$PER$$US-PFIZER INC-PV202400120150$PFIZER$$86$YR$$F$Y$$$20240916$$CN$US$US
243250011$24325001$1$I$$20240916$20240916$20240916$EXP$$CA-GILEAD-2024-0663741$GILEAD$$$$$M$Y$$$20240916$$CN$CA$CA
243250021$24325002$1$I$20231227$20240911$20240916$20240916$PER$$US-GILEAD-2024-0687435$GILEAD$$56$YR$A$F$Y$61.6$KG$20240916$$HP$US$US
243250031$24325003$1$I$$20240905$20240916$20240916$PER$$US-SA-2024SA265720$SANOFI AVENTIS$$$$$M$Y$$$20240916$$CN$US$US
243250041$24325004$1$I$20240901$20240912$20240916$20240916$EXP$$DE-BAYER-2024A131920$BAYER$$78$YR$E$M$Y$$$20240916$$CN$DE$DE
243250051$24325005$1$I$20240801$20240821$20240916$20240916$PER$$US-SA-2024SA264589$SANOFI AVENTIS$$53$YR$A$M$Y$72.73$KG$20240916$$MD$US$US
243250071$24325007$1$I$$20240906$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013401$DR REDDYS$Terashita M, Selamet U, Midha S, Nadeem O, Laubach J, Rennke HG, et al. Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones. Kidney International Reports. 2023;8: 2765-2777. doi:10.1016/j.ekir.2023.09.022.$$$$$Y$$$20240916$$HP$US$US
243250081$24325008$1$I$20240916$20240916$20240916$20240916$DIR$718567$$FDA-CTU$$30$YR$$F$N$$$20240916$N$$US$
243250101$24325010$1$I$20240823$20240916$20240916$20240916$DIR$718571$$FDA-CTU$$36$YR$$F$N$60.75$KG$20240916$N$CN$US$
243250111$24325011$1$I$$20240910$20240916$20240916$EXP$$AR-DSJP-DSJ-2024-144857$DAIICHI$$$$$F$Y$$$20240916$$MD$AR$AR
243250121$24325012$1$I$$20240911$20240916$20240916$EXP$$CA-TEVA-VS-3242579$TEVA$$39$YR$$F$Y$$$20240916$$HP$CA$CA
243250131$24325013$1$I$$20240911$20240916$20240916$EXP$$CA-TEVA-VS-3242948$TEVA$$74$YR$$F$Y$70$KG$20240916$$MD$CA$CA
243250141$24325014$1$I$$20240911$20240916$20240916$EXP$$CA-TEVA-VS-3243478$TEVA$$33$YR$$M$Y$$$20240916$$HP$CA$CA
243250151$24325015$1$I$$20240911$20240916$20240916$EXP$$CA-TEVA-VS-3242875$TEVA$$48$YR$$F$Y$$$20240916$$PH$CA$CA
243250161$24325016$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA264780$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240916$$MD$US$US
243250171$24325017$1$I$$20240906$20240916$20240916$PER$$US-SA-2024SA265718$SANOFI AVENTIS$$8$YR$C$M$Y$48.534$KG$20240916$$MD$US$US
243250181$24325018$1$I$20240901$20240910$20240916$20240916$PER$$US-SA-2024SA265738$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240916$$CN$US$US
243250192$24325019$2$F$20220101$20240916$20240916$20240923$EXP$FR-AFSSAPS-SE2024000694$FR-OTSUKA-2024_025250$OTSUKA$$56$YR$$M$Y$$$20240923$$MD$FR$FR
243250201$24325020$1$I$$20240916$20240916$20240916$EXP$$US-PROD-AS2-212756134-RB-086707-2024$RECKITT BENCKISER$$$$$M$Y$$$20240916$$CN$US$US
243250211$24325021$1$I$$20240913$20240916$20240916$EXP$$SE-ABBVIE-5925553$ABBVIE$$$$$F$Y$$$20240916$$MD$SE$SE
243250221$24325022$1$I$$20240912$20240916$20240916$PER$$US-ALXN-202409USA000949US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240916$$CN$US$US
243250231$24325023$1$I$$20240911$20240916$20240916$EXP$$NVSC2024CA183067$NOVARTIS$$62$YR$$F$Y$$$20240916$$HP$CA$CA
243250241$24325024$1$I$$20240911$20240916$20240916$EXP$$NVSC2024CA183286$NOVARTIS$$39$YR$$F$Y$$$20240916$$HP$CA$CA
243250251$24325025$1$I$20240101$20240906$20240916$20240916$PER$$US-SA-2024SA265658$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240916$$MD$US$US
243250261$24325026$1$I$$20240915$20240916$20240916$PER$$NVSC2024US184656$NOVARTIS$$$$$$Y$$$20240916$$CN$US$US
243250271$24325027$1$I$20240126$20240913$20240916$20240916$EXP$FR-AFSSAPS-NY2024001062$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-146229$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$80$KG$20240916$$MD$FR$FR
243250281$24325028$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265643$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240916$$MD$US$US
243250291$24325029$1$I$20240710$20240916$20240916$20240916$EXP$ES-AEMPS-1568947$ES-GILEAD-2024-0687847$GILEAD$$70$YR$E$M$Y$62$KG$20240916$$MD$ES$ES
243250301$24325030$1$I$$20240910$20240916$20240916$PER$$US-SA-2024SA265755$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240916$$HP$US$US
243250311$24325031$1$I$20240821$20240910$20240916$20240916$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006667$AURINIA PHARMACEUTICALS$$18$YR$$F$Y$$$20240916$$MD$US$US
243250321$24325032$1$I$$20240913$20240916$20240916$PER$$US-BAUSCH-BL-2024-013831$BAUSCH AND LOMB$$60$YR$$M$Y$86.18$KG$20240916$$CN$US$US
243250331$24325033$1$I$$20240913$20240916$20240916$EXP$$DE-BAUSCH-BL-2024-013851$BAUSCH AND LOMB$$$$$M$Y$$$20240916$$CN$DE$DE
243250341$24325034$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008125$ELI LILLY AND CO$$$$$M$Y$$$20240916$$CN$US$US
243250351$24325035$1$I$20240902$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009431$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240916$$CN$US$US
243250361$24325036$1$I$$20240910$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409006337$ELI LILLY AND CO$$67$YR$E$$Y$$$20240916$$CN$US$US
243250371$24325037$1$I$20240801$20240911$20240916$20240916$PER$$US-IMP-2024000734$Harrow Health$$96$YR$E$F$Y$$$20240916$$CN$US$US
243250381$24325038$1$I$20240907$20240909$20240916$20240916$PER$$US-SA-2024SA265580$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240916$$MD$US$US
243250402$24325040$2$F$20240910$20240916$20240916$20240923$EXP$$US-INTERCEPT-PM2024001842$INTERCEPT PHARMACEUTICALS$$72$YR$$F$Y$$$20240923$$CN$US$US
243250411$24325041$1$I$20240101$20240711$20240916$20240916$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003463$PAREXEL$$72$YR$$F$Y$$$20240916$$CN$US$US
243250431$24325043$1$I$20240403$20240916$20240916$20240916$EXP$$US-PROD-AS2-212756134-RB-086981-2024$RECKITT BENCKISER$$83$YR$$M$Y$$$20240916$$CN$US$US
243250451$24325045$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146277$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240916$$CN$US$US
243250461$24325046$1$I$20240909$20240910$20240916$20240916$EXP$$US-RDY-SPO/USA/24/0013291$DR REDDYS$$75$YR$E$F$Y$$$20240916$$HP$US$US
243250472$24325047$2$F$$20240916$20240916$20240919$EXP$GB-002147023-NVSC2024GB179605$GB-RDY-SPO/GBR/24/0013346$DR REDDYS$$$$A$F$Y$$$20240919$$MD$GB$GB
243250481$24325048$1$I$20210101$20240906$20240916$20240916$PER$$US-SA-2024SA265626$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240916$$HP$US$US
243250491$24325049$1$I$20240101$20240826$20240916$20240916$PER$$US-SA-2024SA266138$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240916$$CN$US$US
243250501$24325050$1$I$$20240904$20240916$20240916$PER$$US-JNJFOC-20240928079$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$MD$US$US
243250511$24325051$1$I$$20240906$20240916$20240916$PER$$US-JNJFOC-20240920744$JOHNSON AND JOHNSON$$$$$$Y$$$20240916$$HP$US$US
243250521$24325052$1$I$20240908$20240910$20240916$20240916$PER$$US-JNJFOC-20240928158$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240916$$HP$US$US
243250531$24325053$1$I$20240817$20240910$20240916$20240916$PER$$US-JNJFOC-20240928753$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240916$$HP$US$US
243250552$24325055$2$F$20200901$20240917$20240916$20240920$EXP$$AU-ABBVIE-5918974$ABBVIE$$83$YR$$F$Y$$$20240920$$MD$AU$AU
243250561$24325056$1$I$20240801$20240913$20240916$20240916$PER$$NVSC2024US184822$NOVARTIS$$$$$F$Y$$$20240916$$HP$US$US
243250571$24325057$1$I$$20240904$20240916$20240916$PER$$US-SA-2024SA264277$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240916$$CN$US$US
243250581$24325058$1$I$20240912$20240913$20240916$20240916$EXP$$NVSC2024CN183908$NOVARTIS$$58$YR$$M$Y$60$KG$20240916$$HP$CN$CN
243250601$24325060$1$I$20210527$20240912$20240916$20240916$EXP$$NVSC2021FR166012$NOVARTIS$$73$YR$$F$Y$41$KG$20240916$$MD$FR$FR
243250611$24325061$1$I$20240721$20240721$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00462$BRAINTREE$$$$A$F$Y$$$20240916$$CN$US$US
243250621$24325062$1$I$20240701$20240731$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00478$BRAINTREE$$$$A$M$Y$$$20240916$$CN$US$US
243250631$24325063$1$I$20230814$20230814$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00576$BRAINTREE$$72$YR$$F$Y$54.422$KG$20240916$$CN$US$US
243250641$24325064$1$I$$20230822$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00606$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250651$24325065$1$I$20230823$20230823$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00610$BRAINTREE$$70$YR$$F$Y$$$20240916$$CN$US$US
243250661$24325066$1$I$20230823$20230823$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00613$BRAINTREE$$61$YR$$F$Y$79.365$KG$20240916$$CN$US$US
243250671$24325067$1$I$20160101$20230823$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00616$BRAINTREE$$$$$F$Y$78.458$KG$20240916$$CN$US$US
243250681$24325068$1$I$20230828$20230828$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00621$BRAINTREE$$65$YR$$F$Y$$$20240916$$CN$US$US
243250691$24325069$1$I$20230905$20230906$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00641$BRAINTREE$$70$YR$$F$Y$$$20240916$$CN$US$US
243250701$24325070$1$I$20240701$20240730$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00475$BRAINTREE$$67$YR$$F$Y$59.874$KG$20240916$$CN$US$US
243250711$24325071$1$I$20230912$20230912$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00650$BRAINTREE$$71$YR$$F$Y$70.295$KG$20240916$$CN$US$US
243250721$24325072$1$I$20230901$20230918$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00658$BRAINTREE$$65$YR$$M$Y$81.633$KG$20240916$$CN$US$US
243250731$24325073$1$I$20230927$20230927$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00687$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250741$24325074$1$I$20230925$20230925$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00676$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250751$24325075$1$I$20231005$20231005$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00713$BRAINTREE$$$$A$F$Y$$$20240916$$CN$US$US
243250761$24325076$1$I$20230101$20231010$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00719$BRAINTREE$$$$$F$Y$63.673$KG$20240916$$CN$US$US
243250771$24325077$1$I$20231011$20231011$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00725$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250781$24325078$1$I$$20230927$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00702$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250791$24325079$1$I$20231010$20231011$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00721$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250801$24325080$1$I$20231011$20231011$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00726$BRAINTREE$$$$$M$Y$$$20240916$$CN$US$US
243250811$24325081$1$I$20231015$20231015$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00729$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250821$24325082$1$I$20231114$20231114$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00834$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250831$24325083$1$I$20231115$20231115$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00843$BRAINTREE$$73$YR$$M$Y$$$20240916$$CN$US$US
243250841$24325084$1$I$20231127$20231127$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00878$BRAINTREE$$58$YR$$F$Y$52.617$KG$20240916$$CN$US$US
243250851$24325085$1$I$20231130$20231130$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00891$BRAINTREE$$48$YR$$F$Y$$$20240916$$CN$US$US
243250861$24325086$1$I$20240102$20240103$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00003$BRAINTREE$$$$A$F$Y$$$20240916$$CN$US$US
243250871$24325087$1$I$20231207$20231207$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00906$BRAINTREE$$49$YR$$F$Y$49.895$KG$20240916$$CN$US$US
243250881$24325088$1$I$20240101$20240119$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00033$BRAINTREE$$75$YR$$F$Y$79.379$KG$20240916$$CN$US$US
243250891$24325089$1$I$$20240604$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00037$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250901$24325090$1$I$20240124$20240125$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00045$BRAINTREE$$53$YR$$F$Y$51.02$KG$20240916$$CN$US$US
243250911$24325091$1$I$20240130$20240130$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00054$BRAINTREE$$$$$M$Y$$$20240916$$CN$US$US
243250921$24325092$1$I$20150101$20240205$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00070$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250931$24325093$1$I$20100101$20240213$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00084$BRAINTREE$$$$$F$Y$60.328$KG$20240916$$CN$US$US
243250941$24325094$1$I$20240228$20240229$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00111$BRAINTREE$$69$YR$$$Y$$$20240916$$CN$US$US
243250951$24325095$1$I$$20240312$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00133$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250961$24325096$1$I$20240319$20240319$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00144$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250971$24325097$1$I$20240331$20240331$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00178$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243250981$24325098$1$I$20240401$20240401$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00182$BRAINTREE$$73$YR$$F$Y$46.259$KG$20240916$$CN$US$US
243250991$24325099$1$I$20240402$20240402$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00187$BRAINTREE$$35$YR$$F$Y$$$20240916$$CN$US$US
243251001$24325100$1$I$20240407$20240407$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00194$BRAINTREE$$23$YR$$F$Y$54.431$KG$20240916$$CN$US$US
243251011$24325101$1$I$20240417$20240417$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00226$BRAINTREE$$$$A$F$Y$$$20240916$$CN$US$US
243251021$24325102$1$I$20240424$20240424$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00241$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243251031$24325103$1$I$$20240425$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00247$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243251041$24325104$1$I$20240401$20240429$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00255$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243251051$24325105$1$I$20240430$20240430$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00260$BRAINTREE$$$$$M$Y$$$20240916$$CN$US$US
243251061$24325106$1$I$20240507$20240507$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00272$BRAINTREE$$$$A$M$Y$$$20240916$$CN$US$US
243251071$24325107$1$I$20231018$20231018$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00738$BRAINTREE$$52$YR$$F$Y$46.712$KG$20240916$$CN$US$US
243251081$24325108$1$I$20240410$20240411$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00207$BRAINTREE$$72$YR$$M$Y$68.027$KG$20240916$$CN$US$US
243251091$24325109$1$I$$20240517$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00297$BRAINTREE$$$$$$Y$$$20240916$$CN$US$US
243251101$24325110$1$I$20240522$20240522$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00304$BRAINTREE$$54$YR$$F$Y$95.254$KG$20240916$$CN$US$US
243251111$24325111$1$I$20240527$20240527$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00310$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243251121$24325112$1$I$20140101$20240605$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00332$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243251131$24325113$1$I$20240606$20240606$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00333$BRAINTREE$$$$A$F$Y$$$20240916$$CN$US$US
243251141$24325114$1$I$20240609$20240609$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00338$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243251151$24325115$1$I$$20240613$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00348$BRAINTREE$$$$A$M$Y$$$20240916$$CN$US$US
243251161$24325116$1$I$20240708$20240708$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00424$BRAINTREE$$$$$M$Y$$$20240916$$CN$US$US
243251171$24325117$1$I$20240205$20240206$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00074$BRAINTREE$$58$YR$$F$Y$65.76$KG$20240916$$CN$US$US
243251181$24325118$1$I$20240715$20240715$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00448$BRAINTREE$$74$YR$$M$Y$$$20240916$$CN$US$US
243251191$24325119$1$I$20240715$20240715$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00451$BRAINTREE$$$$A$F$Y$$$20240916$$CN$US$US
243251201$24325120$1$I$20231019$20231019$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00742$BRAINTREE$$60$YR$$F$Y$$$20240916$$CN$US$US
243251211$24325121$1$I$20231017$20231020$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00749$BRAINTREE$$$$E$M$Y$$$20240916$$CN$US$US
243251221$24325122$1$I$20231108$20231108$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00800$BRAINTREE$$65$YR$$M$Y$$$20240916$$CN$US$US
243251231$24325123$1$I$20200101$20231129$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00840$BRAINTREE$$$$$F$Y$53.061$KG$20240916$$CN$US$US
243251241$24325124$1$I$20220901$20231120$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00868$BRAINTREE$$$$$F$Y$70.295$KG$20240916$$CN$US$US
243251251$24325125$1$I$20231127$20231127$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00879$BRAINTREE$$47$YR$$F$Y$$$20240916$$CN$US$US
243251261$24325126$1$I$20231205$20231205$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00897$BRAINTREE$$$$A$F$Y$$$20240916$$CN$US$US
243251271$24325127$1$I$20240122$20240122$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00038$BRAINTREE$$65$YR$$F$Y$$$20240916$$CN$US$US
243251281$24325128$1$I$20220101$20231208$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00907$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243251291$24325129$1$I$20190101$20240119$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00034$BRAINTREE$$$$$F$Y$$$20240916$$CN$US$US
243251301$24325130$1$I$20240901$20240904$20240916$20240916$EXP$$AE-DSJP-DSJ-2024-144717$DAIICHI$$$$$F$Y$$$20240916$$CN$AE$AE
243251311$24325131$1$I$$20240912$20240916$20240916$PER$$US-ABBVIE-5925388$ABBVIE$$$$$$Y$$$20240916$$HP$US$US
243251321$24325132$1$I$20240327$20240909$20240916$20240916$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-143699$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240916$$HP$AU$AU
243251332$24325133$2$F$20240908$20240917$20240916$20240919$EXP$$NVSC2024IE080690$NOVARTIS$$$$$M$Y$$$20240919$$HP$IE$IE
243251341$24325134$1$I$$20240829$20240916$20240916$PER$$US-JNJFOC-20240880354$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240916$$CN$US$US
243251351$24325135$1$I$20240708$20240709$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00425$BRAINTREE$$82$YR$$M$Y$86.182$KG$20240916$$CN$US$US
243251362$24325136$2$F$$20240910$20240916$20240920$EXP$$GB-RDY-SPO/GBR/24/0013397$DR REDDYS$$39$YR$A$M$Y$$$20240920$$CN$GB$GB
243251372$24325137$2$F$$20240910$20240916$20240921$EXP$$NVSC2024AU184015$NOVARTIS$Harris K, Dalton B, Learmont BG, Isoardi KZ. Rationalising the dose threshold for severe carbamazepine toxicity: a retrospective series. CLINICAL TOXICOLOGY. 2024;62(8):533-5$21$YR$$$Y$$$20240921$$HP$AU$AU
243251381$24325138$1$I$20230301$20231122$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2023BTE00772$BRAINTREE$$53$YR$$M$Y$145.13$KG$20240916$$CN$US$US
243251391$24325139$1$I$20240115$20240115$20240916$20240916$PER$$US-BRAINTREE LABORATORIES, INC.-2024BTE00024$BRAINTREE$$50$YR$$F$Y$56.699$KG$20240916$$CN$US$US
243251401$24325140$1$I$$20240909$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144099$BRISTOL MYERS SQUIBB$Arif TB, Alabbas B, Vinayek R. Upper gastrointestinal bleeding due to metastatic lung adenocarcinoma in the stomach and duodenum. ACG Case Reports Journal. 2024 Aug 22;11(8):1-4. doi:10.14309/crj.0000000000001474.$79$YR$E$M$Y$$$20240916$$MD$US$US
243251421$24325142$1$I$20240910$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009253$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240916$$CN$US$US
243251431$24325143$1$I$$20240911$20240916$20240916$PER$$US-ABBVIE-5922457$ABBVIE$$$$$$Y$$$20240916$$CN$US$US
243251441$24325144$1$I$20240910$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409007340$ELI LILLY AND CO$$55$YR$A$$Y$$$20240916$$CN$US$US
243251461$24325146$1$I$20240101$20240912$20240916$20240916$PER$$US-IDORSIA-008330-2024-US$IDORSIA PHARMACEUTICALS$$$$$F$Y$$$20240916$$CN$US$US
243251471$24325147$1$I$20190101$20240913$20240916$20240916$EXP$$BG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051580$BOEHRINGER INGELHEIM$Asov S, Petrov N, Odiseeva E, Dobrev S. Patients with metformin intoxication and intensive care - what is the survival rate?. Anaesthesiology and intensive care. 2024 Sep 11;(2): 3-8.$$$$$Y$$$20240916$$MD$BG$BG
243251481$24325148$1$I$20240830$20240905$20240916$20240916$PER$$NVSC2024US179404$NOVARTIS$$17$YR$$F$Y$$$20240916$$CN$US$US
243251511$24325151$1$I$$20240912$20240916$20240916$PER$$NVSC2024US184658$NOVARTIS$$$$$F$Y$$$20240916$$CN$US$US
243251521$24325152$1$I$$20240914$20240916$20240916$PER$$NVSC2024US184532$NOVARTIS$$$$$$Y$$$20240916$$CN$US$US
243251531$24325153$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184840$NOVARTIS$$$$$$Y$$$20240916$$MD$US$US
243251543$24325154$3$F$20220901$20240913$20240916$20240925$EXP$$NVSC2024US181418$NOVARTIS$$80$YR$$F$Y$79.4$KG$20240925$$CN$US$US
243251551$24325155$1$I$$20240912$20240916$20240916$PER$$US-ABBVIE-5924208$ABBVIE$$$$$$Y$$$20240916$$MD$US$US
243251561$24325156$1$I$20240101$20240826$20240916$20240916$PER$$US-SA-2024SA266249$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240916$$MD$US$US
243251571$24325157$1$I$20240808$20240905$20240916$20240916$EXP$$CN-ROCHE-10000075669$ROCHE$$64$YR$A$F$Y$$$20240916$$CN$CN$CN
243251581$24325158$1$I$$20240826$20240916$20240916$PER$$US-SA-2024SA266118$SANOFI AVENTIS$$$$A$F$Y$77.27$KG$20240916$$MD$US$US
243251591$24325159$1$I$20240808$20240905$20240916$20240916$EXP$$CN-ROCHE-10000075627$ROCHE$$60$YR$A$M$Y$$$20240916$$CN$CN$CN
243251601$24325160$1$I$$20240910$20240916$20240916$PER$$NVSC2024US181916$NOVARTIS$$$$$$Y$$$20240916$$CN$US$US
243251611$24325161$1$I$20240909$20240909$20240916$20240916$PER$$US-BIOGEN-2024BI01282114$BIOGEN$$$$$$Y$$$20240916$$CN$US$US
243251621$24325162$1$I$20230801$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146538$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240916$$CN$US$US
243251631$24325163$1$I$20240724$20240909$20240916$20240916$EXP$$US-AMGEN-USASL2024179719$AMGEN$$80$YR$E$F$Y$$$20240916$$CN$US$US
243251641$24325164$1$I$$20240913$20240916$20240916$PER$$NVSC2024US184828$NOVARTIS$$$$$$Y$$$20240916$$PH$US$US
243251651$24325165$1$I$$20240911$20240916$20240916$EXP$$NVSC2024CA183250$NOVARTIS$$46$YR$$F$Y$$$20240916$$PH$CA$CA
243251661$24325166$1$I$$20240909$20240916$20240916$PER$$NVSC2024US181739$NOVARTIS$$$$$$Y$$$20240916$$CN$US$US
243251671$24325167$1$I$$20240827$20240916$20240916$PER$$US-SA-2024SA266099$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240916$$HP$US$US
243251681$24325168$1$I$$20240912$20240916$20240916$PER$$NVSC2024US184692$NOVARTIS$$$$$M$Y$$$20240917$$CN$US$US
243251692$24325169$2$F$20220101$20240918$20240916$20240920$EXP$$TW-009507513-2409TWN004371$MERCK$$86$YR$$F$Y$$$20240920$$MD$TW$TW
243251711$24325171$1$I$20240101$20240904$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002903$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240916$$CN$US$US
243251721$24325172$1$I$20240901$20240904$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003661$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240916$$CN$US$US
243251731$24325173$1$I$$20240904$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002925$ELI LILLY AND CO$$$$$M$Y$$$20240916$$CN$US$US
243251741$24325174$1$I$20240827$20240905$20240916$20240916$EXP$$CN-ROCHE-10000075589$ROCHE$$49$YR$A$F$Y$$$20240916$$CN$CN$CN
243251751$24325175$1$I$20231101$20240904$20240916$20240916$EXP$$US-ELI_LILLY_AND_COMPANY-US202409002923$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240916$$CN$US$US
243251761$24325176$1$I$$20240906$20240916$20240916$EXP$$CN-ROCHE-10000076417$ROCHE$$70$YR$E$M$Y$$$20240916$$CN$CN$CN
243251771$24325177$1$I$$20240903$20240916$20240916$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08895$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240916$$HP$US$US
243251781$24325178$1$I$$20240912$20240916$20240916$PER$$NVSC2024US184792$NOVARTIS$$$$$M$Y$$$20240917$$CN$US$US
243251791$24325179$1$I$$20240910$20240916$20240916$EXP$$NVSC2024AU184010$NOVARTIS$Harris K, Dalton B, Learmont BG, Isoardi K. Rationalising the dose threshold for severe carbamazepine toxicity: a retrospective series.. CLINICAL TOXICOLOGY. 2024;62 (8):533?5$15$YR$$$Y$$$20240917$$HP$AU$AU
243251801$24325180$1$I$20240813$20240911$20240916$20240916$EXP$FR-AFSSAPS-MP2024001369$FR-009507513-2409FRA004153$MERCK$$17$YR$$F$Y$$$20240916$$MD$FR$FR
243251811$24325181$1$I$20240830$20240906$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143004$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240916$$HP$US$US
243251821$24325182$1$I$20240826$20240909$20240916$20240916$EXP$CN-91110000556821568D-2024DRL001736$CN-RDY-SPO/CHN/24/0013372$DR REDDYS$$54$YR$A$F$Y$49$KG$20240916$$HP$CN$CN
243251831$24325183$1$I$$20240911$20240916$20240916$EXP$$NVSC2024CA183244$NOVARTIS$$42$YR$$F$Y$$$20240917$$HP$CA$CA
243251841$24325184$1$I$$20240910$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146535$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240916$$CN$US$US
243251851$24325185$1$I$$20240822$20240916$20240916$PER$$US-JNJFOC-20240935201$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$US$US
243251861$24325186$1$I$$20240911$20240916$20240916$EXP$$US-TAKEDA-2024TUS061015$TAKEDA$$$$$M$Y$66.213$KG$20240916$$HP$US$US
243251871$24325187$1$I$20240101$20240910$20240916$20240916$EXP$$JP-009507513-2407JPN003330J$MERCK$$7$DEC$$F$Y$$$20240916$$MD$JP$JP
243251881$24325188$1$I$$20240912$20240916$20240916$PER$$US-JNJFOC-20240933658$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240916$$PH$US$US
243251891$24325189$1$I$$20240828$20240916$20240916$PER$$US-SA-2024SA266120$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240917$$CN$US$US
243251901$24325190$1$I$$20240912$20240916$20240916$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09227$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240916$$CN$US$US
243251911$24325191$1$I$20240328$20240913$20240916$20240916$EXP$$US-TAKEDA-2024TUS092036$TAKEDA$$22$YR$$M$Y$$$20240916$$CN$US$US
243251921$24325192$1$I$20240910$20240910$20240916$20240916$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-146580$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240916$$MD$JP$JP
243251931$24325193$1$I$$20240910$20240916$20240916$EXP$$GB-BIOMARINAP-GB-2024-160475$BIOMARIN$$$$$$Y$$$20240916$$CN$GB$GB
243251941$24325194$1$I$$20240912$20240916$20240916$EXP$$AU-BIOMARINAP-AU-2024-160544$BIOMARIN$$$$$$Y$$$20240916$$CN$AU$AU
243251951$24325195$1$I$20240901$20240910$20240916$20240916$EXP$$JP-009507513-2409JPN001453J$MERCK$$8$DEC$$M$Y$$$20240916$$MD$JP$JP
243251961$24325196$1$I$20240912$20240912$20240916$20240916$EXP$$AR-BIOMARINAP-AR-2024-160572$BIOMARIN$$$$$$Y$$$20240916$$CN$AR$AR
243251971$24325197$1$I$$20240916$20240916$20240916$EXP$$AR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-049983$BOEHRINGER INGELHEIM$$84$YR$E$F$Y$$$20240916$$MD$AR$AR
243251981$24325198$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146929$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240916$$CN$US$US
243251991$24325199$1$I$20240821$20240911$20240916$20240916$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014972$JAZZ$$23$YR$$F$Y$$$20240916$$CN$US$US
243252001$24325200$1$I$$20240912$20240916$20240916$EXP$$GB-JNJFOC-20240939983$JOHNSON AND JOHNSON$$92$YR$E$F$Y$$$20240916$$CN$GB$GB
243252011$24325201$1$I$20240101$20240906$20240916$20240916$PER$$US-JNJFOC-20240919887$JOHNSON AND JOHNSON$$$$$M$Y$$$20240916$$CN$US$US
243252021$24325202$1$I$20240816$20240905$20240916$20240916$EXP$$CA-HLS-202402242$HLS THERAPEUTICS$$61$YR$A$F$Y$$$20240916$$PH$CA$CA
243252031$24325203$1$I$$20240912$20240916$20240916$EXP$$CA-JNJFOC-20240941226$JOHNSON AND JOHNSON$$$$$F$Y$$$20240916$$CN$CA$CA
243252042$24325204$2$F$20240912$20240916$20240916$20240925$EXP$$CA-HLS-202402322$HLS THERAPEUTICS$$37$YR$A$F$Y$$$20240925$$CN$CA$CA
243252051$24325205$1$I$20240817$20240913$20240916$20240916$EXP$$HR-JNJFOC-20240941243$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240916$$HP$HR$DE
243252061$24325206$1$I$$20240904$20240916$20240916$PER$$US-BIOMARINAP-US-2024-160403$BIOMARIN$Cooney E.,  Ammous Z., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024$$$$$Y$$$20240916$$MD$US$US
243252071$24325207$1$I$20240826$20240913$20240916$20240916$EXP$GB-MHRA-MED-202409131649470820-SDRLB$GB-JNJFOC-20240940325$JOHNSON AND JOHNSON$$81$YR$E$M$Y$95$KG$20240916$$HP$GB$GB
243252082$24325208$2$F$$20240924$20240916$20240926$EXP$$US-PURDUE PHARMA-USA-2024-0311993$PURDUE$$54$YR$$M$Y$$$20240926$$CN$US$US
243252091$24325209$1$I$20220101$20240913$20240916$20240916$EXP$$US-PURDUE PHARMA-USA-2024-0311975$PURDUE$$15$YR$$F$Y$$$20240917$$CN$US$US
243252101$24325210$1$I$20230101$20240910$20240916$20240916$EXP$$TR-PURDUE-USA-2024-0311998$PURDUE$Buyukkal U, Temelturk RD, Tekin D.. Acute Dystonic Reaction Following Methylphenidate Discontinuation During Combination Therapy with Risperidone: A Case Study. Journal of Ankara University Faculty of Medicine.. 2024;77 (2):222-6$6$YR$$M$Y$$$20240917$$HP$TR$TR
243252112$24325211$2$F$$20240911$20240916$20240920$PER$$US-JNJFOC-20240919555$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243252121$24325212$1$I$$20240913$20240916$20240916$EXP$$FR-JNJFOC-20240935582$JOHNSON AND JOHNSON$$68$YR$E$$Y$$$20240917$$MD$FR$FR
243252131$24325213$1$I$20240901$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146958$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240917$$CN$US$US
243252141$24325214$1$I$$20240909$20240916$20240916$EXP$$FR-AstraZeneca-2024A208402$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$FR$
243252151$24325215$1$I$$20240912$20240916$20240916$EXP$$PH-AstraZeneca-2024A208345$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$PH$
243252161$24325216$1$I$$20240913$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US080086$SANDOZ$$4$YR$$M$Y$$$20240916$$MD$US$US
243252171$24325217$1$I$$20240904$20240916$20240916$EXP$$JP-SMPA-2024SMP008026$SUNOVION$$$$$$Y$$$20240916$$CN$JP$JP
243252191$24325219$1$I$20140101$20240913$20240916$20240916$EXP$$PL-SANDOZ INC.-SDZ2024PL080199$SANDOZ$$44$YR$$F$Y$$$20240916$$MD$PL$PL
243252201$24325220$1$I$$20240911$20240916$20240916$EXP$$CA-SANDOZ INC.-SDZ2024CA079587$SANDOZ$$44$YR$$F$Y$$$20240916$$HP$CA$CA
243252211$24325221$1$I$20240714$20240913$20240916$20240916$EXP$FR-AFSSAPS-LL2024001723$FR-SANDOZ INC.-SDZ2024FR080116$SANDOZ$$85$YR$$M$Y$$$20240916$$MD$FR$FR
243252221$24325222$1$I$$20240911$20240916$20240916$EXP$$JP-TAKEDA-2024TJP013471$TAKEDA$$53$YR$$$Y$$$20240916$$MD$JP$JP
243252231$24325223$1$I$20240710$20240911$20240916$20240916$EXP$$CN-AstraZeneca-2024A209659$ASTRAZENECA$$71$YR$$M$Y$63$KG$20240917$$MD$CN$
243252251$24325225$1$I$20240101$20240910$20240916$20240916$PER$$US-AMGEN-USASP2024180732$AMGEN$$49$YR$A$M$Y$$$20240916$$CN$US$US
243252261$24325226$1$I$20240101$20240905$20240916$20240916$EXP$$US-JNJFOC-20240919697$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$PH$US$US
243252272$24325227$2$F$20240710$20240919$20240916$20240920$EXP$$JP-TAKEDA-2024TJP013504$TAKEDA$$66$YR$$F$Y$$$20240920$$MD$JP$JP
243252282$24325228$2$F$20240904$20240917$20240916$20240918$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051686$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240918$$CN$US$US
243252291$24325229$1$I$20240908$20240912$20240916$20240916$EXP$$US-AstraZeneca-2024A208637$ASTRAZENECA$$28837$DY$$M$Y$$$20240917$$HP$US$
243252301$24325230$1$I$20220510$20240912$20240916$20240916$EXP$$JP-TAKEDA-2024TJP013496$TAKEDA$$4$DEC$$M$Y$$$20240916$$MD$JP$JP
243252311$24325231$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024182628$AMGEN$$$$$$Y$$$20240916$$CN$US$US
243252331$24325233$1$I$20240517$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146168$BRISTOL MYERS SQUIBB$$86$YR$E$$Y$71.67$KG$20240917$$PH$US$US
243252341$24325234$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008468$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240916$$CN$US$US
243252351$24325235$1$I$$20240911$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US079981$SANDOZ$$$$$F$Y$$$20240916$$CN$US$US
243252361$24325236$1$I$$20240905$20240916$20240916$PER$$US-RDY-SPO/USA/24/0013040$DR REDDYS$$67$YR$E$M$Y$$$20240917$$HP$US$US
243252371$24325237$1$I$$20240906$20240916$20240916$EXP$$US-JNJFOC-20240920225$JOHNSON AND JOHNSON$$68$YR$E$F$Y$90.2$KG$20240917$$CN$US$US
243252381$24325238$1$I$20240601$20240909$20240916$20240916$EXP$$FR-AMGEN-FRASP2024183503$AMGEN$$56$YR$A$F$Y$58.6$KG$20240916$$MD$FR$FR
243252391$24325239$1$I$$20240907$20240916$20240916$EXP$$GB-JNJFOC-20240924094$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$MD$GB$GB
243252402$24325240$2$F$$20240913$20240916$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-146026$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240920$$MD$JP$JP
243252411$24325241$1$I$20220101$20240913$20240916$20240916$PER$$US-PURDUE PHARMA-USA-2024-0311974$PURDUE$$30$YR$$M$Y$$$20240917$$CN$US$US
243252421$24325242$1$I$$20240913$20240916$20240916$PER$$US-PURDUE PHARMA-USA-2024-0311989$PURDUE$$$$$M$Y$$$20240917$$CN$US$US
243252431$24325243$1$I$$20240913$20240916$20240916$PER$$US-PURDUE PHARMA-USA-2024-0311976$PURDUE$$63$YR$$F$Y$$$20240917$$CN$US$US
243252441$24325244$1$I$$20240913$20240916$20240916$PER$$US-PURDUE PHARMA-USA-2024-0311977$PURDUE$$33$YR$$M$Y$$$20240917$$CN$US$US
243252451$24325245$1$I$$20240911$20240916$20240916$EXP$$JP-TAKEDA-2023TJP014144$TAKEDA$$47$YR$$M$Y$$$20240916$$PH$JP$JP
243252461$24325246$1$I$$20240912$20240916$20240916$PER$$US-PURDUE PHARMA-USA-2024-0311973$PURDUE$$$$$F$Y$$$20240917$$CN$US$US
243252471$24325247$1$I$$20240916$20240916$20240916$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051690$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240917$$CN$US$US
243252481$24325248$1$I$20240701$20240901$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147097$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240917$$CN$US$US
243252492$24325249$2$F$20240911$20240911$20240916$20240918$EXP$$JP-SA-2024SA262859$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240919$$MD$JP$JP
243252501$24325250$1$I$20240824$20240911$20240916$20240916$EXP$$JP-TAKEDA-2024TJP013161$TAKEDA$$24$YR$$F$Y$$$20240916$$MD$JP$JP
243252512$24325251$2$F$20240907$20240917$20240916$20240923$PER$$US-AMGEN-USASP2024181044$AMGEN$$48$YR$A$M$Y$73.9$KG$20240923$$PH$US$US
243252521$24325252$1$I$$20240902$20240916$20240916$EXP$$TR-KVK-TECH, INC-20240900131$KVK-TECH$Ayseg?l Efe. A Rare Phenomenon, Recurrent Acute Dystonia after Withdrawal of ^Methylphenidate-immediate Release Form^: A Pediatric Case with ADHD. Clin Psychopharmacol Neurosci. 2024;22(3):544-549$$$$$Y$$$20240916$$HP$TR$TR
243252531$24325253$1$I$$20240902$20240916$20240916$EXP$$TR-KVK-TECH, INC-20240900132$KVK-TECH$Ayseg?l Efe. A Rare Phenomenon, Recurrent Acute Dystonia after Withdrawal of ^Methylphenidate-immediate Release Form^: A Pediatric Case with ADHD. Clin Psychopharmacol Neurosci. 2024;22(3):544-549$$$$$Y$$$20240916$$HP$TR$TR
243252541$24325254$1$I$$20240902$20240916$20240916$EXP$$TR-KVK-TECH, INC-20240900130$KVK-TECH$Ayseg?l Efe. A Rare Phenomenon, Recurrent Acute Dystonia after Withdrawal of ^Methylphenidate-immediate Release Form^: A Pediatric Case with ADHD. Clin Psychopharmacol Neurosci. 2024;22(3):544-549$$$$$Y$$$20240916$$HP$TR$TR
243252551$24325255$1$I$$20240902$20240916$20240916$EXP$$US-KVK-TECH, INC-20240900129$KVK-TECH$Jeremy Liu. Branch retinal artery occlusion in a 49-year-Old woman taking phentermine. Am J Ophthalmol Case Rep.. 2024;35:102013$$$$$Y$$$20240916$$HP$US$US
243252561$24325256$1$I$20240101$20240905$20240916$20240916$EXP$$NL-ABBVIE-5907921$ABBVIE$$$$E$F$Y$$$20240916$$HP$NL$NL
243252571$24325257$1$I$20230101$20240913$20240916$20240916$EXP$$CA-ABBVIE-5924449$ABBVIE$$$$E$M$Y$$$20240916$$CN$CA$CA
243252581$24325258$1$I$20240905$20240905$20240916$20240916$PER$$US-ABBVIE-5916672$ABBVIE$$46$YR$$M$Y$64.41$KG$20240916$$MD$US$US
243252591$24325259$1$I$$20240909$20240916$20240916$PER$$US-JNJFOC-20240922125$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$CN$US$US
243252601$24325260$1$I$$20240911$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US079912$SANDOZ$$$$$$Y$$$20240916$$CN$US$US
243252611$24325261$1$I$20240425$20240912$20240916$20240916$30DAY$$IT-SANDOZ INC.-SDZ2024IT044482$SANDOZ$$13$YR$$M$Y$50$KG$20240916$$CN$IT$IT
243252621$24325262$1$I$$20240904$20240916$20240916$EXP$$GB-AMGEN-GBRSP2024184276$AMGEN$$70$YR$E$F$Y$$$20240916$$MD$GB$GB
243252631$24325263$1$I$20240801$20240910$20240916$20240916$EXP$$US-ABBVIE-5918712$ABBVIE$$71$YR$$M$Y$$$20240916$$CN$US$US
243252641$24325264$1$I$$20240910$20240916$20240916$EXP$$US-JNJFOC-20240925322$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$US$US
243252651$24325265$1$I$$20240912$20240916$20240916$PER$$US-ROCHE-10000081539$ROCHE$$$$E$F$Y$$$20240917$$CN$US$US
243252661$24325266$1$I$$20240913$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147075$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240917$$CN$US$US
243252671$24325267$1$I$20240906$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146641$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240917$$HP$US$US
243252681$24325268$1$I$$20240912$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US080481$SANDOZ$$$$$F$Y$$$20240916$$CN$US$US
243252691$24325269$1$I$$20240911$20240916$20240916$30DAY$$US-SANDOZ INC.-SDZ2024US079799$SANDOZ$$$$$F$Y$$$20240916$$CN$US$US
243252701$24325270$1$I$20240803$20240913$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147106$BRISTOL MYERS SQUIBB$$100$YR$E$F$Y$$$20240917$$CN$US$US
243252711$24325271$1$I$20240801$20240904$20240916$20240916$30DAY$$AT-AMGEN-AUTSP2024177625$AMGEN$$$$$$Y$$$20240916$$CN$AT$AT
243252721$24325272$1$I$20240912$20240912$20240916$20240916$EXP$$US-JNJFOC-20240938161$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240917$$HP$US$US
243252732$24325273$2$F$$20240917$20240916$20240917$EXP$$CI-BRISTOL-MYERS SQUIBB COMPANY-2024-147071$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240918$$MD$CI$CI
243252741$24325274$1$I$$20240913$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146841$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240917$$HP$US$US
243252751$24325275$1$I$20240902$20240909$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409005499$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240916$$CN$US$US
243252761$24325276$1$I$$20240913$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US080419$SANDOZ$$$$$F$Y$$$20240916$$HP$US$US
243252771$24325277$1$I$$20240909$20240916$20240916$EXP$$CO-AMGEN-COLSP2024182619$AMGEN$$$$$$Y$$$20240916$$CN$CO$CO
243252791$24325279$1$I$20240601$20240912$20240916$20240916$EXP$$GB-JNJFOC-20240932290$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240917$$CN$GB$GB
243252801$24325280$1$I$$20240909$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146404$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240917$$CN$US$US
243252811$24325281$1$I$20230101$20240909$20240916$20240916$EXP$$US-ABBVIE-5920130$ABBVIE$$$$$M$Y$113.4$KG$20240916$$CN$US$US
243252821$24325282$1$I$$20240913$20240916$20240916$EXP$$CA-ROCHE-10000082574$ROCHE$$$$A$M$Y$$$20240917$$CN$CA$CA
243252831$24325283$1$I$$20240911$20240916$20240916$EXP$$NVSJ2024JP010875$NOVARTIS$$88$YR$$F$Y$$$20240917$$MD$JP$JP
243252841$24325284$1$I$20240101$20240911$20240916$20240916$EXP$$CA-ABBVIE-5921488$ABBVIE$$85$YR$$M$Y$$$20240916$$CN$CA$CA
243252861$24325286$1$I$$20240913$20240916$20240916$EXP$$GB-ROCHE-10000081968$ROCHE$$32$YR$A$F$Y$$$20240917$$HP$GB$GB
243252871$24325287$1$I$20240912$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009153$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240916$$CN$US$US
243252881$24325288$1$I$20240801$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008321$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240916$$CN$US$US
243252891$24325289$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008205$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240916$$CN$US$US
243252901$24325290$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183352$AMGEN$$$$$F$Y$$$20240916$$CN$US$US
243252911$24325291$1$I$$20240913$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409009612$ELI LILLY AND CO$$20$YR$A$M$Y$$$20240916$$CN$US$US
243252921$24325292$1$I$$20240827$20240916$20240916$PER$$US-SA-2024SA265998$SANOFI AVENTIS$$$$C$F$Y$$$20240917$$MD$US$US
243252931$24325293$1$I$20240101$20240905$20240916$20240916$EXP$$GB-ABBVIE-5923396$ABBVIE$$52$YR$$F$Y$$$20240916$$CN$GB$GB
243252941$24325294$1$I$$20240911$20240916$20240916$EXP$$JP-TAKEDA-2024TJP013481$TAKEDA$$73$YR$$$Y$$$20240916$$MD$JP$JP
243252951$24325295$1$I$20230101$20240909$20240916$20240916$EXP$$US-BIOGEN-2024BI01248668$BIOGEN$$$$$F$Y$$$20240916$$CN$US$US
243252961$24325296$1$I$$20240909$20240916$20240916$PER$$US-SA-2024SA265642$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240917$$HP$US$US
243252971$24325297$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207920$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243252981$24325298$1$I$$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024184063$AMGEN$$$$$F$Y$$$20240916$$HP$US$US
243253001$24325300$1$I$20240701$20240910$20240916$20240916$EXP$$US-ABBVIE-5918904$ABBVIE$$40$YR$$F$Y$$$20240916$$CN$US$US
243253011$24325301$1$I$20240522$20240908$20240916$20240916$EXP$$CZ-BIOGEN-2024BI01281905$BIOGEN$$40$YR$$F$Y$$$20240916$$MD$CZ$CZ
243253021$24325302$1$I$20240701$20240911$20240916$20240916$EXP$$US-ABBVIE-5921512$ABBVIE$$31$YR$$F$Y$$$20240916$$CN$US$US
243253031$24325303$1$I$$20240910$20240916$20240916$EXP$$US-ABBVIE-5917614$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243253041$24325304$1$I$20240916$20240916$20240916$20240916$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051702$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240917$$CN$US$US
243253071$24325307$1$I$$20240911$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008507$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240916$$CN$US$US
243253081$24325308$1$I$20240818$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146768$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$89.36$KG$20240917$$CN$US$US
243253091$24325309$1$I$$20240910$20240916$20240916$EXP$$US-ABBVIE-5918770$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243253101$24325310$1$I$20160101$20240911$20240916$20240916$EXP$$US-ABBVIE-5920829$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243253111$24325311$1$I$$20240910$20240916$20240916$EXP$$US-ABBVIE-5919101$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243253121$24325312$1$I$20240910$20240910$20240916$20240916$EXP$$CA-ABBVIE-5918949$ABBVIE$$$$A$M$Y$$$20240916$$CN$CA$CA
243253141$24325314$1$I$$20240908$20240916$20240916$EXP$$TR-JNJFOC-20240934160$JOHNSON AND JOHNSON$$9$YR$C$$Y$$$20240917$$HP$TR$TR
243253151$24325315$1$I$20240101$20240910$20240916$20240916$EXP$$US-ABBVIE-5917921$ABBVIE$$$$$$Y$$$20240916$$HP$US$US
243253161$24325316$1$I$20240419$20240909$20240916$20240916$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-144365$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240917$$CN$AU$AU
243253171$24325317$1$I$$20240909$20240916$20240916$EXP$$ES-SANDOZ INC.-NVSC2019ES085256$SANDOZ$$56$YR$$F$Y$$$20240916$$MD$ES$ES
243253181$24325318$1$I$$20240909$20240916$20240916$EXP$$JP-ROCHE-10000081430$ROCHE$Kojima K, Uchida T, Otsuka M, Tsuji Y, Shimizu T, Fukui S. S2-1-5 Two case reports in which insufficient effect was noted and chronic myelomonocytic leukaemia was found during treatment for aortitis syndrome. The 68th Meeting of Kyushu College of Rheumatology. 2024;77.$48$YR$A$F$Y$$$20240917$$MD$JP$JP
243253191$24325319$1$I$$20240908$20240916$20240916$EXP$$US-ABBVIE-5925486$ABBVIE$Mircea A, Filimon S, Fradley MG, Donisan T. Transforming cardio-oncology care with wearable technology-using smartwatches tomonitor for arrhythmias in vulnerable patient populations. Heart Rhythm. S799.$73$YR$$M$Y$$$20240916$$HP$US$US
243253201$24325320$1$I$$20240910$20240916$20240916$EXP$$US-ABBVIE-5919624$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243253212$24325321$2$F$20240701$20240918$20240916$20240924$EXP$$US-ABBVIE-5918711$ABBVIE$$65$YR$$M$Y$$$20240924$$CN$US$US
243253221$24325322$1$I$20240701$20240910$20240916$20240916$EXP$$US-ABBVIE-5918187$ABBVIE$$63$YR$$M$Y$$$20240916$$CN$US$US
243253231$24325323$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5920600$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243253251$24325325$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5920863$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243253261$24325326$1$I$20240912$20240912$20240916$20240916$PER$$US-AMGEN-USASP2024183274$AMGEN$$59$YR$A$F$Y$$$20240916$$CN$US$US
243253271$24325327$1$I$$20240909$20240916$20240916$EXP$$JP-ROCHE-10000081588$ROCHE$Kojima K, Uchida T, Otsuka, M, Tsuji Y, Shimizu T, et al. S2-1-5 Two case reports in which insufficient effect was noted and chronic myelomonocytic leukaemia was found during treatment for aortitis syndrome. The 68th Meeting of Kyushu College of Rheumatology. 2024;77.$75$YR$E$M$Y$$$20240917$$MD$JP$JP
243253292$24325329$2$F$20240912$20240915$20240916$20240923$EXP$$CA-JNJFOC-20240939060$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240923$$HP$CA$CA
243253311$24325331$1$I$20240906$20240910$20240916$20240916$PER$$US-SA-2024SA264839$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240917$$CN$US$US
243253321$24325332$1$I$20240908$20240910$20240916$20240916$EXP$$US-ABBVIE-5918159$ABBVIE$$51$YR$$M$Y$$$20240916$$CN$US$US
243253331$24325333$1$I$20240101$20240910$20240916$20240916$EXP$$US-ABBVIE-5917514$ABBVIE$$86$YR$$M$Y$$$20240916$$CN$US$US
243253341$24325334$1$I$20240901$20240910$20240916$20240916$EXP$$US-ABBVIE-5917820$ABBVIE$$72$YR$$F$Y$$$20240916$$CN$US$US
243253371$24325337$1$I$$20240910$20240916$20240916$EXP$$US-ABBVIE-5918957$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243253381$24325338$1$I$20240101$20240911$20240916$20240916$EXP$$GB-ABBVIE-5921491$ABBVIE$$38$YR$$M$Y$$$20240916$$CN$GB$GB
243253391$24325339$1$I$$20240911$20240916$20240916$EXP$$CA-ABBVIE-5920540$ABBVIE$$$$E$F$Y$$$20240916$$CN$CA$CA
243253402$24325340$2$F$20230301$20240917$20240916$20240920$EXP$$US-ABBVIE-5920654$ABBVIE$$56$YR$$F$Y$105.68$KG$20240920$$CN$US$US
243253411$24325341$1$I$$20240912$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146722$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240917$$CN$US$US
243253421$24325342$1$I$20240803$20240913$20240916$20240916$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146765$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240917$$HP$US$US
243253431$24325343$1$I$$20240910$20240916$20240916$EXP$$JP-009507513-2409JPN001655J$MERCK$$$$$F$Y$$$20240916$$MD$JP$JP
243253441$24325344$1$I$20231106$20240911$20240916$20240916$EXP$$US-ABBVIE-5830329$ABBVIE$$37$YR$$M$Y$$$20240916$$HP$US$US
243253451$24325345$1$I$$20240912$20240916$20240916$EXP$$IN-PFIZER INC-PV202400077770$PFIZER$$49$YR$$F$Y$$$20240916$$CN$IN$IN
243253462$24325346$2$F$20240821$20240926$20240916$20240930$EXP$FR-AFSSAPS-BX2024001752$FR-PFIZER INC-202400255091$PFIZER$$69$YR$$F$Y$58$KG$20240930$$PH$FR$FR
243253471$24325347$1$I$$20240909$20240916$20240916$PER$$US-AMGEN-USASP2024182519$AMGEN$Look-why S.; Otto T.S.; Chen X.S. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91 (3):AB354$$$$$Y$$$20240916$$MD$US$US
243253481$24325348$1$I$20240803$20240912$20240916$20240916$EXP$FR-AFSSAPS-LL2024001722$FR-PFIZER INC-202400255127$PFIZER$$63$YR$$M$Y$$$20240916$$PH$FR$FR
243253492$24325349$2$F$20240801$20240918$20240916$20240923$EXP$$US-ABBVIE-5917660$ABBVIE$$73$YR$$F$Y$81$KG$20240923$$CN$US$US
243253501$24325350$1$I$$20231116$20240916$20240916$PER$$US-KVK-TECH, INC-20231100152$KVK-TECH$$$$$F$Y$$$20240916$$CN$US$US
243253511$24325351$1$I$$20231113$20240916$20240916$PER$$US-KVK-TECH, INC-20231100151$KVK-TECH$$60$YR$$F$Y$58.05$KG$20240916$$CN$US$US
243253521$24325352$1$I$$20231120$20240916$20240916$PER$$US-KVK-TECH, INC-20231100153$KVK-TECH$$$$$F$Y$$$20240916$$CN$US$US
243253531$24325353$1$I$20231101$20231121$20240916$20240916$PER$$US-KVK-TECH, INC-20231100154$KVK-TECH$$$$$M$Y$$$20240916$$CN$US$US
243253541$24325354$1$I$20230801$20231207$20240916$20240916$PER$$US-KVK-TECH, INC-20231200160$KVK-TECH$$64$YR$$F$Y$71.655$KG$20240916$$CN$US$US
243253551$24325355$1$I$$20231218$20240916$20240916$PER$$US-KVK-TECH, INC-20231200164$KVK-TECH$$$$$M$Y$$$20240916$$CN$US$US
243253561$24325356$1$I$$20240116$20240916$20240916$PER$$US-KVK-TECH, INC-20240100006$KVK-TECH$$$$$$Y$$$20240916$$CN$US$US
243253571$24325357$1$I$20230101$20240122$20240916$20240916$PER$$US-KVK-TECH, INC-20240100008$KVK-TECH$$65$YR$$F$Y$$$20240916$$CN$US$US
243253581$24325358$1$I$20240129$20240216$20240916$20240916$PER$$US-KVK-TECH, INC-20240200019$KVK-TECH$$$$$M$Y$$$20240916$$CN$US$US
243253591$24325359$1$I$$20240617$20240916$20240916$PER$$US-KVK-TECH, INC-20240600077$KVK-TECH$$$$$$Y$$$20240916$$CN$US$US
243253601$24325360$1$I$$20240707$20240916$20240916$PER$$US-KVK-TECH, INC-20240700088$KVK-TECH$$$$$F$Y$$$20240916$$CN$US$US
243253611$24325361$1$I$20240601$20240722$20240916$20240916$PER$$US-KVK-TECH, INC-20240600082$KVK-TECH$$56$YR$$F$Y$$$20240916$$CN$US$US
243253621$24325362$1$I$20240101$20240812$20240916$20240916$PER$$US-KVK-TECH, INC-20240800103$KVK-TECH$$$$$$Y$$$20240916$$CN$US$US
243253631$24325363$1$I$$20240829$20240916$20240916$PER$$US-KVK-TECH, INC-20240900128$KVK-TECH$$$$$$Y$$$20240916$$PH$US$US
243253641$24325364$1$I$20240501$20240520$20240916$20240916$PER$$US-KVK-TECH, INC-20240500047$KVK-TECH$$71$YR$$M$Y$$$20240916$$CN$US$US
243253651$24325365$1$I$20230901$20230929$20240916$20240916$PER$$US-KVK-TECH, INC-20231000135$KVK-TECH$$$$$$Y$$$20240916$$CN$US$US
243253661$24325366$1$I$20230101$20231012$20240916$20240916$PER$$US-KVK-TECH, INC-20231000136$KVK-TECH$$$$$$Y$$$20240916$$HP$US$US
243253671$24325367$1$I$$20231006$20240916$20240916$PER$$US-KVK-TECH, INC-20231000137$KVK-TECH$$$$$$Y$$$20240916$$CN$US$US
243253681$24325368$1$I$20240118$20240126$20240916$20240916$PER$$US-KVK-TECH, INC-20240100010$KVK-TECH$$70$YR$$M$Y$117.91$KG$20240916$$CN$US$US
243253691$24325369$1$I$$20231009$20240916$20240916$PER$$US-KVK-TECH, INC-20231000138$KVK-TECH$$$$$$Y$$$20240916$$CN$US$US
243253701$24325370$1$I$$20231106$20240916$20240916$PER$$US-KVK-TECH, INC-20231100146$KVK-TECH$$$$$$Y$$$20240916$$CN$US$US
243253711$24325371$1$I$$20231111$20240916$20240916$PER$$US-KVK-TECH, INC-20231100150$KVK-TECH$$$$$F$Y$$$20240916$$CN$US$US
243253721$24325372$1$I$20240101$20240606$20240916$20240916$PER$$US-KVK-TECH, INC-20240300021$KVK-TECH$$35$YR$$F$Y$90.703$KG$20240916$$CN$US$US
243253731$24325373$1$I$$20240304$20240916$20240916$PER$$US-KVK-TECH, INC-20240300023$KVK-TECH$$$$$F$Y$$$20240916$$CN$US$US
243253741$24325374$1$I$$20240327$20240916$20240916$PER$$US-KVK-TECH, INC-20240300030$KVK-TECH$$$$$$Y$$$20240916$$CN$US$US
243253751$24325375$1$I$20240101$20240409$20240916$20240916$PER$$US-KVK-TECH, INC-20240400031$KVK-TECH$$38$YR$$M$Y$81.633$KG$20240916$$CN$US$US
243253761$24325376$1$I$20240417$20240507$20240916$20240916$PER$$US-KVK-TECH, INC-20240400034$KVK-TECH$$36$YR$$F$Y$53.515$KG$20240916$$CN$US$US
243253771$24325377$1$I$20240401$20240509$20240916$20240916$PER$$US-KVK-TECH, INC-20240500043$KVK-TECH$$46$YR$$M$Y$90.703$KG$20240916$$CN$US$US
243253781$24325378$1$I$20240301$20240611$20240916$20240916$PER$$US-KVK-TECH, INC-20240500044$KVK-TECH$$$$$$Y$$$20240916$$CN$US$US
243253791$24325379$1$I$20240826$20240910$20240916$20240916$EXP$$US-ABBVIE-5918924$ABBVIE$$78$YR$$F$Y$$$20240916$$CN$US$US
243253801$24325380$1$I$20240801$20240910$20240916$20240916$EXP$$US-ABBVIE-5919512$ABBVIE$$68$YR$$M$Y$$$20240916$$CN$US$US
243253821$24325382$1$I$$20240903$20240916$20240916$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-26940$SAMSUNG BIOEPIS$$65$YR$E$M$Y$$$20240917$$CN$GB$GB
243253831$24325383$1$I$20240101$20240910$20240916$20240916$EXP$$US-ABBVIE-5844047$ABBVIE$$$$$F$Y$$$20240916$$CN$US$US
243253841$24325384$1$I$$20240916$20240916$20240916$EXP$$CA-ORGANON-O2409CAN001009$ORGANON$$71$YR$$M$Y$77$KG$20240916$$PH$CA$CA
243253851$24325385$1$I$20240101$20240910$20240916$20240916$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR000842$CURRAX PHARMACEUTICALS$$$$$M$Y$142.86$KG$20240917$$CN$CA$CA
243253861$24325386$1$I$20240820$20240823$20240916$20240916$PER$$US-KVK-TECH, INC-20240800110$KVK-TECH$$$$$M$Y$81.633$KG$20240916$$CN$US$US
243253871$24325387$1$I$20240222$20240606$20240916$20240916$PER$$US-KVK-TECH, INC-20240300022$KVK-TECH$$56$YR$$M$Y$90.703$KG$20240916$$CN$US$US
243253881$24325388$1$I$$20240911$20240916$20240916$EXP$$US-AstraZeneca-2024A207693$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243253891$24325389$1$I$$20240912$20240916$20240916$EXP$$VN-AstraZeneca-2024A209700$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$VN$
243253901$24325390$1$I$20230901$20230914$20240916$20240916$PER$$US-KVK-TECH, INC-20230900131$KVK-TECH$$$$$$Y$$$20240916$$CN$US$US
243253911$24325391$1$I$20240101$20240702$20240916$20240916$PER$$US-KVK-TECH, INC-20240500036$KVK-TECH$$29$YR$$F$Y$90.703$KG$20240916$$CN$US$US
243253931$24325393$1$I$$20240912$20240916$20240916$PER$$US-ELI_LILLY_AND_COMPANY-US202409008276$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240916$$CN$US$US
243253941$24325394$1$I$$20240904$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146672$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$81.9$KG$20240917$$HP$US$US
243253951$24325395$1$I$$20240912$20240916$20240916$30DAY$$US-SANDOZ INC.-SDZ2024US080010$SANDOZ$$$$$F$Y$$$20240916$$CN$US$US
243253961$24325396$1$I$20240101$20240911$20240916$20240916$EXP$$CA-ABBVIE-5920579$ABBVIE$$60$YR$$M$Y$$$20240916$$CN$CA$CA
243253971$24325397$1$I$$20240911$20240916$20240916$EXP$$CA-ABBVIE-5923591$ABBVIE$$$$E$M$Y$$$20240916$$CN$CA$CA
243253981$24325398$1$I$$20240913$20240916$20240916$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147219$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240917$$CN$US$US
243253991$24325399$1$I$$20240909$20240916$20240916$EXP$$JP-ASTELLAS-2024JP004503$ASTELLAS$$83$YR$E$F$Y$$$20240917$$MD$JP$JP
243254001$24325400$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5920868$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243254011$24325401$1$I$$20240911$20240916$20240916$EXP$$US-ABBVIE-5920796$ABBVIE$$$$$M$Y$$$20240916$$CN$US$US
243254021$24325402$1$I$$20240910$20240916$20240916$EXP$$US-ABBVIE-5918405$ABBVIE$$$$$$Y$$$20240916$$CN$US$US
243254031$24325403$1$I$$20240909$20240916$20240916$EXP$$US-SANDOZ INC.-SDZ2024US080422$SANDOZ$$$$$F$Y$$$20240916$$CN$US$US
243254042$24325404$2$F$$20240916$20240916$20240919$EXP$$US-TAKEDA-2024TUS048208$TAKEDA$$$$$M$Y$$$20240919$$CN$US$US
243254051$24325405$1$I$$20240911$20240916$20240916$EXP$$JP-TAKEDA-2024TJP013487$TAKEDA$$52$YR$$$Y$$$20240916$$MD$JP$JP
243254061$24325406$1$I$20240101$20240906$20240916$20240916$EXP$$US-ETON PHARMACEUTICALS, INC-2024ETO000233$ETON PHARMACEUTICALS$$$$$$Y$$$20240916$$CN$US$US
243254071$24325407$1$I$$20240911$20240917$20240917$EXP$$AU-AstraZeneca-2024A208837$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$AU$
243254081$24325408$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A209990$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243254091$24325409$1$I$$20240909$20240917$20240917$EXP$$ZA-AstraZeneca-2024A207042$ASTRAZENECA$$73$YR$$M$Y$$$20240917$$CN$ZA$
243254101$24325410$1$I$$20240909$20240917$20240917$PER$$US-AstraZeneca-2024A210747$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243254111$24325411$1$I$$20240910$20240917$20240917$EXP$$PT-CHATTEMPRD-2024OHG031910$CHATTEM$$$$E$$Y$$$20240917$$HP$PT$PT
243254121$24325412$1$I$$20240912$20240917$20240917$EXP$$ZA-AstraZeneca-2024A209260$ASTRAZENECA$$69$YR$$F$Y$$$20240917$$CN$ZA$
243254131$24325413$1$I$$20240906$20240917$20240917$EXP$$JP-TAKEDA-2024TUS091428$TAKEDA$$7$DEC$$M$Y$$$20240917$$MD$JP$JP
243254141$24325414$1$I$20240824$20240911$20240917$20240917$EXP$$GB-CHATTEMPRD-2024OHG031751$CHATTEM$$68$YR$E$F$Y$100$KG$20240917$$HP$GB$GB
243254151$24325415$1$I$20240717$20240911$20240917$20240917$EXP$$US-ABBVIE-5921494$ABBVIE$$58$YR$$F$Y$$$20240917$$CN$US$US
243254161$24325416$1$I$20240101$20240911$20240917$20240917$EXP$$US-ABBVIE-5922060$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243254171$24325417$1$I$$20240904$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409004841$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240916$$CN$US$US
243254181$24325418$1$I$$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183218$AMGEN$$$$$F$Y$$$20240916$$PH$US$US
243254191$24325419$1$I$20240801$20240911$20240917$20240917$EXP$$GB-AMGEN-GBRSP2024184117$AMGEN$$73$YR$E$F$Y$$$20240916$$CN$GB$GB
243254211$24325421$1$I$20240905$20240912$20240917$20240917$EXP$$US-ABBVIE-5922491$ABBVIE$$57$YR$$F$Y$$$20240917$$CN$US$US
243254221$24325422$1$I$20240101$20240911$20240917$20240917$EXP$$AU-ABBVIE-5922187$ABBVIE$$$$$M$Y$$$20240917$$CN$AU$AU
243254232$24325423$2$F$$20240920$20240917$20240924$EXP$$GB-SANDOZ INC.-SDZ2024GB002115$SANDOZ$$$$$F$Y$$$20240924$$CN$GB$GB
243254242$24325424$2$F$20240911$20240925$20240917$20240927$EXP$$JP-TAKEDA-2024TJP013565$TAKEDA$$10$DEC$$M$Y$$$20240926$$PH$JP$JP
243254251$24325425$1$I$$20240912$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146887$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$HP$US$US
243254261$24325426$1$I$20240101$20240912$20240917$20240917$EXP$$US-ABBVIE-5922413$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243254271$24325427$1$I$20240801$20240911$20240917$20240917$EXP$$CA-ABBVIE-5921876$ABBVIE$$27$YR$$M$Y$$$20240917$$CN$CA$CA
243254281$24325428$1$I$20240115$20240905$20240917$20240917$EXP$$JP-ASTELLAS-2024JP000346$ASTELLAS$$9$DEC$E$M$Y$$$20240917$$MD$JP$JP
243254291$24325429$1$I$$20240909$20240917$20240917$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP011673$STRIDES$Kesav P, Vishnu VY, Khurana D.. Fatal disseminated neurobrucellosis.. QJM. 2014;107:321-3$59$YR$$M$Y$$$20240917$$HP$IN$IN
243254301$24325430$1$I$20240801$20240911$20240917$20240917$EXP$$US-ABBVIE-5921515$ABBVIE$$47$YR$$M$Y$$$20240917$$CN$US$US
243254311$24325431$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A208071$ASTRAZENECA$$$$$M$Y$$$20240917$$HP$US$
243254321$24325432$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A208107$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243254331$24325433$1$I$$20240909$20240917$20240917$EXP$$DE-AstraZeneca-2024A204222$ASTRAZENECA$$69$YR$$F$Y$$$20240917$$MD$DE$
243254341$24325434$1$I$$20240906$20240917$20240917$PER$$US-AstraZeneca-2024A204684$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243254351$24325435$1$I$$20240905$20240917$20240917$EXP$$GB-AMNEAL PHARMACEUTICALS-2024-AMRX-03345$AMNEAL$Hussan A, Hasan I, El-Hayani R, Zahra MS.. Simultaneous, Dual Continuous Venovenous Haemodiafiltration as Salvage Therapy for Severe Sodium Valproate Intoxication. Case Rep Crit Care.. 2024;2024(1):2712480 (1-5)$$$A$M$Y$60$KG$20240917$$HP$GB$GB
243254361$24325436$1$I$20240801$20240906$20240917$20240917$EXP$$CN-ASTELLAS-2024-AER-006973$ASTELLAS$$70$YR$E$M$Y$$$20240917$$MD$CN$CN
243254381$24325438$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS071711$TAKEDA$$$$$F$Y$$$20240917$$CN$US$US
243254391$24325439$1$I$20240901$20240912$20240917$20240917$EXP$$US-ABBVIE-5922959$ABBVIE$$41$YR$$F$Y$$$20240917$$CN$US$US
243254401$24325440$1$I$20240901$20240913$20240917$20240917$EXP$$US-ABBVIE-5925006$ABBVIE$$91$YR$$M$Y$$$20240917$$CN$US$US
243254421$24325442$1$I$$20240905$20240917$20240917$EXP$$BR-AMNEAL PHARMACEUTICALS-2024-AMRX-03339$AMNEAL$Cavalcante Neto P.M, Luz L.C, Pereira L.L, De Souza Y.A, Pereira A.D, et al.. Non-Eosinophilic Exudative Pleural Effusion Induced by Valproic Acid. Am. J. Respir. Crit. Care Med.. 2024;209$55$YR$$M$Y$$$20240917$$HP$BR$BR
243254431$24325443$1$I$$20240913$20240917$20240917$30DAY$$US-SANDOZ INC.-SDZ2024US080293$SANDOZ$$$$$$Y$$$20240917$$CN$US$US
243254441$24325444$1$I$$20240227$20240917$20240917$PER$$US-AUROBINDO-AUR-APL-2024-010749$AUROBINDO$$82$YR$$F$Y$86.1$KG$20240917$$CN$US$US
243254451$24325445$1$I$20230101$20240909$20240917$20240917$EXP$$AU-AMGEN-AUSSP2024179825$AMGEN$$79$YR$E$F$Y$$$20240916$$CN$AU$AU
243254461$24325446$1$I$20240601$20240821$20240917$20240917$PER$$US-SA-2024SA161898$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240917$$MD$US$US
243254472$24325447$2$F$$20240913$20240917$20240924$EXP$$DK-AMGEN-DNKSP2024165190$AMGEN$$12$MON$I$F$Y$11$KG$20240923$$HP$DK$DK
243254481$24325448$1$I$$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008849$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243254491$24325449$1$I$20240905$20240911$20240917$20240917$EXP$$CN-ROCHE-10000080100$ROCHE$$63$YR$A$F$Y$$$20240917$$HP$CN$CN
243254502$24325450$2$F$20240807$20240919$20240917$20240920$EXP$$JP-TAKEDA-2024TJP013572$TAKEDA$$3$DEC$$F$Y$$$20240920$$MD$JP$JP
243254512$24325451$2$F$20240517$20240923$20240917$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US057927$SANDOZ$$15$YR$$M$Y$$$20240926$$CN$US$US
243254531$24325453$1$I$20231201$20240909$20240917$20240917$EXP$$US-ABBVIE-5915836$ABBVIE$$54$YR$$F$Y$$$20240917$$CN$US$US
243254541$24325454$1$I$$20240909$20240917$20240917$EXP$$GB-AstraZeneca-2024A209689$ASTRAZENECA$$$$$M$Y$$$20240917$$HP$GB$
243254551$24325455$1$I$20240831$20240909$20240917$20240917$EXP$$CN-AstraZeneca-2024A209242$ASTRAZENECA$$2441$WK$$F$Y$48$KG$20240917$$MD$CN$
243254561$24325456$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A206912$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243254571$24325457$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A207710$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243254581$24325458$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922948$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243254591$24325459$1$I$$20240903$20240917$20240917$PER$$US-SA-2024SA263960$SANOFI AVENTIS$$$$A$M$Y$$$20240917$$HP$US$US
243254601$24325460$1$I$20080719$20240903$20240917$20240917$EXP$$US-ASTELLAS-2024-AER-004693$ASTELLAS$$79$YR$E$M$Y$$$20240917$$HP$US$US
243254612$24325461$2$F$20240101$20240920$20240917$20240923$EXP$$CA-ABBVIE-5921338$ABBVIE$$$$E$F$Y$$$20240923$$CN$CA$CA
243254621$24325462$1$I$20240911$20240911$20240917$20240917$EXP$$US-ABBVIE-5921570$ABBVIE$$52$YR$$M$Y$$$20240917$$CN$US$US
243254631$24325463$1$I$$20240829$20240917$20240917$PER$$US-TEVA-VS-3239123$TEVA$$17$YR$$F$Y$$$20240917$$CN$US$US
243254641$24325464$1$I$20240909$20240910$20240917$20240917$EXP$$US-ABBVIE-5918506$ABBVIE$$82$YR$$M$Y$$$20240917$$CN$US$US
243254651$24325465$1$I$$20240910$20240917$20240917$EXP$$US-CHATTEMPRD-2024OHG031671$CHATTEM$$$$A$F$Y$$$20240917$$CN$US$US
243254661$24325466$1$I$20210917$20240909$20240917$20240917$EXP$$US-CHATTEMPRD-2024OHG031611$CHATTEM$$$$$M$Y$$$20240917$$LW$US$US
243254671$24325467$1$I$20240101$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183192$AMGEN$$63$YR$A$F$Y$$$20240916$$MD$US$US
243254681$24325468$1$I$$20240916$20240917$20240917$EXP$$IT-SANDOZ INC.-SDZ2024IT080345$SANDOZ$$60$YR$$F$Y$$$20240917$$HP$IT$IT
243254691$24325469$1$I$$20240910$20240917$20240917$EXP$$US-ABBVIE-5918779$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243254701$24325470$1$I$20240815$20240911$20240917$20240917$EXP$DE-CADRBFARM-2024330319$DE-JNJFOC-20240938603$JOHNSON AND JOHNSON$$17$YR$T$M$Y$101$KG$20240917$$MD$DE$DE
243254712$24325471$2$F$20240801$20240916$20240917$20240921$EXP$$US-ABBVIE-5920632$ABBVIE$$69$YR$$F$Y$67.131$KG$20240921$$CN$US$US
243254731$24325473$1$I$20240912$20240912$20240917$20240917$EXP$$US-ABBVIE-5922630$ABBVIE$$44$YR$$F$Y$$$20240917$$CN$US$US
243254741$24325474$1$I$$20240911$20240917$20240917$EXP$$US-CHATTEMPRD-2024OHG031761$CHATTEM$$71$YR$E$M$Y$$$20240917$$LW$US$US
243254752$24325475$2$F$20240827$20240925$20240917$20240930$EXP$$US-ABBVIE-5918296$ABBVIE$$72$YR$$M$Y$76$KG$20240930$$CN$US$US
243254761$24325476$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024182563$AMGEN$Look-why S.; Otto T. S.; Chen S. X. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91(3):AB354$$$$$Y$$$20240916$$MD$US$US
243254783$24325478$3$F$20240101$20240923$20240917$20240927$EXP$$US-ABBVIE-5918962$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243254791$24325479$1$I$20240201$20240911$20240917$20240917$EXP$$US-ABBVIE-5919854$ABBVIE$$50$YR$$F$Y$$$20240917$$CN$US$US
243254801$24325480$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922031$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243254812$24325481$2$F$$20240914$20240917$20240918$EXP$$CH-AstraZeneca-2024A209790$ASTRAZENECA$$$$$$Y$$$20240918$$HP$CH$
243254821$24325482$1$I$20240801$20240910$20240917$20240917$PER$$US-SA-2024SA265757$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240917$$MD$US$US
243254831$24325483$1$I$$20240909$20240917$20240917$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP011723$STRIDES$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al.. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.. Liver-Int. 2024;44 (2):286-292$$$$$Y$$$20240917$$HP$ES$ES
243254841$24325484$1$I$$20240909$20240917$20240917$PER$$US-AstraZeneca-2024A205273$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243254851$24325485$1$I$$20240909$20240917$20240917$PER$$US-AstraZeneca-2024A210192$ASTRAZENECA$$75$YR$$M$Y$$$20240917$$CN$US$
243254871$24325487$1$I$$20240912$20240917$20240917$EXP$$ZA-AstraZeneca-2024A208763$ASTRAZENECA$$71$YR$$F$Y$$$20240917$$CN$ZA$
243254881$24325488$1$I$20240101$20240911$20240917$20240917$EXP$$CN-AMGEN-CHNSP2024181406$AMGEN$$71$YR$E$M$Y$$$20240916$$CN$CN$CN
243254891$24325489$1$I$$20240909$20240917$20240917$EXP$$AT-CELLTRION INC.-2024AT022053$CELLTRION$Moser J.. Extension of the therapy algorithm for HER2-positive metastatic gastric carcinoma. JATROS Hematology +amp; Oncology. 2023;23(02):48-51$$$$$Y$$$20240917$$MD$AT$AT
243254901$24325490$1$I$$20240912$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA080103$SANDOZ$$44$YR$$F$Y$$$20240917$$HP$CA$CA
243254912$24325491$2$F$20240901$20240917$20240917$20240920$EXP$$US-ABBVIE-5922114$ABBVIE$$62$YR$$F$Y$$$20240920$$CN$US$US
243254921$24325492$1$I$$20240909$20240917$20240917$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP011690$STRIDES$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al.. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.. Liver-Int. 2024;44 (2):286-292$$$$$Y$$$20240917$$HP$ES$ES
243254931$24325493$1$I$20240901$20240912$20240917$20240917$EXP$$US-ABBVIE-5922043$ABBVIE$$63$YR$$F$Y$$$20240917$$CN$US$US
243254941$24325494$1$I$20240911$20240912$20240917$20240917$EXP$$US-ABBVIE-5921980$ABBVIE$$62$YR$$M$Y$$$20240917$$CN$US$US
243254951$24325495$1$I$$20240913$20240917$20240917$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028943$UNITED THERAPEUTICS$$$$$M$Y$$$20240917$$$US$US
243254961$24325496$1$I$$20240913$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146954$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$67$KG$20240917$$CN$US$US
243254981$24325498$1$I$20240301$20240911$20240917$20240917$EXP$$US-ABBVIE-5892125$ABBVIE$$60$YR$$F$Y$72.121$KG$20240917$$CN$US$US
243254991$24325499$1$I$$20240909$20240917$20240917$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP011691$STRIDES$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al.. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.. Liver-Int. 2024;44 (2):286-292$$$$$Y$$$20240917$$HP$ES$ES
243255002$24325500$2$F$20240829$20240830$20240917$20240917$30DAY$$US-JNJFOC-20240882341$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240917$$PH$US$US
243255011$24325501$1$I$20240901$20240909$20240917$20240917$EXP$$FR-ABBVIE-5920406$ABBVIE$$77$YR$$F$Y$$$20240917$$MD$FR$FR
243255021$24325502$1$I$$20240910$20240917$20240917$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP011729$STRIDES$Morabad SS, Khan ZU, Gad R, Kallur N, Madhabhavi IV, Shalavadi MH, et al.,. Tongue and teeth hyperpigmentation in etoposide, prednisolone, vincristine, and cyclophosphamide regimen in the treatment of cutaneous lymphoma.. Indian Journal of Pharmacology. 2023;55(6):405-407$67$YR$$M$Y$$$20240917$$HP$IN$IN
243255031$24325503$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024181290$AMGEN$Chelius M.; Baron J.; Yegya-raman N. et al.. Radiation in Combination with Bispecific Therapy Does Not Suggest Excess Toxicity in B-Cell Lymphomas. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e614-e615$$$$$Y$$$20240916$$HP$US$US
243255042$24325504$2$F$$20240917$20240917$20240923$EXP$$US-ABBVIE-5922487$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243255051$24325505$1$I$20240905$20240908$20240917$20240917$PER$$US-RDY-SPO/USA/24/0013240$DR REDDYS$$28$YR$A$M$Y$$$20240917$$HP$US$US
243255061$24325506$1$I$20240816$20240909$20240917$20240917$EXP$$US-RDY-SPO/USA/24/0013242$DR REDDYS$$73$YR$E$F$Y$$$20240917$$HP$US$US
243255071$24325507$1$I$$20240911$20240917$20240917$EXP$$ES-ABBVIE-5921899$ABBVIE$$$$$M$Y$$$20240917$$HP$ES$ES
243255081$24325508$1$I$20240911$20240911$20240917$20240917$EXP$$US-ABBVIE-5922421$ABBVIE$$72$YR$$F$Y$$$20240917$$HP$US$US
243255091$24325509$1$I$$20240528$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002476$ENDO$$$$$F$Y$$$20240917$$CN$US$US
243255101$24325510$1$I$$20240528$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002489$ENDO$$$$$$Y$$$20240917$$CN$US$US
243255111$24325511$1$I$$20240521$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002407$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243255121$24325512$1$I$$20240514$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002241$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243255131$24325513$1$I$20240101$20240911$20240917$20240917$EXP$$CA-ABBVIE-5924402$ABBVIE$$41$YR$$$Y$$$20240917$$CN$CA$CA
243255141$24325514$1$I$20240801$20240904$20240917$20240917$PER$$US-SA-2024SA263201$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240917$$HP$US$US
243255151$24325515$1$I$$20240521$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002374$ENDO$$$$$F$Y$$$20240917$$CN$US$US
243255162$24325516$2$F$20240902$20240917$20240917$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005407$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240927$$CN$US$US
243255171$24325517$1$I$$20240326$20240917$20240917$PER$$US-ENDO USA, INC.-2024-001563$ENDO$$$$$M$Y$$$20240917$$LW$US$US
243255181$24325518$1$I$$20231219$20240917$20240917$PER$$US-ENDO USA, INC.-2024-001589$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243255191$24325519$1$I$$20240514$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002226$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243255201$24325520$1$I$$20240319$20240917$20240917$PER$$US-ENDO USA, INC.-2024-001463$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243255211$24325521$1$I$$20240702$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002871$ENDO$$$$$F$Y$$$20240917$$CN$US$US
243255231$24325523$1$I$$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024183784$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243255241$24325524$1$I$$20240911$20240917$20240917$EXP$$US-TAKEDA-2024TUS072898$TAKEDA$$$$$M$Y$$$20240917$$MD$US$US
243255252$24325525$2$F$20240101$20240917$20240917$20240926$EXP$$CA-ABBVIE-5897902$ABBVIE$$$$$F$Y$$$20240926$$HP$CA$CA
243255261$24325526$1$I$$20240514$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002230$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243255271$24325527$1$I$$20240514$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002242$ENDO$$$$$F$Y$$$20240917$$CN$US$US
243255281$24325528$1$I$$20240521$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002370$ENDO$$$$$F$Y$$$20240917$$CN$US$US
243255291$24325529$1$I$20240401$20240909$20240917$20240917$EXP$$US-ABBVIE-5856433$ABBVIE$$64$YR$$M$Y$$$20240917$$CN$US$US
243255301$24325530$1$I$20240912$20240913$20240917$20240917$EXP$$US-ABBVIE-5925021$ABBVIE$$37$YR$$F$Y$$$20240917$$CN$US$US
243255311$24325531$1$I$20240101$20240911$20240917$20240917$EXP$$CA-ABBVIE-5835115$ABBVIE$$84$YR$$F$Y$$$20240917$$HP$CA$CA
243255321$24325532$1$I$$20240911$20240917$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2024113029$VIIV$$$$$$Y$$$20240917$$CN$US$US
243255331$24325533$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5921495$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243255341$24325534$1$I$20240909$20240910$20240917$20240917$EXP$$JP-GSK-JP2024JPN112093$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$JP$JP
243255352$24325535$2$F$$20240918$20240917$20240920$EXP$$US-TAKEDA-2024TUS087506$TAKEDA$$$$$F$Y$$$20240920$$MD$US$US
243255361$24325536$1$I$$20240910$20240917$20240917$PER$$US-ABBVIE-5919504$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243255371$24325537$1$I$20240101$20240910$20240917$20240917$EXP$$US-ABBVIE-5919106$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243255381$24325538$1$I$$20240906$20240917$20240917$PER$$US-ABBVIE-5918791$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243255391$24325539$1$I$$20240909$20240917$20240917$EXP$$BR-AstraZeneca-2024A210011$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$BR$
243255401$24325540$1$I$20231218$20240909$20240917$20240917$EXP$$JP-GENMAB-2023-02442AA$GENMAB$$77$YR$$M$Y$$$20240917$$HP$JP$JP
243255411$24325541$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A209655$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243255421$24325542$1$I$$20240910$20240917$20240917$PER$$US-AstraZeneca-2024A209912$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$US$
243255431$24325543$1$I$20240101$20240910$20240917$20240917$EXP$$GB-ABBVIE-5920446$ABBVIE$$26$YR$$M$Y$$$20240917$$CN$GB$GB
243255441$24325544$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5921550$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243255451$24325545$1$I$$20240913$20240917$20240917$PER$$US-HALEON-2196927$Haleon PLC$$$$$$Y$$$20240917$$CN$US$US
243255461$24325546$1$I$$20240913$20240917$20240917$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051514$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240917$$CN$US$US
243255472$24325547$2$F$$20240913$20240917$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147040$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$110$KG$20240923$$CN$US$US
243255482$24325548$2$F$$20240917$20240917$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145244$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240925$$MD$JP$JP
243255491$24325549$1$I$$20240910$20240917$20240917$EXP$$US-ABBVIE-5919081$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243255501$24325550$1$I$$20240909$20240917$20240917$EXP$$GB-TAKEDA-2021TUS056546$TAKEDA$$$$$M$Y$$$20240917$$CN$GB$GB
243255511$24325551$1$I$20240213$20240913$20240917$20240917$EXP$GB-MHRA-MED-202409130956002900-GBVFD$GB-ORGANON-O2409GBR000988$ORGANON$$4$YR$$M$Y$$$20240917$$CN$GB$GB
243255521$24325552$1$I$20240801$20240910$20240917$20240917$PER$$US-SA-2024SA265656$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240917$$MD$US$US
243255531$24325553$1$I$20240101$20240911$20240917$20240917$EXP$$US-ABBVIE-5921519$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243255541$24325554$1$I$20240801$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009040$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240917$$CN$US$US
243255552$24325555$2$F$$20240918$20240917$20240923$EXP$$US-ABBVIE-5916966$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243255561$24325556$1$I$20240101$20240906$20240917$20240917$EXP$$US-ABBVIE-5917655$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243255571$24325557$1$I$20240909$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024182105$AMGEN$$33$YR$A$M$Y$$$20240916$$CN$US$US
243255591$24325559$1$I$20240812$20240913$20240917$20240917$EXP$$US-TAKEDA-2024TUS092127$TAKEDA$$51$YR$$F$Y$$$20240917$$MD$US$US
243255601$24325560$1$I$$20240712$20240917$20240917$30DAY$$NZ-ABBVIE-5925684$ABBVIE$$$$$$Y$$$20240917$$CN$NZ$NZ
243255622$24325562$2$F$20240701$20240913$20240917$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005332$ACADIA PHARMACEUTICALS$$16$YR$$M$Y$$$20240930$$CN$US$US
243255632$24325563$2$F$20240313$20240917$20240917$20240923$EXP$$US-ABBVIE-5922837$ABBVIE$$76$YR$$M$Y$$$20240923$$CN$US$US
243255641$24325564$1$I$$20240913$20240917$20240917$EXP$$US-ABBVIE-5925574$ABBVIE$$$$$F$Y$$$20240917$$HP$US$US
243255651$24325565$1$I$$20240913$20240917$20240917$EXP$$US-ABBVIE-5885482$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243255661$24325566$1$I$20240101$20240909$20240917$20240917$PER$$US-SA-2024SA265055$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240917$$HP$US$US
243255671$24325567$1$I$20240909$20240914$20240917$20240917$EXP$$CN-ROCHE-10000082214$ROCHE$$35$YR$A$F$Y$60$KG$20240917$$HP$CN$CN
243255681$24325568$1$I$20240101$20240911$20240917$20240917$EXP$$US-ABBVIE-5921567$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243255691$24325569$1$I$20240101$20240905$20240917$20240917$EXP$$CA-ABBVIE-5881494$ABBVIE$$45$YR$$F$Y$$$20240917$$CN$CA$CA
243255701$24325570$1$I$$20240909$20240917$20240917$EXP$$CA-JNJFOC-20240927959$JOHNSON AND JOHNSON$$$$$M$Y$1$KG$20240917$$CN$CA$CA
243255711$24325571$1$I$$20240910$20240917$20240917$PER$$US-LEO Pharma-373480$LEO PHARM$$30$YR$$F$Y$$$20240917$$PH$US$US
243255721$24325572$1$I$20240827$20240909$20240917$20240917$EXP$NO-NOMAADVRE-RELISV-2024-V6zgp6$NO-GE HEALTHCARE-2024CSU010357$GE HEALTHCARE$$73$YR$$F$Y$$$20240917$$MD$NO$NO
243255731$24325573$1$I$20240624$20240624$20240917$20240917$PER$$US-GE HEALTHCARE-2024CSU007098$GE HEALTHCARE$$44$YR$$M$Y$54.3$KG$20240917$$HP$US$US
243255741$24325574$1$I$20240911$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024182889$AMGEN$$$$$$Y$$$20240916$$PH$US$US
243255751$24325575$1$I$$20240823$20240917$20240917$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005013$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243255761$24325576$1$I$$20240913$20240917$20240917$EXP$$US-TAKEDA-2024TUS091840$TAKEDA$$$$$M$Y$$$20240917$$CN$US$US
243255771$24325577$1$I$20240101$20240910$20240917$20240917$EXP$$US-SA-2024SA264740$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240917$$MD$US$US
243255791$24325579$1$I$$20240911$20240917$20240917$PER$$US-LEO Pharma-373477$LEO PHARM$$27$YR$$F$Y$$$20240917$$CN$US$US
243255811$24325581$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A206538$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243255822$24325582$2$F$$20240913$20240917$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005258$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243255831$24325583$1$I$20231201$20240911$20240917$20240917$EXP$$US-ABBVIE-5922037$ABBVIE$$65$YR$$M$Y$$$20240917$$CN$US$US
243255851$24325585$1$I$20240830$20240913$20240917$20240917$EXP$$CO-ABBVIE-5907332$ABBVIE$$14$YR$$M$Y$50$KG$20240917$$CN$CO$CO
243255861$24325586$1$I$$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183173$AMGEN$$45$YR$A$F$Y$$$20240916$$HP$US$US
243255871$24325587$1$I$20240101$20240911$20240917$20240917$PER$$US-SA-2024SA265510$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240917$$MD$US$US
243255881$24325588$1$I$20240906$20240906$20240917$20240917$PER$$US-ABBVIE-5916281$ABBVIE$$66$YR$$F$Y$$$20240917$$CN$US$US
243255891$24325589$1$I$$20240908$20240917$20240917$EXP$$US-AMGEN-USASP2024181265$AMGEN$Patel P.; Prater J.; Baloch B. et al. Spectrum of thyroid disease in a single patient: A case of papillary thyroid carcinoma in a patient with Graves^disease and Hashimoto^s thyroiditis. Clinical case Reports. 2022;10 (9):1-6$65$YR$E$M$Y$$$20240916$$HP$US$US
243255901$24325590$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA264597$SANOFI AVENTIS$$$$A$F$Y$$$20240917$$CN$US$US
243255911$24325591$1$I$$20240909$20240917$20240917$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001326$ALEMBIC$Zou H, Rau A, Thompson L, Henderson D et.al. Pancytopenia Concurrent With Metabolic Encephalopathy. Cureus.. Cureus. 2024;16(8):e67963$$$$$Y$$$20240917$$MD$US$US
243255921$24325592$1$I$20240701$20240905$20240917$20240917$PER$$US-ABBVIE-5919193$ABBVIE$$62$YR$$F$Y$60$KG$20240917$$CN$US$US
243255932$24325593$2$F$$20240917$20240917$20240925$PER$$US-MTPC-MTDA2024-0019349$Unknown Manufacturer$$$$A$M$Y$$$20240925$$CN$US$US
243255942$24325594$2$F$$20240909$20240917$20240919$30DAY$$US-ELI_LILLY_AND_COMPANY-US202409009659$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243255952$24325595$2$F$$20240917$20240917$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009051$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240919$$CN$US$US
243255961$24325596$1$I$$20240905$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409004043$ELI LILLY AND CO$$53$YR$A$$Y$$$20240917$$LW$US$US
243255971$24325597$1$I$$20240909$20240917$20240917$EXP$$JP-SANDOZ INC.-SDZ2024JP079344$SANDOZ$Ebisawa K, Iwashita T, Uchiyama K , Kitayama Y, Takeuchi T. Epstein-Barr virus-positive mucocutaneous ulcer resulting in severe methotrexate intoxication: a case report. Journal of Medical Case Reports. 2024;18:409$9$DEC$$M$Y$$$20240917$$MD$JP$JP
243255981$24325598$1$I$$20240719$20240917$20240917$PER$$US-ROCHE-10000021357$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243256001$24325600$1$I$20240412$20240913$20240917$20240917$EXP$$JP-TAKEDA-2024TJP013571$TAKEDA$$81$YR$$F$Y$47$KG$20240917$$MD$JP$JP
243256011$24325601$1$I$$20240909$20240917$20240917$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028181$UNITED THERAPEUTICS$$$$C$F$Y$$$20240917$$$US$US
243256021$24325602$1$I$$20240911$20240917$20240917$EXP$$JP-AstraZeneca-2024A206745$ASTRAZENECA$Shimbu K., Hisakane K., Kadoma N., Nishima S., Atsumi K., Seike M., Hirose T.. Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six- Case Series. OncoTargets and Therapy 2024;17:717-726.$77$YR$$F$Y$$$20240917$$HP$JP$
243256031$24325603$1$I$$20240909$20240917$20240917$EXP$$ZA-AstraZeneca-2024A205353$ASTRAZENECA$$20454$DY$$F$Y$$$20240917$$CN$ZA$
243256041$24325604$1$I$$20240913$20240917$20240917$PER$$US-ALXN-202409USA001109US$ALEXION PHARMACEUTICALS$$$$$M$Y$169.62$KG$20240917$$CN$US$US
243256051$24325605$1$I$20240902$20240904$20240917$20240917$PER$$US-ROCHE-10000075360$ROCHE$$$$$F$Y$$$20240917$$CN$US$US
243256062$24325606$2$F$$20240913$20240917$20240919$PER$$US-ABBVIE-5924289$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243256072$24325607$2$F$$20240916$20240917$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146252$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$107.95$KG$20240920$$CN$US$US
243256081$24325608$1$I$$20240627$20240917$20240917$PER$$US-ROCHE-10000016342$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243256091$24325609$1$I$$20240911$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA079800$SANDOZ$$48$YR$$F$Y$$$20240917$$HP$CA$CA
243256101$24325610$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024182045$AMGEN$Look-why S.; Otto T. S.; Chen S. X. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91 (3):AB354$$$$$Y$$$20240916$$MD$US$US
243256111$24325611$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184334$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243256121$24325612$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024182039$AMGEN$Look-why S.; Otto T. S.; Chen S. X. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91 (3):AB354$$$$$Y$$$20240916$$MD$US$US
243256131$24325613$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_07205204$CA-Accord-445719$ACCORD$$42$YR$A$M$Y$$$20240917$$HP$CA$CA
243256141$24325614$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000081063$ROCHE$$$$T$F$Y$$$20240917$$CN$US$US
243256151$24325615$1$I$$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409051142525450-WZVKS$GB-Accord-445680$ACCORD$$$$$M$Y$$$20240917$$CN$GB$GB
243256161$24325616$1$I$20240901$20240910$20240917$20240917$EXP$$US-ABBVIE-5918941$ABBVIE$$51$YR$$F$Y$$$20240917$$CN$US$US
243256171$24325617$1$I$$20240625$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002825$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243256181$24325618$1$I$$20240912$20240917$20240917$EXP$$CA-TAKEDA-2024TUS091910$TAKEDA$$$$$M$Y$$$20240917$$CN$CA$CA
243256191$24325619$1$I$19890101$20240528$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002479$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243256201$24325620$1$I$20240101$20240910$20240917$20240917$EXP$$US-ABBVIE-5919076$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243256211$24325621$1$I$$20240528$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002500$ENDO$$$$$$Y$$$20240917$$CN$US$US
243256221$24325622$1$I$$20240528$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002470$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243256231$24325623$1$I$$20240904$20240917$20240917$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27329$SAMSUNG BIOEPIS$$27$YR$A$M$Y$$$20240917$$CN$CA$CA
243256241$24325624$1$I$$20240709$20240917$20240917$PER$$US-ENDO USA, INC.-2024-002934$ENDO$$$$$F$Y$$$20240917$$CN$US$US
243256251$24325625$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000081533$ROCHE$$53$YR$A$F$Y$$$20240917$$CN$US$US
243256261$24325626$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024182503$AMGEN$Look-why S.; Otto T. S.; Chen S. X. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91(3):AB354$$$$$Y$$$20240916$$MD$US$US
243256271$24325627$1$I$20240710$20240906$20240917$20240917$EXP$$CA-TAKEDA-2024TUS071554$TAKEDA$$30$YR$$F$Y$$$20240917$$HP$CA$CA
243256281$24325628$1$I$$20240905$20240917$20240917$EXP$$GB-NOVOPROD-1279385$NOVO NORDISK$$46$YR$$M$Y$$$20240917$$HP$GB$IQ
243256291$24325629$1$I$20240827$20240905$20240917$20240917$EXP$$GB-NOVOPROD-1279355$NOVO NORDISK$$49$YR$$F$Y$97$KG$20240917$$PH$GB$GB
243256311$24325631$1$I$$20240909$20240917$20240917$PER$$US-CHATTEMPRD-2024OHG031620$CHATTEM$$$$$M$Y$$$20240917$$CN$US$US
243256321$24325632$1$I$$20240903$20240917$20240917$EXP$$BR-NOVOPROD-1279493$NOVO NORDISK$$716$MON$$F$Y$$$20240917$$CN$BR$BR
243256331$24325633$1$I$$20240909$20240917$20240917$EXP$$US-ASTELLAS-2024-AER-006100$ASTELLAS$$74$YR$E$M$Y$$$20240917$$CN$US$US
243256341$24325634$1$I$$20231020$20240917$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-005558$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243256351$24325635$1$I$$20240123$20240917$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2024-000561$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243256361$24325636$1$I$$20240723$20240917$20240917$PER$$US-ENDO USA, INC.-2024-003045$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243256371$24325637$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000081707$ROCHE$$$$I$M$Y$9.7$KG$20240917$$CN$US$US
243256381$24325638$1$I$20240906$20240906$20240917$20240917$PER$$US-ROCHE-10000078014$ROCHE$$$$$$Y$$$20240917$$MD$US$US
243256391$24325639$1$I$$20240909$20240917$20240917$EXP$$AU-CELLTRION INC.-2024AU021863$CELLTRION$$$$$$Y$$$20240917$$MD$AU$AU
243256401$24325640$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A207455$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243256411$24325641$1$I$$20240910$20240917$20240917$PER$$US-CHATTEMPRD-2024OHG031641$CHATTEM$$$$$F$Y$$$20240917$$CN$US$US
243256421$24325642$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A206740$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243256432$24325643$2$F$$20240919$20240917$20240926$PER$$US-ROCHE-10000082795$ROCHE$$84$YR$E$F$Y$$$20240926$$CN$US$US
243256451$24325645$1$I$20210508$20240911$20240917$20240917$EXP$PL-URPL-DML-MLP.4401.1.5064.2021$PL-JNJFOC-20240939509$JOHNSON AND JOHNSON$$43$YR$A$F$Y$78$KG$20240917$$MD$PL$PL
243256461$24325646$1$I$20240216$20240905$20240917$20240917$EXP$$US-NOVOPROD-1280271$NOVO NORDISK$$61$YR$$F$Y$$$20240917$$CN$US$US
243256471$24325647$1$I$20240831$20240905$20240917$20240917$EXP$CN-NMPA-5201211531979202400052$CN-NOVOPROD-1280600$NOVO NORDISK$$41$YR$$M$Y$76.8$KG$20240917$$HP$CN$CN
243256481$24325648$1$I$20240825$20240905$20240917$20240917$EXP$CN-NMPA-5201011523869202400105$CN-NOVOPROD-1280594$NOVO NORDISK$$66$YR$$F$Y$75$KG$20240917$$HP$CN$CN
243256491$24325649$1$I$20240815$20240905$20240917$20240917$EXP$$SE-NOVOPROD-1279931$NOVO NORDISK$$42$YR$$F$Y$$$20240917$$CN$SE$SE
243256501$24325650$1$I$$20240905$20240917$20240917$EXP$$BR-NOVOPROD-1279954$NOVO NORDISK$$791$MON$$F$Y$$$20240917$$CN$BR$BR
243256511$24325651$1$I$20230901$20240905$20240917$20240917$EXP$$US-NOVOPROD-1280235$NOVO NORDISK$$61$YR$$M$Y$$$20240917$$CN$US$US
243256531$24325653$1$I$$20240905$20240917$20240917$EXP$$JP-NOVOPROD-1280119$NOVO NORDISK$$7$DEC$$F$Y$$$20240917$$MD$JP$JP
243256541$24325654$1$I$20240901$20240905$20240917$20240917$EXP$$US-NOVOPROD-1280030$NOVO NORDISK$$60$YR$$F$Y$$$20240917$$CN$US$US
243256561$24325656$1$I$$20240905$20240917$20240917$EXP$$US-NOVOPROD-1279519$NOVO NORDISK$$$$E$F$Y$$$20240917$$CN$US$US
243256581$24325658$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009047$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240917$$CN$US$US
243256591$24325659$1$I$$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008365$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243256601$24325660$1$I$$20240909$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409005843$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243256611$24325661$1$I$20240908$20240910$20240917$20240917$PER$$US-AMGEN-USASP2024181088$AMGEN$$89$YR$E$F$Y$$$20240916$$CN$US$US
243256621$24325662$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024182046$AMGEN$Look-why S.; Otto T. S.; Chen S. X. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91 (3):AB354$$$$$Y$$$20240916$$MD$US$US
243256631$24325663$1$I$$20231127$20240917$20240917$PER$$US-ENDO PHARMACEUTICALS INC-2023-005978$ENDO$$$$$$Y$$$20240917$$CN$US$US
243256641$24325664$1$I$$20240910$20240917$20240917$PER$$US-CHATTEMPRD-2024OHG031597$CHATTEM$$$$$F$Y$$$20240917$$CN$US$US
243256652$24325665$2$F$$20240910$20240917$20240927$PER$$US-CHATTEMPRD-2024OHG031690$CHATTEM$$$$$M$Y$$$20240927$$CN$US$US
243256661$24325666$1$I$$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409051515367150-DZBPM$GB-Accord-445437$ACCORD$$$$$M$Y$$$20240917$$HP$GB$GB
243256672$24325667$2$F$$20240910$20240917$20240919$PER$$US-CHATTEMPRD-2024OHG031700$CHATTEM$$$$$$Y$$$20240919$$CN$US$US
243256681$24325668$1$I$$20240905$20240917$20240917$EXP$$TR-NOVOPROD-1280619$NOVO NORDISK$$$$$F$Y$$$20240917$$CN$TR$TR
243256691$24325669$1$I$$20240910$20240917$20240917$PER$$US-CHATTEMPRD-2024OHG031578$CHATTEM$$$$$F$Y$$$20240917$$CN$US$US
243256701$24325670$1$I$$20240911$20240917$20240917$PER$$US-ROCHE-10000082329$ROCHE$$60$YR$A$F$Y$$$20240917$$CN$US$US
243256711$24325671$1$I$$20240910$20240917$20240917$PER$$US-ROCHE-10000082380$ROCHE$$7$YR$C$F$Y$$$20240917$$CN$US$US
243256721$24325672$1$I$$20240910$20240917$20240917$PER$$US-ROCHE-10000079172$ROCHE$$$$A$F$Y$$$20240917$$CN$US$US
243256731$24325673$1$I$$20240906$20240917$20240917$PER$$US-ROCHE-10000076816$ROCHE$$$$A$F$Y$$$20240917$$CN$US$US
243256741$24325674$1$I$$20240911$20240917$20240917$PER$$US-CHATTEMPRD-2024OHG031825$CHATTEM$$$$$M$Y$$$20240917$$CN$US$US
243256751$24325675$1$I$20240101$20240909$20240917$20240917$EXP$$CA-CELLTRION INC.-2024CA014022$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
243256761$24325676$1$I$$20240909$20240917$20240917$EXP$$CA-TAKEDA-2024TUS090395$TAKEDA$$$$$M$Y$$$20240917$$MD$CA$CA
243256771$24325677$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000081488$ROCHE$$53$YR$A$F$Y$$$20240917$$HP$US$US
243256781$24325678$1$I$$20240910$20240917$20240917$EXP$$HR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050472$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$$$20240917$$MD$HR$HR
243256793$24325679$3$F$20240701$20240920$20240917$20240930$PER$$US-ROCHE-10000077291$ROCHE$$72$YR$E$F$Y$70.31$KG$20240930$$CN$US$US
243256801$24325680$1$I$20240209$20240904$20240917$20240917$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-27116$SAMSUNG BIOEPIS$$67$YR$E$M$Y$$$20240917$$MD$DE$DE
243256812$24325681$2$F$20240910$20240912$20240917$20240920$PER$$US-CHATTEMPRD-2024OHG031740$CHATTEM$$$$$$Y$$$20240920$$CN$US$US
243256821$24325682$1$I$$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024182756$AMGEN$$$$$$Y$$$20240916$$PH$US$US
243256831$24325683$1$I$20240910$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024183946$AMGEN$$60$YR$A$F$Y$$$20240916$$CN$US$US
243256841$24325684$1$I$$20240909$20240917$20240917$EXP$$US-AMGEN-USASP2024184230$AMGEN$Lake K. E.; Jackson M.; All S. et al.. Ultra-Low-Dose Adaptive Radiotherapy and Single-Agent Rituximab for Indolent Non-Hodgkin Lymphomas- Where Less is More in Combined Modality Therapy. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e635-e636$$$$$Y$$$20240916$$HP$US$US
243256881$24325688$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000081796$ROCHE$$$$E$F$Y$$$20240917$$CN$US$US
243256892$24325689$2$F$20240101$20240918$20240917$20240925$EXP$$JP-GENMAB-2024-02076AA$GENMAB$$48$YR$$M$Y$$$20240925$$MD$JP$JP
243256901$24325690$1$I$$20240916$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147204$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240917$$CN$US$US
243256912$24325691$2$F$20240909$20240913$20240917$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005117$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240930$$CN$US$US
243256921$24325692$1$I$20231129$20240910$20240917$20240917$EXP$$CA-CELLTRION INC.-2024CA006627$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
243256931$24325693$1$I$$20240912$20240917$20240917$PER$$US-TAKEDA-2024TUS091512$TAKEDA$$$$$F$Y$$$20240917$$CN$US$US
243256941$24325694$1$I$20240902$20240911$20240917$20240917$EXP$$CA-ROCHE-10000080856$ROCHE$$60$YR$A$F$Y$$$20240917$$CN$CA$CA
243256951$24325695$1$I$20240911$20240913$20240917$20240917$EXP$$SE-AstraZeneca-2024A209706$ASTRAZENECA$$71$YR$$M$Y$$$20240917$$MD$SE$
243256982$24325698$2$F$$20240916$20240917$20240917$PER$$US-ROCHE-10000079596$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243256991$24325699$1$I$20240804$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409051609216580-QPWKG$GB-Accord-445411$ACCORD$$57$YR$A$M$Y$$$20240917$$HP$GB$GB
243257001$24325700$1$I$$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409051047363520-LJFDC$GB-Accord-445454$ACCORD$$$$$$Y$65$KG$20240917$$CN$GB$GB
243257011$24325701$1$I$20240904$20240905$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409005370$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240917$$CN$US$US
243257021$24325702$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008983$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240917$$CN$US$US
243257031$24325703$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008270$ELI LILLY AND CO$$$$$$Y$$$20240917$$HP$US$US
243257041$24325704$1$I$$20240909$20240917$20240917$PER$$US-BBU-2024000276$BIOGEN$Lapite A, Sanchez LM, Altaffer AL, Rae M, Ramirez AA, et al. Concomitant sickle cell disease and systemic lupus erythematosus: A single-center case series. Pediatr Blood Cancer. 2024;71:e31194. doi:10.1002/pbc.31194$16$YR$$F$Y$$$20240917$$HP$US$US
243257051$24325705$1$I$20240101$20240909$20240917$20240917$EXP$$CA-CELLTRION INC.-2024CA011338$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
243257061$24325706$1$I$$20240903$20240917$20240917$EXP$$US-BELUSA-2024BELLIT0099$BIOLOGICAL E.$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D, Yue A, Rizvi A, Salgia R.Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.Cancer Immunology, Immunotherapy.2024;73(10):200$$$$$Y$$$20240917$$HP$US$US
243257071$24325707$1$I$$20240905$20240917$20240917$EXP$$DE-ROCHE-10000075790$ROCHE$$$$$$Y$$$20240917$$MD$DE$DE
243257091$24325709$1$I$20240908$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183271$AMGEN$$57$YR$A$F$Y$$$20240916$$CN$US$US
243257101$24325710$1$I$$20240909$20240917$20240917$PER$$US-BIOGEN-2024BI01272931$BIOGEN$$$$$M$Y$$$20240917$$CN$US$US
243257111$24325711$1$I$$20240910$20240917$20240917$EXP$$GB-BIOGEN-2024BI01282229$BIOGEN$$$$$F$Y$$$20240917$$CN$GB$GB
243257121$24325712$1$I$$20240903$20240917$20240917$EXP$$US-BELUSA-2024BELLIT0100$BIOLOGICAL E.$Muddasani R, Talwar N, Mambetsariev I, Fricke J, Lin M, Schmolze D,Yue A,Rizvi A,Salgia R.Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.Cancer Immunology, Immunotherapy.2024;73:200$$$$$Y$$$20240917$$HP$US$US
243257141$24325714$1$I$$20240910$20240917$20240917$EXP$$BR-BIOGEN-2024BI01282259$BIOGEN$$$$$M$Y$81$KG$20240917$$CN$BR$BR
243257151$24325715$1$I$$20240910$20240917$20240917$EXP$$US-BIOGEN-2024BI01282192$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
243257161$24325716$1$I$20240826$20240830$20240917$20240917$PER$$PL-TOLMAR, INC.-24PL052325$TOLMAR$$$$$$Y$$$20240917$$PH$PL$PL
243257171$24325717$1$I$20240819$20240828$20240917$20240917$PER$$TR-TOLMAR, INC.-24TR052027$TOLMAR$$78$YR$$M$Y$$$20240917$$PH$TR$TR
243257181$24325718$1$I$20240829$20240829$20240917$20240917$PER$$TR-TOLMAR, INC.-24TR052297$TOLMAR$$65$YR$$M$Y$$$20240917$$HP$TR$TR
243257191$24325719$1$I$20240815$20240828$20240917$20240917$PER$$TR-TOLMAR, INC.-24TR052300$TOLMAR$$63$YR$$M$Y$$$20240917$$PH$TR$TR
243257201$24325720$1$I$20240829$20240829$20240917$20240917$PER$$TR-TOLMAR, INC.-24TR052294$TOLMAR$$68$YR$$M$Y$$$20240917$$MD$TR$TR
243257211$24325721$1$I$20240828$20240828$20240917$20240917$PER$$TR-TOLMAR, INC.-24TR052304$TOLMAR$$71$YR$$M$Y$$$20240917$$PH$TR$TR
243257231$24325723$1$I$20210901$20240909$20240917$20240917$EXP$$CH-CHEPLA-2024011718$CHEPLAPHARM$Perez-Codesido S, Azzi Virgini V, Fertani S, Jandus P. Successful desensitization to etoposide in a patient after cardiac arrest. Journal of Oncology Pharmacy Practice. 2024:1-5. doi: 10.1177/10781552241280723.$61$YR$$F$Y$$$20240916$$HP$COUNTRY NOT SPECIFIED$CH
243257244$24325724$4$F$20240801$20240926$20240917$20240930$PER$$US-AMGEN-USASP2024183947$AMGEN$$58$YR$A$F$Y$$$20240929$$HP$US$US
243257251$24325725$1$I$20240524$20240823$20240917$20240917$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000861$PAREXEL$$$$$$Y$$$20240917$$HP$US$US
243257261$24325726$1$I$$20240912$20240917$20240917$EXP$$IN-ROCHE-10000081872$ROCHE$$63$YR$A$M$Y$$$20240917$$CN$IN$IN
243257271$24325727$1$I$20240101$20240905$20240917$20240917$EXP$$JP-ROCHE-10000077473$ROCHE$$8$DEC$E$F$Y$$$20240917$$MD$JP$JP
243257281$24325728$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_07208391$CA-Accord-445860$ACCORD$$$$$$Y$$$20240917$$HP$CA$CA
243257291$24325729$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A206539$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$US$
243257301$24325730$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208839$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243257311$24325731$1$I$20240826$20240909$20240917$20240917$EXP$$US-AstraZeneca-2024A207558$ASTRAZENECA$$25371$DY$$F$Y$$$20240917$$CN$US$
243257321$24325732$1$I$$20240905$20240917$20240917$EXP$$US-NOVOPROD-1280811$NOVO NORDISK$$$$$F$Y$$$20240917$$CN$US$US
243257331$24325733$1$I$20210101$20240905$20240917$20240917$EXP$$US-NOVOPROD-1280807$NOVO NORDISK$$64$YR$$F$Y$$$20240917$$CN$US$US
243257342$24325734$2$F$$20240917$20240917$20240926$EXP$$CN-NOVOPROD-1280920$NOVO NORDISK$$80$YR$$F$Y$60$KG$20240926$$CN$CN$CN
243257351$24325735$1$I$$20240905$20240917$20240917$EXP$$BR-NOVOPROD-1280700$NOVO NORDISK$$$$$F$Y$$$20240917$$CN$BR$BR
243257361$24325736$1$I$$20240911$20240917$20240917$EXP$$CA-AstraZeneca-2024A209797$ASTRAZENECA$$69$YR$$M$Y$$$20240917$$MD$CA$
243257371$24325737$1$I$20231030$20240905$20240917$20240917$EXP$AU-TGA-0000791555$AU-NOVOPROD-1280634$NOVO NORDISK$$57$YR$$M$Y$$$20240917$$CN$AU$AU
243257381$24325738$1$I$20240714$20240910$20240917$20240917$EXP$$US-CHEPLA-2024011654$CHEPLAPHARM$$56$YR$$F$Y$147$KG$20240916$$MD$COUNTRY NOT SPECIFIED$US
243257391$24325739$1$I$$20240905$20240917$20240917$EXP$$US-NOVOPROD-1280788$NOVO NORDISK$$$$$$Y$$$20240917$$HP$US$US
243257401$24325740$1$I$$20240912$20240917$20240917$EXP$$IL-JAZZ PHARMACEUTICALS-2024-IL-015121$JAZZ$$57$YR$$M$Y$$$20240916$$HP$IL$IL
243257411$24325741$1$I$$20240911$20240917$20240917$EXP$$JP-GSK-JP2024112882$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$JP$JP
243257421$24325742$1$I$$20240905$20240917$20240917$EXP$$US-NOVOPROD-1280796$NOVO NORDISK$$$$$F$Y$$$20240917$$MD$US$US
243257431$24325743$1$I$$20240902$20240917$20240917$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20116$ALKEM$Duron S, Dominguez M, Calleo V.. Systemic lidocaine toxicity secondary to topical application in a pediatric patient. Clin Toxicol. 2022;61(2):168-169$4$YR$$F$Y$$$20240917$$HP$US$US
243257441$24325744$1$I$$20240902$20240917$20240917$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21142$ALKEM$J. A. Anandadas and P. Simpson. Cardiac tamponade, associated with hydralazine therapy, in a patient with rapid acetylator status. British Journal of Clinical Practice. 1986;40(7):305-306$$$$$Y$$$20240917$$HP$GB$GB
243257451$24325745$1$I$$20240902$20240917$20240917$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19895$ALKEM$Holman SK, Parris D, Meyers S, Ramirez J.. Acute Low-Dose Hydralazine-Induced Lupus Pneumonitis. Case Reports in Pulmonology. 2017;2017:1-4$35$YR$$F$Y$$$20240917$$HP$US$US
243257461$24325746$1$I$20240901$20240902$20240917$20240917$EXP$GB-MHRA-MED-202409011154434140-JTGLQ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-20828$ALKEM$$39$YR$$F$Y$$$20240917$$CN$GB$GB
243257472$24325747$2$F$$20240912$20240917$20240926$EXP$IN-MLMSERVICE-20240826-PI172107-00232-1$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-20819$ALKEM$C SA, P H, Jayanthi N. A Rare Lung Malignancy in a Case of Systemic Sclerosis. Cureus. 2024;16(7):e65146$55$YR$$F$Y$$$20240926$$MD$IN$IN
243257481$24325748$1$I$$20240902$20240917$20240917$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19888$ALKEM$Zeitjian V, Mehdizadeh A.. ANA-Negative Hydralazine-Induced Pericardial Effusion. Case Reports in Medicine. 2017;unk:unk$21$YR$$M$Y$$$20240917$$HP$US$US
243257512$24325751$2$F$$20240912$20240917$20240926$EXP$CN-MLMSERVICE-20240826-PI171126-00060-1$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-20105$ALKEM$Long S, Tang P, Ouyang P, Liao X, Xie L.. A Case Report of a Rare Pulmonary Opportunistic Infection in an Infant Caused by Tsukamurella tyrosinosolvens. International Medical Case Reports Journal. 2024;17:725-31$$$I$F$Y$$$20240926$$MD$CN$CN
243257522$24325752$2$F$$20240912$20240917$20240926$EXP$IN-MLMSERVICE-20240823-PI168809-00163-1$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-20817$ALKEM$Priya L, Alamanda VA, Javali M, Acharya P, Rangaiah P, Nagabushana D.. Gabapentin-induced Multifocal Myoclonus. The Journal of the Association of Physicians of India. 2024;72(8):78-79$66$YR$$M$Y$$$20240926$$MD$IN$IN
243257531$24325753$1$I$$20240902$20240917$20240917$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19891$ALKEM$Iyer P, Dirweesh A, Zijoo R.. Hydralazine Induced Lupus Syndrome Presenting with Recurrent Pericardial Effusion and a Negative Antinuclear Antibody. Case Reports in Rheumatology. 2017;2017 (5245904):3$36$YR$$F$Y$$$20240917$$HP$US$US
243257542$24325754$2$F$20220501$20240912$20240917$20240926$EXP$CN-MLMSERVICE-20240816-PI160717-00306-1$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-20844$ALKEM$Tang LL, Huang YD, Zhang XJ, Zhu L, Li ZP.. Pharmaceutical Care for Tacrolimus-associated Posterior Reversible Encephalopathy Syndrome in A Pediatric Patient with Nephrotic Syndrome. Herald of Medicine-Yiyao Daobao. 2024;43(2):292-8$2$YR$$M$Y$16.6$KG$20240926$$PH$CN$CN
243257551$24325755$1$I$$20240902$20240917$20240917$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-20868$ALKEM$Shintani-Ishida K, Kawamoto M, Kondo H, Onoe T, Ikegaya H.. Fatal pregabalin poisoning in Japan: A case report. Leg Med (Tokyo). 2024;71:102522$50$YR$$M$Y$$$20240917$$HP$JP$JP
243257571$24325757$1$I$$20240913$20240917$20240917$PER$$US-HALEON-2196929$Haleon PLC$$$$$F$Y$$$20240917$$CN$US$US
243257581$24325758$1$I$$20240902$20240917$20240917$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20998$ALKEM$Birnbaum b, Sidhu GS, Smith RL, Pillinger MH, Tagoe CE.. Fulminating hydralazine-induced lupus pneumonitis. Arthritis Care and Research. 2006;55(3):501-506$36$YR$$F$Y$$$20240917$$HP$US$US
243257591$24325759$1$I$$20240902$20240917$20240917$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20996$ALKEM$Chisholm JC Jr. Acute low-dose hydralazine induced lupus syndrome (HILS). Journal of the National Medical Association. 1981;73(3):278-280$34$YR$$F$Y$$$20240917$$HP$US$US
243257601$24325760$1$I$$20240905$20240917$20240917$EXP$$US-NOVOPROD-1281399$NOVO NORDISK$$$$$F$Y$$$20240917$$CN$US$US
243257611$24325761$1$I$$20240905$20240917$20240917$EXP$$US-NOVOPROD-1281545$NOVO NORDISK$$$$$M$Y$$$20240917$$CN$US$US
243257621$24325762$1$I$20240716$20240905$20240917$20240917$EXP$$US-NOVOPROD-1281514$NOVO NORDISK$$$$$M$Y$$$20240917$$CN$US$US
243257631$24325763$1$I$$20240905$20240917$20240917$EXP$$US-NOVOPROD-1281463$NOVO NORDISK$$$$$F$Y$$$20240917$$MD$US$US
243257641$24325764$1$I$20230101$20240905$20240917$20240917$EXP$$US-NOVOPROD-1281019$NOVO NORDISK$$75$YR$$F$Y$$$20240917$$CN$US$US
243257651$24325765$1$I$$20240905$20240917$20240917$EXP$$US-NOVOPROD-1281052$NOVO NORDISK$$61$YR$$$Y$$$20240917$$CN$US$US
243257661$24325766$1$I$$20240905$20240917$20240917$EXP$$DK-NOVOPROD-1281764$NOVO NORDISK$$$$$F$Y$$$20240917$$HP$DK$DK
243257671$24325767$1$I$20240801$20240905$20240917$20240917$EXP$$US-NOVOPROD-1281381$NOVO NORDISK$$64$YR$$F$Y$$$20240917$$HP$US$US
243257681$24325768$1$I$20240705$20240823$20240917$20240917$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000865$PAREXEL$$$$$$Y$$$20240917$$HP$US$US
243257691$24325769$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5922389$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243257701$24325770$1$I$$20240909$20240917$20240917$EXP$$US-RDY-SPO/USA/24/0013501$DR REDDYS$Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Huang BJ, et al. Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies. Pediatric Blood and Cancer. 2023 Jun;70(6): doi:10.1002/pbc.30335.$10$YR$C$M$Y$$$20240917$$HP$US$US
243257711$24325771$1$I$20240907$20240913$20240917$20240917$EXP$$CO-UCBSA-2024047453$UCB$$25$YR$$F$Y$$$20240917$$CN$CO$CO
243257722$24325772$2$F$$20240925$20240917$20240925$EXP$$CA-ORGANON-O2409CAN000940$ORGANON$$68$YR$$M$Y$$$20240925$$CN$CA$CA
243257731$24325773$1$I$20240909$20240912$20240917$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015020$JAZZ$$21$YR$$M$Y$$$20240916$$CN$US$US
243257741$24325774$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000081648$ROCHE$$$$E$F$Y$$$20240917$$CN$US$US
243257751$24325775$1$I$$20240911$20240917$20240917$EXP$$JP-AMGEN-JPNSP2024183964$AMGEN$$$$$$Y$$$20240916$$PH$JP$JP
243257761$24325776$1$I$20240901$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008385$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240917$$CN$US$US
243257771$24325777$1$I$$20240909$20240917$20240917$EXP$$BR-JNJFOC-20240931077$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$MD$BR$BR
243257781$24325778$1$I$$20240911$20240917$20240917$EXP$$ES-JNJFOC-20240933850$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240917$$MD$ES$ES
243257792$24325779$2$F$$20240904$20240917$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145451$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$52.16$KG$20240923$$HP$US$US
243257801$24325780$1$I$$20240909$20240917$20240917$EXP$$CA-APOTEX-2024AP010383$APOTEX$$44$YR$$F$Y$97$KG$20240917$$MD$CA$CA
243257812$24325781$2$F$20240902$20240916$20240917$20240919$EXP$$CA-ABBVIE-5923697$ABBVIE$$33$YR$$F$Y$$$20240919$$CN$CA$CA
243257821$24325782$1$I$20240901$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024183896$AMGEN$$9$YR$C$M$Y$$$20240916$$CN$US$US
243257831$24325783$1$I$20240901$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024182004$AMGEN$$$$$$Y$$$20240916$$PH$US$US
243257841$24325784$1$I$$20240829$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA051901$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243257851$24325785$1$I$20240822$20240828$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA051832$TOLMAR$$74$YR$$M$Y$$$20240917$$CN$CA$CA
243257861$24325786$1$I$20240829$20240829$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA051896$TOLMAR$$62$YR$$M$Y$$$20240917$$CN$CA$CA
243257891$24325789$1$I$$20240829$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA051936$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243257901$24325790$1$I$$20240828$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA051979$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243257911$24325791$1$I$$20240828$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA051952$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243257921$24325792$1$I$20240101$20240829$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA051957$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243257932$24325793$2$F$20240807$20240922$20240917$20240927$EXP$$CA-TOLMAR, INC.-24CA052001$TOLMAR$$80$YR$$M$Y$$$20240927$$CN$CA$CA
243257941$24325794$1$I$$20240910$20240917$20240917$EXP$$GB-SANDOZ INC.-SDZ2024GB079860$SANDOZ$$$$$F$Y$$$20240917$$CN$GB$GB
243257951$24325795$1$I$20240903$20240909$20240917$20240917$EXP$$CN-AstraZeneca-2024A207148$ASTRAZENECA$$3739$WK$$M$Y$60$KG$20240917$$MD$CN$
243257971$24325797$1$I$$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409051036517840-DLRZS$GB-Accord-445456$ACCORD$$$$$F$Y$$$20240917$$CN$GB$GB
243257981$24325798$1$I$$20240904$20240917$20240917$EXP$$PT-AUROBINDO-AUR-APL-2024-044563$AUROBINDO$$$$$F$Y$$$20240917$$CN$PT$PT
243257992$24325799$2$F$$20240904$20240917$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468181$RANBAXY$Olson MT, Walia T, Arjuna A. Suspected Solitary Pulmonary Nodule Later Diagnosed as Post-transbronchial Biopsy Hematoma. Am J Respir Crit Care Med. 2023;207:no pagination$65$YR$$M$Y$$$20240919$$HP$US$US
243258012$24325801$2$F$$20240918$20240917$20240928$EXP$CA-MHPD-E2B_07205181$CA-Accord-445712$ACCORD$$11$YR$C$F$Y$$$20240928$$HP$CA$CA
243258021$24325802$1$I$$20240912$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146187$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240917$$PH$US$US
243258032$24325803$2$F$20240914$20240917$20240917$20240918$PER$$US-AMGEN-USASP2024184491$AMGEN$$69$YR$E$F$Y$$$20240918$$CN$US$US
243258041$24325804$1$I$$20240903$20240917$20240917$30DAY$$AT-UCBSA-2024045597$UCB$$$$$$Y$$$20240917$$CN$AT$AT
243258051$24325805$1$I$$20240912$20240917$20240917$EXP$$US-JNJFOC-20240933486$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$US$US
243258061$24325806$1$I$20240831$20240909$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144820$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240917$$PH$US$US
243258071$24325807$1$I$20240301$20240904$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-044766$AUROBINDO$$74$YR$$M$Y$64$KG$20240917$$MD$FR$FR
243258081$24325808$1$I$$20240909$20240917$20240917$EXP$$US-NOVITIUMPHARMA-2024USNVP01868$NOVITIUM PHARMA$$$$$F$Y$56$KG$20240917$$CN$US$US
243258091$24325809$1$I$20160523$20240911$20240917$20240917$EXP$$US-CHATTEMPRD-2024OHG031811$CHATTEM$$61$YR$A$M$Y$$$20240917$$LW$US$US
243258101$24325810$1$I$20240913$20240913$20240917$20240917$30DAY$$US-SANDOZ INC.-SDZ2024US080280$SANDOZ$$15$YR$$M$Y$$$20240917$$CN$US$US
243258111$24325811$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184303$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology, Biology, Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240916$$HP$US$US
243258121$24325812$1$I$20240909$20240910$20240917$20240917$EXP$$US-AMGEN-USASP2024181339$AMGEN$$65$YR$E$M$Y$$$20240916$$CN$US$US
243258131$24325813$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184302$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology, Biology, Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240916$$HP$US$US
243258141$24325814$1$I$20240912$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183259$AMGEN$$31$YR$A$F$Y$$$20240916$$CN$US$US
243258151$24325815$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184304$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology, Biology, Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240916$$HP$US$US
243258172$24325817$2$F$20190101$20240912$20240917$20240921$EXP$$FR-AUROBINDO-AUR-APL-2023-068818$AUROBINDO$Jeantin L, Shor N, Pallix-Guyot M, Roos-Weil D, Bellanger A, Garff-Tavernier ML et al.. Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod. JOURNAL OF NEUROLOGY. 2023;1-4$61$YR$$F$Y$$$20240921$$HP$FR$FR
243258181$24325818$1$I$$20240905$20240917$20240917$EXP$$NL-KOANAAP-SML-NL-2024-00933$SHILPA MEDICARE$van der Sar I.G.,Wijsenbeek M.S.,Dumoulin D.W.,Jager A.,van der Veldt A.A.M.,Rossius M.J.P.,Dingemans A.-M.C.,Moor C.C.. Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis. Annals of the American Thoracic Society. 2024;21(6):989-992. doi:10.1513/AnnalsATS.202401-112RL$$$A$$Y$$$20240917$$HP$NL$NL
243258191$24325819$1$I$$20240905$20240917$20240917$EXP$$NL-KOANAAP-SML-NL-2024-00931$UNKNOWN$van der Sar I.G.,Wijsenbeek M.S.,Dumoulin D.W.,Jager A.,van der Veldt A.A.M.,Rossius M.J.P.,Dingemans A.-M.C.,Moor C.C. Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis. Annals of the American Thoracic Society. 2024;21(6):989-992. doi:10.1513/AnnalsATS.202401-112RL$$$A$$Y$$$20240917$$HP$NL$NL
243258201$24325820$1$I$20240829$20240904$20240917$20240917$PER$$US-JNJFOC-20240908128$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$US$US
243258211$24325821$1$I$$20240905$20240917$20240917$EXP$$NL-KOANAAP-SML-NL-2024-00930$UNKNOWN$van der Sar I.G.,Wijsenbeek M.S.,Dumoulin D.W.,Jager A.,van der Veldt A.A.M.,Rossius M.J.P.,Dingemans A.-M.C.,Moor C.C.. Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis.. Annals of the American Thoracic Society. 2024;21(6):989-992. doi:10.1513/AnnalsATS.202401-112RL$$$A$$Y$$$20240917$$HP$NL$NL
243258221$24325822$1$I$$20240906$20240917$20240917$EXP$$US-NOVOPROD-1280577$NOVO NORDISK$$$$$F$Y$$$20240917$$CN$US$US
243258231$24325823$1$I$20160101$20240906$20240917$20240917$EXP$FR-AFSSAPS-TS2024000961$FR-NOVOPROD-1279645$NOVO NORDISK$$31$YR$$M$Y$87$KG$20240917$$MD$FR$FR
243258241$24325824$1$I$$20240910$20240917$20240917$PER$$US-AstraZeneca-2024A206643$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243258251$24325825$1$I$20240501$20240905$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-045015$AUROBINDO$$55$YR$$F$Y$$$20240917$$MD$FR$FR
243258261$24325826$1$I$$20240910$20240917$20240917$EXP$$JP-AstraZeneca-2024A209204$ASTRAZENECA$$$$$$Y$$$20240917$$MD$JP$
243258271$24325827$1$I$$20240909$20240917$20240917$EXP$$US-AstraZeneca-2024A205590$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243258281$24325828$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_07206083$CA-Accord-445726$ACCORD$$47$YR$A$F$Y$86$KG$20240917$$HP$CA$CA
243258291$24325829$1$I$$20240911$20240917$20240917$EXP$$US-CHATTEMPRD-2024OHG031788$CHATTEM$$$$A$F$Y$$$20240917$$LW$US$US
243258301$24325830$1$I$$20240906$20240917$20240917$EXP$$US-NOVOPROD-1281999$NOVO NORDISK$$$$$F$Y$$$20240917$$CN$US$US
243258311$24325831$1$I$20240501$20240906$20240917$20240917$EXP$$US-NOVOPROD-1282034$NOVO NORDISK$$$$$M$Y$$$20240917$$CN$US$US
243258331$24325833$1$I$20240801$20240906$20240917$20240917$EXP$$US-NOVOPROD-1280934$NOVO NORDISK$$79$YR$$F$Y$$$20240917$$CN$US$US
243258341$24325834$1$I$$20240906$20240917$20240917$EXP$$US-NOVOPROD-1281554$NOVO NORDISK$$$$$F$Y$$$20240917$$CN$US$US
243258351$24325835$1$I$20231101$20240906$20240917$20240917$EXP$$US-NOVOPROD-1282140$NOVO NORDISK$$66$YR$$F$Y$$$20240917$$CN$US$US
243258361$24325836$1$I$20240906$20240906$20240917$20240917$EXP$$US-NOVOPROD-1281966$NOVO NORDISK$$66$YR$$M$Y$$$20240917$$MD$US$US
243258371$24325837$1$I$$20240906$20240917$20240917$EXP$$US-NOVOPROD-1281958$NOVO NORDISK$$$$A$F$Y$$$20240917$$CN$US$US
243258381$24325838$1$I$20240508$20240906$20240917$20240917$EXP$$US-NOVOPROD-1282151$NOVO NORDISK$$75$YR$$M$Y$$$20240917$$MD$US$US
243258391$24325839$1$I$$20240906$20240917$20240917$EXP$$JP-NOVOPROD-1281341$NOVO NORDISK$$62$YR$$M$Y$$$20240917$$PH$JP$JP
243258401$24325840$1$I$$20240906$20240917$20240917$EXP$$US-NOVOPROD-1282138$NOVO NORDISK$$$$$F$Y$$$20240917$$CN$US$US
243258411$24325841$1$I$$20240909$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409005364$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240917$$CN$US$US
243258421$24325842$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009071$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240917$$CN$US$US
243258431$24325843$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008390$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240917$$CN$US$US
243258451$24325845$1$I$$20240828$20240917$20240917$PER$$US-TEVA-VS-3239373$TEVA$$$$$$Y$$$20240917$$HP$US$US
243258462$24325846$2$F$$20240913$20240917$20240925$EXP$$PL-AUROBINDO-AUR-APL-2024-044105$AUROBINDO$Dzwilewski K, Zawadzka M, Zawadzka D, Kubziakowska W, Mazurkiewicz-be?dzi?ska M. Drug-resistant epilepsy with focal seizures in the  context of focal cortical dysplasia. POLSKI PRZEGL?D NEUROLOGICZNY (POLISH NEUROLOGICAL REVIEW). 2024;20(2):109?114$11$YR$$F$Y$$$20240925$$MD$PL$PL
243258471$24325847$1$I$$20231010$20240917$20240917$PER$$US-ENDO USA, INC.-2023-005434$ENDO$$$$$M$Y$$$20240917$$CN$US$US
243258481$24325848$1$I$$20240908$20240917$20240917$EXP$$IN-HETERO-HET2024IN03103$HETERO$Malani SK, Chigullapalli S, Sujanyal S, Sharma V, Malani S, Sharma Sr V.. Rosuvastatin-Induced Myopathy: A Case Series. Cureus. 2024;16(8):e66180$70$YR$$F$Y$$$20240917$$HP$IN$IN
243258491$24325849$1$I$$20240912$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146180$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240917$$HP$US$US
243258501$24325850$1$I$20230701$20240904$20240917$20240917$EXP$$DE-AUROBINDO-AUR-APL-2024-044840$AUROBINDO$$47$YR$$M$Y$77$KG$20240917$$CN$DE$DE
243258511$24325851$1$I$$20240913$20240917$20240917$PER$$US-HALEON-2197038$Haleon PLC$$$$$$Y$$$20240917$$CN$US$US
243258521$24325852$1$I$$20240910$20240917$20240917$EXP$$DE-SANDOZ INC.-SDZ2024DE079135$SANDOZ$$70$YR$$M$Y$$$20240917$$MD$DE$DE
243258531$24325853$1$I$20240601$20240906$20240917$20240917$EXP$$US-NOVOPROD-1282417$NOVO NORDISK$$47$YR$$F$Y$$$20240917$$CN$US$US
243258541$24325854$1$I$$20240821$20240917$20240917$PER$$US-APOTEX-2024AP009975$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240917$$HP$US$US
243258551$24325855$1$I$$20240909$20240917$20240917$EXP$$JP-TEVA-VS-3242191$TEVA$Morikawa K, Otsuka T, Moriwaki S. Two Cases of Advanced Stage Merkel Cell Carcinoma Treated with Avelumab Immunotherapy. [Japanese]. Skin-Res 2023; 22 (2): 126-132.$58$YR$$F$Y$$$20240917$$MD$JP$JP
243258561$24325856$1$I$$20240911$20240917$20240917$EXP$$US-CHATTEMPRD-2024OHG031768$CHATTEM$$61$YR$A$$Y$$$20240917$$LW$US$US
243258571$24325857$1$I$$20240904$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-044845$AUROBINDO$Groh M, Masciocco G, Kirchner E, Kristen E, Pellegrini C,  Varnous S et al.. Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).. Journal of heart and lung transplantation (F). 2014;1-9$$$$F$Y$$$20240917$$HP$FR$FR
243258581$24325858$1$I$20240301$20240823$20240917$20240917$PER$$BR-TOLMAR, INC.-24BR052203$TOLMAR$$8$YR$$F$Y$$$20240917$$CN$BR$BR
243258601$24325860$1$I$20240823$20240823$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA052128$TOLMAR$$78$YR$$M$Y$$$20240917$$CN$CA$CA
243258611$24325861$1$I$$20240822$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA052127$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243258621$24325862$1$I$$20240909$20240917$20240917$EXP$$PT-NOVITIUMPHARMA-2024PTNVP01703$NOVITIUM PHARMA$Leonor Brito-Santana.Steroid-induced psychosis: a spectrum of neuropsychiatric glucocorticoid side effects.BMJ Case Reports.22-JUL-2024;17:7$$$T$M$Y$$$20240917$$HP$PT$PT
243258631$24325863$1$I$$20240823$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA052130$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243258641$24325864$1$I$20240823$20240823$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA052134$TOLMAR$$73$YR$$M$Y$$$20240917$$CN$CA$CA
243258651$24325865$1$I$$20240823$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA052133$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243258661$24325866$1$I$20240823$20240823$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA052135$TOLMAR$$59$YR$$M$Y$$$20240917$$CN$CA$CA
243258671$24325867$1$I$$20240822$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA052137$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243258681$24325868$1$I$$20240823$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA052136$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243258691$24325869$1$I$20240823$20240823$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA052149$TOLMAR$$83$YR$$M$Y$$$20240917$$CN$CA$CA
243258703$24325870$3$F$20240506$20240918$20240917$20240918$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051645$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240918$$HP$CO$CO
243258711$24325871$1$I$$20240821$20240917$20240917$PER$$US-APOTEX-2024AP009976$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240917$$HP$US$US
243258721$24325872$1$I$$20240909$20240917$20240917$EXP$$JP-ASTELLAS-2024-AER-005737$ASTELLAS$Tongu Y, Ohyama S, Misawa Y, Harada T, Nakamura Y, Yamashita H, et al. A case of neuropsychiatric lupus with opsoclonus myoclonus syndrome developed after herpes zoster. The 698th Kanto District Meeting of the Japanese Society of Internal Medicine (abstract) (held by hybrid) (2024.09.21). 2024;89.$28$YR$A$F$Y$$$20240917$$MD$JP$JP
243258731$24325873$1$I$$20240911$20240917$20240917$EXP$$CA-CELLTRION INC.-2024CA021797$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
243258741$24325874$1$I$$20240911$20240917$20240917$EXP$$US-CHATTEMPRD-2024OHG031771$CHATTEM$$71$YR$E$M$Y$$$20240917$$LW$US$US
243258753$24325875$3$F$$20240918$20240917$20240927$EXP$$PL-AUROBINDO-AUR-APL-2019-080034$AUROBINDO$Boratynska M, Obremska M, Malecki R, Gacka M, Magott M, Kaminska D, et al... Impact of immunosuppressive treatment on the cardiovascular system in patients after hand transplantation. Transplantation Proceedings. 2014;46(8)4:2890-2893$34$YR$$M$Y$$$20240927$$HP$PL$PL
243258761$24325876$1$I$20240101$20240827$20240917$20240917$EXP$$JP-SA-2024SA263282$SANOFI AVENTIS$$58$YR$A$M$Y$55.5$KG$20240917$$PH$JP$JP
243258771$24325877$1$I$20240423$20240910$20240917$20240917$EXP$FR-AFSSAPS-DJ2024000935$FR-GSK-FR2024112388$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$FR$FR
243258781$24325878$1$I$$20240912$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA079874$SANDOZ$$52$YR$$F$Y$$$20240917$$HP$CA$CA
243258791$24325879$1$I$$20240821$20240917$20240917$PER$$US-APOTEX-2024AP009977$APOTEX$Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Wang Y, et al.. Gastrointestinal toxicities of proteasome inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 2024;150 (7):334 (1-8)$$$A$$Y$$$20240917$$HP$US$US
243258802$24325880$2$F$$20240914$20240917$20240924$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005180$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243258811$24325881$1$I$$20240908$20240917$20240917$EXP$$IN-HETERO-HET2024IN03104$HETERO$Malani SK, Chigullapalli S, Sujanyal S, Sharma V. Rosuvastatin-Induced Myopathy: A Case Series. Cureus. 2024;16(8):1-5$78$YR$$F$Y$$$20240917$$HP$IN$IN
243258821$24325882$1$I$$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183922$AMGEN$$$$$$Y$$$20240916$$HP$US$US
243258831$24325883$1$I$20220801$20240909$20240917$20240917$EXP$$SI-BRISTOL-MYERS SQUIBB COMPANY-2024-145503$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240917$$MD$SI$SI
243258841$24325884$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_07208398$CA-Accord-445861$ACCORD$$$$$$Y$$$20240917$$HP$CA$CA
243258852$24325885$2$F$$20240822$20240917$20240921$30DAY$$US-AMGEN-USASL2024168912$AMGEN$$$$$$Y$$$20240920$$HP$US$US
243258861$24325886$1$I$20240812$20240905$20240917$20240917$EXP$FR-AFSSAPS-NT2024001096$FR-Accord-445711$ACCORD$$79$YR$E$M$Y$55$KG$20240917$$PH$FR$FR
243258871$24325887$1$I$$20240911$20240917$20240917$EXP$$US-CHATTEMPRD-2024OHG031773$CHATTEM$$60$YR$A$M$Y$$$20240917$$LW$US$US
243258881$24325888$1$I$20240610$20240913$20240917$20240917$EXP$$JP-TAKEDA-2024TJP011055$TAKEDA$$48$YR$$F$Y$$$20240917$$MD$JP$JP
243258891$24325889$1$I$$20240911$20240917$20240917$PER$$US-ROCHE-10000080884$ROCHE$$$$A$F$Y$$$20240917$$CN$US$US
243258901$24325890$1$I$20230901$20240909$20240917$20240917$PER$$US-AstraZeneca-2024A205931$ASTRAZENECA$$60$YR$$F$Y$70.3$KG$20240917$$HP$US$
243258911$24325891$1$I$20240101$20240911$20240917$20240917$EXP$$US-ABBVIE-5922099$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243258921$24325892$1$I$$20240913$20240917$20240917$EXP$$US-JNJFOC-20240939987$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$CN$US$US
243258931$24325893$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922400$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243258941$24325894$1$I$20240310$20240916$20240917$20240917$EXP$FR-AFSSAPS-TO2024000591$FR-UCBSA-2024044666$UCB$$24$YR$$F$Y$58$KG$20240917$$CN$FR$FR
243258951$24325895$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146886$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240917$$CN$US$US
243258971$24325897$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184745$AMGEN$$$$$$Y$$$20240917$$CN$US$US
243258984$24325898$4$F$$20240925$20240917$20240930$EXP$$US-ROCHE-10000081197$ROCHE$$63$YR$A$M$Y$$$20240930$$HP$US$US
243258991$24325899$1$I$$20240909$20240917$20240917$EXP$$IN-COLLEGIUM PHARMACEUTICAL, INC.-20240900727$COLLEGIUM PHARMACEUTICAL$Aggarwal, Mahak MD; Muskan, MBBS; Kaur, Jasdeep MBBS; Udey, Bharat MD; Singh, Jawahar MD. Tapentadol Withdrawal Dystonia in a Young Adult Male Patient with Opioid Use Disorder. Journal of Clinical Psychopharmacology. 2024;00:00$$$$$Y$$$20240917$$MD$IN$IN
243259001$24325900$1$I$20240205$20240905$20240917$20240917$EXP$ES-AEMPS-1507644$ES-COLLEGIUM PHARMACEUTICAL, INC.-20240900700$COLLEGIUM PHARMACEUTICAL$$51$YR$$M$Y$80$KG$20240917$$MD$ES$ES
243259011$24325901$1$I$20230305$20240903$20240917$20240917$EXP$FR-AFSSAPS-LY2023000573$FR-CELLTRION INC.-2024FR022125$CELLTRION$$$$$$Y$$$20240917$$PH$FR$FR
243259021$24325902$1$I$20240826$20240909$20240917$20240917$EXP$$CA-CELLTRION INC.-2024CA021865$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
243259041$24325904$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000082444$ROCHE$$$$A$F$Y$$$20240917$$CN$US$US
243259051$24325905$1$I$$20240908$20240917$20240917$EXP$$US-GSK-US2024111498$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240917$$CN$US$US
243259061$24325906$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009113$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240917$$CN$US$US
243259071$24325907$1$I$20240825$20240905$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409004743$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240917$$CN$US$US
243259081$24325908$1$I$20240912$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009227$ELI LILLY AND CO$$$$$M$Y$$$20240917$$CN$US$US
243259091$24325909$1$I$20240910$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008467$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243259101$24325910$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008251$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240917$$CN$US$US
243259111$24325911$1$I$20240906$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009043$ELI LILLY AND CO$$64$YR$A$$Y$$$20240917$$CN$US$US
243259121$24325912$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009277$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240917$$CN$US$US
243259131$24325913$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008512$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240917$$CN$US$US
243259141$24325914$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009209$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240917$$CN$US$US
243259151$24325915$1$I$$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008851$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240917$$CN$US$US
243259162$24325916$2$F$20240101$20240919$20240917$20240930$EXP$$US-JNJFOC-20240934171$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$US$US
243259171$24325917$1$I$20240101$20240910$20240917$20240917$EXP$$US-SA-2024SA266188$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240917$$HP$US$US
243259181$24325918$1$I$20190101$20240911$20240917$20240917$EXP$$US-ABBVIE-5921502$ABBVIE$$58$YR$$F$Y$$$20240917$$CN$US$US
243259201$24325920$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5920826$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243259211$24325921$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5921650$ABBVIE$$$$$F$Y$$$20240917$$MD$US$US
243259221$24325922$1$I$20240201$20240912$20240917$20240917$EXP$$DE-ROCHE-10000081945$ROCHE$$50$YR$A$F$Y$55$KG$20240917$$MD$DE$DE
243259231$24325923$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000082306$ROCHE$$$$$$Y$$$20240917$$PH$US$US
243259241$24325924$1$I$20230801$20240911$20240917$20240917$EXP$FR-AFSSAPS-CF2023000486$FR-EMD Serono-2024048825$EMD SERONO INC$$55$YR$A$M$Y$102$KG$20240917$$MD$FR$FR
243259251$24325925$1$I$20240328$20240905$20240917$20240917$EXP$$DE-AUROBINDO-AUR-APL-2024-045026$AUROBINDO$$71$YR$$M$Y$76$KG$20240917$$CN$DE$DE
243259261$24325926$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000081517$ROCHE$$$$E$F$Y$$$20240917$$CN$US$US
243259273$24325927$3$F$20240813$20240920$20240917$20240925$PER$$US-AMGEN-USASP2024184175$AMGEN$$72$YR$E$F$Y$$$20240924$$PH$US$US
243259281$24325928$1$I$20240912$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024182921$AMGEN$$28$YR$A$F$Y$$$20240917$$CN$US$US
243259291$24325929$1$I$$20240904$20240917$20240917$EXP$GB-MHRA-MED-202408291146371510-GMSLN$GB-MSNLABS-2024MSNSPO01948$MSN LABORATORIES$$$$$$Y$$$20240917$$HP$GB$GB
243259301$24325930$1$I$$20240909$20240917$20240917$EXP$$CH-EMD Serono-2024049061$EMD SERONO INC$$$$E$F$Y$$$20240917$$HP$CH$CH
243259311$24325931$1$I$$20240905$20240917$20240917$EXP$GB-MHRA-TPP22581450C966245YC1725435656506$GB-Accord-445397$ACCORD$$45$YR$A$F$Y$73$KG$20240917$$MD$GB$GB
243259321$24325932$1$I$$20240913$20240917$20240917$PER$$US-AstraZeneca-2024A210804$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243259331$24325933$1$I$$20240903$20240917$20240917$EXP$$NL-AUROBINDO-AUR-APL-2024-044163$AUROBINDO$Klingenberg MG, Sinkeler SJ, Koopmans N, Plaat RE.. Severe hypotension requiring resuscitation in tumour-related carotid sinus syndrome: a case report. European heart journal. Case reports. 2024;8(8):ytae393$57$YR$$F$Y$$$20240917$$MD$NL$NL
243259351$24325935$1$I$20240824$20240912$20240917$20240917$PER$$US-ROCHE-10000080612$ROCHE$$37$YR$A$M$Y$$$20240917$$CN$US$US
243259361$24325936$1$I$$20240916$20240917$20240917$EXP$$IT-UCBSA-2024044657$UCB$Levi V, Stanziano M, Pinto C, Zibordi F, Fedeli D, Caldiera V et al. Bilateral Simultaneous Magnetic Resonance?Guided Focused Ultrasound Pallidotomy for Life-Threatening Status Dystonicus. Movement Disorders. 2024;39(8):1408-12$19$YR$$F$Y$$$20240917$$MD$IT$IT
243259371$24325937$1$I$20240815$20240909$20240917$20240917$EXP$$CN-ROCHE-10000077716$ROCHE$$31$YR$A$F$Y$46$KG$20240917$$HP$CN$CN
243259381$24325938$1$I$20240910$20240911$20240917$20240917$EXP$$GB-AMGEN-GBRSP2024182849$AMGEN$$84$YR$E$M$Y$$$20240917$$CN$GB$GB
243259391$24325939$1$I$20240615$20240912$20240917$20240917$EXP$$GB-AMGEN-GBRSP2024182946$AMGEN$$83$YR$E$M$Y$$$20240917$$HP$GB$GB
243259401$24325940$1$I$$20240909$20240917$20240917$EXP$$CO-AMGEN-COLSP2024182574$AMGEN$$$$$F$Y$$$20240917$$CN$CO$CO
243259411$24325941$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000082667$ROCHE$$$$T$M$Y$$$20240917$$CN$US$US
243259421$24325942$1$I$$20240909$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143724$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$76.66$KG$20240917$$CN$US$US
243259431$24325943$1$I$$20240916$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147092$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240917$$CN$US$US
243259441$24325944$1$I$20240908$20240913$20240917$20240917$PER$$US-ROCHE-10000082838$ROCHE$$53$YR$A$M$Y$$$20240917$$CN$US$US
243259452$24325945$2$F$$20240917$20240917$20240927$EXP$$US-ROCHE-10000076281$ROCHE$$68$YR$E$M$Y$$$20240927$$CN$US$US
243259462$24325946$2$F$20240913$20240918$20240917$20240923$EXP$$US-ROCHE-10000082414$ROCHE$$11$YR$C$M$Y$29.5$KG$20240923$$CN$US$US
243259471$24325947$1$I$20240730$20240911$20240917$20240917$EXP$$US-ABBVIE-5921357$ABBVIE$$22$YR$$M$Y$$$20240917$$CN$US$US
243259481$24325948$1$I$20240101$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183175$AMGEN$$47$YR$A$F$Y$$$20240917$$CN$US$US
243259491$24325949$1$I$$20240904$20240917$20240917$PER$$US-APOTEX-2024AP010312$APOTEX$Riopelle AM, Potter CT, Schanbacher CF.. Trigeminal Neuralgia After Mohs Micrographic Surgery. DERMATOLOGIC SURGERY. 2023;49 (10):969-970$43$YR$$M$Y$$$20240917$$MD$US$US
243259501$24325950$1$I$$20240904$20240917$20240917$EXP$GB-MHRA-MED-202409021507418820-GWRHB$GB-MSNLABS-2024MSNSPO01956$MSN LABORATORIES$$$$$$Y$$$20240917$$HP$GB$GB
243259511$24325951$1$I$$20240911$20240917$20240917$EXP$$US-JNJFOC-20240940526$JOHNSON AND JOHNSON$$73$YR$E$M$Y$80.272$KG$20240917$$CN$US$US
243259521$24325952$1$I$$20240911$20240917$20240917$30DAY$$US-SANDOZ INC.-SDZ2024US079968$SANDOZ$$$$$F$Y$$$20240917$$CN$US$US
243259531$24325953$1$I$$20240911$20240917$20240917$EXP$$US-SANDOZ INC.-SDZ2024US079562$SANDOZ$$$$A$F$Y$$$20240917$$MD$US$US
243259541$24325954$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008934$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240917$$CN$US$US
243259551$24325955$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009341$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240917$$HP$US$US
243259561$24325956$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009241$ELI LILLY AND CO$$$$$M$Y$$$20240917$$CN$US$US
243259571$24325957$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009151$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240917$$CN$US$US
243259581$24325958$1$I$20240101$20240912$20240917$20240917$EXP$$GB-AMGEN-GBRSL2024183481$AMGEN$$54$YR$A$F$Y$$$20240917$$MD$GB$GB
243259611$24325961$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184283$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240917$$HP$US$US
243259621$24325962$1$I$20240415$20240911$20240917$20240917$EXP$$US-ABBVIE-5922701$ABBVIE$$67$YR$$F$Y$$$20240917$$CN$US$US
243259632$24325963$2$F$20240612$20240916$20240917$20240917$EXP$IT-MINISAL02-1002179$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-146358$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$45$KG$20240918$$CN$IT$IT
243259641$24325964$1$I$20240418$20240905$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-045070$AUROBINDO$$75$YR$$M$Y$$$20240917$$MD$FR$FR
243259651$24325965$1$I$20240530$20240916$20240917$20240917$EXP$IT-MINISAL02-1001853$IT-UCBSA-2024047416$UCB$$73$YR$$F$Y$$$20240917$$MD$IT$IT
243259661$24325966$1$I$$20240909$20240917$20240917$EXP$$TR-SANDOZ INC.-PHHY2019TR177008$SANDOZ$$45$YR$$F$Y$$$20240917$$MD$TR$TR
243259671$24325967$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208864$ASTRAZENECA$$$$$F$Y$$$20240917$$HP$US$
243259681$24325968$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A207548$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243259701$24325970$1$I$20240827$20240911$20240917$20240917$EXP$$BR-AstraZeneca-2024A210625$ASTRAZENECA$$67$YR$$F$Y$$$20240917$$CN$BR$
243259711$24325971$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A208495$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243259721$24325972$1$I$20240908$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A209842$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243259731$24325973$1$I$$20240909$20240917$20240917$EXP$$CA-CELLTRION INC.-2024CA021926$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
243259741$24325974$1$I$$20240905$20240917$20240917$PER$$US-APOTEX-2024AP010342$APOTEX$Popat D, Sanghavi N, Singh A, Sawhney R.. MM-657 Parsonage Turner Syndrome Complicating Multiple Myeloma Therapy: ^Nothing to Shrug your Shoulders at^. Clinical Lymphoma, Myeloma and Leukemia. 2024;24 (Supp.1):S578$66$YR$$M$Y$$$20240917$$HP$US$US
243259751$24325975$1$I$$20240912$20240917$20240917$PER$$US-BIOGEN-2024BI01282449$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
243259761$24325976$1$I$$20240912$20240917$20240917$PER$$US-BIOGEN-2024BI01273034$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
243259771$24325977$1$I$20240901$20240913$20240917$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015113$JAZZ$$32$YR$$M$Y$$$20240917$$CN$US$US
243259791$24325979$1$I$$20240822$20240917$20240917$30DAY$$US-AMGEN-USASL2024175166$AMGEN$$$$$$Y$$$20240917$$CN$US$US
243259801$24325980$1$I$$20240628$20240917$20240917$PER$$US-ROCHE-10000016614$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243259812$24325981$2$F$20240508$20240916$20240917$20240920$EXP$$CO-TAKEDA-2024TUS047144$TAKEDA$$35$YR$$F$Y$62.8$KG$20240920$$CN$CO$CO
243259821$24325982$1$I$20240826$20240907$20240917$20240917$30DAY$$US-GSK-US2024111483$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240917$$CN$US$US
243259831$24325983$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146905$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240917$$HP$US$US
243259841$24325984$1$I$$20240906$20240917$20240917$PER$$US-APOTEX-2024AP010430$APOTEX$Smith A, Wong-O^Brien B, Lieberman JA, Cookson BT, Grinager E, Truong TT.. The Brief Case: A case of tinea corporis caused by drug-resistant Trichophyton indotineae identified by broad-range fungal DNA sequencing. Journal of Clinical Microbiology. 2024;62(8):e0023424$36$YR$$F$Y$$$20240917$$HP$US$US
243259851$24325985$1$I$20240815$20240911$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146259$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$48.6$KG$20240917$$HP$US$US
243259861$24325986$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184372$AMGEN$$$$$F$Y$$$20240917$$CN$US$US
243259871$24325987$1$I$20240901$20240905$20240917$20240917$30DAY$$US-AMGEN-USASP2024178062$AMGEN$$52$YR$A$$Y$$$20240917$$PH$US$US
243259881$24325988$1$I$20240101$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024182537$AMGEN$$71$YR$E$M$Y$$$20240917$$CN$US$US
243259891$24325989$1$I$$20240902$20240917$20240917$EXP$$MX-ASTELLAS-2024-AER-004679$ASTELLAS$Privacy P. Kidney transplant recipient with history of HIV, HBV, and past HCV infection.. AIDS Res Ther 21. 2024;(57): doi:https://doi.org/10.1186/s12981-024-00647-y.$51$YR$A$M$Y$$$20240917$$HP$MX$MX
243259901$24325990$1$I$$20240912$20240917$20240917$EXP$$US-ORG100016242-2024000580$PACIRA$$$$$M$Y$$$20240917$$MD$US$US
243259911$24325991$1$I$$20240828$20240917$20240917$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000882$PAREXEL$$$$$$Y$$$20240917$$HP$US$US
243259921$24325992$1$I$20240814$20240823$20240917$20240917$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000869$PAREXEL$$$$$$Y$$$20240917$$HP$US$US
243259931$24325993$1$I$$20240708$20240917$20240917$PER$$US-ROCHE-10000022427$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243259941$24325994$1$I$$20240908$20240917$20240917$PER$$US-ABBVIE-5917360$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243259951$24325995$1$I$20240521$20240906$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143386$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240917$$CN$US$US
243259961$24325996$1$I$20240101$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146875$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240917$$HP$US$US
243259971$24325997$1$I$$20240902$20240917$20240917$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08257$HIKMA$$37$YR$$F$Y$85$KG$20240917$$HP$CA$CA
243259981$24325998$1$I$20240221$20240912$20240917$20240917$EXP$$SA-SANDOZ INC.-SDZ2024SA049607$SANDOZ$$36$YR$$F$Y$$$20240917$$CN$SA$SA
243259991$24325999$1$I$$20240911$20240917$20240917$PER$$US-AstraZeneca-2024A211086$ASTRAZENECA$$$$$F$Y$$$20240917$$HP$US$
243260001$24326000$1$I$$20240905$20240917$20240917$PER$$US-AstraZeneca-2024A202803$ASTRAZENECA$$$$$F$Y$$$20240917$$PH$US$
243260011$24326001$1$I$$20240913$20240917$20240917$EXP$$CA-AstraZeneca-2024A210131$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$CA$
243260021$24326002$1$I$$20240911$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA079567$SANDOZ$$$$$F$Y$$$20240917$$HP$CA$CA
243260031$24326003$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008896$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240917$$CN$US$US
243260041$24326004$1$I$$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409007758$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240917$$CN$US$US
243260051$24326005$1$I$20240912$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009091$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240917$$CN$US$US
243260061$24326006$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009281$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240917$$CN$US$US
243260071$24326007$1$I$20240912$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009299$ELI LILLY AND CO$$75$YR$E$$Y$$$20240917$$CN$US$US
243260081$24326008$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009159$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240917$$CN$US$US
243260091$24326009$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008945$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240917$$CN$US$US
243260101$24326010$1$I$$20240905$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409003876$ELI LILLY AND CO$$21$YR$A$M$Y$$$20240917$$CN$US$US
243260111$24326011$1$I$20240801$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008000$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240917$$CN$US$US
243260121$24326012$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008940$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240917$$CN$US$US
243260131$24326013$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008212$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240917$$CN$US$US
243260151$24326015$1$I$$20240909$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144412$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240917$$CN$US$US
243260161$24326016$1$I$$20240905$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142856$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240917$$HP$US$US
243260171$24326017$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184764$AMGEN$$$$$$Y$$$20240917$$MD$US$US
243260181$24326018$1$I$20240801$20240828$20240917$20240917$PER$$US-TEVA-VS-3238896$TEVA$$$$A$F$Y$$$20240917$$HP$US$US
243260191$24326019$1$I$20240826$20240910$20240917$20240917$EXP$$ZA-GILEAD-2024-0687491$GILEAD$$$$$M$Y$$$20240917$$MD$ZA$ZA
243260201$24326020$1$I$$20240911$20240917$20240917$30DAY$$CO-UCBSA-2024047458$UCB$$$$$$Y$$$20240917$$CN$CO$CO
243260211$24326021$1$I$$20240905$20240917$20240917$EXP$$US-ASTELLAS-2024-AER-005887$ASTELLAS$Webb M. Triple-Organ Transplantation: Dual Heart-Kidney Transplantation After Lung Transplantation. JACC: Case Reports. 2024;29(17): 1-5. doi:10.1016/j.jaccas.2024.102493.$$$$M$Y$$$20240917$$MD$US$US
243260232$24326023$2$F$$20240916$20240917$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005459$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243260242$24326024$2$F$20240801$20240913$20240917$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005050$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240926$$CN$US$US
243260251$24326025$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000082119$ROCHE$$$$A$M$Y$$$20240917$$CN$US$US
243260261$24326026$1$I$20240409$20240909$20240917$20240917$EXP$$JP-GSK-JP2024050816$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$JP$JP
243260271$24326027$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185041$NOVARTIS$$$$$$Y$$$20240917$$HP$US$US
243260281$24326028$1$I$20220401$20240916$20240917$20240917$EXP$$JP-SANDOZ INC.-SDZ2024JP080376$SANDOZ$$21$YR$$F$Y$57$KG$20240917$$MD$JP$JP
243260291$24326029$1$I$20230905$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409050707446380-QNDPF$GB-Accord-445367$ACCORD$$45$YR$A$M$Y$69$KG$20240917$$MD$GB$GB
243260302$24326030$2$F$20230101$20240913$20240917$20240923$EXP$$TW-AMGEN-TWNSP2024182669$AMGEN$$$$$F$Y$$$20240923$$CN$TW$TW
243260312$24326031$2$F$20240914$20240918$20240917$20240919$PER$$US-AMGEN-USASP2024184471$AMGEN$$69$YR$E$F$Y$$$20240919$$CN$US$US
243260321$24326032$1$I$$20240916$20240917$20240917$EXP$$JP-SANDOZ INC.-SDZ2024JP080428$SANDOZ$$9$DEC$$M$Y$$$20240917$$MD$JP$JP
243260341$24326034$1$I$$20240910$20240917$20240917$30DAY$$US-SANDOZ INC.-SDZ2024US079426$SANDOZ$$70$YR$$F$Y$47.619$KG$20240917$$MD$US$US
243260351$24326035$1$I$20220901$20240911$20240917$20240917$EXP$$NVSC2022GB281391$NOVARTIS$$$$A$F$Y$$$20240917$$CN$GB$GB
243260361$24326036$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922532$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243260381$24326038$1$I$20240711$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409051602228240-CRTJQ$GB-Accord-445449$ACCORD$$$$$$Y$$$20240917$$HP$GB$GB
243260391$24326039$1$I$20240905$20240912$20240917$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2024114300$VIIV$$58$YR$$$Y$$$20240917$$CN$US$US
243260401$24326040$1$I$20240828$20240829$20240917$20240917$EXP$$US-SA-2024SA266813$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240917$$PH$US$US
243260411$24326041$1$I$20240101$20240913$20240917$20240917$PER$$US-AstraZeneca-2024A210412$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243260421$24326042$1$I$20240801$20240912$20240917$20240917$EXP$$US-ABBVIE-5922410$ABBVIE$$73$YR$$F$Y$$$20240917$$CN$US$US
243260441$24326044$1$I$20230122$20240902$20240917$20240917$EXP$ES-AEMPS-1353927$ES-CELLTRION INC.-2024ES022084$CELLTRION$$$$$$Y$$$20240917$$MD$ES$ES
243260451$24326045$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5924245$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243260461$24326046$1$I$20240501$20240910$20240917$20240917$30DAY$$US-GSK-US2024112513$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240917$$CN$US$US
243260471$24326047$1$I$$20240909$20240917$20240917$EXP$$CA-TAKEDA-2024TUS090518$TAKEDA$$$$$F$Y$$$20240917$$CN$CA$CA
243260481$24326048$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_07201679$CA-Accord-446004$ACCORD$$$$$$Y$$$20240917$$CN$CA$CA
243260491$24326049$1$I$20230324$20240911$20240917$20240917$EXP$$US-ABBVIE-5829275$ABBVIE$$90$YR$$F$Y$61$KG$20240917$$CN$US$US
243260501$24326050$1$I$20240820$20240905$20240917$20240917$EXP$ES-AEMPS-1565077$ES-Accord-445876$ACCORD$$86$YR$E$F$Y$$$20240917$$PH$ES$ES
243260511$24326051$1$I$$20240913$20240917$20240917$EXP$$HR-TAKEDA-2024TUS091844$TAKEDA$$52$YR$$F$Y$$$20240917$$HP$HR$HR
243260522$24326052$2$F$$20240909$20240917$20240923$EXP$$US-SANDOZ INC.-SDZ2024US079807$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
243260541$24326054$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5920703$ABBVIE$$$$$$Y$$$20240917$$HP$US$US
243260551$24326055$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008249$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243260561$24326056$1$I$20240908$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009269$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240917$$CN$US$US
243260571$24326057$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009334$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240917$$CN$US$US
243260582$24326058$2$F$$20240923$20240917$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409009120$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240930$$CN$US$US
243260591$24326059$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008282$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240917$$CN$US$US
243260601$24326060$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008259$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240917$$CN$US$US
243260611$24326061$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009097$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240917$$CN$US$US
243260621$24326062$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008947$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243260631$24326063$1$I$$20240910$20240917$20240917$EXP$$JP-GSK-JP2024113822$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$JP$JP
243260641$24326064$1$I$20240906$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009090$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240917$$CN$US$US
243260651$24326065$1$I$$20240916$20240917$20240917$EXP$$GR-SANDOZ INC.-SDZ2024GR080354$SANDOZ$$46$YR$$F$Y$$$20240917$$HP$GR$GR
243260661$24326066$1$I$20240902$20240907$20240917$20240917$30DAY$$US-GSK-US2024AMR111606$GLAXOSMITHKLINE$$35$YR$$F$Y$$$20240917$$CN$US$US
243260671$24326067$1$I$$20240910$20240917$20240917$EXP$$US-SA-2024SA266437$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240917$$MD$US$US
243260692$24326069$2$F$$20240916$20240917$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147418$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$79.83$KG$20240918$$CN$US$US
243260701$24326070$1$I$20240529$20240910$20240917$20240917$EXP$CH-SM-2024-15366$CH-UCBSA-2024046352$UCB$$59$YR$$M$Y$$$20240917$$HP$CH$CH
243260711$24326071$1$I$20240908$20240909$20240917$20240917$EXP$$CN-QILU TIANHE PHARMACEUTICAL CO. LTD-QLT-000033-2024$QILU TIANHE PHARMACEUTICAL$$68$YR$A$M$Y$$$20240913$$HP$CN$CN
243260721$24326072$1$I$$20240914$20240917$20240917$PER$$US-HALEON-2197025$Haleon PLC$$$$$$Y$$$20240917$$CN$US$US
243260732$24326073$2$F$$20240918$20240917$20240930$EXP$GB-MHRA-MIDB-5cc4d599-e189-497e-af68-6caf3191e77b$GB-Accord-445333$ACCORD$$16$YR$T$$Y$$$20240930$$PH$GB$GB
243260741$24326074$1$I$20240701$20240911$20240917$20240917$EXP$$US-ABBVIE-5922850$ABBVIE$$70$YR$$F$Y$$$20240917$$CN$US$US
243260751$24326075$1$I$$20240909$20240917$20240917$EXP$$CA-APOTEX-2024AP010352$APOTEX$$66$YR$$M$Y$$$20240917$$HP$CA$CA
243260761$24326076$1$I$20240101$20240912$20240917$20240917$EXP$$CA-ABBVIE-5922709$ABBVIE$$43$YR$$M$Y$$$20240917$$CN$CA$CA
243260771$24326077$1$I$20240601$20240911$20240917$20240917$EXP$$US-ABBVIE-5921780$ABBVIE$$33$YR$$F$Y$$$20240917$$CN$US$US
243260781$24326078$1$I$20240911$20240911$20240917$20240917$EXP$$JP-SA-2024SA263597$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240917$$MD$JP$JP
243260791$24326079$1$I$20240501$20240913$20240917$20240917$EXP$FR-AFSSAPS-BX2024001795$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-146314$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240917$$PH$FR$FR
243260801$24326080$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147433$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240917$$CN$US$US
243260821$24326082$1$I$20240616$20240617$20240917$20240917$PER$$US-CELLTRION INC.-2024US015059$CELLTRION$$$$$$Y$$$20240917$$CN$US$US
243260831$24326083$1$I$$20240911$20240917$20240917$EXP$$ES-AMGEN-ESPSP2024183023$AMGEN$$53$YR$A$M$Y$$$20240917$$MD$ES$ES
243260842$24326084$2$F$$20240919$20240917$20240927$EXP$$FR-TEVA-VS-3242604$TEVA$Camus C, Poinot M, Pronier C, Rayar M, Neillon AL, Latournerie M, et al. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transpl-Infect-Dis 2024; 26 (3): 1-10.; Camus C, Poinot M, Pronier C, Rayar M, Neillon AL, Latournerie M, et al. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transpl-Infect-Dis 2024; 26 (3): 1-10.; Camus C, Poinot M, Pronier C, Rayar M, Neillon ...$$$$$Y$$$20240927$$HP$FR$FR
243260851$24326085$1$I$$20240911$20240917$20240917$EXP$$DE-JNJFOC-20240934158$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$MD$DE$DE
243260861$24326086$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A209020$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243260871$24326087$1$I$20240911$20240910$20240917$20240917$EXP$$CA-TAKEDA-2024TUS090735$TAKEDA$$73$YR$$F$Y$$$20240917$$CN$CA$CA
243260881$24326088$1$I$$20240909$20240917$20240917$EXP$$VN-AstraZeneca-2024A210258$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$VN$
243260893$24326089$3$F$20240525$20240920$20240917$20240924$EXP$$JP-SA-2024SA263851$SANOFI AVENTIS$$57$YR$A$M$Y$52.9$KG$20240925$$MD$JP$JP
243260901$24326090$1$I$20231227$20240905$20240917$20240917$EXP$FR-AFSSAPS-TS2024000955$FR-Accord-445778$ACCORD$$63$YR$A$F$Y$73$KG$20240917$$MD$FR$FR
243260911$24326091$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000083034$ROCHE$$51$YR$A$M$Y$$$20240917$$CN$US$US
243260922$24326092$2$F$20230101$20240917$20240917$20240926$EXP$$US-Rhythm Pharmaceuticals, Inc.-2023RHM000017$RHYTHM PHARMACEUTICALS$$67$YR$E$M$Y$$$20240926$$MD$US$US
243260931$24326093$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5920587$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243260941$24326094$1$I$20240904$20240912$20240917$20240917$EXP$$US-ABBVIE-5922143$ABBVIE$$66$YR$$F$Y$$$20240917$$CN$US$US
243260951$24326095$1$I$20210612$20240903$20240917$20240917$PER$$US-Kiniksa Pharmaceuticals Ltd.-2021KPU000267$KINIKSA PHARMACEUTICALS$$62$YR$A$F$Y$$$20240913$$CN$US$US
243260981$24326098$1$I$20240101$20240911$20240917$20240917$EXP$$US-ABBVIE-5922138$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243260991$24326099$1$I$20240227$20240909$20240917$20240917$EXP$DE-BFARM-24006125$DE-ABBVIE-5925911$ABBVIE$$39$YR$$M$Y$111$KG$20240917$$MD$DE$DE
243261001$24326100$1$I$$20240912$20240917$20240917$EXP$$US-JNJFOC-20240934953$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240917$$HP$US$US
243261011$24326101$1$I$$20240712$20240917$20240917$PER$$US-CELLTRION INC.-2024US016443$CELLTRION$$$$$$Y$$$20240917$$HP$US$US
243261021$24326102$1$I$$20240903$20240917$20240917$EXP$$US-UCBSA-2024045190$UCB$$$$$F$Y$$$20240917$$CN$US$US
243261032$24326103$2$F$20240319$20240913$20240917$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004514$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$CN$CN
243261041$24326104$1$I$20240911$20240911$20240917$20240917$EXP$$US-JNJFOC-20240938189$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240917$$CN$US$US
243261051$24326105$1$I$$20240729$20240917$20240917$PER$$US-CELLTRION INC.-2024US018520$CELLTRION$$$$$$Y$$$20240917$$CN$US$US
243261061$24326106$1$I$$20240826$20240917$20240917$PER$$US-SERVIER-S24010799$SERVIER$$$$$$Y$$$20240917$$CN$US$US
243261081$24326108$1$I$20240101$20240903$20240917$20240917$EXP$$GB-UCBSA-2024045316$UCB$$$$$F$Y$$$20240917$$CN$GB$GB
243261091$24326109$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009274$ELI LILLY AND CO$$$$A$F$Y$$$20240917$$CN$US$US
243261101$24326110$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008965$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240917$$CN$US$US
243261111$24326111$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202407004083$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243261121$24326112$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008830$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240917$$CN$US$US
243261131$24326113$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009092$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243261141$24326114$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009242$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240917$$CN$US$US
243261151$24326115$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009087$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240917$$CN$US$US
243261161$24326116$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009322$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243261171$24326117$1$I$20240826$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009152$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240917$$CN$US$US
243261181$24326118$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009321$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243261191$24326119$1$I$$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008361$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240917$$CN$US$US
243261201$24326120$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009109$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240917$$CN$US$US
243261211$24326121$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009174$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240917$$CN$US$US
243261221$24326122$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008980$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240917$$CN$US$US
243261231$24326123$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009177$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240917$$CN$US$US
243261251$24326125$1$I$20240905$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009089$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240917$$CN$US$US
243261261$24326126$1$I$20240901$20240907$20240917$20240917$EXP$GB-MHRA-MED-202409071002210420-KPQMS$GB-TEVA-VS-3241879$TEVA$$43$YR$$M$Y$74$KG$20240917$$CN$GB$GB
243261281$24326128$1$I$20240101$20240908$20240917$20240917$EXP$GB-MHRA-MED-202409081949044920-PLMFG$GB-TEVA-VS-3241927$TEVA$$82$YR$$F$Y$$$20240917$$CN$GB$GB
243261291$24326129$1$I$20230625$20240916$20240917$20240917$EXP$$DE-SANDOZ INC.-SDZ2024DE080457$SANDOZ$$31$YR$$F$Y$50$KG$20240917$$MD$DE$DE
243261301$24326130$1$I$$20240905$20240917$20240917$EXP$$BR-Merck Healthcare KGaA-2024047930$MERCK KGAA$$$$$$Y$$$20240913$$CN$BR$BR
243261311$24326131$1$I$$20240909$20240917$20240917$PER$$US-ABBVIE-5916169$ABBVIE$$$$$M$Y$$$20240917$$HP$US$US
243261321$24326132$1$I$20240801$20240913$20240917$20240917$EXP$$US-ABBVIE-5908968$ABBVIE$$82$YR$$M$Y$78$KG$20240917$$CN$US$US
243261331$24326133$1$I$$20240911$20240917$20240917$PER$$US-HALEON-2196557$Haleon PLC$$83$YR$$F$Y$$$20240917$$CN$US$US
243261341$24326134$1$I$$20240909$20240917$20240917$EXP$$FR-TEVA-VS-3242605$TEVA$Camus C, Poinot M, Pronier C, Rayar M, Neillon AL, Latournerie M, et al. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transpl-Infect-Dis 2024; 26 (3): 1-10.; Camus C, Poinot M, Pronier C, Rayar M, Neillon AL, Latournerie M, et al. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transpl-Infect-Dis 2024; 26 (3): 1-10.$$$$$Y$$$20240917$$HP$FR$FR
243261351$24326135$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208567$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243261361$24326136$1$I$$20240913$20240917$20240917$EXP$$SG-AstraZeneca-2024A210226$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$SG$
243261372$24326137$2$F$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A210564$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243261381$24326138$1$I$20240907$20240908$20240917$20240917$EXP$GB-MHRA-MED-202409080153214700-MTCHY$GB-TEVA-VS-3241898$TEVA$$49$YR$$F$Y$82$KG$20240917$$CN$GB$GB
243261401$24326140$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_07208358$CA-Accord-445857$ACCORD$$$$$$Y$$$20240917$$HP$CA$CA
243261411$24326141$1$I$20230331$20240912$20240917$20240917$EXP$FR-AFSSAPS-AN2024001256$FR-RDY-SPO/FRA/24/0013434$DR REDDYS$$81$YR$E$F$Y$$$20240917$$PH$FR$FR
243261421$24326142$1$I$$20240909$20240917$20240917$EXP$$CA-APOTEX-2024AP010353$APOTEX$$3$YR$$$Y$$$20240917$$CN$CA$CA
243261431$24326143$1$I$$20240821$20240917$20240917$PER$$US-CELLTRION INC.-2024US020191$CELLTRION$$$$$$Y$$$20240917$$MD$US$US
243261441$24326144$1$I$20240720$20240912$20240917$20240917$EXP$$CN-JNJFOC-20240936225$JOHNSON AND JOHNSON$$70$YR$E$M$Y$67$KG$20240917$$HP$CN$CN
243261452$24326145$2$F$$20240919$20240917$20240927$EXP$$US-TEVA-VS-3243044$TEVA$Ordway S, Sadowski B, Driggers KE, Kwok R. Severe Drug-Induced Liver Injury in the Military: A Retrospective Review. Mil-Med 2023; 188 (5-6): e991-e996.; Ordway S, Sadowski B, Driggers KE, Kwok R. Severe Drug-Induced Liver Injury in the Military: A Retrospective Review. Mil-Med 2023; 188 (5-6): e991-e996.$$$$M$Y$$$20240927$$MD$US$US
243261461$24326146$1$I$$20240910$20240917$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2024112590$VIIV$$$$$$Y$$$20240917$$MD$US$US
243261472$24326147$2$F$20240801$20240913$20240917$20240926$PER$$US-AMGEN-USASP2024184169$AMGEN$$79$YR$E$M$Y$$$20240926$$CN$US$US
243261481$24326148$1$I$20240621$20240912$20240917$20240917$EXP$$AU-ABBVIE-5922067$ABBVIE$$48$YR$$F$Y$$$20240917$$HP$AU$AU
243261491$24326149$1$I$$20240905$20240917$20240917$EXP$$US-Accord-446294$ACCORD$$$$$F$Y$72.03$KG$20240917$$HP$US$US
243261501$24326150$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_001091011$CA-Accord-445844$ACCORD$$75$YR$E$M$Y$$$20240917$$PH$CA$CA
243261512$24326151$2$F$$20240919$20240917$20240927$EXP$$JP-TEVA-VS-3242315$TEVA$Matsuda M, Funakubo Asanuma Y, Emoto K, Sakai S, Okumura N, Yazawa H, et al. New-onset of rheumatic diseases following COVID-19 vaccination: the report of three cases and a literature review. [Review]. Immuno-Med 2024; 47 (3): 205-216.; Matsuda M, Funakubo Asanuma Y, Emoto K, Sakai S, Okumura N, Yazawa H, et al. New-onset of rheumatic diseases following COVID-19 vaccination: the report of three cases and a literature review. [Review]. Immuno-Med 2024; 47 (3): 205-216.; Matsuda M, Funakubo Asa...$79$YR$$F$Y$$$20240927$$HP$JP$JP
243261521$24326152$1$I$20240907$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184339$AMGEN$$79$YR$E$$Y$$$20240917$$CN$US$US
243261531$24326153$1$I$20230226$20240829$20240917$20240917$EXP$FR-AFSSAPS-TS2023000364$FR-CELLTRION INC.-2024FR022116$CELLTRION$$$$$$Y$$$20240917$$MD$FR$FR
243261541$24326154$1$I$$20240906$20240917$20240917$PER$$US-ROCHE-10000077357$ROCHE$$27$YR$A$F$Y$48.07$KG$20240917$$CN$US$US
243261551$24326155$1$I$$20240915$20240917$20240917$PER$$US-ABBVIE-5925912$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243261561$24326156$1$I$20240101$20240905$20240917$20240917$EXP$$US-Accord-446297$ACCORD$$40$YR$A$F$Y$$$20240917$$MD$US$US
243261571$24326157$1$I$$20240806$20240917$20240917$EXP$GB-MHRA-MED-202408051106299080-ZQGJB$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18333$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261581$24326158$1$I$$20240703$20240917$20240917$EXP$GB-MHRA-MED-202407021430447730-FCDYR$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14909$ALKEM$$$$$M$Y$$$20240917$$HP$GB$GB
243261591$24326159$1$I$$20240706$20240917$20240917$EXP$GB-MHRA-MED-202405101038181010-ZKWGV$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15365$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261601$24326160$1$I$$20240703$20240917$20240917$EXP$GB-MHRA-MED-202407021433266740-BSKJL$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14904$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261611$24326161$1$I$20240704$20240905$20240917$20240917$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08417$HIKMA$$$$$$Y$$$20240917$$MD$US$US
243261621$24326162$1$I$$20240911$20240917$20240917$EXP$$ES-Bion-013856$BIONPHARMA$$66$YR$E$M$Y$$$20240917$$HP$ES$ES
243261631$24326163$1$I$$20240703$20240917$20240917$EXP$GB-MHRA-MED-202407021423559480-GKNYF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14905$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261641$24326164$1$I$$20240806$20240917$20240917$EXP$GB-MHRA-MED-202408051107248440-KDMZT$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18335$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261651$24326165$1$I$$20240605$20240917$20240917$EXP$GB-MHRA-MED-202406040958011830-VMQNJ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-12327$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261661$24326166$1$I$$20240614$20240917$20240917$EXP$GB-MHRA-MED-202406131350489990-FSPJY$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13131$ALKEM$$$$$F$Y$$$20240917$$PH$GB$GB
243261671$24326167$1$I$$20240703$20240917$20240917$EXP$GB-MHRA-MED-202407021429099900-QTSDH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14912$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261682$24326168$2$F$$20240703$20240917$20240917$EXP$GB-MHRA-MED-202407021427568250-NBVLF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14914$ALKEM$$$$$M$Y$$$20240917$$HP$GB$GB
243261691$24326169$1$I$$20240605$20240917$20240917$EXP$GB-MHRA-MED-202406040952531790-CGYMV$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-12321$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261701$24326170$1$I$$20240703$20240917$20240917$EXP$GB-MHRA-MED-202407021435289210-HLGYQ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14919$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261711$24326171$1$I$$20240703$20240917$20240917$EXP$GB-MHRA-MED-202407021436430000-WHJFV$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14918$ALKEM$$$$$M$Y$$$20240917$$HP$GB$GB
243261722$24326172$2$F$$20240703$20240917$20240917$EXP$GB-MHRA-MED-202407021426450680-WLBQY$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14917$ALKEM$$$$$M$Y$$$20240917$$HP$GB$GB
243261731$24326173$1$I$$20240703$20240917$20240917$EXP$GB-MHRA-MED-202407021434271940-JCDZR$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14900$ALKEM$$$$$M$Y$$$20240917$$HP$GB$GB
243261741$24326174$1$I$$20240706$20240917$20240917$EXP$GB-MHRA-MED-202405101029557760-WCFTY$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-15364$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261751$24326175$1$I$$20240703$20240917$20240917$EXP$GB-MHRA-MED-202407021439045280-ZFDNP$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14916$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261761$24326176$1$I$$20240605$20240917$20240917$EXP$GB-MHRA-MED-202406040956239560-TLCRJ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-12325$ALKEM$$$$$M$Y$$$20240917$$HP$GB$GB
243261771$24326177$1$I$$20240605$20240917$20240917$EXP$GB-MHRA-MED-202406040954102600-RCHKN$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-12323$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261781$24326178$1$I$$20240703$20240917$20240917$EXP$GB-MHRA-MED-202407021432128170-BQHLW$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-14908$ALKEM$$$$$M$Y$$$20240917$$HP$GB$GB
243261791$24326179$1$I$$20240806$20240917$20240917$EXP$GB-MHRA-MED-202408051103019560-RBPZF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18361$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261801$24326180$1$I$$20240806$20240917$20240917$EXP$GB-MHRA-MED-202408051108186190-HGLJM$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18339$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261811$24326181$1$I$$20240806$20240917$20240917$EXP$GB-MHRA-MED-202408051057305950-JMWNG$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18354$ALKEM$$$$$M$Y$$$20240917$$HP$GB$GB
243261821$24326182$1$I$$20240806$20240917$20240917$EXP$GB-MHRA-MED-202408051105167870-GSWHT$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18362$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261831$24326183$1$I$$20240806$20240917$20240917$EXP$GB-MHRA-MED-202408051100461950-KYNWH$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-18360$ALKEM$$$$$F$Y$$$20240917$$HP$GB$GB
243261841$24326184$1$I$$20240911$20240917$20240917$EXP$$ES-Bion-013859$BIONPHARMA$$4$MON$I$F$Y$$$20240917$$HP$ES$ES
243261851$24326185$1$I$$20240911$20240917$20240917$EXP$$IT-Bion-013853$BIONPHARMA$$52$YR$A$M$Y$$$20240917$$HP$IT$IT
243261861$24326186$1$I$20240718$20240909$20240917$20240917$EXP$FR-AFSSAPS-RN2024000943$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112116$ZYDUS PHARM$$$$$$Y$$$20240917$$MD$FR$FR
243261871$24326187$1$I$$20240908$20240917$20240917$EXP$$IL-Merck Healthcare KGaA-2024049292$MERCK KGAA$$77$YR$E$F$Y$$$20240916$$CN$IL$IL
243261881$24326188$1$I$20240830$20240913$20240917$20240917$EXP$$US-GILEAD-2024-0687707$GILEAD$$57$YR$A$M$Y$$$20240917$$CN$US$US
243261891$24326189$1$I$$20240911$20240917$20240917$EXP$$PT-Bion-013854$BIONPHARMA$$79$YR$E$M$Y$$$20240917$$HP$PT$PT
243261901$24326190$1$I$20240826$20240911$20240917$20240917$EXP$$CN-AstraZeneca-2024A209832$ASTRAZENECA$$69$YR$$F$Y$48$KG$20240917$$MD$CN$
243261911$24326191$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A208197$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243261921$24326192$1$I$$20240910$20240917$20240917$EXP$$JP-AstraZeneca-2024A200995$ASTRAZENECA$$$$$$Y$$$20240917$$PH$JP$
243261931$24326193$1$I$$20240911$20240917$20240917$EXP$$US-Bion-013846$BIONPHARMA$$$$$F$Y$$$20240917$$HP$US$US
243261941$24326194$1$I$$20240911$20240917$20240917$EXP$$IT-Bion-013855$BIONPHARMA$$$$$F$Y$$$20240917$$HP$IT$IT
243261951$24326195$1$I$$20240911$20240917$20240917$EXP$$FR-AstraZeneca-2024A210021$ASTRAZENECA$$45$YR$$F$Y$$$20240917$$MD$FR$
243261961$24326196$1$I$20240801$20240909$20240917$20240917$EXP$$FR-BAUSCH-BL-2024-013759$BAUSCH AND LOMB$$56$YR$$M$Y$$$20240917$$MD$FR$FR
243261971$24326197$1$I$20240729$20240910$20240917$20240917$EXP$LU-ALMPS-202404298$LU-TEVA-VS-3242243$TEVA$$69$YR$$M$Y$77$KG$20240917$$PH$LU$LU
243261981$24326198$1$I$$20240909$20240917$20240917$EXP$$DK-SANDOZ INC.-SDZ2024DK079529$SANDOZ$Petersen CL, David M, Stilgren L, et al.. Atypical fractures of the lower extremities in two patients with rheumatoid arthritis: clinical presentations of presumed methotrexate osteopathy. BMJ Case Rep. 2024;17:e256567$$$$M$Y$$$20240917$$HP$DK$DK
243261991$24326199$1$I$20240601$20240909$20240917$20240917$EXP$FR-AFSSAPS-LM2024000485$FR-ROCHE-10000076906$ROCHE$$81$YR$E$M$Y$$$20240917$$MD$FR$FR
243262001$24326200$1$I$$20240909$20240917$20240917$EXP$$FR-SANDOZ INC.-PHHY2018FR001753$SANDOZ$$46$YR$$F$Y$61$KG$20240917$$MD$FR$FR
243262011$24326201$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009345$ELI LILLY AND CO$$$$$F$Y$$$20240917$$HP$US$US
243262021$24326202$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009318$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240917$$HP$US$US
243262031$24326203$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009058$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240917$$CN$US$US
243262041$24326204$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009230$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240917$$CN$US$US
243262051$24326205$1$I$20240911$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009168$ELI LILLY AND CO$$44$YR$A$$Y$$$20240917$$CN$US$US
243262061$24326206$1$I$$20240909$20240917$20240917$EXP$$DE-AMGEN-DEUSP2024179597$AMGEN$$88$YR$E$M$Y$$$20240917$$CN$DE$DE
243262071$24326207$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000082768$ROCHE$$$$A$F$Y$$$20240917$$CN$US$US
243262081$24326208$1$I$$20240911$20240917$20240917$EXP$$CA-BAUSCH-BL-2024-013685$BAUSCH AND LOMB$$44$YR$$F$Y$97$KG$20240917$$MD$CA$CA
243262092$24326209$2$F$$20240910$20240917$20240919$EXP$GB-MHRA-31806421$GB-TEVA-VS-3242131$TEVA$$$$$F$Y$$$20240919$$CN$GB$GB
243262101$24326210$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_07205201$CA-Accord-445713$ACCORD$$12$MON$I$M$Y$$$20240917$$HP$CA$CA
243262111$24326211$1$I$20240101$20240911$20240917$20240917$EXP$$CA-ABBVIE-5879138$ABBVIE$$80$YR$$M$Y$$$20240917$$PH$CA$CA
243262122$24326212$2$F$20210915$20240905$20240917$20240930$EXP$$JP-GSK-JP2024JPN110324$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$JP$JP
243262131$24326213$1$I$20240805$20240913$20240917$20240917$EXP$$DE-SANDOZ INC.-SDZ2024DE080071$SANDOZ$$76$YR$$M$Y$86.2$KG$20240917$$MD$DE$DE
243262142$24326214$2$F$20240101$20240918$20240917$20240924$EXP$$US-ABBVIE-5920802$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243262151$24326215$1$I$20240902$20240911$20240917$20240917$EXP$$US-ABBVIE-5920799$ABBVIE$$20$YR$$F$Y$$$20240917$$CN$US$US
243262171$24326217$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5920715$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243262181$24326218$1$I$20240101$20240828$20240917$20240917$PER$$US-JNJFOC-20240901560$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240917$$CN$US$US
243262192$24326219$2$F$20240701$20240927$20240917$20240930$PER$$US-AMGEN-USASP2024184425$AMGEN$$80$YR$E$F$Y$$$20240929$$CN$US$US
243262201$24326220$1$I$20231006$20240909$20240917$20240917$EXP$$CA-CELLTRION INC.-2022CA017053$CELLTRION$$$$$$Y$$$20240917$$HP$CA$CA
243262211$24326221$1$I$$20240906$20240917$20240917$PER$$US-APOTEX-2024AP010438$APOTEX$Liao A, Fajoles-Vasseneix C, Rali A, Ward L, Fernandes A, Patel PS, et al. Visual Morbidity and Outcomes of Scleritis Associated with Intraocular Inflammation Compared to Isolated Scleritis. Ocular Immunology and Inflammation. 2024;32:6:947-954$45$YR$$M$Y$$$20240917$$MD$US$US
243262221$24326222$1$I$$20240801$20240917$20240917$PER$$US-LUNDBECK-DKLU4002621$LUNDBECK$$$$$$Y$$$20240917$$HP$US$US
243262231$24326223$1$I$$20240910$20240917$20240917$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001849$BLUEPRINT MEDICINES$$$$$F$Y$$$20240917$$CN$US$US
243262241$24326224$1$I$$20240911$20240917$20240917$EXP$$HK-009507513-2409HKG004692$MERCK$$$$$F$Y$$$20240917$$MD$HK$HK
243262253$24326225$3$F$$20240913$20240917$20240922$EXP$$US-SANDOZ INC.-SDZ2024US080448$SANDOZ$$$$$F$Y$$$20240922$$CN$US$US
243262261$24326226$1$I$$20240911$20240917$20240917$EXP$$US-Taiho Oncology Inc-2024-008699$TAIHO ONCOLOGY INC$$$$E$M$Y$$$20240917$$CN$US$US
243262281$24326228$1$I$$20240802$20240917$20240917$PER$$US-LUNDBECK-DKLU4002619$LUNDBECK$$$$$$Y$$$20240917$$CN$US$US
243262291$24326229$1$I$20240908$20240908$20240917$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-028297$UNITED THERAPEUTICS$$67$YR$$M$Y$92.971$KG$20240917$$$US$US
243262301$24326230$1$I$$20240902$20240917$20240917$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08312$HIKMA$$$$$$Y$$$20240917$$MD$COUNTRY NOT SPECIFIED$CA
243262311$24326231$1$I$$20240802$20240917$20240917$PER$$US-LUNDBECK-DKLU4002613$LUNDBECK$$$$$$Y$$$20240917$$CN$US$US
243262321$24326232$1$I$$20240828$20240917$20240917$PER$$US-JNJFOC-20240901505$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$CN$US$US
243262331$24326233$1$I$$20240908$20240917$20240917$EXP$$GR-JNJFOC-20240931585$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240917$$HP$GR$GR
243262341$24326234$1$I$$20240329$20240917$20240917$EXP$$US-GSK-US2024AMR114080$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$US$US
243262351$24326235$1$I$$20231206$20240917$20240917$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424764$RANBAXY$$$$$M$Y$$$20240917$$CN$US$US
243262361$24326236$1$I$$20240110$20240917$20240917$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-427567$RANBAXY$$$$E$F$Y$$$20240917$$CN$US$US
243262371$24326237$1$I$$20240912$20240917$20240917$EXP$$US-SANDOZ INC.-NVSC2020US257252$SANDOZ$$$$$M$Y$63.492$KG$20240917$$CN$US$US
243262381$24326238$1$I$$20240806$20240917$20240917$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453807$RANBAXY$$$$E$F$Y$$$20240917$$CN$US$US
243262391$24326239$1$I$$20231012$20240917$20240917$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-409369$RANBAXY$$$$E$F$Y$$$20240917$$CN$US$US
243262401$24326240$1$I$$20231023$20240917$20240917$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415754$RANBAXY$$$$$$Y$$$20240917$$PH$US$US
243262411$24326241$1$I$$20240821$20240917$20240917$EXP$$US-SA-2024SA264742$SANOFI AVENTIS$$$$A$F$Y$56.82$KG$20240917$$MD$US$US
243262421$24326242$1$I$$20240909$20240917$20240917$EXP$$CA-APOTEX-2022AP017082$APOTEX$$$$$F$Y$$$20240917$$HP$CA$CA
243262431$24326243$1$I$20240701$20240802$20240917$20240917$PER$$US-LUNDBECK-DKLU4002611$LUNDBECK$$$$$$Y$$$20240917$$CN$US$US
243262441$24326244$1$I$20240101$20240911$20240917$20240917$EXP$$CA-ABBVIE-5921877$ABBVIE$$42$YR$$F$Y$$$20240917$$PH$CA$CA
243262452$24326245$2$F$20240801$20240917$20240917$20240925$EXP$$US-ABBVIE-5924601$ABBVIE$$77$YR$$F$Y$58$KG$20240925$$CN$US$US
243262461$24326246$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5920464$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243262471$24326247$1$I$20060401$20240911$20240917$20240917$EXP$$DE-CHEPLA-1200025542$CHEPLAPHARM$$43$YR$A$F$Y$67$KG$20240917$$MD$COUNTRY NOT SPECIFIED$DE
243262481$24326248$1$I$20240906$20240911$20240917$20240917$EXP$$US-ABBVIE-5921479$ABBVIE$$83$YR$$F$Y$$$20240917$$CN$US$US
243262491$24326249$1$I$20240906$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183002$AMGEN$$63$YR$A$F$Y$$$20240917$$HP$US$US
243262501$24326250$1$I$20230101$20240912$20240917$20240917$EXP$$US-ABBVIE-5922680$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243262511$24326251$1$I$20240702$20240910$20240917$20240917$EXP$HR-HALMED-300086454$HR-CHEPLA-2024011726$CHEPLAPHARM$$16$YR$$F$Y$$$20240917$$MD$COUNTRY NOT SPECIFIED$HR
243262521$24326252$1$I$$20240801$20240917$20240917$PER$$US-LUNDBECK-DKLU4002616$LUNDBECK$$$$$$Y$$$20240917$$PH$US$US
243262531$24326253$1$I$20240301$20240905$20240917$20240917$EXP$IT-MINISAL02-1000750$IT-Accord-445952$ACCORD$$76$YR$E$F$Y$60$KG$20240917$$MD$IT$IT
243262541$24326254$1$I$20221011$20240829$20240917$20240917$EXP$FR-AFSSAPS-LM2023000196$FR-CELLTRION INC.-2024FR022061$CELLTRION$$$$$$Y$$$20240917$$PH$FR$FR
243262561$24326256$1$I$20240715$20240911$20240917$20240917$EXP$FR-AFSSAPS-BX2024001742$FR-CHEPLA-2024011725$CHEPLAPHARM$$47$YR$$M$Y$88$KG$20240917$$MD$COUNTRY NOT SPECIFIED$FR
243262571$24326257$1$I$20240905$20240912$20240917$20240917$EXP$$US-ABBVIE-5923178$ABBVIE$$78$YR$$F$Y$$$20240917$$CN$US$US
243262581$24326258$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208961$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243262591$24326259$1$I$$20240903$20240917$20240917$PER$$US-AstraZeneca-2024A201193$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243262601$24326260$1$I$$20240905$20240917$20240917$PER$$US-AstraZeneca-2024A202917$ASTRAZENECA$$$$$$Y$$$20240917$$PH$US$
243262611$24326261$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210577$ASTRAZENECA$$$$$M$Y$131.5$KG$20240917$$HP$US$
243262621$24326262$1$I$$20240910$20240917$20240917$EXP$$DE-AMGEN-DEUSP2024180981$AMGEN$$67$YR$E$M$Y$$$20240917$$MD$DE$DE
243262632$24326263$2$F$20240911$20240917$20240917$20240917$PER$$US-AMGEN-USASP2024184836$AMGEN$$67$YR$E$M$Y$$$20240917$$CN$US$US
243262651$24326265$1$I$20240901$20240912$20240917$20240917$EXP$$DE-ROCHE-10000081994$ROCHE$$53$YR$A$F$Y$$$20240917$$MD$DE$DE
243262661$24326266$1$I$20230321$20240904$20240917$20240917$EXP$FR-AFSSAPS-LY2023000551$FR-CELLTRION INC.-2024FR022126$CELLTRION$$$$$$Y$$$20240917$$PH$FR$FR
243262671$24326267$1$I$$20240916$20240917$20240917$EXP$$GB-GILEAD-2024-0687842$GILEAD$$$$A$M$Y$$$20240917$$HP$GB$GB
243262681$24326268$1$I$$20240909$20240917$20240917$EXP$$CA-APOTEX-2024AP010373$APOTEX$$$$$M$Y$$$20240917$$CN$CA$CA
243262691$24326269$1$I$$20240802$20240917$20240917$PER$$US-LUNDBECK-DKLU4002620$LUNDBECK$$$$$$Y$$$20240917$$HP$US$US
243262701$24326270$1$I$20240901$20240916$20240917$20240917$EXP$$US-BAUSCH-BL-2024-013913$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240917$$CN$US$US
243262711$24326271$1$I$$20240916$20240917$20240917$EXP$$US-BAUSCH-BL-2024-013912$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240917$$CN$US$US
243262722$24326272$2$F$$20240912$20240917$20240919$EXP$$US-BAUSCH-BL-2024-013763$BAUSCH AND LOMB$$86$YR$$F$Y$$$20240919$$CN$US$US
243262731$24326273$1$I$$20240909$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409006238$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240917$$CN$US$US
243262741$24326274$1$I$20240101$20240909$20240917$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-028533$UNITED THERAPEUTICS$$$$$F$Y$56.689$KG$20240917$$$US$US
243262751$24326275$1$I$20190717$20240914$20240917$20240917$EXP$$CO-UCBSA-2024047454$UCB$$60$YR$$F$Y$$$20240917$$CN$CO$CO
243262761$24326276$1$I$20240801$20240911$20240917$20240917$EXP$$US-GILEAD-2024-0687615$GILEAD$$38$YR$A$F$Y$$$20240917$$CN$US$US
243262771$24326277$1$I$$20240802$20240917$20240917$PER$$US-LUNDBECK-DKLU4002618$LUNDBECK$$$$$$Y$$$20240917$$HP$US$US
243262791$24326279$1$I$20240901$20240910$20240917$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-028571$UNITED THERAPEUTICS$$63$YR$$M$Y$117.46$KG$20240917$$$US$US
243262801$24326280$1$I$$20240910$20240917$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-028572$UNITED THERAPEUTICS$$$$$M$Y$142.86$KG$20240917$$$US$US
243262811$24326281$1$I$$20240909$20240917$20240917$EXP$$US-JNJFOC-20240927071$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$HP$US$US
243262821$24326282$1$I$20240908$20240910$20240917$20240917$PER$$US-JNJFOC-20240927697$JOHNSON AND JOHNSON$$47$YR$A$$Y$$$20240917$$CN$US$US
243262831$24326283$1$I$$20240904$20240917$20240917$EXP$$US-SINTETICA US LLC-US-SIN-2024-00013$Sintetica$Shayla?Mena, Ashneel?Raj, William?Caldwell, and Amit?Kaushal. The annoyance of singultus: a case report of a rare adverse effect after epidural steroid injection. BMC Anesthesiology. 2024;24:302$49$YR$$M$Y$$$20240911$$MD$US$US
243262841$24326284$1$I$20240617$20240911$20240917$20240917$EXP$$EG-HIKMA PHARMACEUTICALS USA INC.-EG-H14001-24-08501$HIKMA$$37$YR$$F$Y$45$KG$20240917$$HP$EG$EG
243262852$24326285$2$F$20240819$20240919$20240917$20240924$EXP$$JP-GILEAD-2024-0687452$GILEAD$$93$YR$E$F$Y$$$20240924$$PH$JP$JP
243262861$24326286$1$I$$20240802$20240917$20240917$PER$$US-LUNDBECK-DKLU4002617$LUNDBECK$$$$$$Y$$$20240917$$HP$US$US
243262871$24326287$1$I$$20240805$20240917$20240917$PER$$US-LUNDBECK-DKLU4003197$LUNDBECK$$$$$$Y$$$20240917$$CN$US$US
243262881$24326288$1$I$$20240911$20240917$20240917$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900054$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243262891$24326289$1$I$$20240912$20240917$20240917$EXP$$PK-ROCHE-10000080762$ROCHE$$56$YR$A$F$Y$$$20240917$$CN$PK$PK
243262901$24326290$1$I$$20240910$20240917$20240917$PER$$US-ABBVIE-5921499$ABBVIE$$$$$$Y$$$20240917$$PH$US$US
243262911$24326291$1$I$$20240909$20240917$20240917$EXP$$JP-EXELIXIS-EXL-2024-000167$EXELIXIS$$9$DEC$$M$Y$$$20240917$$MD$JP$JP
243262921$24326292$1$I$$20240909$20240917$20240917$EXP$$JP-ROCHE-10000081387$ROCHE$Makabe R, Sasaki K, Fujita M. 49-Circulation-04 A case in which left intraventricular thrombus developed due to cancer therapeutics-related myocardial disorders. The 49th Annual Scientific Meeting of the Japanese Society of Sonographers. 2024$5$DEC$A$F$Y$$$20240917$$HP$JP$JP
243262931$24326293$1$I$$20240909$20240917$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-028635$UNITED THERAPEUTICS$$$$$F$Y$77.098$KG$20240917$$$US$US
243262941$24326294$1$I$$20240904$20240917$20240917$PER$$US-ABBVIE-5918860$ABBVIE$$$$$$Y$$$20240917$$CN$US$US
243262951$24326295$1$I$20240801$20240904$20240917$20240917$PER$$US-AstraZeneca-2024A201861$ASTRAZENECA$$1020$MON$$F$Y$85.7$KG$20240917$$HP$US$
243262961$24326296$1$I$$20240911$20240917$20240917$EXP$$ZA-AstraZeneca-2024A209055$ASTRAZENECA$$81$YR$$F$Y$$$20240917$$CN$ZA$
243262971$24326297$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A207243$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243262984$24326298$4$F$20240901$20240910$20240917$20240919$PER$$US-ROCHE-10000077279$ROCHE$$88$YR$E$F$Y$$$20240919$$CN$US$US
243262991$24326299$1$I$$20240912$20240917$20240917$EXP$$CA-AstraZeneca-2024A209816$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$CA$
243263001$24326300$1$I$20240301$20240912$20240917$20240917$EXP$$US-ABBVIE-5922851$ABBVIE$$52$YR$$M$Y$$$20240917$$CN$US$US
243263011$24326301$1$I$20240909$20240909$20240917$20240917$EXP$$GB-CELLTRION INC.-2024GB022040$CELLTRION$$$$$$Y$$$20240917$$CN$GB$GB
243263021$24326302$1$I$20240812$20240903$20240917$20240917$EXP$$US-BRAINTREE LABORATORIES, INC.-2024BTE00578$BRAINTREE$$$$$F$Y$$$20240917$$CN$US$US
243263031$24326303$1$I$$20240913$20240917$20240917$EXP$$US-GILEAD-2024-0687739$GILEAD$$44$YR$A$M$Y$$$20240917$$HP$US$US
243263041$24326304$1$I$$20240911$20240917$20240917$EXP$$US-JNJFOC-20240935038$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$CN$US$US
243263061$24326306$1$I$$20240905$20240917$20240917$EXP$GB-MHRA-MIDB-05eb5954-9762-4004-9c3d-bcdfff55175c$GB-Accord-445424$ACCORD$$71$YR$E$M$Y$$$20240917$$PH$GB$GB
243263081$24326308$1$I$$20240912$20240917$20240917$PER$$US-ABBVIE-5922654$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243263091$24326309$1$I$20240625$20240912$20240917$20240917$EXP$FR-AFSSAPS-PB2024000980$FR-AMGEN-FRASP2024182600$AMGEN$$80$YR$E$F$Y$49$KG$20240917$$PH$FR$FR
243263101$24326310$1$I$$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183493$AMGEN$$$$$$Y$$$20240917$$CN$US$US
243263111$24326311$1$I$$20240910$20240917$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-028720$UNITED THERAPEUTICS$$$$$M$Y$113.38$KG$20240917$$$US$US
243263121$24326312$1$I$20240911$20240911$20240917$20240917$EXP$$FR-ABBVIE-5923085$ABBVIE$$66$YR$$M$Y$$$20240917$$HP$FR$FR
243263131$24326313$1$I$$20240909$20240917$20240917$EXP$$FR-TEVA-VS-3242606$TEVA$Camus C, Poinot M, Pronier C, Rayar M, Neillon AL, Latournerie M, et al. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transpl-Infect-Dis 2024; 26 (3): 1-10.; Camus C, Poinot M, Pronier C, Rayar M, Neillon AL, Latournerie M, et al. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transpl-Infect-Dis 2024; 26 (3): 1-10.$$$$$Y$$$20240917$$HP$FR$FR
243263141$24326314$1$I$$20240905$20240917$20240917$EXP$NL-LRB-00999255$NL-Accord-446100$ACCORD$$53$YR$A$F$Y$63$KG$20240917$$CN$NL$NL
243263151$24326315$1$I$20240906$20240913$20240917$20240917$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024114166$VIIV$$30$YR$$M$Y$$$20240917$$HP$US$US
243263161$24326316$1$I$$20240910$20240917$20240917$EXP$$DE-ROCHE-10000079456$ROCHE$$$$$F$Y$$$20240917$$CN$DE$DE
243263171$24326317$1$I$20240823$20240912$20240917$20240917$EXP$$JP-GILEAD-2024-0687448$GILEAD$$74$YR$E$F$Y$45.2$KG$20240917$$PH$JP$JP
243263181$24326318$1$I$$20240903$20240917$20240917$EXP$$US-GRAVITIPHARMA-GRA-2409-US-LIT-0377$GRAVITI PHARMACEUTICALS$Steinbacher D, Murray B, Devlin T, Carson SS, Ford HJ.Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy.Pulm-Circ .2024;14:2$33$YR$A$M$Y$$$20240917$$HP$US$US
243263191$24326319$1$I$20080901$20240909$20240917$20240917$EXP$$FR-SANDOZ INC.-PHHY2017FR041418$SANDOZ$$69$YR$$M$Y$$$20240917$$MD$FR$FR
243263201$24326320$1$I$$20240916$20240917$20240917$PER$$US-ROCHE-10000083425$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243263211$24326321$1$I$20190919$20240904$20240917$20240917$EXP$PL-URPL-1-2296-2019$PL-CELLTRION INC.-2024PL022117$CELLTRION$$$$$$Y$$$20240917$$HP$PL$PL
243263221$24326322$1$I$$20240910$20240917$20240917$EXP$$JP-AMGEN-JPNSP2024184261$AMGEN$$$$$$Y$$$20240917$$MD$JP$JP
243263241$24326324$1$I$$20240911$20240917$20240917$PER$$US-ABBVIE-5923703$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243263251$24326325$1$I$$20240910$20240917$20240917$PER$$US-LEO Pharma-373499$LEO PHARM$$22$YR$$M$Y$$$20240917$$PH$US$US
243263261$24326326$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009175$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240917$$CN$US$US
243263271$24326327$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009059$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240917$$CN$US$US
243263282$24326328$2$F$20240913$20240916$20240917$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409009280$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240920$$CN$US$US
243263291$24326329$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009049$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243263302$24326330$2$F$20240101$20240918$20240917$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-021492$UNITED THERAPEUTICS$$$$$M$Y$97.959$KG$20240926$$$US$US
243263311$24326331$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922639$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243263321$24326332$1$I$20240501$20240826$20240917$20240917$PER$$US-JNJFOC-20240873230$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240917$$CN$US$US
243263331$24326333$1$I$$20240914$20240917$20240917$PER$$US-ALXN-202409USA001135US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243263341$24326334$1$I$$20240906$20240917$20240917$PER$$US-APOTEX-2024AP010439$APOTEX$Terashita M, Selamet U, Midha S, Nadeem O, Laubach J, Rennke HG, et al. Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones. Kidney International Reports. 2023;8:2765-2777$$$A$$Y$$$20240917$$HP$US$US
243263362$24326336$2$F$$20240914$20240917$20240917$PER$$US-BIOVITRUM-2024-US-012068$BIOVITRUM$$72$YR$$M$Y$$$20240917$$CN$US$US
243263371$24326337$1$I$$20240912$20240917$20240917$PER$$US-BIOVITRUM-2024-US-012100$BIOVITRUM$$75$YR$$F$Y$$$20240917$$CN$US$US
243263381$24326338$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A206709$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243263391$24326339$1$I$20240824$20240909$20240917$20240917$EXP$$CN-AstraZeneca-2024A208813$ASTRAZENECA$$56$YR$$M$Y$96$KG$20240917$$MD$CN$
243263401$24326340$1$I$20231002$20240916$20240917$20240917$EXP$$FR-AstraZeneca-2024A210762$ASTRAZENECA$$69$YR$$M$Y$93$KG$20240917$$MD$FR$
243263411$24326341$1$I$20240824$20240912$20240917$20240917$PER$$US-BIOVITRUM-2024-US-012092$BIOVITRUM$$73$YR$$F$Y$$$20240917$$CN$US$US
243263421$24326342$1$I$20240910$20240910$20240917$20240917$PER$$US-JNJFOC-20240927586$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$US$US
243263431$24326343$1$I$$20240910$20240917$20240917$EXP$$JP-EXELIXIS-EXL-2024-000171$EXELIXIS$$71$YR$$M$Y$$$20240917$$MD$JP$JP
243263441$24326344$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210587$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243263451$24326345$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_07207810$CA-Accord-445851$ACCORD$$$$C$M$Y$$$20240917$$HP$CA$CA
243263461$24326346$1$I$$20240912$20240917$20240917$PER$$US-ABBVIE-5923366$ABBVIE$$$$$$Y$$$20240917$$CN$US$US
243263472$24326347$2$F$20240915$20240917$20240917$20240918$PER$$US-AMGEN-USASP2024184799$AMGEN$$63$YR$A$M$Y$$$20240918$$CN$US$US
243263501$24326350$1$I$$20240912$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145955$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240917$$CN$US$US
243263511$24326351$1$I$20240910$20240910$20240917$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-028867$UNITED THERAPEUTICS$$59$YR$$F$Y$49.887$KG$20240917$$$US$US
243263522$24326352$2$F$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146933$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240917$$CN$US$US
243263531$24326353$1$I$20240828$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146801$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$71.7$KG$20240917$$PH$US$US
243263541$24326354$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147326$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240917$$CN$US$US
243263551$24326355$1$I$$20240905$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142437$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240917$$CN$US$US
243263563$24326356$3$F$$20240917$20240917$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147348$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240925$$MD$JP$JP
243263572$24326357$2$F$20240630$20240917$20240917$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147411$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240919$$PH$JP$JP
243263581$24326358$1$I$20240801$20240906$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142672$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$56.25$KG$20240917$$PH$US$US
243263591$24326359$1$I$$20240915$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146824$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240917$$MD$US$US
243263601$24326360$1$I$$20240915$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146834$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240917$$HP$US$US
243263611$24326361$1$I$20240817$20240910$20240917$20240917$EXP$$US-EMD Serono-2024048758$EMD SERONO INC$$48$YR$A$M$Y$$$20240917$$HP$US$US
243263621$24326362$1$I$20240830$20240904$20240917$20240917$EXP$CN-HENLIUS-24CN017040$CN-Accord-446953$ACCORD$$61$YR$A$F$Y$59.3$KG$20240917$$MD$CN$CN
243263631$24326363$1$I$20240901$20240913$20240917$20240917$PER$$US-BIOVITRUM-2024-US-012071$BIOVITRUM$$51$YR$$M$Y$$$20240917$$CN$US$US
243263641$24326364$1$I$20240902$20240912$20240917$20240917$EXP$$CO-UCBSA-2024047459$UCB$$64$YR$$M$Y$$$20240917$$CN$CO$CO
243263651$24326365$1$I$$20240910$20240917$20240917$PER$$US-ABBVIE-5919759$ABBVIE$$$$$$Y$$$20240917$$HP$US$US
243263662$24326366$2$F$20240827$20240923$20240917$20240927$EXP$$US-AMGEN-USASP2024180818$AMGEN$$84$YR$E$F$Y$$$20240927$$MD$US$US
243263671$24326367$1$I$20240801$20240913$20240917$20240917$EXP$$JP-TAKEDA-2024TJP013608$TAKEDA$$8$DEC$$F$Y$$$20240917$$MD$JP$JP
243263701$24326370$1$I$20240829$20240910$20240917$20240917$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-122968$REGENERON$$83$YR$$M$Y$$$20240917$$HP$CO$CO
243263711$24326371$1$I$$20240911$20240917$20240917$EXP$$US-TAKEDA-2021TUS069041$TAKEDA$$$$$F$Y$$$20240917$$CN$US$US
243263721$24326372$1$I$$20240909$20240917$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145309$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240917$$CN$JP$JP
243263731$24326373$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147061$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240917$$HP$US$US
243263741$24326374$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147216$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240917$$CN$US$US
243263751$24326375$1$I$$20240911$20240917$20240917$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001856$BLUEPRINT MEDICINES$$$$$M$Y$$$20240917$$CN$US$US
243263761$24326376$1$I$$20240913$20240917$20240917$PER$$US-ALXN-202409USA001103US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243263771$24326377$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001136US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243263781$24326378$1$I$20240401$20240905$20240917$20240917$EXP$FR-AFSSAPS-BX2024001717$FR-ROCHE-10000081223$ROCHE$$62$YR$A$F$Y$49$KG$20240917$$MD$FR$FR
243263791$24326379$1$I$20240811$20240907$20240917$20240917$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-122944$REGENERON$$67$YR$$F$Y$$$20240917$$HP$CO$CO
243263801$24326380$1$I$20240101$20240912$20240917$20240917$EXP$$US-ABBVIE-5923873$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243263811$24326381$1$I$$20240909$20240917$20240917$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024006751$BIOCON$$$$$$Y$$$20240917$$CN$AU$AU
243263821$24326382$1$I$$20240911$20240917$20240917$PER$$US-JNJFOC-20240939292$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243263831$24326383$1$I$$20240110$20240917$20240917$PER$$US-SPECGX-T202400445$SPECGX$$$$$$Y$$$20240917$$HP$US$US
243263841$24326384$1$I$$20240903$20240917$20240917$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01445$INTRA-CELLULAR THERAPIES$$28$YR$$F$Y$$$20240917$$MD$US$US
243263851$24326385$1$I$$20240910$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2023CA033881$SANDOZ$$$$$F$Y$17.73$KG$20240917$$CN$CA$CA
243263861$24326386$1$I$20240718$20240909$20240917$20240917$EXP$AT-BASGAGES-2024-006324$AT-TEVA-VS-3241899$TEVA$$67$YR$$M$Y$$$20240917$$CN$AT$AT
243263871$24326387$1$I$20240827$20240909$20240917$20240917$EXP$$BR-TAKEDA-2022TUS090710$TAKEDA$$54$YR$$F$Y$$$20240917$$CN$BR$BR
243263881$24326388$1$I$20201201$20240909$20240917$20240917$EXP$$PL-SANDOZ INC.-SDZ2024PL079011$SANDOZ$$49$YR$$M$Y$$$20240917$$CN$PL$PL
243263901$24326390$1$I$$20240916$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA080539$SANDOZ$$$$$F$Y$$$20240917$$CN$CA$CA
243263911$24326391$1$I$$20240911$20240917$20240917$PER$$US-AstraZeneca-2024A210781$ASTRAZENECA$$82$YR$$F$Y$$$20240917$$CN$US$
243263921$24326392$1$I$$20240910$20240917$20240917$EXP$$IN-AstraZeneca-2024A206290$ASTRAZENECA$$20088$DY$$F$Y$70$KG$20240917$$CN$IN$
243263931$24326393$1$I$20240913$20240913$20240917$20240917$PER$$US-ROCHE-10000082409$ROCHE$$$$$$Y$$$20240917$$HP$US$US
243263941$24326394$1$I$$20230807$20240917$20240917$PER$US-ALVOGEN-2023091822$US-ALVOGEN-2023091822$ALVOGEN$$$$$M$Y$$$20240917$$CN$US$US
243263951$24326395$1$I$$20240909$20240917$20240917$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024006750$BIOCON$$$$$$Y$$$20240917$$CN$AU$AU
243263972$24326397$2$F$$20240917$20240917$20240927$EXP$$CA-SAMIL-GLO2023CA002435$ASPEN$$$$$$Y$$$20240927$$CN$CA$CA
243263981$24326398$1$I$$20240909$20240917$20240917$EXP$PL-EMA-20170302-vermaevhp-142446004$PL-SANDOZ INC.-SDZ2024PL078823$SANDOZ$$13$YR$$M$Y$$$20240917$$HP$PL$PL
243263991$24326399$1$I$$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009382$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243264001$24326400$1$I$$20240904$20240917$20240917$EXP$$CA-AUROBINDO-AUR-APL-2024-045133$AUROBINDO$$36$YR$$F$Y$$$20240917$$HP$CA$CA
243264011$24326401$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009741$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243264021$24326402$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009157$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240917$$CN$US$US
243264031$24326403$1$I$$20240913$20240917$20240917$EXP$$US-JNJFOC-20240936990$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243264041$24326404$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS091496$TAKEDA$$$$$M$Y$$$20240917$$CN$US$US
243264051$24326405$1$I$$20240910$20240917$20240917$EXP$$DE-JNJFOC-20240931346$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$CN$DE$DE
243264061$24326406$1$I$20200101$20240909$20240917$20240917$EXP$$BR-BIOGEN-2024BI01282105$BIOGEN$$$$$F$Y$62$KG$20240917$$HP$BR$BR
243264071$24326407$1$I$20240519$20240909$20240917$20240917$EXP$$US-ABBVIE-5917482$ABBVIE$$$$$M$Y$3.45$KG$20240917$$CN$US$US
243264081$24326408$1$I$20240101$20240903$20240917$20240917$EXP$$US-INSMED, INC.-2024-02433-US$INSMED$$$$$F$Y$$$20240917$$CN$US$US
243264091$24326409$1$I$20240907$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024182727$AMGEN$$$$$$Y$$$20240917$$CN$US$US
243264102$24326410$2$F$20240914$20240917$20240917$20240918$PER$$US-AMGEN-USASP2024184563$AMGEN$$59$YR$A$F$Y$$$20240918$$CN$US$US
243264111$24326411$1$I$20180201$20240909$20240917$20240917$EXP$$CA-ROCHE-10000081401$ROCHE$$20$YR$A$F$Y$$$20240917$$CN$CA$CA
243264121$24326412$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024179771$AMGEN$$$$$F$Y$$$20240917$$CN$US$US
243264131$24326413$1$I$$20240910$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144813$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240917$$HP$US$US
243264142$24326414$2$F$$20240904$20240917$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-044616$AUROBINDO$Camus C, Poinot M, Pronier C, Rayar M, Neillon AL, Latournerie M, et al.. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients.. Transpl-Infect-Dis. 2024;26(3):1-10$$$$$Y$$$20240918$$HP$FR$FR
243264151$24326415$1$I$$20240910$20240917$20240917$EXP$$GB-TAKEDA-2024TUS091306$TAKEDA$$$$$F$Y$$$20240917$$MD$GB$GB
243264161$24326416$1$I$20240912$20240916$20240917$20240917$PER$$US-ALXN-202409USA001143US$ALEXION PHARMACEUTICALS$$66$YR$$F$Y$$$20240917$$CN$US$US
243264171$24326417$1$I$20240101$20240910$20240917$20240917$EXP$$CA-ABBVIE-5920020$ABBVIE$$62$YR$$F$Y$$$20240917$$CN$CA$CA
243264181$24326418$1$I$20240601$20240911$20240917$20240917$EXP$$US-ABBVIE-5920966$ABBVIE$$67$YR$$F$Y$$$20240917$$CN$US$US
243264191$24326419$1$I$20240904$20240912$20240917$20240917$EXP$$CN-AMGEN-CHNSP2024184354$AMGEN$$10$YR$C$F$Y$$$20240917$$HP$CN$CN
243264201$24326420$1$I$20170101$20240909$20240917$20240917$EXP$$BR-BIOGEN-2024BI01282099$BIOGEN$$$$$F$Y$62$KG$20240917$$HP$BR$BR
243264212$24326421$2$F$20240806$20240904$20240917$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-044600$AUROBINDO$$96$YR$$F$Y$54$KG$20240918$$MD$FR$FR
243264221$24326422$1$I$$20240908$20240917$20240917$EXP$$US-HETERO-HET2024US03087$HETERO$Lodha S, Loriaux D, Faulkner AL, Pearson K, Shah S.. Single-Dose Calcium Channel Blocker Toxicity in a Patient With Severe Liver Disease. Cureus.. 2024;16(8):e66308$56$YR$$F$Y$$$20240917$$HP$US$US
243264232$24326423$2$F$20240904$20240904$20240917$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044350$AUROBINDO$$66$YR$$F$Y$84$KG$20240918$$PH$GB$GB
243264241$24326424$1$I$20240501$20240910$20240917$20240917$EXP$NL-LRB-00999589$NL-TEVA-VS-3242668$TEVA$$53$YR$$F$Y$67$KG$20240917$$CN$NL$NL
243264251$24326425$1$I$$20240908$20240917$20240917$EXP$$TR-JNJFOC-20240934134$JOHNSON AND JOHNSON$$17$YR$T$$Y$$$20240917$$HP$TR$TR
243264261$24326426$1$I$20220101$20240910$20240917$20240917$EXP$$CA-TERSERA THERAPEUTICS LLC-2022TRS004430$TERSERA THERAPEUTICS$$$$$$Y$$$20240917$$CN$CA$CA
243264271$24326427$1$I$$20240909$20240917$20240917$EXP$$BR-TAKEDA-2024TUS017695$TAKEDA$$$$$F$Y$$$20240917$$CN$BR$BR
243264282$24326428$2$F$20240901$20240911$20240917$20240918$EXP$$US-ABBVIE-5918835$ABBVIE$$69$YR$$F$Y$$$20240918$$CN$US$US
243264291$24326429$1$I$$20240909$20240917$20240917$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024006746$BIOCON$$$$$$Y$$$20240917$$CN$AU$AU
243264301$24326430$1$I$$20240909$20240917$20240917$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024006752$BIOCON$$$$$$Y$$$20240917$$$AU$AU
243264311$24326431$1$I$20130925$20150729$20240917$20240917$EXP$$BD-SA-2018SA247971$SANOFI AVENTIS$$70$YR$E$M$Y$70$KG$20240917$$MD$BD$BD
243264331$24326433$1$I$20240905$20240909$20240917$20240917$EXP$$JP-ASTELLAS-2024-AER-005662$ASTELLAS$$8$DEC$E$M$Y$$$20240917$$MD$JP$JP
243264341$24326434$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184630$AMGEN$$23$YR$A$F$Y$$$20240917$$HP$US$US
243264351$24326435$1$I$20240101$20240911$20240917$20240917$EXP$$US-ABBVIE-5920345$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243264362$24326436$2$F$$20240910$20240917$20240917$PER$$US-ABBVIE-5919672$ABBVIE$$$$$$Y$$$20240917$$CN$US$US
243264371$24326437$1$I$20240101$20240821$20240917$20240917$EXP$$US-SA-2024SA266821$SANOFI AVENTIS$$$$E$M$Y$77.27$KG$20240917$$MD$US$US
243264381$24326438$1$I$$20240912$20240917$20240917$EXP$$US-GILEAD-2024-0687732$GILEAD$$$$A$M$Y$$$20240917$$CN$US$US
243264391$24326439$1$I$20240301$20240630$20240917$20240917$PER$$US-ROCHE-10000019028$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243264411$24326441$1$I$$20240911$20240917$20240917$EXP$$JP-GSK-JP2024JPN113210$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$JP$JP
243264421$24326442$1$I$$20240908$20240917$20240917$EXP$$US-HETERO-HET2024US03085$HETERO$Kolosionek TJ, Jiang RY, Meleis MM, Ebeling-Koning NE, Surmaitis RM, Kolosionek T et al. Polyethylene Glycol Misuse Causing Acute Renal Failure and Metabolic Acidosis Requiring Dialysis: A Case Report. Cureus. 2024;16(7):e65838$60$YR$$F$Y$$$20240917$$HP$US$US
243264431$24326443$1$I$20210527$20240904$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-044935$AUROBINDO$$95$YR$$F$Y$56$KG$20240917$$MD$FR$FR
243264441$24326444$1$I$20220101$20240909$20240917$20240917$EXP$$BR-BIOGEN-2024BI01282108$BIOGEN$$$$$F$Y$62$KG$20240917$$HP$BR$BR
243264451$24326445$1$I$20240909$20240913$20240917$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2024114272$VIIV$$29$YR$$M$Y$$$20240917$$CN$US$US
243264461$24326446$1$I$20240519$20240910$20240917$20240917$EXP$$JP-ROCHE-10000080074$ROCHE$$76$YR$E$M$Y$62.3$KG$20240917$$PH$JP$JP
243264471$24326447$1$I$$20240911$20240917$20240917$30DAY$$US-GSK-US2024113157$GLAXOSMITHKLINE$$$$$F$Y$$$20240917$$CN$US$US
243264491$24326449$1$I$$20240910$20240917$20240917$EXP$$CA-TAKEDA-2024TUS087324$TAKEDA$$$$$M$Y$$$20240917$$CN$CA$CA
243264501$24326450$1$I$$20240911$20240917$20240917$EXP$$US-SANDOZ INC.-SDZ2024US080165$SANDOZ$$56$YR$$F$Y$$$20240917$$MD$US$US
243264511$24326451$1$I$$20240912$20240917$20240917$EXP$$US-GILEAD-2024-0687734$GILEAD$$$$A$F$Y$$$20240917$$CN$US$US
243264521$24326452$1$I$$20240910$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145457$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$HP$US$US
243264531$24326453$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146883$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240917$$CN$US$US
243264541$24326454$1$I$$20240911$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146083$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240917$$CN$US$US
243264551$24326455$1$I$$20240912$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145954$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$74.84$KG$20240917$$CN$US$US
243264561$24326456$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS091558$TAKEDA$$$$$M$Y$$$20240917$$CN$US$US
243264571$24326457$1$I$$20240904$20240917$20240917$EXP$$CA-AUROBINDO-AUR-APL-2024-045233$AUROBINDO$$56$YR$$M$Y$$$20240917$$PH$CA$CA
243264582$24326458$2$F$20240901$20240916$20240917$20240925$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-029030$UNITED THERAPEUTICS$$79$YR$$F$Y$$$20240925$$$CA$CA
243264601$24326460$1$I$20240101$20240916$20240917$20240917$PER$$US-ABBVIE-5926277$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243264611$24326461$1$I$20240901$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409051237570570-RSHDJ$GB-FDC-2024GBSPO00682$FDC LIMITED$$70$YR$$$Y$$$20240917$$CN$GB$GB
243264621$24326462$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A211009$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243264631$24326463$1$I$20240912$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208828$ASTRAZENECA$$23938$DY$$$Y$$$20240917$$MD$US$
243264641$24326464$1$I$20240101$20240830$20240917$20240917$EXP$$US-SA-2024SA267311$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240917$$CN$US$US
243264651$24326465$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A209118$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243264661$24326466$1$I$$20240910$20240917$20240917$EXP$$BE-TAKEDA-2024TUS090719$TAKEDA$$$$$F$Y$$$20240917$$MD$BE$BE
243264671$24326467$1$I$$20240909$20240917$20240917$EXP$$JP-ROCHE-10000081477$ROCHE$Suzuki K, Akiyama M, Saito S, Kaneko Y. CASE REPORT Successful high-dose glucocorticoid therapy for anti-mitochondrial antibody-positive myocarditis arising during tocilizumab and low-dose glucocorticoid therapy for rheumatoi darthritis. Immunological Medicine. 2024;47 (3):200-4. doi:10.1080/25785826.2024.2336689.$81$YR$E$F$Y$$$20240917$$MD$JP$JP
243264681$24326468$1$I$20230101$20240904$20240917$20240917$EXP$$DE-AUROBINDO-AUR-APL-2024-044595$AUROBINDO$$65$YR$$F$Y$$$20240917$$CN$DE$DE
243264701$24326470$1$I$20240910$20240911$20240917$20240917$EXP$$FR-ABBVIE-5922595$ABBVIE$$69$YR$$M$Y$$$20240917$$HP$FR$FR
243264712$24326471$2$F$20240912$20240916$20240917$20240919$PER$$US-AMGEN-USASP2024184069$AMGEN$$73$YR$E$M$Y$$$20240918$$CN$US$US
243264722$24326472$2$F$20200401$20240911$20240917$20240923$EXP$$US-SA-2024SA266623$SANOFI AVENTIS$$$$C$M$Y$$$20240923$$MD$US$US
243264731$24326473$1$I$$20240910$20240917$20240917$EXP$$CA-TAKEDA-2024TUS090744$TAKEDA$$$$$F$Y$$$20240917$$MD$CA$CA
243264751$24326475$1$I$20240201$20240910$20240917$20240917$EXP$$CA-GSK-CA2023AMR069308$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$CA$CA
243264761$24326476$1$I$20230816$20231128$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003787$SAREPTA THERAPEUTICS$$10$YR$$M$Y$24.85$KG$20240917$$HP$US$US
243264781$24326478$1$I$$20240904$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2018-002360$AUROBINDO$Didier K, Beguinot I, Abou-Taam M, Servettaz A, Bani-Sadr F.. Sarcoidosis occurring after chemotherapy for breast cancer: Difficulty of drug causality assessment.. Therapie. 2017;72(6):705-8$46$YR$$F$Y$$$20240917$$HP$FR$FR
243264791$24326479$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147305$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240917$$HP$US$US
243264811$24326481$1$I$20240913$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146992$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$PH$US$US
243264822$24326482$2$F$$20240918$20240917$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144606$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240919$$CN$US$US
243264841$24326484$1$I$20240712$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146974$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$97.1$KG$20240917$$HP$US$US
243264851$24326485$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147406$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240917$$HP$US$US
243264861$24326486$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147151$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240917$$CN$US$US
243264871$24326487$1$I$20240101$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146744$BRISTOL MYERS SQUIBB$$27$YR$A$F$Y$$$20240917$$HP$US$US
243264891$24326489$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147193$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240917$$CN$US$US
243264911$24326491$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147208$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240917$$CN$US$US
243264921$24326492$1$I$$20231005$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003879$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240917$$HP$US$US
243264942$24326494$2$F$$20240919$20240917$20240927$EXP$$JP-TEVA-VS-3242194$TEVA$Oshima S, Sakuragi M, Morita H, Oka Y, Tabu H, Marumo S, et al. Successful treatment of tuberculous meningitis in an Indian female under hemodialysis therapy. CEN-Case-Rep 2023; 12 (4): 341-346.; Oshima S, Sakuragi M, Morita H, Oka Y, Tabu H, Marumo S, et al. Successful treatment of tuberculous meningitis in an Indian female under hemodialysis therapy. CEN-Case-Rep 2023; 12 (4): 341-346.; Oshima S, Sakuragi M, Morita H, Oka Y, Tabu H, Marumo S, et al. Successful treatment of tuberculous menin...$61$YR$$F$Y$$$20240927$$HP$JP$JP
243264951$24326495$1$I$20231005$20231006$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003884$SAREPTA THERAPEUTICS$$14$YR$$M$Y$$$20240917$$HP$US$US
243264961$24326496$1$I$20230929$20231002$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003862$SAREPTA THERAPEUTICS$$14$YR$$M$Y$$$20240917$$HP$US$US
243264971$24326497$1$I$20230904$20231206$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003797$SAREPTA THERAPEUTICS$$13$YR$$M$Y$37.596$KG$20240917$$HP$US$US
243264982$24326498$2$F$$20240912$20240917$20240927$EXP$$CN-CHIESI-2024CHF06010$CHIESI$$$$N$M$Y$$$20240927$$MD$CN$CN
243264991$24326499$1$I$20240729$20240913$20240917$20240917$EXP$$KR-ASTELLAS-2024-AER-006735$ASTELLAS$$76$YR$E$F$Y$$$20240917$$CN$KR$KR
243265002$24326500$2$F$20240831$20240917$20240917$20240923$EXP$$US-TAKEDA-2024TUS090791$TAKEDA$$30$YR$$F$Y$$$20240923$$CN$US$US
243265011$24326501$1$I$20240727$20240910$20240917$20240917$EXP$$JP-ASTELLAS-2024-AER-005964$ASTELLAS$$80$YR$E$M$Y$$$20240917$$PH$JP$JP
243265022$24326502$2$F$$20240919$20240917$20240927$EXP$$JP-TEVA-VS-3242193$TEVA$Mitsunaga K, Inoue Y, Naito C, Ogata H, Itoh Y, Natsui Y, et al. A case of A20 haploinsufficiency in which intestinal inflammation improved with thalidomide. Rheumatology 2022; 62 (6): E193-E195.; Mitsunaga K, Inoue Y, Naito C, Ogata H, Itoh Y, Natsui Y, et al. A case of A20 haploinsufficiency in which intestinal inflammation improved with thalidomide. Rheumatology 2022; 62 (6): E193-E195.; Mitsunaga K, Inoue Y, Naito C, Ogata H, Itoh Y, Natsui Y, et al. A case of A20 haploinsufficiency in wh...$$$C$M$Y$$$20240927$$HP$JP$JP
243265031$24326503$1$I$$20240917$20240917$20240917$EXP$$US-PROD-AS2-212756134-RB-109304-2023$RECKITT BENCKISER$$$$$M$Y$$$20240917$$CN$US$US
243265041$24326504$1$I$20231003$20231120$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003889$SAREPTA THERAPEUTICS$$10$YR$$M$Y$25.5$KG$20240917$$HP$US$US
243265051$24326505$1$I$20231108$20231109$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004021$SAREPTA THERAPEUTICS$$25$YR$$M$Y$$$20240917$$HP$US$US
243265061$24326506$1$I$20231013$20231020$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003945$SAREPTA THERAPEUTICS$$23$YR$$M$Y$63.96$KG$20240917$$HP$US$US
243265071$24326507$1$I$20231026$20231204$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004022$SAREPTA THERAPEUTICS$$14$YR$$M$Y$39$KG$20240917$$HP$US$US
243265081$24326508$1$I$$20240904$20240917$20240917$EXP$$US-AMRYT PHARMACEUTICALS DAC-AEGR007388$AEGERION$$$$$F$Y$$$20240917$$CN$US$US
243265091$24326509$1$I$20231026$20231201$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004024$SAREPTA THERAPEUTICS$$12$YR$$M$Y$36.6$KG$20240917$$HP$US$US
243265101$24326510$1$I$$20231229$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004070$SAREPTA THERAPEUTICS$$$$$M$Y$25.5$KG$20240917$$HP$US$US
243265111$24326511$1$I$20231117$20231212$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004055$SAREPTA THERAPEUTICS$$9$YR$$M$Y$27.9$KG$20240917$$HP$US$US
243265121$24326512$1$I$20231121$20231204$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004058$SAREPTA THERAPEUTICS$$14$YR$$M$Y$39.093$KG$20240917$$HP$US$US
243265131$24326513$1$I$20231012$20231031$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003905$SAREPTA THERAPEUTICS$$16$YR$$M$Y$111.11$KG$20240917$$HP$US$US
243265142$24326514$2$F$$20240919$20240917$20240927$EXP$$JP-TEVA-VS-3242188$TEVA$Hirakawa T, Tanimoto T, Hattori Y, Katsura R, Miyake S, Fujita S, et al. Pseudomesotheliomatous Carcinoma of the Lung with Morphological Characteristics of Signet Ring Cell Carcinoma: An Autopsy Case Report. Intern-Med 2024; 63 (7): 979-983.; Hirakawa T, Tanimoto T, Hattori Y, Katsura R, Miyake S, Fujita S, et al. Pseudomesotheliomatous Carcinoma of the Lung with Morphological Characteristics of Signet Ring Cell Carcinoma: An Autopsy Case Report. Intern-Med 2024; 63 (7): 979-983.; Hirakawa T,...$50$YR$$F$Y$$$20240927$$HP$JP$JP
243265151$24326515$1$I$20231013$20231020$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-003944$SAREPTA THERAPEUTICS$$23$YR$$M$Y$53.07$KG$20240917$$HP$US$US
243265161$24326516$1$I$20240829$20240905$20240917$20240917$EXP$IT-MINISAL02-1000925$IT-Accord-445973$ACCORD$$23$YR$A$F$Y$$$20240917$$PH$IT$IT
243265171$24326517$1$I$20240915$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009692$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240917$$CN$US$US
243265181$24326518$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008994$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240917$$CN$US$US
243265191$24326519$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008078$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240917$$CN$US$US
243265201$24326520$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009036$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240917$$CN$US$US
243265211$24326521$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009125$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240917$$CN$US$US
243265221$24326522$1$I$$20240910$20240917$20240917$EXP$$US-TAKEDA-2024TUS090385$TAKEDA$$$$$M$Y$$$20240917$$CN$US$US
243265231$24326523$1$I$20240824$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009468$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240917$$CN$US$US
243265241$24326524$1$I$$20240909$20240917$20240917$EXP$$CA-TAKEDA-2024TUS090317$TAKEDA$$$$$F$Y$$$20240917$$MD$CA$CA
243265251$24326525$1$I$20240801$20240909$20240917$20240917$EXP$$CA-TAKEDA-2024TUS090216$TAKEDA$$43$YR$$M$Y$$$20240917$$CN$CA$CA
243265261$24326526$1$I$20231221$20231227$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004185$SAREPTA THERAPEUTICS$$13$YR$$M$Y$$$20240917$$HP$US$US
243265271$24326527$1$I$$20240903$20240917$20240917$EXP$$IT-AUROBINDO-AUR-APL-2024-045753$AUROBINDO$Castelli B, Fonte C, Guidi M, Di Nicola M, Giunti L, Buccoliero AM, et al. ROLES OF GEMCITABINE-OXALIPLATIN (GEMOX) ADD-ON THERAPYIN INFANT-TYPE BRAIN TUMORS: A SINGLE CENTER EXPERIENCE. NEURO-ONCOLOGY. 2024;26 (Suppl.):iv194$$$I$$Y$$$20240917$$HP$IT$IT
243265281$24326528$1$I$$20240904$20240917$20240917$EXP$$US-AUROBINDO-AUR-APL-2024-044280$AUROBINDO$Ansari A, Dirani K, Malik A, Matthews S. Silent Manifestations of Disseminated Nocardia in a Renal Transplant Patient. Cureus. 2024;16(7):e65523$45$YR$$M$Y$$$20240917$$MD$US$US
243265291$24326529$1$I$20230101$20231211$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004124$SAREPTA THERAPEUTICS$$$$$M$Y$36$KG$20240917$$HP$US$US
243265301$24326530$1$I$20231208$20240102$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004127$SAREPTA THERAPEUTICS$$15$YR$$M$Y$67.574$KG$20240917$$HP$US$US
243265311$24326531$1$I$$20240208$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004160$SAREPTA THERAPEUTICS$$$$$M$Y$53.6$KG$20240917$$HP$US$US
243265321$24326532$1$I$20231204$20240312$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004132$SAREPTA THERAPEUTICS$$19$YR$$M$Y$52.7$KG$20240917$$HP$US$US
243265331$24326533$1$I$20231208$20231208$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004112$SAREPTA THERAPEUTICS$$16$YR$$M$Y$$$20240917$$HP$US$US
243265341$24326534$1$I$20240101$20240312$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004277$SAREPTA THERAPEUTICS$$24$YR$$M$Y$$$20240917$$HP$US$US
243265351$24326535$1$I$$20240906$20240917$20240917$EXP$$JP-AMGEN-JPNSP2024183646$AMGEN$$80$YR$E$F$Y$$$20240917$$CN$JP$JP
243265361$24326536$1$I$20231229$20240112$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004200$SAREPTA THERAPEUTICS$$15$YR$$M$Y$28.8$KG$20240917$$HP$US$US
243265371$24326537$1$I$20231116$20240104$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004168$SAREPTA THERAPEUTICS$$10$YR$$M$Y$27$KG$20240917$$HP$US$US
243265381$24326538$1$I$20240101$20240910$20240917$20240917$EXP$$US-AMGEN-USASP2024181183$AMGEN$$62$YR$A$F$Y$$$20240917$$CN$US$US
243265391$24326539$1$I$$20240909$20240917$20240917$EXP$$CA-TAKEDA-2024TUS090504$TAKEDA$$$$$F$Y$$$20240917$$CN$CA$CA
243265401$24326540$1$I$20231113$20240730$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2023-004101$SAREPTA THERAPEUTICS$$12$YR$$M$Y$56.4$KG$20240917$$PH$US$US
243265411$24326541$1$I$20240625$20240911$20240917$20240917$EXP$$CA-TAKEDA-2024TUS091175$TAKEDA$$72$YR$$F$Y$$$20240917$$MD$CA$CA
243265421$24326542$1$I$$20240909$20240917$20240917$EXP$$US-GSK-US2024111928$GLAXOSMITHKLINE$$$$$F$Y$$$20240917$$MD$US$US
243265441$24326544$1$I$$20240702$20240917$20240917$PER$$US-ROCHE-10000018350$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243265451$24326545$1$I$20201201$20240904$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-044760$AUROBINDO$$64$YR$$M$Y$102$KG$20240917$$MD$FR$FR
243265481$24326548$1$I$$20240912$20240917$20240917$EXP$$CA-TAKEDA-2024TUS091669$TAKEDA$$$$$F$Y$$$20240917$$MD$CA$CA
243265511$24326551$1$I$20240221$20240311$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004419$SAREPTA THERAPEUTICS$$12$YR$$M$Y$54.43$KG$20240917$$HP$US$US
243265521$24326552$1$I$20240128$20240201$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004324$SAREPTA THERAPEUTICS$$17$YR$$M$Y$$$20240917$$CN$US$US
243265531$24326553$1$I$$20240410$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004543$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240917$$HP$US$US
243265541$24326554$1$I$20240408$20240521$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004547$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240917$$HP$US$US
243265551$24326555$1$I$$20240216$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004335$SAREPTA THERAPEUTICS$$$$$M$Y$20.4$KG$20240917$$HP$US$US
243265561$24326556$1$I$20231229$20240129$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004306$SAREPTA THERAPEUTICS$$33$YR$$M$Y$40.9$KG$20240917$$HP$US$US
243265571$24326557$1$I$20240222$20240304$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004400$SAREPTA THERAPEUTICS$$13$YR$$M$Y$26.744$KG$20240917$$HP$US$US
243265581$24326558$1$I$20230809$20240129$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004304$SAREPTA THERAPEUTICS$$16$YR$$M$Y$58.1$KG$20240917$$HP$US$US
243265591$24326559$1$I$20240207$20240225$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004363$SAREPTA THERAPEUTICS$$16$YR$$M$Y$$$20240917$$HP$US$US
243265601$24326560$1$I$20240213$20240326$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004374$SAREPTA THERAPEUTICS$$20$YR$$M$Y$20.78$KG$20240917$$HP$US$US
243265611$24326561$1$I$$20240904$20240917$20240917$EXP$$CA-AUROBINDO-AUR-APL-2024-045322$AUROBINDO$$60$YR$$F$Y$68$KG$20240917$$MD$CA$CA
243265622$24326562$2$F$20240926$20240926$20240917$20240930$EXP$$CA-TAKEDA-2024TUS092226$TAKEDA$$71$YR$$F$Y$$$20240930$$MD$CA$CA
243265631$24326563$1$I$20240401$20240419$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004568$SAREPTA THERAPEUTICS$$9$YR$$M$Y$$$20240917$$HP$US$US
243265641$24326564$1$I$20240404$20240610$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004560$SAREPTA THERAPEUTICS$$19$YR$$M$Y$57.596$KG$20240917$$HP$US$US
243265651$24326565$1$I$$20240913$20240917$20240917$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-123198$REGENERON$$$$$F$Y$$$20240917$$MD$US$US
243265661$24326566$1$I$20240401$20240610$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004752$SAREPTA THERAPEUTICS$$19$YR$$M$Y$57.6$KG$20240917$$HP$US$US
243265671$24326567$1$I$20240701$20240711$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004854$SAREPTA THERAPEUTICS$$17$YR$$M$Y$$$20240917$$HP$US$US
243265681$24326568$1$I$$20240605$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004721$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240917$$HP$US$US
243265691$24326569$1$I$20240404$20240814$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004588$SAREPTA THERAPEUTICS$$16$YR$$M$Y$126.98$KG$20240917$$HP$US$US
243265701$24326570$1$I$20240517$20240619$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004688$SAREPTA THERAPEUTICS$$21$YR$$M$Y$$$20240917$$HP$US$US
243265711$24326571$1$I$20240607$20240612$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004748$SAREPTA THERAPEUTICS$$20$YR$$M$Y$54.43$KG$20240917$$HP$US$US
243265721$24326572$1$I$20240101$20240627$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004810$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240917$$HP$US$US
243265731$24326573$1$I$20240417$20240529$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004570$SAREPTA THERAPEUTICS$$23$YR$$M$Y$79$KG$20240917$$HP$US$US
243265741$24326574$1$I$20201223$20240903$20240917$20240917$EXP$$GB-CIPLA LTD.-2024GB09805$CIPLA$$$$$$Y$$$20240917$$HP$GB$GB
243265752$24326575$2$F$20140101$20240919$20240917$20240924$EXP$$FR-AMGEN-FRASP2024180859$AMGEN$$22$YR$A$F$Y$54$KG$20240924$$MD$FR$FR
243265761$24326576$1$I$20150701$20240910$20240917$20240917$EXP$$AT-AMGEN-AUTSP2024180111$AMGEN$$57$YR$A$M$Y$70$KG$20240917$$MD$AT$AT
243265771$24326577$1$I$20240805$20240912$20240917$20240917$EXP$$DE-AMGEN-DEUSP2024182623$AMGEN$$76$YR$E$M$Y$86.2$KG$20240917$$MD$DE$DE
243265781$24326578$1$I$20231124$20240909$20240917$20240917$EXP$PT-INFARMED-R202408-729$PT-ROCHE-10000076532$ROCHE$$67$YR$E$F$Y$$$20240917$$MD$PT$PT
243265791$24326579$1$I$$20240904$20240917$20240917$EXP$$GB-AUROBINDO-AUR-APL-2024-044336$AUROBINDO$$86$YR$$$Y$$$20240917$$PH$GB$GB
243265801$24326580$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001147US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243265811$24326581$1$I$$20240909$20240917$20240917$EXP$$US-RDY-SPO/USA/24/0013502$DR REDDYS$Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Huang BJ, et al. Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies. Pediatric Blood and Cancer. 2023 Jun;70(6): doi:10.1002/pbc.30335.$14$YR$T$M$Y$$$20240917$$HP$US$US
243265821$24326582$1$I$20240101$20240911$20240917$20240917$EXP$$US-ABBVIE-5921585$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243265831$24326583$1$I$$20240913$20240917$20240917$EXP$$LV-TAKEDA-2024TUS092096$TAKEDA$$$$$F$Y$$$20240917$$CN$LV$LV
243265841$24326584$1$I$20240101$20240730$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004867$SAREPTA THERAPEUTICS$$$$$M$Y$44.99$KG$20240917$$HP$US$US
243265851$24326585$1$I$20240724$20240726$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004907$SAREPTA THERAPEUTICS$$22$YR$$M$Y$$$20240917$$HP$US$US
243265861$24326586$1$I$20240716$20240729$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004883$SAREPTA THERAPEUTICS$$14$YR$$M$Y$18.69$KG$20240917$$HP$US$US
243265871$24326587$1$I$20240101$20240715$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004866$SAREPTA THERAPEUTICS$$$$$M$Y$45.624$KG$20240917$$HP$US$US
243265881$24326588$1$I$20240816$20240828$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004983$SAREPTA THERAPEUTICS$$19$YR$$M$Y$74.4$KG$20240917$$HP$US$US
243265891$24326589$1$I$$20240912$20240917$20240917$EXP$PL-002147023-PHHY2014PL151886$PL-LEO Pharma-373458$LEO PHARM$Kaminska D, Koscielska-Kasprzak K, Myszka M, Banasik M, Chelmonski A, Boratynska M et al.,. Significant infections after hand transplantation in a polish population. TRANSPLANTATION PROCEEDINGS. 2014;46:2887-9.$$$A$M$Y$$$20240917$$HP$PL$PL
243265901$24326590$1$I$20240715$20240908$20240917$20240917$EXP$$RU-AMAROX PHARMA-HET2024RU03061$HETERO$$$$A$F$Y$77$KG$20240917$$MD$RU$RU
243265911$24326591$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A208869$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243265921$24326592$1$I$20240823$20240823$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005007$SAREPTA THERAPEUTICS$$17$YR$$M$Y$$$20240917$$HP$US$US
243265931$24326593$1$I$20240824$20240905$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005045$SAREPTA THERAPEUTICS$$11$YR$$M$Y$$$20240917$$HP$US$US
243265941$24326594$1$I$20240101$20240823$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005008$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240917$$HP$US$US
243265951$24326595$1$I$20240828$20240828$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005024$SAREPTA THERAPEUTICS$$17$YR$$M$Y$$$20240917$$HP$US$US
243265961$24326596$1$I$$20240912$20240917$20240917$EXP$$KR-AstraZeneca-2024A208729$ASTRAZENECA$$$$T$F$Y$38.5$KG$20240917$$CN$KR$
243265971$24326597$1$I$$20240911$20240917$20240917$EXP$$CA-AstraZeneca-2024A210127$ASTRAZENECA$$$$$$Y$$$20240917$$MD$CA$
243265981$24326598$1$I$$20240911$20240917$20240917$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2016-VEL-00170$VELOXIS PHARMACEUTICALS$Rattner P, Sutherland A.. Aspergillus nidulans: A rare cause of invasive pulmonary aspergillosis resulting in diffuse alveolar haemorrhage. Chest. 2016;150(4):157A$25$YR$$F$Y$$$20240917$$MD$US$US
243265991$24326599$1$I$20240820$20240820$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-004990$SAREPTA THERAPEUTICS$$16$YR$$M$Y$57.3$KG$20240917$$HP$US$US
243266001$24326600$1$I$$20240905$20240917$20240917$PER$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005046$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240917$$HP$US$US
243266011$24326601$1$I$20240101$20240905$20240917$20240917$PER$$US-ASTELLAS-2024-AER-005202$ASTELLAS$$86$YR$E$M$Y$$$20240917$$CN$US$US
243266021$24326602$1$I$$20240911$20240917$20240917$EXP$$IN-ROCHE-10000080730$ROCHE$$66$YR$E$F$Y$$$20240917$$CN$IN$IN
243266031$24326603$1$I$$20240908$20240917$20240917$PER$$US-AMGEN-USASP2024179684$AMGEN$$$$$F$Y$$$20240917$$HP$US$US
243266041$24326604$1$I$20240817$20240910$20240917$20240917$EXP$$US-Vifor (International) Inc.-VIT-2024-08276$VIFOR$$22$YR$$F$Y$122.5$KG$20240917$$HP$US$US
243266051$24326605$1$I$20240807$20240910$20240917$20240917$EXP$$US-Vifor (International) Inc.-VIT-2024-08316$VIFOR$$28$YR$$F$Y$51.5$KG$20240917$$HP$US$US
243266061$24326606$1$I$20240827$20240910$20240917$20240917$EXP$$US-Vifor (International) Inc.-VIT-2024-08321$VIFOR$$46$YR$$M$Y$122.5$KG$20240917$$HP$US$US
243266071$24326607$1$I$$20240910$20240917$20240917$EXP$$CZ-TAKEDA-2024TUS091471$TAKEDA$$$$A$M$Y$$$20240917$$CN$CZ$CZ
243266082$24326608$2$F$$20240913$20240917$20240926$EXP$$GB-ADVANZ PHARMA-202408007272$ADVANZ PHARMA$$$$$$Y$$$20240926$$MD$GB$GB
243266091$24326609$1$I$$20240909$20240917$20240917$EXP$$IN-ROCHE-10000055018$ROCHE$$62$YR$A$M$Y$$$20240917$$CN$IN$IN
243266101$24326610$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_07210833$CA-Accord-446014$ACCORD$$48$YR$A$F$Y$$$20240917$$HP$CA$CA
243266111$24326611$1$I$20240809$20240910$20240917$20240917$EXP$$US-Vifor (International) Inc.-VIT-2024-08277$VIFOR$$66$YR$$F$Y$105$KG$20240917$$HP$US$US
243266131$24326613$1$I$$20240910$20240917$20240917$EXP$$US-Taiho Oncology Inc-2024-008680$TAIHO ONCOLOGY INC$$$$A$M$Y$$$20240917$$HP$US$US
243266141$24326614$1$I$$20240914$20240917$20240917$PER$$US-AMGEN-USASP2024184394$AMGEN$$$$A$F$Y$$$20240917$$CN$US$US
243266151$24326615$1$I$$20240909$20240917$20240917$EXP$$US-RDY-SPO/USA/24/0013446$DR REDDYS$Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Huang BJ, et al. Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies. Pediatric Blood and Cancer. 2023 Jun;70(6): doi:10.1002/pbc.30335.$17$YR$T$F$Y$$$20240917$$HP$US$US
243266161$24326616$1$I$$20240909$20240917$20240917$EXP$$US-RDY-SPO/USA/24/0013504$DR REDDYS$Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Huang BJ, et al. Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies. Pediatric Blood and Cancer. 2023 Jun;70(6): doi:10.1002/pbc.30335.$5$YR$C$F$Y$$$20240917$$HP$US$US
243266171$24326617$1$I$20240905$20240909$20240917$20240917$PER$$US-RDY-SPO/USA/24/0013245$DR REDDYS$$34$YR$A$M$Y$$$20240917$$HP$US$US
243266181$24326618$1$I$$20240909$20240917$20240917$EXP$$ES-CHIESI-2024CHF05884$CHIESI$$$$$M$Y$$$20240917$$CN$ES$ES
243266191$24326619$1$I$$20240911$20240917$20240917$EXP$US-MLMSERVICE-20240905-PI180178-00145-1$US-RDY-SPO/USA/24/0013409$DR REDDYS$Schwetye KE, Nair LR, Boyle J, Barash JA. Histopathologic correlates of opioid-associated injury in CHANTER syndrome: first report of a post-mortem examination. Acta neuropathologica. 2024;148(1):33. DOI: 10.1007/s00401-024-02797-9.$45$YR$A$M$Y$$$20240917$$MD$US$US
243266201$24326620$1$I$$20240905$20240917$20240917$PER$$US-ASTELLAS-2024-AER-005257$ASTELLAS$$$$$M$Y$$$20240917$$PH$US$US
243266221$24326622$1$I$$20240910$20240917$20240917$EXP$$AU-GSK-AU2024112166$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$AU$AU
243266231$24326623$1$I$$20240912$20240917$20240917$PER$$US-TAKEDA-2024TUS091301$TAKEDA$$$$$$Y$$$20240917$$CN$US$US
243266241$24326624$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001168US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243266251$24326625$1$I$20230905$20240917$20240917$20240917$EXP$$US-PROD-AS2-212756134-RB-110183-2023$RECKITT BENCKISER$$84$YR$$F$Y$52.61$KG$20240917$$CN$US$US
243266261$24326626$1$I$$20240708$20240917$20240917$PER$$US-ROCHE-10000021812$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243266271$24326627$1$I$20240831$20240909$20240917$20240917$PER$$US-ABBVIE-5916473$ABBVIE$$67$YR$$F$Y$$$20240917$$CN$US$US
243266281$24326628$1$I$$20240910$20240917$20240917$EXP$$AU-EMD Serono-2024048824$EMD SERONO INC$$14$YR$T$M$Y$$$20240917$$CN$AU$AU
243266291$24326629$1$I$20240906$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009001$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243266301$24326630$1$I$20240916$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009695$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243266311$24326631$1$I$20240101$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009123$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243266331$24326633$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009032$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240917$$CN$US$US
243266341$24326634$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009133$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240917$$CN$US$US
243266351$24326635$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000082644$ROCHE$$53$YR$A$F$Y$$$20240917$$CN$US$US
243266361$24326636$1$I$20240909$20240909$20240917$20240917$EXP$$CA-JNJFOC-20240915572$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240917$$HP$CA$CA
243266372$24326637$2$F$$20240919$20240917$20240927$EXP$$US-TEVA-VS-3242972$TEVA$Gondal M, Shirali AC. Isolated Hyperphosphatemia with Suppressed Urinary Phosphate Excretion in a Patient with Undifferentiated Leukemia. J-Am-Soc-Nephrol 2016; 27 (Suppl.) (11): 1025A abstr. PUB529.; Gondal M, Shirali AC. Isolated Hyperphosphatemia with Suppressed Urinary Phosphate Excretion in a Patient with Undifferentiated Leukemia. J-Am-Soc-Nephrol 2016; 27 (Suppl.) (11): 1025A abstr. PUB529.$27$YR$$F$Y$$$20240927$$HP$US$US
243266382$24326638$2$F$20240801$20240917$20240917$20240921$EXP$$US-ABBVIE-5922466$ABBVIE$$$$$M$Y$136.07$KG$20240921$$CN$US$US
243266391$24326639$1$I$$20240912$20240917$20240917$PER$$US-TAKEDA-2024TUS091336$TAKEDA$$$$A$$Y$$$20240917$$CN$US$US
243266401$24326640$1$I$20240601$20240909$20240917$20240917$EXP$IT-MINISAL02-1001010$IT-CHIESI-2024CHF05895$CHIESI$$55$YR$$F$Y$48$KG$20240917$$MD$IT$IT
243266411$24326641$1$I$$20240905$20240917$20240917$EXP$$US-Accord-444865$ACCORD$$$$$M$Y$$$20240917$$HP$US$US
243266431$24326643$1$I$$20240915$20240917$20240917$PER$$US-ABBVIE-5925733$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243266441$24326644$1$I$$20240909$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144324$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$MD$US$US
243266451$24326645$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146772$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240917$$HP$US$US
243266461$24326646$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146606$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240917$$CN$US$US
243266471$24326647$1$I$20240911$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146903$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240917$$HP$US$US
243266481$24326648$1$I$$20240909$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144308$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240917$$HP$US$US
243266491$24326649$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146918$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240917$$CN$US$US
243266501$24326650$1$I$20110729$20240904$20240917$20240917$EXP$$US-ASTELLAS-2024-AER-004862$ASTELLAS$$41$YR$A$F$Y$78.912$KG$20240917$$CN$US$US
243266511$24326651$1$I$$20240819$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133103$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240917$$PH$US$US
243266521$24326652$1$I$$20240912$20240917$20240917$PER$$US-TAKEDA-2024TUS091319$TAKEDA$$$$A$$Y$$$20240917$$CN$US$US
243266531$24326653$1$I$$20240909$20240917$20240917$30DAY$$AU-ABBVIE-5924760$ABBVIE$$$$$$Y$$$20240917$$HP$AU$AU
243266551$24326655$1$I$20240101$20240906$20240917$20240917$EXP$$US-ARDELYX-2024ARDX006806$ARDELYX$$$$$F$Y$$$20240917$$HP$US$US
243266562$24326656$2$F$20240801$20240917$20240917$20240930$EXP$$US-ARDELYX-2024ARDX006837$ARDELYX$$72$YR$$M$Y$$$20240929$$CN$US$US
243266572$24326657$2$F$$20240917$20240917$20240919$EXP$$CA-ROCHE-10000083473$ROCHE$$$$A$F$Y$$$20240919$$CN$CA$CA
243266581$24326658$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210596$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243266591$24326659$1$I$$20240909$20240917$20240917$EXP$$US-AstraZeneca-2024A210338$ASTRAZENECA$$79$YR$$M$Y$$$20240917$$CN$US$
243266601$24326660$1$I$$20240909$20240917$20240917$EXP$$FR-AstraZeneca-2024A210621$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$FR$
243266611$24326661$1$I$20240906$20240913$20240917$20240917$EXP$$CO-AstraZeneca-2024A210460$ASTRAZENECA$$24230$DY$$F$Y$$$20240917$$CN$CO$
243266621$24326662$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208843$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243266631$24326663$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A209452$ASTRAZENECA$Lu K, Tse V, Altaie G, Husain H. Efficacy and tolerability of osimertinib with dabrafenib and trametinib in BRAF V600E acquired EGFR-mutant non-small cell lung cancer: a case series. Journal of Thoracic Disease 16(8):5379-5387.$55$YR$$M$Y$$$20240917$$MD$US$
243266641$24326664$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A209265$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243266651$24326665$1$I$$20240912$20240917$20240917$EXP$$AU-AstraZeneca-2024A210794$ASTRAZENECA$$$$$$Y$$$20240917$$HP$AU$
243266661$24326666$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A209477$ASTRAZENECA$Lu K, Tse V, Altaie G, Husain H. Efficacy and tolerability of osimertinib with dabrafenib and trametinib in BRAF V600E acquired EGFR-mutant non-small cell lung cancer: a case series. Journal of Thoracic Disease 2024;16(8):5379-5387.$71$YR$$M$Y$$$20240917$$MD$US$
243266681$24326668$1$I$20240101$20240912$20240917$20240917$EXP$$JP-AstraZeneca-2024A208675$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$JP$
243266691$24326669$1$I$20240707$20240912$20240917$20240917$EXP$$JP-AstraZeneca-2024A208668$ASTRAZENECA$$67$YR$$F$Y$52$KG$20240917$$MD$JP$
243266702$24326670$2$F$$20240912$20240917$20240927$EXP$$CN-CHIESI-2024CHF06009$CHIESI$$$$N$M$Y$$$20240927$$MD$CN$CN
243266711$24326671$1$I$$20240905$20240917$20240917$EXP$$US-ROCHE-10000075827$ROCHE$Clark J, Blake A V. Near fatal case of mirvetuximab soravtansine-gynx induced interstitial lung disease and a review of the primary literature. Gynecologic Oncology Reports. 2024-Oct;55: doi:10.1016/j.gore.2024.101486.$56$YR$A$F$Y$$$20240917$$HP$US$US
243266721$24326672$1$I$$20240909$20240917$20240917$EXP$$US-CHIESI-2024CHF05997$CHIESI$$$$$M$Y$$$20240917$$MD$US$US
243266731$24326673$1$I$20240912$20240913$20240917$20240917$PER$$US-ROCHE-10000082558$ROCHE$$80$YR$E$M$Y$81.8$KG$20240917$$CN$US$US
243266741$24326674$1$I$20240910$20240910$20240917$20240917$EXP$$US-AMGEN-USASP2024181284$AMGEN$$76$YR$E$F$Y$$$20240917$$CN$US$US
243266751$24326675$1$I$$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024184368$AMGEN$$$$$$Y$$$20240917$$HP$US$US
243266761$24326676$1$I$$20240910$20240917$20240917$PER$$US-AMGEN-USASP2024181341$AMGEN$$$$$$Y$$$20240917$$CN$US$US
243266771$24326677$1$I$$20240905$20240917$20240917$EXP$GB-MHRA-TPP21551222C8960202YC1725437340447$GB-Accord-445434$ACCORD$$75$YR$E$F$Y$$$20240917$$HP$GB$GB
243266801$24326680$1$I$$20240802$20240917$20240917$30DAY$$US-ABBVIE-5916632$ABBVIE$$$$$$Y$$$20240917$$CN$US$US
243266811$24326681$1$I$$20240910$20240917$20240917$EXP$$BR-ROCHE-10000079498$ROCHE$$64$YR$A$M$Y$$$20240917$$MD$BR$BR
243266821$24326682$1$I$$20240913$20240917$20240917$PER$$US-ALXN-202409USA001106US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243266841$24326684$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001153US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240917$$CN$US$US
243266861$24326686$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5920821$ABBVIE$$$$$F$Y$$$20240917$$MD$US$US
243266871$24326687$1$I$$20240911$20240917$20240917$PER$$US-TAKEDA-2024TUS091052$TAKEDA$$3$DEC$$F$Y$$$20240917$$HP$US$US
243266881$24326688$1$I$$20240902$20240917$20240917$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08229$HIKMA$$75$YR$$M$Y$$$20240917$$PH$CA$CA
243266891$24326689$1$I$20240906$20240909$20240917$20240917$PER$$US-ABBVIE-5915765$ABBVIE$$48$YR$$M$Y$$$20240917$$MD$US$US
243266911$24326691$1$I$$20240905$20240917$20240917$EXP$$US-Accord-446299$ACCORD$$$$$M$Y$141.75$KG$20240917$$HP$US$US
243266921$24326692$1$I$20240101$20240711$20240917$20240917$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109806$ZYDUS PHARM$$$$$$Y$$$20240917$$CN$US$US
243266931$24326693$1$I$$20240712$20240917$20240917$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109865$ZYDUS PHARM$$$$$$Y$$$20240917$$CN$US$US
243266941$24326694$1$I$20240101$20240709$20240917$20240917$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109769$ZYDUS PHARM$$$$$$Y$$$20240917$$CN$US$US
243266951$24326695$1$I$20240101$20240709$20240917$20240917$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109738$ZYDUS PHARM$$$$$$Y$$$20240917$$HP$US$US
243266961$24326696$1$I$$20240705$20240917$20240917$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109630$ZYDUS PHARM$$$$$$Y$$$20240917$$HP$US$US
243266981$24326698$1$I$$20240913$20240917$20240917$PER$$NVSC2024US185046$NOVARTIS$$$$$M$Y$121.1$KG$20240917$$CN$US$US
243266991$24326699$1$I$$20240913$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147403$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240917$$CN$US$US
243267001$24326700$1$I$20240901$20240911$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145446$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240917$$HP$US$US
243267011$24326701$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147130$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$HP$US$US
243267021$24326702$1$I$20240801$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147268$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240917$$CN$US$US
243267031$24326703$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147336$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240917$$HP$US$US
243267041$24326704$1$I$$20240905$20240917$20240917$EXP$$ES-CELLTRION INC.-2024ES022069$CELLTRION$$$$$$Y$$$20240917$$MD$ES$ES
243267052$24326705$2$F$20240826$20240917$20240917$20240918$PER$$US-AMGEN-USASP2024184802$AMGEN$$78$YR$E$F$Y$$$20240918$$CN$US$US
243267061$24326706$1$I$$20240905$20240917$20240917$EXP$$CN-ROCHE-10000075752$ROCHE$$77$YR$E$F$Y$$$20240917$$CN$CN$CN
243267071$24326707$1$I$20240902$20240910$20240917$20240917$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-124258$REGENERON$$$$$M$Y$$$20240917$$CN$CA$CA
243267081$24326708$1$I$$20240916$20240917$20240917$PER$$US-ROCHE-10000083659$ROCHE$$$$A$F$Y$$$20240917$$HP$US$US
243267091$24326709$1$I$$20240912$20240917$20240917$EXP$$US-VELOXIS PHARMACEUTICALS, INC.-2017-VEL-00355$VELOXIS PHARMACEUTICALS$Pelletier JH, Nagaraj S, Gbadegesin R, Wigfall D, McGann KA, Foreman J.. Neutropenic enterocolitis (typhlitis) in a pediatric renal transplant patient. A case report and review of the literature.. Pediatric Transplantation. 2017;21(6):Article Number e13022.$15$YR$$M$Y$$$20240917$$MD$US$US
243267101$24326710$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A211014$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243267111$24326711$1$I$$20240906$20240917$20240917$PER$$US-ABBVIE-5918114$ABBVIE$$$$$$Y$$$20240917$$HP$US$US
243267121$24326712$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A207348$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243267131$24326713$1$I$$20240911$20240917$20240917$EXP$$FR-AstraZeneca-2024A209280$ASTRAZENECA$$70$YR$$F$Y$$$20240917$$MD$FR$
243267141$24326714$1$I$20240906$20240910$20240917$20240917$EXP$$CN-AstraZeneca-2024A208685$ASTRAZENECA$$24132$DY$$F$Y$53$KG$20240917$$MD$CN$
243267151$24326715$1$I$20240827$20240906$20240917$20240917$EXP$$CN-ROCHE-10000076402$ROCHE$$75$YR$E$M$Y$65$KG$20240917$$HP$CN$CN
243267161$24326716$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A206817$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243267171$24326717$1$I$$20240913$20240917$20240917$EXP$$IN-ROCHE-10000083081$ROCHE$$76$YR$E$F$Y$$$20240917$$CN$IN$IN
243267181$24326718$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008958$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240917$$CN$US$US
243267191$24326719$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009027$ELI LILLY AND CO$$$$$M$Y$$$20240917$$CN$US$US
243267201$24326720$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008970$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240917$$CN$US$US
243267211$24326721$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009284$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240917$$CN$US$US
243267221$24326722$1$I$$20240909$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409005676$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240917$$CN$US$US
243267231$24326723$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008234$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240917$$CN$US$US
243267241$24326724$1$I$20240801$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009247$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240917$$CN$US$US
243267251$24326725$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001157US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243267261$24326726$1$I$20240911$20240916$20240917$20240917$PER$$US-ALXN-202409USA001149US$ALEXION PHARMACEUTICALS$$6$YR$$M$Y$$$20240917$$CN$US$US
243267281$24326728$1$I$20190101$20240905$20240917$20240917$EXP$$CN-Accord-445944$ACCORD$Chen YU, Fan X, Lu R, Zeng S, Gan P. PARP inhibitor and immune checkpoint inhibitor have synergism efficacy in gallbladder cancer. Genes and Immunity. 2024;25(4):307-16.$56$YR$A$F$Y$$$20240917$$MD$CN$CN
243267292$24326729$2$F$20030101$20240917$20240917$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-044598$AUROBINDO$$74$YR$$M$Y$87$KG$20240926$$CN$FR$FR
243267301$24326730$1$I$20210101$20240911$20240917$20240917$EXP$$US-ABBVIE-5920902$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243267311$24326731$1$I$20240101$20240905$20240917$20240917$EXP$$US-UCBSA-2024045813$UCB$$$$$F$Y$$$20240917$$HP$US$US
243267321$24326732$1$I$$20240905$20240917$20240917$EXP$$US-Accord-446036$ACCORD$Zou H, Rau A, Thompson L, Henderson D. Pancytopenia Concurrent With Metabolic Encephalopathy. Cureus. 2024;16(8):e67963. DOI: 10.7759/cureus.67963.$81$YR$E$F$Y$$$20240917$$MD$US$US
243267331$24326733$1$I$$20240909$20240917$20240917$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024006745$BIOCON$$$$$$Y$$$20240917$$CN$AU$AU
243267341$24326734$1$I$$20240903$20240917$20240917$EXP$$US-INSMED, INC.-2024-03346-US$INSMED$$$$$F$Y$$$20240917$$CN$US$US
243267351$24326735$1$I$$20240912$20240917$20240917$EXP$SE-SEMPA-2024-006593$SE-GSK-SE2024113978$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$SE$SE
243267361$24326736$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147323$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240917$$HP$US$US
243267371$24326737$1$I$$20240911$20240917$20240917$EXP$$US-TAKEDA-2024TUS091198$TAKEDA$$$$$M$Y$$$20240917$$CN$US$US
243267382$24326738$2$F$$20240925$20240917$20240927$EXP$FR-AFSSAPS-AVPO2024000183$FR-SANDOZ INC.-SDZ2024FR080452$SANDOZ$$51$YR$$F$Y$$$20240927$$PH$FR$FR
243267411$24326741$1$I$$20240909$20240917$20240917$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011740$STRIDES$Shukla K, Chaudhari R, Asgharpour A.. Spontaneous Hepatic Hemorrhage Causing Acute Liver Failure Requiring Liver Transplant.. ACG-Case-Rep-J. 2024;11:1-3$$$$$Y$$$20240917$$MD$US$US
243267421$24326742$1$I$$20240909$20240917$20240917$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024006744$BIOCON$$$$$$Y$$$20240917$$CN$AU$AU
243267431$24326743$1$I$$20240911$20240917$20240917$EXP$$US-TAKEDA-2024TUS091235$TAKEDA$$$$$M$Y$$$20240917$$MD$US$US
243267441$24326744$1$I$20240412$20240911$20240917$20240917$EXP$$CA-TAKEDA-2022TUS059664$TAKEDA$$62$YR$$F$Y$$$20240917$$CN$CA$CA
243267451$24326745$1$I$20240821$20240909$20240917$20240917$EXP$$US-GSK-US2024112015$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240917$$CN$US$US
243267461$24326746$1$I$$20240821$20240917$20240917$EXP$$US-SA-2024SA265901$SANOFI AVENTIS$$$$E$F$Y$$$20240917$$MD$US$US
243267481$24326748$1$I$$20240906$20240917$20240917$EXP$$CA-ROCHE-10000077130$ROCHE$$$$A$F$Y$$$20240917$$MD$CA$CA
243267491$24326749$1$I$$20240905$20240917$20240917$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001322$ALEMBIC$Montoya L, Mannava K, Plovanich M.. 54039 The emerging global threat of multidrug-resistant Candida auris- a case of deep fungal cutaneous infection. Journal of the American Academy of Dermatology. 2024;91(3) (AB90)$$$$$Y$$$20240917$$HP$US$US
243267501$24326750$1$I$$20240628$20240917$20240917$PER$$US-ROCHE-10000019004$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243267511$24326751$1$I$20240101$20240906$20240917$20240917$EXP$$BR-ORGANON-O2409BRA000679$ORGANON$$$$$F$Y$$$20240917$$MD$BR$BR
243267521$24326752$1$I$$20240904$20240917$20240917$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001309$ALEMBIC$Sharma V.D, Gupta H.V, Espay A.J.. Copulatory dyskinesia: Pathognomonic manifestation of tardive dyskinesia. Tremor and Other Hyperkinetic Movements. 2020;10 (1) (56):1-3$$$$$Y$$$20240917$$MD$US$US
243267531$24326753$1$I$20110101$20240903$20240917$20240917$EXP$$US-ENDO USA, INC.-2024-003412$ENDO$$$$$$Y$$$20240917$$CN$US$US
243267541$24326754$1$I$$20240903$20240917$20240917$PER$$US-ABBVIE-5926112$ABBVIE$$$$$$Y$$$20240917$$HP$US$US
243267561$24326756$1$I$$20240910$20240917$20240917$EXP$$US-BIOGEN-2024BI01273236$BIOGEN$$$$$F$Y$$$20240917$$HP$US$US
243267571$24326757$1$I$$20240916$20240917$20240917$EXP$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466244$RO-UCBSA-2024047421$UCB$$12$YR$$F$Y$$$20240917$$HP$RO$RO
243267581$24326758$1$I$$20240909$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA080046$SANDOZ$$65$YR$$F$Y$$$20240917$$MD$CA$CA
243267591$24326759$1$I$20230201$20240828$20240917$20240917$EXP$$US-SA-2024SA265806$SANOFI AVENTIS$$64$YR$A$M$Y$70$KG$20240917$$MD$US$US
243267601$24326760$1$I$20230101$20240912$20240917$20240917$EXP$$US-AMGEN-USASP2024183177$AMGEN$$77$YR$E$F$Y$$$20240917$$CN$US$US
243267621$24326762$1$I$$20240903$20240917$20240917$EXP$$US-SA-2024SA263046$SANOFI AVENTIS$$$$E$M$Y$$$20240917$$MD$US$US
243267631$24326763$1$I$$20240910$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA069791$SANDOZ$$$$$F$Y$$$20240917$$MD$CA$CA
243267641$24326764$1$I$20240911$20240912$20240917$20240917$EXP$$CA-AstraZeneca-2024A210492$ASTRAZENECA$$75$YR$$M$Y$$$20240917$$CN$CA$
243267652$24326765$2$F$20230101$20240923$20240917$20240928$EXP$$PL-009507513-2409POL004124$MERCK$Osmanska M.. Pembrolizumab in first-line treatment in metastatic squamous-cell lung cancer with PD-L1 expession below 1%.. ONKOLOGIA W PRAKTYCE KLINICZNEJ- EDUKACJA. 2024;10(Supl. C):C6-C9$73$YR$$M$Y$$$20240928$$MD$PL$PL
243267661$24326766$1$I$$20240910$20240917$20240917$EXP$$JP-AstraZeneca-2024A208020$ASTRAZENECA$$66$YR$$M$Y$$$20240917$$MD$JP$
243267671$24326767$1$I$$20240914$20240917$20240917$EXP$$US-AstraZeneca-2024A210367$ASTRAZENECA$$$$$F$Y$59$KG$20240917$$CN$US$
243267681$24326768$1$I$20240729$20240911$20240917$20240917$EXP$$JP-AstraZeneca-2024A202556$ASTRAZENECA$$70$YR$$M$Y$$$20240917$$MD$JP$
243267691$24326769$1$I$20220408$20240913$20240917$20240917$EXP$$PL-AstraZeneca-2024A209365$ASTRAZENECA$$65$YR$$F$Y$59$KG$20240917$$MD$PL$
243267701$24326770$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A207205$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243267711$24326771$1$I$20240611$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210548$ASTRAZENECA$$26638$DY$$M$Y$$$20240917$$CN$US$
243267721$24326772$1$I$$20240912$20240917$20240917$EXP$$JP-AstraZeneca-2024A209200$ASTRAZENECA$$$$$$Y$$$20240917$$PH$JP$
243267731$24326773$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210437$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243267741$24326774$1$I$20240515$20240909$20240917$20240917$EXP$$CA-ROCHE-10000078489$ROCHE$$40$YR$A$M$Y$$$20240917$$HP$CA$CA
243267751$24326775$1$I$$20240719$20240917$20240917$PER$$US-AstraZeneca-2024A165445$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243267761$24326776$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A206583$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243267771$24326777$1$I$$20240913$20240917$20240917$EXP$$ZA-AstraZeneca-2024A210751$ASTRAZENECA$$$$$M$Y$$$20240917$$HP$ZA$
243267781$24326778$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A210446$ASTRAZENECA$$46$YR$$F$Y$$$20240917$$CN$US$
243267791$24326779$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A210828$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243267811$24326781$1$I$$20240910$20240917$20240917$EXP$$US-TAKEDA-2024TUS075885$TAKEDA$$$$$M$Y$$$20240917$$CN$US$US
243267821$24326782$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146373$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240917$$HP$US$US
243267831$24326783$1$I$$20240909$20240917$20240917$EXP$$CA-TAKEDA-2024TUS086384$TAKEDA$$$$$M$Y$$$20240917$$CN$CA$CA
243267851$24326785$1$I$$20240911$20240917$20240917$EXP$$US-TAKEDA-2024TUS091046$TAKEDA$$$$$F$Y$$$20240917$$CN$US$US
243267861$24326786$1$I$20240810$20240912$20240917$20240917$EXP$$CA-TAKEDA-2024TUS091855$TAKEDA$$46$YR$$F$Y$52.2$KG$20240917$$MD$CA$CA
243267871$24326787$1$I$$20240904$20240917$20240917$EXP$$CA-AUROBINDO-AUR-APL-2024-045304$AUROBINDO$Merette S A M, Kim S, Davis M D, Shapiro A M.. Desalkylgidazepam blood concentrations in 63 forensic investigation cases.. Journal of Analytical Toxicology. 2023;47 (9):858-866$46$YR$$M$Y$$$20240917$$HP$CA$CA
243267881$24326788$1$I$$20240903$20240917$20240917$EXP$$US-BELUSA-2024BELLIT0101$BIOLOGICAL E.$Nanah A, Nair AS, Stoller J. Delayed.Delayed Response to Glucocorticoids in Daptomycin Lung.American Journal of Therapeutics.2024;31(4):e518-e521$$$$$Y$$$20240917$$MD$US$US
243267891$24326789$1$I$20170725$20240911$20240917$20240917$EXP$$CA-TAKEDA-2017TUS022589$TAKEDA$$60$YR$$F$Y$$$20240917$$CN$CA$CA
243267901$24326790$1$I$$20240905$20240917$20240917$EXP$$DE-Accord-446652$ACCORD$Hoffmann E, Toepell A, Peter A, Boke S, De-Colle C, Steinle M, et al. Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy. Strahlenther Onkol. 2024 Sep 4. doi: 10.1007/s00066-024-02287-7.$$$$$Y$$$20240917$$HP$DE$DE
243267911$24326791$1$I$$20240910$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409006805$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240917$$HP$US$US
243267921$24326792$1$I$$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009707$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240917$$CN$US$US
243267931$24326793$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009146$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240917$$CN$US$US
243267941$24326794$1$I$$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009762$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243267951$24326795$1$I$20240101$20240914$20240917$20240917$PER$$US-AMGEN-USASP2024184498$AMGEN$$43$YR$A$M$Y$$$20240917$$HP$US$US
243267963$24326796$3$F$20240813$20240910$20240917$20240921$PER$$US-AMGEN-USASP2024181137$AMGEN$$33$YR$A$$Y$$$20240920$$HP$US$US
243267971$24326797$1$I$20240703$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183466$AMGEN$$$$$$Y$$$20240917$$CN$US$US
243267981$24326798$1$I$$20240912$20240917$20240917$EXP$$IT-AMGEN-ITASP2024182431$AMGEN$Tondulli, L.. A RARE CASE OF PULMONARY VASCULITIS DUE TO NEW ANTIANGIOGENIC DRUGS. Annals of Oncology. 2009;20 (5):20-21$67$YR$E$F$Y$$$20240917$$HP$IT$IT
243267992$24326799$2$F$$20240925$20240917$20240927$EXP$$JP-HALEON-2196675$Haleon PLC$$6$DEC$$M$Y$$$20240927$$PH$JP$JP
243268001$24326800$1$I$20240909$20240912$20240917$20240917$EXP$$US-ABBVIE-5922385$ABBVIE$$49$YR$$F$Y$$$20240917$$CN$US$US
243268011$24326801$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000083145$ROCHE$$40$YR$A$F$Y$$$20240917$$CN$US$US
243268021$24326802$1$I$$20240813$20240917$20240917$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02476$AMNEAL$$$$$F$Y$$$20240917$$CN$US$US
243268031$24326803$1$I$20240716$20240828$20240917$20240917$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02631$AMNEAL$$$$$F$Y$$$20240917$$CN$US$US
243268041$24326804$1$I$$20240815$20240917$20240917$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02434$AMNEAL$$$$$F$Y$$$20240917$$CN$US$US
243268051$24326805$1$I$20240816$20240819$20240917$20240917$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03098$AMNEAL$$$$$M$Y$$$20240917$$CN$US$US
243268061$24326806$1$I$20240812$20240813$20240917$20240917$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03019$AMNEAL$$$$$F$Y$$$20240917$$CN$US$US
243268071$24326807$1$I$$20240830$20240917$20240917$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02764$AMNEAL$$$$$F$Y$$$20240917$$CN$US$US
243268081$24326808$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147238$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240917$$CN$US$US
243268091$24326809$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001164US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243268101$24326810$1$I$$20240826$20240917$20240917$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03203$AMNEAL$$$$$M$Y$$$20240917$$CN$US$US
243268111$24326811$1$I$$20240911$20240917$20240917$EXP$$US-AMGEN-USASP2024183056$AMGEN$$$$$F$Y$$$20240917$$HP$US$US
243268121$24326812$1$I$$20240909$20240917$20240917$EXP$$AU-FDA-BBL2024006747$BIOCON$$$$$$Y$$$20240917$$CN$AU$AU
243268141$24326814$1$I$$20240903$20240917$20240917$EXP$$JP-INSMED, INC.-2024-03543-JP$INSMED$$80$YR$$$Y$$$20240917$$HP$JP$JP
243268152$24326815$2$F$$20240919$20240917$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-044783$AUROBINDO$$$$$F$Y$$$20240928$$MD$GB$GB
243268161$24326816$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922719$ABBVIE$$$$$M$Y$$$20240917$$HP$US$US
243268181$24326818$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_07211769$CA-Accord-445728$ACCORD$$55$YR$A$F$Y$$$20240917$$HP$CA$CA
243268191$24326819$1$I$20240101$20240911$20240917$20240917$EXP$$US-ABBVIE-5920751$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243268201$24326820$1$I$20240912$20240913$20240917$20240917$EXP$$US-INTERCEPT-PM2024001840$INTERCEPT PHARMACEUTICALS$$81$YR$$F$Y$$$20240917$$HP$US$US
243268211$24326821$1$I$$20240905$20240917$20240917$EXP$DE-BFARM-24006085$DE-Accord-445770$ACCORD$$$$$M$Y$$$20240917$$MD$DE$DE
243268221$24326822$1$I$20210101$20240907$20240917$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2021-001953$UNITED THERAPEUTICS$$39$YR$$F$Y$73.016$KG$20240917$$$US$US
243268231$24326823$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5921948$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243268241$24326824$1$I$20240901$20240912$20240917$20240917$EXP$$US-ABBVIE-5922711$ABBVIE$$66$YR$$F$Y$$$20240917$$CN$US$US
243268251$24326825$1$I$20240824$20240916$20240917$20240917$EXP$FR-AFSSAPS-MP2024001357$FR-TAKEDA-2024TUS091859$TAKEDA$$90$YR$$M$Y$60$KG$20240917$$HP$FR$FR
243268263$24326826$3$F$$20240919$20240917$20240920$EXP$$US-GILEAD-2024-0675771$GILEAD$$$$E$F$Y$$$20240920$$CN$US$US
243268271$24326827$1$I$20240101$20240912$20240917$20240917$PER$$US-ABBVIE-5922845$ABBVIE$$$$$F$Y$47.627$KG$20240917$$CN$US$US
243268282$24326828$2$F$20240826$20240919$20240917$20240926$PER$$US-ABBVIE-5925114$ABBVIE$$68$YR$$M$Y$$$20240926$$CN$US$US
243268292$24326829$2$F$20240902$20240924$20240917$20240930$EXP$$US-ABBVIE-5924153$ABBVIE$$77$YR$$M$Y$$$20240930$$CN$US$US
243268301$24326830$1$I$20240101$20240912$20240917$20240917$EXP$SE-SEMPA-2024-006674$SE-ABBVIE-5920370$ABBVIE$$51$YR$$M$Y$$$20240917$$MD$SE$SE
243268321$24326832$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_07208360$CA-Accord-445859$ACCORD$$$$$$Y$$$20240917$$HP$CA$CA
243268331$24326833$1$I$$20240819$20240917$20240917$30DAY$$US-VEROBIOTECH-2024USVEROSPO00217$VERO BIOTECH$$$$$$Y$$$20240917$$HP$US$US
243268341$24326834$1$I$$20240909$20240917$20240917$EXP$$JP-ROCHE-10000080177$ROCHE$$9$DEC$E$$Y$$$20240917$$MD$JP$JP
243268352$24326835$2$F$$20240909$20240917$20240918$EXP$$GB-CELLTRION INC.-2024GB021987$CELLTRION$$$$$$Y$$$20240918$$CN$GB$GB
243268361$24326836$1$I$20240830$20240913$20240917$20240917$EXP$$KE-AstraZeneca-2024A210329$ASTRAZENECA$$52$YR$$F$Y$$$20240917$$CN$KE$
243268371$24326837$1$I$20240828$20240909$20240917$20240917$EXP$$CL-AstraZeneca-2024A199915$ASTRAZENECA$$15484$DY$$F$Y$54$KG$20240917$$CN$CL$
243268391$24326839$1$I$20220101$20240909$20240917$20240917$EXP$$JP-AstraZeneca-2024A192284$ASTRAZENECA$$90$YR$$F$Y$$$20240917$$MD$JP$
243268401$24326840$1$I$$20240904$20240917$20240917$EXP$$IT-AUROBINDO-AUR-APL-2024-044593$AUROBINDO$Garibaldi,B. Belantamab Mafodotin and Relapsed/ Refractory Multiple Myeloma: This Is Not Game Over.. Acta Haematologica.. 2024;147:493-498$69$YR$$F$Y$$$20240917$$HP$IT$IT
243268411$24326841$1$I$$20240910$20240917$20240917$EXP$$FR-AstraZeneca-2024A209866$ASTRAZENECA$$55$YR$$F$Y$$$20240917$$MD$FR$
243268421$24326842$1$I$$20240913$20240917$20240917$EXP$$CA-AstraZeneca-2024A210399$ASTRAZENECA$$87$YR$$F$Y$$$20240917$$MD$CA$
243268431$24326843$1$I$$20240819$20240917$20240917$30DAY$$US-VEROBIOTECH-2024USVEROSPO00218$VERO BIOTECH$$$$$$Y$$$20240917$$HP$US$US
243268441$24326844$1$I$$20240820$20240917$20240917$30DAY$$US-VEROBIOTECH-2024USVEROSPO00220$VERO BIOTECH$$$$$$Y$$$20240917$$HP$US$US
243268451$24326845$1$I$$20240819$20240917$20240917$30DAY$$US-VEROBIOTECH-2024USVEROSPO00219$VERO BIOTECH$$$$$$Y$$$20240917$$HP$US$US
243268461$24326846$1$I$$20240906$20240917$20240917$PER$$US-HALEON-2197023$Haleon PLC$$$$$$Y$$$20240917$$CN$US$US
243268471$24326847$1$I$20240601$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184352$AMGEN$$74$YR$E$F$Y$$$20240917$$CN$US$US
243268481$24326848$1$I$$20240905$20240917$20240917$EXP$$US-ROCHE-10000075763$ROCHE$$$$$M$Y$$$20240917$$MD$US$US
243268491$24326849$1$I$$20240909$20240917$20240917$EXP$$CH-CELLTRION INC.-2024CH021881$CELLTRION$Degtiarova G, Conen A, Klarer A, Teuta A, Guldimann G, Finkener S, et al.. Transfusion-related acute lung injury (TRALI) following intravenous immunoglobulin infusion in a rituximab immunosuppressed patient with long-shedding SARS-CoV-2. BMC Infectious Diseases. 2024;24:916$$$$$Y$$$20240917$$HP$CH$CH
243268501$24326850$1$I$20240101$20240916$20240917$20240917$EXP$$US-ABBVIE-5925954$ABBVIE$$$$$F$Y$$$20240917$$HP$US$US
243268512$24326851$2$F$20240816$20240923$20240917$20240930$EXP$$ZA-ABBVIE-5925842$ABBVIE$$60$YR$$F$Y$$$20240930$$CN$ZA$ZA
243268521$24326852$1$I$20240912$20240912$20240917$20240917$EXP$$US-ABBVIE-5922909$ABBVIE$$60$YR$$F$Y$$$20240917$$CN$US$US
243268531$24326853$1$I$$20240912$20240917$20240917$EXP$$CA-ABBVIE-5922809$ABBVIE$$$$A$F$Y$$$20240917$$HP$CA$CA
243268541$24326854$1$I$20190101$20240909$20240917$20240917$EXP$$BR-BIOGEN-2024BI01282103$BIOGEN$$$$$F$Y$62$KG$20240917$$HP$BR$BR
243268551$24326855$1$I$20240717$20240903$20240917$20240917$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000925$PAREXEL$$$$$$Y$$$20240917$$HP$CN$CN
243268561$24326856$1$I$$20240910$20240917$20240917$EXP$$BR-ROCHE-10000079497$ROCHE$$64$YR$A$F$Y$$$20240917$$MD$BR$BR
243268581$24326858$1$I$20240916$20240916$20240917$20240917$PER$$US-JNJFOC-20240941133$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240917$$CN$US$US
243268591$24326859$1$I$20240820$20240905$20240917$20240917$EXP$$CN-ROCHE-10000075525$ROCHE$$48$YR$A$M$Y$$$20240917$$CN$CN$CN
243268601$24326860$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001169US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243268611$24326861$1$I$$20240905$20240917$20240917$EXP$GB-MHRA-MIDB-bbf5919c-cd1e-4f8b-af5d-123b69d43fae$GB-Accord-445886$ACCORD$$82$YR$E$F$Y$$$20240917$$PH$GB$GB
243268631$24326863$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-0E2B_07211680$CA-Accord-445869$ACCORD$$$$A$F$Y$$$20240917$$MD$CA$CA
243268661$24326866$1$I$20200701$20240823$20240917$20240917$EXP$$NZ-TERSERA THERAPEUTICS LLC-2024TRS004691$TERSERA THERAPEUTICS$$$$$$Y$$$20240917$$MD$NZ$NZ
243268671$24326867$1$I$$20240910$20240917$20240917$PER$$US-JNJFOC-20240937836$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$CN$US$US
243268691$24326869$1$I$20230901$20240909$20240917$20240917$EXP$$CA-862174955-ML2023-05449$MICRO LABS$$69$YR$E$M$Y$$$20240917$$CN$CA$CA
243268701$24326870$1$I$$20240909$20240917$20240917$EXP$DE-BFARM-24006127$DE-862174955-ML2024-04835$MICRO LABS$$$$A$M$Y$$$20240917$$MD$DE$DE
243268711$24326871$1$I$$20240909$20240917$20240917$EXP$$GB-862174955-ML2024-04853$MICRO LABS$$84$YR$E$F$Y$55$KG$20240917$$MD$GB$GB
243268721$24326872$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147214$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240917$$CN$US$US
243268731$24326873$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147311$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240917$$HP$US$US
243268741$24326874$1$I$20240713$20240909$20240917$20240917$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000934$PAREXEL$$$$$$Y$$$20240917$$HP$CN$CN
243268751$24326875$1$I$20150318$20240909$20240917$20240917$EXP$$CA-SANDOZ INC.-PHHY2015CA035824$SANDOZ$$74$YR$$F$Y$$$20240917$$CN$CA$CA
243268761$24326876$1$I$20240101$20240902$20240917$20240917$EXP$$CN-AMIVAS INC.-20240900010$Amivas$Xu Wenxiu. Analysis of a fatal case of imported falciparum malaria. China Tropical Medicine. 2024;24(7):889-892$$$$$Y$$$20240917$$HP$CN$CN
243268771$24326877$1$I$$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409051433016710-GLWVN$GB-ROCHE-10000075460$ROCHE$$$$$$Y$$$20240917$$PH$GB$GB
243268781$24326878$1$I$20190401$20240905$20240917$20240917$EXP$$PL-Accord-206739$ACCORD$Wachula E, Zemczak A, Lebiedzinska A, Gisterek I, Kos-Kudla B. Morphological heterogeneity of pancreatic neuroendocrine neoplasm (transformation from NEN G3 to NEN G1) during treatment of CAP-TEM regimen (capecitabine and temozolomide). ONKOLOGIA W PRAKTYCE KLINICZNEJ - EDUKACJA. 2020;(Supl. G):G23.$32$YR$A$M$Y$$$20240917$$HP$PL$PL
243268791$24326879$1$I$$20240904$20240917$20240917$EXP$GB-MHRA-MED-202409040811487310-HNSRJ$GB-HALEON-2195199$Haleon PLC$$23$YR$$F$Y$$$20240917$$CN$GB$GB
243268801$24326880$1$I$$20240827$20240917$20240917$PER$$AU-TOLMAR, INC.-24AU052237$TOLMAR$$$$$M$Y$$$20240917$$HP$AU$AU
243268811$24326881$1$I$$20240827$20240917$20240917$PER$$AU-TOLMAR, INC.-24AU052248$TOLMAR$$$$$M$Y$$$20240917$$CN$AU$AU
243268821$24326882$1$I$20240814$20240827$20240917$20240917$PER$$BE-TOLMAR, INC.-24BE051985$TOLMAR$$62$YR$$M$Y$$$20240917$$PH$BE$BE
243268831$24326883$1$I$20240201$20240827$20240917$20240917$PER$$BR-TOLMAR, INC.-24BR052267$TOLMAR$$8$YR$$F$Y$$$20240917$$CN$BR$BR
243268841$24326884$1$I$$20240909$20240917$20240917$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024006749$BIOCON$$$$$$Y$$$20240917$$CN$AU$AU
243268851$24326885$1$I$$20240906$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143937$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240917$$HP$US$US
243268861$24326886$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147020$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240917$$CN$US$US
243268871$24326887$1$I$20240827$20240905$20240917$20240917$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000937$PAREXEL$$$$$$Y$$$20240917$$HP$CN$CN
243268881$24326888$1$I$20240912$20240913$20240917$20240917$EXP$$CN-ORGANON-O2409CHN001000$ORGANON$$52$YR$$F$Y$58$KG$20240917$$HP$CN$CN
243268892$24326889$2$F$$20240913$20240917$20240926$EXP$$US-BAXTER-2024BAX024254$BAXTER$$$$$F$Y$$$20240926$$CN$US$US
243268901$24326890$1$I$$20240902$20240917$20240917$PER$$US-COSETTE-CP2024US000243$COSETTE PHARMACEUTICALS$$$$$$Y$$$20240917$$MD$US$US
243268911$24326891$1$I$20240628$20240903$20240917$20240917$EXP$$BR-BAXTER-2024BAX024369$BAXTER$$24$YR$$F$Y$59.5$KG$20240917$$CN$BR$BR
243268921$24326892$1$I$20240309$20240904$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-044604$AUROBINDO$$43$YR$$M$Y$69$KG$20240917$$MD$FR$FR
243268931$24326893$1$I$$20240913$20240917$20240917$EXP$$RU-AstraZeneca-2024A209856$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$RU$
243268941$24326894$1$I$$20240911$20240917$20240917$PER$$US-AstraZeneca-2024A207758$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243268951$24326895$1$I$20240828$20240911$20240917$20240917$EXP$$US-ABBVIE-5922054$ABBVIE$$61$YR$$M$Y$$$20240917$$CN$US$US
243268961$24326896$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A211017$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243268971$24326897$1$I$$20240913$20240917$20240917$EXP$$IN-AstraZeneca-2024A209789$ASTRAZENECA$$$$$F$Y$93$KG$20240917$$CN$IN$
243268991$24326899$1$I$$20240912$20240917$20240917$EXP$$AU-MYLANLABS-2024M1083525$MYLAN$$$$$M$Y$$$20240917$$PH$AU$AU
243269001$24326900$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A211126$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243269011$24326901$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208911$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$US$
243269021$24326902$1$I$$20240909$20240917$20240917$EXP$$US-AstraZeneca-2024A182385$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243269041$24326904$1$I$20220215$20240906$20240917$20240917$EXP$$DE-ROCHE-3037407$ROCHE$$58$YR$A$F$Y$$$20240917$$CN$DE$DE
243269051$24326905$1$I$20240801$20240910$20240917$20240917$EXP$$JP-ASTELLAS-2024-AER-005832$ASTELLAS$$$$E$$Y$$$20240917$$MD$JP$JP
243269061$24326906$1$I$20180202$20240904$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-044483$AUROBINDO$$97$YR$$M$Y$$$20240917$$HP$FR$FR
243269071$24326907$1$I$$20240904$20240917$20240917$EXP$$NL-AUROBINDO-AUR-APL-2024-044639$AUROBINDO$Max Boot MD,Yotam Raz MD.. Een complex hematologisch beeld.. Medisch Contact.. 2024;34-35$69$YR$$F$Y$$$20240917$$MD$NL$NL
243269081$24326908$1$I$20240101$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184088$AMGEN$$48$YR$A$F$Y$$$20240917$$CN$US$US
243269091$24326909$1$I$$20240910$20240917$20240917$PER$$US-AMGEN-USASP2024180682$AMGEN$$67$YR$E$F$Y$$$20240917$$CN$US$US
243269101$24326910$1$I$$20240905$20240917$20240917$EXP$$CN-ROCHE-10000055746$ROCHE$$46$YR$A$F$Y$$$20240917$$CN$CN$CN
243269111$24326911$1$I$$20240828$20240917$20240917$PER$$US-TEVA-VS-3238452$TEVA$$$$$$Y$$$20240917$$HP$US$US
243269121$24326912$1$I$$20240911$20240917$20240917$EXP$$GB-SANDOZ INC.-SDZ2024GB003373$SANDOZ$$$$$M$Y$$$20240917$$CN$GB$GB
243269131$24326913$1$I$$20240910$20240917$20240917$EXP$$CN-MYLANLABS-2024M1083675$MYLAN$Fang Y., Kuang C.. Resistant Hypertension Induced by Left Renal Artery Stenosis in Middle-aged Individuals: A Case Report and Literature Review. Chinese Journal of Arteriosclerosis. 2024;1-8$56$YR$$M$Y$$$20240917$$HP$CN$CN
243269151$24326915$1$I$$20240912$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146855$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240917$$CN$US$US
243269162$24326916$2$F$$20240919$20240917$20240927$EXP$$DE-TEVA-VS-3242626$TEVA$Shamseldin M, Heers H, Steiner T, Puls R. Anatomic locations of ureterovascular fistulae: a review of 532 patients in the literature and a new series of 8 patients. CVIR-Endovasc 2024; 7 (1):.; Shamseldin M, Heers H, Steiner T, Puls R. Anatomic locations of ureterovascular fistulae: a review of 532 patients in the literature and a new series of 8 patients. CVIR-Endovasc 2024; 7 (1):.$80$YR$$F$Y$$$20240927$$HP$DE$DE
243269171$24326917$1$I$20240201$20240904$20240917$20240917$EXP$$DE-AUROBINDO-AUR-APL-2024-044625$AUROBINDO$$66$YR$$F$Y$$$20240917$$MD$DE$DE
243269181$24326918$1$I$20240730$20240906$20240917$20240917$EXP$$US-ROCHE-10000076458$ROCHE$$44$YR$A$F$Y$$$20240917$$MD$US$US
243269211$24326921$1$I$$20240913$20240917$20240917$EXP$$US-SANDOZ INC.-SDZ2024US080117$SANDOZ$$$$$M$Y$$$20240917$$CN$US$US
243269221$24326922$1$I$20240908$20240909$20240917$20240917$EXP$$FR-CHEPLA-2024011719$CHEPLAPHARM$$35$YR$$F$Y$$$20240917$$HP$COUNTRY NOT SPECIFIED$FR
243269231$24326923$1$I$20240910$20240911$20240917$20240917$PER$$US-ABBVIE-5919747$ABBVIE$$$$$$Y$$$20240917$$CN$US$US
243269251$24326925$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000082760$ROCHE$$$$E$F$Y$$$20240917$$CN$US$US
243269261$24326926$1$I$20240520$20240909$20240917$20240917$EXP$$FR-TAKEDA-2024TUS092239$TAKEDA$$56$YR$$M$Y$$$20240917$$MD$FR$FR
243269281$24326928$1$I$$20240911$20240917$20240917$EXP$$RS-ROCHE-10000080808$ROCHE$$$$A$M$Y$$$20240917$$MD$RS$RS
243269291$24326929$1$I$20070801$20240910$20240917$20240917$EXP$FR-EMA-20130418-mgevhumanwt-102307659$FR-Merck Healthcare KGaA-2024048564$MERCK KGAA$$47$YR$A$F$Y$148$KG$20240917$$HP$FR$US
243269311$24326931$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922741$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243269331$24326933$1$I$$20240912$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146852$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240917$$CN$US$US
243269341$24326934$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147401$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240917$$HP$US$US
243269351$24326935$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146949$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240917$$HP$US$US
243269361$24326936$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147652$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240917$$CN$US$US
243269371$24326937$1$I$20240730$20240907$20240917$20240917$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000938$PAREXEL$$$$$$Y$$$20240917$$HP$CN$CN
243269381$24326938$1$I$20240720$20240913$20240917$20240917$EXP$FR-AFSSAPS-AN2024001162$FR-HALEON-2196850$Haleon PLC$$37$YR$$M$Y$68.1$KG$20240917$$MD$FR$FR
243269391$24326939$1$I$20221201$20240904$20240917$20240917$EXP$FR-AFSSAPS-DJ2023000420$FR-CELLTRION INC.-2024FR022112$CELLTRION$$$$$$Y$$$20240917$$MD$FR$FR
243269412$24326941$2$F$20240101$20240913$20240917$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-029006$UNITED THERAPEUTICS$$$$$F$Y$92.517$KG$20240920$$$US$US
243269421$24326942$1$I$20240821$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024182073$AMGEN$$79$YR$E$M$Y$$$20240917$$CN$US$US
243269431$24326943$1$I$20240816$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184793$AMGEN$$74$YR$E$F$Y$$$20240917$$PH$US$US
243269441$24326944$1$I$20240907$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024183606$AMGEN$$24$YR$A$M$Y$$$20240917$$PH$US$US
243269451$24326945$1$I$20240909$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024182559$AMGEN$$24$YR$A$F$Y$$$20240917$$CN$US$US
243269461$24326946$1$I$$20240906$20240917$20240917$EXP$$ES-MYLANLABS-2024M1082969$MYLAN$Garrido-Marin M, Kirkegaard Biosca E, Boixadera A, Fischer Fernandez R, Sanchez Vela L, Pardo Aranda A, et al. Multiresistant Candida Endophthalmitis Treated with Intravitreal Caspofungin: A Case Report. Ocular-Immunol-Inflamm 2024; 32 (6): 858-862.$24$YR$$M$Y$$$20240917$$MD$ES$ES
243269471$24326947$1$I$$20240904$20240917$20240917$EXP$$GB-AUROBINDO-AUR-APL-2024-044441$AUROBINDO$$$$$F$Y$$$20240917$$CN$GB$GB
243269481$24326948$1$I$$20240905$20240917$20240917$EXP$$PT-MYLANLABS-2024M1082853$MYLAN$Farinha I, Ferreira PG. Salvage use of tofacitinib in sarcoidosis patient with refractory multiorgan involvement. Sarccoidosis-Vasc-Diffuse-Lung-Dis 2024; 41 (2):.$44$YR$$M$Y$$$20240917$$MD$PT$PT
243269492$24326949$2$F$$20240919$20240917$20240927$EXP$$JP-TEVA-VS-3242184$TEVA$Tsujino A, Nakajima A, Yabuta H, Sekioka J, Amano M, Fujimura S, et al. An Autopsy Case of Streptococcus dysgalactiae subsp. equisimilis Infectious Endocarditis Accompanied by Streptococcal Toxic Shock Syndrome. Intern-Med 2024; 63 (15): 2209-2214.; Tsujino A, Nakajima A, Yabuta H, Sekioka J, Amano M, Fujimura S, et al. An Autopsy Case of Streptococcus dysgalactiae subsp. equisimilis Infectious Endocarditis Accompanied by Streptococcal Toxic Shock Syndrome. Intern-Med 2024; 63 (15): 2209-2214.$66$YR$$F$Y$75$KG$20240927$$MD$JP$JP
243269501$24326950$1$I$$20240909$20240917$20240917$EXP$$CA-TOLMAR, INC.-24CA052487$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243269521$24326952$1$I$20240101$20240904$20240917$20240917$EXP$$CA-UCBSA-2024023208$UCB$$$$$F$Y$$$20240917$$CN$CA$CA
243269531$24326953$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001155US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243269541$24326954$1$I$$20240909$20240917$20240917$EXP$$CA-TOLMAR, INC.-24CA052480$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243269552$24326955$2$F$$20240912$20240917$20240927$EXP$$CN-CHIESI-2024CHF06011$CHIESI$$$$N$F$Y$$$20240927$$MD$CN$CN
243269561$24326956$1$I$$20240905$20240917$20240917$EXP$$US-MYLANLABS-2024M1082870$MYLAN$Heyman HM, Alberts NM, Rees M, Puri L, Frett MJ, Anghelescu DL. COVID-19 infection and pain in adolescents with sickle cell disease: A case series. EJHaem 2022; 3 (4): 1310-1315.$14$YR$$F$Y$$$20240917$$HP$US$US
243269571$24326957$1$I$$20240909$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA052524$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243269581$24326958$1$I$$20240909$20240917$20240917$EXP$$NL-TOLMAR, INC.-24NL052466$TOLMAR$$$$$M$Y$$$20240917$$CN$NL$NL
243269592$24326959$2$F$$20240821$20240917$20240917$PER$$US-AstraZeneca-2024A192227$ASTRAZENECA$$37$YR$$M$Y$$$20240917$$MD$US$
243269601$24326960$1$I$$20240906$20240917$20240917$EXP$$BE-ASPEN-GLO2024BE006224$ASPEN$$$$$$Y$$$20240917$$HP$BE$BE
243269611$24326961$1$I$20240101$20240909$20240917$20240917$EXP$$US-CHIESI-2024CHF05915$CHIESI$$$$$F$Y$68$KG$20240917$$CN$US$US
243269621$24326962$1$I$$20240826$20240917$20240917$EXP$$GB-GILEAD-2024-0685462$GILEAD$Nana M, Gregori M, Chandler E, Powell H, Goulden B, Watts T, et al.. Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study. The Lancet Rheumatology. 2024;6(9):e625-e635. doi:10.1016/ S2665-9913(24)00124-3$$$I$$Y$$$20240917$$HP$GB$GB
243269631$24326963$1$I$$20240909$20240917$20240917$EXP$$BE-ASPEN-GLO2024BE006273$ASPEN$$$$$$Y$$$20240917$$MD$BE$BE
243269641$24326964$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A207986$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243269651$24326965$1$I$$20240910$20240917$20240917$EXP$$JP-AstraZeneca-2024A208051$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$JP$
243269671$24326967$1$I$$20240911$20240917$20240917$EXP$$AR-AstraZeneca-2024A208824$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$AR$
243269681$24326968$1$I$20171213$20240909$20240917$20240917$EXP$$US-CHIESI-2024CHF05946$CHIESI$$58$YR$$F$Y$55$KG$20240917$$CN$US$US
243269691$24326969$1$I$20240801$20240912$20240917$20240917$EXP$$RO-AstraZeneca-2024A210018$ASTRAZENECA$$47$YR$$F$Y$$$20240917$$MD$RO$
243269701$24326970$1$I$$20240912$20240917$20240917$EXP$$PL-AstraZeneca-2024A210746$ASTRAZENECA$$41$YR$$F$Y$$$20240917$$HP$PL$
243269711$24326971$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A207809$ASTRAZENECA$$$$$$Y$$$20240917$$HP$US$
243269721$24326972$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009402$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240917$$CN$US$US
243269741$24326974$1$I$20240901$20240910$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409006452$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240917$$CN$US$US
243269751$24326975$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009401$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240917$$CN$US$US
243269761$24326976$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008832$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240917$$CN$US$US
243269771$24326977$1$I$$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009725$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240917$$MD$US$US
243269781$24326978$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009270$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240917$$CN$US$US
243269791$24326979$1$I$$20240910$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008481$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243269801$24326980$1$I$20240801$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009053$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240917$$MD$US$US
243269811$24326981$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009165$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240917$$CN$US$US
243269821$24326982$1$I$20240912$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009037$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243269831$24326983$1$I$20230721$20240911$20240917$20240917$EXP$$HR-AstraZeneca-2024A206901$ASTRAZENECA$$65$YR$$M$Y$82$KG$20240917$$MD$HR$
243269841$24326984$1$I$$20240909$20240917$20240917$EXP$$CO-STRIDES ARCOLAB LIMITED-2024SP011742$STRIDES$Rivera Martinez WA, Pantoja Rosero ME, Chaves Cabrera HA, Yory Montalvo N, Velasquez Garcia F, Ocampo Posada M.. Severe Manifestation of Peritoneal Tuberculosis: Clinical Case Report.. Rev-Colomb-Gastroenterol. 2023;38 (3):368-372$61$YR$$M$Y$$$20240917$$HP$CO$CO
243269851$24326985$1$I$20240901$20240909$20240917$20240917$EXP$$PE-AstraZeneca-2024A206475$ASTRAZENECA$$20892$DY$$F$Y$$$20240917$$CN$PE$
243269871$24326987$1$I$20240909$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183473$AMGEN$$70$YR$E$F$Y$$$20240917$$HP$US$US
243269881$24326988$1$I$20230101$20240905$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-044906$AUROBINDO$$81$YR$$F$Y$50.2$KG$20240917$$MD$FR$FR
243269891$24326989$1$I$$20240905$20240917$20240917$EXP$$DE-AUROBINDO-AUR-APL-2024-045019$AUROBINDO$$$$$M$Y$$$20240917$$CN$DE$DE
243269901$24326990$1$I$20231001$20240909$20240917$20240917$EXP$$US-EMD Serono-2024048459$EMD SERONO INC$$65$YR$E$M$Y$$$20240917$$CN$US$US
243269912$24326991$2$F$20240722$20240905$20240917$20240925$EXP$$US-BAYER-2024A128419$BAYER$$67$YR$E$F$Y$$$20240925$$CN$US$US
243269921$24326992$1$I$$20240911$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145193$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240917$$CN$US$US
243269931$24326993$1$I$$20240908$20240917$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-028234$UNITED THERAPEUTICS$$$$$F$Y$66.667$KG$20240917$$$US$US
243269951$24326995$1$I$20240904$20240909$20240917$20240917$EXP$GB-MHRA-MED-202409060906346050-BVTDN$GB-ASPEN-GLO2024GB006225$ASPEN$$$$$$Y$$$20240917$$HP$GB$GB
243269962$24326996$2$F$$20240919$20240917$20240927$EXP$$JP-TEVA-VS-3243138$TEVA$Yamada S, Orisaka M, Kurokawa T, Onuma T, Shinagawa A, Yoshida Y. Combination therapy with paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive recurrent serous carcinoma of the uterine cervix: A case report. J-Obstet-Gynaecol-Res 2024; 1-5.; Yamada S, Orisaka M, Kurokawa T, Onuma T, Shinagawa A, Yoshida Y. Combination therapy with paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive recurrent serous carcinoma of the uterine cervix: A ca...$42$YR$$F$Y$$$20240927$$HP$JP$JP
243269981$24326998$1$I$$20240909$20240917$20240917$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011714$STRIDES$Ishizawa K, Komori T, Shimazaki R, Nakata Y, Tamaru J-I, Sasaki A, et al.. Primary cauda equina lymphoma confirmed by autopsy: A case report.. Neuropathology. 2024;44 (2):147-153$70$YR$$F$Y$$$20240917$$MD$JP$JP
243269991$24326999$1$I$$20240830$20240917$20240917$30DAY$$AT-JNJFOC-20240900088$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$PH$AT$AT
243270001$24327000$1$I$$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409051453393970-JDWLQ$GB-Accord-445447$ACCORD$$$$$F$Y$$$20240917$$PH$GB$GB
243270011$24327001$1$I$$20240909$20240917$20240917$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011692$STRIDES$Tsuburaya-Suzuki R, Ohori S, Hamanaka K, Fujita A, Matsumoto N, Kinoshita M.. Long-term clinical course of adult-onset refractory epilepsy in cardiofaciocutaneous syndrome with a pathogenic MAP2K1 variant: a case report.. Front-Genet. 2024;15:01-06$30$YR$$F$Y$$$20240917$$HP$JP$JP
243270021$24327002$1$I$$20240903$20240917$20240917$EXP$$PH-JUBILANT CADISTA PHARMACEUTICALS-2024PH001271$JUBILANT$Ajon ARS, Camara PT. Camara PT. Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Due to Multiple Anti-Epileptic Drug Hypersensitivity. Cureus. 2024;16(7):e65417$41$YR$$F$Y$$$20240917$$MD$PH$PH
243270032$24327003$2$F$20240831$20240912$20240917$20240921$EXP$$CA-ROCHE-10000078514$ROCHE$$41$YR$A$F$Y$$$20240921$$HP$CA$CA
243270041$24327004$1$I$$20240912$20240917$20240917$EXP$$CA-Orion Corporation ORION PHARMA-24_00031687$ORION$$6$YR$C$F$Y$$$20240917$$HP$CA$
243270051$24327005$1$I$20240222$20240805$20240917$20240917$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-18171$IPSEN$$20$MON$I$M$Y$7.93$KG$20240917$$MD$US$US
243270061$24327006$1$I$20240101$20240910$20240917$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-028654$UNITED THERAPEUTICS$$$$$F$Y$61.224$KG$20240917$$$US$US
243270071$24327007$1$I$$20240905$20240917$20240917$PER$$US-APOTEX-2024AP010327$APOTEX$$43$YR$$M$Y$$$20240917$$CN$US$US
243270081$24327008$1$I$20240814$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024183235$AMGEN$$$$$$Y$$$20240917$$PH$US$US
243270091$24327009$1$I$$20240916$20240917$20240917$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051637$BOEHRINGER INGELHEIM$$47$YR$A$M$Y$$$20240917$$PH$JP$JP
243270101$24327010$1$I$20200501$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024182152$AMGEN$$46$YR$A$F$Y$$$20240917$$PH$US$US
243270111$24327011$1$I$20230101$20240905$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-045071$AUROBINDO$Pabst L, Lopes S, Mascaux C.. Non-small cell lung cancer: the role of immune checkpoint inhibitors in elderly patients, Clinical case study.. Cancer and the Immune System.. 2024;8 (2):79-85$72$YR$$M$Y$$$20240917$$MD$FR$FR
243270121$24327012$1$I$20240312$20240905$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-045025$AUROBINDO$$59$YR$$F$Y$65$KG$20240917$$MD$FR$FR
243270131$24327013$1$I$20240101$20240911$20240917$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-028483$UNITED THERAPEUTICS$$$$$F$Y$120.18$KG$20240917$$$US$US
243270141$24327014$1$I$$20240826$20240917$20240917$PER$$US-ABBVIE-5925941$ABBVIE$$$$$$Y$$$20240917$$HP$US$US
243270151$24327015$1$I$$20240910$20240917$20240917$EXP$$CA-TAKEDA-2024TUS090720$TAKEDA$$$$$F$Y$$$20240917$$CN$CA$CA
243270161$24327016$1$I$$20240911$20240917$20240917$EXP$$CA-TAKEDA-2024TUS091270$TAKEDA$$$$$F$Y$$$20240917$$CN$CA$CA
243270171$24327017$1$I$$20240826$20240917$20240917$PER$$US-ABBVIE-5925994$ABBVIE$$$$$$Y$$$20240917$$HP$US$US
243270181$24327018$1$I$$20240910$20240917$20240917$EXP$$JP-AMGEN-JPNSP2024183498$AMGEN$$$$A$M$Y$$$20240917$$MD$JP$JP
243270202$24327020$2$F$$20240919$20240917$20240927$EXP$$US-TEVA-VS-3243014$TEVA$Miller K, McKean A, Hand J, Rackley S, Leung JG, LeMahieu A, et al. The occurrence of mental health symptoms in isotretinoin-treated adolescents. Pediatr-Dermatol 2024; 41 (4): 635-640.; Miller K, McKean A, Hand J, Rackley S, Leung JG, LeMahieu A, et al. The occurrence of mental health symptoms in isotretinoin-treated adolescents. Pediatr-Dermatol 2024; 41 (4): 635-640.$$$$$Y$$$20240927$$MD$US$US
243270211$24327021$1$I$20240604$20240913$20240917$20240917$EXP$$US-TAKEDA-2024TUS052522$TAKEDA$$41$YR$$F$Y$$$20240917$$MD$US$US
243270221$24327022$1$I$$20240913$20240917$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2024114296$VIIV$$$$$M$Y$$$20240917$$HP$US$US
243270231$24327023$1$I$$20240912$20240917$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2024113512$VIIV$$$$$M$Y$$$20240917$$CN$US$US
243270241$24327024$1$I$$20240906$20240917$20240917$EXP$$US-PADAGIS-2024PAD01463$PADAGIS$$$$$$Y$$$20240917$$MD$US$US
243270251$24327025$1$I$$20240905$20240917$20240917$EXP$$US-PADAGIS-2024PAD01462$PADAGIS$Chan R, Hoyt-Austin A E. Scabies Infection While Expressing Human Milk for Critically Ill Infants: Is It Safe?. BREASTFEEDING MEDICINE. 2024;19(4):306-308$$$$$Y$$$20240917$$HP$US$US
243270261$24327026$1$I$20240820$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184776$AMGEN$$61$YR$A$M$Y$$$20240917$$PH$US$US
243270271$24327027$1$I$$20240829$20240917$20240917$EXP$$US-SA-2024SA266900$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240917$$CN$US$US
243270281$24327028$1$I$$20240916$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147579$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$59.87$KG$20240917$$HP$US$US
243270291$24327029$1$I$20240902$20240902$20240917$20240917$EXP$$CO-SA-2024SA267022$SANOFI AVENTIS$$71$YR$E$F$Y$87$KG$20240917$$CN$CO$CO
243270301$24327030$1$I$$20240906$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144236$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$58.06$KG$20240917$$CN$US$US
243270311$24327031$1$I$$20240910$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144865$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$98.43$KG$20240917$$HP$US$US
243270321$24327032$1$I$20240723$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63561$$FDA-CTU$$84$YR$$M$N$$$20240916$Y$HP$US$
243270331$24327033$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63556$$FDA-CTU$$82$YR$$F$N$$$20240916$N$$US$
243270341$24327034$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63560$$FDA-CTU$$27$YR$$F$N$$$20240916$N$$US$
243270351$24327035$1$I$$20240903$20240916$20240916$DIR$FDA-CDER-CTU-2024-63527$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
243270361$24327036$1$I$$20240912$20240916$20240916$DIR$FDA-CDER-CTU-2024-63473$$FDA-CTU$$$$$F$N$$$20240912$N$HP$US$
243270371$24327037$1$I$20240814$20240914$20240916$20240916$DIR$FDA-CDER-CTU-2024-63577$$FDA-CTU$$78$YR$$M$N$$$20240914$N$HP$US$
243270381$24327038$1$I$$20240913$20240916$20240916$DIR$FDA-CDER-CTU-2024-63514$$FDA-CTU$$$$$M$N$$$20240913$N$HP$US$
243270401$24327040$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63475$$FDA-CTU$$32$YR$$F$N$$$20240916$N$$US$
243270421$24327042$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63474$$FDA-CTU$$60$YR$$F$N$110.68$KG$20240916$N$$US$
243270431$24327043$1$I$$20240913$20240917$20240917$EXP$GB-MHRA-MED-202409131236254910-ZPVYR$GB-HALEON-2196863$Haleon PLC$$$$$F$Y$$$20240917$$PH$GB$GB
243270441$24327044$1$I$20240701$20240916$20240917$20240917$EXP$FR-AFSSAPS-LY2024001287$FR-SANDOZ INC.-SDZ2024FR080445$SANDOZ$$70$YR$$M$Y$99$KG$20240917$$PH$FR$FR
243270451$24327045$1$I$20210101$20240910$20240917$20240917$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP011777$STRIDES$Filippini DM, Abeshi A, Tober N, Marchese PV, Andrini E, Lamberti G et al.. Calcitonin-secreting neuroendocrine tumor of the larynx, a diagnostic challenge of a rare neoplasm: a case report and literature review. AME Case Reports. 2024;8:21$71$YR$$F$Y$$$20240917$$MD$IT$IT
243270461$24327046$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63470$$FDA-CTU$$53$YR$$F$N$106.14$KG$20240916$N$HP$US$
243270471$24327047$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63517$$FDA-CTU$$51$YR$$F$N$$$20240916$N$$US$
243270481$24327048$1$I$$20240910$20240917$20240917$EXP$$ET-STRIDES ARCOLAB LIMITED-2024SP011778$STRIDES$Gashawbeza B, Dereje B, Abubeker FA.. Primary Dysgerminoma of the Uterine Cervix: A Rare Case Report. Case reports in obstetrics and gynecology. 2023$18$YR$$F$Y$$$20240917$$HP$ET$ET
243270491$24327049$1$I$$20240913$20240916$20240916$DIR$FDA-CDER-CTU-2024-63544$$FDA-CTU$$$$$M$N$$$20240913$N$HP$US$
243270501$24327050$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63539$$FDA-CTU$$9$YR$$M$N$26.31$KG$20240916$N$HP$US$
243270511$24327051$1$I$$20240910$20240917$20240917$EXP$$JP-AstraZeneca-2024A208481$ASTRAZENECA$$$$$$Y$$$20240917$$MD$JP$
243270521$24327052$1$I$20201201$20240909$20240917$20240917$EXP$FR-AFSSAPS-NY2024001001$FR-SA-2024SA267699$SANOFI AVENTIS$$64$YR$A$M$Y$102$KG$20240917$$MD$FR$FR
243270531$24327053$1$I$20221204$20240912$20240917$20240917$EXP$$KR-AstraZeneca-2024A209427$ASTRAZENECA$Choi WJ, Lee J, Choi K, Kim D.M, Han N, Choi J-H, Jung J, Lee H, Choi JY, Choi YJ, Eom H-S, Chun JY, Lee E. Outcomes of hematopoietic stem cell transplantation in patients with SARS-CoV-2 infection during the Omicron era. International Journal of Infectious Diseases 2024;147:1-4.$40$YR$$M$Y$$$20240917$$HP$KR$
243270541$24327054$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63559$$FDA-CTU$$41$YR$$F$N$94.8$KG$20240916$N$$US$
243270551$24327055$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63580$$FDA-CTU$$51$YR$$F$N$68.49$KG$20240916$N$$US$
243270561$24327056$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63482$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243270571$24327057$1$I$$20240911$20240917$20240917$EXP$$JP-AstraZeneca-2024A209238$ASTRAZENECA$$49$YR$$F$Y$$$20240917$$MD$JP$
243270581$24327058$1$I$$20240905$20240917$20240917$EXP$$DE-AUROBINDO-AUR-APL-2021-013269$AUROBINDO$Paul LD, Welter-Luedeke J, Penzel S, Zangl A, Graw M. Alpha-Pyrrolidinopentiothiophenone (-PVT): A forensic case study including plasma concentrations. Forensic Science International. 2021;321 (110721):1 to 17$28$YR$$M$Y$$$20240917$$MD$DE$DE
243270591$24327059$1$I$$20240911$20240917$20240917$EXP$$DE-AstraZeneca-2024A209000$ASTRAZENECA$$$$$$Y$$$20240917$$MD$DE$
243270601$24327060$1$I$$20240414$20240917$20240917$PER$$US-AstraZeneca-2024A090241$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243270611$24327061$1$I$$20240426$20240917$20240917$PER$$US-AstraZeneca-2024A101994$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243270621$24327062$1$I$$20240910$20240917$20240917$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011786$STRIDES$Zhang X, Zeng J, Huang X, Li Z.. When chronic obstructive pulmonary  disease meets small cell lung cancer: an unusual  case report of rapid progression. BMC Geriatrics. 2023;23:836$68$YR$$M$Y$$$20240917$$HP$CN$CN
243270631$24327063$1$I$20240526$20240910$20240917$20240917$EXP$$US-BAYER-2024A078940$BAYER$$42$YR$A$M$Y$77.551$KG$20240917$$PH$US$US
243270641$24327064$1$I$$20240516$20240917$20240917$PER$$US-AstraZeneca-2024A115636$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$US$
243270651$24327065$1$I$$20240526$20240917$20240917$PER$$US-AstraZeneca-2024A125829$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243270661$24327066$1$I$$20240607$20240917$20240917$PER$$US-AstraZeneca-2024A135267$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243270671$24327067$1$I$$20240611$20240917$20240917$PER$$US-AstraZeneca-2024A136464$ASTRAZENECA$$$$$M$Y$$$20240917$$HP$US$
243270681$24327068$1$I$$20240616$20240917$20240917$PER$$US-AstraZeneca-2024A145033$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243270691$24327069$1$I$$20240712$20240917$20240917$PER$$US-AstraZeneca-2024A161565$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243270701$24327070$1$I$$20240906$20240917$20240917$PER$$US-AstraZeneca-2024A164784$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$US$
243270711$24327071$1$I$$20240909$20240917$20240917$PER$$US-AstraZeneca-2024A169259$ASTRAZENECA$$$$$$Y$$$20240917$$MD$US$
243270721$24327072$1$I$20230101$20240910$20240917$20240917$EXP$$US-SA-2024SA266168$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240917$$HP$US$US
243270731$24327073$1$I$$20240829$20240917$20240917$PER$$US-AstraZeneca-2024A198566$ASTRAZENECA$$$$$$Y$$$20240917$$MD$US$
243270741$24327074$1$I$$20240904$20240917$20240917$EXP$$GB-UCBSA-2024023899$UCB$$$$$F$Y$$$20240917$$CN$GB$GB
243270751$24327075$1$I$20240522$20240905$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-044826$AUROBINDO$$22$YR$$F$Y$$$20240917$$MD$FR$FR
243270761$24327076$1$I$$20240909$20240917$20240917$EXP$$US-VIVUS, Inc.-2024V1001097$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243270771$24327077$1$I$$20240914$20240917$20240917$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051701$BOEHRINGER INGELHEIM$$$$$$Y$$$20240917$$MD$JP$JP
243270791$24327079$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146613$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240917$$HP$US$US
243270801$24327080$1$I$$20240906$20240917$20240917$EXP$$US-RDY-SPO/USA/24/0013235$DR REDDYS$$64$YR$A$M$Y$$$20240917$$HP$US$US
243270811$24327081$1$I$20240805$20240916$20240917$20240917$EXP$$FR-GILEAD-2024-0687872$GILEAD$$83$YR$E$M$Y$53$KG$20240917$$MD$FR$FR
243270821$24327082$1$I$$20240913$20240917$20240917$PER$$US-BIOGEN-2024BI01282638$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
243270831$24327083$1$I$$20240912$20240917$20240917$PER$$US-BIOGEN-2024BI01282696$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
243270841$24327084$1$I$20240101$20240911$20240917$20240917$PER$$US-ABBVIE-5922825$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243270851$24327085$1$I$$20240911$20240917$20240917$EXP$$IN-ROCHE-10000013179$ROCHE$$73$YR$E$M$Y$$$20240917$$MD$IN$IN
243270861$24327086$1$I$20200911$20240910$20240917$20240917$EXP$PL-URPL-1-2017-2020$PL-TEVA-VS-3242407$TEVA$$60$YR$$F$Y$$$20240917$$MD$PL$PL
243270871$24327087$1$I$20240911$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024182266$AMGEN$$82$YR$E$M$Y$$$20240917$$CN$US$US
243270881$24327088$1$I$20240911$20240912$20240917$20240917$PER$$US-BIOGEN-2024BI01282588$BIOGEN$$69$YR$$F$Y$$$20240917$$CN$US$US
243270891$24327089$1$I$$20240911$20240917$20240917$EXP$$CA-SANDOZ INC.-NVSC2023CA005609$SANDOZ$$5$MON$$F$Y$$$20240917$$HP$CA$CA
243270902$24327090$2$F$20240913$20240924$20240917$20240925$PER$$US-AMGEN-USASP2024184586$AMGEN$$36$YR$A$F$Y$$$20240925$$CN$US$US
243270911$24327091$1$I$$20240910$20240917$20240917$EXP$$SA-STRIDES ARCOLAB LIMITED-2024SP011788$STRIDES$Alamri RM, Alanazi M, AlRajeh RK, Tashkandi SA, Alswayyed AF, Samman MA, et al.. A rare presentation of BCR-ABL1 and RUNX1-MECOM rearrangement in a pediatric patient with acute myeloid leukemia.. Clinical Case reports. 2024;12(5):e8917$13$YR$$F$Y$$$20240917$$HP$SA$SA
243270921$24327092$1$I$$20240910$20240917$20240917$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011766$STRIDES$Tran D, Patel K, Ashfaq A, et al.. Disseminated Miliary and Intestinal Tuberculosis Mimicking Inflammatory Bowel Disease. Cureus. 2023;15(12):e50002$21$YR$$M$Y$$$20240917$$HP$US$US
243270931$24327093$1$I$20240901$20240910$20240917$20240917$PER$$US-ROCHE-10000079709$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243270941$24327094$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000083264$ROCHE$$$$A$F$Y$$$20240917$$CN$US$US
243270951$24327095$1$I$20130321$20240904$20240917$20240917$EXP$PT-INFARMED-J202408-693$PT-MACLEODS PHARMA-MAC2024049287$MACLEODS$$$$$$Y$$$20240917$$CN$PT$PT
243270962$24327096$2$F$$20240917$20240917$20240926$EXP$$ES-MACLEODS PHARMA-MAC2024049310$MACLEODS$Foncillas A, Calvo-Orteu M, Guillen E, Camos-Carrera A, Obach V, Laguno M..Cluster headache-like symptoms after initiation of tenofovir disoproxil fumarate and emtricitabine-containing regimens for post-HIV exposure prophylaxis.Headache: The Journal of Head and Face Pain.02-SEP-2024;1-2$$$$$Y$$$20240926$$MD$ES$ES
243270971$24327097$1$I$$20240905$20240917$20240917$EXP$$FR-MACLEODS PHARMA-MAC2024049313$MACLEODS$Citerne Q, Boyer L, Moreau E, Garon J, Gillet P, Petitpain N..Cluster headache-like symptoms during treatment with tenofovir disoproxil fumarate and emtricitabine.AIDS.15-JUL-2019;33(9):1535-6$$$$$Y$$$20240917$$HP$FR$FR
243270981$24327098$1$I$20240904$20240904$20240917$20240917$EXP$GB-MHRA-MED-202409040717567780-ZLMDV$GB-MACLEODS PHARMA-MAC2024049293$MACLEODS$$$$$$Y$$$20240917$$CN$GB$GB
243270991$24327099$1$I$20240101$20240904$20240917$20240917$EXP$$US-UCBSA-2024027465$UCB$$$$$F$Y$80.7$KG$20240917$$HP$US$US
243271001$24327100$1$I$20240901$20240909$20240917$20240917$EXP$$US-ABBVIE-5916070$ABBVIE$$23$YR$$F$Y$59$KG$20240917$$CN$US$US
243271021$24327102$1$I$$20240904$20240917$20240917$EXP$GB-MHRA-MED-202409031429539670-ZJPQL$GB-MACLEODS PHARMA-MAC2024049299$MACLEODS$$$$$M$Y$$$20240917$$HP$GB$GB
243271042$24327104$2$F$$20240916$20240917$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009951$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243271051$24327105$1$I$20240829$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008224$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240917$$CN$US$US
243271061$24327106$1$I$$20240904$20240917$20240917$EXP$$PL-AUROBINDO-AUR-APL-2024-045301$AUROBINDO$Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoeman H, Ljungman P, Kobbe G, et al.,. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT.. American journal of transplantation. 2015;15:705-714 (1-10)$62$YR$$M$Y$$$20240917$$HP$PL$PL
243271071$24327107$1$I$$20240910$20240917$20240917$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011773$STRIDES$Furuyama T, Asano S, Kondo I, Hinokida M, Tatsutomi Y, Nakazawa K, et. al.. A Case of Intestinal Fistula Associated with Small Intestinal Metastasis from Small Cell Lung Carcinoma.. Gan To Kagaku Ryoho. 2023;50(13):1543-1545.$53$YR$$M$Y$$$20240917$$HP$JP$JP
243271092$24327109$2$F$20240912$20240913$20240917$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146999$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240918$$PH$US$US
243271101$24327110$1$I$$20240914$20240917$20240917$EXP$GB-MHRA-MED-202409131511421900-MPKSC$GB-ORGANON-O2409GBR001083$ORGANON$$$$$M$Y$$$20240917$$CN$GB$GB
243271111$24327111$1$I$$20240910$20240917$20240917$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP011774$STRIDES$Magalh?es A G, Santos M B, Almeida P H, Carvalho AMF, Exposito BT.. Human Herpesvirus 8-Positive Multicentric Castleman Disease in an Immunocompetent Patient: A Diagnostic Challenge. Cureus. 2024;16 (3):e56534$79$YR$$M$Y$$$20240917$$HP$PT$PT
243271121$24327112$1$I$$20240906$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142878$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240917$$CN$US$US
243271131$24327113$1$I$$20240912$20240917$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147286$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$MD$JP$JP
243271142$24327114$2$F$20240101$20240913$20240917$20240925$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-124404$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240925$$PH$DE$DE
243271151$24327115$1$I$$20240915$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146543$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$92.08$KG$20240917$$CN$US$US
243271161$24327116$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63579$$FDA-CTU$$52$YR$$M$N$83.91$KG$20240916$N$$US$
243271171$24327117$1$I$$20240909$20240917$20240917$EXP$$BR-TAKEDA-2024TUS091286$TAKEDA$$$$$M$Y$$$20240917$$CN$BR$BR
243271181$24327118$1$I$$20240905$20240917$20240917$EXP$CA-MHPD-E2B_07206286$CA-Accord-445842$ACCORD$$7$YR$C$F$Y$29$KG$20240917$$HP$CA$CA
243271191$24327119$1$I$20240630$20240907$20240917$20240917$30DAY$$US-GSK-US2024AMR111790$GLAXOSMITHKLINE$$77$YR$$M$Y$81.6$KG$20240917$$CN$US$US
243271201$24327120$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63521$$FDA-CTU$$19$YR$$F$N$$$20240916$N$$US$
243271211$24327121$1$I$$20240913$20240916$20240916$DIR$FDA-CDER-CTU-2024-63511$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243271221$24327122$1$I$20240909$20240913$20240916$20240916$DIR$FDA-CDER-CTU-2024-63558$$FDA-CTU$$67$YR$$M$N$$$20240913$N$HP$US$
243271231$24327123$1$I$$20240909$20240917$20240917$EXP$$JP-BAYER-2024A129150$BAYER$$7$DEC$E$F$Y$50.4$KG$20240917$$HP$JP$JP
243271251$24327125$1$I$$20240905$20240917$20240917$EXP$PT-EMA-DD-20240111-7482715-101621$PT-Accord-404998$ACCORD$$$$E$$Y$$$20240917$$HP$PT$PT
243271261$24327126$1$I$20240712$20240912$20240917$20240917$EXP$$US-BAYER-2024A131891$BAYER$$79$YR$E$M$Y$102.59$KG$20240917$$CN$US$US
243271271$24327127$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63563$$FDA-CTU$$52$YR$$F$N$$$20240916$N$$US$
243271281$24327128$1$I$20240912$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63570$$FDA-CTU$$64$YR$$M$N$$$20240916$Y$HP$US$
243271291$24327129$1$I$20240916$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63567$$FDA-CTU$$75$YR$$F$N$$$20240916$Y$HP$US$
243271301$24327130$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63490$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243271311$24327131$1$I$$20240913$20240916$20240916$DIR$FDA-CDER-CTU-2024-63547$$FDA-CTU$$$$$M$N$$$20240913$N$HP$US$
243271321$24327132$1$I$20240908$20240916$20240916$20240916$DIR$718581$$FDA-CTU$$77$YR$$M$N$78.75$KG$20240916$N$CN$US$
243271331$24327133$1$I$20240817$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63584$$FDA-CTU$$78$YR$$F$N$$$20240916$N$$US$
243271351$24327135$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084098$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$44$YR$$F$Y$$$20240917$$HP$IE$IE
243271361$24327136$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084069$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$32$YR$$F$Y$$$20240917$$HP$IE$IE
243271371$24327137$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084155$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$68$YR$$M$Y$$$20240917$$HP$IE$IE
243271381$24327138$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084117$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$40$YR$$M$Y$$$20240917$$HP$IE$IE
243271391$24327139$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084101$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$37$YR$$F$Y$$$20240917$$HP$IE$IE
243271401$24327140$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084125$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$33$YR$$M$Y$$$20240917$$HP$IE$IE
243271411$24327141$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084100$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$25$YR$$F$Y$$$20240917$$HP$IE$IE
243271421$24327142$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084147$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$50$YR$$M$Y$$$20240917$$HP$IE$IE
243271431$24327143$1$I$20240101$20240904$20240917$20240917$EXP$$US-UCBSA-2024035253$UCB$$$$$F$Y$70.295$KG$20240917$$HP$US$US
243271451$24327145$1$I$$20240819$20240917$20240917$PER$$US-009507513-2408USA006330$MERCK$$$$$M$Y$$$20240917$$CN$US$US
243271461$24327146$1$I$$20240913$20240917$20240917$PER$$US-TAKEDA-2024TUS092169$TAKEDA$$$$$$Y$$$20240917$$PH$US$US
243271471$24327147$1$I$20240906$20240910$20240917$20240917$EXP$$US-BAYER-2024A130304$BAYER$$7$YR$C$M$Y$$$20240917$$CN$US$US
243271482$24327148$2$F$$20240912$20240917$20240920$EXP$$CA-SANDOZ INC.-SDZ2024CA079180$SANDOZ$$67$YR$$F$Y$73$KG$20240920$$MD$CA$CA
243271501$24327150$1$I$20240901$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184453$AMGEN$$65$YR$E$F$Y$$$20240917$$CN$US$US
243271511$24327151$1$I$20240802$20240910$20240917$20240917$EXP$$US-Vifor (International) Inc.-VIT-2024-08322$VIFOR$$63$YR$$M$Y$79.6$KG$20240917$$HP$US$US
243271521$24327152$1$I$$20240913$20240917$20240917$EXP$$DE-SANDOZ INC.-SDZ2024DE080217$SANDOZ$$24$YR$$$Y$$$20240917$$MD$DE$DE
243271531$24327153$1$I$$20240912$20240917$20240917$EXP$GB-MHRA-31806421$GB-STRIDES ARCOLAB LIMITED-2024SP011755$STRIDES$$$$$F$Y$$$20240917$$CN$GB$GB
243271541$24327154$1$I$$20240910$20240917$20240917$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011720$STRIDES$Theik NWY. A Case Report of Aggressive Post-Infectious Hemophagocytic Lymphohistiocytosis in an Immunocompetent Adult. Cureus. 2023;15(2):e51334$77$YR$$F$Y$$$20240917$$HP$US$US
243271551$24327155$1$I$$20240913$20240917$20240917$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-147408$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240917$$HP$GB$GB
243271561$24327156$1$I$20240902$20240913$20240917$20240917$EXP$$US-ROCHE-10000082927$ROCHE$$53$YR$A$F$Y$$$20240917$$CN$US$US
243271571$24327157$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63557$$FDA-CTU$$50$YR$$F$N$$$20240916$N$$US$
243271581$24327158$1$I$$20240913$20240917$20240917$EXP$$DE-SANDOZ INC.-SDZ2024DE080221$SANDOZ$$$$$M$Y$$$20240917$$MD$DE$DE
243271591$24327159$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63568$$FDA-CTU$$87$YR$$F$N$$$20240916$N$$US$
243271601$24327160$1$I$20240914$20240916$20240916$20240916$DIR$718578$$FDA-CTU$$85$YR$$F$N$$$20240916$N$HP$US$
243271611$24327161$1$I$20240817$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63585$$FDA-CTU$$78$YR$$F$N$$$20240916$N$$US$
243271621$24327162$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63502$$FDA-CTU$$52$YR$$F$N$40.82$KG$20240916$N$$US$
243271631$24327163$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63493$$FDA-CTU$$79$YR$$F$N$56.25$KG$20240916$N$$US$
243271641$24327164$1$I$20240822$20240912$20240917$20240917$EXP$$US-BAYER-2024A131946$BAYER$$89$YR$E$M$Y$$$20240917$$CN$US$US
243271651$24327165$1$I$$20240912$20240917$20240917$EXP$GB-002147023-NVSC2024GB179605$GB-STRIDES ARCOLAB LIMITED-2024SP011716$STRIDES$$$$A$F$Y$$$20240917$$MD$GB$GB
243271661$24327166$1$I$20240101$20240828$20240917$20240917$PER$$US-TEVA-VS-3238308$TEVA$$67$YR$$F$Y$$$20240917$$CN$US$US
243271671$24327167$1$I$$20240915$20240916$20240916$DIR$FDA-CDER-CTU-2024-63472$$FDA-CTU$$$$$M$N$$$20240915$N$HP$US$
243271681$24327168$1$I$20240914$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63499$$FDA-CTU$$58$YR$$F$N$$$20240916$N$HP$US$
243271691$24327169$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A211020$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243271701$24327170$1$I$20240909$20240914$20240916$20240916$DIR$FDA-CDER-CTU-2024-63582$$FDA-CTU$$15$YR$$F$N$$$20240914$N$HP$US$
243271712$24327171$2$F$$20240923$20240917$20240927$EXP$$CA-HALEON-2196751$Haleon PLC$$$$$M$Y$$$20240926$$HP$CA$CA
243271721$24327172$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63505$$FDA-CTU$$55$YR$$F$N$56.25$KG$20240916$N$$US$
243271731$24327173$1$I$$20240911$20240917$20240917$EXP$$JP-AstraZeneca-2022A226369$ASTRAZENECA$$$$A$$Y$$$20240917$$MD$JP$
243271741$24327174$1$I$$20240912$20240917$20240917$EXP$$BG-AstraZeneca-2024A211298$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$BG$
243271751$24327175$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210097$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243271761$24327176$1$I$$20240912$20240917$20240917$EXP$$ZA-AstraZeneca-2024A209923$ASTRAZENECA$$83$YR$$F$Y$$$20240917$$CN$ZA$
243271771$24327177$1$I$20240827$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208886$ASTRAZENECA$$$$$M$Y$$$20240917$$HP$US$
243271781$24327178$1$I$20240916$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63581$$FDA-CTU$$74$YR$$F$N$76.2$KG$20240916$N$HP$US$
243271791$24327179$1$I$$20240910$20240917$20240917$EXP$$CN-AstraZeneca-2024A208339$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$CN$
243271801$24327180$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63471$$FDA-CTU$$74$YR$$F$N$$$20240916$N$$US$
243271811$24327181$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63479$$FDA-CTU$$85$YR$$F$N$51.71$KG$20240916$N$$US$
243271821$24327182$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63586$$FDA-CTU$$45$YR$$F$N$$$20240916$N$$US$
243271834$24327183$4$F$$20240918$20240917$20240922$30DAY$$US-SANDOZ INC.-SDZ2024US079725$SANDOZ$$$$$M$Y$$$20240922$$CN$US$US
243271841$24327184$1$I$$20240906$20240917$20240917$EXP$GB-MHRA-MED-202409061107100170-VGBDS$GB-TORRENT-00037890$TORRENT$$37$YR$A$F$Y$$$20240917$$HP$GB$GB
243271851$24327185$1$I$20230730$20240906$20240917$20240917$EXP$GB-MHRA-MED-202409061425441910-NPQTV$GB-TORRENT-00037892$TORRENT$$7$YR$C$F$Y$$$20240917$$CN$GB$GB
243271861$24327186$1$I$$20240904$20240917$20240917$EXP$$US-TORRENT-00013741$TORRENT$$$$$F$Y$$$20240917$$CN$US$US
243271871$24327187$1$I$$20240904$20240917$20240917$EXP$$US-TORRENT-00013743$TORRENT$$$$$F$Y$$$20240917$$CN$US$US
243271881$24327188$1$I$$20240916$20240917$20240917$PER$$US-ABBVIE-5926031$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243271891$24327189$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63578$$FDA-CTU$$52$YR$$F$N$40.82$KG$20240916$N$$US$
243271901$24327190$1$I$20240520$20240906$20240917$20240917$EXP$GB-MHRA-MED-202409061114454530-PRQHZ$GB-TORRENT-00037891$TORRENT$$35$YR$A$M$Y$$$20240917$$MD$GB$GB
243271911$24327191$1$I$$20240904$20240917$20240917$EXP$$US-TORRENT-00013745$TORRENT$$31$YR$A$M$Y$81$KG$20240917$$PH$US$US
243271921$24327192$1$I$$20240913$20240917$20240917$PER$$US-GILEAD-2024-0687796$GILEAD$$$$A$M$Y$$$20240917$$CN$US$US
243271931$24327193$1$I$$20240912$20240917$20240917$PER$$NVSC2024US184948$NOVARTIS$$$$$M$Y$$$20240917$$CN$US$US
243271941$24327194$1$I$$20240910$20240917$20240917$EXP$$US-ABBVIE-5917804$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243271951$24327195$1$I$20240316$20240916$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147325$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240917$$HP$US$US
243271961$24327196$1$I$20230701$20240908$20240917$20240917$EXP$GB-MHRA-MED-202409082049593860-LVBDS$GB-TEVA-VS-3241906$TEVA$$8$YR$$M$Y$28$KG$20240917$$CN$GB$GB
243271972$24327197$2$F$$20240925$20240917$20240930$30DAY$$JP-MYLANLABS-2024M1081511$MYLAN$$$$$F$Y$$$20240930$$CN$JP$JP
243271981$24327198$1$I$$20240916$20240917$20240917$PER$$US-ROCHE-10000083390$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243271991$24327199$1$I$$20240910$20240917$20240917$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001848$BLUEPRINT MEDICINES$$$$$F$Y$$$20240917$$CN$US$US
243272001$24327200$1$I$$20240907$20240917$20240917$PER$$NVSC2024US185149$NOVARTIS$$$$$$Y$$$20240917$$CN$US$US
243272011$24327201$1$I$$20240903$20240917$20240917$EXP$$AR-Unichem Pharmaceuticals (USA) Inc-UCM202409-001123$UNICHEM$$$$C$$Y$$$20240917$$HP$AR$
243272032$24327203$2$F$20240729$20240903$20240917$20240917$EXP$$BR-GLENMARK PHARMACEUTICALS-2024GMK093822$GLENMARK$$$$$$Y$$$20240917$$HP$BR$BR
243272062$24327206$2$F$20200101$20240924$20240917$20240926$EXP$$NVSC2024PL182157$NOVARTIS$$65$YR$$F$Y$$$20240926$$MD$PL$PL
243272071$24327207$1$I$$20240911$20240917$20240917$EXP$$BR-TAKEDA-2024TUS082191$TAKEDA$$75$YR$$M$Y$77$KG$20240917$$CN$BR$BR
243272081$24327208$1$I$$20240911$20240917$20240917$EXP$$US-ROCHE-10000070024$ROCHE$$61$YR$A$F$Y$$$20240917$$CN$US$US
243272101$24327210$1$I$20240914$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63575$$FDA-CTU$$58$YR$$F$N$95.25$KG$20240916$N$HP$US$
243272121$24327212$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63530$$FDA-CTU$$62$YR$$F$N$$$20240916$N$$US$
243272131$24327213$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63553$$FDA-CTU$$40$YR$$F$N$$$20240916$N$$US$
243272141$24327214$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63496$$FDA-CTU$$74$YR$$M$N$$$20240916$N$$US$
243272151$24327215$1$I$20240828$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63534$$FDA-CTU$$61$YR$$F$N$$$20240916$Y$PH$US$
243272161$24327216$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63508$$FDA-CTU$$44$YR$$M$N$$$20240916$N$$US$
243272171$24327217$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63477$$FDA-CTU$$85$YR$$F$N$58.06$KG$20240916$N$$US$
243272181$24327218$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63525$$FDA-CTU$$59$YR$$F$N$$$20240916$N$$US$
243272191$24327219$1$I$$20240914$20240916$20240916$DIR$FDA-CDER-CTU-2024-63562$$FDA-CTU$$$$$F$N$$$20240914$N$HP$US$
243272201$24327220$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63588$$FDA-CTU$$86$YR$$F$N$$$20240916$N$$US$
243272211$24327221$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63504$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243272251$24327225$1$I$$20240911$20240917$20240917$EXP$$GB-SANDOZ INC.-SDZ2024GB079877$SANDOZ$$$$$F$Y$$$20240917$$CN$GB$GB
243272262$24327226$2$F$20240826$20240924$20240917$20240926$EXP$$CO-AMGEN-COLSL2024183195$AMGEN$$68$YR$E$F$Y$$$20240926$$CN$CO$CO
243272271$24327227$1$I$20240906$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147633$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240917$$CN$US$US
243272281$24327228$1$I$$20240911$20240917$20240917$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-122090$REGENERON$$$$$M$Y$$$20240917$$CN$US$US
243272291$24327229$1$I$$20240913$20240916$20240916$DIR$FDA-CDER-CTU-2024-63587$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243272301$24327230$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63590$$FDA-CTU$$59$YR$$F$N$58.06$KG$20240916$N$$US$
243272311$24327231$1$I$$20240911$20240917$20240917$EXP$$US-RDY-SPO/USA/24/0013438$DR REDDYS$$66$YR$E$M$Y$$$20240917$$HP$US$US
243272321$24327232$1$I$$20240716$20240917$20240917$PER$$US-ROCHE-10000031410$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243272331$24327233$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63576$$FDA-CTU$$71$YR$$F$N$84.82$KG$20240916$N$$US$
243272341$24327234$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63480$$FDA-CTU$$68$YR$$F$N$117.93$KG$20240916$N$$US$
243272351$24327235$1$I$$20240915$20240916$20240916$DIR$FDA-CDER-CTU-2024-63589$$FDA-CTU$$$$$F$N$$$20240915$N$HP$US$
243272361$24327236$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63476$$FDA-CTU$$74$YR$$F$N$$$20240916$N$$US$
243272371$24327237$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63487$$FDA-CTU$$66$YR$$F$N$$$20240916$N$$US$
243272381$24327238$1$I$$20240905$20240917$20240917$EXP$$US-Accord-446062$ACCORD$Zhang R V, Carr B R, Reducing Respiratory Complications During Electroconvulsive Therapy (ECT) With Smaller Doses of Succinylcholine in a Morbidly Obese Patient: A Case Report. Cureus 16(7): e65654$48$YR$A$F$Y$110$KG$20240917$$HP$US$US
243272391$24327239$1$I$$20240913$20240916$20240916$DIR$FDA-CDER-CTU-2024-63550$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243272401$24327240$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63484$$FDA-CTU$$58$YR$$M$N$$$20240916$N$$US$
243272411$24327241$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009327$ELI LILLY AND CO$$61$YR$A$$Y$$$20240917$$CN$US$US
243272421$24327242$1$I$$20240911$20240916$20240916$DIR$FDA-CDER-CTU-2024-63591$$FDA-CTU$$$$$F$N$$$20240911$N$HP$US$
243272431$24327243$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008211$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240917$$CN$US$US
243272441$24327244$1$I$20240910$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009178$ELI LILLY AND CO$$$$$M$Y$$$20240917$$CN$US$US
243272451$24327245$1$I$$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009715$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240917$$CN$US$US
243272461$24327246$1$I$$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009713$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240917$$CN$US$US
243272471$24327247$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009360$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240917$$CN$US$US
243272481$24327248$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009905$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243272492$24327249$2$F$$20240911$20240917$20240926$EXP$$CA-AMGEN-CANSP2024183763$AMGEN$$43$YR$A$F$Y$68$KG$20240926$$CN$CA$CA
243272501$24327250$1$I$20230101$20240907$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409006242$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240917$$CN$US$US
243272511$24327251$1$I$20240910$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009380$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243272521$24327252$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008946$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240917$$CN$US$US
243272531$24327253$1$I$$20240910$20240917$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR113819$VIIV$$$$$$Y$$$20240917$$MD$US$US
243272541$24327254$1$I$$20240909$20240917$20240917$EXP$$DE-TEVA-VS-3242627$TEVA$Shamseldin M, Heers H, Steiner T, Puls R. Anatomic locations of ureterovascular fistulae: a review of 532 patients in the literature and a new series of 8 patients. CVIR-Endovasc 2024; 7 (1):.$84$YR$$M$Y$$$20240917$$HP$DE$DE
243272551$24327255$1$I$$20240916$20240917$20240917$PER$$US-ROCHE-10000083793$ROCHE$$$$A$F$Y$$$20240917$$MD$US$US
243272561$24327256$1$I$$20240911$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146275$BRISTOL MYERS SQUIBB$$$$A$M$Y$$$20240917$$HP$US$US
243272571$24327257$1$I$20240910$20240911$20240917$20240917$EXP$$BR-BAYER-2024A130937$BAYER$$56$YR$A$F$Y$$$20240917$$HP$BR$BR
243272581$24327258$1$I$$20240904$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-044614$AUROBINDO$Camus C, Poinot M, Pronier C, Rayar M, Neillon AL, Latournerie M, et al. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transplant-Infectious-Disease. 2024;26(3):1-10$$$$$Y$$$20240917$$HP$FR$FR
243272592$24327259$2$F$20240901$20240913$20240917$20240923$EXP$$NVSJ2024JP010869$NOVARTIS$$75$YR$$M$Y$$$20240924$$PH$JP$JP
243272601$24327260$1$I$$20240913$20240917$20240917$PER$$NVSC2024US184833$NOVARTIS$$$$$F$Y$$$20240917$$MD$US$US
243272611$24327261$1$I$$20240907$20240917$20240917$EXP$$US-PADAGIS-2024PAD01469$PADAGIS$$$$$$Y$$$20240917$$CN$US$US
243272621$24327262$1$I$20240909$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146774$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$54.43$KG$20240917$$CN$US$US
243272631$24327263$1$I$20240101$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184140$AMGEN$$58$YR$A$F$Y$$$20240917$$HP$US$US
243272641$24327264$1$I$$20240912$20240917$20240917$EXP$$ZA-AstraZeneca-2024A209698$ASTRAZENECA$$52$YR$$M$Y$$$20240917$$CN$ZA$
243272651$24327265$1$I$$20240909$20240917$20240917$EXP$$US-AstraZeneca-2024A207838$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243272661$24327266$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A209914$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$US$
243272671$24327267$1$I$$20240916$20240917$20240917$EXP$$US-AstraZeneca-2024A211778$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243272681$24327268$1$I$20240909$20240912$20240917$20240917$EXP$$CN-AstraZeneca-2024A209926$ASTRAZENECA$$16550$DY$$F$Y$42$KG$20240917$$MD$CN$
243272691$24327269$1$I$$20240909$20240917$20240917$EXP$$JP-ASTELLAS-2024-AER-005680$ASTELLAS$Ogawa S, Matsumura Y, Kato T, Kiyohara E, Fujimoto M. Diseases that cause blisters - 11 Drug-induced bullous lichen planus appeared during enfortumab vedotin treatment. Practical Dermatology. 2024;46(3): 268-71.$70$YR$E$M$Y$55.6$KG$20240917$$MD$JP$JP
243272701$24327270$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210458$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243272711$24327271$1$I$$20240911$20240917$20240917$EXP$$VN-AstraZeneca-2024A210197$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$VN$
243272721$24327272$1$I$$20240911$20240917$20240917$EXP$$RU-AstraZeneca-2024A208882$ASTRAZENECA$$26$YR$$M$Y$47.5$KG$20240917$$CN$RU$
243272731$24327273$1$I$20240805$20240909$20240917$20240917$EXP$$US-AstraZeneca-2024A210745$ASTRAZENECA$$4243$WK$$M$Y$$$20240917$$CN$US$
243272741$24327274$1$I$$20240913$20240917$20240917$EXP$$ZA-AstraZeneca-2024A209889$ASTRAZENECA$$86$YR$$F$Y$$$20240917$$PH$ZA$
243272751$24327275$1$I$$20240903$20240917$20240917$30DAY$$US-PFIZER INC-202400250081$PFIZER$$13$YR$$F$Y$47.63$KG$20240917$$CN$US$US
243272761$24327276$1$I$20240501$20240913$20240917$20240917$EXP$IT-MINISAL02-1001942$IT-PFIZER INC-202400255762$PFIZER$$80$YR$$F$Y$$$20240917$$MD$IT$IT
243272771$24327277$1$I$$20240904$20240917$20240917$EXP$$GB-AUROBINDO-AUR-APL-2024-044874$AUROBINDO$Pacini E, Schelenz S, Abdolrasouli A, Mehra V, Ceesay MM, Avenoso D et al.,. Aspergillus calidoustus and Talaromyces columbinus infections in chronic graft-versus-host disease.. Annals of Hematology. 2024$30$YR$$M$Y$$$20240917$$HP$GB$GB
243272791$24327279$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000083114$ROCHE$$28$YR$A$F$Y$$$20240917$$CN$US$US
243272821$24327282$1$I$$20240911$20240917$20240917$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR113956$VIIV$$$$$M$Y$$$20240917$$PH$US$US
243272831$24327283$1$I$$20240903$20240917$20240917$EXP$$US-RISINGPHARMA-US-2024RISLIT00322$RISING PHARMACEUTICALS$Katherine E. Schwetye.Histopathologic correlates of opioid-associated injury in CHANTER  syndrome: frst report of a post-mortem examination.Acta Neuropathologica.25-AUG-2024;148(1):1-4$45$YR$A$M$Y$$$20240917$$HP$US$US
243272841$24327284$1$I$20240501$20240912$20240917$20240917$EXP$$US-PFIZER INC-PV202400120298$PFIZER$$64$YR$$F$Y$$$20240917$$CN$US$US
243272851$24327285$1$I$$20240909$20240917$20240917$30DAY$$US-PFIZER INC-PV202400118453$PFIZER$$$$$M$Y$$$20240917$$CN$US$US
243272861$24327286$1$I$$20240909$20240917$20240917$30DAY$$KR-PFIZER INC-202400257162$PFIZER$$13$YR$$M$Y$$$20240917$$CN$KR$KR
243272872$24327287$2$F$$20240919$20240917$20240927$EXP$$JP-TEVA-VS-3242183$TEVA$Otsuka E, Kitamura M, Sawase K, Nakamura M, Inoue H, Yamaguchi K, et al. Hereditary Hemorrhagic Telangiectasia in a Patient Undergoing Hemodialysis with Anticoagulants and Antiplatelets. Intern-Med 2024; 63 (11): 1609-1614.; Otsuka E, Kitamura M, Sawase K, Nakamura M, Inoue H, Yamaguchi K, et al. Hereditary Hemorrhagic Telangiectasia in a Patient Undergoing Hemodialysis with Anticoagulants and Antiplatelets. Intern-Med 2024; 63 (11): 1609-1614.; Otsuka E, Kitamura M, Sawase K, Nakamura M, Ino...$61$YR$$F$Y$$$20240927$$HP$JP$JP
243272881$24327288$1$I$$20240911$20240917$20240917$30DAY$$US-PFIZER INC-202400254903$PFIZER$$4$YR$$M$Y$$$20240917$$CN$US$US
243272891$24327289$1$I$$20240913$20240917$20240917$EXP$$GB-PFIZER INC-PV202400120461$PFIZER$$87$YR$$F$Y$$$20240917$$HP$GB$GB
243272902$24327290$2$F$$20240903$20240917$20240917$30DAY$$US-PFIZER INC-202400250089$PFIZER$$10$YR$$M$Y$$$20240917$$HP$US$US
243272911$24327291$1$I$$20240904$20240917$20240917$30DAY$$JP-PFIZER INC-PV202400116204$PFIZER$$5$YR$$$Y$$$20240917$$CN$JP$JP
243272921$24327292$1$I$$20240911$20240917$20240917$EXP$$US-BAYER-2024A132225$BAYER$$57$YR$A$M$Y$$$20240917$$CN$US$US
243272931$24327293$1$I$20240910$20240910$20240917$20240917$EXP$$US-AMGEN-USASP2024180835$AMGEN$$64$YR$A$M$Y$$$20240917$$MD$US$US
243272941$24327294$1$I$20240718$20240911$20240917$20240917$EXP$$JP-Eisai-EC-2024-174329$EISAI$$8$DEC$E$F$Y$$$20240917$$MD$JP$JP
243272961$24327296$1$I$20240308$20240909$20240917$20240917$EXP$$CO-ROCHE-10000076560$ROCHE$$$$$F$Y$67$KG$20240917$$CN$CO$CO
243272971$24327297$1$I$$20240910$20240917$20240917$EXP$NL-LRB-01000291$NL-TEVA-VS-3242218$TEVA$$60$YR$$M$Y$75$KG$20240917$$CN$NL$NL
243272981$24327298$1$I$$20240907$20240917$20240917$PER$$US-ABBVIE-5915802$ABBVIE$$$$A$$Y$$$20240917$$MD$US$US
243272991$24327299$1$I$20240110$20240909$20240917$20240917$EXP$IT-MINISAL02-1000707$IT-TEVA-VS-3242139$TEVA$$89$YR$$F$Y$$$20240917$$MD$IT$IT
243273011$24327301$1$I$$20240916$20240916$20240916$DIR$718585$$FDA-CTU$$$$$UNK$N$$$20240916$N$$US$
243273021$24327302$1$I$$20240903$20240916$20240916$DIR$FDA-CDER-CTU-2024-63592$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
243273031$24327303$1$I$20240709$20240916$20240916$20240916$DIR$718607$$FDA-CTU$$64$YR$$F$N$63$KG$20240916$N$CN$US$
243273041$24327304$1$I$20240916$20240916$20240916$20240916$DIR$718577$$FDA-CTU$$$$$UNK$N$$$20240916$N$CN$US$
243273061$24327306$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63595$$FDA-CTU$$60$YR$$M$N$$$20240916$N$$US$
243273071$24327307$1$I$$20240916$20240916$20240916$DIR$718596$$FDA-CTU$$$$$UNK$N$$$20240916$N$CN$US$
243273081$24327308$1$I$$20240905$20240917$20240917$PER$$US-BAYER-2024A131793$BAYER$Haniff S., Santosh Kagathur S., Christy J., Shive Gowda A., Isaac D. IBCL-723 A Case Report of Follicle Center Lymphoma Presenting As Vaginal Mass: Diagnostic Challenges and Treatment Considerations. Clinical Lymphoma, Myeloma and Leukemia. 2024;24 Supplement 1:S508$49$YR$A$F$Y$$$20240917$$HP$US$US
243273091$24327309$1$I$$20240912$20240917$20240917$30DAY$$IL-PFIZER INC-PV202400088645$PFIZER$$10$YR$$F$Y$$$20240917$$HP$IL$IL
243273101$24327310$1$I$$20240910$20240917$20240917$30DAY$$US-PFIZER INC-PV202400056280$PFIZER$$$$$$Y$$$20240917$$HP$US$US
243273111$24327311$1$I$$20240912$20240917$20240917$PER$$US-TAKEDA-2024TUS092103$TAKEDA$$$$$$Y$$$20240917$$CN$US$US
243273121$24327312$1$I$$20240916$20240917$20240917$PER$$US-ROCHE-10000083421$ROCHE$$$$A$F$Y$$$20240917$$CN$US$US
243273131$24327313$1$I$$20240710$20240917$20240917$PER$$US-ROCHE-10000024162$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243273141$24327314$1$I$$20240916$20240917$20240917$EXP$$MA-UCBSA-2024047406$UCB$Bensaghir I, Tahiri L, Farih S, Rkain H, Allali F.. Certolizumab-Induced Liver Injury in Ankylosing Spondylitis: A Case Report and Causality Assessment. Cureus. 2024;16(8):1-4$34$YR$$M$Y$$$20240917$$HP$MA$MA
243273151$24327315$1$I$20160101$20240911$20240917$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014954$JAZZ$$$$$M$Y$$$20240917$$CN$US$US
243273161$24327316$1$I$$20240911$20240917$20240917$30DAY$$US-GSK-US2024113083$GLAXOSMITHKLINE$$$$$F$Y$$$20240917$$CN$US$US
243273171$24327317$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146983$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240917$$HP$US$US
243273181$24327318$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146739$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240917$$CN$US$US
243273191$24327319$1$I$$20240912$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146102$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240917$$CN$US$US
243273201$24327320$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147144$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240917$$HP$US$US
243273211$24327321$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147029$BRISTOL MYERS SQUIBB$$9$YR$C$F$Y$$$20240917$$HP$US$US
243273221$24327322$1$I$20240809$20240829$20240917$20240917$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000883$PAREXEL$$$$$$Y$$$20240917$$HP$US$US
243273241$24327324$1$I$20240101$20240828$20240917$20240917$PER$$US-TEVA-VS-3239180$TEVA$$53$YR$$F$Y$$$20240917$$HP$US$US
243273251$24327325$1$I$$20240909$20240917$20240917$EXP$$CN-ROCHE-10000083512$ROCHE$Chen M, Liu X, Guo Y. Efficacy and safety of retinal photocoagulation combined with intravitreal injection of ranibizumab in the treatment of diabetic macular edema. CLINICAL RESEARCH AND PRACTICE. 2024;9(24):115-8. doi:10.19347/j.cnki.2096-1413.202424029$$$A$$Y$$$20240917$$HP$CN$CN
243273261$24327326$1$I$$20240912$20240917$20240917$EXP$$US-AMGEN-USASP2024183426$AMGEN$$$$A$$Y$$$20240917$$MD$US$US
243273271$24327327$1$I$20080101$20240912$20240917$20240917$EXP$$FR-MYLANLABS-13X-056-1107792-00$MYLAN$$62$YR$$F$Y$$$20240917$$HP$FR$FR
243273281$24327328$1$I$$20240903$20240917$20240917$EXP$$US-RISINGPHARMA-US-2024RISLIT00321$RISING PHARMACEUTICALS$Raymond R. Blush III.Beta-Adrenergic Agonist-Induced Lactic  Acidosis: A Case Report.AACN Advanced Critical Care.2024; 35, Number 3:222-227$54$YR$A$F$Y$$$20240917$$HP$US$US
243273291$24327329$1$I$20240430$20240913$20240917$20240917$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2024-102123$REGENERON$$55$YR$$M$Y$$$20240917$$CN$CO$CO
243273301$24327330$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184436$AMGEN$$$$$$Y$$$20240917$$CN$US$US
243273311$24327331$1$I$20240911$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183129$AMGEN$$44$YR$A$F$Y$$$20240917$$CN$US$US
243273331$24327333$1$I$$20240916$20240916$20240916$DIR$718603$$FDA-CTU$$$$$UNK$N$$$20240916$$CN$US$
243273341$24327334$1$I$20240806$20240905$20240917$20240917$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00834$MIRUM PHARMACEUTICALS$$2$YR$$M$Y$8.8$KG$20240917$$CN$US$US
243273361$24327336$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63596$$FDA-CTU$$76$YR$$M$N$$$20240916$N$$US$
243273371$24327337$1$I$$20240904$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-044615$AUROBINDO$Camus C, Poinot M, Pronier C, Rayar M, Neillon AL,  Revest M, et al. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transplant-Infectious-Disease. 2024;26(3):1-10, e14282$$$$$Y$$$20240917$$HP$FR$FR
243273381$24327338$1$I$$20240906$20240917$20240917$PER$$US-ABBVIE-5919588$ABBVIE$$$$$$Y$$$20240917$$CN$US$US
243273391$24327339$1$I$$20240909$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147465$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240917$$HP$US$US
243273401$24327340$1$I$20220302$20240909$20240917$20240917$EXP$$CN-CHEPLA-2024011815$CHEPLAPHARM$Xiaomin Zhang, Fang Wan, Su Tu. A case of mixed psychoactive drug overdose. Chinese Journal of Industrial Medicine.2024;37:4.DOI: 10. 13631 / j. cnki. zggyyx. 2024. 04. 039.??.$22$YR$$M$Y$$$20240917$$HP$COUNTRY NOT SPECIFIED$CN
243273411$24327341$1$I$20240601$20240910$20240917$20240917$PER$$US-BAYER-2024A129572$BAYER$$33$YR$A$F$Y$$$20240917$$CN$US$US
243273421$24327342$1$I$20230101$20240904$20240917$20240917$EXP$$CA-UCBSA-2023010399$UCB$$$$$F$Y$$$20240917$$CN$CA$CA
243273431$24327343$1$I$20240910$20240910$20240917$20240917$EXP$$FR-AstraZeneca-2024A208636$ASTRAZENECA$$61$YR$$M$Y$$$20240917$$MD$FR$
243273441$24327344$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210378$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243273451$24327345$1$I$$20240910$20240917$20240917$EXP$$ZA-AstraZeneca-2024A207244$ASTRAZENECA$$73$YR$$M$Y$$$20240917$$CN$ZA$
243273461$24327346$1$I$$20240911$20240917$20240917$EXP$$US-CHEPLA-2024011813$CHEPLAPHARM$$50$YR$$M$Y$84$KG$20240917$$HP$COUNTRY NOT SPECIFIED$US
243273471$24327347$1$I$$20240911$20240917$20240917$EXP$$JP-AstraZeneca-2024A208540$ASTRAZENECA$$75$YR$$F$Y$$$20240917$$MD$JP$
243273491$24327349$1$I$$20240902$20240917$20240917$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468256$RANBAXY$Gayretli Aydin ZG, Akturk Acar F, Ozgul Postuk G, Ozkaya E, Mutlu M, Arslan Y. A Case of Pan-resistant Burkholderia cepacia Complex Sepsis in a Newborn Successfully Treated With a Combination Therapy. Pediatr Infect Dis J. 2024;43(9):e334-e336$38$YR$$F$Y$$$20240917$$MD$TR$TR
243273501$24327350$1$I$$20240902$20240917$20240917$EXP$$NZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468100$RANBAXY$Meyer JA, Graydon A, Muthukumaraswamy C, Jones HF. Brachial artery aneurysm and bilateral posterior circulation strokes in a young child with tuberous sclerosis complex. BMJ Case Rep. 2023;16:e255694$$$$M$Y$$$20240917$$HP$NZ$NZ
243273511$24327351$1$I$$20240902$20240917$20240917$EXP$$SI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468257$RANBAXY$Marovt M, Marko PB. Denosumab-induced Acute Generalized Exanthematous Pustulosis. Acta Derm Venereol. 2024;104(0):adv40430$72$YR$$F$Y$$$20240917$$HP$SI$SI
243273521$24327352$1$I$20240519$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467923$RANBAXY$$75$YR$$F$Y$$$20240917$$MD$FR$FR
243273531$24327353$1$I$$20240902$20240917$20240917$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468141$RANBAXY$Tugend M, Washington E, Sekula RF. Outcomes of Trigeminal Ganglion Sparing Surgical Resection of Nonacoustic Cerebellopontine Angle Tumors Causing Trigeminal Neuralgia. World Neurosurg. 2024;Jul; 187:e54-e62$72$YR$$F$Y$$$20240917$$HP$US$US
243273541$24327354$1$I$$20240902$20240917$20240917$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468175$RANBAXY$Ueda Y, Sakai T, Yamada K, Arita K, Ishige Y, Hoshi D, et al. Fatal hemophagocytic lymphohistiocytosis with intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case. Immuno Med. 2024;47 (3):192-199$61$YR$$F$Y$$$20240917$$HP$JP$JP
243273551$24327355$1$I$20210101$20240902$20240917$20240917$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467766$RANBAXY$$38$YR$$M$Y$83$KG$20240917$$CN$GB$GB
243273561$24327356$1$I$20240101$20240909$20240917$20240917$PER$$US-UNITED THERAPEUTICS-UNT-2024-023479$UNITED THERAPEUTICS$$$$$F$Y$78.005$KG$20240917$$$US$US
243273611$24327361$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009115$ELI LILLY AND CO$$$$A$M$Y$$$20240917$$CN$US$US
243273621$24327362$1$I$20240801$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008985$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240917$$CN$US$US
243273631$24327363$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008909$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243273641$24327364$1$I$$20240909$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008064$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243273652$24327365$2$F$20240101$20240910$20240917$20240922$EXP$$US-UCBSA-2024040886$UCB$$$$$F$Y$82.993$KG$20240922$$HP$US$US
243273661$24327366$1$I$$20240913$20240917$20240917$PER$$NVSC2024US184969$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
243273671$24327367$1$I$$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467997$RANBAXY$Tran TNM, Roumeau S, Puravet A, Sapin V, Bouvier D, Oris C. [Methadone-induced central adrenal insufficiency: a case report]. Ann Biol Clin (Paris). 2024;82 (4):Online ahead of print$33$YR$$F$Y$$$20240917$$HP$FR$FR
243273681$24327368$1$I$$20240902$20240917$20240917$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468252$RANBAXY$Ordway S, Sadowski B, Driggers KE, Kwok R. Severe Drug-Induced Liver Injury in the Military: A Retrospective Review. Mil Med. 2023;May/Jun;188;5-6:e991-e996$$$$M$Y$$$20240917$$HP$US$US
243273692$24327369$2$F$$20240912$20240917$20240927$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468153$RANBAXY$Priya L, Alamanda VA, Javali M, Acharya P, Rangaiah P, Nagabushana D. Gabapentin-induced Multifocal Myoclonus. J Assoc Physicians India. 2024;Aug;72 (8):78-79$66$YR$$M$Y$$$20240927$$HP$IN$IN
243273701$24327370$1$I$20240902$20240902$20240917$20240917$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467435$RANBAXY$$54$YR$$F$Y$75$KG$20240917$$MD$GB$GB
243273721$24327372$1$I$$20240902$20240917$20240917$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468146$RANBAXY$Tugend M, Washington E, Sekula RF. Outcomes of Trigeminal Ganglion Sparing Surgical Resection of Nonacoustic Cerebellopontine Angle Tumors Causing Trigeminal Neuralgia. World Neurosurg. 2024;Jul; 187:e54-e62$63$YR$$F$Y$$$20240917$$HP$US$US
243273731$24327373$1$I$$20240902$20240917$20240917$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468000$RANBAXY$Wagner C, Montecino A. Emerging suicidal ideation in a bipolar patient after taking pregabalin: a case report. Fortschr Neurol Psychiatr. 2024;-:Online ahead of print$37$YR$$F$Y$$$20240917$$HP$DE$DE
243273741$24327374$1$I$20240614$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467962$RANBAXY$$72$YR$$F$Y$52$KG$20240917$$MD$FR$FR
243273751$24327375$1$I$$20240902$20240917$20240917$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468150$RANBAXY$Tugend M, Washington E, Sekula RF. Outcomes of Trigeminal Ganglion Sparing Surgical Resection of Nonacoustic Cerebellopontine Angle Tumors Causing Trigeminal Neuralgia. World Neurosurg. 2024;Jul; 187:e54-e62$53$YR$$F$Y$$$20240917$$HP$US$US
243273762$24327376$2$F$$20240907$20240917$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468255$RANBAXY$Fromage Y, Sayadi H, Monchaud C, Labriffe M, Scaramuzzino L, Geniaux H, et al. Synergizing pharmacometrics and pharmacovigilance for medication error management: the case of secukinumab. Eur J Clin Pharmacol. 2024;80:1339-1341$41$YR$$M$Y$84$KG$20240920$$HP$FR$FR
243273771$24327377$1$I$$20240902$20240917$20240917$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468089$RANBAXY$Tavares M, Ribeiro A, Coelho H. Long?Term Remission After Chemotherapy with Bendamustine in a Patient with Refractory Large Granular Lymphocyte Leukemia. Indian J Hematol Blood Transfus. 2024;40:535-537$71$YR$$F$Y$$$20240917$$HP$PT$PT
243273781$24327378$1$I$20240701$20240902$20240917$20240917$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468115$RANBAXY$$71$YR$$M$Y$$$20240917$$PH$IT$IT
243273791$24327379$1$I$$20240902$20240917$20240917$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468154$RANBAXY$Tugend M, Washington E, Sekula RF. Outcomes of Trigeminal Ganglion Sparing Surgical Resection of Nonacoustic Cerebellopontine Angle Tumors Causing Trigeminal Neuralgia. World Neurosurg. 2024;Jul; 187:e54-e62$74$YR$$F$Y$$$20240917$$HP$US$US
243273801$24327380$1$I$$20240902$20240917$20240917$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467760$RANBAXY$$52$YR$$F$Y$55$KG$20240917$$MD$GB$GB
243273811$24327381$1$I$20240601$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467913$RANBAXY$$80$YR$$M$Y$75$KG$20240917$$MD$FR$FR
243273821$24327382$1$I$$20240902$20240917$20240917$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468152$RANBAXY$Tugend M, Washington E, Sekula RF. Outcomes of Trigeminal Ganglion Sparing Surgical Resection of Nonacoustic Cerebellopontine Angle Tumors Causing Trigeminal Neuralgia. World Neurosurg. 2024;Jul; 187:e54-e62$61$YR$$F$Y$$$20240917$$HP$US$US
243273831$24327383$1$I$20240401$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467933$RANBAXY$$75$YR$$F$Y$50$KG$20240917$$PH$FR$FR
243273841$24327384$1$I$$20240902$20240917$20240917$EXP$$AT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468137$RANBAXY$Habenbacher M, Andrianakis A, Gellner V, Braun H, Szkandera J, Liegl-Atzwanger B, et al. Aggressive EWSR1::POU2AF3(COLCA2) spindle/ round cell sarcoma of the sinonasal tract. Histopathology. 2024;85:362-368$32$YR$$M$Y$$$20240917$$HP$AT$AT
243273852$24327385$2$F$$20240913$20240917$20240927$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468059$RANBAXY$Juliao M, Ulrich J, Calaveiras P, Costa E, Lucas I, Faria de SousaP. Ketamine subcutaneous continuous infusion for non-cancer neuropathic pain at home: a case report. BMJ Support Palliat Care. 2023;13(3):1-6$94$YR$$F$Y$$$20240927$$HP$PT$PT
243273861$24327386$1$I$20210701$20240902$20240917$20240917$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468051$RANBAXY$$62$YR$$F$Y$96$KG$20240917$$CN$DE$DE
243273871$24327387$1$I$20240310$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468236$RANBAXY$$20$YR$$F$Y$55$KG$20240917$$MD$FR$FR
243273881$24327388$1$I$20240614$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468229$RANBAXY$$85$YR$$F$Y$71.5$KG$20240917$$PH$FR$FR
243273891$24327389$1$I$20240705$20240902$20240917$20240917$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468133$RANBAXY$$55$YR$$F$Y$$$20240917$$MD$IT$IT
243273901$24327390$1$I$20240421$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468139$RANBAXY$$35$YR$$M$Y$$$20240917$$MD$FR$FR
243273911$24327391$1$I$20240623$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468119$RANBAXY$$54$YR$$M$Y$76$KG$20240917$$MD$FR$FR
243273921$24327392$1$I$20090101$20240902$20240917$20240917$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468176$RANBAXY$$39$YR$$F$Y$77$KG$20240917$$MD$DE$DE
243273931$24327393$1$I$20240404$20240902$20240917$20240917$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468187$RANBAXY$$26$YR$$M$Y$$$20240917$$MD$ES$ES
243273941$24327394$1$I$$20240902$20240917$20240917$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467163$RANBAXY$Jeries H, Daood R, Naffaa ME. Is interleukin-1 blockade a therapeutic option for patients with palindromic rheumatism?. Clin Rheumatol. 2024;43(8):2715-2717$38$YR$$M$Y$$$20240917$$HP$IL$IL
243273951$24327395$1$I$20240703$20240902$20240917$20240917$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468138$RANBAXY$$77$YR$$F$Y$$$20240917$$MD$IT$IT
243273961$24327396$1$I$20240625$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468248$RANBAXY$$51$YR$$M$Y$$$20240917$$MD$FR$FR
243273971$24327397$1$I$$20240902$20240917$20240917$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468217$RANBAXY$$34$YR$$F$Y$53$KG$20240917$$MD$PL$PL
243273981$24327398$1$I$20230828$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468122$RANBAXY$$37$YR$$M$Y$$$20240917$$MD$FR$FR
243273991$24327399$1$I$$20240902$20240917$20240917$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467958$RANBAXY$Montalto S, Di Filippo M, Capra V, Manzitti C, Sementa AR, De Marco P, et al. Abdominal rhabdoid tumor presenting with symptomatic spinal epidural compression in a newborn. A case report. Front Pediatr. 2023;11:1337760;01-06$$$N$F$Y$$$20240917$$HP$IT$IT
243274001$24327400$1$I$20240619$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468244$RANBAXY$$60$YR$$F$Y$71$KG$20240917$$PH$FR$FR
243274011$24327401$1$I$$20240902$20240917$20240917$EXP$$SK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467456$RANBAXY$Helpianska L. Efficacy of maintenance therapy with the PARP inhibitor olaparib in platinum-sensitive recurrent ovarian cancer. Onkologia(Bratisl.). 2024;9(3):224-230$43$YR$$F$Y$$$20240917$$MD$SK$SK
243274021$24327402$1$I$20240627$20240902$20240917$20240917$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468173$RANBAXY$$81$YR$$F$Y$$$20240917$$MD$ES$ES
243274031$24327403$1$I$20240628$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468195$RANBAXY$$79$YR$$F$Y$75$KG$20240917$$PH$FR$FR
243274041$24327404$1$I$$20240902$20240917$20240917$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-459439$RANBAXY$Aguilera D, Janss A, Schniederjan M, Goldman- Yassen A, Velazquez J, Mazewski C, et al. ANAPLASTIC TRANSFORMATION OF DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMORS: TWO PEDIATRIC CASES. Neuro Oncol. 2024;JUN; 26 (S.):iv199/OTHR-25$20$YR$$M$Y$$$20240917$$HP$US$US
243274061$24327406$1$I$20220101$20240902$20240917$20240917$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468351$RANBAXY$Villanueva I, Civico J, Lledo GM, Matas A, Aldecoa I, Milisenda J, et al.. Systemic sclerosis and inflammatory myopathy after treatment with durvalumab in a patient with rectal neoplasm.. Clin Exp Rheumatol. 2024;42 (8):1704-1705$74$YR$$M$Y$$$20240917$$HP$ES$ES
243274071$24327407$1$I$20240209$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468239$RANBAXY$$13$YR$$F$Y$57$KG$20240917$$PH$FR$FR
243274081$24327408$1$I$$20240902$20240917$20240917$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467975$RANBAXY$Triplett JD, Yiannikas C. Multifocal neuropathy and treatment?induced neuropathy of diabetes following diabetic ketoacidosis. Neurol Clin Neurosci. 2019;7:357-360$27$YR$$F$Y$$$20240917$$HP$AU$AU
243274091$24327409$1$I$$20240902$20240917$20240917$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467957$RANBAXY$Purssell A, Leung K, Giguere P, Angel JB. Pritelivir for the treatment of nucleoside analogue-resistant orolabial herpes simplex virus 2 in a person living with HIV. Can J Infect Dis Med Microbiol. 2024;9(2):108-112$53$YR$$M$Y$$$20240917$$MD$CA$CA
243274101$24327410$1$I$$20240902$20240917$20240917$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460642$RANBAXY$Aguilera D, Janss A, Schniederjan M, Goldman-Yassen A, Velazquez J, Mazewski C, et al. ANAPLASTIC TRANSFORMATION OF DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMORS: TWO PEDIATRIC CASES. Neuro Oncol. 2024;26 (Suppl.):iv199/OTHR-25$2$YR$$M$Y$$$20240917$$HP$US$US
243274111$24327411$1$I$$20240902$20240917$20240917$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465928$RANBAXY$Mahajan DS, Kalnawat NR, Paliwal V, Tongaonkar HB. Immunotherapy in Chemorefractory Endometrial Cancer: Ray of Hope?. Indian J Gynecol Oncol. 2023;21 (3):no pagination$52$YR$$F$Y$$$20240917$$HP$IN$IN
243274121$24327412$1$I$$20240902$20240917$20240917$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465408$RANBAXY$Greenwell AM, Bhambhani K, Toll S, Kupsky W, Altinok D, Gorsi HS. HGG-09. CONTRASTING CLINICAL COURSES OF THREE PEDIATRIC PATIENTS WITH PDGFRA AMPLIFIED RADIATION INDUCED HIGH-GRADE GLIOMA. Neuro Oncol. 2024;Jun;26 (Suppl.):iv86-iv87/NOAE064.293/HGG-09$$$C$M$Y$$$20240917$$HP$US$US
243274131$24327413$1$I$20240702$20240902$20240917$20240917$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468225$RANBAXY$$80$YR$$M$Y$$$20240917$$PH$IT$IT
243274141$24327414$1$I$20240512$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468237$RANBAXY$$50$YR$$M$Y$89$KG$20240917$$MD$FR$FR
243274161$24327416$1$I$20240601$20240902$20240917$20240917$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468126$RANBAXY$$44$YR$$F$Y$$$20240917$$PH$FR$FR
243274171$24327417$1$I$$20240902$20240917$20240917$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467166$RANBAXY$Jeries H, Daood R, Naffaa ME. Is interleukin?1 blockade a therapeutic option for patients with palindromic rheumatism?. Clinical Rheumatology. 2024;43 (8):2715?2717$28$YR$$F$Y$$$20240917$$HP$IL$IL
243274181$24327418$1$I$$20240902$20240917$20240917$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466211$RANBAXY$Russe-Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwari A. Rousing drug-induced liver injury through cytochrome p450 isoenzyme overload leading to fulminant liver failure. J Liver Transplant. 2024;14(0):100207$40$YR$$F$Y$$$20240917$$HP$US$US
243274191$24327419$1$I$20231116$20240902$20240917$20240917$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468233$RANBAXY$$54$YR$$F$Y$$$20240917$$MD$IT$IT
243274201$24327420$1$I$20231122$20240902$20240917$20240917$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468296$RANBAXY$$63$YR$$M$Y$$$20240917$$MD$IT$IT
243274211$24327421$1$I$$20240902$20240917$20240917$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468378$RANBAXY$Lin R, Muaadz A, Gwo Fuang H.. A promising response of refractory uterine leiomyosarcoma to pembrolizumab and temozolomide combination therapy. Gynecol Oncol Rep. 2024;51:1-4$68$YR$$F$Y$$$20240917$$HP$GB$GB
243274221$24327422$1$I$$20240902$20240917$20240917$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467161$RANBAXY$Marvin JE, Trubin PA, Azar MM.. Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient. Transpl Infect Dis. 2024;26 (4):e14329$63$YR$$M$Y$$$20240917$$HP$US$US
243274231$24327423$1$I$$20240902$20240917$20240917$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467989$RANBAXY$Takedomi H, Fukuda K, Inoue S, Tsuruoka N, Sakata Y, Aoki S, et al. Combined eosinophilic gastroenteritis and ulcerative colitis successfullytreated by vedolizumab: a case report. Intest Res. 2024;Aug 29:39205502$47$YR$$M$Y$$$20240917$$HP$JP$JP
243274241$24327424$1$I$$20240902$20240917$20240917$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467869$RANBAXY$Huo K, Gao J, Wang Y, Qin X, Ma X. Short segment myelitis as a dominant manifestation of cryptococcal infection: a case report. BMC Infect Dis. 2024;24 (1):863$38$YR$$M$Y$$$20240917$$HP$CN$CN
243274251$24327425$1$I$20240914$20240916$20240917$20240917$EXP$GB-MHRA-MED-202409141025092440-WNLPG$GB-MYLANLABS-2024M1084333$MYLAN$$38$YR$$F$Y$70$KG$20240917$$MD$GB$GB
243274261$24327426$1$I$$20240916$20240917$20240917$EXP$GB-MHRA-MIDB-63c10a59-fb78-409f-a2ce-89d9c954c635$GB-MYLANLABS-2024M1084365$MYLAN$$33$YR$$$Y$$$20240917$$HP$GB$GB
243274271$24327427$1$I$$20240913$20240916$20240916$DIR$FDA-CDER-CTU-2024-63597$$FDA-CTU$$66$YR$$F$N$$$20240913$N$HP$US$
243274281$24327428$1$I$20240101$20240912$20240917$20240917$EXP$$US-ABBVIE-5922730$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243274291$24327429$1$I$$20240912$20240917$20240917$EXP$$SG-ROCHE-10000081163$ROCHE$$56$YR$A$F$Y$$$20240917$$CN$SG$SG
243274301$24327430$1$I$20240910$20240911$20240917$20240917$PER$$US-BAYER-2024A130134$BAYER$$23$YR$A$F$Y$$$20240917$$HP$US$US
243274321$24327432$1$I$20230816$20240916$20240917$20240917$EXP$GB-MHRA-MED-202409150949206770-TCDRY$GB-MYLANLABS-2024M1084364$MYLAN$$62$YR$$F$Y$80$KG$20240917$$CN$GB$GB
243274331$24327433$1$I$$20240902$20240917$20240917$EXP$$SI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467972$RANBAXY$Korosec Hudnik L, Blagus T, Redensek Trampuz S, Dolzan V, Bon J, Pjevac M. Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics. Front Psychiatry. 2024;15 (0):1363051/1-9$60$YR$$F$Y$$$20240917$$HP$SI$SI
243274341$24327434$1$I$$20240916$20240917$20240917$PER$$US-HALEON-2197144$Haleon PLC$$$$$$Y$$$20240917$$CN$US$US
243274351$24327435$1$I$20240101$20240912$20240917$20240917$EXP$$US-BAYER-2024A131021$BAYER$$28$YR$A$M$Y$65.76$KG$20240917$$CN$US$US
243274361$24327436$1$I$$20240909$20240917$20240917$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001838$BLUEPRINT MEDICINES$$$$$F$Y$$$20240917$$CN$US$US
243274371$24327437$1$I$$20240915$20240917$20240917$EXP$$DE-ALXN-202409EEA001139DE$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$MD$DE$DE
243274381$24327438$1$I$20240101$20240911$20240917$20240917$PER$$US-ABBVIE-5920795$ABBVIE$$$$$M$Y$117$KG$20240917$$CN$US$US
243274391$24327439$1$I$20230719$20240904$20240917$20240917$EXP$$FR-AUROBINDO-AUR-APL-2024-044691$AUROBINDO$$52$YR$$F$Y$$$20240917$$HP$FR$FR
243274401$24327440$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001152US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243274411$24327441$1$I$20240912$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63598$$FDA-CTU$$52$YR$$F$N$$$20240916$N$PH$US$
243274421$24327442$1$I$20240829$20240909$20240917$20240917$EXP$IT-MINISAL02-1000828$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-08551$HIKMA$$$$$$Y$$$20240917$$MD$IT$IT
243274431$24327443$1$I$$20240909$20240917$20240917$EXP$$JP-ASTELLAS-2024-AER-005962$ASTELLAS$Komine H, Yamamoto S, Saito K, Kokuzawa A, Sato T, Kamata Y, et al. A case of anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial pneumonia in which baricitinib treatment was effective in the early phase of treatment. The 694th Kanto Regional Meeting of the Japanese Society of Internal Medicine (Abstracts) (Hybrid event) (2024.03.16). 2024;8.$43$YR$A$M$Y$$$20240917$$MD$JP$JP
243274441$24327444$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63599$$FDA-CTU$$44$YR$$F$N$112.94$KG$20240916$N$$US$
243274451$24327445$1$I$$20240916$20240917$20240917$30DAY$$US-SANDOZ INC.-SDZ2024US080564$SANDOZ$$22$YR$$$Y$$$20240917$$HP$US$US
243274461$24327446$1$I$$20240902$20240917$20240917$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467979$RANBAXY$DeHan PJ, Flores SA, Rhodehouse BB, Kaplan JJ, DeGroot DW. Rebound Hyperthermia in Exertional Heat Stroke. Mil Med. 2024;-:Online ahead of print$22$YR$$M$Y$$$20240917$$HP$US$US
243274471$24327447$1$I$$20240912$20240917$20240917$30DAY$$US-GSK-US2024113768$GLAXOSMITHKLINE$$$$$F$Y$$$20240917$$CN$US$US
243274481$24327448$1$I$$20240916$20240917$20240917$EXP$$US-TAKEDA-US201917662$TAKEDA$$$$$F$Y$$$20240917$$HP$US$US
243274491$24327449$1$I$20230824$20240910$20240917$20240917$EXP$$CA-GSK-CA2023116209$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
243274511$24327451$1$I$$20240903$20240917$20240917$EXP$$US-RISINGPHARMA-US-2024RISLIT00324$RISING PHARMACEUTICALS$Rachel Leigh Zachian.Acute generalised exanthematous pustulosis and  herpes simplex virus: a case of possible overlap.BMJ Case Rep.2024;17:1-5$7$DEC$$F$Y$$$20240917$$HP$US$US
243274521$24327452$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63600$$FDA-CTU$$71$YR$$F$N$160$KG$20240916$N$$US$
243274531$24327453$1$I$20240815$20240916$20240916$20240916$DIR$718584$$FDA-CTU$$70$YR$$F$N$$$20240916$Y$HP$US$
243274541$24327454$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63601$$FDA-CTU$$69$YR$$F$N$$$20240916$N$HP$US$
243274571$24327457$1$I$20240731$20240916$20240916$20240916$DIR$718611$$FDA-CTU$$42$YR$$M$N$92.7$KG$20240916$N$HP$US$
243274581$24327458$1$I$20240906$20240916$20240916$20240916$DIR$718609$$FDA-CTU$$30$YR$$F$N$54$KG$20240916$Y$CN$US$
243274601$24327460$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63602$$FDA-CTU$$70$YR$$F$N$$$20240916$N$$US$
243274611$24327461$1$I$20240801$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63603$$FDA-CTU$$60$YR$$F$N$$$20240916$N$HP$US$
243274621$24327462$1$I$$20240916$20240916$20240916$DIR$718588$$FDA-CTU$$78$YR$$M$N$90$KG$20240916$N$$US$
243274631$24327463$1$I$$20240913$20240917$20240917$EXP$$CA-AMGEN-CANSP2024184366$AMGEN$$$$$$Y$$$20240917$$PH$CA$CA
243274641$24327464$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184295$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240917$$HP$US$US
243274651$24327465$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184301$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240917$$HP$US$US
243274661$24327466$1$I$20220101$20240905$20240917$20240917$EXP$$SE-AMGEN-SWESP2024184493$AMGEN$$79$YR$E$F$Y$$$20240917$$HP$SE$SE
243274671$24327467$1$I$20240814$20240903$20240917$20240917$EXP$$BR-CELLTRION INC.-2023BR004701$CELLTRION$$$$$$Y$$$20240917$$CN$BR$BR
243274681$24327468$1$I$20240821$20240913$20240917$20240917$EXP$$CO-UCBSA-2024047512$UCB$$29$YR$$F$Y$$$20240917$$CN$CO$CO
243274691$24327469$1$I$20240902$20240904$20240917$20240917$EXP$$US-UCBSA-2024045288$UCB$$28$YR$$F$Y$$$20240917$$CN$US$US
243274721$24327472$1$I$20240501$20240912$20240917$20240917$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-122605$REGENERON$$$$$F$Y$$$20240917$$CN$US$US
243274731$24327473$1$I$20240821$20240823$20240917$20240917$EXP$$US-SA-2024SA267688$SANOFI AVENTIS$$58$YR$A$F$Y$83$KG$20240917$$MD$US$US
243274741$24327474$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184293$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240917$$HP$US$US
243274751$24327475$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184285$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240917$$HP$US$US
243274761$24327476$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184294$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240917$$HP$US$US
243274771$24327477$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184282$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240917$$HP$US$US
243274781$24327478$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184284$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240917$$HP$US$US
243274791$24327479$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184292$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240917$$HP$US$US
243274801$24327480$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024184286$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240917$$HP$US$US
243274822$24327482$2$F$$20240919$20240917$20240919$PER$$US-BAYER-2024A130445$BAYER$$53$YR$A$F$Y$$$20240919$$CN$US$US
243274831$24327483$1$I$$20240903$20240917$20240917$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00757$GLAND PHARMA$$58$YR$A$F$Y$$$20240917$$HP$CN$CN
243274841$24327484$1$I$$20240911$20240917$20240917$EXP$$BE-TAKEDA-2024TUS091898$TAKEDA$$$$$F$Y$$$20240917$$CN$BE$BE
243274851$24327485$1$I$20220101$20240912$20240917$20240917$PER$$US-BAYER-2024A131339$BAYER$$39$YR$A$F$Y$$$20240917$$MD$US$US
243274861$24327486$1$I$$20240909$20240917$20240917$EXP$$JP-CHEPLA-2023001396$CHEPLAPHARM$Imamura S, Takahashi S, Matsuguchi T, Osada M, Goto A, Nakamura O, et al. A Refractory Gastric Ulcer Case Developing during Postoperative Adjuvant Chemotherapy for Large Intestine Carcinoma inwhich W-ED Tube Placement Was Effective. The 120th Kyushu Regional Conference of the Japanese Society of Gastroenterology.2022;179.$74$YR$$M$Y$$$20240917$$MD$COUNTRY NOT SPECIFIED$JP
243274871$24327487$1$I$20240601$20240911$20240917$20240917$EXP$$JP-AstraZeneca-2024A209161$ASTRAZENECA$$70$YR$$F$Y$$$20240917$$MD$JP$
243274881$24327488$1$I$$20240914$20240917$20240917$PER$$US-AstraZeneca-2024A210285$ASTRAZENECA$$$$$$Y$$$20240917$$MD$US$
243274891$24327489$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210769$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243274911$24327491$1$I$$20240910$20240917$20240917$PER$$US-AstraZeneca-2024A207204$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243274922$24327492$2$F$20240401$20240913$20240917$20240918$EXP$$CL-AstraZeneca-2024A209907$ASTRAZENECA$$30241$DY$$F$Y$$$20240918$$CN$CL$
243274932$24327493$2$F$$20240916$20240917$20240924$EXP$$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-08447$HIKMA$$73$YR$$F$Y$52$KG$20240924$$CN$GB$GB
243274941$24327494$1$I$$20240911$20240917$20240917$EXP$$US-JNJFOC-20240933893$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243274951$24327495$1$I$$20240913$20240917$20240917$EXP$$FR-JNJFOC-20240940422$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240917$$PH$FR$FR
243274961$24327496$1$I$$20240908$20240917$20240917$EXP$$TR-JNJFOC-20240934144$JOHNSON AND JOHNSON$$12$YR$T$$Y$$$20240917$$HP$TR$TR
243274981$24327498$1$I$$20240903$20240917$20240917$EXP$$US-GLANDPHARMA-US-2024GLNLIT00749$GLAND PHARMA$Lauren A Mills.Adverse Events in Patients Aged 90 Days or Younger Receiving Ketamine in the Emergency Department.Pediatr Emerg Care.01-SEP-2024;40:665-667$$$$$Y$$$20240917$$HP$US$US
243274991$24327499$1$I$19900101$20240904$20240917$20240917$EXP$$US-SA-2024SA265453$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240917$$CN$US$US
243275001$24327500$1$I$$20240913$20240917$20240917$EXP$$US-ABBVIE-5924214$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243275011$24327501$1$I$$20240909$20240917$20240917$EXP$$US-MYLANLABS-2024M1083491$MYLAN$Wang M, Reynolds KL, Montazeri K, Schaefer EA, Sullivan RJ, Dougan M. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clin-Gastroenterol-Hepatol 2024; 22 (7): 1539-1541.e2.$61$YR$$F$Y$$$20240917$$MD$US$US
243275021$24327502$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084113$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$19$YR$$M$Y$$$20240917$$HP$IE$IE
243275031$24327503$1$I$20240829$20240912$20240917$20240917$EXP$$GB-MYLANLABS-2024M1083676$MYLAN$$61$YR$$M$Y$82$KG$20240917$$CN$GB$GB
243275041$24327504$1$I$20180701$20240912$20240917$20240917$EXP$GB-MHRA-MED-202409121632016080-FNSLB$GB-MYLANLABS-2024M1083575$MYLAN$$70$YR$$M$Y$115$KG$20240917$$CN$GB$GB
243275051$24327505$1$I$$20240909$20240917$20240917$EXP$$US-MYLANLABS-2024M1083516$MYLAN$Neisewander B, Trapp N. Electroconvulsive therapy complicated by ventricular fibrillation: A case report. Ann-Clin-Psychiatry 2023; 35 133-134.$37$YR$$F$Y$$$20240917$$MD$US$US
243275061$24327506$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084211$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$41$YR$$M$Y$$$20240917$$HP$IE$IE
243275071$24327507$1$I$20180720$20240904$20240917$20240917$EXP$PL-URPL-S1412/2018$PL-CELLTRION INC.-2024PL022080$CELLTRION$$$$$$Y$$$20240917$$MD$PL$PL
243275081$24327508$1$I$$20240909$20240917$20240917$EXP$$US-MYLANLABS-2024M1083686$MYLAN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen+#39;s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.$17$YR$$M$Y$$$20240917$$HP$US$US
243275101$24327510$1$I$$20240909$20240917$20240917$EXP$$US-MYLANLABS-2024M1083681$MYLAN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen+#39;s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.$36$YR$$M$Y$$$20240917$$HP$US$US
243275111$24327511$1$I$$20240916$20240917$20240917$EXP$$CA-BAYER-2024A132296$BAYER$$80$YR$E$M$Y$$$20240917$$HP$CA$CA
243275121$24327512$1$I$$20240909$20240917$20240917$EXP$$US-MYLANLABS-2024M1083572$MYLAN$Lester SC, Johnson EF, Breen WG, Khurana A. Taming the Lion: A Report of Pencil Beam Scanning Proton Therapy for Severe Leonine Facies. Adv-Radiat-Oncol 2024; 9 (9):.$70$YR$$M$Y$$$20240917$$MD$US$US
243275131$24327513$1$I$$20240909$20240917$20240917$EXP$$US-MYLANLABS-2024M1083622$MYLAN$Kim N, Hance F, Barsi J. Septic Arthritis of the Pubic Symphysis in a 16-Year-Old Male Adolescent: A Case Report. JBJS-Case-Connect 2023; 13 (4): 1-4.$16$YR$$M$Y$$$20240917$$HP$US$US
243275141$24327514$1$I$20240829$20240909$20240917$20240917$EXP$IT-MINISAL02-1000925$IT-TEVA-VS-3241940$TEVA$$23$YR$$F$Y$$$20240917$$PH$IT$IT
243275151$24327515$1$I$$20240911$20240917$20240917$PER$$AU-REGENERON PHARMACEUTICALS, INC.-2024-124345$REGENERON$$$$$M$Y$$$20240917$$CN$AU$AU
243275161$24327516$1$I$$20240913$20240917$20240917$PER$$US-BAYER-2024A131815$BAYER$$85$YR$E$F$Y$$$20240917$$CN$US$US
243275172$24327517$2$F$$20240917$20240917$20240919$PER$$US-JNJFOC-20240940157$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243275181$24327518$1$I$$20240905$20240917$20240917$EXP$$JP-JNJFOC-20240941074$JOHNSON AND JOHNSON$$85$YR$E$$Y$$$20240917$$MD$JP$JP
243275191$24327519$1$I$$20240904$20240917$20240917$EXP$$SI-STERISCIENCE B.V.-2024-ST-001386$Steriscience PTE$Bezeljak N, Jerman A, Grenc D, Zorman SK.. Inadvertent Intoxication with Salbutamol, Treated with Hemodialysis: A Case Report and Brief Review of the Literature.. Case-Rep-Nephrol-Dial. 2024;14 (1):88-96$69$YR$$M$Y$$$20240917$$HP$SI$SI
243275211$24327521$1$I$20240829$20240917$20240917$20240917$EXP$PT-INFARMED-R202408-893$PT-BAYER-2024A132339$BAYER$$84$YR$E$M$Y$83$KG$20240917$$HP$PT$PT
243275221$24327522$1$I$$20240913$20240917$20240917$PER$$US-ABBVIE-5925591$ABBVIE$$$$$$Y$$$20240917$$HP$US$US
243275231$24327523$1$I$20240912$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009911$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240917$$CN$US$US
243275241$24327524$1$I$$20240908$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008374$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243275251$24327525$1$I$20240830$20240916$20240916$20240916$DIR$718604$$FDA-CTU$$74$YR$$F$N$86.4$KG$20240916$N$CN$US$
243275261$24327526$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63604$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243275281$24327528$1$I$$20240910$20240917$20240917$EXP$$CN-GSK-CN2024APC112218$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$CN$CN
243275291$24327529$1$I$20240722$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184654$AMGEN$$42$YR$A$F$Y$$$20240917$$CN$US$US
243275301$24327530$1$I$$20240904$20240917$20240917$EXP$$IT-STERISCIENCE B.V.-2024-ST-001398$Steriscience PTE$Falsaperla R, Collotta AD, Sortino V, Marino SD, Marino S, Pisani F, et al.. The Use of Midazolam as an Antiseizure Medication in Neonatal Seizures: Single Center Experience and Literature Review.. CNS-Neurol-Disord-Drug-Targets. 2024;23 (10):1285-1294$$$N$$Y$$$20240917$$HP$IT$IT
243275311$24327531$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147083$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240917$$HP$US$US
243275321$24327532$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147291$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240917$$HP$US$US
243275331$24327533$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000081534$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243275341$24327534$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000081431$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243275351$24327535$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000081474$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243275361$24327536$1$I$$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183479$AMGEN$$$$$$Y$$$20240917$$HP$US$US
243275371$24327537$1$I$20240906$20240912$20240917$20240917$PER$$US-ROCHE-10000082276$ROCHE$$$$$$Y$$$20240917$$PH$US$US
243275381$24327538$1$I$20100204$20240904$20240917$20240917$EXP$$US-ASTELLAS-2024-AER-004826$ASTELLAS$$58$YR$A$M$Y$70$KG$20240917$$CN$US$US
243275391$24327539$1$I$$20240904$20240917$20240917$EXP$$IT-STERISCIENCE B.V.-2024-ST-001400$Steriscience PTE$Falsaperla R, Collotta AD, Sortino V, Marino SD, Marino S, Pisani F, et al.. The Use of Midazolam as an Antiseizure Medication in Neonatal Seizures: Single Center Experience and Literature Review. CNS-Neurol-Disord-Drug-Targets. 2024;23 (10):1285-1294$$$N$$Y$$$20240917$$HP$IT$IT
243275401$24327540$1$I$20230719$20240910$20240917$20240917$EXP$$JP-AMGEN-JPNSP2023204519$AMGEN$$60$YR$A$M$Y$$$20240917$$MD$JP$JP
243275411$24327541$1$I$20240915$20240916$20240916$20240916$DIR$718633$$FDA-CTU$$31$YR$$F$N$58.5$KG$20240916$Y$CN$US$
243275421$24327542$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63605$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243275431$24327543$1$I$20240627$20240916$20240916$20240916$DIR$718621$$FDA-CTU$$30$YR$$F$N$$$20240916$N$CN$US$
243275441$24327544$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63606$$FDA-CTU$$78$YR$$F$N$115.21$KG$20240916$N$$US$
243275451$24327545$1$I$$20240913$20240917$20240917$PER$$US-BAYER-2024A131962$BAYER$$35$YR$A$F$Y$$$20240917$$HP$US$US
243275461$24327546$1$I$20240101$20240902$20240917$20240917$EXP$$GB-TEVA-VS-3240012$TEVA$$79$YR$$F$Y$$$20240917$$CN$GB$GB
243275471$24327547$1$I$20240101$20240913$20240917$20240917$PER$$US-BAYER-2024A132089$BAYER$$46$YR$A$F$Y$$$20240917$$HP$US$US
243275482$24327548$2$F$$20240919$20240917$20240927$EXP$$GB-TEVA-VS-3242619$TEVA$Boal A, Millar C. Case series: Assessment of two anti-HMG-COA reductase antibody-associated immune-mediated necrotising myopathy patients in a Scottish Lipid Clinic. Atherosclerosis 2024; 395 (Suppl.).; Boal A, Millar C. Case series: Assessment of two anti-HMG-COA reductase antibody-associated immune-mediated necrotising myopathy patients in a Scottish Lipid Clinic. Atherosclerosis 2024; 395 (Suppl.).$65$YR$$F$Y$$$20240927$$HP$GB$GB
243275491$24327549$1$I$$20240903$20240917$20240917$EXP$$US-EPICPHARMA-US-2024EPCSPO01106$EPIC PHARM$$$$$$Y$$$20240917$$CN$US$US
243275501$24327550$1$I$20240101$20240904$20240917$20240917$EXP$$KR-ASTELLAS-2024-AER-004849$ASTELLAS$$$$$M$Y$$$20240917$$CN$KR$KR
243275511$24327551$1$I$$20240910$20240917$20240917$EXP$$CA-ROCHE-10000078189$ROCHE$$67$YR$E$F$Y$$$20240917$$MD$CA$CA
243275521$24327552$1$I$$20240909$20240917$20240917$EXP$$GB-TEVA-VS-3242620$TEVA$Boal A, Millar C. Case series: Assessment of two anti-HMG-COA reductase antibody-associated immune-mediated necrotising myopathy patients in a Scottish Lipid Clinic. Atherosclerosis 2024; 395 (Suppl.).$74$YR$$F$Y$$$20240917$$HP$GB$GB
243275541$24327554$1$I$20240910$20240913$20240917$20240917$PER$$US-BAYER-2024A132097$BAYER$$36$YR$A$F$Y$$$20240917$$MD$US$US
243275551$24327555$1$I$20240905$20240911$20240917$20240917$EXP$$CN-ROCHE-10000079639$ROCHE$$62$YR$A$F$Y$41.5$KG$20240917$$HP$CN$CN
243275561$24327556$1$I$$20240905$20240917$20240917$EXP$$CA-PADAGIS-2024PAD01457$PADAGIS$Lagace-Thomassin F, Nateghi A, Kechichian E, Veilleux M. Topical imiquimod adverse event: Beyond the local skin reaction-A case report. SAGE Open Medical Case Reports. 2024;12:1-3$$$$$Y$$$20240917$$HP$CA$CA
243275571$24327557$1$I$20240101$20240909$20240917$20240917$EXP$$GB-TEVA-VS-3243329$TEVA$$36$YR$$F$Y$$$20240917$$HP$GB$GB
243275581$24327558$1$I$$20240904$20240917$20240917$PER$$US-JNJFOC-20240915998$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240917$$CN$US$US
243275592$24327559$2$F$$20240904$20240917$20240917$PER$$US-ASTELLAS-2024-AER-004798$ASTELLAS$$80$YR$E$M$Y$77$KG$20240917$$HP$US$US
243275601$24327560$1$I$20240913$20240913$20240916$20240916$DIR$FDA-CDER-CTU-2024-63607$$FDA-CTU$$90$YR$$M$N$$$20240913$N$HP$US$
243275611$24327561$1$I$20240916$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63608$$FDA-CTU$$65$YR$$M$N$$$20240916$N$$US$
243275621$24327562$1$I$20240916$20240916$20240916$20240916$DIR$718630$$FDA-CTU$$47$YR$$F$N$133.65$KG$20240916$N$CN$US$
243275631$24327563$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63610$$FDA-CTU$$70$YR$$F$N$77.11$KG$20240916$N$$US$
243275641$24327564$1$I$20110101$20240905$20240917$20240917$EXP$$US-PFIZER INC-2011SGN00366$PFIZER$$50$YR$$M$Y$$$20240917$$HP$US$US
243275661$24327566$1$I$$20240909$20240917$20240917$PER$$US-BAYER-2024A129379$BAYER$$$$$$Y$$$20240917$$CN$US$US
243275672$24327567$2$F$20240614$20240918$20240917$20240925$EXP$$CA-ROCHE-10000081758$ROCHE$$16$YR$T$M$Y$$$20240925$$CN$CA$CA
243275682$24327568$2$F$20231101$20240911$20240917$20240920$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-08452$HIKMA$$$$E$F$Y$89$KG$20240920$$MD$GB$GB
243275691$24327569$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000082476$ROCHE$$$$$$Y$$$20240917$$PH$US$US
243275701$24327570$1$I$20240101$20240903$20240917$20240917$EXP$$US-EPICPHARMA-US-2024EPCSPO01125$EPIC PHARM$$$$$$Y$$$20240917$$CN$US$US
243275711$24327571$1$I$20240101$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183064$AMGEN$$41$YR$A$F$Y$$$20240917$$CN$US$US
243275731$24327573$1$I$$20240916$20240917$20240917$EXP$$CA-ORGANON-O2409CAN001066$ORGANON$$32$YR$$F$Y$100$KG$20240917$$CN$CA$CA
243275741$24327574$1$I$20240808$20240910$20240917$20240917$EXP$SE-SEMPA-2024-006435$SE-TEVA-VS-3242209$TEVA$$29$YR$$F$Y$85$KG$20240917$$CN$SE$SE
243275751$24327575$1$I$20240101$20240911$20240917$20240917$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-01018$CATALYST PHARMA$$$$$M$Y$$$20240917$$CN$US$US
243275761$24327576$1$I$$20240905$20240917$20240917$PER$$US-ROCHE-10000074950$ROCHE$$36$YR$A$F$Y$$$20240917$$CN$US$US
243275771$24327577$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147327$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240917$$HP$US$US
243275781$24327578$1$I$$20240912$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146331$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240917$$MD$US$US
243275791$24327579$1$I$$20240905$20240917$20240917$EXP$E2B_02527675$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2019-003523$VALIDUS$$$$$$Y$$$20240917$$CN$CA$CA
243275821$24327582$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63612$$FDA-CTU$$56$YR$$F$N$$$20240916$N$HP$US$
243275841$24327584$1$I$20240824$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63613$$FDA-CTU$$79$YR$$F$N$46.7$KG$20240916$N$HP$US$
243275851$24327585$1$I$$20240819$20240916$20240916$DIR$FDA-CDER-CTU-2024-63614$$FDA-CTU$$$$$M$N$$$20240819$N$HP$US$
243275871$24327587$1$I$$20240911$20240917$20240917$EXP$$JP-AMGEN-JPNSP2024183966$AMGEN$$67$YR$E$$Y$$$20240917$$MD$JP$JP
243275881$24327588$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147387$BRISTOL MYERS SQUIBB$$40$YR$A$M$Y$$$20240917$$HP$US$US
243275891$24327589$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147345$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240917$$HP$US$US
243275901$24327590$1$I$$20240909$20240917$20240917$EXP$$CA-CELLTRION INC.-2024CA021961$CELLTRION$$$$$$Y$$$20240917$$MD$CA$CA
243275911$24327591$1$I$20240901$20240903$20240917$20240917$EXP$$US-Fagron Sterile Services-2161690$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$$$$$Y$$$20240917$$$US$US
243275921$24327592$1$I$20240907$20240916$20240916$20240916$DIR$718613$$FDA-CTU$$69$YR$$M$N$77.1$KG$20240916$N$HP$US$
243275931$24327593$1$I$20240501$20240910$20240917$20240917$EXP$FR-AFSSAPS-ST2024001387$FR-TEVA-VS-3242244$TEVA$$43$YR$$M$Y$60$KG$20240917$$MD$FR$FR
243275941$24327594$1$I$$20240903$20240917$20240917$PER$$US-Appco Pharma LLC-2161698$APPCO PHARMA$$$$$$Y$$$20240917$$$US$US
243275951$24327595$1$I$$20240904$20240917$20240917$EXP$$CN-B.Braun Medical Inc.-2161699$B BRAUN$Literature Article$58$YR$$F$Y$$$20240917$$$CN$CN
243275961$24327596$1$I$$20240904$20240917$20240917$EXP$$US-Fagron Sterile Services-2161692$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$$$$$Y$$$20240917$$$US$US
243275971$24327597$1$I$20240101$20240916$20240917$20240917$PER$$US-ALXN-202409USA001162US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243275991$24327599$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001160US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243276001$24327600$1$I$$20240905$20240917$20240917$EXP$E2B_02161856$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2019-003468$VALIDUS$$$$$$Y$$$20240917$$HP$CA$CA
243276011$24327601$1$I$$20240903$20240917$20240917$EXP$$US-Jerome Stevens Pharmaceuticals, Inc.-2161697$JEROME STEVENS$Literature full text$78$YR$$F$Y$$$20240917$$$US$US
243276021$24327602$1$I$20240201$20240712$20240917$20240917$EXP$$GB-TEVA-VS-3227317$TEVA$$33$YR$$F$Y$$$20240917$$HP$GB$GB
243276031$24327603$1$I$$20240905$20240917$20240917$EXP$$CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2024-019385$VALIDUS$$$$$$Y$$$20240917$$MD$CA$CA
243276041$24327604$1$I$20220101$20240903$20240917$20240917$EXP$$DE-UCBSA-2024046361$UCB$$$$$M$Y$$$20240917$$MD$DE$DE
243276051$24327605$1$I$$20240911$20240917$20240917$PER$$US-JNJFOC-20240935482$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243276062$24327606$2$F$20240909$20240918$20240917$20240924$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409007464$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240924$$CN$JP$JP
243276071$24327607$1$I$20240906$20240913$20240917$20240917$EXP$$NL-ELI_LILLY_AND_COMPANY-NL202409008856$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240917$$CN$NL$NL
243276081$24327608$1$I$$20240909$20240917$20240917$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202409006951$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$BE$BE
243276091$24327609$1$I$20240405$20240906$20240917$20240917$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409009627$ELI LILLY AND CO$$72$YR$E$M$Y$53$KG$20240917$$CN$DE$JP
243276101$24327610$1$I$20240827$20240905$20240917$20240917$EXP$IT-MINISAL02-1000813$IT-ELI_LILLY_AND_COMPANY-IT202409006534$ELI LILLY AND CO$$76$YR$E$M$Y$92$KG$20240917$$CN$DE$IT
243276111$24327611$1$I$$20240911$20240917$20240917$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409006881$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$DE$DE
243276122$24327612$2$F$20240101$20240919$20240917$20240930$EXP$$RO-ELI_LILLY_AND_COMPANY-RO202409005952$ELI LILLY AND CO$$$$E$F$Y$$$20240930$$CN$RO$RO
243276131$24327613$1$I$20240721$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409052256010500-JTWGB$GB-ELI_LILLY_AND_COMPANY-GB202409004185$ELI LILLY AND CO$$39$YR$A$F$Y$112$KG$20240917$$CN$GB$GB
243276142$24327614$2$F$20240905$20240924$20240917$20240927$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409003379AA$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240927$$CN$JP$JP
243276151$24327615$1$I$$20240911$20240917$20240917$EXP$$AT-ELI_LILLY_AND_COMPANY-AT202409007856$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$AT$AT
243276161$24327616$1$I$$20240910$20240917$20240917$EXP$$SK-ELI_LILLY_AND_COMPANY-SK202409006727$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240917$$MD$SK$SK
243276181$24327618$1$I$$20240911$20240917$20240917$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409008392AA$ELI LILLY AND CO$$75$YR$E$$Y$$$20240917$$CN$JP$JP
243276191$24327619$1$I$20240905$20240909$20240917$20240917$EXP$GB-MHRA-MED-202409061544469120-QMTWH$GB-TEVA-VS-3242200$TEVA$$69$YR$$F$Y$$$20240917$$HP$GB$GB
243276201$24327620$1$I$20200601$20240910$20240917$20240917$EXP$PL-URPL-1-2137-2020$PL-TEVA-VS-3242322$TEVA$$34$YR$$M$Y$77$KG$20240917$$MD$PL$PL
243276211$24327621$1$I$20240913$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024183792$AMGEN$$60$YR$A$F$Y$$$20240917$$CN$US$US
243276231$24327623$1$I$$20240912$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145624$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240917$$HP$US$US
243276241$24327624$1$I$$20240911$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146046$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240917$$CN$US$US
243276251$24327625$1$I$$20240909$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143432$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240917$$CN$US$US
243276261$24327626$1$I$$20240909$20240917$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-146181$BRISTOL MYERS SQUIBB$Honda A, Hino Y, Kitano S, Itoi N, Ri T. A case of pulmonary tumor thrombotic microangiopathy with metastatic breast cancer treated effectively by chemotherapy. Japanese Journal of Breast Cancer. 2024 Jan 01;(1):77-83.$62$YR$A$F$Y$$$20240917$$MD$JP$JP
243276281$24327628$1$I$20240901$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147436$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240917$$CN$US$US
243276291$24327629$1$I$20240101$20240911$20240917$20240917$EXP$$CN-009507513-2409CHN005168$MERCK$$87$YR$$M$Y$$$20240917$$HP$CN$CN
243276301$24327630$1$I$$20240912$20240917$20240917$PER$$NVSC2024US185090$NOVARTIS$$$$$$Y$$$20240917$$CN$US$US
243276311$24327631$1$I$$20240912$20240917$20240917$EXP$$IT-EMD Serono-2024049080$EMD SERONO INC$$$$$F$Y$$$20240917$$MD$IT$IT
243276321$24327632$1$I$$20240906$20240917$20240917$30DAY$$US-GSK-US2024111416$GLAXOSMITHKLINE$$$$$F$Y$$$20240917$$CN$US$US
243276331$24327633$1$I$$20240914$20240917$20240917$PER$$US-BAYER-2024A132264$BAYER$$$$$F$Y$$$20240917$$CN$US$US
243276341$24327634$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3242928$TEVA$$56$YR$$F$Y$88$KG$20240917$$HP$CA$CA
243276353$24327635$3$F$20240101$20240925$20240917$20240930$PER$$US-BIOGEN-2024BI01281822$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243276361$24327636$1$I$$20240913$20240917$20240917$PER$$US-BIOGEN-2024BI01274870$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
243276371$24327637$1$I$$20240909$20240917$20240917$EXP$$US-AstraZeneca-2024A210336$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243276383$24327638$3$F$$20240916$20240917$20240924$EXP$$TR-SANDOZ INC.-SDZ2024TR078721$SANDOZ$$4$YR$$M$Y$$$20240924$$CN$TR$TR
243276391$24327639$1$I$20240910$20240912$20240917$20240917$PER$$US-BAYER-2024A130875$BAYER$$94$YR$E$F$Y$$$20240917$$CN$US$US
243276401$24327640$1$I$20240622$20240911$20240917$20240917$PER$GB-MHRA-MED-202406260925423450-FSPWJ$GB-IDORSIA-008462-2024-GB$IDORSIA PHARMACEUTICALS$$$$$M$Y$$$20240917$$PH$GB$GB
243276412$24327641$2$F$$20240917$20240917$20240918$PER$$US-AMGEN-USASP2024184510$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243276421$24327642$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024183889$AMGEN$$$$$F$Y$$$20240917$$CN$US$US
243276431$24327643$1$I$20240828$20240912$20240917$20240917$PER$$US-BAYER-2024A131130$BAYER$$10$YR$C$M$Y$$$20240917$$CN$US$US
243276441$24327644$1$I$$20240909$20240917$20240917$EXP$$JP-ROCHE-10000082507$ROCHE$Inoe Y, Sugiyama T, Takemura K, Hasebe K, Nakamura T, Matsuura I et al.. 16 A case of various types of vasculitis caused by a G-CSF preparation during adjuvant chemotherapy for breast cancer. Proceedings of Kanto Rheumatology Conference. 2024;(56):58-61$72$YR$E$F$Y$46$KG$20240917$$MD$JP$JP
243276451$24327645$1$I$20240401$20240911$20240917$20240917$PER$GB-MHRA-MED-202406061837411730-KMQWN$GB-IDORSIA-008457-2024-GB$IDORSIA PHARMACEUTICALS$$$$$F$Y$86$KG$20240917$$MD$GB$GB
243276461$24327646$1$I$20240625$20240911$20240917$20240917$EXP$$CN-ABBVIE-5923486$ABBVIE$$39$YR$$F$Y$79$KG$20240917$$HP$CN$CN
243276472$24327647$2$F$$20240913$20240917$20240917$30DAY$$US-GSK-US2024113121$GLAXOSMITHKLINE$$$$$F$Y$$$20240917$$CN$US$US
243276481$24327648$1$I$20240901$20240911$20240917$20240917$30DAY$$US-GSK-US2024113068$GLAXOSMITHKLINE$$60$YR$$M$Y$$$20240917$$CN$US$US
243276492$24327649$2$F$20220608$20240917$20240917$20240923$30DAY$$CA-SANDOZ INC.-NVSC2022CA134839$SANDOZ$$24$YR$$F$Y$$$20240923$$CN$CA$CA
243276511$24327651$1$I$20240523$20240917$20240917$20240917$EXP$$US-BAYER-2024A127527$BAYER$$24$YR$A$F$Y$$$20240917$$MD$US$US
243276521$24327652$1$I$$20240909$20240917$20240917$EXP$$AT-ASTELLAS-2024-AER-005786$ASTELLAS$$77$YR$E$M$Y$$$20240917$$MD$AT$AT
243276531$24327653$1$I$$20240903$20240917$20240917$PER$$US-INSUD PHARMA-2409US06912$INSUD PHARMA$$$$$$Y$$$20240917$$CN$US$US
243276542$24327654$2$F$20240905$20240923$20240917$20240926$PER$$US-BIOVITRUM-2024-US-012088$BIOVITRUM$$68$YR$$M$Y$$$20240926$$CN$US$US
243276561$24327656$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63615$$FDA-CTU$$$$$M$N$92$KG$20240916$Y$PH$US$
243276571$24327657$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63616$$FDA-CTU$$73$YR$$F$N$$$20240916$N$$US$
243276581$24327658$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63617$$FDA-CTU$$73$YR$$M$N$$$20240916$N$$US$
243276611$24327661$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63618$$FDA-CTU$$32$YR$$F$N$$$20240916$N$$US$
243276621$24327662$1$I$20240607$20240917$20240917$20240917$DIR$718679$$FDA-CTU$$40$YR$$M$N$68.4$KG$20240917$N$CN$US$
243276631$24327663$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63619$$FDA-CTU$$66$YR$$F$N$$$20240916$N$$US$
243276641$24327664$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63620$$FDA-CTU$$57$YR$$M$N$$$20240916$N$$US$
243276661$24327666$1$I$20240801$20240910$20240917$20240917$EXP$$FR-BEH-2024178667$CSL BEHRING$$81$YR$E$F$Y$$$20240917$$MD$FR$FR
243276671$24327667$1$I$20240901$20240908$20240917$20240917$EXP$$CA-TEVA-VS-3243129$TEVA$$43$YR$$F$Y$$$20240917$$CN$CA$CA
243276681$24327668$1$I$20240601$20240802$20240917$20240917$PER$$US-JNJFOC-20240941234$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243276691$24327669$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001167US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243276701$24327670$1$I$20240815$20240820$20240917$20240917$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00865$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240917$$CN$US$US
243276711$24327671$1$I$$20240913$20240917$20240917$PER$$US-BAYER-2024A131559$BAYER$$89$YR$E$M$Y$$$20240917$$CN$US$US
243276721$24327672$1$I$$20240912$20240917$20240917$PER$$US-AstraZeneca-2024A210649$ASTRAZENECA$$$$$$Y$$$20240917$$HP$US$
243276731$24327673$1$I$20240724$20240909$20240917$20240917$EXP$FR-AFSSAPS-AM2024000705$FR-TEVA-VS-3241962$TEVA$$68$YR$$M$Y$83$KG$20240917$$PH$FR$FR
243276741$24327674$1$I$$20240909$20240917$20240917$EXP$$GB-TEVA-VS-3242790$TEVA$$20$YR$$F$Y$$$20240917$$CN$GB$GB
243276752$24327675$2$F$20121201$20240912$20240917$20240918$EXP$$JP-PFIZER INC-PV202400119614$PFIZER$Makino, T.. Pneumothorax after treatment with bevacizumab-containing chemotherapy for breast cancer-a case report. Jpn J Cancer Chemother. 2014;41(2):233-235$62$YR$$F$Y$$$20240918$$HP$JP$JP
243276761$24327676$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A207526$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243276771$24327677$1$I$20240826$20240913$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147298$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240917$$CN$US$US
243276781$24327678$1$I$20240912$20240912$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146173$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240917$$CN$US$US
243276791$24327679$1$I$20240401$20240910$20240917$20240917$EXP$$BG-BRISTOL-MYERS SQUIBB COMPANY-2024-144328$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240917$$MD$BG$BG
243276801$24327680$1$I$$20240914$20240917$20240917$EXP$$CN-AstraZeneca-2024A211759$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$CN$
243276822$24327682$2$F$$20240920$20240917$20240926$EXP$$PL-009507513-2409POL004111$MERCK$Fajkis M.. Long-term immunotherapy using pembrolizumab in combination with chemotherapy in a patient with metastatic lung cancer and low PD-L1 expression.. ONKOLOGIA W PRAKTYCE KLINICZNEJ - EDUKACJA. 2024;10(Supl. C):C3-C5$61$YR$$F$Y$$$20240926$$MD$PL$PL
243276831$24327683$1$I$20240701$20240906$20240917$20240917$EXP$GB-MHRA-MED-202409061455109460-TDGKZ$GB-UCBSA-2024045769$UCB$$73$YR$$F$Y$$$20240917$$HP$GB$GB
243276841$24327684$1$I$20081015$20240902$20240917$20240917$EXP$ES-AEMPS-1355020$ES-CELLTRION INC.-2024ES022077$CELLTRION$$$$$$Y$$$20240917$$MD$ES$ES
243276851$24327685$1$I$20231013$20240910$20240917$20240917$EXP$$CA-GSK-CA2023AMR092346$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$CA$CA
243276861$24327686$1$I$20240805$20240910$20240917$20240917$PER$$US-BEH-2024178661$CSL BEHRING$$66$YR$E$F$Y$63.492$KG$20240917$$PH$US$US
243276871$24327687$1$I$20240718$20240911$20240917$20240917$EXP$FR-AFSSAPS-RN2024000943$FR-MYLANLABS-2024M1083443$MYLAN$$74$YR$$F$Y$60$KG$20240917$$MD$FR$FR
243276881$24327688$1$I$$20240913$20240917$20240917$PER$$US-BAYER-2024A131757$BAYER$$44$YR$A$F$Y$$$20240917$$CN$US$US
243276892$24327689$2$F$$20240916$20240917$20240930$EXP$$CA-ORGANON-O2409CAN001058$ORGANON$$41$YR$$F$Y$$$20240930$$MD$CA$CA
243276901$24327690$1$I$$20240905$20240917$20240917$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093872$GLENMARK$Zou H, Rau A, Thompson L, Henderson D.. Pancytopenia Concurrent With Metabolic Encephalopathy.. Cureus.. 2024;16(8):e67963$$$$$Y$$$20240917$$MD$US$US
243276911$24327691$1$I$$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183704$AMGEN$$$$$$Y$$$20240917$$PH$US$US
243276921$24327692$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63621$$FDA-CTU$$57$YR$$F$N$$$20240916$N$$US$
243276931$24327693$1$I$20240601$20240913$20240917$20240917$EXP$FR-AFSSAPS-NT2024001131$FR-PFIZER INC-202400255831$PFIZER$$59$YR$$M$Y$$$20240917$$MD$FR$FR
243276941$24327694$1$I$20240831$20240914$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120825$PFIZER$$48$YR$$M$Y$86$KG$20240917$$HP$CN$CN
243276961$24327696$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63622$$FDA-CTU$$29$YR$$F$N$145$LBS$20240916$Y$$US$
243276971$24327697$1$I$$20240911$20240917$20240917$EXP$$DE-PFIZER INC-202400257266$PFIZER$$$$$M$Y$87$KG$20240917$$CN$DE$DE
243276981$24327698$1$I$20240903$20240913$20240917$20240917$EXP$FR-AFSSAPS-BX2024001758$FR-PFIZER INC-202400255861$PFIZER$$2$YR$$F$Y$$$20240917$$HP$FR$FR
243276991$24327699$1$I$20240901$20240913$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120943$PFIZER$$11$YR$$F$Y$37$KG$20240917$$HP$CN$CN
243277001$24327700$1$I$20240415$20240912$20240917$20240917$EXP$$ES-PFIZER INC-202400255236$PFIZER$$51$YR$$M$Y$76$KG$20240917$$HP$ES$ES
243277011$24327701$1$I$20240830$20240913$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120899$PFIZER$$40$YR$$M$Y$104$KG$20240917$$HP$CN$CN
243277021$24327702$1$I$20240201$20240913$20240917$20240917$EXP$FR-AFSSAPS-CN2024000800$FR-PFIZER INC-202400255825$PFIZER$$32$YR$$M$Y$73$KG$20240917$$MD$FR$FR
243277031$24327703$1$I$20240828$20240910$20240917$20240917$DIR$FDA-CDER-CTU-2024-63574$$FDA-CTU$$46$YR$$F$N$90.7$KG$20240910$N$$US$
243277041$24327704$1$I$20240914$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63572$$FDA-CTU$$45$YR$$M$N$59.9$KG$20240916$N$$US$
243277051$24327705$1$I$20240724$20240916$20240917$20240917$EXP$EG-EPVC-300264649$EG-PFIZER INC-PV202400121177$PFIZER$$73$YR$$F$Y$52$KG$20240917$$PH$EG$EG
243277061$24327706$1$I$20240101$20240912$20240917$20240917$EXP$FR-AFSSAPS-LL2024001720$FR-PFIZER INC-202400255134$PFIZER$$33$YR$$M$Y$$$20240917$$MD$FR$FR
243277071$24327707$1$I$20240801$20240913$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120931$PFIZER$$11$YR$$F$Y$30.5$KG$20240917$$HP$CN$CN
243277081$24327708$1$I$20240912$20240913$20240917$20240917$EXP$$VE-PFIZER INC-PV202400121293$PFIZER$$42$YR$$F$Y$$$20240917$$CN$VE$VE
243277091$24327709$1$I$20240801$20240912$20240917$20240917$EXP$$US-ABBVIE-5923768$ABBVIE$$61$YR$$F$Y$$$20240917$$CN$US$US
243277102$24327710$2$F$20240101$20240916$20240917$20240925$PER$$US-ABBVIE-5924154$ABBVIE$$$$$$Y$$$20240925$$CN$US$US
243277111$24327711$1$I$20190101$20240816$20240917$20240917$PER$$US-Eisai-EC-2024-172357$EISAI$$55$YR$A$$Y$$$20240917$$MD$US$US
243277121$24327712$1$I$$20240911$20240917$20240917$EXP$$CZ-MYLANLABS-2024M1083376$MYLAN$Bartlova A,. Pyoderma gangrenosum in a pregnant patient-description of the case. Lecba ran.. 2024;11 (2):6-11$35$YR$$F$Y$$$20240917$$MD$CZ$CZ
243277131$24327713$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147116$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240917$$CN$US$US
243277151$24327715$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146926$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240917$$CN$US$US
243277161$24327716$1$I$$20240910$20240917$20240917$EXP$US-MLMSERVICE-20161207-0527858-1$US-RDY-USA/USA/16/0085610$DR REDDYS$Rattner P, Sutherland A. Aspergillus nidulans: A rare cause of invasive pulmonary aspergillosis resulting in diffuse alveolar haemorrhage. Chest. 2016;150(4): 157A.$25$YR$A$F$Y$$$20240917$$MD$US$US
243277171$24327717$1$I$20240830$20240909$20240917$20240917$EXP$$CN-ROCHE-10000081170$ROCHE$$60$YR$A$M$Y$60$KG$20240917$$HP$CN$CN
243277181$24327718$1$I$$20240904$20240917$20240917$PER$$US-009507513-2409USA001905$MERCK$Fote GM., Urgun K, Davies J, Himstead AS., Gramajo-Aponte K, Lopez A, Hsu FPK., et al.. Cell-in-cell phenomena of intracellular neutrophils in a recurrent pleomorphic xanthoastrocytoma. Free Neuropathology. 2024;5 (17)$10$YR$$M$Y$$$20240917$$HP$US$US
243277191$24327719$1$I$$20240909$20240917$20240917$EXP$$US-ROCHE-10000079356$ROCHE$Joshi A, Law J, Shah N, Ghnaima H, Akanbi M, Tikaria R. Superior and inferior vena cava syndrome caused by a rare lung cancer: A case report. Clinical Case Reports. 2024-Sep;12 (9):1-4. doi:10.1002/ccr3.9391.$50$YR$A$M$Y$$$20240917$$HP$US$US
243277201$24327720$1$I$$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024185003$AMGEN$$$$$F$Y$$$20240917$$MD$US$US
243277211$24327721$1$I$$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183987$AMGEN$$$$$$Y$$$20240917$$PH$US$US
243277221$24327722$1$I$20240301$20240911$20240917$20240917$EXP$$US-ABBVIE-5923694$ABBVIE$$51$YR$$F$Y$$$20240917$$CN$US$US
243277231$24327723$1$I$20240901$20240911$20240917$20240917$PER$$PR-ABBVIE-5921147$ABBVIE$$51$YR$$F$Y$81.647$KG$20240917$$CN$PR$PR
243277241$24327724$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922542$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243277251$24327725$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084166$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$39$YR$$F$Y$$$20240917$$HP$IE$IE
243277261$24327726$1$I$20240116$20240912$20240917$20240917$EXP$GB-MHRA-MED-202409121212346860-QRHWG$GB-ABBVIE-5921324$ABBVIE$$55$YR$$F$Y$120$KG$20240917$$HP$GB$GB
243277272$24327727$2$F$20240801$20240913$20240917$20240926$EXP$FR-AFSSAPS-TS2024000979$FR-ASTELLAS-2024-AER-006907$ASTELLAS$$15$YR$T$F$Y$53$KG$20240926$$MD$FR$FR
243277281$24327728$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084159$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$34$YR$$F$Y$$$20240917$$HP$IE$IE
243277291$24327729$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084133$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$45$YR$$M$Y$$$20240917$$HP$IE$IE
243277301$24327730$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084135$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$34$YR$$F$Y$$$20240917$$HP$IE$IE
243277311$24327731$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084151$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$29$YR$$F$Y$$$20240917$$HP$IE$IE
243277321$24327732$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084212$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$64$YR$$F$Y$$$20240917$$HP$IE$IE
243277331$24327733$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084134$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$36$YR$$F$Y$$$20240917$$HP$IE$IE
243277341$24327734$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084213$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$67$YR$$M$Y$$$20240917$$HP$IE$IE
243277361$24327736$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084112$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$45$YR$$M$Y$$$20240917$$HP$IE$IE
243277371$24327737$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084208$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$47$YR$$F$Y$$$20240917$$HP$IE$IE
243277381$24327738$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084167$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$35$YR$$M$Y$$$20240917$$HP$IE$IE
243277391$24327739$1$I$$20240914$20240917$20240917$PER$$US-BAYER-2024A132136$BAYER$$$$$$Y$$$20240917$$CN$US$US
243277402$24327740$2$F$$20240924$20240917$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409010249$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240925$$CN$US$US
243277412$24327741$2$F$$20240912$20240917$20240923$EXP$$US-UCBSA-2024046220$UCB$$$$$M$Y$86.18$KG$20240923$$HP$US$US
243277421$24327742$1$I$$20240908$20240917$20240917$EXP$$US-TEVA-VS-3241852$TEVA$$43$YR$$F$Y$$$20240917$$CN$US$US
243277431$24327743$1$I$$20240910$20240917$20240917$EXP$$JP-AstraZeneca-2024A208928$ASTRAZENECA$$$$E$F$Y$$$20240917$$MD$JP$
243277441$24327744$1$I$$20240913$20240917$20240917$EXP$$FR-AstraZeneca-2024A211144$ASTRAZENECA$Valet O, Swalduz A, Boussageon M, Buisson A, Avrillon V, Mastroianni B. Response to the Combination of Osimertinib, Dabrafenib, and Trametinib in Leptomeningitis From EGFR-Mutant NSCLC With Acquired BRAF V600E Mutation: A Case Report. JTO Clinical and Research Reports 2021;2(6):$72$YR$$M$Y$$$20240917$$MD$FR$
243277451$24327745$1$I$$20240916$20240917$20240917$EXP$$US-SANDOZ INC.-SDZ2024US080499$SANDOZ$$59$YR$$F$Y$$$20240917$$MD$US$US
243277461$24327746$1$I$20240909$20240910$20240917$20240917$DIR$FDA-CDER-CTU-2024-63573$$FDA-CTU$$68$YR$$F$N$44.09$KG$20240910$N$$US$
243277471$24327747$1$I$20230424$20240916$20240917$20240917$EXP$$GB-MYLANLABS-2023M1044621$MYLAN$$67$YR$$M$Y$$$20240917$$MD$GB$GB
243277481$24327748$1$I$$20240910$20240917$20240917$EXP$$US-ARGENX-2024-ARGX-US007661$ARGENX BVBA$$$$$$Y$$$20240917$$CN$US$US
243277491$24327749$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5920644$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243277501$24327750$1$I$20240901$20240912$20240917$20240917$EXP$$CA-ABBVIE-5922158$ABBVIE$$76$YR$$M$Y$$$20240917$$CN$CA$CA
243277511$24327751$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084180$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$68$YR$$M$Y$$$20240917$$HP$IE$IE
243277521$24327752$1$I$$20240911$20240917$20240917$PER$$US-AstraZeneca-2024A209250$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243277531$24327753$1$I$$20240913$20240917$20240917$EXP$$AU-AstraZeneca-2024A211146$ASTRAZENECA$Davison S, Kanitkar T, Menouhos D, Ewin T, Marshall CS, Boan P, Janson S. Smouldering COVID-19 XBB.1.5. subvariant pneumonitis: a case report. Medical Journal of Australia 2024;221(5):244-245.$64$YR$$M$Y$$$20240917$$HP$AU$
243277541$24327754$1$I$20240909$20240911$20240917$20240917$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005080$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240917$$CN$US$US
243277551$24327755$1$I$20230701$20240911$20240917$20240917$EXP$$US-TAKEDA-2024TUS089927$TAKEDA$$65$YR$$F$Y$$$20240917$$CN$US$US
243277561$24327756$1$I$$20240913$20240917$20240917$EXP$$CN-TAKEDA-2024TUS092049$TAKEDA$$$$$M$Y$$$20240917$$CN$CN$CN
243277591$24327759$1$I$20240701$20240911$20240917$20240917$EXP$$US-ABBVIE-5922045$ABBVIE$$$$$$Y$$$20240917$$CN$US$US
243277621$24327762$1$I$20240801$20240914$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120850$PFIZER$$59$YR$$F$Y$59$KG$20240917$$HP$CN$CN
243277631$24327763$1$I$20240827$20240914$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120851$PFIZER$$52$YR$$F$Y$55$KG$20240917$$HP$CN$CN
243277642$24327764$2$F$20240904$20240920$20240917$20240920$EXP$$CN-PFIZER INC-PV202400120903$PFIZER$$33$YR$$F$Y$53.8$KG$20240920$$HP$CN$CN
243277651$24327765$1$I$$20240913$20240917$20240917$PER$$US-TAKEDA-2024TUS092078$TAKEDA$$$$$$Y$$$20240917$$CN$US$US
243277661$24327766$1$I$20240620$20240916$20240917$20240917$PER$$US-BAYER-2024A132093$BAYER$$35$YR$A$F$Y$$$20240917$$MD$US$US
243277671$24327767$1$I$$20240915$20240917$20240917$PER$$US-BAYER-2024A131617$BAYER$$$$$$Y$$$20240917$$CN$US$US
243277681$24327768$1$I$$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024182673$AMGEN$$30$YR$A$F$Y$$$20240917$$MD$US$US
243277691$24327769$1$I$20240821$20240911$20240917$20240917$EXP$$CN-MYLANLABS-2024M1083297$MYLAN$$85$YR$$F$Y$$$20240917$$HP$CN$CN
243277702$24327770$2$F$$20240923$20240917$20240924$EXP$$PT-MYLANLABS-2024M1083270$MYLAN$$62$YR$$M$Y$$$20240924$$HP$PT$PT
243277711$24327771$1$I$20240509$20240917$20240917$20240917$DIR$718675$$FDA-CTU$$70$YR$$F$N$79.65$KG$20240917$N$CN$US$
243277721$24327772$1$I$$20240906$20240917$20240917$EXP$$CA-UCBSA-2024046104$UCB$$50$YR$$M$Y$$$20240917$$PH$CA$CA
243277731$24327773$1$I$$20240912$20240917$20240917$EXP$$CA-Orion Corporation ORION PHARMA-24_00031689$ORION$$4$YR$C$M$Y$$$20240917$$HP$CA$
243277741$24327774$1$I$$20240905$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009410$INCYTE$$$$$$Y$$$20240917$$PH$US$US
243277751$24327775$1$I$$20240916$20240917$20240917$PER$$US-BAYER-2024A132088$BAYER$$$$$F$Y$$$20240917$$CN$US$US
243277761$24327776$1$I$$20240916$20240917$20240917$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051725$BOEHRINGER INGELHEIM$$87$YR$E$M$Y$$$20240917$$MD$DE$DE
243277771$24327777$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3242776$TEVA$$16$YR$$F$Y$$$20240917$$HP$CA$CA
243277791$24327779$1$I$$20240916$20240917$20240917$EXP$GB-MHRA-MIDB-63c10a59-fb78-409f-a2ce-89d9c954c635$GB-SANDOZ INC.-SDZ2024GB080487$SANDOZ$$33$YR$$$Y$$$20240917$$HP$GB$GB
243277801$24327780$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63625$$FDA-CTU$$68$YR$$M$N$$$20240916$N$$US$
243277821$24327782$1$I$20240828$20240910$20240917$20240917$DIR$FDA-CDER-CTU-2024-63627$$FDA-CTU$$73$YR$$F$N$75.7$KG$20240910$N$$US$
243277841$24327784$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63624$$FDA-CTU$$55$YR$$F$N$240$LBS$20240916$N$$US$
243277851$24327785$1$I$20240828$20240917$20240917$20240917$DIR$718672$$FDA-CTU$$58$YR$$M$N$80$KG$20240917$N$PH$US$
243277871$24327787$1$I$20240820$20240910$20240917$20240917$DIR$FDA-CDER-CTU-2024-63628$$FDA-CTU$$$$$F$N$39.7$KG$20240910$N$$US$
243277881$24327788$1$I$20240816$20240906$20240917$20240917$DIR$FDA-CDER-CTU-2024-63629$$FDA-CTU$$53$YR$$F$N$89$KG$20240906$N$$US$
243277891$24327789$1$I$20240823$20240917$20240917$20240917$DIR$718671$$FDA-CTU$$88$YR$$M$N$81$KG$20240917$N$HP$US$
243277901$24327790$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63630$$FDA-CTU$$78$YR$$M$N$$$20240917$N$$US$
243277932$24327793$2$F$20240811$20240927$20240917$20240930$EXP$$US-TAKEDA-2024TUS092152$TAKEDA$$58$YR$$F$Y$$$20240930$$MD$US$US
243277941$24327794$1$I$$20240906$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009481$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243277961$24327796$1$I$$20240916$20240917$20240917$PER$$US-BAYER-2024A132104$BAYER$$74$YR$E$M$Y$$$20240917$$CN$US$US
243277981$24327798$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184337$AMGEN$$61$YR$A$F$Y$$$20240917$$HP$US$US
243277992$24327799$2$F$$20240912$20240917$20240918$PER$$NVSC2024US183615$NOVARTIS$$$$$$Y$$$20240918$$CN$US$US
243278001$24327800$1$I$$20240910$20240917$20240917$EXP$$IN-PIRAMAL PHARMA LIMITED-2024-PPL-000665$PIRAMAL$Jacob A.T.; Kumar A.H.; Halivana G.; Lukose L.; Nair G.; Subeesh V.. Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database. British Journal of Clinical Pharmacology. 2024;90:8:1804-1810$$$$$Y$$$20240917$$HP$IN$IN
243278011$24327801$1$I$20211021$20240909$20240917$20240917$EXP$GB-MHRA-MED-202409061520071100-MHTSB$GB-TEVA-VS-3242227$TEVA$$61$YR$$F$Y$77$KG$20240917$$CN$GB$GB
243278021$24327802$1$I$$20240906$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009477$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243278031$24327803$1$I$$20240910$20240917$20240917$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001842$BLUEPRINT MEDICINES$$$$$$Y$$$20240917$$CN$US$US
243278061$24327806$1$I$$20240914$20240917$20240917$EXP$$US-BAYER-2024A132054$BAYER$$55$YR$A$M$Y$$$20240917$$CN$US$US
243278072$24327807$2$F$20240101$20240912$20240917$20240919$EXP$$CA-ABBVIE-5923693$ABBVIE$$$$A$F$Y$$$20240919$$CN$CA$CA
243278091$24327809$1$I$20240801$20240906$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009476$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243278101$24327810$1$I$20240803$20240820$20240917$20240917$EXP$$CN-SANDOZ INC.-SDZ2024CN074877$SANDOZ$$59$YR$$F$Y$48$KG$20240917$$HP$CN$CN
243278111$24327811$1$I$$20240912$20240917$20240917$EXP$$GB-ABBVIE-5923465$ABBVIE$$$$E$M$Y$$$20240917$$CN$GB$GB
243278121$24327812$1$I$20240904$20240911$20240917$20240917$EXP$$US-ABBVIE-5921500$ABBVIE$$86$YR$$M$Y$$$20240917$$CN$US$US
243278131$24327813$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5920657$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243278141$24327814$1$I$$20240916$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA080548$SANDOZ$$29$YR$$F$Y$76$KG$20240917$$PH$CA$CA
243278151$24327815$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147087$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240917$$HP$US$US
243278161$24327816$1$I$$20240913$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147317$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240917$$CN$US$US
243278171$24327817$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146847$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240917$$HP$US$US
243278181$24327818$1$I$20240425$20240911$20240917$20240917$EXP$$ES-TAKEDA-2024TUS074344$TAKEDA$$$$$F$Y$$$20240917$$CN$ES$ES
243278191$24327819$1$I$$20240906$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009474$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243278211$24327821$1$I$$20240910$20240917$20240917$EXP$$CA-ROCHE-10000078248$ROCHE$$81$YR$E$M$Y$100$KG$20240917$$CN$CA$CA
243278221$24327822$1$I$20230313$20240829$20240917$20240917$EXP$FR-AFSSAPS-AM2023000292$FR-CELLTRION INC.-2024FR022060$CELLTRION$$$$$$Y$$$20240917$$MD$FR$FR
243278231$24327823$1$I$20240820$20240910$20240917$20240917$EXP$$US-SA-2024SA265444$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240917$$CN$US$US
243278242$24327824$2$F$$20240902$20240917$20240919$EXP$$CA-Orion Corporation ORION PHARMA-24_00031681$ORION$$43$YR$A$F$Y$96$KG$20240919$$HP$CA$
243278252$24327825$2$F$$20240905$20240917$20240919$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093874$GLENMARK$Alhefzi M, Aycart MA, Bueno EM, Kueckelhaus M, Fischer S, Snook RJ et. Guillain-Barr? syndrome associated with resistant cytomegalovirus infection after face transplantation.. Transplant Infectious Disease. 2016;18(2):288-292$$$$$Y$$$20240919$$MD$US$US
243278261$24327826$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A209448$ASTRAZENECA$Lu K, Tse V, Altaie G, Husain H. Efficacy and tolerability of osimertinib with dabrafenib and trametinib in BRAF V600E acquired EGFR-mutant non-small cell lung cancer: a case series. Journal of Thoracic Disease 2024;16(8):5379-5387.$70$YR$$F$Y$$$20240917$$MD$US$
243278271$24327827$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210497$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243278281$24327828$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A209317$ASTRAZENECA$$$$$F$Y$89.4$KG$20240917$$CN$US$
243278291$24327829$1$I$$20240910$20240917$20240917$EXP$$ZA-AstraZeneca-2024A207273$ASTRAZENECA$$26298$DY$$F$Y$$$20240917$$CN$ZA$
243278301$24327830$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210381$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243278312$24327831$2$F$20240701$20240917$20240917$20240926$PER$$US-INCYTE CORPORATION-2024IN009466$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243278341$24327834$1$I$20240101$20240911$20240917$20240917$EXP$$GB-SA-2024SA263834$SANOFI AVENTIS$$$$$F$Y$$$20240917$$HP$GB$GB
243278352$24327835$2$F$$20240916$20240917$20240918$PER$$US-JNJFOC-20240940096$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$CN$US$US
243278361$24327836$1$I$$20240911$20240917$20240917$EXP$PL-URPL-2-1005-2019$PL-JNJFOC-20240938921$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240917$$CN$PL$PL
243278371$24327837$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000081120$ROCHE$$$$$F$Y$$$20240917$$HP$US$GB
243278382$24327838$2$F$$20240919$20240917$20240927$PER$$US-INCYTE CORPORATION-2024IN009458$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243278401$24327840$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024183344$AMGEN$$$$$$Y$$$20240917$$CN$US$US
243278411$24327841$1$I$20240909$20240913$20240917$20240917$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-146786$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240917$$HP$PR$PR
243278431$24327843$1$I$20240830$20240909$20240917$20240917$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00840$MIRUM PHARMACEUTICALS$$$$$$Y$$$20240917$$HP$US$US
243278441$24327844$1$I$20240101$20240916$20240917$20240917$PER$$US-BAYER-2024A132105$BAYER$$24$YR$A$F$Y$$$20240917$$MD$US$US
243278451$24327845$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5920832$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243278471$24327847$1$I$20240605$20240910$20240917$20240917$EXP$$CA-GSK-CA2024070062$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$CA$CA
243278481$24327848$1$I$$20240906$20240917$20240917$EXP$$US-UCBSA-2024046212$UCB$$$$$M$Y$76.644$KG$20240917$$CN$US$US
243278491$24327849$1$I$$20240911$20240917$20240917$EXP$$NVSC2024TR184344$NOVARTIS$$42$YR$$F$Y$$$20240917$$CN$TR$TR
243278501$24327850$1$I$$20240916$20240917$20240917$EXP$$NVSC2024KH184768$NOVARTIS$$$$$M$Y$$$20240917$$MD$KH$KH
243278511$24327851$1$I$$20240911$20240917$20240917$EXP$$NVSC2024RU183986$NOVARTIS$$60$YR$$F$Y$$$20240917$$MD$RU$RU
243278521$24327852$1$I$20240912$20240912$20240917$20240917$EXP$$NVSC2024CN183754$NOVARTIS$$88$YR$$F$Y$$$20240917$$HP$CN$CN
243278531$24327853$1$I$20240824$20240911$20240917$20240917$EXP$$US-Vifor (International) Inc.-VIT-2024-08375$VIFOR$$54$YR$$F$Y$132$KG$20240917$$HP$US$US
243278542$24327854$2$F$20240911$20240917$20240917$20240918$PER$$US-AMGEN-USASP2024185192$AMGEN$$79$YR$E$F$Y$$$20240918$$CN$US$US
243278551$24327855$1$I$$20240916$20240917$20240917$EXP$$US-BAYER-2024A132211$BAYER$$63$YR$A$M$Y$$$20240917$$PH$US$US
243278561$24327856$1$I$$20240916$20240917$20240917$PER$$US-BAYER-2024A132143$BAYER$$$$$M$Y$$$20240917$$CN$US$US
243278571$24327857$1$I$$20240410$20240917$20240917$EXP$$AT-ELI_LILLY_AND_COMPANY-AT202409008564$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$DE$AT
243278582$24327858$2$F$20240916$20240917$20240917$20240918$PER$$US-AMGEN-USASP2024185073$AMGEN$$81$YR$E$F$Y$$$20240918$$CN$US$US
243278591$24327859$1$I$20240830$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024183827$AMGEN$$52$YR$A$F$Y$$$20240917$$HP$US$US
243278601$24327860$1$I$20240913$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184046$AMGEN$$57$YR$A$F$Y$$$20240917$$CN$US$US
243278611$24327861$1$I$$20240910$20240917$20240917$EXP$$DE-ABBVIE-5920439$ABBVIE$$$$A$F$Y$110$KG$20240917$$MD$DE$DE
243278621$24327862$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001146US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243278631$24327863$1$I$20240822$20240913$20240917$20240917$PER$$NVSC2024US185182$NOVARTIS$$83$YR$$M$Y$$$20240917$$HP$US$US
243278641$24327864$1$I$20221101$20240910$20240917$20240917$EXP$$GR-009507513-2409GRC003917$MERCK$Yerolatsite M, Torounidou N, Venetsanopoulou A, Zarkavelis G, Mauri D, Voulgari P. Digital ischemia: a rare immune-related adverse event of immune checkpoint inhibitors?case report and review of the literature. Rheumatology International. 2024$73$YR$$M$Y$$$20240917$$MD$GR$GR
243278651$24327865$1$I$$20240910$20240917$20240917$EXP$$IN-PIRAMAL PHARMA LIMITED-2024-PPL-000666$PIRAMAL$Jacob A.T.; Kumar A.H.; Halivana G.; Lukose L.; Nair G.; Subeesh V.. Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database. British Journal of Clinical Pharmacology. 2024;90:8:1804-1810$$$$$Y$$$20240917$$HP$IN$IN
243278661$24327866$1$I$20230523$20240907$20240917$20240917$EXP$$CA-GSK-CA2023067403$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
243278671$24327867$1$I$20240910$20240916$20240916$20240916$DIR$718602$$FDA-CTU$$47$YR$$M$N$74.25$KG$20240916$N$CN$US$
243278681$24327868$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63632$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243278701$24327870$1$I$20240828$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63633$$FDA-CTU$$59$YR$$F$N$$$20240916$N$HP$US$
243278711$24327871$1$I$20240907$20240916$20240916$20240916$DIR$718610$$FDA-CTU$$14$YR$$M$N$72$KG$20240916$N$HP$US$
243278741$24327874$1$I$$20240913$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA080257$SANDOZ$$64$YR$$F$Y$$$20240917$$HP$CA$CA
243278752$24327875$2$F$$20240926$20240917$20240930$EXP$$JP-OTSUKA-2024_025411$OTSUKA$$88$YR$$M$Y$$$20240930$$MD$JP$JP
243278761$24327876$1$I$20230808$20240827$20240917$20240917$EXP$$KR-JNJFOC-20230858396$JOHNSON AND JOHNSON$$80$YR$E$F$Y$65.8$KG$20240917$$MD$KR$KR
243278771$24327877$1$I$$20240805$20240917$20240917$PER$$US-LUNDBECK-DKLU4002718$LUNDBECK$$$$$$Y$$$20240917$$CN$US$US
243278782$24327878$2$F$20220322$20240918$20240917$20240928$EXP$FR-AFSSAPS-BS2023000320$FR-CELLTRION INC.-2024FR022113$CELLTRION$$$$$$Y$$$20240928$$MD$FR$FR
243278791$24327879$1$I$$20240903$20240917$20240917$PER$$US-MYLANLABS-2024M1081578$MYLAN$$$$$F$Y$59.42$KG$20240917$$CN$US$US
243278801$24327880$1$I$20240805$20240906$20240917$20240917$EXP$$US-MYLANLABS-2024M1082085$MYLAN$$$$$$Y$$$20240917$$CN$US$US
243278811$24327881$1$I$$20240910$20240917$20240917$EXP$DE-BFARM-24006127$DE-TEVA-VS-3242357$TEVA$$$$A$M$Y$$$20240917$$MD$DE$DE
243278822$24327882$2$F$$20240918$20240917$20240930$EXP$$US-ZENPEP LLC-2024AIMT01315$AIMMUNE$$$$$$Y$$$20240928$$HP$US$US
243278832$24327883$2$F$$20240919$20240917$20240927$EXP$$IT-TEVA-VS-3242515$TEVA$Montalto S, Di Filippo M, Capra V, Manzitti C, Sementa AR, De Marco P, et al. Abdominal rhabdoid tumor presenting with symptomatic spinal epidural compression in a newborn. A case report. Front-Pediatr 2023; 11 1-6.; Montalto S, Di Filippo M, Capra V, Manzitti C, Sementa AR, De Marco P, et al. Abdominal rhabdoid tumor presenting with symptomatic spinal epidural compression in a newborn. A case report. Front-Pediatr 2023; 11 1-6.; Montalto S, Di Filippo M, Capra V, Manzitti C, Sementa AR, De M...$$$N$F$Y$$$20240927$$HP$IT$IT
243278841$24327884$1$I$$20240909$20240917$20240917$EXP$NL-LRB-01000211$NL-TEVA-VS-3242024$TEVA$$71$YR$$F$Y$86$KG$20240917$$CN$NL$NL
243278851$24327885$1$I$$20240916$20240917$20240917$EXP$$IT-SANDOZ INC.-SDZ2024IT080381$SANDOZ$$34$YR$$F$Y$$$20240917$$HP$IT$IT
243278861$24327886$1$I$$20240905$20240917$20240917$EXP$$CH-Accord-445943$ACCORD$Corbisier T, Von Bueren AO, Breunis WB, Grazioli S. Role of molecular adsorbent recirculating system in methotrexate-induced acute liver failure: A case report and literature review. Frontiers in pediatrics. 2024;12:1424919. DOI: 10.3389/fped.2024.1424919.$14$YR$T$F$Y$$$20240917$$MD$CH$CH
243278881$24327888$1$I$$20240910$20240917$20240917$EXP$$IN-PIRAMAL PHARMA LIMITED-2024-PPL-000667$PIRAMAL$Jacob A.T.; Kumar A.H.; Halivana G.; Lukose L.; Nair G.; Subeesh V.. Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database. British Journal of Clinical Pharmacology. 2024;90:8:1804-1810$$$$$Y$$$20240917$$HP$IN$IN
243278891$24327889$1$I$20240820$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A209899$ASTRAZENECA$$24053$DY$$M$Y$$$20240917$$CN$US$
243278901$24327890$1$I$$20240910$20240917$20240917$PER$$US-AstraZeneca-2024A206902$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243278931$24327893$1$I$$20240912$20240917$20240917$EXP$$CA-PFIZER INC-202400256263$PFIZER$$76$YR$$M$Y$98$KG$20240917$$HP$CA$CA
243278951$24327895$1$I$20240915$20240916$20240916$20240916$DIR$718586$$FDA-CTU$$64$YR$$F$N$83.25$KG$20240916$Y$CN$US$
243278961$24327896$1$I$20240516$20240913$20240917$20240917$EXP$FR-AFSSAPS-AN2024001251$FR-PFIZER INC-202400255821$PFIZER$$71$YR$$M$Y$64$KG$20240917$$PH$FR$FR
243278971$24327897$1$I$$20240912$20240917$20240917$EXP$$CA-PFIZER INC-202400256177$PFIZER$$7$YR$$F$Y$16$KG$20240917$$HP$CA$CA
243278981$24327898$1$I$20240910$20240913$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120926$PFIZER$$63$YR$$F$Y$71$KG$20240917$$HP$CN$CN
243278991$24327899$1$I$20240827$20240914$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120849$PFIZER$$75$YR$$F$Y$$$20240917$$HP$CN$CN
243279001$24327900$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63637$$FDA-CTU$$1$YR$$M$N$$$20240917$N$$US$
243279011$24327901$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63636$$FDA-CTU$$74$YR$$M$N$$$20240917$N$$US$
243279031$24327903$1$I$$20240912$20240917$20240917$EXP$$US-PFIZER INC-PV202400119959$PFIZER$Ritter, A.. Cavitary lung lesions caused by Pneumocystis jirovecii in a patient with myelofibrosis on ruxolitinib. BMJ case reports. 2024;17(8):10.1136/bcr-2023-258468$7$DEC$$F$Y$$$20240917$$MD$US$US
243279042$24327904$2$F$20240913$20240917$20240917$20240919$EXP$$US-PFIZER INC-202400256522$PFIZER$$24$YR$$F$Y$$$20240919$$CN$US$US
243279061$24327906$1$I$20240720$20240913$20240917$20240917$EXP$$IN-PFIZER INC-PV202400075708$PFIZER$$54$YR$$F$Y$$$20240917$$CN$IN$IN
243279071$24327907$1$I$$20240916$20240917$20240917$EXP$$CA-PFIZER INC-202400257418$PFIZER$$3$YR$$$Y$$$20240917$$CN$CA$CA
243279081$24327908$1$I$20240720$20240913$20240917$20240917$EXP$FR-AFSSAPS-AN2024001217$FR-PFIZER INC-202400255869$PFIZER$$80$YR$$F$Y$70.5$KG$20240917$$MD$FR$FR
243279091$24327909$1$I$$20240912$20240917$20240917$EXP$$AR-PFIZER INC-PV202400120373$PFIZER$Caiza-Zambrano, F.. Cyclosporine- induced erythromelalgia. Pract Neurol. 2023;23:343-345$42$YR$$$Y$$$20240917$$MD$AR$AR
243279101$24327910$1$I$20240911$20240912$20240917$20240917$EXP$$CN-PFIZER INC-202400255570$PFIZER$$72$YR$$F$Y$$$20240917$$MD$CN$CN
243279111$24327911$1$I$20240904$20240913$20240917$20240917$EXP$GB-MHRA-MED-202409111722189650-SVMWZ$GB-PFIZER INC-202400256249$PFIZER$$$$$F$Y$$$20240917$$HP$GB$GB
243279131$24327913$1$I$$20240916$20240917$20240917$PER$$US-BAYER-2024A132151$BAYER$$$$$F$Y$$$20240917$$CN$US$US
243279141$24327914$1$I$20240123$20240911$20240917$20240917$PER$$US-GILEAD-2024-0687409$GILEAD$$67$YR$E$F$Y$71$KG$20240917$$HP$US$US
243279151$24327915$1$I$$20240912$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA080082$SANDOZ$$$$$F$Y$$$20240917$$HP$CA$CA
243279161$24327916$1$I$$20240913$20240917$20240917$EXP$$US-PFIZER INC-PV202400120615$PFIZER$$82$YR$$F$Y$$$20240917$$CN$US$US
243279171$24327917$1$I$20230901$20240905$20240917$20240917$EXP$ES-AEMPS-1565908$ES-GLENMARK PHARMACEUTICALS-2024GMK093880$GLENMARK$$$$$$Y$$$20240917$$MD$ES$ES
243279181$24327918$1$I$20240101$20240911$20240917$20240917$EXP$$US-AMGEN-USASL2024183065$AMGEN$$77$YR$E$F$Y$$$20240917$$CN$US$US
243279191$24327919$1$I$$20240912$20240917$20240917$PER$$US-Mission Pharmacal Company-2161701$MISSION$$29$YR$$F$Y$$$20240917$$$US$US
243279201$24327920$1$I$$20240905$20240917$20240917$EXP$$US-B.Braun Medical Inc.-2161702$B BRAUN$Literature Article$16$YR$$F$Y$$$20240917$$$US$US
243279221$24327922$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147592$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$59.87$KG$20240917$$HP$US$US
243279231$24327923$1$I$20240905$20240909$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143906$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$80.29$KG$20240917$$CN$US$US
243279241$24327924$1$I$$20240910$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019692$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240917$$CN$US$US
243279251$24327925$1$I$20230901$20240827$20240917$20240917$EXP$$KR-JNJFOC-20230956366$JOHNSON AND JOHNSON$$58$YR$A$F$Y$51.7$KG$20240917$$HP$KR$KR
243279262$24327926$2$F$$20240913$20240917$20240919$PER$$US-JNJFOC-20240928744$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$HP$US$US
243279281$24327928$1$I$$20240911$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145395$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$67$KG$20240917$$PH$US$US
243279291$24327929$1$I$20240916$20240916$20240917$20240917$PER$$US-BAYER-2024A132162$BAYER$$$$$F$Y$$$20240917$$CN$US$US
243279302$24327930$2$F$20240701$20240830$20240917$20240919$PER$$US-TEVA-VS-3238502$TEVA$$$$$$Y$$$20240919$$CN$US$US
243279311$24327931$1$I$20240801$20240911$20240917$20240917$EXP$$NVSC2024DE184108$NOVARTIS$$55$YR$$F$Y$$$20240917$$HP$DE$DE
243279331$24327933$1$I$20240916$20240916$20240917$20240917$PER$$US-BAYER-2024A132273$BAYER$$35$YR$A$F$Y$$$20240917$$CN$US$US
243279341$24327934$1$I$20240301$20240909$20240917$20240917$EXP$$CO-AMGEN-COLSP2024181071$AMGEN$$$$E$F$Y$$$20240917$$MD$CO$CO
243279352$24327935$2$F$20240827$20240917$20240917$20240918$PER$$US-AMGEN-USASP2024185168$AMGEN$$79$YR$E$F$Y$$$20240918$$CN$US$US
243279361$24327936$1$I$20240201$20240912$20240917$20240917$EXP$$US-PFIZER INC-PV202200039492$PFIZER$$92$YR$$M$Y$$$20240917$$HP$US$US
243279381$24327938$1$I$$20240912$20240917$20240917$EXP$$IN-PFIZER INC-PV202300078960$PFIZER$$78$YR$$M$Y$48$KG$20240917$$CN$IN$IN
243279392$24327939$2$F$$20240920$20240917$20240923$EXP$$US-PFIZER INC-202400256357$PFIZER$$$$$M$Y$$$20240923$$CN$US$US
243279401$24327940$1$I$$20240913$20240917$20240917$EXP$$PL-PFIZER INC-PV202400120721$PFIZER$Chromik, K.. Toxic epidermal necrolysis after allogeneic hematopoietic stem cell transplantation for refractory Hodgkin^s lymphoma. Acta Haematologica Polonica. 2024;55(4):221-223$24$YR$$M$Y$$$20240917$$HP$PL$PL
243279411$24327941$1$I$$20240912$20240917$20240917$EXP$$CA-PFIZER INC-202400256713$PFIZER$$49$YR$$F$Y$$$20240917$$HP$CA$CA
243279421$24327942$1$I$20240908$20240913$20240917$20240917$EXP$GB-MHRA-MED-202409131352076240-VQJTK$GB-PFIZER INC-202400256226$PFIZER$$68$YR$$F$Y$72$KG$20240917$$CN$GB$GB
243279432$24327943$2$F$20230726$20240919$20240917$20240925$EXP$FR-AFSSAPS-PB2024000992$FR-PFIZER INC-202400256916$PFIZER$$76$YR$$M$Y$57$KG$20240925$$MD$FR$FR
243279441$24327944$1$I$20240622$20240914$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120831$PFIZER$$49$YR$$F$Y$65$KG$20240917$$HP$CN$CN
243279451$24327945$1$I$20230101$20240912$20240917$20240917$EXP$$DE-PFIZER INC-202400256574$PFIZER$$$$E$F$Y$$$20240917$$CN$DE$DE
243279462$24327946$2$F$$20240918$20240917$20240919$EXP$$US-PFIZER INC-202400255522$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243279471$24327947$1$I$20240101$20240912$20240917$20240917$EXP$$CA-PFIZER INC-202300247340$PFIZER$$77$YR$$F$Y$$$20240917$$MD$CA$CA
243279501$24327950$1$I$20240828$20240916$20240916$20240916$DIR$718625$$FDA-CTU$$41$YR$$F$N$75.15$KG$20240916$N$CN$US$
243279522$24327952$2$F$$20240918$20240917$20240918$EXP$$FR-PFIZER INC-PV202400121167$PFIZER$$65$YR$$M$Y$$$20240918$$MD$FR$FR
243279531$24327953$1$I$$20240724$20240917$20240917$PER$$US-TEVA-VS-3232945$TEVA$$32$YR$$$Y$$$20240917$$HP$US$US
243279541$24327954$1$I$20240830$20240913$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120940$PFIZER$$7$YR$$M$Y$20$KG$20240917$$HP$CN$CN
243279551$24327955$1$I$$20240916$20240917$20240917$EXP$GB-MHRA-MED-202409152108305470-GSPLT$GB-PFIZER INC-202400257223$PFIZER$$64$YR$$F$Y$60$KG$20240917$$CN$GB$GB
243279561$24327956$1$I$$20240916$20240917$20240917$EXP$$US-PFIZER INC-202400257944$PFIZER$$$$$$Y$$$20240917$$CN$US$US
243279571$24327957$1$I$$20240916$20240917$20240917$EXP$$KE-PFIZER INC-PV202400121202$PFIZER$$86$YR$$F$Y$$$20240917$$CN$KE$KE
243279581$24327958$1$I$20230101$20240912$20240917$20240917$EXP$$CA-PFIZER INC-202300100198$PFIZER$$61$YR$$F$Y$$$20240917$$MD$CA$CA
243279591$24327959$1$I$$20240913$20240917$20240917$EXP$$BE-PFIZER INC-PV202400121052$PFIZER$Cicek, A.. Thunderclap headache as a first manifestation of acute disseminated encephalomyelitis: case report and literature review. BMC Neurology. 2024;24(1):10.1186/s12883-024-03803-z$62$YR$$F$Y$$$20240917$$HP$BE$BE
243279602$24327960$2$F$$20240917$20240917$20240920$EXP$$RU-PFIZER INC-202400257840$PFIZER$$62$YR$$M$Y$$$20240920$$MD$RU$RU
243279611$24327961$1$I$20240716$20240914$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120828$PFIZER$$95$YR$$M$Y$53$KG$20240917$$HP$CN$CN
243279621$24327962$1$I$$20240916$20240917$20240917$EXP$$RU-PFIZER INC-202400257202$PFIZER$$74$YR$$$Y$$$20240917$$MD$RU$RU
243279641$24327964$1$I$$20240916$20240917$20240917$EXP$GB-MHRA-MED-202409152116426990-KTCGS$GB-PFIZER INC-202400257224$PFIZER$$$$$F$Y$$$20240917$$CN$GB$GB
243279651$24327965$1$I$20240308$20240912$20240917$20240917$EXP$$CA-PFIZER INC-2018267489$PFIZER$$72$YR$$M$Y$98$KG$20240917$$MD$CA$CA
243279661$24327966$1$I$$20240911$20240917$20240917$EXP$$US-JNJFOC-20240933885$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243279671$24327967$1$I$20231005$20240827$20240917$20240917$EXP$$KR-JNJFOC-20231055732$JOHNSON AND JOHNSON$$69$YR$E$F$Y$55$KG$20240917$$MD$KR$KR
243279691$24327969$1$I$$20240910$20240917$20240917$EXP$$IN-PIRAMAL PHARMA LIMITED-2024-PPL-000668$PIRAMAL$Jacob A.T.; Kumar A.H.; Halivana G.; Lukose L.; Nair G.; Subeesh V.. Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database. British Journal of Clinical Pharmacology. 2024;90:8:1804-1810$$$$$Y$$$20240917$$HP$IN$IN
243279701$24327970$1$I$20240704$20240916$20240917$20240917$EXP$FR-AFSSAPS-LL2024001747$NVSC2024FR184665$NOVARTIS$$57$YR$$$Y$57$KG$20240917$$PH$FR$FR
243279711$24327971$1$I$20240912$20240913$20240917$20240917$EXP$$NVSC2024CN183911$NOVARTIS$$77$YR$$F$Y$60$KG$20240917$$HP$CN$CN
243279731$24327973$1$I$$20240819$20240917$20240917$PER$$US-Eisai-EC-2024-172450$EISAI$$$$$M$Y$$$20240917$$CN$US$US
243279742$24327974$2$F$$20240909$20240917$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143437$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$66.68$KG$20240924$$CN$US$US
243279751$24327975$1$I$$20240912$20240917$20240917$EXP$$US-GILEAD-2024-0687568$GILEAD$$$$E$M$Y$$$20240917$$HP$US$US
243279781$24327978$1$I$20240101$20240906$20240917$20240917$EXP$$US-UCBSA-2024008788$UCB$$$$$M$Y$63.1$KG$20240917$$CN$US$US
243279791$24327979$1$I$$20240916$20240917$20240917$EXP$$US-GILEAD-2024-0687867$GILEAD$$78$YR$E$M$Y$$$20240917$$MD$US$US
243279812$24327981$2$F$$20240909$20240917$20240920$EXP$$IT-009507513-2409ITA004190$MERCK$Nardo R, Gazzola L, Bini T, Marchetti G. CLINICAL EXPERIENCE WITH DORAVIRINE: REAL-LIFE STUDY OF THERAPEUTIC EFFICACY AND INFLUENCE ON METABOLIC. Sexually Transmitted Infections. 2024;100(Suppl 1):A130-1$48$YR$$M$Y$$$20240920$$MD$IT$IT
243279821$24327982$1$I$20240101$20240912$20240917$20240917$EXP$$CA-PFIZER INC-202400062562$PFIZER$$36$YR$$F$Y$$$20240917$$HP$CA$CA
243279831$24327983$1$I$20240225$20240913$20240917$20240917$PER$$US-GILEAD-2024-0687664$GILEAD$$68$YR$E$F$Y$81$KG$20240917$$HP$US$US
243279841$24327984$1$I$$20240805$20240917$20240917$PER$$US-LUNDBECK-DKLU4002716$LUNDBECK$$$$$$Y$$$20240917$$CN$US$US
243279861$24327986$1$I$20240901$20240916$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147241$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240917$$HP$US$US
243279872$24327987$2$F$20240912$20240916$20240917$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147233$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240919$$CN$US$US
243279881$24327988$1$I$20240801$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146955$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240917$$HP$US$US
243279891$24327989$1$I$20231219$20240827$20240917$20240917$EXP$$KR-JNJFOC-20231279189$JOHNSON AND JOHNSON$$77$YR$E$F$Y$43$KG$20240917$$MD$KR$KR
243279901$24327990$1$I$20231023$20240827$20240917$20240917$EXP$$KR-JNJFOC-20231131558$JOHNSON AND JOHNSON$$69$YR$E$M$Y$78.8$KG$20240917$$HP$KR$KR
243279921$24327992$1$I$20240701$20240906$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143284$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$89.36$KG$20240917$$PH$US$US
243279941$24327994$1$I$$20240911$20240917$20240917$EXP$$NVSC2024CA184251$NOVARTIS$$42$YR$$M$Y$$$20240917$$HP$CA$CA
243279951$24327995$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000082742$ROCHE$$26$YR$A$F$Y$$$20240917$$HP$US$US
243279961$24327996$1$I$20240914$20240916$20240916$20240916$DIR$718527$$FDA-CTU$$26$YR$$F$N$45$KG$20240916$N$CN$US$
243279971$24327997$1$I$$20240910$20240917$20240917$EXP$$US-ABBVIE-5919079$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243279981$24327998$1$I$$20240910$20240917$20240917$EXP$$IN-PIRAMAL PHARMA LIMITED-2024-PPL-000669$PIRAMAL$Jacob A.T.; Kumar A.H.; Halivana G.; Lukose L.; Nair G.; Subeesh V.. Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database. British Journal of Clinical Pharmacology. 2024;90:8:1804-1810$$$$$Y$$$20240917$$HP$IN$IN
243279992$24327999$2$F$$20240924$20240917$20240926$EXP$$US-GILEAD-2024-0687861$GILEAD$$$$T$M$Y$$$20240926$$HP$US$US
243280001$24328000$1$I$20240323$20240909$20240917$20240917$EXP$$NL-AstraZeneca-2024A211884$ASTRAZENECA$$35$YR$$F$Y$65$KG$20240917$$CN$NL$
243280011$24328001$1$I$$20240911$20240917$20240917$PER$$US-AstraZeneca-2024A211077$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243280022$24328002$2$F$$20240908$20240917$20240919$EXP$$US-AMGEN-USASP2024181244$AMGEN$$$$$$Y$$$20240919$$MD$US$US
243280031$24328003$1$I$$20240909$20240917$20240917$PER$$US-AMGEN-USASP2024182512$AMGEN$Look-why S.; Otto T. S.; Chen S. X. et al.. Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy. Journal of the American Academy of Dermatology. 2024;91(3):AB354$$$$$Y$$$20240917$$MD$US$US
243280041$24328004$1$I$20240101$20240906$20240917$20240917$PER$$US-INSUD PHARMA-2409US06987$INSUD PHARMA$$$$$$Y$$$20240917$$CN$US$US
243280051$24328005$1$I$$20240912$20240917$20240917$EXP$$CN-AMGEN-CHNSP2024183402$AMGEN$Wu D.; Lu J.; Qiu H. et al.. Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial. Journal of Hematology + Oncology. 2024;17 (1):1-5$$$$$Y$$$20240917$$HP$CN$CN
243280061$24328006$1$I$20231004$20240827$20240917$20240917$EXP$$KR-JNJFOC-20240227496$JOHNSON AND JOHNSON$$72$YR$E$M$Y$73$KG$20240917$$HP$KR$KR
243280072$24328007$2$F$$20240919$20240917$20240920$PER$$US-JNJFOC-20240927324$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
243280081$24328008$1$I$$20240916$20240917$20240917$PER$$US-ROCHE-10000083706$ROCHE$$55$YR$A$F$Y$76$KG$20240917$$CN$US$US
243280091$24328009$1$I$$20240716$20240917$20240917$PER$$US-ROCHE-10000023075$ROCHE$$$$$F$Y$$$20240917$$CN$US$US
243280101$24328010$1$I$$20240916$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147288$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240917$$PH$US$US
243280111$24328011$1$I$20240910$20240911$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145469$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$PH$US$US
243280121$24328012$1$I$$20240916$20240917$20240917$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051784$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240917$$CN$US$US
243280131$24328013$1$I$$20240910$20240917$20240917$PER$$US-BAUSCH-BL-2024-013697$BAUSCH AND LOMB$$$$A$F$Y$$$20240917$$HP$US$US
243280142$24328014$2$F$20240708$20240924$20240917$20240925$EXP$$IT-BAUSCH-BL-2024-013809$BAUSCH AND LOMB$$54$YR$$M$Y$$$20240925$$HP$IT$IT
243280151$24328015$1$I$20230120$20240913$20240917$20240917$EXP$$CZ-BAUSCH-BL-2024-013849$BAUSCH AND LOMB$$17$YR$$M$Y$116$KG$20240917$$MD$CZ$CZ
243280161$24328016$1$I$20240907$20240913$20240917$20240917$PER$$US-BIOGEN-2024BI01282642$BIOGEN$$46$YR$$F$Y$$$20240917$$CN$US$US
243280172$24328017$2$F$$20240920$20240917$20240925$PER$$US-BIOGEN-2024BI01282693$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243280181$24328018$1$I$$20240913$20240917$20240917$PER$$US-BIOGEN-2024BI01282647$BIOGEN$$$$$M$Y$$$20240917$$CN$US$US
243280191$24328019$1$I$$20240912$20240917$20240917$PER$$US-BIOGEN-2024BI01282403$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
243280201$24328020$1$I$$20240913$20240917$20240917$PER$$US-BIOGEN-2017BI00499772$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
243280211$24328021$1$I$$20240916$20240916$20240916$DIR$718597$$FDA-CTU$$$$$UNK$N$$$20240916$N$CN$US$
243280221$24328022$1$I$20240712$20240916$20240916$20240916$DIR$718617$$FDA-CTU$$62$YR$$M$N$83.25$KG$20240916$N$CN$US$
243280231$24328023$1$I$20240711$20240915$20240917$20240917$EXP$$FR-BAUSCH-BL-2024-013894$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240917$$HP$FR$FR
243280242$24328024$2$F$$20240919$20240917$20240927$EXP$$JP-TEVA-VS-3242190$TEVA$Motomura Y, Urai S, Hirota Y, Takegawa N, Bando H, Yamamoto M, et al. Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumab. Diabet-Int 2024; 15 130-134.; Motomura Y, Urai S, Hirota Y, Takegawa N, Bando H, Yamamoto M, et al. Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumab. Diabet-Int 2024; 15 130-134.; Motomura Y, Urai S, Hirota Y, Takegawa N, Bando H, Yamamoto M, et al. Type 1 diabetes mellitus affected by potential to...$53$YR$$M$Y$$$20240927$$HP$JP$JP
243280251$24328025$1$I$$20240910$20240917$20240917$EXP$$IN-PIRAMAL PHARMA LIMITED-2024-PPL-000670$PIRAMAL$Jacob A.T.; Kumar A.H.; Halivana G.; Lukose L.; Nair G.; Subeesh V.. Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database. British Journal of Clinical Pharmacology. 2024;90:8:1804-1810$$$$$Y$$$20240917$$HP$IN$IN
243280261$24328026$1$I$20240802$20240909$20240917$20240917$EXP$FR-AFSSAPS-TS2024000952$FR-TEVA-VS-3241998$TEVA$$73$YR$$M$Y$70$KG$20240917$$MD$FR$FR
243280291$24328029$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001211US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243280311$24328031$1$I$$20240916$20240917$20240917$EXP$FR-AFSSAPS-AM2024000731$FR-SANDOZ INC.-SDZ2024FR080551$SANDOZ$$18$YR$$M$Y$105$KG$20240917$$MD$FR$FR
243280321$24328032$1$I$$20240916$20240917$20240917$EXP$$IT-SANDOZ INC.-SDZ2024IT080444$SANDOZ$$53$YR$$F$Y$$$20240917$$HP$IT$IT
243280341$24328034$1$I$$20240912$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147553$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$HP$US$US
243280351$24328035$1$I$$20240916$20240917$20240917$EXP$$IT-SANDOZ INC.-SDZ2024IT080337$SANDOZ$$$$A$$Y$$$20240917$$CN$IT$IT
243280361$24328036$1$I$$20240916$20240916$20240916$DIR$718616$$FDA-CTU$$$$$UNK$N$$$20240916$$CN$US$
243280381$24328038$1$I$20240904$20240916$20240916$20240916$DIR$718612$$FDA-CTU$$34$YR$$F$N$69$KG$20240916$N$PH$US$
243280391$24328039$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5920051$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243280411$24328041$1$I$$20240905$20240917$20240917$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK093894$GLENMARK$$$$$$Y$$$20240917$$PH$GB$GB
243280421$24328042$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024183885$AMGEN$$$$C$$Y$$$20240917$$PH$US$US
243280431$24328043$1$I$20240912$20240912$20240917$20240917$PER$$US-AMGEN-USASL2024182887$AMGEN$$$$$F$Y$$$20240917$$CN$US$US
243280442$24328044$2$F$20240913$20240917$20240917$20240919$PER$$US-AMGEN-USASP2024185120$AMGEN$$68$YR$E$F$Y$$$20240919$$CN$US$US
243280451$24328045$1$I$$20240913$20240917$20240917$EXP$$TR-AMGEN-TURSP2024160445$AMGEN$$68$YR$E$M$Y$$$20240917$$CN$TR$TR
243280461$24328046$1$I$$20240909$20240917$20240917$EXP$$RO-AMGEN-ROUSP2024180424$AMGEN$Brusnic O.; Onisor D.; Mocan S. et al.. Cytomegalovirus in Ulcerative Colitis: An Unwanted Guest. Pathogens. 2024;13 (8):1-15$25$YR$A$M$Y$$$20240917$$HP$RO$RO
243280481$24328048$1$I$20190204$20240909$20240917$20240917$EXP$$ES-FreseniusKabi-FK201903200$FRESENIUS KABI$$64$YR$A$M$Y$$$20240917$$MD$ES$ES
243280501$24328050$1$I$$20240905$20240917$20240917$EXP$$DE-ROCHE-10000075796$ROCHE$$$$$$Y$$$20240917$$MD$DE$DE
243280511$24328051$1$I$$20240909$20240917$20240917$PER$$US-RDY-SPO/USA/24/0013267$DR REDDYS$$21$YR$A$M$Y$$$20240917$$HP$US$US
243280522$24328052$2$F$$20240916$20240917$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147574$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240919$$CN$US$US
243280551$24328055$1$I$$20240916$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147375$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240917$$CN$US$US
243280581$24328058$1$I$$20240911$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA079601$SANDOZ$$50$YR$$F$Y$$$20240917$$HP$CA$CA
243280591$24328059$1$I$20240824$20240916$20240917$20240917$EXP$$US-GILEAD-2024-0687894$GILEAD$$19$YR$A$F$Y$$$20240917$$CN$US$US
243280611$24328061$1$I$$20240910$20240917$20240917$EXP$$IN-PIRAMAL PHARMA LIMITED-2024-PPL-000671$PIRAMAL$Jacob.A.T.; Kumar.A.H.; Halivana.G.; Lukose.L.; Nair.G.; Subeesh.V.. Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database. British Journal of Clinical Pharmacology. 2024;90:8:1804-1810$$$$$Y$$$20240917$$HP$IN$IN
243280621$24328062$1$I$$20240905$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009389$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243280631$24328063$1$I$20230824$20240916$20240917$20240917$EXP$$CN-SANDOZ INC.-SDZ2024CN080394$SANDOZ$$58$YR$$F$Y$$$20240917$$MD$CN$CN
243280641$24328064$1$I$$20240912$20240917$20240917$EXP$$US-SANDOZ INC.-SDZ2024US080454$SANDOZ$$$$$$Y$$$20240917$$MD$US$US
243280651$24328065$1$I$$20240909$20240917$20240917$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006783$BIOCON$$$$$$Y$$$20240917$$PH$CA$CA
243280661$24328066$1$I$20240830$20240916$20240917$20240917$EXP$FR-AFSSAPS-AN2024001268$FR-SANDOZ INC.-SDZ2024FR080527$SANDOZ$$31$YR$$F$Y$$$20240917$$PH$FR$FR
243280671$24328067$1$I$$20240905$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009338$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243280701$24328070$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63646$$FDA-CTU$$71$YR$$F$N$160$LBS$20240917$N$$US$
243280711$24328071$1$I$20211021$20240916$20240916$20240916$DIR$718627$$FDA-CTU$$68$YR$$F$N$49.95$KG$20240916$N$CN$US$
243280721$24328072$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63645$$FDA-CTU$$60$YR$$F$N$$$20240917$N$$US$
243280731$24328073$1$I$20230101$20240916$20240917$20240917$PER$$US-ALXN-202409USA001194US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$HP$US$US
243280741$24328074$1$I$20240707$20240910$20240917$20240917$EXP$FR-AFSSAPS-MA2024001324$FR-OTSUKA-2024_025369$OTSUKA$$49$YR$$F$Y$$$20240917$$CN$FR$FR
243280751$24328075$1$I$20240806$20240909$20240917$20240917$EXP$$CA-TAKEDA-2024TUS083389$TAKEDA$$58$YR$$F$Y$$$20240917$$CN$CA$CA
243280763$24328076$3$F$20240904$20240925$20240917$20240930$EXP$$US-ABBVIE-5920497$ABBVIE$$$$E$M$Y$$$20240930$$HP$US$US
243280771$24328077$1$I$20240101$20240906$20240917$20240917$EXP$$CA-APOTEX-2024AP010432$APOTEX$$$$$$Y$$$20240917$$PH$CA$CA
243280791$24328079$1$I$$20240912$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146937$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240917$$MD$US$US
243280801$24328080$1$I$$20240913$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146891$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240917$$PH$US$US
243280811$24328081$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147198$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240917$$CN$US$US
243280821$24328082$1$I$20230909$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184944$AMGEN$$71$YR$E$F$Y$$$20240917$$CN$US$US
243280831$24328083$1$I$20240908$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024185217$AMGEN$$71$YR$E$M$Y$$$20240917$$HP$US$US
243280841$24328084$1$I$$20240913$20240917$20240917$30DAY$$AU-MYLANLABS-2024M1083708$MYLAN$$$$$$Y$$$20240917$$CN$AU$AU
243280851$24328085$1$I$$20240913$20240917$20240917$30DAY$$CZ-MYLANLABS-2024M1083813$MYLAN$$$$$$Y$$$20240917$$CN$CZ$CZ
243280862$24328086$2$F$$20240919$20240917$20240921$PER$$US-JNJFOC-20240932913$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$HP$US$US
243280871$24328087$1$I$20240501$20240911$20240917$20240917$EXP$FR-AFSSAPS-NT2024001114$FR-GSK-FR2024112787$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$FR$FR
243280881$24328088$1$I$$20240806$20240917$20240917$PER$$US-LUNDBECK-DKLU4002713$LUNDBECK$$$$$$Y$$$20240917$$CN$US$US
243280891$24328089$1$I$$20240910$20240917$20240917$EXP$NL-LRB-01000522$NL-TEVA-VS-3242683$TEVA$$40$YR$$M$Y$94$KG$20240917$$MD$NL$NL
243280901$24328090$1$I$20240909$20240910$20240917$20240917$EXP$$US-BAYER-2024A129621$BAYER$$$$$F$Y$$$20240917$$CN$US$US
243280911$24328091$1$I$20240101$20240905$20240917$20240917$EXP$$DE-AMICUS THERAPEUTICS, INC.-AMI_3366$AMICUS THERAPEUTICS$$$$A$F$Y$$$20240917$$PH$DE$DE
243280921$24328092$1$I$20240831$20240915$20240917$20240917$PER$$US-PFIZER INC-202400257458$PFIZER$$68$YR$$F$Y$$$20240917$$CN$US$US
243280931$24328093$1$I$20240826$20240910$20240917$20240917$EXP$AT-BASGAGES-2024-006540$AT-TEVA-VS-3242632$TEVA$$62$YR$$M$Y$78$KG$20240917$$PH$AT$AT
243280942$24328094$2$F$$20240916$20240917$20240919$PER$$US-PFIZER INC-202400257561$PFIZER$$46$YR$$F$Y$$$20240919$$CN$US$US
243280951$24328095$1$I$$20240916$20240917$20240917$EXP$$US-PFIZER INC-PV202400121563$PFIZER$$20$YR$$M$Y$$$20240917$$CN$US$US
243280961$24328096$1$I$20240101$20240915$20240917$20240917$PER$$US-PFIZER INC-202400256687$PFIZER$$74$YR$$F$Y$$$20240917$$CN$US$US
243280973$24328097$3$F$20240101$20240918$20240917$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025928$UNITED THERAPEUTICS$$$$$M$Y$80.272$KG$20240927$$$US$US
243280991$24328099$1$I$$20240913$20240917$20240917$PER$$US-PFIZER INC-202400256460$PFIZER$$73$YR$$F$Y$$$20240917$$CN$US$US
243281001$24328100$1$I$20240914$20240915$20240917$20240917$PER$$US-PFIZER INC-202400257433$PFIZER$$59$YR$$M$Y$$$20240917$$CN$US$US
243281011$24328101$1$I$20240910$20240914$20240917$20240917$PER$$US-PFIZER INC-202400257132$PFIZER$$51$YR$$M$Y$$$20240917$$CN$US$US
243281021$24328102$1$I$20240801$20240912$20240917$20240917$EXP$$US-PFIZER INC-202400256401$PFIZER$$69$YR$$M$Y$$$20240917$$HP$US$US
243281031$24328103$1$I$$20240915$20240917$20240917$PER$$US-PFIZER INC-PV202400121257$PFIZER$$79$YR$$F$Y$$$20240917$$CN$US$US
243281041$24328104$1$I$20240907$20240915$20240917$20240917$PER$$US-PFIZER INC-202400257435$PFIZER$$41$YR$$F$Y$$$20240917$$HP$US$US
243281051$24328105$1$I$20240830$20240912$20240917$20240917$PER$$US-PFIZER INC-202400256193$PFIZER$$51$YR$$M$Y$$$20240917$$CN$US$US
243281061$24328106$1$I$20240915$20240915$20240917$20240917$PER$$US-PFIZER INC-202400257516$PFIZER$$73$YR$$F$Y$$$20240917$$CN$US$US
243281071$24328107$1$I$$20240914$20240917$20240917$PER$$US-PFIZER INC-202400257107$PFIZER$$$$$$Y$$$20240917$$CN$US$US
243281081$24328108$1$I$20240912$20240913$20240917$20240917$PER$$US-PFIZER INC-202400256204$PFIZER$$76$YR$$F$Y$$$20240917$$CN$US$US
243281111$24328111$1$I$20240911$20240917$20240917$20240917$DIR$718681$$FDA-CTU$$37$YR$$M$N$74.84$KG$20240917$Y$HP$US$
243281121$24328112$1$I$$20240912$20240917$20240917$PER$$US-PFIZER INC-202400256417$PFIZER$$61$YR$$F$Y$$$20240917$$HP$US$US
243281131$24328113$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63649$$FDA-CTU$$59$YR$$F$N$$$20240917$N$$US$
243281141$24328114$1$I$20240806$20240913$20240917$20240917$PER$$US-PFIZER INC-PV202400121310$PFIZER$$76$YR$$F$Y$$$20240917$$MD$US$US
243281151$24328115$1$I$20231001$20240913$20240917$20240917$PER$$US-PFIZER INC-202400256525$PFIZER$$29$YR$$F$Y$$$20240917$$CN$US$US
243281161$24328116$1$I$20240227$20240916$20240916$20240916$DIR$718473$$FDA-CTU$$48$YR$$F$N$54$KG$20240916$N$CN$US$
243281171$24328117$1$I$$20240913$20240917$20240917$PER$$US-PFIZER INC-202400256790$PFIZER$$4$DEC$$F$Y$$$20240917$$CN$US$US
243281181$24328118$1$I$20230420$20240913$20240917$20240917$EXP$FR-AFSSAPS-CF2023000344$FR-PFIZER INC-202400255830$PFIZER$$29$YR$$F$Y$$$20240917$$MD$FR$FR
243281193$24328119$3$F$$20240917$20240917$20240919$PER$$US-PFIZER INC-PV202400121341$PFIZER$$71$YR$$F$Y$80.29$KG$20240919$$CN$US$US
243281201$24328120$1$I$$20240917$20240917$20240917$DIR$718683$$FDA-CTU$$$$$UNK$N$$$20240917$N$CN$US$
243281211$24328121$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63648$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243281232$24328123$2$F$$20240913$20240917$20240917$PER$$US-PFIZER INC-202400256552$PFIZER$$$$E$F$Y$63.95$KG$20240917$$CN$US$US
243281241$24328124$1$I$$20240912$20240917$20240917$PER$$US-PFIZER INC-PV202400120377$PFIZER$$68$YR$$F$Y$$$20240917$$MD$US$US
243281251$24328125$1$I$20230101$20240913$20240917$20240917$PER$$US-PFIZER INC-202400256530$PFIZER$$$$A$F$Y$$$20240917$$HP$US$US
243281261$24328126$1$I$$20240916$20240917$20240917$EXP$$US-PFIZER INC-PV202400121527$PFIZER$$46$YR$$M$Y$$$20240917$$HP$US$US
243281271$24328127$1$I$20240101$20240913$20240917$20240917$PER$$US-PFIZER INC-202400256575$PFIZER$$51$YR$$F$Y$$$20240917$$CN$US$US
243281281$24328128$1$I$$20240916$20240917$20240917$EXP$$CO-PFIZER INC-PV202400121608$PFIZER$$$$$$Y$$$20240917$$MD$CO$CO
243281291$24328129$1$I$$20240915$20240917$20240917$PER$$US-PFIZER INC-PV202400121353$PFIZER$$69$YR$$F$Y$$$20240917$$CN$US$US
243281311$24328131$1$I$20240826$20240913$20240917$20240917$PER$$US-PFIZER INC-202400257484$PFIZER$$62$YR$$M$Y$$$20240917$$HP$US$US
243281322$24328132$2$F$$20240914$20240917$20240917$PER$$US-PFIZER INC-202400256797$PFIZER$$47$YR$$F$Y$81.65$KG$20240917$$CN$US$US
243281331$24328133$1$I$$20240912$20240917$20240917$PER$$US-PFIZER INC-202400255427$PFIZER$$56$YR$$F$Y$$$20240917$$MD$US$US
243281341$24328134$1$I$$20240912$20240917$20240917$PER$$US-PFIZER INC-PV202400120590$PFIZER$$69$YR$$F$Y$$$20240917$$HP$US$US
243281352$24328135$2$F$$20240917$20240917$20240919$PER$$US-PFIZER INC-PV202400121080$PFIZER$$$$$F$Y$$$20240919$$HP$US$US
243281361$24328136$1$I$$20240913$20240917$20240917$PER$$US-PFIZER INC-PV202400120638$PFIZER$$23$YR$$F$Y$$$20240917$$HP$US$US
243281371$24328137$1$I$$20240911$20240917$20240917$PER$$US-PFIZER INC-202400255674$PFIZER$$55$YR$$F$Y$$$20240917$$CN$US$US
243281382$24328138$2$F$20240911$20240912$20240917$20240920$PER$$US-PFIZER INC-202400255425$PFIZER$$78$YR$$F$Y$$$20240920$$CN$US$US
243281392$24328139$2$F$$20240920$20240917$20240924$PER$$US-PFIZER INC-202400257501$PFIZER$$1$YR$$F$Y$$$20240924$$HP$US$US
243281411$24328141$1$I$20240720$20240913$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120958$PFIZER$$67$YR$$M$Y$$$20240917$$HP$CN$CN
243281421$24328142$1$I$$20240912$20240917$20240917$PER$$US-PFIZER INC-202400256399$PFIZER$$62$YR$$F$Y$$$20240917$$HP$US$US
243281431$24328143$1$I$$20240906$20240917$20240917$EXP$$BE-BAYER-2024A129292$BAYER$Florence Vandierendonck, Dominic Stoop. Management of thin endometrium in reproductive medicine. FERTILITY. 2024;Volume 29 no. 5:22-23$30$YR$A$F$Y$$$20240917$$HP$BE$BE
243281441$24328144$1$I$20240907$20240912$20240917$20240917$EXP$$CA-PFIZER INC-202400256288$PFIZER$$70$YR$$F$Y$$$20240917$$CN$CA$CA
243281451$24328145$1$I$20240914$20240915$20240917$20240917$PER$$US-PFIZER INC-202400257425$PFIZER$$$$$$Y$$$20240917$$CN$US$US
243281461$24328146$1$I$$20240913$20240917$20240917$PER$$US-PFIZER INC-202400245919$PFIZER$$27$YR$$F$Y$$$20240917$$CN$US$US
243281471$24328147$1$I$$20240913$20240917$20240917$EXP$$US-PFIZER INC-PV202400120559$PFIZER$Lemonjava, I.. A 72-year-old man with acute lung injury and anti-melanoma differentiation-associated gene 5 antibody: A case report. Respiratory Medicine Case Reports. 2024;51:10.1016/j.rmcr.2024.102098$72$YR$$M$Y$$$20240917$$HP$US$US
243281482$24328148$2$F$$20240917$20240917$20240919$EXP$$US-PFIZER INC-202400257895$PFIZER$$35$YR$$F$Y$$$20240919$$HP$US$US
243281491$24328149$1$I$$20240915$20240917$20240917$PER$$US-PFIZER INC-PV202400071642$PFIZER$$54$YR$$M$Y$$$20240917$$HP$US$US
243281501$24328150$1$I$$20240911$20240917$20240917$PER$$US-PFIZER INC-PV202400121333$PFIZER$$80$YR$$F$Y$$$20240917$$CN$US$US
243281511$24328151$1$I$$20240805$20240917$20240917$PER$$US-LUNDBECK-DKLU4002657$LUNDBECK$$$$$$Y$$$20240917$$CN$US$US
243281521$24328152$1$I$$20240911$20240917$20240917$EXP$$TR-SANDOZ INC.-SDZ2024TR080111$SANDOZ$Neslihan Uslu. Association of Dipeptidiyl Peptidase-4 Inhibitors and Bullose Pemphigoid: A Report of Four Cases. Medeni Med. 2024;28;39(2):140-143.$77$YR$$M$Y$$$20240917$$HP$TR$TR
243281531$24328153$1$I$20240915$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184557$AMGEN$$53$YR$A$M$Y$$$20240917$$CN$US$US
243281541$24328154$1$I$$20240910$20240917$20240917$EXP$$IN-PIRAMAL PHARMA LIMITED-2024-PPL-000672$PIRAMAL$Jacob.A.T.; Kumar.A.H.; Halivana.G.; Lukose.L.; Nair.G.; Subeesh.V.. Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database. British Journal of Clinical Pharmacology. 2024;90:8:1804-1810$$$$$Y$$$20240917$$HP$IN$IN
243281551$24328155$1$I$20240101$20240911$20240917$20240917$EXP$$US-ABBVIE-5921516$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243281561$24328156$1$I$20230101$20240910$20240917$20240917$EXP$$US-ABBVIE-5919089$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243281571$24328157$1$I$$20240819$20240917$20240917$EXP$$BE-GRUNENTHAL-2024-123459$AVERITAS$$71$YR$$M$Y$$$20240917$$MD$BE$BE
243281581$24328158$1$I$20240826$20240909$20240917$20240917$EXP$IT-MINISAL02-1000797$IT-TEVA-VS-3242057$TEVA$$56$YR$$F$Y$$$20240917$$MD$IT$IT
243281591$24328159$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5923668$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243281601$24328160$1$I$20240604$20240912$20240917$20240917$EXP$$DE-ABBVIE-5923516$ABBVIE$$36$YR$$F$Y$$$20240917$$CN$DE$DE
243281611$24328161$1$I$20240912$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024184435$AMGEN$$$$$F$Y$$$20240917$$HP$US$US
243281621$24328162$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922131$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243281641$24328164$1$I$$20240912$20240917$20240917$EXP$$US-BAYER-2024A130809$BAYER$$83$YR$E$M$Y$$$20240917$$CN$US$US
243281661$24328166$1$I$$20240917$20240917$20240917$DIR$718670$$FDA-CTU$$47$YR$$F$N$63$KG$20240917$N$CN$US$
243281671$24328167$1$I$20240917$20240917$20240917$20240917$DIR$718682$$FDA-CTU$$84$YR$$M$N$$$20240917$N$PH$US$
243281691$24328169$1$I$20240914$20240917$20240917$20240917$DIR$718687$$FDA-CTU$$17$YR$$M$N$86.85$KG$20240917$N$CN$US$
243281701$24328170$1$I$20240917$20240917$20240917$20240917$DIR$718690$$FDA-CTU$$$$$UNK$N$$$20240917$N$CN$US$
243281711$24328171$1$I$20240910$20240911$20240917$20240917$EXP$$US-ABBVIE-5921508$ABBVIE$$61$YR$$F$Y$$$20240917$$CN$US$US
243281721$24328172$1$I$$20240912$20240917$20240917$EXP$$US-MYLANLABS-2024M1083390$MYLAN$$$$$$Y$$$20240917$$LW$US$US
243281731$24328173$1$I$$20240916$20240917$20240917$EXP$$GB-SANDOZ INC.-SDZ2024GB080458$SANDOZ$$76$YR$$M$Y$74$KG$20240917$$PH$GB$GB
243281741$24328174$1$I$$20240805$20240917$20240917$PER$$US-LUNDBECK-DKLU4002661$LUNDBECK$$$$$$Y$$$20240917$$CN$US$US
243281751$24328175$1$I$$20240916$20240917$20240917$EXP$$US-PFIZER INC-202400257468$PFIZER$$5$YR$$M$Y$$$20240917$$MD$US$US
243281761$24328176$1$I$20240101$20240916$20240917$20240917$PER$$US-ALXN-202409USA001177US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243281771$24328177$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184429$AMGEN$$$$$$Y$$$20240917$$PH$US$US
243281781$24328178$1$I$20050101$20240910$20240917$20240917$EXP$$BR-SANDOZ INC.-SDZ2024BR080541$SANDOZ$$$$$F$Y$$$20240917$$CN$BR$BR
243281791$24328179$1$I$$20240805$20240917$20240917$PER$$US-LUNDBECK-DKLU4002660$LUNDBECK$$$$$$Y$$$20240917$$CN$US$US
243281801$24328180$1$I$$20240911$20240917$20240917$EXP$$GR-MYLANLABS-2024M1083266$MYLAN$Michailides C, Paraskevas P, Lagadinou M, Papantoniou K, Kavvousanos M, Marangos M, et al.. A case report and literature review of a triple-vaccinated, rituximab-treated systemic lupus erythematosus patient with COVID-19 pneumonia.. ARP rheumatology.. 2024;3 (2):145-50$50$YR$$F$Y$$$20240917$$HP$GR$GR
243281821$24328182$1$I$$20240904$20240917$20240917$EXP$$CA-BAXTER-2024BAX024312$BAXTER$$27$YR$$F$Y$$$20240917$$CN$CA$CA
243281831$24328183$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147607$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240917$$HP$US$US
243281841$24328184$1$I$$20240911$20240917$20240917$EXP$$ES-MYLANLABS-2024M1083532$MYLAN$Ochando D?ez-Canseco M, Reguero Capilla M, Dom?nguez-Romero I et al. DRESS syndrome and flare-up due to antiepileptics: how to solve the problem.. Neurology. 2024;1-3$35$YR$$M$Y$$$20240917$$HP$ES$ES
243281851$24328185$1$I$$20240909$20240917$20240917$30DAY$$US-GSK-US2024111972$GLAXOSMITHKLINE$$$$$M$Y$$$20240917$$MD$US$US
243281872$24328187$2$F$20240801$20240917$20240917$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012835$JAZZ$$45$YR$$F$Y$$$20240922$$MD$US$US
243281881$24328188$1$I$20240101$20240909$20240917$20240917$EXP$$JP-009507513-2401JPN004097J$MERCK$$$$$F$Y$$$20240917$$MD$JP$JP
243281901$24328190$1$I$$20240910$20240917$20240917$EXP$$JP-AstraZeneca-2024A208929$ASTRAZENECA$Matsumoto T, et al.. A case of acute subdural hematoma in which postoperative complications were difficult to treat, after using a direct-acting factor Xa inhibitor neutralizer (original article).. Medical Journal of Japanese Red Cross Akita Hospital. 2024;11(1):61-67.$82$YR$$M$Y$$$20240917$$MD$JP$
243281911$24328191$1$I$20240801$20240913$20240917$20240917$PER$$US-PFIZER INC-202400257531$PFIZER$$8$YR$$F$Y$$$20240917$$CN$US$US
243281921$24328192$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-PV202400121231$PFIZER$$49$YR$$F$Y$$$20240917$$CN$US$US
243281931$24328193$1$I$$20240915$20240917$20240917$PER$$US-PFIZER INC-PV202400121275$PFIZER$$69$YR$$F$Y$$$20240917$$CN$US$US
243281941$24328194$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A209647$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243281952$24328195$2$F$20240220$20240806$20240917$20240917$PER$$US-PFIZER INC-202400204148$PFIZER$$25$YR$$F$Y$$$20240917$$MD$US$US
243281961$24328196$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-PV202400121501$PFIZER$$33$YR$$M$Y$$$20240917$$HP$US$US
243281971$24328197$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-PV202400121241$PFIZER$$$$$$Y$$$20240917$$CN$US$US
243281981$24328198$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-202400257682$PFIZER$$22$YR$$F$Y$$$20240917$$HP$US$US
243281991$24328199$1$I$20240902$20240915$20240917$20240917$PER$$US-PFIZER INC-202400257522$PFIZER$$66$YR$$M$Y$$$20240917$$CN$US$US
243282001$24328200$1$I$20240623$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A209529$ASTRAZENECA$$31449$DY$$M$Y$$$20240917$$CN$US$
243282011$24328201$1$I$20240905$20240911$20240917$20240917$PER$$US-BAYER-2024A130225$BAYER$$29$YR$A$F$Y$$$20240917$$MD$US$US
243282021$24328202$1$I$$20240910$20240917$20240917$EXP$$IN-VANTIVE-2024VAN019701$Vantive US Healthcare$$34$YR$$F$Y$$$20240917$$CN$IN$IN
243282032$24328203$2$F$$20240912$20240917$20240919$EXP$$IN-VANTIVE-2024VAN019702$Vantive US Healthcare$$42$YR$$F$Y$$$20240919$$CN$IN$IN
243282041$24328204$1$I$20240912$20240912$20240917$20240917$EXP$$US-VANTIVE-2024VAN019751$Vantive US Healthcare$$63$YR$$M$Y$$$20240917$$HP$US$US
243282051$24328205$1$I$20220830$20240909$20240917$20240917$EXP$$CA-SANDOZ INC.-NVSC2022CA202692$SANDOZ$$37$YR$$M$Y$$$20240917$$CN$CA$CA
243282061$24328206$1$I$$20240916$20240917$20240917$EXP$$CO-PFIZER INC-PV202400121609$PFIZER$$$$$$Y$$$20240917$$MD$CO$CO
243282091$24328209$1$I$20240101$20240909$20240917$20240917$EXP$$PT-FreseniusKabi-FK202413704$FRESENIUS KABI$$49$YR$A$F$Y$$$20240917$$MD$PT$PT
243282101$24328210$1$I$20240813$20240909$20240917$20240917$EXP$FR-AFSSAPS-MP2024001369$FR-FreseniusKabi-FK202413666$FRESENIUS KABI$$17$YR$T$F$Y$$$20240917$$MD$FR$FR
243282111$24328211$1$I$20240831$20240912$20240917$20240917$PER$$US-RDY-SPO/USA/24/0013459$DR REDDYS$$21$YR$A$M$Y$$$20240917$$MD$US$US
243282121$24328212$1$I$$20240711$20240917$20240917$PER$$US-ROCHE-10000026651$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243282131$24328213$1$I$20240818$20240906$20240917$20240917$PER$$US-ABBVIE-5916417$ABBVIE$$59$YR$$F$Y$$$20240917$$CN$US$US
243282141$24328214$1$I$20240912$20240913$20240917$20240917$PER$$US-BAYER-2024A131759$BAYER$$$$$F$Y$$$20240917$$CN$US$US
243282151$24328215$1$I$$20240905$20240917$20240917$PER$$US-JNJFOC-20240915881$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240917$$CN$US$US
243282162$24328216$2$F$20240909$20240910$20240917$20240927$30DAY$$US-JNJFOC-20240925059$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240927$$HP$US$US
243282171$24328217$1$I$$20240910$20240917$20240917$EXP$$JP-AMGEN-JPNSP2024181277$AMGEN$$$$$$Y$$$20240917$$PH$JP$JP
243282181$24328218$1$I$$20240910$20240917$20240917$EXP$$IN-PIRAMAL PHARMA LIMITED-2024-PPL-000673$PIRAMAL$Jacob.A.T.; Kumar.A.H.; Halivana.G.; Lukose.L.; Nair.G.; Subeesh.V.. Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database. British Journal of Clinical Pharmacology. 2024;90:8:1804-1810$$$$$Y$$$20240917$$HP$IN$IN
243282191$24328219$1$I$$20240911$20240917$20240917$PER$$US-TAKEDA-2024TUS091346$TAKEDA$$$$$M$Y$84$KG$20240917$$CN$US$US
243282201$24328220$1$I$20240101$20240910$20240917$20240917$EXP$$US-ABBVIE-5918480$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243282211$24328221$1$I$20231201$20240911$20240917$20240917$EXP$$FR-MYLANLABS-2024M1083440$MYLAN$$62$YR$$F$Y$$$20240917$$MD$FR$FR
243282222$24328222$2$F$20230101$20240916$20240917$20240921$EXP$$US-ABBVIE-5919787$ABBVIE$$$$$M$Y$66$KG$20240921$$CN$US$US
243282231$24328223$1$I$$20240910$20240917$20240917$EXP$$GB-ABBVIE-5918999$ABBVIE$$$$A$M$Y$$$20240917$$CN$GB$GB
243282241$24328224$1$I$$20240912$20240917$20240917$PER$$US-BAYER-2024A131955$BAYER$$34$YR$A$F$Y$$$20240917$$MD$US$US
243282251$24328225$1$I$$20240912$20240917$20240917$EXP$$US-BAYER-2024A131548$BAYER$$$$$F$Y$$$20240917$$CN$US$US
243282262$24328226$2$F$20240801$20240917$20240917$20240919$EXP$$US-ABBVIE-5922426$ABBVIE$$82$YR$$F$Y$49.895$KG$20240919$$CN$US$US
243282271$24328227$1$I$20230701$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409007446$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240917$$CN$US$US
243282281$24328228$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009143$ELI LILLY AND CO$$$$$F$Y$$$20240917$$HP$US$US
243282292$24328229$2$F$20240628$20240909$20240917$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409006013$ELI LILLY AND CO$$42$YR$A$M$Y$118.37$KG$20240920$$MD$US$US
243282301$24328230$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009255$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240917$$CN$US$US
243282311$24328231$1$I$20240916$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184548$AMGEN$$68$YR$E$F$Y$$$20240917$$CN$US$US
243282321$24328232$1$I$20240915$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184558$AMGEN$$80$YR$E$F$Y$$$20240917$$MD$US$US
243282341$24328234$1$I$$20240912$20240917$20240917$PER$$US-TAKEDA-2024TUS091817$TAKEDA$$$$$$Y$$$20240917$$CN$US$US
243282362$24328236$2$F$$20240919$20240917$20240927$EXP$$JP-TEVA-VS-3242180$TEVA$Ishiguro T, Isono T, Maruyama T, Ueda M, Shimizu Y, Takaku Y. Overlap of Chronic Pulmonary Aspergillosis on Allergic Bronchopulmonary Aspergillosis. Intern-Med 2024; 63 (15): 2167-2171.; Ishiguro T, Isono T, Maruyama T, Ueda M, Shimizu Y, Takaku Y. Overlap of Chronic Pulmonary Aspergillosis on Allergic Bronchopulmonary Aspergillosis. Intern-Med 2024; 63 (15): 2167-2171.$75$YR$$F$Y$$$20240927$$MD$JP$JP
243282371$24328237$1$I$$20240915$20240917$20240917$PER$$US-BAYER-2024A131977$BAYER$$$$$$Y$$$20240917$$CN$US$US
243282381$24328238$1$I$$20240906$20240917$20240917$EXP$$US-JNJFOC-20240922418$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$CN$US$US
243282401$24328240$1$I$$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001771$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282411$24328241$1$I$20240101$20240821$20240917$20240917$PER$$US-SMPA-2024SPA000184$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282421$24328242$1$I$$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001819$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282441$24328244$1$I$$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001788$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282451$24328245$1$I$$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001790$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282461$24328246$1$I$$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001805$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282471$24328247$1$I$$20240820$20240917$20240917$PER$$US-SMPA-2024SPA001676$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282481$24328248$1$I$$20240830$20240917$20240917$PER$$US-SMPA-2024SPA002211$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282493$24328249$3$F$$20240911$20240917$20240925$EXP$$US-SMPA-2024SPA001869$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243282501$24328250$1$I$$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001758$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282511$24328251$1$I$$20240829$20240917$20240917$PER$$US-SMPA-2024SPA002196$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282521$24328252$1$I$$20240822$20240917$20240917$PER$$US-SMPA-2024SPA001851$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282531$24328253$1$I$$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001783$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282541$24328254$1$I$$20240822$20240917$20240917$PER$$US-SMPA-2024SPA001841$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282551$24328255$1$I$$20240904$20240917$20240917$PER$$US-SMPA-2024SPA002320$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282561$24328256$1$I$$20240903$20240917$20240917$PER$$US-SMPA-2024SPA002259$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282591$24328259$1$I$$20240829$20240917$20240917$PER$$US-SMPA-2024SPA002150$SUNOVION$$$$$$Y$$$20240917$$MD$US$US
243282601$24328260$1$I$$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001770$SUNOVION$$$$$$Y$$$20240917$$$US$US
243282611$24328261$1$I$$20240820$20240917$20240917$PER$$US-SMPA-2024SPA001711$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282621$24328262$1$I$$20240911$20240917$20240917$PER$$US-SMPA-2024SPA002682$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282632$24328263$2$F$$20240911$20240917$20240927$PER$$US-SMPA-2024SPA001809$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243282641$24328264$1$I$$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001756$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282661$24328266$1$I$$20240830$20240917$20240917$PER$$US-SMPA-2024SPA002207$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282671$24328267$1$I$$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001785$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282681$24328268$1$I$$20240820$20240917$20240917$PER$$US-SMPA-2024SPA001739$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282693$24328269$3$F$$20240912$20240917$20240926$EXP$$US-SMPA-2024SPA001801$SUNOVION$$$$$$Y$$$20240926$$CN$US$US
243282701$24328270$1$I$$20240820$20240917$20240917$PER$$US-SMPA-2024SPA001712$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282712$24328271$2$F$$20240912$20240917$20240925$PER$$US-SMPA-2024SPA001752$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243282721$24328272$1$I$$20240909$20240917$20240917$PER$$US-SMPA-2024SPA002564$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282741$24328274$1$I$20240801$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001762$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282751$24328275$1$I$20240101$20240820$20240917$20240917$PER$$US-SMPA-2024SPA000249$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282761$24328276$1$I$20240101$20240824$20240917$20240917$PER$$US-SMPA-2024SPA000496$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282771$24328277$1$I$$20240820$20240917$20240917$PER$$US-SMPA-2024SPA001667$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282781$24328278$1$I$$20240829$20240917$20240917$PER$$US-SMPA-2024SPA002099$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282791$24328279$1$I$$20240902$20240917$20240917$PER$$US-SMPA-2024SPA002222$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282801$24328280$1$I$20240701$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001753$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282811$24328281$1$I$$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001782$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282821$24328282$1$I$$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001803$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282831$24328283$1$I$20240801$20240821$20240917$20240917$PER$$US-SMPA-2024SPA001767$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282842$24328284$2$F$$20240916$20240917$20240925$PER$$US-SMPA-2024SPA002257$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243282851$24328285$1$I$$20240822$20240917$20240917$PER$$US-SMPA-2024SPA001864$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243282871$24328287$1$I$20240909$20240916$20240917$20240917$PER$$US-BAYER-2024A132283$BAYER$$38$YR$A$F$Y$$$20240917$$MD$US$US
243282881$24328288$1$I$20240830$20240903$20240917$20240917$EXP$$US-UCBSA-2024045110$UCB$$27$YR$$F$Y$$$20240917$$CN$US$US
243282891$24328289$1$I$20230515$20240912$20240917$20240917$EXP$$CO-UCBSA-2024047456$UCB$$60$YR$$F$Y$$$20240917$$CN$CO$CO
243282901$24328290$1$I$20240828$20240912$20240917$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015019$JAZZ$$53$YR$$M$Y$$$20240917$$CN$US$US
243282911$24328291$1$I$20240829$20240909$20240917$20240917$EXP$$CN-FreseniusKabi-FK202413638$FRESENIUS KABI$$85$YR$E$F$Y$40$KG$20240917$$HP$CN$CN
243282921$24328292$1$I$20240807$20240912$20240917$20240917$EXP$$CN-FreseniusKabi-FK202413826$FRESENIUS KABI$$43$YR$A$F$Y$43$KG$20240917$$HP$CN$CN
243282931$24328293$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3242575$TEVA$$$$$F$Y$$$20240917$$MD$CA$CA
243282942$24328294$2$F$20240801$20240912$20240917$20240920$EXP$$CA-SANDOZ INC.-SDZ2024CA080303$SANDOZ$$63$YR$$M$Y$$$20240920$$MD$CA$CA
243282951$24328295$1$I$$20240910$20240917$20240917$EXP$$HU-ROCHE-10000080336$ROCHE$$60$YR$A$M$Y$$$20240917$$MD$HU$HU
243282961$24328296$1$I$20240804$20240916$20240917$20240917$EXP$FR-AFSSAPS-AM2024000737$FR-SANDOZ INC.-SDZ2024FR080480$SANDOZ$$60$YR$$F$Y$80$KG$20240917$$PH$FR$FR
243282971$24328297$1$I$20240910$20240910$20240917$20240917$30DAY$$US-AMGEN-USASP2024181210$AMGEN$$58$YR$A$M$Y$100$KG$20240917$$PH$US$US
243282981$24328298$1$I$20240101$20240913$20240917$20240917$EXP$$US-ABBVIE-5925569$ABBVIE$$67$YR$$F$Y$$$20240917$$CN$US$US
243282991$24328299$1$I$20240601$20240909$20240917$20240917$EXP$$US-TEVA-VS-3147979$TEVA$$60$YR$$M$Y$$$20240917$$CN$US$US
243283001$24328300$1$I$20240101$20240903$20240917$20240917$EXP$$US-UCBSA-2024045304$UCB$$$$$F$Y$68.027$KG$20240917$$HP$US$US
243283011$24328301$1$I$20240501$20240828$20240917$20240917$PER$$US-TEVA-VS-3207338$TEVA$$61$YR$$M$Y$$$20240917$$CN$US$US
243283021$24328302$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001178US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243283032$24328303$2$F$$20240920$20240917$20240924$EXP$$US-BAYER-2024A130995$BAYER$$40$YR$A$M$Y$86.168$KG$20240924$$CN$US$US
243283041$24328304$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A209521$ASTRAZENECA$$$$$M$Y$$$20240917$$HP$US$
243283061$24328306$1$I$$20240912$20240917$20240917$PER$$US-AstraZeneca-2024A209631$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$US$
243283071$24328307$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A207839$ASTRAZENECA$$84$YR$$M$Y$104$KG$20240917$$CN$US$
243283081$24328308$1$I$$20240911$20240917$20240917$EXP$$JP-AstraZeneca-2024A209203$ASTRAZENECA$$62$YR$$M$Y$$$20240917$$MD$JP$
243283091$24328309$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A206628$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$US$
243283101$24328310$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A211023$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243283111$24328311$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A207594$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243283121$24328312$1$I$$20240911$20240917$20240917$PER$$US-AstraZeneca-2024A207737$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243283131$24328313$1$I$20240831$20240915$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120882$PFIZER$$75$YR$$M$Y$50$KG$20240917$$HP$CN$CN
243283141$24328314$1$I$20240805$20240912$20240917$20240917$EXP$$DE-PFIZER INC-202400255163$PFIZER$$76$YR$$M$Y$86.2$KG$20240917$$MD$DE$DE
243283151$24328315$1$I$20240830$20240912$20240917$20240917$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001862$BLUEPRINT MEDICINES$$90$YR$E$F$Y$$$20240917$$CN$US$US
243283161$24328316$1$I$20240809$20240909$20240917$20240917$EXP$ES-AEMPS-1565578$ES-TEVA-VS-3241858$TEVA$$79$YR$$M$Y$$$20240917$$MD$ES$ES
243283171$24328317$1$I$$20240913$20240917$20240917$EXP$$GB-BAYER-2024A131321$BAYER$$$$$M$Y$$$20240917$$HP$GB$GB
243283181$24328318$1$I$20240101$20240906$20240917$20240917$PER$$US-AMGEN-USASP2024182982$AMGEN$$65$YR$E$F$Y$$$20240917$$CN$US$US
243283191$24328319$1$I$$20240912$20240917$20240917$EXP$$CA-ROCHE-10000081566$ROCHE$$57$YR$A$F$Y$101$KG$20240917$$HP$CA$CA
243283201$24328320$1$I$20240912$20240912$20240917$20240917$EXP$$US-OTSUKA-2024_025713$OTSUKA$$$$$F$Y$$$20240917$$CN$US$US
243283211$24328321$1$I$$20240909$20240917$20240917$EXP$$CA-APOTEX-2024AP010355$APOTEX$$3$YR$$F$Y$16$KG$20240917$$HP$CA$CA
243283221$24328322$1$I$$20240913$20240917$20240917$PER$$US-BAYER-2024A131533$BAYER$$$$$$Y$$$20240917$$CN$US$US
243283232$24328323$2$F$$20240805$20240917$20240920$PER$$US-SMPA-2024SPA002176$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243283241$24328324$1$I$$20240916$20240917$20240917$EXP$$US-BIOVITRUM-2024-US-012121$BIOVITRUM$$4$MON$$M$Y$$$20240917$$HP$US$US
243283251$24328325$1$I$20230101$20240911$20240917$20240917$EXP$$FR-MYLANLABS-2024M1083943$MYLAN$$81$YR$$F$Y$50.2$KG$20240917$$MD$FR$FR
243283262$24328326$2$F$$20240917$20240917$20240923$EXP$$PT-MYLANLABS-2024M1083817$MYLAN$Antunes JH, De Brito SF, Silva TC, Picado B, Machado C, Araujo JL.. The two-in-one lymphoma patient. European Journal of Case Reports in Internal Medicine. 2024;11(1):765$66$YR$$M$Y$$$20240923$$HP$PT$PT
243283271$24328327$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084070$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$46$YR$$F$Y$$$20240917$$HP$IE$IE
243283291$24328329$1$I$20240910$20240913$20240917$20240917$PER$$US-BAUSCH-BL-2024-013857$BAUSCH AND LOMB$$77$YR$$M$Y$118.04$KG$20240917$$CN$US$US
243283301$24328330$1$I$$20240914$20240917$20240917$EXP$$IE-TAKEDA-2024TUS092183$TAKEDA$$$$$$Y$$$20240917$$CN$IE$IE
243283311$24328331$1$I$$20240915$20240917$20240917$EXP$$NVSC2024US184811$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
243283321$24328332$1$I$20230404$20240910$20240917$20240917$EXP$BE-JNJFOC-20230866283$BE-GSK-BE2024112724$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$BE$BE
243283331$24328333$1$I$$20240828$20240917$20240917$PER$$US-TEVA-VS-3239237$TEVA$$$$$F$Y$$$20240917$$CN$US$US
243283341$24328334$1$I$20240901$20240911$20240917$20240917$EXP$$FR-MYLANLABS-2024M1083626$MYLAN$$59$YR$$F$Y$$$20240917$$CN$FR$FR
243283361$24328336$1$I$$20240916$20240917$20240917$EXP$$ES-ABBVIE-5925715$ABBVIE$$$$$F$Y$$$20240917$$HP$ES$ES
243283381$24328338$1$I$20220721$20240906$20240917$20240917$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-22-022989$AKEBIA THERAPEUTICS$$84$YR$$F$Y$48.3$KG$20240917$$MD$JP$JP
243283392$24328339$2$F$$20240908$20240917$20240925$EXP$$TR-JNJFOC-20240934159$JOHNSON AND JOHNSON$$14$YR$T$$Y$$$20240925$$HP$TR$TR
243283401$24328340$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3243488$TEVA$$64$YR$$F$Y$$$20240917$$MD$CA$CA
243283411$24328341$1$I$$20240908$20240917$20240917$30DAY$$US-GSK-US2024AMR112307$GLAXOSMITHKLINE$$$$$M$Y$$$20240917$$CN$US$US
243283421$24328342$1$I$$20240912$20240917$20240917$EXP$$GB-SANDOZ INC.-NVSC2020GB009545$SANDOZ$$$$$M$Y$$$20240917$$CN$GB$GB
243283431$24328343$1$I$$20240916$20240917$20240917$PER$$US-BIOVITRUM-2024-US-012122$BIOVITRUM$$73$YR$$M$Y$$$20240917$$CN$US$US
243283441$24328344$1$I$$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024183225$AMGEN$$71$YR$E$M$Y$$$20240917$$CN$US$US
243283451$24328345$1$I$20240812$20240909$20240917$20240917$EXP$FR-AFSSAPS-TS2024000947$FR-TEVA-VS-3241996$TEVA$$64$YR$$M$Y$$$20240917$$MD$FR$FR
243283461$24328346$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084122$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$27$YR$$M$Y$$$20240917$$HP$IE$IE
243283491$24328349$1$I$20240701$20240910$20240917$20240917$EXP$$US-ABBVIE-5919546$ABBVIE$$73$YR$$F$Y$$$20240917$$CN$US$US
243283502$24328350$2$F$$20240918$20240917$20240926$PER$$US-ABBVIE-5919973$ABBVIE$$19$YR$$$Y$$$20240926$$PH$US$US
243283511$24328351$1$I$20240913$20240916$20240917$20240917$PER$$US-BAYER-2024A132240$BAYER$$60$YR$A$F$Y$$$20240917$$CN$US$US
243283521$24328352$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009351$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240917$$CN$US$US
243283531$24328353$1$I$20240912$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009083$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240917$$CN$US$US
243283541$24328354$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009278$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243283551$24328355$1$I$$20240913$20240917$20240917$EXP$$CA-TAKEDA-2022TUS001020$TAKEDA$$$$$M$Y$$$20240917$$CN$CA$CA
243283561$24328356$1$I$20240601$20240909$20240917$20240917$PER$$US-ABBVIE-5915997$ABBVIE$$66$YR$$F$Y$$$20240917$$CN$US$US
243283581$24328358$1$I$$20240912$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146231$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240917$$HP$US$US
243283591$24328359$1$I$20240610$20240821$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-127038$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240917$$HP$US$US
243283601$24328360$1$I$$20240906$20240917$20240917$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001331$AKEBIA THERAPEUTICS$$92$YR$$M$Y$58$KG$20240917$$MD$JP$JP
243283612$24328361$2$F$$20240924$20240917$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143770$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240925$$CN$US$US
243283621$24328362$1$I$20210301$20240912$20240917$20240917$PER$$US-ORGANON-O2409USA001048$ORGANON$$21$YR$$F$Y$82.1$KG$20240917$$CN$US$US
243283632$24328363$2$F$$20240919$20240917$20240927$PER$$US-GSK-US2024046681$GLAXOSMITHKLINE$$$$$F$Y$46.712$KG$20240927$$CN$US$US
243283641$24328364$1$I$$20240909$20240917$20240917$EXP$$US-JNJFOC-20240934063$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240917$$CN$US$US
243283651$24328365$1$I$$20240913$20240917$20240917$EXP$$JP-JNJFOC-20240942409$JOHNSON AND JOHNSON$$86$YR$E$F$Y$37$KG$20240917$$MD$JP$JP
243283661$24328366$1$I$$20240913$20240917$20240917$PER$$NVSC2024US185096$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
243283671$24328367$1$I$20220101$20240821$20240917$20240917$PER$$US-009507513-2408USA007427$MERCK$Siqueira do Amaral P, Mohan SR, Beckermann KE. Von Hippel-Lindau syndrome-related congenital polycythemia and response to belzutifan. Haematologica. 2024$30$YR$$F$Y$$$20240917$$HP$US$US
243283681$24328368$1$I$$20240911$20240917$20240917$EXP$$GB-AstraZeneca-2024A209679$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$GB$
243283691$24328369$1$I$$20240912$20240917$20240917$EXP$$CO-AstraZeneca-2024A210570$ASTRAZENECA$$$$$F$Y$55$KG$20240917$$CN$CO$
243283701$24328370$1$I$20240907$20240911$20240917$20240917$EXP$$CN-AstraZeneca-2024A208681$ASTRAZENECA$$69$YR$$F$Y$70$KG$20240917$$MD$CN$
243283711$24328371$1$I$$20240910$20240917$20240917$PER$$US-APOTEX-2024AP010780$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240917$$HP$US$US
243283722$24328372$2$F$20240901$20240916$20240917$20240919$PER$$US-PFIZER INC-PV202400121524$PFIZER$$78$YR$$M$Y$$$20240919$$CN$US$US
243283731$24328373$1$I$$20240905$20240917$20240917$EXP$$JP-EMD Serono-2024048785$EMD SERONO INC$$45$YR$A$M$Y$87$KG$20240917$$MD$JP$JP
243283751$24328375$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-PV202400121402$PFIZER$$49$YR$$F$Y$$$20240917$$HP$US$US
243283761$24328376$1$I$20240914$20240916$20240917$20240917$PER$$US-PFIZER INC-202400257891$PFIZER$$19$YR$$F$Y$$$20240917$$CN$US$US
243283771$24328377$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-PV202400121421$PFIZER$$64$YR$$F$Y$$$20240917$$HP$US$US
243283781$24328378$1$I$$20240912$20240917$20240917$PER$$US-PFIZER INC-202400255508$PFIZER$$$$$F$Y$$$20240917$$CN$US$US
243283791$24328379$1$I$$20240913$20240917$20240917$PER$$US-PFIZER INC-202400256748$PFIZER$$89$YR$$F$Y$67.59$KG$20240917$$CN$US$US
243283801$24328380$1$I$20240903$20240916$20240917$20240917$PER$$US-PFIZER INC-202400257472$PFIZER$$$$C$M$Y$$$20240917$$MD$US$US
243283811$24328381$1$I$20240914$20240916$20240917$20240917$PER$$US-PFIZER INC-202400257779$PFIZER$$65$YR$$F$Y$$$20240917$$CN$US$US
243283821$24328382$1$I$20240915$20240916$20240917$20240917$PER$$US-PFIZER INC-202400257665$PFIZER$$71$YR$$M$Y$$$20240917$$CN$US$US
243283831$24328383$1$I$20240916$20240916$20240917$20240917$PER$$US-PFIZER INC-202400257693$PFIZER$$70$YR$$M$Y$$$20240917$$CN$US$US
243283841$24328384$1$I$20240912$20240913$20240917$20240917$PER$$US-PFIZER INC-202400256234$PFIZER$$80$YR$$M$Y$$$20240917$$CN$US$US
243283851$24328385$1$I$20240915$20240916$20240917$20240917$PER$$US-PFIZER INC-202400257863$PFIZER$$45$YR$$M$Y$$$20240917$$CN$US$US
243283861$24328386$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-PV202400121428$PFIZER$$46$YR$$F$Y$$$20240917$$HP$US$US
243283871$24328387$1$I$20240801$20240916$20240917$20240917$PER$$US-PFIZER INC-202400257470$PFIZER$$40$YR$$M$Y$$$20240917$$MD$US$US
243283881$24328388$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-202400086478$PFIZER$$93$YR$$F$Y$$$20240917$$CN$US$US
243283891$24328389$1$I$20240909$20240912$20240917$20240917$PER$$US-PFIZER INC-202400255822$PFIZER$$40$YR$$F$Y$$$20240917$$CN$US$US
243283901$24328390$1$I$$20240912$20240917$20240917$PER$$US-PFIZER INC-202400255985$PFIZER$$$$A$F$Y$$$20240917$$CN$US$US
243283921$24328392$1$I$20231101$20240911$20240917$20240917$EXP$$US-ABBVIE-5921555$ABBVIE$$43$YR$$F$Y$$$20240917$$CN$US$US
243283931$24328393$1$I$20240912$20240916$20240917$20240917$PER$$US-ABBVIE-5925963$ABBVIE$$$$$M$Y$$$20240917$$HP$US$US
243283941$24328394$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-PV202400121281$PFIZER$$63$YR$$F$Y$$$20240917$$HP$US$US
243283951$24328395$1$I$20240914$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184837$AMGEN$$$$$M$Y$$$20240917$$CN$US$US
243283961$24328396$1$I$20240101$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024183961$AMGEN$$$$A$F$Y$$$20240917$$HP$US$US
243283971$24328397$1$I$$20240905$20240917$20240917$PER$$US-RDY-SPO/USA/24/0013302$DR REDDYS$Pacilio RM, Dalack GW. Asthma and Atypical Antipsychotics: A Systematic Literature Review and Case Report of Respiratory Side Effects with Lurasidone, Cariprazine, and Lumateperone. Journal of Clinical Psychopharmacology. 2024 Jul 01;44(4): 436-437.$24$YR$A$M$Y$$$20240917$$MD$US$US
243283981$24328398$1$I$20240912$20240916$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147206$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240917$$CN$US$US
243284011$24328401$1$I$$20240913$20240917$20240917$PER$$US-BIOGEN-2024BI01282615$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
243284021$24328402$1$I$$20240906$20240917$20240917$EXP$$JP-KERYX BIOPHARMACEUTICALS INC.-JP-AKEB-24-001330$AKEBIA THERAPEUTICS$$94$YR$$F$Y$$$20240917$$MD$JP$JP
243284031$24328403$1$I$$20240916$20240917$20240917$EXP$$AR-PFIZER INC-202400257369$PFIZER$$54$YR$$F$Y$$$20240917$$CN$AR$AR
243284042$24328404$2$F$20240101$20240924$20240917$20240927$EXP$$CA-PFIZER INC-202400059465$PFIZER$$69$YR$$F$Y$$$20240927$$HP$CA$CA
243284051$24328405$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5923699$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243284061$24328406$1$I$20240101$20240909$20240917$20240917$EXP$$US-TEVA-VS-3242871$TEVA$$16$YR$$M$Y$$$20240917$$HP$US$US
243284082$24328408$2$F$20240907$20240919$20240917$20240926$EXP$$US-ABBVIE-5923608$ABBVIE$$75$YR$$F$Y$$$20240926$$CN$US$US
243284091$24328409$1$I$20240101$20240912$20240917$20240917$EXP$$US-ABBVIE-5923614$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243284101$24328410$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147301$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$103.87$KG$20240917$$CN$US$US
243284111$24328411$1$I$20240912$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184960$AMGEN$$64$YR$A$M$Y$$$20240917$$CN$US$US
243284121$24328412$1$I$20240911$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024185228$AMGEN$$59$YR$A$F$Y$$$20240917$$CN$US$US
243284131$24328413$1$I$$20240912$20240917$20240917$EXP$$CA-MYLANLABS-2024M1083654$MYLAN$$$$$F$Y$$$20240917$$HP$CA$CA
243284141$24328414$1$I$$20240910$20240917$20240917$PER$$US-APOTEX-2024AP010787$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240917$$HP$US$US
243284151$24328415$1$I$20240701$20240913$20240917$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015159$JAZZ$$29$YR$$F$Y$$$20240917$$CN$US$US
243284161$24328416$1$I$$20240701$20240917$20240917$PER$$US-ROCHE-10000022643$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243284181$24328418$1$I$20231001$20240910$20240917$20240917$EXP$DE-BFARM-24006100$DE-TEVA-VS-3242263$TEVA$$54$YR$$F$Y$52$KG$20240917$$MD$DE$DE
243284201$24328420$1$I$20221019$20240909$20240917$20240917$EXP$$CA-RDY-SPO/CAN/22/0156358$DR REDDYS$$89$YR$E$F$Y$$$20240917$$HP$CA$CA
243284214$24328421$4$F$$20240910$20240917$20240919$PER$$US-ROCHE-10000078104$ROCHE$$$$C$M$Y$30.84$KG$20240919$$CN$US$US
243284221$24328422$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147138$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$HP$US$US
243284231$24328423$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147211$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240917$$CN$US$US
243284241$24328424$1$I$20231004$20240912$20240917$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147532$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240917$$MD$JP$JP
243284251$24328425$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147300$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240917$$HP$US$US
243284261$24328426$1$I$$20240904$20240917$20240917$PER$$PR-JNJFOC-20240911322$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$MD$PR$PR
243284271$24328427$1$I$$20240913$20240917$20240917$PER$$US-JNJFOC-20240935896$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243284281$24328428$1$I$20230814$20240909$20240917$20240917$EXP$PT-INFARMED-R202408-843$PT-FreseniusKabi-FK202413706$FRESENIUS KABI$$48$YR$A$M$Y$$$20240917$$PH$PT$PT
243284291$24328429$1$I$20240518$20240905$20240917$20240917$EXP$$CA-GILEAD-2024-0679230$GILEAD$$52$YR$A$F$Y$$$20240917$$CN$CA$CA
243284302$24328430$2$F$$20240916$20240917$20240923$PER$$US-ROCHE-10000082682$ROCHE$$68$YR$E$F$Y$$$20240923$$CN$US$US
243284311$24328431$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000082681$ROCHE$$$$E$F$Y$$$20240917$$CN$US$US
243284321$24328432$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210027$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243284331$24328433$1$I$20240905$20240916$20240917$20240917$EXP$$US-AstraZeneca-2024A211834$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243284341$24328434$1$I$$20240910$20240917$20240917$EXP$$JP-AstraZeneca-2024A194507$ASTRAZENECA$$$$$$Y$$$20240917$$MD$JP$
243284351$24328435$1$I$$20240912$20240917$20240917$EXP$$CA-MYLANLABS-2024M1083635$MYLAN$$$$$M$Y$$$20240917$$MD$CA$CA
243284361$24328436$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000082877$ROCHE$$$$A$F$Y$$$20240917$$CN$US$US
243284371$24328437$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009212$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240917$$CN$US$US
243284381$24328438$1$I$$20240914$20240917$20240917$30DAY$$US-ELI_LILLY_AND_COMPANY-US202409009635$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240917$$CN$US$US
243284392$24328439$2$F$20240801$20240910$20240917$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409007411$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240919$$CN$US$US
243284401$24328440$1$I$$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409007520$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240917$$CN$US$US
243284411$24328441$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009289$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240917$$CN$US$US
243284421$24328442$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009264$ELI LILLY AND CO$$23$YR$A$M$Y$$$20240917$$CN$US$US
243284432$24328443$2$F$20240911$20240925$20240917$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409010323$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240929$$CN$US$US
243284441$24328444$1$I$20240915$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009727$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240917$$CN$US$US
243284461$24328446$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000083281$ROCHE$$$$E$F$Y$$$20240917$$CN$US$US
243284471$24328447$1$I$$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409007606$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240917$$CN$US$US
243284481$24328448$1$I$$20240911$20240917$20240917$PER$$US-HALEON-2196976$Haleon PLC$$$$$F$Y$$$20240917$$CN$US$US
243284491$24328449$1$I$20240824$20240914$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120820$PFIZER$$56$YR$$M$Y$82$KG$20240917$$HP$CN$CN
243284501$24328450$1$I$20240101$20240910$20240917$20240917$PER$$US-KARYOPHARM-2024KPT001530$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240917$$CN$US$US
243284511$24328451$1$I$$20240909$20240917$20240917$EXP$$GB-TEVA-VS-3242119$TEVA$$59$YR$$M$Y$$$20240917$$CN$GB$GB
243284521$24328452$1$I$$20240909$20240917$20240917$EXP$GB-MHRA-MED-202409091411035560-QNMSL$GB-TEVA-VS-3242293$TEVA$$60$YR$$M$Y$$$20240917$$PH$GB$GB
243284531$24328453$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147730$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240917$$CN$US$US
243284541$24328454$1$I$20240101$20240909$20240917$20240917$EXP$$US-TEVA-VS-3243602$TEVA$$19$YR$$M$Y$$$20240917$$HP$US$US
243284551$24328455$1$I$$20240910$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145151$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240917$$HP$US$US
243284581$24328458$1$I$20240913$20240913$20240917$20240917$PER$$US-BAYER-2024A132475$BAYER$$82$YR$E$$Y$$$20240917$$HP$US$US
243284591$24328459$1$I$$20240904$20240917$20240917$EXP$$AT-MYLANLABS-2024M1081846$MYLAN$$19$YR$$M$Y$$$20240917$$CN$AT$AT
243284601$24328460$1$I$$20240828$20240917$20240917$PER$$US-TEVA-VS-3238199$TEVA$$$$$$Y$$$20240917$$CN$US$US
243284621$24328462$1$I$$20240916$20240917$20240917$EXP$$US-SANDOZ INC.-SDZ2024US080566$SANDOZ$$5$YR$$F$Y$$$20240917$$MD$US$US
243284631$24328463$1$I$$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409051036517840-DLRZS$GB-GLENMARK PHARMACEUTICALS-2024GMK093911$GLENMARK$$$$$$Y$$$20240917$$CN$GB$GB
243284641$24328464$1$I$20240501$20240912$20240917$20240917$PER$$US-AMGEN-USASL2024182963$AMGEN$$$$$$Y$$$20240917$$HP$US$US
243284651$24328465$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3242884$TEVA$$45$YR$$F$Y$$$20240917$$HP$CA$CA
243284671$24328467$1$I$$20240916$20240917$20240917$EXP$$CZ-SANDOZ INC.-SDZ2024CZ080341$SANDOZ$$64$YR$$M$Y$$$20240917$$HP$CZ$CZ
243284681$24328468$1$I$20180101$20240912$20240917$20240917$EXP$$RU-PFIZER INC-PV202400119785$PFIZER$$49$YR$$F$Y$$$20240917$$MD$RU$RU
243284701$24328470$1$I$$20240910$20240917$20240917$EXP$$US-VERTEX PHARMACEUTICALS-2024-014444$VERTEX$$$$$$Y$$$20240917$$CN$US$US
243284712$24328471$2$F$$20240919$20240917$20240925$EXP$$US-VERTEX PHARMACEUTICALS-2024-014475$VERTEX$$$$$$Y$$$20240925$$CN$US$US
243284721$24328472$1$I$$20240910$20240917$20240917$PER$$US-VERTEX PHARMACEUTICALS-2024-014445$VERTEX$$$$$$Y$$$20240917$$CN$US$US
243284732$24328473$2$F$20240721$20240918$20240917$20240926$PER$$US-VERTEX PHARMACEUTICALS-2024-014432$VERTEX$$11$YR$$M$Y$$$20240926$$HP$US$US
243284742$24328474$2$F$20240101$20240917$20240917$20240925$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014588$VERTEX$$$$$F$Y$$$20240925$$CN$GB$GB
243284751$24328475$1$I$$20240905$20240917$20240917$PER$$US-VERTEX PHARMACEUTICALS-2024-014320$VERTEX$$$$$F$Y$$$20240917$$HP$US$US
243284761$24328476$1$I$20240801$20240910$20240917$20240917$EXP$$US-VERTEX PHARMACEUTICALS-2024-014543$VERTEX$$27$YR$$M$Y$$$20240917$$CN$US$US
243284771$24328477$1$I$$20240910$20240917$20240917$EXP$$US-VERTEX PHARMACEUTICALS-2024-014465$VERTEX$$$$$F$Y$$$20240917$$CN$US$US
243284791$24328479$1$I$$20240909$20240917$20240917$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014500$VERTEX$$$$$M$Y$$$20240917$$CN$GB$GB
243284801$24328480$1$I$$20240909$20240917$20240917$EXP$$CL-VERTEX PHARMACEUTICALS-2024-014491$VERTEX$$$$$$Y$$$20240917$$MD$CL$CL
243284811$24328481$1$I$$20240911$20240917$20240917$PER$$US-VERTEX PHARMACEUTICALS-2024-014567$VERTEX$$26$YR$$F$Y$$$20240917$$CN$US$US
243284822$24328482$2$F$20240808$20240918$20240917$20240923$PER$$US-VERTEX PHARMACEUTICALS-2024-014433$VERTEX$$9$YR$$M$Y$$$20240923$$HP$US$US
243284831$24328483$1$I$20240101$20240911$20240917$20240917$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014532$VERTEX$$$$A$M$Y$$$20240917$$CN$GB$GB
243284841$24328484$1$I$$20240909$20240917$20240917$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014494$VERTEX$Clarke E, Gardner J, Gillgrass L, Peckham D, Meng X, Naisbitt D.. Characterisation of liver-derived T-cells during and upon resolution of CFTR modulator induced liver injury. Toxicol Lett. 2024;399:S234$$$$$Y$$$20240917$$HP$GB$GB
243284851$24328485$1$I$20231101$20240904$20240917$20240917$EXP$$DE-NORDICGR-057369$NORDIC PHARMA$$67$YR$$M$Y$$$20240912$$MD$DE$DE
243284861$24328486$1$I$20240813$20240910$20240917$20240917$EXP$$US-VERTEX PHARMACEUTICALS-2024-013770$VERTEX$$22$YR$$M$Y$$$20240917$$HP$US$US
243284871$24328487$1$I$20240614$20240913$20240917$20240917$EXP$$CN-FreseniusKabi-FK202413843$FRESENIUS KABI$$13$YR$T$M$Y$45$KG$20240917$$HP$CN$CN
243284881$24328488$1$I$20240630$20240909$20240917$20240917$PER$$US-RDY-SPO/USA/24/0013383$DR REDDYS$$20$YR$A$F$Y$63$KG$20240917$$CN$US$US
243284891$24328489$1$I$20230807$20240909$20240917$20240917$EXP$ES-AEMPS-1566328$ES-TEVA-VS-3241971$TEVA$$68$YR$$M$Y$$$20240917$$MD$ES$ES
243284901$24328490$1$I$$20240913$20240917$20240917$EXP$$US-ABBVIE-5923474$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243284911$24328491$1$I$20240912$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184828$AMGEN$$89$YR$E$M$Y$$$20240917$$CN$US$US
243284921$24328492$1$I$20240916$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184637$AMGEN$$53$YR$A$F$Y$$$20240917$$CN$US$US
243284931$24328493$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001173US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243284981$24328498$1$I$$20240914$20240917$20240917$PER$$US-BAYER-2024A131993$BAYER$$$$$$Y$$$20240917$$CN$US$US
243284991$24328499$1$I$$20240910$20240917$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2024112641$VIIV$$$$$$Y$$$20240917$$CN$US$US
243285001$24328500$1$I$20240909$20240909$20240917$20240917$EXP$$GB-TEVA-VS-3242333$TEVA$$72$YR$$F$Y$60$KG$20240917$$HP$GB$GB
243285011$24328501$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084131$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$48$YR$$F$Y$$$20240917$$HP$IE$IE
243285021$24328502$1$I$20240101$20240822$20240917$20240917$EXP$$US-SA-2024SA266682$SANOFI AVENTIS$$59$YR$A$M$Y$146.82$KG$20240917$$MD$US$US
243285031$24328503$1$I$20240113$20240909$20240917$20240917$EXP$IT-MINISAL02-1000710$IT-TEVA-VS-3242051$TEVA$$84$YR$$M$Y$$$20240917$$MD$IT$IT
243285041$24328504$1$I$20240913$20240913$20240917$20240917$PER$$US-HALEON-2196911$Haleon PLC$$$$$$Y$$$20240917$$CN$US$US
243285061$24328506$1$I$$20240905$20240917$20240917$EXP$$NVSC2024US183677$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
243285071$24328507$1$I$20240906$20240909$20240917$20240917$EXP$$GB-TEVA-VS-3242103$TEVA$$55$YR$$M$Y$65$KG$20240917$$MD$GB$GB
243285091$24328509$1$I$$20240913$20240917$20240917$PER$$US-BAYER-2024A131989$BAYER$$43$YR$A$F$Y$$$20240917$$CN$US$US
243285101$24328510$1$I$$20240910$20240917$20240917$EXP$$BR-GSK-BR2024AMR112687$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$BR$BR
243285111$24328511$1$I$$20240904$20240917$20240917$EXP$$US-SA-2024SA265183$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240917$$CN$US$US
243285121$24328512$1$I$$20240908$20240917$20240917$EXP$$US-JNJFOC-20240919381$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240917$$CN$US$US
243285131$24328513$1$I$20240911$20240912$20240917$20240917$PER$$US-JNJFOC-20240938623$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240917$$CN$US$US
243285141$24328514$1$I$20240820$20240912$20240917$20240917$EXP$$EG-REGENERON PHARMACEUTICALS, INC.-2024-124284$REGENERON$$49$YR$$F$Y$$$20240917$$MD$EG$EG
243285151$24328515$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210391$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243285162$24328516$2$F$$20240909$20240917$20240919$EXP$$US-AMGEN-USASP2024181997$AMGEN$$$$$F$Y$$$20240919$$CN$US$US
243285171$24328517$1$I$20240913$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024185061$AMGEN$$79$YR$E$F$Y$$$20240917$$CN$US$US
243285191$24328519$1$I$$20240911$20240917$20240917$EXP$$CA-ABBVIE-5921874$ABBVIE$$$$E$M$Y$$$20240917$$CN$CA$CA
243285201$24328520$1$I$20100101$20240909$20240917$20240917$EXP$$GB-AstraZeneca-2024A211254$ASTRAZENECA$Grice S, Hammond S, Hampson L, Wagner A, Naisbitt DJ.. Omeprazole-Associated Atypical Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in a Patient with Positive In VitroDiagnostic Testing to Multiple Proton Pump Inhibitors .. Chem. Res. Toxicol.$62$YR$$M$Y$$$20240917$$HP$GB$
243285211$24328521$1$I$20240101$20240912$20240917$20240917$EXP$$US-ABBVIE-5923755$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243285221$24328522$1$I$20170101$20240911$20240917$20240917$EXP$$US-ABBVIE-5919953$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243285242$24328524$2$F$20211212$20220623$20240917$20240919$EXP$$IN-PFIZER INC-PV202200009117$PFIZER$$51$YR$$M$Y$$$20240919$$CN$IN$IN
243285251$24328525$1$I$$20240911$20240917$20240917$EXP$$BR-ABBVIE-5922023$ABBVIE$$$$$F$Y$$$20240917$$CN$BR$BR
243285261$24328526$1$I$20240501$20240910$20240917$20240917$EXP$$AR-SA-2024SA267493$SANOFI AVENTIS$$$$$F$Y$$$20240917$$MD$AR$AR
243285271$24328527$1$I$20240101$20240910$20240917$20240917$EXP$$US-SA-2024SA266001$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240917$$HP$US$US
243285281$24328528$1$I$$20240909$20240917$20240917$EXP$$US-RDY-SPO/USA/24/0013503$DR REDDYS$Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Huang BJ, et al. Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies. Pediatric Blood and Cancer. 2023 Jun;70(6): doi:10.1002/pbc.30335.$17$YR$T$F$Y$$$20240917$$HP$US$US
243285291$24328529$1$I$$20240905$20240917$20240917$PER$$US-RDY-SPO/USA/24/0013272$DR REDDYS$$25$YR$A$M$Y$107$KG$20240917$$CN$US$US
243285301$24328530$1$I$$20240910$20240917$20240917$PER$$US-RDY-SPO/USA/24/0013334$DR REDDYS$$47$YR$A$F$Y$$$20240917$$MD$US$US
243285311$24328531$1$I$$20240910$20240917$20240917$PER$$US-RDY-SPO/USA/24/0013366$DR REDDYS$$57$YR$A$M$Y$$$20240917$$MD$US$US
243285321$24328532$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147297$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240917$$CN$US$US
243285331$24328533$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147195$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240917$$CN$US$US
243285341$24328534$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147772$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$75.75$KG$20240917$$CN$US$US
243285351$24328535$1$I$$20240906$20240917$20240917$PER$$US-RDY-SPO/USA/24/0013402$DR REDDYS$Smith A, Wong-O^Brien B, Lieberman JA, Cookson BT, Cookson BT, Grinager E, et al. The Brief Case: A case of tinea corporis caused by drug-resistant Trichophyton indotineae identified by broad-range fungal DNA sequencing. Journal of Clinical Microbiology. 2024;62(8): doi:10.1128/jcm.00234-24.$36$YR$A$F$Y$$$20240917$$HP$US$US
243285361$24328536$1$I$20240817$20240911$20240917$20240917$EXP$FR-AFSSAPS-TO2024001718$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-144980$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240917$$PH$FR$FR
243285371$24328537$1$I$$20240828$20240917$20240917$PER$$US-TEVA-VS-3238167$TEVA$$$$$F$Y$$$20240917$$HP$US$US
243285382$24328538$2$F$20240914$20240926$20240917$20240930$PER$$US-AMGEN-USASP2024185035$AMGEN$$77$YR$E$F$Y$$$20240928$$HP$US$US
243285391$24328539$1$I$20240906$20240913$20240917$20240917$EXP$$CN-SA-2024SA267583$SANOFI AVENTIS$$71$YR$E$M$Y$80$KG$20240917$$HP$CN$CN
243285401$24328540$1$I$20240906$20240909$20240917$20240917$30DAY$$US-AMGEN-USASP2024180029$AMGEN$$73$YR$E$M$Y$94.1$KG$20240917$$HP$US$US
243285411$24328541$1$I$$20240912$20240917$20240917$PER$$US-BAYER-2024A131100$BAYER$$$$$$Y$$$20240917$$CN$US$US
243285421$24328542$1$I$$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409010335$ELI LILLY AND CO$$$$$M$Y$$$20240917$$CN$US$US
243285431$24328543$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008331$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240917$$CN$US$US
243285441$24328544$1$I$20240911$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008410$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240917$$CN$US$US
243285451$24328545$1$I$20240801$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009555$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240917$$CN$US$US
243285461$24328546$1$I$20240911$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008266$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240917$$CN$US$US
243285491$24328549$1$I$20190814$20240911$20240917$20240917$EXP$$BR-ABBVIE-5922928$ABBVIE$$47$YR$$M$Y$$$20240917$$MD$BR$BR
243285501$24328550$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147722$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240917$$CN$US$US
243285511$24328551$1$I$$20240910$20240917$20240917$EXP$$AT-JNJFOC-20240929609$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240917$$MD$AT$AT
243285521$24328552$1$I$$20240912$20240917$20240917$EXP$$CA-MYLANLABS-2024M1083660$MYLAN$$62$YR$$F$Y$103$KG$20240917$$MD$CA$CA
243285531$24328553$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS092191$TAKEDA$$$$$F$Y$43.08$KG$20240917$$MD$US$US
243285541$24328554$1$I$$20240912$20240917$20240917$EXP$$CA-009507513-2409CAN005179$MERCK$$54$YR$$M$Y$$$20240917$$MD$CA$CA
243285551$24328555$1$I$20240509$20240913$20240917$20240917$EXP$$GB-MYLANLABS-2024M1083751$MYLAN$$85$YR$$F$Y$$$20240917$$MD$GB$GB
243285561$24328556$1$I$20240913$20240917$20240917$20240917$DIR$718692$$FDA-CTU$$31$YR$$M$N$79.5$KG$20240917$N$PH$US$
243285571$24328557$1$I$$20240906$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009500$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243285581$24328558$1$I$$20240912$20240917$20240917$EXP$$CA-MYLANLABS-2024M1083757$MYLAN$$49$YR$$F$Y$72$KG$20240917$$HP$CA$CA
243285611$24328561$1$I$$20240917$20240917$20240917$DIR$718696$$FDA-CTU$$$$$UNK$N$$$20240917$$CN$US$
243285641$24328564$1$I$$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024183055$AMGEN$$$$$M$Y$$$20240917$$CN$US$US
243285652$24328565$2$F$$20240923$20240917$20240926$EXP$$US-UCBSA-2024047535$UCB$Romero KN, O^Brein MC, Agarwal A, Hasan I. Creatine Kinase Surge: Levetiracetam-Induced Rhabdomyolysis. Cureus. 2024;16(8):1-5$27$YR$$M$Y$$$20240926$$MD$US$US
243285661$24328566$1$I$$20240906$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009499$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243285671$24328567$1$I$20240905$20240910$20240917$20240917$EXP$$US-ALKERMES INC.-ALK-2024-002373$ALKERMES$$43$YR$$F$Y$$$20240917$$CN$US$US
243285681$24328568$1$I$20240312$20240911$20240917$20240917$EXP$$CA-TAKEDA-2024TUS024815$TAKEDA$$70$YR$$M$Y$$$20240917$$CN$CA$CA
243285691$24328569$1$I$$20240909$20240917$20240917$EXP$$JP-Taiho Oncology Inc-2024-008588$TAIHO ONCOLOGY INC$Shiraishi Y, et al. A Case of Posterior Reversible Encephalopathy Syndrome After Treatment for Postrenal Failure Which Concurrently Developed During Chemotherapy for Rectal Cancer (translated by Taiho, original title in Japanese). Proceedings of the 694th Kanto Regional Meeting of the Japanese Society of Internal Medicine (the 694th Kanto Regional Meeting of the Japanese Society of Internal Medicine) (hybrid event). 2024 January 01;:51.$70$YR$E$F$Y$$$20240917$$HP$JP$JP
243285701$24328570$1$I$20240729$20240911$20240917$20240917$EXP$IT-MINISAL02-1001344$IT-MYLANLABS-2024M1083617$MYLAN$$18$YR$$F$Y$$$20240917$$MD$IT$IT
243285721$24328572$1$I$$20240906$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009493$INCYTE$$$$$$Y$$$20240917$$PH$US$US
243285731$24328573$1$I$20240308$20240913$20240917$20240917$PER$$US-APELLIS-2024-APL-0000302$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240917$$HP$US$US
243285741$24328574$1$I$$20240912$20240917$20240917$PER$$US-GILEAD-2024-0687566$GILEAD$$32$YR$A$M$Y$$$20240917$$HP$US$US
243285751$24328575$1$I$$20240906$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009472$INCYTE$$$$$$Y$$$20240917$$MD$US$US
243285762$24328576$2$F$$20240919$20240917$20240927$EXP$$US-TEVA-VS-3243012$TEVA$Blackmon J, Blackmon L, Goode C, Douthit N. Systemic Cobalt Toxicity Secondary to Metal-on-Metal Prosthetic Hip Replacement: a Case Report. J-Gen-Intern-Med 2024; 39 133-137; Blackmon J, Blackmon L, Goode C, Douthit N. Systemic Cobalt Toxicity Secondary to Metal-on-Metal Prosthetic Hip Replacement: a Case Report. J-Gen-Intern-Med 2024; 39 133-137.$58$YR$$M$Y$$$20240927$$MD$US$US
243285771$24328577$1$I$20231204$20240827$20240917$20240917$EXP$$KR-JNJFOC-20240251670$JOHNSON AND JOHNSON$$40$YR$A$M$Y$51.8$KG$20240917$$HP$KR$KR
243285781$24328578$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63658$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243285792$24328579$2$F$20231021$20240919$20240917$20240930$EXP$$KR-JNJFOC-20240239870$JOHNSON AND JOHNSON$$81$YR$E$F$Y$43$KG$20240930$$MD$KR$KR
243285801$24328580$1$I$$20240905$20240917$20240917$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18163$IPSEN$$$$$$Y$$$20240917$$HP$US$US
243285811$24328581$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63656$$FDA-CTU$$85$YR$$M$N$$$20240917$N$$US$
243285821$24328582$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63667$$FDA-CTU$$$$$M$N$90.7$KG$20240917$N$PH$US$
243285831$24328583$1$I$$20240916$20240917$20240917$PER$$US-JNJFOC-20240942862$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243285841$24328584$1$I$$20240906$20240917$20240917$PER$$US-AstraZeneca-2024A204790$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243285851$24328585$1$I$$20240905$20240917$20240917$PER$$US-TEVA-VS-3242014$TEVA$$12$YR$$M$Y$$$20240917$$CN$US$US
243285861$24328586$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63664$$FDA-CTU$$68$YR$$F$N$104.33$KG$20240917$N$$US$
243285871$24328587$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63668$$FDA-CTU$$78$YR$$M$N$$$20240917$N$$US$
243285881$24328588$1$I$20240916$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63663$$FDA-CTU$$7$YR$$F$N$$$20240917$N$$US$
243285891$24328589$1$I$$20240911$20240917$20240917$EXP$$JP-AstraZeneca-2024A206790$ASTRAZENECA$Shimbu K., Hisakane K., Kadoma N., Nishima S., Atsumi K., Seike M., Hirose T.. Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six- Case Series. OncoTargets and Therapy 2024;17:717-726.$70$YR$$F$Y$$$20240917$$HP$JP$
243285901$24328590$1$I$$20240911$20240917$20240917$EXP$$BR-AstraZeneca-2024A209743$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$BR$
243285911$24328591$1$I$$20240913$20240917$20240917$EXP$$DE-AstraZeneca-2024A210176$ASTRAZENECA$Burkhard-Meier C.; Beckmann L.; Nieper P. P.; Hallek M.; Boll B.; Frenzel L. P.. Secondary acute lymphoblastic leukemia in breast cancer patients treated with poly(ADP-ribose) polymerase inhibitors: A case series. 2024 Annual Meeting of the German, Austrian, Swiss Societies for Haematology and Medical Oncology (DGHO) 2024;$39$YR$$F$Y$$$20240917$$HP$DE$
243285921$24328592$1$I$20240820$20240904$20240917$20240917$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161711$JIANGSU HANSOH PHARMACEUTICAL$$74$YR$$M$Y$45$KG$20240917$$MD$CN$CN
243285931$24328593$1$I$$20240905$20240917$20240917$EXP$$ES-B.Braun Medical Inc.-2161707$B BRAUN$Literature Article$45$YR$$M$Y$$$20240917$$$ES$ES
243285951$24328595$1$I$20240516$20240916$20240917$20240917$EXP$FR-AFSSAPS-GR2024001061$FR-GSK-FR2024114744$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$PH$FR$FR
243285961$24328596$1$I$20240823$20240906$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009461$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243285971$24328597$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3242569$TEVA$$69$YR$$M$Y$70$KG$20240917$$HP$CA$CA
243285991$24328599$1$I$20240715$20240903$20240917$20240917$PER$$US-ALKERMES INC.-ALK-2024-002304$ALKERMES$$28$YR$$F$Y$89$KG$20240917$$MD$US$US
243286001$24328600$1$I$20240901$20240911$20240917$20240917$30DAY$$US-PFIZER INC-202400255139$PFIZER$$14$YR$$M$Y$$$20240917$$CN$US$US
243286011$24328601$1$I$20240825$20240909$20240917$20240917$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028662$UNITED THERAPEUTICS$$56$YR$$F$Y$73.469$KG$20240917$$$US$US
243286021$24328602$1$I$20220401$20240906$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009445$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243286031$24328603$1$I$20240801$20240905$20240917$20240917$EXP$$US-FARMAPROD-202409-3192$DOMPE FARMACEUTICI$$78$YR$E$F$Y$$$20240917$$CN$US$US
243286041$24328604$1$I$$20240912$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145731$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240917$$CN$US$US
243286051$24328605$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS091923$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243286061$24328606$1$I$20240913$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184153$AMGEN$$70$YR$E$M$Y$$$20240917$$CN$US$US
243286081$24328608$1$I$20230803$20240827$20240917$20240917$EXP$$KR-JNJFOC-20240455808$JOHNSON AND JOHNSON$$60$YR$A$F$Y$66$KG$20240917$$MD$KR$KR
243286091$24328609$1$I$20231212$20240827$20240917$20240917$EXP$$KR-JNJFOC-20240377819$JOHNSON AND JOHNSON$$61$YR$A$F$Y$51.3$KG$20240917$$MD$KR$KR
243286101$24328610$1$I$20101101$20240910$20240917$20240917$EXP$$AU-TAKEDA-2024TUS091663$TAKEDA$$45$YR$$F$Y$$$20240917$$MD$AU$AU
243286111$24328611$1$I$20240401$20240910$20240917$20240917$EXP$$AR-GSK-AR2024AMR060043$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$AR$AR
243286122$24328612$2$F$20030101$20240917$20240917$20240920$EXP$$FR-ORGANON-O2409FRA000663$ORGANON$$74$YR$$M$Y$87$KG$20240920$$CN$FR$NL
243286131$24328613$1$I$20231101$20240906$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009435$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243286141$24328614$1$I$20240901$20240904$20240917$20240917$PER$$US-ALKERMES INC.-ALK-2024-002333$ALKERMES$$53$YR$$M$Y$$$20240917$$HP$US$US
243286151$24328615$1$I$$20240904$20240917$20240917$PER$$US-ALKERMES INC.-ALK-2024-002305$ALKERMES$$$$$F$Y$$$20240917$$CN$US$US
243286162$24328616$2$F$$20240913$20240917$20240924$EXP$$CN-ROCHE-10000081198$ROCHE$Lou S, Wang X, Yuan F, Zhao G, Feng M, Ding Y, et al. Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy. Frontiers in Pharmacology. 2024-Jan;15: doi:10.3389/fphar.2024.1453595.$63$YR$A$$Y$$$20240924$$HP$CN$CN
243286191$24328619$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63669$$FDA-CTU$$57$YR$$F$N$$$20240917$N$$US$
243286201$24328620$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63674$$FDA-CTU$$67$YR$$M$N$$$20240917$N$$US$
243286211$24328621$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63670$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243286221$24328622$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63672$$FDA-CTU$$48$YR$$M$N$$$20240917$N$$US$
243286231$24328623$1$I$$20240909$20240917$20240917$EXP$SK-SUKLSK-20218950$SK-FreseniusKabi-FK202413764$FRESENIUS KABI$$$$$F$Y$$$20240917$$MD$SK$SK
243286241$24328624$1$I$$20240905$20240917$20240917$EXP$$TW-B.Braun Medical Inc.-2161713$B BRAUN$Literature Article$3$YR$$F$Y$13.6$KG$20240917$$$TW$TW
243286251$24328625$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS091925$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243286261$24328626$1$I$20240814$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63671$$FDA-CTU$$66$YR$$M$N$$$20240917$Y$HP$US$
243286272$24328627$2$F$$20240913$20240917$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009019$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240918$$CN$US$US
243286281$24328628$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63678$$FDA-CTU$$82$YR$$F$N$$$20240917$N$$US$
243286291$24328629$1$I$$20240905$20240917$20240917$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202409004262$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$MX$MX
243286301$24328630$1$I$$20240909$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409005294$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240917$$CN$US$US
243286311$24328631$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63657$$FDA-CTU$$55$YR$$F$N$$$20240917$N$$US$
243286321$24328632$1$I$20240701$20240905$20240917$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003770$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240917$$CN$US$US
243286331$24328633$1$I$$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409007480$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240917$$CN$US$US
243286341$24328634$1$I$20240803$20240905$20240917$20240917$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409003905$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240917$$CN$CN$CN
243286351$24328635$1$I$$20240912$20240917$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409008408$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240917$$CN$US$US
243286361$24328636$1$I$$20240905$20240917$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003677$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240917$$CN$US$US
243286371$24328637$1$I$$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409051210047080-WKVJZ$GB-ELI_LILLY_AND_COMPANY-GB202409004032$ELI LILLY AND CO$$49$YR$A$F$Y$90$KG$20240917$$CN$GB$GB
243286381$24328638$1$I$$20240911$20240917$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409007102$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240917$$CN$US$US
243286391$24328639$1$I$$20240904$20240917$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409004238$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240917$$CN$US$US
243286401$24328640$1$I$20240101$20240905$20240917$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003772$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240917$$CN$US$US
243286411$24328641$1$I$20160101$20240905$20240917$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003897$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240917$$CN$US$US
243286431$24328643$1$I$$20240905$20240917$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409004821$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243286461$24328646$1$I$20240405$20240828$20240917$20240917$EXP$$KR-JNJFOC-20240569709$JOHNSON AND JOHNSON$$83$YR$E$M$Y$57$KG$20240917$$MD$KR$KR
243286471$24328647$1$I$20240424$20240822$20240917$20240917$EXP$$KR-JNJFOC-20240513474$JOHNSON AND JOHNSON$$82$YR$E$M$Y$71.8$KG$20240917$$MD$KR$KR
243286481$24328648$1$I$20240101$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184849$AMGEN$$79$YR$E$F$Y$$$20240917$$CN$US$US
243286491$24328649$1$I$$20240910$20240917$20240917$EXP$$DE-TAKEDA-2024TUS060120$TAKEDA$$$$$$Y$$$20240917$$CN$DE$DE
243286501$24328650$1$I$20240905$20240905$20240917$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409004439$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240917$$CN$US$US
243286511$24328651$1$I$$20240905$20240917$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409004422$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243286521$24328652$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147535$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$85.28$KG$20240917$$CN$US$US
243286531$24328653$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146963$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240917$$CN$US$US
243286541$24328654$1$I$$20240912$20240917$20240917$EXP$$CA-ABBVIE-5924027$ABBVIE$$$$$F$Y$$$20240917$$CN$CA$CA
243286551$24328655$1$I$20231016$20240827$20240917$20240917$EXP$$KR-JNJFOC-20240673305$JOHNSON AND JOHNSON$$73$YR$E$M$Y$65$KG$20240917$$MD$KR$KR
243286561$24328656$1$I$$20240911$20240917$20240917$EXP$$US-JNJFOC-20240939805$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240917$$HP$US$US
243286571$24328657$1$I$20240501$20240912$20240917$20240917$PER$$US-JNJFOC-20240933105$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240917$$CN$US$US
243286581$24328658$1$I$20230904$20240823$20240917$20240917$EXP$$KR-JNJFOC-20240607014$JOHNSON AND JOHNSON$$61$YR$A$M$Y$62.5$KG$20240917$$MD$KR$KR
243286592$24328659$2$F$20240903$20240916$20240917$20240924$30DAY$$US-JNJFOC-20240919765$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240925$$CN$US$US
243286601$24328660$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A208162$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243286631$24328663$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS092006$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243286651$24328665$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001214US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240917$$CN$US$US
243286661$24328666$1$I$20240301$20240911$20240917$20240917$PER$$CA-Eisai-EC-2024-174343$EISAI$$68$YR$E$F$Y$89.3$KG$20240917$$CN$CA$CA
243286671$24328667$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146711$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240917$$CN$US$US
243286681$24328668$1$I$$20240917$20240917$20240917$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051771$BOEHRINGER INGELHEIM$$$$$$Y$$$20240917$$PH$JP$JP
243286691$24328669$1$I$20240822$20240911$20240917$20240917$PER$$US-RDY-SPO/USA/24/0012888$DR REDDYS$$40$YR$A$M$Y$$$20240917$$HP$US$US
243286711$24328671$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63679$$FDA-CTU$$62$YR$$M$N$$$20240917$N$$US$
243286721$24328672$1$I$20240620$20240917$20240917$20240917$DIR$718708$$FDA-CTU$$24$YR$$F$N$85.5$KG$20240917$$CN$US$
243286731$24328673$1$I$$20240914$20240917$20240917$PER$$NVSC2024US184737$NOVARTIS$$$$$$Y$$$20240917$$CN$US$US
243286741$24328674$1$I$20240722$20240916$20240917$20240917$EXP$HR-HALMED-300086544$NVSC2024HR184719$NOVARTIS$$37$YR$$M$Y$$$20240917$$MD$HR$HR
243286751$24328675$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3242568$TEVA$$28$YR$$F$Y$$$20240917$$PH$CA$CA
243286761$24328676$1$I$20240501$20240906$20240917$20240917$EXP$$JP-ROCHE-10000082415$ROCHE$$$$$M$Y$$$20240917$$CN$JP$JP
243286771$24328677$1$I$$20240910$20240917$20240917$PER$$US-JNJFOC-20240935491$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$CN$US$US
243286791$24328679$1$I$$20240909$20240917$20240917$EXP$$US-ALKERMES INC.-ALK-2024-002357$ALKERMES$$$$$M$Y$86.168$KG$20240917$$CN$US$US
243286811$24328681$1$I$$20240913$20240917$20240917$EXP$$US-BAUSCH-BL-2024-013879$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240917$$CN$US$US
243286821$24328682$1$I$20240719$20240913$20240917$20240917$EXP$$BE-BAUSCH-BL-2024-013846$BAUSCH AND LOMB$$$$$F$Y$$$20240917$$CN$BE$BE
243286842$24328684$2$F$20240911$20240923$20240917$20240925$PER$$US-AMGEN-USASP2024183978$AMGEN$$67$YR$E$F$Y$$$20240925$$CN$US$US
243286852$24328685$2$F$$20240917$20240917$20240925$EXP$$JP-MALLINCKRODT-MNK202405702$MALLINCKRODT$$71$YR$E$M$Y$$$20240925$$HP$JP$JP
243286861$24328686$1$I$$20240911$20240917$20240917$EXP$$NVSC2024KZ183741$NOVARTIS$$$$$F$Y$$$20240917$$MD$KZ$KZ
243286871$24328687$1$I$$20240914$20240917$20240917$EXP$$NVSC2024VN184667$NOVARTIS$$$$A$$Y$$$20240917$$MD$VN$VN
243286882$24328688$2$F$$20240923$20240917$20240926$EXP$$CA-BAUSCH-BL-2024-013691$BAUSCH AND LOMB$$43$YR$$F$Y$$$20240926$$MD$CA$CA
243286891$24328689$1$I$20240829$20240829$20240917$20240917$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000895$PAREXEL$$$$$$Y$$$20240917$$PH$US$US
243286901$24328690$1$I$20240101$20240911$20240917$20240917$EXP$$US-ABBVIE-5922076$ABBVIE$$$$$F$Y$$$20240917$$CN$US$MX
243286911$24328691$1$I$20240709$20240912$20240917$20240917$EXP$$JP-ABBVIE-5922027$ABBVIE$$40$YR$$M$Y$$$20240917$$MD$JP$JP
243286941$24328694$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922455$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243286961$24328696$1$I$20240801$20240830$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA052288$TOLMAR$$87$YR$$M$Y$$$20240917$$CN$CA$CA
243286971$24328697$1$I$$20240829$20240917$20240917$PER$$CA-TOLMAR, INC.-24CA052299$TOLMAR$$$$$M$Y$$$20240917$$CN$CA$CA
243286981$24328698$1$I$20240824$20240827$20240917$20240917$PER$$FR-TOLMAR, INC.-24FR052260$TOLMAR$$65$YR$$M$Y$$$20240917$$PH$FR$FR
243286991$24328699$1$I$20240827$20240827$20240917$20240917$PER$$FR-TOLMAR, INC.-24FR052261$TOLMAR$$86$YR$$M$Y$$$20240917$$PH$FR$FR
243287001$24328700$1$I$$20240827$20240917$20240917$PER$$TR-TOLMAR, INC.-24TR052227$TOLMAR$$$$$M$Y$$$20240917$$MD$TR$TR
243287011$24328701$1$I$20240827$20240827$20240917$20240917$PER$$TR-TOLMAR, INC.-24TR052258$TOLMAR$$91$YR$$M$Y$$$20240917$$HP$TR$TR
243287021$24328702$1$I$20240827$20240827$20240917$20240917$PER$$TR-TOLMAR, INC.-24TR052239$TOLMAR$$64$YR$$M$Y$$$20240917$$HP$TR$TR
243287031$24328703$1$I$20240822$20240827$20240917$20240917$PER$$US-TOLMAR, INC.-24US052245$TOLMAR$$83$YR$$M$Y$$$20240917$$PH$US$US
243287051$24328705$1$I$20240823$20240827$20240917$20240917$PER$$US-TOLMAR, INC.-24US052223$TOLMAR$$$$$$Y$$$20240917$$CN$US$US
243287061$24328706$1$I$$20240827$20240917$20240917$PER$$US-TOLMAR, INC.-24US052247$TOLMAR$$76$YR$$M$Y$$$20240917$$CN$US$US
243287071$24328707$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000082900$ROCHE$$$$I$M$Y$$$20240917$$CN$US$US
243287081$24328708$1$I$20240822$20240913$20240917$20240917$PER$$US-ROCHE-10000082779$ROCHE$$26$YR$A$M$Y$$$20240917$$CN$US$US
243287091$24328709$1$I$20240827$20240827$20240917$20240917$PER$$US-TOLMAR, INC.-24US052246$TOLMAR$$70$YR$$M$Y$$$20240917$$HP$US$US
243287101$24328710$1$I$20210501$20240913$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120375$PFIZER$Dong, H.. Traditional Chinese medicine treatment of severe cutaneous adverse reactions associated with dacomitinib. Journal of China-Japan Friendship Hospital. 2024;38(4):232-234$63$YR$$M$Y$$$20240917$$HP$CN$CN
243287111$24328711$1$I$20240804$20240913$20240917$20240917$EXP$DK-DKMA-30738661$DK-PFIZER INC-202400255860$PFIZER$$37$YR$$F$Y$$$20240917$$CN$DK$DK
243287121$24328712$1$I$20240813$20240911$20240917$20240917$EXP$$CN-ABBVIE-5918274$ABBVIE$$72$YR$$F$Y$$$20240917$$MD$CN$CN
243287131$24328713$1$I$20240411$20240913$20240917$20240917$EXP$FR-AFSSAPS-AN2024001250$FR-PFIZER INC-202400255873$PFIZER$$69$YR$$M$Y$$$20240917$$PH$FR$FR
243287141$24328714$1$I$20240910$20240913$20240917$20240917$EXP$$ZA-BIOVITRUM-2024-ZA-012126$BIOVITRUM$$171$DY$$M$Y$$$20240917$$CN$ZA$ZA
243287151$24328715$1$I$20240830$20240913$20240917$20240917$PER$$US-ROCHE-10000082802$ROCHE$$16$YR$T$M$Y$$$20240917$$CN$US$US
243287161$24328716$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001158US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243287171$24328717$1$I$$20240913$20240917$20240917$PER$$US-ROCHE-10000083226$ROCHE$$$$A$M$Y$$$20240917$$CN$US$US
243287181$24328718$1$I$20240910$20240913$20240917$20240917$PER$$US-ROCHE-10000082793$ROCHE$$20$YR$A$M$Y$$$20240917$$CN$US$US
243287191$24328719$1$I$$20240912$20240917$20240917$PER$$US-ROCHE-10000083056$ROCHE$$22$YR$A$M$Y$$$20240917$$CN$US$US
243287201$24328720$1$I$$20240916$20240917$20240917$PER$$US-ROCHE-10000083236$ROCHE$$$$A$M$Y$$$20240917$$CN$US$US
243287211$24328721$1$I$20210101$20240909$20240917$20240917$EXP$$SE-TEVA-VS-3242829$TEVA$$58$YR$$M$Y$$$20240917$$CN$SE$SE
243287221$24328722$1$I$20240601$20240913$20240917$20240917$PER$$US-GILEAD-2024-0687674$GILEAD$$65$YR$E$F$Y$69.1$KG$20240917$$HP$US$US
243287231$24328723$1$I$$20240909$20240917$20240917$EXP$$TH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050398$BOEHRINGER INGELHEIM$$66$YR$E$F$Y$$$20240917$$MD$TH$TH
243287241$24328724$1$I$20240823$20240912$20240917$20240917$EXP$$FR-AstraZeneca-2024A209702$ASTRAZENECA$$49$YR$$F$Y$$$20240917$$MD$FR$
243287251$24328725$1$I$$20240911$20240917$20240917$EXP$$FR-ABBVIE-5915654$ABBVIE$$$$E$M$Y$$$20240917$$MD$FR$FR
243287261$24328726$1$I$20240128$20240913$20240917$20240917$PER$$US-GILEAD-2024-0687680$GILEAD$$66$YR$E$M$Y$112.7$KG$20240917$$HP$US$US
243287281$24328728$1$I$20240905$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63675$$FDA-CTU$$76$YR$$F$N$$$20240917$Y$PH$US$
243287291$24328729$1$I$20240801$20240917$20240917$20240917$DIR$718710$$FDA-CTU$$20$YR$$F$N$53.1$KG$20240917$N$CN$US$
243287301$24328730$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63673$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243287311$24328731$1$I$$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409010329$ELI LILLY AND CO$$14$YR$T$M$Y$$$20240917$$CN$US$US
243287321$24328732$1$I$20240824$20240911$20240917$20240917$EXP$$CA-ABBVIE-5922175$ABBVIE$$49$YR$$M$Y$$$20240917$$HP$CA$CA
243287331$24328733$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63688$$FDA-CTU$$72$YR$$F$N$$$20240917$N$$US$
243287341$24328734$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922479$ABBVIE$$$$$$Y$$$20240914$$CN$US$US
243287351$24328735$1$I$$20240909$20240917$20240917$EXP$$US-TEVA-VS-3243722$TEVA$$79$YR$$F$Y$$$20240917$$CN$US$US
243287362$24328736$2$F$$20240917$20240917$20240923$EXP$$US-ABBVIE-5918933$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243287371$24328737$1$I$$20240913$20240917$20240917$EXP$$US-SANDOZ INC.-SDZ2024US080227$SANDOZ$$$$$F$Y$$$20240917$$CN$US$US
243287381$24328738$1$I$$20240913$20240917$20240917$EXP$$US-AVEO PHARMACEUTICALS, INC.-2024-AVEO-US000685$PAREXEL$$$$$$Y$$$20240917$$CN$US$US
243287392$24328739$2$F$$20240909$20240917$20240923$PER$$US-AMGEN-USASP2024180546$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243287401$24328740$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS091924$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243287411$24328741$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147756$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240917$$CN$US$US
243287431$24328743$1$I$20240321$20240909$20240917$20240917$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-143852$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240917$$CN$AU$AU
243287441$24328744$1$I$$20240911$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145226$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240917$$HP$US$US
243287451$24328745$1$I$$20240909$20240917$20240917$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-145354$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240917$$MD$AU$AU
243287461$24328746$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3243069$TEVA$$$$$M$Y$$$20240917$$LW$CA$CA
243287471$24328747$1$I$20231216$20240903$20240917$20240917$EXP$$CA-UCBSA-2024045259$UCB$$74$YR$$F$Y$$$20240917$$CN$CA$CA
243287491$24328749$1$I$$20240906$20240917$20240917$EXP$$IN-GILEAD-2024-0686750$GILEAD$$45$YR$A$F$Y$$$20240917$$CN$IN$IN
243287501$24328750$1$I$20240101$20240909$20240917$20240917$EXP$$US-TEVA-VS-3242866$TEVA$$16$YR$$F$Y$$$20240917$$HP$US$US
243287511$24328751$1$I$20240914$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184866$AMGEN$$71$YR$E$M$Y$$$20240917$$CN$US$US
243287523$24328752$3$F$20240905$20240927$20240917$20240928$PER$$US-AMGEN-USASP2024184203$AMGEN$$76$YR$E$M$Y$$$20240928$$CN$US$US
243287531$24328753$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001182US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243287541$24328754$1$I$20240910$20240912$20240917$20240917$EXP$$US-ABBVIE-5922781$ABBVIE$$69$YR$$M$Y$$$20240917$$CN$US$US
243287551$24328755$1$I$20240906$20240912$20240917$20240917$EXP$$US-ABBVIE-5923062$ABBVIE$$54$YR$$F$Y$$$20240917$$CN$US$US
243287561$24328756$1$I$20240101$20240911$20240917$20240917$EXP$$GB-ABBVIE-5923520$ABBVIE$$72$YR$$F$Y$$$20240917$$CN$GB$GB
243287571$24328757$1$I$20240725$20240909$20240917$20240917$EXP$$US-RDY-SPO/USA/24/0013266$DR REDDYS$$30$YR$A$F$Y$$$20240917$$MD$US$US
243287581$24328758$1$I$20240909$20240909$20240917$20240917$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-18064$IPSEN$$65$YR$E$F$Y$$$20240917$$CN$GB$GB
243287602$24328760$2$F$$20240923$20240917$20240924$EXP$$PT-MYLANLABS-2024M1083261$MYLAN$$62$YR$$M$Y$$$20240924$$HP$PT$PT
243287611$24328761$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147466$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240917$$HP$US$US
243287621$24328762$1$I$20201201$20240911$20240917$20240917$EXP$$PL-MYLANLABS-2024M1083435$MYLAN$$49$YR$$M$Y$$$20240917$$HP$PL$PL
243287631$24328763$1$I$20240101$20240910$20240917$20240917$EXP$$US-ABBVIE-5917944$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243287641$24328764$1$I$$20240913$20240917$20240917$PER$$US-JNJFOC-20240935866$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$CN$US$US
243287651$24328765$1$I$20240813$20240912$20240917$20240917$EXP$$US-ABBVIE-5922394$ABBVIE$$70$YR$$F$Y$$$20240917$$CN$US$US
243287661$24328766$1$I$20240204$20240913$20240917$20240917$PER$$US-GILEAD-2024-0687684$GILEAD$$56$YR$A$F$Y$68.1$KG$20240917$$HP$US$US
243287681$24328768$1$I$20240821$20240911$20240917$20240917$EXP$$US-ABBVIE-5920349$ABBVIE$$6$YR$$M$Y$$$20240917$$CN$US$US
243287701$24328770$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63662$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243287711$24328771$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63689$$FDA-CTU$$57$YR$$F$N$101.15$KG$20240917$N$$US$
243287731$24328773$1$I$20240401$20240909$20240917$20240917$EXP$DK-DKMA-30737681$DK-TEVA-VS-3242047$TEVA$$67$YR$$F$Y$95.6$KG$20240917$$MD$DK$DK
243287741$24328774$1$I$$20240916$20240917$20240917$EXP$$IT-SANDOZ INC.-NVSC2020IT122914$SANDOZ$$$$N$F$Y$2.21$KG$20240917$$MD$IT$IT
243287751$24328775$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A206838$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243287761$24328776$1$I$20240913$20240916$20240917$20240917$EXP$$US-AstraZeneca-2024A211890$ASTRAZENECA$$$$$F$Y$$$20240917$$HP$US$
243287771$24328777$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001172US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243287781$24328778$1$I$$20240916$20240917$20240917$EXP$$US-AstraZeneca-2024A211773$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243287791$24328779$1$I$$20240911$20240917$20240917$EXP$$GB-AstraZeneca-2024A207242$ASTRAZENECA$$87$YR$$F$Y$53$KG$20240917$$MD$GB$
243287801$24328780$1$I$$20240913$20240917$20240917$EXP$$GB-AstraZeneca-2024A211741$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$GB$
243287811$24328781$1$I$$20240912$20240917$20240917$EXP$$DE-TAKEDA-2024TUS092131$TAKEDA$$13$YR$$M$Y$$$20240917$$CN$DE$DE
243287821$24328782$1$I$$20240911$20240917$20240917$EXP$$US-ABBVIE-5922293$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243287831$24328783$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922284$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243287852$24328785$2$F$$20240915$20240917$20240917$EXP$$US-GILEAD-2024-0687726$GILEAD$$$$$$Y$$$20240917$$HP$US$US
243287871$24328787$1$I$20240801$20240913$20240917$20240917$PER$$US-JNJFOC-20240937221$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243287881$24328788$1$I$$20240911$20240917$20240917$PER$$US-JNJFOC-20240929554$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$CN$US$US
243287891$24328789$1$I$$20240909$20240917$20240917$EXP$$US-JNJFOC-20240926778$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$CN$US$US
243287901$24328790$1$I$20240101$20240909$20240917$20240917$EXP$$US-JNJFOC-20240925132$JOHNSON AND JOHNSON$$24$YR$A$F$Y$$$20240917$$HP$US$US
243287911$24328791$1$I$20240908$20240910$20240917$20240917$EXP$$US-GSK-US2024112660$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$US$US
243287921$24328792$1$I$$20240911$20240917$20240917$EXP$$SK-MYLANLABS-2024M1084252$MYLAN$Jana Gabajova.. Optimal treatment sequence in the treatment of locally advanced unresectable and metastatic urothelial carcinoma under current reimbursement mechanisms in Slovakia.. Oncology. 2024;19(3):210-214$60$YR$$M$Y$$$20240917$$MD$SK$SK
243287941$24328794$1$I$20240904$20240916$20240917$20240917$EXP$GB-MHRA-MED-202409161419259700-WJZBP$GB-SANDOZ INC.-SDZ2024GB080648$SANDOZ$$$$$F$Y$58$KG$20240917$$HP$GB$GB
243287952$24328795$2$F$20240101$20240911$20240917$20240925$EXP$$CA-UCBSA-2024045462$UCB$$$$$F$Y$$$20240925$$CN$CA$CA
243287961$24328796$1$I$20201201$20240905$20240917$20240917$EXP$SK-SUKLSK-20213821$SK-ELI_LILLY_AND_COMPANY-SK202409004181$ELI LILLY AND CO$$72$YR$E$F$Y$71$KG$20240917$$CN$SK$SK
243287971$24328797$1$I$20240912$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009901$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240917$$CN$US$US
243287991$24328799$1$I$$20240912$20240917$20240917$EXP$$US-BAYER-2024A130914$BAYER$$19$YR$A$F$Y$$$20240917$$CN$US$US
243288001$24328800$1$I$$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009723$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240917$$HP$US$US
243288011$24328801$1$I$20240913$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009534$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240917$$CN$US$US
243288021$24328802$1$I$20240101$20240909$20240917$20240917$EXP$$JP-GENMAB-2024-01710AA$GENMAB$$82$YR$$M$Y$$$20240917$$MD$JP$JP
243288031$24328803$1$I$20240401$20240909$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409005601$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240917$$CN$US$US
243288041$24328804$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008993$ELI LILLY AND CO$$$$$$Y$$$20240917$$CN$US$US
243288051$24328805$1$I$$20240909$20240917$20240917$EXP$DE-BFARM-24006097$DE-TEVA-VS-3241668$TEVA$$$$$M$Y$$$20240917$$CN$DE$DE
243288061$24328806$1$I$20240906$20240909$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409006158$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240917$$CN$US$US
243288071$24328807$1$I$20240717$20240905$20240917$20240917$EXP$$DE-ABBVIE-5925905$ABBVIE$$61$YR$$F$Y$$$20240917$$HP$DE$DE
243288091$24328809$1$I$20240101$20240913$20240917$20240917$EXP$$US-ABBVIE-5925831$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243288101$24328810$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147559$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240917$$CN$US$US
243288111$24328811$1$I$$20240912$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA080063$SANDOZ$$87$YR$$F$Y$69$KG$20240917$$MD$CA$CA
243288121$24328812$1$I$20231218$20240913$20240917$20240917$EXP$$IE-BAYER-2024A131382$BAYER$$65$YR$E$M$Y$$$20240917$$HP$IE$IE
243288131$24328813$1$I$20240910$20240912$20240917$20240917$EXP$$US-ABBVIE-5923698$ABBVIE$$75$YR$$M$Y$$$20240917$$CN$US$US
243288141$24328814$1$I$20240916$20240917$20240917$20240917$DIR$718714$$FDA-CTU$$$$$UNK$N$$$20240917$N$CN$US$
243288161$24328816$1$I$$20240912$20240917$20240917$EXP$$JP-MALLINCKRODT-MNK202405716$MALLINCKRODT$$10$DEC$E$M$Y$$$20240917$$MD$JP$JP
243288171$24328817$1$I$20240802$20240912$20240917$20240917$EXP$$NVSC2024US184004$NOVARTIS$$46$YR$$F$Y$62.14$KG$20240917$$MD$US$US
243288181$24328818$1$I$$20240910$20240917$20240917$EXP$$US-GSK-US2024113149$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$US$US
243288192$24328819$2$F$$20240912$20240917$20240918$EXP$$US-Eisai-EC-2024-174344$EISAI$$63$YR$A$M$Y$$$20240918$$CN$US$US
243288201$24328820$1$I$$20240905$20240917$20240917$EXP$$US-SMPA-2024SPA002393$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243288211$24328821$1$I$$20240903$20240917$20240917$EXP$$US-UCBSA-2024044727$UCB$$$$$F$Y$$$20240917$$MD$US$US
243288221$24328822$1$I$$20240905$20240917$20240917$EXP$$US-SMPA-2024MYSCI0700075$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243288241$24328824$1$I$$20240905$20240917$20240917$EXP$$US-SMPA-2023MYSCI1100813$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243288251$24328825$1$I$$20240912$20240917$20240917$EXP$$US-SMPA-2024SPA002684$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243288271$24328827$1$I$$20240910$20240917$20240917$PER$$US-APOTEX-2024AP010752$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240917$$HP$US$US
243288281$24328828$1$I$$20240910$20240917$20240917$EXP$$ZA-AstraZeneca-2024A207304$ASTRAZENECA$$28489$DY$$M$Y$$$20240917$$CN$ZA$
243288291$24328829$1$I$$20240904$20240917$20240917$EXP$$CA-BAXTER-2024BAX024247$BAXTER$$55$YR$$M$Y$$$20240917$$HP$CA$CA
243288301$24328830$1$I$20240201$20240912$20240917$20240917$EXP$$FR-AstraZeneca-2024A208041$ASTRAZENECA$$76$YR$$M$Y$$$20240917$$MD$FR$
243288321$24328832$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208705$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$US$
243288331$24328833$1$I$20240907$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208962$ASTRAZENECA$$$$$M$Y$$$20240917$$HP$US$
243288341$24328834$1$I$$20240916$20240917$20240917$EXP$$AU-AstraZeneca-2024A211839$ASTRAZENECA$$67$YR$$M$Y$$$20240917$$CN$AU$
243288351$24328835$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208991$ASTRAZENECA$$12053$DY$$F$Y$$$20240917$$HP$US$
243288361$24328836$1$I$$20240916$20240917$20240917$EXP$$US-AstraZeneca-2024A211882$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243288381$24328838$1$I$20240301$20240912$20240917$20240917$EXP$$CA-ABBVIE-5924369$ABBVIE$$73$YR$$M$Y$$$20240917$$CN$CA$CA
243288391$24328839$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A210803$ASTRAZENECA$$$$$F$Y$$$20240917$$HP$US$
243288401$24328840$1$I$$20240911$20240917$20240917$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001850$BLUEPRINT MEDICINES$$$$$F$Y$$$20240917$$CN$US$US
243288411$24328841$1$I$20240110$20240909$20240917$20240917$EXP$$JP-APELLIS-APL-2024-003597$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240917$$MD$JP$JP
243288421$24328842$1$I$20230331$20240913$20240917$20240917$EXP$FR-AFSSAPS-AN2024001256$FR-INCYTE CORPORATION-2024IN009754$INCYTE$$$$$$Y$$$20240917$$HP$FR$FR
243288431$24328843$1$I$20240501$20240910$20240917$20240917$EXP$$NVSC2024DE184049$NOVARTIS$$$$A$F$Y$$$20240917$$CN$DE$DE
243288451$24328845$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147726$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240917$$CN$US$US
243288461$24328846$1$I$$20240910$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144682$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240917$$CN$US$US
243288471$24328847$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185314$NOVARTIS$$$$$$Y$$$20240917$$MD$US$US
243288481$24328848$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001195US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243288491$24328849$1$I$20230331$20240912$20240917$20240917$EXP$FR-AFSSAPS-AN2024001256$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-146021$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240917$$PH$FR$FR
243288501$24328850$1$I$20200609$20240910$20240917$20240917$EXP$PL-URPL-1-2128-2020$PL-TEVA-VS-3242353$TEVA$$71$YR$$M$Y$80$KG$20240917$$MD$PL$PL
243288511$24328851$1$I$$20240910$20240917$20240917$EXP$$US-GSK-US2024AMR112897$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$US$US
243288541$24328854$1$I$$20240909$20240917$20240917$EXP$$GB-TEVA-VS-3242355$TEVA$$58$YR$$M$Y$$$20240917$$HP$GB$GB
243288551$24328855$1$I$20240911$20240912$20240917$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147296$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240917$$MD$JP$JP
243288561$24328856$1$I$$20240909$20240917$20240917$EXP$$GB-TEVA-VS-3242350$TEVA$$67$YR$$M$Y$120$KG$20240917$$MD$GB$GB
243288571$24328857$1$I$$20240906$20240917$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2024GSK111632$VIIV$Koss CA, Gandhi M, Halvas EK, Okochi H, Chu C, Glidden DV et al. First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine Care. Open Forum Infectious Diseases. 2024;11 (9)$$$$$Y$$$20240917$$MD$US$US
243288581$24328858$1$I$$20240909$20240917$20240917$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2024JPN112111$VIIV$Endo Aki. Pharmacist experience learned from medical care of HIV infection (Specific case experienced in an HIV team medicine). 122$$$$$Y$$$20240917$$PH$JP$JP
243288591$24328859$1$I$$20240909$20240917$20240917$EXP$$US-GSK-US2024GSK112436$GLAXOSMITHKLINE$Zreik J, LaPage MJ, Zreik H. Congenital Long QT Syndrome Unmasked by Albuterol in an Adolescent with Asthma. The Journal of emergency medicine. 2024$$$$$Y$$$20240917$$HP$US$US
243288601$24328860$1$I$$20240909$20240917$20240917$EXP$$JP-GSK-JP2024JPN112138$GLAXOSMITHKLINE$Ueda Y, Sakai T, Yamada K, Arita K, Ishige Y, Hoshi D, et al. CASE REPORT Fatal hemophagocytic lymphohistiocytosis with?intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case. Immunological Medicine. 2024;47:192-199$$$$$Y$$$20240917$$MD$JP$JP
243288611$24328861$1$I$$20240819$20240917$20240917$PER$$US-TRAVERE-2024TVT00824$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
243288624$24328862$4$F$20240816$20240909$20240917$20240930$PER$$US-TRAVERE-2024TVT00823$TRAVERE THERAPEUTICS$$65$YR$E$F$Y$$$20240930$$CN$US$US
243288631$24328863$1$I$$20240909$20240917$20240917$EXP$$US-GSK-US2024GSK114257$GLAXOSMITHKLINE$Blush RR. Beta-Adrenergic Agonist-Induced Lactic Acidosis: A Case Report. AACN advanced critical care. 2024;35(3):222-227$$$$$Y$$$20240917$$HP$US$US
243288641$24328864$1$I$$20240819$20240917$20240917$PER$$US-TRAVERE-2024TVT00822$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240917$$CN$US$US
243288651$24328865$1$I$$20240819$20240917$20240917$PER$$US-TRAVERE-2024TVT00825$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$HP$US$US
243288661$24328866$1$I$$20240910$20240917$20240917$PER$$US-APOTEX-2024AP010753$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240917$$HP$US$US
243288671$24328867$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009421$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240917$$CN$US$US
243288681$24328868$1$I$20210913$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008090$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240917$$CN$US$US
243288691$24328869$1$I$$20240910$20240917$20240917$EXP$$CA-GSK-CA2024112956$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$CA$CA
243288701$24328870$1$I$20240902$20240910$20240917$20240917$EXP$$CO-GSK-CO2024AMR112822$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$CO$CO
243288711$24328871$1$I$20240901$20240916$20240917$20240917$PER$$US-JNJFOC-20240942617$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243288723$24328872$3$F$$20240926$20240917$20240930$EXP$$US-JNJFOC-20240927879$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$MD$US$US
243288731$24328873$1$I$$20240912$20240917$20240917$EXP$$DE-JNJFOC-20240940114$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$MD$DE$DE
243288741$24328874$1$I$$20240906$20240917$20240917$EXP$$CN-JNJFOC-20240925819$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$CN$CN
243288751$24328875$1$I$$20240906$20240917$20240917$EXP$$US-JNJFOC-20240922881$JOHNSON AND JOHNSON$$11$YR$C$M$Y$52$KG$20240917$$HP$US$US
243288761$24328876$1$I$20240901$20240916$20240917$20240917$PER$$US-JNJFOC-20240942628$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243288771$24328877$1$I$20240819$20240910$20240917$20240917$EXP$GB-MHRA-MED-202409100939453490-TKBLM$GB-GSK-GB2024112274$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$HP$GB$GB
243288781$24328878$1$I$20240801$20240822$20240917$20240917$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000915$PAREXEL$$$$$$Y$$$20240917$$PH$US$US
243288791$24328879$1$I$$20240905$20240917$20240917$EXP$$PT-Accord-446488$ACCORD$Almeida R, Sitari C, Patraquim A, Blanco R, Pereira R, Mendonca C. PO-0611 - (2544) -Trombocitopenia induxida por azitromicina  a proposito de um caso clinico. 30 Congresso Nacional de Medicina Interna. 2024 Maio 23-26; Vilamoura.$79$YR$E$F$Y$$$20240917$$MD$PT$PT
243288801$24328880$1$I$20240829$20240830$20240917$20240917$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000898$PAREXEL$$$$$$Y$$$20240917$$PH$US$US
243288811$24328881$1$I$20240815$20240904$20240917$20240917$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000907$PAREXEL$$$$$$Y$$$20240917$$HP$US$US
243288821$24328882$1$I$20240804$20240906$20240917$20240917$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000924$PAREXEL$$$$$$Y$$$20240917$$HP$CN$CN
243288831$24328883$1$I$20240829$20240903$20240917$20240917$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000908$PAREXEL$$$$$$Y$$$20240917$$HP$US$US
243288841$24328884$1$I$$20240909$20240917$20240917$EXP$$JP-AstraZeneca-2024A206847$ASTRAZENECA$$56$YR$$M$Y$$$20240917$$MD$JP$
243288851$24328885$1$I$20240808$20240912$20240917$20240917$EXP$$CO-AstraZeneca-2024A211228$ASTRAZENECA$$31343$DY$$F$Y$52$KG$20240917$$CN$CO$
243288861$24328886$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A210620$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243288871$24328887$1$I$$20240825$20240917$20240917$EXP$$KR-JNJFOC-20240877444$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$KR$KR
243288881$24328888$1$I$$20240906$20240917$20240917$30DAY$$CL-PFIZER INC-PV202400118052$PFIZER$$6$YR$$F$Y$$$20240917$$CN$CL$CL
243288891$24328889$1$I$$20240916$20240917$20240917$EXP$$GB-SANDOZ INC.-SDZ2024GB028212$SANDOZ$$$$$F$Y$$$20240917$$CN$GB$GB
243288901$24328890$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3243480$TEVA$$33$YR$$M$Y$$$20240917$$HP$CA$CA
243288911$24328891$1$I$20230720$20240911$20240917$20240917$EXP$FR-AFSSAPS-CF2023000372$FR-009507513-2409FRA004865$MERCK$$69$YR$$M$Y$72$KG$20240917$$MD$FR$FR
243288931$24328893$1$I$20240817$20240820$20240917$20240917$PER$$US-TRAVERE-2024TVT00826$TRAVERE THERAPEUTICS$$45$YR$A$F$Y$$$20240917$$CN$US$US
243288941$24328894$1$I$20240827$20240913$20240917$20240917$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051685$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$$$20240917$$PH$JP$JP
243288951$24328895$1$I$$20240910$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144618$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240917$$CN$US$US
243288961$24328896$1$I$20240901$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147302$BRISTOL MYERS SQUIBB$$65$YR$A$M$Y$$$20240917$$HP$US$US
243288981$24328898$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084143$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$49$YR$$M$Y$$$20240917$$HP$IE$IE
243288991$24328899$1$I$$20240909$20240917$20240917$EXP$$IE-MYLANLABS-2024M1084146$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$46$YR$$M$Y$$$20240917$$HP$IE$IE
243289001$24328900$1$I$20240704$20240829$20240917$20240917$DIR$FDA-CDER-CTU-2024-63690$$FDA-CTU$$19$YR$$M$N$79.7$KG$20240829$Y$MD$US$
243289011$24328901$1$I$20240912$20240917$20240917$20240917$DIR$718735$$FDA-CTU$$83$YR$$M$N$67.6$KG$20240917$N$HP$US$
243289021$24328902$1$I$$20240816$20240917$20240917$PER$$US-AMGEN-USASP2024185296$AMGEN$$40$YR$A$M$Y$$$20240917$$MD$US$US
243289031$24328903$1$I$20240912$20240914$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120775$PFIZER$$9$YR$$M$Y$26$KG$20240917$$HP$CN$CN
243289041$24328904$1$I$20240901$20240912$20240917$20240917$EXP$$US-PFIZER INC-202400256407$PFIZER$$$$$F$Y$$$20240917$$MD$US$US
243289051$24328905$1$I$$20240912$20240917$20240917$30DAY$$CO-PFIZER INC-PV202400120477$PFIZER$$$$$M$Y$$$20240917$$CN$CO$CO
243289061$24328906$1$I$20240826$20240909$20240917$20240917$EXP$$CN-PFIZER INC-202400256565$PFIZER$$72$YR$$M$Y$43$KG$20240917$$HP$CN$CN
243289071$24328907$1$I$$20240910$20240917$20240917$PER$$US-APOTEX-2024AP010754$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240917$$HP$US$US
243289081$24328908$1$I$20240411$20240911$20240917$20240917$EXP$FR-AFSSAPS-AVMA2024000380$FR-MYLANLABS-2024M1083828$MYLAN$$44$YR$$M$Y$$$20240917$$PH$FR$FR
243289091$24328909$1$I$$20240910$20240917$20240917$EXP$$SA-GSK-SA2024EME015569$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$SA$SA
243289103$24328910$3$F$$20240920$20240917$20240924$EXP$$US-GSK-US2024112391$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$US$US
243289111$24328911$1$I$$20240916$20240917$20240917$EXP$$US-SANDOZ INC.-SDZ2024US080726$SANDOZ$$$$$F$Y$$$20240917$$CN$US$US
243289121$24328912$1$I$$20240913$20240917$20240917$30DAY$$US-SANDOZ INC.-SDZ2024US080407$SANDOZ$$$$$F$Y$$$20240917$$CN$US$US
243289131$24328913$1$I$$20240916$20240917$20240917$EXP$$US-SANDOZ INC.-PHHY2017US134355$SANDOZ$$15$YR$$M$Y$$$20240917$$MD$US$US
243289141$24328914$1$I$20240911$20240911$20240917$20240917$EXP$$US-AMGEN-USASP2024182120$AMGEN$$35$YR$A$M$Y$$$20240917$$HP$US$US
243289151$24328915$1$I$$20240914$20240917$20240917$PER$$US-AMGEN-USASP2024185156$AMGEN$$$$$F$Y$$$20240917$$CN$US$US
243289161$24328916$1$I$20200930$20240905$20240917$20240917$EXP$$BE-Accord-446052$ACCORD$Ferdinande K, Declerck L, Melis C, Missiaen L, Seynhaeve L, De Vloo C, et al. CYP2D6 polymorphism may contribute to Trazodone-induced hepatotoxicity: a rare case of drug-drug-gene induced liver injury. Acta Gastro-Enterologica Belgica. 2024;87(2):332-5.$46$YR$A$F$Y$$$20240917$$HP$BE$BE
243289171$24328917$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185474$NOVARTIS$$$$$$Y$$$20240917$$MD$US$US
243289191$24328919$1$I$$20240906$20240917$20240917$PER$$US-TAKEDA-2024TUS089361$TAKEDA$$$$A$M$Y$70$KG$20240917$$MD$US$US
243289201$24328920$1$I$$20240913$20240917$20240917$PER$$NVSC2024US184848$NOVARTIS$$$$$M$Y$$$20240917$$CN$US$US
243289221$24328922$1$I$$20240912$20240917$20240917$PER$$NVSC2024US184867$NOVARTIS$$$$$F$Y$$$20240917$$MD$US$US
243289231$24328923$1$I$20240913$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184514$AMGEN$$74$YR$E$F$Y$$$20240917$$CN$US$US
243289241$24328924$1$I$20240801$20240916$20240917$20240917$PER$$US-JNJFOC-20240942204$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240917$$CN$US$US
243289251$24328925$1$I$20240910$20240916$20240917$20240917$PER$$US-JNJFOC-20240940450$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243289261$24328926$1$I$$20240916$20240917$20240917$PER$$US-JNJFOC-20240942188$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240917$$CN$US$US
243289281$24328928$1$I$20240120$20240802$20240917$20240917$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-18162$IPSEN$$3$YR$C$M$Y$18$KG$20240917$$MD$US$US
243289291$24328929$1$I$20190202$20240909$20240917$20240917$EXP$IT-MINISAL02-1000740$IT-TEVA-VS-3242045$TEVA$$47$YR$$F$Y$70$KG$20240917$$CN$IT$IT
243289301$24328930$1$I$$20240821$20240917$20240917$PER$$US-TRAVERE-2024TVT00834$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
243289312$24328931$2$F$20240821$20240823$20240917$20240917$PER$$US-TRAVERE-2024TVT00831$TRAVERE THERAPEUTICS$$46$YR$A$M$Y$$$20240917$$MD$US$US
243289321$24328932$1$I$$20240821$20240917$20240917$PER$$US-TRAVERE-2024TVT00828$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
243289332$24328933$2$F$$20240911$20240917$20240930$PER$$US-TRAVERE-2024TVT00830$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243289341$24328934$1$I$20240822$20240906$20240917$20240917$EXP$FR-AFSSAPS-PB2024000958$FR-BAXTER-2024BAX024326$BAXTER$$67$YR$$F$Y$$$20240917$$MD$FR$FR
243289351$24328935$1$I$20240719$20240913$20240917$20240917$30DAY$$US-SANDOZ INC.-SDZ2024US073098$SANDOZ$$12$YR$$$Y$$$20240917$$PH$US$US
243289361$24328936$1$I$20240719$20240911$20240917$20240917$PER$$CN-Eisai-EC-2024-174276$EISAI$$67$YR$E$M$Y$$$20240917$$MD$CN$CN
243289372$24328937$2$F$$20240919$20240917$20240927$EXP$$IL-TEVA-VS-3243011$TEVA$Avidan Y, Aker A, Tabachnikov V. Prolonged asystole following adenosine. Was it necessary?. J-Geriatr-Cardiol 2024; 21 (6): 686-688; Avidan Y, Aker A, Tabachnikov V. Prolonged asystole following adenosine. Was it necessary?. J-Geriatr-Cardiol 2024; 21 (6): 686-688.$77$YR$$F$Y$$$20240927$$HP$IL$IL
243289381$24328938$1$I$$20240913$20240917$20240917$PER$$US-HALEON-2196986$Haleon PLC$$$$$$Y$$$20240917$$CN$US$US
243289401$24328940$1$I$$20240916$20240917$20240917$PER$$NVSC2024US184897$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
243289411$24328941$1$I$$20240911$20240917$20240917$EXP$$US-VIIV HEALTHCARE LIMITED-US2024113726$VIIV$$$$$$Y$$$20240917$$MD$US$US
243289421$24328942$1$I$$20240914$20240917$20240917$PER$$US-AstraZeneca-2024A212013$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243289431$24328943$1$I$20221207$20240912$20240917$20240917$EXP$$KR-AstraZeneca-2024A209350$ASTRAZENECA$Choi WJ, Lee J, Choi K, Kim D.M, Han N, Choi J-H, Jung J, Lee H, Choi JY, Choi YJ, Eom H-S, Chun JY, Lee E. Outcomes of hematopoietic stem cell transplantation in patients with SARS-CoV-2 infection during the Omicron era. International Journal of Infectious Diseases 2024;147:1-4.$32$YR$$F$Y$$$20240917$$HP$KR$
243289441$24328944$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210724$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243289451$24328945$1$I$$20240912$20240917$20240917$EXP$$KR-AstraZeneca-2024A209412$ASTRAZENECA$Choi WJ, Lee J, Choi K, Kim D.M, Han N, Choi J-H, Jung J, Lee H, Choi JY, Choi YJ, Eom H-S, Chun JY, Lee E. Outcomes of hematopoietic stem cell transplantation in patients with SARS-CoV-2 infection during the Omicron era. International Journal of Infectious Diseases 2024;147:1-4.$72$YR$$F$Y$$$20240917$$HP$KR$
243289461$24328946$1$I$$20240910$20240917$20240917$PER$$US-APOTEX-2024AP010755$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240917$$HP$US$US
243289481$24328948$1$I$$20240910$20240917$20240917$EXP$$NVSC2024CA181855$NOVARTIS$$52$YR$$$Y$$$20240917$$HP$CA$CA
243289501$24328950$1$I$$20240917$20240917$20240917$DIR$718725$$FDA-CTU$$$$$UNK$N$$$20240917$N$CN$US$
243289511$24328951$1$I$20240704$20240829$20240917$20240917$DIR$FDA-CDER-CTU-2024-63691$$FDA-CTU$$69$YR$$M$N$109.6$KG$20240829$Y$HP$US$
243289521$24328952$1$I$20210228$20240917$20240917$20240917$DIR$718726$$FDA-CTU$$30$YR$$F$N$67.5$KG$20240917$N$CN$US$
243289531$24328953$1$I$20230101$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409010044$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240917$$CN$US$US
243289541$24328954$1$I$20240913$20240913$20240917$20240917$PER$$US-JNJFOC-20240936167$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$MD$US$US
243289551$24328955$1$I$20240912$20240917$20240917$20240917$DIR$718724$$FDA-CTU$$51$YR$$F$N$90$KG$20240917$N$CN$US$
243289561$24328956$1$I$$20240909$20240917$20240917$EXP$$JP-JNJFOC-20240934307$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240917$$CN$JP$JP
243289571$24328957$1$I$$20240830$20240917$20240917$EXP$$MY-ASTELLAS-2024-AER-007061$ASTELLAS$$$$$$Y$$$20240917$$MD$MY$MY
243289581$24328958$1$I$$20240910$20240917$20240917$EXP$$GB-ROCHE-3154616$ROCHE$$$$A$F$Y$$$20240917$$CN$GB$GB
243289591$24328959$1$I$$20240910$20240917$20240917$EXP$$US-SANDOZ INC.-SDZ2024US080758$SANDOZ$$$$$$Y$$$20240917$$PH$US$US
243289601$24328960$1$I$$20240911$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145261$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240917$$CN$US$US
243289611$24328961$1$I$$20240910$20240917$20240917$EXP$$DE-TAKEDA-2024TUS092104$TAKEDA$$$$$$Y$$$20240917$$MD$DE$DE
243289631$24328963$1$I$20240101$20240913$20240917$20240917$PER$$US-BIOGEN-2024BI01282705$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
243289651$24328965$1$I$$20240911$20240917$20240917$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006682$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243289662$24328966$2$F$20240915$20240917$20240917$20240918$PER$$US-AMGEN-USASP2024185259$AMGEN$$68$YR$E$M$Y$$$20240918$$CN$US$US
243289671$24328967$1$I$$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024185113$AMGEN$$$$$$Y$$$20240917$$MD$US$US
243289681$24328968$1$I$$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184861$AMGEN$$$$$F$Y$$$20240917$$CN$US$US
243289691$24328969$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185473$NOVARTIS$$$$$$Y$$$20240917$$HP$US$US
243289711$24328971$1$I$$20240911$20240917$20240917$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006687$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243289721$24328972$1$I$$20240911$20240917$20240917$EXP$$NVSC2024CA183153$NOVARTIS$$70$YR$$F$Y$87$KG$20240917$$HP$CA$CA
243289732$24328973$2$F$20240826$20240916$20240917$20240923$EXP$$NVSC2024IT182209$NOVARTIS$$16$MON$$M$Y$6.99$KG$20240923$$MD$IT$IT
243289741$24328974$1$I$$20240823$20240917$20240917$PER$$US-TRAVERE-2024TVT00841$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240917$$CN$US$US
243289751$24328975$1$I$$20240822$20240917$20240917$PER$$US-TRAVERE-2024TVT00837$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
243289761$24328976$1$I$$20240823$20240917$20240917$PER$$US-TRAVERE-2024TVT00840$TRAVERE THERAPEUTICS$$61$YR$A$M$Y$$$20240917$$CN$US$US
243289772$24328977$2$F$20240822$20240827$20240917$20240917$PER$$US-TRAVERE-2024TVT00842$TRAVERE THERAPEUTICS$$55$YR$A$F$Y$$$20240917$$CN$US$US
243289781$24328978$1$I$$20240822$20240917$20240917$PER$$US-TRAVERE-2024TVT00838$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240917$$CN$US$US
243289791$24328979$1$I$$20240822$20240917$20240917$PER$$US-TRAVERE-2024TVT00839$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240917$$CN$US$US
243289801$24328980$1$I$$20240821$20240917$20240917$PER$$US-TRAVERE-2024TVT00835$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240917$$CN$US$US
243289811$24328981$1$I$20240917$20240917$20240917$20240917$DIR$718740$$FDA-CTU$$46$YR$$F$N$$$20240917$N$HP$US$
243289821$24328982$1$I$20240101$20240913$20240917$20240917$EXP$$GB-SANDOZ INC.-SDZ2024GB080530$SANDOZ$$$$$F$Y$$$20240917$$CN$GB$GB
243289831$24328983$1$I$20240723$20240917$20240917$20240917$DIR$718722$$FDA-CTU$$72$YR$$M$N$82.2$KG$20240917$N$HP$US$
243289841$24328984$1$I$20240913$20240914$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120824$PFIZER$$6$YR$$M$Y$20$KG$20240917$$HP$CN$CN
243289851$24328985$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3242553$TEVA$$83$YR$$F$Y$77$KG$20240917$$HP$CA$CA
243289861$24328986$1$I$20240629$20240914$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120774$PFIZER$$7$YR$$F$Y$20$KG$20240917$$HP$CN$CN
243289871$24328987$1$I$20240112$20240913$20240917$20240917$PER$$US-GILEAD-2024-0687689$GILEAD$$54$YR$A$M$Y$113.2$KG$20240917$$HP$US$US
243289902$24328990$2$F$20240904$20240919$20240917$20240930$PER$$US-ALKERMES INC.-ALK-2024-002309$ALKERMES$$53$YR$$M$Y$$$20240930$$PH$US$US
243289911$24328991$1$I$$20240910$20240917$20240917$EXP$$US-GSK-US2024112648$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$US$US
243289921$24328992$1$I$$20240914$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146897$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240917$$CN$US$US
243289931$24328993$1$I$20240419$20240912$20240917$20240917$EXP$FR-AFSSAPS-LY2024001371$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-145707$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$51$KG$20240917$$PH$FR$FR
243289941$24328994$1$I$20240723$20240917$20240917$20240917$DIR$718736$$FDA-CTU$$69$YR$$M$N$65.6$KG$20240917$N$HP$US$
243289951$24328995$1$I$20240723$20240917$20240917$20240917$DIR$718734$$FDA-CTU$$69$YR$$M$N$65.1$KG$20240917$N$HP$US$
243289961$24328996$1$I$20240725$20240917$20240917$20240917$DIR$718739$$FDA-CTU$$66$YR$$F$N$82.8$KG$20240917$N$HP$US$
243289971$24328997$1$I$20240725$20240917$20240917$20240917$DIR$718741$$FDA-CTU$$66$YR$$F$N$82.8$KG$20240917$N$HP$US$
243289981$24328998$1$I$20240913$20240916$20240917$20240917$PER$$US-ALXN-202409USA001221US$ALEXION PHARMACEUTICALS$$66$YR$$F$Y$$$20240917$$CN$US$US
243289992$24328999$2$F$20230419$20240920$20240917$20240926$EXP$$ES-AMGEN-ESPSP2024182651$AMGEN$$55$YR$A$F$Y$64.6$KG$20240926$$MD$ES$ES
243290002$24329000$2$F$20060101$20240913$20240917$20240920$PER$$US-AMGEN-USASP2024183834$AMGEN$$60$YR$A$F$Y$$$20240920$$CN$US$US
243290011$24329001$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001197US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240917$$CN$US$US
243290021$24329002$1$I$20240330$20240805$20240917$20240917$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-18157$IPSEN$$25$MON$C$F$Y$12.3$KG$20240917$$MD$US$US
243290031$24329003$1$I$20231116$20240913$20240917$20240917$PER$$US-GILEAD-2024-0687688$GILEAD$$51$YR$A$F$Y$92.2$KG$20240917$$HP$US$US
243290041$24329004$1$I$20240910$20240911$20240917$20240917$PER$$US-ROCHE-10000079669$ROCHE$$$$$$Y$$$20240917$$PH$US$US
243290052$24329005$2$F$$20240926$20240917$20240930$PER$$US-ROCHE-10000082915$ROCHE$$67$YR$E$M$Y$74.4$KG$20241001$$CN$US$US
243290072$24329007$2$F$20240914$20240917$20240917$20240920$EXP$$US-KYOWAKIRIN-2024KK021519$KYOWA$$$$$$Y$$$20240920$$HP$US$US
243290081$24329008$1$I$$20240913$20240917$20240917$EXP$$US-TAKEDA-2024TUS092218$TAKEDA$$$$$F$Y$$$20240917$$HP$US$US
243290091$24329009$1$I$$20240912$20240917$20240917$EXP$$JP-AstraZeneca-2024A209108$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$JP$
243290101$24329010$1$I$$20240916$20240917$20240917$PER$$US-AstraZeneca-2024A211816$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243290111$24329011$1$I$20240304$20240911$20240917$20240917$EXP$$CA-TAKEDA-2024TUS021302$TAKEDA$$65$YR$$M$Y$$$20240917$$CN$CA$CA
243290121$24329012$1$I$$20240914$20240917$20240917$EXP$$US-SANDOZ INC.-SDZ2023US045260$SANDOZ$$$$$M$Y$$$20240917$$CN$US$US
243290131$24329013$1$I$20240807$20240912$20240917$20240917$EXP$$CA-AstraZeneca-2024A181269$ASTRAZENECA$$82$YR$$F$Y$56.8$KG$20240917$$CN$CA$
243290141$24329014$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A210094$ASTRAZENECA$$$$$M$Y$74.4$KG$20240917$$CN$US$
243290151$24329015$1$I$$20240913$20240917$20240917$EXP$$NZ-AstraZeneca-2024A209879$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$NZ$
243290161$24329016$1$I$20240911$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210574$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$US$
243290171$24329017$1$I$$20240916$20240917$20240917$PER$$US-AstraZeneca-2024A211315$ASTRAZENECA$$$$A$F$Y$$$20240917$$CN$US$
243290182$24329018$2$F$20240101$20240912$20240917$20240930$EXP$$US-SA-2024SA267564$SANOFI AVENTIS$$45$YR$A$F$Y$61.82$KG$20240930$$MD$US$US
243290191$24329019$1$I$20240825$20240910$20240917$20240917$EXP$$FR-ANIPHARMA-2024-FR-000162$ANI$$64$YR$$F$Y$66$KG$20240917$$MD$FR$FR
243290201$24329020$1$I$20240812$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210678$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$US$
243290211$24329021$1$I$$20240916$20240917$20240917$PER$$US-BAYER-2024A132461$BAYER$$$$$$Y$$$20240917$$CN$US$US
243290221$24329022$1$I$20240801$20240826$20240917$20240917$PER$$US-TRAVERE-2024TVT00845$TRAVERE THERAPEUTICS$$65$YR$E$M$Y$$$20240917$$CN$US$US
243290232$24329023$2$F$$20240918$20240917$20240930$PER$$US-TRAVERE-2024TVT00844$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243290251$24329025$1$I$$20240911$20240917$20240917$EXP$$KR-INCYTE CORPORATION-2024IN009770$INCYTE$Kim HM, Lee J, Kim S, Lee JW, Kim H-J, Cho Y-S.. Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease. BLOOD RESEARCH. 2023;58(3):145-48$$$$$Y$$$20240917$$HP$KR$KR
243290261$24329026$1$I$$20240906$20240917$20240917$PER$$US-ABBVIE-5916232$ABBVIE$$$$$F$Y$$$20240917$$HP$US$US
243290271$24329027$1$I$$20240909$20240917$20240917$PER$$US-JNJFOC-20240920564$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$CN$US$US
243290291$24329029$1$I$$20240823$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160083$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243290301$24329030$1$I$20240901$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008976$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$US$US
243290311$24329031$1$I$20240101$20240913$20240917$20240917$EXP$FR-AFSSAPS-LL2024001720$FR-SANDOZ INC.-SDZ2024FR080024$SANDOZ$$33$YR$$M$Y$$$20240917$$MD$FR$FR
243290321$24329032$1$I$$20240912$20240917$20240917$EXP$$US-SA-2024SA268506$SANOFI AVENTIS$$$$A$M$Y$$$20240917$$MD$US$US
243290331$24329033$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009366$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240917$$CN$US$US
243290351$24329035$1$I$$20240911$20240917$20240917$EXP$$PT-MYLANLABS-2024M1083837$MYLAN$Freitas J, Rodrigues A, Lisboa S, Mariz J.. Composite mantle cell and Burkitt lymphoma: a rare case report (Letter to the Editor). Porto Biomedical Journal. 2024;9 (3):1-2$68$YR$$M$Y$$$20240917$$HP$PT$PT
243290361$24329036$1$I$20240601$20240911$20240917$20240917$EXP$FR-AFSSAPS-AN2024001209$FR-MYLANLABS-2024M1083693$MYLAN$$34$YR$$F$Y$88$KG$20240917$$MD$FR$FR
243290371$24329037$1$I$$20240911$20240917$20240917$EXP$FR-AFSSAPS-AVBX2024000496$FR-MYLANLABS-2024M1083870$MYLAN$$27$YR$$M$Y$$$20240917$$CN$FR$FR
243290381$24329038$1$I$$20240911$20240917$20240917$EXP$$PT-MYLANLABS-2024M1083511$MYLAN$Vasconcelos A, Silva L, Ferreira P, Ribeiro R, Monteiro M, Araujo R.. Complications and relapse in a mantle cell lymphoma patient: a case report.. Medicina Interna.. 2024;31 (2):66-72$73$YR$$M$Y$$$20240917$$MD$PT$PT
243290391$24329039$1$I$20230401$20240910$20240917$20240917$EXP$$US-GSK-US2024112583$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$US$US
243290401$24329040$1$I$$20240913$20240917$20240917$PER$$US-HALEON-2196966$Haleon PLC$$$$$$Y$$$20240917$$CN$US$US
243290411$24329041$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147780$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240917$$CN$US$US
243290421$24329042$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS091929$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243290431$24329043$1$I$$20240914$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146751$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$102.97$KG$20240917$$CN$US$US
243290442$24329044$2$F$$20240909$20240917$20240919$PER$$US-Calliditas-2024CAL01683$CALLIDITAS THERAPEUTICS$$58$YR$A$M$Y$88.9$KG$20240919$$CN$US$US
243290451$24329045$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001198US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240917$$CN$US$US
243290461$24329046$1$I$$20240908$20240917$20240917$PER$$US-ALXN-202409USA001185US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243290471$24329047$1$I$$20240821$20240917$20240917$EXP$$CA-ASTELLAS-2024-AER-002289$ASTELLAS$$43$YR$A$F$Y$96$KG$20240917$$HP$CA$CA
243290481$24329048$1$I$$20240909$20240917$20240917$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001834$BLUEPRINT MEDICINES$$$$$F$Y$$$20240917$$CN$US$US
243290491$24329049$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS092000$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243290501$24329050$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS091927$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243290512$24329051$2$F$$20240923$20240917$20240927$EXP$$CA-BAUSCH-BL-2024-013641$BAUSCH AND LOMB$$40$YR$$F$Y$$$20240927$$HP$CA$CA
243290521$24329052$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024183721$AMGEN$$$$$F$Y$$$20240917$$CN$US$US
243290531$24329053$1$I$$20240912$20240917$20240917$EXP$$ZA-AMERICAN REGENT INC-2024003511$AMERICAN REGENT$$$$$M$Y$$$20240917$$HP$ZA$ZA
243290541$24329054$1$I$20240821$20240830$20240917$20240917$EXP$$US-BEH-2024174783$CSL BEHRING$$61$YR$A$M$Y$79.37$KG$20240917$$HP$US$US
243290551$24329055$1$I$$20240902$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160280$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243290561$24329056$1$I$20240829$20240830$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160271$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243290572$24329057$2$F$$20240916$20240917$20240918$EXP$$CA-BIOMARINAP-CA-2024-160477$BIOMARIN$$$$$$Y$$$20240918$$CN$CA$CA
243290581$24329058$1$I$20240829$20240902$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160279$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243290591$24329059$1$I$$20240830$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160290$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243290601$24329060$1$I$20240829$20240830$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160269$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243290611$24329061$1$I$$20240903$20240917$20240917$EXP$$US-HLS-202401166$HLS THERAPEUTICS$$40$YR$A$M$Y$$$20240917$$HP$ES$US
243290621$24329062$1$I$$20240903$20240917$20240917$EXP$$CA-GILEAD-2024-0660636$GILEAD$$41$YR$A$F$Y$$$20240917$$MD$CA$CA
243290631$24329063$1$I$20240406$20240910$20240917$20240917$EXP$$US-GSK-US2024AMR113934$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$US$US
243290641$24329064$1$I$$20240917$20240917$20240917$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051738$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240917$$MD$AU$AU
243290652$24329065$2$F$20240801$20240919$20240917$20240930$PER$$US-TRAVERE-2024TVT00851$TRAVERE THERAPEUTICS$$41$YR$A$M$Y$$$20240930$$CN$US$US
243290661$24329066$1$I$$20240826$20240917$20240917$PER$$US-TRAVERE-2024TVT00849$TRAVERE THERAPEUTICS$$63$YR$A$F$Y$$$20240917$$CN$US$US
243290673$24329067$3$F$$20240913$20240917$20240930$PER$$US-TRAVERE-2024TVT00847$TRAVERE THERAPEUTICS$$70$YR$E$M$Y$$$20240930$$CN$US$US
243290681$24329068$1$I$$20240826$20240917$20240917$PER$$US-TRAVERE-2024TVT00848$TRAVERE THERAPEUTICS$$18$YR$A$M$Y$$$20240917$$CN$US$US
243290691$24329069$1$I$20240101$20240911$20240917$20240917$EXP$$FR-PURDUE-USA-2024-0311996$PURDUE$$$$E$F$Y$$$20240917$$MD$FR$FR
243290701$24329070$1$I$$20240914$20240917$20240917$EXP$$US-PURDUE PHARMA-USA-2024-0311999$PURDUE$$25$YR$$M$Y$$$20240917$$CN$US$US
243290711$24329071$1$I$20240906$20240906$20240917$20240917$PER$$US-JNJFOC-20240927657$JOHNSON AND JOHNSON$$26$YR$A$$Y$$$20240917$$HP$US$US
243290721$24329072$1$I$20240823$20240827$20240917$20240917$PER$$US-TRAVERE-2024TVT00853$TRAVERE THERAPEUTICS$$35$YR$A$F$Y$$$20240917$$CN$US$US
243290733$24329073$3$F$$20240913$20240917$20240930$PER$$US-TRAVERE-2024TVT00854$TRAVERE THERAPEUTICS$$39$YR$A$F$Y$$$20240930$$CN$US$US
243290741$24329074$1$I$20230718$20240909$20240917$20240917$EXP$$JP-PURDUE-USA-2024-0311631$PURDUE$Yokota H, Akamine Y, Kobayashi M, Kitabayashi T, Horie M, Endo T, et al.. Naldemedine-induced perforation of a diverticulum in the sigmoid colon of a patient with opioid-related constipation: a case report. Journal of pharmaceutical health care and sciences. 2024;10(1):50$65$YR$$M$Y$$$20240917$$PH$JP$JP
243290751$24329075$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS092001$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243290761$24329076$1$I$$20240904$20240917$20240917$EXP$$CA-BAXTER-2024BAX024316$BAXTER$$69$YR$$F$Y$$$20240917$$HP$CA$CA
243290781$24329078$1$I$20240906$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210449$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243290791$24329079$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208676$ASTRAZENECA$$$$$F$Y$$$20240917$$HP$US$
243290801$24329080$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210723$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243290811$24329081$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210373$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243290821$24329082$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS091928$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243290831$24329083$1$I$$20240912$20240917$20240917$EXP$$JP-ANIPHARMA-2024-JP-000261$ANI$$90$YR$$F$Y$$$20240917$$PH$JP$JP
243290841$24329084$1$I$$20240905$20240917$20240917$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18095$IPSEN$$$$$F$Y$$$20240917$$HP$US$US
243290851$24329085$1$I$20070801$20240913$20240917$20240917$EXP$$FR-ANIPHARMA-2024-FR-000165$ANI$$47$YR$$F$Y$$$20240917$$HP$FR$FR
243290861$24329086$1$I$20240101$20240916$20240917$20240917$PER$$US-JNJFOC-20240940742$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240917$$CN$US$US
243290871$24329087$1$I$20240901$20240916$20240917$20240917$PER$$US-JNJFOC-20240940413$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240917$$MD$US$US
243290881$24329088$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS091926$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243290891$24329089$1$I$$20240911$20240917$20240917$EXP$$DE-MYLANLABS-2024M1083481$MYLAN$$$$$M$Y$$$20240917$$CN$DE$DE
243290901$24329090$1$I$20240805$20240906$20240917$20240917$EXP$CN-NMPACDR-1304011038225202400106$CN-BAXTER-2024BAX024514$BAXTER$$67$YR$$F$Y$71$KG$20240917$$MD$CN$CN
243290911$24329091$1$I$20240728$20240911$20240917$20240917$EXP$IT-MINISAL02-999731$IT-MYLANLABS-2024M1079729$MYLAN$$85$YR$$F$Y$55$KG$20240917$$MD$IT$IT
243290921$24329092$1$I$$20240911$20240917$20240917$EXP$$RO-MYLANLABS-2024M1083245$MYLAN$$70$YR$$$Y$$$20240917$$HP$RO$RO
243290931$24329093$1$I$$20240911$20240917$20240917$EXP$$DE-MYLANLABS-2024M1083437$MYLAN$$79$YR$$$Y$$$20240917$$MD$DE$DE
243290941$24329094$1$I$$20240910$20240917$20240917$EXP$$US-GSK-US2024AMR113361$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$CN$US$US
243290951$24329095$1$I$20240911$20240912$20240917$20240917$PER$$US-AMGEN-USASP2024182939$AMGEN$$55$YR$A$F$Y$$$20240917$$CN$US$US
243290961$24329096$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS092004$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243290971$24329097$1$I$$20240910$20240917$20240917$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001847$BLUEPRINT MEDICINES$$$$$F$Y$$$20240917$$CN$US$US
243290981$24329098$1$I$$20240913$20240917$20240917$EXP$$CA-SANDOZ INC.-SDZ2024CA080361$SANDOZ$$69$YR$$F$Y$70$KG$20240917$$MD$CA$CA
243290991$24329099$1$I$20240915$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024185108$AMGEN$$53$YR$A$M$Y$$$20240917$$MD$US$US
243291001$24329100$1$I$20240807$20240820$20240917$20240917$EXP$$US-PHOTOCURE ASA-PHCUS2024000008$PHOTOCURE$$$$$$Y$$$20240917$$HP$US$US
243291031$24329103$1$I$$20240828$20240917$20240917$PER$$US-TRAVERE-2024TVT00862$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
243291042$24329104$2$F$20240701$20240910$20240917$20240930$PER$$US-TRAVERE-2024TVT00861$TRAVERE THERAPEUTICS$$70$YR$E$M$Y$$$20240930$$CN$US$US
243291052$24329105$2$F$20240827$20240919$20240917$20240930$PER$$US-TRAVERE-2024TVT00856$TRAVERE THERAPEUTICS$$39$YR$A$M$Y$$$20240930$$CN$US$US
243291061$24329106$1$I$$20240827$20240917$20240917$PER$$US-TRAVERE-2024TVT00858$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
243291073$24329107$3$F$$20240916$20240917$20240930$PER$$US-TRAVERE-2024TVT00857$TRAVERE THERAPEUTICS$$50$YR$A$M$Y$$$20240930$$CN$US$US
243291082$24329108$2$F$$20240917$20240917$20240930$PER$$US-TRAVERE-2024TVT00859$TRAVERE THERAPEUTICS$$41$YR$A$F$Y$$$20240930$$CN$US$US
243291091$24329109$1$I$20240828$20240828$20240917$20240917$PER$$US-TRAVERE-2024TVT00860$TRAVERE THERAPEUTICS$$35$YR$A$M$Y$$$20240917$$MD$US$US
243291101$24329110$1$I$$20240827$20240917$20240917$PER$$US-TRAVERE-2024TVT00855$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
243291111$24329111$1$I$$20240902$20240917$20240917$EXP$$NVSC2024TW179553$NOVARTIS$Chung BS, Lin PC, Chen SH, Yeh YM. Combination of Anti-programmed Cell Death Protein 1 and Antiangiogenesis Displaying a Response Disparity between Pulmonary and Nonpulmonary Metastases. JOURNAL OF CANCER RESEARCH AND PRACTICE. 2023;10(4):150-3$69$YR$$F$Y$$$20240917$$HP$TW$TW
243291121$24329112$1$I$$20190611$20240917$20240917$EXP$$NVSC2019GB122841$NOVARTIS$$$$$$Y$$$20240917$$CN$GB$GB
243291131$24329113$1$I$20220318$20220413$20240917$20240917$EXP$$NVSC2022HK304849$NOVARTIS$$$$$$Y$$$20240917$$MD$HK$HK
243291141$24329114$1$I$$20210720$20240917$20240917$EXP$$NVSC2021US318490$NOVARTIS$$$$$$Y$$$20240917$$HP$US$US
243291152$24329115$2$F$$20240919$20240917$20240923$EXP$$JP-Eisai-EC-2024-174490$EISAI$$21$YR$A$F$Y$30$KG$20240923$$MD$JP$JP
243291161$24329116$1$I$$20240911$20240917$20240917$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR113930$VIIV$$$$$F$Y$$$20240917$$CN$US$US
243291171$24329117$1$I$20240904$20240909$20240917$20240917$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000936$PAREXEL$$$$$$Y$$$20240917$$HP$CN$CN
243291181$24329118$1$I$20240913$20240917$20240917$20240917$EXP$GB-MHRA-31894728$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051814$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240917$$CN$GB$GB
243291191$24329119$1$I$20240210$20240812$20240917$20240917$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-18168$IPSEN$$4$YR$C$M$Y$17.2$KG$20240917$$MD$GB$GB
243291201$24329120$1$I$$20240912$20240917$20240917$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001860$BLUEPRINT MEDICINES$$$$$F$Y$$$20240917$$CN$US$US
243291211$24329121$1$I$$20240916$20240917$20240917$EXP$$JP-SANDOZ INC.-SDZ2024JP080518$SANDOZ$$$$A$F$Y$$$20240917$$MD$JP$JP
243291221$24329122$1$I$20240901$20240910$20240917$20240917$EXP$$US-GSK-US2024112629$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240917$$CN$US$US
243291232$24329123$2$F$20240908$20240918$20240917$20240924$PER$$MX-REGENERON PHARMACEUTICALS, INC.-2024-122606$REGENERON$$73$YR$$F$Y$$$20240924$$CN$MX$MX
243291241$24329124$1$I$20240823$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184492$AMGEN$$73$YR$E$F$Y$$$20240917$$HP$US$US
243291251$24329125$1$I$20240730$20240912$20240917$20240917$EXP$GB-MHRA-MED-202409121738305820-FBWNG$GB-MYLANLABS-2024M1083569$MYLAN$$72$YR$$M$Y$$$20240917$$MD$GB$GB
243291262$24329126$2$F$$20240919$20240917$20240924$EXP$$GB-MYLANLABS-2024M1084019$MYLAN$$$$$M$Y$$$20240924$$HP$GB$GB
243291271$24329127$1$I$$20240912$20240917$20240917$EXP$$CA-MYLANLABS-2024M1083754$MYLAN$$69$YR$$F$Y$$$20240917$$HP$CA$CA
243291281$24329128$1$I$$20240911$20240917$20240917$EXP$$US-AMGEN-USASP2024181318$AMGEN$Abou-samra A.; Mctavish S.; Whitehair R. et al.. Hit and Run: Bilateral Massive Intraocular Lymphomatous Infiltration after CAR-T Therapy. Ocular Immunology and Inflammation. 2024;32 (7):1444-1447$62$YR$A$M$Y$$$20240917$$MD$US$US
243291291$24329129$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009099$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240917$$CN$US$US
243291301$24329130$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009488$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240917$$CN$US$US
243291311$24329131$1$I$20240902$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409007308$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240917$$CN$US$US
243291321$24329132$1$I$20240910$20240911$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409007719$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240917$$CN$US$US
243291331$24329133$1$I$$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409010117$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240917$$CN$US$US
243291341$24329134$1$I$$20240909$20240917$20240917$PER$$US-HALEON-2196605$Haleon PLC$$30$YR$$M$Y$$$20240917$$MD$US$US
243291351$24329135$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS092003$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243291361$24329136$1$I$$20240909$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147951$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$97.98$KG$20240917$$HP$US$US
243291371$24329137$1$I$$20240915$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146508$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$78.47$KG$20240917$$CN$US$US
243291381$24329138$1$I$20240915$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024185175$AMGEN$$71$YR$E$F$Y$$$20240917$$CN$US$US
243291391$24329139$1$I$$20240912$20240917$20240917$EXP$$NVSC2024US142663$NOVARTIS$$$$$F$Y$81.82$KG$20240917$$MD$US$US
243291401$24329140$1$I$$20240912$20240917$20240917$EXP$$JP-AstraZeneca-2024A209202$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$JP$
243291411$24329141$1$I$$20240830$20240917$20240917$PER$$US-JNJFOC-20240902906$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243291421$24329142$1$I$20240813$20240909$20240917$20240917$EXP$FR-AFSSAPS-BX2024001702$FR-BAXTER-2024BAX024399$BAXTER$$12$YR$$M$Y$21$KG$20240917$$PH$FR$FR
243291431$24329143$1$I$20141114$20240913$20240917$20240917$EXP$FR-002147023-PHHY2015FR012809$FR-ROCHE-10000081878$ROCHE$$$$$$Y$$$20240917$$HP$FR$FR
243291441$24329144$1$I$$20240909$20240917$20240917$PER$$US-ABBVIE-5918072$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243291451$24329145$1$I$20240821$20240917$20240917$20240917$EXP$$US-BAYER-2024A132523$BAYER$$90$YR$E$M$Y$$$20240917$$CN$US$US
243291471$24329147$1$I$$20240913$20240917$20240917$EXP$$NO-AstraZeneca-2024A212089$ASTRAZENECA$$$$$M$Y$$$20240917$$HP$NO$
243291481$24329148$1$I$20240517$20240913$20240917$20240917$PER$$US-GILEAD-2024-0687690$GILEAD$$68$YR$E$M$Y$69.3$KG$20240917$$HP$US$US
243291492$24329149$2$F$$20240909$20240917$20240917$EXP$$US-AMGEN-USASP2024182099$AMGEN$Young A.; Lu K.; Dai A. et al.. Biologic efficacy and reasons for discontinuation in a tertiary referral hidradenitis suppurativa clinic. Journal of the American Academy of Dermatology. 2024;91 (3):AB25$$$$$Y$$$20240917$$MD$US$US
243291501$24329150$1$I$$20240912$20240917$20240917$EXP$$US-INCYTE CORPORATION-2024IN009649$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243291511$24329151$1$I$$20240909$20240917$20240917$EXP$$GB-INCYTE CORPORATION-2024IN009781$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J et al.. Ruxolitinib versus Best Available Therapy for PV intolerant or resistant to Hydroxycarbamide in a Randomized trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41 (9):3534-45$$$$$Y$$$20240917$$HP$GB$GB
243291521$24329152$1$I$$20240829$20240917$20240917$PER$$US-TRAVERE-2024TVT00868$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
243291531$24329153$1$I$$20240828$20240917$20240917$PER$$US-TRAVERE-2024TVT00865$TRAVERE THERAPEUTICS$$51$YR$A$F$Y$$$20240917$$CN$US$US
243291541$24329154$1$I$$20240829$20240917$20240917$PER$$US-TRAVERE-2024TVT00866$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240917$$CN$US$US
243291571$24329157$1$I$20240828$20240829$20240917$20240917$PER$$US-TRAVERE-2024TVT00869$TRAVERE THERAPEUTICS$$59$YR$A$F$Y$$$20240917$$CN$US$US
243291581$24329158$1$I$$20240829$20240917$20240917$PER$$US-TRAVERE-2024TVT00870$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$MD$US$US
243291591$24329159$1$I$$20240909$20240917$20240917$EXP$$GB-INCYTE CORPORATION-2024IN009780$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J e al.. Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41(19):3534-44$$$$$Y$$$20240917$$HP$GB$GB
243291601$24329160$1$I$$20240910$20240917$20240917$EXP$$CN-MYLANLABS-2024M1083313$MYLAN$Li H, Cheng W, Yang H, Yang J, Li W, Chen P, et al. Clinical Study on Benefiting-Qi Arthralgia-eliminating Decoction in the Treatment of Knee Synovitis of Dysfunction of Spleen in Transportation Pattern. Western Journal of Traditional Chinese Medicine. 2024;37(8):124-128$$$A$$Y$$$20240917$$HP$CN$CN
243291611$24329161$1$I$$20240909$20240917$20240917$EXP$GB-MHRA-TPP5695104C581080YC1725638235203$GB-TEVA-VS-3242363$TEVA$$62$YR$$F$Y$73$KG$20240917$$MD$GB$GB
243291621$24329162$1$I$$20240909$20240917$20240917$EXP$$GB-INCYTE CORPORATION-2024IN009779$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O Sullivan J et al.. Ruxolitinib versus Best Available Therapy for PV intolerant or resistant to Hydroxycarbamide in a Randomized trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41 (9):3534-45$$$$$Y$$$20240917$$HP$GB$GB
243291631$24329163$1$I$20240909$20240909$20240917$20240917$EXP$$GB-TEVA-VS-3242359$TEVA$$82$YR$$F$Y$74$KG$20240917$$MD$GB$GB
243291641$24329164$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS091930$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243291661$24329166$1$I$20240501$20240909$20240917$20240917$EXP$FR-AFSSAPS-TO2024001685$FR-TEVA-VS-3242011$TEVA$$21$YR$$M$Y$$$20240917$$PH$FR$FR
243291672$24329167$2$F$$20240919$20240917$20240927$EXP$$US-TEVA-VS-3243088$TEVA$Erol LA, Layman CP. Paraneoplastic Hyperthyroidism Secondary to a Chemotherapy-Induced Surge in beta-hCG in a Patient with Non-Seminomatous Germ Cell Tumor. [Review]. Hawaii-J-Health-Soc-Welf 2024; 83 (2): 45-47.; Erol LA, Layman CP. Paraneoplastic Hyperthyroidism Secondary to a Chemotherapy-Induced Surge in beta-hCG in a Patient with Non-Seminomatous Germ Cell Tumor. [Review]. Hawaii-J-Health-Soc-Welf 2024; 83 (2): 45-47.$21$YR$$M$Y$$$20240927$$MD$US$US
243291691$24329169$1$I$$20240909$20240917$20240917$EXP$$GB-INCYTE CORPORATION-2024IN009772$INCYTE$Harrison CN, Nangalia J, Boucher J, Jackson A, Yap C, O^Sullivan J e al.. Ruxolitinib versus Best Available Therapy for PV intolerant or resistant to Hydroxycarbamide in Randomized trial.. Journal of Clinical Oncology.. 2023;41 (19):3534-44$$$$$Y$$$20240917$$HP$GB$GB
243291701$24329170$1$I$$20240909$20240917$20240917$EXP$$GB-INCYTE CORPORATION-2024IN009771$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J e al.. Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41(19):3534-44$$$$$Y$$$20240917$$HP$GB$GB
243291711$24329171$1$I$20240911$20240916$20240917$20240917$EXP$$US-GILEAD-2024-0687899$GILEAD$$50$YR$A$M$Y$$$20240917$$CN$US$US
243291721$24329172$1$I$20200817$20240911$20240917$20240917$EXP$$DE-PFIZER INC-202400252392$PFIZER$$$$$M$Y$$$20240917$$MD$DE$DE
243291732$24329173$2$F$20170613$20240917$20240917$20240923$EXP$$CA-PFIZER INC-202400257520$PFIZER$$37$YR$$F$Y$$$20240923$$MD$CA$CA
243291741$24329174$1$I$20240101$20240910$20240917$20240917$PER$$US-ABBVIE-5920744$ABBVIE$$$$$F$Y$$$20240917$$MD$US$US
243291751$24329175$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001215US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243291761$24329176$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147504$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240917$$HP$US$US
243291771$24329177$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147550$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240917$$HP$US$US
243291781$24329178$1$I$$20240916$20240917$20240917$EXP$$IT-SANDOZ INC.-SDZ2024IT080405$SANDOZ$$50$YR$$M$Y$$$20240917$$HP$IT$IT
243291791$24329179$1$I$$20240916$20240917$20240917$EXP$$IT-SANDOZ INC.-SDZ2024IT080362$SANDOZ$$45$YR$$M$Y$$$20240917$$HP$IT$IT
243291801$24329180$1$I$$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024185155$AMGEN$$$$$$Y$$$20240917$$PH$US$US
243291811$24329181$1$I$20240909$20240911$20240917$20240917$EXP$$US-FERRINGPH-2024FE05167$FERRING$$$$$$Y$$$20240917$$CN$US$US
243291821$24329182$1$I$$20240909$20240917$20240917$EXP$$JP-FERRINGPH-2024FE05206$FERRING$$$$$$Y$$$20240917$$MD$JP$JP
243291831$24329183$1$I$20240807$20240909$20240917$20240917$EXP$$US-FERRINGPH-2024FE05147$FERRING$$$$$$Y$$$20240917$$CN$US$US
243291851$24329185$1$I$20240101$20240912$20240917$20240917$EXP$$DE-ORGANON-O2409DEU001128$ORGANON$$46$YR$$F$Y$$$20240917$$MD$DE$DE
243291861$24329186$1$I$$20240909$20240917$20240917$30DAY$$US-PFIZER INC-202400253274$PFIZER$$14$YR$$M$Y$$$20240917$$CN$US$US
243291872$24329187$2$F$20240101$20240909$20240917$20240919$30DAY$$CA-PFIZER INC-202400254621$PFIZER$$$$$$Y$$$20240919$$HP$CA$CA
243291891$24329189$1$I$$20240830$20240917$20240917$PER$$US-TRAVERE-2024TVT00872$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
243291903$24329190$3$F$$20240918$20240917$20240930$PER$$US-TRAVERE-2024TVT00873$TRAVERE THERAPEUTICS$$37$YR$A$F$Y$$$20240930$$CN$US$US
243291911$24329191$1$I$$20240830$20240917$20240917$PER$$US-TRAVERE-2024TVT00874$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240917$$CN$US$US
243291922$24329192$2$F$$20240918$20240917$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147028$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240920$$MD$US$US
243291931$24329193$1$I$$20240910$20240917$20240917$PER$US-MLMSERVICE-20240903-PI181707-00307-1$US-RDY-SPO/USA/24/0013349$DR REDDYS$Hussain SA, Berenji R, Faisal S, Ali L, Knavel A. A rare case of symmetrical drug-related intertriginous and flexural erythema with tamoxifen use. Clinical case reports. 2024;12(9):e9401. DOI: 10.1002/ccr3.9401.$48$YR$A$F$Y$$$20240917$$MD$US$US
243291941$24329194$1$I$$20240914$20240917$20240917$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR114554$VIIV$$$$$$Y$$$20240917$$HP$US$US
243291951$24329195$1$I$$20240912$20240917$20240917$PER$$NVSC2024US184039$NOVARTIS$$$$$M$Y$$$20240917$$CN$US$US
243291961$24329196$1$I$20240910$20240910$20240917$20240917$PER$$NVSC2024US184187$NOVARTIS$$72$YR$$M$Y$$$20240917$$CN$US$US
243291971$24329197$1$I$$20240911$20240917$20240917$EXP$$NVSC2024CA183260$NOVARTIS$$27$YR$$$Y$$$20240917$$HP$CA$CA
243291981$24329198$1$I$20240830$20240912$20240917$20240917$EXP$AT-BASGAGES-2024-006750$AT-ABBVIE-5920445$ABBVIE$$84$YR$$M$Y$75$KG$20240917$$MD$AT$AT
243291993$24329199$3$F$20240902$20240923$20240917$20240930$EXP$$NVSC2024ZA184358$NOVARTIS$$57$YR$$M$Y$$$20240930$$HP$ZA$ZA
243292001$24329200$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A208080$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243292011$24329201$1$I$20240701$20240913$20240917$20240917$PER$$US-BAYER-2024A131928$BAYER$$36$YR$A$F$Y$$$20240917$$CN$US$US
243292021$24329202$1$I$$20240910$20240917$20240917$PER$$US-ABBVIE-5919972$ABBVIE$$4$YR$$$Y$$$20240917$$HP$US$US
243292031$24329203$1$I$$20240910$20240917$20240917$PER$$US-EMD Serono-2024048900$EMD SERONO INC$$$$A$$Y$$$20240917$$PH$US$US
243292041$24329204$1$I$$20240910$20240917$20240917$EXP$NL-LRB-00999635$NL-TEVA-VS-3242364$TEVA$$77$YR$$M$Y$70$KG$20240917$$MD$NL$NL
243292081$24329208$1$I$$20240910$20240917$20240917$EXP$$US-SANDOZ INC.-SDZ2024US079604$SANDOZ$Raymond R. Blush III. ?-Adrenergic Agonist?Induced Lactic Acidosis: A Case Report. 2024$54$YR$$F$Y$$$20240917$$HP$US$US
243292091$24329209$1$I$20240814$20240913$20240917$20240917$EXP$IT-MINISAL02-1001904$IT-PFIZER INC-202400255943$PFIZER$$17$YR$$M$Y$$$20240917$$CN$IT$IT
243292111$24329211$1$I$20240709$20240916$20240917$20240917$EXP$FR-AFSSAPS-GR2024001073$FR-PFIZER INC-202400257021$PFIZER$$73$YR$$F$Y$$$20240917$$PH$FR$FR
243292121$24329212$1$I$20240101$20240913$20240917$20240917$EXP$$CN-PFIZER INC-PV202400120917$PFIZER$$73$YR$$F$Y$$$20240917$$HP$CN$CN
243292141$24329214$1$I$$20240905$20240917$20240917$EXP$$IN-B.Braun Medical Inc.-2161721$B BRAUN$Literature Article$41$YR$$F$Y$$$20240917$$$IN$IN
243292151$24329215$1$I$20240315$20240805$20240917$20240917$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-18159$IPSEN$$1$YR$I$M$Y$9.5$KG$20240917$$MD$GB$GB
243292172$24329217$2$F$20240321$20240913$20240917$20240920$EXP$$CO-TAKEDA-2024TUS029690$TAKEDA$$63$YR$$M$Y$51$KG$20240920$$CN$CO$CO
243292191$24329219$1$I$$20240913$20240917$20240917$EXP$$US-TAKEDA-2024TUS092466$TAKEDA$$$$$M$Y$$$20240917$$CN$US$US
243292201$24329220$1$I$20230901$20240905$20240917$20240917$EXP$$US-ROCHE-3521935$ROCHE$$47$YR$A$M$Y$$$20240917$$MD$US$US
243292211$24329221$1$I$20240823$20240903$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160282$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243292221$24329222$1$I$20240819$20240902$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160281$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243292231$24329223$1$I$$20240903$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160303$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243292242$24329224$2$F$$20240923$20240917$20240925$EXP$$PT-MYLANLABS-2024M1083267$MYLAN$$62$YR$$M$Y$$$20240925$$MD$PT$PT
243292251$24329225$1$I$$20240909$20240917$20240917$EXP$$US-JNJFOC-20240934743$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240917$$HP$US$US
243292261$24329226$1$I$$20240913$20240917$20240917$PER$$NVSC2024US184846$NOVARTIS$$$$$F$Y$$$20240917$$HP$US$US
243292281$24329228$1$I$$20240829$20240917$20240917$EXP$$US-SA-2024SA268432$SANOFI AVENTIS$$$$E$F$Y$95.45$KG$20240917$$MD$US$US
243292292$24329229$2$F$$20240909$20240917$20240919$EXP$$JP-009507513-2409JPN001461J$MERCK$$63$YR$$F$Y$$$20240919$$HP$JP$JP
243292301$24329230$1$I$20240101$20240829$20240917$20240917$EXP$$US-SA-2024SA267990$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240917$$PH$US$US
243292311$24329231$1$I$$20240910$20240917$20240917$EXP$$IL-009507513-2409ISR005157$MERCK$Shawer R, Solomon A. Adverse effects of anti-cancer biologics on the ocular surface. Current Opinion in Allergy and Clinical Immunology. 2024;24 (5):390-6$46$YR$$M$Y$$$20240917$$HP$IL$IL
243292331$24329233$1$I$$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147817$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240917$$CN$US$US
243292341$24329234$1$I$$20240916$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147745$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240917$$CN$US$US
243292351$24329235$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147692$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$66.68$KG$20240917$$CN$US$US
243292371$24329237$1$I$20200901$20240909$20240917$20240917$EXP$$SI-SANDOZ INC.-NVSC2020SI262657$SANDOZ$$83$YR$$M$Y$$$20240917$$MD$SI$SI
243292381$24329238$1$I$$20240911$20240917$20240917$EXP$$US-SA-2024SA267496$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240917$$HP$US$US
243292391$24329239$1$I$$20240910$20240917$20240917$EXP$$US-SA-2024SA268496$SANOFI AVENTIS$$$$A$M$Y$$$20240917$$MD$US$US
243292401$24329240$1$I$$20240904$20240917$20240917$PER$$US-ALKERMES INC.-ALK-2024-002307$ALKERMES$$19$YR$$F$Y$$$20240917$$HP$US$US
243292411$24329241$1$I$$20240908$20240917$20240917$EXP$$ES-AMGEN-ESPSP2024181779$AMGEN$Moralejo Lozano O.; Ruano Dlaz L.; Abanades Tercero M. et al.. INTESTINAL ULTRASOUND AND ITS ROLE IN THE ACUTE SETTING: STENOSING CROHN^S DISEASE AND ACUTE BOWEL OBSTRUCTION DUE TO FOREIGN BODY INGESTION (DENTAL POST AND CROWN). Revista espanola de enfermedades digestivas. 2024;119$39$YR$A$F$Y$$$20240917$$HP$ES$ES
243292421$24329242$1$I$20240911$20240914$20240917$20240917$EXP$$CN-SA-2024SA268251$SANOFI AVENTIS$$70$YR$E$M$Y$60$KG$20240917$$HP$CN$CN
243292431$24329243$1$I$$20240812$20240917$20240917$PER$$CH-TRAVERE-2024TVT00880$TRAVERE THERAPEUTICS$$$$$$Y$$$20240917$$MD$CH$CH
243292441$24329244$1$I$$20240830$20240917$20240917$PER$$US-TRAVERE-2024TVT00877$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240917$$CN$US$US
243292453$24329245$3$F$20240801$20240911$20240917$20240930$PER$$US-TRAVERE-2024TVT00878$TRAVERE THERAPEUTICS$$57$YR$A$M$Y$$$20240930$$CN$US$US
243292461$24329246$1$I$$20240830$20240917$20240917$PER$$US-TRAVERE-2024TVT00879$TRAVERE THERAPEUTICS$$43$YR$A$M$Y$$$20240917$$CN$US$US
243292472$24329247$2$F$20240722$20240922$20240917$20240926$EXP$$US-Eisai-EC-2024-174373$EISAI$$69$YR$E$F$Y$86$KG$20240926$$MD$US$US
243292481$24329248$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3242979$TEVA$$50$YR$$F$Y$$$20240917$$CN$CA$CA
243292491$24329249$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3244162$TEVA$$60$YR$$F$Y$$$20240917$$HP$CA$CA
243292501$24329250$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009187$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240917$$CN$US$US
243292511$24329251$1$I$20240709$20240916$20240917$20240917$PER$$US-ALXN-202409USA001200US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$HP$US$US
243292521$24329252$1$I$$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409010127$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240917$$CN$US$US
243292531$24329253$1$I$$20240912$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008453$ELI LILLY AND CO$$$$$M$Y$$$20240917$$CN$US$US
243292541$24329254$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001159US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243292551$24329255$1$I$20240201$20240911$20240917$20240917$EXP$FR-AFSSAPS-RN2024000963$FR-009507513-2409FRA004269$MERCK$$72$YR$$M$Y$$$20240917$$MD$FR$FR
243292571$24329257$1$I$$20240909$20240917$20240917$PER$$US-ABBVIE-5917288$ABBVIE$$45$YR$$F$Y$$$20240917$$HP$US$US
243292581$24329258$1$I$$20240911$20240917$20240917$EXP$$ES-AMGEN-ESPSP2024183857$AMGEN$Lluch P.; Ballester M. P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240917$$MD$ES$ES
243292591$24329259$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3243637$TEVA$$$$$$Y$$$20240917$$HP$CA$CA
243292601$24329260$1$I$$20240912$20240917$20240917$EXP$$US-GILEAD-2024-0687623$GILEAD$$$$A$F$Y$$$20240917$$CN$US$US
243292611$24329261$1$I$20240101$20240913$20240917$20240917$PER$$US-PFIZER INC-202400257538$PFIZER$$29$YR$$M$Y$$$20240917$$HP$US$US
243292631$24329263$1$I$20240912$20240915$20240917$20240917$PER$$US-PFIZER INC-202400257530$PFIZER$$$$E$F$Y$$$20240917$$CN$US$US
243292641$24329264$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-202400257910$PFIZER$$47$YR$$M$Y$$$20240917$$MD$US$US
243292651$24329265$1$I$$20240914$20240917$20240917$PER$$US-PFIZER INC-PV202400121322$PFIZER$$$$$$Y$$$20240917$$CN$US$US
243292661$24329266$1$I$20240101$20240912$20240917$20240917$PER$$US-PFIZER INC-202400256230$PFIZER$$$$$M$Y$$$20240917$$CN$US$US
243292671$24329267$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-202400257881$PFIZER$$31$YR$$M$Y$$$20240917$$MD$US$US
243292681$24329268$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-PV202400121509$PFIZER$$52$YR$$F$Y$$$20240917$$HP$US$US
243292691$24329269$1$I$20240915$20240915$20240917$20240917$PER$$US-PFIZER INC-202400257288$PFIZER$$67$YR$$F$Y$$$20240917$$CN$US$US
243292701$24329270$1$I$20240701$20240912$20240917$20240917$PER$$US-PFIZER INC-PV202300105790$PFIZER$$65$YR$$F$Y$$$20240917$$MD$US$US
243292711$24329271$1$I$$20240913$20240917$20240917$PER$$US-PFIZER INC-PV202400120627$PFIZER$$56$YR$$$Y$$$20240917$$CN$US$US
243292721$24329272$1$I$20230101$20240916$20240917$20240917$PER$$US-PFIZER INC-202400257603$PFIZER$$$$A$M$Y$$$20240917$$CN$US$US
243292731$24329273$1$I$$20240916$20240917$20240917$PER$$US-PFIZER INC-PV202400121536$PFIZER$$57$YR$$M$Y$$$20240917$$HP$US$US
243292741$24329274$1$I$20240904$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160299$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243292752$24329275$2$F$20220901$20240919$20240917$20240927$EXP$$US-TEVA-VS-3243165$TEVA$Yohane M, Naufal F, Mendoza-Ticona A, Svensson EM, Weir IR, Scarsi KK, et al. Conjugated hyperbilirubinemia associated with accidental rifapentine overdose. Int-J-Tuberc-Lung-Dis 2024; 28 (7): 354-356.; Yohane M, Naufal F, Mendoza-Ticona A, Svensson EM, Weir IR, Scarsi KK, et al. Conjugated hyperbilirubinemia associated with accidental rifapentine overdose. Int-J-Tuberc-Lung-Dis 2024; 28 (7): 354-356.; Yohane M, Naufal F, Mendoza-Ticona A, Svensson EM, Weir IR, Scarsi KK, et al. Conjugated hy...$22$YR$$F$Y$33$KG$20240927$$HP$US$US
243292761$24329276$1$I$$20240812$20240917$20240917$PER$$CH-TRAVERE-2024TVT00904$TRAVERE THERAPEUTICS$$$$$$Y$$$20240917$$MD$CH$CH
243292772$24329277$2$F$$20240923$20240917$20240925$PER$$US-BIOMARINAP-US-2024-160316$BIOMARIN$$$$$$Y$$$20240925$$CN$US$US
243292781$24329278$1$I$$20240812$20240917$20240917$PER$$CH-TRAVERE-2024TVT00901$TRAVERE THERAPEUTICS$$$$$$Y$$$20240917$$MD$CH$CH
243292791$24329279$1$I$$20240812$20240917$20240917$PER$$CH-TRAVERE-2024TVT00881$TRAVERE THERAPEUTICS$$$$$$Y$$$20240917$$MD$CH$CH
243292801$24329280$1$I$20240412$20240910$20240917$20240917$EXP$$US-ABBVIE-5919522$ABBVIE$$85$YR$$F$Y$$$20240917$$CN$US$US
243292811$24329281$1$I$20240101$20240905$20240917$20240917$EXP$$CN-UCBSA-2024010812$UCB$$43$YR$$F$Y$60$KG$20240917$$MD$CN$CN
243292831$24329283$1$I$20240901$20240916$20240917$20240917$EXP$$US-KYOWAKIRIN-2024KK021527$KYOWA$$$$$$Y$$$20240917$$HP$US$US
243292861$24329286$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001216US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240917$$CN$US$US
243292872$24329287$2$F$20240101$20240909$20240917$20240920$EXP$$AU-TAKEDA-2024TUS001766$TAKEDA$$16$YR$$M$Y$$$20240920$$MD$AU$AU
243292881$24329288$1$I$20240902$20240907$20240917$20240917$EXP$$US-RADIUS HEALTH INC.-2024US007035$RADIUS PHARM$$63$YR$$F$Y$$$20240917$$CN$US$US
243292891$24329289$1$I$20240712$20240909$20240917$20240917$EXP$$US-ABBVIE-5917578$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243292901$24329290$1$I$$20240911$20240917$20240917$EXP$$US-009507513-2409USA004271$MERCK$$$$$M$Y$$$20240917$$CN$US$US
243292911$24329291$1$I$$20240913$20240917$20240917$PER$$US-TAKEDA-2024TUS091888$TAKEDA$$$$$F$Y$$$20240917$$MD$US$US
243292931$24329293$1$I$$20240909$20240917$20240917$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-129433$BRISTOL MYERS SQUIBB$Sampaio B, Leal M, Urmal I, Rebelo M, Gomes F, Lisboa M. Uma insuficiencia suprarrenal multifatorial?. Congressos da Sociedade Portuguesa de Medicina Interna: 30.o Congresso Nacional. 2024;30:606.$83$YR$E$M$Y$$$20240917$$MD$PT$PT
243292941$24329294$1$I$20240819$20240916$20240917$20240917$EXP$FR-AFSSAPS-AVCF2024000580$FR-SANDOZ INC.-SDZ2024FR080521$SANDOZ$$49$YR$$F$Y$$$20240917$$HP$FR$FR
243292952$24329295$2$F$$20240919$20240917$20240927$EXP$$US-TEVA-VS-3242977$TEVA$Ansari AN, Johnson EF, Wang KL, Koster MJ, Cantwell HM. SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing. JAAD-Case-Rep 2024; 43 57-59.; Ansari AN, Johnson EF, Wang KL, Koster MJ, Cantwell HM. SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing. JAAD-Case-Rep 2024; 43 57-59.; Ansari AN, Johnson EF, Wang KL, Koster MJ, Cantwell HM. SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing. JAAD-Case-Rep 2024; 43 57-59.$50$YR$$M$Y$$$20240927$$MD$US$US
243292961$24329296$1$I$$20240916$20240917$20240917$PER$$US-ALXN-202409USA001199US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240917$$CN$US$US
243292971$24329297$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185431$NOVARTIS$$$$$M$Y$$$20240917$$CN$US$US
243293001$24329300$1$I$$20240915$20240917$20240917$PER$$NVSC2024US184845$NOVARTIS$$$$$$Y$$$20240917$$CN$US$US
243293021$24329302$1$I$$20240830$20240917$20240917$30DAY$$CA-JNJFOC-20240901808$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$HP$CA$CA
243293031$24329303$1$I$$20240905$20240917$20240917$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409004539$ELI LILLY AND CO$$30$YR$A$F$Y$70$KG$20240917$$CN$CN$CN
243293041$24329304$1$I$20240908$20240909$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409005736$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240917$$CN$US$US
243293051$24329305$1$I$20240718$20240916$20240917$20240917$EXP$GB-MHRA-MED-202409151541129150-HSZFD$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-147649$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$105$KG$20240917$$MD$GB$GB
243293061$24329306$1$I$20240720$20240911$20240917$20240917$EXP$FR-AFSSAPS-AN2024001217$FR-ELI_LILLY_AND_COMPANY-FR202409007799$ELI LILLY AND CO$$80$YR$E$F$Y$70.5$KG$20240917$$CN$FR$FR
243293081$24329308$1$I$20240201$20240912$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146920$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240917$$CN$US$US
243293091$24329309$1$I$20240101$20240911$20240917$20240917$PER$$US-JNJFOC-20240934952$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$CN$US$US
243293101$24329310$1$I$$20240909$20240917$20240917$EXP$$GB-TEVA-VS-3241766$TEVA$$84$YR$$F$Y$55$KG$20240917$$MD$GB$GB
243293111$24329311$1$I$$20240910$20240917$20240917$EXP$$NVSC2024CA181835$NOVARTIS$$52$YR$$F$Y$$$20240917$$HP$CA$CA
243293121$24329312$1$I$20240905$20240916$20240917$20240917$EXP$$US-KYOWAKIRIN-2024KK021536$KYOWA$$$$$$Y$$$20240917$$HP$US$US
243293131$24329313$1$I$20240916$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024185194$AMGEN$$70$YR$E$F$Y$$$20240917$$CN$US$US
243293141$24329314$1$I$$20240909$20240917$20240917$EXP$$GB-TEVA-VS-3242326$TEVA$$70$YR$$F$Y$68$KG$20240917$$MD$GB$GB
243293151$24329315$1$I$20230901$20240909$20240917$20240917$EXP$GB-MHRA-MED-202409091928410690-VLMKN$GB-TEVA-VS-3242391$TEVA$$38$YR$$F$Y$91$KG$20240917$$CN$GB$GB
243293161$24329316$1$I$20240913$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184903$AMGEN$$61$YR$A$M$Y$$$20240917$$CN$US$US
243293171$24329317$1$I$20240916$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024185134$AMGEN$$61$YR$A$F$Y$$$20240917$$CN$US$US
243293181$24329318$1$I$20220701$20240910$20240917$20240917$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051158$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240917$$CN$US$US
243293191$24329319$1$I$20240101$20240913$20240917$20240917$PER$$US-JNJFOC-20240936303$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$CN$US$US
243293201$24329320$1$I$$20240912$20240917$20240917$PER$$US-JNJFOC-20240935157$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$CN$US$US
243293212$24329321$2$F$20230517$20240916$20240917$20240925$EXP$$CA-VER-202400479$VERITY PHARMACEUTICALS$$81$YR$E$M$Y$$$20240925$$PH$CA$CA
243293221$24329322$1$I$20240101$20240912$20240917$20240917$PER$$US-ABBVIE-5922579$ABBVIE$$$$$$Y$$$20240917$$CN$US$US
243293231$24329323$1$I$$20240912$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146912$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240917$$MD$US$US
243293241$24329324$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147271$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240917$$CN$US$US
243293251$24329325$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147610$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240917$$CN$US$US
243293261$24329326$1$I$20101228$20240905$20240917$20240917$EXP$$US-ASTELLAS-2024-AER-005281$ASTELLAS$$66$YR$E$F$Y$68.027$KG$20240917$$CN$US$US
243293271$24329327$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147358$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$65.77$KG$20240917$$CN$US$US
243293281$24329328$1$I$$20240903$20240917$20240917$EXP$$US-HLS-202401167$HLS THERAPEUTICS$$28$YR$A$M$Y$$$20240917$$MD$JP$US
243293291$24329329$1$I$$20240913$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147694$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240917$$CN$US$US
243293301$24329330$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147578$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240917$$CN$US$US
243293311$24329331$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147644$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$128.37$KG$20240917$$CN$US$US
243293321$24329332$1$I$$20240909$20240917$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-143886$BRISTOL MYERS SQUIBB$Niimoto T, Todaka T, Kimura H, Suzuki S, Yoshino S, Hoashi K, et al. Cytokine release syndrome following covid-19 infection during treatment with nivolumab for cancer of esophagogastric junction carcinoma: a case report and review. International Journal of Emergency Medicine. 2024 Sep 02;17(1):1-10. doi:10.1186/s12245-024-00691-5.$60$YR$A$M$Y$$$20240917$$HP$JP$JP
243293331$24329333$1$I$$20240915$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146525$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$65.77$KG$20240917$$CN$US$US
243293341$24329334$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147704$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240917$$CN$US$US
243293351$24329335$1$I$20240830$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146917$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240917$$PH$US$US
243293361$24329336$1$I$20240905$20240913$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147813$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240917$$CN$US$US
243293382$24329338$2$F$20240606$20240925$20240917$20240930$EXP$$CA-BIOGEN-2024BI01282179$BIOGEN$$18$YR$$M$Y$$$20240930$$MD$CA$CA
243293391$24329339$1$I$$20240907$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160447$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243293401$24329340$1$I$20240912$20240913$20240917$20240917$EXP$$DE-BIOMARINAP-DE-2024-160578$BIOMARIN$$$$$$Y$$$20240917$$CN$DE$DE
243293411$24329341$1$I$20240403$20240916$20240917$20240917$EXP$ES-AEMPS-1569832$ES-GILEAD-2024-0687873$GILEAD$$48$YR$A$F$Y$63$KG$20240917$$MD$ES$ES
243293421$24329342$1$I$$20240916$20240917$20240917$PER$$US-BAYER-2024A132256$BAYER$$44$YR$A$F$Y$$$20240917$$HP$US$US
243293431$24329343$1$I$20180814$20240916$20240917$20240917$EXP$$FR-SANDOZ INC.-PHHY2018FR092604$SANDOZ$$89$YR$$F$Y$69$KG$20240917$$PH$FR$FR
243293441$24329344$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147593$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240917$$CN$US$US
243293451$24329345$1$I$$20240910$20240917$20240917$EXP$$APELLIS-2024-APL-0000984$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240917$$MD$COUNTRY NOT SPECIFIED$US
243293461$24329346$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922715$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243293471$24329347$1$I$$20240905$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009405$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243293491$24329349$1$I$$20240905$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009409$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243293501$24329350$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409008929$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240917$$CN$US$US
243293511$24329351$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3243452$TEVA$$75$YR$$F$Y$$$20240917$$HP$CA$CA
243293521$24329352$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3243477$TEVA$$33$YR$$M$Y$$$20240917$$MD$CA$CA
243293531$24329353$1$I$$20240906$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009456$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243293541$24329354$1$I$20240830$20240909$20240917$20240917$PER$$US-009507513-2409USA003408$MERCK$$$$$$Y$$$20240917$$HP$US$US
243293551$24329355$1$I$$20240912$20240917$20240917$PER$$US-JNJFOC-20240934957$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243293561$24329356$1$I$$20240911$20240917$20240917$PER$$US-JNJFOC-20240937960$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$CN$US$US
243293571$24329357$1$I$$20240916$20240917$20240917$EXP$$US-GILEAD-2024-0687891$GILEAD$$36$YR$A$F$Y$$$20240917$$CN$US$US
243293581$24329358$1$I$$20240911$20240917$20240917$EXP$$CA-TEVA-VS-3242850$TEVA$$9$YR$$M$Y$$$20240917$$CN$CA$CA
243293601$24329360$1$I$$20240906$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160456$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243293611$24329361$1$I$$20240827$20240917$20240917$EXP$$US-SA-2024SA267557$SANOFI AVENTIS$$$$A$F$Y$130$KG$20240917$$MD$US$US
243293621$24329362$1$I$20240731$20240913$20240917$20240917$EXP$$US-KYOWAKIRIN-2024KK021458$KYOWA$$$$$$Y$$$20240917$$HP$US$US
243293631$24329363$1$I$20240831$20240913$20240917$20240917$EXP$$US-AMERICAN REGENT INC-2024003530$AMERICAN REGENT$$65$YR$$F$Y$113.9$KG$20240917$$HP$US$US
243293641$24329364$1$I$$20240909$20240917$20240917$PER$$US-JNJFOC-20240935445$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$HP$US$US
243293651$24329365$1$I$$20240910$20240917$20240917$PER$$US-JNJFOC-20240940269$JOHNSON AND JOHNSON$$4$DEC$A$$Y$$$20240917$$HP$US$US
243293661$24329366$1$I$20240601$20240905$20240917$20240917$PER$$US-JNJFOC-20240931559$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240917$$HP$US$US
243293671$24329367$1$I$$20240909$20240917$20240917$PER$$US-JNJFOC-20240935925$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20240917$$MD$US$US
243293681$24329368$1$I$$20240905$20240917$20240917$PER$$US-JNJFOC-20240930701$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$MD$US$US
243293691$24329369$1$I$20240915$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024185174$AMGEN$$76$YR$E$F$Y$$$20240917$$CN$US$US
243293701$24329370$1$I$$20240911$20240917$20240917$EXP$$DE-MYLANLABS-2024M1083748$MYLAN$$$$$M$Y$87$KG$20240917$$CN$DE$DE
243293721$24329372$1$I$20240910$20240910$20240917$20240917$EXP$$RU-GE HEALTHCARE-2024CSU010426$GE HEALTHCARE$$40$YR$$F$Y$58$KG$20240917$$MD$RU$RU
243293731$24329373$1$I$20211123$20240909$20240917$20240917$EXP$$IL-ABBVIE-4141255$ABBVIE$$70$YR$$M$Y$73$KG$20240917$$MD$IL$IL
243293741$24329374$1$I$20240625$20240625$20240917$20240917$PER$$US-GE HEALTHCARE-2024CSU007157$GE HEALTHCARE$$$$$$Y$$$20240917$$HP$US$US
243293761$24329376$1$I$20240508$20240621$20240917$20240917$EXP$$US-GE HEALTHCARE-2024CSU005188$GE HEALTHCARE$$$$$M$Y$$$20240917$$HP$US$US
243293771$24329377$1$I$$20240916$20240917$20240917$EXP$$US-KYOWAKIRIN-2024KK021538$KYOWA$$$$$$Y$$$20240917$$HP$US$US
243293791$24329379$1$I$$20240905$20240917$20240917$PER$$US-JNJFOC-20240772780$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$PH$US$US
243293801$24329380$1$I$$20240909$20240917$20240917$PER$$US-JNJFOC-20240931508$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240917$$HP$US$US
243293811$24329381$1$I$$20240906$20240917$20240917$PER$$US-JNJFOC-20240934656$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$HP$US$US
243293821$24329382$1$I$$20240912$20240917$20240917$EXP$$CA-PFIZER INC-202400256282$PFIZER$$86$YR$$M$Y$$$20240917$$HP$CA$CA
243293831$24329383$1$I$$20240912$20240917$20240917$PER$$US-ABBVIE-5924007$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243293841$24329384$1$I$$20231117$20240917$20240917$PER$$US-LANNETT COMPANY, INC.-US-2023LAN000147$LANNETT$$$$$F$Y$$$20240917$$CN$US$US
243293852$24329385$2$F$20240222$20240917$20240917$20240921$EXP$JP-MMM-RJZP4FKE$JP-ABBVIE-5926677$ABBVIE$$$$$M$Y$$$20240921$$MD$JP$JP
243293861$24329386$1$I$$20240718$20240917$20240917$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000167$LANNETT$$$$$M$Y$$$20240917$$CN$US$US
243293871$24329387$1$I$$20240130$20240917$20240917$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000022$LANNETT$$$$$F$Y$$$20240917$$CN$US$US
243293881$24329388$1$I$20240412$20240412$20240917$20240917$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000053$LANNETT$$$$$M$Y$$$20240917$$CN$US$US
243293891$24329389$1$I$$20230817$20240917$20240917$PER$$US-LANNETT COMPANY, INC.-US-2023LAN000102$LANNETT$$$$$F$Y$$$20240917$$CN$US$US
243293901$24329390$1$I$20230101$20230919$20240917$20240917$PER$$US-LANNETT COMPANY, INC.-US-2023LAN000115$LANNETT$$$$$F$Y$$$20240917$$CN$US$US
243293911$24329391$1$I$20240301$20240323$20240917$20240917$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000049$LANNETT$$$$$$Y$$$20240917$$CN$US$US
243293921$24329392$1$I$$20240430$20240917$20240917$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000118$LANNETT$$$$$$Y$$$20240917$$CN$US$US
243293931$24329393$1$I$$20231019$20240917$20240917$PER$$US-LANNETT COMPANY, INC.-US-2023LAN000135$LANNETT$$$$$$Y$$$20240917$$CN$US$US
243293951$24329395$1$I$$20230808$20240917$20240917$PER$$US-LANNETT COMPANY, INC.-US-2023LAN000101$LANNETT$$$$$F$Y$$$20240917$$CN$US$US
243293961$24329396$1$I$$20240723$20240917$20240917$PER$$US-LANNETT COMPANY, INC.-US-2024LAN000168$LANNETT$$$$$F$Y$$$20240917$$CN$US$US
243293971$24329397$1$I$$20240916$20240917$20240917$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-069343$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240917$$MD$GB$GB
243293991$24329399$1$I$20240812$20240909$20240917$20240917$EXP$FR-AFSSAPS-NT2024001096$FR-TEVA-VS-3242002$TEVA$$79$YR$$M$Y$55$KG$20240917$$PH$FR$FR
243294001$24329400$1$I$$20240911$20240917$20240917$PER$$US-JNJFOC-20240940533$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$PH$US$US
243294012$24329401$2$F$20240610$20240920$20240917$20240926$EXP$$JP-009507513-2409JPN001623J$MERCK$$59$YR$$F$Y$$$20240926$$MD$JP$JP
243294021$24329402$1$I$20240801$20240916$20240917$20240917$EXP$FR-AFSSAPS-MP2024001362$FR-PFIZER INC-202400257029$PFIZER$$65$YR$$F$Y$42$KG$20240917$$PH$FR$FR
243294031$24329403$1$I$20240101$20240911$20240917$20240917$EXP$$US-009507513-2409USA004472$MERCK$$$$$M$Y$$$20240917$$MD$US$US
243294041$24329404$1$I$$20240912$20240917$20240917$EXP$$US-OTSUKA-2024_025709$OTSUKA$$$$$M$Y$75.28$KG$20240917$$CN$US$US
243294051$24329405$1$I$20240501$20240909$20240917$20240917$EXP$$US-SPRINGWORKS THERAPEUTICS-SW-001740$SPRINGWORKS THERAPEUTIC$$17$YR$$F$Y$$$20240917$$CN$US$US
243294061$24329406$1$I$20240715$20240913$20240917$20240917$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-147074$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240917$$CN$TW$TW
243294081$24329408$1$I$20190213$20240916$20240917$20240917$EXP$AU-TGA-469394$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051651$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240917$$HP$AU$AU
243294101$24329410$1$I$20240501$20240912$20240917$20240917$EXP$$CA-ABBVIE-5924070$ABBVIE$$$$A$$Y$$$20240917$$CN$CA$CA
243294111$24329411$1$I$$20240904$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009354$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243294121$24329412$1$I$$20240903$20240917$20240917$EXP$$CA-TARO PHARMACEUTICALS USA INC.-2024TAR01534$TARO$Lagace-Thomassin F, Nateghi A, Kechichian E, Veilleux M. Topical imiquimod adverse event: Beyond the local skin reaction-A case report. SAGE Open Med Case Rep. 2024;12:No pagination$$$$$Y$$$20240918$$HP$CA$CA
243294131$24329413$1$I$$20240906$20240917$20240917$PER$$US-JNJFOC-20240942283$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240917$$CN$US$US
243294141$24329414$1$I$20240829$20240904$20240917$20240917$EXP$$CA-HLS-202402220$HLS THERAPEUTICS$$67$YR$E$F$Y$$$20240917$$HP$CA$CA
243294152$24329415$2$F$$20240913$20240917$20240918$PER$$NVSC2024US184681$NOVARTIS$$$$$$Y$$$20240918$$CN$US$US
243294161$24329416$1$I$$20240911$20240917$20240917$PER$$US-ABBVIE-5920695$ABBVIE$$$$$$Y$$$20240917$$HP$US$US
243294171$24329417$1$I$$20240905$20240917$20240917$EXP$$ZA-DSJP-DSJ-2024-144827$DAIICHI$$$$$F$Y$$$20240917$$MD$ZA$ZA
243294181$24329418$1$I$$20240912$20240917$20240917$EXP$$CA-MYLANLABS-2024M1083820$MYLAN$$53$YR$$F$Y$53$KG$20240917$$CN$CA$CA
243294191$24329419$1$I$20240915$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024185200$AMGEN$$81$YR$E$F$Y$$$20240917$$CN$US$US
243294201$24329420$1$I$$20240910$20240917$20240917$EXP$GB-MLMSERVICE-20240903-PI179979-00029-1$GB-PERRIGO-24GB008657$PERRIGO$Chean CS, Ali AIAH, Malick H. Bilateral simultaneous acute angle closure glaucoma triggered by an over-the-counter cold and influenza medication. BMJ case reports. 2024;17(8):e260950. DOI: 10.1136/bcr-2024-260950.$$$E$F$Y$$$20240917$$MD$GB$GB
243294211$24329421$1$I$20240101$20240909$20240917$20240917$EXP$$JP-009507513-2408JPN000637J$MERCK$$7$DEC$$M$Y$$$20240917$$MD$JP$JP
243294222$24329422$2$F$20240830$20240910$20240917$20240923$EXP$$CN-009507513-2409CHN004267$MERCK$$65$YR$$F$Y$60$KG$20240923$$HP$CN$CN
243294231$24329423$1$I$$20240911$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145953$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240917$$CN$US$US
243294271$24329427$1$I$$20240913$20240917$20240917$EXP$$NVSC2024US184296$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
243294281$24329428$1$I$$20240904$20240917$20240917$EXP$$GB-ADVANZ PHARMA-202409007383$ADVANZ PHARMA$$$$$$Y$$$20240917$$MD$GB$GB
243294291$24329429$1$I$$20240916$20240917$20240917$EXP$$US-ALXN-202409USA001202US$ALEXION PHARMACEUTICALS$$66$YR$$F$Y$$$20240917$$CN$US$US
243294301$24329430$1$I$20240101$20240910$20240917$20240917$PER$$US-AMGEN-USASP2024180890$AMGEN$$$$A$M$Y$$$20240917$$CN$US$US
243294311$24329431$1$I$20220331$20240911$20240917$20240917$EXP$FR-AFSSAPS-PC2024000687$FR-009507513-2409FRA005026$MERCK$$70$YR$$F$Y$$$20240917$$PH$FR$FR
243294321$24329432$1$I$$20240914$20240917$20240917$PER$$NVSC2024US184509$NOVARTIS$$$$$$Y$$$20240917$$CN$US$US
243294331$24329433$1$I$$20240910$20240917$20240917$PER$$US-ABBVIE-5920015$ABBVIE$$$$I$$Y$$$20240917$$PH$US$US
243294342$24329434$2$F$$20240919$20240917$20240927$EXP$$DE-TEVA-VS-3243082$TEVA$Liesenfeld LF, Brandl A. Influence of hyperthermic intraperitoneal chemotherapy on renal blood perfusion. Langenbecks-Arch-Surg 2023; 408 (1): 1-11; Liesenfeld LF, Brandl A. Influence of hyperthermic intraperitoneal chemotherapy on renal blood perfusion. Langenbecks-Arch-Surg 2023; 408 (1): 1-11.$$$$$Y$$$20240927$$HP$DE$DE
243294361$24329436$1$I$$20240912$20240917$20240917$PER$$US-AstraZeneca-2024A209541$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243294371$24329437$1$I$20240110$20240913$20240917$20240917$EXP$$SG-AstraZeneca-2024A211285$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$SG$
243294381$24329438$1$I$20240728$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210687$ASTRAZENECA$$$$$M$Y$$$20240917$$CN$US$
243294391$24329439$1$I$20240725$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210658$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$US$
243294401$24329440$1$I$$20240916$20240917$20240917$EXP$$US-AstraZeneca-2024A211370$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243294421$24329442$1$I$$20240908$20240917$20240917$PER$$US-AstraZeneca-2024A206067$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243294431$24329443$1$I$$20240909$20240917$20240917$PER$$US-AstraZeneca-2024A207267$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243294441$24329444$1$I$$20240911$20240917$20240917$PER$$US-VERTEX PHARMACEUTICALS-2024-014540$VERTEX$$$$$$Y$$$20240917$$CN$US$US
243294452$24329445$2$F$$20240916$20240917$20240917$PER$$US-ALXN-202409USA000576US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240917$$HP$US$US
243294461$24329446$1$I$$20240908$20240917$20240917$PER$$US-ABBVIE-5916893$ABBVIE$$$$$$Y$$$20240917$$HP$US$US
243294491$24329449$1$I$20240801$20240910$20240917$20240917$PER$$US-AMGEN-USASP2024180958$AMGEN$$$$$$Y$$$20240917$$MD$US$US
243294502$24329450$2$F$$20240912$20240917$20240918$PER$$US-009507513-2409USA005363$MERCK$$$$$F$Y$$$20240918$$CN$US$US
243294511$24329451$1$I$20240424$20240805$20240917$20240917$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-18172$IPSEN$$2$YR$C$M$Y$12$KG$20240917$$MD$US$US
243294521$24329452$1$I$$20240913$20240917$20240917$EXP$$US-BAUSCH-BL-2022-006963$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240917$$CN$US$US
243294531$24329453$1$I$$20240906$20240917$20240917$PER$$US-IMP-2024000728$Harrow Health$$$$E$F$Y$$$20240917$$CN$US$US
243294541$24329454$1$I$$20240911$20240917$20240917$EXP$$CA-BAUSCH-BL-2024-013679$BAUSCH AND LOMB$$$$$F$Y$$$20240917$$MD$CA$CA
243294551$24329455$1$I$20240228$20240909$20240917$20240917$EXP$FR-AFSSAPS-TO2024001646$FR-TEVA-VS-3241890$TEVA$$83$YR$$M$Y$46$KG$20240917$$MD$FR$FR
243294571$24329457$1$I$$20240913$20240917$20240917$EXP$$MQ-AstraZeneca-2024A211503$ASTRAZENECA$$$$$F$Y$$$20240917$$MD$MQ$FR
243294581$24329458$1$I$$20240913$20240917$20240917$EXP$$RO-AstraZeneca-2024A209965$ASTRAZENECA$$$$$M$Y$$$20240917$$MD$RO$
243294591$24329459$1$I$$20240905$20240917$20240917$PER$$US-AstraZeneca-2024A202856$ASTRAZENECA$$$$$F$Y$$$20240917$$CN$US$
243294601$24329460$1$I$$20240911$20240917$20240917$PER$$US-AstraZeneca-2024A208451$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243294611$24329461$1$I$$20240912$20240917$20240917$EXP$$ZA-AstraZeneca-2024A210325$ASTRAZENECA$$62$YR$$M$Y$$$20240917$$CN$ZA$
243294621$24329462$1$I$$20240906$20240917$20240917$PER$$US-JNJFOC-20240919563$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$CN$US$US
243294631$24329463$1$I$20240901$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409010090$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240917$$CN$US$US
243294651$24329465$1$I$$20240904$20240917$20240917$EXP$$US-ABBVIE-5910158$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243294671$24329467$1$I$20240831$20240912$20240917$20240917$PER$$US-009507513-2409USA004985$MERCK$$$$$F$Y$74.376$KG$20240917$$CN$US$US
243294682$24329468$2$F$20240909$20240924$20240917$20240927$EXP$$JP-Eisai-EC-2024-174328$EISAI$$$$E$F$Y$$$20240927$$MD$JP$JP
243294692$24329469$2$F$20240901$20240917$20240917$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147016$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240924$$CN$US$US
243294701$24329470$1$I$$20240915$20240917$20240917$EXP$$BE-BAUSCH-BL-2024-013889$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240917$$MD$BE$BE
243294721$24329472$1$I$$20240909$20240917$20240917$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-015291$JAZZ$A. Yuasa, et.al. A study on early diagnosis of post-transplant SOS and short-term prognosis using HokUS-6. The 49th Annual Scientific Meeting of the Japanese Society of Sonographers$$$$$Y$$$20240917$$HP$JP$JP
243294731$24329473$1$I$$20240906$20240917$20240917$PER$$US-JNJFOC-20240919552$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$CN$US$US
243294751$24329475$1$I$20240901$20240904$20240917$20240917$PER$$US-ALKERMES INC.-ALK-2024-002316$ALKERMES$$$$$M$Y$$$20240917$$HP$US$US
243294761$24329476$1$I$$20240904$20240917$20240917$PER$$US-ALKERMES INC.-ALK-2024-002314$ALKERMES$$$$$M$Y$$$20240917$$MD$US$US
243294771$24329477$1$I$$20240716$20240917$20240917$EXP$$US-OTSUKA-2024_025833$OTSUKA$$$$$F$Y$$$20240917$$CN$US$US
243294781$24329478$1$I$$20240905$20240917$20240917$PER$$US-ALKERMES INC.-ALK-2024-002324$ALKERMES$$$$$M$Y$$$20240917$$HP$US$US
243294791$24329479$1$I$$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160346$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243294802$24329480$2$F$20240901$20240918$20240917$20240927$PER$$US-ALKERMES INC.-ALK-2024-002318$ALKERMES$$46$YR$$M$Y$91.61$KG$20240927$$CN$US$US
243294811$24329481$1$I$$20240805$20240917$20240917$PER$$US-FMCRTG-FMC-2408-000976$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240917$$CN$US$US
243294821$24329482$1$I$$20240816$20240917$20240917$PER$$US-FMCRTG-FMC-2408-001025$FRESENIUS MEDICAL CARE$$68$YR$E$F$Y$$$20240917$$CN$US$US
243294832$24329483$2$F$$20240916$20240917$20240927$EXP$$US-FMCRTG-FMC-2409-001112$FRESENIUS MEDICAL CARE$$75$YR$E$M$Y$107.5$KG$20240927$$HP$US$US
243294841$24329484$1$I$$20240905$20240917$20240917$EXP$$US-FMCRTG-FMC-2409-001111$FRESENIUS MEDICAL CARE$$73$YR$E$M$Y$95$KG$20240917$$HP$US$US
243294851$24329485$1$I$$20240805$20240917$20240917$PER$$US-FMCRTG-FMC-2408-000975$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240917$$HP$US$US
243294861$24329486$1$I$$20240910$20240917$20240917$EXP$$NVSC2024CA181848$NOVARTIS$$52$YR$$F$Y$$$20240917$$HP$CA$CA
243294871$24329487$1$I$$20240806$20240917$20240917$PER$$US-FMCRTG-FMC-2408-000954$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240917$$CN$US$US
243294881$24329488$1$I$20240813$20240814$20240917$20240917$PER$$US-FMCRTG-FMC-2408-001020$FRESENIUS MEDICAL CARE$$47$YR$A$F$Y$$$20240917$$HP$US$US
243294891$24329489$1$I$20240802$20240807$20240917$20240917$PER$$US-FMCRTG-FMC-2408-000952$FRESENIUS MEDICAL CARE$$79$YR$E$M$Y$$$20240917$$HP$US$US
243294901$24329490$1$I$20231111$20240820$20240917$20240917$PER$$US-FMCRTG-FMC-2408-001047$FRESENIUS MEDICAL CARE$$44$YR$A$F$Y$$$20240917$$HP$US$US
243294911$24329491$1$I$20240905$20240905$20240917$20240917$PER$$US-ALKERMES INC.-ALK-2024-002336$ALKERMES$$29$YR$$M$Y$$$20240917$$PH$US$US
243294921$24329492$1$I$$20240905$20240917$20240917$PER$$US-ALKERMES INC.-ALK-2024-002331$ALKERMES$$$$$F$Y$$$20240917$$HP$US$US
243294931$24329493$1$I$$20240905$20240917$20240917$PER$$US-ALKERMES INC.-ALK-2024-002334$ALKERMES$$16$YR$$M$Y$$$20240917$$HP$US$US
243294941$24329494$1$I$$20240913$20240917$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015120$JAZZ$$$$$F$Y$28$KG$20240917$$CN$US$US
243294951$24329495$1$I$$20240913$20240917$20240917$EXP$$DE-PURDUE-USA-2024-0312012$PURDUE$$$$$M$Y$87$KG$20240917$$CN$DE$DE
243294961$24329496$1$I$$20240913$20240917$20240917$PER$$NVSC2024US184781$NOVARTIS$$$$$F$Y$$$20240917$$HP$US$US
243294971$24329497$1$I$$20240913$20240917$20240917$PER$$NVSC2024US184616$NOVARTIS$$$$$F$Y$$$20240917$$CN$US$US
243294981$24329498$1$I$$20240905$20240917$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003823$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240917$$CN$US$US
243294992$24329499$2$F$20230927$20240914$20240917$20240919$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409009196$ELI LILLY AND CO$$68$YR$E$F$Y$69$KG$20240919$$CN$CN$CN
243295001$24329500$1$I$20240904$20240905$20240917$20240917$EXP$$US-ELI_LILLY_AND_COMPANY-US202409003655$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240917$$CN$US$US
243295021$24329502$1$I$20240626$20240905$20240917$20240917$EXP$GB-MHRA-MED-202409050854384920-STPFZ$GB-ELI_LILLY_AND_COMPANY-GB202409004138$ELI LILLY AND CO$$57$YR$A$F$Y$73$KG$20240917$$CN$GB$GB
243295031$24329503$1$I$$20240905$20240917$20240917$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409003108$ELI LILLY AND CO$$$$$F$Y$$$20240917$$MD$GB$GB
243295041$24329504$1$I$$20240910$20240917$20240917$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409006905$ELI LILLY AND CO$$$$$F$Y$$$20240917$$CN$FR$FR
243295051$24329505$1$I$$20240906$20240917$20240917$EXP$$JP-BAUSCHBL-2024BNL031443$BAUSCH AND LOMB$$$$E$M$Y$$$20240917$$PH$JP$JP
243295061$24329506$1$I$20240905$20240912$20240917$20240917$EXP$$CN-PURDUE-USA-2024-0312008$PURDUE$$74$YR$$M$Y$57$KG$20240917$$HP$CN$CN
243295071$24329507$1$I$$20240912$20240917$20240917$EXP$$AT-PURDUE-USA-2024-0312015$PURDUE$Scorza CA, Finsterer J, Scorza FA. Takotsubo syndrome is triggered by hypoactive delirium and recognized by increased catecholamine requirement in the ICU. Clinics. 2024;79$60$YR$$F$Y$75$KG$20240917$$HP$AT$AT
243295081$24329508$1$I$$20240913$20240917$20240917$EXP$CA-HEALTHCANVIG-E2B_07261966$CA-PURDUE-USA-2024-0312011$PURDUE$$45$YR$$M$Y$$$20240917$$CN$CA$CA
243295091$24329509$1$I$$20240905$20240917$20240917$PER$$US-ALKERMES INC.-ALK-2024-002347$ALKERMES$$$$$F$Y$$$20240917$$CN$US$US
243295101$24329510$1$I$$20240916$20240917$20240917$PER$$US-PURDUE PHARMA-USA-2024-0312001$PURDUE$$$$$F$Y$$$20240917$$CN$US$US
243295111$24329511$1$I$$20240916$20240917$20240917$PER$$US-PURDUE PHARMA-USA-2024-0312000$PURDUE$$$$$F$Y$$$20240917$$CN$US$US
243295121$24329512$1$I$$20240916$20240917$20240917$PER$$US-PURDUE PHARMA-USA-2024-0312002$PURDUE$$$$$$Y$$$20240917$$CN$US$US
243295141$24329514$1$I$$20240912$20240917$20240917$EXP$$NVSC2024FR184765$NOVARTIS$$56$YR$$F$Y$$$20240917$$MD$FR$FR
243295161$24329516$1$I$20240101$20240905$20240917$20240917$PER$$US-ALKERMES INC.-ALK-2024-002340$ALKERMES$$19$YR$$F$Y$$$20240917$$HP$US$US
243295171$24329517$1$I$20240913$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184703$AMGEN$$71$YR$E$F$Y$$$20240917$$CN$US$US
243295201$24329520$1$I$$20240913$20240917$20240917$PER$$NVSC2024US184666$NOVARTIS$$$$$$Y$$$20240917$$CN$US$US
243295211$24329521$1$I$$20240912$20240917$20240917$PER$$NVSC2024US183988$NOVARTIS$$$$$M$Y$$$20240917$$MD$US$US
243295222$24329522$2$F$20240101$20240913$20240917$20240918$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051510$BOEHRINGER INGELHEIM$$40$YR$A$F$Y$$$20240918$$CN$US$US
243295232$24329523$2$F$$20240913$20240917$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147645$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240918$$CN$US$US
243295241$24329524$1$I$$20240916$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147596$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240917$$HP$US$US
243295251$24329525$1$I$20240822$20240912$20240917$20240917$EXP$$US-Eisai-EC-2024-174341$EISAI$$78$YR$E$F$Y$$$20240917$$MD$US$US
243295261$24329526$1$I$$20240909$20240917$20240917$PER$$US-AstraZeneca-2024A207262$ASTRAZENECA$$$$$$Y$$$20240917$$CN$US$
243295271$24329527$1$I$$20240909$20240917$20240917$PER$$US-AstraZeneca-2024A204983$ASTRAZENECA$$$$$$Y$$$20240917$$HP$US$
243295281$24329528$1$I$$20240912$20240917$20240917$PER$$US-JNJFOC-20240931951$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$US$US
243295291$24329529$1$I$$20240911$20240917$20240917$PER$$US-JNJFOC-20240929189$JOHNSON AND JOHNSON$$10$YR$C$$Y$31.78$KG$20240917$$CN$US$US
243295311$24329531$1$I$20240909$20240911$20240917$20240917$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000277$DENDREON$$$$$$Y$$$20240917$$HP$US$US
243295341$24329534$1$I$$20240911$20240917$20240917$PER$$US-JNJFOC-20240928442$JOHNSON AND JOHNSON$$$$$$Y$$$20240917$$HP$US$US
243295351$24329535$1$I$$20240913$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147150$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240917$$HP$US$US
243295364$24329536$4$F$$20240910$20240917$20240925$EXP$$ES-009507513-2409ESP004473$MERCK$Flota-Ruiz D, Garcia Reyes ME, Goncalves Martins G, Ruiz Carmona C, Sanchez Besalduch L, et al. Arterial Pseudoaneurysms, a Rare Complication of BCG Treatment: Three Case Reports. European Journal of Vascular and Endovascular. 2024;67(3):e61$72$YR$$M$Y$$$20240925$$HP$ES$ES
243295371$24329537$1$I$20240909$20240909$20240917$20240917$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27718$SAMSUNG BIOEPIS$$77$YR$E$F$Y$$$20240917$$HP$CA$CA
243295381$24329538$1$I$$20240905$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009449$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243295391$24329539$1$I$$20240904$20240917$20240917$PER$$US-JNJFOC-20240919959$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$CN$US$US
243295401$24329540$1$I$$20240905$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009406$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243295411$24329541$1$I$$20240905$20240917$20240917$PER$$US-INCYTE CORPORATION-2024IN009407$INCYTE$$$$$$Y$$$20240917$$CN$US$US
243295421$24329542$1$I$20240801$20240902$20240917$20240917$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27040$SAMSUNG BIOEPIS$$87$YR$E$M$Y$$$20240917$$CN$CA$CA
243295461$24329546$1$I$20240101$20240906$20240917$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014471$JAZZ$$$$$F$Y$$$20240917$$CN$US$US
243295471$24329547$1$I$20190101$20240906$20240917$20240917$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409004080$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240917$$CN$NL$CN
243295481$24329548$1$I$$20240913$20240917$20240917$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-147768$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240917$$HP$GB$GB
243295512$24329551$2$F$20240916$20240917$20240917$20240918$PER$$US-AMGEN-USASP2024184588$AMGEN$$54$YR$A$M$Y$$$20240918$$CN$US$US
243295531$24329553$1$I$$20240909$20240917$20240917$EXP$$US-AstraZeneca-2024A206269$ASTRAZENECA$$$$$M$Y$95.3$KG$20240917$$CN$US$
243295541$24329554$1$I$20240705$20240912$20240917$20240917$PER$$US-009507513-2408USA002067$MERCK$$50$YR$$F$Y$96.145$KG$20240917$$HP$US$US
243295551$24329555$1$I$$20240916$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409010135$ELI LILLY AND CO$$89$YR$E$F$Y$$$20240917$$CN$US$US
243295561$24329556$1$I$$20240911$20240917$20240917$EXP$$NVSC2024BR184355$NOVARTIS$$$$$M$Y$$$20240918$$CN$BR$BR
243295571$24329557$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185589$NOVARTIS$$$$$$Y$$$20240918$$PH$US$US
243295581$24329558$1$I$$20240910$20240917$20240917$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014771$JAZZ$$$$$F$Y$$$20240917$$HP$US$US
243295591$24329559$1$I$20240821$20240904$20240917$20240917$EXP$$AR-TAKEDA-2024TUS092326$TAKEDA$$30$YR$$M$Y$$$20240917$$CN$AR$AR
243295601$24329560$1$I$$20240916$20240917$20240917$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051705$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240917$$PH$US$US
243295611$24329561$1$I$$20240910$20240917$20240917$PER$$NVSC2024US182160$NOVARTIS$$$$$$Y$$$20240918$$CN$US$US
243295621$24329562$1$I$$20240903$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160294$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243295631$24329563$1$I$20240830$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160306$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243295641$24329564$1$I$$20240909$20240917$20240917$PER$$US-BIOGEN-2024BI01274664$BIOGEN$$$$$F$Y$$$20240917$$CN$US$US
243295651$24329565$1$I$$20240916$20240917$20240917$EXP$GB-MHRA-MED-202409151929339600-GQDVT$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051732$BOEHRINGER INGELHEIM$$47$YR$A$M$Y$160$KG$20240917$$CN$GB$GB
243295661$24329566$1$I$20240101$20240910$20240917$20240917$PER$$US-ABBVIE-5920736$ABBVIE$$$$$$Y$$$20240917$$MD$US$US
243295681$24329568$1$I$20240201$20240913$20240917$20240917$EXP$$BB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051823$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240917$$MD$BB$BB
243295701$24329570$1$I$$20240904$20240917$20240917$EXP$$US-BIOMARINAP-US-2024-160407$BIOMARIN$Cooney E.,  Ammous Z., Andersson H., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5-years of experience with pegvaliase in US clinics: A case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240917$$MD$US$US
243295711$24329571$1$I$$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160404$BIOMARIN$Cooney E.,  Ammous Z., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240917$$MD$US$US
243295721$24329572$1$I$$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160406$BIOMARIN$Cooney E.,  Ammous Z., Andersson H., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5-years of experience with pegvaliase in US clinics: A case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240917$$MD$US$US
243295731$24329573$1$I$20240828$20240905$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160330$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243295741$24329574$1$I$$20240905$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160372$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243295751$24329575$1$I$20240801$20240916$20240917$20240917$EXP$$NVSC2024US184970$NOVARTIS$$77$YR$$M$Y$$$20240918$$HP$US$US
243295761$24329576$1$I$$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160405$BIOMARIN$Cooney E.,  Ammous Z., Andersson H., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5-years of experience with pegvaliase in US clinics: A case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240917$$MD$US$US
243295771$24329577$1$I$$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160355$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243295782$24329578$2$F$$20240917$20240917$20240918$PER$$NVSC2024US185300$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243295792$24329579$2$F$20240905$20240923$20240917$20240925$EXP$$NVSC2024ZA183045$NOVARTIS$$54$YR$$F$Y$$$20240925$$HP$ZA$ZA
243295801$24329580$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185627$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243295811$24329581$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185459$NOVARTIS$$$$$F$Y$$$20240918$$MD$US$US
243295821$24329582$1$I$20240724$20240726$20240917$20240917$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000110$UROGEN PHARMA$$$$$$Y$$$20240918$$CN$US$US
243295831$24329583$1$I$20240905$20240910$20240917$20240917$EXP$$NVSC2024BR125450$NOVARTIS$$40$YR$$F$Y$$$20240918$$CN$BR$BR
243295841$24329584$1$I$$20240722$20240917$20240917$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000108$UROGEN PHARMA$$$$$$Y$$$20240918$$CN$US$US
243295851$24329585$1$I$$20240801$20240917$20240917$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000109$UROGEN PHARMA$$$$$$Y$$$20240918$$MD$US$US
243295861$24329586$1$I$$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160408$BIOMARIN$Cooney E.,  Ammous Z., Andersson H., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5-years of experience with pegvaliase in US clinics: A case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240917$$MD$US$US
243295871$24329587$1$I$$20240906$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160382$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243295881$24329588$1$I$20240909$20240909$20240917$20240917$PER$$US-BIOGEN-2024BI01281735$BIOGEN$$51$YR$$M$Y$$$20240917$$CN$US$US
243295891$24329589$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147659$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$88.9$KG$20240917$$CN$US$US
243295921$24329592$1$I$20240801$20240821$20240917$20240917$PER$$US-SA-2024SA265913$SANOFI AVENTIS$$4$YR$C$M$Y$14.7$KG$20240918$$HP$US$US
243295931$24329593$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA266564$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243295941$24329594$1$I$20240101$20240821$20240917$20240917$PER$$US-SA-2024SA266229$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240918$$CN$US$US
243295951$24329595$1$I$20240801$20240821$20240917$20240917$PER$$US-SA-2024SA266292$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240918$$CN$US$US
243295961$24329596$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA266044$SANOFI AVENTIS$$$$$M$Y$$$20240918$$CN$US$US
243295971$24329597$1$I$20240101$20240821$20240917$20240917$PER$$US-SA-2024SA266876$SANOFI AVENTIS$$2$YR$C$M$Y$15.64$KG$20240918$$MD$US$US
243295981$24329598$1$I$20240101$20240820$20240917$20240917$PER$$US-SA-2024SA267397$SANOFI AVENTIS$$53$YR$A$F$Y$65.76$KG$20240918$$MD$US$US
243295991$24329599$1$I$20240101$20240821$20240917$20240917$PER$$US-SA-2024SA266310$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240918$$MD$US$US
243296001$24329600$1$I$20240101$20240821$20240917$20240917$PER$$US-SA-2024SA266735$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240918$$MD$US$US
243296011$24329601$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA265840$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$MD$US$US
243296021$24329602$1$I$20240801$20240821$20240917$20240917$PER$$US-SA-2024SA266729$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240918$$MD$US$US
243296031$24329603$1$I$20240729$20240805$20240917$20240917$PER$$US-SA-2024SA266639$SANOFI AVENTIS$$$$$F$Y$$$20240918$$CN$US$US
243296041$24329604$1$I$20240601$20240821$20240917$20240917$PER$$US-SA-2024SA266498$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240918$$MD$US$US
243296051$24329605$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA266647$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240918$$CN$US$US
243296062$24329606$2$F$$20240917$20240917$20240925$EXP$$VN-TAKEDA-2024TUS091575$TAKEDA$$63$YR$$M$Y$62$KG$20240925$$CN$VN$VN
243296071$24329607$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA266937$SANOFI AVENTIS$$$$A$M$Y$77.11$KG$20240918$$HP$US$US
243296081$24329608$1$I$$20240820$20240917$20240917$PER$$US-SA-2024SA263699$SANOFI AVENTIS$$$$A$F$Y$104$KG$20240918$$MD$US$US
243296091$24329609$1$I$20240724$20240821$20240917$20240917$PER$$US-SA-2024SA265874$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240918$$MD$US$US
243296101$24329610$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA267617$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$CN$US$US
243296111$24329611$1$I$20240601$20240821$20240917$20240917$PER$$US-SA-2024SA268018$SANOFI AVENTIS$$$$$F$Y$$$20240918$$MD$US$US
243296121$24329612$1$I$$20240820$20240917$20240917$PER$$US-SA-2024SA264014$SANOFI AVENTIS$$$$E$F$Y$69.478$KG$20240918$$MD$US$US
243296131$24329613$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA262924$SANOFI AVENTIS$$$$A$M$Y$50$KG$20240918$$MD$US$US
243296141$24329614$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA267077$SANOFI AVENTIS$$$$C$F$Y$10.82$KG$20240918$$MD$US$US
243296151$24329615$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA264173$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$MD$US$US
243296161$24329616$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA266084$SANOFI AVENTIS$$$$C$M$Y$$$20240918$$MD$US$CA
243296171$24329617$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA266836$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243296181$24329618$1$I$20240815$20240820$20240917$20240917$PER$$US-SA-2024SA266255$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240918$$CN$US$US
243296191$24329619$1$I$20240820$20240821$20240917$20240917$PER$$US-SA-2024SA266108$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240918$$CN$US$US
243296201$24329620$1$I$$20240820$20240917$20240917$PER$$US-SA-2024SA266686$SANOFI AVENTIS$$$$C$M$Y$$$20240918$$MD$US$US
243296211$24329621$1$I$20240601$20240821$20240917$20240917$PER$$US-SA-2024SA266931$SANOFI AVENTIS$$56$YR$A$M$Y$96.145$KG$20240918$$MD$US$US
243296221$24329622$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA267368$SANOFI AVENTIS$$$$A$M$Y$90.71$KG$20240918$$MD$US$US
243296241$24329624$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA267984$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240918$$MD$US$US
243296251$24329625$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA266919$SANOFI AVENTIS$$$$A$M$Y$102.27$KG$20240918$$MD$US$US
243296261$24329626$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA266941$SANOFI AVENTIS$$$$E$F$Y$95.91$KG$20240918$$MD$US$US
243296271$24329627$1$I$20240822$20240822$20240917$20240917$PER$$US-SA-2024SA265945$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240918$$MD$US$US
243296281$24329628$1$I$20240901$20240821$20240917$20240917$PER$$US-SA-2024SA267179$SANOFI AVENTIS$$38$YR$A$F$Y$77.73$KG$20240918$$MD$US$US
243296291$24329629$1$I$20240101$20240821$20240917$20240917$PER$$US-SA-2024SA265929$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240918$$CN$US$US
243296301$24329630$1$I$$20240822$20240917$20240917$PER$$US-SA-2024SA266012$SANOFI AVENTIS$$$$C$M$Y$$$20240918$$MD$US$US
243296311$24329631$1$I$$20240822$20240917$20240917$PER$$US-SA-2024SA267727$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$HP$US$US
243296321$24329632$1$I$20240101$20240822$20240917$20240917$PER$$US-SA-2024SA266551$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240918$$CN$US$US
243296341$24329634$1$I$$20240822$20240917$20240917$PER$$US-SA-2024SA266745$SANOFI AVENTIS$$68$YR$E$M$Y$65$KG$20240918$$MD$US$US
243296351$24329635$1$I$20240801$20240822$20240917$20240917$PER$$US-SA-2024SA266807$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240918$$CN$US$US
243296361$24329636$1$I$20240807$20240821$20240917$20240917$PER$$US-SA-2024SA265969$SANOFI AVENTIS$$73$YR$E$F$Y$64.55$KG$20240918$$MD$US$US
243296371$24329637$1$I$20240801$20240822$20240917$20240917$PER$$US-SA-2024SA267902$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240918$$MD$US$US
243296381$24329638$1$I$$20240822$20240917$20240917$PER$$US-SA-2024SA267141$SANOFI AVENTIS$$$$E$F$Y$62.73$KG$20240918$$MD$US$US
243296391$24329639$1$I$$20240822$20240917$20240917$PER$$US-SA-2024SA267618$SANOFI AVENTIS$$$$A$F$Y$101.36$KG$20240918$$MD$US$US
243296401$24329640$1$I$20240818$20240822$20240917$20240917$PER$$US-SA-2024SA266474$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240918$$CN$US$US
243296411$24329641$1$I$20240822$20240822$20240917$20240917$PER$$US-SA-2024SA267682$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240918$$CN$US$US
243296421$24329642$1$I$20240801$20240822$20240917$20240917$PER$$US-SA-2024SA266679$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240918$$MD$US$US
243296431$24329643$1$I$$20240822$20240917$20240917$PER$$US-SA-2024SA266922$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$CN$US$US
243296441$24329644$1$I$20240101$20240822$20240917$20240917$PER$$US-SA-2024SA264556$SANOFI AVENTIS$$81$YR$E$M$Y$95.45$KG$20240918$$MD$US$US
243296451$24329645$1$I$20240101$20240822$20240917$20240917$PER$$US-SA-2024SA266620$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240918$$CN$US$US
243296461$24329646$1$I$$20240822$20240917$20240917$PER$$US-SA-2024SA265938$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243296471$24329647$1$I$$20240822$20240917$20240917$PER$$US-SA-2024SA267133$SANOFI AVENTIS$$9$YR$C$M$Y$37.86$KG$20240918$$MD$US$US
243296481$24329648$1$I$20240801$20240822$20240917$20240917$PER$$US-SA-2024SA004435$SANOFI AVENTIS$$19$YR$A$F$Y$52.27$KG$20240918$$MD$US$US
243296491$24329649$1$I$20240801$20240822$20240917$20240917$PER$$US-SA-2024SA266462$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240918$$HP$US$US
243296501$24329650$1$I$$20240822$20240917$20240917$PER$$US-SA-2024SA266379$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$MD$US$US
243296511$24329651$1$I$20240821$20240822$20240917$20240917$PER$$US-SA-2024SA265813$SANOFI AVENTIS$$16$YR$T$M$Y$65.91$KG$20240918$$MD$US$US
243296521$24329652$1$I$20240801$20240823$20240917$20240917$PER$$US-SA-2024SA267658$SANOFI AVENTIS$$51$YR$A$F$Y$65.91$KG$20240918$$MD$US$US
243296531$24329653$1$I$20240101$20240823$20240917$20240917$PER$$US-SA-2024SA268450$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240918$$MD$US$US
243296541$24329654$1$I$$20240822$20240917$20240917$PER$$US-SA-2024SA266960$SANOFI AVENTIS$$$$C$M$Y$39.73$KG$20240918$$MD$US$US
243296561$24329656$1$I$$20240823$20240917$20240917$PER$$US-SA-2024SA264698$SANOFI AVENTIS$$$$C$F$Y$27$KG$20240918$$MD$US$US
243296571$24329657$1$I$$20240823$20240917$20240917$PER$$US-SA-2024SA266196$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243296581$24329658$1$I$20240101$20240823$20240917$20240917$PER$$US-SA-2024SA134964$SANOFI AVENTIS$$15$YR$T$F$Y$63.64$KG$20240918$$MD$US$US
243296591$24329659$1$I$$20240823$20240917$20240917$PER$$US-SA-2024SA266581$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243296601$24329660$1$I$$20240823$20240917$20240917$PER$$US-SA-2024SA267404$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$MD$US$US
243296611$24329661$1$I$20200101$20240823$20240917$20240917$PER$$US-SA-2024SA264221$SANOFI AVENTIS$$58$YR$A$F$Y$85.45$KG$20240918$$MD$US$US
243296621$24329662$1$I$20240801$20240823$20240917$20240917$PER$$US-SA-2024SA267449$SANOFI AVENTIS$$34$YR$A$F$Y$66.17$KG$20240918$$MD$US$US
243296631$24329663$1$I$$20240823$20240917$20240917$PER$$US-SA-2024SA267165$SANOFI AVENTIS$$73$YR$E$F$Y$94.55$KG$20240918$$MD$US$US
243296641$24329664$1$I$20240101$20240823$20240917$20240917$PER$$US-SA-2024SA264746$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240918$$MD$US$US
243296651$24329665$1$I$$20240822$20240917$20240917$PER$$US-SA-2024SA266633$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240918$$MD$US$US
243296661$24329666$1$I$$20240823$20240917$20240917$PER$$US-SA-2024SA266316$SANOFI AVENTIS$$$$E$M$Y$100.68$KG$20240918$$MD$US$US
243296671$24329667$1$I$$20240822$20240917$20240917$PER$$US-SA-2024SA267934$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240918$$CN$US$US
243296681$24329668$1$I$20240101$20240822$20240917$20240917$PER$$US-SA-2024SA266648$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240918$$MD$US$US
243296691$24329669$1$I$20240812$20240823$20240917$20240917$PER$$US-SA-2024SA266929$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240918$$MD$US$US
243296701$24329670$1$I$20240401$20240823$20240917$20240917$PER$$US-SA-2024SA267321$SANOFI AVENTIS$$18$YR$A$F$Y$59.09$KG$20240918$$MD$US$US
243296711$24329671$1$I$20240809$20240822$20240917$20240917$PER$$US-SA-2024SA268084$SANOFI AVENTIS$$62$YR$A$M$Y$102.27$KG$20240918$$HP$US$US
243296721$24329672$1$I$20230901$20240823$20240917$20240917$PER$$US-SA-2024SA264481$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240918$$CN$US$US
243296731$24329673$1$I$$20240823$20240917$20240917$PER$$US-SA-2024SA266844$SANOFI AVENTIS$$56$YR$A$F$Y$50$KG$20240918$$MD$US$US
243296741$24329674$1$I$$20240823$20240917$20240917$PER$$US-SA-2024SA266532$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240918$$PH$US$US
243296751$24329675$1$I$$20240823$20240917$20240917$PER$$US-SA-2024SA178271$SANOFI AVENTIS$$$$A$F$Y$77.27$KG$20240918$$MD$US$US
243296761$24329676$1$I$$20240823$20240917$20240917$PER$$US-SA-2024SA267401$SANOFI AVENTIS$$$$A$F$Y$133$KG$20240918$$MD$US$US
243296771$24329677$1$I$$20240823$20240917$20240917$PER$$US-SA-2024SA267829$SANOFI AVENTIS$$$$E$F$Y$112$KG$20240918$$MD$US$US
243296781$24329678$1$I$20240101$20240823$20240917$20240917$PER$$US-SA-2024SA267256$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240918$$HP$US$US
243296791$24329679$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA267302$SANOFI AVENTIS$$$$A$F$Y$72.73$KG$20240918$$MD$US$US
243296801$24329680$1$I$$20240827$20240917$20240917$PER$$US-SA-2024SA267307$SANOFI AVENTIS$$$$A$F$Y$86.1$KG$20240918$$MD$US$US
243296811$24329681$1$I$$20240826$20240917$20240917$PER$$US-SA-2024SA262837$SANOFI AVENTIS$$$$A$F$Y$54.55$KG$20240918$$MD$US$US
243296821$24329682$1$I$20240101$20240827$20240917$20240917$PER$$US-SA-2024SA266311$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240918$$MD$US$US
243296831$24329683$1$I$20240701$20240828$20240917$20240917$PER$$US-SA-2024SA267294$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240918$$MD$US$US
243296841$24329684$1$I$$20240826$20240917$20240917$PER$$US-SA-2024SA262078$SANOFI AVENTIS$$32$YR$A$M$Y$75$KG$20240918$$MD$US$US
243296851$24329685$1$I$20240101$20240823$20240917$20240917$PER$$US-SA-2024SA266859$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240918$$MD$US$US
243296862$24329686$2$F$20240827$20240911$20240917$20240920$PER$$US-SA-2024SA267485$SANOFI AVENTIS$$25$YR$A$M$Y$78.82$KG$20240920$$MD$US$US
243296872$24329687$2$F$$20240905$20240917$20240930$PER$$US-SA-2024SA266284$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240930$$MD$US$US
243296881$24329688$1$I$20220101$20240827$20240917$20240917$PER$$US-SA-2024SA267228$SANOFI AVENTIS$$20$YR$A$F$Y$59.09$KG$20240918$$MD$US$US
243296891$24329689$1$I$20240701$20240823$20240917$20240917$PER$$US-SA-2024SA266638$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240918$$MD$US$US
243296901$24329690$1$I$$20240826$20240917$20240917$PER$$US-SA-2024SA267243$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$CN$US$US
243296911$24329691$1$I$$20240826$20240917$20240917$PER$$US-SA-2024SA262488$SANOFI AVENTIS$$$$A$M$Y$79.55$KG$20240918$$MD$US$US
243296921$24329692$1$I$$20240827$20240917$20240917$PER$$US-SA-2024SA266565$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240918$$HP$US$US
243296931$24329693$1$I$20240801$20240823$20240917$20240917$PER$$US-SA-2024SA266631$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240918$$CN$US$US
243296941$24329694$1$I$20240101$20240824$20240917$20240917$PER$$US-SA-2024SA264500$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240918$$MD$US$US
243296951$24329695$1$I$20240801$20240828$20240917$20240917$PER$$US-SA-2024SA267132$SANOFI AVENTIS$$24$YR$A$M$Y$71.36$KG$20240918$$MD$US$US
243296961$24329696$1$I$20240101$20240824$20240917$20240917$PER$$US-SA-2024SA264776$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240918$$MD$US$US
243296971$24329697$1$I$20240101$20240827$20240917$20240917$PER$$US-SA-2024SA267229$SANOFI AVENTIS$$43$YR$A$M$Y$85.91$KG$20240918$$MD$US$US
243296981$24329698$1$I$20240601$20240827$20240917$20240917$PER$$US-SA-2024SA266694$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240918$$CN$US$US
243296991$24329699$1$I$20240828$20240828$20240917$20240917$PER$$US-SA-2024SA267930$SANOFI AVENTIS$$11$MON$I$F$Y$$$20240918$$PH$US$US
243297011$24329701$1$I$20240601$20240827$20240917$20240917$PER$$US-SA-2024SA266380$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240918$$MD$US$US
243297021$24329702$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA267032$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240918$$CN$US$US
243297031$24329703$1$I$$20240904$20240917$20240917$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08991$NEUROCRINE BIOSCIENCES$$45$YR$$F$Y$$$20240917$$HP$US$US
243297041$24329704$1$I$20240701$20240828$20240917$20240917$PER$$US-SA-2024SA266913$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240918$$MD$US$US
243297051$24329705$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA267034$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240918$$CN$US$US
243297061$24329706$1$I$$20240827$20240917$20240917$PER$$US-SA-2024SA266515$SANOFI AVENTIS$$$$$M$Y$$$20240918$$CN$US$US
243297071$24329707$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA267048$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240918$$MD$US$US
243297081$24329708$1$I$$20240827$20240917$20240917$PER$$US-SA-2024SA267282$SANOFI AVENTIS$$74$YR$E$F$Y$92.32$KG$20240918$$MD$US$US
243297091$24329709$1$I$$20240826$20240917$20240917$PER$$US-SA-2024SA267966$SANOFI AVENTIS$$$$$F$Y$$$20240918$$CN$US$US
243297101$24329710$1$I$20240101$20240826$20240917$20240917$PER$$US-SA-2024SA266685$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240918$$HP$US$US
243297111$24329711$1$I$$20240826$20240917$20240917$PER$$US-SA-2024SA266887$SANOFI AVENTIS$$12$YR$T$F$Y$52.27$KG$20240918$$MD$US$US
243297121$24329712$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA267166$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$MD$US$US
243297131$24329713$1$I$$20240827$20240917$20240917$PER$$US-SA-2024SA266058$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$MD$US$US
243297141$24329714$1$I$20240101$20240827$20240917$20240917$PER$$US-SA-2024SA266671$SANOFI AVENTIS$$40$YR$A$F$Y$87.99$KG$20240918$$MD$US$US
243297151$24329715$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA267047$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240918$$CN$US$US
243297161$24329716$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA267079$SANOFI AVENTIS$$$$$M$Y$$$20240918$$PH$US$US
243297171$24329717$1$I$$20240826$20240917$20240917$PER$$US-SA-2024SA266843$SANOFI AVENTIS$$$$A$F$Y$63.64$KG$20240918$$HP$US$US
243297181$24329718$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA267044$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240918$$HP$US$US
243297191$24329719$1$I$20240101$20240828$20240917$20240917$PER$$US-SA-2024SA266355$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240918$$CN$US$US
243297201$24329720$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA266884$SANOFI AVENTIS$$$$A$M$Y$79.3$KG$20240918$$MD$US$US
243297211$24329721$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA266111$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$CN$US$CA
243297221$24329722$1$I$$20240826$20240917$20240917$PER$$US-SA-2024SA263997$SANOFI AVENTIS$$$$$M$Y$$$20240918$$HP$US$US
243297231$24329723$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA264002$SANOFI AVENTIS$$$$A$$Y$$$20240918$$CN$US$US
243297241$24329724$1$I$20231201$20240828$20240917$20240917$PER$$US-SA-2024SA267149$SANOFI AVENTIS$$52$YR$A$F$Y$229.5$KG$20240918$$MD$US$US
243297251$24329725$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA266696$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243297261$24329726$1$I$20240101$20240827$20240917$20240917$PER$$US-SA-2024SA266241$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240918$$CN$US$US
243297271$24329727$1$I$20240101$20240828$20240917$20240917$PER$$US-SA-2024SA266712$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240918$$CN$US$US
243297281$24329728$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA266799$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240918$$CN$US$US
243297291$24329729$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA266942$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240918$$CN$US$US
243297301$24329730$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA267039$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$MD$US$US
243297321$24329732$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA266613$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240918$$HP$US$US
243297331$24329733$1$I$20240825$20240827$20240917$20240917$PER$$US-SA-2024SA266916$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240918$$HP$US$US
243297341$24329734$1$I$20240801$20240828$20240917$20240917$PER$$US-SA-2024SA267042$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240918$$MD$US$US
243297351$24329735$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA266769$SANOFI AVENTIS$$$$A$F$Y$73.4$KG$20240918$$MD$US$US
243297361$24329736$1$I$$20240827$20240917$20240917$PER$$US-SA-2024SA252920$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240918$$CN$US$US
243297371$24329737$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA267747$SANOFI AVENTIS$$$$A$F$Y$64$KG$20240918$$MD$US$US
243297381$24329738$1$I$20240101$20240827$20240917$20240917$PER$$US-SA-2024SA267537$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240918$$CN$US$US
243297391$24329739$1$I$20240801$20240826$20240917$20240917$PER$$US-SA-2024SA267138$SANOFI AVENTIS$$31$YR$A$M$Y$68.18$KG$20240918$$MD$US$US
243297401$24329740$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA267206$SANOFI AVENTIS$$$$A$M$Y$155.91$KG$20240918$$MD$US$US
243297411$24329741$1$I$$20240826$20240917$20240917$PER$$US-SA-2024SA262332$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240918$$MD$US$US
243297421$24329742$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA265857$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$CN$US$US
243297431$24329743$1$I$20240901$20240828$20240917$20240917$PER$$US-SA-2024SA266909$SANOFI AVENTIS$$16$YR$T$M$Y$109.09$KG$20240918$$MD$US$US
243297451$24329745$1$I$$20240827$20240917$20240917$PER$$US-SA-2024SA266602$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$MD$US$US
243297461$24329746$1$I$$20240827$20240917$20240917$PER$$US-SA-2024SA267295$SANOFI AVENTIS$$$$A$F$Y$40.91$KG$20240918$$MD$US$US
243297471$24329747$1$I$$20240827$20240917$20240917$PER$$US-SA-2024SA266823$SANOFI AVENTIS$$$$A$F$Y$65.77$KG$20240918$$MD$US$US
243297481$24329748$1$I$20240101$20240828$20240917$20240917$PER$$US-SA-2024SA266342$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240918$$MD$US$US
243297491$24329749$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA267898$SANOFI AVENTIS$$$$A$F$Y$104.55$KG$20240918$$MD$US$US
243297501$24329750$1$I$$20240827$20240917$20240917$PER$$US-SA-2024SA266933$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240918$$MD$US$US
243297511$24329751$1$I$20240801$20240829$20240917$20240917$PER$$US-SA-2024SA266984$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240918$$HP$US$US
243297521$24329752$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA266715$SANOFI AVENTIS$$$$C$M$Y$$$20240918$$MD$US$US
243297531$24329753$1$I$20240501$20240828$20240917$20240917$PER$$US-SA-2024SA266794$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240918$$CN$US$US
243297541$24329754$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267036$SANOFI AVENTIS$$62$YR$A$$Y$$$20240918$$CN$US$US
243297561$24329756$1$I$20240801$20240829$20240917$20240917$PER$$US-SA-2024SA266312$SANOFI AVENTIS$$$$A$M$Y$54.43$KG$20240918$$MD$US$US
243297571$24329757$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267038$SANOFI AVENTIS$$95$YR$E$M$Y$$$20240918$$CN$US$US
243297581$24329758$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267029$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240918$$MD$US$US
243297591$24329759$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267030$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240918$$MD$US$US
243297601$24329760$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA266855$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243297611$24329761$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267027$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$MD$US$US
243297621$24329762$1$I$$20240830$20240917$20240917$PER$$US-SA-2024SA267067$SANOFI AVENTIS$$68$YR$E$$Y$$$20240918$$HP$US$US
243297631$24329763$1$I$$20240830$20240917$20240917$PER$$US-SA-2024SA267996$SANOFI AVENTIS$$$$A$M$Y$98.18$KG$20240918$$MD$US$US
243297641$24329764$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA266453$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$HP$US$US
243297651$24329765$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267035$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240918$$CN$US$US
243297661$24329766$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267028$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240918$$MD$US$US
243297671$24329767$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA266925$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243297681$24329768$1$I$$20240830$20240917$20240917$PER$$US-SA-2024SA266979$SANOFI AVENTIS$$$$$F$Y$$$20240918$$CN$US$US
243297691$24329769$1$I$20240101$20240830$20240917$20240917$PER$$US-SA-2024SA266976$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240918$$CN$US$US
243297711$24329771$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA266880$SANOFI AVENTIS$$$$$$Y$$$20240918$$CN$US$US
243297721$24329772$1$I$$20240830$20240917$20240917$PER$$US-SA-2024SA267060$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240918$$HP$US$US
243297731$24329773$1$I$$20240830$20240917$20240917$PER$$US-SA-2024SA267061$SANOFI AVENTIS$$55$YR$A$$Y$$$20240918$$HP$US$US
243297741$24329774$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267062$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240918$$CN$US$US
243297751$24329775$1$I$20240101$20240903$20240917$20240917$PER$$US-SA-2024SA267932$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240918$$CN$US$US
243297761$24329776$1$I$20240902$20240904$20240917$20240917$PER$$US-SA-2024SA256746$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240918$$CN$US$US
243297771$24329777$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267033$SANOFI AVENTIS$$53$YR$A$$Y$$$20240918$$CN$US$US
243297781$24329778$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267016$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240918$$MD$US$US
243297791$24329779$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267056$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240918$$MD$US$US
243297801$24329780$1$I$$20240830$20240917$20240917$PER$$US-SA-2024SA267117$SANOFI AVENTIS$$$$A$M$Y$101.82$KG$20240918$$MD$US$US
243297811$24329781$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267012$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243297821$24329782$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267175$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$MD$US$US
243297831$24329783$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267031$SANOFI AVENTIS$$61$YR$A$$Y$$$20240918$$MD$US$US
243297841$24329784$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267045$SANOFI AVENTIS$$60$YR$A$$Y$$$20240918$$CN$US$US
243297851$24329785$1$I$$20240829$20240917$20240917$PER$$US-SA-2024SA267017$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240918$$MD$US$US
243297861$24329786$1$I$20240101$20240903$20240917$20240917$PER$$US-SA-2024SA265103$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240918$$CN$US$US
243297871$24329787$1$I$20240815$20240904$20240917$20240917$PER$$US-SA-2024SA267231$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$CN$US$US
243297881$24329788$1$I$$20240904$20240917$20240917$PER$$US-SA-2024SA267479$SANOFI AVENTIS$$38$YR$A$$Y$$$20240918$$CN$US$US
243297891$24329789$1$I$20240101$20240829$20240917$20240917$PER$$US-SA-2024SA266871$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240918$$CN$US$US
243297901$24329790$1$I$20240101$20240902$20240917$20240917$PER$$US-SA-2024SA268041$SANOFI AVENTIS$$$$C$F$Y$$$20240918$$MD$US$US
243297911$24329791$1$I$$20240904$20240917$20240917$PER$$US-SA-2024SA263806$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240918$$MD$US$US
243297921$24329792$1$I$20240904$20240904$20240917$20240917$PER$$US-SA-2024SA259025$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240918$$MD$US$US
243297931$24329793$1$I$$20240904$20240917$20240917$PER$$US-SA-2024SA268245$SANOFI AVENTIS$$78$YR$E$$Y$$$20240918$$HP$US$US
243297941$24329794$1$I$20240101$20240904$20240917$20240917$PER$$US-SA-2024SA263327$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240918$$HP$US$US
243297951$24329795$1$I$20240904$20240904$20240917$20240917$PER$$US-SA-2024SA265136$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240918$$MD$US$US
243297961$24329796$1$I$20240905$20240905$20240917$20240917$PER$$US-SA-2024SA266713$SANOFI AVENTIS$$12$YR$T$M$Y$55$KG$20240918$$CN$US$US
243297971$24329797$1$I$$20240904$20240917$20240917$PER$$US-SA-2024SA263653$SANOFI AVENTIS$$$$C$F$Y$$$20240918$$MD$US$US
243297981$24329798$1$I$$20240902$20240917$20240917$PER$$US-SA-2024SA268375$SANOFI AVENTIS$$$$E$M$Y$88.4$KG$20240918$$MD$US$US
243297991$24329799$1$I$20240904$20240905$20240917$20240917$PER$$US-SA-2024SA266436$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240918$$HP$US$US
243298001$24329800$1$I$$20240904$20240917$20240917$PER$$US-SA-2024SA268161$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240918$$HP$US$US
243298011$24329801$1$I$$20240903$20240917$20240917$PER$$US-SA-2024SA267009$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240918$$HP$US$US
243298021$24329802$1$I$$20240903$20240917$20240917$PER$$US-SA-2024SA267413$SANOFI AVENTIS$$55$YR$A$$Y$$$20240918$$CN$US$US
243298031$24329803$1$I$$20240904$20240917$20240917$PER$$US-SA-2024SA259059$SANOFI AVENTIS$$$$T$F$Y$$$20240918$$CN$US$US
243298041$24329804$1$I$$20240904$20240917$20240917$PER$$US-SA-2024SA267250$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240918$$HP$US$US
243298051$24329805$1$I$20240101$20240904$20240917$20240917$PER$$US-SA-2024SA106300$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240918$$HP$US$US
243298061$24329806$1$I$$20240904$20240917$20240917$PER$$US-SA-2024SA263432$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240918$$HP$US$US
243298071$24329807$1$I$$20240904$20240917$20240917$PER$$US-SA-2024SA268440$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240918$$HP$US$US
243298081$24329808$1$I$20240905$20240905$20240917$20240917$PER$$US-SA-2024SA266104$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240918$$CN$US$US
243298091$24329809$1$I$20240101$20240904$20240917$20240917$PER$$US-SA-2024SA264941$SANOFI AVENTIS$$$$$M$Y$$$20240918$$HP$US$US
243298101$24329810$1$I$$20240904$20240917$20240917$PER$$US-SA-2024SA263491$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240918$$MD$US$US
243298111$24329811$1$I$20240701$20240904$20240917$20240917$PER$$US-SA-2024SA263772$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240918$$MD$US$US
243298121$24329812$1$I$20240101$20240905$20240917$20240917$PER$$US-SA-2024SA060019$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240918$$MD$US$US
243298131$24329813$1$I$$20240905$20240917$20240917$PER$$US-SA-2024SA266658$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240918$$CN$US$US
243298141$24329814$1$I$20240101$20240905$20240917$20240917$PER$$US-SA-2024SA267334$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240918$$MD$US$US
243298151$24329815$1$I$$20240905$20240917$20240917$PER$$US-SA-2024SA267278$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240918$$MD$US$US
243298162$24329816$2$F$20240904$20240905$20240917$20240919$PER$$US-SA-2024SA265283$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240919$$HP$US$US
243298171$24329817$1$I$$20240905$20240917$20240917$PER$$US-SA-2024SA266014$SANOFI AVENTIS$$$$A$$Y$$$20240918$$HP$US$US
243298182$24329818$2$F$20240901$20240905$20240917$20240919$PER$$US-SA-2024SA265340$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240919$$HP$US$US
243298191$24329819$1$I$$20240905$20240917$20240917$PER$$US-SA-2024SA267089$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240918$$CN$US$US
243298201$24329820$1$I$$20240906$20240917$20240917$PER$$US-SA-2024SA264843$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$HP$US$US
243298211$24329821$1$I$20240101$20240905$20240917$20240917$PER$$US-SA-2024SA266281$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240918$$CN$US$US
243298221$24329822$1$I$20240101$20240905$20240917$20240917$PER$$US-SA-2024SA264574$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240918$$MD$US$US
243298231$24329823$1$I$$20240905$20240917$20240917$PER$$US-SA-2024SA264005$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240918$$MD$US$US
243298241$24329824$1$I$$20240905$20240917$20240917$PER$$US-SA-2024SA265915$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240918$$CN$US$US
243298251$24329825$1$I$$20240906$20240917$20240917$PER$$US-SA-2024SA266137$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240918$$HP$US$US
243298261$24329826$1$I$$20240906$20240917$20240917$PER$$US-SA-2024SA264830$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240918$$MD$US$US
243298271$24329827$1$I$20240801$20240906$20240917$20240917$PER$$US-SA-2023SA337197$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240918$$HP$US$US
243298281$24329828$1$I$$20240906$20240917$20240917$PER$$US-SA-2024SA265799$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240918$$MD$US$US
243298291$24329829$1$I$$20240906$20240917$20240917$PER$$US-SA-2024SA266226$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240918$$HP$US$US
243298301$24329830$1$I$20240101$20240906$20240917$20240917$PER$$US-SA-2024SA264610$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240918$$HP$US$US
243298311$24329831$1$I$$20240906$20240917$20240917$PER$$US-SA-2024SA126732$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240918$$HP$US$US
243298321$24329832$1$I$20240801$20240906$20240917$20240917$PER$$US-SA-2024SA264765$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240918$$CN$US$US
243298331$24329833$1$I$20240901$20240906$20240917$20240917$PER$$US-SA-2024SA264803$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240918$$HP$US$US
243298341$24329834$1$I$$20240906$20240917$20240917$PER$$US-SA-2024SA264789$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240918$$HP$US$US
243298351$24329835$1$I$$20240906$20240917$20240917$PER$$US-SA-2024SA265701$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240918$$HP$US$US
243298361$24329836$1$I$$20240906$20240917$20240917$PER$$US-SA-2024SA243385$SANOFI AVENTIS$$16$YR$T$M$Y$105.05$KG$20240918$$MD$US$US
243298371$24329837$1$I$$20240906$20240917$20240917$PER$$US-SA-2024SA264792$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240918$$MD$US$US
243298381$24329838$1$I$$20240906$20240917$20240917$PER$$US-SA-2024SA264208$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240918$$MD$US$US
243298391$24329839$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA265706$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240918$$HP$US$US
243298401$24329840$1$I$20240101$20240908$20240917$20240917$PER$$US-SA-2024SA265131$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240918$$HP$US$US
243298411$24329841$1$I$20230101$20240909$20240917$20240917$PER$$US-SA-2024SA265579$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240918$$MD$US$US
243298421$24329842$1$I$20240101$20240906$20240917$20240917$PER$$US-SA-2024SA263969$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240918$$MD$US$US
243298431$24329843$1$I$$20240906$20240917$20240917$PER$$US-SA-2024SA265682$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240918$$MD$US$US
243298441$24329844$1$I$20240801$20240911$20240917$20240917$PER$$US-SA-2024SA265891$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240918$$HP$US$US
243298451$24329845$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA265547$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240918$$MD$US$US
243298461$24329846$1$I$20240901$20240909$20240917$20240917$PER$$US-SA-2024SA265942$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240918$$HP$US$US
243298471$24329847$1$I$20231016$20240909$20240917$20240917$PER$$US-SA-2023SA345659$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240918$$MD$US$US
243298481$24329848$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA266025$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240918$$MD$US$US
243298491$24329849$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA266064$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240918$$MD$US$US
243298501$24329850$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA265761$SANOFI AVENTIS$$$$C$F$Y$$$20240918$$MD$US$US
243298511$24329851$1$I$20240910$20240910$20240917$20240917$PER$$US-SA-2024SA264948$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240918$$MD$US$US
243298521$24329852$1$I$20240101$20240910$20240917$20240917$PER$$US-SA-2024SA265495$SANOFI AVENTIS$$$$I$M$Y$$$20240918$$MD$US$US
243298531$24329853$1$I$20240101$20240909$20240917$20240917$PER$$US-SA-2024SA263962$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240918$$HP$US$US
243298541$24329854$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA266146$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240918$$MD$US$US
243298551$24329855$1$I$20240901$20240910$20240917$20240917$PER$$US-SA-2024SA266008$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240918$$HP$US$US
243298561$24329856$1$I$20240827$20240910$20240917$20240917$PER$$US-SA-2024SA266189$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240918$$MD$US$US
243298571$24329857$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA266560$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240918$$HP$US$US
243298581$24329858$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA264988$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240918$$HP$US$US
243298591$24329859$1$I$20240101$20240911$20240917$20240917$PER$$US-SA-2024SA265884$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240918$$MD$US$US
243298601$24329860$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA266260$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240918$$MD$US$US
243298611$24329861$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA265986$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240918$$MD$US$US
243298621$24329862$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA265651$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$HP$US$US
243298631$24329863$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA266296$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240918$$HP$US$US
243298641$24329864$1$I$$20240905$20240917$20240917$PER$$US-SA-2024SA266708$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240918$$MD$US$US
243298651$24329865$1$I$20240101$20240910$20240917$20240917$PER$$US-SA-2024SA265671$SANOFI AVENTIS$$$$T$M$Y$$$20240918$$HP$US$US
243298661$24329866$1$I$20240101$20240909$20240917$20240917$PER$$US-SA-2024SA266442$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240918$$HP$US$US
243298671$24329867$1$I$$20240904$20240917$20240917$PER$$US-SA-2024SA266463$SANOFI AVENTIS$$$$$$Y$$$20240918$$HP$US$US
243298681$24329868$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA265883$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240918$$HP$US$US
243298691$24329869$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA265971$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240918$$HP$US$US
243298701$24329870$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA265960$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240918$$HP$US$US
243298711$24329871$1$I$20240101$20240829$20240917$20240917$PER$$US-SA-2024SA267204$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240918$$MD$US$US
243298721$24329872$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA266553$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240918$$HP$US$US
243298731$24329873$1$I$20240909$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184509$AMGEN$$64$YR$A$M$Y$$$20240917$$CN$US$US
243298741$24329874$1$I$20240101$20240910$20240917$20240917$PER$$US-SA-2024SA266177$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240918$$MD$US$US
243298751$24329875$1$I$20240901$20240909$20240917$20240917$PER$$US-SA-2024SA109902$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240918$$MD$US$US
243298761$24329876$1$I$20230101$20240910$20240917$20240917$PER$$US-SA-2024SA266768$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240918$$HP$US$US
243298771$24329877$1$I$20240701$20240910$20240917$20240917$PER$$US-SA-2024SA265043$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240918$$HP$US$US
243298781$24329878$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA265811$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240918$$MD$US$US
243298801$24329880$1$I$20240101$20240909$20240917$20240917$PER$$US-SA-2024SA265033$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240918$$MD$US$US
243298811$24329881$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA266202$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240918$$MD$US$US
243298831$24329883$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA265796$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$HP$US$US
243298841$24329884$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA265902$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240918$$HP$US$US
243298851$24329885$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA265830$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240918$$HP$US$US
243298861$24329886$1$I$20240701$20240910$20240917$20240917$PER$$US-SA-2024SA265996$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240918$$HP$US$US
243298871$24329887$1$I$20240101$20240909$20240917$20240917$PER$$US-SA-2024SA265810$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$HP$US$US
243298881$24329888$1$I$20240813$20240910$20240917$20240917$PER$$US-SA-2024SA266062$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240918$$MD$US$US
243298891$24329889$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA265696$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240918$$MD$US$US
243298901$24329890$1$I$$20240911$20240917$20240917$PER$$US-SA-2024SA265892$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240918$$MD$US$US
243298911$24329891$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA265050$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240918$$HP$US$US
243298921$24329892$1$I$20211201$20240910$20240917$20240917$PER$$US-SA-2024SA267156$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240918$$MD$US$US
243298931$24329893$1$I$20240701$20240909$20240917$20240917$PER$$US-SA-2024SA266554$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240918$$HP$US$US
243298941$24329894$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA265597$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240918$$HP$US$US
243298951$24329895$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA265987$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240918$$MD$US$US
243298961$24329896$1$I$20240101$20240910$20240917$20240917$PER$$US-SA-2024SA265619$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240918$$HP$US$US
243298971$24329897$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA266213$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240918$$MD$US$US
243298981$24329898$1$I$20240101$20240910$20240917$20240917$PER$$US-SA-2024SA265984$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240918$$HP$US$US
243298991$24329899$1$I$20240101$20240909$20240917$20240917$PER$$US-SA-2024SA265577$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240918$$MD$US$US
243299001$24329900$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA266562$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240918$$HP$US$US
243299011$24329901$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA265046$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243299022$24329902$2$F$20240101$20240912$20240917$20240923$PER$$US-SA-2024SA265621$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240923$$MD$US$US
243299031$24329903$1$I$20240802$20240909$20240917$20240917$PER$$US-SA-2024SA264899$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240918$$HP$US$US
243299041$24329904$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA265989$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240918$$HP$US$US
243299051$24329905$1$I$20240524$20240910$20240917$20240917$PER$$US-SA-2024SA266074$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$MD$US$US
243299061$24329906$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA266002$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240918$$HP$US$US
243299071$24329907$1$I$20220401$20240910$20240917$20240917$PER$$US-SA-2024SA265566$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240918$$MD$US$US
243299081$24329908$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA266016$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240918$$HP$US$US
243299091$24329909$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA265800$SANOFI AVENTIS$$$$I$F$Y$$$20240918$$MD$US$US
243299101$24329910$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA266236$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240918$$MD$US$US
243299111$24329911$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA266056$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240918$$MD$US$US
243299121$24329912$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA265997$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240918$$HP$US$US
243299131$24329913$1$I$20240901$20240910$20240917$20240917$PER$$US-SA-2024SA265760$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240918$$MD$US$US
243299151$24329915$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA265994$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240918$$CN$US$US
243299161$24329916$1$I$20240101$20240909$20240917$20240917$PER$$US-SA-2024SA264980$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240918$$HP$US$US
243299171$24329917$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA265991$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240918$$HP$US$US
243299181$24329918$1$I$20240910$20240910$20240917$20240917$PER$$US-SA-2024SA266192$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240918$$HP$US$US
243299201$24329920$1$I$20240101$20240909$20240917$20240917$PER$$US-SA-2024SA265787$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240918$$HP$US$US
243299211$24329921$1$I$20240101$20240909$20240917$20240917$PER$$US-SA-2024SA265790$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240918$$MD$US$US
243299231$24329923$1$I$20240906$20240909$20240917$20240917$PER$$US-SA-2024SA265894$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240918$$HP$US$US
243299241$24329924$1$I$20240901$20240910$20240917$20240917$PER$$US-SA-2024SA266000$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240918$$HP$US$US
243299251$24329925$1$I$20240101$20240912$20240917$20240917$PER$$US-SA-2024SA265850$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243299261$24329926$1$I$$20240912$20240917$20240917$PER$$US-SA-2024SA267956$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240918$$MD$US$US
243299271$24329927$1$I$$20240909$20240917$20240917$PER$$US-SA-2024SA265045$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$HP$US$US
243299281$24329928$1$I$20240101$20240913$20240917$20240917$PER$$US-SA-2024SA268051$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240918$$HP$US$US
243299291$24329929$1$I$20240901$20240910$20240917$20240917$PER$$US-SA-2024SA265694$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240918$$HP$US$US
243299301$24329930$1$I$20240101$20240912$20240917$20240917$PER$$US-SA-2024SA265832$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$MD$US$US
243299312$24329931$2$F$$20240910$20240917$20240919$PER$$US-SA-2024SA265756$SANOFI AVENTIS$$18$YR$A$M$Y$59$KG$20240919$$MD$US$US
243299321$24329932$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA266045$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240918$$MD$US$US
243299331$24329933$1$I$20240901$20240909$20240917$20240917$PER$$US-SA-2024SA265922$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240918$$HP$US$US
243299341$24329934$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA265742$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243299351$24329935$1$I$20240101$20240909$20240917$20240917$PER$$US-SA-2024SA268059$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240918$$CN$US$US
243299361$24329936$1$I$$20240906$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160457$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299371$24329937$1$I$20240801$20240913$20240917$20240917$EXP$$NVSC2024LC184952$NOVARTIS$$78$YR$$F$Y$$$20240918$$CN$LC$LC
243299381$24329938$1$I$$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160411$BIOMARIN$Cooney E.,  Ammous Z., Andersson H., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5-years of experience with pegvaliase in US clinics: A case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240917$$MD$US$US
243299391$24329939$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185478$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243299401$24329940$1$I$$20240909$20240917$20240917$EXP$$NVSC2024AU182658$NOVARTIS$French M, Mohd-Zaki N, De Malmanche J, Bhagwandeen R, Collins N. Acute Stent Thrombosis in an Immune Thrombocytopenic Purpura Patient: Striking the Balance Using Eltrombopag. JACC CASE REPORTS. 2024;29 (1):102508$57$YR$$F$Y$$$20240918$$HP$AU$AU
243299411$24329941$1$I$$20240913$20240917$20240917$PER$$NVSC2024US184852$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
243299421$24329942$1$I$$20240827$20240917$20240917$PER$$US-SA-2024SA267510$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243299431$24329943$1$I$20240828$20240911$20240917$20240917$EXP$$CN-AstraZeneca-2024A208364$ASTRAZENECA$$$$$F$Y$53$KG$20240917$$MD$CN$
243299441$24329944$1$I$20240301$20240909$20240917$20240917$PER$$US-BIOGEN-2024BI01274204$BIOGEN$$26$YR$$F$Y$$$20240917$$CN$US$US
243299461$24329946$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA266408$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243299471$24329947$1$I$$20240911$20240917$20240917$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144815$DAIICHI$$$$$M$Y$$$20240917$$CN$US$US
243299482$24329948$2$F$$20240918$20240917$20240923$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-110632$DAIICHI$$$$$M$Y$$$20240923$$MD$US$US
243299491$24329949$1$I$$20240828$20240917$20240917$PER$$US-DAIICHI SANKYO, INC.-DS-2024-100240-US$DAIICHI$$$$$F$Y$$$20240917$$MD$US$US
243299501$24329950$1$I$20240903$20240904$20240917$20240917$PER$$US-JNJFOC-20240914298$JOHNSON AND JOHNSON$$$$$F$Y$$$20240917$$CN$US$US
243299511$24329951$1$I$$20240906$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160454$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299521$24329952$1$I$20240716$20240909$20240917$20240917$EXP$$JP-GALDERMA-JP2024011885$GALDERMA$$$$$$Y$$$20240917$$MD$JP$JP
243299541$24329954$1$I$$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160416$BIOMARIN$Cooney E.,  Ammous Z., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240917$$MD$US$US
243299552$24329955$2$F$20240701$20240916$20240917$20240923$EXP$$CH-TAKEDA-2024TUS092097$TAKEDA$$64$YR$$F$Y$$$20240923$$HP$CH$CH
243299561$24329956$1$I$$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160415$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et.al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024$$$$$Y$$$20240917$$MD$US$US
243299571$24329957$1$I$$20240912$20240917$20240917$EXP$$DE-JNJFOC-20240945087$JOHNSON AND JOHNSON$$$$$M$Y$$$20240917$$PH$DE$DE
243299581$24329958$1$I$$20240913$20240917$20240917$PER$$NVSC2024US184949$NOVARTIS$$$$$F$Y$78$KG$20240918$$CN$US$US
243299591$24329959$1$I$20240901$20240906$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160399$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299602$24329960$2$F$$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160413$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et. al. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240917$$MD$US$US
243299611$24329961$1$I$$20240906$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160397$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299621$24329962$1$I$$20240906$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160400$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299631$24329963$1$I$$20240910$20240917$20240917$PER$$US-ROCHE-10000080810$ROCHE$$25$YR$A$F$Y$$$20240917$$CN$US$US
243299651$24329965$1$I$$20240916$20240917$20240917$PER$$US-ROCHE-10000083660$ROCHE$$$$$$Y$$$20240917$$CN$US$US
243299661$24329966$1$I$20240906$20240906$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160396$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299671$24329967$1$I$20240101$20240913$20240917$20240917$EXP$$US-ABBVIE-5923966$ABBVIE$$$$$F$Y$$$20240917$$HP$US$US
243299681$24329968$1$I$20240101$20240912$20240917$20240917$EXP$$US-ABBVIE-5801667$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243299691$24329969$1$I$$20240910$20240917$20240917$EXP$$JP-MTPC-MTPC2024-0019233$UNKNOWN$Naruse K, Kaneko R, Kayashima M, Maehiro Y, Watanabe N,  Ono T, et al.. 23 A case of clival metastasis of hepatocellular carcinoma detected with epistaxis following cerebral Infarction. The 381st Annual Meeting of the Kanto Branch of the Japanese. 2024;31$72$YR$$M$Y$$$20240917$$MD$JP$JP
243299701$24329970$1$I$20240801$20240912$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160553$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299711$24329971$1$I$$20240910$20240917$20240917$EXP$$BR-ABBVIE-5925991$ABBVIE$$$$$F$Y$90$KG$20240917$$CN$BR$BR
243299721$24329972$1$I$$20240828$20240917$20240917$PER$$US-SA-2024SA268482$SANOFI AVENTIS$$$$C$M$Y$$$20240918$$MD$US$US
243299731$24329973$1$I$$20240913$20240917$20240917$PER$$US-MTPC-MTDA2024-0019353$MITSUBISHI TANABE PHARMA$$$$E$F$Y$$$20240917$$MD$US$US
243299741$24329974$1$I$$20240905$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160388$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299751$24329975$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185640$NOVARTIS$$$$$M$Y$123$KG$20240918$$CN$US$US
243299762$24329976$2$F$20230426$20240924$20240917$20240927$EXP$$NVSC2023IN103263$NOVARTIS$$69$YR$$F$Y$$$20240927$$CN$IN$IN
243299781$24329978$1$I$$20240905$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160353$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299791$24329979$1$I$$20240905$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160398$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299801$24329980$1$I$$20240912$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160562$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299811$24329981$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185643$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243299821$24329982$1$I$$20240906$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160523$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299831$24329983$1$I$$20240913$20240917$20240917$PER$$NVSC2024US184993$NOVARTIS$$$$$M$Y$88$KG$20240918$$CN$US$US
243299841$24329984$1$I$$20240913$20240917$20240917$PER$$NVSC2024US184476$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243299851$24329985$1$I$$20240913$20240917$20240917$EXP$$NVSC2024US057063$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243299861$24329986$1$I$20240730$20240913$20240917$20240917$EXP$$NVSJ2024JP010932$NOVARTIS$$77$YR$$M$Y$$$20240918$$PH$JP$JP
243299871$24329987$1$I$20230227$20240916$20240917$20240917$EXP$BE-ASTELLAS-2023EU003761$NVSC2024BE184654$NOVARTIS$$85$YR$$M$Y$$$20240918$$HP$BE$BE
243299881$24329988$1$I$$20240905$20240917$20240917$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08984$NEUROCRINE BIOSCIENCES$$$$A$F$Y$$$20240918$$HP$US$US
243299891$24329989$1$I$20240701$20240912$20240917$20240917$EXP$$NVSC2024CA144136$NOVARTIS$$55$YR$$M$Y$$$20240918$$CN$CA$CA
243299901$24329990$1$I$$20240909$20240917$20240917$EXP$$NVSC2024CN181863$NOVARTIS$Yang X. One case of hematologic damage and liver injury induced by oxcarbazepine. STRAIT PHARMACEUTICAL JOURNAL. 2024;36(7)$28$YR$$M$Y$$$20240918$$HP$CN$CN
243299931$24329993$1$I$$20240910$20240917$20240917$PER$$US-JNJFOC-20240924616$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$PH$US$US
243299951$24329995$1$I$20240110$20240913$20240917$20240917$EXP$$SG-AstraZeneca-2024A210224$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$SG$
243299981$24329998$1$I$$20240905$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160354$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243299991$24329999$1$I$$20240905$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160376$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243300011$24330001$1$I$20240910$20240914$20240917$20240917$EXP$$CN-SANDOZ INC.-SDZ2024CN080364$SANDOZ$$64$YR$$F$Y$62$KG$20240917$$HP$CN$CN
243300051$24330005$1$I$$20240905$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160385$BIOMARIN$$$$$$Y$$$20240917$$CN$US$US
243300061$24330006$1$I$$20240909$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160386$BIOMARIN$$$$$$Y$$$20240917$$HP$US$US
243300071$24330007$1$I$$20240916$20240917$20240917$EXP$$FR-SANDOZ INC.-PHHY2014FR146120$SANDOZ$$$$$F$Y$$$20240917$$MD$FR$FR
243300081$24330008$1$I$20240901$20240912$20240917$20240917$EXP$$FR-AstraZeneca-2024A207974$ASTRAZENECA$$62$YR$$M$Y$$$20240918$$MD$FR$
243300091$24330009$1$I$$20240911$20240917$20240917$EXP$$IT-AstraZeneca-2024A211900$ASTRAZENECA$$$$$M$Y$$$20240918$$HP$IT$
243300101$24330010$1$I$20240101$20240913$20240917$20240917$EXP$$SG-AstraZeneca-2024A210156$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$SG$
243300111$24330011$1$I$20240901$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A211755$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$US$
243300121$24330012$1$I$$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A208266$ASTRAZENECA$$$$$M$Y$$$20240918$$PH$US$
243300131$24330013$1$I$20240101$20240912$20240917$20240917$EXP$$US-ABBVIE-5922458$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243300141$24330014$1$I$20240427$20240912$20240917$20240917$EXP$$CA-ABBVIE-5922714$ABBVIE$$48$YR$$F$Y$$$20240917$$CN$CA$CA
243300152$24330015$2$F$20240101$20240919$20240917$20240924$EXP$$US-ABBVIE-5913781$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243300162$24330016$2$F$20240723$20240916$20240917$20240920$EXP$$EC-ORGANON-O2408ECU000365$ORGANON$$16$YR$$F$Y$48.8$KG$20240920$$MD$EC$EC
243300171$24330017$1$I$20240101$20240912$20240917$20240917$EXP$$GB-ABBVIE-5923509$ABBVIE$$71$YR$$M$Y$$$20240917$$CN$GB$GB
243300181$24330018$1$I$20240101$20240913$20240917$20240917$EXP$$US-ABBVIE-5923752$ABBVIE$$73$YR$$F$Y$$$20240917$$CN$US$US
243300191$24330019$1$I$20240906$20240906$20240917$20240917$EXP$$US-JNJFOC-20240919954$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240918$$HP$US$US
243300201$24330020$1$I$20240416$20240912$20240917$20240917$EXP$$NVSC2024GB112634$NOVARTIS$$66$YR$$M$Y$$$20240918$$CN$GB$GB
243300211$24330021$1$I$$20240916$20240917$20240917$EXP$$FR-SANDOZ INC.-SDZ2024FR080417$SANDOZ$$4$YR$$M$Y$$$20240917$$HP$FR$FR
243300221$24330022$1$I$$20240914$20240917$20240917$PER$$NVSC2024US185265$NOVARTIS$$$$$$Y$$$20240918$$CN$US$US
243300231$24330023$1$I$$20240913$20240917$20240917$PER$$NVSC2024US184843$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
243300251$24330025$1$I$20240821$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210498$ASTRAZENECA$$$$$M$Y$$$20240918$$MD$US$
243300271$24330027$1$I$$20240914$20240917$20240917$EXP$$SG-AstraZeneca-2024A211666$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$SG$
243300281$24330028$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185650$NOVARTIS$$$$$$Y$$$20240918$$MD$US$US
243300291$24330029$1$I$$20240904$20240917$20240917$PER$$US-BIOMARINAP-US-2024-160438$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et.al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240917$$MD$US$US
243300301$24330030$1$I$$20240906$20240917$20240917$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00339$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240916$$CN$US$US
243300311$24330031$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185455$NOVARTIS$$$$$$Y$$$20240918$$MD$US$US
243300321$24330032$1$I$$20240906$20240917$20240917$EXP$$US-JNJFOC-20240919747$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240918$$CN$US$US
243300341$24330034$1$I$20240901$20240917$20240917$20240917$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051910$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$$$20240918$$CN$US$US
243300351$24330035$1$I$$20240910$20240917$20240917$EXP$$DE-AstraZeneca-2024A205792$ASTRAZENECA$$$$$M$Y$87$KG$20240918$$MD$DE$
243300361$24330036$1$I$20180101$20240916$20240917$20240917$EXP$$IT-ORGANON-1901ITA003625$ORGANON$$59$YR$$M$Y$119$KG$20240917$$MD$IT$IT
243300371$24330037$1$I$$20240911$20240917$20240917$PER$$US-AstraZeneca-2024A209935$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243300381$24330038$1$I$$20240903$20240917$20240917$PER$$US-AstraZeneca-2024A201006$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243300391$24330039$1$I$$20240912$20240917$20240917$EXP$$US-JNJFOC-20240939722$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$CN$US$US
243300411$24330041$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A208856$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243300421$24330042$1$I$$20240913$20240917$20240917$PER$$US-AstraZeneca-2024A210614$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243300431$24330043$1$I$20240912$20240913$20240917$20240917$EXP$$CN-SANDOZ INC.-SDZ2024CN080632$SANDOZ$$58$YR$$M$Y$60$KG$20240917$$HP$CN$CN
243300441$24330044$1$I$$20240916$20240917$20240917$EXP$$AU-SANDOZ INC.-SDZ2024AU080594$SANDOZ$$31$YR$$F$Y$$$20240917$$MD$AU$AU
243300452$24330045$2$F$$20240917$20240917$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145203$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240925$$MD$JP$JP
243300461$24330046$1$I$$20240911$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146515$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240918$$HP$US$US
243300471$24330047$1$I$20240911$20240911$20240917$20240917$PER$$US-AMGEN-USASP2024182212$AMGEN$$85$YR$E$$Y$$$20240917$$HP$US$US
243300481$24330048$1$I$$20240829$20240917$20240917$PER$$US-JNJFOC-20240934508$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240918$$HP$US$US
243300491$24330049$1$I$$20240911$20240917$20240917$EXP$$JP-JNJFOC-20240937998$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$HP$JP$JP
243300502$24330050$2$F$20240825$20240912$20240917$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009128$ELI LILLY AND CO$$55$YR$A$$Y$$$20240919$$CN$US$US
243300531$24330053$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210318$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243300542$24330054$2$F$20090101$20240916$20240917$20240919$EXP$$FR-ABBVIE-10P-056-0621482-00$ABBVIE$$59$YR$$M$Y$$$20240919$$PH$FR$FR
243300551$24330055$1$I$20240601$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A207477$ASTRAZENECA$$728$MON$$F$Y$$$20240918$$CN$US$
243300561$24330056$1$I$$20240911$20240917$20240917$30DAY$$EG-SANDOZ INC.-SDZ2024EG080763$SANDOZ$$$$$M$Y$$$20240917$$CN$EG$EG
243300581$24330058$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210612$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243300601$24330060$1$I$20240912$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024183544$AMGEN$$79$YR$E$M$Y$$$20240917$$CN$US$US
243300611$24330061$1$I$$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184391$AMGEN$$$$$F$Y$$$20240917$$CN$US$US
243300621$24330062$1$I$$20240916$20240917$20240917$EXP$$CA-ORGANON-O2409CAN001086$ORGANON$$$$$$Y$$$20240917$$CN$CA$CA
243300631$24330063$1$I$20180801$20240903$20240917$20240917$EXP$$JP-JNJFOC-20240919812$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240918$$CN$JP$JP
243300641$24330064$1$I$20240901$20240912$20240917$20240917$PER$$US-ABBVIE-5922547$ABBVIE$$$$$$Y$$$20240917$$CN$US$US
243300651$24330065$1$I$$20240917$20240917$20240917$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051920$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240918$$HP$US$US
243300661$24330066$1$I$20240501$20240906$20240917$20240917$EXP$$ZA-ABBVIE-5888969$ABBVIE$$57$YR$$F$Y$$$20240917$$CN$ZA$ZA
243300671$24330067$1$I$$20240904$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142182$BRISTOL MYERS SQUIBB$Macit B, Arora A, Reginato AM, Qureshi AA. Cerebral toxoplasmosis in a patient with systemic sclerosis under thalidomide treatment: a case report. JAAD Case Reports. 2024 Sep 01;51:100-3. doi:10.1016/j.jdcr.2024.03.009.$49$YR$A$F$Y$$$20240918$$MD$US$US
243300681$24330068$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS091433$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243300701$24330070$1$I$20240729$20240911$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145950$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240918$$HP$US$US
243300711$24330071$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210006$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243300721$24330072$1$I$$20240829$20240917$20240917$PER$$US-AstraZeneca-2024A212188$ASTRAZENECA$$$$$M$Y$$$20240918$$MD$US$
243300731$24330073$1$I$20240801$20240913$20240917$20240917$EXP$$RO-AstraZeneca-2024A209685$ASTRAZENECA$$53$YR$$M$Y$$$20240918$$MD$RO$
243300741$24330074$1$I$20230915$20240910$20240917$20240917$PER$$US-JNJFOC-20240937548$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240918$$HP$US$US
243300751$24330075$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A209913$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243300761$24330076$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210435$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243300771$24330077$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A210576$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243300781$24330078$1$I$$20240916$20240917$20240917$EXP$$CA-ORGANON-O2409CAN001054$ORGANON$$26$YR$$F$Y$56.69$KG$20240917$$MD$CA$CA
243300791$24330079$1$I$$20240917$20240917$20240917$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051914$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240918$$CN$US$US
243300801$24330080$1$I$20240915$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184999$AMGEN$$72$YR$E$F$Y$$$20240917$$CN$US$US
243300821$24330082$1$I$20240904$20240911$20240917$20240917$EXP$$GR-ABBVIE-5908249$ABBVIE$$81$YR$$M$Y$75$KG$20240917$$CN$GR$GR
243300841$24330084$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208773$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243300851$24330085$1$I$20240118$20240911$20240917$20240917$EXP$$DE-ABBVIE-5923430$ABBVIE$$59$YR$$F$Y$$$20240917$$MD$DE$DE
243300861$24330086$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A209264$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243300871$24330087$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210454$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243300881$24330088$1$I$20240911$20240912$20240917$20240917$EXP$$US-ABBVIE-5922666$ABBVIE$$75$YR$$M$Y$$$20240917$$CN$US$US
243300891$24330089$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A209867$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243300901$24330090$1$I$$20240827$20240917$20240917$PER$$US-Eisai-EC-2024-174562$EISAI$$$$$$Y$$$20240918$$HP$US$US
243300911$24330091$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A211179$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243300921$24330092$1$I$$20240909$20240917$20240917$PER$$US-JNJFOC-20240922452$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$HP$US$US
243300931$24330093$1$I$$20240913$20240917$20240917$PER$$US-AstraZeneca-2024A210575$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243300941$24330094$1$I$$20240913$20240917$20240917$PER$$US-ELI_LILLY_AND_COMPANY-US202409009510$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240917$$CN$US$US
243300962$24330096$2$F$20240910$20240911$20240917$20240918$EXP$$US-ABBVIE-5920647$ABBVIE$$51$YR$$F$Y$$$20240918$$CN$US$US
243300971$24330097$1$I$20240607$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210484$ASTRAZENECA$$33187$DY$$M$Y$$$20240918$$CN$US$
243300981$24330098$1$I$$20240905$20240917$20240917$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-139028$BRISTOL MYERS SQUIBB$Takanori.T et al. Consider of Isa20D regimen from our experience. International Journal of Myeloma.  2024;14(3);106.$71$YR$E$F$Y$$$20240918$$MD$JP$JP
243300992$24330099$2$F$20240907$20240925$20240917$20240930$EXP$$US-BIOGEN-2024BI01282075$BIOGEN$$59$YR$$F$Y$$$20240930$$CN$US$US
243301001$24330100$1$I$20240701$20240911$20240917$20240917$EXP$$US-ABBVIE-5921044$ABBVIE$$39$YR$$F$Y$$$20240917$$CN$US$US
243301011$24330101$1$I$$20240912$20240917$20240917$EXP$$JP-AstraZeneca-2024A208677$ASTRAZENECA$$$$$$Y$$$20240918$$PH$JP$
243301021$24330102$1$I$20240501$20240911$20240917$20240917$EXP$$US-ABBVIE-5771245$ABBVIE$$63$YR$$M$Y$$$20240917$$CN$US$US
243301031$24330103$1$I$$20240911$20240917$20240917$PER$$US-AstraZeneca-2024A211879$ASTRAZENECA$$$$E$$Y$$$20240918$$MD$US$
243301041$24330104$1$I$$20240911$20240917$20240917$EXP$$JP-AstraZeneca-2024A208477$ASTRAZENECA$$73$YR$$M$Y$$$20240918$$MD$JP$
243301051$24330105$1$I$$20240916$20240917$20240917$EXP$$CA-AstraZeneca-2024A212111$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$CA$
243301061$24330106$1$I$$20240912$20240917$20240917$EXP$$JP-AstraZeneca-2024A209159$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$JP$
243301071$24330107$1$I$20231013$20240910$20240917$20240917$EXP$$ZA-ABBVIE-5925502$ABBVIE$$51$YR$$M$Y$$$20240917$$CN$ZA$ZA
243301081$24330108$1$I$20190401$20240911$20240917$20240917$EXP$$IL-ABBVIE-5887485$ABBVIE$$51$YR$$F$Y$$$20240917$$CN$IL$IL
243301091$24330109$1$I$$20240827$20240917$20240917$PER$$US-Eisai-EC-2024-173101$EISAI$$$$$$Y$$$20240918$$HP$US$US
243301101$24330110$1$I$$20240913$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147536$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240918$$CN$US$US
243301121$24330112$1$I$20240828$20240911$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145813$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$44$KG$20240918$$PH$US$US
243301141$24330114$1$I$$20240916$20240917$20240917$EXP$$IT-SANDOZ INC.-SDZ2024IT080443$SANDOZ$$40$YR$$M$Y$$$20240917$$HP$IT$IT
243301151$24330115$1$I$20240501$20240912$20240917$20240917$EXP$$US-ABBVIE-5922433$ABBVIE$$65$YR$$M$Y$$$20240917$$CN$US$US
243301161$24330116$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922584$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243301171$24330117$1$I$20240910$20240910$20240917$20240917$PER$$US-JNJFOC-20240925246$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$HP$US$US
243301181$24330118$1$I$20230101$20240909$20240917$20240917$EXP$$US-ABBVIE-5809693$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243301191$24330119$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5922807$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243301201$24330120$1$I$$20240911$20240917$20240917$EXP$$US-SANDOZ INC.-SDZ2024US068718$SANDOZ$$$$$F$Y$$$20240917$$MD$US$US
243301212$24330121$2$F$20180101$20240918$20240917$20240928$EXP$$US-ABBVIE-5925455$ABBVIE$$$$$F$Y$82$KG$20240928$$CN$US$US
243301221$24330122$1$I$20200501$20240909$20240917$20240917$EXP$$BR-BIOGEN-2024BI01282107$BIOGEN$$51$YR$$F$Y$62$KG$20240917$$HP$BR$BR
243301231$24330123$1$I$20180101$20240909$20240917$20240917$EXP$$BR-BIOGEN-2024BI01282102$BIOGEN$$$$$F$Y$62$KG$20240917$$HP$BR$BR
243301241$24330124$1$I$20240909$20240911$20240917$20240917$EXP$$US-SMPA-2024SPA002627$SUNOVION$$$$$$Y$$$20240917$$CN$US$US
243301251$24330125$1$I$$20240916$20240917$20240917$EXP$$IT-SANDOZ INC.-SDZ2024IT080493$SANDOZ$$66$YR$$F$Y$$$20240917$$HP$IT$IT
243301261$24330126$1$I$20240425$20240909$20240917$20240917$EXP$$US-ABBVIE-5757861$ABBVIE$$65$YR$$M$Y$$$20240917$$CN$US$US
243301271$24330127$1$I$$20240916$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147863$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240918$$MD$US$US
243301291$24330129$1$I$20231020$20240910$20240917$20240917$EXP$$TR-BIOGEN-2024BI01282318$BIOGEN$$3$YR$$F$Y$$$20240917$$MD$TR$TR
243301301$24330130$1$I$$20240911$20240917$20240917$EXP$$JP-GSK-JP2024JPN113182$GLAXOSMITHKLINE$$$$$$Y$$$20240917$$MD$JP$JP
243301311$24330131$1$I$$20240913$20240917$20240917$EXP$GB-MHRA-MED-202409131649564270-KVRPN$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-146717$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240918$$HP$GB$GB
243301321$24330132$1$I$$20240906$20240917$20240917$PER$$US-RDY-SPO/USA/24/0013403$DR REDDYS$Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, et al. Psychedelic Therapy: A Primer for Primary Care Clinicians - Historical Perspective and Overview. American Journal of Therapeutics. 2024;31(2): E97-E103. doi:10.1097/MJT.0000000000001727.$29$YR$A$M$Y$$$20240918$$MD$US$US
243301331$24330133$1$I$$20240912$20240917$20240917$EXP$$NVSC2024DE184849$NOVARTIS$$61$YR$$F$Y$$$20240918$$MD$DE$DE
243301341$24330134$1$I$$20240917$20240917$20240917$PER$$NVSC2024US185678$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243301351$24330135$1$I$$20240917$20240917$20240917$PER$$NVSC2024US185684$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243301361$24330136$1$I$$20240826$20240917$20240917$30DAY$$DE-JNJFOC-20240876421$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$PH$DE$DE
243301371$24330137$1$I$20240901$20240913$20240917$20240917$EXP$$CN-ABBVIE-5923846$ABBVIE$$55$YR$$F$Y$67$KG$20240917$$MD$CN$CN
243301381$24330138$1$I$20240901$20240913$20240917$20240917$EXP$$CA-ABBVIE-5923996$ABBVIE$$63$YR$$F$Y$$$20240917$$CN$CA$CA
243301391$24330139$1$I$$20240913$20240917$20240917$EXP$$US-ABBVIE-5925124$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243301401$24330140$1$I$20240101$20240912$20240917$20240917$EXP$$CA-ABBVIE-5923541$ABBVIE$$64$YR$$M$Y$$$20240917$$CN$CA$CA
243301411$24330141$1$I$20240916$20240916$20240917$20240917$EXP$$AU-ABBVIE-5926646$ABBVIE$$77$YR$$M$Y$$$20240917$$CN$AU$AU
243301421$24330142$1$I$20230530$20240916$20240917$20240917$EXP$GB-MHRA-MED-202409152057037670-CFHJT$GB-ORGANON-O2409GBR001095$ORGANON$$43$YR$$F$Y$$$20240917$$CN$GB$GB
243301431$24330143$1$I$20240603$20240906$20240917$20240917$EXP$$NVSC2024PL178690$NOVARTIS$$21$YR$$F$Y$$$20240918$$MD$PL$PL
243301441$24330144$1$I$$20240904$20240917$20240917$EXP$$JP-Unichem Pharmaceuticals (USA) Inc-UCM202409-001128$UNICHEM$$76$YR$E$$Y$$$20240918$$HP$JP$
243301451$24330145$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185679$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243301461$24330146$1$I$$20240914$20240917$20240917$PER$$NVSC2024US185565$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
243301471$24330147$1$I$$20240916$20240917$20240917$PER$$NVSC2024US185675$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243301481$24330148$1$I$20240101$20240916$20240917$20240917$PER$$US-ABBVIE-5926164$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243301491$24330149$1$I$$20240916$20240917$20240917$EXP$$IT-SANDOZ INC.-SDZ2024IT080426$SANDOZ$$65$YR$$F$Y$$$20240917$$HP$IT$IT
243301501$24330150$1$I$$20240916$20240917$20240917$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051902$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240918$$MD$US$US
243301511$24330151$1$I$20240601$20240912$20240917$20240917$EXP$$US-ABBVIE-5925275$ABBVIE$$67$YR$$M$Y$$$20240917$$CN$US$US
243301522$24330152$2$F$20240101$20240918$20240917$20240921$EXP$$US-ABBVIE-5924088$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243301531$24330153$1$I$$20240911$20240917$20240917$EXP$$US-BIOGEN-2024BI01282538$BIOGEN$$$$$M$Y$88$KG$20240917$$MD$US$US
243301551$24330155$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A208865$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243301571$24330157$1$I$$20240916$20240917$20240917$EXP$$ZA-AstraZeneca-2024A212103$ASTRAZENECA$$83$YR$$F$Y$$$20240918$$CN$ZA$
243301581$24330158$1$I$$20240916$20240917$20240917$EXP$$US-AstraZeneca-2024A211189$ASTRAZENECA$$26298$DY$$F$Y$$$20240918$$MD$US$
243301591$24330159$1$I$$20240913$20240917$20240917$PER$$US-AstraZeneca-2024A210495$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243301601$24330160$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A209974$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243301611$24330161$1$I$$20240910$20240917$20240917$EXP$$PT-CHATTEMPRD-2024OHG031921$CHATTEM$$$$E$$Y$$$20240918$$HP$PT$PT
243301621$24330162$1$I$$20240911$20240917$20240917$EXP$$CA-AstraZeneca-2024A210916$ASTRAZENECA$$45$YR$$F$Y$95$KG$20240918$$MD$CA$
243301631$24330163$1$I$20240101$20240827$20240917$20240917$PER$$US-SA-2024SA267120$SANOFI AVENTIS$$34$YR$A$F$Y$81.82$KG$20240918$$MD$US$US
243301641$24330164$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A210583$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243301651$24330165$1$I$20240507$20240916$20240917$20240917$EXP$$DE-AstraZeneca-2024A210837$ASTRAZENECA$$73$YR$$M$Y$$$20240918$$MD$DE$
243301661$24330166$1$I$$20240916$20240917$20240917$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051906$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240918$$CN$US$US
243301671$24330167$1$I$$20240912$20240917$20240917$EXP$$US-RDY-SPO/USA/24/0013465$DR REDDYS$$42$YR$A$M$Y$$$20240918$$HP$US$US
243301681$24330168$1$I$20240805$20240910$20240917$20240917$PER$$US-RDY-SPO/USA/24/0013321$DR REDDYS$$75$YR$E$M$Y$$$20240918$$HP$US$US
243301691$24330169$1$I$$20240912$20240917$20240917$EXP$$US-AstraZeneca-2024A210597$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243301701$24330170$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA266136$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240918$$MD$US$US
243301711$24330171$1$I$20240101$20240910$20240917$20240917$PER$$US-SA-2024SA266060$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240918$$MD$US$US
243301721$24330172$1$I$$20240913$20240917$20240917$EXP$GB-MHRA-MED-202409131509190230-BKPTH$GB-CHATTEMPRD-2024OHG032050$CHATTEM$$$$$F$Y$$$20240918$$HP$GB$GB
243301731$24330173$1$I$$20240910$20240917$20240917$PER$$US-SA-2024SA266050$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240918$$HP$US$US
243301741$24330174$1$I$20240901$20240909$20240917$20240917$PER$$US-SA-2024SA265961$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$HP$US$US
243301751$24330175$1$I$20240718$20240904$20240917$20240917$PER$$US-SA-2024SA265051$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240918$$CN$US$US
243301761$24330176$1$I$$20240905$20240917$20240917$PER$$US-SA-2024SA266106$SANOFI AVENTIS$$$$$F$Y$$$20240918$$CN$US$US
243301771$24330177$1$I$$20240916$20240917$20240917$PER$$US-AMGEN-USASP2024184805$AMGEN$$54$YR$A$F$Y$$$20240917$$PH$US$US
243301782$24330178$2$F$20240916$20240917$20240917$20240918$PER$$US-AMGEN-USASP2024185189$AMGEN$$77$YR$E$F$Y$$$20240918$$CN$US$US
243301791$24330179$1$I$$20240916$20240917$20240917$EXP$$CA-ORGANON-O2409CAN001046$ORGANON$Unknown. Unknown. Unknown. Unkn$18$YR$$F$Y$$$20240917$$HP$CA$CA
243301801$24330180$1$I$$20240916$20240917$20240917$EXP$$CA-ORGANON-O2409CAN001047$ORGANON$Unknown. Unknown. Unknown. Unkn;Unknown:Unknown$18$YR$$F$Y$$$20240917$$HP$CA$CA
243301811$24330181$1$I$$20240913$20240917$20240917$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147959$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240918$$CN$US$US
243301821$24330182$1$I$$20240912$20240917$20240917$EXP$$US-JNJFOC-20240932481$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$MD$US$US
243301831$24330183$1$I$20240819$20240912$20240917$20240917$EXP$$GB-AstraZeneca-2024A208415$ASTRAZENECA$$$$$F$Y$71$KG$20240918$$MD$GB$
243301841$24330184$1$I$20240101$20240913$20240917$20240917$PER$$US-AMGEN-USASP2024184147$AMGEN$$62$YR$A$F$Y$$$20240917$$HP$US$US
243301851$24330185$1$I$20240909$20240909$20240917$20240917$PER$$US-JNJFOC-20240929764$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$HP$US$US
243301861$24330186$1$I$20240801$20240906$20240917$20240917$PER$$US-SA-2024SA266167$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240918$$HP$US$US
243301871$24330187$1$I$$20240821$20240917$20240917$PER$$US-SA-2024SA266357$SANOFI AVENTIS$$$$$M$Y$$$20240918$$CN$US$US
243301881$24330188$1$I$20230612$20240902$20240917$20240917$EXP$$JP-AMGEN-JPNNI2024019207$AMGEN$Endo T. O-187 Efficacy and safety of avacopan for ANCA-associated vasculitis in our department. Journal of Japanese Society of Nephrology. 2024;66(4):607.$74$YR$E$M$Y$51$KG$20240917$$MD$JP$JP
243301901$24330190$1$I$20240207$20240911$20240917$20240917$EXP$$MX-TAKEDA-2024TUS010671$TAKEDA$$21$YR$$M$Y$21$KG$20240917$$CN$MX$MX
243301912$24330191$2$F$20240807$20240917$20240917$20240930$EXP$$US-UCBSA-2024041462$UCB$$63$YR$$M$Y$$$20241001$$CN$US$US
243301921$24330192$1$I$20240702$20240911$20240917$20240917$EXP$$TN-ABBVIE-5922838$ABBVIE$$42$YR$$F$Y$$$20240917$$CN$TN$TN
243301931$24330193$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS091921$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. Al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243301941$24330194$1$I$20230101$20240911$20240917$20240917$EXP$$US-CHATTEMPRD-2024OHG031753$CHATTEM$$$$E$F$Y$$$20240918$$LW$US$US
243301951$24330195$1$I$$20240911$20240917$20240917$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145065$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240918$$HP$US$US
243301961$24330196$1$I$$20240912$20240917$20240917$EXP$$US-CHATTEMPRD-2024OHG031871$CHATTEM$$$$$F$Y$$$20240918$$CN$US$US
243301971$24330197$1$I$$20240914$20240917$20240917$EXP$$US-AstraZeneca-2024A211338$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243301981$24330198$1$I$$20240914$20240917$20240917$EXP$$IN-AstraZeneca-2024A210282$ASTRAZENECA$$47$YR$$F$Y$89$KG$20240918$$CN$IN$
243301991$24330199$1$I$$20240916$20240917$20240917$EXP$$AU-AstraZeneca-2024A211515$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$AU$
243302011$24330201$1$I$20240908$20240910$20240917$20240917$EXP$$US-AstraZeneca-2024A210256$ASTRAZENECA$$29832$DY$$F$Y$$$20240918$$CN$US$
243302021$24330202$1$I$$20240911$20240917$20240917$EXP$$US-AstraZeneca-2024A207587$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243302031$24330203$1$I$$20240903$20240917$20240917$PER$$US-ABBVIE-5926180$ABBVIE$$$$$$Y$$$20240917$$HP$US$US
243302042$24330204$2$F$20230726$20240911$20240917$20240925$EXP$$JP-AMGEN-JPNNI2024184488$AMGEN$$77$YR$E$F$Y$26.6$KG$20240925$$MD$JP$JP
243302051$24330205$1$I$20240901$20240911$20240917$20240917$EXP$$CA-ABBVIE-5921872$ABBVIE$$55$YR$$F$Y$$$20240917$$CN$CA$CA
243302062$24330206$2$F$20240101$20240917$20240917$20240920$EXP$$US-ABBVIE-5922146$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243302071$24330207$1$I$20210301$20240904$20240917$20240917$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-145665$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240918$$MD$DE$DE
243302082$24330208$2$F$20240903$20240903$20240917$20240924$30DAY$$US-JNJFOC-20240904768$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240925$$HP$US$US
243302091$24330209$1$I$20240901$20240913$20240917$20240917$PER$$US-JNJFOC-20240936637$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$CN$US$US
243302101$24330210$1$I$20240101$20240916$20240917$20240917$EXP$$US-ABBVIE-5926455$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243302111$24330211$1$I$$20240913$20240917$20240917$EXP$$US-TAKEDA-2024TUS091992$TAKEDA$$$$$M$Y$$$20240917$$CN$US$US
243302121$24330212$1$I$$20240909$20240917$20240917$EXP$$US-ABBVIE-5917215$ABBVIE$$$$$F$Y$$$20240917$$CN$US$US
243302131$24330213$1$I$$20240911$20240917$20240917$PER$$US-AstraZeneca-2024A207472$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243302141$24330214$1$I$20240106$20240916$20240917$20240917$EXP$$SG-AstraZeneca-2024A211667$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$SG$
243302171$24330217$1$I$$20240911$20240917$20240917$PER$$US-JNJFOC-20240938880$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$MD$US$US
243302201$24330220$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A209930$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243302221$24330222$1$I$$20240913$20240917$20240917$PER$$US-AstraZeneca-2024A210506$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243302231$24330223$1$I$$20240913$20240917$20240917$EXP$$US-AstraZeneca-2024A211002$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243302241$24330224$1$I$$20240906$20240917$20240917$PER$$US-TAKEDA-2024TUS089917$TAKEDA$$$$$F$Y$53$KG$20240917$$MD$US$US
243302251$24330225$1$I$20240830$20240914$20240917$20240917$EXP$$CN-BEIGENE-BGN-2024-014675$BEIGENE$$$$$$Y$$$20240917$$HP$CN$CN
243302261$24330226$1$I$20240402$20240909$20240917$20240917$EXP$$JP-009507513-2404JPN000729J$MERCK$$79$YR$$M$Y$62$KG$20240917$$MD$JP$JP
243302271$24330227$1$I$$20240916$20240917$20240917$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051703$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240918$$CN$US$US
243302281$24330228$1$I$$20240904$20240917$20240917$EXP$GB-MHRA-MED-202409041405391010-BPMQY$GB-862174955-ML2024-04909$MICRO LABS$$73$YR$E$F$Y$52$KG$20240918$$CN$GB$GB
243302291$24330229$1$I$$20240912$20240917$20240917$EXP$$US-ABBVIE-5923317$ABBVIE$$$$$M$Y$$$20240917$$CN$US$US
243302301$24330230$1$I$$20240912$20240917$20240917$EXP$$US-TAKEDA-2024TUS092005$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240917$$MD$US$US
243302311$24330231$1$I$20240708$20240910$20240918$20240918$PER$$US-AstraZeneca-2024A206781$ASTRAZENECA$$30365$DY$$F$Y$$$20240918$$CN$US$
243302321$24330232$1$I$$20240912$20240918$20240918$PER$$US-AMGEN-USASP2024183345$AMGEN$$46$YR$A$F$Y$$$20240917$$HP$US$US
243302331$24330233$1$I$$20240110$20240918$20240918$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-428983$RANBAXY$$$$$F$Y$$$20240918$$CN$US$US
243302341$24330234$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS091999$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240918$$MD$US$US
243302351$24330235$1$I$$20231113$20240918$20240918$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420110$RANBAXY$$$$E$F$Y$$$20240918$$CN$US$US
243302361$24330236$1$I$20240101$20240913$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147428$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240918$$CN$US$US
243302381$24330238$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5922354$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243302391$24330239$1$I$$20240910$20240918$20240918$PER$$US-AMGEN-USASP2024183026$AMGEN$Enyeji A.M.; Arora A.; Mangat H.S.. Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports. Viral Immunology. 2024;37(6):298-307$44$YR$A$M$Y$$$20240917$$MD$US$US
243302401$24330240$1$I$$20240913$20240918$20240918$30DAY$$US-SANDOZ INC.-SDZ2024US080387$SANDOZ$$$$$M$Y$$$20240918$$CN$US$US
243302411$24330241$1$I$20240101$20240911$20240918$20240918$EXP$$US-ABBVIE-5920297$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243302421$24330242$1$I$20240101$20240912$20240918$20240918$EXP$$CA-ABBVIE-5922708$ABBVIE$$65$YR$$F$Y$$$20240918$$CN$CA$CA
243302431$24330243$1$I$$20240913$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US080193$SANDOZ$$28$YR$$$Y$$$20240918$$CN$US$US
243302441$24330244$1$I$20240101$20240911$20240918$20240918$EXP$$US-ABBVIE-5921509$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243302451$24330245$1$I$20240906$20240909$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409005821$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240917$$CN$US$US
243302461$24330246$1$I$20240429$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS048235$TAKEDA$$75$YR$$M$Y$$$20240918$$MD$US$US
243302471$24330247$1$I$20240703$20240912$20240918$20240918$EXP$$US-ABBVIE-5923686$ABBVIE$$80$YR$$F$Y$$$20240918$$CN$US$US
243302481$24330248$1$I$$20240909$20240918$20240918$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000317$EMCURE$$$$$$Y$$$20240917$$CN$US$US
243302491$24330249$1$I$$20240910$20240918$20240918$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000323$EMCURE$Maclennan APH, Sitner-Medvedovsky E, Varon D, Parikh A, Shah A, Chhabra M.. Ventricular Tachyarrhythmia in a Newborn Baby. Oxford medical case reports. 2024;9:396-399$$$N$F$Y$$$20240918$$HP$US$US
243302501$24330250$1$I$$20240912$20240918$20240918$EXP$$US-AMGEN-USASP2024183985$AMGEN$$$$$F$Y$$$20240917$$HP$US$US
243302511$24330251$1$I$$20240913$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147987$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240918$$CN$US$US
243302521$24330252$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5926477$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243302531$24330253$1$I$20220101$20240910$20240918$20240918$PER$$US-AMGEN-USASP2024181884$AMGEN$Song D.; Goldbaum M.; Ginsberg C. et al.. Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis. American Journal of Ophthalmology Case Reports. 2024;36:1-4$32$YR$A$F$Y$$$20240917$$HP$US$US
243302541$24330254$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A209954$ASTRAZENECA$$$$$M$Y$$$20240918$$HP$US$
243302551$24330255$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211910$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243302561$24330256$1$I$20240401$20240911$20240918$20240918$EXP$$US-ABBVIE-5752029$ABBVIE$$64$YR$$F$Y$61$KG$20240918$$CN$US$US
243302571$24330257$1$I$20231113$20240911$20240918$20240918$EXP$$DE-AstraZeneca-2024A206972$ASTRAZENECA$$$$A$M$Y$$$20240918$$MD$DE$
243302591$24330259$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211962$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243302601$24330260$1$I$$20240913$20240918$20240918$EXP$$CA-AstraZeneca-2024A209929$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$CA$
243302611$24330261$1$I$$20240915$20240918$20240918$EXP$$CA-ABBVIE-5925405$ABBVIE$$$$A$F$Y$$$20240918$$CN$CA$CA
243302641$24330264$1$I$$20240910$20240918$20240918$EXP$$US-ABBVIE-5918722$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243302651$24330265$1$I$20240101$20240911$20240918$20240918$EXP$$US-ABBVIE-5923595$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243302661$24330266$1$I$$20240913$20240918$20240918$EXP$$US-TAKEDA-2024TUS091748$TAKEDA$$$$$F$Y$$$20240918$$CN$US$US
243302671$24330267$1$I$20240801$20240905$20240918$20240918$EXP$$NL-ABBVIE-5926214$ABBVIE$$77$YR$$M$Y$$$20240918$$CN$NL$NL
243302691$24330269$1$I$20240829$20240913$20240918$20240918$PER$$US-ABBVIE-5924209$ABBVIE$$24$YR$$F$Y$54$KG$20240918$$CN$US$US
243302711$24330271$1$I$20081001$20190206$20240918$20240918$EXP$$FR-ABBVIE-08P-056-0494696-00$ABBVIE$$83$YR$$F$Y$$$20240918$$HP$FR$FR
243302721$24330272$1$I$20231101$20240806$20240918$20240918$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-147860$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240918$$MD$DE$DE
243302731$24330273$1$I$$20240913$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148153$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240918$$CN$US$US
243302741$24330274$1$I$20240801$20240911$20240918$20240918$EXP$$US-ABBVIE-5921503$ABBVIE$$60$YR$$M$Y$$$20240918$$CN$US$US
243302751$24330275$1$I$20240912$20240913$20240918$20240918$EXP$$US-ABBVIE-5923705$ABBVIE$$67$YR$$M$Y$$$20240918$$CN$US$US
243302761$24330276$1$I$$20240911$20240918$20240918$PER$$US-ABBVIE-5920911$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243302771$24330277$1$I$$20240914$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010537$ELI LILLY AND CO$$$$$$Y$$$20240918$$HP$US$US
243302781$24330278$1$I$20240101$20240912$20240918$20240918$EXP$$US-ABBVIE-5924721$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243302801$24330280$1$I$$20231218$20240918$20240918$PER$$US-ENDO USA, INC.-2023-006396$ENDO$$$$$F$Y$$$20240918$$CN$US$US
243302811$24330281$1$I$20190601$20231218$20240918$20240918$PER$$US-ENDO USA, INC.-2023-006425$ENDO$$$$$M$Y$$$20240918$$CN$US$US
243302821$24330282$1$I$$20231218$20240918$20240918$PER$$US-ENDO USA, INC.-2024-000015$ENDO$$$$$F$Y$$$20240918$$CN$US$US
243302831$24330283$1$I$$20231218$20240918$20240918$PER$$US-ENDO USA, INC.-2023-006361$ENDO$$$$$M$Y$$$20240918$$CN$US$US
243302851$24330285$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A210530$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243302861$24330286$1$I$$20240912$20240918$20240918$EXP$$FR-AstraZeneca-2024A210344$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$FR$
243302871$24330287$1$I$$20240913$20240918$20240918$PER$$US-AstraZeneca-2024A210552$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$US$
243302881$24330288$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5922690$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243302891$24330289$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211696$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243302901$24330290$1$I$20240828$20240912$20240918$20240918$EXP$$US-ABBVIE-5922127$ABBVIE$$50$YR$$F$Y$$$20240918$$CN$US$US
243302911$24330291$1$I$$20240916$20240918$20240918$PER$$US-AstraZeneca-2024A212192$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243302921$24330292$1$I$$20240912$20240918$20240918$EXP$$US-AstraZeneca-2024A209363$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243302931$24330293$1$I$$20240911$20240918$20240918$EXP$$JP-AstraZeneca-2022A226370$ASTRAZENECA$$78$YR$$$Y$$$20240918$$MD$JP$
243302942$24330294$2$F$20240101$20240916$20240918$20240920$EXP$$CA-ABBVIE-5924509$ABBVIE$$69$YR$$F$Y$$$20240920$$CN$CA$CA
243302951$24330295$1$I$20240813$20240912$20240918$20240918$EXP$$US-ABBVIE-5922148$ABBVIE$$38$YR$$F$Y$$$20240918$$CN$US$US
243302961$24330296$1$I$20240916$20240916$20240918$20240918$EXP$$US-ABBVIE-5926625$ABBVIE$$59$YR$$F$Y$$$20240918$$CN$US$US
243302971$24330297$1$I$$20240904$20240918$20240918$PER$$US-JNJFOC-20240908754$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$CN$US$US
243302981$24330298$1$I$20230815$20240911$20240918$20240918$EXP$$CA-JNJFOC-20240734236$JOHNSON AND JOHNSON$$17$YR$T$F$Y$$$20240918$$HP$CA$CA
243303001$24330300$1$I$$20240911$20240918$20240918$EXP$$US-JNJFOC-20240928160$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$CN$US$US
243303011$24330301$1$I$$20240904$20240918$20240918$PER$$US-JNJFOC-20240908789$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243303021$24330302$1$I$20231019$20240906$20240918$20240918$EXP$$US-RDY-SPO/USA/23/0181112$DR REDDYS$$74$YR$E$F$Y$$$20240918$$MD$US$US
243303031$24330303$1$I$20240612$20240910$20240918$20240918$EXP$$JP-ASTELLAS-2024JP004212$ASTELLAS$$6$DEC$A$F$Y$$$20240918$$MD$JP$JP
243303041$24330304$1$I$$20240904$20240918$20240918$PER$$US-JNJFOC-20240908894$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243303051$24330305$1$I$20240101$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024183630$AMGEN$$68$YR$E$M$Y$$$20240917$$CN$US$US
243303061$24330306$1$I$20240101$20240914$20240918$20240918$EXP$$TR-ABBVIE-5925959$ABBVIE$$$$$M$Y$$$20240918$$MD$TR$TR
243303071$24330307$1$I$20240801$20240911$20240918$20240918$EXP$$NVSC2024BR184328$NOVARTIS$$41$YR$$F$Y$79$KG$20240918$$CN$BR$BR
243303081$24330308$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5923978$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243303092$24330309$2$F$20240915$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185068$AMGEN$$67$YR$E$F$Y$$$20240918$$CN$US$US
243303103$24330310$3$F$$20240904$20240918$20240930$30DAY$$US-JNJFOC-20240909012$JOHNSON AND JOHNSON$$$$$$Y$$$20240929$$PH$US$US
243303111$24330311$1$I$20240901$20240910$20240918$20240918$EXP$$US-JNJFOC-20240932321$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240918$$CN$US$US
243303121$24330312$1$I$20240801$20240913$20240918$20240918$EXP$$ES-ABBVIE-5924055$ABBVIE$$85$YR$$M$Y$70$KG$20240918$$CN$ES$ES
243303131$24330313$1$I$20240101$20240913$20240918$20240918$PER$$US-ABBVIE-5924251$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243303141$24330314$1$I$$20240904$20240918$20240918$EXP$NL-LRB-01000186$NL-JUBILANT CADISTA PHARMACEUTICALS-2024NL001272$JUBILANT$$59$YR$$M$Y$118$KG$20240918$$CN$NL$NL
243303151$24330315$1$I$$20240903$20240918$20240918$PER$$US-SA-2024SA267892$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240918$$HP$US$US
243303161$24330316$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267161$SANOFI AVENTIS$$$$E$F$Y$65.91$KG$20240918$$MD$US$US
243303171$24330317$1$I$20240901$20240830$20240918$20240918$PER$$US-SA-2024SA267330$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240918$$MD$US$US
243303181$24330318$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267106$SANOFI AVENTIS$$$$A$M$Y$110.45$KG$20240918$$MD$US$US
243303191$24330319$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA267331$SANOFI AVENTIS$$$$A$F$Y$302.64$KG$20240918$$MD$US$US
243303201$24330320$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211357$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243303211$24330321$1$I$20240814$20240912$20240918$20240918$EXP$$US-AstraZeneca-2024A189326$ASTRAZENECA$$23210$DY$$F$Y$106.1$KG$20240918$$HP$US$
243303221$24330322$1$I$20240101$20240828$20240918$20240918$PER$$US-SA-2024SA266811$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240918$$CN$US$US
243303231$24330323$1$I$$20240910$20240918$20240918$EXP$$RU-AstraZeneca-2024A208727$ASTRAZENECA$$56$YR$$F$Y$80$KG$20240918$$MD$RU$
243303241$24330324$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211577$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243303261$24330326$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5923874$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243303271$24330327$1$I$20231104$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010471$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240918$$CN$US$US
243303281$24330328$1$I$$20240909$20240918$20240918$EXP$$US-JNJFOC-20240921194$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$CN$US$US
243303291$24330329$1$I$20231017$20240904$20240918$20240918$EXP$AU-TGA-0000818199$AU-NOVOPROD-1279470$NOVO NORDISK$$69$YR$$M$Y$$$20240918$$HP$AU$AU
243303301$24330330$1$I$20240902$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185055$AMGEN$$62$YR$A$F$Y$$$20240917$$HP$US$US
243303311$24330331$1$I$$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024183973$AMGEN$$$$$$Y$$$20240917$$HP$US$US
243303321$24330332$1$I$$20240911$20240918$20240918$EXP$$NVSC2024RU184203$NOVARTIS$$$$$F$Y$$$20240918$$MD$RU$RU
243303331$24330333$1$I$$20240911$20240918$20240918$EXP$$BE-ABBVIE-5921558$ABBVIE$$78$YR$$F$Y$57$KG$20240918$$CN$BE$BE
243303341$24330334$1$I$20240815$20240906$20240918$20240918$EXP$$CA-NOVOPROD-1281375$NOVO NORDISK$$67$YR$$F$Y$$$20240918$$CN$CA$CA
243303351$24330335$1$I$20240701$20240906$20240918$20240918$EXP$$US-NOVOPROD-1281420$NOVO NORDISK$$$$$M$Y$$$20240918$$CN$US$US
243303361$24330336$1$I$$20240906$20240918$20240918$EXP$$CO-NOVOPROD-1281227$NOVO NORDISK$$51$YR$$F$Y$96$KG$20240918$$CN$CO$CO
243303371$24330337$1$I$20240826$20240906$20240918$20240918$EXP$$AT-NOVOPROD-1281368$NOVO NORDISK$$$$A$F$Y$$$20240918$$HP$AT$AT
243303381$24330338$1$I$$20240909$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011811$STRIDES$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al.. Novel approaches in the treatment of Hansen+#39;s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States.. Ther-Adv-Infect-Dis. 2022;9:1-10$27$YR$$M$Y$$$20240918$$HP$US$US
243303391$24330339$1$I$20240825$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409061035309390-YWJNC$GB-NOVOPROD-1280481$NOVO NORDISK$$43$YR$$M$Y$136$KG$20240918$$MD$GB$GB
243303401$24330340$1$I$$20240906$20240918$20240918$EXP$$PH-NOVOPROD-1281349$NOVO NORDISK$$67$YR$$M$Y$$$20240918$$CN$PH$PH
243303411$24330341$1$I$$20240906$20240918$20240918$EXP$$CA-NOVOPROD-1281358$NOVO NORDISK$$$$$F$Y$$$20240918$$HP$CA$CA
243303431$24330343$1$I$$20240903$20240918$20240918$EXP$$US-AUROBINDO-AUR-APL-2024-046001$AUROBINDO$Schwartz W, Christiansen AC, Patel SS. Intraorbital amphotericin B for mucormycosis in an Allo-HSCT recipient. Bone Marrow Transplantation. 2024;59(8):1176-1177$68$YR$$M$Y$$$20240918$$MD$US$US
243303441$24330344$1$I$$20240910$20240918$20240918$EXP$$BR-DEXPHARM-2024-3178$DEXCEL$Souza, C. C.; Rigueto, L. G.; Santiago, H. C.; Seguro, A. C.; Girardi, A. C. C.; Luchi, W. M.  Multiple electrolyte disorders triggered by proton pump inhibitor-induced hypomagnesemia: Case reports with a mini-review of the literature. Clinical Nephrology - Case Studies 2024, V12, P6-11$65$YR$A$F$Y$$$20240918$$HP$BR$BR
243303451$24330345$1$I$$20240910$20240918$20240918$EXP$$BR-DEXPHARM-2024-3173$DEXCEL$Souza, C. C.; Rigueto, L. G.; Santiago, H. C.; Seguro, A. C.; Girardi, A. C. C.; Luchi, W. M.  Multiple electrolyte disorders triggered by proton pump inhibitor-induced hypomagnesemia: Case reports with a mini-review of the literature. Clinical Nephrology - Case Studies 2024, V12, P6-11$35$YR$A$M$Y$$$20240918$$HP$BR$BR
243303462$24330346$2$F$20240101$20240910$20240918$20240924$EXP$$NVSC2024IN184761$NOVARTIS$$$$$M$Y$82.2$KG$20240924$$CN$IN$IN
243303471$24330347$1$I$$20240909$20240918$20240918$EXP$$ZA-ABBVIE-5906491$ABBVIE$$85$YR$$F$Y$$$20240918$$HP$ZA$ZA
243303482$24330348$2$F$20240914$20240927$20240918$20240928$PER$$US-AMGEN-USASP2024184545$AMGEN$$80$YR$E$M$Y$$$20240928$$CN$US$US
243303491$24330349$1$I$$20240908$20240918$20240918$EXP$$EG-NOVOPROD-1280721$NOVO NORDISK$$$$$$Y$$$20240918$$CN$EG$EG
243303501$24330350$1$I$20240201$20240906$20240918$20240918$EXP$$US-NOVOPROD-1281992$NOVO NORDISK$$70$YR$$M$Y$$$20240918$$HP$US$US
243303511$24330351$1$I$$20240909$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011812$STRIDES$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al.. Novel approaches in the treatment of Hansen+#39;s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States.. Ther-Adv-Infect-Dis. 2022;9:1-10$36$YR$$M$Y$$$20240918$$HP$US$US
243303521$24330352$1$I$20161001$20240906$20240918$20240918$EXP$$NL-KOANAAP-SML-NL-2024-00939$SHILPA MEDICARE$Cate IMR, Maten JV, Overbeek MJ, Holder JTT. Organising pneumonia and non-specific interstitial pneumonia as a late consequence of treatment with imatinib in a patient with chronic myeloid leukaemia. Ned Tijdschr Allergie, Astma, Klin Immunol. 2019;19: 22-27.$68$YR$E$M$Y$$$20240918$$HP$NL$NL
243303531$24330353$1$I$20240801$20240907$20240918$20240918$EXP$$BR-NOVOPROD-1281605$NOVO NORDISK$$$$$F$Y$$$20240918$$CN$BR$BR
243303541$24330354$1$I$20240601$20240906$20240918$20240918$EXP$$US-NOVOPROD-1282241$NOVO NORDISK$$$$$F$Y$$$20240918$$CN$US$US
243303551$24330355$1$I$$20240908$20240918$20240918$EXP$$IE-NOVOPROD-1281974$NOVO NORDISK$$$$$F$Y$$$20240918$$CN$IE$IE
243303561$24330356$1$I$20240614$20240906$20240918$20240918$EXP$$CA-NOVOPROD-1282164$NOVO NORDISK$$80$YR$$M$Y$$$20240918$$MD$CA$CA
243303571$24330357$1$I$$20240909$20240918$20240918$EXP$$US-NOVOPROD-1283246$NOVO NORDISK$$$$$F$Y$$$20240918$$CN$US$US
243303581$24330358$1$I$$20240906$20240918$20240918$EXP$$US-NOVOPROD-1282176$NOVO NORDISK$$$$$$Y$$$20240918$$CN$US$US
243303591$24330359$1$I$$20240906$20240918$20240918$EXP$$US-NOVOPROD-1282072$NOVO NORDISK$$$$$F$Y$$$20240918$$CN$US$US
243303601$24330360$1$I$20240726$20240907$20240918$20240918$EXP$CN-NMPA-2102011010986202400202$CN-NOVOPROD-1280972$NOVO NORDISK$$53$YR$$F$Y$49$KG$20240918$$HP$CN$CN
243303611$24330361$1$I$$20240909$20240918$20240918$EXP$$US-NOVOPROD-1282900$NOVO NORDISK$$44$YR$$M$Y$$$20240918$$CN$US$US
243303621$24330362$1$I$$20240906$20240918$20240918$EXP$$CN-NOVOPROD-1282000$NOVO NORDISK$$86$YR$$M$Y$$$20240918$$CN$CN$CN
243303631$24330363$1$I$20230901$20240909$20240918$20240918$EXP$$US-NOVOPROD-1282918$NOVO NORDISK$$78$YR$$F$Y$$$20240918$$CN$US$US
243303641$24330364$1$I$$20240909$20240918$20240918$EXP$$US-NOVOPROD-1282937$NOVO NORDISK$$$$$F$Y$$$20240918$$CN$US$US
243303661$24330366$1$I$20200101$20240909$20240918$20240918$EXP$$AU-ASTELLAS-2024-AER-005899$ASTELLAS$Bennett GD. Two instances of successful oral desensitisation following hypersensitivity reaction in a patient receiving osimertinib: a case report. Journal of Pharmacy Practice and Research. 2024;54(4): 328-32. doi:10.1002/jppr.1928.$70$YR$E$F$Y$$$20240918$$PH$AU$AU
243303671$24330367$1$I$$20240909$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011814$STRIDES$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al.. Novel approaches in the treatment of Hansen+#39;s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States.. Ther-Adv-Infect-Dis. 2022;9:1-10$72$YR$$F$Y$$$20240918$$HP$US$US
243303691$24330369$1$I$$20240909$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011813$STRIDES$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al.. Novel approaches in the treatment of Hansen+#39;s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States.. Ther-Adv-Infect-Dis. 2022;9:1-10$77$YR$$M$Y$$$20240918$$HP$US$US
243303701$24330370$1$I$$20240903$20240918$20240918$PER$$US-ABBVIE-5926236$ABBVIE$$$$$$Y$$$20240918$$HP$US$US
243303711$24330371$1$I$$20240904$20240918$20240918$EXP$$CA-AUROBINDO-AUR-APL-2024-045217$AUROBINDO$$30$YR$$F$Y$$$20240918$$CN$CA$CA
243303721$24330372$1$I$$20240916$20240918$20240918$EXP$$US-ABBVIE-5926593$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243303731$24330373$1$I$20240501$20240913$20240918$20240918$EXP$$US-ABBVIE-5924065$ABBVIE$$75$YR$$F$Y$$$20240918$$CN$US$US
243303741$24330374$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924219$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243303751$24330375$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5922612$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243303762$24330376$2$F$$20240909$20240918$20240926$EXP$$JP-009507513-2409JPN001424J$MERCK$Onotogi H, Yamazaki S, Okamura T, Kuboki S, Natsume Y, Kurosaka Y, et al.. 49-AB-38 A Case of IrAE Liver Injury in which Chronic Changes were Observed by Ultrasonography. The 49th Annual Scientific Meeting of the Japanese Society of Sonographers.$6$DEC$$M$Y$$$20240926$$MD$JP$JP
243303791$24330379$1$I$$20240909$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011815$STRIDES$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al.. Novel approaches in the treatment of Hansen+#39;s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States.. Ther-Adv-Infect-Dis. 2022;9:1-10$37$YR$$M$Y$$$20240918$$HP$US$US
243303801$24330380$1$I$$20240909$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011818$STRIDES$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al.. Novel approaches in the treatment of Hansen+#39;s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States.. Ther-Adv-Infect-Dis. 2022;9:1-10$39$YR$$M$Y$$$20240918$$HP$US$US
243303811$24330381$1$I$$20240909$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011817$STRIDES$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al.. Novel approaches in the treatment of Hansen+#39;s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States.. Ther-Adv-Infect-Dis. 2022;9:1-10$17$YR$$M$Y$$$20240918$$HP$US$US
243303831$24330383$1$I$$20240912$20240918$20240918$EXP$$US-AstraZeneca-2024A209117$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243303861$24330386$1$I$$20240910$20240918$20240918$EXP$$IN-AstraZeneca-2024A207450$ASTRAZENECA$$70$YR$$M$Y$45$KG$20240918$$CN$IN$
243303872$24330387$2$F$20240101$20240916$20240918$20240925$EXP$$CA-CELLTRION INC.-2024CA021199$CELLTRION$$$$$$Y$$$20240925$$CN$CA$CA
243303883$24330388$3$F$20240914$20240923$20240918$20240927$PER$$US-AMGEN-USASP2024184754$AMGEN$$72$YR$E$F$Y$$$20240927$$CN$US$US
243303911$24330391$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS092007$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240918$$MD$US$US
243303922$24330392$2$F$20240702$20240917$20240918$20240922$EXP$$US-ABBVIE-5918150$ABBVIE$$77$YR$$F$Y$$$20240922$$CN$US$US
243303931$24330393$1$I$$20240916$20240918$20240918$EXP$$ES-SANDOZ INC.-SDZ2024ES080351$SANDOZ$$29$YR$$F$Y$$$20240918$$HP$ES$ES
243303941$24330394$1$I$$20240904$20240918$20240918$EXP$$GB-CIPLA LTD.-2024GB09857$CIPLA$$$$$$Y$$$20240918$$MD$GB$GB
243303951$24330395$1$I$20240301$20240912$20240918$20240918$PER$$PR-ABBVIE-5922568$ABBVIE$$54$YR$$F$Y$95$KG$20240918$$CN$PR$PR
243303962$24330396$2$F$20240910$20240920$20240918$20240927$EXP$$KR-TAKEDA-2024TUS092085$TAKEDA$$49$YR$$F$Y$43.3$KG$20240927$$MD$KR$KR
243303971$24330397$1$I$20231018$20240911$20240918$20240918$EXP$$DE-ABBVIE-5921587$ABBVIE$$23$YR$$M$Y$$$20240918$$MD$DE$DE
243303981$24330398$1$I$$20240909$20240918$20240918$EXP$$JP-ASTELLAS-2024-AER-006117$ASTELLAS$Sekiguchi E, Sakurai M, Inoue T, Masuda K, Kubota Y, Sindo T, et al. A case in which endoscopic balloon dilation was effective for esophageal stenosis lesions in chronic graft versus host disease. The 20th Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology Program and Abstracts (2024.03.09). 2024;17.$50$YR$A$M$Y$$$20240918$$MD$JP$JP
243303991$24330399$1$I$$20240909$20240918$20240918$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP011928$STRIDES$Rybka J, Kuszczak B, Bogucka-Fedorczuk A.. Treatment of primary central nervous system lymphoma (PCNSL) - single center experience and literature review.. Acta-Haematol-Polon. 2024;55 (3):151-156$$$$$Y$$$20240918$$HP$PL$PL
243304001$24330400$1$I$$20240909$20240918$20240918$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP011929$STRIDES$Rybka J, Kuszczak B, Bogucka-Fedorczuk A.. Treatment of primary central nervous system lymphoma (PCNSL) - single center experience and literature review.. Acta-Haematol-Polon. 2024;55 (3):151-156$$$$$Y$$$20240918$$HP$PL$PL
243304011$24330401$1$I$20240905$20240906$20240918$20240918$PER$$US-ABBVIE-5916498$ABBVIE$$65$YR$$M$Y$$$20240918$$CN$US$US
243304021$24330402$1$I$$20240907$20240918$20240918$PER$$US-ASTELLAS-2024-AER-005857$ASTELLAS$$84$YR$E$M$Y$$$20240918$$MD$US$US
243304031$24330403$1$I$$20240910$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145982$BRISTOL MYERS SQUIBB$Ichikawa S, Goshima S. Key CT and MRI findings of drug-associated hepatobiliary and pancreatic disorders. Japanese Journal of Radiology. 2024;42(3):235-45. doi:10.1007/s11604-023-01505-z.$65$YR$E$M$Y$$$20240918$$MD$JP$JP
243304041$24330404$1$I$$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024184413$AMGEN$$$$$$Y$$$20240917$$CN$US$US
243304051$24330405$1$I$20240914$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184685$AMGEN$$80$YR$E$M$Y$$$20240917$$CN$US$US
243304061$24330406$1$I$$20240909$20240918$20240918$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP011931$STRIDES$Rybka J, Kuszczak B, Bogucka-Fedorczuk A.. Treatment of primary central nervous system lymphoma (PCNSL) - single center experience and literature review.. Acta-Haematol-Polon. 2024;55 (3):151-156$$$$$Y$$$20240918$$HP$PL$PL
243304071$24330407$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS092026$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240918$$MD$US$US
243304081$24330408$1$I$20240101$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185044$AMGEN$$52$YR$A$F$Y$$$20240917$$HP$US$US
243304091$24330409$1$I$$20240416$20240918$20240918$PER$$US-Accord-420854$ACCORD$$59$YR$A$F$Y$$$20240918$$CN$US$US
243304101$24330410$1$I$$20240823$20240918$20240918$PER$$US-SA-2024SA267853$SANOFI AVENTIS$$$$A$F$Y$68.9$KG$20240918$$MD$US$US
243304111$24330411$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA266637$SANOFI AVENTIS$$15$YR$T$F$Y$57.73$KG$20240918$$MD$US$US
243304121$24330412$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA264079$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240918$$MD$US$US
243304131$24330413$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA217987$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240918$$MD$US$US
243304141$24330414$1$I$$20240822$20240918$20240918$PER$$US-SA-2024SA266298$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240918$$CN$US$US
243304151$24330415$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266252$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240918$$HP$US$US
243304161$24330416$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266154$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240918$$MD$US$US
243304171$24330417$1$I$20240101$20240828$20240918$20240918$PER$$US-SA-2024SA267843$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240918$$MD$US$US
243304181$24330418$1$I$$20240822$20240918$20240918$PER$$US-SA-2024SA267608$SANOFI AVENTIS$$8$YR$C$F$Y$25.397$KG$20240918$$MD$US$US
243304191$24330419$1$I$20240101$20240828$20240918$20240918$PER$$US-SA-2024SA266831$SANOFI AVENTIS$$6$YR$C$F$Y$26.82$KG$20240918$$MD$US$US
243304201$24330420$1$I$20240822$20240823$20240918$20240918$PER$$US-SA-2024SA264139$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240918$$HP$US$US
243304211$24330421$1$I$20240822$20240823$20240918$20240918$PER$$US-SA-2024SA267187$SANOFI AVENTIS$$7$YR$C$F$Y$27.2$KG$20240918$$MD$US$US
243304221$24330422$1$I$$20240822$20240918$20240918$PER$$US-SA-2024SA266458$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240918$$CN$US$US
243304231$24330423$1$I$20240101$20240827$20240918$20240918$PER$$US-SA-2024SA266609$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240918$$PH$US$US
243304242$24330424$2$F$20240101$20240913$20240918$20240920$PER$$US-SA-2024SA266587$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240920$$CN$US$US
243304261$24330426$1$I$20240801$20240909$20240918$20240918$EXP$$CA-CELLTRION INC.-2024CA021931$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
243304271$24330427$1$I$$20240910$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011772$STRIDES$Jamison K, Medepalli L C, Ye S.. Isolated Pericardial Effusion Without Associated Myocarditis in a Small-Cell Lung Cancer Patient Undergoing Atezolizumab Therapy.. Cureus. 2024;16(5):e60184$67$YR$$M$Y$$$20240918$$HP$US$US
243304281$24330428$1$I$$20240628$20240918$20240918$PER$$US-Accord-436518$ACCORD$$68$YR$$M$Y$$$20240918$$CN$US$US
243304291$24330429$1$I$$20240626$20240918$20240918$PER$$US-Accord-436507$ACCORD$$69$YR$E$M$Y$$$20240918$$CN$US$US
243304321$24330432$1$I$$20240823$20240918$20240918$PER$$US-SA-2024SA268418$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240918$$CN$US$US
243304331$24330433$1$I$20240901$20240910$20240918$20240918$PER$$US-SA-2024SA266065$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240918$$HP$US$US
243304341$24330434$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267904$SANOFI AVENTIS$$$$$M$Y$$$20240918$$CN$US$US
243304351$24330435$1$I$20240716$20240828$20240918$20240918$PER$$US-SA-2024SA266618$SANOFI AVENTIS$$62$YR$A$$Y$93.18$KG$20240918$$PH$US$US
243304361$24330436$1$I$$20240904$20240918$20240918$PER$$US-SA-2024SA258972$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240918$$HP$US$US
243304371$24330437$1$I$20240901$20240910$20240918$20240918$PER$$US-SA-2024SA266078$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240918$$MD$US$US
243304381$24330438$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA265285$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$HP$US$US
243304391$24330439$1$I$20230911$20240910$20240918$20240918$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011732$STRIDES$Song B, Luo Y, Li Q, Pan H, Li D.. Experience and Lessons Learned in the Treatment of Transforming Small Cell Neuroendocrine Carcinoma of the Prostate: A Case Report and Literature Review.. Case Rep Oncol.. 2024;17(1):247-255$8$DEC$$M$Y$$$20240918$$HP$CN$CN
243304411$24330441$1$I$$20240828$20240918$20240918$PER$$US-CHATTEMPRD-2024OHG031952$CHATTEM$$$$A$M$Y$$$20240918$$CN$US$US
243304421$24330442$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5923623$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243304431$24330443$1$I$$20240826$20240918$20240918$PER$$US-CHATTEMPRD-2024OHG031956$CHATTEM$$$$A$M$Y$$$20240918$$CN$US$US
243304441$24330444$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS092024$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240918$$MD$US$US
243304451$24330445$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS092028$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240918$$MD$US$US
243304461$24330446$1$I$20240801$20240913$20240918$20240918$EXP$$JP-ABBVIE-5926279$ABBVIE$$79$YR$$F$Y$$$20240918$$MD$JP$JP
243304471$24330447$1$I$20240901$20240913$20240918$20240918$EXP$$US-TAKEDA-2024TUS092113$TAKEDA$$60$YR$$F$Y$$$20240918$$CN$US$US
243304481$24330448$1$I$20240411$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A210481$ASTRAZENECA$$24312$DY$$F$Y$$$20240918$$CN$US$
243304491$24330449$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A210562$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243304501$24330450$1$I$20240709$20240912$20240918$20240918$EXP$$JP-AstraZeneca-2024A208598$ASTRAZENECA$$66$YR$$F$Y$51$KG$20240918$$MD$JP$
243304511$24330451$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211561$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243304521$24330452$1$I$20240829$20240912$20240918$20240918$EXP$$CO-AstraZeneca-2024A211369$ASTRAZENECA$$11095$DY$$F$Y$$$20240918$$CN$CO$
243304551$24330455$1$I$$20240913$20240918$20240918$PER$$US-AstraZeneca-2024A210554$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243304561$24330456$1$I$20230203$20240906$20240918$20240918$EXP$FR-AFSSAPS-PC2024000682$FR-Accord-446113$ACCORD$$52$YR$A$F$Y$83$KG$20240918$$PH$FR$FR
243304571$24330457$1$I$$20240916$20240918$20240918$EXP$GB-MHRA-MED-202409152107096570-GKDVY$GB-ORGANON-O2409GBR001150$ORGANON$$$$$$Y$$$20240918$$CN$GB$GB
243304581$24330458$1$I$$20240911$20240918$20240918$PER$$US-CHATTEMPRD-2024OHG031832$CHATTEM$$$$$$Y$$$20240918$$CN$US$US
243304592$24330459$2$F$$20240910$20240918$20240925$PER$$US-CHATTEMPRD-2024OHG031691$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243304601$24330460$1$I$$20240830$20240918$20240918$PER$$US-CHATTEMPRD-2024OHG032016$CHATTEM$$$$A$F$Y$$$20240918$$CN$US$US
243304611$24330461$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147629$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$101.15$KG$20240918$$HP$US$US
243304641$24330464$1$I$$20240911$20240918$20240918$PER$$US-CHATTEMPRD-2024OHG031830$CHATTEM$$$$$F$Y$$$20240918$$CN$US$US
243304661$24330466$1$I$20240903$20240903$20240918$20240918$PER$$US-TEVA-VS-3240123$TEVA$$$$$F$Y$$$20240918$$CN$US$US
243304671$24330467$1$I$20240901$20240910$20240918$20240918$EXP$$CN-BEIGENE-BGN-2024-014391$BEIGENE$$$$$$Y$$$20240918$$HP$CN$CN
243304681$24330468$1$I$$20240910$20240918$20240918$EXP$$CA-HALEON-2197060$Haleon PLC$$$$$F$Y$97$KG$20240918$$HP$CA$CA
243304691$24330469$1$I$$20240911$20240918$20240918$EXP$$US-JNJFOC-20240929468$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$HP$US$US
243304701$24330470$1$I$20240807$20240910$20240918$20240918$EXP$$CN-BEIGENE-BGN-2024-014381$BEIGENE$$$$$$Y$$$20240918$$HP$CN$CN
243304711$24330471$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS092008$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240918$$MD$US$US
243304721$24330472$1$I$$20240911$20240918$20240918$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051106$BOEHRINGER INGELHEIM$Chauhan S, Diaz V, Ogbu IR, Sanchez JP, Manov AE, Shah P. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis Masked by Urinary Tract Infection. Cureus. 2024 Aug 07;16(8): e66408-e66408. doi:10.7759/cureus.66408.$90$YR$E$M$Y$$$20240918$$HP$US$US
243304731$24330473$1$I$20230201$20240909$20240918$20240918$EXP$$DE-ABBVIE-5918787$ABBVIE$$$$E$M$Y$$$20240918$$MD$DE$DE
243304741$24330474$1$I$20240101$20240906$20240918$20240918$EXP$SE-SEMPA-2024-006460$SE-Accord-445951$ACCORD$$70$YR$E$F$Y$60$KG$20240918$$MD$SE$SE
243304751$24330475$1$I$$20240911$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008852$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240918$$CN$US$US
243304761$24330476$1$I$$20231102$20240918$20240918$PER$$US-ENDO USA, INC.-2023-005786$ENDO$$$$$M$Y$$$20240918$$CN$US$US
243304771$24330477$1$I$20240904$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409061635586740-YFCKS$GB-Accord-445781$ACCORD$$76$YR$E$F$Y$95$KG$20240918$$PH$GB$GB
243304781$24330478$1$I$$20240909$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143319$BRISTOL MYERS SQUIBB$Ladwa A, Elghawy O, Kaur V. Single institution experience with immune checkpoint inhibitors in vulvar and vaginal melanomas. Obstetrics and Gynecology International. 2024 Jan 01;1-6.doi:10.1155/2024/7327692.$53$YR$A$F$Y$$$20240918$$HP$US$US
243304793$24330479$3$F$20240101$20240919$20240918$20240928$EXP$$CA-CELLTRION INC.-2024CA021936$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
243304801$24330480$1$I$20240101$20240910$20240918$20240918$EXP$$US-JNJFOC-20240934360$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240918$$HP$US$US
243304811$24330481$1$I$20240401$20240909$20240918$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-012148$UNITED THERAPEUTICS$$67$YR$$F$Y$88.435$KG$20240918$$$US$US
243304821$24330482$1$I$$20240829$20240918$20240918$30DAY$$CA-JNJFOC-20240880950$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$CN$CA$CA
243304831$24330483$1$I$20240826$20240910$20240918$20240918$EXP$$CN-BEIGENE-BGN-2024-014384$BEIGENE$$$$$$Y$$$20240918$$HP$CN$CN
243304841$24330484$1$I$$20240909$20240918$20240918$EXP$$JP-ROCHE-10000079366$ROCHE$Sho T, Suda G, Ohara M, Kohya R, Sasaki T, Yoshida S, et al. Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment. Targeted Oncology. 2024; doi:10.1007/s11523-024-01092-7.$$$$$Y$$$20240918$$HP$JP$JP
243304861$24330486$1$I$$20240904$20240918$20240918$PER$$US-AstraZeneca-2024A201990$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243304871$24330487$1$I$$20240912$20240918$20240918$PER$$NVSC2024US185170$NOVARTIS$$$$$M$Y$$$20240918$$HP$US$US
243304881$24330488$1$I$20240912$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024183612$AMGEN$$64$YR$A$M$Y$$$20240917$$CN$US$US
243304891$24330489$1$I$$20240909$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147848$BRISTOL MYERS SQUIBB$Ladwa A, Elghawy O, Kaur V. Single institution experience with immune checkpoint inhibitors in vulvar and vaginal melanomas. Obstetrics and Gynecology International. 2024 Jan 01;1-6.doi:10.1155/2024/7327692.$69$YR$E$F$Y$$$20240918$$HP$US$US
243304901$24330490$1$I$20240912$20240912$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145695$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240918$$HP$US$US
243304911$24330491$1$I$$20240807$20240918$20240918$30DAY$$US-ABBVIE-5925677$ABBVIE$$$$$$Y$$$20240918$$CN$US$US
243304921$24330492$1$I$20240130$20240910$20240918$20240918$EXP$$CN-BEIGENE-BGN-2024-014387$BEIGENE$$$$$$Y$$$20240918$$HP$CN$CN
243304931$24330493$1$I$$20240909$20240918$20240918$EXP$$SK-CELLTRION INC.-2024SK022010$CELLTRION$Bellova B, Michalko D, Antony L, Figurova J, Deptova J, Felsoci M, et al.. Difuzny velkobunkovy B-lymfom (DLBCL) u stareho mladenca. Interna medicina. 2024;24(4):169-171$$$$$Y$$$20240918$$HP$SK$SK
243304951$24330495$1$I$$20240906$20240918$20240918$EXP$NL-LRB-01000291$NL-Accord-446130$ACCORD$$60$YR$A$M$Y$75$KG$20240918$$CN$NL$NL
243304961$24330496$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000083931$ROCHE$$64$YR$A$F$Y$$$20240918$$CN$US$US
243304971$24330497$1$I$20240314$20240909$20240918$20240918$30DAY$$US-AMGEN-USASP2024179857$AMGEN$$49$YR$A$F$Y$74$KG$20240917$$HP$US$US
243304981$24330498$1$I$20240828$20240909$20240918$20240918$30DAY$$US-AMGEN-USASP2024179915$AMGEN$$$$$F$Y$$$20240917$$PH$US$US
243305001$24330500$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA265034$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240918$$HP$US$US
243305011$24330501$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267940$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240918$$HP$US$US
243305021$24330502$1$I$$20240909$20240918$20240918$EXP$$ES-INDOCO-IND-2024-ES-LIT-00095$INDOCO$Laserna PA, Fajardo MC, De Victoria Carazo JM, Fidel MV, Raquel RF.DONT FORGET THE DRUGS. AN ATYPICAL CASE OF RENOPULMONARY SYNDROME IN AN ADULT MALE.European Journal of Case Reports in Internal Medicine.2024;11(Sup 1):1018$69$YR$E$M$Y$$$20240918$$HP$ES$ES
243305031$24330503$1$I$$20231219$20240918$20240918$PER$$US-ENDO USA, INC.-2024-000029$ENDO$$$$$M$Y$$$20240918$$CN$US$US
243305041$24330504$1$I$$20231219$20240918$20240918$PER$$US-ENDO USA, INC.-2024-000059$ENDO$$$$$M$Y$$$20240918$$CN$US$US
243305051$24330505$1$I$$20231218$20240918$20240918$PER$$US-ENDO USA, INC.-2024-000064$ENDO$$$$$F$Y$$$20240918$$CN$US$US
243305061$24330506$1$I$$20231219$20240918$20240918$PER$$US-ENDO USA, INC.-2024-000089$ENDO$$$$$M$Y$$$20240918$$CN$US$US
243305071$24330507$1$I$$20240910$20240918$20240918$EXP$$NVSC2024CA182349$NOVARTIS$$10$MON$$F$Y$$$20240918$$HP$CA$CA
243305081$24330508$1$I$$20231218$20240918$20240918$PER$$US-ENDO USA, INC.-2024-000107$ENDO$$$$$F$Y$$$20240918$$CN$US$US
243305091$24330509$1$I$$20240904$20240918$20240918$EXP$$IL-STERISCIENCE B.V.-2024-ST-001384$Steriscience PTE$Avidan Y, Aker A, Tabachnikov V.. Prolonged asystole following adenosine. Was it necessary?.. J-Geriatr-Cardiol. 2024;21 (6):686-688$77$YR$$F$Y$$$20240918$$HP$IL$IL
243305101$24330510$1$I$$20240912$20240918$20240918$EXP$$US-GSK-US2024GSK114508$GLAXOSMITHKLINE$Rodriguez S, Marty D, Folga B, Alrahmani L. Congenital Umbilical Cord Hernia: Prenatal and Postnatal Management. AJP Reports. 2024;14(3)$$$$$Y$$$20240918$$MD$US$US
243305111$24330511$1$I$$20240910$20240918$20240918$EXP$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-466244$RO-GSK-RO2024112387$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$RO$RO
243305121$24330512$1$I$20240301$20240917$20240918$20240918$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051927$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240918$$CN$US$US
243305131$24330513$1$I$$20240911$20240918$20240918$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-145470$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$66.22$KG$20240918$$CN$PR$PR
243305181$24330518$1$I$$20240913$20240918$20240918$PER$$US-ROCHE-10000082608$ROCHE$$$$E$F$Y$$$20240918$$CN$US$US
243305191$24330519$1$I$20240826$20240827$20240918$20240918$PER$$US-BEIGENE-BGN-2024-013626$BEIGENE$$$$$$Y$$$20240918$$CN$US$US
243305201$24330520$1$I$20240904$20240910$20240918$20240918$EXP$$CN-BEIGENE-BGN-2024-014394$BEIGENE$$$$$$Y$$$20240918$$HP$CN$CN
243305211$24330521$1$I$20240706$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A210020$ASTRAZENECA$$23252$DY$$F$Y$$$20240918$$CN$US$
243305221$24330522$1$I$$20240916$20240918$20240918$PER$$US-AstraZeneca-2024A212185$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243305231$24330523$1$I$$20240915$20240918$20240918$EXP$$US-AstraZeneca-2024A210317$ASTRAZENECA$$$$$F$Y$51.7$KG$20240918$$CN$US$
243305242$24330524$2$F$$20240916$20240918$20240926$EXP$$US-AstraZeneca-2024A211919$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240926$$MD$US$US
243305251$24330525$1$I$$20240910$20240918$20240918$EXP$PL-BAUSCH-BL-2024-010507$PL-GSK-PL2024091062$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$PL$PL
243305261$24330526$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211225$ASTRAZENECA$$$$$M$Y$$$20240918$$HP$US$
243305281$24330528$1$I$$20240912$20240918$20240918$PER$$US-AstraZeneca-2024A209337$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243305301$24330530$1$I$$20240911$20240918$20240918$EXP$$GB-AstraZeneca-2024A211478$ASTRAZENECA$$11$YR$$F$Y$44$KG$20240918$$MD$GB$
243305311$24330531$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009356$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240918$$CN$US$US
243305321$24330532$1$I$20220101$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009724$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243305331$24330533$1$I$$20240911$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008261$ELI LILLY AND CO$$$$A$F$Y$$$20240918$$CN$US$US
243305341$24330534$1$I$$20240911$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008881$ELI LILLY AND CO$$17$YR$T$F$Y$44$KG$20240918$$MD$US$US
243305351$24330535$1$I$20230101$20240911$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409007582$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240918$$CN$US$US
243305372$24330537$2$F$20240916$20240918$20240918$20240919$PER$$US-AMGEN-USASP2024185549$AMGEN$$52$YR$A$F$Y$$$20240919$$HP$US$US
243305381$24330538$1$I$20230120$20240906$20240918$20240918$EXP$FR-AFSSAPS-PC2024000680$FR-Accord-446153$ACCORD$$50$YR$A$F$Y$$$20240918$$PH$FR$FR
243305391$24330539$1$I$20240814$20240911$20240918$20240918$PER$$US-AMGEN-USASP2024182893$AMGEN$$54$YR$A$F$Y$$$20240917$$PH$US$US
243305401$24330540$1$I$$20231218$20240918$20240918$PER$$US-ENDO USA, INC.-2023-006337$ENDO$$$$$M$Y$$$20240918$$CN$US$US
243305411$24330541$1$I$20240830$20240910$20240918$20240918$EXP$$CN-BEIGENE-BGN-2024-014398$BEIGENE$$$$$$Y$$$20240918$$HP$CN$CN
243305441$24330544$1$I$20240824$20240910$20240918$20240918$EXP$$CN-BEIGENE-BGN-2024-014397$BEIGENE$$$$$$Y$$$20240918$$HP$CN$CN
243305451$24330545$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA071503$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240918$$HP$US$US
243305461$24330546$1$I$20240901$20240911$20240918$20240918$PER$$US-SA-2024SA266261$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240918$$HP$US$US
243305471$24330547$1$I$$20240822$20240918$20240918$PER$$US-SA-2024SA267276$SANOFI AVENTIS$$$$E$M$Y$68.18$KG$20240918$$MD$US$US
243305481$24330548$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000083624$ROCHE$$56$YR$A$F$Y$$$20240918$$CN$US$US
243305491$24330549$1$I$20240707$20240906$20240918$20240918$EXP$$US-Accord-445977$ACCORD$$57$YR$A$M$Y$$$20240918$$HP$US$US
243305501$24330550$1$I$$20231219$20240918$20240918$PER$$US-ENDO USA, INC.-2024-000154$ENDO$$$$$F$Y$$$20240918$$CN$US$US
243305511$24330551$1$I$$20240909$20240918$20240918$PER$$US-009507513-2409USA003386$MERCK$$77$YR$$F$Y$$$20240918$$CN$US$US
243305521$24330552$1$I$$20231219$20240918$20240918$PER$$US-ENDO USA, INC.-2024-000167$ENDO$$$$$M$Y$$$20240918$$CN$US$US
243305531$24330553$1$I$$20231218$20240918$20240918$PER$$US-ENDO USA, INC.-2024-000144$ENDO$$$$$F$Y$$$20240918$$CN$US$US
243305542$24330554$2$F$$20240911$20240918$20240925$EXP$$DE-JNJFOC-20240935968$JOHNSON AND JOHNSON$$$$E$$Y$$$20240925$$MD$DE$DE
243305551$24330555$1$I$20240914$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185008$AMGEN$$49$YR$A$M$Y$$$20240917$$CN$US$US
243305562$24330556$2$F$20240908$20240910$20240918$20240926$EXP$$CA-CELLTRION INC.-2024CA021947$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243305571$24330557$1$I$20240520$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409061114454530-PRQHZ$GB-Accord-445657$ACCORD$$35$YR$A$M$Y$$$20240918$$MD$GB$GB
243305581$24330558$1$I$20120101$20240912$20240918$20240918$EXP$CZ-EMA-DD-20190327-faizan_m-095723$CZ-CHEPLA-1200111727$CHEPLAPHARM$Kiss I. The treatment of the developed mCRC (metastatic colorectal cancer) in a nutshell. Farmakoterapie 2018;14 (3):305-480.$52$YR$$F$Y$$$20240917$$MD$COUNTRY NOT SPECIFIED$CZ
243305591$24330559$1$I$$20240905$20240918$20240918$EXP$$PT-AUROBINDO-AUR-APL-2024-044813$AUROBINDO$$67$YR$$F$Y$$$20240918$$MD$PT$PT
243305601$24330560$1$I$$20231218$20240918$20240918$PER$$US-ENDO USA, INC.-2023-006346$ENDO$$$$$F$Y$$$20240918$$CN$US$US
243305611$24330561$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5924978$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243305621$24330562$1$I$20240805$20240828$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147518$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$112.04$KG$20240918$$HP$US$US
243305631$24330563$1$I$$20240911$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146213$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240918$$CN$US$US
243305641$24330564$1$I$$20240909$20240918$20240918$PER$$US-SA-2022SA315786$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240918$$MD$US$US
243305651$24330565$1$I$$20240916$20240918$20240918$EXP$$DE-ROCHE-10000084446$ROCHE$$$$$$Y$$$20240918$$MD$DE$DE
243305661$24330566$1$I$$20240829$20240918$20240918$PER$$US-TEVA-VS-3240014$TEVA$$$$$F$Y$$$20240918$$CN$US$US
243305681$24330568$1$I$$20240904$20240918$20240918$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004778$PAREXEL$$$$$$Y$$$20240918$$CN$US$US
243305691$24330569$1$I$$20240909$20240918$20240918$PER$$US-AMGEN-USASP2024184305$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240917$$HP$US$US
243305701$24330570$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211981$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243305711$24330571$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211209$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243305721$24330572$1$I$$20240916$20240918$20240918$EXP$$IN-AstraZeneca-2024A211354$ASTRAZENECA$$18262$DY$$F$Y$$$20240918$$CN$IN$
243305732$24330573$2$F$$20240911$20240918$20240918$EXP$$US-AstraZeneca-2024A205579$ASTRAZENECA$$80$YR$$M$Y$$$20240918$$CN$US$
243305741$24330574$1$I$$20240912$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US079975$SANDOZ$$$$$M$Y$$$20240918$$MD$US$US
243305751$24330575$1$I$$20240916$20240918$20240918$EXP$$DE-ROCHE-10000084445$ROCHE$$$$$$Y$$$20240918$$MD$DE$DE
243305761$24330576$1$I$$20240904$20240918$20240918$EXP$$US-Axsome Therapeutics, Inc.-AXS202409-001349$AXSOME THERAPEUTICS$$$$$F$Y$$$20240918$$$US$
243305774$24330577$4$F$$20240918$20240918$20240927$PER$$US-SA-2024SA266505$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240927$$HP$US$US
243305781$24330578$1$I$$20240822$20240918$20240918$PER$$US-SA-2024SA265825$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240918$$CN$US$US
243305791$24330579$1$I$$20240823$20240918$20240918$PER$$US-SA-2024SA267848$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240918$$CN$US$US
243305801$24330580$1$I$20240601$20240823$20240918$20240918$PER$$US-SA-2024SA267665$SANOFI AVENTIS$$74$YR$E$M$Y$136.36$KG$20240918$$MD$US$US
243305811$24330581$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA266259$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240918$$CN$US$US
243305821$24330582$1$I$$20240821$20240918$20240918$PER$$US-SA-2024SA266145$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$MD$US$US
243305831$24330583$1$I$$20240823$20240918$20240918$PER$$US-SA-2024SA267997$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243305841$24330584$1$I$$20231218$20240918$20240918$PER$$US-ENDO USA, INC.-2023-006393$ENDO$$$$$M$Y$$$20240918$$CN$US$US
243305851$24330585$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009316$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$US$US
243305862$24330586$2$F$20240101$20240912$20240918$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-028396$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240920$$$US$US
243305871$24330587$1$I$$20240909$20240918$20240918$PER$$US-AMGEN-USASP2024184300$AMGEN$Krishnamurthy R.; Cherry D.R.; Rodriguez-russo C. et al.. Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus. International Journal of Radiation Oncology Biology Physics. 2024;120 (2):e456-e457$$$$$Y$$$20240917$$HP$US$US
243305881$24330588$1$I$20240905$20240906$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409004645$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$US$US
243305891$24330589$1$I$20240828$20240911$20240918$20240918$EXP$$CN-ROCHE-10000079917$ROCHE$$49$YR$A$F$Y$66.8$KG$20240918$$HP$CN$CN
243305901$24330590$1$I$20240901$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010077$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240918$$CN$US$US
243305911$24330591$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010157$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240918$$CN$US$US
243305921$24330592$1$I$$20240910$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008570$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240918$$CN$US$US
243305931$24330593$1$I$20240904$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409051400377550-QNDRW$GB-Accord-445663$ACCORD$$53$YR$A$F$Y$$$20240918$$HP$GB$GB
243305942$24330594$2$F$$20240920$20240918$20240925$PER$$US-BIOGEN-2024BI01282773$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243305951$24330595$1$I$$20240904$20240918$20240918$EXP$$TR-PBT-009688$PANACEA BIOTEC$Ercan LD, Durmaz O, Kaymakoglu S, Onal Z, Buyukbabani N, Gulluoglu M, ET AL I. The Consequences of HLA Screening in the Prevention of Graft-Versus-Host Disease in Living Donor Liver Transplantation. Pediatr Transplant. 2024 Sep;28(6):e14846. doi: 10.1111/petr.14846.$12$YR$T$M$Y$$$20240918$$HP$TR$TR
243305961$24330596$1$I$20240101$20240916$20240918$20240918$PER$$US-BIOGEN-2024BI01269712$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
243305971$24330597$1$I$$20240904$20240918$20240918$EXP$$TR-PBT-009687$PANACEA BIOTEC$Ercan LD, Durmaz O, Kaymakoglu S, Onal Z, Buyukbabani N, Gulluoglu M, ET AL I. The Consequences of HLA Screening in the Prevention of Graft-Versus-Host Disease in Living Donor Liver Transplantation. Pediatr Transplant. 2024 Sep;28(6):e14846. doi: 10.1111/petr.14846.$17$YR$T$F$Y$$$20240918$$HP$TR$TR
243305981$24330598$1$I$20240911$20240912$20240918$20240918$PER$$US-BIOGEN-2024BI01282359$BIOGEN$$64$YR$$F$Y$$$20240918$$CN$US$US
243305991$24330599$1$I$$20240911$20240918$20240918$EXP$$JP-SANDOZ INC.-SDZ2024JP080764$SANDOZ$$88$YR$$F$Y$$$20240918$$MD$JP$JP
243306011$24330601$1$I$$20240913$20240918$20240918$PER$$US-BIOGEN-2024BI01282648$BIOGEN$$$$$M$Y$$$20240918$$MD$US$US
243306021$24330602$1$I$20240915$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185026$AMGEN$$62$YR$A$M$Y$$$20240917$$CN$US$US
243306031$24330603$1$I$$20240913$20240918$20240918$PER$$US-HALEON-2196805$Haleon PLC$$$$A$F$Y$$$20240918$$MD$US$US
243306041$24330604$1$I$$20240911$20240918$20240918$EXP$$CA-SANDOZ INC.-NVSC2023CA052451$SANDOZ$$15$YR$$M$Y$127$KG$20240918$$CN$CA$CA
243306051$24330605$1$I$$20240909$20240918$20240918$EXP$$CA-JNJFOC-20240942273$JOHNSON AND JOHNSON$$44$YR$A$F$Y$70$KG$20240918$$MD$CA$CA
243306061$24330606$1$I$$20240912$20240918$20240918$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024113611$VIIV$$$$$M$Y$$$20240918$$HP$US$US
243306071$24330607$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267945$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243306081$24330608$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266017$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$MD$US$US
243306091$24330609$1$I$20240916$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185278$AMGEN$$79$YR$E$M$Y$$$20240917$$CN$US$US
243306101$24330610$1$I$$20231219$20240918$20240918$PER$$US-ENDO USA, INC.-2024-000005$ENDO$$$$$M$Y$$$20240918$$CN$US$US
243306111$24330611$1$I$$20231218$20240918$20240918$PER$$US-ENDO USA, INC.-2024-000011$ENDO$$$$$F$Y$$$20240918$$CN$US$US
243306121$24330612$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000083807$ROCHE$$35$YR$A$M$Y$$$20240918$$CN$US$US
243306131$24330613$1$I$$20240909$20240918$20240918$EXP$$DE-GlaxoSmithKline-B0842772A$Haleon PLC$Krengel S, Satzger l, Alter M, Kapp A, Gutzmer R. Remission of an iatrogenic Kaposi sarcoma in a patient with myasthenia gravis after switching immunosuppressive therapy to the mTOR inhibitor everolimus. Dermatologist 2012 Jul;63(7):573-6. DOI: 10.1007/s00105-011-2274-y. Embase accession number:22751858.; Krengel S. Azathioprine/prednisolone: Kaposi^s sarcoma in an elderly patient: case report. Reactions weekly. 2012 OCT 01;12-13.; Krengel S,Satzger I,Alter M,Kapp A,Gutzmer R. Remission of an...$80$YR$$M$Y$$$20240918$$MD$DE$DE
243306141$24330614$1$I$$20240911$20240918$20240918$EXP$$BR-AstraZeneca-2024A210757$ASTRAZENECA$$$$$$Y$$$20240918$$MD$BR$
243306151$24330615$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211686$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243306161$24330616$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A212168$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243306172$24330617$2$F$20180101$20240912$20240918$20240926$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-20890$ALKEM$$51$YR$$M$Y$$$20240926$$CN$DE$DE
243306181$24330618$1$I$20240820$20240903$20240918$20240918$EXP$GB-MHRA-MED-202409022234579740-WNRKQ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-20872$ALKEM$$48$YR$$M$Y$85$KG$20240918$$CN$GB$GB
243306191$24330619$1$I$$20240903$20240918$20240918$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-20951$ALKEM$Ohara H, Kikutsuji N, Iguchi N, Kinoshita M.. Efgartigimod combined with steroids as a fast-acting therapy for myasthenic crisis: a case report. BMC Neurology. 2024;24:292$70$YR$$F$Y$$$20240918$$HP$JP$JP
243306201$24330620$1$I$$20240904$20240918$20240918$EXP$$US-UCBSA-2024045702$UCB$$$$$M$Y$$$20240918$$MD$US$US
243306221$24330622$1$I$$20240903$20240918$20240918$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21250$ALKEM$Soldera J.. Navigating treatment resistance: Janus kinase inhibitors for ulcerative colitis. World Journal of Clinical Cases. 2024;12(24):5468-5472$57$YR$$F$Y$$$20240918$$MD$GB$GB
243306231$24330623$1$I$20230101$20240903$20240918$20240918$EXP$IT-MLMSERVICE-20240826-PI171177-00271-2$IT-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20460$ALKEM$Corcione S, Lupia T, Vita D, Sidoti F, Zanotto E, Solidoro P, Biancone L, Costa C, Balagna R, De Rosa FG.. Maribavir treatment for resistant cytomegalovirus disseminated disease in kidney transplant recipients: A case-based scoping review of real life data in literature. Transplantation Reviews. 2024;38(4):100873$54$YR$$F$Y$$$20240918$$MD$IT$IT
243306241$24330624$1$I$20220501$20240227$20240918$20240918$PER$$US-ENDO USA, INC.-2024-001214$ENDO$$$$$M$Y$$$20240918$$CN$US$US
243306251$24330625$1$I$$20240213$20240918$20240918$PER$$US-ENDO USA, INC.-2024-001047$ENDO$$$$$M$Y$$$20240918$$CN$US$US
243306261$24330626$1$I$20230601$20240910$20240918$20240918$EXP$CH-SM-2024-15518$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-145453$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240918$$MD$CH$CH
243306271$24330627$1$I$$20240904$20240918$20240918$EXP$$CA-UCBSA-2024045757$UCB$$$$$F$Y$$$20240918$$CN$CA$CA
243306281$24330628$1$I$$20240625$20240918$20240918$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14592$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48(5):299-313$35$YR$$F$Y$$$20240918$$HP$DE$DE
243306291$24330629$1$I$$20240625$20240918$20240918$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14615$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$34$YR$$M$Y$$$20240918$$HP$DE$DE
243306301$24330630$1$I$$20240625$20240918$20240918$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14635$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$26$YR$$F$Y$$$20240918$$HP$DE$DE
243306311$24330631$1$I$$20240808$20240918$20240918$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-15916$ALKEM$$72$YR$$F$Y$$$20240918$$CN$US$US
243306321$24330632$1$I$$20240913$20240918$20240918$PER$$US-HALEON-2196917$Haleon PLC$$$$E$F$Y$$$20240918$$CN$US$US
243306341$24330634$1$I$$20240625$20240918$20240918$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14656$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$30$YR$$M$Y$$$20240918$$HP$DE$DE
243306351$24330635$1$I$20240101$20240827$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA051907$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
243306361$24330636$1$I$$20240827$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052171$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
243306371$24330637$1$I$20240827$20240827$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052173$TOLMAR$$63$YR$$M$Y$$$20240918$$CN$CA$CA
243306381$24330638$1$I$$20240710$20240918$20240918$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-15552$ALKEM$$36$YR$$F$Y$$$20240918$$HP$AU$AU
243306391$24330639$1$I$20200101$20240827$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA051904$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
243306401$24330640$1$I$20240101$20240827$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052174$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
243306421$24330642$1$I$$20240827$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052179$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
243306431$24330643$1$I$20240827$20240827$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052217$TOLMAR$$69$YR$$M$Y$$$20240918$$CN$CA$CA
243306441$24330644$1$I$$20240827$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052269$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
243306451$24330645$1$I$20240501$20240827$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052219$TOLMAR$$80$YR$$M$Y$$$20240918$$CN$CA$CA
243306461$24330646$1$I$$20240809$20240918$20240918$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-19094$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$29$YR$$F$Y$$$20240918$$HP$DE$DE
243306471$24330647$1$I$$20240625$20240918$20240918$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-14594$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48:299-313$36$YR$$M$Y$$$20240918$$HP$DE$DE
243306481$24330648$1$I$$20240827$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052273$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
243306491$24330649$1$I$20200101$20240827$20240918$20240918$PER$$CO-TOLMAR, INC.-24CO052327$TOLMAR$$$$$M$Y$$$20240918$$CN$CO$CO
243306502$24330650$2$F$20240130$20240918$20240918$20240926$EXP$$DE-ROCHE-3521488$ROCHE$$45$YR$A$F$Y$70$KG$20240926$$MD$DE$DE
243306511$24330651$1$I$$20240809$20240918$20240918$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-19092$ALKEM$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. ?-Pyrrolidinohexanophenone (?-PHP) vs. ?-pyrrolidinoisohexanophenone (?-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. Journal of Analytical Toxicology. 2024;48 (5):299-313$42$YR$$M$Y$$$20240918$$HP$DE$DE
243306521$24330652$1$I$$20240911$20240918$20240918$EXP$$US-GSK-US2024113139$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243306531$24330653$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185105$AMGEN$$$$$$Y$$$20240917$$PH$US$US
243306542$24330654$2$F$$20240911$20240918$20240918$EXP$$CA-JNJFOC-20240934630$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240918$$HP$CA$CA
243306561$24330656$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010749$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243306572$24330657$2$F$$20240919$20240918$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US080300$SANDOZ$$$$$M$Y$$$20240923$$CN$US$US
243306581$24330658$1$I$20240101$20240906$20240918$20240918$PER$$US-SA-2024SA266243$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240918$$HP$US$US
243306591$24330659$1$I$20240101$20240909$20240918$20240918$PER$$US-SA-2024SA264936$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240918$$HP$US$US
243306601$24330660$1$I$20240901$20240909$20240918$20240918$PER$$US-SA-2024SA266179$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240918$$HP$US$US
243306611$24330661$1$I$20240101$20240829$20240918$20240918$PER$$US-SA-2024SA268123$SANOFI AVENTIS$$71$YR$E$M$Y$86.82$KG$20240918$$MD$US$US
243306621$24330662$1$I$$20240917$20240918$20240918$EXP$$TR-SA-2024SA264132$SANOFI AVENTIS$$13$YR$T$F$Y$40$KG$20240918$$MD$TR$TR
243306641$24330664$1$I$20240501$20240909$20240918$20240918$PER$$US-SA-2024SA265037$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240918$$HP$US$US
243306651$24330665$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267961$SANOFI AVENTIS$$53$YR$A$M$Y$117.27$KG$20240918$$MD$US$US
243306661$24330666$1$I$$20240823$20240918$20240918$PER$$US-SA-2024SA263787$SANOFI AVENTIS$$$$A$M$Y$102.04$KG$20240918$$MD$US$US
243306671$24330667$1$I$20240822$20240909$20240918$20240918$PER$$US-ROCHE-10000077306$ROCHE$$72$YR$E$F$Y$113.39$KG$20240918$$MD$US$US
243306681$24330668$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA266974$SANOFI AVENTIS$$51$YR$A$$Y$$$20240918$$MD$US$US
243306691$24330669$1$I$20240612$20240911$20240918$20240918$PER$GB-MHRA-MED-202406211430444280-FGLZH$GB-IDORSIA-008461-2024-GB$IDORSIA PHARMACEUTICALS$$31$YR$$M$Y$$$20240918$$MD$GB$GB
243306702$24330670$2$F$$20240916$20240918$20240922$PER$$US-AMGEN-USASP2024184659$AMGEN$$89$YR$E$M$Y$$$20240922$$PH$US$US
243306712$24330671$2$F$$20240910$20240918$20240918$PER$$US-ABBVIE-5920381$ABBVIE$$$$$F$Y$$$20240918$$HP$US$US
243306722$24330672$2$F$20240828$20240909$20240918$20240920$EXP$$NVSC2024CN182072$NOVARTIS$$34$YR$$F$Y$56.5$KG$20240920$$HP$CN$CN
243306741$24330674$1$I$20240725$20240905$20240918$20240918$EXP$$DE-AUROBINDO-AUR-APL-2024-045076$AUROBINDO$$$$A$F$Y$130$KG$20240918$$MD$DE$DE
243306761$24330676$1$I$20240905$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212722$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$US$
243306771$24330677$1$I$$20240716$20240918$20240918$EXP$$DE-SANDOZ INC.-SDZ2024DE065955$SANDOZ$$$$A$F$Y$65$KG$20240918$$MD$DE$DE
243306781$24330678$1$I$$20240909$20240918$20240918$EXP$$JP-JNJFOC-20240930346$JOHNSON AND JOHNSON$Airi TSUKAMOTO et al.; Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine. A case of trisomy 8-associated intestinal Behcet^s disease-like disease successfully treated with USTEKINUMAB. Proceedings of Kanto Rheumatology Conference (Interesting Cases and their Problems)/.2024;(56)13-16$75$YR$E$M$Y$$$20240918$$MD$JP$JP
243306791$24330679$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A210507$ASTRAZENECA$$$$$M$Y$87.2$KG$20240918$$CN$US$
243306801$24330680$1$I$$20240912$20240918$20240918$EXP$$US-AstraZeneca-2024A209029$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243306811$24330681$1$I$$20240905$20240918$20240918$EXP$$JP-AMGEN-JPNSP2024182754$AMGEN$$$$$$Y$$$20240917$$MD$JP$JP
243306821$24330682$1$I$20240901$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184767$AMGEN$$33$YR$A$F$Y$$$20240917$$CN$US$US
243306841$24330684$1$I$$20240910$20240918$20240918$EXP$$SE-AstraZeneca-2024A210883$ASTRAZENECA$$$$$$Y$$$20240918$$MD$SE$
243306851$24330685$1$I$$20240912$20240918$20240918$EXP$$BG-AstraZeneca-2024A211442$ASTRAZENECA$$$$$M$Y$$$20240918$$MD$BG$
243306861$24330686$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211188$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243306881$24330688$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211656$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243306891$24330689$1$I$20240909$20240911$20240918$20240918$EXP$JP-MMM-C7WUOHMP$JP-GSK-JP2024112919$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$PH$JP$JP
243306901$24330690$1$I$20240824$20240905$20240918$20240918$PER$$US-APOTEX-2024AP010331$APOTEX$$$$$M$Y$$$20240918$$CN$US$US
243306911$24330691$1$I$$20240912$20240918$20240918$PER$$US-ROCHE-10000082017$ROCHE$$$$E$F$Y$$$20240918$$CN$US$US
243306921$24330692$1$I$$20240915$20240918$20240918$PER$$US-ROCHE-10000083320$ROCHE$$49$YR$A$F$Y$$$20240918$$CN$US$US
243306931$24330693$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA266975$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240918$$CN$US$US
243306941$24330694$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA267761$SANOFI AVENTIS$$$$A$F$Y$68.03$KG$20240918$$MD$US$US
243306951$24330695$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA267393$SANOFI AVENTIS$$$$T$M$Y$26.77$KG$20240918$$MD$US$US
243306961$24330696$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266239$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$HP$US$US
243306971$24330697$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA265608$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240918$$HP$US$US
243306981$24330698$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA266970$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240918$$CN$US$US
243306993$24330699$3$F$$20240919$20240918$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-133996$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240925$$PH$JP$JP
243307001$24330700$1$I$$20240916$20240918$20240918$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-147748$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240918$$MD$PR$PR
243307021$24330702$1$I$20240527$20240905$20240918$20240918$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-142793$BRISTOL MYERS SQUIBB$$24$YR$A$F$Y$$$20240918$$MD$AT$AT
243307031$24330703$1$I$$20240909$20240918$20240918$EXP$$US-CELLTRION INC.-2024US022047$CELLTRION$$$$$$Y$$$20240918$$CN$US$US
243307051$24330705$1$I$$20240910$20240918$20240918$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011912$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic. J-Eur-Acad-Dermatol-Venereol. 2024$41$YR$$M$Y$$$20240918$$HP$FR$FR
243307061$24330706$1$I$20240912$20240912$20240918$20240918$EXP$$US-ABBVIE-5922092$ABBVIE$$55$YR$$F$Y$$$20240918$$CN$US$US
243307072$24330707$2$F$20240101$20240913$20240918$20240923$EXP$$CA-CELLTRION INC.-2024CA021951$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
243307081$24330708$1$I$20240910$20240913$20240918$20240918$EXP$$CN-ABBVIE-5922700$ABBVIE$$40$YR$$M$Y$104$KG$20240918$$MD$CN$CN
243307091$24330709$1$I$20230101$20240911$20240918$20240918$EXP$$JP-009507513-2308JPN001507J$MERCK$$78$YR$$F$Y$$$20240918$$MD$JP$JP
243307111$24330711$1$I$$20240825$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005047$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243307131$24330713$1$I$20240724$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005015$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240918$$CN$US$US
243307141$24330714$1$I$$20240916$20240918$20240918$EXP$$US-ROCHE-10000083811$ROCHE$$82$YR$E$M$Y$$$20240918$$CN$US$US
243307151$24330715$1$I$20210805$20240824$20240918$20240918$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005016$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240918$$CN$US$US
243307161$24330716$1$I$$20240912$20240918$20240918$PER$$US-BEH-2024178752$CSL BEHRING$$$$A$F$Y$$$20240918$$CN$US$US
243307171$24330717$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5922710$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243307192$24330719$2$F$20240826$20240924$20240918$20240930$EXP$$CA-ABBVIE-5923531$ABBVIE$$76$YR$$F$Y$$$20240930$$MD$CA$CA
243307201$24330720$1$I$20240903$20240912$20240918$20240918$EXP$$US-SA-2024SA260429$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240918$$MD$US$US
243307211$24330721$1$I$$20240916$20240918$20240918$EXP$$DE-ROCHE-10000084346$ROCHE$$$$$$Y$$$20240918$$MD$DE$DE
243307221$24330722$1$I$$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044464$AUROBINDO$$36$YR$$F$Y$67$KG$20240918$$MD$GB$GB
243307231$24330723$1$I$$20240903$20240918$20240918$PER$$US-JNJFOC-20240904834$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$HP$US$US
243307243$24330724$3$F$20240101$20240927$20240918$20240930$EXP$$US-SA-2024SA267982$SANOFI AVENTIS$$69$YR$E$F$Y$67$KG$20240930$$MD$US$US
243307252$24330725$2$F$20201006$20240913$20240918$20240926$EXP$PL-URPL-1-3322-2020$PL-JNJFOC-20240943102$JOHNSON AND JOHNSON$$59$YR$A$F$Y$80$KG$20240927$$PH$PL$PL
243307261$24330726$1$I$$20240910$20240918$20240918$EXP$$US-JNJFOC-20240926734$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$HP$US$US
243307271$24330727$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005043$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243307281$24330728$1$I$20130326$20240911$20240918$20240918$EXP$$US-CHEPLA-2024011784$CHEPLAPHARM$$70$YR$$M$Y$103.59$KG$20240918$$HP$COUNTRY NOT SPECIFIED$US
243307291$24330729$1$I$20240718$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045042$AUROBINDO$$74$YR$$F$Y$60$KG$20240918$$MD$FR$FR
243307301$24330730$1$I$$20240905$20240918$20240918$EXP$$IT-AUROBINDO-AUR-APL-2024-045172$AUROBINDO$Piolatto A, Gaglioti CM, Clemente MG, Tesio N, Culcasi M, Matrone A. An emerging pattern in thalassemia patients?. British Society for Haematology and John Wiley + Sons Ltd. 2024;(205):719-721.$24$YR$$F$Y$$$20240918$$HP$IT$IT
243307311$24330731$1$I$20240801$20240909$20240918$20240918$PER$$US-SA-2024SA177806$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240918$$HP$US$US
243307321$24330732$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA264871$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240918$$MD$US$US
243307331$24330733$1$I$$20240909$20240918$20240918$EXP$$US-EMD Serono-2024048478$EMD SERONO INC$$$$A$F$Y$$$20240918$$CN$US$US
243307341$24330734$1$I$$20240905$20240918$20240918$EXP$$DE-AUROBINDO-AUR-APL-2024-045243$AUROBINDO$$$$E$F$Y$$$20240918$$MD$DE$DE
243307351$24330735$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005051$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243307362$24330736$2$F$20240916$20240916$20240918$20240920$PER$$US-AMGEN-USASP2024185204$AMGEN$$72$YR$E$M$Y$$$20240920$$PH$US$US
243307371$24330737$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA267006$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240918$$MD$US$US
243307391$24330739$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA268212$SANOFI AVENTIS$$$$E$M$Y$72.109$KG$20240918$$MD$US$US
243307401$24330740$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA266992$SANOFI AVENTIS$$65$YR$E$$Y$$$20240918$$HP$US$US
243307411$24330741$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266263$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240918$$HP$US$US
243307421$24330742$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA267894$SANOFI AVENTIS$$$$A$F$Y$61.6$KG$20240918$$MD$US$US
243307431$24330743$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA267454$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240918$$CN$US$US
243307441$24330744$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA266923$SANOFI AVENTIS$$51$YR$A$M$Y$145$KG$20240918$$MD$US$US
243307451$24330745$1$I$20240901$20240909$20240918$20240918$PER$$US-SA-2024SA266585$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240918$$HP$US$US
243307461$24330746$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266606$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240918$$HP$US$US
243307471$24330747$1$I$$20240820$20240918$20240918$PER$$US-SA-2024SA268240$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240918$$CN$US$US
243307481$24330748$1$I$$20240913$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147361$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$82.55$KG$20240918$$CN$US$US
243307501$24330750$1$I$20170413$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2017-48418$AUROBINDO$$36$YR$$M$Y$82.4$KG$20240918$$MD$FR$FR
243307511$24330751$1$I$$20240917$20240918$20240918$EXP$CL-MLMSERVICE-20240227-4854280-1$CL-SANDOZ INC.-SDZ2024CL080804$SANDOZ$$16$YR$$M$Y$$$20240918$$MD$CL$CL
243307521$24330752$1$I$$20240909$20240918$20240918$EXP$$CN-ROCHE-10000077914$ROCHE$$60$YR$A$M$Y$$$20240918$$MD$CN$CN
243307531$24330753$1$I$$20240917$20240918$20240918$EXP$GB-MHRA-MIDB-3c878ed0-5fd9-4b44-ae2d-19eae366651c$GB-JNJFOC-20240943742$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240918$$PH$GB$GB
243307551$24330755$1$I$$20240907$20240918$20240918$EXP$$IN-ROCHE-10000076429$ROCHE$$80$YR$E$M$Y$$$20240918$$CN$IN$IN
243307561$24330756$1$I$$20240903$20240918$20240918$PER$$US-ABBVIE-5926254$ABBVIE$$$$$$Y$$$20240918$$HP$US$US
243307571$24330757$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A210301$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243307581$24330758$1$I$$20240914$20240918$20240918$EXP$$JP-AstraZeneca-2024A211938$ASTRAZENECA$$$$A$F$Y$$$20240918$$MD$JP$
243307591$24330759$1$I$$20240916$20240918$20240918$EXP$$GB-AstraZeneca-2024A211391$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$GB$
243307601$24330760$1$I$$20240913$20240918$20240918$EXP$$ZA-AstraZeneca-2024A210039$ASTRAZENECA$$65$YR$$F$Y$$$20240918$$CN$ZA$
243307611$24330761$1$I$20240813$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185101$AMGEN$$$$$$Y$$$20240917$$PH$US$US
243307621$24330762$1$I$20240528$20240906$20240918$20240918$EXP$FR-AFSSAPS-DJ2024000934$FR-Accord-446152$ACCORD$$51$YR$A$M$Y$65$KG$20240918$$MD$FR$FR
243307641$24330764$1$I$$20240913$20240918$20240918$EXP$$BR-AstraZeneca-2024A211695$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$BR$
243307651$24330765$1$I$20240809$20240916$20240918$20240918$EXP$GB-MHRA-MED-202409141145499420-KSPBV$GB-SANDOZ INC.-SDZ2024GB080654$SANDOZ$$68$YR$$F$Y$69$KG$20240918$$CN$GB$GB
243307661$24330766$1$I$$20240911$20240918$20240918$EXP$$US-AstraZeneca-2024A207914$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243307671$24330767$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212471$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$US$
243307681$24330768$1$I$$20240916$20240918$20240918$EXP$$ZA-AstraZeneca-2024A211494$ASTRAZENECA$$56$YR$$F$Y$$$20240918$$CN$ZA$
243307691$24330769$1$I$$20240915$20240918$20240918$PER$$US-AstraZeneca-2024A212075$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243307701$24330770$1$I$$20240912$20240918$20240918$EXP$$CN-AstraZeneca-2024A202674$ASTRAZENECA$$60$YR$$M$Y$$$20240918$$CN$CN$
243307711$24330771$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009841$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240918$$CN$US$US
243307721$24330772$1$I$20240913$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009868$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240918$$CN$US$US
243307731$24330773$1$I$20240801$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010257$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240918$$CN$US$US
243307741$24330774$1$I$20240801$20240911$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409007535$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240918$$CN$US$US
243307751$24330775$1$I$20240826$20240912$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009381$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$US$US
243307761$24330776$1$I$20240915$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010340$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240918$$CN$US$US
243307771$24330777$1$I$$20240906$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409004588$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240918$$CN$US$US
243307781$24330778$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009765$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240918$$CN$US$US
243307791$24330779$1$I$20240831$20240906$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409003493$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240918$$CN$US$US
243307802$24330780$2$F$20240814$20240925$20240918$20240928$PER$$US-ELI_LILLY_AND_COMPANY-US202409007814$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240928$$CN$US$US
243307811$24330781$1$I$$20240910$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009657$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243307821$24330782$1$I$20240913$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009336$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240918$$CN$US$US
243307831$24330783$1$I$$20240906$20240918$20240918$PER$$US-APOTEX-2024AP010456$APOTEX$Terashita M, Selamet U, Midha S, Nadeem O, Laubach J, Rennke HG, et al. Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones. Kidney International Reports. 2023;8:2765-2777$$$A$$Y$$$20240918$$HP$US$US
243307841$24330784$1$I$20240501$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008992$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240918$$CN$US$US
243307851$24330785$1$I$20240821$20240913$20240918$20240918$EXP$$US-ROCHE-10000082395$ROCHE$$65$YR$E$M$Y$$$20240918$$CN$US$US
243307861$24330786$1$I$20240830$20240910$20240918$20240918$EXP$$CN-BEIGENE-BGN-2024-014382$BEIGENE$$$$$$Y$$$20240918$$HP$CN$CN
243307871$24330787$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265954$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240918$$HP$US$US
243307881$24330788$1$I$20240901$20240911$20240918$20240918$PER$$US-SA-2024SA266475$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240918$$MD$US$US
243307891$24330789$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA266990$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240918$$HP$US$US
243307901$24330790$1$I$20240731$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045028$AUROBINDO$$20$YR$$F$Y$80$KG$20240918$$MD$FR$FR
243307911$24330791$1$I$20240904$20240905$20240918$20240918$PER$$US-SA-2024SA266043$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240918$$CN$US$US
243307921$24330792$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266412$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240918$$HP$US$US
243307931$24330793$1$I$20240827$20240909$20240918$20240918$PER$$US-SA-2024SA265261$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240918$$HP$US$US
243307941$24330794$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA266981$SANOFI AVENTIS$$53$YR$A$$Y$$$20240918$$CN$US$US
243307951$24330795$1$I$20010101$20240916$20240918$20240918$PER$$NVSC2024US185576$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
243307961$24330796$1$I$$20240916$20240918$20240918$PER$$NVSC2024US185503$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243307971$24330797$1$I$20240916$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184889$AMGEN$$69$YR$E$M$Y$$$20240917$$CN$US$US
243307981$24330798$1$I$$20240905$20240918$20240918$EXP$$ES-AUROBINDO-AUR-APL-2024-044865$AUROBINDO$$32$YR$$M$Y$$$20240918$$HP$ES$ES
243307991$24330799$1$I$$20240910$20240918$20240918$EXP$$NVSC2024CA181828$NOVARTIS$$52$YR$$F$Y$$$20240918$$HP$CA$CA
243308001$24330800$1$I$$20240910$20240918$20240918$EXP$$PH-STRIDES ARCOLAB LIMITED-2024SP011920$STRIDES$Legaspi LAE, Ondinee-Igot M, Fernando G.. Rare Metastatic Primary Intra-Abdominal Follicular Dendritic Cell Sarcoma Poorly Responsive to Chemotherapy: A Case Report.. Phil-J-Intern-Med. 2024;62 (1):308-313$33$YR$$F$Y$$$20240918$$MD$PH$PH
243308011$24330801$1$I$$20240914$20240918$20240918$PER$$US-ALXN-202409USA001213US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243308021$24330802$1$I$20240902$20240916$20240918$20240918$EXP$FR-AFSSAPS-MA2024001457$FR-UCBSA-2024047412$UCB$$61$YR$$F$Y$$$20240918$$HP$FR$FR
243308033$24330803$3$F$$20240927$20240918$20240930$EXP$$PL-JNJFOC-20240943265$JOHNSON AND JOHNSON$$$$$F$Y$$$20240929$$CN$PL$PL
243308051$24330805$1$I$20240906$20240909$20240918$20240918$EXP$$CA-CELLTRION INC.-2024CA021956$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
243308061$24330806$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010750$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243308081$24330808$1$I$20191101$20240911$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011704$STRIDES$Rodulfo A, Goldstein S, Meriden Z. The Challenge of Managing Refractory Psychosis Amid Multiple Medication Side Effects: A Case Report and Review of the Literature. Cureus. 2023;15(12):e50063$35$YR$$F$Y$$$20240918$$HP$US$US
243308091$24330809$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010809$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243308101$24330810$1$I$$20240913$20240918$20240918$PER$$US-TAKEDA-2024TUS092156$TAKEDA$$$$$M$Y$$$20240918$$HP$US$US
243308111$24330811$1$I$$20240911$20240918$20240918$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP011706$STRIDES$Gunes S, Inal Ulutas G, Sefik P, Ozluk HK, Tanrikulu EE.. Acute Extrapyramidal Side Effects Associated With the Combined Use of Low Doses of Haloperidol and Clarithromycin.. Cureus. 2023;15 (12):e51020$12$YR$$M$Y$$$20240918$$HP$TR$TR
243308122$24330812$2$F$20240101$20240905$20240918$20240919$PER$$US-SERVIER-S24011265$SERVIER$$$$$$Y$$$20240919$$PH$US$US
243308131$24330813$1$I$$20240905$20240918$20240918$EXP$$DE-AUROBINDO-AUR-APL-2024-044797$AUROBINDO$$70$YR$$F$Y$$$20240918$$MD$DE$DE
243308141$24330814$1$I$$20240916$20240918$20240918$EXP$$CA-SANDOZ INC.-SDZ2024CA080625$SANDOZ$$66$YR$$M$Y$$$20240918$$HP$CA$CA
243308151$24330815$1$I$20240823$20240913$20240918$20240918$EXP$US-ABBVIE-5899914$GB-STRIDES ARCOLAB LIMITED-2024SP011794$STRIDES$$51$YR$$F$Y$48$KG$20240918$$PH$GB$GB
243308161$24330816$1$I$20240815$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005070$ACADIA PHARMACEUTICALS$$90$YR$$M$Y$$$20240918$$CN$US$US
243308171$24330817$1$I$20240821$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005090$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240918$$CN$US$US
243308181$24330818$1$I$20240101$20240909$20240918$20240918$EXP$$CA-TEVA-VS-3243265$TEVA$$26$YR$$F$Y$$$20240918$$CN$CA$CA
243308191$24330819$1$I$$20240910$20240918$20240918$EXP$$CA-HALEON-2196954$Haleon PLC$$43$YR$$F$Y$68$KG$20240918$$CN$CA$CA
243308201$24330820$1$I$20230101$20240909$20240918$20240918$EXP$$US-ROCHE-10000078138$ROCHE$$60$YR$A$F$Y$86.18$KG$20240918$$CN$US$US
243308221$24330822$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005021$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243308232$24330823$2$F$20240809$20240920$20240918$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-044986$AUROBINDO$$43$YR$$F$Y$152$KG$20240928$$PH$FR$FR
243308241$24330824$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005071$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243308251$24330825$1$I$20240101$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185265$AMGEN$$71$YR$E$M$Y$$$20240917$$CN$US$US
243308261$24330826$1$I$20240823$20240916$20240918$20240918$EXP$$DE-ROCHE-10000084100$ROCHE$$58$YR$A$F$Y$$$20240918$$MD$DE$DE
243308271$24330827$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010751$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243308281$24330828$1$I$20230901$20230929$20240918$20240918$PER$$US-APOTEX-2023AP014905$APOTEX$$70$YR$E$F$Y$$$20240918$$CN$US$US
243308291$24330829$1$I$$20240905$20240918$20240918$EXP$$PL-AUROBINDO-AUR-APL-2019-083592$AUROBINDO$Boratynska M, Obremska M, Malecki R, Gacka M, Magott M, Kaminska D, et al. Impact of immunosuppressive treatment on the cardiovascular system in patients after hand transplantation.. Transplant-Proc. 2014;46(8):2890-3$56$YR$$F$Y$$$20240918$$MD$PL$PL
243308301$24330830$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005078$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243308311$24330831$1$I$$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044529$AUROBINDO$$75$YR$$F$Y$$$20240918$$HP$GB$GB
243308332$24330833$2$F$20240914$20240916$20240918$20240919$PER$$US-AMGEN-USASP2024185286$AMGEN$$72$YR$E$M$Y$$$20240918$$MD$US$US
243308341$24330834$1$I$20240411$20240426$20240918$20240918$EXP$$DE-SANDOZ INC.-SDZ2024DE043628$SANDOZ$$59$YR$$M$Y$82.2$KG$20240918$$HP$DE$DE
243308352$24330835$2$F$$20240916$20240918$20240919$PER$$US-JNJFOC-20240940047$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243308361$24330836$1$I$20240101$20240912$20240918$20240918$EXP$$US-JNJFOC-20240938135$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240918$$HP$US$US
243308371$24330837$1$I$$20240912$20240918$20240918$EXP$$CA-JNJFOC-20240943437$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240918$$HP$CA$CA
243308391$24330839$1$I$20240901$20240912$20240918$20240918$EXP$$CA-AstraZeneca-2024A203990$ASTRAZENECA$$798$MON$$F$Y$$$20240918$$CN$CA$
243308411$24330841$1$I$20240817$20240916$20240918$20240918$EXP$$FR-AstraZeneca-2024A210825$ASTRAZENECA$$85$YR$$M$Y$74$KG$20240918$$MD$FR$
243308431$24330843$1$I$$20240913$20240918$20240918$EXP$$GB-AstraZeneca-2024A210510$ASTRAZENECA$$$$$M$Y$$$20240918$$HP$GB$
243308441$24330844$1$I$$20240912$20240918$20240918$PER$$US-AstraZeneca-2024A210519$ASTRAZENECA$$$$$$Y$$$20240918$$MD$US$
243308451$24330845$1$I$20240915$20240917$20240918$20240918$PER$$US-AstraZeneca-2024A212318$ASTRAZENECA$$27096$DY$$F$Y$70$KG$20240918$$CN$US$
243308461$24330846$1$I$$20240912$20240918$20240918$EXP$$ZA-AstraZeneca-2024A209741$ASTRAZENECA$$77$YR$$F$Y$$$20240918$$CN$ZA$
243308471$24330847$1$I$20240704$20240912$20240918$20240918$EXP$$JP-AstraZeneca-2024A157690$ASTRAZENECA$$80$YR$$M$Y$$$20240918$$MD$JP$
243308481$24330848$1$I$20230703$20240912$20240918$20240918$EXP$$DE-AstraZeneca-2024A209952$ASTRAZENECA$$72$YR$$M$Y$63$KG$20240918$$MD$DE$
243308511$24330851$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005079$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243308521$24330852$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010804$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243308531$24330853$1$I$20240328$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045032$AUROBINDO$$20$YR$$F$Y$80$KG$20240918$$MD$FR$FR
243308541$24330854$1$I$20240829$20240903$20240918$20240918$PER$$US-TEVA-VS-3240439$TEVA$$24$YR$$M$Y$$$20240918$$PH$US$US
243308551$24330855$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005086$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243308561$24330856$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005029$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243308571$24330857$1$I$20240817$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005032$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240918$$CN$US$US
243308591$24330859$1$I$$20240906$20240918$20240918$EXP$$US-INSMED, INC.-2024-03684-US$INSMED$$$$$$Y$$$20240918$$CN$US$US
243308601$24330860$1$I$$20240904$20240918$20240918$EXP$$DE-SA-2024SA268660$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240918$$MD$DE$DE
243308611$24330861$1$I$20240801$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005036$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240918$$CN$US$US
243308621$24330862$1$I$$20240905$20240918$20240918$EXP$GB-MHRA-MED-202409041405391010-BPMQY$GB-LUPIN EUROPE GMBH-2024-08881$LUPIN$$$$$$Y$$$20240918$$CN$GB$GB
243308631$24330863$1$I$20210101$20231122$20240918$20240918$PER$$US-APOTEX-2023AP017237$APOTEX$Musurakis C, Rimal P, Gilden JL.. A Series of COVID Reinfections in a Vaccinated Patient leading to Development of Neurogenic Orthostatic Hypotension and Postural Orthostatic Tachycardia. Journal of the Endocrine Society. 2022;6 (Suppl. 1):A482$32$YR$$F$Y$$$20240918$$HP$US$US
243308641$24330864$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005034$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243308651$24330865$1$I$20240818$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-044994$AUROBINDO$$34$YR$$F$Y$88$KG$20240918$$MD$FR$FR
243308661$24330866$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010810$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243308671$24330867$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA268163$SANOFI AVENTIS$$$$A$F$Y$46.36$KG$20240918$$MD$US$US
243308681$24330868$1$I$$20240823$20240918$20240918$PER$$US-SA-2024SA264533$SANOFI AVENTIS$$65$YR$E$F$Y$64.55$KG$20240918$$MD$US$US
243308691$24330869$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267026$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240918$$MD$US$US
243308701$24330870$1$I$20240101$20240822$20240918$20240918$PER$$US-SA-2024SA266370$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240918$$MD$US$US
243308711$24330871$1$I$20240701$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009894$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240918$$CN$US$US
243308721$24330872$1$I$$20240913$20240918$20240918$EXP$$US-JNJFOC-20240935792$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$HP$US$US
243308731$24330873$1$I$$20240830$20240918$20240918$PER$$US-SA-2024SA266667$SANOFI AVENTIS$$97$YR$E$M$Y$$$20240918$$CN$US$US
243308741$24330874$1$I$20231101$20240911$20240918$20240918$EXP$$US-TAKEDA-2023TUS053707$TAKEDA$$19$YR$$F$Y$$$20240918$$CN$US$US
243308751$24330875$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266364$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240918$$MD$US$US
243308761$24330876$1$I$20240701$20240910$20240918$20240918$PER$$US-SA-2024SA265304$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240918$$MD$US$US
243308771$24330877$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265958$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240918$$HP$US$US
243308781$24330878$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005042$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243308791$24330879$1$I$20240914$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185051$AMGEN$$81$YR$E$M$Y$$$20240918$$CN$US$US
243308801$24330880$1$I$20240915$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185211$AMGEN$$75$YR$E$F$Y$$$20240918$$CN$US$US
243308811$24330881$1$I$$20240905$20240918$20240918$EXP$$DE-AUROBINDO-AUR-APL-2024-044815$AUROBINDO$Becker, K. Cardiotoxicity of the antiproliferative compound fluorouracil.. Drugs. 1999;57(4):475-84$48$YR$$M$Y$$$20240918$$HP$DE$DE
243308821$24330882$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005030$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243308831$24330883$1$I$$20240905$20240918$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-044917$AUROBINDO$Stacel T, Sybila P, M?drala A, Ochman M, N?cki M, Pasek P, et al.. Lung Transplantation in Patients With Systemic Scleroderma-Description of the First Consecutive Cases in Poland. Case Series Report and a Short Literature Review. Transplantation Proceedings. 2004;56 (4):868-76$58$YR$$F$Y$$$20240918$$HP$PL$PL
243308841$24330884$1$I$20120604$20240905$20240918$20240918$EXP$$IT-AUROBINDO-AUR-APL-2017-15568$AUROBINDO$$42$YR$$M$Y$$$20240918$$MD$IT$IT
243308851$24330885$1$I$20240912$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185297$AMGEN$$66$YR$E$F$Y$$$20240918$$CN$US$US
243308861$24330886$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005091$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243308871$24330887$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010805$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243308881$24330888$1$I$$20240917$20240918$20240918$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051930$BOEHRINGER INGELHEIM$$$$E$$Y$$$20240918$$HP$US$US
243308891$24330889$1$I$20240711$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044558$AUROBINDO$$$$$$Y$$$20240918$$HP$GB$GB
243308901$24330890$1$I$$20240911$20240918$20240918$EXP$$CN-Bion-013862$BIONPHARMA$$35$YR$$M$Y$$$20240918$$HP$CN$CN
243308911$24330891$1$I$$20231220$20240918$20240918$PER$$US-APOTEX-2023AP018355$APOTEX$Tran L, Brodeur MR. Midodrine-Induced Nightmares in the Treatment of Orthostatic Hypotension: A Case Report. The Senior Care Pharmacist. 2023;38:501-505$83$YR$$M$Y$$$20240918$$PH$US$US
243308921$24330892$1$I$$20240911$20240918$20240918$EXP$$JP-Bion-013851$BIONPHARMA$$51$YR$A$F$Y$$$20240918$$HP$JP$JP
243308931$24330893$1$I$20180101$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-044963$AUROBINDO$$14$YR$$F$Y$86$KG$20240918$$PH$FR$FR
243308941$24330894$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010811$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243308951$24330895$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005080$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243308961$24330896$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212539$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243308971$24330897$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A211769$ASTRAZENECA$$$$$M$Y$83.5$KG$20240918$$CN$US$
243308991$24330899$1$I$20240915$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212428$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243309001$24330900$1$I$$20240913$20240918$20240918$PER$$US-AstraZeneca-2024A163321$ASTRAZENECA$$6$YR$$M$Y$$$20240918$$CN$US$
243309011$24330901$1$I$20201001$20240917$20240918$20240918$EXP$$PL-AstraZeneca-2024A212007$ASTRAZENECA$$23$YR$$F$Y$65$KG$20240918$$MD$PL$
243309021$24330902$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211952$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243309031$24330903$1$I$$20240909$20240918$20240918$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001832$BLUEPRINT MEDICINES$$$$$F$Y$$$20240918$$CN$US$US
243309041$24330904$1$I$$20240916$20240918$20240918$PER$$US-AstraZeneca-2024A211495$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243309051$24330905$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A212166$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243309061$24330906$1$I$20240904$20240913$20240918$20240918$EXP$$ZA-AstraZeneca-2024A211396$ASTRAZENECA$$73$YR$$M$Y$$$20240918$$CN$ZA$
243309081$24330908$1$I$20240915$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184547$AMGEN$$72$YR$E$M$Y$$$20240918$$CN$US$US
243309091$24330909$1$I$20240101$20240912$20240918$20240918$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-118429$REGENERON$$$$$F$Y$$$20240918$$MD$US$US
243309101$24330910$1$I$$20240905$20240918$20240918$EXP$$DE-AUROBINDO-AUR-APL-2024-045018$AUROBINDO$$8$DEC$$$Y$$$20240918$$MD$DE$DE
243309111$24330911$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010806$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243309121$24330912$1$I$20240909$20240909$20240918$20240918$EXP$$JP-ROCHE-10000081388$ROCHE$$78$YR$E$F$Y$$$20240918$$PH$JP$JP
243309131$24330913$1$I$$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044609$AUROBINDO$$$$$F$Y$$$20240918$$PH$GB$GB
243309141$24330914$1$I$20240729$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005081$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20240918$$CN$US$US
243309151$24330915$1$I$$20230815$20240918$20240918$EXP$$US-Accord-374728$ACCORD$$59$YR$A$F$Y$$$20240918$$CN$US$US
243309161$24330916$1$I$$20240910$20240918$20240918$PER$$US-JNJFOC-20240927343$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243309171$24330917$1$I$20240726$20240917$20240918$20240918$EXP$FR-AFSSAPS-NC2024001072$FR-ROCHE-10000083704$ROCHE$$16$YR$T$M$Y$22$KG$20240918$$MD$FR$FR
243309181$24330918$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005083$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243309191$24330919$1$I$$20240912$20240918$20240918$PER$$US-AMGEN-USASP2024183472$AMGEN$$77$YR$E$F$Y$$$20240918$$HP$US$US
243309201$24330920$1$I$$20240909$20240918$20240918$EXP$$CA-CELLTRION INC.-2024CA021159$CELLTRION$$$$$$Y$$$20240918$$CN$CA$CA
243309211$24330921$1$I$$20240130$20240918$20240918$PER$$US-Accord-401515$ACCORD$$80$YR$E$M$Y$$$20240918$$CN$US$US
243309221$24330922$1$I$$20240909$20240918$20240918$30DAY$$US-GSK-US2024112024$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243309231$24330923$1$I$$20240105$20240918$20240918$PER$$US-Accord-408295$ACCORD$$75$YR$$M$Y$$$20240918$$CN$US$US
243309241$24330924$1$I$$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013392$DR REDDYS$$15$YR$T$$Y$$$20240918$$MD$US$US
243309251$24330925$1$I$20240701$20240913$20240918$20240918$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051761$BOEHRINGER INGELHEIM$$68$YR$E$M$Y$71.5$KG$20240918$$PH$JP$JP
243309261$24330926$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS091922$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240918$$MD$US$US
243309281$24330928$1$I$$20240911$20240918$20240918$PER$$US-ABBVIE-5921798$ABBVIE$$$$$$Y$$$20240918$$CN$US$US
243309291$24330929$1$I$20240318$20240904$20240918$20240918$EXP$$US-UCBSA-2024002156$UCB$$10$YR$$M$Y$27$KG$20240918$$CN$US$US
243309301$24330930$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA267020$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240918$$MD$US$US
243309311$24330931$1$I$$20240202$20240918$20240918$PER$$US-Accord-411448$ACCORD$$61$YR$A$M$Y$$$20240918$$CN$US$US
243309321$24330932$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA267007$SANOFI AVENTIS$$72$YR$E$$Y$$$20240918$$HP$US$US
243309331$24330933$1$I$$20240912$20240918$20240918$PER$$US-UNITED THERAPEUTICS-UNT-2024-029126$UNITED THERAPEUTICS$$$$$F$Y$$$20240918$$$US$US
243309341$24330934$1$I$20240301$20240828$20240918$20240918$PER$$US-SA-2024SA268033$SANOFI AVENTIS$$27$YR$A$F$Y$89.09$KG$20240918$$MD$US$US
243309351$24330935$1$I$20240201$20240910$20240918$20240918$PER$$US-SA-2024SA265944$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240918$$CN$US$US
243309361$24330936$1$I$20240101$20240913$20240918$20240918$EXP$$US-JNJFOC-20240941255$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240918$$HP$US$US
243309372$24330937$2$F$20240801$20240920$20240918$20240927$EXP$$JP-009507513-2409JPN001845J$MERCK$$7$DEC$$M$Y$$$20240927$$MD$JP$JP
243309381$24330938$1$I$$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185456$AMGEN$$$$A$F$Y$$$20240918$$HP$US$US
243309391$24330939$1$I$20240801$20240909$20240918$20240918$EXP$SE-SEMPA-2024-006437$SE-GE HEALTHCARE-2024CSU010354$GE HEALTHCARE$$60$YR$$F$Y$71$KG$20240918$$MD$SE$SE
243309421$24330942$1$I$$20240910$20240918$20240918$EXP$$AU-CELLTRION INC.-2024AU022092$CELLTRION$$$$$$Y$$$20240918$$HP$AU$AU
243309431$24330943$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010781$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243309441$24330944$1$I$20240821$20240904$20240918$20240918$EXP$$CA-Rigel Pharmaceuticals, Inc.-20240900060$RIGEL PHARMACEUTICALS$$66$YR$$M$Y$$$20240918$$CN$CA$CA
243309451$24330945$1$I$$20240912$20240918$20240918$EXP$$DE-AstraZeneca-2024A211520$ASTRAZENECA$$$$$M$Y$$$20240918$$MD$DE$
243309461$24330946$1$I$$20240916$20240918$20240918$EXP$$GB-AstraZeneca-2024A211367$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$GB$
243309471$24330947$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010812$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243309481$24330948$1$I$$20240906$20240918$20240918$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202409-000598$AZURITY PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243309491$24330949$1$I$$20240911$20240918$20240918$PER$$US-AstraZeneca-2024A209396$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243309501$24330950$1$I$$20240906$20240918$20240918$PER$$US-AstraZeneca-2024A212546$ASTRAZENECA$$$$$$Y$$$20240918$$PH$US$
243309511$24330951$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A210194$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243309521$24330952$1$I$$20240911$20240918$20240918$EXP$$US-AstraZeneca-2024A210653$ASTRAZENECA$$62$YR$$F$Y$$$20240918$$MD$US$
243309531$24330953$1$I$20240906$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211742$ASTRAZENECA$$25068$DY$$M$Y$$$20240918$$CN$US$
243309541$24330954$1$I$20240101$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211909$ASTRAZENECA$$82$YR$$F$Y$$$20240918$$CN$US$
243309561$24330956$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211984$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243309571$24330957$1$I$$20240916$20240918$20240918$EXP$$CA-AstraZeneca-2024A211822$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$CA$
243309581$24330958$1$I$20240801$20240906$20240918$20240918$PER$$US-AstraZeneca-2024A204447$ASTRAZENECA$$694$MON$$F$Y$$$20240918$$CN$US$
243309592$24330959$2$F$20240101$20240909$20240918$20240923$EXP$$US-ROCHE-10000073589$ROCHE$$65$YR$E$F$Y$84.82$KG$20240923$$CN$US$US
243309602$24330960$2$F$20240426$20240917$20240918$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-044978$AUROBINDO$$43$YR$$F$Y$118$KG$20240926$$MD$FR$FR
243309612$24330961$2$F$$20240918$20240918$20240919$PER$$US-AMGEN-USASP2024185400$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243309621$24330962$1$I$$20240912$20240918$20240918$EXP$$CA-AstraZeneca-2024A212354$ASTRAZENECA$$65$YR$$F$Y$34$KG$20240918$$MD$CA$
243309631$24330963$1$I$$20240910$20240918$20240918$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP011699$STRIDES$Bernab? R, Liu SV, S?nchez-Gastaldo A, Alonso Garc?a M.. Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab.. Oncol Ther. 2024;12(1):175-182$61$YR$$M$Y$$$20240918$$HP$ES$ES
243309641$24330964$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184874$AMGEN$$$$$M$Y$$$20240918$$CN$US$US
243309651$24330965$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266302$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240918$$MD$US$US
243309661$24330966$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266264$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$MD$US$US
243309671$24330967$1$I$$20240910$20240918$20240918$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011898$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic?.. J-Eur-Acad-Dermatol-Venereol. 2024$47$YR$$M$Y$$$20240918$$HP$FR$FR
243309681$24330968$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266157$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240918$$HP$US$US
243309691$24330969$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266267$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240918$$HP$US$US
243309701$24330970$1$I$$20240905$20240918$20240918$PER$$US-SA-2024SA265415$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$CN$US$US
243309711$24330971$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265882$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240918$$HP$US$US
243309721$24330972$1$I$$20240913$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US080140$SANDOZ$$20$YR$$F$Y$$$20240918$$MD$US$US
243309731$24330973$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA073033$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240918$$HP$US$US
243309741$24330974$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266096$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240918$$HP$US$US
243309751$24330975$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA145938$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240918$$HP$US$US
243309761$24330976$1$I$20240101$20240909$20240918$20240918$PER$$US-SA-2024SA238681$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240918$$MD$US$US
243309771$24330977$1$I$20240101$20240909$20240918$20240918$PER$$US-SA-2024SA266627$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240918$$HP$US$US
243309781$24330978$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266476$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240918$$MD$US$US
243309791$24330979$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA202453$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240918$$MD$US$US
243309801$24330980$1$I$$20240822$20240918$20240918$PER$$US-SA-2024SA266230$SANOFI AVENTIS$$$$E$F$Y$79.37$KG$20240918$$MD$UM$US
243309811$24330981$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147937$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240918$$HP$US$US
243309821$24330982$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147972$BRISTOL MYERS SQUIBB$$25$YR$A$M$Y$$$20240918$$HP$US$US
243309831$24330983$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147918$BRISTOL MYERS SQUIBB$$31$YR$A$F$Y$53.07$KG$20240918$$CN$US$US
243309841$24330984$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147751$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240918$$CN$US$US
243309851$24330985$1$I$20240901$20240910$20240918$20240918$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001839$BLUEPRINT MEDICINES$$48$YR$A$M$Y$$$20240918$$CN$US$US
243309861$24330986$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010807$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243309872$24330987$2$F$20240906$20240906$20240918$20240919$PER$$US-SA-2024SA268052$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240919$$MD$US$US
243309881$24330988$1$I$$20240821$20240918$20240918$PER$$US-SA-2024SA266059$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240918$$CN$US$US
243309901$24330990$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA268262$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243309911$24330991$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA267756$SANOFI AVENTIS$$$$A$F$Y$67.73$KG$20240918$$MD$US$US
243309921$24330992$1$I$20230814$20240910$20240918$20240918$EXP$$CA-CELLTRION INC.-2023CA016522$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
243309931$24330993$1$I$20240701$20240827$20240918$20240918$PER$$US-SA-2024SA266998$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240918$$MD$US$US
243309941$24330994$1$I$20240801$20240821$20240918$20240918$PER$$US-SA-2024SA267762$SANOFI AVENTIS$$60$YR$A$F$Y$81.82$KG$20240918$$MD$US$US
243309951$24330995$1$I$20240101$20240828$20240918$20240918$PER$$US-SA-2024SA268342$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240918$$MD$US$US
243309961$24330996$1$I$$20240822$20240918$20240918$PER$$US-SA-2024SA266895$SANOFI AVENTIS$$59$YR$A$F$Y$77.27$KG$20240918$$MD$US$US
243309971$24330997$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010756$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243309981$24330998$1$I$20240823$20240910$20240918$20240918$EXP$ES-AEMPS-1565724$ES-TAKEDA-2024TUS092267$TAKEDA$$79$YR$$F$Y$$$20240918$$HP$ES$ES
243309991$24330999$1$I$20240101$20240827$20240918$20240918$PER$$US-SA-2024SA267936$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240918$$CN$US$US
243310001$24331000$1$I$20240601$20240828$20240918$20240918$PER$$US-SA-2024SA268243$SANOFI AVENTIS$$32$YR$A$M$Y$90.71$KG$20240918$$MD$US$US
243310011$24331001$1$I$20240801$20240827$20240918$20240918$PER$$US-SA-2024SA267509$SANOFI AVENTIS$$1$YR$I$M$Y$14.05$KG$20240918$$MD$US$US
243310021$24331002$1$I$20240101$20240829$20240918$20240918$PER$$US-SA-2024SA268044$SANOFI AVENTIS$$36$YR$A$F$Y$138$KG$20240918$$MD$US$US
243310032$24331003$2$F$$20240911$20240918$20240923$PER$$US-SA-2024SA267417$SANOFI AVENTIS$$$$E$F$Y$$$20240923$$CN$US$US
243310041$24331004$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266479$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240918$$HP$US$US
243310052$24331005$2$F$$20240909$20240918$20240923$PER$$US-SA-2024SA266251$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240923$$HP$US$US
243310061$24331006$1$I$20240906$20240910$20240918$20240918$PER$$US-SA-2024SA267355$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240918$$MD$US$US
243310071$24331007$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA266299$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240918$$HP$US$US
243310081$24331008$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266566$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240918$$HP$US$US
243310091$24331009$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA221444$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240918$$MD$US$US
243310101$24331010$1$I$$20240904$20240918$20240918$PER$$US-SA-2024SA268681$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240918$$CN$US$US
243310111$24331011$1$I$20240701$20240910$20240918$20240918$PER$$US-SA-2024SA266015$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240918$$MD$US$US
243310122$24331012$2$F$$20240923$20240918$20240930$EXP$$IT-TEVA-VS-3242585$TEVA$Signorini F, Puccini M, Materazzi G, Ugolini C. ^Incidental^ lipoadenoma of the parathyroid gland: A case report of a rare entity. J-Clin-Transl-Endocrinol-Case-Rep 2024; 33 (0):.; Signorini F, Puccini M, Materazzi G, Ugolini C. ^Incidental^ lipoadenoma of the parathyroid gland: A case report of a rare entity. J-Clin-Transl-Endocrinol-Case-Rep 2024; 33 (0):.; Signorini F, Puccini M, Materazzi G, Ugolini C. ^Incidental^ lipoadenoma of the parathyroid gland: A case report of a rare entity. J-Cl...$48$YR$$M$Y$$$20240930$$HP$IT$IT
243310151$24331015$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010808$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243310161$24331016$1$I$20240912$20240913$20240918$20240918$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900069$RIGEL PHARMACEUTICALS$$74$YR$$F$Y$65.771$KG$20240918$$CN$US$US
243310171$24331017$1$I$$20240906$20240918$20240918$EXP$$US-ROCHE-10000076337$ROCHE$$64$YR$A$M$Y$$$20240918$$CN$US$US
243310181$24331018$1$I$$20240907$20240918$20240918$EXP$$IN-ROCHE-10000082403$ROCHE$$69$YR$E$M$Y$63$KG$20240918$$HP$IN$IN
243310191$24331019$1$I$$20240909$20240918$20240918$EXP$$CA-ROCHE-10000076977$ROCHE$$$$$F$Y$$$20240918$$HP$CA$CA
243310202$24331020$2$F$$20240923$20240918$20240930$EXP$$ES-TEVA-VS-3242644$TEVA$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transpl-Infect-Dis 2024; 26 (3): e14276.; Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transpl-Infect-Dis 2024; 26 (3): e14276.$6$MON$$M$Y$$$20240930$$HP$ES$ES
243310211$24331021$1$I$20240816$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024183965$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243310241$24331024$1$I$$20240910$20240918$20240918$EXP$$CA-GSK-CA2023141250$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$CA$CA
243310251$24331025$1$I$20230520$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045061$AUROBINDO$$71$YR$$F$Y$62$KG$20240918$$MD$FR$FR
243310261$24331026$1$I$$20240909$20240918$20240918$EXP$$JP-JNJFOC-20240943098$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240918$$MD$JP$JP
243310271$24331027$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA179620$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240918$$HP$US$US
243310281$24331028$1$I$$20240912$20240918$20240918$EXP$$US-AstraZeneca-2024A208656$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243310291$24331029$1$I$20240915$20240916$20240918$20240918$EXP$$CO-AstraZeneca-2024A212524$ASTRAZENECA$$4481$WK$$M$Y$43$KG$20240918$$CN$CO$
243310301$24331030$1$I$$20240916$20240918$20240918$EXP$$GB-AstraZeneca-2024A212518$ASTRAZENECA$$$$$$Y$$$20240918$$MD$GB$
243310311$24331031$1$I$$20240913$20240918$20240918$EXP$$CH-AstraZeneca-2024A211326$ASTRAZENECA$$$$$$Y$$$20240918$$MD$CH$
243310321$24331032$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005084$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243310331$24331033$1$I$20240701$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212594$ASTRAZENECA$$26045$DY$$M$Y$$$20240918$$CN$US$
243310352$24331035$2$F$20170704$20240916$20240918$20240925$EXP$$FR-SANDOZ INC.-PHHY2018FR049315$SANDOZ$$1$DY$$M$Y$1.89$KG$20240925$$PH$FR$FR
243310361$24331036$1$I$$20240910$20240918$20240918$PER$$US-AstraZeneca-2024A206247$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243310371$24331037$1$I$$20240914$20240918$20240918$EXP$$US-AstraZeneca-2024A210387$ASTRAZENECA$$$$C$F$Y$27.2$KG$20240918$$CN$US$
243310391$24331039$1$I$$20240916$20240918$20240918$EXP$$ZA-AstraZeneca-2024A212543$ASTRAZENECA$$76$YR$$M$Y$$$20240918$$CN$ZA$
243310401$24331040$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A210702$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243310411$24331041$1$I$$20240911$20240918$20240918$PER$$US-AstraZeneca-2024A207823$ASTRAZENECA$$$$$M$Y$$$20240918$$MD$US$
243310421$24331042$1$I$$20240911$20240918$20240918$EXP$$US-AstraZeneca-2024A208878$ASTRAZENECA$$$$$M$Y$64.4$KG$20240918$$CN$US$
243310431$24331043$1$I$$20240910$20240918$20240918$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001843$BLUEPRINT MEDICINES$$$$$M$Y$$$20240918$$CN$US$US
243310471$24331047$1$I$20240911$20240911$20240918$20240918$EXP$$AR-TAKEDA-2024TUS092318$TAKEDA$$7$YR$$M$Y$$$20240918$$HP$AR$AR
243310481$24331048$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147936$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240918$$CN$US$US
243310491$24331049$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010833$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243310502$24331050$2$F$20240809$20240920$20240918$20240930$EXP$$JP-BAUSCHBL-2024BNL033128$BAUSCH AND LOMB$$87$YR$$M$Y$$$20240930$$MD$JP$JP
243310511$24331051$1$I$20230620$20230620$20240918$20240918$EXP$$CN-ROCHE-10000080087$ROCHE$$$$$$Y$$$20240918$$MD$CN$CN
243310521$24331052$1$I$$20240906$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044690$AUROBINDO$$$$$F$Y$$$20240918$$PH$GB$GB
243310531$24331053$1$I$20240708$20240909$20240918$20240918$EXP$FR-AFSSAPS-BS2024000613$FR-Taiho Oncology Inc-2024-008762$TAIHO ONCOLOGY INC$$79$YR$E$F$Y$85$KG$20240918$$PH$FR$FR
243310541$24331054$1$I$$20240906$20240918$20240918$EXP$$US-ROCHE-10000076973$ROCHE$$80$YR$E$F$Y$$$20240918$$CN$US$US
243310551$24331055$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148190$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240918$$CN$US$US
243310561$24331056$1$I$$20240909$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147850$BRISTOL MYERS SQUIBB$Ladwa A, Elghawy O, Kaur V. Single institution experience with immune checkpoint inhibitors in vulvar and vaginal melanomas. Obstetrics and Gynecology International. 2024 Jan 01;1-6. doi:10.1155/2024/7327692.$70$YR$E$F$Y$$$20240918$$HP$US$US
243310571$24331057$1$I$20240801$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147685$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240918$$HP$US$US
243310581$24331058$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148162$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$$$20240918$$CN$US$US
243310591$24331059$1$I$$20240905$20240918$20240918$PER$$US-SA-2024SA265458$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$CN$US$US
243310602$24331060$2$F$20240915$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185465$AMGEN$$69$YR$E$M$Y$$$20240918$$CN$US$US
243310611$24331061$1$I$20240101$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184647$AMGEN$$20$YR$A$F$Y$$$20240918$$HP$US$US
243310621$24331062$1$I$20220701$20240912$20240918$20240918$EXP$$EU-BAUSCHBL-2024BNL033355$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240918$$MD$EU$EU
243310631$24331063$1$I$$20240912$20240918$20240918$EXP$$BR-TAKEDA-2024TUS092212$TAKEDA$$$$$F$Y$66.6$KG$20240918$$CN$BR$BR
243310641$24331064$1$I$$20240910$20240918$20240918$EXP$$US-BAUSCHBL-2024BNL033290$BAUSCH AND LOMB$$$$$M$Y$$$20240918$$CN$US$US
243310651$24331065$1$I$20230912$20240909$20240918$20240918$EXP$$US-BAUSCHBL-2024BNL033254$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240918$$CN$US$US
243310661$24331066$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010782$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243310671$24331067$1$I$$20240912$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US080060$SANDOZ$$$$$M$Y$$$20240918$$CN$US$US
243310681$24331068$1$I$$20240912$20240918$20240918$PER$$US-ROCHE-10000081204$ROCHE$$72$YR$E$F$Y$$$20240918$$CN$US$US
243310691$24331069$1$I$20190924$20240912$20240918$20240918$EXP$FR-AFSSAPS-MP20191337$EU-BAUSCHBL-2024BNL033424$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240918$$MD$EU$EU
243310711$24331071$1$I$$20240909$20240918$20240918$30DAY$$DE-JNJFOC-20240939949$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$PH$DE$DE
243310721$24331072$1$I$$20240906$20240918$20240918$EXP$$SE-AUROBINDO-AUR-APL-2024-045397$AUROBINDO$Glimelius B, Khan T, Adolfsson K, Angenete E, Berglund A, Bonde K, et al.. Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US).. E Clinical Medicine.. 2024;75:1-12$61$YR$$F$Y$$$20240918$$HP$SE$SE
243310731$24331073$1$I$20240916$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184911$AMGEN$$87$YR$E$F$Y$$$20240918$$PH$US$US
243310741$24331074$1$I$$20240913$20240918$20240918$EXP$$NVSJ2024JP010989$NOVARTIS$$79$YR$$$Y$$$20240918$$PH$JP$JP
243310761$24331076$1$I$$20240912$20240918$20240918$EXP$$NVSJ2024JP010943$NOVARTIS$$$$E$F$Y$$$20240918$$MD$JP$JP
243310771$24331077$1$I$$20240909$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145926$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240918$$PH$JP$JP
243310781$24331078$1$I$$20240904$20240918$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-045293$AUROBINDO$Basak GW, Wiktor-jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. American Journal of Transplantation. 2015;15:705?714$32$YR$$M$Y$$$20240918$$HP$PL$PL
243310791$24331079$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147673$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$106.59$KG$20240918$$CN$US$US
243310801$24331080$1$I$20240912$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148124$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240918$$CN$US$US
243310811$24331081$1$I$20220101$20240906$20240918$20240918$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-144090$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240918$$CN$DE$DE
243310821$24331082$1$I$20230504$20240906$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045117$AUROBINDO$$28$YR$$F$Y$57$KG$20240918$$PH$FR$FR
243310831$24331083$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A212579$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243310841$24331084$1$I$20240101$20240912$20240918$20240918$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900061$RIGEL PHARMACEUTICALS$$$$$F$Y$129.73$KG$20240918$$CN$US$US
243310851$24331085$1$I$$20240913$20240918$20240918$EXP$$GB-AstraZeneca-2024A211143$ASTRAZENECA$$76$YR$$M$Y$74$KG$20240918$$MD$GB$
243310861$24331086$1$I$$20240916$20240918$20240918$PER$$US-AstraZeneca-2024A211771$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243310871$24331087$1$I$20240914$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212483$ASTRAZENECA$$29317$DY$$M$Y$$$20240918$$CN$US$
243310882$24331088$2$F$20240801$20240912$20240918$20240921$EXP$$US-ABBVIE-5922852$ABBVIE$$64$YR$$F$Y$$$20240921$$CN$US$US
243310891$24331089$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5923734$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243310901$24331090$1$I$$20240917$20240918$20240918$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051960$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240918$$CN$US$US
243310911$24331091$1$I$20240626$20240829$20240918$20240918$EXP$$IT-ROCHE-10000070280$ROCHE$$8$YR$C$F$Y$$$20240918$$MD$IT$IT
243310921$24331092$1$I$20240101$20240914$20240918$20240918$EXP$$CN-ABBVIE-5924093$ABBVIE$$54$YR$$F$Y$$$20240918$$MD$CN$CN
243310931$24331093$1$I$20240801$20240910$20240918$20240918$EXP$$US-JNJFOC-20240938198$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240918$$HP$US$US
243310941$24331094$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147773$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240918$$MD$US$US
243310951$24331095$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147538$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240918$$HP$US$US
243310961$24331096$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147827$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240918$$CN$US$US
243310971$24331097$1$I$20240101$20240910$20240918$20240918$EXP$$US-TEVA-VS-3242769$TEVA$$$$$M$Y$$$20240918$$CN$US$US
243310981$24331098$1$I$$20240911$20240918$20240918$PER$$US-ABBVIE-5922509$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243310992$24331099$2$F$20240828$20240921$20240918$20240925$EXP$$FR-TAKEDA-2024TUS091579$TAKEDA$$$$$$Y$$$20240925$$CN$FR$FR
243311001$24331100$1$I$$20240904$20240918$20240918$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08406$HIKMA$$$$$F$Y$$$20240918$$MD$US$US
243311011$24331101$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010652$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240918$$CN$US$US
243311021$24331102$1$I$20240913$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024183662$AMGEN$$79$YR$E$M$Y$$$20240918$$CN$US$US
243311031$24331103$1$I$20240823$20240909$20240918$20240918$EXP$$US-TEVA-VS-3237536$TEVA$$85$YR$$F$Y$64$KG$20240918$$CN$US$US
243311041$24331104$1$I$$20240916$20240918$20240918$EXP$$DE-SANDOZ INC.-SDZ2024DE080522$SANDOZ$$$$$M$Y$$$20240918$$PH$DE$DE
243311051$24331105$1$I$20240913$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010006$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$US$US
243311063$24331106$3$F$$20240917$20240918$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409009805$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240923$$CN$US$US
243311072$24331107$2$F$20230301$20240918$20240918$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409009775$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240925$$CN$US$US
243311081$24331108$1$I$20240915$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009773$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240918$$CN$US$US
243311091$24331109$1$I$20230219$20240910$20240918$20240918$EXP$$BR-CELLTRION INC.-2023BR005016$CELLTRION$$$$$$Y$$$20240918$$CN$BR$BR
243311101$24331110$1$I$20240910$20240917$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148229$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$87.1$KG$20240918$$PH$US$US
243311111$24331111$1$I$$20240909$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145820$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240918$$PH$JP$JP
243311121$24331112$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA268130$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240918$$CN$US$US
243311131$24331113$1$I$$20240821$20240918$20240918$PER$$US-SA-2024SA268715$SANOFI AVENTIS$$$$$$Y$$$20240918$$MD$US$US
243311141$24331114$1$I$20230101$20240826$20240918$20240918$PER$$US-SA-2024SA264330$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$MD$US$US
243311151$24331115$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA263435$SANOFI AVENTIS$$$$$F$Y$$$20240918$$PH$US$US
243311161$24331116$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA268555$SANOFI AVENTIS$$$$E$F$Y$72.73$KG$20240918$$MD$US$US
243311171$24331117$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010783$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243311191$24331119$1$I$20210129$20240909$20240918$20240918$EXP$$FR-SERVIER-S24011430$SERVIER$$$$$$Y$$$20240918$$MD$FR$FR
243311201$24331120$1$I$20240801$20240826$20240918$20240918$PER$$US-SA-2024SA265931$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240918$$MD$US$US
243311211$24331121$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267041$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240918$$MD$US$US
243311221$24331122$1$I$20240801$20240912$20240918$20240918$EXP$$US-ABBVIE-5922606$ABBVIE$$77$YR$$M$Y$$$20240918$$CN$US$US
243311231$24331123$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5925904$ABBVIE$$$$$M$Y$$$20240918$$HP$US$US
243311241$24331124$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266482$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240918$$MD$US$US
243311251$24331125$1$I$20240701$20240829$20240918$20240918$PER$$US-SA-2024SA266965$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240918$$HP$US$US
243311261$24331126$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266616$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240918$$HP$US$US
243311271$24331127$1$I$20240101$20240909$20240918$20240918$PER$$US-SA-2024SA266038$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240918$$MD$US$US
243311281$24331128$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA268627$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240918$$HP$US$US
243311291$24331129$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA265032$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240918$$HP$US$US
243311301$24331130$1$I$20240601$20240911$20240918$20240918$PER$$US-SA-2024SA266317$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240918$$MD$US$US
243311311$24331131$1$I$20240901$20240909$20240918$20240918$PER$$US-SA-2024SA266672$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240918$$HP$US$US
243311321$24331132$1$I$$20240910$20240918$20240918$EXP$$AT-CELLTRION INC.-2024AT021681$CELLTRION$$$$$$Y$$$20240918$$MD$AT$AT
243311331$24331133$1$I$$20240910$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147225$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240918$$MD$JP$JP
243311341$24331134$1$I$20240801$20240910$20240918$20240918$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-144309$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240918$$CN$PR$PR
243311362$24331136$2$F$$20240912$20240918$20240919$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051301$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240919$$CN$US$US
243311371$24331137$1$I$$20240911$20240918$20240918$PER$$US-AMGEN-USASP2024182450$AMGEN$$$$$F$Y$$$20240918$$HP$US$US
243311381$24331138$1$I$20240817$20240906$20240918$20240918$EXP$FR-AFSSAPS-LL2024001684$FR-ROCHE-10000076505$ROCHE$$29$YR$A$F$Y$$$20240918$$MD$FR$FR
243311391$24331139$1$I$$20240911$20240918$20240918$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050833$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$70$KG$20240918$$HP$CA$CA
243311401$24331140$1$I$20240101$20240913$20240918$20240918$EXP$$JP-AstraZeneca-2024A211893$ASTRAZENECA$$$$$$Y$$$20240918$$MD$JP$
243311411$24331141$1$I$$20240915$20240918$20240918$EXP$$US-AstraZeneca-2024A212160$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243311421$24331142$1$I$$20240914$20240918$20240918$EXP$$US-AstraZeneca-2024A211979$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243311431$24331143$1$I$$20240909$20240918$20240918$EXP$$CA-CELLTRION INC.-2024CA021945$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
243311441$24331144$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212486$ASTRAZENECA$$$$$M$Y$$$20240918$$MD$US$
243311451$24331145$1$I$$20240905$20240918$20240918$EXP$$ES-AUROBINDO-AUR-APL-2024-044867$AUROBINDO$Alonso G, Alonso Garcia L, Romero M, Macias E, Canton O, Rubio C. Severe Food Protein-Induced Enterocolitis Syndrome After Hematopoietic Stem Cell Transplantation: Pediatric Case Report. Pediatric Transplantation. 2024;28 (5):1-3$$$C$F$Y$$$20240918$$HP$ES$ES
243311461$24331146$1$I$$20240820$20240918$20240918$EXP$$US-EXELAPHARMA-2024EXLA00026$EXELA PHARMA SCIENCES$$$$$$Y$$$20240918$$HP$US$US
243311472$24331147$2$F$20240901$20240923$20240918$20240927$EXP$$GR-ABBVIE-5923505$ABBVIE$$77$YR$$F$Y$77$KG$20240927$$CN$GR$GR
243311481$24331148$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5923724$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243311491$24331149$1$I$$20240917$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147991$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240918$$HP$US$US
243311501$24331150$1$I$$20240910$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147224$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240918$$MD$JP$JP
243311511$24331151$1$I$$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005088$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243311522$24331152$2$F$20240801$20240919$20240918$20240924$EXP$$US-ABBVIE-5924063$ABBVIE$$81$YR$$M$Y$85$KG$20240924$$CN$US$US
243311531$24331153$1$I$20240915$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184749$AMGEN$$41$YR$A$M$Y$$$20240918$$CN$US$US
243311541$24331154$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185362$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243311551$24331155$1$I$20240625$20240909$20240918$20240918$EXP$IT-MINISAL02-1000836$IT-TEVA-VS-3241767$TEVA$$45$YR$$F$Y$$$20240918$$PH$IT$IT
243311561$24331156$1$I$$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024183971$AMGEN$$76$YR$E$M$Y$$$20240918$$HP$US$US
243311571$24331157$1$I$$20240904$20240918$20240918$PER$$US-SA-2024SA269142$SANOFI AVENTIS$$49$YR$A$$Y$$$20240918$$CN$US$US
243311581$24331158$1$I$20240101$20240828$20240918$20240918$PER$$US-SA-2024SA266986$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240918$$MD$US$US
243311591$24331159$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA267760$SANOFI AVENTIS$$$$C$F$Y$52.27$KG$20240918$$MD$US$US
243311601$24331160$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266654$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240918$$HP$US$US
243311611$24331161$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA265002$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240918$$MD$US$US
243311621$24331162$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA122832$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240918$$MD$US$US
243311632$24331163$2$F$20220101$20240918$20240918$20240919$EXP$$US-ABBVIE-5923680$ABBVIE$$$$$M$Y$58.966$KG$20240919$$CN$US$US
243311641$24331164$1$I$20180130$20240911$20240918$20240918$EXP$$BR-ABBVIE-5927333$ABBVIE$$70$YR$$M$Y$$$20240918$$MD$BR$BR
243311652$24331165$2$F$20240801$20240918$20240918$20240919$EXP$$US-ABBVIE-5924087$ABBVIE$$67$YR$$F$Y$$$20240919$$CN$US$US
243311661$24331166$1$I$20240912$20240916$20240918$20240918$EXP$$US-ABBVIE-5926798$ABBVIE$$86$YR$$M$Y$$$20240918$$CN$US$US
243311671$24331167$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010784$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243311681$24331168$1$I$20240810$20240910$20240918$20240918$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-097917$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240918$$CN$CA$CA
243311691$24331169$1$I$$20240909$20240918$20240918$EXP$$TR-AMGEN-TURSP2024182903$AMGEN$Ilhan Y.. Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy. Expert Opinion on Pharmacotherapy. 2024;25(11):1555-1563$$$$$Y$$$20240918$$MD$TR$TR
243311701$24331170$1$I$20240101$20240822$20240918$20240918$PER$$US-SA-2024SA267668$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240918$$MD$US$US
243311711$24331171$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266320$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240918$$HP$US$US
243311721$24331172$1$I$$20240905$20240918$20240918$PER$$US-SA-2024SA267274$SANOFI AVENTIS$$$$$$Y$$$20240918$$HP$US$US
243311731$24331173$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA265678$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240918$$HP$US$US
243311741$24331174$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5926385$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243311751$24331175$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009923$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243311761$24331176$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009928$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240918$$CN$US$US
243311771$24331177$1$I$$20231020$20240918$20240918$PER$$US-Accord-378554$ACCORD$$72$YR$E$M$Y$$$20240918$$CN$US$US
243311781$24331178$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009670$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240918$$CN$US$US
243311791$24331179$1$I$20240909$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009668$ELI LILLY AND CO$$$$$M$Y$$$20240918$$CN$US$US
243311801$24331180$1$I$20240915$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010398$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240918$$CN$US$US
243311811$24331181$1$I$20240916$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010064$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$US$US
243311821$24331182$1$I$$20240912$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008552$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240918$$CN$US$US
243311831$24331183$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009236$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240918$$CN$US$US
243311841$24331184$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009900$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240918$$CN$US$US
243311851$24331185$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009813$ELI LILLY AND CO$$$$$$Y$$$20240918$$HP$US$US
243311861$24331186$1$I$20240916$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009958$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240918$$CN$US$US
243311871$24331187$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009909$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240918$$CN$US$US
243311881$24331188$1$I$$20240904$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010224$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240918$$CN$US$US
243311891$24331189$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009856$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243311901$24331190$1$I$$20240912$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009849$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$US$US
243311911$24331191$1$I$20240101$20240916$20240918$20240918$EXP$$US-ABBVIE-5926885$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243311921$24331192$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147728$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$73.03$KG$20240918$$HP$US$US
243311931$24331193$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148086$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240918$$HP$US$US
243311951$24331195$1$I$$20240914$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148052$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$58.97$KG$20240918$$CN$US$US
243311961$24331196$1$I$20240901$20240910$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144726$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240918$$CN$US$US
243311971$24331197$1$I$20240201$20240327$20240918$20240918$PER$$US-Accord-403858$ACCORD$$75$YR$E$M$Y$$$20240918$$CN$US$US
243311981$24331198$1$I$20240101$20240910$20240918$20240918$PER$$US-JNJFOC-20240934747$JOHNSON AND JOHNSON$$47$YR$A$F$Y$73.9$KG$20240918$$CN$US$US
243311992$24331199$2$F$$20240911$20240918$20240920$EXP$$CA-GSK-CA2024113108$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$CA$CA
243312001$24331200$1$I$$20240912$20240918$20240918$EXP$$US-SA-2024SA267696$SANOFI AVENTIS$$$$A$M$Y$77.09$KG$20240918$$MD$US$US
243312011$24331201$1$I$$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024184747$AMGEN$$$$$$Y$$$20240918$$HP$US$US
243312021$24331202$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA266993$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240918$$CN$US$US
243312031$24331203$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265870$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240918$$HP$US$US
243312041$24331204$1$I$$20240823$20240918$20240918$PER$$US-SA-2024SA267803$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$HP$US$US
243312051$24331205$1$I$$20240904$20240918$20240918$PER$$US-SA-2024SA268971$SANOFI AVENTIS$$$$A$$Y$$$20240918$$HP$US$US
243312061$24331206$1$I$$20240914$20240918$20240918$EXP$$US-AstraZeneca-2024A211328$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243312071$24331207$1$I$$20240226$20240918$20240918$PER$$US-Accord-413568$ACCORD$$67$YR$E$M$Y$$$20240918$$CN$US$US
243312081$24331208$1$I$$20240912$20240918$20240918$EXP$$CN-AstraZeneca-2024A205006$ASTRAZENECA$$86$YR$$F$Y$$$20240918$$CN$CN$
243312091$24331209$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212455$ASTRAZENECA$$$$$$Y$$$20240918$$PH$US$
243312101$24331210$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211878$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243312111$24331211$1$I$$20240910$20240918$20240918$EXP$$JP-EXELIXIS-EXL-2024-000172$EXELIXIS$$76$YR$$M$Y$$$20240918$$MD$JP$JP
243312121$24331212$1$I$20170810$20240905$20240918$20240918$EXP$$BE-AUROBINDO-AUR-APL-2024-045568$AUROBINDO$$66$YR$$M$Y$85$KG$20240918$$MD$BE$BE
243312131$24331213$1$I$$20240827$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08767$LUPIN$$$$$$Y$$$20240918$$MD$US$US
243312151$24331215$1$I$$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044568$AUROBINDO$$82$YR$$F$Y$63$KG$20240918$$PH$GB$GB
243312171$24331217$1$I$20240820$20240912$20240918$20240918$EXP$$IL-JNJFOC-20240934452$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240918$$MD$IL$IL
243312181$24331218$1$I$$20240718$20240918$20240918$EXP$$US-ABBVIE-5927535$ABBVIE$$$$$$Y$$$20240918$$MD$US$US
243312192$24331219$2$F$$20240923$20240918$20240928$EXP$$US-RDY-SPO/USA/24/0013457$DR REDDYS$$30$YR$A$M$Y$$$20240928$$MD$US$US
243312201$24331220$1$I$20221101$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013384$DR REDDYS$$24$YR$A$F$Y$$$20240918$$CN$US$US
243312211$24331221$1$I$$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013241$DR REDDYS$$34$YR$A$F$Y$$$20240918$$HP$US$US
243312221$24331222$1$I$$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013391$DR REDDYS$$16$YR$T$$Y$$$20240918$$MD$US$US
243312231$24331223$1$I$20240605$20240909$20240918$20240918$EXP$$US-RDY-SPO/USA/24/0013309$DR REDDYS$$68$YR$E$F$Y$$$20240918$$MD$US$US
243312241$24331224$1$I$$20240716$20240918$20240918$PER$$US-ROCHE-10000030260$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243312251$24331225$1$I$20240101$20240904$20240918$20240918$EXP$$GB-UCBSA-2024045767$UCB$$$$$F$Y$$$20240918$$CN$GB$GB
243312261$24331226$1$I$20240909$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013390$DR REDDYS$$57$YR$A$F$Y$85$KG$20240918$$CN$US$US
243312271$24331227$1$I$$20240903$20240918$20240918$PER$$US-TEVA-VS-3240398$TEVA$$$$$F$Y$$$20240918$$HP$US$US
243312291$24331229$1$I$$20240916$20240918$20240918$EXP$$NVSC2024AZ185639$NOVARTIS$$$$A$M$Y$$$20240918$$MD$AZ$AZ
243312301$24331230$1$I$$20240905$20240918$20240918$EXP$$IT-AUROBINDO-AUR-APL-2024-045006$AUROBINDO$$58$YR$$M$Y$78$KG$20240918$$HP$IT$IT
243312311$24331231$1$I$$20240910$20240918$20240918$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011899$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic?.. J-Eur-Acad-Dermatol-Venereol. 2024$25$YR$$M$Y$$$20240918$$HP$FR$FR
243312321$24331232$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147548$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240918$$CN$US$US
243312331$24331233$1$I$$20240912$20240918$20240918$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900065$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243312343$24331234$3$F$20240903$20240923$20240918$20240925$EXP$$NVSC2024ZA183228$NOVARTIS$$47$YR$$F$Y$$$20240925$$HP$ZA$ZA
243312351$24331235$1$I$$20240912$20240918$20240918$PER$$US-ABBVIE-5922245$ABBVIE$$$$$F$Y$$$20240918$$HP$US$US
243312361$24331236$1$I$$20240917$20240918$20240918$PER$$NVSC2024US185904$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243312371$24331237$1$I$$20240916$20240918$20240918$PER$$NVSC2024US185831$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
243312381$24331238$1$I$$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024184750$AMGEN$$$$$$Y$$$20240918$$HP$US$US
243312401$24331240$1$I$$20240910$20240918$20240918$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011910$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic.. J-Eur-Acad-Dermatol-Venereol. 2024$38$YR$$M$Y$$$20240918$$HP$FR$FR
243312411$24331241$1$I$20240813$20240906$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045112$AUROBINDO$$68$YR$$M$Y$69$KG$20240918$$PH$FR$FR
243312431$24331243$1$I$$20240912$20240918$20240918$PER$$US-ABBVIE-5922707$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243312441$24331244$1$I$$20240913$20240918$20240918$EXP$$DE-JNJFOC-20240937476$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$MD$DE$DE
243312451$24331245$1$I$$20240910$20240918$20240918$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011911$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic. J-Eur-Acad-Dermatol-Venereol. 2024$50$YR$$M$Y$$$20240918$$HP$FR$FR
243312471$24331247$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148072$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240918$$HP$US$US
243312491$24331249$1$I$$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013395$DR REDDYS$$$$$M$Y$$$20240918$$CN$US$US
243312501$24331250$1$I$$20240905$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013355$DR REDDYS$$78$YR$E$F$Y$$$20240918$$HP$US$US
243312511$24331251$1$I$$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013394$DR REDDYS$$$$$F$Y$$$20240918$$CN$US$US
243312521$24331252$1$I$$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013294$DR REDDYS$$40$YR$A$F$Y$$$20240918$$HP$US$US
243312532$24331253$2$F$$20240913$20240918$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08788$LUPIN$$$$$$Y$$$20240921$$MD$US$US
243312541$24331254$1$I$20240312$20240911$20240918$20240918$EXP$FR-AFSSAPS-DJ2024001012$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08582$HIKMA$$$$$$Y$$$20240917$$MD$FR$FR
243312551$24331255$1$I$20240913$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024184197$AMGEN$$82$YR$E$F$Y$$$20240918$$CN$US$US
243312561$24331256$1$I$20240909$20240910$20240918$20240918$EXP$$TW-AMGEN-TWNSP2024183724$AMGEN$$70$YR$E$F$Y$$$20240918$$HP$TW$TW
243312572$24331257$2$F$20230101$20240916$20240918$20240920$EXP$$US-AMGEN-USASP2024184604$AMGEN$$47$YR$A$M$Y$$$20240920$$CN$US$US
243312581$24331258$1$I$20240701$20240913$20240918$20240918$EXP$$NVSC2024US162651$NOVARTIS$$67$YR$$F$Y$$$20240918$$CN$US$US
243312591$24331259$1$I$20240701$20240911$20240918$20240918$EXP$IT-MINISAL02-1001172$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-08588$HIKMA$$77$YR$$M$Y$$$20240918$$MD$IT$IT
243312601$24331260$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010820$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243312621$24331262$1$I$$20240916$20240918$20240918$PER$$US-AstraZeneca-2024A213217$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243312641$24331264$1$I$$20240912$20240918$20240918$EXP$$CA-AstraZeneca-2024A212343$ASTRAZENECA$$65$YR$$F$Y$34$KG$20240918$$MD$CA$
243312651$24331265$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010813$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243312661$24331266$1$I$20200510$20240906$20240918$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-045104$AUROBINDO$$75$YR$$F$Y$$$20240918$$PH$PL$PL
243312671$24331267$1$I$$20240913$20240918$20240918$EXP$$NVSJ2024JP010974$NOVARTIS$$$$$$Y$$$20240918$$MD$JP$JP
243312681$24331268$1$I$$20240910$20240918$20240918$EXP$$TR-EXELIXIS-EXL-2024-000225$EXELIXIS$Kirmizidemir IN.. Vanishing bile duct syndrome after therapy with nivolumab and cabozantinib in a patient with advanced clear cell renal carcinoma.. European Journal of Case Reports in Internal Medicine.. 2024;1:759$56$YR$$M$Y$$$20240918$$HP$TR$TR
243312691$24331269$1$I$$20240823$20240918$20240918$PER$$US-SA-2024SA268995$SANOFI AVENTIS$$$$A$F$Y$99.773$KG$20240918$$MD$US$US
243312701$24331270$1$I$$20240911$20240918$20240918$EXP$$US-ABBVIE-5922119$ABBVIE$$$$$$Y$$$20240918$$CN$US$US
243312711$24331271$1$I$20240825$20240906$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045277$AUROBINDO$$64$YR$$F$Y$66$KG$20240918$$MD$FR$FR
243312721$24331272$1$I$$20240702$20240918$20240918$PER$$US-ROCHE-10000023746$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243312731$24331273$1$I$$20240909$20240918$20240918$EXP$$ES-TEVA-VS-3242646$TEVA$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transpl-Infect-Dis 2024; 26 (3): e14276.$5$MON$$M$Y$$$20240918$$HP$ES$ES
243312741$24331274$1$I$20240723$20240902$20240918$20240918$EXP$HR-HALMED-300086520$HR-TAKEDA-2024TUS092244$TAKEDA$$66$YR$$M$Y$$$20240918$$HP$HR$HR
243312751$24331275$1$I$$20240904$20240918$20240918$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08994$LUPIN$Darnell H, Brenner A, Kern C, Flomenhoft D, Lee E. Sevelamer-induced ischemic enteritis. American Journal of Gastroenterology Case Reports Journal. 2024;11:e01451:1-4$35$YR$$M$Y$$$20240918$$MD$US$US
243312762$24331276$2$F$$20240912$20240918$20240924$EXP$$TR-AMGEN-TURSP2024184541$AMGEN$Ugurlu, Z.. Recurrent refractory polychondritis: A case report. Journal of Turkish Society For Rheumatology. 2024;16(2):82-86$42$YR$A$M$Y$$$20240924$$MD$TR$TR
243312771$24331277$1$I$20130923$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2014-00139$AUROBINDO$$21$YR$$F$Y$84.36$KG$20240918$$CN$GB$GB
243312781$24331278$1$I$$20240909$20240918$20240918$EXP$$US-RDY-SPO/USA/24/0013452$DR REDDYS$Lester SC, Johnson EF, Breen WG, Khurana A. Taming the Lion: A Report of Pencil Beam Scanning Proton Therapy for Severe Leonine Facies. Advances in Radiation Oncology. 2024 Sep;9(9): doi:10.1016/j.adro.2024.101559.$70$YR$E$M$Y$$$20240918$$MD$US$US
243312802$24331280$2$F$20240914$20240923$20240918$20240925$PER$$US-AMGEN-USASP2024185334$AMGEN$$75$YR$E$M$Y$$$20240925$$CN$US$US
243312811$24331281$1$I$20240913$20240914$20240918$20240918$PER$$US-AMGEN-USASP2024184693$AMGEN$$22$YR$A$F$Y$$$20240918$$CN$US$US
243312821$24331282$1$I$$20240909$20240918$20240918$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-08563$HIKMA$Picciolli I, Ratti A, Rinaldi B, Baban A, Iascone M, Francescato G, Capelleri A, Magliozzi M, Novelli A, Parlapiano G, Colli MA, Persico N, Carugo S, Mosca F, Bedeschi FM. Picciolli I, Ratti A, Rinaldi B, Baban A, Iascone M, Francescato G, et al. Biallelic NEXN variants and fetal onset dilated cardiomyopathy: two independent case reports and revision of literature.. Italian Journal of Pediatrics.. 2024;50(1):156$$$$$Y$$$20240918$$MD$IT$IT
243312841$24331284$1$I$$20240904$20240918$20240918$EXP$$DE-AUROBINDO-AUR-APL-2024-044634$AUROBINDO$Hansen N, Teegen B, Hirschel S, Wiltfang J, Schott BH, Bartels C, et al.. Case report: Mixed dementia associated with autoantibodies targeting the vesicular glutamate transporter 2. Front Psychiatry. 2023;01-05$71$YR$$F$Y$$$20240918$$HP$DE$DE
243312851$24331285$1$I$$20240910$20240918$20240918$PER$$US-UNITED THERAPEUTICS-UNT-2024-007097$UNITED THERAPEUTICS$$$$$M$Y$90.703$KG$20240918$$$US$US
243312871$24331287$1$I$20240610$20240904$20240918$20240918$EXP$$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-08362$HIKMA$$55$YR$$F$Y$$$20240918$$MD$FR$FR
243312891$24331289$1$I$20240906$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024184206$AMGEN$$62$YR$A$F$Y$$$20240918$$CN$US$US
243312901$24331290$1$I$20240804$20240912$20240918$20240918$EXP$$US-GSK-US2024113567$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$US$US
243312911$24331291$1$I$$20240904$20240918$20240918$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-08946$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243312921$24331292$1$I$$20240912$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US042399$SANDOZ$$$$$F$Y$$$20240918$$CN$US$US
243312931$24331293$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010814$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243312941$24331294$1$I$20230730$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409061425441910-NPQTV$GB-GLENMARK PHARMACEUTICALS-2024GMK093923$GLENMARK$$$$$$Y$$$20240918$$CN$GB$GB
243312961$24331296$1$I$20240916$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212564$ASTRAZENECA$$$$$M$Y$$$20240918$$MD$US$
243312971$24331297$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A175119$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243312981$24331298$1$I$20231105$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212477$ASTRAZENECA$$25299$DY$$M$Y$$$20240918$$CN$US$
243312991$24331299$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211866$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243313001$24331300$1$I$$20240916$20240918$20240918$EXP$$ZA-AstraZeneca-2024A211477$ASTRAZENECA$$77$YR$$M$Y$$$20240918$$CN$ZA$
243313011$24331301$1$I$$20240912$20240918$20240918$PER$$US-ABBVIE-5923508$ABBVIE$$$$$$Y$$$20240918$$CN$US$US
243313021$24331302$1$I$$20240711$20240918$20240918$PER$$US-ROCHE-10000025660$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243313031$24331303$1$I$$20240913$20240918$20240918$EXP$$CA-SANDOZ INC.-SDZ2024CA080296$SANDOZ$$58$YR$$M$Y$$$20240918$$HP$CA$CA
243313041$24331304$1$I$20240101$20240910$20240918$20240918$PER$$US-UNITED THERAPEUTICS-UNT-2024-028100$UNITED THERAPEUTICS$$$$$M$Y$90.703$KG$20240918$$$US$US
243313061$24331306$1$I$20240601$20240916$20240918$20240918$EXP$$MM-ROCHE-10000082741$ROCHE$$43$YR$A$M$Y$$$20240918$$CN$MM$MM
243313071$24331307$1$I$$20240909$20240918$20240918$EXP$$CA-ROCHE-10000076929$ROCHE$$43$YR$A$M$Y$111$KG$20240918$$CN$CA$CA
243313081$24331308$1$I$20151223$20240910$20240918$20240918$EXP$$CA-JNJFOC-20220632120$JOHNSON AND JOHNSON$$54$YR$A$F$Y$64$KG$20240918$$HP$CA$CA
243313091$24331309$1$I$20240911$20240912$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013479$DR REDDYS$$19$YR$A$M$Y$$$20240918$$MD$US$US
243313101$24331310$1$I$$20240916$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US080750$SANDOZ$$$$$F$Y$$$20240918$$HP$US$US
243313111$24331311$1$I$$20240916$20240918$20240918$EXP$$CA-SANDOZ INC.-SDZ2024CA080629$SANDOZ$$63$YR$$M$Y$$$20240918$$PH$CA$CA
243313121$24331312$1$I$$20240914$20240918$20240918$EXP$$IN-SANDOZ INC.-SDZ2024IN080571$SANDOZ$$$$$M$Y$$$20240918$$CN$IN$IN
243313131$24331313$1$I$20240501$20240909$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-045475$AUROBINDO$$$$$F$Y$$$20240918$$CN$GB$GB
243313141$24331314$1$I$20240904$20240904$20240918$20240918$PER$$US-TEVA-VS-3240750$TEVA$$71$YR$$F$Y$$$20240918$$PH$US$US
243313151$24331315$1$I$20240915$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184909$AMGEN$$63$YR$A$F$Y$$$20240918$$CN$US$US
243313161$24331316$1$I$$20240916$20240918$20240918$EXP$$CA-SANDOZ INC.-SDZ2024CA080686$SANDOZ$$73$YR$$M$Y$65$KG$20240918$$HP$CA$CA
243313171$24331317$1$I$$20240910$20240918$20240918$PER$$US-AMGEN-USASP2024185772$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243313181$24331318$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185404$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243313191$24331319$1$I$$20240903$20240918$20240918$EXP$$US-TEVA-VS-3244049$TEVA$$$$$F$Y$$$20240918$$LW$US$US
243313202$24331320$2$F$20240811$20240919$20240918$20240919$EXP$$FR-PFIZER INC-202400255823$PFIZER$$57$YR$$F$Y$58$KG$20240919$$MD$FR$FR
243313211$24331321$1$I$20240101$20240913$20240918$20240918$EXP$$CA-PFIZER INC-202400257595$PFIZER$$70$YR$$F$Y$$$20240918$$HP$CA$CA
243313221$24331322$1$I$20220922$20240913$20240918$20240918$EXP$GB-MHRA-MED-202409131510347000-FHCDP$GB-PFIZER INC-202400256274$PFIZER$$28$YR$$F$Y$58$KG$20240918$$HP$GB$GB
243313231$24331323$1$I$$20240912$20240918$20240918$EXP$$NVSJ2024JP010942$NOVARTIS$$$$E$M$Y$$$20240918$$MD$JP$JP
243313241$24331324$1$I$$20240917$20240918$20240918$PER$$NVSC2024US185719$NOVARTIS$$$$$$Y$$$20240918$$CN$US$US
243313252$24331325$2$F$20240101$20240920$20240918$20240930$PER$$US-ABBVIE-5922350$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243313261$24331326$1$I$$20240913$20240918$20240918$EXP$$US-GILEAD-2024-0687892$GILEAD$$69$YR$E$M$Y$$$20240918$$CN$US$US
243313271$24331327$1$I$$20240904$20240918$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-045286$AUROBINDO$Basak GW, Wiktor-jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. American Journal of Transplantation. 2015;15:705?714$9$YR$$F$Y$$$20240918$$HP$PL$PL
243313281$24331328$1$I$$20240419$20240918$20240918$PER$$US-Accord-419906$ACCORD$$64$YR$A$M$Y$$$20240918$$CN$US$US
243313291$24331329$1$I$20240612$20240729$20240918$20240918$EXP$$CO-RECORDATI-2024004753$RECORDATI$$$$$$Y$$$20240918$$CN$CO$CO
243313302$24331330$2$F$20240325$20240917$20240918$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148177$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240925$$CN$US$US
243313311$24331331$1$I$20240329$20240909$20240918$20240918$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-143739$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240918$$HP$AU$AU
243313322$24331332$2$F$$20240907$20240918$20240927$EXP$$JP-GSK-JP2024JPN112646$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$JP$JP
243313331$24331333$1$I$$20240911$20240918$20240918$PER$$US-AMGEN-USASP2024182788$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243313341$24331334$1$I$$20240917$20240918$20240918$PER$$NVSC2024US185945$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243313351$24331335$1$I$20240719$20240911$20240918$20240918$EXP$$CA-GSK-CA2023149382$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$CA$CA
243313361$24331336$1$I$$20240916$20240918$20240918$PER$$NVSC2024US185725$NOVARTIS$$$$$F$Y$$$20240918$$HP$US$US
243313371$24331337$1$I$$20240909$20240918$20240918$PER$$US-ABBVIE-5917871$ABBVIE$$$$$F$Y$$$20240918$$MD$US$US
243313381$24331338$1$I$$20240916$20240918$20240918$PER$$NVSC2024US185668$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
243313391$24331339$1$I$$20240917$20240918$20240918$PER$$NVSC2024US185899$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243313401$24331340$1$I$20240823$20240905$20240918$20240918$EXP$$DE-AUROBINDO-AUR-APL-2024-044850$AUROBINDO$$72$YR$$F$Y$$$20240918$$MD$DE$DE
243313421$24331342$1$I$$20240829$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08795$LUPIN$$$$$$Y$$$20240918$$MD$US$US
243313431$24331343$1$I$$20240912$20240918$20240918$PER$$US-JNJFOC-20240939270$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$CN$US$US
243313441$24331344$1$I$$20240913$20240918$20240918$PER$$US-JNJFOC-20240936232$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$CN$US$US
243313451$24331345$1$I$20131001$20240913$20240918$20240918$PER$$US-JNJFOC-20240939269$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240918$$HP$US$US
243313461$24331346$1$I$20240101$20240913$20240918$20240918$EXP$$US-JNJFOC-20240939961$JOHNSON AND JOHNSON$$24$YR$A$F$Y$$$20240918$$HP$US$US
243313471$24331347$1$I$$20240905$20240918$20240918$EXP$$JP-JNJFOC-20240919446$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240918$$MD$JP$JP
243313481$24331348$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010792$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243313491$24331349$1$I$$20240913$20240918$20240918$EXP$$NVSJ2024JP010971$NOVARTIS$$$$$$Y$$$20240918$$MD$JP$JP
243313501$24331350$1$I$$20240716$20240918$20240918$PER$$US-ROCHE-10000030056$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243313511$24331351$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010843$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243313522$24331352$2$F$$20240924$20240918$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-045505$AUROBINDO$$$$$F$Y$$$20240927$$CN$US$US
243313531$24331353$1$I$$20240909$20240918$20240918$EXP$$US-HETERO-HET2024US03089$HETERO$$$$$M$Y$$$20240918$$CN$US$US
243313541$24331354$1$I$20240904$20240905$20240918$20240918$EXP$$US-AUROBINDO-AUR-APL-2024-045799$AUROBINDO$$72$YR$$F$Y$$$20240918$$MD$US$US
243313551$24331355$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211337$ASTRAZENECA$$$$$M$Y$$$20240918$$HP$US$
243313561$24331356$1$I$20240819$20240912$20240918$20240918$EXP$$CO-AstraZeneca-2024A210314$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$CO$
243313571$24331357$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212469$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243313591$24331359$1$I$20240906$20240916$20240918$20240918$EXP$$CA-AstraZeneca-2024A205842$ASTRAZENECA$$11050$DY$$F$Y$$$20240918$$CN$CA$
243313601$24331360$1$I$20240901$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212531$ASTRAZENECA$$29233$DY$$F$Y$$$20240918$$CN$US$
243313611$24331361$1$I$$20240916$20240918$20240918$EXP$$ZA-AstraZeneca-2024A211380$ASTRAZENECA$$73$YR$$F$Y$$$20240918$$CN$ZA$
243313642$24331364$2$F$20240903$20240918$20240918$20240918$PER$$US-AMGEN-USASP2024185704$AMGEN$$66$YR$E$F$Y$$$20240918$$CN$US$US
243313651$24331365$1$I$$20240916$20240918$20240918$EXP$$ZA-AstraZeneca-2024A212304$ASTRAZENECA$$71$YR$$M$Y$$$20240918$$CN$ZA$
243313661$24331366$1$I$$20240912$20240918$20240918$EXP$$CA-AstraZeneca-2024A212337$ASTRAZENECA$$65$YR$$F$Y$$$20240918$$MD$CA$
243313681$24331368$1$I$20240811$20240909$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045477$AUROBINDO$$16$YR$$M$Y$$$20240918$$MD$FR$FR
243313691$24331369$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147995$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240918$$CN$US$US
243313701$24331370$1$I$$20240911$20240918$20240918$EXP$$US-TAKEDA-2024TUS086832$TAKEDA$$$$$M$Y$159$KG$20240918$$CN$US$US
243313711$24331371$1$I$20230826$20240912$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-124755$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240918$$MD$JP$JP
243313721$24331372$1$I$20150414$20240905$20240918$20240918$EXP$$IT-AUROBINDO-AUR-APL-2016-04948$AUROBINDO$$35$YR$$F$Y$$$20240918$$MD$IT$IT
243313731$24331373$1$I$20240911$20240916$20240918$20240918$EXP$$US-GILEAD-2024-0687971$GILEAD$$35$YR$A$M$Y$$$20240918$$CN$US$US
243313741$24331374$1$I$$20240904$20240918$20240918$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08407$HIKMA$$$$$F$Y$$$20240918$$CN$US$US
243313751$24331375$1$I$$20240912$20240918$20240918$EXP$$JP-JNJFOC-20240946696$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240918$$MD$JP$JP
243313761$24331376$1$I$20240101$20240904$20240918$20240918$EXP$$GB-UCBSA-2024045703$UCB$$$$$F$Y$$$20240918$$CN$GB$GB
243313781$24331378$1$I$$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044530$AUROBINDO$$45$YR$$F$Y$73$KG$20240918$$MD$GB$GB
243313791$24331379$1$I$20200702$20240905$20240918$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-044803$AUROBINDO$$56$YR$$F$Y$$$20240918$$MD$PL$PL
243313801$24331380$1$I$$20240913$20240918$20240918$EXP$$US-GILEAD-2024-0687931$GILEAD$$$$T$M$Y$$$20240918$$CN$US$US
243313811$24331381$1$I$20190401$20240905$20240918$20240918$EXP$$NL-AUROBINDO-AUR-APL-2021-022844$AUROBINDO$Hussaarts KGAM, van Doorn L, Bins S, Sprengers D, de Bruijn P, van Leeuwen RWF  et al.. Combining sorafenib and immunosuppression in liver transplant recipients with hepatocellular carcinoma.. Pharmaceuticals. 2021;14(1):1-10$65$YR$$M$Y$$$20240918$$MD$NL$NL
243313821$24331382$1$I$$20240916$20240918$20240918$EXP$$CA-ORGANON-O2409CAN001164$ORGANON$Unknown. Unknown. Unknown$35$YR$$F$Y$$$20240918$$HP$CA$CA
243313831$24331383$1$I$$20240829$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08889$LUPIN$$$$$$Y$$$20240918$$MD$US$US
243313841$24331384$1$I$20240815$20240912$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013472$DR REDDYS$$30$YR$A$M$Y$$$20240918$$MD$US$US
243313851$24331385$1$I$$20240905$20240918$20240918$EXP$$US-RDY-SPO/USA/24/0013035$DR REDDYS$$72$YR$E$F$Y$$$20240918$$HP$US$US
243313871$24331387$1$I$20240731$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045030$AUROBINDO$$60$YR$$M$Y$72$KG$20240918$$PH$FR$FR
243313882$24331388$2$F$$20240919$20240918$20240924$PER$$US-JNJFOC-20240934448$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243313891$24331389$1$I$$20240802$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010455$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243313901$24331390$1$I$$20240903$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08886$LUPIN$$$$$$Y$$$20240918$$MD$US$US
243313911$24331391$1$I$20240101$20240911$20240918$20240918$EXP$$US-CHIESI-2024CHF05970$CHIESI$$$$$M$Y$$$20240918$$MD$US$US
243313921$24331392$1$I$20240908$20240909$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409005571$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240918$$CN$US$US
243313931$24331393$1$I$$20240911$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145548$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240918$$HP$US$US
243313941$24331394$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147598$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$59.87$KG$20240918$$HP$US$US
243313951$24331395$1$I$$20240916$20240918$20240918$PER$$US-TAKEDA-2024TUS092574$TAKEDA$$$$$M$Y$$$20240918$$CN$US$US
243313961$24331396$1$I$$20240905$20240918$20240918$EXP$$CA-UCBSA-2022047216$UCB$$$$$F$Y$$$20240918$$CN$CA$CA
243313971$24331397$1$I$20240826$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184648$AMGEN$$$$$$Y$$$20240918$$HP$US$US
243313981$24331398$1$I$20240828$20240912$20240918$20240918$EXP$$CN-JNJFOC-20240936227$JOHNSON AND JOHNSON$$69$YR$E$F$Y$45$KG$20240918$$HP$CN$CN
243313991$24331399$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010844$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243314001$24331400$1$I$$20240911$20240918$20240918$30DAY$$US-GSK-US2024113171$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243314011$24331401$1$I$20240903$20240913$20240918$20240918$EXP$$NVSC2024CN183876$NOVARTIS$$32$YR$$M$Y$65$KG$20240918$$HP$CN$CN
243314031$24331403$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211659$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243314041$24331404$1$I$$20240903$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08887$LUPIN$$$$$$Y$$$20240918$$MD$US$US
243314051$24331405$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A210691$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243314061$24331406$1$I$$20240913$20240918$20240918$EXP$$AU-AstraZeneca-2024A211403$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$AU$
243314071$24331407$1$I$$20240916$20240918$20240918$PER$$US-AstraZeneca-2024A211798$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243314081$24331408$1$I$20230201$20240910$20240918$20240918$EXP$$NL-AstraZeneca-2024A205629$ASTRAZENECA$$879$MON$$F$Y$$$20240918$$MD$NL$
243314091$24331409$1$I$$20240916$20240918$20240918$EXP$$GB-AstraZeneca-2024A211100$ASTRAZENECA$$60$YR$$F$Y$$$20240918$$MD$GB$
243314101$24331410$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A211751$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243314121$24331412$1$I$20240616$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212643$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$US$
243314131$24331413$1$I$20240821$20240910$20240918$20240918$EXP$IT-MINISAL02-1001256$IT-AMGEN-ITASP2024180754$AMGEN$$69$YR$E$M$Y$83$KG$20240918$$MD$IT$IT
243314141$24331414$1$I$20240914$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184946$AMGEN$$87$YR$E$F$Y$$$20240918$$CN$US$US
243314153$24331415$3$F$20240914$20240926$20240918$20240926$PER$$US-AMGEN-USASP2024185402$AMGEN$$73$YR$E$F$Y$$$20240926$$CN$US$US
243314161$24331416$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010793$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243314171$24331417$1$I$20240906$20240910$20240918$20240918$EXP$GB-MHRA-MED-202409101005112570-PDHLV$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-002206$IPCA$$$$$$Y$$$20240918$$CN$GB$GB
243314191$24331419$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001316US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$US$US
243314201$24331420$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001321US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243314211$24331421$1$I$$20240917$20240918$20240918$EXP$$US-ALXN-202409USA001309US$ALEXION PHARMACEUTICALS$$$$$F$Y$63.946$KG$20240918$$CN$US$US
243314221$24331422$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001300US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243314233$24331423$3$F$$20240920$20240918$20240927$EXP$$GB-SANDOZ INC.-SDZ2024GB080567$SANDOZ$$$$E$F$Y$$$20240927$$CN$GB$GB
243314241$24331424$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001301US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243314251$24331425$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010777$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243314261$24331426$1$I$$20240913$20240918$20240918$EXP$$NVSJ2024JP010972$NOVARTIS$$$$E$$Y$$$20240918$$PH$JP$JP
243314271$24331427$1$I$20240818$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013389$DR REDDYS$$22$YR$A$F$Y$$$20240918$$HP$US$US
243314281$24331428$1$I$20240904$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013420$DR REDDYS$$17$YR$T$M$Y$$$20240918$$CN$US$US
243314291$24331429$1$I$$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013396$DR REDDYS$$$$$F$Y$$$20240918$$CN$US$US
243314302$24331430$2$F$$20240923$20240918$20240930$EXP$$IT-TEVA-VS-3242622$TEVA$Castelli B, Fonte C, Guidi M, Di Nicola M, Giunti L, Buccoliero AM, et al. ROLES OF GEMCITABINE-OXALIPLATIN (GEMOX) ADD-ON THERAPY IN INFANT-TYPE BRAIN TUMORS: A SINGLE CENTER EXPERIENCE. Neuro-Oncol 2024; 26 (Suppl.) iv194.; Castelli B, Fonte C, Guidi M, Di Nicola M, Giunti L, Buccoliero AM, et al. ROLES OF GEMCITABINE-OXALIPLATIN (GEMOX) ADD-ON THERAPY IN INFANT-TYPE BRAIN TUMORS: A SINGLE CENTER EXPERIENCE. Neuro-Oncol 2024; 26 (Suppl.) iv194.$$$I$$Y$$$20240930$$HP$IT$IT
243314311$24331431$1$I$$20240909$20240918$20240918$EXP$$IT-TEVA-VS-3242621$TEVA$Castelli B, Fonte C, Guidi M, Di Nicola M, Giunti L, Buccoliero AM, et al. ROLES OF GEMCITABINE-OXALIPLATIN (GEMOX) ADD-ON THERAPY IN INFANT-TYPE BRAIN TUMORS: A SINGLE CENTER EXPERIENCE. Neuro-Oncol 2024; 26 (Suppl.) iv194.$$$I$$Y$$$20240918$$HP$IT$IT
243314321$24331432$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010879$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243314331$24331433$1$I$20240712$20240909$20240918$20240918$PER$$US-ABBVIE-5923402$ABBVIE$$0$YR$$M$Y$$$20240918$$CN$US$US
243314351$24331435$1$I$$20240912$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147662$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240918$$MD$JP$JP
243314361$24331436$1$I$20240801$20240913$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146846$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$89.36$KG$20240918$$CN$US$US
243314371$24331437$1$I$$20240914$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147787$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240918$$CN$US$US
243314391$24331439$1$I$$20240727$20240918$20240918$EXP$$JP-AMGEN-JPNSP2024185409$AMGEN$$82$YR$E$M$Y$$$20240918$$MD$JP$JP
243314401$24331440$1$I$20240913$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184531$AMGEN$$68$YR$E$F$Y$$$20240918$$CN$US$US
243314421$24331442$1$I$$20240913$20240918$20240918$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-124824$REGENERON$$68$YR$$F$Y$$$20240918$$HP$JP$JP
243314431$24331443$1$I$$20240906$20240918$20240918$EXP$$BG-CELLTRION INC.-2024BG022212$CELLTRION$Kindekov I, Racheva G, and Grancharova E. Chronic Lymphocytic Leukaemia Complicated by Autoimmune Anaemia: A Case Report and Literature Review.. Bulgarian medicine. 2023;13 (1):22-30$$$$$Y$$$20240918$$MD$BG$BG
243314441$24331444$1$I$$20240910$20240918$20240918$PER$$NVSC2024US182455$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
243314451$24331445$1$I$$20240916$20240918$20240918$PER$$US-ALXN-202409USA001201US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243314461$24331446$1$I$20240627$20240916$20240918$20240918$PER$$US-ALXN-202409USA001226US$ALEXION PHARMACEUTICALS$$70$YR$$F$Y$$$20240918$$CN$US$US
243314471$24331447$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010836$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243314481$24331448$1$I$20240905$20240913$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147410$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240918$$CN$US$US
243314491$24331449$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148057$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240918$$CN$US$US
243314501$24331450$1$I$20240618$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147783$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240918$$CN$US$US
243314511$24331451$1$I$$20240715$20240918$20240918$PER$$US-ROCHE-10000027724$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243314521$24331452$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010845$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243314531$24331453$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010778$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243314541$24331454$1$I$$20240910$20240918$20240918$EXP$$PL-ROCHE-10000079592$ROCHE$$$$$F$Y$$$20240918$$MD$PL$PL
243314551$24331455$1$I$$20240906$20240918$20240918$PER$$US-JNJFOC-20240927820$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240918$$HP$US$US
243314561$24331456$1$I$20240823$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185891$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243314571$24331457$1$I$$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185718$AMGEN$$$$$M$Y$$$20240918$$CN$US$US
243314582$24331458$2$F$20240916$20240918$20240918$20240918$PER$$US-AMGEN-USASP2024185525$AMGEN$$59$YR$A$M$Y$$$20240918$$CN$US$US
243314591$24331459$1$I$$20240909$20240918$20240918$30DAY$$US-GSK-US2024111938$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243314601$24331460$1$I$20240731$20240911$20240918$20240918$EXP$$MY-GSK-MY2024APC107577$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$MY$MY
243314611$24331461$1$I$20240731$20240911$20240918$20240918$EXP$$MY-VIIV HEALTHCARE LIMITED-MY2024APC107577$VIIV$$$$$$Y$$$20240918$$MD$MY$MY
243314621$24331462$1$I$20130601$20240913$20240918$20240918$PER$$US-JNJFOC-20240939279$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240918$$HP$US$US
243314633$24331463$3$F$20240908$20240916$20240918$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028535$UNITED THERAPEUTICS$$82$YR$$F$Y$61.678$KG$20240925$$$US$US
243314641$24331464$1$I$20240806$20240917$20240918$20240918$EXP$$CR-AstraZeneca-2024A212681$ASTRAZENECA$$13865$DY$$F$Y$$$20240918$$CN$CR$
243314651$24331465$1$I$$20240912$20240918$20240918$PER$$US-AstraZeneca-2024A210130$ASTRAZENECA$$60$YR$$F$Y$$$20240918$$HP$US$
243314661$24331466$1$I$$20240913$20240918$20240918$EXP$$JP-AstraZeneca-2024A211595$ASTRAZENECA$$72$YR$$F$Y$$$20240918$$MD$JP$
243314681$24331468$1$I$$20240916$20240918$20240918$EXP$$ZA-AstraZeneca-2024A212315$ASTRAZENECA$$75$YR$$F$Y$$$20240918$$CN$ZA$
243314691$24331469$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A212792$ASTRAZENECA$$34$YR$$F$Y$$$20240918$$HP$US$
243314701$24331470$1$I$$20240906$20240918$20240918$PER$$US-AstraZeneca-2024A204027$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243314711$24331471$1$I$$20240906$20240918$20240918$EXP$$AU-ABBVIE-5927270$ABBVIE$$$$$$Y$$$20240918$$MD$AU$AU
243314731$24331473$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212530$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243314741$24331474$1$I$20240101$20240918$20240918$20240918$EXP$$SG-AstraZeneca-2024A213159$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$SG$
243314751$24331475$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212482$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243314761$24331476$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A213221$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243314781$24331478$1$I$20240828$20240912$20240918$20240918$EXP$$CZ-ABBVIE-5923462$ABBVIE$$29$YR$$M$Y$$$20240918$$HP$CZ$CZ
243314791$24331479$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010880$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243314801$24331480$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147382$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240918$$HP$US$US
243314811$24331481$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5923942$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243314821$24331482$1$I$20240101$20240905$20240918$20240918$PER$$US-TEVA-VS-3241889$TEVA$$74$YR$$F$Y$$$20240918$$CN$US$US
243314831$24331483$1$I$$20240909$20240918$20240918$EXP$$GR-CELLTRION INC.-2024GR021927$CELLTRION$Unknown.. Ankylosing spondylitis patient treated with Anti-TNF developed ulcerative colitis.. 3rd PANHELLENIC SUMMER SYMPOSIUM ON MUSCULOSKELETAL HEALTH-INTERACTIVE CASE.. 2023$$$$$Y$$$20240918$$HP$GR$GR
243314842$24331484$2$F$$20240916$20240918$20240922$EXP$$FR-ROCHE-10000083195$ROCHE$$35$YR$A$M$Y$$$20240922$$MD$FR$FR
243314852$24331485$2$F$20210701$20240918$20240918$20240921$EXP$$US-ABBVIE-5923992$ABBVIE$$87$YR$$F$Y$67$KG$20240921$$CN$US$US
243314861$24331486$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5923956$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243314871$24331487$1$I$$20240913$20240918$20240918$PER$$US-JNJFOC-20240935786$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$HP$US$US
243314881$24331488$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010837$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243314891$24331489$1$I$$20240909$20240918$20240918$EXP$$CA-JNJFOC-20240931625$JOHNSON AND JOHNSON$$$$$F$Y$47$KG$20240918$$HP$CA$CA
243314901$24331490$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924962$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243314911$24331491$1$I$$20240913$20240918$20240918$EXP$$IN-ROCHE-10000082304$ROCHE$$39$YR$A$F$Y$$$20240918$$CN$IN$IN
243314921$24331492$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5925050$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243314931$24331493$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5846737$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243314951$24331495$1$I$20240615$20240912$20240918$20240918$EXP$$GR-TAKEDA-2024TUS091552$TAKEDA$$75$YR$$M$Y$$$20240918$$CN$GR$GR
243314961$24331496$1$I$20240909$20240913$20240918$20240918$EXP$$US-ABBVIE-5923866$ABBVIE$$59$YR$$F$Y$$$20240918$$CN$US$US
243314971$24331497$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001302US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243314981$24331498$1$I$20240101$20240913$20240918$20240918$EXP$$CA-ABBVIE-5924448$ABBVIE$$82$YR$$M$Y$$$20240918$$MD$CA$CA
243314991$24331499$1$I$20240101$20240910$20240918$20240918$EXP$$CA-CELLTRION INC.-2024CA002648$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
243315001$24331500$1$I$20160404$20240912$20240918$20240918$EXP$$US-ABBVIE-5922806$ABBVIE$$24$YR$$F$Y$$$20240918$$CN$US$US
243315012$24331501$2$F$20240901$20240919$20240918$20240924$EXP$$US-ABBVIE-5922853$ABBVIE$$59$YR$$M$Y$107.04$KG$20240924$$CN$US$US
243315021$24331502$1$I$$20240908$20240918$20240918$PER$$US-AMGEN-USASP2024182317$AMGEN$Strober,B. Treatment Discontinuation Patterns in Patients With Psoriasis Receiving Apremilast in North America: A Registry-Based Analysis. Journal of the American Academy of Dermatology. 2024;91(3):AB93$$$$$Y$$$20240918$$MD$US$US
243315031$24331503$1$I$20240915$20240915$20240918$20240918$PER$$US-AMGEN-USASP2024185191$AMGEN$$72$YR$E$F$Y$$$20240918$$CN$US$US
243315041$24331504$1$I$20240901$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185311$AMGEN$$67$YR$E$F$Y$$$20240918$$CN$US$US
243315052$24331505$2$F$20240912$20240918$20240918$20240918$PER$$US-AMGEN-USASP2024185784$AMGEN$$68$YR$E$M$Y$$$20240918$$CN$US$US
243315071$24331507$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010779$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243315081$24331508$1$I$$20240912$20240918$20240918$EXP$$US-RDY-SPO/USA/24/0013461$DR REDDYS$$51$YR$A$F$Y$$$20240918$$HP$US$US
243315091$24331509$1$I$20240101$20240909$20240918$20240918$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112110$ZYDUS PHARM$$$$$$Y$$$20240918$$CN$US$US
243315101$24331510$1$I$$20240909$20240918$20240918$EXP$$SK-CELLTRION INC.-2024SK022009$CELLTRION$Zahorak M.. Vyuzitie kmenovych buniek v orofacialnej oblasti. Lekarske listy, priloha ZN.. 2024;8:7-9$$$$$Y$$$20240918$$HP$SK$SK
243315111$24331511$1$I$20240324$20240913$20240918$20240918$EXP$$US-ABBVIE-5908853$ABBVIE$$74$YR$$M$Y$97$KG$20240918$$CN$US$US
243315121$24331512$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010821$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243315131$24331513$1$I$20240201$20240913$20240918$20240918$EXP$$MM-ROCHE-10000082610$ROCHE$$51$YR$A$M$Y$$$20240918$$CN$MM$MM
243315142$24331514$2$F$20240916$20240916$20240918$20240924$PER$$US-AMGEN-USASP2024184831$AMGEN$$73$YR$E$F$Y$$$20240923$$CN$US$US
243315151$24331515$1$I$20240831$20240912$20240918$20240918$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000176-2024$QILU PHARMACEUTICAL$$39$YR$A$M$Y$57$KG$20240918$$HP$CN$CN
243315161$24331516$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010861$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243315171$24331517$1$I$$20240911$20240918$20240918$30DAY$$US-GSK-US2024113153$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243315181$24331518$1$I$$20240911$20240918$20240918$EXP$$US-TAKEDA-2024TUS090940$TAKEDA$$$$$F$Y$$$20240918$$CN$US$US
243315211$24331521$1$I$$20240909$20240918$20240918$PER$$US-ABBVIE-5919015$ABBVIE$$$$$$Y$$$20240918$$HP$US$US
243315232$24331523$2$F$20240801$20240917$20240918$20240921$EXP$$US-ABBVIE-5925230$ABBVIE$$39$YR$$F$Y$$$20240921$$CN$US$US
243315241$24331524$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010881$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243315251$24331525$1$I$20240905$20240913$20240918$20240918$EXP$$US-ABBVIE-5925746$ABBVIE$$59$YR$$F$Y$$$20240918$$CN$US$US
243315261$24331526$1$I$20240706$20240910$20240918$20240918$EXP$$TR-BIOGEN-2024BI01282316$BIOGEN$$1$YR$$M$Y$$$20240918$$MD$TR$TR
243315281$24331528$1$I$$20240916$20240918$20240918$PER$$US-BIOVITRUM-2024-US-010392$BIOVITRUM$$55$YR$$F$Y$$$20240918$$CN$US$US
243315291$24331529$1$I$$20240719$20240918$20240918$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009244$STRIDES$Rayasam V, Cherian SV, Estrada-Y-Martin RM.. A Case of Caplan Syndrome in a Patient With Silicosis.. Am-J-Respir-Crit-Care-Med. 2024;209:A5981$38$YR$$M$Y$$$20240918$$HP$US$US
243315301$24331530$1$I$$20240730$20240918$20240918$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009721$STRIDES$Zouridis S, Oo YH, Syn W-K.. Role of Sirolimus and Rituximab in the Treatment of Autoimmune Hepatitis. ACG-Case-Rep-J. 2024;11 (7):e01414$$$$F$Y$$$20240918$$MD$US$US
243315311$24331531$1$I$$20240620$20240918$20240918$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007604$STRIDES$Brown AF, Fowler CM.. Diffuse Interstitial Lung Disease With Organizing Pneumonia in 12-year- Old Female With TNFRSF13B Monoallelic Common Variable Immunodeficiency.. Am-J-Respir-Crit-Care-Med. 2024;209 (0)$12$YR$$F$Y$$$20240918$$HP$US$US
243315321$24331532$1$I$$20240705$20240918$20240918$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008443$STRIDES$Kassels A, Edwards L, Kraus CN.. Treatment of erosive vulvovaginal lichen planus with tofacitinib: A case series.. JAAD-Case-Rep. 2023;40:14-18.$$$$F$Y$$$20240918$$MD$US$US
243315331$24331533$1$I$$20240809$20240918$20240918$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010412$STRIDES$Dykes K, Tzachanis D, Koura D.. A Difficult Case of Calcineurin Inhibitor Neurotoxicity Post-Haploidentical HCT With a Successful Novel Solution: Cytotoxic T-Lymphocyte-Associated Protein 4-Immunoglobulin Blockade for GVHD Prophylaxis.. Cell-Transplant. 2024;33:01-07.$24$YR$$M$Y$$$20240918$$HP$US$US
243315341$24331534$1$I$$20240715$20240918$20240918$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009020$STRIDES$Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, et al.. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies. J-Ophthalmic-Inflamm-Infect. 2024;14$65$YR$$M$Y$$$20240918$$HP$US$US
243315351$24331535$1$I$$20240807$20240918$20240918$PER$$US-STRIDES PHARMA UK LTD.-2024SP010193$STRIDES$Scullin D, Goetz R, Wille K, Rusanov V, Gongora E, Orozco Hernandez E, et al.. Acute Graft versus Host Disease in a Lung Transplant Recipient.. J-Heart-Lung-Transplant. 2024;43 (Suppl.) (4):S489-S490 abstr. 1051$$$$$Y$$$20240918$$HP$US$US
243315361$24331536$1$I$$20240731$20240918$20240918$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009832$STRIDES$Mccreary DL, Talon A, Young K, Suliman SA.. Acute Pulmonary Manifestations and Management of Idiopathic Inflammatory Myopathies.. Am-J-Respir-Crit-Care-Med. 2024;209(plusPoster)$44$YR$$M$Y$$$20240918$$HP$US$US
243315371$24331537$1$I$20240703$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212881$ASTRAZENECA$$17958$DY$$F$Y$68.7$KG$20240918$$CN$US$
243315391$24331539$1$I$$20240916$20240918$20240918$PER$$US-ALXN-202409USA001266US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243315401$24331540$1$I$$20240912$20240918$20240918$PER$$US-AstraZeneca-2024A209101$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243315411$24331541$1$I$$20240916$20240918$20240918$PER$$US-ALXN-202409USA001181US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243315431$24331543$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001317US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243315441$24331544$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A212333$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243315451$24331545$1$I$$20240912$20240918$20240918$EXP$$CA-AstraZeneca-2024A212344$ASTRAZENECA$$65$YR$$F$Y$34$KG$20240918$$MD$CA$
243315461$24331546$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001272US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243315471$24331547$1$I$$20240911$20240918$20240918$EXP$$JP-AstraZeneca-2024A208480$ASTRAZENECA$$72$YR$$M$Y$$$20240918$$MD$JP$
243315481$24331548$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212903$ASTRAZENECA$$$$$F$Y$$$20240918$$HP$US$
243315491$24331549$1$I$20240629$20240917$20240918$20240918$EXP$$AR-AstraZeneca-2024A212521$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$AR$
243315501$24331550$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A210397$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243315511$24331551$1$I$$20240917$20240918$20240918$EXP$$CA-AstraZeneca-2024A212419$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$CA$
243315521$24331552$1$I$20240827$20240912$20240918$20240918$EXP$$IN-ROCHE-10000081881$ROCHE$$43$YR$A$F$Y$73$KG$20240918$$MD$IN$IN
243315531$24331553$1$I$$20240913$20240918$20240918$EXP$$JP-AstraZeneca-2024A169201$ASTRAZENECA$$84$YR$$F$Y$$$20240918$$MD$JP$
243315551$24331555$1$I$$20240909$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143918$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$97.98$KG$20240918$$HP$US$US
243315561$24331556$1$I$20240916$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147631$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240918$$HP$US$US
243315581$24331558$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186092$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243315591$24331559$1$I$20210101$20240913$20240918$20240918$EXP$SE-SEMPA-2024-006651$SE-AMGEN-SWESP2024184280$AMGEN$$46$YR$A$F$Y$58$KG$20240918$$CN$SE$SE
243315601$24331560$1$I$$20240903$20240918$20240918$EXP$$US-HALEON-2196788$Haleon PLC$$17$YR$$F$Y$$$20240918$$MD$US$US
243315611$24331561$1$I$$20240906$20240918$20240918$EXP$$TR-Accord-446148$ACCORD$Aydin T, Kaya SK, Ozguroglu M, Seyahi N, Ar MC. CASE OF ALVEOLAR HEMORRHAGE ACCOMPANYING ATYPICAL HAEMOLYTIC UREMIC SYNDROME. European Journal of Case Reports in Internal Medicine. 2024;11(Supplement 1):783-4. DOI: 10.12890/2024_V11Sup1.$45$YR$A$M$Y$$$20240918$$MD$TR$TR
243315621$24331562$1$I$20240817$20240826$20240918$20240918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005065$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240918$$CN$US$US
243315631$24331563$1$I$20240801$20240911$20240918$20240918$EXP$$US-TAKEDA-2024TUS091358$TAKEDA$$74$YR$$M$Y$$$20240918$$CN$US$US
243315641$24331564$1$I$$20240911$20240918$20240918$EXP$$CA-APOTEX-2024AP010550$APOTEX$$$$$M$Y$$$20240918$$CN$CA$CA
243315661$24331566$1$I$20231226$20240910$20240918$20240918$EXP$$TR-BIOGEN-2024BI01282319$BIOGEN$$0$YR$$M$Y$$$20240918$$MD$TR$TR
243315691$24331569$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010862$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243315701$24331570$1$I$$20240909$20240918$20240918$EXP$$AU-JNJFOC-20240931422$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$MD$AU$AU
243315711$24331571$1$I$20210118$20240909$20240918$20240918$EXP$$DE-JNJFOC-20220430949$JOHNSON AND JOHNSON$$6$YR$C$F$Y$17$KG$20240918$$MD$DE$DE
243315721$24331572$1$I$20240101$20240909$20240918$20240918$EXP$$US-BIOGEN-2024BI01281920$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
243315731$24331573$1$I$$20240806$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010650$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243315741$24331574$1$I$$20240910$20240918$20240918$EXP$$US-BIOGEN-2024BI01282295$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
243315751$24331575$1$I$20240909$20240911$20240918$20240918$EXP$$CN-SA-2024SA267776$SANOFI AVENTIS$$49$YR$A$F$Y$55$KG$20240918$$HP$CN$CN
243315761$24331576$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010815$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243315771$24331577$1$I$20240913$20240913$20240918$20240918$EXP$$NVSC2024DE185711$NOVARTIS$$50$YR$$F$Y$$$20240918$$MD$DE$DE
243315781$24331578$1$I$20130913$20240913$20240918$20240918$PER$$US-JNJFOC-20240939436$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20240918$$HP$US$US
243315791$24331579$1$I$$20240909$20240918$20240918$EXP$$CA-JNJFOC-20240930844$JOHNSON AND JOHNSON$$17$YR$T$F$Y$47$KG$20240918$$HP$CA$CA
243315801$24331580$1$I$$20240904$20240918$20240918$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093870$GLENMARK$Shirini K, Gautam U, Ahmed H, Meier RP, Drachenberg C, Haririan A.. Masked kidney allograft failure after simultaneous liver and kidney transplantation: A case report.. Journal of Liver Transplantation. 2024;16:100237$$$$$Y$$$20240918$$MD$US$US
243315811$24331581$1$I$20180928$20240916$20240918$20240918$EXP$$DE-SANDOZ INC.-PHHY2019DE205796$SANDOZ$$77$YR$$F$Y$86$KG$20240918$$HP$DE$DE
243315821$24331582$1$I$20240910$20240910$20240918$20240918$PER$$US-BIOGEN-2024BI01282324$BIOGEN$$29$YR$$F$Y$$$20240918$$CN$US$US
243315831$24331583$1$I$20240910$20240910$20240918$20240918$PER$$US-BIOGEN-2024BI01282120$BIOGEN$$16$YR$$$Y$$$20240918$$CN$US$US
243315841$24331584$1$I$20170101$20240909$20240918$20240918$EXP$$BR-BIOGEN-2024BI01282100$BIOGEN$$$$$F$Y$62$KG$20240918$$HP$BR$BR
243315851$24331585$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010765$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243315871$24331587$1$I$20200101$20240908$20240918$20240918$EXP$$KR-009507513-2409KOR004052$MERCK$$56$YR$$F$Y$$$20240918$$MD$KR$KR
243315881$24331588$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186116$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243315891$24331589$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001325US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243315901$24331590$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001344US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243315911$24331591$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186107$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243315921$24331592$1$I$20240721$20240912$20240918$20240918$EXP$$JP-GSK-JP2024JPN091903$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$PH$JP$JP
243315931$24331593$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010882$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243315941$24331594$1$I$$20240917$20240918$20240918$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051942$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240918$$CN$US$US
243315951$24331595$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010846$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243315961$24331596$1$I$$20240906$20240918$20240918$EXP$DE-BFARM-24006127$DE-Accord-445838$ACCORD$$$$A$M$Y$$$20240918$$MD$DE$DE
243315971$24331597$1$I$$20240912$20240918$20240918$EXP$$BR-TAKEDA-2024TUS092300$TAKEDA$$$$$M$Y$$$20240918$$CN$BR$BR
243315981$24331598$1$I$$20240903$20240918$20240918$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468418$RANBAXY$MSc., Ph.D., EDIC. Euglycemic ketoacidosis associated with SGLT2 inhibitors and DPP4 inhibitors - discussion of case reports. Anesteziol Intenz Med. 2024;35 (2):116-121$61$YR$$M$Y$$$20240918$$HP$CZ$CZ
243315991$24331599$1$I$$20240903$20240918$20240918$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468310$RANBAXY$Galimov AN, Lepik EE, Kozlov AV, Gevorgyan AG, Kazantsev IV, Yukhta TV, et al. The treatment of relapsed/refractory anaplastic large cell lymphoma expressing the anaplastic lymphoma kinase: a single-center experience. Pediatr Hematol Oncol Immunopathol. 2023;22 (1):22-31$26$YR$$$Y$$$20240918$$HP$RU$RU
243316001$24331600$1$I$$20240903$20240918$20240918$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468006$RANBAXY$Koi Y, Tajiri W, Kawasaki J, Akiyoshi S, Ijichi H, Nakamura Y, et al. A dramatic response to an immune checkpoint inhibitor plus chemotherapy in a patient with metastatic metaplastic carcinoma of the breast: A case report. Thorac Cancer. 2024;Sep 1:39219055$46$YR$$F$Y$$$20240918$$HP$JP$JP
243316011$24331601$1$I$$20240903$20240918$20240918$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468315$RANBAXY$Galimov AN, Lepik EE, Kozlov AV, Gevorgyan AG, Kazantsev IV, Yukhta TV, et al. The treatment of relapsed/refractory anaplastic large cell lymphoma expressing the anaplastic lymphoma kinase: a single-center experience. Pediatr Hematol Oncol Immunopathol. 2023;22 (1):22-31$28$YR$$$Y$$$20240918$$HP$RU$RU
243316021$24331602$1$I$$20240903$20240918$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468318$RANBAXY$$67$YR$$F$Y$$$20240918$$CN$US$US
243316031$24331603$1$I$$20240903$20240918$20240918$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468261$RANBAXY$$74$YR$$F$Y$73$KG$20240918$$PH$GB$GB
243316041$24331604$1$I$$20240903$20240918$20240918$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468384$RANBAXY$Singh V, Srivastava D, Kotarya N, Ora M, Pradhan PK. Unveiling the Metabolic Maze: FDG PET/CT Findings in Peritoneal Carcinomatosis - A Case Series. Asia Ocean J Nucl Med Biol. 2024;12(2):189-201$42$YR$$F$Y$$$20240918$$HP$IN$IN
243316051$24331605$1$I$20240808$20240903$20240918$20240918$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468264$RANBAXY$$53$YR$$M$Y$58$KG$20240918$$CN$GB$GB
243316061$24331606$1$I$$20240903$20240918$20240918$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468185$RANBAXY$$67$YR$$$Y$$$20240918$$PH$GB$GB
243316071$24331607$1$I$$20240903$20240918$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468512$RANBAXY$Gangat N, Ajufo H, Abdelmagid M, Karrar O, McCullough K, Badar T, et al. IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience. Br J Haematol. 2023;203:e87-e92$57$YR$$M$Y$$$20240918$$HP$US$US
243316081$24331608$1$I$$20240903$20240918$20240918$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468363$RANBAXY$Singh DP, Raghunathan V, Dhaliwal MS, Singh R, Kumar A. Acute Levalbuterol Toxicity With Use of Metered Dose Inhaler. Clin Pediatr. 2024;63(3):297-299$8$YR$$M$Y$$$20240918$$MD$IN$IN
243316091$24331609$1$I$20240601$20240912$20240918$20240918$EXP$$US-ABBVIE-5922243$ABBVIE$$59$YR$$F$Y$$$20240918$$CN$US$US
243316101$24331610$1$I$20240308$20240903$20240918$20240918$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468182$RANBAXY$$66$YR$$F$Y$48$KG$20240918$$PH$GB$GB
243316111$24331611$1$I$$20240903$20240918$20240918$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468306$RANBAXY$Galimov AN, Lepik EE, Kozlov AV, Gevorgyan AG, Kazantsev IV, Yukhta TV, et al. The treatment of relapsed/refractory anaplastic large cell lymphoma expressing the anaplastic lymphoma kinase: a single-center experience. Pediatr Hematol Oncol Immunopathol. 2023;22 (1):22-31$12$YR$$$Y$$$20240918$$HP$RU$RU
243316121$24331612$1$I$$20240903$20240918$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468028$RANBAXY$Halim HJ, Burk BG, Fargason RE, Birur B. Manic episode following psilocybin use in a man with bipolar II disorder: a case report. Front Psychiatry. 2023;14:1-5$21$YR$$M$Y$$$20240918$$HP$US$US
243316131$24331613$1$I$$20240903$20240918$20240918$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468425$RANBAXY$Sitina M, Sramek V. Euglycemic ketoacidosis associated with SGLT2 inhibitors and DPP4 inhibitors - discussion of case reports. Anesteziol Intenz Med. 2024;35 (2):116-121$59$YR$$F$Y$$$20240918$$HP$CZ$CZ
243316141$24331614$1$I$$20240903$20240918$20240918$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468386$RANBAXY$Singh V, Srivastava D, Kotarya N, Ora M, Pradhan PK. Unveiling the Metabolic Maze: FDG PET/CT Findings in Peritoneal Carcinomatosis - A Case Series. Asia Ocean J Nucl Med Biol. 2024;12(2):189-201$45$YR$$F$Y$$$20240918$$HP$IN$IN
243316151$24331615$1$I$$20240903$20240918$20240918$EXP$$FR-SUN PHARMACEUTICALS INDUSTRIES LTD.-2024RR-466696$RANBAXY$$$$E$F$Y$$$20240918$$CN$FR$FR
243316161$24331616$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5922671$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243316171$24331617$1$I$$20240903$20240918$20240918$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468262$RANBAXY$$80$YR$$F$Y$68$KG$20240918$$MD$GB$GB
243316191$24331619$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5923442$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243316202$24331620$2$F$20201201$20240913$20240918$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468466$RANBAXY$Horaguchi T, Tanaka Y, Sato Y, Yamamoto K, Fukada M, Yasufuku I, et al. Successful direct oral anticoagulant management of asymptomatic superior mesenteric vein thrombosis after adjuvant chemotherapy for colorectal cancer patient: A case report. Exper Ther Med. 2024;28 (4):396;1-5$71$YR$$F$Y$$$20240927$$HP$JP$JP
243316212$24331621$2$F$$20240914$20240918$20240927$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-433927$RANBAXY$Laroussi S, Bouattour N, Daoud S, Moalla KS, Sakka S, Damak M, et al. Reversible dementia and seizures due to metformin-induced vitamin B12 deficiency. Encephale. 2024;Feb17/AUG50 (4):Online ahead of print/474-477$64$YR$$F$Y$$$20240927$$HP$TN$TN
243316221$24331622$1$I$$20240903$20240918$20240918$EXP$$AE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468479$RANBAXY$Fatima N, Hamza LK, Almulla AAA, Salman A. Favourable outcome in a primigravida with hydroxychloroquine (HCQ) induced (most likely) cardiomyopathy: a case report and literature review. Ital J Gyn?col Obstet. 2023;35:488-492$28$YR$$F$Y$$$20240918$$HP$AE$AE
243316231$24331623$1$I$$20240903$20240918$20240918$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468329$RANBAXY$$39$YR$$F$Y$111$KG$20240918$$MD$GB$GB
243316241$24331624$1$I$$20240903$20240918$20240918$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468379$RANBAXY$Kachlik Z, Blazewicz I, Ciarka A, Nowicki RJ. Case report: Lichenoid eruption under immunotherapy with MK-4830 and pembrolizumabina breast cancer patient. Front Pharmacol. 2024;15 (0):1445685;01-06$41$YR$$F$Y$$$20240918$$HP$PL$PL
243316251$24331625$1$I$$20240903$20240918$20240918$EXP$$AE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468481$RANBAXY$Fatima N, Hamza LK, Almulla AAA, Salman A. Favourable outcome in a primigravida with hydroxychloroquine (HCQ) induced (most likely) cardiomyopathy: a case report and literature review. Ital J Gyn?col Obstet. 2023;35:488-492$$$$M$Y$$$20240918$$HP$AE$AE
243316261$24331626$1$I$20230830$20240903$20240918$20240918$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468263$RANBAXY$$58$YR$$M$Y$72$KG$20240918$$MD$GB$GB
243316271$24331627$1$I$20240826$20240903$20240918$20240918$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468468$RANBAXY$$59$YR$$F$Y$$$20240918$$CN$GB$GB
243316281$24331628$1$I$$20240903$20240918$20240918$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468397$RANBAXY$$67$YR$$$Y$$$20240918$$PH$GB$GB
243316291$24331629$1$I$$20240903$20240918$20240918$EXP$$TH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467395$RANBAXY$Siranart N, Sowalertrat W, Limotai C. Epilepsy with Basal Ganglia Calcification and Hypocalcemia: a Case Report. SN Compr Clin Med. 2023;5:127(1-5)$26$YR$$F$Y$54$KG$20240918$$HP$TH$TH
243316301$24331630$1$I$$20240903$20240918$20240918$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468034$RANBAXY$Gilbert-Falardeau A, Drolet A-M. Remission of necrobiotic xanthogranuloma after intravenous immunoglobulin interruption: A case report. SAGE Open Med Case Rep. 2024;12 (0):1-3$92$YR$$F$Y$$$20240918$$HP$CA$CA
243316311$24331631$1$I$$20240906$20240918$20240918$EXP$$GR-Accord-446096$ACCORD$Kotsi E, Kaparou P, Pelekanos A, Papavdi M, Vasilopoulos D, Deutsch M, et al. A CASE OF DRESS SYNDROME INITIALLY TREATED AS SCARLET FEVER. European Journal of Case Reports in Internal Medicine. 2024;11(Supplement 1):992. DOI: 10.12890/2024_V11Sup1.$74$YR$E$F$Y$$$20240918$$MD$GR$GR
243316321$24331632$1$I$$20240911$20240918$20240918$EXP$$HK-GILEAD-2024-0687549$GILEAD$$72$YR$E$F$Y$58.6$KG$20240918$$MD$HK$HK
243316331$24331633$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5921967$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243316341$24331634$1$I$20240618$20240912$20240918$20240918$EXP$$CN-ABBVIE-5920816$ABBVIE$$77$YR$$F$Y$63$KG$20240918$$MD$CN$CN
243316351$24331635$1$I$20240101$20240912$20240918$20240918$EXP$$US-ABBVIE-5922190$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243316371$24331637$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010766$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243316381$24331638$1$I$$20240917$20240918$20240918$EXP$$ZA-AstraZeneca-2024A212861$ASTRAZENECA$$81$YR$$F$Y$$$20240918$$CN$ZA$
243316401$24331640$1$I$$20240915$20240918$20240918$PER$$US-AstraZeneca-2024A211987$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243316411$24331641$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A209997$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243316421$24331642$1$I$$20240911$20240918$20240918$EXP$$JP-AstraZeneca-2024A202099$ASTRAZENECA$$80$YR$$F$Y$$$20240918$$MD$JP$
243316441$24331644$1$I$20240821$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212569$ASTRAZENECA$$52$YR$$F$Y$105.7$KG$20240918$$CN$US$
243316451$24331645$1$I$$20240917$20240918$20240918$EXP$$ZA-AstraZeneca-2024A212787$ASTRAZENECA$$48$YR$$F$Y$$$20240918$$CN$ZA$
243316461$24331646$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185148$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243316472$24331647$2$F$20240917$20240918$20240918$20240919$PER$$US-AMGEN-USASP2024185725$AMGEN$$68$YR$E$F$Y$$$20240919$$CN$US$US
243316482$24331648$2$F$$20240920$20240918$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148066$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$66.22$KG$20240926$$MD$US$US
243316491$24331649$1$I$$20240911$20240918$20240918$EXP$$CO-AMGEN-COLSL2024183224$AMGEN$$$$E$F$Y$$$20240918$$CN$CO$CO
243316501$24331650$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147688$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$85.73$KG$20240918$$CN$US$US
243316511$24331651$1$I$$20240906$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145189$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240918$$PH$JP$JP
243316521$24331652$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147643$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240918$$CN$US$US
243316531$24331653$1$I$20240717$20240913$20240918$20240918$EXP$$US-ABBVIE-5926205$ABBVIE$$52$YR$$F$Y$$$20240918$$CN$US$US
243316541$24331654$1$I$$20240903$20240918$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467494$RANBAXY$$$$$F$Y$$$20240918$$CN$US$US
243316551$24331655$1$I$$20240903$20240918$20240918$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468124$RANBAXY$Singanamalla B, Gunasekaran P, Saini AG. Facial dysmorphism and limb abnormalities of fetal Valproate Syndrome. QJM. 2024;00(0):1-2$$$N$$Y$$$20240918$$HP$IN$IN
243316561$24331656$1$I$$20240903$20240918$20240918$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468489$RANBAXY$Kounatidis D, Chatzieleftheriou E, Vallianou NG. Lithium induced neurotoxicity: The SILENT killer. Hippokratia. 2023;27 (3):115-116$72$YR$$F$Y$$$20240918$$HP$GR$GR
243316571$24331657$1$I$$20240903$20240918$20240918$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468377$RANBAXY$Skinner T, Liang S, Sanagapalli S. Budesonide Orodispersible Tablet for the Treatment of Refractory Esophageal Lichen Planus. ACG Case Rep J. 2024;11 (8)$61$YR$$F$Y$$$20240918$$HP$AU$AU
243316581$24331658$1$I$$20240903$20240918$20240918$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468370$RANBAXY$n Heinig S, Aigner T, Bloss H-G, Grabenbauer GG. Spinal and cervical nodal metastases in a patient with glioblastoma. Strahlenther Onkol. 2024;200(9):838-843$54$YR$$M$Y$$$20240918$$HP$DE$DE
243316591$24331659$1$I$$20240903$20240918$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468374$RANBAXY$Gangat N, Ajufo H, Abdelmagid M, Karrar O, McCullough K, Badar T, et al. IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience. Br J Haematol. 2023;203:e87-e92$81$YR$$F$Y$$$20240918$$HP$US$US
243316601$24331660$1$I$$20240903$20240918$20240918$EXP$$PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468272$RANBAXY$Rizwanullah, Khan M, Bassi R, Hamad SB, Eisa R, Patel H. CHRONIC PROTON PUMP INHIBITOR USE LEADING TO REFRACTORY HYPOMAGNESAEMIA IN A PATIENT WITH RHEUMATOID ARTHRITIS: A CASE REPORT. J Populat Therap Clin Pharmacol. 2024;31 (8):160-163$43$YR$$F$Y$$$20240918$$HP$PK$PK
243316611$24331661$1$I$$20240903$20240918$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468309$RANBAXY$Farkouh EK, Michel IM,Harrison DJ,Issa N. Dual Donor-Derived Renal Allograft Mucormycosis. Mayo Clin Proc. 2024;Aug;99(8):1339-1346$$$A$F$Y$$$20240918$$HP$US$US
243316621$24331662$1$I$$20240903$20240918$20240918$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468170$RANBAXY$Liu Z, Wang F, Zhang Y, Lu J, Yang Y. Combination treatment with anti-HER2 therapeutic antibody RC48, PD-1 inhibitor, radiotherapy, and granulocyte macrophage-colony stimulating factor (GM-CSF) in patient with metastatic gastric cancer: a case report. Front Immunol. 2024;15:1321946/1-10$58$YR$$M$Y$$$20240918$$HP$CN$CN
243316631$24331663$1$I$20240820$20240903$20240918$20240918$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468266$RANBAXY$$48$YR$$M$Y$85$KG$20240918$$CN$GB$GB
243316641$24331664$1$I$$20240903$20240918$20240918$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468019$RANBAXY$Pan Q, Li P. Challenges in autoimmune polyendocrine syndrome type 2 with the full triad induced by anti-programmed cell death 1: a case report and review of the literature. Front Immunol. 2024;Apr;15:1366335$60$YR$$F$Y$45$KG$20240918$$HP$CN$CN
243316651$24331665$1$I$$20240903$20240918$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468510$RANBAXY$Gangat N, Ajufo H, Abdelmagid M, Karrar O, McCullough K, Badar T, et al. IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience. Br J Haematol. 2023;203:e87-e92$75$YR$$F$Y$$$20240918$$HP$US$US
243316661$24331666$1$I$$20240903$20240918$20240918$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468134$RANBAXY$Madhu, Anshul, Kumar P, Anupma, Asha. Emergency Laparotomy in Dilated Cardiomyopathy An Anaesthesiologist^s Challenge: A Case Report and Review of Literature. Int J Pharmac Clin Res. 2024;16 (7):1019-1023$55$YR$$F$Y$45$KG$20240918$$HP$IN$IN
243316671$24331667$1$I$$20240903$20240918$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468041$RANBAXY$Higgins E, Yuan J, Lange S, Boilson BA, Pritt BS, Rizza SA. Fever, Cough, and Pancytopenia in a Transplant Recipient. Clin Infect Dis. 2023;Oct 1;77:1065-1067$19$YR$$M$Y$$$20240918$$HP$US$US
243316681$24331668$1$I$$20240903$20240918$20240918$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468367$RANBAXY$Untan I, Cil AS. A rare cause of erectile dysfunction: Bilateral thrombosed internal iliac artery aneurysms. Pak J Med Sci. 2024;40 (8):1885-1888$52$YR$$M$Y$87$KG$20240918$$HP$TR$TR
243316691$24331669$1$I$$20240903$20240918$20240918$EXP$$ZA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468342$RANBAXY$Soni AJ, Rugbeer Y, Rozmiarek J, Manesh A, Marais S. Tumor necrosis factor-alpha antagonists in patients with complicated spinal tuberculosis: A case series and literature review. Infect Dis Now. 2024;54 (6):104941;1-6$16$YR$$M$Y$$$20240918$$HP$ZA$ZA
243316701$24331670$1$I$$20240903$20240918$20240918$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466769$RANBAXY$Goyal J, Kumar N. An interesting case report of serotonin syndrome in critically ill patient admitted with benzodiazepine overdose. Int J Life Sci Biotechnol Pharma Res. 2024;13(8):217-220$32$YR$$M$Y$$$20240918$$MD$IN$IN
243316711$24331671$1$I$$20240903$20240918$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468038$RANBAXY$Diaz MJ, Liu VY, Motaparthi K. Noninflammatory extrafacial edema as a clue to the diagnosis of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. JAAD Case Rep. 2024;47 (0):96-98$$$A$M$Y$$$20240918$$HP$US$US
243316721$24331672$1$I$$20240903$20240918$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468380$RANBAXY$Gone J, Fontaine T, Kumar G. A rare case of progressive multifocal leukoencephalopathy. Radiol Case Rep. 2024;19 (10):4654-4658$40$YR$$F$Y$$$20240918$$MD$US$US
243316731$24331673$1$I$20230101$20240913$20240918$20240918$EXP$$US-ABBVIE-5923687$ABBVIE$$$$$$Y$$$20240918$$CN$US$US
243316741$24331674$1$I$20240101$20240913$20240918$20240918$EXP$$CA-ABBVIE-5924343$ABBVIE$$71$YR$$F$Y$$$20240918$$CN$CA$CA
243316751$24331675$1$I$$20240906$20240918$20240918$PER$$US-HBP-2024US031218$HELSINN HEALTHCARE$$$$$M$Y$$$20240918$$CN$US$US
243316761$24331676$1$I$$20240903$20240918$20240918$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468032$RANBAXY$Mostafa MA, Elseidy S, Metwally RA, Mahmoud A, Abdelhay A, Imran FS. First reported use of immune checkpoint inhibitor for treatment of cancer in a patient with acquired hemophilia A. Clin Immunol Commun. 2024;5 (0):41-44$79$YR$$F$Y$$$20240918$$HP$US$US
243316771$24331677$1$I$20240101$20240826$20240918$20240918$PER$$US-JNJFOC-20240903189$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240918$$CN$US$US
243316781$24331678$1$I$20240801$20240910$20240918$20240918$EXP$$CA-JNJFOC-20240927420$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240918$$HP$CA$CA
243316791$24331679$1$I$20240701$20240912$20240918$20240918$EXP$$US-JNJFOC-20240938776$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20240918$$CN$US$US
243316801$24331680$1$I$$20240904$20240918$20240918$30DAY$$TR-JNJFOC-20240931544$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$TR$TR
243316811$24331681$1$I$$20240830$20240918$20240918$PER$$US-TEVA-VS-3239528$TEVA$$28$YR$$F$Y$$$20240918$$CN$US$US
243316821$24331682$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5923834$ABBVIE$$73$YR$$M$Y$$$20240918$$HP$US$US
243316831$24331683$1$I$20240822$20240909$20240918$20240918$PER$$US-BIOGEN-2024BI01281738$BIOGEN$$11$YR$$$Y$$$20240918$$HP$US$US
243316841$24331684$1$I$20240101$20240912$20240918$20240918$EXP$$US-ABBVIE-5922135$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243316861$24331686$1$I$$20240916$20240918$20240918$PER$$US-ALXN-202409USA001174US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243316871$24331687$1$I$20240901$20240916$20240918$20240918$PER$$US-ALXN-202409USA001273US$ALEXION PHARMACEUTICALS$$80$YR$$F$Y$$$20240918$$CN$US$US
243316881$24331688$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010767$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243316891$24331689$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5923977$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243316901$24331690$1$I$$20240819$20240918$20240918$EXP$$US-Vifor (International) Inc.-VIT-2024-07677$VIFOR$$$$$F$Y$$$20240918$$HP$US$US
243316911$24331691$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010937$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243316921$24331692$1$I$$20240902$20240918$20240918$EXP$$GE-PBT-009677$PANACEA BIOTEC$Skalak HM, Haas K, Laub M, Mulloy LL. New Onset Diabetic Ketoacidosis in a Renal Transplant Recipient. Am J Med Sci. 2024 Aug 28:S0002-9629(24)01439-3. doi: 10.1016/j.amjms.2024.08.023.$38$YR$A$M$Y$$$20240913$$HP$GE$GE
243316931$24331693$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924949$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243316951$24331695$1$I$$20240917$20240918$20240918$PER$$US-ABBVIE-5928134$ABBVIE$$$$$$Y$$$20240918$$CN$US$US
243316961$24331696$1$I$20211119$20240909$20240918$20240918$EXP$PL-URPL-DML-MLP.4401.1.5051.2021$PL-TEVA-VS-3242040$TEVA$$49$YR$$$Y$100$KG$20240918$$MD$PL$PL
243316971$24331697$1$I$$20240915$20240918$20240918$EXP$$AU-GILEAD-2024-0687797$GILEAD$$$$$M$Y$$$20240918$$CN$AU$AU
243316981$24331698$1$I$20240301$20240912$20240918$20240918$EXP$$US-ABBVIE-5923529$ABBVIE$$64$YR$$M$Y$$$20240918$$CN$US$US
243316991$24331699$1$I$20240915$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185272$AMGEN$$75$YR$E$F$Y$$$20240918$$PH$US$US
243317001$24331700$1$I$$20240912$20240918$20240918$PER$$US-AMGEN-USASP2024184424$AMGEN$$6$YR$C$F$Y$$$20240918$$HP$US$US
243317012$24331701$2$F$20240916$20240916$20240918$20240925$30DAY$$US-ELI_LILLY_AND_COMPANY-US202409010258$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240925$$CN$US$US
243317021$24331702$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009922$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240918$$CN$US$US
243317031$24331703$1$I$20240913$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009977$ELI LILLY AND CO$$29$YR$A$$Y$$$20240918$$CN$US$US
243317041$24331704$1$I$20240915$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009739$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240918$$CN$US$US
243317051$24331705$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009795$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243317061$24331706$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010631$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240918$$CN$US$US
243317071$24331707$1$I$20240915$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010430$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240918$$CN$US$US
243317081$24331708$1$I$20240906$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009940$ELI LILLY AND CO$$$$$M$Y$$$20240918$$CN$US$US
243317091$24331709$1$I$20240913$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009935$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240918$$CN$US$US
243317101$24331710$1$I$$20240912$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008404$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243317111$24331711$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010400$ELI LILLY AND CO$$43$YR$A$$Y$$$20240918$$CN$US$US
243317121$24331712$1$I$$20240912$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009863$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243317131$24331713$1$I$20231001$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009873$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240918$$CN$US$US
243317141$24331714$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010243$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240918$$CN$US$US
243317151$24331715$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009855$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240918$$CN$US$US
243317162$24331716$2$F$$20240917$20240918$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010026$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240920$$CN$US$US
243317171$24331717$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009964$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240918$$CN$US$US
243317181$24331718$1$I$20240913$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010054$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240918$$CN$US$US
243317191$24331719$1$I$$20240913$20240918$20240918$PER$$US-HALEON-2197071$Haleon PLC$$$$$F$Y$$$20240918$$CN$US$US
243317201$24331720$1$I$$20240909$20240918$20240918$EXP$$GR-CELLTRION INC.-2024GR021924$CELLTRION$Syrmou V, Koutalos AA, Karapli M et al.. Giant Hip Synovial Cyst Causing Deep Vein Thrombosis and Femoral Head Osteonecrosis in a Rheumatoid Arthritis Patient. 3rd Panhellenic Summer Symposium on Musculoskeletal Health-Interactive Case Disc. 2023$$$$$Y$$$20240918$$HP$GR$GR
243317211$24331721$1$I$$20240906$20240918$20240918$EXP$$JP-IPCA LABORATORIES LIMITED-IPC-2024-JP-002221$IPCA$Tomohiro Saito, Yuuki Mima, Motonori Sugiyama et al.. Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility. CEN Case Reports. 2020;9:122-128$$$$$Y$$$20240918$$HP$JP$JP
243317221$24331722$1$I$20240901$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148023$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240918$$CN$US$US
243317231$24331723$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147566$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240918$$CN$US$US
243317241$24331724$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147299$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240918$$HP$US$US
243317261$24331726$1$I$$20240916$20240918$20240918$EXP$$CA-SANDOZ INC.-SDZ2024CA080709$SANDOZ$$63$YR$$M$Y$$$20240918$$CN$CA$CA
243317271$24331727$1$I$20240901$20240916$20240918$20240918$EXP$$US-TAKEDA-2024TUS088414$TAKEDA$$25$YR$$M$Y$$$20240918$$MD$US$US
243317281$24331728$1$I$$20240909$20240918$20240918$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024006748$BIOCON$$$$$$Y$$$20240918$$CN$AU$AU
243317291$24331729$1$I$$20240916$20240918$20240918$PER$$US-ALXN-202409USA001274US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243317311$24331731$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001287US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243317321$24331732$1$I$20240905$20240910$20240918$20240918$EXP$$CN-AstraZeneca-2024A213297$ASTRAZENECA$$33$YR$$M$Y$75$KG$20240918$$MD$CN$
243317331$24331733$1$I$20240913$20240913$20240918$20240918$PER$$US-AstraZeneca-2024A210718$ASTRAZENECA$$26458$DY$$F$Y$$$20240918$$CN$US$
243317341$24331734$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211959$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243317351$24331735$1$I$$20240917$20240918$20240918$EXP$$ZA-AstraZeneca-2024A212695$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$ZA$
243317361$24331736$1$I$$20240911$20240918$20240918$EXP$$US-TAKEDA-US202006033$TAKEDA$$$$$M$Y$75$KG$20240918$$HP$US$US
243317381$24331738$1$I$$20240913$20240918$20240918$PER$$US-AstraZeneca-2024A210638$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243317391$24331739$1$I$$20240916$20240918$20240918$EXP$$CZ-SANDOZ INC.-NVSC2022CZ108791$SANDOZ$$56$YR$$F$Y$$$20240918$$HP$CZ$CZ
243317401$24331740$1$I$20240711$20240917$20240918$20240918$EXP$$ES-AstraZeneca-2024A212016$ASTRAZENECA$$46$YR$$F$Y$$$20240918$$MD$ES$
243317411$24331741$1$I$$20240916$20240918$20240918$EXP$$GB-SANDOZ INC.-NVSC2021GB240522$SANDOZ$$$$A$M$Y$$$20240918$$CN$GB$GB
243317421$24331742$1$I$20240528$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211836$ASTRAZENECA$$31933$DY$$M$Y$$$20240918$$CN$US$
243317431$24331743$1$I$$20240913$20240918$20240918$EXP$$JP-AstraZeneca-2024A211273$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$JP$
243317441$24331744$1$I$$20240912$20240918$20240918$EXP$$CA-AstraZeneca-2024A212367$ASTRAZENECA$$65$YR$$F$Y$$$20240918$$MD$CA$
243317471$24331747$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A210120$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243317481$24331748$1$I$20240808$20240912$20240918$20240918$EXP$$JP-GILEAD-2024-0687447$GILEAD$$102$YR$E$M$Y$$$20240918$$PH$JP$JP
243317491$24331749$1$I$20240611$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212495$ASTRAZENECA$$26638$DY$$M$Y$$$20240918$$CN$US$
243317501$24331750$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212592$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243317511$24331751$1$I$20240916$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185530$AMGEN$$$$$M$Y$$$20240918$$CN$US$US
243317521$24331752$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212532$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243317541$24331754$1$I$$20240917$20240918$20240918$PER$$US-AstraZeneca-2024A212754$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243317551$24331755$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A213256$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243317562$24331756$2$F$20240501$20240919$20240918$20240923$EXP$$US-ABBVIE-5926673$ABBVIE$$66$YR$$M$Y$97$KG$20240923$$CN$US$US
243317571$24331757$1$I$$20240909$20240918$20240918$EXP$$US-862174955-ML2024-04866$MICRO LABS$$80$YR$E$F$Y$63.5$KG$20240918$$CN$US$US
243317581$24331758$1$I$$20240909$20240918$20240918$EXP$$US-862174955-ML2024-04865$Unknown Manufacturer$$$$$M$Y$$$20240918$$CN$US$US
243317591$24331759$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010768$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243317601$24331760$1$I$20240915$20240917$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148305$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240918$$CN$US$US
243317611$24331761$1$I$$20240910$20240918$20240918$EXP$$US-TAKEDA-2024TUS090985$TAKEDA$$$$$M$Y$$$20240918$$MD$US$US
243317621$24331762$1$I$$20240916$20240918$20240918$EXP$$AU-SANDOZ INC.-SDZ2024AU080588$SANDOZ$$76$YR$$M$Y$$$20240918$$MD$AU$AU
243317631$24331763$1$I$20240701$20240913$20240918$20240918$EXP$$US-ABBVIE-5925661$ABBVIE$$23$YR$$F$Y$$$20240918$$CN$US$US
243317641$24331764$1$I$20240801$20240906$20240918$20240918$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000364$Unknown Manufacturer$$$$$$Y$$$20240918$$CN$US$US
243317651$24331765$1$I$$20240713$20240918$20240918$PER$$US-ROCHE-10000027616$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243317661$24331766$1$I$$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013449$DR REDDYS$Ward J, Portnof J, Barreto V, Freedman P, Reich R, Kerpel S. Two cases of imatinib induced oral pigmentation affecting the palate. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2024;138(4): e79-e84. doi:10.1016/j.oooo.2024.03.010.$69$YR$E$F$Y$$$20240918$$HP$US$US
243317671$24331767$1$I$$20240910$20240918$20240918$PER$US-MLMSERVICE-20240903-PI179947-00117-1$US-RDY-SPO/USA/24/0013347$DR REDDYS$Satma JN, Moradi I, Khachik L, Saad G, Gonzalez C. Intersecting Pathologies: A Case Report on the Co-presentation of Quasi-Moyamoya Disease and Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Plasma Cell Disorder, and Skin Changes (POEMS) Syndrome. Cureus. 2024;16(8):e65934. DOI:10.7759/cureus.65934.$54$YR$A$M$Y$$$20240918$$MD$US$US
243317702$24331770$2$F$20240906$20240919$20240918$20240926$EXP$$US-ABBVIE-5925308$ABBVIE$$73$YR$$M$Y$65.77$KG$20240926$$CN$US$US
243317711$24331771$1$I$20240101$20240910$20240918$20240918$PER$$US-ABBVIE-5921353$ABBVIE$$$$$$Y$$$20240918$$MD$US$US
243317721$24331772$1$I$20240903$20240913$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US080796$SANDOZ$$$$$$Y$$$20240918$$MD$US$US
243317731$24331773$1$I$20240916$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185901$AMGEN$$$$$M$Y$$$20240918$$CN$US$US
243317741$24331774$1$I$$20240906$20240918$20240918$EXP$$ES-Accord-446092$ACCORD$Cantero AB, Nunez ML, Luis GR, Lucena CR, Rueda JR. NON-INFECTIOUS FEVER. ABOUT A CASE. European Journal of Case Reports in Internal Medicine. 2024;11(Supplement 1):915.$62$YR$A$F$Y$$$20240918$$MD$ES$ES
243317751$24331775$1$I$$20240909$20240918$20240918$30DAY$$US-GSK-US2024112039$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243317761$24331776$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010841$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243317771$24331777$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010816$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243317781$24331778$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5925258$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243317791$24331779$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010851$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243317801$24331780$1$I$$20240913$20240918$20240918$PER$$US-BIOVITRUM-2024-US-012097$BIOVITRUM$$74$YR$$F$Y$$$20240918$$CN$US$US
243317811$24331781$1$I$$20240911$20240918$20240918$EXP$$JP-AMGEN-JPNSP2024182412$AMGEN$$$$$$Y$$$20240918$$PH$JP$JP
243317821$24331782$1$I$$20240916$20240918$20240918$EXP$DE-AMGEN-DEUSP2024175347$DE-SANDOZ INC.-SDZ2024DE080886$SANDOZ$$53$YR$$F$Y$$$20240918$$MD$DE$DE
243317832$24331783$2$F$20240912$20240912$20240918$20240922$PER$$US-AMGEN-USASP2024183456$AMGEN$$55$YR$A$M$Y$$$20240922$$MD$US$US
243317841$24331784$1$I$$20240912$20240918$20240918$EXP$$CO-AMGEN-COLSL2024164146$AMGEN$$87$YR$E$F$Y$$$20240918$$CN$CO$CO
243317851$24331785$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001306US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240918$$HP$US$US
243317861$24331786$1$I$20240510$20240916$20240918$20240918$EXP$$CO-GILEAD-2024-0687413$GILEAD$$$$$M$Y$$$20240918$$MD$CO$CO
243317881$24331788$1$I$$20240906$20240918$20240918$EXP$$JP-IPCA LABORATORIES LIMITED-IPC-2024-JP-002222$IPCA$Tomohiro Saito, Yuuki Mima, Motonori Sugiyama et al.. Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility. CEN Case Reports. 2020;9:122-128$$$$$Y$$$20240918$$HP$JP$JP
243317891$24331789$1$I$20240802$20240910$20240918$20240918$EXP$$US-BIOGEN-2024BI01282059$BIOGEN$$62$YR$$F$Y$$$20240918$$CN$US$US
243317901$24331790$1$I$20240907$20240910$20240918$20240918$EXP$$CN-JNJFOC-20240941142$JOHNSON AND JOHNSON$$4$YR$C$M$Y$15$KG$20240918$$HP$CN$CN
243317913$24331791$3$F$20240917$20240926$20240918$20240928$PER$$US-AMGEN-USASP2024185748$AMGEN$$83$YR$E$F$Y$$$20240928$$CN$US$US
243317921$24331792$1$I$$20240906$20240918$20240918$EXP$$GB-Accord-446095$ACCORD$Thiha A, Rai B, Bachrati P, Lawrence J, Clynes M. A PUZZLE OF A FEBRILE LADY. European Journal of Case Reports in Internal Medicine. 2024;11(Supplement 1):1029.$64$YR$A$F$Y$$$20240918$$MD$GB$GB
243317931$24331793$1$I$$20240911$20240918$20240918$EXP$$US-RDY-SPO/USA/24/0013456$DR REDDYS$$64$YR$A$$Y$$$20240918$$HP$US$US
243317941$24331794$1$I$20240910$20240911$20240918$20240918$EXP$GB-MHRA-MED-202409110838475070-FNRBT$GB-RDY-SPO/GBR/24/0013422$DR REDDYS$$53$YR$A$F$Y$$$20240918$$HP$GB$GB
243317952$24331795$2$F$20240904$20240913$20240918$20240923$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27747$SAMSUNG BIOEPIS$$48$YR$A$F$Y$$$20240923$$CN$CA$CA
243317961$24331796$1$I$20240306$20240911$20240918$20240918$EXP$$JP-ABBVIE-5704948$ABBVIE$$77$YR$$F$Y$$$20240918$$MD$JP$JP
243317971$24331797$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010852$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243317981$24331798$1$I$$20240911$20240918$20240918$EXP$$GB-009507513-2409GBR004615$MERCK$Platt J, Allotey J, Alouani E, Glasbey J, Intini R, Lonardi S, et al. Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series. ESMO Open. 2024;9(9)$66$YR$$F$Y$$$20240918$$MD$GB$GB
243317991$24331799$1$I$$20240911$20240918$20240918$EXP$$US-AstraZeneca-2024A208056$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$US$
243318011$24331801$1$I$$20240906$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045223$AUROBINDO$$$$A$M$Y$$$20240918$$CN$FR$FR
243318021$24331802$1$I$$20240917$20240918$20240918$EXP$$CN-AstraZeneca-2024A212245$ASTRAZENECA$Li X, Luan X, Zhang M, Wang R, Guo J, Lv J, Qiu W and Zhao S. Potential therapeutic option for EGFR-mutant small cell lung cancer transformation: a case report and literature review. Front. Immunol. 2024;15(1439033):$68$YR$$F$Y$$$20240918$$HP$CN$
243318031$24331803$1$I$$20240904$20240918$20240918$PER$$US-AstraZeneca-2024A166877$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243318041$24331804$1$I$$20240917$20240918$20240918$EXP$$SK-AstraZeneca-2024A212996$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$SK$
243318051$24331805$1$I$$20240917$20240918$20240918$EXP$$CN-AstraZeneca-2024A213141$ASTRAZENECA$Yang Z., Lin Y., Wang H.. Transformation of non-small cell lung cancer into small cell lung cancer in a patient with advanced lung cancer: a case report. Journal of International Medical Research 2021;49(8):1-6.$57$YR$$M$Y$$$20240918$$HP$CN$
243318061$24331806$1$I$20140301$20240913$20240918$20240918$PER$$US-JNJFOC-20240940330$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240918$$HP$US$US
243318071$24331807$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212964$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243318081$24331808$1$I$20240425$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212348$ASTRAZENECA$$32164$DY$$M$Y$$$20240918$$MD$US$
243318091$24331809$1$I$$20240914$20240918$20240918$EXP$$CA-AstraZeneca-2024A212538$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$CA$
243318101$24331810$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A212024$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243318111$24331811$1$I$20240912$20240913$20240918$20240918$EXP$$JP-AstraZeneca-2024A211591$ASTRAZENECA$$75$YR$$M$Y$$$20240918$$MD$JP$
243318121$24331812$1$I$20240521$20240911$20240918$20240918$EXP$$MX-AstraZeneca-2024A182806$ASTRAZENECA$$13$YR$T$M$Y$44$KG$20240918$$CN$MX$
243318131$24331813$1$I$20240502$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A140572$ASTRAZENECA$$22614$DY$$F$Y$$$20240918$$MD$US$
243318141$24331814$1$I$$20240911$20240918$20240918$EXP$$US-AstraZeneca-2024A208176$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243318151$24331815$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009710$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240918$$CN$US$US
243318161$24331816$1$I$20230101$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009985$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240918$$CN$US$US
243318171$24331817$1$I$20240801$20240912$20240918$20240918$PER$$AU-REGENERON PHARMACEUTICALS, INC.-2024-124867$REGENERON$$84$YR$$M$Y$$$20240918$$CN$AU$AU
243318181$24331818$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010097$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240918$$CN$US$US
243318191$24331819$1$I$20240726$20240916$20240918$20240918$EXP$FR-AFSSAPS-RN2024000962$FR-UCBSA-2024047400$UCB$$75$YR$$M$Y$$$20240918$$MD$FR$FR
243318201$24331820$1$I$20151201$20240905$20240918$20240918$EXP$$US-COOPERSURGICAL, INC.-2024CPS002752$COOPERSURGICAL$$$$$F$Y$$$20240918$$LW$US$US
243318211$24331821$1$I$20210901$20240905$20240918$20240918$EXP$$US-COOPERSURGICAL, INC.-2024CPS002751$COOPERSURGICAL$$$$$F$Y$$$20240918$$LW$US$US
243318221$24331822$1$I$20141001$20240905$20240918$20240918$EXP$$US-COOPERSURGICAL, INC.-2024CPS002739$COOPERSURGICAL$$$$$F$Y$$$20240918$$LW$US$US
243318231$24331823$1$I$20200901$20240905$20240918$20240918$EXP$$US-COOPERSURGICAL, INC.-2024CPS002720$COOPERSURGICAL$$$$$F$Y$$$20240918$$LW$US$US
243318241$24331824$1$I$20220713$20240910$20240918$20240918$EXP$$CA-TAKEDA-2024TUS009675$TAKEDA$$64$YR$$F$Y$81.6$KG$20240918$$CN$CA$CA
243318251$24331825$1$I$20240729$20240906$20240918$20240918$EXP$LU-ALMPS-202404298$LU-Accord-446154$ACCORD$$69$YR$E$M$Y$77$KG$20240918$$PH$LU$LU
243318261$24331826$1$I$$20240911$20240918$20240918$EXP$$BR-CHEPLA-2024011761$CHEPLAPHARM$$$$$F$Y$$$20240918$$CN$COUNTRY NOT SPECIFIED$BR
243318272$24331827$2$F$$20240914$20240918$20240919$PER$$NVSC2024US184502$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
243318281$24331828$1$I$20240911$20240916$20240918$20240918$EXP$$US-ABBVIE-5927293$ABBVIE$$76$YR$$M$Y$$$20240918$$CN$US$US
243318291$24331829$1$I$20240828$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185595$AMGEN$$72$YR$E$F$Y$$$20240918$$CN$US$US
243318301$24331830$1$I$$20240916$20240918$20240918$PER$$US-ALXN-202409USA001192US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243318311$24331831$1$I$20240916$20240916$20240918$20240918$PER$$US-ALXN-202409USA001307US$ALEXION PHARMACEUTICALS$$8$YR$$F$Y$23.178$KG$20240918$$CN$US$US
243318321$24331832$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001346US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243318331$24331833$1$I$$20240904$20240918$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-046145$AUROBINDO$Basak GW, Wiktor-jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. American Journal of Transplantation. 2015;15:705?714$9$YR$$F$Y$$$20240918$$HP$PL$PL
243318341$24331834$1$I$$20231218$20240918$20240918$PER$$US-ENDO USA, INC.-2024-000054$ENDO$$$$$M$Y$$$20240918$$LW$US$US
243318351$24331835$1$I$20240911$20240911$20240918$20240918$30DAY$$US-GSK-US2024113042$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240918$$CN$US$US
243318361$24331836$1$I$20240101$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409060814270460-MWQVD$GB-Accord-445662$ACCORD$$45$YR$A$F$Y$47$KG$20240918$$CN$GB$GB
243318371$24331837$1$I$$20240906$20240918$20240918$EXP$$SE-AUROBINDO-AUR-APL-2024-045183$AUROBINDO$$59$YR$$F$Y$$$20240918$$MD$SE$SE
243318381$24331838$1$I$$20240713$20240918$20240918$PER$$US-ROCHE-10000029916$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243318391$24331839$1$I$$20240904$20240918$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-045290$AUROBINDO$Basak GW, Wiktor-jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. American Journal of Transplantation. 2015;15:705?714$41$YR$$M$Y$$$20240918$$HP$PL$PL
243318401$24331840$1$I$$20240909$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013450$DR REDDYS$Ward J, Portnof J, Barreto V, Freedman P, Reich R, Kerpel S. Two cases of imatinib induced oral pigmentation affecting the palate. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2024;138(4): e79-e84. doi:10.1016/j.oooo.2024.03.010.$69$YR$E$F$Y$$$20240918$$HP$US$US
243318411$24331841$1$I$$20240910$20240918$20240918$EXP$$CA-TAKEDA-2024TUS080704$TAKEDA$$$$$M$Y$$$20240918$$CN$CA$CA
243318421$24331842$1$I$20240910$20240911$20240918$20240918$EXP$$CO-BIOVITRUM-2024-CO-012145$BIOVITRUM$$46$DY$$F$Y$3.1$KG$20240918$$CN$CO$CO
243318431$24331843$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010817$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243318441$24331844$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010769$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243318451$24331845$1$I$$20240905$20240918$20240918$EXP$$JP-UCBSA-2024046247$UCB$$8$DEC$$M$Y$$$20240918$$PH$JP$JP
243318471$24331847$1$I$$20240910$20240918$20240918$EXP$$CA-TAKEDA-2024TUS090818$TAKEDA$$$$$F$Y$$$20240918$$MD$CA$CA
243318481$24331848$1$I$20240423$20240906$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045276$AUROBINDO$$50$YR$$F$Y$$$20240918$$MD$FR$FR
243318501$24331850$1$I$20230730$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409061425441910-NPQTV$GB-Accord-445710$ACCORD$$7$YR$C$F$Y$$$20240918$$CN$GB$GB
243318511$24331851$1$I$20240907$20240909$20240918$20240918$30DAY$$US-GSK-US2024112014$GLAXOSMITHKLINE$$52$YR$$F$Y$$$20240918$$CN$US$US
243318521$24331852$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010853$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243318531$24331853$1$I$20240101$20240913$20240918$20240918$EXP$$EG-SANDOZ INC.-NVSC2023EG044651$SANDOZ$$10$YR$$F$Y$$$20240918$$CN$EG$EG
243318541$24331854$1$I$$20240906$20240918$20240918$EXP$$BG-Accord-445787$ACCORD$IVANOV KZ, Malignant ascites and place of peritoneal tunnel catheters in their treatment. Journal of the Bulgarian Oncological Scientific Society/Journal of Bulgarian Cancer Scientific Society, 2024/2, pg: 3-45.$64$YR$A$F$Y$$$20240918$$MD$BG$BG
243318551$24331855$1$I$20240410$20240913$20240918$20240918$EXP$ES-AEMPS-1567931$ES-VIIV HEALTHCARE LIMITED-ES2024114182$VIIV$$$$$$Y$$$20240918$$PH$ES$ES
243318561$24331856$1$I$$20240911$20240918$20240918$EXP$$CA-GSK-CA2024101858$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$CA$CA
243318571$24331857$1$I$20240828$20240829$20240918$20240918$EXP$$US-SA-2024SA267757$SANOFI AVENTIS$$26$YR$A$F$Y$170$KG$20240918$$MD$US$US
243318581$24331858$1$I$$20240904$20240918$20240918$EXP$$US-BECTON DICKINSON-US-BD-24-000528$BECTON DICKINSON$Hansen LM, Lindahl AC, Eller EB, Day CS.. Cutibacterium acnes Infection as a Cause of Nonunion After Ulnar-Shortening Osteotomy. Orthopedics. 2024;47(4):211-213$51$YR$$M$Y$$$20240918$$MD$US$US
243318601$24331860$1$I$$20240913$20240918$20240918$EXP$$CA-TAKEDA-2024TUS092379$TAKEDA$$$$$F$Y$$$20240918$$CN$CA$CA
243318611$24331861$1$I$$20240909$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011824$STRIDES$Lester SC, Johnson EF, Breen WG, Khurana A.. Taming the Lion: A Report of Pencil Beam Scanning Proton Therapy for Severe Leonine Facies.  ; 9 (9):.. Adv-Radiat-Oncol. 2024;9 (9)$$$$$Y$$$20240918$$MD$US$US
243318631$24331863$1$I$$20240906$20240918$20240918$EXP$$US-IPCA LABORATORIES LIMITED-IPC-2024-US-002218$IPCA$Megan C. Smith , Evan Gleaves , Aniruddha Singh et al.. Anticoagulation in a patient with mechanical prosthetic valves and calcific uremic arteriolopathy on warfarin. Cureus. 2021;13 (3):1-4$$$$$Y$$$20240918$$HP$US$US
243318651$24331865$1$I$$20240915$20240918$20240918$EXP$$US-GILEAD-2024-0687731$GILEAD$$$$A$M$Y$$$20240918$$CN$US$US
243318661$24331866$1$I$$20240913$20240918$20240918$EXP$$UA-ROCHE-10000082892$ROCHE$$62$YR$A$M$Y$$$20240918$$MD$UA$UA
243318671$24331867$1$I$$20240914$20240918$20240918$PER$$US-ABBVIE-5927108$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243318681$24331868$1$I$20240501$20240910$20240918$20240918$EXP$FR-AFSSAPS-SE2024000683$FR-TEVA-VS-3242689$TEVA$$78$YR$$M$Y$$$20240918$$MD$FR$FR
243318691$24331869$1$I$$20240906$20240918$20240918$EXP$$CN-ROCHE-10000076453$ROCHE$$54$YR$A$F$Y$$$20240918$$CN$CN$CN
243318711$24331871$1$I$$20240913$20240918$20240918$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005116$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$US$US
243318741$24331874$1$I$$20240911$20240918$20240918$EXP$$US-TAKEDA-2024TUS091264$TAKEDA$$$$$F$Y$$$20240918$$CN$US$US
243318751$24331875$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185005$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243318761$24331876$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010955$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243318771$24331877$1$I$20240101$20240913$20240918$20240918$EXP$$US-JNJFOC-20240939885$JOHNSON AND JOHNSON$$3$DEC$A$$Y$$$20240918$$HP$US$US
243318781$24331878$1$I$20240828$20240913$20240918$20240918$EXP$$PE-JNJFOC-20240941765$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240918$$CN$PE$PE
243318791$24331879$1$I$$20240911$20240918$20240918$PER$$US-JNJFOC-20240933849$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243318802$24331880$2$F$$20240923$20240918$20240930$EXP$$US-TEVA-VS-3243028$TEVA$Wright B, Moore A, Becker-Weidman D, Joyce D. Primary B cell lymphoma of the patella presenting as anterior knee pain: A case report. J-Orthop 2024; 48 60-63.; Wright B, Moore A, Becker-Weidman D, Joyce D. Primary B cell lymphoma of the patella presenting as anterior knee pain: A case report. J-Orthop 2024; 48 60-63.$76$YR$$F$Y$$$20240930$$HP$US$US
243318811$24331881$1$I$$20240904$20240918$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-045297$AUROBINDO$Basak GW, Wiktor-jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. American Journal of Transplantation. 2015;15:705?714$50$YR$$F$Y$$$20240918$$HP$PL$PL
243318821$24331882$1$I$20220201$20240905$20240918$20240918$EXP$$DE-UCBSA-2024045911$UCB$$$$$M$Y$$$20240918$$MD$DE$DE
243318832$24331883$2$F$$20240910$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011737$STRIDES$Jahshan B, Owczarczyk A B, Daw H, et al.. A Case of Secondary Hemophagocytic Lymphohistiocytosis in a Patient With T-cell Lymphoma.. Cureus. 2024;16(3):e56558$$$$$Y$$$20240918$$HP$US$US
243318841$24331884$1$I$20240101$20240718$20240918$20240918$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110172$ZYDUS PHARM$$$$$$Y$$$20240918$$CN$US$US
243318851$24331885$1$I$20240101$20240715$20240918$20240918$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110100$ZYDUS PHARM$$$$$$Y$$$20240918$$CN$US$US
243318861$24331886$1$I$20240101$20240715$20240918$20240918$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109960$ZYDUS PHARM$$$$$$Y$$$20240918$$CN$US$US
243318871$24331887$1$I$20240101$20240711$20240918$20240918$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109869$ZYDUS PHARM$$$$$$Y$$$20240918$$HP$US$US
243318881$24331888$1$I$20240101$20240712$20240918$20240918$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109868$ZYDUS PHARM$$$$$$Y$$$20240918$$CN$US$US
243318891$24331889$1$I$$20240904$20240918$20240918$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111997$ZYDUS PHARM$Hennen M-A, Zhang V, Opler DJ.. An unwelcome side-effect of trazodone use in a trans-male.. Psychiatr-Clin-Neurosci. 2024;78(6):376.$$$$$Y$$$20240918$$HP$US$US
243318901$24331890$1$I$$20240712$20240918$20240918$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109866$ZYDUS PHARM$$$$$$Y$$$20240918$$CN$US$US
243318911$24331891$1$I$20240818$20240909$20240918$20240918$EXP$FR-AFSSAPS-AN2024001208$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112107$ZYDUS PHARM$$$$$$Y$$$20240918$$MD$FR$FR
243318921$24331892$1$I$20240827$20240909$20240918$20240918$EXP$FR-AFSSAPS-AN2024001223$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112092$ZYDUS PHARM$$$$$$Y$$$20240918$$MD$FR$FR
243318932$24331893$2$F$$20240923$20240918$20240930$EXP$$CA-TEVA-VS-3243214$TEVA$Scarffe LA, Chen T, Traboulsee AL. Safety of Tocilizumab in the Treatment of COVID-19-Related Longitudinally Extensive Transverse Myelitis. Can-J-Neurol-Sci 2024; 51 (3): 466-468.; Scarffe LA, Chen T, Traboulsee AL. Safety of Tocilizumab in the Treatment of COVID-19-Related Longitudinally Extensive Transverse Myelitis. Can-J-Neurol-Sci 2024; 51 (3): 466-468.; Scarffe LA, Chen T, Traboulsee AL. Safety of Tocilizumab in the Treatment of COVID-19-Related Longitudinally Extensive Transverse Myeli...$41$YR$$M$Y$$$20240930$$HP$CA$CA
243318941$24331894$1$I$$20240911$20240918$20240918$EXP$$CO-ROCHE-10000083646$ROCHE$$46$YR$A$F$Y$54$KG$20240918$$CN$CO$CO
243318951$24331895$1$I$$20240904$20240918$20240918$EXP$$CA-AUROBINDO-AUR-APL-2023-063899$AUROBINDO$Kwan C, Kolivakis T, Huot P. Dopamine Agonist Withdrawal Syndrome and Suicidality in Parkinson^s Disease. Canadian Journal of Neurological Sciences. 2023;50(5):779-80$42$YR$$M$Y$$$20240918$$MD$CA$CA
243318961$24331896$1$I$$20240912$20240918$20240918$EXP$$US-AMGEN-USASP2024183040$AMGEN$$$$$F$Y$$$20240918$$HP$US$US
243318971$24331897$1$I$$20240916$20240918$20240918$EXP$$US-GILEAD-2024-0687974$GILEAD$$$$A$F$Y$$$20240918$$CN$US$US
243318982$24331898$2$F$20240801$20240918$20240918$20240922$EXP$$US-ABBVIE-5920495$ABBVIE$$81$YR$$F$Y$47.627$KG$20240922$$CN$US$US
243318991$24331899$1$I$$20240910$20240918$20240918$EXP$$IN-ROCHE-10000082910$ROCHE$$$$A$F$Y$$$20240918$$CN$IN$IN
243319001$24331900$1$I$$20240909$20240918$20240918$EXP$$US-ROCHE-10000078089$ROCHE$$76$YR$E$M$Y$$$20240918$$CN$US$US
243319012$24331901$2$F$20230601$20240911$20240918$20240925$EXP$$US-ABBVIE-5647151$ABBVIE$$65$YR$$F$Y$54.431$KG$20240925$$CN$US$US
243319023$24331902$3$F$20240101$20240923$20240918$20240925$PER$$US-BIOGEN-2024BI01282840$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243319031$24331903$1$I$20230222$20240909$20240918$20240918$EXP$$CA-TAKEDA-2024TUS090470$TAKEDA$$70$YR$$M$Y$$$20240918$$CN$CA$CA
243319051$24331905$1$I$20240901$20240916$20240918$20240918$PER$$US-BIOGEN-2024BI01282750$BIOGEN$$71$YR$$F$Y$$$20240918$$CN$US$US
243319061$24331906$1$I$$20240913$20240918$20240918$PER$$US-BIOGEN-2024BI01282576$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
243319071$24331907$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009960$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240918$$CN$US$US
243319081$24331908$1$I$$20240911$20240918$20240918$EXP$$VN-ROCHE-10000081936$ROCHE$$40$YR$A$M$Y$$$20240918$$MD$VN$VN
243319101$24331910$1$I$$20240815$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010582$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243319111$24331911$1$I$$20240704$20240918$20240918$PER$$US-ROCHE-10000018973$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243319121$24331912$1$I$$20240916$20240918$20240918$PER$$PR-ABBVIE-5926391$ABBVIE$$$$E$$Y$$$20240918$$CN$PR$PR
243319131$24331913$1$I$20160329$20240905$20240918$20240918$EXP$$ES-AUROBINDO-AUR-APL-2017-44089$AUROBINDO$$72$YR$$F$Y$$$20240918$$MD$ES$ES
243319141$24331914$1$I$20240101$20240912$20240918$20240918$PER$$US-BIOGEN-2024BI01282723$BIOGEN$$$$$F$Y$$$20240918$$MD$US$US
243319151$24331915$1$I$20240101$20240905$20240918$20240918$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01674$AVADEL CNS PHARMA$$$$$M$Y$$$20240918$$CN$US$US
243319161$24331916$1$I$$20240916$20240918$20240918$PER$$US-HALEON-2197221$Haleon PLC$$$$$$Y$$$20240918$$CN$US$US
243319171$24331917$1$I$$20240916$20240918$20240918$EXP$$US-ABBVIE-5926801$ABBVIE$$$$$M$Y$$$20240918$$HP$US$US
243319181$24331918$1$I$$20240910$20240918$20240918$EXP$$CA-TOLMAR, INC.-24CA050785$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
243319201$24331920$1$I$$20240910$20240918$20240918$EXP$$CA-TOLMAR, INC.-24CA052522$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
243319211$24331921$1$I$$20240910$20240918$20240918$EXP$$AU-TOLMAR, INC.-24AU052532$TOLMAR$$$$$M$Y$$$20240918$$CN$AU$AU
243319222$24331922$2$F$$20240916$20240918$20240920$PER$$US-JNJFOC-20240938446$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
243319231$24331923$1$I$$20240908$20240918$20240918$EXP$$GB-JNJFOC-20240942452$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20240918$$HP$GB$GB
243319241$24331924$1$I$$20240910$20240918$20240918$EXP$$JP-EXELIXIS-EXL-2024-000170$EXELIXIS$$56$YR$$M$Y$$$20240918$$MD$JP$JP
243319251$24331925$1$I$$20240916$20240918$20240918$EXP$$SA-GILEAD-2024-0687818$GILEAD$$$$A$M$Y$$$20240918$$MD$SA$SA
243319261$24331926$1$I$20240101$20240915$20240918$20240918$EXP$$GR-ABBVIE-5925895$ABBVIE$$$$$F$Y$$$20240918$$CN$GR$GR
243319271$24331927$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001315US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243319281$24331928$1$I$$20240911$20240918$20240918$EXP$NL-LRB-01000436$NL-TEVA-VS-3242879$TEVA$$38$YR$$M$Y$85$KG$20240918$$MD$NL$NL
243319291$24331929$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001308US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243319301$24331930$1$I$20240916$20240917$20240918$20240918$PER$$US-ALXN-202409USA001310US$ALEXION PHARMACEUTICALS$$$$$F$Y$38.095$KG$20240918$$CN$US$US
243319311$24331931$1$I$$20240830$20240918$20240918$PER$$US-TEVA-VS-3241205$TEVA$$$$$F$Y$$$20240918$$CN$US$US
243319322$24331932$2$F$$20240912$20240918$20240918$PER$$US-ROCHE-3490476$ROCHE$$$$E$F$Y$$$20240918$$CN$US$US
243319331$24331933$1$I$20240514$20240910$20240918$20240918$EXP$FR-AFSSAPS-NC2024001046$FR-TEVA-VS-3242601$TEVA$$17$YR$$F$Y$$$20240918$$MD$FR$FR
243319341$24331934$1$I$20240101$20240914$20240918$20240918$EXP$$US-ABBVIE-5892001$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243319351$24331935$1$I$20240624$20240916$20240918$20240918$EXP$$GB-ABBVIE-5926120$ABBVIE$$80$YR$$M$Y$$$20240918$$HP$GB$GB
243319361$24331936$1$I$20240101$20240904$20240918$20240918$EXP$$US-INSMED, INC.-2024-03574-US$INSMED$$$$$M$Y$$$20240918$$CN$US$US
243319372$24331937$2$F$20240915$20240916$20240918$20240920$EXP$$DE-ABBVIE-5925871$ABBVIE$$77$YR$$F$Y$$$20240920$$MD$DE$DE
243319381$24331938$1$I$$20240905$20240918$20240918$EXP$$IN-Nexus Pharma-000308$NEXUS PHARMACEUTICALS$Sebastian B, Ganesan V, Sebastian P. Tirofiban-induced diffuse alveolar haemorrhage. BMJ Case Rep. 2024 Aug 29;17(8):e256335.$$$$M$Y$$$20240918$$HP$IN$IN
243319391$24331939$1$I$$20240905$20240918$20240918$EXP$$US-CIPLA LTD.-2024US09923$CIPLA$Zou H, Rau A, Thompson L, Henderson D.. Pancytopenia concurrent with metabolic encephalopathy. Cureus. 2024;16(8):e67963$$$$$Y$$$20240918$$MD$US$US
243319401$24331940$1$I$$20240912$20240918$20240918$EXP$$FR-SANDOZ INC.-SDZ2024FR079823$SANDOZ$$37$YR$$F$Y$$$20240918$$HP$FR$FR
243319411$24331941$1$I$20190101$20240905$20240918$20240918$EXP$$GB-CIPLA LTD.-2024GB09882$CIPLA$$$$$$Y$$$20240918$$CN$GB$GB
243319422$24331942$2$F$20231201$20240910$20240918$20240925$EXP$$CN-ROCHE-10000079518$ROCHE$$$$$F$Y$$$20240925$$MD$CN$CN
243319431$24331943$1$I$20240101$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184857$AMGEN$$35$YR$A$F$Y$77.098$KG$20240918$$CN$US$US
243319441$24331944$1$I$$20240911$20240918$20240918$EXP$$GB-ROCHE-10000080695$ROCHE$$64$YR$A$F$Y$$$20240918$$HP$GB$GB
243319451$24331945$1$I$20120101$20240912$20240918$20240918$PER$$US-BIOGEN-2015BI039376$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
243319461$24331946$1$I$20221130$20240911$20240918$20240918$EXP$$US-SA-2024SA254892$SANOFI AVENTIS$$52$YR$A$M$Y$79.2$KG$20240918$$HP$US$US
243319472$24331947$2$F$20240910$20240918$20240918$20240919$PER$$US-AMGEN-USASP2024185519$AMGEN$$74$YR$E$F$Y$$$20240919$$CN$US$US
243319491$24331949$1$I$20240818$20240916$20240918$20240918$EXP$ES-AEMPS-1566791$ES-JNJFOC-20240944138$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240918$$MD$ES$ES
243319503$24331950$3$F$$20240918$20240918$20240923$PER$$US-JNJFOC-20240939863$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240923$$HP$US$US
243319511$24331951$1$I$$20240828$20240918$20240918$PER$$US-JNJFOC-20240876333$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$CN$US$US
243319521$24331952$1$I$20240801$20240916$20240918$20240918$EXP$$US-ABBVIE-5926984$ABBVIE$$70$YR$$M$Y$$$20240918$$CN$US$US
243319531$24331953$1$I$$20240906$20240918$20240918$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17944$IPSEN$$$$$M$Y$$$20240918$$MD$US$US
243319541$24331954$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5925356$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243319551$24331955$1$I$20240828$20240911$20240918$20240918$EXP$$IT-AUROBINDO-AUR-APL-2024-045668$AUROBINDO$$54$YR$$M$Y$69$KG$20240918$$MD$IT$IT
243319561$24331956$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS092002$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240918$$MD$US$US
243319571$24331957$1$I$$20240910$20240918$20240918$EXP$$GB-ROCHE-10000079730$ROCHE$$38$YR$A$F$Y$$$20240918$$MD$GB$GB
243319581$24331958$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924568$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243319591$24331959$1$I$$20240913$20240918$20240918$EXP$$CA-ABBVIE-5924341$ABBVIE$$$$A$M$Y$$$20240918$$CN$CA$CA
243319611$24331961$1$I$$20240909$20240918$20240918$EXP$$US-ROCHE-10000077683$ROCHE$$77$YR$E$M$Y$$$20240918$$CN$US$US
243319621$24331962$1$I$$20240911$20240918$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029075$UNITED THERAPEUTICS$$$$$F$Y$117.01$KG$20240918$$$US$US
243319631$24331963$1$I$20240101$20240912$20240918$20240918$EXP$$US-ABBVIE-5923066$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243319641$24331964$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212745$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243319651$24331965$1$I$$20240910$20240918$20240918$EXP$$NO-AstraZeneca-2024A209854$ASTRAZENECA$$$$$M$Y$$$20240918$$HP$NO$
243319671$24331967$1$I$$20240914$20240918$20240918$EXP$$JP-AstraZeneca-2024A212228$ASTRAZENECA$Niimi K.. Initial and recurrent treatment options in empathizing with the ovarian cancer patients.. The 71st Annual Meeting of the Northern Japan Society of Obstetrics and Gynecology Sponsored Seminar. 2024;0-.$$$A$F$Y$$$20240918$$MD$JP$
243319681$24331968$1$I$$20240913$20240918$20240918$EXP$$GB-AstraZeneca-2024A212567$ASTRAZENECA$$54$YR$$M$Y$$$20240918$$HP$GB$
243319691$24331969$1$I$$20240913$20240918$20240918$PER$$US-AstraZeneca-2024A210711$ASTRAZENECA$$76$YR$$M$Y$$$20240918$$HP$US$
243319701$24331970$1$I$$20240917$20240918$20240918$EXP$$JP-AstraZeneca-2024A212220$ASTRAZENECA$$81$YR$$M$Y$$$20240918$$MD$JP$
243319711$24331971$1$I$$20240917$20240918$20240918$30DAY$$US-SANDOZ INC.-SDZ2024US080998$SANDOZ$$$$$F$Y$$$20240918$$CN$US$US
243319721$24331972$1$I$20240826$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212557$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243319731$24331973$1$I$$20240914$20240918$20240918$PER$$US-AstraZeneca-2024A212083$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243319751$24331975$1$I$$20240916$20240918$20240918$EXP$$DE-AstraZeneca-2024A211346$ASTRAZENECA$$$$$F$Y$$$20240918$$HP$DE$
243319761$24331976$1$I$$20240913$20240918$20240918$EXP$$JP-AstraZeneca-2024A211590$ASTRAZENECA$$$$$$Y$$$20240918$$MD$JP$
243319771$24331977$1$I$$20240917$20240918$20240918$EXP$$CN-AstraZeneca-2024A213121$ASTRAZENECA$Zhang, P.; Luo, J.; Zhou, B.; Yang, J.; Qian, H.; Zhao, Y.; She, F.; Liu, F.. Recurrent ventricular arrhythmias and heart failure induced by osimertinib- a case report. Frontiers in cardiovascular medicine 2024;$70$YR$$F$Y$$$20240918$$HP$CN$
243319791$24331979$1$I$20240818$20240917$20240918$20240918$EXP$$MX-AstraZeneca-2024A212870$ASTRAZENECA$$30037$DY$$M$Y$75$KG$20240918$$CN$MX$
243319801$24331980$1$I$$20240913$20240918$20240918$EXP$$JP-AstraZeneca-2024A211252$ASTRAZENECA$$$$$$Y$$$20240918$$PH$JP$
243319812$24331981$2$F$20240923$20240923$20240918$20240926$EXP$$CA-TAKEDA-2024TUS091110$TAKEDA$$75$YR$$F$Y$$$20240926$$CN$CA$CA
243319821$24331982$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS092029$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240918$$MD$US$US
243319831$24331983$1$I$20240908$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212441$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243319841$24331984$1$I$$20240913$20240918$20240918$EXP$$JP-AstraZeneca-2024A211593$ASTRAZENECA$$$$$$Y$$$20240918$$PH$JP$
243319851$24331985$1$I$$20240912$20240918$20240918$EXP$$US-AstraZeneca-2024A209164$ASTRAZENECA$$$$$M$Y$$$20240918$$CN$US$
243319861$24331986$1$I$$20240916$20240918$20240918$EXP$$ZA-AstraZeneca-2024A212921$ASTRAZENECA$$65$YR$$F$Y$$$20240918$$CN$ZA$
243319871$24331987$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211678$ASTRAZENECA$$74$YR$$M$Y$$$20240918$$MD$US$
243319891$24331989$1$I$$20240913$20240918$20240918$EXP$$US-AstraZeneca-2024A212125$ASTRAZENECA$$$$$$Y$$$20240918$$CN$US$
243319901$24331990$1$I$20240905$20240912$20240918$20240918$EXP$$US-ABBVIE-5922858$ABBVIE$$83$YR$$F$Y$$$20240918$$CN$US$US
243319911$24331991$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212387$ASTRAZENECA$$$$$M$Y$$$20240918$$HP$US$
243319921$24331992$1$I$20240724$20240907$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145784$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240918$$MD$JP$JP
243319941$24331994$1$I$20240801$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148325$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240918$$HP$US$US
243319951$24331995$1$I$$20240910$20240918$20240918$EXP$$CA-AstraZeneca-2024A212918$ASTRAZENECA$$53$YR$$M$Y$$$20240918$$HP$CA$
243319961$24331996$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A212435$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243319971$24331997$1$I$20240101$20240912$20240918$20240918$EXP$$US-ABBVIE-5922687$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243319981$24331998$1$I$$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A212946$ASTRAZENECA$$$$$M$Y$80.3$KG$20240918$$CN$US$
243319991$24331999$1$I$20231201$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045060$AUROBINDO$$62$YR$$F$Y$$$20240918$$MD$FR$FR
243320011$24332001$1$I$$20240904$20240918$20240918$PER$$US-JNJFOC-20240908173$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$CN$US$US
243320021$24332002$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS092025$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240918$$MD$US$US
243320041$24332004$1$I$$20240910$20240918$20240918$EXP$$CA-CELLTRION INC.-2022CA002368$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
243320051$24332005$1$I$$20240916$20240918$20240918$PER$$US-ABBVIE-5926843$ABBVIE$$$$$$Y$$$20240918$$HP$US$US
243320061$24332006$1$I$$20240912$20240918$20240918$EXP$$US-AMGEN-USASL2024184223$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243320071$24332007$1$I$20240606$20240911$20240918$20240918$PER$$US-ABBVIE-5924223$ABBVIE$$36$YR$$F$Y$$$20240918$$HP$US$US
243320081$24332008$1$I$$20240912$20240918$20240918$PER$$US-ABBVIE-5923640$ABBVIE$$$$$$Y$$$20240918$$CN$US$US
243320091$24332009$1$I$$20240905$20240918$20240918$EXP$$NL-AUROBINDO-AUR-APL-2024-045207$AUROBINDO$van der Sar I.G.,Wijsenbeek M.S.,Dumoulin D.W.,Jager A.,van der Veldt A.A.M.,R, Rossius M.J.P, et, al. Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis. Annals of the American Thoracic Society. 2024;21(6):989-992$$$A$$Y$$$20240918$$HP$NL$NL
243320101$24332010$1$I$$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045205$AUROBINDO$Frangie C, Morel D S.. A rare infection in a renal transplant recipient.. A rare infection in a renal transplant recipient. 2001;16(6):1285-7$50$YR$$M$Y$$$20240918$$HP$FR$FR
243320111$24332011$1$I$$20240910$20240918$20240918$EXP$$CA-TAKEDA-2024TUS090838$TAKEDA$$$$$M$Y$$$20240918$$MD$CA$CA
243320121$24332012$1$I$20240528$20240905$20240918$20240918$EXP$$DE-AUROBINDO-AUR-APL-2024-044910$AUROBINDO$$72$YR$$F$Y$$$20240918$$MD$DE$DE
243320131$24332013$1$I$$20240826$20240918$20240918$PER$$US-ABBVIE-5926039$ABBVIE$$$$$$Y$$$20240918$$HP$US$US
243320142$24332014$2$F$$20240919$20240918$20240930$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18198$IPSEN$$20$YR$A$F$Y$65.31$KG$20240930$$CN$US$US
243320151$24332015$1$I$20240801$20240913$20240918$20240918$EXP$$US-ABBVIE-5924019$ABBVIE$$72$YR$$F$Y$$$20240918$$HP$US$US
243320181$24332018$1$I$$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044475$AUROBINDO$$$$$$Y$$$20240918$$HP$GB$GB
243320191$24332019$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010822$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243320201$24332020$1$I$$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044531$AUROBINDO$$64$YR$$F$Y$69$KG$20240918$$PH$GB$GB
243320211$24332021$1$I$$20240914$20240918$20240918$EXP$$AU-TAKEDA-2024TUS092451$TAKEDA$$$$A$M$Y$$$20240918$$CN$AU$AU
243320232$24332023$2$F$20240914$20240917$20240918$20240919$PER$$US-AMGEN-USASP2024185294$AMGEN$$77$YR$E$M$Y$$$20240919$$CN$US$US
243320241$24332024$1$I$20240718$20240911$20240918$20240918$EXP$$CN-AMGEN-CHNSP2024183087$AMGEN$$66$YR$E$F$Y$51$KG$20240918$$HP$CN$CN
243320251$24332025$1$I$$20240905$20240918$20240918$EXP$$US-UCBSA-2024045816$UCB$$$$$M$Y$$$20240918$$HP$US$US
243320281$24332028$1$I$$20240911$20240918$20240918$EXP$$GB-009507513-2409GBR005260$MERCK$Platt J, Allotey J, Alouani E, Glasbey J, Intini R, Lonardi S, et al. Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series. ESMO Open. 2024;9(9)$77$YR$$F$Y$$$20240918$$MD$GB$GB
243320291$24332029$1$I$$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045063$AUROBINDO$$41$YR$$M$Y$$$20240918$$MD$FR$FR
243320301$24332030$1$I$20240914$20240915$20240918$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015200$JAZZ$$28$YR$$M$Y$$$20240918$$HP$US$US
243320311$24332031$1$I$20240101$20240906$20240918$20240918$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01471$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240918$$HP$US$US
243320321$24332032$1$I$20240901$20240905$20240918$20240918$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01456$INTRA-CELLULAR THERAPIES$$20$YR$$M$Y$62.132$KG$20240918$$HP$US$US
243320331$24332033$1$I$$20240906$20240918$20240918$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01474$INTRA-CELLULAR THERAPIES$$$$A$M$Y$$$20240918$$MD$US$US
243320341$24332034$1$I$$20240905$20240918$20240918$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01466$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240918$$HP$US$US
243320351$24332035$1$I$$20240916$20240918$20240918$EXP$IT-AMGEN-ITASP2024179082$IT-SANDOZ INC.-SDZ2024IT080430$SANDOZ$$51$YR$$M$Y$$$20240918$$HP$IT$IT
243320372$24332037$2$F$$20240919$20240918$20240925$EXP$$IE-MYLANLABS-2024M1083509$MYLAN$Tomkins .E., Ruttledge. M.. Case study 2: Layering multiple migraine treatments - tales of the unexpected. Hosp Doct Irel. 2024;30:3-4$50$YR$$F$Y$$$20240925$$HP$IE$IE
243320381$24332038$1$I$$20240905$20240918$20240918$EXP$$US-MYLANLABS-2024M1084390$MYLAN$$$$$M$Y$$$20240918$$CN$US$US
243320392$24332039$2$F$20240915$20240920$20240918$20240924$PER$$US-AMGEN-USASP2024185624$AMGEN$$80$YR$E$F$Y$$$20240924$$CN$US$US
243320401$24332040$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185295$AMGEN$$$$$$Y$$$20240918$$PH$US$US
243320412$24332041$2$F$20240910$20240918$20240918$20240919$PER$$US-AMGEN-USASP2024185709$AMGEN$$92$YR$E$M$Y$$$20240918$$CN$US$US
243320431$24332043$1$I$$20240912$20240918$20240918$PER$$US-AMGEN-USASP2024182926$AMGEN$$$$$$Y$$$20240918$$HP$US$US
243320441$24332044$1$I$$20240826$20240918$20240918$PER$$US-ABBVIE-5926055$ABBVIE$$$$$$Y$$$20240918$$HP$US$US
243320451$24332045$1$I$20240101$20240710$20240918$20240918$EXP$$CA-CELLTRION INC.-2024CA018929$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
243320471$24332047$1$I$$20240909$20240918$20240918$EXP$$US-AstraZeneca-2024A205212$ASTRAZENECA$$$$$F$Y$$$20240918$$CN$US$
243320481$24332048$1$I$20240719$20240911$20240918$20240918$EXP$FR-AFSSAPS-MA2024001386$FR-TEVA-VS-3242822$TEVA$$58$YR$$F$Y$$$20240918$$MD$FR$FR
243320491$24332049$1$I$20240816$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212618$ASTRAZENECA$$24482$DY$$M$Y$$$20240918$$HP$US$
243320501$24332050$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212504$ASTRAZENECA$$65$YR$$F$Y$$$20240918$$PH$US$
243320521$24332052$1$I$$20240912$20240918$20240918$PER$$US-AstraZeneca-2024A208521$ASTRAZENECA$$$$$F$Y$$$20240918$$MD$US$
243320531$24332053$1$I$$20240911$20240918$20240918$EXP$$NL-AstraZeneca-2024A203686$ASTRAZENECA$$59$YR$$M$Y$118$KG$20240918$$MD$NL$
243320541$24332054$1$I$20240916$20240916$20240918$20240918$EXP$$US-AstraZeneca-2024A211409$ASTRAZENECA$$29608$DY$$M$Y$$$20240918$$CN$US$
243320561$24332056$1$I$$20240917$20240918$20240918$EXP$$US-AstraZeneca-2024A212351$ASTRAZENECA$$$$$M$Y$$$20240918$$MD$US$
243320571$24332057$1$I$20240309$20240911$20240918$20240918$EXP$$FR-AstraZeneca-2024A203649$ASTRAZENECA$$43$YR$$M$Y$69$KG$20240918$$MD$FR$
243320581$24332058$1$I$$20240909$20240918$20240918$30DAY$$US-GSK-US2024111856$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243320591$24332059$1$I$$20240911$20240918$20240918$30DAY$$US-GSK-US2024113084$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243320601$24332060$1$I$20240501$20240909$20240918$20240918$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08433$HIKMA$$65$YR$$M$Y$83.4$KG$20240918$$MD$US$US
243320611$24332061$1$I$$20240905$20240918$20240918$EXP$$CA-B.Braun Medical Inc.-2161725$B BRAUN$Literature Article$32$YR$$F$Y$$$20240918$$$CA$CA
243320621$24332062$1$I$$20240906$20240918$20240918$PER$$US-P+L Developments of Newyork Corporation-2161746$PL DEVELOPMENTS$$$$$F$Y$$$20240918$$$US$US
243320631$24332063$1$I$$20240903$20240918$20240918$EXP$$CA-Ascend Therapeutics US, LLC-2161733$ASCEND$$$$$F$Y$$$20240918$$$CA$CA
243320641$24332064$1$I$$20240905$20240918$20240918$PER$$US-P+L Developments of Newyork Corporation-2161743$PL DEVELOPMENTS$$$$$F$Y$$$20240918$$$US$US
243320651$24332065$1$I$$20240905$20240918$20240918$EXP$$US-P+L Developments of Newyork Corporation-2161745$PL DEVELOPMENTS$Initial$69$YR$$M$Y$$$20240918$$$US$US
243320661$24332066$1$I$20240821$20240909$20240918$20240918$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161744$JIANGSU HANSOH PHARMACEUTICAL$$76$YR$$F$Y$47$KG$20240918$$MD$CN$CN
243320681$24332068$1$I$$20240916$20240918$20240918$PER$$US-Mission Pharmacal Company-2161729$MISSION$$66$YR$$M$Y$$$20240918$$$US$US
243320691$24332069$1$I$20240219$20240905$20240918$20240918$EXP$$IT-AUROBINDO-AUR-APL-2024-044972$AUROBINDO$$60$YR$$M$Y$$$20240918$$MD$IT$IT
243320701$24332070$1$I$$20240904$20240918$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-045299$AUROBINDO$Basak GW, Wiktor-jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. American Journal of Transplantation. 2015;15:705?714$26$YR$$F$Y$$$20240918$$HP$PL$PL
243320711$24332071$1$I$20240722$20240909$20240918$20240918$EXP$$PT-Integrated Therapeutic Solutions Inc.-2161732$Integrated Therapeutic Solutions$$70$YR$$F$Y$$$20240918$$$PT$PT
243320721$24332072$1$I$$20240916$20240918$20240918$PER$$US-Mission Pharmacal Company-2161730$MISSION$$66$YR$$M$Y$$$20240918$$$US$US
243320731$24332073$1$I$20230301$20240911$20240918$20240918$EXP$DE-BFARM-24006193$DE-TEVA-VS-3242921$TEVA$$$$$$Y$$$20240918$$CN$DE$DE
243320741$24332074$1$I$$20240916$20240918$20240918$EXP$$CA-SANDOZ INC.-SDZ2024CA080725$SANDOZ$$71$YR$$F$Y$62$KG$20240918$$CN$CA$CA
243320751$24332075$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010863$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243320761$24332076$1$I$20240815$20240910$20240918$20240918$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161740$JIANGSU HENGRUI MEDICINE$$47$YR$$F$Y$39$KG$20240918$$MD$CN$CN
243320771$24332077$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5922791$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243320781$24332078$1$I$$20240905$20240918$20240918$EXP$$GB-P+L Developments of Newyork Corporation-2161742$PL DEVELOPMENTS$Initial$41$YR$$M$Y$$$20240918$$$GB$GB
243320791$24332079$1$I$$20240911$20240918$20240918$EXP$$CA-ROCHE-10000081454$ROCHE$$34$YR$A$M$Y$93$KG$20240918$$HP$CA$CA
243320801$24332080$1$I$20230119$20240906$20240918$20240918$EXP$FR-AFSSAPS-PC2024000681$FR-Accord-446128$ACCORD$$52$YR$A$F$Y$83$KG$20240918$$PH$FR$FR
243320811$24332081$1$I$$20240903$20240918$20240918$EXP$$US-Pharmascience Inc.-2161731$PHARMASCIENCE$Literature abstract$54$YR$$F$Y$$$20240918$$$US$US
243320821$24332082$1$I$20240906$20240908$20240918$20240918$EXP$$CN-Hisun Pharmaceuticals-2161736$HISUN PHARMACEUTICALS$$61$YR$$F$Y$63$KG$20240918$$$CN$CN
243320831$24332083$1$I$$20240828$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08639$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243320841$24332084$1$I$$20240916$20240918$20240918$PER$$NVSC2024US186103$NOVARTIS$$$$$F$Y$$$20240918$$MD$US$US
243320851$24332085$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186155$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243320861$24332086$1$I$20230115$20240906$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045278$AUROBINDO$$74$YR$$M$Y$78$KG$20240918$$PH$FR$FR
243320871$24332087$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010823$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243320881$24332088$1$I$$20240909$20240918$20240918$EXP$$US-TEVA-VS-3243246$TEVA$Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans. Am-J-Gastroenterol 2024; 119 200-202.; Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans. Am-J-Gastroenterol 2024; 119 200-202.$$$$$Y$$$20240918$$MD$US$US
243320901$24332090$1$I$20240601$20240830$20240918$20240918$PER$$US-TEVA-VS-3239564$TEVA$$36$YR$$F$Y$$$20240918$$MD$US$US
243320911$24332091$1$I$$20240906$20240918$20240918$PER$$US-P+L Developments of Newyork Corporation-2161747$PL DEVELOPMENTS$$$$$M$Y$$$20240918$$$US$US
243320921$24332092$1$I$20240801$20240911$20240918$20240918$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024113729$VIIV$$$$$M$Y$$$20240918$$HP$US$US
243320941$24332094$1$I$$20240904$20240918$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-045289$AUROBINDO$Basak GW, Wiktor-jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. American Journal of Transplantation. 2015;15:705?714$$$$M$Y$$$20240918$$HP$PL$PL
243320951$24332095$1$I$$20240916$20240918$20240918$PER$$US-ABBVIE-5927471$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243320961$24332096$1$I$20240901$20240917$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148198$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240918$$HP$US$US
243320971$24332097$1$I$20240101$20240909$20240918$20240918$EXP$$CA-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00931$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$CA$CA
243320981$24332098$1$I$$20240912$20240918$20240918$EXP$$CA-JNJFOC-20240939632$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240918$$HP$CA$CA
243320991$24332099$1$I$20240301$20240305$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240300178$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$CN$US$US
243321001$24332100$1$I$$20240311$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240300202$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$MD$US$US
243321011$24332101$1$I$20240101$20240313$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240300211$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$HP$US$US
243321021$24332102$1$I$20240318$20240318$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240300230$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$HP$US$US
243321031$24332103$1$I$20240101$20240327$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240300248$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$CN$US$US
243321041$24332104$1$I$20240401$20240401$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240400256$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321051$24332105$1$I$20231023$20240424$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240400260$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$HP$US$US
243321061$24332106$1$I$20240412$20240412$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240400281$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321071$24332107$1$I$20240401$20240417$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240400288$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$CN$US$US
243321081$24332108$1$I$$20240508$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240500339$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$HP$US$US
243321091$24332109$1$I$20240407$20240514$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240500362$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321101$24332110$1$I$20240430$20240514$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240500363$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$CN$US$US
243321111$24332111$1$I$20240607$20240607$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240600447$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321121$24332112$1$I$20240611$20240619$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240600482$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321131$24332113$1$I$20240709$20240709$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240700526$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321141$24332114$1$I$20240622$20240627$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240600497$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321151$24332115$1$I$20240719$20240719$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240700547$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321161$24332116$1$I$20240718$20240719$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240700549$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321171$24332117$1$I$20240717$20240719$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240700574$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$HP$US$US
243321181$24332118$1$I$20240104$20240104$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240100017$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321191$24332119$1$I$$20240105$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240100018$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321201$24332120$1$I$20240109$20240110$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240100027$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321211$24332121$1$I$20240206$20240206$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240200087$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321221$24332122$1$I$20240108$20240110$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240100030$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321231$24332123$1$I$20240215$20240215$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240200118$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321241$24332124$1$I$20240312$20240312$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240300198$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321251$24332125$1$I$20240301$20240312$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240300204$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321261$24332126$1$I$20240701$20240723$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240700559$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321271$24332127$1$I$20240801$20240809$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240800621$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$HP$US$US
243321281$24332128$1$I$20240611$20240617$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240600479$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$CN$US$US
243321291$24332129$1$I$$20240313$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240300210$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$CN$US$US
243321301$24332130$1$I$20240801$20240815$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240800634$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$CN$US$US
243321311$24332131$1$I$$20240816$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240800635$COLLEGIUM PHARMACEUTICAL$$$$$F$Y$$$20240918$$MD$US$US
243321321$24332132$1$I$20240813$20240816$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240800645$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321331$24332133$1$I$20240801$20240821$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240800656$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321341$24332134$1$I$20231002$20231005$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20231000830$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$PH$US$US
243321351$24332135$1$I$20230101$20231017$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20231000860$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$CN$US$US
243321361$24332136$1$I$20231101$20231129$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20231100960$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$CN$US$US
243321371$24332137$1$I$$20240709$20240918$20240918$PER$$US-ROCHE-10000023083$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243321381$24332138$1$I$$20240913$20240918$20240918$EXP$$MM-ROCHE-10000082636$ROCHE$$63$YR$A$M$Y$$$20240918$$CN$MM$MM
243321401$24332140$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010864$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243321411$24332141$1$I$20240701$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185616$AMGEN$$$$$M$Y$$$20240918$$CN$US$US
243321421$24332142$1$I$$20240913$20240918$20240918$EXP$$US-AMGEN-USASP2024183669$AMGEN$$$$A$M$Y$$$20240918$$CN$US$US
243321431$24332143$1$I$20240201$20240207$20240918$20240918$PER$$US-COLLEGIUM PHARMACEUTICAL, INC.-20240200097$COLLEGIUM PHARMACEUTICAL$$$$$$Y$$$20240918$$CN$US$US
243321441$24332144$1$I$20240725$20240916$20240918$20240918$EXP$$PK-ROCHE-10000082981$ROCHE$$56$YR$A$F$Y$$$20240918$$CN$PK$PK
243321451$24332145$1$I$20240712$20240912$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045775$AUROBINDO$$85$YR$$M$Y$$$20240918$$MD$FR$FR
243321461$24332146$1$I$$20240906$20240918$20240918$EXP$$TR-Accord-446146$ACCORD$Ozalp YC, Saygin B, Eren E, Karaca A, Akkoyun A, Sahin O, et al. BONE MARROW HYPOPLASIA DUE TO IRREGULAR METHOTREXATE TREATMENT FOR PSORIASIS. European Journal of Case Reports in Internal Medicine. 2024;11(Supplement 1):779.$66$YR$E$M$Y$$$20240918$$MD$TR$TR
243321471$24332147$1$I$$20240916$20240918$20240918$EXP$$FR-SANDOZ INC.-NVSC2020FR202907$SANDOZ$$77$YR$$F$Y$$$20240918$$PH$FR$FR
243321482$24332148$2$F$$20240920$20240918$20240923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147642$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240923$$MD$JP$JP
243321491$24332149$1$I$$20240909$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147849$BRISTOL MYERS SQUIBB$Ladwa A, Elghawy O, Kaur V. Single institution experience with immune checkpoint inhibitors in vulvar and vaginal melanomas. Obstetrics and Gynecology International. 2024 Jan 01;1-6. doi:10.1155/2024/7327692.$31$YR$A$F$Y$$$20240918$$HP$US$US
243321501$24332150$1$I$20240705$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148008$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240918$$CN$US$US
243321511$24332151$1$I$$20240913$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148009$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240918$$CN$US$US
243321521$24332152$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147676$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$101.15$KG$20240918$$CN$US$US
243321532$24332153$2$F$$20240905$20240918$20240925$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-2024-147285$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240925$$MD$AT$AT
243321541$24332154$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147100$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240918$$CN$US$US
243321551$24332155$1$I$$20240913$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146902$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240918$$CN$US$US
243321561$24332156$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147611$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$100.24$KG$20240918$$CN$US$US
243321571$24332157$1$I$$20240909$20240918$20240918$PER$$US-UNITED THERAPEUTICS-UNT-2024-028664$UNITED THERAPEUTICS$$$$$F$Y$48.526$KG$20240918$$$US$US
243321581$24332158$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148035$BRISTOL MYERS SQUIBB$$93$YR$E$M$Y$$$20240918$$CN$US$US
243321591$24332159$1$I$20240322$20240909$20240918$20240918$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-143912$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240918$$HP$AU$AU
243321601$24332160$1$I$20240910$20240912$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013518$DR REDDYS$$47$YR$A$F$Y$$$20240918$$MD$US$US
243321611$24332161$1$I$$20240904$20240918$20240918$EXP$$US-CIPLA LTD.-2024US09887$CIPLA$$$$$$Y$$$20240918$$CN$US$US
243321621$24332162$1$I$$20240910$20240918$20240918$PER$$US-UNITED THERAPEUTICS-UNT-2024-028706$UNITED THERAPEUTICS$$$$$F$Y$$$20240918$$$US$US
243321631$24332163$1$I$$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044586$AUROBINDO$$$$$F$Y$$$20240918$$CN$GB$GB
243321641$24332164$1$I$20240908$20240909$20240918$20240918$EXP$$US-CHIESI-2024CHF05936$CHIESI$$38$YR$$F$Y$62$KG$20240918$$CN$US$US
243321651$24332165$1$I$$20240827$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07569$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243321661$24332166$1$I$$20240911$20240918$20240918$EXP$$GB-009507513-2409GBR005261$MERCK$Platt J, Allotey J, Alouani E, Glasbey J, Intini R, Lonardi S, et al. Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series. ESMO Open. 2024;9(9)$48$YR$$F$Y$$$20240918$$MD$GB$GB
243321671$24332167$1$I$20240818$20240910$20240918$20240918$EXP$$US-ROCHE-10000079865$ROCHE$$56$YR$A$F$Y$$$20240918$$MD$US$US
243321681$24332168$1$I$20240217$20240912$20240918$20240918$EXP$PT-INFARMED-J202408-899$PT-009507513-2409PRT004625$MERCK$$65$YR$$F$Y$60$KG$20240918$$MD$PT$PT
243321692$24332169$2$F$$20240923$20240918$20240930$EXP$$TR-TEVA-VS-3242505$TEVA$Yildirim S, Ozel M, Gunay M, Hosoglu E, Turan B. Exploring Methylphenidate-Induced Intraocular Pressure: A Cautionary Tale in Pediatric ADHD Management. Clin-Neuropharmacol 2024;.; Yildirim S, Ozel M, Gunay M, Hosoglu E, Turan B. Exploring Methylphenidate-Induced Intraocular Pressure: A Cautionary Tale in Pediatric ADHD Management. Clin-Neuropharmacol 2024;.; Yildirim S, Ozel M, Gunay M, Hosoglu E, Turan B. Exploring Methylphenidate-Induced Intraocular Pressure: A Cautionary Tale in Pediatric...$6$YR$$F$Y$25$KG$20240930$$MD$TR$TR
243321701$24332170$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010824$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243321711$24332171$1$I$$20240911$20240918$20240918$EXP$$US-ARGENX-2024-ARGX-US007806$ARGENX BVBA$$$$$$Y$$$20240918$$HP$US$US
243321722$24332172$2$F$20240601$20240917$20240918$20240919$EXP$$MM-ROCHE-10000082728$ROCHE$$70$YR$E$M$Y$$$20240919$$CN$MM$MM
243321731$24332173$1$I$$20240909$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011810$STRIDES$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al.. Novel approaches in the treatment of Hansen+#39;s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States.. Ther-Adv-Infect-Dis. 2022;9:1-10$20$YR$$M$Y$$$20240918$$HP$US$US
243321741$24332174$1$I$$20240911$20240918$20240918$EXP$$GB-ROCHE-10000080727$ROCHE$$36$YR$A$$Y$120$KG$20240918$$HP$GB$GB
243321751$24332175$1$I$20240915$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010048$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240918$$CN$US$US
243321761$24332176$1$I$20200101$20240916$20240918$20240918$EXP$$ES-SANDOZ INC.-NVSC2020ES250514$SANDOZ$$52$YR$$F$Y$$$20240918$$MD$ES$ES
243321771$24332177$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010088$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240918$$CN$US$US
243321781$24332178$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010057$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240918$$CN$US$US
243321791$24332179$1$I$$20240912$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010015$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240918$$CN$US$US
243321801$24332180$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010133$ELI LILLY AND CO$$$$$M$Y$$$20240918$$CN$US$US
243321811$24332181$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010119$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240918$$HP$US$US
243321821$24332182$1$I$20240916$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009997$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240918$$CN$US$US
243321831$24332183$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010675$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240918$$CN$US$US
243321841$24332184$1$I$$20240903$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008214$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240918$$CN$US$US
243321851$24332185$1$I$20240915$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010060$ELI LILLY AND CO$$48$YR$A$$Y$$$20240918$$CN$US$US
243321861$24332186$1$I$20240916$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010083$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$US$US
243321871$24332187$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010042$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240918$$CN$US$US
243321881$24332188$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010011$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240918$$CN$US$US
243321891$24332189$1$I$20240201$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010594$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240918$$CN$US$US
243321901$24332190$1$I$$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044492$AUROBINDO$$71$YR$$M$Y$$$20240918$$PH$GB$GB
243321911$24332191$1$I$20230902$20240909$20240918$20240918$EXP$ES-AEMPS-1568369$ES-AMAROX PHARMA-AMR2024ES03056$HETERO$$58$YR$$M$Y$$$20240918$$MD$ES$ES
243321922$24332192$2$F$20240912$20240917$20240918$20240919$EXP$$AU-MYLANLABS-2024M1083667$MYLAN$$76$YR$$F$Y$$$20240919$$HP$AU$AU
243321931$24332193$1$I$$20240910$20240918$20240918$EXP$$ES-ALXN-202409EEA000609ES$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$MD$ES$ES
243321941$24332194$1$I$20240826$20240909$20240918$20240918$EXP$$US-ROCHE-10000049696$ROCHE$$74$YR$E$F$Y$$$20240918$$HP$US$US
243321951$24332195$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010829$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243321961$24332196$1$I$20240914$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184613$AMGEN$$52$YR$A$F$Y$$$20240918$$PH$US$US
243321971$24332197$1$I$$20240912$20240918$20240918$EXP$$US-AMGEN-USASP2024183386$AMGEN$$$$$F$Y$$$20240918$$MD$US$US
243321981$24332198$1$I$$20240716$20240918$20240918$PER$$US-ROCHE-10000029875$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243321992$24332199$2$F$20231201$20240923$20240918$20240930$PER$$US-AMGEN-USASP2024183887$AMGEN$$30$YR$A$F$Y$65.76$KG$20240930$$MD$US$US
243322002$24332200$2$F$20240816$20240916$20240918$20240927$EXP$$ALC2024ES004168$ALCON$$$$$$Y$$$20240927$$CN$ES$ES
243322021$24332202$1$I$$20240629$20240918$20240918$PER$$US-ROCHE-10000016711$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243322031$24332203$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000084607$ROCHE$$57$YR$A$M$Y$$$20240918$$HP$US$US
243322041$24332204$1$I$20240826$20240913$20240918$20240918$EXP$$US-AMGEN-USASP2024183658$AMGEN$$61$YR$A$F$Y$$$20240918$$PH$US$US
243322051$24332205$1$I$$20240911$20240918$20240918$EXP$$GB-009507513-2409GBR005262$MERCK$Platt J, Allotey J, Alouani E, Glasbey J, Intini R, Lonardi S, et al. Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series. ESMO Open. 2024;9(9)$45$YR$$M$Y$$$20240918$$MD$GB$GB
243322061$24332206$1$I$$20240829$20240918$20240918$PER$$US-TEVA-VS-3238971$TEVA$$60$YR$$F$Y$$$20240918$$PH$US$US
243322071$24332207$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010818$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243322101$24332210$1$I$$20240909$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147851$BRISTOL MYERS SQUIBB$Ladwa A, Elghawy O, Kaur V. Single institution experience with immune checkpoint inhibitors in vulvar and vaginal melanomas. Obstetrics and Gynecology International. 2024 Jan 01;1-6. doi:10.1155/2024/7327692.$71$YR$E$F$Y$$$20240918$$HP$US$US
243322112$24332211$2$F$20240916$20240917$20240918$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147905$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240920$$HP$US$US
243322121$24332212$1$I$$20240706$20240918$20240918$PER$$US-ROCHE-10000020975$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243322131$24332213$1$I$$20240909$20240918$20240918$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP011823$STRIDES$Dutta Majumder P, Shah M, Sen P.. Surgical management of a case of non-resolving bullous retinal detachment due to probable Vogt-Koyanagi-Harada syndrome.. Eur-J-Ophthalmol. 2024;34 (4):NP12-NP15$45$YR$$M$Y$$$20240918$$HP$IN$IN
243322141$24332214$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010830$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243322151$24332215$1$I$20240822$20240916$20240918$20240918$EXP$$AU-AMGEN-AUSSP2024184455$AMGEN$$$$$M$Y$$$20240918$$HP$AU$AU
243322171$24332217$1$I$$20240905$20240918$20240918$EXP$$US-AUROBINDO-AUR-APL-2024-044493$AUROBINDO$Aifuwa E, Kandahari A, Steinberg A.. HL-298 Concomitant methotrexate withdrawal and brentuximab vedotin therapy for treatment of methotrexate associated Hodgkin lymphoma. Clinical Lymphoma, Myeloma and Leukemia. 2024;24(Suppl 1):S446-7$82$YR$$M$Y$$$20240918$$MD$US$US
243322182$24332218$2$F$$20240918$20240918$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-044525$AUROBINDO$$16$YR$$$Y$$$20240926$$PH$GB$GB
243322191$24332219$1$I$20240906$20240909$20240918$20240918$EXP$$IE-CELLTRION INC.-2024IE022041$CELLTRION$$$$$$Y$$$20240918$$CN$IE$IE
243322201$24332220$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010948$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243322211$24332221$1$I$20240901$20240917$20240918$20240918$PER$$US-ALXN-202409USA001290US$ALEXION PHARMACEUTICALS$$69$YR$$M$Y$$$20240918$$CN$US$US
243322231$24332223$1$I$20170302$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045768$AUROBINDO$$69$YR$$M$Y$$$20240918$$MD$FR$FR
243322241$24332224$1$I$20240101$20240910$20240918$20240918$PER$$US-ABBVIE-5921952$ABBVIE$$$$$$Y$$$20240918$$HP$US$US
243322251$24332225$1$I$$20240906$20240918$20240918$EXP$$US-Accord-446305$ACCORD$$$$$F$Y$$$20240918$$MD$US$US
243322261$24332226$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147604$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240918$$CN$US$US
243322271$24332227$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148005$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240918$$CN$US$US
243322291$24332229$1$I$20180718$20240909$20240918$20240918$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-143801$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240918$$MD$AU$AU
243322301$24332230$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63931$$FDA-CTU$$83$YR$$M$N$71.67$KG$20240917$N$HP$US$
243322321$24332232$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63867$$FDA-CTU$$30$YR$$F$N$$$20240917$N$$US$
243322341$24332234$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63798$$FDA-CTU$$$$$M$N$$$20240917$N$HP$US$
243322351$24332235$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63836$$FDA-CTU$$61$YR$$M$N$$$20240917$N$$US$
243322361$24332236$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63826$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243322371$24332237$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63936$$FDA-CTU$$105$YR$$M$N$150$LBS$20240917$N$$US$
243322381$24332238$1$I$$20240913$20240918$20240918$EXP$$JP-GSK-JP2024114067$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$JP$JP
243322401$24332240$1$I$$20240909$20240918$20240918$EXP$$PL-STRIDES ARCOLAB LIMITED-2024SP011876$STRIDES$Richert-Przygonska M, Milewska M, Debski R, Cisek J, Czyzewski K.. Sclerodermatous manifestation of chronic graft-versus-host disease: therapy challenges.. Acta-Haematol-Polon. 2023;54 (5):308-312$14$YR$$M$Y$$$20240918$$HP$PL$PL
243322411$24332241$1$I$$20240911$20240918$20240918$EXP$$JP-AMGEN-JPNSP2024181995$AMGEN$$$$$$Y$$$20240918$$HP$JP$JP
243322421$24332242$1$I$$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044485$AUROBINDO$$82$YR$$F$Y$$$20240918$$PH$GB$GB
243322431$24332243$1$I$20240201$20240822$20240918$20240918$EXP$$US-SA-2024SA267515$SANOFI AVENTIS$$70$YR$E$F$Y$75$KG$20240918$$MD$US$US
243322441$24332244$1$I$20240906$20240912$20240918$20240918$EXP$$US-INSMED, INC.-2024-03577-US$INSMED$$58$YR$$F$Y$$$20240918$$CN$US$US
243322452$24332245$2$F$20240618$20240919$20240918$20240924$EXP$$PT-BAYER-2024A120263$BAYER$$76$YR$E$M$Y$$$20240924$$HP$PT$PT
243322461$24332246$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010831$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243322471$24332247$1$I$$20240912$20240918$20240918$EXP$$DE-AUROBINDO-AUR-APL-2024-045766$AUROBINDO$$73$YR$$$Y$$$20240918$$MD$DE$DE
243322481$24332248$1$I$$20240905$20240918$20240918$EXP$$PT-AUROBINDO-AUR-APL-2024-044949$AUROBINDO$Ana Albuquerque ; Rafael Third; Carolina Palma ; Ivo Mendes ; Daniela Cruz ; In?s Goldfinch. PERICARDITIS AN ATYPICAL MANIFESTATION.. 30th National Congress of Internal Medicine. 2024;405:PO-0031-2378$71$YR$$M$Y$$$20240918$$HP$PT$PT
243322491$24332249$1$I$$20240715$20240918$20240918$PER$$US-ROCHE-10000030375$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243322501$24332250$1$I$$20240906$20240918$20240918$EXP$$CZ-ROCHE-10000077147$ROCHE$$$$$F$Y$$$20240918$$CN$CZ$CZ
243322511$24332251$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010840$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243322521$24332252$1$I$$20240905$20240918$20240918$EXP$$PL-AUROBINDO-AUR-APL-2024-045228$AUROBINDO$Czubkowski P, Pawlowska J, Jankowska I, Teisseyre M, Kaminska D, Markiewicz M, et al.. Successful sirolimus rescue in tacrolimus-induced thromboticmicroangiopathy after living-related liver transplantation.. Pediatr Transplant. 2011$1$YR$$F$Y$$$20240918$$MD$PL$PL
243322531$24332253$1$I$20230601$20240909$20240918$20240918$EXP$$PT-STRIDES ARCOLAB LIMITED-2024SP011889$STRIDES$Fraga Dias B, Marques R, Faria V, Domingues P, Ribeiro C, Silvano J, et al.. Renal Artery Stenosis in Living Donor Kidney Transplantation: A Rare Cause of ^Flash Edema^.. Transplant-Proc. 2024;56 (5):1055-1058$37$YR$$M$Y$$$20240918$$MD$PT$PT
243322551$24332255$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084223$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$43$YR$$F$Y$$$20240918$$HP$IE$IE
243322561$24332256$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084209$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$39$YR$$F$Y$$$20240918$$HP$IE$IE
243322571$24332257$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084201$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$28$YR$$M$Y$$$20240918$$HP$IE$IE
243322581$24332258$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084203$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$62$YR$$F$Y$$$20240918$$HP$IE$IE
243322591$24332259$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084206$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$23$YR$$F$Y$$$20240918$$HP$IE$IE
243322601$24332260$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084193$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$26$YR$$F$Y$$$20240918$$HP$IE$IE
243322611$24332261$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084221$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$40$YR$$F$Y$$$20240918$$HP$IE$IE
243322621$24332262$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084194$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$30$YR$$M$Y$$$20240918$$HP$IE$IE
243322631$24332263$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084216$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$60$YR$$F$Y$$$20240918$$HP$IE$IE
243322641$24332264$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084219$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$65$YR$$F$Y$$$20240918$$HP$IE$IE
243322651$24332265$1$I$20240906$20240912$20240918$20240918$EXP$$US-AMGEN-USASP2024183079$AMGEN$$25$YR$A$F$Y$$$20240918$$CN$US$US
243322661$24332266$1$I$20200911$20240906$20240918$20240918$EXP$PL-URPL-1-2051-2020$PL-BAXTER-2024BAX024325$BAXTER$$65$YR$$$Y$87$KG$20240918$$MD$PL$PL
243322671$24332267$1$I$20240825$20240909$20240918$20240918$PER$$US-AMGEN-USASP2024180516$AMGEN$$66$YR$E$F$Y$$$20240918$$CN$US$US
243322681$24332268$1$I$$20240906$20240918$20240918$EXP$$ES-Accord-446093$ACCORD$Caro MG, Marti DL, Garcia PR, Garcia PR. Drug-induced anaemia. European Journal of Case Reports in Internal Medicine. 2024;11(Suppl 1):757. DOI: 10.12890/2024_V11Sup1.$40$YR$A$M$Y$$$20240918$$MD$ES$ES
243322691$24332269$1$I$20191125$20240909$20240918$20240918$EXP$FR-AFSSAPS-AN20201156$FR-BAXTER-2024BAX024401$BAXTER$$43$YR$$F$Y$63$KG$20240918$$PH$FR$FR
243322701$24332270$1$I$20240903$20240909$20240918$20240918$EXP$GB-MHRA-MED-202409091514475910-SNZJF$GB-BAXTER-2024BAX024519$BAXTER$$96$YR$$F$Y$$$20240918$$PH$GB$GB
243322712$24332271$2$F$20240226$20240917$20240918$20240928$EXP$FR-AFSSAPS-MA2024001349$FR-BAXTER-2024BAX024394$BAXTER$$58$YR$$F$Y$57$KG$20240928$$CN$FR$FR
243322721$24332272$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147484$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240918$$CN$US$US
243322731$24332273$1$I$20240717$20240909$20240918$20240918$EXP$GB-MHRA-MED-202409091821142190-TSHCV$GB-AMAROX PHARMA-AMR2024GB03076$HETERO$$$$$M$Y$$$20240918$$HP$GB$GB
243322751$24332275$1$I$$20240911$20240918$20240918$EXP$GB-MHRA-MED-202409111600130520-LCVQZ$GB-RDY-SPO/GBR/24/0013410$DR REDDYS$$$$$M$Y$72$KG$20240918$$HP$GB$GB
243322761$24332276$1$I$20210101$20240910$20240918$20240918$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011782$STRIDES$Ikeda R, Matsuoka Y, Inoue M, Ishikawa A, Akagi K, Kageyama Y.. Treatment-related neuroendocrine prostate cancer with BRCA2 germline mutation treated with olaparib.. IJU Case Reports. 2024;7:115-119$8$DEC$$M$Y$$$20240918$$MD$JP$JP
243322771$24332277$1$I$$20240830$20240918$20240918$EXP$$RO-CELLTRION INC.-2024RO022137$CELLTRION$$$$$$Y$$$20240918$$MD$RO$RO
243322781$24332278$1$I$20230101$20240906$20240918$20240918$EXP$$US-SA-2024SA268561$SANOFI AVENTIS$$$$$F$Y$$$20240918$$CN$US$US
243322791$24332279$1$I$$20240906$20240918$20240918$EXP$$ES-BAYER-2024A129300$BAYER$Aldaz-Burgoa A.; Rodriguez-Albacete N.; Franco-Rubio L.; Lopez-Trashorras L.; Abizanda-Saro P.; Gomez Escalonilla-Escobar C.I.; Jurado A.L.F.-L.; Gonzalez-Garcia N.. Reversible cerebral vasoconstriction syndrome. Recurrence of thunderclap headaches after treatment with corticosteroids. Revista de Neurologia. 2024;79:2:67-70$44$YR$A$F$Y$$$20240918$$HP$ES$ES
243322802$24332280$2$F$$20240808$20240918$20240925$EXP$$JP-ROCHE-10000083618$ROCHE$$7$DEC$E$F$Y$$$20240925$$PH$JP$JP
243322811$24332281$1$I$$20240910$20240918$20240918$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011785$STRIDES$Zhang W, Ji Y, Sun Y, Zhi K, Yang H, Zhang M, Lu P, Zhang Y.. Case report: a cataract induced by bleomycin in a patient with testicular cancer.. Frontiers in Pharmacology. 2024;15:1339662$22$YR$$M$Y$$$20240918$$HP$CN$CN
243322821$24332282$1$I$$20240910$20240918$20240918$EXP$FR-MLMSERVICE-20240821-PI165802-00129-4$FR-STRIDES ARCOLAB LIMITED-2024SP011804$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic?.. J-Eur-Acad-Dermatol-Venereol. 2024$26$YR$$M$Y$$$20240918$$HP$FR$FR
243322832$24332283$2$F$$20240913$20240918$20240925$EXP$$IE-AUROBINDO-AUR-APL-2024-044877$AUROBINDO$Tomkins .E., Ruttledge. M.. Case study 2: Layering multiple migraine treatments ? tales of the unexpected.. Hosp Doct Irel.. 2024;30:3-4$50$YR$$F$Y$$$20240925$$MD$IE$IE
243322842$24332284$2$F$$20240923$20240918$20240930$EXP$$US-TEVA-VS-3243245$TEVA$Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans. Am-J-Gastroenterol 2024; 119 200-202.; Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans. Am-J-Gastroenterol 2024; 119 200-202.; Nicoletti P, Dellinger A, L...$$$$$Y$$$20240930$$MD$US$US
243322851$24332285$1$I$$20240907$20240918$20240918$PER$$US-ASTELLAS-2024-AER-005755$ASTELLAS$$$$$F$Y$$$20240918$$PH$US$US
243322861$24332286$1$I$$20240904$20240918$20240918$30DAY$$CA-JNJFOC-20240931463$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$HP$CA$CA
243322871$24332287$1$I$$20240910$20240918$20240918$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011801$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic?.. J-Eur-Acad-Dermatol-Venereol. 2024$38$YR$$M$Y$$$20240918$$HP$FR$FR
243322881$24332288$1$I$20240813$20240912$20240918$20240918$EXP$FR-AFSSAPS-MP2024001369$FR-TEVA-VS-3243401$TEVA$$17$YR$$F$Y$$$20240918$$MD$FR$FR
243322891$24332289$1$I$$20240910$20240918$20240918$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP011733$STRIDES$Mira AR, Brincat MR, Zalawadia S, Sideris M, Dilley J.. Immature ovarian teratoma with gliomatosis peritonei, paraneoplastic hyponatremia and growing teratoma syndrome: a case report and literature review.. Annals of Medicine + Surgery.. 2024;86(8):4907-4912$26$YR$$F$Y$$$20240918$$MD$GB$GB
243322901$24332290$1$I$$20240916$20240918$20240918$PER$$US-ALXN-202409USA001186US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243322921$24332292$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010003$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240918$$CN$US$US
243322931$24332293$1$I$20240913$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009703$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240918$$CN$US$US
243322941$24332294$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010376$ELI LILLY AND CO$$$$$$Y$$$20240918$$PH$US$US
243322951$24332295$1$I$20240917$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010969$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240918$$CN$US$US
243322961$24332296$1$I$20230101$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009726$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240918$$CN$US$US
243322971$24332297$1$I$$20240905$20240918$20240918$EXP$$ES-AUROBINDO-AUR-APL-2016-11937$AUROBINDO$Valera Rubio M, et al. Pharmacological approach for the management of  adrenocortical carcinoma: A case report. European Journal of Clinical Pharmacy. 2016;18 (3):199-201$16$YR$$F$Y$$$20240918$$HP$ES$ES
243322981$24332298$1$I$20240915$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010111$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240918$$CN$US$US
243322991$24332299$1$I$20231123$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044470$AUROBINDO$$$$E$F$Y$89$KG$20240918$$MD$GB$GB
243323001$24332300$1$I$20240829$20240914$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009804$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240918$$CN$US$US
243323011$24332301$1$I$20240917$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409011047$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240918$$CN$US$US
243323021$24332302$1$I$20240916$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009955$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240918$$CN$US$US
243323031$24332303$1$I$20240913$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009947$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240918$$HP$US$US
243323041$24332304$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010511$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240918$$CN$US$US
243323051$24332305$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009824$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240918$$CN$US$US
243323061$24332306$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009716$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$US$US
243323071$24332307$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010104$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240918$$CN$US$US
243323081$24332308$1$I$20240912$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009891$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240918$$CN$US$US
243323091$24332309$1$I$20240906$20240913$20240918$20240918$EXP$$US-AMGEN-USASP2024183930$AMGEN$$35$YR$A$F$Y$$$20240918$$HP$US$US
243323101$24332310$1$I$$20240912$20240918$20240918$EXP$$US-AMGEN-USASP2024183384$AMGEN$$$$$M$Y$$$20240918$$HP$US$US
243323111$24332311$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63881$$FDA-CTU$$39$YR$$F$N$$$20240917$N$$US$
243323121$24332312$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009770$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240918$$CN$US$US
243323131$24332313$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63927$$FDA-CTU$$105$YR$$M$N$68.04$KG$20240917$N$$US$
243323141$24332314$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010949$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243323151$24332315$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010819$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243323161$24332316$1$I$20230411$20240906$20240918$20240918$EXP$FR-AFSSAPS-LL2023000596$FR-CELLTRION INC.-2024FR022172$CELLTRION$$$$$$Y$$$20240918$$MD$FR$FR
243323171$24332317$1$I$$20240910$20240918$20240918$EXP$FR-MLMSERVICE-20240821-PI165802-00129-2$FR-STRIDES ARCOLAB LIMITED-2024SP011802$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic?.. J-Eur-Acad-Dermatol-Venereol. 2024$27$YR$$M$Y$$$20240918$$HP$FR$FR
243323181$24332318$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63830$$FDA-CTU$$29$YR$$M$N$$$20240917$N$$US$
243323191$24332319$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63870$$FDA-CTU$$48$YR$$F$N$$$20240917$N$$US$
243323201$24332320$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63924$$FDA-CTU$$38$YR$$F$N$$$20240917$N$$US$
243323221$24332322$1$I$$20240905$20240918$20240918$EXP$$CN-AMNEAL PHARMACEUTICALS-2024-AMRX-03391$AMNEAL$Chen P, Yang Y, Guo Y, Li J, Wang G, et al.. Pleural Effusion Associated With Divalproex Sodium A Case Report and Literature Review. J Clin Psychopharmacol. 2023;43:541-543$19$YR$$M$Y$$$20240918$$HP$CN$CN
243323231$24332323$1$I$$20240917$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148318$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240918$$CN$US$US
243323241$24332324$1$I$$20240913$20240918$20240918$PER$$US-TAKEDA-2024TUS091900$TAKEDA$$$$$F$Y$$$20240918$$CN$US$US
243323253$24332325$3$F$20240705$20240921$20240918$20240930$PER$$US-ROCHE-10000077479$ROCHE$$$$E$F$Y$71.21$KG$20240930$$CN$US$US
243323261$24332326$1$I$$20240910$20240918$20240918$EXP$FR-MLMSERVICE-20240821-PI165802-00129-3$FR-STRIDES ARCOLAB LIMITED-2024SP011803$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic?.. J-Eur-Acad-Dermatol-Venereol. 2024$37$YR$$M$Y$$$20240918$$HP$FR$FR
243323271$24332327$1$I$$20240910$20240918$20240918$EXP$FR-MLMSERVICE-20240821-PI165802-00129-5$FR-STRIDES ARCOLAB LIMITED-2024SP011805$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic?.. J-Eur-Acad-Dermatol-Venereol. 2024$28$YR$$F$Y$$$20240918$$HP$FR$FR
243323281$24332328$1$I$20240907$20240911$20240918$20240918$EXP$$CN-SA-2024SA265512$SANOFI AVENTIS$$88$YR$E$F$Y$42.5$KG$20240918$$HP$CN$CN
243323291$24332329$1$I$20070801$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045136$AUROBINDO$$47$YR$$F$Y$148$KG$20240918$$MD$FR$FR
243323301$24332330$1$I$20240916$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185899$AMGEN$$66$YR$E$F$Y$$$20240918$$CN$US$US
243323311$24332331$1$I$$20240916$20240918$20240918$PER$$US-TAKEDA-2024TUS092411$TAKEDA$$$$$F$Y$$$20240918$$CN$US$US
243323321$24332332$1$I$$20240905$20240918$20240918$PER$$US-AMGEN-USASP2024180385$AMGEN$$$$$M$Y$$$20240918$$CN$US$US
243323331$24332333$1$I$$20240913$20240918$20240918$PER$$US-TAKEDA-2024TUS092284$TAKEDA$$$$$$Y$$$20240918$$CN$US$US
243323341$24332334$1$I$20221114$20240909$20240918$20240918$EXP$$BE-CHEPLA-2022012420$CHEPLAPHARM$$66$YR$$F$Y$42$KG$20240918$$MD$COUNTRY NOT SPECIFIED$BE
243323351$24332335$1$I$$20240909$20240918$20240918$EXP$$AU-ABBVIE-5926002$ABBVIE$$$$$$Y$$$20240918$$CN$AU$AU
243323372$24332337$2$F$$20240913$20240918$20240925$PER$$US-TAKEDA-2024TUS092281$TAKEDA$$$$$$Y$$$20240925$$CN$US$US
243323381$24332338$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63913$$FDA-CTU$$75$YR$$F$N$$$20240917$N$$US$
243323391$24332339$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63905$$FDA-CTU$$68$YR$$M$N$132.9$KG$20240917$N$$US$
243323401$24332340$1$I$20240916$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63751$$FDA-CTU$$$$$$N$$$20240916$N$CN$US$
243323421$24332342$1$I$$20240912$20240918$20240918$EXP$$GR-ROCHE-10000083075$ROCHE$$$$A$F$Y$17$KG$20240918$$CN$GR$GR
243323431$24332343$1$I$20240601$20240912$20240918$20240918$EXP$$US-ABBVIE-5922891$ABBVIE$$81$YR$$M$Y$$$20240918$$CN$US$US
243323441$24332344$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010832$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243323451$24332345$1$I$$20240912$20240918$20240918$PER$$US-ROCHE-10000081238$ROCHE$$$$E$M$Y$95.25$KG$20240918$$CN$US$US
243323461$24332346$1$I$20240905$20240912$20240918$20240918$EXP$$US-AMGEN-USASP2024183522$AMGEN$$69$YR$E$F$Y$$$20240918$$CN$US$US
243323471$24332347$1$I$20240831$20240910$20240918$20240918$PER$$US-AMGEN-USASP2024182906$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243323481$24332348$1$I$$20240916$20240918$20240918$EXP$$AU-SANDOZ INC.-SDZ2024AU080655$SANDOZ$$48$YR$$M$Y$$$20240918$$MD$AU$AU
243323491$24332349$1$I$$20240912$20240918$20240918$EXP$$US-RDY-SPO/USA/24/0013468$DR REDDYS$$33$YR$A$M$Y$$$20240918$$MD$US$US
243323501$24332350$1$I$$20240910$20240918$20240918$EXP$$US-RDY-SPO/USA/24/0013581$DR REDDYS$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. Journal of Oncology Pharmacy Practice. 2024;0(0): doi:10.1177/10781552241265884.$61$YR$A$M$Y$$$20240918$$HP$US$US
243323511$24332351$1$I$20240219$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63754$$FDA-CTU$$28$YR$$F$N$180$LBS$20240916$N$CN$US$
243323521$24332352$1$I$20240916$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63722$$FDA-CTU$$$$$$N$$$20240916$N$CN$US$
243323531$24332353$1$I$$20240916$20240918$20240918$EXP$$US-SA-2024SA268665$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240918$$HP$US$US
243323541$24332354$1$I$$20240909$20240918$20240918$EXP$$CA-APOTEX-2024AP010413$APOTEX$$48$YR$$F$Y$68$KG$20240918$$HP$CA$CA
243323551$24332355$1$I$$20240911$20240918$20240918$EXP$$US-GSK-US2024113089$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$US$US
243323561$24332356$1$I$$20240912$20240918$20240918$EXP$$JP-GSK-JP2024115039$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$JP$JP
243323581$24332358$1$I$$20240913$20240918$20240918$EXP$$NVSJ2024JP010948$NOVARTIS$$$$$$Y$$$20240918$$MD$JP$JP
243323591$24332359$1$I$$20240903$20240918$20240918$PER$$US-TEVA-VS-3240896$TEVA$$$$$M$Y$$$20240918$$CN$US$US
243323601$24332360$1$I$$20240911$20240918$20240918$EXP$$CA-HALEON-2196982$Haleon PLC$$58$YR$$F$Y$$$20240918$$HP$CA$CA
243323611$24332361$1$I$$20240916$20240918$20240918$EXP$$NVSC2024VN184620$NOVARTIS$Binh VTT, Nguyen BK, Nhung NT, Thuy DT, Hong TT, Huong DPT. ket qua ghep te bao goc dong loai mau ngoai vi tu nguoi hien phu hop hoan toan hla dieu tr? benh suy tuy xuong t?i vien huyet h?c - truyen mau trung uong (2010-2022). VIETNAM MEDICAL JOURNAL. 2022;520:41-50$$$$$Y$$$20240918$$HP$VN$VN
243323621$24332362$1$I$$20240912$20240918$20240918$EXP$$NVSC2024US145687$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243323641$24332364$1$I$20130701$20240909$20240918$20240918$EXP$$NVSC2024CN183475$NOVARTIS$Xing Q, Wang L, Chen Y. Chen yiping?s experience in treating idiopathic membranous nephropathy with mediating three-jiao. SHANDONG JOURNAL OF TRADITIONAL CHINESE MEDICINE. 2024;43(9):1000-5$71$YR$$M$Y$$$20240918$$HP$CN$CN
243323651$24332365$1$I$$20240911$20240918$20240918$EXP$$CO-ASTELLAS-2024-AER-006569$ASTELLAS$$72$YR$E$M$Y$80$KG$20240918$$CN$CO$CO
243323661$24332366$1$I$$20240913$20240918$20240918$PER$$US-TAKEDA-2024TUS092274$TAKEDA$$$$$M$Y$$$20240918$$CN$US$US
243323671$24332367$1$I$$20240911$20240918$20240918$EXP$$NVSC2024CA183737$NOVARTIS$$8$YR$$F$Y$$$20240918$$HP$CA$CA
243323681$24332368$1$I$20231001$20240912$20240918$20240918$EXP$$NVSC2024US184043$NOVARTIS$$54$YR$$F$Y$$$20240918$$MD$US$US
243323692$24332369$2$F$20220101$20240918$20240918$20240925$EXP$$NVSJ2024JP010969$NOVARTIS$$$$$F$Y$59.3$KG$20240925$$MD$JP$JP
243323701$24332370$1$I$$20240910$20240918$20240918$EXP$$NVSC2024CA181537$NOVARTIS$$63$YR$$M$Y$61$KG$20240918$$HP$CA$CA
243323711$24332371$1$I$$20240909$20240918$20240918$EXP$$US-AMAROX PHARMA-HET2024US03148$HETERO$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:102625:1-6$67$YR$$$Y$$$20240918$$HP$US$US
243323731$24332373$1$I$20240831$20240916$20240918$20240918$EXP$$BE-SANDOZ INC.-SDZ2024BE080748$SANDOZ$$22$YR$$F$Y$$$20240918$$PH$BE$BE
243323741$24332374$1$I$20150804$20240423$20240918$20240918$PER$$US-ENDO USA, INC.-2023-005539$ENDO$$0$YR$$F$Y$$$20240918$$CN$US$US
243323752$24332375$2$F$$20240913$20240918$20240925$EXP$$IT-AUROBINDO-AUR-APL-2024-045216$AUROBINDO$Pilotto C, Coassin E, Borsatti E, Tuniz F, Pegolo E, D^Agostini S, et al. USING [18F]FET-PET/CT SCAN TO DIFFERENTIATE RADIONECROSIS FROM RECURRENCE/NEW TUMOURS: THE CASE OF A CNS SARCOMA. Neuro-Oncology. 2024;26(4):107-107$5$YR$$F$Y$$$20240925$$HP$IT$IT
243323761$24332376$1$I$$20240917$20240918$20240918$PER$$US-ROCHE-10000085059$ROCHE$$22$YR$A$F$Y$$$20240918$$MD$US$US
243323771$24332377$1$I$20230101$20240910$20240918$20240918$EXP$$BR-ROCHE-10000083486$ROCHE$$63$YR$A$F$Y$52$KG$20240918$$HP$BR$BR
243323781$24332378$1$I$$20240912$20240918$20240918$PER$$US-TAKEDA-2024TUS091387$TAKEDA$$$$$M$Y$83$KG$20240918$$CN$US$US
243323791$24332379$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001323US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$US$US
243323801$24332380$1$I$20230101$20240910$20240918$20240918$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011807$STRIDES$Qian Y, Zhi Z, Ai J, Kang L, Qiu G, Huang X, et al.. Immune-related intestinal pseudo-obstruction caused by immune checkpoint inhibitors: case report.. Front-Oncol. 2024;14$64$YR$$M$Y$$$20240918$$HP$CN$CN
243323811$24332381$1$I$20240301$20240906$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045200$AUROBINDO$$61$YR$$F$Y$$$20240918$$MD$FR$FR
243323822$24332382$2$F$$20240910$20240918$20240918$PER$$US-ROCHE-10000078005$ROCHE$$55$YR$A$F$Y$$$20240918$$CN$US$US
243323841$24332384$1$I$$20240916$20240918$20240918$EXP$$ZA-AstraZeneca-2024A212049$ASTRAZENECA$$64$YR$$F$Y$$$20240918$$CN$ZA$
243323851$24332385$1$I$$20240916$20240918$20240918$EXP$$ZA-AstraZeneca-2024A213024$ASTRAZENECA$$84$YR$$M$Y$$$20240918$$CN$ZA$
243323861$24332386$1$I$$20240905$20240918$20240918$EXP$$NL-AUROBINDO-AUR-APL-2017-05269$AUROBINDO$Bakker NA, van Dijk JMC, Slart RHJA, Coppes MH, Van Imhoff GW, Verschuuren EAM.. Extradural Thoracic Spinal Cord Compression: Unusual Initial Presentation of Post-transplant Lymphoproliferative Disorder.. The Journal of Heart and Lung Transplantation. 2008;27(10):1165-1168$44$YR$$M$Y$$$20240918$$MD$NL$NL
243323871$24332387$1$I$20240801$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184482$AMGEN$$57$YR$A$F$Y$$$20240918$$HP$US$US
243323891$24332389$1$I$$20240916$20240918$20240918$EXP$$RU-AstraZeneca-2024A212365$ASTRAZENECA$Katushkina Yu.A., Tatarintseva Z.G., Kosmacheva E.D.. A case of severe euglycemic ketoacidosis arising during dapagliflozin intake. Therapy 2024;10(6):129-136.$43$YR$$M$Y$$$20240918$$MD$RU$
243323902$24332390$2$F$$20240910$20240918$20240918$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP011866$STRIDES$Rampi A, Comini LV, Galli A, Howardson BO, Tettamanti A, Luparello P, et al.. Reconstructive Surgery of the Head and Neck in Organ Transplant Recipients: A Case Report and a Review of the Literature.. J-Clin-Med. 2024;13 (16):1-11$74$YR$$M$Y$$$20240918$$HP$IT$IT
243323911$24332391$1$I$20230801$20240906$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045355$AUROBINDO$$55$YR$$M$Y$102$KG$20240918$$MD$FR$FR
243323921$24332392$1$I$$20240827$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08633$LUPIN$$$$$$Y$$$20240918$$PH$US$US
243323931$24332393$1$I$$20240905$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045108$AUROBINDO$$71$YR$$F$Y$52$KG$20240918$$CN$FR$FR
243323941$24332394$1$I$$20240909$20240918$20240918$30DAY$$US-GSK-US2024112047$GLAXOSMITHKLINE$$$$$M$Y$$$20240918$$CN$US$US
243323952$24332395$2$F$$20240923$20240918$20240930$EXP$$TR-TEVA-VS-3242520$TEVA$Gokten DB, Kavak FY, Mercan R. Bilateral hand dactylitis: An unusual presentation of the great imitator: Tuberculosis. Mod-Rheumatol-Case-Rep 2024; 8 (2): 365-367.; Gokten DB, Kavak FY, Mercan R. Bilateral hand dactylitis: An unusual presentation of the great imitator: Tuberculosis. Mod-Rheumatol-Case-Rep 2024; 8 (2): 365-367.$42$YR$$M$Y$$$20240930$$HP$TR$TR
243323961$24332396$1$I$20240901$20240911$20240918$20240918$EXP$$US-JNJFOC-20240929467$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240918$$HP$US$US
243323971$24332397$1$I$20240814$20240909$20240918$20240918$EXP$$US-BAYER-2024A128966$BAYER$$77$YR$E$M$Y$$$20240918$$PH$US$US
243323982$24332398$2$F$$20240923$20240918$20240930$EXP$$RU-TEVA-VS-3242506$TEVA$Romanenko VA, Aksenova VA, Klevno NI, Kazakov AV, Sokolskaya EA. Non-injection chemotherapy schemes for pediatric multidrug-resistant tuberculosis. Infect-Chemotherap 2024; 56 (Suppl.) S172.; Romanenko VA, Aksenova VA, Klevno NI, Kazakov AV, Sokolskaya EA. Non-injection chemotherapy schemes for pediatric multidrug-resistant tuberculosis. Infect-Chemotherap 2024; 56 (Suppl.) S172.$$$$$Y$$$20240930$$HP$RU$RU
243323991$24332399$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010838$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243324002$24332400$2$F$20180101$20240916$20240918$20240924$EXP$DK-SANDOZ-SDZ2024DK080492$DK-SANDOZ INC.-SDZ2024DK080492$SANDOZ$$$$E$F$Y$$$20240924$$MD$DK$DK
243324011$24332401$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010865$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243324021$24332402$1$I$20240818$20240912$20240918$20240918$EXP$$IN-ROCHE-10000081870$ROCHE$$53$YR$A$M$Y$$$20240918$$CN$IN$IN
243324031$24332403$1$I$20240701$20240916$20240918$20240918$EXP$$MM-ROCHE-10000083130$ROCHE$$59$YR$A$M$Y$$$20240918$$CN$MM$MM
243324041$24332404$1$I$20211021$20240911$20240918$20240918$EXP$GB-MHRA-MED-202409061520071100-MHTSB$GB-LEO Pharma-373416$LEO PHARM$$61$YR$$F$Y$77$KG$20240918$$CN$GB$GB
243324051$24332405$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010950$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243324061$24332406$1$I$$20240910$20240918$20240918$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP011822$STRIDES$Aydin T, Kaya SK, Ozguroglu M, Seyahi N, Ar MC.. CASE OF ALVEOLAR HEMORRHAGE ACCOMPANYING ATYPICAL HAEMOLYTIC UREMIC SYNDROME.. Eur-J-Case-Rep-Intern-Med. 2024;11 (Suppl.):783-784 abstr. 2754.$45$YR$$M$Y$$$20240918$$HP$TR$TR
243324071$24332407$1$I$$20240910$20240918$20240918$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP011890$STRIDES$Yu MD, Bommakanti N, Yonekawa Y, Pulido JS.. Minocycline-induced retinal pigment epithelium hyperpigmentation masquerading as age-related macular degeneration: Case presentation and proposed mechanism.. Am-J-Ophthalmol-Case-Rep. 2024;36 (0)$80$YR$$M$Y$$$20240918$$MD$US$US
243324081$24332408$1$I$$20240910$20240918$20240918$EXP$$US-BEH-2024178536$CSL BEHRING$$$$A$F$Y$$$20240918$$HP$US$US
243324101$24332410$1$I$20240817$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63865$$FDA-CTU$$78$YR$$F$N$$$20240916$N$HP$US$
243324111$24332411$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63941$$FDA-CTU$$43$YR$$M$N$$$20240917$N$$US$
243324121$24332412$1$I$$20240909$20240918$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024625$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240918$$$US$US
243324131$24332413$1$I$20240916$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63758$$FDA-CTU$$$$$$N$$$20240916$N$$US$
243324141$24332414$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63799$$FDA-CTU$$63$YR$$F$N$$$20240917$N$HP$US$
243324151$24332415$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63802$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243324161$24332416$1$I$$20240916$20240918$20240918$EXP$$MM-ROCHE-10000082791$ROCHE$$48$YR$A$M$Y$$$20240918$$CN$MM$MM
243324171$24332417$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63942$$FDA-CTU$$66$YR$$F$N$$$20240917$N$$US$
243324181$24332418$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63938$$FDA-CTU$$30$YR$$F$N$$$20240917$N$$US$
243324191$24332419$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010770$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243324211$24332421$1$I$$20240911$20240918$20240918$EXP$$GB-009507513-2409GBR005263$MERCK$Platt J, Allotey J, Alouani E, Glasbey J, Intini R, Lonardi S, et al. Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series. ESMO Open. 2024;9(9)$49$YR$$M$Y$$$20240918$$MD$GB$GB
243324221$24332422$1$I$$20240910$20240918$20240918$EXP$$US-RDY-SPO/USA/24/0013525$DR REDDYS$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. Journal of Oncology Pharmacy Practice. 2024;0(0): doi:10.1177/10781552241265884.$69$YR$E$F$Y$$$20240918$$HP$US$US
243324231$24332423$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63943$$FDA-CTU$$63$YR$$M$N$92.53$KG$20240917$N$$US$
243324241$24332424$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63894$$FDA-CTU$$68$YR$$F$N$147.42$KG$20240917$N$$US$
243324251$24332425$1$I$$20240912$20240918$20240918$EXP$$IN-ROCHE-10000082279$ROCHE$$48$YR$A$M$Y$$$20240918$$MD$IN$IN
243324261$24332426$1$I$20240821$20240910$20240918$20240918$EXP$IT-MINISAL02-1001256$IT-ROCHE-10000078191$ROCHE$$69$YR$E$M$Y$83$KG$20240918$$MD$IT$IT
243324271$24332427$1$I$$20240909$20240918$20240918$EXP$$AR-GSK-AR2024AMR113835$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$AR$AR
243324292$24332429$2$F$$20240911$20240918$20240923$EXP$$NL-ABBVIE-5927456$ABBVIE$$71$YR$$F$Y$$$20240923$$CN$NL$NL
243324301$24332430$1$I$20240911$20240912$20240918$20240918$EXP$$ZA-ABBVIE-5927243$ABBVIE$$69$YR$$F$Y$$$20240918$$CN$ZA$ZA
243324311$24332431$1$I$20240711$20240903$20240918$20240918$EXP$$BR-BAXTER-2024BAX024370$BAXTER$$18$YR$$F$Y$68$KG$20240918$$CN$BR$BR
243324321$24332432$1$I$$20240913$20240918$20240918$EXP$$AE-ROCHE-10000083139$ROCHE$$72$YR$E$M$Y$$$20240918$$CN$AE$AE
243324331$24332433$1$I$$20240912$20240918$20240918$EXP$$FR-ABBVIE-5909470$ABBVIE$$$$A$F$Y$68$KG$20240918$$MD$FR$FR
243324341$24332434$1$I$$20240909$20240918$20240918$EXP$$GR-BAXTER-2019BAX005754$BAXTER$Alexanian I..The implementation of the guidelines for heart failure in clinical practice.DECONGESTION IN HEART FAILURE WITH LOW BLOOD PRESSURE ;:.$75$YR$$M$Y$$$20240918$$MD$GR$GR
243324351$24332435$1$I$20240910$20240911$20240918$20240918$PER$$US-ROCHE-10000080375$ROCHE$$84$YR$E$F$Y$$$20240918$$CN$US$US
243324361$24332436$1$I$$20240904$20240918$20240918$EXP$$US-AUROBINDO-AUR-APL-2024-044842$AUROBINDO$Hussain SA, Berenji R, Faisal S, Ali L, Knavel A.. A rare case of symmetrical drug-related intertriginous and flexural erythema with tamoxifen use. Clinical case reports. 2024;12 (9):e9401$48$YR$$F$Y$$$20240918$$MD$US$US
243324371$24332437$1$I$20240829$20240905$20240918$20240918$EXP$$GB-AUROBINDO-AUR-APL-2024-044478$AUROBINDO$$50$YR$$F$Y$93$KG$20240918$$HP$GB$GB
243324381$24332438$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010882$ELI LILLY AND CO$$$$$M$Y$$$20240918$$CN$US$US
243324391$24332439$1$I$20240913$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010010$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240918$$CN$US$US
243324401$24332440$1$I$20240827$20240906$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409004367$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240918$$CN$US$US
243324411$24332441$1$I$20240901$20240912$20240918$20240918$EXP$$US-AMGEN-USASL2024178283$AMGEN$$64$YR$A$M$Y$$$20240918$$CN$US$US
243324421$24332442$1$I$$20240911$20240918$20240918$EXP$$GB-009507513-2409GBR005265$MERCK$Platt J, Allotey J, Alouani E, Glasbey J, Intini R, Lonardi S, et al. Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series. ESMO Open. 2024;9(9)$64$YR$$F$Y$$$20240918$$MD$GB$GB
243324431$24332443$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010866$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243324441$24332444$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010842$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243324451$24332445$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000084758$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243324461$24332446$1$I$$20240909$20240918$20240918$30DAY$$US-GSK-US2024112022$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243324471$24332447$1$I$20240915$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184967$AMGEN$$64$YR$A$F$Y$$$20240918$$CN$US$US
243324481$24332448$1$I$20240902$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148013$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240918$$CN$US$US
243324491$24332449$1$I$20210101$20240906$20240918$20240918$EXP$$NL-Accord-446223$ACCORD$Sogbein O, Gamilla-Crudo AKN, Mujtaba MA, Hussain SA. Transplant Graft TMA Injury Post COVID-19 Vaccination. American Journal of Kidney Diseases.. 2022;79(4 Suppl 2):S31.$48$YR$A$M$Y$$$20240918$$HP$NL$US
243324501$24332450$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147582$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240918$$CN$US$US
243324511$24332451$1$I$20240501$20240913$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146393$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240918$$HP$US$US
243324521$24332452$1$I$20240101$20240906$20240918$20240918$EXP$$GR-AMICUS THERAPEUTICS, INC.-AMI_3370$AMICUS THERAPEUTICS$$72$YR$$M$Y$$$20240918$$MD$GR$GR
243324531$24332453$1$I$$20240906$20240918$20240918$EXP$$US-BEH-2024178380$CSL BEHRING$$$$$$Y$$$20240918$$MD$US$US
243324541$24332454$1$I$$20240909$20240918$20240918$EXP$$US-AMAROX PHARMA-HET2024US03144$HETERO$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:1-6$65$YR$$$Y$$$20240918$$HP$US$US
243324551$24332455$1$I$$20240913$20240918$20240918$EXP$$CA-ROCHE-10000081630$ROCHE$$56$YR$A$F$Y$$$20240918$$HP$CA$CA
243324561$24332456$1$I$20210101$20240910$20240918$20240918$EXP$$US-MYLANLABS-2024M1083704$MYLAN$$44$YR$$M$Y$$$20240918$$CN$US$US
243324571$24332457$1$I$$20240910$20240918$20240918$EXP$$PH-MYLANLABS-2024M1083727$MYLAN$Legaspi LAE, Ondinee-Igot M, Fernando G. Rare Metastatic Primary Intra-Abdominal Follicular Dendritic Cell Sarcoma Poorly Responsive to Chemotherapy: A Case Report. Phil-J-Intern-Med 2024; 62 (1): 308-313.$33$YR$$F$Y$$$20240918$$MD$PH$PH
243324581$24332458$1$I$$20240910$20240918$20240918$EXP$$CA-HLS-202402286$HLS THERAPEUTICS$$65$YR$$M$Y$$$20240917$$HP$CA$CA
243324591$24332459$1$I$$20240904$20240918$20240918$EXP$$US-ASTELLAS-2024US022127$ASTELLAS$$65$YR$E$M$Y$$$20240918$$CN$US$US
243324601$24332460$1$I$$20240910$20240918$20240918$EXP$$IT-MYLANLABS-2024M1084091$MYLAN$Suanno G, Pederzolli M, Lasagni Vitar RM, Fonteyne P, Ferrari G. Topical fosaprepitant for the treatment of ocular pain and inflammation. Am-J-Ophthalmol-Case-Rep 2023; 32.$18$YR$$F$Y$$$20240918$$HP$IT$IT
243324621$24332462$1$I$20240501$20240906$20240918$20240918$EXP$FR-AFSSAPS-ST2024001387$FR-Accord-445949$ACCORD$$43$YR$A$M$Y$60$KG$20240918$$MD$FR$FR
243324631$24332463$1$I$$20240910$20240918$20240918$EXP$$CH-ROCHE-10000079571$ROCHE$$$$$$Y$$$20240918$$MD$CH$CH
243324641$24332464$1$I$20230901$20240911$20240918$20240918$EXP$$AT-ROCHE-10000080754$ROCHE$$64$YR$A$F$Y$$$20240918$$MD$AT$AT
243324661$24332466$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63948$$FDA-CTU$$55$YR$$M$N$$$20240917$N$$US$
243324671$24332467$1$I$$20240910$20240918$20240918$EXP$$CA-AstraZeneca-2024A213063$ASTRAZENECA$$70$YR$$F$Y$$$20240918$$HP$CA$
243324681$24332468$1$I$$20240905$20240918$20240918$EXP$$US-B.Braun Medical Inc.-2161751$B BRAUN$Literature Article$42$YR$$F$Y$$$20240918$$$US$US
243324691$24332469$1$I$20240520$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409061114454530-PRQHZ$GB-MACLEODS PHARMA-MAC2024049352$MACLEODS$$$$$$Y$$$20240918$$MD$GB$GB
243324701$24332470$1$I$$20240905$20240918$20240918$EXP$GB-MHRA-MIDB-05eb5954-9762-4004-9c3d-bcdfff55175c$GB-MACLEODS PHARMA-MAC2024049332$MACLEODS$$$$$$Y$$$20240918$$PH$GB$GB
243324711$24332471$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63944$$FDA-CTU$$54$YR$$F$N$76.2$KG$20240917$N$$US$
243324721$24332472$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63940$$FDA-CTU$$71$YR$$F$N$$$20240917$N$$US$
243324732$24332473$2$F$20240908$20240917$20240918$20240919$PER$$US-AMGEN-USASP2024185926$AMGEN$$77$YR$E$F$Y$$$20240919$$CN$US$US
243324741$24332474$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010758$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243324751$24332475$1$I$20231120$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63773$$FDA-CTU$$74$YR$$F$N$161$LBS$20240916$N$MD$US$
243324761$24332476$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63929$$FDA-CTU$$36$YR$$M$N$$$20240917$N$$US$
243324771$24332477$1$I$20240730$20240906$20240918$20240918$EXP$$FR-AUROBINDO-AUR-APL-2024-045273$AUROBINDO$$51$YR$$M$Y$$$20240918$$HP$FR$FR
243324781$24332478$1$I$20240712$20240910$20240918$20240918$EXP$$US-ORGANON-O2409USA000799$ORGANON$$$$I$M$Y$$$20240918$$HP$US$US
243324791$24332479$1$I$20240814$20240906$20240918$20240918$EXP$GB-MHRA-MED-202408240949589110-FRWHK$GB-862174955-ML2024-04641$Unknown Manufacturer$$$$$M$Y$89$KG$20240918$$CN$GB$GB
243324801$24332480$1$I$20240826$20240909$20240918$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028475$UNITED THERAPEUTICS$$68$YR$$F$Y$74.376$KG$20240918$$$US$US
243324811$24332481$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148216$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240918$$HP$US$US
243324821$24332482$1$I$20240101$20240830$20240918$20240918$EXP$$US-RDY-CLI/USA/24/0013476$DR REDDYS$$22$YR$A$F$Y$$$20240918$$MD$US$US
243324841$24332484$1$I$20240914$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63755$$FDA-CTU$$34$YR$$F$N$125$LBS$20240916$N$CN$US$
243324851$24332485$1$I$$20240911$20240918$20240918$EXP$$GB-JNJFOC-20240931700$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240918$$CN$GB$GB
243324871$24332487$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010771$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243324881$24332488$1$I$$20240917$20240918$20240918$EXP$$CA-SANDOZ INC.-SDZ2024CA075620$SANDOZ$$35$YR$$M$Y$$$20240918$$MD$CA$CA
243324891$24332489$1$I$20240808$20240916$20240918$20240918$EXP$$AU-AMERICAN REGENT INC-2024003531$AMERICAN REGENT$$16$YR$$F$Y$$$20240918$$MD$AU$AU
243324901$24332490$1$I$20240801$20240910$20240918$20240918$PER$$US-ABBVIE-5918107$ABBVIE$$46$YR$$F$Y$$$20240918$$CN$US$US
243324911$24332491$1$I$20161101$20240830$20240918$20240918$EXP$$DE-CELLTRION INC.-2024DE022138$CELLTRION$Michl GM, Vogt FM, Nouriani A, Ladurner R, Kremer M, Reislander T, et al. Long-Term Progression-Free Survival of a Pre-Treated Patient with Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil. Chemotherapy. 2024;69(1):27-34$$$$$Y$$$20240918$$MD$DE$DE
243324931$24332493$1$I$$20240911$20240918$20240918$EXP$$GB-009507513-2409GBR005266$MERCK$Platt J, Allotey J, Alouani E, Glasbey J, Intini R, Lonardi S, et al. Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series. ESMO Open. 2024;9(9)$71$YR$$F$Y$$$20240918$$MD$GB$GB
243324941$24332494$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084177$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$41$YR$$F$Y$$$20240918$$HP$IE$IE
243324951$24332495$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084171$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$60$YR$$M$Y$$$20240918$$HP$IE$IE
243324961$24332496$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084163$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$32$YR$$M$Y$$$20240918$$HP$IE$IE
243324971$24332497$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084165$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$60$YR$$M$Y$$$20240918$$HP$IE$IE
243324981$24332498$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084164$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$64$YR$$F$Y$$$20240918$$HP$IE$IE
243324991$24332499$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084176$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$26$YR$$M$Y$$$20240918$$HP$IE$IE
243325001$24332500$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084182$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$67$YR$$F$Y$$$20240918$$HP$IE$IE
243325011$24332501$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084170$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$42$YR$$M$Y$$$20240918$$HP$IE$IE
243325021$24332502$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084169$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$77$YR$$M$Y$$$20240918$$HP$IE$IE
243325031$24332503$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084160$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$33$YR$$F$Y$$$20240918$$HP$IE$IE
243325041$24332504$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084173$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$48$YR$$F$Y$$$20240918$$HP$IE$IE
243325051$24332505$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084174$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$57$YR$$F$Y$$$20240918$$HP$IE$IE
243325061$24332506$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010839$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243325071$24332507$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084168$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$55$YR$$F$Y$$$20240918$$HP$IE$IE
243325081$24332508$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084162$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$57$YR$$F$Y$$$20240918$$HP$IE$IE
243325091$24332509$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084191$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$43$YR$$F$Y$$$20240918$$HP$IE$IE
243325101$24332510$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010854$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243325111$24332511$1$I$$20240911$20240918$20240918$EXP$$GB-009507513-2409GBR005267$MERCK$Platt J, Allotey J, Alouani E, Glasbey J, Intini R, Lonardi S, et al. Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series. ESMO Open. 2024;9(9)$24$YR$$F$Y$$$20240918$$MD$GB$GB
243325121$24332512$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185071$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243325131$24332513$1$I$20240914$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185027$AMGEN$$84$YR$E$F$Y$$$20240918$$CN$US$US
243325141$24332514$1$I$20240101$20240912$20240918$20240918$EXP$$US-ABBVIE-5924075$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243325151$24332515$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5914202$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243325181$24332518$1$I$$20240911$20240918$20240918$EXP$$SG-AMGEN-SGPSP2024182290$AMGEN$$$$A$F$Y$$$20240918$$MD$SG$SG
243325192$24332519$2$F$20240401$20240924$20240918$20240925$PER$$US-AMGEN-USASP2024185538$AMGEN$$79$YR$E$F$Y$$$20240925$$MD$US$US
243325201$24332520$1$I$20240520$20240911$20240918$20240918$EXP$$US-ABBVIE-5873492$ABBVIE$$70$YR$$M$Y$122$KG$20240918$$MD$US$US
243325211$24332521$1$I$20231010$20240913$20240918$20240918$EXP$$JP-ABBVIE-5922533$ABBVIE$$75$YR$$M$Y$$$20240918$$MD$JP$JP
243325221$24332522$1$I$$20240827$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08619$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243325231$24332523$1$I$$20240912$20240918$20240918$PER$$US-AMGEN-USASP2024183445$AMGEN$$$$$$Y$$$20240918$$HP$US$US
243325241$24332524$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185131$AMGEN$$$$$$Y$$$20240918$$HP$US$US
243325251$24332525$1$I$$20240910$20240918$20240918$EXP$$US-MYLANLABS-2024M1084220$MYLAN$Horblitt A, Jain D, Kabra N, Jolly G, Gupta S, Dhaduk K. Synthetic angiotensin ii exacerbation of septic myocarditis, cautious utilization of novel vasopressor pharmaceuticals. J-Am-Coll-Cardiol 2019; 73 (Suppl.) (9): 2600.$33$YR$$M$Y$$$20240918$$HP$US$US
243325261$24332526$1$I$$20240912$20240918$20240918$EXP$$GB-MYLANLABS-2024M1083989$MYLAN$$$$$M$Y$$$20240918$$PH$GB$GB
243325271$24332527$1$I$$20240911$20240918$20240918$EXP$$BE-MYLANLABS-2024M1084262$MYLAN$Soetaert S, Smets C. Adrenaline in the treatment of anaphylaxis: Hard on the heart. [Dutch]. Tijdschr-Geneeskd 2024; 80 (7).$46$YR$$F$Y$$$20240918$$HP$BE$BE
243325281$24332528$1$I$20240501$20240912$20240918$20240918$EXP$FR-AFSSAPS-AVLY2024000175$FR-MYLANLABS-2024M1083887$MYLAN$$44$YR$$M$Y$$$20240918$$MD$FR$FR
243325291$24332529$1$I$$20240911$20240918$20240918$EXP$$HR-MYLANLABS-2024M1084484$MYLAN$Belancic A, Pavesic Radonja A, Ganoc L, Vitezic D, Bozina N. Challenging pharmacotherapy management of a psychotic disorder due to a delicate pharmacogenetic profile and drug-drug interactions: a case report and literature review. [Review]. Croat-Med-J 2024; 65 (4): 383-395.$$$A$F$Y$$$20240918$$HP$HR$HR
243325301$24332530$1$I$$20240912$20240918$20240918$EXP$$GB-MYLANLABS-2024M1083972$MYLAN$$$$$M$Y$$$20240918$$MD$GB$GB
243325311$24332531$1$I$$20240910$20240918$20240918$EXP$$CA-HLS-202402288$HLS THERAPEUTICS$$70$YR$E$M$Y$$$20240917$$HP$CA$CA
243325321$24332532$1$I$$20240911$20240918$20240918$EXP$$US-MYLANLABS-2024M1084497$MYLAN$Clark J, Blake A, Vasher S, Boucher RC, Jones AR, Choi HJ, et al. Near fatal case of mirvetuximab soravtansine-gynx induced interstitial lung disease and a review of the primary literature. Gynecol-Oncol-Rep 2024; 55 1-7.$56$YR$$F$Y$$$20240918$$HP$US$US
243325331$24332533$1$I$$20240910$20240918$20240918$EXP$$US-MYLANLABS-2024M1084245$MYLAN$Allen C, Zagunis DC, Weston SD, Liu LL. Extrinsic Positive End-Expiratory Pressure due to Failure of the Positive-Pressure Relief Valve Within the Scavenging System: A Case Report. A-A-Pract 2024; 18 (7):.$47$YR$$M$Y$$$20240918$$MD$US$US
243325341$24332534$1$I$20240604$20240914$20240918$20240918$EXP$$PK-ROCHE-10000011196$ROCHE$$67$YR$E$M$Y$$$20240918$$CN$PK$PK
243325351$24332535$1$I$$20240910$20240918$20240918$EXP$$CA-HLS-202402287$HLS THERAPEUTICS$$26$YR$A$M$Y$$$20240917$$HP$CA$CA
243325361$24332536$1$I$$20240910$20240918$20240918$EXP$$CA-HLS-202402290$HLS THERAPEUTICS$$$$$M$Y$$$20240917$$HP$CA$CA
243325372$24332537$2$F$$20240916$20240918$20240925$EXP$$CA-HLS-202402341$HLS THERAPEUTICS$$$$A$M$Y$$$20240925$$HP$CA$CA
243325381$24332538$1$I$$20240910$20240918$20240918$EXP$$CA-HLS-202402289$HLS THERAPEUTICS$$$$$M$Y$$$20240917$$HP$CA$CA
243325391$24332539$1$I$20240904$20240912$20240918$20240918$PER$$US-AMGEN-USASP2024182956$AMGEN$$$$$F$Y$$$20240918$$HP$US$US
243325401$24332540$1$I$20240912$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024183666$AMGEN$$72$YR$E$$Y$$$20240918$$MD$US$US
243325411$24332541$1$I$$20240917$20240918$20240918$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051934$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240918$$HP$US$US
243325421$24332542$1$I$$20240911$20240918$20240918$EXP$$US-GSK-US2024113019$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243325431$24332543$1$I$$20240911$20240918$20240918$EXP$$US-GSK-US2024113087$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243325441$24332544$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63923$$FDA-CTU$$73$YR$$F$N$78.93$KG$20240917$N$$US$
243325451$24332545$1$I$$20240818$20240918$20240918$PER$$US-HALEON-2196367$Haleon PLC$$19$YR$$F$Y$$$20240918$$HP$US$US
243325461$24332546$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147733$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$98.43$KG$20240918$$CN$US$US
243325482$24332548$2$F$$20240904$20240918$20240918$EXP$$US-ASTELLAS-2024-AER-004799$ASTELLAS$$62$YR$A$F$Y$102$KG$20240918$$HP$US$US
243325491$24332549$1$I$$20240906$20240918$20240918$EXP$$US-UCBSA-2024046146$UCB$$$$$$Y$$$20240918$$MD$US$US
243325501$24332550$1$I$$20240911$20240918$20240918$EXP$$JP-ROCHE-10000083429$ROCHE$$41$YR$A$F$Y$$$20240918$$MD$JP$JP
243325511$24332551$1$I$20240905$20240911$20240918$20240918$EXP$$IT-JNJFOC-20240937602$JOHNSON AND JOHNSON$$51$YR$A$M$Y$50$KG$20240918$$MD$IT$IT
243325521$24332552$1$I$$20240917$20240917$20240917$DIR$718797$$FDA-CTU$$$$$M$N$$$20240917$Y$HP$US$
243325531$24332553$1$I$20240917$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63954$$FDA-CTU$$57$YR$$$N$$$20240918$N$$US$
243325541$24332554$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63953$$FDA-CTU$$45$YR$$F$N$$$20240917$N$$US$
243325551$24332555$1$I$20240914$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63955$$FDA-CTU$$58$YR$$F$N$$$20240917$Y$HP$US$
243325561$24332556$1$I$$20240917$20240917$20240917$DIR$718770$$FDA-CTU$$$$$F$N$$$20240917$Y$HP$US$
243325571$24332557$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63945$$FDA-CTU$$48$YR$$F$N$83.01$KG$20240917$N$HP$US$
243325601$24332560$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009743$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240918$$CN$US$US
243325611$24332561$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009078$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240918$$CN$US$US
243325621$24332562$1$I$$20240903$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009866$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240918$$CN$US$US
243325631$24332563$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009730$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240918$$CN$US$US
243325641$24332564$1$I$20240301$20240912$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008541$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240918$$CN$US$US
243325651$24332565$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009962$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240918$$CN$US$US
243325671$24332567$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010022$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240918$$CN$US$US
243325681$24332568$1$I$20240914$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010121$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240918$$CN$US$US
243325691$24332569$1$I$20240323$20240909$20240918$20240918$EXP$$GB-TEVA-VS-3242959$TEVA$$$$C$$Y$$$20240918$$CN$GB$GB
243325702$24332570$2$F$20230101$20240919$20240918$20240926$EXP$$GB-009507513-2409GBR005264$MERCK$Platt J, Allotey J, Alouani E, Glasbey J, Intini R, Lonardi S, et al. Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series. ESMO Open. 2024;9(9)$76$YR$$F$Y$53.5$KG$20240926$$MD$GB$GB
243325712$24332571$2$F$$20240923$20240918$20240930$EXP$$US-TEVA-VS-3243779$TEVA$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.; Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240930$$MD$US$US
243325721$24332572$1$I$$20240910$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145977$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240918$$HP$US$US
243325731$24332573$1$I$20240916$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148018$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$97.98$KG$20240918$$PH$US$US
243325751$24332575$1$I$20240901$20240912$20240918$20240918$EXP$$CA-TAKEDA-2024TUS091740$TAKEDA$$79$YR$$M$Y$$$20240918$$MD$CA$CA
243325772$24332577$2$F$20240912$20240924$20240918$20240930$PER$$US-AMGEN-USASP2024183880$AMGEN$$74$YR$E$F$Y$78.74$KG$20240930$$HP$US$US
243325781$24332578$1$I$20221130$20240914$20240918$20240918$PER$$US-009507513-2409USA005503$MERCK$$71$YR$$F$Y$$$20240918$$CN$US$US
243325791$24332579$1$I$$20240911$20240918$20240918$PER$$US-JNJFOC-20240940838$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243325801$24332580$1$I$$20240909$20240918$20240918$PER$$US-JNJFOC-20240929897$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$HP$US$US
243325811$24332581$1$I$$20240905$20240918$20240918$30DAY$$HK-JNJFOC-20240931450$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$PH$HK$HK
243325821$24332582$1$I$20240701$20240910$20240918$20240918$EXP$$US-TEVA-VS-3225434$TEVA$$79$YR$$M$Y$69.3$KG$20240918$$PH$US$US
243325831$24332583$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010772$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243325841$24332584$1$I$20240101$20240912$20240918$20240918$EXP$$JP-009507513-2409JPN002004J$MERCK$$7$DEC$$F$Y$$$20240918$$MD$JP$JP
243325861$24332586$1$I$$20240905$20240918$20240918$EXP$$US-PFIZER INC-PV202400121787$PFIZER$$80$YR$$M$Y$$$20240918$$CN$US$US
243325872$24332587$2$F$$20240919$20240918$20240919$EXP$$CA-PFIZER INC-202400258277$PFIZER$$$$$M$Y$$$20240919$$HP$CA$CA
243325883$24332588$3$F$$20240917$20240918$20240923$EXP$$US-PFIZER INC-PV202400063627$PFIZER$$83$YR$$M$Y$$$20240923$$HP$US$US
243325891$24332589$1$I$20240910$20240916$20240918$20240918$EXP$$US-PFIZER INC-PV202400096013$PFIZER$$56$YR$$M$Y$$$20240918$$PH$US$US
243325901$24332590$1$I$20240901$20240912$20240918$20240918$EXP$$JP-AMGEN-JPNSP2024183304$AMGEN$$$$E$$Y$$$20240918$$MD$JP$JP
243325921$24332592$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010788$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243325931$24332593$1$I$20240916$20240917$20240917$20240917$DIR$718771$$FDA-CTU$$5$YR$$M$N$22.5$KG$20240917$N$CN$US$
243325941$24332594$1$I$20240423$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63791$$FDA-CTU$$19$YR$$F$N$$$20240916$N$PH$US$
243325951$24332595$1$I$20240917$20240917$20240917$20240917$DIR$718819$$FDA-CTU$$36$YR$$F$N$59.85$KG$20240917$N$CN$US$
243325971$24332597$1$I$20240613$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63771$$FDA-CTU$$35$YR$$F$N$$$20240916$N$PH$US$
243325981$24332598$1$I$20070101$20240911$20240918$20240918$EXP$$FI-MYLANLABS-2024M1083993$MYLAN$$$$$F$Y$$$20240918$$MD$FI$FI
243326001$24332600$1$I$20240426$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63740$$FDA-CTU$$21$YR$$F$N$$$20240916$N$PH$US$
243326011$24332601$1$I$$20240917$20240917$20240917$DIR$718765$$FDA-CTU$$$$$UNK$N$$$20240917$N$CN$US$
243326021$24332602$1$I$$20240909$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147846$BRISTOL MYERS SQUIBB$Ladwa A, Elghawy O, Kaur V. Single institution experience with immune checkpoint inhibitors in vulvar and vaginal melanomas. Obstetrics and Gynecology International. 2024 Jan 01;1-6.doi:10.1155/2024/7327692.$69$YR$E$F$Y$$$20240918$$HP$US$US
243326031$24332603$1$I$$20240911$20240918$20240918$EXP$$ES-MYLANLABS-2024M1083211$MYLAN$$$$$$Y$$$20240918$$CN$ES$ES
243326042$24332604$2$F$20240807$20240924$20240918$20240926$EXP$FR-AFSSAPS-AM2024000712$FR-MYLANLABS-2024M1083465$MYLAN$$67$YR$$M$Y$125$KG$20240926$$MD$FR$FR
243326051$24332605$1$I$20240521$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63782$$FDA-CTU$$60$YR$$M$N$$$20240916$N$PH$US$
243326061$24332606$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63907$$FDA-CTU$$62$YR$$F$N$$$20240917$N$$US$
243326071$24332607$1$I$$20240911$20240918$20240918$EXP$$AU-MYLANLABS-2024M1083483$MYLAN$Lee E, Bosi I, Peacock K, Lau C, Ford LS, Wong M, et al. Novel infantile presentations of chronic granulomatous disease. Pediatr-Allergy-Immunol 2024; 35 (7): 1-5.$5$WK$$M$Y$$$20240918$$HP$AU$AU
243326081$24332608$1$I$20240914$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63812$$FDA-CTU$$63$YR$$F$N$$$20240917$N$HP$US$
243326091$24332609$1$I$20240905$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63809$$FDA-CTU$$70$YR$$M$N$$$20240917$N$$US$
243326101$24332610$1$I$$20240911$20240918$20240918$EXP$$DE-MYLANLABS-2024M1083566$MYLAN$$69$YR$$M$Y$$$20240918$$CN$DE$DE
243326121$24332612$1$I$20240825$20240912$20240918$20240918$EXP$$US-BAYER-2024A131032$BAYER$$42$YR$A$M$Y$$$20240918$$CN$US$US
243326141$24332614$1$I$$20240912$20240918$20240918$EXP$$CA-MYLANLABS-2024M1084662$MYLAN$Woo J, Eisa M. Clozapine-induced priapism in a man with schizoaffective disorder. J-Psychiatry-Neurosci 2024; 49 (4): E263-E264.$46$YR$$M$Y$$$20240918$$MD$CA$CA
243326151$24332615$1$I$20240507$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63777$$FDA-CTU$$39$YR$$F$N$$$20240916$N$PH$US$
243326161$24332616$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010774$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243326171$24332617$1$I$$20240912$20240918$20240918$EXP$$GB-MYLANLABS-2024M1084637$MYLAN$Karaduman S, Zarif A, Talpeka A, Haseeb M. Transient haemoptysis after taking sildenafil. BMJ-Case-Rep 2024; 17 (7): 1-3.$8$DEC$$M$Y$$$20240918$$HP$GB$GB
243326181$24332618$1$I$$20240912$20240918$20240918$EXP$$JP-ROCHE-10000080019$ROCHE$$9$DEC$E$F$Y$$$20240918$$MD$JP$JP
243326191$24332619$1$I$$20240909$20240918$20240918$EXP$$DE-TAKEDA-2024TUS092616$TAKEDA$$59$YR$$M$Y$$$20240918$$HP$DE$DE
243326201$24332620$1$I$20240817$20240913$20240918$20240918$EXP$$JP-JNJFOC-20240943408$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240918$$PH$JP$JP
243326221$24332622$1$I$20240507$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63780$$FDA-CTU$$39$YR$$F$N$$$20240916$N$PH$US$
243326241$24332624$1$I$20240708$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63718$$FDA-CTU$$69$YR$$F$N$$$20240916$N$PH$US$
243326251$24332625$1$I$20240402$20240917$20240917$20240917$DIR$718755$$FDA-CTU$$18$YR$$M$N$74.5$KG$20240917$N$PH$US$
243326261$24332626$1$I$20240410$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63787$$FDA-CTU$$70$YR$$M$N$$$20240916$N$PH$US$
243326271$24332627$1$I$20240607$20240917$20240917$20240917$DIR$718761$$FDA-CTU$$10$YR$$F$N$50.9$KG$20240917$N$PH$US$
243326281$24332628$1$I$$20240916$20240916$20240916$DIR$FDA-CDER-CTU-2024-63784$$FDA-CTU$$$$$$N$$$20240916$$CN$US$
243326291$24332629$1$I$$20240916$20240918$20240918$EXP$$NVSC2024US185289$NOVARTIS$$$$$F$Y$$$20240918$$HP$US$US
243326301$24332630$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010714$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243326311$24332631$1$I$$20240911$20240918$20240918$PER$$US-UNITED THERAPEUTICS-UNT-2024-029021$UNITED THERAPEUTICS$$$$$F$Y$$$20240918$$$US$US
243326321$24332632$1$I$$20240905$20240918$20240918$EXP$$FR-B.Braun Medical Inc.-2161753$B BRAUN$Literature Article$66$YR$$F$Y$$$20240918$$$FR$FR
243326331$24332633$1$I$$20240910$20240918$20240918$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR113979$VIIV$$$$$M$Y$$$20240918$$HP$US$US
243326351$24332635$1$I$20240912$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185831$AMGEN$$$$$$Y$$$20240918$$PH$US$US
243326361$24332636$1$I$$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185743$AMGEN$$$$$F$Y$$$20240918$$HP$US$US
243326371$24332637$1$I$20240101$20240909$20240918$20240918$EXP$$JP-TAKEDA-2024TUS086103$TAKEDA$$19$YR$$M$Y$$$20240918$$PH$JP$JP
243326381$24332638$1$I$$20240910$20240918$20240918$EXP$$IN-ROCHE-10000079359$ROCHE$$73$YR$E$F$Y$$$20240918$$CN$IN$IN
243326391$24332639$1$I$$20240910$20240918$20240918$EXP$$GB-AMGEN-GBRSP2024180823$AMGEN$$$$A$F$Y$$$20240918$$MD$GB$GB
243326401$24332640$1$I$$20240913$20240918$20240918$PER$$US-ROCHE-10000082618$ROCHE$$51$YR$A$F$Y$$$20240918$$CN$US$US
243326411$24332641$1$I$20240901$20240916$20240918$20240918$PER$$US-ALXN-202409USA001269US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243326421$24332642$1$I$20240901$20240917$20240918$20240918$PER$$US-ALXN-202409USA001288US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243326441$24332644$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001343US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243326451$24332645$1$I$$20240917$20240918$20240918$EXP$$CA-SANDOZ INC.-NVSC2021CA274775$SANDOZ$$52$YR$$F$Y$$$20240918$$CN$CA$CA
243326471$24332647$1$I$$20240909$20240918$20240918$EXP$$CA-ROCHE-10000076960$ROCHE$$32$YR$A$M$Y$$$20240918$$HP$CA$CA
243326481$24332648$1$I$$20240909$20240918$20240918$EXP$$US-ACORDA-ACO_177943_2024$ACORDA$$$$$F$Y$$$20240918$$CN$US$US
243326491$24332649$1$I$20240801$20240912$20240918$20240918$EXP$$US-BAYER-2024A131915$BAYER$$77$YR$E$F$Y$48.073$KG$20240918$$HP$US$US
243326501$24332650$1$I$$20240905$20240918$20240918$EXP$US-MLMSERVICE-20240829-PI176376-00307-1$US-STRIDES ARCOLAB LIMITED-2024SP011502$STRIDES$Zou H, Rau A, Thompson L, Henderson D. Pancytopenia Concurrent With Metabolic Encephalopathy. Cureus. 2024;16(8):e67963$81$YR$$F$Y$$$20240918$$MD$US$US
243326511$24332651$1$I$$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185760$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243326522$24332652$2$F$$20240917$20240918$20240925$EXP$$PL-GILEAD-2024-0687955$GILEAD$$$$$F$Y$$$20240925$$MD$PL$PL
243326531$24332653$1$I$$20240907$20240918$20240918$EXP$$JP-INSMED, INC.-2024-03614-JP$INSMED$$79$YR$$F$Y$$$20240918$$CN$JP$JP
243326541$24332654$1$I$20240905$20240912$20240918$20240918$EXP$$US-AMGEN-USASP2024182873$AMGEN$$84$YR$E$F$Y$$$20240918$$CN$US$US
243326551$24332655$1$I$$20240911$20240918$20240918$EXP$$VN-TAKEDA-2024TUS092588$TAKEDA$$65$YR$$$Y$$$20240918$$MD$VN$VN
243326561$24332656$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147866$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240918$$CN$US$US
243326571$24332657$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS092027$TAKEDA$Parrondo RD, Laplant BR, Elliott J, Femandez A, Flott CJ, Arrington D et. al. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer Journal. 2024;14:152$$$$$Y$$$20240918$$MD$US$US
243326581$24332658$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010773$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243326591$24332659$1$I$$20240912$20240918$20240918$EXP$$JP-GSK-JP2024115102$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$JP$JP
243326601$24332660$1$I$$20240913$20240918$20240918$PER$$US-009507513-2409USA005440$MERCK$$$$$$Y$$$20240918$$HP$US$US
243326611$24332661$1$I$$20240910$20240918$20240918$EXP$$JP-CHEPLA-2024011886$CHEPLAPHARM$$85$YR$$M$Y$$$20240918$$PH$COUNTRY NOT SPECIFIED$JP
243326621$24332662$1$I$$20240904$20240918$20240918$PER$$US-RISINGPHARMA-US-2024RISSPO00325$RISING PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$US$US
243326631$24332663$1$I$$20240917$20240918$20240918$EXP$$GB-MYLANLABS-2024M1084877$MYLAN$$$$E$M$Y$$$20240918$$HP$GB$GB
243326641$24332664$1$I$$20240916$20240918$20240918$EXP$GB-MHRA-MED-202409140958417690-DKJSH$GB-MYLANLABS-2024M1084528$MYLAN$$$$$F$Y$$$20240918$$CN$GB$GB
243326651$24332665$1$I$20240824$20240917$20240918$20240918$EXP$$UA-MYLANLABS-2024M1084775$MYLAN$$28$YR$$M$Y$$$20240918$$HP$UA$UA
243326663$24332666$3$F$20240901$20240918$20240918$20240924$EXP$$US-MYLANLABS-2024M1084804$MYLAN$$$$$$Y$$$20240924$$CN$US$US
243326671$24332667$1$I$20240824$20240912$20240918$20240918$EXP$$BE-ROCHE-10000083587$ROCHE$$86$YR$E$M$Y$$$20240918$$MD$BE$BE
243326681$24332668$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010789$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243326691$24332669$1$I$$20240910$20240918$20240918$EXP$$CA-TEVA-VS-3243943$TEVA$$89$YR$$F$Y$$$20240918$$MD$CA$CA
243326701$24332670$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010193$ELI LILLY AND CO$$$$A$F$Y$$$20240918$$CN$US$US
243326711$24332671$1$I$20240815$20240912$20240918$20240918$EXP$$CN-CHEPLA-2024011754$CHEPLAPHARM$$56$YR$$F$Y$$$20240918$$HP$COUNTRY NOT SPECIFIED$CN
243326721$24332672$1$I$$20240912$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008544$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240918$$CN$US$US
243326731$24332673$1$I$$20240829$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202408019139$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240918$$PH$US$US
243326741$24332674$1$I$$20240910$20240918$20240918$EXP$$JP-PERRIGO-24JP008674$PERRIGO$Kitaya S, Nakano M, Katori Y, Yasuda S, Kanamori H. QTc Interval Prolongation as an Adverse Event of Azole Antifungal Drugs: Case Report and Literature Review. Microorganisms. 2024;12(8):1619. DOI: 10.3390/microorganisms12081619.$77$YR$$M$Y$$$20240918$$MD$JP$JP
243326751$24332675$1$I$20240801$20240910$20240918$20240918$EXP$$US-ZENPEP LLC-2024AIMT01335$AIMMUNE$$$$$$Y$$$20240918$$HP$US$US
243326762$24332676$2$F$20240912$20240914$20240918$20240919$EXP$$CN-BAYER-2024A132792$BAYER$$67$YR$E$M$Y$80$KG$20240919$$HP$CN$CN
243326771$24332677$1$I$$20240909$20240918$20240918$EXP$$JP-VANTIVE-2024VAN019530$Vantive US Healthcare$$91$YR$$F$Y$$$20240918$$HP$JP$JP
243326781$24332678$1$I$20240902$20240909$20240918$20240918$EXP$$US-VANTIVE-2024VAN019645$Vantive US Healthcare$$$$$$Y$$$20240918$$CN$US$US
243326791$24332679$1$I$20240905$20240910$20240918$20240918$EXP$$JP-VANTIVE-2024VAN019569$Vantive US Healthcare$$$$$F$Y$$$20240918$$HP$JP$JP
243326801$24332680$1$I$$20240909$20240918$20240918$EXP$$CA-VANTIVE-2024VAN019695$Vantive US Healthcare$$$$$M$Y$$$20240918$$CN$CA$CA
243326811$24332681$1$I$$20240916$20240918$20240918$EXP$$TR-ROCHE-10000083724$ROCHE$Aksoz Z,  A case report of relapsed/refractory primary central nervous system lymphoma. Journal of Current Hematology + Oncology Research. 2024-Aug-01;2 (3):76-8. doi:10.51271/JCHOR-0043.$42$YR$A$M$Y$$$20240918$$HP$TR$TR
243326841$24332684$1$I$20240729$20240912$20240918$20240918$EXP$$GB-MYLANLABS-2024M1080074$MYLAN$$$$$M$Y$$$20240918$$HP$GB$GB
243326851$24332685$1$I$20240513$20240909$20240918$20240918$EXP$$NVSC2024KR149365$NOVARTIS$$39$YR$$F$Y$$$20240918$$MD$KR$KR
243326861$24332686$1$I$20230101$20240912$20240918$20240918$EXP$$FR-MYLANLABS-2024M1084030$MYLAN$$81$YR$$F$Y$50.2$KG$20240918$$MD$FR$FR
243326881$24332688$1$I$20240109$20240912$20240918$20240918$EXP$ES-AEMPS-1565636$ES-MYLANLABS-2024M1083223$MYLAN$$83$YR$$M$Y$$$20240918$$MD$ES$ES
243326891$24332689$1$I$$20240904$20240918$20240918$EXP$$SE-ROCHE-10000083853$ROCHE$$$$$M$Y$$$20240918$$CN$SE$SE
243326901$24332690$1$I$20240713$20240912$20240918$20240918$EXP$FR-AFSSAPS-AVLY2024000171$FR-MYLANLABS-2024M1083922$MYLAN$$33$YR$$F$Y$$$20240918$$MD$FR$FR
243326911$24332691$1$I$$20240912$20240918$20240918$EXP$$US-INCYTE CORPORATION-2024IN009736$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243326931$24332693$1$I$20240105$20240917$20240917$20240917$DIR$718750$$FDA-CTU$$19$YR$$F$N$131$KG$20240917$N$PH$US$
243326941$24332694$1$I$20231031$20240917$20240917$20240917$DIR$718743$$FDA-CTU$$5$YR$$M$N$23.5$KG$20240917$N$PH$US$
243326951$24332695$1$I$$20240910$20240918$20240918$PER$$US-AMGEN-USASP2024185791$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243326971$24332697$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63814$$FDA-CTU$$79$YR$$M$N$$$20240917$N$$US$
243326981$24332698$1$I$20240608$20240909$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US079263$SANDOZ$$23$YR$$F$Y$54.4$KG$20240918$$CN$US$US
243327001$24332700$1$I$20240903$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63920$$FDA-CTU$$12$YR$$F$N$$$20240917$N$HP$US$
243327011$24332701$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63797$$FDA-CTU$$41$YR$$F$N$$$20240917$N$$US$
243327021$24332702$1$I$20240512$20240917$20240917$20240917$DIR$718767$$FDA-CTU$$28$YR$$M$N$66.6$KG$20240917$N$CN$US$
243327031$24332703$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63962$$FDA-CTU$$49$YR$$F$N$$$20240917$N$$US$
243327041$24332704$1$I$20240903$20240917$20240917$20240917$DIR$718759$$FDA-CTU$$72$YR$$M$N$101.25$KG$20240917$N$CN$US$
243327051$24332705$1$I$20240913$20240913$20240918$20240918$PER$$NVSC2024US185926$NOVARTIS$$67$YR$$M$Y$$$20240918$$CN$US$US
243327061$24332706$1$I$20200101$20240909$20240918$20240918$EXP$$AT-CELLTRION INC.-2024AT022051$CELLTRION$Extension of the therapy algorithm for HER2-positive metastatic gastric carcinoma$$$$$Y$$$20240918$$MD$AT$AT
243327073$24332707$3$F$20240910$20240923$20240918$20240926$EXP$$NVSC2024ZA183545$NOVARTIS$$60$YR$$M$Y$$$20240926$$HP$ZA$ZA
243327081$24332708$1$I$$20240910$20240918$20240918$EXP$$DE-BAYER-2024A130020$BAYER$$44$YR$A$F$Y$$$20240918$$PH$DE$DE
243327092$24332709$2$F$20240627$20240920$20240918$20240924$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-036782$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240924$$CN$JP$JP
243327101$24332710$1$I$20240701$20240905$20240918$20240918$EXP$$JP-INSMED, INC.-2024-02738-JP$INSMED$$76$YR$$F$Y$35.7$KG$20240918$$CN$JP$JP
243327111$24332711$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001314US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243327121$24332712$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010748$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243327131$24332713$1$I$$20240906$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009475$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243327151$24332715$1$I$20240830$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147724$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240918$$HP$US$US
243327161$24332716$1$I$$20240909$20240918$20240918$EXP$$IN-ROCHE-10000014951$ROCHE$$65$YR$E$M$Y$$$20240918$$CN$IN$IN
243327171$24332717$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010790$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243327181$24332718$1$I$$20240911$20240918$20240918$EXP$$US-ABBVIE-5919835$ABBVIE$$$$$F$Y$$$20240918$$HP$US$US
243327191$24332719$1$I$20240121$20240910$20240918$20240918$EXP$$US-HALEON-2196603$Haleon PLC$$$$A$F$Y$141.07$KG$20240918$$HP$US$US
243327202$24332720$2$F$20231019$20240920$20240918$20240925$EXP$$AU-MYLANLABS-2023M1112995$MYLAN$$50$YR$$M$Y$110$KG$20240925$$HP$AU$AU
243327211$24332721$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186177$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243327221$24332722$1$I$$20240906$20240918$20240918$PER$$US-IMP-2024000726$Harrow Health$$$$E$F$Y$$$20240918$$CN$US$US
243327232$24332723$2$F$$20240915$20240918$20240920$30DAY$$US-PFIZER INC-PV202400045658$PFIZER$$10$YR$$F$Y$$$20240920$$HP$US$US
243327242$24332724$2$F$$20240926$20240918$20240927$EXP$$CA-BAYER-2024A130220$BAYER$$28$YR$A$F$Y$$$20240927$$MD$CA$CA
243327251$24332725$1$I$20240908$20240916$20240918$20240918$EXP$$US-BAYER-2024A132236$BAYER$$83$YR$E$M$Y$$$20240918$$CN$US$US
243327271$24332727$1$I$$20240828$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08666$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243327281$24332728$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63801$$FDA-CTU$$96$YR$$F$N$$$20240917$N$$US$
243327291$24332729$1$I$$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024184029$AMGEN$$$$A$F$Y$$$20240918$$HP$US$US
243327301$24332730$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63884$$FDA-CTU$$68$YR$$F$N$$$20240917$N$$US$
243327311$24332731$1$I$20240910$20240917$20240917$20240917$DIR$718775$$FDA-CTU$$78$YR$$F$N$78.75$KG$20240917$N$CN$US$
243327321$24332732$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63804$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243327331$24332733$1$I$$20240911$20240918$20240918$EXP$$US-TAKEDA-2024TUS067670$TAKEDA$$$$$F$Y$$$20240918$$CN$US$US
243327341$24332734$1$I$20240823$20240909$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143859$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240918$$HP$US$US
243327351$24332735$1$I$20240905$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63803$$FDA-CTU$$65$YR$$F$N$$$20240917$Y$PH$US$
243327361$24332736$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010855$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243327372$24332737$2$F$20240103$20240906$20240918$20240918$EXP$$US-ROCHE-10000077499$ROCHE$$81$YR$E$F$Y$$$20240918$$CN$US$US
243327381$24332738$1$I$$20240906$20240918$20240918$EXP$$ES-ROCHE-10000076459$ROCHE$$$$$$Y$$$20240918$$MD$ES$ES
243327391$24332739$1$I$$20240904$20240918$20240918$EXP$$KR-AMNEAL PHARMACEUTICALS-2024-AMRX-03388$AMNEAL$Sagong M, Kim K.T, Jang B.K.. Atezolizumab- and bevacizumab -induced encephalitis in a patient with advanced hepatocellular carcinoma: a case report and literature review. J Cancer Res Clin Oncol.. 2024;150$45$YR$$M$Y$$$20240918$$HP$KR$KR
243327402$24332740$2$F$$20240917$20240918$20240920$PER$$NVSC2024US186093$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243327421$24332742$1$I$20220401$20240913$20240918$20240918$EXP$$US-ABBVIE-5925575$ABBVIE$$63$YR$$F$Y$$$20240918$$CN$US$US
243327441$24332744$1$I$$20240828$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08711$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243327451$24332745$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924101$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243327461$24332746$1$I$20240909$20240909$20240918$20240918$EXP$$CA-JNJFOC-20240925464$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240918$$HP$CA$CA
243327472$24332747$2$F$20240101$20240916$20240918$20240924$EXP$$CA-CELLTRION INC.-2024CA014975$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
243327481$24332748$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924870$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243327491$24332749$1$I$$20240910$20240918$20240918$PER$$US-IMP-2024000731$Harrow Health$$$$A$F$Y$$$20240918$$CN$US$US
243327501$24332750$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5925585$ABBVIE$$48$YR$$F$Y$$$20240918$$CN$US$US
243327511$24332751$1$I$$20240911$20240918$20240918$EXP$$US-TAKEDA-2024TUS074330$TAKEDA$$$$$M$Y$146$KG$20240918$$HP$US$US
243327521$24332752$1$I$$20240910$20240918$20240918$PER$$US-TEVA-VS-3243991$TEVA$$69$YR$$F$Y$$$20240918$$CN$US$US
243327531$24332753$1$I$20240101$20240913$20240918$20240918$EXP$$CA-ABBVIE-5924356$ABBVIE$$$$E$M$Y$$$20240918$$CN$CA$CA
243327541$24332754$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5924047$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243327551$24332755$1$I$20240826$20240911$20240918$20240918$PER$GB-MHRA-MED-202408281145417780-GLBST$GB-IDORSIA-008470-2024-GB$IDORSIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240918$$MD$GB$GB
243327561$24332756$1$I$$20240906$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009469$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243327571$24332757$1$I$20240321$20240916$20240918$20240918$EXP$FR-AFSSAPS-TO2024001737$FR-PFIZER INC-202400257033$PFIZER$$72$YR$$F$Y$$$20240918$$MD$FR$FR
243327581$24332758$1$I$20240822$20240914$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120786$PFIZER$$49$YR$$F$Y$$$20240918$$HP$CN$CN
243327591$24332759$1$I$$20240910$20240918$20240918$EXP$$ES-PFIZER INC-2020SGN00295$PFIZER$$$$$F$Y$$$20240918$$MD$ES$ES
243327601$24332760$1$I$20240829$20240914$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120791$PFIZER$$75$YR$$F$Y$$$20240918$$HP$CN$CN
243327611$24332761$1$I$20210101$20240913$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120425$PFIZER$Liu, Q.. Analysis of 1 case of drug interaction between linezolid and clarithromycin. Central South Pharmacy. 2024;22(8):2221-2224$9$YR$$M$Y$55$KG$20240918$$PH$CN$CN
243327621$24332762$1$I$$20240909$20240918$20240918$EXP$$ES-PFIZER INC-202400252677$PFIZER$Ochando Diez-Canseco, M.. DRESS syndrome and flare-up due to antiepileptics: how to solve the problem.. Neurology. 2024;1-3$35$YR$$M$Y$$$20240918$$HP$ES$ES
243327631$24332763$1$I$20240301$20240907$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009498$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243327641$24332764$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010797$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243327651$24332765$1$I$20090101$20240916$20240918$20240918$EXP$FR-EMA-20170223-sandevhp-170507137$FR-PFIZER INC-202400258133$PFIZER$$59$YR$$M$Y$59$KG$20240918$$HP$FR$FR
243327671$24332767$1$I$$20240917$20240917$20240917$DIR$718829$$FDA-CTU$$37$YR$$F$N$76.05$KG$20240917$N$CN$US$
243327681$24332768$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63818$$FDA-CTU$$50$YR$$M$N$$$20240917$N$$US$
243327701$24332770$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63916$$FDA-CTU$$47$YR$$F$N$$$20240917$N$$US$
243327731$24332773$1$I$$20240906$20240918$20240918$EXP$$ES-ROCHE-10000076395$ROCHE$$$$$$Y$$$20240918$$MD$ES$ES
243327751$24332775$1$I$$20240911$20240918$20240918$EXP$$LT-BAYER-2024A130577$BAYER$$$$$F$Y$$$20240918$$CN$LT$LT
243327761$24332776$1$I$20240806$20240912$20240918$20240918$EXP$$CN-MYLANLABS-2024M1083651$MYLAN$$73$YR$$M$Y$97$KG$20240918$$HP$CN$CN
243327771$24332777$1$I$$20240916$20240918$20240918$PER$$US-ALXN-202409USA001237US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243327782$24332778$2$F$20230101$20240920$20240918$20240926$EXP$$US-ABBVIE-5924864$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243327801$24332780$1$I$$20240916$20240918$20240918$EXP$$US-ROCHE-10000083780$ROCHE$$$$E$F$Y$$$20240918$$CN$US$US
243327811$24332781$1$I$20240827$20240917$20240917$20240917$DIR$718787$$FDA-CTU$$13$YR$$M$N$$$20240917$N$PH$US$
243327831$24332783$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63935$$FDA-CTU$$53$YR$$F$N$160$LBS$20240917$N$$US$
243327841$24332784$1$I$$20240913$20240918$20240918$EXP$$BR-TAKEDA-2024TUS092647$TAKEDA$$60$YR$$M$Y$$$20240918$$MD$BR$BR
243327851$24332785$1$I$20240901$20240917$20240917$20240917$DIR$718814$$FDA-CTU$$43$YR$$F$N$$$20240917$Y$PH$US$
243327861$24332786$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010148$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240918$$CN$US$US
243327871$24332787$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010210$ELI LILLY AND CO$$$$$M$Y$$$20240918$$CN$US$US
243327882$24332788$2$F$20210525$20240909$20240918$20240921$EXP$FR-AFSSAPS-AN20214761$FR-TEVA-2022-FR-1997916$TEVA$$49$YR$$F$Y$$$20240921$$MD$FR$FR
243327891$24332789$1$I$20240916$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185292$AMGEN$$86$YR$E$F$Y$$$20240918$$CN$US$US
243327901$24332790$1$I$$20240906$20240918$20240918$30DAY$$US-PFIZER INC-202400252166$PFIZER$$$$$$Y$$$20240918$$HP$US$US
243327911$24332791$1$I$$20240913$20240918$20240918$EXP$$GB-PFIZER INC-PV202400121151$PFIZER$$$$$M$Y$$$20240918$$CN$GB$GB
243327921$24332792$1$I$20230101$20240909$20240918$20240918$30DAY$$CL-PFIZER INC-PV202400118077$PFIZER$$8$YR$$M$Y$$$20240918$$CN$CL$CL
243327941$24332794$1$I$20240604$20240916$20240918$20240918$EXP$FR-AFSSAPS-LY2024001289$FR-PFIZER INC-202400257026$PFIZER$$58$YR$$M$Y$76$KG$20240918$$PH$FR$FR
243327951$24332795$1$I$$20240911$20240918$20240918$EXP$$US-PFIZER INC-202400255534$PFIZER$$14$YR$$F$Y$$$20240918$$CN$US$US
243327961$24332796$1$I$$20240911$20240918$20240918$30DAY$$US-PFIZER INC-202400254901$PFIZER$$14$YR$$M$Y$$$20240918$$CN$US$US
243327971$24332797$1$I$$20240906$20240918$20240918$30DAY$$US-PFIZER INC-202400252004$PFIZER$$13$YR$$F$Y$$$20240918$$CN$US$US
243327981$24332798$1$I$20240810$20240911$20240918$20240918$30DAY$$US-PFIZER INC-202400254970$PFIZER$$58$YR$$F$Y$65.77$KG$20240918$$CN$US$US
243327991$24332799$1$I$$20240910$20240918$20240918$30DAY$$US-PFIZER INC-202400254233$PFIZER$$13$YR$$M$Y$$$20240918$$CN$US$US
243328003$24332800$3$F$20240910$20240919$20240918$20240925$30DAY$$US-PFIZER INC-202400254876$PFIZER$$4$YR$$F$Y$13.61$KG$20240925$$HP$US$US
243328011$24332801$1$I$$20240909$20240918$20240918$30DAY$$CH-PFIZER INC-202400257896$PFIZER$$$$$$Y$$$20240918$$HP$CH$CH
243328021$24332802$1$I$$20240915$20240918$20240918$EXP$$US-PFIZER INC-202400257413$PFIZER$$$$$$Y$$$20240918$$CN$US$US
243328031$24332803$1$I$$20240909$20240918$20240918$30DAY$$DE-PFIZER INC-202400252741$PFIZER$$$$$$Y$$$20240918$$HP$DE$DE
243328041$24332804$1$I$20240731$20240916$20240918$20240918$EXP$FR-AFSSAPS-LY2024001404$FR-PFIZER INC-202400257010$PFIZER$$59$YR$$M$Y$$$20240918$$PH$FR$FR
243328051$24332805$1$I$$20240912$20240918$20240918$EXP$$ES-PFIZER INC-08H-144-0315035-00$PFIZER$Polo-romero, F.. Propofol-induced acute toxic hepatitis after brief sedation for endoscopic retrograde cholangiopancreatography. Endoscopy. 2008;40:E49-E49$66$YR$$M$Y$$$20240918$$MD$ES$ES
243328061$24332806$1$I$$20240912$20240918$20240918$EXP$$CA-PFIZER INC-202300229642$PFIZER$$55$YR$$F$Y$$$20240918$$HP$CA$CA
243328081$24332808$1$I$$20240913$20240918$20240918$EXP$GB-MHRA-MED-202409131731545670-ZPHJS$GB-MYLANLABS-2024M1083939$MYLAN$$61$YR$$M$Y$$$20240918$$HP$GB$GB
243328091$24332809$1$I$$20240913$20240918$20240918$EXP$GB-MHRA-MED-202409131738386140-YDRGS$GB-MYLANLABS-2024M1083925$MYLAN$$58$YR$$M$Y$$$20240918$$HP$GB$GB
243328101$24332810$1$I$$20240913$20240918$20240918$EXP$$GB-MYLANLABS-2024M1083894$MYLAN$$$$$F$Y$$$20240918$$MD$GB$GB
243328111$24332811$1$I$$20240913$20240918$20240918$EXP$$GB-MYLANLABS-2024M1083903$MYLAN$$$$$M$Y$$$20240918$$HP$GB$GB
243328122$24332812$2$F$$20240913$20240918$20240918$PER$$NVSC2024US185056$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243328132$24332813$2$F$20240814$20240920$20240918$20240926$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-122977$REGENERON$$$$$M$Y$$$20240926$$HP$US$US
243328141$24332814$1$I$$20240907$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009478$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243328151$24332815$1$I$$20240910$20240918$20240918$EXP$$US-TEVA-VS-3244224$TEVA$$57$YR$$F$Y$$$20240918$$CN$US$US
243328161$24332816$1$I$$20240818$20240918$20240918$PER$$US-HALEON-2197219$Haleon PLC$$31$YR$$M$Y$$$20240918$$HP$US$US
243328171$24332817$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147961$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240918$$HP$US$US
243328181$24332818$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148040$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240918$$HP$US$US
243328191$24332819$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148022$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240918$$CN$US$US
243328201$24332820$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147939$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240918$$CN$US$US
243328211$24332821$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148462$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240918$$CN$US$US
243328221$24332822$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147956$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$100.7$KG$20240918$$CN$US$US
243328231$24332823$1$I$$20240912$20240918$20240918$EXP$$TW-ROCHE-10000080969$ROCHE$$$$$$Y$$$20240918$$MD$TW$TW
243328241$24332824$1$I$$20240906$20240918$20240918$PER$$US-IMP-2024000750$Harrow Health$$$$$$Y$$$20240918$$MD$US$US
243328251$24332825$1$I$$20240907$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009473$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243328261$24332826$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010798$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243328271$24332827$1$I$$20240905$20240918$20240918$EXP$$US-BIOCODEX2-2024001262$BIOCODEX$$3$YR$$F$Y$14.6$KG$20240917$$CN$US$US
243328282$24332828$2$F$20240729$20240917$20240918$20240920$EXP$$GB-MYLANLABS-2024M1079604$MYLAN$$$$$M$Y$$$20240920$$CN$GB$GB
243328301$24332830$1$I$$20240914$20240918$20240918$EXP$$US-GSK-US2024115630$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$US$US
243328311$24332831$1$I$$20240905$20240918$20240918$30DAY$$BE-JNJFOC-20240931095$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$BE$BE
243328321$24332832$1$I$20240101$20240910$20240918$20240918$EXP$$US-TEVA-VS-3244122$TEVA$$86$YR$$F$Y$$$20240918$$CN$US$US
243328332$24332833$2$F$20240101$20240912$20240918$20240924$30DAY$$US-PFIZER INC-202400255420$PFIZER$$6$YR$$M$Y$46.27$KG$20240924$$CN$US$US
243328341$24332834$1$I$$20240912$20240918$20240918$30DAY$$IL-PFIZER INC-PV202400120704$PFIZER$$11$YR$$F$Y$$$20240918$$CN$IL$IL
243328373$24332837$3$F$$20240918$20240918$20240924$30DAY$$US-PFIZER INC-202400254335$PFIZER$$12$YR$$M$Y$$$20240924$$CN$US$US
243328381$24332838$1$I$20240910$20240911$20240918$20240918$30DAY$$US-PFIZER INC-202400255020$PFIZER$$15$YR$$M$Y$$$20240918$$CN$US$US
243328391$24332839$1$I$$20240913$20240918$20240918$30DAY$$US-PFIZER INC-202400244607$PFIZER$$5$YR$$M$Y$$$20240918$$CN$US$US
243328401$24332840$1$I$20240511$20240913$20240918$20240918$30DAY$$US-PFIZER INC-PV202400072400$PFIZER$$$$$$Y$$$20240918$$HP$US$US
243328411$24332841$1$I$20240914$20240914$20240918$20240918$30DAY$$US-PFIZER INC-202400257047$PFIZER$$45$YR$$F$Y$61.23$KG$20240918$$CN$US$US
243328421$24332842$1$I$$20240912$20240918$20240918$30DAY$$CA-PFIZER INC-202400256348$PFIZER$$43$YR$$F$Y$$$20240918$$CN$CA$CA
243328433$24332843$3$F$20240914$20240920$20240918$20240927$30DAY$$US-PFIZER INC-202400253240$PFIZER$$10$YR$$F$Y$$$20240927$$HP$US$US
243328441$24332844$1$I$$20240912$20240918$20240918$30DAY$$US-PFIZER INC-202400255593$PFIZER$$14$YR$$M$Y$$$20240918$$CN$US$US
243328451$24332845$1$I$$20240911$20240918$20240918$30DAY$$US-PFIZER INC-202400255053$PFIZER$$52$YR$$F$Y$$$20240918$$CN$US$US
243328463$24332846$3$F$20240914$20240919$20240918$20240924$30DAY$$US-PFIZER INC-202400257513$PFIZER$$11$YR$$M$Y$$$20240924$$MD$US$US
243328481$24332848$1$I$20240401$20240909$20240918$20240918$EXP$IT-MINISAL02-1000831$IT-TEVA-VS-3241760$TEVA$$73$YR$$F$Y$$$20240918$$PH$IT$IT
243328491$24332849$1$I$$20240917$20240918$20240918$EXP$$US-BAYER-2024A132647$BAYER$$66$YR$E$M$Y$$$20240918$$CN$US$US
243328501$24332850$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010757$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243328511$24332851$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010856$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243328521$24332852$1$I$20240801$20240906$20240918$20240918$EXP$$US-IMP-2024000720$Harrow Health$$$$E$F$Y$$$20240918$$CN$US$US
243328531$24332853$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63937$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243328541$24332854$1$I$20240917$20240917$20240917$20240917$DIR$718754$$FDA-CTU$$27$YR$$F$N$91.6$KG$20240917$N$PH$US$
243328571$24332857$1$I$$20240916$20240918$20240918$PER$$US-ALXN-202409USA001193US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243328581$24332858$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63910$$FDA-CTU$$29$YR$$M$N$$$20240917$N$$US$
243328601$24332860$1$I$20200101$20240913$20240918$20240918$EXP$$US-ROCHE-2662249$ROCHE$$81$YR$E$F$Y$$$20240918$$CN$US$US
243328611$24332861$1$I$20240905$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63961$$FDA-CTU$$77$YR$$M$N$$$20240917$Y$PH$US$
243328621$24332862$1$I$$20240912$20240918$20240918$EXP$NL-LRB-01000060$NL-TEVA-VS-3243236$TEVA$$60$YR$$F$Y$72$KG$20240918$$CN$NL$NL
243328633$24332863$3$F$20240909$20240926$20240918$20240930$30DAY$$US-PFIZER INC-202400256489$PFIZER$$8$YR$$M$Y$18.14$KG$20240930$$CN$US$US
243328641$24332864$1$I$20240915$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63958$$FDA-CTU$$10$YR$$F$N$37.8$KG$20240917$N$MD$US$
243328651$24332865$1$I$20240917$20240917$20240917$20240917$DIR$718751$$FDA-CTU$$40$YR$$M$N$$$20240917$Y$PH$US$
243328662$24332866$2$F$20240823$20240916$20240918$20240927$EXP$$ALC2024ES004172$ALCON$$$$$$Y$$$20240927$$CN$ES$ES
243328671$24332867$1$I$20240908$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63849$$FDA-CTU$$67$YR$$F$N$$$20240917$Y$PH$US$
243328681$24332868$1$I$$20240916$20240918$20240918$PER$$US-LEO Pharma-373542$LEO PHARM$$62$YR$$F$Y$$$20240918$$CN$US$US
243328691$24332869$1$I$$20240913$20240918$20240918$EXP$SE-SEMPA-2024-006554$SE-TEVA-VS-3243733$TEVA$$59$YR$$F$Y$$$20240918$$MD$SE$SE
243328701$24332870$1$I$$20240913$20240918$20240918$EXP$GB-MHRA-MED-202409131649417600-DFGJR$GB-MYLANLABS-2024M1083902$MYLAN$$$$$$Y$$$20240918$$PH$GB$GB
243328711$24332871$1$I$20240101$20240916$20240918$20240918$EXP$DK-DKMA-30738335$DK-UCBSA-2024047413$UCB$$$$$$Y$$$20240918$$MD$DK$DK
243328721$24332872$1$I$$20240913$20240918$20240918$EXP$GB-MHRA-MED-202409131511421900-MPKSC$GB-MYLANLABS-2024M1083948$MYLAN$$$$$M$Y$$$20240918$$CN$GB$GB
243328731$24332873$1$I$$20240913$20240918$20240918$EXP$GB-MHRA-MED-202409131509190230-BKPTH$GB-MYLANLABS-2024M1083940$MYLAN$$$$$F$Y$$$20240918$$HP$GB$GB
243328741$24332874$1$I$$20240913$20240918$20240918$EXP$GB-MHRA-MED-202409131322524410-MCGDB$GB-MYLANLABS-2024M1083873$MYLAN$$$$$$Y$$$20240918$$PH$GB$GB
243328751$24332875$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5926194$ABBVIE$$$$$M$Y$$$20240918$$HP$US$US
243328762$24332876$2$F$$20240918$20240918$20240919$PER$$US-AMGEN-USASP2024185997$AMGEN$$$$$M$Y$$$20240919$$HP$US$US
243328771$24332877$1$I$20240801$20240911$20240918$20240918$EXP$$JP-009507513-2409JPN001633J$MERCK$$74$YR$$$Y$$$20240918$$MD$JP$JP
243328781$24332878$1$I$$20240806$20240918$20240918$PER$$US-LUNDBECK-DKLU4002724$LUNDBECK$$$$$$Y$$$20240918$$CN$US$US
243328791$24332879$1$I$20240830$20240902$20240918$20240918$30DAY$$AR-JNJFOC-20240907503$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240918$$CN$AR$AR
243328801$24332880$1$I$20221114$20240910$20240918$20240918$EXP$$BE-TEVA-VS-3242202$TEVA$$66$YR$$F$Y$42$KG$20240918$$MD$BE$BE
243328811$24332881$1$I$20150210$20240912$20240918$20240918$EXP$$AU-TAKEDA-2024TUS091909$TAKEDA$$71$YR$$M$Y$$$20240918$$MD$AU$AU
243328821$24332882$1$I$20220731$20240913$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120350$PFIZER$Gao, L.. Diagnosis and Treatment Analysis of One Case of Neutropenic Fever Caused by Linezolid Substitution for Vancomycin. Anti-Infection Pharmacy. 2024;21(6):574-577$55$YR$$M$Y$$$20240918$$PH$CN$CN
243328831$24332883$1$I$20240125$20240916$20240918$20240918$EXP$$PL-PFIZER INC-202400256972$PFIZER$$64$YR$$M$Y$43$KG$20240918$$MD$PL$PL
243328842$24332884$2$F$20231221$20240923$20240918$20240926$EXP$$FR-PFIZER INC-202400191012$PFIZER$$68$YR$$F$Y$$$20240926$$MD$FR$FR
243328851$24332885$1$I$20240722$20240916$20240918$20240918$EXP$$EG-PFIZER INC-PV202400121165$PFIZER$$37$YR$$F$Y$75$KG$20240918$$MD$EG$EG
243328861$24332886$1$I$20240801$20240909$20240918$20240918$PER$$US-UNITED THERAPEUTICS-UNT-2024-028674$UNITED THERAPEUTICS$$27$YR$$F$Y$50.794$KG$20240918$$$US$US
243328871$24332887$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010799$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243328881$24332888$1$I$$20240910$20240918$20240918$PER$$US-BAYER-2024A132258$BAYER$$40$YR$A$M$Y$$$20240918$$CN$US$US
243328891$24332889$1$I$20240904$20240913$20240918$20240918$EXP$FR-AFSSAPS-RE2024000884$FR-BEH-2024178799$CSL BEHRING$$17$YR$T$F$Y$75$KG$20240918$$MD$FR$FR
243328901$24332890$1$I$20240101$20240906$20240918$20240918$PER$$US-ASTELLAS-2024-AER-005494$ASTELLAS$$41$YR$A$F$Y$$$20240918$$CN$US$US
243328911$24332891$1$I$20240528$20240910$20240918$20240918$EXP$FR-AFSSAPS-DJ2024000934$FR-TEVA-VS-3242250$TEVA$$51$YR$$M$Y$65$KG$20240918$$MD$FR$FR
243328921$24332892$1$I$$20240905$20240918$20240918$EXP$$FR-B.Braun Medical Inc.-2161754$B BRAUN$Literature Article$66$YR$$F$Y$$$20240918$$$FR$FR
243328931$24332893$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084123$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$21$YR$$F$Y$$$20240918$$HP$IE$IE
243328941$24332894$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084141$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$54$YR$$F$Y$$$20240918$$HP$IE$IE
243328951$24332895$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084142$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$60$YR$$M$Y$$$20240918$$HP$IE$IE
243328961$24332896$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084140$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$30$YR$$F$Y$$$20240918$$HP$IE$IE
243328971$24332897$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084119$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$59$YR$$F$Y$$$20240918$$HP$IE$IE
243328991$24332899$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084137$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$41$YR$$F$Y$$$20240918$$HP$IE$IE
243329001$24332900$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084127$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$37$YR$$F$Y$$$20240918$$HP$IE$IE
243329011$24332901$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084139$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$64$YR$$M$Y$$$20240918$$HP$IE$IE
243329021$24332902$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084152$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$65$YR$$M$Y$$$20240918$$HP$IE$IE
243329031$24332903$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084153$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$35$YR$$M$Y$$$20240918$$HP$IE$IE
243329041$24332904$1$I$$20240909$20240918$20240918$EXP$$GB-TEVA-VS-3242576$TEVA$$71$YR$$F$Y$$$20240918$$CN$GB$GB
243329051$24332905$1$I$20240101$20240912$20240918$20240918$PER$$US-BAYER-2024A131484$BAYER$$37$YR$A$F$Y$$$20240918$$HP$US$US
243329061$24332906$1$I$$20240911$20240918$20240918$PER$$US-BAYER-2024A130206$BAYER$$61$YR$A$F$Y$$$20240918$$CN$US$US
243329071$24332907$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63932$$FDA-CTU$$66$YR$$F$N$160$LBS$20240917$N$$US$
243329081$24332908$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63795$$FDA-CTU$$63$YR$$M$N$$$20240917$N$$US$
243329091$24332909$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084149$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$28$YR$$F$Y$$$20240918$$HP$IE$IE
243329101$24332910$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084156$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$56$YR$$F$Y$$$20240918$$HP$IE$IE
243329111$24332911$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084136$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$36$YR$$F$Y$$$20240918$$HP$IE$IE
243329121$24332912$1$I$$20240911$20240918$20240918$EXP$$NVSC2024RO057088$NOVARTIS$$$$$F$Y$$$20240918$$MD$RO$RO
243329131$24332913$1$I$$20240912$20240918$20240918$EXP$$NVSC2024US184850$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
243329141$24332914$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084157$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$50$YR$$F$Y$$$20240918$$HP$IE$IE
243329151$24332915$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084126$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$57$YR$$F$Y$$$20240918$$HP$IE$IE
243329161$24332916$1$I$20230120$20240910$20240918$20240918$EXP$FR-AFSSAPS-PC2024000680$FR-TEVA-VS-3242291$TEVA$$50$YR$$F$Y$$$20240918$$PH$FR$FR
243329172$24332917$2$F$$20240910$20240918$20240923$EXP$$NVSC2024AU184018$NOVARTIS$Harris K, Dalton B, Learmont BG, Isoardi KZ. Rationalising the dose threshold for severe carbamazepine toxicity:  a retrospective series. CLINICAL TOXICOLOGY. 2024;62(8):533-5$16$YR$$$Y$$$20240923$$HP$AU$AU
243329181$24332918$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084138$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$53$YR$$F$Y$$$20240918$$HP$IE$IE
243329191$24332919$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63956$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243329201$24332920$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084154$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$31$YR$$F$Y$$$20240918$$HP$IE$IE
243329211$24332921$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084118$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$44$YR$$F$Y$$$20240918$$HP$IE$IE
243329221$24332922$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63928$$FDA-CTU$$59$YR$$M$N$$$20240917$N$$US$
243329231$24332923$1$I$20240917$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63828$$FDA-CTU$$69$YR$$F$N$$$20240917$Y$PH$US$
243329241$24332924$1$I$$20240916$20240918$20240918$EXP$$NVSC2024US185125$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243329251$24332925$1$I$$20240916$20240918$20240918$EXP$IS-IMA-8734$IS-PFIZER INC-202400257102$PFIZER$$$$A$M$Y$$$20240918$$PH$IS$IS
243329261$24332926$1$I$20240405$20240910$20240918$20240918$EXP$FR-AFSSAPS-AVMA2024000377$FR-TEVA-VS-3242591$TEVA$$46$YR$$M$Y$$$20240918$$PH$FR$FR
243329281$24332928$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084150$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$45$YR$$F$Y$$$20240918$$HP$IE$IE
243329291$24332929$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084128$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$20$YR$$F$Y$$$20240918$$HP$IE$IE
243329301$24332930$1$I$$20240916$20240918$20240918$EXP$$US-PFIZER INC-202400257555$PFIZER$$82$YR$$F$Y$$$20240918$$CN$US$US
243329311$24332931$1$I$20240906$20240914$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120822$PFIZER$$35$YR$$F$Y$62$KG$20240918$$HP$CN$CN
243329321$24332932$1$I$$20240916$20240918$20240918$EXP$$US-PFIZER INC-202400258377$PFIZER$$44$YR$$M$Y$$$20240918$$MD$US$US
243329331$24332933$1$I$20240917$20240917$20240918$20240918$PER$$US-ALXN-202409USA001328US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$MD$US$US
243329341$24332934$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010785$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243329351$24332935$1$I$$20240913$20240918$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015270$JAZZ$$$$$M$Y$$$20240918$$CN$US$US
243329361$24332936$1$I$20240101$20240912$20240918$20240918$EXP$$FR-009507513-2409FRA005514$MERCK$$$$$F$Y$$$20240918$$MD$FR$FR
243329371$24332937$1$I$20230120$20240903$20240918$20240918$EXP$$FR-PHARMAAND GMBH-2024PHR00525$pharmaAND$$51$YR$$F$Y$61$KG$20240918$$MD$FR$FR
243329382$24332938$2$F$$20240918$20240918$20240925$PER$$US-JNJFOC-20240941320$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243329391$24332939$1$I$20240906$20240906$20240918$20240918$PER$$US-MYLANLABS-2024M1082637$MYLAN$$$$$F$Y$$$20240918$$CN$US$US
243329401$24332940$1$I$$20240912$20240918$20240918$EXP$$US-BAYER-2024A131481$BAYER$$41$YR$A$F$Y$$$20240918$$HP$US$US
243329411$24332941$1$I$$20240912$20240918$20240918$EXP$$US-INCYTE CORPORATION-2024IN009650$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243329421$24332942$1$I$$20240910$20240918$20240918$EXP$$IN-ROCHE-10000084709$ROCHE$$$$$M$Y$$$20240918$$CN$IN$IN
243329431$24332943$1$I$$20240913$20240918$20240918$EXP$$NVSC2024CA185012$NOVARTIS$$46$YR$$F$Y$$$20240918$$CN$CA$CA
243329441$24332944$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010775$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243329451$24332945$1$I$$20240917$20240918$20240918$PER$$US-GILEAD-2024-0688004$GILEAD$$$$$F$Y$$$20240918$$MD$US$US
243329461$24332946$1$I$20240905$20240913$20240918$20240918$EXP$$US-INCYTE CORPORATION-2024IN009727$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243329471$24332947$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010947$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243329481$24332948$1$I$20240715$20240909$20240918$20240918$EXP$FR-AFSSAPS-SE2024000688$FR-TEVA-VS-3242962$TEVA$$86$YR$$F$Y$$$20240918$$MD$FR$FR
243329491$24332949$1$I$$20240909$20240918$20240918$PER$$US-APOTEX-2024AP010995$APOTEX$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65 (1):33-38$51$YR$$F$Y$$$20240918$$MD$US$US
243329501$24332950$1$I$20240523$20240912$20240918$20240918$EXP$$US-AMGEN-USASP2024183308$AMGEN$$76$YR$E$F$Y$56.236$KG$20240918$$MD$US$US
243329511$24332951$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924717$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243329521$24332952$1$I$20240801$20240906$20240918$20240918$PER$$US-MYLANLABS-2024M1082032$MYLAN$$62$YR$$F$Y$79.38$KG$20240918$$CN$US$US
243329531$24332953$1$I$$20240913$20240918$20240918$EXP$$US-INCYTE CORPORATION-2024IN009725$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243329541$24332954$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63901$$FDA-CTU$$85$YR$$F$N$139$LBS$20240917$N$$US$
243329551$24332955$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63839$$FDA-CTU$$50$YR$$M$N$349$LBS$20240917$N$$US$
243329561$24332956$1$I$20240328$20240911$20240918$20240918$EXP$$CA-TAKEDA-2024TUS030479$TAKEDA$$48$YR$$F$Y$$$20240918$$CN$CA$CA
243329571$24332957$1$I$20240101$20240909$20240918$20240918$PER$$US-JNJFOC-20240923589$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$CN$US$US
243329581$24332958$1$I$$20240909$20240918$20240918$EXP$$BR-JNJFOC-20240932756$JOHNSON AND JOHNSON$$56$YR$A$F$Y$98$KG$20240918$$CN$BR$BR
243329591$24332959$1$I$$20240913$20240918$20240918$PER$$CA-BRACCO-2024CA05785$BRACCO$$42$YR$$F$Y$$$20240918$$HP$CA$CA
243329601$24332960$1$I$$20240910$20240918$20240918$PER$$US-MYLANLABS-2024M1083333$MYLAN$$$$$$Y$$$20240918$$CN$US$US
243329611$24332961$1$I$20240912$20240913$20240918$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015231$JAZZ$$7$YR$$M$Y$$$20240918$$HP$US$US
243329641$24332964$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63897$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243329651$24332965$1$I$20240911$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63806$$FDA-CTU$$74$YR$$M$N$67.5$KG$20240917$N$$US$
243329671$24332967$1$I$20240912$20240912$20240917$20240917$DIR$FDA-CDER-CTU-2024-63949$$FDA-CTU$$94$YR$$M$N$$$20240912$N$HP$US$
243329691$24332969$1$I$20240914$20240917$20240917$20240917$DIR$718791$$FDA-CTU$$62$YR$$F$N$87$KG$20240917$Y$$US$
243329701$24332970$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63822$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243329711$24332971$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63833$$FDA-CTU$$$$$M$N$108.1$KG$20240917$Y$PH$US$
243329721$24332972$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63800$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243329731$24332973$1$I$20240916$20240917$20240917$20240917$DIR$718821$$FDA-CTU$$58$YR$$M$N$123.75$KG$20240917$N$CN$US$
243329741$24332974$1$I$$20240903$20240917$20240917$DIR$FDA-CDER-CTU-2024-63862$$FDA-CTU$$$$$F$N$$$20240903$N$HP$US$
243329751$24332975$1$I$20240917$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63934$$FDA-CTU$$73$YR$$F$N$142.8$LBS$20240917$Y$PH$US$
243329762$24332976$2$F$$20240906$20240918$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466433$RANBAXY$Akhdar G. Navigating the Nexus: Lenalidomide-Associated Thrombotic Thrombocytopenic Purpura (TTP). Clin Lymphoma Myeloma Leuk. 2024;Sep;24 (Suppl.):S555/MM-388$56$YR$$M$Y$$$20240920$$MD$US$US
243329771$24332977$1$I$20240301$20240826$20240918$20240918$EXP$$US-SA-2024SA267356$SANOFI AVENTIS$$19$YR$A$M$Y$78$KG$20240918$$MD$US$US
243329781$24332978$1$I$20240301$20240913$20240918$20240918$EXP$FR-AFSSAPS-RN2024000965$FR-TEVA-VS-3243668$TEVA$$61$YR$$F$Y$$$20240918$$MD$FR$FR
243329791$24332979$1$I$$20240905$20240918$20240918$EXP$$US-TORRENT-00013746$TORRENT$$$$$F$Y$$$20240918$$CN$US$US
243329801$24332980$1$I$20240501$20240909$20240918$20240918$EXP$GB-MHRA-MED-202409091717574630-PJNTZ$GB-TORRENT-00037919$TORRENT$$$$$F$Y$$$20240918$$CN$GB$GB
243329812$24332981$2$F$20240820$20240912$20240918$20240924$EXP$$US-TORRENT-00013748$TORRENT$$17$YR$T$F$Y$87$KG$20240924$$PH$US$US
243329821$24332982$1$I$20240906$20240913$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120945$PFIZER$$38$YR$$M$Y$75$KG$20240918$$PH$CN$CN
243329831$24332983$1$I$$20240905$20240918$20240918$EXP$$US-P+L Developments of Newyork Corporation-2161755$PL DEVELOPMENTS$Initial$55$YR$$F$Y$$$20240918$$$US$US
243329841$24332984$1$I$20240723$20240916$20240918$20240918$EXP$$EG-PFIZER INC-PV202400121191$PFIZER$$45$YR$$M$Y$$$20240918$$PH$EG$EG
243329851$24332985$1$I$20240726$20240916$20240918$20240918$EXP$ES-AEMPS-1568895$ES-PFIZER INC-202400256942$PFIZER$$88$YR$$F$Y$$$20240918$$MD$ES$ES
243329861$24332986$1$I$$20240909$20240918$20240918$PER$$US-MYLANLABS-2024M1082770$MYLAN$$$$$F$Y$54.43$KG$20240918$$CN$US$US
243329871$24332987$1$I$$20240911$20240918$20240918$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001854$BLUEPRINT MEDICINES$$$$$F$Y$$$20240918$$CN$US$US
243329881$24332988$1$I$20240417$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63960$$FDA-CTU$$86$YR$$M$N$$$20240917$Y$PH$US$
243329891$24332989$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63855$$FDA-CTU$$75$YR$$F$N$$$20240917$N$$US$
243329901$24332990$1$I$20240823$20240911$20240918$20240918$EXP$$US-Vifor (International) Inc.-VIT-2024-08356$VIFOR$$24$YR$$F$Y$52$KG$20240918$$HP$US$US
243329921$24332992$1$I$$20240913$20240918$20240918$PER$$CH-Blueprint Medicines Corporation-SP-CH-2024-001866$BLUEPRINT MEDICINES$$$$$$Y$$$20240918$$MD$CH$CH
243329931$24332993$1$I$20240906$20240911$20240918$20240918$EXP$$US-Vifor (International) Inc.-VIT-2024-08327$VIFOR$$61$YR$$F$Y$74.5$KG$20240918$$HP$US$US
243329941$24332994$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63891$$FDA-CTU$$77$YR$$M$N$64.5$KG$20240917$Y$PH$US$
243329952$24332995$2$F$20240101$20240904$20240918$20240923$EXP$$US-SA-2024SA269309$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240923$$MD$US$US
243329961$24332996$1$I$$20240911$20240918$20240918$EXP$$GB-BAUSCHBL-2024BNL033283$BAUSCH AND LOMB$Mansour H, Ali J, Swamy A, Leahy A. A case of haemorrhagic emphysematous gastritis. Cureus. 2024 AUG 03;16 (8):1-5. doi:10.7759/cureus.66084$70$YR$$F$Y$$$20240918$$MD$GB$GB
243329971$24332997$1$I$$20240909$20240918$20240918$PER$$US-BAUSCHBL-2024BNL033171$BAUSCH AND LOMB$$$$$F$Y$$$20240918$$CN$US$US
243329981$24332998$1$I$$20240913$20240918$20240918$EXP$$EU-BAUSCHBL-2024BNL033437$BAUSCH AND LOMB$$$$$M$Y$$$20240918$$CN$EU$EU
243329991$24332999$1$I$20240910$20240913$20240918$20240918$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-029243$UNITED THERAPEUTICS$$38$YR$$F$Y$$$20240918$$MD$JP$JP
243330001$24333000$1$I$$20240912$20240918$20240918$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001861$BLUEPRINT MEDICINES$$$$$F$Y$$$20240918$$MD$US$US
243330021$24333002$1$I$$20240830$20240918$20240918$EXP$$US-SA-2024SA267922$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$MD$US$US
243330031$24333003$1$I$20240501$20240913$20240918$20240918$EXP$$US-MYLANLABS-2024M1084606$MYLAN$$36$YR$$F$Y$57$KG$20240918$$PH$US$US
243330041$24333004$1$I$20230911$20240913$20240918$20240918$EXP$$GB-MYLANLABS-2024M1083897$MYLAN$$$$E$M$Y$$$20240918$$CN$GB$GB
243330051$24333005$1$I$$20240909$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009542$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243330061$24333006$1$I$$20240806$20240918$20240918$PER$$US-LUNDBECK-DKLU4002709$LUNDBECK$$$$$$Y$$$20240918$$HP$US$US
243330074$24333007$4$F$20240901$20240923$20240918$20240928$EXP$$US-AMGEN-USASP2024185116$AMGEN$$50$YR$A$F$Y$$$20240928$$CN$US$US
243330081$24333008$1$I$20240101$20240829$20240918$20240918$PER$$US-TEVA-VS-3239507$TEVA$$$$$$Y$$$20240918$$CN$US$US
243330091$24333009$1$I$20240914$20240916$20240918$20240918$PER$$US-ABBVIE-5926131$ABBVIE$$71$YR$$$Y$57$KG$20240918$$CN$US$US
243330101$24333010$1$I$$20240909$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009539$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243330111$24333011$1$I$20240718$20240909$20240918$20240918$EXP$$CA-CELLTRION INC.-2024CA018865$CELLTRION$$$$$$Y$$$20240918$$HP$CA$CA
243330121$24333012$1$I$20240912$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185115$AMGEN$$62$YR$A$M$Y$$$20240918$$CN$US$US
243330131$24333013$1$I$$20240818$20240918$20240918$PER$$US-HALEON-2197225$Haleon PLC$$26$YR$$M$Y$$$20240918$$HP$US$US
243330141$24333014$1$I$$20240909$20240918$20240918$30DAY$$CL-PFIZER INC-PV202400118632$PFIZER$$8$YR$$F$Y$$$20240918$$CN$CL$CL
243330151$24333015$1$I$20240901$20240910$20240918$20240918$PER$$US-JNJFOC-20240927421$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240918$$CN$US$US
243330161$24333016$1$I$$20240906$20240918$20240918$EXP$$CY-EMD Serono-2024048158$EMD SERONO INC$Louka R. NEUROMUSCULAR ADVERSE EFFECTS FROM IMMUNE CHECKPOINT INHIBITORS: CLINICAL FINDINGS AND MANAGEMENT OF TWO CASES. 35th PANHELLENIC CONGRESS ON NEUROLOGY. 2024;223.$77$YR$E$M$Y$$$20240918$$MD$CY$CY
243330171$24333017$1$I$$20240915$20240918$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015282$JAZZ$$$$$F$Y$$$20240918$$CN$US$US
243330181$24333018$1$I$$20240909$20240918$20240918$EXP$$US-MYLANLABS-2024M1083682$MYLAN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.$72$YR$$F$Y$$$20240918$$HP$US$US
243330191$24333019$1$I$$20240909$20240918$20240918$EXP$$US-MYLANLABS-2024M1083507$MYLAN$Wang M, Reynolds KL, Montazeri K, Schaefer EA, Sullivan RJ, Dougan M. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clin-Gastroenterol-Hepatol 2024; 22 (7): 1539-1541.e2.$46$YR$$F$Y$$$20240918$$MD$US$US
243330201$24333020$1$I$20240902$20240912$20240918$20240918$EXP$$NVSC2024CA178870$NOVARTIS$$64$YR$$F$Y$$$20240918$$CN$CA$CA
243330211$24333021$1$I$$20240912$20240918$20240918$EXP$HU-CELLTRION INC.-2024HU020976$HU-ROCHE-10000080306$ROCHE$Szamosi S, Bodoki L. Beszamolo a Magyar Reumatologusok Egyesulete Eszak-Kelet-Magyarorszagi Szekciojanak 2023. oszi egri szekciouleserol. Magyar Reumatologia. 2024;1:25 - 28$$$$M$Y$$$20240918$$MD$HU$HU
243330221$24333022$1$I$$20240909$20240918$20240918$EXP$$JP-MYE-2024M1083457AA$MYLAN$Aiba M, Okada K, Funakoshi T, Nozu R, Takahashi T, Ozu S, et al. Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma. J-Infect-Chemother 2024; 30 (10): 1065-1068.. 2024;30 (10):1065-1068$6$DEC$$F$Y$$$20240918$$HP$JP$JP
243330231$24333023$1$I$$20240913$20240918$20240918$EXP$$NVSC2024RU185671$NOVARTIS$$$$$F$Y$$$20240918$$MD$RU$RU
243330241$24333024$1$I$$20240912$20240918$20240918$EXP$$NVSC2024GB184151$NOVARTIS$$$$$F$Y$$$20240918$$CN$GB$GB
243330261$24333026$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084104$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6).$68$YR$$F$Y$$$20240918$$HP$IE$IE
243330271$24333027$1$I$$20240904$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08933$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243330281$24333028$1$I$$20240909$20240918$20240918$EXP$$ES-SANDOZ INC.-NVSC2020ES202051$SANDOZ$$43$YR$$M$Y$$$20240918$$MD$ES$ES
243330291$24333029$1$I$$20240909$20240918$20240918$EXP$$IE-MYLANLABS-2024M1084114$MYLAN$Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, et al. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia 2023; 43 (6):.$42$YR$$F$Y$$$20240918$$HP$IE$IE
243330301$24333030$1$I$$20240909$20240918$20240918$EXP$$CN-SA-2024SA263792$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240918$$HP$CN$CN
243330311$24333031$1$I$$20240910$20240918$20240918$EXP$$NVSC2024CA181826$NOVARTIS$$43$YR$$F$Y$129$KG$20240918$$HP$CA$CA
243330321$24333032$1$I$$20240909$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009538$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243330332$24333033$2$F$20240523$20240918$20240918$20240923$30DAY$$US-AMGEN-USASL2024178091$AMGEN$$81$YR$E$F$Y$49.2$KG$20240923$$PH$US$US
243330341$24333034$1$I$$20240911$20240918$20240918$EXP$$ES-AMGEN-ESPSP2024183843$AMGEN$Lluch P.; Ballester M.P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240918$$MD$ES$ES
243330351$24333035$1$I$$20240911$20240918$20240918$EXP$$ES-AMGEN-ESPSP2024183832$AMGEN$Lluch P.; Ballester M.P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240918$$MD$ES$ES
243330361$24333036$1$I$$20240909$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009536$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243330371$24333037$1$I$20240101$20240913$20240918$20240918$EXP$$US-SA-2024SA269106$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240918$$HP$US$US
243330381$24333038$1$I$20240601$20240916$20240918$20240918$EXP$$US-GILEAD-2024-0687896$GILEAD$$46$YR$A$M$Y$$$20240918$$CN$US$US
243330391$24333039$1$I$$20240913$20240918$20240918$EXP$$CO-SA-2024SA268603$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$CN$CO$CO
243330411$24333041$1$I$20240905$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009952$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243330421$24333042$1$I$20240101$20240910$20240918$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029035$UNITED THERAPEUTICS$$$$$F$Y$62.132$KG$20240918$$$US$US
243330431$24333043$1$I$$20240911$20240918$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202409008579$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$US$US
243330441$24333044$1$I$20240915$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010164$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240918$$CN$US$US
243330451$24333045$1$I$20240803$20240914$20240918$20240918$EXP$$CN-ALXN-202409GLO000243CN$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240918$$MD$CN$CN
243330461$24333046$1$I$20240101$20240909$20240918$20240918$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409005269$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$JP$JP
243330472$24333047$2$F$$20240911$20240918$20240927$EXP$$CA-HALEON-2196971$Haleon PLC$$43$YR$$F$Y$68$KG$20240927$$HP$CA$CA
243330481$24333048$1$I$20240906$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010142$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240918$$CN$US$US
243330491$24333049$1$I$20240905$20240911$20240918$20240918$EXP$GB-MHRA-MED-202409111836552650-PDWQK$GB-ELI_LILLY_AND_COMPANY-GB202409007880$ELI LILLY AND CO$$39$YR$A$F$Y$88$KG$20240918$$CN$GB$GB
243330501$24333050$1$I$$20240911$20240918$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202409007387$ELI LILLY AND CO$$88$YR$E$F$Y$$$20240918$$CN$US$US
243330511$24333051$1$I$20240904$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009293$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240918$$CN$US$US
243330521$24333052$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010036$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240918$$CN$US$US
243330531$24333053$1$I$20240101$20240910$20240918$20240918$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409006133$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$JP$JP
243330541$24333054$1$I$20240701$20240909$20240918$20240918$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409005376$ELI LILLY AND CO$$$$$M$Y$$$20240918$$CN$JP$JP
243330551$24333055$1$I$20240806$20240906$20240918$20240918$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409004112$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240918$$CN$DE$DE
243330561$24333056$1$I$20240911$20240917$20240917$20240917$DIR$718815$$FDA-CTU$$73$YR$$M$N$$$20240917$Y$PH$US$
243330571$24333057$1$I$20240801$20240911$20240918$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202409007451$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240918$$CN$US$US
243330581$24333058$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009702$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240918$$CN$US$US
243330591$24333059$1$I$$20240906$20240918$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202409005281$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240918$$CN$US$US
243330601$24333060$1$I$20240827$20240917$20240917$20240917$DIR$718805$$FDA-CTU$$66$YR$$M$N$$$20240917$Y$PH$US$
243330611$24333061$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63852$$FDA-CTU$$32$YR$$F$N$$$20240917$N$$US$
243330621$24333062$1$I$20240914$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010235$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240918$$CN$US$US
243330641$24333064$1$I$$20240906$20240918$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202409004639$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240918$$CN$US$US
243330651$24333065$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409011084$ELI LILLY AND CO$$$$$$Y$$$20240918$$PH$US$US
243330661$24333066$1$I$20240820$20240917$20240917$20240917$DIR$718808$$FDA-CTU$$77$YR$$F$N$$$20240917$Y$HP$US$
243330671$24333067$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63845$$FDA-CTU$$58$YR$$F$N$$$20240917$N$$US$
243330681$24333068$1$I$$20240912$20240918$20240918$PER$$US-TAKEDA-2024TUS090810$TAKEDA$$$$E$F$Y$$$20240918$$MD$US$US
243330691$24333069$1$I$20240528$20240911$20240918$20240918$EXP$$CA-JNJFOC-20240625927$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240918$$HP$CA$CA
243330701$24333070$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010776$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243330711$24333071$1$I$20240101$20240913$20240918$20240918$PER$$US-DSJP-DS-2024-100145-US$DAIICHI$$$$$F$Y$$$20240918$$CN$US$US
243330721$24333072$1$I$20240101$20240911$20240918$20240918$EXP$$US-GSK-US2024113043$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$US$US
243330731$24333073$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63950$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243330741$24333074$1$I$20240620$20240917$20240917$20240917$DIR$718742$$FDA-CTU$$73$YR$$M$N$111$KG$20240917$N$$US$
243330751$24333075$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63819$$FDA-CTU$$49$YR$$M$N$223$LBS$20240917$N$$US$
243330761$24333076$1$I$20240619$20240624$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003698$PAREXEL$$73$YR$$F$Y$$$20240918$$CN$US$US
243330771$24333077$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5925069$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243330781$24333078$1$I$20240629$20240916$20240918$20240918$EXP$$US-TAKEDA-2024TUS033095$TAKEDA$$64$YR$$F$Y$$$20240918$$CN$US$US
243330791$24333079$1$I$$20240905$20240918$20240918$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08415$HIKMA$Bendayan S, Bendayan J, Cohen Y, Aintabi D, De Marchie M.. Bendayan S, Bendayan J, Cohen Y, Aintabi D, De Marchie M. Osmotic demyelination syndrome refractory to plasmapheresis treated with botulinum toxin injections: A case report and review of the literature. The Canadian Journal of General Internal Medicine. 2024;19.3:1-7$40$YR$$M$Y$$$20240918$$MD$CA$CA
243330801$24333080$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63842$$FDA-CTU$$71$YR$$F$N$154$LBS$20240917$N$$US$
243330811$24333081$1$I$20240914$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63875$$FDA-CTU$$69$YR$$M$N$$$20240917$N$CN$US$
243330821$24333082$1$I$20221028$20240917$20240917$20240917$DIR$718745$$FDA-CTU$$70$YR$$F$N$60.75$KG$20240917$N$CN$US$
243330831$24333083$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63824$$FDA-CTU$$77$YR$$F$N$117.93$KG$20240917$N$$US$
243330841$24333084$1$I$$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63898$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243330851$24333085$1$I$20240911$20240918$20240918$20240918$EXP$$JP-PFIZER INC-PV202400121952$PFIZER$$18$YR$$M$Y$$$20240918$$MD$JP$JP
243330861$24333086$1$I$$20240913$20240918$20240918$EXP$$CA-PFIZER INC-202400258157$PFIZER$$44$YR$$F$Y$$$20240918$$MD$CA$CA
243330871$24333087$1$I$20230601$20240917$20240918$20240918$EXP$FR-AFSSAPS-MA2024001486$FR-PFIZER INC-202400257804$PFIZER$$32$YR$$F$Y$66$KG$20240918$$CN$FR$FR
243330881$24333088$1$I$20240828$20240913$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120955$PFIZER$$67$YR$$F$Y$57$KG$20240918$$HP$CN$CN
243330893$24333089$3$F$20240907$20240918$20240918$20240920$EXP$$US-PFIZER INC-202400258712$PFIZER$$86$YR$$M$Y$$$20240920$$CN$US$US
243330901$24333090$1$I$$20240913$20240918$20240918$EXP$$US-PFIZER INC-2020501656$PFIZER$$89$YR$$F$Y$61.8$KG$20240918$$HP$US$US
243330911$24333091$1$I$$20240918$20240918$20240918$EXP$$RU-PFIZER INC-202400258333$PFIZER$$$$E$F$Y$$$20240918$$MD$RU$RU
243330922$24333092$2$F$$20240925$20240918$20240926$EXP$$US-PFIZER INC-202400257381$PFIZER$$15$YR$$F$Y$$$20240926$$CN$US$US
243330931$24333093$1$I$$20240917$20240918$20240918$EXP$$AR-PFIZER INC-202400258180$PFIZER$$20$YR$$M$Y$$$20240918$$CN$AR$AR
243330941$24333094$1$I$20240914$20240917$20240918$20240918$EXP$$IN-PFIZER INC-PV202400122090$PFIZER$$28$YR$$M$Y$$$20240918$$CN$IN$IN
243330962$24333096$2$F$20140101$20240926$20240918$20240927$EXP$FR-AFSSAPS-TS2024001011$FR-PFIZER INC-202400256930$PFIZER$$61$YR$$F$Y$53$KG$20240927$$CN$FR$FR
243330971$24333097$1$I$$20240916$20240918$20240918$EXP$$US-PFIZER INC-202201391147$PFIZER$$82$YR$$F$Y$$$20240918$$CN$US$US
243330981$24333098$1$I$20240821$20240916$20240918$20240918$EXP$FR-AFSSAPS-CF2024000466$FR-PFIZER INC-202400257028$PFIZER$$73$YR$$M$Y$54$KG$20240918$$PH$FR$FR
243330992$24333099$2$F$$20240918$20240918$20240919$EXP$$US-PFIZER INC-202400258158$PFIZER$$$$$$Y$$$20240919$$HP$US$US
243331001$24333100$1$I$20240906$20240916$20240918$20240918$EXP$FR-AFSSAPS-CN2024000872$FR-PFIZER INC-202400256997$PFIZER$$63$YR$$M$Y$110$KG$20240918$$MD$FR$FR
243331011$24333101$1$I$$20240917$20240918$20240918$EXP$$AR-PFIZER INC-202400258229$PFIZER$$74$YR$$F$Y$$$20240918$$CN$AR$AR
243331021$24333102$1$I$$20240916$20240918$20240918$EXP$$US-PFIZER INC-PV202400121405$PFIZER$$95$YR$$M$Y$$$20240918$$HP$US$US
243331031$24333103$1$I$$20240916$20240918$20240918$EXP$GB-MHRA-MED-202409151540153110-QMJZB$GB-PFIZER INC-202400257208$PFIZER$$50$YR$$F$Y$$$20240918$$PH$GB$GB
243331041$24333104$1$I$$20240916$20240918$20240918$EXP$$CA-PFIZER INC-202400258252$PFIZER$$63$YR$$F$Y$$$20240918$$HP$CA$CA
243331051$24333105$1$I$20240627$20240916$20240918$20240918$EXP$EG-EPVC-300264329$EG-PFIZER INC-PV202400121182$PFIZER$$55$YR$$F$Y$$$20240918$$PH$EG$EG
243331061$24333106$1$I$20240712$20240916$20240918$20240918$EXP$FR-AFSSAPS-NC2024001068$FR-PFIZER INC-202400257022$PFIZER$$85$YR$$M$Y$$$20240918$$MD$FR$FR
243331071$24333107$1$I$$20240917$20240918$20240918$EXP$$US-PFIZER INC-202400258343$PFIZER$$35$YR$$F$Y$$$20240918$$CN$US$US
243331091$24333109$1$I$20240401$20240918$20240918$20240918$EXP$$RU-PFIZER INC-202400258334$PFIZER$$$$A$F$Y$$$20240918$$MD$RU$RU
243331121$24333112$1$I$20240904$20240914$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120838$PFIZER$$93$YR$$M$Y$65$KG$20240918$$HP$CN$CN
243331131$24333113$1$I$$20240912$20240918$20240918$EXP$$CA-PFIZER INC-202400257351$PFIZER$$40$YR$$$Y$$$20240918$$MD$CA$CA
243331141$24333114$1$I$20230331$20240916$20240918$20240918$EXP$FR-AFSSAPS-AN2024001256$FR-PFIZER INC-202400256991$PFIZER$$81$YR$$F$Y$$$20240918$$PH$FR$FR
243331172$24333117$2$F$$20240918$20240918$20240920$PER$$US-LEO Pharma-373526$LEO PHARM$$62$YR$$M$Y$$$20240920$$PH$US$US
243331181$24333118$1$I$$20240916$20240918$20240918$EXP$$US-VIIV HEALTHCARE LIMITED-US2024114853$VIIV$$$$$M$Y$$$20240918$$PH$US$US
243331191$24333119$1$I$$20240911$20240918$20240918$EXP$$US-GSK-US2024AMR113223$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$US$US
243331202$24333120$2$F$20240916$20240917$20240918$20240919$EXP$$US-SANDOZ INC.-SDZ2024US078701$SANDOZ$$14$YR$$M$Y$$$20240919$$HP$US$US
243331211$24333121$1$I$20240903$20240913$20240918$20240918$PER$$US-RDY-SPO/USA/24/0012966$DR REDDYS$$38$YR$A$M$Y$$$20240918$$MD$US$US
243331221$24333122$1$I$20240906$20240910$20240918$20240918$EXP$RU-RZN-2553873$RU-SERVIER-S24011433$SERVIER$$$$$$Y$$$20240918$$HP$RU$RU
243331231$24333123$1$I$$20240913$20240918$20240918$EXP$$US-LUNDBECK-DKLU4004347$LUNDBECK$$$$$$Y$$$20240918$$HP$US$US
243331241$24333124$1$I$$20240818$20240918$20240918$PER$$US-HALEON-2197228$Haleon PLC$$24$YR$$M$Y$$$20240918$$HP$US$US
243331251$24333125$1$I$20240915$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024186018$AMGEN$$67$YR$E$F$Y$$$20240918$$CN$US$US
243331261$24333126$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010859$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243331271$24333127$1$I$20240711$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63878$$FDA-CTU$$61$YR$$M$N$$$20240916$N$HP$US$
243331281$24333128$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63796$$FDA-CTU$$56$YR$$F$N$81.65$KG$20240917$N$$US$
243331291$24333129$1$I$20240801$20240906$20240918$20240918$EXP$$US-UCBSA-2024046143$UCB$$40$YR$$F$Y$$$20240918$$HP$US$US
243331321$24333132$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63893$$FDA-CTU$$68$YR$$F$N$$$20240917$N$$US$
243331331$24333133$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63858$$FDA-CTU$$70$YR$$M$N$132$KG$20240917$N$$US$
243331341$24333134$1$I$$20240911$20240918$20240918$EXP$$CA-TEVA-VS-3243486$TEVA$$77$YR$$F$Y$$$20240918$$HP$CA$CA
243331352$24333135$2$F$20240904$20240920$20240918$20240926$PER$$US-AMGEN-USASP2024178864$AMGEN$$44$YR$A$F$Y$$$20240926$$PH$US$US
243331361$24333136$1$I$$20240917$20240917$20240917$DIR$718776$$FDA-CTU$$$$$UNK$N$$$20240917$$CN$US$
243331371$24333137$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63939$$FDA-CTU$$54$YR$$F$N$$$20240917$N$$US$
243331381$24333138$1$I$20240904$20240910$20240918$20240918$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-08494$HIKMA$$59$YR$$M$Y$45$KG$20240918$$HP$EG$EG
243331391$24333139$1$I$20240101$20240904$20240918$20240918$PER$$US-TEVA-VS-3241441$TEVA$$47$YR$$F$Y$$$20240918$$CN$US$US
243331401$24333140$1$I$$20240909$20240918$20240918$PER$$US-ABBVIE-5917118$ABBVIE$$$$$$Y$$$20240918$$CN$US$US
243331411$24333141$1$I$$20240912$20240918$20240918$EXP$SE-SEMPA-2024-006554$SE-MYLANLABS-2024M1083790$MYLAN$$59$YR$$F$Y$$$20240918$$MD$SE$SE
243331421$24333142$1$I$$20240916$20240918$20240918$EXP$$AU-MYLANLABS-2024M1084613$MYLAN$$$$$F$Y$$$20240918$$PH$AU$AU
243331432$24333143$2$F$$20240913$20240918$20240920$EXP$$JP-BAYER-2024A132142$BAYER$$$$$F$Y$$$20240920$$MD$JP$JP
243331441$24333144$1$I$$20240912$20240918$20240918$EXP$$US-LUNDBECK-DKLU4004322$LUNDBECK$$$$$$Y$$$20240918$$HP$US$US
243331451$24333145$1$I$$20240911$20240918$20240918$EXP$GB-MHRA-MED-202409111600130520-LCVQZ$GB-TEVA-VS-3243124$TEVA$$$$$M$Y$72$KG$20240918$$HP$GB$GB
243331461$24333146$1$I$$20240909$20240918$20240918$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006715$BIOCON$$$$$$Y$$$20240918$$HP$CA$CA
243331471$24333147$1$I$$20240918$20240918$20240918$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-088833$REGENERON$$$$$F$Y$$$20240918$$CN$CA$CA
243331481$24333148$1$I$20240501$20240909$20240918$20240918$EXP$GB-MHRA-MED-202409091717574630-PJNTZ$GB-TEVA-VS-3242433$TEVA$$$$$F$Y$$$20240918$$CN$GB$GB
243331491$24333149$1$I$$20240913$20240918$20240918$EXP$$CN-PFIZER INC-202400255980$PFIZER$$56$YR$$F$Y$$$20240918$$CN$CN$CN
243331501$24333150$1$I$20240712$20240917$20240918$20240918$EXP$FR-AFSSAPS-GR2024001088$FR-PFIZER INC-202400257924$PFIZER$$39$YR$$M$Y$$$20240918$$PH$FR$FR
243331521$24333152$1$I$20240723$20240916$20240918$20240918$EXP$FR-AFSSAPS-LL2024001748$FR-PFIZER INC-202400257037$PFIZER$$53$YR$$F$Y$58$KG$20240918$$PH$FR$FR
243331541$24333154$1$I$$20240912$20240918$20240918$EXP$$US-PFIZER INC-202400256404$PFIZER$$$$$F$Y$$$20240918$$MD$US$US
243331551$24333155$1$I$20240807$20240916$20240918$20240918$EXP$$DE-PFIZER INC-202400257051$PFIZER$$77$YR$$F$Y$62$KG$20240918$$MD$DE$DE
243331561$24333156$1$I$$20240913$20240918$20240918$PER$$US-JNJFOC-20240937352$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$CN$US$US
243331571$24333157$1$I$$20240913$20240918$20240918$PER$$US-JNJFOC-20240937289$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$CN$US$US
243331581$24333158$1$I$20240101$20240912$20240918$20240918$EXP$$US-JNJFOC-20240938692$JOHNSON AND JOHNSON$$35$YR$A$F$Y$$$20240918$$HP$US$US
243331591$24333159$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63925$$FDA-CTU$$59$YR$$M$N$$$20240917$N$$US$
243331601$24333160$1$I$20240917$20240917$20240917$20240917$DIR$718784$$FDA-CTU$$37$YR$$M$N$117$KG$20240917$N$CN$US$
243331611$24333161$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63933$$FDA-CTU$$72$YR$$F$N$$$20240917$N$$US$
243331621$24333162$1$I$20240917$20240917$20240917$20240917$DIR$718793$$FDA-CTU$$58$YR$$F$N$51.3$KG$20240917$Y$$US$
243331631$24333163$1$I$$20240913$20240918$20240918$EXP$$US-AMGEN-USASP2024184251$AMGEN$Hoang T.D.; Flor R.J.; De La Torre S. et al.. Effects of teprotumumab and role of HLA markers in patients with thyroid eye disease. American Association Of Clinical Endocrinologists. 2024;1-36$$$$$Y$$$20240918$$MD$US$US
243331641$24333164$1$I$20230401$20240911$20240918$20240918$EXP$$US-AMGEN-USASP2024183121$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243331651$24333165$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024186162$AMGEN$$$$$$Y$$$20240918$$PH$US$US
243331661$24333166$1$I$$20240911$20240918$20240918$EXP$$CA-LUNDBECK-DKLU4004327$LUNDBECK$$$$$$Y$$$20240918$$HP$CA$CA
243331671$24333167$1$I$$20240910$20240918$20240918$EXP$$US-SERB S.A.S.-2161756$LABORATOIRES SERB$Case description$12$YR$$M$Y$$$20240918$$$US$US
243331681$24333168$1$I$$20240828$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08643$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243331691$24333169$1$I$$20240916$20240918$20240918$PER$$US-ALXN-202409USA001190US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243331711$24333171$1$I$$20240914$20240918$20240918$PER$$US-AMGEN-USASP2024184865$AMGEN$$$$$$Y$$$20240918$$HP$US$US
243331721$24333172$1$I$$20240913$20240918$20240918$EXP$$US-OTSUKA-2024_025829$OTSUKA$$63$YR$$M$Y$$$20240918$$HP$US$US
243331731$24333173$1$I$20240831$20240909$20240918$20240918$EXP$$JP-ROCHE-10000079200$ROCHE$$5$DEC$A$F$Y$$$20240918$$MD$JP$JP
243331752$24333175$2$F$20130101$20240918$20240918$20240925$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409009925$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240925$$CN$DE$DE
243331761$24333176$1$I$$20240910$20240918$20240918$EXP$$CA-HALEON-2196711$Haleon PLC$$43$YR$$F$Y$$$20240918$$HP$CA$CA
243331771$24333177$1$I$20240814$20240911$20240918$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202409007304$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240918$$CN$US$US
243331781$24333178$1$I$$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409061107100170-VGBDS$GB-ELI_LILLY_AND_COMPANY-GB202409004987$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240918$$CN$GB$GB
243331791$24333179$1$I$20240822$20240910$20240918$20240918$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409009085$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240918$$CN$DE$CN
243331801$24333180$1$I$$20240906$20240918$20240918$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408017852$ELI LILLY AND CO$$91$YR$E$M$Y$$$20240918$$CN$JP$JP
243331811$24333181$1$I$20230801$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409061634083920-WMZTR$GB-ELI_LILLY_AND_COMPANY-GB202409004998$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240918$$CN$GB$GB
243331821$24333182$1$I$20201118$20240906$20240918$20240918$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409005933$ELI LILLY AND CO$$28$YR$A$M$Y$60$KG$20240918$$MD$FR$FR
243331831$24333183$1$I$20240817$20240906$20240918$20240918$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202402003095$ELI LILLY AND CO$$88$YR$E$M$Y$$$20240918$$CN$JP$JP
243331841$24333184$1$I$20240501$20240906$20240918$20240918$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409009662$ELI LILLY AND CO$$$$$M$Y$$$20240918$$CN$JP$JP
243331851$24333185$1$I$20231001$20240906$20240918$20240918$EXP$FR-AFSSAPS-TS2024000962$FR-ELI_LILLY_AND_COMPANY-FR202409004966$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240918$$CN$FR$FR
243331861$24333186$1$I$20240504$20240909$20240918$20240918$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409006056$ELI LILLY AND CO$$72$YR$E$M$Y$70$KG$20240918$$PH$FR$FR
243331881$24333188$1$I$$20240906$20240918$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202409004434$ELI LILLY AND CO$$18$YR$A$M$Y$$$20240918$$CN$US$US
243331891$24333189$1$I$20240525$20240906$20240918$20240918$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409008405$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240918$$CN$FR$FR
243331901$24333190$1$I$20240601$20240911$20240918$20240918$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006695$AURINIA PHARMACEUTICALS$$61$YR$$M$Y$$$20240918$$MD$US$US
243331911$24333191$1$I$$20240910$20240918$20240918$EXP$$CA-SANDOZ INC.-SDZ2024CA080951$SANDOZ$$$$$F$Y$$$20240918$$CN$CA$CA
243331922$24333192$2$F$$20240912$20240918$20240923$EXP$$IN-SANDOZ INC.-SDZ2024IN080549$SANDOZ$$$$$F$Y$$$20240923$$CN$IN$IN
243331931$24333193$1$I$20240705$20240909$20240918$20240918$EXP$$CA-LUNDBECK-DKLU4001317$LUNDBECK$$$$$$Y$$$20240918$$CN$CA$CA
243331951$24333195$1$I$20240917$20240917$20240917$20240917$DIR$718777$$FDA-CTU$$74$YR$$M$N$$$20240917$N$$US$
243331961$24333196$1$I$$20240828$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08641$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243331971$24333197$1$I$20240101$20240913$20240918$20240918$EXP$SE-SEMPA-2024-006426$SE-MYLANLABS-2024M1083872$MYLAN$$$$$F$Y$$$20240918$$CN$SE$SE
243331981$24333198$1$I$$20240912$20240918$20240918$EXP$IT-MINISAL02-1001243$IT-MYLANLABS-2024M1083842$MYLAN$$58$YR$$M$Y$78$KG$20240918$$HP$IT$IT
243331991$24333199$1$I$$20240806$20240918$20240918$PER$$US-LUNDBECK-DKLU4002925$LUNDBECK$$$$$$Y$$$20240918$$HP$US$US
243332001$24333200$1$I$20231004$20240917$20240917$20240917$DIR$718766$$FDA-CTU$$48$YR$$F$N$77.85$KG$20240917$N$CN$US$
243332011$24333201$1$I$20240823$20240917$20240917$20240917$DIR$718796$$FDA-CTU$$78$YR$$F$N$$$20240917$Y$PH$US$
243332021$24333202$1$I$$20240828$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08640$LUPIN$$$$$$Y$$$20240918$$PH$US$US
243332031$24333203$1$I$$20240916$20240918$20240918$EXP$$US-GILEAD-2024-0687967$GILEAD$$72$YR$E$M$Y$$$20240918$$CN$US$US
243332041$24333204$1$I$20240823$20240917$20240918$20240918$EXP$$US-PFIZER INC-PV202400121906$PFIZER$$72$YR$$F$Y$$$20240918$$HP$US$US
243332061$24333206$1$I$20240101$20240909$20240918$20240918$EXP$$CA-CELLTRION INC.-2024CA019084$CELLTRION$$$$$$Y$$$20240918$$MD$CA$CA
243332071$24333207$1$I$20240911$20240916$20240918$20240918$EXP$$US-PFIZER INC-202400033772$PFIZER$$81$YR$$M$Y$84.82$KG$20240918$$CN$US$US
243332081$24333208$1$I$20240826$20240914$20240918$20240918$EXP$BR-ANVISA-300290070$BR-PFIZER INC-PV202400121278$PFIZER$$75$YR$$M$Y$67$KG$20240918$$PH$BR$BR
243332091$24333209$1$I$20230101$20240913$20240918$20240918$EXP$$JP-PFIZER INC-202400256053$PFIZER$$$$$M$Y$$$20240918$$CN$JP$JP
243332101$24333210$1$I$$20240916$20240918$20240918$EXP$$US-PFIZER INC-PV202400121539$PFIZER$$76$YR$$M$Y$$$20240918$$CN$US$US
243332111$24333211$1$I$$20240916$20240918$20240918$EXP$$CA-PFIZER INC-202400258166$PFIZER$$8$YR$$F$Y$29$KG$20240918$$HP$CA$CA
243332121$24333212$1$I$$20240916$20240918$20240918$EXP$$CA-PFIZER INC-202400257409$PFIZER$$4$YR$$F$Y$$$20240918$$PH$CA$CA
243332131$24333213$1$I$20230325$20240913$20240918$20240918$EXP$FR-AFSSAPS-MA2024001461$FR-PFIZER INC-202400255832$PFIZER$$50$YR$$F$Y$50$KG$20240918$$CN$FR$FR
243332141$24333214$1$I$20240501$20240916$20240918$20240918$EXP$$CA-PFIZER INC-202400258203$PFIZER$$74$YR$$M$Y$$$20240918$$MD$CA$CA
243332152$24333215$2$F$20240727$20240917$20240918$20240920$EXP$$US-PFIZER INC-202300004809$PFIZER$$60$YR$$M$Y$121.56$KG$20240920$$CN$US$US
243332161$24333216$1$I$$20240912$20240918$20240918$EXP$$US-ABBVIE-5922405$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243332171$24333217$1$I$$20240909$20240918$20240918$30DAY$$US-GSK-US2024111779$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243332181$24333218$1$I$$20240909$20240918$20240918$30DAY$$US-GSK-US2024111931$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243332191$24333219$1$I$$20240916$20240918$20240918$EXP$$CA-PFIZER INC-202400258181$PFIZER$$7$YR$$M$Y$26$KG$20240918$$HP$CA$CA
243332201$24333220$1$I$$20240909$20240918$20240918$EXP$$US-TEVA-VS-3243301$TEVA$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024; 67 (0): no pagination.; Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024; 67 (0): no pagination.$49$YR$$F$Y$$$20240918$$HP$US$US
243332211$24333221$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010877$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243332221$24333222$1$I$20240908$20240910$20240918$20240918$EXP$$US-BEH-2024178548$CSL BEHRING$$47$YR$A$F$Y$$$20240918$$HP$US$US
243332231$24333223$1$I$$20240911$20240918$20240918$EXP$$US-RDY-SPO/USA/24/0013593$DR REDDYS$Clark J, Blake A, Vasher S, Boucher RC, Jones AR, Choi HJ, et al. Near fatal case of mirvetuximab soravtansine-gynx induced interstitial lung disease and a review of the primary literature. Gynecologic Oncology Reports. 2024 Aug 22;55: 1-7. doi:10.1016/j.gore.2024.101486.$56$YR$A$F$Y$$$20240918$$HP$US$US
243332241$24333224$1$I$20240701$20240916$20240918$20240918$EXP$FR-AFSSAPS-LY2024001287$FR-PFIZER INC-202400257031$PFIZER$$70$YR$$M$Y$99$KG$20240918$$PH$FR$FR
243332251$24333225$1$I$$20240911$20240918$20240918$EXP$$CA-HALEON-2197039$Haleon PLC$$$$$F$Y$$$20240918$$HP$CA$CA
243332261$24333226$1$I$$20240916$20240918$20240918$PER$$US-TAKEDA-2024TUS092472$TAKEDA$$$$$$Y$$$20240918$$CN$US$US
243332281$24333228$1$I$20240518$20240905$20240918$20240918$EXP$$CN-UCBSA-2024045786$UCB$$0$YR$$M$Y$1.85$KG$20240918$$CN$CN$CN
243332301$24333230$1$I$$20240828$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08777$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243332321$24333232$1$I$20240520$20240913$20240918$20240918$EXP$IT-MINISAL02-1001310$IT-TEVA-VS-3243426$TEVA$$4$YR$$M$Y$17$KG$20240918$$MD$IT$IT
243332331$24333233$1$I$$20240916$20240918$20240918$EXP$$US-GILEAD-2024-0687920$GILEAD$$1$MON$I$F$Y$$$20240918$$HP$US$US
243332341$24333234$1$I$$20240627$20240918$20240918$PER$$US-Mundipharma Research Limited-2161757$MUNDIPHARMA EDO$$$$$F$Y$$$20240918$$MD$US$US
243332351$24333235$1$I$$20240905$20240918$20240918$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00871$Phathom Pharmaceuticals$$$$E$F$Y$$$20240918$$HP$JP$JP
243332381$24333238$1$I$$20240917$20240918$20240918$EXP$$AU-SANDOZ INC.-SDZ2024AU080966$SANDOZ$$$$$F$Y$$$20240918$$HP$AU$AU
243332391$24333239$1$I$$20240913$20240918$20240918$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001869$BLUEPRINT MEDICINES$$$$$M$Y$$$20240918$$CN$US$US
243332402$24333240$2$F$$20240923$20240918$20240930$EXP$$GR-TEVA-VS-3242507$TEVA$Vasilopoulou A, Spaho M, Theotokis P, Grekou A, Meditskou S, Manthou ME. Fatal misdiagnosis of progressive disseminated histoplasmosis. Med-Mycol-Case-Reports 2024; 45 1-4.; Vasilopoulou A, Spaho M, Theotokis P, Grekou A, Meditskou S, Manthou ME. Fatal misdiagnosis of progressive disseminated histoplasmosis. Med-Mycol-Case-Reports 2024; 45 1-4.; Vasilopoulou A, Spaho M, Theotokis P, Grekou A, Meditskou S, Manthou ME. Fatal misdiagnosis of progressive disseminated histoplasmosis. Med-Mycol-Cas...$39$YR$$M$Y$$$20240930$$HP$GR$GR
243332411$24333241$1$I$20240101$20240910$20240918$20240918$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00893$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$US$US
243332422$24333242$2$F$$20240911$20240918$20240925$PER$$US-AGIOS-2409US03884$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
243332431$24333243$1$I$20240912$20240916$20240917$20240917$DIR$FDA-CDER-CTU-2024-63947$$FDA-CTU$$51$YR$$F$N$$$20240916$N$HP$US$
243332451$24333245$1$I$20240507$20240917$20240917$20240917$DIR$718801$$FDA-CTU$$39$YR$$F$N$63$KG$20240917$Y$CN$US$
243332461$24333246$1$I$20230923$20240904$20240918$20240918$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-23-00791$Unknown Manufacturer$$2$YR$$M$Y$12.25$KG$20240918$$CN$US$US
243332471$24333247$1$I$$20240913$20240918$20240918$EXP$$RU-AMERICAN REGENT INC-2024003532$AMERICAN REGENT$$$$$F$Y$$$20240918$$MD$RU$RU
243332481$24333248$1$I$$20240705$20240918$20240918$PER$$US-ROCHE-10000021259$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243332491$24333249$1$I$$20240911$20240918$20240918$PER$$US-JNJFOC-20240928543$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$PH$US$US
243332511$24333251$1$I$20240728$20240916$20240918$20240918$EXP$$FR-SANDOZ INC.-SDZ2024FR080416$SANDOZ$$57$YR$$F$Y$58$KG$20240918$$MD$FR$FR
243332521$24333252$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010800$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243332531$24333253$1$I$$20240911$20240918$20240918$PER$$ZA-REGENERON PHARMACEUTICALS, INC.-2024-124835$REGENERON$$$$$F$Y$$$20240918$$MD$ZA$ZA
243332541$24333254$1$I$$20240908$20240918$20240918$EXP$$CH-HIKMA PHARMACEUTICALS USA INC.-PT-H14001-24-08434$HIKMA$Vetter C, Biedermann C, Berger-Estilita J, B?tikofer A.. Vetter C, Biedermann C, Berger-Estilita J, B?tikofer A. Coma After Droperidol Administration: A Case Report.. A A Practice. 2024;18(8):e01831:1-3pgs$32$YR$$F$Y$65$KG$20240918$$MD$CH$PT
243332552$24333255$2$F$20240101$20240911$20240918$20240924$EXP$$CN-009507513-2409CHN005393$MERCK$$60$YR$$M$Y$49.1$KG$20240924$$HP$CN$CN
243332561$24333256$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186269$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243332571$24333257$1$I$$20240904$20240918$20240918$EXP$$US-CHATTEMPRD-2024OHG031379$CHATTEM$Grosso D, Wagner JL, O^connor A, Keck K, Huang Y, Wang Z, et al. Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19. Blood Advances. 2024; 8(15); 4113-4124; DOI: 10.1182/bloodadvances.2024013344$83$YR$E$F$Y$$$20240918$$HP$US$US
243332582$24333258$2$F$$20240919$20240918$20240923$PER$$US-PFIZER INC-PV202400121537$PFIZER$$84$YR$$F$Y$$$20240923$$HP$US$US
243332591$24333259$1$I$20230902$20240916$20240918$20240918$PER$$US-PFIZER INC-2023SGN13145$PFIZER$$87$YR$$F$Y$$$20240918$$CN$US$US
243332601$24333260$1$I$20240101$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257600$PFIZER$$83$YR$$F$Y$65.77$KG$20240918$$CN$US$US
243332611$24333261$1$I$20240915$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257713$PFIZER$$54$YR$$F$Y$$$20240918$$CN$US$US
243332621$24333262$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202400121558$PFIZER$$50$YR$$M$Y$$$20240918$$HP$US$US
243332631$24333263$1$I$20240901$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257574$PFIZER$$67$YR$$M$Y$$$20240918$$CN$US$US
243332641$24333264$1$I$20240915$20240916$20240918$20240918$PER$$US-PFIZER INC-202400255620$PFIZER$$58$YR$$F$Y$$$20240918$$CN$US$US
243332652$24333265$2$F$$20240924$20240918$20240927$PER$$US-PFIZER INC-PV202400121439$PFIZER$$65$YR$$M$Y$$$20240927$$HP$US$US
243332671$24333267$1$I$20240901$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202400121490$PFIZER$$48$YR$$M$Y$$$20240918$$HP$US$US
243332681$24333268$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202400121552$PFIZER$$54$YR$$F$Y$$$20240918$$HP$US$US
243332701$24333270$1$I$20240911$20240915$20240918$20240918$PER$$US-PFIZER INC-202400257527$PFIZER$$74$YR$$M$Y$$$20240918$$CN$US$US
243332711$24333271$1$I$20240822$20240917$20240917$20240917$DIR$718811$$FDA-CTU$$60$YR$$F$N$83.25$KG$20240917$N$CN$US$
243332721$24333272$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257757$PFIZER$$59$YR$$F$Y$$$20240918$$CN$US$US
243332731$24333273$1$I$20240101$20240913$20240918$20240918$PER$$US-PFIZER INC-PV202400120608$PFIZER$$73$YR$$F$Y$$$20240918$$CN$US$US
243332741$24333274$1$I$20240907$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257788$PFIZER$$46$YR$$M$Y$$$20240918$$CN$US$US
243332761$24333276$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257643$PFIZER$$$$A$F$Y$$$20240918$$HP$US$US
243332781$24333278$1$I$20240916$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257553$PFIZER$$86$YR$$F$Y$$$20240918$$PH$US$US
243332791$24333279$1$I$20240801$20240912$20240918$20240918$PER$$US-PFIZER INC-202400256042$PFIZER$$40$YR$$F$Y$$$20240918$$HP$US$US
243332801$24333280$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202400121533$PFIZER$$$$A$F$Y$$$20240918$$CN$US$US
243332811$24333281$1$I$20240913$20240915$20240918$20240918$PER$$US-PFIZER INC-202400257525$PFIZER$$46$YR$$F$Y$$$20240918$$CN$US$US
243332821$24333282$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202400121462$PFIZER$$70$YR$$F$Y$$$20240918$$HP$US$US
243332831$24333283$1$I$20240101$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257599$PFIZER$$85$YR$$F$Y$57.15$KG$20240918$$CN$US$US
243332841$24333284$1$I$20240914$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257617$PFIZER$$87$YR$$M$Y$$$20240918$$CN$US$US
243332851$24333285$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202400121543$PFIZER$$88$YR$$F$Y$$$20240918$$HP$US$US
243332861$24333286$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202300103793$PFIZER$$74$YR$$F$Y$117.5$KG$20240918$$CN$US$US
243332872$24333287$2$F$20240916$20240918$20240918$20240920$PER$$US-PFIZER INC-202400258386$PFIZER$$63$YR$$M$Y$$$20240920$$HP$US$US
243332881$24333288$1$I$$20240913$20240918$20240918$PER$$US-PFIZER INC-PV202400120612$PFIZER$$$$$F$Y$$$20240918$$CN$US$US
243332891$24333289$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202400121424$PFIZER$$53$YR$$F$Y$$$20240918$$CN$US$US
243332901$24333290$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257473$PFIZER$$$$$F$Y$$$20240918$$MD$US$US
243332911$24333291$1$I$$20240913$20240918$20240918$PER$$US-PFIZER INC-PV202400120684$PFIZER$$65$YR$$F$Y$$$20240918$$CN$US$US
243332921$24333292$1$I$20240629$20240915$20240918$20240918$PER$$US-PFIZER INC-202400257536$PFIZER$$61$YR$$F$Y$$$20240918$$MD$US$US
243332931$24333293$1$I$20240912$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202400121425$PFIZER$$43$YR$$F$Y$$$20240918$$HP$US$US
243332941$24333294$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202400121441$PFIZER$$$$E$F$Y$$$20240918$$HP$US$US
243332961$24333296$1$I$20240915$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257626$PFIZER$$71$YR$$F$Y$$$20240918$$CN$US$US
243332971$24333297$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257609$PFIZER$$43$YR$$F$Y$$$20240918$$CN$US$US
243332981$24333298$1$I$$20240913$20240918$20240918$PER$$US-PFIZER INC-202400256633$PFIZER$$58$YR$$F$Y$$$20240918$$CN$US$US
243332991$24333299$1$I$20240401$20240917$20240917$20240917$DIR$718807$$FDA-CTU$$44$YR$$M$N$74.25$KG$20240917$N$CN$US$
243333011$24333301$1$I$20240912$20240912$20240918$20240918$PER$$US-PFIZER INC-202400256044$PFIZER$$24$YR$$$Y$$$20240918$$CN$US$US
243333021$24333302$1$I$20240914$20240915$20240918$20240918$PER$$US-PFIZER INC-202400257419$PFIZER$$58$YR$$M$Y$$$20240918$$CN$US$US
243333032$24333303$2$F$20240910$20240918$20240918$20240925$EXP$$JP-ARGENX-2024-ARGX-JP007684$ARGENX BVBA$$$$$$Y$$$20240925$$PH$JP$JP
243333041$24333304$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63951$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243333051$24333305$1$I$20240917$20240917$20240917$20240917$DIR$718809$$FDA-CTU$$49$YR$$F$N$97.2$KG$20240917$N$CN$US$
243333061$24333306$1$I$20240910$20240915$20240918$20240918$PER$$US-PFIZER INC-202400257452$PFIZER$$51$YR$$F$Y$$$20240918$$CN$US$US
243333071$24333307$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257333$PFIZER$$$$$$Y$$$20240918$$PH$US$US
243333081$24333308$1$I$20240915$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257383$PFIZER$$$$$M$Y$$$20240918$$CN$US$US
243333092$24333309$2$F$$20240917$20240918$20240920$PER$$US-PFIZER INC-202400257575$PFIZER$$70$YR$$F$Y$$$20240920$$HP$US$US
243333101$24333310$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63946$$FDA-CTU$$80$YR$$F$N$$$20240917$N$$US$
243333111$24333311$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63952$$FDA-CTU$$36$YR$$M$N$$$20240917$N$$US$
243333121$24333312$1$I$$20240917$20240917$20240917$DIR$718760$$FDA-CTU$$73$YR$$F$N$$$20240917$N$PH$US$
243333131$24333313$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-202400258352$PFIZER$$58$YR$$F$Y$$$20240918$$HP$US$US
243333151$24333315$1$I$20240801$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202400061245$PFIZER$$72$YR$$F$Y$$$20240918$$HP$US$US
243333161$24333316$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257701$PFIZER$$$$$$Y$$$20240918$$CN$US$US
243333171$24333317$1$I$20240909$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63888$$FDA-CTU$$76$YR$$M$N$$$20240917$N$HP$US$
243333181$24333318$1$I$20240901$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257376$PFIZER$$$$$F$Y$$$20240918$$MD$US$US
243333191$24333319$1$I$$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202400121518$PFIZER$$29$YR$$M$Y$$$20240918$$HP$US$US
243333201$24333320$1$I$20240903$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257784$PFIZER$$19$YR$$F$Y$$$20240918$$HP$US$US
243333211$24333321$1$I$20240916$20240916$20240918$20240918$PER$$US-PFIZER INC-202400257706$PFIZER$$58$YR$$M$Y$$$20240918$$CN$US$US
243333221$24333322$1$I$$20240716$20240918$20240918$PER$$US-Mundipharma Research Limited-2161758$MUNDIPHARMA EDO$$$$$F$Y$$$20240918$$MD$US$US
243333241$24333324$1$I$20240701$20240909$20240918$20240918$PER$$US-JNJFOC-20240923644$JOHNSON AND JOHNSON$$92$YR$E$F$Y$$$20240918$$CN$US$US
243333251$24333325$1$I$20240101$20240730$20240918$20240918$EXP$$US-UCBSA-2024038692$UCB$$$$$F$Y$$$20240918$$HP$US$US
243333261$24333326$1$I$20240801$20240829$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138841$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240918$$CN$US$US
243333271$24333327$1$I$$20240912$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146258$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240918$$PH$US$US
243333281$24333328$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148033$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240918$$HP$US$US
243333291$24333329$1$I$20240101$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147678$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$71$KG$20240918$$PH$US$US
243333302$24333330$2$F$$20240923$20240918$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147202$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$89.36$KG$20240924$$CN$US$US
243333311$24333331$1$I$$20240912$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147829$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240918$$PH$JP$JP
243333321$24333332$1$I$20240828$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148155$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240918$$PH$US$US
243333332$24333333$2$F$$20240917$20240918$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145963$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240925$$CN$US$US
243333341$24333334$1$I$$20240711$20240918$20240918$PER$$US-ROCHE-10000025621$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243333351$24333335$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147250$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240918$$CN$US$US
243333361$24333336$1$I$$20240909$20240918$20240918$EXP$GB-MHRA-MED-202409091520068670-BNVCF$GB-BAXTER-2024BAX024518$BAXTER$$82$YR$$F$Y$$$20240918$$PH$GB$GB
243333371$24333337$1$I$20240826$20240907$20240918$20240918$EXP$CN-NMPACDR-1305011517231202400109$CN-BAXTER-2024BAX024510$BAXTER$$66$YR$$M$Y$90$KG$20240918$$MD$CN$CN
243333381$24333338$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01119$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243333391$24333339$1$I$20240912$20240912$20240918$20240918$PER$$US-BAYER-2024A132113$BAYER$$$$$$Y$$$20240918$$CN$US$US
243333401$24333340$1$I$$20240916$20240918$20240918$PER$$US-BAYER-2024A132602$BAYER$$30$YR$A$F$Y$$$20240918$$MD$US$US
243333421$24333342$1$I$$20240913$20240918$20240918$EXP$$NVSC2024HR185000$NOVARTIS$$$$A$M$Y$$$20240918$$MD$HR$HR
243333431$24333343$1$I$$20240909$20240918$20240918$PER$$US-Calliditas-2024CAL01793$CALLIDITAS THERAPEUTICS$$57$YR$A$F$Y$$$20240918$$CN$US$US
243333441$24333344$1$I$20230710$20240906$20240918$20240918$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08424$HIKMA$$76$YR$$F$Y$92.2$KG$20240918$$HP$US$US
243333451$24333345$1$I$20240913$20240913$20240918$20240918$PER$$US-BAYER-2024A132379$BAYER$$74$YR$E$F$Y$$$20240918$$CN$US$US
243333461$24333346$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010801$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243333471$24333347$1$I$20240719$20240917$20240917$20240917$DIR$718757$$FDA-CTU$$36$YR$$F$N$86.3$KG$20240917$N$HP$US$
243333481$24333348$1$I$20240915$20240917$20240917$20240917$DIR$718810$$FDA-CTU$$31$YR$$F$N$$$20240917$Y$PH$US$
243333491$24333349$1$I$$20240909$20240918$20240918$30DAY$$US-GSK-US2024112048$GLAXOSMITHKLINE$$$$$M$Y$$$20240918$$CN$US$US
243333501$24333350$1$I$$20240910$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-148372$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240918$$MD$JP$JP
243333511$24333351$1$I$20240903$20240913$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147304$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240918$$HP$US$US
243333521$24333352$1$I$20240901$20240910$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144771$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$80.29$KG$20240918$$HP$US$US
243333541$24333354$1$I$$20240916$20240918$20240918$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-148311$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240918$$MD$FR$FR
243333551$24333355$1$I$20240822$20240913$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146885$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240918$$CN$US$US
243333561$24333356$1$I$20240912$20240917$20240918$20240918$PER$$US-ALXN-202409USA001298US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243333571$24333357$1$I$$20240914$20240918$20240918$PER$$US-BAYER-2024A132027$BAYER$$$$$$Y$$$20240918$$CN$US$US
243333581$24333358$1$I$20240718$20240917$20240917$20240917$DIR$718752$$FDA-CTU$$36$YR$$F$N$86.1$KG$20240917$N$HP$US$
243333591$24333359$1$I$20240913$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63983$$FDA-CTU$$49$YR$$F$N$98.6$KG$20240917$N$PH$US$
243333601$24333360$1$I$20240901$20240912$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146165$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240918$$HP$US$US
243333611$24333361$1$I$20240911$20240911$20240918$20240918$EXP$$US-JNJFOC-20240929618$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240918$$CN$US$US
243333621$24333362$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01114$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243333631$24333363$1$I$20240917$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-64024$$FDA-CTU$$80$YR$$F$N$$$20240917$N$$US$
243333641$24333364$1$I$20240828$20240917$20240917$20240917$DIR$718813$$FDA-CTU$$33$YR$$F$N$$$20240917$Y$PH$US$
243333651$24333365$1$I$20240913$20240917$20240917$20240917$DIR$718812$$FDA-CTU$$32$YR$$F$N$$$20240917$Y$PH$US$
243333661$24333366$1$I$$20240917$20240917$20240917$DIR$718756$$FDA-CTU$$$$$UNK$N$$$20240917$$CN$US$
243333671$24333367$1$I$20240829$20240917$20240917$20240917$DIR$718747$$FDA-CTU$$44$YR$$F$N$$$20240917$N$HP$US$
243333681$24333368$1$I$20240725$20240917$20240917$20240917$DIR$718763$$FDA-CTU$$56$YR$$F$N$$$20240917$N$$US$
243333701$24333370$1$I$20240912$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-63963$$FDA-CTU$$70$YR$$M$N$82.7$KG$20240917$N$$US$
243333711$24333371$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64052$$FDA-CTU$$74$YR$$F$N$$$20240918$N$$US$
243333721$24333372$1$I$20240129$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-63965$$FDA-CTU$$78$YR$$F$N$78.74$KG$20240917$N$$US$
243333731$24333373$1$I$$20240916$20240918$20240918$EXP$$IN-VANTIVE-2024VAN019847$Vantive US Healthcare$$45$YR$$F$Y$$$20240918$$CN$IN$IN
243333742$24333374$2$F$$20240917$20240918$20240923$EXP$$IN-VANTIVE-2024VAN019810$Vantive US Healthcare$$27$YR$$M$Y$$$20240923$$CN$IN$IN
243333752$24333375$2$F$$20240917$20240918$20240926$EXP$$US-VANTIVE-2024VAN019796$Vantive US Healthcare$$$$$M$Y$$$20240926$$CN$US$US
243333771$24333377$1$I$20240901$20240917$20240918$20240918$EXP$$JP-BAYER-2024A129627$BAYER$$24$YR$A$F$Y$$$20240918$$PH$JP$JP
243333781$24333378$1$I$20240901$20240913$20240918$20240918$EXP$$US-ABBVIE-5923857$ABBVIE$$82$YR$$M$Y$$$20240918$$CN$US$US
243333791$24333379$1$I$20240101$20240912$20240918$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-023106$UNITED THERAPEUTICS$$$$$M$Y$90.703$KG$20240918$$$US$US
243333801$24333380$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64057$$FDA-CTU$$65$YR$$M$N$$$20240918$N$$US$
243333821$24333382$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64048$$FDA-CTU$$76$YR$$M$N$$$20240918$N$$US$
243333831$24333383$1$I$20240817$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-64023$$FDA-CTU$$71$YR$$F$N$95.25$KG$20240917$N$CN$US$
243333841$24333384$1$I$20240701$20240912$20240918$20240918$EXP$$JP-009507513-2407JPN005250J$MERCK$$8$DEC$$M$Y$$$20240918$$MD$JP$JP
243333851$24333385$1$I$20240821$20240910$20240918$20240918$30DAY$$AR-PFIZER INC-202400253876$PFIZER$$15$YR$$M$Y$$$20240918$$CN$AR$AR
243333861$24333386$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01120$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243333871$24333387$1$I$20240912$20240912$20240918$20240918$EXP$$US-JNJFOC-20240933774$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240918$$HP$US$US
243333881$24333388$1$I$20240909$20240913$20240918$20240918$PER$$US-JNJFOC-20240936828$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20240918$$CN$US$US
243333891$24333389$1$I$$20240916$20240918$20240918$PER$$US-BAYER-2024A132051$BAYER$$35$YR$A$M$Y$$$20240918$$CN$US$US
243333901$24333390$1$I$20240820$20240917$20240918$20240918$PER$$NVSC2024US186154$NOVARTIS$$$$$F$Y$$$20240918$$HP$US$US
243333921$24333392$1$I$20240710$20240912$20240918$20240918$EXP$$TH-EXELIXIS-CABO-24079470$EXELIXIS$$76$YR$$M$Y$$$20240918$$CN$TH$TH
243333941$24333394$1$I$$20240916$20240918$20240918$PER$$US-BAYER-2024A132186$BAYER$$$$$M$Y$$$20240918$$CN$US$US
243333963$24333396$3$F$20200321$20240916$20240918$20240927$EXP$$DE-SANDOZ INC.-NVSC2020DE090459$SANDOZ$$$$A$M$Y$127$KG$20240927$$CN$DE$DE
243333971$24333397$1$I$$20240915$20240918$20240918$PER$$US-PFIZER INC-202400257394$PFIZER$$$$$F$Y$$$20240918$$CN$US$US
243333981$24333398$1$I$$20240906$20240918$20240918$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18099$IPSEN$$$$$$Y$$$20240918$$HP$US$US
243333992$24333399$2$F$20240101$20240925$20240918$20240926$PER$$US-PFIZER INC-202400257415$PFIZER$$84$YR$$F$Y$$$20240926$$CN$US$US
243334001$24333400$1$I$$20240910$20240918$20240918$EXP$$US-ARGENX-2024-ARGX-US007667$ARGENX BVBA$$$$$$Y$$$20240918$$MD$US$US
243334011$24333401$1$I$$20240903$20240918$20240918$PER$$US-TEVA-VS-3240579$TEVA$$$$$M$Y$$$20240918$$HP$US$US
243334021$24333402$1$I$$20240912$20240918$20240918$PER$$US-TAKEDA-2024TUS091470$TAKEDA$$$$$F$Y$68$KG$20240918$$HP$US$US
243334032$24333403$2$F$20240410$20240920$20240918$20240927$EXP$GB-MHRA-MED-202409120819116990-PQWJZ$GB-BEH-2024178839$CSL BEHRING$$31$YR$A$F$Y$58$KG$20240927$$MD$GB$GB
243334051$24333405$1$I$$20240916$20240918$20240918$PER$$US-BAYER-2024A132622$BAYER$$35$YR$A$F$Y$$$20240918$$MD$US$US
243334061$24333406$1$I$20240101$20240910$20240918$20240918$EXP$$NVSC2024PT184339$NOVARTIS$$$$$F$Y$$$20240918$$MD$PT$PT
243334071$24333407$1$I$20240727$20240913$20240918$20240918$EXP$$US-SA-2024SA269005$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240918$$HP$US$US
243334081$24333408$1$I$$20240916$20240918$20240918$EXP$$US-SA-2024SA269262$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240918$$HP$US$US
243334091$24333409$1$I$20240101$20240916$20240918$20240918$EXP$GB-MHRA-MED-202409141447069040-LHFYT$GB-PFIZER INC-202400257222$PFIZER$$47$YR$$F$Y$83$KG$20240918$$CN$GB$GB
243334101$24333410$1$I$20230911$20240913$20240918$20240918$EXP$$GB-JNJFOC-20240939619$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240918$$CN$GB$GB
243334111$24333411$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001357US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$US$US
243334121$24333412$1$I$$20240903$20240918$20240918$PER$$US-TEVA-VS-3240475$TEVA$$$$A$$Y$$$20240918$$HP$US$US
243334131$24333413$1$I$$20240917$20240918$20240918$PER$$US-BAYER-2024A132615$BAYER$$49$YR$A$F$Y$$$20240918$$CN$US$US
243334141$24333414$1$I$20240906$20240906$20240918$20240918$PER$$US-ALKERMES INC.-ALK-2024-002332$ALKERMES$$41$YR$$F$Y$99.773$KG$20240918$$HP$US$US
243334151$24333415$1$I$20231026$20240906$20240918$20240918$EXP$PT-INFARMED-R202408-732$PT-JNJFOC-20240923946$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240918$$MD$PT$PT
243334161$24333416$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010848$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243334171$24333417$1$I$$20240828$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08642$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243334181$24333418$1$I$20130321$20240911$20240918$20240918$EXP$PT-INFARMED-J202408-693$PT-TEVA-VS-3243144$TEVA$$66$YR$$F$Y$52$KG$20240918$$CN$PT$PT
243334191$24333419$1$I$$20240906$20240918$20240918$PER$$US-MYLANLABS-2024M1083024$MYLAN$$$$$F$Y$$$20240918$$CN$US$US
243334201$24333420$1$I$20231109$20240913$20240918$20240918$EXP$$US-ASCENDIS PHARMA-2023US003768$ASCENDIS PHARMA$$$$$$Y$$$20240918$$MD$US$US
243334211$24333421$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01113$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243334221$24333422$1$I$$20240911$20240918$20240918$EXP$$NVSC2024ZA183001$NOVARTIS$$52$YR$$M$Y$$$20240918$$HP$ZA$ZA
243334231$24333423$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186271$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243334241$24333424$1$I$$20240913$20240918$20240918$EXP$$NVSC2024AU185461$NOVARTIS$$$$$M$Y$$$20240918$$MD$AU$AU
243334251$24333425$1$I$20240805$20240913$20240918$20240918$EXP$IT-MINISAL02-1001334$IT-TEVA-VS-3243588$TEVA$$3$YR$$M$Y$12.5$KG$20240918$$MD$IT$IT
243334261$24333426$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010967$ELI LILLY AND CO$$32$YR$A$M$Y$$$20240918$$CN$US$US
243334271$24333427$1$I$$20240911$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008610$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240918$$CN$US$US
243334281$24333428$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010915$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240918$$CN$US$US
243334292$24333429$2$F$20240801$20240917$20240918$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409008565$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240920$$CN$US$US
243334301$24333430$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009885$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240918$$CN$US$US
243334311$24333431$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009540$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240918$$CN$US$US
243334321$24333432$1$I$$20240911$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010564$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240918$$CN$US$US
243334331$24333433$1$I$20240914$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009945$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240918$$CN$US$US
243334341$24333434$1$I$20240601$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009992$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240918$$CN$US$US
243334351$24333435$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010220$ELI LILLY AND CO$$71$YR$E$$Y$$$20240918$$LW$US$US
243334361$24333436$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010843$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240918$$CN$US$US
243334371$24333437$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409006212$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240918$$CN$US$US
243334381$24333438$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010718$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240918$$CN$US$US
243334391$24333439$1$I$20240914$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409011096$ELI LILLY AND CO$$88$YR$E$F$Y$$$20240918$$CN$US$US
243334401$24333440$1$I$20240901$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010289$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240918$$CN$US$US
243334411$24333441$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009124$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240918$$CN$US$US
243334421$24333442$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010056$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240918$$CN$US$US
243334431$24333443$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010122$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243334441$24333444$1$I$20240913$20240917$20240918$20240918$PER$$US-BAYER-2024A132540$BAYER$$18$YR$A$M$Y$$$20240918$$CN$US$US
243334451$24333445$1$I$20230101$20240910$20240918$20240918$PER$$US-BAYER-2024A130293$BAYER$$$$$F$Y$$$20240918$$CN$US$US
243334461$24333446$1$I$20240902$20240903$20240918$20240918$PER$$US-COSETTE-CP2024US000239$COSETTE PHARMACEUTICALS$$79$YR$E$F$Y$$$20240918$$CN$US$US
243334471$24333447$1$I$$20240906$20240918$20240918$PER$$US-ALKERMES INC.-ALK-2024-002352$ALKERMES$$$$$M$Y$$$20240918$$MD$US$US
243334481$24333448$1$I$20230926$20240903$20240918$20240918$EXP$$DE-UCBSA-2024047750$UCB$$$$N$M$Y$$$20240918$$MD$DE$DE
243334492$24333449$2$F$20201201$20240919$20240918$20240924$EXP$PL-ROCHE-10000012697$PL-ASTELLAS-2024-AER-005730$ASTELLAS$$49$YR$A$M$Y$$$20240924$$HP$PL$PL
243334511$24333451$1$I$20240906$20240906$20240918$20240918$PER$$US-ALKERMES INC.-ALK-2024-002341$ALKERMES$$41$YR$$M$Y$$$20240918$$HP$US$US
243334521$24333452$1$I$$20240917$20240918$20240918$PER$$US-BAYER-2024A132683$BAYER$$$$$$Y$$$20240918$$CN$US$US
243334531$24333453$1$I$$20240914$20240918$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015147$JAZZ$$$$$$Y$$$20240918$$HP$US$US
243334542$24333454$2$F$20240905$20240907$20240918$20240919$PER$$US-ALKERMES INC.-ALK-2024-002344$ALKERMES$$47$YR$$M$Y$62.585$KG$20240919$$CN$US$US
243334561$24333456$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01115$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243334571$24333457$1$I$20240307$20240912$20240918$20240918$EXP$$DE-TAKEDA-2024TUS091260$TAKEDA$$57$YR$$M$Y$147$KG$20240918$$MD$DE$DE
243334591$24333459$1$I$20000405$20240917$20240917$20240917$DIR$718820$$FDA-CTU$$5$YR$$M$N$$$20240917$N$CN$US$
243334631$24333463$1$I$$20240828$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08776$LUPIN$$$$$$Y$$$20240918$$HP$US$US
243334641$24333464$1$I$20240917$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-64015$$FDA-CTU$$43$YR$$F$N$$$20240917$N$$US$
243334652$24333465$2$F$20240401$20240916$20240918$20240924$EXP$FR-AFSSAPS-AVMA2024000376$FR-TEVA-VS-3242288$TEVA$$52$YR$$M$Y$$$20240924$$PH$FR$FR
243334661$24333466$1$I$$20240911$20240918$20240918$EXP$$CA-TAKEDA-2024TUS004365$TAKEDA$$$$$F$Y$$$20240918$$MD$CA$CA
243334671$24333467$1$I$$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-64000$$FDA-CTU$$$$$$N$$$20240917$$CN$US$
243334681$24333468$1$I$$20240917$20240918$20240918$EXP$$AU-SANDOZ INC.-SDZ2024AU080970$SANDOZ$$$$$F$Y$$$20240918$$MD$AU$AU
243334691$24333469$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001305US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243334701$24333470$1$I$$20240917$20240918$20240918$PER$$US-BAYER-2024A132871$BAYER$$63$YR$A$F$Y$$$20240918$$CN$US$US
243334711$24333471$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001350US$ALEXION PHARMACEUTICALS$$$$$M$Y$$$20240918$$CN$US$US
243334721$24333472$1$I$$20240910$20240918$20240918$PER$$US-APOTEX-2024AP010849$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240918$$HP$US$US
243334731$24333473$1$I$$20240917$20240918$20240918$PER$$US-ALXN-A202113618$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243334741$24333474$1$I$$20240909$20240918$20240918$PER$$US-JNJFOC-20240923973$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243334751$24333475$1$I$$20240912$20240918$20240918$EXP$$CA-TAKEDA-2024TUS091762$TAKEDA$$$$$M$Y$$$20240918$$CN$CA$CA
243334761$24333476$1$I$$20240912$20240918$20240918$EXP$$DE-MYLANLABS-2024M1084189$MYLAN$$$$$F$Y$$$20240918$$PH$DE$DE
243334771$24333477$1$I$20231110$20240917$20240918$20240918$EXP$GB-MHRA-MED-202409160834156140-WPZYT$GB-MYLANLABS-2024M1084762$MYLAN$$75$YR$$$Y$105$KG$20240918$$CN$GB$GB
243334781$24333478$1$I$$20240910$20240918$20240918$EXP$$US-ROCHE-10000078444$ROCHE$$$$A$F$Y$$$20240918$$CN$US$US
243334791$24333479$1$I$$20240829$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08712$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243334801$24333480$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01116$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243334811$24333481$1$I$$20240910$20240918$20240918$EXP$$TR-ASTELLAS-2024-AER-006218$ASTELLAS$$71$YR$E$M$Y$$$20240918$$MD$TR$TR
243334821$24333482$1$I$$20240903$20240918$20240918$PER$$US-COSETTE-CP2024US000241$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243334832$24333483$2$F$20140904$20240916$20240918$20240927$EXP$$BE-ABBVIE-15P-013-1353183-00$ABBVIE$$53$YR$$M$Y$$$20240927$$MD$BE$BE
243334851$24333485$1$I$20240828$20240911$20240918$20240918$EXP$$CN-TERSERA THERAPEUTICS LLC-2024TRS004722$TERSERA THERAPEUTICS$$$$$$Y$$$20240918$$MD$CN$CN
243334861$24333486$1$I$20240101$20240912$20240918$20240918$EXP$$CA-ABBVIE-5924368$ABBVIE$$77$YR$$M$Y$$$20240918$$CN$CA$CA
243334871$24333487$1$I$$20240916$20240918$20240918$EXP$$US-ABBVIE-5926417$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243334881$24333488$1$I$$20240911$20240918$20240918$EXP$$FR-ABBVIE-5927283$ABBVIE$$30$YR$$M$Y$$$20240918$$CN$FR$FR
243334891$24333489$1$I$20240827$20240909$20240918$20240918$EXP$GB-MHRA-MED-202409091414208770-DCQFK$GB-BAXTER-2024BAX024521$BAXTER$$74$YR$$F$Y$$$20240918$$PH$GB$GB
243334901$24333490$1$I$20230412$20240912$20240918$20240918$EXP$SE-SEMPA-2024-006459$SE-TEVA-VS-3243408$TEVA$$78$YR$$F$Y$55$KG$20240918$$MD$SE$SE
243334912$24333491$2$F$$20240916$20240918$20240923$EXP$$FR-BAXTER-2024BAX024545$BAXTER$$25$YR$$M$Y$$$20240923$$HP$FR$FR
243334921$24333492$1$I$20240805$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148100$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240918$$CN$US$US
243334931$24333493$1$I$$20240829$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08756$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243334941$24333494$1$I$$20240917$20240918$20240918$PER$$US-BAYER-2024A132900$BAYER$$$$$M$Y$$$20240918$$CN$US$US
243334961$24333496$1$I$20240816$20240830$20240918$20240918$PER$$US-TEVA-VS-3239736$TEVA$$27$YR$$F$Y$$$20240918$$CN$US$US
243334971$24333497$1$I$$20240903$20240918$20240918$PER$$US-COSETTE-CP2024US000242$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243334982$24333498$2$F$$20240923$20240918$20240930$EXP$$GR-TEVA-VS-3243296$TEVA$Michailides C, Paraskevas P, Lagadinou M, Papantoniou K, Kavvousanos M, Marangos M, et al. A case report and literature review of a triple-vaccinated, rituximab-treated systemic lupus erythematosus patient with COVID-19 pneumonia. ARP Rheumatology. 2024;3(2):145-50; Michailides C, Paraskevas P, Lagadinou M, Papantoniou K, Kavvousanos M, Marangos M, et al. A case report and literature review of a triple-vaccinated, rituximab-treated systemic lupus erythematosus patient with COVID-19 pneumonia....$50$YR$$F$Y$$$20240930$$HP$GR$GR
243334991$24333499$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01118$EPIC PHARM$$$$$F$Y$$$20240918$$CN$US$US
243335011$24333501$1$I$$20240917$20240918$20240918$PER$$US-PFIZER INC-202400258449$PFIZER$$82$YR$$F$Y$$$20240918$$MD$US$US
243335021$24333502$1$I$$20240917$20240918$20240918$PER$$US-PFIZER INC-PV202400122079$PFIZER$$69$YR$$M$Y$$$20240918$$CN$US$US
243335031$24333503$1$I$20240917$20240917$20240918$20240918$PER$$US-PFIZER INC-202400258365$PFIZER$$85$YR$$M$Y$$$20240918$$CN$US$US
243335041$24333504$1$I$$20240917$20240918$20240918$PER$$US-PFIZER INC-202400258281$PFIZER$$$$$M$Y$$$20240918$$MD$US$US
243335052$24333505$2$F$20240908$20240927$20240918$20240930$PER$$US-PFIZER INC-202400258370$PFIZER$$46$YR$$F$Y$$$20240930$$CN$US$US
243335061$24333506$1$I$$20240917$20240918$20240918$PER$$US-PFIZER INC-PV202400121987$PFIZER$$$$$F$Y$$$20240918$$CN$US$US
243335072$24333507$2$F$$20240926$20240918$20240930$PER$$US-PFIZER INC-PV202400121562$PFIZER$$59$YR$$F$Y$$$20240930$$HP$US$US
243335081$24333508$1$I$20240916$20240917$20240918$20240918$PER$$US-PFIZER INC-202400258562$PFIZER$$42$YR$$F$Y$$$20240918$$CN$US$US
243335091$24333509$1$I$$20240918$20240918$20240918$DIR$718871$$FDA-CTU$$$$$UNK$N$$$20240918$N$CN$US$
243335111$24333511$1$I$20240917$20240917$20240918$20240918$PER$$US-PFIZER INC-202400258560$PFIZER$$68$YR$$F$Y$$$20240918$$CN$US$US
243335121$24333512$1$I$20240916$20240917$20240918$20240918$PER$$US-PFIZER INC-202400258363$PFIZER$$59$YR$$M$Y$$$20240918$$CN$US$US
243335141$24333514$1$I$$20240916$20240918$20240918$PER$$US-ALXN-202409USA001188US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243335151$24333515$1$I$20240918$20240918$20240918$20240918$DIR$718877$$FDA-CTU$$75$YR$$F$N$92.25$KG$20240918$N$PH$US$
243335161$24333516$1$I$$20240918$20240918$20240918$DIR$718848$$FDA-CTU$$$$$UNK$N$$$20240918$N$CN$US$
243335201$24333520$1$I$20240901$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-63964$$FDA-CTU$$17$YR$$F$N$59.7$KG$20240917$N$$US$
243335211$24333521$1$I$$20240918$20240918$20240918$DIR$718867$$FDA-CTU$$$$$UNK$N$$$20240918$$CN$US$
243335231$24333523$1$I$$20240918$20240918$20240918$DIR$718862$$FDA-CTU$$$$$UNK$N$$$20240918$N$CN$US$
243335251$24333525$1$I$20240906$20240909$20240918$20240918$EXP$$US-ALXN-202409USA000646US$ALEXION PHARMACEUTICALS$$60$YR$$M$Y$147.39$KG$20240918$$CN$US$US
243335261$24333526$1$I$$20240916$20240918$20240918$EXP$$US-ALXN-202409USA001210US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$US$US
243335271$24333527$1$I$$20240829$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08685$LUPIN$$$$$$Y$$$20240918$$PH$US$US
243335281$24333528$1$I$$20240910$20240918$20240918$EXP$$NVSC2024ZA182965$NOVARTIS$$52$YR$$M$Y$$$20240918$$HP$ZA$ZA
243335291$24333529$1$I$$20240905$20240918$20240918$EXP$$GB-LAURUS LABS LIMITED-2024LAU000066$LAURUS LABS LIMITED$$$$$M$Y$100$KG$20240918$$CN$GB$GB
243335301$24333530$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148536$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240918$$MD$US$US
243335311$24333531$1$I$$20240905$20240918$20240918$EXP$$GB-LAURUS LABS LIMITED-2024LAU000065$LAURUS LABS LIMITED$$48$YR$$M$Y$105$KG$20240918$$HP$GB$GB
243335321$24333532$1$I$20211101$20240911$20240918$20240918$PER$$US-BIOGEN-2021BI01068520$BIOGEN$$57$YR$$F$Y$$$20240918$$CN$US$US
243335331$24333533$1$I$20240828$20240828$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052314$TOLMAR$$62$YR$$M$Y$$$20240918$$CN$CA$CA
243335341$24333534$1$I$20240829$20240829$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052334$TOLMAR$$62$YR$$M$Y$$$20240918$$CN$CA$CA
243335351$24333535$1$I$20240829$20240829$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052333$TOLMAR$$77$YR$$M$Y$$$20240918$$CN$CA$CA
243335361$24333536$1$I$20240830$20240830$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052374$TOLMAR$$93$YR$$M$Y$$$20240918$$CN$CA$CA
243335371$24333537$1$I$20240830$20240830$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052375$TOLMAR$$79$YR$$M$Y$$$20240918$$CN$CA$CA
243335381$24333538$1$I$20240830$20240830$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052376$TOLMAR$$88$YR$$M$Y$$$20240918$$CN$CA$CA
243335391$24333539$1$I$20240830$20240830$20240918$20240918$PER$$CA-TOLMAR, INC.-24CA052484$TOLMAR$$79$YR$$M$Y$$$20240918$$CN$CA$CA
243335401$24333540$1$I$20240101$20240828$20240918$20240918$PER$$CO-TOLMAR, INC.-24CO052290$TOLMAR$$$$$M$Y$$$20240918$$CN$CO$CO
243335411$24333541$1$I$20240828$20240830$20240918$20240918$PER$$CO-TOLMAR, INC.-24CO052335$TOLMAR$$73$YR$$M$Y$$$20240918$$CN$CO$CO
243335421$24333542$1$I$20240815$20240829$20240918$20240918$PER$$CO-TOLMAR, INC.-24CO052338$TOLMAR$$63$YR$$M$Y$$$20240918$$CN$CO$CO
243335431$24333543$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01123$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243335441$24333544$1$I$$20240829$20240918$20240918$PER$$DO-TOLMAR, INC.-24DO052106$TOLMAR$$$$$M$Y$$$20240918$$CN$DO$DO
243335451$24333545$1$I$20240517$20240829$20240918$20240918$PER$$ES-TOLMAR, INC.-24ES052221$TOLMAR$$80$YR$$M$Y$$$20240918$$MD$ES$ES
243335461$24333546$1$I$20230901$20240913$20240918$20240918$PER$$US-ORGANON-O2409USA001101$ORGANON$$30$YR$$F$Y$79.365$KG$20240918$$CN$US$US
243335471$24333547$1$I$$20240916$20240918$20240918$EXP$$US-TAKEDA-2024TUS092478$TAKEDA$$$$$F$Y$$$20240918$$CN$US$US
243335491$24333549$1$I$$20240910$20240918$20240918$PER$$US-JNJFOC-20240927892$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$CN$US$US
243335501$24333550$1$I$20240904$20240912$20240918$20240918$EXP$$CN-JNJFOC-20240936049$JOHNSON AND JOHNSON$$60$YR$A$M$Y$77$KG$20240918$$HP$CN$CN
243335511$24333551$1$I$20240101$20240910$20240918$20240918$EXP$$SG-JNJFOC-20240943994$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240918$$CN$SG$SG
243335522$24333552$2$F$$20240913$20240918$20240919$EXP$$EG-ELI_LILLY_AND_COMPANY-EG202409008553$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240919$$MD$EG$EG
243335532$24333553$2$F$20230601$20240913$20240918$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409005275$ELI LILLY AND CO$$55$YR$A$M$Y$68$KG$20240920$$LW$US$US
243335551$24333555$1$I$$20240909$20240918$20240918$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409006569$ELI LILLY AND CO$$88$YR$E$M$Y$$$20240918$$CN$JP$JP
243335561$24333556$1$I$$20240913$20240918$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009142$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240918$$CN$US$US
243335601$24333560$1$I$20240703$20240911$20240918$20240918$EXP$$TR-BAYER-2024A131670$BAYER$$66$YR$E$F$Y$79$KG$20240918$$MD$TR$TR
243335611$24333561$1$I$$20240913$20240918$20240918$PER$$US-009507513-2409USA005567$MERCK$$$$$F$Y$$$20240918$$CN$US$US
243335621$24333562$1$I$$20240910$20240918$20240918$EXP$$US-GSK-US2024112544$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$US$US
243335631$24333563$1$I$$20240912$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147113$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240918$$CN$US$US
243335671$24333567$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01126$EPIC PHARM$$$$$F$Y$$$20240918$$CN$US$US
243335681$24333568$1$I$$20240916$20240918$20240918$EXP$$US-GILEAD-2024-0687915$GILEAD$$9$YR$C$F$Y$$$20240918$$HP$US$US
243335691$24333569$1$I$$20240829$20240918$20240918$PER$$US-TEVA-VS-3239432$TEVA$$$$$F$Y$$$20240918$$MD$US$US
243335711$24333571$1$I$$20240913$20240918$20240918$EXP$$US-BAYER-2024A131508$BAYER$$$$$$Y$$$20240918$$CN$US$US
243335721$24333572$1$I$$20240903$20240918$20240918$PER$$US-QUAGEN-2024QUASPO00295$QUAGEN PHARMACEUTICALS$$5$YR$C$M$Y$$$20240918$$CN$US$US
243335731$24333573$1$I$20240617$20240711$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003721$PAREXEL$$80$YR$$F$Y$$$20240918$$CN$US$US
243335741$24333574$1$I$$20240716$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003871$PAREXEL$$60$YR$$F$Y$$$20240918$$CN$US$US
243335751$24333575$1$I$$20240812$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US003691$PAREXEL$$64$YR$$F$Y$$$20240918$$CN$US$US
243335761$24333576$1$I$$20240722$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003652$PAREXEL$$61$YR$$F$Y$$$20240918$$CN$US$US
243335771$24333577$1$I$$20240723$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003659$PAREXEL$$67$YR$$F$Y$$$20240918$$CN$US$US
243335781$24333578$1$I$$20240727$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003822$PAREXEL$$88$YR$$F$Y$$$20240918$$CN$US$US
243335791$24333579$1$I$$20240713$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003918$PAREXEL$$56$YR$$F$Y$$$20240918$$CN$US$US
243335801$24333580$1$I$20240601$20240715$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003734$PAREXEL$$44$YR$$F$Y$$$20240918$$CN$US$US
243335811$24333581$1$I$$20240729$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003913$PAREXEL$$70$YR$$F$Y$$$20240918$$CN$US$US
243335821$24333582$1$I$20240808$20240914$20240918$20240918$EXP$$CN-BAYER-2024A132952$BAYER$$58$YR$A$F$Y$$$20240918$$HP$CN$CN
243335831$24333583$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01124$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243335841$24333584$1$I$$20240701$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003680$PAREXEL$$72$YR$$F$Y$$$20240918$$CN$US$US
243335851$24333585$1$I$$20240701$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003732$PAREXEL$$82$YR$$F$Y$$$20240918$$CN$US$US
243335861$24333586$1$I$$20240701$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003808$PAREXEL$$52$YR$$F$Y$$$20240918$$CN$US$US
243335871$24333587$1$I$$20240829$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08748$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243335881$24333588$1$I$$20240628$20240918$20240918$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003754$PAREXEL$$45$YR$$F$Y$$$20240918$$CN$US$US
243335891$24333589$1$I$20240101$20240913$20240918$20240918$EXP$SE-SEMPA-2024-006523$SE-TEVA-VS-3243741$TEVA$$57$YR$$M$Y$90$KG$20240918$$CN$SE$SE
243335901$24333590$1$I$20040101$20240916$20240918$20240918$EXP$$US-ORGANON-O2409USA001134$ORGANON$$$$$F$Y$$$20240918$$CN$US$US
243335911$24333591$1$I$$20240829$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08683$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243335921$24333592$1$I$$20240909$20240918$20240918$EXP$$US-RDY-SPO/USA/24/0013520$DR REDDYS$Wang D, Li C, Turabi A. Atypical refractory occipital neuralgia treated with a unilateral dual-lead occipital nerve stimulator: a case report. Pain Management. 2024;14(5-6): 241-246. doi:10.1080/17581869.2024.2376515.$53$YR$A$M$Y$$$20240918$$HP$US$US
243335931$24333593$1$I$20240719$20240917$20240917$20240917$DIR$FDA-CDER-CTU-2024-63978$$FDA-CTU$$65$YR$$F$N$105$LBS$20240917$N$CN$US$
243335951$24333595$1$I$20240828$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64047$$FDA-CTU$$65$YR$$F$N$$$20240917$N$HP$US$
243335961$24333596$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-63967$$FDA-CTU$$54$YR$$F$N$161.48$KG$20240918$N$$US$
243335971$24333597$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-63969$$FDA-CTU$$77$YR$$F$N$$$20240918$N$$US$
243335981$24333598$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64055$$FDA-CTU$$$$$M$N$$$20240917$N$HP$US$
243335991$24333599$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64069$$FDA-CTU$$89$YR$$M$N$$$20240918$N$$US$
243336001$24333600$1$I$$20240918$20240918$20240918$DIR$718863$$FDA-CTU$$$$$UNK$N$$$20240918$$CN$US$
243336021$24333602$1$I$$20240629$20240918$20240918$PER$$US-ROCHE-10000016144$ROCHE$$$$$M$Y$$$20240918$$CN$US$US
243336031$24333603$1$I$$20240904$20240918$20240918$EXP$$US-NORDICGR-057371$NORDIC PHARMA$Seitz V, Davidson ER. Retained Tampon Fragment as an Unusual Cause of Vesicovaginal Fistula. Obstetrics and Gynecology. 2024;144(1):e1-e3.DOI: 10.1097/AOG.0000000000005608.$53$YR$$F$Y$$$20240918$$MD$US$US
243336041$24333604$1$I$$20240906$20240918$20240918$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-144198$DAIICHI$$90$YR$$$Y$$$20240918$$PH$JP$JP
243336051$24333605$1$I$$20240916$20240918$20240918$EXP$$AU-SANDOZ INC.-SDZ2024AU080604$SANDOZ$$$$$F$Y$$$20240918$$HP$AU$AU
243336071$24333607$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01107$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243336082$24333608$2$F$20240501$20240919$20240918$20240926$PER$$US-Calliditas-2024CAL01801$CALLIDITAS THERAPEUTICS$$27$YR$A$F$Y$68.67$KG$20240926$$CN$US$US
243336091$24333609$1$I$$20240909$20240918$20240918$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024006702$BIOCON$$$$$$Y$$$20240918$$CN$AU$AU
243336101$24333610$1$I$$20240917$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US065409$SANDOZ$$$$$F$Y$$$20240918$$CN$US$US
243336111$24333611$1$I$$20240916$20240918$20240918$EXP$$AU-SANDOZ INC.-SDZ2024AU080643$SANDOZ$$53$YR$$F$Y$$$20240918$$HP$AU$AU
243336121$24333612$1$I$20240401$20240904$20240918$20240918$EXP$$US-SK LIFE SCIENCE, INC-SKPVG-2024-001402$SK LIFE SCIENCE$$$$$$Y$$$20240918$$CN$US$US
243336131$24333613$1$I$20240201$20240904$20240918$20240918$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-001193$SK LIFE SCIENCE$$$$$$Y$$$20240918$$CN$US$US
243336141$24333614$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64037$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243336151$24333615$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64029$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243336181$24333618$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64049$$FDA-CTU$$81$YR$$M$N$$$20240917$N$$US$
243336191$24333619$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64074$$FDA-CTU$$$$$M$N$$$20240917$N$HP$US$
243336201$24333620$1$I$20240101$20240912$20240918$20240918$EXP$$US-JNJFOC-20240939972$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240918$$HP$US$US
243336221$24333622$1$I$$20240704$20240918$20240918$PER$$US-ROCHE-10000019211$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243336231$24333623$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64038$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243336241$24333624$1$I$20240917$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64053$$FDA-CTU$$66$YR$$F$N$$$20240918$N$$US$
243336251$24333625$1$I$$20240905$20240918$20240918$EXP$$GB-ACRAF SpA-2024-035717$SK LIFE SCIENCE$$$$$$Y$$$20240918$$HP$GB$GB
243336271$24333627$1$I$20240101$20240905$20240918$20240918$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-002166$SK LIFE SCIENCE$$$$$$Y$$$20240918$$HP$CA$CA
243336281$24333628$1$I$20240708$20240905$20240918$20240918$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-002096$SK LIFE SCIENCE$$$$$$Y$$$20240918$$CN$US$US
243336292$24333629$2$F$$20240905$20240918$20240920$EXP$$GB-ACRAF SpA-2024-035710$SK LIFE SCIENCE$$$$$$Y$$$20240920$$HP$GB$GB
243336301$24333630$1$I$20240730$20240912$20240918$20240918$EXP$FR-AFSSAPS-RN2024000949$FR-MYLANLABS-2024M1083689$MYLAN$$51$YR$$M$Y$$$20240918$$HP$FR$FR
243336311$24333631$1$I$20220701$20240912$20240918$20240918$EXP$$DE-MYLANLABS-2024M1084535$MYLAN$$82$YR$$F$Y$$$20240918$$CN$DE$DE
243336321$24333632$1$I$20240801$20240905$20240918$20240918$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-002090$SK LIFE SCIENCE$$$$$$Y$$$20240918$$CN$US$US
243336331$24333633$1$I$$20240916$20240918$20240918$EXP$$GB-MYLANLABS-2024M1084615$MYLAN$$$$$M$Y$$$20240918$$CN$GB$GB
243336361$24333636$1$I$$20240917$20240918$20240918$EXP$$US-JNJFOC-20240946161$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$HP$US$US
243336371$24333637$1$I$20240828$20240909$20240918$20240918$EXP$GB-MHRA-MED-202409091422392590-BPDGQ$GB-TEVA-VS-3242371$TEVA$$90$YR$$M$Y$$$20240918$$PH$GB$GB
243336381$24333638$1$I$$20240918$20240918$20240918$DIR$718861$$FDA-CTU$$$$$UNK$N$$$20240918$N$CN$US$
243336391$24333639$1$I$$20240918$20240918$20240918$DIR$718850$$FDA-CTU$$$$$UNK$N$$$20240918$N$CN$US$
243336431$24333643$1$I$20240903$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009722$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243336441$24333644$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009944$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240918$$CN$US$US
243336451$24333645$1$I$$20240903$20240918$20240918$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08884$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240918$$HP$US$US
243336461$24333646$1$I$20240901$20240906$20240918$20240918$EXP$$IT-UCBSA-2024046770$UCB$$84$YR$$F$Y$$$20240918$$CN$IT$IT
243336471$24333647$1$I$$20240903$20240918$20240918$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08891$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240918$$HP$US$US
243336481$24333648$1$I$20191223$20240912$20240918$20240918$EXP$$CO-UCBSA-2024047497$UCB$$68$YR$$F$Y$$$20240918$$CN$CO$CO
243336491$24333649$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01108$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243336501$24333650$1$I$$20240904$20240918$20240918$EXP$$IE-TEVA-VS-3244404$TEVA$$63$YR$$M$Y$$$20240918$$MD$IE$IE
243336511$24333651$1$I$$20240909$20240918$20240918$PER$$US-ABBVIE-5919293$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243336521$24333652$1$I$$20240909$20240918$20240918$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006790$BIOCON$$$$$$Y$$$20240918$$CN$CA$CA
243336531$24333653$1$I$$20240913$20240918$20240918$PER$$CA-BRACCO-2024CA05802$BRACCO$$84$YR$$M$Y$$$20240918$$HP$CA$CA
243336551$24333655$1$I$$20240702$20240918$20240918$PER$$US-ROCHE-10000019064$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243336561$24333656$1$I$20240301$20240913$20240918$20240918$EXP$$IN-ROCHE-10000084696$ROCHE$$90$YR$E$M$Y$$$20240918$$CN$IN$IN
243336571$24333657$1$I$$20240906$20240918$20240918$EXP$IT-PFIZER INC-2019025187$IT-GUERBET / LLC-IT-20190020$GUERBET$BELLI L. Arteritis following intra-arterial chemotherapy for liver tumors. EUROPEAN RADIOLOGY. 1997;7: 323-326.$58$YR$A$F$Y$$$20240918$$MD$IT$IT
243336581$24333658$1$I$$20240906$20240918$20240918$EXP$IT-PFIZER INC-2019025188$IT-GUERBET / LLC-IT-20190021$GUERBET$BELLI L. Arteritis following intra-arterial chemotherapy for liver tumors. EUROPEAN RADIOLOGY. 1997;7: 323-326.$60$YR$A$M$Y$$$20240918$$MD$IT$IT
243336591$24333659$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01111$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243336611$24333661$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64075$$FDA-CTU$$$$$M$N$$$20240917$N$HP$US$
243336621$24333662$1$I$20240917$20240918$20240918$20240918$DIR$718884$$FDA-CTU$$56$YR$$F$N$69.75$KG$20240918$N$CN$US$
243336631$24333663$1$I$20240901$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64059$$FDA-CTU$$87$YR$$F$N$$$20240917$N$HP$US$
243336651$24333665$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64054$$FDA-CTU$$$$$M$N$$$20240917$N$HP$US$
243336661$24333666$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64056$$FDA-CTU$$$$$M$N$65.77$KG$20240917$N$$US$
243336671$24333667$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64058$$FDA-CTU$$59$YR$$M$N$$$20240918$N$$US$
243336681$24333668$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64073$$FDA-CTU$$73$YR$$F$N$$$20240918$N$$US$
243336701$24333670$1$I$$20240911$20240918$20240918$PER$$US-ORGANON-O2409USA000807$ORGANON$$$$$$Y$$$20240918$$CN$US$US
243336711$24333671$1$I$$20240912$20240918$20240918$PER$$US-ORGANON-O2409USA000957$ORGANON$$$$$F$Y$115.21$KG$20240918$$CN$US$US
243336721$24333672$1$I$20240101$20240828$20240918$20240918$EXP$$US-SA-2024SA266927$SANOFI AVENTIS$$80$YR$E$F$Y$63.5$KG$20240918$$MD$US$US
243336731$24333673$1$I$20240801$20240829$20240918$20240918$EXP$$US-SA-2024SA244020$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240918$$MD$US$US
243336741$24333674$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01110$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243336751$24333675$1$I$20240101$20240912$20240918$20240918$EXP$$US-ABBVIE-5923436$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243336761$24333676$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01121$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243336771$24333677$1$I$$20240903$20240918$20240918$EXP$$US-SA-2024SA269799$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240918$$CN$US$US
243336781$24333678$1$I$20230613$20240903$20240918$20240918$EXP$$SG-SA-2023SA242933$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240918$$HP$SG$SG
243336791$24333679$1$I$20240908$20240915$20240918$20240918$EXP$$SA-SANDOZ INC.-SDZ2024SA080734$SANDOZ$$78$YR$$F$Y$$$20240918$$CN$SA$SA
243336831$24333683$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64084$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243336841$24333684$1$I$20240916$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64085$$FDA-CTU$$79$YR$$F$N$60.78$KG$20240918$N$PH$US$
243336851$24333685$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64086$$FDA-CTU$$42$YR$$F$N$$$20240918$N$$US$
243336861$24333686$1$I$20240731$20240918$20240918$20240918$DIR$718885$$FDA-CTU$$68$YR$$M$N$60.1$KG$20240918$N$HP$US$
243336871$24333687$1$I$$20240918$20240918$20240918$DIR$718891$$FDA-CTU$$$$$UNK$N$$$20240918$$CN$US$
243336901$24333690$1$I$$20240904$20240918$20240918$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08910$NEUROCRINE BIOSCIENCES$$5$DEC$$F$Y$$$20240918$$HP$US$US
243336911$24333691$1$I$$20240913$20240918$20240918$EXP$$US-VERTEX PHARMACEUTICALS-2024-014712$VERTEX$$$$$F$Y$$$20240918$$CN$US$US
243336931$24333693$1$I$$20240912$20240918$20240918$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014586$VERTEX$$$$A$M$Y$$$20240918$$CN$GB$GB
243336941$24333694$1$I$20240101$20240912$20240918$20240918$EXP$$US-VERTEX PHARMACEUTICALS-2024-014583$VERTEX$$$$$F$Y$$$20240918$$CN$US$US
243336951$24333695$1$I$$20240912$20240918$20240918$EXP$$AU-VERTEX PHARMACEUTICALS-2024-014575$VERTEX$$$$C$$Y$$$20240918$$HP$AU$AU
243336961$24333696$1$I$$20240912$20240918$20240918$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014587$VERTEX$$$$A$M$Y$$$20240918$$CN$GB$GB
243336971$24333697$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01117$EPIC PHARM$$$$$$Y$$$20240918$$CN$US$US
243336981$24333698$1$I$$20240910$20240918$20240918$EXP$$US-OTSUKA-2024_025601$OTSUKA$$$$$M$Y$$$20240918$$HP$US$US
243336992$24333699$2$F$20230701$20240910$20240918$20240919$EXP$$ZA-JNJFOC-20240939652$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240920$$HP$ZA$ZA
243337002$24333700$2$F$$20240917$20240918$20240919$PER$$US-JNJFOC-20240947467$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243337011$24333701$1$I$$20240916$20240918$20240918$PER$$US-JNJFOC-20240941347$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243337022$24333702$2$F$20240101$20240916$20240918$20240928$EXP$$US-SA-2024SA269284$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240928$$CN$US$US
243337031$24333703$1$I$20240827$20240906$20240918$20240918$EXP$$CN-JNJFOC-20240915487$JOHNSON AND JOHNSON$$39$YR$A$M$Y$60$KG$20240918$$HP$CN$CN
243337041$24333704$1$I$20240816$20240913$20240918$20240918$EXP$$CN-SA-2024SA267535$SANOFI AVENTIS$$56$YR$A$F$Y$70$KG$20240918$$HP$CN$CN
243337051$24333705$1$I$20240911$20240913$20240918$20240918$EXP$$CN-SA-2024SA267435$SANOFI AVENTIS$$66$YR$E$M$Y$73$KG$20240918$$HP$CN$CN
243337061$24333706$1$I$$20240917$20240918$20240918$PER$$US-ALXN-202409USA001326US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243337081$24333708$1$I$$20240716$20240918$20240918$PER$$US-ROCHE-10000029834$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243337091$24333709$1$I$20240906$20240906$20240918$20240918$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01326$AIMMUNE$$$$$$Y$$$20240918$$CN$US$US
243337101$24333710$1$I$20240801$20240912$20240918$20240918$PER$$PR-ABBVIE-5922598$ABBVIE$$79$YR$$F$Y$64$KG$20240918$$CN$PR$PR
243337111$24333711$1$I$20240101$20240916$20240918$20240918$EXP$$US-ABBVIE-5888598$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243337121$24333712$1$I$20240911$20240913$20240918$20240918$EXP$$US-ABBVIE-5925197$ABBVIE$$43$YR$$M$Y$$$20240918$$CN$US$US
243337141$24333714$1$I$20240101$20240828$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-04960$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243337151$24333715$1$I$$20240629$20240918$20240918$PER$$US-ROCHE-10000020911$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243337161$24333716$1$I$20240914$20240916$20240918$20240918$EXP$$US-JNJFOC-20240946272$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240918$$HP$US$US
243337171$24333717$1$I$20240827$20240912$20240918$20240918$EXP$$CN-PURDUE-USA-2024-0312020$PURDUE$$57$YR$$F$Y$50.5$KG$20240918$$HP$CN$CN
243337181$24333718$1$I$20190501$20240912$20240918$20240918$EXP$$PHHY2019CO131249$NOVARTIS$$68$YR$$F$Y$93.3$KG$20240918$$CN$CO$CO
243337191$24333719$1$I$$20240917$20240918$20240918$EXP$$US-PURDUE PHARMA-USA-2024-0312022$PURDUE$$$$$F$Y$$$20240918$$CN$US$US
243337201$24333720$1$I$$20240903$20240918$20240918$PER$$US-EPICPHARMA-US-2024EPCSPO01112$EPIC PHARM$$30$YR$A$$Y$$$20240918$$CN$US$US
243337212$24333721$2$F$$20240916$20240918$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010070$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240923$$CN$US$US
243337221$24333722$1$I$$20240916$20240918$20240918$PER$$US-HALEON-2197335$Haleon PLC$$23$YR$$M$Y$$$20240918$$MD$US$US
243337231$24333723$1$I$$20240916$20240918$20240918$PER$$US-BIOGEN-2024BI01282788$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
243337241$24333724$1$I$$20240913$20240918$20240918$EXP$CA-HEALTHCANVIG-001097759$CA-PURDUE-USA-2024-0312010$PURDUE$$15$YR$$M$Y$81$KG$20240918$$HP$CA$CA
243337251$24333725$1$I$20240907$20240910$20240918$20240918$DIR$FDA-CDER-CTU-2024-64042$$FDA-CTU$$76$YR$$F$N$140$LBS$20240910$Y$CN$US$
243337291$24333729$1$I$20240917$20240917$20240917$20240917$DIR$718795$$FDA-CTU$$37$YR$$F$N$69.3$KG$20240917$N$MD$US$
243337301$24333730$1$I$20240911$20240916$20240918$20240918$PER$$US-JNJFOC-20240943656$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$HP$US$US
243337311$24333731$1$I$$20240916$20240918$20240918$PER$$US-ABBVIE-5927961$ABBVIE$$$$$$Y$$$20240918$$CN$US$US
243337321$24333732$1$I$20240601$20240917$20240918$20240918$EXP$$US-PFIZER INC-202400258584$PFIZER$$63$YR$$F$Y$$$20240918$$CN$US$US
243337331$24333733$1$I$20240624$20240916$20240918$20240918$EXP$FR-AFSSAPS-GR2024001066$FR-PFIZER INC-202400257009$PFIZER$$72$YR$$F$Y$$$20240918$$PH$FR$FR
243337341$24333734$1$I$20240101$20240911$20240918$20240918$EXP$$CN-PFIZER INC-PV202400119189$PFIZER$$20$YR$$F$Y$$$20240918$$CN$CN$CN
243337351$24333735$1$I$20220401$20240912$20240918$20240918$EXP$$CA-PFIZER INC-202201051520$PFIZER$$61$YR$$M$Y$$$20240918$$MD$CA$CA
243337361$24333736$1$I$20240913$20240913$20240918$20240918$EXP$$CA-PFIZER INC-202400257295$PFIZER$$47$YR$$F$Y$$$20240918$$HP$CA$CA
243337371$24333737$1$I$20240830$20240914$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120754$PFIZER$$22$YR$$M$Y$$$20240918$$HP$CN$CN
243337381$24333738$1$I$20240901$20240916$20240918$20240918$EXP$GB-MHRA-MED-202409131557444200-LWKJF$GB-PFIZER INC-202400257290$PFIZER$$59$YR$$M$Y$$$20240918$$MD$GB$GB
243337391$24333739$1$I$20240728$20240917$20240918$20240918$EXP$FR-AFSSAPS-PV2024000868$FR-PFIZER INC-202400257925$PFIZER$$56$YR$$M$Y$70$KG$20240918$$MD$FR$FR
243337401$24333740$1$I$20240819$20240916$20240918$20240918$EXP$$CA-PFIZER INC-202400258139$PFIZER$$71$YR$$M$Y$$$20240918$$HP$CA$CA
243337411$24333741$1$I$20230101$20240917$20240918$20240918$EXP$FR-AFSSAPS-LM2024000518$FR-PFIZER INC-202400257807$PFIZER$$67$YR$$F$Y$$$20240918$$MD$FR$FR
243337421$24333742$1$I$20000101$20240916$20240918$20240918$EXP$$SE-SANDOZ INC.-PHHY2017SE202318$SANDOZ$$32$YR$$F$Y$39$KG$20240918$$CN$SE$SE
243337441$24333744$1$I$$20240820$20240918$20240918$30DAY$$US-VEROBIOTECH-2024USVEROSPO00221$VERO BIOTECH$$7$YR$C$F$Y$$$20240918$$HP$US$US
243337451$24333745$1$I$$20240918$20240918$20240918$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052021$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240918$$HP$DE$DE
243337461$24333746$1$I$20240903$20240904$20240918$20240918$DIR$FDA-CDER-CTU-2024-64040$$FDA-CTU$$72$YR$$F$N$$$20240904$N$CN$US$
243337471$24333747$1$I$$20240913$20240918$20240918$EXP$$NL-MYLANLABS-2024M1083843$MYLAN$Fijen ML, Petersan SR, Cohn MD. Facial swelling due to angioedema:often mast cell mediated, but not always.. Dutch Journal of Medicine.. 2023;167:D7610$30$YR$$M$Y$$$20240918$$HP$NL$NL
243337481$24333748$1$I$$20240915$20240918$20240918$PER$$US-HALEON-2197137$Haleon PLC$$$$$$Y$$$20240918$$CN$US$US
243337491$24333749$1$I$20240911$20240912$20240918$20240918$30DAY$$CO-PFIZER INC-PV202400120488$PFIZER$$8$YR$$M$Y$$$20240918$$CN$CO$CO
243337501$24333750$1$I$20240901$20240917$20240917$20240917$DIR$718828$$FDA-CTU$$55$YR$$F$N$50.85$KG$20240917$Y$CN$US$
243337511$24333751$1$I$$20240910$20240918$20240918$EXP$$CA-SANDOZ INC.-SDZ2024CA081003$SANDOZ$$66$YR$$M$Y$$$20240918$$HP$CA$CA
243337521$24333752$1$I$20240410$20240904$20240918$20240918$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09019$LUPIN$Peshin S, Kapadia C, Krishnadasan R. Insights into neulasta-associated splenic infarction: unveiling a rare complication in chemotherapy for chronic myelomonocytic leukemia. Clinical Lymphoma, Myeloma + Leukemia. 2024;24 (1):S372$67$YR$$M$Y$$$20240918$$MD$US$US
243337532$24333753$2$F$$20240923$20240918$20240930$EXP$$IT-TEVA-VS-3242551$TEVA$Fassi E, Amoroso V, Cosentini D, Ferrari V, Lagana M, Berruti A, et al. Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report. Front-Oncol 2024; 14 (0); Fassi E, Amoroso V, Cosentini D, Ferrari V, Lagana M, Berruti A, et al. Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report. Front-Oncol 2024; 14 (0):.; Fassi E, Amoroso V, Cosentini D, Ferrari V, Lagana M, Berruti A, et al. Regorafenib-related ery...$58$YR$$F$Y$$$20240930$$HP$IT$IT
243337541$24333754$1$I$$20240905$20240918$20240918$EXP$$US-PIERREL S.P.A.-2024PIR00059$PIERREL$$$$$$Y$$$20240918$$HP$US$US
243337551$24333755$1$I$$20240905$20240918$20240918$EXP$$US-PIERREL S.P.A.-2024PIR00060$PIERREL$$$$$$Y$$$20240918$$HP$US$US
243337561$24333756$1$I$$20240823$20240918$20240918$30DAY$$US-VEROBIOTECH-2024USVEROSPO00223$VERO BIOTECH$$$$$F$Y$$$20240918$$HP$US$US
243337571$24333757$1$I$$20240914$20240918$20240918$EXP$$CN-TAKEDA-2024TUS092393$TAKEDA$$$$$M$Y$$$20240918$$CN$CN$CN
243337581$24333758$1$I$$20240912$20240918$20240918$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR114498$VIIV$$$$$$Y$$$20240918$$MD$US$US
243337591$24333759$1$I$$20240913$20240918$20240918$PER$$US-JNJFOC-20240940000$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$CN$US$US
243337621$24333762$1$I$20240801$20240912$20240918$20240918$DIR$FDA-CDER-CTU-2024-64043$$FDA-CTU$$67$YR$$F$N$153$LBS$20240912$N$CN$US$
243337631$24333763$1$I$20240101$20240916$20240918$20240918$EXP$$US-JNJFOC-20240943556$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240918$$HP$US$US
243337641$24333764$1$I$$20240910$20240918$20240918$EXP$$US-JNJFOC-20240927424$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$HP$US$US
243337651$24333765$1$I$20220426$20240917$20240917$20240917$DIR$718783$$FDA-CTU$$52$YR$$F$N$70.65$KG$20240917$N$CN$US$
243337662$24333766$2$F$20240101$20240917$20240918$20240925$EXP$$CO-JNJFOC-20240866967$JOHNSON AND JOHNSON$$68$YR$E$F$Y$63$KG$20240925$$HP$CO$CO
243337671$24333767$1$I$20240101$20240912$20240918$20240918$EXP$$JP-009507513-2409JPN000345J$MERCK$$7$DEC$$F$Y$$$20240918$$MD$JP$JP
243337681$24333768$1$I$$20240912$20240918$20240918$EXP$$CA-TAKEDA-2024TUS091659$TAKEDA$$$$$F$Y$$$20240918$$MD$CA$CA
243337691$24333769$1$I$$20240913$20240918$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015247$JAZZ$$$$$F$Y$24.943$KG$20240918$$CN$US$US
243337701$24333770$1$I$20240826$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009920$ELI LILLY AND CO$$16$YR$T$F$Y$$$20240918$$CN$US$US
243337711$24333771$1$I$20240916$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009870$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240918$$CN$US$US
243337721$24333772$1$I$20240901$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010260$ELI LILLY AND CO$$82$YR$E$$Y$$$20240918$$CN$US$US
243337731$24333773$1$I$$20240910$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409006073$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240918$$CN$US$US
243337741$24333774$1$I$$20240806$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010669$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$US$US
243337751$24333775$1$I$20240815$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409061525550710-ZCTVK$GB-ELI_LILLY_AND_COMPANY-GB202409004992$ELI LILLY AND CO$$66$YR$E$$Y$$$20240918$$CN$GB$GB
243337761$24333776$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009747$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240918$$CN$US$US
243337771$24333777$1$I$$20240912$20240918$20240918$PER$$US-ABBVIE-5923676$ABBVIE$$$$$$Y$$$20240918$$HP$US$US
243337781$24333778$1$I$20150701$20240912$20240918$20240918$EXP$$AT-TEVA-VS-3243395$TEVA$$57$YR$$M$Y$70$KG$20240918$$MD$AT$AT
243337791$24333779$1$I$20230901$20240913$20240918$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015174$JAZZ$$61$YR$$F$Y$$$20240918$$CN$US$US
243337801$24333780$1$I$$20240909$20240918$20240918$EXP$$US-TEVA-VS-3243300$TEVA$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024; 67 (0): no pagination.; Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024; 67 (0): no pagination.$65$YR$$M$Y$$$20240918$$HP$US$US
243337821$24333782$1$I$$20240911$20240918$20240918$EXP$$NVSJ2024JP010890$NOVARTIS$$$$A$M$Y$$$20240918$$MD$JP$JP
243337831$24333783$1$I$20240501$20240917$20240918$20240918$EXP$$DE-SANDOZ INC.-SDZ2024DE080794$SANDOZ$$68$YR$$M$Y$$$20240918$$MD$DE$DE
243337841$24333784$1$I$20240423$20240912$20240918$20240918$EXP$FR-AFSSAPS-DJ2024000935$FR-MYLANLABS-2024M1083696$MYLAN$$50$YR$$F$Y$$$20240918$$MD$FR$FR
243337851$24333785$1$I$20230106$20240916$20240918$20240918$EXP$$FR-ROCHE-10000032955$ROCHE$$65$YR$E$M$Y$70$KG$20240918$$MD$FR$FR
243337861$24333786$1$I$20240911$20240914$20240918$20240918$EXP$$CN-FreseniusKabi-FK202413905$FRESENIUS KABI$$66$YR$E$F$Y$36$KG$20240918$$HP$CN$CN
243337871$24333787$1$I$20240501$20240912$20240918$20240918$PER$$US-FreseniusKabi-FK202413816$FRESENIUS KABI$$56$YR$A$F$Y$$$20240918$$CN$US$US
243337901$24333790$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148014$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240918$$CN$US$US
243337921$24333792$1$I$20240916$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147371$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240918$$CN$US$US
243337931$24333793$1$I$$20240910$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-148432$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240918$$MD$JP$JP
243337941$24333794$1$I$20240713$20240909$20240918$20240918$EXP$$SG-ASTELLAS-2024-AER-005752$ASTELLAS$$61$YR$A$M$Y$$$20240918$$HP$SG$SG
243337961$24333796$1$I$20240601$20240912$20240918$20240918$DIR$FDA-CDER-CTU-2024-64041$$FDA-CTU$$82$YR$$F$N$115.21$KG$20240912$N$CN$US$
243337991$24333799$1$I$20220901$20240911$20240918$20240918$PER$$US-BAUSCH-BL-2024-013692$BAUSCH AND LOMB$$55$YR$$F$Y$67.192$KG$20240918$$CN$US$US
243338011$24333801$1$I$$20240912$20240918$20240918$PER$$US-BAUSCH-BL-2024-013833$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240918$$CN$US$US
243338021$24333802$1$I$$20240909$20240918$20240918$PER$$US-BAUSCH-BL-2024-013491$BAUSCH AND LOMB$$83$YR$$F$Y$77.18$KG$20240918$$CN$US$US
243338031$24333803$1$I$20240909$20240909$20240918$20240918$PER$$US-BAUSCH-BL-2024-013569$BAUSCH AND LOMB$$$$$F$Y$$$20240918$$CN$US$US
243338041$24333804$1$I$20230801$20240910$20240918$20240918$PER$$US-BAYER-2024A130408$BAYER$$54$YR$A$F$Y$$$20240918$$CN$US$US
243338051$24333805$1$I$20230519$20230522$20240918$20240918$EXP$$PH-ASTELLAS-AER-2023-014190$ASTELLAS$$$$$M$Y$$$20240918$$CN$PH$PH
243338062$24333806$2$F$$20240917$20240918$20240922$EXP$$US-JNJFOC-20240936755$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$PH$US$US
243338071$24333807$1$I$$20240911$20240918$20240918$EXP$$JP-ASTELLAS-2024-AER-006064$ASTELLAS$$84$YR$E$M$Y$$$20240918$$PH$JP$JP
243338081$24333808$1$I$$20240913$20240918$20240918$PER$$NVSC2024US184769$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243338091$24333809$1$I$$20240912$20240918$20240918$EXP$$CO-SANDOZ INC.-SDZ2024CO080260$SANDOZ$$$$$F$Y$$$20240918$$CN$CO$CO
243338101$24333810$1$I$$20240904$20240918$20240918$PER$$US-BAYER-2024A132422$BAYER$Singh D, Ann Wilfred A, Brandon B. Undiagnosed Extreme Essential Thrombocythemia as Cause of Miscarriages and Pseudo-Electrolyte Abnormalities in a Young  Female: A Case Report. CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2024;S435$22$YR$A$F$Y$$$20240918$$HP$US$US
243338121$24333812$1$I$20240701$20240822$20240918$20240918$PER$$US-SA-2024SA267088$SANOFI AVENTIS$$46$YR$A$M$Y$155$KG$20240918$$MD$US$US
243338131$24333813$1$I$20240101$20240821$20240918$20240918$PER$$US-SA-2024SA269380$SANOFI AVENTIS$$$$I$$Y$$$20240918$$MD$US$US
243338141$24333814$1$I$$20240821$20240918$20240918$PER$$US-SA-2024SA265972$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$MD$US$US
243338151$24333815$1$I$20240101$20240821$20240918$20240918$PER$$US-SA-2024SA264023$SANOFI AVENTIS$$56$YR$A$F$Y$85.91$KG$20240918$$MD$US$US
243338161$24333816$1$I$20240819$20240822$20240918$20240918$PER$$US-SA-2024SA267465$SANOFI AVENTIS$$60$YR$A$F$Y$70$KG$20240918$$MD$US$US
243338171$24333817$1$I$20240801$20240821$20240918$20240918$PER$$US-SA-2024SA267459$SANOFI AVENTIS$$9$YR$C$M$Y$26$KG$20240918$$MD$US$US
243338191$24333819$1$I$20240101$20240823$20240918$20240918$PER$$US-SA-2024SA268207$SANOFI AVENTIS$$57$YR$A$M$Y$147.27$KG$20240918$$MD$US$US
243338211$24333821$1$I$20240101$20240823$20240918$20240918$PER$$US-SA-2024SA266042$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240918$$HP$US$US
243338221$24333822$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA263735$SANOFI AVENTIS$$$$A$F$Y$77.1$KG$20240918$$MD$US$US
243338231$24333823$1$I$$20240823$20240918$20240918$PER$$US-SA-2024SA267822$SANOFI AVENTIS$$$$$M$Y$$$20240918$$MD$US$US
243338241$24333824$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA263537$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240918$$MD$US$US
243338251$24333825$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA267962$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$MD$US$US
243338261$24333826$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA267000$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243338271$24333827$1$I$$20240822$20240918$20240918$PER$$US-SA-2024SA266854$SANOFI AVENTIS$$$$C$M$Y$36.36$KG$20240918$$MD$US$US
243338281$24333828$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA107879$SANOFI AVENTIS$$$$A$F$Y$83.18$KG$20240918$$HP$US$US
243338291$24333829$1$I$20230101$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148524$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240918$$CN$US$US
243338301$24333830$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147338$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240918$$CN$US$US
243338311$24333831$1$I$$20240913$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147269$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240918$$CN$US$US
243338322$24333832$2$F$20240829$20240920$20240918$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146191$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240925$$HP$US$US
243338332$24333833$2$F$20240914$20240917$20240918$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147634$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240924$$PH$US$US
243338341$24333834$1$I$$20240912$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146361$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240918$$CN$US$US
243338351$24333835$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA266999$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240918$$CN$US$US
243338361$24333836$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA267410$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243338371$24333837$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA264586$SANOFI AVENTIS$$$$E$F$Y$102.27$KG$20240918$$MD$US$US
243338381$24333838$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267025$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240918$$MD$US$US
243338391$24333839$1$I$20240101$20240826$20240918$20240918$PER$$US-SA-2024SA266980$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240918$$HP$US$US
243338401$24333840$1$I$20240101$20240827$20240918$20240918$PER$$US-SA-2024SA266953$SANOFI AVENTIS$$12$YR$T$M$Y$75.91$KG$20240918$$MD$US$US
243338411$24333841$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA266971$SANOFI AVENTIS$$56$YR$A$$Y$$$20240918$$CN$US$US
243338421$24333842$1$I$20240801$20240828$20240918$20240918$PER$$US-SA-2024SA267013$SANOFI AVENTIS$$$$T$F$Y$$$20240918$$MD$US$US
243338431$24333843$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA266816$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243338441$24333844$1$I$20231201$20240826$20240918$20240918$PER$$US-SA-2023SA391307$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240918$$CN$US$US
243338451$24333845$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA266997$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240918$$HP$US$US
243338461$24333846$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA266973$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240918$$CN$US$US
243338471$24333847$1$I$20240101$20240827$20240918$20240918$PER$$US-SA-2024SA254020$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240918$$CN$US$US
243338481$24333848$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA267021$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$HP$US$US
243338491$24333849$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA268714$SANOFI AVENTIS$$$$C$M$Y$29.4$KG$20240918$$MD$US$US
243338501$24333850$1$I$20240101$20240826$20240918$20240918$PER$$US-SA-2024SA268896$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$MD$US$US
243338511$24333851$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA266484$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$MD$US$US
243338521$24333852$1$I$20240101$20240827$20240918$20240918$PER$$US-SA-2024SA267019$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240918$$CN$US$US
243338531$24333853$1$I$20240101$20240826$20240918$20240918$PER$$US-SA-2024SA265236$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240918$$MD$US$US
243338541$24333854$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA267570$SANOFI AVENTIS$$$$A$F$Y$49$KG$20240918$$MD$US$US
243338551$24333855$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267037$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240918$$MD$US$US
243338571$24333857$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA264633$SANOFI AVENTIS$$$$A$F$Y$79.55$KG$20240918$$MD$US$US
243338581$24333858$1$I$20240101$20240826$20240918$20240918$PER$$US-SA-2024SA266736$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240918$$MD$US$US
243338601$24333860$1$I$$20240827$20240918$20240918$PER$$US-SA-2023SA246112$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240918$$CN$US$US
243338611$24333861$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA263992$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243338621$24333862$1$I$20240801$20240826$20240918$20240918$PER$$US-SA-2024SA267160$SANOFI AVENTIS$$60$YR$A$F$Y$57.73$KG$20240918$$MD$US$US
243338631$24333863$1$I$20240101$20240827$20240918$20240918$PER$$US-SA-2024SA264026$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240918$$MD$US$US
243338651$24333865$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA266327$SANOFI AVENTIS$$$$E$F$Y$$$20240918$$MD$US$US
243338661$24333866$1$I$20240101$20240826$20240918$20240918$PER$$US-SA-2024SA267824$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240918$$MD$US$US
243338671$24333867$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA267773$SANOFI AVENTIS$$$$A$F$Y$104.55$KG$20240918$$MD$US$US
243338681$24333868$1$I$20240801$20240827$20240918$20240918$PER$$US-SA-2024SA264429$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240918$$MD$US$US
243338691$24333869$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA267057$SANOFI AVENTIS$$53$YR$A$$Y$$$20240918$$MD$US$US
243338701$24333870$1$I$20240701$20240911$20240918$20240918$EXP$$JP-ASTELLAS-2024-AER-006322$ASTELLAS$$9$DEC$E$F$Y$$$20240918$$MD$JP$JP
243338711$24333871$1$I$20240829$20240829$20240918$20240918$PER$$US-SA-2024SA268074$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$CN$US$US
243338721$24333872$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267430$SANOFI AVENTIS$$$$E$M$Y$77.27$KG$20240918$$MD$US$US
243338731$24333873$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA268504$SANOFI AVENTIS$$$$E$M$Y$85.27$KG$20240918$$MD$US$US
243338741$24333874$1$I$20240101$20240829$20240918$20240918$PER$$US-SA-2024SA268442$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240918$$MD$US$US
243338751$24333875$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA268753$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$CN$US$US
243338761$24333876$1$I$20240801$20240826$20240918$20240918$PER$$US-SA-2024SA267489$SANOFI AVENTIS$$17$YR$T$M$Y$77.27$KG$20240918$$MD$US$US
243338771$24333877$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA266969$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240918$$CN$US$US
243338781$24333878$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA266894$SANOFI AVENTIS$$$$A$M$Y$102$KG$20240918$$MD$US$US
243338791$24333879$1$I$20240101$20240828$20240918$20240918$PER$$US-SA-2024SA268365$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240918$$PH$US$US
243338801$24333880$1$I$20240801$20240829$20240918$20240918$PER$$US-SA-2024SA267556$SANOFI AVENTIS$$9$YR$C$M$Y$28$KG$20240918$$MD$US$US
243338811$24333881$1$I$20240801$20240826$20240918$20240918$PER$$US-SA-2024SA263757$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240918$$CN$US$US
243338822$24333882$2$F$$20240826$20240918$20240923$PER$$US-SA-2024SA266386$SANOFI AVENTIS$$$$A$M$Y$$$20240923$$MD$US$US
243338831$24333883$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA266972$SANOFI AVENTIS$$51$YR$A$$Y$$$20240918$$CN$US$US
243338841$24333884$1$I$20240101$20240829$20240918$20240918$PER$$US-SA-2024SA266776$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240918$$CN$US$US
243338851$24333885$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA268727$SANOFI AVENTIS$$$$A$M$Y$77.27$KG$20240918$$MD$US$US
243338871$24333887$1$I$20240101$20240829$20240918$20240918$PER$$US-SA-2024SA268430$SANOFI AVENTIS$$59$YR$A$M$Y$86.36$KG$20240918$$MD$US$US
243338881$24333888$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA267672$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243338891$24333889$1$I$20240101$20240829$20240918$20240918$PER$$US-SA-2024SA268169$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240918$$MD$US$US
243338901$24333890$1$I$20240101$20240829$20240918$20240918$PER$$US-SA-2024SA267388$SANOFI AVENTIS$$64$YR$A$M$Y$104$KG$20240918$$MD$US$US
243338911$24333891$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA268168$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240918$$HP$US$US
243338921$24333892$1$I$20240815$20240829$20240918$20240918$PER$$US-SA-2024SA268291$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240918$$MD$US$US
243338931$24333893$1$I$20240501$20240829$20240918$20240918$PER$$US-SA-2024SA268467$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240918$$CN$US$US
243338941$24333894$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA267938$SANOFI AVENTIS$$$$T$F$Y$53.23$KG$20240918$$MD$US$US
243338951$24333895$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA267098$SANOFI AVENTIS$$$$T$$Y$$$20240918$$CN$US$US
243338961$24333896$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA268376$SANOFI AVENTIS$$$$A$F$Y$79.09$KG$20240918$$MD$US$US
243338971$24333897$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA267508$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240918$$CN$US$US
243338981$24333898$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA267750$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240918$$MD$US$US
243338991$24333899$1$I$20240816$20240829$20240918$20240918$PER$$US-SA-2024SA268563$SANOFI AVENTIS$$53$YR$A$F$Y$156$KG$20240918$$MD$US$US
243339001$24333900$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA267994$SANOFI AVENTIS$$$$$F$Y$$$20240918$$CN$US$US
243339011$24333901$1$I$20240101$20240829$20240918$20240918$PER$$US-SA-2024SA268218$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240918$$CN$US$US
243339021$24333902$1$I$20240101$20240829$20240918$20240918$PER$$US-SA-2024SA267202$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240918$$MD$US$US
243339031$24333903$1$I$20240101$20240829$20240918$20240918$PER$$US-SA-2024SA267977$SANOFI AVENTIS$$52$YR$A$F$Y$75.45$KG$20240918$$MD$US$US
243339041$24333904$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA268244$SANOFI AVENTIS$$90$YR$E$F$Y$$$20240918$$CN$US$US
243339051$24333905$1$I$20240812$20240917$20240917$20240917$DIR$718825$$FDA-CTU$$59$YR$$M$N$99$KG$20240917$N$CN$US$
243339061$24333906$1$I$$20240916$20240918$20240918$EXP$$CA-GSK-CA2024AMR115275$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$CA$CA
243339071$24333907$1$I$$20240912$20240918$20240918$PER$$US-BAYER-2024A131380$BAYER$$$$$F$Y$$$20240918$$HP$US$US
243339081$24333908$1$I$$20240917$20240918$20240918$EXP$$US-JNJFOC-20240946093$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$HP$US$US
243339091$24333909$1$I$20191207$20240916$20240918$20240918$EXP$GB-MHRA-MED-202409141425377270-JTYGR$GB-JNJFOC-20240940898$JOHNSON AND JOHNSON$$26$YR$A$M$Y$97$KG$20240918$$CN$GB$GB
243339101$24333910$1$I$$20240830$20240918$20240918$PER$$US-SA-2024SA268631$SANOFI AVENTIS$$$$$F$Y$$$20240918$$CN$US$US
243339111$24333911$1$I$$20240830$20240918$20240918$PER$$US-SA-2024SA268096$SANOFI AVENTIS$$3$YR$C$$Y$15$KG$20240918$$MD$US$US
243339121$24333912$1$I$20240101$20240830$20240918$20240918$PER$$US-SA-2024SA268549$SANOFI AVENTIS$$56$YR$A$M$Y$95.45$KG$20240918$$MD$US$US
243339131$24333913$1$I$20230301$20240830$20240918$20240918$PER$$US-SA-2024SA268076$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240918$$CN$US$US
243339141$24333914$1$I$$20240904$20240918$20240918$PER$$US-SA-2024SA266580$SANOFI AVENTIS$$$$$M$Y$$$20240918$$CN$US$US
243339151$24333915$1$I$20240317$20240917$20240917$20240917$DIR$718782$$FDA-CTU$$70$YR$$F$N$76.5$KG$20240917$Y$CN$US$
243339161$24333916$1$I$$20240830$20240918$20240918$PER$$US-SA-2024SA266872$SANOFI AVENTIS$$$$$M$Y$$$20240918$$CN$US$US
243339171$24333917$1$I$20240101$20240830$20240918$20240918$PER$$US-SA-2024SA268326$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240918$$MD$US$US
243339181$24333918$1$I$20240101$20240830$20240918$20240918$PER$$US-SA-2024SA268466$SANOFI AVENTIS$$54$YR$A$F$Y$77.73$KG$20240918$$MD$US$US
243339191$24333919$1$I$20240401$20240903$20240918$20240918$PER$$US-SA-2024SA268723$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240918$$MD$US$US
243339201$24333920$1$I$$20240904$20240918$20240918$PER$$US-SA-2024SA267573$SANOFI AVENTIS$$43$YR$A$$Y$$$20240918$$CN$US$US
243339211$24333921$1$I$$20240904$20240918$20240918$PER$$US-SA-2024SA268182$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240918$$MD$US$US
243339221$24333922$1$I$20240101$20240830$20240918$20240918$PER$$US-SA-2024SA268129$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240918$$MD$US$US
243339231$24333923$1$I$20240101$20240830$20240918$20240918$PER$$US-SA-2024SA268007$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240918$$CN$US$US
243339241$24333924$1$I$20240701$20240830$20240918$20240918$PER$$US-SA-2024SA268532$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240918$$MD$US$US
243339251$24333925$1$I$$20240830$20240918$20240918$PER$$US-SA-2024SA268454$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243339261$24333926$1$I$$20240830$20240918$20240918$PER$$US-SA-2024SA268105$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$CN$US$US
243339271$24333927$1$I$$20240830$20240918$20240918$PER$$US-SA-2024SA268150$SANOFI AVENTIS$$$$$M$Y$$$20240918$$CN$US$US
243339281$24333928$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA267440$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240918$$MD$US$US
243339291$24333929$1$I$20240101$20240830$20240918$20240918$PER$$US-SA-2024SA268232$SANOFI AVENTIS$$40$YR$A$F$Y$81.82$KG$20240918$$MD$US$US
243339301$24333930$1$I$20240823$20240830$20240918$20240918$PER$$US-SA-2024SA268072$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240918$$MD$US$US
243339311$24333931$1$I$20240801$20240913$20240918$20240918$EXP$$JP-009507513-2409JPN002050J$MERCK$$8$DEC$$M$Y$$$20240918$$MD$JP$JP
243339321$24333932$1$I$$20240911$20240918$20240918$EXP$FR-AFSSAPS-AN2024001224$FR-TEVA-VS-3242800$TEVA$$54$YR$$M$Y$155$KG$20240918$$CN$FR$FR
243339331$24333933$1$I$20240403$20240905$20240918$20240918$PER$$US-SA-2024SA265359$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240918$$CN$US$US
243339341$24333934$1$I$20240905$20240905$20240918$20240918$PER$$US-SA-2024SA265965$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240918$$CN$US$US
243339351$24333935$1$I$$20240906$20240918$20240918$PER$$US-SA-2024SA268116$SANOFI AVENTIS$$$$C$M$Y$$$20240918$$CN$US$US
243339361$24333936$1$I$$20240902$20240918$20240918$PER$$US-SA-2024SA268328$SANOFI AVENTIS$$$$A$F$Y$67.73$KG$20240918$$MD$US$US
243339371$24333937$1$I$20240904$20240905$20240918$20240918$PER$$US-SA-2024SA265273$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240918$$CN$US$US
243339381$24333938$1$I$$20240904$20240918$20240918$PER$$US-SA-2024SA269045$SANOFI AVENTIS$$61$YR$A$$Y$$$20240918$$CN$US$US
243339391$24333939$1$I$$20240905$20240918$20240918$PER$$US-SA-2024SA264200$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240918$$HP$US$US
243339401$24333940$1$I$$20240904$20240918$20240918$PER$$US-SA-2024SA263606$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240918$$MD$US$US
243339411$24333941$1$I$20240101$20240904$20240918$20240918$PER$$US-SA-2024SA269486$SANOFI AVENTIS$$$$E$F$Y$74.55$KG$20240918$$MD$US$US
243339421$24333942$1$I$$20240905$20240918$20240918$PER$$US-SA-2024SA268613$SANOFI AVENTIS$$$$$$Y$$$20240918$$CN$CH$US
243339431$24333943$1$I$20240905$20240905$20240918$20240918$PER$$US-SA-2024SA269364$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240918$$MD$US$US
243339441$24333944$1$I$$20240906$20240918$20240918$PER$$US-SA-2024SA269550$SANOFI AVENTIS$$$$$F$Y$$$20240918$$MD$US$US
243339451$24333945$1$I$$20240905$20240918$20240918$PER$$US-SA-2024SA269276$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240918$$HP$US$US
243339461$24333946$1$I$$20240906$20240918$20240918$PER$$US-SA-2024SA266191$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240918$$HP$US$US
243339471$24333947$1$I$20240904$20240905$20240918$20240918$PER$$US-SA-2024SA266377$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240918$$MD$US$US
243339481$24333948$1$I$$20240904$20240918$20240918$PER$$US-SA-2024SA268195$SANOFI AVENTIS$$91$YR$E$$Y$$$20240918$$CN$US$US
243339491$24333949$1$I$$20240905$20240918$20240918$PER$$US-SA-2024SA269422$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240918$$CN$US$US
243339501$24333950$1$I$$20240904$20240918$20240918$PER$$US-SA-2024SA267504$SANOFI AVENTIS$$41$YR$A$$Y$$$20240918$$CN$US$US
243339511$24333951$1$I$20240801$20240905$20240918$20240918$PER$$US-SA-2024SA179084$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240918$$MD$US$US
243339531$24333953$1$I$20240801$20240905$20240918$20240918$PER$$US-SA-2024SA268807$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240918$$CN$US$US
243339541$24333954$1$I$20240706$20240911$20240918$20240918$EXP$ES-AEMPS-1567419$ES-MYLANLABS-2024M1083692$MYLAN$$$$A$M$Y$$$20240918$$PH$ES$ES
243339551$24333955$1$I$$20240916$20240918$20240918$PER$$US-BAYER-2024A132806$BAYER$$$$$M$Y$$$20240918$$CN$US$US
243339561$24333956$1$I$$20240910$20240918$20240918$EXP$$GB-ROCHE-10000052494$ROCHE$$49$YR$A$F$Y$71.9$KG$20240918$$MD$GB$GB
243339571$24333957$1$I$$20240906$20240918$20240918$PER$$US-SA-2024SA165444$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240918$$HP$US$US
243339581$24333958$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266031$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240918$$MD$US$US
243339591$24333959$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265926$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240918$$HP$US$US
243339601$24333960$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA266691$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240918$$MD$US$US
243339611$24333961$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA265629$SANOFI AVENTIS$$$$C$M$Y$$$20240918$$MD$US$US
243339621$24333962$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA265098$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240918$$HP$US$US
243339631$24333963$1$I$20240908$20240911$20240918$20240918$PER$$US-SA-2024SA265667$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$CN$US$US
243339641$24333964$1$I$20240901$20240909$20240918$20240918$PER$$US-SA-2024SA266615$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240918$$HP$US$US
243339651$24333965$1$I$20240101$20240909$20240918$20240918$PER$$US-SA-2024SA266614$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240918$$HP$US$US
243339661$24333966$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266578$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240918$$HP$US$US
243339671$24333967$1$I$20240901$20240911$20240918$20240918$PER$$US-SA-2024SA266374$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240918$$HP$US$US
243339681$24333968$1$I$20240801$20240910$20240918$20240918$PER$$US-SA-2024SA266037$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240918$$MD$US$US
243339691$24333969$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266003$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240918$$MD$US$US
243339701$24333970$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266431$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240918$$HP$US$US
243339711$24333971$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA241472$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240918$$HP$US$US
243339721$24333972$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266010$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240918$$MD$US$US
243339731$24333973$1$I$$20240829$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08742$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243339741$24333974$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266524$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240918$$MD$US$US
243339751$24333975$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA266100$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240918$$HP$US$US
243339761$24333976$1$I$20230726$20240910$20240918$20240918$PER$$US-SA-2024SA017963$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240918$$MD$US$US
243339771$24333977$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266521$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240918$$MD$US$US
243339781$24333978$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266404$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240918$$HP$US$US
243339791$24333979$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA265612$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240918$$MD$US$US
243339811$24333981$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA197697$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243339821$24333982$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA269673$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$HP$US$US
243339831$24333983$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266660$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240918$$MD$US$US
243339841$24333984$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA265762$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240918$$MD$US$US
243339851$24333985$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266019$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240918$$HP$US$US
243339861$24333986$1$I$20231101$20240911$20240918$20240918$PER$$US-SA-2024SA265855$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240918$$HP$US$US
243339871$24333987$1$I$20240901$20240910$20240918$20240918$PER$$US-SA-2024SA266160$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240918$$MD$US$US
243339881$24333988$1$I$20240901$20240910$20240918$20240918$PER$$US-SA-2024SA266052$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240918$$MD$US$US
243339891$24333989$1$I$20240701$20240909$20240918$20240918$PER$$US-SA-2024SA269292$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240918$$MD$US$US
243339901$24333990$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266286$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240918$$HP$US$US
243339911$24333991$1$I$$20240912$20240918$20240918$EXP$$NVSJ2024JP010926$NOVARTIS$$$$E$F$Y$$$20240918$$PH$JP$JP
243339931$24333993$1$I$20240703$20240916$20240918$20240918$EXP$FR-AFSSAPS-GR2024001066$FR-FreseniusKabi-FK202413970$FRESENIUS KABI$$72$YR$E$F$Y$$$20240918$$PH$FR$FR
243339941$24333994$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265904$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240918$$HP$US$US
243339951$24333995$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA267273$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243339961$24333996$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA265979$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240918$$HP$US$US
243339971$24333997$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265823$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240918$$HP$US$US
243339981$24333998$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266200$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240918$$MD$US$US
243339991$24333999$1$I$20240801$20240911$20240918$20240918$PER$$US-SA-2024SA265917$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240918$$MD$US$US
243340001$24334000$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266385$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240918$$HP$US$US
243340011$24334001$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266465$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240918$$HP$US$US
243340021$24334002$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266257$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240918$$MD$US$US
243340031$24334003$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265781$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$HP$US$US
243340041$24334004$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266011$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240918$$HP$US$US
243340051$24334005$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266053$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240918$$HP$US$US
243340061$24334006$1$I$$20240909$20240918$20240918$EXP$$GB-INCYTE CORPORATION-2024IN009850$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J e al.. Ruxolitinib versus best available therapy for polycythemia vera intolerant or resistant to hydroxycarbamide in a randomized trial.. JOURNAL OF CLINICAL ONCOLOGY. 2023;41(19):3534-44$$$$$Y$$$20240918$$HP$GB$GB
243340071$24334007$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265887$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240918$$HP$US$US
243340081$24334008$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA267319$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240918$$HP$US$US
243340091$24334009$1$I$20240901$20240909$20240918$20240918$PER$$US-SA-2024SA265042$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243340101$24334010$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266797$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240918$$HP$US$US
243340111$24334011$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266535$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240918$$PH$US$US
243340121$24334012$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266110$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240918$$HP$US$US
243340131$24334013$1$I$20240101$20240909$20240918$20240918$PER$$US-SA-2024SA269784$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$HP$US$US
243340141$24334014$1$I$20240901$20240911$20240918$20240918$PER$$US-SA-2024SA265943$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240918$$MD$US$US
243340151$24334015$1$I$$20240904$20240918$20240918$PER$$US-009507513-2409USA002974$MERCK$Rieth J. M., Belzer A. C., Walhof M. L., Milhem M. M.. Pembrolizumab plus Pharmacologic Ascorbate in the Treatment of Leiomyosarcoma. Case Reports in Oncology. 2024;17:906-912$58$YR$$F$Y$$$20240918$$HP$US$US
243340161$24334016$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA263575$SANOFI AVENTIS$$$$C$M$Y$$$20240918$$CN$US$US
243340171$24334017$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266127$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240918$$HP$US$US
243340181$24334018$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA265934$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243340191$24334019$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266541$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240918$$MD$US$US
243340201$24334020$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265865$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240918$$HP$US$US
243340211$24334021$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA268136$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240918$$HP$US$US
243340221$24334022$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266632$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240918$$CN$US$US
243340231$24334023$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266207$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240918$$HP$US$US
243340241$24334024$1$I$20240901$20240911$20240918$20240918$PER$$US-SA-2024SA266497$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240918$$HP$US$US
243340261$24334026$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266665$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240918$$HP$US$US
243340271$24334027$1$I$20240910$20240910$20240918$20240918$PER$$US-SA-2024SA268587$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240918$$MD$US$US
243340281$24334028$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266467$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$MD$US$US
243340291$24334029$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265109$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$MD$US$US
243340301$24334030$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA265786$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240918$$HP$US$US
243340311$24334031$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA265952$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$HP$US$US
243340321$24334032$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266362$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240918$$HP$US$US
243340331$24334033$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266216$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240918$$MD$US$US
243340341$24334034$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA269618$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240918$$CN$US$US
243340351$24334035$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266266$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240918$$HP$US$US
243340361$24334036$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266511$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240918$$HP$US$US
243340371$24334037$1$I$20240909$20240910$20240918$20240918$PER$$US-SA-2024SA266512$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240918$$MD$US$US
243340381$24334038$1$I$20240901$20240911$20240918$20240918$PER$$US-SA-2024SA266076$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240918$$HP$US$US
243340391$24334039$1$I$$20240912$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146099$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240918$$CN$US$US
243340401$24334040$1$I$$20240910$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147605$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240918$$MD$JP$JP
243340411$24334041$1$I$$20240910$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144576$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$88.45$KG$20240918$$CN$US$US
243340421$24334042$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148612$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240918$$CN$US$US
243340431$24334043$1$I$20220618$20240917$20240918$20240918$EXP$HR-HALMED-300086643$HR-SANDOZ INC.-SDZ2024HR080711$SANDOZ$$43$YR$$M$Y$100$KG$20240918$$MD$HR$HR
243340441$24334044$1$I$$20240906$20240918$20240918$PER$$US-ASTELLAS-2024-AER-005503$ASTELLAS$$87$YR$E$M$Y$$$20240918$$CN$US$US
243340451$24334045$1$I$20240901$20240910$20240918$20240918$PER$$US-SA-2024SA266020$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240918$$HP$US$US
243340462$24334046$2$F$20240907$20240911$20240918$20240920$PER$$US-SA-2024SA269035$SANOFI AVENTIS$$89$YR$E$M$Y$$$20240920$$CN$US$US
243340471$24334047$1$I$20240501$20240910$20240918$20240918$PER$$US-SA-2024SA265993$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240918$$HP$US$US
243340481$24334048$1$I$20240901$20240911$20240918$20240918$PER$$US-SA-2024SA266520$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240918$$MD$US$US
243340491$24334049$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266695$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240918$$MD$US$US
243340501$24334050$1$I$20240901$20240911$20240918$20240918$PER$$US-SA-2024SA265805$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240918$$HP$US$US
243340511$24334051$1$I$20240901$20240909$20240918$20240918$PER$$US-SA-2024SA266573$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240918$$MD$US$US
243340521$24334052$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266528$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$MD$US$US
243340531$24334053$1$I$20240801$20240909$20240918$20240918$PER$$US-SA-2024SA267462$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240918$$MD$US$US
243340541$24334054$1$I$20240901$20240911$20240918$20240918$PER$$US-SA-2024SA266518$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240918$$MD$US$US
243340551$24334055$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266174$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240918$$HP$US$US
243340561$24334056$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266228$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240918$$CN$US$US
243340571$24334057$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266144$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240918$$HP$US$US
243340581$24334058$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA268101$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$HP$US$US
243340591$24334059$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2023SA262849$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240918$$MD$US$US
243340601$24334060$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266451$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240918$$MD$US$US
243340611$24334061$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266506$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240918$$CN$US$US
243340621$24334062$1$I$20240101$20240909$20240918$20240918$PER$$US-SA-2024SA269690$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240918$$CN$US$US
243340631$24334063$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266753$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240918$$MD$US$US
243340641$24334064$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266173$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240918$$MD$US$US
243340651$24334065$1$I$20240701$20240909$20240918$20240918$PER$$US-SA-2024SA265966$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240918$$MD$US$US
243340661$24334066$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266142$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240918$$HP$US$US
243340671$24334067$1$I$20240101$20240909$20240918$20240918$PER$$US-SA-2024SA266231$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240918$$HP$US$US
243340681$24334068$1$I$20240101$20240909$20240918$20240918$PER$$US-SA-2024SA266798$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240918$$MD$US$US
243340691$24334069$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265921$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240918$$CN$US$US
243340711$24334071$1$I$20240901$20240910$20240918$20240918$PER$$US-SA-2024SA094030$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240918$$MD$US$US
243340721$24334072$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA265897$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240918$$HP$US$US
243340731$24334073$1$I$20240911$20240911$20240918$20240918$PER$$US-SA-2024SA266344$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240918$$HP$US$US
243340741$24334074$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266219$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240918$$HP$US$US
243340751$24334075$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266449$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240918$$HP$US$US
243340761$24334076$1$I$$20240916$20240918$20240918$EXP$$AU-SANDOZ INC.-SDZ2024AU080502$SANDOZ$$43$YR$$F$Y$$$20240918$$MD$AU$AU
243340771$24334077$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266599$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240918$$HP$US$US
243340781$24334078$1$I$$20240914$20240918$20240918$PER$$US-SA-2024SA269229$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240918$$MD$US$US
243340791$24334079$1$I$20240501$20240913$20240918$20240918$PER$$US-SA-2024SA267927$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240918$$HP$US$US
243340801$24334080$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266491$SANOFI AVENTIS$$3$YR$C$F$Y$14.3$KG$20240918$$HP$US$US
243340811$24334081$1$I$$20240829$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08690$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243340822$24334082$2$F$$20240909$20240918$20240919$EXP$$GB-INCYTE CORPORATION-2024IN009849$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J et al.. Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41 (9):3534-45$$$$$Y$$$20240919$$HP$GB$GB
243340831$24334083$1$I$$20240909$20240918$20240918$EXP$$GB-INCYTE CORPORATION-2024IN009837$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J e al.. Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41 (19):3534-44$$$$$Y$$$20240918$$HP$GB$GB
243340841$24334084$1$I$$20240912$20240918$20240918$PER$$US-BAYER-2024A131464$BAYER$$31$YR$A$F$Y$$$20240918$$HP$US$US
243340851$24334085$1$I$$20240913$20240918$20240918$PER$$US-SA-2024SA269033$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240918$$CN$US$US
243340861$24334086$1$I$20240913$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010007$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240918$$CN$US$US
243340872$24334087$2$F$$20240913$20240918$20240918$PER$$US-ROCHE-10000083694$ROCHE$$$$$$Y$$$20240918$$CN$US$US
243340881$24334088$1$I$20240915$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010068$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240918$$CN$US$US
243340891$24334089$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010813$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240918$$CN$US$US
243340901$24334090$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924050$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243340911$24334091$1$I$20240703$20240916$20240918$20240918$EXP$FR-AFSSAPS-GR2024001066$FR-SANDOZ INC.-SDZ2024FR080640$SANDOZ$$72$YR$$F$Y$$$20240918$$PH$FR$FR
243340931$24334093$1$I$$20240909$20240918$20240918$EXP$$US-TEVA-VS-3243108$TEVA$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J-Forens-Legal-Med 2024; 101.$84$YR$$F$Y$$$20240918$$HP$US$US
243340941$24334094$1$I$$20240909$20240918$20240918$EXP$$GB-INCYTE CORPORATION-2024IN009833$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J e al.. Ruxolitinib versus Best Available Therapy for PV intolerant or resistant to Hydroxycarbamide in a Randomized trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41 (19):3534-44$$$$$Y$$$20240918$$HP$GB$GB
243340961$24334096$1$I$20240527$20240913$20240918$20240918$EXP$FR-AFSSAPS-AVMA2024000394$FR-MYLANLABS-2024M1084016$MYLAN$$47$YR$$F$Y$$$20240918$$PH$FR$FR
243340971$24334097$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147981$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240918$$HP$US$US
243340981$24334098$1$I$$20240909$20240918$20240918$EXP$$GB-INCYTE CORPORATION-2024IN009831$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J e al.. Ruxolitinib versus Best Available Therapy for PV intolerant or resistant to Hydroxycarbamide in a Randomized trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41 (19):3534-44$$$$$Y$$$20240918$$HP$GB$GB
243340991$24334099$1$I$$20240829$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08686$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243341011$24334101$1$I$$20240905$20240918$20240918$PER$$US-SA-2024SA265611$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$CN$US$US
243341021$24334102$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA266354$SANOFI AVENTIS$$$$A$F$Y$95.45$KG$20240918$$MD$US$US
243341041$24334104$1$I$20240904$20240904$20240918$20240918$PER$$US-SA-2024SA267480$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240918$$HP$US$US
243341051$24334105$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA265835$SANOFI AVENTIS$$$$E$M$Y$$$20240918$$MD$US$US
243341061$24334106$1$I$$20240911$20240918$20240918$EXP$$CA-BIOMARINAP-CA-2024-160546$BIOMARIN$$$$$$Y$$$20240918$$CN$CA$CA
243341072$24334107$2$F$20240831$20240918$20240918$20240920$EXP$$TW-BIOMARINAP-TW-2024-160539$BIOMARIN$$$$$$Y$$$20240920$$CN$TW$TW
243341081$24334108$1$I$$20240917$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160615$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243341091$24334109$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA265861$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240918$$HP$US$US
243341101$24334110$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA265822$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243341111$24334111$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266245$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240918$$HP$US$US
243341121$24334112$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265973$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240918$$HP$US$US
243341131$24334113$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA265836$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240918$$MD$US$US
243341141$24334114$1$I$20240801$20240910$20240918$20240918$PER$$US-SA-2024SA265766$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240918$$MD$US$US
243341151$24334115$1$I$20240901$20240910$20240918$20240918$PER$$US-SA-2024SA266114$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240918$$MD$US$US
243341161$24334116$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA266237$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240918$$MD$US$US
243341171$24334117$1$I$$20240906$20240918$20240918$EXP$$NL-Accord-446219$ACCORD$Hovens M, Vaessen N, Sijpkens Y, Fijte DE J. Unusual presentation of central nervous system manifestations of Varicella zoster virus vasculopathy in renal transplant recipients. Transplant Infectious Disease. 2007;9:237-240.$51$YR$A$F$Y$$$20240918$$HP$NL$NL
243341181$24334118$1$I$$20240829$20240918$20240918$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08750$LUPIN$$$$$$Y$$$20240918$$CN$US$US
243341201$24334120$1$I$20211001$20240912$20240918$20240918$EXP$FR-AFSSAPS-AN2024001204$FR-TEVA-VS-3243359$TEVA$$52$YR$$F$Y$67.3$KG$20240918$$MD$FR$FR
243341212$24334121$2$F$20240913$20240923$20240918$20240927$PER$$US-BAYER-2024A131775$BAYER$$40$YR$A$F$Y$$$20240927$$HP$US$US
243341221$24334122$1$I$$20240906$20240918$20240918$EXP$IT-PFIZER INC-2019025189$IT-GUERBET / LLC-IT-20190023$GUERBET$BELLI L. EUROPEAN RADIOLOGY. Arteritis following intra-arterial chemotherapy for liver tumors. 1997;7: 323-326.$65$YR$E$M$Y$$$20240918$$MD$IT$IT
243341231$24334123$1$I$$20240910$20240918$20240918$EXP$$JP-ASTELLAS-2024-AER-006784$ASTELLAS$Yasukawa R, Kawamoto B, Muraoka K, Nakamura K, Honda M, Takenaka A. Excellent Response to 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in a Patient with Treatment-Related Neuroendocrine Prostate Cancer with Urinary Retention and Rectal Obstruction: A Case Report. Yonago Acta Medica. 2024;67(3): 266-9. doi:10.33160/yam.2024.08.010.$65$YR$E$M$Y$$$20240918$$MD$JP$JP
243341241$24334124$1$I$20240831$20240917$20240918$20240918$EXP$$US-BAUSCH-BL-2024-014034$BAUSCH AND LOMB$$48$YR$$M$Y$$$20240918$$CN$US$US
243341251$24334125$1$I$20240419$20240916$20240918$20240918$EXP$FR-AFSSAPS-AN2024001269$FR-FreseniusKabi-FK202413974$FRESENIUS KABI$$29$YR$A$F$Y$79$KG$20240918$$MD$FR$FR
243341261$24334126$1$I$20240801$20240912$20240918$20240918$EXP$$US-BAUSCH-BL-2024-013727$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240918$$CN$US$US
243341271$24334127$1$I$$20240916$20240918$20240918$EXP$$US-BAUSCH-BL-2024-013898$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240918$$CN$US$US
243341281$24334128$1$I$$20240906$20240918$20240918$EXP$$ES-Accord-446094$ACCORD$Laserna PA, Fajardo MC, De Victoria Carazo JM, Fidel MV, Raquel RF. Don^t forget the drugs. An atypical case of renopulmonary syndrome in an adult male. European Journal of Case Reports in Internal Medicine. 2024;11(Suppl 1):1018.$69$YR$E$M$Y$$$20240918$$MD$ES$ES
243341301$24334130$1$I$$20240911$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013042$DR REDDYS$$36$YR$A$M$Y$$$20240918$$CN$US$US
243341311$24334131$1$I$$20240910$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013528$DR REDDYS$Garraway C, Yang K, Kantamneni K, Kissel R, Pavlidakey PG. Imatinib-induced hyperpigmentation. JAAD Case Reports. doi:10.1016/j.jdcr.2024.06.038.$46$YR$A$F$Y$$$20240918$$MD$US$US
243341322$24334132$2$F$20240827$20240920$20240918$20240923$EXP$IT-MINISAL02-1002025$IT-GILEAD-2024-0687841$GILEAD$$83$YR$E$M$Y$$$20240923$$MD$IT$IT
243341331$24334133$1$I$20240801$20240907$20240918$20240918$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18041$IPSEN$$63$YR$A$F$Y$$$20240918$$CN$US$US
243341341$24334134$1$I$$20240907$20240918$20240918$PER$$US-ASTELLAS-2024-AER-006466$ASTELLAS$$84$YR$E$M$Y$$$20240918$$MD$US$US
243341351$24334135$1$I$$20240913$20240918$20240918$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18643$IPSEN$$63$YR$A$M$Y$90.7$KG$20240918$$CN$US$US
243341371$24334137$1$I$$20240910$20240918$20240918$PER$$US-HALEON-2196478$Haleon PLC$$$$$$Y$$$20240918$$CN$US$US
243341381$24334138$1$I$20240101$20240909$20240918$20240918$EXP$$ES-ALCON LABORATORIES-ALC2024ES004155$ALCON$$$$$$Y$$$20240918$$CN$ES$ES
243341391$24334139$1$I$20240901$20240917$20240918$20240918$PER$$US-ALXN-202409USA001355US$ALEXION PHARMACEUTICALS$$77$YR$$$Y$$$20240918$$CN$US$US
243341401$24334140$1$I$$20240829$20240918$20240918$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000037$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240917$$CN$US$US
243341411$24334141$1$I$$20240913$20240918$20240918$EXP$$NVSC2024US185231$NOVARTIS$$73$YR$$F$Y$$$20240918$$CN$US$US
243341421$24334142$1$I$$20240910$20240918$20240918$EXP$$GB-TEVA-VS-3242571$TEVA$$70$YR$$F$Y$74$KG$20240918$$MD$GB$GB
243341431$24334143$1$I$20240801$20240904$20240918$20240918$PER$$US-SA-2024SA179083$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240918$$HP$US$US
243341441$24334144$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA265637$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240918$$MD$US$US
243341451$24334145$1$I$20240822$20240829$20240918$20240918$PER$$US-SA-2024SA268158$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240918$$MD$US$US
243341471$24334147$1$I$20240801$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS091376$TAKEDA$$64$YR$$F$Y$$$20240918$$CN$US$US
243341481$24334148$1$I$$20240912$20240918$20240918$PER$$US-BAYER-2024A131837$BAYER$$$$$F$Y$$$20240918$$HP$US$US
243341492$24334149$2$F$20240801$20240910$20240918$20240918$EXP$$US-ASTELLAS-2024-AER-006837$ASTELLAS$$70$YR$E$M$Y$$$20240918$$HP$US$US
243341511$24334151$1$I$$20240905$20240918$20240918$PER$$US-JNJFOC-20240914783$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$CN$US$US
243341521$24334152$1$I$20240515$20240912$20240918$20240918$EXP$$CA-JNJFOC-20240622404$JOHNSON AND JOHNSON$$53$YR$A$F$Y$91$KG$20240918$$HP$CA$CA
243341531$24334153$1$I$20240801$20240912$20240918$20240918$EXP$$US-ABBVIE-5922160$ABBVIE$$52$YR$$F$Y$$$20240918$$CN$US$US
243341541$24334154$1$I$20240916$20240916$20240918$20240918$PER$$US-BAYER-2024A132391$BAYER$$3$YR$C$M$Y$$$20240918$$CN$US$US
243341551$24334155$1$I$$20240916$20240918$20240918$EXP$$GR-BAUSCH-BL-2024-014025$BAUSCH AND LOMB$Annousi E. Corticobasal syndrome of subacute establishment as manifestation of progressive multifocal leukoencephalopathy.. 35th Panhellenic Congress On Neurology. 2024;139.$78$YR$$M$Y$$$20240918$$MD$GR$GR
243341561$24334156$1$I$20240702$20240913$20240918$20240918$PER$$US-BAYER-2024A131859$BAYER$$33$YR$A$F$Y$$$20240918$$CN$US$US
243341571$24334157$1$I$$20240905$20240918$20240918$PER$$US-ASTELLAS-2024-AER-005224$ASTELLAS$$$$E$$Y$$$20240918$$CN$US$US
243341581$24334158$1$I$20240101$20240828$20240918$20240918$30DAY$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00475$XERIS PHARMACEUTICALS$$$$$$Y$$$20240918$$HP$US$US
243341591$24334159$1$I$$20240913$20240918$20240918$EXP$$US-GILEAD-2024-0687908$GILEAD$$$$A$M$Y$$$20240918$$CN$US$US
243341601$24334160$1$I$$20240911$20240918$20240918$EXP$$GB-TAKEDA-2024TUS091767$TAKEDA$$$$$F$Y$$$20240918$$CN$GB$GB
243341611$24334161$1$I$$20240911$20240918$20240918$EXP$NL-LRB-01000186$NL-TEVA-VS-3242905$TEVA$$59$YR$$M$Y$118$KG$20240918$$CN$NL$NL
243341621$24334162$1$I$$20240821$20240918$20240918$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000178$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$US$US
243341631$24334163$1$I$$20240912$20240918$20240918$PER$$US-BAYER-2024A131973$BAYER$$$$$F$Y$$$20240918$$HP$US$US
243341641$24334164$1$I$20240423$20240911$20240918$20240918$EXP$IT-MINISAL02-1000982$IT-TEVA-VS-3242931$TEVA$$47$YR$$M$Y$80$KG$20240918$$PH$IT$IT
243341651$24334165$1$I$20240101$20240913$20240918$20240918$EXP$$CA-ABBVIE-5924405$ABBVIE$$63$YR$$F$Y$$$20240918$$CN$CA$CA
243341661$24334166$1$I$20240807$20240917$20240918$20240918$EXP$$DE-PFIZER INC-202400257830$PFIZER$$75$YR$$M$Y$58$KG$20240918$$MD$DE$DE
243341671$24334167$1$I$$20240916$20240918$20240918$EXP$$PT-PFIZER INC-202400258027$PFIZER$Correa, J.. POSA-049 - (2564) - INVASIVE PNEUMOCOCCAL DISEASE COMPLICATED WITH BILATERAL EMPIEMA. Medicina Interna - Congressos Nacionais. 30CNMI. 2024;1121$38$YR$$M$Y$$$20240918$$MD$PT$PT
243341681$24334168$1$I$20220213$20240916$20240918$20240918$EXP$ES-AEMPS-1569459$ES-PFIZER INC-202400256949$PFIZER$$26$YR$$M$Y$$$20240918$$PH$ES$ES
243341691$24334169$1$I$20240906$20240914$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120854$PFIZER$$66$YR$$F$Y$53$KG$20240918$$HP$CN$CN
243341703$24334170$3$F$20220610$20240919$20240918$20240926$EXP$$JP-PFIZER INC-PV202400108849$PFIZER$Hazeki, D.. Two Cases of stent Obstruction Immediately Following Changes in Drug Control. The 60th annual meeting of Japanese Society of Pediatric Cardiology and Cardiac. 2024$2$YR$$M$Y$$$20240926$$PH$JP$JP
243341711$24334171$1$I$$20240918$20240918$20240918$DIR$718836$$FDA-CTU$$33$YR$$UNK$N$83.25$KG$20240918$N$CN$US$
243341721$24334172$1$I$$20240904$20240918$20240918$30DAY$$JP-JNJFOC-20240931082$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$PH$JP$JP
243341732$24334173$2$F$$20240916$20240918$20240922$PER$$US-JNJFOC-20240939873$JOHNSON AND JOHNSON$$$$$M$Y$$$20240922$$CN$US$US
243341742$24334174$2$F$20240901$20240912$20240918$20240923$PER$$US-Eisai-EC-2024-174359$EISAI$$84$YR$E$F$Y$$$20240923$$CN$US$US
243341751$24334175$1$I$$20240913$20240918$20240918$EXP$$CA-ABBVIE-4335374$ABBVIE$$$$$F$Y$$$20240918$$CN$CA$CA
243341761$24334176$1$I$20240801$20240907$20240918$20240918$EXP$$US-JNJFOC-20240924423$JOHNSON AND JOHNSON$$55$YR$A$M$Y$122$KG$20240918$$CN$US$US
243341771$24334177$1$I$20240905$20240912$20240918$20240918$PER$$CN-Eisai-EC-2024-174313$EISAI$$41$YR$A$F$Y$50$KG$20240918$$HP$CN$CN
243341781$24334178$1$I$$20240913$20240918$20240918$EXP$GB-MHRA-MED-202409132324583640-WTRCD$GB-Eisai-EC-2024-174390$EISAI$$82$YR$E$F$Y$$$20240918$$HP$GB$GB
243341791$24334179$1$I$20240811$20240917$20240918$20240918$EXP$$TR-PFIZER INC-PV202400121878$PFIZER$$64$YR$$M$Y$$$20240918$$CN$TR$TR
243341802$24334180$2$F$20240825$20240909$20240918$20240924$EXP$$CN-JNJFOC-20240923419$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240924$$HP$CN$CN
243341811$24334181$1$I$$20240913$20240918$20240918$PER$$US-FreseniusKabi-FK202413817$FRESENIUS KABI$$$$$$Y$$$20240918$$HP$US$US
243341821$24334182$1$I$20230701$20240916$20240918$20240918$EXP$FR-AFSSAPS-LM2024000494$FR-FreseniusKabi-FK202413953$FRESENIUS KABI$$58$YR$A$M$Y$$$20240918$$MD$FR$FR
243341831$24334183$1$I$20240905$20240912$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013481$DR REDDYS$$37$YR$A$F$Y$$$20240918$$HP$US$US
243341841$24334184$1$I$$20240912$20240918$20240918$PER$$JP-Eisai-EC-2024-174332$EISAI$Hiroki Kubota. 10 cases to be considered from 2023 onwards. Len/Pem treatment results (2023 and after).$70$YR$E$F$Y$$$20240918$$MD$JP$JP
243341851$24334185$1$I$$20240910$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013421$DR REDDYS$$72$YR$E$M$Y$$$20240918$$MD$US$US
243341871$24334187$1$I$$20240910$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013432$DR REDDYS$$24$YR$A$F$Y$$$20240918$$MD$US$US
243341881$24334188$1$I$$20240912$20240918$20240918$EXP$$DE-ABBVIE-5925732$ABBVIE$$$$E$M$Y$$$20240918$$HP$DE$DE
243341891$24334189$1$I$20240913$20240916$20240918$20240918$PER$$US-BAYER-2024A132148$BAYER$$23$YR$A$F$Y$$$20240918$$MD$US$US
243341901$24334190$1$I$$20240911$20240918$20240918$EXP$$NVSC2024DE184219$NOVARTIS$$49$YR$$F$Y$$$20240918$$MD$DE$DE
243341911$24334191$1$I$$20210816$20240918$20240918$PER$$NVSC2021US318491$NOVARTIS$$$$$$Y$$$20240918$$MD$US$US
243341921$24334192$1$I$20230717$20240917$20240918$20240918$PER$$NVSC2024US185628$NOVARTIS$$$$$F$Y$$$20240918$$HP$US$US
243341931$24334193$1$I$20240901$20240911$20240918$20240918$EXP$$US-BIOGEN-2024BI01282542$BIOGEN$$30$YR$$F$Y$$$20240918$$CN$US$US
243341941$24334194$1$I$20240607$20240912$20240918$20240918$EXP$$JP-GSK-JP2024115040$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$JP$JP
243341961$24334196$1$I$20240908$20240911$20240918$20240918$EXP$$CA-GSK-CA2024113039$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$CA$CA
243341971$24334197$1$I$$20240916$20240918$20240918$EXP$GB-MHRA-MED-202409131339159150-KBHVG$GB-SANDOZ INC.-SDZ2024GB080505$SANDOZ$$50$YR$$F$Y$$$20240918$$HP$GB$GB
243341981$24334198$1$I$$20240916$20240918$20240918$EXP$$EG-PFIZER INC-PV202400121203$PFIZER$$27$YR$$F$Y$$$20240918$$PH$EG$EG
243341991$24334199$1$I$20240126$20240913$20240918$20240918$EXP$IT-MINISAL02-1001940$IT-PFIZER INC-202400255925$PFIZER$$65$YR$$M$Y$103$KG$20240918$$MD$IT$IT
243342001$24334200$1$I$20240101$20240916$20240918$20240918$PER$$US-BAYER-2024A132598$BAYER$$24$YR$A$F$Y$$$20240918$$HP$US$US
243342011$24334201$1$I$$20240908$20240918$20240918$EXP$$IL-Merck Healthcare KGaA-2024048200$MERCK KGAA$$64$YR$A$F$Y$$$20240916$$CN$IL$IL
243342021$24334202$1$I$$20240913$20240918$20240918$EXP$$US-SA-2024SA268760$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240918$$HP$US$US
243342031$24334203$1$I$20240823$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010031$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240918$$CN$US$US
243342041$24334204$1$I$$20240910$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409006062$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240918$$CN$US$US
243342051$24334205$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009673$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$US$US
243342062$24334206$2$F$20240901$20240921$20240918$20240930$PER$$US-ABBVIE-5923566$ABBVIE$$59$YR$$F$Y$$$20240930$$CN$US$US
243342071$24334207$1$I$$20240913$20240918$20240918$PER$$US-HALEON-2197026$Haleon PLC$$$$$$Y$$$20240918$$CN$US$US
243342081$24334208$1$I$20240801$20240910$20240918$20240918$EXP$DE-BFARM-24006087$DE-TEVA-VS-3242270$TEVA$$15$YR$$F$Y$70$KG$20240918$$MD$DE$DE
243342091$24334209$1$I$$20201215$20240918$20240918$EXP$$NVSC2020US371145$NOVARTIS$$$$$$Y$$$20240918$$MD$US$US
243342101$24334210$1$I$20240624$20240823$20240918$20240918$PER$$US-SA-2024SA265333$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240918$$MD$US$US
243342111$24334211$1$I$$20240914$20240918$20240918$PER$$NVSC2024US184548$NOVARTIS$$$$$$Y$$$20240918$$CN$US$US
243342131$24334213$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA266214$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240918$$MD$US$US
243342141$24334214$1$I$20240701$20240911$20240918$20240918$PER$$US-SA-2024SA265885$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240918$$MD$US$US
243342151$24334215$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA267606$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$HP$US$US
243342161$24334216$1$I$20240809$20240828$20240918$20240918$PER$$US-SA-2024SA268815$SANOFI AVENTIS$$$$$M$Y$$$20240918$$CN$US$US
243342171$24334217$1$I$20240801$20240828$20240918$20240918$PER$$US-SA-2024SA266995$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240918$$HP$US$US
243342181$24334218$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267610$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240918$$MD$US$US
243342191$24334219$1$I$$20240912$20240918$20240918$PER$$US-JNJFOC-20240938471$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$MD$US$US
243342201$24334220$1$I$20240801$20240912$20240918$20240918$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001859$BLUEPRINT MEDICINES$$30$YR$A$F$Y$$$20240918$$CN$US$US
243342211$24334221$1$I$20240911$20240916$20240918$20240918$PER$$US-BAYER-2024A132679$BAYER$$41$YR$A$F$Y$$$20240918$$HP$US$US
243342221$24334222$1$I$20230203$20240910$20240918$20240918$EXP$FR-AFSSAPS-PC2024000682$FR-TEVA-VS-3242309$TEVA$$52$YR$$F$Y$83$KG$20240918$$PH$FR$FR
243342231$24334223$1$I$20240801$20240827$20240918$20240918$PER$$US-SA-2024SA266982$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240918$$HP$US$US
243342241$24334224$1$I$$20240823$20240918$20240918$PER$$US-SA-2024SA266486$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243342251$24334225$1$I$20240101$20240830$20240918$20240918$PER$$US-SA-2024SA267014$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240918$$CN$US$US
243342261$24334226$1$I$20240101$20240828$20240918$20240918$PER$$US-SA-2024SA267445$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240918$$CN$US$US
243342271$24334227$1$I$20240626$20240911$20240918$20240918$EXP$$CA-GSK-CA2024113507$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$CA$CA
243342281$24334228$1$I$$20240916$20240918$20240918$EXP$$AU-TGA-0000817576$SANDOZ$$$$$$Y$$$20240918$$HP$AU$AU
243342291$24334229$1$I$20240917$20240917$20240918$20240918$PER$$US-BAYER-2024A132609$BAYER$$$$$F$Y$$$20240918$$MD$US$US
243342311$24334231$1$I$$20240912$20240918$20240918$PER$$JP-Eisai-EC-2024-174331$EISAI$Hiroki Kubota. 10 cases to be considered from 2023 onwards. Len/Pem treatment results (2023 and after).$84$YR$E$$Y$$$20240918$$MD$JP$JP
243342321$24334232$1$I$20240101$20240820$20240918$20240918$PER$$US-Eisai-EC-2024-172501$EISAI$$74$YR$E$F$Y$$$20240918$$CN$US$US
243342331$24334233$1$I$20240813$20240820$20240918$20240918$PER$$US-Eisai-EC-2024-172472$EISAI$$57$YR$A$F$Y$$$20240918$$CN$US$US
243342341$24334234$1$I$$20240820$20240918$20240918$PER$$US-Eisai-EC-2024-173108$EISAI$$$$$F$Y$$$20240918$$MD$US$US
243342351$24334235$1$I$$20240910$20240918$20240918$EXP$GB-MHRA-MED-202409101408266480-TPVQN$GB-TEVA-VS-3243351$TEVA$$36$YR$$$Y$$$20240918$$PH$GB$GB
243342361$24334236$1$I$20240704$20240909$20240918$20240918$EXP$GB-MHRA-MED-202409071040229170-TKRFC$GB-TEVA-VS-3242087$TEVA$$72$YR$$F$Y$90$KG$20240918$$CN$GB$GB
243342382$24334238$2$F$20240902$20240925$20240918$20240925$30DAY$$AR-PFIZER INC-202400251643$PFIZER$$10$YR$$F$Y$$$20240925$$CN$AR$AR
243342391$24334239$1$I$$20240917$20240918$20240918$PER$$US-BAYER-2024A132611$BAYER$$37$YR$A$F$Y$$$20240918$$CN$US$US
243342404$24334240$4$F$$20240918$20240918$20240924$PER$$NVSC2024US186138$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243342411$24334241$1$I$$20240909$20240918$20240918$EXP$GB-MHRA-MED-202409071112464930-LVPWQ$GB-TEVA-VS-3242084$TEVA$$62$YR$$F$Y$78$KG$20240918$$CN$GB$GB
243342421$24334242$1$I$$20240913$20240918$20240918$PER$$NVSC2024US184233$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
243342431$24334243$1$I$$20240909$20240918$20240918$PER$$GB-Eisai-EC-2024-174185$EISAI$$64$YR$A$$Y$$$20240918$$HP$GB$GB
243342441$24334244$1$I$20240101$20240909$20240918$20240918$PER$$AU-Eisai-EC-2024-167915$EISAI$$46$YR$A$F$Y$$$20240918$$MD$AU$AU
243342451$24334245$1$I$$20240912$20240918$20240918$EXP$GB-MHRA-MED-202409121633045170-MFKQT$GB-RDY-SPO/GBR/24/0013462$DR REDDYS$$$$$M$Y$$$20240918$$MD$GB$GB
243342461$24334246$1$I$$20240906$20240918$20240918$EXP$$PHBS1998FR16254$NOVARTIS$Ciclosporine : fibroad?nomes du sein. LA REVUE PRESCRIRE. 2024;44:666$17$YR$$F$Y$$$20240918$$HP$FR$FR
243342471$24334247$1$I$20240831$20240912$20240918$20240918$PER$$CN-Eisai-EC-2024-174312$EISAI$$41$YR$A$M$Y$53$KG$20240918$$HP$CN$CN
243342481$24334248$1$I$$20240911$20240918$20240918$EXP$$JP-Eisai-EC-2024-174228$EISAI$Toeda Mitsuru et al.. A case of encephalopathy during combination therapy with lenvatinib and pembrolizumab for recurrent uterine cancer. The 409th Tokyo Society of Obstetrics and Gynecology Regular Meeting and the 47th Joint Training Session with the Tokyo Society of Obstetrics and Gynecology.$$$$F$Y$$$20240918$$MD$JP$JP
243342491$24334249$1$I$$20240913$20240918$20240918$PER$$US-ABBVIE-5924328$ABBVIE$$$$$F$Y$$$20240918$$HP$US$US
243342511$24334251$1$I$$20240910$20240918$20240918$PER$$US-JNJFOC-20240933125$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$CN$US$US
243342531$24334253$1$I$$20240913$20240918$20240918$PER$$US-JNJFOC-20240937196$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243342542$24334254$2$F$20240901$20240920$20240918$20240926$PER$$US-GILEAD-2024-0688025$GILEAD$$34$YR$A$F$Y$$$20240926$$HP$US$US
243342551$24334255$1$I$20240909$20240909$20240918$20240918$EXP$$CN-VANTIVE-2024VAN019680$Vantive US Healthcare$$42$YR$$F$Y$$$20240918$$CN$CN$CN
243342561$24334256$1$I$20240909$20240910$20240918$20240918$PER$$US-ROCHE-10000079360$ROCHE$$26$YR$A$F$Y$72.57$KG$20240918$$CN$US$US
243342571$24334257$1$I$20240101$20240828$20240918$20240918$PER$$US-SA-2024SA131432$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240918$$MD$US$US
243342581$24334258$1$I$$20240911$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US080120$SANDOZ$$$$$$Y$$$20240918$$PH$US$US
243342591$24334259$1$I$$20240910$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US079177$SANDOZ$$$$$M$Y$$$20240918$$MD$US$US
243342601$24334260$1$I$20240502$20240910$20240918$20240918$EXP$$AU-SPRINGWORKS THERAPEUTICS-SW-001970$SPRINGWORKS THERAPEUTIC$$$$$$Y$$$20240918$$MD$AU$AU
243342611$24334261$1$I$20240520$20240916$20240918$20240918$EXP$$DE-PFIZER INC-PV202400121386$PFIZER$$67$YR$$F$Y$85$KG$20240918$$MD$DE$DE
243342621$24334262$1$I$$20240917$20240918$20240918$PER$$US-BAYER-2024A132617$BAYER$$27$YR$A$F$Y$$$20240918$$MD$US$US
243342631$24334263$1$I$$20240909$20240918$20240918$30DAY$$CO-PFIZER INC-PV202400119306$PFIZER$$$$$$Y$$$20240918$$CN$CO$CO
243342641$24334264$1$I$$20240913$20240918$20240918$30DAY$$CO-PFIZER INC-PV202400121300$PFIZER$$$$$F$Y$$$20240918$$CN$CO$CO
243342661$24334266$1$I$$20240908$20240918$20240918$EXP$$IL-Merck Healthcare KGaA-2024048607$MERCK KGAA$$77$YR$E$F$Y$$$20240916$$CN$IL$IL
243342671$24334267$1$I$$20240917$20240918$20240918$PER$$US-BAYER-2024A132874$BAYER$$$$$F$Y$$$20240918$$CN$US$US
243342681$24334268$1$I$$20240909$20240918$20240918$EXP$$GB-INCYTE CORPORATION-2024IN009829$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J e al.. Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41(19):3534-44$$$$$Y$$$20240918$$HP$GB$GB
243342691$24334269$1$I$$20240909$20240918$20240918$EXP$$DE-TEVA-VS-3242560$TEVA$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.; Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.$6$YR$$M$Y$$$20240918$$HP$DE$DE
243342701$24334270$1$I$20230517$20240913$20240918$20240918$EXP$$IT-ALXN-202409EEA000016IT$ALEXION PHARMACEUTICALS$$48$YR$$F$Y$72$KG$20240918$$MD$IT$IT
243342711$24334271$1$I$20240522$20240912$20240918$20240918$EXP$FR-AFSSAPS-MA2024001446$FR-TEVA-VS-3243225$TEVA$$22$YR$$F$Y$$$20240918$$MD$FR$FR
243342721$24334272$1$I$$20240904$20240918$20240918$30DAY$$FR-JNJFOC-20240913109$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$MD$FR$FR
243342731$24334273$1$I$$20240912$20240918$20240918$EXP$$US-ALXN-202409USA000944US$ALEXION PHARMACEUTICALS$$$$$F$Y$$$20240918$$CN$US$US
243342741$24334274$1$I$$20240917$20240918$20240918$PER$$US-BAYER-2024A132956$BAYER$$$$$F$Y$$$20240918$$CN$US$US
243342751$24334275$1$I$20240301$20240909$20240918$20240918$EXP$IT-MINISAL02-1000750$IT-TEVA-VS-3242049$TEVA$$76$YR$$F$Y$60$KG$20240918$$MD$IT$IT
243342761$24334276$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267592$SANOFI AVENTIS$$$$E$M$Y$73.469$KG$20240918$$MD$US$US
243342771$24334277$1$I$20240106$20240911$20240918$20240918$EXP$$IT-ZAMBON SWITZERLAND LTD.-2024-ZAM-IT000047$PAREXEL$$$$$$Y$$$20240918$$MD$IT$IT
243342791$24334279$1$I$$20240904$20240918$20240918$PER$$US-009507513-2409USA005697$MERCK$Rieth J. M., Belzer A. C., Walhof M. L., Milhem M. M.. Pembrolizumab plus Pharmacologic Ascorbate in the Treatment of Leiomyosarcoma. Case Reports in Oncology 2024-01-01 (): 906-912. 2024;17:906-12$53$YR$$F$Y$$$20240918$$HP$US$US
243342801$24334280$1$I$20240801$20240909$20240918$20240918$PER$$US-SA-2024SA267309$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240918$$MD$US$US
243342811$24334281$1$I$$20240912$20240918$20240918$EXP$$CA-TAKEDA-2024TUS091563$TAKEDA$$$$$M$Y$$$20240918$$CN$CA$CA
243342821$24334282$1$I$20210101$20240908$20240918$20240918$EXP$$KR-009507513-2409KOR004065$MERCK$$60$YR$$F$Y$$$20240918$$MD$KR$KR
243342841$24334284$1$I$20240831$20240916$20240918$20240918$EXP$$BE-FreseniusKabi-FK202413944$FRESENIUS KABI$$22$YR$A$F$Y$$$20240918$$PH$BE$BE
243342852$24334285$2$F$20240823$20240920$20240918$20240926$EXP$$RU-FreseniusKabi-FK202413805$FRESENIUS KABI$$76$YR$E$F$Y$95$KG$20240926$$MD$RU$RU
243342861$24334286$1$I$$20240911$20240918$20240918$PER$$US-ABBVIE-5922499$ABBVIE$$$$$$Y$$$20240918$$HP$US$US
243342871$24334287$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA267227$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240918$$HP$US$US
243342891$24334289$1$I$20240701$20240910$20240918$20240918$PER$$US-SA-2024SA266067$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240918$$MD$US$US
243342901$24334290$1$I$20240801$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010806$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240918$$CN$US$US
243342911$24334291$1$I$20240828$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409061147147980-VCHBS$GB-ELI_LILLY_AND_COMPANY-GB202409004989$ELI LILLY AND CO$$53$YR$A$F$Y$95$KG$20240918$$CN$GB$GB
243342921$24334292$1$I$$20240909$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409005002$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240918$$CN$US$US
243342931$24334293$1$I$$20240911$20240918$20240918$EXP$US-MLMSERVICE-20170914-0885468-1$US-RDY-USA/USA/17/0093719$DR REDDYS$Pelletier JH, Nagaraj S, Gbadegesin R, Wigfall D, McGann KA, Foreman J. Neutropenic enterocolitis (typhlitis) in a pediatric renal transplant patient. A case report and review of the literature. Pediatric Transplantation. 2017;21(6):Article Number e13022.$15$YR$T$M$Y$$$20240918$$MD$US$US
243342941$24334294$1$I$20240915$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009745$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240918$$CN$US$US
243342951$24334295$1$I$$20240910$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409006605$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240918$$CN$US$US
243342962$24334296$2$F$20240601$20240917$20240918$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010173$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243342971$24334297$1$I$20240811$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409060821395280-WSMKT$GB-ELI_LILLY_AND_COMPANY-GB202409004985$ELI LILLY AND CO$$43$YR$A$F$Y$80$KG$20240918$$CN$GB$GB
243342981$24334298$1$I$$20240909$20240918$20240918$30DAY$$US-GSK-US2024111826$GLAXOSMITHKLINE$$$$$M$Y$$$20240918$$CN$US$US
243342991$24334299$1$I$20240816$20240914$20240918$20240918$EXP$$NVSC2024IN185436$NOVARTIS$$62$YR$$F$Y$$$20240918$$MD$IN$IN
243343001$24334300$1$I$20240101$20240909$20240918$20240918$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028503$UNITED THERAPEUTICS$$$$$F$Y$$$20240918$$$US$US
243343011$24334301$1$I$20240901$20240916$20240918$20240918$EXP$$US-KYOWAKIRIN-2024KK021567$KYOWA$$$$$$Y$$$20240918$$HP$US$US
243343021$24334302$1$I$$20240916$20240918$20240918$EXP$$CA-ABBVIE-5927284$ABBVIE$$$$A$F$Y$$$20240918$$MD$CA$CA
243343041$24334304$1$I$20230303$20240912$20240918$20240918$EXP$FR-AFSSAPS-AM2024000709$FR-TEVA-VS-3243353$TEVA$$71$YR$$F$Y$62$KG$20240918$$MD$FR$FR
243343051$24334305$1$I$$20240905$20240918$20240918$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27420$SAMSUNG BIOEPIS$$$$$F$Y$$$20240918$$PH$CA$CA
243343061$24334306$1$I$$20240912$20240918$20240918$EXP$$CA-TEVA-VS-3243740$TEVA$$$$$$Y$$$20240918$$HP$CA$CA
243343071$24334307$1$I$20240911$20240912$20240918$20240918$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051329$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240918$$CN$BR$BR
243343081$24334308$1$I$$20240913$20240918$20240918$EXP$$US-Taiho Oncology Inc-2024-008789$TAIHO ONCOLOGY INC$$59$YR$A$M$Y$115.03$KG$20240918$$CN$US$US
243343091$24334309$1$I$20240701$20240914$20240918$20240918$PER$$US-Taiho Oncology Inc-2024-008757$TAIHO ONCOLOGY INC$$52$YR$A$M$Y$$$20240918$$PH$US$US
243343101$24334310$1$I$$20240916$20240918$20240918$PER$$US-JNJFOC-20240942338$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243343111$24334311$1$I$$20240911$20240918$20240918$EXP$$NVSC2024AR184844$NOVARTIS$$66$YR$$M$Y$$$20240918$$MD$AR$AR
243343122$24334312$2$F$$20240913$20240918$20240919$PER$$NVSC2024US184234$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
243343131$24334313$1$I$20240901$20240913$20240918$20240918$EXP$$US-BAUSCH-BL-2024-013433$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240918$$CN$US$US
243343141$24334314$1$I$20240101$20240911$20240918$20240918$EXP$SE-SEMPA-2024-006472$SE-TEVA-VS-3243133$TEVA$$76$YR$$M$Y$$$20240918$$MD$SE$SE
243343151$24334315$1$I$20240729$20240912$20240918$20240918$EXP$FR-AFSSAPS-TS2024000973$FR-BAUSCH-BL-2024-013800$BAUSCH AND LOMB$$56$YR$$M$Y$$$20240918$$MD$FR$FR
243343161$24334316$1$I$20240726$20240916$20240918$20240918$EXP$FR-AFSSAPS-GR2024001087$FR-BAUSCH-BL-2024-013945$BAUSCH AND LOMB$$21$YR$$M$Y$86$KG$20240918$$PH$FR$FR
243343171$24334317$1$I$$20240915$20240918$20240918$EXP$$GR-BAUSCH-BL-2024-013890$BAUSCH AND LOMB$$68$YR$$$Y$$$20240918$$MD$GR$GR
243343181$24334318$1$I$$20240911$20240918$20240918$EXP$$US-BAUSCH-BL-2024-013700$BAUSCH AND LOMB$Blush III R. ?-Adrenergic Agonist-Induced Lactic Acidosis: A Case Report. AACN advanced critical care. 2024;35(3):222-227. doi:10.4037/aacnacc2024787$54$YR$$F$Y$$$20240918$$HP$US$US
243343191$24334319$1$I$20240727$20240916$20240918$20240918$EXP$HR-HALMED-300086558$HR-BAUSCH-BL-2024-013940$BAUSCH AND LOMB$$$$A$M$Y$$$20240918$$MD$HR$HR
243343201$24334320$1$I$$20240918$20240918$20240918$DIR$718847$$FDA-CTU$$$$$UNK$N$$$20240918$N$CN$US$
243343211$24334321$1$I$20240913$20240918$20240918$20240918$DIR$718900$$FDA-CTU$$54$YR$$F$N$76.5$KG$20240918$N$$US$
243343221$24334322$1$I$$20240911$20240918$20240918$EXP$$CA-BAUSCH-BL-2024-013649$BAUSCH AND LOMB$$53$YR$$M$Y$$$20240918$$HP$CA$CA
243343231$24334323$1$I$20240829$20240904$20240918$20240918$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000926$PAREXEL$$$$$$Y$$$20240918$$HP$CN$CN
243343242$24334324$2$F$20200101$20240917$20240918$20240926$EXP$$US-ROCHE-10000084670$ROCHE$$50$YR$A$F$Y$$$20240926$$CN$US$US
243343251$24334325$1$I$$20240917$20240918$20240918$PER$$US-JNJFOC-20240945203$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243343261$24334326$1$I$20240910$20240910$20240918$20240918$PER$$US-EMERGENT BIOSOLUTIONS,-24000131$EMERGENT BIOSOLUTIONS$$32$YR$$F$Y$154.22$KG$20240918$$CN$US$US
243343271$24334327$1$I$$20240917$20240918$20240918$EXP$$US-ALXN-202409USA001312US$ALEXION PHARMACEUTICALS$$$$$M$Y$92.971$KG$20240918$$HP$US$US
243343291$24334329$1$I$$20240909$20240918$20240918$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27712$SAMSUNG BIOEPIS$$21$YR$A$F$Y$$$20240918$$MD$CA$CA
243343301$24334330$1$I$20240611$20240913$20240918$20240918$EXP$$US-009507513-2409USA005382$MERCK$$$$$F$Y$$$20240918$$CN$US$US
243343311$24334331$1$I$$20240911$20240918$20240918$EXP$$RS-GILEAD-2024-0687541$GILEAD$$50$YR$A$M$Y$$$20240918$$HP$RS$RS
243343321$24334332$1$I$$20240909$20240918$20240918$EXP$$US-BAXTER-2024BAX024609$BAXTER$$80$YR$$F$Y$$$20240918$$HP$US$US
243343331$24334333$1$I$20130318$20240916$20240918$20240918$EXP$DE-EMA-DD-20240912-7482675-125626$DE-SANDOZ INC.-SDZ2024DE080729$SANDOZ$$35$YR$$F$Y$$$20240918$$MD$DE$DE
243343341$24334334$1$I$$20240905$20240918$20240918$EXP$$US-UCBSA-2024045854$UCB$$$$$F$Y$60.771$KG$20240918$$HP$US$US
243343351$24334335$1$I$20240902$20240913$20240918$20240918$EXP$GB-MHRA-MED-202409101300091540-GRMQV$GB-MYLANLABS-2024M1084341$MYLAN$$90$YR$$F$Y$36$KG$20240918$$HP$GB$GB
243343361$24334336$1$I$20240227$20240917$20240918$20240918$EXP$$CA-MYLANLABS-2024M1032192$MYLAN$$76$YR$$F$Y$69.8$KG$20240918$$HP$CA$CA
243343371$24334337$1$I$20220204$20240912$20240918$20240918$EXP$$JP-DSJP-DSJ-2022-132788$DAIICHI$Kishino E, Oota Y, Daitoku K, Matsumoto K, Nakamura Y, Saitou W, et al.. EP-1131 Two cases of drug-induced lung injury due to ENHERTU experienced at our hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Association. 2024;460$81$YR$$F$Y$56.9$KG$20240918$$MD$JP$JP
243343381$24334338$1$I$$20240913$20240918$20240918$EXP$$GB-MYLANLABS-2024M1084190$MYLAN$$$$$M$Y$$$20240918$$PH$GB$GB
243343391$24334339$1$I$$20240904$20240918$20240918$PER$$US-009507513-2409USA005698$MERCK$Rieth J. M., Belzer A. C., Walhof M. L., Milhem M. M.. Pembrolizumab plus Pharmacologic Ascorbate in the Treatment of Leiomyosarcoma. Case Reports in Oncology. 2024;17:906-912$75$YR$$F$Y$$$20240918$$HP$US$US
243343401$24334340$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5923951$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243343412$24334341$2$F$$20240916$20240918$20240925$EXP$$GB-TEVA-VS-3242473$TEVA$$$$A$F$Y$$$20240925$$MD$GB$GB
243343421$24334342$1$I$20240916$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009932$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240918$$CN$US$US
243343431$24334343$1$I$20240915$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010004$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240918$$CN$US$US
243343441$24334344$1$I$20240901$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010184$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240918$$CN$US$US
243343491$24334349$1$I$20240614$20240911$20240918$20240918$EXP$ES-AEMPS-1566611$ES-TEVA-VS-3242943$TEVA$$75$YR$$M$Y$$$20240918$$MD$ES$ES
243343502$24334350$2$F$$20240917$20240918$20240921$PER$$US-JNJFOC-20240939268$JOHNSON AND JOHNSON$$$$$M$Y$$$20240921$$CN$US$US
243343511$24334351$1$I$$20240905$20240918$20240918$EXP$$CA-UCBSA-2024045975$UCB$$$$$F$Y$$$20240918$$MD$CA$CA
243343531$24334353$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64107$$FDA-CTU$$33$YR$$F$N$$$20240918$N$$US$
243343541$24334354$1$I$$20240916$20240918$20240918$DIR$FDA-CDER-CTU-2024-64087$$FDA-CTU$$81$YR$$F$N$$$20240916$N$$US$
243343551$24334355$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64105$$FDA-CTU$$54$YR$$F$N$$$20240918$N$$US$
243343573$24334357$3$F$20240101$20240924$20240918$20240927$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2023-10671$IPSEN$$72$YR$E$F$Y$$$20240927$$HP$GB$GB
243343581$24334358$1$I$$20240830$20240918$20240918$PER$$US-SA-2024SA267983$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240918$$HP$US$US
243343591$24334359$1$I$$20240902$20240918$20240918$PER$$US-SA-2024SA269056$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240918$$HP$US$US
243343601$24334360$1$I$$20240913$20240918$20240918$PER$$US-SA-2024SA269620$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$HP$US$US
243343611$24334361$1$I$$20240912$20240918$20240918$EXP$$CA-TEVA-VS-3243725$TEVA$$59$YR$$F$Y$72.575$KG$20240918$$PH$CA$CA
243343621$24334362$1$I$$20240912$20240918$20240918$EXP$$CA-TEVA-VS-3243492$TEVA$$69$YR$$F$Y$61$KG$20240918$$MD$CA$CA
243343632$24334363$2$F$20240911$20240924$20240918$20240926$PER$$US-ROCHE-10000083307$ROCHE$$4$YR$C$M$Y$$$20240926$$PH$US$US
243343651$24334365$1$I$$20240917$20240918$20240918$EXP$$IT-SANDOZ INC.-SDZ2024IT080715$SANDOZ$$$$A$$Y$$$20240918$$HP$IT$IT
243343662$24334366$2$F$$20240923$20240918$20240930$EXP$$DE-TEVA-VS-3242558$TEVA$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.; Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.; Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-De...$15$YR$$F$Y$$$20240930$$HP$DE$DE
243343671$24334367$1$I$$20240909$20240918$20240918$EXP$$CA-GSK-CA2024111971$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$MD$CA$CA
243343681$24334368$1$I$20240628$20240906$20240918$20240918$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27635$SAMSUNG BIOEPIS$$77$YR$E$M$Y$$$20240918$$CN$CA$CA
243343691$24334369$1$I$$20240907$20240918$20240918$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-27499$SAMSUNG BIOEPIS$$77$YR$E$F$Y$$$20240918$$CN$GB$GB
243343701$24334370$1$I$$20240909$20240918$20240918$EXP$$GB-INCYTE CORPORATION-2024IN009820$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J e al.. Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41(19):3534-44$$$$$Y$$$20240918$$HP$GB$GB
243343721$24334372$1$I$20240828$20240913$20240918$20240918$PER$$US-ROCHE-10000082855$ROCHE$$13$YR$T$M$Y$$$20240918$$CN$US$US
243343731$24334373$1$I$20240823$20240913$20240918$20240918$PER$$US-ROCHE-10000083279$ROCHE$$47$YR$A$M$Y$$$20240918$$CN$US$US
243343741$24334374$1$I$20240903$20240913$20240918$20240918$PER$$US-ROCHE-10000082579$ROCHE$$10$YR$C$M$Y$$$20240918$$CN$US$US
243343751$24334375$1$I$$20240821$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133319$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240918$$CN$US$US
243343761$24334376$1$I$20240913$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184959$AMGEN$$20$YR$A$F$Y$$$20240918$$CN$US$US
243343771$24334377$1$I$20240917$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185634$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243343781$24334378$1$I$20240916$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185250$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243343792$24334379$2$F$$20240916$20240918$20240923$PER$$US-AMGEN-USASP2024185439$AMGEN$$67$YR$E$F$Y$$$20240923$$MD$US$US
243343801$24334380$1$I$20240914$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185469$AMGEN$$$$$M$Y$$$20240918$$CN$US$US
243343811$24334381$1$I$$20240910$20240918$20240918$PER$$US-AMGEN-USASP2024183705$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243343821$24334382$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185157$AMGEN$$$$$M$Y$$$20240918$$MD$US$US
243343831$24334383$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184508$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243343841$24334384$1$I$20240601$20240913$20240918$20240918$EXP$FR-AFSSAPS-NT2024001131$FR-AMGEN-FRASP2024183566$AMGEN$$59$YR$A$M$Y$$$20240918$$MD$FR$FR
243343851$24334385$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185238$AMGEN$$64$YR$A$F$Y$$$20240918$$PH$US$US
243343861$24334386$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185717$AMGEN$$54$YR$A$F$Y$$$20240918$$PH$US$US
243343872$24334387$2$F$$20240916$20240918$20240923$PER$$US-AMGEN-USASP2024185344$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
243343881$24334388$1$I$20240819$20240918$20240918$20240918$DIR$718902$$FDA-CTU$$37$YR$$F$N$$$20240918$N$PH$US$
243343901$24334390$1$I$20240917$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64093$$FDA-CTU$$30$YR$$F$N$$$20240917$N$HP$US$
243343911$24334391$1$I$20240829$20240909$20240918$20240918$DIR$FDA-CDER-CTU-2024-64039$$FDA-CTU$$72$YR$$F$N$147$LBS$20240909$Y$CN$US$
243343921$24334392$1$I$20220101$20240910$20240918$20240918$EXP$$RO-AMGEN-ROUSP2024180899$AMGEN$$59$YR$A$$Y$$$20240918$$MD$RO$RO
243343931$24334393$1$I$20240816$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024186127$AMGEN$$82$YR$E$F$Y$$$20240918$$CN$US$US
243343941$24334394$1$I$20240912$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184670$AMGEN$$58$YR$A$F$Y$$$20240918$$PH$US$US
243343952$24334395$2$F$20240904$20240920$20240918$20240925$PER$$US-AMGEN-USASP2024184928$AMGEN$$74$YR$E$F$Y$$$20240925$$CN$US$US
243343962$24334396$2$F$$20240918$20240918$20240924$EXP$$US-AMGEN-USASP2024185053$AMGEN$$19$YR$A$F$Y$$$20240924$$HP$US$US
243343972$24334397$2$F$20240917$20240918$20240918$20240919$PER$$US-AMGEN-USASP2024185638$AMGEN$$64$YR$A$M$Y$$$20240919$$CN$US$US
243343982$24334398$2$F$$20240913$20240918$20240927$EXP$$JP-AMGEN-JPNSP2024183935$AMGEN$Shimogawa T, Miyamoto Y, Hiyoshi Y, Ouchi M, Kosumi K, Eto K, et al. Intracranial Subdural Empyema During Long-term Chemotherapy for Metastatic Colorectal Cancer: Case Report. in vivo. 2024;38:2557-61$69$YR$E$F$Y$$$20240926$$HP$JP$JP
243344001$24334400$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185254$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243344013$24334401$3$F$20240901$20240920$20240918$20240924$PER$$US-AMGEN-USASP2024186066$AMGEN$$76$YR$E$F$Y$$$20240923$$CN$US$US
243344021$24334402$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184619$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243344041$24334404$1$I$$20240910$20240918$20240918$EXP$$US-AMGEN-USASP2024181910$AMGEN$Song D.; Goldbaum M.; Ginsberg C. et al.. Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis. American Journal of Ophthalmology Case Reports. 2024;36:1-4$57$YR$A$M$Y$$$20240918$$HP$US$US
243344051$24334405$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184818$AMGEN$$53$YR$A$M$Y$$$20240918$$PH$US$US
243344061$24334406$1$I$20240810$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184997$AMGEN$$69$YR$E$F$Y$$$20240918$$CN$US$US
243344071$24334407$1$I$20240905$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185325$AMGEN$$71$YR$E$F$Y$$$20240918$$HP$US$US
243344081$24334408$1$I$20240101$20240912$20240918$20240918$EXP$$MX-AMGEN-MEXSL2024182832$AMGEN$$86$YR$E$F$Y$48$KG$20240918$$MD$MX$MX
243344092$24334409$2$F$20240816$20240924$20240918$20240927$PER$$US-AMGEN-USASP2024185302$AMGEN$$32$YR$A$F$Y$$$20240927$$HP$US$US
243344101$24334410$1$I$20240913$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024183937$AMGEN$$25$YR$A$F$Y$$$20240918$$CN$US$US
243344111$24334411$1$I$20240916$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024186058$AMGEN$$70$YR$E$M$Y$$$20240918$$CN$US$US
243344122$24334412$2$F$20240915$20240925$20240918$20240927$PER$$US-AMGEN-USASP2024184651$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243344141$24334414$1$I$20240912$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024184071$AMGEN$$33$YR$A$F$Y$$$20240918$$CN$US$US
243344151$24334415$1$I$$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024183823$AMGEN$$$$$M$Y$$$20240918$$HP$US$US
243344161$24334416$1$I$20240917$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024186156$AMGEN$$72$YR$E$F$Y$$$20240918$$CN$US$US
243344172$24334417$2$F$20240906$20240912$20240918$20240923$PER$$US-AMGEN-USASP2024183494$AMGEN$$91$YR$E$F$Y$$$20240923$$HP$US$US
243344181$24334418$1$I$$20240911$20240918$20240918$EXP$$US-AMGEN-USASP2024181771$AMGEN$Mundluru J.; Ingawale S.; Dhanjal K. et al.. BTK Inhibitors: A Double-Edged Sword in Richter^s Transformation to Plasmablastic Lymphoma? Case Report. Clinical Lymphoma, Myeloma + Leukemia. 2024;24 (1):S360-S360$57$YR$A$M$Y$$$20240918$$HP$US$US
243344192$24334419$2$F$20240913$20240913$20240918$20240922$PER$$US-AMGEN-USASP2024184045$AMGEN$$74$YR$E$F$Y$$$20240922$$CN$US$US
243344201$24334420$1$I$$20240913$20240918$20240918$PER$$US-ROCHE-10000082874$ROCHE$$$$E$F$Y$$$20240918$$CN$US$US
243344211$24334421$1$I$$20240915$20240918$20240918$EXP$$AU-BAYER-2024A132312$BAYER$$$$$M$Y$$$20240918$$MD$AU$AU
243344231$24334423$1$I$20240101$20240911$20240918$20240918$EXP$$US-SA-2024SA266418$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240918$$MD$US$US
243344242$24334424$2$F$$20240830$20240918$20240927$PER$$US-SA-2024SA266563$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240927$$MD$US$US
243344251$24334425$1$I$$20240909$20240918$20240918$EXP$$GB-INCYTE CORPORATION-2024IN009825$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J e al.. Ruxolitinib versus best available therapy for pv intolerant or resistant to hydroxycarbamide in a randomized trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41(19):3534-44$$$$$Y$$$20240918$$HP$GB$GB
243344261$24334426$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266079$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240918$$MD$US$US
243344271$24334427$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266269$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240918$$MD$US$US
243344281$24334428$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265803$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240918$$CN$US$US
243344291$24334429$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266303$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240918$$HP$US$US
243344301$24334430$1$I$20240701$20240911$20240918$20240918$PER$$US-SA-2024SA266201$SANOFI AVENTIS$$$$A$M$Y$$$20240918$$MD$US$US
243344311$24334431$1$I$20240806$20240911$20240918$20240918$EXP$$NVSC2024US182794$NOVARTIS$$27$YR$$F$Y$$$20240918$$HP$US$US
243344322$24334432$2$F$20240723$20240917$20240918$20240919$PER$$NVSC2024US185648$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
243344341$24334434$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000083857$ROCHE$$$$A$M$Y$$$20240918$$CN$US$US
243344351$24334435$1$I$20240729$20240916$20240918$20240918$PER$$US-ROCHE-10000083664$ROCHE$$58$YR$A$M$Y$$$20240918$$CN$US$US
243344361$24334436$1$I$20240601$20240910$20240918$20240918$EXP$$CO-JNJFOC-20240916345$JOHNSON AND JOHNSON$$35$YR$A$F$Y$52$KG$20240918$$HP$CO$CO
243344371$24334437$1$I$$20240909$20240918$20240918$PER$$US-APOTEX-2024AP010524$APOTEX$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65 (1):33-38$44$YR$$M$Y$$$20240918$$MD$US$US
243344381$24334438$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64094$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243344391$24334439$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64095$$FDA-CTU$$65$YR$$F$N$$$20240918$N$CN$US$
243344401$24334440$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64097$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243344411$24334441$1$I$20230119$20240910$20240918$20240918$EXP$FR-AFSSAPS-PC2024000681$FR-TEVA-VS-3242341$TEVA$$52$YR$$F$Y$83$KG$20240918$$PH$FR$FR
243344421$24334442$1$I$20240908$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64098$$FDA-CTU$$55$YR$$M$N$$$20240917$N$HP$US$
243344431$24334443$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000083735$ROCHE$$$$A$M$Y$$$20240918$$CN$US$US
243344441$24334444$1$I$20240913$20240916$20240918$20240918$PER$$US-ROCHE-10000083739$ROCHE$$7$YR$C$M$Y$$$20240918$$CN$US$US
243344451$24334445$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64099$$FDA-CTU$$46$YR$$F$N$173$LBS$20240918$N$$US$
243344461$24334446$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64104$$FDA-CTU$$61$YR$$F$N$99.34$KG$20240918$N$$US$
243344471$24334447$1$I$20240319$20240918$20240918$20240918$DIR$718901$$FDA-CTU$$62$YR$$M$N$58.95$KG$20240918$Y$CN$US$
243344481$24334448$1$I$$20240904$20240918$20240918$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI08911$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240918$$HP$US$US
243344491$24334449$1$I$$20240911$20240918$20240918$EXP$$PL-EMD Serono-2024049095$EMD SERONO INC$$62$YR$A$M$Y$$$20240918$$MD$PL$PL
243344501$24334450$1$I$20240826$20240911$20240918$20240918$EXP$IT-MINISAL02-1000523$IT-TEVA-VS-3242909$TEVA$$33$YR$$F$Y$$$20240918$$MD$IT$IT
243344511$24334451$1$I$20240901$20240912$20240918$20240918$30DAY$$US-AMGEN-USASP2024183120$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243344521$24334452$1$I$20240414$20240916$20240918$20240918$EXP$FR-AFSSAPS-NT2024001100$FR-SANDOZ INC.-SDZ2024FR080526$SANDOZ$$25$YR$$M$Y$$$20240918$$MD$FR$FR
243344531$24334453$1$I$$20240911$20240918$20240918$EXP$$ES-AMGEN-ESPSP2024183853$AMGEN$Lluch P.; Ballester M. P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240918$$MD$ES$ES
243344541$24334454$1$I$$20240911$20240918$20240918$EXP$$ES-AMGEN-ESPSP2024183854$AMGEN$Lluch P.; Ballester M. P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240918$$MD$ES$ES
243344551$24334455$1$I$$20240911$20240918$20240918$EXP$$JP-AMGEN-JPNSP2024182419$AMGEN$$$$$$Y$$$20240918$$PH$JP$JP
243344571$24334457$1$I$$20240909$20240918$20240918$EXP$$GB-INCYTE CORPORATION-2024IN009826$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J et al.. Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41 (9):3534-45$$$$$Y$$$20240918$$HP$GB$GB
243344581$24334458$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000083776$ROCHE$$$$C$M$Y$$$20240918$$CN$US$US
243344591$24334459$1$I$20240816$20240916$20240918$20240918$EXP$$NVSC2024GB185360$NOVARTIS$$50$YR$$F$Y$$$20240918$$CN$GB$GB
243344601$24334460$1$I$20240906$20240917$20240918$20240918$EXP$GB-MHRA-MED-202409061341022800-GMYCL$NVSC2024GB185662$NOVARTIS$$41$YR$$F$Y$$$20240918$$CN$GB$GB
243344611$24334461$1$I$20240710$20240906$20240918$20240918$EXP$$US-SMPA-2024SPA002567$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243344621$24334462$1$I$20240801$20240906$20240918$20240918$EXP$$US-SMPA-2024SPA002449$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243344631$24334463$1$I$20240903$20240904$20240918$20240918$EXP$$US-SA-2024SA269763$SANOFI AVENTIS$$70$YR$E$F$Y$77.18$KG$20240918$$MD$US$US
243344641$24334464$1$I$$20240906$20240918$20240918$EXP$$US-SMPA-2024SPA002438$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243344651$24334465$1$I$$20240905$20240918$20240918$EXP$$JP-SMPA-2024SPA002630$SUNOVION$$$$$$Y$$$20240918$$PH$JP$JP
243344661$24334466$1$I$$20240907$20240918$20240918$EXP$$US-SMPA-2024SPA002474$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243344671$24334467$1$I$$20240906$20240918$20240918$EXP$$US-SMPA-2024SPA002506$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243344681$24334468$1$I$$20240905$20240918$20240918$EXP$$US-SMPA-2024SPA002433$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243344691$24334469$1$I$20240618$20240906$20240918$20240918$EXP$$US-SMPA-2024SPA002487$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243344701$24334470$1$I$$20240912$20240918$20240918$EXP$IE-JNJFOC-20240250925$IE-TAKEDA-2024TUS091050$TAKEDA$$38$YR$$F$Y$$$20240918$$CN$IE$IE
243344711$24334471$1$I$20231125$20240915$20240918$20240918$EXP$$SA-GSK-SA2023EME181302$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$SA$SA
243344731$24334473$1$I$20240801$20240828$20240918$20240918$PER$$US-SA-2024SA266985$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240918$$CN$US$US
243344741$24334474$1$I$$20240827$20240918$20240918$PER$$US-SA-2024SA267255$SANOFI AVENTIS$$$$A$M$Y$70.295$KG$20240918$$MD$US$US
243344751$24334475$1$I$20240701$20240828$20240918$20240918$PER$$US-SA-2024SA267628$SANOFI AVENTIS$$24$YR$A$F$Y$77.73$KG$20240918$$MD$US$US
243344761$24334476$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266489$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240918$$MD$US$US
243344771$24334477$1$I$$20240823$20240918$20240918$PER$$US-SA-2024SA267525$SANOFI AVENTIS$$$$T$F$Y$47.62$KG$20240918$$MD$US$US
243344781$24334478$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000084412$ROCHE$$$$A$M$Y$$$20240918$$CN$US$US
243344791$24334479$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000083613$ROCHE$$$$C$M$Y$$$20240918$$CN$US$US
243344801$24334480$1$I$$20240909$20240918$20240918$EXP$$GB-INCYTE CORPORATION-2024IN009827$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J et al.. Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41 (9):3534-45$$$$$Y$$$20240918$$HP$GB$GB
243344811$24334481$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000083427$ROCHE$$8$YR$C$M$Y$$$20240918$$HP$US$US
243344821$24334482$1$I$$20240914$20240918$20240918$PER$$US-ROCHE-10000083397$ROCHE$$14$YR$T$M$Y$$$20240918$$HP$US$US
243344831$24334483$1$I$$20240905$20240918$20240918$EXP$GB-MHRA-MED-202409050949464120-WBHYV$HU-SMPA-2024SPA002638$SUNOVION$$$$$$Y$$$20240918$$PH$GB$GB
243344841$24334484$1$I$20240816$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409060528311790-GZSTC$HU-SMPA-2024SPA002633$SUNOVION$$$$$$Y$$$20240918$$CN$GB$GB
243344851$24334485$1$I$20220202$20240909$20240918$20240918$EXP$PL-URPL-DML-MLP.4401.1.1273.2022$PL-Taiho Oncology Inc-2024-008801$TAIHO ONCOLOGY INC$$58$YR$A$F$Y$66$KG$20240918$$MD$PL$PL
243344871$24334487$1$I$$20240909$20240918$20240918$EXP$$US-JNJFOC-20240927611$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240918$$HP$US$US
243344881$24334488$1$I$20240821$20240918$20240918$20240918$DIR$718889$$FDA-CTU$$60$YR$$F$N$91.8$KG$20240918$N$CN$US$
243344891$24334489$1$I$20240915$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185145$AMGEN$$52$YR$A$M$Y$$$20240918$$CN$US$US
243344901$24334490$1$I$$20240911$20240918$20240918$EXP$$ES-AMGEN-ESPSP2024183855$AMGEN$Lluch P.; Ballester M. P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240918$$MD$ES$ES
243344921$24334492$1$I$20240801$20240913$20240918$20240918$EXP$FR-AFSSAPS-TS2024000975$FR-REGENERON PHARMACEUTICALS, INC.-2024-124036$REGENERON$$72$YR$$M$Y$$$20240918$$MD$FR$FR
243344931$24334493$1$I$20240827$20240828$20240918$20240918$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000885$PAREXEL$$$$$$Y$$$20240918$$PH$US$US
243344941$24334494$1$I$$20240912$20240918$20240918$EXP$$NL-MYLANLABS-2024M1083780$MYLAN$$6$YR$$M$Y$$$20240918$$MD$NL$NL
243344951$24334495$1$I$20240501$20240912$20240918$20240918$EXP$FR-AFSSAPS-AVLY2024000144$FR-MYLANLABS-2024M1083901$MYLAN$$30$YR$$F$Y$56$KG$20240918$$MD$FR$FR
243344971$24334497$1$I$20240411$20240912$20240918$20240918$EXP$FR-AFSSAPS-AVMA2024000381$FR-MYLANLABS-2024M1083573$MYLAN$$30$YR$$M$Y$$$20240918$$PH$FR$FR
243344981$24334498$1$I$$20240917$20240918$20240918$PER$$US-ROCHE-3571869$ROCHE$$$$E$F$Y$$$20240918$$MD$US$US
243344991$24334499$1$I$$20240916$20240918$20240918$EXP$$GB-SANDOZ INC.-SDZ2024GB028162$SANDOZ$$$$$F$Y$$$20240918$$CN$GB$GB
243345001$24334500$1$I$20230101$20240912$20240918$20240918$EXP$$CA-ABBVIE-5528052$ABBVIE$$$$$F$Y$$$20240918$$CN$CA$CA
243345011$24334501$1$I$20240810$20240911$20240918$20240918$EXP$$CO-GSK-CO2024AMR107114$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$CN$CO$CO
243345021$24334502$1$I$$20240909$20240918$20240918$EXP$$GB-INCYTE CORPORATION-2024IN009830$INCYTE$Harisson CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J e al... Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.. JOURNAL OF CLINICAL ONCOLOGY.. 2023;41(19):3534-44$$$$$Y$$$20240918$$HP$GB$GB
243345031$24334503$1$I$20240913$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009936$ELI LILLY AND CO$$91$YR$E$F$Y$$$20240918$$CN$US$US
243345042$24334504$2$F$$20240912$20240918$20240921$EXP$$JP-ROCHE-10000080071$ROCHE$$7$DEC$E$F$Y$$$20240921$$MD$JP$JP
243345051$24334505$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010095$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240918$$CN$US$US
243345071$24334507$1$I$$20240910$20240918$20240918$PER$$US-EMD Serono-2024048725$EMD SERONO INC$$60$YR$A$F$Y$$$20240918$$CN$US$US
243345081$24334508$1$I$20240101$20240801$20240918$20240918$PER$$US-KARYOPHARM-2024KPT001386$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240918$$CN$US$US
243345091$24334509$1$I$$20240911$20240918$20240918$EXP$$ES-AMGEN-ESPSP2024183856$AMGEN$Lluch P.; Ballester M. P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240918$$MD$ES$ES
243345101$24334510$1$I$20240826$20240827$20240918$20240918$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000893$PAREXEL$$$$$$Y$$$20240918$$HP$US$US
243345111$24334511$1$I$20240918$20240918$20240918$20240918$DIR$718899$$FDA-CTU$$25$YR$$UNK$N$60.75$KG$20240918$Y$CN$US$
243345131$24334513$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924727$ABBVIE$$$$$F$Y$$$20240918$$HP$US$US
243345141$24334514$1$I$$20240913$20240918$20240918$EXP$$BG-ABBVIE-5926312$ABBVIE$$74$YR$$M$Y$$$20240918$$CN$BG$BG
243345171$24334517$1$I$$20240906$20240918$20240918$PER$$US-009507513-2409USA003112$MERCK$Ueberroth B, Lieu C, Lentz R. Prolonged Response to Dabrafenib/Trametinib in Grade 3 Metastatic Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E Mutation. Journal of Gastrointestinal Cancer2024-09-01 55 (3): 1448-1452. 2024;55 (3):1448-52$87$YR$$M$Y$$$20240918$$HP$US$US
243345181$24334518$1$I$20230801$20240912$20240918$20240918$EXP$FR-AFSSAPS-CF2023000486$FR-MYLANLABS-2024M1083501$MYLAN$$55$YR$$M$Y$102$KG$20240918$$MD$FR$FR
243345191$24334519$1$I$$20240912$20240918$20240918$EXP$$FR-MYLANLABS-2024M1083503$MYLAN$Almeida C, Dubertrand C, Achard A, Cabaret B, Petitcollin A.. Accidental discovery of ketamine poisoning in a 10-month-old infant during hospitalization: contribution of plasma and capillary analyses. Analytical and Clinical Toxicology. 2024;32:43$10$MON$$M$Y$$$20240918$$MD$FR$FR
243345201$24334520$1$I$20240814$20240912$20240918$20240918$EXP$FR-AFSSAPS-AM2024000719$FR-MYLANLABS-2024M1083546$MYLAN$$63$YR$$F$Y$$$20240918$$PH$FR$FR
243345211$24334521$1$I$20210807$20240912$20240918$20240918$EXP$FR-AFSSAPS-PA2024001509$FR-MYLANLABS-2024M1083551$MYLAN$$24$YR$$F$Y$55$KG$20240918$$MD$FR$FR
243345221$24334522$1$I$$20240911$20240918$20240918$EXP$$JP-009507513-2409JPN001761J$MERCK$$85$YR$$M$Y$$$20240918$$MD$JP$JP
243345231$24334523$1$I$$20240917$20240918$20240918$EXP$$US-GILEAD-2024-0688135$GILEAD$$$$E$F$Y$$$20240918$$CN$US$US
243345241$24334524$1$I$20240508$20240531$20240918$20240918$EXP$$DE-SANDOZ INC.-SDZ2024DE053805$SANDOZ$$77$YR$$F$Y$60$KG$20240918$$MD$DE$DE
243345251$24334525$1$I$20240909$20240912$20240918$20240918$EXP$$JP-GENMAB-2024-03310$GENMAB$$6$DEC$$M$Y$$$20240918$$MD$JP$JP
243345261$24334526$1$I$$20240913$20240918$20240918$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005138$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240918$$MD$FR$FR
243345271$24334527$1$I$$20240916$20240918$20240918$EXP$$NL-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005142$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240918$$HP$NL$NL
243345281$24334528$1$I$20240901$20240917$20240918$20240918$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005154$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$IT$IT
243345291$24334529$1$I$20240819$20240910$20240918$20240918$EXP$FR-AFSSAPS-LY2024001350$FR-TEVA-VS-3242354$TEVA$$55$YR$$F$Y$$$20240918$$HP$FR$FR
243345301$24334530$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA267921$SANOFI AVENTIS$$$$C$F$Y$90.703$KG$20240918$$MD$US$US
243345311$24334531$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266645$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240918$$HP$US$US
243345321$24334532$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA266837$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240918$$MD$US$US
243345331$24334533$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266644$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240918$$MD$US$US
243345341$24334534$1$I$20240901$20240911$20240918$20240918$EXP$$US-SA-2024SA269557$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240918$$MD$US$US
243345351$24334535$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266365$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240918$$CN$US$US
243345361$24334536$1$I$20240101$20240823$20240918$20240918$PER$$US-SA-2024SA267180$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240918$$MD$US$US
243345371$24334537$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266420$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240918$$MD$US$US
243345381$24334538$1$I$20240720$20240910$20240918$20240918$EXP$$NVSC2024MY170597$NOVARTIS$$20$YR$$M$Y$$$20240918$$HP$MY$MY
243345391$24334539$1$I$20240915$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185682$AMGEN$$66$YR$E$F$Y$$$20240918$$CN$US$US
243345401$24334540$1$I$$20240912$20240918$20240918$EXP$$TR-AMGEN-TURSP2024184216$AMGEN$Ozyar E.; Ugurluer G.; Dincer N. et al.. Nuclear protein in testis (NUT) midline carcinoma of the larynx: A rare case report of a paediatric patient and literature review. Cancer/Radiotherapie. 2024;28(4):385-389$17$YR$T$M$Y$$$20240918$$HP$TR$TR
243345411$24334541$1$I$20240907$20240912$20240918$20240918$EXP$$JP-GENMAB-2024-03319$GENMAB$$$$$$Y$$$20240918$$MD$JP$JP
243345431$24334543$1$I$20240422$20240910$20240918$20240918$EXP$$GB-TEVA-VS-3242546$TEVA$$72$YR$$M$Y$77$KG$20240918$$PH$GB$GB
243345452$24334545$2$F$20240917$20240918$20240918$20240919$PER$$US-AMGEN-USASP2024185550$AMGEN$$81$YR$E$F$Y$$$20240919$$CN$US$US
243345461$24334546$1$I$$20240911$20240918$20240918$EXP$$NVSC2024IN184245$NOVARTIS$$$$$M$Y$$$20240918$$CN$IN$IN
243345481$24334548$1$I$20240917$20240917$20240918$20240918$PER$$NVSC2024US186320$NOVARTIS$$$$$$Y$$$20240918$$MD$US$US
243345491$24334549$1$I$$20240908$20240918$20240918$PER$$US-TEVA-VS-3243145$TEVA$$52$YR$$F$Y$$$20240918$$CN$US$US
243345501$24334550$1$I$20240426$20240913$20240918$20240918$EXP$$NVSC2024US092938$NOVARTIS$$69$YR$$F$Y$$$20240918$$CN$US$US
243345511$24334551$1$I$20240701$20240709$20240918$20240918$PER$$US-KARYOPHARM-2024KPT001291$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240918$$CN$US$US
243345521$24334552$1$I$$20240910$20240918$20240918$EXP$$JP-GALDERMA-JP2024009189$GALDERMA$$$$$$Y$$$20240918$$MD$JP$JP
243345531$24334553$1$I$20231226$20240911$20240918$20240918$EXP$$JP-GALDERMA-JP2024001707$GALDERMA$$$$$$Y$$$20240918$$MD$JP$JP
243345551$24334555$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266075$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240918$$MD$US$US
243345561$24334556$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266490$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240918$$MD$US$US
243345581$24334558$1$I$20240918$20240918$20240918$20240918$DIR$718837$$FDA-CTU$$33$YR$$F$N$$$20240918$N$CN$US$
243345591$24334559$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64126$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243345601$24334560$1$I$20240911$20240918$20240918$20240918$DIR$718869$$FDA-CTU$$54$YR$$F$N$74.25$KG$20240918$Y$CN$US$
243345631$24334563$1$I$$20240904$20240918$20240918$PER$$US-SMPA-2024SPA002309$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345641$24334564$1$I$$20240821$20240918$20240918$PER$$US-SMPA-2024SPA001743$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345652$24334565$2$F$$20240916$20240918$20240925$PER$$US-SMPA-2024SPA002418$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243345671$24334567$1$I$20240712$20240914$20240918$20240918$EXP$$CN-GSK-CN2024APC114484$GLAXOSMITHKLINE$$$$$$Y$$$20240918$$HP$CN$CN
243345681$24334568$1$I$20240812$20240910$20240918$20240918$EXP$FR-AFSSAPS-PA2024001498$FR-TEVA-VS-3242344$TEVA$$69$YR$$M$Y$64.2$KG$20240918$$MD$FR$FR
243345692$24334569$2$F$$20240916$20240918$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148511$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240919$$CN$US$US
243345701$24334570$1$I$$20240912$20240918$20240918$EXP$$US-BAYER-2024A130994$BAYER$$85$YR$E$M$Y$$$20240918$$CN$US$US
243345711$24334571$1$I$$20240917$20240918$20240918$PER$$NVSC2024US185971$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243345731$24334573$1$I$$20240904$20240918$20240918$PER$$US-SMPA-2024SPA002344$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345741$24334574$1$I$$20240906$20240918$20240918$PER$$US-SMPA-2024SPA002453$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345751$24334575$1$I$$20240913$20240918$20240918$PER$$US-SMPA-2024SPA002780$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345761$24334576$1$I$$20240822$20240918$20240918$PER$$US-SMPA-2024SPA001827$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345771$24334577$1$I$$20240904$20240918$20240918$PER$$US-SMPA-2024SPA002347$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345782$24334578$2$F$$20240905$20240918$20240927$PER$$US-SMPA-2024SPA001815$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243345791$24334579$1$I$$20240903$20240918$20240918$PER$$US-SMPA-2024MYSCI0600083$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345802$24334580$2$F$20240101$20240919$20240918$20240930$PER$$US-SMPA-2024SPA001929$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243345811$24334581$1$I$$20240806$20240918$20240918$PER$$US-SMPA-2024SPA002542$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345831$24334583$1$I$20240823$20240823$20240918$20240918$PER$$US-SMPA-2024SPA001912$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345841$24334584$1$I$20240101$20240820$20240918$20240918$PER$$US-SMPA-2024SPA001719$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345871$24334587$1$I$20240101$20240823$20240918$20240918$PER$$US-SMPA-2024SPA001950$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345892$24334589$2$F$$20240910$20240918$20240930$PER$$US-SMPA-2024SPA001876$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243345901$24334590$1$I$$20240822$20240918$20240918$PER$$US-SMPA-2024SPA001794$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345911$24334591$1$I$$20240821$20240918$20240918$PER$$US-SMPA-2024SPA001776$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345931$24334593$1$I$$20240902$20240918$20240918$PER$$US-SMPA-2024SPA002224$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345941$24334594$1$I$$20240820$20240918$20240918$PER$$US-SMPA-2024SPA001740$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345951$24334595$1$I$$20240822$20240918$20240918$PER$$US-SMPA-2024SPA001787$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345961$24334596$1$I$20240808$20240822$20240918$20240918$PER$$US-SMPA-2024SPA000795$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345971$24334597$1$I$20240101$20240823$20240918$20240918$PER$$US-SMPA-2024SPA001916$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243345981$24334598$1$I$$20240903$20240918$20240918$PER$$US-SMPA-2024SPA002246$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346012$24334601$2$F$$20240905$20240918$20240924$PER$$US-SMPA-2024SPA002365$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243346021$24334602$1$I$$20240820$20240918$20240918$PER$$US-SMPA-2024SPA001745$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346031$24334603$1$I$$20240821$20240918$20240918$PER$$US-SMPA-2024SPA001854$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346041$24334604$1$I$$20240821$20240918$20240918$PER$$US-SMPA-2024SPA001765$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346051$24334605$1$I$$20240822$20240918$20240918$PER$$US-SMPA-2024SPA001859$SUNOVION$$$$$$Y$$$20240918$$HP$US$US
243346061$24334606$1$I$$20240912$20240918$20240918$PER$$US-SMPA-2024SPA002728$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346071$24334607$1$I$$20240904$20240918$20240918$PER$$US-SMPA-2024SPA002291$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346081$24334608$1$I$$20240822$20240918$20240918$PER$$US-SMPA-2024SPA001889$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346091$24334609$1$I$$20240822$20240918$20240918$PER$$US-SMPA-2024SPA001868$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346101$24334610$1$I$$20240821$20240918$20240918$PER$$US-SMPA-2024MYSCI0100536$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346111$24334611$1$I$$20240822$20240918$20240918$PER$$US-SMPA-2024SPA001874$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346121$24334612$1$I$$20240822$20240918$20240918$PER$$US-SMPA-2024SPA001847$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346141$24334614$1$I$$20240820$20240918$20240918$PER$$US-SMPA-2024SPA001708$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346151$24334615$1$I$$20240903$20240918$20240918$PER$$US-SMPA-2024SPA002249$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346161$24334616$1$I$$20240820$20240918$20240918$PER$$US-SMPA-2024SPA000262$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346171$24334617$1$I$$20240821$20240918$20240918$PER$$US-SMPA-2024SPA000791$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346181$24334618$1$I$20240902$20240911$20240918$20240918$PER$$US-SMPA-2024SPA002655$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346191$24334619$1$I$$20240822$20240918$20240918$PER$$US-SMPA-2024SPA001812$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346201$24334620$1$I$$20240821$20240918$20240918$PER$$US-SMPA-2024SPA000180$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346211$24334621$1$I$$20240820$20240918$20240918$PER$$US-SMPA-2024SPA001675$SUNOVION$$$$$$Y$$$20240918$$MD$US$US
243346221$24334622$1$I$$20240904$20240918$20240918$PER$$US-SMPA-2024SPA002307$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346231$24334623$1$I$$20240823$20240918$20240918$PER$$US-SMPA-2024SPA001887$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346241$24334624$1$I$20240808$20240822$20240918$20240918$PER$$US-SMPA-2024SPA001774$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346251$24334625$1$I$$20240904$20240918$20240918$PER$$US-SMPA-2024SPA002359$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346261$24334626$1$I$$20240904$20240918$20240918$PER$$US-SMPA-2024SPA002300$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346272$24334627$2$F$$20240917$20240918$20240924$PER$$US-SMPA-2024MYSCI0400271$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243346281$24334628$1$I$$20240911$20240918$20240918$PER$$US-SMPA-2024SPA002670$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346291$24334629$1$I$$20240902$20240918$20240918$PER$$US-SMPA-2024SPA002226$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346301$24334630$1$I$$20240823$20240918$20240918$PER$$US-SMPA-2024SPA000219$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346311$24334631$1$I$$20240823$20240918$20240918$PER$$US-SMPA-2024SPA000817$SUNOVION$$$$$$Y$$$20240918$$CN$US$US
243346322$24334632$2$F$$20240913$20240918$20240930$PER$$US-SMPA-2024SPA001836$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243346331$24334633$1$I$$20240916$20240918$20240918$EXP$$US-ABBVIE-5927487$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243346341$24334634$1$I$$20240903$20240918$20240918$EXP$$JP-ASTELLAS-2024-AER-004527$ASTELLAS$$9$DEC$E$M$Y$$$20240918$$MD$JP$JP
243346361$24334636$1$I$20240906$20240906$20240918$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202409008825$ELI LILLY AND CO$$$$$$Y$$$20240918$$CN$US$US
243346371$24334637$1$I$20240401$20240916$20240918$20240918$EXP$$PL-ORGANON-O2409POL001187$ORGANON$$84$YR$$F$Y$$$20240918$$CN$PL$PL
243346382$24334638$2$F$$20240920$20240918$20240924$EXP$$TR-SA-2024SA269098$SANOFI AVENTIS$Degerli E.. Docetaxel-induced severe neuropathy, a case of breast cancer with GTSP1 polymorphism. J Oncol Pharm Practice.. 2024;Unknown:1-4$35$YR$A$F$Y$$$20240924$$MD$TR$TR
243346391$24334639$1$I$20240913$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008998$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240918$$CN$US$US
243346401$24334640$1$I$20240825$20240906$20240918$20240918$EXP$FR-AFSSAPS-BR2024000705$FR-ELI_LILLY_AND_COMPANY-FR202409004955$ELI LILLY AND CO$$64$YR$A$F$Y$66$KG$20240918$$CN$FR$FR
243346411$24334641$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266653$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240918$$HP$US$US
243346421$24334642$1$I$20240825$20240826$20240918$20240918$PER$$US-SA-2024SA267137$SANOFI AVENTIS$$49$YR$A$M$Y$93.18$KG$20240918$$MD$US$US
243346431$24334643$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266630$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240918$$MD$US$US
243346441$24334644$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409011088$ELI LILLY AND CO$$92$YR$E$M$Y$$$20240918$$CN$US$US
243346451$24334645$1$I$20220101$20240910$20240918$20240918$PER$$US-SA-2024SA266195$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240918$$HP$US$US
243346461$24334646$1$I$20240101$20240911$20240918$20240918$PER$$US-SA-2024SA265851$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240918$$MD$US$US
243346471$24334647$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266222$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240918$$HP$US$US
243346481$24334648$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA265814$SANOFI AVENTIS$$$$C$F$Y$$$20240918$$MD$US$US
243346491$24334649$1$I$$20240912$20240918$20240918$EXP$$JP-INCYTE CORPORATION-2024IN009823$INCYTE$$$$$$Y$$$20240918$$PH$JP$JP
243346501$24334650$1$I$$20240916$20240918$20240918$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR115196$VIIV$$$$$$Y$$$20240918$$CN$US$US
243346511$24334651$1$I$20240830$20240911$20240918$20240918$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024112961$VIIV$$54$YR$$M$Y$$$20240918$$HP$US$US
243346521$24334652$1$I$20140814$20240917$20240918$20240918$EXP$$DE-SANDOZ INC.-GXKR2014DE004512$SANDOZ$$25$YR$$M$Y$$$20240918$$MD$DE$DE
243346531$24334653$1$I$$20240912$20240918$20240918$EXP$$US-BAYER-2024A131272$BAYER$$65$YR$E$M$Y$$$20240918$$CN$US$US
243346541$24334654$1$I$$20240903$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160283$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243346561$24334656$1$I$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160424$BIOMARIN$Cooney E.,  Ammous Z., Andersson H., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5-years of experience with pegvaliase in US clinics: A case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240918$$MD$US$US
243346571$24334657$1$I$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160421$BIOMARIN$Cooney E.,  Ammous Z., Andersson H., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5-years of experience with pegvaliase in US clinics: A case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240918$$MD$US$US
243346581$24334658$1$I$$20240916$20240918$20240918$PER$$US-HALEON-2197134$Haleon PLC$$$$$$Y$$$20240918$$CN$US$US
243346591$24334659$1$I$20240823$20240916$20240918$20240918$30DAY$$US-SANDOZ INC.-SDZ2024US080738$SANDOZ$$12$YR$$M$Y$$$20240918$$CN$US$US
243346601$24334660$1$I$20211123$20240911$20240918$20240918$EXP$$GB-TEVA-VS-3242661$TEVA$$17$YR$$F$Y$$$20240918$$CN$GB$GB
243346611$24334661$1$I$$20240911$20240918$20240918$EXP$$GB-AMGEN-GBRSP2024181786$AMGEN$Garcia-murillas I.; Cutts R.; Ulrich L. et al.. Association of post-operative ctDNA detection with outcomes of patients with early breast cancers. ESMO Open. 2024;9 (9):1-7$$$$$Y$$$20240918$$HP$GB$GB
243346621$24334662$1$I$20240909$20240913$20240918$20240918$EXP$$GB-MYLANLABS-2024M1083983$MYLAN$$$$$F$Y$$$20240918$$PH$GB$GB
243346631$24334663$1$I$$20240916$20240918$20240918$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024114790$VIIV$$$$$M$Y$77.02$KG$20240918$$HP$US$US
243346641$24334664$1$I$20240815$20240913$20240918$20240918$EXP$GB-MHRA-MED-202409131036107640-YGNJK$GB-MYLANLABS-2024M1083796$MYLAN$$32$YR$$M$Y$$$20240918$$PH$GB$GB
243346651$24334665$1$I$20240801$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147562$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240918$$CN$US$US
243346661$24334666$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148609$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240918$$CN$US$US
243346671$24334667$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148694$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240918$$CN$US$US
243346681$24334668$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148495$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240918$$CN$US$US
243346691$24334669$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148223$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240918$$CN$US$US
243346701$24334670$1$I$$20240909$20240918$20240918$EXP$$US-AMGEN-USASP2024181945$AMGEN$Murakami N.; Liu A.; Nayak L. et al.. Masked Arginine Vasopressin Deficiency in a Kidney Transplant Recipient With Posttransplant Lymphoproliferative Disorder. Kidney international reports. 2024;9 (9):2832-2834$62$YR$A$M$Y$$$20240918$$HP$US$US
243346711$24334671$1$I$$20240911$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145071$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240918$$HP$US$US
243346721$24334672$1$I$$20240913$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148002$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240918$$HP$US$US
243346732$24334673$2$F$20240601$20240919$20240918$20240923$EXP$FR-AFSSAPS-NT2024001146$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-148045$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$65.8$KG$20240923$$PH$FR$FR
243346741$24334674$1$I$20230101$20240910$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148670$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240918$$CN$US$US
243346761$24334676$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148247$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240918$$CN$US$US
243346771$24334677$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147928$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240918$$CN$US$US
243346781$24334678$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148441$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240918$$HP$US$US
243346791$24334679$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148581$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240918$$CN$US$US
243346801$24334680$1$I$20240911$20240913$20240918$20240918$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-147307$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$96.16$KG$20240918$$CN$PR$PR
243346811$24334681$1$I$$20240918$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148668$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240918$$CN$US$US
243346831$24334683$1$I$20240905$20240911$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146347$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240918$$PH$US$US
243346841$24334684$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148132$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240918$$HP$US$US
243346851$24334685$1$I$$20240911$20240918$20240918$EXP$$HK-BRISTOL-MYERS SQUIBB COMPANY-2024-145274$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240918$$MD$HK$HK
243346861$24334686$1$I$$20240913$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147998$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240918$$CN$US$US
243346871$24334687$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148499$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240918$$CN$US$US
243346891$24334689$1$I$20211001$20240916$20240918$20240918$EXP$SE-SEMPA-2024-006728$SE-SANDOZ INC.-SDZ2024SE080928$SANDOZ$$65$YR$$F$Y$$$20240918$$MD$SE$SE
243346901$24334690$1$I$$20240911$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145348$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240918$$PH$US$US
243346911$24334691$1$I$20240818$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147999$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240918$$CN$US$US
243346922$24334692$2$F$20240818$20240906$20240918$20240923$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-143922$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$63$KG$20240923$$CN$CN$CN
243346931$24334693$1$I$$20240912$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146170$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240918$$CN$US$US
243346941$24334694$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147888$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240918$$CN$US$US
243346951$24334695$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148528$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240918$$CN$US$US
243346961$24334696$1$I$$20240911$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145745$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240918$$PH$US$US
243346971$24334697$1$I$20240128$20240909$20240918$20240918$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-145455$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240918$$HP$AU$AU
243346981$24334698$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148490$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240918$$CN$US$US
243347001$24334700$1$I$20240721$20240917$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148738$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240918$$CN$US$US
243347011$24334701$1$I$20240511$20240917$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148602$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240918$$CN$US$US
243347021$24334702$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147282$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$108.86$KG$20240918$$CN$US$US
243347031$24334703$1$I$$20240911$20240918$20240918$EXP$$IL-SAREPTA THERAPEUTICS INC.-SRP2024-005069$SAREPTA THERAPEUTICS$$$$$$Y$$$20240918$$MD$IL$IL
243347041$24334704$1$I$$20240916$20240918$20240918$EXP$$NVSC2024US075821$NOVARTIS$$$$$M$Y$$$20240918$$CN$US$US
243347051$24334705$1$I$$20240906$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009457$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243347061$24334706$1$I$20240912$20240913$20240918$20240918$EXP$$CN-SANDOZ INC.-SDZ2024CN080908$SANDOZ$$77$YR$$F$Y$60$KG$20240918$$HP$CN$CN
243347091$24334709$1$I$20240901$20240917$20240918$20240918$EXP$$US-BAYER-2024A132639$BAYER$$$$$M$Y$$$20240918$$HP$US$US
243347101$24334710$1$I$$20240916$20240918$20240918$PER$$US-BAYER-2024A132910$BAYER$$$$$F$Y$$$20240918$$HP$US$US
243347111$24334711$1$I$$20240912$20240918$20240918$EXP$$AU-AMERICAN REGENT INC-2024003515$AMERICAN REGENT$$48$YR$$F$Y$$$20240918$$CN$AU$AU
243347123$24334712$3$F$$20240920$20240918$20240923$PER$$NVSC2024US185107$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
243347131$24334713$1$I$$20240911$20240918$20240918$EXP$NL-LRB-00999766$NL-TEVA-VS-3243135$TEVA$$67$YR$$F$Y$94$KG$20240918$$CN$NL$NL
243347141$24334714$1$I$$20240916$20240918$20240918$EXP$$NVSC2024US086445$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243347151$24334715$1$I$$20240909$20240918$20240918$EXP$IT-SANDOZ-SDZ2024IT062617$NVSC2024IT185317$NOVARTIS$Nicolai R, Merli P, Moran Alvarez P, Bracaglia C, Del Bufalo F et. al. Autologous CD19- targeting CAR T cells in refractory juvenile dermatomyositis. ARTHRITIS + RHEUMATOLOGY (HOBOKEN, N.J.). 2024$12$YR$$M$Y$$$20240918$$HP$IT$IT
243347161$24334716$1$I$$20240906$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009450$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243347181$24334718$1$I$20240913$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185874$AMGEN$$59$YR$A$M$Y$$$20240918$$CN$US$US
243347191$24334719$1$I$20240601$20240911$20240918$20240918$EXP$$JP-AMGEN-JPNSP2024137889$AMGEN$$$$A$$Y$$$20240918$$MD$JP$JP
243347201$24334720$1$I$20240910$20240918$20240918$20240918$DIR$718873$$FDA-CTU$$61$YR$$F$N$92.25$KG$20240918$N$CN$US$
243347211$24334721$1$I$$20240918$20240918$20240918$PER$$US-BAYER-2024A133400$BAYER$$$$$$Y$$$20240918$$CN$US$US
243347221$24334722$1$I$20240726$20240906$20240918$20240918$EXP$GB-MHRA-MED-202409061111195770-CMFGZ$GB-ELI_LILLY_AND_COMPANY-GB202409004988$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240918$$CN$GB$GB
243347231$24334723$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010677$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243347241$24334724$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010131$ELI LILLY AND CO$$$$$M$Y$$$20240918$$CN$US$US
243347251$24334725$1$I$$20240911$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409007958$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240918$$CN$US$US
243347261$24334726$1$I$20240731$20240814$20240918$20240918$EXP$$US-ELI_LILLY_AND_COMPANY-US202408009186$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240918$$CN$US$US
243347271$24334727$1$I$20240801$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010229$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240918$$CN$US$US
243347281$24334728$1$I$$20240909$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409005310$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240918$$CN$US$US
243347291$24334729$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186377$NOVARTIS$$61$YR$$F$Y$$$20240918$$HP$US$US
243347301$24334730$1$I$$20240917$20240918$20240918$PER$$NVSC2024US185644$NOVARTIS$$$$$F$Y$$$20240918$$HP$US$US
243347311$24334731$1$I$$20240906$20240918$20240918$EXP$$NVSC2024BR185955$NOVARTIS$$$$$$Y$$$20240918$$CN$BR$BR
243347321$24334732$1$I$20240905$20240906$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009494$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243347331$24334733$1$I$$20240910$20240918$20240918$EXP$$TZ-MYLANLABS-2024M1081182$MYLAN$Katale B, Rofael S, Elton L, Mbugi E, Mpagama S, Mtunga D, et. al.. Clinical application of whole-genome sequencing in the management of extensively drug-resistant tuberculosis: a case report. Annals of Clinical Microbiology and Antimicrobials. 2024;23(1):76$32$YR$$M$Y$65$KG$20240918$$MD$TZ$TZ
243347341$24334734$1$I$20240701$20240910$20240918$20240918$PER$$US-INCYTE CORPORATION-2024IN009564$INCYTE$$$$$$Y$$$20240918$$CN$US$US
243347351$24334735$1$I$$20240909$20240918$20240918$EXP$$US-Calliditas-2024CAL01797$CALLIDITAS THERAPEUTICS$$60$YR$A$M$Y$$$20240918$$MD$US$US
243347361$24334736$1$I$20240701$20240910$20240918$20240918$EXP$$BR-BIOGEN-2024BI01282214$BIOGEN$$22$YR$$M$Y$60$KG$20240918$$CN$BR$BR
243347371$24334737$1$I$$20240911$20240918$20240918$EXP$$NVSC2024CA183541$NOVARTIS$$48$YR$$F$Y$$$20240918$$HP$CA$CA
243347381$24334738$1$I$20240624$20240916$20240918$20240918$EXP$$NVSC2024GB185788$NOVARTIS$$$$E$M$Y$$$20240918$$HP$GB$GB
243347391$24334739$1$I$$20240910$20240918$20240918$PER$$NVSC2024US182158$NOVARTIS$$$$$F$Y$$$20240918$$HP$US$US
243347401$24334740$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266668$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240918$$HP$US$US
243347411$24334741$1$I$$20240916$20240918$20240918$PER$$US-HALEON-2197163$Haleon PLC$$$$$$Y$$$20240918$$CN$US$US
243347441$24334744$1$I$$20240917$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148482$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240918$$HP$US$US
243347451$24334745$1$I$20240618$20240912$20240918$20240918$EXP$FR-AFSSAPS-LY2024001343$FR-MYLANLABS-2024M1083565$MYLAN$$80$YR$$F$Y$59$KG$20240918$$PH$FR$FR
243347462$24334746$2$F$$20240916$20240918$20240925$EXP$$AU-MYLANLABS-2024M1084082$MYLAN$$$$$F$Y$$$20240925$$HP$AU$AU
243347471$24334747$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS058763$TAKEDA$$$$$M$Y$$$20240918$$CN$US$US
243347481$24334748$1$I$20240731$20240912$20240918$20240918$EXP$FR-AFSSAPS-PO2024000948$FR-MYLANLABS-2024M1084021$MYLAN$$60$YR$$M$Y$72$KG$20240918$$PH$FR$FR
243347491$24334749$1$I$$20240917$20240918$20240918$EXP$$BR-GILEAD-2024-0688041$GILEAD$$$$$F$Y$$$20240918$$MD$BR$BR
243347501$24334750$1$I$$20240916$20240918$20240918$PER$$US-BAYER-2024A132263$BAYER$$$$$$Y$$$20240918$$CN$US$US
243347511$24334751$1$I$$20240918$20240918$20240918$DIR$718903$$FDA-CTU$$$$$UNK$N$$$20240918$$CN$US$
243347521$24334752$1$I$$20240909$20240918$20240918$EXP$$US-TEVA-VS-3243117$TEVA$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J-Forens-Legal-Med 2024; 101.$69$YR$$$Y$$$20240918$$HP$US$US
243347531$24334753$1$I$$20240913$20240918$20240918$PER$$US-AMGEN-USASP2024184628$AMGEN$$58$YR$A$F$Y$$$20240918$$CN$US$US
243347541$24334754$1$I$$20240911$20240918$20240918$30DAY$$US-PFIZER INC-PV202400108383$PFIZER$$8$YR$$M$Y$$$20240918$$MD$US$US
243347551$24334755$1$I$20230701$20240911$20240918$20240918$EXP$$FR-Ipsen Biopharmaceuticals, Inc.-2024-18183$IPSEN$$10$YR$C$M$Y$25$KG$20240918$$MD$FR$FR
243347561$24334756$1$I$$20240904$20240918$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-013930$JAZZ$$$$$M$Y$$$20240918$$MD$US$US
243347571$24334757$1$I$$20240911$20240918$20240918$EXP$$NVSC2024CA184517$NOVARTIS$$65$YR$$F$Y$$$20240918$$HP$CA$CA
243347581$24334758$1$I$$20240909$20240918$20240918$PER$$US-ABBVIE-5918643$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243347591$24334759$1$I$20240819$20240912$20240918$20240918$EXP$$CN-009507513-2409CHN005559$MERCK$$55$YR$$M$Y$54$KG$20240918$$HP$CN$CN
243347601$24334760$1$I$20240916$20240916$20240918$20240918$EXP$$US-BAYER-2024A133302$BAYER$$90$YR$E$F$Y$65.306$KG$20240918$$CN$US$US
243347611$24334761$1$I$20240812$20240911$20240918$20240918$EXP$FR-AFSSAPS-RN2024000951$FR-TEVA-VS-3242765$TEVA$$85$YR$$F$Y$$$20240918$$MD$FR$FR
243347621$24334762$1$I$20240723$20240724$20240918$20240918$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00777$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$US$US
243347631$24334763$1$I$$20240910$20240918$20240918$EXP$$NVSC2024CA181862$NOVARTIS$$50$YR$$M$Y$$$20240918$$CN$CA$CA
243347641$24334764$1$I$20231001$20240910$20240918$20240918$EXP$$CO-ASTELLAS-2024US010671$ASTELLAS$$67$YR$E$F$Y$38$KG$20240918$$CN$CO$CO
243347661$24334766$1$I$$20240914$20240918$20240918$EXP$$US-GILEAD-2024-0687898$GILEAD$$$$A$F$Y$$$20240918$$PH$US$US
243347671$24334767$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5923991$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243347681$24334768$1$I$20231001$20240912$20240918$20240918$EXP$FR-AFSSAPS-TS2024000962$FR-MYLANLABS-2024M1083621$MYLAN$$72$YR$$F$Y$$$20240918$$MD$FR$FR
243347691$24334769$1$I$20240917$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024186151$AMGEN$$72$YR$E$F$Y$$$20240918$$CN$US$US
243347701$24334770$1$I$$20240913$20240918$20240918$EXP$$US-TAKEDA-2024TUS092115$TAKEDA$$$$$M$Y$$$20240918$$CN$US$US
243347711$24334771$1$I$$20240905$20240918$20240918$PER$$US-Calliditas-2024CAL01922$CALLIDITAS THERAPEUTICS$$36$YR$A$M$Y$$$20240918$$MD$US$US
243347721$24334772$1$I$20240828$20240911$20240918$20240918$PER$$US-SA-2024SA266212$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240918$$HP$US$US
243347731$24334773$1$I$20240101$20240826$20240918$20240918$PER$$US-SA-2024SA266915$SANOFI AVENTIS$$34$YR$A$F$Y$85.91$KG$20240918$$MD$US$US
243347741$24334774$1$I$$20240912$20240918$20240918$PER$$US-ABBVIE-5924189$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243347751$24334775$1$I$20240101$20240916$20240918$20240918$PER$$US-PFIZER INC-PV202400121682$PFIZER$$78$YR$$M$Y$62$KG$20240918$$MD$US$US
243347762$24334776$2$F$$20240917$20240918$20240919$PER$$US-PFIZER INC-202400257585$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243347772$24334777$2$F$20240916$20240920$20240918$20240924$PER$$US-PFIZER INC-PV202400121651$PFIZER$$67$YR$$F$Y$$$20240924$$CN$US$US
243347781$24334778$1$I$$20240917$20240918$20240918$30DAY$$US-SANDOZ INC.-SDZ2024US080985$SANDOZ$$$$$M$Y$$$20240918$$CN$US$US
243347791$24334779$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010720$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240918$$CN$US$US
243347801$24334780$1$I$$20240913$20240918$20240918$EXP$$US-TAKEDA-2019TUS051910$TAKEDA$$$$$F$Y$$$20240918$$HP$US$US
243347811$24334781$1$I$$20240911$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146017$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240918$$MD$US$US
243347821$24334782$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148176$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$84.82$KG$20240918$$CN$US$US
243347831$24334783$1$I$$20240910$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144652$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240918$$CN$US$US
243347841$24334784$1$I$$20240912$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146862$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240918$$HP$US$US
243347851$24334785$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148196$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$78.02$KG$20240918$$CN$US$US
243347861$24334786$1$I$20240903$20240914$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120787$PFIZER$$53$YR$$F$Y$$$20240918$$HP$CN$CN
243347871$24334787$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148764$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240918$$CN$US$US
243347882$24334788$2$F$20230901$20240917$20240918$20240926$PER$$PR-JNJFOC-20240931135$JOHNSON AND JOHNSON$$98$YR$E$M$Y$72$KG$20240926$$CN$PR$PR
243347891$24334789$1$I$$20240914$20240918$20240918$PER$$US-JNJFOC-20240944665$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$HP$US$US
243347901$24334790$1$I$$20240911$20240918$20240918$PER$$US-JNJFOC-20240944582$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240918$$CN$US$US
243347911$24334791$1$I$$20240911$20240918$20240918$EXP$SE-SEMPA-2024-006438$SE-TAKEDA-2024TUS090378$TAKEDA$$43$YR$$M$Y$$$20240918$$HP$SE$SE
243347921$24334792$1$I$$20240904$20240918$20240918$EXP$$CA-HLS-202402223$HLS THERAPEUTICS$$$$E$M$Y$$$20240918$$HP$CA$CA
243347931$24334793$1$I$20240813$20240916$20240918$20240918$EXP$$CA-ROCHE-10000051384$ROCHE$$40$YR$A$M$Y$$$20240918$$CN$CA$CA
243347941$24334794$1$I$$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024186017$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243347951$24334795$1$I$$20240909$20240918$20240918$EXP$$IN-ROCHE-10000077803$ROCHE$$79$YR$E$M$Y$58$KG$20240918$$CN$IN$IN
243347961$24334796$1$I$$20240912$20240918$20240918$EXP$$US-TAKEDA-2024TUS091753$TAKEDA$$$$$F$Y$$$20240918$$CN$US$US
243347971$24334797$1$I$$20240911$20240918$20240918$EXP$$JP-009507513-2409JPN001784J$MERCK$$74$YR$$M$Y$$$20240918$$MD$JP$JP
243347981$24334798$1$I$$20240912$20240918$20240918$EXP$$CH-TAKEDA-2024TUS091633$TAKEDA$$$$A$F$Y$$$20240918$$CN$CH$CH
243347991$24334799$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266617$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240918$$MD$US$US
243348001$24334800$1$I$20240906$20240912$20240918$20240918$EXP$$CA-BAYER-2024A129015$BAYER$$38$YR$A$M$Y$$$20240918$$HP$CA$CA
243348011$24334801$1$I$$20240913$20240918$20240918$EXP$$CZ-BAUSCH-BL-2024-013848$BAUSCH AND LOMB$$$$$F$Y$$$20240918$$MD$CZ$CZ
243348021$24334802$1$I$$20240914$20240918$20240918$EXP$$IE-BAUSCH-BL-2024-013859$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240918$$MD$IE$IE
243348031$24334803$1$I$$20240911$20240918$20240918$EXP$$US-ABBVIE-5923815$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243348041$24334804$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147628$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240918$$CN$US$US
243348051$24334805$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147854$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240918$$CN$US$US
243348061$24334806$1$I$20240917$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148449$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$40.37$KG$20240918$$PH$US$US
243348071$24334807$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148514$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240918$$CN$US$US
243348081$24334808$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148144$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240918$$CN$US$US
243348091$24334809$1$I$20240906$20240909$20240918$20240918$EXP$$US-Calliditas-2024CAL01800$CALLIDITAS THERAPEUTICS$$32$YR$A$M$Y$$$20240918$$CN$US$US
243348101$24334810$1$I$20240913$20240916$20240918$20240918$PER$$US-JNJFOC-20240942113$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240918$$CN$US$US
243348111$24334811$1$I$$20240917$20240918$20240918$PER$$US-JNJFOC-20240945748$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243348121$24334812$1$I$$20240911$20240918$20240918$PER$$US-JNJFOC-20240943678$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240918$$PH$US$US
243348131$24334813$1$I$20240701$20240916$20240918$20240918$PER$$US-JNJFOC-20240942191$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$CN$US$US
243348151$24334815$1$I$$20240909$20240918$20240918$PER$$US-BAUSCH-BL-2024-013711$BAUSCH AND LOMB$$$$$$Y$$$20240918$$CN$US$US
243348161$24334816$1$I$$20240917$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148400$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240918$$CN$US$US
243348171$24334817$1$I$20240101$20240916$20240918$20240918$EXP$$US-BAUSCH-BL-2024-013908$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240918$$CN$US$US
243348182$24334818$2$F$20240914$20240918$20240918$20240920$PER$$US-AMGEN-USASP2024185084$AMGEN$$84$YR$E$M$Y$$$20240919$$CN$US$US
243348191$24334819$1$I$$20240912$20240918$20240918$EXP$FR-AFSSAPS-AVPO2024000178$FR-BAUSCH-BL-2024-013804$BAUSCH AND LOMB$$55$YR$$F$Y$$$20240918$$PH$FR$FR
243348211$24334821$1$I$20230801$20240909$20240918$20240918$EXP$$JP-ROCHE-10000009441$ROCHE$Tanaka K, Azuma K, Azuma Y. Study 23: A case of hepatocellular carcinoma complicated by isolated ACTH deficiency and secondary hypoadrenocorticism as atezolizumab-induced immune-related adverse events (irAEs). The 123rd Kyushu Branch Regular Meeting of the Japanese Society of Gastroenterol. 2024;116.$77$YR$E$M$Y$$$20240918$$MD$JP$JP
243348221$24334822$1$I$20240327$20240909$20240918$20240918$EXP$FR-AFSSAPS-TO2024001638$FR-TEVA-VS-3242013$TEVA$$88$YR$$F$Y$$$20240918$$MD$FR$FR
243348231$24334823$1$I$$20240911$20240918$20240918$EXP$$RO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050765$BOEHRINGER INGELHEIM$$38$YR$A$F$Y$$$20240918$$MD$RO$RO
243348241$24334824$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148123$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$73.03$KG$20240918$$HP$US$US
243348252$24334825$2$F$20240814$20240920$20240918$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148782$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240923$$CN$US$US
243348261$24334826$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148298$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$93.89$KG$20240918$$CN$US$US
243348271$24334827$1$I$20230910$20240912$20240918$20240918$EXP$GB-MHRA-MED-202409092211043050-VNYST$GB-RDY-SPO/GBR/24/0013480$DR REDDYS$$62$YR$A$M$Y$$$20240918$$MD$GB$GB
243348281$24334828$1$I$20180802$20240913$20240918$20240918$EXP$DE-drreddys-GER/GER/18/0102996$DE-RDY-GER/GER/18/0102996$DR REDDYS$$51$YR$A$M$Y$90$KG$20240918$$MD$DE$DE
243348291$24334829$1$I$$20240913$20240918$20240918$EXP$GB-MHRA-MED-202409131511421900-MPKSC$GB-RDY-SPO/GBR/24/0013543$DR REDDYS$$$$$M$Y$$$20240918$$CN$GB$GB
243348301$24334830$1$I$20220101$20240908$20240918$20240918$PER$$KR-Eisai-EC-2024-174186$EISAI$$59$YR$A$F$Y$$$20240918$$HP$KR$KR
243348311$24334831$1$I$20240908$20240910$20240918$20240918$EXP$GB-MHRA-MED-202409102056411630-YPGBV$GB-TEVA-VS-3243211$TEVA$$75$YR$$F$Y$60$KG$20240918$$CN$GB$GB
243348321$24334832$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266619$SANOFI AVENTIS$$$$A$F$Y$$$20240918$$MD$US$US
243348331$24334833$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA266346$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240918$$MD$US$US
243348341$24334834$1$I$$20240806$20240918$20240918$EXP$$ES-GILEAD-2024-0683135$GILEAD$$$$$$Y$$$20240918$$CN$ES$ES
243348351$24334835$1$I$20240901$20240913$20240918$20240918$PER$$US-PHARMING-PHAUS2024000802$PHARMING GROUP$$$$$$Y$$$20240918$$CN$US$US
243348361$24334836$1$I$20240808$20240909$20240918$20240918$EXP$FR-AFSSAPS-TS2024000948$FR-TEVA-VS-3241970$TEVA$$46$YR$$F$Y$58$KG$20240918$$MD$FR$FR
243348371$24334837$1$I$20240901$20240916$20240918$20240918$EXP$$US-KYOWAKIRIN-2024KK021480$KYOWA$$$$$$Y$$$20240918$$HP$US$US
243348381$24334838$1$I$$20240916$20240918$20240918$EXP$$US-TAKEDA-2021TUS075195$TAKEDA$$$$$F$Y$$$20240918$$CN$US$US
243348391$24334839$1$I$$20240913$20240918$20240918$EXP$$CA-ABBVIE-5924429$ABBVIE$$$$A$M$Y$$$20240918$$MD$CA$CA
243348401$24334840$1$I$20240817$20240911$20240918$20240918$EXP$FR-AFSSAPS-PO2024000956$FR-TEVA-VS-3242791$TEVA$$49$YR$$M$Y$$$20240918$$MD$FR$FR
243348411$24334841$1$I$20240910$20240917$20240918$20240918$PER$$US-ROCHE-10000084841$ROCHE$$52$YR$A$F$Y$90.72$KG$20240918$$CN$US$US
243348421$24334842$1$I$20240101$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148149$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240918$$CN$US$US
243348441$24334844$1$I$20240822$20240910$20240918$20240918$EXP$FR-AFSSAPS-PB2024000958$FR-TEVA-VS-3242707$TEVA$$67$YR$$F$Y$$$20240918$$MD$FR$FR
243348451$24334845$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924286$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243348461$24334846$1$I$20240101$20240911$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-146043$BRISTOL MYERS SQUIBB$Kitazawa T, Yamamoto A, Nakayama S, Kawase K, Wakabayashi Y. Disseminated nontuberculous mycobacterium infection during treatment of multiple myeloma: a case report and review of the literature. Internal Medicine. 2024 Sep 04;1-5. doi:10.2169/internalmedicine.4234-24.$74$YR$E$M$Y$$$20240918$$MD$JP$JP
243348471$24334847$1$I$20240826$20240911$20240918$20240918$EXP$FR-AFSSAPS-AN2024001222$FR-TEVA-VS-3242913$TEVA$$74$YR$$M$Y$88$KG$20240918$$MD$FR$FR
243348481$24334848$1$I$$20240909$20240918$20240918$PER$$US-SA-2024SA266283$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240918$$HP$US$US
243348501$24334850$1$I$20240910$20240910$20240918$20240918$PER$$US-JNJFOC-20240927176$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240918$$CN$US$US
243348511$24334851$1$I$20240101$20240911$20240918$20240918$EXP$$US-BIOGEN-2024BI01282422$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
243348522$24334852$2$F$20240913$20240919$20240918$20240920$EXP$$AR-PFIZER INC-202400258894$PFIZER$$86$YR$$M$Y$$$20240920$$CN$AR$AR
243348531$24334853$1$I$$20240910$20240918$20240918$EXP$$NVSC2024CA181668$NOVARTIS$$9$YR$$M$Y$$$20240918$$CN$CA$CA
243348541$24334854$1$I$20240501$20240911$20240918$20240918$EXP$FR-AFSSAPS-SE2024000681$FR-TEVA-VS-3242982$TEVA$$35$YR$$M$Y$$$20240918$$MD$FR$FR
243348551$24334855$1$I$$20240912$20240918$20240918$EXP$$US-PHARMING-PHAUS2024000809$PHARMING GROUP$$$$$$Y$$$20240918$$CN$US$US
243348561$24334856$1$I$20240501$20240912$20240918$20240918$EXP$FR-AFSSAPS-AM2024000707$FR-TEVA-VS-3243226$TEVA$$65$YR$$F$Y$$$20240918$$MD$FR$FR
243348571$24334857$1$I$20200510$20240912$20240918$20240918$EXP$PL-URPL-1-1646-2020$PL-MYLANLABS-2024M1083742$MYLAN$$75$YR$$F$Y$$$20240918$$PH$PL$PL
243348581$24334858$1$I$$20240917$20240918$20240918$EXP$$CA-ABBVIE-5928192$ABBVIE$$40$YR$$F$Y$$$20240918$$CN$CA$CA
243348591$24334859$1$I$20220101$20240912$20240918$20240918$EXP$FR-AFSSAPS-SE2024000694$FR-MYLANLABS-2024M1083832$MYLAN$$56$YR$$M$Y$$$20240918$$MD$FR$FR
243348601$24334860$1$I$$20240912$20240918$20240918$EXP$$DE-MYLANLABS-2024M1083800$MYLAN$$36$YR$$M$Y$$$20240918$$CN$DE$DE
243348612$24334861$2$F$20240911$20240917$20240918$20240924$EXP$$GB-MYLANLABS-2024M1083670$MYLAN$$$$$M$Y$$$20240924$$CN$GB$GB
243348621$24334862$1$I$$20240911$20240918$20240918$EXP$$US-VIIV HEALTHCARE LIMITED-US2024113724$VIIV$$$$$M$Y$$$20240918$$MD$US$US
243348631$24334863$1$I$$20240917$20240918$20240918$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-148184$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240918$$CN$DE$DE
243348641$24334864$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148619$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$66.68$KG$20240918$$CN$US$US
243348651$24334865$1$I$20140101$20240912$20240918$20240918$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-148472$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240918$$CN$CA$CA
243348661$24334866$1$I$$20240913$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147764$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240918$$CN$US$US
243348671$24334867$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148172$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240918$$HP$US$US
243348681$24334868$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148560$BRISTOL MYERS SQUIBB$$40$YR$A$M$Y$$$20240918$$CN$US$US
243348691$24334869$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148138$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$84.82$KG$20240918$$HP$US$US
243348701$24334870$1$I$$20240911$20240918$20240918$PER$$US-RDY-SPO/USA/24/0013435$DR REDDYS$$67$YR$E$F$Y$$$20240918$$HP$US$US
243348711$24334871$1$I$$20240918$20240918$20240918$EXP$$US-GILEAD-2024-0688128$GILEAD$$48$YR$A$M$Y$$$20240918$$HP$US$US
243348721$24334872$1$I$20240804$20240915$20240918$20240918$EXP$EG-EPVC-300267513$EG-PFIZER INC-PV202400121139$PFIZER$$39$YR$$F$Y$$$20240918$$PH$EG$EG
243348731$24334873$1$I$20240818$20240912$20240918$20240918$EXP$FR-AFSSAPS-AN2024001208$FR-TEVA-VS-3243400$TEVA$$34$YR$$F$Y$88$KG$20240918$$MD$FR$FR
243348741$24334874$1$I$20240501$20240913$20240918$20240918$EXP$$CA-ROCHE-10000083335$ROCHE$$43$YR$A$F$Y$$$20240918$$CN$CA$CA
243348751$24334875$1$I$20240706$20240913$20240918$20240918$EXP$ES-AEMPS-1567419$ES-TEVA-VS-3243730$TEVA$$$$A$M$Y$$$20240918$$PH$ES$ES
243348771$24334877$1$I$20240821$20240913$20240918$20240918$EXP$CZ-CZSUKL-24002510$CZ-TEVA-VS-3243723$TEVA$$53$YR$$F$Y$70$KG$20240918$$PH$CZ$CZ
243348781$24334878$1$I$$20240912$20240918$20240918$EXP$GB-MHRA-MED-202409120054073910-CTVMQ$GB-TEVA-VS-3242878$TEVA$$21$YR$$M$Y$84$KG$20240918$$CN$GB$GB
243348791$24334879$1$I$20240722$20240912$20240918$20240918$EXP$FR-AFSSAPS-RN2024000950$FR-TEVA-VS-3243201$TEVA$$52$YR$$M$Y$99$KG$20240918$$MD$FR$FR
243348822$24334882$2$F$20240715$20240924$20240918$20240928$EXP$$DE-ROCHE-10000084371$ROCHE$$28$YR$A$F$Y$100$KG$20240928$$MD$DE$DE
243348832$24334883$2$F$20240917$20240918$20240918$20240919$PER$$US-AMGEN-USASP2024185863$AMGEN$$56$YR$A$M$Y$$$20240919$$HP$US$US
243348841$24334884$1$I$20240101$20240911$20240918$20240918$EXP$$US-BIOGEN-2024BI01282529$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
243348851$24334885$1$I$$20240905$20240918$20240918$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27464$SAMSUNG BIOEPIS$$$$$M$Y$$$20240918$$HP$CA$CA
243348861$24334886$1$I$$20240913$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US044548$SANDOZ$$$$$F$Y$$$20240918$$HP$US$US
243348871$24334887$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148410$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240918$$CN$US$US
243348881$24334888$1$I$$20240917$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148548$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240918$$HP$US$US
243348891$24334889$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148330$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240918$$CN$US$US
243348902$24334890$2$F$$20240928$20240918$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148476$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240930$$HP$US$US
243348911$24334891$1$I$$20240917$20240918$20240918$EXP$$CA-ROCHE-10000084289$ROCHE$$48$YR$A$F$Y$64$KG$20240918$$CN$CA$CA
243348921$24334892$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924692$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243348931$24334893$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5923881$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243348941$24334894$1$I$$20240909$20240918$20240918$EXP$$KR-ROCHE-10000084692$ROCHE$Kim JS. Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case Report. CASE REPORTS IN OPHTHALMOLOGY. 2024;15 (1):196-201. doi:10.1159/000537755$78$YR$E$M$Y$$$20240918$$HP$KR$KR
243348951$24334895$1$I$20240903$20240913$20240918$20240918$EXP$DE-CADRBFARM-2024330333$DE-MYLANLABS-2024M1083883$MYLAN$$43$YR$$M$Y$84$KG$20240918$$MD$DE$DE
243348961$24334896$1$I$$20240916$20240918$20240918$EXP$$US-ABBVIE-5927455$ABBVIE$$$$$F$Y$$$20240918$$HP$US$US
243348971$24334897$1$I$20240901$20240913$20240918$20240918$EXP$IT-MINISAL02-1001567$IT-MYLANLABS-2024M1083933$MYLAN$$76$YR$$F$Y$55$KG$20240918$$MD$IT$IT
243348991$24334899$1$I$20240905$20240913$20240918$20240918$EXP$$US-ABBVIE-5925339$ABBVIE$$62$YR$$M$Y$$$20240918$$CN$US$US
243349001$24334900$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185182$AMGEN$$51$YR$A$F$Y$$$20240918$$MD$US$US
243349012$24334901$2$F$$20240923$20240918$20240926$EXP$$US-BIOGEN-2024BI01282491$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243349021$24334902$1$I$20240903$20240913$20240918$20240918$EXP$$US-ABBVIE-5925104$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243349031$24334903$1$I$$20240905$20240918$20240918$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17886$IPSEN$$$$$F$Y$73.79$KG$20240918$$CN$US$US
243349042$24334904$2$F$20240401$20240913$20240918$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409008536$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$US$US
243349051$24334905$1$I$20240916$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009871$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240918$$CN$US$US
243349061$24334906$1$I$$20240907$20240918$20240918$EXP$GB-MHRA-MED-202409071152372570-RQDWT$GB-ELI_LILLY_AND_COMPANY-GB202409005003$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240918$$CN$GB$GB
243349071$24334907$1$I$20240914$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010094$ELI LILLY AND CO$$62$YR$A$$Y$$$20240918$$CN$US$US
243349081$24334908$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009986$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240918$$CN$US$US
243349101$24334910$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5925507$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243349111$24334911$1$I$20240527$20240911$20240918$20240918$EXP$$NL-BIOGEN-2024BI01282539$BIOGEN$$70$YR$$M$Y$$$20240918$$CN$NL$NL
243349121$24334912$1$I$20240401$20240911$20240918$20240918$PER$$CN-Eisai-EC-2024-174188$EISAI$$66$YR$E$M$Y$58$KG$20240918$$MD$CN$CN
243349131$24334913$1$I$20240801$20240912$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145937$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240918$$HP$US$US
243349142$24334914$2$F$20240913$20240923$20240918$20240925$EXP$GB-MHRA-MED-202409161436243740-DKYJC$GB-009507513-2409GBR005759$MERCK$$76$YR$$M$Y$$$20240925$$HP$GB$GB
243349151$24334915$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147441$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240918$$HP$US$US
243349161$24334916$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000083549$ROCHE$$$$$$Y$$$20240918$$MD$US$US
243349171$24334917$1$I$20240101$20240917$20240918$20240918$EXP$$AU-PFIZER INC-PV202400121735$PFIZER$$84$YR$$M$Y$$$20240918$$PH$AU$AU
243349191$24334919$1$I$20240728$20240913$20240918$20240918$EXP$$FR-PFIZER INC-202400255827$PFIZER$$57$YR$$F$Y$58$KG$20240918$$MD$FR$FR
243349201$24334920$1$I$20240418$20240912$20240918$20240918$EXP$FR-AFSSAPS-AVMA2024000384$FR-MYLANLABS-2024M1083833$MYLAN$$37$YR$$F$Y$$$20240918$$PH$FR$FR
243349211$24334921$1$I$$20240909$20240918$20240918$EXP$$NVSC2024IT180761$NOVARTIS$Piolatto A, Gaglioti CM, Clemente MG, Tesio N, Culcasi M, Matrone A et al.. Deferasirox film-coated tablet-associated ulcerative colitis: An emerging pattern in thalassemia patients?. BRITISH SOCIETY FOR HAEMATOLOGY AND JOHN WILEY + SONS LTD.. 2024;(205):719-21$50$YR$$F$Y$$$20240918$$HP$IT$IT
243349221$24334922$1$I$$20240910$20240918$20240918$EXP$$CA-TAKEDA-2024TUS090717$TAKEDA$$78$YR$$F$Y$93$KG$20240918$$HP$CA$CA
243349231$24334923$1$I$$20240905$20240918$20240918$PER$$US-SA-2024SA265914$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240918$$CN$US$US
243349241$24334924$1$I$$20240916$20240918$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015253$JAZZ$$33$YR$$M$Y$$$20240918$$CN$US$US
243349251$24334925$1$I$$20240910$20240918$20240918$PER$$US-ABBVIE-5919251$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243349261$24334926$1$I$$20240916$20240918$20240918$EXP$$US-TAKEDA-2024TUS092398$TAKEDA$$$$$M$Y$$$20240918$$CN$US$US
243349271$24334927$1$I$20240901$20240913$20240918$20240918$EXP$$US-ABBVIE-5924758$ABBVIE$$61$YR$$M$Y$$$20240918$$CN$US$US
243349281$24334928$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5923962$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243349291$24334929$1$I$20240301$20240913$20240918$20240918$EXP$$JP-009507513-2409JPN002053J$MERCK$$8$DEC$$M$Y$$$20240918$$MD$JP$JP
243349301$24334930$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000083364$ROCHE$$48$YR$A$F$Y$$$20240918$$CN$US$US
243349311$24334931$1$I$20240909$20240909$20240918$20240918$PER$$US-ABBVIE-5918418$ABBVIE$$19$YR$$M$Y$$$20240918$$CN$US$US
243349321$24334932$1$I$$20240909$20240918$20240918$PER$$US-ABBVIE-5919037$ABBVIE$$$$A$$Y$$$20240918$$MD$US$US
243349332$24334933$2$F$20240901$20240918$20240918$20240919$PER$$US-AMGEN-USASP2024186072$AMGEN$$78$YR$E$F$Y$$$20240919$$CN$US$US
243349341$24334934$1$I$20240916$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185093$AMGEN$$27$YR$A$F$Y$$$20240918$$PH$US$US
243349351$24334935$1$I$20240501$20240917$20240918$20240918$EXP$$US-PURDUE PHARMA-USA-2024-0312025$PURDUE$$15$YR$$F$Y$$$20240918$$CN$US$US
243349362$24334936$2$F$20240809$20240918$20240918$20240923$EXP$$ES-PURDUE-USA-2024-0312048$PURDUE$$88$YR$$M$Y$$$20240923$$MD$ES$ES
243349371$24334937$1$I$$20240917$20240918$20240918$EXP$$CA-PURDUE-USA-2024-0312044$PURDUE$$65$YR$$M$Y$$$20240918$$HP$CA$CA
243349381$24334938$1$I$20240805$20240916$20240918$20240918$EXP$$ES-PURDUE-USA-2024-0312032$PURDUE$$88$YR$$F$Y$$$20240918$$MD$ES$ES
243349391$24334939$1$I$20240907$20240911$20240918$20240918$EXP$$US-BIOGEN-2024BI01282020$BIOGEN$$36$YR$$M$Y$$$20240918$$CN$US$US
243349401$24334940$1$I$20240724$20240911$20240918$20240918$EXP$$AR-BIOGEN-2024BI01282370$BIOGEN$$65$YR$$F$Y$$$20240918$$CN$AR$AR
243349411$24334941$1$I$20240910$20240911$20240918$20240918$EXP$GB-MHRA-MED-202409111649186280-GRTYV$GB-BIOGEN-2024BI01282420$BIOGEN$$63$YR$$F$Y$$$20240918$$HP$GB$GB
243349422$24334942$2$F$$20240917$20240918$20240925$EXP$$ID-PURDUE-USA-2024-0312039$PURDUE$Auerkari AN, Sedono R, Pryambodho P.. Severe Neuropathic Back Pain as the Initial Presentation in Angiostrongylus cantonensis Infection: The Role of ICU Management in Overcoming Diagnostic and Analgosedation Challenges.. Archives of Clinical Infectious Diseases. 2024;19(4):e135637$27$YR$$F$Y$$$20240925$$MD$ID$ID
243349431$24334943$1$I$20240101$20240910$20240918$20240918$PER$$US-SA-2024SA268203$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240918$$HP$US$US
243349441$24334944$1$I$$20240909$20240918$20240918$EXP$$US-TEVA-VS-3243148$TEVA$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J-Forens-Legal-Med 2024; 101.$67$YR$$$Y$$$20240918$$HP$US$US
243349462$24334946$2$F$$20240918$20240918$20240925$EXP$$JP-Eisai-EC-2024-174006$EISAI$$79$YR$E$M$Y$$$20240925$$MD$JP$JP
243349471$24334947$1$I$20231005$20240911$20240918$20240918$EXP$$CN-Eisai-EC-2024-174242$EISAI$$57$YR$A$M$Y$83$KG$20240918$$MD$CN$CN
243349481$24334948$1$I$20240910$20240911$20240918$20240918$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051314$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240918$$CN$US$US
243349501$24334950$1$I$$20240912$20240918$20240918$PER$$NVSC2024US184240$NOVARTIS$$28$YR$$$Y$$$20240918$$CN$US$US
243349511$24334951$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147575$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240918$$CN$US$US
243349521$24334952$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148407$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240918$$CN$US$US
243349531$24334953$1$I$$20240909$20240918$20240918$PER$$US-ABBVIE-5928847$ABBVIE$$$$$$Y$$$20240918$$CN$US$US
243349541$24334954$1$I$20240101$20240912$20240918$20240918$EXP$DK-DKMA-30738125$DK-009507513-2409DNK004913$MERCK$$60$YR$$M$Y$90$KG$20240918$$MD$DK$DK
243349551$24334955$1$I$20240910$20240912$20240918$20240918$EXP$$US-SA-2024SA268682$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240918$$MD$US$US
243349571$24334957$1$I$$20240913$20240918$20240918$PER$$US-ROCHE-10000083288$ROCHE$$$$A$F$Y$$$20240918$$CN$US$US
243349581$24334958$1$I$$20240913$20240918$20240918$EXP$$US-ROCHE-10000082945$ROCHE$$55$YR$A$F$Y$81.64$KG$20240918$$CN$US$US
243349591$24334959$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266194$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240918$$HP$US$US
243349601$24334960$1$I$$20240830$20240918$20240918$PER$$US-SA-2024SA268324$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240918$$MD$US$US
243349631$24334963$1$I$$20240917$20240918$20240918$PER$$US-PURDUE PHARMA-USA-2024-0312021$PURDUE$$$$$M$Y$$$20240918$$CN$US$US
243349641$24334964$1$I$$20240917$20240918$20240918$PER$$US-PURDUE PHARMA-USA-2024-0312023$PURDUE$$46$YR$$M$Y$$$20240918$$CN$US$US
243349651$24334965$1$I$20240101$20240906$20240918$20240918$PER$$US-PURDUE-USA-2024-0312042$PURDUE$$$$$F$Y$$$20240918$$CN$US$US
243349671$24334967$1$I$$20240906$20240918$20240918$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17906$IPSEN$$$$$F$Y$$$20240918$$HP$US$US
243349681$24334968$1$I$20230101$20240911$20240918$20240918$PER$$US-JNJFOC-20240931948$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240918$$CN$US$US
243349691$24334969$1$I$$20240913$20240918$20240918$PER$$US-JNJFOC-20240939803$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$MD$US$US
243349701$24334970$1$I$20220101$20240909$20240918$20240918$EXP$$JP-Eisai-EC-2022-108522$EISAI$Fuse S. Considerations based on usage experience of Lenvatinib and Pembrolizumab combination therapy for endometrial cancer. Endometrial cancer treatment meeting.$83$YR$E$F$Y$$$20240918$$MD$JP$JP
243349711$24334971$1$I$20240610$20240906$20240918$20240918$PER$$JP-Eisai-EC-2024-169289$EISAI$$$$E$M$Y$$$20240918$$MD$JP$JP
243349721$24334972$1$I$20240101$20240911$20240918$20240918$PER$$US-AMGEN-USASP2024182079$AMGEN$$46$YR$A$F$Y$$$20240918$$CN$US$US
243349731$24334973$1$I$20240701$20240917$20240918$20240918$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051939$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$$$20240918$$MD$US$US
243349751$24334975$1$I$$20240917$20240918$20240918$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051881$BOEHRINGER INGELHEIM$$$$$$Y$$$20240918$$HP$US$US
243349761$24334976$1$I$$20240909$20240918$20240918$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-144722$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240918$$MD$PL$PL
243349771$24334977$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147710$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240918$$HP$US$US
243349781$24334978$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148437$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240918$$CN$US$US
243349792$24334979$2$F$$20240927$20240918$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148294$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$86.18$KG$20240930$$CN$US$US
243349831$24334983$1$I$20240830$20240910$20240918$20240918$EXP$$US-OTSUKA-2024_025592$OTSUKA$$$$$M$Y$$$20240918$$CN$US$US
243349841$24334984$1$I$$20240912$20240918$20240918$EXP$$GB-BIOGEN-2024BI01281077$BIOGEN$$$$E$F$Y$$$20240918$$CN$GB$GB
243349872$24334987$2$F$$20240906$20240918$20240920$30DAY$$AR-PFIZER INC-202400252751$PFIZER$$11$YR$$F$Y$$$20240920$$CN$AR$AR
243349881$24334988$1$I$$20240911$20240918$20240918$EXP$$NVSC2024CA183294$NOVARTIS$$40$YR$$F$Y$$$20240918$$HP$CA$CA
243349891$24334989$1$I$$20240916$20240918$20240918$PER$$NVSC2024US186296$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243349901$24334990$1$I$$20240911$20240918$20240918$EXP$$NVSC2024US183156$NOVARTIS$$$$$M$Y$90.72$KG$20240918$$CN$US$US
243349911$24334991$1$I$$20240913$20240918$20240918$PER$$NVSC2024US184671$NOVARTIS$$$$$$Y$$$20240918$$CN$US$US
243349921$24334992$1$I$20240101$20240912$20240918$20240918$PER$$JP-Eisai-EC-2024-174324$EISAI$$$$E$F$Y$$$20240918$$MD$JP$JP
243349951$24334995$1$I$20240911$20240912$20240918$20240918$30DAY$$CO-PFIZER INC-PV202400120494$PFIZER$$8$YR$$M$Y$$$20240918$$CN$CO$CO
243349961$24334996$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148342$BRISTOL MYERS SQUIBB$$45$YR$A$M$Y$$$20240918$$CN$US$US
243349981$24334998$1$I$$20240706$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010948$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243349991$24334999$1$I$20240901$20240917$20240918$20240918$PER$$US-PFIZER INC-202400258149$PFIZER$$60$YR$$M$Y$$$20240918$$CN$US$US
243350002$24335000$2$F$$20240917$20240918$20240920$PER$$US-PFIZER INC-202400258303$PFIZER$$83$YR$$M$Y$72.57$KG$20240920$$CN$US$US
243350011$24335001$1$I$20240912$20240916$20240918$20240918$EXP$$US-BAYER-2024A133364$BAYER$$57$YR$A$M$Y$83.9$KG$20240918$$CN$US$US
243350021$24335002$1$I$$20240917$20240918$20240918$PER$$US-PFIZER INC-PV202400121948$PFIZER$$61$YR$$M$Y$$$20240918$$HP$US$US
243350031$24335003$1$I$$20240911$20240918$20240918$PER$$US-Calliditas-2024CAL01821$CALLIDITAS THERAPEUTICS$$30$YR$A$M$Y$$$20240918$$CN$US$US
243350041$24335004$1$I$20240917$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185839$AMGEN$$$$$$Y$$$20240918$$HP$US$US
243350051$24335005$1$I$20220510$20240912$20240918$20240918$PER$$JP-Eisai-EC-2022-114774$EISAI$Iwai K. P-039 Experiences with Lenvatinib + Pembrolizumab Therapy for Endometrial Cancer. Japanese Journal of Gynecologic Oncology. 2024;(42(3)): 364.$80$YR$E$F$Y$$$20240918$$MD$JP$JP
243350061$24335006$1$I$20240101$20240916$20240918$20240918$PER$$US-Eisai-EC-2024-174615$EISAI$$75$YR$E$F$Y$$$20240918$$CN$US$US
243350071$24335007$1$I$20240101$20240909$20240918$20240918$EXP$$RU-BIOGEN-2024BI01264106$BIOGEN$$$$$F$Y$65$KG$20240918$$MD$RU$RU
243350081$24335008$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148280$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240918$$CN$US$US
243350091$24335009$1$I$$20240911$20240918$20240918$EXP$$CA-ROCHE-10000079948$ROCHE$$$$A$F$Y$$$20240918$$CN$CA$CA
243350101$24335010$1$I$$20240910$20240918$20240918$EXP$$IE-ROCHE-10000080745$ROCHE$$$$$F$Y$$$20240918$$CN$IE$IE
243350111$24335011$1$I$20240801$20240912$20240918$20240918$EXP$$JP-009507513-2409JPN001848J$MERCK$$8$DEC$$F$Y$$$20240918$$MD$JP$JP
243350122$24335012$2$F$20240827$20240910$20240918$20240926$EXP$$US-RADIUS HEALTH INC.-2024US007031$RADIUS PHARM$$74$YR$$F$Y$$$20240926$$CN$US$US
243350141$24335014$1$I$$20240906$20240918$20240918$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27450$SAMSUNG BIOEPIS$$77$YR$E$M$Y$$$20240918$$HP$CA$CA
243350151$24335015$1$I$20230701$20240917$20240918$20240918$EXP$$US-ROCHE-10000084869$ROCHE$$51$YR$A$M$Y$113.4$KG$20240918$$CN$US$US
243350161$24335016$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010924$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243350171$24335017$1$I$20240914$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148312$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$73.55$KG$20240918$$PH$US$US
243350181$24335018$1$I$20230101$20240906$20240918$20240918$PER$$US-JNJFOC-20240935126$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240918$$CN$US$US
243350191$24335019$1$I$20240801$20240909$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409005826$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240918$$CN$US$US
243350201$24335020$1$I$$20240911$20240918$20240918$EXP$$CA-JNJFOC-20240934124$JOHNSON AND JOHNSON$$$$$F$Y$$$20240918$$HP$CA$CA
243350212$24335021$2$F$20240801$20240919$20240918$20240921$EXP$$GB-ROCHE-10000079550$ROCHE$$45$YR$A$F$Y$$$20240921$$HP$GB$GB
243350221$24335022$1$I$20240801$20240910$20240918$20240918$PER$$JP-Eisai-EC-2024-174536$EISAI$$$$E$F$Y$$$20240918$$MD$JP$JP
243350231$24335023$1$I$$20240909$20240918$20240918$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-015297$JAZZ$Murasawa R, et.al. A case of infantile leukemia with cytokine storm acute encephalopathy during remission induction therapy. Journal of the Japanese Pediatric Society. 128(8):1065-1070$2$MON$$M$Y$$$20240918$$HP$JP$JP
243350241$24335024$1$I$$20220427$20240918$20240918$PER$$NVSC2022US304853$NOVARTIS$$$$$$Y$$$20240918$$MD$US$US
243350251$24335025$1$I$$20240913$20240918$20240918$EXP$$NVSC2024US184592$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243350261$24335026$1$I$20240917$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185619$AMGEN$$32$YR$A$M$Y$$$20240918$$PH$US$US
243350271$24335027$1$I$$20240915$20240918$20240918$PER$$US-HALEON-2197176$Haleon PLC$$$$$$Y$$$20240918$$CN$US$US
243350281$24335028$1$I$$20240912$20240918$20240918$PER$$US-Calliditas-2024CAL01843$CALLIDITAS THERAPEUTICS$$37$YR$A$M$Y$$$20240918$$CN$US$US
243350291$24335029$1$I$20240101$20240912$20240918$20240918$EXP$$US-ABBVIE-5922689$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243350301$24335030$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186449$NOVARTIS$$$$$$Y$$$20240918$$HP$US$US
243350322$24335032$2$F$$20240917$20240918$20240930$EXP$$JP-INSMED, INC.-2024-03626-JP$INSMED$$78$YR$$M$Y$$$20240930$$HP$JP$JP
243350331$24335033$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148632$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240918$$CN$US$US
243350341$24335034$1$I$20240906$20240906$20240918$20240918$EXP$$US-AMGEN-USASP2024179472$AMGEN$$56$YR$A$M$Y$$$20240918$$HP$US$US
243350351$24335035$1$I$$20240916$20240918$20240918$PER$$US-ROCHE-10000084043$ROCHE$Taleb S, Ji-hyun Lee J, Asanad S, Starkman S, Hamilton S, Gornbein J. Modified Rankin Scale disability status at day 4 poststroke is an informative predictor of long-term day 90 outcome. Journal of Stroke and Cerebrovascular Diseases. 2024;33 (11):1-8. doi:10.1016/j.jstrokecerebrovasdis.2024.107902.$$$$$Y$$$20240918$$MD$US$US
243350362$24335036$2$F$20240825$20240912$20240918$20240920$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900064$RIGEL PHARMACEUTICALS$$57$YR$$M$Y$113.85$KG$20240920$$HP$US$US
243350372$24335037$2$F$$20240917$20240918$20240923$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-27137$SAMSUNG BIOEPIS$$37$YR$A$M$Y$$$20240923$$CN$GB$GB
243350381$24335038$1$I$20240701$20240912$20240918$20240918$EXP$GB-MHRA-MED-202409121840361200-NQMYK$GB-EMD Serono-2024049164$EMD SERONO INC$$$$$F$Y$$$20240918$$MD$GB$GB
243350391$24335039$1$I$20240905$20240913$20240918$20240918$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900070$RIGEL PHARMACEUTICALS$$62$YR$$F$Y$86.636$KG$20240918$$MD$US$US
243350412$24335041$2$F$$20240917$20240918$20240925$PER$$US-Calliditas-2024CAL01834$CALLIDITAS THERAPEUTICS$$30$YR$A$F$Y$$$20240924$$CN$US$US
243350421$24335042$1$I$$20240910$20240918$20240918$EXP$$NVSC2024DE184373$NOVARTIS$$$$$$Y$$$20240918$$MD$DE$DE
243350432$24335043$2$F$$20240911$20240918$20240918$PER$$US-ROCHE-10000082376$ROCHE$Gasimova U, Al-Hakeem H. Severe orolingual angioedema leading to intubation after tenecteplase administration. Gulhane Medical Journal.. Gulhane Medical Journal. 2024;66 (3):152-4. doi:10.4274/gulhane.galenos.2024.81894.$67$YR$E$F$Y$$$20240918$$MD$US$US
243350441$24335044$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148577$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240918$$CN$US$US
243350451$24335045$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148154$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240918$$HP$US$US
243350462$24335046$2$F$$20240917$20240918$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143940$BRISTOL MYERS SQUIBB$Taritsa I, Fay C, Choi S, Allais B, LeBoeuf N. 53412 History does not always repeat itself: nonrecurrence of ICI-induced bullous pemphigoid after restarting anti-pd-1 therapy. Journal of the American Academy of Dermatology. 2024 Sep 01;91(3):AB50.$77$YR$E$M$Y$$$20240920$$HP$US$US
243350471$24335047$1$I$$20240909$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147853$BRISTOL MYERS SQUIBB$Ladwa A, Elghawy O, Kaur V. Single institution experience with immune checkpoint inhibitors in vulvar and vaginal melanomas. Obstetrics and Gynecology International. 2024 Jan 01;1-6.doi:10.1155/2024/7327692.$65$YR$E$F$Y$$$20240918$$HP$US$US
243350481$24335048$1$I$$20240913$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147825$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$59.87$KG$20240918$$CN$US$US
243350491$24335049$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148597$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240918$$CN$US$US
243350501$24335050$1$I$$20240910$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144478$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240918$$CN$US$US
243350511$24335051$1$I$$20240913$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146850$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240918$$CN$US$US
243350521$24335052$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147815$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240918$$CN$US$US
243350532$24335053$2$F$20240901$20240919$20240918$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145143$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240920$$CN$US$US
243350541$24335054$1$I$$20240916$20240918$20240918$EXP$$NVSC2024GB185856$NOVARTIS$$$$$$Y$$$20240918$$MD$GB$GB
243350551$24335055$1$I$20180718$20240909$20240918$20240918$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-148187$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240918$$MD$AU$AU
243350561$24335056$1$I$20240801$20240911$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145112$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240918$$PH$US$US
243350571$24335057$1$I$$20240916$20240918$20240918$EXP$$NVSC2024US185443$NOVARTIS$$$$$F$Y$$$20240918$$HP$US$US
243350591$24335059$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010155$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240918$$CN$US$US
243350601$24335060$1$I$20240913$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010181$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243350611$24335061$1$I$$20240911$20240918$20240918$EXP$$NVSJ2024JP010851$NOVARTIS$$71$YR$$F$Y$$$20240918$$PH$JP$JP
243350622$24335062$2$F$$20240916$20240918$20240923$EXP$$NVSC2024IT179557$NOVARTIS$Fassi E, Amoroso V, Cosentini D, Ferrari V, Lagana M, Berruti A et al.. Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report. FRONTIERS IN ONCOLOGY. 2024;14(:1398055$58$YR$$F$Y$$$20240923$$HP$IT$IT
243350631$24335063$1$I$20240701$20240912$20240918$20240918$PER$$US-Calliditas-2024CAL01589$CALLIDITAS THERAPEUTICS$$73$YR$E$F$Y$58$KG$20240918$$CN$US$US
243350641$24335064$1$I$$20240912$20240918$20240918$PER$$US-JNJFOC-20240933474$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$HP$US$US
243350651$24335065$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148592$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240918$$CN$US$US
243350661$24335066$1$I$20240909$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148208$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$70.31$KG$20240918$$HP$US$US
243350671$24335067$1$I$$20240916$20240918$20240918$EXP$$NVSC2024GB185781$NOVARTIS$$$$E$M$Y$$$20240918$$CN$GB$GB
243350681$24335068$1$I$20240601$20240917$20240918$20240918$PER$$US-ABBVIE-5928055$ABBVIE$$69$YR$$F$Y$$$20240918$$HP$US$US
243350692$24335069$2$F$20240816$20240926$20240918$20240930$EXP$$NVSC2024CH180464$NOVARTIS$$52$YR$$F$Y$104.8$KG$20240930$$MD$CH$CH
243350701$24335070$1$I$20220101$20240913$20240918$20240918$EXP$$DE-009507513-2409DEU005733$MERCK$$28$YR$$F$Y$$$20240918$$MD$DE$DE
243350711$24335071$1$I$$20240906$20240918$20240918$PER$$US-SA-2024SA268755$SANOFI AVENTIS$$56$YR$A$$Y$$$20240918$$HP$US$US
243350722$24335072$2$F$$20240917$20240918$20240919$PER$$NVSC2024US185646$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
243350731$24335073$1$I$$20240917$20240918$20240918$PER$$NVSC2024US185633$NOVARTIS$$$$$F$Y$$$20240918$$HP$US$US
243350741$24335074$1$I$$20240911$20240918$20240918$EXP$$NVSC2024CA183123$NOVARTIS$$42$YR$$M$Y$$$20240918$$HP$CA$CA
243350751$24335075$1$I$$20240916$20240918$20240918$EXP$$NVSC2024US185344$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243350761$24335076$1$I$20240101$20240909$20240918$20240918$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-012617$JAZZ$$65$YR$$M$Y$$$20240918$$HP$JP$JP
243350772$24335077$2$F$20240612$20240919$20240918$20240924$EXP$$JP-PFIZER INC-202400237092$PFIZER$$66$YR$$M$Y$$$20240924$$MD$JP$JP
243350781$24335078$1$I$20240913$20240913$20240918$20240918$EXP$GB-MHRA-MED-202409131907486120-VZYSR$GB-PFIZER INC-202400256331$PFIZER$$$$$$Y$$$20240918$$HP$GB$GB
243350791$24335079$1$I$$20240912$20240918$20240918$EXP$$IT-009507513-2409ITA005015$MERCK$Fabozzi A, Paciucci G, Repaci E, Iacovelli A, Panza L, Migliarini A, et al.. Hemophagocytic lymphohistiocytosis and pulmonary embolism caused by bacillus Calmette-Guerin intravesical installation. Acta Biomed. 2024;95(4:e2024104):1-6$66$YR$$M$Y$$$20240918$$MD$IT$IT
243350801$24335080$1$I$20240819$20240912$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120034$PFIZER$$12$YR$$F$Y$40.8$KG$20240918$$HP$CN$CN
243350811$24335081$1$I$$20240909$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160449$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243350821$24335082$1$I$$20240911$20240918$20240918$EXP$$NVSC2024US183108$NOVARTIS$$$$$F$Y$$$20240918$$CN$US$US
243350831$24335083$1$I$$20240909$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160474$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243350841$24335084$1$I$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160427$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et.al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240918$$MD$US$US
243350851$24335085$1$I$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160425$BIOMARIN$Cooney E.,  Ammous Z., Andersson H., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5-years of experience with pegvaliase in US clinics: A case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240918$$MD$US$US
243350861$24335086$1$I$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160437$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et.al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024$$$$$Y$$$20240918$$MD$US$US
243350871$24335087$1$I$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160428$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et.al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024$$$$$Y$$$20240918$$MD$US$US
243350881$24335088$1$I$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160422$BIOMARIN$Cooney E.,  Ammous Z., Andersson H., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5-years of experience with pegvaliase in US clinics: A case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240918$$MD$US$US
243350892$24335089$2$F$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160423$BIOMARIN$Cooney E.,  Ammous Z., Andersson H., Bender T., Clague G., Clifford M., et al.. Lessons learned from 5-years of experience with pegvaliase in US clinics: A case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240918$$MD$US$US
243350901$24335090$1$I$$20240913$20240918$20240918$PER$$US-Taiho Oncology Inc-2024-007914$TAIHO ONCOLOGY INC$$$$E$F$Y$$$20240918$$CN$US$US
243350911$24335091$1$I$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160426$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et.al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240918$$MD$US$US
243350921$24335092$1$I$$20240913$20240918$20240918$PER$$US-Calliditas-2024CAL01865$CALLIDITAS THERAPEUTICS$$48$YR$A$M$Y$$$20240918$$CN$US$US
243350931$24335093$1$I$$20240916$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160622$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243350941$24335094$1$I$$20240910$20240918$20240918$EXP$$US-BEH-2024178607$CSL BEHRING$$71$YR$E$F$Y$$$20240918$$HP$US$US
243350981$24335098$1$I$$20240916$20240918$20240918$PER$$US-ABBVIE-5928072$ABBVIE$$$$$F$Y$$$20240918$$HP$US$US
243350991$24335099$1$I$20240905$20240905$20240918$20240918$PER$$US-AMGEN-USASP2024178253$AMGEN$$38$YR$A$F$Y$72.562$KG$20240918$$PH$US$US
243351002$24335100$2$F$$20240918$20240918$20240918$PER$$US-GILEAD-2024-0688131$GILEAD$$$$A$M$Y$$$20240918$$HP$US$US
243351011$24335101$1$I$$20240910$20240918$20240918$PER$$US-ABBVIE-5917996$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243351031$24335103$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148296$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240918$$CN$US$US
243351041$24335104$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186514$NOVARTIS$$$$$F$Y$82$KG$20240919$$CN$US$US
243351051$24335105$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009735$ELI LILLY AND CO$$$$$M$Y$$$20240918$$CN$US$US
243351061$24335106$1$I$20240911$20240911$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409007762$ELI LILLY AND CO$$47$YR$A$$Y$$$20240918$$CN$US$US
243351071$24335107$1$I$$20240801$20240918$20240918$EXP$$JP-009507513-2409JPN005067$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$79$YR$$F$Y$$$20240918$$HP$JP$JP
243351081$24335108$1$I$$20240912$20240918$20240918$EXP$$TW-009507513-2409TWN005285$MERCK$$51$YR$$$Y$$$20240918$$MD$TW$TW
243351091$24335109$1$I$$20200311$20240918$20240918$PER$$NVSC2020US371146$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243351101$24335110$1$I$$20240911$20240918$20240918$EXP$$NVSC2024US182784$NOVARTIS$$$$E$F$Y$$$20240919$$HP$US$US
243351111$24335111$1$I$$20240913$20240918$20240918$PER$$NVSC2024US186518$NOVARTIS$$$$$M$Y$$$20240919$$MD$US$US
243351121$24335112$1$I$$20240913$20240918$20240918$PER$$NVSC2024US184346$NOVARTIS$$$$$M$Y$104$KG$20240919$$HP$US$US
243351131$24335113$1$I$$20240918$20240918$20240918$PER$$NVSC2024US186491$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243351141$24335114$1$I$$20210309$20240918$20240918$PER$$NVSC2021US318492$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243351153$24335115$3$F$$20240917$20240918$20240919$PER$$NVSC2024US185608$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
243351161$24335116$1$I$$20240917$20240918$20240918$EXP$$US-TAKEDA-2024TUS092765$TAKEDA$$$$$F$Y$$$20240918$$PH$US$US
243351172$24335117$2$F$$20240918$20240918$20240925$PER$$US-MTPC-MTDA2024-0019555$Unknown Manufacturer$$$$A$F$Y$$$20240925$$CN$US$US
243351181$24335118$1$I$$20240916$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160610$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351191$24335119$1$I$20221010$20240910$20240918$20240918$EXP$$NVSC2023DE044358$NOVARTIS$$$$E$F$Y$$$20240919$$HP$DE$DE
243351201$24335120$1$I$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160429$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et.al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024$$$$$Y$$$20240918$$MD$US$US
243351212$24335121$2$F$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160436$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et.al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024$$$$$Y$$$20240918$$MD$US$US
243351221$24335122$1$I$20240901$20240917$20240918$20240918$PER$$US-JNJFOC-20240944364$JOHNSON AND JOHNSON$$$$$$Y$$$20240918$$HP$US$US
243351231$24335123$1$I$20110712$20240917$20240918$20240918$PER$$NVSC2024US186423$NOVARTIS$$62$YR$$F$Y$$$20240919$$CN$US$US
243351252$24335125$2$F$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160435$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et.al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024;141$$$$$Y$$$20240918$$MD$US$US
243351262$24335126$2$F$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160434$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et.al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024$$$$$Y$$$20240918$$MD$US$US
243351271$24335127$1$I$$20240905$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160394$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351281$24335128$1$I$$20240918$20240918$20240918$PER$$NVSC2024US186489$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243351291$24335129$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186018$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
243351301$24335130$1$I$$20240910$20240918$20240918$PER$$US-BEH-2024178551$CSL BEHRING$$$$A$F$Y$$$20240918$$CN$US$US
243351311$24335131$1$I$$20240916$20240918$20240918$PER$$NVSC2024US186486$NOVARTIS$$$$$F$Y$$$20240919$$MD$US$US
243351321$24335132$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186455$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243351333$24335133$3$F$$20240920$20240918$20240923$PER$$NVSC2024US183719$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243351343$24335134$3$F$$20240924$20240918$20240927$EXP$$NVSC2024PL182980$NOVARTIS$$$$$F$Y$$$20240927$$MD$PL$PL
243351351$24335135$1$I$$20240915$20240918$20240918$EXP$$NVSC2024SE185585$NOVARTIS$$$$$$Y$$$20240919$$MD$SE$SE
243351361$24335136$1$I$20230319$20240906$20240918$20240918$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27548$SAMSUNG BIOEPIS$$39$YR$A$F$Y$$$20240918$$CN$CA$CA
243351371$24335137$1$I$$20240910$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160509$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351381$24335138$1$I$$20240910$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160505$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351391$24335139$1$I$$20240910$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160507$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351401$24335140$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186380$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243351411$24335141$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186382$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
243351421$24335142$1$I$$20240904$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160430$BIOMARIN$Cooney, E., Ammous, Z., Bender, T., Clague, G.E., Clifford, M., et.al.. Lessons learned from 5 years of pegvaliase in US clinics: a case series. Molecular Genetics and Metabolism. 2024$$$$$Y$$$20240918$$MD$US$US
243351431$24335143$1$I$$20240917$20240918$20240918$PER$$NVSC2024US186345$NOVARTIS$$$$$$Y$$$20240919$$MD$US$US
243351442$24335144$2$F$20240830$20240920$20240918$20240927$EXP$$NVSC2024IN184163$NOVARTIS$$56$YR$$M$Y$82.2$KG$20240927$$CN$IN$IN
243351451$24335145$1$I$$20240916$20240918$20240918$PER$$NVSC2024US186256$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
243351471$24335147$1$I$$20240918$20240918$20240918$PER$$NVSC2024US186521$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243351481$24335148$1$I$$20240911$20240918$20240918$EXP$$NVSC2024CA185075$NOVARTIS$$44$YR$$F$Y$$$20240919$$HP$CA$CA
243351491$24335149$1$I$20240916$20240916$20240918$20240918$PER$$US-JNJFOC-20240941579$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$CN$US$US
243351501$24335150$1$I$$20240911$20240918$20240918$EXP$$NVSC2024CO184184$NOVARTIS$$$$$F$Y$$$20240919$$MD$CO$CO
243351512$24335151$2$F$$20240916$20240918$20240927$PER$$US-JNJFOC-20240941269$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$MD$US$US
243351521$24335152$1$I$20240830$20240912$20240918$20240918$EXP$$NVSC2024US181837$NOVARTIS$$48$YR$$F$Y$$$20240919$$CN$US$US
243351531$24335153$1$I$20240903$20240917$20240918$20240918$PER$$NVSC2024US186529$NOVARTIS$$$$$M$Y$$$20240919$$MD$US$US
243351541$24335154$1$I$$20240911$20240918$20240918$PER$$NVSC2024US183529$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243351551$24335155$1$I$$20240913$20240918$20240918$PER$$NVSC2024US184275$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243351561$24335156$1$I$$20240916$20240918$20240918$EXP$$GB-GILEAD-2024-0687785$GILEAD$$$$$M$Y$$$20240918$$MD$GB$GB
243351571$24335157$1$I$$20240918$20240918$20240918$PER$$NVSC2024US186530$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243351581$24335158$1$I$$20240912$20240918$20240918$PER$$US-JNJFOC-20240939283$JOHNSON AND JOHNSON$$$$$M$Y$$$20240918$$HP$US$US
243351591$24335159$1$I$20240914$20240915$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160585$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351601$24335160$1$I$$20240918$20240918$20240918$PER$$NVSC2024US186533$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
243351611$24335161$1$I$$20240916$20240918$20240918$EXP$$NVSC2024US185616$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
243351621$24335162$1$I$$20240918$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409011333$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240918$$CN$US$US
243351631$24335163$1$I$20240701$20240912$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160551$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351642$24335164$2$F$$20240918$20240918$20240923$PER$$US-BIOMARINAP-US-2024-160559$BIOMARIN$$$$$$Y$$$20240923$$CN$US$US
243351651$24335165$1$I$$20240911$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160533$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351661$24335166$1$I$$20240912$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160558$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351671$24335167$1$I$$20240912$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160560$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351681$24335168$1$I$$20240911$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160512$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351691$24335169$1$I$20240911$20240911$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160503$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351701$24335170$1$I$$20240913$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160574$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351711$24335171$1$I$20240606$20240913$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160580$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351721$24335172$1$I$20240905$20240911$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160517$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351731$24335173$1$I$20240830$20240910$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160524$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351741$24335174$1$I$20240830$20240913$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160581$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351761$24335176$1$I$$20240910$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160510$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351771$24335177$1$I$$20240910$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409008827$ELI LILLY AND CO$$10$YR$C$M$Y$$$20240918$$CN$US$US
243351791$24335179$1$I$$20240909$20240918$20240918$EXP$$BE-JNJFOC-20240915988$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$BE$BE
243351801$24335180$1$I$$20240911$20240918$20240918$PER$$US-JNJFOC-20240928410$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$HP$US$US
243351811$24335181$1$I$$20240912$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160563$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351821$24335182$1$I$20240810$20240912$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160573$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351831$24335183$1$I$$20240912$20240918$20240918$PER$$US-BIOMARINAP-US-2024-160561$BIOMARIN$$$$$$Y$$$20240918$$CN$US$US
243351841$24335184$1$I$$20240907$20240918$20240918$PER$$US-ABBVIE-5915387$ABBVIE$$$$A$M$Y$$$20240918$$MD$US$US
243351851$24335185$1$I$20240907$20240909$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409005076$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240918$$CN$US$US
243351861$24335186$1$I$20180101$20240910$20240918$20240918$EXP$$JP-AMGEN-JPNCT2024104226$AMGEN$Saitou Y, Miyate H, Sugai Y, Nakasato H, Miyasawa M. P-1-14 Case series study of medication-related osteonecrosis of the jaw (MRONJ) in the elderly with over 90 years old. The 2nd Annual Meeting of the Young Oral Surgeons Exchange Meeting. 2024;88$$$$$Y$$$20240918$$MD$JP$JP
243351871$24335187$1$I$20230101$20240910$20240918$20240918$PER$$US-BIOGEN-2024BI01282175$BIOGEN$$$$$M$Y$$$20240918$$CN$US$US
243351891$24335189$1$I$20220519$20240910$20240918$20240918$EXP$$JP-AMGEN-JPNCT2024104228$AMGEN$Saitou Y, Miyate H, Sugai Y, Nakasato H, Miyasawa M. P-1-14 Case series study of medication-related osteonecrosis of the jaw (MRONJ) in the elderly with over 90 years old. The 2nd Annual Meeting of the Young Oral Surgeons Exchange Meeting. 2024;88$92$YR$E$F$Y$$$20240918$$MD$JP$JP
243351911$24335191$1$I$20240827$20240827$20240918$20240918$PER$$US-SA-2024SA265842$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240919$$MD$US$US
243351931$24335193$1$I$20240101$20240906$20240918$20240918$PER$$US-ABBVIE-5926292$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243351961$24335196$1$I$$20240829$20240918$20240918$PER$$US-MRZWEB-2024090000026$MERZ$$$$$F$Y$$$20240919$$MD$US$US
243351981$24335198$1$I$$20240829$20240918$20240918$PER$$US-Merz Pharmaceuticals GmbH-2024090000027$MERZ$$$$$F$Y$$$20240919$$MD$US$US
243352001$24335200$1$I$$20240915$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US080369$SANDOZ$$52$YR$$F$Y$$$20240918$$MD$US$US
243352011$24335201$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA266085$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240919$$MD$US$US
243352021$24335202$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA267887$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240919$$CN$US$US
243352031$24335203$1$I$$20240830$20240918$20240918$PER$$US-Merz Pharmaceuticals GmbH-2024090000023$MERZ$$$$$F$Y$$$20240919$$HP$US$US
243352081$24335208$1$I$20240912$20240912$20240918$20240918$EXP$$FR-JNJFOC-20240939534$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$MD$FR$FR
243352091$24335209$1$I$$20240828$20240918$20240918$PER$$US-Merz Pharmaceuticals GmbH-2024090000120$MERZ$$$$$$Y$$$20240919$$HP$US$US
243352101$24335210$1$I$$20240830$20240918$20240918$PER$$US-Merz Pharmaceuticals GmbH-2024090000025$MERZ$$$$$$Y$$$20240919$$MD$US$US
243352111$24335211$1$I$$20240906$20240918$20240918$PER$$US-Merz Pharmaceuticals GmbH-2024090000093$MERZ$$53$YR$$F$Y$$$20240919$$CN$US$US
243352151$24335215$1$I$$20240830$20240918$20240918$PER$$US-Merz Pharmaceuticals GmbH-2024090000024$MERZ$$75$YR$$F$Y$$$20240919$$CN$US$US
243352161$24335216$1$I$$20240829$20240918$20240918$PER$$US-Merz Pharmaceuticals GmbH-2024090000028$MERZ$$$$$$Y$$$20240919$$HP$US$US
243352171$24335217$1$I$$20240821$20240918$20240918$EXP$$DE-TEVA-VS-3237242$TEVA$$46$YR$$M$Y$$$20240918$$CN$DE$DE
243352181$24335218$1$I$20240501$20240912$20240918$20240918$EXP$$NVSJ2024JP010923$NOVARTIS$$$$E$F$Y$$$20240919$$MD$JP$JP
243352191$24335219$1$I$$20240916$20240918$20240918$EXP$AU-MYLANLABS-2024M1072260$AU-SANDOZ INC.-SDZ2024AU080677$SANDOZ$$54$YR$$F$Y$$$20240918$$MD$AU$AU
243352211$24335221$1$I$$20240916$20240918$20240918$EXP$$CA-ORGANON-O2409CAN001180$ORGANON$$52$YR$$M$Y$$$20240918$$HP$CA$CA
243352221$24335222$1$I$$20240910$20240918$20240918$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147384$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240919$$MD$JP$JP
243352231$24335223$1$I$20240701$20240912$20240918$20240918$EXP$$JP-009507513-2409JPN001820J$MERCK$$7$DEC$$M$Y$$$20240918$$MD$JP$JP
243352241$24335224$1$I$$20240821$20240918$20240918$EXP$$IL-TEVA-VS-3236942$TEVA$$50$YR$$F$Y$$$20240918$$HP$IL$IL
243352251$24335225$1$I$$20240905$20240918$20240918$EXP$AU-TGA-808399$AU-Orient Pharma-000265$ORIENT PHARMA$$74$YR$E$M$Y$$$20240918$$HP$AU$AU
243352261$24335226$1$I$20240101$20240909$20240918$20240918$EXP$$US-TEVA-VS-3242852$TEVA$$29$YR$$F$Y$$$20240918$$HP$US$US
243352281$24335228$1$I$$20240912$20240918$20240918$EXP$$JP-JNJFOC-20240946927$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240919$$MD$JP$JP
243352291$24335229$1$I$$20240906$20240918$20240918$EXP$$CA-JNJFOC-20240945811$JOHNSON AND JOHNSON$$$$N$M$Y$$$20240919$$MD$CA$CA
243352303$24335230$3$F$20130101$20240916$20240918$20240923$EXP$$IE-SANDOZ INC.-PHHY2018IE086011$SANDOZ$$87$YR$$M$Y$$$20240923$$MD$IE$IE
243352311$24335231$1$I$20140101$20240916$20240918$20240918$EXP$$DE-SANDOZ INC.-SDZ2024DE080330$SANDOZ$$25$YR$$F$Y$$$20240918$$MD$DE$DE
243352321$24335232$1$I$20240913$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024185338$AMGEN$$56$YR$A$M$Y$$$20240918$$CN$US$US
243352331$24335233$1$I$20240101$20240916$20240918$20240918$EXP$$AU-SANDOZ INC.-SDZ2024AU080650$SANDOZ$$38$YR$$F$Y$$$20240918$$MD$AU$AU
243352341$24335234$1$I$20240101$20240827$20240918$20240918$PER$$US-SA-2024SA267809$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240919$$MD$US$US
243352361$24335236$1$I$20240801$20240911$20240918$20240918$PER$$US-JNJFOC-20240947316$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$HP$US$US
243352381$24335238$1$I$20240801$20240916$20240918$20240918$EXP$FR-AFSSAPS-RN2024001010$FR-SANDOZ INC.-SDZ2024FR080649$SANDOZ$$62$YR$$M$Y$111$KG$20240918$$MD$FR$FR
243352392$24335239$2$F$$20240917$20240918$20240920$EXP$$US-SANDOZ INC.-SDZ2024US080964$SANDOZ$S. Jawad Zafar. Cefazolin-induced hemolytic anemia in septic arthritis: A case report. IDCases. 2024;1:37$50$YR$$F$Y$$$20240920$$HP$US$US
243352401$24335240$1$I$20200101$20240916$20240918$20240918$EXP$$ES-SANDOZ INC.-SDZ2024ES076976$SANDOZ$$61$YR$$M$Y$$$20240918$$HP$ES$ES
243352411$24335241$1$I$20240901$20240910$20240918$20240918$PER$$US-ABBVIE-5917969$ABBVIE$$46$YR$$M$Y$$$20240918$$CN$US$US
243352421$24335242$1$I$$20240912$20240918$20240918$PER$$US-JNJFOC-20240939029$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240919$$CN$US$US
243352441$24335244$1$I$$20240910$20240918$20240918$EXP$$JP-ARGENX-2024-ARGX-JP007593$ARGENX BVBA$$$$$$Y$$$20240918$$MD$JP$JP
243352451$24335245$1$I$$20240915$20240918$20240918$PER$$US-AMGEN-USASP2024184460$AMGEN$$$$$M$Y$$$20240918$$HP$US$US
243352461$24335246$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924038$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243352471$24335247$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924826$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243352481$24335248$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924876$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243352501$24335250$1$I$$20240912$20240918$20240918$PER$$US-ROCHE-10000081746$ROCHE$$84$YR$E$M$Y$$$20240919$$HP$US$US
243352511$24335251$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5924116$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243352521$24335252$1$I$$20240910$20240918$20240918$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27734$SAMSUNG BIOEPIS$$$$$F$Y$$$20240919$$HP$CA$CA
243352531$24335253$1$I$20240820$20240910$20240918$20240918$EXP$$CA-JNJFOC-20240928282$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240919$$HP$CA$CA
243352543$24335254$3$F$20240101$20240919$20240918$20240926$EXP$$US-ABBVIE-5925091$ABBVIE$$$$$F$Y$82.1$KG$20240926$$CN$US$US
243352551$24335255$1$I$$20240916$20240918$20240918$EXP$$CA-ABBVIE-5926657$ABBVIE$$$$E$M$Y$$$20240918$$CN$CA$CA
243352561$24335256$1$I$20240905$20240909$20240918$20240918$PER$$US-ABBVIE-5919322$ABBVIE$$50$YR$$F$Y$$$20240918$$CN$US$US
243352571$24335257$1$I$$20240903$20240918$20240918$PER$$US-SA-2024SA267070$SANOFI AVENTIS$$40$YR$A$$Y$$$20240919$$CN$US$US
243352581$24335258$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA266914$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240919$$MD$US$US
243352601$24335260$1$I$20240915$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010968$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240918$$CN$US$US
243352611$24335261$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009983$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240918$$CN$US$US
243352621$24335262$1$I$$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185893$AMGEN$$$$A$M$Y$$$20240918$$CN$US$US
243352641$24335264$1$I$$20240910$20240918$20240918$PER$$US-JNJFOC-20240927757$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243352651$24335265$1$I$20240101$20240909$20240918$20240918$EXP$$US-JNJFOC-20240941156$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240919$$HP$US$US
243352661$24335266$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5924775$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243352671$24335267$1$I$$20240914$20240918$20240918$EXP$$CN-ROCHE-10000082187$ROCHE$$$$$F$Y$45$KG$20240919$$HP$CN$CN
243352701$24335270$1$I$20240716$20240909$20240918$20240918$PER$$US-BIOGEN-2024BI01281921$BIOGEN$$68$YR$$F$Y$$$20240918$$PH$US$US
243352711$24335271$1$I$$20240913$20240918$20240918$EXP$$NVSJ2024JP010981$NOVARTIS$$$$A$F$Y$$$20240919$$MD$JP$JP
243352721$24335272$1$I$20240915$20240917$20240918$20240918$PER$$US-AMGEN-USASP2024185856$AMGEN$$66$YR$E$F$Y$$$20240918$$CN$US$US
243352731$24335273$1$I$20240601$20240909$20240918$20240918$PER$$US-ABBVIE-5916435$ABBVIE$$66$YR$$F$Y$$$20240918$$CN$US$US
243352741$24335274$1$I$20210101$20240910$20240918$20240918$EXP$$US-ABBVIE-5817410$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243352751$24335275$1$I$20220101$20240911$20240918$20240918$EXP$$US-ABBVIE-5920324$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243352771$24335277$1$I$20240910$20240913$20240918$20240918$EXP$$PK-ROCHE-10000082318$ROCHE$$34$YR$A$F$Y$$$20240919$$CN$PK$PK
243352781$24335278$1$I$20240101$20240910$20240918$20240918$PER$$US-AMGEN-USASP2024182112$AMGEN$$65$YR$E$M$Y$$$20240918$$CN$US$US
243352791$24335279$1$I$20240109$20240814$20240918$20240918$EXP$$CN-UCBSA-2024041575$UCB$$$$N$F$Y$2.5$KG$20240919$$CN$CN$CN
243352801$24335280$1$I$$20240911$20240918$20240918$EXP$$CA-CELLTRION INC.-2024CA021829$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
243352811$24335281$1$I$20240101$20240910$20240918$20240918$EXP$$US-ABBVIE-5901844$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243352821$24335282$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5925049$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243352831$24335283$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA266781$SANOFI AVENTIS$$50$YR$A$F$Y$90.91$KG$20240919$$MD$US$US
243352841$24335284$1$I$20240911$20240911$20240918$20240918$EXP$$US-JNJFOC-20240937307$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240919$$HP$US$US
243352851$24335285$1$I$$20240913$20240918$20240918$EXP$$US-ABBVIE-5925083$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243352861$24335286$1$I$20240901$20240913$20240918$20240918$EXP$$US-ABBVIE-5924100$ABBVIE$$42$YR$$F$Y$$$20240918$$CN$US$US
243352871$24335287$1$I$20240601$20240914$20240918$20240918$EXP$$US-ABBVIE-5829639$ABBVIE$$20$YR$$M$Y$$$20240918$$CN$US$US
243352882$24335288$2$F$$20240912$20240918$20240924$EXP$$JP-JNJFOC-20240946699$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240924$$MD$JP$JP
243352891$24335289$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5923827$ABBVIE$$$$$F$Y$$$20240918$$HP$US$US
243352901$24335290$1$I$20240712$20240911$20240918$20240918$PER$$US-JNJFOC-20240935214$JOHNSON AND JOHNSON$$19$YR$A$M$Y$81.6$KG$20240919$$MD$US$US
243352911$24335291$1$I$20240901$20240913$20240918$20240918$EXP$$AR-TAKEDA-2024TUS092867$TAKEDA$$35$YR$$F$Y$$$20240918$$CN$AR$AR
243352921$24335292$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010074$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240918$$CN$US$US
243352941$24335294$1$I$$20240913$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010411$ELI LILLY AND CO$$$$$F$Y$$$20240918$$HP$US$US
243352951$24335295$1$I$$20240917$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010987$ELI LILLY AND CO$$$$$F$Y$$$20240918$$CN$US$US
243352961$24335296$1$I$20240101$20240916$20240918$20240918$EXP$$CO-ABBVIE-5928031$ABBVIE$$$$$M$Y$70$KG$20240918$$CN$CO$CO
243352981$24335298$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266187$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240919$$MD$US$US
243352991$24335299$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA267091$SANOFI AVENTIS$$19$YR$A$F$Y$73.18$KG$20240919$$MD$US$US
243353001$24335300$1$I$20230601$20240916$20240918$20240918$EXP$$US-ABBVIE-5850501$ABBVIE$$63$YR$$M$Y$$$20240918$$CN$US$US
243353011$24335301$1$I$$20240916$20240918$20240918$EXP$$US-ABBVIE-5926779$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243353021$24335302$1$I$20240820$20240916$20240918$20240918$EXP$$US-ABBVIE-5926441$ABBVIE$$73$YR$$M$Y$$$20240918$$CN$US$US
243353031$24335303$1$I$20240101$20240913$20240918$20240918$EXP$$US-ABBVIE-5923982$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243353041$24335304$1$I$20240823$20240915$20240918$20240918$EXP$$CA-ABBVIE-5927391$ABBVIE$$80$YR$$M$Y$$$20240918$$CN$CA$CA
243353051$24335305$1$I$$20240916$20240918$20240918$EXP$$CA-PFIZER INC-202400258330$PFIZER$$24$YR$$F$Y$$$20240918$$HP$CA$CA
243353061$24335306$1$I$20240827$20240916$20240918$20240918$EXP$$US-PFIZER INC-202400258222$PFIZER$$94$YR$$M$Y$$$20240918$$HP$US$US
243353071$24335307$1$I$$20240913$20240918$20240918$EXP$$US-PFIZER INC-PV202400121429$PFIZER$$39$YR$$F$Y$$$20240918$$CN$US$US
243353081$24335308$1$I$20240101$20240916$20240918$20240918$EXP$$US-ABBVIE-5926334$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243353091$24335309$1$I$20240807$20240914$20240918$20240918$EXP$$CN-PFIZER INC-PV202400120847$PFIZER$$27$YR$$M$Y$72$KG$20240918$$HP$CN$CN
243353101$24335310$1$I$20240911$20240917$20240918$20240918$EXP$$US-ABBVIE-5928417$ABBVIE$$71$YR$$M$Y$$$20240918$$CN$US$US
243353111$24335311$1$I$$20240917$20240918$20240918$30DAY$$US-SANDOZ INC.-SDZ2024US080977$SANDOZ$$$$$M$Y$$$20240918$$CN$US$US
243353121$24335312$1$I$$20240909$20240918$20240918$PER$$US-ABBVIE-5920309$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243353131$24335313$1$I$20240906$20240911$20240918$20240918$EXP$$US-JNJFOC-20240935691$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243353141$24335314$1$I$$20240917$20240918$20240918$EXP$$US-ABBVIE-5928420$ABBVIE$$$$$M$Y$$$20240918$$CN$US$US
243353171$24335317$1$I$$20240917$20240918$20240918$30DAY$$US-SANDOZ INC.-SDZ2024US081022$SANDOZ$$$$$M$Y$$$20240918$$CN$US$US
243353191$24335319$1$I$$20240909$20240918$20240918$EXP$$CA-APOTEX-2024AP010349$APOTEX$$66$YR$$M$Y$$$20240918$$HP$CA$CA
243353201$24335320$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147674$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240919$$HP$US$US
243353211$24335321$1$I$$20240917$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148566$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240919$$CN$US$US
243353221$24335322$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147750$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240919$$HP$US$US
243353231$24335323$1$I$$20240916$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148634$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240919$$CN$US$US
243353251$24335325$1$I$$20240916$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147816$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240919$$CN$US$US
243353261$24335326$1$I$$20240916$20240918$20240918$EXP$$US-ABBVIE-5927364$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243353271$24335327$1$I$20240816$20240913$20240918$20240918$EXP$$CA-JNJFOC-20240937827$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240919$$HP$CA$CA
243353281$24335328$1$I$20240902$20240911$20240918$20240918$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-124256$REGENERON$$92$YR$$M$Y$$$20240919$$CN$CO$CO
243353291$24335329$1$I$$20240910$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144270$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240919$$HP$US$US
243353301$24335330$1$I$20240401$20240916$20240918$20240918$EXP$$US-ABBVIE-5926772$ABBVIE$$66$YR$$M$Y$$$20240918$$CN$US$US
243353312$24335331$2$F$20240101$20240920$20240918$20240925$EXP$$US-ABBVIE-5926488$ABBVIE$$$$$F$Y$112$KG$20240925$$CN$US$US
243353322$24335332$2$F$$20240919$20240918$20240923$PER$$NVSC2024US186613$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243353331$24335333$1$I$$20240918$20240918$20240918$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052170$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240919$$MD$CA$CA
243353341$24335334$1$I$$20240912$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146019$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$90.26$KG$20240919$$CN$US$US
243353352$24335335$2$F$$20240920$20240918$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147196$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240923$$CN$US$US
243353361$24335336$1$I$20240911$20240917$20240918$20240918$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148693$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240919$$PH$US$US
243353371$24335337$1$I$$20240917$20240918$20240918$EXP$$US-ABBVIE-5928660$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243353382$24335338$2$F$$20240826$20240918$20240919$PER$$US-SA-2024SA267182$SANOFI AVENTIS$$$$A$M$Y$82.73$KG$20240919$$MD$US$US
243353391$24335339$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010246$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240918$$CN$US$US
243353401$24335340$1$I$20240916$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010231$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240918$$CN$US$US
243353412$24335341$2$F$20240903$20240919$20240918$20240924$EXP$$US-ABBVIE-5927740$ABBVIE$$73$YR$$M$Y$81.646$KG$20240924$$CN$US$US
243353421$24335342$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010017$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240918$$CN$US$US
243353431$24335343$1$I$$20240912$20240918$20240918$PER$$NVSC2024US183847$NOVARTIS$$$$$M$Y$$$20240919$$HP$US$US
243353441$24335344$1$I$20240711$20240910$20240918$20240918$EXP$$US-JNJFOC-20240935125$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240919$$HP$US$US
243353452$24335345$2$F$$20240921$20240918$20240930$EXP$$GR-JNJFOC-20240946324$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240930$$HP$GR$GR
243353461$24335346$1$I$$20240828$20240918$20240918$PER$$US-SA-2024SA267582$SANOFI AVENTIS$$$$T$F$Y$$$20240919$$MD$US$US
243353472$24335347$2$F$20240101$20240923$20240918$20240927$EXP$$US-ABBVIE-5926421$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243353501$24335350$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266156$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240919$$HP$US$US
243353511$24335351$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA268034$SANOFI AVENTIS$$$$A$M$Y$$$20240919$$MD$US$US
243353521$24335352$1$I$20240828$20240830$20240918$20240918$PER$$US-BEIGENE-BGN-2024-013814$BEIGENE$$$$$$Y$$$20240918$$CN$US$US
243353531$24335353$1$I$$20240916$20240918$20240918$30DAY$$FR-SANDOZ INC.-SDZ2024FR031198$SANDOZ$$$$$M$Y$$$20240918$$HP$FR$FR
243353541$24335354$1$I$20240101$20240916$20240918$20240918$EXP$$US-ABBVIE-5803996$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243353551$24335355$1$I$$20240830$20240918$20240918$PER$$US-SA-2024SA259741$SANOFI AVENTIS$$$$A$M$Y$$$20240919$$MD$US$US
243353561$24335356$1$I$$20240826$20240918$20240918$PER$$US-SA-2024SA267908$SANOFI AVENTIS$$$$A$M$Y$83.9$KG$20240919$$MD$US$US
243353571$24335357$1$I$20240907$20240909$20240918$20240918$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005057$SAREPTA THERAPEUTICS$$4$YR$$M$Y$$$20240919$$HP$US$US
243353582$24335358$2$F$20240101$20240919$20240918$20240923$EXP$$US-ABBVIE-5926667$ABBVIE$$$$$F$Y$60.781$KG$20240923$$CN$US$US
243353591$24335359$1$I$$20240916$20240918$20240918$EXP$$US-ABBVIE-5926789$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243353601$24335360$1$I$$20240916$20240918$20240918$EXP$$IT-SANDOZ INC.-SDZ2024IT080438$SANDOZ$$54$YR$$M$Y$$$20240918$$HP$IT$IT
243353611$24335361$1$I$$20240916$20240918$20240918$PER$$US-JNJFOC-20240940902$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$HP$US$US
243353621$24335362$1$I$20240101$20240910$20240918$20240918$EXP$$ZA-JNJFOC-20240924708$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240919$$MD$ZA$ZA
243353631$24335363$1$I$$20240912$20240918$20240918$EXP$$US-BIOGEN-2024BI01282545$BIOGEN$$$$$M$Y$$$20240918$$MD$US$US
243353641$24335364$1$I$$20240913$20240918$20240918$EXP$$US-BIOGEN-2024BI01282024$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
243353651$24335365$1$I$$20240520$20240918$20240918$EXP$$RU-ROCHE-3568570$ROCHE$$$$$$Y$$$20240919$$MD$RU$RU
243353661$24335366$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409009793$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240918$$CN$US$US
243353671$24335367$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010169$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240918$$CN$US$US
243353681$24335368$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010115$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240918$$CN$US$US
243353691$24335369$1$I$20240901$20240913$20240918$20240918$PER$$US-ABBVIE-5924242$ABBVIE$$49$YR$$F$Y$$$20240918$$HP$US$US
243353701$24335370$1$I$$20240913$20240918$20240918$EXP$$US-SANDOZ INC.-SDZ2024US080446$SANDOZ$$60$YR$$F$Y$$$20240918$$CN$US$US
243353711$24335371$1$I$20240101$20240914$20240918$20240918$EXP$$CN-ABBVIE-5924861$ABBVIE$$47$YR$$F$Y$60$KG$20240918$$MD$CN$CN
243353721$24335372$1$I$$20240910$20240918$20240918$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014843$JAZZ$$$$$F$Y$77$KG$20240918$$CN$US$US
243353731$24335373$1$I$20240801$20240910$20240918$20240918$EXP$$CA-JNJFOC-20240930884$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20240919$$HP$CA$CA
243353751$24335375$1$I$20240511$20240917$20240918$20240918$EXP$$CA-ABBVIE-5928580$ABBVIE$$70$YR$$M$Y$$$20240918$$HP$CA$CA
243353761$24335376$1$I$$20240913$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146812$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240919$$HP$US$US
243353771$24335377$1$I$$20240917$20240918$20240918$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148230$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240919$$CN$US$US
243353782$24335378$2$F$20240101$20240916$20240918$20240921$EXP$$CA-ABBVIE-5926345$ABBVIE$$41$YR$$M$Y$$$20240921$$CN$CA$CA
243353791$24335379$1$I$20240906$20240912$20240918$20240918$EXP$$US-BIOGEN-2024BI01282711$BIOGEN$$48$YR$$F$Y$106.69$KG$20240918$$CN$US$US
243353802$24335380$2$F$20240902$20240916$20240918$20240923$EXP$$US-ABBVIE-5926356$ABBVIE$$71$YR$$F$Y$$$20240923$$CN$US$US
243353811$24335381$1$I$$20240912$20240918$20240918$EXP$$CA-BIOGEN-2024BI01282614$BIOGEN$$$$$F$Y$$$20240918$$CN$CA$CA
243353821$24335382$1$I$$20240911$20240918$20240918$EXP$$US-BIOGEN-2024BI01278566$BIOGEN$$$$$M$Y$$$20240918$$CN$US$US
243353831$24335383$1$I$$20240909$20240918$20240918$EXP$$IE-TEVA-VS-3241830$TEVA$$31$YR$$M$Y$$$20240918$$HP$IE$IE
243353841$24335384$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA267328$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$HP$US$US
243353851$24335385$1$I$$20240911$20240918$20240918$EXP$$DE-ABBVIE-5927405$ABBVIE$$$$A$M$Y$$$20240918$$MD$DE$DE
243353861$24335386$1$I$$20240904$20240918$20240918$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-20950$ALKEM$$27$YR$$F$Y$$$20240918$$MD$DE$DE
243353871$24335387$1$I$$20240904$20240918$20240918$EXP$GB-MHRA-TPP8647950C571455YC1725025248270$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-20941$ALKEM$$55$YR$$F$Y$79$KG$20240918$$MD$GB$GB
243353891$24335389$1$I$19990801$20240904$20240918$20240918$EXP$DE-EMA-DD-20240903-7482831-084148$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-21021$ALKEM$Romagosa, R. et al.. Treatment of psoriasis with 6-thioguanine and hepatic venoocclusive disease. j Am Acad Dermatol. 2002;47(6):970-972$47$YR$$F$Y$$$20240918$$MD$DE$DE
243353911$24335391$1$I$$20240906$20240918$20240918$PER$$US-SA-2024SA268650$SANOFI AVENTIS$$$$$M$Y$$$20240919$$HP$US$US
243353921$24335392$1$I$$20240829$20240918$20240918$PER$$US-SA-2024SA268037$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240919$$CN$US$US
243353931$24335393$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA267322$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240919$$HP$US$US
243353951$24335395$1$I$20160101$20240904$20240918$20240918$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-21042$ALKEM$$80$YR$$F$Y$$$20240918$$CN$DE$DE
243353961$24335396$1$I$$20240916$20240918$20240918$PER$$US-ELI_LILLY_AND_COMPANY-US202409010092$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240918$$CN$US$US
243353981$24335398$1$I$$20240912$20240918$20240918$EXP$$JP-AMGEN-JPNSP2024185605$AMGEN$$58$YR$A$M$Y$$$20240918$$MD$JP$JP
243353991$24335399$1$I$20240904$20240911$20240918$20240918$EXP$$GB-PCCINC-2024-PPL-000675$PIRAMAL$$$$$$Y$$$20240919$$PH$GB$GB
243354001$24335400$1$I$20240101$20240917$20240918$20240918$EXP$$US-ABBVIE-5928330$ABBVIE$$$$$$Y$$$20240918$$HP$US$US
243354021$24335402$1$I$$20240911$20240918$20240918$EXP$$US-BIOGEN-2024BI01281598$BIOGEN$$$$$F$Y$$$20240918$$CN$US$US
243354031$24335403$1$I$$20240911$20240918$20240918$PER$$US-SA-2024SA266170$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240919$$HP$US$US
243354041$24335404$1$I$$20240910$20240918$20240918$PER$$US-SA-2024SA265936$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240919$$MD$US$US
243354051$24335405$1$I$20240101$20240829$20240918$20240918$PER$$US-SA-2024SA268124$SANOFI AVENTIS$$15$YR$T$F$Y$45.351$KG$20240919$$MD$US$US
243354061$24335406$1$I$20240101$20240910$20240918$20240918$EXP$$US-ABBVIE-5774149$ABBVIE$$$$$F$Y$$$20240918$$CN$US$US
243354071$24335407$1$I$20240901$20240912$20240918$20240918$EXP$$CN-ABBVIE-5928955$ABBVIE$$30$YR$$F$Y$$$20240918$$HP$CN$CN
243354081$24335408$1$I$$20240909$20240918$20240918$EXP$$US-JNJFOC-20240924913$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240919$$MD$US$US
243354091$24335409$1$I$20240903$20240912$20240918$20240918$EXP$$US-ABBVIE-5923180$ABBVIE$$35$YR$$M$Y$$$20240918$$CN$US$US
243354111$24335411$1$I$$20240909$20240918$20240918$EXP$$US-GSK-US2024111891$GLAXOSMITHKLINE$$$$$F$Y$$$20240918$$CN$US$US
243354121$24335412$1$I$20240717$20240910$20240918$20240918$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02919$AMNEAL$$27$YR$$F$Y$$$20240919$$MD$US$US
243354132$24335413$2$F$20240909$20240918$20240918$20240925$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000275$DENDREON$$$$$$Y$$$20240925$$HP$US$US
243354141$24335414$1$I$$20240916$20240918$20240918$PER$$US-AMGEN-USASP2024184576$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243354151$24335415$1$I$20240411$20240910$20240918$20240918$EXP$$US-AMGEN-USASL2024138679$AMGEN$$68$YR$E$M$Y$$$20240918$$CN$US$US
243354161$24335416$1$I$20240803$20240912$20240919$20240919$EXP$$CA-BIOGEN-2024BI01282630$BIOGEN$$49$YR$$F$Y$$$20240918$$CN$CA$CA
243354172$24335417$2$F$20240910$20240913$20240919$20240919$EXP$$US-ABBVIE-5927727$ABBVIE$$81$YR$$M$Y$$$20240919$$CN$US$US
243354181$24335418$1$I$20240302$20240916$20240919$20240919$EXP$FR-AFSSAPS-BS2024000624$FR-ORGANON-O2409FRA001097$ORGANON$$54$YR$$M$Y$71$KG$20240918$$MD$FR$FR
243354191$24335419$1$I$20240501$20240614$20240919$20240919$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202406-000714$UNICHEM$$$$$F$Y$$$20240919$$PH$US$
243354201$24335420$1$I$20231001$20231122$20240919$20240919$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202311-001378$UNICHEM$$78$YR$E$F$Y$$$20240919$$CN$US$
243354211$24335421$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266072$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240919$$HP$US$US
243354221$24335422$1$I$$20240912$20240919$20240919$EXP$$IL-GSK-IL2024EME114473$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$IL$IL
243354231$24335423$1$I$20240917$20240917$20240919$20240919$EXP$$AU-ABBVIE-5927614$ABBVIE$$69$YR$$M$Y$$$20240919$$HP$AU$AU
243354241$24335424$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148909$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240919$$CN$US$US
243354251$24335425$1$I$$20240913$20240919$20240919$EXP$$US-ABBVIE-5925454$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243354261$24335426$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5928121$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243354271$24335427$1$I$$20240910$20240919$20240919$PER$$US-LEO Pharma-373487$LEO PHARM$$36$YR$$M$Y$$$20240919$$CN$US$US
243354281$24335428$1$I$$20240913$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US081133$SANDOZ$$$$$$Y$$$20240919$$HP$US$US
243354291$24335429$1$I$$20240911$20240919$20240919$EXP$$US-JNJFOC-20240935314$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240919$$HP$US$US
243354302$24335430$2$F$20240915$20240918$20240919$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409009791$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240920$$CN$US$US
243354311$24335431$1$I$20240101$20240916$20240919$20240919$EXP$$US-ABBVIE-5926959$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243354321$24335432$1$I$20240901$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024183999$AMGEN$$35$YR$A$M$Y$$$20240918$$CN$US$US
243354341$24335434$1$I$$20231023$20240919$20240919$PER$$US-Accord-388020$ACCORD$$$$$$Y$$$20240918$$HP$US$US
243354351$24335435$1$I$$20240419$20240919$20240919$EXP$$US-Accord-421072$ACCORD$$$$$M$Y$$$20240918$$CN$US$US
243354371$24335437$1$I$20240101$20240916$20240919$20240919$EXP$$US-ABBVIE-5927000$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243354381$24335438$1$I$20210521$20240912$20240919$20240919$EXP$$AR-GSK-AR2021AMR108702$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$AR$AR
243354391$24335439$1$I$20240101$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024184989$AMGEN$$39$YR$A$F$Y$$$20240918$$HP$US$US
243354401$24335440$1$I$$20240916$20240919$20240919$EXP$$NVSC2024ZA179901$NOVARTIS$$63$YR$$F$Y$$$20240919$$HP$ZA$ZA
243354411$24335441$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5926393$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243354421$24335442$1$I$$20240913$20240919$20240919$EXP$$US-ABBVIE-5924862$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243354431$24335443$1$I$$20240917$20240919$20240919$PER$$NVSC2024US186352$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243354441$24335444$1$I$$20240909$20240919$20240919$EXP$$CA-ROCHE-10000077096$ROCHE$$67$YR$E$F$Y$$$20240919$$HP$CA$CA
243354451$24335445$1$I$20240725$20240913$20240919$20240919$EXP$$US-TAKEDA-2024TUS064943$TAKEDA$$47$YR$$F$Y$$$20240919$$CN$US$US
243354461$24335446$1$I$$20240906$20240919$20240919$PER$$US-ASTELLAS-2024-AER-005846$ASTELLAS$$50$YR$A$F$Y$$$20240918$$HP$US$US
243354472$24335447$2$F$$20240909$20240919$20240920$EXP$$US-ABBVIE-5929098$ABBVIE$Dawson EF, Pateriya S, Blashinsky ZA, Landa-Galindez A. From Botox Party to Botulism: A Case Report and Public Health Warning on Adulterated Botulinum Toxin Injection. Cureus. 2024;16(8):e68016.$59$YR$$F$Y$$$20240920$$HP$US$US
243354482$24335448$2$F$20240807$20240916$20240919$20240923$EXP$$NVSC2024DE184622$NOVARTIS$$77$YR$$F$Y$62$KG$20240923$$MD$DE$DE
243354491$24335449$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5926351$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243354502$24335450$2$F$$20240909$20240919$20240919$PER$$US-ASTELLAS-2024-AER-006139$ASTELLAS$$$$$F$Y$$$20240919$$HP$US$US
243354511$24335451$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5927060$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243354521$24335452$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA265899$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240919$$MD$US$US
243354531$24335453$1$I$20240729$20240913$20240919$20240919$EXP$$US-ABBVIE-5925017$ABBVIE$$61$YR$$F$Y$$$20240919$$CN$US$US
243354541$24335454$1$I$$20240905$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409004244$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240919$$CN$US$US
243354551$24335455$1$I$20240915$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010040$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240919$$CN$US$US
243354571$24335457$1$I$$20240912$20240919$20240919$EXP$$DE-ABBVIE-5927457$ABBVIE$$$$E$M$Y$$$20240919$$MD$DE$DE
243354591$24335459$1$I$$20240918$20240919$20240919$PER$$NVSC2024US186635$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
243354601$24335460$1$I$$20240910$20240919$20240919$PER$$NVSC2024US184741$NOVARTIS$$$$$M$Y$$$20240919$$HP$US$US
243354631$24335463$1$I$$20240916$20240919$20240919$PER$$NVSC2024US186260$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
243354641$24335464$1$I$20240915$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185900$AMGEN$$72$YR$E$M$Y$$$20240918$$CN$US$US
243354661$24335466$1$I$$20240910$20240919$20240919$EXP$$CA-JNJFOC-20240533798$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$HP$CA$CA
243354672$24335467$2$F$$20240920$20240919$20240924$PER$$US-JNJFOC-20240939767$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243354681$24335468$1$I$20240811$20240916$20240919$20240919$EXP$DE-BFARM-24006421$DE-ORGANON-O2409DEU001156$ORGANON$$33$YR$$F$Y$$$20240919$$MD$DE$DE
243354691$24335469$1$I$20240201$20240918$20240919$20240919$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052180$BOEHRINGER INGELHEIM$$$$$$Y$$$20240919$$MD$JP$JP
243354701$24335470$1$I$$20240913$20240919$20240919$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP012026$STRIDES$Gunes EC, Tekgoz E, Colak S, Ustunel G, Cinar M, Yilmaz S.. THE MORTALITY OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASE: RESULTS OF LONG-TERM FOLLOW-UP.. Eur-J-Case-Rep-Intern-Med. 2024;11 (Suppl. 1):1074 abstr. 2753$61$YR$$M$Y$$$20240919$$HP$TR$TR
243354711$24335471$1$I$$20240710$20240919$20240919$PER$$US-ROCHE-10000023997$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243354721$24335472$1$I$20240910$20240911$20240919$20240919$EXP$$US-ABBVIE-5922686$ABBVIE$$69$YR$$F$Y$$$20240919$$CN$US$US
243354731$24335473$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186350$AMGEN$$$$$$Y$$$20240918$$MD$US$US
243354741$24335474$1$I$$20240916$20240919$20240919$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015341$JAZZ$$$$$M$Y$$$20240918$$CN$US$US
243354761$24335476$1$I$$20240913$20240919$20240919$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP011991$STRIDES$Lee S, Kim G, Park G-M, Jeong J, Jung E, Lee BS, et al.. Management of newborns and healthcare workers exposed to isoniazid-resistant congenital tuberculosis in the neonatal intensive care unit.. J-Hosp-Infect. 2024;147:40-46$$$$M$Y$$$20240919$$HP$KR$KR
243354772$24335477$2$F$20240626$20240920$20240919$20240926$EXP$$US-ABBVIE-5926886$ABBVIE$$77$YR$$M$Y$99.79$KG$20240926$$CN$US$US
243354781$24335478$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5926960$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243354801$24335480$1$I$$20240912$20240919$20240919$EXP$$US-ABBVIE-5925597$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243354811$24335481$1$I$$20240910$20240919$20240919$EXP$IT-MYLANLABS-2024M1079243$IT-ROCHE-10000078125$ROCHE$Conti EA, Chironi F, Petaccia A, Lanni S, Minoia F, Filocamo G. Safety and efficacy of concomitant use of anti IL17 and anti IL6 agents in a case of severe refractory systemic JIA: Report of the first 18 months of treatment. Pediatr-Rheumatol 2023; 21 (Suppl.).$$$$F$Y$$$20240919$$HP$IT$IT
243354821$24335482$1$I$$20240909$20240919$20240919$EXP$$CA-STRIDES ARCOLAB LIMITED-2024SP011800$STRIDES$Neves Briard J, Duquette A, Cayrol R, Lapalme-Remis S.. Refractory Status Epilepticus in a Patient With Aducanumab-Induced Amyloid-Related Imaging Abnormalities.. Neurology. 2024;103 (5)$75$YR$$F$Y$$$20240919$$MD$CA$CA
243354831$24335483$1$I$$20240910$20240919$20240919$EXP$TR-MLMSERVICE-20240903-PI180877-00232-1$TR-STRIDES ARCOLAB LIMITED-2024SP011879$STRIDES$Sabanci M, Tasdemir M, Oksuz B, Altuner Torun Y, Sutcu M, Ozkaya O.. Managing recurrent parvovirus B19-associated anemia after a pediatric kidney transplant.. Pediatric Nephrology. 2024;39:2923-2925$13$YR$$F$Y$40$KG$20240919$$MD$TR$TR
243354841$24335484$1$I$$20240916$20240919$20240919$EXP$GB-MHRA-MED-202409131322524410-MCGDB$GB-STRIDES ARCOLAB LIMITED-2024SP012042$STRIDES$$$$$$Y$$$20240919$$PH$GB$GB
243354851$24335485$1$I$$20240910$20240919$20240919$EXP$FR-MLMSERVICE-20240821-PI165802-00129-11$FR-STRIDES ARCOLAB LIMITED-2024SP011895$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic?.. J-Eur-Acad-Dermatol-Venereol. 2024$31$YR$$M$Y$$$20240919$$HP$FR$FR
243354862$24335486$2$F$20240101$20240912$20240919$20240920$EXP$$US-ABBVIE-5926691$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243354872$24335487$2$F$20190601$20240924$20240919$20240928$EXP$$US-ABBVIE-5918800$ABBVIE$$68$YR$$M$Y$95.254$KG$20240928$$CN$US$US
243354881$24335488$1$I$$20240910$20240919$20240919$EXP$FR-MLMSERVICE-20240821-PI165802-00129-12$FR-STRIDES ARCOLAB LIMITED-2024SP011896$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic?.. J-Eur-Acad-Dermatol-Venereol. 2024$49$YR$$M$Y$$$20240919$$HP$FR$FR
243354891$24335489$1$I$$20240916$20240919$20240919$EXP$GB-MHRA-MED-202409131649417600-DFGJR$GB-STRIDES ARCOLAB LIMITED-2024SP012044$STRIDES$$$$$$Y$$$20240919$$PH$GB$GB
243354901$24335490$1$I$20240101$20240913$20240919$20240919$EXP$$GB-ABBVIE-5925424$ABBVIE$$67$YR$$M$Y$$$20240919$$CN$GB$GB
243354911$24335491$1$I$20240801$20240829$20240919$20240919$PER$$US-SA-2024SA268221$SANOFI AVENTIS$$38$YR$A$F$Y$104.55$KG$20240919$$MD$US$US
243354921$24335492$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA265932$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240919$$MD$US$US
243354931$24335493$1$I$20240916$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185678$AMGEN$$74$YR$E$F$Y$$$20240918$$CN$US$US
243354941$24335494$1$I$$20240910$20240919$20240919$EXP$FR-MLMSERVICE-20240821-PI165802-00129-13$FR-STRIDES ARCOLAB LIMITED-2024SP011897$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic?.. J-Eur-Acad-Dermatol-Venereol. 2024$27$YR$$M$Y$$$20240919$$HP$FR$FR
243354961$24335496$1$I$$20240911$20240919$20240919$EXP$$CA-TAKEDA-2024TUS091245$TAKEDA$$$$$F$Y$$$20240919$$CN$CA$CA
243354971$24335497$1$I$$20240913$20240919$20240919$PER$$US-ABBVIE-5925704$ABBVIE$$$$$M$Y$$$20240919$$MD$US$US
243354981$24335498$1$I$$20240917$20240919$20240919$PER$$US-HALEON-2197312$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243354992$24335499$2$F$$20240923$20240919$20240926$EXP$$ES-ABBVIE-5928630$ABBVIE$$$$$F$Y$$$20240926$$MD$ES$ES
243355002$24335500$2$F$20240909$20240919$20240919$20240927$EXP$$NL-ABBVIE-5927874$ABBVIE$$71$YR$$M$Y$$$20240927$$HP$NL$NL
243355011$24335501$1$I$$20240911$20240919$20240919$EXP$$JP-ROCHE-10000070490$ROCHE$$8$DEC$E$$Y$$$20240919$$MD$JP$JP
243355021$24335502$1$I$20240701$20240916$20240919$20240919$EXP$$US-ABBVIE-5919452$ABBVIE$$56$YR$$M$Y$$$20240919$$CN$US$US
243355031$24335503$1$I$$20240916$20240919$20240919$EXP$GB-MHRA-MED-202409121426155180-YVMGP$GB-STRIDES ARCOLAB LIMITED-2024SP012036$STRIDES$$$$$F$Y$$$20240919$$HP$GB$GB
243355041$24335504$1$I$$20240913$20240919$20240919$EXP$$US-ABBVIE-5928119$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243355051$24335505$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA266055$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240919$$HP$US$US
243355061$24335506$1$I$20240901$20240916$20240919$20240919$EXP$$US-ABBVIE-5926331$ABBVIE$$14$YR$$F$Y$$$20240919$$CN$US$US
243355071$24335507$1$I$$20240910$20240919$20240919$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011908$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic?.. J-Eur-Acad-Dermatol-Venereol. 2024$29$YR$$M$Y$$$20240919$$HP$FR$FR
243355081$24335508$1$I$$20240909$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-028517$UNITED THERAPEUTICS$$$$$F$Y$126.98$KG$20240919$$$US$US
243355091$24335509$1$I$$20240912$20240919$20240919$PER$$US-ROCHE-10000081399$ROCHE$$$$$F$Y$$$20240919$$CN$US$US
243355101$24335510$1$I$$20240910$20240919$20240919$PER$$US-ABBVIE-5920163$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243355111$24335511$1$I$20240730$20240911$20240919$20240919$PER$$US-SA-2024SA267277$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240919$$HP$US$US
243355121$24335512$1$I$20240801$20240911$20240919$20240919$PER$$US-SA-2024SA265968$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240919$$CN$US$US
243355131$24335513$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009679$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240919$$CN$US$US
243355141$24335514$1$I$$20240912$20240919$20240919$EXP$$NVSC2024GB184331$NOVARTIS$$$$A$$Y$$$20240919$$HP$GB$GB
243355151$24335515$1$I$20240906$20240909$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409005007$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240919$$CN$US$US
243355161$24335516$1$I$$20240910$20240919$20240919$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP011909$STRIDES$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al.. Doxycycline-induced fixed drug eruption: The new epidemic. J-Eur-Acad-Dermatol-Venereol. 2024$32$YR$$M$Y$$$20240919$$HP$FR$FR
243355171$24335517$1$I$20240101$20240912$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-029020$UNITED THERAPEUTICS$$$$$F$Y$81.633$KG$20240919$$MD$US$US
243355181$24335518$1$I$20231201$20240913$20240919$20240919$EXP$$US-ABBVIE-5924110$ABBVIE$$51$YR$$F$Y$$$20240919$$CN$US$US
243355191$24335519$1$I$$20240708$20240919$20240919$PER$$US-ROCHE-10000021958$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243355201$24335520$1$I$$20240910$20240919$20240919$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011916$STRIDES$Kusaka K, Miyagawa I, Kosaka S, Matsunaga S, Nakayamada S, Tanaka Y.. A case of glucocorticoid-resistant adult Still^s disease complicated by pulmonary hypertension and interstitial lung disease.. Mod-Rheumatol-Case-Rep. 2023;7 (1):182-187$7$DEC$$F$Y$$$20240919$$HP$JP$JP
243355211$24335521$1$I$20240829$20240829$20240919$20240919$PER$$US-TOLMAR, INC.-24US052303$TOLMAR$$66$YR$$M$Y$$$20240919$$HP$US$US
243355221$24335522$1$I$$20240829$20240919$20240919$PER$$US-TOLMAR, INC.-24US052308$TOLMAR$$$$$$Y$$$20240919$$HP$US$US
243355231$24335523$1$I$$20240831$20240919$20240919$PER$$CA-TOLMAR, INC.-24CA052352$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
243355241$24335524$1$I$20240829$20240829$20240919$20240919$PER$$US-TOLMAR, INC.-24US052313$TOLMAR$$81$YR$$M$Y$$$20240919$$HP$US$US
243355251$24335525$1$I$20240830$20240830$20240919$20240919$PER$$US-TOLMAR, INC.-24US052322$TOLMAR$$70$YR$$M$Y$$$20240919$$HP$US$US
243355261$24335526$1$I$20240829$20240829$20240919$20240919$PER$$US-TOLMAR, INC.-24US052316$TOLMAR$$40$YR$$F$Y$$$20240919$$HP$US$US
243355271$24335527$1$I$20240828$20240828$20240919$20240919$PER$$US-TOLMAR, INC.-24US052401$TOLMAR$$$$$M$Y$$$20240919$$HP$US$US
243355281$24335528$1$I$$20240912$20240919$20240919$PER$$US-ROCHE-2128405$ROCHE$Akhter S, Krishnan P, Kaul P. Tigecycline-Associated Acute Pancreatitis.. American Journal of Therapeutics. 2018;25 (6):e749-50. doi:10.1097/MJT.0000000000000763.$61$YR$A$M$Y$$$20240919$$MD$US$US
243355291$24335529$1$I$$20240910$20240919$20240919$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP011922$STRIDES$Shinohara K, Itoi S, Nakamura S, Miyazaki Y, Mutoh Y, Hagiwara S, et al.. Micafungin-breakthrough Coniochaeta hoffmannii (Lecythophora hoffmannii) fungemia following cord blood transplant in a patient with acute myeloid leukemia successfully treated with voriconazole.. J-Infect-Chemother. 2024;30 (9):934-937.$48$YR$$F$Y$$$20240919$$HP$JP$JP
243355301$24335530$1$I$$20240905$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045116$AUROBINDO$Poli E, Kounis I, Guettier C, Verstuyft C, Coilly A, Sobesky R et al. Post-Liver Transplantation Sinusoidal Obstruction Syndrome With Refractory Ascites Induced by Mycophenolate Mofetil. Hepatology. 2019$41$YR$$M$Y$$$20240919$$HP$FR$FR
243355311$24335531$1$I$20240601$20240913$20240919$20240919$EXP$$US-ABBVIE-5924863$ABBVIE$$80$YR$$F$Y$$$20240919$$CN$US$US
243355321$24335532$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147814$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240919$$CN$US$US
243355331$24335533$1$I$$20240910$20240919$20240919$EXP$$CA-ROCHE-10000077994$ROCHE$$88$YR$E$M$Y$$$20240919$$HP$CA$CA
243355341$24335534$1$I$$20240716$20240919$20240919$PER$$US-MankindUS-000201$MANKIND PHARMA$$$$$$Y$$$20240919$$CN$US$US
243355351$24335535$1$I$$20240617$20240919$20240919$PER$$US-MankindUS-000203$MANKIND PHARMA$$$$$$Y$$$20240919$$CN$US$US
243355361$24335536$1$I$$20240617$20240919$20240919$PER$$US-MankindUS-000202$MANKIND PHARMA$$$$$$Y$$$20240919$$CN$US$US
243355371$24335537$1$I$$20240617$20240919$20240919$PER$$US-MankindUS-000206$MANKIND PHARMA$$$$$$Y$$$20240919$$CN$US$US
243355381$24335538$1$I$$20240617$20240919$20240919$PER$$US-MankindUS-000204$MANKIND PHARMA$$$$$$Y$$$20240919$$CN$US$US
243355391$24335539$1$I$$20240617$20240919$20240919$PER$$US-MankindUS-000205$MANKIND PHARMA$$$$$$Y$$$20240919$$CN$US$US
243355401$24335540$1$I$$20240617$20240919$20240919$PER$$US-MankindUS-000208$MANKIND PHARMA$$$$$$Y$$$20240919$$CN$US$US
243355411$24335541$1$I$$20240617$20240919$20240919$PER$$US-MankindUS-000209$MANKIND PHARMA$$$$$$Y$$$20240919$$CN$US$US
243355421$24335542$1$I$$20240617$20240919$20240919$PER$$US-MankindUS-000207$MANKIND PHARMA$$$$$$Y$$$20240919$$CN$US$US
243355432$24335543$2$F$$20240919$20240919$20240923$EXP$$US-BIOVITRUM-2024-US-012139$BIOVITRUM$$$$$F$Y$$$20240923$$MD$US$US
243355442$24335544$2$F$20240101$20240917$20240919$20240924$PER$$US-AMGEN-USASP2024186154$AMGEN$$87$YR$E$M$Y$$$20240923$$MD$US$US
243355451$24335545$1$I$$20240911$20240919$20240919$EXP$$NL-STRIDES ARCOLAB LIMITED-2024SP011759$STRIDES$Kraaijvanger N, Mieloo T.. Neuroleptic malignant syndrome after overdose of haloperidol - A case report.. Toxicol Rep. 2024;12:356-360$23$YR$$M$Y$$$20240919$$HP$NL$NL
243355461$24335546$1$I$20240816$20240911$20240919$20240919$EXP$$JO-EMD Serono-2024048959$EMD SERONO INC$$31$YR$A$F$Y$$$20240919$$CN$JO$JO
243355471$24335547$1$I$20240731$20240917$20240919$20240919$EXP$FI-FIMEA-202403368$FI-BRISTOL-MYERS SQUIBB COMPANY-2024-148724$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240919$$MD$FI$FI
243355481$24335548$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147209$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240919$$CN$US$US
243355491$24335549$1$I$20240601$20240905$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-044992$AUROBINDO$$34$YR$$F$Y$88$KG$20240919$$MD$FR$FR
243355501$24335550$1$I$20230101$20240916$20240919$20240919$EXP$$US-ABBVIE-5927834$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243355511$24335551$1$I$$20240911$20240919$20240919$EXP$$SA-STRIDES ARCOLAB LIMITED-2024SP011739$STRIDES$Ibn Auf A, Mohammed M A, Wahhas H. A Case Report of Recurrent Acute Laryngeal Dystonia With Different Novel Antipsychotics: Aripiprazole and Olanzapine. Cureus. 2024;16(1):e52001$$$A$M$Y$$$20240919$$HP$SA$SA
243355521$24335552$1$I$20240101$20240830$20240919$20240919$PER$$US-SA-2024SA268112$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240919$$MD$US$US
243355531$24335553$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA266472$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240919$$HP$US$US
243355541$24335554$1$I$$20240911$20240919$20240919$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP011893$STRIDES$Kim HM, Lee J, Kim S, Lee JW, Kim H-J, Cho Y-S.. Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease.. Blood-Res. 2023;58 (3):145-148$52$YR$$F$Y$$$20240919$$HP$KR$KR
243355551$24335555$1$I$20240915$20240916$20240919$20240919$EXP$$IT-ABBVIE-5928308$ABBVIE$$73$YR$$F$Y$$$20240919$$MD$IT$IT
243355561$24335556$1$I$$20240913$20240919$20240919$PER$$US-ABBVIE-5924442$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243355571$24335557$1$I$$20240917$20240919$20240919$EXP$$US-ROCHE-10000085065$ROCHE$$43$YR$A$F$Y$$$20240919$$CN$US$US
243355591$24335559$1$I$$20240913$20240919$20240919$PER$$US-JNJFOC-20240936642$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$CN$US$US
243355601$24335560$1$I$20240908$20240916$20240919$20240919$EXP$IT-MINISAL02-1002010$IT-JNJFOC-20240946997$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$MD$IT$IT
243355621$24335562$1$I$20240807$20240917$20240919$20240919$EXP$SI-JAZMP-NCPHV-2024SI0935_0935$SI-REGENERON PHARMACEUTICALS, INC.-2024-124834$REGENERON$$84$YR$$F$Y$$$20240919$$MD$SI$SI
243355631$24335563$1$I$$20240713$20240919$20240919$PER$$US-ROCHE-10000027993$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243355641$24335564$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185663$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243355652$24335565$2$F$$20240919$20240919$20240926$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR113832$VIIV$$$$$$Y$$$20240926$$CN$US$US
243355662$24335566$2$F$20240726$20240925$20240919$20240930$EXP$$CZ-JNJFOC-20240947193$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240930$$MD$CZ$CZ
243355671$24335567$1$I$$20240911$20240919$20240919$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP011894$STRIDES$Kim HM, Lee J, Kim S, Lee JW, Kim H-J, Cho Y-S. Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease.. Blood-Res. 2023;58 (3):145-148$31$YR$$F$Y$$$20240919$$HP$KR$KR
243355681$24335568$1$I$20240901$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186107$AMGEN$$76$YR$E$M$Y$$$20240918$$CN$US$US
243355701$24335570$1$I$20240301$20240913$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009186$ELI LILLY AND CO$$70$YR$E$$Y$$$20240919$$CN$US$US
243355711$24335571$1$I$20231101$20240917$20240919$20240919$EXP$$US-ROCHE-10000085111$ROCHE$$70$YR$E$M$Y$$$20240919$$CN$US$US
243355721$24335572$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147308$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240919$$CN$US$US
243355731$24335573$1$I$20240709$20240917$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148133$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240919$$CN$US$US
243355741$24335574$1$I$20240301$20240910$20240919$20240919$EXP$$US-VIIV HEALTHCARE LIMITED-US2024112982$VIIV$$62$YR$$M$Y$88.45$KG$20240919$$CN$US$US
243355751$24335575$1$I$$20240911$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-028862$UNITED THERAPEUTICS$$$$$M$Y$60.317$KG$20240919$$$US$US
243355761$24335576$1$I$$20240913$20240919$20240919$EXP$$CA-002147023-NVSC2020CA102759$Haleon PLC$$53$YR$$M$Y$$$20240919$$CN$CA$CA
243355771$24335577$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA266186$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240919$$CN$US$US
243355781$24335578$1$I$20240801$20240821$20240919$20240919$PER$$US-SA-2024SA266080$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240919$$PH$US$US
243355791$24335579$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA266373$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240919$$MD$US$US
243355801$24335580$1$I$$20240620$20240919$20240919$PER$$US-AUROBINDO-AUR-APL-2024-031732$AUROBINDO$$$$A$F$Y$$$20240919$$CN$US$US
243355812$24335581$2$F$$20240701$20240919$20240919$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-14846$ALKEM$Sakamoto S, Kikuchi N, Ichikawa A, Sano G, Satoh K, Sugino K, Isobe K, Takai Y, Shibuya K, Homma S.. Everolimus-induced pneumonitis after drug-eluting stent implantation: a case report. Cardiovasc Intervent Radiol. 2013;36(4):1151-4$72$YR$$F$Y$$$20240918$$HP$JP$JP
243355821$24335582$1$I$$20240913$20240919$20240919$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP011986$STRIDES$Seong EY, Kim DW, Kim HJ, Rhee H, Song SH.. Incomplete distal renal tubular acidosis uncovered during pregnancy: A case report. World Journal of Clinical Case. 2023;11(25):5988-5993$32$YR$$F$Y$82.1$KG$20240919$$MD$KR$KR
243355831$24335583$1$I$$20240610$20240919$20240919$EXP$$FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2024-13086$ALKEM$Moraly J, Rossignol J, Rouzaud C, Gabas T, et.al.. Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study. American Journal of Hematology. 2024;99(6):1095-1102$$$$$Y$$$20240919$$HP$FR$FR
243355841$24335584$1$I$20220101$20240702$20240919$20240919$EXP$CO-MLMSERVICE-20240613-PI100110-00271-1$CO-ALKEM LABORATORIES LIMITED-CO-ALKEM-2024-13946$ALKEM$Valderrama MA, Suarez MR, Buendia ME, Mendez M, Agudelo J, Duenas E.. Chronic Cough in an Immunosuppressed Patient: A Challenging Asthma Case. A Case Report. American Journal of Respiratory and Critical Care Medicine. 2024;209:A6408$8$YR$$$Y$$$20240919$$MD$CO$CO
243355851$24335585$1$I$$20240624$20240919$20240919$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-14150$ALKEM$Jeon SY, Yhim HY, Lee NR, Song EK, Kwak JY, Yim CY.. Everolimus-induced activation of latent Mycobacterium tuberculosis infection in a patient with metastatic renal cell carcinoma. Korean J Intern Med (Korean Assoc Intern Med). 2017;32(2):365-8$$$$$Y$$$20240918$$HP$KR$KR
243355861$24335586$1$I$$20240604$20240919$20240919$EXP$$PL-ALKEM LABORATORIES LIMITED-PL-ALKEM-2024-11737$ALKEM$Tarasewicz A, Debska-Slizien A, Bulanowski M, Weicek A, Rutkowski B.. Everolimus in immunosuppressive treatment after kidney transplantation in a patient with tuberous sclerosis: case report. Transplantation Proceedings. 2014;46:2912-2915$34$YR$$F$Y$$$20240919$$HP$PL$PL
243355871$24335587$1$I$$20240701$20240919$20240919$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-14920$ALKEM$Kobayashi H. Everolimus-Eluting Stent-induced Pneumonitis. Am J Respir Crit Care Med. 2022;205(6):12-3$68$YR$$F$Y$$$20240918$$HP$JP$JP
243355881$24335588$1$I$$20240612$20240919$20240919$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-13232$ALKEM$Cavero T, Rabasco C, Lopez A, Roman E, Avila A, Sevillano A, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, Garcia A, Mendizabal S, Gavela E, Macia M, Quintana LF, Maria Romera A, et al.. Eculizumab in secondary atypical haemolytic uraemic syndrome. Nephrol Dial Transplant.. 2017;32(3):466-474$36$YR$$F$Y$$$20240918$$HP$ES$ES
243355891$24335589$1$I$$20240612$20240919$20240919$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-13238$ALKEM$Cavero T, Rabasco C, Lopez A, Roman E, Avila A, Sevillano A, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, Garcia A, Mendizabal S, Gavela E, Macia M, Quintana LF, Maria Romera A, et al.. Eculizumab in secondary atypical haemolytic uraemic syndrome. Nephrol Dial Transplant. 2017;32(3):466-474$59$YR$$M$Y$$$20240918$$HP$ES$ES
243355901$24335590$1$I$$20240612$20240919$20240919$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-13235$ALKEM$Cavero T, Rabasco C, Lopez A, Roman E, Avila A, Sevillano A, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, Garcia A, Mendizabal S, Gavela E, Macia M, Quintana LF, Maria Romera A, et al.. Eculizumab in secondary atypical haemolytic uraemic syndrome. Nephrol Dial Transplant. 2017;32(3):466-474$67$YR$$M$Y$$$20240918$$HP$ES$ES
243355911$24335591$1$I$$20240626$20240919$20240919$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14175$ALKEM$$47$YR$$M$Y$$$20240919$$HP$AU$AU
243355921$24335592$1$I$$20240626$20240919$20240919$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-13142$ALKEM$$47$YR$$M$Y$$$20240919$$HP$AU$AU
243355931$24335593$1$I$$20240701$20240919$20240919$EXP$$CN-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-14844$ALKEM$Chiba T, Ishizuka T, Ogata T, Tadaki S, Fujita H, Yamaguchi N, Onoue N, Tanaka  M, Shinozaki T, Kikuchi Y. Case report: A case of drug-induced interstitial pneumonitis by everolimus-eluting coronary stent. Nihon Naika Gakkai Zasshi. 2012;101(12):3522-4$68$YR$$F$Y$$$20240918$$HP$CN$JP
243355942$24335594$2$F$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14263$ALKEM$Mauro C, De Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D Agustini N, Angel M, Luca R, Nunez JE, O Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$68$YR$$M$Y$$$20240918$$HP$BR$BR
243355951$24335595$1$I$$20240612$20240919$20240919$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-13240$ALKEM$Cavero T, Rabasco C, Lopez A, Roman E, et.al.. Eculizumab in secondary atypical haemolytic uraemic syndrome. Nephrology Dialysis Transplantation. 2017;32:466-474$65$YR$$M$Y$$$20240918$$HP$ES$ES
243355961$24335596$1$I$$20240805$20240919$20240919$EXP$JP-MLMSERVICE-20240718-PI134281-00306-1$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-17145$ALKEM$Iwasaki Y, Seguchi O, Ikura M, Arisato T, Hada T, Mochizuki H, et al.. BK polyomavirus nephropathy after heart transplantation: A case report. Journal of Cardiology Cases. 2024;unk:unk$7$DEC$$M$Y$$$20240918$$MD$JP$JP
243355971$24335597$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14266$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$36$YR$$F$Y$$$20240918$$HP$BR$BR
243355981$24335598$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14261$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$75$YR$$M$Y$$$20240918$$HP$BR$BR
243355991$24335599$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14260$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$68$YR$$M$Y$$$20240918$$HP$BR$BR
243356002$24335600$2$F$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14256$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$53$YR$$M$Y$$$20240918$$HP$BR$BR
243356011$24335601$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14259$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$66$YR$$M$Y$$$20240918$$HP$BR$BR
243356021$24335602$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14253$ALKEM$Mauro C, De Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D Agustini N, Angel M, Luca R, Nunez JE, O Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$76$YR$$F$Y$$$20240918$$HP$BR$BR
243356031$24335603$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14248$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$65$YR$$M$Y$$$20240918$$HP$BR$BR
243356041$24335604$1$I$$20240625$20240919$20240919$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-14294$ALKEM$Colina-Garcia JF, Caso JM, Gonzalez-Garcia C, Folgueira MD, Hernandez AM, Aunon P, Andres A, Cavero T, Lopez-Medrano F, Morales E. Severe Presentation of Mpox With Skin, Lung and Pleural Involvement in a Non-HIV Infected Kidney Transplant Recipient. American Journal of Kidney Diseases. 2024;Unk:S0272-6386(24)00792-3$43$YR$$F$Y$$$20240918$$MD$ES$ES
243356051$24335605$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14258$ALKEM$Mauro C, De Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D Agustini N, Angel M, Luca R, Nunez JE, O Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$52$YR$$F$Y$$$20240918$$HP$BR$BR
243356061$24335606$1$I$$20240618$20240919$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-12449$ALKEM$Schaffrin-Nabe D, Josten-Nabe A, Tannapfel A, Uhl W, Garmer M, Kurzrock R, Crook T, Limaye S, Schuster S, Patil D, Schaffrin M, Mokbel K and Voigtmann R.. Dynamic changes in tumor profiling reveal intra- and inter-tumoral heterogeneity focused on an uncharacterized HER2 mutation: a case report of a young breast cancer patient. Frontiers in Oncology. 2024;14:1-5$46$YR$$F$Y$$$20240918$$HP$DE$DE
243356071$24335607$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14254$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$62$YR$$M$Y$$$20240918$$HP$BR$BR
243356081$24335608$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14245$ALKEM$Mauro C, De Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D Agustini N, Angel M, Luca R, Nunez JE, O Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$68$YR$$M$Y$$$20240918$$HP$BR$BR
243356092$24335609$2$F$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14223$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$72$YR$$F$Y$$$20240918$$HP$BR$BR
243356101$24335610$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14244$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$77$YR$$M$Y$$$20240918$$HP$BR$BR
243356111$24335611$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14257$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$25$YR$$M$Y$$$20240918$$HP$BR$BR
243356121$24335612$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14234$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$48$YR$$M$Y$$$20240918$$HP$BR$BR
243356131$24335613$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14247$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$53$YR$$M$Y$$$20240918$$HP$BR$BR
243356141$24335614$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14250$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$46$YR$$M$Y$$$20240918$$HP$BR$BR
243356151$24335615$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14233$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$82$YR$$F$Y$$$20240918$$HP$BR$BR
243356161$24335616$1$I$$20240823$20240919$20240919$EXP$US-MLMSERVICE-20240805-PI149518-00202-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18996$ALKEM$Li XR, Kumar D, Bo AY, Le JT, Ellis A, Young K, Wanat KA, Dhariwal M, Jha P, Green J, Aldrete S.. A Case of Disseminated Mycobacterium Haemophilum in a Kidney Transplant Recipient Presenting With Subcutaneous Nodules. Wisconsin Medical Journal. 2024;123(3):233-37$63$YR$$M$Y$$$20240918$$MD$US$US
243356171$24335617$1$I$$20240802$20240919$20240919$EXP$AU-MLMSERVICE-20231010-4597531-1$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14213$ALKEM$McMullen L, Khoo L, Anderson L, Strasser S, Gracey DM.. BK viraemia as a cause of anaemia in after ABO-incompatible liver transplant: a case report.. BMC Infectious Diseases. 2023;23(1):609$59$YR$$M$Y$$$20240918$$HP$AU$AU
243356181$24335618$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14232$ALKEM$Mauro C, De Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D Agustini N, Angel M, Luca R, Nunez JE, O Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$66$YR$$F$Y$$$20240918$$HP$BR$BR
243356191$24335619$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14230$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$39$YR$$M$Y$$$20240918$$HP$BR$BR
243356201$24335620$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14229$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$79$YR$$M$Y$$$20240918$$HP$BR$BR
243356211$24335621$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14227$ALKEM$Mauro C, de Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D^Agustini N, Angel M, Luca R, Nunez JE, O^Connor JM, Riechelmann RP. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$48$YR$$M$Y$$$20240918$$HP$BR$BR
243356221$24335622$1$I$$20240624$20240919$20240919$EXP$$BR-ALKEM LABORATORIES LIMITED-BR-ALKEM-2024-14225$ALKEM$Mauro C, De Jesus VHF, Barros M, Costa FP, Weschenfelder RF, D Agustini N, Angel M, Luca R, Nunez JE, O Connor JM, Riechelmann RP.. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients. Neuroendocrinology. 2021;111:631-638$35$YR$$M$Y$$$20240918$$HP$BR$BR
243356231$24335623$1$I$$20240626$20240919$20240919$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14186$ALKEM$$$$$$Y$$$20240918$$HP$AU$AU
243356241$24335624$1$I$$20240626$20240919$20240919$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14187$ALKEM$$$$$$Y$$$20240918$$HP$AU$AU
243356251$24335625$1$I$$20240626$20240919$20240919$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14190$ALKEM$$$$$$Y$$$20240918$$HP$AU$AU
243356261$24335626$1$I$$20240626$20240919$20240919$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14188$ALKEM$$$$$$Y$$$20240918$$HP$AU$AU
243356271$24335627$1$I$$20240624$20240919$20240919$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14148$ALKEM$Kuik KT, Trubiano J, Worth LJ, Harun NS, Steinfort D, Johnson D.. Pneumocystis jirovecii pneumonia following everolimus treatment of metastatic breast cancer. Med Mycol Case Rep. 2014;6:34-6$75$YR$$F$Y$$$20240918$$HP$AU$AU
243356281$24335628$1$I$$20240626$20240919$20240919$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14183$ALKEM$$$$$$Y$$$20240918$$HP$AU$AU
243356291$24335629$1$I$$20240626$20240919$20240919$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14185$ALKEM$$$$$$Y$$$20240918$$HP$AU$AU
243356301$24335630$1$I$$20240626$20240919$20240919$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14178$ALKEM$$$$$$Y$$$20240918$$HP$AU$AU
243356311$24335631$1$I$$20240626$20240919$20240919$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14181$ALKEM$$$$$$Y$$$20240918$$HP$AU$AU
243356321$24335632$1$I$$20240913$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146869$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240919$$HP$US$US
243356331$24335633$1$I$$20240913$20240919$20240919$EXP$$US-AMGEN-USASP2024183670$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243356342$24335634$2$F$$20240924$20240919$20240926$PER$$US-ROCHE-10000083100$ROCHE$$$$A$F$Y$$$20240926$$CN$US$US
243356351$24335635$1$I$$20240828$20240919$20240919$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-19763$ALKEM$Wildermann T, Becker F, Jesse S, Baier H, Wagner J.. Successful use of Fenfluramine in super-refractory status epilepticus in a patient with tuberous sclerosis complex and Lennox-Gastaut syndrome. Epilepsy and Behavior Reports. 2024;27:100697$24$YR$$F$Y$$$20240918$$HP$DE$DE
243356361$24335636$1$I$$20240613$20240919$20240919$EXP$AU-TGA-0000808216$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-13189$ALKEM$Carrozzi A, Hunter-Dickson M, Li JW.. A Case Report of Primaquine Associated Methemoglobinemia in a Man With Pneumocystis Jirovecii Pneumonia Following Cardiac and Renal Transplantation. Transplant-Proc. 2024;56 (2):453-455$51$YR$$M$Y$$$20240918$$HP$AU$AU
243356371$24335637$1$I$20240830$20240911$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014475$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243356381$24335638$1$I$$20240909$20240919$20240919$EXP$$IT-STERISCIENCE B.V.-2017-ST-000002$Steriscience PTE$Giuri, P. Acinetobacter Baumannii multi drug resistance (MDR): pathogen increasingly present in our departments and cause of deaths. Congresso Nazionale SIMIT.. 306 Atti 10:285$$$E$F$Y$$$20240919$$MD$IT$IT
243356391$24335639$1$I$20230501$20240911$20240919$20240919$EXP$$JP-AMGEN-JPNSP2024183969$AMGEN$$$$$F$Y$$$20240918$$CN$JP$JP
243356402$24335640$2$F$$20240925$20240919$20240926$PER$$US-AMGEN-USASP2024183587$AMGEN$$$$$M$Y$$$20240926$$HP$US$US
243356412$24335641$2$F$20240917$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024185884$AMGEN$$75$YR$E$F$Y$$$20240919$$CN$US$US
243356421$24335642$1$I$20240909$20240909$20240919$20240919$PER$$US-ABBVIE-5918683$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243356431$24335643$1$I$$20240909$20240919$20240919$EXP$$GR-STERISCIENCE B.V.-2018-ST-000003$Steriscience PTE$Mamali V.. Clinical Tutorial: The contribution of the lab to the prompt and accurate diagnosis and treatment of sepsis. Case presentation ^Possibly Duet, definately Symphony^. 10th Panhellenic Congress of Medical Biopathology (book of proceedings). 2018$65$YR$$M$Y$$$20240919$$MD$GR$GR
243356441$24335644$1$I$20240917$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186347$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243356451$24335645$1$I$$20240908$20240919$20240919$EXP$$ES-JNJFOC-20240940443$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$HP$ES$ES
243356471$24335647$1$I$$20240821$20240919$20240919$PER$$US-AVYXA HOLDINGS, LLC-2024AVY000003$Avyxa Holdings$$$$$$Y$$$20240919$$CN$US$US
243356481$24335648$1$I$20240806$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005089$ACADIA PHARMACEUTICALS$$63$YR$$M$Y$$$20240919$$CN$US$US
243356491$24335649$1$I$$20240909$20240919$20240919$EXP$$GR-STERISCIENCE B.V.-2019-ST-000006$Steriscience PTE$Sargianou M.. Invasive pulmonary aspergillosis (IPA) in a severely afflicted immunocompetent ICU patient.. 19th Panhellenic Congress of Infections, Book of proceedings.. 2019;120-121$62$YR$$F$Y$$$20240919$$MD$GR$GR
243356501$24335650$1$I$20240201$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005095$ACADIA PHARMACEUTICALS$$58$YR$$M$Y$$$20240919$$CN$US$US
243356521$24335652$1$I$20240902$20240916$20240919$20240919$PER$$US-ROCHE-10000083381$ROCHE$$17$YR$T$M$Y$$$20240919$$CN$US$US
243356531$24335653$1$I$$20240909$20240919$20240919$EXP$$GR-STERISCIENCE B.V.-2019-ST-000008$Steriscience PTE$Tziolos N. Presentation of Cases and Discussion.. Archives of Hellenic Medicine.. 2019;36(Suppl 1)$68$YR$$M$Y$$$20240919$$MD$GR$GR
243356541$24335654$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005096$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
243356551$24335655$1$I$20240917$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185631$AMGEN$$73$YR$E$F$Y$$$20240918$$CN$US$US
243356561$24335656$1$I$$20240912$20240919$20240919$EXP$$US-JNJFOC-20240938143$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240919$$HP$US$US
243356572$24335657$2$F$20240101$20240917$20240919$20240919$EXP$$US-JNJFOC-20240934423$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240919$$HP$US$US
243356581$24335658$1$I$$20240830$20240919$20240919$PER$$US-TEVA-VS-3239322$TEVA$$$$$$Y$$$20240919$$HP$US$US
243356591$24335659$1$I$20240101$20240905$20240919$20240919$PER$$US-TEVA-VS-3241779$TEVA$$41$YR$$F$Y$$$20240919$$PH$US$US
243356601$24335660$1$I$$20240909$20240919$20240919$EXP$$GR-STERISCIENCE B.V.-2019-ST-000010$Steriscience PTE$Mpristogiannis, S. Fulminant meningitis from a panresistant strain of Acinetobacter baumannii.. 19th Panhellenic Congress of Infections. 2019;91$48$YR$$F$Y$$$20240919$$MD$GR$GR
243356612$24335661$2$F$20240830$20240918$20240919$20240920$PER$$US-AMGEN-USASP2024185661$AMGEN$$71$YR$E$F$Y$$$20240920$$CN$US$US
243356621$24335662$1$I$20240904$20240911$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014464$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243356631$24335663$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005099$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$HP$US$US
243356651$24335665$1$I$20240801$20240916$20240919$20240919$PER$$US-GILEAD-2024-0687910$GILEAD$$42$YR$A$F$Y$$$20240918$$PH$US$US
243356661$24335666$1$I$20240909$20240911$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014495$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243356671$24335667$1$I$$20240916$20240919$20240919$PER$$US-ROCHE-10000083685$ROCHE$$63$YR$A$F$Y$$$20240919$$CN$US$US
243356691$24335669$1$I$$20240910$20240919$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-146069$BRISTOL MYERS SQUIBB$Totsuka K, Nishiyama R, Shibayama T, Kagoo T, Ueno H, Shiraishi J, et al. Chronic myeloid leukemia complicated with dasatinib-related lymphoproliferative disease. The 20th Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology (Programs and Abstracts).  2024; 42.$55$YR$A$M$Y$$$20240919$$MD$JP$JP
243356701$24335670$1$I$$20240910$20240919$20240919$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000321$EMCURE$Lodha S, Loriaux D, Faulkner AL, Pearson K, Shah S. Single-Dose Calcium Channel Blocker Toxicity in a Patient With Severe Liver Disease. Cureus. 2024;16(8):e66308$56$YR$$F$Y$$$20240919$$HP$US$US
243356711$24335671$1$I$20240822$20240911$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014494$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243356721$24335672$1$I$20240624$20240911$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014490$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243356731$24335673$1$I$$20240905$20240919$20240919$EXP$$BR-NOVOPROD-1282581$NOVO NORDISK$$$$$F$Y$$$20240919$$CN$BR$BR
243356741$24335674$1$I$20240513$20240905$20240919$20240919$EXP$$US-NOVOPROD-1280853$NOVO NORDISK$$76$YR$$M$Y$$$20240919$$CN$US$US
243356751$24335675$1$I$$20240914$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146964$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240919$$HP$US$US
243356761$24335676$1$I$20240401$20240905$20240919$20240919$EXP$$US-NOVOPROD-1281476$NOVO NORDISK$$57$YR$$F$Y$$$20240919$$CN$US$US
243356771$24335677$1$I$$20240916$20240919$20240919$PER$$US-ABBVIE-5927716$ABBVIE$$55$YR$$F$Y$$$20240919$$HP$US$US
243356781$24335678$1$I$20240814$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467647$RANBAXY$$65$YR$$F$Y$$$20240919$$MD$US$US
243356791$24335679$1$I$$20240905$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467664$RANBAXY$$$$E$M$Y$$$20240919$$HP$US$US
243356801$24335680$1$I$$20240715$20240919$20240919$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092460$GLENMARK$$$$$$Y$$$20240919$$CN$US$US
243356811$24335681$1$I$$20240723$20240919$20240919$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092837$GLENMARK$$$$$$Y$$$20240919$$CN$US$US
243356821$24335682$1$I$$20240628$20240919$20240919$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092085$GLENMARK$$$$$$Y$$$20240919$$CN$US$US
243356831$24335683$1$I$$20240822$20240919$20240919$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092744$GLENMARK$$$$$$Y$$$20240919$$CN$US$US
243356841$24335684$1$I$$20240606$20240919$20240919$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091513$GLENMARK$$$$$$Y$$$20240919$$CN$US$US
243356851$24335685$1$I$$20240912$20240919$20240919$PER$$US-ROCHE-10000081583$ROCHE$$$$$F$Y$$$20240919$$CN$US$US
243356861$24335686$1$I$$20240808$20240919$20240919$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092464$GLENMARK$$$$$$Y$$$20240919$$CN$US$US
243356871$24335687$1$I$$20240723$20240919$20240919$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092804$GLENMARK$$$$$$Y$$$20240919$$CN$US$US
243356881$24335688$1$I$$20240909$20240919$20240919$EXP$$IT-STERISCIENCE B.V.-2019-ST-000009$Steriscience PTE$$38$YR$$M$Y$70$KG$20240919$$MD$IT$IT
243356891$24335689$1$I$20240903$20240911$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014469$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243356901$24335690$1$I$20240309$20240909$20240919$20240919$EXP$FR-AFSSAPS-PA2024001385$FR-Accord-446115$ACCORD$$43$YR$A$M$Y$69$KG$20240919$$MD$FR$FR
243356911$24335691$1$I$$20240910$20240919$20240919$EXP$$FR-TAKEDA-2024TUS091169$TAKEDA$$33$YR$$$Y$$$20240919$$CN$FR$FR
243356921$24335692$1$I$20230915$20240916$20240919$20240919$EXP$$US-ABBVIE-5926481$ABBVIE$$43$YR$$F$Y$$$20240919$$CN$US$US
243356931$24335693$1$I$$20240710$20240919$20240919$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092339$GLENMARK$$$$$$Y$$$20240919$$CN$US$US
243356941$24335694$1$I$20240909$20240916$20240919$20240919$EXP$$US-ABBVIE-5926728$ABBVIE$$66$YR$$F$Y$$$20240919$$CN$US$US
243356951$24335695$1$I$$20240908$20240919$20240919$EXP$$EG-NOVOPROD-1280701$NOVO NORDISK$$$$N$$Y$$$20240919$$CN$EG$EG
243356961$24335696$1$I$20231001$20240907$20240919$20240919$EXP$$US-NOVOPROD-1282838$NOVO NORDISK$$$$$F$Y$$$20240919$$CN$US$US
243356991$24335699$1$I$$20240906$20240919$20240919$EXP$$US-NOVOPROD-1281988$NOVO NORDISK$$$$$F$Y$$$20240919$$CN$US$US
243357001$24335700$1$I$$20240906$20240919$20240919$EXP$$US-NOVOPROD-1281995$NOVO NORDISK$$$$$M$Y$$$20240919$$CN$US$US
243357021$24335702$1$I$$20240917$20240919$20240919$PER$$US-ROCHE-10000084354$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243357032$24335703$2$F$20240910$20240923$20240919$20240924$PER$$US-ROCHE-10000085115$ROCHE$$28$YR$A$M$Y$$$20240924$$CN$US$US
243357041$24335704$1$I$20240822$20240911$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014483$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243357051$24335705$1$I$$20240905$20240919$20240919$EXP$$DE-STERISCIENCE B.V.-2024-ST-001413$Steriscience PTE$Traidl S, Wedi B. Case of a multiple drug hypersensitivity syndrom - challange of allergological diagnostics. [German].. Allergologie. 2023;46 (2):94-98$52$YR$$M$Y$$$20240919$$MD$DE$DE
243357061$24335706$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010834$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243357071$24335707$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148142$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240919$$HP$US$US
243357081$24335708$1$I$$20240909$20240919$20240919$30DAY$$US-GSK-US2024111937$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243357092$24335709$2$F$20240901$20240916$20240919$20240923$PER$$US-ROCHE-10000083810$ROCHE$$57$YR$A$F$Y$71.66$KG$20240923$$CN$US$US
243357101$24335710$1$I$$20240917$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148183$BRISTOL MYERS SQUIBB$$96$YR$E$F$Y$$$20240919$$HP$US$US
243357111$24335711$1$I$$20240916$20240919$20240919$PER$$US-ABBVIE-5927690$ABBVIE$$$$$$Y$$$20240919$$HP$US$US
243357121$24335712$1$I$$20240909$20240919$20240919$EXP$$JP-NOVOPROD-1282019$NOVO NORDISK$$$$E$M$Y$$$20240919$$MD$JP$JP
243357131$24335713$1$I$$20240909$20240919$20240919$EXP$$CN-NOVOPROD-1281342$NOVO NORDISK$$$$$M$Y$$$20240919$$CN$CN$CN
243357141$24335714$1$I$$20240909$20240919$20240919$EXP$$US-NOVOPROD-1282304$NOVO NORDISK$$59$YR$$$Y$$$20240919$$CN$US$US
243357151$24335715$1$I$$20240909$20240919$20240919$EXP$$US-NOVOPROD-1281765$NOVO NORDISK$$$$$$Y$$$20240919$$CN$US$US
243357161$24335716$1$I$$20240909$20240919$20240919$EXP$$CN-NOVOPROD-1281407$NOVO NORDISK$$$$$F$Y$$$20240919$$CN$CN$CN
243357171$24335717$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-E2B_06770729$CA-NOVOPROD-1282525$NOVO NORDISK$$41$YR$$F$Y$$$20240919$$MD$CA$CA
243357181$24335718$1$I$$20240909$20240919$20240919$EXP$$CN-NOVOPROD-1281579$NOVO NORDISK$$95$YR$$F$Y$59$KG$20240919$$CN$CN$CN
243357191$24335719$1$I$$20240909$20240919$20240919$EXP$$IL-NOVOPROD-1280875$NOVO NORDISK$$$$$M$Y$$$20240919$$HP$IL$IL
243357201$24335720$1$I$$20240909$20240919$20240919$EXP$$GB-NOVOPROD-1281436$NOVO NORDISK$$$$$M$Y$$$20240919$$CN$GB$GB
243357211$24335721$1$I$$20240909$20240919$20240919$EXP$$US-NOVOPROD-1282346$NOVO NORDISK$$$$$F$Y$$$20240919$$CN$US$US
243357221$24335722$1$I$20240101$20240909$20240919$20240919$EXP$$AU-NOVOPROD-1281480$NOVO NORDISK$$$$$$Y$$$20240919$$CN$AU$AU
243357231$24335723$1$I$20240901$20240909$20240919$20240919$EXP$$CN-NOVOPROD-1281753$NOVO NORDISK$$$$$F$Y$$$20240919$$CN$CN$CN
243357261$24335726$1$I$20240812$20240911$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014462$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243357271$24335727$1$I$20240827$20240912$20240919$20240919$EXP$$CN-TAKEDA-2024TUS092440$TAKEDA$$69$YR$$M$Y$63$KG$20240919$$HP$CN$CN
243357281$24335728$1$I$$20240913$20240919$20240919$PER$$US-ROCHE-10000083196$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243357291$24335729$1$I$20240913$20240913$20240919$20240919$PER$$US-ROCHE-10000082425$ROCHE$$76$YR$E$F$Y$56.7$KG$20240919$$CN$US$US
243357301$24335730$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148267$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240919$$HP$US$US
243357311$24335731$1$I$$20240909$20240919$20240919$EXP$$US-NOVOPROD-1282639$NOVO NORDISK$$$$$F$Y$$$20240919$$CN$US$US
243357321$24335732$1$I$$20240909$20240919$20240919$EXP$$US-NOVOPROD-1282620$NOVO NORDISK$$$$A$F$Y$$$20240919$$CN$US$US
243357341$24335734$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-E2B_07290076$CA-NOVOPROD-1282548$NOVO NORDISK$$72$YR$$M$Y$$$20240919$$CN$CA$CA
243357351$24335735$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-001100156$CA-NOVOPROD-1282547$NOVO NORDISK$$72$YR$$F$Y$$$20240919$$MD$CA$CA
243357361$24335736$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-001099683$CA-NOVOPROD-1282636$NOVO NORDISK$$53$YR$$F$Y$$$20240919$$PH$CA$CA
243357371$24335737$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-E2B_06609943$CA-NOVOPROD-1282571$NOVO NORDISK$$6$YR$$M$Y$$$20240919$$HP$CA$CA
243357381$24335738$1$I$$20240909$20240919$20240919$EXP$$CO-NOVOPROD-1282637$NOVO NORDISK$$61$YR$$F$Y$94$KG$20240919$$CN$CO$CO
243357391$24335739$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-001100104$CA-NOVOPROD-1282580$NOVO NORDISK$$45$YR$$F$Y$$$20240919$$HP$CA$CA
243357401$24335740$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-E2B_07270884$CA-NOVOPROD-1282594$NOVO NORDISK$$7$YR$$F$Y$$$20240919$$HP$CA$CA
243357411$24335741$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-001100007$CA-NOVOPROD-1282641$NOVO NORDISK$$67$YR$$M$Y$104$KG$20240919$$MD$CA$CA
243357421$24335742$1$I$$20240910$20240919$20240919$EXP$BE-ROCHE-10000081563$BE-ROCHE-10000081563$ROCHE$Orazem, M.. A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy. Clinical Journal of Gastroenterology. 2021;14(4):1121-1125. doi:10.1007/s12328-021-01399-2$$$A$M$Y$$$20240919$$MD$BE$BE
243357431$24335743$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-07261142$CA-NOVOPROD-1282551$NOVO NORDISK$$41$YR$$F$Y$$$20240919$$HP$CA$CA
243357441$24335744$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-001096718$CA-NOVOPROD-1282544$NOVO NORDISK$$$$$M$Y$112$KG$20240919$$PH$CA$CA
243357452$24335745$2$F$$20240912$20240919$20240920$30DAY$$AT-UCBSA-2024045669$UCB$$$$E$F$Y$$$20240920$$PH$AT$AT
243357461$24335746$1$I$$20240909$20240919$20240919$EXP$$DE-STERISCIENCE B.V.-2020-ST-000004$Steriscience PTE$Haenle, M. Infections after primary and revision total hip replacement caused by enterobacteria producing extended spectrum beta-lactamases (ESBL): A case series.. HIP International. 2010;20 (2):248-254$67$YR$$F$Y$$$20240919$$HP$DE$DE
243357471$24335747$1$I$20240814$20240911$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014479$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243357481$24335748$1$I$$20240916$20240919$20240919$EXP$$CA-ORGANON-O2409CAN001044$ORGANON$$65$YR$$M$Y$$$20240919$$HP$CA$CA
243357491$24335749$1$I$$20240911$20240919$20240919$EXP$$US-BIOGEN-2024BI01282381$BIOGEN$$$$$M$Y$$$20240919$$CN$US$US
243357501$24335750$1$I$20230401$20240910$20240919$20240919$EXP$$BR-BIOGEN-2024BI01282942$BIOGEN$$40$YR$$F$Y$82$KG$20240919$$CN$BR$BR
243357511$24335751$1$I$$20240916$20240919$20240919$PER$$US-ABBVIE-5927569$ABBVIE$$$$$F$Y$$$20240919$$HP$US$US
243357521$24335752$1$I$20240801$20240830$20240919$20240919$PER$$US-SA-2024SA268712$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240919$$CN$US$US
243357531$24335753$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA266763$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240919$$MD$US$US
243357541$24335754$1$I$20240901$20240911$20240919$20240919$PER$$US-SA-2024SA266047$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240919$$HP$US$US
243357551$24335755$1$I$20240912$20240912$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409008876$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240919$$CN$US$US
243357562$24335756$2$F$20240101$20240916$20240919$20240921$EXP$GB-MHRA-MED-202409061156439840-KJWMZ$GB-ABBVIE-5926195$ABBVIE$$1$YR$$M$Y$11$KG$20240921$$HP$GB$GB
243357571$24335757$1$I$$20240913$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011471$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240919$$CN$US$US
243357581$24335758$1$I$$20240916$20240919$20240919$PER$$US-ROCHE-10000083943$ROCHE$$$$E$M$Y$90.71$KG$20240919$$CN$US$US
243357591$24335759$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005103$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$CN$US$US
243357602$24335760$2$F$20230801$20240909$20240919$20240920$30DAY$$US-JNJFOC-20240922685$JOHNSON AND JOHNSON$$7$YR$C$F$Y$$$20240920$$PH$US$US
243357611$24335761$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005106$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$HP$US$US
243357621$24335762$1$I$20131124$20240905$20240919$20240919$EXP$$DE-AUROBINDO-AUR-APL-2014-05982$AUROBINDO$$1$DY$$F$Y$4.27$KG$20240919$$MD$DE$DE
243357631$24335763$1$I$20220331$20240911$20240919$20240919$EXP$FR-AFSSAPS-PC2024000687$FR-ROCHE-10000078977$ROCHE$$70$YR$E$F$Y$$$20240919$$PH$FR$FR
243357641$24335764$1$I$20240901$20240913$20240919$20240919$30DAY$$GR-SANDOZ INC.-SDZ2024GR080835$SANDOZ$$16$YR$$F$Y$$$20240919$$CN$GR$GR
243357652$24335765$2$F$20240913$20240917$20240919$20240920$EXP$$US-BEIGENE-BGN-2024-014637$BEIGENE$$$$$$Y$$$20240920$$MD$US$US
243357661$24335766$1$I$$20240910$20240919$20240919$EXP$$CA-HALEON-2196787$Haleon PLC$$$$$F$Y$$$20240918$$HP$CA$CA
243357671$24335767$1$I$20240101$20240913$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147781$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$95.71$KG$20240919$$HP$US$US
243357681$24335768$1$I$$20240911$20240919$20240919$PER$$US-ROCHE-10000081073$ROCHE$$$$E$F$Y$$$20240919$$CN$US$US
243357691$24335769$1$I$$20240912$20240919$20240919$PER$$US-ROCHE-10000081302$ROCHE$$$$A$M$Y$$$20240919$$CN$US$US
243357701$24335770$1$I$$20240909$20240919$20240919$PER$$US-CHATTEMPRD-2024OHG032269$CHATTEM$$$$$F$Y$$$20240919$$CN$US$US
243357711$24335771$1$I$20240916$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185258$AMGEN$$65$YR$E$M$Y$$$20240918$$CN$US$US
243357721$24335772$1$I$$20240902$20240919$20240919$PER$$US-CHATTEMPRD-2024OHG032317$CHATTEM$$$$A$M$Y$$$20240919$$CN$US$US
243357741$24335774$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005116$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
243357751$24335775$1$I$$20240904$20240919$20240919$EXP$$PL-AUROBINDO-AUR-APL-2024-046262$AUROBINDO$Basak GW, Wiktor-jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. American Journal of Transplantation. 2015;15:705?714$32$YR$$M$Y$$$20240919$$HP$PL$PL
243357761$24335776$1$I$20240801$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005124$ACADIA PHARMACEUTICALS$$84$YR$$F$Y$$$20240919$$CN$US$US
243357771$24335777$1$I$20240904$20240909$20240919$20240919$EXP$GB-MHRA-MED-202409090625485510-WKVZJ$GB-TEVA-VS-3242005$TEVA$$42$YR$$F$Y$$$20240919$$HP$GB$GB
243357781$24335778$1$I$20240824$20240916$20240919$20240919$EXP$$US-TAKEDA-2024TUS092814$TAKEDA$$48$YR$$M$Y$111.57$KG$20240919$$MD$US$US
243357792$24335779$2$F$20240911$20240918$20240919$20240920$PER$$US-AMGEN-USASP2024186096$AMGEN$$70$YR$E$F$Y$$$20240920$$CN$US$US
243357801$24335780$1$I$20240908$20240909$20240919$20240919$EXP$GB-MHRA-MED-202409090610146860-MGRBQ$GB-TEVA-VS-3242016$TEVA$$43$YR$$M$Y$102$KG$20240919$$CN$GB$GB
243357811$24335781$1$I$20240901$20240913$20240919$20240919$EXP$$US-ABBVIE-5925631$ABBVIE$$19$YR$$F$Y$$$20240919$$CN$US$US
243357821$24335782$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010360$APOTEX$$65$YR$$F$Y$34$KG$20240919$$MD$CA$CA
243357841$24335784$1$I$$20240411$20240919$20240919$PER$$US-AUROBINDO-AUR-APL-2024-016452$AUROBINDO$$86$YR$$M$Y$$$20240919$$CN$US$US
243357851$24335785$1$I$$20240209$20240919$20240919$PER$$US-AUROBINDO-AUR-APL-2024-007513$AUROBINDO$$$$A$F$Y$53.52$KG$20240919$$CN$US$US
243357861$24335786$1$I$$20240626$20240919$20240919$PER$$US-AUROBINDO-AUR-APL-2024-011752$AUROBINDO$$$$$$Y$$$20240919$$HP$US$US
243357871$24335787$1$I$$20240910$20240919$20240919$EXP$$CA-ROCHE-10000083479$ROCHE$$65$YR$E$F$Y$$$20240919$$MD$CA$CA
243357881$24335788$1$I$20240101$20240911$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147746$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240919$$MD$US$US
243357891$24335789$1$I$20240824$20240827$20240919$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005128$ACADIA PHARMACEUTICALS$$12$YR$$F$Y$37$KG$20240919$$CN$US$US
243357901$24335790$1$I$20131216$20240905$20240919$20240919$EXP$$IT-AUROBINDO-AUR-APL-2014-00484$AUROBINDO$$40$YR$$F$Y$$$20240919$$MD$IT$IT
243357912$24335791$2$F$20240916$20240920$20240919$20240927$PER$$US-AMGEN-USASP2024186142$AMGEN$$62$YR$A$F$Y$$$20240927$$PH$US$US
243357941$24335794$1$I$$20240911$20240919$20240919$EXP$$CA-HALEON-2197240$Haleon PLC$$3$DEC$$M$Y$$$20240918$$HP$CA$CA
243357951$24335795$1$I$20240628$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010183$ELI LILLY AND CO$$$$$$Y$$$20240919$$CN$US$US
243357961$24335796$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010727$ELI LILLY AND CO$$22$YR$A$M$Y$$$20240919$$CN$US$US
243357971$24335797$1$I$20240101$20240916$20240919$20240919$EXP$$US-ABBVIE-5926917$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243357981$24335798$1$I$$20240912$20240919$20240919$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-001895$Alvotech$$38$YR$$F$Y$$$20240919$$MD$CA$CA
243357991$24335799$1$I$$20240911$20240919$20240919$EXP$$ES-ALVOTECHPMS-2024-ALVOTECHPMS-002317$Alvotech$Literature Reference: Moralejo Lozano O, Ruano Diaz L, Abanades Tercero M, Munoz Rosas C, Salmoral Luque R, Gonzalez de Frutos C, Gomez Rodriguez RA. INTESTINAL ULTRASOUND AND ITS ROLE IN THE ACUTE SETTING: STENOSING CROHN^S DISEASE AND ACUTE BOWEL OBSTRUCTION DUE TO FOREIGN BODY INGESTION (DENTAL POST AND CROWN). Rev Esp Enferm Dig. 2024 Sep 5;119. doi: 10.17235/reed.2024.10677/2024. Epub ahead of print. PMID: 39235174.$39$YR$$F$Y$$$20240919$$HP$ES$
243358011$24335801$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5927268$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243358021$24335802$1$I$$20240621$20240919$20240919$EXP$$ES-AUROBINDO-AUR-APL-2022-013752$AUROBINDO$Marcos-Vadillo E, Carrascal-Laso L, Ramos-Gallego I, Gaedigk A, Garc?a-Berrocal B, Mayor-Toranzo E, et al.. Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype.. Frontiers in Psychiatry. 2022;12:830608$$$E$M$Y$$$20240919$$MD$ES$ES
243358031$24335803$1$I$$20240910$20240919$20240919$EXP$$IN-KOANAAP-SML-IN-2024-00942$Unknown Manufacturer$Tripathi S, Balraam V, Nayak AR, P N, R C, J D. CML-754 IschemicStroke as a Presenting Feature of Promyelocytic Blast Phase in Chronic Myeloid Leukemia - anUncommon Presentation of an Exceptionally Rare Blastic Transformation of MyeloproliferativeNeoplasm. Clin-Lymphoma-Myeloma-Leuk 2024. 2024 Sep;24: S384-S385.$45$YR$A$F$Y$$$20240919$$MD$IN$IN
243358051$24335805$1$I$$20240910$20240919$20240919$EXP$$CA-HALEON-2197037$Haleon PLC$$44$YR$$F$Y$$$20240918$$HP$CA$CA
243358061$24335806$1$I$$20240905$20240919$20240919$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09049$LUPIN$Pacilio RM, Dalack GW. Asthma and atypical antipsychotics: A systematic literature review and case report of respiratory side effects with lurasidone, cariprazine and lumateperone. Journal of Clinical Psychopharmacology. 2024;44 (4):436-437$24$YR$$M$Y$$$20240919$$MD$US$US
243358081$24335808$1$I$$20240910$20240919$20240919$EXP$$HU-ORPHANEU-2024007048$RECORDATI$Brugos B, Simon Z, Mehes G, Illes A, Pfliegler G. Diagnostic challenges in patients with Castleman disease, a single center experience from Hungary. Pathology and Oncology Research. 2024;30:1611785:1-10$$$$$Y$$$20240919$$HP$HU$HU
243358092$24335809$2$F$$20240911$20240919$20240921$EXP$$FR-UNITED THERAPEUTICS-UNT-2024-022290$UNITED THERAPEUTICS$$75$YR$$$Y$$$20240921$$MD$FR$FR
243358101$24335810$1$I$20240917$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185649$AMGEN$$$$$M$Y$$$20240918$$CN$US$US
243358111$24335811$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243958$TEVA$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024; 67 (0): no pagination.; Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024; 67 (0): no pagination.$68$YR$$M$Y$$$20240919$$HP$US$US
243358121$24335812$1$I$20240101$20240831$20240919$20240919$PER$$US-009507513-2409USA000464$MERCK$$$$$F$Y$$$20240919$$CN$US$US
243358141$24335814$1$I$$20240911$20240919$20240919$EXP$$US-ROCHE-10000079724$ROCHE$$$$$F$Y$$$20240919$$MD$US$US
243358151$24335815$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010835$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243358161$24335816$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA268053$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240919$$HP$US$US
243358171$24335817$1$I$20240826$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045185$AUROBINDO$$68$YR$$F$Y$51$KG$20240919$$MD$FR$FR
243358201$24335820$1$I$$20240910$20240919$20240919$EXP$$CA-HALEON-2196978$Haleon PLC$$43$YR$$F$Y$96$KG$20240919$$HP$CA$CA
243358211$24335821$1$I$$20240910$20240919$20240919$EXP$$CA-HALEON-2197000$Haleon PLC$$44$YR$$F$Y$$$20240918$$HP$CA$CA
243358221$24335822$1$I$20240101$20240916$20240919$20240919$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051766$BOEHRINGER INGELHEIM$$59$YR$A$F$Y$$$20240919$$CN$US$US
243358231$24335823$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010850$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243358241$24335824$1$I$20230701$20240908$20240919$20240919$EXP$GB-MHRA-MED-202409082049593860-LVBDS$GB-Accord-445816$ACCORD$$8$YR$C$M$Y$28$KG$20240919$$CN$GB$GB
243358251$24335825$1$I$$20240908$20240919$20240919$EXP$$AM-JNJFOC-20240927578$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$HP$AM$AM
243358261$24335826$1$I$$20240917$20240919$20240919$PER$$NVSC2024US186453$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243358271$24335827$1$I$20240622$20240909$20240919$20240919$EXP$$US-NOVOPROD-1282964$NOVO NORDISK$$33$YR$$F$Y$$$20240919$$CN$US$US
243358281$24335828$1$I$$20240909$20240919$20240919$EXP$$US-NOVOPROD-1283117$NOVO NORDISK$$52$YR$$$Y$$$20240919$$HP$US$US
243358301$24335830$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-E2B_06475985$CA-NOVOPROD-1282643$NOVO NORDISK$$49$YR$$F$Y$$$20240919$$HP$CA$CA
243358321$24335832$1$I$20230418$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045206$AUROBINDO$$62$YR$$F$Y$73$KG$20240919$$PH$FR$FR
243358331$24335833$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-E2B_07275097$CA-NOVOPROD-1282860$NOVO NORDISK$$$$$$Y$$$20240919$$CN$CA$CA
243358341$24335834$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005076$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
243358351$24335835$1$I$$20240909$20240919$20240919$PER$$US-ASTELLAS-2024-AER-005765$ASTELLAS$$58$YR$A$F$Y$$$20240919$$MD$US$US
243358361$24335836$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005077$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
243358371$24335837$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005072$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$CN$US$US
243358381$24335838$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005075$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
243358391$24335839$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005067$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
243358401$24335840$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010869$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243358411$24335841$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011513$ELI LILLY AND CO$$$$$$Y$$$20240919$$CN$US$US
243358421$24335842$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010745$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240919$$CN$US$US
243358431$24335843$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010998$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243358461$24335846$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010931$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240919$$CN$US$US
243358471$24335847$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009896$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240919$$CN$US$US
243358481$24335848$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010735$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240919$$CN$US$US
243358491$24335849$1$I$$20240909$20240919$20240919$EXP$GB-MHRA-MED-202409071112464930-LVPWQ$GB-Accord-446157$ACCORD$$62$YR$A$F$Y$78$KG$20240919$$CN$GB$GB
243358501$24335850$1$I$20230101$20240909$20240919$20240919$EXP$$US-NOVOPROD-1282646$NOVO NORDISK$$71$YR$$F$Y$$$20240919$$CN$US$US
243358521$24335852$1$I$$20240909$20240919$20240919$EXP$$US-NOVOPROD-1282785$NOVO NORDISK$$$$A$$Y$$$20240919$$CN$US$US
243358551$24335855$1$I$20240907$20240909$20240919$20240919$PER$$US-ASTELLAS-2024-AER-005811$ASTELLAS$$67$YR$E$F$Y$$$20240919$$CN$US$US
243358561$24335856$1$I$$20240909$20240919$20240919$EXP$$US-NOVOPROD-1282696$NOVO NORDISK$$$$$M$Y$$$20240919$$CN$US$US
243358571$24335857$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-E2B_07147078$CA-NOVOPROD-1282679$NOVO NORDISK$$65$YR$$F$Y$58$KG$20240919$$HP$CA$CA
243358581$24335858$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-001095494$CA-NOVOPROD-1282768$NOVO NORDISK$$$$$F$Y$$$20240919$$PH$CA$CA
243358591$24335859$1$I$20160101$20240909$20240919$20240919$EXP$$CO-NOVOPROD-1282645$NOVO NORDISK$$$$$M$Y$$$20240919$$CN$CO$CO
243358611$24335861$1$I$$20240910$20240919$20240919$PER$$US-ABBVIE-5918757$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243358621$24335862$1$I$20210807$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045109$AUROBINDO$$24$YR$$F$Y$55$KG$20240919$$MD$FR$FR
243358631$24335863$1$I$$20240910$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA081125$SANDOZ$$65$YR$$F$Y$34$KG$20240919$$HP$CA$CA
243358641$24335864$1$I$$20240910$20240919$20240919$EXP$$CA-HALEON-2197246$Haleon PLC$$40$YR$$F$Y$$$20240919$$HP$CA$CA
243358651$24335865$1$I$$20240909$20240919$20240919$EXP$CA-HEALTHCANVIG-E2B_07289094$CA-NOVOPROD-1282811$NOVO NORDISK$$54$YR$$F$Y$$$20240919$$CN$CA$CA
243358662$24335866$2$F$$20240918$20240919$20240919$PER$$US-JNJFOC-20240949679$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243358671$24335867$1$I$$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185106$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243358693$24335869$3$F$20240913$20240923$20240919$20240924$PER$$US-AMGEN-USASP2024185850$AMGEN$$82$YR$E$M$Y$$$20240924$$CN$US$US
243358701$24335870$1$I$$20240914$20240919$20240919$PER$$US-EMD Serono-2024049511$EMD SERONO INC$$71$YR$E$F$Y$$$20240919$$CN$US$US
243358711$24335871$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010997$APOTEX$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65 (1):33-38$64$YR$$M$Y$$$20240919$$MD$US$US
243358722$24335872$2$F$20240101$20240917$20240919$20240924$PER$$US-AMGEN-USASP2024186075$AMGEN$$70$YR$E$F$Y$$$20240924$$CN$US$US
243358731$24335873$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005130$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$CN$US$US
243358741$24335874$1$I$20240914$20240916$20240919$20240919$EXP$$US-VIIV HEALTHCARE LIMITED-US2024114944$VIIV$$34$YR$$M$Y$$$20240919$$CN$US$US
243358751$24335875$1$I$20240906$20240909$20240919$20240919$PER$$US-RDY-SPO/USA/24/0013315$DR REDDYS$$58$YR$A$F$Y$$$20240919$$HP$US$US
243358761$24335876$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010870$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243358771$24335877$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010876$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243358781$24335878$1$I$$20240716$20240919$20240919$EXP$$IT-SANDOZ INC.-SDZ2024IT065998$SANDOZ$$72$YR$$M$Y$70$KG$20240919$$MD$IT$IT
243358791$24335879$1$I$$20240911$20240919$20240919$EXP$$CA-HALEON-2197187$Haleon PLC$$29$YR$$F$Y$$$20240919$$CN$CA$CA
243358801$24335880$1$I$$20240917$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA081060$SANDOZ$$$$$M$Y$$$20240919$$CN$CA$CA
243358811$24335881$1$I$$20240906$20240919$20240919$PER$$US-ABBVIE-5916296$ABBVIE$$$$$$Y$$$20240919$$MD$US$US
243358821$24335882$1$I$$20240909$20240919$20240919$EXP$GB-MHRA-TPP29955816C10415492YC1725617707558$GB-Accord-446220$ACCORD$$90$YR$E$F$Y$51$KG$20240919$$HP$GB$GB
243358831$24335883$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005386$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$HP$US$US
243358841$24335884$1$I$$20240916$20240919$20240919$EXP$$MX-GSK-MX2024GSK114566$GLAXOSMITHKLINE$Jaquez-Quintana JO, Ramos-Matamoros C, Gonzalez-Martinez C, Herrera Elizondo JL.. Lamotrigine induced drug reaction with eosinophilia and systemic symptoms (DRESS) presenting with eosinophilic pan-colitis, cholestasis and cytomegalovirus reactivation. Revista espanola de enfermedades digestivas. 2024$$$$$Y$$$20240919$$HP$MX$MX
243358851$24335885$1$I$20230701$20240908$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044852$AUROBINDO$$8$YR$$M$Y$28$KG$20240919$$CN$GB$GB
243358861$24335886$1$I$$20240911$20240919$20240919$EXP$$FR-GSK-FR2024EME113459$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$FR$FR
243358871$24335887$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010895$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243358881$24335888$1$I$20240913$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185946$AMGEN$$64$YR$A$F$Y$$$20240918$$PH$US$US
243358891$24335889$1$I$20040601$20240909$20240919$20240919$EXP$$FR-TEVA-VS-3241839$TEVA$$44$YR$$M$Y$$$20240919$$MD$FR$FR
243358901$24335890$1$I$$20240911$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA081050$SANDOZ$$68$YR$$M$Y$$$20240919$$HP$CA$CA
243358911$24335891$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010356$APOTEX$$67$YR$$F$Y$$$20240919$$HP$CA$CA
243358921$24335892$1$I$20170101$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185440$AMGEN$$$$$F$Y$$$20240918$$CN$US$US
243358931$24335893$1$I$$20240909$20240919$20240919$EXP$GB-MHRA-TPP5695104C581080YC1725638235203$GB-Accord-446158$ACCORD$$62$YR$A$F$Y$73$KG$20240919$$MD$GB$GB
243358941$24335894$1$I$20240707$20240909$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045490$AUROBINDO$$49$YR$$F$Y$$$20240919$$CN$FR$FR
243358951$24335895$1$I$20240801$20240909$20240919$20240919$EXP$$ES-AUROBINDO-AUR-APL-2024-045606$AUROBINDO$$89$YR$$F$Y$$$20240919$$MD$ES$ES
243358961$24335896$1$I$20240909$20240913$20240919$20240919$EXP$$US-HALEON-2196939$Haleon PLC$$82$YR$$F$Y$$$20240918$$CN$US$US
243358971$24335897$1$I$20240916$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148971$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240919$$HP$US$US
243358981$24335898$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3391585$ROCHE$$$$$$Y$$$20240919$$HP$ID$ID
243358991$24335899$1$I$20230904$20231116$20240919$20240919$PER$$JP-ROCHE-3419841$ROCHE$$5$YR$C$$Y$$$20240919$$MD$JP$JP
243359001$24335900$1$I$$20231016$20240919$20240919$PER$$US-ROCHE-2957449$ROCHE$$58$YR$A$F$Y$$$20240919$$MD$US$US
243359011$24335901$1$I$20240905$20240910$20240919$20240919$PER$$US-RDY-SPO/USA/24/0013374$DR REDDYS$$14$YR$T$M$Y$$$20240919$$HP$US$US
243359021$24335902$1$I$$20240909$20240919$20240919$PER$$US-RDY-SPO/USA/24/0013263$DR REDDYS$$32$YR$A$M$Y$$$20240919$$HP$US$US
243359031$24335903$1$I$$20240917$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA059309$SANDOZ$$90$YR$$F$Y$60$KG$20240919$$HP$CA$CA
243359041$24335904$1$I$$20230928$20240919$20240919$PER$$US-ROCHE-2975384$ROCHE$$59$YR$A$F$Y$$$20240919$$MD$US$US
243359051$24335905$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427134$ROCHE$$35$YR$A$F$Y$$$20240919$$HP$ID$ID
243359061$24335906$1$I$$20240129$20240919$20240919$PER$$TR-ROCHE-3008055$ROCHE$$$$$$Y$$$20240919$$MD$TR$TR
243359091$24335909$1$I$20220628$20231109$20240919$20240919$PER$$CN-ROCHE-3129194$ROCHE$$28$YR$A$F$Y$$$20240919$$CN$CN$CN
243359101$24335910$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427260$ROCHE$$20$YR$A$F$Y$$$20240919$$HP$ID$ID
243359111$24335911$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427242$ROCHE$$52$YR$A$F$Y$$$20240919$$HP$ID$ID
243359121$24335912$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010795$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243359131$24335913$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427246$ROCHE$$26$YR$A$M$Y$$$20240919$$HP$ID$ID
243359141$24335914$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427245$ROCHE$$55$YR$A$F$Y$$$20240919$$HP$ID$ID
243359151$24335915$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427244$ROCHE$$55$YR$A$M$Y$$$20240919$$HP$ID$ID
243359161$24335916$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427243$ROCHE$$36$YR$A$F$Y$$$20240919$$HP$ID$ID
243359171$24335917$1$I$20240903$20240909$20240919$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005417$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240919$$CN$US$US
243359181$24335918$1$I$20240911$20240913$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409008952$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240919$$CN$US$US
243359191$24335919$1$I$20240915$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010830$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240919$$CN$US$US
243359201$24335920$1$I$20240914$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010984$ELI LILLY AND CO$$58$YR$A$$Y$$$20240919$$CN$US$US
243359211$24335921$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010543$ELI LILLY AND CO$$$$$$Y$$$20240919$$CN$US$US
243359221$24335922$1$I$20240916$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010310$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243359231$24335923$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009978$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240919$$CN$US$US
243359241$24335924$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010292$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243359252$24335925$2$F$$20240912$20240919$20240924$30DAY$$FI-UCBSA-2024047927$UCB$$$$$$Y$$$20240924$$PH$FI$FI
243359261$24335926$1$I$$20240909$20240919$20240919$EXP$$US-Square Pharmaceuticals PLC-000046$SQUARE PHARMACEUTICALS$US-Square Pharmaceuticals PLC-000046-01_Initial Source Document$78$YR$E$F$Y$$$20240919$$HP$US$
243359271$24335927$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427247$ROCHE$$29$YR$A$F$Y$$$20240919$$HP$ID$ID
243359281$24335928$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010884$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243359291$24335929$1$I$$20240912$20240919$20240919$EXP$$AR-SANDOZ INC.-NVSC2020AR279941$SANDOZ$$$$$F$Y$33$KG$20240919$$CN$AR$AR
243359301$24335930$1$I$20240901$20240909$20240919$20240919$EXP$$IT-AUROBINDO-AUR-APL-2024-045403$AUROBINDO$$76$YR$$F$Y$55$KG$20240919$$MD$IT$IT
243359311$24335931$1$I$20240101$20240913$20240919$20240919$EXP$$US-JNJFOC-20240939906$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240919$$HP$US$US
243359322$24335932$2$F$20240903$20240912$20240919$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-028368$UNITED THERAPEUTICS$$76$YR$$F$Y$71.202$KG$20240921$$$US$US
243359331$24335933$1$I$20240825$20240909$20240919$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005445$ACADIA PHARMACEUTICALS$$87$YR$$F$Y$$$20240919$$CN$US$US
243359341$24335934$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010896$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243359351$24335935$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010796$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243359361$24335936$1$I$$20240910$20240919$20240919$30DAY$$US-GSK-US2024112637$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243359371$24335937$1$I$20210101$20240909$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045569$AUROBINDO$$13$YR$$F$Y$$$20240919$$MD$FR$FR
243359381$24335938$1$I$$20240723$20240919$20240919$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009356$STRIDES$Akers KL.. Return-to-Play Post-COVID-19 in 2023: A Pediatric Case Report. J-Pediatr-Health-Care. 2024;38 (4):619-623$13$YR$$F$Y$$$20240919$$HP$US$US
243359391$24335939$1$I$$20240916$20240919$20240919$PER$$US-JNJFOC-20240946406$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$CN$US$US
243359401$24335940$1$I$20240830$20240909$20240919$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005450$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240919$$CN$US$US
243359411$24335941$1$I$20240916$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185727$AMGEN$$54$YR$A$M$Y$$$20240918$$CN$US$US
243359421$24335942$1$I$$20240916$20240919$20240919$PER$$US-GILEAD-2024-0687919$GILEAD$$17$YR$T$F$Y$$$20240918$$HP$US$US
243359431$24335943$1$I$$20231205$20240919$20240919$PER$$US-STRIDES ARCOLAB LIMITED-2023SP018242$STRIDES$$76$YR$$M$Y$$$20240919$$CN$US$US
243359451$24335945$1$I$20240911$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024184868$AMGEN$$$$$$Y$$$20240918$$CN$US$US
243359461$24335946$1$I$20240225$20240227$20240919$20240919$PER$$US-STRIDES ARCOLAB LIMITED-2024SP002424$STRIDES$$78$YR$$F$Y$71.202$KG$20240919$$CN$US$US
243359471$24335947$1$I$20240917$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186016$AMGEN$$45$YR$A$M$Y$$$20240918$$CN$US$US
243359481$24335948$1$I$$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185147$AMGEN$$$$A$F$Y$$$20240918$$CN$US$US
243359491$24335949$1$I$$20240911$20240919$20240919$EXP$$JP-ASTELLAS-2024-AER-006286$ASTELLAS$$$$E$F$Y$$$20240919$$MD$JP$JP
243359512$24335951$2$F$20240828$20240917$20240919$20240923$PER$$US-AMGEN-USASP2024185865$AMGEN$$69$YR$E$F$Y$$$20240923$$CN$US$US
243359521$24335952$1$I$$20240910$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-028663$UNITED THERAPEUTICS$$$$$M$Y$113.38$KG$20240919$$$US$US
243359541$24335954$1$I$20240910$20240911$20240919$20240919$EXP$$DE-JNJFOC-20240937680$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240919$$HP$DE$DE
243359551$24335955$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010956$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243359561$24335956$1$I$$20240830$20240919$20240919$PER$$US-TEVA-VS-3239520$TEVA$$51$YR$$F$Y$$$20240919$$CN$US$US
243359571$24335957$1$I$$20240917$20240919$20240919$EXP$$NVSJ2024JP011032$NOVARTIS$$$$$$Y$$$20240919$$MD$JP$JP
243359581$24335958$1$I$$20240910$20240919$20240919$EXP$$US-SPECGX-T202401897$SPECGX$Bansal S, Khan R, Tietjen PA. Naloxone-induced pulmonary edema. Chest. 2007;132(4)$49$YR$$F$Y$$$20240919$$MD$US$US
243359591$24335959$1$I$$20240910$20240919$20240919$EXP$$US-SPECGX-T202401906$SPECGX$Meyer D, Tobias JD. Adverse effects following the inadvertent administration of opioids to infants and children. Clin Pediatr (Phila). 2005;44(6):499-503$5$WK$$$Y$$$20240919$$HP$US$US
243359601$24335960$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010367$APOTEX$$65$YR$$F$Y$34$KG$20240919$$HP$CA$CA
243359611$24335961$1$I$20240626$20240913$20240919$20240919$EXP$$NVSC2024US133807$NOVARTIS$$27$YR$$F$Y$$$20240919$$CN$US$US
243359621$24335962$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010885$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243359631$24335963$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010554$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240919$$HP$US$US
243359642$24335964$2$F$$20240916$20240919$20240919$EXP$$IT-ROCHE-10000078245$ROCHE$$$$$F$Y$$$20240919$$MD$IT$IT
243359651$24335965$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010906$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243359661$24335966$1$I$$20240916$20240919$20240919$EXP$$US-SA-2024SA268488$SANOFI AVENTIS$Daso G, Hernandez E.. Transaminitis in setting of Cholelithiasis and leflunomide: A case report.. Journal of General Internal Medicine: JGIM. 2022;Unk:S536$69$YR$E$F$Y$$$20240919$$HP$US$US
243359671$24335967$1$I$20240916$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186327$AMGEN$$63$YR$A$$Y$$$20240919$$CN$US$US
243359681$24335968$1$I$$20240916$20240919$20240919$PER$$US-ABBVIE-5926961$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243359691$24335969$1$I$20220527$20240906$20240919$20240919$EXP$$BE-AUROBINDO-AUR-APL-2024-045225$AUROBINDO$$$$$F$Y$$$20240919$$HP$BE$BE
243359701$24335970$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010587$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240919$$HP$US$US
243359711$24335971$1$I$$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024184871$AMGEN$$$$$F$Y$$$20240919$$CN$US$US
243359721$24335972$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010886$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243359731$24335973$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010588$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240919$$HP$US$US
243359742$24335974$2$F$$20240916$20240919$20240923$PER$$US-AMGEN-USASP2024185364$AMGEN$$$$$F$Y$$$20240923$$HP$US$US
243359752$24335975$2$F$$20240917$20240919$20240923$PER$$US-AMGEN-USASP2024185840$AMGEN$$$$$F$Y$$$20240923$$PH$US$US
243359761$24335976$1$I$20240903$20240909$20240919$20240919$EXP$GB-MHRA-MED-202409091514475910-SNZJF$GB-Accord-446222$ACCORD$$96$YR$E$F$Y$$$20240919$$PH$GB$GB
243359771$24335977$1$I$20240101$20240906$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044761$AUROBINDO$$45$YR$$F$Y$47$KG$20240919$$CN$GB$GB
243359781$24335978$1$I$20240101$20240909$20240919$20240919$EXP$SE-SEMPA-2024-006472$SE-Accord-446181$ACCORD$$76$YR$E$M$Y$$$20240919$$MD$SE$SE
243359791$24335979$1$I$20240508$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045280$AUROBINDO$$40$YR$$F$Y$$$20240919$$PH$FR$FR
243359801$24335980$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011425$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240919$$CN$US$US
243359811$24335981$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011558$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240919$$CN$US$US
243359821$24335982$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011540$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240919$$CN$US$US
243359831$24335983$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011119$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240919$$CN$US$US
243359841$24335984$1$I$20240916$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010982$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240919$$CN$US$US
243359851$24335985$1$I$20240301$20240913$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009914$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240919$$CN$US$US
243359861$24335986$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011052$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240919$$CN$US$US
243359881$24335988$1$I$20240701$20240913$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US080284$SANDOZ$$58$YR$$F$Y$$$20240919$$CN$US$US
243359891$24335989$1$I$20240621$20240917$20240919$20240919$EXP$FR-AFSSAPS-SE2024000725$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-148818$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$64.4$KG$20240919$$MD$FR$FR
243359901$24335990$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010887$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243359911$24335991$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010907$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243359921$24335992$1$I$$20240909$20240919$20240919$EXP$NL-LRB-01000186$NL-Accord-446731$ACCORD$$59$YR$A$M$Y$118$KG$20240919$$CN$NL$NL
243359931$24335993$1$I$$20240916$20240919$20240919$PER$$NVSC2024US186667$NOVARTIS$$$$$F$Y$$$20240919$$MD$US$US
243359941$24335994$1$I$$20240909$20240919$20240919$EXP$$US-JNJFOC-20240921573$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$PH$US$US
243359962$24335996$2$F$20240101$20240910$20240919$20240920$EXP$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000505$REVANCE THERAPEUTICS$$$$$$Y$$$20240920$$MD$US$US
243359981$24335998$1$I$$20240906$20240919$20240919$EXP$$ES-CELLTRION INC.-2024ES022222$CELLTRION$$$$$$Y$$$20240919$$MD$ES$ES
243359992$24335999$2$F$20240601$20240927$20240919$20240928$PER$$US-AMGEN-USASP2024184529$AMGEN$$71$YR$E$$Y$$$20240928$$CN$US$US
243360001$24336000$1$I$$20240110$20240919$20240919$PER$$JP-ROCHE-3493865$ROCHE$$9$DEC$E$M$Y$$$20240919$$MD$JP$JP
243360011$24336001$1$I$20240101$20240109$20240919$20240919$PER$$JP-ROCHE-3493097$ROCHE$$9$YR$C$F$Y$33$KG$20240919$$PH$JP$JP
243360021$24336002$1$I$20231231$20240117$20240919$20240919$PER$ES-AEMPS-1473195$ES-ROCHE-3493471$ROCHE$$43$YR$A$M$Y$$$20240919$$MD$ES$ES
243360031$24336003$1$I$20240114$20240114$20240919$20240919$PER$$BG-ROCHE-3492873$ROCHE$$12$YR$T$M$Y$26.6$KG$20240919$$CN$BG$BG
243360041$24336004$1$I$20240104$20240118$20240919$20240919$PER$FR-AFSSAPS-LL2024000046$FR-ROCHE-3494348$ROCHE$$68$YR$E$M$Y$$$20240919$$PH$FR$FR
243360051$24336005$1$I$20240113$20240116$20240919$20240919$PER$$CN-ROCHE-3493426$ROCHE$$16$YR$T$M$Y$$$20240919$$CN$CN$CN
243360071$24336007$1$I$20240909$20240912$20240919$20240919$PER$$US-RDY-SPO/USA/24/0013463$DR REDDYS$$54$YR$A$F$Y$$$20240919$$HP$US$US
243360081$24336008$1$I$$20240117$20240919$20240919$PER$$ID-ROCHE-3494319$ROCHE$$$$$$Y$$$20240919$$HP$ID$ID
243360091$24336009$1$I$$20240913$20240919$20240919$EXP$$US-TAKEDA-2024TUS073977$TAKEDA$$$$$M$Y$52.1$KG$20240919$$HP$US$US
243360101$24336010$1$I$20240101$20240115$20240919$20240919$PER$$CN-ROCHE-3492592$ROCHE$$88$YR$E$F$Y$55$KG$20240919$$HP$CN$CN
243360111$24336011$1$I$20240114$20240116$20240919$20240919$PER$$CN-ROCHE-3494218$ROCHE$$$$$F$Y$$$20240919$$CN$CN$CN
243360121$24336012$1$I$$20240111$20240919$20240919$PER$$JP-ROCHE-3493925$ROCHE$$$$A$F$Y$$$20240919$$PH$JP$JP
243360131$24336013$1$I$20240112$20240112$20240919$20240919$PER$$JP-ROCHE-3494693$ROCHE$$19$YR$A$$Y$$$20240919$$HP$JP$JP
243360141$24336014$1$I$$20240119$20240919$20240919$PER$$JP-ROCHE-3493878$ROCHE$$1$YR$I$F$Y$$$20240919$$PH$JP$JP
243360151$24336015$1$I$20240111$20240112$20240919$20240919$PER$$JP-ROCHE-3494666$ROCHE$$4$DEC$A$F$Y$$$20240919$$CN$JP$JP
243360161$24336016$1$I$$20240110$20240919$20240919$PER$$JP-ROCHE-3493872$ROCHE$$2$DEC$A$$Y$$$20240919$$MD$JP$JP
243360171$24336017$1$I$20240112$20240115$20240919$20240919$PER$$CN-ROCHE-3492623$ROCHE$$24$YR$A$F$Y$40$KG$20240919$$HP$CN$CN
243360181$24336018$1$I$$20240118$20240919$20240919$PER$$ES-ROCHE-3494554$ROCHE$$78$YR$E$M$Y$$$20240919$$CN$ES$ES
243360191$24336019$1$I$20231211$20240112$20240919$20240919$PER$$CN-ROCHE-3492591$ROCHE$$88$YR$E$M$Y$65$KG$20240919$$HP$CN$CN
243360201$24336020$1$I$$20240116$20240919$20240919$PER$$US-ROCHE-3493110$ROCHE$$$$$F$Y$$$20240919$$CN$US$US
243360211$24336021$1$I$20231228$20240111$20240919$20240919$PER$$JP-ROCHE-3493952$ROCHE$$5$DEC$A$F$Y$$$20240919$$PH$JP$JP
243360221$24336022$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010888$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243360231$24336023$1$I$$20240115$20240919$20240919$PER$$CN-ROCHE-3493580$ROCHE$$$$$F$Y$$$20240919$$CN$CN$CN
243360241$24336024$1$I$20210527$20240911$20240919$20240919$EXP$FR-AFSSAPS-NY2024001015$FR-TEVA-VS-3242907$TEVA$$95$YR$$F$Y$56$KG$20240919$$MD$FR$FR
243360251$24336025$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010363$APOTEX$$65$YR$$F$Y$$$20240919$$MD$CA$CA
243360261$24336026$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010962$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243360271$24336027$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010878$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243360281$24336028$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186085$AMGEN$$$$$$Y$$$20240919$$MD$US$US
243360291$24336029$1$I$20130805$20240916$20240919$20240919$PER$$US-BIOGEN-2013BI080546$BIOGEN$$34$YR$$F$Y$$$20240919$$CN$US$US
243360301$24336030$1$I$$20240916$20240919$20240919$PER$$US-BIOGEN-2024BI01282831$BIOGEN$$$$$F$Y$$$20240919$$HP$US$US
243360321$24336032$1$I$$20240916$20240919$20240919$PER$$US-BIOGEN-2024BI01268681$BIOGEN$$$$$F$Y$$$20240919$$CN$US$US
243360341$24336034$1$I$20240901$20240916$20240919$20240919$PER$$US-BIOGEN-2024BI01282749$BIOGEN$$48$YR$$F$Y$$$20240919$$CN$US$US
243360351$24336035$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010589$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240919$$HP$US$US
243360361$24336036$1$I$20240309$20240911$20240919$20240919$EXP$FR-AFSSAPS-PA2024001385$FR-TEVA-VS-3242804$TEVA$$43$YR$$M$Y$69$KG$20240919$$MD$FR$FR
243360371$24336037$1$I$20240612$20240916$20240919$20240919$EXP$$IN-ROCHE-3577038$ROCHE$$70$YR$E$M$Y$$$20240919$$CN$IN$IN
243360381$24336038$1$I$20240115$20240124$20240919$20240919$PER$$CN-ROCHE-3499033$ROCHE$$77$YR$E$F$Y$64$KG$20240919$$HP$CN$CN
243360391$24336039$1$I$20240119$20240123$20240919$20240919$PER$$CN-ROCHE-3497797$ROCHE$$29$YR$A$F$Y$62$KG$20240919$$HP$CN$CN
243360401$24336040$1$I$20231230$20240129$20240919$20240919$PER$FR-AFSSAPS-AN2024000118$FR-ROCHE-3500410$ROCHE$$56$YR$A$F$Y$80$KG$20240919$$PH$FR$FR
243360411$24336041$1$I$20240124$20240126$20240919$20240919$PER$GB-MHRA-MED-202401251240410870-TWGLF$GB-ROCHE-3500579$ROCHE$$1$MON$I$F$Y$$$20240919$$MD$GB$GB
243360421$24336042$1$I$$20240120$20240919$20240919$PER$$FR-ROCHE-3497072$ROCHE$$6$YR$C$M$Y$$$20240919$$CN$FR$FR
243360431$24336043$1$I$20240106$20240119$20240919$20240919$PER$$CN-ROCHE-3495725$ROCHE$$27$YR$A$F$Y$60$KG$20240919$$HP$CN$CN
243360441$24336044$1$I$$20240118$20240919$20240919$PER$$JP-ROCHE-3498237$ROCHE$$25$YR$A$M$Y$$$20240919$$CN$JP$JP
243360451$24336045$1$I$$20240916$20240919$20240919$EXP$$US-JNJFOC-20240941886$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$MD$US$US
243360471$24336047$1$I$20240118$20240126$20240919$20240919$PER$$CN-ROCHE-3500463$ROCHE$$67$YR$E$F$Y$65.2$KG$20240919$$HP$CN$CN
243360481$24336048$1$I$20240117$20240119$20240919$20240919$PER$$CN-ROCHE-3496042$ROCHE$$25$YR$A$F$Y$55$KG$20240919$$HP$CN$CN
243360491$24336049$1$I$$20240115$20240919$20240919$PER$$JP-ROCHE-3496545$ROCHE$$70$YR$E$M$Y$$$20240919$$CN$JP$JP
243360501$24336050$1$I$20240110$20240125$20240919$20240919$PER$$CN-ROCHE-3499040$ROCHE$$37$YR$A$F$Y$50$KG$20240919$$HP$CN$CN
243360511$24336051$1$I$$20240912$20240919$20240919$EXP$$CA-HALEON-2197348$Haleon PLC$$44$YR$$F$Y$97$KG$20240919$$MD$CA$CA
243360522$24336052$2$F$$20240124$20240919$20240923$PER$$GR-ROCHE-3498859$ROCHE$$7$YR$C$M$Y$$$20240923$$CN$GR$GR
243360531$24336053$1$I$$20240115$20240919$20240919$PER$$JP-ROCHE-3495774$ROCHE$$$$A$$Y$$$20240919$$PH$JP$JP
243360541$24336054$1$I$$20240129$20240919$20240919$PER$$TR-ROCHE-3500636$ROCHE$$$$$F$Y$$$20240919$$HP$TR$TR
243360551$24336055$1$I$20240123$20240123$20240919$20240919$PER$$RO-ROCHE-3498069$ROCHE$$8$YR$C$$Y$$$20240919$$CN$RO$RO
243360561$24336056$1$I$20240111$20240119$20240919$20240919$PER$$CN-ROCHE-3496057$ROCHE$$71$YR$E$F$Y$50$KG$20240919$$HP$CN$CN
243360571$24336057$1$I$20240101$20240118$20240919$20240919$PER$$JP-ROCHE-3499256$ROCHE$$6$YR$C$F$Y$$$20240919$$PH$JP$JP
243360581$24336058$1$I$20240111$20240125$20240919$20240919$PER$$CN-ROCHE-3499455$ROCHE$$73$YR$E$M$Y$70$KG$20240919$$HP$CN$CN
243360591$24336059$1$I$$20240123$20240919$20240919$PER$$DE-ROCHE-3498087$ROCHE$$$$$$Y$$$20240919$$PH$DE$DE
243360601$24336060$1$I$20240104$20240125$20240919$20240919$PER$$CN-ROCHE-3499466$ROCHE$$41$YR$A$F$Y$60$KG$20240919$$HP$CN$CN
243360621$24336062$1$I$20240110$20240129$20240919$20240919$PER$$CN-ROCHE-3501202$ROCHE$$4$YR$C$F$Y$17.6$KG$20240919$$HP$CN$CN
243360631$24336063$1$I$20231201$20240117$20240919$20240919$PER$$JP-ROCHE-3498309$ROCHE$$5$DEC$A$M$Y$$$20240919$$PH$JP$JP
243360641$24336064$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010590$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240919$$HP$US$US
243360651$24336065$1$I$20240117$20240117$20240919$20240919$PER$$JP-ROCHE-3498174$ROCHE$$28$YR$A$F$Y$$$20240919$$PH$JP$JP
243360661$24336066$1$I$20240112$20240115$20240919$20240919$PER$$JP-ROCHE-3495765$ROCHE$$4$DEC$A$M$Y$$$20240919$$MD$JP$JP
243360671$24336067$1$I$$20240129$20240919$20240919$PER$$US-ROCHE-3501120$ROCHE$$$$$M$Y$$$20240919$$MD$US$US
243360681$24336068$1$I$20240101$20240919$20240919$20240919$EXP$FR-AFSSAPS-TS2024001021$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052234$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240919$$MD$FR$FR
243360691$24336069$1$I$20240115$20240116$20240919$20240919$PER$$JP-ROCHE-3496588$ROCHE$$55$YR$A$F$Y$$$20240919$$PH$JP$JP
243360701$24336070$1$I$20240116$20240116$20240919$20240919$PER$$JP-ROCHE-3496578$ROCHE$$3$YR$C$F$Y$$$20240919$$PH$JP$JP
243360711$24336071$1$I$20240117$20240117$20240919$20240919$PER$$JP-ROCHE-3498195$ROCHE$$87$YR$E$F$Y$$$20240919$$PH$JP$JP
243360721$24336072$1$I$20240110$20240111$20240919$20240919$PER$$JP-ROCHE-3494872$ROCHE$$5$YR$C$F$Y$$$20240919$$PH$JP$JP
243360731$24336073$1$I$$20240118$20240919$20240919$PER$$CN-ROCHE-3496450$ROCHE$Zhang X, Hu M, Kang F, Wang J, Lan X 18F-mFBG imaging for COVID-19-induced cardiac sympathetic innervation impairment. DOI:10.1007/s00259-023-06432-9. European Journal of Nuclear Medicine and Molecular Imaging 2024 Jan;51 (2):604-5.$20$YR$A$M$Y$$$20240919$$HP$CN$CN
243360741$24336074$1$I$20240115$20240116$20240919$20240919$PER$$JP-ROCHE-3496584$ROCHE$$17$YR$T$M$Y$$$20240919$$PH$JP$JP
243360751$24336075$1$I$20240118$20240119$20240919$20240919$PER$$CN-ROCHE-3494997$ROCHE$$19$YR$A$M$Y$55$KG$20240919$$CN$CN$CN
243360761$24336076$1$I$$20240122$20240919$20240919$PER$$ID-ROCHE-3496595$ROCHE$$$$$$Y$$$20240919$$HP$ID$ID
243360771$24336077$1$I$20240104$20240122$20240919$20240919$PER$$CN-ROCHE-3496764$ROCHE$$28$YR$A$F$Y$61.5$KG$20240919$$HP$CN$CN
243360781$24336078$1$I$$20240208$20240919$20240919$PER$$CN-ROCHE-3506864$ROCHE$$$$$$Y$$$20240919$$HP$CN$CN
243360801$24336080$1$I$$20240115$20240919$20240919$PER$$JP-ROCHE-3496458$ROCHE$$$$A$$Y$$$20240919$$PH$JP$JP
243360811$24336081$1$I$20231223$20240116$20240919$20240919$PER$$JP-ROCHE-3497429$ROCHE$$76$YR$E$F$Y$$$20240919$$PH$JP$JP
243360821$24336082$1$I$$20240202$20240919$20240919$PER$$AU-ROCHE-3503749$ROCHE$$$$$$Y$$$20240919$$CN$AU$AU
243360831$24336083$1$I$20240104$20240129$20240919$20240919$PER$$CN-ROCHE-3501403$ROCHE$$48$YR$A$F$Y$61.1$KG$20240919$$HP$CN$CN
243360841$24336084$1$I$$20240129$20240919$20240919$PER$$JP-ROCHE-3507430$ROCHE$$43$YR$A$F$Y$$$20240919$$PH$JP$JP
243360851$24336085$1$I$$20240116$20240919$20240919$PER$$JP-ROCHE-3497437$ROCHE$$17$YR$T$F$Y$$$20240919$$PH$JP$JP
243360861$24336086$1$I$$20240204$20240919$20240919$PER$$CN-ROCHE-3506654$ROCHE$$33$YR$A$M$Y$$$20240919$$CN$CN$CN
243360871$24336087$1$I$$20240131$20240919$20240919$PER$$CN-ROCHE-3503444$ROCHE$$45$YR$A$F$Y$$$20240919$$CN$CN$CN
243360881$24336088$1$I$20240110$20240123$20240919$20240919$PER$$CN-ROCHE-3497654$ROCHE$$89$YR$E$M$Y$66.5$KG$20240919$$HP$CN$CN
243360891$24336089$1$I$$20240119$20240919$20240919$PER$$BR-ROCHE-3495833$ROCHE$$$$$$Y$$$20240919$$HP$BR$BR
243360901$24336090$1$I$20240103$20240130$20240919$20240919$PER$$CN-ROCHE-3502877$ROCHE$$35$YR$A$M$Y$70$KG$20240919$$HP$CN$CN
243360911$24336091$1$I$$20240910$20240919$20240919$EXP$$CA-RDY-CLI/CAN/24/0013497$DR REDDYS$$70$YR$E$F$Y$$$20240919$$HP$CA$CA
243360921$24336092$1$I$$20240906$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044771$AUROBINDO$$$$$M$Y$$$20240919$$MD$GB$GB
243360931$24336093$1$I$20240816$20240911$20240919$20240919$EXP$$JO-EMD Serono-2024049279$EMD SERONO INC$$0$YR$N$M$Y$3$KG$20240919$$CN$JO$JO
243360941$24336094$1$I$20240905$20240912$20240919$20240919$PER$$US-ABBVIE-5925412$ABBVIE$$33$YR$$F$Y$$$20240919$$MD$US$US
243360951$24336095$1$I$20240126$20240126$20240919$20240919$PER$$JP-ROCHE-3506087$ROCHE$$5$YR$C$F$Y$$$20240919$$MD$JP$JP
243360961$24336096$1$I$20240125$20240202$20240919$20240919$PER$$CN-ROCHE-3504118$ROCHE$$14$YR$T$M$Y$$$20240919$$HP$CN$CN
243360971$24336097$1$I$$20240912$20240919$20240919$EXP$$NL-AMGEN-NLDSP2024182881$AMGEN$$$$$$Y$$$20240919$$CN$NL$NL
243360981$24336098$1$I$$20240130$20240919$20240919$PER$$IE-ROCHE-3503741$ROCHE$$$$A$$Y$$$20240919$$PH$IE$IE
243360991$24336099$1$I$20240118$20240204$20240919$20240919$PER$$CN-ROCHE-3504187$ROCHE$$31$YR$A$F$Y$62$KG$20240919$$HP$CN$CN
243361001$24336100$1$I$20240127$20240219$20240919$20240919$PER$$US-ROCHE-3505338$ROCHE$$9$YR$C$M$Y$$$20240919$$CN$US$US
243361011$24336101$1$I$20240101$20240126$20240919$20240919$PER$$JP-ROCHE-3506123$ROCHE$$$$$F$Y$$$20240919$$CN$JP$JP
243361021$24336102$1$I$20240122$20240122$20240919$20240919$PER$$JP-ROCHE-3501696$ROCHE$$63$YR$A$F$Y$$$20240919$$PH$JP$JP
243361031$24336103$1$I$20240120$20240122$20240919$20240919$PER$$JP-ROCHE-3501693$ROCHE$$38$YR$A$M$Y$$$20240919$$PH$JP$JP
243361041$24336104$1$I$$20240206$20240919$20240919$PER$$US-ROCHE-3505940$ROCHE$$3$YR$C$M$Y$$$20240919$$CN$US$US
243361051$24336105$1$I$20240128$20240129$20240919$20240919$PER$$JP-ROCHE-3506606$ROCHE$$$$A$$Y$$$20240919$$PH$JP$JP
243361061$24336106$1$I$20240202$20240219$20240919$20240919$PER$$US-ROCHE-3506050$ROCHE$$70$YR$E$F$Y$58.97$KG$20240919$$CN$US$US
243361071$24336107$1$I$20240120$20240202$20240919$20240919$PER$$CN-ROCHE-3503638$ROCHE$$13$YR$T$M$Y$57$KG$20240919$$HP$CN$CN
243361081$24336108$1$I$$20240130$20240919$20240919$PER$$PL-ROCHE-3502402$ROCHE$$$$$$Y$$$20240919$$CN$PL$PL
243361091$24336109$1$I$$20240916$20240919$20240919$EXP$$IN-ROCHE-10000051269$ROCHE$$54$YR$A$M$Y$$$20240919$$MD$IN$IN
243361101$24336110$1$I$$20240205$20240919$20240919$PER$$KR-ROCHE-3505367$ROCHE$$13$YR$T$F$Y$$$20240919$$HP$KR$KR
243361111$24336111$1$I$$20240219$20240919$20240919$PER$$GB-ROCHE-3503632$ROCHE$$$$$$Y$$$20240919$$PH$GB$GB
243361121$24336112$1$I$$20240130$20240919$20240919$PER$$US-ROCHE-3501556$ROCHE$$$$$M$Y$$$20240919$$CN$US$US
243361131$24336113$1$I$$20240129$20240919$20240919$PER$$TR-ROCHE-3502888$ROCHE$$$$$F$Y$$$20240919$$HP$TR$TR
243361141$24336114$1$I$20240121$20240206$20240919$20240919$PER$FR-AFSSAPS-PO2024000097$FR-ROCHE-3505291$ROCHE$$91$YR$E$M$Y$$$20240919$$PH$FR$FR
243361151$24336115$1$I$$20240123$20240919$20240919$PER$$JP-ROCHE-3502475$ROCHE$$69$YR$E$F$Y$$$20240919$$PH$JP$JP
243361161$24336116$1$I$20240101$20240201$20240919$20240919$PER$$CN-ROCHE-3502816$ROCHE$$39$YR$A$F$Y$66$KG$20240919$$HP$CN$CN
243361171$24336117$1$I$$20240130$20240919$20240919$PER$$GR-ROCHE-3503173$ROCHE$$40$YR$A$M$Y$$$20240919$$CN$GR$GR
243361181$24336118$1$I$20240124$20240129$20240919$20240919$PER$$CN-ROCHE-3501298$ROCHE$$26$YR$A$F$Y$52$KG$20240919$$HP$CN$CN
243361191$24336119$1$I$20230801$20240206$20240919$20240919$PER$$CN-ROCHE-3506046$ROCHE$$51$YR$A$F$Y$56$KG$20240919$$HP$CN$CN
243361201$24336120$1$I$$20240129$20240919$20240919$PER$$TR-ROCHE-3502889$ROCHE$$$$$F$Y$$$20240919$$HP$TR$TR
243361211$24336121$1$I$20240112$20240204$20240919$20240919$PER$$CN-ROCHE-3506383$ROCHE$$71$YR$E$M$Y$55$KG$20240919$$HP$CN$CN
243361224$24336122$4$F$$20240919$20240919$20240923$PER$$US-BIOGEN-2024BI01281611$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
243361231$24336123$1$I$$20230922$20240919$20240919$PER$$IR-ROCHE-3428448$ROCHE$$$$$$Y$$$20240919$$MD$IR$IR
243361241$24336124$1$I$20240130$20240214$20240919$20240919$PER$$BG-ROCHE-3503062$ROCHE$$11$MON$I$$Y$11$KG$20240919$$CN$BG$BG
243361251$24336125$1$I$20240124$20240209$20240919$20240919$PER$$BG-ROCHE-3503833$ROCHE$$3$YR$C$F$Y$15$KG$20240919$$CN$BG$BG
243361261$24336126$1$I$$20230922$20240919$20240919$PER$$KR-ROCHE-3428952$ROCHE$$$$$F$Y$$$20240919$$CN$KR$KR
243361271$24336127$1$I$$20240130$20240919$20240919$PER$$IE-ROCHE-3503738$ROCHE$$$$A$$Y$$$20240919$$PH$IE$IE
243361281$24336128$1$I$$20240201$20240919$20240919$PER$$AR-ROCHE-3504332$ROCHE$$$$$$Y$$$20240919$$HP$AR$AR
243361291$24336129$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427282$ROCHE$$32$YR$A$M$Y$$$20240919$$HP$ID$ID
243361301$24336130$1$I$20231221$20240207$20240919$20240919$PER$$RO-ROCHE-3506171$ROCHE$$5$YR$C$F$Y$18$KG$20240919$$CN$RO$RO
243361311$24336131$1$I$$20240204$20240919$20240919$PER$$CN-ROCHE-3506053$ROCHE$$38$YR$A$F$Y$$$20240919$$CN$CN$CN
243361321$24336132$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427283$ROCHE$$34$YR$A$M$Y$$$20240919$$HP$ID$ID
243361331$24336133$1$I$20240104$20240206$20240919$20240919$PER$$CN-ROCHE-3505370$ROCHE$$45$YR$A$M$Y$75$KG$20240919$$HP$CN$CN
243361341$24336134$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427281$ROCHE$$40$YR$A$M$Y$$$20240919$$HP$ID$ID
243361351$24336135$1$I$20240101$20240129$20240919$20240919$PER$$CN-ROCHE-3502842$ROCHE$$59$YR$A$F$Y$68.3$KG$20240919$$HP$CN$CN
243361361$24336136$1$I$20240824$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045270$AUROBINDO$$90$YR$$F$Y$$$20240919$$MD$FR$FR
243361371$24336137$1$I$20240917$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010927$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240919$$CN$US$US
243361381$24336138$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010118$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240919$$HP$US$US
243361401$24336140$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186145$AMGEN$$$$$$Y$$$20240919$$MD$US$US
243361411$24336141$1$I$20240913$20240913$20240919$20240919$EXP$$US-JNJFOC-20240941155$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240919$$HP$US$US
243361421$24336142$1$I$20240826$20240911$20240919$20240919$EXP$$RU-JNJFOC-20240950016$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240919$$HP$RU$RU
243361431$24336143$1$I$20230410$20230925$20240919$20240919$PER$$CN-ROCHE-3428862$ROCHE$$22$YR$A$M$Y$59$KG$20240919$$HP$CN$CN
243361441$24336144$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427264$ROCHE$$35$YR$A$M$Y$$$20240919$$HP$ID$ID
243361451$24336145$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427284$ROCHE$$31$YR$A$F$Y$$$20240919$$HP$ID$ID
243361461$24336146$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427304$ROCHE$$26$YR$A$F$Y$$$20240919$$HP$ID$ID
243361471$24336147$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427285$ROCHE$$24$YR$A$F$Y$$$20240919$$HP$ID$ID
243361481$24336148$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427262$ROCHE$$61$YR$A$F$Y$$$20240919$$HP$ID$ID
243361491$24336149$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427263$ROCHE$$65$YR$E$F$Y$$$20240919$$HP$ID$ID
243361501$24336150$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427261$ROCHE$$61$YR$A$F$Y$$$20240919$$HP$ID$ID
243361511$24336151$1$I$$20240909$20240919$20240919$EXP$$IN-ROCHE-10000078156$ROCHE$$56$YR$A$F$Y$$$20240919$$CN$IN$IN
243361521$24336152$1$I$20240915$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185199$AMGEN$$67$YR$E$F$Y$$$20240919$$CN$US$US
243361531$24336153$1$I$20240916$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185077$AMGEN$$77$YR$E$F$Y$$$20240919$$CN$US$US
243361551$24336155$1$I$$20230926$20240919$20240919$PER$$TW-ROCHE-3429563$ROCHE$$80$YR$E$F$Y$$$20240919$$CN$TW$TW
243361561$24336156$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427267$ROCHE$$65$YR$E$F$Y$$$20240919$$HP$ID$ID
243361571$24336157$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427348$ROCHE$$59$YR$A$F$Y$$$20240919$$HP$ID$ID
243361581$24336158$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427353$ROCHE$$48$YR$A$M$Y$$$20240919$$HP$ID$ID
243361592$24336159$2$F$$20230921$20240919$20240919$PER$$JP-ROCHE-3430064$ROCHE$$68$YR$E$F$Y$$$20240919$$PH$JP$JP
243361601$24336160$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427349$ROCHE$$58$YR$A$M$Y$$$20240919$$HP$ID$ID
243361611$24336161$1$I$$20240910$20240919$20240919$EXP$$CA-ROCHE-10000079735$ROCHE$$48$YR$A$F$Y$$$20240919$$HP$CA$CA
243361621$24336162$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427266$ROCHE$$52$YR$A$M$Y$$$20240919$$HP$ID$ID
243361631$24336163$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427352$ROCHE$$30$YR$A$M$Y$$$20240919$$HP$ID$ID
243361641$24336164$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010582$APOTEX$Garraway C, Yang K, Kantamneni K, Kissel R, Pavlidakey PG.. Imatinib-induced hyperpigmentation. Journal of The American Academy of Dermatology Case Reports. 2024;52:28-30$46$YR$$F$Y$$$20240919$$MD$US$US
243361651$24336165$1$I$$20240916$20240919$20240919$EXP$$NVSC2024VE186570$NOVARTIS$$$$A$M$Y$$$20240919$$CN$VE$VE
243361661$24336166$1$I$$20240918$20240919$20240919$PER$$NVSC2024US186723$NOVARTIS$$$$$M$Y$$$20240919$$HP$US$US
243361671$24336167$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427401$ROCHE$$34$YR$A$M$Y$$$20240919$$HP$ID$ID
243361681$24336168$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427268$ROCHE$$54$YR$A$M$Y$$$20240919$$HP$ID$ID
243361691$24336169$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427354$ROCHE$$33$YR$A$F$Y$$$20240919$$HP$ID$ID
243361701$24336170$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427350$ROCHE$$44$YR$A$M$Y$$$20240919$$HP$ID$ID
243361711$24336171$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427402$ROCHE$$44$YR$A$F$Y$$$20240919$$HP$ID$ID
243361721$24336172$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427400$ROCHE$$31$YR$A$M$Y$$$20240919$$HP$ID$ID
243361731$24336173$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427351$ROCHE$$64$YR$A$F$Y$$$20240919$$HP$ID$ID
243361741$24336174$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010951$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243361751$24336175$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427398$ROCHE$$31$YR$A$M$Y$$$20240919$$HP$ID$ID
243361761$24336176$1$I$$20230921$20240919$20240919$PER$$ID-ROCHE-3427399$ROCHE$$35$YR$A$F$Y$$$20240919$$HP$ID$ID
243361771$24336177$1$I$$20240205$20240919$20240919$PER$$JP-ROCHE-3511955$ROCHE$$$$A$F$Y$$$20240919$$PH$JP$JP
243361781$24336178$1$I$$20240223$20240919$20240919$PER$$CN-ROCHE-3515828$ROCHE$$$$$M$Y$$$20240919$$CN$CN$CN
243361791$24336179$1$I$$20240131$20240919$20240919$PER$$JP-ROCHE-3509789$ROCHE$$7$YR$C$M$Y$50$KG$20240919$$PH$JP$JP
243361801$24336180$1$I$20240302$20240307$20240919$20240919$PER$$CN-ROCHE-3522350$ROCHE$$66$YR$E$M$Y$62$KG$20240919$$HP$CN$CN
243361821$24336182$1$I$$20240220$20240919$20240919$PER$$JP-ROCHE-3520379$ROCHE$$$$$F$Y$$$20240919$$PH$JP$JP
243361831$24336183$1$I$$20240214$20240919$20240919$PER$$JP-ROCHE-3517135$ROCHE$$38$YR$A$F$Y$$$20240919$$MD$JP$JP
243361841$24336184$1$I$20240201$20240202$20240919$20240919$PER$$JP-ROCHE-3510538$ROCHE$$10$YR$C$M$Y$$$20240919$$PH$JP$JP
243361851$24336185$1$I$$20240213$20240919$20240919$PER$$LV-ROCHE-3510214$ROCHE$$44$YR$A$F$Y$58$KG$20240919$$CN$LV$LV
243361861$24336186$1$I$20240219$20240220$20240919$20240919$PER$$BR-ROCHE-3513999$ROCHE$$$$E$F$Y$$$20240919$$CN$BR$BR
243361871$24336187$1$I$20240211$20240305$20240919$20240919$PER$FR-AFSSAPS-TS2024000241$FR-ROCHE-3520870$ROCHE$$59$YR$A$F$Y$90$KG$20240919$$MD$FR$FR
243361881$24336188$1$I$$20240219$20240919$20240919$PER$$US-ROCHE-3513249$ROCHE$$66$YR$E$F$Y$74.84$KG$20240919$$CN$US$US
243361891$24336189$1$I$20240209$20240209$20240919$20240919$PER$$JP-ROCHE-3516209$ROCHE$$1$YR$I$M$Y$$$20240919$$PH$JP$JP
243361901$24336190$1$I$20240123$20240227$20240919$20240919$PER$FR-AFSSAPS-CN2024000172$FR-ROCHE-3516807$ROCHE$$73$YR$E$M$Y$70$KG$20240919$$PH$FR$FR
243361911$24336191$1$I$20240207$20240222$20240919$20240919$PER$$JP-ROCHE-3514455$ROCHE$$$$I$$Y$$$20240919$$MD$JP$JP
243361921$24336192$1$I$$20240227$20240919$20240919$PER$$US-ROCHE-3518838$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243361931$24336193$1$I$20240122$20240221$20240919$20240919$PER$$CN-ROCHE-3514422$ROCHE$$27$YR$A$F$Y$50$KG$20240919$$HP$CN$CN
243361941$24336194$1$I$$20240917$20240919$20240919$EXP$$JP-009507513-2409JPN002482J$MERCK$$30$YR$$F$Y$$$20240919$$HP$JP$JP
243361952$24336195$2$F$$20240917$20240919$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004877$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243361961$24336196$1$I$20230901$20240213$20240919$20240919$PER$$SG-ROCHE-3509539$ROCHE$$36$YR$A$M$Y$$$20240919$$HP$SG$SG
243361971$24336197$1$I$20240214$20240215$20240919$20240919$PER$$JP-ROCHE-3517905$ROCHE$$27$YR$A$F$Y$$$20240919$$PH$JP$JP
243361981$24336198$1$I$20240209$20240219$20240919$20240919$PER$DE-CADRBFARM-2024326062$DE-ROCHE-3512298$ROCHE$$47$YR$A$F$Y$58$KG$20240919$$CN$DE$DE
243361991$24336199$1$I$20240208$20240221$20240919$20240919$PER$$CN-ROCHE-3514196$ROCHE$$42$YR$A$M$Y$68$KG$20240919$$HP$CN$CN
243362001$24336200$1$I$$20240227$20240919$20240919$PER$$US-ROCHE-3517771$ROCHE$$67$YR$E$F$Y$$$20240919$$MD$US$US
243362011$24336201$1$I$$20240219$20240919$20240919$PER$$FR-ROCHE-3513927$ROCHE$$18$YR$A$F$Y$$$20240919$$PH$FR$FR
243362021$24336202$1$I$$20240215$20240919$20240919$PER$$JP-ROCHE-3518976$ROCHE$$$$$F$Y$$$20240919$$PH$JP$JP
243362031$24336203$1$I$20240219$20240219$20240919$20240919$PER$$JP-ROCHE-3520415$ROCHE$$5$YR$C$M$Y$$$20240919$$PH$JP$JP
243362041$24336204$1$I$20240207$20240221$20240919$20240919$PER$FR-AFSSAPS-SE2024000128$FR-ROCHE-3513583$ROCHE$$81$YR$E$F$Y$79.3$KG$20240919$$MD$FR$FR
243362051$24336205$1$I$20240206$20240207$20240919$20240919$PER$$JP-ROCHE-3513296$ROCHE$$10$YR$C$F$Y$$$20240919$$PH$JP$JP
243362061$24336206$1$I$$20240301$20240919$20240919$PER$$US-ROCHE-3519761$ROCHE$$$$$F$Y$$$20240919$$CN$US$US
243362071$24336207$1$I$20240127$20240215$20240919$20240919$PER$$PT-ROCHE-3511294$ROCHE$$88$YR$E$M$Y$$$20240919$$MD$PT$PT
243362081$24336208$1$I$20240909$20240909$20240919$20240919$PER$$US-JNJFOC-20240934257$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$HP$US$US
243362091$24336209$1$I$20240209$20240219$20240919$20240919$PER$$CN-ROCHE-3512902$ROCHE$$64$YR$A$M$Y$65$KG$20240919$$HP$CN$CN
243362101$24336210$1$I$$20240214$20240919$20240919$PER$$DK-ROCHE-3516935$ROCHE$$$$A$F$Y$$$20240919$$CN$DK$DK
243362111$24336211$1$I$$20240228$20240919$20240919$PER$$JP-ROCHE-3522059$ROCHE$$17$YR$T$$Y$$$20240919$$PH$JP$JP
243362121$24336212$1$I$$20240321$20240919$20240919$PER$$JP-ROCHE-3548573$ROCHE$$9$YR$C$$Y$$$20240919$$PH$JP$JP
243362141$24336214$1$I$$20240221$20240919$20240919$PER$$US-ROCHE-3514510$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243362151$24336215$1$I$20240219$20240229$20240919$20240919$PER$$CN-ROCHE-3519932$ROCHE$$89$YR$E$M$Y$$$20240919$$HP$CN$CN
243362161$24336216$1$I$$20240223$20240919$20240919$PER$$RU-ROCHE-3516052$ROCHE$$$$$F$Y$50$KG$20240919$$CN$RU$RU
243362171$24336217$1$I$20240214$20240221$20240919$20240919$PER$$CN-ROCHE-3514163$ROCHE$$22$YR$A$F$Y$56$KG$20240919$$HP$CN$CN
243362181$24336218$1$I$$20240222$20240919$20240919$PER$$GR-ROCHE-3511000$ROCHE$$3$YR$C$F$Y$13$KG$20240919$$CN$GR$GR
243362191$24336219$1$I$20240201$20240228$20240919$20240919$PER$$CN-ROCHE-3519121$ROCHE$$35$YR$A$F$Y$65$KG$20240919$$HP$CN$CN
243362201$24336220$1$I$$20240301$20240919$20240919$PER$$JP-ROCHE-3533832$ROCHE$$16$YR$T$M$Y$$$20240919$$PH$JP$JP
243362211$24336221$1$I$20240120$20240206$20240919$20240919$PER$$CN-ROCHE-3508426$ROCHE$$88$YR$E$M$Y$60$KG$20240919$$HP$CN$CN
243362221$24336222$1$I$20240205$20240208$20240919$20240919$PER$$JP-ROCHE-3515722$ROCHE$$5$DEC$A$F$Y$$$20240919$$MD$JP$JP
243362231$24336223$1$I$$20240215$20240919$20240919$PER$$RU-ROCHE-3511427$ROCHE$$$$$F$Y$$$20240919$$CN$RU$RU
243362241$24336224$1$I$20240128$20240219$20240919$20240919$PER$$CN-ROCHE-3512869$ROCHE$$83$YR$E$F$Y$60$KG$20240919$$HP$CN$CN
243362251$24336225$1$I$$20240130$20240919$20240919$PER$$JP-ROCHE-3509149$ROCHE$$16$YR$T$M$Y$$$20240919$$MD$JP$JP
243362261$24336226$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005135$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$CN$US$US
243362271$24336227$1$I$$20240206$20240919$20240919$PER$$JP-ROCHE-3512622$ROCHE$$11$YR$C$F$Y$43$KG$20240919$$PH$JP$JP
243362281$24336228$1$I$$20240301$20240919$20240919$PER$$JP-ROCHE-3533586$ROCHE$$1$YR$I$M$Y$$$20240919$$CN$JP$JP
243362291$24336229$1$I$$20240301$20240919$20240919$PER$$JP-ROCHE-3533578$ROCHE$$1$YR$I$F$Y$$$20240919$$HP$JP$JP
243362301$24336230$1$I$$20240301$20240919$20240919$PER$$JP-ROCHE-3533606$ROCHE$$16$YR$T$M$Y$$$20240919$$CN$JP$JP
243362311$24336231$1$I$20240229$20240328$20240919$20240919$PER$$CN-ROCHE-3535448$ROCHE$$90$YR$E$M$Y$$$20240919$$HP$CN$CN
243362321$24336232$1$I$20240220$20240305$20240919$20240919$PER$$CN-ROCHE-3521572$ROCHE$$24$YR$A$F$Y$52$KG$20240919$$HP$CN$CN
243362331$24336233$1$I$$20240301$20240919$20240919$PER$$JP-ROCHE-3533561$ROCHE$$5$YR$C$F$Y$$$20240919$$CN$JP$JP
243362341$24336234$1$I$20240201$20240229$20240919$20240919$PER$$JP-ROCHE-3535606$ROCHE$$7$YR$C$M$Y$$$20240919$$PH$JP$JP
243362351$24336235$1$I$20240213$20240214$20240919$20240919$PER$$JP-ROCHE-3517078$ROCHE$$4$DEC$A$F$Y$$$20240919$$PH$JP$JP
243362361$24336236$1$I$20231028$20240206$20240919$20240919$PER$$JP-ROCHE-3512613$ROCHE$$47$YR$A$F$Y$$$20240919$$PH$JP$JP
243362371$24336237$1$I$$20240403$20240919$20240919$PER$$US-ROCHE-3538398$ROCHE$$12$YR$T$M$Y$$$20240919$$HP$US$US
243362381$24336238$1$I$$20240223$20240919$20240919$PER$$IN-ROCHE-3515772$ROCHE$$$$$$Y$$$20240919$$HP$IN$IN
243362391$24336239$1$I$20240311$20240321$20240919$20240919$PER$$CN-ROCHE-3531748$ROCHE$$82$YR$E$F$Y$55$KG$20240919$$HP$CN$CN
243362402$24336240$2$F$$20240219$20240919$20240923$PER$$JP-ROCHE-3519661$ROCHE$$5$YR$C$M$Y$$$20240923$$PH$JP$JP
243362411$24336241$1$I$20240101$20240909$20240919$20240919$EXP$IT-MINISAL02-1001162$IT-ORGANON-O2409ITA000650$ORGANON$$$$$F$Y$45$KG$20240919$$CN$IT$IT
243362421$24336242$1$I$$20240129$20240919$20240919$PER$$JP-ROCHE-3507473$ROCHE$$17$YR$T$$Y$$$20240919$$PH$JP$JP
243362431$24336243$1$I$20240125$20240219$20240919$20240919$PER$$CN-ROCHE-3512906$ROCHE$$42$YR$A$F$Y$60$KG$20240919$$HP$CN$CN
243362441$24336244$1$I$$20240130$20240919$20240919$PER$$JP-ROCHE-3509136$ROCHE$$$$A$$Y$$$20240919$$PH$JP$JP
243362451$24336245$1$I$$20240405$20240919$20240919$PER$$IR-ROCHE-3541783$ROCHE$$$$$$Y$$$20240919$$HP$IR$IR
243362461$24336246$1$I$$20240410$20240919$20240919$PER$LT-SMCA-9266N$LT-ROCHE-3543624$ROCHE$$13$YR$T$M$Y$$$20240919$$CN$LT$LT
243362471$24336247$1$I$20240129$20240312$20240919$20240919$PER$$SG-ROCHE-3525728$ROCHE$$34$YR$A$$Y$$$20240919$$HP$SG$SG
243362481$24336248$1$I$20240213$20240229$20240919$20240919$PER$$JP-ROCHE-3516182$ROCHE$$86$YR$E$M$Y$$$20240919$$PH$JP$JP
243362491$24336249$1$I$20240124$20240306$20240919$20240919$PER$FR-AFSSAPS-LY2024000159$FR-ROCHE-3521482$ROCHE$$24$YR$A$F$Y$43$KG$20240919$$CN$FR$FR
243362501$24336250$1$I$$20240311$20240919$20240919$PER$$RO-ROCHE-3529398$ROCHE$Rus M, Ghitoaica B, Lazar A, Man M, Briciu V, Muntean M, Leucuta D and Lupse M. Changes in Epidemiology and Antibiotic Prescription of Influenza: Before and after the Emergence of COVID-19. DOI: 10.3390/ph17020181. Pharmaceuticals 2024 Jan 30;17 (2):1-14.$$$$$Y$$$20240919$$HP$RO$RO
243362511$24336251$1$I$20240222$20240222$20240919$20240919$PER$$JP-ROCHE-3525271$ROCHE$$$$$M$Y$$$20240919$$CN$JP$JP
243362521$24336252$1$I$20240213$20240214$20240919$20240919$PER$$JP-ROCHE-3517144$ROCHE$$26$YR$A$F$Y$$$20240919$$MD$JP$JP
243362531$24336253$1$I$$20240226$20240919$20240919$PER$$US-ROCHE-3516601$ROCHE$$55$YR$A$F$Y$$$20240919$$MD$US$US
243362541$24336254$1$I$20240213$20240408$20240919$20240919$PER$$SG-ROCHE-3542168$ROCHE$$30$YR$A$F$Y$$$20240919$$HP$SG$SG
243362551$24336255$1$I$$20240219$20240919$20240919$PER$$JP-ROCHE-3520007$ROCHE$$$$$F$Y$$$20240919$$PH$JP$JP
243362561$24336256$1$I$20240216$20240216$20240919$20240919$PER$$JP-ROCHE-3526091$ROCHE$$4$YR$C$F$Y$$$20240919$$PH$JP$JP
243362571$24336257$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010382$APOTEX$$61$YR$$F$Y$$$20240919$$PH$CA$CA
243362581$24336258$1$I$$20240214$20240919$20240919$PER$$JP-ROCHE-3517201$ROCHE$$45$YR$A$M$Y$$$20240919$$PH$JP$JP
243362591$24336259$1$I$20231222$20240213$20240919$20240919$PER$$SG-ROCHE-3509565$ROCHE$$13$YR$T$F$Y$$$20240919$$HP$SG$SG
243362601$24336260$1$I$$20240216$20240919$20240919$PER$$KR-ROCHE-3513650$ROCHE$$40$YR$A$F$Y$$$20240919$$CN$KR$KR
243362611$24336261$1$I$$20240226$20240919$20240919$PER$$JP-ROCHE-3524543$ROCHE$$14$YR$T$F$Y$$$20240919$$PH$JP$JP
243362621$24336262$1$I$$20240307$20240919$20240919$PER$$GB-ROCHE-3522493$ROCHE$$$$$$Y$$$20240919$$HP$GB$GB
243362631$24336263$1$I$20240205$20240227$20240919$20240919$PER$CZ-CZSUKL-24000472$CZ-ROCHE-3516585$ROCHE$$77$YR$E$M$Y$82$KG$20240919$$MD$CZ$CZ
243362641$24336264$1$I$20240123$20240312$20240919$20240919$PER$$SG-ROCHE-3525369$ROCHE$$31$YR$A$$Y$$$20240919$$HP$SG$SG
243362651$24336265$1$I$$20240212$20240919$20240919$PER$$US-ROCHE-3509601$ROCHE$$$$$M$Y$$$20240919$$PH$US$US
243362661$24336266$1$I$$20240311$20240919$20240919$PER$$RO-ROCHE-3527018$ROCHE$$$$$$Y$$$20240919$$HP$RO$RO
243362671$24336267$1$I$20231228$20240314$20240919$20240919$PER$$CN-ROCHE-3527269$ROCHE$$31$YR$A$M$Y$67.8$KG$20240919$$HP$CN$CN
243362691$24336269$1$I$$20240216$20240919$20240919$PER$$US-ROCHE-3512271$ROCHE$$$$C$F$Y$$$20240919$$CN$US$US
243362701$24336270$1$I$20230911$20240125$20240919$20240919$PER$$JP-ROCHE-3511239$ROCHE$$15$YR$T$M$Y$54$KG$20240919$$PH$JP$JP
243362711$24336271$1$I$$20240208$20240919$20240919$PER$$JP-ROCHE-3515572$ROCHE$$$$T$M$Y$$$20240919$$PH$JP$JP
243362721$24336272$1$I$$20240228$20240919$20240919$PER$$JP-ROCHE-3526931$ROCHE$$13$YR$T$M$Y$$$20240919$$PH$JP$JP
243362731$24336273$1$I$$20240913$20240919$20240919$EXP$GB-MHRA-MED-202409131322524410-MCGDB$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-002237$IPCA$$$$$$Y$$$20240919$$PH$GB$GB
243362741$24336274$1$I$$20240227$20240919$20240919$PER$$JP-ROCHE-3526941$ROCHE$$5$YR$C$F$Y$$$20240919$$PH$JP$JP
243362751$24336275$1$I$20240124$20240227$20240919$20240919$PER$$CN-ROCHE-3517403$ROCHE$$36$YR$A$F$Y$73$KG$20240919$$HP$CN$CN
243362761$24336276$1$I$20240226$20240306$20240919$20240919$PER$$CN-ROCHE-3522307$ROCHE$$11$YR$C$F$Y$47$KG$20240919$$HP$CN$CN
243362771$24336277$1$I$$20240429$20240919$20240919$PER$$KR-ROCHE-3555793$ROCHE$$61$YR$A$M$Y$$$20240919$$HP$KR$KR
243362781$24336278$1$I$20240301$20240328$20240919$20240919$PER$$JP-ROCHE-3552821$ROCHE$$46$YR$A$F$Y$$$20240919$$PH$JP$JP
243362791$24336279$1$I$$20240424$20240919$20240919$PER$$US-ROCHE-3542518$ROCHE$$56$YR$A$F$Y$$$20240919$$MD$US$US
243362801$24336280$1$I$$20240213$20240919$20240919$PER$$JP-ROCHE-3515576$ROCHE$$25$YR$A$F$Y$$$20240919$$PH$JP$JP
243362811$24336281$1$I$20240206$20240314$20240919$20240919$PER$$CN-ROCHE-3527103$ROCHE$$51$YR$A$M$Y$$$20240919$$HP$CN$CN
243362821$24336282$1$I$$20240405$20240919$20240919$PER$$IR-ROCHE-3543080$ROCHE$$$$$$Y$$$20240919$$HP$IR$IR
243362831$24336283$1$I$20240229$20240304$20240919$20240919$PER$$JP-ROCHE-3535227$ROCHE$$2$DEC$A$F$Y$$$20240919$$MD$JP$JP
243362841$24336284$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005136$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
243362851$24336285$1$I$$20240301$20240919$20240919$PER$$US-ROCHE-3520368$ROCHE$$$$$F$Y$$$20240919$$CN$US$US
243362861$24336286$1$I$$20240219$20240919$20240919$PER$$US-ROCHE-3513528$ROCHE$$36$YR$A$M$Y$$$20240919$$MD$US$US
243362871$24336287$1$I$$20240205$20240919$20240919$PER$$JP-ROCHE-3511993$ROCHE$$$$C$$Y$$$20240919$$PH$JP$JP
243362881$24336288$1$I$20240219$20240306$20240919$20240919$PER$$CN-ROCHE-3522323$ROCHE$$38$YR$A$F$Y$51$KG$20240919$$HP$CN$CN
243362891$24336289$1$I$20240308$20240327$20240919$20240919$PER$FR-AFSSAPS-SE2024000237$FR-ROCHE-3533997$ROCHE$$84$YR$E$F$Y$74$KG$20240919$$MD$FR$FR
243362901$24336290$1$I$$20240326$20240919$20240919$PER$$CA-ROCHE-3534945$ROCHE$$$$$$Y$$$20240919$$MD$CA$CA
243362911$24336291$1$I$20240407$20240416$20240919$20240919$PER$$CN-ROCHE-3547627$ROCHE$$2$YR$C$M$Y$13$KG$20240919$$HP$CN$CN
243362921$24336292$1$I$20230730$20240906$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044748$AUROBINDO$$7$YR$$F$Y$$$20240919$$CN$GB$GB
243362931$24336293$1$I$$20240312$20240919$20240919$PER$$JP-ROCHE-3544282$ROCHE$$9$YR$C$M$Y$30$KG$20240919$$PH$JP$JP
243362941$24336294$1$I$$20240304$20240919$20240919$PER$$JP-ROCHE-3535240$ROCHE$$45$YR$A$F$Y$$$20240919$$PH$JP$JP
243362951$24336295$1$I$$20240213$20240919$20240919$PER$$JP-ROCHE-3515562$ROCHE$$22$YR$A$F$Y$$$20240919$$PH$JP$JP
243362961$24336296$1$I$20240116$20240312$20240919$20240919$PER$$SG-ROCHE-3525389$ROCHE$$4$YR$C$$Y$$$20240919$$HP$SG$SG
243362971$24336297$1$I$$20240409$20240919$20240919$PER$$JP-ROCHE-3559773$ROCHE$$$$C$$Y$$$20240919$$PH$JP$JP
243362981$24336298$1$I$$20240219$20240919$20240919$PER$$JP-ROCHE-3519669$ROCHE$$86$YR$E$F$Y$$$20240919$$PH$JP$JP
243362991$24336299$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010359$APOTEX$$82$YR$$F$Y$83$KG$20240919$$HP$CA$CA
243363001$24336300$1$I$20240225$20240429$20240919$20240919$PER$LT-SMCA-9304N$LT-ROCHE-3554979$ROCHE$$38$YR$A$F$Y$$$20240919$$CN$LT$LT
243363011$24336301$1$I$$20240319$20240919$20240919$PER$$US-ROCHE-3529624$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243363021$24336302$1$I$20230104$20240429$20240919$20240919$PER$$KR-ROCHE-3555829$ROCHE$$41$YR$A$$Y$$$20240919$$HP$KR$KR
243363031$24336303$1$I$$20240305$20240919$20240919$PER$$JP-ROCHE-3536096$ROCHE$$12$YR$T$F$Y$$$20240919$$PH$JP$JP
243363051$24336305$1$I$20231201$20240306$20240919$20240919$PER$NO-NOMAADVRE-PASRAPP-2024-Vwrj9q$NO-ROCHE-3521527$ROCHE$$48$YR$A$M$Y$$$20240919$$CN$NO$NO
243363061$24336306$1$I$$20240215$20240919$20240919$PER$$US-ROCHE-3515154$ROCHE$$45$YR$A$F$Y$$$20240919$$MD$US$US
243363071$24336307$1$I$20240201$20240306$20240919$20240919$PER$$CN-ROCHE-3521821$ROCHE$$19$YR$A$F$Y$$$20240919$$HP$CN$CN
243363081$24336308$1$I$$20240422$20240919$20240919$PER$$US-ROCHE-3551474$ROCHE$$45$YR$A$F$Y$$$20240919$$MD$US$US
243363091$24336309$1$I$$20240507$20240919$20240919$PER$$AU-ROCHE-3559060$ROCHE$$$$$$Y$$$20240919$$PH$AU$AU
243363101$24336310$1$I$$20240429$20240919$20240919$PER$$KR-ROCHE-3555816$ROCHE$$$$A$F$Y$$$20240919$$HP$KR$KR
243363111$24336311$1$I$20230507$20240429$20240919$20240919$PER$$KR-ROCHE-3555725$ROCHE$$$$T$M$Y$$$20240919$$HP$KR$KR
243363121$24336312$1$I$20240326$20240403$20240919$20240919$PER$$CN-ROCHE-3537705$ROCHE$$35$YR$A$F$Y$45$KG$20240919$$HP$CN$CN
243363131$24336313$1$I$$20240321$20240919$20240919$PER$$US-ROCHE-3531459$ROCHE$$$$$F$Y$$$20240919$$CN$US$US
243363141$24336314$1$I$20230221$20240429$20240919$20240919$PER$$KR-ROCHE-3555694$ROCHE$$43$YR$A$M$Y$92.55$KG$20240919$$HP$KR$KR
243363151$24336315$1$I$20240128$20240312$20240919$20240919$PER$$SG-ROCHE-3525352$ROCHE$$10$YR$C$$Y$$$20240919$$HP$SG$SG
243363161$24336316$1$I$20240207$20240207$20240919$20240919$PER$$JP-ROCHE-3513285$ROCHE$$9$MON$I$M$Y$7.9$KG$20240919$$PH$JP$JP
243363171$24336317$1$I$20190101$20240429$20240919$20240919$PER$$KR-ROCHE-3555812$ROCHE$$11$YR$C$F$Y$$$20240919$$HP$KR$KR
243363181$24336318$1$I$20240110$20240219$20240919$20240919$PER$$JP-ROCHE-3520555$ROCHE$$5$DEC$A$F$Y$$$20240919$$PH$JP$JP
243363191$24336319$1$I$20230411$20240429$20240919$20240919$PER$$KR-ROCHE-3555692$ROCHE$$62$YR$A$F$Y$$$20240919$$HP$KR$KR
243363201$24336320$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005138$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$CN$US$US
243363211$24336321$1$I$20240220$20240506$20240919$20240919$PER$FR-AFSSAPS-NY2024000259$FR-ROCHE-3558763$ROCHE$$53$YR$A$M$Y$60.2$KG$20240919$$PH$FR$FR
243363221$24336322$1$I$20240408$20240411$20240919$20240919$PER$$JP-ROCHE-3559944$ROCHE$$2$DEC$A$M$Y$$$20240919$$MD$JP$JP
243363231$24336323$1$I$20240204$20240415$20240919$20240919$PER$GR-GREOF-202400265$GR-ROCHE-3546138$ROCHE$$39$YR$A$F$Y$$$20240919$$MD$GR$GR
243363241$24336324$1$I$$20240223$20240919$20240919$PER$$US-ROCHE-3516186$ROCHE$$62$YR$A$F$Y$$$20240919$$MD$US$US
243363251$24336325$1$I$$20240307$20240919$20240919$PER$$JP-ROCHE-3533721$ROCHE$$8$YR$C$$Y$$$20240919$$CN$JP$JP
243363261$24336326$1$I$20240323$20240403$20240919$20240919$PER$$CN-ROCHE-3540867$ROCHE$$69$YR$E$M$Y$65$KG$20240919$$HP$CN$CN
243363271$24336327$1$I$20231019$20240917$20240919$20240919$EXP$$NVSC2024IN186451$NOVARTIS$$$$A$M$Y$$$20240919$$CN$IN$IN
243363281$24336328$1$I$20240122$20240226$20240919$20240919$PER$$CN-ROCHE-3516629$ROCHE$$27$YR$A$F$Y$50$KG$20240919$$HP$CN$CN
243363291$24336329$1$I$$20240909$20240919$20240919$PER$$NVSC2024US182488$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243363301$24336330$1$I$$20240909$20240919$20240919$EXP$$NL-AUROBINDO-AUR-APL-2024-045522$AUROBINDO$Fijen ML, Petersan SR, Cohn MD.. Facial swelling due to angioedema:often mast cell mediated, but not always.. Dutch Journal of Medicine. 2023;167:D7610$30$YR$$M$Y$$$20240919$$HP$NL$NL
243363311$24336331$1$I$20240701$20240910$20240919$20240919$EXP$$AR-AMGEN-ARGSP2024183727$AMGEN$$57$YR$A$F$Y$$$20240919$$CN$AR$AR
243363321$24336332$1$I$20240305$20240329$20240919$20240919$PER$$CN-ROCHE-3536180$ROCHE$$97$YR$E$M$Y$70$KG$20240919$$HP$CN$CN
243363331$24336333$1$I$20240329$20240401$20240919$20240919$PER$$JP-ROCHE-3553561$ROCHE$$2$DEC$A$F$Y$$$20240919$$MD$JP$JP
243363341$24336334$1$I$20240131$20240202$20240919$20240919$PER$$JP-ROCHE-3510449$ROCHE$$$$$F$Y$$$20240919$$PH$JP$JP
243363351$24336335$1$I$20240111$20240312$20240919$20240919$PER$$SG-ROCHE-3525397$ROCHE$$35$YR$A$M$Y$$$20240919$$HP$SG$SG
243363361$24336336$1$I$20240401$20240411$20240919$20240919$PER$$JP-ROCHE-3560649$ROCHE$$51$YR$A$F$Y$$$20240919$$PH$JP$JP
243363371$24336337$1$I$20240229$20240311$20240919$20240919$PER$$CN-ROCHE-3524480$ROCHE$$30$YR$A$F$Y$$$20240919$$HP$CN$CN
243363381$24336338$1$I$$20240412$20240919$20240919$PER$$US-ROCHE-3545613$ROCHE$$$$A$M$Y$$$20240919$$CN$US$US
243363391$24336339$1$I$20240325$20240326$20240919$20240919$PER$$JP-ROCHE-3550893$ROCHE$$12$YR$T$F$Y$$$20240919$$PH$JP$JP
243363401$24336340$1$I$20240221$20240221$20240919$20240919$PER$$JP-ROCHE-3522013$ROCHE$$10$YR$C$F$Y$30$KG$20240919$$CN$JP$JP
243363411$24336341$1$I$$20240411$20240919$20240919$PER$$US-ROCHE-3544924$ROCHE$$$$$F$Y$$$20240919$$CN$US$US
243363421$24336342$1$I$20240123$20240202$20240919$20240919$PER$$JP-ROCHE-3510426$ROCHE$$2$DEC$A$M$Y$$$20240919$$PH$JP$JP
243363431$24336343$1$I$20230411$20240429$20240919$20240919$PER$$KR-ROCHE-3555697$ROCHE$$23$YR$A$F$Y$$$20240919$$HP$KR$KR
243363441$24336344$1$I$$20240410$20240919$20240919$PER$$US-ROCHE-3543962$ROCHE$$$$$M$Y$$$20240919$$CN$US$US
243363451$24336345$1$I$20240313$20240325$20240919$20240919$PER$IT-MINISAL02-976531$IT-ROCHE-3533117$ROCHE$$62$YR$A$F$Y$$$20240919$$MD$IT$IT
243363461$24336346$1$I$20240408$20240411$20240919$20240919$PER$$JP-ROCHE-3556367$ROCHE$$42$YR$A$M$Y$$$20240919$$PH$JP$JP
243363471$24336347$1$I$20240129$20240201$20240919$20240919$PER$$JP-ROCHE-3510424$ROCHE$$$$C$M$Y$$$20240919$$PH$JP$JP
243363481$24336348$1$I$20181216$20240429$20240919$20240919$PER$$KR-ROCHE-3555570$ROCHE$$43$YR$A$F$Y$$$20240919$$HP$KR$KR
243363491$24336349$1$I$$20240426$20240919$20240919$PER$$HK-ROCHE-3521637$ROCHE$$$$$$Y$$$20240919$$CN$HK$HK
243363501$24336350$1$I$$20240329$20240919$20240919$PER$$JP-ROCHE-3552777$ROCHE$$6$MON$I$$Y$$$20240919$$PH$JP$JP
243363511$24336351$1$I$20240212$20240213$20240919$20240919$PER$$JP-ROCHE-3517529$ROCHE$$$$$F$Y$$$20240919$$CN$JP$JP
243363521$24336352$1$I$20240211$20240313$20240919$20240919$PER$RO-NMA-2024-SP0188$RO-ROCHE-3525492$ROCHE$$4$YR$C$M$Y$30$KG$20240919$$MD$RO$RO
243363531$24336353$1$I$20240129$20240201$20240919$20240919$PER$$JP-ROCHE-3510463$ROCHE$$$$C$M$Y$$$20240919$$PH$JP$JP
243363541$24336354$1$I$20240111$20240404$20240919$20240919$PER$$US-ROCHE-3538694$ROCHE$$$$T$M$Y$$$20240919$$CN$US$US
243363551$24336355$1$I$20240202$20240314$20240919$20240919$PER$$JP-ROCHE-3510392$ROCHE$$32$YR$A$F$Y$$$20240919$$PH$JP$JP
243363561$24336356$1$I$20230414$20240429$20240919$20240919$PER$$KR-ROCHE-3555591$ROCHE$$13$YR$T$M$Y$$$20240919$$HP$KR$KR
243363571$24336357$1$I$20230411$20240429$20240919$20240919$PER$$KR-ROCHE-3555589$ROCHE$$13$YR$T$F$Y$$$20240919$$HP$KR$KR
243363581$24336358$1$I$20230523$20240429$20240919$20240919$PER$$KR-ROCHE-3555809$ROCHE$$7$YR$C$M$Y$$$20240919$$HP$KR$KR
243363591$24336359$1$I$20240223$20240401$20240919$20240919$PER$AT-BASGAGES-2024-001460$AT-ROCHE-3536965$ROCHE$$51$YR$A$F$Y$$$20240919$$CN$AT$AT
243363601$24336360$1$I$20231226$20240213$20240919$20240919$PER$$SG-ROCHE-3509550$ROCHE$$17$YR$T$M$Y$$$20240919$$HP$SG$SG
243363611$24336361$1$I$20240303$20240311$20240919$20240919$PER$$CN-ROCHE-3524853$ROCHE$$30$YR$A$M$Y$78$KG$20240919$$HP$CN$CN
243363621$24336362$1$I$20231128$20240304$20240919$20240919$PER$$JP-ROCHE-3535279$ROCHE$$5$DEC$A$F$Y$$$20240919$$PH$JP$JP
243363631$24336363$1$I$20240213$20240416$20240919$20240919$PER$$JP-ROCHE-3559785$ROCHE$$9$YR$C$M$Y$23$KG$20240919$$PH$JP$JP
243363641$24336364$1$I$20240119$20240304$20240919$20240919$PER$RO-NMA-2024-SP0108$RO-ROCHE-3520033$ROCHE$$11$YR$C$M$Y$50$KG$20240919$$CN$RO$RO
243363651$24336365$1$I$$20240131$20240919$20240919$PER$$TW-ROCHE-3512695$ROCHE$$$$$M$Y$$$20240919$$CN$TW$TW
243363661$24336366$1$I$$20240131$20240919$20240919$PER$$JP-ROCHE-3509866$ROCHE$$8$YR$C$$Y$$$20240919$$CN$JP$JP
243363671$24336367$1$I$20240321$20240321$20240919$20240919$PER$$JP-ROCHE-3548613$ROCHE$$42$YR$A$M$Y$$$20240919$$PH$JP$JP
243363681$24336368$1$I$20240201$20240404$20240919$20240919$PER$$JP-ROCHE-3555308$ROCHE$$6$DEC$A$F$Y$$$20240919$$MD$JP$JP
243363691$24336369$1$I$20231024$20240130$20240919$20240919$PER$$JP-ROCHE-3507479$ROCHE$$$$A$F$Y$$$20240919$$PH$JP$JP
243363701$24336370$1$I$20230326$20240429$20240919$20240919$PER$$KR-ROCHE-3555698$ROCHE$$7$YR$C$M$Y$18.5$KG$20240919$$HP$KR$KR
243363711$24336371$1$I$$20240301$20240919$20240919$PER$$JP-ROCHE-3535605$ROCHE$$34$YR$A$F$Y$$$20240919$$CN$JP$JP
243363721$24336372$1$I$$20240307$20240919$20240919$PER$$JP-ROCHE-3536766$ROCHE$$38$YR$A$F$Y$$$20240919$$PH$JP$JP
243363731$24336373$1$I$20240311$20240312$20240919$20240919$PER$$JP-ROCHE-3544056$ROCHE$$7$YR$C$$Y$$$20240919$$PH$JP$JP
243363741$24336374$1$I$20230520$20240429$20240919$20240919$PER$$KR-ROCHE-3555688$ROCHE$$16$YR$T$F$Y$$$20240919$$HP$KR$KR
243363751$24336375$1$I$20230405$20240429$20240919$20240919$PER$$KR-ROCHE-3555648$ROCHE$$49$YR$A$F$Y$$$20240919$$HP$KR$KR
243363761$24336376$1$I$$20240321$20240919$20240919$PER$$JP-ROCHE-3549077$ROCHE$$14$YR$T$F$Y$$$20240919$$PH$JP$JP
243363771$24336377$1$I$20240422$20240424$20240919$20240919$PER$$CN-ROCHE-3552634$ROCHE$$68$YR$E$F$Y$70$KG$20240919$$HP$CN$CN
243363781$24336378$1$I$$20240307$20240919$20240919$PER$$JP-ROCHE-3539306$ROCHE$$2$YR$C$$Y$$$20240919$$PH$JP$JP
243363791$24336379$1$I$20210604$20240424$20240919$20240919$PER$$US-ROCHE-3553288$ROCHE$$78$YR$E$M$Y$$$20240919$$MD$US$US
243363801$24336380$1$I$20240222$20240321$20240919$20240919$PER$FR-AFSSAPS-NT2024000196$FR-ROCHE-3530752$ROCHE$$48$YR$A$F$Y$75$KG$20240919$$CN$FR$FR
243363811$24336381$1$I$$20240429$20240919$20240919$PER$$KR-ROCHE-3555705$ROCHE$$$$T$M$Y$$$20240919$$CN$KR$KR
243363831$24336383$1$I$$20240301$20240919$20240919$PER$$JP-ROCHE-3533664$ROCHE$$10$YR$C$F$Y$$$20240919$$HP$JP$JP
243363841$24336384$1$I$20230521$20240429$20240919$20240919$PER$$KR-ROCHE-3555696$ROCHE$$$$E$M$Y$$$20240919$$HP$KR$KR
243363851$24336385$1$I$$20240424$20240919$20240919$PER$$US-ROCHE-3553569$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243363861$24336386$1$I$20240227$20240308$20240919$20240919$PER$$JP-ROCHE-3539062$ROCHE$$6$YR$C$F$Y$19.6$KG$20240919$$PH$JP$JP
243363871$24336387$1$I$20240401$20240423$20240919$20240919$PER$$CN-ROCHE-3551634$ROCHE$$43$YR$A$F$Y$$$20240919$$HP$CN$CN
243363881$24336388$1$I$$20240229$20240919$20240919$PER$$JP-ROCHE-3535610$ROCHE$$7$YR$C$F$Y$$$20240919$$PH$JP$JP
243363891$24336389$1$I$20240125$20240516$20240919$20240919$PER$$JP-ROCHE-3514072$ROCHE$$6$YR$C$M$Y$16$KG$20240919$$MD$JP$JP
243363901$24336390$1$I$20240204$20240422$20240919$20240919$PER$$CN-ROCHE-3551261$ROCHE$$42$YR$A$F$Y$50$KG$20240919$$HP$CN$CN
243363911$24336391$1$I$$20240301$20240919$20240919$PER$$JP-ROCHE-3533641$ROCHE$$18$YR$A$M$Y$$$20240919$$CN$JP$JP
243363921$24336392$1$I$20240419$20240422$20240919$20240919$PER$$CN-ROCHE-3551257$ROCHE$$28$YR$A$M$Y$$$20240919$$HP$CN$CN
243363931$24336393$1$I$20240307$20240318$20240919$20240919$PER$$CN-ROCHE-3529780$ROCHE$$41$YR$A$F$Y$$$20240919$$HP$CN$CN
243363941$24336394$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010591$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240919$$HP$US$US
243363951$24336395$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010952$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243363961$24336396$1$I$$20240510$20240919$20240919$PER$$CN-ROCHE-3563168$ROCHE$Zhu H, Zhu S, Wang Q, Wang L, Jiang Q, Hu Y, Huang Y, Zeng L and Luo Z Acute Necrotizing Encephalopathy Associated with SARS-CoV-2 Infection in Children. DOI: 10.4103/aian.aian_912_23. Annals of Indian Academy of Neurology 2024;27 (2):222-5.$3$YR$C$F$Y$$$20240919$$HP$CN$CN
243363971$24336397$1$I$20240418$20240425$20240919$20240919$PER$$CN-ROCHE-3553673$ROCHE$$31$YR$A$M$Y$68$KG$20240919$$HP$CN$CN
243363981$24336398$1$I$20240312$20240313$20240919$20240919$PER$$JP-ROCHE-3545193$ROCHE$$58$YR$A$M$Y$$$20240919$$PH$JP$JP
243363991$24336399$1$I$$20240411$20240919$20240919$PER$$JP-ROCHE-3537405$ROCHE$$2$DEC$A$F$Y$$$20240919$$PH$JP$JP
243364001$24336400$1$I$20240413$20240416$20240919$20240919$PER$$JP-ROCHE-3560595$ROCHE$$23$YR$A$M$Y$$$20240919$$PH$JP$JP
243364011$24336401$1$I$$20240511$20240919$20240919$PER$$CN-ROCHE-3562398$ROCHE$$64$YR$A$F$Y$$$20240919$$CN$CN$CN
243364021$24336402$1$I$$20240417$20240919$20240919$PER$$JP-ROCHE-3563278$ROCHE$$10$YR$C$M$Y$$$20240919$$MD$JP$JP
243364031$24336403$1$I$20240410$20240410$20240919$20240919$PER$$US-ROCHE-3545266$ROCHE$$41$YR$A$M$Y$$$20240919$$MD$US$US
243364042$24336404$2$F$$20240918$20240919$20240926$EXP$$SA-ROCHE-10000084578$ROCHE$Almutairi S, Alessa D. Linear immunoglobulin A bullous dermatosis induced by atezolizumab. Dermatology Reports. 2024;16 (3):1-3. doi:10.4081/dr.2024.9923.$79$YR$E$M$Y$$$20240926$$HP$SA$SA
243364051$24336405$1$I$$20240509$20240919$20240919$PER$$KR-ROCHE-3560345$ROCHE$$11$YR$C$M$Y$$$20240919$$PH$KR$KR
243364061$24336406$1$I$$20240503$20240919$20240919$PER$$PH-ROCHE-3558850$ROCHE$$$$$$Y$$$20240919$$MD$PH$PH
243364071$24336407$1$I$$20240321$20240919$20240919$PER$$CN-ROCHE-3531393$ROCHE$$45$YR$A$M$Y$$$20240919$$CN$CN$CN
243364081$24336408$1$I$$20240307$20240919$20240919$PER$$JP-ROCHE-3533565$ROCHE$$11$YR$C$F$Y$$$20240919$$PH$JP$JP
243364091$24336409$1$I$20240323$20240409$20240919$20240919$PER$$CN-ROCHE-3543403$ROCHE$$52$YR$A$M$Y$62$KG$20240919$$HP$CN$CN
243364101$24336410$1$I$20240209$20240305$20240919$20240919$PER$$JP-ROCHE-3538689$ROCHE$$74$YR$E$F$Y$$$20240919$$PH$JP$JP
243364111$24336411$1$I$20240322$20240408$20240919$20240919$PER$$CN-ROCHE-3542200$ROCHE$$38$YR$A$F$Y$52$KG$20240919$$HP$CN$CN
243364121$24336412$1$I$$20240411$20240919$20240919$PER$$CN-ROCHE-3545268$ROCHE$$$$$$Y$$$20240919$$HP$CN$CN
243364131$24336413$1$I$$20240510$20240919$20240919$PER$$CN-ROCHE-3562789$ROCHE$$$$$$Y$$$20240919$$HP$CN$CN
243364141$24336414$1$I$20240421$20240429$20240919$20240919$PER$$CN-ROCHE-3555532$ROCHE$$48$YR$A$M$Y$48$KG$20240919$$HP$CN$CN
243364151$24336415$1$I$20240506$20240507$20240919$20240919$PER$$GR-ROCHE-3560433$ROCHE$$37$YR$A$F$Y$$$20240919$$CN$GR$GR
243364161$24336416$1$I$$20240402$20240919$20240919$PER$$HK-ROCHE-3537314$ROCHE$$7$YR$C$M$Y$$$20240919$$HP$HK$HK
243364171$24336417$1$I$20240408$20240426$20240919$20240919$PER$$CN-ROCHE-3554428$ROCHE$$82$YR$E$M$Y$$$20240919$$HP$CN$CN
243364181$24336418$1$I$$20240917$20240919$20240919$PER$$NVSC2024US186531$NOVARTIS$$$$$F$Y$63$KG$20240919$$CN$US$US
243364191$24336419$1$I$20240222$20240408$20240919$20240919$PER$$SG-ROCHE-3542358$ROCHE$$5$YR$C$F$Y$$$20240919$$HP$SG$SG
243364201$24336420$1$I$20240425$20240505$20240919$20240919$PER$$CN-ROCHE-3559115$ROCHE$$48$YR$A$F$Y$60$KG$20240919$$HP$CN$CN
243364211$24336421$1$I$$20240416$20240919$20240919$PER$$US-ROCHE-3531425$ROCHE$$7$YR$C$M$Y$$$20240919$$CN$US$US
243364221$24336422$1$I$20240917$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186339$AMGEN$$$$$F$Y$$$20240919$$CN$US$US
243364231$24336423$1$I$$20240910$20240919$20240919$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR115755$VIIV$$$$$$Y$$$20240919$$HP$US$US
243364241$24336424$1$I$20240105$20240514$20240919$20240919$PER$$CN-ROCHE-3564312$ROCHE$$35$YR$A$F$Y$67$KG$20240919$$HP$CN$CN
243364251$24336425$1$I$20240313$20240327$20240919$20240919$PER$$CN-ROCHE-3535537$ROCHE$$34$YR$A$M$Y$108$KG$20240919$$HP$CN$CN
243364261$24336426$1$I$$20240517$20240919$20240919$PER$$US-ROCHE-3566736$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243364271$24336427$1$I$20240223$20240315$20240919$20240919$PER$$JP-ROCHE-3526942$ROCHE$$66$YR$E$M$Y$$$20240919$$MD$JP$JP
243364281$24336428$1$I$$20240408$20240919$20240919$PER$$RO-ROCHE-3544676$ROCHE$$$$$F$Y$$$20240919$$CN$RO$RO
243364291$24336429$1$I$20240312$20240313$20240919$20240919$PER$$JP-ROCHE-3543892$ROCHE$$10$YR$C$M$Y$$$20240919$$MD$JP$JP
243364301$24336430$1$I$$20240515$20240919$20240919$PER$$DE-ROCHE-3564649$ROCHE$$$$$$Y$$$20240919$$CN$DE$DE
243364311$24336431$1$I$$20240517$20240919$20240919$PER$$US-ROCHE-3566541$ROCHE$$$$A$F$Y$$$20240919$$CN$US$US
243364321$24336432$1$I$$20240517$20240919$20240919$PER$$US-ROCHE-3564946$ROCHE$$66$YR$E$F$Y$$$20240919$$CN$US$US
243364331$24336433$1$I$20240426$20240516$20240919$20240919$PER$$CN-ROCHE-3565948$ROCHE$$55$YR$A$F$Y$55$KG$20240919$$HP$CN$CN
243364341$24336434$1$I$$20240328$20240919$20240919$PER$$EG-ROCHE-3535398$ROCHE$$$$$$Y$$$20240919$$HP$EG$EG
243364351$24336435$1$I$20240401$20240419$20240919$20240919$PER$$JP-ROCHE-3563948$ROCHE$$20$YR$A$F$Y$$$20240919$$PH$JP$JP
243364361$24336436$1$I$$20240301$20240919$20240919$PER$$JP-ROCHE-3533716$ROCHE$$19$YR$A$M$Y$$$20240919$$CN$JP$JP
243364371$24336437$1$I$$20240418$20240919$20240919$PER$$JP-ROCHE-3564837$ROCHE$$4$DEC$A$F$Y$$$20240919$$PH$JP$JP
243364381$24336438$1$I$$20240403$20240919$20240919$PER$$VN-ROCHE-3541813$ROCHE$$$$$$Y$$$20240919$$MD$VN$VN
243364391$24336439$1$I$20240114$20240319$20240919$20240919$PER$$CN-ROCHE-3529983$ROCHE$$24$YR$A$M$Y$70$KG$20240919$$HP$CN$CN
243364401$24336440$1$I$$20240518$20240919$20240919$PER$$US-ROCHE-3566726$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243364411$24336441$1$I$20240410$20240414$20240919$20240919$PER$$IN-ROCHE-3546145$ROCHE$$41$YR$A$F$Y$$$20240919$$CN$IN$IN
243364431$24336443$1$I$$20240517$20240919$20240919$PER$PL-URPL-DML-MLP.4401.2.209.2023$PL-ROCHE-3565997$ROCHE$$$$$M$Y$$$20240919$$CN$PL$PL
243364441$24336444$1$I$20240301$20240304$20240919$20240919$PER$$JP-ROCHE-3535288$ROCHE$$2$DEC$A$F$Y$$$20240919$$MD$JP$JP
243364451$24336445$1$I$$20240506$20240919$20240919$PER$$SE-ROCHE-3564721$ROCHE$$$$$$Y$$$20240919$$PH$SE$SE
243364461$24336446$1$I$20240328$20240409$20240919$20240919$PER$$CN-ROCHE-3543420$ROCHE$$81$YR$E$F$Y$48$KG$20240919$$HP$CN$CN
243364471$24336447$1$I$20240314$20240318$20240919$20240919$PER$$CN-ROCHE-3529043$ROCHE$$37$YR$A$M$Y$65$KG$20240919$$HP$CN$CN
243364481$24336448$1$I$$20240426$20240919$20240919$PER$$JP-ROCHE-3567013$ROCHE$$9$YR$C$F$Y$$$20240919$$PH$JP$JP
243364491$24336449$1$I$20240121$20240520$20240919$20240919$PER$HR-HALMED-300084253$HR-ROCHE-3567149$ROCHE$$15$MON$I$M$Y$10$KG$20240919$$MD$HR$HR
243364501$24336450$1$I$20240801$20240906$20240919$20240919$EXP$$US-UCBSA-2024046154$UCB$$45$YR$$F$Y$$$20240919$$HP$US$US
243364512$24336451$2$F$$20240920$20240919$20240925$30DAY$$CA-UCBSA-2024047932$UCB$$$$$F$Y$$$20240925$$PH$CA$CA
243364521$24336452$1$I$20240410$20240418$20240919$20240919$PER$$CN-ROCHE-3549361$ROCHE$$50$YR$A$F$Y$60$KG$20240919$$HP$CN$CN
243364541$24336454$1$I$20240521$20240521$20240919$20240919$PER$$US-ROCHE-3570537$ROCHE$$70$YR$E$F$Y$$$20240919$$MD$US$US
243364551$24336455$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010592$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240919$$HP$US$US
243364561$24336456$1$I$20240407$20240430$20240919$20240919$PER$$CN-ROCHE-3557732$ROCHE$$80$YR$E$M$Y$60$KG$20240919$$HP$CN$CN
243364571$24336457$1$I$20240521$20240521$20240919$20240919$PER$$US-ROCHE-3570539$ROCHE$$74$YR$E$F$Y$$$20240919$$MD$US$US
243364581$24336458$1$I$20240521$20240521$20240919$20240919$PER$$US-ROCHE-3570545$ROCHE$$55$YR$A$F$Y$$$20240919$$MD$US$US
243364591$24336459$1$I$20240227$20240516$20240919$20240919$PER$$JP-ROCHE-3526935$ROCHE$$4$YR$C$F$Y$$$20240919$$MD$JP$JP
243364601$24336460$1$I$20240521$20240521$20240919$20240919$PER$$US-ROCHE-3570540$ROCHE$$66$YR$E$M$Y$$$20240919$$MD$US$US
243364611$24336461$1$I$$20240516$20240919$20240919$PER$$US-ROCHE-3566239$ROCHE$$46$YR$A$F$Y$85.28$KG$20240919$$MD$US$US
243364621$24336462$1$I$20240522$20240522$20240919$20240919$PER$$US-ROCHE-3570100$ROCHE$$33$YR$A$F$Y$$$20240919$$HP$US$US
243364631$24336463$1$I$20240521$20240521$20240919$20240919$PER$$US-ROCHE-3570544$ROCHE$$38$YR$A$F$Y$$$20240919$$MD$US$US
243364641$24336464$1$I$20240401$20240513$20240919$20240919$PER$$JP-ROCHE-3570580$ROCHE$$10$YR$C$M$Y$$$20240919$$PH$JP$JP
243364651$24336465$1$I$$20240524$20240919$20240919$PER$$BR-ROCHE-3570076$ROCHE$$$$$$Y$$$20240919$$HP$BR$BR
243364661$24336466$1$I$$20240516$20240919$20240919$PER$$HK-ROCHE-3564667$ROCHE$$39$YR$A$$Y$$$20240919$$MD$HK$HK
243364671$24336467$1$I$$20240912$20240919$20240919$EXP$$HU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051186$BOEHRINGER INGELHEIM$$60$YR$A$M$Y$$$20240919$$MD$HU$HU
243364681$24336468$1$I$20240101$20240916$20240919$20240919$EXP$$US-JNJFOC-20240943617$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240919$$HP$US$US
243364691$24336469$1$I$20240915$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149041$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240919$$CN$US$US
243364711$24336471$1$I$20240512$20240529$20240919$20240919$PER$$CN-ROCHE-3573315$ROCHE$$49$YR$A$F$Y$$$20240919$$HP$CN$CN
243364721$24336472$1$I$$20240604$20240919$20240919$PER$$SG-ROCHE-3578501$ROCHE$$$$$F$Y$$$20240919$$HP$SG$SG
243364741$24336474$1$I$20240524$20240524$20240919$20240919$PER$$US-ROCHE-3571044$ROCHE$$35$YR$A$F$Y$$$20240919$$CN$US$US
243364751$24336475$1$I$$20240529$20240919$20240919$PER$$BR-ROCHE-3562223$ROCHE$$$$$F$Y$$$20240919$$CN$BR$BR
243364761$24336476$1$I$20240530$20240530$20240919$20240919$PER$$CN-ROCHE-3573319$ROCHE$$30$YR$A$F$Y$$$20240919$$CN$CN$CN
243364771$24336477$1$I$20240209$20240531$20240919$20240919$PER$FR-AFSSAPS-PV2024000160$FR-ROCHE-3574791$ROCHE$$89$YR$E$F$Y$46$KG$20240919$$MD$FR$FR
243364781$24336478$1$I$20240525$20240607$20240919$20240919$PER$$CN-ROCHE-3578687$ROCHE$$36$YR$A$M$Y$$$20240919$$HP$CN$CN
243364791$24336479$1$I$20230320$20240606$20240919$20240919$PER$$CN-ROCHE-3574165$ROCHE$Zhou P, Li S A case of amenorrhea: Caused by Oseltamivir or Influenza a virus? DOI: 10.1111/aji.13867. American journal of reproductive immunology (New York, N.Y. : 1989) 2024 May;91 (5):1-2.$32$YR$A$F$Y$$$20240919$$HP$CN$CN
243364801$24336480$1$I$20231107$20240520$20240919$20240919$PER$$JP-ROCHE-3572976$ROCHE$$14$YR$T$M$Y$$$20240919$$PH$JP$JP
243364811$24336481$1$I$$20240527$20240919$20240919$PER$$US-ROCHE-3571912$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243364822$24336482$2$F$$20240924$20240919$20240926$PER$$NVSC2024US186749$NOVARTIS$$$$$$Y$$$20240926$$CN$US$US
243364831$24336483$1$I$20240523$20240523$20240919$20240919$PER$$US-ROCHE-3570172$ROCHE$$48$YR$A$F$Y$$$20240919$$HP$US$US
243364841$24336484$1$I$$20240513$20240919$20240919$PER$$JP-ROCHE-3571509$ROCHE$Suzuki K. Case: A case of a five-year-old female patient in which rash was noted after the use of acetaminophen suppositories and a drug-induced lymphocyte stimulation test showed a positive reaction.. Pediatrics of Japan 2024;65 (4):388-92.$5$YR$C$F$Y$17$KG$20240919$$MD$JP$JP
243364851$24336485$1$I$$20240603$20240919$20240919$PER$$US-ROCHE-3576537$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243364861$24336486$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010593$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240919$$HP$US$US
243364871$24336487$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009996$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240919$$CN$US$US
243364881$24336488$1$I$$20240910$20240919$20240919$EXP$$US-INDIVIOR US-INDV-156435-2024$RECKITT BENCKISER$Summer B. Piwowarski , Michael W. McGehee , Derek W. White. Necrotizing Fasciitis Mimicking Interstitial Cystitis: An Atypical Clinical Presentation. Cureus. 2024;16(9):e68649$60$YR$$F$Y$$$20240919$$MD$US$US
243364891$24336489$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011579$ELI LILLY AND CO$$$$$$Y$$$20240919$$HP$US$US
243364901$24336490$1$I$$20240908$20240919$20240919$PER$$US-JNJFOC-20240922522$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243364911$24336491$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010185$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240919$$CN$US$US
243364921$24336492$1$I$20240819$20240911$20240919$20240919$EXP$FR-AFSSAPS-AN2024001188$FR-TEVA-VS-3242796$TEVA$$59$YR$$F$Y$$$20240919$$MD$FR$FR
243364931$24336493$1$I$$20240912$20240919$20240919$EXP$$CA-002147023-NVSC2024CA031633$Haleon PLC$$44$YR$$F$Y$97$KG$20240919$$HP$CA$CA
243364941$24336494$1$I$$20240913$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146622$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240919$$HP$US$US
243364951$24336495$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010594$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240919$$HP$US$US
243364961$24336496$1$I$20190101$20240913$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147314$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$90$KG$20240919$$CN$US$US
243364971$24336497$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010953$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243364981$24336498$1$I$20240807$20240912$20240919$20240919$EXP$$AU-Indivior Limited-INDV-156445-2024$RECKITT BENCKISER$$$$$$Y$$$20240919$$MD$AU$AU
243364991$24336499$1$I$20240419$20240911$20240919$20240919$EXP$FR-AFSSAPS-PA2024001076$FR-TEVA-VS-3242789$TEVA$$59$YR$$F$Y$57.5$KG$20240919$$MD$FR$FR
243365001$24336500$1$I$20240915$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185078$AMGEN$$73$YR$E$F$Y$$$20240919$$CN$US$US
243365012$24336501$2$F$20240101$20240918$20240919$20240924$EXP$$US-ABBVIE-5928299$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243365022$24336502$2$F$$20240924$20240919$20240930$EXP$$US-SANDOZ INC.-NVSC2022US223158$SANDOZ$$$$$M$Y$136.05$KG$20240930$$CN$US$US
243365031$24336503$1$I$$20240831$20240919$20240919$PER$$US-TEVA-VS-3239737$TEVA$$$$$$Y$$$20240919$$HP$US$US
243365052$24336505$2$F$20240813$20240917$20240919$20240924$EXP$$IQ-ROCHE-10000080186$ROCHE$$$$$M$Y$$$20240924$$MD$IQ$IQ
243365061$24336506$1$I$20240913$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185501$AMGEN$$59$YR$A$F$Y$$$20240919$$HP$US$US
243365071$24336507$1$I$20240913$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024186735$AMGEN$$$$$$Y$$$20240919$$HP$US$US
243365081$24336508$1$I$$20240827$20240919$20240919$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005126$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$CN$US$US
243365091$24336509$1$I$$20240913$20240919$20240919$EXP$$JP-ROCHE-10000085821$ROCHE$$7$DEC$E$M$Y$$$20240919$$MD$JP$JP
243365101$24336510$1$I$$20240917$20240919$20240919$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052013$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240919$$HP$US$US
243365111$24336511$1$I$$20240904$20240919$20240919$EXP$$CH-AZURITY PHARMACEUTICALS, INC.-AZR202409-000616$AZURITY PHARMACEUTICALS$Corbisier T, Von Bueren AO, Breunis WB, Grazioli S.. Role of molecular adsorbent recirculating system in methotrexate-induced acute liver failure: a case report and literature review. Front Pediatr.. 2024;12$14$YR$$F$Y$$$20240918$$HP$CH$CH
243365121$24336512$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010595$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240919$$HP$US$US
243365132$24336513$2$F$$20240917$20240919$20240930$EXP$$ZA-HALEON-2197194$Haleon PLC$$$$$$Y$$$20240928$$CN$ZA$ZA
243365141$24336514$1$I$20240601$20240909$20240919$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-019045$UNITED THERAPEUTICS$$80$YR$$M$Y$63.492$KG$20240919$$$US$US
243365151$24336515$1$I$$20240904$20240919$20240919$PER$$US-SA-2024SA269707$SANOFI AVENTIS$$$$A$M$Y$81.82$KG$20240919$$MD$US$US
243365161$24336516$1$I$20240101$20240829$20240919$20240919$PER$$US-SA-2024SA268325$SANOFI AVENTIS$$$$A$F$Y$87.08$KG$20240919$$MD$US$US
243365171$24336517$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA265935$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240919$$HP$US$US
243365181$24336518$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA268988$SANOFI AVENTIS$$$$E$F$Y$$$20240919$$MD$US$US
243365191$24336519$1$I$20240731$20240828$20240919$20240919$PER$$US-SA-2024SA267790$SANOFI AVENTIS$$65$YR$E$M$Y$81.82$KG$20240919$$MD$US$US
243365201$24336520$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA265845$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240919$$MD$US$US
243365211$24336521$1$I$20240801$20240828$20240919$20240919$PER$$US-SA-2024SA268385$SANOFI AVENTIS$$32$YR$A$M$Y$79.3$KG$20240919$$MD$US$US
243365221$24336522$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA269360$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240919$$MD$US$US
243365231$24336523$1$I$$20240821$20240919$20240919$PER$$US-SA-2024SA266049$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240919$$CN$US$US
243365241$24336524$1$I$20240101$20240905$20240919$20240919$PER$$US-SA-2024SA266814$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240919$$CN$US$US
243365251$24336525$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA268160$SANOFI AVENTIS$$$$$$Y$$$20240919$$HP$US$US
243365261$24336526$1$I$$20240828$20240919$20240919$PER$$US-SA-2024SA267392$SANOFI AVENTIS$$$$A$F$Y$44$KG$20240919$$MD$US$US
243365271$24336527$1$I$20240301$20240828$20240919$20240919$PER$$US-SA-2024SA267766$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240919$$MD$US$US
243365281$24336528$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266163$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240919$$MD$US$US
243365291$24336529$1$I$20240101$20240829$20240919$20240919$PER$$PR-SA-2024SA267386$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240919$$MD$PR$PR
243365301$24336530$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA266092$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240919$$HP$US$US
243365311$24336531$1$I$20240901$20240910$20240919$20240919$PER$$US-SA-2024SA266181$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240919$$MD$US$US
243365321$24336532$1$I$20240801$20240829$20240919$20240919$PER$$US-SA-2024SA267581$SANOFI AVENTIS$$67$YR$E$M$Y$99.79$KG$20240919$$MD$US$US
243365331$24336533$1$I$$20240827$20240919$20240919$PER$$US-SA-2024SA267918$SANOFI AVENTIS$$$$E$F$Y$77.1$KG$20240919$$HP$US$US
243365341$24336534$1$I$20240901$20240910$20240919$20240919$PER$$US-SA-2024SA265879$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240919$$HP$US$US
243365351$24336535$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA229912$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240919$$CN$US$US
243365361$24336536$1$I$$20240828$20240919$20240919$PER$$US-SA-2024SA266812$SANOFI AVENTIS$$$$A$M$Y$$$20240919$$MD$US$US
243365371$24336537$1$I$20240101$20240828$20240919$20240919$PER$$US-SA-2024SA267415$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240919$$MD$US$US
243365381$24336538$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA266444$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240919$$MD$US$US
243365391$24336539$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266197$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240919$$MD$US$US
243365401$24336540$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA266677$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240919$$MD$US$US
243365411$24336541$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA269038$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240919$$CN$US$US
243365421$24336542$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA267283$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240919$$CN$US$US
243365431$24336543$1$I$20240801$20240830$20240919$20240919$PER$$US-SA-2024SA269626$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240919$$CN$US$US
243365441$24336544$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266349$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240919$$MD$US$US
243365451$24336545$1$I$20240801$20240828$20240919$20240919$PER$$US-SA-2024SA266994$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240919$$HP$US$US
243365461$24336546$1$I$20240803$20240911$20240919$20240919$PER$$US-SA-2024SA266822$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240919$$MD$US$US
243365471$24336547$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266390$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240919$$MD$US$US
243365481$24336548$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA266153$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240919$$HP$US$US
243365491$24336549$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267135$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240919$$HP$US$US
243365501$24336550$1$I$20210301$20240912$20240919$20240919$PER$$US-SA-2024SA269739$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240919$$MD$US$US
243365511$24336551$1$I$20240801$20240913$20240919$20240919$PER$$US-SA-2024SA268864$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240919$$HP$US$US
243365521$24336552$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266336$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240919$$MD$US$US
243365531$24336553$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268698$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240919$$MD$US$US
243365541$24336554$1$I$$20240909$20240919$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005473$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
243365551$24336555$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010954$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243365561$24336556$1$I$$20240911$20240919$20240919$EXP$$US-EMD Serono-2024048928$EMD SERONO INC$$$$$F$Y$$$20240919$$CN$US$US
243365571$24336557$1$I$$20240910$20240919$20240919$EXP$$ES-AUROBINDO-AUR-APL-2022-032516$AUROBINDO$Macias-Iglesias EM, Campanon-Toro MV, Moreno Rodilla E, de Arriba-Mendez S, Sobrino-Garcia M, Gallardo-Higueras A, et al.. DRESS Syndrome Induced by a Gadolinium-Based Contrast Agent in a 13-Year-Old Boy. J Investig Allergol Clin Immunol. 2022;32(3):238-240$13$YR$$M$Y$$$20240919$$MD$ES$ES
243365581$24336558$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010596$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240919$$HP$US$US
243365592$24336559$2$F$$20240920$20240919$20240930$EXP$$BR-CELLTRION INC.-2023BR005276$CELLTRION$$$$$$Y$$$20240930$$CN$BR$BR
243365601$24336560$1$I$20240829$20240906$20240919$20240919$EXP$$US-INSMED, INC.-2024-03598-US$INSMED$$60$YR$$M$Y$$$20240919$$HP$US$US
243365611$24336561$1$I$$20240917$20240919$20240919$PER$$US-ROCHE-10000085356$ROCHE$$64$YR$A$F$Y$$$20240919$$CN$US$US
243365622$24336562$2$F$$20240913$20240919$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08682$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243365632$24336563$2$F$20240101$20240918$20240919$20240928$PER$$US-JNJFOC-20240948771$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240928$$CN$US$US
243365641$24336564$1$I$$20240910$20240919$20240919$PER$$US-JNJFOC-20240939822$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240919$$CN$US$US
243365651$24336565$1$I$20240501$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185820$AMGEN$$65$YR$E$F$Y$$$20240919$$PH$US$US
243365661$24336566$1$I$20231231$20231231$20240919$20240919$PER$$GR-ROCHE-3484427$ROCHE$$37$YR$A$F$Y$$$20240919$$CN$GR$GR
243365671$24336567$1$I$20231228$20240103$20240919$20240919$PER$$CN-ROCHE-3485696$ROCHE$$17$YR$T$F$Y$40$KG$20240919$$HP$CN$CN
243365681$24336568$1$I$20231225$20231225$20240919$20240919$PER$$JP-ROCHE-3484045$ROCHE$$95$YR$E$F$Y$$$20240919$$PH$JP$JP
243365691$24336569$1$I$$20240102$20240919$20240919$PER$$CN-ROCHE-3485003$ROCHE$$34$YR$A$F$Y$$$20240919$$CN$CN$CN
243365701$24336570$1$I$20231208$20231226$20240919$20240919$PER$$JP-ROCHE-3484167$ROCHE$$74$YR$E$F$Y$$$20240919$$PH$JP$JP
243365711$24336571$1$I$20231227$20240102$20240919$20240919$PER$$CN-ROCHE-3485057$ROCHE$$54$YR$A$M$Y$$$20240919$$HP$CN$CN
243365721$24336572$1$I$20160623$20240104$20240919$20240919$PER$FR-AFSSAPS-NC2023001550$FR-ROCHE-3485580$ROCHE$$8$YR$C$F$Y$$$20240919$$MD$FR$FR
243365731$24336573$1$I$$20240913$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147788$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240919$$HP$US$US
243365751$24336575$1$I$20240915$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185529$AMGEN$$71$YR$E$F$Y$$$20240919$$CN$US$US
243365762$24336576$2$F$20240906$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024186030$AMGEN$$52$YR$A$F$Y$$$20240919$$CN$US$US
243365771$24336577$1$I$20240910$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024184055$AMGEN$$78$YR$E$M$Y$$$20240919$$CN$US$US
243365791$24336579$1$I$$20231222$20240919$20240919$PER$$JP-ROCHE-3484103$ROCHE$$82$YR$E$M$Y$$$20240919$$PH$JP$JP
243365801$24336580$1$I$$20240910$20240919$20240919$EXP$GB-MHRA-MED-202409091441383670-QWGDL$GB-CELLTRION INC.-2024GB021859$CELLTRION$$$$$$Y$$$20240919$$CN$GB$GB
243365811$24336581$1$I$20231207$20231229$20240919$20240919$PER$$CN-ROCHE-3484528$ROCHE$$35$YR$A$F$Y$53$KG$20240919$$HP$CN$CN
243365821$24336582$1$I$$20240104$20240919$20240919$PER$$US-ROCHE-3485117$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243365831$24336583$1$I$20231202$20231227$20240919$20240919$PER$$CN-ROCHE-3483942$ROCHE$$32$YR$A$M$Y$75$KG$20240919$$HP$CN$CN
243365841$24336584$1$I$20231222$20231222$20240919$20240919$PER$$JP-ROCHE-3484075$ROCHE$$5$YR$C$F$Y$$$20240919$$PH$JP$JP
243365851$24336585$1$I$$20240102$20240919$20240919$PER$$KR-ROCHE-3485144$ROCHE$$$$$F$Y$$$20240919$$CN$KR$KR
243365861$24336586$1$I$20231211$20231226$20240919$20240919$PER$$CN-ROCHE-3483964$ROCHE$$24$YR$A$F$Y$$$20240919$$HP$CN$CN
243365871$24336587$1$I$20231225$20231226$20240919$20240919$PER$$JP-ROCHE-3484189$ROCHE$$3$DEC$A$F$Y$$$20240919$$MD$JP$JP
243365881$24336588$1$I$$20231225$20240919$20240919$PER$$JP-ROCHE-3484297$ROCHE$$$$$M$Y$$$20240919$$CN$JP$JP
243365891$24336589$1$I$$20231228$20240919$20240919$PER$$US-ROCHE-3483941$ROCHE$$46$YR$A$F$Y$$$20240919$$CN$US$US
243365902$24336590$2$F$$20240918$20240919$20240920$PER$$NVSC2024US186756$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
243365911$24336591$1$I$20231225$20240102$20240919$20240919$PER$$CN-ROCHE-3485056$ROCHE$$67$YR$E$F$Y$65$KG$20240919$$HP$CN$CN
243365921$24336592$1$I$20231207$20240103$20240919$20240919$PER$$CN-ROCHE-3485492$ROCHE$$47$YR$A$F$Y$63$KG$20240919$$HP$CN$CN
243365931$24336593$1$I$20231201$20231226$20240919$20240919$PER$$JP-ROCHE-3484113$ROCHE$$$$$M$Y$$$20240919$$PH$JP$JP
243365951$24336595$1$I$20240101$20240904$20240919$20240919$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000776$DECIPHERA PHARMACEUTICALS$$83$YR$E$F$Y$$$20240919$$MD$US$US
243365961$24336596$1$I$$20240909$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-018026$AUROBINDO$$$$$F$Y$$$20240919$$HP$GB$GB
243365971$24336597$1$I$$20240913$20240919$20240919$EXP$$US-TAKEDA-2024TUS077816$TAKEDA$$$$$F$Y$$$20240919$$CN$US$US
243365981$24336598$1$I$$20240910$20240919$20240919$PER$$US-GILEAD-2024-0687933$GILEAD$$$$$$Y$$$20240919$$CN$US$US
243365991$24336599$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010065$ELI LILLY AND CO$$$$$$Y$$$20240919$$CN$US$US
243366001$24336600$1$I$$20240910$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409007013$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240919$$CN$US$US
243366011$24336601$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010685$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243366021$24336602$1$I$20240801$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010562$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240919$$CN$US$US
243366031$24336603$1$I$20240913$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010504$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240919$$CN$US$US
243366041$24336604$1$I$20240915$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010704$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240919$$CN$US$US
243366051$24336605$1$I$$20240913$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010296$ELI LILLY AND CO$$69$YR$E$$Y$$$20240919$$LW$US$US
243366061$24336606$1$I$$20240913$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010256$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240919$$CN$US$US
243366081$24336608$1$I$20240910$20240913$20240919$20240919$PER$$US-ABBVIE-5926384$ABBVIE$$29$YR$$F$Y$$$20240919$$MD$US$US
243366091$24336609$1$I$20231203$20231226$20240919$20240919$PER$$JP-ROCHE-3486237$ROCHE$$$$$M$Y$$$20240919$$PH$JP$JP
243366101$24336610$1$I$$20240906$20240919$20240919$EXP$$PL-AUROBINDO-AUR-APL-2024-045189$AUROBINDO$Saczek A, Saczek A, Batko K, Krzanowska K, Swiatek M, Okon K, et al.. Multicellular echinococcosis (alvococcosis) in a kidney transplant patient.. Polish Archives of Internal Medicine. 2024;134 (5)::1-3.$70$YR$$F$Y$$$20240919$$HP$PL$PL
243366111$24336611$1$I$$20231227$20240919$20240919$PER$$JP-ROCHE-3486292$ROCHE$$$$A$$Y$$$20240919$$PH$JP$JP
243366121$24336612$1$I$$20231227$20240919$20240919$PER$$JP-ROCHE-3486240$ROCHE$$62$YR$A$F$Y$$$20240919$$PH$JP$JP
243366131$24336613$1$I$20231223$20240104$20240919$20240919$PER$$CN-ROCHE-3486313$ROCHE$$48$YR$A$M$Y$80$KG$20240919$$HP$CN$CN
243366141$24336614$1$I$$20231228$20240919$20240919$PER$$JP-ROCHE-3486233$ROCHE$$48$YR$A$F$Y$$$20240919$$PH$JP$JP
243366151$24336615$1$I$$20231227$20240919$20240919$PER$$JP-ROCHE-3486242$ROCHE$$85$YR$E$F$Y$$$20240919$$PH$JP$JP
243366161$24336616$1$I$20231216$20231226$20240919$20240919$PER$$JP-ROCHE-3486154$ROCHE$$14$YR$T$M$Y$51$KG$20240919$$PH$JP$JP
243366171$24336617$1$I$$20240913$20240919$20240919$PER$$US-ROCHE-10000083255$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243366181$24336618$1$I$$20240909$20240919$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005448$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
243366191$24336619$1$I$20231205$20231226$20240919$20240919$PER$$JP-ROCHE-3486146$ROCHE$$4$YR$C$M$Y$$$20240919$$PH$JP$JP
243366201$24336620$1$I$20231201$20231226$20240919$20240919$PER$$JP-ROCHE-3486133$ROCHE$$36$YR$A$M$Y$$$20240919$$PH$JP$JP
243366211$24336621$1$I$$20240102$20240919$20240919$PER$$CN-ROCHE-3485699$ROCHE$$$$$$Y$18$KG$20240919$$CN$CN$CN
243366221$24336622$1$I$$20231228$20240919$20240919$PER$$JP-ROCHE-3486269$ROCHE$$32$YR$A$M$Y$$$20240919$$PH$JP$JP
243366231$24336623$1$I$$20231227$20240919$20240919$PER$$JP-ROCHE-3486184$ROCHE$$59$YR$A$M$Y$$$20240919$$PH$JP$JP
243366241$24336624$1$I$20231101$20240103$20240919$20240919$PER$$SG-ROCHE-3485885$ROCHE$$9$YR$C$M$Y$$$20240919$$HP$SG$SG
243366251$24336625$1$I$$20231228$20240919$20240919$PER$$JP-ROCHE-3486250$ROCHE$$91$YR$E$F$Y$$$20240919$$PH$JP$JP
243366261$24336626$1$I$20231227$20231227$20240919$20240919$PER$$JP-ROCHE-3486138$ROCHE$$68$YR$E$F$Y$$$20240919$$PH$JP$JP
243366271$24336627$1$I$20231127$20240103$20240919$20240919$PER$$CN-ROCHE-3485717$ROCHE$$22$YR$A$M$Y$60$KG$20240919$$HP$CN$CN
243366281$24336628$1$I$$20231226$20240919$20240919$PER$$JP-ROCHE-3486192$ROCHE$$13$YR$T$F$Y$$$20240919$$PH$JP$JP
243366291$24336629$1$I$20231201$20240118$20240919$20240919$PER$$JP-ROCHE-3486290$ROCHE$$60$YR$A$F$Y$$$20240919$$PH$JP$JP
243366301$24336630$1$I$$20240909$20240919$20240919$EXP$$US-ROCHE-3305844$ROCHE$$81$YR$E$M$Y$$$20240919$$CN$US$US
243366311$24336631$1$I$20240916$20240917$20240919$20240919$EXP$$US-ABBVIE-5928501$ABBVIE$$66$YR$$F$Y$$$20240919$$CN$US$US
243366321$24336632$1$I$20231226$20231227$20240919$20240919$PER$$JP-ROCHE-3486174$ROCHE$$36$YR$A$M$Y$$$20240919$$CN$JP$JP
243366331$24336633$1$I$20231206$20240103$20240919$20240919$PER$$CN-ROCHE-3485701$ROCHE$$27$YR$A$F$Y$58$KG$20240919$$HP$CN$CN
243366341$24336634$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3486802$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243366351$24336635$1$I$20231203$20231226$20240919$20240919$PER$$JP-ROCHE-3486181$ROCHE$$44$YR$A$F$Y$$$20240919$$PH$JP$JP
243366361$24336636$1$I$$20240906$20240919$20240919$EXP$$ES-AUROBINDO-AUR-APL-2024-045249$AUROBINDO$Beltra-Pico I, D?az-Gonzalez M, Nalda-Molina R, Ramon-Lopez A, Pascual-Bartolome S, Miralles-Macia C, et al. Cassia angustifolia and tacrolimus interaction in a liver transplant patient, a case report. British Journal of Clinical Pharmacology. 2024;90 (7):1745-50$60$YR$$M$Y$59$KG$20240919$$HP$ES$ES
243366371$24336637$1$I$20231201$20231226$20240919$20240919$PER$$JP-ROCHE-3486131$ROCHE$$78$YR$E$M$Y$$$20240919$$PH$JP$JP
243366381$24336638$1$I$$20231229$20240919$20240919$PER$$JP-ROCHE-3486194$ROCHE$$46$YR$A$F$Y$$$20240919$$PH$JP$JP
243366391$24336639$1$I$20231227$20240102$20240919$20240919$PER$$CN-ROCHE-3487028$ROCHE$$24$YR$A$M$Y$65$KG$20240919$$HP$CN$CN
243366401$24336640$1$I$20231224$20240104$20240919$20240919$PER$$CN-ROCHE-3486927$ROCHE$$8$YR$C$F$Y$42$KG$20240919$$HP$CN$CN
243366411$24336641$1$I$$20231226$20240919$20240919$PER$$JP-ROCHE-3486143$ROCHE$$$$A$F$Y$$$20240919$$PH$JP$JP
243366421$24336642$1$I$20231228$20240102$20240919$20240919$PER$$CN-ROCHE-3487029$ROCHE$$47$YR$A$F$Y$$$20240919$$HP$CN$CN
243366431$24336643$1$I$20240612$20240916$20240919$20240919$EXP$$US-SA-2024SA269271$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240919$$HP$US$US
243366441$24336644$1$I$20080801$20240916$20240919$20240919$EXP$$GB-SA-2024SA268497$SANOFI AVENTIS$Edwin Lim CS., Lian Low SB, Joy C, Hill L, Davies P.. Leflunomide-associated severe dyslipidaemia in a rheumatoid arthritis patient.. Rheumatology (United Kingdom). 2012;51:10.45-11.45$62$YR$A$M$Y$$$20240919$$HP$GB$GB
243366451$24336645$1$I$$20240905$20240919$20240919$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000777$DECIPHERA PHARMACEUTICALS$$80$YR$E$F$Y$68.1$KG$20240919$$CN$US$US
243366461$24336646$1$I$$20240913$20240919$20240919$EXP$$US-ABBVIE-5925241$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243366472$24336647$2$F$20240401$20240919$20240919$20240925$EXP$$US-ABBVIE-5924927$ABBVIE$$70$YR$$F$Y$101.15$KG$20240925$$CN$US$US
243366481$24336648$1$I$$20240905$20240919$20240919$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08514$HIKMA$Zou H, Rau A, Thompson L, Henderson D.. Zou H, Rau A, Thompson L, Henderson D. Pancytopenia Concurrent With Metabolic Encephalopathy. Cureus. Cureus. 2024;16(8):/$81$YR$$F$Y$$$20240919$$MD$US$US
243366491$24336649$1$I$20230101$20240917$20240919$20240919$EXP$$NVSJ2024JP011012$NOVARTIS$$58$YR$$F$Y$$$20240919$$PH$JP$JP
243366501$24336650$1$I$$20240103$20240919$20240919$PER$$US-ROCHE-3485872$ROCHE$$$$$F$Y$$$20240919$$CN$US$US
243366511$24336651$1$I$20240822$20240916$20240919$20240919$PER$$US-ROCHE-10000085633$ROCHE$$$$$F$Y$$$20240919$$CN$US$US
243366521$24336652$1$I$20231201$20231226$20240919$20240919$PER$$JP-ROCHE-3486246$ROCHE$$$$$F$Y$$$20240919$$PH$JP$JP
243366531$24336653$1$I$$20240912$20240919$20240919$PER$$US-JNJFOC-20240932817$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$MD$US$US
243366541$24336654$1$I$20240101$20240912$20240919$20240919$EXP$$DE-JNJFOC-20240940042$JOHNSON AND JOHNSON$$$$$M$Y$2.835$KG$20240919$$MD$DE$DE
243366551$24336655$1$I$20230801$20240913$20240919$20240919$EXP$FR-AFSSAPS-CF2023000486$FR-TEVA-VS-3243915$TEVA$$55$YR$$M$Y$102$KG$20240919$$MD$FR$FR
243366561$24336656$1$I$20240721$20240912$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014559$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243366571$24336657$1$I$$20240910$20240919$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147368$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240919$$MD$JP$JP
243366581$24336658$1$I$$20240912$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145756$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240919$$CN$US$US
243366591$24336659$1$I$20240501$20240910$20240919$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-090582$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240919$$MD$JP$JP
243366601$24336660$1$I$$20240906$20240919$20240919$EXP$$NL-AUROBINDO-AUR-APL-2024-045368$AUROBINDO$Inthasot S, Leemans S, Hing M, Vanderhulst J.. Fever of unknown origin revealing testicular nocardiosis: a case report and literature review.. BMC Infectious Diseases.. 2024;24 (614):1-11$52$YR$$M$Y$$$20240919$$HP$NL$NL
243366611$24336661$1$I$20240906$20240910$20240919$20240919$EXP$$FR-ROCHE-10000079485$ROCHE$$$$$F$Y$$$20240919$$HP$FR$FR
243366621$24336662$1$I$20240909$20240909$20240919$20240919$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000781$DECIPHERA PHARMACEUTICALS$$63$YR$A$F$Y$$$20240919$$CN$US$US
243366631$24336663$1$I$20240917$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185824$AMGEN$$64$YR$A$F$Y$$$20240919$$CN$US$US
243366641$24336664$1$I$20240908$20240909$20240919$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005415$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240919$$CN$US$US
243366653$24336665$3$F$20240913$20240920$20240919$20240924$EXP$$US-ABBVIE-5925053$ABBVIE$$90$YR$$$Y$70$KG$20240924$$CN$US$US
243366661$24336666$1$I$20240911$20240913$20240919$20240919$EXP$$CN-SPECGX-T202401919$SPECGX$$33$YR$$M$Y$50$KG$20240919$$CN$CN$CN
243366671$24336667$1$I$20240901$20240916$20240919$20240919$EXP$$US-SA-2024SA268265$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240919$$CN$US$US
243366701$24336670$1$I$20240713$20240916$20240919$20240919$EXP$$EG-ROCHE-10000082804$ROCHE$$55$YR$A$F$Y$$$20240919$$HP$EG$EG
243366711$24336671$1$I$20240901$20240914$20240919$20240919$EXP$$US-ABBVIE-5925820$ABBVIE$$64$YR$$M$Y$$$20240919$$CN$US$US
243366721$24336672$1$I$20240901$20240909$20240919$20240919$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000786$DECIPHERA PHARMACEUTICALS$$76$YR$E$F$Y$$$20240919$$CN$US$US
243366731$24336673$1$I$$20240910$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144801$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240919$$CN$US$US
243366751$24336675$1$I$$20240917$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148700$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240919$$CN$US$US
243366771$24336677$1$I$$20240917$20240919$20240919$PER$$US-ROCHE-10000085661$ROCHE$$$$A$M$Y$$$20240919$$MD$US$US
243366781$24336678$1$I$20240831$20240912$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014554$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243366791$24336679$1$I$20231228$20231228$20240919$20240919$PER$$JP-ROCHE-3487879$ROCHE$$5$YR$C$M$Y$$$20240919$$PH$JP$JP
243366801$24336680$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487974$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243366811$24336681$1$I$$20240118$20240919$20240919$PER$$BR-ROCHE-3487756$ROCHE$$18$YR$A$F$Y$$$20240919$$CN$BR$BR
243366821$24336682$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487956$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243366831$24336683$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487958$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243366841$24336684$1$I$20231106$20240105$20240919$20240919$PER$$CN-ROCHE-3487386$ROCHE$$28$YR$A$M$Y$100$KG$20240919$$HP$CN$CN
243366851$24336685$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487986$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243366861$24336686$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487988$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243366871$24336687$1$I$$20231228$20240919$20240919$PER$$JP-ROCHE-3487843$ROCHE$$61$YR$A$F$Y$$$20240919$$PH$JP$JP
243366881$24336688$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487989$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243366891$24336689$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487957$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243366901$24336690$1$I$$20240105$20240919$20240919$PER$$KR-ROCHE-3487501$ROCHE$$$$A$M$Y$$$20240919$$PH$KR$KR
243366911$24336691$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487987$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243366921$24336692$1$I$20240901$20240912$20240919$20240919$PER$$US-ABBVIE-5923847$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243366931$24336693$1$I$20240910$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024183671$AMGEN$$67$YR$E$F$Y$94.5$KG$20240919$$HP$US$US
243366941$24336694$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487999$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243366951$24336695$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487998$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243366961$24336696$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487997$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243366971$24336697$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487995$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243366981$24336698$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488000$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243366991$24336699$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487993$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367001$24336700$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488001$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367011$24336701$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487992$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367021$24336702$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487994$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367031$24336703$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487990$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367041$24336704$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487996$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367051$24336705$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487991$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367061$24336706$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488002$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367071$24336707$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488006$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367081$24336708$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488011$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367091$24336709$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488008$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367101$24336710$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488004$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367111$24336711$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488009$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367121$24336712$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488007$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367131$24336713$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488005$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367141$24336714$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488013$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367151$24336715$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488012$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367161$24336716$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488003$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367181$24336718$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488010$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367191$24336719$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488022$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367201$24336720$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488014$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367211$24336721$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488016$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367221$24336722$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488024$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367231$24336723$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487965$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367241$24336724$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488018$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367251$24336725$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488021$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367261$24336726$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488017$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367271$24336727$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488020$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367281$24336728$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488019$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367291$24336729$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488015$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367301$24336730$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488023$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367311$24336731$1$I$20231201$20240913$20240919$20240919$PER$$US-ORGANON-O2409USA001074$ORGANON$$$$$F$Y$$$20240919$$CN$US$US
243367321$24336732$1$I$$20240909$20240919$20240919$EXP$$AU-009507513-2409AUS004545$MERCK$$61$YR$$$Y$$$20240919$$MD$AU$AU
243367331$24336733$1$I$$20240912$20240919$20240919$PER$$US-TAKEDA-2024TUS092362$TAKEDA$$$$$F$Y$$$20240919$$CN$US$US
243367341$24336734$1$I$$20240917$20240919$20240919$EXP$$JP-TAKEDA-2024TJP013707$TAKEDA$$4$DEC$$F$Y$$$20240919$$MD$JP$JP
243367351$24336735$1$I$20240825$20240918$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US081179$SANDOZ$$$$$F$Y$$$20240919$$CN$US$US
243367361$24336736$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3487977$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243367371$24336737$1$I$20240813$20240917$20240919$20240919$EXP$FR-AFSSAPS-NC2024001092$FR-ORGANON-O2409FRA001208$ORGANON$$40$YR$$M$Y$62.8$KG$20240919$$MD$FR$FR
243367381$24336738$1$I$20240101$20240908$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044846$AUROBINDO$$82$YR$$F$Y$$$20240919$$CN$GB$GB
243367391$24336739$1$I$$20240910$20240919$20240919$EXP$$US-ROCHE-10000079017$ROCHE$$86$YR$E$M$Y$$$20240919$$CN$US$US
243367401$24336740$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010555$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243367411$24336741$1$I$20240916$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010757$ELI LILLY AND CO$$26$YR$A$M$Y$$$20240919$$CN$US$US
243367421$24336742$1$I$20240901$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011041$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240919$$CN$US$US
243367432$24336743$2$F$$20240916$20240919$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409009800$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240923$$CN$US$US
243367441$24336744$1$I$20240916$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011181$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240919$$CN$US$US
243367451$24336745$1$I$20240804$20240912$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014561$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243367462$24336746$2$F$$20240926$20240919$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409011183$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240930$$CN$US$US
243367471$24336747$1$I$$20240916$20240919$20240919$EXP$$US-TAKEDA-2024TUS060184$TAKEDA$$$$$F$Y$$$20240919$$CN$US$US
243367481$24336748$1$I$20240901$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024184530$AMGEN$$77$YR$E$M$Y$$$20240919$$CN$US$US
243367501$24336750$1$I$$20240911$20240919$20240919$EXP$$US-JNJFOC-20240933921$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$CN$US$US
243367511$24336751$1$I$$20240909$20240919$20240919$EXP$$CN-ROCHE-10000084777$ROCHE$Chen M, Liu X, Guo Y. Efficacy and safety of retinal photocoagulation combined with intravitreal injection of ranibizumab in the treatment of diabetic macular edema. CLINICAL RESEARCH AND PRACTICE. 2024;24 (9):115-8. doi:10.19347/j.cnki.2096-1413.202424029.$$$$$Y$$$20240919$$HP$CN$CN
243367521$24336752$1$I$20170501$20240914$20240919$20240919$EXP$$IR-REGENERON PHARMACEUTICALS, INC.-2024-124969$REGENERON$$$$$M$Y$$$20240919$$HP$IR$IR
243367531$24336753$1$I$20240904$20240913$20240919$20240919$EXP$$CO-BIOVITRUM-2024-CO-012187$BIOVITRUM$$54$WK$$M$Y$8.5$KG$20240919$$CN$CO$CO
243367541$24336754$1$I$20240831$20240913$20240919$20240919$EXP$$BE-JNJFOC-20240939842$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240919$$PH$BE$BE
243367551$24336755$1$I$$20240911$20240919$20240919$EXP$$CA-CELLTRION INC.-2024CA021799$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
243367562$24336756$2$F$$20240912$20240919$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08958$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243367571$24336757$1$I$$20240911$20240919$20240919$EXP$$BR-CELLTRION INC.-2023BR005351$CELLTRION$$$$$$Y$$$20240919$$CN$BR$BR
243367581$24336758$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488060$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367591$24336759$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488061$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367601$24336760$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488057$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367611$24336761$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488058$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367621$24336762$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488059$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367631$24336763$1$I$20240909$20240912$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014555$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243367641$24336764$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488067$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367651$24336765$1$I$$20240909$20240919$20240919$EXP$$CH-ROCHE-10000077169$ROCHE$$$$$F$Y$43$KG$20240919$$MD$CH$CH
243367661$24336766$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488066$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367671$24336767$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488062$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367681$24336768$1$I$$20240909$20240919$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005478$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240919$$MD$US$US
243367691$24336769$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488063$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367701$24336770$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488070$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367711$24336771$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488064$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367721$24336772$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488068$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367731$24336773$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488065$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367741$24336774$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488069$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367751$24336775$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488071$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367761$24336776$1$I$20240708$20240910$20240919$20240919$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-08482$HIKMA$$45$YR$$F$Y$95$KG$20240919$$PH$EG$EG
243367771$24336777$1$I$20240913$20240913$20240919$20240919$EXP$$CN-GSK-CN2024APC113936$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$CN$CN
243367782$24336778$2$F$$20240916$20240919$20240922$PER$$US-JNJFOC-20240942736$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240922$$CN$US$US
243367791$24336779$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488076$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367801$24336780$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488028$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367811$24336781$1$I$20240501$20240910$20240919$20240919$EXP$$IE-ABBVIE-5927370$ABBVIE$$87$YR$$M$Y$$$20240919$$HP$IE$IE
243367821$24336782$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488033$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367831$24336783$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488034$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367841$24336784$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488029$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367851$24336785$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488072$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367861$24336786$1$I$$20240910$20240919$20240919$EXP$$IN-ROCHE-10000079455$ROCHE$$31$YR$A$M$Y$$$20240919$$CN$IN$IN
243367871$24336787$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488074$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367881$24336788$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488031$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367891$24336789$1$I$20230905$20240910$20240919$20240919$EXP$$BR-CELLTRION INC.-2023BR004856$CELLTRION$$$$$$Y$$$20240919$$CN$BR$BR
243367901$24336790$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488073$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367911$24336791$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488032$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367921$24336792$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488075$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367931$24336793$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488030$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367941$24336794$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488038$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367951$24336795$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488040$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367961$24336796$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488036$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367971$24336797$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488039$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367981$24336798$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488041$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243367991$24336799$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488037$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368001$24336800$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488045$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368011$24336801$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488042$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368021$24336802$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488035$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368031$24336803$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488044$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368041$24336804$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488043$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368051$24336805$1$I$$20240915$20240919$20240919$PER$$US-HALEON-2197155$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243368061$24336806$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488056$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368071$24336807$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488048$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368081$24336808$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488046$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368091$24336809$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488054$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368101$24336810$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488051$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368111$24336811$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488052$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368121$24336812$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488026$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368131$24336813$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488050$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368141$24336814$1$I$20240909$20240916$20240919$20240919$PER$$US-ROCHE-10000085384$ROCHE$$52$YR$A$M$Y$102.05$KG$20240919$$CN$US$US
243368151$24336815$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488055$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368161$24336816$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488049$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368171$24336817$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488053$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368181$24336818$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488047$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368192$24336819$2$F$20240801$20240916$20240919$20240927$PER$$US-AMGEN-USASP2024185097$AMGEN$$71$YR$$F$Y$$$20240927$$HP$US$US
243368201$24336820$1$I$$20240918$20240919$20240919$PER$$US-ROCHE-10000085474$ROCHE$$$$$F$Y$$$20240919$$HP$US$US
243368231$24336823$1$I$$20240820$20240919$20240919$PER$$AU-TOLMAR, INC.-24AU052010$TOLMAR$$$$$M$Y$$$20240919$$CN$AU$AU
243368241$24336824$1$I$20240822$20240828$20240919$20240919$PER$$US-TOLMAR, INC.-24US052101$TOLMAR$$73$YR$$M$Y$$$20240919$$HP$US$US
243368251$24336825$1$I$20240821$20240828$20240919$20240919$PER$$US-TOLMAR, INC.-24US052145$TOLMAR$$90$YR$$M$Y$$$20240919$$HP$US$US
243368261$24336826$1$I$$20240829$20240919$20240919$PER$$US-TOLMAR, INC.-24US051937$TOLMAR$$$$$M$Y$$$20240919$$CN$US$US
243368271$24336827$1$I$20230101$20240828$20240919$20240919$PER$$US-TOLMAR, INC.-24US052274$TOLMAR$$$$$F$Y$$$20240919$$CN$US$US
243368281$24336828$1$I$20240828$20240828$20240919$20240919$PER$$US-TOLMAR, INC.-24US052271$TOLMAR$$$$$M$Y$$$20240919$$HP$US$US
243368291$24336829$1$I$20240829$20240830$20240919$20240919$PER$$US-TOLMAR, INC.-24US052276$TOLMAR$$73$YR$$M$Y$$$20240919$$PH$US$US
243368301$24336830$1$I$20240829$20240829$20240919$20240919$PER$$US-TOLMAR, INC.-24US052301$TOLMAR$$86$YR$$M$Y$$$20240919$$HP$US$US
243368311$24336831$1$I$20240815$20240829$20240919$20240919$PER$$US-TOLMAR, INC.-24US052278$TOLMAR$$77$YR$$M$Y$$$20240919$$HP$US$US
243368321$24336832$1$I$20240901$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024184635$AMGEN$$63$YR$A$F$Y$$$20240919$$CN$US$US
243368331$24336833$1$I$$20240916$20240919$20240919$EXP$$DE-ROCHE-10000084448$ROCHE$$$$$$Y$$$20240919$$MD$DE$DE
243368341$24336834$1$I$$20240909$20240919$20240919$EXP$$JP-Accord-446277$ACCORD$Kimura M, Fujiwara S, Kuroda H, Kanamori M, Kawamoto M. Choroid plexitis caused by Burkholderia cepacia complex after COVID-19. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2024; 147:107201.$67$YR$E$F$Y$$$20240919$$MD$JP$JP
243368351$24336835$1$I$20240819$20240909$20240919$20240919$EXP$FR-AFSSAPS-AN2024001188$FR-Accord-446358$ACCORD$$59$YR$A$F$Y$$$20240919$$MD$FR$FR
243368371$24336837$1$I$$20240913$20240919$20240919$PER$$US-ROCHE-10000083270$ROCHE$$$$A$F$Y$$$20240919$$CN$US$US
243368382$24336838$2$F$$20240919$20240919$20240924$EXP$$CA-ROCHE-10000085532$ROCHE$$$$A$F$Y$$$20240924$$CN$CA$CA
243368391$24336839$1$I$$20240911$20240919$20240919$EXP$$US-ROCHE-10000079985$ROCHE$$66$YR$E$F$Y$$$20240919$$CN$US$US
243368411$24336841$1$I$$20240910$20240919$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-146015$BRISTOL MYERS SQUIBB$Matsunaga K, Anndou k, Tachibana S, Satou M, Kobayashi Y, Sugiyama Y, et al. A case of MSI-high colorectal cancer presenting with various immune-related adverse events during ipilimumab + nivolumab therapy. The 134th Japanese Society of Gastroenterology Hokkaido Branch Meeting/The 128th Japan Gastroenterological Endoscopy Society Hokkaido Branch Meeting(Programs and Abstracts). 2024;64.$5$DEC$A$F$Y$$$20240919$$MD$JP$JP
243368421$24336842$1$I$$20220221$20240919$20240919$EXP$$DE-ASTELLAS-AER-2022-000727$ASTELLAS$$$$$M$Y$$$20240919$$PH$DE$DE
243368431$24336843$1$I$20240906$20240909$20240919$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005485$ACADIA PHARMACEUTICALS$$94$YR$$F$Y$$$20240919$$CN$US$US
243368442$24336844$2$F$$20240917$20240919$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015301$JAZZ$$$$$F$Y$$$20240922$$HP$US$US
243368451$24336845$1$I$$20240911$20240919$20240919$EXP$$ES-AMGEN-ESPSP2024183852$AMGEN$Lluch P.; Ballester M.P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240919$$MD$ES$ES
243368461$24336846$1$I$20120101$20240916$20240919$20240919$EXP$DE-EMA-DD-20240912-7482829-083036$DE-SANDOZ INC.-SDZ2024DE080425$SANDOZ$$59$YR$$M$Y$84$KG$20240919$$CN$DE$DE
243368471$24336847$1$I$$20240909$20240919$20240919$EXP$ES-SA-2017SA223311$ES-Accord-062006$ACCORD$Sanchez VG, Pedregosa LE, Martos ML, Cano VR, Gonzalez ER, Mendoza AE, et al. Subacute polyneuropathy by pharmacological toxicity. 12th European Paediatric Neurology Society Congress, EPNS 2017; 2017 Jun 20-24; Lyon, France. Eur J Paediatr Neurol. 2017 Jun 01;21(Suppl 1):e232-3. doi: 10.1016/j.ejpn.2017.04.1254$6$YR$C$F$Y$$$20240919$$HP$ES$ES
243368481$24336848$1$I$$20240916$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US080690$SANDOZ$$74$YR$$M$Y$$$20240919$$MD$US$US
243368491$24336849$1$I$20240901$20240909$20240919$20240919$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005490$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240919$$CN$US$US
243368501$24336850$1$I$$20240909$20240919$20240919$30DAY$$US-GSK-US2024112050$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243368511$24336851$1$I$$20240919$20240919$20240919$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052245$BOEHRINGER INGELHEIM$Isern de^Val I, Mercado Castillo H, Diaz Mele MD. Euglycemic diabetic ketoacidosis  associated with sodium-glucose cotransporter type 2 inhibitors. Med-Clin-Barc. 2024;163(2): 101-102.$42$YR$A$F$Y$$$20240919$$MD$ES$ES
243368521$24336852$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148525$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240919$$CN$US$US
243368531$24336853$1$I$20240815$20240912$20240919$20240919$PER$$PR-ABBVIE-5924403$ABBVIE$$41$YR$$F$Y$$$20240919$$CN$PR$US
243368541$24336854$1$I$20240325$20240916$20240919$20240919$EXP$$US-ABBVIE-5926992$ABBVIE$$71$YR$$F$Y$$$20240919$$CN$US$US
243368551$24336855$1$I$$20240514$20240919$20240919$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-07067$HIKMA$Sarkar S, Rav E, Stitzlein L, Gibson A, McCall D, Nunez C, Roth M, Ragoonanan D, Connors J, Herzog CE, Cuglievan B, Garcia MB. Sarkar S, Rav E, Stitzlein L, Gibson A, McCall D, Nunez C, et al. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia.. Pediatric Blood and Cancer.. 2024;71(6)$$$$$Y$$$20240919$$MD$US$US
243368561$24336856$1$I$$20240906$20240919$20240919$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000299$NOVAST$Liao L, Zhang Z. Severe sepsis induced by zoledronic acid A case report. Medicine (Baltimore). 2024;103(35)$58$YR$$F$Y$$$20240919$$MD$CN$CN
243368571$24336857$1$I$$20240906$20240919$20240919$EXP$$JP-NOVAST LABORATORIES INC.-2024NOV000298$NOVAST$Terashima Y, Matsumoto M, Ozaki S, Nakagawa M, Nakagome S, Terasaki Y et.al.,. Ig A vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report. Front Immunol. 2024;15$73$YR$$M$Y$$$20240919$$HP$JP$JP
243368581$24336858$1$I$$20240906$20240919$20240919$EXP$$LB-NOVAST LABORATORIES INC.-2024NOV000297$NOVAST$Khattab NW, Razzouk R, Tanios B, Nahouli L, Bou Khalil P, El Khoury N. Pulmonary Edema Following Nifedipine Use in Pregnancy: A Case Report. Cureus. 2024;16(9)$24$YR$$F$Y$$$20240919$$HP$LB$LB
243368592$24336859$2$F$$20240916$20240919$20240923$EXP$$NVSC2024US185591$NOVARTIS$$$$$M$Y$$$20240923$$MD$US$US
243368601$24336860$1$I$$20240911$20240919$20240919$EXP$$CA-CELLTRION INC.-2024CA021856$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
243368611$24336861$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488117$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368621$24336862$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488077$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368631$24336863$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488143$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368641$24336864$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488115$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368651$24336865$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488113$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368661$24336866$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488114$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368671$24336867$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488116$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368681$24336868$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488118$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368691$24336869$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488112$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368701$24336870$1$I$$20240913$20240919$20240919$PER$$US-ROCHE-10000082985$ROCHE$$$$E$M$Y$$$20240919$$CN$US$US
243368711$24336871$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488078$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368721$24336872$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488079$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368731$24336873$1$I$$20240910$20240919$20240919$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03343$AMNEAL$$$$$M$Y$$$20240919$$HP$US$US
243368741$24336874$1$I$$20240910$20240919$20240919$EXP$$FI-UCBSA-2024047776$UCB$Stjerna S, Huber-Mollema Y, Tomson T, Perucca E, Battino D, Craig J et al.. Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol. Epilepsy + Behavior. 2024;159:1525-5050$$$$F$Y$$$20240919$$HP$FI$FI
243368751$24336875$1$I$$20240824$20240919$20240919$PER$$US-BEIGENE-BGN-2024-011203$BEIGENE$$$$$$Y$$$20240919$$PH$US$US
243368761$24336876$1$I$$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024183898$AMGEN$$$$A$M$Y$$$20240919$$HP$US$US
243368771$24336877$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011724$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240919$$CN$US$US
243368781$24336878$1$I$$20240912$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010964$ELI LILLY AND CO$$$$$$Y$$$20240919$$CN$US$US
243368791$24336879$1$I$$20240905$20240919$20240919$EXP$$CA-BAXTER-2024BAX024449$BAXTER$$72$YR$$F$Y$$$20240919$$HP$CA$CA
243368801$24336880$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010743$ELI LILLY AND CO$$$$A$F$Y$$$20240919$$CN$US$US
243368811$24336881$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010784$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240919$$CN$US$US
243368821$24336882$1$I$20240912$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010905$ELI LILLY AND CO$$31$YR$A$M$Y$$$20240919$$CN$US$US
243368831$24336883$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011324$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240919$$CN$US$US
243368841$24336884$1$I$$20240904$20240919$20240919$EXP$$CA-BAXTER-2024BAX024246$BAXTER$$50$YR$$M$Y$$$20240919$$HP$CA$CA
243368851$24336885$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010983$ELI LILLY AND CO$$$$$M$Y$$$20240919$$CN$US$US
243368861$24336886$1$I$20240918$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202408002389$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240919$$CN$US$US
243368871$24336887$1$I$20240701$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010869$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240919$$CN$US$US
243368881$24336888$1$I$20240201$20240912$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409008291$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240919$$CN$US$US
243368891$24336889$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010753$ELI LILLY AND CO$$$$A$M$Y$$$20240919$$CN$US$US
243368901$24336890$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488120$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368911$24336891$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488122$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368921$24336892$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488124$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368931$24336893$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488123$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368941$24336894$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488081$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368951$24336895$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488119$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368961$24336896$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488121$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368971$24336897$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488127$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243368981$24336898$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488080$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243368991$24336899$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488125$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243369001$24336900$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488126$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243369011$24336901$1$I$20240804$20240828$20240919$20240919$EXP$$AR-ASTELLAS-2024US022542$ASTELLAS$$72$YR$E$M$Y$$$20240919$$MD$AR$AR
243369021$24336902$1$I$20240819$20240909$20240919$20240919$PER$$US-ABBVIE-5918323$ABBVIE$$41$YR$$F$Y$$$20240919$$CN$US$US
243369031$24336903$1$I$$20240910$20240919$20240919$EXP$$JP-AMGEN-JPNSP2024183777$AMGEN$Takuya Shimogawa, Yuji Miyamoto, Yukiharu Hiyoshi, Mayuko Ouchi, Keisuke Kosumi, Kojiro Eto, et al.. Intracranial subdural empyema during long-term chemotherapy for metastatic colorectal cancer: case report. In Vivo. 2024;38:2557-61$69$YR$E$F$Y$$$20240919$$MD$JP$JP
243369051$24336905$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488084$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369061$24336906$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488091$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369071$24336907$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488092$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369081$24336908$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488090$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369091$24336909$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488085$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369101$24336910$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488087$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369111$24336911$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488083$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369121$24336912$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488082$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369131$24336913$1$I$$20240916$20240919$20240919$PER$$US-ABBVIE-5927470$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243369141$24336914$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488099$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369151$24336915$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488105$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369161$24336916$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488093$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369171$24336917$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488101$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369181$24336918$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488097$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369191$24336919$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488106$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369201$24336920$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488102$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369211$24336921$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488094$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369221$24336922$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488096$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369231$24336923$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488095$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369241$24336924$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488089$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369251$24336925$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488104$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369261$24336926$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488086$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369271$24336927$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488098$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369281$24336928$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488088$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369291$24336929$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488103$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369301$24336930$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488100$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369321$24336932$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488108$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369331$24336933$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488109$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369341$24336934$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488107$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243369351$24336935$1$I$$20240910$20240919$20240919$EXP$$CA-ROCHE-10000084743$ROCHE$$65$YR$E$F$Y$34$KG$20240919$$CN$CA$CA
243369362$24336936$2$F$$20240918$20240919$20240923$EXP$$EG-SANDOZ INC.-SDZ2024EG080717$SANDOZ$$11$YR$$M$Y$$$20240923$$HP$EG$EG
243369371$24336937$1$I$$20240905$20240919$20240919$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08471$HIKMA$Salk G, Mangala YO, Onukogu ID, Meleveedu K. Salk G, Mangala YO, Onukogu ID, Meleveedu K. ALL-747 Methotrexate-induced neurotoxicity due to ommaya reservoir malfunction in a patient with acute lymphoblastic leukemia. Clinical Lymphoma, Myeloma and Leukemia. 2024;24:282-3$$$$$Y$$$20240919$$MD$US$US
243369383$24336938$3$F$$20240916$20240919$20240919$EXP$$US-ROCHE-10000079781$ROCHE$$$$$M$Y$$$20240919$$CN$US$US
243369391$24336939$1$I$$20240918$20240919$20240919$PER$$US-ROCHE-10000085797$ROCHE$$$$A$F$Y$$$20240919$$CN$US$US
243369411$24336941$1$I$$20240909$20240919$20240919$PER$$US-ROCHE-10000077506$ROCHE$$85$YR$E$$Y$$$20240919$$MD$US$US
243369431$24336943$1$I$20240912$20240913$20240919$20240919$EXP$$CA-ABBVIE-5924393$ABBVIE$$26$YR$$F$Y$$$20240919$$CN$CA$CA
243369442$24336944$2$F$20240701$20240919$20240919$20240923$EXP$$CA-SANDOZ INC.-SDZ2023CA027537$SANDOZ$$23$YR$$M$Y$$$20240923$$CN$CA$CA
243369451$24336945$1$I$20240510$20240909$20240919$20240919$EXP$PT-INFARMED-E202408-874$PT-Accord-446585$ACCORD$$65$YR$E$M$Y$60$KG$20240919$$PH$PT$PT
243369461$24336946$1$I$$20240917$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2023CA039638$SANDOZ$$$$$M$Y$$$20240919$$CN$CA$CA
243369471$24336947$1$I$$20240916$20240919$20240919$EXP$$CN-ROCHE-10000082887$ROCHE$Yu S, Lyu J, Zhang Y, Zu Y, Feng X. Clinical characteristics and prognosis of anti-Leucine-rich glioma inactivated 1 antibody-associated encephalitis: an analysis of 85 cases. Journal of Brain and Nervous Diseases. 2024;32 (10):599-603.$$$$$Y$$$20240919$$HP$CN$CN
243369481$24336948$1$I$$20240906$20240919$20240919$PER$$US-JNJFOC-20240927519$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240919$$CN$US$US
243369491$24336949$1$I$$20240911$20240919$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-148284$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240919$$MD$JP$JP
243369501$24336950$1$I$20240101$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148901$BRISTOL MYERS SQUIBB$$28$YR$A$M$Y$$$20240919$$HP$US$US
243369511$24336951$1$I$20230101$20231117$20240919$20240919$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67467$HIKMA$$$$$F$Y$54.4$KG$20240919$$CN$US$US
243369521$24336952$1$I$20240108$20240916$20240919$20240919$PER$$NVSC2024US185709$NOVARTIS$$77$YR$$F$Y$$$20240919$$HP$US$US
243369531$24336953$1$I$20240101$20240916$20240919$20240919$EXP$FR-AFSSAPS-AVLY2024000178$FR-CHEPLA-2024011915$CHEPLAPHARM$$35$YR$$M$Y$70$KG$20240919$$MD$COUNTRY NOT SPECIFIED$FR
243369541$24336954$1$I$$20240910$20240919$20240919$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03383$AMNEAL$$$$$M$Y$$$20240919$$HP$US$US
243369551$24336955$1$I$20240101$20240913$20240919$20240919$EXP$$US-009507513-2409USA005137$MERCK$$$$$F$Y$$$20240919$$HP$US$US
243369561$24336956$1$I$$20240911$20240919$20240919$EXP$$US-ROCHE-10000079894$ROCHE$$63$YR$A$F$Y$$$20240919$$CN$US$US
243369572$24336957$2$F$$20240924$20240919$20240930$PER$$US-ABBVIE-5925532$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243369581$24336958$1$I$20240713$20240910$20240919$20240919$EXP$$EG-HIKMA PHARMACEUTICALS USA INC.-EG-H14001-24-08483$HIKMA$$59$YR$$F$Y$$$20240919$$HP$EG$EG
243369591$24336959$1$I$20240830$20240914$20240919$20240919$EXP$$CN-009507513-2409CHN006353$MERCK$$59$YR$$F$Y$$$20240919$$HP$CN$CN
243369601$24336960$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010996$APOTEX$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65 (1):33-38$32$YR$$F$Y$$$20240919$$MD$US$US
243369611$24336961$1$I$20220405$20240913$20240919$20240919$EXP$$US-TAKEDA-US201838188$TAKEDA$$9$YR$$M$Y$27$KG$20240919$$CN$US$US
243369621$24336962$1$I$$20240910$20240919$20240919$EXP$$CA-ROCHE-10000084973$ROCHE$$65$YR$E$F$Y$$$20240919$$MD$CA$CA
243369631$24336963$1$I$20240825$20240911$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014465$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243369641$24336964$1$I$20240910$20240910$20240919$20240919$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001906$BLUEPRINT MEDICINES$$35$YR$A$F$Y$$$20240919$$CN$US$US
243369651$24336965$1$I$$20240911$20240919$20240919$EXP$$ES-AMGEN-ESPSP2024183851$AMGEN$Lluch P.; Ballester M. P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240919$$MD$ES$ES
243369661$24336966$1$I$$20240911$20240919$20240919$EXP$$ES-AMGEN-ESPSP2024183849$AMGEN$Lluch P.; Ballester M. P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240919$$MD$ES$ES
243369671$24336967$1$I$$20240911$20240919$20240919$EXP$$ES-AMGEN-ESPSP2024183850$AMGEN$Lluch P.; Ballester M. P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240919$$MD$ES$ES
243369691$24336969$1$I$$20240909$20240919$20240919$EXP$$AU-NOVOPROD-1281337$NOVO NORDISK$$$$$$Y$$$20240919$$CN$AU$AU
243369701$24336970$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010927$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243369711$24336971$1$I$20240101$20240831$20240919$20240919$EXP$$US-SA-2024SA269583$SANOFI AVENTIS$$26$YR$A$F$Y$52.73$KG$20240919$$MD$US$US
243369721$24336972$1$I$20230901$20240910$20240919$20240919$PER$$US-ABBVIE-5920732$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243369731$24336973$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010346$APOTEX$$66$YR$$M$Y$$$20240919$$HP$CA$CA
243369741$24336974$1$I$$20240906$20240919$20240919$EXP$$US-SA-2024SA267292$SANOFI AVENTIS$$$$A$M$Y$82.18$KG$20240919$$MD$US$US
243369751$24336975$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185942$AMGEN$$$$$F$Y$$$20240919$$MD$US$US
243369761$24336976$1$I$20240909$20240916$20240919$20240919$30DAY$$BR-UCBSA-2024047268$UCB$$$$A$F$Y$$$20240919$$CN$BR$BR
243369771$24336977$1$I$20240823$20240913$20240919$20240919$EXP$$US-NALPROPION PHARMACEUTICALS INC.-US-2024CUR004114$CURRAX PHARMACEUTICALS$$62$YR$$F$Y$$$20240919$$CN$US$US
243369781$24336978$1$I$20240901$20240918$20240919$20240919$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052209$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240919$$CN$US$US
243369791$24336979$1$I$$20240905$20240919$20240919$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-27253$SAMSUNG BIOEPIS$$60$YR$A$M$Y$$$20240919$$CN$GB$GB
243369801$24336980$1$I$$20240909$20240919$20240919$PER$$US-ASTELLAS-2024-AER-005869$ASTELLAS$$86$YR$E$M$Y$$$20240919$$MD$US$US
243369811$24336981$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148397$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240919$$CN$US$US
243369831$24336983$1$I$20240227$20240912$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014541$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243369841$24336984$1$I$20240723$20240909$20240919$20240919$EXP$IT-MINISAL02-998024$IT-Accord-442737$ACCORD$$76$YR$E$F$Y$50$KG$20240919$$MD$IT$IT
243369851$24336985$1$I$20240901$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186250$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243369861$24336986$1$I$20240913$20240913$20240919$20240919$EXP$$CN-AMGEN-CHNSP2024183301$AMGEN$$$$$$Y$$$20240919$$HP$CN$CN
243369871$24336987$1$I$$20240912$20240919$20240919$PER$$US-AMGEN-USASP2024184258$AMGEN$$$$$M$Y$$$20240919$$MD$US$US
243369901$24336990$1$I$$20240918$20240919$20240919$PER$$NVSC2024US186934$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243369911$24336991$1$I$$20240915$20240919$20240919$EXP$$NVSC2024US185306$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
243369921$24336992$1$I$20240829$20240916$20240919$20240919$EXP$$NVSC2024US185676$NOVARTIS$$65$YR$$$Y$77.098$KG$20240919$$CN$US$US
243369931$24336993$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488357$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243369941$24336994$1$I$20240104$20240104$20240919$20240919$PER$$JP-ROCHE-3488300$ROCHE$$27$YR$A$F$Y$$$20240919$$PH$JP$JP
243369951$24336995$1$I$20240104$20240104$20240919$20240919$PER$$JP-ROCHE-3488175$ROCHE$$19$YR$A$F$Y$$$20240919$$CN$JP$JP
243369961$24336996$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488359$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243369971$24336997$1$I$20240105$20240110$20240919$20240919$PER$$US-ROCHE-3488343$ROCHE$$$$A$M$Y$$$20240919$$CN$US$US
243369981$24336998$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488358$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243369991$24336999$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488356$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370001$24337000$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010857$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243370011$24337001$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011647$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240919$$CN$US$US
243370022$24337002$2$F$20240917$20240919$20240919$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011773$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240923$$CN$US$US
243370031$24337003$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011523$ELI LILLY AND CO$$$$$M$Y$$$20240919$$CN$US$US
243370051$24337005$1$I$$20240912$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409008193$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240919$$CN$US$US
243370061$24337006$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011842$ELI LILLY AND CO$$$$$$Y$$$20240919$$CN$US$US
243370071$24337007$1$I$20240915$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010633$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240919$$CN$US$US
243370081$24337008$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010988$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243370091$24337009$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010766$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240919$$CN$US$US
243370101$24337010$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010641$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240919$$CN$US$US
243370111$24337011$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488250$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370121$24337012$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488354$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370131$24337013$1$I$20240901$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010933$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240919$$CN$US$US
243370141$24337014$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488362$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370151$24337015$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488251$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370162$24337016$2$F$20240916$20240914$20240919$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409010066$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240924$$CN$US$US
243370171$24337017$1$I$$20240104$20240919$20240919$PER$$JP-ROCHE-3488171$ROCHE$$10$DEC$E$$Y$$$20240919$$PH$JP$JP
243370181$24337018$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488352$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370191$24337019$1$I$$20240913$20240919$20240919$EXP$$NZ-TERSERA THERAPEUTICS LLC-2024TRS004737$TERSERA THERAPEUTICS$$$$$$Y$$$20240919$$MD$NZ$NZ
243370201$24337020$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488361$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370211$24337021$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488360$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370221$24337022$1$I$$20240918$20240919$20240919$EXP$$CA-ROCHE-10000085734$ROCHE$$$$A$F$Y$$$20240919$$CN$CA$CA
243370231$24337023$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488252$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370241$24337024$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488355$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370251$24337025$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488353$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370261$24337026$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488253$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370271$24337027$1$I$$20240912$20240919$20240919$EXP$GB-MHRA-MED-202409121633045170-MFKQT$GB-SA-2024SA269345$SANOFI AVENTIS$$$$$M$Y$$$20240919$$MD$GB$GB
243370281$24337028$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488261$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370291$24337029$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488255$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370301$24337030$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488267$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370311$24337031$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488259$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370321$24337032$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488254$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370331$24337033$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488263$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370341$24337034$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488258$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370351$24337035$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488262$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370361$24337036$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488265$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370371$24337037$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488260$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370381$24337038$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488264$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370391$24337039$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488266$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370401$24337040$1$I$20240821$20240916$20240919$20240919$EXP$$AU-ASTELLAS-2024-AER-007359$ASTELLAS$$71$YR$E$F$Y$$$20240919$$HP$AU$AU
243370411$24337041$1$I$$20240918$20240919$20240919$PER$$NVSC2024US186932$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243370421$24337042$1$I$$20240918$20240919$20240919$PER$$NVSC2024US186925$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243370431$24337043$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488270$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370441$24337044$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488276$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370451$24337045$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488271$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370461$24337046$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488274$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370471$24337047$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488268$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370481$24337048$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488277$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370491$24337049$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488278$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370501$24337050$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488279$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370511$24337051$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488273$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370521$24337052$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488269$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370531$24337053$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488272$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370541$24337054$1$I$$20240903$20240919$20240919$PER$$US-TEVA-VS-3240434$TEVA$$$$$$Y$$$20240919$$HP$US$US
243370551$24337055$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488275$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370561$24337056$1$I$$20240911$20240919$20240919$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000796$DECIPHERA PHARMACEUTICALS$$84$YR$E$F$Y$$$20240919$$CN$US$US
243370571$24337057$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488287$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370581$24337058$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488283$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370591$24337059$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488280$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370601$24337060$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488291$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370611$24337061$1$I$$20240909$20240919$20240919$PER$$US-TEVA-VS-3242019$TEVA$$$$$$Y$$$20240919$$CN$US$US
243370621$24337062$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488286$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370631$24337063$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488289$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370641$24337064$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488288$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370651$24337065$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488281$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370661$24337066$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488285$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370671$24337067$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488284$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370681$24337068$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488290$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370691$24337069$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488282$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370701$24337070$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488297$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370711$24337071$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488293$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370721$24337072$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488298$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370731$24337073$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488296$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370741$24337074$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488292$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370751$24337075$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488294$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370761$24337076$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488144$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370771$24337077$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488145$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370781$24337078$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488147$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370791$24337079$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488299$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370801$24337080$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488295$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243370811$24337081$1$I$$20240907$20240919$20240919$EXP$$IN-PBT-009691$PANACEA BIOTEC$Aggarwal J, Rathore V, Agrawal V, Badge RP, Sharma AR, Sharma A, et al. Metastatic Calcification in Allograft Kidney Due to Persistent Secondary Hyperparathyroidism: A Rare Cause of Graft Dysfunction. Exp Clin Transplant. 2024 Jul;22(7):568-571. doi: 10.6002/ect.2024.0116.$48$YR$$F$Y$$$20240919$$HP$IN$IN
243370821$24337082$1$I$$20240917$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA080905$SANDOZ$$44$YR$$F$Y$$$20240919$$CN$CA$CA
243370831$24337083$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488146$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370841$24337084$1$I$20240910$20240913$20240919$20240919$EXP$$JP-009507513-2409JPN002007J$MERCK$$$$$F$Y$$$20240919$$CN$JP$JP
243370851$24337085$1$I$20240829$20240912$20240919$20240919$EXP$$JP-AMGEN-JPNSP2024183942$AMGEN$$$$$$Y$$$20240919$$MD$JP$JP
243370861$24337086$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488156$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370871$24337087$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488155$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370881$24337088$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488149$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370891$24337089$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488154$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370901$24337090$1$I$$20240911$20240919$20240919$EXP$$CA-ROCHE-10000084804$ROCHE$$$$$F$Y$$$20240919$$HP$CA$CA
243370911$24337091$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488152$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370921$24337092$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488153$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370931$24337093$1$I$$20240910$20240919$20240919$EXP$NL-ASTELLAS-2024EU007477$NL-ROCHE-10000067432$ROCHE$Ghambari K, de Jong DM, Bruno MJ, Polak WG, van Driel LMJW, den Hoed CM. Risks of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis After Liver Transplantation. Clinical Transplantation 2024;38(7):1-9. DOI:10.1111/ctr.15399$24$YR$A$M$Y$$$20240919$$HP$NL$NL
243370941$24337094$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488316$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370951$24337095$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488315$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370961$24337096$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488150$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370971$24337097$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488157$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370981$24337098$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488151$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243370991$24337099$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488148$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371001$24337100$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488326$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371011$24337101$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488321$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371021$24337102$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488320$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371031$24337103$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488322$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371041$24337104$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488325$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371051$24337105$1$I$20240909$20240913$20240919$20240919$PER$$US-ROCHE-10000084503$ROCHE$$43$YR$A$F$Y$62.6$KG$20240919$$CN$US$US
243371061$24337106$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488327$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371071$24337107$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488319$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371081$24337108$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488328$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371091$24337109$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488323$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371101$24337110$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488324$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371111$24337111$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488317$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371121$24337112$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488318$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371131$24337113$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010926$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243371141$24337114$1$I$20240905$20240906$20240919$20240919$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-27547$SAMSUNG BIOEPIS$$59$YR$A$M$Y$72$KG$20240919$$MD$DE$DE
243371151$24337115$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488331$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371161$24337116$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488330$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371171$24337117$1$I$20200724$20240916$20240919$20240919$EXP$$DE-ORGANON-2008DEU000607$ORGANON$$73$YR$$F$Y$60$KG$20240919$$CN$DE$DE
243371181$24337118$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488332$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371191$24337119$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488334$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371201$24337120$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488329$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371211$24337121$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488336$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371221$24337122$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488333$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371231$24337123$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488335$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371241$24337124$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488350$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243371261$24337126$1$I$20240201$20240914$20240919$20240919$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-125379$REGENERON$$66$YR$$M$Y$$$20240919$$HP$CO$CO
243371271$24337127$1$I$20231001$20240907$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044775$AUROBINDO$$69$YR$$M$Y$112$KG$20240919$$CN$GB$GB
243371281$24337128$1$I$$20240909$20240919$20240919$30DAY$$US-GSK-US2024AMR112285$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$PH$US$US
243371291$24337129$1$I$20240827$20240909$20240919$20240919$EXP$GB-MHRA-MED-202409091414208770-DCQFK$GB-Accord-446199$ACCORD$$74$YR$E$F$Y$$$20240919$$PH$GB$GB
243371301$24337130$1$I$$20240910$20240919$20240919$PER$$US-ABBVIE-5920104$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243371311$24337131$1$I$20240801$20240911$20240919$20240919$EXP$$FR-Orion Corporation ORION PHARMA-TREX2024-0226$ORION$$34$YR$A$M$Y$93$KG$20240919$$MD$FR$
243371321$24337132$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148825$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240919$$CN$US$US
243371341$24337134$1$I$20240801$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148448$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$73.03$KG$20240919$$CN$US$US
243371351$24337135$1$I$$20240830$20240919$20240919$PER$$US-TEVA-VS-3241143$TEVA$$$$$F$Y$$$20240919$$CN$US$US
243371361$24337136$1$I$$20240909$20240919$20240919$EXP$$PT-AUROBINDO-AUR-APL-2024-045480$AUROBINDO$Marques, A. EP-066 - CNS INFECTION BY VARICELLA ZOSTER. Sinapse. 2023;23(Suppl 1):293-294$$$E$$Y$$$20240919$$MD$PT$PT
243371371$24337137$1$I$$20240906$20240919$20240919$EXP$$ES-AUROBINDO-AUR-APL-2024-045263$AUROBINDO$Cueto-Sanchez A, Niu H, Alvarez-Alvarez I, Lopez-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, et al. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage. Br-J-Clin-Pharmacol. 2023;89 (8):2497-2507$43$YR$$M$Y$$$20240919$$HP$ES$ES
243371381$24337138$1$I$$20240918$20240919$20240919$PER$$US-ROCHE-10000085908$ROCHE$$34$YR$A$F$Y$$$20240919$$HP$US$US
243371391$24337139$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010925$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243371401$24337140$1$I$$20240918$20240919$20240919$PER$$US-ROCHE-10000086063$ROCHE$$27$YR$A$F$Y$$$20240919$$HP$US$US
243371412$24337141$2$F$20230101$20240918$20240919$20240927$EXP$$CA-CELLTRION INC.-2023CA025019$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
243371421$24337142$1$I$20240822$20240906$20240919$20240919$EXP$$DE-AUROBINDO-AUR-APL-2024-045197$AUROBINDO$$88$YR$$F$Y$81$KG$20240919$$MD$DE$DE
243371431$24337143$1$I$20240301$20240912$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-029074$UNITED THERAPEUTICS$$65$YR$$M$Y$86.168$KG$20240919$$$US$US
243371442$24337144$2$F$20210101$20240917$20240919$20240924$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-23-00591$CATALYST PHARMA$$$$$M$Y$$$20240924$$CN$US$US
243371451$24337145$1$I$20230803$20230803$20240919$20240919$EXP$$CN-ROCHE-10000080563$ROCHE$$$$$$Y$$$20240919$$MD$CN$CN
243371461$24337146$1$I$20240910$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024184406$AMGEN$$$$$$Y$$$20240919$$HP$US$US
243371481$24337148$1$I$$20240912$20240919$20240919$PER$$US-AMGEN-USASP2024183977$AMGEN$$$$E$F$Y$$$20240919$$MD$US$US
243371491$24337149$1$I$$20240910$20240919$20240919$EXP$$CA-ROCHE-10000084682$ROCHE$$46$YR$A$F$Y$$$20240919$$HP$CA$CA
243371501$24337150$1$I$$20240909$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044901$AUROBINDO$$84$YR$$F$Y$55$KG$20240919$$MD$GB$GB
243371511$24337151$1$I$20240101$20240916$20240919$20240919$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-18825$IPSEN$$75$YR$E$F$Y$$$20240919$$CN$GB$GB
243371521$24337152$1$I$20240820$20240917$20240919$20240919$EXP$$US-ABBVIE-5927941$ABBVIE$$$$$F$Y$$$20240919$$HP$US$US
243371531$24337153$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010924$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243371541$24337154$1$I$$20240909$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-028730$UNITED THERAPEUTICS$$$$$F$Y$46.259$KG$20240919$$$US$US
243371551$24337155$1$I$20240301$20240913$20240919$20240919$30DAY$$FR-UCBSA-2024046851$UCB$$56$YR$$F$Y$$$20240919$$PH$FR$FR
243371561$24337156$1$I$$20240906$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044730$AUROBINDO$$37$YR$$F$Y$$$20240919$$HP$GB$GB
243371571$24337157$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010858$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243371581$24337158$1$I$$20240918$20240919$20240919$EXP$$US-GILEAD-2024-0681108$GILEAD$$$$E$M$Y$$$20240919$$CN$US$US
243371591$24337159$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010719$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243371601$24337160$1$I$20240801$20240913$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009272$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240919$$CN$US$US
243371611$24337161$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010507$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240919$$CN$US$US
243371621$24337162$1$I$20240915$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010809$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240919$$CN$US$US
243371631$24337163$1$I$20240801$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011100$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240919$$CN$US$US
243371651$24337165$1$I$20240729$20240912$20240919$20240919$EXP$FR-AFSSAPS-TS2024000973$FR-GSK-FR2024113914$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$FR$FR
243371661$24337166$1$I$$20240906$20240919$20240919$EXP$$DE-AUROBINDO-AUR-APL-2024-045405$AUROBINDO$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.. J Anal Toxicol.. 2024;48 (5):299-313.$33$YR$$M$Y$$$20240919$$HP$DE$DE
243371671$24337167$1$I$$20240913$20240919$20240919$EXP$$JP-GSK-JP2024JPN115016$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$JP$JP
243371681$24337168$1$I$$20240911$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-028204$UNITED THERAPEUTICS$$$$$F$Y$93.878$KG$20240919$$$US$US
243371691$24337169$1$I$$20240109$20240919$20240919$PER$$US-ROCHE-3489434$ROCHE$$79$YR$E$M$Y$$$20240919$$MD$US$US
243371701$24337170$1$I$$20240914$20240919$20240919$PER$$NVSC2024US185653$NOVARTIS$$$$$F$Y$143$KG$20240919$$CN$US$US
243371711$24337171$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488420$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371721$24337172$1$I$20160817$20240909$20240919$20240919$EXP$$CA-TAKEDA-2018TUS021581$TAKEDA$$59$YR$$M$Y$$$20240919$$CN$CA$CA
243371731$24337173$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488421$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371741$24337174$1$I$$20240111$20240919$20240919$PER$$QA-ROCHE-3490136$ROCHE$$$$$$Y$$$20240919$$HP$QA$QA
243371751$24337175$1$I$20231218$20240110$20240919$20240919$PER$$CN-ROCHE-3490038$ROCHE$$35$YR$A$F$Y$$$20240919$$HP$CN$CN
243371761$24337176$1$I$$20240913$20240919$20240919$PER$$US-ROCHE-10000083271$ROCHE$$47$YR$A$F$Y$$$20240919$$CN$US$US
243371771$24337177$1$I$20240111$20240115$20240919$20240919$PER$$CN-ROCHE-3492552$ROCHE$$52$YR$A$F$Y$68$KG$20240919$$HP$CN$CN
243371781$24337178$1$I$$20240910$20240919$20240919$PER$$US-ASTELLAS-2024-AER-006015$ASTELLAS$$$$$F$Y$$$20240919$$MD$US$US
243371791$24337179$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010803$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243371801$24337180$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488429$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371811$24337181$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488424$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371821$24337182$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488426$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371831$24337183$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488432$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371841$24337184$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488430$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371851$24337185$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488422$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371861$24337186$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488425$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371871$24337187$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488434$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371881$24337188$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488428$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371891$24337189$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488423$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371901$24337190$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488433$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371911$24337191$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010358$APOTEX$$65$YR$$F$Y$$$20240919$$MD$CA$CA
243371921$24337192$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488431$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371931$24337193$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488427$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371941$24337194$1$I$20240908$20240908$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044860$AUROBINDO$$31$YR$$F$Y$54$KG$20240919$$CN$GB$GB
243371961$24337196$1$I$$20240909$20240919$20240919$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006794$BIOCON$$$$$$Y$$$20240919$$HP$CA$CA
243371971$24337197$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488437$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371981$24337198$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488436$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243371991$24337199$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488444$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372001$24337200$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488439$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372011$24337201$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488446$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372021$24337202$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488438$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372031$24337203$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488441$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372041$24337204$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488440$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372051$24337205$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488445$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372061$24337206$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488435$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372071$24337207$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488442$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372081$24337208$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488443$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372091$24337209$1$I$20231017$20240916$20240919$20240919$EXP$DE-DCGMA-24203826$DE-ROCHE-10000082499$ROCHE$$12$YR$T$M$Y$37.4$KG$20240919$$PH$DE$DE
243372101$24337210$1$I$20240822$20240909$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-026633$UNITED THERAPEUTICS$$35$YR$$F$Y$69.841$KG$20240919$$$US$US
243372111$24337211$1$I$$20231115$20240919$20240919$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017467$STRIDES$Gandhi A, Mortensen M, Alsayed M, Targovnik JH, Vinales KL, Correa RR.. Hypomagnesemia-Induced Hypocalcemia Successfully Treated With Sodium-Glucose Cotransport Inhibitor (SGLT-2i), a Case Report.. J-Endocr-Soc. 2021;5 (Suppl.1):A201$74$YR$$M$Y$$$20240919$$MD$US$US
243372121$24337212$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488369$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372131$24337213$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488448$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372141$24337214$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488363$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372151$24337215$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488447$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372161$24337216$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488449$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372171$24337217$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488366$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372181$24337218$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488370$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372201$24337220$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488365$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372211$24337221$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488364$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372221$24337222$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488367$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372231$24337223$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488368$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372241$24337224$1$I$20240101$20240109$20240919$20240919$PER$$CN-ROCHE-3489994$ROCHE$$37$YR$A$F$Y$60$KG$20240919$$HP$CN$CN
243372251$24337225$1$I$$20240909$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-028641$UNITED THERAPEUTICS$$$$$M$Y$97.506$KG$20240919$$$US$US
243372261$24337226$1$I$$20240914$20240919$20240919$PER$$US-AMGEN-USASP2024184873$AMGEN$$$$$$Y$$$20240919$$MD$US$US
243372281$24337228$1$I$$20240829$20240919$20240919$30DAY$$US-BECTON DICKINSON-US-BD-24-000539$BECTON DICKINSON$$$$$$Y$$$20240919$$CN$US$US
243372301$24337230$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488373$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372311$24337231$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488376$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372321$24337232$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488374$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372331$24337233$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488382$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372341$24337234$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488372$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372351$24337235$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488380$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372361$24337236$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488379$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372371$24337237$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488377$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372381$24337238$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488378$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372391$24337239$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488381$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372401$24337240$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488375$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372411$24337241$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488371$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372421$24337242$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010860$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243372431$24337243$1$I$20231201$20240917$20240919$20240919$EXP$$US-GILEAD-2024-0688161$GILEAD$$45$YR$A$F$Y$$$20240919$$HP$US$US
243372441$24337244$1$I$20240901$20240913$20240919$20240919$EXP$$AT-009507513-2409AUT005887$MERCK$$$$$M$Y$$$20240919$$CN$AT$AT
243372452$24337245$2$F$20240904$20240920$20240919$20240924$30DAY$$JP-UCBSA-2024047819$UCB$$$$$$Y$$$20240924$$PH$JP$JP
243372461$24337246$1$I$$20240112$20240919$20240919$PER$$KR-ROCHE-3491881$ROCHE$$$$A$$Y$$$20240919$$MD$KR$KR
243372471$24337247$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488384$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372481$24337248$1$I$20231002$20240910$20240919$20240919$EXP$$JP-ROCHE-3440677$ROCHE$$82$YR$E$M$Y$52$KG$20240919$$HP$JP$JP
243372491$24337249$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488534$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372501$24337250$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488383$ROCHE$$$$$F$Y$$$20240919$$MD$CN$CN
243372511$24337251$1$I$20231201$20240125$20240919$20240919$PER$$CA-ROCHE-3489684$ROCHE$$26$YR$A$F$Y$$$20240919$$CN$CA$CA
243372521$24337252$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488535$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372531$24337253$1$I$20240820$20240910$20240919$20240919$EXP$$DE-ROCHE-10000079078$ROCHE$$35$YR$A$F$Y$$$20240919$$CN$DE$DE
243372541$24337254$1$I$$20240104$20240919$20240919$PER$$JP-ROCHE-3489692$ROCHE$$12$YR$T$M$Y$$$20240919$$HP$JP$JP
243372551$24337255$1$I$20240104$20240105$20240919$20240919$PER$$JP-ROCHE-3489973$ROCHE$$34$YR$A$M$Y$$$20240919$$PH$JP$JP
243372561$24337256$1$I$20231226$20240108$20240919$20240919$PER$$CN-ROCHE-3489675$ROCHE$$5$YR$C$M$Y$20$KG$20240919$$HP$CN$CN
243372571$24337257$1$I$20240906$20240913$20240919$20240919$EXP$$US-ABBVIE-5924881$ABBVIE$$65$YR$$M$Y$$$20240919$$CN$US$US
243372581$24337258$1$I$$20240229$20240919$20240919$PER$$JP-ROCHE-3492211$ROCHE$$90$YR$E$F$Y$$$20240919$$PH$JP$JP
243372591$24337259$1$I$$20240105$20240919$20240919$PER$$IE-ROCHE-3489429$ROCHE$$$$$F$Y$$$20240919$$PH$IE$IE
243372601$24337260$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010802$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243372611$24337261$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488544$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372621$24337262$1$I$20221101$20240913$20240919$20240919$EXP$$US-ABBVIE-5890375$ABBVIE$$75$YR$$M$Y$98$KG$20240919$$CN$US$US
243372631$24337263$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488547$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372641$24337264$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488538$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372651$24337265$1$I$20231210$20240105$20240919$20240919$PER$$CN-ROCHE-3489252$ROCHE$$66$YR$E$M$Y$80$KG$20240919$$HP$CN$CN
243372661$24337266$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488536$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372671$24337267$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488546$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372681$24337268$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488545$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372691$24337269$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488541$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372701$24337270$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488540$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372711$24337271$1$I$20240301$20240916$20240919$20240919$EXP$$US-ABBVIE-5917391$ABBVIE$$57$YR$$F$Y$97.522$KG$20240919$$CN$US$US
243372721$24337272$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488539$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372731$24337273$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488542$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372741$24337274$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488537$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372751$24337275$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488543$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372761$24337276$1$I$20190607$20240916$20240919$20240919$EXP$$HU-SANDOZ INC.-PHHY2019HU158280$SANDOZ$$59$YR$$F$Y$$$20240919$$MD$HU$HU
243372771$24337277$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010909$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243372781$24337278$1$I$20231225$20240108$20240919$20240919$PER$$CN-ROCHE-3488405$ROCHE$$35$YR$A$M$Y$80$KG$20240919$$HP$CN$CN
243372791$24337279$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488548$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372801$24337280$1$I$$20240108$20240919$20240919$PER$$HK-ROCHE-3489876$ROCHE$$$$$$Y$$$20240919$$HP$HK$HK
243372811$24337281$1$I$20240110$20240111$20240919$20240919$PER$$CN-ROCHE-3490833$ROCHE$$29$YR$A$F$Y$$$20240919$$CN$CN$CN
243372821$24337282$1$I$20240108$20240109$20240919$20240919$PER$$GR-ROCHE-3491165$ROCHE$$42$YR$A$F$Y$$$20240919$$CN$GR$GR
243372831$24337283$1$I$$20240110$20240919$20240919$PER$$US-ROCHE-3488630$ROCHE$$$$A$M$Y$$$20240919$$CN$US$US
243372841$24337284$1$I$20240107$20240108$20240919$20240919$PER$$CN-ROCHE-3488390$ROCHE$$12$YR$T$M$Y$$$20240919$$CN$CN$CN
243372851$24337285$1$I$$20240115$20240919$20240919$PER$$ES-ROCHE-3492078$ROCHE$$81$YR$E$M$Y$$$20240919$$CN$ES$ES
243372861$24337286$1$I$$20240110$20240919$20240919$PER$$PT-ROCHE-3489591$ROCHE$$80$YR$E$F$Y$$$20240919$$PH$PT$PT
243372871$24337287$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488550$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372881$24337288$1$I$$20240104$20240919$20240919$PER$$CN-ROCHE-3488549$ROCHE$$$$$M$Y$$$20240919$$MD$CN$CN
243372891$24337289$1$I$$20240913$20240919$20240919$EXP$$IT-AMGEN-ITASP2024183884$AMGEN$Caldarola G.; Traini D.O.; Falco G.M. et al.. Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patients. International Journal of Dermatology. 2024;63 (9):1185-1192$$$$$Y$$$20240919$$HP$IT$IT
243372901$24337290$1$I$$20240916$20240919$20240919$EXP$$US-GILEAD-2024-0688086$GILEAD$$$$T$F$Y$$$20240919$$CN$US$US
243372911$24337291$1$I$20231231$20240111$20240919$20240919$PER$$CN-ROCHE-3491814$ROCHE$$28$YR$A$F$Y$75$KG$20240919$$HP$CN$CN
243372921$24337292$1$I$20240501$20240911$20240919$20240919$EXP$$US-ABBVIE-5811164$ABBVIE$$39$YR$$F$Y$$$20240919$$CN$US$US
243372931$24337293$1$I$20240104$20240425$20240919$20240919$PER$$JP-ROCHE-3488388$ROCHE$$6$DEC$A$$Y$$$20240919$$PH$JP$JP
243372941$24337294$1$I$$20240911$20240919$20240919$EXP$$US-ROCHE-10000080067$ROCHE$$$$A$M$Y$$$20240919$$CN$US$US
243372962$24337296$2$F$20231101$20240912$20240919$20240919$PER$$US-AMGEN-USASP2024183347$AMGEN$$63$YR$A$M$Y$$$20240919$$CN$US$US
243372981$24337298$1$I$20231001$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045194$AUROBINDO$$72$YR$$F$Y$$$20240919$$MD$FR$FR
243372991$24337299$1$I$20240401$20240916$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147407$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240919$$CN$US$US
243373001$24337300$1$I$20240901$20240913$20240919$20240919$EXP$$DE-ABBVIE-5925889$ABBVIE$$80$YR$$M$Y$$$20240919$$MD$DE$DE
243373022$24337302$2$F$$20240918$20240919$20240921$EXP$$US-ROCHE-10000085844$ROCHE$$$$E$M$Y$111$KG$20240921$$CN$US$US
243373031$24337303$1$I$$20240915$20240919$20240919$PER$$US-HALEON-2197162$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243373041$24337304$1$I$20240813$20240913$20240919$20240919$EXP$FR-AFSSAPS-RN2024000970$FR-TEVA-VS-3243933$TEVA$$68$YR$$M$Y$69$KG$20240919$$PH$FR$FR
243373051$24337305$1$I$20240820$20240911$20240919$20240919$EXP$$JP-ROCHE-10000085395$ROCHE$$$$A$F$Y$$$20240919$$MD$JP$JP
243373061$24337306$1$I$$20240917$20240919$20240919$EXP$$RO-UCBSA-2024047856$UCB$Oprean AM, Epure DA, Perjoc R-S, Paslaru AC, Teleanu RI. Neurodevelopmental disorder related to TANC2 gene. Romanian Journal of Child and Adolescent Neurology and Psychiatry. 2024;30(1):65-9$$$C$F$Y$$$20240919$$HP$RO$RO
243373081$24337308$1$I$$20240911$20240919$20240919$EXP$$CN-UCBSA-2024046826$UCB$Chen X. Comparative analysis and safety study of Levetiracetam and Carbamazepine in the treatment of refractory epilepsy. Chinese Science and Technology Journal Database (Citation Edition) Medicine and. 2024;8:9-15$$$$$Y$$$20240919$$MD$CN$CN
243373091$24337309$1$I$$20240909$20240919$20240919$EXP$$US-GSK-US2024111865$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243373101$24337310$1$I$$20240912$20240919$20240919$PER$$US-BIOGEN-2024BI01282633$BIOGEN$$$$$F$Y$$$20240919$$CN$US$US
243373111$24337311$1$I$20240816$20240906$20240919$20240919$EXP$$IT-AUROBINDO-AUR-APL-2024-045090$AUROBINDO$$47$YR$$M$Y$$$20240919$$MD$IT$IT
243373121$24337312$1$I$$20240909$20240919$20240919$EXP$$US-GSK-US2024111878$GLAXOSMITHKLINE$$37$YR$$F$Y$$$20240919$$CN$US$US
243373131$24337313$1$I$$20240905$20240919$20240919$EXP$$US-AUROBINDO-AUR-APL-2024-044481$AUROBINDO$Zou H, Rau A, Thompson L, Henderson D. Pancytopenia Concurrent With Metabolic Encephalopathy. Cureus. 2024;16(8):e67963$81$YR$$F$Y$$$20240919$$MD$US$US
243373141$24337314$1$I$20240909$20240911$20240919$20240919$PER$$US-BIOGEN-2024BI01282364$BIOGEN$$39$YR$$F$Y$$$20240919$$CN$US$US
243373151$24337315$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148814$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240919$$HP$US$US
243373161$24337316$1$I$$20240910$20240919$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147355$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240919$$MD$JP$JP
243373171$24337317$1$I$20240604$20240906$20240919$20240919$EXP$FR-AFSSAPS-RN2024000936$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08515$HIKMA$$46$YR$$M$Y$79$KG$20240919$$MD$FR$FR
243373182$24337318$2$F$$20240917$20240919$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-044488$AUROBINDO$Salk G, Mangala YO, Onukogu ID, Meleveedu K. ALL-747 Methotrexate-induced neurotoxicity due to ommaya reservoir malfunction in a patient with acute lymphoblastic leukemia.. Clinical Lymphoma, Myeloma and Leukemia.. 2024;24(Suppl1):S282-3$36$YR$$F$Y$$$20240927$$MD$US$US
243373191$24337319$1$I$$20240917$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148666$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240919$$HP$US$US
243373201$24337320$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148822$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240919$$HP$US$US
243373212$24337321$2$F$$20240925$20240919$20240927$EXP$$JP-GILEAD-2024-0686283$GILEAD$$89$YR$E$F$Y$$$20240927$$PH$JP$JP
243373221$24337322$1$I$$20240911$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-028683$UNITED THERAPEUTICS$$$$E$M$Y$$$20240919$$MD$US$US
243373231$24337323$1$I$20230220$20240909$20240919$20240919$EXP$ES-AEMPS-1565829$ES-TEVA-VS-3241947$TEVA$$69$YR$$F$Y$65$KG$20240919$$PH$ES$ES
243373241$24337324$1$I$$20240911$20240919$20240919$EXP$$US-EMD Serono-2024046834$EMD SERONO INC$$38$YR$A$M$Y$$$20240919$$MD$US$US
243373251$24337325$1$I$20240201$20240913$20240919$20240919$EXP$FR-AFSSAPS-RN2024000947$FR-TEVA-VS-3243621$TEVA$$42$YR$$F$Y$$$20240919$$MD$FR$FR
243373261$24337326$1$I$20240501$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045279$AUROBINDO$$40$YR$$M$Y$$$20240919$$PH$FR$FR
243373281$24337328$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010867$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243373291$24337329$1$I$$20240917$20240919$20240919$EXP$$CA-ORGANON-O2409CAN001165$ORGANON$$54$YR$$F$Y$$$20240919$$HP$CA$CA
243373301$24337330$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010762$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243373311$24337331$1$I$$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045436$AUROBINDO$$29$YR$$M$Y$$$20240919$$PH$FR$FR
243373321$24337332$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010364$APOTEX$$65$YR$$F$Y$34$KG$20240919$$CN$CA$CA
243373341$24337334$1$I$20240901$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010761$ELI LILLY AND CO$$44$YR$A$$Y$$$20240919$$CN$US$US
243373352$24337335$2$F$$20240917$20240919$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010415$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240923$$CN$US$US
243373361$24337336$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011736$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240919$$CN$US$US
243373371$24337337$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010935$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243373381$24337338$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011032$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240919$$CN$US$US
243373391$24337339$1$I$20240916$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010897$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240919$$CN$US$US
243373401$24337340$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011876$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240919$$CN$US$US
243373411$24337341$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010729$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240919$$CN$US$US
243373431$24337343$1$I$$20240913$20240919$20240919$EXP$$US-AMGEN-USASP2024183659$AMGEN$$$$$F$Y$$$20240919$$PH$US$US
243373441$24337344$1$I$20240101$20240910$20240919$20240919$EXP$$US-TEVA-VS-3242760$TEVA$$$$E$F$Y$$$20240919$$CN$US$US
243373451$24337345$1$I$$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045360$AUROBINDO$Almeida C, Dubertrand C, Achard A, Cabaret B, Petitcollin A.. D?couverte fortuite d?une intoxication ? la k?tamine chez un nourisson de 10 mois au cours d?une hospitalisation : apport des analyses plasmatiques et capillaires.. Toxicologie Analytique et Clinique. 2024;32:43$10$MON$$M$Y$$$20240919$$MD$FR$FR
243373461$24337346$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010910$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243373481$24337348$1$I$$20240919$20240919$20240919$EXP$$US-PROD-AS2-212756134-RB-135243-2023$RECKITT BENCKISER$$$$$M$Y$$$20240919$$CN$US$US
243373491$24337349$1$I$$20240910$20240919$20240919$30DAY$$US-GSK-US2024114150$GLAXOSMITHKLINE$$$$$M$Y$$$20240919$$HP$US$US
243373502$24337350$2$F$20240101$20240918$20240919$20240920$EXP$$US-JNJFOC-20240936575$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240920$$CN$US$US
243373511$24337351$1$I$20240805$20240912$20240919$20240919$EXP$$FR-JNJFOC-20240941147$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240919$$MD$FR$FR
243373521$24337352$1$I$$20240918$20240919$20240919$PER$$US-JNJFOC-20240947588$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243373542$24337354$2$F$20240328$20240918$20240919$20240923$EXP$$US-ROCHE-10000083502$ROCHE$$54$YR$A$F$Y$$$20240923$$MD$US$US
243373571$24337357$1$I$$20240913$20240919$20240919$PER$$US-ASTELLAS-2024-AER-007239$ASTELLAS$$76$YR$E$F$Y$$$20240919$$CN$US$US
243373581$24337358$1$I$$20231003$20240919$20240919$PER$$JP-ROCHE-3437069$ROCHE$$5$DEC$A$F$Y$$$20240919$$PH$JP$JP
243373591$24337359$1$I$$20230926$20240919$20240919$PER$$JP-ROCHE-3431188$ROCHE$$9$YR$C$M$Y$$$20240919$$PH$JP$JP
243373601$24337360$1$I$20230817$20231003$20240919$20240919$PER$$SG-ROCHE-3433515$ROCHE$$$$$$Y$$$20240919$$HP$SG$SG
243373621$24337362$1$I$$20240918$20240919$20240919$PER$$NVSC2024US186996$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243373631$24337363$1$I$$20230921$20240919$20240919$PER$$JP-ROCHE-3430098$ROCHE$$35$YR$A$F$Y$$$20240919$$PH$JP$JP
243373641$24337364$1$I$$20231006$20240919$20240919$PER$$JP-ROCHE-3438939$ROCHE$$5$DEC$A$M$Y$$$20240919$$PH$JP$JP
243373661$24337366$1$I$$20231121$20240919$20240919$PER$$US-ROCHE-3441696$ROCHE$$6$YR$C$F$Y$$$20240919$$HP$US$US
243373671$24337367$1$I$$20231013$20240919$20240919$PER$$IN-ROCHE-3440882$ROCHE$Chavan S, Chandrashekhar T. Lobomycosis in a Post-Covid 19 Patient: A Case Report and Review of Literature. DOI: 10.5146/tjpath.2023.01604. Turk Patoloji Dergisi 2023;39 (3):206-11.$53$YR$A$M$Y$$$20240919$$HP$IN$IN
243373681$24337368$1$I$$20231004$20240919$20240919$PER$$JP-ROCHE-3439075$ROCHE$$28$YR$A$F$Y$$$20240919$$PH$JP$JP
243373691$24337369$1$I$$20240910$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-028890$UNITED THERAPEUTICS$$$$$F$Y$86.168$KG$20240919$$$US$US
243373701$24337370$1$I$$20240125$20240919$20240919$PER$$RU-ROCHE-3435243$ROCHE$$$$$F$Y$$$20240919$$MD$RU$RU
243373711$24337371$1$I$$20231006$20240919$20240919$PER$$US-ROCHE-3435670$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243373721$24337372$1$I$$20231017$20240919$20240919$PER$$KR-ROCHE-3442088$ROCHE$$10$YR$C$M$Y$28$KG$20240919$$CN$KR$KR
243373731$24337373$1$I$20231001$20231005$20240919$20240919$PER$$JP-ROCHE-3438953$ROCHE$$10$YR$C$M$Y$$$20240919$$PH$JP$JP
243373741$24337374$1$I$$20231010$20240919$20240919$PER$$JP-ROCHE-3440025$ROCHE$$2$DEC$A$F$Y$$$20240919$$PH$JP$JP
243373751$24337375$1$I$20240907$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024184085$AMGEN$$65$YR$E$F$Y$$$20240919$$CN$US$US
243373761$24337376$1$I$20230909$20230921$20240919$20240919$PER$$JP-ROCHE-3430326$ROCHE$$9$YR$C$M$Y$44$KG$20240919$$PH$JP$JP
243373771$24337377$1$I$20190101$20240910$20240919$20240919$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043580$BOEHRINGER INGELHEIM$$79$YR$E$M$Y$$$20240919$$CN$CA$CA
243373782$24337378$2$F$20240913$20240919$20240919$20240924$PER$$US-AMGEN-USASP2024184159$AMGEN$$80$YR$E$F$Y$$$20240924$$HP$US$US
243373791$24337379$1$I$20231012$20231013$20240919$20240919$PER$$JP-ROCHE-3444186$ROCHE$$3$DEC$A$M$Y$$$20240919$$PH$JP$JP
243373801$24337380$1$I$20231012$20231012$20240919$20240919$PER$$JP-ROCHE-3442276$ROCHE$$6$DEC$A$F$Y$$$20240919$$PH$JP$JP
243373811$24337381$1$I$20230227$20231019$20240919$20240919$PER$NO-NOMAADVRE-PASRAPP-2023-V9ngkq$NO-ROCHE-3442993$ROCHE$$30$YR$A$F$Y$56$KG$20240919$$CN$NO$NO
243373821$24337382$1$I$20230922$20231016$20240919$20240919$PER$$JP-ROCHE-3431106$ROCHE$$9$YR$C$M$Y$$$20240919$$PH$JP$JP
243373831$24337383$1$I$20231002$20231011$20240919$20240919$PER$$JP-ROCHE-3441509$ROCHE$$$$E$F$Y$$$20240919$$PH$JP$JP
243373841$24337384$1$I$20230926$20231130$20240919$20240919$PER$$JP-ROCHE-3434177$ROCHE$$23$YR$A$M$Y$$$20240919$$PH$JP$JP
243373851$24337385$1$I$$20231006$20240919$20240919$PER$$US-ROCHE-3436184$ROCHE$$$$$F$Y$$$20240919$$CN$US$US
243373861$24337386$1$I$$20231013$20240919$20240919$PER$$JP-ROCHE-3443117$ROCHE$$33$YR$A$F$Y$$$20240919$$PH$JP$JP
243373871$24337387$1$I$$20231010$20240919$20240919$PER$$KR-ROCHE-3440435$ROCHE$$5$YR$C$F$Y$$$20240919$$MD$KR$KR
243373881$24337388$1$I$$20231010$20240919$20240919$PER$$KR-ROCHE-3440454$ROCHE$$$$C$F$Y$$$20240919$$MD$KR$KR
243373891$24337389$1$I$$20231009$20240919$20240919$PER$$CN-ROCHE-3436493$ROCHE$$$$$$Y$$$20240919$$HP$CN$CN
243373901$24337390$1$I$$20240912$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145983$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240919$$CN$US$US
243373911$24337391$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148805$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240919$$CN$US$US
243373921$24337392$1$I$$20240911$20240919$20240919$PER$$US-RDY-SPO/USA/24/0013591$DR REDDYS$Abugrin M, Aboulqassim B, Panchal A, Bilal M, Virk J. Timely Transesophageal Echocardiography After Left Atrial Appendage Occlusion May Avoid Delayed Detection of Device-Related Thrombus. CASE. 2024 Sep;8(9): 456-460. doi:10.1016/j.case.2024.05.007.$72$YR$E$M$Y$$$20240919$$MD$US$US
243373931$24337393$1$I$20231011$20231012$20240919$20240919$PER$$JP-ROCHE-3442254$ROCHE$$4$YR$C$M$Y$15$KG$20240919$$PH$JP$JP
243373941$24337394$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010912$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243373981$24337398$1$I$$20240820$20240919$20240919$PER$$US-ABBVIE-5928103$ABBVIE$$$$$$Y$$$20240919$$HP$US$US
243373991$24337399$1$I$20240908$20240911$20240919$20240919$EXP$$ZA-BIOVITRUM-2024-ZA-012090$BIOVITRUM$$132$DY$$M$Y$5.5$KG$20240919$$CN$ZA$ZA
243374001$24337400$1$I$$20231005$20240919$20240919$PER$$JP-ROCHE-3438989$ROCHE$$$$C$$Y$$$20240919$$PH$JP$JP
243374011$24337401$1$I$20240101$20240910$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-028711$UNITED THERAPEUTICS$$$$$M$Y$53.515$KG$20240919$$$US$US
243374021$24337402$1$I$$20230926$20240919$20240919$PER$$JP-ROCHE-3431150$ROCHE$$30$YR$A$F$Y$$$20240919$$PH$JP$JP
243374031$24337403$1$I$$20231006$20240919$20240919$PER$$KR-ROCHE-3436041$ROCHE$$$$$F$Y$$$20240919$$CN$KR$KR
243374041$24337404$1$I$$20231010$20240919$20240919$PER$$KR-ROCHE-3440427$ROCHE$$$$C$M$Y$$$20240919$$MD$KR$KR
243374051$24337405$1$I$$20230926$20240919$20240919$PER$$JP-ROCHE-3434004$ROCHE$$29$YR$A$F$Y$$$20240919$$PH$JP$JP
243374061$24337406$1$I$$20231006$20240919$20240919$PER$$CN-ROCHE-3436024$ROCHE$$$$$$Y$$$20240919$$HP$CN$CN
243374071$24337407$1$I$20231001$20231010$20240919$20240919$PER$$JP-ROCHE-3442206$ROCHE$$17$YR$T$M$Y$$$20240919$$PH$JP$JP
243374081$24337408$1$I$$20230926$20240919$20240919$PER$$JP-ROCHE-3431153$ROCHE$$$$A$$Y$$$20240919$$PH$JP$JP
243374091$24337409$1$I$20230926$20230926$20240919$20240919$PER$$JP-ROCHE-3433974$ROCHE$$3$YR$C$$Y$$$20240919$$CN$JP$JP
243374101$24337410$1$I$$20230921$20240919$20240919$PER$$JP-ROCHE-3430330$ROCHE$$35$YR$A$F$Y$$$20240919$$PH$JP$JP
243374112$24337411$2$F$20240831$20240905$20240919$20240927$EXP$$US-SA-2024SA269900$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240927$$CN$US$US
243374121$24337412$1$I$$20240916$20240919$20240919$EXP$$BR-BIOVITRUM-2024-BR-012202$BIOVITRUM$$$$I$F$Y$$$20240919$$CN$BR$BR
243374131$24337413$1$I$20240101$20240912$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-029033$UNITED THERAPEUTICS$$$$$F$Y$62.585$KG$20240919$$$US$US
243374141$24337414$1$I$$20240911$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-029040$UNITED THERAPEUTICS$$$$$F$Y$108.84$KG$20240919$$$US$US
243374151$24337415$1$I$$20240909$20240919$20240919$PER$$US-ASTELLAS-2024-AER-005836$ASTELLAS$$$$A$F$Y$$$20240919$$CN$US$US
243374161$24337416$1$I$$20231013$20240919$20240919$PER$$JP-ROCHE-3444216$ROCHE$$11$YR$C$F$Y$$$20240919$$PH$JP$JP
243374171$24337417$1$I$$20231108$20240919$20240919$PER$$JP-ROCHE-3448485$ROCHE$$12$YR$T$$Y$40$KG$20240919$$PH$JP$JP
243374181$24337418$1$I$$20231030$20240919$20240919$PER$$KR-ROCHE-3451542$ROCHE$$$$$$Y$$$20240919$$HP$KR$KR
243374191$24337419$1$I$$20231023$20240919$20240919$PER$$KR-ROCHE-3445325$ROCHE$$17$YR$T$M$Y$$$20240919$$CN$KR$KR
243374211$24337421$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447813$ROCHE$$$$$F$Y$$$20240919$$PH$ID$ID
243374221$24337422$1$I$20230309$20231101$20240919$20240919$PER$$CN-ROCHE-3451208$ROCHE$$12$YR$T$F$Y$41$KG$20240919$$HP$CN$CN
243374231$24337423$1$I$$20231026$20240919$20240919$PER$$CN-ROCHE-3447623$ROCHE$Lu X. One case of haemolytic anaemia caused by toxic epidermal necrolysis treated with intravenous injection gamma globulin. Chinese Journal of Dermatology 2023;56 (9):-.$35$YR$A$F$Y$$$20240919$$HP$CN$CN
243374241$24337424$1$I$$20231023$20240919$20240919$PER$$KR-ROCHE-3445341$ROCHE$$$$$$Y$$$20240919$$CN$KR$KR
243374251$24337425$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3445366$ROCHE$$$$$$Y$$$20240919$$PH$ID$ID
243374261$24337426$1$I$$20231012$20240919$20240919$PER$$JP-ROCHE-3444213$ROCHE$$53$YR$A$M$Y$$$20240919$$PH$JP$JP
243374271$24337427$1$I$20240909$20240911$20240919$20240919$PER$$US-AMGEN-USASP2024185995$AMGEN$$20$YR$A$F$Y$$$20240919$$CN$US$US
243374281$24337428$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148608$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240919$$CN$US$US
243374291$24337429$1$I$20230601$20240912$20240919$20240919$EXP$$CA-GSK-CA2023055824$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$CA$CA
243374301$24337430$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010761$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243374311$24337431$1$I$20231020$20231020$20240919$20240919$PER$$JP-ROCHE-3448501$ROCHE$$49$YR$A$F$Y$$$20240919$$PH$JP$JP
243374321$24337432$1$I$20240901$20240912$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-029063$UNITED THERAPEUTICS$$82$YR$$M$Y$72.562$KG$20240919$$$US$US
243374331$24337433$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447865$ROCHE$$$$$M$Y$$$20240919$$PH$ID$ID
243374341$24337434$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3445487$ROCHE$$$$$$Y$$$20240919$$PH$ID$ID
243374352$24337435$2$F$$20231106$20240919$20240923$PER$$HK-ROCHE-3449075$ROCHE$$$$$$Y$$$20240923$$PH$HK$HK
243374361$24337436$1$I$20230910$20231020$20240919$20240919$PER$$CN-ROCHE-3444433$ROCHE$$25$YR$A$F$Y$61$KG$20240919$$HP$CN$CN
243374371$24337437$1$I$20230316$20231020$20240919$20240919$PER$$CN-ROCHE-3444432$ROCHE$$43$YR$A$M$Y$76$KG$20240919$$HP$CN$CN
243374381$24337438$1$I$$20231023$20240919$20240919$PER$$JP-ROCHE-3450233$ROCHE$$$$$M$Y$$$20240919$$CN$JP$JP
243374391$24337439$1$I$20230901$20231027$20240919$20240919$PER$$CN-ROCHE-3448798$ROCHE$$78$YR$E$M$Y$$$20240919$$HP$CN$CN
243374401$24337440$1$I$$20231031$20240919$20240919$PER$$KR-ROCHE-3450647$ROCHE$$13$YR$T$M$Y$$$20240919$$PH$KR$KR
243374411$24337441$1$I$20231020$20231020$20240919$20240919$PER$$JP-ROCHE-3448446$ROCHE$$49$YR$A$F$Y$$$20240919$$PH$JP$JP
243374421$24337442$1$I$20231011$20231030$20240919$20240919$PER$$CN-ROCHE-3449677$ROCHE$$11$YR$C$F$Y$46$KG$20240919$$HP$CN$CN
243374431$24337443$1$I$$20231031$20240919$20240919$PER$$KR-ROCHE-3450661$ROCHE$$8$YR$C$F$Y$$$20240919$$CN$KR$KR
243374441$24337444$1$I$$20240125$20240919$20240919$PER$$RU-ROCHE-3445517$ROCHE$$$$A$$Y$$$20240919$$MD$RU$RU
243374451$24337445$1$I$$20231016$20240919$20240919$PER$$JP-ROCHE-3444309$ROCHE$$35$YR$A$F$Y$$$20240919$$PH$JP$JP
243374461$24337446$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010828$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243374471$24337447$1$I$$20231025$20240919$20240919$PER$$JP-ROCHE-3450279$ROCHE$$$$C$$Y$$$20240919$$PH$JP$JP
243374481$24337448$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447887$ROCHE$$$$$F$Y$$$20240919$$PH$ID$ID
243374491$24337449$1$I$20240501$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045135$AUROBINDO$$44$YR$$M$Y$$$20240919$$MD$FR$FR
243374501$24337450$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447883$ROCHE$$$$$F$Y$$$20240919$$PH$ID$ID
243374511$24337451$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447880$ROCHE$$$$$F$Y$$$20240919$$PH$ID$ID
243374521$24337452$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447882$ROCHE$$$$$F$Y$$$20240919$$PH$ID$ID
243374531$24337453$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447881$ROCHE$$$$$F$Y$$$20240919$$PH$ID$ID
243374541$24337454$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447885$ROCHE$$$$$F$Y$$$20240919$$PH$ID$ID
243374551$24337455$1$I$$20231101$20240919$20240919$PER$$CN-ROCHE-3451104$ROCHE$$$$$$Y$$$20240919$$CN$CN$CN
243374561$24337456$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447886$ROCHE$$$$$F$Y$$$20240919$$PH$ID$ID
243374571$24337457$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447879$ROCHE$$$$$F$Y$$$20240919$$PH$ID$ID
243374581$24337458$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447884$ROCHE$$$$$F$Y$$$20240919$$PH$ID$ID
243374591$24337459$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447888$ROCHE$$$$$F$Y$$$20240919$$PH$ID$ID
243374601$24337460$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447891$ROCHE$$$$$M$Y$$$20240919$$PH$ID$ID
243374611$24337461$1$I$$20231019$20240919$20240919$PER$$JP-ROCHE-3446665$ROCHE$$62$YR$A$M$Y$$$20240919$$PH$JP$JP
243374621$24337462$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447871$ROCHE$$$$$M$Y$$$20240919$$PH$ID$ID
243374631$24337463$1$I$$20231024$20240919$20240919$PER$$CH-ROCHE-3447836$ROCHE$$$$$$Y$$$20240919$$MD$CH$CH
243374641$24337464$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447869$ROCHE$$$$$M$Y$$$20240919$$PH$ID$ID
243374651$24337465$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447868$ROCHE$$$$$M$Y$$$20240919$$PH$ID$ID
243374661$24337466$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447873$ROCHE$$$$$M$Y$$$20240919$$PH$ID$ID
243374671$24337467$1$I$$20231018$20240919$20240919$PER$$JP-ROCHE-3446580$ROCHE$$7$YR$C$F$Y$$$20240919$$PH$JP$JP
243374681$24337468$1$I$20240101$20240911$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-024754$UNITED THERAPEUTICS$$$$$F$Y$46.259$KG$20240919$$$US$US
243374691$24337469$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447870$ROCHE$$$$$M$Y$$$20240919$$PH$ID$ID
243374701$24337470$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447872$ROCHE$$$$$M$Y$$$20240919$$PH$ID$ID
243374711$24337471$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447889$ROCHE$$$$$F$Y$$$20240919$$PH$ID$ID
243374721$24337472$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447874$ROCHE$$$$$M$Y$$$20240919$$PH$ID$ID
243374731$24337473$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010368$APOTEX$$9$YR$$M$Y$$$20240919$$CN$CA$CA
243374741$24337474$1$I$$20240910$20240919$20240919$EXP$$CA-HALEON-2196696$Haleon PLC$$$$$F$Y$$$20240919$$MD$CA$CA
243374751$24337475$1$I$20231014$20231016$20240919$20240919$PER$$JP-ROCHE-3444972$ROCHE$$13$YR$T$$Y$$$20240919$$CN$JP$JP
243374761$24337476$1$I$20210628$20231026$20240919$20240919$PER$$CN-ROCHE-3447680$ROCHE$$33$YR$A$F$Y$$$20240919$$HP$CN$CN
243374771$24337477$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447876$ROCHE$$$$$M$Y$$$20240919$$PH$ID$ID
243374782$24337478$2$F$20231016$20231101$20240919$20240923$PER$$JP-ROCHE-3444189$ROCHE$$9$YR$C$M$Y$$$20240923$$PH$JP$JP
243374791$24337479$1$I$$20231016$20240919$20240919$PER$$JP-ROCHE-3444929$ROCHE$$70$YR$E$F$Y$$$20240919$$PH$JP$JP
243374801$24337480$1$I$$20231019$20240919$20240919$PER$$ID-ROCHE-3447875$ROCHE$$$$$M$Y$$$20240919$$PH$ID$ID
243374811$24337481$1$I$20231017$20231018$20240919$20240919$PER$$JP-ROCHE-3446634$ROCHE$$32$YR$A$F$Y$$$20240919$$MD$JP$JP
243374821$24337482$1$I$$20231026$20240919$20240919$PER$$KR-ROCHE-3447984$ROCHE$$$$$F$Y$$$20240919$$PH$KR$KR
243374831$24337483$1$I$$20231019$20240919$20240919$PER$$JP-ROCHE-3446647$ROCHE$$51$YR$A$F$Y$$$20240919$$PH$JP$JP
243374841$24337484$1$I$20230901$20240916$20240919$20240919$EXP$$CA-AMGEN-CANSP2024184872$AMGEN$$74$YR$E$F$Y$$$20240919$$MD$CA$CA
243374851$24337485$1$I$$20240910$20240919$20240919$PER$$US-ABBVIE-5920422$ABBVIE$$$$A$F$Y$$$20240919$$CN$US$US
243374871$24337487$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010913$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243374881$24337488$1$I$$20240906$20240919$20240919$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-09087$LUPIN$Singh J, Saluja P, Thacker A, More A, Tripathi S, Sen A. Disseminated tuberculosis presenting as ciliary body and thyroid mass lesions: a case report. Ocular Immunology and Inflammation. 2024;32 (6):1097-1100$17$YR$$M$Y$$$20240919$$MD$IN$IN
243374901$24337490$1$I$20240101$20240913$20240919$20240919$EXP$$CA-ABBVIE-5924435$ABBVIE$$18$YR$$M$Y$$$20240919$$CN$CA$CA
243374911$24337491$1$I$$20240911$20240919$20240919$EXP$$JP-ROCHE-10000084916$ROCHE$$63$YR$A$F$Y$$$20240919$$MD$JP$JP
243374921$24337492$1$I$20240912$20240913$20240919$20240919$EXP$$NVSC2024US184153$NOVARTIS$$35$YR$$F$Y$$$20240919$$CN$US$US
243374931$24337493$1$I$20230101$20240603$20240919$20240919$PER$$US-ALVOGEN-2024094806$ALVOGEN$$$$$M$Y$$$20240919$$CN$US$US
243374941$24337494$1$I$20240704$20240910$20240919$20240919$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-08486$HIKMA$$52$YR$$F$Y$100$KG$20240919$$PH$EG$EG
243374951$24337495$1$I$$20240913$20240919$20240919$PER$$NVSC2024US184714$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243374961$24337496$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010868$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243374971$24337497$1$I$$20240605$20240919$20240919$PER$$US-ALVOGEN-2024094829$ALVOGEN$$$$$M$Y$$$20240919$$CN$US$US
243374981$24337498$1$I$20230925$20231106$20240919$20240919$PER$$SG-ROCHE-3453208$ROCHE$$40$YR$A$$Y$$$20240919$$HP$SG$SG
243375001$24337500$1$I$20231108$20231108$20240919$20240919$PER$$JP-ROCHE-3458842$ROCHE$$4$YR$C$M$Y$$$20240919$$PH$JP$JP
243375011$24337501$1$I$20231106$20231109$20240919$20240919$PER$$CN-ROCHE-3455968$ROCHE$$36$YR$A$M$Y$60$KG$20240919$$HP$CN$CN
243375021$24337502$1$I$$20231116$20240919$20240919$PER$$KR-ROCHE-3460046$ROCHE$$12$YR$T$M$Y$$$20240919$$CN$KR$KR
243375031$24337503$1$I$20230926$20231106$20240919$20240919$PER$$SG-ROCHE-3453258$ROCHE$$27$YR$A$$Y$$$20240919$$HP$SG$SG
243375041$24337504$1$I$$20231116$20240919$20240919$PER$$KR-ROCHE-3459963$ROCHE$$5$YR$C$M$Y$$$20240919$$PH$KR$KR
243375051$24337505$1$I$20231101$20231120$20240919$20240919$PER$$JP-ROCHE-3465313$ROCHE$$3$YR$C$F$Y$$$20240919$$PH$JP$JP
243375061$24337506$1$I$20231109$20231110$20240919$20240919$PER$$JP-ROCHE-3460475$ROCHE$$11$YR$C$M$Y$$$20240919$$PH$JP$JP
243375071$24337507$1$I$20230221$20240719$20240919$20240919$PER$$US-ALVOGEN-2024095038$ALVOGEN$$$$$F$Y$$$20240919$$HP$US$US
243375081$24337508$1$I$20231108$20231110$20240919$20240919$PER$$CN-ROCHE-3455970$ROCHE$$21$YR$A$M$Y$67$KG$20240919$$HP$CN$CN
243375091$24337509$1$I$20240101$20240716$20240919$20240919$PER$$US-ALVOGEN-2024095053$ALVOGEN$$$$$M$Y$$$20240919$$CN$US$US
243375101$24337510$1$I$20240610$20240807$20240919$20240919$PER$$US-ALVOGEN-2024094959$ALVOGEN$$$$$F$Y$$$20240919$$MD$US$US
243375112$24337511$2$F$20240101$20240909$20240919$20240924$EXP$$US-INSMED-2024-03302-USAA$INSMED$$$$$F$Y$$$20240924$$CN$US$US
243375121$24337512$1$I$$20231128$20240919$20240919$PER$$KR-ROCHE-3466641$ROCHE$$$$$$Y$$$20240919$$PH$KR$KR
243375131$24337513$1$I$$20231113$20240919$20240919$PER$$JP-ROCHE-3461345$ROCHE$$12$YR$T$F$Y$$$20240919$$PH$JP$JP
243375141$24337514$1$I$$20231120$20240919$20240919$PER$$DE-ROCHE-3462146$ROCHE$$$$$F$Y$$$20240919$$CN$DE$DE
243375151$24337515$1$I$20231106$20231110$20240919$20240919$PER$$CN-ROCHE-3456833$ROCHE$$7$YR$C$F$Y$30$KG$20240919$$HP$CN$CN
243375161$24337516$1$I$20231121$20231122$20240919$20240919$PER$$JP-ROCHE-3467242$ROCHE$$10$YR$C$F$Y$35$KG$20240919$$PH$JP$JP
243375171$24337517$1$I$$20231110$20240919$20240919$PER$$IN-ROCHE-3455795$ROCHE$$$$$$Y$$$20240919$$MD$IN$IN
243375181$24337518$1$I$$20231121$20240919$20240919$PER$$JP-ROCHE-3467024$ROCHE$$8$YR$C$M$Y$$$20240919$$PH$JP$JP
243375191$24337519$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010354$APOTEX$$65$YR$$F$Y$34$KG$20240919$$HP$CA$CA
243375201$24337520$1$I$20231120$20231121$20240919$20240919$PER$$JP-ROCHE-3467069$ROCHE$$1$YR$I$F$Y$$$20240919$$PH$JP$JP
243375211$24337521$1$I$$20231109$20240919$20240919$PER$$JP-ROCHE-3460503$ROCHE$$$$C$$Y$$$20240919$$PH$JP$JP
243375221$24337522$1$I$20231116$20231116$20240919$20240919$PER$$JP-ROCHE-3464810$ROCHE$$7$YR$C$F$Y$$$20240919$$PH$JP$JP
243375231$24337523$1$I$20240623$20240729$20240919$20240919$PER$$US-ALVOGEN-2024095228$ALVOGEN$$$$$M$Y$$$20240919$$HP$US$US
243375241$24337524$1$I$20240725$20240913$20240919$20240919$PER$$US-ROCHE-10000083287$ROCHE$$43$YR$A$M$Y$$$20240919$$CN$US$US
243375251$24337525$1$I$$20231115$20240919$20240919$PER$$JP-ROCHE-3463853$ROCHE$$11$YR$C$M$Y$$$20240919$$PH$JP$JP
243375261$24337526$1$I$20231121$20231122$20240919$20240919$PER$$JP-ROCHE-3467022$ROCHE$$60$YR$A$M$Y$$$20240919$$PH$JP$JP
243375271$24337527$1$I$$20240628$20240919$20240919$PER$$US-ALVOGEN-2024095013$ALVOGEN$$$$$M$Y$$$20240919$$PH$US$US
243375281$24337528$1$I$$20240916$20240919$20240919$PER$$US-ROCHE-10000085122$ROCHE$Viscardi C, Rho J, Blake C. Bilateral neovascular glaucoma associated with Radium-223 infusions for prostate cancer. American Journal of Ophthalmology Case Reports. 2024;36:1-3. doi:10.1016/j.ajoc.2024.102142.$65$YR$E$M$Y$$$20240919$$HP$US$US
243375291$24337529$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010654$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240919$$CN$US$US
243375301$24337530$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010802$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240919$$CN$US$US
243375311$24337531$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010846$ELI LILLY AND CO$$24$YR$A$M$Y$$$20240919$$CN$US$US
243375323$24337532$3$F$$20240913$20240919$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409009440$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240927$$CN$US$US
243375331$24337533$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010645$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240919$$CN$US$US
243375341$24337534$1$I$$20240604$20240919$20240919$PER$$US-ALVOGEN-2024094813$ALVOGEN$$$$$F$Y$$$20240919$$CN$US$US
243375351$24337535$1$I$$20240916$20240919$20240919$EXP$$AU-ASTELLAS-2024-AER-007256$ASTELLAS$$35$YR$A$F$Y$$$20240919$$MD$AU$AU
243375361$24337536$1$I$20240101$20240913$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-021737$UNITED THERAPEUTICS$$$$$F$Y$88.435$KG$20240919$$$US$US
243375371$24337537$1$I$$20231109$20240919$20240919$PER$$JP-ROCHE-3460501$ROCHE$$86$YR$E$F$Y$$$20240919$$PH$JP$JP
243375381$24337538$1$I$20231109$20240115$20240919$20240919$PER$$JP-ROCHE-3460469$ROCHE$$49$YR$A$F$Y$$$20240919$$PH$JP$JP
243375391$24337539$1$I$20231116$20231117$20240919$20240919$PER$$JP-ROCHE-3464646$ROCHE$$4$YR$C$M$Y$$$20240919$$MD$JP$JP
243375401$24337540$1$I$20231101$20231107$20240919$20240919$PER$$CN-ROCHE-3456427$ROCHE$$47$YR$A$M$Y$80$KG$20240919$$HP$CN$CN
243375411$24337541$1$I$20231115$20231115$20240919$20240919$PER$$JP-ROCHE-3463968$ROCHE$$52$YR$A$M$Y$$$20240919$$PH$JP$JP
243375421$24337542$1$I$$20231124$20240919$20240919$PER$$KR-ROCHE-3464619$ROCHE$$9$YR$C$M$Y$$$20240919$$CN$KR$KR
243375431$24337543$1$I$20231116$20231116$20240919$20240919$PER$$JP-ROCHE-3464593$ROCHE$$17$YR$T$M$Y$$$20240919$$PH$JP$JP
243375441$24337544$1$I$20231110$20231110$20240919$20240919$PER$$JP-ROCHE-3461456$ROCHE$$$$$F$Y$$$20240919$$CN$JP$JP
243375451$24337545$1$I$$20231120$20240919$20240919$PER$$JP-ROCHE-3464648$ROCHE$$7$YR$C$F$Y$$$20240919$$PH$JP$JP
243375461$24337546$1$I$$20231109$20240919$20240919$PER$$JP-ROCHE-3460512$ROCHE$$10$YR$C$F$Y$35$KG$20240919$$CN$JP$JP
243375471$24337547$1$I$$20231109$20240919$20240919$PER$$CN-ROCHE-3455909$ROCHE$$$$$$Y$$$20240919$$HP$CN$CN
243375481$24337548$1$I$$20240715$20240919$20240919$PER$$US-ALVOGEN-2024095037$ALVOGEN$$$$$M$Y$$$20240919$$HP$US$US
243375491$24337549$1$I$$20231113$20240919$20240919$PER$$JP-ROCHE-3461391$ROCHE$$8$DEC$E$M$Y$$$20240919$$PH$JP$JP
243375501$24337550$1$I$20231012$20231116$20240919$20240919$PER$$JP-ROCHE-3464673$ROCHE$$71$YR$E$F$Y$$$20240919$$MD$JP$JP
243375511$24337551$1$I$$20240909$20240919$20240919$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002324$Alvotech$$65$YR$$M$Y$$$20240919$$CN$CA$CA
243375521$24337552$1$I$20240601$20240910$20240919$20240919$EXP$$CH-GILEAD-2024-0687469$GILEAD$$75$YR$E$F$Y$$$20240919$$MD$CH$CH
243375531$24337553$1$I$20230101$20240725$20240919$20240919$PER$$US-ALVOGEN-2024095203$ALVOGEN$$$$$M$Y$$$20240919$$CN$US$US
243375541$24337554$1$I$$20231120$20240919$20240919$PER$$JP-ROCHE-3465309$ROCHE$$5$DEC$A$F$Y$$$20240919$$PH$JP$JP
243375551$24337555$1$I$$20231123$20240919$20240919$PER$$KR-ROCHE-3464592$ROCHE$$$$$$Y$$$20240919$$PH$KR$KR
243375561$24337556$1$I$$20231121$20240919$20240919$PER$$KR-ROCHE-3462784$ROCHE$$$$$$Y$$$20240919$$MD$KR$KR
243375571$24337557$1$I$$20231120$20240919$20240919$PER$$JP-ROCHE-3465307$ROCHE$$35$YR$A$M$Y$$$20240919$$PH$JP$JP
243375591$24337559$1$I$$20231116$20240919$20240919$PER$$IR-ROCHE-3459865$ROCHE$$$$$$Y$$$20240919$$HP$IR$IR
243375601$24337560$1$I$$20231101$20240919$20240919$PER$$JP-ROCHE-3455747$ROCHE$$4$YR$C$F$Y$$$20240919$$PH$JP$JP
243375611$24337561$1$I$$20231123$20240919$20240919$PER$$KR-ROCHE-3464316$ROCHE$$$$A$M$Y$$$20240919$$PH$KR$KR
243375621$24337562$1$I$20231021$20231031$20240919$20240919$PER$$JP-ROCHE-3455683$ROCHE$$1$YR$I$F$Y$8.4$KG$20240919$$PH$JP$JP
243375631$24337563$1$I$20240101$20240913$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-029272$UNITED THERAPEUTICS$$$$$F$Y$107.03$KG$20240919$$$US$US
243375641$24337564$1$I$$20231116$20240919$20240919$PER$$SA-ROCHE-3459335$ROCHE$Alzahrani M, Moussa M and Alfaraj D Acute Generalized Exanthematous Pustulosis After COVID-19 Infection: A Case Report From Saudi Arabia. DOI: 10.7759/cureus.11609. Cureus 2020 Nov 21;12 (11):1-4.$34$YR$A$M$Y$$$20240919$$HP$SA$SA
243375651$24337565$1$I$$20231127$20240919$20240919$PER$$PK-ROCHE-3468119$ROCHE$Abbasi R, Abbas S. CO-INFECTION OF INFLUENZA AND DENGUE VIRUSES IN A PATIENT WITH GRAM-NEGATIVE BACTEREMIA- A CASE REPORT. Doi: 10.61529/idjp.v32i3.155.. INFECTIOUS DISEASES JOURNAL OF PAKISTAN 2023;32 (3):105-8.$68$YR$E$M$Y$$$20240919$$HP$PK$PK
243375661$24337566$1$I$20230301$20231121$20240919$20240919$PER$$CN-ROCHE-3462279$ROCHE$$4$YR$C$F$Y$$$20240919$$CN$CN$CN
243375671$24337567$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148930$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$45.36$KG$20240919$$HP$US$US
243375681$24337568$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148399$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240919$$CN$US$US
243375691$24337569$1$I$20240901$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148268$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240919$$HP$US$US
243375701$24337570$1$I$20240718$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148429$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240919$$CN$US$US
243375711$24337571$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148906$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240919$$CN$US$US
243375732$24337573$2$F$$20240923$20240919$20240927$PER$$US-HALEON-2197346$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243375741$24337574$1$I$$20240913$20240919$20240919$EXP$FR-AFSSAPS-AVPO2024000174$FR-TEVA-VS-3243921$TEVA$$42$YR$$F$Y$$$20240919$$PH$FR$FR
243375751$24337575$1$I$$20231026$20240919$20240919$PER$$JP-ROCHE-3452455$ROCHE$$85$YR$E$M$Y$$$20240919$$PH$JP$JP
243375761$24337576$1$I$$20231026$20240919$20240919$PER$$GB-ROCHE-3452227$ROCHE$$$$$$Y$$$20240919$$HP$GB$GB
243375771$24337577$1$I$$20231127$20240919$20240919$PER$$CN-ROCHE-3466508$ROCHE$$28$YR$A$F$Y$80$KG$20240919$$CN$CN$CN
243375781$24337578$1$I$$20231122$20240919$20240919$PER$GR-GREOF-202301137$GR-ROCHE-3462722$ROCHE$$34$YR$A$M$Y$$$20240919$$MD$GR$GR
243375791$24337579$1$I$$20231107$20240919$20240919$PER$$JP-ROCHE-3458090$ROCHE$$6$DEC$A$M$Y$$$20240919$$PH$JP$JP
243375801$24337580$1$I$$20231122$20240919$20240919$PER$$JP-ROCHE-3467097$ROCHE$$9$YR$C$F$Y$$$20240919$$PH$JP$JP
243375811$24337581$1$I$$20231031$20240919$20240919$PER$$KR-ROCHE-3451927$ROCHE$$13$YR$T$$Y$$$20240919$$HP$KR$KR
243375821$24337582$1$I$20231104$20231114$20240919$20240919$PER$$CN-ROCHE-3458387$ROCHE$$5$YR$C$M$Y$35$KG$20240919$$HP$CN$CN
243375831$24337583$1$I$20231128$20231128$20240919$20240919$PER$$US-ROCHE-3466500$ROCHE$$19$YR$A$F$Y$$$20240919$$CN$US$US
243375841$24337584$1$I$$20231109$20240919$20240919$PER$$ID-ROCHE-3457081$ROCHE$$$$$$Y$$$20240919$$HP$ID$ID
243375851$24337585$1$I$$20231109$20240919$20240919$PER$$KR-ROCHE-3455843$ROCHE$$$$$$Y$$$20240919$$HP$KR$KR
243375861$24337586$1$I$$20231127$20240919$20240919$PER$$GR-ROCHE-3464412$ROCHE$$11$YR$C$M$Y$$$20240919$$CN$GR$GR
243375871$24337587$1$I$$20231121$20240919$20240919$PER$$JP-ROCHE-3467092$ROCHE$$12$YR$T$F$Y$$$20240919$$PH$JP$JP
243375881$24337588$1$I$20240901$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185756$AMGEN$$$$$$Y$$$20240919$$PH$US$US
243375901$24337590$1$I$20231019$20240912$20240919$20240919$EXP$$JP-AMGEN-JPNSP2024185119$AMGEN$$7$DEC$E$M$Y$$$20240919$$PH$JP$JP
243375911$24337591$1$I$$20240906$20240919$20240919$EXP$$DE-AUROBINDO-AUR-APL-2024-045195$AUROBINDO$$$$$F$Y$$$20240919$$CN$DE$DE
243375921$24337592$1$I$$20231107$20240919$20240919$PER$$KR-ROCHE-3454747$ROCHE$$$$A$$Y$$$20240919$$PH$KR$KR
243375931$24337593$1$I$20231129$20240206$20240919$20240919$PER$$JP-ROCHE-3471309$ROCHE$$2$DEC$A$M$Y$$$20240919$$PH$JP$JP
243375941$24337594$1$I$$20231102$20240919$20240919$PER$$JP-ROCHE-3455736$ROCHE$$7$YR$C$M$Y$$$20240919$$PH$JP$JP
243375951$24337595$1$I$20231201$20231205$20240919$20240919$PER$$JP-ROCHE-3477334$ROCHE$$82$YR$E$F$Y$$$20240919$$PH$JP$JP
243375961$24337596$1$I$$20231207$20240919$20240919$PER$$JP-ROCHE-3477322$ROCHE$$12$YR$T$M$Y$$$20240919$$PH$JP$JP
243375971$24337597$1$I$20231114$20231117$20240919$20240919$PER$$GB-ROCHE-3463946$ROCHE$$44$YR$A$M$Y$80$KG$20240919$$MD$GB$GB
243375981$24337598$1$I$20231121$20231122$20240919$20240919$PER$$JP-ROCHE-3467067$ROCHE$$17$YR$T$M$Y$$$20240919$$PH$JP$JP
243375991$24337599$1$I$20231118$20231120$20240919$20240919$PER$$JP-ROCHE-3465343$ROCHE$$3$DEC$A$F$Y$$$20240919$$PH$JP$JP
243376001$24337600$1$I$20231120$20231128$20240919$20240919$PER$$CN-ROCHE-3466459$ROCHE$$43$YR$A$F$Y$43$KG$20240919$$HP$CN$CN
243376011$24337601$1$I$$20231121$20240919$20240919$PER$$JP-ROCHE-3465258$ROCHE$$45$YR$A$F$Y$$$20240919$$PH$JP$JP
243376021$24337602$1$I$$20231122$20240919$20240919$PER$$JP-ROCHE-3467071$ROCHE$$15$YR$T$M$Y$$$20240919$$PH$JP$JP
243376031$24337603$1$I$20231101$20231114$20240919$20240919$PER$$JP-ROCHE-3463943$ROCHE$$1$YR$I$$Y$$$20240919$$CN$JP$JP
243376041$24337604$1$I$20231101$20231124$20240919$20240919$PER$$JP-ROCHE-3468011$ROCHE$$8$YR$C$F$Y$$$20240919$$PH$JP$JP
243376051$24337605$1$I$20231129$20231129$20240919$20240919$PER$$JP-ROCHE-3471292$ROCHE$$1$YR$I$M$Y$$$20240919$$PH$JP$JP
243376061$24337606$1$I$20231206$20231207$20240919$20240919$PER$$JP-ROCHE-3477321$ROCHE$$20$YR$A$M$Y$$$20240919$$PH$JP$JP
243376071$24337607$1$I$$20231107$20240919$20240919$PER$$JP-ROCHE-3458850$ROCHE$$15$YR$T$M$Y$$$20240919$$PH$JP$JP
243376081$24337608$1$I$$20231208$20240919$20240919$PER$$JP-ROCHE-3477325$ROCHE$$7$YR$C$F$Y$$$20240919$$PH$JP$JP
243376091$24337609$1$I$$20231207$20240919$20240919$PER$$JP-ROCHE-3477323$ROCHE$$2$YR$C$M$Y$$$20240919$$PH$JP$JP
243376111$24337611$1$I$$20231101$20240919$20240919$PER$$JP-ROCHE-3455743$ROCHE$$12$YR$T$F$Y$$$20240919$$PH$JP$JP
243376121$24337612$1$I$20231207$20231225$20240919$20240919$PER$$CN-ROCHE-3481784$ROCHE$$6$YR$C$M$Y$30$KG$20240919$$HP$CN$CN
243376131$24337613$1$I$20240717$20240916$20240919$20240919$EXP$$US-ABBVIE-5927078$ABBVIE$$68$YR$$F$Y$$$20240919$$CN$US$US
243376141$24337614$1$I$$20231031$20240919$20240919$PER$$JP-ROCHE-3455734$ROCHE$$12$YR$T$F$Y$$$20240919$$PH$JP$JP
243376151$24337615$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010939$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243376161$24337616$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010914$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243376171$24337617$1$I$20240101$20240916$20240919$20240919$EXP$$US-ABBVIE-5888392$ABBVIE$$$$$M$Y$113$KG$20240919$$CN$US$US
243376181$24337618$1$I$$20240917$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA081014$SANDOZ$$34$YR$$F$Y$$$20240919$$CN$CA$CA
243376191$24337619$1$I$20231209$20231211$20240919$20240919$PER$$JP-ROCHE-3479439$ROCHE$$$$C$$Y$21.6$KG$20240919$$PH$JP$JP
243376201$24337620$1$I$$20231121$20240919$20240919$PER$$JP-ROCHE-3467105$ROCHE$$44$YR$A$F$Y$$$20240919$$PH$JP$JP
243376221$24337622$1$I$$20231115$20240919$20240919$PER$$US-ROCHE-3463182$ROCHE$Ali R, Mirza T, Sangha I, Ravichander B, Malik M and Avula A. Don^t underestimate the flu: a case of non-neutropenic pulmonary aspergillosis after influenza. Doi;10.1016/j.chest.2023.07.827. Chest 2023 Oct 09;164 (4 SUPPL):A1143-44.$53$YR$A$M$Y$$$20240919$$HP$US$US
243376241$24337624$1$I$20231204$20231205$20240919$20240919$PER$$JP-ROCHE-3477340$ROCHE$$12$YR$T$F$Y$$$20240919$$MD$JP$JP
243376251$24337625$1$I$$20231127$20240919$20240919$PER$$JP-ROCHE-3468921$ROCHE$$7$YR$C$M$Y$$$20240919$$PH$JP$JP
243376261$24337626$1$I$20240101$20240913$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-028733$UNITED THERAPEUTICS$$$$$F$Y$81.633$KG$20240919$$$US$US
243376271$24337627$1$I$20240912$20240918$20240919$20240919$EXP$$US-ROCHE-10000085977$ROCHE$$87$YR$E$F$Y$$$20240919$$CN$US$US
243376281$24337628$1$I$$20231127$20240919$20240919$PER$$JP-ROCHE-3469348$ROCHE$$4$YR$C$F$Y$$$20240919$$PH$JP$JP
243376291$24337629$1$I$$20231121$20240919$20240919$PER$$JP-ROCHE-3467250$ROCHE$$8$YR$C$F$Y$$$20240919$$PH$JP$JP
243376301$24337630$1$I$$20231109$20240919$20240919$PER$$FR-ROCHE-3456861$ROCHE$$$$$$Y$$$20240919$$HP$FR$FR
243376311$24337631$1$I$$20231116$20240919$20240919$PER$$CN-ROCHE-3459075$ROCHE$Xue L, Wang H and Luo S. A case of hemolytic anemia caused by the treatment of toxic epidermal necrolysis with intravenous gamma globulin. DOI: 10.35541/cjd.20210190. Chinese Journal of Dermatology 2023 Sep;56 (9):868-9.$35$YR$A$F$Y$$$20240919$$HP$CN$CN
243376321$24337632$1$I$$20231107$20240919$20240919$PER$$JP-ROCHE-3458903$ROCHE$$$$I$$Y$$$20240919$$PH$JP$JP
243376331$24337633$1$I$$20231121$20240919$20240919$PER$$KR-ROCHE-3462803$ROCHE$$$$$$Y$$$20240919$$PH$KR$KR
243376341$24337634$1$I$$20231213$20240919$20240919$PER$$JP-ROCHE-3479473$ROCHE$$80$YR$E$$Y$50$KG$20240919$$PH$JP$JP
243376351$24337635$1$I$$20231127$20240919$20240919$PER$$JP-ROCHE-3469914$ROCHE$$$$C$$Y$$$20240919$$PH$JP$JP
243376361$24337636$1$I$20231219$20231219$20240919$20240919$PER$$JP-ROCHE-3481621$ROCHE$$13$YR$T$F$Y$$$20240919$$PH$JP$JP
243376371$24337637$1$I$20231210$20231214$20240919$20240919$PER$$JP-ROCHE-3481021$ROCHE$$18$YR$A$M$Y$$$20240919$$CN$JP$JP
243376381$24337638$1$I$$20231121$20240919$20240919$PER$$JP-ROCHE-3467106$ROCHE$$10$YR$C$$Y$$$20240919$$PH$JP$JP
243376401$24337640$1$I$$20231121$20240919$20240919$PER$$JP-ROCHE-3467152$ROCHE$$35$YR$A$F$Y$$$20240919$$PH$JP$JP
243376411$24337641$1$I$20231127$20231127$20240919$20240919$PER$$JP-ROCHE-3469049$ROCHE$$41$YR$A$F$Y$$$20240919$$PH$JP$JP
243376421$24337642$1$I$20231122$20231130$20240919$20240919$PER$$JP-ROCHE-3467014$ROCHE$$6$YR$C$M$Y$$$20240919$$PH$JP$JP
243376431$24337643$1$I$20231109$20231123$20240919$20240919$PER$$CN-ROCHE-3465617$ROCHE$$74$YR$E$M$Y$70$KG$20240919$$HP$CN$CN
243376441$24337644$1$I$20231115$20231116$20240919$20240919$PER$$JP-ROCHE-3464575$ROCHE$$4$YR$C$M$Y$$$20240919$$PH$JP$JP
243376451$24337645$1$I$20231012$20231110$20240919$20240919$PER$$CN-ROCHE-3456917$ROCHE$$73$YR$E$M$Y$53$KG$20240919$$HP$CN$CN
243376471$24337647$1$I$$20231205$20240919$20240919$PER$$JP-ROCHE-3475736$ROCHE$$4$YR$C$M$Y$$$20240919$$PH$JP$JP
243376481$24337648$1$I$20240917$20240918$20240919$20240919$PER$$US-JNJFOC-20240947890$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243376491$24337649$1$I$20240913$20240916$20240919$20240919$EXP$$CO-JNJFOC-20240944900$JOHNSON AND JOHNSON$$56$YR$A$F$Y$65$KG$20240919$$HP$CO$CO
243376501$24337650$1$I$$20240911$20240919$20240919$PER$$PR-ABBVIE-5920397$ABBVIE$$$$A$F$Y$$$20240919$$MD$PR$PR
243376511$24337651$1$I$20240511$20240917$20240919$20240919$EXP$$US-ABBVIE-5928694$ABBVIE$$67$YR$$F$Y$$$20240919$$CN$US$US
243376521$24337652$1$I$$20231026$20240919$20240919$PER$$JP-ROCHE-3452507$ROCHE$$17$YR$T$F$Y$$$20240919$$PH$JP$JP
243376531$24337653$1$I$$20231109$20240919$20240919$PER$$ID-ROCHE-3457312$ROCHE$$$$$$Y$$$20240919$$HP$ID$ID
243376541$24337654$1$I$$20240910$20240919$20240919$PER$$US-ROCHE-10000082614$ROCHE$$$$$F$Y$$$20240919$$CN$US$US
243376551$24337655$1$I$20231031$20231031$20240919$20240919$PER$$JP-ROCHE-3455692$ROCHE$$2$DEC$A$M$Y$$$20240919$$PH$JP$JP
243376561$24337656$1$I$$20231115$20240919$20240919$PER$$JP-ROCHE-3463867$ROCHE$$3$YR$C$M$Y$$$20240919$$PH$JP$JP
243376571$24337657$1$I$$20231110$20240919$20240919$PER$$AU-ROCHE-3456162$ROCHE$$$$A$F$Y$$$20240919$$PH$AU$AU
243376581$24337658$1$I$20231203$20231204$20240919$20240919$PER$$JP-ROCHE-3473958$ROCHE$$6$YR$C$F$Y$$$20240919$$PH$JP$JP
243376591$24337659$1$I$$20231130$20240919$20240919$PER$$US-ROCHE-3470054$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243376601$24337660$1$I$20231213$20231218$20240919$20240919$PER$$CN-ROCHE-3480498$ROCHE$$$$$F$Y$52$KG$20240919$$HP$CN$CN
243376611$24337661$1$I$$20231102$20240919$20240919$PER$$KR-ROCHE-3451941$ROCHE$$$$$$Y$$$20240919$$PH$KR$KR
243376622$24337662$2$F$20231026$20231215$20240919$20240923$PER$$JP-ROCHE-3452641$ROCHE$$8$YR$C$F$Y$$$20240923$$PH$JP$JP
243376631$24337663$1$I$$20231106$20240919$20240919$PER$$SG-ROCHE-3453205$ROCHE$$67$YR$E$F$Y$$$20240919$$HP$SG$SG
243376641$24337664$1$I$$20231214$20240919$20240919$PER$$KR-ROCHE-3477562$ROCHE$$$$$F$Y$$$20240919$$CN$KR$KR
243376651$24337665$1$I$20231204$20231220$20240919$20240919$PER$$CN-ROCHE-3479819$ROCHE$$17$YR$T$F$Y$50$KG$20240919$$HP$CN$CN
243376661$24337666$1$I$$20231204$20240919$20240919$PER$$JP-ROCHE-3473755$ROCHE$$4$DEC$A$M$Y$$$20240919$$PH$JP$JP
243376671$24337667$1$I$$20231027$20240919$20240919$PER$$JP-ROCHE-3452454$ROCHE$$38$YR$A$F$Y$$$20240919$$MD$JP$JP
243376681$24337668$1$I$$20231130$20240919$20240919$PER$$JP-ROCHE-3473786$ROCHE$$5$DEC$A$$Y$$$20240919$$PH$JP$JP
243376691$24337669$1$I$20231214$20231214$20240919$20240919$PER$$JP-ROCHE-3481023$ROCHE$$70$YR$E$F$Y$$$20240919$$PH$JP$JP
243376701$24337670$1$I$$20231212$20240919$20240919$PER$$JP-ROCHE-3479404$ROCHE$$38$YR$A$M$Y$$$20240919$$PH$JP$JP
243376711$24337671$1$I$$20231030$20240919$20240919$PER$$JP-ROCHE-3454288$ROCHE$$$$$F$Y$$$20240919$$CN$JP$JP
243376721$24337672$1$I$20231129$20231129$20240919$20240919$PER$$JP-ROCHE-3471356$ROCHE$$2$YR$C$M$Y$$$20240919$$PH$JP$JP
243376731$24337673$1$I$$20231128$20240919$20240919$PER$$US-ROCHE-3466653$ROCHE$$51$YR$A$F$Y$$$20240919$$MD$US$US
243376741$24337674$1$I$20231211$20231225$20240919$20240919$PER$$JP-ROCHE-3478857$ROCHE$$4$YR$C$M$Y$$$20240919$$PH$JP$JP
243376751$24337675$1$I$20231025$20231026$20240919$20240919$PER$$JP-ROCHE-3452526$ROCHE$$5$YR$C$M$Y$$$20240919$$PH$JP$JP
243376761$24337676$1$I$$20231228$20240919$20240919$PER$$ES-ROCHE-3482590$ROCHE$$82$YR$E$F$Y$$$20240919$$CN$ES$ES
243376771$24337677$1$I$20231201$20240118$20240919$20240919$PER$$JP-ROCHE-3482460$ROCHE$$74$YR$E$M$Y$$$20240919$$PH$JP$JP
243376781$24337678$1$I$$20240917$20240919$20240919$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052184$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240919$$MD$AU$AU
243376791$24337679$1$I$$20231223$20240919$20240919$PER$$US-ROCHE-3482210$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243376801$24337680$1$I$20231113$20231201$20240919$20240919$PER$$JP-ROCHE-3473750$ROCHE$$6$DEC$A$F$Y$$$20240919$$PH$JP$JP
243376821$24337682$1$I$$20231213$20240919$20240919$PER$$JP-ROCHE-3479503$ROCHE$$25$YR$A$M$Y$$$20240919$$PH$JP$JP
243376831$24337683$1$I$$20231128$20240919$20240919$PER$$KR-ROCHE-3467529$ROCHE$$16$YR$T$M$Y$$$20240919$$MD$KR$KR
243376841$24337684$1$I$20231205$20231219$20240919$20240919$PER$$JP-ROCHE-3482705$ROCHE$$6$DEC$A$M$Y$$$20240919$$MD$JP$JP
243376851$24337685$1$I$20231220$20231220$20240919$20240919$PER$$JP-ROCHE-3482790$ROCHE$$1$YR$I$$Y$$$20240919$$PH$JP$JP
243376861$24337686$1$I$20231128$20231206$20240919$20240919$PER$$CN-ROCHE-3471052$ROCHE$$74$YR$E$F$Y$70$KG$20240919$$HP$CN$CN
243376871$24337687$1$I$$20231213$20240919$20240919$PER$$CN-ROCHE-3475760$ROCHE$$80$YR$E$F$Y$$$20240919$$CN$CN$CN
243376881$24337688$1$I$$20231205$20240919$20240919$PER$$SG-ROCHE-3470735$ROCHE$$64$YR$A$$Y$$$20240919$$HP$SG$SG
243376891$24337689$1$I$$20231127$20240919$20240919$PER$$JP-ROCHE-3470049$ROCHE$$$$A$$Y$$$20240919$$PH$JP$JP
243376901$24337690$1$I$$20231127$20240919$20240919$PER$$JP-ROCHE-3468960$ROCHE$$$$A$$Y$$$20240919$$PH$JP$JP
243376911$24337691$1$I$20231213$20231213$20240919$20240919$PER$$JP-ROCHE-3479528$ROCHE$$52$YR$A$F$Y$$$20240919$$PH$JP$JP
243376922$24337692$2$F$20231122$20231205$20240919$20240923$PER$$JP-ROCHE-3468951$ROCHE$$5$YR$C$M$Y$18$KG$20240923$$PH$JP$JP
243376931$24337693$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010938$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243376941$24337694$1$I$$20240906$20240919$20240919$EXP$$US-AUROBINDO-AUR-APL-2024-045097$AUROBINDO$Samantha R. K, Amutha R, Edward R.C, Robert D.. A case of disseminated coccidioidomycosis and immune reconstitution  inflammatory syndrome (IRIS) in a patient with HIV/AIDS. ID Cases. 2023;34:e01896$50$YR$$M$Y$$$20240919$$HP$US$US
243376951$24337695$1$I$$20231211$20240919$20240919$PER$$JP-ROCHE-3478011$ROCHE$$8$YR$C$$Y$$$20240919$$PH$JP$JP
243376961$24337696$1$I$20231211$20231219$20240919$20240919$PER$$JP-ROCHE-3477993$ROCHE$$49$YR$A$F$Y$$$20240919$$PH$JP$JP
243376971$24337697$1$I$20231127$20231220$20240919$20240919$PER$$CN-ROCHE-3479808$ROCHE$$62$YR$A$M$Y$$$20240919$$HP$CN$CN
243376991$24337699$1$I$20231127$20231207$20240919$20240919$PER$$CN-ROCHE-3472943$ROCHE$$30$YR$A$F$Y$65$KG$20240919$$HP$CN$CN
243377001$24337700$1$I$20231211$20231212$20240919$20240919$PER$$JP-ROCHE-3479420$ROCHE$$37$YR$A$F$Y$$$20240919$$PH$JP$JP
243377011$24337701$1$I$$20231130$20240919$20240919$PER$$JP-ROCHE-3473733$ROCHE$$53$YR$A$F$Y$$$20240919$$PH$JP$JP
243377021$24337702$1$I$20231206$20231206$20240919$20240919$PER$$JP-ROCHE-3477415$ROCHE$$36$YR$A$F$Y$$$20240919$$PH$JP$JP
243377031$24337703$1$I$20231127$20231205$20240919$20240919$PER$$JP-ROCHE-3475616$ROCHE$$$$C$M$Y$$$20240919$$PH$JP$JP
243377041$24337704$1$I$$20231219$20240919$20240919$PER$$JP-ROCHE-3482683$ROCHE$$8$DEC$E$F$Y$$$20240919$$PH$JP$JP
243377051$24337705$1$I$$20231205$20240919$20240919$PER$$JP-ROCHE-3475679$ROCHE$$7$DEC$E$F$Y$$$20240919$$CN$JP$JP
243377061$24337706$1$I$20231130$20231227$20240919$20240919$PER$$CN-ROCHE-3482805$ROCHE$$23$YR$A$M$Y$69$KG$20240919$$HP$CN$CN
243377071$24337707$1$I$20231211$20231211$20240919$20240919$PER$$JP-ROCHE-3479427$ROCHE$$45$YR$A$F$Y$$$20240919$$PH$JP$JP
243377091$24337709$1$I$20240101$20240916$20240919$20240919$EXP$$US-ABBVIE-5926450$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243377101$24337710$1$I$20240822$20240906$20240919$20240919$EXP$CN-NMPACDR-6201011025963202400269$CN-BAXTER-2024BAX024503$BAXTER$$34$YR$$F$Y$$$20240919$$MD$CN$CN
243377111$24337711$1$I$$20240909$20240919$20240919$EXP$$DE-TEVA-VS-3242564$TEVA$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.; Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.$2$YR$$M$Y$$$20240919$$HP$DE$DE
243377121$24337712$1$I$20240901$20240916$20240919$20240919$EXP$$US-ABBVIE-5926475$ABBVIE$$64$YR$$F$Y$$$20240919$$CN$US$US
243377131$24337713$1$I$20231206$20231206$20240919$20240919$PER$$JP-ROCHE-3477267$ROCHE$$12$YR$T$F$Y$$$20240919$$PH$JP$JP
243377141$24337714$1$I$20231205$20231205$20240919$20240919$PER$$JP-ROCHE-3475546$ROCHE$$5$DEC$A$M$Y$$$20240919$$PH$JP$JP
243377151$24337715$1$I$$20231128$20240919$20240919$PER$$JP-ROCHE-3470142$ROCHE$$97$YR$E$F$Y$$$20240919$$PH$JP$JP
243377161$24337716$1$I$20231207$20231207$20240919$20240919$PER$$JP-ROCHE-3477496$ROCHE$$6$YR$C$M$Y$$$20240919$$PH$JP$JP
243377171$24337717$1$I$20231205$20231212$20240919$20240919$PER$$CN-ROCHE-3474803$ROCHE$$66$YR$E$F$Y$$$20240919$$HP$CN$CN
243377181$24337718$1$I$20231116$20231124$20240919$20240919$PER$$JP-ROCHE-3468882$ROCHE$$50$YR$A$F$Y$$$20240919$$PH$JP$JP
243377191$24337719$1$I$20231208$20231225$20240919$20240919$PER$$CN-ROCHE-3481885$ROCHE$$42$YR$A$F$Y$59$KG$20240919$$HP$CN$CN
243377201$24337720$1$I$20231228$20231229$20240919$20240919$PER$$CN-ROCHE-3483676$ROCHE$$10$YR$C$M$Y$27.5$KG$20240919$$CN$CN$CN
243377211$24337721$1$I$$20231124$20240919$20240919$PER$$JP-ROCHE-3469027$ROCHE$$4$DEC$A$F$Y$$$20240919$$PH$JP$JP
243377221$24337722$1$I$20231211$20231211$20240919$20240919$PER$$JP-ROCHE-3477964$ROCHE$$$$A$$Y$$$20240919$$PH$JP$JP
243377231$24337723$1$I$$20231219$20240919$20240919$PER$$JP-ROCHE-3481710$ROCHE$$$$E$F$Y$$$20240919$$PH$JP$JP
243377241$24337724$1$I$20231114$20231128$20240919$20240919$PER$$JP-ROCHE-3471291$ROCHE$$3$DEC$A$$Y$$$20240919$$PH$JP$JP
243377251$24337725$1$I$20231010$20231201$20240919$20240919$PER$$CN-ROCHE-3469224$ROCHE$$37$YR$A$F$Y$$$20240919$$HP$CN$CN
243377261$24337726$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010347$APOTEX$$66$YR$$M$Y$$$20240919$$HP$CA$CA
243377271$24337727$1$I$$20240905$20240919$20240919$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001320$ALEMBIC$Han S.C, Katus L, Frucht S.. Dramatic response to pramipexole in delayed-onset parkinsonism from osmotic demyelinating syndrome. Tremor and Other Hyperkinetic Movements. 2020;10 (1) 9:1-7$$$$$Y$$$20240919$$MD$US$US
243377281$24337728$1$I$20240912$20240918$20240919$20240919$PER$$US-JNJFOC-20240947778$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$CN$US$US
243377291$24337729$1$I$$20240916$20240919$20240919$EXP$$TR-ABBVIE-5928187$ABBVIE$$$$$$Y$$$20240919$$MD$TR$TR
243377301$24337730$1$I$$20231207$20240919$20240919$PER$$JP-ROCHE-3478067$ROCHE$$32$YR$A$F$Y$$$20240919$$PH$JP$JP
243377311$24337731$1$I$20231215$20231215$20240919$20240919$PER$$JP-ROCHE-3481041$ROCHE$$5$YR$C$M$Y$$$20240919$$PH$JP$JP
243377321$24337732$1$I$20231213$20231213$20240919$20240919$PER$$JP-ROCHE-3479620$ROCHE$$4$DEC$A$F$Y$$$20240919$$PH$JP$JP
243377331$24337733$1$I$$20231115$20240919$20240919$PER$$US-STRIDES ARCOLAB LIMITED-2023SP017437$STRIDES$Garg D, Garcia GA, Praw SS.. A Rare Case of Anaphylaxis to Methimazole in a Patient With Graves^ Disease.. J-Endocr-Soc. 2021;5 (Suppl. 1):A915-A916$3$DEC$$F$Y$$$20240919$$MD$US$US
243377341$24337734$1$I$$20240619$20240919$20240919$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007517$STRIDES$Lodh A, Blankenship S, Minish-Pron J, Lalani I.. Treatment of Acute Respiratory Failure Secondary to Chronic Graft-Versus-Host Disease With Fluticasone, Azithromycin, Montelukast, and High-Dose Glucocorticoids.. Am-J-Respir-Crit-Care-Med. 2024;209:A5898 (plus Poster).$38$YR$$M$Y$$$20240919$$HP$US$US
243377351$24337735$1$I$20231220$20231220$20240919$20240919$PER$$JP-ROCHE-3482692$ROCHE$$19$YR$A$F$Y$$$20240919$$PH$JP$JP
243377361$24337736$1$I$20231214$20231220$20240919$20240919$PER$$CN-ROCHE-3479841$ROCHE$$27$YR$A$F$Y$50$KG$20240919$$HP$CN$CN
243377371$24337737$1$I$$20231227$20240919$20240919$PER$$CN-ROCHE-3482976$ROCHE$$13$YR$T$F$Y$$$20240919$$CN$CN$CN
243377381$24337738$1$I$20231030$20231205$20240919$20240919$PER$$SG-ROCHE-3470753$ROCHE$$6$YR$C$M$Y$$$20240919$$HP$SG$SG
243377391$24337739$1$I$20231214$20231214$20240919$20240919$PER$$JP-ROCHE-3481034$ROCHE$$3$DEC$A$F$Y$$$20240919$$PH$JP$JP
243377401$24337740$1$I$20231220$20231220$20240919$20240919$PER$$JP-ROCHE-3482717$ROCHE$$13$YR$T$M$Y$$$20240919$$PH$JP$JP
243377411$24337741$1$I$$20231227$20240919$20240919$PER$$GR-ROCHE-3482570$ROCHE$$5$YR$C$F$Y$$$20240919$$CN$GR$GR
243377421$24337742$1$I$20230101$20231205$20240919$20240919$PER$$SG-ROCHE-3470745$ROCHE$$$$$$Y$$$20240919$$HP$SG$SG
243377431$24337743$1$I$$20231206$20240919$20240919$PER$$KR-ROCHE-3472221$ROCHE$$$$A$M$Y$$$20240919$$PH$KR$KR
243377441$24337744$1$I$20231122$20231127$20240919$20240919$PER$$JP-ROCHE-3469974$ROCHE$$5$YR$C$F$Y$$$20240919$$PH$JP$JP
243377451$24337745$1$I$$20231208$20240919$20240919$PER$$CN-ROCHE-3473047$ROCHE$$14$YR$T$$Y$$$20240919$$CN$CN$CN
243377461$24337746$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010827$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243377471$24337747$1$I$$20231221$20240919$20240919$PER$$IR-ROCHE-3480237$ROCHE$$$$$$Y$$$20240919$$HP$IR$IR
243377481$24337748$1$I$$20231207$20240919$20240919$PER$$JP-ROCHE-3477383$ROCHE$$6$YR$C$F$Y$$$20240919$$PH$JP$JP
243377501$24337750$1$I$$20231201$20240919$20240919$PER$$JP-ROCHE-3473690$ROCHE$$10$YR$C$M$Y$$$20240919$$CN$JP$JP
243377511$24337751$1$I$$20231204$20240919$20240919$PER$$JP-ROCHE-3473808$ROCHE$$$$C$$Y$$$20240919$$PH$JP$JP
243377521$24337752$1$I$20231124$20231124$20240919$20240919$PER$$JP-ROCHE-3468915$ROCHE$$21$YR$A$F$Y$$$20240919$$MD$JP$JP
243377541$24337754$1$I$$20231221$20240919$20240919$PER$$JP-ROCHE-3482862$ROCHE$$19$YR$A$M$Y$$$20240919$$PH$JP$JP
243377551$24337755$1$I$$20231206$20240919$20240919$PER$$KR-ROCHE-3472242$ROCHE$$$$A$M$Y$$$20240919$$PH$KR$KR
243377561$24337756$1$I$20231206$20231225$20240919$20240919$PER$$JP-ROCHE-3477342$ROCHE$$8$YR$C$F$Y$$$20240919$$PH$JP$JP
243377571$24337757$1$I$$20240905$20240919$20240919$EXP$$DE-AUROBINDO-AUR-APL-2024-044686$AUROBINDO$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. Rheumatic musculoskeletal disease-Open. 2024;10:e004381$10$YR$$M$Y$$$20240919$$MD$DE$DE
243377581$24337758$1$I$20231214$20231215$20240919$20240919$PER$$JP-ROCHE-3481073$ROCHE$$5$YR$C$M$Y$$$20240919$$PH$JP$JP
243377591$24337759$1$I$20231214$20231214$20240919$20240919$PER$$JP-ROCHE-3481221$ROCHE$$7$YR$C$M$Y$$$20240919$$PH$JP$JP
243377601$24337760$1$I$$20231213$20240919$20240919$PER$$JP-ROCHE-3479544$ROCHE$$$$A$$Y$$$20240919$$PH$JP$JP
243377611$24337761$1$I$20231213$20231214$20240919$20240919$PER$$JP-ROCHE-3481075$ROCHE$$50$YR$A$M$Y$$$20240919$$PH$JP$JP
243377621$24337762$1$I$20231214$20231226$20240919$20240919$PER$$CN-ROCHE-3483001$ROCHE$$8$YR$C$F$Y$23$KG$20240919$$HP$CN$CN
243377631$24337763$1$I$20240801$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148332$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240919$$HP$US$US
243377641$24337764$1$I$$20240917$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148505$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240919$$CN$US$US
243377651$24337765$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148174$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240919$$HP$US$US
243377661$24337766$1$I$20240701$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148053$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240919$$HP$US$US
243377671$24337767$1$I$$20240910$20240919$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147487$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240919$$MD$JP$JP
243377681$24337768$1$I$$20240917$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148732$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$52.16$KG$20240919$$CN$US$US
243377692$24337769$2$F$$20240920$20240919$20240930$EXP$$DE-AUROBINDO-AUR-APL-2024-045257$AUROBINDO$Gallinger A, Osei-Davies R, Hennersdorf F.. Reversibility of a critical intraventricular conduction delay under flecainide and lacosamide by sodium bicarbonate.. Inn Med (Heidelb). 2024;1-4$72$YR$$F$Y$$$20240930$$MD$DE$DE
243377701$24337770$1$I$20231129$20231201$20240919$20240919$PER$$JP-ROCHE-3473797$ROCHE$$$$E$$Y$$$20240919$$MD$JP$JP
243377711$24337771$1$I$$20231205$20240919$20240919$PER$$SG-ROCHE-3470728$ROCHE$$$$$$Y$$$20240919$$HP$SG$SG
243377721$24337772$1$I$20231212$20231219$20240919$20240919$PER$$CN-ROCHE-3479045$ROCHE$$3$YR$C$M$Y$14$KG$20240919$$HP$CN$CN
243377731$24337773$1$I$20231216$20231218$20240919$20240919$PER$$JP-ROCHE-3482027$ROCHE$$50$YR$A$F$Y$$$20240919$$PH$JP$JP
243377741$24337774$1$I$20230910$20240913$20240919$20240919$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-019044$JAZZ$$14$YR$$M$Y$$$20240919$$CN$US$US
243377751$24337775$1$I$20231123$20231201$20240919$20240919$PER$$CN-ROCHE-3468822$ROCHE$$48$YR$A$F$Y$65$KG$20240919$$HP$CN$CN
243377761$24337776$1$I$$20231208$20240919$20240919$PER$$CN-ROCHE-3473222$ROCHE$$17$YR$T$M$Y$$$20240919$$CN$CN$CN
243377771$24337777$1$I$20231214$20240119$20240919$20240919$PER$$JP-ROCHE-3481043$ROCHE$$4$DEC$A$F$Y$$$20240919$$PH$JP$JP
243377781$24337778$1$I$$20231208$20240919$20240919$PER$$JP-ROCHE-3477366$ROCHE$$58$YR$A$F$Y$$$20240919$$PH$JP$JP
243377791$24337779$1$I$$20231201$20240919$20240919$PER$$JP-ROCHE-3473839$ROCHE$$33$YR$A$F$Y$$$20240919$$PH$JP$JP
243377801$24337780$1$I$$20231221$20240919$20240919$PER$$KR-ROCHE-3480421$ROCHE$$40$YR$A$F$Y$$$20240919$$CN$KR$KR
243377811$24337781$1$I$20231128$20231213$20240919$20240919$PER$$CN-ROCHE-3477189$ROCHE$$62$YR$A$F$Y$65$KG$20240919$$HP$CN$CN
243377821$24337782$1$I$20231222$20240110$20240919$20240919$PER$$JP-ROCHE-3483400$ROCHE$$16$YR$T$M$Y$$$20240919$$PH$JP$JP
243377831$24337783$1$I$$20231221$20240919$20240919$PER$$JP-ROCHE-3482868$ROCHE$$44$YR$A$$Y$$$20240919$$PH$JP$JP
243377841$24337784$1$I$$20240830$20240919$20240919$PER$$US-ALVOGEN-2024095440$ALVOGEN$$$$$F$Y$$$20240919$$HP$US$US
243377851$24337785$1$I$20240101$20240916$20240919$20240919$EXP$$US-ABBVIE-5928657$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243377861$24337786$1$I$$20240906$20240919$20240919$EXP$$IT-AUROBINDO-AUR-APL-2024-043353$AUROBINDO$Pozzi E, Corsini C, Bertini A, Belladelli F, Raffo M, Salonia A, et al. Spontaneous erectile function recovery among young men with erectile dysfunction taking tadalafil 5 mg once a day. The Journal of Sexual Medicine. 2024;21(8):671-675$$$A$M$Y$$$20240919$$MD$IT$IT
243377871$24337787$1$I$$20231218$20240919$20240919$PER$$JP-ROCHE-3481638$ROCHE$$5$DEC$A$F$Y$$$20240919$$PH$JP$JP
243377881$24337788$1$I$20231122$20231124$20240919$20240919$PER$$JP-ROCHE-3469073$ROCHE$$5$YR$C$M$Y$$$20240919$$MD$JP$JP
243377891$24337789$1$I$20231212$20240111$20240919$20240919$PER$$JP-ROCHE-3479494$ROCHE$$13$YR$T$F$Y$$$20240919$$PH$JP$JP
243377901$24337790$1$I$20231205$20231208$20240919$20240919$PER$$CN-ROCHE-3472499$ROCHE$$40$YR$A$M$Y$$$20240919$$CN$CN$CN
243377911$24337791$1$I$20231219$20231225$20240919$20240919$PER$$CN-ROCHE-3483675$ROCHE$$41$YR$A$F$Y$71$KG$20240919$$HP$CN$CN
243377921$24337792$1$I$$20231227$20240919$20240919$PER$$PL-ROCHE-3483868$ROCHE$$$$$$Y$$$20240919$$CN$PL$PL
243377931$24337793$1$I$20231206$20231220$20240919$20240919$PER$$CN-ROCHE-3479759$ROCHE$$50$YR$A$M$Y$65$KG$20240919$$HP$CN$CN
243377941$24337794$1$I$$20231208$20240919$20240919$PER$$JP-ROCHE-3477320$ROCHE$$43$YR$A$M$Y$$$20240919$$PH$JP$JP
243377951$24337795$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5926912$ABBVIE$$$$$$Y$$$20240919$$MD$US$US
243377961$24337796$1$I$$20231126$20240919$20240919$PER$$JP-ROCHE-3468981$ROCHE$$$$$F$Y$$$20240919$$MD$JP$JP
243377971$24337797$1$I$20231211$20231213$20240919$20240919$PER$$JP-ROCHE-3479456$ROCHE$$51$YR$A$F$Y$$$20240919$$PH$JP$JP
243377981$24337798$1$I$$20231214$20240919$20240919$PER$$JP-ROCHE-3481018$ROCHE$$2$YR$C$F$Y$$$20240919$$PH$JP$JP
243377991$24337799$1$I$$20231213$20240919$20240919$PER$$JP-ROCHE-3479418$ROCHE$$33$YR$A$F$Y$$$20240919$$PH$JP$JP
243378001$24337800$1$I$20231211$20231211$20240919$20240919$PER$$JP-ROCHE-3478131$ROCHE$$93$YR$E$F$Y$$$20240919$$PH$JP$JP
243378011$24337801$1$I$$20231214$20240919$20240919$PER$$JP-ROCHE-3481126$ROCHE$$60$YR$A$M$Y$$$20240919$$PH$JP$JP
243378021$24337802$1$I$20231212$20231212$20240919$20240919$PER$$JP-ROCHE-3479459$ROCHE$$96$YR$E$M$Y$$$20240919$$PH$JP$JP
243378031$24337803$1$I$20231212$20231213$20240919$20240919$PER$$JP-ROCHE-3479416$ROCHE$$8$YR$C$F$Y$$$20240919$$MD$JP$JP
243378041$24337804$1$I$20231128$20231128$20240919$20240919$PER$$JP-ROCHE-3469920$ROCHE$$66$YR$E$M$Y$$$20240919$$PH$JP$JP
243378051$24337805$1$I$20231125$20231211$20240919$20240919$PER$$CN-ROCHE-3477075$ROCHE$$59$YR$A$F$Y$72$KG$20240919$$HP$CN$CN
243378061$24337806$1$I$20231204$20231204$20240919$20240919$PER$$JP-ROCHE-3475513$ROCHE$$21$YR$A$F$Y$$$20240919$$MD$JP$JP
243378071$24337807$1$I$$20240606$20240919$20240919$PER$$JP-ROCHE-3481022$ROCHE$$$$$F$Y$$$20240919$$PH$JP$JP
243378081$24337808$1$I$$20231215$20240919$20240919$PER$$JP-ROCHE-3481048$ROCHE$$16$YR$T$M$Y$$$20240919$$MD$JP$JP
243378091$24337809$1$I$$20231205$20240919$20240919$PER$$JP-ROCHE-3475515$ROCHE$$$$A$$Y$$$20240919$$HP$JP$JP
243378101$24337810$1$I$$20231206$20240919$20240919$PER$$JP-ROCHE-3477303$ROCHE$$5$DEC$A$F$Y$$$20240919$$PH$JP$JP
243378111$24337811$1$I$$20231211$20240919$20240919$PER$$JP-ROCHE-3477969$ROCHE$$17$YR$T$F$Y$$$20240919$$CN$JP$JP
243378121$24337812$1$I$$20231221$20240919$20240919$PER$$JP-ROCHE-3482747$ROCHE$$81$YR$E$F$Y$$$20240919$$PH$JP$JP
243378141$24337814$1$I$$20231214$20240919$20240919$PER$$JP-ROCHE-3481044$ROCHE$$87$YR$E$F$Y$$$20240919$$PH$JP$JP
243378151$24337815$1$I$$20231214$20240919$20240919$PER$$JP-ROCHE-3481172$ROCHE$$2$YR$C$$Y$$$20240919$$PH$JP$JP
243378161$24337816$1$I$$20231223$20240919$20240919$PER$$CN-ROCHE-3481884$ROCHE$$40$YR$A$F$Y$$$20240919$$CN$CN$CN
243378171$24337817$1$I$20231124$20231213$20240919$20240919$PER$$JP-ROCHE-3469094$ROCHE$$9$YR$C$F$Y$$$20240919$$PH$JP$JP
243378181$24337818$1$I$20240908$20240917$20240919$20240919$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052182$BOEHRINGER INGELHEIM$$50$YR$A$F$Y$$$20240919$$MD$AU$AU
243378191$24337819$1$I$20240901$20240918$20240919$20240919$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052206$BOEHRINGER INGELHEIM$$$$$$Y$$$20240919$$CN$US$US
243378201$24337820$1$I$$20240916$20240919$20240919$PER$$US-ABBVIE-5927811$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243378211$24337821$1$I$$20240916$20240919$20240919$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-148417$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240919$$MD$FR$FR
243378221$24337822$1$I$20240817$20240918$20240919$20240919$PER$$US-JNJFOC-20240948695$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243378231$24337823$1$I$20240726$20240912$20240919$20240919$EXP$$US-APCER-AZR202409-000627$AZURITY PHARMACEUTICALS$$4$YR$$F$Y$$$20240919$$CN$US$US
243378241$24337824$1$I$20240901$20240918$20240919$20240919$PER$$US-JNJFOC-20240948280$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243378251$24337825$1$I$$20240916$20240919$20240919$EXP$$NVSC2024CA186520$NOVARTIS$$47$YR$$M$Y$$$20240919$$CN$CA$CA
243378261$24337826$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010847$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243378271$24337827$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011497$ELI LILLY AND CO$$35$YR$A$$Y$$$20240919$$LW$US$US
243378281$24337828$1$I$20240914$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010665$ELI LILLY AND CO$$46$YR$A$$Y$$$20240919$$CN$US$US
243378293$24337829$3$F$$20240924$20240919$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409011110$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240925$$CN$US$US
243378301$24337830$1$I$20240101$20240910$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-020433$UNITED THERAPEUTICS$$$$$F$Y$111.57$KG$20240919$$$US$US
243378311$24337831$1$I$20180101$20240909$20240919$20240919$EXP$FR-AFSSAPS-NY20190233$FR-TEVA-2019-FR-1016977$TEVA$$32$YR$$F$Y$$$20240919$$MD$FR$FR
243378321$24337832$1$I$20240101$20240911$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-028853$UNITED THERAPEUTICS$$$$$F$Y$84.807$KG$20240919$$$US$US
243378342$24337834$2$F$$20240909$20240919$20240924$EXP$$US-MSNLABS-2024MSNLIT01990$MSN LABORATORIES$Bierly JJ, Peterson BL.Distribution of donepezil in postmortem casework.Journal of Forensic and Legal Medicine.2024;101:102625$$$$$Y$$$20240924$$HP$US$US
243378361$24337836$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148808$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240919$$CN$US$US
243378372$24337837$2$F$20240918$20240918$20240919$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149148$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240923$$CN$US$US
243378381$24337838$1$I$$20240913$20240919$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147617$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240919$$MD$JP$JP
243378391$24337839$1$I$20240801$20240909$20240919$20240919$30DAY$$US-GSK-US2024111947$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240919$$HP$US$US
243378402$24337840$2$F$$20240916$20240919$20240925$EXP$$US-GILEAD-2024-0687930$GILEAD$$$$N$M$Y$2.65$KG$20240925$$HP$US$US
243378411$24337841$1$I$$20240904$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08995$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243378421$24337842$1$I$20240805$20240913$20240919$20240919$EXP$IT-MINISAL02-1001327$IT-TEVA-VS-3243428$TEVA$$13$YR$$F$Y$60$KG$20240919$$MD$IT$IT
243378431$24337843$1$I$20240909$20240911$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-028816$UNITED THERAPEUTICS$$89$YR$$M$Y$90.703$KG$20240919$$$US$US
243378441$24337844$1$I$20240902$20240910$20240919$20240919$EXP$GB-MHRA-MED-202409101338390340-GYBDW$GB-TEVA-VS-3242847$TEVA$$55$YR$$F$Y$83$KG$20240919$$HP$GB$GB
243378451$24337845$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243780$TEVA$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240919$$MD$US$US
243378471$24337847$1$I$20240411$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045123$AUROBINDO$$44$YR$$M$Y$$$20240919$$PH$FR$FR
243378491$24337849$1$I$$20240916$20240919$20240919$EXP$$MM-ROCHE-10000084890$ROCHE$$$$A$M$Y$$$20240919$$CN$MM$MM
243378501$24337850$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010378$APOTEX$$$$$M$Y$$$20240919$$CN$CA$CA
243378511$24337851$1$I$20240608$20240911$20240919$20240919$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-08502$HIKMA$$64$YR$$M$Y$51$KG$20240919$$CN$EG$EG
243378521$24337852$1$I$$20240917$20240919$20240919$PER$$US-ROCHE-10000085025$ROCHE$$$$E$F$Y$$$20240919$$CN$US$US
243378531$24337853$1$I$20240701$20240911$20240919$20240919$EXP$$US-JNJFOC-20240938120$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240919$$CN$US$US
243378541$24337854$1$I$20240101$20240916$20240919$20240919$PER$$US-ABBVIE-5927663$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243378551$24337855$1$I$20240801$20240909$20240919$20240919$PER$$US-ASTELLAS-2024-AER-005818$ASTELLAS$$64$YR$A$F$Y$$$20240919$$CN$US$US
243378571$24337857$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010826$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243378581$24337858$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243781$TEVA$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240919$$MD$US$US
243378601$24337860$1$I$$20240909$20240919$20240919$EXP$$TR-AMGEN-TURSP2024182913$AMGEN$Ilhan Y.. Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy. Expert Opinion on Pharmacotherapy. 2024;25 (11):1555-1563$$$$$Y$$$20240919$$HP$TR$TR
243378611$24337861$1$I$$20240916$20240919$20240919$PER$$US-ABBVIE-5926618$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243378621$24337862$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010426$APOTEX$$54$YR$$F$Y$$$20240919$$CN$CA$CA
243378631$24337863$1$I$20240722$20240910$20240919$20240919$EXP$$US-BIOGEN-2024BI01282189$BIOGEN$$53$YR$$F$Y$$$20240919$$HP$US$US
243378642$24337864$2$F$20240601$20240918$20240919$20240924$EXP$$RU-ROCHE-10000085145$ROCHE$$60$YR$A$F$Y$$$20240924$$MD$RU$RU
243378651$24337865$1$I$20240717$20240912$20240919$20240919$EXP$$US-AMGEN-USASP2024183244$AMGEN$$77$YR$E$F$Y$$$20240919$$CN$US$US
243378661$24337866$1$I$$20240916$20240919$20240919$PER$$US-ROCHE-10000086392$ROCHE$Viscardi C, Rho J, Blake C. Bilateral neovascular glaucoma associated with Radium-223 infusions for prostate cancer. American Journal of Ophthalmology Case Reports. 2024;36:1-3. doi:10.1016/j.ajoc.2024.102142.$74$YR$E$M$Y$$$20240919$$HP$US$US
243378671$24337867$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243299$TEVA$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024; 67 (0): no pagination.; Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024; 67 (0): no pagination.$58$YR$$M$Y$$$20240919$$HP$US$US
243378681$24337868$1$I$20200101$20240905$20240919$20240919$EXP$$US-AUROBINDO-AUR-APL-2024-044513$AUROBINDO$Ahmed A, Naji A, Zhang J, Raoufi M, Alhamar M, Salgia R, et al. Mantle Cell Lymphoma Presenting as Diarrhea in a Liver Transplant Recipient. ACG Case Reports Journal. 2021;8(7):E00635$63$YR$$M$Y$$$20240919$$MD$US$US
243378691$24337869$1$I$20240507$20240910$20240919$20240919$EXP$$CA-JNJFOC-20240554393$JOHNSON AND JOHNSON$$15$YR$T$M$Y$35$KG$20240919$$CN$CA$CA
243378701$24337870$1$I$$20240912$20240919$20240919$EXP$$JP-AMGEN-JPNSP2024185614$AMGEN$$58$YR$A$M$Y$$$20240919$$MD$JP$JP
243378722$24337872$2$F$20240901$20240920$20240919$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-029127$UNITED THERAPEUTICS$$78$YR$$M$Y$86.168$KG$20240927$$$US$US
243378731$24337873$1$I$20240101$20240911$20240919$20240919$EXP$$CA-CELLTRION INC.-2024CA018412$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
243378751$24337875$1$I$$20240909$20240919$20240919$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004835$PAREXEL$$$$$$Y$$$20240919$$HP$US$US
243378761$24337876$1$I$20240825$20240910$20240919$20240919$EXP$$CN-MELINTA THERAPEUTICS, LLC-CN-MLNT-24-00445$Unknown Manufacturer$$$$$$Y$$$20240919$$MD$CN$CN
243378771$24337877$1$I$20240602$20240905$20240919$20240919$EXP$CH-SM-2024-13874$CH-MELINTA THERAPEUTICS, LLC-CH-MLNT-24-00431$Unknown Manufacturer$$$$$$Y$$$20240919$$MD$CH$CH
243378781$24337878$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010915$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243378791$24337879$1$I$$20240918$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148951$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240919$$CN$US$US
243378801$24337880$1$I$20240820$20240909$20240919$20240919$EXP$ES-AEMPS-1563313$ES-MELINTA THERAPEUTICS, LLC-ES-MLNT-24-00443$Unknown Manufacturer$$$$$$Y$$$20240919$$MD$ES$ES
243378811$24337881$1$I$$20240909$20240919$20240919$EXP$$RU-MELINTA THERAPEUTICS, LLC-RU-MLNT-24-00441$Unknown Manufacturer$Shekhovtsova E. V, Lukashik E. V, Bogochanova O. A, Kolonutov M. S, Kudinova M. A, Reznik E. V. et al... Systemic amyloidosis in a patient with acute heart failure. Klinitsist = The Clinician. 2024;18((2)):30-7$$$$$Y$$$20240919$$HP$RU$RU
243378821$24337882$1$I$20240524$20240905$20240919$20240919$EXP$$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-08457$HIKMA$$$$$$Y$$$20240919$$MD$FR$FR
243378831$24337883$1$I$$20240910$20240919$20240919$EXP$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00438$Unknown Manufacturer$$$$$$Y$$$20240919$$CN$US$US
243378841$24337884$1$I$$20240912$20240919$20240919$PER$$US-AMGEN-USASP2024184113$AMGEN$$83$YR$E$M$Y$$$20240919$$CN$US$US
243378851$24337885$1$I$$20240910$20240919$20240919$EXP$$BR-CELLTRION INC.-2024BR022186$CELLTRION$$$$$$Y$$$20240919$$CN$BR$BR
243378861$24337886$1$I$20240706$20240910$20240919$20240919$EXP$$EG-HIKMA PHARMACEUTICALS USA INC.-EG-H14001-24-08490$HIKMA$$62$YR$$F$Y$100$KG$20240919$$PH$EG$EG
243378871$24337887$1$I$$20240910$20240919$20240919$EXP$$US-LUOXIN-LUX-2024-US-LIT-00052$LUOXIN AUROVITAS PHARMA(CHENGDU)$Jad Zreik, Martin J LaPage, Hani Zreik..Congenital Long QT Syndrome Unmasked by Albuterol in an  Adolescent with Asthma.The Journal of Emergency Medicine.31-MAY-2024;NA:1-5$12$YR$C$F$Y$$$20240919$$HP$US$US
243378881$24337888$1$I$20240610$20240913$20240919$20240919$EXP$$NVSC2024CO044533$NOVARTIS$$57$YR$$F$Y$67$KG$20240919$$CN$CO$CO
243378891$24337889$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010871$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243378902$24337890$2$F$19990801$20240909$20240919$20240919$PER$DE-EMA-DD-20240903-7482831-084148$DE-ROCHE-10000077148$ROCHE$Romagosa, R. et al. Treatment of psoriasis with 6-thioguanine and hepatic venoocclusive disease. j Am Acad Dermatol December 2002;47(6):970-972.$47$YR$A$F$Y$$$20240919$$MD$DE$US
243378912$24337891$2$F$20240821$20240912$20240919$20240924$EXP$$US-ROCHE-10000081327$ROCHE$$48$YR$A$F$Y$$$20240924$$CN$US$US
243378921$24337892$1$I$$20240913$20240919$20240919$EXP$$TW-UCBSA-2024047914$UCB$$64$YR$$F$Y$$$20240919$$CN$TW$TW
243378931$24337893$1$I$20240717$20240912$20240919$20240919$EXP$$US-TAKEDA-2022TUS097183$TAKEDA$$69$YR$$M$Y$91$KG$20240919$$CN$US$US
243378951$24337895$1$I$$20240913$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009847$ELI LILLY AND CO$$$$$$Y$$$20240919$$CN$US$US
243378961$24337896$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011020$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240919$$CN$US$US
243378971$24337897$1$I$20240101$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011494$ELI LILLY AND CO$$$$$$Y$$$20240919$$CN$US$US
243378981$24337898$1$I$$20240913$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010420$ELI LILLY AND CO$$25$YR$A$M$Y$$$20240919$$CN$US$US
243378991$24337899$1$I$20240910$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010558$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240919$$CN$US$US
243379001$24337900$1$I$20240617$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010997$ELI LILLY AND CO$$$$$$Y$$$20240919$$CN$US$US
243379011$24337901$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243653$TEVA$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$68$YR$$F$Y$$$20240919$$MD$US$US
243379021$24337902$1$I$$20240911$20240919$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-148863$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240919$$PH$JP$JP
243379031$24337903$1$I$20240822$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148716$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240919$$HP$US$US
243379041$24337904$1$I$$20240909$20240919$20240919$30DAY$$US-GSK-US2024AMR112913$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$PH$US$US
243379051$24337905$1$I$20240301$20240913$20240919$20240919$EXP$HR-HALMED-300086429$HR-TEVA-VS-3243721$TEVA$$36$YR$$M$Y$90$KG$20240919$$MD$HR$HR
243379061$24337906$1$I$20240101$20240912$20240919$20240919$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112207$ZYDUS PHARM$$$$$$Y$$$20240919$$CN$US$US
243379071$24337907$1$I$$20240906$20240919$20240919$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112166$ZYDUS PHARM$Ghezzi L, Levasseur VA, Perantie DC, Wu GF, Cross AH.. Extensive rebound MS activity following dimethyl fumarate discontinuation in a 63 year old - A case report.. Neuroimmunol-Rep. 2023;3:1-4$$$$$Y$$$20240919$$HP$US$US
243379081$24337908$1$I$$20240911$20240919$20240919$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112282$ZYDUS PHARM$Aifuwa E, Kandahari A, Steinberg A.. HL-298 Concomitant Methotrexate Withdrawal and Brentuximab Vedotin Therapy for Treatment of Methotrexate Associated Hodgkin Lymphoma.. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S446-S447.$$$$$Y$$$20240919$$HP$US$US
243379091$24337909$1$I$20230617$20240913$20240919$20240919$EXP$$CO-TAKEDA-2023TUS061774$TAKEDA$$74$YR$$F$Y$42$KG$20240919$$CN$CO$CO
243379101$24337910$1$I$$20240911$20240919$20240919$EXP$$CA-CELLTRION INC.-2024CA021905$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
243379111$24337911$1$I$$20240910$20240919$20240919$EXP$$NVSC2024GB182188$NOVARTIS$$$$$M$Y$$$20240919$$HP$GB$GB
243379121$24337912$1$I$$20240917$20240919$20240919$EXP$$NVSC2024US186575$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243379131$24337913$1$I$20240905$20240905$20240919$20240919$PER$$US-TRIS PHARMA, INC.-24US011629$TRIS PHARM$$$$$$Y$$$20240919$$CN$US$US
243379141$24337914$1$I$20240801$20240913$20240919$20240919$EXP$$CA-LEO Pharma-373272$LEO PHARM$$70$YR$$M$Y$$$20240919$$CN$CA$CA
243379151$24337915$1$I$20240801$20240905$20240919$20240919$EXP$$US-UCBSA-2024045753$UCB$$59$YR$$F$Y$$$20240919$$CN$US$US
243379161$24337916$1$I$$20240918$20240919$20240919$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052156$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240919$$CN$US$US
243379171$24337917$1$I$20240601$20240703$20240919$20240919$EXP$$CA-TEVA-VS-3240211$TEVA$$$$E$F$Y$$$20240919$$CN$CA$CA
243379181$24337918$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010916$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243379191$24337919$1$I$20230101$20240913$20240919$20240919$EXP$$DE-009507513-2409DEU005815$MERCK$$$$$F$Y$$$20240919$$CN$DE$DE
243379201$24337920$1$I$$20240915$20240919$20240919$PER$$US-LEO Pharma-373575$LEO PHARM$$29$YR$$M$Y$$$20240919$$PH$US$US
243379211$24337921$1$I$20240731$20240910$20240919$20240919$EXP$CH-SM-2024-15403$CH-TEVA-VS-3242609$TEVA$$64$YR$$F$Y$$$20240919$$MD$CH$CH
243379231$24337923$1$I$20240908$20240912$20240919$20240919$PER$$US-EMD Serono-2024049109$EMD SERONO INC$$45$YR$A$F$Y$$$20240919$$HP$US$US
243379241$24337924$1$I$20240813$20240909$20240919$20240919$EXP$FR-AFSSAPS-MP2024001369$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112103$ZYDUS PHARM$$$$$$Y$$$20240919$$MD$FR$FR
243379252$24337925$2$F$20230501$20240911$20240919$20240925$EXP$$US-AMGEN-USASL2024182430$AMGEN$$72$YR$E$M$Y$$$20240925$$CN$US$US
243379261$24337926$1$I$20240915$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024184796$AMGEN$$75$YR$E$F$Y$$$20240919$$CN$US$US
243379271$24337927$1$I$20240909$20240909$20240919$20240919$EXP$GB-NEBO-669607$GB-NEBO-669607$PHARMACOSMOS$$$$$$Y$$$20240919$$HP$GB$GB
243379292$24337929$2$F$$20240918$20240919$20240920$PER$$NVSC2024US186542$NOVARTIS$$$$$M$Y$$$20240921$$CN$US$US
243379302$24337930$2$F$$20240920$20240919$20240927$EXP$$US-GSK-US2024113653$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
243379311$24337931$1$I$$20240912$20240919$20240919$PER$$US-ROCHE-10000082230$ROCHE$$$$E$M$Y$$$20240919$$MD$US$US
243379331$24337933$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010825$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243379341$24337934$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010872$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243379351$24337935$1$I$$20240911$20240919$20240919$EXP$$AU-CELLTRION INC.-2024AU022241$CELLTRION$$$$$$Y$$$20240919$$MD$AU$AU
243379371$24337937$1$I$20240907$20240907$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044831$AUROBINDO$$27$YR$$F$Y$118$KG$20240919$$CN$GB$GB
243379381$24337938$1$I$$20240916$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US080857$SANDOZ$$81$YR$$F$Y$$$20240919$$MD$US$US
243379391$24337939$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148949$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240919$$CN$US$US
243379401$24337940$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148302$BRISTOL MYERS SQUIBB$$23$YR$A$M$Y$$$20240919$$HP$US$US
243379411$24337941$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148130$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240919$$CN$US$US
243379421$24337942$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148440$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240919$$CN$US$US
243379461$24337946$1$I$20210702$20240912$20240919$20240919$EXP$$CA-TAKEDA-2021TUS041949$TAKEDA$$60$YR$$F$Y$$$20240919$$MD$CA$CA
243379471$24337947$1$I$20181201$20240910$20240919$20240919$EXP$$BR-ROCHE-10000079389$ROCHE$$32$YR$A$F$Y$$$20240919$$MD$BR$BR
243379481$24337948$1$I$20240101$20240912$20240919$20240919$EXP$$US-SA-2024SA269452$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240919$$CN$US$US
243379491$24337949$1$I$20240816$20240914$20240919$20240919$EXP$$CN-SA-2024SA268266$SANOFI AVENTIS$$47$YR$A$F$Y$53$KG$20240919$$HP$CN$CN
243379511$24337951$1$I$$20240918$20240919$20240919$PER$$US-ROCHE-10000085810$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243379521$24337952$1$I$$20240912$20240919$20240919$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-125574$REGENERON$$$$$$Y$$$20240919$$MD$JP$JP
243379541$24337954$1$I$20240828$20240914$20240919$20240919$EXP$$CN-JNJFOC-20240947097$JOHNSON AND JOHNSON$$26$YR$A$F$Y$58$KG$20240919$$HP$CN$CN
243379551$24337955$1$I$$20240910$20240919$20240919$PER$$US-ABBVIE-5920820$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243379561$24337956$1$I$20240705$20240906$20240919$20240919$EXP$$ES-AUROBINDO-AUR-APL-2024-045180$AUROBINDO$$$$E$M$Y$$$20240919$$HP$ES$ES
243379571$24337957$1$I$$20240904$20240919$20240919$EXP$$EG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468616$RANBAXY$Maher M, Abdelmooti Samra M, Abdelfattah RM, ElGammal MM, Kamel HM. CML-137 With the financial toxicity and other adverse events of 2g TKI, is Imatinib still a valid option in higher-risk young patients with newly diagnosed chronic-phase CML?. Clin Lymphoma Myeloma Leuk. 2024;Sept:S363-S364$$$A$$Y$$$20240919$$CN$EG$EG
243379582$24337958$2$F$$20240910$20240919$20240925$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468530$RANBAXY$Laserna PA, Fajardo MC, De Victoria Carazo JM, Fidel MV, Raquel RF. DON^T FORGET THE DRUGS. AN ATYPICAL CASE OF RENOPULMONARY SYNDROME IN AN ADULT MALE. Eur JCase Rep Intern Med. 2024;11 (Suppl.):1018$69$YR$$M$Y$$$20240925$$HP$ES$ES
243379591$24337959$1$I$$20240904$20240919$20240919$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468606$RANBAXY$$68$YR$$M$Y$82$KG$20240919$$CN$NL$NL
243379601$24337960$1$I$$20240904$20240919$20240919$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468626$RANBAXY$$46$YR$$F$Y$$$20240919$$CN$GB$GB
243379611$24337961$1$I$$20240904$20240919$20240919$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468517$RANBAXY$Motomura Y, Urai S, Hirota Y, Takegawa N, Bando H, Yamamoto M, et al. Type 1 diabetes mellitus affected by potential toxicity from long term use of nivolumab. Diabet Int. 2024;15:130-134$53$YR$$M$Y$55.9$KG$20240919$$HP$JP$JP
243379631$24337963$1$I$$20240904$20240919$20240919$EXP$$EG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468611$RANBAXY$Maher M, Abdelmooti Samra M, Abdelfattah RM, ElGammal MM, Kamel HM. CML-137 With the financial toxicity and other adverse events of 2g TKI, is Imatinib still a valid option in higher-risk young patients with newly diagnosed chronic-phase CML?. Clin Lymphoma Myeloma Leuk. 2024;Sept:S363-S364$$$A$$Y$$$20240919$$CN$EG$EG
243379641$24337964$1$I$20240625$20240904$20240919$20240919$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468580$RANBAXY$$74$YR$$M$Y$123$KG$20240919$$MD$FR$FR
243379651$24337965$1$I$20240619$20240904$20240919$20240919$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468557$RANBAXY$$83$YR$$F$Y$52.7$KG$20240919$$MD$ES$ES
243379661$24337966$1$I$20240313$20240904$20240919$20240919$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468553$RANBAXY$$64$YR$$M$Y$$$20240919$$PH$FR$FR
243379671$24337967$1$I$$20240904$20240919$20240919$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468550$RANBAXY$$46$YR$$F$Y$74$KG$20240919$$CN$NL$NL
243379681$24337968$1$I$$20240910$20240919$20240919$EXP$$US-PADAGIS-2024PAD01470$PADAGIS$$$$$$Y$$$20240919$$CN$US$US
243379692$24337969$2$F$$20240910$20240919$20240925$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468413$RANBAXY$Laczkovits B, Macaes C, Andrade P, Costa A. ERTAPENEM INDUCED DRUG RELATED EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) SYNDROME - A CASE REPORT. Eur JCase Rep Intern Med. 2024;11 (Suppl):980-981$89$YR$$F$Y$$$20240925$$HP$PT$PT
243379701$24337970$1$I$$20240904$20240919$20240919$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468594$RANBAXY$$48$YR$$M$Y$78$KG$20240919$$MD$NL$NL
243379711$24337971$1$I$20240702$20240904$20240919$20240919$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468281$RANBAXY$$86$YR$$F$Y$$$20240919$$MD$FR$FR
243379721$24337972$1$I$$20240904$20240919$20240919$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468575$RANBAXY$$58$YR$$M$Y$90$KG$20240919$$MD$NL$NL
243379732$24337973$2$F$$20240913$20240919$20240927$EXP$$LY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468705$RANBAXY$Hammad R, Grain M. ALL in Pregnancy With Challenging Conditions and Side Effects. Clin Lymphoma Myeloma Leuk. 2024;Sep;24 (Suppl.1:S281;ALL-701$33$YR$$F$Y$$$20240927$$PH$LY$LY
243379741$24337974$1$I$$20240904$20240919$20240919$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468321$RANBAXY$$31$YR$$F$Y$78$KG$20240919$$CN$NL$NL
243379751$24337975$1$I$20240502$20240904$20240919$20240919$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468416$RANBAXY$$71$YR$$M$Y$74.5$KG$20240919$$MD$FR$FR
243379771$24337977$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468719$RANBAXY$De La Presa M, Ibach M, Berdahl J, Holland EJ. Anterior Scleral and Limbal Inflammatory Necrosis After Adjuvant Miltefosine for Recalcitrant Acanthamoeba Keratitis. Cornea. 2022;41:775-778$37$YR$$F$Y$$$20240919$$MD$US$US
243379781$24337978$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468865$RANBAXY$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin Arthritis Rheum. 2024;67(0):152460(1-7)$28$YR$$F$Y$$$20240919$$HP$US$US
243379791$24337979$1$I$$20240904$20240919$20240919$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468344$RANBAXY$$49$YR$$M$Y$72.5$KG$20240919$$CN$NL$NL
243379801$24337980$1$I$$20240904$20240919$20240919$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468332$RANBAXY$$63$YR$$M$Y$72$KG$20240919$$MD$NL$NL
243379811$24337981$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468801$RANBAXY$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J Forens Legal Med. 2024;101:102625;1-6$95$YR$$$Y$$$20240919$$HP$US$US
243379822$24337982$2$F$$20240906$20240919$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468681$RANBAXY$Aifuwa E, Kandahari A, Steinberg A. HL-298 Concomitant Methotrexate Withdrawal and Brentuximab Vedotin Therapy for Treatment of Methotrexate Associated Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk. 2024;24 (Suppl.):S446-S447$82$YR$$M$Y$$$20240920$$HP$US$US
243379831$24337983$1$I$$20240904$20240919$20240919$EXP$$SI-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468693$RANBAXY$Bezeljak N, Jerman A, Grenc D, Zorman SK. Inadvertent Intoxication with Salbutamol, Treated with Hemodialysis: A Case Report and Brief Review of the Literature. Case Rep Nephrol Dial. 2024;14(1):88-96$69$YR$$M$Y$$$20240919$$HP$SI$SI
243379851$24337985$1$I$$20240911$20240919$20240919$EXP$$TW-AMGEN-TWNSP2024184059$AMGEN$$50$YR$A$F$Y$$$20240919$$HP$TW$TW
243379862$24337986$2$F$$20240904$20240919$20240927$EXP$$LY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468709$RANBAXY$Hammad R, Grain M. ALL in Pregnancy With Challenging Conditions + Side Effects. Clin Lymphoma Myeloma Leuk. 2024;Sep;24 (Suppl.1:S281;ALL-701$$$N$M$Y$$$20240927$$PH$LY$LY
243379882$24337988$2$F$$20240913$20240919$20240927$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468686$RANBAXY$Silva JC, Gaspar M, Fernandes V, Verdasca F, Pinheiro M. HERPETIC RETINITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS. Eur J Case Rep Intern Med. 2024;11 (Suppl.):1040-1041$30$YR$$F$Y$$$20240927$$HP$PT$PT
243379891$24337989$1$I$$20240904$20240919$20240919$EXP$$IL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468605$RANBAXY$Avidan Y, Aker A, Tabachnikov V. Prolonged asystole following adenosine. Was it necessary?. J Geriatr Cardiol. 2024;21 (6):686-688$77$YR$$F$Y$$$20240919$$HP$IL$IL
243379901$24337990$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468864$RANBAXY$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin Arthritis Rheum. 2024;67(0):152460(1-7)$$$$M$Y$$$20240919$$HP$US$US
243379911$24337991$1$I$20220315$20240904$20240919$20240919$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468529$RANBAXY$$17$YR$$F$Y$53$KG$20240919$$MD$PL$PL
243379921$24337992$1$I$20240627$20240904$20240919$20240919$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468422$RANBAXY$$19$YR$$F$Y$$$20240919$$MD$FR$FR
243379931$24337993$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468853$RANBAXY$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin Arthritis Rheum. 2024;67(0):152460(1-7)$62$YR$$M$Y$$$20240919$$HP$US$US
243379941$24337994$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468450$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243379951$24337995$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468454$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243379962$24337996$2$F$$20240913$20240919$20240927$EXP$$CR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468718$RANBAXY$Fernandoenez F. T-Cell Prolymphocytic Leukemia:  A Case Report. Clin Lymphoma Myeloma Leuk. 2024;24 (Suppl. 1):S354$86$YR$$M$Y$$$20240927$$HP$CR$CR
243379971$24337997$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468817$RANBAXY$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J Forens Legal Med. 2024;101:102625, 1-6$84$YR$$F$Y$$$20240919$$HP$US$US
243379991$24337999$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468460$RANBAXY$Bian W, Huaqing W, Fengting L, Zhi C, Ke Z. Reactive cutaneous capillary endothelial proliferation caused by the PD?1 inhibitor camrelizumab during the treatment of malignant tumors: two case reports. Chin J Dermatol. 2021;Mar, 54 (3):252- 253$64$YR$$F$Y$$$20240919$$HP$CN$CN
243380001$24338000$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468816$RANBAXY$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J Forens Legal Med. 2024;101:1-6, 102625$82$YR$$$Y$$$20240919$$HP$US$US
243380011$24338001$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468448$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380021$24338002$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468847$RANBAXY$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin Arthritis Rheum. 2024;67(0):152460(1-7)$69$YR$$F$Y$$$20240919$$HP$US$US
243380031$24338003$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468444$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380051$24338005$1$I$$20240904$20240919$20240919$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468483$RANBAXY$Hong L, Witton LD, Jolly EC. Pneumocystis jirovecii pneumonia presenting with severe, refractory hypercalcaemia in an immunosuppressed renal transplant patient: Review of the literature and novel biochemical insights. Clin Med London. 2024;24:100011;1-3$48$YR$$F$Y$$$20240919$$HP$GB$GB
243380061$24338006$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468499$RANBAXY$Huang P, Wen F, Wang X. Case report: Pyrotinib and tegafur combined with radiotherapy achieved notable response in HER2-amplified rectal cancer with multiple metastases after multiline treatments. Front Pharmacol. 2024;15 (0):1-7$39$YR$$F$Y$$$20240919$$HP$CN$CN
243380071$24338007$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468503$RANBAXY$Schuster H, Kinnan S. Catatonia Associated With Valbenazine Treatment. J Clin Psychopharmacol. 2023;Jul/Aug;43(4):389-391$$$$F$Y$$$20240919$$MD$US$US
243380082$24338008$2$F$$20240906$20240919$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468712$RANBAXY$Grain M, Idriss M, Bouzed M, Tang Z. CLL-594 Chronic Lymphocytic Leukemia With Richter^s Transformation Presented With Imminent Tumor Lysis Syndrome: Case Report. Clin Lymphoma Myeloma Leuk. 2024;24 (Suppl.):S360$65$YR$$M$Y$$$20240920$$HP$US$US
243380091$24338009$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468447$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380101$24338010$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468443$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380111$24338011$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468445$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380121$24338012$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468453$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380132$24338013$2$F$$20240913$20240919$20240927$EXP$$PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468690$RANBAXY$Khan MWZ, Talha M, Khan A, Khan S. FATAL CASE OF ALK-NEGATIVE INTRAVASCULAR ANAPLASTIC LARGE T-CELL LYMPHOMA IN A YOUNG ADULT: A RARE CASE PRESENTATION. Eur J Case Rep Intern Med. 2024;11 (Suppl.):780 (Abs.2704)$33$YR$$M$Y$$$20240927$$HP$PK$PK
243380141$24338014$1$I$20221201$20240904$20240919$20240919$EXP$$PE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468589$RANBAXY$Perez WR, Delgado Del Aguila JL. Near-fatal Asthma: Report of an emergency case at Santa Rosa Hospital. Rev Fac Med Hum. 2024;24(3):20-26$23$YR$$M$Y$$$20240919$$HP$PE$PE
243380161$24338016$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468651$RANBAXY$Orsagova D, Mohamed Ramzy Hasan F, Sayed S, Sharma A, Khillan R. Beyond the Surface: A Case Study of Cutaneous Involvement in Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2024;SEP;24 (S.):S563/MM-494$47$YR$$F$Y$$$20240919$$HP$US$US
243380171$24338017$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468452$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380181$24338018$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468446$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380191$24338019$1$I$20240815$20240917$20240919$20240919$EXP$$NVSC2024US186277$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
243380202$24338020$2$F$$20240919$20240919$20240926$EXP$$CA-BIOGEN-2024BI01282746$BIOGEN$$$$$F$Y$$$20240926$$CN$CA$CA
243380211$24338021$1$I$20240712$20240917$20240919$20240919$PER$$NVSC2024US185817$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243380221$24338022$1$I$20240902$20240912$20240919$20240919$EXP$$US-BIOGEN-2024BI01282553$BIOGEN$$56$YR$$F$Y$$$20240919$$CN$US$US
243380231$24338023$1$I$$20240916$20240919$20240919$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051714$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240919$$MD$US$US
243380241$24338024$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468434$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380251$24338025$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010936$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243380261$24338026$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468435$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380271$24338027$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468438$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380281$24338028$1$I$$20240909$20240919$20240919$EXP$$CA-APOTEX-2024AP010380$APOTEX$$$$$M$Y$$$20240919$$HP$CA$CA
243380291$24338029$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468807$RANBAXY$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J Forens Legal Med. 2024;101:102625;1-6$85$YR$$$Y$$$20240919$$HP$US$US
243380301$24338030$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468343$RANBAXY$MOHAMMADZADEH N, PUNSONI M, ALHUSAINI S, FRIEDMAN JH. Autopsy-Proven Pure Parkinson^s Disease with Rapidly Progressive Dementia and Cognitive Fluctuations in a Patient with GBA Mutation. R I Med J. 2024;Aug:50-53$75$YR$$F$Y$$$20240919$$MD$US$US
243380321$24338032$1$I$$20240904$20240919$20240919$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468683$RANBAXY$$53$YR$$F$Y$$$20240919$$PH$GB$GB
243380331$24338033$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468044$RANBAXY$Santistevan L, Lonergan D, Eyvazzadeh AD. First case report of serous otitis media as a complication of severe ovarian hyperstimulation syndrome: Case report and literature review. Int J Gynaecol Obstet. 2024;164:843-847$30$YR$$F$Y$52.2$KG$20240919$$HP$US$US
243380341$24338034$1$I$20240829$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467284$RANBAXY$$47$YR$$F$Y$62$KG$20240919$$HP$CN$CN
243380351$24338035$1$I$20240610$20240904$20240919$20240919$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468785$RANBAXY$$67$YR$$M$Y$77$KG$20240919$$CN$GB$GB
243380361$24338036$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-413876$RANBAXY$Pillai SS, Robilliard R, Fredette ME, Serrano-Gonzalez M, Scully KJ. Persistent hypercalcemia mimicking hypophosphatasia after discontinuation of a ketogenic diet: a case report. J Pediatr Endocrinol Metab. 2023;36(11):1109-1113$35$MON$$M$Y$12.9$KG$20240919$$HP$US$US
243380371$24338037$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468811$RANBAXY$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J Forens Legal Med. 2024;101:102625;1-6$65$YR$$$Y$$$20240919$$HP$US$US
243380381$24338038$1$I$$20240904$20240919$20240919$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468770$RANBAXY$Fassi E, Amoroso V, Cosentini D, Ferrari V, Lagana M, Berruti A, et al. Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report.. Front Oncol. 2024;14 (0):1-5$58$YR$$F$Y$$$20240919$$HP$IT$IT
243380391$24338039$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467169$RANBAXY$$$$E$M$Y$$$20240919$$MD$US$US
243380401$24338040$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468436$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380411$24338041$1$I$$20240904$20240919$20240919$EXP$$KZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-465717$RANBAXY$Sheyshenov Zh.O., Kenbayev A.B., Joshibaev S., Narbaev D.A., Azimzhanova A.U., Kapusidi.K.G. Clinical case of cardiac echinococcosis. Clinical and Experimental Surgery.. Petrovsky. 2024;12 (1):113-7$24$YR$$M$Y$$$20240919$$MD$KZ$KZ
243380421$24338042$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468437$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380431$24338043$1$I$20240825$20240904$20240919$20240919$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468672$RANBAXY$$55$YR$$M$Y$$$20240919$$HP$GB$GB
243380441$24338044$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468353$RANBAXY$Wright B, Moore A, Becker-Weidman D, Joyce D. Primary B cell lymphoma of the patella presenting as anterior knee pain: A case report. J Orthop. 2024;48:60-63$76$YR$$F$Y$$$20240919$$HP$US$US
243380451$24338045$1$I$20230228$20240904$20240919$20240919$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-398442$RANBAXY$$46$YR$$M$Y$$$20240919$$HP$IT$IT
243380461$24338046$1$I$20240903$20240904$20240919$20240919$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468748$RANBAXY$$76$YR$$M$Y$$$20240919$$HP$GB$GB
243380471$24338047$1$I$$20240904$20240919$20240919$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451403$RANBAXY$$$$$F$Y$$$20240919$$CN$CA$CA
243380482$24338048$2$F$$20240910$20240919$20240925$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468789$RANBAXY$Pozo IB, Comesana MS, Castillo AC, Oliva MP, Vazquez GP.. PUTTING PIECES TOGETHER TO REACH THE DIAGNOSIS.. Eur J Case Rep Intern Med. 2024;11 (Suppl.):791$66$YR$$M$Y$$$20240925$$HP$ES$ES
243380491$24338049$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468442$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380501$24338050$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468253$RANBAXY$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J Forens Legal Med. 2024;101:102625;1-6$88$YR$$$Y$$$20240919$$HP$US$US
243380511$24338051$1$I$$20240904$20240919$20240919$EXP$$AL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468007$RANBAXY$Jorgaqi E, Ezenne K, Brown M, Zhou AE, Khachemoune A. Congenital Erythropoietic Porphyria: A Case of Hepatic Failure and Angioedema Following Ferrous Sulfate Supplementation. Pediatr Dermatol. 2024;Sep 3:Online ahead of print$$$A$F$Y$$$20240919$$HP$AL$AL
243380521$24338052$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468439$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380531$24338053$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468441$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380541$24338054$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468440$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380551$24338055$1$I$20240601$20240904$20240919$20240919$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468633$RANBAXY$$82$YR$$M$Y$71$KG$20240919$$MD$FR$FR
243380561$24338056$1$I$$20240918$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149043$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240919$$CN$US$US
243380571$24338057$1$I$$20240916$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148795$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240919$$CN$US$US
243380581$24338058$1$I$20240915$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148769$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240919$$CN$US$US
243380591$24338059$1$I$20240101$20240905$20240919$20240919$EXP$$CA-UCBSA-2024045810$UCB$$$$$F$Y$$$20240919$$CN$CA$CA
243380601$24338060$1$I$$20240910$20240919$20240919$PER$$US-TAKEDA-2024TUS090515$TAKEDA$$$$$M$Y$$$20240919$$CN$US$US
243380611$24338061$1$I$$20240911$20240919$20240919$PER$$US-ABBVIE-5920434$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243380621$24338062$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010909$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240919$$CN$US$US
243380631$24338063$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010692$ELI LILLY AND CO$$63$YR$A$$Y$$$20240919$$CN$US$US
243380641$24338064$1$I$20240918$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011963$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240919$$CN$US$US
243380651$24338065$1$I$20240915$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011774$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240919$$CN$US$US
243380661$24338066$1$I$$20240909$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409005443$ELI LILLY AND CO$$53$YR$A$$Y$$$20240919$$LW$US$US
243380671$24338067$1$I$20240817$20240916$20240919$20240919$EXP$$US-ROCHE-10000083738$ROCHE$$78$YR$E$M$Y$$$20240919$$HP$US$US
243380681$24338068$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010917$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243380691$24338069$1$I$$20240904$20240919$20240919$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468415$RANBAXY$$63$YR$$F$Y$66$KG$20240919$$CN$NL$NL
243380701$24338070$1$I$$20240904$20240919$20240919$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468300$RANBAXY$$48$YR$$F$Y$$$20240919$$MD$NL$NL
243380711$24338071$1$I$$20240911$20240919$20240919$EXP$$US-ROCHE-10000080044$ROCHE$$77$YR$E$F$Y$$$20240919$$CN$US$US
243380721$24338072$1$I$20240613$20240904$20240919$20240919$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468585$RANBAXY$$83$YR$$F$Y$$$20240919$$MD$FR$FR
243380731$24338073$1$I$20240529$20240904$20240919$20240919$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468549$RANBAXY$$21$YR$$M$Y$$$20240919$$PH$IT$IT
243380751$24338075$1$I$$20240904$20240919$20240919$EXP$$NL-SUNPHARMA-2024RR-468628AA$RANBAXY$$21$YR$$F$Y$70$KG$20240919$$CN$NL$NL
243380761$24338076$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468822$RANBAXY$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J Forens Legal Med$67$YR$$$Y$$$20240919$$HP$US$US
243380771$24338077$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468859$RANBAXY$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin Arthritis Rheum. 2024;67(0):152460(1-7)$$$$F$Y$$$20240919$$HP$US$US
243380782$24338078$2$F$$20240910$20240919$20240925$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-452672$RANBAXY$Guillen MLA, Abinzano NG, Carmen M, Velasco MCM, Betran VJ, Mazuelas MA et al. OLD DRUGS ARE STILL EFFECTIVE AND USEFUL. Eur J Case Rep Intern Med. 2024;11(1):986$84$YR$$F$Y$$$20240925$$HP$ES$ES
243380791$24338079$1$I$$20240904$20240919$20240919$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468742$RANBAXY$Maksymowicz R, Straczek CN, Matysek JJ, Lech DM, Nosek K. Comprehensive management of painful diabetic neuropathy-Addressing opioid-induced hyperalgesia through multimodal approaches. Medicine. 2024;103(31):e39126(1-3)$64$YR$$M$Y$$$20240919$$HP$PL$PL
243380811$24338081$1$I$$20240912$20240919$20240919$PER$$US-ROCHE-10000081944$ROCHE$$$$E$F$Y$$$20240919$$CN$US$US
243380821$24338082$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468825$RANBAXY$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J Forens Legal Med. 2024;101:102625, 1-6$61$YR$$$Y$$$20240919$$HP$US$US
243380851$24338085$1$I$20240507$20240904$20240919$20240919$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468492$RANBAXY$$68$YR$$M$Y$105.6$KG$20240919$$PH$FR$FR
243380861$24338086$1$I$$20240909$20240919$20240919$EXP$CA-APOTEX-2024AP010352$CA-Accord-447041$ACCORD$$66$YR$E$M$Y$$$20240919$$HP$CA$CA
243380871$24338087$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468819$RANBAXY$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J Forens Legal Med. 2024;101:102625, 1-6$69$YR$$$Y$$$20240919$$HP$US$US
243380881$24338088$1$I$$20240904$20240919$20240919$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468554$RANBAXY$Koga Y, Akai T, Shiro T, Kuroda S. Pituitary lymphoma appearing 9 years after pituitary adenoma resection. Surg Neurol Int. 2024;15(262):1-7$51$YR$$F$Y$$$20240919$$HP$JP$JP
243380891$24338089$1$I$$20240904$20240919$20240919$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468578$RANBAXY$$72$YR$$M$Y$70$KG$20240919$$CN$NL$NL
243380901$24338090$1$I$20240501$20240904$20240919$20240919$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468607$RANBAXY$$52$YR$$M$Y$$$20240919$$PH$ES$ES
243380911$24338091$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468850$RANBAXY$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin Arthritis Rheum. 2024;67(0):152460(1-7)$58$YR$$$Y$$$20240919$$HP$US$US
243380921$24338092$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468451$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243380941$24338094$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468866$RANBAXY$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin Arthritis Rheum. 2024;67(0):152460(1-7)$26$YR$$F$Y$$$20240919$$HP$US$US
243380952$24338095$2$F$$20240906$20240919$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468687$RANBAXY$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B, et al. Hematological Malignancies and Pregnancy: A Single-Institution Experience. Clin Lymphoma Myeloma Leuk. 2024;24(Suppl.):S333-S334$$$$F$Y$$$20240920$$HP$US$US
243380962$24338096$2$F$$20240910$20240919$20240925$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-453601$RANBAXY$Haidar NA, Vaillant W, Salignon K, Jounblat Y, Borel C. ABCL-159 Successful Treatment of a Gray Zone Lymphoma With Immunotherapy: A Case Report. Clin Lymphoma Myeloma Leuk. 2024;24 (Suppl.):S459$66$YR$$F$Y$$$20240925$$HP$FR$FR
243380972$24338097$2$F$$20240913$20240919$20240927$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468714$RANBAXY$Exilus LK, Julio AM, Mont CE, Llaurado GO. CHEST PAIN AND ANTIPHOSPHOLIPID SYNDROME(APS). AN ASSOCIATION THAT SHOULD NEVER BE IGNORED. Eur J Case Rep Intern Med. 2024;11 (Suppl):1081-1082;2969$46$YR$$F$Y$$$20240927$$HP$ES$ES
243380991$24338099$1$I$$20240904$20240919$20240919$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468544$RANBAXY$Chami M, Di Primio S. Energy drink consumption can induce cardiovascular events, two case reports and a literature review. Toxic Analyt Clinique. 2024;36:43-61$28$YR$$M$Y$$$20240919$$HP$BE$BE
243381031$24338103$1$I$$20240916$20240919$20240919$EXP$$NVSC2024US185754$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243381041$24338104$1$I$$20240904$20240919$20240919$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468540$RANBAXY$Chami M, Di Primio S. Energy drink consumption can induce cardiovascular events, two case reports and a literature review. Toxic Analyt Clinique. 2024;36:43-61$25$YR$$M$Y$$$20240919$$HP$BE$BE
243381061$24338106$1$I$$20240904$20240919$20240919$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468576$RANBAXY$$61$YR$$F$Y$63$KG$20240919$$MD$NL$NL
243381081$24338108$1$I$$20240904$20240919$20240919$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468449$RANBAXY$Liu Q, Zhang Y, Zhang J, Chen L, Yang Y, Liu Y. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Front Oncol. 2024;14:1374149 (1-9)$$$$$Y$$$20240919$$HP$CN$CN
243381102$24338110$2$F$$20240906$20240919$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468692$RANBAXY$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B, et al. Hematological Malignancies and Pregnancy: A Single-Institution Experience. Clin Lymphoma Myeloma Leuk. 2024;Sep;24sup:S333-S334;AML-713$$$N$$Y$$$20240920$$MD$US$US
243381132$24338113$2$F$20240918$20240919$20240919$20240920$PER$$US-AMGEN-USASP2024186577$AMGEN$$68$YR$E$F$Y$$$20240920$$CN$US$US
243381141$24338114$1$I$20240101$20240912$20240919$20240919$EXP$$JP-ROCHE-10000063112$ROCHE$$8$DEC$E$M$Y$$$20240919$$MD$JP$JP
243381151$24338115$1$I$20240601$20240912$20240919$20240919$EXP$FR-AFSSAPS-AN2024001209$FR-TEVA-VS-3243220$TEVA$$34$YR$$F$Y$88$KG$20240919$$MD$FR$FR
243381161$24338116$1$I$$20240910$20240919$20240919$EXP$$US-PADAGIS-2024PAD01483$PADAGIS$$$$$$Y$$$20240919$$HP$US$US
243381191$24338119$1$I$$20240906$20240919$20240919$EXP$$PL-AUROBINDO-AUR-APL-2024-044224$AUROBINDO$Osma?ska M. Pembrolizumab in first-line treatment in  metastatic squamous-cell lung cancer with PD-L1  expession below 1%. ONKOLOGIA W PRAKTYCE KLINICZNEJ - EDUKACJA (ONCOLOGY IN PRACTICE CLINICAL - EDU). 2024;10 (Suppl. C):C6-C9$73$YR$$M$Y$$$20240919$$MD$PL$PL
243381211$24338121$1$I$20240604$20240906$20240919$20240919$PER$$US-BAUSCHBL-2024BNL027533$BAUSCH AND LOMB$$81$YR$$F$Y$$$20240919$$CN$US$US
243381221$24338122$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010935$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243381231$24338123$1$I$$20240905$20240919$20240919$PER$$US-ABBVIE-5913549$ABBVIE$$$$$$Y$$$20240919$$HP$US$US
243381241$24338124$1$I$$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045130$AUROBINDO$$42$YR$$F$Y$$$20240919$$PH$FR$FR
243381251$24338125$1$I$$20240905$20240919$20240919$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-21237$ALKEM$Xiong YJ, Xiao Y, Xie L, Gao L, Han Y, Huang PF, Liu S, Liang YX, Wang H. Contezolid for the Treatment of Drug-Resistant Tuberculosis in China: A Clinical Case Series. Infection and drug resistance. 2024;17:3491-3499$$$$F$Y$$$20240919$$HP$CN$CN
243381261$24338126$1$I$20240828$20240905$20240919$20240919$EXP$GB-MHRA-MED-202408311919019530-BRPHJ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21038$ALKEM$$59$YR$$F$Y$$$20240919$$MD$GB$GB
243381271$24338127$1$I$$20240905$20240919$20240919$EXP$$HR-ALKEM LABORATORIES LIMITED-HR-ALKEM-2024-21448$ALKEM$Bosnic Kovacic I, Matosevic M, Laganovic M, Dika Z, Fistrek Prlic M, Ivandic E, Coric M, Bulimbasic S, Durakovic N, Peric Z, Desnica L, Vrhovac R, Jelakovic B, Sethi S, Vukovic Brinar I.. Specific antigen-based stratification of membranous nephropathy in patients after haematopoietic stem cell allotransplantation-a case series and literature review. BMC Nephrology. 2024;25:254$55$YR$$M$Y$$$20240919$$HP$HR$HR
243381291$24338129$1$I$$20240905$20240919$20240919$EXP$$HR-ALKEM LABORATORIES LIMITED-HR-ALKEM-2024-21449$ALKEM$Bosnic Kovacic I, Matosevic M, Laganovic M, Dika Z, Fistrek Prlic M, Ivandic E, Coric M, Bulimbasic S, Durakovic N, Peric Z, Desnica L, Vrhovac R, Jelakovic B, Sethi S, Vukovic Brinar I.. Specific antigen-based stratification of membranous nephropathy in patients after haematopoietic stem cell allotransplantation - a case series and literature review. BMC Nephrology. 2024;25:254$45$YR$$M$Y$$$20240919$$HP$HR$HR
243381311$24338131$1$I$$20240905$20240919$20240919$EXP$GB-MHRA-TPP26022338C7949041YC1725392840562$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21045$ALKEM$$73$YR$$M$Y$72$KG$20240919$$MD$GB$GB
243381341$24338134$1$I$$20240905$20240919$20240919$EXP$GB-MHRA-MED-202409040811487310-HNSRJ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21046$ALKEM$$23$YR$$F$Y$$$20240919$$CN$GB$GB
243381351$24338135$1$I$$20240913$20240919$20240919$EXP$$US-BIOGEN-2024BI01282826$BIOGEN$$$$$M$Y$$$20240919$$CN$US$US
243381361$24338136$1$I$$20240905$20240919$20240919$EXP$HR-MLMSERVICE-20240819-PI167235-00232-1$HR-ALKEM LABORATORIES LIMITED-HR-ALKEM-2024-20434$ALKEM$Bosnic Kovacic I, Matosevic M, Laganovic M, Dika Z, Fistrek Prlic M, Ivandic E, et al.. Specific antigen-based stratification of membranous nephropathy in patients after haematopoietic stem cell allotransplantation-a case series and literature review. BMC Nephrology. 2024;25(1):254$41$YR$$F$Y$$$20240919$$MD$HR$HR
243381371$24338137$1$I$$20240905$20240919$20240919$EXP$$GR-ALKEM LABORATORIES LIMITED-GR-ALKEM-2024-20690$ALKEM$Kargiotis O, Marangos M, Polychronopoulos P.. An unusual case of isoniazid toxicity. Neurol Sci. 2015;36:1037-1039$75$YR$$M$Y$$$20240919$$HP$GR$GR
243381382$24338138$2$F$$20240912$20240919$20240926$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-21298$ALKEM$Barkhordarian M, Grijalva M, Lee A, Jarri A, Belyayeva A, Weissman S.. Statin-Induced Autoimmune Myopathy: A Diagnostic Challenge in Muscle Weakness. American Journal of Case reports. 2024;25:e944261$69$YR$$M$Y$$$20240926$$HP$US$US
243381391$24338139$1$I$$20240913$20240919$20240919$EXP$$US-BIOGEN-2024BI01282928$BIOGEN$$$$$F$Y$$$20240919$$MD$US$US
243381401$24338140$1$I$20240101$20240911$20240919$20240919$EXP$$SG-ROCHE-10000081529$ROCHE$$72$YR$E$F$Y$$$20240919$$CN$SG$SG
243381411$24338141$1$I$$20240911$20240919$20240919$EXP$$US-RDY-SPO/USA/24/0013594$DR REDDYS$Shah A, Kunkel H, Aghazadeh NM, Tollefson M. 54647 Efficacy of Colchicine Treatment for Aphthous Ulcers in Pediatric Patients. Journal of the American Academy of Dermatology. 2024 Sep;91(3): doi:10.1016/j.jaad.2024.07.154.$$$C$$Y$$$20240919$$HP$US$US
243381421$24338142$1$I$20240501$20240909$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143761$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240919$$CN$US$US
243381433$24338143$3$F$20240914$20240920$20240919$20240921$PER$$US-AMGEN-USASP2024186821$AMGEN$$58$YR$A$F$Y$$$20240921$$CN$US$US
243381441$24338144$1$I$20240913$20240913$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-029309$UNITED THERAPEUTICS$$54$YR$$F$Y$77.098$KG$20240919$$$US$US
243381451$24338145$1$I$20240830$20240918$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US081292$SANDOZ$$68$YR$$$Y$$$20240919$$CN$US$US
243381461$24338146$1$I$$20240917$20240919$20240919$EXP$$ZA-BIOVITRUM-2024-ZA-012205$BIOVITRUM$$26$WK$$$Y$$$20240919$$HP$ZA$ZA
243381471$24338147$1$I$20230912$20240911$20240919$20240919$EXP$$IE-CELLTRION INC.-2024IE022184$CELLTRION$$$$$$Y$$$20240919$$CN$IE$IE
243381481$24338148$1$I$20240916$20240916$20240919$20240919$EXP$$PE-BIOVITRUM-2024-PE-012201$BIOVITRUM$$15$DY$$M$Y$$$20240919$$CN$PE$PE
243381491$24338149$1$I$$20240906$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044717$AUROBINDO$$91$YR$$M$Y$61$KG$20240919$$HP$GB$GB
243381501$24338150$1$I$20240510$20240912$20240919$20240919$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-125572$REGENERON$$$$$$Y$$$20240919$$MD$JP$JP
243381511$24338151$1$I$20230719$20240909$20240919$20240919$EXP$FR-BIOCON BIOLOGICS LIMITED-BBL2024006194$FR-ROCHE-10000077077$ROCHE$$52$YR$A$F$Y$$$20240919$$CN$FR$FR
243381521$24338152$1$I$$20240911$20240919$20240919$EXP$$AU-TOLMAR, INC.-24AU047402$TOLMAR$$$$$M$Y$$$20240919$$CN$AU$AU
243381531$24338153$1$I$$20240911$20240919$20240919$EXP$$CA-TOLMAR, INC.-24CA052583$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
243381541$24338154$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243783$TEVA$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240919$$MD$US$US
243381551$24338155$1$I$20210101$20240911$20240919$20240919$EXP$FR-AFSSAPS-AVPO2024000169$FR-TEVA-VS-3242768$TEVA$$30$YR$$M$Y$$$20240919$$PH$FR$FR
243381561$24338156$1$I$$20240910$20240919$20240919$EXP$$US-INTERCEPT-PM2024001809$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
243381591$24338159$1$I$$20240917$20240919$20240919$EXP$$CA-TAKEDA-2024TUS093082$TAKEDA$$$$$F$Y$$$20240919$$MD$CA$CA
243381601$24338160$1$I$20220314$20240913$20240919$20240919$EXP$FR-AFSSAPS-MA2024001460$FR-ABBVIE-5928084$ABBVIE$$66$YR$$M$Y$76$KG$20240919$$CN$FR$FR
243381611$24338161$1$I$20240909$20240911$20240919$20240919$EXP$$CO-BIOVITRUM-2024-CO-012182$BIOVITRUM$$476$DY$$M$Y$4.5$KG$20240919$$CN$CO$CO
243381621$24338162$1$I$$20240909$20240919$20240919$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006717$BIOCON$$$$$$Y$$$20240919$$HP$CA$CA
243381631$24338163$1$I$$20240913$20240919$20240919$EXP$$US-ABBVIE-5925307$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243381641$24338164$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243784$TEVA$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240919$$MD$US$US
243381651$24338165$1$I$$20240913$20240919$20240919$EXP$$GB-ABBVIE-5925977$ABBVIE$$$$A$M$Y$$$20240919$$CN$GB$GB
243381661$24338166$1$I$$20240916$20240919$20240919$EXP$$TW-ROCHE-10000084395$ROCHE$Lin T, Huang H, Liu C, Na M, Tsai H, Chang J. Bidirectional approach of vascular access for balloon angioplasty in permcath-associated superior vena cava syndrome presenting with transudative chylothorax. Pediatrics and Neonatology. 2024-Sep;65 (5):506-8. doi:10.1016/j.pedneo.2023.11.004.$4$YR$C$F$Y$$$20240919$$HP$TW$TW
243381681$24338168$1$I$$20240912$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147602$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$65.7$KG$20240919$$MD$US$US
243381691$24338169$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148671$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240919$$CN$US$US
243381711$24338171$1$I$$20240911$20240919$20240919$EXP$$US-ROCHE-10000079364$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243381721$24338172$1$I$$20240913$20240919$20240919$PER$$US-ROCHE-10000082525$ROCHE$$54$YR$A$M$Y$$$20240919$$MD$US$US
243381731$24338173$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011071$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240919$$CN$US$US
243381741$24338174$1$I$20240915$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010107$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240919$$CN$US$US
243381751$24338175$1$I$$20240905$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409004171$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240919$$HP$US$US
243381761$24338176$1$I$20240911$20240912$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409008848$ELI LILLY AND CO$$89$YR$E$F$Y$$$20240919$$CN$US$US
243381771$24338177$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010918$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240919$$CN$US$US
243381781$24338178$1$I$20240901$20240918$20240919$20240919$EXP$$US-GILEAD-2024-0688165$GILEAD$$32$YR$A$M$Y$$$20240919$$MD$US$US
243381801$24338180$1$I$20240910$20240913$20240919$20240919$EXP$$US-BIOGEN-2024BI01282751$BIOGEN$$71$YR$$F$Y$$$20240919$$CN$US$US
243381811$24338181$1$I$$20240829$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08680$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243381821$24338182$1$I$$20240918$20240919$20240919$EXP$$JP-TAKEDA-2024TJP013787AA$TAKEDA$$8$DEC$$M$Y$$$20240919$$MD$JP$JP
243381841$24338184$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147908$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$73.48$KG$20240919$$CN$US$US
243381851$24338185$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148712$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240919$$HP$US$US
243381861$24338186$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5926708$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243381871$24338187$1$I$$20240909$20240919$20240919$EXP$$US-GSK-US2024112056$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243381881$24338188$1$I$$20240909$20240919$20240919$30DAY$$US-GSK-US2024112023$GLAXOSMITHKLINE$$$$$M$Y$$$20240919$$CN$US$US
243381892$24338189$2$F$20240701$20240924$20240919$20240928$EXP$$DE-ABBVIE-5927103$ABBVIE$$69$YR$$F$Y$$$20240928$$MD$DE$DE
243381901$24338190$1$I$$20240909$20240919$20240919$EXP$$ES-CELLTRION INC.-2024ES021833$CELLTRION$Ballester MP, Abril C, Merino V, Alos M, Segarra G, Tosca J, et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4(5):623-630$$$$$Y$$$20240919$$MD$ES$ES
243381921$24338192$1$I$20220101$20240911$20240919$20240919$EXP$$CA-CELLTRION INC.-2022CA018894$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
243381931$24338193$1$I$$20240916$20240919$20240919$EXP$$IL-ADIENNEP-2024AD000747$ADIENNE PHARMA + BIOTECH$Shadur B, NasserEddin A, Zaidman I, Schejter YD, Even-Or E, Berkun Y et al. Successful Haematopoietic Stem Cell Transplantation for LRBA Deficiency with Fludarabine, Treosulfan, and Thiotepa-Based Conditioning. J Clin Immunol. 2024 Sep 12;45(1):3. doi: 10.1007/s10875-024-01770-1.$$$C$M$Y$$$20240917$$MD$IL$
243381941$24338194$1$I$20240417$20240906$20240919$20240919$EXP$$FR-AUROBINDO-AUR-APL-2024-045119$AUROBINDO$$41$YR$$M$Y$$$20240919$$PH$FR$FR
243381951$24338195$1$I$$20240823$20240919$20240919$PER$$US-SA-2024SA267799$SANOFI AVENTIS$$$$A$M$Y$$$20240919$$CN$US$US
243381961$24338196$1$I$20220101$20240823$20240919$20240919$PER$$US-SA-2024SA267835$SANOFI AVENTIS$$45$YR$A$F$Y$123.3$KG$20240919$$MD$US$US
243381971$24338197$1$I$$20240823$20240919$20240919$PER$$US-SA-2024SA267597$SANOFI AVENTIS$$$$A$F$Y$70.45$KG$20240919$$MD$US$US
243381981$24338198$1$I$20240101$20240828$20240919$20240919$PER$$US-SA-2024SA267421$SANOFI AVENTIS$$22$YR$A$F$Y$69.09$KG$20240919$$MD$US$US
243381991$24338199$1$I$20240101$20240821$20240919$20240919$PER$$US-SA-2024SA266867$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240919$$MD$US$US
243382011$24338201$1$I$20240823$20240827$20240919$20240919$PER$$US-SA-2024SA267402$SANOFI AVENTIS$$16$YR$T$M$Y$90.91$KG$20240919$$MD$US$US
243382022$24338202$2$F$$20240912$20240919$20240924$EXP$$CA-UCBSA-2024045872$UCB$$$$$F$Y$$$20240925$$CN$CA$CA
243382031$24338203$1$I$$20240916$20240919$20240919$EXP$$IL-ADIENNEP-2024AD000748$ADIENNE PHARMA + BIOTECH$Shadur B, NasserEddin A, Zaidman I, Schejter YD, Even-Or E, Berkun Y et al. Successful Haematopoietic Stem Cell Transplantation for LRBA Deficiency with Fludarabine, Treosulfan, and Thiotepa-Based Conditioning. J Clin Immunol. 2024 Sep 12;45(1):3. doi: 10.1007/s10875-024-01770-1.$$$T$M$Y$$$20240917$$MD$IL$
243382041$24338204$1$I$20240101$20240827$20240919$20240919$PER$$US-SA-2024SA269490$SANOFI AVENTIS$$25$YR$A$F$Y$90.45$KG$20240919$$MD$US$US
243382051$24338205$1$I$20240801$20240828$20240919$20240919$PER$$US-SA-2024SA266996$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240919$$HP$US$US
243382061$24338206$1$I$$20240828$20240919$20240919$PER$$US-SA-2024SA267024$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240919$$HP$US$US
243382071$24338207$1$I$$20240828$20240919$20240919$PER$$US-SA-2024SA267018$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$HP$US$US
243382081$24338208$1$I$$20240912$20240919$20240919$PER$$NVSC2024US186537$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243382091$24338209$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA269141$SANOFI AVENTIS$$$$E$F$Y$$$20240919$$MD$US$US
243382101$24338210$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA269811$SANOFI AVENTIS$$$$A$M$Y$$$20240919$$MD$US$US
243382111$24338211$1$I$20240801$20240830$20240919$20240919$PER$$US-SA-2024SA269163$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240919$$MD$US$US
243382121$24338212$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA268225$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
243382131$24338213$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA269076$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
243382141$24338214$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA270159$SANOFI AVENTIS$$$$$F$Y$$$20240919$$MD$US$US
243382151$24338215$1$I$$20240827$20240919$20240919$PER$$US-SA-2024SA266775$SANOFI AVENTIS$$$$E$F$Y$$$20240919$$MD$US$US
243382161$24338216$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA269036$SANOFI AVENTIS$$$$A$$Y$104.55$KG$20240919$$MD$US$US
243382172$24338217$2$F$$20240924$20240919$20240930$PER$$US-SA-2024SA269269$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240930$$HP$US$US
243382181$24338218$1$I$$20240904$20240919$20240919$PER$$US-SA-2024SA218189$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240919$$CN$US$US
243382191$24338219$1$I$20240101$20240830$20240919$20240919$PER$$US-SA-2024SA269479$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240919$$MD$US$US
243382201$24338220$1$I$20240501$20240830$20240919$20240919$PER$$US-SA-2024SA268229$SANOFI AVENTIS$$$$A$F$Y$81.82$KG$20240919$$MD$US$US
243382211$24338221$1$I$$20240905$20240919$20240919$PER$$US-SA-2024SA269208$SANOFI AVENTIS$$$$$$Y$$$20240919$$MD$US$US
243382221$24338222$1$I$$20240904$20240919$20240919$PER$$US-SA-2024SA270673$SANOFI AVENTIS$$$$$M$Y$$$20240919$$MD$US$US
243382231$24338223$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA269267$SANOFI AVENTIS$$$$E$F$Y$$$20240919$$MD$US$US
243382241$24338224$1$I$20240801$20240829$20240919$20240919$PER$$US-SA-2024SA267466$SANOFI AVENTIS$$51$YR$A$F$Y$58.64$KG$20240919$$MD$US$US
243382251$24338225$1$I$20240101$20240830$20240919$20240919$PER$$US-SA-2024SA268094$SANOFI AVENTIS$$46$YR$A$F$Y$135.91$KG$20240919$$MD$US$US
243382261$24338226$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA269007$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240919$$CN$US$US
243382281$24338228$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA269055$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240919$$CN$US$US
243382291$24338229$1$I$20240731$20240905$20240919$20240919$PER$$US-SA-2024SA268438$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240919$$HP$US$US
243382301$24338230$1$I$20240101$20240905$20240919$20240919$PER$$US-SA-2024SA265492$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240919$$CN$US$US
243382311$24338231$1$I$$20240906$20240919$20240919$PER$$US-SA-2023SA332083$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240919$$MD$US$US
243382321$24338232$1$I$$20240905$20240919$20240919$PER$$US-SA-2024SA266866$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240919$$CN$US$US
243382331$24338233$1$I$20240101$20240906$20240919$20240919$PER$$US-SA-2024SA270441$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240919$$CN$US$US
243382341$24338234$1$I$20230101$20240905$20240919$20240919$PER$$US-SA-2024SA268833$SANOFI AVENTIS$$$$A$M$Y$$$20240919$$MD$US$US
243382351$24338235$1$I$20240905$20240905$20240919$20240919$PER$$US-SA-2024SA266582$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240919$$MD$US$US
243382362$24338236$2$F$$20240905$20240919$20240930$PER$$US-SA-2024SA266772$SANOFI AVENTIS$$$$C$M$Y$17.73$KG$20240930$$MD$US$US
243382371$24338237$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA269090$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240919$$CN$US$US
243382381$24338238$1$I$$20240910$20240919$20240919$PER$$US-ROCHE-10000082369$ROCHE$$$$E$F$Y$$$20240919$$CN$US$US
243382411$24338241$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA266824$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240919$$CN$US$US
243382422$24338242$2$F$20240901$20240910$20240919$20240925$PER$$US-SA-2024SA269230$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240925$$CN$US$US
243382431$24338243$1$I$$20240916$20240919$20240919$EXP$$IL-ADIENNEP-2024AD000749$ADIENNE PHARMA + BIOTECH$Shadur B, NasserEddin A, Zaidman I, Schejter YD, Even-Or E, Berkun Y et al. Successful Haematopoietic Stem Cell Transplantation for LRBA Deficiency with Fludarabine, Treosulfan, and Thiotepa-Based Conditioning. J Clin Immunol. 2024 Sep 12;45(1):3. doi: 10.1007/s10875-024-01770-1.$$$C$M$Y$$$20240917$$MD$IL$
243382441$24338244$1$I$$20240909$20240919$20240919$PER$$US-SA-2024SA266180$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240919$$HP$US$US
243382451$24338245$1$I$20230301$20240908$20240919$20240919$EXP$$JP-VKT-000591$VKT PHARMA PRIVATE LIMITED$$19$YR$A$F$Y$$$20240913$$MD$JP$JP
243382461$24338246$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA267559$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240919$$MD$US$US
243382471$24338247$1$I$20240901$20240910$20240919$20240919$PER$$US-SA-2024SA266178$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240919$$HP$US$US
243382481$24338248$1$I$20240801$20240911$20240919$20240919$PER$$US-SA-2024SA267484$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240919$$HP$US$US
243382491$24338249$1$I$20240902$20240906$20240919$20240919$PER$$US-SA-2024SA268850$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240919$$CN$US$US
243382501$24338250$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA266279$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240919$$MD$US$US
243382511$24338251$1$I$20240101$20240906$20240919$20240919$PER$$US-SA-2024SA270365$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240919$$MD$US$US
243382521$24338252$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA269523$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240919$$HP$US$US
243382531$24338253$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA265939$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240919$$HP$US$US
243382541$24338254$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA266611$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240919$$MD$US$US
243382552$24338255$2$F$$20240911$20240919$20240924$PER$$US-SA-2024SA268994$SANOFI AVENTIS$$$$$M$Y$$$20240924$$CN$US$US
243382581$24338258$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA269569$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240919$$MD$US$US
243382591$24338259$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA270282$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240919$$CN$US$US
243382601$24338260$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA267944$SANOFI AVENTIS$$$$C$F$Y$16.78$KG$20240919$$MD$US$US
243382611$24338261$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA266574$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240919$$MD$US$US
243382621$24338262$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266459$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
243382631$24338263$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA265910$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240919$$HP$US$US
243382641$24338264$1$I$$20240907$20240919$20240919$PER$$US-SA-2024SA269143$SANOFI AVENTIS$$$$$F$Y$$$20240919$$MD$US$US
243382651$24338265$1$I$20240908$20240910$20240919$20240919$PER$$US-SA-2024SA265614$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240919$$HP$US$US
243382661$24338266$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA265985$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240919$$MD$US$US
243382671$24338267$1$I$20240801$20240911$20240919$20240919$PER$$US-SA-2024SA267196$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240919$$HP$US$US
243382681$24338268$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA265906$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
243382691$24338269$1$I$20240906$20240906$20240919$20240919$PER$$US-SA-2024SA268963$SANOFI AVENTIS$$$$$F$Y$$$20240919$$CN$US$US
243382701$24338270$1$I$20240101$20240907$20240919$20240919$PER$$US-SA-2024SA269813$SANOFI AVENTIS$$7$YR$C$M$Y$25$KG$20240919$$CN$US$US
243382711$24338271$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA266819$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240919$$MD$US$US
243382721$24338272$1$I$20240901$20240911$20240919$20240919$PER$$US-SA-2024SA267208$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240919$$MD$US$US
243382731$24338273$1$I$20240901$20240911$20240919$20240919$PER$$US-SA-2024SA266853$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240919$$MD$US$US
243382741$24338274$1$I$20240801$20240911$20240919$20240919$PER$$US-SA-2024SA267475$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240919$$HP$US$US
243382761$24338276$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA266612$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240919$$MD$US$US
243382771$24338277$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA265890$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240919$$HP$US$US
243382781$24338278$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA181579$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240919$$HP$US$US
243382791$24338279$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266246$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240919$$MD$US$US
243382801$24338280$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA266838$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$HP$US$US
243382811$24338281$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA265858$SANOFI AVENTIS$$14$YR$T$F$Y$57.7$KG$20240919$$MD$US$US
243382821$24338282$1$I$20240909$20240910$20240919$20240919$PER$$US-SA-2023SA140685$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240919$$HP$US$US
243382831$24338283$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA266870$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240919$$MD$US$US
243382841$24338284$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA267594$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240919$$HP$US$US
243382851$24338285$1$I$20210601$20240911$20240919$20240919$PER$$US-SA-2024SA266826$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240919$$HP$US$US
243382861$24338286$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA267221$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240919$$MD$US$US
243382871$24338287$1$I$$20240911$20240919$20240919$PER$$US-SA-2022SA371303$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240919$$MD$US$US
243382881$24338288$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA265812$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240919$$MD$US$US
243382891$24338289$1$I$20230101$20240913$20240919$20240919$PER$$US-SA-2024SA268680$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240919$$MD$US$US
243382901$24338290$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA268855$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240919$$MD$US$US
243382911$24338291$1$I$20210101$20240911$20240919$20240919$PER$$US-SA-2024SA266899$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240919$$HP$US$US
243382921$24338292$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA266848$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240919$$MD$US$US
243382931$24338293$1$I$20230601$20240913$20240919$20240919$PER$$US-SA-2024SA268361$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240919$$MD$US$US
243382941$24338294$1$I$20240901$20240913$20240919$20240919$PER$$US-SA-2024SA268824$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240919$$HP$US$US
243382951$24338295$1$I$20240914$20240914$20240919$20240919$PER$$US-SA-2024SA269352$SANOFI AVENTIS$$63$YR$A$F$Y$50$KG$20240919$$MD$US$US
243382961$24338296$1$I$20240903$20240912$20240919$20240919$PER$$US-SA-2024SA266796$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240919$$MD$US$US
243382971$24338297$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA071015$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240919$$MD$US$US
243382981$24338298$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA269801$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240919$$MD$US$US
243382991$24338299$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA268654$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240919$$MD$US$US
243383001$24338300$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268705$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240919$$HP$US$US
243383011$24338301$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267602$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240919$$HP$US$US
243383021$24338302$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA268005$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240919$$HP$US$US
243383031$24338303$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA266932$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240919$$HP$US$US
243383041$24338304$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268851$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240919$$HP$US$US
243383051$24338305$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267263$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240919$$HP$US$US
243383071$24338307$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267896$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240919$$HP$US$US
243383081$24338308$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267438$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240919$$MD$US$US
243383091$24338309$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA268998$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240919$$MD$US$US
243383101$24338310$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266225$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240919$$HP$US$US
243383111$24338311$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267365$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240919$$HP$US$US
243383121$24338312$1$I$20240901$20240913$20240919$20240919$PER$$US-SA-2024SA268360$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240919$$CN$US$US
243383131$24338313$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267300$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240919$$HP$US$US
243383141$24338314$1$I$20240827$20240907$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044780$AUROBINDO$$59$YR$$M$Y$75$KG$20240919$$CN$GB$GB
243383161$24338316$1$I$$20240829$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08761$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243383171$24338317$1$I$20231215$20240911$20240919$20240919$EXP$IT-MINISAL02-1001430$IT-AMGEN-ITASP2024181425$AMGEN$$61$YR$A$M$Y$$$20240919$$MD$IT$IT
243383181$24338318$1$I$$20240827$20240919$20240919$EXP$$US-SA-2024SA266740$SANOFI AVENTIS$$$$E$F$Y$$$20240919$$MD$US$US
243383191$24338319$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243655$TEVA$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$59$YR$$F$Y$$$20240919$$MD$US$US
243383201$24338320$1$I$20240701$20240916$20240919$20240919$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-125037$REGENERON$$$$$F$Y$$$20240919$$MD$US$US
243383211$24338321$1$I$20240907$20240914$20240919$20240919$EXP$$CN-JNJFOC-20240938157$JOHNSON AND JOHNSON$$68$YR$E$M$Y$66.5$KG$20240919$$HP$CN$CN
243383221$24338322$1$I$$20240908$20240919$20240919$EXP$$GB-JNJFOC-20240927294$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240919$$HP$GB$GB
243383232$24338323$2$F$20240101$20240913$20240919$20240923$EXP$$US-TEVA-VS-3242592$TEVA$$74$YR$$F$Y$$$20240923$$HP$US$US
243383241$24338324$1$I$20240101$20240910$20240919$20240919$EXP$$US-TEVA-VS-3242851$TEVA$$73$YR$$F$Y$$$20240919$$CN$US$US
243383251$24338325$1$I$20240304$20240909$20240919$20240919$EXP$$CL-ROCHE-10000079354$ROCHE$$57$YR$A$F$Y$$$20240919$$CN$CL$CL
243383261$24338326$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147907$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240919$$MD$US$US
243383271$24338327$1$I$$20240916$20240919$20240919$PER$$US-ABBVIE-5927067$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243383281$24338328$1$I$$20240909$20240919$20240919$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2024US001320$JUBILANT$Claus D, Etter D, Ryder SC. Nuances of gender affirming therapy for transgender women with spinal cord  injury. The Journal of Spinal Cord Medicine. 2024;3:1-3$56$YR$$$Y$$$20240919$$HP$US$US
243383301$24338330$1$I$$20240909$20240919$20240919$EXP$US-MLMSERVICE-20240903-PI177112-00198-1$US-JUBILANT CADISTA PHARMACEUTICALS-2024US001293$JUBILANT$Al-Chalabi M, Martinez Salazar A, Bradshaw A. Fluoroquinolone-Induced Demyelinating Polyneuropathy.. Journal of Clinical Neuromuscular Disease.. 2024;26(1):49-53$60$YR$$M$Y$$$20240919$$MD$US$US
243383311$24338331$1$I$$20240910$20240919$20240919$EXP$JP-MLMSERVICE-20240903-PI179990-00125-1$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP001302$JUBILANT$Hara K, Miura E, Umeda Y, Umeda M, Oyake M, Fujita N.. A case of Parkinson^s disease with marked head drop after administration of donepezil hydrochloride.. Rinsho shinkeigaku = Clinical neurology.. 2024$76$YR$$F$Y$39$KG$20240919$$MD$JP$JP
243383321$24338332$1$I$20230101$20240910$20240919$20240919$EXP$$TR-JUBILANT CADISTA PHARMACEUTICALS-2024TR001300$JUBILANT$Buyukkal U, Temelturk RD, Tekin D.. Acute Dystonic Reaction Following Methylphenidate Discontinuation During Combination Therapy with Risperidone: A Case Study.. Journal of Ankara University Faculty of Medicine. 2024;77(2):222-6$6$YR$$M$Y$$$20240919$$MD$TR$TR
243383332$24338333$2$F$$20240920$20240919$20240930$EXP$$US-MYLANLABS-2024M1084087$MYLAN$Pant P, Grewal DS. Pentosan polysulfate maculopathy-associated cystoid macular edema responsive to intravitreal steroids. Retin-Cases-Brief-Rep 2024; 18 (5): 549-552.$52$YR$$F$Y$$$20240930$$MD$US$US
243383341$24338334$1$I$$20240828$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08775$LUPIN$$$$$M$Y$$$20240919$$PH$US$US
243383351$24338335$1$I$$20240909$20240919$20240919$EXP$$US-MYLANLABS-2024M1083732$MYLAN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.$37$YR$$M$Y$$$20240919$$HP$US$US
243383361$24338336$1$I$$20240909$20240919$20240919$EXP$$US-MYLANLABS-2024M1083679$MYLAN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.$20$YR$$M$Y$$$20240919$$HP$US$US
243383371$24338337$1$I$$20240909$20240919$20240919$EXP$$US-MYLANLABS-2024M1083489$MYLAN$Shukla K, Chaudhari R, Asgharpour A. Spontaneous Hepatic Hemorrhage Causing Acute Liver Failure Requiring Liver Transplant. ACG-Case-Rep-J 2024; 11 1-3.$59$YR$$F$Y$$$20240919$$MD$US$US
243383381$24338338$1$I$$20240909$20240919$20240919$EXP$$PT-MYLANLABS-2024M1084106$MYLAN$Fraga Dias B, Marques R, Faria V, Domingues P, Ribeiro C, Silvano J, et al. Renal Artery Stenosis in Living Donor Kidney Transplantation: A Rare Cause of ^Flash Edema^. Transplant-Proc 2024; 56 (5): 1055-1058.$37$YR$$M$Y$$$20240919$$MD$PT$PT
243383391$24338339$1$I$$20240909$20240919$20240919$EXP$$IN-MYLANLABS-2024M1084089$MYLAN$Shikarwar T, Tiwari V, Bhalla AK. Disseminated histoplasmosis with refractory thrombocytopenia in a renal transplant patient. Transpl-Infect-Dis 2023; 25.$44$YR$$M$Y$$$20240919$$HP$IN$IN
243383401$24338340$1$I$$20240909$20240919$20240919$EXP$$JP-MYLANLABS-2024M1084418$MYLAN$Nakanuma S, Gabata R, Okazaki M, Seki A, Hosokawa K, Yokoyama T, et al. Hemophagocytic Lymphohistiocytosis With Elevated Cytokines Related to Macrophage Activation After Liver Transplantation for Autoimmune Hepatitis: A Case Report. Transplant-Proc 2023; 55 (8): 1946-1950.. 2023;55 (8):1946-1950$24$YR$$F$Y$$$20240919$$HP$JP$JP
243383411$24338341$1$I$$20240916$20240919$20240919$EXP$$NVSC2024CA186048$NOVARTIS$$$$$F$Y$$$20240919$$CN$CA$CA
243383421$24338342$1$I$20240101$20240917$20240919$20240919$EXP$$TR-ABBVIE-5929081$ABBVIE$$22$YR$$F$Y$$$20240919$$MD$TR$TR
243383431$24338343$1$I$$20240916$20240919$20240919$EXP$$CA-Orion Corporation ORION PHARMA-24_00031750$ORION$$$$$M$Y$$$20240919$$HP$CA$
243383441$24338344$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010873$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243383471$24338347$1$I$$20240807$20240919$20240919$PER$$US-ALVOGEN-2024095313$ALVOGEN$$$$$F$Y$$$20240919$$HP$US$US
243383481$24338348$1$I$20230101$20240913$20240919$20240919$EXP$$US-BIOGEN-2024BI01282744$BIOGEN$$$$$F$Y$$$20240919$$CN$US$US
243383491$24338349$1$I$20240401$20240611$20240919$20240919$PER$$US-ALVOGEN-2024094879$ALVOGEN$$70$YR$$M$Y$$$20240919$$CN$US$US
243383511$24338351$1$I$$20240916$20240919$20240919$EXP$IT-MINISAL02-1002471$IT-RDY-SPO/ITA/24/0013554$DR REDDYS$$79$YR$E$F$Y$$$20240919$$MD$IT$IT
243383521$24338352$1$I$$20240607$20240919$20240919$PER$$US-ALVOGEN-2024094845$ALVOGEN$$$$$F$Y$$$20240919$$CN$US$US
243383531$24338353$1$I$$20240913$20240919$20240919$EXP$US-drreddys-SPO/USA/22/0156593$US-RDY-SPO/USA/22/0156593$DR REDDYS$VanDolah H, Crossley JR, Kim HJ. Three Cases of Uncommon Medication- Induced Osteonecrosis of Temporal Bone. Otolaryngology - Head and Neck Surgery. 2022;167(1): P245-P246. doi:10.1177/019459982211076..$69$YR$E$M$Y$$$20240919$$MD$US$US
243383541$24338354$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147831$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240919$$CN$US$US
243383551$24338355$1$I$$20240916$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147997$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$86.18$KG$20240919$$CN$US$US
243383561$24338356$1$I$$20240610$20240919$20240919$PER$$US-ALVOGEN-2024094858$ALVOGEN$$$$$M$Y$$$20240919$$HP$US$US
243383571$24338357$1$I$$20240903$20240919$20240919$PER$$US-TEVA-VS-3240426$TEVA$$40$YR$$F$Y$$$20240919$$CN$US$US
243383581$24338358$1$I$$20240917$20240919$20240919$EXP$$NVSC2024AT186760$NOVARTIS$$$$$F$Y$$$20240919$$MD$AT$AT
243383591$24338359$1$I$$20240624$20240919$20240919$PER$$US-ALVOGEN-2024094969$ALVOGEN$$$$$M$Y$$$20240919$$CN$US$US
243383601$24338360$1$I$$20240909$20240919$20240919$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR115835$VIIV$$$$$$Y$$$20240919$$HP$US$US
243383611$24338361$1$I$$20240913$20240919$20240919$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005151$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240919$$CN$US$US
243383631$24338363$1$I$20240101$20240717$20240919$20240919$PER$$US-ALVOGEN-2024095154$ALVOGEN$$$$$F$Y$$$20240919$$HP$US$US
243383641$24338364$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA269979$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240919$$MD$US$US
243383651$24338365$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA269316$SANOFI AVENTIS$$$$A$M$Y$$$20240919$$HP$US$US
243383661$24338366$1$I$$20240905$20240919$20240919$PER$$US-SA-2024SA270429$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240919$$MD$US$US
243383671$24338367$1$I$20240829$20240829$20240919$20240919$PER$$US-SA-2024SA268132$SANOFI AVENTIS$$51$YR$A$F$Y$121.82$KG$20240919$$MD$US$US
243383681$24338368$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA263409$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240919$$MD$US$US
243383691$24338369$1$I$20240101$20240830$20240919$20240919$PER$$US-SA-2024SA266911$SANOFI AVENTIS$$15$YR$T$F$Y$66.05$KG$20240919$$MD$US$US
243383701$24338370$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA268605$SANOFI AVENTIS$$$$$F$Y$$$20240919$$HP$US$US
243383721$24338372$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266176$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240919$$MD$US$US
243383731$24338373$1$I$20240902$20240905$20240919$20240919$PER$$US-SA-2024SA261098$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240919$$CN$US$US
243383741$24338374$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266235$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240919$$HP$US$US
243383751$24338375$1$I$$20240905$20240919$20240919$PER$$US-SA-2024SA270890$SANOFI AVENTIS$$70$YR$E$$Y$$$20240919$$CN$US$US
243383761$24338376$1$I$20240801$20240910$20240919$20240919$PER$$US-SA-2024SA266061$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240919$$MD$US$US
243383771$24338377$1$I$$20240730$20240919$20240919$PER$$US-ALVOGEN-2024095268$ALVOGEN$$$$$M$Y$$$20240919$$MD$US$US
243383781$24338378$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA266873$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240919$$HP$US$US
243383791$24338379$1$I$20240912$20240913$20240919$20240919$PER$$US-SA-2024SA268281$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240919$$MD$US$US
243383801$24338380$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268541$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240919$$HP$US$US
243383811$24338381$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA269776$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240919$$MD$US$US
243383831$24338383$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268380$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240919$$MD$US$US
243383841$24338384$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA266936$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240919$$HP$US$US
243383851$24338385$1$I$20240912$20240912$20240919$20240919$PER$$US-SA-2024SA266747$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240919$$MD$US$US
243383861$24338386$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA269517$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240919$$HP$US$US
243383871$24338387$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA269797$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240919$$HP$US$US
243383881$24338388$1$I$20240609$20240912$20240919$20240919$PER$$US-SA-2024SA266906$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240919$$HP$US$US
243383891$24338389$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268392$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240919$$MD$US$US
243383901$24338390$1$I$20240101$20240809$20240919$20240919$PER$$US-ALVOGEN-2024095298$ALVOGEN$$$$$F$Y$$$20240919$$HP$US$US
243383911$24338391$1$I$$20240829$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08743$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243383921$24338392$1$I$20240101$20240809$20240919$20240919$PER$$US-ALVOGEN-2024095118$ALVOGEN$$$$$F$Y$$$20240919$$HP$US$US
243383931$24338393$1$I$20240509$20240912$20240919$20240919$EXP$FR-AFSSAPS-AVMA2024000388$FR-CHEPLA-2024011801$CHEPLAPHARM$$22$YR$$M$Y$$$20240919$$PH$COUNTRY NOT SPECIFIED$FR
243383941$24338394$1$I$$20240905$20240919$20240919$PER$$US-SERVIER-S24011834$SERVIER$$$$$$Y$$$20240919$$MD$US$US
243383951$24338395$1$I$$20240917$20240919$20240919$PER$$US-HALEON-2197415$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243383961$24338396$1$I$20240826$20240826$20240919$20240919$PER$$US-009507513-2408USA008875$MERCK$$77$YR$$$Y$92.517$KG$20240919$$CN$US$US
243383971$24338397$1$I$20240825$20240913$20240919$20240919$EXP$FR-AFSSAPS-BR2024000705$FR-TEVA-VS-3243647$TEVA$$64$YR$$F$Y$66$KG$20240919$$MD$FR$FR
243384001$24338400$1$I$20240801$20240830$20240919$20240919$PER$$US-ALVOGEN-2024095439$ALVOGEN$$$$$M$Y$$$20240919$$HP$US$US
243384011$24338401$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185905$AMGEN$$$$A$F$Y$$$20240919$$CN$US$US
243384021$24338402$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011873$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240919$$CN$US$US
243384031$24338403$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010891$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240919$$CN$US$US
243384041$24338404$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011783$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240919$$CN$US$US
243384051$24338405$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010875$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240919$$CN$US$US
243384061$24338406$1$I$$20240912$20240919$20240919$EXP$$BE-AUROBINDO-AUR-APL-2024-045838$AUROBINDO$Velazquez-Armenta E, Han J, Choi J, Yang K, Nava-Ocampo A.. Angiotensin II receptor blockers in pregnancy: A case report and systematic review of the literature. HYPERTENSION IN PREGNANCY. 2007;26(1)::51-66.$1$DY$$F$Y$2.2$KG$20240919$$MD$BE$BE
243384071$24338407$1$I$20240704$20240705$20240919$20240919$PER$$US-ALVOGEN-2024095050$ALVOGEN$$$$$M$Y$$$20240919$$HP$US$US
243384081$24338408$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010611$ELI LILLY AND CO$$63$YR$A$$Y$$$20240919$$CN$US$US
243384091$24338409$1$I$20240725$20240917$20240919$20240919$EXP$$CA-ABBVIE-5929085$ABBVIE$$82$YR$$M$Y$$$20240919$$CN$CA$CA
243384101$24338410$1$I$$20240911$20240919$20240919$EXP$$US-ROCHE-10000080093$ROCHE$$28$YR$A$F$Y$$$20240919$$CN$US$US
243384111$24338411$1$I$20240830$20240830$20240919$20240919$PER$$US-SA-2024SA269053$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240919$$PH$US$US
243384121$24338412$1$I$$20240906$20240919$20240919$EXP$$BE-CELLTRION INC.-2024BE022223$CELLTRION$De Melo E Sousa JA. An unusual presentation of TAFRO syndrome.. Polish Archives of Internal Medicine.. 2023;(1):6:133$$$$$Y$$$20240919$$MD$BE$BE
243384131$24338413$1$I$20240901$20240913$20240919$20240919$PER$$US-SA-2024SA268771$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240919$$MD$US$US
243384141$24338414$1$I$$20240828$20240919$20240919$PER$$US-SA-2024SA267512$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
243384151$24338415$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA266804$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240919$$PH$US$US
243384161$24338416$1$I$20240101$20240913$20240919$20240919$EXP$$US-ABBVIE-5925518$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243384171$24338417$1$I$$20240917$20240919$20240919$PER$$US-ROCHE-10000085034$ROCHE$$8$YR$C$M$Y$$$20240919$$HP$US$US
243384181$24338418$1$I$$20240910$20240919$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147187$BRISTOL MYERS SQUIBB$Nishihara K, Aoki E, Sasaki N, Yamamoto S, Fujisawa Y, Matsushita S. A case of cytokine release syndrome induced by nivolumab + ipilimumab combination therapy for primary rectal melanoma. The 76th Annual Meeting of the Western Division of JDA Association Program and Abstracts. 2024;135$77$YR$E$F$Y$$$20240919$$MD$JP$JP
243384191$24338419$1$I$$20240909$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143684$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240919$$CN$US$US
243384201$24338420$1$I$$20240918$20240919$20240919$PER$$NVSC2024US187063$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243384211$24338421$1$I$20240813$20240911$20240919$20240919$EXP$FR-AFSSAPS-MP2024001369$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-08584$HIKMA$$17$YR$$F$Y$$$20240919$$MD$FR$FR
243384221$24338422$1$I$20240505$20240910$20240919$20240919$EXP$$NVSC2024BR176869$NOVARTIS$$41$YR$$M$Y$98$KG$20240919$$MD$BR$BR
243384231$24338423$1$I$$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185378$AMGEN$$$$$$Y$$$20240919$$HP$US$US
243384241$24338424$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010889$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243384251$24338425$1$I$20240910$20240911$20240919$20240919$PER$$US-ABBVIE-5923289$ABBVIE$$41$YR$$$Y$$$20240919$$HP$US$US
243384281$24338428$1$I$$20240916$20240919$20240919$EXP$$GR-MYLANLABS-2024M1080679$MYLAN$$72$YR$$F$Y$$$20240919$$CN$GR$GR
243384302$24338430$2$F$$20240920$20240919$20240927$EXP$$GB-MYLANLABS-2024M1084888$MYLAN$$$$$F$Y$$$20240927$$PH$GB$GB
243384311$24338431$1$I$20240601$20240909$20240919$20240919$EXP$FR-AFSSAPS-AN2024001209$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112104$ZYDUS PHARM$$$$$$Y$$$20240919$$MD$FR$FR
243384321$24338432$1$I$20240901$20240912$20240919$20240919$EXP$$NVSC2024DE186532$NOVARTIS$$$$A$F$Y$$$20240919$$CN$DE$DE
243384331$24338433$1$I$$20240911$20240919$20240919$EXP$$NVSC2024CA184316$NOVARTIS$$69$YR$$M$Y$$$20240919$$CN$CA$CA
243384341$24338434$1$I$20240101$20240911$20240919$20240919$PER$$US-ABBVIE-5920482$ABBVIE$$$$$M$Y$72$KG$20240919$$CN$US$US
243384351$24338435$1$I$$20240910$20240919$20240919$EXP$$NVSC2024CN184034$NOVARTIS$Zhao K, Liu Y, Gao W, Cai J. Early severe neurological complications after pediatric liver transplantation: a report of 15 patients. CHIN J HEPATOBILIARY SURG. 2020;26 (11):812-5$18$MON$$$Y$$$20240919$$HP$CN$CN
243384361$24338436$1$I$20240830$20240905$20240919$20240919$EXP$$US-UCBSA-2024045759$UCB$$55$YR$$F$Y$$$20240919$$CN$US$US
243384371$24338437$1$I$$20240910$20240919$20240919$EXP$$NVSC2024CN184026$NOVARTIS$Zhao K, Liu Y, Gao W, Cai J. Early severe neurological complications after pediatric  liver transplantation: a report of 15 patients. CHIN J HEPATOBILIARY SURG. 2020;26(11):812-5$45$MON$$$Y$$$20240919$$HP$CN$CN
243384382$24338438$2$F$$20240911$20240919$20240924$EXP$$NVSC2024IT183112$NOVARTIS$$$$$$Y$$$20240924$$MD$IT$IT
243384391$24338439$1$I$$20240916$20240919$20240919$EXP$$NVSC2024US077246$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
243384401$24338440$1$I$20240101$20240916$20240919$20240919$EXP$$NVSC2024CR186538$NOVARTIS$$$$$M$Y$$$20240919$$CN$CR$CR
243384411$24338441$1$I$20240821$20240916$20240919$20240919$EXP$$NVSC2024US178030$NOVARTIS$$75$YR$$F$Y$58.9$KG$20240919$$MD$US$US
243384421$24338442$1$I$$20240910$20240919$20240919$EXP$$NVSC2024ES184772$NOVARTIS$Copete S, Garcia-Garcia JG, Judez E. Dexamethasone intravitreal implant in the treatment of macular edema secondary to necrotizing retinitis.. EUROPEAN JOURNAL OF OPHTHALMOLOGY. 2024;1-5$68$YR$$F$Y$$$20240919$$HP$ES$ES
243384432$24338443$2$F$$20240917$20240919$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-029002$UNITED THERAPEUTICS$$$$$M$Y$77.098$KG$20240925$$$US$US
243384442$24338444$2$F$20231016$20240910$20240919$20240920$EXP$$NVSC2024CH184008$NOVARTIS$$65$YR$$F$Y$95$KG$20240920$$CN$CH$CH
243384451$24338445$1$I$$20240911$20240919$20240919$EXP$$NVSC2024US185584$NOVARTIS$$56$YR$$F$Y$$$20240919$$MD$US$US
243384461$24338446$1$I$$20240910$20240919$20240919$EXP$$NVSC2024CA094429$NOVARTIS$$5$DEC$$F$Y$$$20240919$$CN$CA$CA
243384471$24338447$1$I$20240701$20240915$20240919$20240919$EXP$$NVSJ2024JP010991$NOVARTIS$$76$YR$$M$Y$$$20240919$$MD$JP$JP
243384481$24338448$1$I$20230701$20240908$20240919$20240919$EXP$GB-MHRA-MED-202409082049593860-LVBDS$GB-TORRENT-00037909$TORRENT$$8$YR$C$M$Y$28$KG$20240919$$CN$GB$GB
243384494$24338449$4$F$20240328$20240920$20240919$20240930$EXP$DE-CADRBFARM-2024330314$DE-TORRENT-00027301$TORRENT$$71$YR$E$M$Y$76$KG$20240930$$CN$DE$DE
243384501$24338450$1$I$20240306$20240912$20240919$20240919$EXP$$NVSC2024IT069879$NOVARTIS$$$$E$F$Y$46.2$KG$20240919$$MD$IT$IT
243384511$24338451$1$I$$20240912$20240919$20240919$EXP$$CA-BIOGEN-2024BI01282672$BIOGEN$$$$$F$Y$$$20240919$$CN$CA$CA
243384521$24338452$1$I$$20240909$20240919$20240919$EXP$GB-MHRA-EMIS-4466-98ea284f-a476-4633-98b6-f958c5430d73$GB-TORRENT-00037945$TORRENT$$84$YR$E$F$Y$55$KG$20240919$$MD$GB$GB
243384531$24338453$1$I$$20240909$20240919$20240919$EXP$$US-TORRENT-00013747$TORRENT$$60$YR$A$M$Y$$$20240919$$MD$US$US
243384542$24338454$2$F$20230301$20240913$20240919$20240925$EXP$$NVSC2024FR184534$NOVARTIS$Albert M, Burlet S, Pistre P, Lepage C, Boulin M. Traitement Par Therapie Ciblee Dune Malade Atteinte Dune Tumeur Neuroendocrine Pancreatique - Treatment With Targeted Therapy Of A Patient With A Relapsed Pancreatic Neuroendocrine Tumor. DOSSIER DU CNHIM. 2024;XLV (4):103-9$70$YR$$F$Y$106$KG$20240925$$HP$FR$FR
243384572$24338457$2$F$20240813$20240912$20240919$20240923$PER$$US-JNJFOC-20240933657$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240923$$CN$US$US
243384581$24338458$1$I$20240522$20240912$20240919$20240919$PER$$US-AMGEN-USASP2024183349$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243384591$24338459$1$I$$20240912$20240919$20240919$EXP$$CN-AMGEN-CHNSP2024183408$AMGEN$Wu D.; Lu J.; Qiu H. et al.. Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial. Journal of Hematology + Oncology. 2024;17 (1):1-5$$$$$Y$$$20240919$$HP$CN$CN
243384601$24338460$1$I$$20240910$20240919$20240919$EXP$$NVSC2024CA181536$NOVARTIS$$63$YR$$M$Y$61$KG$20240919$$HP$CA$CA
243384611$24338461$1$I$$20240911$20240919$20240919$PER$$DE-REGENERON PHARMACEUTICALS, INC.-2024-125506$REGENERON$$$$$$Y$$$20240919$$MD$DE$DE
243384621$24338462$1$I$20240905$20240906$20240919$20240919$EXP$$US-SA-2024SA270668$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240919$$MD$US$US
243384631$24338463$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010890$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243384641$24338464$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267650$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240919$$HP$US$US
243384651$24338465$1$I$20240614$20240802$20240919$20240919$EXP$$IT-TEVA-VS-3237940$TEVA$$46$YR$$F$Y$59$KG$20240919$$MD$IT$IT
243384661$24338466$1$I$20240819$20240820$20240919$20240919$PER$$US-SA-2024SA267230$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240919$$CN$US$US
243384672$24338467$2$F$20240601$20240913$20240919$20240927$PER$$US-SA-2024SA269994$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240927$$MD$US$US
243384681$24338468$1$I$$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024186684$AMGEN$$$$A$M$Y$$$20240919$$CN$US$US
243384701$24338470$1$I$20190611$20240909$20240919$20240919$EXP$$AU-TAKEDA-2024TUS092591$TAKEDA$$52$YR$$F$Y$$$20240919$$MD$AU$AU
243384711$24338471$1$I$$20240905$20240919$20240919$EXP$$US-ADVANZ PHARMA-202409007379$ADVANZ PHARMA$$$$$$Y$$$20240919$$HP$US$US
243384721$24338472$1$I$$20240908$20240919$20240919$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08446$HIKMA$Avra T, Torres J, Vasudevan KF, Samuels EA. Avra T, Torres J, Vasudevan KF, Samuels EA. ^K cramps,^ recurrent abdominal pain in a patient with chronic ketamine use: A case report. Clinical Practice and Cases in Emergency Medicine. 2024;8(3):1-6$31$YR$$M$Y$$$20240919$$MD$US$US
243384731$24338473$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010874$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243384741$24338474$1$I$$20240905$20240919$20240919$EXP$GB-MHRA-MED-202409051453393970-JDWLQ$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-08456$HIKMA$$$$A$F$Y$$$20240919$$PH$GB$GB
243384751$24338475$1$I$20240906$20240907$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044777$AUROBINDO$$21$YR$$F$Y$$$20240919$$CN$GB$GB
243384761$24338476$1$I$$20240910$20240919$20240919$EXP$$CA-ROCHE-10000084962$ROCHE$$65$YR$E$F$Y$$$20240919$$HP$CA$CA
243384771$24338477$1$I$20160823$20240912$20240919$20240919$EXP$$US-TAKEDA-US201611275$TAKEDA$$58$YR$$F$Y$74.83$KG$20240919$$CN$US$US
243384781$24338478$1$I$20240902$20240910$20240919$20240919$EXP$$US-BAYER-2024A130608$BAYER$$40$YR$A$F$Y$130.16$KG$20240919$$CN$US$US
243384801$24338480$1$I$20240902$20240916$20240918$20240918$DIR$FDA-CDER-CTU-2024-64149$$FDA-CTU$$50$YR$$M$N$$$20240916$N$HP$US$
243384811$24338481$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64189$$FDA-CTU$$53$YR$$F$N$246$LBS$20240918$N$$US$
243384821$24338482$1$I$20240917$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64211$$FDA-CTU$$57$YR$$M$N$$$20240917$N$$US$
243384851$24338485$1$I$20130107$20240916$20240919$20240919$EXP$GB-MHRA-MED-202409151424039420-YTVZK$GB-ABBVIE-5929000$ABBVIE$$30$YR$$M$Y$$$20240919$$CN$GB$GB
243384871$24338487$1$I$20240701$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147639$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$68.49$KG$20240919$$CN$US$US
243384881$24338488$1$I$20240101$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148629$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$78.7$KG$20240919$$PH$US$US
243384891$24338489$1$I$20240911$20240916$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147386$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240919$$HP$US$US
243384901$24338490$1$I$$20240906$20240919$20240919$EXP$$GB-AUROBINDO-AUR-APL-2024-044697$AUROBINDO$$88$YR$$$Y$$$20240919$$PH$GB$GB
243384911$24338491$1$I$$20240910$20240919$20240919$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP011702$STRIDES$Zhong B, Zhang T, Dong Y, Yin W, Zhang J-X and Jin W-D.. Case report: A case with atypical presentation of testicular choriocarcinoma. Frontiers in Oncology. 2024;14:1223873$29$YR$$M$Y$$$20240919$$HP$CN$CN
243384921$24338492$1$I$20240509$20240916$20240919$20240919$EXP$GB-MHRA-TPP13367089C8456410YC1715258564975$GB-STRIDES ARCOLAB LIMITED-2024SP012041$STRIDES$$85$YR$$F$Y$$$20240919$$MD$GB$GB
243384931$24338493$1$I$20240725$20240909$20240919$20240919$EXP$GB-MHRA-MED-202409072058056690-YJFKV$GB-ROCHE-10000076900$ROCHE$$85$YR$E$F$Y$$$20240919$$CN$GB$GB
243384951$24338495$1$I$$20240906$20240919$20240919$EXP$$US-AUROBINDO-AUR-APL-2024-044733$AUROBINDO$Pacholec M, Sami F, Newell K, el Atrouni W. Fatal disseminated Mycobacterium haemophilum infection involving the central nervous system in a renal transplant recipient. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2020;21:100197$65$YR$$M$Y$$$20240919$$MD$US$US
243384962$24338496$2$F$20240910$20240912$20240919$20240925$PER$$US-SA-2024SA270243$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240925$$MD$US$US
243384971$24338497$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA268233$SANOFI AVENTIS$$$$A$F$Y$113.38$KG$20240919$$MD$US$US
243384981$24338498$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA268205$SANOFI AVENTIS$$$$E$F$Y$69.09$KG$20240919$$MD$US$US
243384991$24338499$1$I$20240901$20240913$20240919$20240919$PER$$US-SA-2024SA268770$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240919$$MD$US$US
243385001$24338500$1$I$20240828$20240829$20240919$20240919$PER$$US-SA-2024SA266951$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240919$$CN$US$US
243385011$24338501$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA269001$SANOFI AVENTIS$$$$E$F$Y$$$20240919$$MD$US$US
243385021$24338502$1$I$$20240905$20240919$20240919$PER$$US-SA-2024SA269496$SANOFI AVENTIS$$$$A$M$Y$$$20240919$$CN$US$US
243385031$24338503$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA265912$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240919$$HP$US$US
243385041$24338504$1$I$$20240909$20240919$20240919$EXP$$ES-ROCHE-10000079558$ROCHE$$$$$$Y$$$20240919$$MD$ES$ES
243385051$24338505$1$I$$20240916$20240919$20240919$EXP$$IL-ADIENNEP-2024AD000744$ADIENNE PHARMA + BIOTECH$Shadur B, NasserEddin A, Zaidman I, Schejter YD, Even-Or E, Berkun Y et al. Successful Haematopoietic Stem Cell Transplantation for LRBA Deficiency with Fludarabine, Treosulfan, and Thiotepa-Based Conditioning. J Clin Immunol. 2024 Sep 12;45(1):3. doi: 10.1007/s10875-024-01770-1.$17$YR$$M$Y$$$20240917$$MD$IL$
243385061$24338506$1$I$20240908$20240911$20240919$20240919$EXP$$US-ROCHE-10000080707$ROCHE$$77$YR$E$M$Y$$$20240919$$CN$US$US
243385071$24338507$1$I$20240915$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024184842$AMGEN$$69$YR$E$M$Y$$$20240919$$CN$US$US
243385081$24338508$1$I$20240915$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024184794$AMGEN$$65$YR$E$F$Y$$$20240919$$CN$US$US
243385091$24338509$1$I$$20240913$20240919$20240919$EXP$$US-AMGEN-USASP2024184248$AMGEN$Hoang T.D.; Flor R.J.; De La Torre S. et al.. Effects of teprotumumab and role of HLA markers in patients with thyroid eye disease. American Association Of Clinical Endocrinologists. 2024;1-36$$$$$Y$$$20240919$$MD$US$US
243385101$24338510$1$I$$20240916$20240919$20240919$EXP$$AU-SANDOZ INC.-SDZ2024AU080716$SANDOZ$$35$YR$$F$Y$$$20240919$$MD$AU$AU
243385113$24338511$3$F$$20240919$20240919$20240930$EXP$GB-MLMSERVICE-20240814-PI162505-00306-1$GB-STRIDES ARCOLAB LIMITED-2024SP012045$STRIDES$Farrugia L, Baston V, Burfield L, Melly L, Borman AM, Bal AM.. Cutaneous Purpureocillium lilacinum and Fusarium coinfection in a heart transplant recipient.. Medical Mycology Case Reports. 2024;45:1-4$63$YR$$M$Y$$$20240930$$MD$GB$GB
243385131$24338513$1$I$$20240830$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08769$LUPIN$$$$$$Y$$$20240919$$PH$US$US
243385141$24338514$1$I$$20240916$20240919$20240919$EXP$$IL-ADIENNEP-2024AD000745$ADIENNE PHARMA + BIOTECH$Shadur B, NasserEddin A, Zaidman I, Schejter YD, Even-Or E, Berkun Y et al. Successful Haematopoietic Stem Cell Transplantation for LRBA Deficiency with Fludarabine, Treosulfan, and Thiotepa-Based Conditioning. J Clin Immunol. 2024 Sep 12;45(1):3. doi: 10.1007/s10875-024-01770-1.$$$A$M$Y$$$20240917$$MD$IL$
243385151$24338515$1$I$$20240910$20240919$20240919$EXP$$ES-STRIDES ARCOLAB LIMITED-2024SP011882$STRIDES$Chovi-Trull M, Ballesta-Lopez O, Navarro Buendia GA, Sivera-Mascaro R, Albert-Mari A, Ruiz Caldes MJ, et al.. Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.. Eur-J-Hosp-Pharm. 2024$53$YR$$M$Y$$$20240919$$MD$ES$ES
243385161$24338516$1$I$20240101$20240912$20240919$20240919$EXP$$US-BIOGEN-2024BI01282549$BIOGEN$$$$$M$Y$$$20240919$$CN$US$US
243385172$24338517$2$F$20240101$20240913$20240919$20240927$EXP$$US-TEVA-VS-3244092$TEVA$$66$YR$$F$Y$$$20240927$$CN$US$US
243385191$24338519$1$I$$20240912$20240919$20240919$EXP$$DE-STRIDES ARCOLAB LIMITED-2024SP012085$STRIDES$Metzner B, Muller TH, Casper J, Kimmich C, Kohne C-H, Petershofen E, et al.. Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.. Eur-J-Haematol. 2023;111 (2):220-228$$$$M$Y$$$20240919$$MD$DE$DE
243385201$24338520$1$I$20240811$20240827$20240919$20240919$30DAY$$BR-JNJFOC-20240881861$JOHNSON AND JOHNSON$$28$YR$A$F$Y$80$KG$20240919$$CN$BR$BR
243385211$24338521$1$I$20240628$20240917$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148937$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240919$$CN$US$US
243385221$24338522$1$I$$20240910$20240919$20240919$EXP$$US-862174955-ML2024-04927$Unknown Manufacturer$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2023 Nov 29;101(102625): 1-6. doi:10.1016/j.jflm.2023.102625.$61$YR$A$$Y$$$20240919$$HP$US$US
243385231$24338523$1$I$$20240912$20240919$20240919$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-127903$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$47$KG$20240919$$MD$JP$JP
243385242$24338524$2$F$$20240920$20240919$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148796$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240925$$CN$US$US
243385251$24338525$1$I$$20240912$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146383$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240919$$HP$US$US
243385261$24338526$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148519$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240919$$CN$US$US
243385271$24338527$1$I$$20240917$20240919$20240919$EXP$PL-EMA-20150312-AUTODUP-377798$PL-ROCHE-10000075826$ROCHE$Basak G, Wiktor-Jedrzejczak W, Labopin M, Schoeman H, Ljungman P, Kobbe G. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. American journal of transplantation. 2015;1-10.$39$YR$A$M$Y$$$20240919$$HP$PL$PL
243385301$24338530$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148491$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240919$$CN$US$US
243385311$24338531$1$I$$20240916$20240919$20240919$EXP$$IL-ADIENNEP-2024AD000746$ADIENNE PHARMA + BIOTECH$Shadur B, NasserEddin A, Zaidman I, Schejter YD, Even-Or E, Berkun Y et al. Successful Haematopoietic Stem Cell Transplantation for LRBA Deficiency with Fludarabine, Treosulfan, and Thiotepa-Based Conditioning. J Clin Immunol. 2024 Sep 12;45(1):3. doi: 10.1007/s10875-024-01770-1.$$$C$M$Y$$$20240917$$MD$IL$
243385321$24338532$1$I$$20240910$20240919$20240919$EXP$$CL-STRIDES ARCOLAB LIMITED-2024SP011963$STRIDES$Folatre I, Kyonen M, Schnettler D, Yilorm M, Monzon P, Martinez P, et al.. Pseudohiponatremia secondary to hypertriglyceridemia during the treatment of lymphoblastic lymphoma with corticoids and L-asparaginase.. Andes-Pediatr. 2024;95 (4):442-448$14$YR$$M$Y$$$20240919$$HP$CL$CL
243385362$24338536$2$F$20240101$20240925$20240919$20240927$EXP$$AU-UCBSA-2024047699$UCB$$$$$F$Y$22$KG$20240927$$CN$AU$AU
243385371$24338537$1$I$20240910$20240911$20240919$20240919$EXP$$GB-TEVA-VS-3244090$TEVA$$30$YR$$M$Y$$$20240919$$CN$GB$GB
243385381$24338538$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010873$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240919$$CN$US$US
243385391$24338539$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009717$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240919$$CN$US$US
243385401$24338540$1$I$20240909$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010144$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240919$$CN$US$US
243385411$24338541$1$I$20240917$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010941$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240919$$CN$US$US
243385421$24338542$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010932$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240919$$CN$US$US
243385432$24338543$2$F$$20240920$20240919$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409010878$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240927$$CN$US$US
243385441$24338544$1$I$20240701$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010821$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240919$$CN$US$US
243385451$24338545$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011652$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240919$$CN$US$US
243385461$24338546$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010664$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240919$$CN$US$US
243385471$24338547$1$I$20240916$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010076$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240919$$CN$US$US
243385481$24338548$1$I$20240907$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010787$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240919$$CN$US$US
243385491$24338549$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011043$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240919$$CN$US$US
243385501$24338550$1$I$20240401$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011220$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240919$$CN$US$US
243385511$24338551$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010550$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240919$$CN$US$US
243385521$24338552$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010275$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240919$$CN$US$US
243385532$24338553$2$F$20240915$20240924$20240919$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409009931$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240925$$CN$US$US
243385541$24338554$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011055$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240919$$CN$US$US
243385551$24338555$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010975$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243385561$24338556$1$I$20240801$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010132$ELI LILLY AND CO$$71$YR$E$$Y$$$20240919$$CN$US$US
243385571$24338557$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010749$ELI LILLY AND CO$$$$A$M$Y$$$20240919$$CN$US$US
243385581$24338558$1$I$$20240911$20240919$20240919$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP011900$STRIDES$Kim HM, Lee J, Kim S, Lee JW, Kim H-J, Cho Y-S.. Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease.. Blood-Res. 2023;58 (3):145-148$48$YR$$F$Y$$$20240919$$HP$KR$KR
243385591$24338559$1$I$20240617$20240911$20240919$20240919$EXP$$EG-HIKMA PHARMACEUTICALS USA INC.-EG-H14001-24-08511$HIKMA$$55$YR$$F$Y$74$KG$20240919$$HP$EG$EG
243385601$24338560$1$I$$20240830$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08812$LUPIN$$$$$$Y$$$20240919$$PH$US$US
243385611$24338561$1$I$$20240911$20240919$20240919$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP011968$STRIDES$Rezende RC, Oliveira IC, de CarvalhoDSL, Andrade GB, de Jesus TeixeiraABM, de AraujoWM, et al.. Severe hypercalcemia caused by repeated mineral oil injections: a case report.. Arch-Endocrinol-Metab. 2023;67 (3):450-455$27$YR$$M$Y$$$20240919$$HP$BR$BR
243385621$24338562$1$I$$20240828$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08652$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243385641$24338564$1$I$$20240911$20240919$20240919$EXP$$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-08596$HIKMA$$34$YR$$M$Y$$$20240919$$PH$GB$GB
243385651$24338565$1$I$$20240917$20240919$20240919$PER$$US-ROCHE-10000085044$ROCHE$$61$YR$A$M$Y$$$20240919$$HP$US$US
243385661$24338566$1$I$20240820$20240912$20240919$20240919$EXP$i2410003713$JP-MYLANLABS-2024M1083180$MYLAN$$64$YR$$F$Y$79.2$KG$20240919$$PH$JP$JP
243385671$24338567$1$I$$20240911$20240919$20240919$PER$$US-EMD Serono-2024048950$EMD SERONO INC$$$$$F$Y$$$20240919$$CN$US$US
243385681$24338568$1$I$$20240909$20240919$20240919$EXP$$CA-ROCHE-10000084944$ROCHE$$65$YR$E$F$Y$34$KG$20240919$$MD$CA$CA
243385691$24338569$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267167$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240919$$HP$US$US
243385701$24338570$1$I$20240806$20240909$20240919$20240919$30DAY$$US-GSK-US2024111918$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243385711$24338571$1$I$$20240918$20240919$20240919$EXP$$AU-SANDOZ INC.-SDZ2024AU081237$SANDOZ$$$$$$Y$$$20240919$$HP$AU$AU
243385721$24338572$1$I$$20240906$20240919$20240919$EXP$$US-SA-2024SA269969$SANOFI AVENTIS$$53$YR$A$F$Y$84.09$KG$20240919$$MD$US$US
243385731$24338573$1$I$$20240911$20240919$20240919$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP012018$STRIDES$Yoshii R, Kajiwara K, Uemura N, Matsushita K, Nakamura T, Tomita M, et al.. The successful treatment of microscopic polyangiitis associated with non-tuberculous mycobacterial-pulmonary disease.. CEN-Case-Rep. 2024;13 (4):271-276$72$YR$$M$Y$$$20240919$$HP$JP$JP
243385741$24338574$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64168$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243385751$24338575$1$I$20240917$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64186$$FDA-CTU$$57$YR$$M$N$$$20240918$N$HP$US$
243385762$24338576$2$F$$20240920$20240919$20240920$EXP$$BR-BAYER-2024A133717$BAYER$$$$$F$Y$$$20240920$$CN$BR$BR
243385771$24338577$1$I$20240916$20240917$20240919$20240919$PER$$US-HALEON-2197327$Haleon PLC$$62$YR$$F$Y$$$20240919$$CN$US$US
243385781$24338578$1$I$$20240912$20240919$20240919$EXP$$MX-STRIDES ARCOLAB LIMITED-2024SP011870$STRIDES$Baquero-Ospina P, Cantu-Rosales C, Concha-Del-Rio LE.. OOD SYNDROME: CYTOMEGALOVIRUS RETINITIS CASE CHALLENGE.. Retin-Cases-Brief-Rep. 2024;18 (1):112-115.$71$YR$$F$Y$$$20240919$$MD$MX$MX
243385791$24338579$1$I$$20240822$20240919$20240919$30DAY$$US-VEROBIOTECH-2024USVEROSPO00224$VERO BIOTECH$$$$$$Y$$$20240919$$HP$US$US
243385801$24338580$1$I$$20240913$20240919$20240919$EXP$$KR-STRIDES ARCOLAB LIMITED-2024SP011987$STRIDES$Seong EY, Kim DW, Kim HJ, Rhee H, Song SH.. Incomplete distal renal tubular acidosis uncovered during pregnancy: A case report. World Journal of Clinical Cases. 2023;11(25):5988-5993$$$$$Y$$$20240919$$MD$KR$KR
243385811$24338581$1$I$$20240910$20240919$20240919$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005065$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240919$$HP$US$US
243385821$24338582$1$I$20200101$20240912$20240919$20240919$EXP$$TW-STRIDES ARCOLAB LIMITED-2024SP011919$STRIDES$Wang Q-A, Chan T-M.. Case report: Management of Epstein-Barr virus positive and methotrexate-associated B-cell lymphoma.. Int-J-Rheum-Diseases. 2024;27 (3)$68$YR$$M$Y$$$20240919$$HP$TW$TW
243385831$24338583$1$I$$20240911$20240919$20240919$EXP$NL-LRB-01000599$NL-TEVA-VS-3243194$TEVA$$62$YR$$F$Y$71$KG$20240919$$CN$NL$NL
243385841$24338584$1$I$20240916$20240917$20240919$20240919$PER$$US-BIOGEN-2024BI01282977$BIOGEN$$34$YR$$F$Y$$$20240919$$CN$US$US
243385861$24338586$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64234$$FDA-CTU$$36$YR$$F$N$90.72$KG$20240918$N$$US$
243385881$24338588$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149024$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240919$$MD$US$US
243385891$24338589$1$I$20240801$20240916$20240919$20240919$EXP$$DE-SANDOZ INC.-SDZ2024DE081054$SANDOZ$$$$A$F$Y$$$20240919$$MD$DE$DE
243385901$24338590$1$I$20240528$20240916$20240919$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US055251$SANDOZ$$7$YR$$$Y$$$20240919$$HP$US$US
243385911$24338591$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64225$$FDA-CTU$$$$$F$N$$$20240918$N$HP$US$
243385921$24338592$1$I$$20240913$20240919$20240919$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP011989$STRIDES$Gunes EC, Tekgoz E, Colak S, Ustunel G, Cinar M, Yilmaz S.. THE MORTALITY OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASE: RESULTS OF LONG-TERM FOLLOW-UP.. Eur-J-Case-Rep-Intern-Med. 2024;11(Suppl.1):107 abstr. 2753.$64$YR$$F$Y$$$20240919$$HP$TR$TR
243385931$24338593$1$I$20240801$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64158$$FDA-CTU$$65$YR$$M$N$$$20240918$N$HP$US$
243385941$24338594$1$I$$20240913$20240919$20240919$EXP$$US-CHEPLA-2024011852$CHEPLAPHARM$$66$YR$$M$Y$$$20240919$$CN$COUNTRY NOT SPECIFIED$US
243385951$24338595$1$I$20040101$20240909$20240919$20240919$EXP$FR-AFSSAPS-MP2024001359$FR-STRIDES PHARMA UK LTD.-2024SP011591$STRIDES$$50$YR$$F$Y$72$KG$20240919$$HP$FR$FR
243385961$24338596$1$I$20240414$20240912$20240919$20240919$EXP$$AR-GSK-AR2024AMR061594$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$AR$AR
243385971$24338597$1$I$$20240909$20240919$20240919$30DAY$$US-GSK-US2024112011$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243385981$24338598$1$I$$20240910$20240919$20240919$EXP$$US-GSK-US2024112439$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243385991$24338599$1$I$$20240909$20240919$20240919$30DAY$$US-GSK-US2024111934$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243386001$24338600$1$I$$20240913$20240919$20240919$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP011990$STRIDES$Gunes EC, Tekgoz E, Colak S, Ustunel G, Cinar M, Yilmaz S.. THE MORTALITY OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASE: RESULTS OF LONG-TERM FOLLOW-UP.. Eur-J-Case-Rep-Intern-Med. 2024;11 (Suppl. 1):1074 abstr. 2753.$57$YR$$M$Y$$$20240919$$HP$TR$TR
243386011$24338601$1$I$20240614$20240912$20240919$20240919$EXP$$JP-MYLANLABS-2024M1083484$MYLAN$$63$YR$$F$Y$58$KG$20240919$$PH$JP$JP
243386021$24338602$1$I$20240319$20240912$20240919$20240919$EXP$$JP-MYE-2024M1083478AA$MYLAN$$73$YR$$F$Y$46.3$KG$20240919$$PH$JP$JP
243386031$24338603$1$I$20240814$20240914$20240919$20240919$EXP$$NVSC2024CN186231$NOVARTIS$$33$YR$$M$Y$65$KG$20240919$$HP$CN$CN
243386051$24338605$1$I$$20240916$20240919$20240919$EXP$$NVSC2024US185747$NOVARTIS$$70$YR$$F$Y$100.23$KG$20240919$$CN$US$US
243386071$24338607$1$I$20240116$20240904$20240919$20240919$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468515$RANBAXY$$93$YR$$F$Y$54.8$KG$20240919$$PH$FR$FR
243386082$24338608$2$F$20240908$20240911$20240919$20240920$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03329$AMNEAL$$$$$F$Y$$$20240920$$CN$US$US
243386091$24338609$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010934$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243386101$24338610$1$I$$20240917$20240919$20240919$PER$$US-HALEON-2197311$Haleon PLC$$62$YR$$F$Y$$$20240919$$CN$US$US
243386111$24338611$1$I$$20240822$20240919$20240919$30DAY$$CA-Kaleo, Inc.-2024KL000040$KALEO$$$$$F$Y$$$20240918$$CN$CA$CA
243386121$24338612$1$I$20240809$20240913$20240919$20240919$EXP$$DE-ROCHE-10000082595$ROCHE$$80$YR$E$F$Y$52$KG$20240919$$MD$DE$DE
243386131$24338613$1$I$$20240917$20240919$20240919$PER$$US-ROCHE-10000084773$ROCHE$$65$YR$E$M$Y$$$20240919$$MD$US$US
243386151$24338615$1$I$$20240703$20240919$20240919$PER$$US-Mundipharma Research Limited-2161774$MUNDIPHARMA EDO$$$$$F$Y$$$20240919$$$US$US
243386161$24338616$1$I$$20240731$20240919$20240919$PER$$US-Mundipharma Research Limited-2161773$MUNDIPHARMA EDO$$$$$F$Y$$$20240919$$MD$US$US
243386172$24338617$2$F$$20240917$20240919$20240923$PER$$US-BIOGEN-2024BI01283076$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
243386181$24338618$1$I$20240811$20240916$20240919$20240919$EXP$$US-ABBVIE-5927404$ABBVIE$$85$YR$$F$Y$$$20240919$$CN$US$US
243386191$24338619$1$I$20240430$20240917$20240919$20240919$EXP$$EU-ALSI-2024000247$AIRGAS$$$$$$Y$$$20240919$$MD$FR$FR
243386201$24338620$1$I$$20240917$20240919$20240919$PER$$US-BIOGEN-2015BI111177$BIOGEN$$$$$F$Y$$$20240919$$CN$US$US
243386211$24338621$1$I$$20240911$20240919$20240919$EXP$$IN-ASTELLAS-2024-AER-006900$ASTELLAS$Gaur L. Herpes Simplex Virus Type-2 Nephritis: An Unexpected Plot Twist in a Kidney Transplant Recipient. Indian Journal of Nephrology. 2024;34(5): 512-3. doi:10.4103/ijn.ijn_359_23.$32$YR$A$M$Y$$$20240919$$MD$IN$IN
243386221$24338622$1$I$$20240912$20240919$20240919$EXP$$TW-MYLANLABS-2024M1084588$MYLAN$Wang Q-A, Chan T-M. Case report: Management of Epstein-Barr virus positive and methotrexate-associated B-cell lymphoma. Int-J-Rheum-Diseases 2024; 27 (3).$68$YR$$M$Y$$$20240919$$HP$TW$TW
243386231$24338623$1$I$$20240905$20240919$20240919$EXP$$GB-B.Braun Medical Inc.-2161783$B BRAUN$$$$$F$Y$89$KG$20240919$$$GB$GB
243386241$24338624$1$I$$20240912$20240919$20240919$EXP$$US-MYLANLABS-2024M1084650$MYLAN$Gibson CL, Abdallah SB, Neumann NR, Millard H, Riley S. Methemoglobinemia in a Patent Presenting with an Undisclosed Intentional Overdose. Harv-Rev-Psychiatry 2022; 30 (6): 361-368.$20$YR$$F$Y$$$20240919$$MD$US$US
243386251$24338625$1$I$20240916$20240918$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148919$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240919$$CN$US$US
243386261$24338626$1$I$$20240912$20240919$20240919$EXP$$DE-MYLANLABS-2024M1084685$MYLAN$Metzner B, Muller TH, Casper J, Kimmich C, Kohne C-H, Petershofen E, et al. Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation. Eur-J-Haematol 2023; 111 (2): 220-228.$$$$M$Y$$$20240919$$MD$DE$DE
243386271$24338627$1$I$$20240916$20240919$20240919$PER$$US-HALEON-2197198$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243386281$24338628$1$I$$20240722$20240919$20240919$PER$$US-Mundipharma Research Limited-2161771$MUNDIPHARMA EDO$$$$$$Y$$$20240919$$$US$US
243386291$24338629$1$I$$20240723$20240919$20240919$PER$$US-Mundipharma Research Limited-2161776$MUNDIPHARMA EDO$$$$$F$Y$$$20240919$$MD$US$US
243386301$24338630$1$I$$20240906$20240919$20240919$PER$$US-ASTELLAS-2024-AER-005567$ASTELLAS$$$$$M$Y$136$KG$20240919$$HP$US$US
243386311$24338631$1$I$$20240917$20240919$20240919$EXP$$DE-SANDOZ INC.-PHHY2017DE123411$SANDOZ$$1$YR$$M$Y$6.6$KG$20240919$$HP$DE$DE
243386321$24338632$1$I$$20240823$20240919$20240919$30DAY$$US-Kaleo, Inc.-2024KL000039$KALEO$$17$YR$T$M$Y$$$20240918$$CN$US$US
243386331$24338633$1$I$$20240913$20240919$20240919$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP012011$STRIDES$Gunes EC, Tekgoz E, Colak S, Ustunel G, Cinar M, Yilmaz S.. THE MORTALITY OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASE: RESULTS OF LONG-TERM FOLLOW-UP.. Eur-J-Case-Rep-Intern-Med. 2024;11 (Suppl. 1):1074 abstr. 2753.$79$YR$$F$Y$$$20240919$$HP$TR$TR
243386341$24338634$1$I$20240901$20240911$20240919$20240919$EXP$$JP-EXELIXIS-EXL-2024-000265$EXELIXIS$$77$YR$$F$Y$$$20240919$$MD$JP$JP
243386351$24338635$1$I$$20240911$20240919$20240919$EXP$$JP-EXELIXIS-EXL-2024-000262$EXELIXIS$$6$DEC$$M$Y$$$20240919$$MD$JP$JP
243386361$24338636$1$I$$20240918$20240919$20240919$PER$$NVSC2024US187085$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243386381$24338638$1$I$20240615$20240911$20240919$20240919$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-08535$HIKMA$$$$$$Y$$$20240919$$CN$EG$EG
243386401$24338640$1$I$$20240913$20240919$20240919$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP012016$STRIDES$Gunes EC, Tekgoz E, Colak S, Ustunel G, Cinar M, Yilmaz S.. THE MORTALITY OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASE: RESULTS OF LONG-TERM FOLLOW-UP.. Eur-J-Case-Rep-Intern-Med. 2024;11 (Suppl. 1):1074 abstr. 2753$63$YR$$F$Y$$$20240919$$HP$TR$TR
243386411$24338641$1$I$$20240912$20240919$20240919$30DAY$$US-GSK-US2024113761$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243386421$24338642$1$I$20240911$20240912$20240919$20240919$30DAY$$US-GSK-US2024113752$GLAXOSMITHKLINE$$77$YR$$F$Y$$$20240919$$CN$US$US
243386431$24338643$1$I$$20240828$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08654$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243386441$24338644$1$I$20240101$20240911$20240919$20240919$EXP$$US-TEVA-VS-3244271$TEVA$$52$YR$$M$Y$$$20240919$$CN$US$US
243386451$24338645$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64167$$FDA-CTU$$76$YR$$M$N$$$20240918$N$$US$
243386461$24338646$1$I$20240806$20240910$20240919$20240919$EXP$$FR-ALSI-2024000240$AIRGAS$$16$YR$$F$Y$$$20240919$$MD$FR$FR
243386471$24338647$1$I$$20240912$20240919$20240919$EXP$$NZ-MYLANLABS-2024M1084878$MYLAN$Kamalaksha S, McGrath N, Low CS, Ghosh S. An uncommon case of rhabdomyolysis in severe hypothyroidism. N-Z-Med-J 2024; 137 (1590): 100-102.$77$YR$$F$Y$$$20240919$$MD$NZ$NZ
243386481$24338648$1$I$$20240830$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08848$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243386491$24338649$1$I$$20240903$20240919$20240919$PER$$US-Mundipharma Research Limited-2161769$MUNDIPHARMA EDO$$$$$F$Y$$$20240919$$MD$US$US
243386501$24338650$1$I$$20240914$20240919$20240919$PER$$US-AMGEN-USASP2024184904$AMGEN$$$$$$Y$$$20240919$$MD$US$US
243386511$24338651$1$I$20240427$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64143$$FDA-CTU$$79$YR$$M$N$107.3$KG$20240918$N$$US$
243386521$24338652$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64214$$FDA-CTU$$52$YR$$F$N$$$20240918$N$$US$
243386531$24338653$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64239$$FDA-CTU$$38$YR$$M$N$$$20240918$N$$US$
243386541$24338654$1$I$20240101$20240912$20240919$20240919$EXP$$JP-AMGEN-JPNSP2024183143$AMGEN$$$$A$M$Y$$$20240919$$MD$JP$JP
243386551$24338655$1$I$$20240801$20240919$20240919$PER$$US-Mundipharma Research Limited-2161778$MUNDIPHARMA EDO$$$$$F$Y$$$20240919$$$US$US
243386561$24338656$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA268978$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240919$$CN$US$US
243386571$24338657$1$I$20240201$20240912$20240919$20240919$PER$$US-SA-2024SA270179$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240919$$HP$US$US
243386581$24338658$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA267128$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240919$$MD$US$US
243386591$24338659$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64173$$FDA-CTU$$62$YR$$F$N$200$LBS$20240918$N$$US$
243386601$24338660$1$I$20240801$20240904$20240919$20240919$PER$$US-SA-2024SA270749$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240919$$MD$US$US
243386611$24338661$1$I$$20240906$20240918$20240918$DIR$FDA-CDER-CTU-2024-64156$$FDA-CTU$$$$$F$N$$$20240906$N$HP$US$
243386631$24338663$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64183$$FDA-CTU$$60$YR$$M$N$111.13$KG$20240918$N$$US$
243386641$24338664$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64203$$FDA-CTU$$58$YR$$F$N$190$LBS$20240918$N$$US$
243386651$24338665$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010794$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243386661$24338666$1$I$$20240910$20240918$20240918$DIR$FDA-CDER-CTU-2024-64159$$FDA-CTU$$$$$F$N$$$20240910$N$HP$US$
243386671$24338667$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64195$$FDA-CTU$$61$YR$$F$N$125$LBS$20240918$N$$US$
243386681$24338668$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010930$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243386691$24338669$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64200$$FDA-CTU$$61$YR$$F$N$$$20240918$N$$US$
243386701$24338670$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64145$$FDA-CTU$$23$YR$$F$N$$$20240918$N$$US$
243386711$24338671$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64191$$FDA-CTU$$69$YR$$F$N$$$20240918$N$$US$
243386721$24338672$1$I$20240830$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64146$$FDA-CTU$$40$YR$$F$N$$$20240918$N$PH$US$
243386731$24338673$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64207$$FDA-CTU$$41$YR$$F$N$135.17$KG$20240918$N$$US$
243386741$24338674$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64190$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243386751$24338675$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64184$$FDA-CTU$$68$YR$$F$N$84.37$KG$20240918$N$$US$
243386761$24338676$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64219$$FDA-CTU$$39$YR$$M$N$$$20240918$N$$US$
243386771$24338677$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64176$$FDA-CTU$$43$YR$$F$N$$$20240918$N$HP$US$
243386781$24338678$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64160$$FDA-CTU$$87$YR$$F$N$$$20240918$N$$US$
243386791$24338679$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64144$$FDA-CTU$$53$YR$$F$N$$$20240918$N$$US$
243386801$24338680$1$I$20240915$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64182$$FDA-CTU$$73$YR$$F$N$$$20240917$N$HP$US$
243386811$24338681$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64204$$FDA-CTU$$49$YR$$F$N$117.03$KG$20240918$N$$US$
243386821$24338682$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64193$$FDA-CTU$$33$YR$$F$N$74.84$KG$20240918$N$$US$
243386831$24338683$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64148$$FDA-CTU$$72$YR$$M$N$$$20240918$N$$US$
243386841$24338684$1$I$20240906$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64192$$FDA-CTU$$53$YR$$F$N$$$20240918$N$$US$
243386871$24338687$1$I$$20240905$20240919$20240919$EXP$$PL-JNJFOC-20240933280$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240919$$HP$PL$PL
243386881$24338688$1$I$20240826$20240827$20240919$20240919$PER$$US-BAYER-2024A133550$BAYER$$41$YR$A$F$Y$$$20240919$$CN$US$US
243386891$24338689$1$I$$20240910$20240919$20240919$EXP$$FR-MYLANLABS-2024M1084229$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$37$YR$$M$Y$$$20240919$$HP$FR$FR
243386901$24338690$1$I$$20240910$20240919$20240919$EXP$$FR-MYLANLABS-2024M1084234$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024.$27$YR$$M$Y$$$20240919$$HP$FR$FR
243386911$24338691$1$I$$20240910$20240919$20240919$EXP$$FR-MYLANLABS-2024M1084232$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$25$YR$$M$Y$$$20240919$$HP$FR$FR
243386921$24338692$1$I$$20240910$20240919$20240919$EXP$$FR-MYLANLABS-2024M1084231$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024.$38$YR$$M$Y$$$20240919$$HP$FR$FR
243386931$24338693$1$I$$20240910$20240919$20240919$EXP$$US-MYLANLABS-2024M1084092$MYLAN$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. J-Oncol-Pharm-Pract 2024; 0 (0):.$61$YR$$M$Y$$$20240919$$HP$US$US
243386941$24338694$1$I$$20240910$20240919$20240919$EXP$$FR-MYLANLABS-2024M1084228$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$50$YR$$M$Y$$$20240919$$HP$FR$FR
243386951$24338695$1$I$$20240910$20240919$20240919$EXP$$US-MYLANLABS-2024M1084250$MYLAN$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. J-Oncol-Pharm-Pract 2024; 0 (0).$34$YR$$F$Y$$$20240919$$HP$US$US
243386961$24338696$1$I$$20240910$20240919$20240919$EXP$$FR-MYLANLABS-2024M1084230$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic? J-Eur-Acad-Dermatol-Venereol 2024.$47$YR$$M$Y$$$20240919$$HP$FR$FR
243386971$24338697$1$I$$20240910$20240919$20240919$EXP$$ES-MYLANLABS-2024M1084111$MYLAN$Copete S, Garcia-Garcia JG, Judez E. Dexamethasone intravitreal implant in the treatment of macular edema secondary to necrotizing retinitis. Eur-J-Ophthalmol 2024; 0 (0):.$68$YR$$F$Y$$$20240919$$HP$ES$ES
243386981$24338698$1$I$$20240910$20240919$20240919$EXP$$FR-MYLANLABS-2024M1084240$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$32$YR$$M$Y$$$20240919$$HP$FR$FR
243386991$24338699$1$I$$20240910$20240919$20240919$EXP$$FR-MYLANLABS-2024M1084243$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic. J-Eur-Acad-Dermatol-Venereol 2024.$26$YR$$M$Y$$$20240919$$HP$FR$FR
243387001$24338700$1$I$20210101$20240910$20240919$20240919$EXP$$JP-MYLANLABS-2024M1084439$MYLAN$Ohshima M, Suzuki T, Suzuki A. Case Series of Changes in Greyscale and Power Doppler Signals on Salivary Gland Ultrasonography after Treatment in Patients with Sjogren^s Syndrome. Intern-Med 2024; 63 (15): 2203-2208.. 2024;63 (15):2203-2208$60$YR$$F$Y$$$20240919$$MD$JP$JP
243387011$24338701$1$I$$20240910$20240919$20240919$EXP$$FR-MYLANLABS-2024M1084244$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$28$YR$$F$Y$$$20240919$$HP$FR$FR
243387021$24338702$1$I$$20240819$20240919$20240919$PER$$US-Mundipharma Research Limited-2161766$MUNDIPHARMA EDO$$$$$$Y$$$20240919$$$US$US
243387031$24338703$1$I$$20240903$20240919$20240919$PER$$US-Mundipharma Research Limited-2161768$MUNDIPHARMA EDO$$$$$M$Y$$$20240919$$MD$US$US
243387041$24338704$1$I$$20240805$20240919$20240919$PER$$US-Mundipharma Research Limited-2161777$MUNDIPHARMA EDO$$$$$$Y$$$20240919$$MD$US$US
243387051$24338705$1$I$$20240708$20240919$20240919$PER$$US-Mundipharma Research Limited-2161765$MUNDIPHARMA EDO$$$$$F$Y$$$20240919$$MD$US$US
243387061$24338706$1$I$$20240619$20240919$20240919$PER$$US-Mundipharma Research Limited-2161775$MUNDIPHARMA EDO$$$$$M$Y$$$20240919$$MD$US$US
243387071$24338707$1$I$$20240830$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08794$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243387081$24338708$1$I$20240902$20240909$20240919$20240919$PER$$US-Xttrium Laboratories, Inc-2161761$XTTRIUM$$$$$F$Y$$$20240919$$$US$US
243387091$24338709$1$I$$20240913$20240919$20240919$PER$$US-ROCHE-10000083227$ROCHE$$$$A$M$Y$$$20240919$$CN$US$US
243387102$24338710$2$F$$20240918$20240919$20240923$PER$$NVSC2024US187093$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
243387111$24338711$1$I$$20240821$20240919$20240919$PER$$US-Mundipharma Research Limited-2161767$MUNDIPHARMA EDO$$$$$F$Y$$$20240919$$MD$US$US
243387121$24338712$1$I$$20240910$20240919$20240919$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-08497$HIKMA$Tarek R, El Ashry A, AbdElhakam M, Markos M, Husein M, Abd Elhamid E. Tarek R, El Ashry A, AbdElhakam M, Markos M, Husein M, Abd Elhamid E. Cytarabine induced CNS adverse reactions.. Egyptian Pharmaceutical Vigilance Centre (EPVC) Newsletter. 2024;15(9):3-4$27$YR$$F$Y$54$KG$20240919$$MD$EG$EG
243387141$24338714$1$I$20240914$20240916$20240919$20240919$PER$$US-ROCHE-10000083442$ROCHE$$32$YR$A$M$Y$$$20240919$$CN$US$US
243387161$24338716$1$I$$20240722$20240919$20240919$PER$$US-Mundipharma Research Limited-2161763$MUNDIPHARMA EDO$$$$$$Y$$$20240919$$$US$US
243387171$24338717$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011174$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240919$$CN$US$US
243387181$24338718$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010792$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240919$$CN$US$US
243387191$24338719$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010572$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240919$$CN$US$US
243387202$24338720$2$F$$20240917$20240919$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409010713$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240924$$HP$US$US
243387211$24338721$1$I$$20240905$20240919$20240919$EXP$$CN-P+L Developments of Newyork Corporation-2161802$PL DEVELOPMENTS$Initial$4$YR$$F$Y$$$20240919$$$CN$CN
243387221$24338722$1$I$$20240906$20240919$20240919$EXP$$ES-B.Braun Medical Inc.-2161812$B BRAUN$$73$YR$$F$Y$$$20240919$$$ES$ES
243387231$24338723$1$I$$20240911$20240919$20240919$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08590$HIKMA$$54$YR$$F$Y$$$20240919$$HP$US$US
243387241$24338724$1$I$$20240905$20240919$20240919$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161803$JIANGSU HENGRUI MEDICINE$Literature title: Pulmonary parasitic infection induced by belimumab combined with immunosup-pressive therapy: a case report. ?Literature publication journal: Practical Pharmacy And Clinical Remedies 2024; 24 (8): 636-640.?Literature authors: Huang Niya, Zhou Yan, Ma Ling.$40$YR$$F$Y$$$20240919$$PH$CN$CN
243387252$24338725$2$F$20240501$20240921$20240919$20240924$30DAY$$US-PFIZER INC-202400099636$PFIZER$$17$YR$$M$Y$$$20240924$$CN$US$US
243387261$24338726$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64163$$FDA-CTU$$61$YR$$F$N$$$20240918$N$$US$
243387271$24338727$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64136$$FDA-CTU$$57$YR$$M$N$$$20240918$N$$US$
243387281$24338728$1$I$$20240826$20240919$20240919$PER$$US-SA-2024SA267828$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240919$$MD$US$US
243387291$24338729$1$I$20240902$20240917$20240919$20240919$PER$$US-ROCHE-10000085026$ROCHE$$48$YR$A$M$Y$$$20240919$$CN$US$US
243387301$24338730$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64175$$FDA-CTU$$$$$F$N$$$20240918$N$HP$US$
243387311$24338731$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64153$$FDA-CTU$$64$YR$$F$N$$$20240918$N$$US$
243387321$24338732$1$I$20240912$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64161$$FDA-CTU$$87$YR$$F$N$$$20240918$N$$US$
243387331$24338733$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010929$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243387341$24338734$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010983$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243387352$24338735$2$F$20240901$20240919$20240919$20240923$PER$$US-ABBVIE-5927755$ABBVIE$$77$YR$$F$Y$60$KG$20240923$$HP$US$US
243387361$24338736$1$I$$20240912$20240919$20240919$EXP$$US-SA-2024SA269958$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
243387371$24338737$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267197$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240919$$MD$US$US
243387381$24338738$1$I$20240901$20240910$20240919$20240919$PER$$US-SA-2024SA266040$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240919$$HP$US$US
243387391$24338739$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA268739$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240919$$HP$US$US
243387401$24338740$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA268216$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240919$$HP$US$US
243387411$24338741$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64132$$FDA-CTU$$69$YR$$M$N$$$20240918$N$$US$
243387421$24338742$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64157$$FDA-CTU$$51$YR$$F$N$$$20240918$N$$US$
243387431$24338743$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64180$$FDA-CTU$$$$$M$N$$$20240918$N$HP$US$
243387441$24338744$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64261$$FDA-CTU$$$$$F$N$$$20240918$N$$US$
243387451$24338745$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA268958$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240919$$CN$US$US
243387461$24338746$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA267080$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240919$$MD$US$US
243387471$24338747$1$I$20240910$20240913$20240919$20240919$PER$$US-SA-2024SA267775$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240919$$MD$US$US
243387481$24338748$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267324$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240919$$MD$US$US
243387491$24338749$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA267662$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240919$$HP$US$US
243387501$24338750$1$I$20240904$20240906$20240919$20240919$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161807$JIANGSU HANSOH PHARMACEUTICAL$$67$YR$$F$Y$66$KG$20240919$$MD$CN$CN
243387511$24338751$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64138$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243387521$24338752$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64166$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243387531$24338753$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64179$$FDA-CTU$$91$YR$$F$N$$$20240918$N$$US$
243387541$24338754$1$I$20240902$20240905$20240919$20240919$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161801$JIANGSU HENGRUI MEDICINE$$39$YR$$M$Y$68$KG$20240919$$MD$CN$CN
243387551$24338755$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148481$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$119.75$KG$20240919$$HP$US$US
243387561$24338756$1$I$$20240916$20240919$20240919$EXP$$US-AMGEN-USASP2024185141$AMGEN$$$$$F$Y$$$20240919$$HP$US$US
243387571$24338757$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64125$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243387581$24338758$1$I$20240815$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64154$$FDA-CTU$$82$YR$$F$N$$$20240918$N$$US$
243387591$24338759$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64262$$FDA-CTU$$43$YR$$F$N$$$20240918$N$$US$
243387601$24338760$1$I$$20240918$20240919$20240919$PER$$US-ROCHE-10000086017$ROCHE$$4$YR$C$M$Y$$$20240919$$CN$US$US
243387611$24338761$1$I$20240901$20240913$20240919$20240919$EXP$$NVSC2024CN183903$NOVARTIS$$39$YR$$M$Y$65$KG$20240919$$HP$CN$CN
243387631$24338763$1$I$20240903$20240910$20240919$20240919$PER$$US-ABBVIE-5919722$ABBVIE$$53$YR$$M$Y$$$20240919$$CN$US$US
243387641$24338764$1$I$$20240912$20240919$20240919$PER$$US-BAYER-2024A131456$BAYER$$33$YR$A$F$Y$$$20240919$$CN$US$US
243387651$24338765$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64155$$FDA-CTU$$$$$M$N$$$20240918$N$HP$US$
243387661$24338766$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64151$$FDA-CTU$$74$YR$$F$N$$$20240918$N$$US$
243387681$24338768$1$I$20240904$20240905$20240919$20240919$30DAY$$GB-PFIZER INC-202400253483$PFIZER$$23$YR$$F$Y$$$20240919$$CN$GB$GB
243387691$24338769$1$I$$20240909$20240919$20240919$30DAY$$US-PFIZER INC-202400253406$PFIZER$$11$YR$$M$Y$$$20240919$$CN$US$US
243387701$24338770$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA268547$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240919$$MD$US$US
243387711$24338771$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA255708$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240919$$HP$US$US
243387721$24338772$1$I$20240425$20240910$20240919$20240919$PER$$US-SA-2024SA266034$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240919$$MD$US$US
243387731$24338773$1$I$20220813$20240823$20240919$20240919$PER$$US-SA-2024SA266143$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240919$$CN$US$US
243387741$24338774$1$I$$20240916$20240919$20240919$EXP$$CA-Orion Corporation ORION PHARMA-24_00031758$ORION$$$$$F$Y$$$20240919$$HP$CA$
243387771$24338777$1$I$20240830$20240906$20240919$20240919$30DAY$$BR-PFIZER INC-202400258296$PFIZER$$$$$$Y$$$20240919$$HP$BR$BR
243387781$24338778$1$I$$20240909$20240919$20240919$30DAY$$US-PFIZER INC-202400254050$PFIZER$$$$$$Y$$$20240919$$CN$US$US
243387792$24338779$2$F$$20240925$20240919$20240926$EXP$$US-PFIZER INC-PV202400121820$PFIZER$$73$YR$$$Y$$$20240926$$CN$US$US
243387811$24338781$1$I$$20240904$20240919$20240919$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468806$RANBAXY$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J Forens Legal Med. 2024;101:102625;1-6$95$YR$$$Y$$$20240919$$HP$US$US
243387832$24338783$2$F$20240828$20240920$20240919$20240921$EXP$$US-BAYER-2024A131611$BAYER$$45$YR$A$F$Y$$$20240921$$HP$US$US
243387841$24338784$1$I$20240101$20240912$20240919$20240919$EXP$$US-862174955-ML2024-04912$Unknown Manufacturer$$$$$M$Y$$$20240919$$CN$US$US
243387851$24338785$1$I$$20240910$20240919$20240919$PER$$US-ASTELLAS-2024-AER-006178$ASTELLAS$$53$YR$A$F$Y$$$20240919$$MD$US$US
243387861$24338786$1$I$20240911$20240912$20240919$20240919$PER$$US-RDY-SPO/USA/24/0013467$DR REDDYS$$40$YR$A$F$Y$$$20240919$$HP$US$US
243387871$24338787$1$I$$20240913$20240919$20240919$EXP$$FR-ROCHE-10000085828$ROCHE$$23$YR$A$F$Y$$$20240919$$PH$FR$FR
243387881$24338788$1$I$$20240912$20240919$20240919$PER$$US-ROCHE-10000081807$ROCHE$Kefas J, Harwood C, Lewis M, Szlosarek P. Small vessel vasculitis and dry gangrene secondary to combined CTLA-4 and PD-1 blockade in malignant mesothelioma. BMC Rheumatol. 2022;6 (10):1-5.$35$YR$A$M$Y$$$20240919$$HP$US$US
243387891$24338789$1$I$$20240910$20240919$20240919$EXP$$US-PTA-005784$BANNER$$63$YR$A$F$Y$$$20240919$$CN$US$
243387903$24338790$3$F$$20240919$20240919$20240925$PER$$US-AMGEN-USASP2024185284$AMGEN$$53$YR$A$M$Y$$$20240925$$HP$US$US
243387911$24338791$1$I$$20240911$20240919$20240919$EXP$$CA-CELLTRION INC.-2024CA021825$CELLTRION$$$$$$Y$$$20240919$$CN$CA$CA
243387921$24338792$1$I$$20240909$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143808$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$89.81$KG$20240919$$CN$US$US
243387931$24338793$1$I$20240101$20240912$20240919$20240919$EXP$$IT-UCBSA-2024047926$UCB$$$$E$F$Y$$$20240919$$MD$IT$IT
243387941$24338794$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010892$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243387951$24338795$1$I$20240909$20240909$20240919$20240919$30DAY$$US-JNJFOC-20240922229$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240919$$CN$US$US
243387961$24338796$1$I$$20240906$20240919$20240919$EXP$$US-AUROBINDO-AUR-APL-2024-045487$AUROBINDO$$$$A$F$Y$84.3$KG$20240919$$PH$US$US
243387971$24338797$1$I$$20240916$20240918$20240918$DIR$FDA-CDER-CTU-2024-64133$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243387981$24338798$1$I$20240901$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64250$$FDA-CTU$$66$YR$$F$N$$$20240918$Y$PH$US$
243387991$24338799$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64113$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243388001$24338800$1$I$20240906$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64194$$FDA-CTU$$53$YR$$F$N$$$20240918$N$$US$
243388011$24338801$1$I$20240914$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64223$$FDA-CTU$$52$YR$$F$N$58.97$KG$20240918$N$$US$
243388021$24338802$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64141$$FDA-CTU$$35$YR$$F$N$$$20240918$N$$US$
243388031$24338803$1$I$$20240918$20240918$20240918$DIR$718924$$FDA-CTU$$$$$UNK$N$$$20240918$N$CN$US$
243388041$24338804$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64142$$FDA-CTU$$33$YR$$F$N$$$20240918$N$$US$
243388051$24338805$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64263$$FDA-CTU$$41$YR$$M$N$$$20240918$N$$US$
243388061$24338806$1$I$$20240910$20240918$20240918$DIR$FDA-CDER-CTU-2024-64134$$FDA-CTU$$$$$M$N$$$20240910$N$HP$US$
243388071$24338807$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64242$$FDA-CTU$$71$YR$$F$N$$$20240918$N$$US$
243388081$24338808$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64137$$FDA-CTU$$57$YR$$F$N$$$20240918$N$$US$
243388091$24338809$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243782$TEVA$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240919$$MD$US$US
243388101$24338810$1$I$$20240909$20240919$20240919$EXP$$DE-TEVA-VS-3242562$TEVA$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.; Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.$14$YR$$F$Y$$$20240919$$HP$DE$DE
243388111$24338811$1$I$$20240916$20240919$20240919$EXP$$AU-TGA0000819272$SANDOZ$$51$YR$$M$Y$$$20240919$$MD$AU$AU
243388121$24338812$1$I$20240720$20240911$20240919$20240919$EXP$$IN-ROCHE-10000080702$ROCHE$$64$YR$A$F$Y$$$20240919$$MD$IN$IN
243388131$24338813$1$I$$20240917$20240919$20240919$PER$$NVSC2024US186465$NOVARTIS$$60$YR$$F$Y$$$20240919$$CN$US$US
243388151$24338815$1$I$20240908$20240913$20240919$20240919$EXP$$GB-MYLANLABS-2024M1083891$MYLAN$$$$$M$Y$$$20240919$$PH$GB$GB
243388161$24338816$1$I$20240901$20240918$20240919$20240919$PER$$US-ABBVIE-5929642$ABBVIE$$$$$$Y$$$20240919$$HP$US$US
243388171$24338817$1$I$$20240913$20240919$20240919$EXP$$US-MYLANLABS-2024M1084508$MYLAN$Lemonjava I, Manzano JMM, Sultan S, Bhat R, Minimo C, Azmaiparashvili Z, et al. A 72-year-old man with acute lung injury and anti-melanoma differentiation-associated gene 5 antibody: A case report. Respirat-Med-Case-Report 2024; 51 102098.$72$YR$$M$Y$$$20240919$$HP$US$US
243388191$24338819$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243785$TEVA$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240919$$MD$US$US
243388201$24338820$1$I$20240101$20240905$20240919$20240919$EXP$$AU-UCBSA-2024046001$UCB$$$$$F$Y$120$KG$20240919$$MD$AU$AU
243388211$24338821$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010786$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243388221$24338822$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64265$$FDA-CTU$$47$YR$$F$N$$$20240918$N$$US$
243388231$24338823$1$I$20240623$20240910$20240919$20240919$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-08479$HIKMA$$$$$$Y$$$20240919$$HP$EG$EG
243388252$24338825$2$F$$20240919$20240919$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145964$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240927$$MD$JP$JP
243388261$24338826$1$I$20240911$20240913$20240919$20240919$EXP$$US-BAYER-2024A131797$BAYER$$46$YR$A$F$Y$$$20240919$$CN$US$US
243388271$24338827$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64266$$FDA-CTU$$40$YR$$F$N$$$20240918$N$$US$
243388281$24338828$1$I$20240916$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64177$$FDA-CTU$$46$YR$$F$N$$$20240917$N$HP$US$
243388291$24338829$1$I$20240913$20240913$20240919$20240919$EXP$$US-JNJFOC-20240941260$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240919$$MD$US$US
243388311$24338831$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64140$$FDA-CTU$$89$YR$$F$N$$$20240918$N$$US$
243388321$24338832$1$I$20240710$20240711$20240918$20240918$DIR$FDA-CDER-CTU-2024-64139$$FDA-CTU$$75$YR$$F$N$$$20240711$N$PH$US$
243388331$24338833$1$I$20240710$20240911$20240919$20240919$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-08508$HIKMA$$$$$$Y$$$20240919$$PH$EG$EG
243388341$24338834$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010918$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243388351$24338835$1$I$20240916$20240918$20240918$20240918$DIR$718908$$FDA-CTU$$27$YR$$M$N$88.65$KG$20240918$N$CN$US$
243388361$24338836$1$I$$20240910$20240918$20240918$DIR$FDA-CDER-CTU-2024-64135$$FDA-CTU$$$$$M$N$$$20240910$N$HP$US$
243388371$24338837$1$I$20240830$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64267$$FDA-CTU$$46$YR$$F$N$$$20240918$N$PH$US$
243388381$24338838$1$I$20240912$20240917$20240919$20240919$EXP$$US-ABBVIE-5927968$ABBVIE$$26$YR$$F$Y$$$20240919$$CN$US$US
243388391$24338839$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64150$$FDA-CTU$$62$YR$$M$N$$$20240918$N$CN$US$
243388411$24338841$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA270448$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240919$$MD$US$US
243388421$24338842$1$I$$20240909$20240919$20240919$EXP$$SI-NOVITIUMPHARMA-2024SINVP01862$NOVITIUM PHARMA$Liam Korosec Hudnik.Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics.Frontiers in Psychiatry.19-MAR-2024;15:1-9$$$A$F$Y$$$20240919$$HP$SI$SI
243388431$24338843$1$I$$20240917$20240919$20240919$EXP$$NVSC2024GR186479$NOVARTIS$$$$$M$Y$$$20240919$$MD$GR$GR
243388441$24338844$1$I$20240801$20240912$20240919$20240919$PER$$US-SA-2024SA266773$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240919$$HP$US$US
243388451$24338845$1$I$$20240916$20240919$20240919$EXP$$DE-BAYER-2024A132514$BAYER$$69$YR$E$M$Y$$$20240919$$CN$DE$DE
243388461$24338846$1$I$$20240914$20240919$20240919$EXP$$TH-BAYER-2024A132230$BAYER$$$$$F$Y$$$20240919$$HP$TH$TH
243388481$24338848$1$I$$20240906$20240919$20240919$EXP$$ES-AUROBINDO-AUR-APL-2024-044716$AUROBINDO$Cantero AB, Nunez ML, Luis GR, Lucena CR, Rueda JR. NON-INFECTIOUS FEVER. ABOUT A CASE. European Journal of Case Reports in Internal Medicine. 2024;11 (Suppl. 1):915$62$YR$$F$Y$$$20240919$$MD$ES$ES
243388491$24338849$1$I$$20240827$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-07645$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243388501$24338850$1$I$$20240919$20240919$20240919$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052277$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240919$$MD$ES$ES
243388511$24338851$1$I$$20240913$20240919$20240919$PER$$US-RDY-SPO/USA/24/0012972$DR REDDYS$$57$YR$A$F$Y$$$20240919$$CN$US$US
243388522$24338852$2$F$20240917$20240919$20240919$20240921$PER$$US-AMGEN-USASP2024186862$AMGEN$$79$YR$E$M$Y$$$20240921$$CN$US$US
243388531$24338853$1$I$$20240910$20240919$20240919$EXP$$US-ROCHE-10000078874$ROCHE$$70$YR$E$F$Y$$$20240919$$CN$US$US
243388541$24338854$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148515$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$73.03$KG$20240919$$CN$US$US
243388552$24338855$2$F$$20240912$20240919$20240920$PER$$US-JNJFOC-20240940320$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243388562$24338856$2$F$$20240909$20240919$20240923$PER$$US-TEVA-VS-3240858$TEVA$$72$YR$$F$Y$$$20240923$$PH$US$US
243388571$24338857$1$I$20240101$20240916$20240919$20240919$EXP$$FR-EXELIXIS-EXL-2024-000348$EXELIXIS$$88$YR$$M$Y$78$KG$20240919$$PH$FR$FR
243388581$24338858$1$I$20240801$20240906$20240919$20240919$PER$$US-BAUSCHBL-2024BNL033100$BAUSCH AND LOMB$$$$$F$Y$$$20240919$$CN$US$US
243388601$24338860$1$I$20220101$20240910$20240919$20240919$EXP$$BR-MYLANLABS-2024M1083614$MYLAN$Morau MV, Seguin CS, Perroud Junior MW, Dagli-Hernandez C, Pincinato EDC, Moriel P. Gefitinib-Induced Severe Dermatological Adverse Reactions: A Case Report and Pharmacogenetic Profile. Pharmaceuticals 2024; 17 (8):.$55$YR$$F$Y$$$20240919$$HP$BR$BR
243388612$24338861$2$F$$20240923$20240919$20240924$EXP$$PT-MYLANLABS-2024M1083262$MYLAN$$62$YR$$M$Y$$$20240924$$HP$PT$PT
243388621$24338862$1$I$$20240911$20240919$20240919$EXP$$US-MYLANLABS-2024M1083585$MYLAN$Jabbar SB, Monaghan S, Chen W, Koduru P, Kumar KR. Acute Myeloid Leukemia With a Rare t(7;14) (q21;q32) andTrisomy 4 With Poor Clinical Outcome: A Case Report. Lab-Med 2017; 48 (4): 376-380.$40$YR$$F$Y$$$20240919$$MD$US$US
243388631$24338863$1$I$20230101$20240910$20240919$20240919$EXP$$US-MYLANLABS-2024M1083286$MYLAN$Hosseini R, Brooks SP, Gadelha E, Schaap R, Cook J, Husan A. Effective Treatment of Methotrexate Induced Oral Mucositis With a Morphine Mouthwash Solution: A Case Report. J-Pharm-Pract 2024.$67$YR$$F$Y$$$20240919$$PH$US$US
243388641$24338864$1$I$$20240911$20240919$20240919$EXP$$DK-MYLANLABS-2024M1084265$MYLAN$Clipet-Jensen A, Fjeldsoe-Nielsen H, Kirkegaard PR. Foot Drop Following a Popliteal Sciatic Nerve Block with Ropivacaine, A Case Report and Literature Review. Local-Reg-Anesth 2024; 17 87-91.$74$YR$$M$Y$$$20240919$$HP$DK$DK
243388651$24338865$1$I$$20240910$20240919$20240919$EXP$$IT-MYLANLABS-2024M1084072$MYLAN$Rampi A, Comini LV, Galli A, Howardson BO, Tettamanti A, Luparello P, et al. Reconstructive Surgery of the Head and Neck in Organ Transplant Recipients: A Case Report and a Review of the Literature. J-Clin-Med 2024; 13 (16): 1-11.$74$YR$$M$Y$$$20240919$$HP$IT$IT
243388661$24338866$1$I$$20240911$20240919$20240919$EXP$$US-MYLANLABS-2024M1084275$MYLAN$Eakes J, Hatch L, Hennessy K, Ravichandran S, Ayoubi N, Fourzali K, et al. Pembrolizumab-Induced Lichenoid Drug Eruption Successfully Treated with Dupilumab - A Case Report. J-Am-Acad-Dermatol 2024; 91 (Suppl.) (3): AB70 abstr. 50699.$85$YR$$M$Y$$$20240919$$HP$US$US
243388671$24338867$1$I$$20240906$20240919$20240919$PER$$US-BAUSCHBL-2024BNL033117$BAUSCH AND LOMB$$$$$F$Y$$$20240919$$CN$US$US
243388681$24338868$1$I$20240101$20240911$20240919$20240919$PER$$US-UNITED THERAPEUTICS-UNT-2024-012712$UNITED THERAPEUTICS$$$$$F$Y$65.306$KG$20240919$$$US$US
243388691$24338869$1$I$$20240910$20240919$20240919$EXP$$ES-MYLANLABS-2024M1084076$MYLAN$Copete S, Garcia-Garcia JG, Judez E. Dexamethasone intravitreal implant in the treatment of macular edema secondary to necrotizing retinitis. Eur-J-Ophthalmol 2024; 0 (0).$37$YR$$M$Y$$$20240919$$HP$ES$ES
243388721$24338872$1$I$$20240909$20240919$20240919$PER$$US-BAUSCHBL-2024BNL033190$BAUSCH AND LOMB$$$$$F$Y$$$20240919$$CN$US$US
243388731$24338873$1$I$$20240917$20240919$20240919$PER$$US-BAYER-2024A133486$BAYER$$27$YR$A$F$Y$$$20240919$$MD$US$US
243388741$24338874$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010893$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243388771$24338877$1$I$$20240915$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010963$ELI LILLY AND CO$$$$$M$Y$$$20240919$$CN$US$US
243388781$24338878$1$I$20240905$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010736$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240919$$CN$US$US
243388791$24338879$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010778$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240919$$CN$US$US
243388801$24338880$1$I$20240917$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010610$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240919$$CN$US$US
243388811$24338881$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010853$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240919$$CN$US$US
243388821$24338882$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010952$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240919$$CN$US$US
243388831$24338883$1$I$$20240912$20240919$20240919$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-125600$REGENERON$$$$$M$Y$$$20240919$$CN$CA$CA
243388842$24338884$2$F$20240101$20240916$20240919$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US080667$SANDOZ$$$$$M$Y$$$20240919$$CN$US$US
243388851$24338885$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186384$AMGEN$$$$$$Y$$$20240919$$PH$US$US
243388862$24338886$2$F$$20240916$20240919$20240924$30DAY$$US-PFIZER INC-202400257510$PFIZER$$16$YR$$M$Y$$$20240924$$CN$US$US
243388871$24338887$1$I$$20240909$20240919$20240919$30DAY$$US-PFIZER INC-202400254073$PFIZER$$15$YR$$M$Y$$$20240919$$CN$US$US
243388891$24338889$1$I$$20240910$20240919$20240919$EXP$$CA-ROCHE-10000084766$ROCHE$$65$YR$E$F$Y$34$KG$20240919$$HP$CA$CA
243388902$24338890$2$F$20240901$20240923$20240919$20240927$30DAY$$CO-PFIZER INC-PV202400121316$PFIZER$$11$YR$$F$Y$24$KG$20240927$$CN$CO$CO
243388941$24338894$1$I$$20240912$20240919$20240919$30DAY$$US-PFIZER INC-202400255693$PFIZER$$13$YR$$F$Y$$$20240919$$CN$US$US
243388951$24338895$1$I$$20240913$20240919$20240919$30DAY$$US-PFIZER INC-202400256469$PFIZER$$10$YR$$M$Y$$$20240919$$CN$US$US
243388962$24338896$2$F$$20240916$20240919$20240927$30DAY$$DE-PFIZER INC-202400257216$PFIZER$$$$$F$Y$$$20240927$$PH$DE$DE
243388971$24338897$1$I$$20240910$20240919$20240919$30DAY$$US-PFIZER INC-202400257959$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243388981$24338898$1$I$$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64165$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243388991$24338899$1$I$$20240916$20240919$20240919$30DAY$$US-PFIZER INC-PV202400072324$PFIZER$$$$$$Y$$$20240919$$CN$US$US
243389002$24338900$2$F$$20240918$20240919$20240923$30DAY$$DE-PFIZER INC-202400258141$PFIZER$$$$$$Y$$$20240923$$CN$DE$DE
243389012$24338901$2$F$$20240920$20240919$20240926$30DAY$$US-PFIZER INC-PV202400120569$PFIZER$$13$YR$$$Y$$$20240926$$MD$US$US
243389021$24338902$1$I$20240101$20240912$20240919$20240919$30DAY$$CA-PFIZER INC-202400256222$PFIZER$$53$YR$$M$Y$$$20240919$$HP$CA$CA
243389032$24338903$2$F$$20240925$20240919$20240926$30DAY$$HK-PFIZER INC-202400254356$PFIZER$$$$$$Y$$$20240926$$PH$HK$HK
243389041$24338904$1$I$20240101$20240912$20240919$20240919$30DAY$$CA-PFIZER INC-202400257354$PFIZER$$66$YR$$M$Y$$$20240919$$CN$CA$CA
243389051$24338905$1$I$20240917$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024186595$AMGEN$$70$YR$E$M$Y$$$20240919$$CN$US$US
243389061$24338906$1$I$20240915$20240917$20240918$20240918$DIR$FDA-CDER-CTU-2024-64181$$FDA-CTU$$73$YR$$F$N$$$20240917$N$HP$US$
243389081$24338908$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010894$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240919$$CN$US$US
243389091$24338909$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009886$ELI LILLY AND CO$$16$YR$T$M$Y$$$20240919$$CN$US$US
243389101$24338910$1$I$$20240918$20240918$20240918$DIR$718952$$FDA-CTU$$$$$F$N$$$20240918$N$HP$US$
243389121$24338912$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64170$$FDA-CTU$$66$YR$$F$N$$$20240918$N$$US$
243389131$24338913$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64174$$FDA-CTU$$66$YR$$M$N$$$20240918$N$$US$
243389141$24338914$1$I$20240902$20240918$20240918$20240918$DIR$718940$$FDA-CTU$$$$$M$N$$$20240918$N$CN$US$
243389161$24338916$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64172$$FDA-CTU$$56$YR$$M$N$$$20240918$N$$US$
243389171$24338917$1$I$$20240911$20240919$20240919$EXP$$US-MYLANLABS-2024M1084511$MYLAN$Trabzonlu L, McDermott S, Pitman MB, Chebib I. Pulmonary Kaposi sarcoma in a patient with bilateral lung transplant: An unexpected diagnosis on transbronchial fine needle aspiration and core biopsy. Diagn-Cytopathol 2024; 52 (9): E215-E221.$70$YR$$F$Y$$$20240919$$MD$US$US
243389181$24338918$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64162$$FDA-CTU$$83$YR$$F$N$134$LBS$20240918$N$$US$
243389191$24338919$1$I$20200101$20240909$20240919$20240919$EXP$IN-MLMSERVICE-20240903-PI178651-00218-2$IN-STRIDES ARCOLAB LIMITED-2024SP011796$STRIDES$Chhabra N, Rahim JS, Ganguly S.. Occult Lymphoma in a Case of Resistant Dermatomyositis Complicated by Tubercular Lymphadenitis and Gumma. Indian J Dermatol. 2024;69(4):365$64$YR$$M$Y$$$20240919$$MD$IN$IN
243389201$24338920$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010883$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243389211$24338921$1$I$$20240916$20240919$20240919$EXP$$DE-ROCHE-10000084447$ROCHE$$$$$$Y$$$20240919$$MD$DE$DE
243389241$24338924$1$I$20240804$20240917$20240919$20240919$EXP$$DE-BAYER-2024A118265$BAYER$$56$YR$A$M$Y$$$20240919$$CN$DE$DE
243389261$24338926$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64147$$FDA-CTU$$51$YR$$F$N$$$20240918$N$$US$
243389271$24338927$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA266113$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240919$$HP$US$US
243389281$24338928$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA265975$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240919$$MD$US$US
243389291$24338929$1$I$20240101$20240904$20240919$20240919$PER$$US-SA-2024SA270996$SANOFI AVENTIS$$79$YR$E$F$Y$74.55$KG$20240919$$MD$US$US
243389301$24338930$1$I$20240301$20240827$20240919$20240919$PER$$US-SA-2024SA266676$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240919$$MD$US$US
243389311$24338931$1$I$20240912$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64264$$FDA-CTU$$74$YR$$F$N$$$20240918$N$PH$US$
243389321$24338932$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA267675$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240919$$HP$US$US
243389331$24338933$1$I$$20240909$20240919$20240919$30DAY$$US-GSK-US2024112008$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243389341$24338934$1$I$$20240911$20240919$20240919$30DAY$$US-GSK-US2024113147$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243389351$24338935$1$I$$20240909$20240919$20240919$30DAY$$US-GSK-US2024AMR112234$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243389361$24338936$1$I$$20240909$20240919$20240919$EXP$$CA-TAKEDA-2023TUS013259$TAKEDA$$$$$F$Y$$$20240919$$CN$CA$CA
243389371$24338937$1$I$$20240913$20240919$20240919$PER$$US-ABBVIE-5924436$ABBVIE$$$$$M$Y$$$20240919$$HP$US$US
243389381$24338938$1$I$$20240918$20240919$20240919$EXP$$US-BAYER-2024A133591$BAYER$$93$YR$E$M$Y$$$20240919$$HP$US$US
243389401$24338940$1$I$$20240916$20240919$20240919$EXP$$CA-Orion Corporation ORION PHARMA-24_00031761$ORION$$63$YR$A$F$Y$$$20240919$$HP$CA$
243389411$24338941$1$I$20240101$20240917$20240919$20240919$EXP$$US-ABBVIE-5928780$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243389421$24338942$1$I$20240820$20240917$20240919$20240919$PER$$NVSC2024US187104$NOVARTIS$$57$YR$$F$Y$91$KG$20240919$$CN$US$US
243389431$24338943$1$I$20240101$20240905$20240919$20240919$EXP$$CA-UCBSA-2024045960$UCB$$$$$F$Y$$$20240919$$CN$CA$CA
243389441$24338944$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010875$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243389451$24338945$1$I$$20240910$20240919$20240919$PER$$US-RDY-SPO/USA/24/0013524$DR REDDYS$Yu MD, Bommakanti N, Yonekawa Y, Pulido JS. Minocycline-induced retinal pigment epithelium hyperpigmentation masquerading as age-related macular degeneration: Case presentation and proposed mechanism. American Journal of Ophthalmology Case Reports. 2024;36(0): doi:10.1016/j.ajoc.2024.102154.$80$YR$E$M$Y$$$20240919$$HP$US$US
243389461$24338946$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010966$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243389471$24338947$1$I$20240101$20240911$20240919$20240919$EXP$$CA-CELLTRION INC.-2024CA022219$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
243389481$24338948$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64187$$FDA-CTU$$$$$F$N$$$20240918$N$HP$US$
243389491$24338949$1$I$$20240916$20240918$20240918$DIR$FDA-CDER-CTU-2024-64171$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243389501$24338950$1$I$20240918$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64217$$FDA-CTU$$64$YR$$F$N$$$20240918$N$$US$
243389511$24338951$1$I$20240705$20240918$20240918$20240918$DIR$718930$$FDA-CTU$$65$YR$$F$N$76.5$KG$20240918$N$CN$US$
243389521$24338952$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64254$$FDA-CTU$$$$$M$N$$$20240918$N$HP$US$
243389531$24338953$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64236$$FDA-CTU$$74$YR$$F$N$$$20240918$N$$US$
243389541$24338954$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64255$$FDA-CTU$$74$YR$$M$N$$$20240918$N$$US$
243389551$24338955$1$I$20240918$20240918$20240918$20240918$DIR$718922$$FDA-CTU$$27$YR$$F$N$$$20240918$N$HP$US$
243389561$24338956$1$I$20240823$20240907$20240918$20240918$DIR$FDA-CDER-CTU-2024-64260$$FDA-CTU$$51$YR$$F$N$$$20240907$N$PH$US$
243389571$24338957$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64164$$FDA-CTU$$73$YR$$F$N$117.93$KG$20240918$N$HP$US$
243389581$24338958$1$I$20240917$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185876$AMGEN$$75$YR$E$F$Y$$$20240919$$CN$US$US
243389591$24338959$1$I$20240522$20240910$20240919$20240919$EXP$$EG-HIKMA PHARMACEUTICALS USA INC.-EG-H14001-24-08480$HIKMA$$$$$$Y$$$20240919$$MD$EG$EG
243389601$24338960$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010994$APOTEX$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65 (1):33-38$61$YR$$M$Y$$$20240919$$MD$US$US
243389611$24338961$1$I$$20240905$20240919$20240919$30DAY$$PT-JNJFOC-20240937609$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$PT$PT
243389621$24338962$1$I$$20240909$20240919$20240919$30DAY$$US-GSK-US2024AMR112346$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243389631$24338963$1$I$$20240908$20240919$20240919$PER$$US-JNJFOC-20240918914$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243389641$24338964$1$I$$20240911$20240919$20240919$EXP$$BR-JNJFOC-20240938826$JOHNSON AND JOHNSON$$19$YR$A$M$Y$72$KG$20240919$$CN$BR$BR
243389651$24338965$1$I$20240701$20240906$20240919$20240919$EXP$$JP-BOTANIX PHARMACEUTICALS-2024BOT00002$BOTANIX PHARMACEUTICALS$$18$YR$$F$Y$$$20240919$$MD$JP$JP
243389661$24338966$1$I$$20240917$20240919$20240919$PER$$US-JNJFOC-20240950162$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243389671$24338967$1$I$20160414$20240904$20240919$20240919$EXP$$US-COOPERSURGICAL, INC.-2024CPS002705$COOPERSURGICAL$$$$$F$Y$$$20240919$$LW$US$US
243389681$24338968$1$I$20170710$20240904$20240919$20240919$EXP$$US-COOPERSURGICAL, INC.-2024CPS002706$COOPERSURGICAL$$$$$F$Y$$$20240919$$LW$US$US
243389691$24338969$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010891$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243389701$24338970$1$I$$20240910$20240919$20240919$EXP$$CA-ROCHE-10000085256$ROCHE$$60$YR$A$F$Y$$$20240919$$HP$CA$CA
243389711$24338971$1$I$$20240916$20240919$20240919$EXP$$CA-Orion Corporation ORION PHARMA-24_00031745$ORION$$35$YR$A$M$Y$$$20240919$$MD$CA$
243389721$24338972$1$I$20240901$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185215$AMGEN$$61$YR$A$F$Y$$$20240919$$CN$US$US
243389731$24338973$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148838$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240919$$CN$US$US
243389741$24338974$1$I$$20240903$20240919$20240919$PER$$US-TEVA-VS-3240415$TEVA$$$$$F$Y$$$20240919$$HP$US$US
243389751$24338975$1$I$$20240906$20240919$20240919$EXP$$DE-B.Braun Medical Inc.-2161813$B BRAUN$$82$YR$$M$Y$80$KG$20240919$$$DE$DE
243389761$24338976$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010967$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243389771$24338977$1$I$20240301$20240916$20240919$20240919$EXP$$CO-UCBSA-2024047960$UCB$$42$YR$$F$Y$$$20240919$$CN$CO$CO
243389781$24338978$1$I$20240101$20240829$20240919$20240919$PER$$US-SA-2024SA267669$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240919$$MD$US$US
243389791$24338979$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA268900$SANOFI AVENTIS$$$$C$M$Y$16.3$KG$20240919$$MD$US$US
243389801$24338980$1$I$$20201207$20240919$20240919$EXP$$NVSC2020GB371144$NOVARTIS$$$$$$Y$$$20240919$$MD$GB$GB
243389812$24338981$2$F$20220505$20240920$20240919$20240927$EXP$$KR-ASTELLAS-2024-AER-007725$ASTELLAS$$$$A$M$Y$$$20240927$$HP$KR$KR
243389821$24338982$1$I$20210101$20240913$20240919$20240919$PER$$US-SA-2024SA268393$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240919$$MD$US$US
243389831$24338983$1$I$20240726$20240909$20240919$20240919$EXP$$US-VIIV HEALTHCARE LIMITED-US2024094257$VIIV$$46$YR$$M$Y$$$20240919$$CN$US$US
243389841$24338984$1$I$$20240909$20240919$20240919$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR115848$VIIV$$$$$$Y$$$20240919$$HP$US$US
243389851$24338985$1$I$$20240913$20240919$20240919$EXP$$US-EXELIXIS-EXL-2024-000215$EXELIXIS$$$$$M$Y$$$20240919$$CN$US$US
243389861$24338986$1$I$$20240917$20240919$20240919$EXP$$CA-TAKEDA-2024TUS093063$TAKEDA$$$$$M$Y$$$20240919$$CN$CA$CA
243389881$24338988$1$I$20240528$20240905$20240919$20240919$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09004$LUPIN$$$$$$Y$$$20240919$$MD$US$US
243389891$24338989$1$I$$20240916$20240919$20240919$EXP$$GB-AMGEN-GBRSL2024185380$AMGEN$$$$$F$Y$$$20240919$$CN$GB$GB
243389901$24338990$1$I$$20240903$20240919$20240919$EXP$$US-GSK-US2024110034$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$US$US
243389921$24338992$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA268897$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240919$$CN$US$US
243389931$24338993$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA268837$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240919$$CN$US$US
243389941$24338994$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA266948$SANOFI AVENTIS$$$$C$M$Y$$$20240919$$MD$US$US
243389951$24338995$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA240227$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240919$$MD$US$US
243389971$24338997$1$I$20240801$20240903$20240919$20240919$PER$$US-SA-2024SA270826$SANOFI AVENTIS$$73$YR$E$F$Y$41.82$KG$20240919$$MD$US$US
243389981$24338998$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA267212$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240919$$HP$US$US
243389991$24338999$1$I$$20240912$20240919$20240919$PER$$US-HALEON-2196729$Haleon PLC$$73$YR$$F$Y$$$20240919$$CN$US$US
243390001$24339000$1$I$20240812$20240830$20240919$20240919$PER$$US-SA-2024SA268367$SANOFI AVENTIS$$74$YR$E$M$Y$107.73$KG$20240919$$MD$US$US
243390011$24339001$1$I$20240917$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011192$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243390031$24339003$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011465$ELI LILLY AND CO$$55$YR$A$$Y$$$20240919$$LW$US$US
243390041$24339004$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011549$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243390051$24339005$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011905$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243390061$24339006$1$I$20130107$20240916$20240919$20240919$EXP$GB-MHRA-MED-202409151424039420-YTVZK$GB-MYLANLABS-2024M1084366$MYLAN$$30$YR$$M$Y$70$KG$20240919$$CN$GB$GB
243390071$24339007$1$I$$20240917$20240919$20240919$EXP$$EG-PFIZER INC-PV202400121766$PFIZER$Khattab. Characteristics of DNMT3a mutation in acute myeloid leukemia and its prognostic implication. Egyptian Journal of Medical Human Genetics. 2024;25(1):10.1186/s43042-024-00570-x$$$A$$Y$$$20240919$$HP$EG$EG
243390082$24339008$2$F$$20240918$20240919$20240923$EXP$$US-PFIZER INC-202400258408$PFIZER$Arif, T.. Upper gastrointestinal bleeding due to metastatic lung adenocarcinoma in the stomach and duodenum. ACG Case Reports Journal. 2024;11(8):1-4$79$YR$$M$Y$$$20240923$$MD$US$US
243390101$24339010$1$I$$20240913$20240919$20240919$EXP$$US-ABBVIE-5924983$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243390121$24339012$1$I$$20240822$20240919$20240919$PER$$US-009507513-2408USA009450$MERCK$Pechacek J, Schmitt MM, Ferre EMN, Webb T, Goldberg J, Pathan S, et al. Successful Treatment of Refractory Cutaneous Protothecosis With MAT2203, an Oral Lipid Nanocrystal Formulation of Amphotericin B. Open Forum Infectious Diseases. 2024;11 (8)$71$YR$$M$Y$$$20240919$$HP$US$US
243390131$24339013$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010968$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243390141$24339014$1$I$$20240911$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147009$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240919$$MD$US$US
243390151$24339015$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148166$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240919$$HP$US$US
243390161$24339016$1$I$20240701$20240917$20240919$20240919$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-148766$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240919$$HP$PR$PR
243390171$24339017$1$I$$20240917$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148811$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240919$$HP$US$US
243390181$24339018$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148598$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240919$$CN$US$US
243390191$24339019$1$I$20240913$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024184867$AMGEN$$79$YR$E$F$Y$$$20240919$$CN$US$US
243390201$24339020$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010946$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243390211$24339021$1$I$20240501$20240917$20240919$20240919$EXP$$NVSC2024VN186265$NOVARTIS$$$$A$F$Y$$$20240919$$MD$VN$VN
243390231$24339023$1$I$20240604$20240906$20240919$20240919$PER$$US-BAYER-2024A132651$BAYER$$32$YR$A$F$Y$$$20240919$$MD$US$US
243390241$24339024$1$I$$20240910$20240919$20240919$PER$$US-ABBVIE-5921085$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243390251$24339025$1$I$$20240830$20240919$20240919$PER$$US-TEVA-VS-3239653$TEVA$$$$$F$Y$$$20240919$$CN$US$US
243390261$24339026$1$I$$20240917$20240919$20240919$EXP$$CA-Orion Corporation ORION PHARMA-24_00031748$ORION$$24$YR$A$F$Y$$$20240919$$HP$CA$
243390271$24339027$1$I$$20240917$20240919$20240919$EXP$$US-GILEAD-2024-0688174$GILEAD$$$$E$F$Y$$$20240919$$CN$US$US
243390281$24339028$1$I$$20240913$20240919$20240919$EXP$$CO-VANTIVE-2024VAN019415$Vantive US Healthcare$$$$$M$Y$83$KG$20240919$$HP$CO$CO
243390291$24339029$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64124$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243390301$24339030$1$I$20240101$20240905$20240919$20240919$EXP$$US-UCBSA-2024045938$UCB$$$$$F$Y$$$20240919$$CN$US$US
243390321$24339032$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267703$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240919$$HP$US$US
243390331$24339033$1$I$20240801$20240911$20240919$20240919$PER$$US-SA-2024SA266934$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240919$$MD$US$US
243390341$24339034$1$I$20240831$20240909$20240919$20240919$PER$$CN-Eisai-EC-2024-173987$EISAI$$49$YR$A$F$Y$50$KG$20240919$$HP$CN$CN
243390351$24339035$1$I$$20240914$20240919$20240919$PER$$US-LEO Pharma-373539$LEO PHARM$$65$YR$$M$Y$$$20240919$$CN$US$US
243390361$24339036$1$I$$20240917$20240919$20240919$PER$$US-ROCHE-10000085353$ROCHE$$13$YR$T$F$Y$$$20240919$$MD$US$US
243390371$24339037$1$I$$20240829$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08746$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243390381$24339038$1$I$$20240811$20240919$20240919$PER$$US-FMCRTG-FMC-2408-000972$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240919$$HP$US$US
243390391$24339039$1$I$$20240809$20240919$20240919$PER$$US-FMCRTG-FMC-2408-000970$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240919$$CN$US$US
243390401$24339040$1$I$$20240809$20240919$20240919$PER$$US-FMCRTG-FMC-2408-000990$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240919$$HP$US$US
243390411$24339041$1$I$20240911$20240918$20240918$20240918$DIR$718996$$FDA-CTU$$82$YR$$F$N$67.1$KG$20240918$Y$$US$
243390421$24339042$1$I$$20240809$20240919$20240919$PER$$US-FMCRTG-FMC-2408-000988$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240919$$CN$US$US
243390431$24339043$1$I$$20240810$20240919$20240919$PER$$US-FMCRTG-FMC-2408-001001$FRESENIUS MEDICAL CARE$$78$YR$E$F$Y$90$KG$20240919$$HP$US$US
243390441$24339044$1$I$$20240812$20240919$20240919$PER$$US-FMCRTG-FMC-2408-000978$FRESENIUS MEDICAL CARE$$28$YR$A$M$Y$$$20240919$$HP$US$US
243390451$24339045$1$I$$20240808$20240919$20240919$PER$$US-FMCRTG-FMC-2408-000993$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240919$$CN$US$US
243390461$24339046$1$I$$20240808$20240919$20240919$PER$$US-FMCRTG-FMC-2408-000964$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240919$$CN$US$US
243390481$24339048$1$I$$20240730$20240919$20240919$PER$$US-FMCRTG-FMC-2408-000986$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240919$$HP$US$US
243390491$24339049$1$I$$20240910$20240919$20240919$EXP$$AU-CELLTRION INC.-2024AU022085$CELLTRION$$$$$$Y$$$20240919$$HP$AU$AU
243390511$24339051$1$I$$20240909$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143815$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240919$$MD$US$US
243390521$24339052$1$I$$20240917$20240919$20240919$EXP$GB-MHRA-TPP2549368C9495261YC1726502467565$GB-SANDOZ INC.-SDZ2024GB080837$SANDOZ$$32$YR$$F$Y$87$KG$20240919$$MD$GB$GB
243390531$24339053$1$I$20240917$20240917$20240919$20240919$EXP$$JP-ROCHE-10000085824$ROCHE$$9$DEC$E$M$Y$$$20240919$$MD$JP$JP
243390541$24339054$1$I$$20240708$20240919$20240919$EXP$$IT-GILEAD-2024-0688098$GILEAD$Crobu M, Ravanini P., Impaloni C., Martello C., Bargiacchi O., Di DC etal. Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection. Viruses. 2024;16(6):UNK. doi:10.3390/v16060992$$$$M$Y$$$20240919$$HP$IT$IT
243390551$24339055$1$I$20240101$20240910$20240919$20240919$EXP$$US-RECORDATI RARE DISEASE INC.-2024007090$RECORDATI$$$$$$Y$$$20240919$$CN$US$US
243390561$24339056$1$I$20240801$20240830$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08955$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243390581$24339058$1$I$20220201$20240906$20240919$20240919$EXP$$IT-CELLTRION INC.-2023IT012780$CELLTRION$Graziani L, Gori L, Manciulli T, Basile G, Campolmi I, Borchi B et al.. Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19.. Journal of  Antimicrobial Chemotherapy. 2023;78 (2):555-8$$$$$Y$$$20240919$$HP$IT$IT
243390591$24339059$1$I$$20240912$20240919$20240919$EXP$$GB-SANDOZ INC.-SDZ2024GB079937$SANDOZ$$$$$F$Y$$$20240919$$CN$GB$GB
243390601$24339060$1$I$$20240913$20240919$20240919$EXP$$CA-Orion Corporation ORION PHARMA-24_00031747$ORION$$40$YR$A$$Y$$$20240919$$MD$CA$
243390611$24339061$1$I$$20240917$20240919$20240919$PER$$US-ABBVIE-5929264$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243390621$24339062$1$I$20230831$20240904$20240919$20240919$EXP$$US-COOPERSURGICAL, INC.-2024CPS002710$COOPERSURGICAL$$$$$F$Y$$$20240919$$LW$US$US
243390631$24339063$1$I$20210611$20240904$20240919$20240919$EXP$$US-COOPERSURGICAL, INC.-2024CPS002711$COOPERSURGICAL$$$$$F$Y$$$20240919$$LW$US$US
243390651$24339065$1$I$20160916$20240904$20240919$20240919$EXP$$US-COOPERSURGICAL, INC.-2024CPS002707$COOPERSURGICAL$$$$$F$Y$$$20240919$$LW$US$US
243390661$24339066$1$I$20240801$20240905$20240919$20240919$EXP$$US-UCBSA-2024045962$UCB$$55$YR$$F$Y$$$20240919$$HP$US$US
243390671$24339067$1$I$20231101$20240715$20240919$20240919$PER$$US-ANIPHARMA-2024-US-038550$ANI$$46$YR$$F$Y$63.5$KG$20240919$$CN$US$US
243390681$24339068$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010957$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243390691$24339069$1$I$$20240917$20240919$20240919$EXP$$US-BAYER-2024A132860$BAYER$$$$$F$Y$$$20240919$$CN$US$US
243390701$24339070$1$I$20240916$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185319$AMGEN$$43$YR$A$F$Y$$$20240919$$CN$US$US
243390711$24339071$1$I$20240101$20240911$20240919$20240919$EXP$$CA-CELLTRION INC.-2024CA022214$CELLTRION$$$$$$Y$$$20240919$$HP$CA$CA
243390721$24339072$1$I$$20240914$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US081053$SANDOZ$$$$$F$Y$47.63$KG$20240919$$HP$US$US
243390741$24339074$1$I$$20240912$20240919$20240919$EXP$$US-SA-2024SA270561$SANOFI AVENTIS$$$$$F$Y$$$20240919$$PH$US$US
243390751$24339075$1$I$20240729$20240911$20240919$20240919$EXP$$EG-HIKMA PHARMACEUTICALS-EG-H14001-24-08532$HIKMA$$50$YR$$F$Y$117$KG$20240919$$MD$EG$EG
243390761$24339076$1$I$$20240918$20240919$20240919$EXP$$AU-SANDOZ INC.-SDZ2024AU081183$SANDOZ$$$$E$$Y$$$20240919$$HP$AU$AU
243390771$24339077$1$I$$20240913$20240919$20240919$EXP$$GB-ROCHE-10000081985$ROCHE$$56$YR$A$F$Y$$$20240919$$MD$GB$GB
243390781$24339078$1$I$20240910$20240913$20240919$20240919$EXP$$NVSC2024RU184995$NOVARTIS$$34$YR$$M$Y$98$KG$20240919$$HP$RU$RU
243390791$24339079$1$I$$20240917$20240919$20240919$EXP$$NVSC2024US186372$NOVARTIS$$60$YR$$F$Y$$$20240919$$CN$US$US
243390801$24339080$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010969$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243390821$24339082$1$I$$20240910$20240919$20240919$PER$$US-BAYER-2024A130254$BAYER$$$$$F$Y$$$20240919$$HP$US$US
243390831$24339083$1$I$$20240825$20240919$20240919$30DAY$$US-VEROBIOTECH-2024USVEROSPO00225$VERO BIOTECH$$$$A$M$Y$$$20240919$$HP$US$US
243390841$24339084$1$I$20240801$20240906$20240919$20240919$EXP$$US-UCBSA-2024046578$UCB$$46$YR$$F$Y$$$20240919$$HP$US$US
243390851$24339085$1$I$$20240914$20240919$20240919$EXP$$US-JNJFOC-20240946565$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243390861$24339086$1$I$20240830$20240905$20240919$20240919$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-17937$IPSEN$$62$YR$A$F$Y$$$20240919$$HP$US$US
243390871$24339087$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA266881$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240919$$HP$US$US
243390881$24339088$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA266883$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240919$$HP$US$US
243390891$24339089$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA266947$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240919$$HP$US$US
243390901$24339090$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267083$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240919$$HP$US$US
243390911$24339091$1$I$20240801$20240912$20240919$20240919$PER$$US-SA-2024SA266852$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240919$$HP$US$US
243390921$24339092$1$I$20240101$20240829$20240919$20240919$PER$$US-SA-2024SA267935$SANOFI AVENTIS$$27$YR$A$M$Y$77.27$KG$20240919$$MD$US$US
243390941$24339094$1$I$$20240913$20240919$20240919$EXP$$VN-MYLANLABS-2024M1085311$MYLAN$Do Thanh H, Anh DV, Hai GN, Le Xuan D. Community-acquired necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus in a healthy pregnant woman after being infected with influenza A: A case report for early warning. Respirol-Case-Rep 2024; 12 (7):.$40$YR$$F$Y$$$20240919$$MD$VN$VN
243390951$24339095$1$I$$20240912$20240919$20240919$EXP$$US-SA-2024SA270048$SANOFI AVENTIS$$24$YR$A$M$Y$295$KG$20240919$$MD$US$US
243390961$24339096$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268594$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240919$$MD$US$US
243390971$24339097$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268981$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240919$$MD$US$US
243390981$24339098$1$I$20240101$20240904$20240919$20240919$PER$$US-SA-2024SA270805$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240919$$MD$US$US
243390991$24339099$1$I$$20240904$20240919$20240919$PER$$US-SA-2024SA271070$SANOFI AVENTIS$$$$T$F$Y$63.64$KG$20240919$$MD$US$US
243391001$24339100$1$I$$20240910$20240919$20240919$PER$$US-SA-2023SA299783$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240919$$HP$US$US
243391011$24339101$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA267856$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240919$$MD$US$US
243391021$24339102$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA267877$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240919$$HP$US$US
243391031$24339103$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268552$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240919$$MD$US$US
243391041$24339104$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA267420$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$HP$US$US
243391051$24339105$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA268303$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240919$$HP$US$US
243391061$24339106$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268576$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240919$$MD$US$US
243391081$24339108$1$I$20240903$20240918$20240918$20240918$DIR$719000$$FDA-CTU$$82$YR$$F$N$67.1$KG$20240918$Y$$US$
243391091$24339109$1$I$20240909$20240918$20240918$20240918$DIR$718994$$FDA-CTU$$63$YR$$M$N$123.75$KG$20240918$N$CN$US$
243391101$24339110$1$I$20240915$20240916$20240919$20240919$DIR$FDA-CDER-CTU-2024-64268$$FDA-CTU$$69$YR$$M$N$61$KG$20240916$N$$US$
243391121$24339112$1$I$$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024184452$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243391131$24339113$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148522$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240919$$CN$US$US
243391142$24339114$2$F$20240906$20240919$20240919$20240926$EXP$$US-Calliditas-2024CAL01809$CALLIDITAS THERAPEUTICS$$53$YR$A$F$Y$98.11$KG$20240926$$HP$US$US
243391151$24339115$1$I$20220101$20240916$20240919$20240919$EXP$$DK-SANDOZ INC.-SDZ2024DK081193$SANDOZ$$$$E$M$Y$$$20240919$$MD$DK$DK
243391161$24339116$1$I$$20240917$20240919$20240919$EXP$$AU-MYLANLABS-2024M1084953$MYLAN$$$$$M$Y$$$20240919$$PH$AU$AU
243391171$24339117$1$I$20230601$20240913$20240919$20240919$EXP$$JP-009507513-2408JPN002003J$MERCK$$66$YR$$M$Y$$$20240919$$MD$JP$JP
243391181$24339118$1$I$$20240910$20240919$20240919$EXP$$FR-MYLANLABS-2024M1084238$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$29$YR$$M$Y$$$20240919$$HP$FR$FR
243391192$24339119$2$F$$20240918$20240919$20240924$EXP$$CA-SANDOZ INC.-SDZ2024CA080974$SANDOZ$$65$YR$$F$Y$$$20240924$$MD$CA$CA
243391201$24339120$1$I$20240816$20240905$20240919$20240919$PER$$US-INSUD PHARMA-2409US06934$INSUD PHARMA$$$$$$Y$$$20240919$$CN$US$US
243391221$24339122$1$I$$20240909$20240919$20240919$EXP$$ES-INSUD PHARMA-2409ES07116$INSUD PHARMA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, Saez-Penataro J, Andrade RJ, Lucena MI, Marino Z, Diaz A, Lens S, Londono MC, Forns X. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver International. 2024;44:286-292$$$$$Y$$$20240919$$HP$ES$ES
243391231$24339123$1$I$20240301$20240904$20240919$20240919$PER$$US-INSUD PHARMA-2409US06931$INSUD PHARMA$$$$$$Y$$$20240919$$CN$US$US
243391241$24339124$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010894$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243391251$24339125$1$I$20240913$20240918$20240919$20240919$EXP$RU-RZN-2565259$RU-BAYER-2024A133484$BAYER$$74$YR$E$M$Y$$$20240919$$HP$RU$RU
243391271$24339127$1$I$20240818$20240827$20240919$20240919$DIR$FDA-CDER-CTU-2024-64274$$FDA-CTU$$55$YR$$F$N$89.4$KG$20240827$N$$US$
243391291$24339129$1$I$$20240906$20240919$20240919$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01473$INTRA-CELLULAR THERAPIES$$$$A$F$Y$$$20240919$$MD$US$US
243391301$24339130$1$I$20240101$20240906$20240919$20240919$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01470$INTRA-CELLULAR THERAPIES$$66$YR$$M$Y$$$20240919$$CN$US$US
243391311$24339131$1$I$$20240905$20240919$20240919$EXP$$CA-BAXTER-2024BAX024450$BAXTER$$61$YR$$M$Y$$$20240919$$HP$CA$CA
243391321$24339132$1$I$20240904$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011743$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240919$$CN$US$US
243391331$24339133$1$I$20240912$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011179$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240919$$CN$US$US
243391341$24339134$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011869$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240919$$CN$US$US
243391351$24339135$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010854$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240919$$CN$US$US
243391361$24339136$1$I$$20240905$20240919$20240919$30DAY$$US-JNJFOC-20240937397$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$MD$US$US
243391381$24339138$1$I$$20240916$20240919$20240919$PER$$US-LEO Pharma-373597$LEO PHARM$$65$YR$$M$Y$$$20240919$$CN$US$US
243391391$24339139$1$I$$20240915$20240919$20240919$EXP$$NVSC2024US185016$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
243391401$24339140$1$I$$20240912$20240919$20240919$PER$$NVSC2024US183660$NOVARTIS$$$$$$Y$$$20240919$$MD$US$US
243391411$24339141$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010970$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243391421$24339142$1$I$$20240916$20240919$20240919$PER$$US-TAKEDA-2024TUS092316$TAKEDA$$$$$F$Y$$$20240919$$CN$US$US
243391431$24339143$1$I$$20240912$20240919$20240919$EXP$$CA-GSK-CA2023096144$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$CA$CA
243391441$24339144$1$I$20240801$20240917$20240919$20240919$EXP$$US-SA-2024SA269415$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240919$$HP$US$US
243391451$24339145$1$I$$20240910$20240919$20240919$EXP$$JP-CHEPLA-2024011810$CHEPLAPHARM$$$$E$F$Y$$$20240919$$PH$COUNTRY NOT SPECIFIED$JP
243391461$24339146$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268444$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240919$$MD$US$US
243391471$24339147$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA268652$SANOFI AVENTIS$$$$$F$Y$$$20240919$$HP$US$US
243391481$24339148$1$I$20240201$20240912$20240919$20240919$PER$$US-SA-2024SA266815$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240919$$MD$US$US
243391491$24339149$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA004828$SANOFI AVENTIS$$$$C$F$Y$$$20240919$$MD$US$US
243391501$24339150$1$I$20240901$20240911$20240919$20240919$PER$$US-SA-2024SA267085$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240919$$MD$US$US
243391511$24339151$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA269860$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240919$$MD$US$US
243391521$24339152$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA267078$SANOFI AVENTIS$$$$A$M$Y$$$20240919$$MD$US$US
243391531$24339153$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA267245$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240919$$HP$US$US
243391541$24339154$1$I$$20240823$20240919$20240919$PER$$US-SA-2024SA265970$SANOFI AVENTIS$$$$A$F$Y$75$KG$20240919$$MD$US$US
243391551$24339155$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA270062$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240919$$CN$US$US
243391561$24339156$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA267346$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240919$$MD$US$US
243391572$24339157$2$F$20240901$20240910$20240919$20240925$PER$$US-SA-2024SA265819$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240925$$MD$US$US
243391581$24339158$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA267140$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240919$$MD$US$US
243391591$24339159$1$I$20240801$20240911$20240919$20240919$PER$$US-SA-2024SA267147$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240919$$MD$US$US
243391611$24339161$1$I$$20240905$20240919$20240919$PER$$US-TEVA-VS-3241715$TEVA$$36$YR$$F$Y$$$20240919$$CN$US$US
243391621$24339162$1$I$$20240827$20240919$20240919$PER$$US-SA-2024SA267648$SANOFI AVENTIS$$$$A$M$Y$100$KG$20240919$$MD$US$US
243391631$24339163$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA268049$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
243391641$24339164$1$I$20240912$20240918$20240919$20240919$EXP$$CN-BAYER-2024A133577$BAYER$$64$YR$A$M$Y$80$KG$20240919$$HP$CN$CN
243391652$24339165$2$F$20240917$20240924$20240919$20240926$PER$$US-AMGEN-USASP2024185668$AMGEN$$38$YR$A$F$Y$$$20240926$$CN$US$US
243391661$24339166$1$I$$20240905$20240919$20240919$PER$$US-SERVIER-S24011831$SERVIER$$$$$$Y$$$20240919$$MD$US$US
243391671$24339167$1$I$$20240910$20240919$20240919$EXP$$DE-INFO-20240289$INFORLIFE$Haenle, M.. Infections after primary and revision total hip replacement caused by enterobacteria producing extended spectrum beta-lactamases (ESBL): A case series. HIP International. 2010;20 (2):248-254. doi:10.1177/112070001002000217$67$YR$A$F$Y$$$20240913$$HP$DE$DE
243391682$24339168$2$F$20240701$20240914$20240919$20240926$EXP$$IT-UCBSA-2024043971$UCB$$$$E$M$Y$$$20240926$$CN$IT$IT
243391691$24339169$1$I$$20240906$20240919$20240919$EXP$$US-JNJFOC-20240925706$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$HP$US$US
243391711$24339171$1$I$20240101$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024186375$AMGEN$$$$$F$Y$$$20240919$$CN$US$US
243391741$24339174$1$I$20240826$20240904$20240919$20240919$DIR$FDA-CDER-CTU-2024-64273$$FDA-CTU$$$$$M$N$78.3$KG$20240904$N$$US$
243391751$24339175$1$I$20200101$20240919$20240919$20240919$EXP$$FI-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052283$BOEHRINGER INGELHEIM$$$$$$Y$$$20240919$$MD$FI$FI
243391781$24339178$1$I$$20240905$20240919$20240919$PER$$US-SERVIER-S24011832$SERVIER$$$$$$Y$$$20240919$$MD$US$US
243391791$24339179$1$I$$20240911$20240919$20240919$EXP$$AU-Orion Corporation ORION PHARMA-24_00031709$ORION$$37$YR$A$M$Y$73$KG$20240919$$MD$AU$
243391811$24339181$1$I$20240701$20240918$20240918$20240918$DIR$718966$$FDA-CTU$$53$YR$$M$N$96.75$KG$20240918$N$CN$US$
243391821$24339182$1$I$20240829$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64272$$FDA-CTU$$$$$M$N$200.5$KG$20240918$N$$US$
243391831$24339183$1$I$20210915$20240918$20240918$20240918$DIR$719010$$FDA-CTU$$22$YR$$M$N$90$KG$20240918$N$CN$US$
243391841$24339184$1$I$$20240911$20240919$20240919$PER$$US-BAYER-2024A131042$BAYER$$$$$F$Y$$$20240919$$CN$US$US
243391851$24339185$1$I$20240801$20240905$20240919$20240919$EXP$$US-UCBSA-2024045860$UCB$$33$YR$$F$Y$$$20240919$$HP$US$US
243391861$24339186$1$I$20240904$20240916$20240919$20240919$PER$$US-HALEON-2197170$Haleon PLC$$76$YR$$F$Y$$$20240919$$CN$US$US
243391871$24339187$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA269193$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240919$$CN$US$US
243391881$24339188$1$I$$20240911$20240919$20240919$PER$$US-009507513-2409USA004424$MERCK$$$$$F$Y$$$20240919$$CN$US$US
243391891$24339189$1$I$20240901$20240906$20240919$20240919$PER$$US-MYLANLABS-2024M1082448$MYLAN$$70$YR$$M$Y$$$20240919$$PH$US$US
243391901$24339190$1$I$20240820$20240826$20240919$20240919$PER$$CA-MYLANLABS-2024M1079165$MYLAN$$40$YR$$F$Y$46.72$KG$20240919$$CN$CA$US
243391911$24339191$1$I$$20240917$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA080925$SANDOZ$$$$$F$Y$$$20240919$$HP$CA$CA
243391922$24339192$2$F$$20240914$20240919$20240919$PER$$US-ROCHE-RCA4926405$ROCHE$$51$YR$A$F$Y$$$20240919$$CN$US$US
243391931$24339193$1$I$20240101$20240913$20240919$20240919$PER$$US-SA-2024SA268433$SANOFI AVENTIS$$13$YR$T$M$Y$34$KG$20240919$$MD$US$US
243391941$24339194$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA268580$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240919$$HP$US$US
243391951$24339195$1$I$20240906$20240909$20240919$20240919$30DAY$$US-GSK-US2024112028$GLAXOSMITHKLINE$$20$YR$$F$Y$$$20240919$$CN$US$US
243391961$24339196$1$I$20240801$20240913$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147847$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$100.24$KG$20240919$$PH$US$US
243391971$24339197$1$I$20240917$20240918$20240918$20240918$DIR$718941$$FDA-CTU$$$$$F$N$$$20240918$N$$US$
243391982$24339198$2$F$$20240916$20240919$20240923$EXP$$NVSC2024FR184913$NOVARTIS$$$$E$F$Y$$$20240923$$MD$FR$FR
243391992$24339199$2$F$$20240919$20240919$20240930$EXP$$CA-CELLTRION INC.-2024CA022104$CELLTRION$$$$$$Y$$$20240930$$CN$CA$CA
243392001$24339200$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148308$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$102.97$KG$20240919$$CN$US$US
243392011$24339201$1$I$$20240916$20240919$20240919$PER$$US-HALEON-2197331$Haleon PLC$$$$$F$Y$$$20240919$$CN$US$US
243392031$24339203$1$I$20240702$20240909$20240919$20240919$EXP$$US-UCBSA-2024034554$UCB$$14$YR$$M$Y$$$20240919$$CN$US$US
243392041$24339204$1$I$$20240913$20240919$20240919$PER$$US-ROCHE-10000082384$ROCHE$$$$$M$Y$$$20240919$$HP$US$US
243392051$24339205$1$I$$20240904$20240919$20240919$EXP$$CA-BAXTER-2024BAX024245$BAXTER$$53$YR$$M$Y$$$20240919$$HP$CA$CA
243392061$24339206$1$I$20240911$20240915$20240919$20240919$PER$$US-BAYER-2024A131691$BAYER$$28$YR$A$F$Y$$$20240919$$HP$US$US
243392071$24339207$1$I$$20240917$20240919$20240919$PER$$US-HALEON-2197326$Haleon PLC$$$$$M$Y$$$20240919$$CN$US$US
243392081$24339208$1$I$20240305$20240917$20240919$20240919$EXP$$US-INCYTE CORPORATION-2024IN009848$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243392101$24339210$1$I$$20240916$20240919$20240919$PER$$US-ROCHE-10000085352$ROCHE$$$$$M$Y$$$20240919$$MD$US$US
243392111$24339211$1$I$20240101$20240917$20240919$20240919$EXP$$IN-PFIZER INC-PV202400101981$PFIZER$$58$YR$$M$Y$43$KG$20240919$$CN$IN$IN
243392121$24339212$1$I$$20240917$20240919$20240919$EXP$$US-PFIZER INC-202400258109$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243392132$24339213$2$F$$20240917$20240919$20240924$EXP$$US-PFIZER INC-PV202400121967$PFIZER$Hussein, G.. Stone heart syndrome: A curious case of digoxin toxicity and calcium infusion. Clinical Case Reports. 2024;12(9):10.1002/ccr3.9376$78$YR$$F$Y$$$20240924$$HP$US$US
243392141$24339214$1$I$$20240917$20240919$20240919$EXP$$US-PFIZER INC-PV202400121989$PFIZER$$86$YR$$M$Y$$$20240919$$HP$US$US
243392152$24339215$2$F$$20240919$20240919$20240923$EXP$$US-PFIZER INC-202400259136$PFIZER$$93$YR$$M$Y$$$20240923$$HP$US$US
243392161$24339216$1$I$$20240917$20240919$20240919$EXP$$US-PFIZER INC-PV202400121935$PFIZER$$80$YR$$F$Y$$$20240919$$CN$US$US
243392171$24339217$1$I$20240501$20240916$20240919$20240919$EXP$FR-AFSSAPS-GR2024001056$FR-PFIZER INC-202400257951$PFIZER$$69$YR$$F$Y$$$20240919$$PH$FR$FR
243392182$24339218$2$F$$20240917$20240919$20240920$EXP$$US-PFIZER INC-202400228043$PFIZER$$54$YR$$F$Y$83.46$KG$20240920$$HP$US$US
243392201$24339220$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266182$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240919$$MD$US$US
243392211$24339221$1$I$20240901$20240910$20240919$20240919$PER$$US-SA-2024SA266543$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240919$$MD$US$US
243392221$24339222$1$I$20240901$20240911$20240919$20240919$PER$$US-SA-2024SA267427$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240919$$HP$US$US
243392231$24339223$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA267979$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
243392241$24339224$1$I$20240101$20240917$20240919$20240919$EXP$$FI-PFIZER INC-202400244601$PFIZER$$44$YR$$F$Y$53.5$KG$20240919$$CN$FI$FI
243392271$24339227$1$I$$20240917$20240919$20240919$EXP$$JP-PFIZER INC-PV202400121749$PFIZER$Furuhara, Y.. A case of methotrexate-associated lymphoproliferative disorder that was not detected early enough to save the patient^s life. The 245th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2024;245th$94$YR$$F$Y$$$20240919$$HP$JP$JP
243392291$24339229$1$I$$20240913$20240919$20240919$EXP$$JP-PFIZER INC-PV202400120541$PFIZER$Sasaki, A.. Exceptional Response to Pembrolizumab in HER2-Positive Gallbladder Carcinoma with High Tumor Mutational Burden.. Journal of Gastrointestinal Cancer. 2024;10.1007/s12029-024-01112-9$67$YR$$M$Y$$$20240919$$HP$JP$JP
243392321$24339232$1$I$20240101$20240918$20240919$20240919$EXP$$US-ABBVIE-5929516$ABBVIE$$$$$$Y$$$20240919$$HP$US$US
243392331$24339233$1$I$20240701$20240917$20240919$20240919$EXP$$GB-PFIZER INC-202400258032$PFIZER$$$$$$Y$$$20240919$$CN$GB$GB
243392342$24339234$2$F$$20240917$20240919$20240920$EXP$$US-PFIZER INC-PV202400121408$PFIZER$$70$YR$$F$Y$$$20240920$$HP$US$US
243392351$24339235$1$I$$20240918$20240919$20240919$EXP$$JP-PFIZER INC-PV202400122231$PFIZER$$$$$M$Y$$$20240919$$MD$JP$JP
243392361$24339236$1$I$$20240916$20240919$20240919$EXP$$IN-PFIZER INC-PV202300103130$PFIZER$$62$YR$$M$Y$69$KG$20240919$$CN$IN$IN
243392371$24339237$1$I$20220301$20240913$20240919$20240919$EXP$$DE-PFIZER INC-PV202200008821$PFIZER$$40$YR$$M$Y$$$20240919$$MD$DE$DE
243392381$24339238$1$I$20240601$20240916$20240919$20240919$EXP$FR-AFSSAPS-BR2024000702$FR-PFIZER INC-202400256994$PFIZER$$49$YR$$M$Y$96$KG$20240919$$MD$FR$FR
243392411$24339241$1$I$20240801$20240916$20240919$20240919$EXP$DE-PEI-202400020020$DE-PFIZER INC-202400256953$PFIZER$$47$YR$$F$Y$$$20240919$$MD$DE$DE
243392422$24339242$2$F$20240905$20240923$20240919$20240927$EXP$$CN-PFIZER INC-PV202400120962$PFIZER$$83$YR$$F$Y$55$KG$20240927$$HP$CN$CN
243392431$24339243$1$I$20240313$20240916$20240919$20240919$EXP$IT-MINISAL02-1002272$IT-PFIZER INC-202400256977$PFIZER$$46$YR$$F$Y$$$20240919$$MD$IT$IT
243392441$24339244$1$I$20240607$20240916$20240919$20240919$EXP$$EG-PFIZER INC-PV202400121207$PFIZER$$69$YR$$F$Y$94$KG$20240919$$PH$EG$EG
243392451$24339245$1$I$20240811$20240917$20240919$20240919$EXP$FR-AFSSAPS-LL2024001758$FR-PFIZER INC-202400257801$PFIZER$$44$YR$$M$Y$$$20240919$$MD$FR$FR
243392472$24339247$2$F$20240912$20240920$20240919$20240925$EXP$$BR-PFIZER INC-202400258245$PFIZER$$85$YR$$M$Y$53.7$KG$20240925$$PH$BR$BR
243392481$24339248$1$I$$20240917$20240919$20240919$EXP$$AR-PFIZER INC-202400258888$PFIZER$$56$YR$$M$Y$$$20240919$$CN$AR$AR
243392501$24339250$1$I$20240829$20240916$20240919$20240919$EXP$BE-FAMHP-DHH-N2024-122579$BE-PFIZER INC-202400256986$PFIZER$$72$YR$$F$Y$$$20240919$$PH$BE$BE
243392511$24339251$1$I$20240517$20240916$20240919$20240919$EXP$FR-AFSSAPS-AM2024000717$FR-PFIZER INC-202400256989$PFIZER$$82$YR$$M$Y$61$KG$20240919$$PH$FR$FR
243392521$24339252$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010911$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243392531$24339253$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010971$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243392541$24339254$1$I$20240910$20240911$20240919$20240919$EXP$$US-JNJFOC-20240935779$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240919$$HP$US$US
243392551$24339255$1$I$20240827$20240917$20240919$20240919$EXP$$US-ABBVIE-5928590$ABBVIE$$60$YR$$M$Y$$$20240919$$CN$US$US
243392561$24339256$1$I$20221001$20240911$20240919$20240919$EXP$$AT-CELLTRION INC.-2024AT022224$CELLTRION$$$$$$Y$$$20240919$$CN$AT$AT
243392571$24339257$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148719$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240919$$HP$US$US
243392582$24339258$2$F$$20240914$20240919$20240919$PER$$NVSC2024US184729$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
243392591$24339259$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149278$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240919$$CN$US$US
243392601$24339260$1$I$$20240917$20240919$20240919$PER$$US-TAKEDA-2024TUS092933$TAKEDA$$$$$$Y$$$20240919$$CN$US$US
243392611$24339261$1$I$20240206$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64277$$FDA-CTU$$33$YR$$M$N$84.5$KG$20240918$N$$US$
243392641$24339264$1$I$20240913$20240917$20240919$20240919$DIR$FDA-CDER-CTU-2024-64269$$FDA-CTU$$68$YR$$M$N$65.1$KG$20240917$N$$US$
243392651$24339265$1$I$20240918$20240918$20240918$20240918$DIR$718986$$FDA-CTU$$73$YR$$M$N$$$20240918$N$$US$
243392662$24339266$2$F$$20240919$20240919$20240923$EXP$$US-ROCHE-10000078391$ROCHE$$81$YR$E$M$Y$$$20240923$$CN$US$US
243392671$24339267$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010902$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243392681$24339268$1$I$$20240910$20240919$20240919$EXP$$DE-ACS-20240352$ACS DOBFAR$Haenle, M.. Infections after primary and revision total hip replacement caused by enterobacteria producing extended spectrum beta-lactamases (ESBL): A case series. HIP International. 2010;20 (2):248-254. doi:10.1177/112070001002000217$67$YR$A$F$Y$$$20240910$$HP$DE$DE
243392691$24339269$1$I$$20240913$20240919$20240919$EXP$$JP-CHEPLA-2024011885$CHEPLAPHARM$Hasegawa Tomohiko. A case of ocular dystonia caused by olanzapine administration. The 78th Tama Pediatric Neurology Conference. 2024;2.$$$$$Y$$$20240919$$MD$COUNTRY NOT SPECIFIED$JP
243392711$24339271$1$I$$20240913$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009376$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240919$$CN$US$US
243392721$24339272$1$I$20240912$20240913$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010085$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240919$$CN$US$US
243392731$24339273$1$I$$20240916$20240919$20240919$EXP$$CA-Orion Corporation ORION PHARMA-24_00031719$ORION$$3$YR$C$$Y$$$20240919$$CN$CA$
243392741$24339274$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010961$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243392751$24339275$1$I$$20240912$20240919$20240919$30DAY$$US-PFIZER INC-202400255882$PFIZER$$11$YR$$M$Y$$$20240919$$CN$US$US
243392761$24339276$1$I$$20240916$20240919$20240919$PER$$US-SA-2024SA267541$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240919$$HP$US$US
243392771$24339277$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA265645$SANOFI AVENTIS$$93$YR$E$F$Y$$$20240919$$HP$US$US
243392781$24339278$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267270$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240919$$HP$US$US
243392791$24339279$1$I$20240101$20240823$20240919$20240919$PER$$US-SA-2024SA265962$SANOFI AVENTIS$$$$A$M$Y$$$20240919$$MD$US$US
243392801$24339280$1$I$20240904$20240911$20240919$20240919$EXP$$US-GSK-US2024113047$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240919$$CN$US$US
243392811$24339281$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA268658$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240919$$CN$US$US
243392831$24339283$1$I$20210617$20240916$20240919$20240919$EXP$$IL-ABBVIE-4128188$ABBVIE$$56$YR$$M$Y$74$KG$20240919$$MD$IL$IL
243392841$24339284$1$I$20240812$20240916$20240919$20240919$EXP$$SE-ABBVIE-5925239$ABBVIE$$71$YR$$F$Y$$$20240919$$CN$SE$SE
243392851$24339285$1$I$$20240915$20240919$20240919$PER$$US-BAYER-2024A132304$BAYER$$$$$F$Y$$$20240919$$CN$US$US
243392861$24339286$1$I$$20240910$20240919$20240919$PER$$US-009507513-2409USA004765$MERCK$Eakes J, Hatch L, Hennessy K, Ravichandran S, Ayoubi N, Fourzali K, et al. 50699 Pembrolizumab-Induced Lichenoid Drug Eruption Successfully Treated with Dupilumab - A Case Report. Journal of the American Academy of Dermatology. 2024;91 (3):AB70$85$YR$$M$Y$$$20240919$$HP$US$US
243392871$24339287$1$I$20240901$20240916$20240919$20240919$EXP$$BE-ABBVIE-5927485$ABBVIE$$78$YR$$F$Y$$$20240919$$HP$BE$BE
243392881$24339288$1$I$20240913$20240916$20240919$20240919$PER$$US-BAYER-2024A132315$BAYER$$25$YR$A$F$Y$$$20240919$$HP$US$US
243392891$24339289$1$I$$20240906$20240919$20240919$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09008$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243392901$24339290$1$I$20240101$20240917$20240919$20240919$EXP$$DE-JNJFOC-20240949401$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$MD$DE$DE
243392911$24339291$1$I$$20240905$20240919$20240919$30DAY$$BR-JNJFOC-20240937236$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$BR$BR
243392921$24339292$1$I$$20240911$20240919$20240919$EXP$$CA-CELLTRION INC.-2024CA021901$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
243392932$24339293$2$F$$20240918$20240919$20240919$PER$$NVSC2024US186527$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
243392941$24339294$1$I$20240905$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64271$$FDA-CTU$$71$YR$$M$N$129.23$KG$20240918$N$$US$
243392951$24339295$1$I$$20240914$20240919$20240919$PER$$US-ROCHE-3546929$ROCHE$$35$YR$A$F$Y$$$20240919$$MD$US$US
243392981$24339298$1$I$20231123$20240912$20240919$20240919$EXP$$JP-ROCHE-10000086020$ROCHE$$81$YR$E$M$Y$49.5$KG$20240919$$PH$JP$JP
243393001$24339300$1$I$20240806$20240918$20240918$20240918$DIR$718938$$FDA-CTU$$8$YR$$F$N$46.7$KG$20240918$N$PH$US$
243393011$24339301$1$I$$20240829$20240919$20240919$EXP$$US-SA-2024SA268930$SANOFI AVENTIS$$$$A$M$Y$86.5$KG$20240919$$MD$US$US
243393031$24339303$1$I$$20240905$20240919$20240919$EXP$$US-SA-2024SA269843$SANOFI AVENTIS$$$$E$F$Y$67.27$KG$20240919$$MD$US$US
243393043$24339304$3$F$$20240917$20240919$20240926$EXP$$DE-PFIZER INC-202400258677$PFIZER$Kommer, A.. Long-term survival of kidney-transplant recipient with donor-transmitted malignant melanoma after provoked rejection. Transplant Immunology. 2024;87:1-3$55$YR$$M$Y$$$20240926$$HP$DE$DE
243393051$24339305$1$I$20240101$20240916$20240919$20240919$EXP$$CA-TAKEDA-2024TUS093003$TAKEDA$$$$$M$Y$$$20240919$$CN$CA$CA
243393061$24339306$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186402$AMGEN$$$$$$Y$$$20240919$$PH$US$US
243393071$24339307$1$I$$20240826$20240919$20240919$30DAY$$US-VEROBIOTECH-2024USVEROSPO00226$VERO BIOTECH$$$$$$Y$$$20240919$$HP$US$US
243393111$24339311$1$I$20230101$20240912$20240919$20240919$EXP$$RU-KOWA-24EU002306$KOWA PHARM$$$$$$Y$$$20240919$$MD$RU$RU
243393121$24339312$1$I$20240912$20240918$20240919$20240919$EXP$$CN-BAYER-2024A133609$BAYER$$24$YR$A$M$Y$$$20240919$$HP$CN$CN
243393141$24339314$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA266961$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240919$$MD$US$US
243393151$24339315$1$I$20230101$20240913$20240919$20240919$PER$$US-SA-2024SA270123$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240919$$HP$US$US
243393161$24339316$1$I$20230101$20240912$20240919$20240919$PER$$US-SA-2024SA267150$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240919$$HP$US$US
243393171$24339317$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA268009$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240919$$CN$US$US
243393181$24339318$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267271$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240919$$HP$US$US
243393191$24339319$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267987$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240919$$MD$US$US
243393201$24339320$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267448$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240919$$HP$US$US
243393211$24339321$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267203$SANOFI AVENTIS$$$$C$M$Y$$$20240919$$HP$US$US
243393221$24339322$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267178$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240919$$HP$US$US
243393231$24339323$1$I$$20240827$20240919$20240919$PER$$US-SA-2024SA266786$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240919$$HP$US$US
243393241$24339324$1$I$$20240913$20240919$20240919$EXP$$FR-INCYTE CORPORATION-2024IN009815$INCYTE$$$$$$Y$$$20240919$$MD$FR$FR
243393251$24339325$1$I$$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024187096$AMGEN$$$$$$Y$$$20240919$$PH$US$US
243393261$24339326$1$I$20240101$20240903$20240919$20240919$PER$$US-FDC-2024USSPO00700$FDC LIMITED$$98$YR$E$F$Y$129$KG$20240919$$CN$US$US
243393281$24339328$1$I$$20240913$20240919$20240919$EXP$$US-INCYTE CORPORATION-2024IN009730$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243393291$24339329$1$I$20240101$20240916$20240919$20240919$EXP$$DK-UCBSA-2024047917$UCB$$30$YR$$F$Y$$$20240919$$MD$DK$DK
243393301$24339330$1$I$$20240916$20240919$20240919$PER$$US-BAYER-2024A132564$BAYER$$34$YR$A$F$Y$$$20240919$$MD$US$US
243393311$24339331$1$I$$20240912$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147736$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240919$$CN$US$US
243393321$24339332$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148858$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240919$$CN$US$US
243393331$24339333$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148852$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240919$$HP$US$US
243393341$24339334$1$I$$20240913$20240919$20240919$EXP$$FR-INCYTE CORPORATION-2024IN009729$INCYTE$$$$$$Y$$$20240919$$MD$FR$FR
243393351$24339335$1$I$$20240913$20240919$20240919$EXP$$JP-ROCHE-10000084959$ROCHE$$77$YR$E$F$Y$$$20240919$$MD$JP$JP
243393361$24339336$1$I$20240910$20240911$20240919$20240919$DIR$FDA-CDER-CTU-2024-64270$$FDA-CTU$$54$YR$$F$N$70$KG$20240911$N$$US$
243393371$24339337$1$I$20200917$20240918$20240918$20240918$DIR$718949$$FDA-CTU$$17$YR$$M$N$76.5$KG$20240918$Y$CN$US$
243393381$24339338$1$I$$20240918$20240918$20240918$DIR$718943$$FDA-CTU$$83$YR$$M$N$$$20240918$N$PH$US$
243393391$24339339$1$I$$20240918$20240918$20240918$DIR$718950$$FDA-CTU$$$$$UNK$N$$$20240918$N$CN$US$
243393401$24339340$1$I$20240918$20240918$20240918$20240918$DIR$718920$$FDA-CTU$$64$YR$$F$N$73.5$KG$20240918$N$PH$US$
243393421$24339342$1$I$$20240918$20240918$20240918$DIR$718951$$FDA-CTU$$$$$UNK$N$$$20240918$N$CN$US$
243393431$24339343$1$I$$20240918$20240918$20240918$DIR$718933$$FDA-CTU$$41$YR$$M$N$$$20240918$N$$US$
243393451$24339345$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010903$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243393461$24339346$1$I$$20240918$20240919$20240919$EXP$$AU-SANDOZ INC.-SDZ2024AU081228$SANDOZ$$$$E$$Y$$$20240919$$HP$AU$AU
243393481$24339348$1$I$$20240913$20240919$20240919$EXP$$NVSC2024GB185160$NOVARTIS$$49$YR$$$Y$$$20240919$$HP$GB$GB
243393501$24339350$1$I$$20240912$20240919$20240919$EXP$$US-MYLANLABS-2024M1084898$MYLAN$Skalak HM, Haas K, Laub M, Mulloy LL. New Onset Diabetic Ketoacidosis in a Renal Transplant Recipient. Am-J-Med-Sci 2024; 0 (0):.$38$YR$$M$Y$$$20240919$$HP$US$US
243393511$24339351$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010931$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243393521$24339352$1$I$20230501$20240913$20240919$20240919$EXP$$CN-PFIZER INC-PV202400120291$PFIZER$Pan, R.. Nursing experience of 1 patient with cor pulmonale who developed psychiatric symptoms and acute heart failure after using methylprednisolone. DA JIAN KANG. 2024;(16):34-36$86$YR$$M$Y$$$20240919$$HP$CN$CN
243393531$24339353$1$I$20240910$20240917$20240919$20240919$PER$$US-BAYER-2024A132605$BAYER$$$$$F$Y$$$20240919$$MD$US$US
243393542$24339354$2$F$$20240918$20240919$20240923$EXP$$DE-PFIZER INC-202400258617$PFIZER$Hagedorn, F.. Detection of multiple activating NRAS variants under BRAF/MEK-inhibitor therapy in BRAF positive malignant melanoma using liquid biopsy. JAAD Case Reports. 2024;52:4-7$28$YR$$M$Y$$$20240923$$MD$DE$DE
243393551$24339355$1$I$$20240917$20240919$20240919$PER$$US-BAYER-2024A133080$BAYER$$$$$$Y$$$20240919$$CN$US$US
243393561$24339356$1$I$$20240909$20240919$20240919$EXP$$JP-EMD Serono-2024048400$EMD SERONO INC$Sorimachi S. A Case of Pyothorax That Developed During Tepotinib Therapy for Lung Adenocarcinoma. The 698th Kanto Regional Meeting Held by the Japanese Society of Internal Medicine (abstracts). 2024;63-63. doi:Literature No.: 249A0544.$72$YR$E$F$Y$$$20240919$$MD$JP$JP
243393571$24339357$1$I$$20240909$20240919$20240919$PER$$US-ABBVIE-5920452$ABBVIE$$$$$$Y$$$20240919$$HP$US$US
243393591$24339359$1$I$$20240917$20240919$20240919$EXP$$GB-ANIPHARMA-2024-UK-000191$ANI$$59$YR$$F$Y$10$KG$20240919$$MD$GB$GB
243393601$24339360$1$I$20240903$20240903$20240919$20240919$PER$$US-JNJFOC-20240913600$JOHNSON AND JOHNSON$$1$YR$I$$Y$$$20240919$$CN$US$US
243393611$24339361$1$I$$20240905$20240919$20240919$30DAY$$US-JNJFOC-20240935332$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243393622$24339362$2$F$$20240919$20240919$20240920$PER$$US-JNJFOC-20240951368$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243393641$24339364$1$I$20240101$20240912$20240919$20240919$PER$$JP-Eisai-EC-2024-166883$EISAI$$$$E$M$Y$$$20240919$$MD$JP$JP
243393651$24339365$1$I$$20240910$20240919$20240919$EXP$$JP-Eisai-EC-2024-157608$EISAI$Sakane Tadashi ,et al.. A case of thymic carcinoma, which was thought to have developed pneumonia caused by Lenvatinib. The 43rd Japanese Society for Thymus Research Program and Abstracts. 2024: 29-29.$70$YR$E$M$Y$$$20240919$$MD$JP$JP
243393671$24339367$1$I$20240101$20240829$20240919$20240919$PER$$US-FDC-2024USSPO00687$FDC LIMITED$$63$YR$A$M$Y$$$20240919$$CN$US$US
243393681$24339368$1$I$20220430$20240910$20240919$20240919$EXP$$IN-ROCHE-10000084761$ROCHE$$87$YR$E$M$Y$58$KG$20240919$$HP$IN$IN
243393711$24339371$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149052$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240919$$CN$US$US
243393721$24339372$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148797$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$107.5$KG$20240919$$CN$US$US
243393732$24339373$2$F$$20240917$20240919$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148496$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240920$$CN$US$US
243393741$24339374$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148730$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240919$$HP$US$US
243393751$24339375$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148243$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240919$$CN$US$US
243393761$24339376$1$I$20240101$20240918$20240919$20240919$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052257$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240919$$MD$US$US
243393771$24339377$1$I$20240501$20240913$20240919$20240919$EXP$$US-009507513-2409USA005197$MERCK$$$$$M$Y$$$20240919$$MD$US$US
243393781$24339378$1$I$20240701$20240917$20240919$20240919$PER$$US-BAYER-2024A133422$BAYER$$40$YR$A$F$Y$$$20240919$$MD$US$US
243393791$24339379$1$I$20191201$20240909$20240919$20240919$EXP$$US-UCBSA-2024046414$UCB$$86$YR$$M$Y$$$20240919$$HP$US$US
243393801$24339380$1$I$20240101$20240909$20240919$20240919$EXP$$US-UCBSA-2024046457$UCB$$$$$M$Y$$$20240919$$CN$US$US
243393811$24339381$1$I$$20240916$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US081213$SANDOZ$$$$$F$Y$49.89$KG$20240919$$CN$US$US
243393821$24339382$1$I$$20240906$20240919$20240919$PER$$US-ABBVIE-5926256$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243393841$24339384$1$I$$20240917$20240919$20240919$PER$$US-BAYER-2024A133472$BAYER$$40$YR$A$F$Y$$$20240919$$HP$US$US
243393851$24339385$1$I$$20240918$20240918$20240918$DIR$718962$$FDA-CTU$$$$$UNK$N$$$20240918$$CN$US$
243393861$24339386$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010779$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240919$$CN$US$US
243393871$24339387$1$I$$20240910$20240919$20240919$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202409007941$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240919$$CN$BE$BE
243393881$24339388$1$I$20240801$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010888$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243393891$24339389$1$I$20240905$20240918$20240918$20240918$DIR$718958$$FDA-CTU$$14$YR$$F$N$85.05$KG$20240918$Y$CN$US$
243393901$24339390$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64322$$FDA-CTU$$65$YR$$M$N$$$20240919$N$$US$
243393912$24339391$2$F$$20240904$20240919$20240925$EXP$$DE-SA-2024SA270845$SANOFI AVENTIS$$$$$F$Y$$$20240925$$CN$DE$DE
243393921$24339392$1$I$20160101$20240911$20240919$20240919$EXP$$RU-JNJFOC-20240933728$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240919$$HP$RU$RU
243393931$24339393$1$I$$20240904$20240919$20240919$30DAY$$KR-JNJFOC-20240937425$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$PH$KR$KR
243393941$24339394$1$I$$20240910$20240919$20240919$EXP$$CA-JNJFOC-20240926328$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$68$KG$20240919$$HP$CA$CA
243393951$24339395$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64323$$FDA-CTU$$46$YR$$F$N$204.12$KG$20240919$N$$US$
243394001$24339400$1$I$20240901$20240909$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009534$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243394011$24339401$1$I$$20240917$20240919$20240919$PER$$US-HALEON-2197361$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243394021$24339402$1$I$20240917$20240918$20240918$20240918$DIR$718947$$FDA-CTU$$67$YR$$F$N$67.95$KG$20240918$N$PH$US$
243394031$24339403$1$I$20240807$20240910$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009585$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243394042$24339404$2$F$20240322$20240926$20240919$20240930$EXP$$US-ABBVIE-5927407$ABBVIE$$58$YR$$F$Y$$$20240930$$CN$US$US
243394051$24339405$1$I$$20240911$20240919$20240919$EXP$$NVSC2024US182874$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243394061$24339406$1$I$20240828$20240919$20240919$20240919$EXP$ES-AEMPS-1569549$ES-BAYER-2024A133791$BAYER$$67$YR$E$M$Y$87$KG$20240919$$MD$ES$ES
243394071$24339407$1$I$20240316$20240916$20240919$20240919$EXP$$US-ABBVIE-5926884$ABBVIE$$68$YR$$M$Y$$$20240919$$CN$US$US
243394081$24339408$1$I$$20240904$20240919$20240919$EXP$$RO-AZURITY PHARMACEUTICALS, INC.-AZR202409-000614$AZURITY PHARMACEUTICALS$Chisavu F, Gafencu M, Steflea RM, Vaduva A, Izvernariu F, Stroescu RF.. Acute glomerulonephritis following systemic scabies in two brothers.. Children. 2024;11:981$13$YR$$M$Y$$$20240919$$HP$RO$RO
243394101$24339410$1$I$$20240910$20240919$20240919$EXP$$IN-ROCHE-10000082430$ROCHE$$$$A$M$Y$$$20240919$$CN$IN$IN
243394111$24339411$1$I$$20240904$20240919$20240919$EXP$$RO-AZURITY PHARMACEUTICALS, INC.-AZR202409-000615$AZURITY PHARMACEUTICALS$Chisavu F, Gafencu M, Steflea RM, Vaduva A, Izvernariu F, Stroescu RF.. Acute glomerulonephritis following systemic scabies in two brothers.. Children. 2024;11:981$11$YR$$M$Y$$$20240919$$HP$RO$RO
243394131$24339413$1$I$$20240918$20240918$20240918$DIR$718954$$FDA-CTU$$$$$UNK$N$$$20240918$N$CN$US$
243394141$24339414$1$I$20240914$20240918$20240918$20240918$DIR$718987$$FDA-CTU$$52$YR$$F$N$58.5$KG$20240918$N$$US$
243394161$24339416$1$I$20240918$20240918$20240918$20240918$DIR$718989$$FDA-CTU$$50$YR$$M$N$112.5$KG$20240918$N$CN$US$
243394171$24339417$1$I$$20240918$20240918$20240918$DIR$718995$$FDA-CTU$$$$$F$N$$$20240918$N$$US$
243394182$24339418$2$F$$20240918$20240919$20240921$PER$$US-HALEON-2197192$Haleon PLC$$$$$$Y$$$20240921$$CN$US$US
243394191$24339419$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243787$TEVA$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240919$$MD$US$US
243394211$24339421$1$I$$20240909$20240919$20240919$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR115850$VIIV$$$$$$Y$$$20240919$$HP$US$US
243394231$24339423$1$I$20240824$20240909$20240919$20240919$PER$$CN-Eisai-EC-2024-173988$EISAI$$65$YR$E$F$Y$50$KG$20240919$$HP$CN$CN
243394261$24339426$1$I$$20240906$20240919$20240919$30DAY$$AU-JNJFOC-20240934846$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$PH$AU$AU
243394271$24339427$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA270028$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240919$$MD$US$US
243394281$24339428$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268859$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
243394291$24339429$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA266912$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240919$$HP$US$US
243394301$24339430$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA267383$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240919$$MD$US$US
243394311$24339431$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267344$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240919$$HP$US$US
243394321$24339432$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268841$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240919$$HP$US$US
243394341$24339434$1$I$$20240917$20240919$20240919$EXP$$US-ABBVIE-5927974$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243394351$24339435$1$I$$20240912$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146627$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240919$$PH$US$US
243394361$24339436$1$I$$20240917$20240919$20240919$EXP$$US-ABBVIE-5928145$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243394371$24339437$1$I$$20240916$20240919$20240919$EXP$$GB-SANDOZ INC.-SDZ2024GB029049$SANDOZ$$$$$F$Y$$$20240919$$CN$GB$GB
243394381$24339438$1$I$$20240913$20240919$20240919$EXP$$NVSC2024CA176838$NOVARTIS$$25$YR$$F$Y$$$20240919$$CN$CA$CA
243394391$24339439$1$I$$20240913$20240919$20240919$EXP$GB-MHRA-MED-202409131526270130-VJHLW$GB-009507513-2409GBR005329$MERCK$$62$YR$$F$Y$$$20240919$$HP$GB$GB
243394411$24339441$1$I$20240115$20240913$20240919$20240919$EXP$$NVSC2024FR170314$NOVARTIS$$52$YR$$M$Y$75$KG$20240919$$MD$FR$FR
243394421$24339442$1$I$$20240910$20240919$20240919$EXP$$IT-ACS-20240351$ACS DOBFAR$Giuri, P.. Acinetobacter Baumannii multi drug resistance (MDR): pathogen increasingly present in our departments and cause of deaths.. Congresso Nazionale SIMIT. 306 Atti 10:285$$$E$F$Y$$$20240910$$MD$IT$IT
243394431$24339443$1$I$$20240917$20240919$20240919$PER$$US-BAYER-2024A133474$BAYER$$36$YR$A$F$Y$$$20240919$$HP$US$US
243394441$24339444$1$I$20240801$20240910$20240919$20240919$EXP$$US-BIOCODEX2-2024001133$BIOCODEX$$10$YR$$M$Y$28.9$KG$20240919$$MD$US$US
243394461$24339446$1$I$$20240910$20240919$20240919$EXP$$JP-JNJFOC-20240950350$JOHNSON AND JOHNSON$Tsukamoto A, Kogami M, Tsukahara T, Tada K, Yamaji K, Tamura N. [3 A case of trisomy 8 associated intestinal Bechet^s disease effectively treated with ustekinumab] Proceedings of Kanto Rheumatology Conference. Curious cases and their problems. 2024.5.24;56:13-16$75$YR$E$M$Y$$$20240919$$MD$JP$JP
243394471$24339447$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA267532$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240919$$MD$US$US
243394481$24339448$1$I$$20240917$20240919$20240919$EXP$$AT-PFIZER INC-PV202400121913$PFIZER$Winklehner, M.. Progressive Encephalomyelitis With Rigidity and Myoclonus With Glycine Receptor and GAD65 Antibodies: Case Report and Potential Mechanisms. Neurology neuroimmunology + neuroinflammation. 2024;11(6):10.1212/NXI.0000000000200298$75$YR$$M$Y$$$20240919$$MD$AT$AT
243394501$24339450$1$I$$20240917$20240919$20240919$PER$$US-BAYER-2024A133225$BAYER$$$$$$Y$$$20240919$$CN$US$US
243394511$24339451$1$I$$20240909$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009530$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243394521$24339452$1$I$$20240910$20240919$20240919$PER$$US-MYLANLABS-2024M1083281$MYLAN$$81$YR$$F$Y$$$20240919$$CN$US$US
243394531$24339453$1$I$20240711$20240904$20240919$20240919$PER$$US-MYLANLABS-2024M1082627$MYLAN$$83$YR$$$Y$$$20240919$$CN$US$US
243394541$24339454$1$I$$20240909$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009522$INCYTE$$$$$$Y$$$20240919$$PH$US$US
243394551$24339455$1$I$$20240917$20240919$20240919$EXP$$NVSC2024US129921$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243394561$24339456$1$I$20240905$20240918$20240918$20240918$DIR$718914$$FDA-CTU$$71$YR$$F$N$83.19$KG$20240918$N$PH$US$
243394571$24339457$1$I$20240415$20240909$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009508$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243394581$24339458$1$I$$20240917$20240919$20240919$EXP$$CA-ANIPHARMA-2024-CA-004035$ANI$$53$YR$$M$Y$$$20240919$$HP$CA$CA
243394591$24339459$1$I$$20240917$20240919$20240919$EXP$$ET-GILEAD-2024-0688127$GILEAD$Gedefaw A., Tadesse B, Berhan Y., Makonnen E., Vella S., Aklillu E. The safety of a dolutegravir (DTG)-based antiretroviral treatment (ART) regimen for pregnancy and birth outcomes in Ethiopia: evidence from multicenter cohort study. BMC Infectious Diseases. 2024;24(1):unk. doi:10.1186/s12879-024-09763-6$$$$F$Y$$$20240919$$HP$ET$ET
243394601$24339460$1$I$$20240918$20240919$20240919$EXP$$AU-SANDOZ INC.-SDZ2024AU081199$SANDOZ$$$$E$$Y$$$20240919$$HP$AU$AU
243394611$24339461$1$I$20240101$20240905$20240919$20240919$EXP$$US-UCBSA-2024039687$UCB$$$$$F$Y$$$20240919$$CN$US$US
243394621$24339462$1$I$$20240904$20240919$20240919$PER$$US-GRANULES-US-2024GRASPO00401$GRANULES INDIA$$$$$$Y$$$20240919$$PH$US$US
243394631$24339463$1$I$20240626$20240912$20240919$20240919$EXP$FR-AFSSAPS-AVMA2024000402$FR-Waylis Therapeutics LLC-ATNAHS20240902604$Waylis$$35$YR$A$M$Y$$$20240919$$PH$FR$FR
243394641$24339464$1$I$20240524$20240912$20240919$20240919$EXP$$CA-TAKEDA-2024TUS091651$TAKEDA$$56$YR$$F$Y$69$KG$20240919$$MD$CA$CA
243394651$24339465$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA071062$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240919$$HP$US$US
243394661$24339466$1$I$$20240905$20240919$20240919$PER$$US-SA-2024SA266718$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240919$$CN$US$US
243394671$24339467$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267424$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240919$$HP$US$US
243394682$24339468$2$F$$20240919$20240919$20240923$EXP$$NVSC2024VE186535$NOVARTIS$$$$A$M$Y$$$20240923$$CN$VE$VE
243394691$24339469$1$I$20240806$20240918$20240919$20240919$EXP$IT-MINISAL02-1002658$NVSC2024IT186141$NOVARTIS$$44$YR$$M$Y$$$20240919$$CN$IT$IT
243394701$24339470$1$I$20230701$20240917$20240919$20240919$EXP$$NVSC2024US186275$NOVARTIS$$74$YR$$F$Y$$$20240919$$CN$US$US
243394711$24339471$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149056$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240919$$CN$US$US
243394721$24339472$1$I$$20240909$20240919$20240919$EXP$$US-UCBSA-2024046456$UCB$$$$$F$Y$$$20240919$$HP$US$US
243394741$24339474$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147723$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240919$$CN$US$US
243394751$24339475$1$I$$20240912$20240919$20240919$PER$$ES-Atnahs Limited-ATNAHS20240902603$Atnahs Healthcare$$29$YR$A$F$Y$$$20240919$$HP$ES$ES
243394761$24339476$1$I$$20240829$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139155$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240919$$CN$US$US
243394781$24339478$1$I$20240827$20240916$20240919$20240919$EXP$FR-AFSSAPS-NT2024001145$FR-FreseniusKabi-FK202414009$FRESENIUS KABI$$55$YR$A$M$Y$88$KG$20240919$$PH$FR$FR
243394791$24339479$1$I$$20240916$20240919$20240919$EXP$FR-AFSSAPS-AVPO2024000183$FR-FreseniusKabi-FK202413977$FRESENIUS KABI$$51$YR$A$F$Y$$$20240919$$PH$FR$FR
243394801$24339480$1$I$$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64328$$FDA-CTU$$$$$M$N$$$20240918$N$HP$US$
243394811$24339481$1$I$20240701$20240909$20240919$20240919$EXP$$US-Eisai-EC-2024-174084$EISAI$$61$YR$A$M$Y$$$20240919$$CN$US$US
243394821$24339482$1$I$20240509$20240910$20240919$20240919$EXP$$JP-Eisai-EC-2024-167209$EISAI$$57$YR$A$F$Y$$$20240919$$MD$JP$JP
243394831$24339483$1$I$20220101$20240909$20240919$20240919$EXP$$JP-Eisai-EC-2022-119241$EISAI$$66$YR$E$F$Y$$$20240919$$MD$JP$JP
243394841$24339484$1$I$$20240909$20240919$20240919$PER$$JP-Eisai-EC-2024-174110$EISAI$Anri Azuma. Considerations based on usage experience of LEN + PEN at our hospital.$$$E$F$Y$$$20240919$$MD$JP$JP
243394851$24339485$1$I$20240909$20240910$20240919$20240919$PER$$CN-Eisai-EC-2024-174198$EISAI$$49$YR$A$F$Y$61$KG$20240919$$HP$CN$CN
243394862$24339486$2$F$20231101$20240918$20240919$20240923$PER$$US-BIOGEN-2023BI01237915$BIOGEN$$67$YR$$F$Y$$$20240923$$CN$US$US
243394872$24339487$2$F$$20240917$20240919$20240927$PER$$US-MYLANLABS-2024M1084667$MYLAN$$$$$F$Y$65.77$KG$20240927$$CN$US$US
243394881$24339488$1$I$20240513$20240905$20240919$20240919$EXP$AU-TGA-816718$AU-SERVIER-S24011184$SERVIER$$$$$$Y$$$20240919$$CN$AU$AU
243394891$24339489$1$I$20240828$20240913$20240919$20240919$EXP$ES-AEMPS-1569549$ES-Atnahs Limited-ATNAHS20240902619$Atnahs Healthcare$$67$YR$E$M$Y$87$KG$20240919$$MD$ES$ES
243394901$24339490$1$I$20240715$20240917$20240919$20240919$PER$$US-BAYER-2024A133692$BAYER$$34$YR$A$F$Y$$$20240919$$MD$US$US
243394911$24339491$1$I$$20240904$20240919$20240919$PER$$US-GRANULES-US-2024GRASPO00402$GRANULES INDIA$$$$$M$Y$$$20240919$$PH$US$US
243394921$24339492$1$I$20180401$20240910$20240919$20240919$EXP$$DE-ROCHE-10000080848$ROCHE$$36$YR$A$F$Y$60$KG$20240919$$MD$DE$DE
243394941$24339494$1$I$$20240911$20240919$20240919$EXP$$US-TAKEDA-2024TUS033817$TAKEDA$$$$$M$Y$$$20240919$$CN$US$US
243394951$24339495$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010831$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240919$$CN$US$US
243394971$24339497$1$I$$20240913$20240919$20240919$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409008734$ELI LILLY AND CO$Placke, JM., Dissemond, J., Gratsias, E..Fulminant eczema herpeticum associated with baricitinib treatment.Dtsch Arztebl Int 2024;121:617.DOI:10.3238/arztebl.m2024.0024$22$YR$A$M$Y$$$20240919$$MD$DE$DE
243394981$24339498$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011536$ELI LILLY AND CO$$25$YR$A$M$Y$$$20240919$$CN$US$US
243394991$24339499$1$I$20240917$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010992$ELI LILLY AND CO$$88$YR$E$$Y$$$20240919$$CN$US$US
243395001$24339500$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010016$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240919$$CN$US$US
243395012$24339501$2$F$20240701$20240930$20240919$20240930$EXP$FR-AFSSAPS-BR2024000756$FR-ABBVIE-5928577$ABBVIE$$78$YR$$F$Y$65$KG$20240930$$PH$FR$FR
243395031$24339503$1$I$$20240905$20240919$20240919$30DAY$$KR-JNJFOC-20240934681$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$PH$KR$KR
243395041$24339504$1$I$20240909$20240909$20240919$20240919$EXP$$US-JNJFOC-20240923825$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20240919$$CN$US$US
243395072$24339507$2$F$20230608$20240918$20240919$20240920$EXP$$JP-JNJFOC-20240668909$JOHNSON AND JOHNSON$$72$YR$E$F$Y$37.5$KG$20240920$$MD$JP$JP
243395081$24339508$1$I$20220901$20240909$20240919$20240919$30DAY$$US-GSK-US2024112016$GLAXOSMITHKLINE$$46$YR$$F$Y$$$20240919$$CN$US$US
243395091$24339509$1$I$20240917$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185511$AMGEN$$79$YR$E$F$Y$$$20240919$$CN$US$US
243395101$24339510$1$I$$20240912$20240919$20240919$PER$$US-MYLANLABS-2024M1083985$MYLAN$$$$$F$Y$$$20240919$$CN$US$US
243395131$24339513$1$I$20240819$20240904$20240919$20240919$EXP$FR-AFSSAPS-LY2024001366$FR-DEXPHARM-2024-3201$DEXCEL$$8$MON$I$M$Y$9.4$KG$20240919$$MD$FR$FR
243395142$24339514$2$F$20240911$20240920$20240919$20240925$PER$$US-AMGEN-USASP2024183317$AMGEN$$48$YR$A$M$Y$125$KG$20240925$$PH$US$US
243395162$24339516$2$F$20240823$20240910$20240919$20240924$EXP$FR-AFSSAPS-PA2024001523$FR-Merz Pharmaceuticals GmbH-2024090000073$MERZ$$$$$$Y$$$20240924$$MD$FR$FR
243395171$24339517$1$I$$20240909$20240919$20240919$PER$$US-TEVA-VS-3243656$TEVA$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients. J-Am-Acad-Dermatol 2024; 90 (3): 642-644.$43$YR$$M$Y$$$20240919$$MD$US$US
243395193$24339519$3$F$20240917$20240925$20240919$20240926$PER$$US-AMGEN-USASP2024186526$AMGEN$$82$YR$E$F$Y$$$20240926$$HP$US$US
243395202$24339520$2$F$20240917$20240919$20240919$20240923$PER$$US-AMGEN-USASP2024186456$AMGEN$$33$YR$A$F$Y$$$20240923$$PH$US$US
243395211$24339521$1$I$$20240912$20240919$20240919$EXP$$CA-TAKEDA-2024TUS050726$TAKEDA$$$$$F$Y$$$20240919$$CN$CA$CA
243395221$24339522$1$I$$20240913$20240919$20240919$EXP$$US-AMGEN-USASP2024184252$AMGEN$Hoang T.D.; Flor R.J.; De La Torre S. et al.. Effects of teprotumumab and role of HLA markers in patients with thyroid eye disease. American Association Of Clinical Endocrinologists. 2024;1-36$$$$$Y$$$20240919$$MD$US$US
243395251$24339525$1$I$20240916$20240917$20240919$20240919$PER$$US-JNJFOC-20240943840$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$PH$US$US
243395261$24339526$1$I$$20240916$20240919$20240919$EXP$$US-JNJFOC-20240946833$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240919$$MD$US$US
243395271$24339527$1$I$$20240904$20240919$20240919$EXP$$US-GRANULES-US-2024GRASPO00403$GRANULES INDIA$$65$YR$E$M$Y$86.18$KG$20240919$$CN$US$US
243395282$24339528$2$F$$20240916$20240919$20240924$EXP$$PL-SANDOZ INC.-PHHY2018PL088437$SANDOZ$$65$YR$$F$Y$$$20240924$$MD$PL$PL
243395291$24339529$1$I$$20240918$20240919$20240919$PER$$NVSC2024US187227$NOVARTIS$$$$$$Y$$$20240919$$MD$US$US
243395301$24339530$1$I$20221104$20240916$20240919$20240919$EXP$$ES-FreseniusKabi-FK202413881$FRESENIUS KABI$$37$YR$A$M$Y$78.7$KG$20240919$$MD$ES$ES
243395311$24339531$1$I$$20240908$20240919$20240919$EXP$$GB-TAKEDA-2024TUS087058$TAKEDA$$$$$M$Y$$$20240919$$CN$GB$GB
243395321$24339532$1$I$20220910$20240910$20240919$20240919$PER$$US-RDY-OTH/USA/23/0181663$DR REDDYS$$61$YR$A$M$Y$$$20240919$$HP$US$US
243395341$24339534$1$I$$20240909$20240919$20240919$EXP$$AR-ROCHE-3435134$ROCHE$Casales F, Miguez J, Heriz A, Varela L, Gonzalez C, burbano C, Alonso R, Silva B Safety of high efficacy therapies in older people with multiple sclerosis: a real world evidence study (Abstract: P342/1088). Multiple Sclerosis Journal 2023;29 (3S):381-82.$$$$$Y$$$20240919$$HP$AR$AR
243395361$24339536$1$I$20240529$20240911$20240919$20240919$PER$GB-MHRA-MED-202406111554198940-SZPQT$GB-IDORSIA-008458-2024-GB$IDORSIA PHARMACEUTICALS$$66$YR$$M$Y$80$KG$20240919$$MD$GB$GB
243395371$24339537$1$I$20240918$20240918$20240918$20240918$DIR$718981$$FDA-CTU$$65$YR$$F$N$$$20240918$N$$US$
243395381$24339538$1$I$20240917$20240918$20240918$20240918$DIR$718955$$FDA-CTU$$53$YR$$F$N$$$20240918$N$PH$US$
243395391$24339539$1$I$20240917$20240918$20240918$20240918$DIR$719007$$FDA-CTU$$58$YR$$F$N$124.2$KG$20240918$N$CN$US$
243395401$24339540$1$I$$20240918$20240918$20240918$DIR$718910$$FDA-CTU$$$$$UNK$N$$$20240918$$CN$US$
243395411$24339541$1$I$$20240909$20240919$20240919$EXP$$ES-BEH-2024178594$CSL BEHRING$$$$$M$Y$$$20240919$$MD$ES$ES
243395421$24339542$1$I$$20240917$20240919$20240919$EXP$$GB-SANDOZ INC.-PHHY2019GB224679$SANDOZ$$$$$F$Y$$$20240919$$HP$GB$GB
243395431$24339543$1$I$$20240917$20240919$20240919$EXP$$GR-PFIZER INC-PV202400122125$PFIZER$$70$YR$$F$Y$$$20240919$$MD$GR$GR
243395441$24339544$1$I$$20240918$20240918$20240918$DIR$718991$$FDA-CTU$$63$YR$$M$N$$$20240918$N$PH$US$
243395451$24339545$1$I$$20240910$20240919$20240919$EXP$$CA-OTSUKA-2024_025571$OTSUKA$$36$YR$$M$Y$$$20240919$$MD$CA$CA
243395461$24339546$1$I$20240918$20240918$20240919$20240919$EXP$$US-PFIZER INC-PV202200021723$PFIZER$$62$YR$$M$Y$$$20240919$$HP$US$US
243395471$24339547$1$I$20240807$20240918$20240918$20240918$DIR$718918$$FDA-CTU$$76$YR$$F$N$$$20240918$Y$MD$US$
243395481$24339548$1$I$20240906$20240918$20240918$20240918$DIR$718976$$FDA-CTU$$70$YR$$M$N$84.15$KG$20240918$N$MD$US$
243395491$24339549$1$I$$20240911$20240919$20240919$EXP$$US-Bion-013839$BIONPHARMA$$5$DEC$A$F$Y$$$20240919$$HP$US$US
243395501$24339550$1$I$20231201$20240913$20240919$20240919$EXP$$US-PFIZER INC-202400256363$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243395521$24339552$1$I$20240917$20240918$20240918$20240918$DIR$718915$$FDA-CTU$$36$YR$$F$N$81$KG$20240918$N$MD$US$
243395541$24339554$1$I$$20240916$20240919$20240919$EXP$$NVSC2024PH185947$NOVARTIS$$61$YR$$F$Y$$$20240919$$CN$PH$PH
243395551$24339555$1$I$$20240917$20240919$20240919$PER$$US-BAYER-2024A133766$BAYER$$76$YR$E$F$Y$$$20240919$$CN$US$US
243395561$24339556$1$I$20240810$20240912$20240919$20240919$EXP$GB-MHRA-MED-202409121424552380-CGQTW$GB-TAKEDA-2024TUS091053$TAKEDA$$54$YR$$F$Y$68$KG$20240919$$HP$GB$GB
243395571$24339557$1$I$20141119$20240909$20240919$20240919$EXP$$JP-HBP-2024JP031263$HELSINN HEALTHCARE$$64$YR$$M$Y$68.1$KG$20240919$$MD$JP$JP
243395581$24339558$1$I$$20240904$20240919$20240919$PER$$US-GRANULES-US-2024GRASPO00405$GRANULES INDIA$$$$$M$Y$$$20240919$$CN$US$US
243395621$24339562$1$I$20240801$20240909$20240919$20240919$EXP$$BG-UCBSA-2024046436$UCB$$$$A$F$Y$$$20240919$$CN$BG$BG
243395631$24339563$1$I$$20240905$20240919$20240919$EXP$$GB-UCBSA-2024045893$UCB$$$$$F$Y$$$20240919$$CN$GB$GB
243395641$24339564$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148918$BRISTOL MYERS SQUIBB$$69$YR$E$$Y$$$20240919$$CN$US$US
243395651$24339565$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147911$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240919$$CN$US$US
243395661$24339566$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147369$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$87.09$KG$20240919$$PH$US$US
243395682$24339568$2$F$$20240925$20240919$20240930$EXP$$PL-AMGEN-POLSP2024182438$AMGEN$$74$YR$E$M$Y$$$20240930$$MD$PL$PL
243395691$24339569$1$I$$20240916$20240919$20240919$EXP$$NVSC2024CA186365$NOVARTIS$$55$YR$$F$Y$$$20240919$$CN$CA$CA
243395701$24339570$1$I$$20240917$20240919$20240919$PER$$NVSC2024US186606$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
243395711$24339571$1$I$$20240912$20240919$20240919$EXP$$JP-MALLINCKRODT-MNK202405765$MALLINCKRODT$$$$A$$Y$$$20240919$$HP$JP$JP
243395721$24339572$1$I$$20240910$20240919$20240919$EXP$$US-MALLINCKRODT-MNK202405711$MALLINCKRODT$Cao Zhang AM, Zale AD, Tabbara N, Yui JC.Concomitant oxidative haemolysis and methaemoglobinaemia following inhaled nitric oxide in a patient with G6PD deficiency.BMJ Case Rep.29-AUG-2024;17(8)$6$DEC$A$M$Y$$$20240919$$HP$US$US
243395731$24339573$1$I$$20240912$20240919$20240919$EXP$$JP-MALLINCKRODT-MNK202405766$MALLINCKRODT$$$$A$$Y$$$20240919$$HP$JP$JP
243395742$24339574$2$F$20240604$20240920$20240919$20240926$EXP$$US-ABBVIE-5926864$ABBVIE$$75$YR$$M$Y$81$KG$20240926$$CN$US$US
243395751$24339575$1$I$$20240904$20240919$20240919$PER$$US-GRANULES-US-2024GRASPO00406$GRANULES INDIA$$$$$M$Y$$$20240919$$CN$US$US
243395761$24339576$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5926862$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243395772$24339577$2$F$20240917$20240919$20240919$20240920$PER$$US-AMGEN-USASP2024186717$AMGEN$$81$YR$E$M$Y$$$20240920$$CN$US$US
243395781$24339578$1$I$$20240918$20240919$20240919$EXP$GB-ROCHE-10000080695$GB-SANDOZ INC.-SDZ2024GB081256$SANDOZ$$64$YR$$F$Y$$$20240919$$HP$GB$GB
243395791$24339579$1$I$$20240916$20240919$20240919$EXP$$US-JNJFOC-20240943686$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240919$$HP$US$US
243395801$24339580$1$I$$20240918$20240919$20240919$PER$$US-BAYER-2024A133594$BAYER$$73$YR$E$M$Y$$$20240919$$CN$US$US
243395811$24339581$1$I$20240730$20240918$20240919$20240919$PER$$US-BAYER-2024A133395$BAYER$$31$YR$A$F$Y$$$20240919$$CN$US$US
243395821$24339582$1$I$$20240918$20240919$20240919$PER$$US-GILEAD-2024-0688202$GILEAD$$$$$F$Y$$$20240919$$PH$US$US
243395831$24339583$1$I$20240905$20240917$20240919$20240919$EXP$$HU-FreseniusKabi-FK202413954$FRESENIUS KABI$$72$YR$E$F$Y$$$20240919$$MD$HU$HU
243395841$24339584$1$I$20240805$20240916$20240919$20240919$EXP$$DE-FreseniusKabi-FK202413919$FRESENIUS KABI$$76$YR$E$M$Y$86.2$KG$20240919$$MD$DE$DE
243395851$24339585$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147777$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240919$$CN$US$US
243395861$24339586$1$I$20240101$20240913$20240919$20240919$EXP$$JP-Eisai-EC-2024-174499$EISAI$Yoshiki Saeki, et al.. The use experience and discussion of Pem + LEN therapy for renal cell carcinoma at our hospital. Renal Cell Carcinoma Seminar in Higashiharima.$62$YR$A$M$Y$$$20240919$$MD$JP$JP
243395871$24339587$1$I$20240703$20240916$20240919$20240919$EXP$FR-AFSSAPS-RN2024000978$FR-FreseniusKabi-FK202413964$FRESENIUS KABI$$68$YR$E$F$Y$$$20240919$$PH$FR$FR
243395881$24339588$1$I$20160919$20240913$20240919$20240919$EXP$DE-EMA-DD-20181210-deep_a-114042$DE-RDY-GER/GER/18/0106313$DR REDDYS$$84$YR$E$M$Y$$$20240919$$MD$DE$DE
243395891$24339589$1$I$20240903$20240914$20240919$20240919$PER$$CN-Eisai-EC-2024-174439$EISAI$$42$YR$A$F$Y$48.5$KG$20240919$$HP$CN$CN
243395901$24339590$1$I$20240312$20240910$20240919$20240919$PER$$JP-Eisai-EC-2024-174445$EISAI$$$$E$F$Y$43.5$KG$20240919$$PH$JP$JP
243395912$24339591$2$F$$20240920$20240919$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148889$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$56.7$KG$20240923$$CN$US$US
243395921$24339592$1$I$20240915$20240917$20240919$20240919$PER$$US-ABBVIE-5927765$ABBVIE$$71$YR$$$Y$76.203$KG$20240919$$CN$US$US
243395931$24339593$1$I$20240913$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024187010$AMGEN$$$$$$Y$$$20240919$$HP$US$US
243395941$24339594$1$I$$20240911$20240919$20240919$EXP$$US-AMGEN-USASP2024181813$AMGEN$$$$$M$Y$$$20240919$$CN$US$US
243395951$24339595$1$I$$20240916$20240919$20240919$EXP$$GB-MYLANLABS-2024M1084923$MYLAN$$$$$M$Y$$$20240919$$CN$GB$GB
243395961$24339596$1$I$20240327$20240910$20240919$20240919$EXP$$JP-AMGEN-JPNSP2024095413$AMGEN$$80$YR$E$F$Y$47$KG$20240919$$MD$JP$JP
243395971$24339597$1$I$$20240913$20240919$20240919$EXP$$BE-MYLANLABS-2024M1083916$MYLAN$$74$YR$$F$Y$$$20240919$$MD$BE$BE
243395981$24339598$1$I$$20240912$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409008164$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240919$$CN$US$US
243395991$24339599$1$I$$20240918$20240919$20240919$PER$$US-BAYER-2024A133508$BAYER$$31$YR$A$F$Y$$$20240919$$MD$US$US
243396001$24339600$1$I$$20240830$20240919$20240919$EXP$$US-SA-2024SA270634$SANOFI AVENTIS$$67$YR$E$M$Y$81.633$KG$20240919$$MD$US$US
243396011$24339601$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA267884$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240919$$HP$US$US
243396021$24339602$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA267926$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240919$$MD$US$US
243396031$24339603$1$I$$20240905$20240919$20240919$EXP$$US-UCBSA-2024046005$UCB$$$$$F$Y$$$20240919$$CN$US$US
243396041$24339604$1$I$$20240909$20240919$20240919$EXP$$DE-TEVA-VS-3242563$TEVA$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.; Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.$1$YR$$M$Y$$$20240919$$HP$DE$DE
243396051$24339605$1$I$20240830$20240918$20240918$20240918$DIR$718982$$FDA-CTU$$61$YR$$F$N$85.5$KG$20240918$N$CN$US$
243396061$24339606$1$I$$20240918$20240918$20240918$DIR$718993$$FDA-CTU$$$$$M$N$$$20240918$N$CN$US$
243396071$24339607$1$I$$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64329$$FDA-CTU$$$$$F$N$$$20240918$N$HP$US$
243396081$24339608$1$I$$20240918$20240918$20240918$DIR$718961$$FDA-CTU$$68$YR$$M$N$75.15$KG$20240918$N$CN$US$
243396101$24339610$1$I$20240115$20240918$20240918$20240918$DIR$718932$$FDA-CTU$$61$YR$$F$N$61.2$KG$20240918$N$CN$US$
243396111$24339611$1$I$$20240913$20240919$20240919$PER$$US-ADVANZ PHARMA-202409007623$ADVANZ PHARMA$$$$$$Y$$$20240919$$MD$US$US
243396121$24339612$1$I$$20240904$20240919$20240919$PER$$US-GRANULES-US-2024GRASPO00407$GRANULES INDIA$$$$$M$Y$$$20240919$$CN$US$US
243396131$24339613$1$I$$20240916$20240919$20240919$EXP$$US-JNJFOC-20240942263$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$PH$US$US
243396141$24339614$1$I$$20240904$20240919$20240919$PER$$US-UniquePharma-US-2024UPLSPO00037$UNIQUE PHARMACEUTICALS$$$$$$Y$$$20240919$$CN$US$US
243396151$24339615$1$I$$20240918$20240919$20240919$PER$$NVSC2024US187202$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
243396162$24339616$2$F$20240101$20240919$20240919$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028263$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240925$$$US$US
243396171$24339617$1$I$$20240918$20240919$20240919$PER$$NVSC2024US187218$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
243396181$24339618$1$I$20240101$20240911$20240919$20240919$EXP$$US-ALKERMES INC.-ALK-2024-002384$ALKERMES$$$$$M$Y$$$20240919$$CN$US$US
243396191$24339619$1$I$$20240910$20240919$20240919$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27845$SAMSUNG BIOEPIS$$69$YR$E$F$Y$$$20240919$$MD$CA$CA
243396201$24339620$1$I$20240101$20240910$20240919$20240919$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27955$SAMSUNG BIOEPIS$$42$YR$A$F$Y$80$KG$20240919$$CN$CA$CA
243396211$24339621$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186175$AMGEN$$$$$$Y$$$20240919$$PH$US$US
243396221$24339622$1$I$20240101$20240911$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009623$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243396231$24339623$1$I$20240831$20240911$20240919$20240919$EXP$$BR-JNJFOC-20240936941$JOHNSON AND JOHNSON$$76$YR$E$F$Y$62$KG$20240919$$CN$BR$BR
243396242$24339624$2$F$20240806$20240918$20240919$20240925$EXP$$CA-GSK-CA2024098480$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$CA$CA
243396251$24339625$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149037$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240919$$CN$US$US
243396261$24339626$1$I$20240901$20240913$20240919$20240919$EXP$$JP-009507513-2409JPN002293J$MERCK$$73$YR$$$Y$$$20240919$$MD$JP$JP
243396271$24339627$1$I$$20240904$20240919$20240919$PER$$US-LEADINGPHARMA-US-2024LEASPO00399$LEADING PHARMA$$$$$F$Y$$$20240919$$CN$US$US
243396281$24339628$1$I$$20240918$20240918$20240918$DIR$718974$$FDA-CTU$$61$YR$$UNK$N$87.5$KG$20240918$N$PH$US$
243396311$24339631$1$I$$20240919$20240919$20240919$DIR$719043$$FDA-CTU$$$$$F$N$$$20240919$N$HP$US$
243396321$24339632$1$I$$20240909$20240919$20240919$EXP$$US-MRZWEB-2024090000091$MERZ$$$$$$Y$$$20240919$$MD$US$US
243396331$24339633$1$I$$20240910$20240919$20240919$EXP$$US-AMGEN-USASP2024183035$AMGEN$Enyeji A.M.; Arora A.; Mangat H.S.. Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports. Viral Immunology. 2024;37(6):298-307$67$YR$E$F$Y$52.154$KG$20240919$$HP$US$US
243396351$24339635$1$I$$20240918$20240919$20240919$PER$$US-BAYER-2024A133518$BAYER$$39$YR$A$F$Y$$$20240919$$MD$US$US
243396371$24339637$1$I$$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024186528$AMGEN$$$$$F$Y$$$20240919$$CN$US$US
243396381$24339638$1$I$$20240911$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009622$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243396391$24339639$1$I$$20240827$20240919$20240919$PER$$US-SA-2024SA266964$SANOFI AVENTIS$$68$YR$E$F$Y$61.82$KG$20240919$$MD$US$US
243396401$24339640$1$I$$20240828$20240919$20240919$PER$$US-SA-2024SA267023$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240919$$HP$US$US
243396411$24339641$1$I$20240801$20240910$20240919$20240919$PER$$US-SA-2024SA265817$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240919$$MD$US$US
243396421$24339642$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA266278$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240919$$MD$US$US
243396431$24339643$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267332$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240919$$HP$US$US
243396441$24339644$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA268178$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240919$$MD$US$US
243396451$24339645$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267963$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240919$$HP$US$US
243396461$24339646$1$I$20240909$20240913$20240919$20240919$PER$$US-SA-2024SA267710$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240919$$HP$US$US
243396471$24339647$1$I$$20240905$20240919$20240919$PER$$US-LEADINGPHARMA-US-2024LEASPO00424$LEADING PHARMA$$$$$$Y$$$20240919$$CN$US$US
243396481$24339648$1$I$20240716$20240911$20240919$20240919$EXP$$NVSC2024RU184491$NOVARTIS$$$$E$F$Y$$$20240919$$MD$RU$RU
243396511$24339651$1$I$20240101$20240918$20240919$20240919$PER$$US-BAYER-2024A133752$BAYER$$35$YR$A$F$Y$$$20240919$$MD$US$US
243396521$24339652$1$I$20220101$20240913$20240919$20240919$EXP$$CA-TAKEDA-2023TUS011271$TAKEDA$$$$$M$Y$$$20240919$$CN$CA$CA
243396541$24339654$1$I$$20240916$20240919$20240919$PER$$US-JNJFOC-20240941711$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$HP$US$US
243396551$24339655$1$I$$20240916$20240919$20240919$EXP$$ZA-BIOVITRUM-2024-ZA-012203$BIOVITRUM$$$$I$M$Y$$$20240919$$CN$ZA$ZA
243396561$24339656$1$I$$20240911$20240919$20240919$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27810$SAMSUNG BIOEPIS$$$$$M$Y$70$KG$20240919$$HP$CA$CA
243396571$24339657$1$I$$20240911$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009618$INCYTE$$$$$$Y$$$20240919$$HP$US$US
243396591$24339659$1$I$20240101$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148878$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240919$$CN$US$US
243396601$24339660$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147941$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240919$$HP$US$US
243396611$24339661$1$I$20240728$20240906$20240919$20240919$PER$$US-COSETTE-CP2024US000245$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240919$$CN$US$US
243396621$24339662$1$I$$20240909$20240919$20240919$30DAY$$US-GSK-US2024112037$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243396631$24339663$1$I$$20240916$20240919$20240919$EXP$$SA-TAKEDA-2024TUS092517$TAKEDA$$$$$F$Y$$$20240919$$HP$SA$SA
243396641$24339664$1$I$20240823$20240903$20240919$20240919$PER$$US-JNJFOC-20240906662$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$HP$US$US
243396651$24339665$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186367$AMGEN$$$$$$Y$$$20240919$$PH$US$US
243396661$24339666$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185637$AMGEN$$$$$M$Y$$$20240919$$CN$US$US
243396671$24339667$1$I$$20240912$20240919$20240919$EXP$GB-ADVANZ PHARMA-202108005843$GB-RDY-SPO/UKI/21/0139786$DR REDDYS$Sadik A, Jelley M, Ward R. Depression with psychosis following pregabalin discontinuation. Prog Neurol Psychiatry. 2021;25(1): 19-22. doi:10.1002/pnp.693.$74$YR$E$F$Y$$$20240919$$MD$GB$GB
243396681$24339668$1$I$$20240911$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009617$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243396691$24339669$1$I$$20240917$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA081106$SANDOZ$$71$YR$$M$Y$$$20240919$$CN$CA$CA
243396711$24339671$1$I$$20240913$20240919$20240919$EXP$$NVSC2024US186931$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
243396721$24339672$1$I$$20240905$20240919$20240919$EXP$$CA-UCBSA-2024045882$UCB$$$$$M$Y$$$20240919$$CN$CA$CA
243396741$24339674$1$I$20180101$20240918$20240919$20240919$EXP$$NVSC2024US186928$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
243396751$24339675$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243788$TEVA$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240919$$MD$US$US
243396761$24339676$1$I$$20240909$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409009883$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240919$$CN$US$US
243396771$24339677$1$I$20240901$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010862$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240919$$CN$US$US
243396781$24339678$1$I$20240101$20240906$20240919$20240919$EXP$$US-SA-2024SA268926$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240919$$HP$US$US
243396791$24339679$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243789$TEVA$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240919$$MD$US$US
243396801$24339680$1$I$$20240913$20240919$20240919$EXP$$CA-ABBVIE-5928834$ABBVIE$$$$$M$Y$$$20240919$$CN$CA$CA
243396811$24339681$1$I$$20240917$20240919$20240919$EXP$$US-SANDOZ INC.-NVSC2022US244551$SANDOZ$$69$YR$$M$Y$$$20240919$$MD$US$US
243396821$24339682$1$I$20240701$20240910$20240919$20240919$EXP$$US-JNJFOC-20240924618$JOHNSON AND JOHNSON$$76$YR$$F$Y$$$20240919$$CN$US$US
243396831$24339683$1$I$20240808$20240916$20240919$20240919$EXP$$US-ABBVIE-5926652$ABBVIE$$43$YR$$F$Y$$$20240919$$CN$US$US
243396841$24339684$1$I$20220101$20240917$20240919$20240919$PER$$US-ABBVIE-5928250$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243396852$24339685$2$F$20240906$20240919$20240919$20240927$30DAY$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03336$AMNEAL$$$$$F$Y$$$20240927$$HP$US$US
243396861$24339686$1$I$20090101$20240917$20240919$20240919$EXP$$FR-GILEAD-2024-0687989$GILEAD$$59$YR$A$M$Y$59$KG$20240919$$PH$FR$FR
243396891$24339689$1$I$20240918$20240919$20240919$20240919$DIR$719032$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243396911$24339691$1$I$20240530$20240919$20240919$20240919$DIR$719022$$FDA-CTU$$65$YR$$F$N$67.27$KG$20240919$N$$US$
243396931$24339693$1$I$$20240918$20240919$20240919$EXP$$AU-TGA-0000818353$SANDOZ$$$$E$$Y$$$20240919$$HP$AU$AU
243396941$24339694$1$I$20220824$20240912$20240919$20240919$EXP$$CA-TAKEDA-2022TUS055338$TAKEDA$$33$YR$$F$Y$$$20240919$$CN$CA$CA
243396951$24339695$1$I$20240101$20240916$20240919$20240919$PER$$US-SA-2024SA268340$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240919$$HP$US$US
243396971$24339697$1$I$20240101$20240830$20240919$20240919$EXP$$US-SA-2024SA269962$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240919$$MD$US$US
243396981$24339698$1$I$$20240911$20240919$20240919$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-27885$SAMSUNG BIOEPIS$$86$YR$E$F$Y$$$20240919$$CN$GB$GB
243396991$24339699$1$I$20240901$20240909$20240919$20240919$30DAY$$US-GSK-US2024112021$GLAXOSMITHKLINE$$85$YR$$F$Y$$$20240919$$CN$US$US
243397011$24339701$1$I$$20240916$20240919$20240919$EXP$$CA-TAKEDA-2024TUS092720$TAKEDA$$$$$M$Y$$$20240919$$CN$CA$CA
243397021$24339702$1$I$$20240916$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA080656$SANDOZ$$49$YR$$F$Y$77$KG$20240919$$HP$CA$CA
243397031$24339703$1$I$20240909$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185672$AMGEN$$63$YR$A$F$Y$$$20240919$$CN$US$US
243397041$24339704$1$I$20240912$20240914$20240919$20240919$PER$$US-AMGEN-USASP2024184450$AMGEN$$57$YR$A$F$Y$$$20240919$$CN$US$US
243397051$24339705$1$I$$20240911$20240919$20240919$PER$$US-SA-2023SA124641$SANOFI AVENTIS$$$$A$F$Y$58.9$KG$20240919$$MD$US$US
243397061$24339706$1$I$$20240821$20240919$20240919$PER$$US-SA-2024SA268297$SANOFI AVENTIS$$$$A$F$Y$65$KG$20240919$$MD$US$US
243397081$24339708$1$I$20240801$20240913$20240919$20240919$PER$$US-SA-2024SA268413$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240919$$MD$US$US
243397091$24339709$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA270227$SANOFI AVENTIS$$$$C$M$Y$$$20240919$$MD$US$US
243397101$24339710$1$I$20240823$20240823$20240919$20240919$PER$$CA-TOLMAR, INC.-24CA052196$TOLMAR$$74$YR$$M$Y$$$20240918$$CN$CA$CA
243397111$24339711$1$I$20240902$20240902$20240919$20240919$PER$$CA-TOLMAR, INC.-24CA051770$TOLMAR$$93$YR$$M$Y$$$20240918$$CN$CA$CA
243397121$24339712$1$I$20240902$20240902$20240919$20240919$PER$$CA-TOLMAR, INC.-24CA052372$TOLMAR$$80$YR$$M$Y$$$20240918$$CN$CA$CA
243397131$24339713$1$I$20240902$20240902$20240919$20240919$PER$$CA-TOLMAR, INC.-24CA052350$TOLMAR$$61$YR$$M$Y$$$20240918$$CN$CA$CA
243397141$24339714$1$I$20240101$20240902$20240919$20240919$PER$$CA-TOLMAR, INC.-24CA052351$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
243397151$24339715$1$I$$20240902$20240919$20240919$PER$$CA-TOLMAR, INC.-24CA052373$TOLMAR$$$$$M$Y$$$20240918$$CN$CA$CA
243397161$24339716$1$I$20240701$20240902$20240919$20240919$PER$$CO-TOLMAR, INC.-24CO052358$TOLMAR$$82$YR$$M$Y$$$20240918$$CN$CO$CO
243397171$24339717$1$I$20240902$20240902$20240919$20240919$PER$$FR-TOLMAR, INC.-24FR052340$TOLMAR$$83$YR$$M$Y$$$20240918$$PH$FR$FR
243397181$24339718$1$I$$20240823$20240919$20240919$PER$$DE-TOLMAR, INC.-24DE052198$TOLMAR$$$$$$Y$$$20240918$$HP$DE$DE
243397191$24339719$1$I$20240829$20240902$20240919$20240919$PER$$IT-TOLMAR, INC.-24IT052443$TOLMAR$$$$$$Y$$$20240918$$PH$IT$IT
243397201$24339720$1$I$20240902$20240902$20240919$20240919$PER$$TR-TOLMAR, INC.-24TR052339$TOLMAR$$74$YR$$M$Y$$$20240918$$PH$TR$TR
243397212$24339721$2$F$$20240918$20240919$20240926$EXP$$CA-TAKEDA-2024TUS093124$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
243397221$24339722$1$I$20240907$20240909$20240919$20240919$PER$GB-MHRA-MED-202409091023449280-GQMKJ$GB-IGSA-BIG0030631$GRIFOLS$$$$$M$Y$$$20240919$$HP$GB$GB
243397231$24339723$1$I$$20240909$20240919$20240919$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024111988$VIIV$$$$$M$Y$$$20240919$$HP$US$US
243397241$24339724$1$I$20240601$20240911$20240919$20240919$EXP$$US-Calliditas-2024CAL01682$CALLIDITAS THERAPEUTICS$$54$YR$A$F$Y$$$20240919$$CN$US$US
243397251$24339725$1$I$$20240916$20240919$20240919$PER$$US-ABBVIE-5926459$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243397271$24339727$1$I$$20240903$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08896$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243397291$24339729$1$I$20240917$20240918$20240919$20240919$PER$$US-BAYER-2024A133326$BAYER$$35$YR$A$F$Y$$$20240919$$MD$US$US
243397301$24339730$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243164$TEVA$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J-Forens-Legal-Med 2024; 101.$61$YR$$$Y$$$20240919$$HP$US$US
243397321$24339732$1$I$$20240918$20240919$20240919$EXP$$NVSC2024GB186541$NOVARTIS$$$$$$Y$$$20240919$$HP$GB$GB
243397331$24339733$1$I$20240101$20240911$20240919$20240919$EXP$$CA-CELLTRION INC.-2024CA015642$CELLTRION$$$$$$Y$$$20240919$$MD$CA$CA
243397341$24339734$1$I$$20240919$20240919$20240919$DIR$719049$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243397351$24339735$1$I$$20240911$20240919$20240919$EXP$$CA-CELLTRION INC.-2024CA021801$CELLTRION$$$$$$Y$$$20240919$$CN$CA$CA
243397361$24339736$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5927393$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243397371$24339737$1$I$$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64337$$FDA-CTU$$$$$F$N$$$20240918$N$HP$US$
243397391$24339739$1$I$$20240919$20240919$20240919$DIR$719046$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243397411$24339741$1$I$$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64330$$FDA-CTU$$$$$M$N$$$20240918$N$HP$US$
243397431$24339743$1$I$$20240919$20240919$20240919$DIR$719048$$FDA-CTU$$$$$M$N$$$20240919$Y$CN$US$
243397451$24339745$1$I$20240918$20240919$20240919$20240919$DIR$719037$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243397461$24339746$1$I$20240918$20240919$20240919$20240919$DIR$719041$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243397481$24339748$1$I$$20240919$20240919$20240919$DIR$719028$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243397491$24339749$1$I$20240817$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64345$$FDA-CTU$$76$YR$$M$N$$$20240919$Y$HP$US$
243397511$24339751$1$I$$20240919$20240919$20240919$DIR$719025$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243397521$24339752$1$I$$20240919$20240919$20240919$DIR$719023$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243397531$24339753$1$I$20240914$20240919$20240919$20240919$DIR$719014$$FDA-CTU$$37$YR$$F$N$45$KG$20240919$N$CN$US$
243397561$24339756$1$I$20240908$20240918$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148933$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240919$$HP$US$US
243397581$24339758$1$I$$20240913$20240919$20240919$EXP$$US-JNJFOC-20240940240$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243397591$24339759$1$I$20240906$20240912$20240919$20240919$EXP$$CN-JNJFOC-20240940444$JOHNSON AND JOHNSON$$46$YR$A$F$Y$70$KG$20240919$$HP$CN$CN
243397602$24339760$2$F$$20240918$20240919$20240924$PER$$US-AMGEN-USASP2024185687$AMGEN$$55$YR$A$F$Y$$$20240924$$HP$US$US
243397611$24339761$1$I$$20240831$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08850$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243397631$24339763$1$I$20240915$20240918$20240919$20240919$PER$$US-BAYER-2024A133382$BAYER$$47$YR$A$F$Y$$$20240919$$MD$US$US
243397641$24339764$1$I$$20240910$20240919$20240919$PER$$US-ABBVIE-5921528$ABBVIE$$$$$$Y$$$20240919$$HP$US$US
243397651$24339765$1$I$20240101$20240912$20240919$20240919$EXP$$SA-SA-2024SA269058$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240919$$HP$SA$SA
243397661$24339766$1$I$20240201$20240910$20240919$20240919$EXP$$NL-ELI_LILLY_AND_COMPANY-NL202409007724$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240919$$HP$NL$NL
243397671$24339767$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011334$ELI LILLY AND CO$$26$YR$A$M$Y$$$20240919$$CN$US$US
243397681$24339768$1$I$$20240912$20240919$20240919$EXP$GB-MHRA-MED-202409121020510640-JTRPD$GB-ELI_LILLY_AND_COMPANY-GB202409008767$ELI LILLY AND CO$$$$$M$Y$$$20240919$$CN$GB$GB
243397701$24339770$1$I$20240701$20240905$20240919$20240919$EXP$GB-MHRA-MED-202408280934033420-PHCZS$GB-ELI_LILLY_AND_COMPANY-GB202409004135$ELI LILLY AND CO$$$$$F$Y$81$KG$20240919$$CN$GB$GB
243397711$24339771$1$I$$20240916$20240919$20240919$EXP$$PL-SANDOZ INC.-PHHY2014PL057371$SANDOZ$$65$YR$$F$Y$$$20240919$$MD$PL$PL
243397721$24339772$1$I$$20240909$20240919$20240919$30DAY$$US-PFIZER INC-PV202400105979$PFIZER$$7$YR$$F$Y$$$20240919$$CN$US$US
243397741$24339774$1$I$$20240910$20240919$20240919$PER$$US-JNJFOC-20240842262$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240919$$HP$US$US
243397751$24339775$1$I$20240601$20240909$20240919$20240919$EXP$$GB-AMGEN-GBRSL2024127443$AMGEN$$41$YR$A$M$Y$$$20240919$$CN$GB$GB
243397761$24339776$1$I$$20240912$20240919$20240919$EXP$$AR-GSK-AR2024AMR106867$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$AR$AR
243397771$24339777$1$I$$20240903$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08864$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243397781$24339778$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64346$$FDA-CTU$$55$YR$$F$N$$$20240919$N$$US$
243397802$24339780$2$F$20240909$20240923$20240919$20240927$EXP$$ZA-BAYER-2024A133237$BAYER$$52$YR$A$F$Y$$$20240927$$HP$ZA$ZA
243397831$24339783$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64347$$FDA-CTU$$54$YR$$F$N$$$20240919$N$HP$US$
243397851$24339785$1$I$20150101$20240913$20240919$20240919$EXP$$US-ABBVIE-5923683$ABBVIE$$$$$F$Y$72$KG$20240919$$CN$US$US
243397861$24339786$1$I$$20240905$20240919$20240919$EXP$$US-SA-2024SA269761$SANOFI AVENTIS$$$$A$$Y$$$20240919$$HP$US$US
243397871$24339787$1$I$$20240917$20240919$20240919$PER$$US-HALEON-2197373$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243397881$24339788$1$I$$20240918$20240919$20240919$PER$$US-BAYER-2024A133513$BAYER$$24$YR$A$F$Y$$$20240919$$CN$US$US
243397891$24339789$1$I$20240101$20240913$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147231$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240919$$CN$US$US
243397901$24339790$1$I$$20240916$20240919$20240919$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051639$BOEHRINGER INGELHEIM$$44$YR$A$$Y$$$20240919$$MD$JP$JP
243397911$24339791$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266253$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240919$$MD$US$US
243397921$24339792$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266321$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240919$$HP$US$US
243397931$24339793$1$I$$20240912$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146166$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240919$$HP$US$US
243397941$24339794$1$I$20240814$20240910$20240919$20240919$EXP$FR-AFSSAPS-CN2024000836$FR-BIOCON BIOLOGICS LIMITED-BBL2024006757$BIOCON$$$$$$Y$$$20240919$$PH$FR$FR
243397951$24339795$1$I$$20240827$20240919$20240919$PER$$US-SA-2024SA267697$SANOFI AVENTIS$$$$A$F$Y$90.91$KG$20240919$$MD$US$US
243397971$24339797$1$I$20240901$20240913$20240919$20240919$PER$$US-SA-2024SA268431$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240919$$MD$US$US
243397981$24339798$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266387$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240919$$MD$US$US
243397991$24339799$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267578$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240919$$MD$US$US
243398002$24339800$2$F$20240906$20240912$20240919$20240919$PER$$US-JNJFOC-20240928165$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$CN$US$US
243398051$24339805$1$I$$20240911$20240919$20240919$EXP$$NVSC2024US174206$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
243398061$24339806$1$I$20240101$20240910$20240919$20240919$EXP$$US-SA-2024SA270349$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240919$$CN$US$US
243398071$24339807$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258805$PFIZER$$65$YR$$F$Y$$$20240919$$CN$US$US
243398081$24339808$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-202400258382$PFIZER$$50$YR$$F$Y$$$20240919$$CN$US$US
243398091$24339809$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-PV202300076967$PFIZER$$67$YR$$F$Y$$$20240919$$CN$US$US
243398121$24339812$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258325$PFIZER$$14$YR$$F$Y$$$20240919$$MD$US$US
243398131$24339813$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400251297$PFIZER$$77$YR$$F$Y$$$20240919$$CN$US$US
243398141$24339814$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-202400257965$PFIZER$$33$YR$$M$Y$$$20240919$$CN$US$US
243398151$24339815$1$I$$20240916$20240919$20240919$EXP$$CA-PFIZER INC-202201378011$PFIZER$$29$YR$$F$Y$$$20240919$$HP$CA$CA
243398161$24339816$1$I$20240901$20240917$20240919$20240919$PER$$US-PFIZER INC-202400259099$PFIZER$$$$$$Y$$$20240919$$CN$US$US
243398171$24339817$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-PV202400121400$PFIZER$$86$YR$$F$Y$$$20240919$$HP$US$US
243398181$24339818$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400122081$PFIZER$$36$YR$$M$Y$$$20240919$$CN$US$US
243398191$24339819$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400121807$PFIZER$$45$YR$$F$Y$$$20240919$$CN$US$US
243398221$24339822$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258243$PFIZER$$66$YR$$F$Y$$$20240919$$CN$US$US
243398231$24339823$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400259081$PFIZER$$$$$F$Y$$$20240919$$MD$US$US
243398241$24339824$1$I$$20240913$20240919$20240919$PER$$US-PFIZER INC-202400256361$PFIZER$$76$YR$$F$Y$$$20240919$$CN$US$US
243398252$24339825$2$F$$20240925$20240919$20240927$PER$$US-PFIZER INC-PV202400121416$PFIZER$$71$YR$$F$Y$$$20240927$$HP$US$US
243398271$24339827$1$I$20240101$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258307$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243398281$24339828$1$I$20240911$20240911$20240919$20240919$PER$$US-PFIZER INC-PV202400122455$PFIZER$$54$YR$$$Y$$$20240919$$CN$US$US
243398291$24339829$1$I$20240101$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258648$PFIZER$$73$YR$$F$Y$$$20240919$$MD$US$US
243398311$24339831$1$I$20240906$20240916$20240919$20240919$PER$$US-PFIZER INC-202400258399$PFIZER$$57$YR$$F$Y$$$20240919$$HP$US$US
243398321$24339832$1$I$$20240913$20240919$20240919$PER$$US-PFIZER INC-202400256472$PFIZER$$76$YR$$F$Y$$$20240919$$CN$US$US
243398331$24339833$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400121929$PFIZER$$37$YR$$M$Y$$$20240919$$CN$US$US
243398341$24339834$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400121927$PFIZER$$59$YR$$M$Y$$$20240919$$HP$US$US
243398351$24339835$1$I$20240801$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400100247$PFIZER$$64$YR$$F$Y$$$20240919$$HP$US$US
243398361$24339836$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258156$PFIZER$$15$YR$$F$Y$$$20240919$$HP$US$US
243398371$24339837$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400122246$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243398381$24339838$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258465$PFIZER$$65$YR$$F$Y$$$20240919$$MD$US$US
243398391$24339839$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-202400055734$PFIZER$$46$YR$$M$Y$$$20240919$$CN$US$US
243398401$24339840$1$I$$20240918$20240919$20240919$EXP$$CA-PFIZER INC-202400259025$PFIZER$$73$YR$$F$Y$$$20240919$$HP$CA$CA
243398411$24339841$1$I$$20240913$20240919$20240919$PER$$US-PFIZER INC-PV202400075192$PFIZER$$51$YR$$F$Y$$$20240919$$HP$US$US
243398421$24339842$1$I$20240916$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258794$PFIZER$$56$YR$$M$Y$$$20240919$$CN$US$US
243398432$24339843$2$F$$20240917$20240919$20240920$EXP$$US-PFIZER INC-PV202400122004$PFIZER$$69$YR$$$Y$$$20240920$$CN$US$US
243398451$24339845$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258607$PFIZER$$44$YR$$F$Y$$$20240919$$MD$US$US
243398461$24339846$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-202300313259$PFIZER$$62$YR$$F$Y$$$20240919$$HP$US$US
243398471$24339847$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-PV202400121873$PFIZER$$$$$M$Y$$$20240919$$CN$US$US
243398481$24339848$1$I$20240101$20240916$20240919$20240919$PER$$US-PFIZER INC-PV202400121494$PFIZER$$61$YR$$F$Y$$$20240919$$HP$US$US
243398491$24339849$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-PV202400075970$PFIZER$$22$YR$$F$Y$$$20240919$$HP$US$US
243398502$24339850$2$F$$20240920$20240919$20240925$EXP$$US-PFIZER INC-202400258398$PFIZER$$68$YR$$M$Y$$$20240925$$HP$US$US
243398512$24339851$2$F$$20240920$20240919$20240924$PER$$US-PFIZER INC-202400258520$PFIZER$$77$YR$$F$Y$$$20240924$$PH$US$US
243398521$24339852$1$I$20240917$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258791$PFIZER$$37$YR$$F$Y$$$20240919$$CN$US$US
243398531$24339853$1$I$20240916$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258774$PFIZER$$61$YR$$F$Y$$$20240919$$HP$US$US
243398541$24339854$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400121981$PFIZER$$74$YR$$F$Y$$$20240919$$HP$US$US
243398551$24339855$1$I$20240915$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258235$PFIZER$$49$YR$$F$Y$$$20240919$$CN$US$US
243398561$24339856$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-PV202400121318$PFIZER$$92$YR$$F$Y$$$20240919$$MD$US$US
243398581$24339858$1$I$20240830$20240918$20240919$20240919$EXP$$CN-PFIZER INC-PV202400122365$PFIZER$$5$YR$$M$Y$14$KG$20240919$$HP$CN$CN
243398591$24339859$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-PV202300102594$PFIZER$$57$YR$$F$Y$$$20240919$$CN$US$US
243398601$24339860$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-PV202400122070$PFIZER$$52$YR$$F$Y$$$20240919$$CN$US$US
243398611$24339861$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400121990$PFIZER$$47$YR$$F$Y$$$20240919$$CN$US$US
243398621$24339862$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-PV202400121454$PFIZER$$49$YR$$F$Y$$$20240919$$PH$US$US
243398652$24339865$2$F$$20240916$20240919$20240923$EXP$$CA-PFIZER INC-202400258902$PFIZER$$54$YR$$F$Y$$$20240923$$CN$CA$CA
243398661$24339866$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-PV202400121229$PFIZER$$56$YR$$F$Y$$$20240919$$MD$US$US
243398672$24339867$2$F$20240917$20240927$20240919$20240930$PER$$US-PFIZER INC-202400258798$PFIZER$$$$$M$Y$$$20240930$$CN$US$US
243398681$24339868$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258542$PFIZER$$55$YR$$F$Y$$$20240919$$CN$US$US
243398691$24339869$1$I$20240101$20240916$20240919$20240919$PER$$US-PFIZER INC-202400257442$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243398701$24339870$1$I$$20240912$20240919$20240919$PER$$US-PFIZER INC-PV202400122464$PFIZER$$72$YR$$F$Y$$$20240919$$CN$US$US
243398711$24339871$1$I$20240913$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258790$PFIZER$$64$YR$$F$Y$$$20240919$$HP$US$US
243398721$24339872$1$I$20240101$20240916$20240919$20240919$PER$$US-PFIZER INC-202400258409$PFIZER$$57$YR$$M$Y$$$20240919$$HP$US$US
243398731$24339873$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-202400258418$PFIZER$$32$YR$$M$Y$$$20240919$$HP$US$US
243398741$24339874$1$I$$20240916$20240919$20240919$PER$$US-PFIZER INC-202400257576$PFIZER$$70$YR$$F$Y$$$20240919$$HP$US$US
243398751$24339875$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258588$PFIZER$$75$YR$$M$Y$$$20240919$$HP$US$US
243398761$24339876$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258705$PFIZER$$46$YR$$M$Y$$$20240919$$HP$US$US
243398771$24339877$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258448$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243398781$24339878$1$I$$20240911$20240919$20240919$EXP$$MX-PFIZER INC-202400258690$PFIZER$Ibarra, T.. Fatal invasive trichosporonosis in a patient with systemic lupus erythematosus: case report. Enfermedades Infecciosas y Microbiologia. 2024;44(2):75-77$52$YR$$F$Y$$$20240919$$MD$MX$MX
243398791$24339879$1$I$20240814$20240918$20240919$20240919$EXP$$CN-PFIZER INC-PV202400122358$PFIZER$$44$YR$$F$Y$54$KG$20240919$$HP$CN$CN
243398801$24339880$1$I$$20240905$20240919$20240919$PER$$US-SA-2024SA266731$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240919$$CN$US$US
243398812$24339881$2$F$20240905$20240910$20240919$20240923$PER$$US-SA-2024SA269287$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240923$$MD$US$US
243398821$24339882$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268493$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240919$$MD$US$US
243398831$24339883$1$I$20240901$20240911$20240919$20240919$PER$$US-SA-2024SA267834$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240919$$HP$US$US
243398841$24339884$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267500$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
243398851$24339885$1$I$20240901$20240910$20240919$20240919$PER$$US-SA-2024SA266369$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240919$$HP$US$US
243398881$24339888$1$I$$20240912$20240919$20240919$PER$$US-TAKEDA-2024TUS091111$TAKEDA$$$$$$Y$$$20240919$$CN$US$US
243398891$24339889$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149067$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$76.66$KG$20240919$$HP$US$US
243398911$24339891$1$I$$20240916$20240919$20240919$EXP$FI-FIMEA-202403305$FI-ORGANON-O2409FIN001099$ORGANON$$$$$F$Y$$$20240919$$CN$FI$FI
243398921$24339892$1$I$$20240603$20240919$20240919$EXP$$US-FERRINGPH-2024FE02964$FERRING$$$$$F$Y$$$20240919$$HP$US$US
243398931$24339893$1$I$20240101$20240604$20240919$20240919$EXP$$US-FERRINGPH-2024FE02992$FERRING$$89$YR$$F$Y$$$20240919$$HP$US$US
243398941$24339894$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148512$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240919$$CN$US$US
243398951$24339895$1$I$20240603$20240605$20240919$20240919$EXP$$US-FERRINGPH-2024FE02997$FERRING$$59$YR$$F$Y$$$20240919$$HP$US$US
243398961$24339896$1$I$$20240604$20240919$20240919$EXP$$US-FERRINGPH-2024FE02968$FERRING$$89$YR$$F$Y$$$20240919$$PH$US$US
243398971$24339897$1$I$$20240626$20240919$20240919$EXP$$US-FERRINGPH-2024FE03516$FERRING$$$$$$Y$$$20240919$$PH$US$US
243398981$24339898$1$I$$20240627$20240919$20240919$EXP$$US-FERRINGPH-2024FE03518$FERRING$$$$$$Y$$$20240919$$MD$US$US
243398991$24339899$1$I$$20240627$20240919$20240919$EXP$$US-FERRINGPH-2024FE03519$FERRING$$$$$M$Y$$$20240919$$CN$US$US
243399001$24339900$1$I$20240715$20240805$20240919$20240919$EXP$$US-FERRINGPH-2024FE04407$FERRING$$77$YR$$F$Y$$$20240919$$HP$US$US
243399011$24339901$1$I$20240101$20240612$20240919$20240919$EXP$$US-FERRINGPH-2024FE03104$FERRING$$$$$F$Y$46.259$KG$20240919$$MD$US$US
243399021$24339902$1$I$20240627$20240809$20240919$20240919$EXP$$US-FERRINGPH-2024FE04528$FERRING$$73$YR$$M$Y$$$20240919$$HP$US$US
243399031$24339903$1$I$$20240815$20240919$20240919$EXP$$US-FERRINGPH-2024FE04657$FERRING$$$$$$Y$$$20240919$$MD$US$US
243399041$24339904$1$I$$20240816$20240919$20240919$EXP$$US-FERRINGPH-2024FE04627$FERRING$$$$$F$Y$$$20240919$$HP$US$US
243399051$24339905$1$I$20240801$20240822$20240919$20240919$EXP$$US-FERRINGPH-2024FE04745$FERRING$$$$$F$Y$$$20240919$$CN$US$US
243399061$24339906$1$I$20240915$20240917$20240919$20240919$EXP$$US-AMGEN-USASP2024185998$AMGEN$$66$YR$E$M$Y$$$20240919$$CN$US$US
243399081$24339908$1$I$20240903$20240912$20240919$20240919$EXP$DE-CADRBFARM-2024330333$DE-PFIZER INC-202400258969$PFIZER$$43$YR$$M$Y$84$KG$20240919$$MD$DE$DE
243399091$24339909$1$I$$20240916$20240919$20240919$EXP$$RO-PFIZER INC-202400257217$PFIZER$Niculae C.. Tigecycline-Based Regimens for Complicated Urinary Tract Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria: Case Series.. Cureus. 2024;16(7)$63$YR$$M$Y$$$20240919$$MD$RO$RO
243399111$24339911$1$I$20240101$20240911$20240919$20240919$PER$$US-MYLANLABS-2024M1069536$MYLAN$$$$$F$Y$86.18$KG$20240919$$CN$US$US
243399131$24339913$1$I$$20240912$20240919$20240919$PER$$US-ROCHE-10000081377$ROCHE$$$$$$Y$$$20240919$$CN$US$US
243399141$24339914$1$I$20240905$20240906$20240919$20240919$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000917$PAREXEL$$$$$$Y$$$20240919$$PH$US$US
243399161$24339916$1$I$20230701$20240916$20240919$20240919$EXP$$RO-FreseniusKabi-FK202413878$FRESENIUS KABI$$43$YR$A$M$Y$$$20240919$$MD$RO$RO
243399171$24339917$1$I$$20240913$20240919$20240919$EXP$$US-ABBVIE-5926956$ABBVIE$$$$$$Y$$$20240919$$HP$US$US
243399181$24339918$1$I$$20240916$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147934$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240919$$CN$US$US
243399211$24339921$1$I$$20240917$20240919$20240919$EXP$$US-JNJFOC-20240948131$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$CN$US$US
243399221$24339922$1$I$20240912$20240912$20240919$20240919$PER$$US-ROCHE-10000083125$ROCHE$$$$$F$Y$$$20240919$$MD$US$US
243399231$24339923$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64350$$FDA-CTU$$67$YR$$F$N$$$20240919$N$$US$
243399241$24339924$1$I$20240905$20240917$20240919$20240919$PER$$US-ABBVIE-5928258$ABBVIE$$47$YR$$F$Y$58$KG$20240919$$CN$US$US
243399251$24339925$1$I$20240918$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64354$$FDA-CTU$$70$YR$$F$N$$$20240919$Y$HP$US$
243399291$24339929$1$I$$20240911$20240919$20240919$PER$$US-ROCHE-10000082423$ROCHE$$$$$$Y$$$20240919$$MD$US$US
243399301$24339930$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010217$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240919$$CN$US$US
243399311$24339931$1$I$20230511$20240912$20240919$20240919$EXP$$NVSC2022GB276737$NOVARTIS$$26$YR$$F$Y$71.6$KG$20240919$$MD$GB$GB
243399341$24339934$1$I$20240801$20240918$20240919$20240919$PER$$US-BAYER-2024A133604$BAYER$$67$YR$E$M$Y$$$20240919$$CN$US$US
243399351$24339935$1$I$$20240916$20240919$20240919$PER$$US-JNJFOC-20240947664$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243399361$24339936$1$I$$20240904$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08952$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243399371$24339937$1$I$20240528$20240912$20240919$20240919$EXP$$JP-DSJP-DSJ-2024-144869$DAIICHI$$71$YR$$F$Y$49.1$KG$20240919$$HP$JP$JP
243399382$24339938$2$F$$20240916$20240919$20240924$EXP$$GB-SANDOZ INC.-NVSC2021GB037196$SANDOZ$$$$E$F$Y$$$20240924$$CN$GB$GB
243399392$24339939$2$F$20211001$20240925$20240919$20240927$EXP$$DE-SANDOZ INC.-NVSC2022DE069476$SANDOZ$$45$YR$$F$Y$109$KG$20240927$$MD$DE$DE
243399401$24339940$1$I$$20240913$20240919$20240919$EXP$$DE-OTSUKA-2024_025915$OTSUKA$$$$E$F$Y$$$20240919$$HP$DE$DE
243399412$24339941$2$F$20240920$20240925$20240919$20240930$EXP$$US-OTSUKA-2024_025807$OTSUKA$$$$$$Y$$$20240930$$CN$US$US
243399421$24339942$1$I$$20240912$20240919$20240919$PER$$US-PFIZER INC-PV202400117245$PFIZER$$15$YR$$M$Y$46.2$KG$20240919$$HP$US$US
243399431$24339943$1$I$20240101$20240827$20240919$20240919$EXP$$US-SA-2024SA267566$SANOFI AVENTIS$$55$YR$A$F$Y$78.18$KG$20240919$$MD$US$US
243399441$24339944$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258271$PFIZER$$16$YR$$F$Y$$$20240919$$HP$US$US
243399451$24339945$1$I$20240826$20240913$20240919$20240919$EXP$$US-BIOMARINAP-US-2024-160587$BIOMARIN$$$$$$Y$$$20240919$$CN$US$US
243399471$24339947$1$I$$20240910$20240919$20240919$EXP$$PT-SA-2024SA270175$SANOFI AVENTIS$$$$E$$Y$$$20240919$$HP$PT$PT
243399482$24339948$2$F$$20240906$20240919$20240920$PER$$US-SA-2024SA268693$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240920$$CN$US$US
243399491$24339949$1$I$20240101$20240917$20240919$20240919$EXP$$US-SA-2024SA123532$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240919$$MD$US$US
243399501$24339950$1$I$20240826$20240914$20240919$20240919$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000945$PAREXEL$$$$$$Y$$$20240919$$HP$CN$CN
243399511$24339951$1$I$20240911$20240911$20240919$20240919$EXP$$US-RDY-SPO/USA/24/0013599$DR REDDYS$$15$YR$T$$Y$$$20240919$$MD$US$US
243399521$24339952$1$I$20240701$20240913$20240919$20240919$EXP$NL-LRB-00996292$NL-GSK-NL2024107081$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$NL$NL
243399541$24339954$1$I$20240913$20240918$20240918$20240918$DIR$718942$$FDA-CTU$$70$YR$$M$N$$$20240918$N$$US$
243399551$24339955$1$I$$20240904$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08900$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243399561$24339956$1$I$$20240916$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US081225$SANDOZ$$$$$$Y$$$20240919$$PH$US$US
243399581$24339958$1$I$$20240912$20240919$20240919$EXP$$JP-MALLINCKRODT-MNK202405767$MALLINCKRODT$$$$A$$Y$$$20240919$$HP$JP$JP
243399591$24339959$1$I$$20240916$20240919$20240919$PER$$US-HALEON-2197231$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243399601$24339960$1$I$20240901$20240910$20240919$20240919$PER$$US-SA-2024SA266531$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240919$$MD$US$US
243399612$24339961$2$F$20240101$20240917$20240919$20240920$EXP$$US-JNJFOC-20240934948$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240920$$MD$US$US
243399621$24339962$1$I$$20240912$20240919$20240919$PER$$US-PFIZER INC-PV202400120570$PFIZER$$15$YR$$$Y$67.3$KG$20240919$$HP$US$US
243399631$24339963$1$I$$20240912$20240919$20240919$30DAY$$AR-PFIZER INC-202400257352$PFIZER$$11$YR$$F$Y$$$20240919$$CN$AR$AR
243399641$24339964$1$I$$20240912$20240919$20240919$30DAY$$US-PFIZER INC-202400255765$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243399651$24339965$1$I$$20240909$20240919$20240919$30DAY$$CO-PFIZER INC-202400254619$PFIZER$$14$YR$$M$Y$$$20240919$$CN$CO$CO
243399661$24339966$1$I$20240420$20240916$20240919$20240919$EXP$$NVSC2024US185796$NOVARTIS$$56$YR$$F$Y$$$20240919$$HP$US$US
243399671$24339967$1$I$$20240904$20240919$20240919$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00872$Phathom Pharmaceuticals$$9$DEC$$M$Y$$$20240919$$MD$JP$JP
243399702$24339970$2$F$$20240918$20240919$20240926$EXP$$IT-ORGANON-O2409ITA001328$ORGANON$Matacena M, Gentili M, Marinaccio PM, Galimenberti C, Carnovale C, Clementi E, et al. Writing is difficult for Bastiano. Pharmacovigilance Focus. 2016;93(3):12$61$YR$$M$Y$$$20240926$$MD$IT$IT
243399711$24339971$1$I$20240819$20240910$20240919$20240919$PER$$US-TEVA-VS-3242815$TEVA$$$$$F$Y$$$20240919$$PH$US$US
243399721$24339972$1$I$20230317$20240913$20240919$20240919$EXP$$BR-TAKEDA-2023TUS031244$TAKEDA$$37$YR$$M$Y$63$KG$20240919$$MD$BR$BR
243399731$24339973$1$I$$20240916$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US081190$SANDOZ$$61$YR$$M$Y$$$20240919$$MD$US$US
243399741$24339974$1$I$20240801$20240909$20240919$20240919$EXP$$US-RADIUS HEALTH INC.-2024US007033$RADIUS PHARM$$68$YR$$F$Y$$$20240919$$CN$US$US
243399751$24339975$1$I$$20240917$20240919$20240919$PER$$US-HALEON-2197428$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243399761$24339976$1$I$20240902$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185736$AMGEN$$66$YR$E$M$Y$$$20240919$$HP$US$US
243399771$24339977$1$I$$20240911$20240919$20240919$EXP$$ES-AMGEN-ESPSP2024183848$AMGEN$Lluch P.; Ballester M.P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240919$$MD$ES$ES
243399791$24339979$1$I$20240701$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024186508$AMGEN$$77$YR$E$F$Y$$$20240919$$CN$US$US
243399801$24339980$1$I$20240801$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024186948$AMGEN$$75$YR$E$F$Y$$$20240919$$CN$US$US
243399811$24339981$1$I$$20240911$20240919$20240919$EXP$$ES-AMGEN-ESPSP2024183844$AMGEN$Lluch P.; Ballester M.P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240919$$MD$ES$ES
243399821$24339982$1$I$20210701$20240916$20240919$20240919$EXP$$CA-TAKEDA-2021TUS044885$TAKEDA$$51$YR$$M$Y$$$20240919$$CN$CA$CA
243399841$24339984$1$I$20220601$20240913$20240919$20240919$EXP$$PL-AMGEN-POLSP2024184064$AMGEN$$71$YR$E$F$Y$$$20240919$$MD$PL$PL
243399851$24339985$1$I$$20240910$20240919$20240919$EXP$CZ-PFIZER INC-2020493774$CZ-ROCHE-10000077796$ROCHE$Effective management of treatment for patients in 3rd line of mCRC and mGC. MEDICAL TRIBUNE. 2020;XVI(22):C4-C5$64$YR$A$M$Y$$$20240919$$HP$CZ$CZ
243399861$24339986$1$I$20240801$20240916$20240919$20240919$EXP$DK-DKMA-30738474$DK-ABBVIE-5925314$ABBVIE$$14$YR$$M$Y$68$KG$20240919$$MD$DK$DK
243399871$24339987$1$I$$20240912$20240919$20240919$EXP$$US-RDY-SPO/USA/24/0013608$DR REDDYS$$25$YR$A$F$Y$$$20240919$$MD$US$US
243399881$24339988$1$I$20210101$20240910$20240919$20240919$EXP$$US-RDY-SPO/USA/24/0013612$DR REDDYS$$48$YR$E$M$Y$$$20240919$$CN$US$US
243399891$24339989$1$I$$20240909$20240919$20240919$PER$$US-JNJFOC-20240923996$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243399901$24339990$1$I$20240101$20240903$20240919$20240919$EXP$$US-SA-2024SA269970$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240919$$CN$US$US
243399921$24339992$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010058$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240919$$CN$US$US
243399931$24339993$1$I$20240915$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010294$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240919$$CN$US$US
243399941$24339994$1$I$$20240911$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409007755$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240919$$CN$US$US
243399952$24339995$2$F$20240829$20240924$20240919$20240930$EXP$$IN-ELI_LILLY_AND_COMPANY-IN202409011140$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240930$$CN$IN$IN
243399961$24339996$1$I$20240916$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010940$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240919$$CN$US$US
243399971$24339997$1$I$$20240916$20240919$20240919$EXP$$US-ELI_LILLY_AND_COMPANY-US202409010783$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240919$$CN$US$US
243400001$24340000$1$I$$20240911$20240919$20240919$EXP$$JP-SA-2024SA271068$SANOFI AVENTIS$Uchiyama M et al.. A case of perineal necrotizing fasciitis developed during rectal cancer chemotherapy. Journal of Japan Surgical Association. 2024;85(2):92$7$DEC$E$M$Y$$$20240919$$MD$JP$JP
243400011$24340001$1$I$$20240917$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA081032$SANDOZ$$27$YR$$F$Y$$$20240919$$HP$CA$CA
243400021$24340002$1$I$20240901$20240911$20240919$20240919$PER$$US-SA-2024SA267907$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240919$$CN$US$US
243400031$24340003$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA270111$SANOFI AVENTIS$$$$E$M$Y$$$20240919$$HP$US$US
243400041$24340004$1$I$20240701$20240910$20240919$20240919$PER$$US-SA-2024SA266280$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240919$$MD$US$US
243400051$24340005$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149055$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240919$$HP$US$US
243400061$24340006$1$I$20240918$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149251$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240919$$CN$US$US
243400071$24340007$1$I$$20240918$20240919$20240919$PER$$NVSC2024US187280$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243400081$24340008$1$I$20230627$20240912$20240919$20240919$EXP$$JP-ROCHE-10000085822$ROCHE$$68$YR$E$M$Y$48.7$KG$20240919$$PH$JP$JP
243400101$24340010$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202300169437$PFIZER$$34$YR$$F$Y$$$20240919$$CN$US$US
243400111$24340011$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258751$PFIZER$$71$YR$$F$Y$$$20240919$$CN$US$US
243400121$24340012$1$I$$20240918$20240919$20240919$PER$$US-PFIZER INC-PV202400122258$PFIZER$$42$YR$$F$Y$$$20240919$$CN$US$US
243400131$24340013$1$I$$20240918$20240919$20240919$PER$$US-PFIZER INC-202400259168$PFIZER$$69$YR$$M$Y$$$20240919$$CN$US$US
243400141$24340014$1$I$20240911$20240912$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148841$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$56.25$KG$20240919$$PH$US$US
243400151$24340015$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400122208$PFIZER$$55$YR$$M$Y$$$20240919$$HP$US$US
243400171$24340017$1$I$20240909$20240918$20240919$20240919$PER$$US-PFIZER INC-202400259553$PFIZER$$35$YR$$F$Y$$$20240919$$CN$US$US
243400181$24340018$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258111$PFIZER$$$$$F$Y$$$20240919$$CN$US$US
243400191$24340019$1$I$20231119$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202300190236$PFIZER$$78$YR$$M$Y$117.9$KG$20240919$$CN$US$US
243400201$24340020$1$I$20240918$20240918$20240919$20240919$PER$$US-PFIZER INC-202400259106$PFIZER$$82$YR$$M$Y$$$20240919$$CN$US$US
243400221$24340022$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400122804$PFIZER$$$$$$Y$$$20240919$$CN$US$US
243400231$24340023$1$I$$20240918$20240919$20240919$PER$$US-PFIZER INC-202400201608$PFIZER$$78$YR$$F$Y$92.53$KG$20240919$$CN$US$US
243400241$24340024$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400083547$PFIZER$$73$YR$$F$Y$$$20240919$$MD$US$US
243400251$24340025$1$I$20240301$20240918$20240919$20240919$PER$$US-PFIZER INC-PV202400122264$PFIZER$$81$YR$$F$Y$$$20240919$$CN$US$US
243400261$24340026$1$I$20240918$20240918$20240919$20240919$PER$$US-PFIZER INC-202400259216$PFIZER$$38$YR$$F$Y$$$20240919$$CN$US$US
243400271$24340027$1$I$20240918$20240918$20240919$20240919$PER$$US-PFIZER INC-202400259242$PFIZER$$60$YR$$F$Y$$$20240919$$CN$US$US
243400281$24340028$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400122252$PFIZER$$60$YR$$F$Y$$$20240919$$HP$US$US
243400291$24340029$1$I$20231025$20240917$20240919$20240919$EXP$$DE-SANDOZ INC.-SDZ2024DE011891$SANDOZ$$58$YR$$M$Y$56$KG$20240919$$MD$DE$DE
243400301$24340030$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258595$PFIZER$$65$YR$$F$Y$$$20240919$$CN$US$US
243400311$24340031$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64356$$FDA-CTU$$63$YR$$F$N$$$20240919$N$$US$
243400321$24340032$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243786$TEVA$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC-Clin-Electrophysiol 2023; 9 (6): 824-832.$$$$$Y$$$20240919$$MD$US$US
243400331$24340033$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400121663$PFIZER$$67$YR$$F$Y$$$20240919$$HP$US$US
243400341$24340034$1$I$20240901$20240912$20240919$20240919$PER$$US-ABBVIE-5922467$ABBVIE$$$$$F$Y$$$20240919$$HP$US$US
243400351$24340035$1$I$20240917$20240918$20240919$20240919$PER$$US-PFIZER INC-202400259576$PFIZER$$73$YR$$M$Y$$$20240919$$CN$US$US
243400361$24340036$1$I$$20240918$20240919$20240919$PER$$US-PFIZER INC-202400259220$PFIZER$$$$$F$Y$$$20240919$$HP$US$US
243400371$24340037$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400122074$PFIZER$$76$YR$$F$Y$$$20240919$$HP$US$US
243400381$24340038$1$I$20240917$20240918$20240919$20240919$PER$$US-PFIZER INC-202400259678$PFIZER$$62$YR$$M$Y$$$20240919$$CN$US$US
243400391$24340039$1$I$$20240918$20240919$20240919$PER$$US-PFIZER INC-202400258977$PFIZER$$75$YR$$F$Y$$$20240919$$CN$US$US
243400411$24340041$1$I$20240831$20240918$20240918$20240918$DIR$719011$$FDA-CTU$$44$YR$$F$N$72.9$KG$20240918$N$CN$US$
243400421$24340042$1$I$$20240918$20240919$20240919$PER$$US-PFIZER INC-202400259114$PFIZER$$$$A$F$Y$$$20240919$$MD$US$US
243400431$24340043$1$I$$20240918$20240919$20240919$PER$$US-PFIZER INC-202400258857$PFIZER$$$$A$F$Y$$$20240919$$HP$US$US
243400441$24340044$1$I$20240918$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64357$$FDA-CTU$$69$YR$$F$N$$$20240919$Y$PH$US$
243400451$24340045$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258504$PFIZER$$$$$F$Y$$$20240919$$MD$US$US
243400461$24340046$1$I$20240101$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400122183$PFIZER$$65$YR$$M$Y$$$20240919$$HP$US$US
243400471$24340047$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258322$PFIZER$$$$T$F$Y$$$20240919$$MD$US$US
243400481$24340048$1$I$20240917$20240918$20240919$20240919$PER$$US-PFIZER INC-202400259244$PFIZER$$56$YR$$F$Y$$$20240919$$CN$US$US
243400491$24340049$1$I$20240913$20240918$20240919$20240919$PER$$US-PFIZER INC-202400259008$PFIZER$$$$E$$Y$$$20240919$$CN$US$US
243400501$24340050$1$I$20240901$20240918$20240919$20240919$PER$$US-PFIZER INC-PV202400122549$PFIZER$$76$YR$$$Y$$$20240919$$CN$US$US
243400511$24340051$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400259226$PFIZER$$47$YR$$F$Y$$$20240919$$CN$US$US
243400521$24340052$1$I$$20240909$20240919$20240919$EXP$$DE-TEVA-VS-3242559$TEVA$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.; Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.$6$YR$$F$Y$$$20240919$$HP$DE$DE
243400531$24340053$1$I$$20240910$20240919$20240919$EXP$$CA-TAKEDA-2024TUS090754$TAKEDA$$$$$F$Y$$$20240919$$CN$CA$CA
243400541$24340054$1$I$$20240918$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149326$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240919$$CN$US$US
243400551$24340055$1$I$$20240910$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145047$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240919$$HP$US$US
243400561$24340056$1$I$20240829$20240912$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146210$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$62.6$KG$20240919$$CN$US$US
243400571$24340057$1$I$20240907$20240912$20240919$20240919$EXP$CN-91110000556821568D-2024DRL001758$CN-RDY-SPO/CHN/24/0013607$DR REDDYS$$34$YR$A$M$Y$$$20240919$$HP$CN$CN
243400581$24340058$1$I$20240711$20240913$20240919$20240919$EXP$CN-91110000556821568D-2024DRL001771$CN-RDY-SPO/CHN/24/0013620$DR REDDYS$$39$YR$A$M$Y$57$KG$20240919$$HP$CN$CN
243400601$24340060$1$I$20240801$20240916$20240919$20240919$PER$$US-Eisai-EC-2024-174812$EISAI$$71$YR$E$F$Y$$$20240919$$CN$US$US
243400611$24340061$1$I$$20240918$20240919$20240919$PER$$US-HALEON-2197575$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243400622$24340062$2$F$$20240920$20240919$20240926$EXP$$NZ-AMGEN-NZLSP2024185004$AMGEN$$$$$$Y$$$20240926$$MD$NZ$NZ
243400631$24340063$1$I$20240818$20240910$20240919$20240919$EXP$$US-BEH-2024178570$CSL BEHRING$$73$YR$E$F$Y$$$20240919$$CN$US$US
243400641$24340064$1$I$$20240917$20240919$20240919$EXP$$PT-PFIZER INC-202400258783$PFIZER$Cardoso,, T. POSA-144 - (4518) - CASO DE PJ. Medicina Interna - Congressos Nacionais. 30CNMI. 2024;1220$79$YR$$F$Y$$$20240919$$MD$PT$PT
243400661$24340066$1$I$20240101$20240905$20240919$20240919$EXP$$US-CURIUM-2024000588$CURIUM PHARMACEUTICALS$$79$YR$$M$Y$$$20240919$$HP$US$US
243400671$24340067$1$I$20240820$20240905$20240919$20240919$EXP$$US-CURIUM-2024000589$CURIUM PHARMACEUTICALS$$43$YR$$M$Y$$$20240919$$HP$US$US
243400681$24340068$1$I$$20240913$20240919$20240919$PER$$US-JNJFOC-20240940757$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$LW$US$US
243400691$24340069$1$I$20240818$20240910$20240919$20240919$EXP$$US-BEH-2024178600$CSL BEHRING$$$$$F$Y$$$20240919$$CN$US$US
243400711$24340071$1$I$$20240909$20240919$20240919$PER$$US-ABBVIE-5920926$ABBVIE$$$$A$F$Y$$$20240919$$MD$US$US
243400721$24340072$1$I$20171223$20200316$20240919$20240919$EXP$$DE-SANDOZ INC.-NVSC2020DE076502$SANDOZ$$47$YR$$F$Y$114.7$KG$20240919$$MD$DE$DE
243400731$24340073$1$I$$20240916$20240919$20240919$EXP$$GB-SANDOZ INC.-SDZ2024GB004447$SANDOZ$$$$$F$Y$$$20240919$$CN$GB$GB
243400741$24340074$1$I$20240904$20240915$20240919$20240919$EXP$$NVSC2024IL133085$NOVARTIS$$76$YR$$F$Y$$$20240919$$HP$IL$IL
243400761$24340076$1$I$20240904$20240914$20240919$20240919$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014383$JAZZ$$1$YR$$F$Y$6$KG$20240919$$HP$US$US
243400772$24340077$2$F$20240101$20240920$20240919$20240924$EXP$$NVSC2024CO109407$NOVARTIS$$15$YR$$F$Y$55$KG$20240924$$CN$CO$CO
243400781$24340078$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010972$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243400801$24340080$1$I$20240618$20240913$20240919$20240919$EXP$$US-TAKEDA-2024TUS091785$TAKEDA$$78$YR$$M$Y$96.2$KG$20240919$$HP$US$US
243400811$24340081$1$I$$20240906$20240919$20240919$PER$$US-TEVA-VS-3241271$TEVA$$$$$$Y$$$20240919$$CN$US$US
243400821$24340082$1$I$$20240911$20240919$20240919$EXP$$US-SA-2024SA269988$SANOFI AVENTIS$$6$YR$C$F$Y$29.05$KG$20240919$$MD$US$US
243400851$24340085$1$I$$20240916$20240919$20240919$EXP$$BR-TAKEDA-2024TUS093217$TAKEDA$$$$$F$Y$79$KG$20240919$$CN$BR$BR
243400861$24340086$1$I$$20240909$20240919$20240919$EXP$$GB-INCYTE CORPORATION-2024IN009901$INCYTE$Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O^Sullivan J e al.. Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial. JOURNAL OF CLINICAL ONCOLOGY. 2023;41(19):3534-44$$$$$Y$$$20240919$$HP$GB$GB
243400871$24340087$1$I$$20240905$20240919$20240919$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09211$LUPIN$$$$$$Y$$$20240919$$CN$US$US
243400881$24340088$1$I$20240321$20240917$20240919$20240919$EXP$FR-AFSSAPS-TO2024001737$FR-ASTELLAS-2024-AER-007498$ASTELLAS$$72$YR$E$F$Y$$$20240919$$MD$FR$FR
243400901$24340090$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243111$TEVA$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J-Forens-Legal-Med 2024; 101.$82$YR$$$Y$$$20240919$$HP$US$US
243400911$24340091$1$I$20230501$20240829$20240919$20240919$PER$$US-SA-2024SA267011$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240919$$MD$US$US
243400921$24340092$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA269468$SANOFI AVENTIS$$$$C$M$Y$25.3$KG$20240919$$MD$US$US
243400941$24340094$1$I$20240821$20240822$20240919$20240919$PER$$US-MEITHEAL-2024MPSPO00269$MEITHEAL PHARMACEUTICALS$$60$YR$A$F$Y$175$KG$20240918$$CN$US$US
243400951$24340095$1$I$$20240726$20240919$20240919$PER$$US-MEITHEAL-2024MPSPO00235$MEITHEAL PHARMACEUTICALS$$$$$$Y$$$20240918$$CN$US$US
243400961$24340096$1$I$$20240913$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010418$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240919$$CN$US$US
243400972$24340097$2$F$20240909$20240920$20240919$20240927$PER$$US-AMGEN-USASP2024183886$AMGEN$$42$YR$A$F$Y$78$KG$20240927$$PH$US$US
243400982$24340098$2$F$20240901$20240913$20240919$20240927$EXP$$US-PFIZER INC-202400256371$PFIZER$$47$YR$$F$Y$79.38$KG$20240927$$CN$US$US
243400991$24340099$1$I$20240906$20240912$20240919$20240919$EXP$$JP-PFIZER INC-202400257966$PFIZER$$$$$M$Y$$$20240919$$MD$JP$JP
243401001$24340100$1$I$20240901$20240916$20240919$20240919$EXP$$CA-ABBVIE-5927227$ABBVIE$$76$YR$$M$Y$$$20240919$$CN$CA$CA
243401011$24340101$1$I$$20240916$20240919$20240919$EXP$$US-KYOWAKIRIN-2024KK021491$KYOWA$$$$$$Y$$$20240919$$CN$US$US
243401021$24340102$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149025$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240919$$CN$US$US
243401041$24340104$1$I$$20240912$20240919$20240919$EXP$$CA-TAKEDA-2024TUS091984$TAKEDA$$$$$M$Y$$$20240919$$CN$CA$CA
243401061$24340106$1$I$20240401$20240916$20240919$20240919$DIR$FDA-CDER-CTU-2024-64365$$FDA-CTU$$68$YR$$F$N$$$20240916$N$HP$US$
243401071$24340107$1$I$$20240910$20240919$20240919$EXP$$FR-DSJP-DSE-2024-144790$DAIICHI$$$$A$F$Y$$$20240919$$MD$FR$FR
243401081$24340108$1$I$20240902$20240914$20240919$20240919$EXP$$CN-VANTIVE-2024VAN019789$Vantive US Healthcare$$80$YR$$M$Y$55$KG$20240919$$CN$CN$CN
243401091$24340109$1$I$20240916$20240918$20240919$20240919$EXP$$SG-VANTIVE-2024VAN019858$Vantive US Healthcare$$71$YR$$M$Y$$$20240919$$CN$SG$SG
243401102$24340110$2$F$20240910$20240917$20240919$20240925$EXP$$IN-VANTIVE-2024VAN019809$Vantive US Healthcare$$61$YR$$M$Y$$$20240925$$CN$IN$IN
243401111$24340111$1$I$20231001$20240904$20240919$20240919$EXP$$TR-CEDIPROF, INC.-2024CED00004$CEDIPROF$Buyukkal U, Temelturk R.D, Tekin D.. Acute Dystonic Reaction Following Methylphenidate Discontinuation During Combination Therapy with RISPERIDONE: A Case Study.. J. Ankara. Univ. Fac. Med. 2024;77(2):222-226$6$YR$$M$Y$$$20240919$$HP$TR$TR
243401121$24340112$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64366$$FDA-CTU$$81$YR$$M$N$$$20240919$N$$US$
243401131$24340113$1$I$$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64367$$FDA-CTU$$$$$F$N$$$20240918$N$HP$US$
243401141$24340114$1$I$$20240918$20240918$20240918$DIR$718906$$FDA-CTU$$$$$UNK$N$$$20240918$N$CN$US$
243401151$24340115$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148037$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240919$$CN$US$US
243401162$24340116$2$F$20240814$20240925$20240919$20240927$PER$$US-JNJFOC-20240922179$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240927$$PH$US$US
243401171$24340117$1$I$$20240916$20240919$20240919$PER$$US-ABBVIE-5926568$ABBVIE$$$$$M$Y$$$20240919$$HP$US$US
243401201$24340120$1$I$20240910$20240916$20240919$20240919$DIR$FDA-CDER-CTU-2024-64368$$FDA-CTU$$70$YR$$M$N$$$20240916$N$HP$US$
243401211$24340121$1$I$20240831$20240917$20240919$20240919$DIR$FDA-CDER-CTU-2024-64369$$FDA-CTU$$72$YR$$F$N$$$20240917$N$HP$US$
243401241$24340124$1$I$20240906$20240909$20240919$20240919$EXP$$US-GSK-US2024112065$GLAXOSMITHKLINE$$52$YR$$$Y$$$20240919$$HP$US$US
243401251$24340125$1$I$20240701$20240912$20240919$20240919$EXP$$US-GSK-US2024AMR113926$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$HP$US$US
243401261$24340126$1$I$20240901$20240917$20240919$20240919$EXP$$FR-ABBVIE-5929608$ABBVIE$$70$YR$$$Y$$$20240919$$PH$FR$FR
243401272$24340127$2$F$20240301$20240920$20240919$20240927$EXP$$US-ABBVIE-5925271$ABBVIE$$77$YR$$F$Y$$$20240927$$CN$US$US
243401301$24340130$1$I$$20240916$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US080737$SANDOZ$Kaitlyn N. Romero, Melville C. O^Brien, Avni Agrawal, Irtiza Hasan. Creatine Kinase Surge: Levetiracetam-InducedRhabdomyolysis. Cureus. 2024$27$YR$$M$Y$$$20240919$$MD$US$US
243401311$24340131$1$I$$20240910$20240919$20240919$EXP$$US-RADIUS HEALTH INC.-2024US007102$RADIUS PHARM$$$$$M$Y$$$20240919$$CN$US$US
243401321$24340132$1$I$$20240909$20240919$20240919$EXP$$KR-ROCHE-10000079071$ROCHE$Oh J, Seo K, Kim H, Choi G. Successful desensitization to atezolizumab-induced near-fatal anaphylaxis in patients with hepatocellular carcinoma: A case report and literature review. Asia Pacific allergy. 2024-Aug;14 (3):139-142. doi:10.5415/apallergy.0000000000000138.$69$YR$E$M$Y$$$20240919$$HP$KR$KR
243401341$24340134$1$I$$20240915$20240919$20240919$EXP$$CA-VERTEX PHARMACEUTICALS-2024-014718$VERTEX$$$$$$Y$$$20240919$$CN$CA$CA
243401352$24340135$2$F$$20240919$20240919$20240925$EXP$$US-VERTEX PHARMACEUTICALS-2024-014402$VERTEX$$$$$$Y$$$20240925$$CN$US$US
243401361$24340136$1$I$20240101$20240912$20240919$20240919$EXP$$CO-VERTEX PHARMACEUTICALS-2024-014584$VERTEX$$16$YR$$M$Y$39$KG$20240919$$CN$CO$CO
243401371$24340137$1$I$$20240912$20240919$20240919$PER$$NVSC2024US183912$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
243401381$24340138$1$I$20160101$20240912$20240919$20240919$EXP$FR-AFSSAPS-TS2024000961$FR-VERTEX PHARMACEUTICALS-2024-014544$VERTEX$$31$YR$$M$Y$87$KG$20240919$$MD$FR$FR
243401391$24340139$1$I$20240802$20240917$20240919$20240919$EXP$$AU-SANDOZ INC.-SDZ2024AU081077$SANDOZ$$82$YR$$M$Y$$$20240919$$MD$AU$AU
243401401$24340140$1$I$$20240916$20240919$20240919$EXP$$US-BAYER-2024A133358$BAYER$$63$YR$A$M$Y$$$20240919$$CN$US$US
243401412$24340141$2$F$20240603$20240923$20240919$20240930$EXP$$CA-GSK-CA2024067103$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$CA$CA
243401431$24340143$1$I$$20240914$20240919$20240919$EXP$$NVSC2024BR186863$NOVARTIS$$$$$M$Y$$$20240919$$CN$BR$BR
243401441$24340144$1$I$$20240918$20240919$20240919$EXP$$RU-ABBVIE-5930037$ABBVIE$$$$A$F$Y$$$20240919$$MD$RU$RU
243401451$24340145$1$I$20240713$20240916$20240919$20240919$EXP$$US-KYOWAKIRIN-2024KK021565$KYOWA$$$$$$Y$$$20240919$$HP$US$US
243401461$24340146$1$I$$20240918$20240919$20240919$EXP$$JP-ABBVIE-5930101$ABBVIE$$79$YR$$F$Y$$$20240919$$MD$JP$JP
243401521$24340152$1$I$20240101$20240912$20240919$20240919$EXP$$US-JNJFOC-20240938405$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240919$$CN$US$US
243401531$24340153$1$I$$20240916$20240919$20240919$PER$$US-JNJFOC-20240945516$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$PH$US$US
243401541$24340154$1$I$20240601$20240909$20240919$20240919$EXP$$US-GSK-US2024113115$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20240919$$CN$US$US
243401551$24340155$1$I$$20240912$20240919$20240919$30DAY$$US-GSK-US2024113766$GLAXOSMITHKLINE$$$$$M$Y$$$20240919$$CN$US$US
243401561$24340156$1$I$20240525$20240913$20240919$20240919$EXP$$DE-MYLANLABS-2024M1084857$MYLAN$$$$$F$Y$$$20240919$$CN$DE$DE
243401571$24340157$1$I$$20240913$20240919$20240919$EXP$$PT-MYLANLABS-2024M1081993$MYLAN$Joao Coutinho De Sousa; Teresa Pinto; Filipe Gomes Pereira; Maria Ines Risto.. PO-0179 - (2250) - Pancytopenia in a patient with severe folic acid deficiency due to methotrexate therapy. 30 CNMI Hematological diseases/ Clinical case. 2024;547$75$YR$$F$Y$$$20240919$$MD$PT$PT
243401581$24340158$1$I$$20240917$20240919$20240919$PER$$US-TAKEDA-2024TUS092736$TAKEDA$$$$$$Y$$$20240919$$CN$US$US
243401592$24340159$2$F$20240902$20240920$20240919$20240927$EXP$$FR-SA-2024SA270521$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240927$$CN$FR$FR
243401601$24340160$1$I$20240125$20240913$20240919$20240919$EXP$IT-MINISAL02-1001580$IT-MYLANLABS-2024M1083779$MYLAN$$58$YR$$F$Y$$$20240919$$MD$IT$IT
243401611$24340161$1$I$$20240919$20240919$20240919$PER$$NVSC2024US187159$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243401621$24340162$1$I$20240905$20240913$20240919$20240919$EXP$$AU-BEH-2024178801$CSL BEHRING$$72$YR$E$F$Y$$$20240919$$HP$AU$AU
243401631$24340163$1$I$$20240919$20240919$20240919$PER$$NVSC2024US187297$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243401661$24340166$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011048$ELI LILLY AND CO$$$$$M$Y$$$20240919$$CN$US$US
243401671$24340167$1$I$20240912$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010944$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240919$$CN$US$US
243401681$24340168$1$I$$20240906$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409005097$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240919$$CN$US$US
243401691$24340169$1$I$20240807$20240905$20240919$20240919$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004805$PAREXEL$$$$$$Y$$$20240919$$CN$US$US
243401701$24340170$1$I$20240711$20240917$20240919$20240919$EXP$$NVSC2024GB145907$NOVARTIS$$$$$F$Y$$$20240919$$CN$GB$GB
243401711$24340171$1$I$$20240911$20240919$20240919$EXP$$US-PRAGMA-2024-US-049279$PRAGMA PHARMACEUTICALS$Russe-Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwari A..Rousing drug-induced liver injury through cytochrome p450 isoenzyme overload leading to fulminant liver failure.Journal of Liver Transplantation.2024;.$40$YR$$F$Y$$$20240919$$HP$US$US
243401721$24340172$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148771$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240919$$CN$US$US
243401731$24340173$1$I$$20240918$20240919$20240919$PER$$US-GILEAD-2024-0688185$GILEAD$$$$$F$Y$$$20240919$$PH$US$US
243401741$24340174$1$I$$20240913$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147517$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240919$$CN$US$US
243401752$24340175$2$F$20221101$20240919$20240919$20240925$EXP$$US-ABBVIE-5435699$ABBVIE$$52$YR$$M$Y$$$20240925$$CN$US$US
243401761$24340176$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5926512$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243401771$24340177$1$I$$20240910$20240919$20240919$EXP$$BR-TAKEDA-2024TUS091895$TAKEDA$$$$$M$Y$$$20240919$$CN$BR$BR
243401782$24340178$2$F$$20240918$20240919$20240924$30DAY$$CO-PFIZER INC-202400255339$PFIZER$$11$YR$$F$Y$$$20240924$$CN$CO$CO
243401801$24340180$1$I$20240101$20240903$20240919$20240919$EXP$$US-SA-2024SA271062$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240919$$CN$US$US
243401811$24340181$1$I$$20240909$20240919$20240919$EXP$$DE-TEVA-VS-3242561$TEVA$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.; Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD-Open 2024; 10 (3):.$13$YR$$F$Y$$$20240919$$HP$DE$DE
243401821$24340182$1$I$$20240911$20240919$20240919$EXP$$CN-INCYTE CORPORATION-2024IN009907$INCYTE$Yan W, Zhao F, Gu M, Liu N, Guo X, Xu X.. Ruxolitinib Treatment of Steroid-Refractory Graft-versus-Host Disease in Children: A Case Series and Review of the Literature. PEDIATRIC DRUGS. 2023;25:577-84$$$$$Y$$$20240919$$HP$CN$CN
243401831$24340183$1$I$20240911$20240912$20240919$20240919$EXP$$CN-Eisai-EC-2024-174415$EISAI$$80$YR$E$F$Y$60$KG$20240919$$MD$CN$CN
243401841$24340184$1$I$20240904$20240912$20240919$20240919$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004917$PAREXEL$$$$$$Y$$$20240919$$CN$US$US
243401861$24340186$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148422$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240919$$CN$US$US
243401871$24340187$1$I$20240909$20240912$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146179$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240919$$CN$US$US
243401881$24340188$1$I$$20240916$20240919$20240919$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051652$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240919$$MD$BR$BR
243401891$24340189$1$I$$20240913$20240919$20240919$EXP$DE-BFARM-24006414$DE-RDY-SPO/DEU/24/0013499$DR REDDYS$$$$A$M$Y$98$KG$20240919$$CN$DE$DE
243401901$24340190$1$I$$20240911$20240919$20240919$EXP$$CN-INCYTE CORPORATION-2024IN009909$INCYTE$Yan W, Zhao F, Gu M, Liu N, Guo X, Xu X.. Ruxolitinib Treatment of Steroid-Refractory Graft-versus-Host Disease in Children: A Case Series and Review of the Literature. PEDIATRIC DRUGS. 2023;25:577-84$$$$$Y$$$20240919$$HP$CN$CN
243401911$24340191$1$I$$20240917$20240919$20240919$EXP$$US-TAKEDA-2024TUS093115$TAKEDA$$$$$M$Y$$$20240919$$CN$US$US
243401921$24340192$1$I$20240101$20240912$20240919$20240919$EXP$ES-AEMPS-1557578$ES-SA-2024SA241209$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240919$$CN$ES$ES
243401931$24340193$1$I$20240801$20240913$20240919$20240919$PER$$US-ABBVIE-5926365$ABBVIE$$41$YR$$F$Y$$$20240919$$HP$US$US
243401951$24340195$1$I$$20240911$20240919$20240919$EXP$$CN-INCYTE CORPORATION-2024IN009910$INCYTE$Yan WL, Zhao FY, Gu ME, Liu N, Guo XP, Xu XJ. Ruxolitinib Treatment of Steroid-Refractory Graft-versus-Host Disease in Children: A Case Series and Review of the Literature. PEDIATRIC DRUGS. 2023;25(5):577-84$$$$$Y$$$20240919$$HP$CN$CN
243401961$24340196$1$I$$20240916$20240919$20240919$DIR$FDA-CDER-CTU-2024-64370$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243401971$24340197$1$I$$20240912$20240919$20240919$EXP$$US-JNJFOC-20240938727$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240919$$HP$US$US
243401981$24340198$1$I$20240916$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185158$AMGEN$$76$YR$E$M$Y$$$20240919$$PH$US$US
243401991$24340199$1$I$$20240913$20240919$20240919$EXP$$CA-JNJFOC-20240937672$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240919$$HP$CA$CA
243402001$24340200$1$I$20240101$20240905$20240919$20240919$EXP$$US-UCBSA-2024035634$UCB$$$$$F$Y$74.649$KG$20240919$$HP$US$US
243402011$24340201$1$I$$20240909$20240919$20240919$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006716$BIOCON$$$$$$Y$$$20240919$$HP$CA$CA
243402021$24340202$1$I$20240801$20240830$20240919$20240919$PER$$US-SA-2024SA268121$SANOFI AVENTIS$$6$YR$C$F$Y$20.82$KG$20240919$$MD$US$US
243402031$24340203$1$I$$20240916$20240919$20240919$EXP$$TR-SA-2024SA268604$SANOFI AVENTIS$Karakayali H, Aktas S, Moray G, Ozcay F, Arslan G, Haberal M.. Pediatric liver transplantation for acute liver failure: Analysis of long-term patient outcome.. Unknown. unk;Unk:119$$$$$Y$$$20240919$$HP$TR$TR
243402041$24340204$1$I$20240828$20240917$20240919$20240919$EXP$$SG-MYLANLABS-2024M1084587$MYLAN$$66$YR$$$Y$$$20240919$$HP$SG$SG
243402051$24340205$1$I$20240601$20240912$20240919$20240919$PER$$US-SA-2024SA269666$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240919$$HP$US$US
243402061$24340206$1$I$20240701$20240911$20240919$20240919$PER$$US-SA-2024SA266790$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240919$$MD$US$US
243402071$24340207$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA267831$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240919$$MD$US$US
243402081$24340208$1$I$20240801$20240911$20240919$20240919$PER$$US-SA-2024SA267159$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240919$$MD$US$US
243402091$24340209$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267201$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240919$$MD$US$US
243402101$24340210$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA266727$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240919$$HP$US$US
243402111$24340211$1$I$20240701$20240911$20240919$20240919$PER$$US-SA-2024SA267676$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240919$$MD$US$US
243402121$24340212$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA267444$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240919$$HP$US$US
243402131$24340213$1$I$$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64371$$FDA-CTU$$$$$F$N$$$20240918$N$HP$US$
243402141$24340214$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64375$$FDA-CTU$$69$YR$$F$N$$$20240919$N$$US$
243402151$24340215$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64372$$FDA-CTU$$41$YR$$M$N$142.43$KG$20240919$N$$US$
243402161$24340216$1$I$$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64373$$FDA-CTU$$$$$M$N$$$20240918$N$HP$US$
243402171$24340217$1$I$$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64383$$FDA-CTU$$$$$F$N$$$20240918$N$HP$US$
243402181$24340218$1$I$$20240913$20240919$20240919$DIR$FDA-CDER-CTU-2024-64374$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243402191$24340219$1$I$20240715$20240919$20240919$20240919$DIR$719060$$FDA-CTU$$$$$UNK$N$$$20240919$N$PH$US$
243402201$24340220$1$I$20240701$20240919$20240919$20240919$DIR$719067$$FDA-CTU$$57$YR$$M$N$76.16$KG$20240919$N$HP$US$
243402221$24340222$1$I$20240903$20240917$20240919$20240919$EXP$$US-INCYTE CORPORATION-2024IN009838$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243402231$24340223$1$I$$20240916$20240919$20240919$PER$$NVSC2024US186272$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
243402241$24340224$1$I$$20240912$20240919$20240919$EXP$$NVSC2024US186060$NOVARTIS$$51$YR$$F$Y$$$20240919$$PH$US$US
243402251$24340225$1$I$20190713$20221025$20240919$20240919$EXP$$RO-SANDOZ INC.-NVSC2020RO189398$SANDOZ$$50$YR$$F$Y$85$KG$20240919$$MD$RO$RO
243402271$24340227$1$I$20240630$20240916$20240919$20240919$EXP$FR-AFSSAPS-AVMA2024000415$FR-INDIVIOR US-INDV-156477-2024$RECKITT BENCKISER$$$$$$Y$$$20240919$$PH$FR$FR
243402281$24340228$1$I$20240819$20240903$20240919$20240919$EXP$$DE-SA-2023SA048939$SANOFI AVENTIS$$$$A$$Y$$$20240919$$HP$DE$DE
243402291$24340229$1$I$$20240912$20240919$20240919$EXP$$NVSC2024CA185479$NOVARTIS$$52$YR$$F$Y$$$20240919$$HP$CA$CA
243402301$24340230$1$I$$20240917$20240919$20240919$PER$$US-HALEON-2197340$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243402311$24340231$1$I$$20240916$20240919$20240919$EXP$$DE-PFIZER INC-202400257020$PFIZER$$73$YR$$$Y$$$20240919$$MD$DE$DE
243402321$24340232$1$I$20240912$20240912$20240919$20240919$EXP$$CA-PFIZER INC-202400256339$PFIZER$$90$YR$$M$Y$$$20240919$$MD$CA$CA
243402341$24340234$1$I$20240801$20240918$20240919$20240919$EXP$$US-PFIZER INC-202400259520$PFIZER$$74$YR$$F$Y$$$20240919$$CN$US$US
243402351$24340235$1$I$20240828$20240910$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009592$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243402371$24340237$1$I$$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024185337$AMGEN$$$$$$Y$$$20240919$$MD$US$US
243402381$24340238$1$I$20240501$20240917$20240919$20240919$EXP$$US-SA-2024SA267234$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240919$$MD$US$US
243402391$24340239$1$I$$20240910$20240919$20240919$EXP$$CA-APOTEX-2024AP010475$APOTEX$$78$YR$$F$Y$$$20240919$$HP$CA$CA
243402401$24340240$1$I$20240912$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024186331$AMGEN$$74$YR$E$F$Y$$$20240919$$CN$US$US
243402411$24340241$1$I$$20240912$20240919$20240919$EXP$$US-EAGLE PHARMACEUTICALS, INC.-US-2024EAG000226$EAGLE$Smith MR, Jegede OA, Martin P, Till BG, Parekh SS, Yang DT, et al.. Randomized study of induction with bendamustine-rituximab ? bortezomib and maintenance with rituximab ? lenalidomide for MCL. Blood. 2024;144(10):1083-1092$$$A$$Y$$$20240919$$MD$US$US
243402421$24340242$1$I$$20240905$20240919$20240919$PER$$US-TEVA-VS-3242557$TEVA$$47$YR$$F$Y$$$20240919$$CN$US$US
243402431$24340243$1$I$$20240910$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144097$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240919$$CN$US$US
243402441$24340244$1$I$$20240913$20240919$20240919$EXP$$DE-MYLANLABS-2024M1083895$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. J Anal Toxicol. 2024;48 (5):299-313$33$YR$$M$Y$$$20240919$$HP$DE$DE
243402461$24340246$1$I$$20240916$20240919$20240919$EXP$$PT-SANDOZ INC.-SDZ2024PT081187$SANDOZ$Silva SP, Eug?nio G,Pinto M, Barcelos A. Clinical and persistent remission in anti-HMGCR immune mediated necrotizing myopathy to a single cycle of rituximab ? a case-based review. ARP Rheumatology. 2024$49$YR$$M$Y$$$20240919$$MD$PT$PT
243402471$24340247$1$I$$20240910$20240919$20240919$PER$$US-RDY-SPO/USA/24/0013437$DR REDDYS$$69$YR$E$M$Y$$$20240919$$HP$US$US
243402481$24340248$1$I$$20240909$20240919$20240919$PER$$US-RDY-SPO/USA/24/0013522$DR REDDYS$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al. Evaluation of off-label rapamycin use on oral health. GeroScience. 2024;46: 4135-4146. doi:10.1007/s11357-024-01221-0.$71$YR$E$F$Y$$$20240919$$HP$US$US
243402501$24340250$1$I$$20240911$20240919$20240919$PER$$US-RDY-SPO/USA/24/0013436$DR REDDYS$$49$YR$A$M$Y$$$20240919$$MD$US$US
243402511$24340251$1$I$20201201$20240911$20240919$20240919$EXP$FR-AFSSAPS-NY2024001001$FR-TEVA-VS-3242782$TEVA$$64$YR$$M$Y$102$KG$20240919$$MD$FR$FR
243402521$24340252$1$I$20240801$20240911$20240919$20240919$EXP$FR-AFSSAPS-TS2024000954$FR-TEVA-VS-3242786$TEVA$$70$YR$$F$Y$45$KG$20240919$$MD$FR$FR
243402531$24340253$1$I$20240821$20240911$20240919$20240919$EXP$FR-AFSSAPS-AN2024001172$FR-TEVA-VS-3242795$TEVA$$79$YR$$M$Y$$$20240919$$PH$FR$FR
243402541$24340254$1$I$$20240918$20240919$20240919$PER$$US-BIOGEN-2024BI01283163$BIOGEN$$$$$F$Y$$$20240919$$CN$US$US
243402551$24340255$1$I$$20240909$20240919$20240919$EXP$$US-GSK-US2024AMR113250$GLAXOSMITHKLINE$$$$$F$Y$68$KG$20240919$$CN$US$US
243402562$24340256$2$F$$20240917$20240919$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015405$JAZZ$$$$$F$Y$$$20240922$$HP$US$US
243402571$24340257$1$I$20240822$20240912$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148351$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$48.1$KG$20240919$$CN$US$US
243402581$24340258$1$I$20240101$20240912$20240919$20240919$EXP$FR-AFSSAPS-RN2024000959$FR-TEVA-VS-3243235$TEVA$$71$YR$$F$Y$$$20240919$$PH$FR$FR
243402591$24340259$1$I$20040101$20240911$20240919$20240919$EXP$FR-AFSSAPS-MP2024001359$FR-TEVA-VS-3242816$TEVA$$50$YR$$F$Y$72$KG$20240919$$HP$FR$FR
243402601$24340260$1$I$20240806$20240911$20240919$20240919$EXP$FR-AFSSAPS-BX2024001727$FR-TEVA-VS-3242808$TEVA$$96$YR$$F$Y$54$KG$20240919$$MD$FR$FR
243402611$24340261$1$I$$20240901$20240919$20240919$EXP$$IL-SA-2024SA269674$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240919$$HP$IL$IL
243402621$24340262$1$I$20240312$20240912$20240919$20240919$EXP$FR-AFSSAPS-DJ2024001012$FR-TEVA-VS-3243394$TEVA$$59$YR$$F$Y$65$KG$20240919$$MD$FR$FR
243402632$24340263$2$F$20240905$20240912$20240919$20240924$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093948$GLENMARK$$$$$$Y$$$20240924$$CN$US$US
243402641$24340264$1$I$20230201$20240909$20240919$20240919$EXP$$BR-JNJFOC-20240927850$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240919$$MD$BR$BR
243402651$24340265$1$I$$20240917$20240919$20240919$DIR$FDA-CDER-CTU-2024-64384$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243402662$24340266$2$F$$20240923$20240919$20240924$EXP$$NVSC2024DE186302$NOVARTIS$$$$$M$Y$$$20240924$$PH$DE$DE
243402671$24340267$1$I$20240731$20240912$20240919$20240919$EXP$FR-AFSSAPS-AM2024000716$FR-TEVA-VS-3243342$TEVA$$20$YR$$F$Y$80$KG$20240919$$MD$FR$FR
243402681$24340268$1$I$$20240918$20240919$20240919$EXP$$GB-MYLANLABS-2024M1085277$MYLAN$$$$$M$Y$$$20240919$$HP$GB$GB
243402691$24340269$1$I$$20240919$20240919$20240919$DIR$719066$$FDA-CTU$$$$$UNK$N$$$20240919$N$PH$US$
243402701$24340270$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011111$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240919$$CN$US$US
243402711$24340271$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266522$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240919$$MD$US$US
243402721$24340272$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267734$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240919$$HP$US$US
243402731$24340273$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64385$$FDA-CTU$$64$YR$$F$N$$$20240919$N$$US$
243402741$24340274$1$I$20231215$20240916$20240919$20240919$EXP$$BR-EMD Serono-2024050088$EMD SERONO INC$$72$YR$E$F$Y$$$20240919$$MD$BR$BR
243402751$24340275$1$I$$20240917$20240919$20240919$DIR$FDA-CDER-CTU-2024-64387$$FDA-CTU$$$$$M$N$$$20240917$N$HP$US$
243402761$24340276$1$I$20240801$20240917$20240919$20240919$DIR$FDA-CDER-CTU-2024-64386$$FDA-CTU$$62$YR$$M$N$$$20240917$N$HP$US$
243402771$24340277$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA270156$SANOFI AVENTIS$$$$E$F$Y$$$20240919$$MD$US$US
243402791$24340279$1$I$$20240826$20240919$20240919$PER$$AU-TOLMAR, INC.-24AU052180$TOLMAR$$$$$M$Y$$$20240919$$CN$AU$AU
243402801$24340280$1$I$$20240826$20240919$20240919$PER$$AU-TOLMAR, INC.-24AU052225$TOLMAR$$$$$M$Y$$$20240919$$CN$AU$AU
243402811$24340281$1$I$20240723$20240826$20240919$20240919$PER$$BR-TOLMAR, INC.-24BR052238$TOLMAR$$10$YR$$F$Y$$$20240919$$CN$BR$BR
243402821$24340282$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64388$$FDA-CTU$$63$YR$$F$N$90.72$KG$20240919$N$$US$
243402831$24340283$1$I$20240601$20240826$20240919$20240919$PER$$BR-TOLMAR, INC.-24BR052243$TOLMAR$$8$YR$$F$Y$$$20240919$$CN$BR$BR
243402841$24340284$1$I$20240101$20240826$20240919$20240919$PER$$CA-TOLMAR, INC.-24CA051808$TOLMAR$$$$$M$Y$$$20240919$$CN$CA$CA
243402861$24340286$1$I$$20240915$20240919$20240919$EXP$$GB-SANDOZ INC.-SDZ2024GB043489$SANDOZ$$$$$M$Y$$$20240919$$CN$GB$GB
243402872$24340287$2$F$20240907$20240925$20240919$20240926$EXP$$JP-BAYER-2024A133555$BAYER$$8$DEC$E$M$Y$$$20240926$$PH$JP$JP
243402881$24340288$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400258287$PFIZER$$55$YR$$M$Y$$$20240919$$CN$US$US
243402891$24340289$1$I$20240610$20240912$20240919$20240919$PER$$US-009507513-2406USA004383$MERCK$$75$YR$$F$Y$72.109$KG$20240919$$HP$US$US
243402911$24340291$1$I$20240101$20240913$20240919$20240919$EXP$$US-ABBVIE-5926565$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243402921$24340292$1$I$20240909$20240917$20240919$20240919$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015451$JAZZ$$19$YR$$M$Y$$$20240919$$CN$US$US
243402941$24340294$1$I$$20240910$20240919$20240919$EXP$$US-SPECGX-T202401899$SPECGX$Elkattawy S, Alyacoub R, Ejikeme C, Noori MAM, Remolina C. Naloxone induced pulmonary edema. Journal of Community Hospital Internal Medicine Perspectives. 2021;11(1):139-42$62$YR$$F$Y$$$20240919$$HP$US$US
243402961$24340296$1$I$20240705$20240919$20240919$20240919$DIR$719061$$FDA-CTU$$24$YR$$F$N$62.82$KG$20240919$N$HP$US$
243402971$24340297$1$I$$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64389$$FDA-CTU$$$$$F$N$$$20240918$N$HP$US$
243402991$24340299$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64390$$FDA-CTU$$65$YR$$M$N$$$20240919$N$$US$
243403011$24340301$1$I$$20240916$20240919$20240919$EXP$$IL-BAYER-2024A132915$BAYER$$$$$$Y$$$20240919$$MD$IL$IL
243403031$24340303$1$I$$20240916$20240919$20240919$PER$$US-HALEON-2197318$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243403041$24340304$1$I$20240818$20240910$20240919$20240919$EXP$$CO-JNJFOC-20240933159$JOHNSON AND JOHNSON$$52$YR$A$F$Y$83$KG$20240919$$HP$CO$CO
243403051$24340305$1$I$$20240916$20240919$20240919$PER$$US-JNJFOC-20240945469$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$CN$US$US
243403061$24340306$1$I$$20240820$20240919$20240919$PER$$US-Eisai-EC-2024-172505$EISAI$$$$$$Y$$$20240919$$MD$US$US
243403071$24340307$1$I$20240919$20240919$20240919$20240919$DIR$719058$$FDA-CTU$$67$YR$$F$N$79.2$KG$20240919$N$PH$US$
243403081$24340308$1$I$$20240909$20240919$20240919$EXP$$CA-BAXTER-2022BAX015146$BAXTER$$82$YR$$F$Y$$$20240919$$HP$CA$CA
243403091$24340309$1$I$20240914$20240919$20240919$20240919$DIR$719057$$FDA-CTU$$65$YR$$M$N$84.6$KG$20240919$N$PH$US$
243403101$24340310$1$I$$20240917$20240919$20240919$EXP$$JP-BAYER-2024A132881$BAYER$$$$$M$Y$$$20240919$$MD$JP$JP
243403111$24340311$1$I$20240822$20240919$20240919$20240919$DIR$719056$$FDA-CTU$$53$YR$$F$N$123.75$KG$20240919$Y$CN$US$
243403121$24340312$1$I$20240803$20240919$20240919$20240919$DIR$719062$$FDA-CTU$$$$$UNK$N$$$20240919$N$PH$US$
243403141$24340314$1$I$$20240905$20240919$20240919$EXP$$CA-BAXTER-2024BAX024444$BAXTER$$21$YR$$F$Y$$$20240919$$CN$CA$CA
243403151$24340315$1$I$$20240906$20240919$20240919$PER$$US-RDY-CLI/USA/24/0013381$DR REDDYS$$6$YR$C$F$Y$17.6$KG$20240919$$CN$US$US
243403161$24340316$1$I$20240903$20240909$20240919$20240919$PER$$US-AMGEN-USASP2024186517$AMGEN$$72$YR$E$M$Y$$$20240919$$HP$US$US
243403181$24340318$1$I$$20240909$20240919$20240919$PER$$US-APOTEX-2024AP010993$APOTEX$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65 (1):33-38$53$YR$$F$Y$$$20240919$$MD$US$US
243403192$24340319$2$F$20240827$20240918$20240919$20240927$EXP$$GB-KARYOPHARM-2024KPT001547$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240927$$MD$GB$GB
243403211$24340321$1$I$$20240917$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2024CA081092$SANDOZ$$$$$F$Y$$$20240919$$MD$CA$CA
243403221$24340322$1$I$$20240908$20240919$20240919$EXP$$US-JNJFOC-20240927652$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$HP$US$US
243403231$24340323$1$I$$20240918$20240919$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US081397$SANDOZ$$$$$M$Y$$$20240919$$HP$US$US
243403241$24340324$1$I$$20240918$20240919$20240919$EXP$AU-AMGEN-AUSSP2024162622$AU-SANDOZ INC.-SDZ2024AU081244$SANDOZ$$$$E$$Y$$$20240919$$HP$AU$AU
243403251$24340325$1$I$$20240911$20240919$20240919$EXP$$ES-AMGEN-ESPSP2024183866$AMGEN$Lluch P.; Ballester M.P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240919$$MD$ES$ES
243403261$24340326$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186968$AMGEN$$$$$$Y$$$20240919$$PH$US$US
243403271$24340327$1$I$$20240916$20240919$20240919$EXP$$NVSC2024CA185960$NOVARTIS$$39$YR$$F$Y$$$20240919$$CN$CA$CA
243403281$24340328$1$I$$20240917$20240919$20240919$EXP$$CA-BAYER-2024A132944$BAYER$$$$$$Y$$$20240919$$MD$CA$CA
243403291$24340329$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA266723$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
243403301$24340330$1$I$$20240827$20240919$20240919$PER$$US-SA-2024SA267216$SANOFI AVENTIS$$$$A$F$Y$69.89$KG$20240919$$MD$US$US
243403311$24340331$1$I$$20240913$20240919$20240919$EXP$$DE-MYLANLABS-2024M1084010$MYLAN$Heinig-Menhard, K... Tuberculosis in the intensive care unit: When to think about it - how to treat it?. Intensivmedizin up2date.. 2024;20(03):325 - 340.$20$YR$$M$Y$$$20240919$$MD$DE$DE
243403321$24340332$1$I$20230701$20240908$20240919$20240919$EXP$GB-MHRA-MED-202409082049593860-LVBDS$GB-GLENMARK PHARMACEUTICALS-2024GMK093943$GLENMARK$$$$$$Y$$$20240919$$CN$GB$GB
243403331$24340333$1$I$$20240905$20240919$20240919$EXP$$CN-RICONPHARMA, LLC-2024RIC000061$RICONPHARMA$Zhang X, Huang D, Lou D, Si X, Mao J.. Stevens-Johnson Syndrome/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review.. BMC Endocr Disord.. 2024;24(1):172$73$YR$$F$Y$$$20240919$$HP$CN$CN
243403341$24340334$1$I$$20240916$20240919$20240919$EXP$$AU-SANDOZ INC.-SDZ2024AU080600$SANDOZ$$22$YR$$M$Y$$$20240919$$HP$AU$AU
243403351$24340335$1$I$$20240917$20240919$20240919$PER$$US-TAKEDA-2024TUS093016$TAKEDA$$$$$M$Y$$$20240919$$HP$US$US
243403361$24340336$1$I$20220601$20240916$20240919$20240919$EXP$$BR-EMD Serono-2024050082$EMD SERONO INC$$88$YR$E$M$Y$$$20240919$$MD$BR$BR
243403371$24340337$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010904$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243403381$24340338$1$I$$20240912$20240919$20240919$EXP$$CA-TEVA-VS-3243731$TEVA$$33$YR$$F$Y$$$20240919$$HP$CA$CA
243403391$24340339$1$I$$20240914$20240919$20240919$EXP$$IE-TAKEDA-2024TUS092158$TAKEDA$$$$$$Y$$$20240919$$CN$IE$IE
243403401$24340340$1$I$20240401$20240916$20240919$20240919$EXP$$DE-MYLANLABS-2024M1084717$MYLAN$$7$YR$$F$Y$21$KG$20240919$$HP$DE$DE
243403411$24340341$1$I$20240601$20240918$20240919$20240919$EXP$FR-AFSSAPS-NC2024001064$FR-009507513-2409FRA006411$MERCK$$67$YR$$F$Y$82$KG$20240919$$MD$FR$FR
243403421$24340342$1$I$$20240911$20240919$20240919$EXP$$CA-JNJFOC-20240932285$JOHNSON AND JOHNSON$$$$$M$Y$88$KG$20240919$$HP$CA$CA
243403431$24340343$1$I$$20240916$20240919$20240919$PER$$US-Taiho Oncology Inc-2024-008827$TAIHO ONCOLOGY INC$$$$A$F$Y$$$20240919$$CN$US$US
243403441$24340344$1$I$$20240913$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146749$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240919$$MD$US$US
243403451$24340345$1$I$$20240913$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147207$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240919$$CN$US$US
243403461$24340346$1$I$$20240919$20240919$20240919$DIR$719068$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243403471$24340347$1$I$$20240919$20240919$20240919$DIR$719065$$FDA-CTU$$$$$UNK$N$$$20240919$N$PH$US$
243403501$24340350$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149191$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240919$$CN$US$US
243403511$24340351$1$I$$20240913$20240919$20240919$PER$$US-MYLANLABS-2024M1085092$MYLAN$$$$$M$Y$$$20240919$$MD$US$US
243403521$24340352$1$I$$20240910$20240919$20240919$PER$$US-JNJFOC-20240927400$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$HP$US$US
243403531$24340353$1$I$$20240904$20240919$20240919$EXP$$CA-BAXTER-2024BAX024310$BAXTER$$74$YR$$M$Y$$$20240919$$CN$CA$CA
243403542$24340354$2$F$$20240919$20240919$20240920$PER$$US-JNJFOC-20240951598$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243403551$24340355$1$I$$20240913$20240919$20240919$EXP$$CA-SANDOZ INC.-SDZ2023CA032475$SANDOZ$$$$$F$Y$$$20240919$$CN$CA$CA
243403561$24340356$1$I$$20240909$20240919$20240919$EXP$$US-SA-2024SA270829$SANOFI AVENTIS$$$$E$F$Y$$$20240919$$MD$US$US
243403571$24340357$1$I$20240101$20240905$20240919$20240919$EXP$$US-SA-2024SA270208$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240919$$MD$US$US
243403581$24340358$1$I$$20240916$20240919$20240919$EXP$FR-AFSSAPS-AVNT2024000679$FR-MYLANLABS-2024M1084534$MYLAN$$45$YR$$M$Y$$$20240919$$PH$FR$FR
243403591$24340359$1$I$$20230828$20240919$20240919$EXP$$NVSC2023PT281181$NOVARTIS$$$$E$$Y$$$20240919$$HP$PT$PT
243403601$24340360$1$I$$20240904$20240919$20240919$PER$$US-TEVA-VS-3241507$TEVA$$55$YR$$F$Y$$$20240919$$CN$US$US
243403611$24340361$1$I$$20240912$20240919$20240919$EXP$$NZ-GSK-NZ2024113597$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$NZ$NZ
243403621$24340362$1$I$20240822$20240911$20240919$20240919$PER$$US-SA-2024SA266800$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240919$$MD$US$US
243403631$24340363$1$I$$20240411$20240919$20240919$EXP$$NVSC2024TH186364$NOVARTIS$$$$$M$Y$$$20240919$$MD$TH$TH
243403641$24340364$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA265956$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240919$$MD$US$US
243403651$24340365$1$I$20240917$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024187068$AMGEN$$75$YR$E$F$Y$$$20240919$$CN$US$US
243403661$24340366$1$I$$20240912$20240919$20240919$EXP$$US-GSK-US2024113756$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$US$US
243403671$24340367$1$I$$20240911$20240919$20240919$PER$$US-ABBVIE-5920111$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243403681$24340368$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA266761$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240919$$MD$US$US
243403691$24340369$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA270209$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240919$$HP$US$US
243403701$24340370$1$I$20240101$20240905$20240919$20240919$PER$$US-SA-2024SA269015$SANOFI AVENTIS$$$$$F$Y$63.492$KG$20240919$$CN$US$US
243403711$24340371$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA269544$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240919$$MD$US$US
243403721$24340372$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267707$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240919$$HP$US$US
243403731$24340373$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA266651$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240919$$HP$US$US
243403741$24340374$1$I$$20240911$20240919$20240919$PER$$US-JNJFOC-20240931127$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243403752$24340375$2$F$$20240919$20240919$20240920$PER$$US-JNJFOC-20240951529$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243403771$24340377$1$I$$20240913$20240919$20240919$PER$$US-TAKEDA-2024TUS092272$TAKEDA$$$$$$Y$88.45$KG$20240919$$MD$US$US
243403781$24340378$1$I$20240801$20240912$20240919$20240919$PER$$US-MYLANLABS-2024M1083700$MYLAN$$82$YR$$F$Y$58.97$KG$20240919$$CN$US$US
243403791$24340379$1$I$20240101$20240918$20240919$20240919$EXP$$JP-BAYER-2024A133468$BAYER$$$$$M$Y$$$20240919$$MD$JP$JP
243403811$24340381$1$I$$20240908$20240919$20240919$EXP$$US-JNJFOC-20240930227$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240919$$MD$US$US
243403821$24340382$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010905$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243403831$24340383$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64392$$FDA-CTU$$$$$F$N$$$20240919$N$HP$US$
243403841$24340384$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64393$$FDA-CTU$$62$YR$$F$N$$$20240919$N$$US$
243403861$24340386$1$I$$20240912$20240919$20240919$EXP$$US-AMGEN-USASP2024184224$AMGEN$Kooienga L.; Burke S.; Kathresal A. et al.. Safety and Efficacy of Vadadustat Once Daily and 3-Times-Weekly in Dialysis-Dependent Chronic Kidney Disease Patients with Anemia. Kidney360. 2024$$$$$Y$$$20240919$$HP$US$US
243403871$24340387$1$I$20240830$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024183748$AMGEN$$65$YR$E$F$Y$$$20240919$$CN$US$US
243403881$24340388$1$I$$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024186486$AMGEN$$$$$M$Y$$$20240919$$CN$US$US
243403891$24340389$1$I$$20240910$20240919$20240919$EXP$$US-RADIUS HEALTH INC.-2024US007103$RADIUS PHARM$$$$$F$Y$$$20240919$$CN$US$US
243403901$24340390$1$I$$20240911$20240919$20240919$EXP$$BR-TAKEDA-BR202000240$TAKEDA$$$$$M$Y$12$KG$20240919$$CN$BR$BR
243403921$24340392$1$I$$20240908$20240919$20240919$EXP$$US-JNJFOC-20240950855$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$HP$US$US
243403931$24340393$1$I$$20240918$20240919$20240919$EXP$$JP-ABBVIE-5930011$ABBVIE$$$$$$Y$$$20240919$$MD$JP$JP
243403941$24340394$1$I$20220209$20240914$20240919$20240919$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-03772$IPSEN$$56$YR$A$F$Y$$$20240919$$MD$CA$CA
243403951$24340395$1$I$$20240911$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145245$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240919$$CN$US$US
243403961$24340396$1$I$$20240915$20240919$20240919$PER$$US-HALEON-2197158$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243403971$24340397$1$I$$20240917$20240919$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US081233$SANDOZ$$$$$F$Y$$$20240919$$CN$US$US
243403981$24340398$1$I$$20240908$20240919$20240919$EXP$$TW-ASTELLAS-2024-AER-005362$ASTELLAS$$57$YR$A$F$Y$$$20240919$$MD$TW$TW
243403991$24340399$1$I$$20240916$20240919$20240919$EXP$$GB-AMGEN-GBRSP2024185477$AMGEN$$$$$M$Y$$$20240919$$CN$GB$GB
243404001$24340400$1$I$20240101$20240912$20240919$20240919$EXP$$US-JNJFOC-20240931688$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240919$$CN$US$US
243404011$24340401$1$I$$20240911$20240919$20240919$EXP$$US-AMGEN-USASP2024184208$AMGEN$Dhakal P.; Sy M.; Sutamtewagul G. et al.. Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real World Clinical Setting. Journal of Immunotherapy and Precision Oncology. 2024;7(3):205-209$65$YR$E$M$Y$$$20240919$$HP$US$US
243404021$24340402$1$I$$20240917$20240919$20240919$PER$$US-JNJFOC-20240944600$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$HP$US$US
243404032$24340403$2$F$$20240926$20240919$20240928$EXP$$CL-JNJFOC-20240820716$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240928$$CN$CL$CL
243404051$24340405$1$I$$20240918$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148944$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$65.77$KG$20240919$$CN$US$US
243404061$24340406$1$I$20240901$20240919$20240919$20240919$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052351$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240919$$CN$US$US
243404071$24340407$1$I$$20240918$20240919$20240919$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005178$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240919$$MD$US$US
243404081$24340408$1$I$20240901$20240916$20240919$20240919$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005136$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240919$$CN$US$US
243404091$24340409$1$I$20240901$20240913$20240919$20240919$PER$$US-ABBVIE-5924249$ABBVIE$$17$YR$$M$Y$$$20240919$$MD$US$US
243404111$24340411$1$I$20240101$20240916$20240919$20240919$EXP$$US-SA-2024SA270188$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240919$$HP$US$US
243404121$24340412$1$I$20240101$20240912$20240919$20240919$EXP$DE-CADRBFARM-2024330333$DE-SA-2024SA270596$SANOFI AVENTIS$$43$YR$A$M$Y$84$KG$20240919$$MD$DE$DE
243404131$24340413$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010908$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243404141$24340414$1$I$$20240913$20240919$20240919$EXP$$US-ABBVIE-5925177$ABBVIE$$$$$F$Y$$$20240919$$HP$US$US
243404151$24340415$1$I$20240101$20240827$20240919$20240919$PER$$US-SA-2024SA267177$SANOFI AVENTIS$$60$YR$A$F$Y$68.027$KG$20240919$$MD$US$US
243404161$24340416$1$I$$20240918$20240919$20240919$PER$$NVSC2024US187304$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243404171$24340417$1$I$$20240912$20240919$20240919$EXP$$NVSC2024US183860$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
243404181$24340418$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA266663$SANOFI AVENTIS$$14$YR$T$F$Y$54.875$KG$20240919$$HP$US$US
243404191$24340419$1$I$20240903$20240906$20240919$20240919$PER$$US-SA-2024SA268211$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240919$$CN$US$US
243404201$24340420$1$I$20240101$20240905$20240919$20240919$PER$$US-SA-2024SA269998$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240919$$MD$US$US
243404212$24340421$2$F$20240801$20240920$20240919$20240926$EXP$$JP-009507513-2409JPN002042J$MERCK$$66$YR$$M$Y$$$20240926$$MD$JP$JP
243404221$24340422$1$I$20240911$20240912$20240919$20240919$PER$$US-ABBVIE-5924224$ABBVIE$$39$YR$$$Y$$$20240919$$MD$US$US
243404241$24340424$1$I$$20240910$20240919$20240919$PER$$US-MYLANLABS-2024M1082972$MYLAN$$$$$F$Y$$$20240919$$CN$US$US
243404251$24340425$1$I$20240909$20240912$20240919$20240919$EXP$$US-GSK-US2024113739$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$CN$US$US
243404261$24340426$1$I$$20240918$20240919$20240919$PER$$NVSC2024US187302$NOVARTIS$$$$$M$Y$$$20240919$$CN$US$US
243404271$24340427$1$I$$20240917$20240919$20240919$EXP$$NVSC2024HK186956$NOVARTIS$$$$$$Y$$$20240919$$MD$HK$HK
243404281$24340428$1$I$$20240910$20240919$20240919$PER$$US-ABBVIE-5919393$ABBVIE$$$$$F$Y$$$20240919$$MD$US$US
243404291$24340429$1$I$20240701$20240913$20240919$20240919$EXP$$US-ABBVIE-5925041$ABBVIE$$60$YR$$F$Y$$$20240919$$CN$US$US
243404301$24340430$1$I$20240911$20240911$20240919$20240919$PER$$US-RDY-SPO/USA/24/0013600$DR REDDYS$$16$YR$T$$Y$$$20240919$$MD$US$US
243404311$24340431$1$I$20240906$20240906$20240919$20240919$PER$$US-RDY-SPO/USA/24/0013379$DR REDDYS$$32$YR$A$$Y$$$20240919$$HP$US$US
243404321$24340432$1$I$20240901$20240918$20240919$20240919$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-149078$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240919$$CN$PR$PR
243404331$24340433$1$I$$20240912$20240919$20240919$EXP$$CA-TEVA-VS-3243491$TEVA$$73$YR$$M$Y$66$KG$20240919$$HP$CA$CA
243404341$24340434$1$I$$20240912$20240919$20240919$EXP$$CA-TEVA-VS-3243737$TEVA$$$$$$Y$$$20240919$$HP$CA$CA
243404351$24340435$1$I$$20240912$20240919$20240919$EXP$$NVSC2024SI183930$NOVARTIS$$$$A$F$Y$$$20240919$$MD$SI$SI
243404361$24340436$1$I$$20240909$20240919$20240919$EXP$$NVSC2024ZA184139$NOVARTIS$$50$YR$$F$Y$$$20240919$$CN$ZA$ZA
243404371$24340437$1$I$$20240917$20240919$20240919$EXP$$NVSC2024AU186590$NOVARTIS$$$$E$F$Y$$$20240919$$MD$AU$AU
243404381$24340438$1$I$$20240917$20240919$20240919$EXP$$NVSC2024US186476$NOVARTIS$$$$$F$Y$$$20240919$$HP$US$US
243404391$24340439$1$I$$20240917$20240919$20240919$EXP$$NVSC2024US185780$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243404401$24340440$1$I$$20240911$20240919$20240919$EXP$$NVSC2024DE185414$NOVARTIS$Maurer E, Eilsberger F, Wachter S, Riera Knorrenschild J, Pehl A, Holzer K, et al. Mutation?based, short term neoadjuvant treatment allows resectability in stage IVB and C anaplastic thyroid cancer. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2023;280:1509-18$73$YR$$M$Y$$$20240919$$HP$DE$DE
243404431$24340443$1$I$$20240911$20240919$20240919$EXP$$NVSC2024VN183500$NOVARTIS$Nguyen TD, Phan TDN, Ton TT, Phan TTH, Dong SS, Che TC. Application of mesenchymal stem cells in treatment for lupus nephritis caused by systemic lupus erythematosus. VIETNAM MEDICAL JOURNAL. 2022;26-32$35$YR$$M$Y$$$20240919$$HP$VN$VN
243404441$24340444$1$I$$20240915$20240919$20240919$PER$$US-GILEAD-2024-0688275$GILEAD$$$$$$Y$$$20240919$$HP$US$US
243404451$24340445$1$I$$20240915$20240919$20240919$PER$$US-GILEAD-2024-0688240$GILEAD$$$$$$Y$$$20240919$$HP$US$US
243404481$24340448$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64115$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243404491$24340449$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64119$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243404501$24340450$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64114$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243404511$24340451$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64128$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243404521$24340452$1$I$$20240917$20240919$20240919$EXP$$CA-TAKEDA-2024TUS093123$TAKEDA$$$$$F$Y$$$20240919$$CN$CA$CA
243404531$24340453$1$I$$20240911$20240919$20240919$EXP$$JP-EMD Serono-2024031658$EMD SERONO INC$$57$YR$A$M$Y$$$20240919$$MD$JP$JP
243404541$24340454$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA270621$SANOFI AVENTIS$$$$C$F$Y$$$20240919$$HP$US$US
243404551$24340455$1$I$$20240905$20240919$20240919$PER$$US-SA-2024SA263294$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240919$$CN$US$US
243404561$24340456$1$I$20221201$20240918$20240919$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US081226$SANDOZ$$50$YR$$F$Y$$$20240919$$CN$US$US
243404571$24340457$1$I$$20240830$20240919$20240919$PER$$US-TEVA-VS-3239348$TEVA$$39$YR$$M$Y$$$20240919$$HP$US$US
243404581$24340458$1$I$$20240912$20240919$20240919$EXP$$CA-TEVA-VS-3243474$TEVA$$83$YR$$F$Y$$$20240919$$HP$CA$CA
243404591$24340459$1$I$$20240906$20240919$20240919$EXP$$US-SMPA-2024SPA002477$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243404602$24340460$2$F$$20240910$20240919$20240924$EXP$$GB-SMPA-2024SPA002718$SUNOVION$$$$$$Y$$$20240924$$MD$CH$CH
243404611$24340461$1$I$$20240906$20240919$20240919$EXP$$JP-SMPA-2024SPA002767$SUNOVION$$$$$$Y$$$20240919$$HP$JP$JP
243404621$24340462$1$I$$20240908$20240919$20240919$EXP$$US-SMPA-2024SPA002484$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243404631$24340463$1$I$20240916$20240917$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149211$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240919$$CN$US$US
243404643$24340464$3$F$$20240926$20240919$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149332$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240927$$CN$US$US
243404651$24340465$1$I$$20240912$20240919$20240919$EXP$$CA-TEVA-VS-3243460$TEVA$$56$YR$$F$Y$$$20240919$$HP$CA$CA
243404661$24340466$1$I$$20240916$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147902$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240919$$HP$US$US
243404671$24340467$1$I$$20240917$20240919$20240919$PER$$US-TAKEDA-2024TUS092874$TAKEDA$$$$$M$Y$$$20240919$$MD$US$US
243404681$24340468$1$I$$20240915$20240919$20240919$PER$$US-GILEAD-2024-0688237$GILEAD$$$$$$Y$$$20240919$$HP$US$US
243404691$24340469$1$I$$20240912$20240919$20240919$EXP$FR-AFSSAPS-AVNT2024000656$FR-TEVA-VS-3243378$TEVA$$40$YR$$F$Y$$$20240919$$MD$FR$FR
243404701$24340470$1$I$20240301$20240911$20240919$20240919$EXP$FR-AFSSAPS-AM2024000694$FR-TEVA-VS-3242882$TEVA$$74$YR$$M$Y$64$KG$20240919$$MD$FR$FR
243404711$24340471$1$I$$20240904$20240919$20240919$EXP$$BR-JUBILANT CADISTA PHARMACEUTICALS-2024JUB00072$JUBILANT$De Almeida Franzoi A.E, Ferreira E.L, Wollmann G.M, de Araujo Meskau M.P, Tensini T.S.. Acute generalized pustulosis secondary to lamotrigine: from clinical  to anatomopathological description. Acta Neurologica Belgica. 2024;124:701-703$65$YR$$F$Y$$$20240919$$HP$BR$BR
243404721$24340472$1$I$$20240912$20240919$20240919$EXP$$CA-TEVA-VS-3243489$TEVA$$49$YR$$F$Y$$$20240919$$PH$CA$CA
243404731$24340473$1$I$$20240904$20240919$20240919$EXP$$GB-JUBILANT CADISTA PHARMACEUTICALS-2024JUB00071$JUBILANT$Chou M, Lai L, Neveu M, Ritchie A.. Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy. BMJ Case Reports. 2024;17:e256961:1-5$$$T$M$Y$$$20240919$$HP$GB$GB
243404741$24340474$1$I$20190101$20240913$20240919$20240919$EXP$FR-AFSSAPS-AVLY2024000145$FR-TEVA-VS-3243842$TEVA$$36$YR$$F$Y$55$KG$20240919$$MD$FR$FR
243404751$24340475$1$I$20240906$20240906$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409012018$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240919$$CN$US$US
243404761$24340476$1$I$$20240917$20240919$20240919$EXP$$JP-ABBVIE-5929041$ABBVIE$$$$$$Y$$$20240919$$PH$JP$JP
243404771$24340477$1$I$$20240917$20240919$20240919$PER$$US-JNJFOC-20240945176$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$CN$US$US
243404782$24340478$2$F$$20240913$20240919$20240920$EXP$$CA-MYLANLABS-2024M1063412$MYLAN$$$$$M$Y$$$20240920$$CN$CA$CA
243404792$24340479$2$F$20240515$20240913$20240919$20240920$EXP$FR-AFSSAPS-AVMA2024000391$FR-MYLANLABS-2024M1084179$MYLAN$$31$YR$$M$Y$$$20240920$$PH$FR$FR
243404802$24340480$2$F$20240527$20240913$20240919$20240920$EXP$FR-AFSSAPS-AVMA2024000395$FR-MYLANLABS-2024M1084009$MYLAN$$43$YR$$M$Y$$$20240920$$PH$FR$FR
243404811$24340481$1$I$$20240905$20240919$20240919$EXP$$US-JNJFOC-A-US2016-142815$JOHNSON AND JOHNSON$$6$MON$I$M$Y$$$20240919$$CN$US$US
243404821$24340482$1$I$$20240917$20240919$20240919$PER$$US-JNJFOC-20240944447$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$CN$US$US
243404831$24340483$1$I$$20240918$20240919$20240919$PER$$NVSC2024US187311$NOVARTIS$$$$$M$Y$$$20240919$$PH$US$US
243404842$24340484$2$F$20240101$20240918$20240919$20240923$PER$$US-BIOGEN-2024BI01283181$BIOGEN$$$$$F$Y$157.99$KG$20240923$$HP$US$US
243404851$24340485$1$I$$20240910$20240919$20240919$PER$$US-AMGEN-USASP2024187127$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243404861$24340486$1$I$$20240918$20240919$20240919$PER$$US-HALEON-2197537$Haleon PLC$$$$$$Y$$$20240919$$CN$US$US
243404881$24340488$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64123$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243404891$24340489$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64116$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243404901$24340490$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64109$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243404911$24340491$1$I$$20240911$20240919$20240919$EXP$$NVSC2024CA184910$NOVARTIS$$48$YR$$F$Y$68$KG$20240919$$HP$CA$CA
243404921$24340492$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64117$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243404931$24340493$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64129$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243404941$24340494$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64111$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243404961$24340496$1$I$20240916$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024186481$AMGEN$$75$YR$E$F$Y$$$20240919$$CN$US$US
243404971$24340497$1$I$20240903$20240916$20240919$20240919$EXP$$US-BAYER-2024A132643$BAYER$$85$YR$E$M$Y$$$20240919$$CN$US$US
243404981$24340498$1$I$$20240906$20240919$20240919$EXP$$SE-B.Braun Medical Inc.-2161824$B BRAUN$$62$YR$$F$Y$$$20240919$$$SE$SE
243404991$24340499$1$I$$20240909$20240919$20240919$30DAY$$US-GSK-US2024AMR113318$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243405001$24340500$1$I$20240401$20240913$20240919$20240919$EXP$$GB-ABBVIE-5923403$ABBVIE$$39$YR$$M$Y$$$20240919$$MD$GB$GB
243405011$24340501$1$I$$20240905$20240919$20240919$PER$$US-SA-2024SA263067$SANOFI AVENTIS$$$$$$Y$$$20240919$$CN$US$US
243405021$24340502$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA265837$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240919$$MD$US$US
243405031$24340503$1$I$$20240906$20240919$20240919$EXP$$FR-B.Braun Medical Inc.-2161831$B BRAUN$$41$YR$$F$Y$$$20240919$$$FR$FR
243405041$24340504$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA266452$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240919$$MD$US$US
243405051$24340505$1$I$20240816$20240821$20240919$20240919$PER$$US-Eisai-EC-2024-172638$EISAI$$77$YR$E$M$Y$$$20240919$$CN$US$US
243405061$24340506$1$I$$20240913$20240919$20240919$EXP$$US-Karo Pharma-2161825$Karo Pharma$$$$$F$Y$$$20240919$$$US$US
243405071$24340507$1$I$$20240912$20240919$20240919$PER$$US-BIOMARINAP-US-2024-160564$BIOMARIN$$$$$$Y$$$20240919$$CN$US$US
243405081$24340508$1$I$$20240913$20240919$20240919$PER$$US-BIOMARINAP-US-2024-160576$BIOMARIN$$$$$$Y$$$20240919$$CN$US$US
243405091$24340509$1$I$$20231228$20240919$20240919$PER$$US-Karo Pharma-2161829$Karo Pharma$$$$$F$Y$$$20240919$$$US$US
243405101$24340510$1$I$$20240913$20240919$20240919$PER$$US-BIOMARINAP-US-2024-160603$BIOMARIN$$$$$$Y$$$20240919$$CN$US$US
243405111$24340511$1$I$20240917$20240917$20240919$20240919$PER$$US-BIOMARINAP-US-2024-160640$BIOMARIN$$$$$$Y$$$20240919$$CN$US$US
243405121$24340512$1$I$$20240916$20240919$20240919$PER$$US-BIOMARINAP-US-2024-160612$BIOMARIN$$$$$$Y$$$20240919$$CN$US$US
243405131$24340513$1$I$$20240906$20240919$20240919$EXP$$GB-B.Braun Medical Inc.-2161828$B BRAUN$$$$$M$Y$$$20240919$$MD$GB$GB
243405141$24340514$1$I$$20240911$20240919$20240919$EXP$$US-JNJFOC-20240929533$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$CN$US$US
243405161$24340516$1$I$20240811$20240912$20240919$20240919$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014892$JAZZ$$64$YR$$F$Y$$$20240919$$CN$US$US
243405171$24340517$1$I$$20240917$20240919$20240919$PER$$US-BIOMARINAP-US-2024-160634$BIOMARIN$$$$$$Y$$$20240919$$CN$US$US
243405181$24340518$1$I$20240901$20240913$20240919$20240919$PER$$US-BIOMARINAP-US-2024-160602$BIOMARIN$$$$$$Y$$$20240919$$CN$US$US
243405191$24340519$1$I$20240918$20240919$20240919$20240919$DIR$719074$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243405201$24340520$1$I$20240918$20240919$20240919$20240919$DIR$719089$$FDA-CTU$$82$YR$$M$N$73.35$KG$20240919$Y$$US$
243405211$24340521$1$I$20240829$20240919$20240919$20240919$DIR$719080$$FDA-CTU$$71$YR$$F$N$66.15$KG$20240919$N$PH$US$
243405221$24340522$1$I$20240919$20240919$20240919$20240919$DIR$719075$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243405231$24340523$1$I$20240919$20240919$20240919$20240919$DIR$719078$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243405241$24340524$1$I$20240824$20240919$20240919$20240919$DIR$719077$$FDA-CTU$$65$YR$$F$N$$$20240919$Y$$US$
243405251$24340525$1$I$20240918$20240919$20240919$20240919$DIR$719076$$FDA-CTU$$60$YR$$M$N$$$20240919$N$$US$
243405261$24340526$1$I$$20240919$20240919$20240919$DIR$719073$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243405271$24340527$1$I$20240919$20240919$20240919$20240919$DIR$719084$$FDA-CTU$$79$YR$$F$N$$$20240919$N$HP$US$
243405311$24340531$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010207$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240919$$CN$US$US
243405321$24340532$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010732$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240919$$CN$US$US
243405331$24340533$1$I$$20240912$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409008823$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240919$$CN$US$US
243405341$24340534$1$I$20240914$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011822$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240919$$CN$US$US
243405351$24340535$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409012058$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240919$$CN$US$US
243405361$24340536$1$I$$20240917$20240919$20240919$EXP$$US-BAYER-2024A133344$BAYER$$54$YR$A$M$Y$$$20240919$$CN$US$US
243405371$24340537$1$I$$20240917$20240919$20240919$PER$$US-BAYER-2024A132980$BAYER$$$$$M$Y$$$20240919$$CN$US$US
243405381$24340538$1$I$$20240918$20240919$20240919$EXP$$US-BAYER-2024A133623$BAYER$$81$YR$E$M$Y$$$20240919$$CN$US$US
243405391$24340539$1$I$$20240910$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144057$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240919$$CN$US$US
243405401$24340540$1$I$$20240917$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149227$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240919$$CN$US$US
243405421$24340542$1$I$20191001$20240911$20240919$20240919$EXP$$US-TAKEDA-2020TUS001118$TAKEDA$$17$YR$$F$Y$$$20240919$$HP$US$US
243405431$24340543$1$I$$20240913$20240919$20240919$EXP$$US-BIOMARINAP-US-2024-160570$BIOMARIN$$$$$$Y$$$20240919$$CN$US$US
243405441$24340544$1$I$20240313$20240916$20240919$20240919$PER$$US-JNJFOC-20240941853$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240919$$HP$US$US
243405451$24340545$1$I$$20240912$20240919$20240919$EXP$$US-BIOGEN-2024BI01282616$BIOGEN$$$$$F$Y$$$20240919$$MD$US$US
243405461$24340546$1$I$$20240917$20240919$20240919$EXP$$AU-SA-2024SA271024$SANOFI AVENTIS$$$$$F$Y$$$20240919$$CN$AU$AU
243405471$24340547$1$I$20240801$20240912$20240919$20240919$EXP$$PR-BIOGEN-2024BI01282373$BIOGEN$$62$YR$$F$Y$$$20240919$$CN$PR$PR
243405481$24340548$1$I$20230504$20240913$20240919$20240919$EXP$FR-AFSSAPS-PC2024000689$FR-TEVA-VS-3243735$TEVA$$28$YR$$F$Y$57$KG$20240919$$PH$FR$FR
243405491$24340549$1$I$20230418$20240913$20240919$20240919$EXP$FR-AFSSAPS-PC2024000688$FR-TEVA-VS-3243414$TEVA$$62$YR$$F$Y$73$KG$20240919$$PH$FR$FR
243405501$24340550$1$I$20240801$20240909$20240919$20240919$EXP$$US-UCBSA-2024046458$UCB$$54$YR$$F$Y$$$20240919$$HP$US$US
243405511$24340551$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA266808$SANOFI AVENTIS$$$$A$F$Y$$$20240919$$MD$US$US
243405521$24340552$1$I$20240108$20240911$20240919$20240919$PER$$JP-Eisai-EC-2024-174530$EISAI$$$$E$M$Y$$$20240919$$MD$JP$JP
243405541$24340554$1$I$20240816$20240913$20240919$20240919$EXP$FR-AFSSAPS-MP2024001358$FR-TEVA-VS-3243773$TEVA$$39$YR$$M$Y$41$KG$20240919$$PH$FR$FR
243405551$24340555$1$I$20240106$20240911$20240919$20240919$PER$$VN-Eisai-EC-2024-174172$EISAI$$$$$M$Y$$$20240919$$MD$VN$VN
243405561$24340556$1$I$20240508$20240913$20240919$20240919$EXP$FR-AFSSAPS-AVMA2024000387$FR-TEVA-VS-3243512$TEVA$$40$YR$$F$Y$$$20240919$$PH$FR$FR
243405571$24340557$1$I$20240830$20240912$20240919$20240919$PER$$JP-Eisai-EC-2024-174227$EISAI$$$$E$F$Y$$$20240919$$MD$JP$JP
243405581$24340558$1$I$$20240912$20240919$20240919$PER$$JP-Eisai-EC-2024-168866$EISAI$$$$E$$Y$$$20240919$$MD$JP$JP
243405591$24340559$1$I$20240805$20240913$20240919$20240919$EXP$IT-MINISAL02-1001335$IT-TEVA-VS-3243596$TEVA$$37$YR$$M$Y$76$KG$20240919$$MD$IT$IT
243405601$24340560$1$I$$20240911$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009637$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243405611$24340561$1$I$20240828$20240904$20240919$20240919$EXP$$CA-HLS-202402227$HLS THERAPEUTICS$$75$YR$E$F$Y$$$20240919$$HP$CA$CA
243405631$24340563$1$I$20231001$20240916$20240919$20240919$EXP$$MT-REGENERON PHARMACEUTICALS, INC.-2024-125389$REGENERON$Montebello A., Grech M., Maniscalco N.,Pisani D.Br J Hosp Med (Lond);. Parathyroid Hormone Related Protein Mediated Hypercalcaemia Due to Metastatic Squamous Cell Carcinoma Originating from Pilonidal Disease: A Case Report.. British Journal of Hospital Medicine. 2024;85:8:(1-7)$56$YR$$M$Y$$$20240919$$MD$MT$MT
243405641$24340564$1$I$20240822$20240913$20240919$20240919$EXP$PT-INFARMED-J202408-818$PT-TEVA-VS-3243430$TEVA$$3$YR$$F$Y$$$20240919$$PH$PT$PT
243405651$24340565$1$I$$20240909$20240919$20240919$EXP$$US-AMAROX PHARMA-HET2024US03147$HETERO$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:102625$69$YR$$$Y$$$20240919$$HP$US$US
243405661$24340566$1$I$$20240913$20240919$20240919$EXP$FR-AFSSAPS-AVPO2024000172$FR-TEVA-VS-3243791$TEVA$$29$YR$$M$Y$$$20240919$$PH$FR$FR
243405671$24340567$1$I$$20240910$20240919$20240919$PER$$US-APOTEX-2024AP010920$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240919$$HP$US$US
243405681$24340568$1$I$20240822$20240829$20240919$20240919$PER$$US-009507513-2408USA010641$MERCK$$$$$$Y$$$20240919$$HP$US$US
243405691$24340569$1$I$$20240918$20240919$20240919$PER$$US-ORGANON-O2409USA001436$ORGANON$$$$$F$Y$64.41$KG$20240919$$HP$US$US
243405711$24340571$1$I$20240915$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010208$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240919$$CN$US$US
243405721$24340572$1$I$$20240913$20240919$20240919$EXP$$JP-009507513-2409JPN002487J$MERCK$$5$DEC$$$Y$$$20240919$$MD$JP$JP
243405731$24340573$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011729$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240919$$CN$US$US
243405741$24340574$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010233$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240919$$CN$US$US
243405751$24340575$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010710$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240919$$CN$US$US
243405761$24340576$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011414$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240919$$CN$US$US
243405771$24340577$1$I$20240730$20240917$20240919$20240919$EXP$$JP-009507513-2409JPN002631J$MERCK$$70$YR$$M$Y$$$20240919$$MD$JP$JP
243405781$24340578$1$I$$20240906$20240919$20240919$PER$$US-009507513-2409USA002957$MERCK$$$$$F$Y$77.6$KG$20240919$$CN$US$US
243405792$24340579$2$F$$20240913$20240919$20240919$PER$$US-ABBVIE-5924071$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243405801$24340580$1$I$20200510$20240913$20240919$20240919$EXP$PL-URPL-1-1646-2020$PL-TEVA-VS-3243632$TEVA$$75$YR$$F$Y$$$20240919$$PH$PL$PL
243405811$24340581$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5926741$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243405821$24340582$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA266762$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240919$$MD$US$US
243405841$24340584$1$I$20240816$20240910$20240919$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026480$UNITED THERAPEUTICS$$88$YR$$F$Y$51.247$KG$20240919$$$US$US
243405851$24340585$1$I$$20240909$20240919$20240919$EXP$$US-AMAROX PHARMA-HET2024US03145$HETERO$Jolene J. Bierly, Brianna L. Peterson. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:102625$82$YR$$$Y$$$20240919$$HP$US$US
243405861$24340586$1$I$$20240918$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149285$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240919$$CN$US$US
243405872$24340587$2$F$20240917$20240918$20240919$20240925$EXP$$US-KYOWAKIRIN-2024KK021621$KYOWA$$$$$$Y$$$20240925$$HP$US$US
243405881$24340588$1$I$20230101$20240916$20240919$20240919$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-148569$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240919$$MD$DE$DE
243405891$24340589$1$I$$20240906$20240919$20240919$PER$$US-JNJFOC-20240923099$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$CN$US$US
243405901$24340590$1$I$20240701$20240911$20240919$20240919$EXP$$JP-AMGEN-JPNSP2024183513$AMGEN$$$$$M$Y$$$20240919$$MD$JP$JP
243405911$24340591$1$I$$20240915$20240919$20240919$PER$$US-GILEAD-2024-0688239$GILEAD$$$$$$Y$$$20240919$$HP$US$US
243405921$24340592$1$I$$20240909$20240919$20240919$EXP$$US-AMAROX PHARMA-HET2024US03146$HETERO$Bierly JJ, Peterson BL.. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:102625$84$YR$$F$Y$$$20240919$$HP$US$US
243405931$24340593$1$I$20240801$20240909$20240919$20240919$EXP$$US-UCBSA-2024046428$UCB$$28$YR$$F$Y$$$20240919$$HP$US$US
243405941$24340594$1$I$$20240910$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009567$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243405951$24340595$1$I$$20240909$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009517$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243405961$24340596$1$I$$20240917$20240919$20240919$EXP$$CA-RDY-SPO/CAN/24/0013665$DR REDDYS$$72$YR$E$F$Y$$$20240919$$HP$CA$CA
243405971$24340597$1$I$20240827$20240911$20240919$20240919$EXP$FR-AFSSAPS-AN2024001223$FR-TEVA-VS-3242813$TEVA$$58$YR$$M$Y$$$20240919$$MD$FR$FR
243405981$24340598$1$I$$20240910$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009569$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243405991$24340599$1$I$$20240912$20240919$20240919$EXP$$US-BIOGEN-2021BI01027495$BIOGEN$$$$$F$Y$$$20240919$$CN$US$US
243406001$24340600$1$I$20240601$20240911$20240919$20240919$EXP$FR-AFSSAPS-RN2024000946$FR-TEVA-VS-3242783$TEVA$$46$YR$$F$Y$$$20240919$$MD$FR$FR
243406022$24340602$2$F$$20240917$20240919$20240923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-149029$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$JP$JP
243406031$24340603$1$I$20240909$20240909$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409006046$ELI LILLY AND CO$$$$A$F$Y$$$20240919$$CN$US$US
243406041$24340604$1$I$$20240911$20240919$20240919$PER$$US-INCYTE CORPORATION-2024IN009629$INCYTE$$$$$$Y$$$20240919$$CN$US$US
243406051$24340605$1$I$$20240910$20240919$20240919$30DAY$$US-GSK-US2024AMR113937$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$HP$US$US
243406061$24340606$1$I$$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024187218$AMGEN$$$$$$Y$$$20240919$$HP$US$US
243406071$24340607$1$I$$20240912$20240919$20240919$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-27927$SAMSUNG BIOEPIS$$86$YR$E$F$Y$$$20240919$$CN$GB$GB
243406081$24340608$1$I$$20240912$20240919$20240919$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-27932$SAMSUNG BIOEPIS$$76$YR$E$F$Y$$$20240919$$CN$GB$GB
243406092$24340609$2$F$$20240918$20240919$20240919$EXP$$JP-ABBVIE-5930084$ABBVIE$$71$YR$$M$Y$$$20240919$$MD$JP$JP
243406101$24340610$1$I$20240215$20240918$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149060$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240919$$HP$US$US
243406111$24340611$1$I$$20240911$20240919$20240919$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-145962$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240919$$MD$CH$CH
243406121$24340612$1$I$20240601$20240911$20240919$20240919$EXP$FR-AFSSAPS-LM2024000485$FR-TEVA-VS-3242732$TEVA$$81$YR$$M$Y$$$20240919$$MD$FR$FR
243406131$24340613$1$I$$20240903$20240919$20240919$PER$$US-ABBVIE-5926100$ABBVIE$$$$$$Y$$$20240919$$HP$US$US
243406151$24340615$1$I$20240815$20240909$20240919$20240919$EXP$$JP-RIGEL-20240800115$RIGEL PHARMACEUTICALS$$7$DEC$$F$Y$$$20240919$$MD$JP$JP
243406161$24340616$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149081$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$90.72$KG$20240919$$CN$US$US
243406181$24340618$1$I$$20240903$20240919$20240919$PER$$US-TEVA-VS-3240451$TEVA$$$$$$Y$$$20240919$$HP$US$US
243406191$24340619$1$I$$20240909$20240919$20240919$EXP$$CH-TEVA-VS-3242703$TEVA$De Pieri M. Is Quetiapine the Best Option for Patients With Antipsychotic-Induced Disorders of Extrinsic Ocular Motricity?. Prim-Care-Comp-CNS-Disorders 2024; 26 (1):.$20$YR$$M$Y$$$20240919$$MD$CH$CH
243406211$24340621$1$I$$20240917$20240919$20240919$EXP$$US-MYLANLABS-2024M1085468$MYLAN$$31$YR$$F$Y$$$20240919$$CN$US$US
243406221$24340622$1$I$$20240918$20240919$20240919$EXP$$SG-MYLANLABS-2024M1085064$MYLAN$$62$YR$$M$Y$$$20240919$$HP$SG$SG
243406231$24340623$1$I$$20240917$20240919$20240919$PER$$US-GILEAD-2024-0688092$GILEAD$$$$$F$Y$$$20240919$$HP$US$US
243406241$24340624$1$I$$20240918$20240919$20240919$PER$$NVSC2024US187346$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243406251$24340625$1$I$$20240909$20240919$20240919$EXP$$US-FMCRTG-FMC-2409-001137$FRESENIUS MEDICAL CARE$$64$YR$A$F$Y$$$20240919$$HP$US$US
243406261$24340626$1$I$$20240905$20240919$20240919$EXP$$US-FMCRTG-FMC-2409-001157$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240919$$HP$US$US
243406271$24340627$1$I$20190502$20240917$20240919$20240919$EXP$AU-TGA-0000819111$AU-SANDOZ INC.-SDZ2024AU081069$SANDOZ$$67$YR$$F$Y$$$20240919$$MD$AU$AU
243406291$24340629$1$I$$20240904$20240919$20240919$PER$$US-SMPA-2024SPA002349$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406301$24340630$1$I$$20240905$20240919$20240919$PER$$US-SMPA-2024SPA002397$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406321$24340632$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA002001$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406331$24340633$1$I$20240801$20240826$20240919$20240919$PER$$US-SMPA-2024SPA002011$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406341$24340634$1$I$$20240913$20240919$20240919$PER$$US-SMPA-2024SPA002765$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406351$24340635$1$I$$20240823$20240919$20240919$PER$$US-SMPA-2024SPA001870$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406361$24340636$1$I$$20240828$20240919$20240919$PER$$US-SMPA-2024SPA002705$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406381$24340638$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA000376$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406391$24340639$1$I$$20240904$20240919$20240919$PER$$US-SMPA-2024SPA002351$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406401$24340640$1$I$$20240823$20240919$20240919$PER$$US-SMPA-2024SPA001926$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406411$24340641$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA001987$SUNOVION$$$$$$Y$$$20240919$$PH$US$US
243406422$24340642$2$F$$20240916$20240919$20240930$PER$$US-SMPA-2024SPA002314$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243406431$24340643$1$I$$20240828$20240919$20240919$PER$$US-SMPA-2024SPA002711$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406441$24340644$1$I$$20240823$20240919$20240919$PER$$US-SMPA-2024SPA001881$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406451$24340645$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024MYSCI0200699$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406461$24340646$1$I$$20240822$20240919$20240919$PER$$US-SMPA-2024SPA001886$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406472$24340647$2$F$$20240918$20240919$20240927$PER$$US-SMPA-2024SPA001895$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243406481$24340648$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA001963$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406491$24340649$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA002006$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406501$24340650$1$I$20240101$20240913$20240919$20240919$PER$$US-SA-2024SA268498$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240919$$MD$US$US
243406511$24340651$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA267625$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240919$$HP$US$US
243406521$24340652$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149073$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240919$$CN$US$US
243406531$24340653$1$I$$20240913$20240919$20240919$PER$$US-SMPA-2024SPA002756$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406541$24340654$1$I$$20240828$20240919$20240919$PER$$US-SMPA-2024SPA002708$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243406562$24340656$2$F$20240101$20240918$20240919$20240923$EXP$$US-ABBVIE-5923718$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243406571$24340657$1$I$20240914$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024187297$AMGEN$$70$YR$E$F$Y$$$20240919$$CN$US$US
243406582$24340658$2$F$20240831$20240917$20240919$20240925$PER$$US-AMGEN-USASP2024186237$AMGEN$$52$YR$A$M$Y$$$20240925$$HP$US$US
243406591$24340659$1$I$$20240919$20240919$20240919$PER$$NVSC2024US187352$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243406601$24340660$1$I$$20240916$20240919$20240919$EXP$$NVSC2024CA148048$NOVARTIS$$76$YR$$F$Y$$$20240919$$CN$CA$CA
243406612$24340661$2$F$20240315$20240920$20240919$20240926$EXP$$NVSC2024GB061021$NOVARTIS$$36$YR$$F$Y$$$20240926$$CN$GB$GB
243406621$24340662$1$I$$20240911$20240919$20240919$PER$$US-MYLANLABS-2024M1083425$MYLAN$$$$$F$Y$$$20240919$$CN$US$US
243406631$24340663$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149069$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240919$$CN$US$US
243406641$24340664$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148813$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240919$$CN$US$US
243406651$24340665$1$I$20240801$20240906$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143146$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240919$$HP$US$US
243406661$24340666$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148975$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240919$$HP$US$US
243406671$24340667$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400121907$PFIZER$$$$$M$Y$$$20240919$$CN$US$US
243406681$24340668$1$I$$20240906$20240919$20240919$PER$$US-009507513-2409USA005826$MERCK$$$$$M$Y$$$20240919$$CN$US$US
243406693$24340669$3$F$$20240920$20240919$20240924$EXP$$NVSC2024AU186586$NOVARTIS$$$$$M$Y$$$20240924$$CN$AU$AU
243406701$24340670$1$I$20240826$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024186478$AMGEN$$48$YR$A$M$Y$$$20240919$$HP$US$US
243406721$24340672$1$I$20240101$20240814$20240919$20240919$EXP$$US-PERRIGO-24US008699$PERRIGO$$$$$F$Y$$$20240919$$CN$US$US
243406731$24340673$1$I$$20240827$20240919$20240919$PER$$US-SA-2024SA267732$SANOFI AVENTIS$$$$A$F$Y$80$KG$20240919$$MD$US$US
243406741$24340674$1$I$$20240918$20240919$20240919$PER$$US-HALEON-2197538$Haleon PLC$$78$YR$$$Y$$$20240919$$CN$US$US
243406751$24340675$1$I$$20240913$20240919$20240919$EXP$NL-LRB-01000203$NL-MYLANLABS-2024M1084052$MYLAN$$31$YR$$F$Y$52$KG$20240919$$CN$NL$NL
243406761$24340676$1$I$20240815$20240913$20240919$20240919$EXP$DE-CADRBFARM-2024330319$DE-MYLANLABS-2024M1084042$MYLAN$$17$YR$$M$Y$101$KG$20240919$$MD$DE$DE
243406771$24340677$1$I$20240208$20240913$20240919$20240919$EXP$IT-MINISAL02-1001704$IT-MYLANLABS-2024M1084562$MYLAN$$79$YR$$F$Y$$$20240919$$PH$IT$IT
243406781$24340678$1$I$$20240916$20240919$20240919$EXP$$GB-SA-2024SA268526$SANOFI AVENTIS$$34$YR$A$F$Y$90$KG$20240919$$CN$GB$GB
243406791$24340679$1$I$$20240916$20240919$20240919$EXP$$US-AMGEN-USASP2024185423$AMGEN$Falchi L.; Cassanello G.; Drill E, et al.. Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience.. Haematologica. 2024;1-27$$$$$Y$$$20240919$$HP$US$US
243406801$24340680$1$I$$20240918$20240919$20240919$EXP$$GB-SANDOZ INC.-SDZ2024GB063186$SANDOZ$$$$$F$Y$$$20240919$$CN$GB$GB
243406811$24340681$1$I$20230310$20240912$20240919$20240919$EXP$$FR-GSK-FR2024EME114399$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$MD$FR$FR
243406821$24340682$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA271247$SANOFI AVENTIS$$$$$M$Y$$$20240919$$MD$US$US
243406831$24340683$1$I$20240801$20240827$20240919$20240919$PER$$US-SA-2024SA267655$SANOFI AVENTIS$$38$YR$A$M$Y$113.64$KG$20240919$$MD$US$US
243406841$24340684$1$I$$20240906$20240919$20240919$PER$$US-SA-2024SA269665$SANOFI AVENTIS$$$$$F$Y$$$20240919$$CN$US$US
243406851$24340685$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA268917$SANOFI AVENTIS$$$$A$M$Y$68.18$KG$20240919$$MD$US$US
243406861$24340686$1$I$20240901$20240917$20240919$20240919$PER$$US-SA-2024SA270680$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240919$$HP$US$US
243406881$24340688$1$I$$20240911$20240919$20240919$EXP$$CA-TEVA-VS-3243485$TEVA$$66$YR$$F$Y$$$20240919$$PH$CA$CA
243406901$24340690$1$I$20240524$20240916$20240919$20240919$EXP$FR-AFSSAPS-AVCN2024000682$FR-MYLANLABS-2024M1084492$MYLAN$$38$YR$$M$Y$$$20240919$$MD$FR$FR
243406911$24340691$1$I$20240801$20240905$20240919$20240919$EXP$$US-SA-2024SA270967$SANOFI AVENTIS$$29$YR$A$M$Y$70$KG$20240919$$MD$US$US
243406921$24340692$1$I$$20240912$20240919$20240919$EXP$$CA-TEVA-VS-3243690$TEVA$$3$YR$$M$Y$15$KG$20240919$$CN$CA$CA
243406931$24340693$1$I$$20240906$20240919$20240919$PER$$US-JNJFOC-20240919712$JOHNSON AND JOHNSON$$$$$F$Y$$$20240919$$CN$US$US
243406941$24340694$1$I$$20240909$20240919$20240919$EXP$$US-Eisai-EC-2024-174128$EISAI$Gibson AW, Elser H, Rosso M, Cornblath EJ, Fonkeu Y, Prasad S, et al. Ischemic stroke associated with amyloid-related imaging abnormalities in a patient treated with lecanemab.. Alzheimer^s dementia: the journal of the Alzheimer^s Association.. 2024 Aug 06;1-6. doi:https://doi.org/10.1002/alz.14223.$71$YR$E$M$Y$$$20240919$$MD$US$US
243406951$24340695$1$I$20240918$20240918$20240919$20240919$PER$$NVSC2024US187319$NOVARTIS$$51$YR$$F$Y$$$20240919$$CN$US$US
243406961$24340696$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148952$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240919$$CN$US$US
243406971$24340697$1$I$$20240911$20240919$20240919$PER$$US-GE HEALTHCARE-2024CSU010484$GE HEALTHCARE$$72$YR$$F$Y$$$20240919$$HP$US$US
243406981$24340698$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149085$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$88.9$KG$20240919$$CN$US$US
243406991$24340699$1$I$20240101$20240906$20240919$20240919$PER$$US-TEVA-VS-3241521$TEVA$$59$YR$$M$Y$$$20240919$$PH$US$US
243407001$24340700$1$I$20240917$20240917$20240919$20240919$EXP$$US-SA-2024SA270246$SANOFI AVENTIS$$$$$$Y$$$20240919$$MD$US$US
243407011$24340701$1$I$20240901$20240906$20240919$20240919$PER$$US-MYLANLABS-2024M1082342$MYLAN$$76$YR$$F$Y$58.97$KG$20240919$$CN$US$US
243407021$24340702$1$I$20240701$20240913$20240919$20240919$EXP$HR-HALMED-300086459$HR-MYLANLABS-2024M1083968$MYLAN$$59$YR$$M$Y$70$KG$20240919$$MD$HR$HR
243407031$24340703$1$I$20240801$20240909$20240919$20240919$PER$$US-MYLANLABS-2024M1083400$MYLAN$$82$YR$$F$Y$$$20240919$$MD$US$US
243407041$24340704$1$I$20240909$20240918$20240919$20240919$EXP$$SG-MYLANLABS-2024M1085191$MYLAN$$82$YR$$M$Y$$$20240919$$HP$SG$SG
243407051$24340705$1$I$$20240913$20240919$20240919$PER$$US-ABBVIE-5924274$ABBVIE$$$$$$Y$$$20240919$$HP$US$US
243407071$24340707$1$I$$20240918$20240919$20240919$PER$$US-PFIZER INC-202400259133$PFIZER$$49$YR$$F$Y$$$20240919$$HP$US$US
243407081$24340708$1$I$$20240904$20240919$20240919$PER$$US-JNJFOC-20240911498$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$CN$US$US
243407091$24340709$1$I$20240824$20240909$20240919$20240919$EXP$$CN-TAKEDA-2024TUS093297$TAKEDA$$28$YR$$F$Y$$$20240919$$HP$CN$CN
243407101$24340710$1$I$20240820$20240916$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148049$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240919$$PH$US$US
243407111$24340711$1$I$$20240912$20240919$20240919$EXP$$GB-TAKEDA-2024TUS026620$TAKEDA$$$$$F$Y$$$20240919$$CN$GB$GB
243407121$24340712$1$I$$20240909$20240919$20240919$EXP$$CA-ROCHE-10000067693$ROCHE$$$$$F$Y$$$20240919$$CN$CA$CA
243407131$24340713$1$I$$20240911$20240919$20240919$EXP$$FI-TEVA-VS-3243868$TEVA$$44$YR$$F$Y$$$20240919$$MD$FI$FI
243407141$24340714$1$I$20240716$20240822$20240919$20240919$PER$$US-FMCRTG-FMC-2408-001053$FRESENIUS MEDICAL CARE$$68$YR$E$M$Y$$$20240919$$HP$US$US
243407151$24340715$1$I$$20240821$20240919$20240919$PER$$US-FMCRTG-FMC-2408-001046$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240919$$HP$US$US
243407161$24340716$1$I$$20240820$20240919$20240919$PER$$US-FMCRTG-FMC-2408-001068$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240919$$CN$US$US
243407171$24340717$1$I$$20240820$20240919$20240919$PER$$US-FMCRTG-FMC-2408-001039$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240919$$HP$US$US
243407181$24340718$1$I$$20240821$20240919$20240919$PER$$US-FMCRTG-FMC-2408-001059$FRESENIUS MEDICAL CARE$$81$YR$E$F$Y$$$20240919$$HP$US$US
243407191$24340719$1$I$20240910$20240913$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147303$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240919$$CN$US$US
243407201$24340720$1$I$20220525$20240913$20240919$20240919$EXP$$JP-009507513-2206JPN002993J$MERCK$Kudo A, Yamamoto K, Makio S, Hikino K, Okawa M, Iida Y, et al.. OS-269 Measures against irAE at our hospital: Efforts of the irAE working group.. The journal of the Japan Society of Gynecologic Oncology The 66th Annual Meeting. 2024;42(3):325$73$YR$$F$Y$$$20240919$$MD$JP$JP
243407211$24340721$1$I$$20240912$20240919$20240919$EXP$$DE-PURDUE-USA-2021-0243691$PURDUE$Paul LD, Welter-Luedeke J, Penzel S, Zangl A, Graw M.. Alpha-Pyrrolidinopentiothiophenone (-PVT): A forensic case study including plasma concentrations. Forensic Sci Int.. 2021;321:110721$28$YR$$M$Y$$$20240919$$HP$DE$DE
243407221$24340722$1$I$$20240909$20240919$20240919$EXP$$US-TEVA-VS-3243052$TEVA$Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J-Med-Toxicol 2024;.; Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J-Med-Toxicol 2024;.$41$YR$$F$Y$$$20240919$$HP$US$US
243407231$24340723$1$I$20240828$20240909$20240919$20240919$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-002121$SK LIFE SCIENCE$$$$$$Y$$$20240919$$CN$US$US
243407241$24340724$1$I$$20240917$20240919$20240919$EXP$$US-PFIZER INC-PV202400121862$PFIZER$$$$$M$Y$$$20240919$$CN$US$US
243407262$24340726$2$F$$20240920$20240919$20240926$EXP$$FR-PURDUE-USA-2024-0311094$PURDUE$$$$$F$Y$$$20240926$$CN$FR$FR
243407271$24340727$1$I$$20240909$20240919$20240919$EXP$$GR-TEVA-201903_00002931$TEVA$Zacharopoulou E, Internos I, Padoula P, Veimou Ch, Moschovis D, Kechagias G, et al.. A patient with severe ulcerative colitis, acute complicated C. difficile infection, bacteremia and possible cmv recurrence.. Clinical Manifestations, 17 Panhellenic Congress of Idiopathic Inflammatory Diseases of the Intestine. 2018;62; Zacharopoulou E, Internos I, Padoula P, Veimou Ch, Moschovis D, Kechagias G, et al.. A patient with severe ulcerative colitis, acute complicated C. difficile infection, bacter...$22$YR$$M$Y$$$20240919$$HP$GR$GR
243407281$24340728$1$I$$20240910$20240919$20240919$EXP$$JP-FERRINGPH-2024FE05209$FERRING$$$$$$Y$$$20240919$$MD$JP$JP
243407291$24340729$1$I$$20240911$20240919$20240919$EXP$$JP-FERRINGPH-2024FE05229$FERRING$$$$$$Y$$$20240919$$PH$JP$JP
243407311$24340731$1$I$$20240913$20240919$20240919$EXP$$US-ABBVIE-5925374$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243407321$24340732$1$I$$20240912$20240919$20240919$PER$$US-MYLANLABS-2024M1083772$MYLAN$$$$$M$Y$$$20240919$$PH$US$US
243407331$24340733$1$I$$20240912$20240919$20240919$EXP$$US-TEVA-VS-3243711$TEVA$$65$YR$$F$Y$$$20240919$$CN$US$US
243407341$24340734$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149242$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$122.02$KG$20240919$$CN$US$US
243407371$24340737$1$I$20240801$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147324$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240919$$CN$US$US
243407381$24340738$1$I$20240816$20240913$20240919$20240919$EXP$IT-MINISAL02-1001391$IT-TEVA-VS-3244005$TEVA$$47$YR$$M$Y$$$20240919$$MD$IT$IT
243407391$24340739$1$I$$20211213$20240919$20240919$EXP$$DE-SANDOZ INC.-NVSC2021DE286335$SANDOZ$$68$YR$$F$Y$$$20240919$$MD$DE$DE
243407402$24340740$2$F$20240915$20240915$20240919$20240920$PER$$US-JNJFOC-20240939411$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240920$$CN$US$US
243407421$24340742$1$I$20240905$20240909$20240919$20240919$EXP$$US-ELI_LILLY_AND_COMPANY-US202409005316$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240919$$CN$US$US
243407431$24340743$1$I$$20240916$20240919$20240919$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011447$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240919$$CN$US$US
243407441$24340744$1$I$20240829$20240907$20240919$20240919$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409009220$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240919$$CN$DE$CN
243407451$24340745$1$I$20240901$20240909$20240919$20240919$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409009415$ELI LILLY AND CO$$48$YR$A$M$Y$65$KG$20240919$$CN$DE$CN
243407461$24340746$1$I$$20240910$20240919$20240919$EXP$$GT-ELI_LILLY_AND_COMPANY-GT202409010435$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$GT$GT
243407471$24340747$1$I$$20240916$20240919$20240919$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409009959$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240919$$CN$DE$DE
243407481$24340748$1$I$20240827$20240907$20240919$20240919$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409009411$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240919$$CN$DE$CN
243407491$24340749$1$I$20240704$20240909$20240919$20240919$EXP$$SE-ELI_LILLY_AND_COMPANY-SE202409006079$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240919$$CN$SE$SE
243407501$24340750$1$I$$20240911$20240919$20240919$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409007835$ELI LILLY AND CO$$$$$M$Y$$$20240919$$CN$FR$FR
243407511$24340751$1$I$20240101$20240917$20240919$20240919$EXP$$AU-ABBVIE-5929100$ABBVIE$$$$$F$Y$$$20240919$$HP$AU$AU
243407522$24340752$2$F$20240901$20240916$20240919$20240920$PER$$US-JNJFOC-20240944356$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240920$$CN$US$US
243407531$24340753$1$I$$20240913$20240919$20240919$EXP$$US-ELI_LILLY_AND_COMPANY-US202409010482$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240919$$CN$US$US
243407542$24340754$2$F$$20240918$20240919$20240924$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18797$IPSEN$$$$$F$Y$$$20240924$$HP$US$US
243407551$24340755$1$I$20220607$20230102$20240919$20240919$EXP$$DE-SANDOZ INC.-NVSC2022DE218156$SANDOZ$$45$YR$$F$Y$83$KG$20240919$$MD$DE$DE
243407561$24340756$1$I$20240501$20240913$20240919$20240919$EXP$$US-ABBVIE-5925731$ABBVIE$$68$YR$$M$Y$$$20240919$$CN$US$US
243407591$24340759$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA267767$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240919$$HP$US$US
243407601$24340760$1$I$20240101$20240913$20240919$20240919$EXP$$US-KARYOPHARM-2024KPT001539$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240919$$CN$US$US
243407611$24340761$1$I$$20240917$20240919$20240919$EXP$$CA-ABBVIE-5928349$ABBVIE$$$$$F$Y$$$20240919$$HP$CA$CA
243407621$24340762$1$I$$20240909$20240919$20240919$EXP$$US-HETERO-HET2024US03140$HETERO$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:1-6$95$YR$$$Y$$$20240919$$HP$US$US
243407631$24340763$1$I$20240912$20240913$20240919$20240919$PER$$CN-Eisai-EC-2024-174394$EISAI$$44$YR$A$F$Y$58$KG$20240919$$HP$CN$CN
243407641$24340764$1$I$$20240910$20240919$20240919$PER$$US-MYLANLABS-2024M1083012$MYLAN$$$$$M$Y$$$20240919$$CN$US$US
243407651$24340765$1$I$20240910$20240910$20240919$20240919$PER$$ID-Eisai-EC-2024-174196$EISAI$$$$$M$Y$$$20240919$$MD$ID$ID
243407671$24340767$1$I$$20240913$20240919$20240919$PER$$JP-Eisai-EC-2024-174459$EISAI$$$$$$Y$$$20240919$$PH$JP$JP
243407682$24340768$2$F$$20240923$20240919$20240925$EXP$$ES-GILEAD-2024-0688225$GILEAD$$$$$M$Y$$$20240925$$MD$ES$ES
243407691$24340769$1$I$$20240916$20240919$20240919$EXP$FR-AFSSAPS-AVPO2024000178$FR-MYLANLABS-2024M1084460$MYLAN$$55$YR$$F$Y$$$20240919$$PH$FR$FR
243407701$24340770$1$I$$20240917$20240919$20240919$EXP$$US-MYLANLABS-2024M1085438$MYLAN$$21$YR$$F$Y$$$20240919$$CN$US$US
243407711$24340771$1$I$20240101$20240916$20240919$20240919$EXP$$BR-JNJFOC-20240951358$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$CN$BR$BR
243407722$24340772$2$F$$20240917$20240919$20240927$EXP$$US-MYLANLABS-2024M1085442$MYLAN$$$$$M$Y$$$20240927$$CN$US$US
243407731$24340773$1$I$$20240916$20240919$20240919$PER$$US-JNJFOC-20240941534$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$MD$US$US
243407741$24340774$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267744$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240919$$HP$US$US
243407751$24340775$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA267308$SANOFI AVENTIS$$$$C$M$Y$$$20240919$$HP$US$US
243407761$24340776$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010835$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240919$$CN$US$US
243407771$24340777$1$I$$20240909$20240919$20240919$EXP$$RU-TEVA-VS-3242513$TEVA$Chelushkin DM, Sergeev AV, Malevanaya NV, Kurnosov AB, Arefiev AM, Shchubelko RV. The course of chronic cluster headache patient during virus-suppressive therapy of chronic recurrent herpes virus infection (Herpes simplex) with valacyclovir: case report. [Russian]. Rus-J-Pain 2023; 21 (2): 33-37.$27$YR$$$Y$$$20240919$$HP$RU$RU
243407781$24340778$1$I$20240917$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010754$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240919$$CN$US$US
243407791$24340779$1$I$20240814$20240910$20240919$20240919$EXP$FR-AFSSAPS-CN2024000836$FR-ELI_LILLY_AND_COMPANY-FR202409006880$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240919$$CN$FR$FR
243407801$24340780$1$I$20240801$20240909$20240919$20240919$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409005900$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240919$$CN$FR$FR
243407811$24340781$1$I$20230307$20240910$20240919$20240919$EXP$$CO-KYOWAKIRIN-2024KK021650$KYOWA$$$$$$Y$$$20240919$$HP$CO$CO
243407821$24340782$1$I$$20240909$20240919$20240919$30DAY$$CO-PFIZER INC-202400254604$PFIZER$$$$$$Y$$$20240919$$CN$CO$CO
243407831$24340783$1$I$$20240916$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148664$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240919$$CN$US$US
243407841$24340784$1$I$20240101$20240917$20240919$20240919$PER$$US-SA-2024SA270917$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240919$$HP$US$US
243407851$24340785$1$I$$20240912$20240919$20240919$EXP$$US-EAGLE PHARMACEUTICALS, INC.-US-2024EAG000221$EAGLE$Smith MR, Jegede OA, Martin P, Till BG, Parekh SS, Yang DT, et al.. Randomized study of induction with bendamustine-rituximab ? bortezomib and maintenance with rituximab ? lenalidomide for MCL. Blood. 2024;144(10):1083-1092$$$A$$Y$$$20240919$$MD$US$US
243407861$24340786$1$I$$20240912$20240919$20240919$EXP$$US-EAGLE PHARMACEUTICALS, INC.-US-2024EAG000222$EAGLE$Smith MR, Jegede OA, Martin P, Till BG, Parekh SS, Yang DT, et al.. Randomized study of induction with bendamustine-rituximab ? bortezomib and maintenance with rituximab ? lenalidomide for MCL. Blood. 2024;144(10):1083-1092$$$A$$Y$$$20240919$$MD$US$US
243407871$24340787$1$I$20240101$20240905$20240919$20240919$EXP$$US-SA-2024SA270825$SANOFI AVENTIS$$64$YR$A$M$Y$95.45$KG$20240919$$MD$US$US
243407882$24340788$2$F$20240101$20240923$20240919$20240930$EXP$$US-ABBVIE-5921895$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243407891$24340789$1$I$20240501$20240913$20240919$20240919$EXP$$US-ABBVIE-5914558$ABBVIE$$18$YR$$M$Y$68.945$KG$20240919$$CN$US$US
243407901$24340790$1$I$20240901$20240916$20240919$20240919$EXP$$US-ABBVIE-5927001$ABBVIE$$49$YR$$F$Y$$$20240919$$CN$US$US
243407911$24340791$1$I$$20240912$20240919$20240919$EXP$$US-EAGLE PHARMACEUTICALS, INC.-US-2024EAG000224$EAGLE$Smith MR, Jegede OA, Martin P, Till BG, Parekh SS, Yang DT, et al.. Randomized study of induction with bendamustine-rituximab ? bortezomib and maintenance with rituximab ? lenalidomide for MCL. Blood. 2024;144(10):1083-1092$$$A$$Y$$$20240919$$MD$US$US
243407921$24340792$1$I$20240901$20240909$20240919$20240919$EXP$$CO-ABBVIE-5929015$ABBVIE$$64$YR$$F$Y$60$KG$20240919$$HP$CO$CO
243407941$24340794$1$I$20240801$20240919$20240919$20240919$EXP$FR-AFSSAPS-RN2024001010$FR-JNJFOC-20240950978$JOHNSON AND JOHNSON$$62$YR$A$M$Y$111$KG$20240919$$MD$FR$FR
243407951$24340795$1$I$$20240910$20240919$20240919$EXP$$CA-TAKEDA-2024TUS092539$TAKEDA$$44$YR$$F$Y$60$KG$20240919$$HP$CA$CA
243407961$24340796$1$I$20240911$20240913$20240919$20240919$PER$$JP-Eisai-EC-2024-174480$EISAI$$$$$F$Y$$$20240919$$MD$JP$JP
243407981$24340798$1$I$$20240913$20240919$20240919$PER$$US-IMP-2024000739$Harrow Health$$$$A$F$Y$$$20240919$$CN$US$US
243408001$24340800$1$I$20240911$20240913$20240919$20240919$PER$$US-ABBVIE-5927077$ABBVIE$$44$YR$$F$Y$$$20240919$$HP$US$US
243408011$24340801$1$I$20240801$20240910$20240919$20240919$PER$$US-IMP-2024000737$Harrow Health$$69$YR$E$M$Y$$$20240919$$CN$US$US
243408021$24340802$1$I$20240916$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011823$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240919$$CN$US$US
243408031$24340803$1$I$20240830$20240911$20240919$20240919$PER$$US-JNJFOC-20240948470$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240919$$HP$US$US
243408041$24340804$1$I$20240401$20240916$20240919$20240919$30DAY$$GT-PFIZER INC-PV202400048569$PFIZER$$11$YR$$F$Y$$$20240919$$HP$GT$GT
243408051$24340805$1$I$20220705$20240912$20240919$20240919$EXP$$JP-Eisai-EC-2022-119190$EISAI$$62$YR$A$F$Y$$$20240919$$MD$JP$JP
243408061$24340806$1$I$$20240919$20240919$20240919$PER$$NVSC2024US187373$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243408071$24340807$1$I$$20240917$20240919$20240919$EXP$$AU-GILEAD-2024-0687928$GILEAD$$$$A$M$Y$$$20240919$$CN$AU$AU
243408081$24340808$1$I$20240904$20240904$20240919$20240919$EXP$$CA-HLS-202402226$HLS THERAPEUTICS$$70$YR$E$F$Y$$$20240919$$HP$CA$CA
243408091$24340809$1$I$20240822$20240917$20240919$20240919$EXP$SE-SEMPA-2024-006601$SE-PURDUE-USA-2024-0312057$PURDUE$$73$YR$$F$Y$$$20240919$$MD$SE$SE
243408101$24340810$1$I$$20240911$20240919$20240919$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-145929$BRISTOL MYERS SQUIBB$$71$YR$E$$Y$$$20240919$$MD$DE$DE
243408111$24340811$1$I$$20240918$20240919$20240919$EXP$$NVSC2024PL186439$NOVARTIS$Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoeman H, Ljungman P, Kobbe G et al.. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. AMERICAN JOURNAL OF TRANSPLANTATION. 2015;15:705-14$33$YR$$M$Y$$$20240919$$HP$PL$PL
243408121$24340812$1$I$$20240917$20240919$20240919$EXP$CA-HEALTHCANVIG-001103177$CA-PURDUE-USA-2024-0312058$PURDUE$$48$YR$$M$Y$$$20240919$$HP$CA$CA
243408131$24340813$1$I$20150101$20240918$20240919$20240919$PER$$US-PURDUE-USA-2021-0282125$PURDUE$$$$$F$Y$58.967$KG$20240919$$CN$US$US
243408141$24340814$1$I$$20240917$20240919$20240919$PER$$US-PURDUE PHARMA-USA-2024-0312055$PURDUE$$$$$M$Y$$$20240919$$CN$US$US
243408151$24340815$1$I$$20240909$20240919$20240919$EXP$$NVSC2024CZ186808$NOVARTIS$Bartlova A. Pyoderma gangrenosum in a pregnant patient-description of the case.. LECBA RAN. 2024;11(2):6-11$35$YR$$F$Y$$$20240919$$HP$CZ$CZ
243408161$24340816$1$I$$20240917$20240919$20240919$PER$$US-PURDUE PHARMA-USA-2024-0312065$PURDUE$$$$$F$Y$$$20240919$$CN$US$US
243408171$24340817$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA266851$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240919$$HP$US$US
243408181$24340818$1$I$$20240828$20240919$20240919$PER$$US-SA-2024SA239057$SANOFI AVENTIS$$$$A$F$Y$59.09$KG$20240919$$HP$US$US
243408201$24340820$1$I$20240423$20240913$20240919$20240919$EXP$FR-AFSSAPS-DJ2024000935$FR-TEVA-VS-3243928$TEVA$$50$YR$$F$Y$$$20240919$$MD$FR$FR
243408211$24340821$1$I$20240813$20240910$20240919$20240919$EXP$$US-GSK-US2024112719$GLAXOSMITHKLINE$$10$YR$$$Y$$$20240919$$PH$US$US
243408221$24340822$1$I$$20240910$20240919$20240919$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028580$UNITED THERAPEUTICS$$$$$M$Y$86.168$KG$20240919$$$US$US
243408231$24340823$1$I$$20240903$20240919$20240919$PER$$US-ABBVIE-5925989$ABBVIE$$$$$$Y$$$20240919$$HP$US$US
243408251$24340825$1$I$$20240918$20240919$20240919$EXP$$IN-PAIPHARMA-2024-IN-000167$PHARMACEUTICAL ASSOC$Lakshmanan K, Khandpur S, Garg S, et al.Rapid steroid withdrawal unveiling tender nodules: a pediatric panniculitis puzzle and its management..Indian Journal of Pediatrics.2024;91(3):312.$5$YR$$M$Y$$$20240919$$HP$IN$IN
243408261$24340826$1$I$$20240917$20240919$20240919$PER$$US-JNJFOC-20240945907$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240919$$HP$US$US
243408271$24340827$1$I$$20240909$20240919$20240919$EXP$$GB-AMAROX PHARMA-AMR2024GB03069$HETERO$$84$YR$$F$Y$55$KG$20240919$$MD$GB$GB
243408293$24340829$3$F$$20240916$20240919$20240925$EXP$$NVSC2024PT184819$NOVARTIS$Monteiro C, Dias B, Vaz-Patto M. Headache as an adverse reaction to the use of medication in the elderly: a pharmacovigilance study. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2021;18(5):1-11$$$E$$Y$$$20240925$$HP$PT$PT
243408301$24340830$1$I$20201109$20240918$20240919$20240919$EXP$PL-URPL-1-3239-2020$PL-PFIZER INC-202400258536$PFIZER$$53$YR$$F$Y$77$KG$20240919$$MD$PL$PL
243408331$24340833$1$I$$20240719$20240919$20240919$PER$$US-FMCRTG-FMC-2408-001030$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240919$$HP$US$US
243408341$24340834$1$I$$20240919$20240919$20240919$PER$$NVSC2024US187331$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243408351$24340835$1$I$20240905$20240905$20240919$20240919$PER$$US-JNJFOC-20240912245$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240919$$CN$US$US
243408361$24340836$1$I$20240908$20240909$20240919$20240919$EXP$$US-FMCRTG-FMC-2409-001127$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240919$$HP$US$US
243408371$24340837$1$I$$20240913$20240919$20240919$EXP$$US-TAKEDA-2024TUS092595$TAKEDA$$$$$F$Y$$$20240919$$CN$US$US
243408391$24340839$1$I$$20240823$20240919$20240919$PER$$US-SMPA-2024SPA001922$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408401$24340840$1$I$$20240913$20240919$20240919$EXP$$IN-ABBVIE-5925830$ABBVIE$Saxena P, Patel KK, Nema M, Kumar S. A Comparative Study of Intravenous Propofol and Inhalational Sevoflurane for Preoperative Induction. International Journal of Current Pharmaceutical Review and Research. 2023;15(8):390-393.$$$A$$Y$$$20240919$$HP$IN$IN
243408411$24340841$1$I$$20240905$20240919$20240919$PER$$US-SMPA-2024SPA002391$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408451$24340845$1$I$20240101$20240906$20240919$20240919$PER$$US-SMPA-2024SPA002459$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408461$24340846$1$I$$20240823$20240919$20240919$PER$$US-SMPA-2024SPA001848$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408471$24340847$1$I$20240101$20240916$20240919$20240919$EXP$$US-ABBVIE-5927465$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243408481$24340848$1$I$20240728$20240905$20240919$20240919$PER$$US-SMPA-2024SPA000466$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408491$24340849$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA001917$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408501$24340850$1$I$$20240904$20240919$20240919$PER$$US-SMPA-2024SPA002352$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408511$24340851$1$I$20240101$20240825$20240919$20240919$PER$$US-SMPA-2024SPA000284$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408541$24340854$1$I$$20240910$20240919$20240919$PER$$US-SMPA-2024SPA002591$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408551$24340855$1$I$$20240906$20240919$20240919$PER$$US-SMPA-2024SPA002463$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408561$24340856$1$I$$20240904$20240919$20240919$PER$$US-SMPA-2024SPA002346$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408571$24340857$1$I$$20240906$20240919$20240919$PER$$US-SMPA-2024SPA002473$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408581$24340858$1$I$$20240828$20240919$20240919$PER$$US-SMPA-2024SPA002712$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408591$24340859$1$I$$20240823$20240919$20240919$PER$$US-SMPA-2024SPA001880$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408601$24340860$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA001973$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408611$24340861$1$I$$20240909$20240919$20240919$PER$$US-SMPA-2024SPA002519$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408621$24340862$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA001977$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408631$24340863$1$I$$20240823$20240919$20240919$PER$$US-SMPA-2024SPA001877$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408641$24340864$1$I$20240327$20240826$20240919$20240919$PER$$US-SMPA-2024SPA001971$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408651$24340865$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA000286$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408671$24340867$1$I$$20240913$20240919$20240919$PER$$US-SMPA-2024SPA002732$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408681$24340868$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA001960$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408691$24340869$1$I$$20240913$20240919$20240919$PER$$US-SMPA-2024SPA000523$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408711$24340871$1$I$$20240905$20240919$20240919$PER$$US-SMPA-2024SPA002436$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408721$24340872$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA001986$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408731$24340873$1$I$$20240904$20240919$20240919$PER$$US-SMPA-2024SPA002364$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408742$24340874$2$F$$20240919$20240919$20240930$PER$$US-SMPA-2024SPA001871$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243408752$24340875$2$F$$20240919$20240919$20240930$PER$$US-SMPA-2024SPA002354$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243408761$24340876$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA266780$SANOFI AVENTIS$$11$MON$I$M$Y$$$20240919$$HP$US$US
243408771$24340877$1$I$$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149338$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240919$$CN$US$US
243408781$24340878$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA073742$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240919$$MD$US$US
243408792$24340879$2$F$$20240920$20240919$20240930$PER$$US-SMPA-2024SPA002621$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243408801$24340880$1$I$$20240914$20240919$20240919$PER$$US-SMPA-2024SPA002836$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243408811$24340881$1$I$$20240918$20240919$20240919$EXP$$JP-ABBVIE-5929976$ABBVIE$$71$YR$$M$Y$$$20240919$$MD$JP$JP
243408821$24340882$1$I$$20240909$20240919$20240919$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR115844$VIIV$$$$$$Y$$$20240919$$HP$US$US
243408831$24340883$1$I$$20240821$20240919$20240919$PER$$US-Eisai-EC-2024-173246$EISAI$$$$$$Y$$$20240919$$MD$US$US
243408841$24340884$1$I$20240810$20240821$20240919$20240919$PER$$US-Eisai-EC-2024-172639$EISAI$$73$YR$E$F$Y$$$20240919$$MD$US$US
243408851$24340885$1$I$20220505$20240906$20240919$20240919$PER$$US-RDY-OTH/USA/23/0182398$DR REDDYS$$69$YR$E$M$Y$$$20240919$$MD$US$US
243408861$24340886$1$I$20240208$20240917$20240919$20240919$EXP$$US-ABBVIE-5929053$ABBVIE$$72$YR$$M$Y$$$20240919$$CN$US$US
243408871$24340887$1$I$$20240916$20240919$20240919$PER$$US-ABBVIE-5926342$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243408881$24340888$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-PV202400122016$PFIZER$$51$YR$$F$Y$$$20240919$$HP$US$US
243408901$24340890$1$I$$20240917$20240919$20240919$PER$$US-PFIZER INC-202400259100$PFIZER$$64$YR$$F$Y$83.91$KG$20240919$$CN$US$US
243408911$24340891$1$I$$20240909$20240919$20240919$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR115845$VIIV$$$$$$Y$$$20240919$$HP$US$US
243408921$24340892$1$I$$20240917$20240919$20240919$EXP$$JP-ABBVIE-5901397$ABBVIE$$70$YR$$F$Y$$$20240919$$MD$JP$JP
243408931$24340893$1$I$20240801$20240913$20240919$20240919$EXP$$AR-JNJFOC-20240941663$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240919$$CN$AR$AR
243408942$24340894$2$F$20220101$20240925$20240919$20240930$EXP$$NVSC2024EG186738$NOVARTIS$$39$YR$$M$Y$90$KG$20240930$$CN$EG$EG
243408951$24340895$1$I$$20240913$20240919$20240919$PER$$US-SA-2024SA268412$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240919$$MD$US$US
243408961$24340896$1$I$20240901$20240912$20240919$20240919$PER$$US-SA-2024SA267268$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240919$$CN$US$US
243408971$24340897$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA268118$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240919$$MD$US$US
243408991$24340899$1$I$20240519$20240913$20240919$20240919$EXP$FR-AFSSAPS-AVMA2024000392$FR-MYLANLABS-2024M1083875$MYLAN$$21$YR$$M$Y$$$20240919$$PH$FR$FR
243409001$24340900$1$I$20240101$20240905$20240919$20240919$EXP$$US-SA-2024SA270443$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240919$$MD$US$US
243409011$24340901$1$I$$20240912$20240919$20240919$EXP$$US-TAKEDA-2023TUS074451$TAKEDA$$$$$F$Y$$$20240919$$CN$US$US
243409021$24340902$1$I$20240101$20240916$20240919$20240919$EXP$$US-SA-2024SA270450$SANOFI AVENTIS$$$$$M$Y$$$20240919$$CN$US$US
243409031$24340903$1$I$20240801$20240910$20240919$20240919$EXP$$US-ANIPHARMA-2024-US-048985$ANI$$33$YR$$F$Y$$$20240919$$HP$US$US
243409041$24340904$1$I$20240909$20240909$20240919$20240919$EXP$GB-MHRA-TPP62625904C22538166YC1725908999002$GB-PERRIGO-24GB008404$PERRIGO$$29$YR$$M$Y$$$20240919$$MD$GB$GB
243409051$24340905$1$I$20240830$20240913$20240919$20240919$EXP$$ES-INCYTE CORPORATION-2024IN009778$INCYTE$$$$$$Y$$$20240919$$MD$ES$ES
243409061$24340906$1$I$20240820$20240829$20240919$20240919$PER$$US-SA-2024SA271449$SANOFI AVENTIS$$79$YR$E$F$Y$62.27$KG$20240919$$MD$US$US
243409081$24340908$1$I$$20240911$20240919$20240919$PER$$US-ABBVIE-5920219$ABBVIE$$64$YR$$M$Y$$$20240919$$MD$US$US
243409091$24340909$1$I$$20240912$20240919$20240919$EXP$$CA-TEVA-VS-3243471$TEVA$$$$A$F$Y$$$20240919$$MD$CA$CA
243409101$24340910$1$I$$20240917$20240919$20240919$EXP$$NVSC2024US185931$NOVARTIS$$$$$F$Y$$$20240919$$CN$US$US
243409111$24340911$1$I$$20240911$20240919$20240919$EXP$$NVSC2024JP186183$NOVARTIS$Yoshii R, Kajiwara K, Uemura N, Matsushita K, Nakamura T, Tomita M et al. The successful treatment of microscopic polyangiitis associated with non?tuberculous mycobacterial?pulmonary disease. CEN CASE REPORTS. 2024;13:271-6$72$YR$$M$Y$$$20240919$$HP$JP$JP
243409121$24340912$1$I$20220521$20240916$20240919$20240919$EXP$$NVSC2022AR145736$NOVARTIS$$60$YR$$F$Y$$$20240919$$MD$AR$AR
243409131$24340913$1$I$$20240912$20240919$20240919$EXP$$CA-TEVA-VS-3243465$TEVA$$4$YR$$F$Y$13$KG$20240919$$HP$CA$CA
243409141$24340914$1$I$$20240912$20240919$20240919$EXP$$CA-TEVA-VS-3243464$TEVA$$3$YR$$$Y$15$KG$20240919$$HP$CA$CA
243409151$24340915$1$I$$20240916$20240919$20240919$PER$$US-JNJFOC-20240943510$JOHNSON AND JOHNSON$$$$$M$Y$$$20240919$$HP$US$US
243409161$24340916$1$I$$20240912$20240919$20240919$EXP$$CA-TEVA-VS-3243718$TEVA$$59$YR$$F$Y$72.575$KG$20240919$$PH$CA$CA
243409171$24340917$1$I$$20240914$20240919$20240919$EXP$$US-SA-2024SA268523$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240919$$MD$US$US
243409181$24340918$1$I$20090914$20240906$20240919$20240919$EXP$$PHHY2010FR32110$NOVARTIS$Cyclosporine: Fibroadenoma of the breast. LA REVUE PRESCRIRE. 2024;44 (491):666$24$YR$$F$Y$$$20240919$$HP$FR$FR
243409191$24340919$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149224$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240919$$CN$US$US
243409211$24340921$1$I$$20240910$20240919$20240919$PER$$US-ABBVIE-5919811$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243409221$24340922$1$I$20240907$20240910$20240919$20240919$EXP$$CN-GE HEALTHCARE-2024CSU010454$GE HEALTHCARE$$45$YR$$F$Y$55.5$KG$20240919$$HP$CN$CN
243409231$24340923$1$I$20240101$20240829$20240919$20240919$PER$$US-SA-2024SA269540$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240919$$MD$US$US
243409241$24340924$1$I$20240101$20240911$20240919$20240919$PER$$US-SA-2024SA266646$SANOFI AVENTIS$$$$A$M$Y$$$20240919$$HP$US$US
243409261$24340926$1$I$20240911$20240916$20240919$20240919$EXP$$US-ABBVIE-5927408$ABBVIE$$54$YR$$F$Y$$$20240919$$CN$US$US
243409271$24340927$1$I$20230101$20240913$20240919$20240919$EXP$$DE-MYLANLABS-2024M1084014$MYLAN$$$$E$F$Y$$$20240919$$CN$DE$DE
243409281$24340928$1$I$$20240909$20240919$20240919$EXP$$CH-TEVA-VS-3242640$TEVA$Dietrich PL, Meier S, Jeger R. Complete Heart Block without Ventricular Escape Rhythm during Left Ventriculography. Cardiovasc-Med 2024; 27 (2): 55-57.$80$YR$$M$Y$$$20240919$$HP$CH$CH
243409291$24340929$1$I$20240101$20240913$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149310$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240919$$HP$US$US
243409301$24340930$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149063$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240919$$CN$US$US
243409312$24340931$2$F$20240703$20240919$20240919$20240925$EXP$JP-PMDA-i2410002579001$JP-TAKEDA-2024TUS092953$TAKEDA$$70$YR$$F$Y$41.5$KG$20240925$$PH$JP$JP
243409341$24340934$1$I$20240815$20240814$20240919$20240919$PER$$US-FMCRTG-FMC-2408-001034$FRESENIUS MEDICAL CARE$$58$YR$A$F$Y$75$KG$20240919$$HP$US$US
243409351$24340935$1$I$$20240814$20240919$20240919$PER$$US-FMCRTG-FMC-2408-001015$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240919$$CN$US$US
243409361$24340936$1$I$$20240818$20240919$20240919$PER$$US-FMCRTG-FMC-2408-001048$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240919$$CN$US$US
243409371$24340937$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149001$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$95.25$KG$20240919$$CN$US$US
243409381$24340938$1$I$20240902$20240917$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149206$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240919$$CN$US$US
243409391$24340939$1$I$20240101$20240917$20240919$20240919$EXP$$US-KYOWAKIRIN-2024KK021566$KYOWA$$$$$$Y$$$20240919$$HP$US$US
243409401$24340940$1$I$$20240914$20240919$20240919$EXP$$IE-TAKEDA-2024TUS065049$TAKEDA$$$$$M$Y$$$20240919$$CN$IE$IE
243409411$24340941$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267807$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240919$$HP$US$US
243409421$24340942$1$I$20190101$20240912$20240919$20240919$EXP$FR-AFSSAPS-CN2024000812$FR-TEVA-VS-3243352$TEVA$$28$YR$$M$Y$73$KG$20240919$$MD$FR$FR
243409431$24340943$1$I$$20240918$20240919$20240919$EXP$$US-PURDUE PHARMA-USA-2024-0312066$PURDUE$$$$$$Y$$$20240919$$CN$US$US
243409441$24340944$1$I$20240909$20240909$20240919$20240919$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-002144$SK LIFE SCIENCE$$$$$$Y$$$20240919$$CN$US$US
243409451$24340945$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149132$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240919$$HP$US$US
243409461$24340946$1$I$$20240910$20240919$20240919$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-002147$SK LIFE SCIENCE$$$$$$Y$$$20240919$$CN$US$US
243409471$24340947$1$I$$20240917$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148356$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$73.03$KG$20240919$$CN$US$US
243409481$24340948$1$I$20240820$20240913$20240919$20240919$EXP$$JP-FERRINGPH-2024FE05281$FERRING$$$$$$Y$$$20240919$$PH$JP$JP
243409491$24340949$1$I$20240909$20240909$20240919$20240919$30DAY$$US-GSK-US2024112067$GLAXOSMITHKLINE$$56$YR$$M$Y$$$20240919$$CN$US$US
243409501$24340950$1$I$$20240912$20240919$20240919$EXP$$GB-FERRINGPH-2024FE05224$FERRING$$$$$$Y$$$20240919$$CN$GB$GB
243409511$24340951$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149317$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240919$$CN$US$US
243409521$24340952$1$I$$20240910$20240919$20240919$EXP$$US-SK LIFE SCIENCE, INC.-SKPVG-2024-002136$SK LIFE SCIENCE$$$$$$Y$$$20240919$$CN$US$US
243409531$24340953$1$I$$20240909$20240919$20240919$EXP$$US-AMAROX PHARMA-HET2024US03139$HETERO$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:102625$88$YR$$$Y$$$20240919$$HP$US$US
243409541$24340954$1$I$$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024187228$AMGEN$$$$$$Y$$$20240919$$HP$US$US
243409551$24340955$1$I$$20240919$20240919$20240919$PER$$NVSC2024US187334$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243409561$24340956$1$I$20240801$20240908$20240919$20240919$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409006110$ELI LILLY AND CO$$30$YR$A$F$Y$55$KG$20240919$$CN$CN$CN
243409571$24340957$1$I$$20240909$20240919$20240919$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409011488$ELI LILLY AND CO$$89$YR$E$F$Y$$$20240919$$CN$DE$JP
243409581$24340958$1$I$20230803$20230804$20240919$20240919$EXP$$MX-SANDOZ INC.-SDZ2023MX013950$SANDOZ$$75$YR$$M$Y$54.3$KG$20240919$$MD$MX$MX
243409602$24340960$2$F$20230501$20240918$20240919$20240925$EXP$$PT-ELI_LILLY_AND_COMPANY-PT202409010432$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240925$$CN$PT$PT
243409611$24340961$1$I$20240401$20240913$20240919$20240919$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409009200$ELI LILLY AND CO$$45$YR$A$$Y$$$20240919$$CN$CN$CN
243409621$24340962$1$I$20240901$20240916$20240919$20240919$PER$$US-ABBVIE-5927505$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243409631$24340963$1$I$20240727$20240910$20240919$20240919$EXP$$GR-ELI_LILLY_AND_COMPANY-GR202409007484$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240919$$CN$GR$GR
243409641$24340964$1$I$$20240912$20240919$20240919$EXP$$US-EAGLE PHARMACEUTICALS, INC.-US-2024EAG000220$EAGLE$Smith MR, Jegede OA, Martin P, Till BG, Parekh SS, Yang DT, et al.. Randomized study of induction with bendamustine-rituximab ? bortezomib and maintenance with rituximab ? lenalidomide for MCL. Blood. 2024;144(10):1083-1092$$$A$$Y$$$20240919$$MD$US$US
243409661$24340966$1$I$$20240916$20240919$20240919$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-18789$IPSEN$$77$YR$E$M$Y$63.5$KG$20240919$$CN$US$US
243409672$24340967$2$F$$20240913$20240919$20240920$EXP$$US-KARYOPHARM-2024KPT001537$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240920$$CN$US$US
243409691$24340969$1$I$20240917$20240917$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148974$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240919$$CN$US$US
243409701$24340970$1$I$20240911$20240913$20240919$20240919$PER$$JP-Eisai-EC-2024-174466$EISAI$$$$$F$Y$$$20240919$$MD$JP$JP
243409711$24340971$1$I$$20220912$20240919$20240919$EXP$$DE-SANDOZ INC.-NVSC2022DE205664$SANDOZ$$60$YR$$F$Y$67$KG$20240919$$PH$DE$DE
243409731$24340973$1$I$$20240910$20240919$20240919$PER$$US-MYLANLABS-2024M1083433$MYLAN$$$$$$Y$$$20240919$$CN$US$US
243409741$24340974$1$I$$20240903$20240919$20240919$PER$$US-ABBVIE-5929168$ABBVIE$$$$$$Y$$$20240919$$HP$US$US
243409761$24340976$1$I$$20240912$20240919$20240919$PER$$JP-Eisai-EC-2024-174322$EISAI$Matsui Tomoya. Consideration of cases of eribulin administration for HER2-negative recurrent breast cancer at our hospital$74$YR$E$F$Y$$$20240919$$MD$JP$JP
243409771$24340977$1$I$$20240913$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146218$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240919$$MD$US$US
243409781$24340978$1$I$20240729$20240909$20240919$20240919$PER$$US-MYLANLABS-2024M1082739$MYLAN$$68$YR$$F$Y$$$20240919$$CN$US$US
243409791$24340979$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010395$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240919$$CN$US$US
243409801$24340980$1$I$$20240909$20240919$20240919$EXP$$US-ELI_LILLY_AND_COMPANY-US202409005409$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240919$$CN$US$US
243409811$24340981$1$I$$20240913$20240919$20240919$PER$$US-MYLANLABS-2024M1084383$MYLAN$$$$$M$Y$$$20240919$$CN$US$US
243409821$24340982$1$I$20240918$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024186491$AMGEN$$80$YR$E$F$Y$$$20240919$$CN$US$US
243409831$24340983$1$I$20240918$20240918$20240919$20240919$PER$$US-AMGEN-USASP2024186466$AMGEN$$78$YR$E$F$Y$$$20240919$$CN$US$US
243409841$24340984$1$I$20240917$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186407$AMGEN$$78$YR$E$F$Y$$$20240919$$CN$US$US
243409851$24340985$1$I$20240916$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010725$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240919$$CN$US$US
243409861$24340986$1$I$20240101$20240916$20240919$20240919$EXP$$US-SA-2024SA271020$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240919$$MD$US$US
243409871$24340987$1$I$20231025$20240911$20240919$20240919$EXP$$CN-Eisai-EC-2024-174187$EISAI$$64$YR$A$M$Y$57$KG$20240919$$MD$CN$CN
243409881$24340988$1$I$$20240910$20240919$20240919$EXP$$JP-ABBVIE-5930223$ABBVIE$Miyazaki, K. Precautions for day surgery for inguinal hernia. Surgery. 2024;86(10):1088-1093.$80$YR$$M$Y$$$20240919$$HP$JP$JP
243409891$24340989$1$I$$20240912$20240919$20240919$EXP$$US-EAGLE PHARMACEUTICALS, INC.-US-2024EAG000223$EAGLE$Smith MR, Jegede OA, Martin P, Till BG, Parekh SS, Yang DT, et al.. Randomized study of induction with bendamustine-rituximab ? bortezomib and maintenance with rituximab ? lenalidomide for MCL. Blood. 2024;144(10):1083-1092$$$A$$Y$$$20240919$$MD$US$US
243409901$24340990$1$I$$20240911$20240919$20240919$EXP$$NVSC2024CA186190$NOVARTIS$$50$YR$$F$Y$$$20240919$$HP$CA$CA
243409911$24340991$1$I$$20240909$20240919$20240919$EXP$$US-AMAROX PHARMA-HET2024US03142$HETERO$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:1-6$85$YR$$$Y$$$20240919$$HP$US$US
243409921$24340992$1$I$$20240912$20240919$20240919$PER$$US-IMP-2024000741$Harrow Health$$$$E$F$Y$$$20240919$$CN$US$US
243409931$24340993$1$I$$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024183361$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243409941$24340994$1$I$20240101$20240916$20240919$20240919$EXP$$US-ABBVIE-5927420$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243409951$24340995$1$I$$20240912$20240919$20240919$EXP$$US-EAGLE PHARMACEUTICALS, INC.-US-2024EAG000225$EAGLE$Smith MR, Jegede OA, Martin P, Till BG, Parekh SS, Yang DT, et al.. Randomized study of induction with bendamustine-rituximab ? bortezomib and maintenance with rituximab ? lenalidomide for MCL. Blood. 2024;144(10):1083-1092$$$A$$Y$$$20240919$$MD$US$US
243409961$24340996$1$I$$20240917$20240919$20240919$EXP$$US-MYLANLABS-2024M1085444$MYLAN$$$$$M$Y$$$20240919$$CN$US$US
243409971$24340997$1$I$$20240916$20240919$20240919$PER$$US-IMP-2024000745$Harrow Health$$$$E$F$Y$$$20240919$$CN$US$US
243409991$24340999$1$I$$20240911$20240919$20240919$EXP$$US-RDY-SPO/USA/24/0013439$DR REDDYS$$25$YR$A$M$Y$$$20240919$$HP$US$US
243410001$24341000$1$I$$20240912$20240919$20240919$PER$$US-JNJFOC-20240948087$JOHNSON AND JOHNSON$$$$$$Y$$$20240919$$MD$US$US
243410022$24341002$2$F$$20240916$20240919$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010651$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240920$$CN$US$US
243410032$24341003$2$F$$20240916$20240919$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010690$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240920$$CN$US$US
243410041$24341004$1$I$$20240910$20240919$20240919$EXP$$JP-ABBVIE-5930238$ABBVIE$Miyazaki, K. Precautions for day surgery for inguinal hernia. Surgery. 2024;86(10):1088-1093.$40$YR$$M$Y$$$20240919$$HP$JP$JP
243410051$24341005$1$I$$20240911$20240919$20240919$PER$$US-SA-2024SA266759$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240919$$HP$US$US
243410062$24341006$2$F$$20240916$20240919$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011145$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240920$$CN$US$US
243410071$24341007$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010624$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240919$$CN$US$US
243410081$24341008$1$I$$20240909$20240919$20240919$EXP$$US-HETERO-HET2024US03143$HETERO$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:1-6$63$YR$$$Y$$$20240919$$HP$US$US
243410091$24341009$1$I$$20240912$20240919$20240919$EXP$$US-EAGLE PHARMACEUTICALS, INC.-US-2024EAG000227$EAGLE$Smith MR, Jegede OA, Martin P, Till BG, Parekh SS, Yang DT, et al.. Randomized study of induction with bendamustine-rituximab ? bortezomib and maintenance with rituximab ? lenalidomide for MCL. Blood. 2024;144(10):1083-1092$$$A$$Y$$$20240919$$MD$US$US
243410101$24341010$1$I$20240411$20240913$20240919$20240919$EXP$FR-AFSSAPS-AVMA2024000380$FR-TEVA-VS-3243827$TEVA$$44$YR$$M$Y$$$20240919$$PH$FR$FR
243410111$24341011$1$I$$20240913$20240919$20240919$EXP$$DE-GILEAD-2024-0687647$GILEAD$$$$$M$Y$$$20240919$$PH$DE$DE
243410121$24341012$1$I$$20240915$20240919$20240919$EXP$$NVSC2024US184977$NOVARTIS$$$$$$Y$$$20240919$$CN$US$US
243410131$24341013$1$I$$20240911$20240919$20240919$EXP$$CA-TEVA-VS-3243093$TEVA$$49$YR$$F$Y$$$20240919$$HP$CA$CA
243410141$24341014$1$I$20240910$20240912$20240919$20240919$EXP$$DE-GILEAD-2024-0687230$GILEAD$$72$YR$E$F$Y$$$20240919$$MD$DE$DE
243410151$24341015$1$I$$20240918$20240919$20240919$PER$$US-PURDUE PHARMA-USA-2024-0312052$PURDUE$$$$$M$Y$$$20240919$$CN$US$US
243410161$24341016$1$I$20240903$20240906$20240919$20240919$PER$$US-SA-2024SA268820$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240919$$CN$US$US
243410172$24341017$2$F$$20240912$20240919$20240920$30DAY$$US-ELI_LILLY_AND_COMPANY-US202409008953$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243410182$24341018$2$F$$20240917$20240919$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409010635$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240927$$CN$US$US
243410191$24341019$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409011127$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240919$$CN$US$US
243410201$24341020$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409012293$ELI LILLY AND CO$$$$$F$Y$$$20240919$$CN$US$US
243410211$24341021$1$I$20240817$20240912$20240919$20240919$EXP$FR-AFSSAPS-RN2024000956$FR-TEVA-VS-3243379$TEVA$$44$YR$$F$Y$$$20240919$$MD$FR$FR
243410221$24341022$1$I$$20240917$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010672$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240919$$CN$US$US
243410231$24341023$1$I$$20240916$20240919$20240919$EXP$$US-JNJFOC-20240942098$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20240919$$HP$US$US
243410241$24341024$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149335$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240919$$CN$US$US
243410251$24341025$1$I$20231001$20240913$20240919$20240919$EXP$FR-AFSSAPS-TS2024000962$FR-TEVA-VS-3243777$TEVA$$72$YR$$F$Y$$$20240919$$MD$FR$FR
243410261$24341026$1$I$$20240919$20240919$20240919$PER$$NVSC2024US187350$NOVARTIS$$$$$$Y$$$20240919$$HP$US$US
243410271$24341027$1$I$$20240918$20240919$20240919$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149341$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240919$$CN$US$US
243410281$24341028$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185768$AMGEN$$$$$F$Y$$$20240919$$PH$US$US
243410291$24341029$1$I$20240101$20240912$20240919$20240919$PER$$US-AMGEN-USASP2024183187$AMGEN$$54$YR$A$M$Y$$$20240919$$HP$US$US
243410301$24341030$1$I$20230101$20240913$20240919$20240919$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146579$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240919$$CN$US$US
243410312$24341031$2$F$$20240919$20240919$20240920$PER$$NVSC2024US187165$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
243410321$24341032$1$I$$20240915$20240919$20240919$EXP$$US-TAKEDA-2024TUS092902$TAKEDA$$$$$F$Y$$$20240919$$CN$US$US
243410331$24341033$1$I$$20240917$20240919$20240919$EXP$$ES-GILEAD-2024-0688170$GILEAD$$$$$$Y$$$20240919$$MD$ES$ES
243410342$24341034$2$F$$20240915$20240919$20240919$PER$$US-GILEAD-2024-0688238$GILEAD$$$$$$Y$$$20240919$$HP$US$US
243410351$24341035$1$I$$20240919$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409012313$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240919$$CN$US$US
243410361$24341036$1$I$$20240918$20240919$20240919$EXP$$US-GILEAD-2024-0688220$GILEAD$$62$YR$A$F$Y$$$20240919$$HP$US$US
243410371$24341037$1$I$20240906$20240906$20240919$20240919$PER$$US-009507513-2409USA002848$MERCK$$34$YR$$F$Y$$$20240919$$CN$US$US
243410391$24341039$1$I$$20240910$20240919$20240919$EXP$$AU-NPI-000039$NIVAGEN PHARMACEUTICALS$$43$YR$A$M$Y$$$20240913$$MD$AU$AU
243410401$24341040$1$I$$20240909$20240919$20240919$PER$$US-ABBVIE-5927101$ABBVIE$$$$A$M$Y$$$20240919$$HP$US$US
243410412$24341041$2$F$20240917$20240919$20240919$20240920$PER$$NVSC2024US187367$NOVARTIS$$22$YR$$F$Y$$$20240920$$CN$US$US
243410422$24341042$2$F$20230608$20240918$20240919$20240923$EXP$$JP-TAKEDA-2024TUS064986$TAKEDA$$72$YR$$F$Y$37.5$KG$20240923$$MD$JP$JP
243410431$24341043$1$I$20240701$20240909$20240919$20240919$EXP$$ES-MAYNE PHARMA-2024MYN000395$MAYNE$$$$$$Y$$$20240919$$CN$ES$ES
243410451$24341045$1$I$$20240823$20240919$20240919$PER$$US-BEIGENE-BGN-2024-010972$BEIGENE$$$$$$Y$$$20240919$$MD$US$US
243410461$24341046$1$I$20240911$20240913$20240919$20240919$EXP$$JP-009507513-2409JPN002360J$MERCK$$$$$F$Y$$$20240919$$MD$JP$JP
243410471$24341047$1$I$20240919$20240919$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409012295$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240919$$CN$US$US
243410481$24341048$1$I$20240101$20240913$20240919$20240919$EXP$$JP-009507513-2408JPN003956J$MERCK$$51$YR$$M$Y$$$20240919$$MD$JP$JP
243410491$24341049$1$I$$20240905$20240919$20240919$EXP$$CA-HLS-202402239$HLS THERAPEUTICS$$$$E$M$Y$$$20240919$$HP$CA$CA
243410501$24341050$1$I$$20240905$20240919$20240919$PER$$US-JNJFOC-20240919564$JOHNSON AND JOHNSON$$$$A$$Y$$$20240919$$CN$US$US
243410511$24341051$1$I$20240801$20240912$20240919$20240919$PER$$US-BIOGEN-2024BI01282626$BIOGEN$$$$$M$Y$$$20240919$$CN$US$US
243410521$24341052$1$I$$20240913$20240919$20240919$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144814$DAIICHI$$$$$F$Y$$$20240919$$CN$US$US
243410531$24341053$1$I$20240909$20240916$20240919$20240919$PER$$US-DAIICHI SANKYO, INC.-DSU-2024-144467$DAIICHI$$52$YR$$F$Y$$$20240919$$HP$US$US
243410541$24341054$1$I$$20240918$20240919$20240919$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052291$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240919$$CN$US$US
243410561$24341056$1$I$$20240916$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409010350$ELI LILLY AND CO$$65$YR$E$$Y$$$20240919$$CN$US$US
243410571$24341057$1$I$$20240905$20240919$20240919$EXP$$CA-HLS-202402248$HLS THERAPEUTICS$$$$A$F$Y$$$20240919$$PH$CA$CA
243410581$24341058$1$I$20230901$20240913$20240919$20240919$EXP$$FR-DSJP-DS-2024-100021-FR$DAIICHI$$71$YR$$F$Y$59$KG$20240919$$MD$FR$FR
243410591$24341059$1$I$$20240905$20240919$20240919$EXP$$CA-HLS-202402249$HLS THERAPEUTICS$$$$E$M$Y$$$20240919$$PH$CA$CA
243410601$24341060$1$I$20240913$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024183914$AMGEN$$60$YR$A$M$Y$$$20240919$$PH$US$US
243410621$24341062$1$I$20190101$20240916$20240919$20240919$EXP$$AU-SANDOZ INC.-SDZ2024AU080617$SANDOZ$$77$YR$$M$Y$$$20240919$$MD$AU$AU
243410631$24341063$1$I$$20240918$20240919$20240919$EXP$$NVSJ2024JP009756$NOVARTIS$$$$$$Y$$$20240920$$PH$JP$JP
243410641$24341064$1$I$$20240917$20240919$20240919$PER$$NVSC2024US186328$NOVARTIS$$$$$$Y$$$20240920$$MD$US$US
243410651$24341065$1$I$$20240909$20240919$20240919$PER$$NVSC2024US181167$NOVARTIS$$$$$$Y$$$20240920$$CN$US$US
243410661$24341066$1$I$$20240916$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US080823$SANDOZ$Malani KA, Finn A. Metformin-associated lactic acidosis: a serious complication of a common drug. BMJ Case Reports. 2024;17:e260592$$$E$M$Y$$$20240919$$HP$US$US
243410671$24341067$1$I$$20240917$20240919$20240919$EXP$$JP-TAKEDA-2024TJP013736$TAKEDA$$4$DEC$$F$Y$$$20240919$$MD$JP$JP
243410681$24341068$1$I$$20240910$20240919$20240919$30DAY$$US-GSK-US2024112649$GLAXOSMITHKLINE$$$$$F$Y$$$20240919$$CN$US$US
243410691$24341069$1$I$$20240916$20240919$20240919$EXP$$NVSJ2024JP011006$NOVARTIS$$80$YR$$M$Y$50$KG$20240920$$MD$JP$JP
243410711$24341071$1$I$$20240917$20240919$20240919$EXP$$JP-TAKEDA-2024TJP013697$TAKEDA$$5$DEC$$F$Y$$$20240919$$PH$JP$JP
243410722$24341072$2$F$$20240917$20240919$20240925$EXP$$CA-SANDOZ INC.-NVSC2022CA264457$SANDOZ$$54$YR$$F$Y$$$20240925$$HP$CA$CA
243410731$24341073$1$I$$20240910$20240919$20240919$EXP$$CA-SANDOZ INC.-NVSC2020CA085805$SANDOZ$$51$YR$$M$Y$$$20240919$$CN$CA$CA
243410741$24341074$1$I$$20240918$20240919$20240919$EXP$$US-ABBVIE-5929964$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243410751$24341075$1$I$20240901$20240911$20240919$20240919$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00341$PRINSTON PHARMACEUTICAL$$26$YR$$F$Y$54.431$KG$20240919$$CN$US$US
243410761$24341076$1$I$$20240913$20240919$20240919$EXP$$CA-JNJFOC-20240945854$JOHNSON AND JOHNSON$$61$YR$A$M$Y$89$KG$20240920$$HP$CA$CA
243410771$24341077$1$I$$20240916$20240919$20240919$EXP$$CA-ABBVIE-5928215$ABBVIE$$$$E$M$Y$$$20240919$$CN$CA$CA
243410791$24341079$1$I$$20240911$20240919$20240919$EXP$$US-ABBVIE-5920712$ABBVIE$$$$$M$Y$$$20240919$$HP$US$US
243410801$24341080$1$I$20210820$20240918$20240919$20240919$EXP$$JP-ABBVIE-22K-087-4533900-00$ABBVIE$$57$YR$$M$Y$61$KG$20240919$$MD$JP$JP
243410811$24341081$1$I$$20240910$20240919$20240919$EXP$$US-JNJFOC-20240930806$JOHNSON AND JOHNSON$$56$YR$A$M$Y$136.1$KG$20240920$$CN$US$US
243410831$24341083$1$I$$20240909$20240919$20240919$EXP$$JP-SMPA-2024SMP013005$SUNOVION$$$$$$Y$$$20240919$$CN$JP$JP
243410841$24341084$1$I$20240601$20240917$20240919$20240919$EXP$$NVSJ2024JP007830$NOVARTIS$$62$YR$$F$Y$$$20240920$$HP$JP$JP
243410851$24341085$1$I$20240501$20240911$20240919$20240919$EXP$$US-JNJFOC-20240938845$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240920$$HP$US$US
243410861$24341086$1$I$$20240910$20240919$20240919$EXP$$JP-BEH-2024178902$CSL BEHRING$$$$N$M$Y$$$20240919$$HP$JP$JP
243410871$24341087$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5926939$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243410881$24341088$1$I$$20240917$20240919$20240919$30DAY$$US-SANDOZ INC.-SDZ2024US056382$SANDOZ$$$$$$Y$$$20240919$$CN$US$US
243410892$24341089$2$F$$20240918$20240919$20240924$EXP$$NVSC2024US186326$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243410901$24341090$1$I$$20240917$20240919$20240919$EXP$$NVSJ2024JP011031$NOVARTIS$$81$YR$$M$Y$$$20240920$$MD$JP$JP
243410911$24341091$1$I$20240101$20240905$20240919$20240919$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002612$CORCEPT$$$$$$Y$$$20240920$$MD$US$US
243410922$24341092$2$F$20240101$20240916$20240919$20240927$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002613$CORCEPT$$$$$$Y$$$20240927$$MD$US$US
243410931$24341093$1$I$$20240912$20240919$20240919$EXP$$CN-AMGEN-CHNSP2024183407$AMGEN$Wu D.; Lu J.; Qiu H. et al.. Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial. Journal of Hematology + Oncology. 2024;17 (1):1-5$$$$$Y$$$20240919$$HP$CN$CN
243410941$24341094$1$I$$20240912$20240919$20240919$EXP$$CN-AMGEN-CHNSP2024183410$AMGEN$Wu D.; Lu J.; Qiu H. et al.. Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial. Journal of Hematology + Oncology. 2024;17 (1):1-5$$$$$Y$$$20240919$$HP$CN$CN
243410951$24341095$1$I$$20240912$20240919$20240919$EXP$$CN-AMGEN-CHNSP2024183412$AMGEN$Wu D.; Lu J.; Qiu H. et al.. Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial. Journal of Hematology + Oncology. 2024;17 (1):1-5$$$$$Y$$$20240919$$HP$CN$CN
243410971$24341097$1$I$20230511$20240918$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014836$BEIGENE$Yang Z, Ning X, Liu Z, Wang W, Yin Q, Yang X. Severe Anemia Associated with Immune Checkpoint Inhibitor: A Case Report. J Int Obstet Gynecol. 2024;51(4):438-441$$$$$Y$$$20240919$$MD$CN$CN
243410982$24341098$2$F$20240101$20240923$20240919$20240924$EXP$$US-JNJFOC-20240932461$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240925$$CN$US$US
243410991$24341099$1$I$$20240914$20240919$20240919$EXP$$CN-AMGEN-CHNSP2024184398$AMGEN$Junsheng G.. Observation of efficacy of Xintong granules combined with Evolocumab in  chronic heart failure with hyperlipidemia not reaching the target. Int J CardioVasc Dis. 2024;51 (4):262-264$$$$$Y$$$20240919$$HP$CN$CN
243411011$24341101$1$I$20240812$20240917$20240919$20240919$EXP$SE-SEMPA-2024-006776$SE-ORGANON-O2409SWE001197$ORGANON$$33$YR$$F$Y$$$20240919$$MD$SE$SE
243411021$24341102$1$I$$20240918$20240919$20240919$EXP$$AU-TGA-0000819140$SANDOZ$$$$$$Y$$$20240919$$HP$AU$AU
243411031$24341103$1$I$$20240918$20240919$20240919$PER$$US-ELI_LILLY_AND_COMPANY-US202409012056$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240919$$CN$US$US
243411041$24341104$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5928656$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243411061$24341106$1$I$$20240916$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US081173$SANDOZ$$$$$M$Y$$$20240919$$CN$US$US
243411071$24341107$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5927418$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243411081$24341108$1$I$20240101$20240917$20240919$20240919$EXP$$US-ABBVIE-5891346$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243411091$24341109$1$I$$20240916$20240919$20240919$EXP$$NVSC2024US186396$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
243411101$24341110$1$I$20240910$20240911$20240919$20240919$PER$$US-ABBVIE-5920408$ABBVIE$$24$YR$$F$Y$110$KG$20240919$$MD$US$US
243411111$24341111$1$I$20240901$20240917$20240919$20240919$EXP$$US-ABBVIE-5929039$ABBVIE$$62$YR$$F$Y$$$20240919$$CN$US$US
243411121$24341112$1$I$20240901$20240910$20240919$20240919$PER$$US-SA-2024SA266509$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240920$$MD$US$US
243411141$24341114$1$I$$20240909$20240919$20240919$EXP$$CN-Unichem Pharmaceuticals (USA) Inc-UCM202409-001155$UNICHEM$$73$YR$E$M$Y$$$20240920$$HP$CN$
243411152$24341115$2$F$20240101$20240916$20240919$20240926$PER$$US-AMGEN-USASP2024185252$AMGEN$$74$YR$E$F$Y$$$20240926$$CN$US$US
243411171$24341117$1$I$$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024184437$AMGEN$$$$$F$Y$$$20240919$$HP$US$US
243411181$24341118$1$I$20240913$20240918$20240919$20240919$PER$$US-ABBVIE-5929622$ABBVIE$$51$YR$$F$Y$68$KG$20240919$$HP$US$US
243411191$24341119$1$I$$20240916$20240919$20240919$EXP$$US-TAKEDA-2023TUS058710$TAKEDA$$$$$M$Y$$$20240919$$CN$US$US
243411201$24341120$1$I$$20240917$20240919$20240919$EXP$$JP-SAKK-2024SA252068AA$SANOFI AVENTIS$$$$$$Y$$$20240920$$PH$JP$JP
243411211$24341121$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA267598$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240920$$HP$US$US
243411221$24341122$1$I$20240101$20240910$20240919$20240919$PER$$US-SA-2024SA265808$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240920$$HP$US$US
243411231$24341123$1$I$$20240917$20240919$20240919$EXP$DE-TORRENT-00013473$DE-JNJFOC-20190409137$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240920$$HP$DE$DE
243411241$24341124$1$I$$20240829$20240919$20240919$PER$$US-SA-2024SA269029$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243411251$24341125$1$I$20240824$20240918$20240919$20240919$EXP$$US-TAKEDA-2024TUS093223$TAKEDA$$83$YR$$F$Y$$$20240919$$CN$US$US
243411261$24341126$1$I$20240909$20240913$20240919$20240919$PER$$US-AMGEN-USASP2024184198$AMGEN$$69$YR$E$F$Y$$$20240919$$CN$US$US
243411281$24341128$1$I$20240901$20240916$20240919$20240919$EXP$$US-ABBVIE-5926883$ABBVIE$$68$YR$$F$Y$$$20240919$$CN$US$US
243411291$24341129$1$I$20240524$20240918$20240919$20240919$EXP$$US-ABBVIE-5929664$ABBVIE$$85$YR$$F$Y$$$20240919$$HP$US$US
243411301$24341130$1$I$20230501$20240916$20240919$20240919$EXP$$DE-ABBVIE-5927508$ABBVIE$$$$$$Y$$$20240919$$CN$DE$DE
243411321$24341132$1$I$20240601$20240917$20240919$20240919$EXP$$US-ABBVIE-5928486$ABBVIE$$74$YR$$M$Y$$$20240919$$CN$US$US
243411331$24341133$1$I$$20240917$20240919$20240919$EXP$$US-ABBVIE-5928998$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243411341$24341134$1$I$20240101$20240917$20240919$20240919$EXP$$US-ABBVIE-5928705$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243411351$24341135$1$I$$20240917$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US081484$SANDOZ$$$$$M$Y$$$20240919$$MD$US$US
243411361$24341136$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267888$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240920$$HP$US$US
243411371$24341137$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA265854$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240920$$MD$US$US
243411381$24341138$1$I$$20240910$20240919$20240919$PER$$US-SA-2024SA266435$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240920$$CN$US$US
243411391$24341139$1$I$$20240910$20240919$20240919$PER$$NVSC2024US182195$NOVARTIS$$$$T$M$Y$$$20240920$$MD$US$US
243411401$24341140$1$I$20240101$20240910$20240919$20240919$EXP$$CA-ABBVIE-5816626$ABBVIE$$42$YR$$M$Y$77$KG$20240919$$CN$CA$CA
243411411$24341141$1$I$$20240910$20240919$20240919$EXP$$TW-DENTSPLY-2024SCDP000265$DENTSPLY$$52$YR$$F$Y$$$20240920$$MD$TW$TW
243411421$24341142$1$I$$20240912$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US081440$SANDOZ$$$$$$Y$$$20240919$$CN$US$US
243411451$24341145$1$I$20240101$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024186081$AMGEN$$81$YR$E$F$Y$$$20240919$$CN$US$US
243411461$24341146$1$I$$20240917$20240919$20240919$PER$$US-AMGEN-USASP2024185770$AMGEN$$$$$$Y$$$20240919$$HP$US$US
243411471$24341147$1$I$20240309$20240911$20240919$20240919$EXP$$FR-DENTSPLY-2024SCDP000267$DENTSPLY$$29$YR$$F$Y$$$20240920$$PH$FR$FR
243411491$24341149$1$I$$20240913$20240919$20240919$EXP$$NL-AMGEN-NLDSP2024184004$AMGEN$Von Dem Borne PA. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$E$$Y$$$20240919$$HP$NL$NL
243411501$24341150$1$I$20240915$20240916$20240919$20240919$EXP$$US-ABBVIE-5926972$ABBVIE$$65$YR$$F$Y$$$20240919$$CN$US$US
243411511$24341151$1$I$20240918$20240919$20240919$20240919$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052451$BOEHRINGER INGELHEIM$$94$YR$E$F$Y$$$20240920$$HP$US$US
243411521$24341152$1$I$$20240916$20240919$20240919$PER$$US-ABBVIE-5926655$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243411531$24341153$1$I$$20240911$20240919$20240919$EXP$$US-JNJFOC-20240932384$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240920$$HP$US$US
243411541$24341154$1$I$20240601$20240909$20240919$20240919$PER$$US-BAUSCHBL-2024BNL033194$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240919$$CN$US$US
243411551$24341155$1$I$$20240911$20240919$20240919$EXP$$IR-Unichem Pharmaceuticals (USA) Inc-UCM202409-001162$UNICHEM$$64$YR$A$F$Y$65$KG$20240920$$HP$IR$
243411561$24341156$1$I$20240701$20240913$20240919$20240919$EXP$$AR-ABBVIE-5923751$ABBVIE$$64$YR$$M$Y$$$20240919$$CN$AR$AR
243411571$24341157$1$I$20240817$20240912$20240919$20240919$EXP$$US-Vifor (International) Inc.-VIT-2024-08424$VIFOR$$44$YR$$F$Y$111$KG$20240919$$HP$US$US
243411581$24341158$1$I$$20240917$20240919$20240919$PER$$US-BAUSCH-BL-2024-014054$BAUSCH AND LOMB$$$$$F$Y$$$20240919$$CN$US$US
243411601$24341160$1$I$$20240908$20240919$20240919$EXP$$CN-Prasco Laboratories-PRAS20241149$PRASCO$Lu J, Qiu H, Wang Y, Zhou X, Dai H, Lu X, Yang X, Gu B, Hong M, Miao M, Lu R, Wang J, Wu Q, Xue M, Wang Y, Deng A, Shen Y, Liu Y, Dou X, Lei Y, Wu D, Zhu Y, Chen S. Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial. Journal of Hematology + Oncology. 2024;17:79:1-5. doi:10.1186/s13045-024-01597-8$$$$$Y$$$20240919$$HP$CN$CN
243411611$24341161$1$I$$20240917$20240919$20240919$EXP$$US-ABBVIE-5929056$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243411621$24341162$1$I$20240101$20240916$20240919$20240919$EXP$$US-ABBVIE-5926683$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243411632$24341163$2$F$20240906$20240923$20240919$20240926$EXP$$US-ABBVIE-5928993$ABBVIE$$69$YR$$M$Y$$$20240926$$CN$US$US
243411641$24341164$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267836$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240920$$HP$US$US
243411651$24341165$1$I$$20240917$20240919$20240919$PER$$US-BAUSCH-BL-2024-013974$BAUSCH AND LOMB$$42$YR$$M$Y$$$20240919$$CN$US$US
243411661$24341166$1$I$$20240916$20240919$20240919$PER$$US-Prasco Laboratories-PRAS20241156$PRASCO$$$$$$Y$$$20240919$$CN$US$US
243411671$24341167$1$I$$20240916$20240919$20240919$EXP$$US-BAUSCH-BL-2024-010099$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240919$$CN$US$US
243411681$24341168$1$I$20220101$20240909$20240919$20240919$PER$$US-BAUSCHBL-2024BNL033223$BAUSCH AND LOMB$$83$YR$$F$Y$$$20240919$$CN$US$US
243411691$24341169$1$I$20240904$20240912$20240919$20240919$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001865$BLUEPRINT MEDICINES$$35$YR$A$F$Y$$$20240919$$CN$US$US
243411701$24341170$1$I$20240711$20240915$20240919$20240919$EXP$$EU-BAUSCHBL-2024BNL033497$BAUSCH AND LOMB$$51$YR$$M$Y$$$20240919$$HP$EU$EU
243411711$24341171$1$I$20240701$20240911$20240919$20240919$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001852$BLUEPRINT MEDICINES$$77$YR$E$F$Y$$$20240919$$CN$US$US
243411721$24341172$1$I$20240717$20240911$20240919$20240919$PER$$US-JNJFOC-20240933441$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
243411731$24341173$1$I$$20240912$20240919$20240919$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001868$BLUEPRINT MEDICINES$$$$$M$Y$$$20240919$$CN$US$US
243411741$24341174$1$I$20200101$20240916$20240919$20240919$EXP$$DE-JNJFOC-20240946430$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240920$$MD$DE$DE
243411751$24341175$1$I$$20240912$20240919$20240919$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001867$BLUEPRINT MEDICINES$$75$YR$E$F$Y$$$20240919$$CN$US$US
243411761$24341176$1$I$$20240916$20240919$20240919$EXP$$CA-BAUSCH-BL-2024-013956$BAUSCH AND LOMB$$65$YR$$F$Y$$$20240919$$CN$CA$CA
243411772$24341177$2$F$20240101$20240916$20240919$20240924$EXP$$US-BAUSCH-BL-2024-013253$BAUSCH AND LOMB$$85$YR$$F$Y$$$20240924$$CN$US$US
243411781$24341178$1$I$$20240911$20240919$20240919$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001855$BLUEPRINT MEDICINES$$$$$F$Y$$$20240919$$CN$US$US
243411791$24341179$1$I$20240813$20240916$20240919$20240919$EXP$$FR-BAUSCH-BL-2024-014111$BAUSCH AND LOMB$$72$YR$$F$Y$70$KG$20240919$$MD$FR$FR
243411801$24341180$1$I$$20240903$20240919$20240919$PER$$US-BAUSCHBL-2024BNL033277$BAUSCH AND LOMB$$57$YR$$F$Y$$$20240919$$CN$US$US
243411811$24341181$1$I$20190926$20240916$20240919$20240919$EXP$PL-URPL-1-3915-2019$PL-BAUSCH-BL-2024-013934$BAUSCH AND LOMB$$36$YR$$F$Y$48$KG$20240919$$HP$PL$PL
243411821$24341182$1$I$$20240916$20240919$20240919$EXP$$CA-BAUSCH-BL-2024-013970$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240919$$CN$CA$CA
243411831$24341183$1$I$$20240916$20240919$20240919$EXP$$CA-BAUSCH-BL-2024-013957$BAUSCH AND LOMB$$58$YR$$F$Y$$$20240919$$CN$CA$CA
243411841$24341184$1$I$$20240916$20240919$20240919$EXP$$CA-BAUSCH-BL-2024-013967$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240919$$CN$CA$CA
243411851$24341185$1$I$$20240913$20240919$20240919$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001870$BLUEPRINT MEDICINES$$$$$M$Y$$$20240919$$CN$US$US
243411861$24341186$1$I$$20240916$20240919$20240919$EXP$$CA-BAUSCH-BL-2024-013984$BAUSCH AND LOMB$$$$$M$Y$$$20240919$$CN$CA$CA
243411871$24341187$1$I$$20240911$20240919$20240919$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001853$BLUEPRINT MEDICINES$$$$$M$Y$$$20240919$$CN$US$US
243411881$24341188$1$I$$20240916$20240919$20240919$EXP$$CA-BAUSCH-BL-2024-014015$BAUSCH AND LOMB$$84$YR$$$Y$$$20240919$$CN$CA$CA
243411891$24341189$1$I$$20240917$20240919$20240919$PER$$US-BAUSCH-BL-2024-014055$BAUSCH AND LOMB$$$$$F$Y$$$20240919$$CN$US$US
243411901$24341190$1$I$$20240918$20240919$20240919$EXP$$NVSJ2024JP011082$NOVARTIS$$$$$$Y$$$20240920$$PH$JP$JP
243411931$24341193$1$I$$20240916$20240919$20240919$EXP$$CA-BAUSCH-BL-2024-014020$BAUSCH AND LOMB$$82$YR$$M$Y$$$20240919$$CN$CA$CA
243411941$24341194$1$I$$20240916$20240919$20240919$EXP$$CA-BAUSCH-BL-2024-014018$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240919$$CN$CA$CA
243411951$24341195$1$I$$20240913$20240919$20240919$PER$$US-BAUSCH-BL-2024-013856$BAUSCH AND LOMB$$43$YR$$F$Y$$$20240919$$CN$US$US
243411961$24341196$1$I$20240801$20240916$20240919$20240919$EXP$$US-BAUSCH-BL-2024-013942$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240919$$CN$US$US
243411971$24341197$1$I$20190924$20240912$20240919$20240919$EXP$FR-AFSSAPS-MP20191337$FR-BAUSCH-BL-2024-013813$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240919$$MD$FR$FR
243411992$24341199$2$F$$20240918$20240919$20240924$EXP$$US-BAUSCH-BL-2024-013965$BAUSCH AND LOMB$Zreik J, LaPage M, Zreik H. Congenital Long QT Syndrome Unmasked by Albuterol in an Adolescent with Asthma. The Journal of emergency medicine.. 2024;1-5. doi:10.1016/j.jemermed.2024.05.011$12$YR$$F$Y$$$20240924$$HP$US$US
243412001$24341200$1$I$20240912$20240912$20240919$20240919$PER$$US-BAUSCH-BL-2024-013787$BAUSCH AND LOMB$$$$$F$Y$$$20240919$$CN$US$US
243412011$24341201$1$I$$20240915$20240919$20240919$EXP$$SK-BAUSCH-BL-2024-013891$BAUSCH AND LOMB$$73$YR$$M$Y$96$KG$20240919$$MD$SK$SK
243412021$24341202$1$I$20240101$20240913$20240919$20240919$EXP$$US-ABBVIE-5924873$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243412031$24341203$1$I$20240802$20240905$20240919$20240919$EXP$$FR-CIPLA LTD.-2024FR09891$CIPLA$$$$$$Y$$$20240920$$PH$FR$FR
243412041$24341204$1$I$20240606$20240918$20240919$20240919$EXP$$DE-ABBVIE-5930087$ABBVIE$$45$YR$$F$Y$105$KG$20240919$$MD$DE$DE
243412051$24341205$1$I$20240702$20240722$20240919$20240919$EXP$$PL-PFIZER INC-202400220323$PFIZER$$64$YR$$M$Y$85.4$KG$20240919$$MD$PL$PL
243412061$24341206$1$I$$20240905$20240919$20240919$EXP$$GB-CIPLA LTD.-2024GB09866$CIPLA$$$$$$Y$$$20240920$$CN$GB$GB
243412071$24341207$1$I$20240101$20240905$20240919$20240919$EXP$$US-CIPLA LTD.-2024US09910$CIPLA$$$$$$Y$$$20240920$$CN$US$US
243412081$24341208$1$I$$20240912$20240919$20240919$EXP$$JP-GSK-JP2024JPN113326$GLAXOSMITHKLINE$$$$$$Y$$$20240919$$PH$JP$JP
243412101$24341210$1$I$$20240916$20240919$20240919$EXP$$GR-ABBVIE-5928170$ABBVIE$$$$$F$Y$$$20240919$$MD$GR$GR
243412111$24341211$1$I$20240829$20240905$20240919$20240919$EXP$$SE-CIPLA LTD.-2024SE09902$CIPLA$$$$$$Y$$$20240920$$MD$SE$SE
243412122$24341212$2$F$$20240917$20240919$20240930$EXP$$US-CIPLA LTD.-2024US10066$CIPLA$Hussein G, Surani S, Krastev P, Mallari AJP, El Labban M, Yadav S et al.. Stone heart syndrome: A curious case of Digoxin toxicity and calcium infusion. Clin Case Rep. 2024;12:e9376:1 to 6$$$$$Y$$$20240930$$HP$US$US
243412131$24341213$1$I$20240701$20240912$20240919$20240919$PER$$US-SA-2024SA266886$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240920$$HP$US$US
243412141$24341214$1$I$20240101$20240912$20240919$20240919$PER$$US-SA-2024SA266858$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240920$$HP$US$US
243412161$24341216$1$I$$20240917$20240919$20240919$EXP$$US-ABBVIE-5928343$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243412171$24341217$1$I$$20240917$20240919$20240919$EXP$$GB-ABBVIE-5929398$ABBVIE$$$$E$M$Y$$$20240919$$HP$GB$GB
243412182$24341218$2$F$20210901$20240916$20240919$20240924$EXP$$DE-ABBVIE-5927344$ABBVIE$$39$YR$$F$Y$$$20240924$$MD$DE$DE
243412191$24341219$1$I$20230101$20240917$20240919$20240919$EXP$$US-DSJP-DSU-2023-132877$DAIICHI$$$$$F$Y$88.884$KG$20240920$$HP$US$US
243412201$24341220$1$I$$20240919$20240919$20240919$PER$$NVSC2024US187463$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243412212$24341221$2$F$20240918$20240923$20240919$20240926$EXP$$CH-ABBVIE-5930096$ABBVIE$$74$YR$$F$Y$$$20240926$$HP$CH$CH
243412231$24341223$1$I$$20240917$20240919$20240919$EXP$$US-SANDOZ INC.-SDZ2024US081487$SANDOZ$$$$$M$Y$168$KG$20240919$$CN$US$US
243412241$24341224$1$I$20240101$20240911$20240919$20240919$PER$$US-ABBVIE-5926811$ABBVIE$$39$YR$$F$Y$84.8$KG$20240919$$CN$US$US
243412251$24341225$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA001983$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243412261$24341226$1$I$$20240820$20240919$20240919$PER$$US-SMPA-2024SPA001669$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243412271$24341227$1$I$$20240909$20240919$20240919$PER$$US-SMPA-2024SPA002557$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243412281$24341228$1$I$$20240916$20240919$20240919$PER$$US-SMPA-2024SPA002897$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243412291$24341229$1$I$$20240823$20240919$20240919$PER$$US-SMPA-2024SPA000556$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243412301$24341230$1$I$$20240913$20240919$20240919$PER$$US-SMPA-2024SPA002832$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243412311$24341231$1$I$$20240826$20240919$20240919$PER$$US-SMPA-2024SPA001952$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243412321$24341232$1$I$$20240909$20240919$20240919$PER$$US-SMPA-2024SPA002515$SUNOVION$$$$$$Y$$$20240919$$CN$US$US
243412341$24341234$1$I$20240101$20240916$20240919$20240919$EXP$NL-LRB-01000779$NL-ABBVIE-5925337$ABBVIE$$34$YR$$F$Y$115$KG$20240919$$HP$NL$NL
243412351$24341235$1$I$$20240910$20240919$20240919$EXP$$GR-AMGEN-GRCSP2024183338$AMGEN$Vedelsbol R.; Anru P. L.; Ryg J. et al.. Drugs with Anticholinergic Properties and Association with Hip Fractures in Older Patients: A Danish Nationwide Cohort-Study. Journal of Frailty, Sarcopenia and Falls (JFSF). 2024;9 (3):207-217$$$$$Y$$$20240919$$HP$GR$GR
243412361$24341236$1$I$20240905$20240918$20240919$20240919$EXP$$CN-BEIGENE-BGN-2024-014822$BEIGENE$$$$$$Y$$$20240919$$HP$CN$CN
243412371$24341237$1$I$$20240909$20240919$20240919$EXP$$CA-JNJFOC-20240930782$JOHNSON AND JOHNSON$$10$YR$C$M$Y$28$KG$20240920$$HP$CA$CA
243412381$24341238$1$I$$20240919$20240919$20240919$PER$$NVSC2024US187479$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243412391$24341239$1$I$$20240913$20240919$20240919$EXP$$US-BEIGENE-BGN-2024-014642$BEIGENE$$$$$$Y$$$20240919$$PH$US$US
243412401$24341240$1$I$20240201$20240912$20240919$20240919$PER$$US-BIOGEN-2024BI01282623$BIOGEN$$17$YR$$F$Y$$$20240919$$MD$US$US
243412411$24341241$1$I$$20240905$20240919$20240919$EXP$$PH-DSJP-DSJ-2024-118786$DAIICHI$$39$YR$$F$Y$$$20240920$$MD$PH$PH
243412421$24341242$1$I$20240101$20240913$20240919$20240919$EXP$$US-ABBVIE-5924006$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243412431$24341243$1$I$20240101$20240917$20240919$20240919$EXP$$US-ABBVIE-5929244$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243412441$24341244$1$I$20240801$20240914$20240919$20240919$EXP$$CA-JNJFOC-20240944014$JOHNSON AND JOHNSON$$15$YR$T$F$Y$$$20240920$$HP$CA$CA
243412451$24341245$1$I$$20240916$20240919$20240919$EXP$$US-BIOGEN-2024BI01283094$BIOGEN$$$$$F$Y$$$20240919$$CN$US$US
243412461$24341246$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA267946$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240920$$HP$US$US
243412471$24341247$1$I$$20240912$20240919$20240919$PER$$US-SA-2024SA269176$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$HP$US$US
243412481$24341248$1$I$20240805$20240918$20240919$20240919$EXP$$JP-SAKK-2024SA231638AA$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240920$$MD$JP$JP
243412492$24341249$2$F$$20240924$20240919$20240930$EXP$$AU-SANDOZ INC.-SDZ2024AU081164$SANDOZ$$51$YR$$F$Y$$$20240930$$HP$AU$AU
243412501$24341250$1$I$20240101$20240916$20240919$20240919$EXP$$US-ABBVIE-5926413$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243412511$24341251$1$I$$20240909$20240919$20240919$EXP$$ZA-JNJFOC-20240947920$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$ZA$ZA
243412521$24341252$1$I$20240801$20240917$20240919$20240919$EXP$$PR-ABBVIE-5928297$ABBVIE$$$$A$F$Y$$$20240919$$MD$PR$PR
243412531$24341253$1$I$20230401$20240916$20240919$20240919$EXP$$US-ABBVIE-5926974$ABBVIE$$57$YR$$F$Y$$$20240919$$CN$US$US
243412541$24341254$1$I$20240101$20240916$20240919$20240919$EXP$$US-ABBVIE-5927419$ABBVIE$$65$YR$$M$Y$$$20240919$$CN$US$US
243412551$24341255$1$I$20240914$20240917$20240919$20240919$EXP$$GB-ABBVIE-5929044$ABBVIE$$66$YR$$M$Y$$$20240919$$HP$GB$GB
243412561$24341256$1$I$20240901$20240917$20240919$20240919$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052015$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240920$$CN$US$US
243412571$24341257$1$I$20240423$20240917$20240919$20240919$EXP$$US-ABBVIE-5928438$ABBVIE$$69$YR$$M$Y$$$20240919$$CN$US$US
243412581$24341258$1$I$20240101$20240917$20240919$20240919$EXP$$US-ABBVIE-5929008$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243412591$24341259$1$I$20231221$20240916$20240919$20240919$EXP$$US-ABBVIE-5927525$ABBVIE$$72$YR$$M$Y$$$20240919$$CN$US$US
243412601$24341260$1$I$20240901$20240913$20240919$20240919$EXP$$US-BIOGEN-2024BI01282735$BIOGEN$$52$YR$$M$Y$$$20240919$$CN$US$US
243412611$24341261$1$I$$20240912$20240919$20240919$PER$$NVSC2024US187487$NOVARTIS$$$$$$Y$$$20240920$$CN$US$US
243412621$24341262$1$I$$20240819$20240919$20240919$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-464220$RANBAXY$$79$YR$$M$Y$81.633$KG$20240920$$HP$US$US
243412631$24341263$1$I$20240101$20240911$20240919$20240919$PER$$US-ABBVIE-5925366$ABBVIE$$$$$$Y$$$20240919$$CN$US$US
243412641$24341264$1$I$$20240830$20240919$20240919$PER$$US-SA-2024SA268290$SANOFI AVENTIS$$74$YR$E$F$Y$79.09$KG$20240920$$HP$US$US
243412651$24341265$1$I$20240101$20240912$20240919$20240919$EXP$$US-BIOGEN-2024BI01282548$BIOGEN$$$$$F$Y$$$20240919$$CN$US$US
243412661$24341266$1$I$20240101$20240827$20240919$20240919$PER$$US-SA-2024SA269989$SANOFI AVENTIS$$74$YR$E$F$Y$116$KG$20240920$$MD$US$US
243412681$24341268$1$I$20240905$20240917$20240919$20240919$EXP$$US-ABBVIE-5929054$ABBVIE$$53$YR$$F$Y$$$20240919$$CN$US$US
243412701$24341270$1$I$$20240917$20240919$20240919$EXP$$US-ABBVIE-5928801$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243412711$24341271$1$I$$20240917$20240919$20240919$EXP$$US-ABBVIE-5928902$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243412721$24341272$1$I$$20240902$20240919$20240919$PER$$US-TEVA-VS-3240262$TEVA$$40$YR$$M$Y$$$20240919$$HP$US$US
243412731$24341273$1$I$$20240912$20240919$20240919$EXP$$US-BIOGEN-2024BI01282727$BIOGEN$$$$$F$Y$63.015$KG$20240919$$MD$US$US
243412741$24341274$1$I$20240801$20240829$20240919$20240919$PER$$US-SA-2024SA268543$SANOFI AVENTIS$$46$YR$A$F$Y$79.55$KG$20240920$$MD$US$US
243412751$24341275$1$I$20240905$20240913$20240919$20240919$EXP$$CA-BIOGEN-2024BI01282912$BIOGEN$$16$YR$$F$Y$$$20240919$$HP$CA$CA
243412761$24341276$1$I$20240905$20240913$20240919$20240919$EXP$$GT-BIOGEN-2024BI01283383$BIOGEN$$35$YR$$M$Y$63.5$KG$20240919$$CN$GT$GT
243412771$24341277$1$I$20240522$20240913$20240919$20240919$EXP$$AR-BIOGEN-2024BI01282852$BIOGEN$$21$YR$$F$Y$$$20240919$$CN$AR$AR
243412781$24341278$1$I$20230101$20240910$20240919$20240919$PER$$US-ABBVIE-5923769$ABBVIE$$84$YR$$F$Y$64$KG$20240919$$CN$US$US
243412791$24341279$1$I$20240903$20240913$20240919$20240919$EXP$$CN-BIOGEN-2024BI01282714$BIOGEN$$0$YR$$F$Y$5.5$KG$20240919$$HP$CN$CN
243412812$24341281$2$F$20240906$20240912$20240919$20240927$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051129$BOEHRINGER INGELHEIM$$34$YR$A$F$Y$86$KG$20240927$$PH$BR$BR
243412821$24341282$1$I$20240101$20240916$20240919$20240919$PER$$US-AMGEN-USASP2024184950$AMGEN$$$$$F$Y$$$20240919$$MD$US$US
243412832$24341283$2$F$$20240917$20240919$20240923$EXP$$US-BIOGEN-2024BI01282992$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
243412841$24341284$1$I$20240801$20240917$20240919$20240919$EXP$$US-ABBVIE-5929114$ABBVIE$$76$YR$$M$Y$$$20240919$$CN$US$US
243412851$24341285$1$I$20240901$20240918$20240919$20240919$EXP$$US-ABBVIE-5930109$ABBVIE$$66$YR$$M$Y$$$20240919$$CN$US$US
243412861$24341286$1$I$$20240918$20240919$20240919$EXP$$US-ABBVIE-5930111$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243412871$24341287$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5926435$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243412881$24341288$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5927246$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243412892$24341289$2$F$20240801$20240918$20240919$20240924$EXP$$FR-BIOGEN-2024BI01283103$BIOGEN$$$$N$$Y$$$20240924$$MD$FR$FR
243412901$24341290$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5926669$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243412911$24341291$1$I$$20240916$20240919$20240919$EXP$$US-ABBVIE-5927459$ABBVIE$$$$$F$Y$$$20240919$$CN$US$US
243412921$24341292$1$I$$20240917$20240919$20240919$EXP$$US-ABBVIE-5929051$ABBVIE$$$$$M$Y$$$20240919$$CN$US$US
243412931$24341293$1$I$20230101$20240916$20240920$20240920$EXP$$CA-ABBVIE-5927543$ABBVIE$$$$E$F$Y$$$20240919$$CN$CA$CA
243412941$24341294$1$I$20221003$20240917$20240920$20240920$EXP$$BR-ABBVIE-5929854$ABBVIE$$71$YR$$F$Y$43$KG$20240919$$CN$BR$BR
243412951$24341295$1$I$20240101$20240912$20240920$20240920$PER$$US-SA-2024SA267340$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240920$$MD$US$US
243412971$24341297$1$I$20240422$20240917$20240920$20240920$EXP$$GR-ABBVIE-5928924$ABBVIE$$67$YR$$M$Y$85$KG$20240920$$MD$GR$GR
243412981$24341298$1$I$20240911$20240910$20240920$20240920$EXP$$BR-CELLTRION INC.-2024BR022105$CELLTRION$$$$$$Y$$$20240920$$PH$BR$BR
243412991$24341299$1$I$20240912$20240917$20240920$20240920$EXP$$US-ABBVIE-5928316$ABBVIE$$39$YR$$F$Y$$$20240920$$CN$US$US
243413001$24341300$1$I$20240818$20240917$20240920$20240920$EXP$$US-ABBVIE-5929029$ABBVIE$$73$YR$$M$Y$$$20240920$$CN$US$US
243413011$24341301$1$I$20240808$20240914$20240920$20240920$EXP$$CO-TAKEDA-2024TUS075830$TAKEDA$$44$YR$$M$Y$58$KG$20240920$$CN$CO$CO
243413021$24341302$1$I$$20240917$20240920$20240920$EXP$$JP-SA-2024SA268239$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240920$$MD$JP$JP
243413031$24341303$1$I$20240917$20240917$20240920$20240920$PER$$US-ABBVIE-5927784$ABBVIE$$32$YR$$M$Y$$$20240920$$CN$US$US
243413041$24341304$1$I$20240731$20240911$20240920$20240920$EXP$$US-ABBVIE-5881561$ABBVIE$$16$YR$$F$Y$$$20240920$$CN$US$US
243413051$24341305$1$I$$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024185576$AMGEN$$$$$F$Y$$$20240919$$CN$US$US
243413061$24341306$1$I$20240101$20240912$20240920$20240920$PER$$US-SA-2024SA267384$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240920$$HP$US$US
243413071$24341307$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268531$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240920$$MD$US$US
243413081$24341308$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267664$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240920$$HP$US$US
243413091$24341309$1$I$20240801$20240906$20240920$20240920$PER$$US-SA-2024SA264793$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240920$$HP$US$US
243413101$24341310$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267684$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240920$$HP$US$US
243413111$24341311$1$I$20240901$20240912$20240920$20240920$PER$$US-SA-2024SA267968$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240920$$MD$US$US
243413122$24341312$2$F$20240901$20240919$20240920$20240921$PER$$US-AMGEN-USASP2024186935$AMGEN$$83$YR$E$F$Y$$$20240921$$CN$US$US
243413131$24341313$1$I$20240101$20240913$20240920$20240920$EXP$$US-009507513-2409USA005365$MERCK$$69$YR$$F$Y$$$20240920$$CN$US$US
243413141$24341314$1$I$$20240916$20240920$20240920$EXP$$JP-SANDOZ INC.-SDZ2024JP080949$SANDOZ$Tada Y, Maeyama A, Hagio T, Sakai M, Maruyama A, Yamamoto T. Usefulness of Sarilumab in Patients with Rheumatoid Arthritis after Regression of Lymphoproliferative Disorders.. Case Reports in Rheumatology. 2023$84$YR$$F$Y$$$20240920$$MD$JP$JP
243413152$24341315$2$F$$20240919$20240920$20240923$PER$$US-TAKEDA-2024TUS093340$TAKEDA$$$$$F$Y$$$20240923$$CN$US$US
243413161$24341316$1$I$20230501$20240919$20240920$20240920$EXP$$JP-TAKEDA-2023TJP005704$TAKEDA$$$$$$Y$$$20240920$$MD$JP$JP
243413171$24341317$1$I$20240101$20240913$20240920$20240920$EXP$$US-ABBVIE-5923252$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243413181$24341318$1$I$$20240911$20240920$20240920$PER$$US-ABBVIE-5921755$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243413191$24341319$1$I$$20240913$20240920$20240920$EXP$$US-ABBVIE-5924008$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243413201$24341320$1$I$20240101$20240913$20240920$20240920$EXP$$US-ABBVIE-5923989$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243413211$24341321$1$I$20240101$20240916$20240920$20240920$EXP$$US-ABBVIE-5926644$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243413231$24341323$1$I$$20240916$20240920$20240920$EXP$$CA-JNJFOC-20240943068$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$HP$CA$CA
243413241$24341324$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5928218$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243413252$24341325$2$F$20240601$20240919$20240920$20240924$EXP$$US-ABBVIE-5926716$ABBVIE$$60$YR$$M$Y$$$20240924$$CN$US$US
243413261$24341326$1$I$20231002$20240910$20240920$20240920$EXP$$JP-JNJFOC-20240949206$JOHNSON AND JOHNSON$$0$DY$N$M$Y$$$20240920$$MD$JP$JP
243413271$24341327$1$I$$20240727$20240920$20240920$EXP$$JP-AMGEN-JPNSP2024186184$AMGEN$$83$YR$E$M$Y$$$20240919$$MD$JP$JP
243413281$24341328$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186566$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243413291$24341329$1$I$$20240917$20240920$20240920$EXP$$JP-SANDOZ INC.-SDZ2024JP080699$SANDOZ$$67$YR$$M$Y$$$20240920$$MD$JP$JP
243413301$24341330$1$I$$20240910$20240920$20240920$PER$$US-JNJFOC-20240927499$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$HP$US$US
243413311$24341331$1$I$20240801$20240917$20240920$20240920$EXP$$US-ABBVIE-5929018$ABBVIE$$79$YR$$F$Y$$$20240920$$CN$US$US
243413321$24341332$1$I$$20240917$20240920$20240920$PER$$NVSC2024US187447$NOVARTIS$$10$MON$$$Y$$$20240920$$MD$US$US
243413351$24341335$1$I$20240901$20240912$20240920$20240920$PER$$US-SA-2024SA267704$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240920$$HP$US$US
243413361$24341336$1$I$20240829$20240916$20240920$20240920$EXP$$CA-ABBVIE-5927928$ABBVIE$$74$YR$$F$Y$$$20240920$$CN$CA$CA
243413381$24341338$1$I$$20240906$20240920$20240920$EXP$$US-SA-2024SA269921$SANOFI AVENTIS$$55$YR$A$F$Y$136.36$KG$20240920$$HP$US$US
243413391$24341339$1$I$20240914$20240916$20240920$20240920$EXP$$US-ABBVIE-5927693$ABBVIE$$38$YR$$M$Y$$$20240920$$CN$US$US
243413411$24341341$1$I$$20240911$20240920$20240920$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000322$EMCURE$Sloan AE, Winter K, Gilbert MR, Aldape K, Choi S, Wen PY et.al. NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma. Neuro-Oncology. 2024;26(9):1628-1637$$$$$Y$$$20240920$$MD$US$US
243413421$24341342$1$I$$20240911$20240920$20240920$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000329$EMCURE$Sloan AE, Winter K, Gilbert MR, Aldape K, Choi S, Wen PY et.al. NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma. Neuro-Oncology. 2024;26(9):1628-1637$$$$$Y$$$20240920$$MD$US$US
243413431$24341343$1$I$$20240913$20240920$20240920$EXP$$GB-AMGEN-GBRSP2024186286$AMGEN$$75$YR$E$F$Y$$$20240919$$CN$GB$GB
243413441$24341344$1$I$20240101$20240916$20240920$20240920$EXP$$US-ABBVIE-5927135$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243413451$24341345$1$I$$20240916$20240920$20240920$EXP$$US-ABBVIE-5927475$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243413461$24341346$1$I$20240101$20240913$20240920$20240920$EXP$$JP-009507513-2408JPN003948J$MERCK$$68$YR$$M$Y$$$20240920$$MD$JP$JP
243413472$24341347$2$F$20230301$20240912$20240920$20240920$EXP$$AT-STRIDES ARCOLAB LIMITED-2024SP012095$STRIDES$Adreana Kleinveld VE, Wanschitz J, Loscher WN, Hotter A, Cornelia Horlings CG.. Deterioration in multifocal motor neuropathy upon treatment of immune-related adverse events of checkpoint inhibition.. Immunotherapy. 2024;16 (9):597-601$72$YR$$M$Y$$$20240920$$HP$AT$AT
243413481$24341348$1$I$20240806$20240916$20240920$20240920$EXP$FR-AFSSAPS-NC2024001061$FR-GSK-FR2024114778$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$MD$FR$FR
243413491$24341349$1$I$20220315$20230814$20240920$20240920$EXP$$AT-SANDOZ INC.-NVSC2023AT070792$SANDOZ$$60$YR$$F$Y$86$KG$20240920$$MD$AT$AT
243413501$24341350$1$I$20240101$20240917$20240920$20240920$EXP$$CA-ABBVIE-5929021$ABBVIE$$61$YR$$F$Y$$$20240920$$MD$CA$CA
243413511$24341351$1$I$20240907$20240912$20240920$20240920$EXP$$TW-ABBVIE-5929955$ABBVIE$$55$YR$$F$Y$70$KG$20240920$$MD$TW$TW
243413521$24341352$1$I$20130801$20240912$20240920$20240920$EXP$$TN-ARROWPHARMA-2016SP002930$STRIDES$Charfi O, Lakhoua G, Sahnoun R, El Aidli S, Daghfous R, Kastalli S, et al. Multiple drug intolerance syndrome in an epileptic woman. Therapie. 2016;78:S85-S86$$$$F$Y$$$20240920$$MD$TN$TN
243413531$24341353$1$I$$20240907$20240920$20240920$EXP$$JP-AMGEN-JPNSP2024186192$AMGEN$Uchida T, Fukui S, Iwamoto N, Tsuji Y, Shimizu T, Umeda M. A review of 23 cases of Avacopan used for ANCA-associated vasculitis at our hospital.. The 68th Meeting of Kyushu College of Rheumatology.. 2024 SEP;76.$$$$$Y$$$20240919$$MD$JP$JP
243413541$24341354$1$I$20240901$20240918$20240920$20240920$EXP$$US-ABBVIE-5930095$ABBVIE$$77$YR$$M$Y$$$20240920$$CN$US$US
243413551$24341355$1$I$$20240913$20240920$20240920$EXP$$JP-GENMAB-2024-03323$GENMAB$$$$$$Y$$$20240920$$HP$JP$JP
243413561$24341356$1$I$$20240916$20240920$20240920$EXP$$US-ABBVIE-5929930$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243413572$24341357$2$F$20240101$20240917$20240920$20240920$EXP$$US-AMGEN-USASP2024182999$AMGEN$$76$YR$E$M$Y$74.25$KG$20240920$$CN$US$US
243413581$24341358$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112654$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243413591$24341359$1$I$$20240916$20240920$20240920$EXP$$US-ABBVIE-5928933$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243413601$24341360$1$I$20240101$20240917$20240920$20240920$EXP$$ZA-ABBVIE-5928879$ABBVIE$$58$YR$$M$Y$$$20240920$$HP$ZA$ZA
243413611$24341361$1$I$$20240709$20240920$20240920$PER$US-MLMSERVICE-20240703-PI117753-00163-1$US-STRIDES ARCOLAB LIMITED-2024SP008711$STRIDES$Naumann J, Naumann T.. Acute Precipitated Opioid Withdrawal With Akathisia, Delirium, and Lactic Acidosis from Low-Dose Naltrexone for Chronic Pain: Case Report.. Pain Medicine Case Reports. 2023;7 (8):353-356$7$DEC$$M$Y$$$20240920$$MD$US$US
243413621$24341362$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010978$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243413631$24341363$1$I$20180101$20240903$20240920$20240920$EXP$$SA-SA-2024SA270440$SANOFI AVENTIS$$$$$M$Y$$$20240920$$HP$SA$SA
243413641$24341364$1$I$20220101$20240917$20240920$20240920$EXP$$US-PFIZER INC-202400259166$PFIZER$$60$YR$$F$Y$$$20240920$$HP$US$US
243413651$24341365$1$I$$20240711$20240920$20240920$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008779$STRIDES$Admane S, Clark M, Bruera E, Reddy A.. Caught in the Name Game: Navigating the Data Linkage Conundrum. J-Pain-Symptom-Manage. 2024;68 (1):e79-e81$55$YR$$F$Y$$$20240920$$MD$US$US
243413671$24341367$1$I$$20240913$20240920$20240920$EXP$$JP-PFIZER INC-2024SGN04462$PFIZER$$10$DEC$$M$Y$$$20240920$$MD$JP$JP
243413681$24341368$1$I$$20240916$20240920$20240920$PER$$US-ABBVIE-5927872$ABBVIE$$80$YR$$F$Y$$$20240920$$CN$US$US
243413691$24341369$1$I$$20240908$20240920$20240920$EXP$$JP-Accord-446682$ACCORD$Horii T, Sasaki J, Ishii H, Sudou M, Takaki R, Tokito T, et al. Thoracic Angiosarcoma Arising from Chronic Tuberculous Pyothorax: A Case Report. Intern Med. 2024 Sep 4.$75$YR$E$M$Y$$$20240920$$HP$JP$JP
243413701$24341370$1$I$$20240917$20240920$20240920$EXP$$ZA-ABBVIE-5927480$ABBVIE$$$$$F$Y$$$20240920$$CN$ZA$ZA
243413711$24341371$1$I$20240101$20240916$20240920$20240920$EXP$$CA-PFIZER INC-202300154185$PFIZER$$66$YR$$F$Y$$$20240920$$MD$CA$CA
243413721$24341372$1$I$20240918$20240919$20240920$20240920$EXP$$IL-ABBVIE-5930107$ABBVIE$$78$YR$$M$Y$$$20240920$$CN$IL$IL
243413731$24341373$1$I$$20240801$20240920$20240920$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009880$STRIDES$Nguyen A, Norman M, O^reilly E, Robinson CL, Fonseca A, Madabhushi S, et al.. Case Series: Spinal Cord Stimulator Therapy Alleviates Neuropathic Pain in Patients with Failed Back Surgery Syndrome in the Setting of Spinal Cord Injury.. Pain-Med-Case-Rep. 2023;7 (7):337-340$49$YR$$M$Y$$$20240920$$MD$US$US
243413741$24341374$1$I$$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024186229$AMGEN$$$$$F$Y$$$20240919$$HP$US$US
243413751$24341375$1$I$$20240918$20240920$20240920$PER$$NVSC2024US187436$NOVARTIS$$71$YR$$M$Y$$$20240920$$CN$US$US
243413772$24341377$2$F$20240918$20240925$20240920$20240926$PER$$US-AMGEN-USASP2024186923$AMGEN$$54$YR$A$F$Y$$$20240926$$CN$US$US
243413781$24341378$1$I$$20240808$20240920$20240920$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010283$STRIDES$Difiore E, Pittman J.. A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting.. Case-Rep-Psychiatry. 2024;2024(0)$54$YR$$M$Y$$$20240920$$HP$US$US
243413791$24341379$1$I$$20240911$20240920$20240920$EXP$$CA-ABBVIE-5930548$ABBVIE$$64$YR$$F$Y$$$20240920$$CN$CA$CA
243413801$24341380$1$I$20240828$20240905$20240920$20240920$EXP$$IT-CIPLA LTD.-2024IT09888$CIPLA$$$$$$Y$$$20240920$$MD$IT$IT
243413811$24341381$1$I$20240917$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186400$AMGEN$$23$YR$A$M$Y$$$20240919$$PH$US$US
243413821$24341382$1$I$20240101$20240907$20240920$20240920$EXP$$JP-AMGEN-JPNSP2024186206$AMGEN$Takeyama Y, Saida M, Komine G, Noda R, Sakai M, Shirahama Y. Use experience of avacopan for ANCA-associated vasculitis in our hospital. The 68th Kyushu Rheumatology Congress. 2024 SEP;76.$$$$$Y$$$20240919$$MD$JP$JP
243413831$24341383$1$I$$20240908$20240920$20240920$EXP$$JP-Accord-446717$ACCORD$$$$$$Y$$$20240920$$HP$JP$JP
243413841$24341384$1$I$20240827$20240909$20240920$20240920$EXP$FR-AFSSAPS-AN2024001223$FR-Accord-446376$ACCORD$$58$YR$A$M$Y$$$20240920$$MD$FR$FR
243413852$24341385$2$F$$20240918$20240920$20240925$PER$$US-AMGEN-USASP2024186675$AMGEN$$$$$$Y$$$20240925$$MD$US$US
243413861$24341386$1$I$20240917$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187368$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243413871$24341387$1$I$$20240909$20240920$20240920$EXP$$JP-Accord-446269$ACCORD$Koshino Y, Sumi T, Suzuki K, Ikeda T, Yamada Y, Keiya T, et al. A Case of Pleurisy as Immune-related Adverse Events of Neoadjuvant Nivolumab and Chemotherapy After Lobectomy. Japanese Journal of Lung Cancer. 2024;64(4):315-20.$63$YR$A$M$Y$73$KG$20240920$$MD$JP$JP
243413881$24341388$1$I$20240801$20240919$20240920$20240920$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052469$BOEHRINGER INGELHEIM$$78$YR$E$F$Y$$$20240920$$CN$US$US
243413891$24341389$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA269170$SANOFI AVENTIS$$18$YR$A$M$Y$54.4$KG$20240920$$CN$US$US
243413901$24341390$1$I$$20240913$20240920$20240920$PER$$US-ABBVIE-5924277$ABBVIE$$$$$F$Y$$$20240920$$MD$US$US
243413912$24341391$2$F$20240903$20240916$20240920$20240925$PER$$US-AMGEN-USASP2024185080$AMGEN$$66$YR$E$M$Y$$$20240925$$CN$US$US
243413921$24341392$1$I$$20240903$20240920$20240920$PER$$US-STRIDES ARCOLAB LIMITED-2024SP011454$STRIDES$Hertz D, Scorza FA, Fiorini AC, Finsterer J.. SARS-CoV-2 vaccination complicated by small fiber neuropathy, mast cell activation syndrome, and pericarditis. Clinics. 2023;78$66$YR$$F$Y$$$20240920$$HP$US$US
243413931$24341393$1$I$$20240908$20240920$20240920$EXP$$JP-Accord-446716$ACCORD$Hokamura N, Fukagawa T, Fukushima R, Kiyokawa T, Horikawa M, Soeda N, Suzuki Y, Kaneshiro S, Abe K, Kodashima S, Yamamoto T, Oshima Y, Ishida T, Sasajima Y, Nomoto A, Shiraishi K, Ito A. Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma. BMC Gastroenterol. 2024 Sep 2;24(1):295.$$$$$Y$$$20240920$$HP$JP$JP
243413941$24341394$1$I$$20240919$20240920$20240920$PER$$NVSC2024US187530$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243413951$24341395$1$I$$20240913$20240920$20240920$EXP$$US-ABBVIE-5872784$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243413971$24341397$1$I$20230823$20240913$20240920$20240920$EXP$$US-ABBVIE-5910493$ABBVIE$$72$YR$$F$Y$66$KG$20240920$$CN$US$US
243413981$24341398$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267729$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240920$$HP$US$US
243414001$24341400$1$I$20240304$20240912$20240920$20240920$PER$$US-AMGEN-USASP2024183153$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243414021$24341402$1$I$$20240619$20240920$20240920$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007473$STRIDES$Khalil M, Dredla B, Cheung J, Castillo P.. DEXTROMETHORPHAN FOR RESTLESS LEGS SYNDROME: TESTING THE GLUTAMATE THEORY.. Sleep. 2024;47 (1):A302 abstr. 0706$45$YR$$F$Y$$$20240920$$HP$US$US
243414031$24341403$1$I$20201208$20240104$20240920$20240920$EXP$$CA-CELLTRION INC.-2020CA035393$CELLTRION$$$$$$Y$$$20240920$$MD$CA$CA
243414041$24341404$1$I$20240901$20240913$20240920$20240920$EXP$$US-ABBVIE-5927909$ABBVIE$$83$YR$$F$Y$$$20240920$$CN$US$US
243414051$24341405$1$I$$20240908$20240920$20240920$EXP$$TN-Accord-446835$ACCORD$Marmech E, Selmi I, Kanzari J, Ouarda H, Azzabi O, Siala N. Effective Use of Zoledronic Acid for Refractory Hypercalcemia in Neonatal Subcutaneous Fat Necrosis. Indian J Pediatr. 2024 Sep 6.$1$MON$I$$Y$$$20240920$$HP$TN$TN
243414061$24341406$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112685$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243414071$24341407$1$I$20240826$20240910$20240920$20240920$PER$$US-ABBVIE-5920553$ABBVIE$$39$YR$$F$Y$$$20240920$$MD$US$US
243414081$24341408$1$I$20240801$20240826$20240920$20240920$PER$$US-SA-2024SA266457$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240920$$MD$US$US
243414091$24341409$1$I$20240916$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024186073$AMGEN$$71$YR$E$F$Y$$$20240919$$CN$US$US
243414101$24341410$1$I$$20240516$20240920$20240920$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202405-000617$UNICHEM$$$$$F$Y$$$20240920$$CN$US$
243414111$24341411$1$I$$20240805$20240920$20240920$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202408-000992$UNICHEM$$81$YR$E$F$Y$$$20240920$$CN$US$
243414121$24341412$1$I$$20230814$20240920$20240920$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202310-001327$UNICHEM$$72$YR$E$F$Y$$$20240920$$CN$US$
243414131$24341413$1$I$$20240909$20240920$20240920$EXP$NL-LRB-01000645$NL-Accord-446384$ACCORD$$67$YR$E$F$Y$94$KG$20240920$$CN$NL$NL
243414141$24341414$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA266791$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$HP$US$US
243414151$24341415$1$I$20240101$20240912$20240920$20240920$PER$$US-SA-2024SA267965$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240920$$MD$US$US
243414161$24341416$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA252803$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240920$$MD$US$US
243414171$24341417$1$I$$20240914$20240920$20240920$PER$$US-SA-2024SA269430$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243414182$24341418$2$F$$20240919$20240920$20240926$PER$$US-TAKEDA-2024TUS093366$TAKEDA$$$$$M$Y$$$20240926$$HP$US$US
243414191$24341419$1$I$$20240916$20240920$20240920$EXP$$US-GSK-US2024114819$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243414201$24341420$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010942$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243414211$24341421$1$I$$20240909$20240920$20240920$EXP$$UA-Accord-446276$ACCORD$Kravtsiv M, Goncharuk O, Dudchenko M, Ivashchenko D, Bevz G, Tytarenko N, et al. A clinical case of hypotonic hyperhydration and cerebral edema after gastric lavage in a young child. Modern Pediatrics. Ukraine. 2024;4(140):113-8. DOI: 10.15574/SP.2024.140.113$4$YR$C$M$Y$19$KG$20240920$$MD$UA$UA
243414221$24341422$1$I$$20240912$20240920$20240920$EXP$$US-SANDOZ INC.-SDZ2024US081483$SANDOZ$$$$$$Y$$$20240920$$HP$US$US
243414231$24341423$1$I$$20240913$20240920$20240920$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-046941$BOEHRINGER INGELHEIM$$90$YR$E$F$Y$$$20240920$$CN$CA$CA
243414241$24341424$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187121$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243414251$24341425$1$I$20240917$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186556$AMGEN$$$$$F$Y$$$20240919$$HP$US$US
243414261$24341426$1$I$20240913$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024184981$AMGEN$$49$YR$A$F$Y$$$20240919$$CN$US$US
243414271$24341427$1$I$20240917$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186604$AMGEN$$70$YR$E$M$Y$$$20240919$$CN$US$US
243414281$24341428$1$I$$20240918$20240920$20240920$PER$$NVSC2024US187469$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
243414291$24341429$1$I$20240903$20240909$20240920$20240920$EXP$CN-HENLIUS-24CN017121$CN-Accord-447402$ACCORD$$69$YR$E$M$Y$60$KG$20240920$$MD$CN$CN
243414301$24341430$1$I$20240101$20240918$20240920$20240920$EXP$$US-ABBVIE-5929771$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243414311$24341431$1$I$20240916$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186952$AMGEN$$60$YR$A$M$Y$$$20240919$$CN$US$US
243414321$24341432$1$I$20240901$20240914$20240920$20240920$EXP$$US-JNJFOC-20240946006$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243414331$24341433$1$I$20220213$20221128$20240920$20240920$EXP$DE-DCGMA-22197006$DE-SANDOZ INC.-NVSC2022DE051222$SANDOZ$$75$YR$$F$Y$64$KG$20240920$$MD$DE$DE
243414341$24341434$1$I$20240906$20240910$20240920$20240920$PER$$US-ABBVIE-5919796$ABBVIE$$46$YR$$F$Y$$$20240920$$CN$US$US
243414351$24341435$1$I$20240731$20240916$20240920$20240920$EXP$$FR-ABBVIE-5926525$ABBVIE$$52$YR$$F$Y$65$KG$20240920$$MD$FR$FR
243414371$24341437$1$I$$20240909$20240920$20240920$EXP$JP-MLMSERVICE-20240906-PI178883-00198-9$JP-JUBILANT CADISTA PHARMACEUTICALS-2024JP001290$JUBILANT$Kimura M, Fujiwara S, Kuroda H, Kanamori M, Kawamoto M. Choroid plexitis caused by Burkholderia cepacia complex after COVID-19.. International journal of infectious diseases. 2024;147:107201$67$YR$$F$Y$$$20240920$$MD$JP$JP
243414381$24341438$1$I$20240501$20240910$20240920$20240920$EXP$FR-AFSSAPS-2024071366$FR-Accord-446553$ACCORD$$55$YR$A$F$Y$$$20240920$$MD$FR$FR
243414391$24341439$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA269175$SANOFI AVENTIS$$$$A$M$Y$$$20240920$$HP$US$US
243414401$24341440$1$I$20240901$20240911$20240920$20240920$PER$$US-SA-2024SA266413$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240920$$CN$US$US
243414411$24341441$1$I$$20240918$20240920$20240920$EXP$$NVSC2024US187340$NOVARTIS$$$$$M$Y$$$20240920$$MD$US$US
243414421$24341442$1$I$20200930$20240910$20240920$20240920$EXP$BE-MLMSERVICE-20240903-PI180147-00136-1$BE-ABBVIE-5930322$ABBVIE$Ferdinande K, Declerck L, Melis C, Missiaen L, Seynhaeve L, De Vloo C, et al. CYP2D6 polymorphism may contribute to Trazodone-induced hepatotoxicity: a rare case of drug-drug-gene induced liver injury. AGEB. 2024;87(2):332-5.$46$YR$$F$Y$$$20240920$$HP$BE$BE
243414431$24341443$1$I$20240401$20240909$20240920$20240920$EXP$$PT-GSK-PT2024EME113045$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$MD$PT$PT
243414441$24341444$1$I$20240401$20240909$20240920$20240920$EXP$$PT-VIIV HEALTHCARE LIMITED-PT2024EME113045$VIIV$$$$$$Y$$$20240920$$MD$PT$PT
243414451$24341445$1$I$$20240910$20240920$20240920$PER$$PR-ABBVIE-5919074$ABBVIE$$$$A$M$Y$$$20240920$$MD$PR$PR
243414461$24341446$1$I$$20240912$20240920$20240920$PER$$US-JNJFOC-20240935432$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243414482$24341448$2$F$20240905$20240917$20240920$20240924$PER$$US-AMGEN-USASP2024182337$AMGEN$$73$YR$E$F$Y$$$20240923$$CN$US$US
243414511$24341451$1$I$20110410$20240916$20240920$20240920$EXP$$FR-JNJFOC-20240946697$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240920$$HP$FR$FR
243414523$24341452$3$F$$20240913$20240920$20240930$PER$$US-CHATTEMPRD-2024OHG032006$CHATTEM$$$$$F$Y$$$20240930$$CN$US$US
243414531$24341453$1$I$$20240912$20240920$20240920$PER$$US-CHATTEMPRD-2024OHG032028$CHATTEM$$$$$F$Y$$$20240920$$CN$US$US
243414541$24341454$1$I$$20240915$20240920$20240920$PER$$US-CHATTEMPRD-2024OHG032255$CHATTEM$$$$$$Y$$$20240920$$CN$US$US
243414551$24341455$1$I$20240101$20240910$20240920$20240920$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-020289$UNITED THERAPEUTICS$$78$YR$$M$Y$$$20240920$$$JP$JP
243414561$24341456$1$I$$20240911$20240920$20240920$EXP$$CA-AMGEN-CANSP2024186417$AMGEN$$54$YR$A$F$Y$$$20240919$$MD$CA$CA
243414571$24341457$1$I$$20240916$20240920$20240920$PER$$NVSC2024US187444$NOVARTIS$$11$YR$$F$Y$76.203$KG$20240920$$HP$US$US
243414581$24341458$1$I$$20240918$20240920$20240920$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-037610$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240920$$MD$GB$GB
243414592$24341459$2$F$20210112$20240910$20240920$20240920$EXP$$US-JNJFOC-20240933880$JOHNSON AND JOHNSON$$18$YR$A$F$Y$101.8$KG$20240920$$MD$US$US
243414601$24341460$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA269982$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240920$$HP$US$US
243414611$24341461$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268955$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240920$$HP$US$US
243414621$24341462$1$I$$20240826$20240920$20240920$PER$$US-SA-2024SA267667$SANOFI AVENTIS$$$$T$F$Y$82.1$KG$20240920$$MD$US$US
243414631$24341463$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA269904$SANOFI AVENTIS$$$$$F$Y$$$20240920$$CN$US$US
243414641$24341464$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA269815$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240920$$HP$US$US
243414651$24341465$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA268972$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240920$$MD$US$US
243414661$24341466$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268889$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240920$$HP$US$US
243414672$24341467$2$F$20240913$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024186838$AMGEN$$$$$M$Y$$$20240920$$CN$US$US
243414681$24341468$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187124$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243414691$24341469$1$I$20240101$20240912$20240920$20240920$EXP$$CA-JNJFOC-20240541267$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$PH$CA$CA
243414701$24341470$1$I$20240701$20240829$20240920$20240920$PER$$US-SA-2024SA269539$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240920$$CN$US$US
243414711$24341471$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA270101$SANOFI AVENTIS$$$$A$M$Y$$$20240920$$HP$US$US
243414721$24341472$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA269928$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240920$$CN$US$US
243414731$24341473$1$I$20240401$20240913$20240920$20240920$EXP$$NVSC2024NL185177$NOVARTIS$$77$YR$$M$Y$$$20240920$$MD$NL$NL
243414741$24341474$1$I$20240905$20240913$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014609$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243414751$24341475$1$I$20240909$20240912$20240920$20240920$PER$$US-JNJFOC-20240933014$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243414761$24341476$1$I$20240828$20240913$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014612$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243414771$24341477$1$I$20240701$20240827$20240920$20240920$PER$$US-SA-2024SA174587$SANOFI AVENTIS$$58$YR$A$F$Y$81.82$KG$20240920$$MD$US$US
243414781$24341478$1$I$20240831$20240913$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014610$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243414791$24341479$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA266793$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$HP$US$US
243414801$24341480$1$I$20240913$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186529$AMGEN$$65$YR$E$F$Y$$$20240919$$CN$US$US
243414811$24341481$1$I$20240801$20240913$20240920$20240920$PER$$US-SA-2024SA269804$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240920$$HP$US$US
243414821$24341482$1$I$20240901$20240912$20240920$20240920$PER$$US-SA-2024SA267740$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240920$$HP$US$US
243414831$24341483$1$I$20240101$20240914$20240920$20240920$PER$$US-SA-2024SA269387$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240920$$MD$US$US
243414851$24341485$1$I$20240301$20240909$20240920$20240920$EXP$FR-AFSSAPS-AM2024000694$FR-Accord-446730$ACCORD$$74$YR$E$M$Y$64$KG$20240920$$MD$FR$FR
243414861$24341486$1$I$20240821$20240913$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014617$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243414871$24341487$1$I$$20240910$20240920$20240920$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-028694$UNITED THERAPEUTICS$$$$$F$Y$$$20240920$$$CA$CA
243414881$24341488$1$I$20201028$20201110$20240920$20240920$EXP$$CA-CELLTRION INC.-2020CA035397$CELLTRION$$$$$$Y$$$20240920$$CN$CA$CA
243414891$24341489$1$I$$20240913$20240920$20240920$PER$$US-AMGEN-USASP2024184374$AMGEN$$$$$F$Y$$$20240919$$CN$US$US
243414901$24341490$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010979$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243414911$24341491$1$I$$20240911$20240920$20240920$EXP$$GB-TEVA-VS-3242929$TEVA$$34$YR$$M$Y$$$20240920$$PH$GB$GB
243414921$24341492$1$I$20240904$20240908$20240920$20240920$EXP$$US-NOVOPROD-1282194$NOVO NORDISK$$18$YR$$F$Y$$$20240920$$CN$US$US
243414931$24341493$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187211$AMGEN$$$$$$Y$$$20240919$$CN$US$US
243414941$24341494$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186718$AMGEN$$80$YR$E$F$Y$$$20240919$$CN$US$US
243414951$24341495$1$I$$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024186176$AMGEN$$$$$M$Y$$$20240919$$CN$US$US
243414961$24341496$1$I$20240521$20240909$20240920$20240920$EXP$$NL-NOVOPROD-1267607$NOVO NORDISK$$68$YR$$F$Y$103$KG$20240920$$HP$NL$NL
243414971$24341497$1$I$$20220912$20240920$20240920$EXP$$GB-SANDOZ INC.-NVSC2022GB207571$SANDOZ$$67$YR$$F$Y$$$20240920$$MD$GB$GB
243414991$24341499$1$I$20240621$20240909$20240920$20240920$EXP$ES-AEMPS-1564454$ES-NOVOPROD-1280166$NOVO NORDISK$$41$YR$$M$Y$113$KG$20240920$$CN$ES$ES
243415001$24341500$1$I$20140101$20240909$20240920$20240920$EXP$$US-NOVOPROD-1267738$NOVO NORDISK$$67$YR$$F$Y$107.94$KG$20240920$$CN$US$US
243415011$24341501$1$I$20240905$20240912$20240920$20240920$PER$$US-JNJFOC-20240933196$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240920$$PH$US$US
243415021$24341502$1$I$20230413$20230518$20240920$20240920$EXP$$DE-SANDOZ INC.-NVSC2023DE108033$SANDOZ$$69$YR$$F$Y$73$KG$20240920$$MD$DE$DE
243415031$24341503$1$I$$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010625$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240920$$CN$US$US
243415041$24341504$1$I$$20240822$20240920$20240920$PER$$US-SA-2024SA266882$SANOFI AVENTIS$$$$E$F$Y$100.23$KG$20240920$$MD$US$US
243415051$24341505$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267107$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240920$$HP$US$US
243415061$24341506$1$I$20240101$20240826$20240920$20240920$PER$$US-SA-2024SA267733$SANOFI AVENTIS$$69$YR$E$F$Y$109.09$KG$20240920$$MD$US$US
243415071$24341507$1$I$20240901$20240913$20240920$20240920$PER$$US-SA-2024SA269967$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240920$$MD$US$US
243415091$24341509$1$I$20180723$20200318$20240920$20240920$EXP$DE-ROCHE-2229169$DE-SANDOZ INC.-PHHY2018DE195884$SANDOZ$$56$YR$$F$Y$56$KG$20240920$$MD$DE$DE
243415101$24341510$1$I$20240907$20240918$20240920$20240920$EXP$$JP-SANDOZ INC.-SDZ2024JP081426$SANDOZ$$79$YR$$F$Y$$$20240920$$CN$JP$JP
243415111$24341511$1$I$20240725$20240909$20240920$20240920$EXP$$FR-TAKEDA-2024TUS092962$TAKEDA$$75$YR$$M$Y$67.1$KG$20240920$$MD$FR$FR
243415121$24341512$1$I$$20240910$20240920$20240920$EXP$$CA-SANDOZ INC.-NVSC2021CA133037$SANDOZ$$69$YR$$F$Y$$$20240920$$CN$CA$CA
243415131$24341513$1$I$20190501$20240914$20240920$20240920$PER$$US-SA-2024SA269594$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240920$$HP$US$US
243415141$24341514$1$I$20170901$20180815$20240920$20240920$EXP$$DE-SANDOZ INC.-PHHY2017DE184885$SANDOZ$$63$YR$$F$Y$80$KG$20240920$$MD$DE$DE
243415161$24341516$1$I$20240808$20240912$20240920$20240920$PER$$US-AMGEN-USASP2024184456$AMGEN$$64$YR$A$F$Y$74$KG$20240919$$PH$US$US
243415171$24341517$1$I$$20240906$20240920$20240920$EXP$$CO-NOVOPROD-1283752$NOVO NORDISK$$$$$F$Y$$$20240920$$MD$CO$CO
243415181$24341518$1$I$$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024186422$AMGEN$Oska S.; Konda S.; Matthews N.. Full-body Multifocal Pyoderma Gangrenosum in the setting of PASH Syndrome. Journal of the American Academy of Dermatology. 2024;91 (3 ):AB47$26$YR$A$M$Y$$$20240919$$MD$US$US
243415191$24341519$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010932$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243415201$24341520$1$I$20240409$20240913$20240920$20240920$EXP$$CA-GSK-CA2024048677$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CA$CA
243415211$24341521$1$I$20240626$20240918$20240920$20240920$EXP$IT-MINISAL02-1001644$IT-JNJFOC-20240953648$JOHNSON AND JOHNSON$$86$YR$E$F$Y$70$KG$20240920$$PH$IT$IT
243415221$24341522$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010526$APOTEX$Ward J, Portnof J, Barreto V, Freedman P, Reich R, Kerpel S. Two cases of imatinib induced oral pigmentation affecting the palate. ORAL AND MAXILLOFACIAL PATHOLOGY. 2024;138 (4):e79-e84$69$YR$$F$Y$$$20240920$$MD$US$US
243415231$24341523$1$I$$20240902$20240920$20240920$PER$$US-TEVA-VS-3240306$TEVA$$64$YR$$F$Y$$$20240920$$CN$US$US
243415241$24341524$1$I$$20240911$20240920$20240920$EXP$$KR-EMD Serono-2024048869$EMD SERONO INC$$$$C$F$Y$$$20240920$$CN$KR$KR
243415251$24341525$1$I$$20240910$20240920$20240920$EXP$$US-KOANAAP-SML-US-2024-00947$SHILPA MEDICARE$Popat D, Singh A, Alfaraj A. MDS-669 Dramatically Decreased Transfusion Dependency With Luspatercept in a Case of High-Risk MDS. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24(Suppl. 1): S402.$81$YR$E$M$Y$$$20240920$$MD$US$US
243415261$24341526$1$I$$20240917$20240920$20240920$EXP$$DO-TAKEDA-2024TUS093216$TAKEDA$$$$$M$Y$$$20240920$$HP$DO$DO
243415271$24341527$1$I$$20240912$20240920$20240920$EXP$$DE-EMD Serono-2024049451$EMD SERONO INC$$$$$M$Y$$$20240920$$CN$DE$DE
243415281$24341528$1$I$$20240910$20240920$20240920$EXP$$IN-KOANAAP-SML-IN-2024-00948$SHILPA MEDICARE$Ganju N, Panda T, Oberoi G, Agarwal M, Mahapatra M. AML-083 AML in Pregnancy: Case Series. Clin-Lymphoma-Myeloma-Leuk 2024;24S293. - [abstract]$$$$F$Y$$$20240920$$MD$IN$IN
243415291$24341529$1$I$20240906$20240913$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014618$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243415301$24341530$1$I$$20240913$20240920$20240920$EXP$$US-GSK-US2024114364$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243415311$24341531$1$I$$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024185076$AMGEN$$$$A$F$Y$$$20240919$$HP$US$US
243415321$24341532$1$I$$20240916$20240920$20240920$EXP$$CA-AMGEN-CANSP2024185247$AMGEN$Leslie W. D.; Lix L. M.; Binkley N.. Treatment reclassification in Canada from the Osteoporosis Canada 2023 clinical practice guidelines: the Manitoba BMD Registry. Archives of Osteoporosis. 2024;1-8$$$$$Y$$$20240919$$HP$CA$CA
243415331$24341533$1$I$$20240910$20240920$20240920$EXP$$US-KOANAAP-SML-US-2024-00943$SHILPA MEDICARE$Peshin S, Kapadia C, Krishnadasan R. CML-401 Insights into Neulasta-Associated SplenicInfarction: Unveiling a Rare Complication in Chemotherapy for Chronic MyelomonocyticLeukemia.. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24: S372.$67$YR$E$M$Y$$$20240920$$MD$US$US
243415341$24341534$1$I$$20240910$20240920$20240920$EXP$$US-KOANAAP-SML-US-2024-00946$SHILPA MEDICARE$Desai AV, Naranjo A, Goldsmith KC, LaBarre B, Granger MP, States L. A pilot study of post-consolidation chemoimmunotherapy for high-risk neuroblastoma (ANBL19P1): A report from the Childrens Oncology Group. J-Clin-Oncol. 2024;42:$$$C$$Y$$$20240920$$MD$US$US
243415351$24341535$1$I$20220816$20240913$20240920$20240920$EXP$$US-TAKEDA-2021TUS056074$TAKEDA$$68$YR$$F$Y$111$KG$20240920$$CN$US$US
243415361$24341536$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149330$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240920$$HP$US$US
243415371$24341537$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010963$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243415391$24341539$1$I$20240419$20240909$20240920$20240920$EXP$FR-AFSSAPS-PA2024001076$FR-Accord-446381$ACCORD$$59$YR$A$F$Y$57.5$KG$20240920$$MD$FR$FR
243415411$24341541$1$I$$20240913$20240920$20240920$EXP$$US-TAKEDA-2024TUS091509$TAKEDA$$$$$F$Y$$$20240920$$CN$US$US
243415421$24341542$1$I$$20240910$20240920$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147459$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240920$$MD$JP$JP
243415431$24341543$1$I$$20240830$20240920$20240920$PER$$US-SA-2024SA268863$SANOFI AVENTIS$$$$T$F$Y$$$20240920$$MD$US$US
243415441$24341544$1$I$20240628$20240909$20240920$20240920$EXP$FR-AFSSAPS-PA2024001358$FR-Accord-446733$ACCORD$$36$YR$A$M$Y$72.9$KG$20240920$$MD$FR$FR
243415451$24341545$1$I$$20240830$20240920$20240920$PER$$US-SA-2024SA269315$SANOFI AVENTIS$$$$E$F$Y$$$20240920$$MD$US$US
243415461$24341546$1$I$$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024185058$AMGEN$$$$$M$Y$$$20240919$$HP$US$US
243415481$24341548$1$I$$20240910$20240920$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-149013$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240920$$MD$JP$JP
243415491$24341549$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149329$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240920$$CN$US$US
243415501$24341550$1$I$20230101$20240917$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148545$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240920$$CN$US$US
243415511$24341551$1$I$20240909$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149515$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240920$$CN$US$US
243415521$24341552$1$I$$20240910$20240920$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-145893$BRISTOL MYERS SQUIBB$Yoshida Risa, Tanaka Uki, Takeda nanami, Nakajima Rui, Okubo Mai, Asako Kurumi. A case of dermatomyositis and myasthenia gravis concomitantly developing as irAEs. The 698th Kanto Regional Meeting of the Japanese Society of Internal Medicine (Abstracts). 2024;$68$YR$E$M$Y$$$20240920$$MD$JP$JP
243415532$24341553$2$F$$20240910$20240920$20240925$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468939$RANBAXY$Godin S-L, Pillai A, El Warrack S, Douglas^Andrea D. From Hodgkin Lymphoma to Mycosis Fungiodes: A Quick Cascade. Clin Lymphoma Myeloma Leuk. 2024;Sep;24 (Suppl.):S448;HL-446$55$YR$$M$Y$$$20240925$$MD$US$US
243415542$24341554$2$F$$20240910$20240920$20240925$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468936$RANBAXY$Popat D, Sanghavi N, Singh A, Sawhney R. Parsonage Turner Syndrome Complicating Multiple Myeloma Therapy: ^Nothing to Shrug your Shoulders at^. Clin Lymphoma Myeloma Leuk. 2024;Sep;24 (Suppl.):S578;MM-657$66$YR$$M$Y$$$20240925$$HP$US$US
243415551$24341555$1$I$$20240905$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468017$RANBAXY$Barrow J, Vendrame M. Low-dose trazodone for REM behavior disorder: report of three cases. Sleep Medicine. 2024;115 (Suppl.):304$74$YR$$M$Y$$$20240920$$HP$US$US
243415561$24341556$1$I$$20240905$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468018$RANBAXY$Barrow J, Vendrame M. Low-dose trazodone for REM behavior disorder: report of three cases. Sleep Medicine. 2024;115 (Suppl.):304$56$YR$$M$Y$$$20240920$$HP$US$US
243415571$24341557$1$I$$20240912$20240920$20240920$EXP$$CA-TOLMAR, INC.-24CA052587$TOLMAR$$$$$M$Y$$$20240920$$CN$CA$CA
243415581$24341558$1$I$$20240912$20240920$20240920$EXP$$CA-TOLMAR, INC.-24CA052588$TOLMAR$$$$$M$Y$$$20240920$$CN$CA$CA
243415591$24341559$1$I$$20240916$20240920$20240920$PER$$US-DAIICHI SANKYO, INC.-DS-2024-100282-US$DAIICHI$$72$YR$$F$Y$$$20240920$$HP$US$US
243415601$24341560$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010964$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243415621$24341562$1$I$$20240918$20240920$20240920$PER$$US-BIOGEN-2024BI01283160$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
243415631$24341563$1$I$20240911$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147509$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240920$$CN$US$US
243415641$24341564$1$I$$20240917$20240920$20240920$EXP$$CA-SANDOZ INC.-SDZ2024CA081371$SANDOZ$$$$$M$Y$$$20240920$$MD$CA$CA
243415651$24341565$1$I$20240911$20240912$20240920$20240920$PER$$US-ABBVIE-5924226$ABBVIE$$25$YR$$$Y$$$20240920$$MD$US$US
243415661$24341566$1$I$20240101$20240911$20240920$20240920$PER$$US-ABBVIE-5923836$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243415671$24341567$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010980$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243415681$24341568$1$I$$20240916$20240920$20240920$EXP$$US-SA-2024SA270489$SANOFI AVENTIS$$$$E$F$Y$$$20240920$$HP$US$US
243415691$24341569$1$I$20240917$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186916$AMGEN$$46$YR$A$F$Y$$$20240919$$CN$US$US
243415701$24341570$1$I$$20240916$20240920$20240920$EXP$$NVSJ2024JP011004$NOVARTIS$$90$YR$$M$Y$60$KG$20240920$$MD$JP$JP
243415711$24341571$1$I$$20240913$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146848$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240920$$HP$US$US
243415722$24341572$2$F$$20240918$20240920$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149265$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240925$$CN$US$US
243415731$24341573$1$I$$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147091$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240920$$HP$US$US
243415741$24341574$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149137$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240920$$CN$US$US
243415751$24341575$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148824$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240920$$HP$US$US
243415771$24341577$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149600$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240920$$CN$US$US
243415781$24341578$1$I$20240901$20240913$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147247$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240920$$HP$US$US
243415791$24341579$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149334$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240920$$CN$US$US
243415801$24341580$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148905$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240920$$CN$US$US
243415811$24341581$1$I$20240829$20240912$20240920$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-148116$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240920$$PH$JP$JP
243415821$24341582$1$I$20240910$20240917$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148350$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240920$$CN$US$US
243415831$24341583$1$I$20160501$20240918$20240920$20240920$PER$$US-BIOGEN-2018BI00677210$BIOGEN$$52$YR$$F$Y$$$20240920$$CN$US$GB
243415841$24341584$1$I$$20240918$20240920$20240920$PER$$US-BIOGEN-2024BI01283262$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
243415851$24341585$1$I$$20240917$20240920$20240920$PER$$US-BIOGEN-2024BI01283027$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
243415861$24341586$1$I$$20240917$20240920$20240920$PER$$US-BIOGEN-2024BI01283098$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
243415871$24341587$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010965$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243415881$24341588$1$I$20240601$20240909$20240920$20240920$EXP$FR-AFSSAPS-RN2024000946$FR-Accord-446391$ACCORD$$46$YR$A$F$Y$$$20240920$$MD$FR$FR
243415891$24341589$1$I$$20240909$20240920$20240920$EXP$$US-HALEON-2196118$Haleon PLC$$48$YR$$F$Y$$$20240919$$HP$US$US
243415901$24341590$1$I$$20240828$20240920$20240920$30DAY$$BR-JNJFOC-20240917093$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$HP$BR$BR
243415911$24341591$1$I$$20240918$20240920$20240920$EXP$$E2B_07261603$SANDOZ$$32$YR$$F$Y$$$20240920$$CN$CA$CA
243415921$24341592$1$I$$20240917$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149177$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240920$$CN$US$US
243415931$24341593$1$I$$20240917$20240920$20240920$EXP$$US-ARGENX-2024-ARGX-US008006$ARGENX BVBA$$$$$$Y$$$20240920$$MD$US$US
243415941$24341594$1$I$$20240917$20240920$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU065890$SANDOZ$$$$$$Y$$$20240920$$HP$AU$AU
243415952$24341595$2$F$$20240918$20240920$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145650$BRISTOL MYERS SQUIBB$Purt B, Nugent A, Wu PS, Paulus YM. Sub-tenon triamcinolone and anti-HIV medication-induced cushing syndrome. JAMA Ophthalmology. 2024 Aug 29;E1-3. doi:10.1001/jamaophthalmol.2024.3284.$82$YR$E$M$Y$$$20240925$$MD$US$US
243415971$24341597$1$I$20240801$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147522$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240920$$HP$US$US
243415981$24341598$1$I$20240626$20240916$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148812$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240920$$CN$US$US
243415991$24341599$1$I$20240918$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186748$AMGEN$$51$YR$A$M$Y$$$20240919$$CN$US$US
243416001$24341600$1$I$$20240910$20240920$20240920$EXP$$US-PIRAMAL PHARMA LIMITED-2024-PPL-000677$PIRAMAL$$$$$$Y$$$20240920$$HP$US$US
243416011$24341601$1$I$20240909$20240913$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014613$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243416021$24341602$1$I$$20240918$20240920$20240920$PER$$NVSC2024US187129$NOVARTIS$$$$$F$Y$$$20240920$$HP$US$US
243416041$24341604$1$I$20240709$20240911$20240920$20240920$EXP$$RS-EMD Serono-2024049076$EMD SERONO INC$$0$YR$$F$Y$3$KG$20240920$$CN$RS$RS
243416051$24341605$1$I$$20240911$20240920$20240920$PER$$US-TAKEDA-2024TUS091119$TAKEDA$$$$$$Y$$$20240920$$HP$US$US
243416061$24341606$1$I$$20240911$20240920$20240920$EXP$$US-SA-2024SA271119$SANOFI AVENTIS$$$$$F$Y$$$20240920$$CN$US$US
243416071$24341607$1$I$20240913$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149130$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$50.89$KG$20240920$$PH$US$US
243416081$24341608$1$I$$20240912$20240920$20240920$PER$$US-TAKEDA-2024TUS091146$TAKEDA$$$$$F$Y$$$20240920$$CN$US$US
243416091$24341609$1$I$$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148976$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240920$$CN$US$US
243416101$24341610$1$I$$20240909$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144045$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240920$$CN$US$US
243416121$24341612$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010597$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243416141$24341614$1$I$$20240827$20240920$20240920$PER$$US-SA-2024SA267751$SANOFI AVENTIS$$$$A$F$Y$72.12$KG$20240920$$MD$US$US
243416161$24341616$1$I$20240801$20240911$20240920$20240920$PER$$US-SA-2024SA266039$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240920$$MD$US$US
243416171$24341617$1$I$20240701$20240823$20240920$20240920$PER$$US-SA-2024SA267827$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240920$$MD$US$US
243416181$24341618$1$I$20230101$20240822$20240920$20240920$PER$$US-SA-2024SA269719$SANOFI AVENTIS$$33$YR$A$F$Y$119$KG$20240920$$MD$US$US
243416191$24341619$1$I$20240101$20240903$20240920$20240920$PER$$US-SA-2024SA270864$SANOFI AVENTIS$$40$YR$A$F$Y$58.9$KG$20240920$$MD$US$US
243416211$24341621$1$I$20220101$20240910$20240920$20240920$EXP$$TN-AJANTA-2024AJA00156$AJANTA PHARMA$Boussaa H, Hamdi O, Miladi S, Makhlouf Y, Abdelghani KB, Fazaa A. et.al..Tofacitinib-Induced Acute Pancreatitis in a Patient with Rheumatoid  Arthritis: A Case Report and Review of the Literature.Current Drug Safety.04-SEP-2024;XX:000-000$58$YR$A$F$Y$$$20240919$$HP$TN$TN
243416221$24341622$1$I$$20240918$20240920$20240920$EXP$GB-MHRA-MED-202409181355589180-TBDKM$GB-SANDOZ INC.-SDZ2024GB081588$SANDOZ$$70$YR$$M$Y$79$KG$20240920$$CN$GB$GB
243416232$24341623$2$F$$20240916$20240920$20240926$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK094041$GLENMARK$$$$$$Y$$$20240926$$MD$GB$GB
243416241$24341624$1$I$$20240910$20240920$20240920$PER$$US-ABBVIE-5920692$ABBVIE$$$$$$Y$$$20240920$$CN$US$US
243416251$24341625$1$I$$20240808$20240920$20240920$PER$$US-SA-2024SA270431$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240920$$HP$US$US
243416261$24341626$1$I$$20240830$20240920$20240920$PER$$US-SA-2024SA270909$SANOFI AVENTIS$$$$C$F$Y$$$20240920$$MD$US$US
243416271$24341627$1$I$20240101$20240829$20240920$20240920$PER$$US-SA-2024SA268946$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240920$$CN$US$US
243416281$24341628$1$I$20240101$20240906$20240920$20240920$PER$$US-SA-2024SA266721$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240920$$MD$US$US
243416291$24341629$1$I$20240101$20240912$20240920$20240920$PER$$US-SA-2024SA246550$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240920$$MD$US$US
243416301$24341630$1$I$$20240917$20240920$20240920$EXP$$PL-JNJFOC-20240951059$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$MD$PL$PL
243416311$24341631$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010958$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243416321$24341632$1$I$20240916$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024184987$AMGEN$$20$YR$A$F$Y$$$20240919$$PH$US$US
243416331$24341633$1$I$$20240829$20240920$20240920$PER$$US-SA-2024SA268987$SANOFI AVENTIS$$$$A$F$Y$72.57$KG$20240920$$MD$US$US
243416341$24341634$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010981$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243416351$24341635$1$I$$20240913$20240920$20240920$PER$$US-ABBVIE-5925458$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243416361$24341636$1$I$20240616$20240620$20240920$20240920$PER$$US-AJANTA-2024AJA00118$AJANTA PHARMA$$77$YR$E$F$Y$130$KG$20240920$$CN$US$US
243416371$24341637$1$I$$20240911$20240920$20240920$EXP$$IN-SANDOZ INC.-SDZ2024IN079839$SANDOZ$$$$$M$Y$71$KG$20240920$$CN$IN$IN
243416382$24341638$2$F$20240601$20240912$20240920$20240926$EXP$$ES-ABBVIE-5927336$ABBVIE$$27$YR$$F$Y$$$20240926$$CN$ES$ES
243416391$24341639$1$I$$20240917$20240920$20240920$PER$$US-TAKEDA-2024TUS092760$TAKEDA$$$$$F$Y$$$20240920$$HP$US$US
243416401$24341640$1$I$20240911$20240912$20240920$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-029073$UNITED THERAPEUTICS$$78$YR$$F$Y$120.18$KG$20240920$$$US$US
243416411$24341641$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010598$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243416421$24341642$1$I$20240917$20240917$20240920$20240920$EXP$$US-ABBVIE-5928992$ABBVIE$$72$YR$$F$Y$$$20240920$$CN$US$US
243416431$24341643$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005178$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243416441$24341644$1$I$$20240913$20240920$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-029174$UNITED THERAPEUTICS$$$$$F$Y$102.04$KG$20240920$$$US$US
243416451$24341645$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010960$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243416462$24341646$2$F$$20240917$20240920$20240925$EXP$$JP-ASTELLAS-2024-AER-006730$ASTELLAS$$9$DEC$E$M$Y$$$20240925$$MD$JP$JP
243416481$24341648$1$I$$20240913$20240920$20240920$30DAY$$IT-UCBSA-2024048231$UCB$$$$$$Y$$$20240920$$CN$IT$IT
243416501$24341650$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010599$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243416512$24341651$2$F$20240906$20240924$20240920$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015376$JAZZ$$41$YR$$F$Y$$$20240926$$CN$US$US
243416521$24341652$1$I$$20240910$20240920$20240920$PER$$US-ASTELLAS-2024-AER-006493$ASTELLAS$$$$$F$Y$$$20240920$$MD$US$US
243416531$24341653$1$I$$20240913$20240920$20240920$PER$$US-HALEON-2197640$Haleon PLC$Tatara AM, Basgoz N, Nelson SB. Fishy story: paradoxical reaction associated with Mycobacterium marinum. BMJ Case?Reports CP. 2024 Aug 1;17(8):e261308$$$A$F$Y$$$20240920$$HP$US$US
243416541$24341654$1$I$20220820$20240914$20240920$20240920$EXP$$CA-AMGEN-CANSP2024185098$AMGEN$$19$YR$A$F$Y$$$20240919$$MD$CA$CA
243416551$24341655$1$I$$20240918$20240920$20240920$EXP$$US-AMGEN-USASP2024186689$AMGEN$$$$E$F$Y$$$20240919$$CN$US$US
243416561$24341656$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010602$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243416571$24341657$1$I$$20240903$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08859$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243416581$24341658$1$I$20230801$20240916$20240920$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015309$JAZZ$$56$YR$$F$Y$$$20240919$$CN$US$US
243416591$24341659$1$I$$20240909$20240920$20240920$EXP$$US-HALEON-2196117$Haleon PLC$Rule JA, Ajayi F, James LP, Tujios SR, Sussman NL, Rakela JL, et al. Differentiating Ischemic Hepatitis from Acetaminophen Overdose in Acute Liver Failure: Role of Acetaminophen Adducts-Ischemic Hepatitis vs Acetaminophen Overdose. Digestive Diseases and Sciences. 2024. DOI: 10.1007/s10620-024-08602-7.$54$YR$$M$Y$$$20240919$$HP$US$US
243416601$24341660$1$I$$20240918$20240920$20240920$EXP$$CN-TAKEDA-2024TUS093291$TAKEDA$$$$$M$Y$$$20240920$$CN$CN$CN
243416611$24341661$1$I$$20240901$20240920$20240920$PER$$US-009507513-2409USA000475$MERCK$$$$$F$Y$47.6$KG$20240920$$CN$US$US
243416622$24341662$2$F$$20240921$20240920$20240930$EXP$$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112039$ZYDUS PHARM$Baudriller A, Abbara C, Briet M, Jousset N, Malbranque S, Zabet D, et al.. Deaths related to pharmacobezoars: A report on two cases.. Toxicologie Analytique et Clinique. 2024$$$$$Y$$$20240930$$HP$FR$FR
243416631$24341663$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010606$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243416641$24341664$1$I$20120101$20240914$20240920$20240920$EXP$$CN-CHEPLA-2024011884$CHEPLAPHARM$Zhang Y, Ge X, Xia H, Xie Y, Zeng Q, Ban C, et al. A Case Report of Hypothyroidism Associated with Schizophrenia. Journal of Psychiatry.2024;37(2). Doi: 10.3969/j.issn.2095-9346.2024.02.020.$38$YR$$F$Y$$$20240920$$HP$COUNTRY NOT SPECIFIED$CN
243416651$24341665$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010618$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243416671$24341667$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010619$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243416681$24341668$1$I$20240724$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005184$ACADIA PHARMACEUTICALS$$85$YR$$F$Y$$$20240920$$CN$US$US
243416692$24341669$2$F$$20240919$20240920$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005280$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243416701$24341670$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA269205$SANOFI AVENTIS$$$$C$F$Y$$$20240920$$MD$US$US
243416711$24341671$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA266693$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240920$$HP$US$US
243416721$24341672$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA268740$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240920$$HP$US$US
243416731$24341673$1$I$20240821$20240916$20240920$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU080565$SANDOZ$$63$YR$$M$Y$$$20240920$$MD$AU$AU
243416741$24341674$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268997$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240920$$HP$US$US
243416751$24341675$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA266845$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240920$$MD$US$US
243416761$24341676$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268754$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240920$$HP$US$US
243416771$24341677$1$I$20240914$20240914$20240920$20240920$PER$$US-SA-2024SA269477$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240920$$HP$US$US
243416781$24341678$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA269688$SANOFI AVENTIS$$63$YR$A$F$Y$71.36$KG$20240920$$HP$US$US
243416791$24341679$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA267654$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240920$$HP$US$US
243416801$24341680$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005183$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243416811$24341681$1$I$20240101$20240912$20240920$20240920$EXP$$US-SA-2024SA270400$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240920$$CN$US$US
243416821$24341682$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010620$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243416832$24341683$2$F$20240521$20240918$20240920$20240923$EXP$$US-ABBVIE-5926666$ABBVIE$$52$YR$$F$Y$$$20240923$$CN$US$US
243416841$24341684$1$I$20240821$20240911$20240920$20240920$EXP$GB-MHRA-MED-202409112330154860-CKLNB$GB-TEVA-VS-3243104$TEVA$$43$YR$$F$Y$120$KG$20240920$$CN$GB$GB
243416852$24341685$2$F$$20240923$20240920$20240926$PER$$US-AMGEN-USASP2024186853$AMGEN$$$$$M$Y$$$20240926$$CN$US$US
243416861$24341686$1$I$$20240914$20240920$20240920$PER$$US-AMGEN-USASP2024184484$AMGEN$$$$$F$Y$$$20240920$$CN$US$US
243416871$24341687$1$I$$20240910$20240920$20240920$EXP$$CA-HALEON-2196753$Haleon PLC$$40$YR$$F$Y$96$KG$20240919$$HP$CA$CA
243416881$24341688$1$I$$20240916$20240920$20240920$EXP$$US-TAKEDA-2024TUS091028$TAKEDA$$$$$F$Y$$$20240920$$CN$US$US
243416891$24341689$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010984$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243416901$24341690$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005125$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243416911$24341691$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010621$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243416921$24341692$1$I$$20240917$20240920$20240920$PER$$NVSC2024US187467$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
243416931$24341693$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010622$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243416941$24341694$1$I$20240814$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005185$ACADIA PHARMACEUTICALS$$64$YR$$M$Y$$$20240920$$CN$US$US
243416951$24341695$1$I$$20240828$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005139$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243416961$24341696$1$I$$20240916$20240920$20240920$EXP$$US-AMGEN-USASP2024185070$AMGEN$$$$$$Y$$$20240920$$HP$US$US
243416971$24341697$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010623$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243416981$24341698$1$I$$20240913$20240920$20240920$EXP$$US-GSK-US2024AMR115858$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243417001$24341700$1$I$$20240910$20240920$20240920$EXP$$CA-HALEON-2197205$Haleon PLC$$44$YR$$F$Y$$$20240919$$HP$CA$CA
243417011$24341701$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010941$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243417021$24341702$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010985$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243417031$24341703$1$I$20240906$20240917$20240920$20240920$EXP$$US-ABBVIE-5928928$ABBVIE$$72$YR$$F$Y$$$20240920$$CN$US$US
243417041$24341704$1$I$20240601$20240828$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003273$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240920$$CN$US$US
243417051$24341705$1$I$20240824$20240828$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005140$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240920$$CN$US$US
243417061$24341706$1$I$20240916$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147784$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240920$$PH$US$US
243417071$24341707$1$I$$20240913$20240920$20240920$EXP$$US-JNJFOC-20240940089$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243417081$24341708$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010624$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243417091$24341709$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5929036$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243417111$24341711$1$I$$20240910$20240920$20240920$EXP$$FR-NOVITIUMPHARMA-2024FRNVP01889$NOVITIUM PHARMA$Margaux Pinana.Cytomegalovirus-induced oral ulcers: A case report and literature review.Clinical Case Reports.07-JUN-2023;11:e7459$62$YR$A$F$Y$$$20240920$$HP$FR$FR
243417121$24341712$1$I$$20240912$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005532$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243417131$24341713$1$I$20240701$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005142$ACADIA PHARMACEUTICALS$$55$YR$$M$Y$$$20240920$$CN$US$US
243417141$24341714$1$I$20220101$20240917$20240920$20240920$EXP$$US-ABBVIE-5928447$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243417151$24341715$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010625$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243417161$24341716$1$I$$20240910$20240920$20240920$EXP$GB-MHRA-TPP35284951C228000YC1725900613113$GB-Accord-446392$ACCORD$$85$YR$E$F$Y$67$KG$20240920$$MD$GB$GB
243417171$24341717$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010626$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243417181$24341718$1$I$$20240824$20240920$20240920$PER$$US-SA-2024SA267171$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240920$$MD$US$US
243417191$24341719$1$I$20240912$20240912$20240920$20240920$EXP$$US-ORG100016242-2024000581$PACIRA$$44$YR$A$F$Y$$$20240920$$PH$US$US
243417201$24341720$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267555$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240920$$MD$US$US
243417211$24341721$1$I$20240801$20240911$20240920$20240920$PER$$US-SA-2024SA267249$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240920$$HP$US$US
243417221$24341722$1$I$$20240830$20240920$20240920$PER$$US-SA-2024SA270770$SANOFI AVENTIS$$$$A$M$Y$102.27$KG$20240920$$MD$US$US
243417241$24341724$1$I$$20240905$20240920$20240920$PER$$US-SA-2024SA265565$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240920$$CN$US$US
243417261$24341726$1$I$20240918$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186501$AMGEN$$79$YR$E$F$Y$$$20240920$$CN$US$US
243417272$24341727$2$F$20240919$20240920$20240920$20240920$PER$$US-AMGEN-USASP2024187381$AMGEN$$63$YR$A$M$Y$$$20240920$$CN$US$US
243417281$24341728$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA268844$SANOFI AVENTIS$$$$E$M$Y$$$20240920$$HP$US$US
243417291$24341729$1$I$$20240910$20240920$20240920$EXP$$CA-HALEON-2197008$Haleon PLC$$44$YR$$F$Y$$$20240919$$HP$CA$CA
243417301$24341730$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005153$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243417311$24341731$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010627$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240920$$HP$US$US
243417321$24341732$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005155$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243417331$24341733$1$I$20240806$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005146$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240920$$CN$US$US
243417341$24341734$1$I$$20240910$20240920$20240920$EXP$$CA-HALEON-2197173$Haleon PLC$$44$YR$$F$Y$97$KG$20240919$$MD$CA$CA
243417361$24341736$1$I$$20240910$20240920$20240920$EXP$$CA-AMGEN-CANSP2024183753$AMGEN$$40$YR$A$F$Y$$$20240920$$HP$CA$CA
243417371$24341737$1$I$20240821$20240906$20240920$20240920$PER$$US-AMGEN-USASP2024178901$AMGEN$$46$YR$A$F$Y$70.6$KG$20240920$$PH$US$US
243417381$24341738$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010628$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240920$$HP$US$US
243417391$24341739$1$I$$20240913$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013703$DR REDDYS$Harper KK, Mutch V, Safran JP, Wu D, Aggarwal N, Maheshwari E, et al. Leukemia cutis and anterior uveitis associated with chronic myelomonocytic leukemia. JAAD Case Reports. 2024;52: 21-24. doi:10.1016/j.jdcr.2024.07.001.$76$YR$E$F$Y$$$20240920$$MD$US$US
243417401$24341740$1$I$20240725$20240902$20240920$20240920$EXP$FR-AFSSAPS-PB2024000868$FR-TAKEDA-2024TUS093093$TAKEDA$$52$YR$$F$Y$$$20240920$$HP$FR$FR
243417411$24341741$1$I$20240911$20240911$20240920$20240920$PER$$US-AMGEN-USASP2024185508$AMGEN$$$$$F$Y$$$20240920$$HP$US$US
243417421$24341742$1$I$20240826$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005158$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240920$$CN$US$US
243417431$24341743$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010933$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243417441$24341744$1$I$20240914$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186928$AMGEN$$58$YR$A$F$Y$$$20240920$$CN$US$US
243417451$24341745$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010629$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240920$$HP$US$US
243417461$24341746$1$I$20240901$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011958$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240920$$CN$US$US
243417471$24341747$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010897$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243417481$24341748$1$I$$20240918$20240920$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU081229$SANDOZ$$$$E$$Y$$$20240920$$HP$AU$AU
243417491$24341749$1$I$$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147767$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240920$$HP$US$US
243417501$24341750$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005181$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243417511$24341751$1$I$20240620$20240913$20240920$20240920$EXP$$US-GSK-US2024114205$GLAXOSMITHKLINE$$34$YR$$F$Y$$$20240920$$CN$US$US
243417521$24341752$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010630$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240920$$HP$US$US
243417531$24341753$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010631$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240920$$HP$US$US
243417542$24341754$2$F$20240918$20240930$20240920$20240930$PER$$US-AMGEN-USASP2024186900$AMGEN$$80$YR$E$F$Y$$$20240930$$CN$US$US
243417551$24341755$1$I$$20240911$20240920$20240920$EXP$$CA-APOTEX-2024AP010536$APOTEX$$44$YR$$F$Y$$$20240920$$HP$CA$CA
243417561$24341756$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010635$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240920$$HP$US$US
243417571$24341757$1$I$20240701$20240830$20240920$20240920$PER$$US-SA-2024SA270876$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240920$$MD$US$US
243417581$24341758$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA269017$SANOFI AVENTIS$$$$$F$Y$$$20240920$$CN$US$US
243417591$24341759$1$I$20240801$20240829$20240920$20240920$PER$$US-SA-2024SA269250$SANOFI AVENTIS$$59$YR$A$F$Y$63.64$KG$20240920$$MD$US$US
243417601$24341760$1$I$$20240905$20240920$20240920$PER$$US-SA-2024SA271248$SANOFI AVENTIS$$60$YR$A$$Y$$$20240920$$CN$US$US
243417611$24341761$1$I$20200501$20240916$20240920$20240920$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051855$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240920$$MD$PL$PL
243417621$24341762$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5928398$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243417631$24341763$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010636$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240920$$HP$US$US
243417641$24341764$1$I$$20240918$20240920$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU081422$SANDOZ$$16$YR$$M$Y$$$20240920$$CN$AU$AU
243417651$24341765$1$I$$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024185143$AMGEN$$$$$F$Y$$$20240920$$CN$US$US
243417671$24341767$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010637$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240920$$HP$US$US
243417681$24341768$1$I$$20240910$20240920$20240920$EXP$$CA-APOTEX-2024AP010463$APOTEX$$$$$M$Y$$$20240920$$MD$CA$CA
243417691$24341769$1$I$20240101$20240911$20240920$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028810$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240920$$$US$US
243417701$24341770$1$I$$20240918$20240920$20240920$PER$$NVSC2024US187279$NOVARTIS$$$$$F$Y$$$20240920$$MD$US$US
243417712$24341771$2$F$$20240924$20240920$20240928$EXP$$US-ABBVIE-5928849$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243417721$24341772$1$I$20240501$20240918$20240920$20240920$EXP$$DE-ABBVIE-5930719$ABBVIE$$79$YR$$M$Y$$$20240920$$CN$DE$DE
243417731$24341773$1$I$20240713$20240906$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045346$AUROBINDO$$33$YR$$F$Y$$$20240920$$MD$FR$FR
243417742$24341774$2$F$20240101$20240920$20240920$20240925$EXP$$US-SA-2024SA270002$SANOFI AVENTIS$$11$YR$C$M$Y$61.224$KG$20240925$$MD$US$US
243417751$24341775$1$I$20240901$20240917$20240920$20240920$EXP$$US-ABBVIE-5928820$ABBVIE$$44$YR$$M$Y$$$20240920$$CN$US$US
243417761$24341776$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010638$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240920$$HP$US$US
243417771$24341777$1$I$$20240910$20240920$20240920$EXP$$NG-NOVITIUMPHARMA-2024NGNVP01896$NOVITIUM PHARMA$Juliet I Mmerem.Monkeypox and chickenpox co-infection in a person living with Human Immunodeficiency Virus.The Journal of Infection in Developing Countries.29-JUL-2024;18(7):1152-1156$30$YR$A$M$Y$$$20240920$$HP$NG$NG
243417781$24341778$1$I$$20240916$20240920$20240920$EXP$$US-JNJFOC-20240947273$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243417791$24341779$1$I$$20240912$20240920$20240920$EXP$$GB-JNJFOC-20240943666$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240920$$CN$GB$GB
243417801$24341780$1$I$$20240917$20240920$20240920$EXP$$FR-JNJFOC-20240947538$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$CN$FR$FR
243417811$24341781$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010898$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243417821$24341782$1$I$$20240906$20240920$20240920$EXP$$BE-AUROBINDO-AUR-APL-2024-045248$AUROBINDO$$74$YR$$F$Y$$$20240920$$MD$BE$BE
243417831$24341783$1$I$20000101$20240916$20240920$20240920$EXP$$SE-SANDOZ INC.-PHHY2018SE076523$SANDOZ$$32$YR$$F$Y$39$KG$20240920$$MD$SE$SE
243417841$24341784$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010639$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240920$$HP$US$US
243417851$24341785$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149529$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240920$$CN$US$US
243417861$24341786$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186831$AMGEN$$$$$F$Y$$$20240920$$HP$US$US
243417871$24341787$1$I$$20240912$20240920$20240920$PER$$US-BEH-2024178781$CSL BEHRING$$$$A$F$Y$$$20240920$$CN$US$US
243417891$24341789$1$I$20240717$20240905$20240920$20240920$EXP$$US-Techdow-2024Techdow000128$SHENZHEN TECHDOW PHARMACEUTICAL$$45$YR$A$F$Y$95.71$KG$20240920$$HP$US$US
243417901$24341790$1$I$$20240910$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005461$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243417911$24341791$1$I$$20240830$20240920$20240920$PER$$US-SA-2024SA271508$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240920$$HP$US$US
243417922$24341792$2$F$20240907$20240918$20240920$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005549$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240927$$CN$US$US
243417931$24341793$1$I$20240906$20240906$20240920$20240920$EXP$$CA-SA-2024SA270168$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240920$$CN$CA$CA
243417941$24341794$1$I$20240101$20240906$20240920$20240920$EXP$$US-UCBSA-2024034142$UCB$$$$$M$Y$$$20240920$$CN$US$US
243417951$24341795$1$I$$20240911$20240920$20240920$EXP$$JP-SANDOZ INC.-SDZ2024JP081425$SANDOZ$Sato K, Shindo H, Tomita A.. [Why Tohoku? That^s why Tohoku!] The Attractiveness of  Breast Cancer Treatment in Tohoku Learned through Renal  Impairment [Muttering in the 20th year].. Program and Abstracts of the 21st Tohoku Regional Meeting of the Japanese Breast. 2024;O5-4$$$A$$Y$$$20240920$$HP$JP$JP
243417961$24341796$1$I$20220905$20240916$20240920$20240920$EXP$$CN-CHEPLA-2022011231$CHEPLAPHARM$$53$YR$$F$Y$59$KG$20240920$$MD$COUNTRY NOT SPECIFIED$CN
243417971$24341797$1$I$20240901$20240912$20240920$20240920$PER$$US-JNJFOC-20240935040$JOHNSON AND JOHNSON$$89$YR$E$M$Y$$$20240920$$CN$US$US
243417991$24341799$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA269733$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240920$$CN$US$US
243418001$24341800$1$I$20240101$20240830$20240920$20240920$PER$$US-SA-2024SA270895$SANOFI AVENTIS$$78$YR$E$F$Y$74.376$KG$20240920$$MD$US$US
243418011$24341801$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA271229$SANOFI AVENTIS$$$$A$M$Y$$$20240920$$CN$US$US
243418021$24341802$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA268045$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240920$$MD$US$US
243418031$24341803$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010600$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243418041$24341804$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112662$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243418051$24341805$1$I$20240101$20240916$20240920$20240920$EXP$$US-ABBVIE-5928011$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243418061$24341806$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149466$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240920$$CN$US$US
243418071$24341807$1$I$20240729$20240916$20240920$20240920$EXP$$DE-AMGEN-DEUSP2024187316$AMGEN$$66$YR$E$F$Y$65$KG$20240920$$MD$DE$DE
243418081$24341808$1$I$20240101$20240911$20240920$20240920$EXP$$US-ENDO USA, INC.-2024-003458$ENDO$$$$$M$Y$$$20240920$$MD$US$US
243418091$24341809$1$I$20240910$20240910$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005513$ACADIA PHARMACEUTICALS$$91$YR$$F$Y$$$20240920$$CN$US$US
243418101$24341810$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010899$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243418113$24341811$3$F$$20240926$20240920$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US081343$SANDOZ$$$$$M$Y$$$20240930$$CN$US$US
243418121$24341812$1$I$20240101$20240918$20240920$20240920$EXP$$US-ORGANON-O2409USA001443$ORGANON$$$$$F$Y$$$20240920$$HP$US$US
243418131$24341813$1$I$$20240917$20240920$20240920$EXP$$VN-JNJFOC-20240951291$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$HP$VN$VN
243418141$24341814$1$I$$20240909$20240920$20240920$PER$$US-APOTEX-2024AP010601$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240920$$HP$US$US
243418151$24341815$1$I$20240501$20240906$20240920$20240920$EXP$$US-UCBSA-2024039665$UCB$$78$YR$$F$Y$$$20240920$$CN$US$US
243418161$24341816$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024AMR112915$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$CN$US$US
243418171$24341817$1$I$$20240909$20240920$20240920$EXP$CA-HEALTHCANVIG-E2B_06318856$CA-NOVOPROD-1282624$NOVO NORDISK$$39$YR$$M$Y$$$20240920$$HP$CA$CA
243418182$24341818$2$F$20230509$20240918$20240920$20240930$EXP$$JP-GSK-JP2024JPN034740$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$JP$JP
243418191$24341819$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA267494$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243418201$24341820$1$I$$20240830$20240920$20240920$PER$$US-SA-2024SA270898$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240920$$MD$US$US
243418211$24341821$1$I$$20240830$20240920$20240920$PER$$US-SA-2024SA270932$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240920$$HP$US$US
243418231$24341823$1$I$20240701$20240828$20240920$20240920$PER$$US-SA-2024SA267725$SANOFI AVENTIS$$$$A$M$Y$83.18$KG$20240920$$MD$US$US
243418241$24341824$1$I$20240101$20240912$20240920$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-029061$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240920$$$US$US
243418251$24341825$1$I$20240901$20240914$20240920$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-029184$UNITED THERAPEUTICS$$54$YR$$F$Y$81.633$KG$20240920$$$US$US
243418261$24341826$1$I$20170101$20240909$20240920$20240920$EXP$$US-NOVOPROD-1282714$NOVO NORDISK$$51$YR$$M$Y$$$20240920$$CN$US$US
243418272$24341827$2$F$20230101$20240917$20240920$20240925$EXP$$US-CIPLA LTD.-2024US09942$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243418281$24341828$1$I$$20240909$20240920$20240920$EXP$$DE-NOVOPROD-1281923$NOVO NORDISK$$$$$F$Y$$$20240920$$MD$DE$DE
243418291$24341829$1$I$20230101$20240909$20240920$20240920$EXP$$US-NOVOPROD-1282970$NOVO NORDISK$$81$YR$$M$Y$$$20240920$$CN$US$US
243418301$24341830$1$I$20240905$20240909$20240920$20240920$EXP$$US-NOVOPROD-1282699$NOVO NORDISK$$72$YR$$M$Y$$$20240920$$CN$US$US
243418311$24341831$1$I$20240701$20240909$20240920$20240920$EXP$NO-NOMAADVRE-RELISSO-2024-Vkq3n6$NO-NOVOPROD-1280177$NOVO NORDISK$$62$YR$$M$Y$$$20240920$$MD$NO$NO
243418321$24341832$1$I$20240904$20240909$20240920$20240920$EXP$CN-NMPA-3610021060959202400068$CN-NOVOPROD-1281833$NOVO NORDISK$$73$YR$$M$Y$56$KG$20240920$$HP$CN$CN
243418331$24341833$1$I$$20240909$20240920$20240920$EXP$$US-NOVOPROD-1282730$NOVO NORDISK$$$$$$Y$$$20240920$$CN$US$US
243418341$24341834$1$I$$20240909$20240920$20240920$EXP$$DE-NOVOPROD-1281921$NOVO NORDISK$$$$$F$Y$$$20240920$$MD$DE$DE
243418361$24341836$1$I$20240201$20240909$20240920$20240920$EXP$RS-ALIMS-300040272$RS-NOVOPROD-1280702$NOVO NORDISK$$62$YR$$M$Y$105$KG$20240920$$HP$RS$RS
243418371$24341837$1$I$$20240909$20240920$20240920$EXP$$US-NOVOPROD-1282972$NOVO NORDISK$$$$$F$Y$$$20240920$$CN$US$US
243418381$24341838$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010900$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243418391$24341839$1$I$$20240906$20240920$20240920$EXP$$CA-UCBSA-2024046370$UCB$$$$$M$Y$$$20240920$$CN$CA$CA
243418401$24341840$1$I$$20240715$20240920$20240920$EXP$$ES-ABBVIE-5926093$ABBVIE$$$$$$Y$$$20240920$$MD$ES$ES
243418411$24341841$1$I$20240913$20240913$20240920$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-148912$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240920$$MD$JP$JP
243418421$24341842$1$I$$20240917$20240920$20240920$EXP$$US-NALPROPION PHARMACEUTICALS INC.-US-2024CUR004196$CURRAX PHARMACEUTICALS$$$$$$Y$$$20240920$$MD$US$US
243418431$24341843$1$I$$20240917$20240920$20240920$EXP$$US-SANDOZ INC.-SDZ2024US081042$SANDOZ$$$$$F$Y$$$20240920$$CN$US$US
243418441$24341844$1$I$20240917$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024185847$AMGEN$$43$YR$A$F$Y$$$20240920$$CN$US$US
243418451$24341845$1$I$$20240912$20240920$20240920$EXP$$US-Sprout Pharmaceuticals, Inc.-2024SP000277$SPROUT PHARMACEUTICALS$$$$A$F$Y$$$20240917$$CN$US$US
243418461$24341846$1$I$20240917$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186772$AMGEN$$43$YR$A$F$Y$$$20240920$$CN$US$US
243418471$24341847$1$I$20240228$20240919$20240920$20240920$EXP$GB-MHRA-MED-202409171124586580-FTHPR$GB-SANDOZ INC.-SDZ2024GB081557$SANDOZ$$63$YR$$M$Y$99$KG$20240920$$PH$GB$GB
243418482$24341848$2$F$$20240917$20240920$20240926$EXP$$AU-NOVOPROD-1281948$NOVO NORDISK$$64$YR$$M$Y$$$20240926$$MD$AU$AU
243418491$24341849$1$I$20240201$20240909$20240920$20240920$EXP$$US-NOVOPROD-1281991$NOVO NORDISK$$74$YR$$F$Y$$$20240920$$CN$US$US
243418501$24341850$1$I$$20240909$20240920$20240920$EXP$$US-NOVOPROD-1282423$NOVO NORDISK$$64$YR$$$Y$$$20240920$$CN$US$US
243418521$24341852$1$I$20240601$20240909$20240920$20240920$EXP$$US-NOVOPROD-1282340$NOVO NORDISK$$76$YR$$F$Y$$$20240920$$CN$US$US
243418531$24341853$1$I$$20240910$20240920$20240920$EXP$$CA-APOTEX-2024AP010466$APOTEX$$59$YR$$M$Y$$$20240920$$PH$CA$CA
243418541$24341854$1$I$$20240909$20240920$20240920$EXP$CA-HEALTHCANVIG-001100630$CA-NOVOPROD-1282449$NOVO NORDISK$$63$YR$$F$Y$$$20240920$$PH$CA$CA
243418562$24341856$2$F$$20240918$20240920$20240923$EXP$$TH-JNJFOC-20240944510$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$MD$TH$TH
243418571$24341857$1$I$20240908$20240909$20240920$20240920$EXP$$CO-RECORDATI RARE DISEASE INC.-2024007017$RECORDATI$$$$$$Y$$$20240920$$CN$CO$CO
243418581$24341858$1$I$$20240909$20240920$20240920$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004512$Unknown Manufacturer$$$$$$Y$$$20240918$$CN$US$US
243418591$24341859$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010760$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243418601$24341860$1$I$$20240910$20240920$20240920$EXP$GB-MHRA-MED-202409102349253270-YZNMC$GB-Accord-446413$ACCORD$$$$$M$Y$$$20240920$$CN$GB$GB
243418612$24341861$2$F$$20240918$20240920$20240926$PER$$US-AMGEN-USASP2024187210$AMGEN$$$$$$Y$$$20240926$$HP$US$US
243418621$24341862$1$I$20240701$20240911$20240920$20240920$30DAY$$US-GSK-US2024113052$GLAXOSMITHKLINE$$68$YR$$F$Y$$$20240920$$HP$US$US
243418631$24341863$1$I$$20240911$20240920$20240920$PER$$US-ABBVIE-5921175$ABBVIE$$$$$$Y$$$20240920$$MD$US$US
243418642$24341864$2$F$20240301$20240913$20240920$20240924$EXP$$CO-AKCEA THERAPEUTICS, INC.-2024IS006478$AKCEA THERAPEUTICS$$$$$$Y$$$20240923$$CN$CO$CO
243418651$24341865$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010901$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243418661$24341866$1$I$$20240919$20240920$20240920$PER$$NVSC2024US187296$NOVARTIS$$$$$F$Y$$$20240920$$HP$US$US
243418672$24341867$2$F$20240917$20240918$20240920$20240925$PER$$US-AMGEN-USASP2024186776$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243418681$24341868$1$I$20240912$20240913$20240920$20240920$EXP$GB-MHRA-MED-202409131616393160-ZJYMV$GB-AMGEN-GBRSP2024183828$AMGEN$$75$YR$E$M$Y$$$20240920$$HP$GB$GB
243418692$24341869$2$F$20240724$20240918$20240920$20240927$EXP$$FR-Rhythm Pharmaceuticals, Inc.-2024RHM000453$RHYTHM PHARMACEUTICALS$$34$YR$A$M$Y$142$KG$20240927$$MD$FR$FR
243418701$24341870$1$I$$20240910$20240920$20240920$EXP$$JP-AMGEN-JPNCT2024183756$AMGEN$Shibahara D, Tanaka K, Togao O, Shiraishi Y, Yoneshima Y, lwama E,et al.. Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer. Clinical Lung Cancer. 2024;25:581-6$77$YR$E$M$Y$$$20240920$$MD$JP$JP
243418711$24341871$1$I$20220301$20240911$20240920$20240920$PER$$US-BEH-2024178760$CSL BEHRING$$48$YR$A$F$Y$$$20240920$$HP$US$US
243418721$24341872$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112663$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243418731$24341873$1$I$20240101$20240911$20240920$20240920$EXP$$JP-RECORDATI RARE DISEASE INC.-2024003691$RECORDATI$$$$$$Y$$$20240920$$MD$JP$JP
243418741$24341874$1$I$$20240907$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-044843$AUROBINDO$$$$$F$Y$$$20240920$$CN$GB$GB
243418751$24341875$1$I$20240805$20240907$20240920$20240920$EXP$$GB-CIPLA LTD.-2024GB09960$CIPLA$$$$$$Y$$$20240920$$HP$GB$GB
243418761$24341876$1$I$20190101$20240911$20240920$20240920$EXP$$US-JNJFOC-20240929573$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240920$$CN$US$US
243418771$24341877$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010759$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243418781$24341878$1$I$$20240910$20240920$20240920$EXP$GB-MHRA-MED-202409101118526150-PLFBG$GB-Accord-446403$ACCORD$$$$$M$Y$$$20240920$$PH$GB$GB
243418801$24341880$1$I$$20240827$20240920$20240920$PER$$US-SA-2024SA266966$SANOFI AVENTIS$$$$A$F$Y$75$KG$20240920$$MD$US$US
243418811$24341881$1$I$20240905$20240906$20240920$20240920$PER$$US-SA-2024SA270200$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240920$$MD$US$US
243418821$24341882$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268979$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240920$$HP$US$US
243418831$24341883$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024113001$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$MD$US$US
243418841$24341884$1$I$20210802$20240909$20240920$20240920$EXP$$NVSC2021CH180514$NOVARTIS$$77$YR$$F$Y$$$20240920$$MD$CH$CH
243418861$24341886$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187232$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243418881$24341888$1$I$20240915$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186997$AMGEN$$76$YR$E$M$Y$$$20240920$$CN$US$US
243418891$24341889$1$I$20170508$20240911$20240920$20240920$EXP$$IT-TEVA-202311_00014623$TEVA$$93$YR$$F$Y$$$20240920$$MD$IT$IT
243418901$24341890$1$I$20240701$20240911$20240920$20240920$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043328$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$$$20240920$$CN$US$US
243418911$24341891$1$I$20240811$20240909$20240920$20240920$EXP$$PT-AUROBINDO-AUR-APL-2024-045578$AUROBINDO$$54$YR$$F$Y$$$20240920$$MD$PT$PT
243418921$24341892$1$I$20240101$20240918$20240920$20240920$EXP$$MX-JNJFOC-20240951842$JOHNSON AND JOHNSON$$25$YR$A$F$Y$54$KG$20240920$$CN$MX$MX
243418931$24341893$1$I$$20240918$20240920$20240920$EXP$$NVSC2024US187432$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243418941$24341894$1$I$$20240917$20240920$20240920$PER$$US-HALEON-2197425$Haleon PLC$$2$YR$$M$Y$$$20240920$$CN$US$US
243418951$24341895$1$I$20240819$20240910$20240920$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024614$UNITED THERAPEUTICS$$44$YR$$F$Y$63.492$KG$20240920$$$US$US
243418961$24341896$1$I$$20240909$20240920$20240920$EXP$$NL-AUROBINDO-AUR-APL-2024-045575$AUROBINDO$$69$YR$$M$Y$70$KG$20240920$$CN$NL$NL
243418972$24341897$2$F$$20240919$20240920$20240920$PER$$NVSC2024US187698$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243418981$24341898$1$I$20240915$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187085$AMGEN$$76$YR$E$$Y$$$20240920$$CN$US$US
243418991$24341899$1$I$$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045327$AUROBINDO$$$$$M$Y$$$20240920$$HP$GB$GB
243419001$24341900$1$I$$20240911$20240920$20240920$EXP$$CA-HALEON-2197371$Haleon PLC$$70$YR$$F$Y$$$20240919$$HP$CA$CA
243419011$24341901$1$I$20240719$20240905$20240920$20240920$EXP$$US-Techdow-2024Techdow000192$SHENZHEN TECHDOW PHARMACEUTICAL$$84$YR$E$M$Y$76.2$KG$20240920$$HP$US$US
243419021$24341902$1$I$$20240912$20240920$20240920$EXP$$JP-ARGENX-2024-ARGX-JP007781$ARGENX BVBA$$$$$$Y$$$20240920$$CN$JP$JP
243419031$24341903$1$I$$20240912$20240920$20240920$EXP$$CA-TAKEDA-2023TUS023938$TAKEDA$$$$$F$Y$$$20240920$$CN$CA$CA
243419041$24341904$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112676$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$CN$US$US
243419051$24341905$1$I$20240914$20240914$20240920$20240920$EXP$$US-Calliditas-2024CAL01890$CALLIDITAS THERAPEUTICS$$65$YR$A$F$Y$80.2$KG$20240920$$CN$US$US
243419061$24341906$1$I$20240301$20240911$20240920$20240920$EXP$$US-CHATTEMPRD-2024OHG031942$CHATTEM$$74$YR$E$M$Y$$$20240920$$LW$US$US
243419071$24341907$1$I$20240915$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187176$AMGEN$$82$YR$E$F$Y$$$20240920$$CN$US$US
243419081$24341908$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148996$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240920$$HP$US$US
243419091$24341909$1$I$20240918$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187230$AMGEN$$$$$$Y$$$20240920$$HP$US$US
243419101$24341910$1$I$$20240917$20240920$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015429$JAZZ$$$$$M$Y$$$20240920$$CN$US$US
243419111$24341911$1$I$20240101$20240918$20240920$20240920$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-015386$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$$$20240920$$CN$JP$JP
243419121$24341912$1$I$$20240913$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013595$DR REDDYS$Lemonjava I, Manzanoe JM, Sultan S, Bhat R, Minimo C, Azmaiparashvili Z, et al. 72-year-old man with acute lung injury and anti-melanoma differentiation-associated gene 5 antibody: A case report. Respiratory Medicine Case Reports. 2024;51: doi:10.1016/j.rmcr.2024.102098.$72$YR$E$F$Y$$$20240920$$HP$US$US
243419131$24341913$1$I$20231002$20240913$20240920$20240920$EXP$$US-CHATTEMPRD-2024OHG032191$CHATTEM$$75$YR$E$M$Y$$$20240920$$LW$US$US
243419141$24341914$1$I$20230901$20240910$20240920$20240920$EXP$$US-NOVOPROD-1283427$NOVO NORDISK$$50$YR$$F$Y$$$20240920$$CN$US$US
243419151$24341915$1$I$20240801$20240905$20240920$20240920$EXP$$CA-TEVA-VS-3241761$TEVA$$29$YR$$F$Y$$$20240920$$HP$CA$CA
243419161$24341916$1$I$20240812$20240910$20240920$20240920$EXP$RU-RZN-2554959$RU-NOVOPROD-1283218$NOVO NORDISK$$63$YR$$F$Y$$$20240920$$HP$RU$RU
243419171$24341917$1$I$$20240910$20240920$20240920$EXP$$US-NOVOPROD-1283657$NOVO NORDISK$$$$A$F$Y$$$20240920$$HP$US$US
243419181$24341918$1$I$20240801$20240910$20240920$20240920$EXP$$CL-NOVOPROD-1277647$NOVO NORDISK$$46$YR$$F$Y$55$KG$20240920$$CN$CL$CL
243419191$24341919$1$I$20240801$20240910$20240920$20240920$EXP$$US-NOVOPROD-1283330$NOVO NORDISK$$69$YR$$M$Y$$$20240920$$CN$US$US
243419201$24341920$1$I$$20240910$20240920$20240920$EXP$$US-NOVOPROD-1283616$NOVO NORDISK$$$$$F$Y$$$20240920$$CN$US$US
243419211$24341921$1$I$$20240910$20240920$20240920$EXP$$US-NOVOPROD-1282914$NOVO NORDISK$$$$$F$Y$$$20240920$$CN$US$US
243419221$24341922$1$I$$20240911$20240920$20240920$EXP$$US-GSK-US2024AMR113818$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$HP$US$US
243419231$24341923$1$I$20240628$20240913$20240920$20240920$EXP$$US-CHATTEMPRD-2024OHG032095$CHATTEM$$76$YR$E$$Y$$$20240920$$LW$US$US
243419241$24341924$1$I$$20240913$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409009452$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240920$$CN$US$US
243419251$24341925$1$I$19720101$20240913$20240920$20240920$EXP$$US-CHATTEMPRD-2024OHG032088$CHATTEM$$$$A$M$Y$$$20240920$$LW$US$US
243419261$24341926$1$I$20240918$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187167$AMGEN$$$$$$Y$$$20240920$$HP$US$US
243419271$24341927$1$I$$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045461$AUROBINDO$$56$YR$$M$Y$$$20240920$$PH$GB$GB
243419281$24341928$1$I$20190927$20240916$20240920$20240920$EXP$$CA-TAKEDA-2024TUS092679$TAKEDA$$68$YR$$M$Y$$$20240920$$CN$CA$CA
243419291$24341929$1$I$20240916$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186524$AMGEN$$75$YR$E$F$Y$$$20240920$$CN$US$US
243419301$24341930$1$I$20240101$20240916$20240920$20240920$EXP$$US-ABBVIE-5927038$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243419311$24341931$1$I$20240101$20240916$20240920$20240920$EXP$$US-ABBVIE-5878613$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243419321$24341932$1$I$20240101$20240916$20240920$20240920$EXP$$US-ABBVIE-5807986$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243419331$24341933$1$I$20230925$20240911$20240920$20240920$EXP$$DE-CELLTRION INC.-2024DE022216$CELLTRION$$$$$$Y$$$20240920$$MD$DE$DE
243419341$24341934$1$I$$20240916$20240920$20240920$EXP$$US-CHATTEMPRD-2024OHG032282$CHATTEM$$$$$M$Y$$$20240920$$LW$US$US
243419351$24341935$1$I$$20240910$20240920$20240920$EXP$$CA-APOTEX-2024AP010509$APOTEX$$41$YR$$F$Y$$$20240920$$CN$CA$CA
243419361$24341936$1$I$20240801$20240917$20240920$20240920$EXP$FR-AFSSAPS-TO2024001540$FR-ORGANON-O2408FRA000957$ORGANON$$78$YR$$F$Y$51$KG$20240920$$PH$FR$FR
243419371$24341937$1$I$$20240913$20240920$20240920$EXP$$CL-JNJFOC-20240941439$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240920$$CN$CL$CL
243419381$24341938$1$I$20240409$20240917$20240920$20240920$EXP$$US-JNJFOC-20240675400$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240920$$CN$US$US
243419391$24341939$1$I$20240916$20240916$20240920$20240920$PER$$US-JNJFOC-20240940594$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243419401$24341940$1$I$$20240830$20240920$20240920$PER$$US-SA-2024SA269675$SANOFI AVENTIS$$$$I$F$Y$$$20240920$$MD$US$US
243419411$24341941$1$I$20240822$20240822$20240920$20240920$PER$$US-SA-2024SA270719$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240920$$CN$US$US
243419421$24341942$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA269299$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240920$$MD$US$US
243419431$24341943$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA266835$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243419441$24341944$1$I$20240901$20240911$20240920$20240920$PER$$US-SA-2024SA265999$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240920$$HP$US$US
243419451$24341945$1$I$20240101$20240905$20240920$20240920$EXP$$US-SA-2024SA269834$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240920$$MD$US$US
243419461$24341946$1$I$20240907$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045386$AUROBINDO$$43$YR$$F$Y$$$20240920$$CN$GB$GB
243419471$24341947$1$I$20240801$20240915$20240920$20240920$PER$$US-SA-2024SA269726$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240920$$MD$US$US
243419481$24341948$1$I$$20240909$20240920$20240920$EXP$$DE-Encube-001328$ENCUBE ETHICALS$Hoffmann E, Toepell A, Peter A, Boke S, De-Colle C, Steinle M, Niyazi M, Gani C. Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy. Strahlenther Onkol. 2024 Sep 4. doi: 10.1007/s00066-024-02287-7.$$$$$Y$$$20240919$$MD$DE$
243419491$24341949$1$I$20240902$20240914$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014669$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243419501$24341950$1$I$20240911$20240911$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013598$DR REDDYS$$16$YR$T$$Y$$$20240920$$MD$US$US
243419511$24341951$1$I$$20240912$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013585$DR REDDYS$$31$YR$A$M$Y$$$20240920$$MD$US$US
243419521$24341952$1$I$20240910$20240910$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013533$DR REDDYS$$16$YR$T$F$Y$$$20240920$$CN$US$US
243419531$24341953$1$I$$20240911$20240920$20240920$EXP$$FR-TAKEDA-2024TUS092868$TAKEDA$$$$E$M$Y$$$20240920$$CN$FR$FR
243419541$24341954$1$I$$20240919$20240920$20240920$PER$$NVSC2024US187477$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243419561$24341956$1$I$20240819$20240906$20240920$20240920$PER$$US-SA-2024SA269333$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240920$$MD$US$US
243419571$24341957$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA267645$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240920$$MD$US$US
243419581$24341958$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA144676$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240920$$HP$US$US
243419591$24341959$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267879$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240920$$HP$US$US
243419601$24341960$1$I$20240101$20240828$20240920$20240920$PER$$US-SA-2024SA267093$SANOFI AVENTIS$$69$YR$E$M$Y$118.18$KG$20240920$$MD$US$US
243419611$24341961$1$I$20240819$20240906$20240920$20240920$PER$$US-SA-2024SA269039$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240920$$CN$US$US
243419621$24341962$1$I$20240901$20240911$20240920$20240920$PER$$US-SA-2024SA266657$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240920$$HP$US$US
243419631$24341963$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA213571$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240920$$MD$US$US
243419641$24341964$1$I$20240830$20240830$20240920$20240920$PER$$US-SA-2024SA270857$SANOFI AVENTIS$$24$YR$A$F$Y$59.09$KG$20240920$$MD$US$US
243419651$24341965$1$I$$20240906$20240920$20240920$PER$$US-JNJFOC-20240916956$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
243419661$24341966$1$I$$20240916$20240920$20240920$EXP$NL-LRB-01003454$NL-CHEPLA-2024011850$CHEPLAPHARM$$30$YR$$M$Y$70$KG$20240920$$MD$COUNTRY NOT SPECIFIED$NL
243419681$24341968$1$I$20230701$20240911$20240920$20240920$EXP$DE-CADRBFARM-2024330270$DE-TEVA-VS-3242877$TEVA$$47$YR$$M$Y$77$KG$20240920$$CN$DE$DE
243419691$24341969$1$I$$20240911$20240920$20240920$EXP$$FR-TAKEDA-2024TUS092870$TAKEDA$$$$E$M$Y$$$20240920$$CN$FR$FR
243419701$24341970$1$I$$20240915$20240920$20240920$EXP$$AU-ASTELLAS-2024-AER-007883$ASTELLAS$$$$E$F$Y$$$20240920$$MD$AU$AU
243419721$24341972$1$I$$20240909$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144043$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240920$$CN$US$US
243419731$24341973$1$I$$20240911$20240920$20240920$EXP$$US-NOVOPROD-1284077$NOVO NORDISK$$65$YR$$M$Y$$$20240920$$MD$US$US
243419741$24341974$1$I$$20240911$20240920$20240920$EXP$$AU-NOVOPROD-1283226$NOVO NORDISK$$65$YR$$F$Y$$$20240920$$MD$AU$AU
243419751$24341975$1$I$20240501$20240911$20240920$20240920$EXP$$TR-NOVOPROD-1284605$NOVO NORDISK$$$$$F$Y$$$20240920$$CN$TR$TR
243419761$24341976$1$I$$20240911$20240920$20240920$EXP$$US-NOVOPROD-1284766$NOVO NORDISK$$40$YR$$F$Y$$$20240920$$HP$US$US
243419771$24341977$1$I$$20240913$20240920$20240920$EXP$$BR-NOVOPROD-1284729$NOVO NORDISK$$32$YR$$M$Y$$$20240920$$CN$BR$BR
243419781$24341978$1$I$$20240913$20240920$20240920$EXP$$BR-NOVOPROD-1285024$NOVO NORDISK$$$$$$Y$$$20240920$$CN$BR$BR
243419791$24341979$1$I$20240601$20240911$20240920$20240920$EXP$$US-NOVOPROD-1284929$NOVO NORDISK$$72$YR$$M$Y$$$20240920$$CN$US$US
243419801$24341980$1$I$20240726$20240917$20240920$20240920$EXP$$CO-UCBSA-2024048236$UCB$$71$YR$$F$Y$$$20240920$$CN$CO$CO
243419811$24341981$1$I$20240823$20240914$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014650$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243419821$24341982$1$I$20240422$20240910$20240920$20240920$EXP$GB-MHRA-EMIS-8587-416054e5-83b0-4660-a9c2-896bac20a053$GB-Accord-446369$ACCORD$$72$YR$E$M$Y$77$KG$20240920$$PH$GB$GB
243419831$24341983$1$I$$20240911$20240920$20240920$EXP$$TR-NOVOPROD-1284243$NOVO NORDISK$$$$$M$Y$$$20240920$$CN$TR$TR
243419841$24341984$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187236$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243419851$24341985$1$I$20240101$20240911$20240920$20240920$EXP$$US-NOVOPROD-1283118$NOVO NORDISK$$76$YR$$F$Y$$$20240920$$CN$US$US
243419861$24341986$1$I$$20240909$20240920$20240920$EXP$$PT-STERISCIENCE B.V.-2024-ST-001441$Steriscience PTE$Fraga Dias B, Marques R, Faria V, Domingues P, Ribeiro C, Silvano J, et al.. Renal Artery Stenosis in Living Donor Kidney Transplantation: A Rare Cause of ^Flash Edema^.. Transplant-Proc. 2024;56 (5):1055-1058$37$YR$$M$Y$$$20240920$$MD$PT$PT
243419871$24341987$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5929350$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243419881$24341988$1$I$$20240917$20240920$20240920$EXP$$US-Orion Corporation ORION PHARMA-24_00031740$ORION$Coutinho P, Johnson K.$73$YR$E$M$Y$72.1$KG$20240920$$MD$US$
243419891$24341989$1$I$20240912$20240916$20240920$20240920$EXP$$US-ABBVIE-5929055$ABBVIE$$70$YR$$M$Y$$$20240920$$HP$US$US
243419901$24341990$1$I$$20240904$20240920$20240920$PER$$US-SA-2024SA271473$SANOFI AVENTIS$$49$YR$A$$Y$$$20240920$$CN$US$US
243419911$24341991$1$I$$20240916$20240920$20240920$EXP$$US-SA-2024SA270885$SANOFI AVENTIS$$$$E$M$Y$97.73$KG$20240920$$MD$US$US
243419921$24341992$1$I$$20240904$20240920$20240920$PER$$US-SA-2024SA271356$SANOFI AVENTIS$$66$YR$E$$Y$$$20240920$$HP$US$US
243419931$24341993$1$I$20240101$20240916$20240920$20240920$PER$$US-SA-2024SA270439$SANOFI AVENTIS$$$$C$F$Y$$$20240920$$HP$US$US
243419941$24341994$1$I$$20240904$20240920$20240920$PER$$US-SA-2024SA271223$SANOFI AVENTIS$$44$YR$A$$Y$$$20240920$$CN$US$US
243419951$24341995$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA269209$SANOFI AVENTIS$$$$E$F$Y$$$20240920$$MD$US$US
243419961$24341996$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149506$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240920$$HP$US$US
243419971$24341997$1$I$20240904$20240914$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014651$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243419981$24341998$1$I$$20240918$20240920$20240920$PER$$US-HALEON-2197542$Haleon PLC$$$$$$Y$$$20240920$$CN$US$US
243419991$24341999$1$I$20240728$20240917$20240920$20240920$EXP$$CO-UCBSA-2024048253$UCB$$81$YR$$M$Y$$$20240920$$CN$CO$CO
243420001$24342000$1$I$$20240905$20240920$20240920$PER$$US-JNJFOC-20240950617$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
243420011$24342001$1$I$$20240910$20240920$20240920$PER$$US-ABBVIE-5921462$ABBVIE$$$$$$Y$$$20240920$$CN$US$US
243420021$24342002$1$I$20240101$20240916$20240920$20240920$EXP$$AU-AMGEN-AUSSP2024184983$AMGEN$$$$$F$Y$$$20240920$$HP$AU$AU
243420031$24342003$1$I$$20240915$20240920$20240920$PER$$US-SA-2024SA269202$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$HP$US$US
243420041$24342004$1$I$$20240916$20240920$20240920$PER$$US-SA-2024SA268808$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240920$$MD$US$US
243420051$24342005$1$I$20240101$20240912$20240920$20240920$PER$$US-SA-2024SA151786$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240920$$HP$US$US
243420061$24342006$1$I$20240701$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149368$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240920$$HP$US$US
243420071$24342007$1$I$$20240916$20240920$20240920$EXP$$CA-ABBVIE-5927503$ABBVIE$$$$E$F$Y$$$20240920$$CN$CA$CA
243420081$24342008$1$I$20240918$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187062$AMGEN$$73$YR$E$F$Y$$$20240920$$CN$US$US
243420101$24342010$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010763$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243420111$24342011$1$I$20240901$20240912$20240920$20240920$EXP$$CN-NEBO-669508$PHARMACOSMOS$$$$$$Y$$$20240920$$MD$CN$CN
243420121$24342012$1$I$20240101$20240917$20240920$20240920$EXP$$US-ABBVIE-5669223$ABBVIE$$$$$M$Y$$$20240920$$MD$US$US
243420131$24342013$1$I$20240914$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024185542$AMGEN$$73$YR$E$F$Y$$$20240920$$CN$US$US
243420141$24342014$1$I$20240713$20240917$20240920$20240920$EXP$$CO-UCBSA-2024048237$UCB$$72$YR$$M$Y$$$20240920$$CN$CO$CO
243420151$24342015$1$I$$20240916$20240920$20240920$EXP$$QA-HALEON-2197441$Haleon PLC$RefID 173634: Parammal Alikutty, Jamsheer, Raj, et al. Rhabdomyolysis-Induced Acute Kidney Injury (AKI) in a Young Bodybuilder: A Case Report..?Cureus?.#PY#;15(2):e34625.?https://dx.doi.org/10.7759/cureus.34625 (https://dx.doi.org/10.7759/cureus.34625)?.; Alikutty JP, Raj A, Soofi Sk, Alkhateeb AA, Soliman AA, Al Amiri FR, et.al., Rhabdomyolysis-Induced Acute Kidney Injury (AKI) in a Young Bodybuilder: A?Case Report. Cureus; 2023; 15(2): e34625. DOI: 10.7759/cureus.34625$22$YR$$M$Y$$$20240919$$HP$QA$QA
243420161$24342016$1$I$$20240919$20240920$20240920$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052472$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240920$$CN$US$US
243420171$24342017$1$I$20240902$20240917$20240920$20240920$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-125518$REGENERON$$$$$F$Y$$$20240920$$CN$CA$CA
243420181$24342018$1$I$20240101$20240913$20240920$20240920$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240800098$UPSHER SMITH LABORATORIES$$$$$F$Y$$$20240920$$$US$US
243420191$24342019$1$I$20240915$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024184735$AMGEN$$$$$$Y$$$20240920$$PH$US$US
243420201$24342020$1$I$20240823$20240910$20240920$20240920$EXP$$CN-ASTELLAS-2024-AER-006771$ASTELLAS$$52$YR$A$M$Y$$$20240920$$HP$CN$CN
243420211$24342021$1$I$20231017$20240917$20240920$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU081074$SANDOZ$$69$YR$$M$Y$$$20240920$$HP$AU$AU
243420231$24342023$1$I$$20240916$20240920$20240920$PER$$US-JNJFOC-20240949753$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243420251$24342025$1$I$$20240715$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16206$ALKEM$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, Sancetta B, Boscarino M, Narducci F, Mecarelli O, Ciccozzi M, Di Lazzaro V, Assenza G.. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology. 2024;163:152-159$63$YR$$F$Y$$$20240919$$HP$IT$IT
243420261$24342026$1$I$$20240708$20240920$20240920$EXP$$PL-ALKEM LABORATORIES LIMITED-PL-ALKEM-2024-14889$ALKEM$Wach A, Kosalka-Wegiel J, Korkosz M.. Double trouble: a case of DRESS syndrome induced by lamotrigine and subsequent skin reaction to levetiracetam. Polish Archives of Internal Medicine. 2024;134(6):1-2$21$YR$$F$Y$$$20240919$$MD$PL$PL
243420271$24342027$1$I$$20240715$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16225$ALKEM$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, Sancetta B, Boscarino M, Narducci F, Mecarelli O, Ciccozzi M, Di Lazzaro V, Assenza G. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology. 2024;163:152-159$42$YR$$M$Y$$$20240919$$HP$IT$IT
243420281$24342028$1$I$$20240715$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16222$ALKEM$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, Sancetta B, Boscarino M, Narducci F, Mecarelli O, Ciccozzi M, Di Lazzaro V, Assenza G.. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology. 2024;163:152-159$37$YR$$M$Y$$$20240919$$HP$IT$IT
243420291$24342029$1$I$$20240826$20240920$20240920$EXP$$AE-ALKEM LABORATORIES LIMITED-AE-ALKEM-2024-20645$ALKEM$Alsaadi T, Kassie S, Farook F, Nasreddine W, Wani S, Saleh B. Antiseizure drugs use during pregnancy and congenital malformations: A retrospective review from the United Arab Emirates. Epilepsy Research. 2020;159:106259$$$$F$Y$$$20240919$$HP$AE$AE
243420301$24342030$1$I$$20240715$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16208$ALKEM$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, Sancetta B, Boscarino M, Narducci F, Mecarelli O, Ciccozzi M, Di Lazzaro V, Assenza G.. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology. 2024;163:152-159$25$YR$$F$Y$$$20240919$$HP$IT$IT
243420311$24342031$1$I$$20240810$20240920$20240920$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-19245$ALKEM$Yim SH, Choi YH, Heo K, Cho KH. A case of dyskinesia after levetiracetam administration. BMC Neurol. 2019;19:292$28$YR$$F$Y$$$20240919$$HP$KR$KR
243420321$24342032$1$I$$20240715$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16209$ALKEM$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, Sancetta B, Boscarino M, Narducci F, Mecarelli O, Ciccozzi M, Di Lazzaro V, Assenza G. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology. 2024;163:152-159$44$YR$$F$Y$$$20240919$$HP$IT$IT
243420331$24342033$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17340$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$75$YR$$M$Y$$$20240919$$HP$IT$IT
243420341$24342034$1$I$$20240715$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16218$ALKEM$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, Sancetta B, Boscarino M, Narducci F, Mecarelli O, Ciccozzi M, Di Lazzaro V, Assenza G.. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology. 2024;163:152-159$76$YR$$M$Y$$$20240919$$HP$IT$IT
243420351$24342035$1$I$$20240826$20240920$20240920$EXP$$AE-ALKEM LABORATORIES LIMITED-AE-ALKEM-2024-20651$ALKEM$Alsaadi T, Kassie S, Farook F, Nasreddine W, Wani S, Saleh B. Antiseizure drugs use during pregnancy and congenital malformations: A retrospective review from the United Arab Emirates. Epilepsy Research. 2020;159:106259$$$$F$Y$$$20240919$$HP$AE$AE
243420361$24342036$1$I$$20240812$20240920$20240920$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-19217$ALKEM$Hoeltzenbein M, Slimi S, Fietz A, Stegherr R, Onken M, Beyersmann J, et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$$F$Y$$$20240919$$HP$DE$DE
243420371$24342037$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17344$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$69$YR$$M$Y$$$20240919$$HP$IT$IT
243420381$24342038$1$I$$20240812$20240920$20240920$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-19215$ALKEM$Hoeltzenbein M, Slimi S, Fietz A, Stegherr R, Onken M, Beyersmann J, et al.. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure: European Journal of Epilepsy. 2023;107:107-113$$$$F$Y$$$20240919$$HP$DE$DE
243420391$24342039$1$I$$20240617$20240920$20240920$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-13999$ALKEM$Bhaskaran D, Thomas S, Scaria LM. Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications. Indian Journal of Pediatrics. 2024;unk:unk$$$$F$Y$$$20240919$$HP$IN$IN
243420401$24342040$1$I$$20240725$20240920$20240920$EXP$$FI-ALKEM LABORATORIES LIMITED-FI-ALKEM-2024-17569$ALKEM$Martikainen MH, Paivarinta M, Jaaskelainen S, Majamaa K.. Successful treatment of POLG-related mitochondrial epilepsy with antiepileptic drugs and low glycaemic index diet. Epileptic Disord. 2012;14(4):438-41$26$YR$$F$Y$$$20240919$$HP$FI$FI
243420411$24342041$1$I$$20240718$20240920$20240920$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-15810$ALKEM$Zhu F, Wang WF, Ma CH, Liang H, Jiang YQ.. Resolution of anti-LGI1-associated autoimmune encephalitis in a patient after treatment with efgartigimod. Journal of Neurology. 2024;unk:unk$$$$$Y$$$20240919$$HP$CN$CN
243420421$24342042$1$I$$20240715$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16215$ALKEM$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, Sancetta B, Boscarino M, Narducci F, Mecarelli O, Ciccozzi M, Di Lazzaro V, Assenza G.. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology. 2024;163:152-159$58$YR$$F$Y$$$20240919$$HP$IT$IT
243420431$24342043$1$I$$20240715$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16202$ALKEM$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, Sancetta B, Boscarino M, Narducci F, Mecarelli O, Ciccozzi M, Di Lazzaro V, Assenza G.. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology. 2024;163:152-159$57$YR$$M$Y$$$20240919$$HP$IT$IT
243420441$24342044$1$I$$20240802$20240920$20240920$EXP$$AT-ALKEM LABORATORIES LIMITED-AT-ALKEM-2024-18452$ALKEM$Finsterer J. Intractable Epilepsy in Maternally Inherited Leigh Syndrome (MILS) Due to the Sporadic Variant m.8993T G in MT-ATP6: A Case Report. Cureus. 2022;14(2):e22716$4$YR$$M$Y$$$20240919$$HP$AT$AT
243420452$24342045$2$F$$20240617$20240920$20240920$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-13521$ALKEM$Crispin H, Otway V, Morris R. Subcutaneous lacosamide for continuous focal seizures. BMJ Support Palliat Care. 2024;0:1-2$9$DEC$$$Y$$$20240919$$HP$GB$GB
243420461$24342046$1$I$$20240715$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16226$ALKEM$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, Sancetta B, Boscarino M, Narducci F, Mecarelli O, Ciccozzi M, Di Lazzaro V, Assenza G.. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology. 2024;163:152-159$51$YR$$F$Y$$$20240919$$HP$IT$IT
243420471$24342047$1$I$$20240715$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16620$ALKEM$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, Sancetta B, Boscarino M, Narducci F, Mecarelli O, Ciccozzi M, Di Lazzaro V, Assenza G.. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology. 2024;163:152-159$69$YR$$F$Y$$$20240919$$HP$IT$IT
243420481$24342048$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17336$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$24$YR$$F$Y$$$20240919$$HP$IT$IT
243420491$24342049$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17329$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$25$YR$$F$Y$$$20240919$$HP$IT$IT
243420501$24342050$1$I$$20240715$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16627$ALKEM$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, Sancetta B, Boscarino M, Narducci F, Mecarelli O, Ciccozzi M, Di Lazzaro V, Assenza G.. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology. 2024;163:152-159$23$YR$$M$Y$$$20240919$$HP$IT$IT
243420511$24342051$1$I$$20240715$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-16624$ALKEM$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, Sancetta B, Boscarino M, Narducci F, Mecarelli O, Ciccozzi M, Di Lazzaro V, Assenza G.. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology. 2024;163:152-159$66$YR$$F$Y$$$20240919$$HP$IT$IT
243420521$24342052$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17327$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$64$YR$$M$Y$$$20240919$$HP$IT$IT
243420531$24342053$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17325$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$73$YR$$F$Y$$$20240919$$HP$IT$IT
243420543$24342054$3$F$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17326$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$36$YR$$M$Y$$$20240919$$HP$IT$IT
243420551$24342055$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17332$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$30$YR$$F$Y$$$20240919$$HP$IT$IT
243420561$24342056$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17331$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$69$YR$$M$Y$$$20240919$$HP$IT$IT
243420571$24342057$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17330$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clin Neurophysiol. 2021;132:3035-3042$20$YR$$F$Y$$$20240919$$HP$IT$IT
243420581$24342058$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17343$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$48$YR$$M$Y$$$20240919$$HP$IT$IT
243420592$24342059$2$F$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17341$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$46$YR$$F$Y$$$20240919$$HP$IT$IT
243420601$24342060$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17333$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$38$YR$$F$Y$$$20240919$$HP$IT$IT
243420611$24342061$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17335$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$64$YR$$M$Y$$$20240919$$HP$IT$IT
243420621$24342062$1$I$$20240809$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18890$ALKEM$Solomon D, Gaines D, Peterson LK. Levetiracetam pharmacokinetics in venovenous extracorporeal membrane oxygenation: A case report. Perfusion. 2024;0(0):1-4$40$YR$$F$Y$57.2$KG$20240919$$HP$US$US
243420631$24342063$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17338$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$58$YR$$F$Y$$$20240919$$HP$IT$IT
243420641$24342064$1$I$$20240723$20240920$20240920$EXP$$IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2024-17334$ALKEM$Croce P, Ricci L, Pulitano P, Boscarino M, Zappasodi F, Lanzone J, Narducci F, Mecarelli O, Di Lazzaro V, Tombini M, Assenza G.. Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy. Clinical Neurophysiology. 2021;132:3035-3042$69$YR$$F$Y$$$20240919$$HP$IT$IT
243420651$24342065$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19371$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$F$Y$$$20240919$$MD$US$US
243420661$24342066$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19384$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$F$Y$$$20240919$$MD$US$US
243420671$24342067$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19380$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$M$Y$$$20240919$$MD$US$US
243420681$24342068$1$I$$20240821$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19249$ALKEM$Zhang JF, Piryani R, Swayampakula AK, Farooq O.. Levetiracetam-induced aggression and acute behavioral changes: A case report and literature review. Clinical Case Reports. 2022;10:unk$13$YR$$M$Y$$$20240919$$HP$US$US
243420691$24342069$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19383$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$F$Y$$$20240919$$MD$US$US
243420701$24342070$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19375$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$M$Y$$$20240919$$MD$US$US
243420712$24342071$2$F$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19378$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$F$Y$$$20240919$$MD$US$US
243420721$24342072$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19381$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$F$Y$$$20240919$$MD$US$US
243420731$24342073$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19385$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$M$Y$$$20240919$$MD$US$US
243420741$24342074$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19386$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$F$Y$$$20240919$$MD$US$US
243420751$24342075$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19389$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$M$Y$$$20240919$$MD$US$US
243420761$24342076$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19388$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study.. Pediatric Neurology. 2024;157:134-140$$$N$M$Y$$$20240919$$MD$US$US
243420772$24342077$2$F$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19390$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$M$Y$$$20240919$$MD$US$US
243420781$24342078$1$I$$20240826$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20562$ALKEM$Bamgbose O, Boyle F, Kean AC, Stefanescu BM, Wing S.. Tolerability and Safety of Lacosamide in Neonatal Population. Journal of Child Neurology. 2023;38(3-4):137-141$$$N$F$Y$2.295$KG$20240919$$HP$US$US
243420791$24342079$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19391$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$M$Y$$$20240919$$MD$US$US
243420801$24342080$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010764$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243420811$24342081$1$I$20240717$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045440$AUROBINDO$$$$$M$Y$$$20240920$$HP$GB$GB
243420821$24342082$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19393$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$M$Y$$$20240919$$MD$US$US
243420831$24342083$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148847$BRISTOL MYERS SQUIBB$$40$YR$A$M$Y$69.85$KG$20240920$$CN$US$US
243420841$24342084$1$I$$20240812$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-19392$ALKEM$Chourasia N, Dohmeier J, Curry J, Parkhurst S, Mudigoudar B, Rivas-Coppola M, Wheless J.. Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 2024;157:134-140$$$N$F$Y$$$20240919$$MD$US$US
243420851$24342085$1$I$$20240911$20240920$20240920$EXP$$PL-HALEON-2197032$Haleon PLC$$30$YR$$M$Y$$$20240920$$HP$PL$PL
243420871$24342087$1$I$$20240913$20240920$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-028651$UNITED THERAPEUTICS$$$$$F$Y$61.224$KG$20240920$$$US$US
243420882$24342088$2$F$20210101$20240916$20240920$20240920$PER$$US-GILEAD-2024-0687944$GILEAD$$$$A$M$Y$$$20240920$$MD$US$US
243420891$24342089$1$I$$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024185082$AMGEN$$$$$M$Y$$$20240920$$CN$US$US
243420901$24342090$1$I$$20240910$20240920$20240920$EXP$$US-AMGEN-USASP2024181398$AMGEN$$$$$M$Y$$$20240920$$CN$US$US
243420911$24342091$1$I$$20240913$20240920$20240920$EXP$$DE-ABBVIE-5929846$ABBVIE$$$$$$Y$$$20240920$$MD$DE$DE
243420921$24342092$1$I$$20240830$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08781$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243420941$24342094$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010791$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243420951$24342095$1$I$20200101$20240913$20240920$20240920$EXP$$JP-ASTELLAS-2024-AER-007229$ASTELLAS$$72$YR$E$M$Y$$$20240920$$MD$JP$JP
243420961$24342096$1$I$20220601$20240908$20240920$20240920$EXP$$AR-Accord-446484$ACCORD$Cobenas CJ, Pereyra P, Spizzirri AP, Gauto Santacruz C, Del Carmen Suarez A, Altamirano E, et al. Epstein-Barr virus-associated post-transplant smooth muscle tumours in a kidney transplant patient. Pediatr Nephrol. 2024 Sep 4. doi: 10.1007/s00467-024-06493-4.$14$YR$T$F$Y$$$20240920$$HP$AR$AR
243420971$24342097$1$I$20240811$20240914$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014645$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243420981$24342098$1$I$20240125$20240909$20240920$20240920$EXP$$IT-AUROBINDO-AUR-APL-2024-045543$AUROBINDO$$58$YR$$F$Y$$$20240920$$MD$IT$IT
243420991$24342099$1$I$$20240911$20240920$20240920$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR114552$VIIV$$$$$M$Y$$$20240920$$HP$US$US
243421001$24342100$1$I$20211201$20240910$20240920$20240920$30DAY$$US-GSK-US2024112466$GLAXOSMITHKLINE$$32$YR$$M$Y$$$20240920$$CN$US$US
243421011$24342101$1$I$20240728$20240911$20240920$20240920$EXP$IT-MINISAL02-1000274$IT-TEVA-VS-3242925$TEVA$$85$YR$$F$Y$$$20240920$$MD$IT$IT
243421021$24342102$1$I$20240830$20240906$20240920$20240920$EXP$$CN-Techdow-J2024HPR000564$SHENZHEN TECHDOW PHARMACEUTICAL$$77$YR$E$M$Y$$$20240920$$MD$CN$CN
243421031$24342103$1$I$20240713$20240917$20240920$20240920$EXP$$CO-UCBSA-2024048234$UCB$$86$YR$$F$Y$$$20240920$$CN$CO$CO
243421051$24342105$1$I$20240904$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045474$AUROBINDO$$89$YR$$M$Y$$$20240920$$PH$GB$GB
243421061$24342106$1$I$$20231106$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-14718$ALKEM$$$$$F$Y$$$20240920$$CN$US$US
243421071$24342107$1$I$$20240415$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06978$ALKEM$$$$$F$Y$$$20240920$$CN$US$US
243421081$24342108$1$I$$20240329$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06995$ALKEM$$$$$F$Y$$$20240920$$CN$US$US
243421091$24342109$1$I$20240404$20240404$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-08311$ALKEM$$54$YR$$F$Y$$$20240920$$CN$US$US
243421101$24342110$1$I$$20240412$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06984$ALKEM$$$$$F$Y$$$20240920$$CN$US$US
243421111$24342111$1$I$$20230815$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-09367$ALKEM$$$$$F$Y$$$20240920$$CN$US$US
243421121$24342112$1$I$$20240329$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-06970$ALKEM$$$$$M$Y$$$20240920$$CN$US$US
243421131$24342113$1$I$20240912$20240912$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013514$DR REDDYS$$68$YR$E$M$Y$$$20240920$$HP$US$US
243421141$24342114$1$I$20240101$20240916$20240920$20240920$EXP$$US-SA-2024SA270219$SANOFI AVENTIS$$$$E$M$Y$$$20240920$$HP$US$US
243421151$24342115$1$I$20210627$20240905$20240920$20240920$EXP$$FR-SERVIER-S21010562$SERVIER$$$$$$Y$$$20240920$$MD$FR$FR
243421161$24342116$1$I$$20240916$20240920$20240920$EXP$$US-JNJFOC-20240948476$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240920$$CN$US$US
243421171$24342117$1$I$20240702$20240909$20240920$20240920$EXP$$HR-AUROBINDO-AUR-APL-2024-045516$AUROBINDO$$16$YR$$F$Y$$$20240920$$MD$HR$HR
243421181$24342118$1$I$$20240910$20240920$20240920$EXP$GB-MHRA-MED-202409101721416010-SRBZJ$GB-TEVA-VS-3242889$TEVA$$$$$F$Y$$$20240920$$HP$GB$GB
243421191$24342119$1$I$$20240918$20240920$20240920$EXP$$US-ABBVIE-5930079$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243421201$24342120$1$I$$20240910$20240920$20240920$EXP$IT-MINISAL02-1001243$IT-Accord-446359$ACCORD$$58$YR$A$M$Y$78$KG$20240920$$HP$IT$IT
243421211$24342121$1$I$20240101$20240916$20240920$20240920$EXP$$US-ABBVIE-5926364$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243421221$24342122$1$I$$20240911$20240920$20240920$EXP$$CA-BEH-2024174012$CSL BEHRING$$73$YR$E$M$Y$98$KG$20240920$$CN$CA$CA
243421231$24342123$1$I$$20240910$20240920$20240920$EXP$$GB-TEVA-VS-3242475$TEVA$$51$YR$$F$Y$$$20240920$$CN$GB$GB
243421242$24342124$2$F$20240910$20240924$20240920$20240925$EXP$$JP-SA-2024SA270444$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240926$$MD$JP$JP
243421251$24342125$1$I$20240101$20240906$20240920$20240920$PER$$US-SA-2024SA269042$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240920$$CN$US$US
243421261$24342126$1$I$$20240916$20240920$20240920$PER$$US-SA-2024SA271147$SANOFI AVENTIS$$$$T$M$Y$$$20240920$$HP$US$US
243421271$24342127$1$I$20240901$20240911$20240920$20240920$PER$$US-SA-2024SA266739$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240920$$MD$US$US
243421281$24342128$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA269283$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240920$$CN$US$US
243421291$24342129$1$I$$20240910$20240920$20240920$EXP$$CA-HALEON-2196999$Haleon PLC$$40$YR$$F$Y$$$20240920$$HP$CA$CA
243421301$24342130$1$I$$20240913$20240920$20240920$EXP$$CA-BEH-2023154549$CSL BEHRING$$78$YR$E$F$Y$59$KG$20240920$$CN$CA$CA
243421311$24342131$1$I$$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148532$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240920$$CN$US$US
243421321$24342132$1$I$20190101$20240916$20240920$20240920$EXP$$BE-SANDOZ INC.-NVSC2021BE123026$SANDOZ$$63$YR$$F$Y$$$20240920$$HP$BE$BE
243421331$24342133$1$I$20240913$20240913$20240920$20240920$EXP$$DK-ABBVIE-5929725$ABBVIE$$$$$F$Y$$$20240920$$CN$DK$DK
243421341$24342134$1$I$$20240916$20240920$20240920$EXP$$US-ABBVIE-5930508$ABBVIE$$$$$$Y$$$20240920$$MD$US$US
243421351$24342135$1$I$20231201$20240916$20240920$20240920$EXP$$CA-ABBVIE-5927546$ABBVIE$$$$A$M$Y$$$20240920$$HP$CA$CA
243421361$24342136$1$I$20240918$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187298$AMGEN$$76$YR$E$F$Y$$$20240920$$CN$US$US
243421371$24342137$1$I$20240917$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186861$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243421391$24342139$1$I$$20240916$20240920$20240920$PER$$US-ABBVIE-5927818$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243421411$24342141$1$I$$20240917$20240920$20240920$EXP$$ES-INDOCO-IND-2024-ES-LIT-00113$INDOCO$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Forns X etal.,.Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.Liver International.FEB-2024;44(2):286-292$$$$$Y$$$20240920$$HP$ES$ES
243421421$24342142$1$I$$20240919$20240920$20240920$EXP$$NVSC2024US187332$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243421432$24342143$2$F$$20240919$20240920$20240920$PER$$NVSC2024US187356$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
243421441$24342144$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005161$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243421452$24342145$2$F$20240101$20240911$20240920$20240926$EXP$$FR-TEVA-VS-3244072$TEVA$$71$YR$$F$Y$$$20240926$$CN$FR$FR
243421461$24342146$1$I$20240101$20240904$20240920$20240920$PER$$US-TEVA-VS-3241336$TEVA$$42$YR$$F$Y$$$20240920$$CN$US$US
243421471$24342147$1$I$20240213$20240913$20240920$20240920$EXP$GB-MHRA-MED-202409130956002900-GBVFD$GB-RDY-SPO/GBR/24/0013548$DR REDDYS$$4$YR$C$M$Y$$$20240920$$CN$GB$GB
243421491$24342149$1$I$20240910$20240911$20240920$20240920$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03418$AMNEAL$$64$YR$$F$Y$$$20240920$$CN$US$US
243421501$24342150$1$I$20210311$20211202$20240920$20240920$EXP$$CA-CELLTRION INC.-2021CA019705$CELLTRION$$$$$$Y$$$20240920$$CN$CA$CA
243421511$24342151$1$I$20240902$20240912$20240920$20240920$EXP$$US-LUNDBECK-DKLU4004324$LUNDBECK$$$$$$Y$$$20240920$$CN$US$US
243421521$24342152$1$I$$20240903$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08840$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243421531$24342153$1$I$20240801$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005160$ACADIA PHARMACEUTICALS$$61$YR$$M$Y$$$20240920$$CN$US$US
243421541$24342154$1$I$$20240906$20240920$20240920$EXP$GB-MHRA-MED-202409051036517840-DLRZS$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21158$ALKEM$$$$$F$Y$$$20240920$$CN$GB$GB
243421551$24342155$1$I$$20240906$20240920$20240920$EXP$GB-MHRA-MED-202409051047363520-LJFDC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21161$ALKEM$$$$$$Y$65$KG$20240920$$CN$GB$GB
243421571$24342157$1$I$$20240906$20240920$20240920$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-21714$ALKEM$Padmapriyadarsini C, Oswal VS, Jain CD, Mariappan MV, et.al.. Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial. Clinical Infectious Diseases. 2024;unk:1-11$19$YR$$F$Y$$$20240920$$HP$IN$IN
243421581$24342158$1$I$$20240906$20240920$20240920$EXP$GB-MHRA-MED-202409051142525450-WZVKS$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21164$ALKEM$$$$$M$Y$$$20240920$$CN$GB$GB
243421591$24342159$1$I$$20240906$20240920$20240920$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-21505$ALKEM$Grau-Lopez L, Daigre C, Mercado N, Casas M, Roncero C. Dystonia in Methylphenidate Withdrawal: A Case Report. J Addict Med. 2017;11:154-156$28$YR$$M$Y$$$20240920$$HP$ES$ES
243421601$24342160$1$I$$20240906$20240920$20240920$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-21405$ALKEM$Sharma SK, Doval D, Khandelwal V, Kumar M, Choudhary D.. Tacrolimus Induced Diabetic Ketoacidosis Following Hematopoietic Stem Cell Transplantation. Indian J Hematol Blood Transfus. 2019;35(4):711-713$5$YR$$M$Y$$$20240920$$HP$IN$IN
243421611$24342161$1$I$$20240906$20240920$20240920$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-21404$ALKEM$Sharma SK, Doval D, Khandelwal V, Kumar M, Choudhary D.. Tacrolimus Induced Diabetic Ketoacidosis Following Hematopoietic Stem Cell Transplantation. Indian J Hematol Blood Transfus. 2019;35(4):711-713$15$YR$$M$Y$$$20240920$$HP$IN$IN
243421621$24342162$1$I$$20240906$20240920$20240920$EXP$$TR-ALKEM LABORATORIES LIMITED-TR-ALKEM-2024-21503$ALKEM$Dogan Y, Bilac O, Kavurma C, Onder A. Acute dystonia due to discontinuing of methylphenidate treatment: a case. Psychiatry Clin Psychopharmacol. 2018;28:119$6$YR$$F$Y$$$20240920$$HP$TR$TR
243421631$24342163$1$I$$20240906$20240920$20240920$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-21209$ALKEM$$$$$F$Y$$$20240920$$CN$DE$DE
243421641$24342164$1$I$20240517$20240912$20240920$20240920$EXP$$KR-CELLTRION INC.-2024KR021964$CELLTRION$$$$$$Y$$$20240920$$HP$KR$KR
243421661$24342166$1$I$$20240906$20240920$20240920$EXP$$IN-ALKEM LABORATORIES LIMITED-IN-ALKEM-2024-20626$ALKEM$Sharma SK, Doval D, Khandelwal V, Kumar M, Choudhary D. Tacrolimus induced diabetic ketoacidosis following hematopoietic stem cell transplantation. Indian J Hematol Blood Transfus. 2019;35(4):711-713$17$YR$$M$Y$$$20240920$$HP$IN$IN
243421671$24342167$1$I$$20240916$20240920$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015329$JAZZ$$$$$F$Y$$$20240920$$CN$US$US
243421681$24342168$1$I$$20240906$20240920$20240920$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-21578$ALKEM$Parraga HC, Sherman BC.. Acute Dystonia After Stimulant Discontinuation in 2 ADHD Children Receiving Aripiprazole. J Clin Psychopharmacol. 2015;35:480-481$9$YR$$F$Y$$$20240920$$HP$US$US
243421691$24342169$1$I$$20240909$20240920$20240920$EXP$$DE-UCBSA-2024046759$UCB$$$$$$Y$$$20240920$$MD$DE$DE
243421711$24342171$1$I$$20240913$20240920$20240920$EXP$$US-LUNDBECK-DKLU4004346$LUNDBECK$$$$$$Y$$$20240920$$PH$US$US
243421721$24342172$1$I$20240904$20240914$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014666$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243421741$24342174$1$I$$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148747$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240920$$CN$US$US
243421751$24342175$1$I$$20240909$20240920$20240920$EXP$$CN-STL-000235$Stallion Laboratories$Zhu F, Wang WF, Ma CH, Liang H, Jiang YQ. Resolution of anti-LGI1-associated autoimmune encephalitis in a patient after treatment with efgartigimod. J Neurol. 2024 Jul 9. doi: 10.1007/s00415-024-12556-1.$$$$$Y$$$20240920$$HP$CN$CN
243421761$24342176$1$I$20240904$20240917$20240920$20240920$EXP$SE-SEMPA-2024-006723$SE-JNJFOC-20240947637$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240920$$MD$SE$SE
243421772$24342177$2$F$$20240920$20240920$20240927$PER$$US-LEO Pharma-373610$LEO PHARM$$58$YR$$F$Y$$$20240927$$PH$US$US
243421781$24342178$1$I$$20240909$20240920$20240920$EXP$$US-Accord-446346$ACCORD$$$$$F$Y$$$20240920$$PH$US$US
243421791$24342179$1$I$20231201$20240909$20240920$20240920$EXP$$FI-STRIDES PHARMA UK LTD.-2024SP011522$STRIDES$$87$YR$$F$Y$$$20240920$$CN$FI$FI
243421801$24342180$1$I$$20240910$20240920$20240920$PER$$US-BAUSCHBL-2024BNL033224$BAUSCH AND LOMB$$$$$F$Y$$$20240920$$CN$US$US
243421811$24342181$1$I$$20240903$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08865$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243421821$24342182$1$I$20240101$20240910$20240920$20240920$PER$$US-BAUSCHBL-2024BNL033196$BAUSCH AND LOMB$$71$YR$$M$Y$$$20240920$$CN$US$US
243421831$24342183$1$I$20240901$20240910$20240920$20240920$PER$$US-BAUSCHBL-2024BNL033239$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240920$$CN$US$US
243421851$24342185$1$I$20240701$20240909$20240920$20240920$EXP$$US-JNJFOC-20240845938$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20240920$$HP$US$US
243421861$24342186$1$I$$20240908$20240920$20240920$EXP$$CA-Accord-446687$ACCORD$Alenezi AF, Alnuaimi A, Liberman D. SIADH and mixed delirium following the abrupt cessation of long-acting benzodiazepines: a case report. Oxf Med Case Reports. 2024 Sep 2;2024(9):omae098. doi: 10.1093/omcr/omae098.$85$YR$E$F$Y$$$20240920$$MD$CA$CA
243421871$24342187$1$I$$20240918$20240920$20240920$PER$$US-JNJFOC-20240947916$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$HP$US$US
243421881$24342188$1$I$20240101$20240531$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108151$ZYDUS PHARM$$$$$$Y$$$20240920$$CN$US$US
243421891$24342189$1$I$20240401$20240603$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108216$ZYDUS PHARM$$$$$$Y$$$20240920$$CN$US$US
243421911$24342191$1$I$$20240530$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108153$ZYDUS PHARM$$$$$$Y$$$20240920$$HP$US$US
243421921$24342192$1$I$$20240605$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108217$ZYDUS PHARM$$$$$$Y$$$20240920$$HP$US$US
243421931$24342193$1$I$20240501$20240603$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108219$ZYDUS PHARM$$$$$$Y$$$20240920$$CN$US$US
243421941$24342194$1$I$$20240607$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108542$ZYDUS PHARM$$$$$$Y$$$20240920$$HP$US$US
243421951$24342195$1$I$20240827$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045470$AUROBINDO$$74$YR$$F$Y$$$20240920$$PH$GB$GB
243421961$24342196$1$I$$20240607$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108570$ZYDUS PHARM$$$$$$Y$$$20240920$$HP$US$US
243421971$24342197$1$I$20240501$20240708$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109540$ZYDUS PHARM$$$$$$Y$$$20240920$$CN$US$US
243421981$24342198$1$I$20231201$20240723$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110099$ZYDUS PHARM$$$$$$Y$$$20240920$$CN$US$US
243421991$24342199$1$I$20240808$20240814$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111399$ZYDUS PHARM$$$$$$Y$$$20240920$$CN$US$US
243422001$24342200$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010919$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243422011$24342201$1$I$20240822$20240828$20240920$20240920$PER$$US-SA-2024SA267738$SANOFI AVENTIS$$76$YR$E$M$Y$95.45$KG$20240920$$MD$US$US
243422021$24342202$1$I$20240801$20240903$20240920$20240920$PER$$US-SA-2024SA271443$SANOFI AVENTIS$$64$YR$A$F$Y$77.27$KG$20240920$$MD$US$US
243422032$24342203$2$F$20240825$20240911$20240920$20240926$PER$$US-SA-2024SA271434$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240926$$CN$US$US
243422041$24342204$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA268012$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240920$$HP$US$US
243422051$24342205$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA205087$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240920$$MD$US$US
243422061$24342206$1$I$20240801$20240919$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149579$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240920$$CN$US$US
243422071$24342207$1$I$20240830$20240919$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149566$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240920$$CN$US$US
243422081$24342208$1$I$$20240909$20240920$20240920$EXP$$IT-BAUSCH-BL-2024-014095$BAUSCH AND LOMB$C I, D B, C C, S C. Delayed haemolytic transfusion reaction (DHTR) due to anti-JK(a) with associated thrombocytopenia in a patient with Sjogren syndrome a case report. Decidere in Medicina. 2024 JUN;3:25-31.$79$YR$$F$Y$$$20240920$$MD$IT$IT
243422091$24342209$1$I$20240903$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045468$AUROBINDO$$96$YR$$F$Y$$$20240920$$PH$GB$GB
243422111$24342211$1$I$20240101$20240910$20240920$20240920$PER$$US-BAUSCHBL-2024BNL033244$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240920$$CN$US$US
243422121$24342212$1$I$$20240828$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005163$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243422131$24342213$1$I$$20240911$20240920$20240920$EXP$$CA-SANDOZ INC.-SDZ2024CA079641$SANDOZ$$$$$F$Y$$$20240920$$HP$CA$CA
243422151$24342215$1$I$20240101$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024187454$AMGEN$$68$YR$E$F$Y$$$20240920$$CN$US$US
243422161$24342216$1$I$$20240912$20240920$20240920$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006844$BIOCON$$$$$$Y$$$20240920$$CN$CA$CA
243422171$24342217$1$I$20240906$20240911$20240920$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028794$UNITED THERAPEUTICS$$88$YR$$F$Y$74.83$KG$20240920$$$US$US
243422181$24342218$1$I$20240701$20240909$20240920$20240920$EXP$$HR-AUROBINDO-AUR-APL-2024-045495$AUROBINDO$$59$YR$$M$Y$70$KG$20240920$$MD$HR$HR
243422191$24342219$1$I$$20240916$20240920$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015344$JAZZ$$$$$F$Y$8.7$KG$20240920$$CN$US$US
243422201$24342220$1$I$20240101$20240910$20240920$20240920$PER$$US-BAUSCHBL-2024BNL033262$BAUSCH AND LOMB$$$$$F$Y$$$20240920$$CN$US$US
243422211$24342221$1$I$20240101$20240910$20240920$20240920$PER$$US-BAUSCHBL-2024BNL033261$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240920$$CN$US$US
243422221$24342222$1$I$$20240903$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08847$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243422231$24342223$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011881$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240920$$CN$US$US
243422242$24342224$2$F$20240916$20240924$20240920$20240930$EXP$$CA-ABBVIE-5930650$ABBVIE$$17$YR$$M$Y$$$20240930$$HP$CA$CA
243422251$24342225$1$I$20240101$20240912$20240920$20240920$PER$$US-BAUSCHBL-2024BNL033432$BAUSCH AND LOMB$$$$$M$Y$$$20240920$$MD$US$US
243422261$24342226$1$I$$20240828$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005164$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243422271$24342227$1$I$20240916$20240916$20240920$20240920$PER$$US-BAUSCHBL-2024BNL033514$BAUSCH AND LOMB$$80$YR$$F$Y$68.03$KG$20240920$$CN$US$US
243422281$24342228$1$I$$20240910$20240920$20240920$PER$$US-BAUSCHBL-2024BNL033319$BAUSCH AND LOMB$$79$YR$$F$Y$$$20240920$$CN$US$US
243422291$24342229$1$I$20240101$20240917$20240920$20240920$EXP$$US-ABBVIE-5929401$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243422301$24342230$1$I$20240905$20240911$20240920$20240920$PER$$US-BAUSCHBL-2024BNL033354$BAUSCH AND LOMB$$$$$F$Y$$$20240920$$CN$US$US
243422311$24342231$1$I$$20240909$20240920$20240920$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-08521$HIKMA$$62$YR$$F$Y$78$KG$20240920$$CN$GB$GB
243422321$24342232$1$I$20240320$20240909$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-019738$AUROBINDO$$57$YR$$M$Y$$$20240920$$HP$FR$FR
243422331$24342233$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149165$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$$$20240920$$CN$US$US
243422341$24342234$1$I$20240909$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147755$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$73.6$KG$20240920$$CN$US$US
243422351$24342235$1$I$$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024186296$AMGEN$$$$$$Y$$$20240920$$PH$US$US
243422361$24342236$1$I$20240219$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186438$AMGEN$$$$$M$Y$$$20240920$$CN$US$US
243422371$24342237$1$I$20240915$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186746$AMGEN$$76$YR$E$M$Y$$$20240920$$CN$US$US
243422392$24342239$2$F$$20240919$20240920$20240927$PER$$US-MTPC-MTDA2024-0019589$MITSUBISHI TANABE PHARMA$$$$E$M$Y$$$20240927$$CN$US$US
243422401$24342240$1$I$$20240903$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08858$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243422411$24342241$1$I$$20240828$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005166$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243422421$24342242$1$I$20240826$20240914$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014654$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243422431$24342243$1$I$20240205$20240910$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-014002$AUROBINDO$$83$YR$$F$Y$$$20240920$$MD$FR$FR
243422441$24342244$1$I$$20240916$20240920$20240920$EXP$$NVSC2024TR187299$NOVARTIS$$$$$F$Y$$$20240920$$CN$TR$TR
243422451$24342245$1$I$20240826$20240914$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014672$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243422462$24342246$2$F$20240828$20240914$20240920$20240923$EXP$$CN-BEIGENE-BGN-2024-014671$BEIGENE$$$$$$Y$$$20240923$$HP$CN$CN
243422471$24342247$1$I$$20240906$20240920$20240920$EXP$$US-UCBSA-2024046596$UCB$$$$$$Y$$$20240920$$CN$US$US
243422481$24342248$1$I$$20240905$20240920$20240920$EXP$$CA-BAXTER-2024BAX024448$BAXTER$$66$YR$$M$Y$$$20240920$$HP$CA$CA
243422491$24342249$1$I$$20240903$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08846$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243422501$24342250$1$I$$20240911$20240920$20240920$EXP$$US-GSK-US2024AMR114226$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243422511$24342251$1$I$$20240913$20240920$20240920$EXP$$JP-ASTELLAS-2024-AER-006712$ASTELLAS$$63$YR$A$M$Y$$$20240920$$HP$JP$JP
243422521$24342252$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010976$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243422531$24342253$1$I$$20240908$20240920$20240920$EXP$$US-Long Grove-000075$Long Grove Pharmaceuticals$Desai D, Nohria A, Alhanshali L, Buontempo M, Lo Sicco KI, Fern C, et. al. Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases. JAAD Case Rep. 2024 Jul 14;51:86-91.$34$YR$A$M$Y$$$20240920$$HP$US$US
243422541$24342254$1$I$20240724$20240909$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045476$AUROBINDO$$75$YR$$M$Y$59.6$KG$20240920$$PH$FR$FR
243422551$24342255$1$I$$20240913$20240920$20240920$EXP$GB-MHRA-MED-202409131649417600-DFGJR$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-002239$IPCA$$$$$$Y$$$20240920$$PH$GB$GB
243422561$24342256$1$I$$20240908$20240920$20240920$EXP$$PT-Inventia-000749$INVENTIA HEALTHCARE$Mestre D, Gil F. Central Venous Catheter Misplacement Presenting With Parotid Gland Swelling: A Case Report. Cureus. 2024 Aug 5;16(8):e66245.$84$YR$E$F$Y$$$20240920$$HP$PT$PT
243422571$24342257$1$I$20230101$20240916$20240920$20240920$EXP$$US-ABBVIE-5926463$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243422581$24342258$1$I$$20240911$20240920$20240920$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024113159$VIIV$$64$YR$$F$Y$$$20240920$$PH$US$US
243422591$24342259$1$I$20240719$20240912$20240920$20240920$EXP$$BR-TEVA-VS-3230668$TEVA$$41$YR$$F$Y$$$20240920$$PH$BR$BR
243422601$24342260$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005168$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243422622$24342262$2$F$20240914$20240923$20240920$20240930$EXP$$US-ABBVIE-5929062$ABBVIE$$15$YR$$F$Y$$$20240929$$CN$US$US
243422631$24342263$1$I$20230101$20240916$20240920$20240920$EXP$$US-ABBVIE-5383945$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243422641$24342264$1$I$$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045008$AUROBINDO$$82$YR$$F$Y$$$20240920$$PH$GB$GB
243422651$24342265$1$I$20210302$20240910$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045318$AUROBINDO$$68$YR$$M$Y$$$20240920$$MD$GB$GB
243422661$24342266$1$I$$20240910$20240920$20240920$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01884$NOVITIUM PHARMA$Seigi Oshima.Successful treatment of tuberculous meningitis in an Indian female under hemodialysis therapy.CEN Case Reports.08-JAN-2023;12(4):341-346$61$YR$A$F$Y$$$20240920$$HP$JP$JP
243422671$24342267$1$I$20240101$20240916$20240920$20240920$EXP$$CA-ABBVIE-5927240$ABBVIE$$31$YR$$F$Y$$$20240920$$CN$CA$CA
243422681$24342268$1$I$20240101$20240910$20240920$20240920$PER$$US-ASTELLAS-2024-AER-006166$ASTELLAS$$$$$M$Y$$$20240920$$MD$US$US
243422702$24342270$2$F$$20240911$20240920$20240924$EXP$$NL-ABBVIE-5922833$ABBVIE$$$$E$M$Y$$$20240924$$CN$NL$NL
243422711$24342271$1$I$$20240910$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045615$AUROBINDO$$21$YR$$M$Y$$$20240920$$PH$FR$FR
243422721$24342272$1$I$20240527$20240909$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045571$AUROBINDO$$43$YR$$M$Y$$$20240920$$PH$FR$FR
243422731$24342273$1$I$20240901$20240917$20240920$20240920$EXP$$US-ABBVIE-5928541$ABBVIE$$41$YR$$M$Y$$$20240920$$CN$US$US
243422741$24342274$1$I$20240902$20240914$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014663$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243422751$24342275$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5903750$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243422761$24342276$1$I$$20240916$20240920$20240920$EXP$$US-LEO Pharma-373595$LEO PHARM$Hailey Konisky, BS,a Alison Kortz, PA-C,b Albert Huho, MD,b and A. Neal Gregory, MDb$55$YR$$M$Y$$$20240920$$MD$US$US
243422772$24342277$2$F$$20240919$20240920$20240920$PER$$NVSC2024US187318$NOVARTIS$$$$$F$Y$$$20240921$$CN$US$US
243422781$24342278$1$I$$20240919$20240920$20240920$EXP$$NVSC2024US187422$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243422791$24342279$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5927960$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243422801$24342280$1$I$$20240904$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08899$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243422811$24342281$1$I$20240812$20240917$20240920$20240920$EXP$$IL-ABBVIE-5928051$ABBVIE$$83$YR$$M$Y$$$20240920$$CN$IL$IL
243422821$24342282$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005171$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243422861$24342286$1$I$20240820$20240909$20240920$20240920$EXP$$ES-AUROBINDO-AUR-APL-2024-045242$AUROBINDO$$52$YR$$F$Y$$$20240920$$PH$ES$ES
243422891$24342289$1$I$20230215$20240917$20240920$20240920$EXP$$US-VIIV HEALTHCARE LIMITED-US2024116075$VIIV$$$$$$Y$$$20240920$$MD$US$US
243422911$24342291$1$I$$20240830$20240920$20240920$PER$$US-AMGEN-USASP2024186519$AMGEN$$$$$$Y$$$20240920$$HP$US$US
243422922$24342292$2$F$$20240919$20240920$20240926$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08528$HIKMA$$$$$M$Y$$$20240926$$HP$US$US
243422931$24342293$1$I$20240501$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005173$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20240920$$CN$US$US
243422941$24342294$1$I$20240815$20240919$20240920$20240920$EXP$$JP-TAKEDA-2024TJP013976$TAKEDA$$7$DEC$$M$Y$$$20240920$$MD$JP$JP
243422971$24342297$1$I$$20240913$20240920$20240920$EXP$$US-GSK-US2024114167$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243422981$24342298$1$I$$20240912$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013508$DR REDDYS$$20$YR$A$F$Y$$$20240920$$PH$US$US
243422991$24342299$1$I$20240101$20240916$20240920$20240920$EXP$$TN-ABBVIE-5928727$ABBVIE$$56$YR$$F$Y$$$20240920$$CN$TN$TN
243423001$24342300$1$I$$20240912$20240920$20240920$30DAY$$US-GSK-US2024114274$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$US$US
243423011$24342301$1$I$$20240913$20240920$20240920$EXP$$CA-GSK-CA2023088555$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CA$CA
243423021$24342302$1$I$$20240904$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08898$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243423031$24342303$1$I$$20240918$20240920$20240920$EXP$$US-GILEAD-2024-0688318$GILEAD$$$$A$$Y$$$20240920$$CN$US$US
243423041$24342304$1$I$20240801$20240918$20240920$20240920$EXP$$US-ABBVIE-5929489$ABBVIE$$62$YR$$M$Y$$$20240920$$CN$US$US
243423051$24342305$1$I$20240910$20240910$20240920$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-024832$UNITED THERAPEUTICS$$79$YR$$F$Y$56.689$KG$20240920$$$US$US
243423061$24342306$1$I$20240701$20240917$20240920$20240920$EXP$$BG-ABBVIE-5929874$ABBVIE$$77$YR$$F$Y$$$20240920$$CN$BG$BG
243423071$24342307$1$I$20240908$20240917$20240920$20240920$EXP$$US-ABBVIE-5928317$ABBVIE$$18$YR$$F$Y$$$20240920$$CN$US$US
243423081$24342308$1$I$20240801$20240917$20240920$20240920$EXP$$US-ABBVIE-5928017$ABBVIE$$52$YR$$M$Y$$$20240920$$CN$US$US
243423091$24342309$1$I$$20240909$20240920$20240920$EXP$$PT-AUROBINDO-AUR-APL-2024-045532$AUROBINDO$Gaspar M., Escaleira R., Martins F., Silva M. Febre persistente de etiologia desconhecida, e agora?. 30? Congresso Nacional de Medicina Interna. 2024;568$18$YR$$M$Y$$$20240920$$MD$PT$PT
243423101$24342310$1$I$$20240829$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08713$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243423111$24342311$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010973$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243423121$24342312$1$I$$20240911$20240920$20240920$EXP$$PT-ASPEN-GLO2024PT006346$ASPEN$Figueiredo AR., Abrantes JF., Neto TA., Simoes de Carvalho M., Ferreira de Silva IS., Sopa I., et al.. PO-0038- (2642) - Lesoes liticas: Um desafio diagnostico.. 30? Congresso Nacional de Medicina Interna. 2024;411$$$$$Y$$$20240920$$MD$PT$PT
243423131$24342313$1$I$$20240916$20240920$20240920$30DAY$$US-SANDOZ INC.-SDZ2024US080765$SANDOZ$$$$$M$Y$$$20240920$$PH$US$US
243423141$24342314$1$I$$20240910$20240920$20240920$EXP$$CA-APOTEX-2024AP010496$APOTEX$$75$YR$$F$Y$$$20240920$$HP$CA$CA
243423151$24342315$1$I$20210726$20240918$20240920$20240920$EXP$$NVSC2024AU187370$NOVARTIS$$40$YR$$F$Y$$$20240920$$MD$AU$AU
243423161$24342316$1$I$$20240912$20240920$20240920$EXP$$CN-JNJFOC-20240937495$JOHNSON AND JOHNSON$$$$$M$Y$42$KG$20240920$$CN$CN$CN
243423171$24342317$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149388$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240920$$HP$US$US
243423181$24342318$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149123$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240920$$PH$US$US
243423191$24342319$1$I$$20240829$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09039$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243423211$24342321$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005172$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243423221$24342322$1$I$$20240918$20240920$20240920$EXP$$CH-KYOWAKIRIN-2024KK021645$KYOWA$$$$$$Y$$$20240920$$MD$DE$CH
243423241$24342324$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112680$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$CN$US$US
243423251$24342325$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005175$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243423261$24342326$1$I$20240328$20240911$20240920$20240920$EXP$$DE-HIKMA PHARMACEUTICALS-DE-H14001-24-08586$HIKMA$$71$YR$$M$Y$76$KG$20240920$$CN$DE$DE
243423271$24342327$1$I$20240820$20240909$20240920$20240920$EXP$$US-Accord-446345$ACCORD$$54$YR$A$M$Y$$$20240920$$PH$US$US
243423282$24342328$2$F$$20240920$20240920$20240923$PER$$US-JNJFOC-20240954435$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243423291$24342329$1$I$20230101$20240909$20240920$20240920$EXP$$DE-AUROBINDO-AUR-APL-2024-045581$AUROBINDO$$$$E$F$Y$$$20240920$$CN$DE$DE
243423301$24342330$1$I$$20240911$20240920$20240920$PER$$US-TAKEDA-2024TUS091162$TAKEDA$$$$$F$Y$$$20240920$$CN$US$US
243423321$24342332$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005110$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243423331$24342333$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005104$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243423341$24342334$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005119$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243423352$24342335$2$F$20240827$20240920$20240920$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005113$ACADIA PHARMACEUTICALS$$7$YR$$F$Y$$$20240927$$CN$US$US
243423361$24342336$1$I$$20240911$20240920$20240920$EXP$$ES-AMGEN-ESPSP2024183847$AMGEN$Lluch P.; Ballester M.P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240920$$MD$ES$ES
243423371$24342337$1$I$$20240829$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08751$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243423381$24342338$1$I$$20240911$20240920$20240920$EXP$$IT-INSMED, INC.-2024-03690-IT$INSMED$$$$$F$Y$$$20240920$$MD$IT$IT
243423401$24342340$1$I$$20240917$20240920$20240920$EXP$CA-DRL-USA-SPO/CAN/24/0013687$CA-RDY-SPO/CAN/24/0013687$DR REDDYS$$7$DEC$E$F$Y$$$20240920$$MD$CA$CA
243423411$24342341$1$I$20240527$20240909$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045493$AUROBINDO$$47$YR$$F$Y$$$20240920$$PH$FR$FR
243423421$24342342$1$I$$20240918$20240920$20240920$PER$$NVSC2024US187330$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
243423431$24342343$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005177$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243423441$24342344$1$I$20240814$20240910$20240920$20240920$EXP$GB-MHRA-MED-202409091625193460-DPYVC$GB-Accord-446396$ACCORD$$89$YR$E$F$Y$43$KG$20240920$$PH$GB$GB
243423451$24342345$1$I$20240730$20240910$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005496$ACADIA PHARMACEUTICALS$$68$YR$$M$Y$$$20240920$$CN$US$US
243423461$24342346$1$I$$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005118$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243423471$24342347$1$I$20240801$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005114$ACADIA PHARMACEUTICALS$$10$YR$$F$Y$$$20240920$$CN$US$US
243423481$24342348$1$I$20240916$20240917$20240920$20240920$PER$$US-009507513-2409USA006393$MERCK$$$$$M$Y$$$20240920$$HP$US$US
243423491$24342349$1$I$$20240912$20240920$20240920$EXP$$JP-EMD Serono-2024049930$EMD SERONO INC$$57$YR$A$F$Y$$$20240920$$MD$JP$JP
243423501$24342350$1$I$$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-044933$AUROBINDO$$46$YR$$F$Y$62$KG$20240920$$HP$GB$GB
243423521$24342352$1$I$$20240904$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08940$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243423541$24342354$1$I$$20240918$20240920$20240920$EXP$$NVSC2024US187171$NOVARTIS$$$$$F$Y$$$20240920$$MD$US$US
243423551$24342355$1$I$20240916$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024185036$AMGEN$$36$YR$A$F$Y$$$20240920$$CN$US$US
243423561$24342356$1$I$$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024187812$AMGEN$$$$$F$Y$$$20240920$$CN$US$US
243423571$24342357$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186841$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243423581$24342358$1$I$20240723$20240911$20240920$20240920$PER$$US-ABBVIE-5925360$ABBVIE$$71$YR$$F$Y$$$20240920$$CN$US$US
243423591$24342359$1$I$20240701$20240917$20240920$20240920$PER$$US-ABBVIE-5928129$ABBVIE$$30$YR$$M$Y$$$20240920$$MD$US$US
243423601$24342360$1$I$20240101$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149139$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240920$$HP$US$US
243423611$24342361$1$I$20240911$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148762$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240920$$PH$US$US
243423621$24342362$1$I$$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148640$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240920$$CN$US$US
243423631$24342363$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149250$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240920$$CN$US$US
243423641$24342364$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5928668$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243423651$24342365$1$I$20240901$20240910$20240920$20240920$30DAY$$US-GSK-US2024112668$GLAXOSMITHKLINE$$22$YR$$M$Y$$$20240920$$CN$US$US
243423661$24342366$1$I$20240903$20240913$20240920$20240920$EXP$$US-SA-2024SA269752$SANOFI AVENTIS$$$$$M$Y$$$20240920$$CN$US$US
243423671$24342367$1$I$20240901$20240910$20240920$20240920$30DAY$$US-GSK-US2024AMR113933$GLAXOSMITHKLINE$$43$YR$$F$Y$$$20240920$$CN$US$US
243423681$24342368$1$I$20230826$20240905$20240920$20240920$EXP$$KR-SERVIER-S24011327$SERVIER$$$$$$Y$$$20240920$$MD$KR$KR
243423691$24342369$1$I$20240101$20240917$20240920$20240920$EXP$$US-ABBVIE-5928468$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243423711$24342371$1$I$20240615$20240917$20240920$20240920$EXP$$CO-UCBSA-2024048248$UCB$$72$YR$$M$Y$$$20240920$$CN$CO$CO
243423721$24342372$1$I$$20240906$20240920$20240920$EXP$$US-UCBSA-2024046321$UCB$$$$$$Y$$$20240920$$CN$US$US
243423732$24342373$2$F$$20240919$20240920$20240924$EXP$$NVSC2024TH187203$NOVARTIS$$74$YR$$F$Y$$$20240924$$MD$TH$TH
243423741$24342374$1$I$$20240910$20240920$20240920$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01950$NOVITIUM PHARMA$Rong Tao.Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade.Oncologist.24-AUG-2023;29(1):E90-E96$35$YR$A$M$Y$$$20240920$$HP$CN$CN
243423761$24342376$1$I$$20240829$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08741$LUPIN$$$$$$Y$$$20240920$$HP$US$US
243423771$24342377$1$I$$20240709$20240920$20240920$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008664$STRIDES$Wilkinson AJ, Yang A, Chen GH.. Stellate ganglion block to mitigate thalamic pain syndrome of an oncological origin.. Pain-Pract. 2024;24 (1):231-234$73$YR$$F$Y$$$20240920$$MD$US$US
243423791$24342379$1$I$$20240702$20240920$20240920$PER$$US-STRIDES PHARMA UK LTD.-2024SP008141$STRIDES$Sablaban IM, Gautam M.. Kratom Stimulant Co-Addiction: A Case Series and Brief Review. [Review]. J-Addict-Dis. 2023;41 (2):181-184$$$$$Y$$$20240920$$HP$US$US
243423801$24342380$1$I$$20240702$20240920$20240920$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008003$STRIDES$Langford B, D^Souza RS, Pingree M, Mauck WD.. Treatment of Ulnar Neuropathic Pain with Peripheral Nerve Stimulation: Two Case Reports.. Pain-Med. 2023;24 (5):566-569$18$YR$$F$Y$$$20240920$$MD$US$US
243423811$24342381$1$I$$20240725$20240920$20240920$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009540$STRIDES$Chen L, Ogbutor C, Kelley KJ, Senna M.. Oral gabapentin for scalp pruritus in patients with lichen planopilaris.. J-Invest-Dermatol. 2024;144 (Suppl.)(8):S43$$$$F$Y$$$20240920$$HP$US$US
243423821$24342382$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010974$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243423831$24342383$1$I$$20240905$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08948$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243423841$24342384$1$I$20230425$20240917$20240920$20240920$EXP$$US-TAKEDA-2023TUS042423$TAKEDA$$72$YR$$M$Y$113$KG$20240920$$CN$US$US
243423861$24342386$1$I$$20240116$20240920$20240920$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00091$TARO$$$$$$Y$$$20240920$$CN$US$US
243423881$24342388$1$I$20240101$20240909$20240920$20240920$EXP$$DE-AUROBINDO-AUR-APL-2024-045485$AUROBINDO$$43$YR$$M$Y$84$KG$20240920$$MD$DE$DE
243423891$24342389$1$I$20240915$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024184549$AMGEN$$55$YR$A$F$Y$$$20240920$$CN$US$US
243423901$24342390$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5928781$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243423911$24342391$1$I$$20240726$20240920$20240920$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009625$STRIDES$Lam L, Bansal V, Chai T, Driver LC.. Recurrent Pain From Chemotherapy-Induced Peripheral Neuropathy After COVID-19 Infection - A Case Report.. Pain-Med-Case-Rep. 2023;7 (8):357-359$59$YR$$M$Y$$$20240920$$HP$US$US
243423921$24342392$1$I$$20240912$20240920$20240920$EXP$$CA-TEVA-VS-3243466$TEVA$$$$E$M$Y$$$20240920$$CN$CA$CA
243423931$24342393$1$I$20070626$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-044895$AUROBINDO$$55$YR$$M$Y$$$20240920$$HP$GB$GB
243423941$24342394$1$I$20240912$20240917$20240920$20240920$EXP$$CO-ABBVIE-5930278$ABBVIE$$73$YR$$F$Y$86$KG$20240920$$CN$CO$CO
243423951$24342395$1$I$$20240912$20240920$20240920$EXP$$CA-TEVA-VS-3243687$TEVA$$12$YR$$F$Y$$$20240920$$MD$CA$CA
243423961$24342396$1$I$20240903$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045464$AUROBINDO$$77$YR$$F$Y$$$20240920$$PH$GB$GB
243423971$24342397$1$I$$20240910$20240920$20240920$EXP$$CA-APOTEX-2024AP010497$APOTEX$$76$YR$$F$Y$$$20240920$$HP$CA$CA
243423981$24342398$1$I$$20240916$20240920$20240920$EXP$$US-ABBVIE-5927476$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243423991$24342399$1$I$20240913$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024185669$AMGEN$$51$YR$A$F$Y$$$20240920$$PH$US$US
243424001$24342400$1$I$20221201$20240906$20240920$20240920$EXP$$ES-CIPLA LTD.-2024ES09945$CIPLA$Diaz-Alberola I, Espuch-Oliver A, Fernandez-Segovia F, Lopez-Nevot MA. Possible role of cytomegalovirus in gastric cancer development and recurrent macrolide-resistant campylobacter jejuni infection in common variable immunodeficiency: A case report and literature discussion. Microorganisms. 2024;12 (6):1078$$$$$Y$$$20240920$$HP$ES$ES
243424011$24342401$1$I$$20240909$20240920$20240920$EXP$$PL-AUROBINDO-AUR-APL-2024-044794$AUROBINDO$Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoeman H, Ljungman P, Kobbe G et al.. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT.. Am J Transplant.. 2015;15:705-14$5$YR$$M$Y$$$20240920$$MD$PL$PL
243424021$24342402$1$I$20240226$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024185846$AMGEN$$$$$$Y$$$20240920$$HP$US$US
243424031$24342403$1$I$$20240624$20240920$20240920$EXP$$US-GSK-US2024AMR116298$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243424041$24342404$1$I$$20240914$20240920$20240920$EXP$$US-JNJFOC-20240947153$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243424051$24342405$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148941$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240920$$CN$US$US
243424061$24342406$1$I$20240804$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149713$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240920$$CN$US$US
243424071$24342407$1$I$$20240912$20240920$20240920$PER$$US-ABBVIE-5923182$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243424081$24342408$1$I$$20240912$20240920$20240920$EXP$$JP-AMGEN-JPNSP2024183180$AMGEN$$$$E$F$Y$$$20240920$$PH$JP$JP
243424091$24342409$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149560$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$60.78$KG$20240920$$CN$US$US
243424101$24342410$1$I$$20240912$20240920$20240920$EXP$$CA-TEVA-VS-3243458$TEVA$$111$MON$$M$Y$$$20240920$$HP$CA$CA
243424111$24342411$1$I$$20240912$20240920$20240920$EXP$$CA-TEVA-VS-3243459$TEVA$$49$MON$$F$Y$$$20240920$$HP$CA$CA
243424121$24342412$1$I$20240910$20240910$20240920$20240920$EXP$$US-GSK-US2024112642$GLAXOSMITHKLINE$$75$YR$$F$Y$$$20240920$$PH$US$US
243424131$24342413$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010975$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243424141$24342414$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5929096$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243424151$24342415$1$I$$20240909$20240920$20240920$EXP$$PT-AUROBINDO-AUR-APL-2024-045562$AUROBINDO$Paracana B, Oliveira A, Lopes AC, Ribeiro E, Sousa M.. Choque T?xico Estreptoc?cico - Uma Complica??o Potenticalmente Fatal (Streptococcal Toxic Shock - A Potentially Fatal Complication). Abstract Book - Congresso Nacional de Medicina Interna, Maio (Abstract Book - Na. 2024$68$YR$$F$Y$$$20240920$$MD$PT$PT
243424161$24342416$1$I$20240824$20240910$20240920$20240920$EXP$$US-PADAGIS-2024PAD01477$PADAGIS$$$$$$Y$$$20240920$$CN$US$US
243424171$24342417$1$I$$20240905$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08983$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243424181$24342418$1$I$$20240916$20240920$20240920$EXP$$CA-AMGEN-CANSP2024185680$AMGEN$$54$YR$A$F$Y$$$20240920$$CN$CA$CA
243424201$24342420$1$I$$20240911$20240920$20240920$PER$$US-ABBVIE-5921728$ABBVIE$$$$$$Y$$$20240920$$CN$US$US
243424212$24342421$2$F$20240815$20240919$20240920$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-045694$AUROBINDO$$65$YR$$M$Y$$$20240928$$PH$FR$FR
243424221$24342422$1$I$$20240911$20240920$20240920$PER$$US-ABBVIE-5922414$ABBVIE$$$$$$Y$$$20240920$$CN$US$US
243424241$24342424$1$I$$20240918$20240920$20240920$PER$$NVSC2024US187329$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
243424251$24342425$1$I$$20240830$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08803$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243424261$24342426$1$I$20240901$20240916$20240920$20240920$EXP$$NVSC2024CN186343$NOVARTIS$$66$YR$$F$Y$$$20240920$$HP$CN$CN
243424272$24342427$2$F$20240101$20240918$20240920$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028280$UNITED THERAPEUTICS$$$$$F$Y$112.47$KG$20240925$$$US$US
243424281$24342428$1$I$$20240916$20240920$20240920$PER$$US-JNJFOC-20240946776$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
243424311$24342431$1$I$$20240905$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08982$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243424321$24342432$1$I$20240903$20240914$20240920$20240920$EXP$$CN-BEIGENE-BGN-2024-014664$BEIGENE$$$$$$Y$$$20240920$$HP$CN$CN
243424331$24342433$1$I$20240819$20240909$20240920$20240920$EXP$CN-NMPACDR-4301011002666202400539$CN-BAXTER-2024BAX024556$BAXTER$$55$YR$$F$Y$59$KG$20240920$$MD$CN$CN
243424351$24342435$1$I$20240813$20240917$20240920$20240920$EXP$$DE-TAKEDA-2024TUS092689$TAKEDA$$21$YR$$M$Y$$$20240920$$HP$DE$DE
243424362$24342436$2$F$20240829$20240918$20240920$20240930$EXP$$US-RIGEL-20240900067$RIGEL PHARMACEUTICALS$$21$YR$$F$Y$$$20240930$$CN$US$US
243424371$24342437$1$I$20200827$20240906$20240920$20240920$EXP$PL-URPL-1-3450-2020$PL-CELLTRION INC.-2024PL022257$CELLTRION$$$$$$Y$$$20240920$$MD$PL$PL
243424381$24342438$1$I$20240826$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045316$AUROBINDO$$78$YR$$F$Y$$$20240920$$PH$GB$GB
243424391$24342439$1$I$20240531$20240912$20240920$20240920$EXP$$US-PADAGIS-2024PAD01479$PADAGIS$$$$$$Y$$$20240920$$CN$US$US
243424401$24342440$1$I$$20240910$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005510$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243424411$24342441$1$I$20240101$20240910$20240920$20240920$EXP$$US-UCBSA-2024025883$UCB$$$$$F$Y$$$20240920$$HP$US$US
243424421$24342442$1$I$$20240910$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045358$AUROBINDO$$$$$F$Y$$$20240920$$HP$GB$GB
243424441$24342444$1$I$20240501$20240912$20240920$20240920$EXP$FR-AFSSAPS-GR2024001022$FR-TEVA-VS-3243210$TEVA$$55$YR$$F$Y$$$20240920$$MD$FR$FR
243424451$24342445$1$I$20230520$20240912$20240920$20240920$EXP$FR-AFSSAPS-AM2024000710$FR-TEVA-VS-3243343$TEVA$$71$YR$$F$Y$62$KG$20240920$$MD$FR$FR
243424461$24342446$1$I$20240916$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148830$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240920$$CN$US$US
243424481$24342448$1$I$20240818$20240916$20240920$20240920$EXP$$DE-AMGEN-DEUSP2024184642$AMGEN$$74$YR$E$F$Y$61$KG$20240920$$PH$DE$DE
243424491$24342449$1$I$20240807$20240910$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005520$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240920$$CN$US$US
243424501$24342450$1$I$20240916$20240917$20240920$20240920$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900085$RIGEL PHARMACEUTICALS$$$$$M$Y$87.543$KG$20240920$$CN$US$US
243424511$24342451$1$I$$20240916$20240920$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001894$BLUEPRINT MEDICINES$$$$$M$Y$$$20240920$$CN$US$US
243424521$24342452$1$I$20240915$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024185734$AMGEN$$43$YR$A$F$Y$$$20240920$$CN$US$US
243424531$24342453$1$I$20240130$20240909$20240920$20240920$30DAY$$US-AMGEN-USASP2024180497$AMGEN$$69$YR$E$F$Y$49.7$KG$20240920$$HP$US$US
243424541$24342454$1$I$20230901$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045370$AUROBINDO$$38$YR$$F$Y$91$KG$20240920$$CN$GB$GB
243424551$24342455$1$I$$20240907$20240920$20240920$EXP$GB-MHRA-MED-202408191528579690-FHGPQ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21325$ALKEM$$$$$F$Y$$$20240920$$PH$GB$GB
243424561$24342456$1$I$20240101$20240907$20240920$20240920$EXP$GB-MHRA-MED-202409060814270460-MWQVD$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21314$ALKEM$$45$YR$$F$Y$47$KG$20240920$$CN$GB$GB
243424581$24342458$1$I$$20240916$20240920$20240920$EXP$$US-ABBVIE-5927148$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243424591$24342459$1$I$$20240916$20240920$20240920$EXP$$US-ABBVIE-5926983$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243424601$24342460$1$I$20240905$20240907$20240920$20240920$EXP$GB-MHRA-TPP37940685C8173900YC1725554043406$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21292$ALKEM$$59$YR$$M$Y$91$KG$20240920$$MD$GB$GB
243424611$24342461$1$I$$20240907$20240920$20240920$EXP$GB-MHRA-TPP18289937C10930527YC1725529246394$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21291$ALKEM$$87$YR$$M$Y$52$KG$20240920$$MD$GB$GB
243424621$24342462$1$I$$20240910$20240920$20240920$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01951$NOVITIUM PHARMA$Rong Tao.Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade.Oncologist.24-AUG-2023;29(1):E90-E96$55$YR$A$M$Y$$$20240920$$HP$CN$CN
243424641$24342464$1$I$$20240909$20240920$20240920$EXP$$CA-UCBSA-2024046863$UCB$$$$$F$Y$$$20240920$$HP$CA$CA
243424661$24342466$1$I$20240601$20240916$20240920$20240920$EXP$$US-ABBVIE-5927536$ABBVIE$$80$YR$$M$Y$$$20240920$$CN$US$US
243424671$24342467$1$I$$20240917$20240920$20240920$EXP$CA-DRL-USA-SPO/CAN/24/0013688$CA-RDY-SPO/CAN/24/0013688$DR REDDYS$$$$$F$Y$$$20240920$$MD$CA$CA
243424681$24342468$1$I$$20240912$20240920$20240920$EXP$$CA-TAKEDA-2024TUS057631$TAKEDA$$$$$F$Y$$$20240920$$CN$CA$CA
243424691$24342469$1$I$20191201$20240910$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045385$AUROBINDO$$25$YR$$F$Y$65$KG$20240920$$CN$GB$GB
243424701$24342470$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010921$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243424711$24342471$1$I$$20240905$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08959$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243424721$24342472$1$I$20240714$20240910$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045617$AUROBINDO$$85$YR$$M$Y$$$20240920$$MD$FR$FR
243424731$24342473$1$I$$20240916$20240920$20240920$EXP$$NVSC2024JM187320$NOVARTIS$$$$$M$Y$$$20240920$$CN$JM$JM
243424741$24342474$1$I$20240918$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186409$AMGEN$$63$YR$A$F$Y$$$20240920$$HP$US$US
243424761$24342476$1$I$$20240910$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409007314$ELI LILLY AND CO$$49$YR$A$$Y$$$20240920$$LW$US$US
243424771$24342477$1$I$$20240919$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012445$ELI LILLY AND CO$$$$$M$Y$$$20240920$$CN$US$US
243424791$24342479$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010622$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240920$$HP$US$US
243424801$24342480$1$I$$20240830$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08780$LUPIN$$$$$$Y$$$20240920$$PH$US$US
243424811$24342481$1$I$$20240918$20240920$20240920$PER$$US-GRUNENTHAL-2024-125472$AVERITAS$$$$A$F$Y$$$20240920$$HP$US$US
243424821$24342482$1$I$$20240909$20240920$20240920$EXP$$JP-JNJFOC-20240937634$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240920$$MD$JP$JP
243424831$24342483$1$I$20240801$20240906$20240920$20240920$PER$$US-JNJFOC-20240919912$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240920$$CN$US$US
243424841$24342484$1$I$20240824$20240912$20240920$20240920$EXP$$US-JNJFOC-20240865978$JOHNSON AND JOHNSON$$20$YR$A$F$Y$$$20240920$$HP$US$US
243424851$24342485$1$I$20240904$20240913$20240920$20240920$EXP$$NVSC2024DE184754$NOVARTIS$$62$YR$$F$Y$95$KG$20240920$$CN$DE$DE
243424861$24342486$1$I$20240101$20240916$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147440$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240920$$HP$US$US
243424871$24342487$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149205$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240920$$CN$US$US
243424881$24342488$1$I$20240101$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149103$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240920$$CN$US$US
243424892$24342489$2$F$20240911$20240917$20240920$20240926$PER$$US-AMGEN-USASP2024183208$AMGEN$$66$YR$E$F$Y$$$20240925$$PH$US$US
243424901$24342490$1$I$$20240909$20240920$20240920$EXP$$US-UCBSA-2024046580$UCB$$$$$F$Y$$$20240920$$HP$US$US
243424911$24342491$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112490$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243424921$24342492$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024AMR113263$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243424931$24342493$1$I$$20240909$20240920$20240920$EXP$$CA-UCBSA-2024046427$UCB$$$$$F$Y$97$KG$20240920$$HP$CA$CA
243424941$24342494$1$I$$20240909$20240920$20240920$EXP$$CA-UCBSA-2024046716$UCB$$40$YR$$F$Y$$$20240920$$HP$CA$CA
243424951$24342495$1$I$20230925$20240912$20240920$20240920$EXP$$DE-CELLTRION INC.-2024DE013866$CELLTRION$$$$$$Y$$$20240920$$HP$DE$DE
243424961$24342496$1$I$$20240910$20240920$20240920$PER$$US-ABBVIE-5920425$ABBVIE$$$$$$Y$$$20240920$$CN$US$US
243424971$24342497$1$I$20200517$20240911$20240920$20240920$EXP$$PL-AUROBINDO-AUR-APL-2024-045697$AUROBINDO$$12$YR$$F$Y$85$KG$20240920$$PH$PL$PL
243424981$24342498$1$I$$20240910$20240920$20240920$EXP$$EG-BEH-2024178945$CSL BEHRING$$$$$$Y$$$20240920$$HP$EG$EG
243425012$24342501$2$F$20240831$20240918$20240920$20240925$EXP$$US-AMGEN-USASP2024185949$AMGEN$$80$YR$E$F$Y$$$20240925$$CN$US$US
243425031$24342503$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5929835$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243425041$24342504$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5928795$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243425051$24342505$1$I$20060615$20240917$20240920$20240920$EXP$$US-ABBVIE-5927751$ABBVIE$$32$YR$$F$Y$$$20240920$$CN$US$US
243425061$24342506$1$I$20230605$20240917$20240920$20240920$EXP$$CO-UCBSA-2024048254$UCB$$81$YR$$M$Y$$$20240920$$CN$CO$CO
243425081$24342508$1$I$$20240917$20240920$20240920$PER$$US-JNJFOC-20240951311$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243425091$24342509$1$I$$20240912$20240920$20240920$EXP$$BR-JNJFOC-20240944801$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$BR$BR
243425111$24342511$1$I$$20240909$20240920$20240920$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004869$PAREXEL$$$$$$Y$$$20240920$$CN$US$US
243425121$24342512$1$I$$20240910$20240920$20240920$EXP$$CA-APOTEX-2024AP010462$APOTEX$$50$YR$$M$Y$$$20240920$$HP$CA$CA
243425151$24342515$1$I$$20240830$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08782$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243425171$24342517$1$I$20210101$20240916$20240920$20240920$EXP$$DE-ABBVIE-5927473$ABBVIE$$61$YR$$F$Y$$$20240920$$CN$DE$DE
243425181$24342518$1$I$20240910$20240916$20240920$20240920$EXP$$US-ABBVIE-5927296$ABBVIE$$17$YR$$F$Y$$$20240920$$CN$US$US
243425191$24342519$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010922$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243425201$24342520$1$I$20240623$20240917$20240920$20240920$EXP$FR-AFSSAPS-SE2024000728$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-148816$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$64.4$KG$20240920$$MD$FR$FR
243425211$24342521$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149142$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240920$$CN$US$US
243425221$24342522$1$I$$20240830$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08804$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243425231$24342523$1$I$20240801$20240913$20240920$20240920$EXP$$CO-SANDOZ INC.-SDZ2024CO080596$SANDOZ$$57$YR$$F$Y$$$20240920$$CN$CO$CO
243425242$24342524$2$F$20240910$20240923$20240920$20240930$EXP$$US-LEO Pharma-373502$LEO PHARM$$70$YR$$F$Y$$$20240930$$PH$US$US
243425251$24342525$1$I$$20240911$20240920$20240920$EXP$$US-GSK-US2024AMR114457$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243425261$24342526$1$I$20240801$20240910$20240920$20240920$EXP$$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-08576$HIKMA$$70$YR$$F$Y$45$KG$20240920$$MD$FR$FR
243425272$24342527$2$F$20240901$20240917$20240920$20240924$EXP$$IT-AMGEN-ITASP2024185757$AMGEN$$70$YR$E$F$Y$$$20240924$$MD$IT$IT
243425281$24342528$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187697$AMGEN$$$$$$Y$$$20240920$$PH$US$US
243425292$24342529$2$F$$20240912$20240920$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08805$LUPIN$$$$$$Y$$$20240930$$HP$US$US
243425301$24342530$1$I$$20240911$20240920$20240920$PER$$US-JNJFOC-20240934480$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$CN$US$US
243425311$24342531$1$I$$20240915$20240920$20240920$PER$$US-LEO Pharma-373578$LEO PHARM$$48$YR$$F$Y$$$20240920$$PH$US$US
243425321$24342532$1$I$20240911$20240917$20240920$20240920$EXP$$CO-UCBSA-2024048247$UCB$$10$YR$$M$Y$$$20240920$$CN$CO$CO
243425331$24342533$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010945$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243425341$24342534$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010815$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243425351$24342535$1$I$20240917$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011034$ELI LILLY AND CO$$57$YR$A$$Y$$$20240920$$CN$US$US
243425361$24342536$1$I$20240914$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409009981$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240920$$CN$US$US
243425371$24342537$1$I$20240914$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011718$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240920$$CN$US$US
243425391$24342539$1$I$$20240910$20240920$20240920$EXP$$CA-ALCON LABORATORIES-ALC2022CA004892$ALCON$$75$YR$$F$Y$70$KG$20240920$$HP$CA$CA
243425401$24342540$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149264$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$77.11$KG$20240920$$HP$US$US
243425411$24342541$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148800$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240920$$HP$US$US
243425431$24342543$1$I$$20240904$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08931$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243425441$24342544$1$I$$20240919$20240920$20240920$EXP$$FR-GILEAD-2024-0687833$GILEAD$$30$YR$A$F$Y$$$20240920$$MD$FR$FR
243425451$24342545$1$I$$20230818$20240920$20240920$PER$$US-STRIDES ARCOLAB LIMITED-2023SP013467$STRIDES$Fareedy S, Khan RR, Mandayam S, Workeneh B.. Unexplained hyperphosphatemia in relapsed aml patient undergoing investigational therapy. a diagnostic enigma.. Am-J-Kidney-Dis. 2023;81(1)(4):S20 abstr. 68.$28$YR$$F$Y$$$20240920$$HP$US$US
243425462$24342546$2$F$$20240917$20240920$20240924$PER$$US-LEO Pharma-373594$LEO PHARM$$51$YR$$M$Y$$$20240924$$HP$US$US
243425471$24342547$1$I$20240827$20240908$20240920$20240920$EXP$$GB-CIPLA (EU) LIMITED-2024GB09963$CIPLA$$$$$$Y$$$20240920$$CN$GB$GB
243425481$24342548$1$I$20240720$20240906$20240920$20240920$EXP$$US-UCBSA-2024042713$UCB$$39$YR$$F$Y$63.5$KG$20240920$$CN$US$US
243425501$24342550$1$I$$20240918$20240920$20240920$PER$$US-HALEON-2197544$Haleon PLC$$$$$$Y$$$20240920$$CN$US$US
243425512$24342551$2$F$20240918$20240923$20240920$20240924$PER$$US-AMGEN-USASP2024186884$AMGEN$$77$YR$E$F$Y$$$20240924$$HP$US$US
243425523$24342552$3$F$20240915$20240923$20240920$20240925$PER$$US-AMGEN-USASP2024184777$AMGEN$$82$YR$E$F$Y$$$20240924$$MD$US$US
243425532$24342553$2$F$20240901$20240925$20240920$20240928$PER$$US-AMGEN-USASP2024186957$AMGEN$$71$YR$E$F$Y$$$20240928$$CN$US$US
243425541$24342554$1$I$20170101$20240913$20240920$20240920$EXP$$US-GSK-US2024114156$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243425551$24342555$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010923$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243425561$24342556$1$I$$20240916$20240920$20240920$PER$$US-LEO Pharma-373601$LEO PHARM$$59$YR$$M$Y$$$20240920$$PH$US$US
243425571$24342557$1$I$20240808$20240920$20240920$20240920$EXP$SE-SEMPA-2024-006852$SE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052522$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20240920$$MD$SE$SE
243425581$24342558$1$I$20240731$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186440$AMGEN$$$$$F$Y$$$20240920$$CN$US$US
243425591$24342559$1$I$$20240913$20240920$20240920$EXP$$JP-AMGEN-JPNSP2024185330$AMGEN$$73$YR$E$F$Y$$$20240920$$PH$JP$JP
243425601$24342560$1$I$$20240902$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08863$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243425611$24342561$1$I$$20240905$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08950$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243425621$24342562$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024AMR112916$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243425631$24342563$1$I$$20240919$20240920$20240920$EXP$$TR-GILEAD-2024-0688312$GILEAD$$$$$F$Y$$$20240920$$MD$TR$TR
243425642$24342564$2$F$$20240920$20240920$20240926$EXP$$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112354$ZYDUS PHARM$Prescrire. solifenacine + tamsulosine (VECALMYS) et hypertrophie benigne de Ia prostate. LA REVUE PRESCRIRE. 2024;TOME 44 No. 488:405-406$$$$$Y$$$20240926$$HP$FR$FR
243425652$24342565$2$F$20240807$20240923$20240920$20240930$EXP$FR-AFSSAPS-AM2024000712$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112119$ZYDUS PHARM$$$$$$Y$$$20240930$$MD$FR$FR
243425661$24342566$1$I$$20240903$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08860$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243425671$24342567$1$I$$20240918$20240920$20240920$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-148842$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240920$$MD$ES$ES
243425681$24342568$1$I$$20240916$20240920$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-148615$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240920$$MD$JP$JP
243425691$24342569$1$I$$20240910$20240920$20240920$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112275$ZYDUS PHARM$Wright B, Moore A, Becker-Weidman D, Joyce D. Primary B cell lymphoma of the patella presenting as anterior knee pain: A case report. J-Orthop. 2024;48:60-63$$$$$Y$$$20240920$$HP$US$US
243425701$24342570$1$I$20240101$20240906$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142986$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240920$$CN$US$US
243425711$24342571$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149412$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$81.19$KG$20240920$$CN$US$US
243425721$24342572$1$I$20240901$20240917$20240920$20240920$EXP$$GB-ABBVIE-5929879$ABBVIE$$$$$F$Y$$$20240920$$HP$GB$GB
243425731$24342573$1$I$20240101$20240917$20240920$20240920$EXP$$US-ABBVIE-5928764$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243425741$24342574$1$I$20240902$20240912$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146967$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$56.25$KG$20240920$$PH$US$US
243425751$24342575$1$I$$20240916$20240920$20240920$PER$$US-LEO Pharma-373619$LEO PHARM$$$$$F$Y$$$20240920$$CN$US$US
243425761$24342576$1$I$20240404$20240829$20240920$20240920$EXP$$US-SA-2024SA268969$SANOFI AVENTIS$$$$E$F$Y$$$20240920$$MD$US$US
243425791$24342579$1$I$$20240912$20240920$20240920$EXP$$CO-NOVITIUMPHARMA-2024CONVP01948$NOVITIUM PHARMA$Maria Alejandra Mesa-Zuluaga. Diagnosis of Celiac Disease after Starting Antitubercular Medication: A Case Report.Revista colombiana de Gastroenterologia.2023;38(4):516-520$41$YR$A$M$Y$$$20240920$$HP$CO$CO
243425811$24342581$1$I$20240101$20240913$20240920$20240920$EXP$$US-JNJFOC-20240942977$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20240920$$HP$US$US
243425821$24342582$1$I$20240910$20240912$20240920$20240920$EXP$$US-JNJFOC-20240938141$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240920$$CN$US$US
243425841$24342584$1$I$$20240913$20240920$20240920$PER$$US-JNJFOC-20240940644$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$CN$US$US
243425861$24342586$1$I$20240830$20240913$20240920$20240920$EXP$$US-TAKEDA-2024TUS092098$TAKEDA$$31$YR$$M$Y$$$20240920$$CN$US$US
243425871$24342587$1$I$20240906$20240910$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045366$AUROBINDO$$70$YR$$F$Y$64$KG$20240920$$CN$GB$GB
243425891$24342589$1$I$$20240911$20240920$20240920$EXP$$CA-CELLTRION INC.-2024CA022276$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
243425901$24342590$1$I$20240213$20240909$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045665$AUROBINDO$$72$YR$$M$Y$70$KG$20240920$$MD$FR$FR
243425921$24342592$1$I$20230101$20240912$20240920$20240920$EXP$$CA-CELLTRION INC.-2023CA011581$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
243425931$24342593$1$I$$20240916$20240920$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001891$BLUEPRINT MEDICINES$$$$$F$Y$$$20240920$$CN$US$US
243425951$24342595$1$I$$20240918$20240920$20240920$EXP$$CA-TAKEDA-2024TUS093498$TAKEDA$$$$$M$Y$$$20240920$$CN$CA$CA
243425961$24342596$1$I$$20240903$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08842$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243425971$24342597$1$I$20240519$20240909$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045479$AUROBINDO$$21$YR$$M$Y$$$20240920$$PH$FR$FR
243425981$24342598$1$I$20240419$20240910$20240920$20240920$EXP$$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-08581$HIKMA$$59$YR$$F$Y$57.5$KG$20240920$$MD$FR$FR
243425991$24342599$1$I$20240101$20240912$20240920$20240920$EXP$$CA-CELLTRION INC.-2024CA022285$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
243426001$24342600$1$I$$20240911$20240920$20240920$EXP$$GB-CELLTRION INC.-2024GB022239$CELLTRION$$$$$$Y$$$20240920$$CN$GB$GB
243426011$24342601$1$I$$20240909$20240920$20240920$EXP$$US-JNJFOC-20240927334$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240920$$HP$US$US
243426031$24342603$1$I$$20240917$20240920$20240920$EXP$CA-DRL-USA-SPO/CAN/24/0013674$CA-RDY-SPO/CAN/24/0013674$DR REDDYS$$81$YR$E$F$Y$$$20240920$$MD$CA$CA
243426061$24342606$1$I$20240830$20240911$20240920$20240920$EXP$CN-91110000556821568D-2024DRL001750$CN-RDY-SPO/CHN/24/0013493$DR REDDYS$$64$YR$A$F$Y$$$20240920$$HP$CN$CN
243426071$24342607$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010928$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243426092$24342609$2$F$20240807$20240925$20240920$20240930$PER$$US-BIOVITRUM-2024-US-012218$BIOVITRUM$$76$YR$$M$Y$$$20240930$$CN$US$US
243426111$24342611$1$I$$20240909$20240920$20240920$EXP$$DE-AUROBINDO-AUR-APL-2024-045033$AUROBINDO$Shamseldin M, Heers H, Steiner T, Puls R. Anatomic locations of ureterovascular fistulae: a review of 532 patients in the literature and a new series of 8 patients. CVIR Endovascular. 2024;7(1):63$84$YR$$M$Y$$$20240920$$HP$DE$DE
243426121$24342612$1$I$$20240910$20240920$20240920$EXP$$PT-SA-2024SA269997$SANOFI AVENTIS$$$$E$$Y$$$20240920$$HP$PT$PT
243426131$24342613$1$I$20240812$20240916$20240920$20240920$EXP$FR-AFSSAPS-NT2024001130$FR-SA-2024SA269948$SANOFI AVENTIS$$55$YR$A$M$Y$56$KG$20240920$$MD$FR$FR
243426141$24342614$1$I$$20240918$20240920$20240920$EXP$$US-TAKEDA-2024TUS093262$TAKEDA$$$$$F$Y$$$20240920$$CN$US$US
243426151$24342615$1$I$20240101$20240917$20240920$20240920$EXP$$US-SA-2024SA270891$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240920$$HP$US$US
243426161$24342616$1$I$$20240903$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08841$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243426172$24342617$2$F$20240101$20240920$20240920$20240925$EXP$$US-SA-2024SA271032$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240925$$HP$US$US
243426182$24342618$2$F$20240916$20240918$20240920$20240925$EXP$$GB-AMGEN-GBRSP2024185875$AMGEN$$$$$F$Y$$$20240925$$CN$GB$GB
243426191$24342619$1$I$$20240908$20240920$20240920$EXP$$IN-Accord-446693$ACCORD$Surapaneni D, Dasi SC, Sam N, M J. Methotrexate Toxicity-Induced Pancytopenia and Mucocutaneous Ulcerations in Psoriasis. Cureus. 2024;16(8):e66222.$5$DEC$A$M$Y$$$20240920$$MD$IN$IN
243426201$24342620$1$I$20240404$20240909$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045585$AUROBINDO$$61$YR$$F$Y$65$KG$20240920$$MD$FR$FR
243426211$24342621$1$I$$20240913$20240920$20240920$EXP$$US-JNJFOC-20240939985$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240920$$HP$US$US
243426231$24342623$1$I$20240731$20240914$20240920$20240920$EXP$BR-ANVISA-300286929$BR-009507513-2409BRA006502$MERCK$$62$YR$$M$Y$64.9$KG$20240920$$PH$BR$BR
243426241$24342624$1$I$20240101$20240913$20240920$20240920$EXP$$JP-009507513-2409JPN002465J$MERCK$$62$YR$$M$Y$$$20240920$$MD$JP$JP
243426251$24342625$1$I$$20240903$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08929$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243426261$24342626$1$I$$20240909$20240920$20240920$EXP$$DE-Encube-001327$ENCUBE ETHICALS$Hoffmann E, Toepell A, Peter A, Boke S, De-Colle C, Steinle M, Niyazi M, Gani C. Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy. Strahlenther Onkol. 2024 Sep 4. doi: 10.1007/s00066-024-02287-7.$$$$$Y$$$20240919$$MD$DE$
243426271$24342627$1$I$$20240912$20240920$20240920$PER$$US-HALEON-2196806$Haleon PLC$$$$$F$Y$$$20240920$$CN$US$US
243426281$24342628$1$I$20240909$20240909$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045375$AUROBINDO$$72$YR$$F$Y$60$KG$20240920$$HP$GB$GB
243426291$24342629$1$I$20230412$20240913$20240920$20240920$EXP$SE-SEMPA-2024-006459$SE-862174955-ML2024-04936$Unknown Manufacturer$$78$YR$E$F$Y$55$KG$20240920$$MD$SE$SE
243426301$24342630$1$I$20240422$20240910$20240920$20240920$EXP$$GB-862174955-ML2024-04879$MICRO LABS$$72$YR$E$M$Y$77$KG$20240920$$PH$GB$GB
243426311$24342631$1$I$20140101$20240909$20240920$20240920$EXP$$GB-862174955-ML2024-04852$Unknown Manufacturer$$$$A$M$Y$73$KG$20240920$$MD$GB$GB
243426321$24342632$1$I$20191125$20240912$20240920$20240920$EXP$GB-MHRA-MED-202409120729514340-FMSJY$GB-862174955-ML2024-04904$Unknown Manufacturer$$41$YR$A$M$Y$144$KG$20240920$$CN$GB$GB
243426331$24342633$1$I$$20240918$20240920$20240920$EXP$$NVSC2024US187425$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243426342$24342634$2$F$20240807$20240910$20240920$20240924$EXP$$US-JNJFOC-20240949777$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240924$$MD$US$US
243426351$24342635$1$I$$20240917$20240920$20240920$EXP$$US-JNJFOC-20240944133$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$MD$US$US
243426361$24342636$1$I$$20240911$20240920$20240920$EXP$$MX-NOVITIUMPHARMA-2024MXNVP01901$NOVITIUM PHARMA$Mariano Garcia-Campa.Gastrointestinal Cytomegalovirus Infection in a Transplantation Recipient With a Negative Serum Viral Load: Case Report.Transplantation Proceedings.JUN-2024;56(5):1188-1191$49$YR$A$M$Y$$$20240920$$HP$MX$MX
243426372$24342637$2$F$$20240920$20240920$20240925$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-18832$IPSEN$$$$$F$Y$$$20240925$$CN$GB$GB
243426381$24342638$1$I$20240903$20240914$20240920$20240920$EXP$$CN-009507513-2409CHN006457$MERCK$$54$YR$$M$Y$$$20240920$$HP$CN$CN
243426391$24342639$1$I$$20240911$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-046039$AUROBINDO$Ikic A, Chatelus E, Epailly E, Kremer H, Sibilia J, Gottenberg J, et al.. Heart transplantation in 6 patients with systemic sclerosis and a primary cardiac involvement.. DEFAULT RECORD. 2014;S740$$$$M$Y$$$20240920$$HP$FR$FR
243426401$24342640$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010959$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243426421$24342642$1$I$$20240909$20240920$20240920$EXP$$DE-AUROBINDO-AUR-APL-2024-045031$AUROBINDO$Shamseldin M, Heers H, Steiner T, Puls R. Anatomic locations of ureterovascular fistulae: a review of 532 patients in the literature and a new series of 8 patients. CVIR Endovascular. 2024;7(1):63$80$YR$$F$Y$$$20240920$$HP$DE$DE
243426431$24342643$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010940$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243426441$24342644$1$I$$20240909$20240920$20240920$EXP$$DE-AUROBINDO-AUR-APL-2024-045547$AUROBINDO$Wurpts G, Merk H... Baboon Syndrome after ingestion of amoxicillin... Der Hautarzt 5.. ;. 2006;57(5):452-4$32$YR$$M$Y$$$20240920$$MD$DE$DE
243426451$24342645$1$I$$20240912$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045839$AUROBINDO$$78$YR$$F$Y$$$20240920$$MD$FR$FR
243426461$24342646$1$I$20240730$20240919$20240920$20240920$EXP$FR-AFSSAPS-LY2024001321$FR-BIOVITRUM-2024-FR-012252$BIOVITRUM$$30$YR$$F$Y$47$KG$20240920$$PH$FR$FR
243426471$24342647$1$I$20210101$20240909$20240920$20240920$EXP$$DE-AUROBINDO-AUR-APL-2024-045240$AUROBINDO$$$$A$F$Y$$$20240920$$MD$DE$DE
243426481$24342648$1$I$$20240912$20240920$20240920$EXP$$CA-CELLTRION INC.-2024CA021541$CELLTRION$$$$$$Y$$$20240920$$MD$CA$CA
243426491$24342649$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149131$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240920$$CN$US$US
243426501$24342650$1$I$20240126$20240913$20240920$20240920$EXP$$CO-UCBSA-2024047727$UCB$$14$YR$$M$Y$$$20240920$$CN$CO$CO
243426511$24342651$1$I$20240101$20240909$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045498$AUROBINDO$$35$YR$$M$Y$70$KG$20240920$$MD$FR$FR
243426521$24342652$1$I$20240911$20240912$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145822$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$87.9$KG$20240920$$PH$US$US
243426531$24342653$1$I$$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024185464$AMGEN$$$$$$Y$$$20240920$$PH$US$US
243426541$24342654$1$I$$20240909$20240920$20240920$EXP$$GR-Accord-446657$ACCORD$Poulia V., Boboli M., Skorda L. Reactivation of hepatitis b in a 40-year-old woman with metastatic breast cancer under everolimus. European Journal of Case Reports in Internal Medicine. 2023;10 (supp1):237.$40$YR$A$F$Y$$$20240920$$HP$GR$GR
243426551$24342655$1$I$$20240909$20240920$20240920$EXP$$CH-Accord-447165$ACCORD$Ovchinnikov A, Andereggen L, Rogers S, Gschwind M. Visual hallucinations after resection of cerebral metastases: two patients with complex phantom images. Strahlentherapie und Onkologie. 2024;200(9):832-7. DOI: 10.1007/s00066-024-02213-x.$8$DEC$E$M$Y$$$20240920$$MD$CH$CH
243426561$24342656$1$I$$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024184698$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243426571$24342657$1$I$$20240911$20240920$20240920$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08614$HIKMA$$$$$M$Y$$$20240920$$CN$US$US
243426591$24342659$1$I$20240501$20240913$20240920$20240920$EXP$FR-AFSSAPS-AVLY2024000175$FR-TEVA-VS-3243969$TEVA$$44$YR$$M$Y$$$20240920$$MD$FR$FR
243426601$24342660$1$I$$20240911$20240920$20240920$PER$$US-TAKEDA-2024TUS091932$TAKEDA$$$$$$Y$$$20240920$$CN$US$US
243426611$24342661$1$I$$20240904$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08901$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243426621$24342662$1$I$$20240910$20240920$20240920$EXP$$PT-Accord-447134$ACCORD$Leao A, Correia J, Broa AL,  Grilo VL, Trabucho I. PO-0701 - (4924) - NOT ALL BEHAVIORAL CHANGES IN THE ELDERLY ARE DELIRIUM. 30 CNMI.$75$YR$E$F$Y$$$20240920$$HP$PT$PT
243426641$24342664$1$I$20240705$20240912$20240920$20240920$EXP$$CA-CELLTRION INC.-2024CA017847$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
243426671$24342667$1$I$$20240909$20240920$20240920$EXP$CA-APOTEX-2024AP010347$CA-Accord-447544$ACCORD$$66$YR$E$M$Y$$$20240920$$HP$CA$CA
243426682$24342668$2$F$$20240919$20240920$20240923$PER$$NVSC2024US187782$NOVARTIS$$$$$M$Y$$$20240923$$CN$US$US
243426701$24342670$1$I$$20240911$20240920$20240920$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01927$NOVITIUM PHARMA$Kaikai Huo.Short segment myelitis as a dominant manifestation of cryptococcal infection: a case report.BMC Infectious Diseases.26-AUG-2024;24:1-5$38$YR$A$M$Y$$$20240920$$HP$CN$CN
243426731$24342673$1$I$20201126$20240910$20240920$20240920$EXP$$PL-AUROBINDO-AUR-APL-2024-045625$AUROBINDO$$28$YR$$F$Y$70$KG$20240920$$MD$PL$PL
243426741$24342674$1$I$$20240911$20240920$20240920$EXP$$CZ-CELLTRION INC.-2024CZ000687$CELLTRION$Sglunda O.. Treatment with Filgotinib in a Patient with Active Rheumatoid Arthritis and a History of Cardiovascular Diseases. MAPO revma Ostrava s.r.o.. 2023;19(6):790, 792$$$$$Y$$$20240920$$MD$CZ$CZ
243426751$24342675$1$I$20240823$20240911$20240920$20240920$EXP$$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-08595$HIKMA$$51$YR$$F$Y$48$KG$20240920$$PH$GB$GB
243426761$24342676$1$I$$20240916$20240920$20240920$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-148029$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$90.72$KG$20240920$$CN$PR$PR
243426771$24342677$1$I$20240620$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149432$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240920$$CN$US$US
243426781$24342678$1$I$$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149447$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240920$$CN$US$US
243426791$24342679$1$I$20240919$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149691$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240920$$HP$US$US
243426801$24342680$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148381$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240920$$HP$US$US
243426811$24342681$1$I$20240827$20240918$20240920$20240920$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-149193$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$71.67$KG$20240920$$CN$PR$PR
243426821$24342682$1$I$20240801$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147668$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240920$$HP$US$US
243426831$24342683$1$I$$20240912$20240920$20240920$PER$$US-JNJFOC-20240940455$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20240920$$CN$US$US
243426851$24342685$1$I$20130101$20240913$20240920$20240920$EXP$FR-AFSSAPS-AVLY2024000144$FR-TEVA-VS-3243917$TEVA$$30$YR$$F$Y$56$KG$20240920$$MD$FR$FR
243426861$24342686$1$I$20240101$20240906$20240920$20240920$EXP$$US-UCBSA-2024045782$UCB$$68$YR$$F$Y$$$20240920$$CN$US$US
243426871$24342687$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010943$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243426881$24342688$1$I$$20240917$20240920$20240920$EXP$CA-DRL-USA-SPO/CAN/24/0013683$CA-RDY-SPO/CAN/24/0013683$DR REDDYS$$$$$M$Y$$$20240920$$MD$CA$CA
243426892$24342689$2$F$$20240909$20240920$20240924$EXP$$US-MSNLABS-2024MSNLIT02041$MSN LABORATORIES$$$$$$Y$$$20240924$$MD$US$US
243426901$24342690$1$I$$20240905$20240920$20240920$PER$$US-LEO Pharma-373348$LEO PHARM$$71$YR$$F$Y$95$KG$20240920$$CN$US$US
243426961$24342696$1$I$20240901$20240910$20240920$20240920$EXP$$US-GSK-US2024112467$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$HP$US$US
243426971$24342697$1$I$$20240911$20240920$20240920$EXP$$US-GSK-US2024112985$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243426982$24342698$2$F$20240901$20240924$20240920$20240927$EXP$$IL-ABBVIE-5925263$ABBVIE$$71$YR$$M$Y$$$20240927$$MD$IL$IL
243426991$24342699$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187233$AMGEN$$$$$F$Y$$$20240920$$HP$US$US
243427001$24342700$1$I$20240917$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186723$AMGEN$$64$YR$A$F$Y$$$20240920$$CN$US$US
243427011$24342701$1$I$$20240913$20240920$20240920$PER$$US-TAKEDA-2024TUS091733$TAKEDA$$$$$M$Y$$$20240920$$CN$US$US
243427031$24342703$1$I$$20240905$20240920$20240920$EXP$$CA-BAXTER-2024BAX024447$BAXTER$$14$YR$$M$Y$$$20240920$$HP$CA$CA
243427041$24342704$1$I$20240811$20240919$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149669$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240920$$CN$US$US
243427052$24342705$2$F$20240201$20240918$20240920$20240924$EXP$$NVSC2024CR186758$NOVARTIS$$55$YR$$F$Y$$$20240924$$CN$CR$CR
243427061$24342706$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149831$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240920$$CN$US$US
243427071$24342707$1$I$$20240910$20240920$20240920$EXP$$JP-MYE-2024M1084448AA$MYLAN$Oishi H, Numasawa T, Nohmi S, Nitobe Y, Ono H, Nagaoki T, et al. Exercise-induced acute rhabdomyolysis with bilateral gluteal, thigh, and leg compartment syndrome: A case report. J-Orthop-Sci 2024; 29 (1): 361-365.. 2024;29 (1):361-365$35$YR$$M$Y$$$20240920$$HP$JP$JP
243427081$24342708$1$I$20240827$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149648$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$88.9$KG$20240920$$CN$US$US
243427091$24342709$1$I$$20240910$20240920$20240920$EXP$$US-MYLANLABS-2024M1084090$MYLAN$Tarantino MD, Hardesty B, Metjian A, Ortel TL, Chen J, Badejo K, et al. Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety study. Haemophilia 2023; 29 (5): 1259-1268.$$$E$F$Y$$$20240920$$HP$US$US
243427101$24342710$1$I$$20240910$20240920$20240920$EXP$$FR-MYLANLABS-2024M1084242$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$49$YR$$M$Y$$$20240920$$HP$FR$FR
243427111$24342711$1$I$$20240910$20240920$20240920$EXP$$FR-MYLANLABS-2024M1084239$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic? J-Eur-Acad-Dermatol-Venereol 2024.$27$YR$$M$Y$$$20240920$$HP$FR$FR
243427121$24342712$1$I$$20240910$20240920$20240920$EXP$$FR-MYLANLABS-2024M1084235$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic. J-Eur-Acad-Dermatol-Venereol 2024;.$41$YR$$M$Y$$$20240920$$HP$FR$FR
243427131$24342713$1$I$$20240911$20240920$20240920$EXP$$JP-MYE-2024M1084449AA$MYLAN$Yoshii R, Kajiwara K, Uemura N, Matsushita K, Nakamura T, Tomita M, et al. The successful treatment of microscopic polyangiitis associated with non-tuberculous mycobacterial-pulmonary disease. CEN-Case-Rep 2024; 13 (4): 271-276.. 2024;13 (4):271-276$72$YR$$M$Y$$$20240920$$HP$JP$JP
243427141$24342714$1$I$$20240911$20240920$20240920$EXP$$US-MYLANLABS-2024M1084498$MYLAN$Abugrin M, Panchal A, Aboulqassim B, Bilal M, Virk J. Timely Transesophageal Echocardiography After Left Atrial Appendage Occlusion May Avoid Delayed Detection of Device-Related Thrombus. CASE-(Morrisville) 2024; 8 (9): 456-460.$72$YR$$$Y$$$20240920$$MD$US$US
243427151$24342715$1$I$$20240905$20240920$20240920$EXP$$CA-BAXTER-2024BAX024535$BAXTER$$$$$F$Y$$$20240920$$HP$CA$CA
243427161$24342716$1$I$$20240909$20240920$20240920$EXP$$US-MYLANLABS-2024M1083730$MYLAN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.$77$YR$$M$Y$$$20240920$$HP$US$US
243427171$24342717$1$I$$20240916$20240920$20240920$EXP$NL-LRB-01000852$NL-TEVA-VS-3244398$TEVA$$69$YR$$M$Y$70$KG$20240920$$CN$NL$NL
243427181$24342718$1$I$$20240910$20240920$20240920$EXP$$CA-APOTEX-2024AP011074$APOTEX$Gharial J, Guilcher G, Truong T, Shah R, Desai S, Rojas-Vasquez M et al. Busulfan with 400 centigray of total body irradiation and higher dose fludarabine: An alternative regimen for hematopoietic stem cell transplantation in pediatric acute lymphoblastic leukemia. Pediatric Blood + Cancer. 2024;71:e30844:1-8$$$C$$Y$$$20240920$$HP$CA$CA
243427191$24342719$1$I$$20240906$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09001$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243427201$24342720$1$I$20240301$20240719$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110242$ZYDUS PHARM$$$$$$Y$$$20240920$$HP$US$US
243427211$24342721$1$I$20240101$20240722$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110243$ZYDUS PHARM$$$$$$Y$$$20240920$$HP$US$US
243427221$24342722$1$I$20240701$20240723$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110319$ZYDUS PHARM$$$$$$Y$$$20240920$$CN$US$US
243427231$24342723$1$I$$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024185470$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243427241$24342724$1$I$20240719$20240722$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110241$ZYDUS PHARM$$$$$$Y$$$20240920$$CN$US$US
243427251$24342725$1$I$20240918$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186818$AMGEN$$80$YR$E$F$Y$$$20240920$$CN$US$US
243427261$24342726$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186911$AMGEN$$$$$F$Y$$$20240920$$MD$US$US
243427271$24342727$1$I$20240101$20240725$20240920$20240920$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110561$ZYDUS PHARM$$$$$$Y$$$20240920$$CN$US$US
243427281$24342728$1$I$20240101$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024184996$AMGEN$$73$YR$E$F$Y$$$20240920$$CN$US$US
243427291$24342729$1$I$$20240905$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08998$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243427303$24342730$3$F$20240801$20240920$20240920$20240926$EXP$$AR-MYLANLABS-2024M1083988$MYLAN$$16$YR$$M$Y$$$20240926$$MD$AR$AR
243427312$24342731$2$F$$20240914$20240920$20240926$PER$$US-AMGEN-USASP2024186959$AMGEN$$$$A$M$Y$$$20240925$$MD$US$US
243427321$24342732$1$I$$20240917$20240920$20240920$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-18831$IPSEN$$64$YR$A$F$Y$$$20240920$$PH$US$US
243427331$24342733$1$I$$20240918$20240920$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU081527$SANDOZ$$$$$$Y$$$20240920$$CN$AU$AU
243427342$24342734$2$F$20240101$20240917$20240920$20240926$EXP$$CA-CELLTRION INC.-2024CA017911$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243427351$24342735$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010944$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243427361$24342736$1$I$20220101$20240910$20240920$20240920$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08609$HIKMA$$62$YR$$M$Y$$$20240920$$MD$US$US
243427371$24342737$1$I$20240801$20240910$20240920$20240920$EXP$$DE-AUROBINDO-AUR-APL-2024-045448$AUROBINDO$$$$A$F$Y$$$20240920$$MD$DE$DE
243427381$24342738$1$I$20240829$20240910$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045740$AUROBINDO$$$DY$$M$Y$3.6$KG$20240920$$MD$FR$FR
243427391$24342739$1$I$$20240919$20240920$20240920$EXP$$GB-TEVA-VS-3245486$TEVA$$32$YR$$M$Y$46$KG$20240920$$CN$GB$GB
243427411$24342741$1$I$20240617$20240911$20240920$20240920$EXP$$BR-EMD Serono-2024048957$EMD SERONO INC$$34$YR$A$F$Y$$$20240920$$CN$BR$BR
243427431$24342743$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011777$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240920$$CN$US$US
243427441$24342744$1$I$20240905$20240919$20240920$20240920$EXP$$SG-MYLANLABS-2024M1085466$MYLAN$$52$YR$$F$Y$$$20240920$$HP$SG$SG
243427452$24342745$2$F$20240917$20240918$20240920$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409010895$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240930$$CN$US$US
243427461$24342746$1$I$19960901$20240917$20240920$20240920$EXP$$NL-SANDOZ INC.-NVSC2008NL004341$SANDOZ$$24$YR$$F$Y$$$20240920$$MD$NL$NL
243427473$24342747$3$F$$20240924$20240920$20240927$EXP$$NZ-MYLANLABS-2024M1085333$MYLAN$$$$$M$Y$$$20240927$$MD$NZ$NZ
243427492$24342749$2$F$$20240924$20240920$20240924$EXP$$NZ-MYLANLABS-2024M1085664$MYLAN$$$$$M$Y$$$20240924$$CN$NZ$NZ
243427501$24342750$1$I$20240918$20240919$20240920$20240920$EXP$GB-MHRA-MED-202409180906584710-RMLZB$GB-MYLANLABS-2024M1085575$MYLAN$$57$YR$$F$Y$70$KG$20240920$$CN$GB$GB
243427511$24342751$1$I$$20240919$20240920$20240920$EXP$$NZ-MYLANLABS-2024M1085671$MYLAN$$$$$M$Y$$$20240920$$HP$NZ$NZ
243427521$24342752$1$I$$20240916$20240920$20240920$EXP$PL-URPL-2-811-2019$PL-CHEPLA-2024011853$CHEPLAPHARM$$$$$M$Y$$$20240920$$CN$COUNTRY NOT SPECIFIED$PL
243427541$24342754$1$I$$20240906$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143144$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240920$$CN$US$US
243427551$24342755$1$I$20240910$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147771$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240920$$PH$US$US
243427561$24342756$1$I$$20240909$20240920$20240920$EXP$$US-INDOCO-IND-2024-US-LIT-00110$INDOCO$Bierly JJ, Peterson BL.Distribution of donepezil in postmortem casework.Journal of Forensic and Legal Medicine.01-JAN-2024;101:1-6$82$YR$E$$Y$$$20240920$$HP$US$US
243427571$24342757$1$I$$20240913$20240920$20240920$EXP$$CA-ABBVIE-5927399$ABBVIE$$61$YR$$F$Y$$$20240920$$MD$CA$CA
243427581$24342758$1$I$20231113$20240909$20240920$20240920$EXP$$DE-AUROBINDO-AUR-APL-2024-045489$AUROBINDO$$$$A$M$Y$$$20240920$$MD$DE$DE
243427592$24342759$2$F$20240101$20240919$20240920$20240926$EXP$$US-ABBVIE-5929864$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243427601$24342760$1$I$$20240905$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08957$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243427611$24342761$1$I$20240515$20240909$20240920$20240920$EXP$$FR-AUROBINDO-AUR-APL-2024-045563$AUROBINDO$$31$YR$$M$Y$$$20240920$$PH$FR$FR
243427622$24342762$2$F$20240901$20240923$20240920$20240927$EXP$$US-ABBVIE-5927775$ABBVIE$$58$YR$$F$Y$$$20240927$$CN$US$US
243427631$24342763$1$I$$20240906$20240920$20240920$30DAY$$JP-JNJFOC-20240950143$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$PH$JP$JP
243427661$24342766$1$I$$20240914$20240920$20240920$EXP$GB-MHRA-MED-202409131236254910-ZPVYR$GB-CHEPLA-2024011857$CHEPLAPHARM$$$$$F$Y$$$20240920$$PH$COUNTRY NOT SPECIFIED$GB
243427671$24342767$1$I$20240101$20240912$20240920$20240920$EXP$$US-INTERCEPT-PM2024001835$INTERCEPT PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243427681$24342768$1$I$20240101$20240913$20240920$20240920$EXP$$US-INTERCEPT-PM2024001850$INTERCEPT PHARMACEUTICALS$$$$$M$Y$72.608$KG$20240920$$CN$US$US
243427691$24342769$1$I$20231201$20240916$20240920$20240920$EXP$FR-AFSSAPS-MA2024001285$FR-ORGANON-O2409FRA001117$ORGANON$$35$YR$$F$Y$$$20240920$$MD$FR$FR
243427711$24342771$1$I$$20240916$20240920$20240920$EXP$$US-ABBVIE-5927945$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243427741$24342774$1$I$20240816$20240911$20240920$20240920$EXP$$CN-JNJFOC-20240934376$JOHNSON AND JOHNSON$$9$MON$I$F$Y$$$20240920$$HP$CN$CN
243427751$24342775$1$I$20201126$20240916$20240920$20240920$EXP$PL-URPL-1-3245-2020$PL-CHEPLA-2024011854$CHEPLAPHARM$$28$YR$A$F$Y$70$KG$20240920$$MD$COUNTRY NOT SPECIFIED$PL
243427761$24342776$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-014014$BAUSCH AND LOMB$$62$YR$$M$Y$$$20240920$$CN$CA$CA
243427771$24342777$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-014019$BAUSCH AND LOMB$$55$YR$$$Y$$$20240920$$CN$CA$CA
243427781$24342778$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013997$BAUSCH AND LOMB$$49$YR$$M$Y$$$20240920$$CN$CA$CA
243427791$24342779$1$I$20240101$20240911$20240920$20240920$PER$$US-ABBVIE-5922312$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243427801$24342780$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149306$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240920$$CN$US$US
243427811$24342781$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-014021$BAUSCH AND LOMB$$81$YR$$M$Y$$$20240920$$CN$CA$CA
243427821$24342782$1$I$$20240913$20240920$20240920$EXP$$CA-CHEPLA-2024011904$CHEPLAPHARM$$42$YR$$M$Y$$$20240920$$CN$COUNTRY NOT SPECIFIED$CA
243427831$24342783$1$I$20240906$20240912$20240920$20240920$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00940$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243427841$24342784$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149394$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240920$$HP$US$US
243427851$24342785$1$I$$20240912$20240920$20240920$EXP$$TH-BRISTOL-MYERS SQUIBB COMPANY-2024-149319$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240920$$CN$TH$TH
243427861$24342786$1$I$$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147753$BRISTOL MYERS SQUIBB$$22$YR$A$F$Y$$$20240920$$CN$US$US
243427871$24342787$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149450$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240920$$HP$US$US
243427881$24342788$1$I$$20240910$20240920$20240920$EXP$$US-MYLANLABS-2024M1083112$MYLAN$$62$YR$$M$Y$$$20240920$$MD$US$US
243427891$24342789$1$I$$20240906$20240920$20240920$EXP$$US-MYLANLABS-2024M1082782$MYLAN$$$$$M$Y$56.7$KG$20240920$$CN$US$US
243427901$24342790$1$I$$20240916$20240920$20240920$EXP$$US-ABBVIE-5927260$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243427913$24342791$3$F$20240918$20240920$20240920$20240924$PER$$US-AMGEN-USASP2024187362$AMGEN$$65$YR$E$F$Y$$$20240924$$CN$US$US
243427921$24342792$1$I$$20221118$20240920$20240920$EXP$$JP-Orion Corporation ORION PHARMA-ENTC2024-0111$ORION$$72$YR$E$F$Y$$$20240920$$PH$JP$
243427931$24342793$1$I$$20240913$20240920$20240920$EXP$$IT-RDY-LIT/ITA/24/0005039$DR REDDYS$Panuccio VA, Tripepi R, Postorino A, Greve B, Sabattini E, Oliva EN. Does Etelcalcetide reverse myelofibrotic bone changes due to hyperparathyroidism? A case report. Frontiers in Medicine. 2022;9: doi:10.3389/fmed.2022.1050062.$32$YR$A$M$Y$$$20240920$$HP$IT$IT
243427942$24342794$2$F$20231223$20240912$20240920$20240924$EXP$$CA-CELLTRION INC.-2023CA025287$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
243427951$24342795$1$I$$20240911$20240920$20240920$EXP$$ZA-Vifor (International) Inc.-VIT-2024-08320$VIFOR$$72$YR$$F$Y$$$20240920$$HP$ZA$ZA
243427961$24342796$1$I$20180905$20240918$20240920$20240920$EXP$$DE-SANDOZ INC.-SDZ2024DE081270$SANDOZ$$$$$M$Y$$$20240920$$HP$DE$DE
243427971$24342797$1$I$20240906$20240912$20240920$20240920$EXP$$US-GSK-US2024113635$GLAXOSMITHKLINE$$68$YR$$M$Y$$$20240920$$HP$US$US
243427981$24342798$1$I$20240904$20240911$20240920$20240920$EXP$$SE-Valinor Pharma, LLC-VLR202409-000108$Valinor Pharma$$80$YR$E$M$Y$$$20240920$$HP$SE$
243427991$24342799$1$I$20240830$20240917$20240920$20240920$30DAY$$US-UCBSA-2024046807$UCB$$47$YR$$F$Y$$$20240920$$CN$US$US
243428002$24342800$2$F$$20240913$20240920$20240927$EXP$$US-MYLANLABS-2024M1084356$MYLAN$$$$$F$Y$$$20240927$$CN$US$US
243428011$24342801$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010977$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243428021$24342802$1$I$20240717$20240916$20240920$20240920$EXP$FI-FIMEA-202403257$FI-CHEPLA-2024011859$CHEPLAPHARM$$73$YR$$F$Y$$$20240920$$MD$COUNTRY NOT SPECIFIED$FI
243428031$24342803$1$I$20240704$20240910$20240920$20240920$EXP$$GB-AUROBINDO-AUR-APL-2024-045323$AUROBINDO$$27$YR$$F$Y$99$KG$20240920$$HP$GB$GB
243428041$24342804$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149556$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240920$$HP$US$US
243428051$24342805$1$I$$20240911$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145373$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240920$$CN$US$US
243428061$24342806$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149700$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240920$$HP$US$US
243428071$24342807$1$I$$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149053$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$70.31$KG$20240920$$CN$US$US
243428081$24342808$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149542$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240920$$HP$US$US
243428091$24342809$1$I$$20240912$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146056$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$100.7$KG$20240920$$CN$US$US
243428111$24342811$1$I$20240101$20240912$20240920$20240920$PER$$US-MYLANLABS-2024M1083818$MYLAN$$$$$F$Y$112.94$KG$20240920$$CN$US$US
243428121$24342812$1$I$20230901$20240916$20240920$20240920$EXP$$US-ABBVIE-5927365$ABBVIE$$54$YR$$M$Y$$$20240920$$CN$US$US
243428131$24342813$1$I$$20240918$20240920$20240920$EXP$$US-UCBSA-2024047945$UCB$Tang A, Yoshida K, Lahey H, Wilcox DR, Guan H, Costenbader K et al. Herpes Simplex Virus Encephalitis in Patients With Autoimmune Conditions or Exposure to Immunomodulatory Medications. Neurology. 2024;102(10):1-8$$$$$Y$$$20240920$$MD$US$US
243428141$24342814$1$I$$20240916$20240920$20240920$EXP$$FR-ORGANON-O2409FRA000887$ORGANON$$$$$F$Y$$$20240920$$MD$FR$FR
243428151$24342815$1$I$$20240910$20240920$20240920$EXP$$US-GSK-US2024AMR113272$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243428161$24342816$1$I$$20240905$20240920$20240920$30DAY$$BE-JNJFOC-20240943362$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$BE$BE
243428171$24342817$1$I$$20240909$20240920$20240920$EXP$$BR-BAYER-2024A132612$BAYER$Bidu NS, Costa ST, Couto RD, Fernandes BJD. Ciprofloxacin^s Structure Causing Fluoride-Related Toxicity: A Case Report.. Current drug safety. 2024$32$YR$A$M$Y$95$KG$20240920$$PH$BR$BR
243428181$24342818$1$I$$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024187757$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243428191$24342819$1$I$20240914$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024185041$AMGEN$$31$YR$A$F$Y$$$20240920$$CN$US$US
243428201$24342820$1$I$20240910$20240916$20240920$20240920$EXP$$US-MYLANLABS-2024M1085394$MYLAN$$56$YR$$M$Y$$$20240920$$CN$US$US
243428211$24342821$1$I$20240101$20240905$20240920$20240920$EXP$$US-SA-2024SA271153$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240920$$MD$US$US
243428221$24342822$1$I$$20240905$20240920$20240920$30DAY$$AT-JNJFOC-20240946241$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$AT$AT
243428231$24342823$1$I$20240917$20240919$20240920$20240920$EXP$GB-MHRA-MED-202409180947199770-YMGQC$GB-TEVA-VS-3245490$TEVA$$38$YR$$M$Y$73$KG$20240920$$CN$GB$GB
243428241$24342824$1$I$$20240910$20240920$20240920$EXP$$US-862174955-ML2024-00003$Unknown Manufacturer$Barkhordarian M, Grijalva M, Jarri A, Belyayeva A, Weissman S. Rare or Disregarded; A Case of Autoimmune Myopathy. Circulation. 2023;(Suppl 1)(148): doi:10.1161/circ.148.suppl_1.16715.$69$YR$E$M$Y$$$20240920$$MD$US$US
243428251$24342825$1$I$$20240909$20240920$20240920$EXP$CA-APOTEX-2024AP010353$CA-Accord-447044$ACCORD$$3$YR$C$$Y$$$20240920$$CN$CA$
243428263$24342826$3$F$20240101$20240919$20240920$20240927$EXP$$US-ABBVIE-5801622$ABBVIE$$$$$F$Y$47$KG$20240927$$CN$US$US
243428271$24342827$1$I$$20240910$20240920$20240920$EXP$$US-862174955-ML2024-04916$Unknown Manufacturer$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2023 Nov 29;101(102625): 1-6. doi:10.1016/j.jflm.2023.102625.$82$YR$E$$Y$$$20240920$$HP$US$US
243428281$24342828$1$I$$20240909$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013639$DR REDDYS$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al. Evaluation of off-label rapamycin use on oral health. GeroScience. 2024;46: 4135-4146. doi:10.1007/s11357-024-01221-0.$73$YR$E$M$Y$$$20240920$$HP$US$US
243428291$24342829$1$I$$20240909$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013638$DR REDDYS$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al. Evaluation of off-label rapamycin use on oral health. GeroScience. 2024;46: 4135-4146. doi:10.1007/s11357-024-01221-0.$67$YR$E$M$Y$$$20240920$$HP$US$US
243428301$24342830$1$I$$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64456$$FDA-CTU$$$$$F$N$$$20240918$N$$US$
243428312$24342831$2$F$$20240920$20240920$20240925$EXP$$NVSC2024GB068824$NOVARTIS$$$$$$Y$$$20240925$$HP$GB$GB
243428321$24342832$1$I$$20240916$20240920$20240920$EXP$$ES-CHEPLA-2024011988$CHEPLAPHARM$Chovi-Trull M, Ballesta- Lopez O, Navarro Buendia GA, Sivera- Mascaro R, Albert- Mari A, Ruiz Caldes MJ, et al. Toxic- metabolic encephalopathy induced by metronidazole and disulfiram: classics never die. European association of hospital pharmacists. 2024;0:1-5. doi:10.1136/ ejhpharm-2024-004184.$53$YR$$M$Y$$$20240920$$MD$COUNTRY NOT SPECIFIED$ES
243428331$24342833$1$I$20240824$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64446$$FDA-CTU$$73$YR$$F$N$$$20240919$Y$PH$US$
243428341$24342834$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187322$AMGEN$$$$$F$Y$$$20240920$$CN$US$US
243428351$24342835$1$I$$20240910$20240920$20240920$EXP$$BE-AUROBINDO-AUR-APL-2024-045632$AUROBINDO$Balthasar Y. Reversible Cerebral VasoconstrictionSyndrome: Case Study and the Role ofSubstance Use, COVID-19, and Psychotropic Drugs. PSYCHIATRY AND COVID-19. 2024;66(6):296-300$27$YR$$M$Y$$$20240920$$MD$BE$BE
243428361$24342836$1$I$$20240912$20240920$20240920$EXP$$US-EMD Serono-2024049191$EMD SERONO INC$$$$E$F$Y$$$20240920$$CN$US$US
243428371$24342837$1$I$$20240913$20240920$20240920$EXP$$US-ABBVIE-5924694$ABBVIE$$$$$M$Y$$$20240920$$HP$US$US
243428382$24342838$2$F$$20240919$20240920$20240925$EXP$$CA-JNJFOC-20240931166$JOHNSON AND JOHNSON$$40$YR$A$F$Y$96$KG$20240925$$CN$CA$CA
243428391$24342839$1$I$$20240914$20240920$20240920$PER$$US-JNJFOC-20240939953$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243428412$24342841$2$F$20240918$20240918$20240920$20240924$PER$$US-AMGEN-USASP2024186850$AMGEN$$82$YR$E$F$Y$$$20240924$$CN$US$US
243428422$24342842$2$F$20240909$20240920$20240920$20240921$PER$$US-AMGEN-USASP2024187911$AMGEN$$81$YR$E$M$Y$$$20240920$$CN$US$US
243428431$24342843$1$I$$20240905$20240920$20240920$EXP$$CA-BAXTER-2024BAX024445$BAXTER$$65$YR$$F$Y$69$KG$20240920$$HP$CA$CA
243428441$24342844$1$I$$20240911$20240920$20240920$EXP$$US-GSK-US2024113138$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$MD$US$US
243428451$24342845$1$I$20240901$20240913$20240920$20240920$EXP$$US-GSK-US2024114340$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243428461$24342846$1$I$$20240910$20240920$20240920$EXP$$US-GSK-US2024AMR113959$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243428471$24342847$1$I$$20240911$20240920$20240920$30DAY$$US-GSK-US2024112957$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$PH$US$US
243428481$24342848$1$I$$20240912$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409009320$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240920$$CN$US$US
243428491$24342849$1$I$20240909$20240909$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409006454$ELI LILLY AND CO$$$$$$Y$$$20240920$$CN$US$US
243428501$24342850$1$I$20240801$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011130$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240920$$CN$US$US
243428511$24342851$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011606$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240920$$CN$US$US
243428521$24342852$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011045$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240920$$CN$US$US
243428531$24342853$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011681$ELI LILLY AND CO$$$$$$Y$$$20240920$$CN$US$US
243428541$24342854$1$I$20240816$20240913$20240920$20240920$EXP$$NVSC2024DE185708$NOVARTIS$$33$YR$$M$Y$70$KG$20240920$$MD$DE$DE
243428561$24342856$1$I$20240720$20240909$20240920$20240920$EXP$ES-AEMPS-1567707$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-144931$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240920$$MD$ES$ES
243428571$24342857$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149594$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$109.32$KG$20240920$$CN$US$US
243428581$24342858$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149524$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240920$$CN$US$US
243428591$24342859$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149561$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240920$$HP$US$US
243428601$24342860$1$I$20240906$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148469$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240920$$HP$US$US
243428611$24342861$1$I$$20240913$20240920$20240920$EXP$$US-ABBVIE-5928543$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243428621$24342862$1$I$20240823$20240913$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147055$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$83.46$KG$20240920$$PH$US$US
243428631$24342863$1$I$$20240906$20240920$20240920$30DAY$$CA-JNJFOC-20240939955$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$HP$CA$CA
243428641$24342864$1$I$20240808$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64468$$FDA-CTU$$48$YR$$F$N$$$20240919$Y$PH$US$
243428651$24342865$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64443$$FDA-CTU$$48$YR$$F$N$$$20240919$N$$US$
243428661$24342866$1$I$20240714$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64437$$FDA-CTU$$37$YR$$F$N$50.8$KG$20240919$Y$$US$
243428671$24342867$1$I$$20240918$20240920$20240920$PER$$US-ORGANON-O2409USA001292$ORGANON$Coutinho PB, Johnson KA, Seritan AL, Galifianakis NB, Coleman R, Wang D, et al.. Elevated Mood Induced by Subthalamic Nucleus Deep Brain Stimulation: A Video-Recorded Case Report.. Tremor and Other Hyperkinetic Movements.. 2024;14(1):1-8$73$YR$$M$Y$72.1$KG$20240920$$MD$US$US
243428681$24342868$1$I$$20240916$20240920$20240920$EXP$$GB-MYLANLABS-2024M1084912$MYLAN$$$$$M$Y$$$20240920$$MD$GB$GB
243428691$24342869$1$I$20240918$20240918$20240920$20240920$PER$$US-ORGANON-O2409USA001459$ORGANON$$$$$$Y$$$20240920$$CN$US$US
243428701$24342870$1$I$20240801$20240910$20240920$20240920$30DAY$$US-GSK-US2024AMR113279$GLAXOSMITHKLINE$$72$YR$$F$Y$$$20240920$$CN$US$US
243428711$24342871$1$I$20240217$20240917$20240920$20240920$EXP$$IT-GILEAD-2024-0687945$GILEAD$$43$YR$A$F$Y$$$20240920$$MD$IT$IT
243428721$24342872$1$I$20240831$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64439$$FDA-CTU$$75$YR$$F$N$$$20240919$Y$PH$US$
243428731$24342873$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64411$$FDA-CTU$$64$YR$$F$N$$$20240919$N$$US$
243428741$24342874$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64445$$FDA-CTU$$78$YR$$F$N$$$20240919$N$$US$
243428751$24342875$1$I$20240101$20240914$20240920$20240920$EXP$$US-SA-2024SA269366$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240920$$MD$US$US
243428761$24342876$1$I$$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024186394$AMGEN$$$$$$Y$$$20240920$$PH$US$US
243428781$24342878$1$I$20240101$20240916$20240920$20240920$EXP$$US-ABBVIE-5927349$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243428791$24342879$1$I$$20240910$20240920$20240920$EXP$$CA-HALEON-2197208$Haleon PLC$$$$$F$Y$97$KG$20240920$$HP$CA$CA
243428801$24342880$1$I$20190927$20240917$20240920$20240920$EXP$$US-TAKEDA-US201933370$TAKEDA$$42$YR$$M$Y$$$20240920$$CN$US$US
243428811$24342881$1$I$$20240913$20240920$20240920$EXP$$CA-TAKEDA-2020TUS027365$TAKEDA$$$$$M$Y$$$20240920$$CN$CA$CA
243428821$24342882$1$I$20221110$20240917$20240920$20240920$EXP$$CO-UCBSA-2024048263$UCB$$67$YR$$M$Y$$$20240920$$CN$CO$CO
243428831$24342883$1$I$20240101$20240906$20240920$20240920$PER$$US-TEVA-VS-3241466$TEVA$$57$YR$$F$Y$$$20240920$$PH$US$US
243428841$24342884$1$I$$20240912$20240920$20240920$EXP$$DE-MYLANLABS-2024M1085183$MYLAN$Lee A, Jahnke AK, Altenmuller E. Fixed dystonia of the left hand in a violinist: A rare functional disorder. Tremor-Other-Hyperkinet-Mov 2013; 1 (1):.$21$YR$$F$Y$$$20240920$$HP$DE$DE
243428851$24342885$1$I$20230914$20240919$20240920$20240920$EXP$GB-MHRA-MED-202409161200570960-VCLGD$GB-MYLANLABS-2024M1085513$MYLAN$$56$YR$$M$Y$75$KG$20240920$$CN$GB$GB
243428861$24342886$1$I$$20240913$20240920$20240920$EXP$$US-MYLANLABS-2024M1085313$MYLAN$Zhen S, Chu F, Kodesh A, Kim J. Ischaemic stroke in a patient with non-valvular atrial fibrillation (NVAF) despite non-vitamin K oral anticoagulant (NOAC) therapy. BMJ-Case-Rep 2024; 17 (1).$8$DEC$$F$Y$$$20240920$$HP$US$US
243428871$24342887$1$I$20231113$20240913$20240920$20240920$EXP$$DE-MYLANLABS-2024M1083876$MYLAN$$$$A$M$Y$$$20240920$$MD$DE$DE
243428881$24342888$1$I$20211104$20240909$20240920$20240920$EXP$$CA-TAKEDA-2015TUS018224$TAKEDA$$74$YR$$F$Y$$$20240920$$MD$CA$CA
243428891$24342889$1$I$20240101$20240917$20240920$20240920$EXP$$US-SA-2024SA271295$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240920$$HP$US$US
243428901$24342890$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186750$AMGEN$$$$$F$Y$$$20240920$$MD$US$US
243428911$24342891$1$I$$20240912$20240920$20240920$PER$$US-AMGEN-USASP2024185628$AMGEN$$68$YR$E$F$Y$$$20240920$$MD$US$US
243428921$24342892$1$I$$20240916$20240920$20240920$EXP$$US-ABBVIE-5928360$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243428931$24342893$1$I$$20240910$20240920$20240920$EXP$$CA-APOTEX-2024AP010522$APOTEX$$88$YR$$M$Y$$$20240920$$HP$CA$CA
243428944$24342894$4$F$20240101$20240926$20240920$20240930$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-149086$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240930$$CN$BR$BR
243428961$24342896$1$I$20240701$20240913$20240920$20240920$EXP$$NVSC2024US187145$NOVARTIS$$58$YR$$F$Y$$$20240920$$CN$US$US
243428983$24342898$3$F$$20240920$20240920$20240930$EXP$$NVSC2024AU187103$NOVARTIS$Estabrooks KL, DeSilva K, Survela L, Stevenson WS. Haemophagocytic lymphohistiocytosis due to leishmaniasis following anti-tumour necrosis factor-alpha therapy.. BRITISH JOURNAL OF HAEMATOLOGY. 2023;203(4):497-8$56$YR$$M$Y$$$20240930$$HP$AU$AU
243428991$24342899$1$I$$20240912$20240920$20240920$EXP$$NVSC2024CA184254$NOVARTIS$$$$A$M$Y$$$20240920$$MD$CA$CA
243429011$24342901$1$I$$20240910$20240920$20240920$EXP$$CA-HALEON-2197002$Haleon PLC$$40$YR$$F$Y$$$20240920$$HP$CA$CA
243429021$24342902$1$I$$20240918$20240920$20240920$PER$$US-JNJFOC-20240948884$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$HP$US$US
243429032$24342903$2$F$$20240920$20240920$20240930$EXP$$NVSC2024AU111880$NOVARTIS$Nguyen JK, Holmes Z, Kelly RI. Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2023;64(2):223-8$74$YR$$F$Y$$$20240930$$HP$AU$AU
243429041$24342904$1$I$$20240908$20240920$20240920$EXP$$US-Accord-446721$ACCORD$Reddy TP, Barrios R, Bernicker E, Qian W, Chang J, Safdar Z. Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension. Pulmonary circulation. 2024;14(3):e12426.$52$YR$A$F$Y$$$20240920$$HP$US$US
243429051$24342905$1$I$20120101$20240912$20240920$20240920$EXP$$NVSC2023SK266006$NOVARTIS$Fabianova J, Cepilova Z, Porubska M, Kralikova A. Serpiginozna choroiditida predpokladanej tuberkuloznej etiologie [Serpiginous chorioditis of suspected tuberculous etiology]. KAZUISTIKY V ALERGOLOGII, PNEUMOLOGII A ORL [CASUISTRIES IN ALERGOLOGY, PNEUMOLO. 2018;2:11-5$45$YR$$M$Y$70$KG$20240920$$HP$SK$SK
243429061$24342906$1$I$$20240918$20240920$20240920$PER$$US-BIOGEN-2024BI01283266$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
243429071$24342907$1$I$$20240915$20240920$20240920$PER$$US-BRACCO-2024US05835$BRACCO$$32$YR$$M$Y$$$20240920$$CN$US$US
243429081$24342908$1$I$$20240911$20240920$20240920$EXP$$CA-HALEON-2197391$Haleon PLC$$$$$F$Y$$$20240920$$HP$CA$CA
243429091$24342909$1$I$$20240918$20240920$20240920$PER$$US-BIOGEN-2024BI01283212$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
243429111$24342911$1$I$$20240918$20240920$20240920$PER$$US-BIOGEN-2024BI01283282$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
243429121$24342912$1$I$20240915$20240916$20240920$20240920$PER$$US-BIOGEN-2024BI01282940$BIOGEN$$65$YR$$M$Y$$$20240920$$CN$US$US
243429131$24342913$1$I$$20240917$20240920$20240920$PER$$US-BIOGEN-2024BI01280943$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
243429141$24342914$1$I$20240401$20240918$20240920$20240920$PER$$US-BIOGEN-2024BI01252145$BIOGEN$$60$YR$$F$Y$$$20240920$$CN$US$US
243429161$24342916$1$I$20240604$20240913$20240920$20240920$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024114145$VIIV$$32$YR$$F$Y$$$20240920$$HP$US$US
243429171$24342917$1$I$$20240918$20240920$20240920$EXP$$CA-SANDOZ INC.-SDZ2024CA081399$SANDOZ$$69$YR$$M$Y$$$20240920$$HP$CA$CA
243429181$24342918$1$I$$20240909$20240920$20240920$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000300$NOVAST$$$$$$Y$$$20240920$$HP$CN$CN
243429201$24342920$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64413$$FDA-CTU$$69$YR$$F$N$97.52$KG$20240919$N$$US$
243429211$24342921$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64425$$FDA-CTU$$77$YR$$F$N$78.93$KG$20240919$N$$US$
243429221$24342922$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64430$$FDA-CTU$$55$YR$$F$N$88$KG$20240919$N$$US$
243429231$24342923$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64438$$FDA-CTU$$55$YR$$F$N$$$20240919$N$$US$
243429251$24342925$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64429$$FDA-CTU$$62$YR$$M$N$$$20240919$N$$US$
243429261$24342926$1$I$$20240917$20240919$20240919$DIR$FDA-CDER-CTU-2024-64420$$FDA-CTU$$$$$M$N$$$20240917$N$HP$US$
243429271$24342927$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64427$$FDA-CTU$$27$YR$$F$N$$$20240919$N$$US$
243429281$24342928$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64433$$FDA-CTU$$49$YR$$M$N$$$20240919$N$$US$
243429291$24342929$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64447$$FDA-CTU$$40$YR$$F$N$$$20240919$N$$US$
243429301$24342930$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64471$$FDA-CTU$$72$YR$$F$N$$$20240919$N$CN$US$
243429311$24342931$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64460$$FDA-CTU$$18$YR$$M$N$$$20240919$N$$US$
243429321$24342932$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64452$$FDA-CTU$$18$YR$$M$N$$$20240919$N$$US$
243429331$24342933$1$I$20240722$20240822$20240919$20240919$DIR$FDA-CDER-CTU-2024-64414$$FDA-CTU$$$$$M$N$$$20240822$N$HP$US$
243429341$24342934$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64416$$FDA-CTU$$87$YR$$M$N$$$20240919$N$$US$
243429351$24342935$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64435$$FDA-CTU$$67$YR$$F$N$51.71$KG$20240919$N$$US$
243429361$24342936$1$I$20240911$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64465$$FDA-CTU$$85$YR$$M$N$$$20240919$Y$HP$US$
243429371$24342937$1$I$20240911$20240909$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013637$DR REDDYS$$63$YR$A$M$Y$$$20240920$$HP$US$US
243429381$24342938$1$I$$20240913$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013613$DR REDDYS$$77$YR$E$M$Y$$$20240920$$CN$US$US
243429391$24342939$1$I$$20240912$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013707$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$66$YR$E$$Y$$$20240920$$MD$US$US
243429401$24342940$1$I$20240101$20240912$20240920$20240920$EXP$$US-RECORDATI RARE DISEASE INC.-2024007097$RECORDATI$$$$$$Y$$$20240920$$HP$US$US
243429411$24342941$1$I$20240101$20240913$20240920$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029234$UNITED THERAPEUTICS$$$$$F$Y$$$20240920$$$US$US
243429421$24342942$1$I$20240912$20240916$20240920$20240920$EXP$$US-VANTIVE-2024VAN019831$Vantive US Healthcare$$$$$M$Y$$$20240920$$HP$US$US
243429431$24342943$1$I$$20240911$20240920$20240920$EXP$$CN-VANTIVE-2024VAN019778$Vantive US Healthcare$$52$YR$$$Y$77$KG$20240920$$CN$CN$CN
243429441$24342944$1$I$$20240911$20240920$20240920$EXP$GB-MHRA-MED-202409111408560500-SGTCZ$GB-TEVA-VS-3243134$TEVA$$$$$M$Y$$$20240920$$PH$GB$GB
243429451$24342945$1$I$20240101$20240913$20240920$20240920$PER$$US-JNJFOC-20240943465$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240920$$CN$US$US
243429461$24342946$1$I$20240727$20240910$20240920$20240920$EXP$$US-BANNER LIFE SCIENCES-USBAN24000139$BANNER$$$$$$Y$$$20240920$$CN$US$US
243429471$24342947$1$I$$20240911$20240920$20240920$EXP$$NL-TAKEDA-2024TUS091787$TAKEDA$$26$YR$$M$Y$$$20240920$$CN$NL$NL
243429481$24342948$1$I$20240918$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011632$ELI LILLY AND CO$$$$$M$Y$$$20240920$$CN$US$US
243429491$24342949$1$I$$20240909$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409005902$ELI LILLY AND CO$$$$$$Y$$$20240920$$CN$US$US
243429501$24342950$1$I$20240901$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011015$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240920$$CN$US$US
243429511$24342951$1$I$20240915$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011576$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240920$$CN$US$US
243429521$24342952$1$I$$20240910$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409007336$ELI LILLY AND CO$$44$YR$A$$Y$$$20240920$$LW$US$US
243429531$24342953$1$I$$20240913$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010374$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240920$$CN$US$US
243429541$24342954$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010838$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240920$$CN$US$US
243429551$24342955$1$I$20240919$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024187785$AMGEN$$78$YR$E$M$Y$$$20240920$$CN$US$US
243429561$24342956$1$I$$20240916$20240920$20240920$EXP$$US-ABBVIE-5928673$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243429581$24342958$1$I$$20240913$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147572$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240920$$CN$US$US
243429601$24342960$1$I$$20240913$20240920$20240920$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08659$HIKMA$$52$YR$$M$Y$$$20240920$$HP$US$US
243429611$24342961$1$I$20240501$20240912$20240920$20240920$EXP$$JP-BAYER-2024A094427$BAYER$$41$YR$A$F$Y$$$20240920$$MD$JP$JP
243429641$24342964$1$I$20230919$20240912$20240920$20240920$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00849$MIRUM PHARMACEUTICALS$$4$YR$$M$Y$17.69$KG$20240920$$CN$US$US
243429651$24342965$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5928337$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243429671$24342967$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64409$$FDA-CTU$$32$YR$$F$N$$$20240919$N$$US$
243429691$24342969$1$I$20240801$20240917$20240920$20240920$PER$$US-JNJFOC-20240949506$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$PH$US$US
243429701$24342970$1$I$$20240905$20240920$20240920$30DAY$$AU-JNJFOC-20240939741$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$PH$AU$AU
243429711$24342971$1$I$20240706$20240916$20240920$20240920$EXP$$US-BAYER-2024A106391$BAYER$$75$YR$E$F$Y$68.027$KG$20240920$$CN$US$US
243429721$24342972$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64449$$FDA-CTU$$59$YR$$F$N$$$20240919$N$$US$
243429731$24342973$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64426$$FDA-CTU$$78$YR$$F$N$44.91$KG$20240919$N$$US$
243429751$24342975$1$I$$20240912$20240920$20240920$EXP$$CA-LUNDBECK-DKLU4004326$LUNDBECK$$$$$$Y$$$20240920$$CN$CA$CA
243429761$24342976$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64428$$FDA-CTU$$59$YR$$F$N$$$20240919$N$$US$
243429771$24342977$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64432$$FDA-CTU$$47$YR$$M$N$209.56$KG$20240919$N$$US$
243429781$24342978$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64415$$FDA-CTU$$70$YR$$$N$62.14$KG$20240919$N$$US$
243429791$24342979$1$I$$20240913$20240920$20240920$EXP$$NVSC2024HR185181$NOVARTIS$$38$YR$$F$Y$$$20240920$$MD$HR$HR
243429801$24342980$1$I$$20240916$20240920$20240920$EXP$$NVSC2024NL186061$NOVARTIS$Aalbersberg EA, de Vries-Huizing DMV, Tesselaar MET, Stokkel MPM, Versleijen MWJ. Post-PRRT scans: which scans to make and what to look for. CANCER IMAGING. 2022;22(1):29$$$$F$Y$$$20240920$$HP$NL$NL
243429811$24342981$1$I$20240918$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64467$$FDA-CTU$$69$YR$$M$N$$$20240919$Y$HP$US$
243429821$24342982$1$I$$20240911$20240920$20240920$EXP$$CA-HALEON-2197409$Haleon PLC$$82$YR$$F$Y$83$KG$20240920$$HP$CA$CA
243429831$24342983$1$I$$20240918$20240919$20240919$DIR$FDA-CDER-CTU-2024-64464$$FDA-CTU$$$$$F$N$$$20240918$N$HP$US$
243429841$24342984$1$I$$20240916$20240919$20240919$DIR$FDA-CDER-CTU-2024-64463$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243429851$24342985$1$I$20240901$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64441$$FDA-CTU$$91$YR$$F$N$$$20240919$Y$HP$US$
243429861$24342986$1$I$20240918$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64436$$FDA-CTU$$76$YR$$F$N$$$20240919$N$$US$
243429871$24342987$1$I$20240919$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64453$$FDA-CTU$$32$YR$$F$N$186$LBS$20240919$N$$US$
243429881$24342988$1$I$$20240913$20240919$20240919$DIR$FDA-CDER-CTU-2024-64469$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243429891$24342989$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64408$$FDA-CTU$$32$YR$$M$N$$$20240919$N$$US$
243429901$24342990$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64442$$FDA-CTU$$74$YR$$F$N$$$20240919$N$$US$
243429911$24342991$1$I$20240918$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64418$$FDA-CTU$$27$YR$$M$N$$$20240919$N$HP$US$
243429921$24342992$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64417$$FDA-CTU$$66$YR$$F$N$$$20240919$N$$US$
243429931$24342993$1$I$$20240911$20240920$20240920$EXP$$US-VIVUS LLC-2024V1001106$VIVUS$$$$E$F$Y$$$20240918$$CN$US$US
243429941$24342994$1$I$20240701$20240910$20240920$20240920$EXP$$US-VIVUS, Inc.-2024V1001105$VIVUS$$64$YR$A$F$Y$$$20240917$$CN$US$US
243429951$24342995$1$I$$20240912$20240920$20240920$EXP$$AU-MYLANLABS-2024M1085173$MYLAN$Rajkumar VS, Li Y. Case report of minimally invasive spinal endoscopic debridement and pedicle screw fixation for severe spinal infection of the lumbosacral spine. N-Am-Spine-Soc-J 2024; 19 (0):.$69$YR$$F$Y$$$20240920$$MD$AU$AU
243429961$24342996$1$I$$20240913$20240920$20240920$EXP$$IN-MYLANLABS-2024M1085347$MYLAN$Pyare R, Dutta Majumder P, Shah M, Kaushik V, Agarwal M, Biswas J. Tofacitinib in Scleritis: A Case Series. Ocular-Immunol-Inflamm 2024; 32 (6): 884-890.$51$YR$$F$Y$$$20240920$$HP$IN$IN
243429971$24342997$1$I$$20240912$20240920$20240920$EXP$$US-MYLANLABS-2024M1084890$MYLAN$Agarwal A, Diaz A, Al-Dehneem R, Pineda RM, Khattri S. Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases. J-Drugs-Dermatol 2023; 22 1183-1190.$28$YR$$F$Y$$$20240920$$MD$US$US
243429981$24342998$1$I$$20240912$20240920$20240920$EXP$$JP-MYLANLABS-2024M1084458$MYLAN$Ohara H, Kikutsuji N, Iguchi N, Kinoshita M. Efgartigimod combined with steroids as a fast-acting therapy for myasthenic crisis: a case report. BMC-Neurol 2024; 24 1-7.. 2024;24:1-7$70$YR$$F$Y$$$20240920$$HP$JP$JP
243429992$24342999$2$F$$20240916$20240920$20240926$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-125801$REGENERON$$86$YR$$M$Y$$$20240926$$MD$US$US
243430001$24343000$1$I$$20240919$20240920$20240920$EXP$$NVSC2024GB187529$NOVARTIS$$$$$F$Y$$$20240920$$CN$GB$GB
243430011$24343001$1$I$20240514$20240913$20240920$20240920$EXP$$NVSC2024US107990$NOVARTIS$$41$YR$$F$Y$$$20240920$$CN$US$US
243430021$24343002$1$I$$20240911$20240920$20240920$30DAY$$US-GSK-US2024113533$GLAXOSMITHKLINE$$$$$F$Y$63.5$KG$20240920$$CN$US$US
243430031$24343003$1$I$$20240912$20240920$20240920$EXP$$US-GSK-US2024AMR114503$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243430041$24343004$1$I$$20240912$20240920$20240920$EXP$$US-GSK-US2024113539$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$CN$US$US
243430051$24343005$1$I$20230418$20240912$20240920$20240920$EXP$$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08646$HIKMA$$$$$$Y$$$20240920$$PH$FR$FR
243430061$24343006$1$I$20200801$20240912$20240920$20240920$EXP$$RO-BRISTOL-MYERS SQUIBB COMPANY-2024-147052$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240920$$MD$RO$RO
243430072$24343007$2$F$20240905$20240923$20240920$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149712$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240925$$CN$US$US
243430081$24343008$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64470$$FDA-CTU$$$$$F$N$$$20240919$N$HP$US$
243430091$24343009$1$I$$20240821$20240920$20240920$PER$$US-009507513-2409USA006006$MERCK$Jones AA, Martin JS, Giangiacomo AL, Costakos DM. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024;36:102131$$$I$M$Y$$$20240920$$HP$US$US
243430101$24343010$1$I$$20240910$20240920$20240920$PER$$US-APOTEX-2024AP010982$APOTEX$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al.. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary Pharmacology + Therapeutics. 2024;60 (6):787-795$$$$$Y$$$20240920$$HP$US$US
243430111$24343011$1$I$$20240916$20240919$20240919$DIR$FDA-CDER-CTU-2024-64419$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243430131$24343013$1$I$20240330$20240911$20240920$20240920$EXP$FR-AFSSAPS-MP2024000984$FR-LUNDBECK-DKLU4004166$LUNDBECK$$$$$$Y$$$20240920$$PH$FR$FR
243430141$24343014$1$I$$20240906$20240920$20240920$EXP$GB-MHRA-MED-202409060214491480-HLYVR$GB-BAXTER-2024BAX024319$BAXTER$$$$$M$Y$$$20240920$$MD$GB$GB
243430151$24343015$1$I$20240808$20240905$20240920$20240920$EXP$$DE-BAXTER-2024BAX023037$BAXTER$$35$YR$$F$Y$$$20240920$$PH$DE$DE
243430161$24343016$1$I$$20240911$20240920$20240920$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01900$NOVITIUM PHARMA$Chun-Yan Yuan.Recurrent multisystem Langerhans cell histiocytosis involving the female genitalia: A case report.World Journal of Clinical Cases.20-JUN-2024;12(28):6222-6229$52$YR$A$F$Y$$$20240920$$HP$CN$CN
243430171$24343017$1$I$$20240917$20240920$20240920$EXP$$US-PFIZER INC-202400258936$PFIZER$Gibson, A.. Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica. 2024;109(9):3042-3047$4$YR$$M$Y$$$20240920$$HP$US$US
243430181$24343018$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64421$$FDA-CTU$$74$YR$$M$N$$$20240919$N$$US$
243430201$24343020$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64422$$FDA-CTU$$50$YR$$F$N$$$20240919$N$$US$
243430221$24343022$1$I$$20240918$20240920$20240920$EXP$$CA-PFIZER INC-202400258989$PFIZER$$$$$$Y$$$20240920$$HP$CA$CA
243430231$24343023$1$I$20240919$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64448$$FDA-CTU$$76$YR$$M$N$$$20240919$Y$HP$US$
243430241$24343024$1$I$20240917$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64466$$FDA-CTU$$61$YR$$F$N$$$20240919$N$HP$US$
243430251$24343025$1$I$$20240624$20240920$20240920$EXP$$NVSC2024CA139735$NOVARTIS$$97$YR$$F$Y$97$KG$20240920$$MD$CA$CA
243430261$24343026$1$I$$20240916$20240920$20240920$EXP$$US-AMGEN-USASP2024185450$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243430271$24343027$1$I$$20240909$20240920$20240920$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK094004$GLENMARK$$$$$$Y$$$20240920$$HP$CA$CA
243430281$24343028$1$I$20240801$20240912$20240920$20240920$30DAY$$US-GSK-US2024113688$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240920$$CN$US$US
243430291$24343029$1$I$20220803$20240912$20240920$20240920$EXP$$US-GSK-US2024113565$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243430301$24343030$1$I$20240919$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64450$$FDA-CTU$$77$YR$$F$N$$$20240919$Y$HP$US$
243430311$24343031$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64455$$FDA-CTU$$78$YR$$F$N$$$20240919$N$$US$
243430321$24343032$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64410$$FDA-CTU$$45$YR$$F$N$$$20240919$N$$US$
243430332$24343033$2$F$20240623$20240920$20240920$20240924$EXP$$NVSC2024GB187437$NOVARTIS$$$$$$Y$$$20240924$$CN$GB$GB
243430341$24343034$1$I$20230401$20240918$20240920$20240920$PER$$NVSC2024US187913$NOVARTIS$$43$YR$$F$Y$$$20240920$$MD$US$US
243430351$24343035$1$I$20240901$20240918$20240920$20240920$EXP$$NVSC2024BG187431$NOVARTIS$$87$YR$$F$Y$$$20240920$$MD$BG$BG
243430361$24343036$1$I$$20240917$20240920$20240920$EXP$$BR-BAYER-2024A133947$BAYER$$$$$F$Y$$$20240920$$CN$BR$BR
243430371$24343037$1$I$$20240914$20240920$20240920$EXP$$US-GSK-US2024AMR114753$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$PH$US$US
243430381$24343038$1$I$$20240913$20240920$20240920$EXP$$US-GSK-US2024AMR115464$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243430401$24343040$1$I$$20240916$20240920$20240920$EXP$$CA-Orion Corporation ORION PHARMA-24_00031744$ORION$$44$YR$A$F$Y$$$20240920$$MD$CA$
243430411$24343041$1$I$20230801$20240911$20240920$20240920$PER$$US-TAKEDA-2024TUS091098$TAKEDA$$64$YR$$F$Y$52$KG$20240920$$MD$US$US
243430421$24343042$1$I$$20240912$20240920$20240920$PER$$US-JNJFOC-20240934766$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243430431$24343043$1$I$$20240911$20240920$20240920$EXP$$GB-TEVA-VS-3242867$TEVA$$72$YR$$F$Y$51$KG$20240920$$HP$GB$GB
243430442$24343044$2$F$20230501$20240924$20240920$20240926$EXP$$PT-SANDOZ INC.-SDZ2024PT081575$SANDOZ$$70$YR$$F$Y$$$20240926$$MD$PT$PT
243430451$24343045$1$I$$20231228$20240920$20240920$PER$$US-HALEON-2197630$Haleon PLC$$$$$F$Y$$$20240920$$HP$US$US
243430461$24343046$1$I$$20240910$20240920$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028196$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240920$$$US$US
243430471$24343047$1$I$$20240911$20240920$20240920$EXP$$RU-SANDOZ INC.-SDZ2024RU081599$SANDOZ$Kholmanskikh AS. ??????? ? ??????? ????? ???????????????? ???????????? ??????? ? ?????????, ?????????? ???????????????? ??????? ?? ?????? ??????????? [Frequency and risk factors of drug-induced osteonecrosis of the jaw in patients receiving antiresorptive therapy for osteoporosis]. OSTEOPOROSIS AND BONE DISEASES. 2024;27(S1): S4-S:108 (S100 to S107)$$$$F$Y$$$20240920$$HP$RU$RU
243430481$24343048$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64454$$FDA-CTU$$78$YR$$F$N$$$20240919$N$$US$
243430501$24343050$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64462$$FDA-CTU$$35$YR$$M$N$$$20240919$N$$US$
243430511$24343051$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64412$$FDA-CTU$$57$YR$$F$N$186$LBS$20240919$N$HP$US$
243430531$24343053$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64423$$FDA-CTU$$81$YR$$F$N$$$20240919$N$$US$
243430541$24343054$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011875$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240920$$CN$US$US
243430551$24343055$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64424$$FDA-CTU$$52$YR$$F$N$96$LBS$20240919$N$$US$
243430561$24343056$1$I$$20240919$20240919$20240919$DIR$719090$$FDA-CTU$$$$$UNK$N$$$20240919$$CN$US$
243430571$24343057$1$I$20240915$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011472$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240920$$CN$US$US
243430581$24343058$1$I$$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409009676$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243430591$24343059$1$I$20240916$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011485$ELI LILLY AND CO$$49$YR$A$$Y$$$20240920$$CN$US$US
243430601$24343060$1$I$20240918$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011886$ELI LILLY AND CO$$$$$$Y$$$20240920$$CN$US$US
243430612$24343061$2$F$20240916$20240923$20240920$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409011538$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240927$$CN$US$US
243430621$24343062$1$I$20240915$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011683$ELI LILLY AND CO$$86$YR$E$F$Y$$$20240920$$CN$US$US
243430631$24343063$1$I$20240918$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011785$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240920$$CN$US$US
243430641$24343064$1$I$20240901$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011622$ELI LILLY AND CO$$$$A$F$Y$$$20240920$$CN$US$US
243430651$24343065$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011727$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240920$$CN$US$US
243430661$24343066$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011933$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240920$$CN$US$US
243430671$24343067$1$I$$20240919$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012519$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243430681$24343068$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011481$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240920$$CN$US$US
243430691$24343069$1$I$20240101$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011799$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240920$$CN$US$US
243430701$24343070$1$I$20240916$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409009880$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240920$$CN$US$US
243430711$24343071$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011917$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243430721$24343072$1$I$20240916$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011149$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240920$$CN$US$US
243430731$24343073$1$I$$20240911$20240920$20240920$30DAY$$US-GSK-US2024113155$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$PH$US$US
243430741$24343074$1$I$20240906$20240913$20240920$20240920$EXP$$US-GSK-US2024114216$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243430751$24343075$1$I$$20240908$20240920$20240920$EXP$$US-Long Grove-000074$Long Grove Pharmaceuticals$Desai D, Nohria A, Alhanshali L, Buontempo M, Lo Sicco KI, Fern C, et. al. Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases. JAAD Case Rep. 2024 Jul 14;51:86-91.$58$YR$A$F$Y$$$20240920$$HP$US$US
243430761$24343076$1$I$$20240916$20240920$20240920$EXP$$CA-GSK-CA2024AMR115559$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CA$CA
243430771$24343077$1$I$$20240908$20240920$20240920$EXP$$US-MankindUS-000251$MANKIND PHARMA$Mena S, Raj A, Caldwell W, Kaushal A. The annoyance of singultus: a case report of a rare adverse effect after epidural steroid injection. BMC Anesthesiol. 2024 Aug 31;24(1):302.$49$YR$A$M$Y$$$20240920$$HP$US$US
243430781$24343078$1$I$20240705$20240913$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147245$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$72.57$KG$20240920$$HP$US$US
243430791$24343079$1$I$$20240917$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149302$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240920$$CN$US$US
243430801$24343080$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148844$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$66.68$KG$20240920$$CN$US$US
243430811$24343081$1$I$$20240913$20240920$20240920$PER$$US-ABBVIE-5924511$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243430821$24343082$1$I$$20240919$20240920$20240920$PER$$US-GRUNENTHAL-2024-125558$AVERITAS$$$$A$M$Y$$$20240920$$CN$US$US
243430831$24343083$1$I$20230504$20240912$20240920$20240920$EXP$FR-AFSSAPS-PC2024000689$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08645$HIKMA$$28$YR$$F$Y$57$KG$20240920$$PH$FR$FR
243430842$24343084$2$F$20240901$20240916$20240920$20240925$EXP$$US-RECORDATI RARE DISEASE INC.-2024007073$RECORDATI$$$$$$Y$$$20240925$$CN$US$US
243430851$24343085$1$I$$20240604$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000526$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243430861$24343086$1$I$$20240607$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000544$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243430871$24343087$1$I$$20240605$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000539$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243430881$24343088$1$I$$20240606$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000543$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243430891$24343089$1$I$$20240604$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000525$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243430901$24343090$1$I$$20240531$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000518$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243430911$24343091$1$I$$20240610$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000550$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243430921$24343092$1$I$$20240606$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000541$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243430931$24343093$1$I$$20240604$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000528$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243430941$24343094$1$I$$20240531$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000514$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243430951$24343095$1$I$$20240610$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000552$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243430961$24343096$1$I$$20240604$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000527$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243430971$24343097$1$I$$20240605$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000535$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243430981$24343098$1$I$$20240610$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000553$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243430991$24343099$1$I$$20240604$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000524$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431001$24343100$1$I$$20240531$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000513$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243431011$24343101$1$I$$20240531$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000533$BRAEBURN PHARMACEUTICALS$$$$$M$Y$79.365$KG$20240920$$CN$US$US
243431021$24343102$1$I$$20240603$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000529$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243431031$24343103$1$I$$20240606$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000538$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243431041$24343104$1$I$$20240604$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000523$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431051$24343105$1$I$$20240830$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08851$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243431061$24343106$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-64461$$FDA-CTU$$35$YR$$M$N$$$20240919$N$$US$
243431071$24343107$1$I$20240624$20240626$20240920$20240920$PER$$US-PERRIGO-24US006137$PERRIGO$$24$YR$$F$Y$76.19$KG$20240920$$CN$US$US
243431081$24343108$1$I$$20240916$20240920$20240920$EXP$$US-TAKEDA-2021TUS061505$TAKEDA$$$$$M$Y$$$20240920$$CN$US$US
243431091$24343109$1$I$$20240612$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000561$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243431101$24343110$1$I$$20240612$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000562$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243431111$24343111$1$I$$20240620$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000589$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243431121$24343112$1$I$20221201$20240913$20240920$20240920$EXP$$AR-SANDOZ INC.-NVSC2021AR049306$SANDOZ$$11$YR$$M$Y$34$KG$20240920$$HP$AR$AR
243431131$24343113$1$I$$20240620$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000590$BRAEBURN PHARMACEUTICALS$$38$YR$$F$Y$$$20240920$$CN$US$US
243431141$24343114$1$I$$20240613$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000573$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431151$24343115$1$I$$20240613$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000568$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243431161$24343116$1$I$$20240618$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000578$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$MD$US$US
243431171$24343117$1$I$$20240620$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000587$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243431181$24343118$1$I$$20240611$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000558$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243431191$24343119$1$I$$20240612$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000567$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243431201$24343120$1$I$$20240613$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000575$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431211$24343121$1$I$20240618$20240618$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000582$BRAEBURN PHARMACEUTICALS$$40$YR$$M$Y$$$20240920$$CN$US$US
243431221$24343122$1$I$20240610$20240611$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000557$BRAEBURN PHARMACEUTICALS$$31$YR$$F$Y$$$20240920$$CN$US$US
243431241$24343124$1$I$20240304$20240618$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000580$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$PH$US$US
243431251$24343125$1$I$$20240613$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000566$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431261$24343126$1$I$$20240612$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000563$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243431271$24343127$1$I$$20240613$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000571$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431281$24343128$1$I$$20240612$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000564$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243431291$24343129$1$I$$20240613$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000572$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431301$24343130$1$I$$20240617$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000583$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431311$24343131$1$I$$20240910$20240920$20240920$EXP$$DE-HQ-20240062$HQ SPECIALTY$Haenle, M.. Infections after primary and revision total hip replacement caused by enterobacteria producing extended spectrum beta-lactamases (ESBL): A case series. HIP International. 2010;20 (2):248-254. doi:10.1177/112070001002000217$67$YR$A$F$Y$$$20240913$$HP$DE$DE
243431321$24343132$1$I$$20240909$20240920$20240920$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK094008$GLENMARK$$$$$$Y$$$20240920$$CN$CA$CA
243431331$24343133$1$I$20240919$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024187962$AMGEN$$79$YR$E$F$Y$$$20240920$$CN$US$US
243431341$24343134$1$I$20240620$20240620$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000591$BRAEBURN PHARMACEUTICALS$$31$YR$$F$Y$$$20240920$$HP$US$US
243431351$24343135$1$I$$20240624$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000594$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431361$24343136$1$I$$20240624$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000595$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243431371$24343137$1$I$$20240619$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000600$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243431381$24343138$1$I$$20240624$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000596$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243431391$24343139$1$I$$20240624$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000603$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243431401$24343140$1$I$20240425$20240718$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000607$BRAEBURN PHARMACEUTICALS$$41$YR$$F$Y$$$20240920$$HP$US$US
243431411$24343141$1$I$$20240625$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000601$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$MD$US$US
243431421$24343142$1$I$20240405$20240806$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000610$BRAEBURN PHARMACEUTICALS$$32$YR$$M$Y$$$20240920$$HP$US$US
243431431$24343143$1$I$$20240913$20240920$20240920$EXP$$US-GSK-US2024114125$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243431441$24343144$1$I$$20240624$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000609$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243431451$24343145$1$I$$20240916$20240920$20240920$EXP$$CA-ZAMBON SWITZERLAND LTD.-2024-ZAM-CA000050$PAREXEL$Kyrillos Faragalla , Daniel Cohen-Lyons ,  Nikoo Parvinnejad,  Hanlin L. Wang , Jimin Liu. Fosfomycin-induced liver injury: A case report and literature review. Canadian Liver Journal. 2024;377-382$$$$$Y$$$20240920$$MD$CA$CA
243431471$24343147$1$I$20240915$20240919$20240919$20240919$DIR$719096$$FDA-CTU$$86$YR$$F$N$$$20240919$N$HP$US$
243431491$24343149$1$I$20240910$20240919$20240919$20240919$DIR$719137$$FDA-CTU$$23$YR$$M$N$95.5$KG$20240919$N$PH$US$
243431511$24343151$1$I$20240919$20240919$20240919$20240919$DIR$719103$$FDA-CTU$$26$YR$$F$N$59.85$KG$20240919$N$HP$US$
243431521$24343152$1$I$20240919$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64472$$FDA-CTU$$$$$M$N$86$KG$20240919$N$$US$
243431541$24343154$1$I$$20240916$20240920$20240920$PER$$US-HALEON-2197232$Haleon PLC$$$$$$Y$$$20240920$$CN$US$US
243431551$24343155$1$I$$20240911$20240920$20240920$PER$IT-PFIZER INC-2019025001$IT-BRACCO-2019IT07232$BRACCO$Belli L, Magistretti G, Puricelli GP, Damiani G, Colombo E, Cornalba GP. Arteritis following intra-arterial chemotherapy for liver tumors. European Radiology. 1997;7 (3):323-326$54$YR$$M$Y$$$20240920$$HP$IT$IT
243431561$24343156$1$I$$20240911$20240920$20240920$EXP$$CZ-CHIESI LTD.-AEGR007404$AEGERION$$$$$$Y$$$20240920$$MD$CZ$CZ
243431571$24343157$1$I$$20240913$20240920$20240920$EXP$$CA-CHEPLA-2024011907$CHEPLAPHARM$$43$YR$$M$Y$$$20240920$$CN$COUNTRY NOT SPECIFIED$CA
243431581$24343158$1$I$$20240919$20240920$20240920$PER$$NVSC2024US187919$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243431591$24343159$1$I$20230101$20240913$20240920$20240920$EXP$$NVSC2024BR184286$NOVARTIS$$$$$M$Y$$$20240920$$CN$BR$BR
243431601$24343160$1$I$20240905$20240910$20240920$20240920$PER$$US-MYLANLABS-2024M1083336$MYLAN$$68$YR$$F$Y$53.52$KG$20240920$$CN$US$US
243431611$24343161$1$I$$20240910$20240920$20240920$PER$$US-MYLANLABS-2024M1083102$MYLAN$$$$$F$Y$90.72$KG$20240920$$CN$US$US
243431623$24343162$3$F$20230711$20240917$20240920$20240926$EXP$$CA-CELLTRION INC.-2024CA007686$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243431631$24343163$1$I$$20240912$20240920$20240920$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP012082$STRIDES$Hara K, Miura E, Umeda Y, Umeda M, Oyake M, Fujita N.. A case of Parkinson^s disease with marked head drop after administration of donepezil hydrochloride. [Japanese].. Rinsho-Shinkeigaku. 2024;1-4.$76$YR$$F$Y$$$20240920$$MD$JP$JP
243431641$24343164$1$I$$20240904$20240920$20240920$EXP$$JP-SA-2024SA271440$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240920$$MD$JP$JP
243431651$24343165$1$I$$20240911$20240920$20240920$PER$IT-PFIZER INC-2019025188$IT-BRACCO-2019IT07231$BRACCO$Belli  L , Magistretti G, Puricelli GP , Damiani G , Colombo E , Cornalba GP. Arteritis following intra-arterial chemotherapy for liver tumors. European Radiology. 1997;7 (3):323-326$60$YR$$M$Y$$$20240920$$HP$IT$IT
243431661$24343166$1$I$$20240919$20240920$20240920$PER$$US-HALEON-2197827$Haleon PLC$$55$YR$$M$Y$$$20240920$$CN$US$US
243431671$24343167$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149725$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240920$$CN$US$US
243431681$24343168$1$I$$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149116$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$93.89$KG$20240920$$HP$US$US
243431691$24343169$1$I$20240817$20240913$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147313$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$90.26$KG$20240920$$CN$US$US
243431701$24343170$1$I$20240702$20240702$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000621$BRAEBURN PHARMACEUTICALS$$41$YR$$F$Y$$$20240920$$CN$US$US
243431711$24343171$1$I$$20240709$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000646$BRAEBURN PHARMACEUTICALS$$$$$F$Y$55.782$KG$20240920$$CN$US$US
243431721$24343172$1$I$20240701$20240724$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000655$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$PH$US$US
243431731$24343173$1$I$$20240703$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000630$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243431741$24343174$1$I$20240627$20240808$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000666$BRAEBURN PHARMACEUTICALS$$33$YR$$F$Y$$$20240920$$HP$US$US
243431751$24343175$1$I$20240626$20240701$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000620$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243431761$24343176$1$I$$20240708$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000636$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243431771$24343177$1$I$20240712$20240713$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000652$BRAEBURN PHARMACEUTICALS$$28$YR$$M$Y$$$20240920$$HP$US$US
243431781$24343178$1$I$20240627$20240627$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000616$BRAEBURN PHARMACEUTICALS$$34$YR$$F$Y$$$20240920$$CN$US$US
243431791$24343179$1$I$$20240627$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000614$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243431801$24343180$1$I$20240712$20240715$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000659$BRAEBURN PHARMACEUTICALS$$40$YR$$M$Y$$$20240920$$HP$US$US
243431811$24343181$1$I$$20240630$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000619$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243431821$24343182$1$I$$20240715$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000656$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431831$24343183$1$I$$20240702$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000634$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243431841$24343184$1$I$$20240716$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000662$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243431851$24343185$1$I$$20240715$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000658$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243431861$24343186$1$I$$20240911$20240920$20240920$PER$IT-PFIZER INC-2019025190$IT-BRACCO-2019IT07230$BRACCO$L.Belli, G. Magistretti, G.P. Puricelli, G.Damiani, E.Colombo, G.P.Cornalba. Arteritis following intra-arterial chemotherapy for liver tumors. European Radiology. 1997;7 (3):323-326$56$YR$$M$Y$$$20240920$$HP$IT$IT
243431871$24343187$1$I$20240823$20240910$20240920$20240920$EXP$$IT-HIKMA PHARMACEUTICALS-IT-H14001-24-08530$HIKMA$$54$YR$$F$Y$55$KG$20240920$$HP$IT$IT
243431881$24343188$1$I$$20240718$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000673$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431891$24343189$1$I$20240718$20240719$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000676$BRAEBURN PHARMACEUTICALS$$32$YR$$M$Y$$$20240920$$HP$US$US
243431901$24343190$1$I$$20240718$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000672$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431911$24343191$1$I$$20240830$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000671$BRAEBURN PHARMACEUTICALS$$34$YR$$F$Y$$$20240920$$HP$US$US
243431921$24343192$1$I$$20240906$20240920$20240920$EXP$$US-SA-2024SA269322$SANOFI AVENTIS$$$$$$Y$$$20240920$$MD$US$US
243431932$24343193$2$F$20240828$20240920$20240920$20240924$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006737$AURINIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240924$$HP$US$US
243431941$24343194$1$I$$20240913$20240920$20240920$PER$$US-HALEON-2196960$Haleon PLC$$$$$$Y$$$20240920$$CN$US$US
243431951$24343195$1$I$$20240730$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000711$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243431961$24343196$1$I$$20240729$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000709$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243431971$24343197$1$I$20240918$20240919$20240919$20240919$DIR$719139$$FDA-CTU$$55$YR$$F$N$69.75$KG$20240919$N$HP$US$
243431981$24343198$1$I$$20240730$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000712$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$MD$US$US
243431991$24343199$1$I$$20240722$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000678$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243432001$24343200$1$I$20240903$20240904$20240920$20240920$DIR$FDA-CDER-CTU-2024-64474$$FDA-CTU$$$$$F$N$56.5$KG$20240904$N$$US$
243432011$24343201$1$I$$20240719$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000681$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243432021$24343202$1$I$$20240731$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000722$BRAEBURN PHARMACEUTICALS$$$$$F$Y$91.156$KG$20240920$$CN$US$US
243432031$24343203$1$I$$20240719$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000682$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243432041$24343204$1$I$$20240801$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000724$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243432051$24343205$1$I$$20240726$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000706$BRAEBURN PHARMACEUTICALS$$33$YR$$M$Y$104.31$KG$20240920$$PH$US$US
243432061$24343206$1$I$20240919$20240919$20240919$20240919$DIR$719144$$FDA-CTU$$86$YR$$M$N$$$20240919$N$$US$
243432071$24343207$1$I$20240701$20240807$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000736$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$MD$US$US
243432081$24343208$1$I$$20240729$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000713$BRAEBURN PHARMACEUTICALS$$$$$M$Y$96.19$KG$20240920$$CN$US$US
243432091$24343209$1$I$$20240805$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000730$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243432101$24343210$1$I$$20240725$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000704$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243432111$24343211$1$I$$20240805$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000726$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243432121$24343212$1$I$$20240730$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000718$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$MD$US$US
243432131$24343213$1$I$$20240802$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000729$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243432141$24343214$1$I$$20240806$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000734$BRAEBURN PHARMACEUTICALS$$$$$M$Y$97.506$KG$20240920$$CN$US$US
243432151$24343215$1$I$$20240725$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000702$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243432161$24343216$1$I$20240603$20240807$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000737$BRAEBURN PHARMACEUTICALS$$40$YR$$F$Y$$$20240920$$CN$US$US
243432171$24343217$1$I$$20240719$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000684$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243432181$24343218$1$I$$20240908$20240920$20240920$EXP$$JP-Accord-446699$ACCORD$Takatani A, Kobayashi T, Iwamoto N, Aramaki T, Terada K, et al. Methotrexate prolonged the shedding of replicable SARS-CoV-2 with re-increased antigens in a rheumatoid arthritis patient. Scand J Rheumatol. 2024 Sep 4.$80$YR$E$F$Y$$$20240920$$HP$JP$JP
243432191$24343219$1$I$$20240912$20240920$20240920$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012087$STRIDES$Gao J, Li M, Liu C, Jing H.. Pembrolizumab Combined With GDP Regimen Inducing Sustained Remission in Histiocytic Sarcoma: A Case Report.. J-Investig-Med-High-Impact-Case-Rep. 2024;12:1-4$66$YR$$F$Y$$$20240920$$MD$CN$CN
243432201$24343220$1$I$20240501$20240911$20240920$20240920$30DAY$$US-GSK-US2024116007$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240920$$CN$US$US
243432221$24343222$1$I$$20240916$20240920$20240920$EXP$$NVSC2024GB166048$NOVARTIS$$$$$F$Y$$$20240920$$CN$GB$GB
243432231$24343223$1$I$20220101$20240507$20240920$20240920$EXP$$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-06695$HIKMA$Dierks S, Buchholz SM, K?nig A, Liersch T, Schanz J.. Dierks S, Buchholz SM, K?nig A, Liersch T, Schanz J. Incomplete DPYD haplotype B3 in a patient with locally advanced gastric cancer: Reconsidering the 5-FU dosage strategy.. European Journal of Cancer. 2024;204: 114076:/$65$YR$$M$Y$$$20240920$$MD$DE$DE
243432242$24343224$2$F$20240801$20240919$20240920$20240924$EXP$$AR-SANDOZ INC.-SDZ2024AR073085$SANDOZ$$39$YR$$F$Y$54$KG$20240924$$HP$AR$AR
243432261$24343226$1$I$$20240813$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000750$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243432281$24343228$1$I$$20240809$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000744$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243432291$24343229$1$I$$20240814$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000755$BRAEBURN PHARMACEUTICALS$$$$$F$Y$86.259$KG$20240920$$HP$US$US
243432301$24343230$1$I$$20240809$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000747$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243432311$24343231$1$I$$20240809$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000746$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243432321$24343232$1$I$$20240912$20240920$20240920$EXP$$CA-CELLTRION INC.-2024CA021944$CELLTRION$$$$$$Y$$$20240920$$HP$CA$CA
243432331$24343233$1$I$$20240814$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000753$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243432341$24343234$1$I$$20240815$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000756$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243432351$24343235$1$I$$20240901$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000758$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243432361$24343236$1$I$$20240916$20240920$20240920$PER$$US-ABBVIE-5926341$ABBVIE$$$$$$Y$$$20240920$$MD$US$US
243432371$24343237$1$I$$20240913$20240920$20240920$EXP$$US-SA-2024SA270964$SANOFI AVENTIS$$$$E$F$Y$$$20240920$$MD$US$US
243432391$24343239$1$I$20240101$20240919$20240920$20240920$EXP$SE-SEMPA-2024-006713$SE-BAYER-2024A133887$BAYER$$41$YR$A$F$Y$$$20240920$$MD$SE$SE
243432401$24343240$1$I$$20240908$20240920$20240920$EXP$$JP-Accord-446830$ACCORD$Koi Y, Tajiri W, Kawasaki J, Akiyoshi S, Ijichi H, Nakamura Y et al. A dramatic response to an immune checkpoint inhibitor plus chemotherapy in a patient with metastatic metaplastic carcinoma of the breast: A case report. Thorac Cancer. 2024 Sep 1.$46$YR$A$F$Y$$$20240920$$HP$JP$JP
243432411$24343241$1$I$$20240910$20240920$20240920$EXP$$CA-AMGEN-CANSP2024185541$AMGEN$$40$YR$A$F$Y$$$20240920$$MD$CA$CA
243432421$24343242$1$I$$20240911$20240920$20240920$PER$IT-PFIZER INC-2019025191$IT-BRACCO-2019IT07228$BRACCO$Belli L, Magistretti G, Puricelli GP, Damiani G, Colombo E, Cornalba GP. Arteritis following intra-arterial chemotherapy for liver tumors.. European Radiology. 1997;7 (3):323-326$61$YR$$M$Y$$$20240920$$HP$IT$IT
243432431$24343243$1$I$20240813$20240910$20240920$20240920$EXP$$CN-JNJFOC-20240931266$JOHNSON AND JOHNSON$$$$$M$Y$0.75$KG$20240920$$HP$CN$CN
243432441$24343244$1$I$$20240916$20240920$20240920$EXP$$US-SA-2024SA268581$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240920$$MD$US$US
243432451$24343245$1$I$20191015$20240917$20240920$20240920$EXP$$CO-UCBSA-2024048240$UCB$$73$YR$$M$Y$$$20240920$$CN$CO$CO
243432461$24343246$1$I$20240401$20240918$20240920$20240920$EXP$$CA-GSK-CA2024116074$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CA$CA
243432471$24343247$1$I$20240101$20240918$20240920$20240920$PER$$US-BIOGEN-2024BI01278516$BIOGEN$$$$$M$Y$$$20240920$$CN$US$US
243432481$24343248$1$I$20210101$20240910$20240920$20240920$EXP$FR-AFSSAPS-BR2024000710$FR-STRIDES ARCOLAB LIMITED-2024SP011634$STRIDES$$13$YR$$F$Y$$$20240920$$MD$FR$FR
243432491$24343249$1$I$$20240911$20240920$20240920$PER$IT-PFIZER INC-2019025186$IT-BRACCO-2019IT07227$BRACCO$Belli L , Magistretti G, Puricelli GP , Damiani G , Colombo E , Cornalba GP. Arteritis following intra-arterial chemotherapy for liver tumors. European Radiology. 1997;7 (3):323-326$65$YR$$M$Y$$$20240920$$HP$IT$IT
243432501$24343250$1$I$20240916$20240919$20240920$20240920$PER$$NVSC2024US187853$NOVARTIS$$78$YR$$M$Y$$$20240920$$CN$US$US
243432511$24343251$1$I$$20240917$20240920$20240920$EXP$$US-SA-2024SA271537$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243432521$24343252$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149062$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240920$$CN$US$US
243432531$24343253$1$I$20240918$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149129$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240920$$CN$US$US
243432541$24343254$1$I$$20240911$20240920$20240920$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001857$BLUEPRINT MEDICINES$$$$$F$Y$$$20240920$$CN$US$US
243432551$24343255$1$I$20240101$20240918$20240920$20240920$EXP$$US-SA-2024SA271517$SANOFI AVENTIS$$$$A$M$Y$$$20240920$$MD$US$US
243432571$24343257$1$I$$20240911$20240920$20240920$PER$IT-PFIZER INC-2019025189$IT-BRACCO-2019IT07226$BRACCO$Belli.L, Magistretti.G, Puricelli.G.P, Damiani.G, Colombo.E, Cornalba.G.P. Arteritis following intra-arterial chemotherapy for liver tumor. European Radiology. 1997;7 (3):323-326$65$YR$$M$Y$$$20240920$$HP$IT$IT
243432582$24343258$2$F$$20240916$20240920$20240925$EXP$JP-MLMSERVICE-20240904-PI178883-00270-5$JP-STRIDES ARCOLAB LIMITED-2024SP011797$STRIDES$Kimura M, Fujiwara S, Kuroda H, Kanamori M, Kawamoto M.. Choroid plexitis caused by Burkholderia cepacia complex after COVID-19. International journal of infectious diseases. 2024;147:107201$67$YR$$F$Y$$$20240925$$MD$JP$JP
243432591$24343259$1$I$20240901$20240906$20240920$20240920$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002634$CORCEPT$$$$$$Y$$$20240920$$MD$US$US
243432611$24343261$1$I$20240831$20240913$20240920$20240920$DIR$FDA-CDER-CTU-2024-64475$$FDA-CTU$$81$YR$$F$N$67.1$KG$20240913$N$$US$
243432621$24343262$1$I$$20240819$20240920$20240920$DIR$FDA-CDER-CTU-2024-64511$$FDA-CTU$$$$$F$N$$$20240819$N$HP$US$
243432631$24343263$1$I$$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64509$$FDA-CTU$$$$$F$N$$$20240919$N$HP$US$
243432641$24343264$1$I$20240911$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64473$$FDA-CTU$$$$$F$N$27.4$KG$20240919$N$$US$
243432661$24343266$1$I$$20240909$20240920$20240920$EXP$$GR-STERISCIENCE B.V.-2019-ST-000005$Steriscience PTE$Grammenou  M. Subdural hemorrhage as a complication of meningoencephalitis by West Nile virus.. Hellenic Journal of Medicine, Book of proceedings. 2019;121(31)$74$YR$$M$Y$$$20240920$$MD$GR$GR
243432671$24343267$1$I$$20240909$20240920$20240920$PER$$NVSC2024US182571$NOVARTIS$$70$YR$$F$Y$$$20240920$$HP$US$US
243432691$24343269$1$I$$20240912$20240920$20240920$EXP$$CA-TAKEDA-2024TUS091759$TAKEDA$$$$$M$Y$$$20240920$$MD$CA$CA
243432701$24343270$1$I$$20240909$20240920$20240920$EXP$$IT-STERISCIENCE B.V.-2020-ST-000002$Steriscience PTE$$67$YR$$M$Y$$$20240920$$MD$IT$IT
243432711$24343271$1$I$20240811$20240909$20240920$20240920$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08556$HIKMA$$23$YR$$F$Y$54.4$KG$20240920$$CN$US$US
243432721$24343272$1$I$20240903$20240904$20240920$20240920$PER$$US-009507513-2409USA002152$MERCK$$66$YR$$F$Y$$$20240920$$CN$US$US
243432731$24343273$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64549$$FDA-CTU$$79$YR$$F$N$$$20240920$N$$US$
243432741$24343274$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64548$$FDA-CTU$$75$YR$$F$N$82.55$KG$20240920$N$$US$
243432751$24343275$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186739$AMGEN$$$$$M$Y$$$20240920$$HP$US$US
243432761$24343276$1$I$20240912$20240913$20240920$20240920$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-01026$CATALYST PHARMA$$63$YR$$M$Y$$$20240920$$CN$US$US
243432771$24343277$1$I$20221122$20240912$20240920$20240920$EXP$$US-RECORDATI RARE DISEASE INC.-2024007199$RECORDATI$$$$$$Y$$$20240920$$CN$US$US
243432781$24343278$1$I$20240728$20240919$20240919$20240919$DIR$719131$$FDA-CTU$$32$YR$$F$N$100$KG$20240919$N$HP$US$
243432791$24343279$1$I$$20240913$20240920$20240920$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-01027$CATALYST PHARMA$$$$$M$Y$$$20240920$$CN$US$US
243432801$24343280$1$I$20240814$20240912$20240920$20240920$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-01022$CATALYST PHARMA$$48$YR$$M$Y$86.168$KG$20240920$$CN$US$US
243432821$24343282$1$I$20230101$20240911$20240920$20240920$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-01012$CATALYST PHARMA$$57$YR$$F$Y$$$20240920$$CN$US$US
243432831$24343283$1$I$$20240917$20240920$20240920$PER$$US-ABBVIE-5928191$ABBVIE$$$$$$Y$$$20240920$$CN$US$US
243432851$24343285$1$I$$20240913$20240920$20240920$EXP$$CA-TAKEDA-2024TUS092234$TAKEDA$$$$$M$Y$$$20240920$$CN$CA$CA
243432861$24343286$1$I$$20240916$20240920$20240920$EXP$$NVSC2024AU185924$NOVARTIS$$31$YR$$F$Y$$$20240920$$MD$AU$AU
243432871$24343287$1$I$$20240918$20240920$20240920$EXP$$NVSC2024US186566$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
243432881$24343288$1$I$$20240913$20240920$20240920$EXP$$NVSC2024US184836$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
243432891$24343289$1$I$$20240916$20240920$20240920$EXP$$NVSC2024CA186658$NOVARTIS$$7$YR$$M$Y$23$KG$20240920$$HP$CA$CA
243432902$24343290$2$F$$20240920$20240920$20240925$EXP$$CA-Orion Corporation ORION PHARMA-24_00031784$ORION$$54$YR$A$F$Y$$$20240925$$CN$CA$
243432911$24343291$1$I$$20240906$20240920$20240920$EXP$$GB-UCBSA-2024045800$UCB$$$$$M$Y$$$20240920$$CN$GB$GB
243432921$24343292$1$I$$20240918$20240920$20240920$PER$$US-HALEON-2197616$Haleon PLC$$$$$F$Y$$$20240920$$CN$US$US
243432931$24343293$1$I$$20240909$20240920$20240920$EXP$$IT-STERISCIENCE B.V.-2021-ST-000007$Steriscience PTE$$69$YR$$F$Y$$$20240920$$HP$IT$IT
243432941$24343294$1$I$$20240917$20240920$20240920$EXP$$US-PFIZER INC-PV202400121895$PFIZER$Wong, E.. Fusobacterium necrophorum endocarditis with intracranial abscesses: A case report and review of the literature. Journal of Cardiology Cases. 2024;30(3):75-78$19$YR$$M$Y$$$20240920$$MD$US$US
243432951$24343295$1$I$$20240917$20240920$20240920$EXP$$US-PFIZER INC-PV202400122122$PFIZER$Gibson, A.. Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica. 2024;109(9):3042-3047$16$YR$$M$Y$$$20240920$$HP$US$US
243432961$24343296$1$I$20240901$20240912$20240920$20240920$EXP$$CN-JNJFOC-20240940246$JOHNSON AND JOHNSON$$31$YR$A$M$Y$83$KG$20240920$$HP$CN$CN
243432971$24343297$1$I$$20240916$20240920$20240920$EXP$$NG-PFIZER INC-PV202400120887$PFIZER$Chinonye, E.. Sublingual misoprostol allergy: A case report. Nigerian Journal of Medicine. 2019;28 (2):195-197$30$YR$$F$Y$$$20240920$$HP$NG$NG
243432982$24343298$2$F$$20240926$20240920$20240927$EXP$$CA-PFIZER INC-202400238393$PFIZER$$63$YR$$F$Y$$$20240927$$HP$CA$CA
243432991$24343299$1$I$$20240917$20240920$20240920$EXP$$RO-PFIZER INC-202400258028$PFIZER$Rusu, CT. Rusu CT, Postolea G, Gurghean AL, Fiedler IMS, Homentcovschi CS. What is hiding behind multiple osteolytic lesions?. European Journal of Case Reports in Internal Medicine. 2024;11(Suppl 1)$73$YR$$M$Y$$$20240920$$HP$RO$RO
243433001$24343300$1$I$$20240918$20240920$20240920$EXP$GB-MHRA-MED-202409181313494410-DLSMC$GB-PFIZER INC-202400258922$PFIZER$$$$$F$Y$$$20240920$$CN$GB$GB
243433021$24343302$1$I$$20240918$20240920$20240920$EXP$$CA-PFIZER INC-202400259778$PFIZER$$67$YR$$M$Y$$$20240920$$HP$CA$CA
243433031$24343303$1$I$$20240918$20240920$20240920$EXP$$CA-PFIZER INC-202400259766$PFIZER$$67$YR$$F$Y$$$20240920$$HP$CA$CA
243433041$24343304$1$I$$20240918$20240920$20240920$EXP$$CA-PFIZER INC-202400069626$PFIZER$$73$YR$$M$Y$$$20240920$$HP$CA$CA
243433052$24343305$2$F$$20240918$20240920$20240924$EXP$$JP-PFIZER INC-202400258361$PFIZER$Tanemura, A.. A rare case of metastatic extramammary Paget disease developing transfusion-related acute lung injury during chemotherapy. Journal of Dermatology. 2024;51(9):e312-313$72$YR$$F$Y$$$20240924$$MD$JP$JP
243433062$24343306$2$F$$20240912$20240920$20240925$EXP$JP-MLMSERVICE-20240902-PI178638-00270-1$JP-STRIDES ARCOLAB LIMITED-2024SP011955$STRIDES$Fujii M, Fujimoto Y, Hiranuma N, Ohashi Y.. Refractory vasospastic angina in a patient with autoimmune hepatitis managed by using combined non-invasive provocation tests: A case report.. Journal of Cardiology Cases.. 2024$49$YR$$M$Y$61$KG$20240925$$MD$JP$JP
243433071$24343307$1$I$$20240910$20240920$20240920$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR113882$VIIV$$$$$M$Y$$$20240920$$CN$US$US
243433081$24343308$1$I$$20240913$20240920$20240920$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006343$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243433091$24343309$1$I$$20240911$20240920$20240920$EXP$$US-PFIZER INC-202400254898$PFIZER$$13$YR$$M$Y$35.38$KG$20240920$$CN$US$US
243433121$24343312$1$I$20230101$20240917$20240920$20240920$EXP$$CA-PFIZER INC-202300405697$PFIZER$$31$YR$$F$Y$$$20240920$$HP$CA$CA
243433141$24343314$1$I$20220101$20240828$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139020$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$56.25$KG$20240920$$CN$US$US
243433151$24343315$1$I$$20240912$20240920$20240920$EXP$$JP-OTSUKA-2024_025758$OTSUKA$$$$$M$Y$$$20240920$$CN$JP$JP
243433161$24343316$1$I$$20240903$20240920$20240920$PER$$US-BAYER-2024A133893$BAYER$$$$$$Y$$$20240920$$CN$US$US
243433171$24343317$1$I$$20240918$20240920$20240920$EXP$$NVSC2024CA187401$NOVARTIS$$59$YR$$F$Y$$$20240920$$CN$CA$CA
243433181$24343318$1$I$$20240111$20240920$20240920$EXP$$NVSC2024US186953$NOVARTIS$$$$$M$Y$$$20240920$$HP$US$US
243433191$24343319$1$I$$20240917$20240920$20240920$EXP$$CA-MYLANLABS-2024M1085716$MYLAN$$$$$M$Y$$$20240920$$PH$CA$CA
243433201$24343320$1$I$20240901$20240918$20240920$20240920$EXP$$SG-MYLANLABS-2024M1085012$MYLAN$$65$YR$$M$Y$$$20240920$$HP$SG$SG
243433211$24343321$1$I$20240807$20240918$20240920$20240920$EXP$$SG-MYLANLABS-2024M1084963$MYLAN$$41$YR$$M$Y$$$20240920$$HP$SG$SG
243433222$24343322$2$F$20240901$20240917$20240920$20240924$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006714$AURINIA PHARMACEUTICALS$$28$YR$$F$Y$$$20240924$$CN$US$US
243433241$24343324$1$I$20220101$20240916$20240920$20240920$EXP$$US-MYLANLABS-2024M1085663$MYLAN$Reddy TP, Barrios R, Bernicker E, Qian W, Chang J, Safdar Z. Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension. Pulm-Circ 2024; 14 (3): 1-8.$52$YR$$F$Y$$$20240920$$HP$US$US
243433251$24343325$1$I$$20240910$20240920$20240920$EXP$$IT-MYLANLABS-2024M1084161$MYLAN$Suanno G, Pederzolli M, Lasagni Vitar RM, Fonteyne P, Ferrari G. Topical fosaprepitant for the treatment of ocular pain and inflammation. Am-J-Ophthalmol-Case-Rep 2023; 32.$82$YR$$F$Y$$$20240920$$HP$IT$IT
243433261$24343326$1$I$20240911$20240912$20240920$20240920$EXP$$US-SERVIER-S24011812$SERVIER$$$$$$Y$$$20240920$$MD$US$US
243433281$24343328$1$I$$20240917$20240920$20240920$EXP$$CA-PFIZER INC-202400259592$PFIZER$$55$YR$$M$Y$$$20240920$$MD$CA$CA
243433291$24343329$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112675$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243433301$24343330$1$I$$20240917$20240920$20240920$EXP$$US-JNJFOC-20240952236$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240920$$HP$US$US
243433321$24343332$1$I$$20240913$20240920$20240920$EXP$$IN-MYLANLABS-2024M1085349$MYLAN$Pyare R, Dutta Majumder P, Shah M, Kaushik V, Agarwal M, Biswas J. Tofacitinib in Scleritis: A Case Series. Ocular-Immunol-Inflamm 2024; 32 (6): 884-890.$51$YR$$M$Y$$$20240920$$HP$IN$IN
243433331$24343333$1$I$$20240910$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013570$DR REDDYS$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. Journal of Oncology Pharmacy Practice. 2024;0(0): doi:10.1177/10781552241265884.$34$YR$A$F$Y$$$20240920$$HP$US$US
243433341$24343334$1$I$20240101$20240913$20240920$20240920$PER$$US-UNITED THERAPEUTICS-UNT-2024-029219$UNITED THERAPEUTICS$$$$$F$Y$100.23$KG$20240920$$$US$US
243433351$24343335$1$I$$20240909$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013521$DR REDDYS$Kim N, Hance F, Barsi J. Septic Arthritis of the Pubic Symphysis in a 16-Year-Old Male Adolescent: A Case Report. JBJS Case Connector. 2023 Dec 04;13(4): 1-4. doi:10.2106/JBJS.CC.23.00475.$16$YR$T$M$Y$$$20240920$$HP$US$US
243433391$24343339$1$I$20240913$20240919$20240919$20240919$DIR$719161$$FDA-CTU$$36$YR$$F$N$121.5$KG$20240919$N$CN$US$
243433401$24343340$1$I$20240801$20240917$20240920$20240920$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006729$AURINIA PHARMACEUTICALS$$48$YR$$F$Y$$$20240920$$CN$US$US
243433412$24343341$2$F$20231026$20240926$20240920$20240930$EXP$$CA-TAKEDA-2023TUS108467$TAKEDA$$50$YR$$M$Y$$$20240930$$CN$CA$CA
243433421$24343342$1$I$20240816$20240912$20240920$20240920$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004932$PAREXEL$$$$$$Y$$$20240920$$CN$US$US
243433431$24343343$1$I$$20240906$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09015$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243433442$24343344$2$F$$20240927$20240920$20240928$PER$$US-AMGEN-USASP2024187384$AMGEN$$$$$F$Y$$$20240928$$CN$US$US
243433451$24343345$1$I$20240501$20240911$20240920$20240920$PER$$US-SA-2024MK000059$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240920$$CN$US$US
243433461$24343346$1$I$$20240916$20240920$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001890$BLUEPRINT MEDICINES$$$$$F$Y$$$20240920$$CN$US$US
243433471$24343347$1$I$$20240909$20240920$20240920$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08566$HIKMA$Sato M, Han Q, Hozumi C, Kujiraoka H, Mizuta K, Morinaga S, Kang B.M, Kobayashi N, Ichikawa Y, Nakajima A, Hoffman R.M. Sato M, Han Q, Hozumi C, Kujiraoka H, Mizuta K, Morinaga S, et al. First-line Chemotherapy in Combination with Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease. Anticancer research. 2024;44(9):3885-3889$63$YR$$F$Y$$$20240920$$MD$US$US
243433481$24343348$1$I$20230120$20240909$20240920$20240920$EXP$FR-AFSSAPS-PC2024000680$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08545$HIKMA$$50$YR$$F$Y$$$20240920$$PH$FR$FR
243433491$24343349$1$I$$20240915$20240920$20240920$EXP$$EG-MYLANLABS-2024M1084671$MYLAN$$8$DY$$F$Y$2.5$KG$20240920$$HP$EG$EG
243433501$24343350$1$I$20240101$20240909$20240920$20240920$EXP$SE-SEMPA-2024-006408$SE-STERISCIENCE B.V.-2024-ST-001404$Steriscience PTE$$50$YR$$M$Y$$$20240920$$MD$SE$SE
243433511$24343351$1$I$$20240919$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012576$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240920$$CN$US$US
243433521$24343352$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202309009280$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240920$$CN$US$US
243433532$24343353$2$F$$20240918$20240920$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011925$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240924$$CN$US$US
243433541$24343354$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010662$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240920$$CN$US$US
243433551$24343355$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011937$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243433561$24343356$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011533$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240920$$CN$US$US
243433571$24343357$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011877$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243433581$24343358$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011853$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243433601$24343360$1$I$20240915$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011068$ELI LILLY AND CO$$31$YR$A$M$Y$$$20240920$$CN$US$US
243433611$24343361$1$I$20240601$20240910$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409006855$ELI LILLY AND CO$$18$YR$A$F$Y$$$20240920$$CN$US$US
243433621$24343362$1$I$$20240909$20240920$20240920$EXP$$GB-CELLTRION INC.-2024GB022325$CELLTRION$$$$$$Y$$$20240920$$CN$GB$GB
243433631$24343363$1$I$20240909$20240909$20240920$20240920$PER$$US-Kiniksa Pharmaceuticals Ltd.-2024KPU001588$KINIKSA PHARMACEUTICALS$$52$YR$A$F$Y$$$20240920$$CN$US$US
243433641$24343364$1$I$$20240912$20240920$20240920$EXP$$CA-TEVA-VS-3243453$TEVA$$77$YR$$F$Y$73$KG$20240920$$PH$CA$CA
243433651$24343365$1$I$$20240909$20240920$20240920$EXP$$SE-STERISCIENCE B.V.-2024-ST-001408$Steriscience PTE$Cewers A, Sunnerhagen T, Gilje P, Wannheden F, Blackberg J, Wierup P, et al.. Even a single positive blood culture may matter - A case of prosthetic valve infective endocarditis caused by Corynebacterium kroppenstedtii.. IDCases. 2024;37$76$YR$$M$Y$$$20240920$$HP$SE$SE
243433661$24343366$1$I$20240625$20240916$20240920$20240920$EXP$$US-GSK-US2024114893$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243433671$24343367$1$I$$20240913$20240920$20240920$PER$$US-JNJFOC-20240946783$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243433691$24343369$1$I$$20240910$20240920$20240920$EXP$$NVSC2024ZA185042$NOVARTIS$$$$$$Y$$$20240920$$CN$ZA$ZA
243433701$24343370$1$I$$20240910$20240920$20240920$EXP$$CA-APOTEX-2024AP010461$APOTEX$$37$YR$$F$Y$$$20240920$$HP$CA$CA
243433711$24343371$1$I$20240831$20240906$20240920$20240920$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161862$JIANGSU HANSOH PHARMACEUTICAL$$71$YR$$M$Y$55$KG$20240920$$MD$CN$CN
243433721$24343372$1$I$20240405$20240908$20240920$20240920$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161861$JIANGSU HANSOH PHARMACEUTICAL$$42$YR$$M$Y$52$KG$20240920$$MD$CN$CN
243433731$24343373$1$I$$20240909$20240920$20240920$EXP$$US-Jiangsu Hengrui Medicine Co., Ltd.-2161860$JIANGSU HENGRUI MEDICINE$$15$YR$$M$Y$46.4$KG$20240920$$$US$US
243433741$24343374$1$I$$20240827$20240920$20240920$PER$$US-B.Braun Medical Inc.-2161864$B BRAUN$$78$YR$$M$Y$83$KG$20240920$$$US$US
243433751$24343375$1$I$20240805$20240910$20240920$20240920$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161863$JIANGSU HANSOH PHARMACEUTICAL$$74$YR$$M$Y$65$KG$20240920$$MD$CN$CN
243433771$24343377$1$I$20240903$20240908$20240920$20240920$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161858$JIANGSU HANSOH PHARMACEUTICAL$$44$YR$$M$Y$56$KG$20240920$$MD$CN$CN
243433781$24343378$1$I$$20240912$20240920$20240920$EXP$$CA-TEVA-VS-3243456$TEVA$$9$YR$$M$Y$$$20240920$$HP$CA$CA
243433791$24343379$1$I$$20240909$20240920$20240920$EXP$$US-STERISCIENCE B.V.-2024-ST-001418$Steriscience PTE$Shukla K, Chaudhari R, Asgharpour A.. Spontaneous Hepatic Hemorrhage Causing Acute Liver Failure Requiring Liver Transplant. ACG-Case-Rep-J. 2024;11:1-3$59$YR$$F$Y$$$20240920$$HP$US$US
243433801$24343380$1$I$20240828$20240912$20240920$20240920$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161853$JIANGSU HENGRUI MEDICINE$$59$YR$$M$Y$82$KG$20240920$$MD$CN$CN
243433811$24343381$1$I$20240301$20240917$20240920$20240920$PER$$US-BAYER-2024A133476$BAYER$$34$YR$A$F$Y$$$20240920$$MD$US$US
243433821$24343382$1$I$20240909$20240912$20240920$20240920$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161857$JIANGSU HENGRUI MEDICINE$$67$YR$$F$Y$$$20240920$$MD$CN$CN
243433831$24343383$1$I$20240831$20240909$20240920$20240920$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161856$JIANGSU HANSOH PHARMACEUTICAL$$59$YR$$F$Y$$$20240920$$MD$CN$CN
243433841$24343384$1$I$$20240516$20240920$20240920$EXP$$CA-Ascend Therapeutics US, LLC-2161852$ASCEND$$56$YR$$M$Y$$$20240920$$$CA$CA
243433851$24343385$1$I$20240614$20240729$20240920$20240920$PER$$US-International Medication Systems, Limited-2161854$INTERNATIONAL MEDICATION SYSTEM$$79$YR$$F$Y$101.9$KG$20240920$$$US$US
243433871$24343387$1$I$$20240913$20240920$20240920$PER$$US-EMD Serono-2024049643$EMD SERONO INC$$72$YR$E$F$Y$$$20240920$$CN$US$US
243433881$24343388$1$I$$20240909$20240920$20240920$30DAY$$US-PFIZER INC-PV202400118550$PFIZER$$$$$M$Y$$$20240920$$CN$US$US
243433901$24343390$1$I$$20240910$20240920$20240920$30DAY$$GB-PFIZER INC-202400255375$PFIZER$$4$YR$$M$Y$$$20240920$$CN$GB$GB
243433911$24343391$1$I$$20240912$20240920$20240920$EXP$$CA-TEVA-VS-3243461$TEVA$$60$YR$$M$Y$73$KG$20240920$$CN$CA$CA
243433924$24343392$4$F$$20240920$20240920$20240924$EXP$$US-PFIZER INC-202400259961$PFIZER$$76$YR$$F$Y$$$20240924$$MD$US$US
243433931$24343393$1$I$20240809$20240909$20240920$20240920$30DAY$$CL-PFIZER INC-202400258898$PFIZER$$8$YR$$$Y$$$20240920$$CN$CL$CL
243433941$24343394$1$I$$20240910$20240920$20240920$30DAY$$US-PFIZER INC-202400254764$PFIZER$$4$YR$$M$Y$$$20240920$$CN$US$US
243433951$24343395$1$I$$20240909$20240920$20240920$30DAY$$US-PFIZER INC-202400254062$PFIZER$$11$YR$$M$Y$$$20240920$$CN$US$US
243433961$24343396$1$I$$20240906$20240920$20240920$30DAY$$CA-PFIZER INC-202400252790$PFIZER$$6$YR$$M$Y$$$20240920$$MD$CA$CA
243433971$24343397$1$I$$20240910$20240920$20240920$30DAY$$US-PFIZER INC-PV202400053842$PFIZER$$2$YR$$F$Y$$$20240920$$MD$US$US
243433981$24343398$1$I$$20240516$20240920$20240920$EXP$$CA-Ascend Therapeutics US, LLC-2161851$ASCEND$$56$YR$$M$Y$$$20240920$$$CA$CA
243433991$24343399$1$I$20240830$20240909$20240920$20240920$30DAY$$CL-PFIZER INC-202400258951$PFIZER$$8$YR$$$Y$$$20240920$$CN$CL$CL
243434001$24343400$1$I$$20240909$20240920$20240920$30DAY$$US-PFIZER INC-202400253308$PFIZER$$35$YR$$M$Y$$$20240920$$HP$US$US
243434011$24343401$1$I$20240701$20240916$20240920$20240920$EXP$$CO-SANDOZ INC.-SDZ2024CO081234$SANDOZ$$$$$F$Y$$$20240920$$CN$CO$CO
243434021$24343402$1$I$20240101$20240911$20240920$20240920$EXP$GB-MHRA-MED-202409100819407220-RDWYF$GB-TEVA-VS-3242654$TEVA$$$$$F$Y$$$20240920$$CN$GB$GB
243434041$24343404$1$I$$20240905$20240920$20240920$EXP$$CH-OTSUKA-2024_025842$OTSUKA$$$$$$Y$$$20240920$$MD$CH$CH
243434051$24343405$1$I$20240909$20240910$20240920$20240920$30DAY$$US-GSK-US2024112644$GLAXOSMITHKLINE$$84$YR$$F$Y$$$20240920$$CN$US$US
243434061$24343406$1$I$$20240909$20240920$20240920$EXP$$CN-STERISCIENCE B.V.-2024-ST-001424$Steriscience PTE$Ye P, Wu M, Cao J, Pei R, Yuan J, Zhuang H, et al.. Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients.. Ann-Hematol. 2024;103 (8):3135-3143.$$$$$Y$$$20240920$$HP$CN$CN
243434081$24343408$1$I$20240822$20240906$20240920$20240920$EXP$$IT-UCBSA-2024047112$UCB$$$$E$M$Y$$$20240920$$CN$IT$IT
243434091$24343409$1$I$$20240917$20240920$20240920$PER$$JP-Eisai-EC-2024-174742$EISAI$Takao Shimizu. A case of Hepatocellular Carcinoma Ruptured in the Omental Bursa. The 134th Annual Meeting of The Japanese Society of Gastroenterology, Hokkaido Branch / The 128th Annual Meeting of Japanese Gastroenterological Endoscopy Society, Hokkaido Branch, Program and Abstracts. 2024; -(-): 019(P46)-019(P46).$$$E$M$Y$$$20240920$$MD$JP$JP
243434101$24343410$1$I$20240911$20240917$20240920$20240920$PER$$US-BAYER-2024A133537$BAYER$$41$YR$A$F$Y$$$20240920$$HP$US$US
243434111$24343411$1$I$20240801$20240916$20240920$20240920$EXP$$RS-009507513-2409SRB006968$MERCK$$$$E$M$Y$$$20240920$$HP$RS$RS
243434121$24343412$1$I$$20240918$20240920$20240920$PER$$NVSC2024US187784$NOVARTIS$$$$$F$Y$$$20240920$$HP$US$US
243434131$24343413$1$I$$20240909$20240920$20240920$EXP$$US-B.Braun Medical Inc.-2161865$B BRAUN$Literature Article$51$YR$$M$Y$$$20240920$$$US$US
243434141$24343414$1$I$20240828$20240909$20240920$20240920$EXP$FR-AFSSAPS-LM2024000483$FR-FreseniusKabi-FK202413636$FRESENIUS KABI$$69$YR$E$M$Y$71$KG$20240920$$MD$FR$FR
243434151$24343415$1$I$$20240909$20240920$20240920$EXP$$ES-FreseniusKabi-FK202413599$FRESENIUS KABI$$43$YR$A$M$Y$$$20240920$$MD$ES$ES
243434161$24343416$1$I$$20240918$20240920$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU081640$SANDOZ$$$$E$$Y$$$20240920$$HP$AU$AU
243434172$24343417$2$F$$20240918$20240920$20240927$EXP$$DK-ABBVIE-5927066$ABBVIE$$$$$$Y$$$20240927$$CN$DK$DK
243434181$24343418$1$I$$20240919$20240920$20240920$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052470$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240920$$CN$US$US
243434192$24343419$2$F$$20240918$20240920$20240925$EXP$$CA-TEVA-VS-3136428$TEVA$Chow MR, Gill N, Alzahrani F, Schuurmans SN, Dytoc MT. Vulvar lichen planus-induced vulvovaginal stenosis: a case. SAGE Open Medical Case Reports. 2023$56$YR$$F$Y$$$20240925$$HP$CA$CA
243434201$24343420$1$I$$20240917$20240920$20240920$PER$$US-BAYER-2024A133767$BAYER$$$$$F$Y$$$20240920$$CN$US$US
243434211$24343421$1$I$$20240909$20240920$20240920$EXP$$US-STERISCIENCE B.V.-2024-ST-001427$Steriscience PTE$Neisewander B, Trapp N.. Electroconvulsive therapy complicated by ventricular fibrillation: A case report. Ann-Clin-Psychiatry. 2023;35:133-134$37$YR$$F$Y$$$20240920$$MD$US$US
243434221$24343422$1$I$20180101$20240909$20240920$20240920$EXP$$SK-STERISCIENCE B.V.-2019-ST-000011$Steriscience PTE$Miklo, M. Neutropenic enterocolitis - not only in children.. GASTROENTEROLOGIA PRE PRAX. 2019;1:25-30$55$YR$$F$Y$70$KG$20240920$$MD$SK$SK
243434233$24343423$3$F$20240922$20240924$20240920$20240930$EXP$$US-SANDOZ INC.-SDZ2024US080967$SANDOZ$$82$YR$$F$Y$43.492$KG$20240930$$MD$US$US
243434261$24343426$1$I$$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64556$$FDA-CTU$$$$$M$N$$$20240919$N$HP$US$
243434291$24343429$1$I$$20240910$20240920$20240920$EXP$$CA-HALEON-2197199$Haleon PLC$$44$YR$$F$Y$$$20240920$$HP$CA$CA
243434321$24343432$1$I$20240909$20240910$20240920$20240920$EXP$GB-MHRA-MED-202409101804559850-CFJKB$GB-UCBSA-2024046661$UCB$$43$YR$$F$Y$80$KG$20240920$$HP$GB$GB
243434331$24343433$1$I$$20240909$20240920$20240920$EXP$$GR-STERISCIENCE B.V.-2019-ST-000012$Steriscience PTE$Giamarellos, E. Presentation of Cases and Discussions. Archives of Hellenic Medicine.. 2019;36(Supp 1)$81$YR$$F$Y$$$20240920$$MD$GR$GR
243434341$24343434$1$I$$20240910$20240920$20240920$EXP$$US-GSK-US2024112576$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243434351$24343435$1$I$20240910$20240918$20240920$20240920$PER$$US-BAYER-2024A133521$BAYER$$61$YR$A$M$Y$$$20240920$$CN$US$US
243434361$24343436$1$I$$20240912$20240920$20240920$PER$$US-BAYER-2024A130831$BAYER$$59$YR$A$M$Y$$$20240920$$CN$US$US
243434371$24343437$1$I$20240906$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024188018$AMGEN$$53$YR$A$M$Y$$$20240920$$CN$US$US
243434381$24343438$1$I$$20240910$20240920$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147434$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240920$$MD$JP$JP
243434391$24343439$1$I$20240715$20240918$20240920$20240920$EXP$FR-AFSSAPS-NY2024001050$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-149372$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$55$KG$20240920$$PH$FR$FR
243434401$24343440$1$I$20240101$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149459$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240920$$CN$US$US
243434422$24343442$2$F$$20240919$20240920$20240920$PER$$US-JNJFOC-20240951383$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243434431$24343443$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149049$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240920$$PH$US$US
243434451$24343445$1$I$$20240912$20240920$20240920$EXP$001031796$CA-Merz Pharmaceuticals GmbH-2024090000146$MERZ$$77$YR$$M$Y$79.4$KG$20240920$$HP$CA$CA
243434461$24343446$1$I$20240914$20240918$20240920$20240920$PER$$US-BAYER-2024A133530$BAYER$$23$YR$A$F$Y$$$20240920$$MD$US$US
243434471$24343447$1$I$$20240911$20240920$20240920$PER$$US-APOTEX-2024AP010706$APOTEX$Abugrin M, Panchal A, Aboulqassim B, Bilal M, Virk J.. Timely Transesophageal Echocardiography After Left Atrial Appendage Occlusion May Avoid Delayed Detection of Device-Related Thrombus. CASE: Cardiovascular Imaging Case Reports. 2024;8 (9):456-460$72$YR$$M$Y$$$20240920$$MD$US$US
243434481$24343448$1$I$20230301$20240910$20240920$20240920$EXP$DE-BFARM-24006193$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-08575$HIKMA$$$$$$Y$$$20240920$$CN$DE$DE
243434491$24343449$1$I$$20240909$20240920$20240920$EXP$$CA-STERISCIENCE B.V.-2024-ST-001428$Steriscience PTE$Neves Briard J, Duquette A, Cayrol R, Lapalme-Remis S. Refractory Status Epilepticus in a Patient With Aducanumab-Induced Amyloid-Related Imaging Abnormalities. Neurology. 2024;103 (5)$75$YR$$F$Y$$$20240920$$MD$CA$CA
243434501$24343450$1$I$$20240918$20240920$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU081210$SANDOZ$$45$YR$$F$Y$$$20240920$$HP$AU$AU
243434521$24343452$1$I$$20240917$20240920$20240920$30DAY$$GB-PFIZER INC-PV202400121576$PFIZER$$65$YR$$F$Y$$$20240920$$CN$GB$GB
243434532$24343453$2$F$$20240918$20240920$20240926$30DAY$$US-PFIZER INC-202400257481$PFIZER$$11$YR$$F$Y$$$20240926$$CN$US$US
243434542$24343454$2$F$$20240920$20240920$20240926$30DAY$$US-PFIZER INC-202400255685$PFIZER$$73$YR$$F$Y$$$20240926$$CN$US$US
243434551$24343455$1$I$$20240912$20240920$20240920$30DAY$$US-PFIZER INC-202400255801$PFIZER$$67$YR$$F$Y$$$20240920$$CN$US$US
243434561$24343456$1$I$$20240919$20240919$20240919$DIR$719127$$FDA-CTU$$50$YR$$M$N$75$KG$20240919$N$HP$US$
243434571$24343457$1$I$$20240916$20240920$20240920$30DAY$$DE-PFIZER INC-202400258052$PFIZER$$27$YR$$F$Y$$$20240920$$MD$DE$DE
243434591$24343459$1$I$20240919$20240919$20240919$20240919$DIR$719133$$FDA-CTU$$64$YR$$M$N$76.5$KG$20240919$Y$HP$US$
243434601$24343460$1$I$20240909$20240910$20240920$20240920$EXP$$JP-UCBSA-2024047080$UCB$$7$DEC$$$Y$$$20240920$$MD$JP$JP
243434621$24343462$1$I$$20240918$20240920$20240920$PER$$US-BAYER-2024A134013$BAYER$$$$$$Y$$$20240920$$CN$US$US
243434631$24343463$1$I$$20240910$20240920$20240920$EXP$$JP-UCBSA-2024047110$UCB$Higuchi T, et al. A case of antibiotic-related encephalopathy due to ceftriaxone with acute renal disorder. The 28th Annual Meeting of Japan Society of Hospital General Medicine. 2024;N-004:()$89$YR$$M$Y$$$20240920$$MD$JP$JP
243434643$24343464$3$F$$20240917$20240920$20240923$EXP$$NVSC2024US185855$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243434652$24343465$2$F$$20240920$20240920$20240926$EXP$$NVSC2024AU186387$NOVARTIS$$76$YR$$M$Y$$$20240926$$MD$AU$AU
243434661$24343466$1$I$$20240910$20240920$20240920$EXP$$JP-UCBSA-2024046687$UCB$Ishii A, et al.. A Case of an Elderly Woman with Complete Atrioventricular Block due to Carbamazepine Poisoning. 694th Kanto Regional Meeting of the Japanese Society of Internal Medicine. 2024;121$79$YR$$F$Y$$$20240920$$MD$JP$JP
243434671$24343467$1$I$$20240918$20240920$20240920$PER$$US-BIOGEN-2024BI01283305$BIOGEN$$$$$F$Y$$$20240920$$HP$US$US
243434681$24343468$1$I$$20240913$20240920$20240920$30DAY$$US-PFIZER INC-202400257497$PFIZER$$15$YR$$M$Y$$$20240920$$CN$US$US
243434692$24343469$2$F$20240910$20240916$20240920$20240923$30DAY$$US-PFIZER INC-202400255019$PFIZER$$21$YR$$M$Y$$$20240923$$CN$US$US
243434701$24343470$1$I$$20240917$20240920$20240920$30DAY$$IL-PFIZER INC-PV202400122013$PFIZER$$$$$M$Y$$$20240920$$MD$IL$IL
243434711$24343471$1$I$$20240917$20240920$20240920$PER$$US-TAKEDA-2024TUS093201$TAKEDA$$$$$$Y$$$20240920$$PH$US$US
243434721$24343472$1$I$$20240919$20240920$20240920$PER$$US-BAYER-2024A134150$BAYER$$32$YR$A$F$Y$$$20240920$$MD$US$US
243434731$24343473$1$I$$20240912$20240920$20240920$EXP$$CA-JNJFOC-20240939751$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240920$$PH$CA$CA
243434741$24343474$1$I$$20240918$20240920$20240920$EXP$$GR-009507513-2409GRC006464$MERCK$Servitzoglou M, Avgerinou G, Dana E, Pelagiadis I, Chatzipantelis E, Papakonstantinou E, et al. First Pediatric Clinic of the University of Athens. 7th PANHELLENIC CONGRESS OF PEDIATRIC HEMATOLOGY AND ONCOLOGY. 2023;73:25-7$$$C$$Y$$$20240920$$MD$GR$GR
243434751$24343475$1$I$$20240911$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145907$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240920$$HP$US$US
243434762$24343476$2$F$$20240909$20240920$20240924$EXP$$GR-ORGANON-1407GRC006081$ORGANON$Daskalakis G, Ntomali A, Pergaliotis, V, Theodora, M, Antsaklis, P, Mesogitis, S, et al.. Delayed interval delivery of the second twin in a woman with altered markers of inflammation. Journal of Maternal-Fetal and Neonatal Medicine. 2014;27 (S1):434-5$34$YR$$F$Y$$$20240924$$HP$GR$GR
243434771$24343477$1$I$20240101$20240917$20240920$20240920$EXP$$US-ABBVIE-5929007$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243434781$24343478$1$I$20240917$20240918$20240920$20240920$PER$$US-BAYER-2024A133597$BAYER$$54$YR$A$F$Y$$$20240920$$CN$US$US
243434791$24343479$1$I$20240809$20240919$20240920$20240920$PER$$US-BAYER-2024A134170$BAYER$$32$YR$A$F$Y$$$20240920$$MD$US$US
243434801$24343480$1$I$$20240912$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013712$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$55$YR$A$$Y$$$20240920$$MD$US$US
243434811$24343481$1$I$$20240912$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013685$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$45$YR$A$$Y$$$20240920$$MD$US$US
243434821$24343482$1$I$$20240912$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013706$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$63$YR$A$$Y$$$20240920$$MD$US$US
243434831$24343483$1$I$$20240918$20240920$20240920$PER$$NVSC2024US187390$NOVARTIS$$$$$M$Y$$$20240920$$CN$US$US
243434842$24343484$2$F$20240601$20240923$20240920$20240925$EXP$$US-ABBVIE-5929748$ABBVIE$$59$YR$$M$Y$$$20240925$$CN$US$US
243434851$24343485$1$I$20240906$20240918$20240920$20240920$EXP$$CA-ABBVIE-5930685$ABBVIE$$79$YR$$M$Y$$$20240920$$HP$CA$CA
243434861$24343486$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013943$BAUSCH AND LOMB$$61$YR$$F$Y$$$20240920$$CN$CA$CA
243434881$24343488$1$I$$20240909$20240920$20240920$EXP$$US-TORRENT-00013749$TORRENT$$$$$F$Y$70$KG$20240920$$CN$US$US
243434892$24343489$2$F$$20240912$20240920$20240923$EXP$$IN-TORRENT-00003664$TORRENT$$16$YR$T$F$Y$$$20240923$$MD$IN$IN
243434921$24343492$1$I$$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64558$$FDA-CTU$$$$$F$N$$$20240919$N$HP$US$
243434931$24343493$1$I$$20240919$20240920$20240920$PER$$US-BAYER-2024A134207$BAYER$$66$YR$E$F$Y$$$20240920$$CN$US$US
243434941$24343494$1$I$$20240913$20240920$20240920$PER$$US-TAKEDA-2024TUS092222$TAKEDA$$$$$F$Y$$$20240920$$MD$US$US
243434951$24343495$1$I$$20240909$20240920$20240920$EXP$GB-MHRA-MED-202409091622566530-RCQKL$GB-TORRENT-00037929$TORRENT$$$$$F$Y$$$20240920$$CN$GB$GB
243434961$24343496$1$I$$20240911$20240920$20240920$EXP$GB-GSK-GB2024092103$GB-TORRENT-00037946$TORRENT$$5$DEC$A$F$Y$$$20240920$$HP$GB$GB
243434971$24343497$1$I$20240911$20240911$20240920$20240920$EXP$GB-MHRA-TPP33280632C5197280YC1726041551632$GB-TORRENT-00037950$TORRENT$$56$YR$A$M$Y$79$KG$20240920$$HP$GB$GB
243434991$24343499$1$I$20211123$20240911$20240920$20240920$EXP$GB-MHRA-31829428$GB-TORRENT-00037949$TORRENT$$17$YR$T$F$Y$$$20240920$$CN$GB$GB
243435001$24343500$1$I$20240901$20240916$20240920$20240920$EXP$$US-ABBVIE-5930099$ABBVIE$$58$YR$$M$Y$$$20240920$$CN$US$US
243435011$24343501$1$I$$20240912$20240920$20240920$EXP$GB-MHRA-MED-202409121633045170-MFKQT$GB-TORRENT-00037956$TORRENT$$$$$M$Y$$$20240920$$MD$GB$GB
243435021$24343502$1$I$$20240909$20240920$20240920$EXP$$US-TORRENT-00013750$TORRENT$$$$N$F$Y$$$20240920$$MD$US$US
243435031$24343503$1$I$$20240918$20240920$20240920$EXP$$US-PFIZER INC-202400259002$PFIZER$$69$YR$$F$Y$$$20240920$$MD$US$US
243435041$24343504$1$I$$20240913$20240920$20240920$EXP$$JP-AMGEN-JPNSP2024184839$AMGEN$$$$A$F$Y$$$20240920$$MD$JP$JP
243435061$24343506$1$I$$20240918$20240920$20240920$EXP$$GR-PFIZER INC-PV202400122512$PFIZER$$42$YR$$M$Y$$$20240920$$MD$GR$GR
243435071$24343507$1$I$$20240918$20240920$20240920$EXP$$US-PFIZER INC-202400259806$PFIZER$$$$$F$Y$$$20240920$$MD$US$US
243435081$24343508$1$I$20240706$20240918$20240920$20240920$EXP$$CN-PFIZER INC-PV202400122381$PFIZER$$53$YR$$M$Y$65$KG$20240920$$HP$CN$CN
243435091$24343509$1$I$$20240911$20240920$20240920$30DAY$$GB-PFIZER INC-PV202400119894$PFIZER$$10$YR$$M$Y$$$20240920$$CN$GB$GB
243435101$24343510$1$I$$20240917$20240920$20240920$EXP$$AR-PFIZER INC-202400258942$PFIZER$$53$YR$$M$Y$$$20240920$$CN$AR$AR
243435111$24343511$1$I$20240901$20240918$20240920$20240920$EXP$$CN-PFIZER INC-PV202400122272$PFIZER$$11$YR$$M$Y$39$KG$20240920$$HP$CN$CN
243435121$24343512$1$I$20240906$20240918$20240920$20240920$EXP$$GB-PFIZER INC-PV202400122716$PFIZER$$78$YR$$F$Y$$$20240920$$CN$GB$GB
243435131$24343513$1$I$20220801$20240917$20240920$20240920$EXP$$CA-PFIZER INC-202201064809$PFIZER$$74$YR$$F$Y$$$20240920$$HP$CA$CA
243435141$24343514$1$I$20240802$20240911$20240920$20240920$PER$$US-009507513-2409USA004663$MERCK$$$$$$Y$$$20240920$$PH$US$US
243435151$24343515$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013964$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240920$$CN$CA$CA
243435161$24343516$1$I$20210101$20240919$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012583$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240920$$CN$US$US
243435171$24343517$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010970$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240920$$CN$US$US
243435182$24343518$2$F$20240911$20240920$20240920$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409010387$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240924$$CN$US$US
243435201$24343520$1$I$$20240919$20240920$20240920$PER$$US-BAYER-2024A134227$BAYER$$33$YR$A$F$Y$$$20240920$$HP$US$US
243435211$24343521$1$I$$20240913$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147738$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240920$$CN$US$US
243435221$24343522$1$I$$20240913$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146708$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240920$$CN$US$US
243435232$24343523$2$F$$20240924$20240920$20240930$EXP$$RU-JNJFOC-20240945884$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$RU$RU
243435241$24343524$1$I$20240101$20240913$20240920$20240920$EXP$$US-ABBVIE-5924083$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243435251$24343525$1$I$20210909$20240912$20240920$20240920$EXP$$AR-JNJFOC-20240938967$JOHNSON AND JOHNSON$$27$YR$A$M$Y$74$KG$20240920$$CN$AR$AR
243435261$24343526$1$I$$20240910$20240920$20240920$EXP$$US-GSK-US2024112674$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$CN$US$US
243435271$24343527$1$I$20240803$20240917$20240920$20240920$EXP$$SG-PFIZER INC-202400258988$PFIZER$$55$YR$$F$Y$$$20240920$$HP$SG$SG
243435292$24343529$2$F$20240801$20240923$20240920$20240925$EXP$$CN-PFIZER INC-PV202400122341$PFIZER$$89$YR$$F$Y$53$KG$20240925$$HP$CN$CN
243435301$24343530$1$I$20240601$20240917$20240920$20240920$EXP$$GR-PFIZER INC-202400257841$PFIZER$$83$YR$$F$Y$$$20240920$$CN$GR$GR
243435321$24343532$1$I$$20240913$20240920$20240920$30DAY$$GR-PFIZER INC-PV202400034058$PFIZER$$13$YR$$M$Y$70$KG$20240920$$CN$GR$GR
243435331$24343533$1$I$$20240918$20240920$20240920$EXP$$JP-PFIZER INC-202400258450$PFIZER$$$$$M$Y$$$20240920$$CN$JP$JP
243435341$24343534$1$I$$20240917$20240920$20240920$EXP$$CA-PFIZER INC-PV202400122217$PFIZER$$76$YR$$M$Y$$$20240920$$HP$CA$CA
243435361$24343536$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013955$BAUSCH AND LOMB$$61$YR$$$Y$$$20240920$$CN$CA$CA
243435371$24343537$1$I$20240716$20240917$20240920$20240920$EXP$$US-PFIZER INC-PV202400121760$PFIZER$$31$YR$$M$Y$77.4$KG$20240920$$HP$US$US
243435381$24343538$1$I$$20240912$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146532$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240920$$MD$US$US
243435391$24343539$1$I$$20240917$20240920$20240920$EXP$$NVSC2024US186351$NOVARTIS$$75$YR$$M$Y$$$20240920$$MD$US$US
243435401$24343540$1$I$20240425$20240919$20240919$20240919$DIR$719126$$FDA-CTU$$84$YR$$F$N$83.25$KG$20240919$N$CN$US$
243435411$24343541$1$I$20240719$20240910$20240920$20240920$EXP$$US-TEVA-VS-3244059$TEVA$$52$YR$$F$Y$$$20240920$$CN$US$US
243435421$24343542$1$I$20240718$20240912$20240920$20240920$EXP$$JP-PFIZER INC-PV202400100025$PFIZER$$3$MON$$M$Y$5$KG$20240920$$PH$JP$JP
243435441$24343544$1$I$$20240918$20240920$20240920$EXP$$IE-PFIZER INC-202400259594$PFIZER$$$$$$Y$$$20240920$$HP$IE$IE
243435461$24343546$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013968$BAUSCH AND LOMB$$75$YR$$M$Y$$$20240920$$CN$CA$CA
243435471$24343547$1$I$$20240920$20240920$20240920$DIR$719177$$FDA-CTU$$$$$UNK$N$$$20240920$N$CN$US$
243435481$24343548$1$I$20240901$20240920$20240920$20240920$DIR$719172$$FDA-CTU$$39$YR$$F$N$$$20240920$N$CN$US$
243435491$24343549$1$I$20240901$20240917$20240920$20240920$EXP$$CO-PFIZER INC-PV202400118033$PFIZER$$14$YR$$F$Y$$$20240920$$CN$CO$CO
243435501$24343550$1$I$$20240918$20240920$20240920$EXP$$JP-PFIZER INC-PV202400122237$PFIZER$$$$$$Y$$$20240920$$MD$JP$JP
243435521$24343552$1$I$20240830$20240918$20240920$20240920$EXP$$CN-PFIZER INC-PV202400122379$PFIZER$$59$YR$$M$Y$60$KG$20240920$$HP$CN$CN
243435531$24343553$1$I$$20240918$20240920$20240920$EXP$$JP-PFIZER INC-PV202400122035$PFIZER$$39$YR$$F$Y$$$20240920$$MD$JP$JP
243435541$24343554$1$I$20230901$20240918$20240920$20240920$EXP$$US-PFIZER INC-202400259322$PFIZER$$53$YR$$M$Y$115.67$KG$20240920$$CN$US$US
243435552$24343555$2$F$20240101$20240919$20240920$20240925$EXP$$CA-PFIZER INC-202400259026$PFIZER$$79$YR$$F$Y$$$20240925$$MD$CA$CA
243435571$24343557$1$I$20240101$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187140$AMGEN$$71$YR$E$F$Y$$$20240920$$CN$US$US
243435581$24343558$1$I$$20240918$20240920$20240920$EXP$$US-PFIZER INC-202400259190$PFIZER$$72$YR$$M$Y$$$20240920$$MD$US$US
243435591$24343559$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013977$BAUSCH AND LOMB$$78$YR$$F$Y$$$20240920$$CN$CA$CA
243435601$24343560$1$I$20240912$20240913$20240920$20240920$30DAY$$KR-PFIZER INC-PV202400120550$PFIZER$$$$$$Y$$$20240920$$CN$KR$KR
243435611$24343561$1$I$$20240918$20240920$20240920$EXP$$US-PFIZER INC-202400259715$PFIZER$$63$YR$$M$Y$$$20240920$$CN$US$US
243435632$24343563$2$F$20240730$20240923$20240920$20240925$EXP$FR-AFSSAPS-AM2024000734$FR-PFIZER INC-202400259906$PFIZER$$79$YR$$M$Y$110$KG$20240925$$MD$FR$FR
243435641$24343564$1$I$20240910$20240910$20240920$20240920$30DAY$$US-PFIZER INC-202400254196$PFIZER$$9$YR$$F$Y$$$20240920$$CN$US$US
243435652$24343565$2$F$20240909$20240923$20240920$20240926$EXP$$CN-PFIZER INC-PV202400122382$PFIZER$$5$YR$$M$Y$19$KG$20240926$$HP$CN$CN
243435661$24343566$1$I$$20240918$20240920$20240920$EXP$$US-PFIZER INC-202400259046$PFIZER$$74$YR$$M$Y$$$20240920$$CN$US$US
243435671$24343567$1$I$$20240918$20240920$20240920$EXP$$CN-PFIZER INC-202400258747$PFIZER$$67$YR$$F$Y$$$20240920$$CN$CN$CN
243435681$24343568$1$I$20240912$20240918$20240920$20240920$EXP$$CN-PFIZER INC-PV202400122368$PFIZER$$30$YR$$M$Y$45$KG$20240920$$HP$CN$CN
243435691$24343569$1$I$20240731$20240913$20240920$20240920$EXP$$FR-ABBVIE-5926863$ABBVIE$$60$YR$$M$Y$72$KG$20240920$$HP$FR$FR
243435701$24343570$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013987$BAUSCH AND LOMB$$86$YR$$M$Y$$$20240920$$CN$CA$CA
243435712$24343571$2$F$20240501$20240918$20240920$20240923$EXP$$US-PFIZER INC-202400259260$PFIZER$$$$$F$Y$$$20240923$$MD$US$US
243435722$24343572$2$F$20240913$20240918$20240920$20240924$EXP$$JP-PFIZER INC-202400258477$PFIZER$$$$$$Y$$$20240924$$MD$JP$JP
243435731$24343573$1$I$20240917$20240917$20240920$20240920$EXP$$US-PFIZER INC-202400258173$PFIZER$$$$$F$Y$$$20240920$$MD$US$US
243435742$24343574$2$F$$20240920$20240920$20240925$EXP$$CA-PFIZER INC-PV202400122772$PFIZER$Shukla, V.. Developmental and epileptic encephalopathies after successful treatment of pediatric ALL: A case series and review of literature. Epileptic Disorders. 2024;1-10$3$YR$$F$Y$$$20240925$$HP$CA$CA
243435761$24343576$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013989$BAUSCH AND LOMB$$83$YR$$$Y$$$20240920$$CN$CA$CA
243435771$24343577$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-014023$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240920$$CN$CA$CA
243435781$24343578$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-014005$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240920$$CN$CA$CA
243435793$24343579$3$F$20030101$20240920$20240920$20240926$EXP$$FR-PFIZER INC-202400251316$PFIZER$$74$YR$$M$Y$87$KG$20240926$$CN$FR$FR
243435813$24343581$3$F$20240913$20240920$20240920$20240927$30DAY$$US-PFIZER INC-202400256820$PFIZER$$12$YR$$M$Y$$$20240927$$CN$US$US
243435821$24343582$1$I$20240819$20240827$20240920$20240920$PER$$US-SA-2024SA267360$SANOFI AVENTIS$$4$YR$C$M$Y$17.1$KG$20240920$$MD$US$US
243435831$24343583$1$I$20240101$20240831$20240920$20240920$PER$$US-SA-2024SA272159$SANOFI AVENTIS$$$$$M$Y$$$20240920$$CN$US$US
243435841$24343584$1$I$$20240830$20240920$20240920$PER$$US-SA-2024SA270426$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240920$$HP$US$US
243435851$24343585$1$I$20240801$20240830$20240920$20240920$PER$$US-SA-2024SA270682$SANOFI AVENTIS$$46$YR$A$F$Y$90.91$KG$20240920$$MD$US$US
243435861$24343586$1$I$20240814$20240826$20240920$20240920$PER$$US-SA-2024SA266640$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240920$$CN$US$US
243435871$24343587$1$I$$20240829$20240920$20240920$PER$$US-SA-2024SA271792$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240920$$CN$US$US
243435881$24343588$1$I$20240701$20240830$20240920$20240920$PER$$US-SA-2024SA270731$SANOFI AVENTIS$$62$YR$A$M$Y$95.45$KG$20240920$$MD$US$US
243435891$24343589$1$I$20240827$20240918$20240920$20240920$EXP$$ES-BAUSCH-BL-2024-014146$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240920$$HP$ES$ES
243435901$24343590$1$I$$20240829$20240920$20240920$PER$$US-SA-2024SA267293$SANOFI AVENTIS$$$$A$F$Y$118.18$KG$20240920$$MD$US$US
243435911$24343591$1$I$20240829$20240831$20240920$20240920$PER$$US-SA-2024SA271590$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240920$$CN$US$US
243435921$24343592$1$I$20240101$20240830$20240920$20240920$PER$$US-SA-2024SA271126$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240920$$CN$US$US
243435931$24343593$1$I$20240901$20240903$20240920$20240920$PER$$US-SA-2024SA270852$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240920$$CN$US$US
243435941$24343594$1$I$$20240826$20240920$20240920$PER$$US-SA-2024SA266820$SANOFI AVENTIS$$$$A$M$Y$$$20240920$$MD$US$US
243435951$24343595$1$I$$20240826$20240920$20240920$PER$$US-SA-2024SA267163$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240920$$HP$US$US
243435962$24343596$2$F$$20240830$20240920$20240926$PER$$US-SA-2024SA270815$SANOFI AVENTIS$$$$C$F$Y$39.09$KG$20240926$$MD$US$US
243435981$24343598$1$I$$20240827$20240920$20240920$PER$$US-SA-2024SA271162$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243435991$24343599$1$I$20240101$20240828$20240920$20240920$PER$$US-SA-2024SA266556$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240920$$MD$US$US
243436001$24343600$1$I$$20240829$20240920$20240920$PER$$US-SA-2024SA266756$SANOFI AVENTIS$$$$A$M$Y$$$20240920$$MD$US$US
243436011$24343601$1$I$$20240829$20240920$20240920$PER$$US-SA-2024SA270339$SANOFI AVENTIS$$$$E$F$Y$66.667$KG$20240920$$MD$US$US
243436021$24343602$1$I$20240101$20240829$20240920$20240920$PER$$US-SA-2024SA269893$SANOFI AVENTIS$$26$YR$A$M$Y$77.27$KG$20240920$$HP$US$US
243436031$24343603$1$I$$20240912$20240920$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001864$BLUEPRINT MEDICINES$$$$$F$Y$$$20240920$$CN$US$US
243436041$24343604$1$I$$20240905$20240920$20240920$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468832$RANBAXY$Yuan C-Y, Zhang Z-R, Guo M-F, Zhang N. Recurrent multisystem Langerhans cell histiocytosis involving the female genitalia: A case report. World J Clin Cases. 2024;Oct 6;12 (28):6222-6229$52$YR$$F$Y$$$20240920$$HP$CN$CN
243436061$24343606$1$I$$20240905$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468923$RANBAXY$Jeunesse E, Miller N, Carroll L, Arbuthnot M. Cat scratch disease requiring incision and drainage: A case report. J Pediatr Surg Case Rep. 2024;108 (0):102851$13$YR$$M$Y$$$20240920$$HP$US$US
243436071$24343607$1$I$$20240905$20240920$20240920$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462419$RANBAXY$Burger D, Wttewaal E, Oosterhof P, Stalenhoef J. Concomitant use of anabolic androgen steroids and cabotegravir/rilpivirine leading to virological failure and development of two-class resistance. AIDS. 2024;38(11):1728-1729$27$YR$$M$Y$119.8$KG$20240920$$MD$NL$NL
243436081$24343608$1$I$$20240905$20240920$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468724$RANBAXY$$53$YR$$F$Y$80$KG$20240920$$MD$GB$GB
243436091$24343609$1$I$$20240905$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468926$RANBAXY$Doliner B, Gaddar H, Kalil R, Postalian A. Modern Perspectives on Hypertrophic Cardiomyopathy-No One Size Fits All. Tex Heart Inst J. 2024;51 (2):e248423$61$YR$$M$Y$$$20240920$$MD$US$US
243436101$24343610$1$I$$20240905$20240920$20240920$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468849$RANBAXY$Ermolenko NA, Krasnorutskaya ON, Bykova VA, Golosnaya GS, Shiryaev OYu. A case of a pathological variant of the PRRT2 gene in twins with paroxysmal kinesiogenic dyskinesia. SS Korsakov J Neurol Psychiat. 2023;123(9 vyp 2):83-86$8$YR$$M$Y$$$20240920$$HP$RU$RU
243436131$24343613$1$I$$20240905$20240920$20240920$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-439156$RANBAXY$Rusu CT, Postolea G, Gurghean AL, Fiedler IMS, Homentcovschi CS.. WHAT IS HIDING BEHIND MULTIPLE OSTEOLYTIC LESIONS?. Eur J Case Rep Intern Med. 2024;11 (Suppl.):704$73$YR$$M$Y$$$20240920$$HP$RO$RO
243436141$24343614$1$I$20231201$20240905$20240920$20240920$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468623$RANBAXY$Eisa N, Alhashimi N, Usman B, Albeladi A, Almutawa A, Almasari A. MM-091 Unusual Relapse of Multiple Myeloma With Synchronous Bilateral Testicular Involvement and Treatment Challenges: A Case Report. Clin Lymphoma Myeloma Leuk. 2024;24 (Suppl.):S535$62$YR$$M$Y$$$20240920$$HP$SA$SA
243436161$24343616$1$I$20240904$20240906$20240920$20240920$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466561$RANBAXY$$31$YR$$F$Y$$$20240920$$MD$JP$JP
243436181$24343618$1$I$$20240905$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467688$RANBAXY$$$$$F$Y$$$20240920$$MD$US$US
243436191$24343619$1$I$20230301$20240905$20240920$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468649$RANBAXY$$45$YR$$F$Y$45$KG$20240920$$CN$GB$GB
243436201$24343620$1$I$$20240905$20240920$20240920$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468856$RANBAXY$Ermolenko NA, Krasnorutskaya ON, Bykova VA, Golosnaya GS, Shiryaev OYu. A case of a pathological variant of the PRRT2 gene in twins with paroxysmal kinesiogenic dyskinesia. SS Korsakov J Neurol Psychiat. 2023;123(9 vyp 2):83-86$8$YR$$M$Y$$$20240920$$HP$RU$RU
243436211$24343621$1$I$$20240905$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468903$RANBAXY$Heyman HM, Alberts NM, Rees M, Puri L, Frett MJ, Anghelescu DL. COVID-19 infection and pain in adolescents with sickle cell disease: A case series. EJHaem. 2022;3 (4):1310-1315$17$YR$$F$Y$$$20240920$$HP$US$US
243436221$24343622$1$I$$20240905$20240920$20240920$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-463442$RANBAXY$Klingenberg MG, Sinkeler SJ, Koopmans N, Plaat RE. Severe hypotension requiring resuscitation in tumour-related carotid sinus syndrome: a case report. Eur Heart J Case Rep. 2024;8 (8):1-4$57$YR$$F$Y$$$20240920$$HP$NL$NL
243436232$24343623$2$F$20240601$20240924$20240920$20240927$PER$$US-BIOGEN-2024BI01278641$BIOGEN$$54$YR$$M$Y$$$20240927$$CN$US$US
243436241$24343624$1$I$$20240905$20240920$20240920$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469070$RANBAXY$Loseva X, Servitzoglou M, Doganis D, Nikita M, Magkou E, Malliou A et al. BOY WITH REFRACTORY BURKITT^S LYMPHOMA OF THE STOMACH. Annales Clinicae Paediatricae Universitatis Atheniensis. 2023;Jan-Mar; 73(1)$10$YR$$M$Y$$$20240920$$HP$GR$GR
243436251$24343625$1$I$20240101$20240903$20240920$20240920$PER$$US-SA-2024SA271252$SANOFI AVENTIS$$39$YR$A$F$Y$113.18$KG$20240920$$MD$US$US
243436261$24343626$1$I$20240101$20240903$20240920$20240920$PER$$US-SA-2024SA271475$SANOFI AVENTIS$$13$YR$T$F$Y$61.82$KG$20240920$$MD$US$US
243436271$24343627$1$I$20240727$20240903$20240920$20240920$PER$$US-SA-2024SA271746$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240920$$CN$US$US
243436281$24343628$1$I$$20240903$20240920$20240920$PER$$US-SA-2024SA270884$SANOFI AVENTIS$$$$A$F$Y$102.27$KG$20240920$$MD$US$US
243436291$24343629$1$I$20240101$20240902$20240920$20240920$PER$$US-SA-2024SA271916$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240920$$MD$US$US
243436301$24343630$1$I$$20240903$20240920$20240920$PER$$US-SA-2024SA270961$SANOFI AVENTIS$$$$E$F$Y$$$20240920$$MD$US$US
243436311$24343631$1$I$20240808$20240903$20240920$20240920$PER$$US-SA-2024SA271363$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240920$$CN$US$US
243436321$24343632$1$I$20240101$20240903$20240920$20240920$PER$$US-SA-2024SA271244$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240920$$PH$US$US
243436331$24343633$1$I$$20240904$20240920$20240920$PER$$US-SA-2024SA271492$SANOFI AVENTIS$$68$YR$E$$Y$$$20240920$$CN$US$US
243436341$24343634$1$I$20240101$20240904$20240920$20240920$PER$$US-SA-2024SA271350$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240920$$MD$US$US
243436351$24343635$1$I$$20240903$20240920$20240920$PER$$US-SA-2024SA270718$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240920$$HP$US$US
243436361$24343636$1$I$$20240917$20240920$20240920$PER$$US-JNJFOC-20240953653$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243436371$24343637$1$I$$20240919$20240920$20240920$PER$$US-BAYER-2024A134235$BAYER$$43$YR$A$F$Y$$$20240920$$CN$US$US
243436381$24343638$1$I$$20240916$20240920$20240920$EXP$$TR-CHEPLA-2024011941$CHEPLAPHARM$Akyol G, Unsal SE, Mandaci NS, Keklik M, Unal A. CT-249 Treatment of Hematopoietic Stem Cell Transplant-Associated Microangiopathy with Eculizumab. Clinical Lymphoma, Myeloma and Leukemia. 2024; 24(S594), Sup 1. DOI: 10.1016/S2152-2650(24)01754-3.$62$YR$$F$Y$$$20240920$$MD$COUNTRY NOT SPECIFIED$TR
243436391$24343639$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA269484$SANOFI AVENTIS$$$$$F$Y$$$20240920$$CN$US$US
243436401$24343640$1$I$20240801$20240911$20240920$20240920$PER$$US-SA-2024SA266542$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240920$$MD$US$US
243436411$24343641$1$I$20240905$20240906$20240920$20240920$PER$$US-SA-2024SA268880$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240920$$CN$US$US
243436421$24343642$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA268676$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240920$$HP$US$US
243436431$24343643$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA268885$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240920$$CN$US$US
243436442$24343644$2$F$$20240913$20240920$20240927$PER$$US-SA-2024SA271237$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240927$$MD$US$US
243436451$24343645$1$I$20240101$20240905$20240920$20240920$PER$$US-SA-2024SA272212$SANOFI AVENTIS$$34$YR$A$F$Y$61.36$KG$20240920$$HP$US$US
243436461$24343646$1$I$$20240910$20240920$20240920$PER$$US-SA-2024SA263395$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240920$$CN$US$US
243436471$24343647$1$I$20240919$20240919$20240919$20240919$DIR$719102$$FDA-CTU$$56$YR$$F$N$$$20240919$N$HP$US$
243436481$24343648$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA270986$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240920$$CN$US$US
243436491$24343649$1$I$$20240905$20240920$20240920$PER$$US-SA-2024SA272197$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240920$$MD$US$US
243436501$24343650$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA271704$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240920$$CN$US$US
243436511$24343651$1$I$20240901$20240911$20240920$20240920$PER$$US-SA-2024SA267460$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240920$$MD$US$US
243436531$24343653$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA266132$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240920$$MD$US$US
243436541$24343654$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA267342$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240920$$HP$US$US
243436551$24343655$1$I$20240901$20240911$20240920$20240920$PER$$US-SA-2024SA266737$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240920$$MD$US$US
243436561$24343656$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA268700$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240920$$HP$US$US
243436571$24343657$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA266850$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240920$$MD$US$US
243436581$24343658$1$I$20240101$20240905$20240920$20240920$PER$$US-SA-2024SA271975$SANOFI AVENTIS$$$$E$M$Y$$$20240920$$MD$US$US
243436591$24343659$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA271187$SANOFI AVENTIS$$$$$F$Y$$$20240920$$CN$US$US
243436601$24343660$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA267259$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240920$$MD$US$US
243436611$24343661$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA266750$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240920$$MD$US$US
243436621$24343662$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA266875$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240920$$CN$US$US
243436631$24343663$1$I$20110101$20240906$20240920$20240920$PER$$US-SA-2024SA269790$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$CN$US$US
243436641$24343664$1$I$20230905$20240905$20240920$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468776$RANBAXY$$45$YR$$M$Y$69$KG$20240920$$MD$GB$GB
243436651$24343665$1$I$20220221$20240906$20240920$20240920$EXP$NO-EMA-DD-20240711-7482701-081106$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469144$RANBAXY$$69$YR$$M$Y$$$20240920$$MD$NO$NO
243436661$24343666$1$I$$20240905$20240920$20240920$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468821$RANBAXY$Tapirdea AO,  Vancea TM, Venter BC, Tertan OB, Patka A, Burz CC. Multiple-focused analysis of breast cancer late recurrence - a case report and literature review. Journal of Medical and Radiation Oncology. 2024;4(1):45-50$76$YR$$F$Y$$$20240920$$HP$RO$RO
243436671$24343667$1$I$$20240906$20240920$20240920$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469192$RANBAXY$Inoue S, Win KHN, Mon CY, Fujikawa T, Hyodo S, Uemura S, et al.. Higher levels of minimal residual disease in peripheral blood than bone marrow before 1st and 2nd relapse/regrowth in a patient with high-risk neuroblastoma: A case report.. Oncol Lett. 2023;26 (3):no pagination$3$YR$$F$Y$$$20240920$$HP$JP$JP
243436681$24343668$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469065$RANBAXY$Shafique N, Khatoon Z, Shafique A, Shafique I, Bajwa S, Shaukat Butt T, et al. Hemophagocytic Lymphohistiocytosis Co-Presenting With Non-Cirrhotic Portal Hypertensive Gastropathy: A Case Report. Clin Lymphoma Myeloma Leuk. 2024;24(Suppl):S393/MDS-337$54$YR$$M$Y$$$20240920$$HP$US$US
243436691$24343669$1$I$20240501$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469107$RANBAXY$$80$YR$$M$Y$$$20240920$$MD$FR$FR
243436701$24343670$1$I$$20240906$20240920$20240920$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469088$RANBAXY$Pitliuk R, da Costa Santos Fucci TPP. IMPROVEMENT OF IRRITABLE BOWEL SYNDROME AND ESSENTIAL TREMOR WITH CANNABIDIOL DESPITE USE OF METHYLPHENIDATE. Rev Bras Neurol Psiq. 2023;27 (2):70-72$34$YR$$M$Y$$$20240920$$HP$BR$BR
243436711$24343671$1$I$$20240905$20240920$20240920$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468780$RANBAXY$Rubio AC, Garcia SS, Calvo AR, De Urbina Fernandez PO, Rubio LC, Rey MP. RADIOLOGICALCLINICAL PROGRESSION. Eur J Case Rep Intern Med. 2024;11(1):786-787$75$YR$$F$Y$$$20240920$$HP$ES$ES
243436721$24343672$1$I$$20240906$20240920$20240920$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469122$RANBAXY$$11$YR$$M$Y$$$20240920$$HP$DE$DE
243436731$24343673$1$I$$20240905$20240920$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468762$RANBAXY$$64$YR$$F$Y$69$KG$20240920$$PH$GB$GB
243436741$24343674$1$I$$20240905$20240920$20240920$EXP$$TN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468860$RANBAXY$Ayed A, Brahim MB, Aissi R, Amor SB, Jaballah L, Brahim MH, et al. UNCOMMON PRESENTATION OF NONSECRETORY MULTIPLE MYELOMA. Eur J Case Rep Intern Med. 2024;11 (Suppl.):762-763$63$YR$$M$Y$$$20240920$$HP$TN$TN
243436751$24343675$1$I$$20240906$20240920$20240920$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469376$RANBAXY$Araki T, Kanda S, Obara M, Agatsuma T, Kakizaki Y, Hama M, et al. EGFR-TKI rechallenge in patients with EGFR-mutated non-small-cell lung cancer who progressed after first-line osimertinib treatment:A multicenter retrospective observational study. Respir Investig. 2024;62:262-268$$$A$$Y$$$20240920$$HP$JP$JP
243436761$24343676$1$I$20240919$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024188035$AMGEN$$79$YR$E$F$Y$$$20240920$$CN$US$US
243436771$24343677$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA268738$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240920$$HP$US$US
243436781$24343678$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA268120$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240920$$HP$US$US
243436791$24343679$1$I$$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469339$RANBAXY$$61$YR$$M$Y$$$20240920$$MD$IT$IT
243436801$24343680$1$I$$20240906$20240920$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469197$RANBAXY$$88$YR$$$Y$$$20240920$$PH$GB$GB
243436811$24343681$1$I$$20240906$20240920$20240920$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469352$RANBAXY$$36$YR$$F$Y$$$20240920$$HP$DE$DE
243436821$24343682$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267815$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240920$$HP$US$US
243436831$24343683$1$I$$20240912$20240920$20240920$PER$$US-SA-2023SA309666$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240920$$MD$US$US
243436841$24343684$1$I$20240101$20240912$20240920$20240920$PER$$US-SA-2024SA268831$SANOFI AVENTIS$$$$A$M$Y$$$20240920$$HP$US$US
243436851$24343685$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA266779$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240920$$MD$US$US
243436861$24343686$1$I$20240716$20240911$20240920$20240920$PER$$US-SA-2024SA266864$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240920$$MD$US$US
243436871$24343687$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA269695$SANOFI AVENTIS$$$$$$Y$$$20240920$$CN$US$US
243436881$24343688$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267207$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240920$$MD$US$US
243436891$24343689$1$I$20240201$20240916$20240920$20240920$EXP$$DE-SANDOZ INC.-SDZ2024DE081515$SANDOZ$$$$$F$Y$$$20240920$$HP$DE$DE
243436901$24343690$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112671$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243436911$24343691$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA266958$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240920$$HP$US$US
243436921$24343692$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA266945$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240920$$HP$US$US
243436931$24343693$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA268317$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243436941$24343694$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA177860$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240920$$MD$US$US
243436951$24343695$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA267275$SANOFI AVENTIS$$$$E$F$Y$$$20240920$$HP$US$US
243436961$24343696$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA266920$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240920$$MD$US$US
243436971$24343697$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267183$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240920$$HP$US$US
243436981$24343698$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA267991$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240920$$CN$US$US
243436991$24343699$1$I$20240701$20240912$20240920$20240920$PER$$US-SA-2024SA023562$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240920$$HP$US$US
243437001$24343700$1$I$20240901$20240913$20240920$20240920$PER$$US-SA-2024SA269410$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240920$$HP$US$US
243437011$24343701$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA267380$SANOFI AVENTIS$$24$YR$A$F$Y$40.91$KG$20240920$$HP$US$US
243437021$24343702$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267335$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240920$$MD$US$US
243437031$24343703$1$I$20240101$20240912$20240920$20240920$PER$$US-SA-2024SA075405$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240920$$HP$US$US
243437042$24343704$2$F$20240101$20240912$20240920$20240925$PER$$US-SA-2024SA267959$SANOFI AVENTIS$$41$YR$A$M$Y$91$KG$20240925$$MD$US$US
243437051$24343705$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268645$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240920$$MD$US$US
243437061$24343706$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268551$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240920$$CN$US$US
243437071$24343707$1$I$20240101$20240912$20240920$20240920$PER$$US-SA-2024SA167845$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240920$$HP$US$US
243437081$24343708$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267396$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240920$$MD$US$US
243437091$24343709$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267152$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240920$$HP$US$US
243437101$24343710$1$I$20240901$20240912$20240920$20240920$PER$$US-SA-2024SA268615$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240920$$HP$US$US
243437111$24343711$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA267481$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240920$$HP$US$US
243437121$24343712$1$I$20240501$20240913$20240920$20240920$PER$$US-SA-2024SA267222$SANOFI AVENTIS$$$$C$F$Y$$$20240920$$MD$US$US
243437131$24343713$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267797$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240920$$HP$US$US
243437141$24343714$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA266952$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240920$$HP$US$US
243437161$24343716$1$I$20240901$20240913$20240920$20240920$PER$$US-SA-2024SA268238$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240920$$HP$US$US
243437171$24343717$1$I$20240801$20240912$20240920$20240920$PER$$US-SA-2024SA267211$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240920$$HP$US$US
243437181$24343718$1$I$20240101$20240912$20240920$20240920$PER$$US-SA-2024SA140809$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240920$$MD$US$US
243437191$24343719$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268092$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240920$$MD$US$US
243437201$24343720$1$I$$20240912$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013718$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$59$YR$A$$Y$$$20240920$$MD$US$US
243437211$24343721$1$I$$20240912$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013713$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$76$YR$E$$Y$$$20240920$$MD$US$US
243437221$24343722$1$I$$20240912$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013717$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$54$YR$A$$Y$$$20240920$$MD$US$US
243437231$24343723$1$I$$20240912$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013716$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$71$YR$E$$Y$$$20240920$$MD$US$US
243437241$24343724$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64559$$FDA-CTU$$65$YR$$M$N$$$20240920$N$$US$
243437251$24343725$1$I$20240829$20240913$20240920$20240920$PER$$US-SA-2024SA271027$SANOFI AVENTIS$$62$YR$A$M$Y$102.27$KG$20240920$$MD$US$US
243437271$24343727$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268159$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240920$$MD$US$US
243437281$24343728$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA269092$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240920$$HP$US$US
243437291$24343729$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA267186$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240920$$MD$US$US
243437301$24343730$1$I$20240709$20240913$20240920$20240920$PER$$US-SA-2024SA268272$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240920$$MD$US$US
243437311$24343731$1$I$20240901$20240913$20240920$20240920$PER$$US-SA-2024SA269134$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240920$$HP$US$US
243437321$24343732$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA267832$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$HP$US$US
243437331$24343733$1$I$20240901$20240913$20240920$20240920$PER$$US-SA-2024SA268327$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240920$$HP$US$US
243437341$24343734$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA267461$SANOFI AVENTIS$$$$E$F$Y$$$20240920$$MD$US$US
243437351$24343735$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA271239$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240920$$HP$US$US
243437361$24343736$1$I$20240625$20240806$20240920$20240920$PER$$US-LUNDBECK-DKLU4002705$LUNDBECK$$$$$$Y$$$20240920$$CN$US$US
243437371$24343737$1$I$20240901$20240913$20240920$20240920$PER$$US-SA-2024SA268304$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240920$$MD$US$US
243437381$24343738$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268204$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240920$$HP$US$US
243437391$24343739$1$I$20240913$20240919$20240920$20240920$PER$$US-BAYER-2024A134268$BAYER$$18$YR$A$F$Y$$$20240920$$HP$US$US
243437401$24343740$1$I$$20240919$20240920$20240920$PER$$US-BAYER-2024A134232$BAYER$$$$$$Y$$$20240920$$CN$US$US
243437411$24343741$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA269162$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240920$$HP$US$US
243437421$24343742$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268522$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240920$$HP$US$US
243437431$24343743$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA269442$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240920$$MD$US$US
243437441$24343744$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA267967$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240920$$MD$US$US
243437451$24343745$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA269024$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240920$$HP$US$US
243437461$24343746$1$I$20240901$20240913$20240920$20240920$PER$$US-SA-2024SA268073$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240920$$MD$US$US
243437471$24343747$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA268184$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240920$$MD$US$US
243437481$24343748$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA269519$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240920$$MD$US$US
243437491$24343749$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA269016$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240920$$HP$US$US
243437501$24343750$1$I$20240913$20240913$20240920$20240920$PER$$US-SA-2024SA268521$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240920$$HP$US$US
243437511$24343751$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268138$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$HP$US$US
243437521$24343752$1$I$20240911$20240913$20240920$20240920$PER$$US-SA-2024SA267736$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240920$$HP$US$US
243437531$24343753$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA269610$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240920$$MD$US$US
243437541$24343754$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA269400$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240920$$MD$US$US
243437561$24343756$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469271$RANBAXY$Terashita M, Selamet U, Midha S, Nadeem O, Laubach J, Rennke HG, et al. Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones. Kidney Int Rep. 2023;8:2765-2777$$$$$Y$$$20240920$$HP$US$US
243437571$24343757$1$I$20240703$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468905$RANBAXY$$21$YR$$F$Y$60$KG$20240920$$PH$FR$FR
243437581$24343758$1$I$20181004$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468975$RANBAXY$$67$YR$$F$Y$60$KG$20240920$$MD$FR$FR
243437591$24343759$1$I$20240507$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469012$RANBAXY$$86$YR$$M$Y$75$KG$20240920$$MD$FR$FR
243437601$24343760$1$I$20220901$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469075$RANBAXY$$36$YR$$F$Y$$$20240920$$PH$FR$FR
243437611$24343761$1$I$$20240906$20240920$20240920$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469074$RANBAXY$Araki T, Kanda S, Obara M, Agatsuma T, Kakizaki Y, Hama M, et al. EGFR-TKI rechallenge in patients with EGFR-mutated non-small-cell lung cancer who progressed after first-line osimertinib treatment:A multicenter retrospective observational study. Respir Investig. 2024;62:262-268$$$A$$Y$$$20240920$$HP$JP$JP
243437621$24343762$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469273$RANBAXY$Terashita M, Selamet U, Midha S, Nadeem O, Laubach J, Rennke HG, et al. Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones. Kidney Int Rep. 2023;8:2765-2777$$$$$Y$$$20240920$$HP$US$US
243437631$24343763$1$I$20240320$20240906$20240920$20240920$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468894$RANBAXY$$81$YR$$F$Y$$$20240920$$MD$ES$ES
243437641$24343764$1$I$20240621$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468841$RANBAXY$$69$YR$$M$Y$$$20240920$$MD$FR$FR
243437651$24343765$1$I$20240405$20240906$20240920$20240920$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469066$RANBAXY$$48$YR$$M$Y$$$20240920$$MD$ES$ES
243437661$24343766$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468026$RANBAXY$$$$E$F$Y$$$20240920$$CN$US$US
243437671$24343767$1$I$20240822$20240906$20240920$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469064$RANBAXY$$56$YR$$F$Y$81$KG$20240920$$CN$GB$GB
243437681$24343768$1$I$$20240906$20240920$20240920$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469129$RANBAXY$Yimenicioglu S, Ekici A. Hot water epilepsy with alone and spontaneous seizures in childhood. Epilepsy Res. 2024;205(0):107418(1-7)$7$YR$$M$Y$$$20240920$$HP$TR$TR
243437691$24343769$1$I$$20240906$20240920$20240920$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469049$RANBAXY$Liu M, Ren K, Ai P, Zou L. Insights into uveitis from Brentuximab vedotin in refractory Hodgkin^s lymphoma: a case report and brief review. Front Oncol. 2024;Aug;14 (0):1419145(1-6)$16$YR$$M$Y$$$20240920$$HP$CN$CN
243437701$24343770$1$I$$20240906$20240920$20240920$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469140$RANBAXY$Yimenicioglu S, Ekici A. Hot water epilepsy with alone and spontaneous seizures in childhood. Epilepsy Res. 2024;205(0):107418(1-7)$1$YR$$F$Y$$$20240920$$HP$TR$TR
243437711$24343771$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64560$$FDA-CTU$$65$YR$$M$N$$$20240920$N$$US$
243437721$24343772$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468954$RANBAXY$Gordon ER, Kwinta BD, Schreidah CM, Fahmy LM, Adeuyan O, Queen D, et al. Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes. Leuk Lymphoma. 2024;65(1):48-54$18$YR$$M$Y$$$20240920$$HP$US$US
243437731$24343773$1$I$$20240906$20240920$20240920$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469145$RANBAXY$Yimenicioglu S, Ekici A. Hot water epilepsy with alone and spontaneous seizures in childhood. Epilepsy Res. 2024;205(0):107418(1-7)$10$YR$$M$Y$$$20240920$$HP$TR$TR
243437741$24343774$1$I$20240501$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468639$RANBAXY$$68$YR$$F$Y$$$20240920$$MD$FR$FR
243437751$24343775$1$I$20240626$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468632$RANBAXY$$88$YR$$F$Y$$$20240920$$PH$FR$FR
243437761$24343776$1$I$$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469223$RANBAXY$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, et al. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clin Neurophysiol. 2024;163 (0):152-159$20$YR$$F$Y$$$20240920$$HP$IT$IT
243437771$24343777$1$I$$20240920$20240920$20240920$DIR$719179$$FDA-CTU$$$$$UNK$N$$$20240920$$CN$US$
243437781$24343778$1$I$20240910$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64561$$FDA-CTU$$70$YR$$F$N$$$20240919$N$HP$US$
243437791$24343779$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468953$RANBAXY$Elmes JB, Moore DC, Pineda-Roman M. Successful Ferric Carboxymaltose Desensitization in a Patient With Prior Reactions to Intravenous Iron Therapies. Am J Ther. 2023;31 (2):e205-e206$55$YR$$F$Y$$$20240920$$MD$US$US
243437801$24343780$1$I$20240527$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468884$RANBAXY$$12$YR$$F$Y$$$20240920$$PH$FR$FR
243437811$24343781$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469270$RANBAXY$Terashita M, Selamet U, Midha S, Nadeem O, Laubach J, Rennke HG, et al. Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones. Kidney Int Rep. 2023;8:2765-2777$$$$$Y$$$20240920$$HP$US$US
243437821$24343782$1$I$20240530$20240906$20240920$20240920$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468943$RANBAXY$$50$YR$$F$Y$$$20240920$$MD$SE$SE
243437831$24343783$1$I$20240625$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468880$RANBAXY$$92$YR$$F$Y$$$20240920$$MD$IT$IT
243437841$24343784$1$I$$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469212$RANBAXY$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clin Neurophysiol. 2024;163 (0):152-159$45$YR$$F$Y$$$20240920$$HP$IT$IT
243437851$24343785$1$I$$20240906$20240920$20240920$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469062$RANBAXY$Araki T, Kanda S, Obara M, Agatsuma T, Kakizaki Y, Hama M, et al. EGFR-TKI rechallenge in patients with EGFR-mutated non-small-cell lung cancer who progressed after first-line osimertinib treatment:A multicenter retrospective observational study. Respir Investig. 2024;62:262-268$$$A$$Y$$$20240920$$HP$JP$JP
243437861$24343786$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468958$RANBAXY$Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, et al. Psychedelic Therapy: A Primer for Primary Care Clinicians- Historical Perspective and Overview. Am J Ther. 2024;31 (2):E97-E103$29$YR$$M$Y$$$20240920$$MD$US$US
243437871$24343787$1$I$20240101$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469036$RANBAXY$$33$YR$$F$Y$$$20240920$$MD$FR$FR
243437881$24343788$1$I$$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469225$RANBAXY$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, et al. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clin Neurophysiol. 2024;163 (0):152-159$76$YR$$M$Y$$$20240920$$HP$IT$IT
243437891$24343789$1$I$$20240906$20240920$20240920$EXP$$EG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469102$RANBAXY$Ismail H-A. RABIES VACCINE INDUCED MICROANGIOPATHY. Atherosclerosis. 2024;395:117627/198/P597/1387$10$YR$$M$Y$$$20240920$$HP$EG$EG
243437901$24343790$1$I$20230320$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468863$RANBAXY$$79$YR$$M$Y$$$20240920$$MD$IT$IT
243437911$24343791$1$I$$20240906$20240920$20240920$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469141$RANBAXY$Yimenicioglu S, Ekici A. Hot water epilepsy with alone and spontaneous seizures in childhood. Epilepsy Res. 2024;205(0):107418(1-7)$1$YR$$M$Y$$$20240920$$HP$TR$TR
243437921$24343792$1$I$$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469133$RANBAXY$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, et al. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clin Neurophysiol. 2024;163(0):152-159$57$YR$$M$Y$$$20240920$$HP$IT$IT
243437931$24343793$1$I$20220505$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-467902$RANBAXY$$60$YR$$M$Y$$$20240920$$MD$IT$IT
243437941$24343794$1$I$20240626$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468852$RANBAXY$$91$YR$$F$Y$$$20240920$$MD$FR$FR
243437951$24343795$1$I$20240706$20240906$20240920$20240920$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469016$RANBAXY$$86$YR$$F$Y$$$20240920$$MD$ES$ES
243437961$24343796$1$I$20240709$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468913$RANBAXY$$86$YR$$F$Y$$$20240920$$PH$IT$IT
243437971$24343797$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467699$RANBAXY$$53$YR$$F$Y$109$KG$20240920$$CN$US$US
243437981$24343798$1$I$$20240906$20240920$20240920$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468909$RANBAXY$Sonoda M, Ishimura M, Inoue H, Eguchi K, Ochiai M, Sakai Y, et al. Non-conditioned cord blood transplantation for infection control in athymic CHARGE syndrome. Pediatr Blood Cancer. 2024;71:e30809; 1-10$$$I$$Y$$$20240920$$HP$JP$JP
243437991$24343799$1$I$20240529$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468869$RANBAXY$$56$YR$$F$Y$$$20240920$$MD$FR$FR
243438001$24343800$1$I$20240529$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468922$RANBAXY$$$$N$M$Y$4.135$KG$20240920$$HP$FR$FR
243438011$24343801$1$I$$20240906$20240920$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469034$RANBAXY$$$$$F$Y$$$20240920$$PH$GB$GB
243438021$24343802$1$I$$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469221$RANBAXY$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, et al. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clin Neurophysiol. 2024;163 (0):152-159$44$YR$$F$Y$$$20240920$$HP$IT$IT
243438031$24343803$1$I$20240401$20240906$20240920$20240920$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469029$RANBAXY$$67$YR$$F$Y$85$KG$20240920$$MD$DE$DE
243438041$24343804$1$I$20240117$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469017$RANBAXY$$75$YR$$F$Y$$$20240920$$HP$FR$FR
243438051$24343805$1$I$$20240906$20240920$20240920$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469076$RANBAXY$Araki T, Kanda S, Obara M, Agatsuma T, Kakizaki Y, Hama M, et al. EGFR-TKI rechallenge in patients with EGFR-mutated non-small-cell lung cancer who progressed after first-line osimertinib treatment:A multicenter retrospective observational study. Respir Investig. 2024;62:262-268$$$A$$Y$$$20240920$$HP$JP$JP
243438061$24343806$1$I$$20240906$20240920$20240920$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469139$RANBAXY$Yimenicioglu S, Ekici A. Hot water epilepsy with alone and spontaneous seizures in childhood. Epilepsy Res. 2024;205(0):107418(1-7)$1$YR$$M$Y$$$20240920$$HP$TR$TR
243438071$24343807$1$I$20240822$20240906$20240920$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469005$RANBAXY$$78$YR$$M$Y$74$KG$20240920$$HP$GB$GB
243438081$24343808$1$I$$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469218$RANBAXY$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, et al. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clin Neurophysiol. 2024;163 (0):152-159$45$YR$$M$Y$$$20240920$$HP$IT$IT
243438091$24343809$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469153$RANBAXY$Mundluru J, Ingawale S, Dhanjal K, Torka P, Dhanjal S. BTK Inhibitors: A Double-Edged Sword in Richter^s Transformation to Plasmablastic Lymphoma? Case Report. Clin Lymphoma Myeloma Leuk. 2024;Sep:S360;CLL-578$57$YR$$M$Y$$$20240920$$MD$US$US
243438101$24343810$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468031$RANBAXY$$$$E$F$Y$$$20240920$$CN$US$US
243438111$24343811$1$I$20231228$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468970$RANBAXY$$41$YR$$F$Y$80$KG$20240920$$MD$FR$FR
243438121$24343812$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468883$RANBAXY$Xing H, Babajanyan H, Kuo A, Bohnenblust E. Cerebral Venous Sinus Thrombosis After Lumbar Epidural Steroid Injection: A Case Report. AA Pract. 2024;18(7):1-3$33$YR$$M$Y$$$20240920$$MD$US$US
243438131$24343813$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468906$RANBAXY$Liao A, Fajoles-Vasseneix C, Rali A, Ward L, Fernandes A, Patel PS, et al. Visual Morbidity and Outcomes of Scleritis Associated with Intraocular Inflammation Compared to Isolated Scleritis. Ocular Immunol Inflamm. 2024;32 (6):947-954$$$$F$Y$$$20240920$$MD$US$US
243438141$24343814$1$I$20220821$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468313$RANBAXY$$64$YR$$M$Y$$$20240920$$MD$IT$IT
243438151$24343815$1$I$$20240906$20240920$20240920$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468879$RANBAXY$$$$A$F$Y$64$KG$20240920$$MD$DE$DE
243438171$24343817$1$I$20240328$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468881$RANBAXY$$75$YR$$M$Y$85$KG$20240920$$MD$FR$FR
243438181$24343818$1$I$$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469213$RANBAXY$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, et al. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clin Neurophysiol. 2024;163 (0):152-159$35$YR$$F$Y$$$20240920$$HP$IT$IT
243438191$24343819$1$I$$20240906$20240920$20240920$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467809$RANBAXY$Bidu NS, Costa ST, Couto RD, Fernandes BJD. Ciprofloxacin^s Structure Causing Fluoride-Related Toxicity: A Case Report. Curr Drug Saf. 2024;Sep 4:39234907$32$YR$$M$Y$$$20240920$$HP$BR$BR
243438201$24343820$1$I$$20240906$20240920$20240920$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469043$RANBAXY$Zargari O, Azimi SZ. Multiple COVID reinfections in a vaccinated psoriatic patient receiving adalimumab. J Dermatolog Treat. 2022;34:2149237$26$YR$$M$Y$$$20240920$$HP$IR$IR
243438221$24343822$1$I$$20240906$20240920$20240920$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469136$RANBAXY$Yimenicioglu S, Ekici A. Hot water epilepsy with alone and spontaneous seizures in childhood. Epilepsy Res. 2024;205(0):107418(1-7)$4$YR$$M$Y$$$20240920$$HP$TR$TR
243438231$24343823$1$I$$20240906$20240920$20240920$EXP$$MX-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469004$RANBAXY$Medina AR, Hammerness P, Ihyembe D, Plummer S, Diekroger E, Fogler J. Complex ADHD Challenging Case: Managing Co-Occurring Attention-Deficit Hyperactivity Disorder and Congenital Heart Disease with a Limited Medication Formulary: A Case from Mexico. J Dev Behav Pediatr. 2024;May/Jun;45 (3):e271-e273$8$YR$$M$Y$$$20240920$$MD$MX$MX
243438241$24343824$1$I$20240731$20240920$20240920$20240920$DIR$719169$$FDA-CTU$$51$YR$$F$N$100.8$KG$20240920$N$CN$US$
243438251$24343825$1$I$20240301$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468937$RANBAXY$$67$YR$$M$Y$101$KG$20240920$$MD$FR$FR
243438261$24343826$1$I$$20240906$20240920$20240920$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468858$RANBAXY$$51$YR$$M$Y$$$20240920$$MD$DE$DE
243438271$24343827$1$I$$20240906$20240920$20240920$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469025$RANBAXY$Meyer HG, Hug BL. Aerococcus urinae endocarditis - A case report. IDCases. 2024;37(0):e02053$69$YR$$M$Y$$$20240920$$HP$CH$CH
243438281$24343828$1$I$20240917$20240919$20240919$20240919$DIR$719151$$FDA-CTU$$20$YR$$F$N$57.15$KG$20240919$N$CN$US$
243438291$24343829$1$I$20240919$20240920$20240920$20240920$DIR$719183$$FDA-CTU$$$$$UNK$N$$$20240920$N$CN$US$
243438301$24343830$1$I$20240525$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468916$RANBAXY$$13$YR$$F$Y$$$20240920$$MD$FR$FR
243438311$24343831$1$I$$20240906$20240920$20240920$EXP$$RS-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468973$RANBAXY$Sallteku L, Gashi F, Komani G, Ukimeraj A, Krasniqi E, Gashi R. AML-102 Skin Presentation of CML Transformation to AML. Clin Lymphoma Myeloma Leuk. 2024;SEP; 24 (S.1):S293-S294/AML-102$70$YR$$M$Y$$$20240920$$MD$RS$RS
243438321$24343832$1$I$$20240917$20240920$20240920$EXP$$US-EXELIXIS-EXL-2024-000272$EXELIXIS$Miljanic M, Vujovic D, Song T, et al. Delayed Radiation Recall in Patients Receiving Cabozantinib: A Case Report and Review of the Literature.. Advances in Radiation Oncology. 2024;NA:9(9)$54$YR$$M$Y$$$20240920$$MD$US$US
243438331$24343833$1$I$$20240916$20240920$20240920$EXP$$CA-PERRIGO-24CA008811$PERRIGO$$13$YR$$M$Y$45$KG$20240920$$HP$CA$CA
243438341$24343834$1$I$20240908$20240908$20240920$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469275$RANBAXY$$31$YR$$F$Y$54$KG$20240920$$CN$GB$GB
243438351$24343835$1$I$$20240907$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469179$RANBAXY$Devjani S, Ezemma O, Jothishankar B, Saberi S, Kelley KJ, Senna MM. Efficacy of Low-Dose Spironolactone for Hair Loss in Women. J Drugs Dermatol. 2024;23 (3):e91-e92$$$A$F$Y$$$20240920$$HP$US$US
243438361$24343836$1$I$$20240907$20240920$20240920$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469390$RANBAXY$Takahashi K, Nakahara H, Arimitsu E, Imamine S, Obata Y, Nakanishi K, et al. Fragmented QRS complex with an additional R-wave attenuated by short RR interval in a patient with acute pulmonary embolism and cardiogenic shock. J Geriatr Cardiol. 2022;19 (12):995-1000$91$YR$$F$Y$$$20240920$$HP$JP$JP
243438371$24343837$1$I$$20240906$20240920$20240920$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467015$RANBAXY$Li Y, Xu Y, Cai S, Ruan F, Xia C, Luo P, et al. Combination of microwave ablation and systemic treatments achieve a long survival time for a patient with metachronous advanced double primary lung and colon adenocarcinoma: A case report. Oncol Lett. 2024;28 (3):407, 1-14$50$YR$$F$Y$$$20240920$$HP$CN$CN
243438381$24343838$1$I$20240719$20240908$20240920$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469269$RANBAXY$$19$YR$$F$Y$64$KG$20240920$$CN$GB$GB
243438391$24343839$1$I$20240725$20240908$20240920$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469263$RANBAXY$$35$YR$$F$Y$65$KG$20240920$$CN$GB$GB
243438401$24343840$1$I$20240827$20240908$20240920$20240920$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469285$RANBAXY$$59$YR$$M$Y$75$KG$20240920$$CN$GB$GB
243438421$24343842$1$I$$20240919$20240920$20240920$PER$$US-BAYER-2024A134327$BAYER$$$$$$Y$$$20240920$$CN$US$US
243438431$24343843$1$I$20240101$20240917$20240920$20240920$EXP$$CA-ABBVIE-5929764$ABBVIE$$22$YR$$M$Y$$$20240920$$CN$CA$CA
243438441$24343844$1$I$20240101$20240904$20240920$20240920$EXP$$US-SA-2024SA271364$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240920$$MD$US$US
243438451$24343845$1$I$20240430$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469091$RANBAXY$$75$YR$$M$Y$$$20240920$$PH$FR$FR
243438461$24343846$1$I$$20240806$20240920$20240920$PER$$US-LUNDBECK-DKLU4002655$LUNDBECK$$$$$$Y$$$20240920$$HP$US$US
243438471$24343847$1$I$20240819$20240820$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000765$BRAEBURN PHARMACEUTICALS$$39$YR$$F$Y$160$KG$20240920$$HP$US$US
243438481$24343848$1$I$$20240819$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000763$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243438491$24343849$1$I$$20240829$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000769$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243438501$24343850$1$I$$20240814$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000754$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243438511$24343851$1$I$$20240913$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000762$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243438531$24343853$1$I$$20240828$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000770$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243438541$24343854$1$I$$20240809$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000745$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$MD$US$US
243438551$24343855$1$I$20240619$20240829$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000767$BRAEBURN PHARMACEUTICALS$$25$YR$$F$Y$$$20240920$$HP$US$US
243438561$24343856$1$I$$20240905$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000759$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243438571$24343857$1$I$20240701$20240916$20240920$20240920$EXP$$CA-ABBVIE-5929472$ABBVIE$$81$YR$$M$Y$$$20240920$$CN$CA$CA
243438581$24343858$1$I$$20240912$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146619$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240920$$CN$US$US
243438591$24343859$1$I$20231201$20240918$20240920$20240920$EXP$FR-AFSSAPS-PO2024000984$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-149349$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$97$KG$20240920$$MD$FR$FR
243438611$24343861$1$I$$20240912$20240920$20240920$EXP$$CA-JNJFOC-20240873111$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240920$$HP$CA$CA
243438621$24343862$1$I$20240911$20240912$20240920$20240920$EXP$$JP-009507513-2409JPN001819J$MERCK$$89$YR$$F$Y$$$20240920$$PH$JP$JP
243438631$24343863$1$I$20240722$20240910$20240920$20240920$EXP$$BE-GE HEALTHCARE-2024CSU010113$GE HEALTHCARE$$50$YR$$M$Y$97$KG$20240920$$HP$BE$BE
243438641$24343864$1$I$20240805$20240910$20240920$20240920$EXP$$BE-GE HEALTHCARE-2024CSU010112$GE HEALTHCARE$$70$YR$$F$Y$83$KG$20240920$$HP$BE$BE
243438651$24343865$1$I$$20240919$20240920$20240920$PER$$US-BAYER-2024A134397$BAYER$$$$$F$Y$$$20240920$$CN$US$US
243438671$24343867$1$I$20240907$20240909$20240920$20240920$PER$$US-FARMAPROD-202409-3223$DOMPE FARMACEUTICI$$68$YR$E$F$Y$$$20240920$$CN$US$US
243438681$24343868$1$I$$20240917$20240920$20240920$EXP$$US-UCBSA-2024048145$UCB$Silverman A, Hyslop A, Gallentine W, Rao C. A Case Series of Novel Monogenic Abnormalities Associated With Developmental Epileptic Encephalopathy With Spike-and-Wave Activation in Sleep. Pediatric Neurology. 2024;161:18-23$6$YR$$F$Y$$$20240920$$MD$US$US
243438691$24343869$1$I$$20240917$20240920$20240920$PER$$US-ABBVIE-5929802$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243438701$24343870$1$I$$20240822$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000772$BRAEBURN PHARMACEUTICALS$$$$$F$Y$87.347$KG$20240920$$CN$US$US
243438711$24343871$1$I$$20240624$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000490$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243438721$24343872$1$I$20240511$20240523$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000491$BRAEBURN PHARMACEUTICALS$$44$YR$$F$Y$$$20240920$$PH$US$US
243438731$24343873$1$I$$20240821$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000771$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243438742$24343874$2$F$$20240919$20240920$20240927$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006853$BIOCON$$$$$$Y$$$20240927$$CN$CA$CA
243438751$24343875$1$I$$20240822$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000814$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243438761$24343876$1$I$20240430$20240906$20240920$20240920$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468944$RANBAXY$$76$YR$$M$Y$$$20240920$$PH$FR$FR
243438771$24343877$1$I$$20240906$20240920$20240920$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469134$RANBAXY$Yimenicioglu S, Ekici A. Hot water epilepsy with alone and spontaneous seizures in childhood. Epilepsy Res. 2024;205(0):107418 (1-7)$5$YR$$M$Y$$$20240920$$HP$TR$TR
243438781$24343878$1$I$$20240906$20240920$20240920$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469222$RANBAXY$Ricci L, Tombini M, Savastano E, Pulitano P, Piccioli M, Forti M, et al. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clin Neurophysiol. 2024;163 (0):152-159$37$YR$$M$Y$$$20240920$$HP$IT$IT
243438791$24343879$1$I$$20240906$20240920$20240920$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469120$RANBAXY$Zhang F-J, Fang W-J,Zhang C-J. Monomorphic epitheliotropic intestinal T-cell lymphoma with bone marrow involved: A case report. World JClin Cases. 2024;Feb 06;12(4):814-819$52$YR$$F$Y$$$20240920$$HP$CN$CN
243438801$24343880$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468931$RANBAXY$Valido K, Murphy MJ, Leventhal JS, Damsky W. Successful treatment of pityriasis rubra pilaris with brodalumab after nonresponse to IL-17A inhibition: A role for the innate cytokine IL-17C. JAAD Case Rep. 2024;48 (0):85-87$80$YR$$M$Y$$$20240920$$HP$US$US
243438811$24343881$1$I$$20240906$20240920$20240920$EXP$$EG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469095$RANBAXY$Abouzid A, Abouzid M. Metachronous Endometrial Carcinoma in a Patient With a History of Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk. 2024;Sep:HL-358/S447$43$YR$$F$Y$$$20240920$$MD$EG$EG
243438821$24343882$1$I$$20240906$20240920$20240920$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469143$RANBAXY$Yimenicioglu S, Ekici A. Hot water epilepsy with alone and spontaneous seizures in childhood. Epilepsy Res. 2024;205(0):107418(1-7)$18$MON$$M$Y$$$20240920$$HP$TR$TR
243438831$24343883$1$I$20211023$20240916$20240920$20240920$EXP$$RO-ASTELLAS-2024-AER-006976$ASTELLAS$$53$YR$A$M$Y$$$20240920$$MD$RO$RO
243438851$24343885$1$I$$20240917$20240920$20240920$EXP$$US-PFIZER INC-202400258750$PFIZER$Dermawan, J.. Novel PAX3::MAML3 Fusion Identified in Alveolar Rhabdomyosarcoma, Using DNA Methylation Profiling to Expand the Genetic Spectrum of ^Fusion-Positive^ Cases. Modern Pathology. 2024;37(11):10.1016/j.modpat.2024.100594$$$T$F$Y$$$20240920$$HP$US$US
243438861$24343886$1$I$20240914$20240919$20240920$20240920$EXP$GB-MHRA-MED-202409161424553710-WZRYN$GB-PFIZER INC-202400259799$PFIZER$$$$$$Y$$$20240920$$PH$GB$GB
243438871$24343887$1$I$20240917$20240919$20240920$20240920$EXP$$US-PFIZER INC-PV202400122862$PFIZER$$82$YR$$M$Y$$$20240920$$CN$US$US
243438882$24343888$2$F$$20240922$20240920$20240924$EXP$$MK-PFIZER INC-202400259911$PFIZER$$63$YR$$F$Y$$$20240924$$MD$MK$MK
243438901$24343890$1$I$$20240919$20240920$20240920$EXP$$JP-PFIZER INC-PV202400122940$PFIZER$$$$$$Y$$$20240920$$MD$JP$JP
243438911$24343891$1$I$$20240920$20240920$20240920$EXP$$JP-PFIZER INC-202400260181$PFIZER$$75$YR$$M$Y$$$20240920$$PH$JP$JP
243438921$24343892$1$I$20240808$20240920$20240920$20240920$DIR$719173$$FDA-CTU$$79$YR$$F$N$54$KG$20240920$N$CN$US$
243438931$24343893$1$I$$20240912$20240920$20240920$EXP$$US-PFIZER INC-PV202400119924$PFIZER$$59$YR$$F$Y$65.7$KG$20240920$$MD$US$US
243438942$24343894$2$F$20240814$20240919$20240920$20240923$EXP$$US-PFIZER INC-PV202300094070$PFIZER$$77$YR$$M$Y$$$20240923$$CN$US$US
243438961$24343896$1$I$$20240919$20240920$20240920$EXP$$US-PFIZER INC-202400260097$PFIZER$$67$YR$$M$Y$$$20240920$$CN$US$US
243438971$24343897$1$I$20240730$20240919$20240920$20240920$EXP$$US-PFIZER INC-PV202300111513$PFIZER$$87$YR$$M$Y$$$20240920$$CN$US$US
243438982$24343898$2$F$$20240920$20240920$20240923$EXP$$US-PFIZER INC-PV202400122946$PFIZER$$93$YR$$M$Y$$$20240923$$HP$US$US
243438991$24343899$1$I$$20240919$20240920$20240920$EXP$$JP-PFIZER INC-PV202400122778$PFIZER$$75$YR$$M$Y$$$20240920$$MD$JP$JP
243439001$24343900$1$I$$20240919$20240920$20240920$EXP$$IN-PFIZER INC-PV202400123313$PFIZER$$54$YR$$F$Y$$$20240920$$CN$IN$IN
243439011$24343901$1$I$$20240919$20240920$20240920$EXP$$FR-PFIZER INC-PV202400122782$PFIZER$$75$YR$$M$Y$$$20240920$$MD$FR$FR
243439031$24343903$1$I$$20240919$20240920$20240920$EXP$$JP-PFIZER INC-202400259335$PFIZER$$$$$$Y$$$20240920$$PH$JP$JP
243439041$24343904$1$I$20240101$20240919$20240920$20240920$EXP$$GB-PFIZER INC-PV202400120445$PFIZER$$88$YR$$M$Y$$$20240920$$CN$GB$GB
243439051$24343905$1$I$20240716$20240918$20240920$20240920$EXP$$CN-PFIZER INC-PV202400122347$PFIZER$$57$YR$$F$Y$50$KG$20240920$$HP$CN$CN
243439061$24343906$1$I$$20240919$20240920$20240920$EXP$$RO-PFIZER INC-PV202400122785$PFIZER$$$$$F$Y$$$20240920$$MD$RO$RO
243439071$24343907$1$I$$20240919$20240920$20240920$EXP$$JP-PFIZER INC-PV202400122784$PFIZER$$82$YR$$M$Y$$$20240920$$MD$JP$JP
243439082$24343908$2$F$20240816$20240912$20240920$20240926$30DAY$$US-ALKERMES INC.-ALK-2024-002187$ALKERMES$$29$YR$$F$Y$$$20240926$$HP$US$US
243439091$24343909$1$I$$20240806$20240920$20240920$PER$$US-LUNDBECK-DKLU4002928$LUNDBECK$$$$$$Y$$$20240920$$CN$US$US
243439101$24343910$1$I$$20240701$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000521$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243439111$24343911$1$I$20240628$20240802$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000615$BRAEBURN PHARMACEUTICALS$$57$YR$$F$Y$$$20240920$$MD$US$US
243439121$24343912$1$I$$20240530$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000515$BRAEBURN PHARMACEUTICALS$$$$$F$Y$79.819$KG$20240920$$HP$US$US
243439131$24343913$1$I$20240531$20240531$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000517$BRAEBURN PHARMACEUTICALS$$38$YR$$F$Y$$$20240920$$CN$US$US
243439141$24343914$1$I$20240601$20240610$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000548$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243439151$24343915$1$I$20240501$20240703$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000536$BRAEBURN PHARMACEUTICALS$$38$YR$$M$Y$$$20240920$$PH$US$US
243439161$24343916$1$I$20240624$20240816$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000599$BRAEBURN PHARMACEUTICALS$$40$YR$$M$Y$$$20240920$$CN$US$US
243439171$24343917$1$I$$20240530$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000510$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243439181$24343918$1$I$20240322$20240730$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000540$BRAEBURN PHARMACEUTICALS$$43$YR$$F$Y$$$20240920$$HP$US$US
243439191$24343919$1$I$20240524$20240702$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000530$BRAEBURN PHARMACEUTICALS$$23$YR$$F$Y$$$20240920$$HP$US$US
243439201$24343920$1$I$$20240731$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000604$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243439211$24343921$1$I$$20240626$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000605$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243439221$24343922$1$I$20240603$20240603$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000531$BRAEBURN PHARMACEUTICALS$$63$YR$$F$Y$$$20240920$$CN$US$US
243439231$24343923$1$I$$20240719$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000598$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243439241$24343924$1$I$$20240531$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000519$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$PH$US$US
243439251$24343925$1$I$$20240610$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000554$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243439261$24343926$1$I$$20240627$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000611$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243439271$24343927$1$I$20240621$20240719$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000597$BRAEBURN PHARMACEUTICALS$$29$YR$$F$Y$$$20240920$$CN$US$US
243439281$24343928$1$I$$20240703$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000549$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$MD$US$US
243439291$24343929$1$I$20240829$20240911$20240920$20240920$PER$$US-ABBVIE-5922315$ABBVIE$$46$YR$$F$Y$$$20240920$$CN$US$US
243439301$24343930$1$I$$20240911$20240920$20240920$30DAY$$CL-PFIZER INC-202400255355$PFIZER$$$$$F$Y$$$20240920$$CN$CL$CL
243439311$24343931$1$I$20240829$20240911$20240920$20240920$30DAY$$CL-PFIZER INC-202400255405$PFIZER$$$$$$Y$$$20240920$$CN$CL$CL
243439321$24343932$1$I$20240911$20240913$20240920$20240920$30DAY$$US-PFIZER INC-202400256486$PFIZER$$11$YR$$F$Y$36.29$KG$20240920$$CN$US$US
243439331$24343933$1$I$$20240913$20240920$20240920$PER$$CA-BRACCO-2024CA05804$BRACCO$$24$YR$$M$Y$$$20240920$$MD$CA$CA
243439341$24343934$1$I$$20240719$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000617$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$MD$US$US
243439351$24343935$1$I$20210301$20240912$20240920$20240920$EXP$$AU-CELLTRION INC.-2024AU022346$CELLTRION$$$$$$Y$$$20240920$$MD$AU$AU
243439362$24343936$2$F$20240715$20240913$20240920$20240923$EXP$GB-MHRA-MED-202408161236046940-MTNSF$GB-SA-2024SA252020$SANOFI AVENTIS$$72$YR$E$M$Y$66$KG$20240923$$CN$GB$GB
243439371$24343937$1$I$$20240903$20240920$20240920$EXP$$US-GSK-US2024AMR114565$GLAXOSMITHKLINE$$32$YR$$F$Y$$$20240920$$MD$US$US
243439381$24343938$1$I$20240903$20240920$20240920$20240920$EXP$$CY-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052544$BOEHRINGER INGELHEIM$$63$YR$A$M$Y$$$20240920$$CN$CY$CY
243439391$24343939$1$I$$20240918$20240920$20240920$EXP$$NVSC2024BO187842$NOVARTIS$$$$$F$Y$$$20240920$$MD$BO$BO
243439401$24343940$1$I$20240819$20240910$20240920$20240920$EXP$$JP-UCBSA-2024047093$UCB$$$$$M$Y$$$20240920$$MD$JP$JP
243439411$24343941$1$I$$20240903$20240920$20240920$PER$$US-ABBVIE-5930913$ABBVIE$$$$$$Y$$$20240920$$HP$US$US
243439421$24343942$1$I$20240821$20240909$20240920$20240920$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000948$PAREXEL$$$$$$Y$$$20240920$$HP$CN$CN
243439431$24343943$1$I$20240901$20240916$20240920$20240920$EXP$$US-SA-2024SA269204$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240920$$MD$US$US
243439471$24343947$1$I$$20240910$20240920$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409006304$ELI LILLY AND CO$Matsuoka A, et al..ORIGINAL ARTICLE Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series.The Journal of Obstetrics and Gynaecology Research 2024;50 (7):1148-1154.$48$YR$A$F$Y$$$20240920$$MD$JP$JP
243439481$24343948$1$I$20240828$20240917$20240920$20240920$30DAY$$CO-PFIZER INC-PV202400122116$PFIZER$$$$$$Y$$$20240920$$CN$CO$CO
243439492$24343949$2$F$$20240919$20240920$20240922$PER$$NVSC2024US187767$NOVARTIS$$$$$F$Y$$$20240923$$HP$US$US
243439501$24343950$1$I$$20240911$20240920$20240920$EXP$$ES-AMGEN-ESPSP2024183845$AMGEN$Lluch P.; Ballester M.P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240920$$MD$ES$ES
243439511$24343951$1$I$20240916$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187870$AMGEN$$74$YR$E$$Y$$$20240920$$PH$US$US
243439551$24343955$1$I$20240101$20240905$20240920$20240920$PER$$US-SA-2024SA184013$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240920$$CN$US$US
243439571$24343957$1$I$20240101$20240903$20240920$20240920$PER$$US-SA-2024SA271051$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240920$$MD$US$US
243439581$24343958$1$I$20240827$20240903$20240920$20240920$PER$$US-SA-2024SA271640$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240920$$HP$US$US
243439591$24343959$1$I$$20240903$20240920$20240920$PER$$US-SA-2024SA270954$SANOFI AVENTIS$$$$E$F$Y$68.18$KG$20240920$$MD$US$US
243439611$24343961$1$I$$20240903$20240920$20240920$PER$$US-SA-2024SA270981$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243439621$24343962$1$I$$20240905$20240920$20240920$PER$$US-SA-2024SA269858$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240920$$CN$US$US
243439631$24343963$1$I$$20240905$20240920$20240920$PER$$US-SA-2024SA272125$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240920$$HP$US$US
243439641$24343964$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA267472$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240920$$MD$US$US
243439651$24343965$1$I$20240901$20240911$20240920$20240920$PER$$US-SA-2024SA266594$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240920$$MD$US$US
243439661$24343966$1$I$$20240909$20240920$20240920$PER$$US-SA-2024SA271499$SANOFI AVENTIS$$$$$F$Y$$$20240920$$CN$US$US
243439671$24343967$1$I$$20240907$20240920$20240920$PER$$US-SA-2024SA268701$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240920$$HP$US$US
243439681$24343968$1$I$$20240907$20240920$20240920$PER$$US-SA-2024SA267596$SANOFI AVENTIS$$56$YR$A$F$Y$50$KG$20240920$$CN$US$US
243439691$24343969$1$I$20240830$20240830$20240920$20240920$PER$$US-SA-2024SA269097$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240920$$PH$US$US
243439701$24343970$1$I$20240901$20240906$20240920$20240920$PER$$US-SA-2024SA272237$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240920$$HP$US$US
243439711$24343971$1$I$$20240912$20240920$20240920$PER$$US-SA-2023SA326608$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240920$$HP$US$US
243439721$24343972$1$I$20230101$20240912$20240920$20240920$PER$$US-SA-2024SA266830$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240920$$MD$US$US
243439731$24343973$1$I$20240101$20240912$20240920$20240920$PER$$US-SA-2024SA266782$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240920$$MD$US$US
243439741$24343974$1$I$20240901$20240911$20240920$20240920$PER$$US-SA-2024SA267864$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240920$$HP$US$US
243439751$24343975$1$I$20240801$20240911$20240920$20240920$PER$$US-SA-2024SA267253$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240920$$HP$US$US
243439761$24343976$1$I$20240101$20240912$20240920$20240920$PER$$US-SA-2024SA268756$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240920$$HP$US$US
243439771$24343977$1$I$$20240913$20240920$20240920$EXP$$ES-AMGEN-ESPSP2024184894$AMGEN$Queiruga-parada J.; Tomaszewska-kiecana M.; Carapuca E. et al.. NM09, a denosumab biosimilar candidate: Biosimilarity demonstration in a phase I study in healthy subjects. Clinical and Translational Science. 2024;17 (9):1-11$$$$$Y$$$20240920$$HP$ES$ES
243439782$24343978$2$F$20240101$20240917$20240920$20240926$PER$$US-AMGEN-USASP2024185733$AMGEN$$72$YR$E$F$Y$$$20240926$$CN$US$US
243439791$24343979$1$I$20240918$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149172$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$97.8$KG$20240920$$HP$US$US
243439801$24343980$1$I$20240709$20240710$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149232$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240920$$PH$US$US
243439811$24343981$1$I$20240907$20240913$20240920$20240920$PER$$US-SA-2024SA267947$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240920$$MD$US$US
243439831$24343983$1$I$20240801$20240913$20240920$20240920$PER$$US-SA-2024SA268056$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240920$$MD$US$US
243439841$24343984$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA269599$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240920$$MD$US$US
243439851$24343985$1$I$20240901$20240913$20240920$20240920$PER$$US-SA-2024SA268197$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240920$$HP$US$US
243439861$24343986$1$I$$20240915$20240920$20240920$PER$$US-SA-2024SA268322$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240920$$MD$US$US
243439871$24343987$1$I$20240811$20240913$20240920$20240920$PER$$US-SA-2024SA267992$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240920$$MD$US$US
243439881$24343988$1$I$20240101$20240915$20240920$20240920$PER$$US-SA-2024SA270213$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240920$$HP$US$US
243439891$24343989$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268137$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240920$$MD$US$US
243439901$24343990$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268635$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240920$$MD$US$US
243439911$24343991$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA269926$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240920$$HP$US$US
243439921$24343992$1$I$20240401$20240915$20240920$20240920$PER$$US-SA-2024SA269494$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240920$$HP$US$US
243439931$24343993$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268257$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240920$$HP$US$US
243439941$24343994$1$I$20231001$20240915$20240920$20240920$PER$$US-SA-2024SA269511$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240920$$HP$US$US
243439951$24343995$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA267329$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240920$$MD$US$US
243439971$24343997$1$I$20240901$20240913$20240920$20240920$PER$$US-SA-2024SA269013$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240920$$HP$US$US
243439981$24343998$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA269585$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240920$$HP$US$US
243439991$24343999$1$I$20240805$20240916$20240920$20240920$PER$$US-SA-2024SA271326$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240920$$MD$US$US
243440001$24344000$1$I$$20240916$20240920$20240920$PER$$US-SA-2024SA268922$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240920$$MD$US$US
243440011$24344001$1$I$20240701$20240916$20240920$20240920$PER$$US-SA-2024SA270524$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240920$$HP$US$US
243440021$24344002$1$I$20240901$20240916$20240920$20240920$PER$$US-SA-2024SA271347$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240920$$CN$US$US
243440031$24344003$1$I$20240701$20240916$20240920$20240920$PER$$US-SA-2024SA270143$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240920$$MD$US$US
243440041$24344004$1$I$20240624$20240916$20240920$20240920$PER$$US-SA-2024SA270534$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240920$$HP$US$US
243440051$24344005$1$I$$20240916$20240920$20240920$PER$$US-SA-2024SA268858$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240920$$HP$US$US
243440061$24344006$1$I$20240101$20240916$20240920$20240920$PER$$US-SA-2024SA270346$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240920$$MD$US$US
243440071$24344007$1$I$20240101$20240916$20240920$20240920$PER$$US-SA-2024SA270315$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240920$$HP$US$US
243440081$24344008$1$I$20240901$20240916$20240920$20240920$PER$$US-SA-2024SA268907$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240920$$MD$US$US
243440091$24344009$1$I$20240101$20240918$20240920$20240920$EXP$$JP-JNJFOC-20240954556$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240920$$MD$JP$JP
243440101$24344010$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112673$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$HP$US$US
243440111$24344011$1$I$$20240905$20240920$20240920$PER$$US-SA-2024SA272442$SANOFI AVENTIS$$$$E$M$Y$$$20240920$$MD$US$US
243440121$24344012$1$I$20240701$20240830$20240920$20240920$PER$$US-SA-2024SA133878$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240920$$CN$US$US
243440132$24344013$2$F$$20240910$20240920$20240925$PER$$US-SA-2024SA271624$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240925$$CN$US$US
243440141$24344014$1$I$$20240821$20240920$20240920$PER$$US-SA-2024SA272257$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240920$$HP$US$US
243440151$24344015$1$I$20240101$20240914$20240920$20240920$EXP$$US-SA-2024SA271656$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240920$$CN$US$US
243440161$24344016$1$I$$20240829$20240920$20240920$PER$$US-SA-2024SA270970$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240920$$MD$US$US
243440171$24344017$1$I$$20240920$20240920$20240920$DIR$719182$$FDA-CTU$$$$$UNK$N$$$20240920$$CN$US$
243440181$24344018$1$I$20240527$20240916$20240920$20240920$EXP$FR-AFSSAPS-AVMA2024000394$FR-TEVA-VS-3244285$TEVA$$47$YR$$F$Y$$$20240920$$PH$FR$FR
243440211$24344021$1$I$$20240912$20240920$20240920$EXP$$US-AMGEN-USASP2024184218$AMGEN$Doumeth S.A; Petrinec E; Chaudhary H. et al. Anti-PL-12 anti-synthetase syndrome manifesting with multiple digital ischemia: Case report + review of the literature. Clinical Case Reports. 2024;12(9):1-9$61$YR$A$M$Y$$$20240920$$HP$US$US
243440221$24344022$1$I$$20240916$20240920$20240920$PER$$US-SA-2024SA271570$SANOFI AVENTIS$$$$E$F$Y$$$20240920$$MD$US$US
243440231$24344023$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA266891$SANOFI AVENTIS$$3$YR$C$F$Y$17$KG$20240920$$MD$US$US
243440241$24344024$1$I$20240301$20240912$20240920$20240920$PER$$US-SA-2024SA267548$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240920$$MD$US$US
243440251$24344025$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267251$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240920$$HP$US$US
243440261$24344026$1$I$20240912$20240912$20240920$20240920$PER$$US-009507513-2409USA005190$MERCK$$71$YR$$F$Y$$$20240920$$CN$US$US
243440271$24344027$1$I$$20240917$20240920$20240920$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-125016$REGENERON$$$$$F$Y$$$20240920$$CN$US$US
243440281$24344028$1$I$$20240912$20240920$20240920$EXP$$CA-APOTEX-2024AP010700$APOTEX$Medina lemus A, Boelman C, Myers KA. Epilepsy in Legius syndrome: Coincidence or causation?. American Journal of Medical Genetics Part A. 2024;194A (6):e63547:1-6$8$YR$$F$Y$$$20240920$$HP$CA$CA
243440301$24344030$1$I$20231210$20240906$20240920$20240920$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468792$RANBAXY$$$$N$M$Y$3$KG$20240920$$MD$NL$NL
243440311$24344031$1$I$$20240913$20240920$20240920$PER$$US-JNJFOC-20240935198$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$HP$US$US
243440321$24344032$1$I$$20240909$20240920$20240920$EXP$$DE-UCBSA-2024046736$UCB$$$$$$Y$$$20240920$$MD$DE$DE
243440341$24344034$1$I$$20240906$20240920$20240920$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469274$RANBAXY$Terashita M, Selamet U, Midha S, Nadeem O, Laubach J, Rennke HG, et al. Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones. Kidney Int Rep. 2023;8:2765-2777$$$$$Y$$$20240920$$HP$US$US
243440351$24344035$1$I$$20240919$20240920$20240920$EXP$$NVSC2024US187411$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243440371$24344037$1$I$$20240912$20240920$20240920$EXP$$NVSC2024NG184238$NOVARTIS$$$$$F$Y$$$20240920$$CN$NG$NG
243440381$24344038$1$I$20240901$20240909$20240920$20240920$EXP$$US-UCBSA-2024046477$UCB$$60$YR$$F$Y$100.36$KG$20240920$$HP$US$US
243440391$24344039$1$I$$20240829$20240920$20240920$PER$$US-009507513-2408USA010546$MERCK$Agarwal V, Nagasubramanian R, Maxwell R, Douglas-Lindsay D, Mercado C, Hayes L, et al. Diffuse pediatric high grade glioma successfully treated with multimodal therapy. Neuro-Oncology. 2024;26 (Suppl. 4):iv97$8$YR$$M$Y$$$20240920$$HP$US$US
243440401$24344040$1$I$$20240723$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000623$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$MD$US$US
243440411$24344041$1$I$20240612$20240703$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000628$BRAEBURN PHARMACEUTICALS$$33$YR$$M$Y$$$20240920$$HP$US$US
243440421$24344042$1$I$20240701$20240919$20240920$20240920$EXP$FR-AFSSAPS-LY2024001287$FR-009507513-2409FRA006934$MERCK$$70$YR$$M$Y$99$KG$20240920$$PH$FR$FR
243440431$24344043$1$I$$20240724$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000653$BRAEBURN PHARMACEUTICALS$$33$YR$$F$Y$$$20240920$$HP$US$US
243440441$24344044$1$I$$20240723$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000624$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$MD$US$US
243440451$24344045$1$I$$20240723$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000648$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243440461$24344046$1$I$$20240723$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000625$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$MD$US$US
243440471$24344047$1$I$$20240812$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000650$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243440481$24344048$1$I$20240120$20240920$20240920$20240920$DIR$719185$$FDA-CTU$$39$YR$$F$N$90$KG$20240920$N$CN$US$
243440491$24344049$1$I$$20240709$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000645$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243440501$24344050$1$I$20240628$20240705$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000635$BRAEBURN PHARMACEUTICALS$$28$YR$$F$Y$$$20240920$$HP$US$US
243440511$24344051$1$I$$20240718$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000640$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243440531$24344053$1$I$20240913$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64563$$FDA-CTU$$68$YR$$F$N$$$20240920$N$HP$US$
243440541$24344054$1$I$$20240919$20240919$20240919$DIR$719141$$FDA-CTU$$$$$UNK$N$$$20240919$$CN$US$
243440561$24344056$1$I$$20240919$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149382$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240920$$CN$US$US
243440571$24344057$1$I$20240101$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148159$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240920$$HP$US$US
243440581$24344058$1$I$20240915$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64564$$FDA-CTU$$19$YR$$M$N$$$20240919$N$HP$US$
243440592$24344059$2$F$$20240919$20240920$20240925$EXP$$US-ABBVIE-5928195$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243440611$24344061$1$I$$20240715$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000664$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243440621$24344062$1$I$20240624$20240715$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000657$BRAEBURN PHARMACEUTICALS$$31$YR$$M$Y$$$20240920$$CN$US$US
243440631$24344063$1$I$$20240716$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000668$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243440641$24344064$1$I$$20240730$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000667$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243440651$24344065$1$I$$20240718$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000675$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243440661$24344066$1$I$20240715$20240715$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000660$BRAEBURN PHARMACEUTICALS$$35$YR$$F$Y$$$20240920$$CN$US$US
243440671$24344067$1$I$$20240729$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000661$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243440681$24344068$1$I$$20240730$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000665$BRAEBURN PHARMACEUTICALS$$39$YR$$F$Y$$$20240920$$MD$US$US
243440691$24344069$1$I$20240703$20240731$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000674$BRAEBURN PHARMACEUTICALS$$54$YR$$F$Y$$$20240920$$HP$US$US
243440701$24344070$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA267646$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240920$$MD$US$US
243440711$24344071$1$I$20240801$20240911$20240920$20240920$PER$$US-SA-2024SA266203$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240920$$MD$US$US
243440721$24344072$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267609$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240920$$HP$US$US
243440731$24344073$1$I$$20240903$20240920$20240920$PER$$US-SA-2024SA270907$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243440741$24344074$1$I$20240101$20240912$20240920$20240920$PER$$US-SA-2024SA267191$SANOFI AVENTIS$$$$E$M$Y$$$20240920$$MD$US$US
243440751$24344075$1$I$$20240913$20240920$20240920$EXP$$US-ALKERMES INC.-ALK-2024-002397$ALKERMES$$$$$F$Y$68.027$KG$20240920$$HP$US$US
243440761$24344076$1$I$$20240725$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000701$BRAEBURN PHARMACEUTICALS$$46$YR$$F$Y$$$20240920$$HP$US$US
243440771$24344077$1$I$$20240814$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000689$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243440781$24344078$1$I$$20240723$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000692$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$MD$US$US
243440791$24344079$1$I$$20240724$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000697$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243440801$24344080$1$I$$20240817$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000703$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243440811$24344081$1$I$$20240726$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000705$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243440821$24344082$1$I$$20240724$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000698$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$PH$US$US
243440831$24344083$1$I$$20240723$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000691$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$MD$US$US
243440841$24344084$1$I$$20240729$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000710$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243440851$24344085$1$I$$20240723$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000693$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243440861$24344086$1$I$20240828$20240905$20240920$20240920$EXP$$DE-BAXTER-2024BAX024365$BAXTER$$81$YR$$F$Y$$$20240920$$HP$DE$DE
243440871$24344087$1$I$$20240806$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000733$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243440881$24344088$1$I$$20240808$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000739$BRAEBURN PHARMACEUTICALS$$30$YR$$M$Y$$$20240920$$HP$US$US
243440891$24344089$1$I$$20240808$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000740$BRAEBURN PHARMACEUTICALS$$51$YR$$M$Y$$$20240920$$HP$US$US
243440901$24344090$1$I$20240910$20240911$20240920$20240920$EXP$GB-MHRA-MED-202409110838475070-FNRBT$GB-TEVA-VS-3242932$TEVA$$53$YR$$F$Y$$$20240920$$HP$GB$GB
243440911$24344091$1$I$$20240821$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000764$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243440921$24344092$1$I$$20240808$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000741$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243440931$24344093$1$I$$20240731$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000721$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243440941$24344094$1$I$$20240806$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000732$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240920$$HP$US$US
243440951$24344095$1$I$20240726$20240820$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000714$BRAEBURN PHARMACEUTICALS$$44$YR$$M$Y$$$20240920$$HP$US$US
243440961$24344096$1$I$$20240822$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000723$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$US$US
243440971$24344097$1$I$$20240910$20240920$20240920$EXP$$US-KOANAAP-SML-US-2024-00954$Unknown Manufacturer$Mohan A, Quingalahua E, Gunchick V, Paul S, Kumar-Sinha C, Crysler O, et al. PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma. Oncologist 2024;29(8):725-730.$$$$F$Y$$$20240920$$MD$US$US
243440981$24344098$1$I$$20240910$20240920$20240920$EXP$$US-KOANAAP-SML-US-2024-00952$UNKNOWN$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024;67no pagination.$60$YR$A$F$Y$$$20240920$$MD$US$US
243440991$24344099$1$I$20240801$20240806$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000731$BRAEBURN PHARMACEUTICALS$$28$YR$$M$Y$$$20240920$$CN$US$US
243441001$24344100$1$I$$20240918$20240920$20240920$EXP$$US-SANDOZ INC.-SDZ2024US081546$SANDOZ$$$$$M$Y$$$20240920$$CN$US$US
243441011$24344101$1$I$$20240916$20240920$20240920$30DAY$$US-SANDOZ INC.-SDZ2024US080660$SANDOZ$$$$$M$Y$$$20240920$$CN$US$US
243441021$24344102$1$I$$20240911$20240920$20240920$EXP$$CA-TAKEDA-2024TUS091192$TAKEDA$$$$$M$Y$$$20240920$$MD$CA$CA
243441041$24344104$1$I$20240801$20240916$20240920$20240920$EXP$$DE-AMGEN-DEUSP2024184623$AMGEN$$47$YR$A$F$Y$$$20240920$$MD$DE$DE
243441051$24344105$1$I$20240913$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024184994$AMGEN$$67$YR$E$F$Y$$$20240920$$CN$US$US
243441061$24344106$1$I$$20240918$20240920$20240920$PER$$US-009507513-2409USA006827$MERCK$$$$$M$Y$$$20240920$$HP$US$US
243441071$24344107$1$I$$20240829$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000768$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$HP$US$US
243441081$24344108$1$I$$20240820$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000766$BRAEBURN PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243441091$24344109$1$I$$20240910$20240920$20240920$EXP$$US-KOANAAP-SML-US-2024-00953$Unknown Manufacturer$Mohan A, Quingalahua E, Gunchick V, Paul S, Kumar-Sinha C, Crysler O, et al. PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma. Oncologist 2024;29(8):725-730.$$$$F$Y$$$20240920$$MD$US$US
243441101$24344110$1$I$20240813$20240919$20240919$20240919$DIR$719150$$FDA-CTU$$81$YR$$F$N$$$20240919$Y$HP$US$
243441111$24344111$1$I$$20240910$20240920$20240920$EXP$$US-KOANAAP-SML-US-2024-00951$UNKNOWN$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024;67no pagination.$49$YR$A$F$Y$$$20240920$$MD$US$US
243441121$24344112$1$I$$20240910$20240920$20240920$EXP$$IN-KOANAAP-SML-IN-2024-00949$Unknown Manufacturer$Ganju N, Panda T, Oberoi G, Agarwal M, Mahapatra M. AML-083 AML in Pregnancy: Case Series. Clin-Lymphoma-Myeloma-Leuk 2024;24S293. - [abstract]$$$$F$Y$$$20240920$$MD$IN$IN
243441131$24344113$1$I$$20240910$20240920$20240920$EXP$$IN-KOANAAP-SML-IN-2024-00950$Unknown Manufacturer$Ganju N, Panda T, Oberoi G, Agarwal M, Mahapatra M. AML-083 AML in Pregnancy: Case Series. Clin-Lymphoma-Myeloma-Leuk 2024;24S293. - [abstract]$$$$F$Y$$$20240920$$MD$IN$IN
243441142$24344114$2$F$20240918$20240918$20240920$20240920$30DAY$$US-SANDOZ INC.-SDZ2024US081517$SANDOZ$$39$YR$$F$Y$$$20240920$$HP$US$US
243441152$24344115$2$F$$20240913$20240920$20240925$EXP$$JP-JNJFOC-20240954619$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240926$$MD$JP$JP
243441161$24344116$1$I$20240813$20240910$20240920$20240920$EXP$$US-GSK-US2024AMR113972$GLAXOSMITHKLINE$$10$YR$$M$Y$$$20240920$$MD$US$US
243441171$24344117$1$I$$20240917$20240920$20240920$EXP$$US-INCYTE CORPORATION-2024IN009915$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243441181$24344118$1$I$$20240910$20240920$20240920$EXP$$US-KOANAAP-SML-US-2024-00955$UNKNOWN$Mohan A, Quingalahua E, Gunchick V, Paul S, Sinha C, Sahai V. PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma. The Oncologist. 2024 Jul 20;725-730. doi:doi.org/10.1093/oncolo/oyae163.$$$$F$Y$$$20240920$$MD$US$US
243441201$24344120$1$I$$20240912$20240920$20240920$PER$$US-MYLANLABS-2024M1084354$MYLAN$$$$$F$Y$$$20240920$$MD$US$US
243441211$24344121$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012422$ELI LILLY AND CO$$59$YR$A$$Y$$$20240920$$LW$US$US
243441221$24344122$1$I$$20240910$20240920$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409006305$ELI LILLY AND CO$Matsuoka A, et al..ORIGINAL ARTICLE Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series.The Journal of Obstetrics and Gynaecology Research 2024;50 (7):1148-1154.$57$YR$A$F$Y$$$20240920$$MD$JP$JP
243441231$24344123$1$I$$20240919$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012702$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243441241$24344124$1$I$$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011343$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240920$$CN$US$US
243441251$24344125$1$I$$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010954$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240920$$CN$US$US
243441261$24344126$1$I$20240901$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011691$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240920$$CN$US$US
243441271$24344127$1$I$$20240910$20240920$20240920$PER$$US-BAYER-2024A130422$BAYER$$33$YR$A$F$Y$$$20240920$$CN$US$US
243441291$24344129$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149395$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$56.25$KG$20240920$$CN$US$US
243441302$24344130$2$F$$20240919$20240920$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148950$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$73.48$KG$20240925$$CN$US$US
243441311$24344131$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148903$BRISTOL MYERS SQUIBB$$58$YR$A$$Y$$$20240920$$MD$US$US
243441321$24344132$1$I$$20240905$20240920$20240920$PER$$US-EPICPHARMA-US-2024EPCSPO01132$EPIC PHARM$$$$$F$Y$$$20240920$$MD$US$US
243441331$24344133$1$I$$20240916$20240920$20240920$EXP$$GB-EMD Serono-2024050032$EMD SERONO INC$$$$A$M$Y$$$20240920$$HP$GB$GB
243441341$24344134$1$I$20240801$20240916$20240920$20240920$PER$$US-SA-2024SA270072$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240920$$MD$US$US
243441351$24344135$1$I$20240101$20240916$20240920$20240920$PER$$US-SA-2024SA270166$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240920$$HP$US$US
243441362$24344136$2$F$$20240911$20240920$20240925$EXP$$CA-UCBSA-2024046328$UCB$$$$$M$Y$$$20240925$$CN$CA$CA
243441371$24344137$1$I$$20240919$20240920$20240920$PER$$US-BAYER-2024A134198$BAYER$$$$$$Y$$$20240920$$CN$US$US
243441381$24344138$1$I$20240913$20240916$20240920$20240920$PER$$US-ABBVIE-5927953$ABBVIE$$17$YR$$F$Y$$$20240920$$HP$US$US
243441391$24344139$1$I$$20240910$20240920$20240920$EXP$$CA-APOTEX-2024AP010490$APOTEX$$73$YR$$F$Y$66$KG$20240920$$HP$CA$CA
243441411$24344141$1$I$$20240919$20240920$20240920$PER$$NVSC2024US188040$NOVARTIS$$$$$F$Y$$$20240920$$HP$US$US
243441422$24344142$2$F$20231128$20240919$20240920$20240930$EXP$$CA-TAKEDA-2023TUS099497$TAKEDA$$44$YR$$F$Y$$$20240930$$CN$CA$CA
243441431$24344143$1$I$$20240907$20240920$20240920$EXP$$GB-B.Braun Medical Inc.-2161869$B BRAUN$$61$YR$$M$Y$88$KG$20240920$$$GB$GB
243441451$24344145$1$I$$20240919$20240920$20240920$PER$$US-PFIZER INC-PV202400123129$PFIZER$$62$YR$$F$Y$$$20240920$$HP$US$US
243441461$24344146$1$I$$20240914$20240920$20240920$PER$$US-PFIZER INC-202400256952$PFIZER$$10$YR$$M$Y$22.23$KG$20240920$$HP$US$US
243441472$24344147$2$F$$20240919$20240920$20240924$PER$$US-PFIZER INC-PV202400122628$PFIZER$$68$YR$$F$Y$$$20240924$$HP$US$US
243441482$24344148$2$F$$20240922$20240920$20240924$PER$$US-PFIZER INC-202400259045$PFIZER$$33$YR$$F$Y$$$20240924$$HP$US$US
243441491$24344149$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-202400260095$PFIZER$$30$YR$$M$Y$$$20240920$$CN$US$US
243441502$24344150$2$F$20240918$20240920$20240920$20240924$PER$$US-PFIZER INC-202400259896$PFIZER$$16$YR$$F$Y$$$20240924$$HP$US$US
243441511$24344151$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258727$PFIZER$$71$YR$$M$Y$$$20240920$$CN$US$US
243441521$24344152$1$I$$20240919$20240920$20240920$PER$$US-PFIZER INC-202400259947$PFIZER$$$$A$$Y$$$20240920$$HP$US$US
243441531$24344153$1$I$20240919$20240919$20240920$20240920$PER$$US-PFIZER INC-202400260529$PFIZER$$50$YR$$F$Y$$$20240920$$CN$US$US
243441541$24344154$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400122901$PFIZER$$53$YR$$F$Y$$$20240920$$CN$US$US
243441551$24344155$1$I$$20240919$20240920$20240920$PER$$US-PFIZER INC-202400259945$PFIZER$$$$A$F$Y$$$20240920$$MD$US$US
243441563$24344156$3$F$$20240927$20240920$20240930$PER$$US-PFIZER INC-202400260078$PFIZER$$24$YR$$F$Y$$$20240930$$CN$US$US
243441571$24344157$1$I$20240801$20240919$20240920$20240920$PER$$US-PFIZER INC-PV202400123246$PFIZER$$52$YR$$F$Y$$$20240920$$HP$US$US
243441581$24344158$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-202400260562$PFIZER$$$$$$Y$$$20240920$$MD$US$US
243441591$24344159$1$I$20240918$20240919$20240920$20240920$PER$$US-PFIZER INC-202400260379$PFIZER$$50$YR$$F$Y$$$20240920$$HP$US$US
243441601$24344160$1$I$20240918$20240918$20240920$20240920$PER$$US-PFIZER INC-202400259539$PFIZER$$56$YR$$F$Y$$$20240920$$CN$US$US
243441621$24344162$1$I$20240913$20240919$20240920$20240920$PER$$US-PFIZER INC-202400260399$PFIZER$$73$YR$$F$Y$$$20240920$$MD$US$US
243441631$24344163$1$I$20240919$20240919$20240920$20240920$PER$$US-PFIZER INC-202400260480$PFIZER$$60$YR$$F$Y$$$20240920$$CN$US$US
243441641$24344164$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-202400259292$PFIZER$$65$YR$$F$Y$$$20240920$$CN$US$US
243441651$24344165$1$I$$20240919$20240920$20240920$PER$$US-PFIZER INC-PV202400123275$PFIZER$$21$YR$$F$Y$$$20240920$$CN$US$US
243441661$24344166$1$I$$20240919$20240920$20240920$PER$$US-PFIZER INC-PV202400123247$PFIZER$$$$$F$Y$$$20240920$$CN$US$US
243441681$24344168$1$I$$20240913$20240920$20240920$PER$$US-MYLANLABS-2024M1084396$MYLAN$$$$$F$Y$$$20240920$$CN$US$US
243441691$24344169$1$I$$20240917$20240920$20240920$EXP$$US-SANDOZ INC.-SDZ2024US081535$SANDOZ$$67$YR$$F$Y$$$20240920$$MD$US$US
243441701$24344170$1$I$$20240918$20240920$20240920$PER$$US-BAYER-2024A134501$BAYER$$$$$$Y$$$20240920$$CN$US$US
243441721$24344172$1$I$20240226$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024184887$AMGEN$$$$$F$Y$$$20240920$$HP$US$US
243441732$24344173$2$F$20221201$20240916$20240920$20240926$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-125822$REGENERON$$89$YR$$F$Y$$$20240926$$MD$US$US
243441741$24344174$1$I$$20240920$20240920$20240920$EXP$$RO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052542$BOEHRINGER INGELHEIM$$69$YR$E$M$Y$$$20240920$$MD$RO$RO
243441751$24344175$1$I$$20240912$20240920$20240920$EXP$$US-GSK-US2024AMR114462$GLAXOSMITHKLINE$$$$$F$Y$74.83$KG$20240920$$CN$US$US
243441761$24344176$1$I$$20240830$20240920$20240920$PER$$US-SA-2024SA269057$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240920$$HP$US$US
243441771$24344177$1$I$$20240906$20240920$20240920$PER$$US-SA-2024SA271769$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240920$$CN$US$US
243441791$24344179$1$I$$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64569$$FDA-CTU$$$$$M$N$$$20240919$N$HP$US$
243441811$24344181$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64571$$FDA-CTU$$87$YR$$M$N$$$20240920$N$$US$
243441821$24344182$1$I$20240907$20240909$20240920$20240920$EXP$$JP-UCBSA-2024046827$UCB$$88$YR$$F$Y$$$20240920$$CN$JP$JP
243441832$24344183$2$F$$20240919$20240920$20240925$EXP$$NVSC2024US184468$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
243441841$24344184$1$I$$20240912$20240920$20240920$PER$$US-BAYER-2024A130686$BAYER$$15$MON$I$$Y$$$20240920$$CN$US$US
243441851$24344185$1$I$20240917$20240919$20240919$20240919$DIR$719164$$FDA-CTU$$43$YR$$F$N$92.25$KG$20240919$N$CN$US$
243441861$24344186$1$I$20230619$20240919$20240919$20240919$DIR$719147$$FDA-CTU$$31$YR$$F$N$57.6$KG$20240919$N$CN$US$
243441871$24344187$1$I$20240101$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64573$$FDA-CTU$$66$YR$$M$N$$$20240919$N$HP$US$
243441881$24344188$1$I$20240101$20240917$20240920$20240920$EXP$$JP-AMGEN-JPNSP2024186195$AMGEN$$$$$M$Y$$$20240920$$MD$JP$JP
243441901$24344190$1$I$20240901$20240916$20240920$20240920$PER$$US-BIOGEN-2024BI01283365$BIOGEN$$38$YR$$F$Y$$$20240920$$MD$US$US
243441911$24344191$1$I$$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149336$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240920$$HP$US$US
243441921$24344192$1$I$20240101$20240908$20240920$20240920$PER$$US-INSUD PHARMA-2409US06995$INSUD PHARMA$$$$$$Y$$$20240920$$CN$US$US
243441931$24344193$1$I$$20240906$20240920$20240920$PER$$US-INSUD PHARMA-2409US06992$INSUD PHARMA$$$$$$Y$$$20240920$$CN$US$US
243441941$24344194$1$I$$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147691$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$77.11$KG$20240920$$CN$US$US
243441951$24344195$1$I$$20240911$20240920$20240920$EXP$FR-AFSSAPS-NT2024001106$FR-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2409FR07108$INSUD PHARMA$$22$YR$$F$Y$$$20240920$$CN$FR$FR
243441961$24344196$1$I$20240514$20240916$20240920$20240920$EXP$$DE-LABORATORIOS LICONSA S.A.-2405DE07161$INSUD PHARMA$$$$A$F$Y$108$KG$20240920$$CN$DE$DE
243441971$24344197$1$I$20240801$20240907$20240920$20240920$PER$$US-INSUD PHARMA-2409US06994$INSUD PHARMA$$$$$$Y$$$20240920$$CN$US$US
243441981$24344198$1$I$20240601$20240914$20240920$20240920$EXP$$US-INSUD PHARMA-2409US07181$INSUD PHARMA$$$$$$Y$$$20240920$$CN$US$US
243441991$24344199$1$I$20240101$20240907$20240920$20240920$PER$$US-INSUD PHARMA-2409US06993$INSUD PHARMA$$$$$$Y$$$20240920$$CN$US$US
243442001$24344200$1$I$$20240912$20240920$20240920$EXP$$US-VIIV HEALTHCARE LIMITED-US2024113723$VIIV$$$$$M$Y$$$20240920$$MD$US$US
243442011$24344201$1$I$20240808$20240910$20240920$20240920$30DAY$$US-GSK-US2024112498$GLAXOSMITHKLINE$$32$YR$$F$Y$59$KG$20240920$$HP$US$US
243442021$24344202$1$I$20191201$20240919$20240920$20240920$EXP$$US-INCYTE CORPORATION-2024IN009947$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243442031$24344203$1$I$20240701$20240919$20240920$20240920$EXP$$US-INCYTE CORPORATION-2024IN009952$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243442041$24344204$1$I$$20240912$20240920$20240920$PER$$US-009507513-2409USA006838$MERCK$$$$$F$Y$$$20240920$$CN$US$US
243442051$24344205$1$I$$20240905$20240920$20240920$EXP$$BG-CPL-004621$CADILA$Tchernev G, Ivanov L. MUSTARDE ROTATION FLAP AS ADEQUATE OPTION FOR HIGH-RISK BCC NEAR THE LOWER EYE LID: THE ADDITIONAL INTAKE OF N-NITROSO-FOLIC-ACID AND N-NITROSO-RIVOROXABAN AS COFACTORS/TRIGGERS OF THE METABOLIC REPROGRAMMING OF THE FUTURE CANCER CELL. Georgian Med News. 2024 Jun;(351):131-137. PMID: 39230235.$74$YR$E$F$Y$$$20240920$$HP$BG$BG
243442061$24344206$1$I$$20240917$20240920$20240920$EXP$$US-PUMA BIOTECHNOLOGY, LTD.-2024-PUM-US001249$PUMA$$$$$$Y$$$20240920$$PH$US$US
243442071$24344207$1$I$$20240917$20240920$20240920$PER$$US-JNJFOC-20240945213$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243442081$24344208$1$I$20230101$20240913$20240920$20240920$PER$$US-BAYER-2024A131550$BAYER$$66$YR$E$F$Y$$$20240920$$CN$US$US
243442101$24344210$1$I$20240915$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186768$AMGEN$$54$YR$A$F$Y$$$20240920$$CN$US$US
243442111$24344211$1$I$20240901$20240919$20240920$20240920$EXP$$US-INCYTE CORPORATION-2024IN009903$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243442121$24344212$1$I$20240801$20240919$20240920$20240920$30DAY$$CO-PFIZER INC-202400253829$PFIZER$$10$YR$$F$Y$$$20240920$$CN$CO$CO
243442132$24344213$2$F$$20240919$20240920$20240924$30DAY$$CO-PFIZER INC-PV202400122167$PFIZER$$8$YR$$M$Y$$$20240924$$CN$CO$CO
243442151$24344215$1$I$20240807$20240910$20240920$20240920$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00240$OPKO HEALTH$$79$YR$$F$Y$$$20240918$$PH$US$US
243442161$24344216$1$I$20240915$20240919$20240920$20240920$EXP$$US-INCYTE CORPORATION-2024IN009946$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243442171$24344217$1$I$$20240910$20240920$20240920$EXP$$US-KOANAAP-SML-US-2024-00957$Unknown Manufacturer$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham III CO, Shah AA. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Seminars in Arthritis and Rheumatism. 2024 May 04;67: 1-7. doi:10.1016/j.semarthrit.2024.152460.$54$YR$A$F$Y$$$20240920$$MD$US$US
243442181$24344218$1$I$$20240917$20240920$20240920$PER$$US-BAYER-2024A133393$BAYER$$36$YR$A$F$Y$$$20240920$$MD$US$US
243442191$24344219$1$I$20240101$20240906$20240920$20240920$PER$$US-INSUD PHARMA-2409US06989$INSUD PHARMA$$$$$$Y$$$20240920$$CN$US$US
243442201$24344220$1$I$$20240906$20240920$20240920$PER$$US-INSUD PHARMA-2409US06990$INSUD PHARMA$$$$$$Y$$$20240920$$CN$US$US
243442211$24344221$1$I$20240101$20240912$20240920$20240920$EXP$$US-JNJFOC-20240313136$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20240920$$CN$US$US
243442221$24344222$1$I$$20240909$20240920$20240920$EXP$$CA-JNJFOC-20240928552$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240920$$CN$CA$CA
243442231$24344223$1$I$$20240911$20240920$20240920$PER$IT-PFIZER INC-2019025187$IT-BRACCO-2019IT07229$BRACCO$Belli.L, Magistretti.G, Puricelli.G.P, Damiani.G, Colombo.E, Cornalba.G.P. Arteritis following intra-arterial chemotherapy for liver tumors. European Radiology. 1997;7 (3):323-326$58$YR$$F$Y$$$20240920$$HP$IT$IT
243442241$24344224$1$I$$20240912$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013719$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$63$YR$A$$Y$$$20240920$$MD$US$US
243442251$24344225$1$I$$20240911$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013592$DR REDDYS$Lee AW, Wang YF, Horowitz DP, Kachnic LA. CBCT-Guided Online Adaptive Radiotherapy for Rectal Cancer: Initial Dosimetric and Clinical Experience. International Journal of Radiation Oncology Biology Physics. 2024;120(2):$$$$$Y$$$20240920$$HP$US$US
243442262$24344226$2$F$20240919$20240920$20240920$20240924$PER$$US-AMGEN-USASP2024187402$AMGEN$$72$YR$E$F$Y$$$20240924$$CN$US$US
243442281$24344228$1$I$20240101$20240906$20240920$20240920$EXP$$CA-UCBSA-2024046295$UCB$$$$$M$Y$$$20240920$$MD$CA$CA
243442291$24344229$1$I$20240101$20240906$20240920$20240920$EXP$$US-UCBSA-2024046223$UCB$$$$$M$Y$78.005$KG$20240920$$HP$US$US
243442301$24344230$1$I$$20240912$20240920$20240920$PER$$US-TAKEDA-2024TUS091472$TAKEDA$$26$YR$$F$Y$$$20240920$$CN$US$US
243442321$24344232$1$I$$20240919$20240920$20240920$PER$$NVSC2024US188028$NOVARTIS$$$$$$Y$$$20240920$$CN$US$US
243442331$24344233$1$I$$20240911$20240920$20240920$PER$$US-INCYTE CORPORATION-2024IN009624$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243442341$24344234$1$I$20240808$20240918$20240920$20240920$EXP$FR-AFSSAPS-BX2024001759$FR-009507513-2409FRA006478$MERCK$$79$YR$$F$Y$$$20240920$$PH$FR$FR
243442361$24344236$1$I$20240801$20240915$20240920$20240920$EXP$$NVSC2024EG185527$NOVARTIS$$59$YR$$F$Y$62$KG$20240920$$CN$EG$EG
243442371$24344237$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149656$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240920$$CN$US$US
243442381$24344238$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148701$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240920$$HP$US$US
243442391$24344239$1$I$$20240910$20240920$20240920$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00239$OPKO HEALTH$$$$$M$Y$$$20240918$$PH$US$US
243442401$24344240$1$I$$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148535$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240920$$CN$US$US
243442411$24344241$1$I$$20240912$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146505$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240920$$HP$US$US
243442421$24344242$1$I$20240904$20240906$20240920$20240920$EXP$$CN-EAGLE PHARMACEUTICALS, INC.-CN-2024EAG000230$EAGLE$$64$YR$$M$Y$42$KG$20240920$$HP$CN$CN
243442431$24344243$1$I$$20240916$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148152$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240920$$CN$US$US
243442441$24344244$1$I$20210101$20240918$20240920$20240920$PER$$US-BAYER-2024A133488$BAYER$$27$YR$A$F$Y$$$20240920$$MD$US$US
243442451$24344245$1$I$$20240910$20240920$20240920$EXP$$GB-TEVA-VS-3243284$TEVA$$34$YR$$F$Y$$$20240920$$CN$GB$GB
243442461$24344246$1$I$20240910$20240910$20240920$20240920$30DAY$$US-GSK-US2024112653$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$CN$US$US
243442471$24344247$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024AMR112914$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243442481$24344248$1$I$20240101$20240916$20240920$20240920$PER$$US-SA-2024SA268848$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240920$$MD$US$US
243442491$24344249$1$I$20240501$20240912$20240920$20240920$EXP$$US-BAYER-2024A066362$BAYER$$74$YR$E$F$Y$115.19$KG$20240920$$CN$US$US
243442501$24344250$1$I$20200601$20240919$20240920$20240920$EXP$$DE-SANDOZ INC.-NVSC2021DE315855$SANDOZ$$80$YR$$M$Y$69$KG$20240920$$HP$DE$DE
243442511$24344251$1$I$$20240919$20240920$20240920$EXP$$TR-GILEAD-2024-0688316$GILEAD$$$$$F$Y$$$20240920$$MD$TR$TR
243442521$24344252$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64574$$FDA-CTU$$76$YR$$M$N$$$20240920$N$$US$
243442531$24344253$1$I$$20240919$20240919$20240919$DIR$719125$$FDA-CTU$$$$$UNK$N$$$20240919$N$$US$
243442541$24344254$1$I$$20240919$20240919$20240919$DIR$719104$$FDA-CTU$$36$YR$$UNK$N$$$20240919$N$PH$US$
243442551$24344255$1$I$20240901$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64575$$FDA-CTU$$50$YR$$M$N$$$20240919$N$HP$US$
243442561$24344256$1$I$20240826$20240909$20240920$20240920$EXP$$US-OPKO PHARMACEUTICALS, LLC.-2024OPK00237$OPKO HEALTH$$77$YR$$M$Y$$$20240918$$PH$US$US
243442581$24344258$1$I$20240101$20240916$20240920$20240920$EXP$$US-INCYTE CORPORATION-2024IN009802$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243442591$24344259$1$I$$20240912$20240920$20240920$EXP$$US-BAYER-2024A131318$BAYER$$$$$F$Y$$$20240920$$MD$US$US
243442601$24344260$1$I$$20240916$20240920$20240920$EXP$$GR-INCYTE CORPORATION-2024IN009828$INCYTE$$$$$$Y$$$20240920$$MD$GR$GR
243442611$24344261$1$I$20240910$20240911$20240920$20240920$30DAY$$GB-JNJFOC-20240928028$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240920$$CN$GB$GB
243442622$24344262$2$F$20240418$20240919$20240920$20240927$EXP$$CA-JNJFOC-20231224525$JOHNSON AND JOHNSON$$30$YR$A$F$Y$71$KG$20240927$$HP$CA$CA
243442631$24344263$1$I$$20240916$20240920$20240920$EXP$$US-INCYTE CORPORATION-2024IN009775$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243442641$24344264$1$I$$20240909$20240920$20240920$PER$$US-IGSA-BIG0030653$GRIFOLS$Julia S.Turock ,Colette J. Matysiak Match,Kristina Adachi,Karin Nielsen-Saines,Shangxin Yang,Sanchi Malhotra. Mycobacterium cosmeticum catheter-related bloodstream infection in an immunocompetent patient: A case report and review of the literature. IDCases. 2024;37:1-5$$$C$M$Y$$$20240920$$MD$US$US
243442661$24344266$1$I$20240101$20240917$20240920$20240920$EXP$$AT-SANDOZ INC.-SDZ2024AT080815$SANDOZ$$34$YR$$$Y$$$20240920$$MD$AT$AT
243442671$24344267$1$I$$20240910$20240920$20240920$EXP$$CA-TEVA-VS-3244890$TEVA$$78$YR$$F$Y$93$KG$20240920$$HP$CA$CA
243442681$24344268$1$I$$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64577$$FDA-CTU$$$$$M$N$$$20240919$N$HP$US$
243442691$24344269$1$I$20240614$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64576$$FDA-CTU$$5$YR$$M$N$$$20240919$N$HP$US$
243442711$24344271$1$I$20240916$20240919$20240919$20240919$DIR$719143$$FDA-CTU$$76$YR$$M$N$94.95$KG$20240919$Y$CN$US$
243442731$24344273$1$I$$20240916$20240920$20240920$PER$$US-HALEON-2197313$Haleon PLC$$45$YR$$F$Y$$$20240920$$CN$US$US
243442741$24344274$1$I$$20240919$20240920$20240920$PER$$US-BAYER-2024A134211$BAYER$$24$YR$A$F$Y$$$20240920$$MD$US$US
243442751$24344275$1$I$20200625$20240911$20240920$20240920$EXP$$JP-EXELIXIS-EXL-2024-000410$EXELIXIS$$71$YR$$M$Y$65.7$KG$20240920$$MD$JP$JP
243442761$24344276$1$I$$20240913$20240920$20240920$EXP$$US-009507513-2409USA005586$MERCK$$$$$F$Y$$$20240920$$CN$US$US
243442771$24344277$1$I$20231201$20240916$20240920$20240920$EXP$$BR-009507513-2409BRA001267$MERCK$$70$YR$$F$Y$$$20240920$$MD$BR$BR
243442781$24344278$1$I$$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149626$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240920$$CN$US$US
243442791$24344279$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149623$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240920$$CN$US$US
243442811$24344281$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149629$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240920$$HP$US$US
243442821$24344282$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149622$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240920$$CN$US$US
243442831$24344283$1$I$$20240919$20240920$20240920$PER$$US-BAYER-2024A134221$BAYER$$43$YR$A$F$Y$$$20240920$$HP$US$US
243442841$24344284$1$I$$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024187459$AMGEN$$$$$$Y$$$20240920$$PH$US$US
243442851$24344285$1$I$$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024185075$AMGEN$$$$$M$Y$$$20240920$$CN$US$US
243442861$24344286$1$I$20240801$20240916$20240920$20240920$EXP$$NVSC2024IE185073$NOVARTIS$$$$$F$Y$$$20240920$$HP$IE$IE
243442881$24344288$1$I$20240726$20240916$20240920$20240920$PER$$US-SA-2024SA270154$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240920$$MD$US$US
243442891$24344289$1$I$20240828$20240911$20240920$20240920$PER$$US-SA-2024SA270057$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240920$$MD$US$US
243442901$24344290$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA267539$SANOFI AVENTIS$$$$T$M$Y$$$20240920$$HP$US$US
243442911$24344291$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267210$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240920$$MD$US$US
243442921$24344292$1$I$$20240916$20240920$20240920$PER$$US-SA-2024SA270153$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240920$$HP$US$US
243442931$24344293$1$I$$20240909$20240920$20240920$PER$$US-SA-2024SA271447$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240920$$CN$US$US
243442941$24344294$1$I$$20240916$20240920$20240920$PER$$US-SA-2024SA270147$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$HP$US$US
243442951$24344295$1$I$20240901$20240918$20240920$20240920$PER$$US-BAYER-2024A134431$BAYER$$$$$F$Y$$$20240920$$CN$US$US
243442961$24344296$1$I$20240101$20240906$20240920$20240920$EXP$$US-UCBSA-2024045837$UCB$$$$$M$Y$$$20240920$$CN$US$US
243442971$24344297$1$I$$20240917$20240920$20240920$EXP$$US-TAKEDA-2024TUS093191$TAKEDA$$$$$M$Y$$$20240920$$MD$US$US
243442981$24344298$1$I$20240914$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024187751$AMGEN$$61$YR$A$F$Y$$$20240920$$CN$US$US
243442991$24344299$1$I$20240913$20240913$20240920$20240920$EXP$$US-LUNDBECK-DKLU4004363$LUNDBECK$$$$$$Y$$$20240920$$HP$US$US
243443002$24344300$2$F$$20240918$20240920$20240924$EXP$$US-ABBVIE-5930193$ABBVIE$$$$A$F$Y$$$20240924$$HP$US$US
243443021$24344302$1$I$$20240919$20240920$20240920$EXP$$US-BAYER-2024A134262$BAYER$$$$$$Y$$$20240920$$HP$US$US
243443031$24344303$1$I$$20240903$20240920$20240920$PER$$US-SA-2024SA270924$SANOFI AVENTIS$$$$$M$Y$$$20240920$$CN$US$US
243443041$24344304$1$I$$20240911$20240920$20240920$EXP$$JP-GALDERMA-JP2024014088$GALDERMA$Matsuda M, Murata T, Otani T, Yoshida K, Sanpei Y, Iijima K, et al. Potential of arterial spin labeling in elucidating the pathogenesis of the splenium of the corpus callosum and cerebellar dentate nucleus in encephalopathy. Brain + Development. 2023;46 (1):73-74$$$$$Y$$$20240920$$HP$JP$JP
243443051$24344305$1$I$$20240905$20240920$20240920$PER$$US-SA-2024SA271912$SANOFI AVENTIS$$$$A$M$Y$$$20240920$$CN$US$US
243443061$24344306$1$I$20240701$20240916$20240920$20240920$PER$$US-SA-2024SA270113$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240920$$MD$US$US
243443071$24344307$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267099$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240920$$MD$US$US
243443081$24344308$1$I$$20240916$20240920$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001880$BLUEPRINT MEDICINES$$$$$M$Y$$$20240920$$CN$US$US
243443091$24344309$1$I$20220101$20240918$20240920$20240920$PER$$US-BAYER-2024A134225$BAYER$$44$YR$A$F$Y$$$20240920$$HP$US$US
243443101$24344310$1$I$20240915$20240916$20240920$20240920$PER$$US-009507513-2409USA006168$MERCK$$79$YR$$F$Y$$$20240920$$CN$US$US
243443111$24344311$1$I$$20240919$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012516$ELI LILLY AND CO$$52$YR$A$$Y$$$20240920$$CN$US$US
243443121$24344312$1$I$$20240911$20240920$20240920$EXP$$JP-GALDERMA-JP2024014087$GALDERMA$Matsuda M, Murata T, Otani T, Yoshida K, Sanpei Y, Iijima K, et al. Potential of arterial spin labeling in elucidating the pathogenesis of the splenium of the corpus callosum and cerebellar dentate nucleus in encephalopathy. Brain + Development. 2023;46 (1):73-74$$$$$Y$$$20240920$$HP$JP$JP
243443131$24344313$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148192$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240920$$CN$US$US
243443141$24344314$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149383$BRISTOL MYERS SQUIBB$$32$YR$A$M$Y$$$20240920$$MD$US$US
243443151$24344315$1$I$$20240913$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146836$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240920$$CN$US$US
243443161$24344316$1$I$$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147239$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240920$$CN$US$US
243443171$24344317$1$I$20240919$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149741$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240920$$MD$US$US
243443181$24344318$1$I$$20240911$20240920$20240920$EXP$$JP-GALDERMA-JP2024006593$GALDERMA$$$$$$Y$$$20240920$$MD$JP$JP
243443192$24344319$2$F$20240904$20240920$20240920$20240924$EXP$$CN-BEIGENE-BGN-2024-014870$BEIGENE$$$$$$Y$$$20240924$$HP$CN$CN
243443201$24344320$1$I$20240917$20240917$20240920$20240920$EXP$$US-AMGEN-USASP2024185629$AMGEN$$$$$M$Y$$$20240920$$CN$US$US
243443211$24344321$1$I$$20240911$20240920$20240920$EXP$$JP-GALDERMA-JP2024014001$GALDERMA$$$$$$Y$$$20240920$$MD$JP$JP
243443221$24344322$1$I$20240101$20240912$20240920$20240920$EXP$$JP-GALDERMA-JP2024005894$GALDERMA$$$$$$Y$$$20240920$$MD$JP$JP
243443231$24344323$1$I$20240101$20240911$20240920$20240920$EXP$$JP-GALDERMA-JP2024014036$GALDERMA$$$$$$Y$$$20240920$$MD$JP$JP
243443241$24344324$1$I$20240919$20240919$20240919$20240919$DIR$719163$$FDA-CTU$$28$YR$$F$N$63$KG$20240919$N$CN$US$
243443261$24344326$1$I$$20240919$20240919$20240919$DIR$719110$$FDA-CTU$$58$YR$$M$N$$$20240919$N$$US$
243443272$24344327$2$F$$20240917$20240920$20240928$EXP$$GB-TAKEDA-2023TUS006354$TAKEDA$$$$$F$Y$$$20240928$$CN$GB$GB
243443292$24344329$2$F$20240918$20240924$20240920$20240926$PER$$US-AMGEN-USASP2024186408$AMGEN$$$$$M$Y$$$20240925$$CN$US$US
243443301$24344330$1$I$$20240916$20240920$20240920$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001879$BLUEPRINT MEDICINES$$$$$F$Y$$$20240920$$CN$US$US
243443331$24344333$1$I$20240805$20240910$20240920$20240920$EXP$$US-FARMAPROD-202408-2912$DOMPE FARMACEUTICI$$85$YR$E$M$Y$$$20240920$$CN$US$US
243443351$24344335$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688241$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243443361$24344336$1$I$$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024187897$AMGEN$$$$$F$Y$$$20240920$$CN$US$US
243443371$24344337$1$I$20240901$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024186550$AMGEN$$$$$M$Y$$$20240920$$CN$US$US
243443381$24344338$1$I$$20240918$20240920$20240920$EXP$$US-TAKEDA-2024TUS093595$TAKEDA$$$$$$Y$$$20240920$$MD$US$US
243443401$24344340$1$I$$20240918$20240920$20240920$PER$$NVSC2024US187246$NOVARTIS$$$$$M$Y$$$20240920$$MD$US$US
243443421$24344342$1$I$$20240918$20240920$20240920$PER$$NVSC2024US187387$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
243443431$24344343$1$I$$20240913$20240920$20240920$EXP$$IT-Waylis Therapeutics LLC-ATNAHS20211118983$Waylis$Corti C, Faiola S, Lanna M, Castoldi F, Lista G, Nespoli L, Mannarino S and Rustico M Monochorionic diamniotic twin pregnancy complicated by discordant premature closure of ductus arteriosus. Clinical Case Reports 2020 Apr 01;8 (4):685-9.$$$$F$Y$2.21$KG$20240920$$MD$IT$IT
243443441$24344344$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688244$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243443451$24344345$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688246$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243443461$24344346$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148419$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$63.5$KG$20240920$$CN$US$US
243443471$24344347$1$I$$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147785$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240920$$MD$US$US
243443481$24344348$1$I$$20240912$20240920$20240920$EXP$$NL-VER-202400059$VERITY PHARMACEUTICALS$$$$$M$Y$$$20240920$$HP$NL$NL
243443491$24344349$1$I$20240501$20240801$20240920$20240920$PER$$US-ALVOGEN-2024095027$ALVOGEN$$$$$$Y$$$20240920$$CN$US$US
243443501$24344350$1$I$20240730$20240910$20240920$20240920$PER$$US-BRAEBURN-US-BRA-24-000715$BRAEBURN PHARMACEUTICALS$$46$YR$$M$Y$$$20240920$$HP$US$US
243443511$24344351$1$I$20240723$20240907$20240920$20240920$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000341$THERATECHNOLOGIES$$$$$$Y$$$20240920$$CN$US$US
243443521$24344352$1$I$20191125$20240912$20240920$20240920$EXP$GB-MHRA-MED-202409120729514340-FMSJY$GB-TEVA-VS-3242885$TEVA$$41$YR$$M$Y$144$KG$20240920$$CN$GB$GB
243443531$24344353$1$I$20240101$20240914$20240920$20240920$EXP$$CN-SA-2024SA268794$SANOFI AVENTIS$$58$YR$A$F$Y$53$KG$20240920$$HP$CN$CN
243443541$24344354$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA268174$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243443553$24344355$3$F$20240919$20240924$20240920$20240927$PER$$US-AMGEN-USASP2024187937$AMGEN$$66$YR$E$F$Y$$$20240927$$CN$US$US
243443571$24344357$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688254$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243443581$24344358$1$I$$20240912$20240920$20240920$EXP$$CA-TEVA-VS-3244779$TEVA$$54$YR$$M$Y$$$20240920$$PH$CA$CA
243443591$24344359$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688247$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243443601$24344360$1$I$$20240827$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005092$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243443611$24344361$1$I$$20240914$20240920$20240920$EXP$$TH-JNJFOC-20240940367$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240920$$MD$TH$TH
243443621$24344362$1$I$$20240917$20240920$20240920$EXP$$GB-JNJFOC-20240946108$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$HP$GB$GB
243443641$24344364$1$I$20240912$20240914$20240920$20240920$EXP$$NVSC2024OM185832$NOVARTIS$$4$YR$$F$Y$12$KG$20240920$$MD$OM$OM
243443651$24344365$1$I$$20240917$20240920$20240920$DIR$FDA-CDER-CTU-2024-64578$$FDA-CTU$$$$$M$N$$$20240917$N$HP$US$
243443671$24344367$1$I$$20240916$20240920$20240920$EXP$$SE-SANDOZ INC.-SDZ2024SE081494$SANDOZ$$77$YR$$M$Y$$$20240920$$CN$SE$SE
243443681$24344368$1$I$$20240916$20240920$20240920$EXP$$US-INCYTE CORPORATION-2024IN009015$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243443691$24344369$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688255$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243443702$24344370$2$F$$20240919$20240920$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149894$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240923$$CN$US$US
243443711$24344371$1$I$20240712$20240828$20240920$20240920$PER$$US-ALVOGEN-2024095168$ALVOGEN$$$$$M$Y$$$20240920$$CN$US$US
243443731$24344373$1$I$20240905$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64588$$FDA-CTU$$42$YR$$F$N$$$20240919$N$HP$US$
243443741$24344374$1$I$20240917$20240919$20240919$20240919$DIR$719166$$FDA-CTU$$19$YR$$F$N$54$KG$20240919$N$CN$US$
243443751$24344375$1$I$20240919$20240919$20240919$20240919$DIR$719153$$FDA-CTU$$82$YR$$F$N$$$20240919$N$PH$US$
243443761$24344376$1$I$20240918$20240919$20240919$20240919$DIR$719142$$FDA-CTU$$76$YR$$M$N$$$20240919$N$PH$US$
243443781$24344378$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64590$$FDA-CTU$$$$$M$N$$$20240920$N$HP$US$
243443791$24344379$1$I$$20240917$20240920$20240920$DIR$FDA-CDER-CTU-2024-64591$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243443811$24344381$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688258$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243443821$24344382$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688259$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243443831$24344383$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688260$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243443841$24344384$1$I$$20240913$20240920$20240920$EXP$$JP-AMGEN-JPNSP2024183290$AMGEN$$$$$$Y$$$20240920$$PH$JP$JP
243443851$24344385$1$I$$20240916$20240920$20240920$EXP$$US-OTSUKA-2024_025980$OTSUKA$$43$YR$$F$Y$$$20240920$$CN$US$US
243443861$24344386$1$I$20240101$20240917$20240920$20240920$EXP$$NL-SANDOZ INC.-SDZ2024NL080752$SANDOZ$$$$E$F$Y$58$KG$20240920$$HP$NL$NL
243443871$24344387$1$I$20190101$20240827$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005143$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240920$$CN$US$US
243443881$24344388$1$I$$20240918$20240920$20240920$EXP$$NVSC2024GR187482$NOVARTIS$$$$$M$Y$$$20240920$$MD$GR$GR
243443891$24344389$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688261$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243443901$24344390$1$I$$20240919$20240920$20240920$EXP$$US-GILEAD-2024-0688372$GILEAD$$67$YR$E$F$Y$$$20240920$$MD$US$US
243443911$24344391$1$I$$20240918$20240920$20240920$PER$$US-BIOVITRUM-2024-US-012269$BIOVITRUM$$81$YR$$F$Y$$$20240920$$CN$US$US
243443921$24344392$1$I$$20240919$20240920$20240920$PER$$US-BIOVITRUM-2024-US-012278$BIOVITRUM$$66$YR$$M$Y$$$20240920$$CN$US$US
243443931$24344393$1$I$$20240919$20240920$20240920$PER$$US-BIOVITRUM-2024-US-012279$BIOVITRUM$$$$$F$Y$$$20240920$$MD$US$US
243443941$24344394$1$I$20240821$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011909$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240920$$CN$US$US
243443951$24344395$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011707$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240920$$CN$US$US
243443961$24344396$1$I$20240920$20240920$20240920$20240920$DIR$719195$$FDA-CTU$$55$YR$$F$N$$$20240920$N$PH$US$
243443971$24344397$1$I$$20240920$20240920$20240920$DIR$719198$$FDA-CTU$$$$$UNK$N$$$20240920$$CN$US$
243443981$24344398$1$I$20240910$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011095$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240920$$CN$US$US
243443991$24344399$1$I$20240915$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010000$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240920$$CN$US$US
243444001$24344400$1$I$20240810$20240919$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012558$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240920$$CN$US$US
243444011$24344401$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012051$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243444021$24344402$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011687$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240920$$CN$US$US
243444031$24344403$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011463$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240920$$CN$US$US
243444051$24344405$1$I$$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011524$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240920$$CN$US$US
243444061$24344406$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011784$ELI LILLY AND CO$$$$$F$Y$$$20240920$$MD$US$US
243444071$24344407$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011658$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240920$$CN$US$US
243444081$24344408$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011682$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240920$$CN$US$US
243444091$24344409$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012102$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240920$$CN$US$US
243444101$24344410$1$I$20240915$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011575$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240920$$CN$US$US
243444111$24344411$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011178$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240920$$CN$US$US
243444121$24344412$1$I$$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011694$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240920$$CN$US$US
243444131$24344413$1$I$$20240919$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012531$ELI LILLY AND CO$$$$$M$Y$$$20240920$$CN$US$US
243444141$24344414$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202406016186$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243444151$24344415$1$I$20240917$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011928$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240920$$CN$US$US
243444161$24344416$1$I$20240918$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011586$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240920$$CN$US$US
243444171$24344417$1$I$20230801$20240912$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409008265$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240920$$CN$US$US
243444181$24344418$1$I$$20240916$20240920$20240920$EXP$$US-INCYTE CORPORATION-2024IN002363$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243444191$24344419$1$I$$20240918$20240920$20240920$EXP$$ES-ABBVIE-5929913$ABBVIE$$$$A$F$Y$$$20240920$$HP$ES$ES
243444201$24344420$1$I$20240805$20240917$20240920$20240920$EXP$$DE-009507513-2409DEU005919$MERCK$$76$YR$$M$Y$86.2$KG$20240920$$MD$DE$DE
243444211$24344421$1$I$20240101$20240913$20240920$20240920$PER$$US-AMGEN-USASP2024183920$AMGEN$$62$YR$A$F$Y$36.281$KG$20240920$$CN$US$US
243444221$24344422$1$I$$20240919$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149776$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$77.56$KG$20240920$$CN$US$US
243444241$24344424$1$I$$20240913$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146901$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240920$$CN$US$US
243444252$24344425$2$F$20240811$20240926$20240920$20240926$PER$$US-BAYER-2024A130137$BAYER$$57$YR$A$F$Y$$$20240926$$CN$US$US
243444261$24344426$1$I$20211201$20240917$20240920$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU080980$SANDOZ$$19$MON$$M$Y$$$20240920$$CN$AU$AU
243444271$24344427$1$I$20240707$20240918$20240920$20240920$EXP$CZ-CZSUKL-24002548$CZ-ASTELLAS-2024-AER-007801$ASTELLAS$$82$YR$E$M$Y$101$KG$20240920$$PH$CZ$CZ
243444291$24344429$1$I$$20240829$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08757$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243444311$24344431$1$I$20240701$20240911$20240920$20240920$EXP$$CN-JNJFOC-20240941014$JOHNSON AND JOHNSON$$$$$M$Y$53$KG$20240920$$HP$CN$CN
243444321$24344432$1$I$$20240913$20240920$20240920$EXP$$JP-JNJFOC-20240954723$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240920$$CN$JP$JP
243444331$24344433$1$I$$20240918$20240920$20240920$EXP$$US-PFIZER INC-PV202400122975$PFIZER$$67$YR$$F$Y$$$20240920$$HP$US$US
243444342$24344434$2$F$$20240920$20240920$20240924$EXP$$US-PFIZER INC-202400259990$PFIZER$$$$$M$Y$$$20240924$$MD$US$US
243444361$24344436$1$I$20231001$20240920$20240920$20240920$DIR$719184$$FDA-CTU$$46$YR$$F$N$99$KG$20240920$N$CN$US$
243444371$24344437$1$I$$20240918$20240920$20240920$EXP$$US-PFIZER INC-PV202400122710$PFIZER$$68$YR$$F$Y$$$20240920$$HP$US$US
243444381$24344438$1$I$$20240919$20240920$20240920$EXP$$JP-PFIZER INC-202400259288$PFIZER$$77$YR$$F$Y$$$20240920$$PH$JP$JP
243444392$24344439$2$F$20180101$20240919$20240920$20240924$EXP$$US-PFIZER INC-202400259161$PFIZER$$61$YR$$F$Y$$$20240924$$HP$US$US
243444401$24344440$1$I$20240101$20240918$20240920$20240920$EXP$$CA-PFIZER INC-202400259842$PFIZER$$32$YR$$F$Y$$$20240920$$HP$CA$CA
243444411$24344441$1$I$20240601$20240918$20240920$20240920$EXP$$US-PFIZER INC-202400260148$PFIZER$$76$YR$$F$Y$$$20240920$$HP$US$US
243444421$24344442$1$I$$20240911$20240920$20240920$EXP$$CA-UCBSA-2024048140$UCB$$$$$F$Y$$$20240920$$HP$CA$CA
243444431$24344443$1$I$$20240905$20240920$20240920$PER$$US-GLANDPHARMA-US-2024GLNSPO00782$GLAND PHARMA$$$$$$Y$$$20240920$$CN$US$US
243444441$24344444$1$I$$20240916$20240920$20240920$EXP$$GR-ABBVIE-5927323$ABBVIE$$30$YR$$M$Y$$$20240920$$MD$GR$GR
243444471$24344447$1$I$$20240918$20240920$20240920$PER$$US-BAYER-2024A133495$BAYER$$48$YR$A$F$Y$$$20240920$$HP$US$US
243444481$24344448$1$I$$20240917$20240920$20240920$EXP$$CA-TAKEDA-2024TUS093252$TAKEDA$$68$YR$$F$Y$$$20240920$$HP$CA$CA
243444492$24344449$2$F$20240826$20240923$20240920$20240926$EXP$IT-MINISAL02-1002512$IT-ORGANON-O2409ITA001204$ORGANON$$66$YR$$F$Y$$$20240926$$MD$IT$IT
243444501$24344450$1$I$20240817$20240828$20240920$20240920$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005145$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240920$$CN$US$US
243444511$24344451$1$I$$20240919$20240920$20240920$EXP$$NVSC2024GB187546$NOVARTIS$$$$E$F$Y$$$20240920$$HP$GB$GB
243444521$24344452$1$I$20240827$20240911$20240920$20240920$EXP$$CN-FreseniusKabi-FK202413797$FRESENIUS KABI$$66$YR$E$M$Y$65$KG$20240920$$HP$CN$CN
243444531$24344453$1$I$$20240919$20240920$20240920$PER$$US-HALEON-2197632$Haleon PLC$$$$$F$Y$$$20240920$$CN$US$US
243444541$24344454$1$I$20240910$20240919$20240920$20240920$PER$$US-BAYER-2024A134237$BAYER$$25$YR$A$F$Y$$$20240920$$CN$US$US
243444551$24344455$1$I$$20240917$20240920$20240920$EXP$$AU-ABBVIE-5930056$ABBVIE$$$$$M$Y$$$20240920$$HP$AU$AU
243444562$24344456$2$F$20240606$20240923$20240920$20240930$EXP$$CA-VER-202400480$VERITY PHARMACEUTICALS$$78$YR$E$M$Y$$$20240930$$HP$CA$CA
243444571$24344457$1$I$20240101$20240913$20240920$20240920$EXP$$US-SA-2024SA271158$SANOFI AVENTIS$$75$YR$E$F$Y$86.36$KG$20240920$$MD$US$US
243444581$24344458$1$I$$20240807$20240920$20240920$PER$$US-LUNDBECK-DKLU4003196$LUNDBECK$$$$$$Y$$$20240920$$CN$US$US
243444591$24344459$1$I$20240501$20240920$20240920$20240920$DIR$719188$$FDA-CTU$$65$YR$$F$N$104.85$KG$20240920$Y$CN$US$
243444601$24344460$1$I$20240830$20240920$20240920$20240920$DIR$719197$$FDA-CTU$$73$YR$$F$N$$$20240920$N$PH$US$
243444611$24344461$1$I$20240911$20240911$20240920$20240920$PER$$PR-JNJFOC-20240934325$JOHNSON AND JOHNSON$$90$YR$E$M$Y$$$20240920$$CN$PR$PR
243444621$24344462$1$I$20240901$20240911$20240920$20240920$PER$$US-SA-2024SA269025$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240920$$CN$US$US
243444631$24344463$1$I$$20240916$20240920$20240920$EXP$$US-SA-2024SA271818$SANOFI AVENTIS$$$$E$$Y$79.55$KG$20240920$$MD$US$US
243444651$24344465$1$I$$20240913$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147294$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240920$$CN$US$US
243444661$24344466$1$I$$20240918$20240920$20240920$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-149792$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240920$$MD$JP$JP
243444672$24344467$2$F$20240919$20240920$20240920$20240923$PER$$US-AMGEN-USASP2024187486$AMGEN$$74$YR$E$$Y$$$20240922$$CN$US$US
243444681$24344468$1$I$$20240911$20240920$20240920$EXP$$CN-INCYTE CORPORATION-2024IN009944$INCYTE$Wei Ling Y, Fen Ying Z, Min Er G, Nan L, Xiao Ping G, Xiao Jun X. Ruxolitinib treatment of steroid-refractory graft-versus-host disease in children: a case series and review of the literature. PEDIATRIC DRUGS. 2023;25:577:84$$$$$Y$$$20240920$$HP$CN$CN
243444691$24344469$1$I$$20240911$20240920$20240920$EXP$$CN-INCYTE CORPORATION-2024IN009950$INCYTE$Yan W-L, Zhao F-Y, Gu M-E, Liu N, Guo X-P, Xu X-J. Ruxolitinib Treatment of Steroid-Refractory Graft-versus-Host Disease in Children: A Case Series and Review of the Literature. PEDIATRIC DRUGS. 2023;25(5):577-84$$$$$Y$$$20240920$$HP$CN$CN
243444701$24344470$1$I$$20240917$20240920$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU081149$SANDOZ$$$$$F$Y$$$20240920$$MD$AU$AU
243444711$24344471$1$I$$20240911$20240920$20240920$EXP$$PT-EMD Serono-2024048816$EMD SERONO INC$Mestre D, Gil F. Central Venous Catheter Misplacement Presenting with Parotid Gland Swelling: A Case Report. Cureus. 2024 Aug 05;16(8): 1-5. doi:10.7759/cureus.66245.$84$YR$E$F$Y$$$20240920$$HP$PT$PT
243444721$24344472$1$I$$20240911$20240920$20240920$EXP$$CN-INCYTE CORPORATION-2024IN009943$INCYTE$Yan W, Zhao F, Gu M, Liu N, Guo X, Xu X. Ruxolitinib Treatment of Steroid-Refractory Graft-versus-Host Disease in Children: A Case Series and Review of the Literature. PEDIATRIC DRUGS. 2023;25:577:84$$$$$Y$$$20240920$$HP$CN$CN
243444732$24344473$2$F$20220704$20240822$20240920$20240930$EXP$$GB-REGENERON PHARMACEUTICALS, INC.-2024-123948$REGENERON$S.G Keohane, J.Botting, P.G. Budny. O.M Dolan, K.Fife, C.A. Harwood, R.Mallipeddi, J.R. Marsden, R.J.Motley, C.Nwelands, C. Proby, A.Rembielak, D.N. Slater, J.A.Smithson, P.Buckley, P.Fairbrother, M.H. British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020. British Journal of Dermatology. 2020;184:401-414$64$YR$$M$Y$$$20240930$$MD$GB$GB
243444741$24344474$1$I$$20240910$20240920$20240920$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001840$BLUEPRINT MEDICINES$$$$$F$Y$$$20240920$$HP$US$US
243444751$24344475$1$I$20240901$20240913$20240920$20240920$PER$$US-SA-2024SA270715$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240920$$MD$US$US
243444761$24344476$1$I$$20240919$20240920$20240920$EXP$GB-MHRA-MED-202409171150049530-QZMVK$GB-SA-2024SA272057$SANOFI AVENTIS$$$$$F$Y$$$20240920$$MD$GB$GB
243444771$24344477$1$I$20240101$20240911$20240920$20240920$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000940$PAREXEL$Yanwei Guo, Junyao Li, Renqin Hu, Jinglan Tan, Huirong Luo, Zheng Zhang, Qinghua Luo, Xuetao Xia. Adalimumab-induced manic episode in an  adolescent with juvenile idiopathic arthritis. BMC Psychiatry. 2024;24:596$$$$$Y$$$20240920$$MD$CN$CN
243444781$24344478$1$I$20240510$20240917$20240920$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014075$JAZZ$$59$YR$$M$Y$$$20240920$$MD$US$US
243444801$24344480$1$I$$20240911$20240920$20240920$EXP$$US-JNJFOC-20240939531$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$MD$US$US
243444811$24344481$1$I$20221216$20240918$20240920$20240920$EXP$$RS-PFIZER INC-PV202400122506$PFIZER$$70$YR$$F$Y$96$KG$20240920$$MD$RS$RS
243444821$24344482$1$I$$20240906$20240920$20240920$EXP$IT-PFIZER INC-2019025001$IT-GUERBET / LLC-IT-20190025$GUERBET$BELLI L. Arteritis following intra-arterial chemotherapy for liver tumors. European Radiology 1997; 7(3): 323-326.$54$YR$A$M$Y$$$20240920$$MD$IT$IT
243444831$24344483$1$I$$20240906$20240920$20240920$EXP$IT-PFIZER INC-2019025191$IT-GUERBET / LLC-IT-20190024$GUERBET$BELLI L. Arteritis following intra-arterial chemotherapy for liver tumors. European Radiology 1997; 7(3): 323-326.$61$YR$A$M$Y$$$20240920$$MD$IT$IT
243444841$24344484$1$I$$20240913$20240920$20240920$30DAY$$US-GSK-US2024114110$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243444853$24344485$3$F$20240101$20240923$20240920$20240926$EXP$$US-ORGANON-O2408USA001460$ORGANON$$$$$F$Y$58.51$KG$20240926$$CN$US$US
243444861$24344486$1$I$20240909$20240919$20240920$20240920$EXP$GB-MHRA-MED-202409181114112600-QNPRF$GB-SANDOZ INC.-SDZ2024GB081731$SANDOZ$$$$$F$Y$$$20240920$$MD$GB$GB
243444872$24344487$2$F$$20240925$20240920$20240930$EXP$$IN-SA-2024SA271303$SANOFI AVENTIS$Gaur L, Duggal R, Singhal MK.. Herpes Simplex Virus Type-2 Nephritis: An Unexpected Plot Twist in a Kidney Transplant Recipient.. Indian Journal of Nephrology. 2024;34(5):512-3$32$YR$A$M$Y$$$20240930$$MD$IN$IN
243444881$24344488$1$I$20240101$20240828$20240920$20240920$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005093$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243444903$24344490$3$F$$20240906$20240920$20240925$EXP$$AU-JNJFOC-20240951960$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$MD$AU$AU
243444911$24344491$1$I$$20240917$20240920$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015328$JAZZ$$$$$F$Y$$$20240920$$CN$US$US
243444922$24344492$2$F$$20240911$20240920$20240921$EXP$$CA-APOTEX-2024AP010575$APOTEX$$61$YR$$F$Y$58$KG$20240921$$HP$CA$CA
243444931$24344493$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012027$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240920$$CN$US$US
243444941$24344494$1$I$$20240910$20240920$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409006308$ELI LILLY AND CO$Matsuoka A, et al..ORIGINAL ARTICLE Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series.The Journal of Obstetrics and Gynaecology Research 2024;50 (7):1148-1154.$65$YR$E$F$Y$$$20240920$$MD$JP$JP
243444951$24344495$1$I$$20240903$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08856$LUPIN$$$$$$Y$$$20240920$$HP$US$US
243444961$24344496$1$I$$20240913$20240920$20240920$EXP$$CA-SANDOZ-SDZ2023CA034251$Haleon PLC$$3$DEC$$M$Y$$$20240920$$HP$CA$CA
243444971$24344497$1$I$$20240918$20240920$20240920$PER$$US-BAYER-2024A134147$BAYER$$61$YR$A$M$Y$71.09$KG$20240920$$HP$US$US
243444991$24344499$1$I$$20240909$20240920$20240920$EXP$$CA-APOTEX-2024AP011108$APOTEX$$$$A$F$Y$$$20240920$$CN$CA$CA
243445011$24344501$1$I$$20240917$20240920$20240920$PER$$US-ABBVIE-5929434$ABBVIE$$$$$M$Y$$$20240920$$HP$US$US
243445021$24344502$1$I$$20240919$20240920$20240920$EXP$$US-ABBVIE-5930802$ABBVIE$$$$$$Y$$$20240920$$HP$US$US
243445031$24344503$1$I$20240905$20240912$20240920$20240920$30DAY$$US-GSK-US2024113522$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243445041$24344504$1$I$$20240822$20240920$20240920$PER$$US-SA-2024SA266285$SANOFI AVENTIS$$47$YR$A$F$Y$58.503$KG$20240920$$MD$US$US
243445051$24344505$1$I$$20240911$20240920$20240920$EXP$$IN-COHERUS BIOSCIENCES, INC-2024-COH-IN000941$PAREXEL$Prabin Pradeep, Tanvi Mittal, Nishanth Jalaja Haridas. Adalimumab-Associated Depressive Symptoms in a Patient With Vasculitis, Autoinflammation, Immunodeficiency, and Hematologic Defects Syndrome. Prim Care Companion CNS Disord.. 2024;26:24cr03745$$$$$Y$$$20240920$$MD$IN$IN
243445061$24344506$1$I$$20240918$20240920$20240920$30DAY$$US-SANDOZ INC.-SDZ2024US081528$SANDOZ$$$$$M$Y$$$20240920$$CN$US$US
243445071$24344507$1$I$$20240912$20240920$20240920$PER$$US-ABBVIE-5926134$ABBVIE$$$$$F$Y$$$20240920$$MD$US$US
243445081$24344508$1$I$$20240913$20240920$20240920$EXP$$CA-GSK-CA2024114243$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$CA$CA
243445091$24344509$1$I$20240101$20240823$20240920$20240920$PER$$US-SA-2024SA266339$SANOFI AVENTIS$$39$YR$A$F$Y$150.57$KG$20240920$$MD$US$US
243445101$24344510$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267288$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240920$$MD$US$US
243445111$24344511$1$I$20240404$20240913$20240920$20240920$EXP$$CA-GSK-CA2024046635$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CA$CA
243445121$24344512$1$I$20240101$20240830$20240920$20240920$PER$$US-SA-2024SA270999$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240920$$MD$US$US
243445131$24344513$1$I$20240905$20240912$20240920$20240920$EXP$$US-Vifor (International) Inc.-VIT-2024-08364$VIFOR$$90$YR$$M$Y$$$20240920$$CN$US$US
243445141$24344514$1$I$$20240912$20240920$20240920$EXP$$CA-Vifor (International) Inc.-VIT-2024-01868$VIFOR$$$$$F$Y$$$20240920$$MD$CA$CA
243445151$24344515$1$I$$20240912$20240920$20240920$EXP$$JP-MALLINCKRODT-MNK202405795$MALLINCKRODT$$$$A$$Y$$$20240920$$HP$JP$JP
243445161$24344516$1$I$$20240912$20240920$20240920$EXP$$JP-MALLINCKRODT-MNK202405768$MALLINCKRODT$$$$A$$Y$$$20240920$$HP$JP$JP
243445171$24344517$1$I$$20240912$20240920$20240920$EXP$$JP-MALLINCKRODT-MNK202405794$MALLINCKRODT$$$$A$$Y$$$20240920$$HP$JP$JP
243445181$24344518$1$I$$20240912$20240920$20240920$EXP$$JP-MALLINCKRODT-MNK202405796$MALLINCKRODT$$$$A$$Y$$$20240920$$HP$JP$JP
243445191$24344519$1$I$20240909$20240913$20240920$20240920$EXP$$US-VANTIVE-2024VAN019794$Vantive US Healthcare$$$$$M$Y$$$20240920$$HP$US$US
243445211$24344521$1$I$20240801$20240918$20240920$20240920$EXP$$US-KYOWAKIRIN-2024KK021704$KYOWA$$$$$$Y$$$20240920$$HP$US$US
243445221$24344522$1$I$$20240912$20240920$20240920$PER$$US-BIOGEN-2024BI01282627$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
243445231$24344523$1$I$$20240906$20240920$20240920$EXP$IT-PFIZER INC-2019025186$IT-GUERBET / LLC-IT-20190027$GUERBET$BELLI L. Arteritis following intra-arterial chemotherapy for liver tumors. EUROPEAN RADIOLOGY. 1997;7: 323-326.$65$YR$E$M$Y$$$20240920$$MD$IT$IT
243445261$24344526$1$I$$20240911$20240920$20240920$EXP$$CN-INCYTE CORPORATION-2024IN009942$INCYTE$Yan W, Zhao F, Gu M, Liu N, Guo X, Xu X.. Ruxolitinib treatment of steroid-refractory graft-versus-host disease in children: a case series and review of the literature. PEDIATRIC DRUGS. 2023;25:577-84$$$$$Y$$$20240920$$HP$CN$CN
243445272$24344527$2$F$$20240920$20240920$20240925$EXP$$JP-MALLINCKRODT-MNK202405770$MALLINCKRODT$$76$YR$E$M$Y$77$KG$20240925$$HP$JP$JP
243445282$24344528$2$F$$20240922$20240920$20240925$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-28049$SAMSUNG BIOEPIS$$78$YR$E$F$Y$$$20240925$$CN$GB$GB
243445291$24344529$1$I$$20240903$20240920$20240920$PER$$AU-TOLMAR, INC.-24AU052361$TOLMAR$$$$$M$Y$$$20240919$$CN$AU$AU
243445301$24344530$1$I$$20240903$20240920$20240920$PER$$AU-TOLMAR, INC.-24AU052381$TOLMAR$$$$$M$Y$$$20240919$$CN$AU$AU
243445311$24344531$1$I$20240101$20240913$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146843$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240920$$HP$US$US
243445321$24344532$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149117$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240920$$HP$US$US
243445331$24344533$1$I$$20240917$20240920$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015456$JAZZ$$$$$M$Y$$$20240920$$CN$US$US
243445341$24344534$1$I$$20240913$20240920$20240920$EXP$$US-BIOGEN-2024BI01268171$BIOGEN$$$$$F$Y$$$20240920$$HP$US$US
243445351$24344535$1$I$20211201$20240912$20240920$20240920$EXP$$PL-BIOGEN-2024BI01283158$BIOGEN$S K. Efficacy and safety of natalizumab treatment in female multiple sclerosis patients during pregnancy. Case report series.. XXV Polish Neurological Society Conference.$27$YR$$F$Y$$$20240920$$MD$PL$PL
243445361$24344536$1$I$$20240906$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09011$LUPIN$$$$$$Y$$$20240920$$CN$US$US
243445371$24344537$1$I$$20240918$20240920$20240920$EXP$$AU-BIOVITRUM-2024-AU-012193$BIOVITRUM$$$$$F$Y$$$20240920$$HP$AU$AU
243445381$24344538$1$I$20240730$20240917$20240920$20240920$PER$$US-BIOVITRUM-2024-US-011392$BIOVITRUM$$12$YR$$F$Y$$$20240920$$CN$US$US
243445391$24344539$1$I$20240826$20240916$20240920$20240920$PER$$US-BIOVITRUM-2024-US-012166$BIOVITRUM$$24$MON$$M$Y$$$20240920$$CN$US$US
243445401$24344540$1$I$$20240916$20240920$20240920$EXP$$US-GILEAD-2024-0688070$GILEAD$$80$YR$E$F$Y$$$20240920$$CN$US$US
243445411$24344541$1$I$20200101$20240916$20240920$20240920$EXP$$DE-AMGEN-DEUSP2024184544$AMGEN$$42$YR$A$F$Y$$$20240920$$MD$DE$DE
243445421$24344542$1$I$20240901$20240916$20240920$20240920$EXP$IT-MINISAL02-1001567$IT-TEVA-VS-3244395$TEVA$$76$YR$$F$Y$55$KG$20240920$$MD$IT$IT
243445431$24344543$1$I$$20240911$20240920$20240920$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR115843$VIIV$$$$$$Y$$$20240920$$HP$US$US
243445441$24344544$1$I$20200301$20240913$20240920$20240920$EXP$$AU-INCYTE CORPORATION-2024IN009958$INCYTE$$$$$$Y$$$20240920$$MD$AU$AU
243445451$24344545$1$I$20240830$20240914$20240920$20240920$EXP$$CN-GILEAD-2024-0687774$GILEAD$$47$YR$A$F$Y$65$KG$20240920$$HP$CN$CN
243445461$24344546$1$I$20240909$20240909$20240920$20240920$EXP$$RU-GLENMARK PHARMACEUTICALS-2024GMK093994$GLENMARK$$$$$$Y$$$20240920$$MD$RU$RU
243445471$24344547$1$I$$20240903$20240920$20240920$PER$$US-TEVA-VS-3240383$TEVA$$$$$$Y$$$20240920$$HP$US$US
243445481$24344548$1$I$20240101$20240912$20240920$20240920$PER$$US-MYLANLABS-2024M1083822$MYLAN$$$$$F$Y$$$20240920$$CN$US$US
243445491$24344549$1$I$20240531$20240919$20240920$20240920$EXP$$AU-BIOVITRUM-2024-AU-011987$BIOVITRUM$$$$A$F$Y$$$20240920$$HP$AU$AU
243445501$24344550$1$I$20240906$20240907$20240920$20240920$EXP$$US-RADIUS HEALTH INC.-2024US007020$RADIUS PHARM$$74$YR$$F$Y$$$20240920$$CN$US$US
243445511$24344551$1$I$$20240919$20240920$20240920$EXP$$US-BIOVITRUM-2024-US-012275$BIOVITRUM$$$$I$M$Y$$$20240920$$CN$US$US
243445521$24344552$1$I$$20240914$20240920$20240920$EXP$$US-SA-2024SA272209$SANOFI AVENTIS$$$$E$F$Y$$$20240920$$MD$US$US
243445531$24344553$1$I$$20240912$20240920$20240920$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-28081$SAMSUNG BIOEPIS$$68$YR$E$F$Y$$$20240920$$CN$CA$CA
243445541$24344554$1$I$20240819$20240919$20240920$20240920$EXP$GB-MHRA-MED-202409191117536600-RKDSH$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052519$BOEHRINGER INGELHEIM$$56$YR$A$F$Y$$$20240920$$CN$GB$GB
243445551$24344555$1$I$20240101$20240824$20240920$20240920$PER$$US-SA-2024SA266282$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240920$$MD$US$US
243445561$24344556$1$I$$20240912$20240920$20240920$30DAY$$US-GSK-US2024113754$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$CN$US$US
243445571$24344557$1$I$20240901$20240912$20240920$20240920$30DAY$$US-GSK-US2024113746$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240920$$CN$US$US
243445581$24344558$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024AMR113895$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$CN$US$US
243445591$24344559$1$I$20240905$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024187458$AMGEN$$$$$$Y$$$20240920$$PH$US$US
243445601$24344560$1$I$20240907$20240912$20240920$20240920$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-28114$SAMSUNG BIOEPIS$$27$YR$A$F$Y$$$20240920$$HP$CA$CA
243445611$24344561$1$I$$20240917$20240920$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015448$JAZZ$$$$$F$Y$$$20240920$$CN$US$US
243445621$24344562$1$I$$20240909$20240920$20240920$EXP$$US-JNJFOC-20240921500$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$HP$US$US
243445631$24344563$1$I$$20240906$20240920$20240920$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09058$LUPIN$$$$$$Y$$$20240920$$PH$US$US
243445641$24344564$1$I$20240910$20240911$20240920$20240920$EXP$$CN-JNJFOC-20240940218$JOHNSON AND JOHNSON$$65$YR$E$F$Y$60$KG$20240920$$HP$CN$CN
243445651$24344565$1$I$$20240909$20240920$20240920$EXP$$US-JNJFOC-20240954096$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240920$$CN$US$US
243445664$24344566$4$F$20240101$20240920$20240920$20240924$PER$$US-GILEAD-2024-0687926$GILEAD$$$$A$M$Y$$$20240924$$CN$US$US
243445671$24344567$1$I$$20240910$20240920$20240920$EXP$$JP-EMD Serono-2024049285$EMD SERONO INC$$88$YR$E$F$Y$55$KG$20240920$$MD$JP$JP
243445681$24344568$1$I$$20240909$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409005653$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240920$$CN$US$US
243445691$24344569$1$I$$20240909$20240920$20240920$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202409004768$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240920$$PH$AU$AU
243445701$24344570$1$I$$20240913$20240920$20240920$EXP$$US-AMGEN-USASP2024184800$AMGEN$Sama S.; Weickhardt A.; Subramanian P. et al.. Phospholipase A2 receptor-negative membranous nephropathy presenting as a rare renal manifestation of IgG4-related disease. SAGE Open Medical Case Reports. 2024;12 (3):1-4$75$YR$E$M$Y$$$20240920$$HP$US$US
243445711$24344571$1$I$20240424$20240909$20240920$20240920$EXP$$DE-DSJP-DS-2024-100660-DE$DAIICHI$$72$YR$$F$Y$63$KG$20240920$$MD$DE$DE
243445721$24344572$1$I$$20240909$20240920$20240920$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409005969$ELI LILLY AND CO$$49$YR$A$F$Y$83$KG$20240920$$CN$GB$GB
243445731$24344573$1$I$20180101$20240909$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409005413$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240920$$CN$US$US
243445741$24344574$1$I$20240908$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010228$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240920$$CN$US$US
243445751$24344575$1$I$20240805$20240910$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409006333$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240920$$CN$US$US
243445771$24344577$1$I$$20240909$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202309007832$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240920$$CN$US$US
243445781$24344578$1$I$$20240909$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409006243$ELI LILLY AND CO$$85$YR$E$M$Y$75$KG$20240920$$MD$US$US
243445801$24344580$1$I$$20240909$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409005404$ELI LILLY AND CO$$$$$M$Y$$$20240920$$CN$US$US
243445811$24344581$1$I$20240911$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011633$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240920$$CN$US$US
243445821$24344582$1$I$$20240909$20240920$20240920$EXP$$QA-ELI_LILLY_AND_COMPANY-QA202409007657$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$QA$QA
243445831$24344583$1$I$$20240909$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409005813$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240920$$CN$US$US
243445841$24344584$1$I$$20240910$20240920$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409006309$ELI LILLY AND CO$Matsuoka A, et al..ORIGINAL ARTICLE Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series.The Journal of Obstetrics and Gynaecology Research 2024;50 (7):1148-1154.$65$YR$E$F$Y$$$20240920$$MD$JP$JP
243445851$24344585$1$I$$20240912$20240920$20240920$EXP$$RO-INCYTE CORPORATION-2024IN009951$INCYTE$Adamesteanu MO, Giurcaneanu C, Orzan O, Popa M, Burlacu G, Teodoreanu RN et al. Outcomes and characteristics of non melanocitary skin cancers and actinic keratosis in a patient with myelofibrosis on fedratinib. DERMATOVENEROL. 2024;69(2):15-23$$$$$Y$$$20240920$$HP$RO$RO
243445862$24344586$2$F$20220815$20240913$20240920$20240927$EXP$$BR-BIOGEN-2023BI01214079$BIOGEN$$44$YR$$M$Y$76$KG$20240927$$CN$BR$BR
243445871$24344587$1$I$$20240917$20240920$20240920$PER$$US-Millicent Holdings Ltd.-MILL20241157$MILLICENT HOLDINGS$$$$A$F$Y$$$20240920$$CN$US$US
243445881$24344588$1$I$$20240912$20240920$20240920$EXP$$US-GSK-US2024113519$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243445891$24344589$1$I$20240822$20240915$20240920$20240920$EXP$$EG-SA-2024SA272082$SANOFI AVENTIS$$66$YR$E$F$Y$100$KG$20240920$$CN$EG$EG
243445901$24344590$1$I$20240827$20240912$20240920$20240920$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-28232$SAMSUNG BIOEPIS$$42$YR$A$M$Y$$$20240920$$CN$CA$CA
243445921$24344592$1$I$$20240913$20240920$20240920$PER$$US-MYLANLABS-2024M1084724$MYLAN$$$$$F$Y$$$20240920$$CN$US$US
243445961$24344596$1$I$$20240911$20240920$20240920$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR115846$VIIV$$$$$$Y$$$20240920$$HP$US$US
243445981$24344598$1$I$20240801$20240917$20240920$20240920$EXP$$BR-BAYER-2024A124221$BAYER$$$$$M$Y$$$20240920$$CN$BR$BR
243445991$24344599$1$I$20240918$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64594$$FDA-CTU$$76$YR$$F$N$$$20240920$N$$US$
243446001$24344600$1$I$$20240919$20240920$20240920$EXP$$US-BAYER-2024A134204$BAYER$$77$YR$E$F$Y$$$20240920$$CN$US$US
243446012$24344601$2$F$20230609$20240919$20240920$20240926$EXP$$CA-GSK-CA2023083623$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CA$CA
243446021$24344602$1$I$20240915$20240916$20240920$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001883$BLUEPRINT MEDICINES$$73$YR$E$F$Y$$$20240920$$CN$US$US
243446031$24344603$1$I$$20240910$20240920$20240920$EXP$$US-ADMA BIOLOGICS INC.-US-2024ADM000117$ADMA BIOLOGICS$Nadeem N, Ahmad MN, Malik MH, Zohaibuddin MM, Ahmed M, Khan F et al.. Kawasaki disease with profound systemic vascular involvements: An insightful pediatric case. Clinical Case Reports. 2024;12:9:e9415$2$MON$$M$Y$$$20240920$$HP$US$US
243446041$24344604$1$I$$20240911$20240920$20240920$EXP$$JP-009507513-2409JPN001853J$MERCK$$$$$F$Y$$$20240920$$MD$JP$JP
243446051$24344605$1$I$$20240917$20240920$20240920$EXP$$NVSC2024CH186840$NOVARTIS$$$$$M$Y$3.175$KG$20240920$$MD$CH$CH
243446071$24344607$1$I$$20240913$20240920$20240920$PER$$US-MYLANLABS-2024M1084394$MYLAN$$$$$$Y$$$20240920$$CN$US$US
243446081$24344608$1$I$$20240910$20240920$20240920$EXP$$US-ASTELLAS-2024-AER-006520$ASTELLAS$$53$YR$A$F$Y$$$20240920$$HP$US$US
243446091$24344609$1$I$20240801$20240906$20240920$20240920$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1636$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240919$$HP$US$US
243446101$24344610$1$I$20240101$20240831$20240920$20240920$PER$$US-SA-2024SA271163$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240920$$CN$US$US
243446111$24344611$1$I$20230901$20240909$20240920$20240920$EXP$GB-MHRA-MED-202409091928410690-VLMKN$GB-GLENMARK PHARMACEUTICALS-2024GMK093986$GLENMARK$$$$$$Y$$$20240920$$CN$GB$GB
243446121$24344612$1$I$$20240827$20240920$20240920$PER$$US-SA-2024SA267458$SANOFI AVENTIS$$$$C$F$Y$19.5$KG$20240920$$MD$US$US
243446131$24344613$1$I$20240801$20240913$20240920$20240920$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-28248$SAMSUNG BIOEPIS$$65$YR$E$F$Y$$$20240920$$CN$CA$CA
243446141$24344614$1$I$$20240910$20240920$20240920$EXP$$US-ADMA BIOLOGICS INC.-US-2024ADM000118$ADMA BIOLOGICS$Nadeem N, Ahmad MN, Malik MH, Zohaibuddin MM, Ahmed M, Khan F et al.. Kawasaki disease with profound systemic vascular involvements: An insightful pediatric case. Clinical Case Reports. 2024;12:9:e9415$2$MON$$M$Y$$$20240920$$HP$US$US
243446151$24344615$1$I$$20240912$20240920$20240920$EXP$$CA-APOTEX-2020AP012355$APOTEX$$43$YR$$F$Y$$$20240920$$HP$CA$CA
243446161$24344616$1$I$20240619$20240913$20240920$20240920$EXP$$US-GSK-US2024114183$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243446171$24344617$1$I$20240101$20240905$20240920$20240920$EXP$$JP-GALDERMA-JP2024010625$GALDERMA$$$$$$Y$$$20240920$$CN$JP$JP
243446181$24344618$1$I$20240918$20240919$20240920$20240920$EXP$$DE-JNJFOC-20240954762$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240920$$CN$DE$DE
243446191$24344619$1$I$20240101$20240910$20240920$20240920$PER$$US-ALKERMES INC.-ALK-2024-001294$ALKERMES$$$$$M$Y$$$20240920$$CN$US$US
243446201$24344620$1$I$$20240917$20240920$20240920$EXP$$DE-PFIZER INC-202400253431$PFIZER$$$$$M$Y$102$KG$20240920$$MD$DE$DE
243446211$24344621$1$I$20231201$20240912$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146174$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240920$$HP$US$US
243446221$24344622$1$I$$20240910$20240920$20240920$PER$$US-ALKERMES INC.-ALK-2024-002386$ALKERMES$$$$$M$Y$$$20240920$$CN$US$US
243446231$24344623$1$I$$20240919$20240920$20240920$PER$$US-BAYER-2024A134219$BAYER$$41$YR$A$F$Y$$$20240920$$CN$US$US
243446241$24344624$1$I$20240131$20240917$20240920$20240920$EXP$FR-AFSSAPS-BR2024000754$FR-ABBVIE-5930523$ABBVIE$$80$YR$$M$Y$79$KG$20240920$$MD$FR$FR
243446251$24344625$1$I$20240901$20240911$20240920$20240920$PER$$US-SA-2024SA267895$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240920$$HP$US$US
243446261$24344626$1$I$$20240906$20240920$20240920$EXP$$US-NORDICGR-057381$NORDIC PHARMA$Bharath SP, Pang H, Kaderi T, Rampolla R, Chen T, Gezalian M, et al. Pearls + Oy-sters: Status Epilepticus and Cerebral Edema From Hyperammonemia Due to Disseminated Ureaplasma and Mycoplasma Species. Neurology. 2022;100(15):727-31. DOI: 10.1212/WNL.0000000000206778.$57$YR$$M$Y$$$20240920$$MD$US$
243446271$24344627$1$I$20240906$20240916$20240920$20240920$PER$$US-SA-2024SA270001$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240920$$HP$US$US
243446281$24344628$1$I$20240801$20240916$20240920$20240920$EXP$HR-HALMED-300086479$HR-TEVA-VS-3244147$TEVA$$24$YR$$F$Y$$$20240920$$MD$HR$HR
243446291$24344629$1$I$$20240910$20240920$20240920$EXP$$US-RADIUS HEALTH INC.-2024US007108$RADIUS PHARM$$$$$F$Y$$$20240920$$CN$US$US
243446301$24344630$1$I$$20240911$20240920$20240920$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR115847$VIIV$$$$$$Y$$$20240920$$HP$US$US
243446312$24344631$2$F$$20240919$20240920$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015396$JAZZ$$$$$F$Y$$$20240924$$CN$US$US
243446321$24344632$1$I$$20240910$20240920$20240920$PER$$US-ALKERMES INC.-ALK-2024-002363$ALKERMES$$$$$F$Y$$$20240920$$HP$US$US
243446331$24344633$1$I$$20240918$20240920$20240920$EXP$$PR-ABBVIE-5930054$ABBVIE$$$$A$F$Y$$$20240920$$MD$PR$PR
243446341$24344634$1$I$$20240909$20240920$20240920$EXP$$AU-JNJFOC-20240934283$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$HP$AU$AU
243446351$24344635$1$I$20240101$20240910$20240920$20240920$PER$$US-ALKERMES INC.-ALK-2024-002364$ALKERMES$$$$$M$Y$$$20240920$$HP$US$US
243446361$24344636$1$I$20240831$20240911$20240920$20240920$PER$$US-AMGEN-USASP2024182907$AMGEN$$$$$M$Y$$$20240920$$CN$US$US
243446391$24344639$1$I$20240909$20240914$20240920$20240920$EXP$$CN-GSK-CN2024APC114482$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CN$CN
243446401$24344640$1$I$$20240905$20240920$20240920$EXP$$CA-BAXTER-2024BAX024443$BAXTER$$65$YR$$F$Y$$$20240920$$HP$CA$CA
243446411$24344641$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64598$$FDA-CTU$$62$YR$$M$N$$$20240920$N$$US$
243446421$24344642$1$I$20240625$20240919$20240919$20240919$DIR$719109$$FDA-CTU$$61$YR$$M$N$83.2$KG$20240919$N$HP$US$
243446431$24344643$1$I$20240805$20240918$20240920$20240920$EXP$$US-SANDOZ INC.-SDZ2024US081338$SANDOZ$$$$$$Y$$$20240920$$HP$US$US
243446441$24344644$1$I$20240912$20240912$20240920$20240920$PER$$US-BIOGEN-2024BI01282927$BIOGEN$$29$YR$$F$Y$$$20240920$$CN$US$US
243446451$24344645$1$I$20240727$20240829$20240920$20240920$EXP$$BR-BAYER-2024A124820$BAYER$$$$$F$Y$$$20240920$$CN$BR$BR
243446461$24344646$1$I$$20240917$20240920$20240920$EXP$$JP-GSK-JP2024116284$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$MD$JP$JP
243446471$24344647$1$I$$20240918$20240920$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU081518$SANDOZ$$$$E$$Y$$$20240920$$HP$AU$AU
243446481$24344648$1$I$$20240910$20240920$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409006306$ELI LILLY AND CO$Matsuoka A, et al..ORIGINAL ARTICLE Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series.The Journal of Obstetrics and Gynaecology Research 2024;50 (7):1148-1154.$61$YR$A$F$Y$$$20240920$$MD$JP$JP
243446491$24344649$1$I$20240825$20240913$20240920$20240920$EXP$$CA-JNJFOC-20240939328$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240920$$HP$CA$CA
243446501$24344650$1$I$$20240911$20240920$20240920$PER$$US-JNJFOC-20240939651$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243446521$24344652$1$I$20240101$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149198$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240920$$CN$US$US
243446531$24344653$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149708$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240920$$CN$US$US
243446541$24344654$1$I$20240901$20240917$20240920$20240920$EXP$$US-ABBVIE-5927694$ABBVIE$$64$YR$$M$Y$$$20240920$$CN$US$US
243446551$24344655$1$I$$20240911$20240920$20240920$PER$$US-ALKERMES INC.-ALK-2024-002372$ALKERMES$$4$DEC$$F$Y$$$20240920$$HP$US$US
243446561$24344656$1$I$$20240918$20240920$20240920$EXP$$US-GSK-US2024116105$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$US$US
243446571$24344657$1$I$20240701$20240914$20240920$20240920$EXP$$IT-GSK-IT2024114837$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$IT$IT
243446581$24344658$1$I$$20240911$20240920$20240920$EXP$$CA-TEVA-VS-3242581$TEVA$$78$YR$$F$Y$$$20240920$$HP$CA$CA
243446591$24344659$1$I$$20240912$20240920$20240920$30DAY$$US-GSK-US2024113745$GLAXOSMITHKLINE$$$$A$F$Y$$$20240920$$CN$US$US
243446603$24344660$3$F$$20240910$20240920$20240925$EXP$$US-SMPA-2024SPA002483$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243446611$24344661$1$I$$20240906$20240920$20240920$PER$$US-SMPA-2024SPA000416$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243446631$24344663$1$I$$20240910$20240920$20240920$PER$$US-SMPA-2024SPA002647$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243446641$24344664$1$I$$20240823$20240920$20240920$PER$$US-SMPA-2024SPA001930$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243446671$24344667$1$I$$20240908$20240920$20240920$PER$$US-SMPA-2024SPA002485$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243446681$24344668$1$I$$20240826$20240920$20240920$PER$$US-SMPA-2024MYSCI0600746$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243446692$24344669$2$F$$20240917$20240920$20240927$PER$$US-SMPA-2024SPA002384$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243446701$24344670$1$I$$20240906$20240920$20240920$PER$$US-SMPA-2024SPA002461$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243446711$24344671$1$I$$20240826$20240920$20240920$PER$$US-SMPA-2024SPA001945$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243446722$24344672$2$F$$20240825$20240920$20240924$PER$$US-SMPA-2024SPA001939$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243446731$24344673$1$I$$20240913$20240920$20240920$PER$$US-SMPA-2024SPA002902$SUNOVION$$$$$$Y$$$20240920$$MD$US$US
243446742$24344674$2$F$$20240911$20240920$20240930$PER$$US-SMPA-2024SPA002105$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243446751$24344675$1$I$$20240826$20240920$20240920$PER$$US-SMPA-2024SPA001946$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243446771$24344677$1$I$$20240905$20240920$20240920$PER$$US-SMPA-2024SPA002419$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243446781$24344678$1$I$20240601$20240723$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00349$Alora Pharma$$12$YR$$M$Y$$$20240816$$CN$US$US
243446792$24344679$2$F$20240701$20240912$20240920$20240927$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00359$Alora Pharma$$28$YR$$F$Y$95.238$KG$20240927$$CN$US$US
243446802$24344680$2$F$20230724$20240916$20240920$20240924$EXP$$AU-INCYTE CORPORATION-2024IN009906$INCYTE$$$$$$Y$$$20240924$$MD$AU$AU
243446811$24344681$1$I$20240101$20240724$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00356$Alora Pharma$$$$$M$Y$$$20240920$$CN$US$US
243446821$24344682$1$I$20240101$20240726$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00368$Alora Pharma$$13$YR$$M$Y$$$20240920$$CN$US$US
243446831$24344683$1$I$20240101$20240430$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00298$Alora Pharma$$$$$M$Y$$$20240920$$CN$US$US
243446841$24344684$1$I$20240101$20240620$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00301$Alora Pharma$$$$$F$Y$77.098$KG$20240920$$CN$US$US
243446851$24344685$1$I$20240101$20240705$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00323$Alora Pharma$$$$$M$Y$$$20240920$$PH$US$US
243446861$24344686$1$I$20240501$20240722$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00347$Alora Pharma$$46$YR$$F$Y$78.912$KG$20240920$$CN$US$US
243446871$24344687$1$I$20240701$20240723$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00358$Alora Pharma$$12$YR$$F$Y$$$20240920$$CN$US$US
243446881$24344688$1$I$20231001$20240724$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00361$Alora Pharma$$43$YR$$M$Y$$$20240920$$CN$US$US
243446891$24344689$1$I$20240101$20240502$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00241$Alora Pharma$$$$$M$Y$95.238$KG$20240920$$CN$US$US
243446901$24344690$1$I$20240715$20240718$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00342$Alora Pharma$$23$YR$$F$Y$77.098$KG$20240920$$CN$US$US
243446911$24344691$1$I$20220101$20240416$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00109$Alora Pharma$$$$$M$Y$$$20240920$$CN$US$US
243446921$24344692$1$I$20240306$20240725$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00391$Alora Pharma$$8$YR$$$Y$$$20240920$$MD$US$US
243446931$24344693$1$I$20230301$20240416$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00102$Alora Pharma$$12$YR$$F$Y$40.816$KG$20240920$$CN$US$US
243446941$24344694$1$I$$20240418$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00110$Alora Pharma$$$$$M$Y$68.027$KG$20240920$$CN$US$US
243446951$24344695$1$I$20170101$20240418$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00112$Alora Pharma$$$$$M$Y$79.819$KG$20240920$$CN$US$US
243446961$24344696$1$I$20210501$20240416$20240920$20240920$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00114$Alora Pharma$$16$YR$$F$Y$68.038$KG$20240920$$CN$US$US
243446971$24344697$1$I$20230101$20240430$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00119$Alora Pharma$$$$$M$Y$88.435$KG$20240920$$CN$US$US
243446981$24344698$1$I$20240101$20240419$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00126$Alora Pharma$$$$$$Y$61.224$KG$20240920$$CN$US$US
243446991$24344699$1$I$20240101$20240503$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00127$Alora Pharma$$35$YR$$$Y$85.714$KG$20240920$$CN$US$US
243447001$24344700$1$I$20231001$20240430$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00128$Alora Pharma$$10$YR$$F$Y$28.118$KG$20240920$$CN$US$US
243447011$24344701$1$I$20240101$20240419$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00130$Alora Pharma$$8$YR$$F$Y$28.345$KG$20240920$$CN$US$US
243447021$24344702$1$I$20240101$20240424$20240920$20240920$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00131$Alora Pharma$$33$YR$$F$Y$124.72$KG$20240920$$CN$US$US
243447031$24344703$1$I$20240501$20240701$20240920$20240920$EXP$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00306$Alora Pharma$$33$YR$$F$Y$48.98$KG$20240920$$CN$US$US
243447041$24344704$1$I$20240201$20240221$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00041$Alora Pharma$$40$YR$$M$Y$$$20240920$$HP$US$US
243447051$24344705$1$I$20240101$20240325$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00056$Alora Pharma$$$$$M$Y$$$20240920$$CN$US$US
243447061$24344706$1$I$20240101$20240312$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00060$Alora Pharma$$46$YR$$F$Y$98.866$KG$20240920$$CN$US$US
243447071$24344707$1$I$20240306$20240314$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00066$Alora Pharma$$34$YR$$F$Y$$$20240920$$HP$US$US
243447081$24344708$1$I$$20240408$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00133$Alora Pharma$$$$$M$Y$$$20240920$$HP$US$US
243447091$24344709$1$I$20240101$20240507$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00207$Alora Pharma$$$$$F$Y$$$20240920$$PH$US$US
243447101$24344710$1$I$$20240906$20240920$20240920$PER$$US-SMPA-2024SPA002478$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243447121$24344712$1$I$20230101$20240620$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00259$Alora Pharma$$$$$M$Y$119.73$KG$20240920$$CN$US$US
243447131$24344713$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64595$$FDA-CTU$$77$YR$$F$N$$$20240920$N$HP$US$
243447151$24344715$1$I$$20240824$20240920$20240920$PER$$US-SMPA-2024SPA002061$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243447161$24344716$1$I$$20240823$20240920$20240920$PER$$US-SMPA-2024SPA001927$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243447171$24344717$1$I$$20240906$20240920$20240920$PER$$US-SMPA-2024SPA002465$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243447181$24344718$1$I$$20240913$20240920$20240920$PER$$US-SMPA-2024SPA002793$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243447191$24344719$1$I$$20240906$20240920$20240920$PER$$US-SMPA-2024SPA002476$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243447201$24344720$1$I$20230101$20240419$20240920$20240920$PER$$US-ACELLA PHARMACEUTICALS, LLC-2024ALO00124$Alora Pharma$$$$$F$Y$102.04$KG$20240920$$CN$US$US
243447231$24344723$1$I$20150101$20240909$20240920$20240920$EXP$$DE-JNJFOC-20240933435$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240920$$MD$DE$DE
243447251$24344725$1$I$20240101$20240906$20240920$20240920$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1667$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243447261$24344726$1$I$$20240916$20240920$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001888$BLUEPRINT MEDICINES$$$$$M$Y$$$20240920$$CN$US$US
243447271$24344727$1$I$20240101$20240911$20240920$20240920$PER$$US-ALKERMES INC.-ALK-2024-002401$ALKERMES$$3$DEC$$F$Y$$$20240920$$HP$US$US
243447281$24344728$1$I$$20240912$20240920$20240920$PER$$US-SMPA-2024SPA002924$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243447291$24344729$1$I$$20240919$20240920$20240920$EXP$$DE-SANDOZ INC.-NVSC2021DE315870$SANDOZ$$80$YR$$M$Y$69$KG$20240920$$HP$DE$DE
243447301$24344730$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64603$$FDA-CTU$$45$YR$$M$N$$$20240920$N$$US$
243447311$24344731$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64602$$FDA-CTU$$73$YR$$F$N$$$20240920$N$$US$
243447321$24344732$1$I$$20240919$20240919$20240919$DIR$719086$$FDA-CTU$$$$$UNK$N$$$20240919$N$CN$US$
243447331$24344733$1$I$$20240915$20240920$20240920$DIR$FDA-CDER-CTU-2024-64601$$FDA-CTU$$$$$F$N$$$20240915$N$HP$US$
243447341$24344734$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64596$$FDA-CTU$$75$YR$$F$N$62.6$KG$20240920$N$$US$
243447351$24344735$1$I$20240509$20240912$20240920$20240920$EXP$GB-MHRA-MED-202409121415226540-ZRGBH$GB-NOVOPROD-1282533$NOVO NORDISK$$21$YR$$M$Y$108$KG$20240920$$MD$GB$GB
243447361$24344736$1$I$$20240911$20240920$20240920$EXP$$FR-VERTEX PHARMACEUTICALS-2024-014735$VERTEX$$$$$F$Y$$$20240920$$MD$FR$FR
243447371$24344737$1$I$20240101$20240916$20240920$20240920$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014744$VERTEX$$$$A$M$Y$$$20240920$$CN$GB$GB
243447381$24344738$1$I$$20240916$20240920$20240920$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014750$VERTEX$$$$C$F$Y$$$20240920$$CN$GB$GB
243447391$24344739$1$I$$20240913$20240920$20240920$EXP$$US-VERTEX PHARMACEUTICALS-2024-014659$VERTEX$$$$$M$Y$$$20240920$$CN$US$US
243447401$24344740$1$I$$20240915$20240920$20240920$EXP$$US-VERTEX PHARMACEUTICALS-2024-014707$VERTEX$$$$$M$Y$$$20240920$$CN$US$US
243447411$24344741$1$I$20240604$20240916$20240920$20240920$EXP$FR-AFSSAPS-LL2024001725$FR-VERTEX PHARMACEUTICALS-2024-014721$VERTEX$$45$YR$$M$Y$$$20240920$$MD$FR$FR
243447421$24344742$1$I$20240101$20240912$20240920$20240920$PER$$US-VERTEX PHARMACEUTICALS-2024-014691$VERTEX$$$$$F$Y$$$20240920$$CN$US$US
243447431$24344743$1$I$$20240909$20240920$20240920$EXP$$DE-THE J. MOLNER COMPANY-202409000033$The J.Molner Company$Noelle Dyballa. A case of a lidocaine intoxication of a 12 week old boy due to a circumcision in a domestic setting - clinical, toxicological and forensic aspects. Forensic Sci Med Pathol. 2024$$$$$Y$$$20240920$$HP$DE$DE
243447441$24344744$1$I$$20240909$20240920$20240920$EXP$$JP-THE J. MOLNER COMPANY-202409000034$The J.Molner Company$Yasufumi Seki. Hyponatremia due to preserved non-osmotic arginine vasopressin secretion in adipsic diabetes insipidus: a case report with review of literature. Endocr J. 2024$$$$$Y$$$20240920$$HP$JP$JP
243447451$24344745$1$I$$20240915$20240920$20240920$EXP$$BE-GSK-BE2024115489$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$MD$BE$BE
243447461$24344746$1$I$$20240919$20240920$20240920$PER$$NVSC2024US188103$NOVARTIS$$$$$F$Y$$$20240920$$HP$US$US
243447471$24344747$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64604$$FDA-CTU$$71$YR$$M$N$$$20240920$N$$US$
243447481$24344748$1$I$$20240910$20240920$20240920$EXP$$CA-APOTEX-2024AP010469$APOTEX$$66$YR$$F$Y$$$20240920$$HP$CA$CA
243447491$24344749$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64607$$FDA-CTU$$70$YR$$F$N$50.8$KG$20240920$N$$US$
243447501$24344750$1$I$20240712$20240919$20240919$20240919$DIR$719064$$FDA-CTU$$23$YR$$F$N$79$KG$20240919$N$HP$US$
243447511$24344751$1$I$20231102$20240913$20240920$20240920$EXP$$NVSC2024DE135306$NOVARTIS$$$$A$M$Y$$$20240920$$MD$DE$DE
243447521$24344752$1$I$20240101$20240911$20240920$20240920$PER$$US-JNJFOC-20240940607$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243447531$24344753$1$I$20240912$20240913$20240920$20240920$EXP$$CA-GSK-CA2019AMR184987$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$MD$CA$CA
243447543$24344754$3$F$20240913$20240925$20240920$20240930$EXP$$CH-BIOGEN-2024BI01282916$BIOGEN$$63$YR$$M$Y$61$KG$20240930$$MD$CH$CH
243447551$24344755$1$I$20240101$20240916$20240920$20240920$EXP$$US-ALKERMES INC.-ALK-2024-002403$ALKERMES$$$$$F$Y$$$20240920$$HP$US$US
243447561$24344756$1$I$20240101$20240828$20240920$20240920$PER$$US-SA-2024SA267830$SANOFI AVENTIS$$$$I$M$Y$$$20240920$$MD$US$US
243447571$24344757$1$I$$20240821$20240920$20240920$PER$$US-SA-2024SA266879$SANOFI AVENTIS$$5$YR$C$M$Y$17.234$KG$20240920$$MD$US$US
243447581$24344758$1$I$20240101$20240831$20240920$20240920$PER$$US-SA-2024SA271426$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240920$$CN$US$US
243447591$24344759$1$I$20240823$20240906$20240920$20240920$PER$$US-SA-2024SA269649$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240920$$CN$US$US
243447602$24344760$2$F$20240501$20240918$20240920$20240926$EXP$$NVSC2024IE113736$NOVARTIS$$53$YR$$F$Y$$$20240926$$CN$IE$IE
243447611$24344761$1$I$$20240919$20240920$20240920$PER$$NVSC2024US188119$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243447621$24344762$1$I$$20240831$20240920$20240920$PER$$US-TEVA-VS-3239983$TEVA$$63$YR$$F$Y$$$20240920$$HP$US$US
243447631$24344763$1$I$20240101$20240912$20240920$20240920$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000192$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243447641$24344764$1$I$20231220$20240917$20240920$20240920$PER$$US-PFIZER INC-PV202400122019$PFIZER$$$$$M$Y$$$20240920$$CN$US$US
243447651$24344765$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-PV202400121979$PFIZER$$65$YR$$F$Y$$$20240920$$HP$US$US
243447661$24344766$1$I$$20240916$20240920$20240920$PER$$US-PFIZER INC-PV202400121640$PFIZER$$79$YR$$F$Y$$$20240920$$CN$US$US
243447682$24344768$2$F$$20240923$20240920$20240924$PER$$US-PFIZER INC-202400258992$PFIZER$$$$$$Y$$$20240924$$MD$US$US
243447692$24344769$2$F$$20240923$20240920$20240924$PER$$US-PFIZER INC-202400258964$PFIZER$$$$$$Y$$$20240924$$MD$US$US
243447702$24344770$2$F$$20240923$20240920$20240924$PER$$US-PFIZER INC-202400258995$PFIZER$$$$$$Y$$$20240924$$MD$US$US
243447721$24344772$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258589$PFIZER$$83$YR$$F$Y$$$20240920$$CN$US$US
243447731$24344773$1$I$20240910$20240919$20240920$20240920$EXP$GB-MHRA-MED-202409171003251260-HZLKY$GB-PFIZER INC-202400259717$PFIZER$$22$YR$$F$Y$69$KG$20240920$$CN$GB$GB
243447751$24344775$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-PV202400121914$PFIZER$$46$YR$$F$Y$$$20240920$$HP$US$US
243447761$24344776$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258285$PFIZER$$82$YR$$F$Y$$$20240920$$CN$US$US
243447771$24344777$1$I$20240901$20240916$20240920$20240920$PER$$US-PFIZER INC-202400257431$PFIZER$$73$YR$$F$Y$$$20240920$$CN$US$US
243447781$24344778$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258469$PFIZER$$7$YR$$M$Y$$$20240920$$HP$US$US
243447801$24344780$1$I$20240917$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258608$PFIZER$$$$$F$Y$$$20240920$$PH$US$US
243447811$24344781$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-PV202400122172$PFIZER$$$$$F$Y$$$20240920$$CN$US$US
243447821$24344782$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258593$PFIZER$$82$YR$$M$Y$91.63$KG$20240920$$PH$US$US
243447831$24344783$1$I$$20240918$20240920$20240920$EXP$$US-PFIZER INC-202400259256$PFIZER$$56$YR$$F$Y$$$20240920$$HP$US$US
243447841$24344784$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258521$PFIZER$$60$YR$$F$Y$65.77$KG$20240920$$CN$US$US
243447851$24344785$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-2020455761$PFIZER$$62$YR$$F$Y$$$20240920$$CN$US$US
243447861$24344786$1$I$$20240916$20240920$20240920$PER$$US-PFIZER INC-202400258407$PFIZER$$59$YR$$F$Y$$$20240920$$HP$US$US
243447871$24344787$1$I$$20240918$20240920$20240920$EXP$$US-PFIZER INC-PV202400122928$PFIZER$$$$$M$Y$$$20240920$$HP$US$US
243447882$24344788$2$F$$20240920$20240920$20240924$PER$$US-PFIZER INC-202400259243$PFIZER$$66$YR$$F$Y$56.281$KG$20240924$$MD$US$US
243447892$24344789$2$F$$20240923$20240920$20240924$PER$$US-PFIZER INC-202400258981$PFIZER$$$$$$Y$$$20240924$$MD$US$US
243447911$24344791$1$I$20240917$20240917$20240920$20240920$PER$$US-PFIZER INC-PV202400093638$PFIZER$$73$YR$$F$Y$$$20240920$$MD$US$US
243447921$24344792$1$I$20240823$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024184761$AMGEN$$79$YR$E$F$Y$$$20240920$$HP$US$US
243447931$24344793$1$I$20240101$20240916$20240920$20240920$EXP$SE-SEMPA-2024-006426$SE-TEVA-VS-3244312$TEVA$$$$$F$Y$$$20240920$$CN$SE$SE
243447941$24344794$1$I$$20240909$20240920$20240920$EXP$FR-AFSSAPS-BX2024001746$FR-BAXTER-2024BAX024393$BAXTER$$39$YR$$M$Y$75$KG$20240920$$MD$FR$FR
243447952$24344795$2$F$$20240919$20240920$20240927$EXP$$US-RADIUS HEALTH INC.-2024US007168$RADIUS PHARM$$$$$M$Y$64$KG$20240927$$HP$US$US
243447972$24344797$2$F$20240901$20240924$20240920$20240930$EXP$$NVSC2024CA185099$NOVARTIS$$24$YR$$M$Y$$$20240930$$CN$CA$CA
243447981$24344798$1$I$$20240916$20240920$20240920$EXP$$PT-BAUSCH-BL-2024-013963$BAUSCH AND LOMB$Mestre D, Gil F. Central Venous Catheter Misplacement Presenting With Parotid Gland Swelling: A Case Report.. Cureus. 2024 AUG 05;16(8):1-5. doi:10.7759/cureus.66245$84$YR$$F$Y$$$20240920$$HP$PT$PT
243447991$24344799$1$I$20240101$20240911$20240920$20240920$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK094121$GLENMARK$$$$$$Y$$$20240920$$PH$US$US
243448001$24344800$1$I$20240408$20240917$20240920$20240920$EXP$$NVSC2024MX081458$NOVARTIS$$69$YR$$F$Y$48$KG$20240920$$CN$MX$MX
243448011$24344801$1$I$20240902$20240913$20240920$20240920$EXP$$CN-Eisai-EC-2024-174391$EISAI$$32$YR$A$M$Y$65$KG$20240920$$HP$CN$CN
243448021$24344802$1$I$20220901$20240911$20240920$20240920$PER$$CN-Eisai-EC-2024-174369$EISAI$$57$YR$A$M$Y$$$20240920$$MD$CN$CN
243448031$24344803$1$I$$20240918$20240920$20240920$PER$$US-BAUSCH-BL-2024-014143$BAUSCH AND LOMB$$80$YR$$F$Y$$$20240920$$CN$US$US
243448061$24344806$1$I$20240801$20240830$20240920$20240920$PER$$US-SA-2024SA272102$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240920$$MD$US$US
243448071$24344807$1$I$$20240912$20240920$20240920$PER$$US-SA-2023SA391041$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240920$$HP$US$US
243448081$24344808$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-202400260079$PFIZER$$46$YR$$F$Y$$$20240920$$HP$US$US
243448091$24344809$1$I$20240818$20240918$20240920$20240920$PER$$US-PFIZER INC-202400260037$PFIZER$$55$YR$$M$Y$$$20240920$$HP$US$US
243448101$24344810$1$I$20240101$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400122843$PFIZER$$58$YR$$F$Y$$$20240920$$HP$US$US
243448111$24344811$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-202400260066$PFIZER$$56$YR$$F$Y$$$20240920$$HP$US$US
243448121$24344812$1$I$$20240910$20240920$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409006307$ELI LILLY AND CO$Matsuoka A, et al..ORIGINAL ARTICLE Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series.The Journal of Obstetrics and Gynaecology Research 2024;50 (7):1148-1154.$64$YR$A$F$Y$$$20240920$$MD$JP$JP
243448131$24344813$1$I$20240805$20240919$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012894$ELI LILLY AND CO$$$$$$Y$$$20240920$$CN$US$US
243448141$24344814$1$I$20240413$20240919$20240919$20240919$DIR$719134$$FDA-CTU$$32$YR$$F$N$62.1$KG$20240919$N$CN$US$
243448151$24344815$1$I$$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64610$$FDA-CTU$$$$$F$N$$$20240919$N$HP$US$
243448161$24344816$1$I$20240916$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011758$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240920$$CN$US$US
243448171$24344817$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011935$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240920$$CN$US$US
243448181$24344818$1$I$$20240910$20240920$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409006310$ELI LILLY AND CO$Matsuoka A, et al..ORIGINAL ARTICLE Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series.The Journal of Obstetrics and Gynaecology Research 2024;50 (7):1148-1154.$79$YR$E$F$Y$$$20240920$$MD$JP$JP
243448201$24344820$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011577$ELI LILLY AND CO$$$$$$Y$$$20240920$$HP$US$US
243448211$24344821$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011010$ELI LILLY AND CO$$$$$$Y$$$20240920$$CN$US$US
243448221$24344822$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012221$ELI LILLY AND CO$$$$$$Y$$$20240920$$CN$US$US
243448232$24344823$2$F$20240914$20240920$20240920$20240924$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005204$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240924$$MD$US$US
243448251$24344825$1$I$20240101$20240919$20240920$20240920$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005208$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243448261$24344826$1$I$20230101$20240910$20240920$20240920$EXP$$JP-009507513-2409JPN001847J$MERCK$Oike T, Oeda R, Inoue T, Inoue N, Nakao K, Ikeda S, et al.. P-040 A retrospective study on 16 cases of recurrent corpus uteri carcinoma treated with pembrolizumab and lenvatinib combination therapy in our hospital. The Journal of the Japan Society of Gynecologic Oncology The 66th Annual Meeting. 2024;42(3):364$62$YR$$F$Y$$$20240920$$MD$JP$JP
243448271$24344827$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013996$BAUSCH AND LOMB$$33$YR$$F$Y$$$20240920$$CN$CA$CA
243448281$24344828$1$I$$20240916$20240920$20240920$EXP$$NVSC2024AU186492$NOVARTIS$$48$YR$$M$Y$$$20240920$$MD$AU$AU
243448291$24344829$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013978$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240920$$CN$CA$CA
243448301$24344830$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-202400259867$PFIZER$$$$$F$Y$$$20240920$$MD$US$US
243448311$24344831$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202300082657$PFIZER$$72$YR$$F$Y$$$20240920$$MD$US$US
243448321$24344832$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400123136$PFIZER$$81$YR$$F$Y$59.592$KG$20240920$$MD$US$US
243448331$24344833$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258736$PFIZER$$$$$F$Y$$$20240920$$MD$US$US
243448341$24344834$1$I$20240913$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258775$PFIZER$$43$YR$$F$Y$$$20240920$$CN$US$US
243448351$24344835$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258769$PFIZER$$$$$$Y$$$20240920$$MD$US$US
243448361$24344836$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400122727$PFIZER$$39$YR$$F$Y$$$20240920$$HP$US$US
243448371$24344837$1$I$20240601$20240918$20240920$20240920$PER$$US-PFIZER INC-202400260034$PFIZER$$65$YR$$F$Y$$$20240920$$HP$US$US
243448381$24344838$1$I$20240917$20240918$20240920$20240920$PER$$US-PFIZER INC-202400260093$PFIZER$$44$YR$$F$Y$$$20240920$$HP$US$US
243448391$24344839$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400122955$PFIZER$$52$YR$$F$Y$$$20240920$$HP$US$US
243448401$24344840$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400259016$PFIZER$$$$A$F$Y$117.93$KG$20240920$$CN$US$US
243448411$24344841$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-202400060602$PFIZER$$59$YR$$F$Y$$$20240920$$CN$US$US
243448421$24344842$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400122611$PFIZER$$68$YR$$F$Y$$$20240920$$HP$US$US
243448432$24344843$2$F$20240911$20240919$20240920$20240923$PER$$US-PFIZER INC-202400259337$PFIZER$$62$YR$$F$Y$$$20240923$$PH$US$US
243448441$24344844$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400259192$PFIZER$$53$YR$$F$Y$$$20240920$$HP$US$US
243448451$24344845$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-202400259344$PFIZER$$76$YR$$F$Y$$$20240920$$PH$US$US
243448461$24344846$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258718$PFIZER$$70$YR$$F$Y$$$20240920$$CN$US$US
243448471$24344847$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400259201$PFIZER$$51$YR$$F$Y$$$20240920$$HP$US$US
243448481$24344848$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202300028708$PFIZER$$79$YR$$F$Y$$$20240920$$CN$US$US
243448491$24344849$1$I$20240801$20240918$20240920$20240920$PER$$US-PFIZER INC-202400239520$PFIZER$$78$YR$$F$Y$$$20240920$$HP$US$US
243448502$24344850$2$F$$20240920$20240920$20240923$PER$$US-PFIZER INC-202400259442$PFIZER$$46$YR$$F$Y$92.99$KG$20240923$$CN$US$US
243448521$24344852$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400122696$PFIZER$$72$YR$$F$Y$$$20240920$$HP$US$US
243448531$24344853$1$I$20240901$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400123099$PFIZER$$43$YR$$M$Y$$$20240920$$HP$US$US
243448541$24344854$1$I$20240801$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400122731$PFIZER$$61$YR$$F$Y$74.376$KG$20240920$$CN$US$US
243448551$24344855$1$I$20240101$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400122620$PFIZER$$65$YR$$M$Y$$$20240920$$HP$US$US
243448561$24344856$1$I$$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258723$PFIZER$$76$YR$$F$Y$$$20240920$$CN$US$US
243448571$24344857$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400123106$PFIZER$$58$YR$$F$Y$$$20240920$$HP$US$US
243448581$24344858$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400122560$PFIZER$$33$YR$$$Y$$$20240920$$CN$US$US
243448591$24344859$1$I$20240101$20240918$20240920$20240920$PER$$US-PFIZER INC-202400260047$PFIZER$$63$YR$$F$Y$$$20240920$$HP$US$US
243448601$24344860$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-202400259109$PFIZER$$$$$F$Y$$$20240920$$CN$US$US
243448611$24344861$1$I$$20240919$20240920$20240920$PER$$US-PFIZER INC-202400260567$PFIZER$$$$$$Y$$$20240920$$CN$US$US
243448621$24344862$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-202400259246$PFIZER$$53$YR$$M$Y$$$20240920$$MD$US$US
243448651$24344865$1$I$20240918$20240918$20240920$20240920$PER$$US-PFIZER INC-202400258553$PFIZER$$33$YR$$F$Y$$$20240920$$CN$US$US
243448661$24344866$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400122623$PFIZER$$69$YR$$M$Y$$$20240920$$HP$US$US
243448672$24344867$2$F$$20240926$20240920$20240927$PER$$US-PFIZER INC-202400259837$PFIZER$$77$YR$$F$Y$$$20240927$$CN$US$US
243448681$24344868$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-PV202400123094$PFIZER$$60$YR$$F$Y$$$20240920$$HP$US$US
243448692$24344869$2$F$20240901$20240927$20240920$20240930$PER$$US-PFIZER INC-202400259079$PFIZER$$68$YR$$$Y$$$20240930$$CN$US$US
243448701$24344870$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149738$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240920$$CN$US$US
243448711$24344871$1$I$$20240909$20240920$20240920$EXP$$CA-JNJFOC-20240928700$JOHNSON AND JOHNSON$$$$$F$Y$5$KG$20240920$$HP$CA$CA
243448721$24344872$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149922$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$114.8$KG$20240920$$CN$US$US
243448731$24344873$1$I$20240901$20240918$20240920$20240920$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015539$JAZZ$$36$YR$$M$Y$$$20240920$$HP$US$US
243448741$24344874$1$I$$20240913$20240920$20240920$PER$$US-BIOGEN-2024BI01283548$BIOGEN$$$$$F$Y$$$20240920$$CN$US$US
243448761$24344876$1$I$$20240918$20240920$20240920$PER$$US-HALEON-2197554$Haleon PLC$$$$$$Y$$$20240920$$CN$US$US
243448771$24344877$1$I$20240201$20240919$20240919$20240919$DIR$719105$$FDA-CTU$$58$YR$$F$N$54$KG$20240919$N$CN$US$
243448781$24344878$1$I$20240713$20240913$20240920$20240920$EXP$FR-AFSSAPS-AVLY2024000171$FR-TEVA-VS-3243835$TEVA$$33$YR$$F$Y$$$20240920$$MD$FR$FR
243448791$24344879$1$I$$20240916$20240920$20240920$EXP$$NVSC2024EG187325$NOVARTIS$$10$YR$$M$Y$$$20240920$$CN$EG$EG
243448801$24344880$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64613$$FDA-CTU$$78$YR$$F$N$$$20240920$N$$US$
243448811$24344881$1$I$20240902$20240920$20240920$20240920$DIR$719211$$FDA-CTU$$50$YR$$F$N$81$KG$20240920$N$CN$US$
243448831$24344883$1$I$$20240916$20240920$20240920$EXP$$US-SANDOZ INC.-SDZ2024IN081442$SANDOZ$$$$$F$Y$$$20240920$$CN$US$IN
243448841$24344884$1$I$$20240917$20240920$20240920$EXP$$US-BAUSCH-BL-2024-013948$BAUSCH AND LOMB$$23$YR$$F$Y$80$KG$20240920$$HP$US$US
243448851$24344885$1$I$20230901$20240916$20240920$20240920$EXP$ES-AEMPS-1565908$ES-TEVA-VS-3244272$TEVA$$57$YR$$M$Y$$$20240920$$MD$ES$ES
243448861$24344886$1$I$20240101$20240919$20240920$20240920$EXP$FR-AFSSAPS-TS2024001021$FR-BAUSCH-BL-2024-014183$BAUSCH AND LOMB$$80$YR$$M$Y$$$20240920$$MD$FR$FR
243448871$24344887$1$I$20170101$20240915$20240920$20240920$EXP$$AU-ABBVIE-5926156$ABBVIE$$$$$$Y$$$20240920$$MD$AU$AU
243448881$24344888$1$I$20240101$20240909$20240920$20240920$EXP$$US-ARDELYX-2024ARDX006167$ARDELYX$$$$$F$Y$90$KG$20240920$$PH$US$US
243448891$24344889$1$I$$20240909$20240920$20240920$PER$$US-JNJFOC-20240946162$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$HP$US$US
243448901$24344890$1$I$20240725$20240917$20240920$20240920$EXP$$US-JNJFOC-20240770005$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240920$$MD$US$US
243448911$24344891$1$I$20240701$20240910$20240920$20240920$EXP$$US-ARDELYX-2024ARDX006870$ARDELYX$$50$YR$$F$Y$$$20240920$$CN$US$US
243448921$24344892$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112566$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$CN$US$US
243448931$24344893$1$I$$20240910$20240920$20240920$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR115836$VIIV$$$$$$Y$$$20240920$$HP$US$US
243448941$24344894$1$I$$20240909$20240920$20240920$EXP$$US-ARDELYX-2024ARDX006353$ARDELYX$$$$$F$Y$$$20240920$$HP$US$US
243448951$24344895$1$I$20240827$20240909$20240920$20240920$EXP$$US-ARDELYX-2024ARDX006873$ARDELYX$$72$YR$$M$Y$$$20240920$$HP$US$US
243448971$24344897$1$I$$20240911$20240920$20240920$EXP$$JP-AZURITY PHARMACEUTICALS, INC.-AZR202409-000633$AZURITY PHARMACEUTICALS$Yamamoto Y, Lino K, Kitazawa M, Nakahara M, Nakabori H, Ueda H. et al.. Fibrin-associated diffuse large B-cell lymphoma in the aortic valve and ascending aorta.. J. Cardiol. Cases. 2024;30:94-6$51$YR$$F$Y$$$20240920$$HP$JP$JP
243448991$24344899$1$I$20240909$20240913$20240920$20240920$EXP$$CN-GSK-CN2024APC114393$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$CN$CN
243449002$24344900$2$F$20240110$20240911$20240920$20240925$EXP$$CN-AZURITY PHARMACEUTICALS, INC.-AZR202409-000654$AZURITY PHARMACEUTICALS$$71$YR$$M$Y$64$KG$20240924$$HP$CN$CN
243449011$24344901$1$I$20240901$20240913$20240920$20240920$EXP$$US-BIOGEN-2024BI01282725$BIOGEN$$31$YR$$$Y$$$20240920$$CN$US$US
243449021$24344902$1$I$20240917$20240918$20240920$20240920$EXP$$GB-MYLANLABS-2024M1085396$MYLAN$$$$$F$Y$$$20240920$$CN$GB$GB
243449031$24344903$1$I$$20240917$20240920$20240920$EXP$$ES-MYLANLABS-2024M1084581$MYLAN$Giangrande N, Maseda AC, Lopez A, Casares P, Lazaro M, Orjales N, Guzman G, Gonzalez K.. Kounis Syndrome During an Oxaliplatin Desensitization Protocol. Journal of Investigational Allergology and Clinical Immunology. 2024;34(4):268$$$$F$Y$$$20240920$$MD$ES$ES
243449041$24344904$1$I$$20240909$20240920$20240920$PER$$US-RDY-CLI/USA/24/0013365$DR REDDYS$$1$YR$I$F$Y$$$20240920$$CN$US$US
243449051$24344905$1$I$$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024187639$AMGEN$$$$$F$Y$$$20240920$$CN$US$US
243449061$24344906$1$I$$20240912$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013684$DR REDDYS$Agarwal A, Diaz A, Al-Dehneem R, Pineda RM, Khattri S. Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases. Journal of Drugs in Dermatology. 2023 Dec;22: 1183-1190. doi:10.36849/JDD.7500.$59$YR$A$M$Y$$$20240920$$HP$US$US
243449081$24344908$1$I$20240801$20240917$20240920$20240920$EXP$FR-AFSSAPS-TS2024000979$FR-MYLANLABS-2024M1085282$MYLAN$$15$YR$$F$Y$53$KG$20240920$$MD$FR$FR
243449091$24344909$1$I$$20240903$20240920$20240920$EXP$$US-SA-2024SA271825$SANOFI AVENTIS$$$$E$F$Y$$$20240920$$MD$US$US
243449101$24344910$1$I$20240914$20240920$20240920$20240920$DIR$719192$$FDA-CTU$$47$YR$$M$N$90$KG$20240920$Y$CN$US$
243449112$24344911$2$F$20240916$20240920$20240920$20240925$EXP$$JP-009507513-2409JPN002304J$MERCK$$$$$M$Y$$$20240925$$PH$JP$JP
243449121$24344912$1$I$$20240913$20240920$20240920$EXP$$IN-ABBVIE-5930240$ABBVIE$Gupta A, Garg N, Jain AK. Comparison of Isoflurane and Sevoflurane in Cardiac Surgery: A comparative trial.?J Cardiovasc Dis Res. 2024;15(8):1631-1636.$$$A$$Y$$$20240920$$MD$IN$IN
243449132$24344913$2$F$$20240918$20240920$20240927$EXP$$SI-VANTIVE-2024VAN019802$Vantive US Healthcare$$$$A$F$Y$$$20240927$$HP$SI$SI
243449171$24344917$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024AMR112917$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243449181$24344918$1$I$$20240913$20240920$20240920$PER$$US-JNJFOC-20240947098$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$HP$US$US
243449191$24344919$1$I$20240731$20240911$20240920$20240920$EXP$$JP-JNJFOC-20240954412$JOHNSON AND JOHNSON$$$$$F$Y$$$20240920$$HP$JP$JP
243449201$24344920$1$I$20240902$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149674$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$101$KG$20240920$$PH$US$US
243449211$24344921$1$I$$20240916$20240920$20240920$EXP$$VN-INCYTE CORPORATION-2024IN009899$INCYTE$$$$$$Y$$$20240920$$MD$VN$VN
243449221$24344922$1$I$20230106$20240918$20240920$20240920$EXP$$CA-VER-202400486$VERITY PHARMACEUTICALS$$83$YR$E$M$Y$$$20240920$$CN$CA$CA
243449231$24344923$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688265$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243449241$24344924$1$I$20230801$20240912$20240920$20240920$EXP$$JP-OTSUKA-2023_023474$OTSUKA$$36$YR$$F$Y$$$20240920$$PH$JP$JP
243449251$24344925$1$I$$20240919$20240920$20240920$PER$$US-HALEON-2197634$Haleon PLC$$$$$$Y$$$20240920$$CN$US$US
243449272$24344927$2$F$20240801$20240913$20240920$20240930$EXP$$BR-BAYER-2024A131877$BAYER$$71$YR$E$F$Y$$$20240930$$CN$BR$BR
243449301$24344930$1$I$$20240917$20240920$20240920$EXP$$FR-PFIZER INC-202400257919$PFIZER$$$$A$F$Y$64$KG$20240920$$CN$FR$FR
243449312$24344931$2$F$$20240922$20240920$20240924$EXP$$MK-PFIZER INC-202400259903$PFIZER$$62$YR$$F$Y$$$20240924$$MD$MK$MK
243449322$24344932$2$F$$20240922$20240920$20240924$EXP$$MK-PFIZER INC-PV202400122830$PFIZER$$57$YR$$M$Y$$$20240924$$MD$MK$MK
243449331$24344933$1$I$20240905$20240906$20240920$20240920$PER$$US-INCYTE CORPORATION-2024IN009460$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243449341$24344934$1$I$$20240906$20240920$20240920$PER$$US-INCYTE CORPORATION-2024IN009480$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243449361$24344936$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688268$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243449371$24344937$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688269$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243449381$24344938$1$I$20240919$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024187480$AMGEN$$$$$F$Y$$$20240920$$CN$US$US
243449391$24344939$1$I$20221130$20240916$20240920$20240920$EXP$$CA-VER-202400485$VERITY PHARMACEUTICALS$$77$YR$E$M$Y$$$20240920$$CN$CA$CA
243449401$24344940$1$I$20240824$20240830$20240920$20240920$PER$$US-SA-2024SA270832$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240920$$MD$US$US
243449411$24344941$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA266809$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243449431$24344943$1$I$20240101$20240830$20240920$20240920$PER$$US-SA-2024SA271468$SANOFI AVENTIS$$14$YR$T$F$Y$58.957$KG$20240920$$MD$US$US
243449441$24344944$1$I$20240501$20240918$20240920$20240920$EXP$FR-AFSSAPS-GR2024001056$FR-009507513-2409FRA006559$MERCK$$69$YR$$F$Y$$$20240920$$PH$FR$FR
243449451$24344945$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688271$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243449461$24344946$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688270$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243449471$24344947$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688281$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243449491$24344949$1$I$$20240910$20240920$20240920$EXP$$GR-TEVA-VS-3243761$TEVA$Papantoniou M., Tsatinas K., Tyrovolas I., Gryllia M. Acute motor axonal neuropathy in a patient on chemotherapy with oxaliplatin: Case report. Neurology. P160$69$YR$$M$Y$$$20240920$$MD$GR$GR
243449501$24344950$1$I$20240801$20240829$20240920$20240920$PER$$US-SA-2024SA267497$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243449521$24344952$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688292$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243449531$24344953$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688282$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243449541$24344954$1$I$20240101$20240916$20240920$20240920$EXP$$US-ABBVIE-5928207$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243449551$24344955$1$I$$20240917$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409010615$ELI LILLY AND CO$$64$YR$A$$Y$$$20240920$$CN$US$US
243449561$24344956$1$I$20231115$20240909$20240920$20240920$EXP$SE-SEMPA-2024-006583$SE-ELI_LILLY_AND_COMPANY-SE202409005950$ELI LILLY AND CO$$55$YR$A$F$Y$85$KG$20240920$$CN$SE$SE
243449571$24344957$1$I$$20240910$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409007229$ELI LILLY AND CO$$$$$$Y$$$20240920$$CN$US$US
243449581$24344958$1$I$$20240909$20240920$20240920$EXP$$RU-ELI_LILLY_AND_COMPANY-RU202409011266$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240920$$CN$DE$RU
243449591$24344959$1$I$20240902$20240910$20240920$20240920$EXP$SE-SEMPA-2024-006595$SE-ELI_LILLY_AND_COMPANY-SE202409006907$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240920$$CN$SE$SE
243449601$24344960$1$I$20240801$20240909$20240920$20240920$EXP$$SK-ELI_LILLY_AND_COMPANY-SK202409006658$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240920$$CN$SK$SK
243449611$24344961$1$I$$20240909$20240920$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409011680$ELI LILLY AND CO$$87$YR$E$M$Y$$$20240920$$CN$JP$JP
243449621$24344962$1$I$20240810$20240912$20240920$20240920$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409009797$ELI LILLY AND CO$$25$YR$A$F$Y$35$KG$20240920$$CN$DE$CN
243449631$24344963$1$I$20230930$20240910$20240920$20240920$EXP$GB-MHRA-MED-202409101453192190-FKZYN$GB-ELI_LILLY_AND_COMPANY-GB202409007031$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$GB$GB
243449641$24344964$1$I$20210430$20240910$20240920$20240920$EXP$PL-URPL-DML-MLP.4401.1.5066.2021$PL-ELI_LILLY_AND_COMPANY-PL202409006900$ELI LILLY AND CO$$53$YR$A$F$Y$77$KG$20240920$$CN$PL$PL
243449651$24344965$1$I$$20240916$20240920$20240920$EXP$$GR-ELI_LILLY_AND_COMPANY-GR202409010177$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$GR$GR
243449661$24344966$1$I$$20240910$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409012607$ELI LILLY AND CO$KEVIN WALSH ROSHAN ACHARYA BADRI GIRI AND ABDULMETIN DURSUN.LYMPHOCYTIC INTERSTITIAL PNEUMONIA IN A PATIENT WITH PSORIASIS.Chest 2023;164:4 Supplemen:A3218-A3219.DOI:10.1016/j.chest.2023.07.2108$43$YR$A$M$Y$$$20240920$$HP$US$US
243449671$24344967$1$I$$20240909$20240920$20240920$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409005772$ELI LILLY AND CO$$30$YR$A$$Y$$$20240920$$CN$DE$DE
243449681$24344968$1$I$$20240913$20240920$20240920$PER$$US-ABBVIE-5925144$ABBVIE$$$$$F$Y$$$20240920$$HP$US$US
243449691$24344969$1$I$$20240913$20240920$20240920$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006709$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240920$$CN$US$US
243449701$24344970$1$I$20240801$20240902$20240920$20240920$EXP$$PR-SA-2024SA269606$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240920$$MD$PR$PR
243449711$24344971$1$I$20240101$20240913$20240920$20240920$EXP$$DE-009507513-2409DEU005515$MERCK$$57$YR$$F$Y$$$20240920$$MD$DE$DE
243449721$24344972$1$I$20240101$20240903$20240920$20240920$PER$$US-SA-2023SA377158$SANOFI AVENTIS$$$$$M$Y$$$20240920$$CN$US$US
243449731$24344973$1$I$$20240905$20240920$20240920$EXP$$US-SA-2024SA271622$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243449741$24344974$1$I$20240821$20240918$20240920$20240920$EXP$$US-BAYER-2024A133575$BAYER$$58$YR$A$F$Y$$$20240920$$CN$US$US
243449751$24344975$1$I$$20240913$20240920$20240920$EXP$$US-GSK-US2024114329$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$HP$US$US
243449771$24344977$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112647$GLAXOSMITHKLINE$$$$$M$Y$$$20240920$$CN$US$US
243449781$24344978$1$I$$20240918$20240920$20240920$30DAY$$US-SANDOZ INC.-SDZ2024US081404$SANDOZ$$$$$$Y$$$20240920$$PH$US$US
243449791$24344979$1$I$$20240910$20240920$20240920$EXP$$US-Eisai-EC-2024-174165$EISAI$$$$$M$Y$$$20240920$$HP$US$US
243449801$24344980$1$I$$20240910$20240920$20240920$EXP$$CA-SANDOZ INC.-NVSC2020CA153277$SANDOZ$$53$YR$$M$Y$$$20240920$$CN$CA$CA
243449811$24344981$1$I$$20240919$20240920$20240920$PER$$NVSC2024US188047$NOVARTIS$$$$$M$Y$$$20240920$$HP$US$US
243449821$24344982$1$I$20240918$20240918$20240920$20240920$EXP$$CA-BAYER-2024A133574$BAYER$$$$$$Y$$$20240920$$MD$CA$CA
243449831$24344983$1$I$20240101$20240831$20240920$20240920$PER$$US-SA-2024SA271105$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240920$$MD$US$US
243449851$24344985$1$I$$20240911$20240920$20240920$PER$$US-009507513-2409USA004877$MERCK$$$$$M$Y$$$20240920$$MD$US$US
243449861$24344986$1$I$20220101$20240911$20240920$20240920$EXP$FR-AFSSAPS-AVCN2024000709$FR-INDIVIOR US-INDV-156415-2024$RECKITT BENCKISER$$$$$$Y$$$20240920$$MD$FR$FR
243449871$24344987$1$I$$20240917$20240920$20240920$EXP$$CA-ABBVIE-5929052$ABBVIE$$$$A$F$Y$$$20240920$$MD$CA$CA
243449891$24344989$1$I$20240401$20240917$20240920$20240920$EXP$$US-ABBVIE-5928586$ABBVIE$$56$YR$$M$Y$$$20240920$$CN$US$US
243449901$24344990$1$I$$20240917$20240920$20240920$30DAY$$CO-PFIZER INC-PV202400122114$PFIZER$$10$YR$$F$Y$$$20240920$$CN$CO$CO
243449911$24344991$1$I$20230902$20240916$20240920$20240920$EXP$ES-AEMPS-1568369$ES-TEVA-VS-3244208$TEVA$$58$YR$$M$Y$$$20240920$$MD$ES$ES
243449921$24344992$1$I$$20240906$20240920$20240920$EXP$$JP-OTSUKA-2024_025273$OTSUKA$$$$$M$Y$$$20240920$$CN$JP$JP
243449931$24344993$1$I$$20240912$20240920$20240920$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-146980$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240920$$MD$GB$GB
243449941$24344994$1$I$20240901$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148784$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240920$$CN$US$US
243449951$24344995$1$I$20240907$20240917$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149736$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240920$$CN$US$US
243449961$24344996$1$I$$20240918$20240920$20240920$EXP$$JP-SANDOZ INC.-SDZ2024JP081836$SANDOZ$$75$YR$$F$Y$$$20240920$$CN$JP$JP
243449971$24344997$1$I$$20240916$20240920$20240920$EXP$$IE-TAKEDA-2024TUS092572$TAKEDA$$$$$$Y$$$20240920$$CN$IE$IE
243449981$24344998$1$I$$20240913$20240920$20240920$EXP$$IN-ABBVIE-5930239$ABBVIE$Gupta A, Garg N, Jain AK. Comparison of Isoflurane and Sevoflurane in Cardiac Surgery: A comparative trial. J Cardiovasc Dis Res. 2024;15(8):1631-1636.$$$A$$Y$$$20240920$$MD$IN$IN
243450001$24345000$1$I$20240911$20240911$20240920$20240920$EXP$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000091$Unknown Manufacturer$$$$$$Y$$$20240920$$CN$US$US
243450021$24345002$1$I$20240830$20240830$20240920$20240920$PER$$US-SA-2024SA269034$SANOFI AVENTIS$$$$$F$Y$65$KG$20240920$$PH$US$US
243450031$24345003$1$I$20240901$20240906$20240920$20240920$EXP$$US-SA-2024SA268320$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240920$$CN$US$US
243450041$24345004$1$I$$20240917$20240920$20240920$EXP$$IL-TEVA-VS-3245377$TEVA$$68$YR$$F$Y$$$20240920$$MD$IL$IL
243450051$24345005$1$I$$20240905$20240920$20240920$EXP$$CA-BAXTER-2024BAX024446$BAXTER$$$$$F$Y$$$20240920$$HP$CA$CA
243450061$24345006$1$I$$20240917$20240920$20240920$PER$$NVSC2024US187272$NOVARTIS$$$$$F$Y$$$20240920$$HP$US$US
243450071$24345007$1$I$$20240918$20240920$20240920$PER$$US-ABBVIE-5930661$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243450081$24345008$1$I$$20240916$20240920$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001898$BLUEPRINT MEDICINES$$$$$M$Y$$$20240920$$CN$US$US
243450091$24345009$1$I$$20240916$20240920$20240920$EXP$$US-GILEAD-2020-0476280$GILEAD$$$$A$M$Y$$$20240920$$CN$US$US
243450101$24345010$1$I$$20240917$20240920$20240920$PER$$US-ABBVIE-5928611$ABBVIE$$$$$$Y$$$20240920$$CN$US$US
243450121$24345012$1$I$20240101$20240912$20240920$20240920$EXP$$US-SA-2024SA272219$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240920$$HP$US$US
243450131$24345013$1$I$$20240918$20240920$20240920$PER$$US-009507513-2409USA006787$MERCK$$$$$M$Y$74.83$KG$20240920$$CN$US$US
243450141$24345014$1$I$$20240917$20240920$20240920$EXP$$US-SANDOZ INC.-SDZ2024US081351$SANDOZ$Singh, Gagandeep, Canton, et al. Probable chlorthalidone-induced hypokalemic rhabdomyolysis. Journal of the American Pharmacists Association : JAPhA. 2024;102249$52$YR$$M$Y$79.4$KG$20240920$$HP$US$US
243450151$24345015$1$I$20240622$20240917$20240920$20240920$EXP$FR-AFSSAPS-TS2024000972$FR-009507513-2409FRA005931$MERCK$$67$YR$$F$Y$$$20240920$$MD$FR$FR
243450161$24345016$1$I$$20240917$20240920$20240920$EXP$$NVSC2024CA187455$NOVARTIS$$$$$F$Y$$$20240920$$MD$CA$CA
243450171$24345017$1$I$$20240916$20240920$20240920$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005163$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243450181$24345018$1$I$$20240911$20240920$20240920$PER$$US-EMD Serono-2024048963$EMD SERONO INC$$$$$M$Y$$$20240920$$HP$US$US
243450191$24345019$1$I$$20240913$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409009276$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243450211$24345021$1$I$$20240916$20240920$20240920$EXP$GB-MHRA-MED-202409151201171240-KSTMV$GB-ELI_LILLY_AND_COMPANY-GB202409010354$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$GB$GB
243450221$24345022$1$I$$20240917$20240920$20240920$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202407011784$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$BR$BR
243450231$24345023$1$I$20240827$20240909$20240920$20240920$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409005968$ELI LILLY AND CO$$44$YR$A$F$Y$75$KG$20240920$$CN$GB$GB
243450241$24345024$1$I$$20240910$20240920$20240920$EXP$GB-MHRA-MED-202409100955529690-RSHFW$GB-ELI_LILLY_AND_COMPANY-GB202409006960$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$GB$GB
243450251$24345025$1$I$$20240909$20240920$20240920$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202406014226$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240920$$CN$BR$BR
243450261$24345026$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011735$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240920$$CN$US$US
243450271$24345027$1$I$$20240916$20240920$20240920$EXP$$CA-PERRIGO-24CA008813$PERRIGO$$85$YR$$F$Y$$$20240920$$PH$CA$CA
243450281$24345028$1$I$$20240912$20240920$20240920$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409008644$ELI LILLY AND CO$$$$$M$Y$$$20240920$$CN$BR$BR
243450291$24345029$1$I$20240910$20240910$20240920$20240920$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202409007388$ELI LILLY AND CO$$$$$F$Y$$$20240920$$MD$AE$AE
243450301$24345030$1$I$$20240911$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409007678$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240920$$CN$US$US
243450311$24345031$1$I$$20240910$20240920$20240920$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409007160$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240920$$CN$JP$JP
243450322$24345032$2$F$$20240923$20240920$20240926$EXP$$TR-ELI_LILLY_AND_COMPANY-TR202409010154$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240926$$CN$TR$TR
243450331$24345033$1$I$$20240910$20240920$20240920$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202409007748$ELI LILLY AND CO$$$$$F$Y$$$20240920$$MD$AE$AE
243450341$24345034$1$I$$20240910$20240920$20240920$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202409007348$ELI LILLY AND CO$$$$$F$Y$$$20240920$$MD$AE$AE
243450351$24345035$1$I$$20240910$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409006791$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240920$$CN$US$US
243450361$24345036$1$I$20230101$20240911$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409007316$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243450371$24345037$1$I$20240910$20240910$20240920$20240920$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202409007399$ELI LILLY AND CO$$$$$F$Y$$$20240920$$MD$AE$AE
243450381$24345038$1$I$20240908$20240910$20240920$20240920$EXP$$US-ELI_LILLY_AND_COMPANY-US202409007309$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240920$$CN$US$US
243450391$24345039$1$I$$20240910$20240920$20240920$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202409007635$ELI LILLY AND CO$$$$$F$Y$$$20240920$$MD$AE$AE
243450402$24345040$2$F$$20240916$20240920$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409011173$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240927$$CN$US$US
243450411$24345041$1$I$20240902$20240910$20240920$20240920$EXP$GB-MHRA-MED-202409100924177930-VTLKW$GB-ELI_LILLY_AND_COMPANY-GB202409006851$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240920$$CN$GB$GB
243450421$24345042$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010868$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240920$$CN$US$US
243450431$24345043$1$I$$20240910$20240920$20240920$EXP$GB-MHRA-MED-202409100938408450-CZBLK$GB-ELI_LILLY_AND_COMPANY-GB202409006953$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$GB$GB
243450441$24345044$1$I$20231001$20240918$20240920$20240920$EXP$$RU-ABBVIE-5930994$ABBVIE$$23$YR$$F$Y$$$20240920$$MD$RU$RU
243450451$24345045$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149615$BRISTOL MYERS SQUIBB$$84$YR$E$$Y$$$20240920$$PH$US$US
243450461$24345046$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149638$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240920$$CN$US$US
243450471$24345047$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148384$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240920$$CN$US$US
243450481$24345048$1$I$$20240912$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147762$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$79.83$KG$20240920$$CN$US$US
243450491$24345049$1$I$$20240916$20240920$20240920$EXP$$BR-JNJFOC-20240948259$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$CN$BR$BR
243450501$24345050$1$I$$20240911$20240920$20240920$PER$$US-JNJFOC-20240934905$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243450511$24345051$1$I$20240801$20240905$20240920$20240920$EXP$$US-RADIUS HEALTH INC.-2024US007007$RADIUS PHARM$$84$YR$$F$Y$$$20240920$$CN$US$US
243450521$24345052$1$I$$20240916$20240920$20240920$PER$$NVSC2024US185578$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243450531$24345053$1$I$$20240916$20240920$20240920$PER$$NVSC2024US185569$NOVARTIS$$$$$$Y$$$20240920$$MD$US$US
243450541$24345054$1$I$$20240919$20240920$20240920$EXP$$IT-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005206$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240920$$MD$IT$IT
243450551$24345055$1$I$$20240911$20240920$20240920$30DAY$$US-GSK-US2024113175$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243450562$24345056$2$F$$20240917$20240920$20240927$EXP$$CA-HLS-202402269$HLS THERAPEUTICS$$$$A$F$Y$$$20240927$$HP$CA$CA
243450571$24345057$1$I$$20240913$20240920$20240920$PER$$US-VERTEX PHARMACEUTICALS-2024-014699$VERTEX$$$$$F$Y$$$20240920$$CN$US$US
243450581$24345058$1$I$$20240917$20240920$20240920$EXP$$US-TAKEDA-2024TUS092945$TAKEDA$$$$$M$Y$$$20240920$$HP$US$US
243450591$24345059$1$I$20240729$20240913$20240920$20240920$EXP$$DE-AMRYT PHARMACEUTICALS DAC-AEGR007302$AEGERION$$$$$$Y$$$20240920$$MD$DE$DE
243450601$24345060$1$I$$20240917$20240920$20240920$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000805$DECIPHERA PHARMACEUTICALS$$83$YR$E$M$Y$$$20240920$$HP$US$US
243450611$24345061$1$I$20240901$20240913$20240920$20240920$PER$$US-SA-2024SA168397$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240920$$MD$US$US
243450631$24345063$1$I$20240101$20240913$20240920$20240920$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000806$DECIPHERA PHARMACEUTICALS$$62$YR$A$M$Y$$$20240920$$CN$US$US
243450641$24345064$1$I$20240101$20240906$20240920$20240920$EXP$$US-UCBSA-2024045792$UCB$$$$$F$Y$$$20240920$$CN$US$US
243450651$24345065$1$I$$20240918$20240920$20240920$EXP$$JP-ABBVIE-5929989$ABBVIE$$83$YR$$F$Y$$$20240920$$MD$JP$JP
243450662$24345066$2$F$20240401$20240920$20240920$20240924$EXP$$NVSC2024GB187428$NOVARTIS$$$$$$Y$$$20240924$$CN$GB$GB
243450671$24345067$1$I$$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148987$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$93.44$KG$20240920$$CN$US$US
243450681$24345068$1$I$20240822$20240920$20240920$20240920$EXP$FR-AFSSAPS-AN2024001264$NVSC2024FR187757$NOVARTIS$$51$YR$$M$Y$$$20240920$$MD$FR$FR
243450691$24345069$1$I$20240101$20240909$20240920$20240920$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000787$DECIPHERA PHARMACEUTICALS$$64$YR$A$M$Y$$$20240920$$CN$US$US
243450711$24345071$1$I$$20240913$20240920$20240920$EXP$$US-BIOVITRUM-2024-US-012080$BIOVITRUM$Henderson LA, Aires BP, Wobma H, Samad A, Chandler MT, Chang MH, et al. Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease. Journal of Rheumatology. 2024 Jul 15;51(8): 811-817. doi:10.3899/jrheum.2024-0180.$15$MON$$F$Y$$$20240920$$MD$US$US
243450741$24345074$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688280$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243450761$24345076$1$I$$20240823$20240920$20240920$EXP$$PT-BEH-2024177629$CSL BEHRING$$$$E$$Y$$$20240920$$HP$PT$PT
243450791$24345079$1$I$20240801$20240826$20240920$20240920$PER$$US-SA-2024SA266664$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240920$$MD$US$US
243450801$24345080$1$I$$20240905$20240920$20240920$PER$$US-SA-2024SA272340$SANOFI AVENTIS$$$$A$M$Y$$$20240920$$MD$US$US
243450813$24345081$3$F$$20240925$20240920$20240927$PER$$NVSC2024US184877$NOVARTIS$$$$$$Y$$$20240927$$CN$US$US
243450821$24345082$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688293$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243450831$24345083$1$I$20240824$20240911$20240920$20240920$EXP$$CN-Blueprint Medicines Corporation-SP-CN-2024-001911$BLUEPRINT MEDICINES$$29$YR$A$F$Y$62$KG$20240920$$HP$CN$CN
243450841$24345084$1$I$$20240912$20240920$20240920$PER$$US-ABBVIE-5922429$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243450851$24345085$1$I$20210301$20240916$20240920$20240920$EXP$$RO-FreseniusKabi-FK202413876$FRESENIUS KABI$$79$YR$E$M$Y$$$20240920$$MD$RO$RO
243450861$24345086$1$I$20240728$20240916$20240920$20240920$EXP$FR-AFSSAPS-PV2024000868$FR-FreseniusKabi-FK202414015$FRESENIUS KABI$$56$YR$A$M$Y$70$KG$20240920$$MD$FR$FR
243450871$24345087$1$I$$20240905$20240920$20240920$PER$$US-USAntibiotics-000335$USAntibiotics$$71$YR$E$M$Y$$$20240918$$CN$US$
243450881$24345088$1$I$$20240827$20240920$20240920$PER$$US-USAntibiotics-000336$USAntibiotics$$$$$F$Y$$$20240919$$HP$US$US
243450891$24345089$1$I$20240701$20240906$20240920$20240920$PER$$US-USAntibiotics-000334$USAntibiotics$$35$YR$A$F$Y$61.7$KG$20240919$$CN$US$
243450901$24345090$1$I$$20240917$20240920$20240920$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001895$BLUEPRINT MEDICINES$$$$$F$Y$$$20240920$$CN$US$US
243450911$24345091$1$I$20220101$20240903$20240920$20240920$PER$$US-TEVA-VS-3239957$TEVA$$$$$F$Y$$$20240920$$CN$US$US
243450921$24345092$1$I$20240801$20240911$20240920$20240920$PER$$US-USAntibiotics-000337$USAntibiotics$$$$$F$Y$$$20240919$$CN$US$US
243450931$24345093$1$I$20240830$20240918$20240920$20240920$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052181$BOEHRINGER INGELHEIM$$84$YR$E$F$Y$50$KG$20240920$$HP$CN$CN
243450951$24345095$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688295$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243450961$24345096$1$I$$20240918$20240920$20240920$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052484$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240920$$CN$US$US
243450971$24345097$1$I$20240801$20240918$20240920$20240920$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052457$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240920$$CN$US$US
243450981$24345098$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688294$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243450991$24345099$1$I$$20240910$20240920$20240920$PER$$US-JNJFOC-20240927240$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243451001$24345100$1$I$$20240916$20240920$20240920$EXP$$NVSC2024CL041443$NOVARTIS$$35$YR$$F$Y$$$20240920$$CN$CL$CL
243451011$24345101$1$I$$20240830$20240920$20240920$PER$$US-SA-2024SA268029$SANOFI AVENTIS$$25$YR$A$F$Y$65$KG$20240920$$MD$US$US
243451021$24345102$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267170$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240920$$CN$US$US
243451031$24345103$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187185$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243451041$24345104$1$I$$20240912$20240920$20240920$PER$$US-AMGEN-USASP2024186379$AMGEN$$75$YR$E$F$Y$$$20240920$$HP$US$US
243451051$24345105$1$I$20240819$20240912$20240920$20240920$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-015650$JAZZ$$76$YR$$F$Y$$$20240920$$PH$JP$JP
243451062$24345106$2$F$20240827$20240924$20240920$20240927$EXP$$JP-ARGENX-2024-ARGX-JP007999AA$ARGENX BVBA$$$$$$Y$$$20240927$$PH$JP$JP
243451081$24345108$1$I$$20240919$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012542$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240920$$CN$US$US
243451091$24345109$1$I$20240918$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011800$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240920$$CN$US$US
243451101$24345110$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012490$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240920$$CN$US$US
243451111$24345111$1$I$$20240919$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012810$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240920$$CN$US$US
243451131$24345113$1$I$20240327$20240910$20240920$20240920$EXP$$US-GSK-US2024112602$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20240920$$CN$US$US
243451151$24345115$1$I$$20240911$20240920$20240920$PER$$US-ABBVIE-5922975$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243451162$24345116$2$F$$20240919$20240920$20240923$PER$$NVSC2024US188128$NOVARTIS$$67$YR$$M$Y$$$20240923$$MD$US$US
243451171$24345117$1$I$$20240919$20240920$20240920$PER$$NVSC2024US187906$NOVARTIS$$$$$$Y$$$20240920$$CN$US$US
243451181$24345118$1$I$20240601$20240906$20240920$20240920$EXP$$US-SA-2024SA271616$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240920$$HP$US$US
243451191$24345119$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688263$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243451201$24345120$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688262$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243451211$24345121$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688276$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243451261$24345126$1$I$$20240910$20240920$20240920$EXP$$US-Alcon Laboratories-ALC2024US004205$ALCON$$$$$F$Y$$$20240920$$HP$US$US
243451271$24345127$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149272$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240920$$HP$US$US
243451281$24345128$1$I$$20240912$20240920$20240920$EXP$$CA-JNJFOC-20240924179$JOHNSON AND JOHNSON$$$$E$F$Y$47$KG$20240920$$HP$CA$CA
243451291$24345129$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688278$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243451301$24345130$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688277$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243451311$24345131$1$I$$20240919$20240920$20240920$EXP$$NVSC2024GR187072$NOVARTIS$Alexandratou A, Ntimenou S, Tsoukra P, Melita S, Oikonomou A, Panourgia M et al. Multiple sclerosis and parkinsonism: accidental or causal coexistence?. 35th PANHELLENIC CONGRESS ON NEUROLOGY$51$YR$$F$Y$$$20240920$$HP$GR$GR
243451321$24345132$1$I$$20240918$20240920$20240920$EXP$$SA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052323$BOEHRINGER INGELHEIM$$47$YR$A$M$Y$$$20240920$$HP$SA$SA
243451331$24345133$1$I$20240911$20240912$20240920$20240920$PER$$NVSC2024US184511$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
243451341$24345134$1$I$$20240908$20240920$20240920$EXP$$CA-NOVOPROD-1285032$NOVO NORDISK$$$$$$Y$$$20240920$$CN$CA$CA
243451351$24345135$1$I$$20240911$20240920$20240920$PER$$US-BAYER-2024A130418$BAYER$$$$C$$Y$$$20240920$$CN$US$US
243451371$24345137$1$I$$20240509$20240920$20240920$30DAY$$CL-PFIZER INC-202400260653$PFIZER$$$$$$Y$$$20240920$$CN$CL$CL
243451382$24345138$2$F$20240802$20240919$20240920$20240926$EXP$DE-AMK-280194$DE-009507513-2409DEU006661$MERCK$$49$YR$$F$Y$63$KG$20240926$$PH$DE$DE
243451391$24345139$1$I$$20240913$20240920$20240920$EXP$$US-AMGEN-USASP2024183839$AMGEN$$$$E$F$Y$$$20240920$$CN$US$US
243451401$24345140$1$I$$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024186381$AMGEN$$$$$$Y$$$20240920$$PH$US$US
243451411$24345141$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149997$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240920$$CN$US$US
243451421$24345142$1$I$20240715$20240911$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145560$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$76$KG$20240920$$PH$US$US
243451441$24345144$1$I$20240901$20240918$20240920$20240920$EXP$$NVSC2024US186807$NOVARTIS$$60$YR$$M$Y$$$20240920$$CN$US$US
243451451$24345145$1$I$$20240917$20240920$20240920$EXP$$NVSC2024US187046$NOVARTIS$$$$$F$Y$$$20240920$$CN$US$US
243451461$24345146$1$I$20240701$20240913$20240920$20240920$EXP$$NVSC2024CN184858$NOVARTIS$$31$YR$$M$Y$$$20240920$$HP$CN$CN
243451471$24345147$1$I$20240101$20240916$20240920$20240920$EXP$$US-ABBVIE-5927317$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243451481$24345148$1$I$20240913$20240920$20240920$20240920$DIR$719168$$FDA-CTU$$41$YR$$M$N$87.75$KG$20240920$Y$CN$US$
243451491$24345149$1$I$20240901$20240917$20240920$20240920$EXP$$US-ABBVIE-5930146$ABBVIE$$96$YR$$F$Y$$$20240920$$CN$US$US
243451502$24345150$2$F$20240101$20240912$20240920$20240924$EXP$$US-SA-2024SA271779$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240924$$MD$US$US
243451511$24345151$1$I$20240823$20240823$20240920$20240920$PER$$US-CSL-2024-007839$CSL Plasma$$32$YR$$F$Y$$$20240920$$HP$US$US
243451521$24345152$1$I$20230101$20240906$20240920$20240920$EXP$$US-SA-2024SA272324$SANOFI AVENTIS$$$$E$M$Y$$$20240920$$CN$US$US
243451531$24345153$1$I$$20240917$20240920$20240920$EXP$$US-SA-2024SA270780$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240920$$HP$US$US
243451541$24345154$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA267181$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240920$$HP$US$US
243451551$24345155$1$I$20240801$20240903$20240920$20240920$PER$$US-SA-2024SA270536$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240920$$MD$US$US
243451561$24345156$1$I$20240905$20240905$20240920$20240920$PER$$US-SA-2024SA265639$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240920$$CN$US$US
243451571$24345157$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268787$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240920$$MD$US$US
243451581$24345158$1$I$$20240905$20240920$20240920$PER$$US-SA-2024SA272354$SANOFI AVENTIS$$$$E$F$Y$$$20240920$$MD$US$US
243451591$24345159$1$I$$20240916$20240920$20240920$30DAY$$CL-PFIZER INC-PV202400121339$PFIZER$$12$YR$$M$Y$$$20240920$$CN$CL$CL
243451611$24345161$1$I$$20240916$20240920$20240920$30DAY$$DO-PFIZER INC-PV202400121623$PFIZER$$14$YR$$M$Y$$$20240920$$CN$DO$DO
243451621$24345162$1$I$$20240911$20240920$20240920$30DAY$$CO-PFIZER INC-PV202400119866$PFIZER$$$$$$Y$$$20240920$$CN$CO$CO
243451632$24345163$2$F$20240913$20240926$20240920$20240926$30DAY$$US-PFIZER INC-PV202400121555$PFIZER$$$$$M$Y$$$20240926$$CN$US$US
243451641$24345164$1$I$$20240918$20240920$20240920$EXP$$NVSC2024IT186424$NOVARTIS$Fassi E, Amoroso V, Cosentini D, Ferrari V, Lagana M, Berruti A, et al.. Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report. FRONTIERS IN ONCOLOGY. 2024;14(0)$52$YR$$F$Y$$$20240920$$HP$IT$IT
243451651$24345165$1$I$20240913$20240913$20240920$20240920$EXP$$AU-TAKEDA-2024TUS092410$TAKEDA$$29$YR$$F$Y$$$20240920$$CN$AU$AU
243451661$24345166$1$I$20240906$20240906$20240920$20240920$EXP$GB-MHRA-MED-202409061544599670-PLZWY$GB-BAXTER-2024BAX024402$BAXTER$$64$YR$$F$Y$57$KG$20240920$$CN$GB$GB
243451671$24345167$1$I$$20240918$20240920$20240920$EXP$AU-TGA-0000817011$AU-SANDOZ INC.-SDZ2024AU081478$SANDOZ$$$$$$Y$$$20240920$$CN$AU$AU
243451681$24345168$1$I$$20240910$20240920$20240920$EXP$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000090$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243451691$24345169$1$I$20240716$20240919$20240920$20240920$EXP$CZ-CZSUKL-24002592$CZ-BRISTOL-MYERS SQUIBB COMPANY-2024-149871$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$61$KG$20240920$$PH$CZ$CZ
243451702$24345170$2$F$20230401$20240910$20240920$20240925$EXP$$CO-OTSUKA-2024_025682$OTSUKA$$$$$$Y$$$20240925$$CN$CO$CO
243451711$24345171$1$I$20240916$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186950$AMGEN$$79$YR$E$M$Y$$$20240920$$CN$US$US
243451721$24345172$1$I$$20240912$20240920$20240920$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006855$BIOCON$$$$$$Y$$$20240920$$HP$CA$CA
243451741$24345174$1$I$$20240920$20240920$20240920$DIR$719176$$FDA-CTU$$$$$M$N$74.25$KG$20240920$N$CN$US$
243451751$24345175$1$I$20240705$20240920$20240920$20240920$DIR$719214$$FDA-CTU$$35$YR$$M$N$130.5$KG$20240920$N$HP$US$
243451761$24345176$1$I$$20240917$20240920$20240920$PER$$US-BAYER-2024A133234$BAYER$$$$$$Y$$$20240920$$CN$US$US
243451771$24345177$1$I$20240101$20240916$20240920$20240920$EXP$IT-MINISAL02-1001500$IT-TEVA-VS-3244113$TEVA$$67$YR$$F$Y$$$20240920$$MD$IT$IT
243451781$24345178$1$I$$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010276$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240920$$CN$US$US
243451791$24345179$1$I$20240915$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011692$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243451801$24345180$1$I$20240918$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011768$ELI LILLY AND CO$$47$YR$A$$Y$$$20240920$$CN$US$US
243451811$24345181$1$I$$20240919$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012551$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243451821$24345182$1$I$20240920$20240920$20240920$20240920$DIR$719219$$FDA-CTU$$$$$UNK$N$$$20240920$N$CN$US$
243451831$24345183$1$I$20240919$20240920$20240920$20240920$DIR$719208$$FDA-CTU$$50$YR$$F$N$$$20240920$N$HP$US$
243451841$24345184$1$I$$20240918$20240920$20240920$EXP$$NVSC2024US187170$NOVARTIS$$$$$F$Y$108$KG$20240920$$MD$US$US
243451851$24345185$1$I$20240816$20240913$20240920$20240920$EXP$$US-OTSUKA-2024_025861$OTSUKA$$18$YR$$F$Y$$$20240920$$CN$US$US
243451861$24345186$1$I$20240826$20240917$20240920$20240920$EXP$$CO-ABBVIE-5930511$ABBVIE$$82$YR$$M$Y$$$20240920$$CN$CO$CO
243451871$24345187$1$I$20240827$20240913$20240920$20240920$EXP$$CN-JNJFOC-20240939102$JOHNSON AND JOHNSON$$51$YR$A$F$Y$50$KG$20240920$$HP$CN$CN
243451891$24345189$1$I$20240901$20240905$20240920$20240920$PER$$US-KARYOPHARM-2024KPT001516$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240920$$CN$US$US
243451901$24345190$1$I$20240916$20240920$20240920$20240920$DIR$719193$$FDA-CTU$$60$YR$$M$N$$$20240920$N$HP$US$
243451921$24345192$1$I$20220616$20240918$20240920$20240920$EXP$FR-AFSSAPS-MA2024001463$FR-009507513-2409FRA006554$MERCK$$43$YR$$F$Y$$$20240920$$CN$FR$FR
243451941$24345194$1$I$20221125$20240916$20240920$20240920$EXP$FR-AFSSAPS-AVPO2024000173$FR-INDIVIOR UK LIMITED-INDV-156467-2024$RECKITT BENCKISER$$$$$$Y$$$20240920$$MD$FR$FR
243451951$24345195$1$I$20240201$20240911$20240920$20240920$EXP$FR-AFSSAPS-AVGR2024000154$FR-INDIVIOR UK LIMITED-INDV-156417-2024$RECKITT BENCKISER$$$$$$Y$$$20240920$$PH$FR$FR
243451961$24345196$1$I$20240525$20240917$20240920$20240920$EXP$FR-AFSSAPS-AVMA2024000421$FR-INDIVIOR UK LIMITED-INDV-156471-2024$RECKITT BENCKISER$$$$$$Y$$$20240920$$PH$FR$FR
243451971$24345197$1$I$20240909$20240917$20240920$20240920$EXP$$JP-PFIZER INC-PV202400121723$PFIZER$$$$$$Y$$$20240920$$MD$JP$JP
243451991$24345199$1$I$20240829$20240914$20240920$20240920$PER$$CN-Eisai-EC-2024-174435$EISAI$$28$YR$A$F$Y$$$20240920$$HP$CN$CN
243452001$24345200$1$I$$20240912$20240920$20240920$30DAY$$US-GSK-US2024113532$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$HP$US$US
243452011$24345201$1$I$20240830$20240906$20240920$20240920$EXP$GB-MHRA-MED-202409061627013810-RJLVN$GB-BAXTER-2024BAX024407$BAXTER$$78$YR$$F$Y$$$20240920$$PH$GB$GB
243452031$24345203$1$I$20240101$20240914$20240920$20240920$PER$$US-JNJFOC-20240943481$JOHNSON AND JOHNSON$$58$YR$A$F$Y$65.8$KG$20240920$$CN$US$US
243452051$24345205$1$I$$20240912$20240920$20240920$EXP$$US-SA-2024SA271267$SANOFI AVENTIS$$$$$F$Y$$$20240920$$HP$US$US
243452061$24345206$1$I$$20240916$20240920$20240920$EXP$$US-OTSUKA-2024_025932$OTSUKA$$$$$F$Y$$$20240920$$HP$US$US
243452071$24345207$1$I$$20240911$20240920$20240920$PER$$US-SA-2024SA270393$SANOFI AVENTIS$$$$A$F$Y$63.64$KG$20240920$$MD$US$US
243452081$24345208$1$I$$20240912$20240920$20240920$EXP$$GB-TAKEDA-2023TUS087433$TAKEDA$$$$$F$Y$$$20240920$$CN$GB$GB
243452091$24345209$1$I$$20240912$20240920$20240920$PER$$US-SA-2024SA267096$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240920$$HP$US$US
243452101$24345210$1$I$20240916$20240916$20240920$20240920$PER$$US-SA-2024SA271054$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240920$$MD$US$US
243452111$24345211$1$I$20240101$20240913$20240920$20240920$EXP$$US-TEVA-VS-3244358$TEVA$$51$YR$$F$Y$$$20240920$$CN$US$US
243452121$24345212$1$I$$20240916$20240920$20240920$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-148661$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240920$$MD$FR$FR
243452131$24345213$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149513$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240920$$HP$US$US
243452141$24345214$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148543$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240920$$CN$US$US
243452151$24345215$1$I$20221102$20240917$20240920$20240920$EXP$$PH-PFIZER INC-PV202400121901$PFIZER$$56$YR$$F$Y$48$KG$20240920$$MD$PH$PH
243452161$24345216$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149595$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240920$$HP$US$US
243452171$24345217$1$I$$20240911$20240920$20240920$PER$$US-HALEON-2196728$Haleon PLC$$$$$$Y$$$20240920$$CN$US$US
243452181$24345218$1$I$$20240918$20240920$20240920$PER$$US-HALEON-2197604$Haleon PLC$$$$$$Y$$$20240920$$CN$US$US
243452191$24345219$1$I$20240606$20240918$20240920$20240920$EXP$$CN-ABBVIE-5902347$ABBVIE$$39$YR$$F$Y$110$KG$20240920$$MD$CN$CN
243452211$24345221$1$I$$20240910$20240920$20240920$EXP$$CA-TEVA-VS-3245376$TEVA$$44$YR$$F$Y$60$KG$20240920$$MD$CA$CA
243452221$24345222$1$I$20240901$20240913$20240920$20240920$PER$$US-ABBVIE-5925067$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243452231$24345223$1$I$$20240917$20240920$20240920$PER$$NVSC2024US188151$NOVARTIS$$$$$M$Y$$$20240920$$MD$US$US
243452241$24345224$1$I$$20240918$20240920$20240920$EXP$$NVSC2024GB187838$NOVARTIS$$$$$$Y$$$20240920$$CN$GB$GB
243452251$24345225$1$I$$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024186399$AMGEN$$$$$$Y$$$20240920$$HP$US$US
243452262$24345226$2$F$$20240917$20240920$20240930$PER$$US-AMGEN-USASP2024186356$AMGEN$$$$$F$Y$$$20240930$$CN$US$US
243452271$24345227$1$I$$20240913$20240920$20240920$EXP$$US-SA-2024SA270163$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$HP$US$US
243452281$24345228$1$I$20240820$20240911$20240920$20240920$EXP$IT-MINISAL02-990434$IL-Taiho Oncology Inc-2024-008273$TAIHO ONCOLOGY INC$$63$YR$A$M$Y$$$20240920$$CN$IL$IL
243452291$24345229$1$I$20240601$20240913$20240920$20240920$EXP$$US-SA-2024SA270794$SANOFI AVENTIS$$9$YR$C$F$Y$29.02$KG$20240920$$MD$US$US
243452301$24345230$1$I$$20240919$20240920$20240920$PER$$US-AMGEN-USASP2024188075$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243452311$24345231$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149567$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240920$$HP$US$US
243452321$24345232$1$I$20240101$20240822$20240920$20240920$PER$$US-Eisai-EC-2024-172765$EISAI$$72$YR$E$F$Y$$$20240920$$CN$US$US
243452331$24345233$1$I$$20240920$20240920$20240920$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052603$BOEHRINGER INGELHEIM$$$$$$Y$$$20240920$$MD$US$US
243452341$24345234$1$I$20240905$20240913$20240920$20240920$EXP$ES-AEMPS-1568400$ES-Amarin Pharma, Inc-2024AMR000474$AMARIN$$73$YR$E$M$Y$75$KG$20240920$$MD$ES$ES
243452351$24345235$1$I$$20240912$20240920$20240920$EXP$$US-RDY-SPO/USA/24/0013720$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$57$YR$A$$Y$$$20240920$$MD$US$US
243452361$24345236$1$I$20240902$20240911$20240920$20240920$EXP$$JP-SA-2024SA272371$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240920$$HP$JP$JP
243452371$24345237$1$I$$20240913$20240920$20240920$EXP$$GB-JNJFOC-20240955116$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240920$$CN$GB$GB
243452381$24345238$1$I$$20240909$20240920$20240920$PER$$US-ASTELLAS-2024-AER-005826$ASTELLAS$$$$$F$Y$$$20240920$$HP$US$US
243452401$24345240$1$I$$20240919$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149647$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240920$$CN$US$US
243452422$24345242$2$F$$20240918$20240920$20240925$EXP$$AU-SANDOZ INC.-SDZ2024AU081138$SANDOZ$$$$A$F$Y$$$20240925$$MD$AU$AU
243452431$24345243$1$I$$20240918$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149350$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240920$$CN$US$US
243452441$24345244$1$I$$20240919$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149804$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240920$$CN$US$US
243452451$24345245$1$I$$20240913$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147046$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$95.5$KG$20240920$$PH$US$US
243452462$24345246$2$F$20240916$20240918$20240920$20240925$EXP$$NVSC2024US186999$NOVARTIS$$46$YR$$M$Y$$$20240925$$CN$US$US
243452471$24345247$1$I$20161004$20240911$20240920$20240920$EXP$$NVSC2020CA310782$NOVARTIS$$37$YR$$M$Y$$$20240920$$MD$CA$CA
243452481$24345248$1$I$20240101$20240828$20240920$20240920$PER$$US-SA-2024SA267636$SANOFI AVENTIS$$24$YR$A$M$Y$117.9$KG$20240920$$MD$US$US
243452491$24345249$1$I$20240801$20240913$20240920$20240920$PER$$US-SA-2024SA267558$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240920$$HP$US$US
243452501$24345250$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688252$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243452511$24345251$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688250$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243452521$24345252$1$I$20220819$20240912$20240920$20240920$EXP$$US-JNJFOC-20240948186$JOHNSON AND JOHNSON$$20$YR$A$F$Y$94.886$KG$20240920$$HP$US$US
243452531$24345253$1$I$20240701$20240910$20240920$20240920$PER$$US-INCYTE CORPORATION-2024IN009572$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243452541$24345254$1$I$$20240906$20240920$20240920$PER$$US-INCYTE CORPORATION-2024IN009451$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243452551$24345255$1$I$$20240915$20240920$20240920$EXP$$AU-REGENERON PHARMACEUTICALS, INC.-2024-125192$REGENERON$$$$$$Y$$$20240920$$MD$AU$AU
243452561$24345256$1$I$20240830$20240910$20240920$20240920$EXP$GB-MHRA-MED-202409051256292140-SDBVF$GB-ASTELLAS-2024-AER-006202$ASTELLAS$$69$YR$E$M$Y$$$20240920$$HP$GB$GB
243452571$24345257$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688251$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243452581$24345258$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688279$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243452591$24345259$1$I$20240101$20240912$20240920$20240920$EXP$$US-TEVA-VS-3244501$TEVA$$22$YR$$M$Y$$$20240920$$HP$US$US
243452601$24345260$1$I$20240601$20240910$20240920$20240920$PER$$US-INCYTE CORPORATION-2024IN009570$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243452611$24345261$1$I$$20240919$20240920$20240920$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052523$BOEHRINGER INGELHEIM$$82$YR$E$M$Y$$$20240920$$PH$GB$GB
243452621$24345262$1$I$$20240916$20240920$20240920$PER$$US-ABBVIE-5930799$ABBVIE$$60$YR$$F$Y$$$20240920$$CN$US$US
243452631$24345263$1$I$$20240910$20240920$20240920$PER$$US-ASTELLAS-2024-AER-006158$ASTELLAS$$$$A$F$Y$$$20240920$$CN$US$US
243452641$24345264$1$I$$20240913$20240920$20240920$EXP$$US-GSK-US2024114199$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243452651$24345265$1$I$$20240915$20240920$20240920$PER$$US-GILEAD-2024-0688154$GILEAD$$$$$$Y$$$20240920$$HP$US$US
243452661$24345266$1$I$20240812$20240821$20240920$20240920$PER$$US-Eisai-EC-2024-172686$EISAI$$62$YR$A$M$Y$98.1$KG$20240920$$HP$US$US
243452671$24345267$1$I$20240820$20240822$20240920$20240920$PER$$US-Eisai-EC-2024-172768$EISAI$$73$YR$E$M$Y$$$20240920$$CN$US$US
243452681$24345268$1$I$20240101$20240822$20240920$20240920$PER$$US-Eisai-EC-2024-172797$EISAI$$$$$$Y$$$20240920$$MD$US$US
243452691$24345269$1$I$$20240822$20240920$20240920$PER$$US-Eisai-EC-2024-172726$EISAI$$$$$F$Y$$$20240920$$CN$US$US
243452711$24345271$1$I$20240819$20240822$20240920$20240920$PER$$US-Eisai-EC-2024-172783$EISAI$$71$YR$E$M$Y$$$20240920$$MD$US$US
243452721$24345272$1$I$20240903$20240912$20240920$20240920$EXP$$JP-TEVA-VS-3244550$TEVA$$$$E$F$Y$$$20240920$$MD$JP$JP
243452731$24345273$1$I$$20240919$20240920$20240920$PER$$NVSC2024US188050$NOVARTIS$$$$$F$Y$$$20240920$$HP$US$US
243452741$24345274$1$I$$20240917$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148922$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240920$$CN$US$US
243452761$24345276$1$I$20240907$20240912$20240920$20240920$EXP$$CN-Merck Healthcare KGaA-2024049151$MERCK KGAA$$74$YR$E$F$Y$49$KG$20240918$$HP$CN$CN
243452771$24345277$1$I$$20240918$20240920$20240920$EXP$$NVSC2024AT187378$NOVARTIS$$60$YR$$M$Y$$$20240920$$MD$AT$AT
243452781$24345278$1$I$20240703$20240918$20240920$20240920$EXP$FR-AFSSAPS-GR2024001066$FR-009507513-2409FRA006482$MERCK$$72$YR$$F$Y$$$20240920$$PH$FR$FR
243452791$24345279$1$I$$20240909$20240920$20240920$EXP$$JP-MEITHEAL-2024MPLIT00285$MEITHEAL PHARMACEUTICALS$K. Yamada et al..Takotsubo syndrome in a cancer patient treated  with a combination of anti-cancer drugs  including immune checkpoint inhibitors:  a case report.European Heart Journal-Case Reports.23-JUL-2024;8 (8):1-5$66$YR$A$F$Y$$$20240920$$HP$JP$JP
243452812$24345281$2$F$$20240919$20240920$20240925$PER$$US-AMGEN-USASP2024187866$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243452824$24345282$4$F$20240730$20240924$20240920$20240930$PER$$US-GILEAD-2024-0687871$GILEAD$$60$YR$A$M$Y$$$20240929$$CN$US$US
243452831$24345283$1$I$$20240916$20240920$20240920$PER$$US-SA-2024SA268798$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240920$$MD$US$US
243452841$24345284$1$I$20240101$20240903$20240920$20240920$PER$$US-SA-2024SA271044$SANOFI AVENTIS$$$$A$F$Y$$$20240920$$MD$US$US
243452851$24345285$1$I$20240830$20240903$20240920$20240920$PER$$US-SA-2024SA271511$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240920$$PH$US$US
243452861$24345286$1$I$20230301$20240917$20240920$20240920$EXP$$US-RVL_Pharmaceuticals-USA-POI1255202400212$RVL PHARMACEUTICALS$$60$YR$A$F$Y$63.56$KG$20240920$$$US$US
243452871$24345287$1$I$$20240912$20240920$20240920$EXP$$US-INCYTE CORPORATION-2024IN009713$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243452891$24345289$1$I$20240101$20240913$20240920$20240920$PER$$US-ABBVIE-5924025$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243452901$24345290$1$I$$20240909$20240920$20240920$EXP$$IL-MEITHEAL-2024MPLIT00287$MEITHEAL PHARMACEUTICALS$Liran R, et al..A Severe Acute Kidney Injury Following Zoledronic Acid Therapy Leading to Chronic Hemodialysis Treatment: A Case Report.Israel Medical Association Journal.DEC-2023;25 (1):828-9$78$YR$E$F$Y$$$20240920$$MD$IL$IL
243452911$24345291$1$I$20190101$20240913$20240920$20240920$EXP$$JP-ASTELLAS-2024-AER-007156$ASTELLAS$$$$$M$Y$$$20240920$$MD$JP$JP
243452921$24345292$1$I$$20240919$20240920$20240920$PER$$NVSC2024US188116$NOVARTIS$$$$$$Y$$$20240920$$MD$US$US
243452931$24345293$1$I$$20240919$20240920$20240920$PER$$NVSC2024US188133$NOVARTIS$$75$YR$$M$Y$$$20240920$$MD$US$US
243452951$24345295$1$I$20240901$20240917$20240920$20240920$30DAY$$AR-PFIZER INC-202400250863$PFIZER$$12$YR$$M$Y$$$20240920$$CN$AR$AR
243452961$24345296$1$I$$20240909$20240920$20240920$EXP$$CH-MEITHEAL-2024MPLIT00288$MEITHEAL PHARMACEUTICALS$Jandus P, et.al.Successful desensitization to etoposide in a patient after cardiac arrest.Journal of Oncology Pharmacy Practice.2024;1 (1):1-5$61$YR$A$F$Y$$$20240920$$HP$CH$CH
243452971$24345297$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013951$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240920$$CN$CA$CA
243452981$24345298$1$I$$20240823$20240920$20240920$EXP$$US-SANDOZ INC.-SDZ2024US081259$SANDOZ$$76$YR$$F$Y$$$20240920$$CN$US$US
243452991$24345299$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013944$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240920$$CN$CA$CA
243453001$24345300$1$I$$20240918$20240920$20240920$EXP$$GB-SANDOZ INC.-SDZ2023GB065285$SANDOZ$$$$$F$Y$$$20240920$$CN$GB$GB
243453011$24345301$1$I$$20240909$20240920$20240920$EXP$$JP-MEITHEAL-2024MPLIT00294$MEITHEAL PHARMACEUTICALS$Kamimura M, et al.Anthracyclines for acute promyelocytic leukemia in a female with congenital long QT syndrome.Pediatric Blood and Cancer.2023;70 (8):1-3$16$YR$T$F$Y$$$20240920$$HP$JP$JP
243453021$24345302$1$I$$20240910$20240920$20240920$30DAY$$US-GSK-US2024112643$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243453031$24345303$1$I$20240820$20240822$20240920$20240920$PER$$US-Eisai-EC-2024-172800$EISAI$$76$YR$E$F$Y$75.5$KG$20240920$$HP$US$US
243453041$24345304$1$I$20240905$20240916$20240920$20240920$EXP$$CN-SA-2024SA269657$SANOFI AVENTIS$$69$YR$E$F$Y$44$KG$20240920$$HP$CN$CN
243453051$24345305$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013976$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240920$$CN$CA$CA
243453061$24345306$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013981$BAUSCH AND LOMB$$54$YR$$F$Y$$$20240920$$CN$CA$CA
243453071$24345307$1$I$$20240919$20240920$20240920$PER$$NVSC2024US188109$NOVARTIS$$$$$$Y$$$20240920$$PH$US$US
243453081$24345308$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013966$BAUSCH AND LOMB$$71$YR$$F$Y$$$20240920$$CN$CA$CA
243453091$24345309$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013982$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240920$$CN$CA$CA
243453101$24345310$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013969$BAUSCH AND LOMB$$61$YR$$M$Y$$$20240920$$CN$CA$CA
243453111$24345311$1$I$20240814$20240913$20240920$20240920$EXP$$GR-KARYOPHARM-2024KPT001554$KARYOPHARM THERAPEUTICS$$78$YR$$M$Y$$$20240920$$CN$GR$GR
243453121$24345312$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013986$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240920$$CN$CA$CA
243453131$24345313$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013983$BAUSCH AND LOMB$$68$YR$$M$Y$$$20240920$$CN$CA$CA
243453142$24345314$2$F$$20240922$20240920$20240924$EXP$$MK-PFIZER INC-PV202400122826$PFIZER$$57$YR$$M$Y$$$20240924$$MD$MK$MK
243453151$24345315$1$I$20240101$20240906$20240920$20240920$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1640$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240920$$CN$US$US
243453161$24345316$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013990$BAUSCH AND LOMB$$47$YR$$M$Y$$$20240920$$CN$CA$CA
243453171$24345317$1$I$$20240917$20240920$20240920$EXP$$GB-TAKEDA-2024TUS093703$TAKEDA$$$$$F$Y$$$20240920$$CN$GB$GB
243453181$24345318$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149678$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240920$$CN$US$US
243453191$24345319$1$I$$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147000$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240920$$HP$US$US
243453201$24345320$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149340$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240920$$HP$US$US
243453211$24345321$1$I$$20240911$20240920$20240920$EXP$$US-GSK-US2024113064$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243453223$24345322$3$F$20240819$20240916$20240920$20240925$PER$$US-ASTELLAS-2024-AER-002038$ASTELLAS$$79$YR$E$F$Y$$$20240925$$MD$US$US
243453231$24345323$1$I$$20240909$20240920$20240920$EXP$$CN-ASTELLAS-2024-AER-000601$ASTELLAS$$12$YR$T$M$Y$$$20240920$$HP$CN$CN
243453241$24345324$1$I$20240716$20240910$20240920$20240920$PER$$US-ASTELLAS-2024-AER-006507$ASTELLAS$$96$YR$E$F$Y$$$20240920$$MD$US$US
243453251$24345325$1$I$$20240912$20240920$20240920$EXP$$BR-TAKEDA-2024TUS092383$TAKEDA$$$$$F$Y$$$20240920$$CN$BR$BR
243453261$24345326$1$I$$20240918$20240920$20240920$EXP$$US-TAKEDA-2024TUS093332$TAKEDA$$$$$M$Y$$$20240920$$CN$US$US
243453281$24345328$1$I$$20240918$20240920$20240920$EXP$$CA-ASTELLAS-2024-AER-007870$ASTELLAS$$$$$F$Y$34$KG$20240920$$HP$CA$CA
243453291$24345329$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013991$BAUSCH AND LOMB$$65$YR$$$Y$$$20240920$$CN$CA$CA
243453302$24345330$2$F$$20240916$20240920$20240925$EXP$$DE-JAZZ PHARMACEUTICALS-2024-DE-014895$JAZZ$$$$$$Y$$$20240925$$HP$DE$DE
243453311$24345331$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013998$BAUSCH AND LOMB$$58$YR$$F$Y$$$20240920$$CN$CA$CA
243453321$24345332$1$I$$20240913$20240920$20240920$EXP$$NL-AMGEN-NLDSP2024184009$AMGEN$Von Dem Borne P.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$A$$Y$$$20240920$$HP$NL$NL
243453331$24345333$1$I$20240401$20240913$20240920$20240920$EXP$$JP-ASTELLAS-2024JP002370$ASTELLAS$$8$DEC$E$M$Y$$$20240920$$MD$JP$JP
243453341$24345334$1$I$20240107$20240911$20240920$20240920$EXP$$US-GSK-US2024113062$GLAXOSMITHKLINE$$32$YR$$F$Y$$$20240920$$CN$US$US
243453351$24345335$1$I$20240708$20240911$20240920$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013506$UNITED THERAPEUTICS$$55$YR$$F$Y$147.85$KG$20240920$$$US$US
243453361$24345336$1$I$$20240912$20240920$20240920$EXP$$AT-DUCHESNAY-2024AT000368$DUCHESNAY$$$$$$Y$$$20240920$$MD$AT$AT
243453371$24345337$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-014024$BAUSCH AND LOMB$$63$YR$$F$Y$$$20240920$$CN$CA$CA
243453381$24345338$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-014007$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240920$$CN$CA$CA
243453391$24345339$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-014006$BAUSCH AND LOMB$$52$YR$$F$Y$$$20240920$$CN$CA$CA
243453411$24345341$1$I$$20240910$20240920$20240920$PER$$US-ASTELLAS-2024-AER-006540$ASTELLAS$$91$YR$E$F$Y$60$KG$20240920$$CN$US$US
243453431$24345343$1$I$$20240906$20240920$20240920$EXP$$US-MALLINCKRODT-MNK202405623$MALLINCKRODT$$$$$F$Y$$$20240920$$HP$US$US
243453441$24345344$1$I$$20240911$20240920$20240920$EXP$$CL-ASTELLAS-2024-AER-006575$ASTELLAS$$$$$F$Y$$$20240920$$CN$CL$CL
243453451$24345345$1$I$$20240911$20240920$20240920$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028808$UNITED THERAPEUTICS$$$$$F$Y$36.281$KG$20240920$$$US$US
243453461$24345346$1$I$20240904$20240919$20240920$20240920$EXP$$SG-MYLANLABS-2024M1085486$MYLAN$$72$YR$$$Y$$$20240920$$HP$SG$SG
243453471$24345347$1$I$20240906$20240906$20240920$20240920$PER$$US-BAUSCHBL-2024BNL033220$BAUSCH AND LOMB$$54$YR$$F$Y$$$20240920$$CN$US$US
243453481$24345348$1$I$$20240911$20240920$20240920$EXP$$PT-Ipsen Biopharmaceuticals, Inc.-2024-18590$IPSEN$$$$$F$Y$$$20240920$$CN$PT$PT
243453501$24345350$1$I$$20240823$20240920$20240920$PER$$US-SCIEGENP-2024SCSPO00361$SCIEGEN$$$$$$Y$$$20240920$$CN$US$US
243453511$24345351$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149884$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240920$$HP$US$US
243453521$24345352$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148967$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240920$$CN$US$US
243453531$24345353$1$I$$20240911$20240920$20240920$EXP$$FR-ASTELLAS-2024-AER-007020$ASTELLAS$Hamine S, Morel A. Extensive thigh pyomyositis secondary to cystic fistulae due to anaerobic-bacterial infection in a kidney transplant recipient. BMC Infectious Diseases. 2024;24(1): 1-4. doi:10.1186/s12879-024-09701-6.$84$YR$E$M$Y$$$20240920$$HP$FR$FR
243453541$24345354$1$I$$20240905$20240920$20240920$PER$$US-INCYTE CORPORATION-2024IN009415$INCYTE$$$$$$Y$$$20240920$$CN$US$US
243453551$24345355$1$I$20240219$20240918$20240920$20240920$EXP$$US-BIOMARINAP-US-2024-160681$BIOMARIN$$$$$$Y$$$20240920$$CN$US$US
243453561$24345356$1$I$20160101$20240911$20240920$20240920$EXP$$SK-TEVA-201907_00006322$TEVA$Mosnarova A, Dvoroznakova M.. Patients life with heart failure. When is it right time for action. Zdravotnicke Noviny Attachement of Kompendium Mediciny. 2019;24:9-13; Dvoroznakova M. Ivot pacienta so SZ. Kedy je ten spravny as na akciu. Zdrav. Nov (Bratisl) Priloha. Kompendium Medicini. 2019;24:9-13; Mosnarova A, Dvoroznakova M. Zivot pacienta so SZ. Kedy je ten spravny cas na akciu. Zdravotnicke Noviny (Bratisl.) Attachment of Kompendium Mediciny. 2019;24:9-13; Mosnarova A.. Patients life w...$53$YR$$F$Y$$$20240920$$MD$SK$SK
243453571$24345357$1$I$20240901$20240910$20240920$20240920$PER$$US-BAUSCHBL-2024BNL033265$BAUSCH AND LOMB$$$$$F$Y$$$20240920$$CN$US$US
243453581$24345358$1$I$20240920$20240920$20240920$20240920$DIR$719206$$FDA-CTU$$44$YR$$M$N$83.25$KG$20240920$N$HP$US$
243453591$24345359$1$I$$20240919$20240920$20240920$PER$$NVSC2024US188106$NOVARTIS$$$$$M$Y$$$20240920$$HP$US$US
243453611$24345361$1$I$20240910$20240910$20240920$20240920$EXP$$JP-Eisai-EC-2024-175036$EISAI$$$$$$Y$$$20240920$$MD$JP$JP
243453621$24345362$1$I$20240101$20240918$20240920$20240920$EXP$$JP-GENMAB-2024-03138$GENMAB$$8$DEC$$M$Y$$$20240920$$PH$JP$JP
243453631$24345363$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187872$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243453641$24345364$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409012253$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240920$$CN$US$US
243453651$24345365$1$I$20240701$20240918$20240920$20240920$EXP$$JP-GENMAB-2024-03402$GENMAB$$8$DEC$$M$Y$$$20240920$$MD$JP$JP
243453661$24345366$1$I$20240101$20240916$20240920$20240920$EXP$$BR-AMGEN-BRASL2024120461$AMGEN$$56$YR$A$F$Y$$$20240920$$CN$BR$BR
243453671$24345367$1$I$20240914$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011325$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240920$$CN$US$US
243453681$24345368$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011588$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240920$$CN$US$US
243453691$24345369$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011888$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240920$$CN$US$US
243453701$24345370$1$I$20240901$20240911$20240920$20240920$EXP$GB-MHRA-MED-202409111421022570-KQNVT$GB-ELI_LILLY_AND_COMPANY-GB202409007919$ELI LILLY AND CO$$46$YR$A$F$Y$74$KG$20240920$$CN$GB$GB
243453711$24345371$1$I$20240916$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011778$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240920$$CN$US$US
243453721$24345372$1$I$20240908$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011125$ELI LILLY AND CO$$66$YR$E$$Y$$$20240920$$CN$US$US
243453741$24345374$1$I$20240906$20240912$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146959$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240920$$CN$US$US
243453751$24345375$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149182$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240920$$CN$US$US
243453761$24345376$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149800$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240920$$CN$US$US
243453771$24345377$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149553$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$83.46$KG$20240920$$CN$US$US
243453781$24345378$1$I$$20240910$20240920$20240920$PER$$US-ABBVIE-5919817$ABBVIE$$$$$$Y$$$20240920$$CN$US$US
243453791$24345379$1$I$$20240916$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149261$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240920$$CN$US$US
243453801$24345380$1$I$$20240911$20240920$20240920$EXP$$US-VIIV HEALTHCARE LIMITED-US2024113725$VIIV$$$$$M$Y$$$20240920$$MD$US$US
243453811$24345381$1$I$20230901$20240912$20240920$20240920$30DAY$$US-GSK-US2024113700$GLAXOSMITHKLINE$$88$YR$$M$Y$$$20240920$$CN$US$US
243453821$24345382$1$I$$20240913$20240920$20240920$EXP$$NL-AMGEN-NLDSP2024183939$AMGEN$Von Dem Borne P.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$E$$Y$$$20240920$$HP$NL$NL
243453871$24345387$1$I$$20240913$20240920$20240920$EXP$$US-TAKEDA-2024TUS092363$TAKEDA$$$$$F$Y$$$20240920$$MD$US$US
243453881$24345388$1$I$20240901$20240910$20240920$20240920$EXP$$US-BAYER-2024A131552$BAYER$$76$YR$E$F$Y$$$20240920$$CN$US$US
243453891$24345389$1$I$20240801$20240914$20240920$20240920$EXP$$US-009507513-2409USA005828$MERCK$$60$YR$$M$Y$$$20240920$$MD$US$US
243453901$24345390$1$I$$20240910$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013530$DR REDDYS$$$$$F$Y$$$20240920$$CN$US$US
243453911$24345391$1$I$$20240913$20240920$20240920$EXP$$JP-BIOGEN-2024BI01282790$BIOGEN$$$$$F$Y$$$20240920$$MD$JP$JP
243453921$24345392$1$I$$20240911$20240920$20240920$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR113457$VIIV$$$$$$Y$$$20240920$$HP$US$US
243453931$24345393$1$I$$20240913$20240920$20240920$30DAY$$US-GSK-US2024AMR114513$GLAXOSMITHKLINE$$$$$F$Y$$$20240920$$CN$US$US
243453941$24345394$1$I$20240901$20240914$20240920$20240920$EXP$$AR-ORGANON-O2409ARG001159$ORGANON$$25$YR$$F$Y$$$20240920$$MD$AR$AR
243453951$24345395$1$I$$20240916$20240920$20240920$EXP$$US-JNJFOC-20240947196$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243453961$24345396$1$I$$20240913$20240920$20240920$PER$$US-EMD Serono-2024049590$EMD SERONO INC$$$$A$F$Y$$$20240920$$CN$US$US
243453982$24345398$2$F$20240901$20240923$20240920$20240924$EXP$$US-ABBVIE-5931352$ABBVIE$$65$YR$$M$Y$$$20240924$$CN$US$US
243454011$24345401$1$I$20240917$20240917$20240920$20240920$PER$$US-PFIZER INC-202400258574$PFIZER$$55$YR$$M$Y$$$20240920$$CN$US$US
243454021$24345402$1$I$$20240918$20240920$20240920$EXP$$US-PFIZER INC-202400259468$PFIZER$Jones, J.. Jones J, Mallory P. Ventilation/Perfusion Mismatch in a Child Following Cocaine Ingestion: Case Report. SN Comprehensive Clinical Medicine. 2024;6(1):92. DOI:10.1007/s42399-024-01725-y. SN Comprehensive Clinical Medicine. 2024;6(1):92$19$MON$$M$Y$11.5$KG$20240920$$MD$US$US
243454031$24345403$1$I$20240801$20240917$20240920$20240920$PER$$US-PFIZER INC-PV202400122028$PFIZER$$56$YR$$F$Y$68.03$KG$20240920$$CN$US$US
243454041$24345404$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-202400253782$PFIZER$$72$YR$$F$Y$$$20240920$$MD$US$US
243454051$24345405$1$I$$20240918$20240920$20240920$PER$$US-PFIZER INC-202400260071$PFIZER$$67$YR$$F$Y$$$20240920$$HP$US$US
243454061$24345406$1$I$20231001$20240911$20240920$20240920$EXP$$JP-009507513-2409JPN001867J$MERCK$Oike T, Oeda R, Inoue T, Inoue N, Nakao K, Ikeda S, et al.. P-040 A retrospective study on 16 cases of recurrent corpus uteri carcinoma treated with pembrolizumab and lenvatinib combination therapy in our hospital. The journal of the Japan Society of Gynecologic Oncology  The 66th Annual Meetin. 2024;42(3):364$6$DEC$$F$Y$$$20240920$$MD$JP$JP
243454071$24345407$1$I$$20240904$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149286$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$85.28$KG$20240920$$CN$US$US
243454081$24345408$1$I$$20240911$20240920$20240920$30DAY$$US-GSK-US2024AMR113974$GLAXOSMITHKLINE$$$$$$Y$$$20240920$$CN$US$US
243454091$24345409$1$I$$20240917$20240920$20240920$PER$$US-HALEON-2197392$Haleon PLC$$$$$$Y$$$20240920$$CN$US$US
243454102$24345410$2$F$20240701$20240913$20240920$20240925$PER$$US-SA-2024SA267943$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240925$$CN$US$US
243454111$24345411$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA269526$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240920$$HP$US$US
243454121$24345412$1$I$$20240904$20240920$20240920$PER$$PR-TEVA-VS-3240369$TEVA$$68$YR$$F$Y$$$20240920$$CN$PR$US
243454141$24345414$1$I$20240101$20240911$20240920$20240920$EXP$$US-TEVA-VS-3243116$TEVA$$60$YR$$M$Y$$$20240920$$CN$US$US
243454152$24345415$2$F$20231201$20240920$20240920$20240926$EXP$$US-ABBVIE-5928811$ABBVIE$$67$YR$$F$Y$66$KG$20240926$$CN$US$US
243454162$24345416$2$F$20240901$20240918$20240920$20240925$30DAY$$AR-PFIZER INC-202400259027$PFIZER$$4$YR$$M$Y$$$20240925$$HP$AR$AR
243454171$24345417$1$I$20240912$20240920$20240920$20240920$DIR$719217$$FDA-CTU$$41$YR$$F$N$56.4$KG$20240920$N$PH$US$
243454181$24345418$1$I$20240705$20240920$20240920$20240920$DIR$719218$$FDA-CTU$$35$YR$$M$N$130.5$KG$20240920$N$HP$US$
243454191$24345419$1$I$$20240912$20240920$20240920$EXP$$ML-ORGANON-O2409MLI001539$ORGANON$Konate D, Doumbia D, Yattara M, Dembele L, Traore A, Camara CBO, et al.. Management of an atypical case of acute central serous chorioretinitis promoted by nasal corticoid spray. Journal of african clinical cases and reviews. 2024;8(3):32-7$22$YR$$F$Y$$$20240920$$HP$ML$ML
243454201$24345420$1$I$20240401$20240918$20240920$20240920$EXP$$US-PFIZER INC-202400259391$PFIZER$$46$YR$$F$Y$93$KG$20240920$$CN$US$US
243454211$24345421$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149672$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240920$$CN$US$US
243454221$24345422$1$I$$20240919$20240920$20240920$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-150015$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240920$$CN$PR$PR
243454231$24345423$1$I$$20240920$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149880$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240920$$CN$US$US
243454241$24345424$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149931$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240920$$CN$US$US
243454251$24345425$1$I$$20240911$20240920$20240920$EXP$$CA-JNJFOC-20240933650$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240920$$HP$CA$CA
243454261$24345426$1$I$$20240917$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149292$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240920$$HP$US$US
243454272$24345427$2$F$$20240920$20240920$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149034$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240923$$MD$US$US
243454281$24345428$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149680$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$90.72$KG$20240920$$CN$US$US
243454291$24345429$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148970$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240920$$HP$US$US
243454301$24345430$1$I$$20240916$20240920$20240920$EXP$$CA-ABBVIE-5929196$ABBVIE$$46$YR$$M$Y$$$20240920$$MD$CA$CA
243454322$24345432$2$F$20240916$20240924$20240920$20240926$EXP$$US-Taiho Oncology Inc-2024-008859$TAIHO ONCOLOGY INC$$75$YR$E$M$Y$$$20240926$$CN$US$US
243454341$24345434$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149655$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240920$$HP$US$US
243454353$24345435$3$F$20110101$20240926$20240920$20240930$EXP$$US-BIOGEN-2014BI038213$BIOGEN$$$$$F$Y$63.015$KG$20240930$$CN$US$US
243454361$24345436$1$I$20240821$20240920$20240920$20240920$DIR$719224$$FDA-CTU$$61$YR$$F$N$65.8$KG$20240920$N$PH$US$
243454371$24345437$1$I$20240824$20240920$20240920$20240920$DIR$719205$$FDA-CTU$$$$$UNK$N$$$20240920$N$CN$US$
243454381$24345438$1$I$20240919$20240920$20240920$20240920$DIR$719212$$FDA-CTU$$50$YR$$M$N$93.9$KG$20240920$N$$US$
243454391$24345439$1$I$20240917$20240920$20240920$20240920$DIR$719220$$FDA-CTU$$59$YR$$M$N$76.41$KG$20240920$N$HP$US$
243454401$24345440$1$I$20240725$20240906$20240920$20240920$EXP$$CN-EAGLE PHARMACEUTICALS, INC.-CN-2024EAG000229$EAGLE$$$$$$Y$$$20240920$$HP$CN$CN
243454411$24345441$1$I$$20240920$20240920$20240920$PER$$NVSC2024US188182$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243454431$24345443$1$I$$20240920$20240920$20240920$DIR$719228$$FDA-CTU$$$$$UNK$N$$$20240920$N$CN$US$
243454442$24345444$2$F$20230223$20240920$20240920$20240925$EXP$FR-EMA-DD-20240916-7482643-083915$FR-SANDOZ INC.-SDZ2024FR081830$SANDOZ$$88$YR$$F$Y$$$20240925$$MD$FR$FR
243454451$24345445$1$I$$20240920$20240920$20240920$PER$$NVSC2024US188183$NOVARTIS$$$$$$Y$$$20240920$$HP$US$US
243454461$24345446$1$I$20240901$20240912$20240920$20240920$PER$$US-TEVA-VS-3243584$TEVA$$$$$F$Y$$$20240920$$PH$US$US
243454471$24345447$1$I$20240920$20240920$20240920$20240920$DIR$719226$$FDA-CTU$$50$YR$$F$N$$$20240920$N$HP$US$
243454481$24345448$1$I$20231201$20240916$20240920$20240920$EXP$$BR-TAKEDA-2024TUS002244$TAKEDA$$40$YR$$F$Y$$$20240920$$CN$BR$BR
243454491$24345449$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5931559$ABBVIE$$$$A$F$Y$$$20240920$$HP$US$US
243454501$24345450$1$I$20240905$20240910$20240920$20240920$30DAY$$US-AMGEN-USASP2024181003$AMGEN$$68$YR$E$M$Y$88$KG$20240920$$PH$US$US
243454531$24345453$1$I$20240912$20240912$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013534$DR REDDYS$$26$YR$A$M$Y$$$20240920$$CN$US$US
243454541$24345454$1$I$20240703$20240913$20240920$20240920$EXP$CN-91110000556821568D-2024DRL001770$CN-RDY-SPO/CHN/24/0013619$DR REDDYS$$56$YR$A$M$Y$60$KG$20240920$$HP$CN$CN
243454551$24345455$1$I$$20240913$20240920$20240920$EXP$GB-MHRA-MED-202409131509190230-BKPTH$GB-RDY-SPO/GBR/24/0013544$DR REDDYS$$$$$F$Y$$$20240920$$HP$GB$GB
243454561$24345456$1$I$20230101$20240913$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-009014$BAUSCH AND LOMB$$28$YR$$F$Y$$$20240920$$CN$CA$CA
243454572$24345457$2$F$20240916$20240924$20240920$20240926$EXP$GB-MHRA-MED-202409190831310010-NKQVT$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052525$BOEHRINGER INGELHEIM$$67$YR$E$M$Y$$$20240926$$PH$GB$GB
243454581$24345458$1$I$$20240912$20240920$20240920$PER$$US-BAUSCH-BL-2024-013741$BAUSCH AND LOMB$$$$$F$Y$$$20240920$$CN$US$US
243454591$24345459$1$I$20201004$20240918$20240920$20240920$EXP$PL-URPL-1-2546-2020$PL-ABBVIE-5928217$ABBVIE$$81$YR$$M$Y$79$KG$20240920$$MD$PL$PL
243454602$24345460$2$F$20240903$20240914$20240920$20240925$EXP$$CN-JNJFOC-20240950345$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240925$$HP$CN$CN
243454611$24345461$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011794$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243454621$24345462$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-014013$BAUSCH AND LOMB$$90$YR$$F$Y$$$20240920$$CN$CA$CA
243454631$24345463$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011760$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240920$$HP$US$US
243454641$24345464$1$I$20240917$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011745$ELI LILLY AND CO$$64$YR$A$$Y$$$20240920$$CN$US$US
243454652$24345465$2$F$$20240920$20240920$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011754$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240924$$CN$US$US
243454661$24345466$1$I$20240801$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010902$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240920$$CN$US$US
243454681$24345468$1$I$$20240916$20240920$20240920$EXP$$US-BAUSCH-BL-2024-014029$BAUSCH AND LOMB$$$$$$Y$$$20240920$$HP$US$US
243454691$24345469$1$I$$20240916$20240920$20240920$EXP$$CA-BAUSCH-BL-2024-013946$BAUSCH AND LOMB$$55$YR$$F$Y$$$20240920$$HP$CA$CA
243454701$24345470$1$I$20240901$20240913$20240920$20240920$EXP$$JP-BAUSCH-BL-2024-014201$BAUSCH AND LOMB$$8$DEC$$F$Y$$$20240920$$MD$JP$JP
243454711$24345471$1$I$$20240916$20240920$20240920$PER$$US-BAUSCH-BL-2024-013910$BAUSCH AND LOMB$$$$$M$Y$77.18$KG$20240920$$CN$US$US
243454721$24345472$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA252699$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240920$$MD$US$US
243454731$24345473$1$I$$20240911$20240920$20240920$PER$$US-MYLANLABS-2024M1083701$MYLAN$$$$$F$Y$58.06$KG$20240920$$CN$US$US
243454741$24345474$1$I$$20240916$20240920$20240920$EXP$$US-TAKEDA-2024TUS039730$TAKEDA$$$$$F$Y$$$20240920$$CN$US$US
243454751$24345475$1$I$20240101$20240911$20240920$20240920$PER$$US-009507513-2409USA004448$MERCK$$$$$$Y$$$20240920$$CN$US$US
243454761$24345476$1$I$20240309$20240915$20240920$20240920$PER$$CN-Eisai-EC-2024-174838$EISAI$$67$YR$E$F$Y$43$KG$20240920$$MD$CN$CN
243454771$24345477$1$I$$20240905$20240920$20240920$PER$$US-TPU-TPU-2024-00469$TEIKOKU$$$$$F$Y$$$20240920$$CN$US$US
243454781$24345478$1$I$$20240905$20240920$20240920$PER$$US-TPU-TPU-2024-00470$TEIKOKU$$$$$$Y$$$20240920$$CN$US$US
243454791$24345479$1$I$$20240903$20240920$20240920$PER$$US-TPU-TPU-2024-00462$TEIKOKU$$$$$F$Y$$$20240920$$CN$US$US
243454801$24345480$1$I$$20240906$20240920$20240920$EXP$$PL-TPU-TPU-2024-00471$TEIKOKU$Woroo J, Siwek M... B6l gardta jako niepokadanakonsekwencja interakcji lekow stosowanych w leczeniu pacjentki chorej na depresje i otytotd. Medycyna Praktyczna-Psychiatria. 2024;04 (99):37-39$31$YR$A$F$Y$$$20240920$$HP$PL$PL
243454811$24345481$1$I$$20240904$20240920$20240920$PER$$US-TPU-TPU-2024-00465$TEIKOKU$$$$T$F$Y$$$20240920$$CN$US$US
243454821$24345482$1$I$$20240912$20240920$20240920$EXP$$FR-ABBVIE-5925998$ABBVIE$$$$A$M$Y$$$20240920$$MD$FR$FR
243454831$24345483$1$I$20240821$20240912$20240920$20240920$EXP$$US-SANDOZ INC.-SDZ2024US080195$SANDOZ$$65$YR$$F$Y$$$20240920$$CN$US$US
243454841$24345484$1$I$$20240917$20240920$20240920$PER$$US-ABBVIE-5929188$ABBVIE$$$$$$Y$$$20240920$$CN$US$US
243454881$24345488$1$I$20240720$20240917$20240920$20240920$EXP$FR-AFSSAPS-AN2024001217$FR-MYLANLABS-2024M1084625$MYLAN$$80$YR$$F$Y$70.5$KG$20240920$$MD$FR$FR
243454891$24345489$1$I$20240101$20240910$20240920$20240920$EXP$$IL-ALNYLAM NETHERLANDS BV-ALN-2024-005212$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240920$$MD$IL$IL
243454901$24345490$1$I$$20240913$20240920$20240920$EXP$$NVSC2024CZ185854$NOVARTIS$$$$$F$Y$$$20240920$$MD$CZ$CZ
243454931$24345493$1$I$20240904$20240914$20240920$20240920$EXP$$CN-SA-2024SA268443$SANOFI AVENTIS$$71$YR$E$F$Y$49$KG$20240920$$HP$CN$CN
243454941$24345494$1$I$$20240912$20240920$20240920$EXP$$US-BEH-2024178844$CSL BEHRING$$81$YR$E$F$Y$66$KG$20240920$$CN$US$US
243454951$24345495$1$I$$20240919$20240920$20240920$EXP$GB-MHRA-MED-202409130914122390-YLHTD$GB-MYLANLABS-2024M1085681$MYLAN$$29$YR$$M$Y$86$KG$20240920$$HP$GB$GB
243454961$24345496$1$I$20230719$20240919$20240920$20240920$EXP$$SG-MYLANLABS-2024M1085589$MYLAN$$77$YR$$F$Y$$$20240920$$HP$SG$SG
243454971$24345497$1$I$20240910$20240919$20240920$20240920$EXP$$SG-MYLANLABS-2024M1085531$MYLAN$$61$YR$$M$Y$$$20240920$$HP$SG$SG
243454981$24345498$1$I$$20240916$20240920$20240920$PER$$US-AMGEN-USASP2024184907$AMGEN$$$$$F$Y$$$20240920$$PH$US$US
243454991$24345499$1$I$20240101$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186954$AMGEN$$82$YR$E$F$Y$$$20240920$$CN$US$US
243455002$24345500$2$F$20240827$20240912$20240920$20240921$EXP$$CN-JNJFOC-20240954523$JOHNSON AND JOHNSON$$31$YR$A$M$Y$83$KG$20240921$$HP$CN$CN
243455011$24345501$1$I$20240301$20240918$20240920$20240920$PER$$PR-ABBVIE-5930873$ABBVIE$$$$$F$Y$57.606$KG$20240920$$CN$PR$PR
243455021$24345502$1$I$$20240917$20240920$20240920$PER$$US-009507513-2409USA006157$MERCK$$$$$M$Y$$$20240920$$CN$US$US
243455031$24345503$1$I$20230801$20240914$20240920$20240920$EXP$$CZ-ABBVIE-5926071$ABBVIE$$60$YR$$F$Y$$$20240920$$CN$CZ$CZ
243455041$24345504$1$I$20240901$20240917$20240920$20240920$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006731$AURINIA PHARMACEUTICALS$$28$YR$$M$Y$$$20240920$$CN$US$US
243455051$24345505$1$I$$20240917$20240920$20240920$EXP$$CA-SANDOZ INC.-NVSC2022CA221479$SANDOZ$$$$$M$Y$$$20240920$$CN$CA$CA
243455061$24345506$1$I$$20240913$20240920$20240920$EXP$$CA-TEVA-VS-3244353$TEVA$$33$YR$$M$Y$$$20240920$$HP$CA$CA
243455071$24345507$1$I$20240910$20240911$20240920$20240920$EXP$$CN-JNJFOC-20240934327$JOHNSON AND JOHNSON$$65$YR$E$F$Y$60$KG$20240920$$HP$CN$CN
243455081$24345508$1$I$$20240919$20240920$20240920$EXP$$US-PURDUE PHARMA-USA-2024-0312076$PURDUE$$60$YR$$M$Y$$$20240920$$CN$US$US
243455092$24345509$2$F$$20240918$20240920$20240928$EXP$$CA-TEVA-VS-3244303$TEVA$$78$YR$$M$Y$$$20240928$$HP$CA$CA
243455101$24345510$1$I$20210301$20240919$20240920$20240920$EXP$$US-PURDUE PHARMA-USA-2024-0312084$PURDUE$$$$$M$Y$$$20240920$$CN$US$US
243455111$24345511$1$I$20240421$20240916$20240920$20240920$EXP$$FR-PURDUE-USA-2024-0312077$PURDUE$$92$YR$$F$Y$55$KG$20240920$$HP$FR$FR
243455122$24345512$2$F$20240911$20240913$20240920$20240924$EXP$$US-CHIESI USA, INC.-2024CHF06059$CHIESI$$0$YR$$M$Y$$$20240924$$CN$US$US
243455131$24345513$1$I$$20240917$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148494$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240920$$HP$US$US
243455141$24345514$1$I$$20240913$20240920$20240920$EXP$$CA-TEVA-VS-3244338$TEVA$$$$$M$Y$$$20240920$$MD$CA$CA
243455151$24345515$1$I$20240701$20240916$20240920$20240920$EXP$$GB-MYLANLABS-2024M1084806$MYLAN$$$$$M$Y$$$20240920$$PH$GB$GB
243455161$24345516$1$I$20211010$20240916$20240920$20240920$EXP$IT-MINISAL02-1001757$IT-MYLANLABS-2024M1084233$MYLAN$$54$YR$$M$Y$$$20240920$$MD$IT$IT
243455171$24345517$1$I$20230501$20240911$20240920$20240920$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-145390$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$63.05$KG$20240920$$CN$PR$PR
243455181$24345518$1$I$20240618$20240916$20240920$20240920$EXP$SE-SEMPA-2024-006549$SE-MYLANLABS-2024M1084997$MYLAN$$57$YR$$M$Y$$$20240920$$MD$SE$SE
243455191$24345519$1$I$20240814$20240918$20240920$20240920$EXP$$CN-MYLANLABS-2024M1085456$MYLAN$$58$YR$$F$Y$60$KG$20240920$$HP$CN$CN
243455201$24345520$1$I$$20240913$20240920$20240920$EXP$$CA-TEVA-VS-3244335$TEVA$$2$DEC$$M$Y$$$20240920$$HP$CA$CA
243455221$24345522$1$I$20230101$20240912$20240920$20240920$EXP$$CZ-TEVA-VS-3244157$TEVA$$$$$M$Y$$$20240920$$MD$CZ$CZ
243455231$24345523$1$I$20240912$20240912$20240920$20240920$PER$$ID-Eisai-EC-2024-174518$EISAI$$$$$$Y$$$20240920$$MD$ID$ID
243455241$24345524$1$I$$20240912$20240920$20240920$EXP$$US-Eisai-EC-2024-174535$EISAI$$$$E$F$Y$$$20240920$$MD$US$US
243455251$24345525$1$I$20240823$20240914$20240920$20240920$EXP$$CN-Eisai-EC-2024-174416$EISAI$$69$YR$E$F$Y$50$KG$20240920$$MD$CN$CN
243455261$24345526$1$I$$20240920$20240920$20240920$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052617$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240920$$MD$US$US
243455271$24345527$1$I$20240909$20240916$20240920$20240920$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-18721$IPSEN$$75$YR$E$M$Y$$$20240920$$CN$US$US
243455281$24345528$1$I$$20240917$20240920$20240920$EXP$$JP-009507513-2409JPN006719$MERCK$Matsubara S, et al. A case of drug-induced pneumatosis coli caused by sitagliptin. The 28th Annual Meeting of the Japanese Society of Hospital General Medicine. 2024;O-150$81$YR$$M$Y$$$20240920$$MD$JP$JP
243455291$24345529$1$I$20240301$20240715$20240920$20240920$EXP$$US-VIVUS, Inc.-2024V1000887$VIVUS$$65$YR$E$F$Y$$$20240720$$CN$US$US
243455301$24345530$1$I$$20240919$20240920$20240920$PER$$US-PURDUE PHARMA-USA-2024-0312081$PURDUE$$28$YR$$M$Y$$$20240920$$CN$US$US
243455311$24345531$1$I$$20240919$20240920$20240920$PER$$US-PURDUE PHARMA-USA-2024-0312074$PURDUE$$$$$M$Y$$$20240920$$CN$US$US
243455331$24345533$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149733$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240920$$CN$US$US
243455343$24345534$3$F$$20240919$20240920$20240925$PER$$US-PURDUE-USA-2024-0312086$PURDUE$$$$$M$Y$73.94$KG$20240925$$CN$US$US
243455351$24345535$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149899$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240920$$HP$US$US
243455361$24345536$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149087$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$87.54$KG$20240920$$CN$US$US
243455371$24345537$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149747$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240920$$CN$US$US
243455381$24345538$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149893$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240920$$CN$US$US
243455391$24345539$1$I$$20240918$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149104$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240920$$CN$US$US
243455401$24345540$1$I$$20240919$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149784$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240920$$CN$US$US
243455411$24345541$1$I$20240902$20240917$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148222$BRISTOL MYERS SQUIBB$$98$YR$E$F$Y$34.02$KG$20240920$$CN$US$US
243455421$24345542$1$I$20240701$20240828$20240920$20240920$PER$$US-SA-2024SA267791$SANOFI AVENTIS$$16$YR$T$M$Y$54.55$KG$20240920$$MD$US$US
243455431$24345543$1$I$$20240627$20240920$20240920$PER$$US-PERRIGO-24US006242$PERRIGO$$$$A$$Y$$$20240920$$CN$US$US
243455441$24345544$1$I$20240808$20240808$20240920$20240920$PER$$US-PERRIGO-24US007514$PERRIGO$$$$A$$Y$$$20240920$$CN$US$US
243455451$24345545$1$I$$20240626$20240920$20240920$PER$$US-PERRIGO-24US006135$PERRIGO$$$$$$Y$$$20240920$$CN$US$US
243455461$24345546$1$I$$20240805$20240920$20240920$PER$$US-PERRIGO-24US007388$PERRIGO$$$$A$$Y$$$20240920$$CN$US$US
243455471$24345547$1$I$20221103$20240918$20240920$20240920$EXP$FR-AFSSAPS-MA2024001470$FR-009507513-2409FRA006767$MERCK$$37$YR$$F$Y$$$20240920$$CN$FR$FR
243455482$24345548$2$F$$20240919$20240920$20240924$EXP$$GB-MYLANLABS-2024M1084903$MYLAN$$$$$F$Y$$$20240924$$CN$GB$GB
243455491$24345549$1$I$$20240916$20240920$20240920$EXP$$GB-MYLANLABS-2024M1084934$MYLAN$$$$$M$Y$$$20240920$$HP$GB$GB
243455501$24345550$1$I$$20240514$20240920$20240920$PER$$US-VIVUS LLC-2024V1000573$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455511$24345551$1$I$$20240514$20240920$20240920$PER$$US-VIVUS LLC-2024V1000574$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455521$24345552$1$I$$20240514$20240920$20240920$PER$$US-VIVUS LLC-2024V1000576$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455531$24345553$1$I$$20240514$20240920$20240920$PER$$US-VIVUS LLC-2024V1000579$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243455541$24345554$1$I$$20240515$20240920$20240920$PER$$US-VIVUS LLC-2024V1000583$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455551$24345555$1$I$$20240515$20240920$20240920$PER$$US-VIVUS LLC-2024V1000585$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243455561$24345556$1$I$$20240515$20240920$20240920$PER$$US-VIVUS LLC-2024V1000587$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455571$24345557$1$I$$20240516$20240920$20240920$PER$$US-VIVUS LLC-2024V1000597$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455581$24345558$1$I$$20240517$20240920$20240920$PER$$US-VIVUS LLC-2024V1000599$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243455591$24345559$1$I$$20240517$20240920$20240920$PER$$US-VIVUS LLC-2024V1000600$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455601$24345560$1$I$$20240515$20240920$20240920$PER$$US-VIVUS LLC-2024V1000580$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243455611$24345561$1$I$$20240517$20240920$20240920$PER$$US-VIVUS LLC-2024V1000598$VIVUS$$42$YR$A$F$Y$93.978$KG$20240913$$CN$US$US
243455621$24345562$1$I$$20240517$20240920$20240920$PER$$US-VIVUS LLC-2024V1000603$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455631$24345563$1$I$$20240520$20240920$20240920$PER$$US-VIVUS LLC-2024V1000606$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455641$24345564$1$I$$20240517$20240920$20240920$PER$$US-VIVUS LLC-2024V1000608$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455651$24345565$1$I$$20240520$20240920$20240920$PER$$US-VIVUS LLC-2024V1000609$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455661$24345566$1$I$$20240517$20240920$20240920$PER$$US-VIVUS LLC-2024V1000614$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243455671$24345567$1$I$$20240520$20240920$20240920$PER$$US-VIVUS LLC-2024V1000612$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243455681$24345568$1$I$$20240520$20240920$20240920$PER$$US-VIVUS LLC-2024V1000615$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455691$24345569$1$I$$20240520$20240920$20240920$PER$$US-VIVUS LLC-2024V1000616$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455701$24345570$1$I$$20240507$20240920$20240920$PER$$US-VIVUS LLC-2024V1000543$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455711$24345571$1$I$$20240507$20240920$20240920$PER$$US-VIVUS LLC-2024V1000544$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455721$24345572$1$I$$20240507$20240920$20240920$PER$$US-VIVUS LLC-2024V1000546$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455731$24345573$1$I$$20240508$20240920$20240920$PER$$US-VIVUS LLC-2024V1000551$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455741$24345574$1$I$$20240509$20240920$20240920$PER$$US-VIVUS LLC-2024V1000556$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455751$24345575$1$I$$20240508$20240920$20240920$PER$$US-VIVUS LLC-2024V1000547$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243455761$24345576$1$I$$20240508$20240920$20240920$PER$$US-VIVUS LLC-2024V1000548$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243455771$24345577$1$I$$20240508$20240920$20240920$PER$$US-VIVUS LLC-2024V1000550$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243455781$24345578$1$I$$20240508$20240920$20240920$PER$$US-VIVUS LLC-2024V1000554$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455791$24345579$1$I$$20240509$20240920$20240920$PER$$US-VIVUS LLC-2024V1000557$VIVUS$$$$A$F$Y$$$20240913$$HP$US$US
243455801$24345580$1$I$20231201$20240510$20240920$20240920$PER$$US-VIVUS LLC-2024V1000561$VIVUS$$61$YR$A$F$Y$$$20240913$$CN$US$US
243455811$24345581$1$I$$20240510$20240920$20240920$PER$$US-VIVUS LLC-2024V1000562$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455821$24345582$1$I$$20240513$20240920$20240920$PER$$US-VIVUS LLC-2024V1000567$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455831$24345583$1$I$$20240510$20240920$20240920$PER$$US-VIVUS LLC-2024V1000564$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455841$24345584$1$I$$20240510$20240920$20240920$PER$$US-VIVUS LLC-2024V1000566$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455851$24345585$1$I$$20240513$20240920$20240920$PER$$US-VIVUS LLC-2024V1000568$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455861$24345586$1$I$$20240513$20240920$20240920$PER$$US-VIVUS LLC-2024V1000569$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243455871$24345587$1$I$$20240513$20240920$20240920$PER$$US-VIVUS LLC-2024V1000570$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455881$24345588$1$I$$20240510$20240920$20240920$PER$$US-VIVUS LLC-2024V1000571$VIVUS$Buchanan L, Canales B, Yamamoto A. Refrqactory Uric Acid Nephrolithiasis Dissolution Using Phentermine/Topiramat: A Case Report. Urology Case Reports. 2024 MAY;.$57$YR$A$F$Y$$$20240913$$MD$US$US
243455891$24345589$1$I$$20240514$20240920$20240920$PER$$US-VIVUS LLC-2024V1000572$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455901$24345590$1$I$$20240429$20240920$20240920$PER$$US-VIVUS LLC-2023V1001343$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243455911$24345591$1$I$$20240502$20240920$20240920$PER$$US-VIVUS LLC-2024V1000515$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455921$24345592$1$I$$20240502$20240920$20240920$PER$$US-VIVUS LLC-2024V1000517$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455931$24345593$1$I$$20240502$20240920$20240920$PER$$US-VIVUS LLC-2024V1000518$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243455941$24345594$1$I$$20240502$20240920$20240920$PER$$US-VIVUS LLC-2024V1000519$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455951$24345595$1$I$$20240502$20240920$20240920$PER$$US-VIVUS LLC-2024V1000520$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243455961$24345596$1$I$$20240503$20240920$20240920$PER$$US-VIVUS LLC-2024V1000522$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243455971$24345597$1$I$$20240506$20240920$20240920$PER$$US-VIVUS LLC-2024V1000523$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455981$24345598$1$I$$20240503$20240920$20240920$PER$$US-VIVUS LLC-2024V1000524$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243455991$24345599$1$I$$20240506$20240920$20240920$PER$$US-VIVUS LLC-2024V1000525$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456001$24345600$1$I$$20240506$20240920$20240920$PER$$US-VIVUS LLC-2024V1000526$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456011$24345601$1$I$$20240506$20240920$20240920$PER$$US-VIVUS LLC-2024V1000529$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456021$24345602$1$I$20240504$20240506$20240920$20240920$PER$$US-VIVUS LLC-2024V1000531$VIVUS$$50$YR$A$F$Y$$$20240913$$CN$US$US
243456031$24345603$1$I$$20240506$20240920$20240920$PER$$US-VIVUS LLC-2024V1000532$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456041$24345604$1$I$$20240506$20240920$20240920$PER$$US-VIVUS LLC-2024V1000533$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456051$24345605$1$I$$20240506$20240920$20240920$PER$$US-VIVUS LLC-2024V1000534$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456061$24345606$1$I$$20240507$20240920$20240920$PER$$US-VIVUS LLC-2024V1000538$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456071$24345607$1$I$$20240507$20240920$20240920$PER$$US-VIVUS LLC-2024V1000539$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456081$24345608$1$I$$20240507$20240920$20240920$PER$$US-VIVUS LLC-2024V1000540$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456091$24345609$1$I$$20240507$20240920$20240920$PER$$US-VIVUS LLC-2024V1000542$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456101$24345610$1$I$$20240604$20240920$20240920$PER$$US-VIVUS LLC-2024V1000696$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456111$24345611$1$I$$20240604$20240920$20240920$PER$$US-VIVUS LLC-2024V1000697$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456121$24345612$1$I$$20240604$20240920$20240920$PER$$US-VIVUS LLC-2024V1000698$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456131$24345613$1$I$$20240604$20240920$20240920$PER$$US-VIVUS LLC-2024V1000699$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456141$24345614$1$I$$20240604$20240920$20240920$PER$$US-VIVUS LLC-2024V1000701$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456151$24345615$1$I$$20240604$20240920$20240920$PER$$US-VIVUS LLC-2024V1000702$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456161$24345616$1$I$$20240605$20240920$20240920$PER$$US-VIVUS LLC-2024V1000703$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456171$24345617$1$I$$20240605$20240920$20240920$PER$$US-VIVUS LLC-2024V1000706$VIVUS$$$$A$F$Y$98.7$KG$20240913$$CN$US$US
243456181$24345618$1$I$$20240605$20240920$20240920$PER$$US-VIVUS LLC-2024V1000710$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243456191$24345619$1$I$$20240605$20240920$20240920$PER$$US-VIVUS LLC-2024V1000708$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456201$24345620$1$I$$20240605$20240920$20240920$PER$$US-VIVUS LLC-2024V1000711$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243456211$24345621$1$I$$20240606$20240920$20240920$PER$$US-VIVUS LLC-2024V1000712$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456221$24345622$1$I$$20240606$20240920$20240920$PER$$US-VIVUS LLC-2024V1000713$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456231$24345623$1$I$$20240606$20240920$20240920$PER$$US-VIVUS LLC-2024V1000715$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456241$24345624$1$I$$20240606$20240920$20240920$PER$$US-VIVUS LLC-2024V1000716$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456251$24345625$1$I$$20240606$20240920$20240920$PER$$US-VIVUS LLC-2024V1000718$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456261$24345626$1$I$$20240607$20240920$20240920$PER$$US-VIVUS LLC-2024V1000721$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456271$24345627$1$I$$20240607$20240920$20240920$PER$$US-VIVUS LLC-2024V1000722$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243456281$24345628$1$I$$20240607$20240920$20240920$PER$$US-VIVUS LLC-2024V1000725$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456291$24345629$1$I$$20240528$20240920$20240920$PER$$US-VIVUS LLC-2024V1000641$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456301$24345630$1$I$$20240528$20240920$20240920$PER$$US-VIVUS LLC-2024V1000642$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243456311$24345631$1$I$$20240528$20240920$20240920$PER$$US-VIVUS LLC-2024V1000643$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456321$24345632$1$I$$20240528$20240920$20240920$PER$$US-VIVUS LLC-2024V1000644$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456331$24345633$1$I$$20240528$20240920$20240920$PER$$US-VIVUS LLC-2024V1000646$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456341$24345634$1$I$$20240528$20240920$20240920$PER$$US-VIVUS LLC-2024V1000647$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456351$24345635$1$I$$20240528$20240920$20240920$PER$$US-VIVUS LLC-2024V1000649$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456361$24345636$1$I$$20240529$20240920$20240920$PER$$US-VIVUS LLC-2024V1000651$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456371$24345637$1$I$$20240529$20240920$20240920$PER$$US-VIVUS LLC-2024V1000652$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456381$24345638$1$I$$20240529$20240920$20240920$PER$$US-VIVUS LLC-2024V1000653$VIVUS$$$$E$M$Y$$$20240913$$CN$US$US
243456391$24345639$1$I$$20240606$20240920$20240920$PER$$US-VIVUS LLC-2024V1000714$VIVUS$$60$YR$A$F$Y$$$20240913$$CN$US$US
243456401$24345640$1$I$$20240529$20240920$20240920$PER$$US-VIVUS LLC-2024V1000654$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456411$24345641$1$I$$20240529$20240920$20240920$PER$$US-VIVUS LLC-2024V1000655$VIVUS$$$$$M$Y$$$20240913$$CN$US$US
243456421$24345642$1$I$$20240528$20240920$20240920$PER$$US-VIVUS LLC-2024V1000658$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456431$24345643$1$I$$20240529$20240920$20240920$PER$$US-VIVUS LLC-2024V1000659$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456441$24345644$1$I$$20240529$20240920$20240920$PER$$US-VIVUS LLC-2024V1000660$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456451$24345645$1$I$$20240529$20240920$20240920$PER$$US-VIVUS LLC-2024V1000661$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456461$24345646$1$I$$20240530$20240920$20240920$PER$$US-VIVUS LLC-2024V1000663$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456471$24345647$1$I$$20240530$20240920$20240920$PER$$US-VIVUS LLC-2024V1000664$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456481$24345648$1$I$$20240530$20240920$20240920$PER$$US-VIVUS LLC-2024V1000666$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456491$24345649$1$I$$20240530$20240920$20240920$PER$$US-VIVUS LLC-2024V1000667$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243456501$24345650$1$I$$20240607$20240920$20240920$PER$$US-VIVUS LLC-2024V1000729$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456511$24345651$1$I$$20240607$20240920$20240920$PER$$US-VIVUS LLC-2024V1000730$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456521$24345652$1$I$$20240610$20240920$20240920$PER$$US-VIVUS LLC-2024V1000732$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456531$24345653$1$I$$20240610$20240920$20240920$PER$$US-VIVUS LLC-2024V1000734$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456541$24345654$1$I$$20240610$20240920$20240920$PER$$US-VIVUS LLC-2024V1000736$VIVUS$$$$$M$Y$$$20240913$$CN$US$US
243456551$24345655$1$I$$20240611$20240920$20240920$PER$$US-VIVUS LLC-2024V1000739$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243456561$24345656$1$I$$20240611$20240920$20240920$PER$$US-VIVUS LLC-2024V1000741$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456571$24345657$1$I$$20240611$20240920$20240920$PER$$US-VIVUS LLC-2024V1000743$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456581$24345658$1$I$$20240611$20240920$20240920$PER$$US-VIVUS LLC-2024V1000744$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456591$24345659$1$I$$20240612$20240920$20240920$PER$$US-VIVUS LLC-2024V1000748$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243456601$24345660$1$I$$20240612$20240920$20240920$PER$$US-VIVUS LLC-2024V1000749$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243456611$24345661$1$I$$20240612$20240920$20240920$PER$$US-VIVUS LLC-2024V1000750$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456621$24345662$1$I$20240401$20240612$20240920$20240920$PER$$US-VIVUS LLC-2024V1000751$VIVUS$$74$YR$E$F$Y$$$20240913$$CN$US$US
243456631$24345663$1$I$$20240611$20240920$20240920$PER$$US-VIVUS LLC-2024V1000752$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456641$24345664$1$I$$20240611$20240920$20240920$PER$$US-VIVUS LLC-2024V1000754$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456651$24345665$1$I$$20240612$20240920$20240920$PER$$US-VIVUS LLC-2024V1000756$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456661$24345666$1$I$$20240612$20240920$20240920$PER$$US-VIVUS LLC-2024V1000758$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456671$24345667$1$I$$20240612$20240920$20240920$PER$$US-VIVUS LLC-2024V1000759$VIVUS$$$$A$F$Y$77.18$KG$20240913$$CN$US$US
243456681$24345668$1$I$$20240612$20240920$20240920$PER$$US-VIVUS LLC-2024V1000760$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456691$24345669$1$I$$20240612$20240920$20240920$PER$$US-VIVUS LLC-2024V1000761$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456701$24345670$1$I$$20240531$20240920$20240920$PER$$US-VIVUS LLC-2024V1000668$VIVUS$$$$E$$Y$82.628$KG$20240913$$CN$US$US
243456711$24345671$1$I$$20240531$20240920$20240920$PER$$US-VIVUS LLC-2024V1000669$VIVUS$$$$A$$Y$$$20240913$$CN$US$US
243456721$24345672$1$I$$20240531$20240920$20240920$PER$$US-VIVUS LLC-2024V1000671$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456731$24345673$1$I$$20240531$20240920$20240920$PER$$US-VIVUS LLC-2024V1000672$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456741$24345674$1$I$$20240531$20240920$20240920$PER$$US-VIVUS LLC-2024V1000675$VIVUS$$$$E$$Y$$$20240913$$CN$US$US
243456751$24345675$1$I$$20240603$20240920$20240920$PER$$US-VIVUS LLC-2024V1000678$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456761$24345676$1$I$$20240603$20240920$20240920$PER$$US-VIVUS LLC-2024V1000679$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456771$24345677$1$I$$20240603$20240920$20240920$PER$$US-VIVUS LLC-2024V1000681$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456781$24345678$1$I$$20240603$20240920$20240920$PER$$US-VIVUS LLC-2024V1000682$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456791$24345679$1$I$$20240603$20240920$20240920$PER$$US-VIVUS LLC-2024V1000683$VIVUS$$$$E$$Y$$$20240913$$CN$US$US
243456801$24345680$1$I$$20240603$20240920$20240920$PER$$US-VIVUS LLC-2024V1000684$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456811$24345681$1$I$$20240603$20240920$20240920$PER$$US-VIVUS LLC-2024V1000685$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456821$24345682$1$I$$20240603$20240920$20240920$PER$$US-VIVUS LLC-2024V1000686$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456831$24345683$1$I$$20240603$20240920$20240920$PER$$US-VIVUS LLC-2024V1000687$VIVUS$$$$A$$Y$$$20240913$$CN$US$US
243456841$24345684$1$I$$20240603$20240920$20240920$PER$$US-VIVUS LLC-2024V1000688$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456851$24345685$1$I$$20240603$20240920$20240920$EXP$$US-VIVUS LLC-2024V1000689$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456861$24345686$1$I$$20240604$20240920$20240920$PER$$US-VIVUS LLC-2024V1000691$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456871$24345687$1$I$$20240603$20240920$20240920$PER$$US-VIVUS LLC-2024V1000692$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456881$24345688$1$I$$20240604$20240920$20240920$PER$$US-VIVUS LLC-2024V1000694$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456891$24345689$1$I$$20240604$20240920$20240920$PER$$US-VIVUS LLC-2024V1000695$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456901$24345690$1$I$$20240628$20240920$20240920$PER$$US-VIVUS LLC-2024V1000104$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243456911$24345691$1$I$$20240627$20240920$20240920$PER$$US-VIVUS LLC-2024V1000237$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456921$24345692$1$I$$20240628$20240920$20240920$PER$$US-VIVUS LLC-2024V1000610$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456931$24345693$1$I$$20240626$20240920$20240920$PER$$US-VIVUS LLC-2024V1000648$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456941$24345694$1$I$$20240626$20240920$20240920$PER$$US-VIVUS LLC-2024V1000819$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456951$24345695$1$I$$20240626$20240920$20240920$PER$$US-VIVUS LLC-2024V1000820$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243456961$24345696$1$I$20230601$20240627$20240920$20240920$PER$$US-VIVUS LLC-2024V1000821$VIVUS$$55$YR$A$F$Y$71.278$KG$20240913$$CN$US$US
243456971$24345697$1$I$$20240627$20240920$20240920$PER$$US-VIVUS LLC-2024V1000822$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243456981$24345698$1$I$$20240627$20240920$20240920$PER$$US-VIVUS LLC-2024V1000823$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243456991$24345699$1$I$$20240627$20240920$20240920$PER$$US-VIVUS LLC-2024V1000824$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457001$24345700$1$I$$20240627$20240920$20240920$PER$$US-VIVUS LLC-2024V1000825$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457011$24345701$1$I$$20240628$20240920$20240920$PER$$US-VIVUS LLC-2024V1000827$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457021$24345702$1$I$$20240628$20240920$20240920$PER$$US-VIVUS LLC-2024V1000828$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457031$24345703$1$I$$20240627$20240920$20240920$PER$$US-VIVUS LLC-2024V1000829$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457041$24345704$1$I$$20240628$20240920$20240920$PER$$US-VIVUS LLC-2024V1000830$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457051$24345705$1$I$$20240628$20240920$20240920$PER$$US-VIVUS LLC-2024V1000831$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457061$24345706$1$I$$20240701$20240920$20240920$PER$$US-VIVUS LLC-2024V1000832$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243457071$24345707$1$I$$20240701$20240920$20240920$PER$$US-VIVUS LLC-2024V1000833$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457081$24345708$1$I$$20240701$20240920$20240920$PER$$US-VIVUS LLC-2024V1000835$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457091$24345709$1$I$$20240702$20240920$20240920$PER$$US-VIVUS LLC-2024V1000836$VIVUS$$$$E$F$Y$68.1$KG$20240913$$CN$US$US
243457101$24345710$1$I$$20240702$20240920$20240920$PER$$US-VIVUS LLC-2024V1000837$VIVUS$$$$A$$Y$$$20240913$$CN$US$US
243457111$24345711$1$I$$20240702$20240920$20240920$PER$$US-VIVUS LLC-2024V1000841$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243457121$24345712$1$I$20240101$20240702$20240920$20240920$PER$$US-VIVUS LLC-2024V1000842$VIVUS$$74$YR$E$F$Y$$$20240913$$CN$US$US
243457131$24345713$1$I$$20240703$20240920$20240920$PER$$US-VIVUS LLC-2024V1000843$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243457141$24345714$1$I$$20240703$20240920$20240920$PER$$US-VIVUS LLC-2024V1000844$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457151$24345715$1$I$$20240703$20240920$20240920$PER$$US-VIVUS LLC-2024V1000846$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457161$24345716$1$I$$20240703$20240920$20240920$PER$$US-VIVUS LLC-2024V1000847$VIVUS$$$$A$M$Y$$$20240913$$CN$US$UM
243457171$24345717$1$I$$20240705$20240920$20240920$PER$$US-VIVUS LLC-2024V1000848$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457181$24345718$1$I$$20240705$20240920$20240920$PER$$US-VIVUS LLC-2024V1000852$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457191$24345719$1$I$$20240705$20240920$20240920$PER$$US-VIVUS LLC-2024V1000853$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457201$24345720$1$I$$20240705$20240920$20240920$PER$$US-VIVUS LLC-2024V1000854$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457211$24345721$1$I$$20240706$20240920$20240920$PER$$US-VIVUS LLC-2024V1000855$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457221$24345722$1$I$$20240708$20240920$20240920$PER$$US-VIVUS LLC-2024V1000856$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457231$24345723$1$I$$20240708$20240920$20240920$PER$$US-VIVUS LLC-2024V1000857$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457241$24345724$1$I$20240501$20240708$20240920$20240920$PER$$US-VIVUS LLC-2024V1000858$VIVUS$$65$YR$E$F$Y$$$20240913$$CN$US$US
243457251$24345725$1$I$$20240709$20240920$20240920$PER$$US-VIVUS LLC-2024V1000859$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243457261$24345726$1$I$$20240709$20240920$20240920$PER$$US-VIVUS LLC-2024V1000862$VIVUS$$$$E$M$Y$$$20240913$$HP$US$US
243457271$24345727$1$I$20240701$20240709$20240920$20240920$PER$$US-VIVUS LLC-2024V1000864$VIVUS$$39$YR$A$F$Y$77.18$KG$20240913$$CN$US$US
243457281$24345728$1$I$$20240710$20240920$20240920$PER$$US-VIVUS LLC-2024V1000866$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457291$24345729$1$I$$20240709$20240920$20240920$PER$$US-VIVUS LLC-2024V1000867$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457301$24345730$1$I$$20240710$20240920$20240920$PER$$US-VIVUS LLC-2024V1000868$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457311$24345731$1$I$$20240710$20240920$20240920$PER$$US-VIVUS LLC-2024V1000870$VIVUS$$$$T$M$Y$$$20240913$$CN$US$US
243457321$24345732$1$I$$20240710$20240920$20240920$PER$$US-VIVUS LLC-2024V1000871$VIVUS$$52$YR$A$F$Y$92.162$KG$20240913$$CN$US$US
243457331$24345733$1$I$$20240710$20240920$20240920$PER$$US-VIVUS LLC-2024V1000872$VIVUS$$$$E$F$Y$65.376$KG$20240913$$CN$US$US
243457341$24345734$1$I$$20240711$20240920$20240920$PER$$US-VIVUS LLC-2024V1000875$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457351$24345735$1$I$$20240711$20240920$20240920$PER$$US-VIVUS LLC-2024V1000877$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457361$24345736$1$I$$20240711$20240920$20240920$PER$$US-VIVUS LLC-2024V1000878$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243457371$24345737$1$I$$20240712$20240920$20240920$PER$$US-VIVUS LLC-2024V1000879$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457381$24345738$1$I$$20240712$20240920$20240920$PER$$US-VIVUS LLC-2024V1000880$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457391$24345739$1$I$$20240712$20240920$20240920$PER$$US-VIVUS LLC-2024V1000881$VIVUS$$61$YR$A$F$Y$$$20240913$$CN$US$US
243457401$24345740$1$I$$20240715$20240920$20240920$PER$$US-VIVUS LLC-2024V1000882$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457411$24345741$1$I$$20240712$20240920$20240920$PER$$US-VIVUS LLC-2024V1000884$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457421$24345742$1$I$$20240715$20240920$20240920$PER$$US-VIVUS LLC-2024V1000885$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457431$24345743$1$I$$20240715$20240920$20240920$PER$$US-VIVUS LLC-2024V1000886$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457441$24345744$1$I$$20240715$20240920$20240920$PER$$US-VIVUS LLC-2024V1000888$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243457451$24345745$1$I$$20240715$20240920$20240920$PER$$US-VIVUS LLC-2024V1000889$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457461$24345746$1$I$$20240715$20240920$20240920$PER$$US-VIVUS LLC-2024V1000890$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457471$24345747$1$I$$20240716$20240920$20240920$PER$$US-VIVUS LLC-2024V1000891$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457481$24345748$1$I$$20240715$20240920$20240920$PER$$US-VIVUS LLC-2024V1000892$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457491$24345749$1$I$$20240715$20240920$20240920$PER$$US-VIVUS LLC-2024V1000893$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457501$24345750$1$I$$20240612$20240920$20240920$PER$$US-VIVUS LLC-2024V1000558$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457511$24345751$1$I$$20240618$20240920$20240920$PER$$US-VIVUS LLC-2024V1000640$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457521$24345752$1$I$$20240614$20240920$20240920$PER$$US-VIVUS LLC-2024V1000645$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457531$24345753$1$I$$20240612$20240920$20240920$PER$$US-VIVUS LLC-2024V1000762$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457541$24345754$1$I$$20240613$20240920$20240920$PER$$US-VIVUS LLC-2024V1000763$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457551$24345755$1$I$$20240613$20240920$20240920$PER$$US-VIVUS LLC-2024V1000764$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457561$24345756$1$I$$20240613$20240920$20240920$PER$$US-VIVUS LLC-2024V1000765$VIVUS$$$$E$M$Y$$$20240913$$CN$US$US
243457571$24345757$1$I$$20240617$20240920$20240920$PER$$US-VIVUS LLC-2024V1000769$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457581$24345758$1$I$$20240617$20240920$20240920$PER$$US-VIVUS LLC-2024V1000771$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457591$24345759$1$I$$20240617$20240920$20240920$PER$$US-VIVUS LLC-2024V1000772$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457601$24345760$1$I$$20240617$20240920$20240920$EXP$$US-VIVUS LLC-2024V1000773$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457611$24345761$1$I$$20240617$20240920$20240920$PER$$US-VIVUS LLC-2024V1000774$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457621$24345762$1$I$$20240618$20240920$20240920$PER$$US-VIVUS LLC-2024V1000776$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457631$24345763$1$I$$20240619$20240920$20240920$PER$$US-VIVUS LLC-2024V1000777$VIVUS$$$$A$F$Y$93.524$KG$20240913$$CN$US$US
243457641$24345764$1$I$$20240618$20240920$20240920$PER$$US-VIVUS LLC-2024V1000778$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243457651$24345765$1$I$$20240619$20240920$20240920$PER$$US-VIVUS LLC-2024V1000779$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457661$24345766$1$I$$20240619$20240920$20240920$PER$$US-VIVUS LLC-2024V1000784$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243457671$24345767$1$I$$20240619$20240920$20240920$PER$$US-VIVUS LLC-2024V1000785$VIVUS$$$$E$M$Y$$$20240913$$CN$US$US
243457681$24345768$1$I$$20240619$20240920$20240920$PER$$US-VIVUS LLC-2024V1000786$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457691$24345769$1$I$$20240619$20240920$20240920$PER$$US-VIVUS LLC-2024V1000787$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457701$24345770$1$I$20230301$20240626$20240920$20240920$PER$$US-VIVUS LLC-2024V1000426$VIVUS$$29$YR$A$F$Y$156.63$KG$20240913$$CN$US$US
243457711$24345771$1$I$$20240625$20240920$20240920$PER$$US-VIVUS LLC-2024V1000611$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457721$24345772$1$I$$20240620$20240920$20240920$PER$$US-VIVUS LLC-2024V1000788$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457731$24345773$1$I$$20240620$20240920$20240920$PER$$US-VIVUS LLC-2024V1000790$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243457741$24345774$1$I$$20240620$20240920$20240920$PER$$US-VIVUS LLC-2024V1000791$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457751$24345775$1$I$$20240620$20240920$20240920$PER$$US-VIVUS LLC-2024V1000792$VIVUS$$$$T$F$Y$$$20240913$$CN$US$US
243457761$24345776$1$I$$20240621$20240920$20240920$PER$$US-VIVUS LLC-2024V1000795$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457771$24345777$1$I$$20240624$20240920$20240920$PER$$US-VIVUS LLC-2024V1000796$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457781$24345778$1$I$$20240624$20240920$20240920$PER$$US-VIVUS LLC-2024V1000797$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457791$24345779$1$I$20240601$20240624$20240920$20240920$PER$$US-VIVUS LLC-2024V1000799$VIVUS$$66$YR$E$F$Y$$$20240913$$CN$US$US
243457801$24345780$1$I$$20240624$20240920$20240920$PER$$US-VIVUS LLC-2024V1000800$VIVUS$$$$A$$Y$$$20240913$$CN$US$US
243457811$24345781$1$I$$20240624$20240920$20240920$PER$$US-VIVUS LLC-2024V1000801$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457821$24345782$1$I$$20240624$20240920$20240920$PER$$US-VIVUS LLC-2024V1000803$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457831$24345783$1$I$$20240624$20240920$20240920$PER$$US-VIVUS LLC-2024V1000805$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457841$24345784$1$I$$20240624$20240920$20240920$PER$$US-VIVUS LLC-2024V1000806$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457851$24345785$1$I$20220901$20240625$20240920$20240920$PER$$US-VIVUS LLC-2024V1000810$VIVUS$$16$YR$T$F$Y$$$20240913$$HP$US$US
243457861$24345786$1$I$$20240625$20240920$20240920$PER$$US-VIVUS LLC-2024V1000811$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243457871$24345787$1$I$$20240625$20240920$20240920$PER$$US-VIVUS LLC-2024V1000812$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243457881$24345788$1$I$$20240625$20240920$20240920$PER$$US-VIVUS LLC-2024V1000815$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457891$24345789$1$I$$20240625$20240920$20240920$PER$$US-VIVUS LLC-2024V1000817$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457901$24345790$1$I$$20230824$20240920$20240920$PER$$US-VIVUS LLC-2023V1000886$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243457911$24345791$1$I$20201201$20230829$20240920$20240920$EXP$$US-VIVUS LLC-2023V1000912$VIVUS$$54$YR$A$F$Y$$$20240913$$CN$US$US
243457921$24345792$1$I$20230101$20231025$20240920$20240920$EXP$$US-VIVUS LLC-2023V1001188$VIVUS$$41$YR$A$F$Y$56.75$KG$20240913$$CN$US$US
243457931$24345793$1$I$$20231027$20240920$20240920$EXP$$US-VIVUS LLC-2023V1001198$VIVUS$$$$$$Y$$$20240913$$MD$US$US
243457941$24345794$1$I$$20231028$20240920$20240920$EXP$$US-VIVUS LLC-2023V1001201$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457951$24345795$1$I$$20231107$20240920$20240920$EXP$$US-VIVUS LLC-2023V1001232$VIVUS$$$$$F$Y$$$20240913$$MD$US$US
243457961$24345796$1$I$$20231106$20240920$20240920$EXP$$KR-VIVUS LLC-2023V1001247$VIVUS$$41$YR$A$M$Y$$$20240913$$MD$KR$KR
243457971$24345797$1$I$20240108$20240111$20240920$20240920$EXP$$US-VIVUS LLC-2024V1000037$VIVUS$$49$YR$A$F$Y$$$20240913$$CN$US$US
243457981$24345798$1$I$$20240205$20240920$20240920$EXP$$US-VIVUS LLC-2024V1000119$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243457991$24345799$1$I$20220701$20240521$20240920$20240920$EXP$$US-VIVUS LLC-2024V1000618$VIVUS$$53$YR$A$F$Y$74.91$KG$20240913$$CN$US$US
243458001$24345800$1$I$$20240528$20240920$20240920$EXP$$US-VIVUS LLC-2024V1000637$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243458011$24345801$1$I$$20240716$20240920$20240920$PER$$US-VIVUS LLC-2024V1000794$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243458021$24345802$1$I$$20240624$20240920$20240920$EXP$$US-VIVUS LLC-2024V1000807$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243458031$24345803$1$I$$20240712$20240920$20240920$PER$$US-VIVUS LLC-2024V1000850$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243458041$24345804$1$I$$20240716$20240920$20240920$PER$$US-VIVUS LLC-2024V1000894$VIVUS$$$$E$M$Y$$$20240913$$CN$US$US
243458051$24345805$1$I$$20240716$20240920$20240920$PER$$US-VIVUS LLC-2024V1000895$VIVUS$$$$$M$Y$$$20240913$$CN$US$US
243458061$24345806$1$I$$20240716$20240920$20240920$PER$$US-VIVUS LLC-2024V1000896$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243458071$24345807$1$I$$20240716$20240920$20240920$PER$$US-VIVUS LLC-2024V1000898$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243458081$24345808$1$I$$20240717$20240920$20240920$PER$$US-VIVUS LLC-2024V1000900$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243458091$24345809$1$I$$20240716$20240920$20240920$PER$$US-VIVUS LLC-2024V1000908$VIVUS$$$$$M$Y$91$KG$20240913$$CN$US$US
243458101$24345810$1$I$20240101$20240717$20240920$20240920$PER$$US-VIVUS LLC-2024V1000909$VIVUS$$30$YR$A$F$Y$88.53$KG$20240913$$CN$US$US
243458121$24345812$1$I$20240911$20240911$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013531$DR REDDYS$$78$YR$E$M$Y$$$20240920$$CN$US$US
243458131$24345813$1$I$20240801$20240911$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013532$DR REDDYS$$16$YR$T$$Y$$$20240920$$CN$US$US
243458141$24345814$1$I$$20240912$20240920$20240920$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052613$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240920$$CN$US$US
243458151$24345815$1$I$$20240910$20240920$20240920$PER$$US-RDY-SPO/USA/24/0013451$DR REDDYS$Kayal M, Gottlieb Z, Glamour B, Ibing S, Spencer E, Dubinsky MC. Acute Pouchitis is Common in Pregnant and Postpartum Women. Clinical and Translational Gastroenterology. 2024 Aug 01;15(8): doi:10.14309/ctg.0000000000000732.$$$$F$Y$$$20240920$$MD$US$US
243458171$24345817$1$I$$20240918$20240920$20240920$PER$$US-BAUSCH-BL-2024-014109$BAUSCH AND LOMB$$$$$M$Y$$$20240920$$CN$US$US
243458181$24345818$1$I$20160301$20240911$20240920$20240920$EXP$$DE-TEVA-2018-DE-892756$TEVA$$82$YR$$F$Y$56$KG$20240920$$MD$DE$DE
243458191$24345819$1$I$20240728$20240912$20240920$20240920$EXP$IT-MINISAL02-999731$IT-TEVA-VS-3239171$TEVA$$85$YR$$F$Y$55$KG$20240920$$MD$IT$IT
243458201$24345820$1$I$20240328$20240912$20240920$20240920$EXP$FR-AFSSAPS-AM2024000715$FR-TEVA-VS-3243350$TEVA$$20$YR$$F$Y$80$KG$20240920$$MD$FR$FR
243458212$24345821$2$F$20230103$20240923$20240920$20240926$EXP$$US-JNJFOC-20240931364$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240926$$CN$US$US
243458221$24345822$1$I$$20240911$20240920$20240920$PER$$US-ABBVIE-5921671$ABBVIE$$$$$$Y$$$20240920$$HP$US$US
243458231$24345823$1$I$$20240916$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148915$BRISTOL MYERS SQUIBB$$$$A$$Y$$$20240920$$MD$US$US
243458241$24345824$1$I$$20240916$20240920$20240920$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149750$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240920$$CN$US$US
243458251$24345825$1$I$$20240821$20240920$20240920$PER$$US-009507513-2408USA008599$MERCK$Jones AA, Martin JS, Giangiacomo AL, Costakos DM. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024;36:102131$8$WK$$M$Y$$$20240920$$HP$US$US
243458261$24345826$1$I$20240810$20240920$20240920$20240920$EXP$ES-AEMPS-1570732$NVSC2024ES187871$NOVARTIS$$18$YR$$F$Y$$$20240920$$MD$ES$ES
243458271$24345827$1$I$20240823$20240916$20240920$20240920$EXP$FR-AFSSAPS-LM2024000496$FR-TEVA-VS-3244294$TEVA$$49$YR$$F$Y$$$20240920$$MD$FR$FR
243458281$24345828$1$I$20240301$20240912$20240920$20240920$EXP$FR-AFSSAPS-TO2024001637$FR-TEVA-VS-3243405$TEVA$$77$YR$$M$Y$$$20240920$$MD$FR$FR
243458291$24345829$1$I$$20240918$20240920$20240920$PER$$NVSC2024US187206$NOVARTIS$$45$YR$$F$Y$$$20240920$$CN$US$US
243458301$24345830$1$I$20240904$20240914$20240920$20240920$PER$$CN-Eisai-EC-2024-174437$EISAI$$55$YR$A$M$Y$55$KG$20240920$$HP$CN$CN
243458311$24345831$1$I$20240806$20240911$20240920$20240920$EXP$ES-AEMPS-1566305$ES-TEVA-VS-3242823$TEVA$$61$YR$$M$Y$$$20240920$$MD$ES$ES
243458331$24345833$1$I$$20240909$20240920$20240920$PER$$US-TPU-TPU-2024-00475$TEIKOKU$$$$$M$Y$120.2$KG$20240920$$CN$US$US
243458341$24345834$1$I$$20240912$20240920$20240920$PER$$US-TPU-TPU-2024-00481$TEIKOKU$$$$$F$Y$$$20240920$$CN$US$US
243458351$24345835$1$I$20240101$20240916$20240920$20240920$EXP$DE-CADRBFARM-2024330333$DE-TEVA-VS-3244176$TEVA$$43$YR$$M$Y$84$KG$20240920$$MD$DE$DE
243458371$24345837$1$I$20240515$20240916$20240920$20240920$EXP$FR-AFSSAPS-AVMA2024000391$FR-TEVA-VS-3244245$TEVA$$31$YR$$M$Y$$$20240920$$PH$FR$FR
243458381$24345838$1$I$$20240915$20240920$20240920$EXP$$US-JNJFOC-20240947107$JOHNSON AND JOHNSON$$$$$M$Y$$$20240920$$CN$US$US
243458391$24345839$1$I$20240101$20240911$20240920$20240920$PER$$US-SA-2024SA266766$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240920$$MD$US$US
243458401$24345840$1$I$20240901$20240912$20240920$20240920$EXP$$ZA-TEVA-VS-3244551$TEVA$$41$YR$$F$Y$82$KG$20240920$$HP$ZA$ZA
243458411$24345841$1$I$$20240911$20240920$20240920$PER$$US-ABBVIE-5922349$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243458421$24345842$1$I$20240603$20240916$20240920$20240920$EXP$IT-MINISAL02-1001531$IT-TEVA-VS-3244257$TEVA$$71$YR$$F$Y$$$20240920$$MD$IT$IT
243458431$24345843$1$I$20240501$20240913$20240920$20240920$EXP$FR-AFSSAPS-AVNT2024000669$FR-TEVA-VS-3243927$TEVA$$40$YR$$M$Y$$$20240920$$PH$FR$FR
243458441$24345844$1$I$$20240914$20240920$20240920$EXP$$US-JNJFOC-20240946115$JOHNSON AND JOHNSON$$$$$$Y$$$20240920$$CN$US$US
243458451$24345845$1$I$$20240917$20240920$20240920$PER$$US-AMGEN-USASP2024187109$AMGEN$$$$$$Y$$$20240920$$MD$US$US
243458461$24345846$1$I$$20240918$20240920$20240920$EXP$$BG-BAUSCH-BL-2024-014149$BAUSCH AND LOMB$Viktoria B, Ivan K. Clinic of Hematology. Military Medical Academy.$62$YR$$M$Y$$$20240920$$MD$BG$BG
243458481$24345848$1$I$20230504$20240915$20240920$20240920$EXP$FR-AFSSAPS-MA2024001469$FR-GE HEALTHCARE-2024CSU010577$GE HEALTHCARE$$75$YR$$M$Y$80$KG$20240920$$PH$FR$FR
243458491$24345849$1$I$20240906$20240913$20240920$20240920$EXP$$GB-GE HEALTHCARE-2024CSU010555$GE HEALTHCARE$$68$YR$$M$Y$76$KG$20240920$$HP$GB$GB
243458511$24345851$1$I$20240801$20240913$20240920$20240920$EXP$$US-009507513-2409USA005653$MERCK$$64$YR$$M$Y$$$20240920$$MD$US$US
243458521$24345852$1$I$20240101$20240909$20240920$20240920$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002663$CORCEPT$$$$$$Y$$$20240920$$MD$US$US
243458532$24345853$2$F$$20240924$20240920$20240927$PER$$US-BIOMARINAP-US-2024-160652$BIOMARIN$$$$$$Y$$$20240927$$CN$US$US
243458551$24345855$1$I$20240306$20240920$20240920$20240920$EXP$FR-AFSSAPS-NY2024001086$NVSC2024FR187770$NOVARTIS$$32$YR$$F$Y$70$KG$20240920$$MD$FR$FR
243458571$24345857$1$I$$20240919$20240920$20240920$PER$$US-BIOMARINAP-US-2024-160682$BIOMARIN$$$$$$Y$$$20240920$$CN$US$US
243458581$24345858$1$I$$20240917$20240920$20240920$PER$$US-BIOMARINAP-US-2024-160668$BIOMARIN$$$$$$Y$$$20240920$$CN$US$US
243458591$24345859$1$I$$20240911$20240920$20240920$PER$$US-IMP-2024000733$Harrow Health$$$$E$F$Y$$$20240920$$CN$US$US
243458601$24345860$1$I$20240612$20240920$20240920$20240920$EXP$FR-AFSSAPS-LL2024001773$NVSC2024FR187781$NOVARTIS$$74$YR$$M$Y$$$20240920$$PH$FR$FR
243458612$24345861$2$F$20240720$20240918$20240920$20240924$EXP$FR-AFSSAPS-AN2024001217$FR-009507513-2409FRA006380$MERCK$$80$YR$$F$Y$70.5$KG$20240924$$MD$FR$FR
243458631$24345863$1$I$20240726$20240916$20240920$20240920$EXP$$AU-009507513-2409AUS006055$MERCK$$78$YR$$M$Y$$$20240920$$HP$AU$AU
243458641$24345864$1$I$$20240911$20240920$20240920$EXP$$NVSC2024US185035$NOVARTIS$$83$YR$$F$Y$$$20240920$$MD$US$US
243458651$24345865$1$I$$20240919$20240920$20240920$PER$$NVSC2024US188125$NOVARTIS$$$$$$Y$$$20240920$$MD$US$US
243458661$24345866$1$I$20200212$20240911$20240920$20240920$EXP$$CN-JNJFOC-20240935767$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240920$$HP$CN$CN
243458671$24345867$1$I$$20240913$20240920$20240920$PER$$US-009507513-2409USA005372$MERCK$$$$$F$Y$$$20240920$$HP$US$US
243458691$24345869$1$I$$20240906$20240920$20240920$EXP$$AU-ABBVIE-5302746$ABBVIE$Verner E, Pati N, Hawkes E, Lee H, Cochrane T, Cheah C, Filshie R, Purtill D, Sia H, Enjeti A, Brown C, Murphy N, Curnow J, Lee K, Gandhi M, Butcher B, Trotman J, Johnston A. FINAL ANALYSIS OF AUSTRALASIAN LEUKAEMIA + LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB,RITUXIMAB AND MINI CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL. Wiley. 426-427.$$$E$$Y$$$20240920$$HP$AU$AU
243458711$24345871$1$I$20240918$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011668$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240920$$CN$US$US
243458721$24345872$1$I$20240913$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011608$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240920$$CN$US$US
243458731$24345873$1$I$20240917$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011705$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243458741$24345874$1$I$20240917$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011944$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240920$$CN$US$US
243458751$24345875$1$I$20240801$20240828$20240920$20240920$PER$$US-SA-2024SA267040$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240920$$MD$US$US
243458761$24345876$1$I$20230131$20240919$20240920$20240920$EXP$FR-AFSSAPS-MA2024001484$FR-009507513-2409FRA007393$MERCK$$68$YR$$F$Y$$$20240920$$CN$FR$FR
243458771$24345877$1$I$20240901$20240916$20240920$20240920$EXP$$US-RIGEL-20240900088$RIGEL PHARMACEUTICALS$$62$YR$$F$Y$$$20240920$$CN$US$US
243458781$24345878$1$I$20240515$20240919$20240920$20240920$EXP$FR-AFSSAPS-AM2024000726$NVSC2024FR186865$NOVARTIS$$35$YR$$M$Y$82$KG$20240920$$MD$FR$FR
243458791$24345879$1$I$20230629$20240910$20240920$20240920$EXP$$JP-RIGEL-20240900091$RIGEL PHARMACEUTICALS$$78$YR$$F$Y$49$KG$20240920$$MD$JP$JP
243458801$24345880$1$I$20240911$20240912$20240920$20240920$PER$$US-IMP-2024000742$Harrow Health$$67$YR$E$F$Y$$$20240920$$CN$US$US
243458811$24345881$1$I$20240823$20240916$20240920$20240920$EXP$ES-AEMPS-1565724$ES-TEVA-VS-3244246$TEVA$$79$YR$$F$Y$$$20240920$$MD$ES$ES
243458831$24345883$1$I$20240906$20240912$20240920$20240920$EXP$$CN-009507513-2409CHN005451$MERCK$$91$YR$$M$Y$$$20240920$$HP$CN$CN
243458841$24345884$1$I$$20240919$20240920$20240920$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052496$BOEHRINGER INGELHEIM$$$$$$Y$$$20240920$$MD$US$US
243458851$24345885$1$I$$20240821$20240920$20240920$PER$$US-009507513-2409USA006007$MERCK$Jones AA, Martin JS, Giangiacomo AL, Costakos DM. Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity. American Journal of Ophthalmology Case Reports. 2024;36:102131$17$WK$$F$Y$$$20240920$$HP$US$US
243458861$24345886$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011307$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240920$$CN$US$US
243458871$24345887$1$I$$20240903$20240920$20240920$PER$$US-ABBVIE-5930905$ABBVIE$$$$$$Y$$$20240920$$HP$US$US
243458881$24345888$1$I$$20240829$20240920$20240920$PER$$US-SA-2023SA255911$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240920$$CN$US$US
243458891$24345889$1$I$20240910$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011789$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240920$$CN$US$US
243458901$24345890$1$I$20240910$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011566$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240920$$CN$US$US
243458911$24345891$1$I$$20240910$20240920$20240920$EXP$$JP-EAGLE PHARMACEUTICALS, INC.-JP-2024EAG000218$EAGLE$Tatsuya Sakai et al.. A case of long COVID-19 developed one year after GB therapy. The 28th Annual Meeting of Japanese Society of Hospital General Medicine. 2024;O-111$$$A$M$Y$$$20240920$$MD$JP$JP
243458931$24345893$1$I$20240902$20240914$20240920$20240920$PER$$CN-Eisai-EC-2024-174436$EISAI$$58$YR$A$F$Y$51$KG$20240920$$HP$CN$CN
243458942$24345894$2$F$$20240917$20240920$20240926$EXP$$US-DSJP-DSU-2024-144818AA$DAIICHI$$$$$F$Y$$$20240926$$CN$US$US
243458951$24345895$1$I$20240806$20240917$20240920$20240920$EXP$$NL-GILEAD-2024-0688001$GILEAD$$$$A$M$Y$86$KG$20240920$$MD$NL$NL
243458961$24345896$1$I$20240910$20240910$20240920$20240920$EXP$$CO-TAKEDA-2024TUS093795$TAKEDA$$38$YR$$F$Y$52$KG$20240920$$CN$CO$CO
243458971$24345897$1$I$$20240914$20240920$20240920$PER$$JP-Eisai-EC-2024-174508$EISAI$Matsumura Noriomi. Cases of Pembrolizumab + Lenvatinib administration at our hospital (cases of administration for 2 months or more). Uterine cancer online lecture.$$$E$F$Y$$$20240920$$MD$JP$JP
243458981$24345898$1$I$20211111$20240916$20240920$20240920$EXP$ES-AEMPS-1568222$ES-TEVA-VS-3244202$TEVA$$37$YR$$F$Y$77$KG$20240920$$PH$ES$ES
243458991$24345899$1$I$$20240916$20240920$20240920$EXP$$AR-BIOGEN-2024BI01283091$BIOGEN$$$$$F$Y$$$20240920$$CN$AR$AR
243459001$24345900$1$I$$20240905$20240920$20240920$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-27082$SAMSUNG BIOEPIS$$79$YR$E$M$Y$$$20240920$$CN$AU$AU
243459011$24345901$1$I$20230405$20240918$20240920$20240920$EXP$$NVSC2024AU187365$NOVARTIS$$74$YR$$F$Y$$$20240920$$MD$AU$AU
243459021$24345902$1$I$$20240911$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409007062$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240920$$CN$US$US
243459031$24345903$1$I$$20240905$20240920$20240920$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-27074$SAMSUNG BIOEPIS$$59$YR$A$F$Y$$$20240920$$MD$AU$AU
243459041$24345904$1$I$20240101$20240917$20240920$20240920$PER$$US-009507513-2409USA006278$MERCK$$$$$M$Y$$$20240920$$CN$US$US
243459051$24345905$1$I$20240201$20240912$20240920$20240920$PER$$US-BIOGEN-2023BI01242279$BIOGEN$$19$YR$$M$Y$$$20240920$$MD$US$US
243459062$24345906$2$F$20200101$20240917$20240920$20240923$EXP$$JP-009507513-2409JPN002035J$MERCK$$69$YR$$F$Y$$$20240923$$MD$JP$JP
243459072$24345907$2$F$$20240920$20240920$20240923$PER$$NVSC2024US187944$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
243459081$24345908$1$I$$20240905$20240920$20240920$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-27078$SAMSUNG BIOEPIS$$$$$F$Y$$$20240920$$MD$AU$AU
243459091$24345909$1$I$$20240919$20240920$20240920$EXP$$ES-GILEAD-2024-0688212$GILEAD$$$$$M$Y$$$20240920$$HP$ES$ES
243459101$24345910$1$I$20240919$20240919$20240920$20240920$EXP$$US-GILEAD-2024-0688349$GILEAD$$37$YR$A$M$Y$$$20240920$$CN$US$US
243459111$24345911$1$I$$20240919$20240920$20240920$EXP$$US-GILEAD-2024-0688376$GILEAD$$70$YR$E$M$Y$$$20240920$$CN$US$US
243459121$24345912$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011868$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240920$$CN$US$US
243459131$24345913$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010649$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240920$$CN$US$US
243459141$24345914$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011849$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240920$$CN$US$US
243459151$24345915$1$I$$20240909$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409006068$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240920$$HP$US$US
243459161$24345916$1$I$$20240917$20240920$20240920$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202409011113$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240920$$MD$SA$SA
243459171$24345917$1$I$$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011757$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240920$$CN$US$US
243459191$24345919$1$I$$20240912$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409007950$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243459201$24345920$1$I$$20240913$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010855$ELI LILLY AND CO$$7$YR$C$F$Y$$$20240920$$CN$US$US
243459211$24345921$1$I$20240917$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011659$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240920$$CN$US$US
243459222$24345922$2$F$20240918$20240920$20240920$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409011698$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240925$$HP$US$US
243459231$24345923$1$I$20240911$20240918$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011861$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240920$$CN$US$US
243459241$24345924$1$I$20240101$20240917$20240920$20240920$EXP$$US-AMGEN-USASL2024185835$AMGEN$$39$YR$A$F$Y$$$20240920$$CN$US$US
243459251$24345925$1$I$$20240919$20240920$20240920$EXP$$AU-GILEAD-2024-0688387$GILEAD$$$$E$M$Y$$$20240920$$HP$AU$AU
243459261$24345926$1$I$$20240905$20240920$20240920$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-27069$SAMSUNG BIOEPIS$A Case of COVID-19 masquerading as presumed Trastuzamab induced subclinical cardiotoxicity. Sonography. 2023 Oct 19;11(1): 48-51. doi:10.1002/sono.12380.$48$YR$A$F$Y$$$20240920$$HP$AU$AU
243459271$24345927$1$I$$20240914$20240920$20240920$PER$$US-AMGEN-USASP2024184395$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243459281$24345928$1$I$$20240903$20240920$20240920$PER$$US-SA-2024SA270548$SANOFI AVENTIS$$$$A$F$Y$66.82$KG$20240921$$MD$US$US
243459291$24345929$1$I$20240801$20240919$20240920$20240920$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149687$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240920$$HP$US$US
243459301$24345930$1$I$$20240917$20240920$20240920$EXP$$US-009507513-2409USA006819$MERCK$$$$$F$Y$$$20240920$$CN$US$US
243459311$24345931$1$I$$20240919$20240920$20240920$PER$$NVSC2024US188191$NOVARTIS$$$$$F$Y$$$20240921$$HP$US$US
243459331$24345933$1$I$20240725$20240916$20240920$20240920$EXP$FR-AFSSAPS-TS2024000964$FR-TEVA-VS-3244407$TEVA$$11$YR$$F$Y$50$KG$20240920$$MD$FR$FR
243459341$24345934$1$I$$20240916$20240920$20240920$EXP$$US-BIOGEN-2024BI01282969$BIOGEN$$$$$F$Y$$$20240920$$MD$US$US
243459351$24345935$1$I$$20240911$20240920$20240920$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09158$NEUROCRINE BIOSCIENCES$$57$YR$$M$Y$$$20240920$$PH$US$US
243459371$24345937$1$I$20210802$20240914$20240920$20240920$EXP$$DE-BIOGEN-2024BI01282923$BIOGEN$$29$YR$$F$Y$64$KG$20240920$$CN$DE$DE
243459381$24345938$1$I$20240901$20240919$20240920$20240920$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052462$BOEHRINGER INGELHEIM$$76$YR$E$M$Y$$$20240920$$CN$US$US
243459391$24345939$1$I$$20240916$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409010136$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240920$$CN$US$US
243459411$24345941$1$I$20240911$20240911$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409007900$ELI LILLY AND CO$$$$A$F$Y$$$20240920$$CN$US$US
243459421$24345942$1$I$$20240910$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409007059$ELI LILLY AND CO$$$$$F$Y$$$20240920$$CN$US$US
243459431$24345943$1$I$20240911$20240911$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409007953$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240920$$CN$US$US
243459442$24345944$2$F$$20240916$20240920$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409011812$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240925$$CN$US$US
243459451$24345945$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011381$ELI LILLY AND CO$$56$YR$A$$Y$$$20240920$$CN$US$US
243459461$24345946$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011380$ELI LILLY AND CO$$59$YR$A$$Y$$$20240920$$CN$US$US
243459471$24345947$1$I$20240101$20240910$20240920$20240920$PER$$US-009507513-2409USA004411$MERCK$$$$$F$Y$$$20240920$$CN$US$US
243459491$24345949$1$I$$20240920$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409013163$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240920$$CN$US$US
243459501$24345950$1$I$20240805$20240911$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409007952$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240920$$CN$US$US
243459511$24345951$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011344$ELI LILLY AND CO$$63$YR$A$$Y$$$20240920$$LW$US$US
243459521$24345952$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011366$ELI LILLY AND CO$$43$YR$A$$Y$$$20240920$$CN$US$US
243459531$24345953$1$I$20240906$20240906$20240920$20240920$EXP$$CA-HLS-202402251$HLS THERAPEUTICS$$63$YR$A$M$Y$$$20240920$$PH$CA$CA
243459542$24345954$2$F$20240919$20240920$20240920$20240921$PER$$US-AMGEN-USASP2024188157$AMGEN$$67$YR$E$F$Y$$$20240921$$CN$US$US
243459551$24345955$1$I$$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011011$ELI LILLY AND CO$$$$$$Y$$$20240920$$CN$US$US
243459561$24345956$1$I$20240426$20240906$20240920$20240920$EXP$$CA-HLS-202402253$HLS THERAPEUTICS$$58$YR$A$F$Y$$$20240920$$HP$CA$CA
243459571$24345957$1$I$$20240914$20240920$20240920$PER$$US-JNJFOC-20240947497$JOHNSON AND JOHNSON$$64$YR$A$F$Y$68$KG$20240920$$CN$US$US
243459581$24345958$1$I$$20240906$20240920$20240920$EXP$$CA-HLS-202402254$HLS THERAPEUTICS$$$$A$M$Y$$$20240920$$HP$CA$CA
243459591$24345959$1$I$20240906$20240906$20240920$20240920$EXP$$CA-HLS-202402259$HLS THERAPEUTICS$$79$YR$E$M$Y$$$20240920$$PH$CA$CA
243459601$24345960$1$I$20240904$20240907$20240920$20240920$EXP$$CA-HLS-202402260$HLS THERAPEUTICS$$30$YR$A$F$Y$$$20240920$$PH$CA$CA
243459611$24345961$1$I$20240916$20240916$20240920$20240920$PER$$US-DAIICHI SANKYO, INC.-DS-2024-100267-US$DAIICHI$$58$YR$$F$Y$$$20240921$$MD$US$US
243459621$24345962$1$I$$20240911$20240920$20240920$EXP$$RU-SANDOZ INC.-SDZ2024RU081809$SANDOZ$Kholmanskikh AS. ??????? ? ??????? ????? ???????????????? ???????????? ??????? ? ?????????, ?????????? ???????????????? ??????? ?? ?????? ??????????? [Frequency and risk factors of drug-induced osteonecrosis of the jaw in patients receiving antiresorptive therapy for osteoporosis]. OSTEOPOROSIS AND BONE DISEASES. 2024;27(S1): S4-S:118$$$E$F$Y$$$20240920$$HP$RU$RU
243459631$24345963$1$I$20240913$20240917$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409011340$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240920$$CN$US$US
243459641$24345964$1$I$$20240910$20240920$20240920$EXP$$CA-HLS-202402275$HLS THERAPEUTICS$$86$YR$E$F$Y$$$20240920$$HP$CA$CA
243459651$24345965$1$I$20240801$20240912$20240920$20240920$EXP$$US-RADIUS HEALTH INC.-2024US007253$RADIUS PHARM$$55$YR$$F$Y$$$20240920$$CN$US$US
243459661$24345966$1$I$$20240916$20240920$20240920$EXP$$PL-SANDOZ INC.-PHHY2015PL150316$SANDOZ$$56$YR$$F$Y$$$20240920$$HP$PL$PL
243459671$24345967$1$I$$20240912$20240920$20240920$EXP$$US-JNJFOC-20240931682$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243459681$24345968$1$I$$20240905$20240920$20240920$EXP$$US-SMPA-2024SPA002007$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243459691$24345969$1$I$$20240910$20240920$20240920$PER$$US-JNJFOC-20240947571$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$HP$US$US
243459701$24345970$1$I$20240708$20240917$20240920$20240920$EXP$$AU-SANDOZ INC.-SDZ2024AU081094$SANDOZ$$70$YR$$F$Y$$$20240920$$HP$AU$AU
243459711$24345971$1$I$$20240911$20240920$20240920$PER$$US-ELI_LILLY_AND_COMPANY-US202409007832$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240920$$CN$US$US
243459731$24345973$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA267503$SANOFI AVENTIS$$$$T$M$Y$$$20240921$$HP$US$US
243459741$24345974$1$I$20240801$20240918$20240920$20240920$EXP$$DE-009507513-2409DEU006750$MERCK$$47$YR$$F$Y$$$20240920$$MD$DE$DE
243459751$24345975$1$I$20240101$20240913$20240920$20240920$PER$$US-SA-2024SA267408$SANOFI AVENTIS$$$$A$F$Y$$$20240921$$MD$US$US
243459761$24345976$1$I$20240901$20240912$20240920$20240920$PER$$US-SA-2024SA267631$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240921$$HP$US$US
243459771$24345977$1$I$$20240826$20240920$20240920$PER$$US-SMPA-2024SPA002005$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243459781$24345978$1$I$$20240826$20240920$20240920$PER$$US-SMPA-2024SPA001954$SUNOVION$$$$$$Y$$$20240920$$CN$US$US
243459791$24345979$1$I$20240909$20240913$20240920$20240920$PER$$US-SA-2024SA267920$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240921$$MD$US$US
243459801$24345980$1$I$$20240913$20240920$20240920$EXP$$BR-AMGEN-BRASP2024183838$AMGEN$$70$YR$E$F$Y$$$20240920$$CN$BR$BR
243459812$24345981$2$F$20240901$20240917$20240920$20240922$EXP$$US-AMGEN-USASP2024185951$AMGEN$$$$T$M$Y$$$20240922$$HP$US$US
243459821$24345982$1$I$20220503$20240918$20240920$20240920$EXP$$CA-ABBVIE-5930780$ABBVIE$$55$YR$$M$Y$$$20240920$$MD$CA$CA
243459831$24345983$1$I$$20240911$20240920$20240920$EXP$$CN-AZURITY PHARMACEUTICALS, INC.-AZR202409-000626$AZURITY PHARMACEUTICALS$Yang Y, Zhang W, Li Y.. Acute retinal necrosis possibly triggered by contra-lateral penetrating trauma. Ocul Immunol Inflamm.. 2024;32(7):1475-8$61$YR$$M$Y$$$20240920$$MD$CN$CN
243459841$24345984$1$I$$20240913$20240920$20240920$PER$$US-ABBVIE-5924581$ABBVIE$$$$$$Y$$$20240920$$HP$US$US
243459851$24345985$1$I$$20240919$20240920$20240920$PER$$NVSC2024US187939$NOVARTIS$$$$$$Y$$$20240921$$CN$US$US
243459861$24345986$1$I$20240101$20240909$20240920$20240920$EXP$$CA-APOTEX-2024AP010491$APOTEX$$$$A$M$Y$$$20240920$$PH$CA$CA
243459872$24345987$2$F$$20240919$20240920$20240925$EXP$$US-ABBVIE-5931003$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243459881$24345988$1$I$$20240919$20240920$20240920$EXP$$CA-ROCHE-10000086099$ROCHE$$$$$F$Y$$$20240921$$MD$CA$CA
243459901$24345990$1$I$$20240801$20240920$20240920$PER$$US-AUROBINDO-AUR-APL-2024-039512$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243459911$24345991$1$I$$20240911$20240920$20240920$EXP$$PK-NOVITIUMPHARMA-2024PKNVP01907$NOVITIUM PHARMA$Malik WZ Khan.FATAL CASE OF ALK-NEGATIVE INTRAVASCULAR ANAPLASTIC LARGE T-CELL LYMPHOMA IN A YOUNG ADULT: A RARE CASE PRESENTATION.European Journal of Case Reports in Internal Medicine.JAN-2024;11(1):2704$33$YR$A$M$Y$$$20240921$$HP$PK$PK
243459931$24345993$1$I$20240913$20240916$20240920$20240920$PER$$US-ABBVIE-5928841$ABBVIE$$29$YR$$F$Y$$$20240920$$MD$US$US
243459942$24345994$2$F$20240919$20240920$20240920$20240923$PER$$US-AMGEN-USASP2024188136$AMGEN$$64$YR$A$F$Y$$$20240923$$CN$US$US
243459951$24345995$1$I$20240101$20240916$20240920$20240920$EXP$$US-ABBVIE-5829984$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243459962$24345996$2$F$20240101$20240913$20240920$20240923$EXP$$CA-CELLTRION INC.-2024CA006788$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
243459972$24345997$2$F$$20240916$20240920$20240925$PER$$US-AMGEN-USASL2024187107$AMGEN$$$$$F$Y$$$20240924$$CN$US$US
243459981$24345998$1$I$$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024187331$AMGEN$$$$$$Y$$$20240920$$HP$US$US
243459991$24345999$1$I$20231101$20240912$20240920$20240920$EXP$$CA-CELLTRION INC.-2024CA010263$CELLTRION$$$$$$Y$$$20240921$$CN$CA$CA
243460001$24346000$1$I$20240913$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186819$AMGEN$$$$$F$Y$$$20240920$$PH$US$US
243460011$24346001$1$I$$20240911$20240920$20240920$EXP$$US-NOVITIUMPHARMA-2024USNVP01904$NOVITIUM PHARMA$Sara Soliman.AML-713 Hematological Malignancies and Pregnancy: A Single-Institution Experience.Clinical Lymphoma, Myeloma and Leukemia.2024;24:S333-S334$$$A$F$Y$$$20240921$$HP$US$US
243460021$24346002$1$I$20230101$20240913$20240920$20240920$EXP$$US-ABBVIE-5310281$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243460031$24346003$1$I$$20240917$20240920$20240920$EXP$$US-ABBVIE-5930387$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243460051$24346005$1$I$20240101$20240918$20240920$20240920$PER$$US-ABBVIE-5929504$ABBVIE$$$$$$Y$$$20240920$$MD$US$US
243460061$24346006$1$I$$20240910$20240920$20240920$EXP$$US-ABBVIE-5921881$ABBVIE$$$$$M$Y$97$KG$20240920$$MD$US$US
243460071$24346007$1$I$20240101$20240918$20240920$20240920$EXP$$US-ABBVIE-5930436$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243460081$24346008$1$I$$20240911$20240920$20240920$EXP$$CR-NOVITIUMPHARMA-2024CRNVP01925$NOVITIUM PHARMA$Fernando Fernandoenez.CLL-457 T-Cell Prolymphocytic Leukemia: A Case Report.Clinical Lymphoma, Myeloma and Leukemia.2024;24:S354$86$YR$E$M$Y$$$20240921$$HP$CR$CR
243460091$24346009$1$I$$20240917$20240920$20240920$EXP$$PH-ABBVIE-5931760$ABBVIE$$$$$$Y$$$20240920$$CN$PH$PH
243460101$24346010$1$I$20230101$20240918$20240920$20240920$PER$$US-AMGEN-USASP2024186762$AMGEN$$$$$M$Y$$$20240920$$HP$US$US
243460111$24346011$1$I$20240910$20240911$20240920$20240920$PER$$US-ABBVIE-5922084$ABBVIE$$32$YR$$M$Y$$$20240920$$CN$US$US
243460121$24346012$1$I$$20240913$20240920$20240920$PER$$US-SA-2024SA268001$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240921$$HP$US$US
243460131$24346013$1$I$20240901$20240917$20240920$20240920$PER$$US-ABBVIE-5930728$ABBVIE$$$$$F$Y$$$20240920$$HP$US$US
243460141$24346014$1$I$$20240910$20240920$20240920$EXP$$CA-APOTEX-2024AP010467$APOTEX$$64$YR$$F$Y$$$20240920$$HP$CA$CA
243460151$24346015$1$I$20220101$20240916$20240920$20240920$EXP$$US-ABBVIE-5927091$ABBVIE$$$$$F$Y$$$20240920$$CN$US$US
243460162$24346016$2$F$20240101$20240923$20240920$20240926$EXP$$US-ABBVIE-5927509$ABBVIE$$$$$F$Y$73$KG$20240926$$CN$US$US
243460171$24346017$1$I$20240815$20240918$20240920$20240920$EXP$$US-ABBVIE-5930419$ABBVIE$$84$YR$$F$Y$$$20240920$$CN$US$US
243460181$24346018$1$I$$20240918$20240920$20240920$EXP$$AR-ABBVIE-5930993$ABBVIE$$$$$F$Y$$$20240920$$CN$AR$AR
243460191$24346019$1$I$20220523$20240916$20240920$20240920$PER$$US-009507513-2409USA005761$MERCK$$$$A$M$Y$$$20240920$$MD$US$US
243460201$24346020$1$I$$20240911$20240920$20240920$EXP$$US-NOVITIUMPHARMA-2024USNVP01928$NOVITIUM PHARMA$Benjamin Wright.Primary B cell lymphoma of the patella presenting as anterior knee pain: A case report.Journal of Orthopaedics.22-NOV-2023;48:60-63$76$YR$E$F$Y$$$20240921$$HP$US$US
243460212$24346021$2$F$$20240923$20240920$20240924$EXP$$US-ABBVIE-5930880$ABBVIE$$$$$M$Y$$$20240924$$HP$US$US
243460221$24346022$1$I$20240907$20240911$20240920$20240920$PER$$US-ABBVIE-5922991$ABBVIE$$33$YR$$F$Y$$$20240920$$CN$US$US
243460231$24346023$1$I$20240917$20240917$20240920$20240920$EXP$$US-ABBVIE-5929343$ABBVIE$$73$YR$$F$Y$$$20240920$$CN$US$US
243460241$24346024$1$I$$20240918$20240920$20240920$EXP$$US-ABBVIE-5930795$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243460251$24346025$1$I$$20240919$20240921$20240921$EXP$$US-ABBVIE-5931596$ABBVIE$$$$$M$Y$$$20240920$$CN$US$US
243460261$24346026$1$I$20240910$20240918$20240921$20240921$PER$$US-HALEON-2197569$Haleon PLC$$37$YR$$F$Y$$$20240921$$CN$US$US
243460271$24346027$1$I$$20240910$20240921$20240921$PER$$US-ASTELLAS-2024-AER-006013$ASTELLAS$$81$YR$E$F$Y$$$20240920$$CN$US$US
243460281$24346028$1$I$$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024187306$AMGEN$$$$$$Y$$$20240920$$PH$US$US
243460291$24346029$1$I$$20240912$20240921$20240921$PER$$US-ABBVIE-5922203$ABBVIE$$61$YR$$$Y$$$20240921$$HP$US$US
243460301$24346030$1$I$20240101$20240919$20240921$20240921$EXP$$US-ABBVIE-5931401$ABBVIE$$$$$F$Y$$$20240921$$HP$US$US
243460311$24346031$1$I$$20240919$20240921$20240921$PER$$US-ABBVIE-5931901$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243460331$24346033$1$I$$20240911$20240921$20240921$EXP$$ES-AUROBINDO-AUR-APL-2024-045720$AUROBINDO$Rubio AC, Garcia SS, Calvo AR, Fernandez PO, Rubio LC, Rey MP, et al.. RADIOLOGICAL-CLINICAL PROGRESSION. European Journal of Case Reports in Internal Medicine. 2024;11 (Suppl. 1):786- 787 abstr. 2774$75$YR$$F$Y$$$20240921$$HP$ES$ES
243460341$24346034$1$I$20240101$20240914$20240921$20240921$PER$$US-ROCHE-10000084036$ROCHE$$83$YR$E$M$Y$$$20240921$$CN$US$US
243460351$24346035$1$I$$20240912$20240921$20240921$EXP$$CA-CELLTRION INC.-2024CA022300$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
243460361$24346036$1$I$20240101$20240913$20240921$20240921$PER$$US-SA-2024SA268109$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240921$$MD$US$US
243460371$24346037$1$I$$20240916$20240921$20240921$PER$$US-SA-2024SA268842$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240921$$MD$US$US
243460381$24346038$1$I$20240909$20240909$20240921$20240921$EXP$GB-MHRA-TPP1899212C3377068YC1725892419792$GB-Accord-446194$ACCORD$$72$YR$E$F$Y$60$KG$20240921$$HP$GB$GB
243460391$24346039$1$I$20240101$20240911$20240921$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028818$UNITED THERAPEUTICS$$$$$F$Y$84.354$KG$20240921$$$US$US
243460401$24346040$1$I$$20240912$20240921$20240921$EXP$$CA-CELLTRION INC.-2024CA022303$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
243460411$24346041$1$I$20240304$20240917$20240921$20240921$EXP$$NVSC2024BR132861$NOVARTIS$$60$YR$$F$Y$$$20240921$$CN$BR$BR
243460422$24346042$2$F$$20240924$20240921$20240927$EXP$$US-ABBVIE-5928039$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243460431$24346043$1$I$20210101$20240917$20240921$20240921$EXP$$US-ABBVIE-5929330$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243460451$24346045$1$I$20240815$20240911$20240921$20240921$PER$$US-ABBVIE-5921174$ABBVIE$$36$YR$$F$Y$$$20240921$$MD$US$US
243460461$24346046$1$I$$20240918$20240921$20240921$EXP$$NVSC2024US186869$NOVARTIS$$$$$F$Y$$$20240921$$CN$US$US
243460471$24346047$1$I$20221207$20240906$20240921$20240921$EXP$$US-UCBSA-2024048518$UCB$$61$YR$$F$Y$$$20240921$$CN$US$US
243460481$24346048$1$I$20240908$20240909$20240921$20240921$PER$$US-ABBVIE-5918891$ABBVIE$$55$YR$$F$Y$$$20240921$$CN$US$US
243460501$24346050$1$I$20231009$20231009$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-063817$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243460513$24346051$3$F$$20240902$20240921$20240923$EXP$$NL-ABBVIE-5929496$ABBVIE$$$$A$F$Y$$$20240923$$CN$NL$NL
243460521$24346052$1$I$20240902$20240917$20240921$20240921$EXP$$TR-ABBVIE-5906861$ABBVIE$$69$YR$$M$Y$$$20240921$$CN$TR$TR
243460531$24346053$1$I$20240901$20240914$20240921$20240921$EXP$$FR-ABBVIE-5929637$ABBVIE$$79$YR$$F$Y$$$20240921$$HP$FR$FR
243460541$24346054$1$I$20240226$20240916$20240921$20240921$PER$$US-AMGEN-USASP2024185406$AMGEN$$66$YR$E$F$Y$86.8$KG$20240920$$HP$US$US
243460551$24346055$1$I$20231020$20231023$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-066093$AUROBINDO$$74$YR$$F$Y$$$20240921$$CN$US$US
243460561$24346056$1$I$20240101$20240918$20240921$20240921$EXP$$US-ABBVIE-5931890$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243460571$24346057$1$I$$20240918$20240921$20240921$EXP$$US-ABBVIE-5931473$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243460581$24346058$1$I$$20240909$20240921$20240921$EXP$$US-AMAROX PHARMA-HET2024US03133$HETERO$Nicoletti P, Dellinger A, Li YJ, Barnhart H, Phillips E, Chalasani N.. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans. The American Journal of GASTROENTEROLOGY. 2024;119:200-202$$$$$Y$$$20240921$$MD$US$US
243460601$24346060$1$I$$20231123$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-067070$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243460611$24346061$1$I$$20240917$20240921$20240921$EXP$$US-ABBVIE-5928897$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243460621$24346062$1$I$20231001$20240909$20240921$20240921$EXP$$DE-AUROBINDO-AUR-APL-2024-045478$AUROBINDO$$$$$F$Y$$$20240921$$CN$DE$DE
243460631$24346063$1$I$20240703$20240912$20240921$20240921$PER$$US-AMGEN-USASP2024183198$AMGEN$$$$$$Y$$$20240920$$CN$US$US
243460641$24346064$1$I$20231123$20240109$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-076180$AUROBINDO$$$$$F$Y$$$20240921$$PH$US$US
243460653$24346065$3$F$$20240919$20240921$20240928$EXP$$ES-AUROBINDO-AUR-APL-2024-044932$AUROBINDO$Pozo IB, Comesana MS, Castillo AC, Oliva MP, Vazquez GP.. Putting pieces together to reach the diagnosis. Oncological and hematological diseases. Eur-J-Case-Rep-Intern-Med. 2024;11 (Suppl. 1):791$66$YR$$M$Y$$$20240928$$HP$ES$ES
243460661$24346066$1$I$$20240910$20240921$20240921$EXP$$AE-NOVITIUMPHARMA-2024AENVP01876$NOVITIUM PHARMA$Al Nuaimi Mohammed.HHV6-Associated Hydrocephalus in a Pediatric Hematopoietic Stem Cell Transplant Recipient: An Unusual Presentation.Journal of Pediatric Hematology Oncology.AUG-2024;46(6):e426-e429$6$YR$C$F$Y$$$20240921$$HP$AE$AE
243460671$24346067$1$I$20220101$20240917$20240921$20240921$PER$$US-ABBVIE-5928689$ABBVIE$$$$$$Y$$$20240921$$CN$US$US
243460681$24346068$1$I$$20240730$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-031162$AUROBINDO$$70$YR$$F$Y$61.235$KG$20240921$$CN$US$US
243460691$24346069$1$I$$20240718$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-028981$AUROBINDO$$71$YR$$F$Y$$$20240921$$CN$US$US
243460701$24346070$1$I$$20240520$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-026106$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243460711$24346071$1$I$$20240911$20240921$20240921$EXP$$ES-AMGEN-ESPSP2024183846$AMGEN$Lluch P.; Ballester M.P.; Abril C. et al.. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor. Cancer Diagnosis + Prognosis. 2024;4 (5):623-630$$$$$Y$$$20240920$$MD$ES$ES
243460721$24346072$1$I$$20240909$20240921$20240921$EXP$CA-APOTEX-2024AP010346$CA-Accord-447535$ACCORD$$66$YR$E$M$Y$$$20240921$$HP$CA$CA
243460731$24346073$1$I$$20240918$20240921$20240921$PER$$US-JNJFOC-20240948881$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$MD$US$US
243460741$24346074$1$I$$20240730$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-039124$AUROBINDO$$$$E$F$Y$$$20240921$$CN$US$US
243460751$24346075$1$I$$20231201$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-077610$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243460761$24346076$1$I$$20231204$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-078036$AUROBINDO$$81$YR$$F$Y$$$20240921$$CN$US$US
243460771$24346077$1$I$$20230911$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-059840$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243460781$24346078$1$I$$20240626$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-032673$AUROBINDO$$73$YR$$F$Y$49.89$KG$20240921$$CN$US$US
243460791$24346079$1$I$20240629$20240710$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-035564$AUROBINDO$$66$YR$$F$Y$62.14$KG$20240921$$PH$US$US
243460801$24346080$1$I$$20231005$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-061404$AUROBINDO$$85$YR$$F$Y$46.26$KG$20240921$$CN$US$US
243460811$24346081$1$I$$20240701$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-033528$AUROBINDO$$62$YR$$F$Y$76.204$KG$20240921$$CN$US$US
243460821$24346082$1$I$$20231227$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-069262$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243460831$24346083$1$I$$20230822$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-056017$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243460841$24346084$1$I$20230624$20230901$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-057994$AUROBINDO$$68$YR$$F$Y$47$KG$20240921$$CN$US$US
243460851$24346085$1$I$$20230927$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-061933$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243460861$24346086$1$I$$20231127$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-076514$AUROBINDO$$57$YR$$F$Y$40$KG$20240921$$CN$US$US
243460871$24346087$1$I$$20231010$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-063938$AUROBINDO$$74$YR$$F$Y$$$20240921$$CN$US$US
243460881$24346088$1$I$$20231024$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-066504$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243460901$24346090$1$I$$20240917$20240921$20240921$EXP$$NVSC2024US181795$NOVARTIS$$$$$M$Y$$$20240921$$CN$US$US
243460921$24346092$1$I$20231124$20231201$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-077615$AUROBINDO$$68$YR$$F$Y$$$20240921$$CN$US$US
243460931$24346093$1$I$$20240917$20240921$20240921$PER$$US-AMGEN-USASP2024186313$AMGEN$$$$$$Y$$$20240920$$MD$US$US
243460941$24346094$1$I$20231118$20240116$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-080478$AUROBINDO$$90$YR$$F$Y$58.05$KG$20240921$$CN$US$US
243460951$24346095$1$I$20240321$20240918$20240921$20240921$PER$$US-ROCHE-3557311$ROCHE$$42$YR$A$M$Y$$$20240921$$CN$US$US
243460961$24346096$1$I$20231005$20231206$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-078411$AUROBINDO$$62$YR$$F$Y$$$20240921$$MD$US$US
243460971$24346097$1$I$$20231227$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-000118$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243460981$24346098$1$I$$20240123$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-080475$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243460991$24346099$1$I$20200101$20240909$20240921$20240921$EXP$$IN-Accord-446274$ACCORD$Chhabra N, Rahim JS, Ganguly S. Occult Lymphoma in a Case of Resistant Dermatomyositis Complicated by Tubercular Lymphadenitis and Gumma. Indian J Dermatol. 2024;69(4):365. DOI:10.4103/ijd.ijd_214_23.$64$YR$A$M$Y$$$20240921$$MD$IN$IN
243461001$24346100$1$I$20231028$20231226$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-081888$AUROBINDO$$74$YR$$F$Y$83.9$KG$20240921$$CN$US$US
243461011$24346101$1$I$$20240918$20240921$20240921$PER$$US-HALEON-2197626$Haleon PLC$$$$$$Y$$$20240921$$CN$US$US
243461021$24346102$1$I$$20240206$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-004586$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243461031$24346103$1$I$$20231214$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-081445$AUROBINDO$$71$YR$$F$Y$$$20240921$$MD$US$US
243461041$24346104$1$I$20220801$20240321$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-006691$AUROBINDO$$86$YR$$F$Y$72.58$KG$20240921$$CN$US$US
243461051$24346105$1$I$$20231018$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-065648$AUROBINDO$$29$YR$$F$Y$$$20240921$$MD$US$US
243461061$24346106$1$I$$20231130$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-077025$AUROBINDO$$42$YR$$M$Y$$$20240921$$MD$US$US
243461071$24346107$1$I$$20231204$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-077886$AUROBINDO$$$$E$M$Y$$$20240921$$HP$US$US
243461081$24346108$1$I$$20240918$20240921$20240921$PER$$US-JNJFOC-20240951179$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243461091$24346109$1$I$$20231013$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-065029$AUROBINDO$$$$$F$Y$$$20240921$$MD$US$US
243461101$24346110$1$I$20240801$20240919$20240921$20240921$PER$$US-JNJFOC-20240953635$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243461111$24346111$1$I$$20240910$20240921$20240921$EXP$CA-MHPD-E2B_001094234$CA-Accord-446461$ACCORD$$67$YR$E$F$Y$$$20240921$$PH$CA$CA
243461121$24346112$1$I$$20240213$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-008308$AUROBINDO$$73$YR$$M$Y$63.502$KG$20240921$$CN$US$US
243461131$24346113$1$I$20240222$20240222$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-009995$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243461142$24346114$2$F$20240915$20240920$20240921$20240925$PER$$US-AMGEN-USASP2024187479$AMGEN$$53$YR$A$F$Y$$$20240925$$CN$US$US
243461151$24346115$1$I$20221026$20240913$20240921$20240921$PER$$US-AMGEN-USASP2024184362$AMGEN$$47$YR$A$F$Y$92.7$KG$20240920$$HP$US$US
243461171$24346117$1$I$20240801$20240912$20240921$20240921$PER$$US-ABBVIE-5922949$ABBVIE$$64$YR$$M$Y$74.842$KG$20240921$$CN$US$US
243461181$24346118$1$I$20240801$20240909$20240921$20240921$EXP$$IT-UCBSA-2024047068$UCB$$$$A$M$Y$$$20240921$$CN$IT$IT
243461191$24346119$1$I$$20240911$20240921$20240921$EXP$$JP-ROCHE-10000085002$ROCHE$$10$DEC$E$M$Y$$$20240921$$MD$JP$JP
243461201$24346120$1$I$20230918$20230920$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-060675$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243461211$24346121$1$I$$20240627$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-010802$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243461241$24346124$1$I$20230731$20230804$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-053168$AUROBINDO$$69$YR$$F$Y$71$KG$20240921$$CN$US$US
243461261$24346126$1$I$20240401$20240919$20240921$20240921$EXP$FR-AFSSAPS-GR2024001085$FR-ROCHE-10000086029$ROCHE$$59$YR$A$F$Y$91$KG$20240921$$PH$FR$FR
243461271$24346127$1$I$$20240912$20240921$20240921$PER$$US-ABBVIE-5922262$ABBVIE$$$$$$Y$$$20240921$$HP$US$US
243461291$24346129$1$I$20230820$20230825$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-056717$AUROBINDO$$84$YR$$F$Y$56$KG$20240921$$CN$US$US
243461301$24346130$1$I$$20230912$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-059094$AUROBINDO$$60$YR$$F$Y$45.35$KG$20240921$$CN$US$US
243461311$24346131$1$I$$20230807$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-054031$AUROBINDO$$$$$$Y$$$20240921$$CN$US$US
243461321$24346132$1$I$$20240618$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-012420$AUROBINDO$$$$$$Y$$$20240921$$CN$US$US
243461332$24346133$2$F$$20240919$20240921$20240930$EXP$$JP-AMGEN-JPNSP2024176587$AMGEN$$10$DEC$E$F$Y$$$20240929$$PH$JP$JP
243461341$24346134$1$I$$20240913$20240921$20240921$EXP$$NL-AMGEN-NLDSP2024184024$AMGEN$Von Dem Borne P. A.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$$$Y$$$20240920$$HP$NL$NL
243461351$24346135$1$I$$20240918$20240921$20240921$PER$$US-ROCHE-10000087036$ROCHE$$$$E$F$Y$$$20240921$$CN$US$US
243461361$24346136$1$I$$20230926$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-061547$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243461371$24346137$1$I$20240904$20240909$20240921$20240921$EXP$$US-UCBSA-2024046652$UCB$$29$YR$$M$Y$$$20240921$$CN$US$US
243461381$24346138$1$I$$20240911$20240921$20240921$EXP$GB-MHRA-MED-202409111408560500-SGTCZ$GB-Accord-446447$ACCORD$$$$$M$Y$$$20240921$$PH$GB$GB
243461391$24346139$1$I$$20240913$20240921$20240921$EXP$$NL-AMGEN-NLDSP2024184012$AMGEN$Von Dem Borne P. A.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$A$$Y$$$20240920$$HP$NL$NL
243461401$24346140$1$I$$20240917$20240921$20240921$EXP$$US-GRAVITIPHARMA-GRA-2409-US-LIT-0424$GRAVITI PHARMACEUTICALS$Dellabella A, May A, Sofio B..Angioedema Following Tenecteplase for Acute Ischemic Stroke.Stroke.2024;55(8):e242-e244$63$YR$A$M$Y$$$20240921$$HP$US$US
243461411$24346141$1$I$20231218$20240911$20240921$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2023-037262$UNITED THERAPEUTICS$$65$YR$$F$Y$50.34$KG$20240921$$$US$US
243461421$24346142$1$I$$20240911$20240921$20240921$EXP$CA-MHPD-E2B_07198847$CA-Accord-446630$ACCORD$$45$YR$A$F$Y$$$20240921$$HP$CA$CA
243461431$24346143$1$I$$20230920$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-060696$AUROBINDO$$84$YR$$F$Y$57$KG$20240921$$CN$US$US
243461441$24346144$1$I$$20231020$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-065676$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243461451$24346145$1$I$$20231118$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-061954$AUROBINDO$$82$YR$$F$Y$77.11$KG$20240921$$CN$US$US
243461461$24346146$1$I$$20240702$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-012664$AUROBINDO$$87$YR$$F$Y$$$20240921$$CN$US$US
243461471$24346147$1$I$$20240909$20240921$20240921$EXP$$CA-UCBSA-2024046609$UCB$$$$$F$Y$$$20240921$$CN$CA$CA
243461481$24346148$1$I$$20240909$20240921$20240921$EXP$$CA-UCBSA-2024046606$UCB$$$$$F$Y$$$20240921$$CN$CA$CA
243461491$24346149$1$I$20240204$20240702$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-017496$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243461501$24346150$1$I$20240828$20240910$20240921$20240921$EXP$CN-HENLIUS-24CN017147$CN-Accord-447613$ACCORD$$49$YR$A$F$Y$66.8$KG$20240921$$MD$CN$CN
243461511$24346151$1$I$20240101$20240912$20240921$20240921$PER$$US-JNJFOC-20240946530$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243461521$24346152$1$I$20240901$20240919$20240921$20240921$PER$$US-JNJFOC-20240952957$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243461531$24346153$1$I$$20240919$20240921$20240921$PER$$US-JNJFOC-20240952536$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243461541$24346154$1$I$$20240909$20240921$20240921$EXP$$US-JNJFOC-20240943467$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240921$$MD$US$US
243461551$24346155$1$I$$20240918$20240921$20240921$EXP$$CA-ROCHE-10000087056$ROCHE$$$$A$F$Y$$$20240921$$CN$CA$CA
243461561$24346156$1$I$20240906$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187961$AMGEN$$$$$F$Y$$$20240920$$CN$US$US
243461571$24346157$1$I$$20240916$20240921$20240921$PER$$US-SA-2024SA268845$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240921$$HP$US$US
243461581$24346158$1$I$20240901$20240913$20240921$20240921$PER$$US-SA-2024SA268209$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240921$$MD$US$US
243461591$24346159$1$I$$20240910$20240921$20240921$EXP$GB-MHRA-MED-202409101118526150-PLFBG$GB-AMAROX PHARMA-AMR2024GB03094$HETERO$$$$$M$Y$$$20240921$$PH$GB$GB
243461601$24346160$1$I$$20231216$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-077605$AUROBINDO$$$$E$M$Y$$$20240921$$CN$US$US
243461611$24346161$1$I$$20240418$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-020971$AUROBINDO$$$$E$F$Y$$$20240921$$PH$US$US
243461621$24346162$1$I$$20240913$20240921$20240921$EXP$$NL-AMGEN-NLDSP2024184017$AMGEN$Von Dem Borne P.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$E$$Y$$$20240920$$HP$NL$NL
243461631$24346163$1$I$$20240912$20240921$20240921$EXP$$VN-ROCHE-10000081947$ROCHE$$52$YR$A$F$Y$$$20240921$$HP$VN$VN
243461641$24346164$1$I$20230929$20231027$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-066912$AUROBINDO$$76$YR$$F$Y$49.4$KG$20240921$$CN$US$US
243461651$24346165$1$I$$20231229$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-073836$AUROBINDO$$78$YR$$F$Y$$$20240921$$CN$US$US
243461661$24346166$1$I$$20240122$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-079324$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243461671$24346167$1$I$$20231204$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-077929$AUROBINDO$$81$YR$$F$Y$$$20240921$$CN$US$US
243461681$24346168$1$I$20240101$20240402$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-008311$AUROBINDO$$64$YR$$F$Y$80.73$KG$20240921$$CN$US$US
243461691$24346169$1$I$$20231221$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-081342$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243461701$24346170$1$I$$20240514$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-022671$AUROBINDO$$60$YR$$F$Y$43$KG$20240921$$PH$US$US
243461711$24346171$1$I$20240601$20240917$20240921$20240921$PER$$US-JNJFOC-20240947690$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243461721$24346172$1$I$20240125$20240220$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-007071$AUROBINDO$$80$YR$$F$Y$58.967$KG$20240921$$CN$US$US
243461731$24346173$1$I$$20240119$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-003775$AUROBINDO$$85$YR$$F$Y$72.5$KG$20240921$$CN$US$US
243461741$24346174$1$I$$20240212$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-007763$AUROBINDO$$$$A$F$Y$$$20240921$$PH$US$US
243461751$24346175$1$I$20240212$20240328$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-008413$AUROBINDO$$80$YR$$F$Y$58.059$KG$20240921$$CN$US$US
243461761$24346176$1$I$20240201$20240202$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-006398$AUROBINDO$$$$E$F$Y$56$KG$20240921$$CN$US$US
243461771$24346177$1$I$$20240125$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-005284$AUROBINDO$$76$YR$$F$Y$86.182$KG$20240921$$CN$US$US
243461781$24346178$1$I$$20240905$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08951$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243461791$24346179$1$I$20240224$20240802$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-010456$AUROBINDO$$$$$F$Y$76.203$KG$20240921$$CN$US$US
243461801$24346180$1$I$$20240410$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-010752$AUROBINDO$$$$$M$Y$$$20240921$$HP$US$US
243461811$24346181$1$I$20230501$20240301$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-011153$AUROBINDO$$76$YR$$F$Y$$$20240921$$CN$US$US
243461821$24346182$1$I$$20240911$20240921$20240921$EXP$CA-MHPD-001091118$CA-Accord-446645$ACCORD$$80$YR$E$M$Y$$$20240921$$PH$CA$CA
243461831$24346183$1$I$$20240809$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-012592$AUROBINDO$$80$YR$$M$Y$110.22$KG$20240921$$CN$US$US
243461841$24346184$1$I$$20240918$20240921$20240921$PER$$US-JNJFOC-20240951371$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243461851$24346185$1$I$$20240410$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-018664$AUROBINDO$$67$YR$$F$Y$$$20240921$$CN$US$US
243461861$24346186$1$I$$20240504$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-023206$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243461871$24346187$1$I$$20240905$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08960$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243461881$24346188$1$I$$20240516$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-015047$AUROBINDO$$70$YR$$F$Y$$$20240921$$PH$US$US
243461891$24346189$1$I$$20240910$20240921$20240921$EXP$$NVSC2024CA010062$NOVARTIS$$44$YR$$F$Y$97$KG$20240921$$CN$CA$CA
243461901$24346190$1$I$$20240531$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-020995$AUROBINDO$$88$YR$$F$Y$49.895$KG$20240921$$CN$US$US
243461911$24346191$1$I$20240919$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187501$AMGEN$$75$YR$E$F$Y$$$20240920$$CN$US$US
243461921$24346192$1$I$$20240502$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-022832$AUROBINDO$$72$YR$$F$Y$52$KG$20240921$$CN$US$US
243461931$24346193$1$I$$20240702$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-024760$AUROBINDO$$83$YR$$F$Y$$$20240921$$CN$US$US
243461951$24346195$1$I$$20240705$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-026532$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243461961$24346196$1$I$$20240506$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-023266$AUROBINDO$$80$YR$$F$Y$$$20240921$$CN$US$US
243461973$24346197$3$F$20240801$20240924$20240921$20240928$PER$$US-ABBVIE-5923076$ABBVIE$$19$YR$$F$Y$$$20240928$$CN$US$US
243461981$24346198$1$I$20240615$20240717$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-031498$AUROBINDO$$66$YR$$F$Y$59.874$KG$20240921$$MD$US$US
243461991$24346199$1$I$$20240726$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-030258$AUROBINDO$$68$YR$$F$Y$175$KG$20240921$$CN$US$US
243462001$24346200$1$I$$20240530$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-024993$AUROBINDO$$80$YR$$F$Y$65.7$KG$20240921$$CN$US$US
243462011$24346201$1$I$$20240829$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-034883$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243462021$24346202$1$I$20240626$20240627$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-032731$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243462031$24346203$1$I$20240501$20240717$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-036722$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243462041$24346204$1$I$$20240918$20240921$20240921$PER$$US-ROCHE-10000086220$ROCHE$$$$$$Y$$$20240921$$HP$US$US
243462051$24346205$1$I$$20240722$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-037415$AUROBINDO$$$$$M$Y$$$20240921$$CN$US$US
243462061$24346206$1$I$20240101$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024186488$AMGEN$$$$A$$Y$$$20240920$$CN$US$US
243462071$24346207$1$I$20240917$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024186747$AMGEN$$69$YR$E$M$Y$$$20240920$$CN$US$US
243462081$24346208$1$I$20240918$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187490$AMGEN$$86$YR$E$$Y$$$20240920$$CN$US$US
243462101$24346210$1$I$$20240911$20240921$20240921$EXP$$BR-ROCHE-10000080893$ROCHE$$$$$M$Y$$$20240921$$MD$BR$BR
243462111$24346211$1$I$$20240910$20240921$20240921$EXP$$CA-ROCHE-10000084705$ROCHE$$60$YR$A$F$Y$$$20240921$$HP$CA$CA
243462121$24346212$1$I$20230901$20240910$20240921$20240921$EXP$GB-MHRA-MED-202409091928410690-VLMKN$GB-AMAROX PHARMA-AMR2024GB03077$HETERO$$38$YR$$F$Y$91$KG$20240921$$CN$GB$GB
243462131$24346213$1$I$$20240906$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09007$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243462141$24346214$1$I$$20240830$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-039128$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243462151$24346215$1$I$$20240912$20240921$20240921$EXP$$DE-TEVA-VS-3244325$TEVA$$67$YR$$F$Y$$$20240921$$MD$DE$DE
243462171$24346217$1$I$20240911$20240911$20240921$20240921$EXP$GB-MHRA-MED-202409110854139840-CSDQP$GB-Accord-446433$ACCORD$$65$YR$E$M$Y$78$KG$20240921$$CN$GB$GB
243462181$24346218$1$I$$20240909$20240921$20240921$EXP$$CA-ROCHE-10000085859$ROCHE$$65$YR$E$F$Y$$$20240921$$MD$CA$CA
243462191$24346219$1$I$20240101$20240913$20240921$20240921$EXP$$JP-AMGEN-JPNSP2024185332$AMGEN$$$$E$F$Y$$$20240920$$CN$JP$JP
243462201$24346220$1$I$$20240911$20240921$20240921$EXP$GB-MHRA-MED-202409112158055820-SRTQY$GB-Accord-446450$ACCORD$$$$$F$Y$$$20240921$$CN$GB$GB
243462211$24346221$1$I$$20240713$20240921$20240921$PER$$US-ROCHE-10000027498$ROCHE$$$$$$Y$$$20240921$$CN$US$US
243462222$24346222$2$F$20240101$20240913$20240921$20240927$EXP$$US-UCBSA-2024046300$UCB$$$$$F$Y$$$20240927$$CN$US$US
243462231$24346223$1$I$$20240911$20240921$20240921$EXP$$JP-AMGEN-JPNSP2024186369$AMGEN$$50$YR$A$$Y$$$20240920$$MD$JP$JP
243462241$24346224$1$I$20240101$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024186470$AMGEN$$$$A$M$Y$$$20240920$$CN$US$US
243462251$24346225$1$I$20240912$20240918$20240921$20240921$PER$$US-ROCHE-10000086606$ROCHE$$48$YR$A$F$Y$$$20240921$$CN$US$US
243462261$24346226$1$I$$20240918$20240921$20240921$PER$$US-ROCHE-10000086118$ROCHE$$$$$$Y$$$20240921$$PH$US$US
243462271$24346227$1$I$20240820$20240911$20240921$20240921$EXP$CN-HENLIUS-24CN017170$CN-Accord-447611$ACCORD$$47$YR$A$F$Y$56$KG$20240921$$MD$CN$CN
243462281$24346228$1$I$$20240910$20240921$20240921$EXP$$CA-ROCHE-10000084719$ROCHE$$35$YR$A$F$Y$$$20240921$$CN$CA$CA
243462291$24346229$1$I$20240908$20240917$20240921$20240921$EXP$$MM-ROCHE-10000085269$ROCHE$$52$YR$A$F$Y$$$20240921$$CN$MM$MM
243462301$24346230$1$I$$20240918$20240921$20240921$PER$$US-ABBVIE-5930547$ABBVIE$$$$$$Y$$$20240921$$CN$US$US
243462311$24346231$1$I$20240529$20240917$20240921$20240921$EXP$$MM-ROCHE-10000085258$ROCHE$$46$YR$A$M$Y$$$20240921$$CN$MM$MM
243462321$24346232$1$I$20240908$20240909$20240921$20240921$EXP$$US-UCBSA-2024046287$UCB$$78$YR$$F$Y$$$20240921$$CN$US$US
243462331$24346233$1$I$$20240910$20240921$20240921$EXP$$CA-ROCHE-10000084809$ROCHE$$65$YR$E$F$Y$34$KG$20240921$$CN$CA$CA
243462352$24346235$2$F$$20240926$20240921$20240930$PER$$US-ROCHE-10000086052$ROCHE$$$$A$F$Y$$$20240930$$MD$US$US
243462361$24346236$1$I$20240101$20240913$20240921$20240921$PER$$US-SA-2024SA268165$SANOFI AVENTIS$$$$A$F$Y$$$20240921$$MD$US$US
243462371$24346237$1$I$20240101$20240913$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-029120$UNITED THERAPEUTICS$$$$$M$Y$$$20240921$$$US$US
243462381$24346238$1$I$$20240917$20240921$20240921$PER$$US-ROCHE-10000084953$ROCHE$$$$E$F$Y$70.3$KG$20240921$$CN$US$US
243462391$24346239$1$I$20240101$20240918$20240921$20240921$PER$$US-JNJFOC-20240951461$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240921$$CN$US$US
243462401$24346240$1$I$$20240910$20240921$20240921$EXP$$US-HETERO-HET2024US03114$HETERO$$$$$F$Y$3.1$KG$20240921$$HP$US$US
243462411$24346241$1$I$$20240830$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08798$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243462421$24346242$1$I$20160101$20240913$20240921$20240921$PER$$US-ROCHE-2199984$ROCHE$Joshi S, Khan D Effective Use of Dupilumab in Managing Systemic Allergic Contact Dermatitis. Dermatitis 2018 Sep 01;29 (5):282-284.$44$YR$A$M$Y$$$20240921$$MD$US$US
243462432$24346243$2$F$20240101$20240919$20240921$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-029279$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240925$$$US$US
243462441$24346244$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA268277$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240921$$HP$US$US
243462451$24346245$1$I$$20240831$20240921$20240921$PER$$US-SA-2024SA271777$SANOFI AVENTIS$$$$T$F$Y$$$20240921$$MD$US$US
243462461$24346246$1$I$$20240731$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-039266$AUROBINDO$$66$YR$$F$Y$76.203$KG$20240921$$CN$US$US
243462472$24346247$2$F$$20240913$20240921$20240921$PER$$US-ROCHE-1997633$ROCHE$Pelletier J, Nagaraj S, Gbadegesin R, Wigfall D, McGann K and Foreman J. Neutropenic enterocolitis (typhlitis) in a pediatric renal transplant patient. A case report and review of the literature (Article Number e13022). Pediatric Transplantation 2017;21(6):-.$15$YR$T$M$Y$$$20240921$$MD$US$US
243462481$24346248$1$I$$20230914$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-055421$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243462491$24346249$1$I$$20240116$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-003068$AUROBINDO$$51$YR$$F$Y$$$20240921$$CN$US$US
243462501$24346250$1$I$$20240606$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-026852$AUROBINDO$$$$$M$Y$$$20240921$$CN$US$US
243462511$24346251$1$I$$20231031$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-067316$AUROBINDO$$71$YR$$F$Y$114.75$KG$20240921$$CN$US$US
243462521$24346252$1$I$$20240515$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-014497$AUROBINDO$$82$YR$$F$Y$63.502$KG$20240921$$CN$US$US
243462531$24346253$1$I$$20240830$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08802$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243462541$24346254$1$I$20240819$20240909$20240921$20240921$EXP$$US-UCBSA-2024046165$UCB$$59$YR$$M$Y$$$20240921$$CN$US$US
243462551$24346255$1$I$$20240321$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-014548$AUROBINDO$$85$YR$$F$Y$65.7$KG$20240921$$CN$US$US
243462561$24346256$1$I$$20240917$20240921$20240921$PER$$US-HALEON-2197420$Haleon PLC$$$$$M$Y$$$20240921$$CN$US$US
243462571$24346257$1$I$$20240124$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-004776$AUROBINDO$$84$YR$$F$Y$71.6$KG$20240921$$CN$US$US
243462581$24346258$1$I$20240619$20240622$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-032081$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243462591$24346259$1$I$$20240217$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-009095$AUROBINDO$$88$YR$$F$Y$$$20240921$$MD$US$US
243462601$24346260$1$I$$20240807$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-026220$AUROBINDO$$67$YR$$F$Y$54.431$KG$20240921$$CN$US$US
243462611$24346261$1$I$$20240528$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-027663$AUROBINDO$$86$YR$$F$Y$49.8$KG$20240921$$CN$US$US
243462621$24346262$1$I$20240913$20240916$20240921$20240921$EXP$$NVSC2024CO186599$NOVARTIS$$61$YR$$F$Y$$$20240921$$CN$CO$CO
243462631$24346263$1$I$20240101$20240912$20240921$20240921$PER$$US-009507513-2409USA004664$MERCK$$$$$F$Y$95.238$KG$20240921$$CN$US$US
243462641$24346264$1$I$$20240102$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-001020$AUROBINDO$$85$YR$$F$Y$58.513$KG$20240921$$CN$US$US
243462651$24346265$1$I$$20240910$20240921$20240921$EXP$$US-AMAROX PHARMA-HET2024US03102$HETERO$Barkhordarian M, Grijalva M, Lee A, Jarri A, Belyayeva A, Weissman S. Statin-Induced  Autoimmune Myopathy: A Diagnostic Challenge in Muscle Weakness. American Journal of Case  Reports. 2024;25:e944261$69$YR$$M$Y$$$20240921$$MD$US$US
243462662$24346266$2$F$20240815$20240920$20240921$20240923$PER$$US-AMGEN-USASP2024188092$AMGEN$$75$YR$E$F$Y$$$20240923$$CN$US$US
243462671$24346267$1$I$$20240911$20240921$20240921$EXP$GB-MHRA-MED-202409110841135440-DLCVZ$GB-Accord-446522$ACCORD$$59$YR$A$F$Y$$$20240921$$CN$GB$GB
243462682$24346268$2$F$$20240911$20240921$20240921$EXP$GB-MHRA-MED-202409102349253270-YZNMC$GB-AMAROX PHARMA-AMR2024GB03093$HETERO$$$$$M$Y$$$20240921$$CN$GB$GB
243462691$24346269$1$I$$20240906$20240921$20240921$PER$$US-009507513-2409USA002996$MERCK$Shelvin KB, Vincent J, Morron S, Morin M, Mammoser A, Nair N. Recurrent high grade serous endometrial cancer with brain metastases: Immunotherapy confers improved quality of life and survival. Gynecologic Oncology Reports. 2024;55:1-4$53$YR$$F$Y$$$20240921$$HP$US$US
243462701$24346270$1$I$$20220209$20240921$20240921$EXP$$GB-ROCHE-10000081285$ROCHE$$$$$$Y$$$20240921$$HP$GB$GB
243462711$24346271$1$I$20240320$20240913$20240921$20240921$EXP$GB-MHRA-MED-202409121937346630-SQFLM$GB-TEVA-VS-3243671$TEVA$$57$YR$$F$Y$55$KG$20240921$$CN$GB$GB
243462721$24346272$1$I$20240919$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024188093$AMGEN$$58$YR$A$F$Y$$$20240920$$CN$US$US
243462731$24346273$1$I$$20240510$20240921$20240921$EXP$DE-TORRENT-00009123-02$DE-PBT-000934$PANACEA BIOTEC$Avsar Y, Cicinnati V, Kabar I, Wolters H, Anthoni C, Schmidt H and Beckebaum S. Allograft failure in an intestinal graft recipient after cytomegalovirus disease without dnaemia. Abs P70. Transplant International 2013 Nov 01;26 (SUP 1):40.$52$YR$A$F$Y$$$20240921$$HP$DE$DE
243462741$24346274$1$I$20240919$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024188090$AMGEN$$83$YR$E$F$Y$$$20240920$$HP$US$US
243462751$24346275$1$I$20240901$20240830$20240921$20240921$PER$$US-SA-2024SA272221$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240921$$CN$US$US
243462761$24346276$1$I$$20240827$20240921$20240921$PER$$US-SA-2024SA271575$SANOFI AVENTIS$$$$E$F$Y$$$20240921$$MD$US$US
243462771$24346277$1$I$20240101$20240831$20240921$20240921$PER$$US-SA-2024SA270802$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240921$$MD$US$US
243462781$24346278$1$I$$20240918$20240921$20240921$PER$$US-HALEON-2197552$Haleon PLC$$$$$F$Y$$$20240921$$CN$US$US
243462791$24346279$1$I$$20240917$20240921$20240921$EXP$$JP-ROCHE-10000085826$ROCHE$$7$DEC$E$$Y$$$20240921$$MD$JP$JP
243462811$24346281$1$I$$20240903$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08857$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243462822$24346282$2$F$$20240917$20240921$20240921$PER$$US-ROCHE-10000083769$ROCHE$$$$$$Y$$$20240921$$MD$US$US
243462831$24346283$1$I$$20240916$20240921$20240921$EXP$$LB-ROCHE-10000083880$ROCHE$Zeineddine M, Raed A, Samar F, Samia K, Ayoubi N, Mahdawi A, et al. Safety and effectiveness of disease-modifying therapies after switching from natalizumab. Multiple Sclerosis Journal. 2024-Jul;30 (8):1026-35. doi:10.1177/ 13524585241261565.$$$$$Y$$$20240921$$HP$LB$LB
243462841$24346284$1$I$$20240830$20240921$20240921$PER$$US-SA-2024SA272105$SANOFI AVENTIS$$$$A$M$Y$77.11$KG$20240921$$MD$US$US
243462851$24346285$1$I$$20240916$20240921$20240921$PER$$US-SA-2024SA270308$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240921$$HP$US$US
243462861$24346286$1$I$$20240903$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08885$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243462871$24346287$1$I$$20240903$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08936$LUPIN$$$$$$Y$$$20240921$$MD$US$US
243462881$24346288$1$I$20220101$20240917$20240921$20240921$EXP$$UY-ABBVIE-4191140$ABBVIE$$$$$M$Y$$$20240921$$CN$UY$UY
243462891$24346289$1$I$$20240917$20240921$20240921$EXP$$US-ABBVIE-5931297$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243462901$24346290$1$I$20240801$20240917$20240921$20240921$EXP$$JP-AMGEN-JPNSP2024186131$AMGEN$$51$YR$A$M$Y$$$20240921$$MD$JP$JP
243462922$24346292$2$F$20240806$20240919$20240921$20240930$EXP$$US-ROCHE-10000079899$ROCHE$$57$YR$A$M$Y$$$20240930$$MD$US$US
243462931$24346293$1$I$20240801$20240917$20240921$20240921$EXP$$US-ABBVIE-5931256$ABBVIE$$62$YR$$M$Y$$$20240921$$CN$US$US
243462941$24346294$1$I$$20240917$20240921$20240921$PER$$US-ROCHE-10000085126$ROCHE$$54$YR$A$F$Y$$$20240921$$CN$US$US
243462951$24346295$1$I$$20240917$20240921$20240921$PER$$US-ROCHE-10000084660$ROCHE$$$$C$M$Y$$$20240921$$HP$US$US
243462981$24346298$1$I$20240904$20240904$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08941$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243463001$24346300$1$I$$20240917$20240921$20240921$EXP$$US-ABBVIE-5931196$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243463011$24346301$1$I$$20240905$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08999$LUPIN$$$$$$Y$$$20240921$$PH$US$US
243463031$24346303$1$I$$20240916$20240921$20240921$EXP$$US-ROCHE-10000084112$ROCHE$$89$YR$E$F$Y$$$20240921$$CN$US$US
243463061$24346306$1$I$$20240913$20240921$20240921$PER$$US-009507513-2409USA005533$MERCK$$$$$F$Y$$$20240921$$HP$US$US
243463071$24346307$1$I$$20240909$20240921$20240921$EXP$CA-APOTEX-2024AP010382$CA-Accord-447519$ACCORD$$61$YR$A$F$Y$$$20240921$$PH$CA$CA
243463081$24346308$1$I$20240307$20240911$20240921$20240921$EXP$PT-INFARMED-R202408-724$PT-ROCHE-10000079278$ROCHE$$54$YR$A$F$Y$$$20240921$$MD$PT$PT
243463091$24346309$1$I$$20240918$20240921$20240921$PER$$US-JNJFOC-20240949200$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243463101$24346310$1$I$20220401$20240909$20240921$20240921$EXP$$CA-ROCHE-3060684$ROCHE$$34$YR$A$F$Y$60$KG$20240921$$HP$CA$CA
243463111$24346311$1$I$$20240911$20240921$20240921$EXP$CA-MHPD-E2B_07238008$CA-Accord-446642$ACCORD$$69$YR$E$F$Y$$$20240921$$HP$CA$CA
243463121$24346312$1$I$$20240916$20240921$20240921$EXP$$US-ROCHE-10000086297$ROCHE$Mahipal A, Zemla T, Patell K, Naleid N, Gile J, Jin Z, et al. Multiinstitutional cohort study of patient outcomes in Child-Pugh (CP) B liver function treated with atezolizumab plus bevacizumab (A+B) for hepatocellular carcinoma (HCC). Journal of Clinical Oncology. 2024-Aug;42 (23):50. doi:10.1200/JCO.2024.42.23_suppl.50.$$$$$Y$$$20240921$$HP$US$US
243463131$24346313$1$I$$20240905$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08986$LUPIN$$$$$$Y$$$20240921$$MD$US$US
243463141$24346314$1$I$$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024187752$AMGEN$$$$$F$Y$$$20240921$$PH$US$US
243463151$24346315$1$I$$20240919$20240921$20240921$EXP$GB-MHRA-MED-202409130914122390-YLHTD$GB-TEVA-VS-3245485$TEVA$$29$YR$$M$Y$86$KG$20240921$$HP$GB$GB
243463161$24346316$1$I$20240101$20240830$20240921$20240921$PER$$US-SA-2024SA271757$SANOFI AVENTIS$$27$YR$A$F$Y$58.96$KG$20240921$$MD$US$US
243463171$24346317$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA268131$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240921$$MD$US$US
243463181$24346318$1$I$$20240905$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09062$LUPIN$$$$$$Y$$$20240921$$MD$US$US
243463192$24346319$2$F$20240919$20240920$20240921$20240925$PER$$US-AMGEN-USASP2024188056$AMGEN$$39$YR$A$F$Y$$$20240925$$CN$US$US
243463201$24346320$1$I$$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024188059$AMGEN$$$$$$Y$$$20240921$$PH$US$US
243463211$24346321$1$I$$20240909$20240921$20240921$EXP$$DE-Accord-446804$ACCORD$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al. Epidemiology of and risk factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant recipients: CERTAIN registry study. TRANSPLANTATION. 2018;103(6):1-33$14$YR$T$$Y$$$20240921$$MD$DE$DE
243463221$24346322$1$I$$20240909$20240921$20240921$EXP$$US-HETERO-HET2024US03149$HETERO$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. Journal of Forensic and Legal Medicine. 2024;101:1-6$61$YR$$$Y$$$20240921$$HP$US$US
243463241$24346324$1$I$$20240917$20240921$20240921$EXP$$ES-ABBVIE-5929883$ABBVIE$$$$A$$Y$$$20240921$$MD$ES$ES
243463251$24346325$1$I$20240101$20240831$20240921$20240921$PER$$US-SA-2024SA270847$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240921$$CN$US$US
243463261$24346326$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA267155$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240921$$HP$US$US
243463271$24346327$1$I$20240801$20240919$20240921$20240921$PER$$US-JNJFOC-20240952971$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243463281$24346328$1$I$$20240916$20240921$20240921$EXP$$CA-ROCHE-10000085804$ROCHE$$59$YR$A$F$Y$$$20240921$$MD$CA$CA
243463291$24346329$1$I$$20240912$20240921$20240921$EXP$$IN-ROCHE-10000081926$ROCHE$$63$YR$A$M$Y$$$20240921$$CN$IN$IN
243463311$24346331$1$I$20240826$20240916$20240921$20240921$PER$$US-AMGEN-USASP2024184974$AMGEN$$39$YR$A$F$Y$70.295$KG$20240921$$HP$US$US
243463321$24346332$1$I$$20240912$20240921$20240921$EXP$$CA-TEVA-VS-3244198$TEVA$$88$YR$$F$Y$$$20240921$$MD$CA$CA
243463331$24346333$1$I$20230101$20240912$20240921$20240921$EXP$$CA-TEVA-VS-3244104$TEVA$$64$YR$$F$Y$$$20240921$$MD$CA$CA
243463342$24346334$2$F$20240904$20240916$20240921$20240924$EXP$IT-MINISAL02-1002388$IT-ROCHE-10000084754$ROCHE$$53$YR$A$F$Y$80$KG$20240924$$MD$IT$IT
243463351$24346335$1$I$$20240912$20240921$20240921$PER$$US-TEVA-VS-3244463$TEVA$$74$YR$$F$Y$$$20240921$$CN$US$US
243463361$24346336$1$I$$20240912$20240921$20240921$EXP$$US-AMGEN-USASP2024182868$AMGEN$Ravandia F.. Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia. Leukemia + Lymphoma. 2024;65 (9):1325-1334$$$$$Y$$$20240921$$HP$US$US
243463371$24346337$1$I$$20240917$20240921$20240921$EXP$$US-ABBVIE-5889766$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243463381$24346338$1$I$20240101$20240913$20240921$20240921$EXP$$US-ABBVIE-5924077$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243463391$24346339$1$I$$20240726$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-038462$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243463401$24346340$1$I$$20240827$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-039257$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243463421$24346342$1$I$20240918$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187611$AMGEN$$78$YR$E$F$Y$$$20240921$$PH$US$US
243463431$24346343$1$I$20240909$20240916$20240921$20240921$PER$$US-AMGEN-USASP2024184935$AMGEN$$$$$$Y$$$20240921$$PH$US$US
243463442$24346344$2$F$$20240925$20240921$20240930$PER$$US-ROCHE-10000081756$ROCHE$$2$YR$C$F$Y$11.34$KG$20240930$$MD$US$US
243463461$24346346$1$I$20230101$20240917$20240921$20240921$EXP$$US-ABBVIE-5930142$ABBVIE$$56$YR$$F$Y$$$20240921$$CN$US$US
243463471$24346347$1$I$20240906$20240912$20240921$20240921$PER$$US-ROCHE-10000083070$ROCHE$$$$A$F$Y$$$20240921$$CN$US$US
243463482$24346348$2$F$$20240911$20240921$20240921$PER$$US-ROCHE-10000080949$ROCHE$$$$A$F$Y$$$20240921$$CN$US$US
243463491$24346349$1$I$$20240909$20240921$20240921$EXP$$US-GRANULES-US-2024GRASPO00408$GRANULES INDIA$$$$$F$Y$$$20240921$$CN$US$US
243463511$24346351$1$I$$20240912$20240921$20240921$PER$$US-ROCHE-10000082455$ROCHE$$$$$F$Y$$$20240921$$CN$US$US
243463522$24346352$2$F$$20240916$20240921$20240921$EXP$$US-ROCHE-10000083537$ROCHE$$$$A$F$Y$$$20240921$$CN$US$US
243463531$24346353$1$I$20230101$20240910$20240921$20240921$EXP$$TR-Accord-446782$ACCORD$Buyukkal U, Temelturk RD, Tekin D. Acute Dystonic Reaction Following Methylphenidate Discontinuation During Combination Therapy with Risperidone: A Case Study. Journal of Ankara University Faculty of Medicine. 2024;77(2):222-6.$6$YR$C$M$Y$$$20240921$$MD$TR$TR
243463541$24346354$1$I$$20240916$20240921$20240921$EXP$$CA-ROCHE-10000085823$ROCHE$$42$YR$A$F$Y$$$20240921$$MD$CA$CA
243463551$24346355$1$I$20240909$20240909$20240921$20240921$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK093981$GLENMARK$$$$$$Y$$$20240921$$MD$GB$GB
243463561$24346356$1$I$$20240916$20240921$20240921$EXP$$CA-ROCHE-10000085970$ROCHE$$26$YR$A$M$Y$$$20240921$$MD$CA$CA
243463571$24346357$1$I$$20240910$20240921$20240921$PER$$US-GRANULES-US-2024GRASPO00414$GRANULES INDIA$$$$$F$Y$$$20240921$$CN$US$US
243463581$24346358$1$I$$20240913$20240921$20240921$EXP$$US-JNJFOC-20240936929$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243463601$24346360$1$I$$20240905$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08949$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243463611$24346361$1$I$$20240830$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08801$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243463621$24346362$1$I$20240701$20240913$20240921$20240921$PER$$US-ABBVIE-5932317$ABBVIE$$37$YR$$$Y$$$20240921$$CN$US$US
243463631$24346363$1$I$$20240905$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09017$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243463641$24346364$1$I$$20240913$20240921$20240921$EXP$$JP-ROCHE-10000085237$ROCHE$$8$DEC$E$M$Y$$$20240921$$PH$JP$JP
243463652$24346365$2$F$$20240916$20240921$20240921$EXP$$US-ROCHE-10000084136$ROCHE$$$$A$F$Y$$$20240921$$CN$US$US
243463661$24346366$1$I$$20240905$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08961$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243463671$24346367$1$I$$20240918$20240921$20240921$PER$$US-ABBVIE-5930976$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243463681$24346368$1$I$20240828$20240911$20240921$20240921$EXP$CN-HENLIUS-24CN017172$CN-Accord-447612$ACCORD$$35$YR$A$F$Y$53$KG$20240921$$MD$CN$CN
243463691$24346369$1$I$$20240702$20240921$20240921$PER$$US-ROCHE-10000019391$ROCHE$$$$$$Y$$$20240921$$CN$US$US
243463701$24346370$1$I$$20240905$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08956$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243463711$24346371$1$I$$20240801$20240921$20240921$EXP$$JP-009507513-2409JPN005075$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$67$YR$$F$Y$$$20240921$$HP$JP$JP
243463724$24346372$4$F$$20240923$20240921$20240930$PER$$US-ROCHE-10000084895$ROCHE$$$$$$Y$$$20240930$$CN$US$US
243463741$24346374$1$I$$20240916$20240921$20240921$EXP$$US-ABBVIE-5930023$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243463751$24346375$1$I$$20240911$20240921$20240921$EXP$CA-MHPD-E2B_001095823$CA-Accord-446648$ACCORD$$83$YR$E$F$Y$60$KG$20240921$$PH$CA$CA
243463761$24346376$1$I$20240904$20240912$20240921$20240921$EXP$$CN-ROCHE-10000081365$ROCHE$$57$YR$A$F$Y$65$KG$20240921$$HP$CN$CN
243463771$24346377$1$I$20240906$20240910$20240921$20240921$PER$$US-ELI_LILLY_AND_COMPANY-US202409007877$ELI LILLY AND CO$$$$A$F$Y$$$20240921$$CN$US$US
243463781$24346378$1$I$$20240919$20240921$20240921$EXP$$IN-ABBVIE-5930978$ABBVIE$Paswan R, Kumar A. A Non-Randomized Controlled Trial to Examine the Effec-tiveness of Surfactant in Preterm Infants 32-36 Weeks Gestation with RDS Grade I and II. International Journal of Current Pharmaceutical Review and Research. 2023;15(10):819-823$$$I$$Y$$$20240921$$MD$IN$IN
243463791$24346379$1$I$$20240916$20240921$20240921$EXP$$CA-ABBVIE-5929781$ABBVIE$$$$E$M$Y$$$20240921$$HP$CA$CA
243463801$24346380$1$I$20240101$20240826$20240921$20240921$PER$$US-009507513-2408USA009401$MERCK$$$$$M$Y$$$20240921$$CN$US$US
243463811$24346381$1$I$20240509$20240910$20240921$20240921$PER$$US-009507513-2409USA003708$MERCK$$67$YR$$F$Y$$$20240921$$CN$US$US
243463821$24346382$1$I$20240918$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187847$AMGEN$$48$YR$A$F$Y$$$20240921$$PH$US$US
243463831$24346383$1$I$$20240912$20240921$20240921$EXP$$IE-ROCHE-10000080780$ROCHE$$$$$M$Y$$$20240921$$CN$IE$IE
243463841$24346384$1$I$$20240919$20240921$20240921$PER$$US-JNJFOC-20240952824$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240921$$CN$US$US
243463861$24346386$1$I$$20240912$20240921$20240921$EXP$$US-ABBVIE-5925281$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243463871$24346387$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA268351$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240921$$MD$US$US
243463881$24346388$1$I$20240901$20240912$20240921$20240921$PER$$US-SA-2024SA267782$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240921$$HP$US$US
243463891$24346389$1$I$$20240912$20240921$20240921$EXP$$IE-ROCHE-10000080895$ROCHE$$$$$F$Y$$$20240921$$CN$IE$IE
243463901$24346390$1$I$$20240903$20240921$20240921$PER$$US-ABBVIE-5926165$ABBVIE$$$$$$Y$$$20240921$$HP$US$US
243463911$24346391$1$I$$20240918$20240921$20240921$PER$$US-ABBVIE-5931978$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243463921$24346392$1$I$$20240827$20240921$20240921$PER$$US-009507513-2408USA009932$MERCK$$37$YR$$F$Y$$$20240921$$CN$US$US
243463931$24346393$1$I$$20240909$20240921$20240921$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-03454$AMNEAL$$$$$$Y$$$20240921$$HP$JP$JP
243463941$24346394$1$I$$20240910$20240921$20240921$EXP$DE-002147023-PHHY2018DE030907$DE-PBT-001045$PANACEA BIOTEC$Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B et al.. Epidemiology of and risk ?factors for BK Polyomavirus replication and nephropathy in pediatric renal transplant ?recipients: CERTAIN registry study. TRANSPLANTATION. 2018;103(6):1-33. ?doi:10.1097/TP.0000000000002414$14$YR$T$$Y$$$20240921$$HP$DE$DE
243463951$24346395$1$I$$20240907$20240921$20240921$EXP$$US-UCBSA-2024046592$UCB$$$$$$Y$$$20240921$$CN$US$US
243463961$24346396$1$I$20240328$20240911$20240921$20240921$EXP$DE-CADRBFARM-2024330314$DE-DEXPHARM-2024-3204$DEXCEL$$71$YR$E$M$Y$76$KG$20240921$$HP$DE$DE
243463971$24346397$1$I$$20240917$20240921$20240921$PER$$US-JNJFOC-20240950223$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240921$$CN$US$US
243463981$24346398$1$I$$20240906$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09010$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243463991$24346399$1$I$$20240916$20240921$20240921$EXP$$CA-ROCHE-10000085725$ROCHE$$57$YR$A$F$Y$97$KG$20240921$$HP$CA$CA
243464011$24346401$1$I$$20240906$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09009$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243464021$24346402$1$I$$20240912$20240921$20240921$EXP$GB-MHRA-MED-202409121514370330-BSKRG$GB-TEVA-VS-3243217$TEVA$$62$YR$$F$Y$56$KG$20240921$$PH$GB$GB
243464031$24346403$1$I$$20240906$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09003$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243464041$24346404$1$I$$20240910$20240921$20240921$EXP$$US-Accord-446710$ACCORD$$21$YR$A$F$Y$$$20240921$$HP$US$US
243464051$24346405$1$I$20240910$20240911$20240921$20240921$EXP$GB-MHRA-MED-202409110838475070-FNRBT$GB-Accord-446423$ACCORD$$53$YR$A$F$Y$$$20240921$$HP$GB$GB
243464061$24346406$1$I$20240101$20240830$20240921$20240921$PER$$US-SA-2024SA271688$SANOFI AVENTIS$$37$YR$A$F$Y$80$KG$20240921$$MD$US$US
243464071$24346407$1$I$20240801$20240901$20240921$20240921$PER$$US-SA-2024SA270965$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240921$$MD$US$US
243464081$24346408$1$I$$20240903$20240921$20240921$PER$$US-SA-2024SA271764$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240921$$CN$US$US
243464091$24346409$1$I$$20240909$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09026$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243464121$24346412$1$I$$20240904$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08897$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243464131$24346413$1$I$$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024187177$AMGEN$$$$$$Y$$$20240921$$PH$US$US
243464141$24346414$1$I$$20240916$20240921$20240921$EXP$$US-ABBVIE-5930217$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243464151$24346415$1$I$20240904$20240913$20240921$20240921$PER$$US-SA-2024SA269660$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240921$$MD$US$US
243464161$24346416$1$I$$20240906$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-038532$AUROBINDO$$78$YR$$F$Y$57.7$KG$20240921$$CN$US$US
243464171$24346417$1$I$$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024187170$AMGEN$$$$$$Y$$$20240921$$PH$US$US
243464191$24346419$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA269048$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240921$$HP$US$US
243464201$24346420$1$I$$20240917$20240921$20240921$PER$$US-ROCHE-10000085225$ROCHE$$25$YR$A$F$Y$$$20240921$$MD$US$US
243464211$24346421$1$I$20240101$20240911$20240921$20240921$EXP$DE-CADRBFARM-2024330333$DE-DEXPHARM-2024-3206$DEXCEL$$43$YR$A$M$Y$84$KG$20240921$$HP$DE$DE
243464222$24346422$2$F$$20240918$20240921$20240921$PER$$US-ROCHE-10000086064$ROCHE$$$$E$F$Y$$$20240921$$CN$US$US
243464231$24346423$1$I$$20240909$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09034$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243464241$24346424$1$I$$20240916$20240921$20240921$EXP$$CN-ROCHE-10000083054$ROCHE$Shu W, Yang Q L. Outcomes of COVID-19 in patients with obinutuzumab compared with patients with rituximab: a retrospective cohort study. Virology journal. 2024-Sep-09;21 (1):212. doi:10.1186/s12985-024-02484-x.$$$$$Y$$$20240921$$HP$CN$CN
243464251$24346425$1$I$20240916$20240916$20240921$20240921$PER$$US-AMGEN-USASP2024184687$AMGEN$$$$$M$Y$$$20240921$$PH$US$US
243464291$24346429$1$I$$20240910$20240921$20240921$EXP$$MX-Accord-446498$ACCORD$Alcocer SM, Santiago BMJ, Ibarra TDM, Zepeda TJM, Tarango MVM, Sanchez MAP. Fatal invasive trichosporonosis in a patient with systemic lupus erythematosus: case report. Enfermedades Infecciosas y Microbiologia. 2024;44(2):75-7.$52$YR$$F$Y$$$20240921$$MD$MX$MX
243464311$24346431$1$I$20240801$20240917$20240921$20240921$EXP$$JP-ROCHE-10000086015$ROCHE$$$$$$Y$$$20240921$$MD$JP$JP
243464321$24346432$1$I$$20240916$20240921$20240921$EXP$$US-AMGEN-USASP2024186640$AMGEN$Zabel K.M.; Rebbe R.; Vasef M. et al.. Case of B-acute lymphoblastic leukaemia with t(1;19)(q23-p13.3)TCF3::PBX1 and co-occurring CBL mutation mutation in an elderly patient. BMJ Case Reports. 2024;17 (9):1-5$$$E$F$Y$$$20240921$$MD$US$US
243464331$24346433$1$I$$20240909$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09030$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243464351$24346435$1$I$$20240911$20240921$20240921$PER$$US-ABBVIE-5921700$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243464371$24346437$1$I$20240101$20240815$20240921$20240921$EXP$$GB-TEVA-VS-3235246$TEVA$$34$YR$$F$Y$$$20240921$$CN$GB$GB
243464381$24346438$1$I$$20240909$20240921$20240921$EXP$$US-AUROBINDO-AUR-APL-2024-045160$AUROBINDO$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework.. J-Forens-Legal-Med. 2024;101:102625$84$YR$$F$Y$$$20240921$$HP$US$US
243464391$24346439$1$I$20240101$20240913$20240921$20240921$EXP$$JP-AMGEN-JPNSP2024185335$AMGEN$$83$YR$E$F$Y$$$20240921$$MD$JP$JP
243464401$24346440$1$I$$20240917$20240921$20240921$EXP$$PL-AMGEN-POLSP2024186560$AMGEN$Prejzner W.; Beldzinska-gadek K.; Zarzycka E. et al.. Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia. Leukemia + Lymphoma. 2024;65 (9):1292-1302$68$YR$E$M$Y$$$20240921$$HP$PL$PL
243464412$24346441$2$F$$20240912$20240921$20240921$PER$$US-ROCHE-10000082705$ROCHE$$$$$F$Y$$$20240921$$MD$US$US
243464421$24346442$1$I$$20240903$20240921$20240921$PER$$US-ABBVIE-5925980$ABBVIE$$$$$$Y$$$20240921$$HP$US$US
243464441$24346444$1$I$$20240916$20240921$20240921$EXP$$US-ABBVIE-5929265$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243464451$24346445$1$I$$20240903$20240921$20240921$PER$$US-ABBVIE-5925979$ABBVIE$$$$$$Y$$$20240921$$HP$US$US
243464461$24346446$1$I$$20240910$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045711$AUROBINDO$$55$YR$$F$Y$$$20240921$$PH$FR$FR
243464481$24346448$1$I$$20240917$20240921$20240921$EXP$$US-ROCHE-10000085588$ROCHE$$56$YR$A$M$Y$$$20240921$$CN$US$US
243464491$24346449$1$I$20240101$20240903$20240921$20240921$PER$$US-SA-2024SA270675$SANOFI AVENTIS$$49$YR$A$F$Y$86.36$KG$20240921$$MD$US$US
243464501$24346450$1$I$20240101$20240913$20240921$20240921$PER$$US-SA-2024SA269243$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240921$$MD$US$US
243464511$24346451$1$I$$20240425$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-018666$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243464521$24346452$1$I$$20240402$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-017238$AUROBINDO$$$$$F$Y$$$20240921$$PH$US$US
243464531$24346453$1$I$$20240910$20240921$20240921$EXP$$DE-AUROBINDO-AUR-APL-2024-045074$AUROBINDO$Obermaier B, Braun C, Hensen L, Ahmad O, Faul C, Lang P et al.. Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience. Transplant Infectious Disease. 2024;26 (4):e14296$24$YR$$$Y$$$20240921$$MD$DE$DE
243464541$24346454$1$I$20240425$20240430$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-022578$AUROBINDO$$62$YR$$F$Y$69.399$KG$20240921$$CN$US$US
243464551$24346455$1$I$$20240506$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-023070$AUROBINDO$$$$$F$Y$$$20240921$$PH$US$US
243464571$24346457$1$I$20240405$20240718$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-025280$AUROBINDO$$67$YR$$F$Y$65.7$KG$20240921$$CN$US$US
243464581$24346458$1$I$20240101$20240916$20240921$20240921$PER$$US-JNJFOC-20240947410$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243464591$24346459$1$I$$20240918$20240921$20240921$EXP$$US-ABBVIE-5930497$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243464601$24346460$1$I$20240101$20240918$20240921$20240921$EXP$$US-ABBVIE-5930895$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243464611$24346461$1$I$20240825$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024188255$AMGEN$$69$YR$E$F$Y$$$20240921$$CN$US$US
243464621$24346462$1$I$$20240629$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-033178$AUROBINDO$$$$$$Y$$$20240921$$CN$US$US
243464631$24346463$1$I$$20240802$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-031504$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243464641$24346464$1$I$$20240909$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-036801$AUROBINDO$$59$YR$$F$Y$136.07$KG$20240921$$CN$US$US
243464651$24346465$1$I$20230729$20230807$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-053697$AUROBINDO$$86$YR$$F$Y$54.4$KG$20240921$$CN$US$US
243464661$24346466$1$I$$20230821$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-055958$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243464671$24346467$1$I$20240612$20240724$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-030465$AUROBINDO$$85$YR$$F$Y$63.5$KG$20240921$$CN$US$US
243464681$24346468$1$I$$20240510$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-024315$AUROBINDO$$$$E$M$Y$$$20240921$$CN$US$US
243464691$24346469$1$I$20231101$20240829$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-035559$AUROBINDO$$82$YR$$F$Y$95.254$KG$20240921$$PH$US$US
243464701$24346470$1$I$20240101$20240910$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045739$AUROBINDO$$33$YR$$M$Y$$$20240921$$MD$FR$FR
243464711$24346471$1$I$$20240916$20240921$20240921$PER$$US-ROCHE-10000083697$ROCHE$$$$$F$Y$$$20240921$$MD$US$US
243464731$24346473$1$I$$20230914$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-057635$AUROBINDO$$71$YR$$F$Y$63.5$KG$20240921$$CN$US$US
243464741$24346474$1$I$20240101$20240910$20240921$20240921$EXP$SE-SEMPA-2024-006593$SE-AUROBINDO-AUR-APL-2024-045641$AUROBINDO$$36$YR$$F$Y$$$20240921$$MD$SE$SE
243464751$24346475$1$I$$20240603$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-028727$AUROBINDO$$75$YR$$F$Y$88.9$KG$20240921$$CN$US$US
243464762$24346476$2$F$$20240923$20240921$20240928$EXP$$CN-ROCHE-10000086171$ROCHE$$31$YR$A$F$Y$$$20240928$$MD$CN$CN
243464772$24346477$2$F$20240828$20240924$20240921$20240927$PER$$US-ROCHE-10000083535$ROCHE$$18$YR$A$M$Y$90.71$KG$20240927$$CN$US$US
243464781$24346478$1$I$$20230926$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-059151$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243464791$24346479$1$I$$20240917$20240921$20240921$EXP$$HU-ROCHE-10000085619$ROCHE$Agnes D,  Good quality of life and sustained progression-free state in metastatic triple-negative breast cancer in elderly patient. Advanced medical training review. 2024-Aug;67-9.$78$YR$E$F$Y$$$20240921$$MD$HU$HU
243464801$24346480$1$I$$20240913$20240921$20240921$PER$$US-ROCHE-10000082898$ROCHE$$$$$$Y$$$20240921$$HP$US$US
243464811$24346481$1$I$$20231028$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-061274$AUROBINDO$$$$E$F$Y$58$KG$20240921$$CN$US$US
243464821$24346482$1$I$$20240310$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2024-012100$AUROBINDO$$$$$F$Y$$$20240921$$CN$US$US
243464831$24346483$1$I$$20230926$20240921$20240921$PER$$US-AUROBINDO-AUR-APL-2023-061575$AUROBINDO$$$$E$F$Y$$$20240921$$CN$US$US
243464841$24346484$1$I$$20240911$20240921$20240921$EXP$GB-MHRA-MED-202409111600130520-LCVQZ$GB-Accord-446519$ACCORD$$$$$M$Y$72$KG$20240921$$HP$GB$GB
243464862$24346486$2$F$$20240917$20240921$20240923$PER$$US-ROCHE-10000083461$ROCHE$$$$A$$Y$$$20240923$$CN$US$US
243464881$24346488$1$I$$20240916$20240921$20240921$PER$$US-ROCHE-10000084044$ROCHE$$$$A$F$Y$67.81$KG$20240921$$MD$US$US
243464891$24346489$1$I$$20240910$20240921$20240921$PER$$US-009507513-2409USA003696$MERCK$$69$YR$$M$Y$$$20240921$$MD$US$US
243464901$24346490$1$I$$20240917$20240921$20240921$EXP$$US-ROCHE-10000085580$ROCHE$$64$YR$A$F$Y$$$20240921$$CN$US$US
243464911$24346491$1$I$20230101$20240916$20240921$20240921$EXP$$CA-ABBVIE-5886325$ABBVIE$$65$YR$$F$Y$$$20240921$$CN$CA$CA
243464921$24346492$1$I$20240801$20240917$20240921$20240921$EXP$$US-ABBVIE-5929060$ABBVIE$$80$YR$$M$Y$$$20240921$$CN$US$US
243464931$24346493$1$I$20240101$20240917$20240921$20240921$EXP$$US-ABBVIE-5927750$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243464941$24346494$1$I$20240827$20240912$20240921$20240921$EXP$GB-MHRA-TPP12519918C10912203YC1726060995923$GB-Accord-446556$ACCORD$$77$YR$E$F$Y$58$KG$20240921$$MD$GB$GB
243464951$24346495$1$I$20240101$20240912$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-022981$UNITED THERAPEUTICS$$$$$F$Y$50.794$KG$20240921$$$US$US
243464961$24346496$1$I$$20240912$20240921$20240921$PER$$US-ABBVIE-5922841$ABBVIE$$$$$F$Y$$$20240921$$MD$US$US
243464971$24346497$1$I$$20240916$20240921$20240921$EXP$$CA-ABBVIE-5931601$ABBVIE$$$$$M$Y$$$20240921$$HP$CA$CA
243464981$24346498$1$I$20240101$20240916$20240921$20240921$EXP$$US-ABBVIE-5897252$ABBVIE$$$$$F$Y$$$20240921$$HP$US$US
243464991$24346499$1$I$20240801$20240913$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-029423$UNITED THERAPEUTICS$$65$YR$$F$Y$52.154$KG$20240921$$$US$US
243465001$24346500$1$I$$20240912$20240921$20240921$EXP$CA-MHPD-E2B_001092746$CA-Accord-446854$ACCORD$$34$YR$A$M$Y$93$KG$20240921$$HP$CA$CA
243465011$24346501$1$I$$20240910$20240921$20240921$EXP$$JP-ROCHE-10000034322$ROCHE$$64$YR$A$M$Y$$$20240921$$MD$JP$JP
243465021$24346502$1$I$$20240829$20240921$20240921$PER$$US-009507513-2408USA010599$MERCK$Pan S. D., Osborne J. R., Chiang G. C., Ramakrishna R., Tsiouris A. J., Fine H. A., Ivanidze J.. Positron Emission Tomography and Magnetic Resonance Imaging Findings in the Diagnosis of Stroke-Like Migraine Attacks after Radiation Therapy Syndrome: A Case Report. Advances in Radiation Oncology. 2024$39$YR$$F$Y$$$20240921$$HP$US$US
243465031$24346503$1$I$20240101$20240914$20240921$20240921$PER$$US-SA-2024SA269980$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240921$$HP$US$US
243465041$24346504$1$I$$20240827$20240921$20240921$PER$$US-SA-2024SA266944$SANOFI AVENTIS$$69$YR$E$M$Y$90.91$KG$20240921$$MD$US$US
243465051$24346505$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA267765$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240921$$HP$US$US
243465061$24346506$1$I$20240801$20240828$20240921$20240921$PER$$US-SA-2024SA267842$SANOFI AVENTIS$$19$YR$A$F$Y$68.18$KG$20240921$$MD$US$US
243465071$24346507$1$I$20240914$20240914$20240921$20240921$PER$$US-SA-2024SA268784$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240921$$MD$US$US
243465081$24346508$1$I$$20240918$20240921$20240921$EXP$$US-ABBVIE-5930043$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243465091$24346509$1$I$20240901$20240916$20240921$20240921$EXP$$ES-ROCHE-10000083576$ROCHE$$64$YR$A$M$Y$$$20240921$$MD$ES$ES
243465101$24346510$1$I$20240101$20240917$20240921$20240921$EXP$$CH-ABBVIE-5930027$ABBVIE$$$$$M$Y$$$20240921$$CN$CH$CH
243465111$24346511$1$I$20240901$20240919$20240921$20240921$EXP$$GB-ABBVIE-5930932$ABBVIE$$78$YR$$F$Y$$$20240921$$CN$GB$GB
243465121$24346512$1$I$20240101$20240916$20240921$20240921$EXP$$CA-ABBVIE-5930812$ABBVIE$$58$YR$$F$Y$$$20240921$$CN$CA$CA
243465141$24346514$1$I$$20240910$20240921$20240921$EXP$$GB-AUROBINDO-AUR-APL-2024-045353$AUROBINDO$$85$YR$$F$Y$67$KG$20240921$$MD$GB$GB
243465161$24346516$1$I$$20240912$20240921$20240921$EXP$$CN-ROCHE-10000005962$ROCHE$$82$YR$E$M$Y$$$20240921$$CN$CN$CN
243465171$24346517$1$I$$20240918$20240921$20240921$PER$$US-JNJFOC-20240951658$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243465181$24346518$1$I$$20240916$20240921$20240921$EXP$$CA-ROCHE-10000085329$ROCHE$$61$YR$A$F$Y$$$20240921$$MD$CA$CA
243465192$24346519$2$F$20240101$20240918$20240921$20240927$EXP$$SE-AUROBINDO-AUR-APL-2024-045801$AUROBINDO$$68$YR$$F$Y$$$20240927$$MD$SE$SE
243465201$24346520$1$I$$20240916$20240921$20240921$EXP$$US-ABBVIE-5927396$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243465212$24346521$2$F$$20240920$20240921$20240927$EXP$$RU-ROCHE-10000085227$ROCHE$$$$$$Y$$$20240927$$MD$RU$RU
243465221$24346522$1$I$$20240910$20240921$20240921$EXP$$CA-ROCHE-10000085881$ROCHE$$63$YR$A$M$Y$61$KG$20240921$$HP$CA$CA
243465231$24346523$1$I$20240801$20240911$20240921$20240921$EXP$$US-UCBSA-2024046955$UCB$$56$YR$$M$Y$$$20240921$$HP$US$US
243465241$24346524$1$I$20231001$20231213$20240921$20240921$PER$$US-CIPLA LTD.-2023US07453$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243465251$24346525$1$I$$20231022$20240921$20240921$PER$$US-CIPLA LTD.-2023US06758$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243465261$24346526$1$I$$20240912$20240921$20240921$EXP$GB-MHRA-TPP12799569C7725762YC1726044735846$GB-TEVA-VS-3243383$TEVA$$29$YR$$F$Y$63$KG$20240921$$MD$GB$GB
243465271$24346527$1$I$20230901$20230928$20240921$20240921$PER$$US-CIPLA LTD.-2023US05996$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243465281$24346528$1$I$20230101$20230929$20240921$20240921$PER$$US-CIPLA LTD.-2023US06018$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243465291$24346529$1$I$20231101$20231211$20240921$20240921$PER$$US-CIPLA LTD.-2023US07542$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243465301$24346530$1$I$$20240910$20240921$20240921$EXP$$CA-APOTEX-2024AP010457$APOTEX$$$$$F$Y$54$KG$20240921$$HP$CA$CA
243465311$24346531$1$I$$20240916$20240921$20240921$EXP$$SA-ROCHE-10000083008$ROCHE$Almarhabi H, Alharbi A, Alalawi M, Ahamed M, El-Hemaidi I, Damfu N. Treatment of persistent coronavirus disease 2019 (COVID-19) in a B cell acute lymphoblastic leukemia patient with using nirmatrelvir/ritonavir extended course: A case report. Journal of Infection and Public Health. 2024;17 (10):1-4. doi:10.1016/j.jiph.2024.102526.$63$YR$A$M$Y$$$20240921$$HP$SA$SA
243465321$24346532$1$I$$20240916$20240921$20240921$EXP$$CA-ROCHE-10000085818$ROCHE$$66$YR$E$F$Y$$$20240921$$MD$CA$CA
243465341$24346534$1$I$$20240909$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09036$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243465351$24346535$1$I$$20240912$20240921$20240921$EXP$$HU-ROCHE-10000081900$ROCHE$$63$YR$A$$Y$$$20240921$$MD$HU$HU
243465361$24346536$1$I$$20240910$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045616$AUROBINDO$$45$YR$$M$Y$$$20240921$$PH$FR$FR
243465371$24346537$1$I$20240803$20240912$20240921$20240921$EXP$$CA-ROCHE-10000081343$ROCHE$$78$YR$E$F$Y$58$KG$20240921$$HP$CA$CA
243465381$24346538$1$I$$20240903$20240921$20240921$PER$$US-009507513-2409USA001708$MERCK$$$$$M$Y$$$20240921$$CN$US$US
243465401$24346540$1$I$20240909$20240916$20240921$20240921$EXP$$PK-ROCHE-10000082975$ROCHE$$72$YR$E$F$Y$$$20240921$$CN$PK$PK
243465411$24346541$1$I$20240101$20240913$20240921$20240921$PER$$US-SA-2024SA269444$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240921$$HP$US$US
243465421$24346542$1$I$20240831$20240914$20240921$20240921$PER$$US-SA-2024SA270074$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240921$$HP$US$US
243465431$24346543$1$I$20240618$20240910$20240921$20240921$EXP$$SE-AUROBINDO-AUR-APL-2024-045791$AUROBINDO$$57$YR$$M$Y$$$20240921$$MD$SE$SE
243465441$24346544$1$I$$20240912$20240921$20240921$EXP$$IT-ROCHE-10000081545$ROCHE$$$$$F$Y$$$20240921$$CN$IT$IT
243465461$24346546$1$I$20240101$20240917$20240921$20240921$EXP$$US-ABBVIE-5931530$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243465472$24346547$2$F$20240803$20240919$20240921$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-045667$AUROBINDO$$63$YR$$M$Y$$$20240927$$PH$FR$FR
243465481$24346548$1$I$20230401$20240912$20240921$20240921$EXP$$FR-CELLTRION INC.-2024FR022313$CELLTRION$$$$$$Y$$$20240921$$PH$FR$FR
243465511$24346551$1$I$20240901$20240916$20240921$20240921$PER$$US-JNJFOC-20240946741$JOHNSON AND JOHNSON$$$$$M$Y$$$20240921$$CN$US$US
243465522$24346552$2$F$20240101$20240916$20240921$20240924$EXP$$US-ABBVIE-5927097$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243465531$24346553$1$I$$20240916$20240921$20240921$PER$$US-ABBVIE-5927981$ABBVIE$$$$$$Y$$$20240921$$CN$US$US
243465541$24346554$1$I$$20240912$20240921$20240921$PER$$US-ABBVIE-5923107$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243465551$24346555$1$I$$20240917$20240921$20240921$EXP$$US-ABBVIE-5769868$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243465571$24346557$1$I$$20240905$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08981$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243465581$24346558$1$I$20240501$20240916$20240921$20240921$EXP$$US-ABBVIE-5927402$ABBVIE$$66$YR$$F$Y$$$20240921$$CN$US$US
243465591$24346559$1$I$$20240917$20240921$20240921$EXP$$US-ABBVIE-5928642$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243465601$24346560$1$I$20240901$20240916$20240921$20240921$EXP$$UY-ABBVIE-5928053$ABBVIE$$48$YR$$F$Y$$$20240921$$CN$UY$UY
243465612$24346561$2$F$20240101$20240919$20240921$20240928$EXP$$CA-CELLTRION INC.-2024CA022370$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
243465621$24346562$1$I$$20240912$20240921$20240921$EXP$$CA-CELLTRION INC.-2024CA022292$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
243465631$24346563$1$I$20240101$20240917$20240921$20240921$EXP$$UY-ABBVIE-5929630$ABBVIE$$$$$F$Y$$$20240921$$CN$UY$UY
243465641$24346564$1$I$$20240910$20240921$20240921$EXP$$GB-AUROBINDO-AUR-APL-2024-045351$AUROBINDO$$34$YR$$F$Y$102$KG$20240921$$MD$GB$GB
243465651$24346565$1$I$20240101$20240913$20240921$20240921$PER$$US-TEVA-VS-3244487$TEVA$$62$YR$$F$Y$$$20240921$$CN$US$US
243465661$24346566$1$I$$20240909$20240921$20240921$EXP$$CA-GLENMARK PHARMACEUTICALS-2023GMK084413$GLENMARK$$$$$$Y$$$20240921$$HP$CA$CA
243465671$24346567$1$I$20240729$20240910$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045677$AUROBINDO$$56$YR$$M$Y$$$20240921$$MD$FR$FR
243465681$24346568$1$I$$20240917$20240921$20240921$EXP$$FR-ABBVIE-5931026$ABBVIE$$86$YR$$M$Y$$$20240921$$HP$FR$FR
243465691$24346569$1$I$20240902$20240910$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045738$AUROBINDO$$71$YR$$M$Y$$$20240921$$MD$FR$FR
243465701$24346570$1$I$$20240917$20240921$20240921$EXP$$US-ORGANON-O2409USA001289$ORGANON$$16$YR$$F$Y$61.224$KG$20240921$$MD$US$US
243465721$24346572$1$I$$20240910$20240921$20240921$EXP$$NL-AUROBINDO-AUR-APL-2024-045692$AUROBINDO$$71$YR$$F$Y$$$20240921$$MD$NL$NL
243465731$24346573$1$I$$20240916$20240921$20240921$PER$$US-JNJFOC-20240950504$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243465741$24346574$1$I$20240601$20240912$20240921$20240921$EXP$FR-AFSSAPS-AN2024001209$FR-Accord-447073$ACCORD$$34$YR$A$F$Y$88$KG$20240921$$MD$FR$FR
243465751$24346575$1$I$$20240912$20240921$20240921$PER$$US-ABBVIE-5924140$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243465761$24346576$1$I$20240716$20240910$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045859$AUROBINDO$$51$YR$$M$Y$70$KG$20240921$$MD$FR$FR
243465771$24346577$1$I$$20240912$20240921$20240921$EXP$$ES-ROCHE-10000082105$ROCHE$Perez A, Gomez D, Montoro J, Chorao P, Hernani R, Guerreiro M, et al. Are any specific respiratory viruses more severe than others in recipients of allogeneic stem cell transplantation? A focus on lower respiratory tract disease. Bone Marrow Transplant.. 2024;59 (8):1118-26.$$$$$Y$$$20240921$$HP$ES$ES
243465781$24346578$1$I$$20240910$20240921$20240921$EXP$$GB-AUROBINDO-AUR-APL-2024-045325$AUROBINDO$$70$YR$$F$Y$74$KG$20240921$$MD$GB$GB
243465791$24346579$1$I$20240911$20240911$20240921$20240921$EXP$$GB-AUROBINDO-AUR-APL-2024-045512$AUROBINDO$$77$YR$$M$Y$$$20240921$$HP$GB$GB
243465801$24346580$1$I$$20240912$20240921$20240921$EXP$CA-MHPD-E2B_07213858$CA-Accord-446883$ACCORD$$57$YR$A$M$Y$$$20240921$$CN$CA$CA
243465821$24346582$1$I$20240703$20240911$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045685$AUROBINDO$$68$YR$$F$Y$$$20240921$$PH$FR$FR
243465831$24346583$1$I$$20240917$20240921$20240921$EXP$$US-ABBVIE-5928227$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243465841$24346584$1$I$20240101$20240918$20240921$20240921$EXP$$US-ABBVIE-5930219$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243465851$24346585$1$I$20240824$20240911$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045860$AUROBINDO$$90$YR$$M$Y$60$KG$20240921$$PH$FR$FR
243465861$24346586$1$I$20240903$20240911$20240921$20240921$EXP$$GB-AUROBINDO-AUR-APL-2024-045430$AUROBINDO$$71$YR$$M$Y$116$KG$20240921$$PH$GB$GB
243465871$24346587$1$I$20240101$20240916$20240921$20240921$EXP$$US-ABBVIE-5926933$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243465881$24346588$1$I$20240912$20240916$20240921$20240921$EXP$$US-ABBVIE-5926336$ABBVIE$$71$YR$$M$Y$127$KG$20240921$$CN$US$US
243465891$24346589$1$I$$20240916$20240921$20240921$PER$$US-HALEON-2197341$Haleon PLC$$55$YR$$F$Y$$$20240921$$CN$US$US
243465901$24346590$1$I$20240801$20240829$20240921$20240921$PER$$US-SA-2024SA267958$SANOFI AVENTIS$$21$YR$A$F$Y$68.03$KG$20240921$$MD$US$US
243465911$24346591$1$I$$20240909$20240921$20240921$PER$$US-SA-2024SA271551$SANOFI AVENTIS$$$$$$Y$$$20240921$$CN$US$US
243465921$24346592$1$I$20240101$20240903$20240921$20240921$PER$$US-SA-2024SA271035$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240921$$CN$US$US
243465931$24346593$1$I$20230420$20240911$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045885$AUROBINDO$$29$YR$$F$Y$$$20240921$$MD$FR$FR
243465941$24346594$1$I$20240813$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187838$AMGEN$$82$YR$E$M$Y$$$20240921$$CN$US$US
243465952$24346595$2$F$$20240923$20240921$20240924$PER$$US-AMGEN-USASP2024187868$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
243465961$24346596$1$I$$20240220$20240921$20240921$PER$$US-CIPLA LTD.-2024US02251$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243465971$24346597$1$I$$20240301$20240921$20240921$PER$$US-CIPLA LTD.-2024US02516$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243465981$24346598$1$I$20231126$20231126$20240921$20240921$PER$$US-CIPLA LTD.-2023US07666$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243465991$24346599$1$I$20231130$20231204$20240921$20240921$PER$$US-CIPLA LTD.-2023US07869$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466001$24346600$1$I$20240216$20240216$20240921$20240921$PER$$US-CIPLA LTD.-2024US02198$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466021$24346602$1$I$20231203$20231203$20240921$20240921$PER$$US-CIPLA LTD.-2023US07889$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466031$24346603$1$I$20240127$20240130$20240921$20240921$PER$$US-CIPLA LTD.-2024US01353$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466041$24346604$1$I$20240108$20240115$20240921$20240921$PER$$US-CIPLA LTD.-2024US00723$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466051$24346605$1$I$20240303$20240304$20240921$20240921$PER$$US-CIPLA LTD.-2024US02668$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466061$24346606$1$I$20220101$20240306$20240921$20240921$PER$$US-CIPLA LTD.-2024US02708$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466071$24346607$1$I$20240207$20240207$20240921$20240921$PER$$US-CIPLA LTD.-2024US01857$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466081$24346608$1$I$$20240918$20240921$20240921$PER$$US-HALEON-2197553$Haleon PLC$$92$YR$$$Y$$$20240921$$CN$US$US
243466092$24346609$2$F$20230101$20240920$20240921$20240928$EXP$$US-ABBVIE-5929069$ABBVIE$$$$$M$Y$104.33$KG$20240928$$CN$US$US
243466101$24346610$1$I$20230101$20240909$20240921$20240921$EXP$$CA-UCBSA-2023021418$UCBPVGPRD$$$$$M$Y$$$20240921$$CN$CA$CA
243466111$24346611$1$I$20231101$20240918$20240921$20240921$EXP$$US-ABBVIE-5930106$ABBVIE$$51$YR$$F$Y$$$20240921$$CN$US$US
243466121$24346612$1$I$20240501$20240917$20240921$20240921$EXP$$US-ABBVIE-5931132$ABBVIE$$60$YR$$M$Y$$$20240921$$CN$US$US
243466131$24346613$1$I$20240901$20240913$20240921$20240921$PER$$US-SA-2024SA268227$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240921$$MD$US$US
243466141$24346614$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA179071$SANOFI AVENTIS$$$$A$M$Y$$$20240921$$MD$US$US
243466151$24346615$1$I$$20240912$20240921$20240921$PER$$US-JNJFOC-20240946421$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240921$$CN$US$US
243466161$24346616$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA268180$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240921$$HP$US$US
243466171$24346617$1$I$$20240912$20240921$20240921$EXP$$FR-ROCHE-10000081884$ROCHE$$$$$$Y$$$20240921$$MD$FR$FR
243466181$24346618$1$I$20180805$20240916$20240921$20240921$EXP$$NL-AUROBINDO-AUR-APL-2018-054770$AUROBINDO$$61$YR$$M$Y$90$KG$20240921$$MD$NL$NL
243466191$24346619$1$I$20200609$20240916$20240921$20240921$EXP$$DE-ABBVIE-21K-062-3739262-00$ABBVIE$$64$YR$$M$Y$105$KG$20240921$$MD$DE$DE
243466201$24346620$1$I$20240913$20240916$20240921$20240921$EXP$$US-ABBVIE-5926109$ABBVIE$$47$YR$$M$Y$$$20240921$$CN$US$US
243466211$24346621$1$I$20240101$20240913$20240921$20240921$EXP$$US-ABBVIE-5927837$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243466221$24346622$1$I$$20240918$20240921$20240921$EXP$$US-ABBVIE-5929441$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243466231$24346623$1$I$20220901$20240918$20240921$20240921$EXP$$US-ABBVIE-5929682$ABBVIE$$58$YR$$F$Y$$$20240921$$CN$US$US
243466242$24346624$2$F$$20240919$20240921$20240923$EXP$$US-ROCHE-10000083584$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243466261$24346626$1$I$20240414$20240916$20240921$20240921$EXP$$MM-ROCHE-10000082740$ROCHE$$54$YR$A$M$Y$$$20240921$$CN$MM$MM
243466272$24346627$2$F$20240910$20240919$20240921$20240930$EXP$$JP-ROCHE-10000084976$ROCHE$$8$DEC$E$F$Y$$$20240930$$PH$JP$JP
243466281$24346628$1$I$$20240918$20240921$20240921$EXP$$US-ABBVIE-5929721$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243466291$24346629$1$I$$20240912$20240921$20240921$EXP$CA-MHPD-E2B_07223789$CA-Accord-446874$ACCORD$$49$YR$A$F$Y$$$20240921$$MD$CA$CA
243466312$24346631$2$F$20240101$20240923$20240921$20240927$EXP$$US-ABBVIE-5928384$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243466331$24346633$1$I$20240325$20240916$20240921$20240921$EXP$$CZ-ABBVIE-5927523$ABBVIE$$17$YR$$F$Y$$$20240921$$HP$CZ$CZ
243466341$24346634$1$I$20240101$20240917$20240921$20240921$EXP$$CA-ABBVIE-5929203$ABBVIE$$58$YR$$F$Y$$$20240921$$CN$CA$CA
243466351$24346635$1$I$20240826$20240917$20240921$20240921$EXP$$CA-ABBVIE-5929066$ABBVIE$$52$YR$$M$Y$$$20240921$$HP$CA$CA
243466361$24346636$1$I$20231101$20240918$20240921$20240921$EXP$$UY-ABBVIE-5929830$ABBVIE$$31$YR$$F$Y$80$KG$20240921$$CN$UY$UY
243466371$24346637$1$I$$20240911$20240921$20240921$PER$$US-JNJFOC-20240933953$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243466381$24346638$1$I$20240829$20240916$20240921$20240921$EXP$$US-ABBVIE-5923482$ABBVIE$$53$YR$$F$Y$$$20240921$$CN$US$US
243466391$24346639$1$I$$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024186857$AMGEN$$$$$$Y$$$20240921$$CN$US$US
243466401$24346640$1$I$$20240917$20240921$20240921$EXP$$CA-ABBVIE-5929935$ABBVIE$$$$A$F$Y$$$20240921$$CN$CA$CA
243466411$24346641$1$I$20240910$20240910$20240921$20240921$PER$$US-ABBVIE-5920697$ABBVIE$$$$$$Y$$$20240921$$HP$US$US
243466441$24346644$1$I$$20240910$20240921$20240921$EXP$$NL-AUROBINDO-AUR-APL-2024-045764$AUROBINDO$$7$YR$$F$Y$20$KG$20240921$$CN$NL$NL
243466451$24346645$1$I$$20240919$20240921$20240921$EXP$$US-ABBVIE-5932567$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243466461$24346646$1$I$20240801$20240913$20240921$20240921$PER$$US-009507513-2409USA005582$MERCK$$75$YR$$F$Y$$$20240921$$CN$US$US
243466471$24346647$1$I$$20240912$20240921$20240921$EXP$CA-MHPD-E2B_07220125$CA-Accord-446882$ACCORD$$56$YR$A$M$Y$$$20240921$$HP$CA$CA
243466481$24346648$1$I$$20240917$20240921$20240921$EXP$$US-ABBVIE-5929449$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243466491$24346649$1$I$$20240912$20240921$20240921$EXP$$BR-TAKEDA-2024TUS092194$TAKEDA$$$$$F$Y$80$KG$20240921$$CN$BR$BR
243466501$24346650$1$I$20240829$20240912$20240921$20240921$EXP$$GB-TEVA-VS-3243099$TEVA$$61$YR$$M$Y$82$KG$20240921$$CN$GB$GB
243466511$24346651$1$I$20240827$20240913$20240921$20240921$PER$$US-SA-2024SA269548$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240921$$MD$US$US
243466521$24346652$1$I$20240201$20240910$20240921$20240921$EXP$$RO-AUROBINDO-AUR-APL-2024-045463$AUROBINDO$Vazar-Tripon DA, Muntean MM, Filimon RA, Jimbu IL. A rare case of acute myeloid leukemia with central nervous system involvement.. Acta Medica Marisiensis. 2024;70(Suppl.3):216-217$73$YR$$F$Y$$$20240921$$HP$RO$RO
243466531$24346653$1$I$$20240322$20240921$20240921$PER$$US-CIPLA LTD.-2024US03173$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466541$24346654$1$I$$20240404$20240921$20240921$PER$$US-CIPLA LTD.-2024US03435$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466551$24346655$1$I$20240613$20240613$20240921$20240921$PER$$US-CIPLA LTD.-2024US06486$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466561$24346656$1$I$20240621$20240621$20240921$20240921$PER$$US-CIPLA LTD.-2024US06790$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466571$24346657$1$I$20240604$20240604$20240921$20240921$PER$$US-CIPLA LTD.-2024US06047$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466581$24346658$1$I$20210101$20240508$20240921$20240921$PER$$US-CIPLA LTD.-2024US04802$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466591$24346659$1$I$20240801$20240916$20240921$20240921$EXP$BE-FAMHP-DHH-N2024-122592$BE-AMGEN-BELSP2024187682$AMGEN$$76$YR$E$F$Y$46.2$KG$20240921$$MD$BE$BE
243466601$24346660$1$I$20240501$20240520$20240921$20240921$PER$$US-CIPLA LTD.-2024US05346$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466611$24346661$1$I$$20240612$20240921$20240921$PER$$US-CIPLA LTD.-2024US04555$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466621$24346662$1$I$$20240917$20240921$20240921$EXP$$US-ABBVIE-5807171$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243466631$24346663$1$I$$20240408$20240921$20240921$PER$$US-CIPLA LTD.-2024US03658$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466641$24346664$1$I$$20240912$20240921$20240921$EXP$GB-MHRA-MED-202409121406173940-YGNML$GB-Accord-446584$ACCORD$$19$YR$A$$Y$$$20240921$$CN$GB$GB
243466651$24346665$1$I$$20240919$20240921$20240921$EXP$$CA-ROCHE-10000086157$ROCHE$$$$$F$Y$$$20240921$$MD$CA$CA
243466661$24346666$1$I$20240501$20240530$20240921$20240921$PER$$US-CIPLA LTD.-2024US05344$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243466671$24346667$1$I$20240101$20240911$20240921$20240921$EXP$$CN-ABBVIE-5929001$ABBVIE$$20$YR$$F$Y$$$20240921$$CN$CN$CN
243466681$24346668$1$I$20240905$20240909$20240921$20240921$PER$$US-SA-2024SA271355$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240921$$CN$US$US
243466691$24346669$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA270430$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240921$$HP$US$US
243466701$24346670$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA267819$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240921$$HP$US$US
243466711$24346671$1$I$20240911$20240917$20240921$20240921$PER$$US-ABBVIE-5928619$ABBVIE$$46$YR$$$Y$$$20240921$$MD$US$US
243466721$24346672$1$I$$20240917$20240921$20240921$EXP$$US-ABBVIE-5930150$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243466731$24346673$1$I$$20240910$20240921$20240921$EXP$$DE-AUROBINDO-AUR-APL-2024-045072$AUROBINDO$Obermaier B, Braun C, Hensen L, Ahmad O, Faul C, Lang P et al.. Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience.. Transpl Infect Dis. 2024;26(4):e14296$46$YR$$$Y$$$20240921$$MD$DE$DE
243466741$24346674$1$I$20220111$20240917$20240921$20240921$EXP$$US-ABBVIE-5888294$ABBVIE$$21$YR$$F$Y$88$KG$20240921$$CN$US$US
243466751$24346675$1$I$20240801$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024186882$AMGEN$$70$YR$E$F$Y$$$20240921$$CN$US$US
243466761$24346676$1$I$20240701$20240916$20240921$20240921$EXP$$PR-ABBVIE-5930748$ABBVIE$$78$YR$$M$Y$$$20240921$$CN$PR$PR
243466772$24346677$2$F$20220101$20240917$20240921$20240925$EXP$$JP-ABBVIE-5932336$ABBVIE$$$$$$Y$$$20240925$$HP$JP$JP
243466791$24346679$1$I$20240901$20240917$20240921$20240921$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-029694$UNITED THERAPEUTICS$$$$$M$Y$$$20240921$$MD$JP$JP
243466801$24346680$1$I$20240820$20240917$20240921$20240921$EXP$$CA-ABBVIE-5930677$ABBVIE$$82$YR$$M$Y$$$20240921$$CN$CA$CA
243466811$24346681$1$I$20240717$20240917$20240921$20240921$EXP$$US-ABBVIE-5930395$ABBVIE$$52$YR$$F$Y$$$20240921$$CN$US$US
243466821$24346682$1$I$$20240911$20240921$20240921$EXP$$PL-AUROBINDO-AUR-APL-2024-045858$AUROBINDO$$$$$M$Y$$$20240921$$CN$PL$PL
243466831$24346683$1$I$$20240917$20240921$20240921$EXP$$US-ABBVIE-5930504$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243466851$24346685$1$I$$20240829$20240921$20240921$PER$$US-009507513-2409USA002440$MERCK$Marvin-Peek J, Sasaki K, Kontoyiannis D, Adachi J, Ohanian M, Takahashi K, et al. Nontuberculosis mycobacteria (NTM) infections in patients with leukemia: a single center case series. Frontiers in Medicine. 2024;11$78$YR$$F$Y$$$20240921$$HP$US$US
243466861$24346686$1$I$$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024186678$AMGEN$$$$$$Y$$$20240921$$CN$US$US
243466871$24346687$1$I$$20240903$20240921$20240921$PER$$US-ABBVIE-5926043$ABBVIE$$$$$$Y$$$20240921$$HP$US$US
243466881$24346688$1$I$$20240910$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09081$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243466892$24346689$2$F$20240904$20240919$20240921$20240927$EXP$DE-PEI-CADR2024330457$DE-ROCHE-10000084753$ROCHE$$59$YR$A$F$Y$60$KG$20240927$$MD$DE$DE
243466901$24346690$1$I$20240903$20240917$20240921$20240921$EXP$$US-ABBVIE-5930174$ABBVIE$$71$YR$$F$Y$$$20240921$$CN$US$US
243466911$24346691$1$I$$20240911$20240921$20240921$PER$$US-JNJFOC-20240939290$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243466921$24346692$1$I$$20240912$20240921$20240921$EXP$GB-MHRA-MED-202409092211043050-VNYST$GB-Accord-446613$ACCORD$$62$YR$A$M$Y$$$20240921$$MD$GB$GB
243466931$24346693$1$I$20240101$20240917$20240921$20240921$EXP$$ES-ABBVIE-5929984$ABBVIE$$$$$F$Y$$$20240921$$CN$ES$ES
243466942$24346694$2$F$$20240917$20240921$20240925$EXP$$BE-ABBVIE-5932251$ABBVIE$$$$E$M$Y$68$KG$20240925$$HP$BE$BE
243466951$24346695$1$I$20240904$20240918$20240921$20240921$EXP$$CN-ROCHE-10000086031$ROCHE$$49$YR$A$F$Y$47.6$KG$20240921$$HP$CN$CN
243466961$24346696$1$I$$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187806$AMGEN$$$$$$Y$$$20240921$$CN$US$US
243466981$24346698$1$I$$20240912$20240921$20240921$EXP$$GB-TEVA-VS-3243130$TEVA$$76$YR$$F$Y$64$KG$20240921$$MD$GB$GB
243466991$24346699$1$I$20210218$20240910$20240921$20240921$EXP$$JP-ABBVIE-5932341$ABBVIE$$47$YR$$M$Y$59$KG$20240921$$MD$JP$JP
243467002$24346700$2$F$20230502$20240918$20240921$20240927$EXP$FR-AFSSAPS-PB2023000594$FR-CELLTRION INC.-2024FR022383$CELLTRION$$$$$$Y$$$20240927$$MD$FR$FR
243467011$24346701$1$I$$20240916$20240921$20240921$EXP$$US-ROCHE-10000083782$ROCHE$$40$YR$A$M$Y$$$20240921$$CN$US$US
243467021$24346702$1$I$20230102$20240913$20240921$20240921$EXP$$CA-CELLTRION INC.-2023CA000586$CELLTRION$$$$$$Y$$$20240921$$CN$CA$CA
243467032$24346703$2$F$20240816$20240918$20240921$20240927$EXP$$CN-ROCHE-10000086021$ROCHE$$47$YR$A$F$Y$53$KG$20240927$$HP$CN$CN
243467041$24346704$1$I$20221001$20240917$20240921$20240921$EXP$PT-PFIZER INC-202400248518$PT-ROCHE-10000079920$ROCHE$Goncalves R, Nogueira J, Braga M, Mesquita P, Andrade J, Vilela F. Cerebral nocardiosis as a complication of immunosuppression case report.  [Abstract number: PO-0441 - (4962)]. National Internal Medicine Congress.. 2024;801.$60$YR$A$M$Y$$$20240921$$MD$PT$PT
243467051$24346705$1$I$$20240912$20240921$20240921$PER$$US-ABBVIE-5924325$ABBVIE$$$$$F$Y$$$20240921$$MD$US$US
243467091$24346709$1$I$20240201$20240912$20240921$20240921$EXP$FR-AFSSAPS-BR2024000717$FR-Accord-446844$ACCORD$$55$YR$A$M$Y$85$KG$20240921$$MD$FR$FR
243467121$24346712$1$I$$20240911$20240921$20240921$PER$$US-JNJFOC-20240931259$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243467131$24346713$1$I$$20240913$20240921$20240921$EXP$$CA-CELLTRION INC.-2024CA022342$CELLTRION$$$$$$Y$$$20240921$$MD$CA$CA
243467141$24346714$1$I$20240713$20240713$20240921$20240921$PER$$US-CIPLA LTD.-2024US07769$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243467151$24346715$1$I$$20231023$20240921$20240921$PER$$US-CIPLA LTD.-2023US06748$CIPLA$$$$$$Y$$$20240921$$HP$US$US
243467161$24346716$1$I$$20231023$20240921$20240921$PER$$US-CIPLA LTD.-2023US06811$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243467171$24346717$1$I$20230906$20230907$20240921$20240921$PER$$US-CIPLA LTD.-2023US05504$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243467181$24346718$1$I$20240122$20240122$20240921$20240921$PER$$US-CIPLA LTD.-2024US01061$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243467191$24346719$1$I$$20240410$20240921$20240921$PER$$US-CIPLA LTD.-2024US03757$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243467201$24346720$1$I$20240511$20240511$20240921$20240921$PER$$US-CIPLA LTD.-2024US04991$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243467211$24346721$1$I$20240728$20240728$20240921$20240921$PER$$US-CIPLA LTD.-2024US08334$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243467221$24346722$1$I$$20240428$20240921$20240921$PER$$US-CIPLA LTD.-2024US04397$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243467231$24346723$1$I$20240101$20240626$20240921$20240921$PER$$US-CIPLA LTD.-2024US07222$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243467241$24346724$1$I$$20240910$20240921$20240921$EXP$$NL-ROCHE-10000084691$ROCHE$$66$YR$E$F$Y$$$20240921$$MD$NL$NL
243467251$24346725$1$I$20240702$20240702$20240921$20240921$PER$$US-CIPLA LTD.-2024US07229$CIPLA$$$$$$Y$$$20240921$$CN$US$US
243467261$24346726$1$I$20240801$20240917$20240921$20240921$EXP$DE-PEI-202400020020$DE-ROCHE-10000083675$ROCHE$$47$YR$A$F$Y$$$20240921$$MD$DE$DE
243467271$24346727$1$I$20240101$20240916$20240921$20240921$EXP$$US-AMGEN-USASP2024184451$AMGEN$$79$YR$E$F$Y$$$20240921$$CN$US$US
243467281$24346728$1$I$$20240918$20240921$20240921$PER$$US-ABBVIE-5931211$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243467291$24346729$1$I$20240914$20240914$20240921$20240921$PER$$US-SA-2024SA270126$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240921$$HP$US$US
243467301$24346730$1$I$20240901$20240918$20240921$20240921$EXP$$US-009507513-2409USA006975$MERCK$$$$$F$Y$$$20240921$$CN$US$US
243467312$24346731$2$F$$20240925$20240921$20240928$EXP$$GB-ROCHE-10000085904$ROCHE$$39$YR$A$F$Y$$$20240928$$HP$GB$GB
243467321$24346732$1$I$$20240919$20240921$20240921$EXP$GB-MHRA-MED-202409190911322330-LVWZM$GB-ROCHE-10000086436$ROCHE$$$$$$Y$$$20240921$$PH$GB$GB
243467331$24346733$1$I$$20240912$20240921$20240921$EXP$GB-MHRA-MED-202409121254530970-CSLMN$GB-TEVA-VS-3243514$TEVA$$26$YR$$M$Y$$$20240921$$CN$GB$GB
243467351$24346735$1$I$$20240909$20240921$20240921$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09132$LUPIN$Janowski JPB, Suarez L, Allen ND, Sampson SM. A case series of 11 patients with subacute serotonin syndrome. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;65 (1):33-38$44$YR$$M$Y$$$20240921$$MD$US$US
243467361$24346736$1$I$20240826$20240913$20240921$20240921$EXP$GB-MHRA-MED-202409130922310840-KZDLW$GB-CELLTRION INC.-2024GB022444$CELLTRION$$$$$$Y$$$20240921$$PH$GB$GB
243467371$24346737$1$I$20240916$20240918$20240921$20240921$PER$$US-ELI_LILLY_AND_COMPANY-US202409011988$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240921$$CN$US$US
243467381$24346738$1$I$$20240919$20240921$20240921$PER$$US-ELI_LILLY_AND_COMPANY-US202409012684$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240921$$CN$US$US
243467412$24346741$2$F$$20240923$20240921$20240925$PER$$US-AMGEN-USASP2024188362$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243467421$24346742$1$I$20240917$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187465$AMGEN$$$$$M$Y$$$20240921$$CN$US$US
243467431$24346743$1$I$$20240918$20240921$20240921$EXP$$US-ABBVIE-5930014$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243467441$24346744$1$I$20240101$20240911$20240921$20240921$EXP$$US-UCBSA-2024047134$UCB$$$$$F$Y$60.771$KG$20240921$$HP$US$US
243467451$24346745$1$I$20240912$20240918$20240921$20240921$EXP$$CO-ABBVIE-5931616$ABBVIE$$61$YR$$M$Y$86$KG$20240921$$HP$CO$CO
243467461$24346746$1$I$20240101$20240917$20240921$20240921$EXP$$US-ABBVIE-5930796$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243467471$24346747$1$I$20240914$20240917$20240921$20240921$EXP$$IN-ROCHE-10000085462$ROCHE$$74$YR$E$M$Y$$$20240921$$CN$IN$IN
243467481$24346748$1$I$20240821$20240910$20240921$20240921$EXP$$US-Accord-446349$ACCORD$$14$YR$T$M$Y$94.8$KG$20240921$$HP$US$US
243467491$24346749$1$I$$20240913$20240921$20240921$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09316$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243467501$24346750$1$I$$20240912$20240921$20240921$EXP$GB-MHRA-MED-202409121426155180-YVMGP$GB-TEVA-VS-3243519$TEVA$$$$$F$Y$$$20240921$$HP$GB$GB
243467511$24346751$1$I$20240601$20240916$20240921$20240921$EXP$FR-AFSSAPS-NT2024001131$FR-ROCHE-10000082611$ROCHE$$59$YR$A$M$Y$$$20240921$$MD$FR$FR
243467522$24346752$2$F$$20240921$20240921$20240924$EXP$$ZA-ROCHE-3569202$ROCHE$$$$E$F$Y$$$20240924$$MD$ZA$ZA
243467531$24346753$1$I$$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024186462$AMGEN$$$$A$$Y$$$20240921$$CN$US$US
243467541$24346754$1$I$$20240909$20240921$20240921$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK094011$GLENMARK$$$$$$Y$$$20240921$$MD$CA$CA
243467551$24346755$1$I$$20240917$20240921$20240921$PER$$US-AMGEN-USASP2024186302$AMGEN$$$$$$Y$$$20240921$$MD$US$US
243467561$24346756$1$I$20240917$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024186615$AMGEN$$63$YR$A$F$Y$$$20240921$$CN$US$US
243467571$24346757$1$I$$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024186482$AMGEN$$$$A$$Y$$$20240921$$CN$US$US
243467581$24346758$1$I$20240819$20240910$20240921$20240921$EXP$$ES-AUROBINDO-AUR-APL-2024-045723$AUROBINDO$$63$YR$$F$Y$$$20240921$$MD$ES$ES
243467591$24346759$1$I$$20240918$20240921$20240921$EXP$$US-ABBVIE-5929999$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243467602$24346760$2$F$20240301$20240923$20240921$20240926$EXP$$US-ABBVIE-5929429$ABBVIE$$79$YR$$F$Y$$$20240926$$CN$US$US
243467611$24346761$1$I$$20240918$20240921$20240921$EXP$$US-ABBVIE-5930166$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243467621$24346762$1$I$$20240910$20240921$20240921$EXP$$US-Accord-446707$ACCORD$$$$$F$Y$108.86$KG$20240921$$MD$US$US
243467641$24346764$1$I$$20240911$20240921$20240921$EXP$$US-UCBSA-2024047215$UCB$$$$$$Y$$$20240921$$CN$US$US
243467651$24346765$1$I$$20240916$20240921$20240921$PER$$US-SA-2024SA268875$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240921$$HP$US$US
243467661$24346766$1$I$$20240913$20240921$20240921$EXP$$GB-NOVITIUMPHARMA-2024GBNVP01944$NOVITIUM PHARMA$Sidra Hussain.Unusual reaction to a local corticosteroid injection to the heel: Tachon^s syndrome.Rheumatology Advances in Practice.31-JUL-2024;8(3):1-2$42$YR$A$M$Y$$$20240921$$HP$GB$GB
243467671$24346767$1$I$$20240910$20240921$20240921$EXP$$TR-Accord-446500$ACCORD$Sabanci M, Tasdemir M, Oksuz B, Altuner Torun Y, Sutcu M, Ozkaya O. Managing recurrent parvovirus B19-associated anemia after a pediatric kidney transplant. Pediatric Nephrology. 2024;39(10):2923-5. DOI:10.1007/s00467-024-06378-6.$13$YR$$F$Y$40$KG$20240921$$MD$TR$TR
243467681$24346768$1$I$$20240918$20240921$20240921$EXP$$US-TAKEDA-2023TUS110426$TAKEDA$$$$$M$Y$$$20240921$$CN$US$US
243467691$24346769$1$I$$20240919$20240921$20240921$EXP$$CA-ROCHE-10000086509$ROCHE$$58$YR$A$F$Y$76$KG$20240921$$MD$CA$CA
243467701$24346770$1$I$20240403$20240913$20240921$20240921$EXP$$CA-TAKEDA-2024TUS092419$TAKEDA$$70$YR$$F$Y$$$20240921$$CN$CA$CA
243467711$24346771$1$I$$20240917$20240921$20240921$PER$$US-AMGEN-USASP2024186437$AMGEN$$$$$$Y$$$20240921$$MD$US$US
243467721$24346772$1$I$20201027$20240911$20240921$20240921$EXP$$PL-AUROBINDO-AUR-APL-2024-045693$AUROBINDO$$33$YR$$M$Y$$$20240921$$MD$PL$PL
243467732$24346773$2$F$20240101$20240920$20240921$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-026681$UNITED THERAPEUTICS$$$$$F$Y$133.33$KG$20240927$$$US$US
243467741$24346774$1$I$$20240911$20240921$20240921$EXP$$US-UCBSA-2024047264$UCB$$$$$$Y$$$20240921$$CN$US$US
243467751$24346775$1$I$$20240912$20240921$20240921$PER$$US-ABBVIE-5923077$ABBVIE$$$$$$Y$$$20240921$$HP$US$US
243467761$24346776$1$I$$20240917$20240921$20240921$EXP$$ES-ABBVIE-5932727$ABBVIE$$$$$$Y$$$20240921$$PH$ES$ES
243467771$24346777$1$I$$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024186751$AMGEN$$$$A$F$Y$$$20240921$$MD$US$US
243467781$24346778$1$I$$20240919$20240921$20240921$EXP$$CA-ROCHE-10000086186$ROCHE$$$$$F$Y$$$20240921$$MD$CA$CA
243467791$24346779$1$I$20240905$20240919$20240921$20240921$EXP$$LB-ROCHE-10000086870$ROCHE$$70$YR$E$M$Y$$$20240921$$CN$LB$LB
243467811$24346781$1$I$$20240916$20240921$20240921$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-28182$SAMSUNG BIOEPIS$$61$YR$A$F$Y$$$20240921$$CN$CA$CA
243467821$24346782$1$I$$20240913$20240921$20240921$EXP$$US-TAKEDA-2024TUS092609$TAKEDA$$$$$F$Y$$$20240921$$CN$US$US
243467831$24346783$1$I$20240601$20240919$20240921$20240921$PER$$US-JNJFOC-20240954328$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240921$$CN$US$US
243467841$24346784$1$I$20240418$20240911$20240921$20240921$EXP$$DE-AUROBINDO-AUR-APL-2024-045712$AUROBINDO$$59$YR$$F$Y$$$20240921$$MD$DE$DE
243467851$24346785$1$I$20240813$20240911$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045881$AUROBINDO$$58$YR$$M$Y$$$20240921$$HP$FR$FR
243467861$24346786$1$I$20240730$20240912$20240921$20240921$EXP$GB-MHRA-MED-202409121738305820-FBWNG$GB-TEVA-VS-3243524$TEVA$$72$YR$$M$Y$$$20240921$$MD$GB$GB
243467871$24346787$1$I$20240801$20240911$20240921$20240921$EXP$$US-UCBSA-2024047504$UCB$$57$YR$$F$Y$$$20240921$$HP$US$US
243467881$24346788$1$I$20240101$20240914$20240921$20240921$PER$$US-009507513-2409USA005509$MERCK$$$$$F$Y$54$KG$20240921$$CN$US$US
243467891$24346789$1$I$20240101$20240916$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-023129$UNITED THERAPEUTICS$$$$$M$Y$102.04$KG$20240921$$$US$US
243467901$24346790$1$I$$20240916$20240921$20240921$PER$$US-ROCHE-10000083712$ROCHE$$$$$$Y$$$20240921$$PH$US$US
243467911$24346791$1$I$20240830$20240918$20240921$20240921$EXP$$PK-ROCHE-10000085382$ROCHE$$61$YR$A$F$Y$$$20240921$$CN$PK$PK
243467921$24346792$1$I$$20240916$20240921$20240921$PER$$US-SA-2024SA270212$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240921$$HP$US$US
243467931$24346793$1$I$20240101$20240911$20240921$20240921$PER$$US-SA-2024SA267763$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240921$$HP$US$US
243467941$24346794$1$I$20240807$20240828$20240921$20240921$PER$$US-SA-2024SA243069$SANOFI AVENTIS$$39$YR$A$F$Y$90.7$KG$20240921$$MD$US$US
243467951$24346795$1$I$$20240913$20240921$20240921$EXP$$CA-TAKEDA-2024TUS092828$TAKEDA$$$$$M$Y$81.7$KG$20240921$$HP$CA$CA
243467961$24346796$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA127630$SANOFI AVENTIS$$$$A$F$Y$$$20240921$$MD$US$US
243467971$24346797$1$I$20240801$20240916$20240921$20240921$PER$$US-ROCHE-10000083751$ROCHE$$62$YR$A$F$Y$52.16$KG$20240921$$CN$US$US
243467981$24346798$1$I$20240908$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187456$AMGEN$$74$YR$E$F$Y$$$20240921$$CN$US$US
243467991$24346799$1$I$$20240913$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-029165$UNITED THERAPEUTICS$$$$$M$Y$113.38$KG$20240921$$$US$US
243468011$24346801$1$I$$20240828$20240921$20240921$EXP$$IL-ABBVIE-5932808$ABBVIE$$$$$M$Y$$$20240921$$MD$IL$IL
243468021$24346802$1$I$20240101$20240916$20240921$20240921$PER$$US-SA-2024SA270171$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240921$$HP$US$US
243468031$24346803$1$I$$20240912$20240921$20240921$EXP$$US-SAMSUNG BIOEPIS-SB-2024-28068$SAMSUNG BIOEPIS$$76$YR$E$M$Y$$$20240921$$HP$US$US
243468041$24346804$1$I$$20240916$20240921$20240921$PER$$US-ROCHE-10000083188$ROCHE$Little J, Hurtado R, Boire N, Baden L, Laga A, Silk A. Disseminated Mycobacterium avium Complex Infection Following CD3/CD20 Bispecific Antibody Therapy in a Patient With Follicular Lymphoma. Open Forum Infectious Diseases. 2024-Sep-01;11 (9):1-4. doi:10.1093/ofid/ofae460.$75$YR$E$M$Y$$$20240921$$MD$US$US
243468051$24346805$1$I$$20240919$20240921$20240921$PER$$NVSC2024US187891$NOVARTIS$$$$$$Y$$$20240921$$CN$US$US
243468061$24346806$1$I$$20240919$20240921$20240921$PER$$NVSC2024US188293$NOVARTIS$$$$$$Y$$$20240921$$CN$US$US
243468071$24346807$1$I$$20240909$20240921$20240921$EXP$$US-AUROBINDO-AUR-APL-2024-044947$AUROBINDO$Timothy LD, Healy CM, Quintanilla NM, Montgomery N, Okcu MF. Nocardiosis in an infant with spindle cell rhabdomyosarcoma treated with mild immunosuppressive chemotherapy. Pediatr-BloodCancer. 2024;71No. 4$9$DY$$F$Y$$$20240921$$HP$US$US
243468081$24346808$1$I$20240805$20240910$20240921$20240921$EXP$$DE-AUROBINDO-AUR-APL-2024-045658$AUROBINDO$$76$YR$$M$Y$86.2$KG$20240921$$MD$DE$DE
243468091$24346809$1$I$$20240910$20240921$20240921$EXP$$GB-AUROBINDO-AUR-APL-2024-045349$AUROBINDO$$84$YR$$F$Y$61$KG$20240921$$HP$GB$GB
243468101$24346810$1$I$$20240910$20240921$20240921$EXP$$NL-AUROBINDO-AUR-APL-2024-045608$AUROBINDO$$71$YR$$F$Y$67$KG$20240921$$CN$NL$NL
243468111$24346811$1$I$$20240919$20240921$20240921$PER$$US-HALEON-2197792$Haleon PLC$$$$$$Y$$$20240921$$CN$US$US
243468131$24346813$1$I$20240101$20240913$20240921$20240921$EXP$$CA-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00492$VELOXIS PHARMACEUTICALS$$54$YR$$F$Y$$$20240921$$MD$CA$CA
243468141$24346814$1$I$$20240908$20240921$20240921$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09121$LUPIN$$$$$$Y$$$20240921$$CN$US$US
243468151$24346815$1$I$$20240910$20240921$20240921$EXP$$DE-AUROBINDO-AUR-APL-2024-045663$AUROBINDO$$$$$M$Y$$$20240921$$MD$DE$DE
243468161$24346816$1$I$20240905$20240918$20240921$20240921$EXP$$CN-ROCHE-10000086136$ROCHE$$79$YR$E$F$Y$45$KG$20240921$$HP$CN$CN
243468171$24346817$1$I$20220501$20240917$20240921$20240921$EXP$$PL-AMGEN-POLSP2024186565$AMGEN$Prejzner W. ; Befdzihska-gcldek K. ; Zarzycka E.. Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia. Leukemia + Lymphoma. 2024;65 (9):1292-1302$63$YR$A$F$Y$$$20240921$$HP$PL$PL
243468181$24346818$1$I$$20240916$20240921$20240921$PER$$US-ROCHE-10000083521$ROCHE$$$$A$M$Y$$$20240921$$CN$US$US
243468191$24346819$1$I$20240422$20240910$20240921$20240921$EXP$$GB-AUROBINDO-AUR-APL-2024-045326$AUROBINDO$$72$YR$$M$Y$77$KG$20240921$$PH$GB$GB
243468201$24346820$1$I$20160101$20240911$20240921$20240921$EXP$FR-AFSSAPS-TS2024000961$FR-ROCHE-10000079371$ROCHE$$31$YR$A$M$Y$87$KG$20240921$$MD$FR$FR
243468211$24346821$1$I$20240526$20240911$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045864$AUROBINDO$$33$YR$$F$Y$$$20240921$$PH$FR$FR
243468221$24346822$1$I$$20240912$20240921$20240921$EXP$GB-MHRA-ADR 25879755$GB-TEVA-VS-3243538$TEVA$$74$YR$$F$Y$$$20240921$$MD$GB$GB
243468231$24346823$1$I$$20240913$20240921$20240921$EXP$GB-MHRA-MED-202409131322524410-MCGDB$GB-BAXTER-2024BAX024837$BAXTER$$$$$$Y$$$20240921$$PH$GB$GB
243468241$24346824$1$I$20230207$20240912$20240921$20240921$EXP$$FR-CELLTRION INC.-2024FR022310$CELLTRION$$$$$$Y$$$20240921$$PH$FR$FR
243468251$24346825$1$I$$20240917$20240921$20240921$PER$$US-ROCHE-10000086272$ROCHE$$$$E$F$Y$$$20240921$$CN$US$US
243468261$24346826$1$I$$20240829$20240921$20240921$PER$$US-009507513-2409USA007218$MERCK$Marvin-Peek J, Sasaki K, Kontoyiannis D, Adachi J, Ohanian M, Takahashi K, et al. Nontuberculosis mycobacteria (NTM) infections in patients with leukemia: a single center case series. Frontiers in Medicine. 2024;11 ()$81$YR$$M$Y$$$20240921$$HP$US$US
243468271$24346827$1$I$$20240909$20240921$20240921$EXP$$US-MACLEODS PHARMA-MAC2024049360$MACLEODS$Al-Chalabi M, Martinez Salazar A, Bradshaw A..Fluoroquinolone-Induced Demyelinating Polyneuropathy.Journal of Clinical Neuromuscular Disease.2024;26(1):49-53$$$$$Y$$$20240921$$MD$US$US
243468281$24346828$1$I$$20240909$20240921$20240921$EXP$$TW-MACLEODS PHARMA-MAC2024049366$MACLEODS$Liu C, Cheng P.Transient Unilateral Lateral Gaze Palsy after Sphenopalatine Ganglion Block..Ear, Nose and Throat Journal.2024;103(8):473-4$$$$$Y$$$20240921$$MD$TW$TW
243468291$24346829$1$I$$20240910$20240921$20240921$EXP$$ZA-MACLEODS PHARMA-MAC2024048998$MACLEODS$$$$$$Y$$$20240921$$CN$ZA$ZA
243468301$24346830$1$I$20240101$20240913$20240921$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025090$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240921$$$US$US
243468311$24346831$1$I$20240905$20240909$20240921$20240921$EXP$GB-MHRA-MED-202409061544469120-QMTWH$GB-MACLEODS PHARMA-MAC2024049390$MACLEODS$$69$YR$E$F$Y$$$20240921$$HP$GB$GB
243468321$24346832$1$I$$20240909$20240921$20240921$EXP$$UA-MACLEODS PHARMA-MAC2024049368$MACLEODS$Kravtsiv M, Goncharuk O, Dudchenko M, Ivashchenko D, Bevz G, Tytarenko N, et al..A clinical case of hypotonic hyperhydration and cerebral edema after gastric lavage in a  young child..Modern Pediatrics.2024;4(140):113-8$4$YR$C$M$Y$19$KG$20240921$$MD$UA$UA
243468331$24346833$1$I$20240501$20240909$20240921$20240921$EXP$GB-MHRA-MED-202409091717574630-PJNTZ$GB-MACLEODS PHARMA-MAC2024049394$MACLEODS$$$$$$Y$$$20240921$$CN$GB$GB
243468341$24346834$1$I$20240717$20240909$20240921$20240921$EXP$GB-MHRA-MED-202409091821142190-TSHCV$GB-MACLEODS PHARMA-MAC2024049395$MACLEODS$$$$$$Y$$$20240921$$HP$GB$GB
243468351$24346835$1$I$20210302$20240910$20240921$20240921$EXP$$GB-MACLEODS PHARMA-MAC2024049405$MACLEODS$$$$$$Y$$$20240921$$MD$GB$GB
243468361$24346836$1$I$$20240909$20240921$20240921$EXP$$JP-MACLEODS PHARMA-MAC2024049370$MACLEODS$Kimura M, Fujiwara S, Kuroda H, Kanamori M, Kawamoto M..Choroid plexitis caused by Burkholderia cepacia complex after COVID-19.International journal of infectious diseases.2024;147:107201$$$$$Y$$$20240921$$MD$JP$JP
243468381$24346838$1$I$$20240909$20240921$20240921$EXP$$ZA-MACLEODS PHARMA-MAC2024049380$MACLEODS$$$$$$Y$$$20240921$$CN$ZA$ZA
243468391$24346839$1$I$$20240909$20240921$20240921$EXP$$ZA-MACLEODS PHARMA-MAC2024049379$MACLEODS$$$$$$Y$$$20240921$$CN$ZA$ZA
243468411$24346841$1$I$$20240829$20240921$20240921$PER$$US-009507513-2409USA002182$MERCK$Ostby S.A., Daniel S., Kalogera E., De Vitis L., Fought A.J., McGree M.E., et al.. Treatment outcomes of vulvar and vaginal melanoma at an NCCN institution between 1993 and 2021. Gynecologic Oncology Reports. 2024;55:1-6$$$$F$Y$$$20240921$$HP$US$US
243468421$24346842$1$I$$20240911$20240921$20240921$EXP$$NL-AUROBINDO-AUR-APL-2024-045861$AUROBINDO$Joost Lesterhuis w, Milan T, Stumpenhausen Georg A, Reinout van C. Acute generalised exanthematous pustulosis mimicking septic shock.. The American Journal of Medicine. 2004;116(8):574-575$63$YR$$M$Y$$$20240921$$MD$NL$NL
243468432$24346843$2$F$20240914$20240916$20240921$20240925$PER$$US-JNJFOC-20240946533$JOHNSON AND JOHNSON$$27$YR$A$$Y$$$20240925$$CN$US$US
243468441$24346844$1$I$20210517$20240912$20240921$20240921$EXP$FR-AFSSAPS-MA2023001528$FR-CELLTRION INC.-2024FR022351$CELLTRION$$$$$$Y$$$20240921$$PH$FR$FR
243468461$24346846$1$I$20220929$20240917$20240921$20240921$EXP$$JP-ABBVIE-5689635$ABBVIE$Sekiguchi Y, Tsutsumi H, Gomyo A, Kudo M, Maseki N, Iizaki Y, et al. A case of relapsed/refractory cd56-positive acute promyelocytic leukemia, in which complete molecular remission was achieved following combination therapy with venetoclax and azacitidine. Jpn J Cancer Chemother. 2024;51(3):291-297.$84$YR$$F$Y$$$20240921$$HP$JP$JP
243468471$24346847$1$I$$20240918$20240921$20240921$PER$$US-ROCHE-10000086012$ROCHE$$56$YR$A$F$Y$$$20240921$$CN$US$US
243468481$24346848$1$I$20240901$20240914$20240921$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029388$UNITED THERAPEUTICS$$57$YR$$F$Y$58.957$KG$20240921$$$US$US
243468501$24346850$1$I$$20240910$20240921$20240921$EXP$$US-Accord-446265$ACCORD$Au-Yeung NM, Regennitter NS, Stepherson J, Seele J, Rosenblatt E, Carter W. Folate Deficiency and Medication-Induced Severe Pancytopenia in a Bilateral Lung Transplantee. Cureus. 2024 Jul 30;16(7):e65780.$74$YR$E$M$Y$$$20240921$$HP$US$US
243468512$24346851$2$F$$20240917$20240921$20240924$EXP$$IE-ROCHE-10000081979$ROCHE$$90$YR$E$F$Y$$$20240924$$MD$IE$IE
243468521$24346852$1$I$$20240917$20240921$20240921$EXP$$US-AMGEN-USASP2024186805$AMGEN$Molmenti E..P.; Nair V.; Jandovitz N. et.al. COVID-19 in kidney transplant recipients. American Journal of Transplantation. 2020;20 (7):1819-1825$56$YR$A$M$Y$$$20240921$$HP$US$US
243468531$24346853$1$I$20240101$20240919$20240921$20240921$PER$$US-JNJFOC-20240954468$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240921$$CN$US$US
243468541$24346854$1$I$$20240919$20240921$20240921$PER$$US-ROCHE-10000087473$ROCHE$$35$YR$A$M$Y$$$20240921$$HP$US$US
243468551$24346855$1$I$$20240911$20240921$20240921$EXP$$GB-AUROBINDO-AUR-APL-2024-045433$AUROBINDO$$$$$M$Y$$$20240921$$PH$GB$GB
243468561$24346856$1$I$20240904$20240918$20240921$20240921$EXP$$CN-ROCHE-10000086006$ROCHE$$46$YR$A$M$Y$59$KG$20240921$$HP$CN$CN
243468571$24346857$1$I$20240917$20240917$20240921$20240921$EXP$$US-ABBVIE-5928515$ABBVIE$$87$YR$$F$Y$$$20240921$$CN$US$US
243468581$24346858$1$I$20240912$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187802$AMGEN$$$$$$Y$$$20240921$$PH$US$US
243468591$24346859$1$I$$20240917$20240921$20240921$EXP$$US-AMGEN-USASP2024186808$AMGEN$Molmenti E..P.; Nair V.; Jandovitz N. et.al. COVID-19 in kidney transplant recipients. American Journal of Transplantation. 2020;20 (7):1819-1825$74$YR$E$F$Y$$$20240921$$HP$US$US
243468601$24346860$1$I$$20240917$20240921$20240921$EXP$$US-AMGEN-USASP2024186807$AMGEN$Molmenti E..P.; Nair V.; Jandovitz N. et.al. COVID-19 in kidney transplant recipients. American Journal of Transplantation. 2020;20 (7):1819-1825$68$YR$E$M$Y$$$20240921$$HP$US$US
243468611$24346861$1$I$$20240911$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045700$AUROBINDO$$75$YR$$M$Y$$$20240921$$MD$FR$FR
243468621$24346862$1$I$$20240909$20240921$20240921$EXP$$US-AMAROX PHARMA-HET2024US03132$HETERO$Akhdar G, Akpan I.. Navigating the Nexus: Lenalidomide Associated Thrombotic Thrombocytopenic Purpura (TTP). Cureus. 2024;16(6):e62975$56$YR$$M$Y$$$20240921$$MD$US$US
243468631$24346863$1$I$20240620$20240911$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045812$AUROBINDO$$63$YR$$M$Y$74$KG$20240921$$MD$FR$FR
243468641$24346864$1$I$$20240912$20240921$20240921$EXP$GB-MHRA-MED-202409121628358730-BKNLY$GB-TEVA-VS-3243546$TEVA$$$$$M$Y$$$20240921$$MD$GB$GB
243468651$24346865$1$I$$20240912$20240921$20240921$EXP$$CA-ROCHE-10000082233$ROCHE$$85$YR$E$M$Y$$$20240921$$CN$CA$CA
243468661$24346866$1$I$$20240918$20240921$20240921$PER$$US-ABBVIE-5930307$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243468672$24346867$2$F$20240101$20240912$20240921$20240926$EXP$$US-UCBSA-2024046272$UCB$$$$$F$Y$$$20240926$$CN$US$US
243468681$24346868$1$I$$20240909$20240921$20240921$EXP$$US-UCBSA-2024046076$UCB$$$$$F$Y$$$20240921$$CN$US$US
243468692$24346869$2$F$20240901$20240923$20240921$20240926$EXP$$US-ABBVIE-5930423$ABBVIE$$79$YR$$M$Y$$$20240926$$CN$US$US
243468701$24346870$1$I$$20240916$20240921$20240921$PER$$US-JNJFOC-20240946523$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243468712$24346871$2$F$$20240924$20240921$20240930$EXP$$US-JNJFOC-20240927164$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$HP$US$US
243468721$24346872$1$I$20240101$20240917$20240921$20240921$EXP$$US-ABBVIE-5929014$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243468731$24346873$1$I$$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187917$AMGEN$$$$$F$Y$$$20240921$$HP$US$US
243468741$24346874$1$I$$20240910$20240921$20240921$EXP$$ES-Accord-446486$ACCORD$Valera-Barrero A, Madera-Fernandez J, Gonzalez-Quintanilla V, Sedano-Tous MJ, Martinez-Dubarbie F. Metastases Affecting Cranial Nervous Structures in Male Breast Cancer: Two Case Reports. Oncology Research and Treatment. 2024;47:368-71.$54$YR$A$M$Y$$$20240921$$MD$ES$ES
243468751$24346875$1$I$20240909$20240909$20240921$20240921$EXP$$US-UCBSA-2024046286$UCB$$78$YR$$F$Y$$$20240921$$CN$US$US
243468761$24346876$1$I$20240901$20240913$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-026060$UNITED THERAPEUTICS$$54$YR$$F$Y$108.84$KG$20240921$$$US$US
243468771$24346877$1$I$20240702$20240911$20240921$20240921$EXP$$FR-AUROBINDO-AUR-APL-2024-045551$AUROBINDO$$30$YR$$F$Y$51$KG$20240921$$PH$FR$FR
243468781$24346878$1$I$$20240916$20240921$20240921$PER$$US-ABBVIE-5928043$ABBVIE$$$$$F$Y$$$20240921$$CN$US$US
243468791$24346879$1$I$20240904$20240913$20240921$20240921$EXP$GB-MHRA-MED-202409111722189650-SVMWZ$GB-TEVA-VS-3243819$TEVA$$$$$F$Y$$$20240921$$HP$GB$GB
243468801$24346880$1$I$20240101$20240909$20240921$20240921$EXP$$GB-UCBSA-2024046294$UCB$$$$$F$Y$$$20240921$$CN$GB$GB
243468811$24346881$1$I$$20240909$20240921$20240921$EXP$$US-UCBSA-2024046375$UCB$$$$$F$Y$$$20240921$$CN$US$US
243468821$24346882$1$I$20240916$20240917$20240921$20240921$PER$$US-JNJFOC-20240951401$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240921$$CN$US$US
243468831$24346883$1$I$$20240911$20240921$20240921$EXP$$TW-JNJFOC-20240934557$JOHNSON AND JOHNSON$$$$$M$Y$$$20240921$$MD$TW$TW
243468841$24346884$1$I$$20240913$20240921$20240921$EXP$$CA-CELLTRION INC.-2024CA022096$CELLTRION$$$$$$Y$$$20240921$$CN$CA$CA
243468851$24346885$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA272050$SANOFI AVENTIS$$$$A$M$Y$$$20240921$$HP$US$US
243468861$24346886$1$I$$20240916$20240921$20240921$EXP$$TH-ROCHE-10000084405$ROCHE$$49$YR$A$F$Y$$$20240921$$CN$TH$TH
243468871$24346887$1$I$$20240913$20240921$20240921$EXP$$US-ROCHE-10000082689$ROCHE$$61$YR$A$F$Y$$$20240921$$CN$US$US
243468882$24346888$2$F$20240101$20240919$20240921$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028988$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240928$$$US$US
243468911$24346891$1$I$20240101$20240909$20240921$20240921$EXP$$US-UCBSA-2024046512$UCB$$$$$F$Y$69$KG$20240921$$HP$US$US
243468921$24346892$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA209734$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240921$$MD$US$US
243468931$24346893$1$I$20240101$20240913$20240921$20240921$PER$$US-SA-2024SA271924$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240921$$HP$US$US
243468941$24346894$1$I$20240901$20240826$20240921$20240921$PER$$US-SA-2024SA267890$SANOFI AVENTIS$$47$YR$A$M$Y$70$KG$20240921$$MD$US$US
243468951$24346895$1$I$$20240909$20240921$20240921$EXP$$PT-Accord-446725$ACCORD$Fernandes AC, Sobrosa P, Araujo P, Risto MI, Parente AF, Bezerra J, et al. PO-0615 - (4864) Complications of chemotherapy: Mucositis, febrile neutropenia and hand-foot syndrome. Case report . 30 CNMI Oncological Diseases.$82$YR$E$M$Y$$$20240921$$HP$PT$PT
243468961$24346896$1$I$20240101$20240913$20240921$20240921$EXP$$US-ABBVIE-5808183$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243468981$24346898$1$I$$20240919$20240921$20240921$PER$$US-ROCHE-3536749$ROCHE$$35$YR$A$F$Y$$$20240921$$MD$US$US
243468992$24346899$2$F$$20240913$20240921$20240924$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029076$UNITED THERAPEUTICS$$$$$F$Y$$$20240924$$$US$US
243469001$24346900$1$I$$20240913$20240921$20240921$EXP$GB-MHRA-MED-202409131509190230-BKPTH$GB-TEVA-VS-3243888$TEVA$$$$$F$Y$$$20240921$$HP$GB$GB
243469011$24346901$1$I$20240601$20240911$20240921$20240921$PER$$US-ROCHE-10000081546$ROCHE$$81$YR$E$F$Y$58.06$KG$20240921$$CN$US$US
243469021$24346902$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA268294$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240921$$HP$US$US
243469031$24346903$1$I$$20240917$20240921$20240921$EXP$$GB-ROCHE-10000084582$ROCHE$$$$A$F$Y$$$20240921$$HP$GB$GB
243469041$24346904$1$I$20240101$20240909$20240921$20240921$EXP$$CA-UCBSA-2024046631$UCB$$$$$F$Y$$$20240921$$CN$CA$CA
243469051$24346905$1$I$20240916$20240919$20240921$20240921$PER$$US-JNJFOC-20240954576$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243469061$24346906$1$I$$20240909$20240921$20240921$EXP$$JP-UCBSA-2024046809$UCB$$$$$F$Y$$$20240921$$PH$JP$JP
243469071$24346907$1$I$$20240919$20240921$20240921$EXP$$CA-ROCHE-10000087196$ROCHE$$$$A$F$Y$$$20240921$$CN$CA$CA
243469081$24346908$1$I$20240915$20240919$20240921$20240921$PER$$PR-ROCHE-10000087147$ROCHE$$51$YR$A$M$Y$$$20240921$$HP$PR$PR
243469091$24346909$1$I$$20240912$20240921$20240921$EXP$$GR-TEVA-202111_00012421$TEVA$Lamprou M. Toxic epidermal necrolysis in pediatric patient me non-Hodgkin B-cell lymphoma and PRES encephalopathy. Annales Clinicae Paediatricae Universitatis Atheniensis, Book of Abstracts. 2023;73(1):69; Lamprou M. Toxic epidermal necrolysis in pediatric patient me non-Hodgkin B-cell lymphoma and PRES encephalopathy. 7th Panhellenic Congress Of Pediatric Heamatology-Oncology, Developments-Data-Pr. 2021; Lamprou M. Toxic epidermal necrolysis in pediatric patient me non-Hodgkin B-cell lymphom...$12$YR$$M$Y$$$20240921$$HP$GR$GR
243469101$24346910$1$I$$20240912$20240921$20240921$EXP$$JP-ROCHE-10000086586$ROCHE$$$$A$F$Y$$$20240921$$MD$JP$JP
243469111$24346911$1$I$20240911$20240911$20240921$20240921$PER$$US-ABBVIE-5922059$ABBVIE$$31$YR$$F$Y$$$20240921$$CN$US$US
243469121$24346912$1$I$20240813$20240918$20240921$20240921$EXP$FR-AFSSAPS-PC2024000729$FR-009507513-2409FRA006534$MERCK$$75$YR$$F$Y$$$20240921$$MD$FR$FR
243469141$24346914$1$I$$20240912$20240921$20240921$EXP$$BR-JNJFOC-20240945063$JOHNSON AND JOHNSON$$39$YR$A$M$Y$72$KG$20240921$$CN$BR$BR
243469151$24346915$1$I$$20240911$20240921$20240921$EXP$$CA-TEVA-VS-3242975$TEVA$$$$$F$Y$$$20240921$$HP$CA$CA
243469161$24346916$1$I$20240914$20240916$20240921$20240921$PER$$US-ABBVIE-5925985$ABBVIE$$75$YR$$F$Y$$$20240921$$CN$US$US
243469171$24346917$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA269078$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240921$$HP$US$US
243469181$24346918$1$I$$20240918$20240921$20240921$PER$$US-JNJFOC-20240953258$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$MD$US$US
243469191$24346919$1$I$$20240918$20240921$20240921$PER$$US-ELI_LILLY_AND_COMPANY-US202409011762$ELI LILLY AND CO$$$$$$Y$$$20240921$$HP$US$US
243469211$24346921$1$I$$20240918$20240921$20240921$EXP$$CA-ROCHE-10000087047$ROCHE$$$$A$F$Y$$$20240921$$CN$CA$CA
243469221$24346922$1$I$20240723$20240919$20240921$20240921$EXP$FR-AFSSAPS-NC2024001073$FR-ROCHE-10000086233$ROCHE$$83$YR$E$F$Y$51.5$KG$20240921$$MD$FR$FR
243469231$24346923$1$I$$20240829$20240921$20240921$PER$$US-009507513-2409USA007219$MERCK$Marvin-Peek J, Sasaki K, Kontoyiannis D, Adachi J, Ohanian M, Takahashi K, et al. Nontuberculosis mycobacteria (NTM) infections in patients with leukemia: a single center case series. Frontiers in Medicine. 2024;11$28$YR$$M$Y$$$20240921$$HP$US$US
243469241$24346924$1$I$$20240912$20240921$20240921$PER$$US-ABBVIE-5923919$ABBVIE$$$$$F$Y$$$20240921$$MD$US$US
243469251$24346925$1$I$$20240912$20240921$20240921$EXP$BE-FAMHP-DHH-N2023-120277$BE-CELLTRION INC.-2024BE022368$CELLTRION$$$$$$Y$$$20240921$$CN$BE$BE
243469261$24346926$1$I$20240702$20240910$20240921$20240921$EXP$$US-TAKEDA-2024TUS070594$TAKEDA$$67$YR$$M$Y$$$20240921$$CN$US$US
243469282$24346928$2$F$20230501$20240916$20240921$20240926$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-125808$REGENERON$$53$YR$$M$Y$$$20240926$$MD$US$US
243469291$24346929$1$I$$20240918$20240921$20240921$EXP$$JP-ABBVIE-5930104$ABBVIE$$76$YR$$M$Y$69$KG$20240921$$MD$JP$JP
243469341$24346934$1$I$20240917$20240917$20240921$20240921$EXP$$US-ABBVIE-5929167$ABBVIE$$67$YR$$M$Y$$$20240921$$PH$US$US
243469352$24346935$2$F$$20240916$20240921$20240926$PER$$US-ABBVIE-5927288$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243469361$24346936$1$I$$20240908$20240921$20240921$EXP$$PT-Indicus Pharma-001040$INDICUS$Mestre D, Gil F. Central Venous Catheter Misplacement Presenting With Parotid Gland Swelling: A Case Report. Cureus. 2024 Aug 5;16(8):e66245.$84$YR$E$F$Y$$$20240921$$HP$PT$PT
243469371$24346937$1$I$$20240912$20240921$20240921$EXP$DE-JNJFOC-20230146164$DE-CELLTRION INC.-2024DE022322$CELLTRION$Brioli A, Wyrwa A, Ruddel U, Yomade O, Lindig U, Franz W.. Mutations in the plasma cell clone identify mechanism of polyneuropathy in a case of POEMS syndrome associated with Castleman disease and multiple myeloma.. Ann Hematol. 2022;102:239-242$$$$$Y$$$20240921$$HP$DE$DE
243469381$24346938$1$I$20230101$20240917$20240921$20240921$EXP$$CA-ABBVIE-5929124$ABBVIE$$$$A$M$Y$$$20240921$$CN$CA$CA
243469391$24346939$1$I$$20240913$20240921$20240921$EXP$$US-ROCHE-10000082504$ROCHE$$85$YR$E$M$Y$$$20240921$$HP$US$US
243469401$24346940$1$I$20230901$20240916$20240921$20240921$EXP$$DE-ABBVIE-5929360$ABBVIE$$23$YR$$M$Y$76$KG$20240921$$MD$DE$DE
243469421$24346942$1$I$$20240918$20240921$20240921$PER$$US-JNJFOC-20240953777$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243469431$24346943$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA267813$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240921$$HP$US$US
243469441$24346944$1$I$20240101$20240918$20240921$20240921$PER$$US-009507513-2409USA006985$MERCK$$80$YR$$M$Y$$$20240921$$CN$US$US
243469452$24346945$2$F$$20240919$20240921$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-029482$UNITED THERAPEUTICS$$$$$F$Y$82.086$KG$20240926$$$US$US
243469461$24346946$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA272128$SANOFI AVENTIS$$$$A$F$Y$$$20240921$$HP$US$US
243469471$24346947$1$I$$20240913$20240921$20240921$EXP$GB-MHRA-MED-202409131738386140-YDRGS$GB-TEVA-VS-3243923$TEVA$$58$YR$$M$Y$$$20240921$$HP$GB$GB
243469491$24346949$1$I$$20240916$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-029499$UNITED THERAPEUTICS$$$$$F$Y$97.959$KG$20240921$$$US$US
243469511$24346951$1$I$$20240916$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-029295$UNITED THERAPEUTICS$$$$$F$Y$64.853$KG$20240921$$$US$US
243469531$24346953$1$I$20240101$20240913$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-027920$UNITED THERAPEUTICS$$$$$F$Y$126.98$KG$20240921$$$US$US
243469581$24346958$1$I$20240914$20240916$20240921$20240921$PER$$US-JNJFOC-20240941044$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243469591$24346959$1$I$$20240913$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-029000$UNITED THERAPEUTICS$$$$$$Y$$$20240921$$$US$US
243469611$24346961$1$I$$20240917$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-029518$UNITED THERAPEUTICS$$$$$F$Y$64.399$KG$20240921$$$US$US
243469621$24346962$1$I$20240101$20240917$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-029539$UNITED THERAPEUTICS$$$$$F$Y$97.959$KG$20240921$$$US$US
243469631$24346963$1$I$$20240918$20240921$20240921$EXP$$CA-TAKEDA-2024TUS093486$TAKEDA$$$$$F$Y$$$20240921$$CN$CA$CA
243469641$24346964$1$I$20240101$20240911$20240921$20240921$PER$$US-JNJFOC-20240933872$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243469661$24346966$1$I$$20240914$20240921$20240921$PER$$US-JNJFOC-20240940486$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243469671$24346967$1$I$$20240909$20240921$20240921$PER$$US-ROCHE-10000082443$ROCHE$Marvin J, Trubin P, Azar M. Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient. Transplant Infectious disease. 2024;(26):e14329. doi:10.1111/tid.14329..$63$YR$A$M$Y$$$20240921$$PH$US$US
243469681$24346968$1$I$$20240918$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-029701$UNITED THERAPEUTICS$$$$$F$Y$71.202$KG$20240921$$$US$US
243469711$24346971$1$I$$20240912$20240921$20240921$EXP$$CA-CELLTRION INC.-2024CA015394$CELLTRION$$$$$$Y$$$20240921$$CN$CA$CA
243469721$24346972$1$I$$20240906$20240921$20240921$PER$$US-SA-2024SA268866$SANOFI AVENTIS$$$$$$Y$$$20240921$$HP$US$US
243469731$24346973$1$I$20240905$20240916$20240921$20240921$EXP$$US-ABBVIE-5930804$ABBVIE$$76$YR$$M$Y$$$20240921$$CN$US$US
243469741$24346974$1$I$20240801$20240913$20240921$20240921$PER$$US-SA-2024SA269396$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240921$$HP$US$US
243469751$24346975$1$I$20240901$20240912$20240921$20240921$PER$$US-SA-2024SA267749$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240921$$HP$US$US
243469761$24346976$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA272097$SANOFI AVENTIS$$$$A$M$Y$$$20240921$$HP$US$US
243469771$24346977$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA179119$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240921$$HP$US$US
243469781$24346978$1$I$$20240909$20240921$20240921$PER$$US-ROCHE-10000084755$ROCHE$Benador-Shen C, Shantha J, Lee J, Qian Y, Doan T, Gonzales J. Multiple Anterior Chamber Paracenteses May Be Needed to Identify Cytomegalovirus Anterior Uveitis. American Journal of Ophthalmology. 2024; doi:10.1016/j.ajo.2024.08.025.$45$YR$A$M$Y$$$20240921$$MD$US$US
243469791$24346979$1$I$20240101$20240918$20240921$20240921$EXP$$BG-ABBVIE-5931773$ABBVIE$$72$YR$$M$Y$$$20240921$$CN$BG$BG
243469801$24346980$1$I$20240605$20240902$20240921$20240921$PER$$US-JNJFOC-20240903468$JOHNSON AND JOHNSON$$$$$M$Y$$$20240921$$CN$US$US
243469821$24346982$1$I$$20240910$20240921$20240921$EXP$$JP-UCBSA-2024047120$UCB$Yoichiro Maekawa, et al. A case of anti-SRP antibody-positive immune-mediated necrotizing myopathy, diagnosed after sudden increase in CK. The 28th Annual Meeting of Japan Society of Hospital General Medicine. 2024;0-042$64$YR$$M$Y$$$20240921$$MD$JP$JP
243469831$24346983$1$I$20240506$20240918$20240921$20240921$EXP$IT-MINISAL02-1001834$IT-009507513-2409ITA006747$MERCK$$75$YR$$F$Y$74$KG$20240921$$MD$IT$IT
243469841$24346984$1$I$20240909$20240913$20240921$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029240$UNITED THERAPEUTICS$$64$YR$$F$Y$80.272$KG$20240921$$$US$US
243469851$24346985$1$I$20240828$20240913$20240921$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027133$UNITED THERAPEUTICS$$53$YR$$F$Y$71.655$KG$20240921$$PH$US$US
243469901$24346990$1$I$$20240910$20240921$20240921$PER$$US-009507513-2409USA003770$MERCK$Yadav R, Din S, Moussaris H, Yadav V, Raman S, Gandhi, A, et al. Atypical Site of Presentation of a Rare Type of SMARCA4-Positive Cutaneous Squamous Cell Carcinoma of the Skin: Case Report and Review of the Literature. Journal of Investigative Medicine High Impact Case Reports. 2024;12$50$YR$$M$Y$$$20240921$$MD$US$US
243469911$24346991$1$I$$20240915$20240921$20240921$PER$$US-JNJFOC-20240945848$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243469921$24346992$1$I$$20240918$20240921$20240921$EXP$$US-ABBVIE-5929979$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243469931$24346993$1$I$$20240911$20240921$20240921$PER$$US-JNJFOC-20240940295$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$MD$US$US
243469941$24346994$1$I$$20240909$20240921$20240921$PER$$US-SA-2024SA271651$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240921$$CN$US$US
243469951$24346995$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA269455$SANOFI AVENTIS$$$$A$M$Y$$$20240921$$HP$US$US
243469961$24346996$1$I$20240627$20240913$20240921$20240921$PER$$US-SA-2024SA270740$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240921$$HP$US$US
243469971$24346997$1$I$20240101$20240913$20240921$20240921$PER$$US-SA-2024SA272269$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240921$$MD$US$US
243469981$24346998$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA267674$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240921$$HP$US$US
243470011$24347001$1$I$$20240916$20240921$20240921$EXP$$US-ABBVIE-5930340$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243470031$24347003$1$I$$20240911$20240921$20240921$PER$$US-JNJFOC-20240931436$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243470042$24347004$2$F$$20240925$20240921$20240927$PER$$US-JNJFOC-20240956308$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243470051$24347005$1$I$20240918$20240918$20240921$20240921$PER$$US-009507513-2409USA007007$MERCK$$71$YR$$F$Y$$$20240921$$CN$US$US
243470061$24347006$1$I$20240101$20240909$20240921$20240921$PER$$US-SA-2024SA271905$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240921$$CN$US$US
243470071$24347007$1$I$$20240909$20240921$20240921$PER$$US-SA-2024SA271643$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240921$$CN$US$US
243470081$24347008$1$I$$20240916$20240921$20240921$PER$$US-SA-2024SA268803$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240921$$CN$US$US
243470091$24347009$1$I$20230712$20240912$20240921$20240921$EXP$$RU-ROCHE-10000081813$ROCHE$$73$YR$E$M$Y$$$20240921$$MD$RU$RU
243470101$24347010$1$I$$20240910$20240921$20240921$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-09185$LUPIN$Ravikumar K, Chendan L, Sujatha V, Gurmeet, Shivanna K, Rajanna P. Ethambutol induced optic neuropathy in ankle tuberculosis patient-a case report. Journal of Population Therapeutics  + Clinical Pharmacology. 2024;31 (6):1332-1339$61$YR$$F$Y$60$KG$20240921$$MD$IN$IN
243470131$24347013$1$I$20240101$20240828$20240921$20240921$PER$$US-SA-2024SA267474$SANOFI AVENTIS$$24$YR$A$M$Y$65.91$KG$20240921$$MD$US$US
243470141$24347014$1$I$$20240917$20240921$20240921$PER$$US-JNJFOC-20240947573$JOHNSON AND JOHNSON$$$$$M$Y$$$20240921$$CN$US$US
243470151$24347015$1$I$20240909$20240909$20240921$20240921$PER$$US-SA-2024SA271827$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240921$$CN$US$US
243470161$24347016$1$I$$20240909$20240921$20240921$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK094070$GLENMARK$$$$$$Y$$$20240921$$HP$CA$CA
243470171$24347017$1$I$$20240914$20240921$20240921$PER$$US-JNJFOC-20240940504$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243470181$24347018$1$I$$20240917$20240921$20240921$PER$$US-JNJFOC-20240951863$JOHNSON AND JOHNSON$$$$$M$Y$$$20240921$$HP$US$US
243470191$24347019$1$I$20240716$20240910$20240921$20240921$EXP$$US-ROCHE-10000076319$ROCHE$$69$YR$E$M$Y$110.22$KG$20240921$$CN$US$US
243470201$24347020$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA267806$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240921$$HP$US$US
243470211$24347021$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA266869$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240921$$HP$US$US
243470231$24347023$1$I$20240901$20240916$20240921$20240921$PER$$US-SA-2024SA268853$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240921$$MD$US$US
243470241$24347024$1$I$$20240910$20240921$20240921$EXP$$CA-ROCHE-10000085239$ROCHE$$63$YR$A$M$Y$61$KG$20240921$$HP$CA$CA
243470251$24347025$1$I$$20240919$20240921$20240921$PER$$US-JNJFOC-20240953005$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243470261$24347026$1$I$20240917$20240918$20240921$20240921$PER$$US-JNJFOC-20240951315$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243470281$24347028$1$I$$20240920$20240921$20240921$EXP$$US-ROCHE-10000087552$ROCHE$$$$A$F$Y$138.8$KG$20240921$$MD$US$US
243470291$24347029$1$I$$20240916$20240921$20240921$PER$$US-ROCHE-10000082889$ROCHE$$$$$$Y$$$20240921$$CN$US$US
243470301$24347030$1$I$$20240919$20240921$20240921$EXP$$CA-ROCHE-10000087528$ROCHE$$$$A$M$Y$$$20240921$$HP$CA$CA
243470311$24347031$1$I$$20240913$20240921$20240921$PER$$US-ROCHE-10000086726$ROCHE$$$$$F$Y$$$20240921$$MD$US$US
243470321$24347032$1$I$$20240919$20240921$20240921$EXP$$GB-ROCHE-10000087043$ROCHE$$$$$$Y$$$20240921$$MD$GB$GB
243470332$24347033$2$F$$20240920$20240921$20240926$EXP$$GB-ROCHE-10000086141$ROCHE$$$$$$Y$$$20240926$$MD$GB$GB
243470341$24347034$1$I$$20240910$20240921$20240921$EXP$$CA-ROCHE-10000084702$ROCHE$$63$YR$A$F$Y$$$20240921$$CN$CA$CA
243470351$24347035$1$I$$20240916$20240921$20240921$EXP$$ES-ROCHE-10000087653$ROCHE$Morales L, Gracia J. Pneumocystis jirovecii pneumonia as a complication of anti-CD20 monoclonal antibody [Abstract: P1757/447]. Multiple Sclerosis Journal. 2024;30 (3S):1108-9.$45$YR$A$M$Y$$$20240921$$HP$ES$ES
243470361$24347036$1$I$$20240916$20240921$20240921$EXP$$GB-ROCHE-10000087517$ROCHE$Kabiri B, Blount S, Garjani A, Evangelou N. Pertussis during ocrelizumab treatment for multiple sclerosis [Abstract Number: P1654/2204]. Multiple Sclerosis Journal. 2024;30 (3S):1046-47.$50$YR$A$F$Y$$$20240921$$HP$GB$GB
243470371$24347037$1$I$$20240919$20240921$20240921$PER$$US-HALEON-2197752$Haleon PLC$$$$$$Y$$$20240921$$CN$US$US
243470381$24347038$1$I$20240914$20240918$20240921$20240921$PER$$US-ROCHE-10000085759$ROCHE$$$$$$Y$$$20240921$$PH$US$US
243470391$24347039$1$I$20240101$20240916$20240921$20240921$PER$$US-SA-2024SA268944$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240921$$MD$US$US
243470401$24347040$1$I$20240301$20240913$20240921$20240921$PER$$US-ABBVIE-5924166$ABBVIE$$45$YR$$M$Y$$$20240921$$CN$US$US
243470411$24347041$1$I$$20240918$20240921$20240921$EXP$$US-ROCHE-10000087029$ROCHE$$$$E$F$Y$$$20240921$$CN$US$US
243470421$24347042$1$I$20240901$20240919$20240921$20240921$EXP$IT-MINISAL02-1002620$IT-ROCHE-10000086094$ROCHE$$42$YR$A$F$Y$$$20240921$$MD$IT$IT
243470431$24347043$1$I$20210601$20240919$20240921$20240921$EXP$$AU-ROCHE-10000086839$ROCHE$$$$$$Y$$$20240921$$MD$AU$AU
243470441$24347044$1$I$$20240918$20240921$20240921$PER$$US-ROCHE-10000086030$ROCHE$$$$$$Y$$$20240921$$CN$US$US
243470451$24347045$1$I$$20240919$20240921$20240921$EXP$$CA-ROCHE-10000086510$ROCHE$$37$YR$A$F$Y$$$20240921$$HP$CA$CA
243470461$24347046$1$I$$20240909$20240921$20240921$EXP$$IT-Ipsen Biopharmaceuticals, Inc.-2024-18603$IPSEN$$$$$$Y$$$20240921$$MD$IT$IT
243470471$24347047$1$I$$20240913$20240921$20240921$PER$$US-JNJFOC-20240945804$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243470482$24347048$2$F$$20240913$20240921$20240921$EXP$$US-ROCHE-10000082572$ROCHE$$$$$$Y$$$20240921$$CN$US$US
243470491$24347049$1$I$20240606$20240917$20240921$20240921$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-18854$IPSEN$$61$YR$A$F$Y$$$20240921$$HP$US$US
243470501$24347050$1$I$$20240913$20240921$20240921$EXP$$AR-ROCHE-10000083156$ROCHE$$27$YR$A$F$Y$$$20240921$$MD$AR$AR
243470511$24347051$1$I$20240914$20240918$20240921$20240921$EXP$$CA-ROCHE-10000086998$ROCHE$$51$YR$A$F$Y$$$20240921$$CN$CA$CA
243470521$24347052$1$I$20240913$20240918$20240921$20240921$PER$$US-ELI_LILLY_AND_COMPANY-US202409011594$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240921$$CN$US$US
243470531$24347053$1$I$20240901$20240912$20240921$20240921$EXP$$IT-ROCHE-10000081787$ROCHE$$43$YR$A$F$Y$$$20240921$$MD$IT$IT
243470541$24347054$1$I$$20240912$20240921$20240921$PER$$US-ELI_LILLY_AND_COMPANY-US202409011368$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240921$$CN$US$US
243470551$24347055$1$I$20240916$20240917$20240921$20240921$PER$$US-ELI_LILLY_AND_COMPANY-US202409011716$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240921$$CN$US$US
243470561$24347056$1$I$$20240919$20240921$20240921$PER$$US-HALEON-2197744$Haleon PLC$$$$$F$Y$$$20240921$$CN$US$US
243470571$24347057$1$I$20101001$20240912$20240921$20240921$EXP$$SK-TEVA-VS-3244526$TEVA$$69$YR$$M$Y$$$20240921$$MD$SK$SK
243470581$24347058$1$I$20240901$20240911$20240921$20240921$EXP$$IN-Ipsen Biopharmaceuticals, Inc.-2024-18922$IPSEN$$59$YR$A$M$Y$$$20240921$$CN$IN$IN
243470591$24347059$1$I$20240101$20240910$20240921$20240921$PER$$US-009507513-2409USA003664$MERCK$$$$$F$Y$330$KG$20240921$$CN$US$US
243470602$24347060$2$F$$20240917$20240921$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-029010$UNITED THERAPEUTICS$$$$$F$Y$108.84$KG$20240926$$$US$US
243470611$24347061$1$I$20240910$20240911$20240921$20240921$PER$$US-JNJFOC-20240933807$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243470621$24347062$1$I$$20240910$20240921$20240921$PER$$US-SA-2024SA272090$SANOFI AVENTIS$$$$A$F$Y$$$20240921$$CN$US$US
243470631$24347063$1$I$20240401$20240913$20240921$20240921$PER$$US-SA-2024SA271717$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240921$$HP$US$US
243470641$24347064$1$I$$20240914$20240921$20240921$EXP$$HR-ROCHE-10000082108$ROCHE$Skegro S, Penezic L, Simicevic L, Hudolin T, Bozina N, Trkulja V. The reduced function allele SLCO1B1 c.521T}C is of no practical relevance for the renal graft function over the first post-transplant year in patients treated with mycophenolic acid.. Pharmacogenetics + Genomics. 2024;34 (7):226-35.$$$$$Y$$$20240921$$HP$HR$HR
243470651$24347065$1$I$$20240916$20240921$20240921$EXP$$US-ROCHE-10000087263$ROCHE$Fearey M, Greenawalt P, Stine S, Bouley A, Lathi E, Katz J. ACAPELLA: Hypogammaglobulinemia in Ocrelizumab-Treated Patients, Year Seven Data [Abstract No: P1681/187]. Multiple Sclerosis Journal. 2024;30 (3S):1062-3.$$$$$Y$$$20240921$$HP$US$US
243470662$24347066$2$F$$20240917$20240921$20240927$EXP$$GB-TEVA-VS-3243212$TEVA$Farrugia L, Baston V, Burfield L, Melly L, Borman AM, Bal AM. Cutaneous Purpureocillium lilacinum and Fusarium coinfection in a heart transplant recipient. Med Mycol Case Rep. 2024 Jul 23;45; Farrugia L, Baston V, Burfield L, Melly L, Borman AM, Bal AM. Cutaneous Purpureocillium lilacinum and Fusarium coinfection in a heart transplant recipient. Med Mycol Case Rep. 2024 Jul 23;45; Farrugia L, Baston V, Burfield L, Melly L, Borman AM, Bal AM.. Cutaneous Purpureocillium lilacinum and Fusarium c...$63$YR$$M$Y$$$20240927$$MD$GB$GB
243470671$24347067$1$I$$20240910$20240921$20240921$PER$$US-ELI_LILLY_AND_COMPANY-US202409006375$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240921$$CN$US$US
243470681$24347068$1$I$$20240913$20240921$20240921$PER$$US-UNITED THERAPEUTICS-UNT-2024-029203$UNITED THERAPEUTICS$$$$$F$Y$70.748$KG$20240921$$$US$US
243470691$24347069$1$I$$20240918$20240921$20240921$PER$$US-JNJFOC-20240948584$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243470701$24347070$1$I$$20240909$20240921$20240921$EXP$$FR-DSJP-DSE-2024-144643$DAIICHI$$$$E$F$Y$$$20240921$$MD$FR$FR
243470711$24347071$1$I$$20240914$20240921$20240921$EXP$IT-MINISAL02-1002531$IT-STALCOR-2024-AER-02096$Unknown Manufacturer$$17$YR$T$M$Y$$$20240921$$MD$IT$IT
243470721$24347072$1$I$20240801$20240916$20240921$20240921$PER$$US-SA-2024SA268961$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240921$$MD$US$US
243470731$24347073$1$I$20240101$20240916$20240921$20240921$PER$$US-SA-2024SA270351$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240921$$MD$US$US
243470741$24347074$1$I$20231101$20240912$20240921$20240921$PER$$US-SA-2024SA272103$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240921$$HP$US$US
243470751$24347075$1$I$20240810$20240920$20240921$20240921$EXP$$US-BAYER-2024A134747$BAYER$$90$YR$E$M$Y$$$20240921$$HP$US$US
243470761$24347076$1$I$$20240917$20240921$20240921$PER$$US-JNJFOC-20240947498$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243470781$24347078$1$I$$20240828$20240921$20240921$PER$$US-SA-2024SA267482$SANOFI AVENTIS$$$$A$F$Y$55$KG$20240921$$MD$US$US
243470792$24347079$2$F$$20240924$20240921$20240926$EXP$$US-ABBVIE-5932272$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243470801$24347080$1$I$20240101$20240916$20240921$20240921$EXP$$US-ABBVIE-5926861$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243470811$24347081$1$I$20240401$20240913$20240921$20240921$PER$$US-SA-2024SA272091$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240921$$HP$US$US
243470821$24347082$1$I$20240901$20240918$20240921$20240921$PER$$US-JNJFOC-20240949374$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243470831$24347083$1$I$20240501$20240917$20240921$20240921$PER$$US-BAYER-2024A132608$BAYER$$35$YR$A$F$Y$$$20240921$$HP$US$US
243470841$24347084$1$I$20240101$20240912$20240921$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025240$UNITED THERAPEUTICS$$$$$M$Y$$$20240921$$$US$US
243470851$24347085$1$I$20240909$20240909$20240921$20240921$PER$$US-SA-2024SA272158$SANOFI AVENTIS$$56$YR$A$F$Y$92$KG$20240921$$MD$US$US
243470861$24347086$1$I$$20240916$20240921$20240921$PER$$US-SA-2024SA268792$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240921$$HP$US$US
243470871$24347087$1$I$20240101$20240916$20240921$20240921$PER$$US-SA-2024SA270466$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240921$$HP$US$US
243470892$24347089$2$F$$20240923$20240921$20240923$PER$$US-BAYER-2024A132371$BAYER$$78$YR$E$F$Y$$$20240923$$CN$US$US
243470902$24347090$2$F$20240101$20240918$20240921$20240926$EXP$$US-DSJP-DSU-2024-138163$DAIICHI$$$$$F$Y$61.5$KG$20240926$$CN$US$US
243470911$24347091$1$I$$20240916$20240921$20240921$PER$$US-BAYER-2024A132606$BAYER$$25$YR$A$F$Y$$$20240921$$HP$US$US
243470921$24347092$1$I$$20240917$20240921$20240921$PER$$US-JNJFOC-20240947509$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243470931$24347093$1$I$$20240915$20240921$20240921$EXP$$GB-DSJP-DS-2024-100204-GB$DAIICHI$$75$YR$$F$Y$$$20240921$$MD$GB$GB
243470941$24347094$1$I$20220901$20240915$20240921$20240921$EXP$$GB-DSJP-DS-2024-100196-GB$DAIICHI$$46$YR$$F$Y$$$20240921$$MD$GB$GB
243470951$24347095$1$I$$20240909$20240921$20240921$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK094071$GLENMARK$$$$$$Y$$$20240921$$CN$CA$CA
243470961$24347096$1$I$$20240916$20240921$20240921$PER$$US-ELI_LILLY_AND_COMPANY-US202409010946$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240921$$HP$US$US
243470971$24347097$1$I$$20240910$20240921$20240921$EXP$$CN-DSJP-DSJ-2024-144579$DAIICHI$$$$$F$Y$60$KG$20240921$$HP$CN$CN
243470981$24347098$1$I$$20240912$20240921$20240921$EXP$$CA-CELLTRION INC.-2024CA022364$CELLTRION$$$$$$Y$$$20240921$$HP$CA$CA
243470991$24347099$1$I$$20240909$20240921$20240921$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK094150$GLENMARK$$$$$$Y$$$20240921$$HP$CA$CA
243471001$24347100$1$I$20240101$20240916$20240921$20240921$PER$$US-JNJFOC-20240942500$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243471011$24347101$1$I$$20240916$20240921$20240921$EXP$$NVSC2024BE186090$NOVARTIS$$$$$$Y$$$20240921$$MD$BE$BE
243471021$24347102$1$I$20150101$20240917$20240921$20240921$EXP$$ZA-ABBVIE-5930320$ABBVIE$$60$YR$$M$Y$88$KG$20240921$$HP$ZA$ZA
243471031$24347103$1$I$$20240910$20240921$20240921$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK093970$GLENMARK$Rattner P, Sutherland A.. Aspergillus nidulans: A rare cause of invasive pulmonary aspergillosis resulting in diffuse alveolar haemorrhage.. Chest.. 2016;150(4):157A$$$$$Y$$$20240921$$MD$US$US
243471041$24347104$1$I$20240101$20240913$20240921$20240921$PER$$US-009507513-2409USA005350$MERCK$$$$$M$Y$$$20240921$$CN$US$US
243471061$24347106$1$I$20240803$20240917$20240921$20240921$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-024804$UNITED THERAPEUTICS$$74$YR$$M$Y$$$20240921$$$JP$JP
243471071$24347107$1$I$20240725$20240910$20240921$20240921$EXP$FR-AFSSAPS-TS2024000964$FR-BAXTER-2024BAX024486$BAXTER$$11$YR$$F$Y$50$KG$20240921$$MD$FR$FR
243471081$24347108$1$I$20240101$20240916$20240921$20240921$PER$$US-SA-2024SA270218$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240921$$HP$US$US
243471091$24347109$1$I$20240826$20240910$20240921$20240921$EXP$CN-NMPACDR-3704011509867202400771$CN-BAXTER-2024BAX024630$BAXTER$$51$YR$$F$Y$58$KG$20240921$$MD$CN$CN
243471101$24347110$1$I$20240902$20240910$20240921$20240921$EXP$CN-NMPACDR-4401841005149202400273$CN-BAXTER-2024BAX024634$BAXTER$$73$YR$$M$Y$48$KG$20240921$$MD$CN$CN
243471111$24347111$1$I$20240906$20240910$20240921$20240921$EXP$CN-NMPACDR-5301001002141202401027$CN-BAXTER-2024BAX024621$BAXTER$$37$YR$$M$Y$61$KG$20240921$$MD$CN$CN
243471131$24347113$1$I$$20240917$20240921$20240921$PER$$US-JNJFOC-20240945697$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243471141$24347114$1$I$$20240911$20240921$20240921$EXP$$CA-TAKEDA-2021TUS049004$TAKEDA$$$$$M$Y$$$20240921$$MD$CA$CA
243471151$24347115$1$I$20230901$20240916$20240921$20240921$EXP$$US-ABBVIE-5926941$ABBVIE$$49$YR$$F$Y$$$20240921$$CN$US$US
243471161$24347116$1$I$20240101$20240916$20240921$20240921$EXP$$US-ABBVIE-5926733$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243471181$24347118$1$I$$20240916$20240921$20240921$PER$$US-SA-2024SA270234$SANOFI AVENTIS$$$$C$F$Y$$$20240921$$HP$US$US
243471191$24347119$1$I$$20240918$20240921$20240921$EXP$$US-ABBVIE-5929691$ABBVIE$$$$$M$Y$$$20240921$$CN$US$US
243471221$24347122$1$I$20240701$20240917$20240921$20240921$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-029697$UNITED THERAPEUTICS$$68$YR$$M$Y$$$20240921$$$JP$JP
243471231$24347123$1$I$20240916$20240916$20240921$20240921$EXP$$AU-ABBVIE-5927766$ABBVIE$$78$YR$$F$Y$$$20240921$$HP$AU$AU
243471241$24347124$1$I$20240101$20240911$20240921$20240921$PER$$US-SA-2024SA266921$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240921$$HP$US$US
243471252$24347125$2$F$$20240925$20240921$20240930$PER$$US-JNJFOC-20240937274$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243471261$24347126$1$I$$20240913$20240921$20240921$EXP$$DE-AMGEN-DEUSP2024184772$AMGEN$Fuchs, F.. A Case of Pseudomonas straminea Blood Stream Infection in an Elderly Woman with Cellulitis. Infectious Disease Reports. 2024;16(4):699-706$82$YR$E$F$Y$$$20240921$$HP$DE$DE
243471271$24347127$1$I$$20240917$20240921$20240921$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052433$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240921$$CN$US$US
243471281$24347128$1$I$20240918$20240920$20240921$20240921$PER$$US-AMGEN-USASP2024188607$AMGEN$$38$YR$A$M$Y$$$20240921$$CN$US$US
243471292$24347129$2$F$20240902$20240923$20240921$20240924$PER$$US-AMGEN-USASP2024188647$AMGEN$$68$YR$E$M$Y$$$20240923$$CN$US$US
243471301$24347130$1$I$20240910$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187788$AMGEN$$$$$$Y$$$20240921$$PH$US$US
243471311$24347131$1$I$20240914$20240920$20240921$20240921$PER$$US-AMGEN-USASP2024188386$AMGEN$$52$YR$A$F$Y$$$20240921$$CN$US$US
243471322$24347132$2$F$20240920$20240920$20240921$20240924$PER$$US-AMGEN-USASP2024188575$AMGEN$$71$YR$E$F$Y$$$20240924$$CN$US$US
243471331$24347133$1$I$$20240913$20240921$20240921$EXP$$NL-AMGEN-NLDSP2024184022$AMGEN$Von Dem Borne PA. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$$$Y$$$20240921$$HP$NL$NL
243471341$24347134$1$I$$20240913$20240921$20240921$EXP$$NL-AMGEN-NLDSP2024184016$AMGEN$Von Dem Borne PA. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$A$$Y$$$20240921$$HP$NL$NL
243471351$24347135$1$I$$20240917$20240921$20240921$EXP$$US-AMGEN-USASP2024185745$AMGEN$Owczarzak L.; Dave A.; Schwartz M. et al.. A Challenging Diagnosis of HHV-8- Associated Diffuse Large B-Cell  Lymphoma, Not Otherwise Specified, in a Young Man with Newly-Diagnosed HIV. The American journal of case reports. 2024;25:e945162-1 to e945162-9$26$YR$A$M$Y$$$20240921$$HP$US$US
243471361$24347136$1$I$$20240917$20240921$20240921$PER$$US-AMGEN-USASP2024186303$AMGEN$$$$$$Y$$$20240921$$PH$US$US
243471371$24347137$1$I$20240918$20240918$20240921$20240921$PER$$US-AMGEN-USASP2024187057$AMGEN$$55$YR$A$M$Y$$$20240921$$CN$US$US
243471381$24347138$1$I$$20240913$20240921$20240921$EXP$$NL-AMGEN-NLDSP2024184010$AMGEN$Von Dem Borne PA. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$A$$Y$$$20240921$$HP$NL$NL
243471392$24347139$2$F$20240918$20240925$20240921$20240927$PER$$US-AMGEN-USASP2024186764$AMGEN$$57$YR$A$M$Y$$$20240927$$HP$US$US
243471402$24347140$2$F$20240918$20240923$20240921$20240924$PER$$US-AMGEN-USASP2024187457$AMGEN$$62$YR$A$F$Y$$$20240924$$MD$US$US
243471412$24347141$2$F$20240916$20240923$20240921$20240925$PER$$US-AMGEN-USASP2024188237$AMGEN$$78$YR$E$F$Y$$$20240925$$CN$US$US
243471421$24347142$1$I$$20240920$20240921$20240921$PER$$US-AMGEN-USASP2024188881$AMGEN$$$$$F$Y$$$20240921$$CN$US$US
243471431$24347143$1$I$20240906$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187793$AMGEN$$$$$$Y$$$20240921$$PH$US$US
243471441$24347144$1$I$$20240913$20240921$20240921$EXP$$NL-AMGEN-NLDSP2024184021$AMGEN$Von Dem Borne P.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$$$Y$$$20240921$$HP$NL$NL
243471452$24347145$2$F$20240904$20240923$20240921$20240924$PER$$US-AMGEN-USASP2024188463$AMGEN$$84$YR$E$M$Y$$$20240924$$CN$US$US
243471471$24347147$1$I$20240915$20240918$20240921$20240921$PER$$US-ELI_LILLY_AND_COMPANY-US202409011825$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240921$$CN$US$US
243471481$24347148$1$I$20240101$20240904$20240921$20240921$PER$$US-009507513-2409USA002392$MERCK$$69$YR$$F$Y$$$20240921$$CN$US$US
243471501$24347150$1$I$20240101$20240918$20240921$20240921$PER$$US-TAKEDA-2024TUS093326$TAKEDA$$$$$F$Y$$$20240921$$CN$US$US
243471511$24347151$1$I$$20240910$20240921$20240921$PER$$US-SA-2024SA271859$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240921$$CN$US$US
243471521$24347152$1$I$20240913$20240916$20240921$20240921$PER$$US-SA-2024SA269706$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240921$$MD$US$US
243471531$24347153$1$I$20240101$20240916$20240921$20240921$PER$$US-SA-2024SA268847$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240921$$HP$US$US
243471541$24347154$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA267260$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240921$$HP$US$US
243471551$24347155$1$I$20240901$20240916$20240921$20240921$PER$$US-SA-2024SA268911$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240921$$HP$US$US
243471561$24347156$1$I$20240101$20240916$20240921$20240921$PER$$US-SA-2024SA270273$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240921$$HP$US$US
243471581$24347158$1$I$20240701$20240912$20240921$20240921$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025234$UNITED THERAPEUTICS$$31$YR$$F$Y$$$20240921$$$US$US
243471591$24347159$1$I$20240101$20240916$20240921$20240921$PER$$US-SA-2024SA270464$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240921$$HP$US$US
243471601$24347160$1$I$20240101$20240907$20240921$20240921$EXP$$US-Axsome Therapeutics, Inc.-AXS202409-001402$AXSOME THERAPEUTICS$$$$$$Y$$$20240921$$CN$US$
243471611$24347161$1$I$$20240916$20240921$20240921$PER$$US-SA-2024SA270317$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240921$$HP$US$US
243471621$24347162$1$I$20240905$20240919$20240921$20240921$PER$$US-JNJFOC-20240952920$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240921$$CN$US$US
243471631$24347163$1$I$20181001$20240918$20240921$20240921$EXP$$AU-TAKEDA-2024TUS093787$TAKEDA$$73$YR$$F$Y$$$20240921$$MD$AU$AU
243471641$24347164$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA266719$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240921$$HP$US$US
243471651$24347165$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA268435$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240921$$CN$US$US
243471661$24347166$1$I$20240919$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187725$AMGEN$$77$YR$E$F$Y$$$20240921$$CN$US$US
243471672$24347167$2$F$20240916$20240923$20240921$20240923$PER$$US-AMGEN-USASP2024188670$AMGEN$$71$YR$E$F$Y$$$20240923$$CN$US$US
243471681$24347168$1$I$20220119$20240918$20240921$20240921$EXP$$NVSC2024AU187364$NOVARTIS$$78$YR$$F$Y$$$20240921$$MD$AU$AU
243471691$24347169$1$I$$20240918$20240921$20240921$PER$$US-HALEON-2197522$Haleon PLC$$$$$$Y$$$20240921$$CN$US$US
243471701$24347170$1$I$20230101$20240911$20240921$20240921$EXP$$US-ABBVIE-5808404$ABBVIE$$$$$F$Y$80$KG$20240921$$CN$US$US
243471711$24347171$1$I$$20240917$20240921$20240921$EXP$$US-TAKEDA-2024TUS093079$TAKEDA$$$$$M$Y$$$20240921$$CN$US$US
243471721$24347172$1$I$$20240917$20240921$20240921$PER$$US-AMGEN-USASP2024186305$AMGEN$$$$$$Y$$$20240921$$PH$US$US
243471732$24347173$2$F$$20240923$20240921$20240924$PER$$US-AMGEN-USASP2024188687$AMGEN$$$$$M$Y$$$20240924$$CN$US$US
243471741$24347174$1$I$20220801$20240918$20240921$20240921$PER$$US-009507513-2409USA006734$MERCK$Patel J D, Pozorski V J, Tavberidze N, Buehler D G, Huang W, Bennett D D, et al. Successful Treatment of Metastatic Primary Cutaneous Adnexal Carcinoma With a PD-1 Inhibitor. Journal of Immunotherapy. 2024;47 (8):323-327$$$A$$Y$$$20240921$$HP$US$US
243471751$24347175$1$I$$20240911$20240921$20240921$EXP$GB-MHRA-MED-202409111139155900-NDJVR$GB-HETERO-AMR2024GB03118$HETERO$$$$$F$Y$$$20240921$$CN$GB$GB
243471761$24347176$1$I$20230901$20240918$20240921$20240921$EXP$$CA-ABBVIE-5667193$ABBVIE$$59$YR$$M$Y$103.4$KG$20240921$$MD$CA$CA
243471771$24347177$1$I$$20240913$20240921$20240921$EXP$$GB-JNJFOC-20240939643$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240921$$PH$GB$GB
243471781$24347178$1$I$$20240910$20240921$20240921$PER$$US-SA-2024SA271991$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240921$$CN$US$US
243471791$24347179$1$I$$20240828$20240921$20240921$PER$$US-SA-2024SA267741$SANOFI AVENTIS$$7$YR$C$M$Y$46$KG$20240921$$HP$US$US
243471801$24347180$1$I$$20240917$20240921$20240921$PER$$US-JNJFOC-20240950707$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243471811$24347181$1$I$$20240820$20240921$20240921$EXP$$DE-TEVA-VS-3241420$TEVA$$$$$$Y$$$20240921$$MD$DE$DE
243471831$24347183$1$I$$20240913$20240921$20240921$PER$$US-JNJFOC-20240940759$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243471841$24347184$1$I$20240731$20240830$20240921$20240921$PER$$US-SA-2024SA271112$SANOFI AVENTIS$$13$YR$T$F$Y$61.995$KG$20240921$$MD$US$US
243471851$24347185$1$I$20240824$20240828$20240921$20240921$PER$$US-SA-2024SA267651$SANOFI AVENTIS$$11$YR$C$M$Y$32.27$KG$20240921$$MD$US$US
243471861$24347186$1$I$$20240830$20240921$20240921$PER$$US-SA-2024SA271528$SANOFI AVENTIS$$$$A$F$Y$76.2$KG$20240921$$MD$US$US
243471871$24347187$1$I$$20240919$20240921$20240921$EXP$$CN-TAKEDA-2024TUS093632$TAKEDA$$$$$F$Y$$$20240921$$CN$CN$CN
243471921$24347192$1$I$$20240828$20240921$20240921$PER$$US-SA-2024SA267661$SANOFI AVENTIS$$$$A$F$Y$62.05$KG$20240921$$HP$US$US
243471931$24347193$1$I$$20240912$20240921$20240921$EXP$DE-CADRBFARM-2024330421$DE-AMAROX PHARMA-AMR2024DE03012$HETERO$$$$A$$Y$$$20240921$$CN$DE$DE
243471941$24347194$1$I$$20240914$20240921$20240921$PER$$US-JNJFOC-20240940672$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243471951$24347195$1$I$$20240917$20240921$20240921$PER$$US-JNJFOC-20240947767$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243471961$24347196$1$I$$20240918$20240921$20240921$PER$$US-JNJFOC-20240953953$JOHNSON AND JOHNSON$$$$$M$Y$$$20240921$$HP$US$US
243471971$24347197$1$I$19900101$20240912$20240921$20240921$PER$$US-JNJFOC-20240935051$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243471981$24347198$1$I$20240301$20240909$20240921$20240921$EXP$$AT-DSJP-DSE-2024-144473$DAIICHI$$84$YR$$F$Y$57$KG$20240921$$CN$AT$AT
243471991$24347199$1$I$$20240914$20240921$20240921$PER$$US-JNJFOC-20240940337$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243472001$24347200$1$I$20240911$20240913$20240921$20240921$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-126193$REGENERON$$$$$F$Y$$$20240921$$CN$CA$CA
243472011$24347201$1$I$$20240913$20240921$20240921$PER$$US-JNJFOC-20240939831$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243472021$24347202$1$I$20240801$20240913$20240921$20240921$EXP$$US-AMGEN-USASP2024183569$AMGEN$$$$$F$Y$$$20240921$$CN$US$US
243472031$24347203$1$I$$20240828$20240921$20240921$PER$$US-SA-2024SA269187$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240921$$HP$US$US
243472041$24347204$1$I$20230910$20240912$20240921$20240921$EXP$GB-MHRA-MED-202409092211043050-VNYST$GB-HETERO-AMR2024GB03126$HETERO$$62$YR$$M$Y$$$20240921$$MD$GB$GB
243472051$24347205$1$I$$20240912$20240921$20240921$PER$$US-JNJFOC-20240934577$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243472071$24347207$1$I$$20240917$20240921$20240921$PER$$US-TAKEDA-2024TUS092808$TAKEDA$$$$$F$Y$$$20240921$$CN$US$US
243472081$24347208$1$I$20240916$20240917$20240921$20240921$PER$$US-JNJFOC-20240944987$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$PH$US$US
243472091$24347209$1$I$$20240820$20240921$20240921$EXP$$DE-TEVA-VS-3241419$TEVA$$$$$$Y$$$20240921$$MD$DE$DE
243472112$24347211$2$F$20240906$20240906$20240921$20240924$PER$$US-JNJFOC-20240919708$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240924$$CN$US$US
243472121$24347212$1$I$$20240911$20240921$20240921$PER$$US-JNJFOC-20240934407$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$CN$US$US
243472131$24347213$1$I$$20240911$20240921$20240921$EXP$$US-ARDELYX-2024ARDX006932$ARDELYX$$$$$F$Y$$$20240921$$HP$US$US
243472141$24347214$1$I$$20240911$20240921$20240921$EXP$$US-ARDELYX-2024ARDX006943$ARDELYX$$54$YR$$M$Y$$$20240921$$HP$US$US
243472161$24347216$1$I$20240601$20240917$20240921$20240921$EXP$$US-ABBVIE-5929038$ABBVIE$$57$YR$$M$Y$$$20240921$$CN$US$US
243472201$24347220$1$I$20240101$20240910$20240921$20240921$PER$$US-JNJFOC-20240927109$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240921$$CN$US$US
243472231$24347223$1$I$$20240919$20240921$20240921$PER$$US-HALEON-2197782$Haleon PLC$$$$$$Y$$$20240921$$CN$US$US
243472241$24347224$1$I$$20240919$20240921$20240921$PER$$US-JNJFOC-20240953482$JOHNSON AND JOHNSON$$$$$M$Y$$$20240921$$CN$US$US
243472261$24347226$1$I$$20240904$20240921$20240921$PER$$US-009507513-2409USA001899$MERCK$$$$$F$Y$57.143$KG$20240921$$HP$US$US
243472271$24347227$1$I$$20240918$20240921$20240921$PER$$US-JNJFOC-20240949523$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$HP$US$US
243472281$24347228$1$I$$20240917$20240921$20240921$PER$$US-JNJFOC-20240949802$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243472291$24347229$1$I$$20240918$20240921$20240921$PER$$US-JNJFOC-20240951645$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$HP$US$US
243472301$24347230$1$I$$20240911$20240921$20240921$PER$$US-JNJFOC-20240956103$JOHNSON AND JOHNSON$$$$$$Y$$$20240921$$HP$US$US
243472311$24347231$1$I$$20240911$20240921$20240921$PER$$US-JNJFOC-20240954534$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240921$$PH$US$US
243472321$24347232$1$I$20240901$20240912$20240921$20240921$PER$$US-JNJFOC-20240939622$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243472331$24347233$1$I$$20240911$20240921$20240921$PER$$US-JNJFOC-20240940339$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240921$$CN$US$US
243472351$24347235$1$I$20240814$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187680$AMGEN$$61$YR$A$F$Y$$$20240921$$CN$US$US
243472361$24347236$1$I$$20240914$20240921$20240921$PER$$US-SA-2024SA269908$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240921$$HP$US$US
243472371$24347237$1$I$20240828$20240828$20240921$20240921$PER$$US-SA-2024SA268728$SANOFI AVENTIS$$54$YR$A$F$Y$62.73$KG$20240921$$MD$US$US
243472381$24347238$1$I$$20240917$20240921$20240921$PER$$US-JNJFOC-20240949973$JOHNSON AND JOHNSON$$$$$F$Y$$$20240921$$CN$US$US
243472391$24347239$1$I$$20240828$20240921$20240921$PER$$US-SA-2024SA267235$SANOFI AVENTIS$$$$A$F$Y$49.09$KG$20240921$$MD$US$US
243472401$24347240$1$I$20240901$20240912$20240921$20240921$PER$$US-SA-2024SA164591$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240921$$HP$US$US
243472411$24347241$1$I$$20240913$20240921$20240921$EXP$$ES-JNJFOC-20240938101$JOHNSON AND JOHNSON$$9$YR$C$F$Y$60$KG$20240921$$CN$ES$ES
243472422$24347242$2$F$20240901$20240916$20240921$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029181$UNITED THERAPEUTICS$$75$YR$$M$Y$125.62$KG$20240925$$$US$US
243472431$24347243$1$I$20240101$20240912$20240921$20240921$PER$$US-SA-2024SA267157$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240921$$MD$US$US
243472441$24347244$1$I$20240901$20240912$20240921$20240921$PER$$US-SA-2024SA266898$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240921$$HP$US$US
243472451$24347245$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA023681$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240921$$MD$US$US
243472461$24347246$1$I$20240823$20240828$20240921$20240921$PER$$US-SA-2024SA267612$SANOFI AVENTIS$$6$YR$C$M$Y$21.31$KG$20240921$$MD$US$US
243472471$24347247$1$I$20240101$20240828$20240921$20240921$PER$$US-SA-2024SA267692$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240921$$CN$US$US
243472491$24347249$1$I$20240523$20240911$20240921$20240921$EXP$$US-UCBSA-2024026433$UCB$$18$YR$$M$Y$$$20240921$$CN$US$US
243472501$24347250$1$I$20240912$20240920$20240921$20240921$PER$$NVSC2024US188211$NOVARTIS$$42$YR$$M$Y$$$20240921$$CN$US$US
243472511$24347251$1$I$$20240913$20240921$20240921$PER$$US-DAIICHI SANKYO, INC.-DS-2024-100235-US$DAIICHI$$$$E$F$Y$$$20240921$$MD$US$US
243472521$24347252$1$I$20240901$20240917$20240921$20240921$PER$$US-DAIICHI SANKYO, INC.-DS-2024-100530-US$DAIICHI$$36$YR$$F$Y$$$20240921$$CN$US$US
243472531$24347253$1$I$$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187420$AMGEN$$$$$F$Y$$$20240921$$CN$US$US
243472541$24347254$1$I$20240905$20240919$20240921$20240921$PER$$US-AMGEN-USASP2024187621$AMGEN$$88$YR$E$M$Y$$$20240921$$CN$US$US
243472561$24347256$1$I$20231123$20240911$20240921$20240921$EXP$$GB-JNJFOC-20240931748$JOHNSON AND JOHNSON$$$$E$F$Y$89$KG$20240921$$MD$GB$GB
243472571$24347257$1$I$$20240914$20240921$20240921$PER$$US-SA-2024SA268406$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240921$$HP$US$US
243472581$24347258$1$I$20240101$20240904$20240921$20240921$PER$$US-SA-2024SA272264$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240921$$MD$US$US
243472591$24347259$1$I$20240101$20240912$20240921$20240921$PER$$US-SA-2024SA269324$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240921$$HP$US$US
243472601$24347260$1$I$$20240914$20240921$20240921$PER$$US-SA-2024SA268151$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240921$$MD$US$US
243472611$24347261$1$I$$20240829$20240921$20240921$PER$$US-009507513-2408USA010737$MERCK$Brandt CM, Zajo KN, Ronsley R, McAllister AS, Sribnick EA, Salloum R.. RESPONSE OF A CENTRAL NERVOUS SYSTEM (CNS) HEMANGIOBLASTOMA TO BELZUTIFAN IN A PEDIATRIC PATIENT WITH VON HIPPEL-LINDAU DISEASE (VHL). Neuro-Oncology. 2024;26 Supplement 4:iv164$15$YR$$M$Y$$$20240921$$HP$US$US
243472621$24347262$1$I$$20240914$20240921$20240921$PER$$US-SA-2024SA270220$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240921$$HP$US$US
243472631$24347263$1$I$20240101$20240905$20240921$20240921$PER$$US-009507513-2409USA002318$MERCK$$$$$F$Y$$$20240921$$HP$US$US
243472641$24347264$1$I$20240101$20240912$20240921$20240921$PER$$US-SA-2024SA266908$SANOFI AVENTIS$$7$MON$I$M$Y$$$20240921$$MD$US$US
243472651$24347265$1$I$$20240828$20240921$20240921$PER$$US-SA-2024SA266265$SANOFI AVENTIS$$$$E$F$Y$$$20240921$$MD$US$US
243472671$24347267$1$I$$20240911$20240921$20240921$EXP$$US-GSK-US2024113170$GLAXOSMITHKLINE$$$$$$Y$$$20240921$$MD$US$US
243472681$24347268$1$I$$20240911$20240921$20240921$30DAY$$US-GSK-US2024113160$GLAXOSMITHKLINE$$89$YR$$F$Y$$$20240921$$CN$US$US
243472691$24347269$1$I$20240901$20240911$20240921$20240921$30DAY$$US-GSK-US2024113164$GLAXOSMITHKLINE$$56$YR$$M$Y$$$20240921$$CN$US$US
243472701$24347270$1$I$20240911$20240912$20240921$20240921$30DAY$$US-GSK-US2024113528$GLAXOSMITHKLINE$$80$YR$$F$Y$54.43$KG$20240921$$CN$US$US
243472721$24347272$1$I$$20240911$20240921$20240921$EXP$$US-GSK-US2024113018$GLAXOSMITHKLINE$$$$$$Y$$$20240921$$MD$US$US
243472731$24347273$1$I$$20240911$20240921$20240921$30DAY$$US-GSK-US2024AMR113982$GLAXOSMITHKLINE$$$$$M$Y$$$20240921$$CN$US$US
243472741$24347274$1$I$$20240912$20240921$20240921$30DAY$$US-GSK-US2024113748$GLAXOSMITHKLINE$$$$$M$Y$$$20240921$$CN$US$US
243472751$24347275$1$I$$20240911$20240921$20240921$EXP$$US-GSK-US2024113161$GLAXOSMITHKLINE$$$$$$Y$$$20240921$$MD$US$US
243472761$24347276$1$I$$20240912$20240921$20240921$30DAY$$US-VIIV HEALTHCARE LIMITED-US2024AMR115834$VIIV$$$$$$Y$$$20240921$$HP$US$US
243472771$24347277$1$I$$20240911$20240921$20240921$30DAY$$US-GSK-US2024AMR114213$GLAXOSMITHKLINE$$$$$F$Y$$$20240921$$CN$US$US
243472781$24347278$1$I$$20240912$20240921$20240921$30DAY$$US-GSK-US2024113758$GLAXOSMITHKLINE$$$$$M$Y$$$20240921$$CN$US$US
243472791$24347279$1$I$$20240911$20240921$20240921$EXP$$US-GSK-US2024113114$GLAXOSMITHKLINE$$$$$F$Y$$$20240921$$MD$US$US
243472801$24347280$1$I$$20240912$20240921$20240921$EXP$$US-GSK-US2024113699$GLAXOSMITHKLINE$$$$$F$Y$$$20240921$$MD$US$US
243472811$24347281$1$I$$20240911$20240921$20240921$30DAY$$US-GSK-US2024113154$GLAXOSMITHKLINE$$$$$M$Y$$$20240921$$CN$US$US
243472821$24347282$1$I$20240904$20240911$20240921$20240921$30DAY$$US-GSK-US2024113144$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240921$$CN$US$US
243472831$24347283$1$I$$20240911$20240921$20240921$30DAY$$US-GSK-US2024AMR113392$GLAXOSMITHKLINE$$$$$F$Y$$$20240921$$CN$US$US
243472841$24347284$1$I$$20240903$20240921$20240921$PER$$US-SA-2024SA271026$SANOFI AVENTIS$$$$E$M$Y$65$KG$20240921$$MD$US$US
243472851$24347285$1$I$$20240917$20240921$20240921$EXP$$US-009507513-2409USA006236$MERCK$Tran MM, Mirza FN, Gaghan L, Robinson-Bostom L, DiMarco C.. Delayed onset eruptive keratoacanthomas following immune checkpoint inhibitor therapy. International Journal of Dermatology. 2024$77$YR$$M$Y$$$20240921$$HP$US$US
243472861$24347286$1$I$20240101$20240906$20240921$20240921$PER$$US-TEVA-VS-3241401$TEVA$$72$YR$$F$Y$72.57$KG$20240921$$CN$US$US
243472881$24347288$1$I$20240101$20240830$20240921$20240921$PER$$US-SA-2024SA268248$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240921$$HP$US$US
243472891$24347289$1$I$$20240919$20240921$20240921$PER$$US-HALEON-2197770$Haleon PLC$$86$YR$$F$Y$$$20240921$$CN$US$US
243472901$24347290$1$I$$20240912$20240921$20240921$PER$$US-SA-2024SA267825$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240921$$MD$US$US
243472911$24347291$1$I$$20240913$20240921$20240921$PER$$US-SA-2024SA207604$SANOFI AVENTIS$$14$YR$T$F$Y$48.08$KG$20240921$$MD$US$US
243472922$24347292$2$F$20240918$20240920$20240921$20240924$PER$$NVSC2024US188135$NOVARTIS$$22$YR$$F$Y$$$20240924$$CN$US$US
243472931$24347293$1$I$$20240903$20240921$20240921$PER$$US-SA-2024SA270714$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240921$$HP$US$US
243472942$24347294$2$F$$20240913$20240921$20240925$EXP$$DE-UCBSA-2024046704$UCB$$20$YR$$M$Y$$$20240925$$CN$DE$DE
243472951$24347295$1$I$$20240911$20240921$20240921$PER$$US-SA-2024SA266810$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240921$$MD$US$US
243472961$24347296$1$I$$20240801$20240921$20240921$EXP$$JP-009507513-2409JPN005076$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$79$YR$$F$Y$$$20240921$$HP$JP$JP
243472971$24347297$1$I$20240801$20240911$20240921$20240921$EXP$$US-UCBSA-2024046953$UCB$$30$YR$$F$Y$$$20240921$$HP$US$US
243472981$24347298$1$I$$20240911$20240921$20240921$EXP$$US-UCBSA-2024047216$UCB$$$$$$Y$$$20240921$$CN$US$US
243472991$24347299$1$I$20240501$20240903$20240921$20240921$PER$$US-SA-2024SA270519$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240921$$MD$US$US
243473001$24347300$1$I$20240101$20240911$20240921$20240921$EXP$$US-UCBSA-2024046968$UCB$$$$$F$Y$78.367$KG$20240921$$HP$US$US
243473011$24347301$1$I$$20240911$20240921$20240921$EXP$$DE-UCBSA-2024047273$UCB$$$$$F$Y$$$20240921$$MD$DE$DE
243473021$24347302$1$I$$20240910$20240921$20240921$PER$$US-SA-2024SA271826$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240921$$HP$US$US
243473031$24347303$1$I$$20240801$20240921$20240921$EXP$$JP-009507513-2409JPN005077$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$56$YR$$F$Y$$$20240921$$HP$JP$JP
243473041$24347304$1$I$20240101$20240905$20240921$20240921$PER$$US-SA-2024SA271620$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240921$$CN$US$US
243473051$24347305$1$I$20240901$20240916$20240921$20240921$PER$$US-SA-2024SA270510$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240921$$HP$US$US
243473061$24347306$1$I$20240101$20240916$20240921$20240921$PER$$US-SA-2024SA270231$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240921$$MD$US$US
243473071$24347307$1$I$$20240914$20240921$20240921$PER$$US-SA-2024SA268162$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240921$$MD$US$US
243473081$24347308$1$I$20230610$20240916$20240921$20240921$EXP$$JP-009507513-2409JPN002365J$MERCK$$71$YR$$F$Y$42$KG$20240921$$MD$JP$JP
243473091$24347309$1$I$$20240914$20240921$20240921$PER$$US-SA-2024SA268316$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240922$$HP$US$US
243473101$24347310$1$I$$20240914$20240921$20240921$PER$$US-SA-2024SA268258$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240922$$HP$US$US
243473111$24347311$1$I$20240101$20240912$20240921$20240921$EXP$$US-UCBSA-2024018176$UCB$$$$$F$Y$$$20240922$$CN$US$US
243473121$24347312$1$I$20240101$20240916$20240921$20240921$PER$$US-SA-2024SA270261$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240922$$HP$US$US
243473131$24347313$1$I$20240701$20240916$20240921$20240921$PER$$US-SA-2024SA269770$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240922$$MD$US$US
243473141$24347314$1$I$$20240801$20240921$20240921$EXP$$JP-009507513-2409JPN005078$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$80$YR$$F$Y$$$20240921$$HP$JP$JP
243473152$24347315$2$F$20240901$20240924$20240921$20240926$PER$$US-JNJFOC-20240951234$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240926$$CN$US$US
243473161$24347316$1$I$$20240801$20240921$20240921$EXP$$JP-009507513-2409JPN005079$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$76$YR$$M$Y$$$20240921$$HP$JP$JP
243473171$24347317$1$I$20221110$20240919$20240921$20240921$EXP$FR-AFSSAPS-MA2024001487$FR-009507513-2409FRA007270$MERCK$$85$YR$$F$Y$$$20240921$$CN$FR$FR
243473181$24347318$1$I$$20240801$20240921$20240921$EXP$$JP-009507513-2409JPN005080$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$70$YR$$M$Y$$$20240921$$HP$JP$JP
243473191$24347319$1$I$$20240916$20240921$20240921$EXP$$FR-DSJP-DS-2024-100218-FR$DAIICHI$$$$A$F$Y$77$KG$20240922$$MD$FR$FR
243473201$24347320$1$I$$20240913$20240921$20240921$EXP$$FR-DSJP-DS-2024-100239-FR$DAIICHI$$$$A$F$Y$$$20240922$$MD$FR$FR
243473211$24347321$1$I$20200101$20240912$20240921$20240921$PER$$US-009507513-2409USA005428$MERCK$Reddy TP, Barrios R, Bernicker E, Qian EW, Chang J, Saftar J. Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension. Pulmonary Circulation. 2014;14:e12426$52$YR$$F$Y$$$20240921$$HP$US$US
243473221$24347322$1$I$$20240913$20240921$20240921$EXP$$FR-DSJP-DS-2024-100182-FR$DAIICHI$$$$A$F$Y$$$20240922$$MD$FR$FR
243473231$24347323$1$I$$20240913$20240921$20240921$EXP$GB-MHRA-TPP8495079C10782261YC1726061428192$GB-DSJP-DS-2024-100064-GB$DAIICHI$$85$YR$$F$Y$75$KG$20240922$$HP$GB$GB
243473241$24347324$1$I$20240729$20240913$20240921$20240921$EXP$$CN-DSJP-DS-2024-100056-CN$DAIICHI$$45$YR$$F$Y$62$KG$20240922$$HP$CN$CN
243473251$24347325$1$I$$20240918$20240921$20240921$EXP$$JP-DSJP-DS-2024-100395-JP$DAIICHI$Okano N, Migita T, Egi A, Okada K, Miki T, Kimura M. P02-02 A Case of Achieving Successful Hemostasis After Andexanet Alfa Administration for Critical Postoperative Lower Extremity Bleeding, The 61st Academic Meeting of the Chugoku-Shikoku Branch of the 2024 Annual Meeting of the Japanese Society of Anesthesiologist. See Journal Title following the Article Title in the Title field. 2024;42$6$DEC$$F$Y$52$KG$20240922$$MD$JP$JP
243473261$24347326$1$I$20240516$20240917$20240921$20240921$EXP$$JP-DSJP-DS-2024-100123-JP$DAIICHI$$68$YR$$F$Y$61.4$KG$20240922$$MD$JP$JP
243473271$24347327$1$I$$20240910$20240921$20240921$PER$$US-009507513-2409USA004281$MERCK$Shetty A, Baeza D, Amescua G, Galor A.. Idiopathic Fusarium Sclerouveitis: A Case Report. Cornea. 2024$79$YR$$M$Y$$$20240921$$MD$US$US
243473282$24347328$2$F$20240919$20240923$20240921$20240923$PER$$US-AMGEN-USASP2024188402$AMGEN$$80$YR$E$F$Y$$$20240923$$CN$US$US
243473341$24347334$1$I$$20240916$20240921$20240921$PER$$US-ELI_LILLY_AND_COMPANY-US202409010100$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240921$$CN$US$US
243473401$24347340$1$I$$20240913$20240921$20240921$EXP$$US-OTSUKA-2024_025798$OTSUKA$$5$DEC$$M$Y$$$20240922$$HP$US$US
243473411$24347341$1$I$20240809$20240909$20240921$20240921$PER$$US-SA-2024SA270553$SANOFI AVENTIS$$49$YR$A$F$Y$92.53$KG$20240922$$CN$US$US
243473481$24347348$1$I$$20240909$20240921$20240921$PER$$US-SA-2024SA271569$SANOFI AVENTIS$$$$$F$Y$$$20240922$$CN$US$US
243473531$24347353$1$I$$20240919$20240921$20240921$PER$$US-HALEON-2197858$Haleon PLC$$$$$$Y$$$20240921$$CN$US$US
243473581$24347358$1$I$$20240912$20240922$20240922$PER$$US-GSK-US2024AMR113953$GLAXOSMITHKLINE$$$$$$Y$$$20240922$$CN$US$US
243473601$24347360$1$I$$20240917$20240922$20240922$EXP$$CA-ROCHE-10000084299$ROCHE$$$$$F$Y$$$20240922$$PH$CA$CA
243473611$24347361$1$I$$20240903$20240922$20240922$PER$$US-SA-2024SA271694$SANOFI AVENTIS$$$$E$M$Y$$$20240922$$MD$US$US
243473641$24347364$1$I$$20240913$20240922$20240922$EXP$$IT-ROCHE-10000083830$ROCHE$$35$YR$A$F$Y$$$20240922$$MD$IT$IT
243473651$24347365$1$I$$20240912$20240922$20240922$PER$$US-GSK-US2024113670$GLAXOSMITHKLINE$$$$$F$Y$$$20240922$$CN$US$US
243473661$24347366$1$I$20240918$20240919$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012936$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240922$$CN$US$US
243473671$24347367$1$I$20230101$20230926$20240922$20240922$PER$$US-CIPLA LTD.-2023US05935$CIPLA$$$$$$Y$$$20240922$$CN$US$US
243473681$24347368$1$I$$20231002$20240922$20240922$PER$$US-CIPLA LTD.-2023US06098$CIPLA$$$$$$Y$$$20240922$$CN$US$US
243473691$24347369$1$I$$20230908$20240922$20240922$PER$$US-CIPLA LTD.-2023US05525$CIPLA$$$$$$Y$$$20240922$$CN$US$US
243473701$24347370$1$I$20230901$20230915$20240922$20240922$PER$$US-CIPLA LTD.-2023US05682$CIPLA$$$$$$Y$$$20240922$$CN$US$US
243473711$24347371$1$I$20230901$20230914$20240922$20240922$PER$$US-CIPLA LTD.-2023US05612$CIPLA$$$$$$Y$$$20240922$$CN$US$US
243473721$24347372$1$I$20230801$20230823$20240922$20240922$PER$$US-CIPLA LTD.-2023US05160$CIPLA$$$$$$Y$$$20240922$$CN$US$US
243473731$24347373$1$I$20230825$20230911$20240922$20240922$PER$$US-CIPLA LTD.-2023US05363$CIPLA$$$$$$Y$$$20240922$$CN$US$US
243473741$24347374$1$I$20230801$20230817$20240922$20240922$PER$$US-CIPLA LTD.-2023US05097$CIPLA$$$$$$Y$$$20240922$$CN$US$US
243473751$24347375$1$I$20230901$20230916$20240922$20240922$PER$$US-CIPLA LTD.-2023US05692$CIPLA$$$$$$Y$$$20240922$$CN$US$US
243473761$24347376$1$I$20230703$20230821$20240922$20240922$PER$$US-CIPLA LTD.-2023US05119$CIPLA$$$$$$Y$$$20240922$$CN$US$US
243473771$24347377$1$I$20230815$20230817$20240922$20240922$PER$$US-CIPLA LTD.-2023US05064$CIPLA$$$$$$Y$$$20240922$$CN$US$US
243473781$24347378$1$I$20220101$20231002$20240922$20240922$PER$$US-CIPLA LTD.-2023US06096$CIPLA$$$$$$Y$$$20240922$$CN$US$US
243473791$24347379$1$I$$20240917$20240922$20240922$PER$$US-AMGEN-USASP2024186435$AMGEN$$$$$$Y$$$20240921$$MD$US$US
243473801$24347380$1$I$$20240909$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409005186$ELI LILLY AND CO$$63$YR$A$$Y$$$20240922$$CN$US$US
243473811$24347381$1$I$20240919$20240919$20240922$20240922$PER$$US-AMGEN-USASP2024188420$AMGEN$$$$$M$Y$$$20240921$$CN$US$US
243473821$24347382$1$I$20240101$20240909$20240922$20240922$PER$$US-009507513-2409USA003307$MERCK$$$$$F$Y$55.329$KG$20240922$$CN$US$US
243473831$24347383$1$I$$20240917$20240922$20240922$PER$$US-ABBVIE-5928840$ABBVIE$$49$YR$$M$Y$$$20240922$$MD$US$US
243473841$24347384$1$I$$20240916$20240922$20240922$EXP$$ES-ROCHE-10000086556$ROCHE$Lopez G, Pascual J, Arjona M, Illan P, Gabarron L, Lopez A. Efficacy and safety of switching to Ocrelizumab in Natalizumab-treated patients at high risk of progressive multifocal leukoencephalopathy (Abstract number: P1640/973). Multiple Sclerosis Journal. 2024;30 (3S):1037-8.$$$$$Y$$$20240922$$HP$ES$ES
243473861$24347386$1$I$20240916$20240917$20240922$20240922$PER$$US-AMGEN-USASP2024186283$AMGEN$$$$$$Y$$$20240921$$HP$US$US
243473872$24347387$2$F$$20240923$20240922$20240930$PER$$US-HALEON-2197154$Haleon PLC$$$$$F$Y$$$20240930$$CN$US$US
243473881$24347388$1$I$$20240919$20240922$20240922$PER$$US-AMGEN-USASP2024188411$AMGEN$$$$$$Y$$$20240921$$HP$US$US
243473891$24347389$1$I$$20240919$20240922$20240922$PER$$US-009507513-2409USA007057$MERCK$$$$$M$Y$$$20240922$$CN$US$US
243473912$24347391$2$F$$20240923$20240922$20240925$PER$$US-HALEON-2197153$Haleon PLC$$$$$M$Y$$$20240925$$CN$US$US
243473921$24347392$1$I$$20240919$20240922$20240922$PER$$US-AMGEN-USASP2024188317$AMGEN$$$$$$Y$$$20240922$$PH$US$US
243473931$24347393$1$I$$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012061$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240922$$CN$US$US
243473941$24347394$1$I$$20240903$20240922$20240922$PER$$US-SA-2024SA271103$SANOFI AVENTIS$$$$E$F$Y$$$20240922$$MD$US$US
243473951$24347395$1$I$20240508$20240909$20240922$20240922$EXP$$US-UCBSA-2024009693$UCB$$3$YR$$F$Y$13.2$KG$20240922$$CN$US$US
243473961$24347396$1$I$20240101$20240917$20240922$20240922$EXP$$DE-009507513-2409DEU007158$MERCK$$$$$M$Y$$$20240922$$MD$DE$DE
243473971$24347397$1$I$$20240912$20240922$20240922$PER$$US-GSK-US2024AMR114458$GLAXOSMITHKLINE$$$$$M$Y$$$20240922$$CN$US$US
243473981$24347398$1$I$20230424$20240915$20240922$20240922$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149519$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240922$$MD$PT$PT
243473991$24347399$1$I$20240101$20240909$20240922$20240922$EXP$DK-DKMA-30738335$DK-JUBILANT CADISTA PHARMACEUTICALS-2024DK001287$JUBILANT$$$$N$$Y$$$20240922$$MD$DK$DK
243474002$24347400$2$F$20240101$20240913$20240922$20240926$PER$$US-SA-2024SA271989$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240926$$MD$US$US
243474011$24347401$1$I$20240101$20240912$20240922$20240922$PER$$US-SA-2024SA267195$SANOFI AVENTIS$$$$E$F$Y$$$20240922$$MD$US$US
243474021$24347402$1$I$$20240919$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012911$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240922$$CN$US$US
243474031$24347403$1$I$20240801$20240910$20240922$20240922$EXP$$US-JNJFOC-20240945930$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240922$$MD$US$US
243474041$24347404$1$I$20240912$20240912$20240922$20240922$PER$$US-GSK-US2024113776$GLAXOSMITHKLINE$$$$$$Y$$$20240922$$PH$US$US
243474051$24347405$1$I$20240901$20240919$20240922$20240922$PER$$US-SA-2024SA269217$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240922$$CN$US$US
243474061$24347406$1$I$$20240914$20240922$20240922$PER$$US-SA-2024SA268348$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240922$$CN$US$US
243474071$24347407$1$I$$20240917$20240922$20240922$PER$$US-ROCHE-10000085622$ROCHE$$57$YR$A$F$Y$$$20240922$$CN$US$US
243474081$24347408$1$I$20240101$20240911$20240922$20240922$PER$$US-TEVA-VS-3243845$TEVA$$69$YR$$F$Y$$$20240922$$CN$US$US
243474091$24347409$1$I$20240601$20240912$20240922$20240922$PER$$US-GSK-US2024113782$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240922$$CN$US$US
243474101$24347410$1$I$$20240918$20240922$20240922$EXP$$US-SANDOZ INC.-SDZ2024US081765$SANDOZ$$$$$F$Y$$$20240922$$PH$US$US
243474111$24347411$1$I$20240723$20240917$20240922$20240922$EXP$$AU-TGA-0000817242$SANDOZ$$75$YR$$F$Y$85$KG$20240922$$MD$AU$AU
243474121$24347412$1$I$$20240914$20240922$20240922$EXP$$US-SANDOZ INC.-SDZ2023US055190$SANDOZ$$$$$$Y$$$20240922$$CN$US$US
243474131$24347413$1$I$$20240917$20240922$20240922$EXP$$US-SANDOZ INC.-SDZ2024US081485$SANDOZ$$$$$M$Y$$$20240922$$MD$US$US
243474141$24347414$1$I$$20240916$20240922$20240922$EXP$$US-SANDOZ INC.-SDZ2024US081519$SANDOZ$$$$$M$Y$$$20240922$$CN$US$US
243474151$24347415$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA268874$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240922$$HP$US$US
243474161$24347416$1$I$$20240919$20240922$20240922$30DAY$$US-SANDOZ INC.-SDZ2024US081908$SANDOZ$$$$$M$Y$$$20240922$$CN$US$US
243474171$24347417$1$I$20240701$20240913$20240922$20240922$PER$$US-SA-2022SA234099$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240922$$HP$US$US
243474181$24347418$1$I$20240626$20240910$20240922$20240922$PER$$US-SA-2024SA271980$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240922$$CN$US$US
243474191$24347419$1$I$20240501$20240913$20240922$20240922$PER$$US-SA-2024SA272198$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240922$$HP$US$US
243474201$24347420$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA268904$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240922$$HP$US$US
243474211$24347421$1$I$$20240914$20240922$20240922$PER$$US-SA-2024SA269158$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240922$$HP$US$US
243474221$24347422$1$I$20240101$20240910$20240922$20240922$PER$$US-009507513-2409USA003693$MERCK$$73$YR$$F$Y$$$20240922$$CN$US$US
243474231$24347423$1$I$20240916$20240916$20240922$20240922$PER$$US-009507513-2409USA006017$MERCK$$$$$F$Y$$$20240922$$HP$US$US
243474241$24347424$1$I$20170101$20240915$20240922$20240922$EXP$$US-JNJFOC-20240939366$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240922$$CN$US$US
243474251$24347425$1$I$$20240912$20240922$20240922$PER$$US-GSK-US2024AMR115519$GLAXOSMITHKLINE$$$$$$Y$$$20240922$$HP$US$US
243474261$24347426$1$I$$20240913$20240922$20240922$PER$$US-009507513-2409USA005178$MERCK$$$$$M$Y$99.8$KG$20240922$$PH$US$US
243474271$24347427$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA268974$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240922$$HP$US$US
243474281$24347428$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA268887$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240922$$HP$US$US
243474291$24347429$1$I$$20240901$20240922$20240922$PER$$US-SA-2024SA272089$SANOFI AVENTIS$$$$E$M$Y$$$20240922$$MD$US$US
243474301$24347430$1$I$$20240903$20240922$20240922$PER$$US-SA-2024SA270681$SANOFI AVENTIS$$$$C$M$Y$$$20240922$$MD$US$US
243474311$24347431$1$I$$20240903$20240922$20240922$PER$$US-SA-2024SA271549$SANOFI AVENTIS$$$$A$F$Y$57.73$KG$20240922$$MD$US$US
243474321$24347432$1$I$20240910$20240912$20240922$20240922$PER$$US-SA-2024SA267296$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240922$$HP$US$US
243474332$24347433$2$F$$20240911$20240922$20240924$PER$$US-SA-2024SA272405$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240924$$CN$US$US
243474351$24347435$1$I$$20240919$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012560$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240922$$CN$US$US
243474361$24347436$1$I$20240101$20240908$20240922$20240922$PER$$US-SA-2024SA272076$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240922$$CN$US$US
243474371$24347437$1$I$$20240903$20240922$20240922$PER$$US-SA-2024SA271697$SANOFI AVENTIS$$$$E$M$Y$72.73$KG$20240922$$MD$US$US
243474381$24347438$1$I$$20240903$20240922$20240922$PER$$US-SA-2024SA271736$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240922$$HP$US$US
243474391$24347439$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA268965$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240922$$HP$US$US
243474401$24347440$1$I$$20240911$20240922$20240922$EXP$$JP-UCBSA-2024047667$UCB$$$$$$Y$$$20240922$$PH$JP$JP
243474411$24347441$1$I$$20240912$20240922$20240922$PER$$US-GSK-US2024AMR113975$GLAXOSMITHKLINE$$$$$F$Y$$$20240922$$CN$US$US
243474421$24347442$1$I$20240821$20240916$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409010114$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240922$$CN$US$US
243474431$24347443$1$I$20240829$20240829$20240922$20240922$PER$$US-009507513-2408USA010480$MERCK$$$$$F$Y$$$20240922$$CN$US$US
243474441$24347444$1$I$$20240909$20240922$20240922$EXP$$BR-JNJFOC-20240936668$JOHNSON AND JOHNSON$$56$YR$A$F$Y$98$KG$20240922$$CN$BR$BR
243474451$24347445$1$I$20240101$20240831$20240922$20240922$PER$$US-SA-2024SA268980$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240922$$MD$US$US
243474471$24347447$1$I$$20240920$20240922$20240922$PER$$US-HALEON-2197855$Haleon PLC$$$$$$Y$$$20240922$$CN$US$US
243474481$24347448$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA268906$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240922$$HP$US$US
243474491$24347449$1$I$$20240909$20240922$20240922$PER$$US-SA-2024SA271731$SANOFI AVENTIS$$$$E$F$Y$$$20240922$$MD$US$US
243474501$24347450$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA268929$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240922$$HP$US$US
243474511$24347451$1$I$$20240904$20240922$20240922$PER$$US-SA-2024SA271561$SANOFI AVENTIS$$$$T$F$Y$$$20240922$$MD$US$US
243474521$24347452$1$I$20240101$20240831$20240922$20240922$PER$$US-SA-2024SA270824$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240922$$CN$US$US
243474532$24347453$2$F$$20240829$20240922$20240923$EXP$$US-SA-2024SA267949$SANOFI AVENTIS$$$$E$F$Y$72.73$KG$20240923$$MD$US$US
243474541$24347454$1$I$20240903$20240903$20240922$20240922$PER$$US-SA-2024SA271944$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240922$$CN$US$US
243474551$24347455$1$I$$20240913$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409009315$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240922$$CN$US$US
243474561$24347456$1$I$$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012031$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240922$$CN$US$US
243474571$24347457$1$I$20240801$20240830$20240922$20240922$PER$$US-SA-2024SA271387$SANOFI AVENTIS$$50$YR$A$F$Y$88.64$KG$20240922$$MD$US$US
243474591$24347459$1$I$$20240917$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409011039$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240922$$CN$US$US
243474601$24347460$1$I$20240901$20240911$20240922$20240922$EXP$$US-ROCHE-10000079905$ROCHE$$54$YR$A$F$Y$$$20240922$$CN$US$US
243474611$24347461$1$I$$20240919$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409013359$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240922$$CN$US$US
243474621$24347462$1$I$20240901$20240916$20240922$20240922$PER$$US-SA-2024SA268822$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240922$$HP$US$US
243474631$24347463$1$I$20240101$20240909$20240922$20240922$EXP$$CA-UCBSA-2024013912$UCB$$$$$M$Y$$$20240922$$CN$CA$CA
243474651$24347465$1$I$$20240911$20240922$20240922$PER$$US-SA-2024SA271917$SANOFI AVENTIS$$$$E$F$Y$$$20240922$$CN$US$US
243474661$24347466$1$I$$20240914$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409010977$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240922$$CN$US$US
243474671$24347467$1$I$20240909$20240909$20240922$20240922$EXP$$CA-UCBSA-2024030234$UCB$$57$YR$$F$Y$$$20240922$$HP$CA$CA
243474681$24347468$1$I$20240911$20240912$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146224$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240922$$PH$US$US
243474691$24347469$1$I$20240813$20240911$20240922$20240922$EXP$$CA-JNJFOC-20240836263$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240922$$HP$CA$CA
243474711$24347471$1$I$$20240911$20240922$20240922$PER$$US-GSK-US2024AMR114099$GLAXOSMITHKLINE$$$$$M$Y$$$20240922$$CN$US$US
243474721$24347472$1$I$20240905$20240912$20240922$20240922$EXP$$JP-VANTIVE-2024VAN019753$Vantive US Healthcare$$53$YR$$M$Y$$$20240922$$MD$JP$JP
243474731$24347473$1$I$$20240905$20240922$20240922$PER$$US-009507513-2409USA002132$MERCK$$$$$F$Y$$$20240922$$MD$US$US
243474741$24347474$1$I$20240801$20240916$20240922$20240922$PER$$US-SA-2024SA268873$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240922$$MD$US$US
243474751$24347475$1$I$$20240909$20240922$20240922$PER$$US-SA-2024SA271742$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240922$$CN$US$US
243474761$24347476$1$I$20240601$20240913$20240922$20240922$PER$$US-SA-2024SA267422$SANOFI AVENTIS$$92$YR$E$F$Y$$$20240922$$HP$US$US
243474771$24347477$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA269985$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240922$$MD$US$US
243474781$24347478$1$I$$20240912$20240922$20240922$PER$$US-SA-2024SA168463$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240922$$MD$US$US
243474792$24347479$2$F$20240819$20240920$20240922$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149577$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$88.9$KG$20240923$$PH$US$US
243474801$24347480$1$I$20240101$20240904$20240922$20240922$PER$$US-SA-2024SA174020$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240922$$MD$US$US
243474811$24347481$1$I$20230801$20240910$20240922$20240922$PER$$US-SA-2024SA266093$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240922$$MD$US$US
243474821$24347482$1$I$20240701$20240913$20240922$20240922$PER$$US-SA-2024SA268223$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240922$$MD$US$US
243474831$24347483$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA269453$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240922$$MD$US$US
243474841$24347484$1$I$$20240912$20240922$20240922$PER$$US-GSK-US2024113780$GLAXOSMITHKLINE$$$$$M$Y$$$20240922$$CN$US$US
243474851$24347485$1$I$$20240903$20240922$20240922$PER$$US-SA-2024SA270723$SANOFI AVENTIS$$37$YR$A$F$Y$113.18$KG$20240922$$MD$US$US
243474861$24347486$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA270294$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240922$$HP$US$US
243474871$24347487$1$I$20240801$20240912$20240922$20240922$PER$$US-GSK-US2024113656$GLAXOSMITHKLINE$$89$YR$$F$Y$$$20240922$$CN$US$US
243474881$24347488$1$I$$20240912$20240922$20240922$PER$$US-GSK-US2024113657$GLAXOSMITHKLINE$$$$$M$Y$$$20240922$$HP$US$US
243474891$24347489$1$I$20240101$20240903$20240922$20240922$PER$$US-SA-2024SA270905$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240922$$MD$US$US
243474901$24347490$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA268651$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240922$$MD$US$US
243474911$24347491$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA269004$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240922$$MD$US$US
243474921$24347492$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA268583$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240922$$HP$US$US
243474931$24347493$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA268602$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240922$$MD$US$US
243474941$24347494$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA268673$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240922$$HP$US$US
243474951$24347495$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA268644$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240922$$HP$US$US
243474961$24347496$1$I$20240901$20240916$20240922$20240922$PER$$US-SA-2024SA268695$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240922$$HP$US$US
243474971$24347497$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA268672$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240922$$HP$US$US
243474981$24347498$1$I$$20240911$20240922$20240922$PER$$US-GSK-US2024AMR114093$GLAXOSMITHKLINE$$$$$M$Y$$$20240922$$CN$US$US
243474991$24347499$1$I$$20240912$20240922$20240922$PER$$US-SA-2024SA272036$SANOFI AVENTIS$$$$$F$Y$$$20240922$$CN$US$US
243475001$24347500$1$I$20230101$20240908$20240922$20240922$PER$$US-SA-2024SA272078$SANOFI AVENTIS$$$$$$Y$$$20240922$$CN$US$US
243475011$24347501$1$I$20240801$20240903$20240922$20240922$PER$$US-SA-2024SA271165$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240922$$MD$US$US
243475021$24347502$1$I$20240917$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409011991$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240922$$CN$US$US
243475031$24347503$1$I$$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012043$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240922$$CN$US$US
243475041$24347504$1$I$$20240916$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409010143$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240922$$CN$US$US
243475051$24347505$1$I$$20240912$20240922$20240922$PER$$US-JNJFOC-20240933481$JOHNSON AND JOHNSON$$$$$M$Y$$$20240922$$HP$US$US
243475061$24347506$1$I$20230101$20240913$20240922$20240922$EXP$$US-JNJFOC-20240937276$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$$$20240922$$CN$US$US
243475071$24347507$1$I$$20240913$20240922$20240922$PER$$US-JNJFOC-20240947596$JOHNSON AND JOHNSON$$$$$M$Y$$$20240922$$HP$US$US
243475081$24347508$1$I$$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409011543$ELI LILLY AND CO$$$$$M$Y$$$20240922$$CN$US$US
243475091$24347509$1$I$$20240909$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409005470$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240922$$CN$US$US
243475101$24347510$1$I$20240901$20240912$20240922$20240922$PER$$US-SA-2024SA266868$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240922$$HP$US$US
243475111$24347511$1$I$20230101$20240909$20240922$20240922$PER$$US-SA-2024SA271940$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240922$$CN$US$US
243475121$24347512$1$I$20240101$20240903$20240922$20240922$PER$$US-SA-2024SA270842$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240922$$CN$US$US
243475131$24347513$1$I$20240101$20240913$20240922$20240922$PER$$US-SA-2024SA267225$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240922$$HP$US$US
243475141$24347514$1$I$$20240912$20240922$20240922$EXP$$US-RDY-SPO/USA/24/0013724$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$56$YR$A$$Y$$$20240922$$MD$US$US
243475151$24347515$1$I$20231003$20240913$20240922$20240922$PER$$US-RDY-SPO/USA/23/0179550$DR REDDYS$$47$YR$A$M$Y$$$20240922$$HP$US$US
243475161$24347516$1$I$20240101$20240831$20240922$20240922$PER$$US-SA-2024SA271406$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240922$$CN$US$US
243475171$24347517$1$I$$20240912$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013726$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$21$YR$A$$Y$$$20240922$$MD$US$US
243475181$24347518$1$I$20240101$20240913$20240922$20240922$PER$$US-SA-2024SA267937$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240922$$MD$US$US
243475191$24347519$1$I$$20240911$20240922$20240922$PER$$US-009507513-2409USA004341$MERCK$Benador-Shen C, Shantha J, Lee J, Qian Y, Doan T, Gonzales JA. Multiple Anterior Chamber Paracenteses May Be Needed to Identify Cytomegalovirus Anterior Uveitis. American journal of ophthalmology. 2024$45$YR$$M$Y$$$20240922$$MD$US$US
243475201$24347520$1$I$$20240912$20240922$20240922$EXP$$US-RDY-SPO/USA/24/0013810$DR REDDYS$Agarwal A, Diaz A, Al-Dehneem R, Pineda RM, Khattri S. Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases. Journal of Drugs in Dermatology. 2023 Dec;22: 1183-1190. doi:10.36849/JDD.7500.$35$YR$A$F$Y$$$20240922$$HP$US$US
243475212$24347521$2$F$20240901$20240911$20240922$20240924$PER$$US-SA-2024SA272189$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240924$$CN$US$US
243475221$24347522$1$I$20240101$20240910$20240922$20240922$PER$$US-SA-2024SA264887$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240922$$MD$US$US
243475231$24347523$1$I$20121001$20240913$20240922$20240922$PER$$US-JNJFOC-20240941597$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240922$$HP$US$US
243475242$24347524$2$F$20240918$20240919$20240922$20240925$PER$$US-AMGEN-USASP2024187645$AMGEN$$82$YR$E$F$Y$$$20240924$$PH$US$US
243475251$24347525$1$I$20240906$20240909$20240922$20240922$PER$$US-SA-2024SA271959$SANOFI AVENTIS$$$$$F$Y$$$20240922$$CN$US$US
243475261$24347526$1$I$$20240827$20240922$20240922$PER$$US-SA-2024SA270779$SANOFI AVENTIS$$13$YR$T$F$Y$68$KG$20240922$$HP$US$US
243475271$24347527$1$I$$20240912$20240922$20240922$EXP$$US-RDY-SPO/USA/24/0013723$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$77$YR$E$$Y$$$20240922$$MD$US$US
243475281$24347528$1$I$$20240912$20240922$20240922$EXP$$US-RDY-SPO/USA/24/0013721$DR REDDYS$Mahoney RC, DeLoughery TG, Jung E, Shalhub S, Liem TK. Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era. Annals of Vascular Surgery. 2024;108(0): 166-170. doi:10.1016/j.avsg.2024.05.005.$67$YR$E$$Y$$$20240922$$MD$US$US
243475291$24347529$1$I$20240727$20240913$20240922$20240922$EXP$$US-RDY-SPO/USA/24/0013708$DR REDDYS$$76$YR$E$M$Y$86$KG$20240922$$MD$US$US
243475301$24347530$1$I$$20240919$20240922$20240922$PER$$US-BAYER-2024A134216$BAYER$$$$$F$Y$$$20240922$$MD$US$US
243475311$24347531$1$I$20240822$20240912$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013588$DR REDDYS$$49$YR$A$F$Y$$$20240922$$HP$US$US
243475321$24347532$1$I$$20240912$20240922$20240922$EXP$$US-RDY-SPO/USA/24/0013564$DR REDDYS$$62$YR$A$F$Y$$$20240922$$HP$US$US
243475331$24347533$1$I$$20240919$20240922$20240922$PER$$US-BAYER-2024A134445$BAYER$$85$YR$E$F$Y$$$20240922$$CN$US$US
243475341$24347534$1$I$20240818$20240917$20240922$20240922$PER$$US-BAYER-2024A132547$BAYER$$18$YR$A$F$Y$$$20240922$$MD$US$US
243475351$24347535$1$I$20240101$20240913$20240922$20240922$PER$$US-SA-2024SA269381$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240922$$HP$US$US
243475361$24347536$1$I$20240901$20240913$20240922$20240922$PER$$US-SA-2024SA220967$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240922$$CN$US$US
243475371$24347537$1$I$$20240916$20240922$20240922$PER$$US-VIIV HEALTHCARE LIMITED-US2024114852$VIIV$$$$$M$Y$$$20240922$$CN$US$US
243475381$24347538$1$I$20240101$20240913$20240922$20240922$PER$$US-SA-2024SA267266$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240922$$HP$US$US
243475391$24347539$1$I$20240908$20240916$20240922$20240922$PER$$US-SA-2024SA270482$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240922$$HP$US$US
243475401$24347540$1$I$20240917$20240917$20240922$20240922$PER$$US-VIIV HEALTHCARE LIMITED-US2024115610$VIIV$$48$YR$$F$Y$$$20240922$$CN$US$US
243475411$24347541$1$I$$20240917$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012105$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240922$$CN$US$US
243475421$24347542$1$I$$20240912$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409008548$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240922$$CN$US$US
243475431$24347543$1$I$20211001$20240919$20240922$20240922$EXP$SE-SEMPA-2024-006728$SE-BAYER-2024A133795$BAYER$$65$YR$E$F$Y$$$20240922$$MD$SE$SE
243475441$24347544$1$I$$20240916$20240922$20240922$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR115234$VIIV$$$$$M$Y$$$20240922$$CN$US$US
243475452$24347545$2$F$20240917$20240918$20240922$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011781$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240924$$CN$US$US
243475461$24347546$1$I$20240101$20240910$20240922$20240922$PER$$US-SA-2024SA263961$SANOFI AVENTIS$$38$YR$A$F$Y$61.224$KG$20240922$$MD$US$US
243475471$24347547$1$I$20240912$20240913$20240922$20240922$PER$$US-JNJFOC-20240939727$JOHNSON AND JOHNSON$$$$$M$Y$$$20240922$$CN$US$US
243475481$24347548$1$I$$20240913$20240922$20240922$EXP$$NL-AMGEN-NLDSP2024184007$AMGEN$Von Dem Borne P.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$E$$Y$$$20240922$$HP$NL$NL
243475491$24347549$1$I$$20240917$20240922$20240922$PER$$US-JNJFOC-20240953344$JOHNSON AND JOHNSON$$$$$M$Y$$$20240922$$CN$US$US
243475501$24347550$1$I$$20240919$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012592$ELI LILLY AND CO$$$$$M$Y$$$20240922$$CN$US$US
243475511$24347551$1$I$$20240919$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012801$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240922$$CN$US$US
243475521$24347552$1$I$$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012020$ELI LILLY AND CO$$11$YR$C$F$Y$$$20240922$$CN$US$US
243475531$24347553$1$I$$20240918$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149068$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240922$$HP$US$US
243475541$24347554$1$I$$20240917$20240922$20240922$PER$$US-JNJFOC-20240945889$JOHNSON AND JOHNSON$$$$$$Y$$$20240922$$MD$US$US
243475551$24347555$1$I$$20240917$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012144$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240922$$CN$US$US
243475561$24347556$1$I$$20240912$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013576$DR REDDYS$$65$YR$E$M$Y$$$20240922$$MD$US$US
243475571$24347557$1$I$$20240916$20240922$20240922$PER$$US-JNJFOC-20240947212$JOHNSON AND JOHNSON$$$$$F$Y$$$20240922$$CN$US$US
243475581$24347558$1$I$$20240913$20240922$20240922$EXP$$US-RDY-SPO/USA/24/0013636$DR REDDYS$$62$YR$A$F$Y$$$20240922$$HP$US$US
243475591$24347559$1$I$20240911$20240913$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013624$DR REDDYS$$34$YR$A$M$Y$$$20240922$$HP$US$US
243475601$24347560$1$I$20240912$20240912$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013517$DR REDDYS$$44$YR$A$M$Y$$$20240922$$HP$US$US
243475611$24347561$1$I$$20240913$20240922$20240922$EXP$$US-RDY-SPO/USA/24/0013654$DR REDDYS$$68$YR$E$M$Y$$$20240922$$HP$US$US
243475631$24347563$1$I$$20240912$20240922$20240922$EXP$$US-RDY-SPO/USA/24/0013573$DR REDDYS$$28$YR$A$M$Y$$$20240922$$HP$US$US
243475641$24347564$1$I$$20240912$20240922$20240922$EXP$$US-RDY-SPO/USA/24/0013535$DR REDDYS$$35$YR$A$F$Y$$$20240922$$MD$US$US
243475651$24347565$1$I$$20240919$20240922$20240922$PER$$US-JNJFOC-20240952641$JOHNSON AND JOHNSON$$$$$F$Y$$$20240922$$CN$US$US
243475661$24347566$1$I$$20240911$20240922$20240922$EXP$GB-MHRA-MED-202409100853562620-RVDTB$GB-DEXPHARM-2024-3195$DEXCEL$$11$YR$C$F$Y$44$KG$20240922$$HP$GB$GB
243475671$24347567$1$I$$20240913$20240922$20240922$PER$$US-JNJFOC-20240939320$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20240922$$HP$US$US
243475681$24347568$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA269778$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240922$$HP$US$US
243475691$24347569$1$I$20240828$20240829$20240922$20240922$PER$$US-SA-2024SA267858$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240922$$HP$US$US
243475701$24347570$1$I$$20240913$20240922$20240922$PER$$US-SA-2023SA237573$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240922$$MD$US$US
243475711$24347571$1$I$20240901$20240916$20240922$20240922$PER$$US-SA-2024SA270225$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240922$$CN$US$US
243475722$24347572$2$F$$20240923$20240922$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409012276$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240927$$HP$US$US
243475731$24347573$1$I$$20240911$20240922$20240922$EXP$GB-002147023-NVSC2024GB179605$GB-DEXPHARM-2024-3192$DEXCEL$$$$A$F$Y$$$20240922$$HP$GB$GB
243475741$24347574$1$I$$20240919$20240922$20240922$PER$$US-AMGEN-USASP2024187768$AMGEN$$$$$M$Y$$$20240922$$CN$US$US
243475751$24347575$1$I$20240901$20240919$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149739$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240922$$MD$US$US
243475761$24347576$1$I$$20240913$20240922$20240922$PER$$US-JNJFOC-20240953949$JOHNSON AND JOHNSON$$$$$M$Y$$$20240922$$HP$US$US
243475771$24347577$1$I$20240701$20240916$20240922$20240922$EXP$$US-SA-2024SA271403$SANOFI AVENTIS$$58$YR$A$F$Y$74.55$KG$20240922$$MD$US$US
243475781$24347578$1$I$$20240913$20240922$20240922$EXP$$NL-AMGEN-NLDSP2024184011$AMGEN$Von Dem Borne P.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$E$$Y$$$20240922$$HP$NL$NL
243475791$24347579$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA270172$SANOFI AVENTIS$$8$YR$C$M$Y$$$20240922$$MD$US$US
243475801$24347580$1$I$$20240917$20240922$20240922$PER$$US-AMGEN-USASP2024185693$AMGEN$Bui N. E.; Savla P.; Galvis A. E. et al.. Symptomatic central nervous system tuberculosis and human herpesvirus-6 coinfection with associated hydrocephalus managed with endoscopic third ventriculostomy: A case report and review of human herpesvirus-6 neuropathology. Surgical Neurology International. 2024;15 (287):1-11$18$MON$I$F$Y$$$20240922$$HP$US$US
243475811$24347581$1$I$20240601$20240912$20240922$20240922$PER$$US-GSK-US2024113633$GLAXOSMITHKLINE$$57$YR$$M$Y$$$20240922$$CN$US$US
243475822$24347582$2$F$20240821$20240924$20240922$20240926$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-125541$REGENERON$$$$$F$Y$$$20240926$$HP$US$US
243475831$24347583$1$I$20120801$20240916$20240922$20240922$PER$$US-JNJFOC-20240944485$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240922$$HP$US$US
243475841$24347584$1$I$$20240913$20240922$20240922$EXP$$US-RDY-SPO/USA/24/0013577$DR REDDYS$$46$YR$A$M$Y$$$20240922$$HP$US$US
243475851$24347585$1$I$20240904$20240913$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013566$DR REDDYS$$49$YR$A$M$Y$$$20240922$$HP$US$US
243475861$24347586$1$I$20240820$20240914$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013580$DR REDDYS$$72$YR$E$M$Y$$$20240922$$HP$US$US
243475871$24347587$1$I$20240912$20240914$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013582$DR REDDYS$$53$YR$A$F$Y$$$20240922$$HP$US$US
243475881$24347588$1$I$20240913$20240913$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013575$DR REDDYS$$40$YR$A$M$Y$$$20240922$$MD$US$US
243475891$24347589$1$I$20240913$20240913$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013622$DR REDDYS$$58$YR$A$M$Y$$$20240922$$HP$US$US
243475901$24347590$1$I$$20240914$20240922$20240922$EXP$$US-RDY-SPO/USA/24/0013578$DR REDDYS$$60$YR$A$F$Y$$$20240922$$PH$US$US
243475911$24347591$1$I$20240821$20240913$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013587$DR REDDYS$$$$$M$Y$$$20240922$$MD$US$US
243475921$24347592$1$I$20240912$20240914$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013579$DR REDDYS$$47$YR$A$F$Y$$$20240922$$HP$US$US
243475931$24347593$1$I$20240911$20240913$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013623$DR REDDYS$$28$YR$A$M$Y$$$20240922$$HP$US$US
243475941$24347594$1$I$20240828$20240914$20240922$20240922$PER$$US-RDY-SPO/USA/24/0013583$DR REDDYS$$72$YR$E$F$Y$$$20240922$$HP$US$US
243475952$24347595$2$F$$20240904$20240922$20240930$PER$$US-SA-2024SA272813$SANOFI AVENTIS$$61$YR$A$$Y$$$20240930$$MD$US$US
243475961$24347596$1$I$20240301$20240912$20240922$20240922$PER$$US-SA-2024SA270648$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240922$$HP$US$US
243475971$24347597$1$I$$20240912$20240922$20240922$PER$$US-GSK-US2024113658$GLAXOSMITHKLINE$$$$$F$Y$$$20240922$$CN$US$US
243475981$24347598$1$I$20240614$20240913$20240922$20240922$EXP$$US-JNJFOC-20240939973$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240922$$CN$US$US
243475991$24347599$1$I$$20240913$20240922$20240922$EXP$$NL-AMGEN-NLDSP2024184015$AMGEN$Von Dem Borne P.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$E$$Y$$$20240922$$HP$NL$NL
243476001$24347600$1$I$$20240919$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149563$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240922$$HP$US$US
243476011$24347601$1$I$$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012135$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240922$$CN$US$US
243476021$24347602$1$I$20240826$20240916$20240922$20240922$EXP$$PE-ROCHE-10000084683$ROCHE$$71$YR$E$F$Y$$$20240922$$MD$PE$PE
243476041$24347604$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA269725$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240922$$MD$US$US
243476051$24347605$1$I$$20240901$20240922$20240922$PER$$US-SA-2024SA272147$SANOFI AVENTIS$$$$A$F$Y$65.7$KG$20240922$$MD$US$US
243476061$24347606$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA270239$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240922$$HP$US$US
243476071$24347607$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA270438$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240922$$HP$US$US
243476081$24347608$1$I$20240801$20240916$20240922$20240922$PER$$US-SA-2024SA270241$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240922$$HP$US$US
243476091$24347609$1$I$20240101$20240913$20240922$20240922$PER$$US-SA-2024SA267476$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240922$$MD$US$US
243476101$24347610$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA270189$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240922$$HP$US$US
243476111$24347611$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA269671$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240922$$HP$US$US
243476121$24347612$1$I$$20240909$20240922$20240922$PER$$US-SA-2024SA271413$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240922$$CN$US$US
243476132$24347613$2$F$20240101$20240911$20240922$20240923$PER$$US-SA-2024SA272004$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240923$$CN$US$US
243476141$24347614$1$I$$20240912$20240922$20240922$PER$$US-SA-2024SA267874$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240922$$HP$US$US
243476151$24347615$1$I$$20240913$20240922$20240922$EXP$$NL-AMGEN-NLDSP2024184023$AMGEN$Von Dem Borne P.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$$$Y$$$20240922$$HP$NL$NL
243476171$24347617$1$I$$20240912$20240922$20240922$PER$$US-SA-2024SA267745$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240922$$HP$US$US
243476181$24347618$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA270260$SANOFI AVENTIS$$$$A$F$Y$$$20240922$$HP$US$US
243476191$24347619$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA270228$SANOFI AVENTIS$$$$A$M$Y$$$20240922$$HP$US$US
243476202$24347620$2$F$$20240919$20240922$20240922$PER$$US-ROCHE-10000087596$ROCHE$$80$YR$E$F$Y$$$20240922$$HP$US$US
243476212$24347621$2$F$$20240919$20240922$20240922$PER$$US-ROCHE-10000087683$ROCHE$$57$YR$A$M$Y$$$20240922$$HP$US$US
243476221$24347622$1$I$20240724$20240912$20240922$20240922$PER$$US-GSK-US2024AMR113896$GLAXOSMITHKLINE$$27$YR$$F$Y$$$20240922$$HP$US$US
243476231$24347623$1$I$$20240918$20240922$20240922$PER$$US-ROCHE-10000087199$ROCHE$El Labban M, El Zibaoui R, Amadi, A Z, Khan S. P24-06499: Life-Threatening tPA-Associated Angioedema:  A Rare Case Report and Critical Review. American Journal of Case Reports. 2024-Sep-14;(25):e944221. doi:10.12659/AJCR.944221.$79$YR$E$M$Y$$$20240922$$HP$US$US
243476241$24347624$1$I$$20240912$20240922$20240922$PER$$US-SA-2024SA146095$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240922$$MD$US$US
243476252$24347625$2$F$20240716$20240916$20240922$20240930$PER$$US-SA-2024SA270488$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240930$$HP$US$US
243476261$24347626$1$I$20240801$20240916$20240922$20240922$PER$$US-SA-2024SA270258$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240922$$HP$US$US
243476271$24347627$1$I$20240919$20240919$20240922$20240922$PER$$NVSC2024US188239$NOVARTIS$$62$YR$$F$Y$$$20240922$$CN$US$US
243476281$24347628$1$I$$20240828$20240922$20240922$PER$$US-SA-2024SA254046$SANOFI AVENTIS$$63$YR$A$F$Y$85.91$KG$20240922$$MD$US$US
243476291$24347629$1$I$$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409011820$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240922$$HP$US$US
243476301$24347630$1$I$20240916$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409011814$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240922$$CN$US$US
243476321$24347632$1$I$$20240919$20240922$20240922$PER$$NVSC2024US188203$NOVARTIS$$$$$M$Y$$$20240922$$HP$US$US
243476331$24347633$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA270312$SANOFI AVENTIS$$$$A$M$Y$$$20240922$$MD$US$US
243476351$24347635$1$I$20240703$20240913$20240922$20240922$PER$$US-SA-2024SA267303$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240922$$MD$US$US
243476361$24347636$1$I$$20240917$20240922$20240922$PER$$US-ABBVIE-5929427$ABBVIE$$$$$$Y$$$20240922$$CN$US$US
243476371$24347637$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA270011$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240922$$HP$US$US
243476381$24347638$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA270210$SANOFI AVENTIS$$$$A$M$Y$$$20240922$$MD$US$US
243476391$24347639$1$I$20240901$20240913$20240922$20240922$PER$$US-SA-2024SA267889$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240922$$HP$US$US
243476401$24347640$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA268886$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240922$$MD$US$US
243476411$24347641$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA269713$SANOFI AVENTIS$$20$MON$I$M$Y$$$20240922$$MD$US$US
243476421$24347642$1$I$$20240919$20240922$20240922$EXP$$IL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052677$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240922$$MD$IL$IL
243476451$24347645$1$I$$20240919$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150021$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$64.86$KG$20240922$$CN$US$US
243476461$24347646$1$I$$20240916$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409009979$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240922$$CN$US$US
243476471$24347647$1$I$20240918$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409011864$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240922$$CN$US$US
243476481$24347648$1$I$$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409011804$ELI LILLY AND CO$$54$YR$A$$Y$$$20240922$$CN$US$US
243476491$24347649$1$I$$20240903$20240922$20240922$PER$$US-SA-2024SA272113$SANOFI AVENTIS$$$$T$F$Y$74.68$KG$20240922$$MD$US$US
243476521$24347652$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA268843$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240922$$HP$US$US
243476531$24347653$1$I$20240919$20240919$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149978$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240922$$PH$US$US
243476541$24347654$1$I$$20240919$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149951$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240922$$CN$US$US
243476551$24347655$1$I$$20240916$20240922$20240922$EXP$$US-JNJFOC-20240941619$JOHNSON AND JOHNSON$$$$$F$Y$$$20240922$$CN$US$US
243476561$24347656$1$I$$20240911$20240922$20240922$EXP$$CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-24-08611$HIKMA$$$$$$Y$$$20240920$$HP$CA$CA
243476581$24347658$1$I$20240919$20240919$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012808$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240922$$CN$US$US
243476591$24347659$1$I$20240918$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409011675$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240922$$HP$US$US
243476601$24347660$1$I$$20240916$20240922$20240922$EXP$$US-JNJFOC-20240941962$JOHNSON AND JOHNSON$$$$$M$Y$$$20240922$$HP$US$US
243476611$24347661$1$I$$20240916$20240922$20240922$EXP$$US-JNJFOC-20240941867$JOHNSON AND JOHNSON$$$$$F$Y$$$20240922$$CN$US$US
243476631$24347663$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA272199$SANOFI AVENTIS$$$$A$M$Y$$$20240922$$HP$US$US
243476641$24347664$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA267988$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240922$$CN$US$US
243476671$24347667$1$I$20240919$20240919$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149821$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240922$$HP$US$US
243476681$24347668$1$I$20130101$20240916$20240922$20240922$PER$$US-JNJFOC-20240943694$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240922$$HP$US$US
243476691$24347669$1$I$$20240913$20240922$20240922$EXP$$NL-AMGEN-NLDSP2024184008$AMGEN$Von Dem Borne P.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$E$$Y$$$20240922$$HP$NL$NL
243476721$24347672$1$I$20240907$20240910$20240922$20240922$EXP$$US-UCBSA-2024046783$UCB$$82$YR$$F$Y$$$20240922$$PH$US$US
243476761$24347676$1$I$$20240911$20240922$20240922$EXP$$US-UCBSA-2024046961$UCB$$$$$$Y$$$20240922$$CN$US$US
243476771$24347677$1$I$$20240911$20240922$20240922$EXP$$US-UCBSA-2024047233$UCB$$$$$$Y$$$20240922$$CN$US$US
243476781$24347678$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA269777$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240922$$HP$US$US
243476821$24347682$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA269788$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240922$$HP$US$US
243476831$24347683$1$I$$20240801$20240922$20240922$EXP$$JP-009507513-2409JPN005081$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$71$YR$$M$Y$$$20240922$$HP$JP$JP
243476841$24347684$1$I$$20240919$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012820$ELI LILLY AND CO$$$$$F$Y$$$20240922$$CN$US$US
243476851$24347685$1$I$$20240919$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409013373$ELI LILLY AND CO$$63$YR$A$$Y$$$20240922$$CN$US$US
243476861$24347686$1$I$$20240919$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012811$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240922$$CN$US$US
243476871$24347687$1$I$20240101$20240913$20240922$20240922$PER$$US-SA-2024SA268154$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240922$$HP$US$US
243477011$24347701$1$I$20240908$20240909$20240922$20240922$PER$$US-JNJFOC-20240924006$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240922$$CN$US$US
243477021$24347702$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA272002$SANOFI AVENTIS$$$$E$F$Y$$$20240922$$MD$US$US
243477031$24347703$1$I$$20240830$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-139768$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$75.7$KG$20240922$$CN$US$US
243477051$24347705$1$I$$20240801$20240922$20240922$EXP$$JP-009507513-2409JPN005082$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$47$YR$$M$Y$$$20240922$$HP$JP$JP
243477071$24347707$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA269808$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240922$$MD$US$US
243477081$24347708$1$I$20240918$20240919$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409013377$ELI LILLY AND CO$$$$$F$Y$$$20240922$$CN$US$US
243477091$24347709$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA269827$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240922$$MD$US$US
243477101$24347710$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA268202$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240922$$HP$US$US
243477111$24347711$1$I$20230615$20240913$20240922$20240922$PER$$US-SA-2024SA268083$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240922$$HP$US$US
243477151$24347715$1$I$$20240911$20240922$20240922$EXP$$NVSC2024RU185876$NOVARTIS$Semochkin SV, Lunin VV, Kaplanskaya IB, Fedenko AA. Opyt primeneniya kombinacii ciklosporina i eltrombopaga v terapii vtorichnoj nesostoyatel^nosti transplantata posle transplantacii autologichnyh gemopoeticheskih stvolovyh kletok [Cyclosporine combined with eltrombopag for treatment of secondary graft failure after autologous hematopoietic stem cell transplantation]. ONCOHEMATOLOGY. 2024;19(3):132 - 41$57$YR$$F$Y$$$20240922$$HP$RU$RU
243477161$24347716$1$I$$20240918$20240922$20240922$EXP$$NVSC2024VN187016$NOVARTIS$Dang Nguyen TB, Huynh MV. Ghep te bao goc dong loai lan hai trong dieu tr? cac truong hop thai ghep/tai phat t?i benh vien tmhh tp.hcm [The second allogeneic hematopoietic stem cell transplantation in treatment of relapse/rejection cases at blood transfusion hematology hospital, ho chi minh city]. VIETNAM MEDICAL JOURNAL. 2022;520:51-7$39$YR$$M$Y$$$20240922$$HP$VN$VN
243477173$24347717$3$F$$20240920$20240922$20240927$EXP$$NVSC2024AU187316$NOVARTIS$$35$YR$$F$Y$$$20240927$$MD$AU$AU
243477191$24347719$1$I$$20240801$20240922$20240922$EXP$$JP-009507513-2409JPN005083$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$54$YR$$M$Y$$$20240922$$HP$JP$JP
243477231$24347723$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA269792$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240923$$HP$US$US
243477241$24347724$1$I$20240801$20240827$20240922$20240922$PER$$US-SA-2024SA266801$SANOFI AVENTIS$$3$YR$C$M$Y$17$KG$20240923$$MD$US$US
243477251$24347725$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA268318$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240923$$MD$US$US
243477261$24347726$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA268259$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240923$$HP$US$US
243477271$24347727$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA269833$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240923$$HP$US$US
243477281$24347728$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA269835$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240923$$HP$US$US
243477301$24347730$1$I$$20240801$20240922$20240922$EXP$$JP-009507513-2409JPN005084$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$18$YR$$M$Y$$$20240922$$HP$JP$JP
243477311$24347731$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA269022$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240923$$HP$US$US
243477321$24347732$1$I$$20240917$20240922$20240922$EXP$$ID-JNJFOC-20240955467$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240922$$CN$ID$ID
243477331$24347733$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA269138$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240923$$HP$US$US
243477341$24347734$1$I$20240723$20240920$20240922$20240922$EXP$FR-AFSSAPS-GR2024001086$FR-JNJFOC-20240959141$JOHNSON AND JOHNSON$$43$YR$A$M$Y$48.073$KG$20240922$$PH$FR$FR
243477351$24347735$1$I$20240101$20240913$20240922$20240922$PER$$US-SA-2024SA269520$SANOFI AVENTIS$$$$E$M$Y$$$20240923$$HP$US$US
243477361$24347736$1$I$$20240917$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150194$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240922$$MD$US$US
243477381$24347738$1$I$20240101$20240913$20240922$20240922$PER$$US-SA-2024SA269424$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240923$$HP$US$US
243477391$24347739$1$I$$20240901$20240922$20240922$PER$$US-SA-2024SA271811$SANOFI AVENTIS$$$$T$M$Y$$$20240923$$MD$US$US
243477401$24347740$1$I$$20240913$20240922$20240922$PER$$US-SA-2024SA269658$SANOFI AVENTIS$$$$C$M$Y$$$20240923$$MD$US$US
243477411$24347741$1$I$20240910$20240918$20240922$20240922$EXP$$US-MTPC-MTDA2024-0019691$Unknown Manufacturer$$51$YR$$F$Y$$$20240922$$CN$US$US
243477421$24347742$1$I$20240827$20240918$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149909$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240923$$CN$US$US
243477441$24347744$1$I$20240815$20240916$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409010038$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240922$$CN$US$US
243477451$24347745$1$I$$20240919$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149762$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240923$$HP$US$US
243477461$24347746$1$I$$20240903$20240922$20240922$PER$$US-SA-2024SA272242$SANOFI AVENTIS$$$$E$M$Y$$$20240923$$MD$US$US
243477481$24347748$1$I$$20240917$20240922$20240922$PER$$US-AMGEN-USASP2024186249$AMGEN$$$$$F$Y$$$20240922$$MD$US$US
243477492$24347749$2$F$20240101$20240921$20240922$20240927$EXP$$US-SANDOZ INC.-SDZ2024US081848$SANDOZ$$$$$F$Y$$$20240927$$CN$US$US
243477521$24347752$1$I$20240319$20240910$20240922$20240922$EXP$$IT-ESPERIONTHERAPEUTICS-2024ITA01451$ESPERION THERAPEUTICS$$72$YR$$F$Y$53.5$KG$20240923$$MD$IT$IT
243477542$24347754$2$F$20240912$20240916$20240922$20240927$EXP$GB-MHRA-TPP43939065C5412154YC1726140901092$GB-ESPERIONTHERAPEUTICS-2024GBR01449$ESPERION THERAPEUTICS$$79$YR$$M$Y$81$KG$20240927$$PH$GB$GB
243477551$24347755$1$I$20230921$20240914$20240922$20240922$EXP$$US-SANDOZ INC.-SDZ2023US033072$SANDOZ$$$$$$Y$$$20240922$$CN$US$US
243477571$24347757$1$I$20240101$20240918$20240922$20240922$EXP$$US-ABBVIE-5930003$ABBVIE$$$$$M$Y$$$20240922$$CN$US$US
243477591$24347759$1$I$20240101$20240916$20240922$20240922$EXP$$US-JNJFOC-20240947018$JOHNSON AND JOHNSON$$8$DEC$E$F$Y$$$20240923$$CN$US$US
243477601$24347760$1$I$20240918$20240918$20240922$20240922$PER$$US-AMGEN-USASP2024188343$AMGEN$$72$YR$E$F$Y$$$20240922$$CN$US$US
243477611$24347761$1$I$$20240916$20240922$20240922$EXP$$US-BEIGENE-BGN-2024-014790$BEIGENE$$$$$$Y$$$20240922$$MD$US$US
243477621$24347762$1$I$$20240916$20240922$20240922$EXP$$US-JNJFOC-20240946864$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$CN$US$US
243477631$24347763$1$I$20240727$20240918$20240922$20240922$EXP$$US-ABBVIE-5930451$ABBVIE$$67$YR$$M$Y$$$20240922$$CN$US$US
243477641$24347764$1$I$20240901$20240918$20240922$20240922$EXP$$CA-ABBVIE-5930550$ABBVIE$$67$YR$$M$Y$$$20240922$$CN$CA$CA
243477651$24347765$1$I$20240801$20240919$20240922$20240922$EXP$$US-ABBVIE-5932441$ABBVIE$$$$$M$Y$$$20240922$$CN$US$US
243477661$24347766$1$I$20240913$20240916$20240922$20240922$EXP$$GB-BIOGEN-2024BI01282931$BIOGEN$$75$YR$$F$Y$$$20240922$$CN$GB$GB
243477671$24347767$1$I$$20240918$20240922$20240922$PER$$NVSC2024US187625$NOVARTIS$$$$A$F$Y$$$20240923$$CN$US$US
243477681$24347768$1$I$$20240916$20240922$20240922$EXP$$NVSC2024US185447$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
243477701$24347770$1$I$$20240917$20240922$20240922$EXP$$CA-ABBVIE-5930284$ABBVIE$$$$A$M$Y$$$20240922$$CN$CA$CA
243477731$24347773$1$I$20240723$20240916$20240922$20240922$EXP$$DE-JNJFOC-20240956333$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240923$$CN$DE$DE
243477741$24347774$1$I$$20240903$20240922$20240922$30DAY$$CA-JNJFOC-20240908546$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20240923$$HP$CA$CA
243477751$24347775$1$I$$20240917$20240922$20240922$PER$$US-JNJFOC-20240946124$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240923$$CN$US$US
243477761$24347776$1$I$$20240917$20240922$20240922$EXP$$BR-TAKEDA-2024TUS093086$TAKEDA$$$$$$Y$$$20240922$$CN$BR$BR
243477771$24347777$1$I$$20240918$20240922$20240922$EXP$$CA-ABBVIE-5851987$ABBVIE$$$$A$F$Y$$$20240922$$CN$CA$CA
243477781$24347778$1$I$20210101$20240917$20240922$20240922$PER$$US-JNJFOC-20240944633$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$CN$US$US
243477791$24347779$1$I$$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012062$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240922$$CN$US$US
243477801$24347780$1$I$20240803$20240913$20240922$20240922$EXP$$DE-ORGANON-O2409DEU001212$ORGANON$$$$$F$Y$$$20240922$$HP$DE$DE
243477811$24347781$1$I$$20240919$20240922$20240922$PER$$NVSC2024US188010$NOVARTIS$$$$$$Y$$$20240923$$CN$US$US
243477831$24347783$1$I$$20240916$20240922$20240922$EXP$$US-BIOGEN-2024BI01282755$BIOGEN$$$$$F$Y$$$20240922$$CN$US$US
243477841$24347784$1$I$20240829$20240920$20240922$20240922$EXP$FR-AFSSAPS-NT2024001147$FR-JNJFOC-20240955212$JOHNSON AND JOHNSON$$84$YR$E$F$Y$44.5$KG$20240923$$MD$FR$FR
243477851$24347785$1$I$$20240916$20240922$20240922$EXP$$US-ABBVIE-5926325$ABBVIE$$$$$M$Y$$$20240922$$CN$US$US
243477861$24347786$1$I$$20240918$20240922$20240922$EXP$$SE-ABBVIE-5929399$ABBVIE$$$$$F$Y$$$20240922$$HP$SE$SE
243477871$24347787$1$I$20240101$20240916$20240922$20240922$EXP$$US-ABBVIE-5927598$ABBVIE$$$$$F$Y$$$20240922$$CN$US$US
243477881$24347788$1$I$$20240918$20240922$20240922$EXP$$BR-ORGANON-O2409BRA001510$ORGANON$$$$$F$Y$$$20240922$$CN$BR$BR
243477891$24347789$1$I$$20240913$20240922$20240922$EXP$$US-JNJFOC-20240936273$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243477902$24347790$2$F$$20240916$20240922$20240925$PER$$US-JNJFOC-20240941286$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$CN$US$US
243477911$24347791$1$I$20210101$20240919$20240922$20240922$EXP$$US-ABBVIE-5931378$ABBVIE$$77$YR$$M$Y$$$20240922$$CN$US$US
243477921$24347792$1$I$20240810$20240919$20240922$20240922$EXP$$CN-BEIGENE-BGN-2024-014915$BEIGENE$$$$$$Y$$$20240922$$HP$CN$CN
243477931$24347793$1$I$$20240910$20240922$20240922$EXP$$JP-ABBVIE-5932374$ABBVIE$$$$$M$Y$69$KG$20240922$$MD$JP$JP
243477941$24347794$1$I$$20240913$20240922$20240922$PER$$US-BEIGENE-BGN-2024-014762$BEIGENE$$$$$$Y$$$20240922$$CN$US$US
243477951$24347795$1$I$20240701$20240916$20240922$20240922$PER$$US-SA-2024SA269845$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$MD$US$US
243477961$24347796$1$I$$20240918$20240922$20240922$EXP$$US-ABBVIE-5930560$ABBVIE$$$$$F$Y$$$20240922$$CN$US$US
243477971$24347797$1$I$$20240918$20240922$20240922$EXP$$US-ABBVIE-5931869$ABBVIE$$$$$M$Y$$$20240922$$CN$US$US
243477982$24347798$2$F$20240909$20240923$20240922$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149230$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$81.5$KG$20240925$$PH$US$US
243477991$24347799$1$I$20240917$20240918$20240922$20240922$PER$$US-009507513-2409USA006375$MERCK$$4$YR$$$Y$$$20240922$$HP$US$US
243478011$24347801$1$I$20211201$20240909$20240922$20240922$EXP$$TR-JNJFOC-20240939512$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20240923$$HP$TR$TR
243478021$24347802$1$I$$20240917$20240922$20240922$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-149240$BRISTOL MYERS SQUIBB$Ishiwata K, et al. A case of tako-tsubo cardiomyopathy due to diabetic ketoacidosis in type 1 diabetes mellitus. The 694th Kanto Regional Meeting of the Japanese Society of Internal Medicine. 2024;15.$7$DEC$E$M$Y$$$20240923$$MD$JP$JP
243478031$24347803$1$I$$20240918$20240922$20240922$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-149552$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240923$$MD$DE$DE
243478041$24347804$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA269867$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240923$$HP$US$US
243478051$24347805$1$I$20240904$20240917$20240922$20240922$EXP$$GB-AMGEN-GBRNI2024185892$AMGEN$$54$YR$A$M$Y$89$KG$20240922$$HP$GB$GB
243478061$24347806$1$I$20240101$20240614$20240922$20240922$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108757$ZYDUS PHARM$$$$$$Y$$$20240923$$HP$US$US
243478071$24347807$1$I$20240301$20240620$20240922$20240922$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108759$ZYDUS PHARM$$$$$$Y$$$20240923$$CN$US$US
243478081$24347808$1$I$$20240614$20240922$20240922$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108638$ZYDUS PHARM$$$$$$Y$$$20240923$$HP$US$US
243478091$24347809$1$I$20240101$20240619$20240922$20240922$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109056$ZYDUS PHARM$$$$$$Y$$$20240923$$HP$US$US
243478101$24347810$1$I$20240601$20240626$20240922$20240922$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109138$ZYDUS PHARM$$$$$$Y$$$20240923$$HP$US$US
243478111$24347811$1$I$20240614$20240619$20240922$20240922$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108917$ZYDUS PHARM$$$$$$Y$$$20240923$$HP$US$US
243478122$24347812$2$F$$20240916$20240922$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409010560$ELI LILLY AND CO$$36$YR$A$M$Y$$$20240924$$CN$US$US
243478143$24347814$3$F$20240901$20240923$20240922$20240930$EXP$$US-ABBVIE-5930752$ABBVIE$$67$YR$$F$Y$56.699$KG$20240929$$CN$US$US
243478152$24347815$2$F$20240101$20240923$20240922$20240930$EXP$$US-ABBVIE-5930899$ABBVIE$$$$$F$Y$75$KG$20240930$$CN$US$US
243478161$24347816$1$I$$20240917$20240922$20240922$EXP$$US-JNJFOC-20240950329$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$CN$US$US
243478172$24347817$2$F$$20240916$20240922$20240924$EXP$$US-AMGEN-USASP2024185057$AMGEN$$$$$M$Y$$$20240924$$HP$US$US
243478191$24347819$1$I$20240801$20240917$20240922$20240922$PER$$US-ABBVIE-5930819$ABBVIE$$$$$F$Y$$$20240922$$CN$US$US
243478201$24347820$1$I$20240827$20240919$20240922$20240922$EXP$$AR-ABBVIE-5931778$ABBVIE$$43$YR$$F$Y$$$20240922$$CN$AR$AR
243478211$24347821$1$I$20240101$20240918$20240922$20240922$EXP$$US-ABBVIE-5930066$ABBVIE$$$$$F$Y$$$20240922$$CN$US$US
243478221$24347822$1$I$$20240918$20240922$20240922$EXP$$US-ABBVIE-5929929$ABBVIE$$$$$F$Y$$$20240922$$CN$US$US
243478242$24347824$2$F$$20240918$20240922$20240930$PER$$US-AMGEN-USASP2024187584$AMGEN$$$$A$F$Y$$$20240930$$MD$US$US
243478251$24347825$1$I$$20240913$20240922$20240922$EXP$$US-NOVITIUMPHARMA-2024USNVP01945$NOVITIUM PHARMA$Jose R. Russe-Russe.Rousing drug-induced liver injury through cytochrome p450 isoenzyme overload leading to fulminant liver failure.Journal of Liver Transplantation.23-FEB-2024;14:1-3$40$YR$A$F$Y$$$20240923$$HP$US$US
243478261$24347826$1$I$20240101$20240827$20240922$20240922$PER$$US-SA-2024SA267513$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240923$$CN$US$US
243478271$24347827$1$I$$20240918$20240922$20240922$EXP$$ES-ABBVIE-5930934$ABBVIE$$$$$$Y$$$20240922$$MD$ES$ES
243478291$24347829$1$I$$20240911$20240922$20240922$EXP$$IN-Unichem Pharmaceuticals (USA) Inc-UCM202409-001164$UNICHEM$$16$YR$T$F$Y$$$20240923$$HP$IN$
243478301$24347830$1$I$$20240911$20240922$20240922$EXP$$IN-Unichem Pharmaceuticals (USA) Inc-UCM202409-001163$UNICHEM$$14$YR$T$M$Y$$$20240923$$HP$IN$
243478311$24347831$1$I$20240913$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012075$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240922$$CN$US$US
243478322$24347832$2$F$$20240920$20240922$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013396$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240925$$CN$US$US
243478331$24347833$1$I$20240903$20240918$20240922$20240922$EXP$$CA-ABBVIE-5931027$ABBVIE$$72$YR$$F$Y$$$20240922$$CN$CA$CA
243478341$24347834$1$I$20240801$20240916$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409009600$ELI LILLY AND CO$$$$$F$Y$$$20240922$$HP$US$US
243478351$24347835$1$I$$20240918$20240922$20240922$EXP$$US-ABBVIE-5931453$ABBVIE$$$$$M$Y$$$20240922$$HP$US$US
243478361$24347836$1$I$20240916$20240919$20240922$20240922$EXP$$US-ABBVIE-5931187$ABBVIE$$78$YR$$M$Y$$$20240922$$CN$US$US
243478371$24347837$1$I$$20240917$20240922$20240922$EXP$$US-ABBVIE-5929998$ABBVIE$$$$$F$Y$$$20240922$$CN$US$US
243478381$24347838$1$I$$20240919$20240922$20240922$EXP$$CA-ABBVIE-5932490$ABBVIE$$63$YR$$F$Y$$$20240922$$CN$CA$CA
243478391$24347839$1$I$20240912$20240919$20240922$20240922$EXP$$US-ABBVIE-5932466$ABBVIE$$45$YR$$F$Y$$$20240922$$CN$US$US
243478401$24347840$1$I$20240901$20240916$20240922$20240922$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001877$BLUEPRINT MEDICINES$$32$YR$A$F$Y$$$20240923$$PH$US$US
243478411$24347841$1$I$$20231228$20240922$20240922$PER$$NVSC2023US281223$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
243478421$24347842$1$I$20240101$20240916$20240922$20240922$PER$$US-SA-2024SA269889$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240923$$MD$US$US
243478431$24347843$1$I$20240813$20240909$20240922$20240922$PER$$US-SA-2024SA272017$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240923$$CN$US$US
243478441$24347844$1$I$$20240919$20240922$20240922$EXP$$NVSC2024GR188124$NOVARTIS$$$$$M$Y$$$20240923$$MD$GR$GR
243478451$24347845$1$I$$20240920$20240922$20240922$EXP$$US-SANDOZ INC.-SDZ2024US081976$SANDOZ$$$$$$Y$$$20240922$$CN$US$US
243478461$24347846$1$I$20240904$20240917$20240922$20240922$PER$$US-ABBVIE-5929891$ABBVIE$$22$YR$$F$Y$$$20240922$$MD$US$US
243478471$24347847$1$I$20240911$20240917$20240922$20240922$EXP$$US-TAKEDA-2024TUS092842$TAKEDA$$64$YR$$F$Y$$$20240922$$CN$US$US
243478481$24347848$1$I$$20240916$20240922$20240922$EXP$$US-ABBVIE-5931326$ABBVIE$$$$$M$Y$$$20240922$$CN$US$US
243478491$24347849$1$I$20240917$20240917$20240922$20240922$EXP$$CA-ABBVIE-5930494$ABBVIE$$76$YR$$F$Y$$$20240922$$CN$CA$CA
243478501$24347850$1$I$$20240918$20240922$20240922$EXP$$US-ABBVIE-5930194$ABBVIE$$$$$F$Y$$$20240922$$CN$US$US
243478512$24347851$2$F$$20240920$20240922$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012030$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240923$$CN$US$US
243478521$24347852$1$I$$20240911$20240922$20240922$EXP$$JP-AMGEN-JPNSP2024186320$AMGEN$$78$YR$E$$Y$$$20240922$$MD$JP$JP
243478531$24347853$1$I$$20240918$20240922$20240922$EXP$$CA-ABBVIE-5930514$ABBVIE$$$$A$M$Y$$$20240922$$CN$CA$CA
243478541$24347854$1$I$$20240915$20240922$20240922$EXP$$JP-ORGANON-O2210JPN000245$ORGANON$Shinotsuka S., et al.. A case of successful mandibular nerve block with radiofrequency thermocoagulation for intractable pain due to medicationrelated osteonecrosis of jaw (in Japanese). Abstracts of the 56th Annual Meeting of the Japan Society of Pain Clinicians (We. 2022;153(O28-3)$86$YR$$F$Y$$$20240922$$HP$JP$JP
243478551$24347855$1$I$$20240918$20240922$20240922$EXP$$US-ABBVIE-5932437$ABBVIE$$$$$M$Y$$$20240922$$CN$US$US
243478561$24347856$1$I$20240915$20240916$20240922$20240922$EXP$$CO-JNJFOC-20240951359$JOHNSON AND JOHNSON$$32$YR$A$F$Y$77$KG$20240923$$HP$CO$CO
243478571$24347857$1$I$$20240919$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149716$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240923$$HP$US$US
243478581$24347858$1$I$20231012$20240909$20240922$20240922$EXP$$JP-DSJP-DSJ-2023-142482$DAIICHI$$76$YR$$F$Y$51.2$KG$20240923$$MD$JP$JP
243478591$24347859$1$I$20240910$20240911$20240922$20240922$EXP$$CH-ROCHE-10000080889$ROCHE$$25$YR$A$F$Y$$$20240923$$MD$CH$CH
243478601$24347860$1$I$$20240918$20240922$20240922$EXP$$AU-SANDOZ INC.-SDZ2024AU066421$SANDOZ$$$$$$Y$$$20240922$$HP$AU$AU
243478612$24347861$2$F$20240913$20240924$20240922$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148899$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$CN$US$US
243478621$24347862$1$I$$20240919$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149824$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$53.52$KG$20240923$$CN$US$US
243478632$24347863$2$F$20240723$20240925$20240922$20240927$EXP$$NVSC2024QA165802$NOVARTIS$$51$YR$$F$Y$$$20240927$$CN$QA$QA
243478641$24347864$1$I$$20240913$20240922$20240922$PER$$US-ABBVIE-5925442$ABBVIE$$$$$$Y$$$20240922$$CN$US$US
243478651$24347865$1$I$$20240910$20240922$20240922$PER$$US-JNJFOC-20240955403$JOHNSON AND JOHNSON$$$$$F$Y$73.3$KG$20240923$$MD$US$US
243478661$24347866$1$I$20240801$20240912$20240922$20240922$EXP$$CA-JNJFOC-20240937981$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240923$$HP$CA$CA
243478671$24347867$1$I$$20240918$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409012365$ELI LILLY AND CO$$85$YR$E$F$Y$$$20240922$$CN$US$US
243478681$24347868$1$I$$20240919$20240922$20240922$PER$$US-ELI_LILLY_AND_COMPANY-US202409013409$ELI LILLY AND CO$$$$$M$Y$$$20240922$$CN$US$US
243478691$24347869$1$I$20240906$20240919$20240922$20240922$PER$$US-AMGEN-USASP2024187975$AMGEN$$57$YR$A$F$Y$$$20240922$$CN$US$US
243478701$24347870$1$I$20240719$20240919$20240922$20240922$EXP$$CA-ABBVIE-5932356$ABBVIE$$84$YR$$F$Y$$$20240922$$CN$CA$CA
243478711$24347871$1$I$20240917$20240919$20240922$20240922$EXP$$DE-ABBVIE-5932040$ABBVIE$$25$YR$$F$Y$103$KG$20240922$$MD$DE$DE
243478721$24347872$1$I$$20240918$20240922$20240922$EXP$$US-ABBVIE-5930733$ABBVIE$$$$$M$Y$$$20240922$$CN$US$US
243478731$24347873$1$I$20240901$20240918$20240922$20240922$EXP$$CA-ABBVIE-5930687$ABBVIE$$66$YR$$M$Y$$$20240922$$PH$CA$CA
243478741$24347874$1$I$$20240917$20240922$20240922$EXP$$US-ABBVIE-5930875$ABBVIE$$$$$F$Y$$$20240922$$CN$US$US
243478751$24347875$1$I$20240101$20240917$20240922$20240922$EXP$$US-ABBVIE-5930761$ABBVIE$$$$$F$Y$$$20240922$$CN$US$US
243478762$24347876$2$F$20240101$20240923$20240922$20240926$EXP$$CA-ABBVIE-5930806$ABBVIE$$$$A$F$Y$$$20240926$$CN$CA$CA
243478771$24347877$1$I$20240807$20240918$20240922$20240922$EXP$$US-ABBVIE-5930892$ABBVIE$$58$YR$$M$Y$$$20240922$$CN$US$US
243478791$24347879$1$I$20240912$20240919$20240922$20240922$EXP$$TR-ABBVIE-5932278$ABBVIE$$64$YR$$M$Y$$$20240922$$CN$TR$TR
243478801$24347880$1$I$$20240919$20240922$20240922$EXP$$US-ABBVIE-5920783$ABBVIE$$$$$M$Y$$$20240922$$HP$US$US
243478821$24347882$1$I$$20240918$20240922$20240922$PER$$US-AMGEN-USASP2024187309$AMGEN$$$$$$Y$$$20240922$$PH$US$US
243478831$24347883$1$I$$20240911$20240922$20240922$PER$$US-BAUSCHBL-2024BNL033359$BAUSCH AND LOMB$$$$$F$Y$$$20240923$$CN$US$US
243478841$24347884$1$I$$20240912$20240922$20240922$PER$$US-BAUSCHBL-2024BNL033451$BAUSCH AND LOMB$$$$$F$Y$$$20240923$$CN$US$US
243478851$24347885$1$I$20240815$20240912$20240922$20240922$EXP$$US-JNJFOC-20240939819$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240923$$CN$US$US
243478861$24347886$1$I$$20240916$20240922$20240922$PER$$US-SA-2024SA268628$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240923$$HP$US$US
243478871$24347887$1$I$20240901$20240912$20240922$20240922$PER$$US-BAUSCHBL-2024BNL033399$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240923$$CN$US$US
243478881$24347888$1$I$20240903$20240913$20240922$20240922$EXP$$CN-BEIGENE-BGN-2024-014924$BEIGENE$$$$$$Y$$$20240922$$MD$CN$CN
243478891$24347889$1$I$$20240918$20240922$20240922$EXP$$US-ABBVIE-5930055$ABBVIE$$$$$M$Y$$$20240922$$CN$US$US
243478901$24347890$1$I$$20240919$20240922$20240922$EXP$NL-LRB-01003954$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-150113$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$77$KG$20240923$$CN$NL$NL
243478911$24347891$1$I$20240919$20240919$20240922$20240922$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149545$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240923$$HP$US$US
243478921$24347892$1$I$20230901$20240916$20240922$20240922$EXP$$US-ABBVIE-5780960$ABBVIE$$59$YR$$F$Y$$$20240922$$CN$US$US
243478931$24347893$1$I$20240907$20240911$20240922$20240922$EXP$$CN-ABBVIE-5932389$ABBVIE$$51$YR$$F$Y$60$KG$20240922$$HP$CN$CN
243478943$24347894$3$F$20240604$20240730$20240923$20240924$EXP$$CA-ABBVIE-5932457$ABBVIE$$78$YR$$$Y$69.9$KG$20240924$$MD$CA$CA
243478951$24347895$1$I$20240912$20240912$20240923$20240923$PER$$US-ABBVIE-5924201$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243478961$24347896$1$I$20240101$20240913$20240923$20240923$EXP$$NL-AMGEN-NLDSL2024184804$AMGEN$$82$YR$E$F$Y$$$20240922$$MD$NL$NL
243478971$24347897$1$I$$20240911$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024187622$AMGEN$$$$$$Y$$$20240922$$PH$JP$JP
243478981$24347898$1$I$20240918$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187024$AMGEN$$66$YR$E$F$Y$$$20240922$$CN$US$US
243478991$24347899$1$I$20230525$20240917$20240923$20240923$EXP$FR-AFSSAPS-MA2024001496$FR-ORGANON-O2409FRA001190$ORGANON$$46$YR$$F$Y$57$KG$20240923$$CN$FR$FR
243479001$24347900$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150226$BRISTOL MYERS SQUIBB$Adkins K, Williams RJ, Esteso P, Kobayashi R, Gauvreau K, VanderPluym C, et al. Real-world use and outcomes of apixaban for early post-surgical fontan thromboprophylaxis. Pediatric Cardiology. 2024 Sep 12;doi:10.1007/s00246-024-03641-3.$$$C$$Y$$$20240923$$HP$US$US
243479011$24347901$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268536$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240923$$MD$US$US
243479021$24347902$1$I$20240101$20240913$20240923$20240923$PER$$US-SA-2024SA268127$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240923$$CN$US$US
243479041$24347904$1$I$20240913$20240918$20240923$20240923$EXP$$US-ABBVIE-5931885$ABBVIE$$64$YR$$M$Y$$$20240923$$CN$US$US
243479051$24347905$1$I$$20240909$20240923$20240923$EXP$$DE-Encube-001326$ENCUBE ETHICALS$Hoffmann E, Toepell A, Peter A, Boke S, De-Colle C, Steinle M, Niyazi M, Gani C. Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy. Strahlenther Onkol. 2024 Sep 4. doi: 10.1007/s00066-024-02287-7.$$$$$Y$$$20240919$$MD$DE$
243479061$24347906$1$I$20230101$20240917$20240923$20240923$EXP$$US-ABBVIE-5917572$ABBVIE$$$$$F$Y$90$KG$20240923$$CN$US$US
243479071$24347907$1$I$20240101$20240918$20240923$20240923$EXP$$CA-ABBVIE-5886433$ABBVIE$$79$YR$$M$Y$78$KG$20240923$$CN$CA$CA
243479081$24347908$1$I$$20240919$20240923$20240923$PER$$NVSC2024US188234$NOVARTIS$$$$$$Y$$$20240923$$CN$US$US
243479091$24347909$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5930128$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243479103$24347910$3$F$20240229$20240924$20240923$20240930$EXP$$US-ABBVIE-5930837$ABBVIE$$88$YR$$F$Y$70$KG$20240930$$HP$US$US
243479121$24347912$1$I$$20240919$20240923$20240923$EXP$$US-ABBVIE-5931241$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243479131$24347913$1$I$$20240916$20240923$20240923$EXP$$CA-Orion Corporation ORION PHARMA-24_00031791$ORION$$73$YR$E$F$Y$$$20240923$$HP$CA$
243479152$24347915$2$F$20230401$20240914$20240923$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-149721$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240925$$MD$JP$JP
243479161$24347916$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150219$BRISTOL MYERS SQUIBB$Adkins K, Williams RJ, Esteso P, Kobayashi R, Gauvreau K, VanderPluym C, et al. Real-world use and outcomes of apixaban for early post-surgical fontan thromboprophylaxis. Pediatric Cardiology. 2024 Sep 12;doi:10.1007/s00246-024-03641-3.$$$C$$Y$$$20240923$$HP$US$US
243479171$24347917$1$I$$20240829$20240923$20240923$EXP$$GB-SA-2024SA269083$SANOFI AVENTIS$$34$YR$A$F$Y$90$KG$20240923$$CN$GB$GB
243479181$24347918$1$I$$20240829$20240923$20240923$EXP$$GB-SA-2024SA268894$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240923$$CN$GB$GB
243479191$24347919$1$I$20240101$20240918$20240923$20240923$EXP$$US-ABBVIE-5930562$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243479202$24347920$2$F$20240101$20240918$20240923$20240925$EXP$$US-ABBVIE-5930140$ABBVIE$$$$$M$Y$72.574$KG$20240925$$CN$US$US
243479211$24347921$1$I$$20240905$20240923$20240923$PER$$US-JNJFOC-20240912414$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243479221$24347922$1$I$20240814$20240916$20240923$20240923$EXP$$US-ABBVIE-5926444$ABBVIE$$52$YR$$F$Y$$$20240923$$CN$US$US
243479231$24347923$1$I$20240603$20240913$20240923$20240923$EXP$IT-MINISAL02-1001867$IT-AMGEN-ITASP2024185662$AMGEN$$54$YR$A$F$Y$$$20240922$$MD$IT$IT
243479241$24347924$1$I$$20240917$20240923$20240923$EXP$$JP-009507513-2409JPN002486J$MERCK$$$$$F$Y$$$20240923$$MD$JP$JP
243479251$24347925$1$I$$20240919$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US081951$SANDOZ$$$$$M$Y$$$20240923$$MD$US$US
243479261$24347926$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188120$AMGEN$$$$$$Y$$$20240922$$HP$US$US
243479272$24347927$2$F$20240919$20240925$20240923$20240928$PER$$US-AMGEN-USASP2024187374$AMGEN$$54$YR$A$F$Y$$$20240928$$MD$US$US
243479281$24347928$1$I$20190501$20240918$20240923$20240923$EXP$$US-ABBVIE-5930465$ABBVIE$$41$YR$$F$Y$$$20240923$$CN$US$US
243479291$24347929$1$I$20240601$20240918$20240923$20240923$EXP$$BR-ABBVIE-5931065$ABBVIE$$77$YR$$F$Y$82$KG$20240923$$CN$BR$BR
243479301$24347930$1$I$20240101$20240918$20240923$20240923$EXP$$CA-ABBVIE-5931070$ABBVIE$$54$YR$$F$Y$$$20240923$$MD$CA$CA
243479311$24347931$1$I$$20240917$20240923$20240923$PER$$US-HALEON-2197342$Haleon PLC$$$$$$Y$$$20240923$$CN$US$US
243479321$24347932$1$I$$20240919$20240923$20240923$EXP$$NVSC2024US188176$NOVARTIS$$$$$M$Y$$$20240923$$MD$US$US
243479331$24347933$1$I$20240906$20240911$20240923$20240923$PER$$US-ABBVIE-5922295$ABBVIE$$47$YR$$F$Y$$$20240923$$HP$US$US
243479341$24347934$1$I$20240601$20240918$20240923$20240923$EXP$$US-ABBVIE-5930470$ABBVIE$$73$YR$$F$Y$$$20240923$$CN$US$US
243479362$24347936$2$F$20240801$20240925$20240923$20240930$EXP$$US-ABBVIE-5930909$ABBVIE$$75$YR$$M$Y$91$KG$20240930$$CN$US$US
243479371$24347937$1$I$20240901$20240918$20240923$20240923$EXP$$US-ABBVIE-5932280$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243479381$24347938$1$I$$20240918$20240923$20240923$EXP$$BR-ABBVIE-5930903$ABBVIE$$$$$F$Y$$$20240923$$MD$BR$BR
243479401$24347940$1$I$$20240911$20240923$20240923$EXP$$BR-JNJFOC-20240936886$JOHNSON AND JOHNSON$$64$YR$A$F$Y$72$KG$20240923$$CN$BR$BR
243479411$24347941$1$I$$20240918$20240923$20240923$EXP$$US-JNJFOC-20240948682$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243479421$24347942$1$I$20240201$20240313$20240923$20240923$EXP$$GB-BEH-2023161666$CSL BEHRING$$$$E$F$Y$$$20240923$$CN$GB$GB
243479431$24347943$1$I$$20240919$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150176$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240923$$CN$US$US
243479441$24347944$1$I$20240101$20240909$20240923$20240923$PER$$US-SA-2024SA272045$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240923$$CN$US$US
243479451$24347945$1$I$$20240905$20240923$20240923$EXP$$SE-AMGEN-SWESP2024187487$AMGEN$$79$YR$E$F$Y$$$20240922$$HP$SE$SE
243479461$24347946$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5930117$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243479471$24347947$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5930556$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243479481$24347948$1$I$20240101$20240917$20240923$20240923$EXP$$CA-ABBVIE-5930723$ABBVIE$$53$YR$$F$Y$$$20240923$$CN$CA$CA
243479491$24347949$1$I$$20240918$20240923$20240923$PER$$US-ABBVIE-5931064$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243479501$24347950$1$I$20230601$20240918$20240923$20240923$EXP$$DE-ABBVIE-5686116$ABBVIE$$46$YR$$F$Y$$$20240923$$CN$DE$DE
243479511$24347951$1$I$20240821$20240918$20240923$20240923$EXP$$CA-ABBVIE-5930805$ABBVIE$$29$YR$$F$Y$$$20240923$$CN$CA$CA
243479521$24347952$1$I$20220301$20240916$20240923$20240923$EXP$$US-AMGEN-USASP2024184636$AMGEN$$41$YR$A$F$Y$$$20240922$$CN$US$US
243479531$24347953$1$I$20240618$20240918$20240923$20240923$EXP$$US-ABBVIE-5923999$ABBVIE$$57$YR$$F$Y$99.7$KG$20240923$$CN$US$US
243479541$24347954$1$I$$20240909$20240923$20240923$EXP$$US-BEH-2024178989$CSL BEHRING$$$$$F$Y$$$20240923$$CN$US$US
243479551$24347955$1$I$20240220$20240919$20240923$20240923$EXP$$NVSC2024DE188178$NOVARTIS$$$$$$Y$$$20240923$$CN$DE$DE
243479561$24347956$1$I$$20240919$20240923$20240923$EXP$$US-ABBVIE-5931119$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243479571$24347957$1$I$20240101$20240918$20240923$20240923$EXP$$US-ABBVIE-5930985$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243479581$24347958$1$I$$20240624$20240923$20240923$PER$$US-CIPLA LTD.-2024US06898$CIPLA$$$$$$Y$$$20240923$$PH$US$US
243479591$24347959$1$I$20240101$20240912$20240923$20240923$PER$$US-BAUSCHBL-2024BNL033405$BAUSCH AND LOMB$$$$$F$Y$$$20240923$$CN$US$US
243479601$24347960$1$I$20240101$20240916$20240923$20240923$PER$$US-SA-2024SA270140$SANOFI AVENTIS$$$$E$F$Y$$$20240923$$HP$US$US
243479611$24347961$1$I$20240901$20240916$20240923$20240923$EXP$$US-SA-2024SA271586$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240923$$MD$US$US
243479631$24347963$1$I$$20240827$20240923$20240923$PER$$US-SA-2024SA267213$SANOFI AVENTIS$$79$YR$E$F$Y$54$KG$20240923$$MD$US$US
243479641$24347964$1$I$$20240911$20240923$20240923$PER$$US-BAUSCHBL-2024BNL033403$BAUSCH AND LOMB$$$$$M$Y$$$20240923$$CN$US$US
243479651$24347965$1$I$20220101$20240911$20240923$20240923$PER$$US-BAUSCHBL-2024BNL033327$BAUSCH AND LOMB$$49$YR$$F$Y$$$20240923$$CN$US$US
243479661$24347966$1$I$20240911$20240911$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409007481$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240923$$CN$US$US
243479671$24347967$1$I$20240417$20240917$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148920$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240923$$MD$US$US
243479681$24347968$1$I$$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148882$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240923$$CN$US$US
243479691$24347969$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187247$AMGEN$$$$$$Y$$$20240922$$PH$US$US
243479701$24347970$1$I$20240919$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188668$AMGEN$$77$YR$E$M$Y$$$20240922$$CN$US$US
243479711$24347971$1$I$20240918$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188297$AMGEN$$$$$$Y$$$20240922$$PH$US$US
243479721$24347972$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188068$AMGEN$$$$$$Y$$$20240922$$PH$US$US
243479731$24347973$1$I$20240917$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186982$AMGEN$$78$YR$E$F$Y$$$20240922$$CN$US$US
243479741$24347974$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188060$AMGEN$$$$$$Y$$$20240922$$CN$US$US
243479751$24347975$1$I$20240903$20240916$20240923$20240923$PER$$US-VIIV HEALTHCARE LIMITED-US2024114812$VIIV$$39$YR$$M$Y$$$20240923$$CN$US$US
243479761$24347976$1$I$$20240919$20240923$20240923$EXP$$CA-ROCHE-10000087657$ROCHE$$$$E$M$Y$$$20240923$$CN$CA$CA
243479771$24347977$1$I$$20240918$20240923$20240923$EXP$$BG-ABBVIE-5930998$ABBVIE$$79$YR$$F$Y$$$20240923$$CN$BG$BG
243479781$24347978$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188634$AMGEN$$$$$$Y$$$20240922$$PH$US$US
243479791$24347979$1$I$$20240911$20240923$20240923$PER$$US-IMP-2024000736$Harrow Health$$$$E$M$Y$$$20240923$$CN$US$US
243479801$24347980$1$I$$20240918$20240923$20240923$EXP$$US-ROCHE-10000087071$ROCHE$$80$YR$E$M$Y$$$20240923$$MD$US$US
243479821$24347982$1$I$20201201$20240909$20240923$20240923$EXP$$US-NOVOPROD-1257314$NOVO NORDISK$Clayton P. Burrruss, BS,  Jordan M. Jones, MD and Jyoti B. Burruss, MD. Semaglutide associated Bullous Pemphigoid. JAAD case reports. 2021;15:107-109$64$YR$$F$Y$$$20240923$$CN$US$US
243479831$24347983$1$I$20240101$20240918$20240923$20240923$EXP$$GB-ABBVIE-5931022$ABBVIE$$71$YR$$F$Y$$$20240923$$CN$GB$GB
243479841$24347984$1$I$20220519$20240917$20240923$20240923$EXP$$AU-SANDOZ INC.-NVSC2022AU127903$SANDOZ$$78$YR$$M$Y$63.3$KG$20240923$$MD$AU$AU
243479851$24347985$1$I$20240628$20240909$20240923$20240923$EXP$$DE-NOVOPROD-1281336$NOVO NORDISK$$612$MON$$F$Y$$$20240923$$CN$DE$DE
243479861$24347986$1$I$$20240911$20240923$20240923$PER$$US-JNJFOC-20240931527$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240923$$CN$US$US
243479871$24347987$1$I$$20240909$20240923$20240923$EXP$$CN-NOVOPROD-1281947$NOVO NORDISK$Yin Huanli et al. Severe liver injury caused by semaglutide injection. Adverse Drug Reactions Journal. 2023;25:12$25$YR$$F$Y$70$KG$20240923$$HP$CN$CN
243479881$24347988$1$I$20240726$20240910$20240923$20240923$EXP$$US-NOVOPROD-1283257$NOVO NORDISK$$61$YR$$F$Y$$$20240923$$CN$US$US
243479901$24347990$1$I$$20240912$20240923$20240923$PER$$US-IMP-2024000743$Harrow Health$$$$E$F$Y$$$20240923$$CN$US$US
243479911$24347991$1$I$$20240913$20240923$20240923$PER$$US-ROCHE-10000083032$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243479931$24347993$1$I$20231101$20240910$20240923$20240923$EXP$FR-AFSSAPS-BX2024001739$FR-NOVOPROD-1280968$NOVO NORDISK$$39$YR$$M$Y$109$KG$20240923$$PH$FR$FR
243479941$24347994$1$I$$20240910$20240923$20240923$EXP$$DK-NOVOPROD-1281926$NOVO NORDISK$$50$YR$$F$Y$$$20240923$$HP$DK$DK
243479951$24347995$1$I$20240101$20240910$20240923$20240923$EXP$$US-NOVOPROD-1283306$NOVO NORDISK$$67$YR$$F$Y$$$20240923$$CN$US$US
243479961$24347996$1$I$$20240910$20240923$20240923$EXP$$EG-NOVOPROD-1281929$NOVO NORDISK$$$$$M$Y$$$20240923$$CN$EG$EG
243479981$24347998$1$I$20230101$20240910$20240923$20240923$EXP$$MX-NOVOPROD-1282134$NOVO NORDISK$$37$YR$$M$Y$$$20240923$$CN$MX$MX
243480001$24348000$1$I$20240831$20240910$20240923$20240923$EXP$DE-CADRBFARM-2024330362$DE-NOVOPROD-1280927$NOVO NORDISK$$42$YR$$M$Y$115$KG$20240923$$CN$DE$DE
243480011$24348001$1$I$20240904$20240910$20240923$20240923$EXP$CN-NMPA-4408001005701202400342$CN-NOVOPROD-1281913$NOVO NORDISK$$67$YR$$M$Y$46$KG$20240923$$HP$CN$CN
243480021$24348002$1$I$$20240910$20240923$20240923$EXP$$DE-NOVOPROD-1281956$NOVO NORDISK$$$$$F$Y$$$20240923$$CN$DE$DE
243480031$24348003$1$I$20240823$20240910$20240923$20240923$EXP$FI-FIMEA-202403261$FI-NOVOPROD-1280942$NOVO NORDISK$$29$YR$$F$Y$$$20240923$$HP$FI$FI
243480051$24348005$1$I$20240908$20240910$20240923$20240923$EXP$CN-NMPA-4403041004565202400644$CN-NOVOPROD-1281924$NOVO NORDISK$$30$YR$$F$Y$75$KG$20240923$$HP$CN$CN
243480062$24348006$2$F$20240905$20240918$20240923$20240927$PER$$GB-ABBVIE-5924521$ABBVIE$$42$YR$$$Y$$$20240927$$HP$US$US
243480091$24348009$1$I$$20240919$20240923$20240923$EXP$$US-SA-2024SA272251$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240923$$CN$US$US
243480101$24348010$1$I$$20240905$20240923$20240923$PER$$US-JNJFOC-20240912936$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$CN$US$US
243480111$24348011$1$I$20240908$20240910$20240923$20240923$EXP$$US-NOVOPROD-1283256$NOVO NORDISK$$80$YR$$F$Y$$$20240923$$CN$US$US
243480121$24348012$1$I$20240901$20240910$20240923$20240923$EXP$$JP-NOVOPROD-1283079$NOVO NORDISK$$7$DEC$$F$Y$$$20240923$$PH$JP$JP
243480131$24348013$1$I$$20240910$20240923$20240923$EXP$$TR-NOVOPROD-1282676$NOVO NORDISK$$$$$F$Y$$$20240923$$CN$TR$TR
243480151$24348015$1$I$20240101$20240910$20240923$20240923$EXP$$JP-NOVOPROD-1282655$NOVO NORDISK$$80$YR$$F$Y$$$20240923$$MD$JP$JP
243480161$24348016$1$I$$20240913$20240923$20240923$EXP$$BR-CELLTRION INC.-2024BR022341$CELLTRION$$$$$$Y$$$20240923$$PH$BR$BR
243480171$24348017$1$I$$20240917$20240923$20240923$EXP$$US-ABBVIE-5929035$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243480181$24348018$1$I$$20240912$20240923$20240923$EXP$CA-MHPD-E2B_001095481$CA-Accord-446884$ACCORD$$6$YR$C$M$Y$37$KG$20240923$$HP$CA$CA
243480191$24348019$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA272530$SANOFI AVENTIS$$65$YR$E$F$Y$68.18$KG$20240923$$MD$US$US
243480201$24348020$1$I$20240828$20240828$20240923$20240923$PER$$FR-TOLMAR, INC.-24FR052263$TOLMAR$$77$YR$$M$Y$$$20240923$$PH$FR$FR
243480211$24348021$1$I$20240830$20240830$20240923$20240923$PER$$FR-TOLMAR, INC.-24FR052319$TOLMAR$$77$YR$$M$Y$$$20240923$$PH$FR$FR
243480221$24348022$1$I$$20240909$20240923$20240923$PER$$US-NOVITIUMPHARMA-2024USNVP01930$NOVITIUM PHARMA$$$$$M$Y$$$20240923$$CN$US$US
243480231$24348023$1$I$20240101$20240828$20240923$20240923$PER$$IL-TOLMAR, INC.-24IL052296$TOLMAR$$$$$M$Y$$$20240923$$HP$IL$IL
243480241$24348024$1$I$20240830$20240830$20240923$20240923$PER$$FR-TOLMAR, INC.-24FR052320$TOLMAR$$70$YR$$M$Y$$$20240923$$HP$FR$FR
243480251$24348025$1$I$$20240829$20240923$20240923$PER$$NL-TOLMAR, INC.-24NL052026$TOLMAR$$$$$M$Y$$$20240923$$CN$NL$NL
243480261$24348026$1$I$20240801$20240828$20240923$20240923$PER$$NI-TOLMAR, INC.-24NI052302$TOLMAR$$9$YR$$F$Y$$$20240923$$CN$NI$NI
243480271$24348027$1$I$20240829$20240829$20240923$20240923$PER$$NL-TOLMAR, INC.-24NL052222$TOLMAR$$64$YR$$M$Y$$$20240923$$HP$NL$NL
243480281$24348028$1$I$$20240829$20240923$20240923$PER$$NL-TOLMAR, INC.-24NL052259$TOLMAR$$$$$M$Y$$$20240923$$HP$NL$NL
243480291$24348029$1$I$20230907$20240830$20240923$20240923$PER$$NL-TOLMAR, INC.-24NL052336$TOLMAR$$73$YR$$M$Y$$$20240923$$CN$NL$NL
243480301$24348030$1$I$20240101$20240913$20240923$20240923$EXP$$US-ORGANON-O2409USA001113$ORGANON$$$$$F$Y$$$20240923$$CN$US$US
243480321$24348032$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269641$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240923$$HP$US$US
243480331$24348033$1$I$20240918$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188156$AMGEN$$82$YR$E$M$Y$$$20240922$$CN$US$US
243480341$24348034$1$I$20240901$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024186785$AMGEN$$68$YR$E$F$Y$$$20240922$$HP$US$US
243480351$24348035$1$I$20240801$20240917$20240923$20240923$EXP$$GR-CHATTEMPRD-2024OHG032556$CHATTEM$$24$YR$A$F$Y$55$KG$20240923$$CN$GR$GR
243480361$24348036$1$I$20240614$20240912$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024186788$AMGEN$$63$YR$A$F$Y$$$20240922$$HP$JP$JP
243480371$24348037$1$I$$20240917$20240923$20240923$EXP$$JP-JNJFOC-20240954424$JOHNSON AND JOHNSON$Shunsuke SAKAI et al. Department of Diagnostic and Interventional Radiology Graduate School of Medicine, Osaka Metropolitan University Hospital. A case of severe heat stroke with out-of-hospital cardiac arrest due to ventricular fibrillation. Journal of the Japanese Society of Intensive Care Medicine/.2024;31(5)513-514$57$YR$A$M$Y$49.3$KG$20240923$$HP$JP$JP
243480381$24348038$1$I$$20240913$20240923$20240923$PER$$US-ROCHE-10000082716$ROCHE$$$$$$Y$$$20240923$$PH$US$US
243480391$24348039$1$I$$20240916$20240923$20240923$PER$$US-ROCHE-10000084401$ROCHE$$$$C$M$Y$$$20240923$$CN$US$US
243480401$24348040$1$I$$20240918$20240923$20240923$PER$$US-ROCHE-10000085786$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
243480411$24348041$1$I$20240807$20240909$20240923$20240923$EXP$$US-ADAMAS Pharma-ADM202409-003366$ADAMAS PHARMA$$73$YR$$F$Y$$$20240923$$CN$US$
243480431$24348043$1$I$20240706$20240912$20240923$20240923$EXP$NO-NOMAADVRE-E2B_00098529$NO-Accord-447193$ACCORD$$57$YR$A$M$Y$$$20240923$$MD$NO$NO
243480441$24348044$1$I$$20240911$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005516$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243480453$24348045$3$F$$20240924$20240923$20240928$EXP$$CA-ROCHE-10000086133$ROCHE$$$$A$M$Y$$$20240928$$CN$CA$CA
243480472$24348047$2$F$$20240919$20240923$20240930$PER$$US-ROCHE-10000087505$ROCHE$$$$A$M$Y$$$20240930$$CN$US$US
243480481$24348048$1$I$$20240917$20240923$20240923$EXP$$US-LUOXIN-LUX-2024-US-LIT-00053$LUOXIN AUROVITAS PHARMA(CHENGDU)$Allen C, Zagunis DC, Weston SD, Liu LL. .Extrinsic  Positive End-Expiratory Pressure due to Failure of  the Positive-Pressure Relief Valve Within the  Scavenging System: A Case Report..A-A-Pract .2024;18:7$47$YR$A$M$Y$$$20240923$$MD$US$US
243480491$24348049$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087645$ROCHE$$$$C$M$Y$$$20240923$$CN$US$US
243480501$24348050$1$I$20240918$20240919$20240923$20240923$PER$$US-ROCHE-10000087437$ROCHE$$15$YR$T$M$Y$$$20240923$$CN$US$US
243480511$24348051$1$I$20240806$20240919$20240923$20240923$PER$$US-ROCHE-10000087535$ROCHE$$14$YR$T$M$Y$$$20240923$$CN$US$US
243480521$24348052$1$I$20240915$20240919$20240923$20240923$PER$$US-ROCHE-10000087370$ROCHE$$5$YR$C$M$Y$$$20240923$$CN$US$US
243480531$24348053$1$I$$20240918$20240923$20240923$EXP$$US-JNJFOC-20240954136$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240923$$HP$US$US
243480542$24348054$2$F$$20240912$20240923$20240924$PER$$US-JNJFOC-20240946575$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243480551$24348055$1$I$20240101$20240918$20240923$20240923$EXP$$US-JNJFOC-20240954133$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240923$$HP$US$US
243480561$24348056$1$I$$20240916$20240923$20240923$EXP$$US-CHATTEMPRD-2024OHG032285$CHATTEM$$$$A$M$Y$$$20240923$$LW$US$US
243480601$24348060$1$I$20240516$20240917$20240923$20240923$EXP$$CO-UCBSA-2024048262$UCB$$55$YR$$M$Y$$$20240923$$CN$CO$CO
243480611$24348061$1$I$$20240913$20240923$20240923$PER$$US-SA-2024SA268293$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240923$$MD$US$US
243480621$24348062$1$I$20201101$20240916$20240923$20240923$PER$$US-SA-2024SA269403$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240923$$HP$US$US
243480641$24348064$1$I$20240531$20240913$20240923$20240923$EXP$IT-MINISAL02-1001842$IT-AMGEN-ITASP2024185636$AMGEN$$48$YR$A$F$Y$$$20240922$$MD$IT$IT
243480651$24348065$1$I$20240101$20240918$20240923$20240923$PER$$US-ABBVIE-5930078$ABBVIE$$$$$$Y$$$20240923$$HP$US$US
243480661$24348066$1$I$20240915$20240915$20240923$20240923$PER$$US-AMGEN-USASP2024184464$AMGEN$$85$YR$E$M$Y$$$20240922$$CN$US$US
243480671$24348067$1$I$$20240913$20240923$20240923$EXP$$CN-ROCHE-10000082949$ROCHE$$35$YR$A$F$Y$$$20240923$$MD$CN$CN
243480681$24348068$1$I$20240831$20240914$20240923$20240923$EXP$$CN-BEIGENE-BGN-2024-014674$BEIGENE$$$$$$Y$$$20240923$$HP$CN$CN
243480702$24348070$2$F$$20240919$20240923$20240923$30DAY$US-SANDOZ-SDZ2024US081171$US-SANDOZ INC.-SDZ2024US081171$SANDOZ$$$$$M$Y$$$20240923$$PH$US$US
243480711$24348071$1$I$20240101$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186812$AMGEN$$64$YR$A$M$Y$$$20240922$$CN$US$US
243480721$24348072$1$I$20240831$20240914$20240923$20240923$EXP$$CN-BEIGENE-BGN-2024-014677$BEIGENE$$$$$$Y$$$20240923$$HP$CN$CN
243480731$24348073$1$I$$20240913$20240923$20240923$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP012091$STRIDES$Medford S, Jalal Eldin A, Brgdar A, Obwolo L, Ojo AS, Mere C, et.al.. Beyond the Norm: A Case of Multiorgan Injury Triggered by Ibuprofen. Cureus. 2023;15(10):e46461$$$$$Y$$$20240923$$HP$US$US
243480741$24348074$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011211$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240923$$CN$US$US
243480752$24348075$2$F$20240918$20240926$20240923$20240930$EXP$$NVSC2024DE188131$NOVARTIS$$75$YR$$F$Y$57$KG$20240930$$MD$DE$DE
243480761$24348076$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149995$BRISTOL MYERS SQUIBB$Phillipps J, Nassief G, Morecroft R, Adeyelu T, Elliott A, Abdulla F, et al. Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma. npj Precision Oncology. 2024;8(1):1-7. doi:10.1038/s41698-024-00684-w.$70$YR$E$M$Y$$$20240923$$HP$US$US
243480771$24348077$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010607$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243480781$24348078$1$I$20240322$20240911$20240923$20240923$EXP$$GB-AMGEN-GBRNI2024188557$AMGEN$$27$YR$A$F$Y$126$KG$20240922$$HP$GB$GB
243480791$24348079$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010608$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243480801$24348080$1$I$20170228$20230912$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408687$RANBAXY$$$$$$Y$$$20240923$$MD$US$US
243480811$24348081$1$I$20231024$20231108$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415486$RANBAXY$$$$$$Y$$$20240923$$MD$US$US
243480821$24348082$1$I$$20231219$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425993$RANBAXY$$56$YR$$F$Y$$$20240923$$MD$US$US
243480831$24348083$1$I$20221001$20240708$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-457157$RANBAXY$$51$YR$A$M$Y$$$20240923$$MD$US$US
243480841$24348084$1$I$$20231221$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425513$RANBAXY$$$$$M$Y$$$20240923$$CN$US$US
243480851$24348085$1$I$$20240429$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-445330$RANBAXY$$$$E$F$Y$$$20240923$$CN$US$US
243480861$24348086$1$I$$20231211$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421726$RANBAXY$$$$A$F$Y$$$20240923$$CN$US$US
243480871$24348087$1$I$$20231204$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424339$RANBAXY$$$$$$Y$$$20240923$$CN$US$US
243480882$24348088$2$F$$20240913$20240923$20240923$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP012160$STRIDES$Stark JE, Montgomery CM.. Administering a Soda Beverage With the Hepatitis C Treatment Sofosbuvir/Velpatasvir and the Proton-Pump Inhibitor Pantoprazole: A Case Report.. J-Pharm-Pract. 2024;37 (4):1011-1014$$$$$Y$$$20240923$$PH$US$US
243480891$24348089$1$I$$20230817$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-406547$RANBAXY$$$$A$F$Y$$$20240923$$CN$US$US
243480901$24348090$1$I$$20240525$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-449639$RANBAXY$$$$A$F$Y$$$20240923$$CN$US$US
243480911$24348091$1$I$$20231219$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425998$RANBAXY$$$$A$F$Y$$$20240923$$MD$US$US
243480921$24348092$1$I$$20230816$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-405637$RANBAXY$$$$T$F$Y$$$20240923$$MD$US$US
243480931$24348093$1$I$$20230825$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407417$RANBAXY$$51$YR$$M$Y$$$20240923$$MD$US$US
243480941$24348094$1$I$$20231204$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-424402$RANBAXY$$$$$$Y$$$20240923$$MD$US$US
243480951$24348095$1$I$$20231122$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-421451$RANBAXY$$$$A$F$Y$$$20240923$$CN$US$US
243480961$24348096$1$I$$20240912$20240923$20240923$EXP$$US-ROCHE-10000082913$ROCHE$$53$YR$A$M$Y$$$20240923$$CN$US$US
243480971$24348097$1$I$$20240913$20240923$20240923$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP012122$STRIDES$Cherradi S, Roux S, Duong HT.. Using individual-centric model to detect immune-mediated idiosyncratic drug-induced liver injury at preclinical stage.. Toxicol-Lett. 2024;399 (Suppl. 2):S110-S111 abstr. P02-18$45$YR$$M$Y$$$20240923$$HP$FR$FR
243480981$24348098$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010609$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243480991$24348099$1$I$$20240919$20240923$20240923$EXP$$FI-ABBVIE-5933430$ABBVIE$$$$$$Y$$$20240923$$MD$FI$FI
243481001$24348100$1$I$$20240913$20240923$20240923$EXP$$CH-STRIDES ARCOLAB LIMITED-2024SP012174$STRIDES$Perez-Codesido S, Azzi Virgini V, Fertani S, Jandus P.. Successful desensitization to etoposide in a patient after cardiac arrest.. J-Oncol-Pharm-Pract. 2024;0 (0)$61$YR$$F$Y$$$20240923$$HP$CH$CH
243481011$24348101$1$I$$20240913$20240923$20240923$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP012125$STRIDES$Buyukkal U, Temelturk RD, Tekin D.. Acute Dystonic Reaction Following Methylphenidate Discontinuation During Combination Therapy with Risperidone: A Case Study.. J-Ankara-Univ-Fac-Med. 2024;77 (2):222-226$6$YR$$M$Y$$$20240923$$HP$TR$TR
243481021$24348102$1$I$$20240913$20240923$20240923$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP012155$STRIDES$Pyare R, Dutta Majumder P, Shah M, Kaushik V, Agarwal M, Biswas J.. Tofacitinib in Scleritis: A Case Series.. Ocular-Immunol-Inflamm. 2024;32 (6):884-890.$51$YR$$M$Y$$$20240923$$HP$IN$IN
243481031$24348103$1$I$$20240916$20240923$20240923$PER$$US-ABBVIE-5926637$ABBVIE$$$$$F$Y$$$20240923$$HP$US$US
243481041$24348104$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010610$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243481051$24348105$1$I$$20240913$20240923$20240923$EXP$$TW-STRIDES ARCOLAB LIMITED-2024SP012158$STRIDES$Fang W-C, Chiu L-W.. Antigranulocyte macrophage colony stimulating factor autoantibodies: The underlying cause in seemingly immunocompetent patients with disseminated cryptococcosis.. J-Dermatol. 2024;51 (8):e270-e271$50$YR$$M$Y$$$20240923$$HP$TW$TW
243481061$24348106$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010611$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243481071$24348107$1$I$20240901$20240918$20240923$20240923$PER$$US-ORGANON-O2409USA001490$ORGANON$$16$YR$$F$Y$48.526$KG$20240923$$HP$US$US
243481081$24348108$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010612$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243481091$24348109$1$I$$20240911$20240923$20240923$EXP$$AU-NOVOPROD-1282907$NOVO NORDISK$$$$E$M$Y$$$20240923$$PH$AU$AU
243481101$24348110$1$I$$20240911$20240923$20240923$EXP$$CN-NOVOPROD-1282665$NOVO NORDISK$$$$$F$Y$$$20240923$$CN$CN$CN
243481111$24348111$1$I$$20240912$20240923$20240923$EXP$NL-ASTELLAS-2024EU007417$NL-ROCHE-10000066924$ROCHE$De Jong D, Bruno M, Polak W, Van Driel L, Den Hoed C. Risks of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis After Liver Transplantation. Clinical Transplantation. 2024;38 (7):1-9.$72$YR$E$M$Y$$$20240923$$HP$NL$NL
243481121$24348112$1$I$$20240911$20240923$20240923$EXP$$BR-NOVOPROD-1282663$NOVO NORDISK$$$$$F$Y$$$20240923$$CN$BR$BR
243481131$24348113$1$I$$20240911$20240923$20240923$EXP$GB-MHRA-MED-202409111512115900-PJFDC$GB-NOVOPROD-1282109$NOVO NORDISK$$49$YR$$M$Y$132$KG$20240923$$PH$GB$GB
243481141$24348114$1$I$$20240911$20240923$20240923$EXP$NL-LRB-01003169$NL-NOVOPROD-1281674$NOVO NORDISK$$51$YR$$F$Y$62$KG$20240923$$CN$NL$NL
243481151$24348115$1$I$$20240911$20240923$20240923$EXP$$US-NOVOPROD-1282428$NOVO NORDISK$$$$$F$Y$$$20240923$$PH$US$US
243481161$24348116$1$I$$20240910$20240923$20240923$EXP$$US-NOVOPROD-1284824$NOVO NORDISK$$$$$F$Y$$$20240923$$HP$US$US
243481171$24348117$1$I$$20240911$20240923$20240923$EXP$NL-LRB-01003215$NL-NOVOPROD-1281664$NOVO NORDISK$$59$YR$$F$Y$103$KG$20240923$$PH$NL$NL
243481181$24348118$1$I$$20240911$20240923$20240923$EXP$$US-NOVOPROD-1282105$NOVO NORDISK$$$$$F$Y$$$20240923$$CN$US$US
243481191$24348119$1$I$20240512$20240911$20240923$20240923$EXP$$DE-NOVOPROD-1282735$NOVO NORDISK$$468$MON$$M$Y$85.2$KG$20240923$$HP$DE$DE
243481201$24348120$1$I$20190101$20240910$20240923$20240923$EXP$$CO-NOVOPROD-1285285$NOVO NORDISK$$78$YR$$M$Y$82$KG$20240923$$CN$CO$CO
243481211$24348121$1$I$20240401$20240911$20240923$20240923$EXP$$DE-NOVOPROD-1282667$NOVO NORDISK$$468$MON$$M$Y$85.2$KG$20240923$$HP$DE$DE
243481221$24348122$1$I$$20240919$20240923$20240923$EXP$JP-WT-2024-07654$JP-WT-2024-07654$Waylis$$25$YR$$F$Y$$$20240923$$HP$JP$JP
243481231$24348123$1$I$20240501$20240912$20240923$20240923$EXP$FR-AFSSAPS-AM2024000707$FR-Accord-446839$ACCORD$$65$YR$E$F$Y$$$20240923$$MD$FR$FR
243481241$24348124$1$I$20230101$20240911$20240923$20240923$EXP$$BR-NOVOPROD-1282016$NOVO NORDISK$$29$YR$$F$Y$118.1$KG$20240923$$MD$BR$BR
243481251$24348125$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010613$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243481261$24348126$1$I$$20240916$20240923$20240923$EXP$$CA-ROCHE-10000085873$ROCHE$$31$YR$A$F$Y$$$20240923$$MD$CA$CA
243481271$24348127$1$I$$20240912$20240923$20240923$EXP$CA-MHPD-E2B_03767270$CA-Accord-259201$ACCORD$$$$$F$Y$$$20240923$$HP$CA$CA
243481281$24348128$1$I$$20240911$20240923$20240923$EXP$$US-NOVOPROD-1283296$NOVO NORDISK$$82$YR$$F$Y$$$20240923$$CN$US$US
243481291$24348129$1$I$$20240911$20240923$20240923$EXP$$AU-NOVOPROD-1283281$NOVO NORDISK$$$$$M$Y$$$20240923$$MD$AU$AU
243481311$24348131$1$I$20240502$20240911$20240923$20240923$EXP$$IS-NOVOPROD-1260716$NOVO NORDISK$$67$YR$$F$Y$90$KG$20240923$$MD$IS$IS
243481321$24348132$1$I$20231009$20240911$20240923$20240923$EXP$$US-NOVOPROD-1283635$NOVO NORDISK$$76$YR$$F$Y$$$20240923$$CN$US$US
243481332$24348133$2$F$$20240919$20240923$20240930$EXP$$BR-NOVOPROD-1282925$NOVO NORDISK$$$$$F$Y$$$20240930$$CN$BR$BR
243481341$24348134$1$I$$20240911$20240923$20240923$EXP$$AU-NOVOPROD-1283215$NOVO NORDISK$$$$$F$Y$$$20240923$$MD$AU$AU
243481351$24348135$1$I$$20240911$20240923$20240923$EXP$$KZ-NOVOPROD-1283728$NOVO NORDISK$$40$YR$$$Y$$$20240923$$MD$KZ$KZ
243481361$24348136$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010614$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243481371$24348137$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188112$AMGEN$$$$$$Y$$$20240922$$CN$US$US
243481381$24348138$1$I$$20240911$20240923$20240923$EXP$$US-NOVOPROD-1276506$NOVO NORDISK$$$$$F$Y$$$20240923$$CN$US$US
243481391$24348139$1$I$$20240919$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149900$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240923$$CN$US$US
243481401$24348140$1$I$20240109$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149464$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243481411$24348141$1$I$$20240913$20240923$20240923$EXP$$CA-APOTEX-2024AP010734$APOTEX$$76$YR$$F$Y$64$KG$20240923$$HP$CA$CA
243481421$24348142$1$I$$20240912$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146554$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240923$$CN$US$US
243481432$24348143$2$F$20240915$20240923$20240923$20240924$PER$$US-AMGEN-USASP2024188820$AMGEN$$66$YR$E$F$Y$$$20240924$$CN$US$US
243481441$24348144$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010632$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240923$$HP$US$US
243481451$24348145$1$I$$20240919$20240923$20240923$PER$$US-ABBVIE-5932608$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243481461$24348146$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186442$AMGEN$$$$$F$Y$$$20240922$$CN$US$US
243481471$24348147$1$I$20240101$20240904$20240923$20240923$EXP$$DE-SA-2024SA271526$SANOFI AVENTIS$$$$$F$Y$$$20240923$$MD$DE$DE
243481481$24348148$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010633$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240923$$HP$US$US
243481501$24348150$1$I$$20240919$20240923$20240923$PER$$US-ABBVIE-5933217$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243481511$24348151$1$I$20240801$20240828$20240923$20240923$PER$$US-009507513-2408USA009809$MERCK$$82$YR$$F$Y$$$20240923$$CN$US$US
243481521$24348152$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010634$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$F$Y$$$20240923$$HP$US$US
243481532$24348153$2$F$20240903$20240923$20240923$20240925$EXP$$CN-CHEPLA-2024011848$CHEPLAPHARM$$37$YR$$F$Y$60$KG$20240924$$HP$COUNTRY NOT SPECIFIED$CN
243481541$24348154$1$I$$20240913$20240923$20240923$EXP$$CA-CHEPLA-2024011898$CHEPLAPHARM$$$$$M$Y$$$20240920$$MD$COUNTRY NOT SPECIFIED$CA
243481561$24348156$1$I$$20240918$20240923$20240923$EXP$$US-JNJFOC-20240948270$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$US$US
243481571$24348157$1$I$20191125$20240912$20240923$20240923$EXP$GB-MHRA-MED-202409120729514340-FMSJY$GB-Accord-446609$ACCORD$$41$YR$A$M$Y$144$KG$20240923$$CN$GB$GB
243481582$24348158$2$F$20240719$20240927$20240923$20240930$PER$$US-ABBVIE-5931886$ABBVIE$$37$YR$$F$Y$$$20240930$$HP$US$US
243481591$24348159$1$I$$20240919$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149936$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240923$$CN$US$US
243481601$24348160$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188218$AMGEN$$$$$$Y$$$20240922$$CN$US$US
243481611$24348161$1$I$$20240918$20240923$20240923$PER$$US-JNJFOC-20240948214$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240923$$HP$US$US
243481621$24348162$1$I$$20240830$20240923$20240923$30DAY$$AU-JNJFOC-20240900134$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$AU$AU
243481641$24348164$1$I$20240101$20240919$20240923$20240923$PER$$US-ABBVIE-5932528$ABBVIE$$$$$$Y$$$20240923$$HP$US$US
243481651$24348165$1$I$$20240917$20240923$20240923$EXP$$US-BEIGENE-BGN-2024-014788$BEIGENE$$$$$$Y$$$20240923$$CN$US$US
243481661$24348166$1$I$$20240911$20240923$20240923$EXP$$CA-HALEON-2197605$Haleon PLC$$53$YR$$M$Y$$$20240920$$HP$CA$CA
243481671$24348167$1$I$20240913$20240913$20240923$20240923$PER$$US-GSK-US2024114335$GLAXOSMITHKLINE$$74$YR$$M$Y$$$20240923$$CN$US$US
243481681$24348168$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA270094$SANOFI AVENTIS$$7$YR$C$F$Y$23.6$KG$20240923$$MD$US$US
243481691$24348169$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA272974$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240923$$MD$US$US
243481701$24348170$1$I$$20240905$20240923$20240923$PER$$US-SA-2024SA273103$SANOFI AVENTIS$$$$A$M$Y$99.773$KG$20240923$$HP$US$US
243481711$24348171$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272897$SANOFI AVENTIS$$35$YR$A$M$Y$70.45$KG$20240923$$MD$US$US
243481721$24348172$1$I$20240601$20240827$20240923$20240923$PER$$US-SA-2024SA267257$SANOFI AVENTIS$$51$YR$A$M$Y$88.64$KG$20240923$$MD$US$US
243481731$24348173$1$I$$20240920$20240923$20240923$PER$$US-ROCHE-10000087446$ROCHE$$60$YR$A$F$Y$100$KG$20240923$$CN$US$US
243481741$24348174$1$I$$20240918$20240923$20240923$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-2024-149964$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$AU$AU
243481751$24348175$1$I$20231201$20240911$20240923$20240923$EXP$$US-Accord-446713$ACCORD$$52$YR$A$F$Y$$$20240923$$MD$US$US
243481762$24348176$2$F$$20240925$20240923$20240930$EXP$$IE-TAKEDA-2024TUS092977$TAKEDA$$$$$M$Y$$$20240930$$CN$IE$IE
243481771$24348177$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000084802$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243481781$24348178$1$I$$20240911$20240923$20240923$EXP$$US-Accord-447343$ACCORD$$70$YR$E$F$Y$$$20240923$$HP$US$US
243481792$24348179$2$F$$20240923$20240923$20240925$PER$$US-JNJFOC-20240959698$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243481801$24348180$1$I$$20240917$20240923$20240923$PER$$US-JNJFOC-20240947615$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243481821$24348182$1$I$20240101$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186567$AMGEN$$56$YR$A$F$Y$$$20240922$$CN$US$US
243481831$24348183$1$I$20240101$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024185879$AMGEN$$$$A$M$Y$$$20240922$$CN$US$US
243481841$24348184$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188231$AMGEN$$$$$$Y$$$20240922$$CN$US$US
243481851$24348185$1$I$20230106$20240910$20240923$20240923$EXP$$AU-TAKEDA-2023TUS002974$TAKEDA$$56$YR$$F$Y$$$20240923$$HP$AU$AU
243481861$24348186$1$I$20240913$20240913$20240923$20240923$PER$$US-VIIV HEALTHCARE LIMITED-US2024114123$VIIV$$61$YR$$M$Y$$$20240923$$CN$US$US
243481871$24348187$1$I$$20240913$20240923$20240923$EXP$$US-RDY-SPO/USA/24/0013749$DR REDDYS$Stark JE, Montgomery CM. Administering a Soda Beverage With the Hepatitis C Treatment Sofosbuvir/Velpatasvir and the Proton-Pump Inhibitor Pantoprazole: A Case Report. Journal of Pharmacy Practice. 2024 Aug;37(4): 1011-1014. doi:10.1177/08971900231183036.$64$YR$A$M$Y$$$20240923$$PH$US$US
243481881$24348188$1$I$$20240913$20240923$20240923$EXP$$US-SPECGX-T200300053$SPECGX$Cruciani RA, Lussier D, Miller-Saultz D, Arbuck DM. Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone. Journal of Pain and Symptom Management. 2003;25(6):491-4$61$YR$$M$Y$$$20240923$$MD$US$US
243481891$24348189$1$I$20240901$20240917$20240923$20240923$EXP$$JP-009507513-2409JPN002494J$MERCK$$6$DEC$$F$Y$$$20240923$$MD$JP$JP
243481903$24348190$3$F$20240919$20240925$20240923$20240927$EXP$$US-PFIZER INC-202400257730$PFIZER$$71$YR$$F$Y$$$20240927$$HP$US$US
243481911$24348191$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149853$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240923$$HP$US$US
243481921$24348192$1$I$20240814$20240918$20240923$20240923$EXP$IT-MINISAL02-1002584$IT-JNJFOC-20240959104$JOHNSON AND JOHNSON$$76$YR$E$M$Y$61$KG$20240923$$MD$IT$IT
243481941$24348194$1$I$$20240912$20240923$20240923$PER$$US-ABBVIE-5923833$ABBVIE$$$$$$Y$$$20240923$$MD$US$US
243481951$24348195$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087712$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243481961$24348196$1$I$$20240913$20240923$20240923$PER$$US-ROCHE-10000082920$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
243481981$24348198$1$I$$20240903$20240923$20240923$PER$$US-TEVA-VS-3241330$TEVA$$68$YR$$F$Y$$$20240923$$MD$US$US
243481991$24348199$1$I$20240901$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187720$AMGEN$$71$YR$E$F$Y$$$20240922$$PH$US$US
243482001$24348200$1$I$$20240913$20240923$20240923$PER$$US-TEVA-VS-3244819$TEVA$$33$YR$$$Y$$$20240923$$CN$US$US
243482011$24348201$1$I$$20240916$20240923$20240923$EXP$$IN-NOVITIUMPHARMA-2024INNVP01959$NOVITIUM PHARMA$Bondalapati S.Clinical and laboratory findings of Brucella bacteremia in a tertiary care hospital from India.European Journal of Cardiovascular Medicine.2023;13(4):764-767$48$YR$A$M$Y$$$20240923$$HP$IN$IN
243482021$24348202$1$I$$20240919$20240923$20240923$EXP$$US-JNJFOC-20240959022$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$HP$US$US
243482031$24348203$1$I$20240911$20240918$20240923$20240923$EXP$$CN-JNJFOC-20240954627$JOHNSON AND JOHNSON$$61$YR$A$M$Y$65$KG$20240923$$HP$CN$CN
243482041$24348204$1$I$$20240830$20240923$20240923$30DAY$$FR-JNJFOC-20240902014$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20240923$$PH$FR$FR
243482061$24348206$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188244$AMGEN$$$$$$Y$$$20240922$$CN$US$US
243482071$24348207$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188239$AMGEN$$$$$$Y$$$20240922$$CN$US$US
243482081$24348208$1$I$$20240918$20240923$20240923$PER$$US-ABBVIE-5930376$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243482091$24348209$1$I$$20240920$20240923$20240923$PER$$US-ROCHE-10000087766$ROCHE$$53$YR$A$F$Y$$$20240923$$MD$US$US
243482101$24348210$1$I$$20240912$20240923$20240923$PER$$NVSC2024US185691$NOVARTIS$$$$$F$Y$$$20240923$$HP$US$US
243482111$24348211$1$I$$20240130$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430100$RANBAXY$$$$$$Y$$$20240923$$HP$US$US
243482131$24348213$1$I$20220101$20230906$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419427$RANBAXY$$$$A$F$Y$$$20240923$$CN$US$US
243482141$24348214$1$I$20240701$20240912$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145997$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240923$$CN$US$US
243482161$24348216$1$I$$20240917$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148379$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240923$$CN$US$US
243482171$24348217$1$I$$20240916$20240923$20240923$PER$$US-ROCHE-10000084123$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243482181$24348218$1$I$20240829$20240909$20240923$20240923$PER$$US-SA-2024SA272003$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240923$$MD$US$US
243482191$24348219$1$I$20240801$20240916$20240923$20240923$EXP$$CA-JNJFOC-20240116014$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240923$$HP$CA$CA
243482201$24348220$1$I$$20240326$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-439083$RANBAXY$$$$A$F$Y$$$20240923$$CN$US$US
243482211$24348221$1$I$$20240206$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-431985$RANBAXY$$$$E$F$Y$$$20240923$$CN$US$US
243482221$24348222$1$I$$20240910$20240923$20240923$EXP$GB-MHRA-TPP5695104C581080YC1725638235203$GB-MSNLABS-2024MSNSPO02015$MSN LABORATORIES$$$$$$Y$$$20240923$$MD$GB$GB
243482231$24348223$1$I$$20240401$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-441106$RANBAXY$$$$A$F$Y$$$20240923$$CN$US$US
243482241$24348224$1$I$20231126$20240617$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453793$RANBAXY$$7$YR$C$M$Y$$$20240923$$CN$US$US
243482251$24348225$1$I$$20240605$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-451316$RANBAXY$$$$T$M$Y$$$20240923$$MD$US$US
243482261$24348226$1$I$$20240617$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453792$RANBAXY$$$$A$F$Y$$$20240923$$CN$US$US
243482271$24348227$1$I$$20240305$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-436938$RANBAXY$$$$A$M$Y$$$20240923$$CN$US$US
243482281$24348228$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188250$AMGEN$$$$$$Y$$$20240922$$CN$US$US
243482291$24348229$1$I$20210101$20240916$20240923$20240923$EXP$$US-ABBVIE-4308420$ABBVIE$$68$YR$$F$Y$$$20240923$$CN$US$US
243482301$24348230$1$I$$20240131$20240923$20240923$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-431144$RANBAXY$$$$A$F$Y$104$KG$20240923$$CN$US$US
243482311$24348231$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000085177$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243482331$24348233$1$I$20240808$20240912$20240923$20240923$EXP$FR-AFSSAPS-GR2024001040$FR-Accord-446806$ACCORD$$79$YR$E$M$Y$$$20240923$$PH$FR$FR
243482341$24348234$1$I$$20240911$20240923$20240923$PER$$US-ASTELLAS-2024-AER-006505$ASTELLAS$$$$$M$Y$80.5$KG$20240923$$PH$US$US
243482361$24348236$1$I$20240907$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013349$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240923$$CN$US$US
243482371$24348237$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000085351$ROCHE$$71$YR$E$F$Y$$$20240923$$CN$US$US
243482381$24348238$1$I$$20240916$20240923$20240923$PER$$US-ROCHE-10000086502$ROCHE$$$$A$F$Y$$$20240923$$MD$US$US
243482391$24348239$1$I$$20240912$20240923$20240923$EXP$$IL-TAKEDA-2024TUS093182$TAKEDA$$$$$F$Y$$$20240923$$CN$IL$IL
243482401$24348240$1$I$$20240918$20240923$20240923$PER$$US-ROCHE-10000085512$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243482411$24348241$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000086982$ROCHE$$72$YR$E$F$Y$$$20240923$$CN$US$US
243482421$24348242$1$I$$20240917$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147967$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240923$$HP$US$US
243482431$24348243$1$I$$20240913$20240923$20240923$EXP$$CA-TOLMAR, INC.-24CA052132$TOLMAR$$$$$M$Y$$$20240923$$CN$CA$CA
243482441$24348244$1$I$$20240918$20240923$20240923$EXP$PL-URPL-2-807-2019$PL-JNJFOC-20240957560$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$CN$PL$PL
243482451$24348245$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010603$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243482461$24348246$1$I$$20240918$20240923$20240923$PER$$NVSC2024US188368$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243482471$24348247$1$I$20240801$20240910$20240923$20240923$PER$$US-SA-2024SA271632$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240923$$MD$US$US
243482481$24348248$1$I$$20240913$20240923$20240923$PER$$US-SA-2024SA037057$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240923$$HP$US$US
243482491$24348249$1$I$$20240914$20240923$20240923$PER$$US-SA-2024SA268964$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240923$$MD$US$US
243482501$24348250$1$I$20240901$20240912$20240923$20240923$PER$$US-SA-2024SA267759$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240923$$HP$US$US
243482511$24348251$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA269279$SANOFI AVENTIS$$$$C$F$Y$$$20240923$$MD$US$US
243482521$24348252$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA269434$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$HP$US$US
243482531$24348253$1$I$20240101$20240916$20240923$20240923$PER$$US-SA-2024SA269436$SANOFI AVENTIS$$$$C$M$Y$$$20240923$$MD$US$US
243482541$24348254$1$I$$20240918$20240923$20240923$PER$$US-ROCHE-10000086166$ROCHE$$61$YR$A$F$Y$$$20240923$$CN$US$US
243482551$24348255$1$I$20240601$20240916$20240923$20240923$EXP$$US-ABBVIE-5903042$ABBVIE$$55$YR$$F$Y$$$20240923$$CN$US$US
243482561$24348256$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000086565$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243482581$24348258$1$I$$20240917$20240923$20240923$EXP$$CA-ABBVIE-5931086$ABBVIE$$$$$M$Y$$$20240923$$HP$CA$CA
243482601$24348260$1$I$$20240912$20240923$20240923$EXP$CA-MHPD-E2B_001092051$CA-Accord-447032$ACCORD$$78$YR$E$M$Y$80$KG$20240923$$HP$CA$CA
243482611$24348261$1$I$$20240911$20240923$20240923$EXP$$US-NOVOPROD-1284162$NOVO NORDISK$$56$YR$$M$Y$$$20240923$$MD$US$US
243482621$24348262$1$I$$20240911$20240923$20240923$EXP$$US-NOVOPROD-1284075$NOVO NORDISK$$$$$M$Y$$$20240923$$HP$US$US
243482631$24348263$1$I$$20240911$20240923$20240923$EXP$$US-NOVOPROD-1284186$NOVO NORDISK$$$$$$Y$$$20240923$$CN$US$US
243482641$24348264$1$I$20240601$20240911$20240923$20240923$EXP$$US-NOVOPROD-1284105$NOVO NORDISK$$61$YR$$F$Y$$$20240923$$CN$US$US
243482651$24348265$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010604$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243482661$24348266$1$I$$20240912$20240923$20240923$EXP$$GB-ROCHE-10000080896$ROCHE$$$$$F$Y$$$20240923$$MD$GB$GB
243482671$24348267$1$I$20240918$20240919$20240923$20240923$PER$$US-ROCHE-10000087601$ROCHE$$38$YR$A$F$Y$72.57$KG$20240923$$CN$US$US
243482681$24348268$1$I$$20240909$20240923$20240923$PER$$US-JNJFOC-20240922030$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$US$US
243482691$24348269$1$I$$20240912$20240923$20240923$EXP$$IE-TAKEDA-2024TUS092378$TAKEDA$$$$$F$Y$$$20240923$$MD$IE$IE
243482701$24348270$1$I$20130201$20240903$20240923$20240923$EXP$$CH-SA-2024SA269662$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240923$$CN$CH$CH
243482711$24348271$1$I$20240724$20240911$20240923$20240923$EXP$$FR-NOVOPROD-1284864$NOVO NORDISK$$70$YR$$F$Y$$$20240923$$CN$FR$FR
243482721$24348272$1$I$$20240909$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-044969$AUROBINDO$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum. 2024;67no pagination$68$YR$$M$Y$$$20240923$$HP$US$US
243482731$24348273$1$I$$20240911$20240923$20240923$EXP$$US-NOVOPROD-1284419$NOVO NORDISK$$$$$F$Y$$$20240923$$CN$US$US
243482741$24348274$1$I$$20240911$20240923$20240923$EXP$$US-NOVOPROD-1284194$NOVO NORDISK$$$$$F$Y$$$20240923$$CN$US$US
243482751$24348275$1$I$20240101$20240910$20240923$20240923$EXP$SE-SEMPA-2024-006457$SE-GLENMARK PHARMACEUTICALS-2024GMK094063$GLENMARK$$$$$$Y$$$20240923$$CN$SE$SE
243482761$24348276$1$I$20240101$20240917$20240923$20240923$PER$$US-SA-2024SA270319$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240923$$HP$US$US
243482772$24348277$2$F$20240825$20240911$20240923$20240925$PER$$US-SA-2024SA271348$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240925$$CN$US$US
243482791$24348279$1$I$$20200925$20240923$20240923$EXP$$CA-HALEON-2197209$Haleon PLC$$43$YR$$F$Y$68$KG$20240921$$CN$CA$CA
243482801$24348280$1$I$20220716$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149418$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243482812$24348281$2$F$$20240912$20240923$20240924$PER$$US-CHATTEMPRD-2024OHG032136$CHATTEM$$$$A$F$Y$$$20240924$$CN$US$US
243482821$24348282$1$I$$20240917$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148420$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240923$$HP$US$US
243482831$24348283$1$I$$20240911$20240923$20240923$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002314$Alvotech$$$$$F$Y$$$20240923$$CN$CA$CA
243482841$24348284$1$I$$20240919$20240923$20240923$EXP$$US-ABBVIE-5932346$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243482861$24348286$1$I$20240915$20240916$20240923$20240923$EXP$$AU-NOVOPROD-1286669$NOVO NORDISK$$82$YR$$F$Y$$$20240923$$PH$AU$AU
243482871$24348287$1$I$$20240912$20240923$20240923$EXP$GB-MHRA-MED-202409121514535800-RKYLJ$GB-NOVOPROD-1282532$NOVO NORDISK$$$$$F$Y$$$20240923$$PH$GB$GB
243482881$24348288$1$I$20240301$20240912$20240923$20240923$EXP$$MX-NOVOPROD-1283284$NOVO NORDISK$$37$YR$$F$Y$$$20240923$$CN$MX$MX
243482891$24348289$1$I$$20240911$20240923$20240923$EXP$$CN-ALVOTECHPMS-2024-ALVOTECHPMS-002312$Alvotech$Guo Y, Li J, Hu R, Tan J, Luo H, Zhang Z, Luo Q, Xia X. Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis. BMC Psychiatry. 2024 Sep 4;24(1):596. doi: 10.1186/s12888-024-06037-y. PMID: 39232752; PMCID: PMC11373102.$12$YR$$M$Y$$$20240923$$HP$CN$
243482901$24348290$1$I$20240506$20240912$20240923$20240923$EXP$SE-SEMPA-2024-006619$SE-NOVOPROD-1282162$NOVO NORDISK$$40$YR$$F$Y$$$20240923$$MD$SE$SE
243482911$24348291$1$I$$20240912$20240923$20240923$EXP$$US-NOVOPROD-1284935$NOVO NORDISK$$$$A$F$Y$$$20240923$$CN$US$US
243482921$24348292$1$I$$20240913$20240923$20240923$EXP$$BR-NOVOPROD-1284720$NOVO NORDISK$$$$$M$Y$$$20240923$$CN$BR$BR
243482931$24348293$1$I$$20240916$20240923$20240923$PER$$US-CHATTEMPRD-2024OHG032416$CHATTEM$$$$$$Y$$$20240923$$CN$US$US
243482941$24348294$1$I$$20240912$20240923$20240923$PER$$US-ROCHE-10000081486$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
243482951$24348295$1$I$20240724$20240915$20240923$20240923$EXP$$NVSC2024CA156709$NOVARTIS$$76$YR$$F$Y$118$KG$20240923$$CN$CA$CA
243482961$24348296$1$I$$20240916$20240923$20240923$PER$$US-CHATTEMPRD-2024OHG032414$CHATTEM$$$$$$Y$$$20240923$$CN$US$US
243482971$24348297$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186489$AMGEN$$$$$F$Y$$$20240922$$CN$US$US
243482981$24348298$1$I$20240908$20240910$20240923$20240923$PER$$US-BEH-2024178651$CSL BEHRING$$47$YR$A$M$Y$$$20240923$$CN$US$US
243482991$24348299$1$I$20230522$20240916$20240923$20240923$EXP$$NL-HALEON-2197395$Haleon PLC$$9$YR$$M$Y$$$20240921$$CN$NL$NL
243483001$24348300$1$I$$20240916$20240923$20240923$PER$$US-CHATTEMPRD-2024OHG032424$CHATTEM$$$$$$Y$$$20240923$$CN$US$US
243483011$24348301$1$I$20240915$20240916$20240923$20240923$PER$$US-CHATTEMPRD-2024OHG032607$CHATTEM$$$$$M$Y$$$20240923$$CN$US$US
243483031$24348303$1$I$$20240911$20240923$20240923$EXP$$IN-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001366$ALEMBIC$Padmapriyadarsini C, Oswal V.S, Jain C.D, Mariappan M.V, Singla N, Kumar S. et.al.. Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial. Clinical infectious diseases : an official publication of the Infectious Disease. 2024;1-11$$$$$Y$$$20240923$$HP$IN$IN
243483041$24348304$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA272951$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240923$$CN$US$US
243483051$24348305$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114184$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243483061$24348306$1$I$$20240916$20240923$20240923$PER$$US-CHATTEMPRD-2024OHG032387$CHATTEM$$$$$$Y$$$20240923$$CN$US$US
243483071$24348307$1$I$$20240917$20240923$20240923$PER$$US-CHATTEMPRD-2024OHG032600$CHATTEM$$$$$F$Y$$$20240923$$CN$US$US
243483081$24348308$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087561$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243483091$24348309$1$I$$20240626$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109222$ZYDUS PHARM$$$$$$Y$$$20240923$$HP$US$US
243483101$24348310$1$I$20240101$20240701$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109291$ZYDUS PHARM$$$$$$Y$$$20240923$$CN$US$US
243483111$24348311$1$I$20240101$20240702$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109406$ZYDUS PHARM$$$$$$Y$$$20240923$$HP$US$US
243483121$24348312$1$I$20240101$20240703$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109629$ZYDUS PHARM$$$$$$Y$$$20240923$$CN$US$US
243483131$24348313$1$I$$20240805$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111122$ZYDUS PHARM$$$$$$Y$$$20240923$$CN$US$US
243483141$24348314$1$I$$20240807$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111230$ZYDUS PHARM$$$$$$Y$$$20240923$$HP$US$US
243483151$24348315$1$I$20240101$20240807$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111231$ZYDUS PHARM$$$$$$Y$$$20240923$$CN$US$US
243483161$24348316$1$I$20240101$20240813$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111332$ZYDUS PHARM$$$$$$Y$$$20240923$$CN$US$US
243483171$24348317$1$I$20240101$20240815$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111461$ZYDUS PHARM$$$$$$Y$$$20240923$$CN$US$US
243483181$24348318$1$I$20240830$20240830$20240923$20240923$30DAY$$US-JNJFOC-20240901676$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$PH$US$US
243483191$24348319$1$I$$20240918$20240923$20240923$EXP$$GB-AMGEN-GBRSP2024187708$AMGEN$$$$$M$Y$$$20240922$$CN$GB$GB
243483201$24348320$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186998$AMGEN$$$$$F$Y$$$20240922$$MD$US$US
243483211$24348321$1$I$20240830$20240916$20240923$20240923$EXP$FI-FIMEA-202403258$FI-CHEPLA-2024011980$CHEPLAPHARM$$48$YR$$F$Y$$$20240923$$MD$COUNTRY NOT SPECIFIED$FI
243483221$24348322$1$I$20240814$20240918$20240923$20240923$EXP$$CN-ABBVIE-5932340$ABBVIE$$19$MON$$M$Y$12$KG$20240923$$HP$CN$CN
243483231$24348323$1$I$20240101$20240915$20240923$20240923$EXP$$US-SA-2024SA269200$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240923$$HP$US$US
243483241$24348324$1$I$$20240802$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111117$ZYDUS PHARM$$$$$$Y$$$20240923$$HP$US$US
243483251$24348325$1$I$20240101$20240802$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-111118$ZYDUS PHARM$$$$$$Y$$$20240923$$HP$US$US
243483261$24348326$1$I$$20240731$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110923$ZYDUS PHARM$$$$$$Y$$$20240923$$HP$US$US
243483271$24348327$1$I$20240101$20240726$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110654$ZYDUS PHARM$$$$$$Y$$$20240923$$CN$US$US
243483281$24348328$1$I$20240101$20240729$20240923$20240923$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110820$ZYDUS PHARM$$$$$$Y$$$20240923$$CN$US$US
243483291$24348329$1$I$20240101$20240918$20240923$20240923$EXP$$US-ABBVIE-5931039$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243483301$24348330$1$I$$20240916$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409009989$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240923$$CN$US$US
243483311$24348331$1$I$$20240910$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409007726$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240923$$CN$US$US
243483321$24348332$1$I$20240909$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012916$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240923$$CN$US$US
243483331$24348333$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012752$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243483341$24348334$1$I$$20240911$20240923$20240923$EXP$$CA-HALEON-2197193$Haleon PLC$$$$$F$Y$$$20240922$$HP$CA$CA
243483351$24348335$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150068$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$57.61$KG$20240923$$CN$US$US
243483361$24348336$1$I$$20240919$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149728$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240923$$PH$US$US
243483372$24348337$2$F$$20240913$20240923$20240925$EXP$$CN-ROCHE-10000082179$ROCHE$$57$YR$A$F$Y$60$KG$20240925$$MD$CN$CN
243483381$24348338$1$I$20240823$20240916$20240923$20240923$EXP$$IN-ROCHE-10000084138$ROCHE$$74$YR$E$M$Y$43$KG$20240923$$CN$IN$IN
243483391$24348339$1$I$20230328$20240916$20240923$20240923$EXP$FI-FIMEA-202403255$FI-CHEPLA-2024011896$CHEPLAPHARM$$38$YR$$M$Y$$$20240923$$MD$COUNTRY NOT SPECIFIED$FI
243483401$24348340$1$I$20240101$20240918$20240923$20240923$EXP$$FR-DECIPHERA PHARMACEUTICALS LLC-2024FR000814$DECIPHERA PHARMACEUTICALS$$$$A$M$Y$92$KG$20240923$$PH$FR$FR
243483411$24348341$1$I$20240901$20240917$20240923$20240923$PER$$US-CHATTEMPRD-2024OHG032513$CHATTEM$$$$$M$Y$$$20240923$$CN$US$US
243483421$24348342$1$I$20240101$20240916$20240923$20240923$PER$$US-SA-2024SA269439$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240923$$HP$US$US
243483431$24348343$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270428$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240923$$HP$US$US
243483441$24348344$1$I$20230203$20240830$20240923$20240923$PER$$US-SA-2024SA272432$SANOFI AVENTIS$$28$YR$A$M$Y$90.71$KG$20240923$$MD$US$US
243483451$24348345$1$I$$20240913$20240923$20240923$EXP$DE-CADRBFARM-2024330342$DE-GLENMARK PHARMACEUTICALS-2024GMK094065$GLENMARK$$$$$$Y$$$20240923$$CN$DE$DE
243483461$24348346$1$I$$20240916$20240923$20240923$EXP$$CN-CHEPLA-2024012006$CHEPLAPHARM$Zhang Y, Yang J, Xie J. Torsade de Pointes Caused by a Compound Licorice Tablet. International Heart Journal Association. 2024;65(4):770-774. doi: 10.1536/ihj.23-609.$34$YR$$F$Y$$$20240923$$MD$COUNTRY NOT SPECIFIED$CN
243483471$24348347$1$I$$20240917$20240923$20240923$EXP$$US-JNJFOC-20240955281$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$MD$US$US
243483481$24348348$1$I$$20240916$20240923$20240923$EXP$NL-LRB-01003339$NL-ORGANON-O2409NLD001110$ORGANON$$66$YR$$F$Y$70$KG$20240923$$CN$NL$NL
243483491$24348349$1$I$$20240911$20240923$20240923$EXP$$US-Accord-446711$ACCORD$$$$$M$Y$$$20240923$$PH$US$US
243483501$24348350$1$I$$20240918$20240923$20240923$PER$$US-CHATTEMPRD-2024OHG032652$CHATTEM$$$$$F$Y$$$20240923$$CN$US$US
243483512$24348351$2$F$$20240920$20240923$20240930$PER$$US-AMGEN-USASP2024187869$AMGEN$$$$$F$Y$$$20240929$$CN$US$US
243483521$24348352$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024188037$AMGEN$$$$$M$Y$$$20240922$$HP$US$US
243483531$24348353$1$I$20240917$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187624$AMGEN$$65$YR$E$F$Y$$$20240922$$CN$US$US
243483541$24348354$1$I$$20240920$20240923$20240923$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052730$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240923$$MD$US$US
243483551$24348355$1$I$20240101$20240912$20240923$20240923$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000797$DECIPHERA PHARMACEUTICALS$$52$YR$A$F$Y$$$20240923$$CN$US$US
243483561$24348356$1$I$20240101$20240909$20240923$20240923$PER$$US-Encube-001324$ENCUBE ETHICALS$$$$$M$Y$$$20240920$$CN$US$
243483571$24348357$1$I$$20240920$20240923$20240923$PER$$US-JNJFOC-20240955206$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$US$US
243483591$24348359$1$I$20240821$20240904$20240923$20240923$PER$$FR-TOLMAR, INC.-24FR052049$TOLMAR$$71$YR$$M$Y$$$20240921$$HP$FR$FR
243483601$24348360$1$I$20240821$20240903$20240923$20240923$PER$$FR-TOLMAR, INC.-24FR052093$TOLMAR$$80$YR$$M$Y$$$20240921$$PH$FR$FR
243483611$24348361$1$I$20240823$20240903$20240923$20240923$PER$$FR-TOLMAR, INC.-24FR052123$TOLMAR$$$$$F$Y$$$20240921$$HP$FR$FR
243483621$24348362$1$I$$20240820$20240923$20240923$PER$$NL-TOLMAR, INC.-24NL052048$TOLMAR$$$$E$M$Y$$$20240921$$HP$NL$NL
243483631$24348363$1$I$20240821$20240821$20240923$20240923$PER$$CA-TOLMAR, INC.-24CA052585$TOLMAR$$83$YR$$M$Y$$$20240923$$CN$CA$CA
243483641$24348364$1$I$$20240918$20240923$20240923$PER$$US-ROCHE-10000086051$ROCHE$$64$YR$A$F$Y$$$20240923$$CN$US$US
243483651$24348365$1$I$20240914$20240917$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147988$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240923$$HP$US$US
243483661$24348366$1$I$20240917$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187871$AMGEN$$85$YR$E$M$Y$$$20240922$$CN$US$US
243483671$24348367$1$I$$20240918$20240923$20240923$EXP$$CA-TAKEDA-2023TUS108424$TAKEDA$$$$$M$Y$$$20240923$$CN$CA$CA
243483681$24348368$1$I$$20240910$20240923$20240923$EXP$$US-SPECGX-T202401459$SPECGX$Bio LL, Hiroshima L, Schwenk HT, Green S. Successful enteral administration of crushed posaconazole delayed-release tablets in children. Pediatric Blood + Cancer. 2024;71(2):1-5$11$MON$$F$Y$$$20240923$$HP$US$US
243483691$24348369$1$I$20240101$20240911$20240923$20240923$EXP$$CA-ABBVIE-5926158$ABBVIE$$$$A$F$Y$$$20240923$$CN$CA$CA
243483701$24348370$1$I$$20240916$20240923$20240923$EXP$$AU-JNJFOC-20240940733$JOHNSON AND JOHNSON$$21$YR$A$F$Y$60$KG$20240923$$MD$AU$AU
243483711$24348371$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5931043$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243483721$24348372$1$I$$20240910$20240923$20240923$EXP$$US-SPECGX-T202401876$SPECGX$Au-Yeung NM, Regennitter NS, Stepherson J, Seele J, Rosenblatt E, Carter W. Folate deficiency and medication-induced severe pancytopenia in a bilateral lung transplantee. Cureus. 2024;16(7)$74$YR$$M$Y$$$20240923$$HP$US$US
243483731$24348373$1$I$20240101$20240913$20240923$20240923$EXP$$CA-CELLTRION INC.-2024CA018567$CELLTRION$$$$$$Y$$$20240923$$MD$CA$CA
243483751$24348375$1$I$20240518$20240705$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-PR-REV-2024-000361$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$PR
243483761$24348376$1$I$20240101$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187948$AMGEN$$58$YR$A$F$Y$$$20240923$$HP$US$US
243483771$24348377$1$I$$20240910$20240923$20240923$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2024NBI09406$NEUROCRINE BIOSCIENCES$$72$YR$$M$Y$$$20240923$$MD$JP$JP
243483781$24348378$1$I$20240730$20240913$20240923$20240923$EXP$GB-MHRA-MED-202409121738305820-FBWNG$GB-AMAROX PHARMA-AMR2024GB03130$HETERO$$72$YR$$M$Y$$$20240923$$MD$GB$GB
243483791$24348379$1$I$20240906$20240909$20240923$20240923$EXP$$GB-ADVANZ PHARMA-202409007450$ADVANZ PHARMA$$$$$$Y$$$20240923$$MD$GB$GB
243483801$24348380$1$I$$20240917$20240923$20240923$EXP$$US-ABBVIE-5928301$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243483811$24348381$1$I$$20240902$20240923$20240923$30DAY$$AU-JNJFOC-20240903276$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$PH$AU$AU
243483821$24348382$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087921$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243483831$24348383$1$I$20240101$20240802$20240923$20240923$PER$$PR-REVANCE THERAPEUTICS INC.-PR-REV-2024-000443$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$PR$PR
243483841$24348384$1$I$20240701$20240914$20240923$20240923$PER$$US-SA-2024SA267453$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240923$$MD$US$US
243483851$24348385$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269680$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240923$$HP$US$US
243483861$24348386$1$I$$20240918$20240923$20240923$PER$$US-BIOGEN-2024BI01283270$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
243483871$24348387$1$I$$20240918$20240923$20240923$PER$$US-BIOGEN-2024BI01282605$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
243483881$24348388$1$I$20240101$20240916$20240923$20240923$PER$$US-SA-2024SA268560$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240923$$MD$US$US
243483891$24348389$1$I$20240829$20240913$20240923$20240923$PER$$US-SA-2024SA269009$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240923$$HP$US$US
243483901$24348390$1$I$$20240919$20240923$20240923$PER$$US-BIOGEN-2020BI00957075$BIOGEN$$$$$F$Y$$$20240923$$PH$US$US
243483911$24348391$1$I$$20240918$20240923$20240923$PER$$US-BIOGEN-2024BI01283319$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
243483921$24348392$1$I$$20240918$20240923$20240923$PER$$US-BIOGEN-2015BI060554$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
243483931$24348393$1$I$$20240916$20240923$20240923$EXP$$US-HALEON-2197336$Haleon PLC$$$$$$Y$$$20240921$$CN$US$US
243483941$24348394$1$I$$20240913$20240923$20240923$PER$$US-ABBVIE-5931855$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243483951$24348395$1$I$20240911$20240912$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409009256$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240923$$CN$US$US
243483961$24348396$1$I$$20240912$20240923$20240923$EXP$CA-MHPD-E2B_07220852$CA-Accord-447029$ACCORD$$68$YR$E$M$Y$$$20240923$$HP$CA$CA
243483971$24348397$1$I$20240901$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012837$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240923$$CN$US$US
243483981$24348398$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012727$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240923$$CN$US$US
243483991$24348399$1$I$20240906$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013427$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243484001$24348400$1$I$20240910$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010659$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240923$$CN$US$US
243484011$24348401$1$I$20240101$20240919$20240923$20240923$EXP$$US-ABBVIE-5932793$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243484021$24348402$1$I$$20240910$20240923$20240923$EXP$$US-SPECGX-T202401885$SPECGX$Bio LL, Hiroshima L, Schwenk HT, Green S. Successful enteral administration of crushed posaconazole delayed-release tablets in children. Pediatr Blood Cancer. 2024;71:1-5$7$YR$$M$Y$$$20240923$$HP$US$US
243484031$24348403$1$I$20230801$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148089$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$54.88$KG$20240923$$CN$US$US
243484041$24348404$1$I$20210912$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149441$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243484051$24348405$1$I$$20240827$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-043927$AUROBINDO$$73$YR$$F$Y$$$20240923$$CN$US$US
243484061$24348406$1$I$20240901$20240917$20240923$20240923$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-150044$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$64$KG$20240923$$MD$DE$DE
243484071$24348407$1$I$20240916$20240919$20240923$20240923$EXP$GB-MHRA-MED-202409171610203580-WKBCM$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-150025$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240923$$HP$GB$GB
243484091$24348409$1$I$$20240910$20240923$20240923$EXP$$US-SPECGX-T202401888$SPECGX$Bio LL, Hiroshima L, Schwenk HT, Green S. Successful enteral administration of crushed posaconazole delayed-release tablets in children. Pediatr Blood Cancer. 2024;71:1-5$15$YR$$M$Y$$$20240923$$HP$US$US
243484102$24348410$2$F$20240915$20240923$20240923$20240923$PER$$US-AMGEN-USASP2024188516$AMGEN$$68$YR$E$$Y$$$20240923$$CN$US$US
243484121$24348412$1$I$20240101$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186913$AMGEN$$$$A$$Y$$$20240923$$CN$US$US
243484131$24348413$1$I$20240806$20240918$20240923$20240923$EXP$FR-AFSSAPS-TS2024001013$FR-JNJFOC-20240959289$JOHNSON AND JOHNSON$$87$YR$E$M$Y$$$20240923$$PH$FR$FR
243484151$24348415$1$I$$20240910$20240923$20240923$EXP$$US-SPECGX-T202401900$SPECGX$Veet C, Vu N, Kohli A. Reversing opiates in a flash: Intranasal naloxone-induced noncardiogenic pulmonary edema. SGIM Forum. 2018;41:1-2$27$YR$$M$Y$$$20240923$$HP$US$US
243484171$24348417$1$I$$20240912$20240923$20240923$EXP$GB-MHRA-MED-202409121633045170-MFKQT$GB-Accord-446620$ACCORD$$$$$M$Y$$$20240923$$MD$GB$GB
243484181$24348418$1$I$20240828$20240913$20240923$20240923$EXP$$CA-CELLTRION INC.-2024CA022144$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
243484191$24348419$1$I$$20240916$20240923$20240923$PER$$US-ABBVIE-5926702$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243484201$24348420$1$I$20240806$20240909$20240923$20240923$PER$$US-IGSA-BIG0030700$GRIFOLS$$60$YR$$M$Y$93.424$KG$20240923$$CN$US$US
243484211$24348421$1$I$$20240801$20240923$20240923$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009881$STRIDES$Nguyen A, Norman M, O^reilly E, Robinson CL, Fonseca A, Madabhushi S, et al.. Case Series: Spinal Cord Stimulator Therapy Alleviates Neuropathic Pain in Patients with Failed Back Surgery Syndrome in the Setting of Spinal Cord Injury.. Pain-Med-Case-Rep. 2023;7 (7):337-340$50$YR$$M$Y$$$20240923$$MD$US$US
243484221$24348422$1$I$$20231004$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2023-061169$AUROBINDO$$$$$F$Y$$$20240923$$CN$US$US
243484232$24348423$2$F$$20240924$20240923$20240926$EXP$$NVSC2024GB188177$NOVARTIS$$$$$$Y$$$20240926$$MD$GB$GB
243484241$24348424$1$I$$20240909$20240923$20240923$EXP$$IT-AUROBINDO-AUR-APL-2024-044939$AUROBINDO$Picciolli I, Ratti A, Rinaldi B, Baban A, Iascone M, Francescato G, et al.. Biallelic NEXN variants and fetal onset dilated cardiomyopathy: two independent case reports and revision of literature. Italian Journal of Pediatrics. 2024;50(1):156$$$N$M$Y$3.2$KG$20240923$$MD$IT$IT
243484251$24348425$1$I$$20240613$20240923$20240923$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007221$STRIDES$Hirsch TI, Friedman R, Granoff M, Tsai LL, Critchlow JF, Sharma R, et al.. Omental vascularized lymph node transplant for the treatment of breast lymphedema: A case report.. Microsurgery. 2023;43 (4):387-391$48$YR$$F$Y$$$20240923$$MD$US$US
243484261$24348426$1$I$$20240710$20240923$20240923$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008712$STRIDES$Heard S, Lin J.. Systemic Allergic Reaction to a Spinal Cord Stimulator Trial: A Case Report. Pain-Med-Case-Rep. 2023;7 (3):121-124$52$YR$$F$Y$$$20240923$$HP$US$US
243484271$24348427$1$I$$20240710$20240923$20240923$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008739$STRIDES$Kraus MJ, Nguyen J.. Unilateral Anterior Spinal Artery Syndrome following Spinal Anesthesia for Cesarian Section: A Case Report.. Case-Rep-Neurol. 2024;16 (1):142-147.$38$YR$$F$Y$$$20240923$$HP$US$US
243484281$24348428$1$I$$20240913$20240923$20240923$EXP$$BR-CELLTRION INC.-2022BR014618$CELLTRION$$$$$$Y$$$20240923$$CN$BR$BR
243484291$24348429$1$I$$20240722$20240923$20240923$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009299$STRIDES$Pina FJR, Sottosanti E, Bulat E, Madabhushi S, Alrowaily F, Kollenburg L, et al.. Prior Hypermobile Spinal Cord Stimulator Removal With Difficult Reimplantation due to Epidural Scarring Provides Relief in Postlaminectomy Syndrome.. Pain-Med-Case-Rep. 2024;8 (2):61-64$$$$M$Y$$$20240923$$MD$US$US
243484301$24348430$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA269086$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240923$$HP$US$US
243484311$24348431$1$I$20240901$20240917$20240923$20240923$PER$$US-SA-2024SA270320$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240923$$HP$US$US
243484321$24348432$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270293$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240923$$HP$US$US
243484331$24348433$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270425$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240923$$HP$US$US
243484341$24348434$1$I$20240723$20240725$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-035974$AUROBINDO$$54$YR$$F$Y$76.204$KG$20240923$$CN$US$US
243484352$24348435$2$F$$20240918$20240923$20240924$PER$$NVSC2024US187376$NOVARTIS$$75$YR$$F$Y$$$20240924$$MD$US$US
243484361$24348436$1$I$$20240822$20240923$20240923$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010844$STRIDES$Shah T, Aboumerhi H.. Are New Diagnostic Criteria Needed? Diffuse Idiopathic Skeletal Hyperostosis Concealed by Cervical Radiculopathy: A Case Report. Pain-Med-Case-Rep. 2023;7 (3):139-142$52$YR$$M$Y$$$20240923$$MD$US$US
243484371$24348437$1$I$20230201$20231027$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2023-056398$AUROBINDO$$62$YR$$F$Y$64.41$KG$20240923$$CN$US$US
243484391$24348439$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150368$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240923$$CN$US$US
243484401$24348440$1$I$20240919$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149612$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$83.91$KG$20240923$$HP$US$US
243484411$24348441$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114362$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243484421$24348442$1$I$$20240909$20240923$20240923$EXP$$BE-AUROBINDO-AUR-APL-2024-045564$AUROBINDO$De Temmerman L, Ci?ek A, De Weweire M, De Backer H, Buyle M, Clement F. Thunderclap headache as a first manifestation  of acute disseminated encephalomyelitis: case  report and literature review. BMC Neurology. 2024;24(315):1-8$62$YR$$F$Y$$$20240923$$HP$BE$BE
243484431$24348443$1$I$20240820$20240913$20240923$20240923$EXP$$IT-HALEON-2197254$Haleon PLC$$68$YR$$F$Y$$$20240923$$MD$IT$IT
243484442$24348444$2$F$20240901$20240923$20240923$20240923$PER$$US-AMGEN-USASP2024188816$AMGEN$$67$YR$E$M$Y$$$20240923$$CN$US$US
243484451$24348445$1$I$$20231019$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2023-065292$AUROBINDO$$65$YR$$F$Y$52.163$KG$20240923$$CN$US$US
243484462$24348446$2$F$20240920$20240923$20240923$20240923$PER$$US-AMGEN-USASP2024188610$AMGEN$$82$YR$E$F$Y$$$20240923$$CN$US$US
243484491$24348449$1$I$$20240916$20240923$20240923$EXP$$US-JNJFOC-20240941817$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$US$US
243484501$24348450$1$I$20240901$20240918$20240923$20240923$EXP$$ES-AMGEN-ESPSP2024186428$AMGEN$$60$YR$A$M$Y$70$KG$20240923$$MD$ES$ES
243484511$24348451$1$I$20240101$20240910$20240923$20240923$PER$$US-TEVA-VS-3243396$TEVA$$74$YR$$F$Y$$$20240923$$CN$US$US
243484521$24348452$1$I$20240809$20240916$20240923$20240923$PER$$US-SA-2024SA269313$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240923$$MD$US$US
243484531$24348453$1$I$$20240829$20240923$20240923$PER$$US-SA-2024SA267715$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$MD$US$US
243484541$24348454$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270203$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240923$$HP$US$US
243484551$24348455$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270270$SANOFI AVENTIS$$$$T$M$Y$$$20240923$$HP$US$US
243484561$24348456$1$I$$20240830$20240923$20240923$PER$$US-SA-2024SA272132$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240923$$MD$US$US
243484571$24348457$1$I$20240901$20240918$20240923$20240923$PER$$US-SA-2024SA272037$SANOFI AVENTIS$$38$YR$A$F$Y$130$KG$20240923$$HP$US$US
243484591$24348459$1$I$$20231026$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2023-066701$AUROBINDO$$70$YR$$F$Y$90.7$KG$20240923$$CN$US$US
243484601$24348460$1$I$$20240912$20240923$20240923$EXP$$DE-ROCHE-10000081966$ROCHE$$70$YR$E$F$Y$$$20240923$$MD$DE$DE
243484611$24348461$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114363$GLAXOSMITHKLINE$$$$$M$Y$$$20240923$$CN$US$US
243484623$24348462$3$F$20240918$20240925$20240923$20240926$PER$$US-AMGEN-USASP2024188344$AMGEN$$44$YR$A$F$Y$$$20240926$$MD$US$US
243484631$24348463$1$I$20240918$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188258$AMGEN$$79$YR$E$F$Y$$$20240923$$CN$US$US
243484641$24348464$1$I$$20240913$20240923$20240923$EXP$$CA-EMD Serono-2024049490$EMD SERONO INC$$$$A$F$Y$$$20240923$$HP$CA$CA
243484651$24348465$1$I$$20231222$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2023-069064$AUROBINDO$$$$$$Y$$$20240923$$CN$US$US
243484661$24348466$1$I$$20240607$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000330$REVANCE THERAPEUTICS$Michael Lafkas, MD. Achieving Durable Forehead Line Outcomes With DaxibotulinumtoxinA: Early Experience in Real-World Clinical Practice. Aesthetic Surgery Journal Open Forum. 2024;6$$$$$Y$$$20240923$$MD$US$US
243484671$24348467$1$I$$20240918$20240923$20240923$EXP$$CN-JNJFOC-20240955804$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$CN$CN
243484681$24348468$1$I$$20231128$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2023-076931$AUROBINDO$$$$$F$Y$$$20240923$$CN$US$US
243484691$24348469$1$I$20240909$20240916$20240923$20240923$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001887$BLUEPRINT MEDICINES$$50$YR$A$M$Y$$$20240923$$CN$US$US
243484701$24348470$1$I$20240101$20240919$20240923$20240923$EXP$$FI-ABBVIE-5933116$ABBVIE$$48$YR$$F$Y$$$20240923$$MD$FI$FI
243484711$24348471$1$I$$20240914$20240923$20240923$EXP$$US-SA-2024SA272613$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240923$$CN$US$US
243484721$24348472$1$I$20240906$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024187092$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243484731$24348473$1$I$$20240911$20240923$20240923$EXP$$CA-APOTEX-2024AP010580$APOTEX$$$$E$M$Y$$$20240923$$HP$CA$CA
243484741$24348474$1$I$$20240909$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-044970$AUROBINDO$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al.. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum 2024;67no pagination. 2024;67$65$YR$$M$Y$$$20240923$$HP$US$US
243484751$24348475$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011734$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240923$$CN$US$US
243484761$24348476$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012877$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240923$$CN$US$US
243484771$24348477$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012008$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240923$$CN$US$US
243484781$24348478$1$I$$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013525$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240923$$CN$US$US
243484791$24348479$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011151$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240923$$CN$US$US
243484801$24348480$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012450$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240923$$CN$US$US
243484821$24348482$1$I$20240918$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012601$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240923$$CN$US$US
243484831$24348483$1$I$20240917$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010999$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240923$$CN$US$US
243484841$24348484$1$I$20240918$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012556$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240923$$CN$US$US
243484851$24348485$1$I$20240915$20240916$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010333$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240923$$CN$US$US
243484862$24348486$2$F$$20240925$20240923$20240930$EXP$$JP-ROCHE-10000083475$ROCHE$$$$E$$Y$$$20240929$$MD$JP$JP
243484871$24348487$1$I$$20240913$20240923$20240923$EXP$$JP-ROCHE-10000084920$ROCHE$$8$DEC$E$F$Y$$$20240923$$MD$JP$JP
243484881$24348488$1$I$$20240918$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024186063$AMGEN$$$$$$Y$$$20240923$$PH$JP$JP
243484891$24348489$1$I$$20240912$20240923$20240923$PER$$US-TEVA-VS-3243354$TEVA$$41$YR$$F$Y$$$20240923$$PH$US$US
243484901$24348490$1$I$20240620$20240913$20240923$20240923$PER$$US-SA-2024SA272205$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240923$$HP$US$US
243484911$24348491$1$I$20240901$20240917$20240923$20240923$PER$$US-SA-2024SA270311$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240923$$HP$US$US
243484921$24348492$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269722$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240923$$MD$US$US
243484931$24348493$1$I$20240101$20240916$20240923$20240923$PER$$US-SA-2024SA269460$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240923$$HP$US$US
243484941$24348494$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270064$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240923$$HP$US$US
243484951$24348495$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269724$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240923$$HP$US$US
243484961$24348496$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270262$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240923$$HP$US$US
243484971$24348497$1$I$$20240607$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000331$REVANCE THERAPEUTICS$Michael Lafkas, MD. Achieving Durable Forehead Line Outcomes With DaxibotulinumtoxinA: Early Experience in Real-World Clinical Practice. Aesthetic Surgery Journal Open Forum. 2024;6$$$$$Y$$$20240923$$MD$US$US
243484981$24348498$1$I$$20231218$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2023-080003$AUROBINDO$$$$$$Y$$$20240923$$CN$US$US
243484991$24348499$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148783$BRISTOL MYERS SQUIBB$Adkins K, Williams RJ, Esteso P, Kobayashi R, Gauvreau K, VanderPluym C, et al. Real-world use and outcomes of apixaban for early post-surgical fontan thromboprophylaxis. Pediatric Cardiology. 2024 Sep 12;doi:10.1007/s00246-024-03641-3.$$$C$$Y$$$20240923$$HP$US$US
243485001$24348500$1$I$20230916$20240105$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-001645$AUROBINDO$$53$YR$$F$Y$71.66$KG$20240923$$CN$US$US
243485021$24348502$1$I$$20240913$20240923$20240923$EXP$$DE-EMD Serono-2024049484$EMD SERONO INC$$43$YR$A$M$Y$$$20240923$$CN$DE$DE
243485031$24348503$1$I$$20240909$20240923$20240923$EXP$$NL-AUROBINDO-AUR-APL-2024-045127$AUROBINDO$Rossel CAJ, Hendrickx APA, van Alphen LB, van der HorstRPJ, Janssen AHJW, Kooyman CC, et al. Tracing the origin of NDM-1-producing and extensively drug-resistant Pseudomonas aeruginosa ST357 in the Netherlands. BMC Infectious Diseases. 2024;24(1):817$$$$$Y$$$20240923$$HP$NL$NL
243485051$24348505$1$I$$20240916$20240923$20240923$EXP$$US-JNJFOC-20240943661$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20240923$$CN$US$US
243485061$24348506$1$I$$20240917$20240923$20240923$EXP$$CO-AMGEN-COLSL2024186934$AMGEN$$50$YR$A$F$Y$$$20240923$$CN$CO$CO
243485071$24348507$1$I$20240217$20240312$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-012888$AUROBINDO$$69$YR$$F$Y$58.9$KG$20240923$$CN$US$US
243485081$24348508$1$I$$20240918$20240923$20240923$EXP$$US-SA-2024SA270869$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240923$$MD$US$US
243485091$24348509$1$I$20240901$20240918$20240923$20240923$EXP$$US-SA-2024SA271354$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240923$$CN$US$US
243485101$24348510$1$I$$20240607$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000332$REVANCE THERAPEUTICS$Michael Lafkas, MD. Achieving Durable Forehead Line Outcomes With DaxibotulinumtoxinA: Early Experience in Real-World Clinical Practice. Aesthetic Surgery Journal Open Forum. 2024;6$$$$$Y$$$20240923$$MD$US$US
243485111$24348511$1$I$20240101$20240919$20240923$20240923$EXP$$US-SA-2024SA272735$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240923$$MD$US$US
243485121$24348512$1$I$$20240909$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045175$AUROBINDO$Lee JZ, Tan MC, Karikalan S, Deshmukh AJ, Srivathsan K, Shen WK, et al.. Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction. JACC: CLINICAL ELECTROPHYSIOLOGY. 2023;9(6):824-832$70$YR$$F$Y$$$20240923$$MD$US$US
243485131$24348513$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114162$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243485141$24348514$1$I$$20240909$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-046745$AUROBINDO$Gangat N, Ajufo H, Abdelmagid M, Karrar O, McCullough K, Badar T, et al.. IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience.. Br-J-Haematol. 2023;203(3):e87-e92$$$$M$Y$$$20240923$$HP$US$US
243485151$24348515$1$I$$20240416$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-020475$AUROBINDO$$72$YR$$F$Y$63.5$KG$20240923$$CN$US$US
243485162$24348516$2$F$20240426$20240913$20240923$20240925$EXP$$US-UCBSA-2024021211$UCB$$2$YR$$F$Y$11.5$KG$20240925$$CN$US$US
243485171$24348517$1$I$$20240919$20240923$20240923$EXP$CA-MHPD-E2B_07214923$CA-Accord-447560$ACCORD$$4$YR$C$F$Y$20$KG$20240923$$HP$CA$CA
243485181$24348518$1$I$$20240903$20240923$20240923$PER$$US-TEVA-VS-3241341$TEVA$$54$YR$$F$Y$$$20240923$$CN$US$US
243485191$24348519$1$I$20240423$20240508$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-023893$AUROBINDO$$36$YR$$F$Y$41.276$KG$20240923$$CN$US$US
243485211$24348521$1$I$$20240916$20240923$20240923$PER$$US-BIOCON-BCN-2024-000191$BIOCON$$$$$M$Y$$$20240923$$CN$US$US
243485231$24348523$1$I$20240101$20240611$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000338$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243485241$24348524$1$I$$20240712$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-026538$AUROBINDO$$$$$F$Y$$$20240923$$CN$US$US
243485251$24348525$1$I$$20240910$20240923$20240923$EXP$$IN-AUROBINDO-AUR-APL-2024-045672$AUROBINDO$Mukartihal R, Das R, Krishna B, Patil S. Aspergillus hip arthritis in COVID-19 era: Two case reports. J-Arthrosc-Joint-Surg. 2023;10(1):29-35$74$YR$$M$Y$$$20240923$$HP$IN$IN
243485261$24348526$1$I$$20240916$20240923$20240923$PER$$US-JNJFOC-20240943725$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240923$$CN$US$US
243485271$24348527$1$I$$20240910$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045657$AUROBINDO$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients.. J-Am-Acad-Dermatol. 2024;90(3):642-644$56$YR$$F$Y$$$20240923$$MD$US$US
243485281$24348528$1$I$20230320$20240923$20240923$20240923$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-088842$REGENERON$$$$$M$Y$$$20240923$$CN$CA$CA
243485291$24348529$1$I$20240501$20240912$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145894$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240923$$CN$US$US
243485312$24348531$2$F$$20240918$20240923$20240924$EXP$$IR-MSNLABS-2024MSNLIT01971$MSN LABORATORIES$Atapour A, Momenzadeh M, Panahishokouh M, Badri S.Rosuvastatin-Induced Rhabdomyolysis as a Result of Drug Interaction With Sitagliptin: A Case Report.Clinical Medicine Insights Case Reports.2024;17:1-4$$$$$Y$$$20240924$$PH$IR$IR
243485321$24348532$1$I$$20240917$20240923$20240923$PER$$US-ABBVIE-5931342$ABBVIE$$$$$$Y$$$20240923$$HP$US$US
243485351$24348535$1$I$$20240727$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024188494$AMGEN$$83$YR$E$M$Y$$$20240923$$MD$JP$JP
243485362$24348536$2$F$20240801$20240919$20240923$20240925$PER$$US-AMGEN-USASP2024188124$AMGEN$$73$YR$E$F$Y$$$20240925$$HP$US$US
243485371$24348537$1$I$20230515$20240913$20240923$20240923$EXP$AT-BASGAGES-2023-003609$AT-CELLTRION INC.-2024AT022411$CELLTRION$$$$$$Y$$$20240923$$PH$AT$AT
243485381$24348538$1$I$20240518$20240617$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000339$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
243485391$24348539$1$I$$20240910$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045648$AUROBINDO$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW.. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients.. J-Am-Acad-Dermatol. 2024;90(3):642-644$68$YR$$F$Y$$$20240923$$MD$US$US
243485401$24348540$1$I$$20240913$20240923$20240923$PER$$US-APOTEX-2024AP011106$APOTEX$Stimpfl JN, Soe KC.. Transdermal Asenapine for Agitation and Irritability in a Child With Complete Intravenous Dependence. Journal of the American Academy of Child + Adolescent Psychiatry. 2024;0 (0):1-3$5$YR$$M$Y$25$KG$20240923$$MD$US$US
243485411$24348541$1$I$$20240911$20240923$20240923$PER$$US-ASTELLAS-2024-AER-006838$ASTELLAS$$$$$M$Y$$$20240923$$MD$US$US
243485421$24348542$1$I$$20240920$20240923$20240923$PER$$US-ABBVIE-5933957$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243485432$24348543$2$F$20230101$20240918$20240923$20240923$PER$$US-ROCHE-10000086279$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243485442$24348544$2$F$$20240918$20240923$20240928$EXP$$US-AUROBINDO-AUR-APL-2024-044545$AUROBINDO$Crystal B Chen, Marwan Badri, Erik Kelly. Case report: dyslipidaemia-dramatic increase in haemoglobin A1c following statin initiation. European Heart Journal. 2024;8:436$52$YR$$M$Y$$$20240928$$MD$US$US
243485451$24348545$1$I$20240501$20240626$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000343$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243485462$24348546$2$F$20240920$20240923$20240923$20240923$PER$$US-AMGEN-USASP2024188500$AMGEN$$70$YR$E$M$Y$$$20240923$$CN$US$US
243485481$24348548$1$I$$20240910$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045165$AUROBINDO$Au-Yeung NM, Regennitter NS, Stepherson J, Seele J, Rosenblatt E, Carter W. Folate Deficiency and Medication-Induced Severe Pancytopenia in a Bilateral Lung Transplantee. Cureus. 2024;16(7):e65780$74$YR$$M$Y$$$20240923$$MD$US$US
243485491$24348549$1$I$$20240910$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045174$AUROBINDO$Purt B, Nugent A, Wu PS, Paulus YM. Sub-tenon triamcinolone and anti-HIV medication-induced Cushing syndrome.. JAMA ophthalmology. 2024$82$YR$$M$Y$$$20240923$$MD$US$US
243485511$24348551$1$I$$20240910$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045215$AUROBINDO$Desai AV, Naranjo A, Barre BL, Goldsmith KC, Granger MP, States L, et al. A pilot study of postconsolidation chemoimmunotherapy for high-risk neuroblastoma (ANBL19P1): A report from the Children^s Oncology Group. J-Clin-Oncol. 2024;42 (Suppl.) 16$$$C$$Y$$$20240923$$HP$US$US
243485522$24348552$2$F$$20240926$20240923$20240928$EXP$$CA-JNJFOC-20240947652$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240928$$PH$CA$CA
243485531$24348553$1$I$20240523$20240614$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000344$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243485541$24348554$1$I$$20240912$20240923$20240923$EXP$$US-Accord-446965$ACCORD$$$$$F$Y$75.3$KG$20240923$$HP$US$US
243485551$24348555$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011775$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240923$$CN$US$US
243485561$24348556$1$I$20240731$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012449$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240923$$CN$US$US
243485572$24348557$2$F$$20240916$20240923$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409009141$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243485581$24348558$1$I$20240101$20240919$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149651$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240923$$HP$US$US
243485591$24348559$1$I$20240101$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150067$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240923$$CN$US$US
243485601$24348560$1$I$20240906$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188827$AMGEN$$$$E$F$Y$$$20240923$$CN$US$US
243485611$24348561$1$I$$20240911$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-136926$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240923$$CN$US$US
243485621$24348562$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188358$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243485631$24348563$1$I$$20240913$20240923$20240923$EXP$$ES-AUROBINDO-AUR-APL-2024-046443$AUROBINDO$Albert-Lopez E, Villafranca CM, Acosta AR, Benayas IB, Montiel EDC... Checkpoint inhibitors, a milestone. But what about complications?. European Journal of Case Reports in Internal Medicine. 2024;V11Sup1:988$52$YR$$M$Y$$$20240923$$HP$ES$ES
243485641$24348564$1$I$20240819$20240920$20240923$20240923$EXP$FR-AFSSAPS-MP2024001359$FR-HALEON-2197874$Haleon PLC$$50$YR$$F$Y$72$KG$20240922$$HP$FR$FR
243485651$24348565$1$I$$20240912$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024188591$AMGEN$$$$$$Y$$$20240923$$PH$JP$JP
243485661$24348566$1$I$20220331$20240917$20240923$20240923$EXP$$NL-AMGEN-NLDSP2024185564$AMGEN$$51$YR$A$F$Y$$$20240923$$MD$NL$NL
243485671$24348567$1$I$$20240912$20240923$20240923$PER$$US-ROCHE-10000081188$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
243485681$24348568$1$I$20240904$20240912$20240923$20240923$PER$$US-JNJFOC-20240939621$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240923$$HP$US$US
243485691$24348569$1$I$20230119$20240909$20240923$20240923$EXP$FR-AFSSAPS-PC2024000681$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-08544$HIKMA$$52$YR$$F$Y$83$KG$20240923$$PH$FR$FR
243485701$24348570$1$I$20240501$20240614$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000345$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243485721$24348572$1$I$$20240919$20240923$20240923$PER$$US-ABBVIE-5932804$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243485731$24348573$1$I$20240901$20240918$20240923$20240923$PER$$US-ABBVIE-5930132$ABBVIE$$$$$F$Y$$$20240923$$HP$US$US
243485741$24348574$1$I$$20240912$20240923$20240923$PER$$US-ABBVIE-5924865$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243485772$24348577$2$F$20240913$20240926$20240923$20240930$EXP$$CN-SA-2024SA269558$SANOFI AVENTIS$$64$YR$A$M$Y$73.5$KG$20240930$$CN$CN$CN
243485781$24348578$1$I$20240612$20240620$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000349$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$CN$US$US
243485791$24348579$1$I$$20240919$20240923$20240923$EXP$CA-MHPD-E2B_07214930$CA-Accord-447565$ACCORD$$$$$F$Y$7$KG$20240923$$HP$CA$CA
243485801$24348580$1$I$$20240916$20240923$20240923$EXP$$US-JNJFOC-20240944350$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243485811$24348581$1$I$20240718$20240912$20240923$20240923$EXP$FR-AFSSAPS-RN2024000943$FR-Accord-446843$ACCORD$$74$YR$E$F$Y$60$KG$20240923$$MD$FR$FR
243485821$24348582$1$I$$20240911$20240923$20240923$EXP$$GR-HALEON-2196538$Haleon PLC$Kalfoutzou A, Petroulakis P, Tsiouri E, Fafoutis T, Mylonakis A, Dimitrakoudi M, et al. Ibuprofen: The Hidden Culprit Behind Aseptic Meningitis. Cureus. 2024;16(8): e65936. DOI: 10.7759/cureus.65936$54$YR$$M$Y$$$20240921$$HP$GR$GR
243485831$24348583$1$I$$20240827$20240923$20240923$PER$$US-SA-2024SA266874$SANOFI AVENTIS$$$$A$F$Y$74.55$KG$20240923$$MD$US$US
243485841$24348584$1$I$20240801$20240828$20240923$20240923$PER$$US-SA-2021SA041289$SANOFI AVENTIS$$73$YR$E$F$Y$65.91$KG$20240923$$MD$US$US
243485851$24348585$1$I$20180101$20240913$20240923$20240923$EXP$$IT-EMD Serono-9062738$EMD SERONO INC$$59$YR$A$M$Y$119$KG$20240923$$MD$IT$IT
243485861$24348586$1$I$20240101$20240830$20240923$20240923$PER$$US-SA-2024SA272672$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240923$$CN$US$US
243485871$24348587$1$I$$20240829$20240923$20240923$PER$$US-SA-2024SA266771$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$MD$US$US
243485881$24348588$1$I$20240606$20240618$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000351$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243485891$24348589$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASL2024186906$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243485901$24348590$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA272508$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240923$$MD$US$US
243485911$24348591$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA271000$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240923$$MD$US$US
243485921$24348592$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA272467$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240923$$CN$US$US
243485941$24348594$1$I$$20240906$20240923$20240923$PER$$US-SA-2024SA266205$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240923$$HP$US$US
243485951$24348595$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA270989$SANOFI AVENTIS$$$$$$Y$$$20240923$$CN$US$US
243485961$24348596$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA273514$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240923$$CN$US$US
243485971$24348597$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA273625$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240923$$CN$US$US
243485981$24348598$1$I$20240801$20240903$20240923$20240923$PER$$PR-SA-2024SA272167$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240923$$MD$PR$PR
243485991$24348599$1$I$20240909$20240909$20240923$20240923$PER$$US-SA-2024SA272648$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240923$$CN$US$US
243486001$24348600$1$I$20240812$20240909$20240923$20240923$EXP$$CN-AMGEN-CHNSP2024186216$AMGEN$$30$YR$A$M$Y$$$20240923$$HP$CN$CN
243486012$24348601$2$F$20240910$20240923$20240923$20240924$PER$$US-AMGEN-USASP2024188811$AMGEN$$72$YR$E$F$Y$$$20240923$$CN$US$US
243486021$24348602$1$I$$20240829$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005108$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243486031$24348603$1$I$20240905$20240911$20240923$20240923$EXP$$US-BEH-2024178724$CSL BEHRING$$60$YR$A$F$Y$$$20240923$$HP$US$US
243486041$24348604$1$I$$20240913$20240923$20240923$PER$$US-SA-2024SA268038$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240923$$MD$US$US
243486051$24348605$1$I$$20240830$20240923$20240923$PER$$US-SA-2024SA272178$SANOFI AVENTIS$$$$E$M$Y$72.27$KG$20240923$$MD$US$US
243486061$24348606$1$I$$20240912$20240923$20240923$PER$$US-SA-2024SA155417$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240923$$MD$US$US
243486071$24348607$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268479$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240923$$HP$US$US
243486081$24348608$1$I$20221201$20240912$20240923$20240923$PER$$US-SA-2024SA272151$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240923$$HP$US$US
243486091$24348609$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA273036$SANOFI AVENTIS$$$$A$F$Y$64.55$KG$20240923$$MD$US$US
243486101$24348610$1$I$$20240913$20240923$20240923$PER$$US-SA-2024SA269074$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240923$$HP$US$US
243486111$24348611$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269769$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240923$$HP$US$US
243486121$24348612$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270601$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240923$$HP$US$US
243486131$24348613$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA272475$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240923$$CN$US$US
243486141$24348614$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268731$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240923$$CN$US$US
243486151$24348615$1$I$20240101$20240916$20240923$20240923$PER$$US-SA-2024SA269663$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240923$$HP$US$US
243486161$24348616$1$I$20240807$20240912$20240923$20240923$EXP$$ES-TERSERA THERAPEUTICS LLC-2024TRS004788$TERSERA THERAPEUTICS$$$$$$Y$$$20240923$$MD$ES$ES
243486172$24348617$2$F$$20240920$20240923$20240927$EXP$$GB-JNJFOC-20240954716$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240927$$CN$GB$GB
243486181$24348618$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270148$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240923$$HP$US$US
243486191$24348619$1$I$20160101$20240917$20240923$20240923$EXP$$US-BIOGEN-2024BI01283248$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
243486211$24348621$1$I$$20240912$20240923$20240923$EXP$$US-ORGANON-O2409USA000925$ORGANON$$$$$$Y$$$20240923$$CN$US$US
243486221$24348622$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270146$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240923$$MD$US$US
243486231$24348623$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA269473$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240923$$HP$US$US
243486241$24348624$1$I$20240101$20240917$20240923$20240923$PER$$US-SA-2024SA269775$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240923$$MD$US$US
243486251$24348625$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005148$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243486261$24348626$1$I$$20240911$20240923$20240923$EXP$$FR-TAKEDA-2024TUS092741$TAKEDA$$$$E$F$Y$$$20240923$$CN$FR$FR
243486271$24348627$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004453$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243486281$24348628$1$I$$20240917$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148246$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240923$$CN$US$US
243486291$24348629$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149905$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240923$$HP$US$US
243486301$24348630$1$I$$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024187122$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243486311$24348631$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114346$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243486321$24348632$1$I$$20240913$20240923$20240923$EXP$FR-AFSSAPS-PC2024000698$FR-TEVA-VS-3243575$TEVA$$74$YR$$M$Y$78$KG$20240923$$PH$FR$FR
243486332$24348633$2$F$$20240917$20240923$20240927$EXP$$DE-AUROBINDO-AUR-APL-2024-045681$AUROBINDO$Winter Y, Abou Dargham R, Patino Tobon S, Groppa S, Fuest S. Cenobamate as an Early Adjunctive Treatment in Drug-Resistant Focal-Onset Seizures: An Observational Cohort Study. CNSDrugs. 2024;38(9):733-742$$$$$Y$$$20240927$$HP$DE$DE
243486341$24348634$1$I$20240429$20240619$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000353$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243486351$24348635$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005149$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243486361$24348636$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005189$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243486371$24348637$1$I$$20240913$20240923$20240923$EXP$$IT-TAKEDA-2024TUS093716$TAKEDA$$23$YR$$F$Y$$$20240923$$MD$IT$IT
243486381$24348638$1$I$$20240919$20240923$20240923$PER$$US-ABBVIE-5932968$ABBVIE$$$$$$Y$$$20240923$$MD$US$US
243486391$24348639$1$I$20240913$20240913$20240923$20240923$PER$$US-TRIS PHARMA, INC.-24US011642$TRIS PHARM$$$$$$Y$$$20240923$$CN$US$US
243486401$24348640$1$I$20240910$20240910$20240923$20240923$PER$$US-TRIS PHARMA, INC.-24US011639$TRIS PHARM$$$$$$Y$$$20240923$$CN$US$US
243486411$24348641$1$I$20240824$20240912$20240923$20240923$PER$$US-ABBVIE-5922844$ABBVIE$$25$YR$$F$Y$59$KG$20240923$$CN$US$US
243486421$24348642$1$I$$20240905$20240923$20240923$PER$$US-JNJFOC-20240912867$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$US$US
243486431$24348643$1$I$20240904$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187840$AMGEN$$53$YR$A$F$Y$$$20240923$$CN$US$US
243486451$24348645$1$I$20240830$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012504$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240923$$CN$US$US
243486461$24348646$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012754$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240923$$CN$US$US
243486471$24348647$1$I$20240720$20240911$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045955$AUROBINDO$$80$YR$$F$Y$70.5$KG$20240923$$MD$FR$FR
243486481$24348648$1$I$$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013479$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240923$$CN$US$US
243486491$24348649$1$I$$20240911$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409008250$ELI LILLY AND CO$$62$YR$A$$Y$$$20240923$$LW$US$US
243486501$24348650$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012799$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243486511$24348651$1$I$20240601$20240624$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000357$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
243486521$24348652$1$I$20240801$20240912$20240923$20240923$EXP$FR-AFSSAPS-PB2024000991$FR-ASTELLAS-2024-AER-006828$ASTELLAS$$87$YR$E$M$Y$68$KG$20240923$$MD$FR$FR
243486531$24348653$1$I$19700101$20240916$20240923$20240923$EXP$$US-CHATTEMPRD-2024OHG032334$CHATTEM$$$$C$M$Y$$$20240923$$LW$US$US
243486551$24348655$1$I$$20240910$20240923$20240923$PER$$US-JNJFOC-20240937843$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$PH$US$US
243486561$24348656$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005150$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243486571$24348657$1$I$20240419$20240626$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000358$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243486581$24348658$1$I$20240227$20240916$20240923$20240923$EXP$$US-CHATTEMPRD-2024OHG032244$CHATTEM$$55$YR$A$F$Y$$$20240923$$LW$US$US
243486591$24348659$1$I$20240705$20240911$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045875$AUROBINDO$$53$YR$$M$Y$104$KG$20240923$$MD$FR$FR
243486601$24348660$1$I$20240801$20240912$20240923$20240923$PER$$US-SA-2024SA211803$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240923$$MD$US$US
243486611$24348661$1$I$$20240918$20240923$20240923$EXP$$US-HALEON-2197662$Haleon PLC$$60$YR$$M$Y$92.1$KG$20240923$$HP$US$US
243486621$24348662$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010605$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243486631$24348663$1$I$20230910$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149419$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243486641$24348664$1$I$20210301$20240911$20240923$20240923$EXP$$RO-AUROBINDO-AUR-APL-2024-045978$AUROBINDO$$79$YR$$M$Y$$$20240923$$MD$RO$RO
243486651$24348665$1$I$$20240919$20240923$20240923$EXP$CA-MHPD-E2B_07214925$CA-Accord-447562$ACCORD$$14$YR$T$M$Y$19$KG$20240923$$HP$CA$CA
243486661$24348666$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187649$AMGEN$Yannuzzi N. A.; Shaheen A.; Ashkenazy N. et al.. Faricimab in Previously Treated Eyes With Neovascular Age-Related Macular Degeneration: An Assessment of Durability and Treatment Outcomes. Ophthalmic Surgery, Lasers, and Imaging Retina. 2024;55 (9):504-509$$$$$Y$$$20240923$$MD$US$US
243486672$24348667$2$F$20240101$20240920$20240923$20240927$EXP$$US-ABBVIE-5927392$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243486681$24348668$1$I$20240101$20240917$20240923$20240923$EXP$$CA-ABBVIE-5930074$ABBVIE$$$$A$F$Y$$$20240923$$CN$CA$CA
243486691$24348669$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5930057$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243486701$24348670$1$I$20240603$20240626$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000362$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
243486711$24348671$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010615$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243486721$24348672$1$I$$20240911$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045827$AUROBINDO$Ikic A, Chatelus E, Epailly E, Kremer H, Sibilia J, Gottenberg J, et al.. Heart transplantation in 6 patients with systemic sclerosis and a primary cardiac involvement.. DEFAULT RECORD. 2014;1$$$$F$Y$$$20240923$$HP$FR$FR
243486731$24348673$1$I$20240622$20240801$20240923$20240923$EXP$$US-Accord-433221$ACCORD$$70$YR$E$F$Y$86.8$KG$20240923$$HP$US$US
243486741$24348674$1$I$$20240911$20240923$20240923$EXP$$PT-AUROBINDO-AUR-APL-2024-045843$AUROBINDO$Dias, L.. EP-062 - ENCEPHALITIS: A DOUBLE-EDGED SWORD. National Congress of Neurology - 2022.. E-Posters. Synapse. 23(Suppl 1). 2023;1$$$$M$Y$$$20240923$$HP$PT$PT
243486751$24348675$1$I$20240601$20240919$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150293$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240923$$CN$US$US
243486761$24348676$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150061$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240923$$CN$US$US
243486771$24348677$1$I$$20240912$20240923$20240923$PER$$US-ABBVIE-5923553$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243486781$24348678$1$I$$20240916$20240923$20240923$EXP$$NVSC2024CA176565$NOVARTIS$$$$$F$Y$$$20240923$$CN$CA$CA
243486791$24348679$1$I$20240528$20240626$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000363$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243486801$24348680$1$I$20240910$20240911$20240923$20240923$EXP$$FR-GILEAD-2024-0687429$GILEAD$$$$$F$Y$$$20240923$$MD$FR$FR
243486811$24348681$1$I$$20240909$20240923$20240923$PER$$US-APOTEX-2024AP010616$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240923$$HP$US$US
243486821$24348682$1$I$20240312$20240912$20240923$20240923$EXP$FR-AFSSAPS-DJ2024001012$FR-Accord-446867$ACCORD$$59$YR$A$F$Y$65$KG$20240923$$MD$FR$FR
243486831$24348683$1$I$20240418$20240626$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000364$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243486841$24348684$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5931289$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243486851$24348685$1$I$20240401$20240918$20240923$20240923$EXP$$CA-ABBVIE-5930999$ABBVIE$$70$YR$$M$Y$$$20240923$$CN$CA$CA
243486862$24348686$2$F$20230401$20240919$20240923$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-045870$AUROBINDO$$15$YR$$F$Y$53$KG$20240927$$MD$FR$FR
243486871$24348687$1$I$$20240917$20240923$20240923$EXP$CA-DRL-USA-SPO/CAN/24/0013678$CA-RDY-SPO/CAN/24/0013678$DR REDDYS$$54$YR$A$M$Y$$$20240923$$CN$CA$CA
243486891$24348689$1$I$20240609$20240626$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000366$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243486901$24348690$1$I$$20240912$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024188289$AMGEN$$$$$$Y$$$20240923$$MD$JP$JP
243486911$24348691$1$I$$20240913$20240923$20240923$EXP$$NL-AMGEN-NLDSP2024184014$AMGEN$Von Dem Borne P.A.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$E$$Y$$$20240923$$HP$NL$NL
243486921$24348692$1$I$20240101$20240917$20240923$20240923$EXP$$US-009507513-2409USA006357$MERCK$$$$$F$Y$$$20240923$$MD$US$US
243486931$24348693$1$I$20240827$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005157$ACADIA PHARMACEUTICALS$$86$YR$$F$Y$$$20240923$$CN$US$US
243486941$24348694$1$I$20240903$20240903$20240923$20240923$EXP$$US-SA-2024SA272116$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240923$$MD$US$US
243486951$24348695$1$I$$20240916$20240923$20240923$EXP$CA-NEBO-670086$CA-NEBO-670086$PHARMACOSMOS$$50$YR$$F$Y$73$KG$20240923$$HP$CA$CA
243486962$24348696$2$F$$20240924$20240923$20240925$PER$$US-JNJFOC-20240945818$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243486971$24348697$1$I$$20240912$20240923$20240923$PER$$US-Encube-001334$ENCUBE ETHICALS$$$$$M$Y$$$20240920$$CN$US$
243486981$24348698$1$I$$20240829$20240923$20240923$PER$$US-SA-2024SA270819$SANOFI AVENTIS$$$$E$F$Y$$$20240923$$HP$US$US
243486991$24348699$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA272454$SANOFI AVENTIS$$5$YR$C$M$Y$22.73$KG$20240923$$HP$US$US
243487001$24348700$1$I$20240628$20240628$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000369$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243487011$24348701$1$I$$20240919$20240923$20240923$EXP$$US-ABBVIE-5931110$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243487021$24348702$1$I$20240901$20240916$20240923$20240923$PER$$US-SA-2024SA269157$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240923$$HP$US$US
243487051$24348705$1$I$20240914$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011697$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240923$$CN$US$US
243487061$24348706$1$I$$20240916$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010673$ELI LILLY AND CO$$$$A$F$Y$$$20240923$$CN$US$US
243487071$24348707$1$I$20240715$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012528$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240923$$CN$US$US
243487081$24348708$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012657$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240923$$CN$US$US
243487091$24348709$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012459$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243487101$24348710$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011920$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240923$$CN$US$US
243487111$24348711$1$I$20240918$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012045$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240923$$CN$US$US
243487121$24348712$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011806$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240923$$CN$US$US
243487131$24348713$1$I$20240202$20240919$20240923$20240923$EXP$$US-ABBVIE-5931175$ABBVIE$$32$YR$$F$Y$$$20240923$$CN$US$US
243487141$24348714$1$I$$20240919$20240923$20240923$EXP$CA-MHPD-E2B_07215495$CA-Accord-447576$ACCORD$$6$YR$C$M$Y$22$KG$20240923$$HP$CA$CA
243487151$24348715$1$I$$20240909$20240923$20240923$EXP$$IT-AUROBINDO-AUR-APL-2024-045199$AUROBINDO$De Nigris A, Arenella M, Di Nardo G, Marco GMD, Mormile A, Lauretta D, et al. The diagnostic and therapeutic challenge of atrial flutter in children: a case report. Italian Journal of Pediatrics. 2023;49 (137):1-5$11$YR$$M$Y$$$20240923$$HP$IT$IT
243487161$24348716$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000086578$ROCHE$$73$YR$E$F$Y$$$20240923$$HP$US$US
243487171$24348717$1$I$20240826$20240913$20240923$20240923$EXP$$CA-ROCHE-10000086514$ROCHE$$49$YR$A$F$Y$$$20240923$$CN$CA$CA
243487181$24348718$1$I$$20240918$20240923$20240923$EXP$$US-HALEON-2197848$Haleon PLC$$$$E$M$Y$$$20240921$$CN$US$US
243487191$24348719$1$I$20230510$20240913$20240923$20240923$EXP$FR-AFSSAPS-LY2023000836$FR-CELLTRION INC.-2024FR022388$CELLTRION$$$$$$Y$$$20240923$$PH$FR$FR
243487201$24348720$1$I$$20240910$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045644$AUROBINDO$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. et all.. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients.. J-Am-Acad-Dermatol. 2024;90(3):642-644$52$YR$$F$Y$$$20240923$$MD$US$US
243487211$24348721$1$I$20130314$20240913$20240923$20240923$EXP$$US-JNJFOC-20240937579$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240923$$HP$US$US
243487221$24348722$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150089$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240923$$CN$US$US
243487231$24348723$1$I$$20240915$20240923$20240923$EXP$$US-JNJFOC-20240952296$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240923$$HP$US$US
243487241$24348724$1$I$$20240912$20240923$20240923$EXP$$US-JNJFOC-20240931913$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$CN$US$US
243487251$24348725$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150105$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240923$$CN$US$US
243487261$24348726$1$I$20240627$20240628$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000371$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243487271$24348727$1$I$20230720$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149478$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243487281$24348728$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114347$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$HP$US$US
243487291$24348729$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114159$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240923$$CN$US$US
243487302$24348730$2$F$20240101$20240920$20240923$20240930$EXP$$CA-CELLTRION INC.-2024CA015227$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
243487311$24348731$1$I$$20240912$20240923$20240923$EXP$$CA-APOTEX-2024AP010649$APOTEX$$69$YR$$F$Y$$$20240923$$HP$CA$CA
243487321$24348732$1$I$$20240911$20240923$20240923$EXP$$CA-APOTEX-2024AP010529$APOTEX$$5$DEC$$F$Y$$$20240923$$CN$CA$CA
243487331$24348733$1$I$20190201$20240910$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045222$AUROBINDO$Gooden T, Harriss P. Tacrolimus-induced remission of autoimmune enteropathy. American Journal of Gastroenterology. 2020;115:S1484$28$YR$$M$Y$$$20240923$$HP$US$US
243487341$24348734$1$I$$20240919$20240923$20240923$EXP$$US-JNJFOC-20240953094$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$US$US
243487351$24348735$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005232$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243487361$24348736$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005198$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243487371$24348737$1$I$$20240913$20240923$20240923$EXP$$GB-AMAROX PHARMA-AMR2024GB03167$HETERO$$27$YR$$M$Y$$$20240923$$CN$GB$GB
243487381$24348738$1$I$20240607$20240709$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000372$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
243487391$24348739$1$I$$20240912$20240923$20240923$EXP$CA-MHPD-E2B_07193712$CA-Accord-447157$ACCORD$$32$YR$A$M$Y$$$20240923$$MD$CA$CA
243487401$24348740$1$I$$20240919$20240923$20240923$EXP$CA-MHPD-E2B_07214928$CA-Accord-447564$ACCORD$$$$C$F$Y$70$KG$20240923$$HP$CA$CA
243487411$24348741$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005199$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243487421$24348742$1$I$$20240919$20240923$20240923$EXP$CA-MHPD-E2B_07214922$CA-Accord-447558$ACCORD$$$$$F$Y$47$KG$20240923$$HP$CA$CA
243487431$24348743$1$I$20240101$20240917$20240923$20240923$EXP$$US-ABBVIE-5929507$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243487441$24348744$1$I$20240501$20240913$20240923$20240923$EXP$$CA-CELLTRION INC.-2024CA013739$CELLTRION$$$$$$Y$$$20240923$$CN$CA$CA
243487451$24348745$1$I$$20240905$20240923$20240923$EXP$$US-SA-2024SA273231$SANOFI AVENTIS$$$$E$M$Y$77.27$KG$20240923$$MD$US$US
243487461$24348746$1$I$$20240919$20240923$20240923$EXP$$US-ABBVIE-5931254$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243487472$24348747$2$F$20240905$20240920$20240923$20240925$PER$$US-JNJFOC-20240922425$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240925$$CN$US$US
243487481$24348748$1$I$20240916$20240918$20240923$20240923$EXP$$US-JNJFOC-20240958898$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240923$$HP$US$US
243487491$24348749$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005190$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243487501$24348750$1$I$$20240917$20240923$20240923$EXP$$PT-SA-2024SA272298$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240923$$CN$PT$PT
243487511$24348751$1$I$$20240919$20240923$20240923$EXP$$ES-GSK-ES2024GSK116865$GLAXOSMITHKLINE$Enriquez-Fuentes JE, Lorenzo-Castro J, Pascual-Santiago MA, Colino-Gallardo AM, Arriola-Villalobos P. Bilateral Panuveitis After Endometrial Cancer Treatment with Dostarlimab: A Case Report. Ocular immunology and inflammation. 2024;1-3$$$$$Y$$$20240923$$MD$ES$ES
243487521$24348752$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005201$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243487531$24348753$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA273648$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$CN$US$US
243487541$24348754$1$I$$20240902$20240923$20240923$PER$$US-SA-2024SA270771$SANOFI AVENTIS$$$$$F$Y$$$20240923$$CN$US$US
243487551$24348755$1$I$$20240919$20240923$20240923$EXP$$CO-GSK-CO2024GSK116737$GLAXOSMITHKLINE$Velez-Tirado N, Araque-Munoz P, Amador-Patarroyo J. Secondary hemophagocytic syndrome: a severity expression of disease in patients with drug reaction with eosinophilia and systemic symptoms (dress). Case report. International Journal of Dermatology and Venereology. 2024$$$$$Y$$$20240923$$HP$CO$CO
243487571$24348757$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA272497$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240923$$MD$US$US
243487581$24348758$1$I$20231101$20240916$20240923$20240923$PER$$US-SA-2024SA269553$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240923$$HP$US$US
243487591$24348759$1$I$20240919$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187750$AMGEN$$72$YR$E$M$Y$$$20240923$$CN$US$US
243487601$24348760$1$I$20240911$20240911$20240923$20240923$PER$$US-RDY-SPO/USA/24/0013705$DR REDDYS$$17$YR$T$F$Y$$$20240923$$CN$US$US
243487611$24348761$1$I$$20240913$20240923$20240923$PER$$US-RDY-SPO/USA/24/0013722$DR REDDYS$$29$YR$A$M$Y$$$20240923$$MD$US$US
243487621$24348762$1$I$20240801$20240912$20240923$20240923$PER$$US-RDY-SPO/USA/24/0013603$DR REDDYS$$47$YR$A$$Y$$$20240923$$CN$US$US
243487631$24348763$1$I$$20240909$20240923$20240923$PER$$US-RDY-SPO/USA/24/0013704$DR REDDYS$$$$$F$Y$$$20240923$$CN$US$US
243487641$24348764$1$I$20240912$20240912$20240923$20240923$PER$$US-RDY-SPO/USA/24/0013601$DR REDDYS$$19$YR$A$F$Y$$$20240923$$MD$US$US
243487651$24348765$1$I$20240909$20240916$20240923$20240923$EXP$$GB-GSK-GB2024EME115709$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$GB$GB
243487671$24348767$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005203$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243487681$24348768$1$I$20240821$20240829$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-004725$ACADIA PHARMACEUTICALS$$94$YR$$F$Y$$$20240923$$CN$US$US
243487701$24348770$1$I$20240913$20240918$20240923$20240923$PER$$US-JNJFOC-20240949375$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243487711$24348771$1$I$$20240916$20240923$20240923$EXP$$CA-JNJFOC-20240943670$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240923$$HP$CA$CA
243487722$24348772$2$F$20240913$20240917$20240923$20240925$PER$$US-JNJFOC-20240949990$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240925$$CN$US$US
243487731$24348773$1$I$$20240916$20240923$20240923$PER$$US-JNJFOC-20240942349$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$PH$US$US
243487741$24348774$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011170$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240923$$CN$US$US
243487751$24348775$1$I$$20240912$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202408017655$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240923$$CN$US$US
243487761$24348776$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012809$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240923$$CN$US$US
243487771$24348777$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012743$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240923$$CN$US$US
243487781$24348778$1$I$20230404$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149485$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243487791$24348779$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005192$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243487801$24348780$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005191$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$HP$US$US
243487811$24348781$1$I$$20240919$20240923$20240923$EXP$CA-MHPD-E2B_07214963$CA-Accord-447575$ACCORD$$$$$F$Y$17$KG$20240923$$HP$CA$CA
243487821$24348782$1$I$20240919$20240919$20240923$20240923$EXP$GB-MHRA-TPP4324518C8637806YC1726747247554$GB-SANDOZ INC.-SDZ2024GB081686$SANDOZ$$70$YR$$M$Y$119$KG$20240923$$PH$GB$GB
243487831$24348783$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005206$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243487841$24348784$1$I$20240401$20240918$20240923$20240923$EXP$$JP-SANDOZ INC.-SDZ2024JP081901$SANDOZ$$80$YR$$F$Y$$$20240923$$CN$JP$JP
243487861$24348786$1$I$$20240920$20240923$20240923$EXP$$FR-SANDOZ INC.-SDZ2024FR081972$SANDOZ$$76$YR$$M$Y$$$20240923$$HP$FR$FR
243487871$24348787$1$I$20240601$20240705$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000375$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243487881$24348788$1$I$20240829$20240830$20240923$20240923$PER$$US-SA-2024SA268782$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240923$$PH$US$US
243487891$24348789$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA247782$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240923$$CN$US$US
243487901$24348790$1$I$$20240912$20240923$20240923$EXP$$CA-APOTEX-2024AP010678$APOTEX$$$$$F$Y$$$20240923$$CN$CA$CA
243487911$24348791$1$I$20240822$20240914$20240923$20240923$EXP$$CA-CELLTRION INC.-2024CA022452$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
243487921$24348792$1$I$20240801$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005196$ACADIA PHARMACEUTICALS$$59$YR$$M$Y$$$20240923$$CN$US$US
243487931$24348793$1$I$20240531$20240829$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005207$ACADIA PHARMACEUTICALS$$90$YR$$M$Y$$$20240923$$CN$US$US
243487941$24348794$1$I$20240905$20240919$20240923$20240923$EXP$$US-ABBVIE-5931249$ABBVIE$$78$YR$$M$Y$$$20240923$$CN$US$US
243487951$24348795$1$I$$20240920$20240923$20240923$EXP$$NVSC2024RO188089$NOVARTIS$$$$$F$Y$$$20240923$$MD$RO$RO
243487961$24348796$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5931555$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243487972$24348797$2$F$20240801$20240917$20240923$20240924$EXP$$ZA-ABBVIE-5927412$ABBVIE$$59$YR$$F$Y$$$20240924$$CN$ZA$ZA
243487982$24348798$2$F$20240901$20240927$20240923$20240927$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052749$BOEHRINGER INGELHEIM$$70$YR$E$F$Y$$$20240927$$CN$US$US
243487991$24348799$1$I$20240824$20240913$20240923$20240923$PER$$US-GSK-US2024114357$GLAXOSMITHKLINE$$80$YR$$F$Y$$$20240923$$CN$US$US
243488001$24348800$1$I$20240101$20240917$20240923$20240923$EXP$$GB-ABBVIE-5929965$ABBVIE$$49$YR$$F$Y$$$20240923$$CN$GB$GB
243488011$24348801$1$I$20240422$20240916$20240923$20240923$EXP$$US-PHARMING-PHAUS2024000808$PHARMING GROUP$$$$$$Y$$$20240923$$MD$US$US
243488021$24348802$1$I$$20240913$20240923$20240923$EXP$$US-PHARMING-PHAUS2024000803$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243488031$24348803$1$I$$20240910$20240923$20240923$EXP$$JP-CPL-004584$CADILA$Hara K, Miura E, Umeda Y, Umeda M, Oyake M, Fujita N. (A case of Parkinson^s disease with marked head drop after administration of donepezil hydrochloride). Rinsho Shinkeigaku. 2024 Aug 24. Japanese.$76$YR$E$F$Y$39$KG$20240923$$HP$JP$JP
243488041$24348804$1$I$$20240918$20240923$20240923$PER$$US-ABBVIE-5932777$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243488051$24348805$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005208$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243488071$24348807$1$I$$20240918$20240923$20240923$EXP$$SG-JNJFOC-20240953326$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$PH$SG$SG
243488081$24348808$1$I$$20240919$20240923$20240923$PER$$NVSC2024US188238$NOVARTIS$$$$$$Y$$$20240923$$CN$US$US
243488091$24348809$1$I$$20240917$20240923$20240923$EXP$$US-PHARMING-PHAUS2024000819$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243488101$24348810$1$I$$20240916$20240923$20240923$EXP$$US-PHARMING-PHAUS2024000816$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243488111$24348811$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010464$APOTEX$$58$YR$$F$Y$$$20240923$$CN$CA$CA
243488121$24348812$1$I$$20240916$20240923$20240923$PER$$US-AMGEN-USASP2024184940$AMGEN$$74$YR$$F$Y$$$20240923$$CN$US$US
243488131$24348813$1$I$20240829$20240829$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005210$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240923$$CN$US$US
243488141$24348814$1$I$20240101$20240919$20240923$20240923$30DAY$$US-UCBSA-2024039295$UCB$$$$$F$Y$$$20240923$$CN$US$US
243488151$24348815$1$I$$20240708$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000377$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243488161$24348816$1$I$20240918$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186774$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243488171$24348817$1$I$$20240918$20240923$20240923$EXP$$US-AMGEN-USASP2024186513$AMGEN$$$$$M$Y$$$20240923$$CN$US$US
243488181$24348818$1$I$20240901$20240917$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148653$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$HP$US$US
243488191$24348819$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147821$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240923$$CN$US$US
243488201$24348820$1$I$20230410$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149480$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243488211$24348821$1$I$20220521$20240916$20240923$20240923$EXP$$AR-SANDOZ INC.-NVSC2022AR145736$SANDOZ$$60$YR$$F$Y$$$20240923$$MD$AR$AR
243488221$24348822$1$I$$20240917$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US081872$SANDOZ$$$$$$Y$$$20240923$$HP$US$US
243488231$24348823$1$I$20240613$20240913$20240923$20240923$EXP$$CA-CELLTRION INC.-2024CA015623$CELLTRION$$$$$$Y$$$20240923$$HP$CA$CA
243488241$24348824$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005159$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243488252$24348825$2$F$20240901$20240922$20240923$20240925$EXP$$EG-SANDOZ INC.-SDZ2024EG081983$SANDOZ$$71$YR$$M$Y$125$KG$20240925$$CN$EG$EG
243488261$24348826$1$I$$20240910$20240923$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA081401$SANDOZ$$48$YR$$M$Y$$$20240923$$HP$CA$CA
243488271$24348827$1$I$20240812$20240919$20240923$20240923$EXP$$CO-ABBVIE-5933103$ABBVIE$$71$YR$$F$Y$$$20240923$$HP$CO$CO
243488281$24348828$1$I$$20240916$20240923$20240923$EXP$$BE-ABBVIE-5933102$ABBVIE$$$$E$F$Y$56$KG$20240923$$HP$BE$BE
243488301$24348830$1$I$20240916$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188456$AMGEN$$58$YR$A$F$Y$$$20240923$$PH$US$US
243488311$24348831$1$I$20230105$20240913$20240923$20240923$EXP$FR-AFSSAPS-AN2023000052$FR-TEVA-2023-FR-2854515$TEVA$$59$YR$$F$Y$$$20240923$$PH$FR$FR
243488322$24348832$2$F$20240919$20240923$20240923$20240924$PER$$US-AMGEN-USASP2024188837$AMGEN$$72$YR$E$F$Y$$$20240924$$CN$US$US
243488331$24348833$1$I$$20240920$20240923$20240923$PER$$US-ROCHE-10000087984$ROCHE$$73$YR$E$F$Y$$$20240923$$MD$US$US
243488341$24348834$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005225$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243488351$24348835$1$I$20240725$20240829$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005216$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240923$$CN$US$US
243488361$24348836$1$I$$20240917$20240923$20240923$EXP$$IN-SANDOZ INC.-SDZ2024IN081297$SANDOZ$$$$$M$Y$$$20240923$$CN$IN$IN
243488371$24348837$1$I$$20240918$20240923$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US081567$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
243488381$24348838$1$I$20240101$20240709$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000381$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243488391$24348839$1$I$20231110$20240917$20240923$20240923$EXP$GB-MHRA-MED-202409160834156140-WPZYT$GB-ORGANON-O2409GBR001168$ORGANON$$75$YR$$$Y$105$KG$20240923$$CN$GB$GB
243488401$24348840$1$I$20240821$20240918$20240923$20240923$EXP$$CN-SA-2024SA272149$SANOFI AVENTIS$$55$YR$A$M$Y$65$KG$20240923$$HP$CN$CN
243488411$24348841$1$I$20240101$20240916$20240923$20240923$PER$$US-SA-2024SA269597$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240923$$HP$US$US
243488421$24348842$1$I$20240918$20240918$20240923$20240923$PER$$US-ABBVIE-5929889$ABBVIE$$39$YR$$F$Y$$$20240923$$MD$US$US
243488431$24348843$1$I$20240513$20240919$20240923$20240923$EXP$$PE-UCBSA-2024026875$UCB$$71$YR$$F$Y$$$20240923$$CN$PE$PE
243488441$24348844$1$I$$20240917$20240923$20240923$PER$$US-JNJFOC-20240945319$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$HP$US$US
243488451$24348845$1$I$20240801$20240917$20240923$20240923$PER$$US-SA-2024SA270235$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240923$$MD$US$US
243488461$24348846$1$I$$20240829$20240923$20240923$PER$$US-SA-2024SA267826$SANOFI AVENTIS$$$$E$F$Y$$$20240923$$MD$US$US
243488471$24348847$1$I$20240912$20240919$20240923$20240923$EXP$$TR-ABBVIE-5933244$ABBVIE$$79$YR$$M$Y$$$20240923$$CN$TR$TR
243488481$24348848$1$I$20240813$20240917$20240923$20240923$EXP$DE-DCGMA-24203920$DE-RDY-SPO/DEU/24/0013628$DR REDDYS$$81$YR$E$M$Y$52$KG$20240923$$MD$DE$DE
243488491$24348849$1$I$$20240823$20240923$20240923$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010877$STRIDES$Finn R, Jex B, Singh A.. Resolution of Brachial Plexus Neuritis from Post-Herpetic Neuralgia by Serial Brachial Plexus Blocks with Steroid.. J-Pain. 2019;20 (Suppl.) (4):S47.$$$$$Y$$$20240923$$HP$US$US
243488501$24348850$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005221$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243488521$24348852$1$I$20240613$20240710$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000383$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243488531$24348853$1$I$$20240823$20240923$20240923$PER$$US-STRIDES ARCOLAB LIMITED-2024SP010912$STRIDES$Benson D, Thorsen T, Kirchen G.. Lumbar Radiculopathy in the Pregnant Patient.. J-Pain. 2019;20 (Suppl.) (4):S47$$$$$Y$$$20240923$$HP$US$US
243488541$24348854$1$I$$20240621$20240923$20240923$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007679$STRIDES$Manjunath J, Liao V, Kambala A, Bao A, Kollhoff AL, Ma EZ, et al. Immune stimulus exposure as a trigger for the development of chronic pruritus and circulating blood type 2 inflammation.. JAAD-Int. 2024;16:97-102.$$$$$Y$$$20240923$$MD$US$US
243488551$24348855$1$I$$20240709$20240923$20240923$PER$US-MLMSERVICE-20240703-PI117867-00163-1$US-STRIDES ARCOLAB LIMITED-2024SP008784$STRIDES$Badawy AH.. Peripheral Nerve Stimulation Uses High-Frequency Electromagnetic Coupling Technology to Power an Implanted Neurostimulator With a Separate Receiver at the Ilioinguinal Nerve for the Treatment of Chronic Groin and Abdominal Pain: Case Report.. Pain Medicine Case Reports.. 2024;8(1):1-4$$$$$Y$$$20240923$$MD$US$US
243488561$24348856$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005226$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243488571$24348857$1$I$$20240619$20240923$20240923$PER$$US-STRIDES ARCOLAB LIMITED-2024SP007513$STRIDES$Kramkowski J, Rath S.. Efficacious retrial of electroconvulsive therapy for major depressive disorder after a prolonged seizure in an older adult.. BMJ-Case-Rep. 2023;16 (5):1-4$$$$$Y$$$20240923$$MD$US$US
243488581$24348858$1$I$20240910$20240915$20240923$20240923$EXP$$CN-SANDOZ INC.-SDZ2024CN081841$SANDOZ$$68$YR$$F$Y$$$20240923$$HP$CN$CN
243488591$24348859$1$I$20240827$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005274$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240923$$CN$US$US
243488611$24348861$1$I$$20240919$20240923$20240923$EXP$$NVSC2024US188204$NOVARTIS$$$$$M$Y$$$20240923$$CN$US$US
243488621$24348862$1$I$20240801$20240903$20240923$20240923$PER$$US-SA-2024SA272775$SANOFI AVENTIS$$55$YR$A$M$Y$65.31$KG$20240923$$MD$US$US
243488631$24348863$1$I$20240101$20240917$20240923$20240923$PER$$US-SA-2024SA269696$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240923$$HP$US$US
243488641$24348864$1$I$20240801$20240903$20240923$20240923$PER$$US-SA-2024SA272953$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240923$$MD$US$US
243488651$24348865$1$I$$20240917$20240923$20240923$EXP$$AR-SANDOZ INC.-SDZ2024AR081665$SANDOZ$$$$$M$Y$37.5$KG$20240923$$CN$AR$AR
243488661$24348866$1$I$20240531$20240917$20240923$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US055758$SANDOZ$$70$YR$$F$Y$$$20240923$$CN$US$US
243488671$24348867$1$I$20130101$20240916$20240923$20240923$EXP$$CA-SANDOZ INC.-PHHY2009CA40509$SANDOZ$$$$$F$Y$54$KG$20240923$$CN$CA$CA
243488681$24348868$1$I$$20240917$20240923$20240923$EXP$$US-ABBVIE-5930268$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243488691$24348869$1$I$$20240912$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409009273$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240923$$CN$US$US
243488701$24348870$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012420$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240923$$CN$US$US
243488711$24348871$1$I$20240920$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013654$ELI LILLY AND CO$$70$YR$E$$Y$$$20240923$$CN$US$US
243488721$24348872$1$I$$20240913$20240923$20240923$PER$$US-ASTELLAS-2024-AER-007244$ASTELLAS$$72$YR$E$F$Y$$$20240923$$CN$US$US
243488731$24348873$1$I$20240626$20240710$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000384$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243488741$24348874$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186569$AMGEN$$$$$M$Y$$$20240923$$PH$US$US
243488751$24348875$1$I$20240901$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150101$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240923$$HP$US$US
243488761$24348876$1$I$20240201$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149925$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240923$$CN$US$US
243488771$24348877$1$I$$20240919$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US081968$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
243488781$24348878$1$I$$20240913$20240923$20240923$EXP$$NL-AMGEN-NLDSP2024184005$AMGEN$Von Dem Borne P.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$E$$Y$$$20240923$$HP$NL$NL
243488791$24348879$1$I$20220902$20240917$20240923$20240923$EXP$$IN-SANDOZ INC.-NVSC2022IN264713$SANDOZ$$26$YR$$F$Y$$$20240923$$CN$IN$IN
243488801$24348880$1$I$$20240829$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005223$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$PH$US$US
243488811$24348881$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114332$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243488821$24348882$1$I$20240701$20240912$20240923$20240923$EXP$IT-MINISAL02-1001172$IT-Accord-446807$ACCORD$$77$YR$E$M$Y$$$20240923$$MD$IT$IT
243488831$24348883$1$I$$20240909$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045171$AUROBINDO$Gangat N, Ajufo H, Abdelmagid M, Karrar O, McCullough K, Badar T, et al.. IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience.. Br-J-Haematol. 2023;203(3):e87-e92$$$$F$Y$$$20240923$$HP$US$US
243488841$24348884$1$I$$20240909$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2019-024914$AUROBINDO$Kang M, Aslam S. Varicella zoster virus encephalitis in solid organ transplant recipients: Case series and review of literature. Transplant Infectious Disease. 2019;21(2):Article Number e13038$66$YR$$M$Y$$$20240923$$MD$US$US
243488851$24348885$1$I$20240601$20240710$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000385$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243488861$24348886$1$I$$20240910$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045148$AUROBINDO$Ahmed A, Ammar H, Mageau R.. Challenging illness scripts: a case of pernicious anaemia and axonal neuropathy. BMJ case reports. 2024;17(8):e260967$4$DEC$$M$Y$$$20240923$$MD$US$US
243488871$24348887$1$I$$20240913$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005574$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243488881$24348888$1$I$$20240920$20240923$20240923$PER$$NVSC2024US188631$NOVARTIS$$$$$F$Y$$$20240923$$MD$US$US
243488891$24348889$1$I$$20240913$20240923$20240923$EXP$$NL-AMGEN-NLDSP2024184013$AMGEN$Von Dem Borne P.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$A$$Y$$$20240923$$HP$NL$NL
243488901$24348890$1$I$$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024186167$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243488911$24348891$1$I$20240911$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188299$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243488921$24348892$1$I$$20240606$20240923$20240923$EXP$$GB-AMGEN-GBRSL2024186432$AMGEN$$62$YR$A$F$Y$$$20240923$$CN$GB$GB
243488933$24348893$3$F$20240918$20240923$20240923$20240930$EXP$$US-AMGEN-USASP2024188502$AMGEN$$41$YR$A$F$Y$$$20240930$$CN$US$US
243488941$24348894$1$I$$20240913$20240923$20240923$EXP$$NL-AMGEN-NLDSP2024184018$AMGEN$Von Dem Borne P. A.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$$$Y$$$20240923$$HP$NL$NL
243488951$24348895$1$I$$20240911$20240923$20240923$PER$$US-JNJFOC-20240931671$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$CN$US$US
243488961$24348896$1$I$20240501$20240710$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000386$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243488981$24348898$1$I$20240101$20240909$20240923$20240923$PER$$US-SA-2024SA271798$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240923$$MD$US$US
243488991$24348899$1$I$20200101$20240918$20240923$20240923$EXP$$US-ABBVIE-5930261$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243489002$24348900$2$F$20240101$20240911$20240923$20240924$PER$$US-SA-2024SA271663$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240924$$CN$US$US
243489022$24348902$2$F$$20240911$20240923$20240924$PER$$US-SA-2024SA271785$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240924$$CN$US$US
243489031$24348903$1$I$20240901$20240919$20240923$20240923$EXP$$US-SA-2024SA272685$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240923$$HP$US$US
243489041$24348904$1$I$$20240828$20240923$20240923$PER$$US-SA-2024SA267627$SANOFI AVENTIS$$$$E$M$Y$88.64$KG$20240923$$MD$US$US
243489051$24348905$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270158$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240923$$MD$US$US
243489061$24348906$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272338$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240923$$MD$US$US
243489071$24348907$1$I$20240901$20240916$20240923$20240923$PER$$US-SA-2024SA269019$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240923$$HP$US$US
243489081$24348908$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269401$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240923$$MD$US$US
243489092$24348909$2$F$$20240909$20240923$20240924$EXP$$ES-MSNLABS-2024MSNLIT01988$MSN LABORATORIES$Pozo IB, Comesana MS, Castillo AC, Oliva MP, Vazquez GP.PUTTING PIECES TOGETHER TO REACH THE DIAGNOSIS.European Journal of Case Reports in Internal Medicine.2024;11(1):791$$$$$Y$$$20240924$$HP$ES$ES
243489101$24348910$1$I$$20240911$20240923$20240923$PER$$US-ABBVIE-5924099$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243489111$24348911$1$I$$20240710$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000387$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243489121$24348912$1$I$$20240912$20240923$20240923$PER$$US-ABBVIE-5924185$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243489131$24348913$1$I$$20240916$20240923$20240923$PER$$US-TAKEDA-2024TUS092346$TAKEDA$$$$C$$Y$$$20240923$$MD$US$US
243489151$24348915$1$I$$20240909$20240923$20240923$EXP$$CA-AUROBINDO-AUR-APL-2024-044993$AUROBINDO$Purssell A, Leung K, Giguere P, Angel JB. Pritelivir for the treatment of nucleoside analogueresistant orolabial herpes simplex virus 2 in a person living with HIV. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2024;9(2):108-112$53$YR$$M$Y$$$20240923$$MD$CA$CA
243489161$24348916$1$I$20230717$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149406$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243489171$24348917$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149865$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240923$$CN$US$US
243489181$24348918$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150057$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240923$$CN$US$US
243489191$24348919$1$I$20240711$20240712$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000388$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
243489201$24348920$1$I$20240101$20240909$20240923$20240923$EXP$$US-INSMED, INC.-2024-02845-US$INSMED$$$$$M$Y$$$20240923$$CN$US$US
243489211$24348921$1$I$20230101$20240917$20240923$20240923$PER$$US-VIIV HEALTHCARE LIMITED-US2024115606$VIIV$$3$DEC$$M$Y$$$20240923$$MD$US$US
243489221$24348922$1$I$20190821$20240918$20240923$20240923$EXP$$CO-UCBSA-2024048524$UCB$$76$YR$$M$Y$$$20240923$$CN$CO$CO
243489231$24348923$1$I$$20240916$20240923$20240923$EXP$$NVSC2024NL184798$NOVARTIS$Aalbersberg EA, de Vries-Huizing DMV, Tesselaar MET, Stokkel MPM, Versleijen MWJ. Post-PRRT scans: which scans to make and what to look for. CANCER IMAGING. 2022;22(1):29$$$$F$Y$$$20240923$$HP$NL$NL
243489241$24348924$1$I$$20240913$20240923$20240923$EXP$$DK-JUBILANT CADISTA PHARMACEUTICALS-2024DK001328$JUBILANT$Hoeck PR, Kessing LV, Pagsberg AK, Andersen M.. 15-year-old with bipolar affective disorder treated with ECT.. Ugeskrift L?ger.. 2024;186:V02240137$15$YR$$F$Y$$$20240923$$MD$DK$DK
243489251$24348925$1$I$20240708$20240913$20240923$20240923$EXP$SE-SEMPA-2024-006711$SE-JUBILANT CADISTA PHARMACEUTICALS-2024SE001316$JUBILANT$$44$YR$$F$Y$$$20240923$$MD$SE$SE
243489261$24348926$1$I$$20240830$20240923$20240923$PER$$US-SA-2024SA271701$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240923$$HP$US$US
243489271$24348927$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005227$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243489281$24348928$1$I$$20230809$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2023-054009$AUROBINDO$$$$$M$Y$$$20240923$$CN$US$US
243489291$24348929$1$I$20240328$20240912$20240923$20240923$EXP$FR-AFSSAPS-AM2024000715$FR-Accord-447066$ACCORD$$20$YR$A$F$Y$80$KG$20240923$$MD$FR$FR
243489311$24348931$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150217$BRISTOL MYERS SQUIBB$Adkins K, Williams RJ, Esteso P, Kobayashi R, Gauvreau K, VanderPluym C, et al. Real-world use and outcomes of apixaban for early post-surgical fontan thromboprophylaxis. Pediatric Cardiology. 2024 Sep 12;doi:10.1007/s00246-024-03641-3.$$$C$$Y$$$20240923$$HP$US$US
243489322$24348932$2$F$20240908$20240920$20240923$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046060$AUROBINDO$$39$YR$$F$Y$$$20240928$$CN$GB$GB
243489331$24348933$1$I$20240711$20240713$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000391$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243489341$24348934$1$I$20240808$20240829$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005228$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240923$$CN$US$US
243489351$24348935$1$I$$20240912$20240923$20240923$EXP$GB-MHRA-MED-202409122332144960-GDBCZ$GB-Accord-446604$ACCORD$$37$YR$A$F$Y$56$KG$20240923$$CN$GB$GB
243489361$24348936$1$I$20220516$20240913$20240923$20240923$EXP$FR-AFSSAPS-SE20220626$FR-CELLTRION INC.-2024FR022412$CELLTRION$$$$$$Y$$$20240923$$MD$FR$FR
243489371$24348937$1$I$$20240910$20240923$20240923$EXP$$NVSC2024MY182930$NOVARTIS$$$$$M$Y$$$20240923$$MD$MY$MY
243489381$24348938$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012591$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240923$$CN$US$US
243489391$24348939$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268565$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240923$$HP$US$US
243489401$24348940$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA272852$SANOFI AVENTIS$$$$T$F$Y$43$KG$20240923$$MD$US$US
243489411$24348941$1$I$$20240819$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-016023$AUROBINDO$$$$$$Y$$$20240923$$HP$US$US
243489421$24348942$1$I$$20240912$20240923$20240923$PER$$US-TRIS PHARMA, INC.-24US011649$TRIS PHARM$$$$$$Y$$$20240923$$CN$US$US
243489431$24348943$1$I$20240901$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188452$AMGEN$$$$$M$Y$$$20240923$$CN$US$US
243489441$24348944$1$I$$20240910$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045652$AUROBINDO$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. et all.. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients.. J-Am-Acad-Dermatol. 2024;90(3):642-644$55$YR$$F$Y$$$20240923$$HP$US$US
243489461$24348946$1$I$20240101$20240903$20240923$20240923$PER$$US-TEVA-VS-3240576$TEVA$$$$$F$Y$$$20240923$$CN$US$US
243489471$24348947$1$I$20240528$20240715$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000392$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243489481$24348948$1$I$$20240713$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-026670$AUROBINDO$$$$$M$Y$$$20240923$$CN$US$US
243489491$24348949$1$I$20240809$20240829$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005230$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240923$$CN$US$US
243489511$24348951$1$I$20240101$20240918$20240923$20240923$EXP$$US-AMGEN-USASP2024186439$AMGEN$$80$YR$E$F$Y$$$20240923$$HP$US$US
243489521$24348952$1$I$20240101$20240918$20240923$20240923$EXP$HR-HALMED-300086480$HR-TEVA-VS-3244937$TEVA$$33$YR$$F$Y$$$20240923$$MD$HR$HR
243489531$24348953$1$I$$20240829$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005169$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243489541$24348954$1$I$$20240911$20240923$20240923$EXP$$NL-AUROBINDO-AUR-APL-2024-045678$AUROBINDO$$70$YR$$M$Y$99$KG$20240923$$CN$NL$NL
243489571$24348957$1$I$20231219$20240715$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000393$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243489581$24348958$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5930834$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243489591$24348959$1$I$$20240915$20240923$20240923$EXP$$SA-JNJFOC-20240944372$JOHNSON AND JOHNSON$$$$$$Y$30$KG$20240923$$MD$SA$SA
243489601$24348960$1$I$$20240910$20240923$20240923$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000301$NOVAST$$$$$$Y$$$20240923$$HP$CN$CN
243489611$24348961$1$I$$20240916$20240923$20240923$EXP$$US-AMGEN-USASP2024185419$AMGEN$$77$YR$E$F$Y$$$20240923$$HP$US$US
243489621$24348962$1$I$$20240612$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-027877$AUROBINDO$$$$$$Y$$$20240923$$HP$US$US
243489631$24348963$1$I$$20240920$20240923$20240923$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052739$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$$$20240923$$CN$US$US
243489641$24348964$1$I$$20240916$20240923$20240923$PER$$US-ABBVIE-5926531$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243489651$24348965$1$I$$20240913$20240923$20240923$EXP$$IN-ROCHE-3407934$ROCHE$$58$YR$A$F$Y$69.59$KG$20240923$$MD$IN$IN
243489661$24348966$1$I$20240811$20240829$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005174$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240923$$CN$US$US
243489671$24348967$1$I$20240712$20240911$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045704$AUROBINDO$$33$YR$$F$Y$$$20240923$$CN$FR$FR
243489682$24348968$2$F$20240801$20240924$20240923$20240926$EXP$$FR-GSK-FR2024114772$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$PH$FR$FR
243489691$24348969$1$I$20240529$20240715$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000394$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243489701$24348970$1$I$$20240708$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-032000$AUROBINDO$$$$$F$Y$$$20240923$$HP$US$US
243489711$24348971$1$I$$20240916$20240923$20240923$EXP$$RO-ROCHE-2695642$ROCHE$$53$YR$A$F$Y$83$KG$20240923$$CN$RO$RO
243489741$24348974$1$I$$20240917$20240923$20240923$EXP$$US-ROCHE-10000084394$ROCHE$Dave A, Schwartz M, Van J, Owczarzak L, Miller I, Jain S. A Challenging Diagnosis of HHV-8-Associated Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, in a Young Man with Newly-Diagnosed HIV. American Journal of Case Reports. 2024-Jan;25:e945162-1-e945162-9. doi:10.12659/AJCR.945162.$26$YR$A$M$Y$$$20240923$$HP$US$US
243489762$24348976$2$F$$20240918$20240923$20240927$EXP$$US-TEVA-VS-3244817$TEVA$Bragg K, Miller H, Buckshaw R, Simon LV, King C. Testosterone Therapy as an Isolated Risk Factor for Venous Thrombosis: A Case Report. Cureus. 2024;16(7):e63611 .; Bragg K, Miller H, Buckshaw R, Simon LV, King C. Testosterone Therapy as an Isolated Risk Factor for Venous Thrombosis: A Case Report. Cureus. 2024;16(7):e63611. DOI: 10.7759/cureus.63611.$$$A$M$Y$$$20240927$$MD$US$US
243489771$24348977$1$I$$20240910$20240923$20240923$PER$$US-PHARMING-PHAUS2024000793$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243489781$24348978$1$I$$20240911$20240923$20240923$PER$$US-PHARMING-PHAUS2024000799$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243489791$24348979$1$I$$20240911$20240923$20240923$PER$$US-PHARMING-PHAUS2024000798$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243489801$24348980$1$I$$20240912$20240923$20240923$PER$$US-PHARMING-PHAUS2024000797$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243489812$24348981$2$F$$20240926$20240923$20240930$PER$$US-PHARMING-PHAUS2024000791$PHARMING GROUP$$$$$$Y$$$20240930$$CN$US$US
243489822$24348982$2$F$20240811$20240917$20240923$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-045686$AUROBINDO$$57$YR$$F$Y$58$KG$20240926$$MD$FR$FR
243489831$24348983$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270046$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240923$$HP$US$US
243489841$24348984$1$I$$20240910$20240923$20240923$PER$$US-SA-2024SA272243$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240923$$CN$US$US
243489851$24348985$1$I$20240911$20240912$20240923$20240923$PER$$US-ASTELLAS-2024-AER-006785$ASTELLAS$$$$$M$Y$$$20240923$$CN$US$US
243489861$24348986$1$I$20240820$20240913$20240923$20240923$EXP$ES-AEMPS-1567709$ES-HIKMA PHARMACEUTICALS USA INC.-ES-H14001-24-08668$HIKMA$$52$YR$$F$Y$$$20240923$$PH$ES$ES
243489871$24348987$1$I$$20240917$20240923$20240923$EXP$$US-AMGEN-USASP2024186803$AMGEN$Molmenti E.P.; Nair V.; Jandovitz N. et.al. COVID-19 in kidney transplant recipients. American Journal of Transplantation. 2020;20 (7):1819-1825$37$YR$A$M$Y$$$20240923$$HP$US$US
243489881$24348988$1$I$$20240909$20240923$20240923$EXP$$US-CIPLA LTD.-2024US09986$CIPLA$$$$$$Y$$$20240923$$HP$US$US
243489891$24348989$1$I$$20240913$20240923$20240923$PER$$US-ASTELLAS-2024-AER-007247$ASTELLAS$$71$YR$E$F$Y$$$20240923$$CN$US$US
243489901$24348990$1$I$20240116$20240715$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000395$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243489911$24348991$1$I$$20240916$20240923$20240923$EXP$$JP-TEVA-VS-3244605$TEVA$Furuya C, Yasuda H, Hiki M, Shirane S, Yamana T, Uchimura A, et al. Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases. Front-Immunol 2024; 15.; Furuya C, Yasuda H, Hiki M, Shirane S, Yamana T, Uchimura A, et al. Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases. Front-Immunol 2024; 15.$76$YR$$M$Y$$$20240923$$HP$JP$JP
243489921$24348992$1$I$$20240909$20240923$20240923$EXP$$GB-CIPLA LTD.-2024GB10009$CIPLA$$$$$$Y$$$20240923$$MD$GB$GB
243489931$24348993$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150220$BRISTOL MYERS SQUIBB$Adkins K, Williams RJ, Esteso P, Kobayashi R, Gauvreau K, VanderPluym C, et al. Real-world use and outcomes of apixaban for early post-surgical fontan thromboprophylaxis. Pediatric Cardiology. 2024 Sep 12;doi:10.1007/s00246-024-03641-3.$$$C$$Y$$$20240923$$HP$US$US
243489941$24348994$1$I$20240901$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150292$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$70.31$KG$20240923$$CN$US$US
243489951$24348995$1$I$$20240919$20240923$20240923$EXP$$GH-JNJFOC-20240959852$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$MD$GH$GH
243489961$24348996$1$I$$20240909$20240923$20240923$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08715$HIKMA$Sulaiman ZI, Sharma D, Salva JR, Rast J, Samra H, Askar G.. Sulaiman ZI, Sharma D, Salva JR, Rast J, Samra H, Askar G. A Rare Case of Cerebral Abscess due to Fusobacterium nucleatum with Native Aortic Valve Infective Endocarditis and Pyogenic Liver Abscess.. Journal of Investigative Medicine High Impact Case Reports. 2024;12:1-6$62$YR$$M$Y$$$20240923$$MD$US$US
243489971$24348997$1$I$$20240910$20240923$20240923$EXP$$CA-ROCHE-10000084695$ROCHE$$65$YR$E$F$Y$$$20240923$$MD$CA$CA
243489981$24348998$1$I$$20240910$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045226$AUROBINDO$O?Connor W, Arshia A, Prabakar D, Sabesan V, Spindel JF.. Nuclear envelope lamin-related dilated cardiomyopathy: a case series including histopathology.. European Heart Journal - Case Reports.. 2024;8(8)::ytae412$36$YR$$M$Y$$$20240923$$MD$US$US
243489991$24348999$1$I$$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005176$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243490001$24349000$1$I$$20240910$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045236$AUROBINDO$Chean CS, Ali AIAH, Malick H.. Bilateral simultaneous acute angle closure glaucoma triggered by an over-the-counter cold and influenza medication. BMJ case reports.. 2024;17(8):e260950$7$DEC$$F$Y$$$20240923$$MD$GB$GB
243490011$24349001$1$I$$20240919$20240923$20240923$EXP$$US-SA-2024SA272463$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240923$$MD$US$US
243490021$24349002$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA270624$SANOFI AVENTIS$$$$A$M$Y$78.01$KG$20240923$$MD$US$US
243490031$24349003$1$I$20240101$20240829$20240923$20240923$PER$$US-SA-2024SA268716$SANOFI AVENTIS$$8$YR$C$F$Y$39.91$KG$20240923$$MD$US$US
243490041$24349004$1$I$20240101$20240913$20240923$20240923$EXP$$US-ORPHANEU-2024007202$RECORDATI$$$$$$Y$$$20240923$$CN$US$US
243490061$24349006$1$I$20240713$20240715$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000396$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243490071$24349007$1$I$$20240911$20240923$20240923$EXP$$BR-Accord-447278$ACCORD$$64$YR$A$M$Y$$$20240923$$PH$BR$BR
243490081$24349008$1$I$20240829$20240912$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045817$AUROBINDO$$61$YR$$M$Y$82$KG$20240923$$CN$GB$GB
243490091$24349009$1$I$$20240918$20240923$20240923$EXP$$US-AMGEN-USASP2024186743$AMGEN$$$$$$Y$$$20240923$$MD$US$US
243490101$24349010$1$I$$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024187084$AMGEN$$63$YR$A$F$Y$113$KG$20240923$$CN$US$US
243490111$24349011$1$I$20240905$20240912$20240923$20240923$EXP$$RO-AMGEN-ROUSP2024187808$AMGEN$$55$YR$A$F$Y$$$20240923$$MD$RO$RO
243490121$24349012$1$I$20231110$20240917$20240923$20240923$EXP$GB-MHRA-MED-202409160834156140-WPZYT$GB-RDY-SPO/GBR/24/0013702$DR REDDYS$$75$YR$E$$Y$105$KG$20240923$$CN$GB$GB
243490131$24349013$1$I$$20240912$20240923$20240923$EXP$$CA-APOTEX-2024AP010687$APOTEX$$$$$M$Y$$$20240923$$MD$CA$CA
243490141$24349014$1$I$20240101$20240715$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000397$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
243490151$24349015$1$I$$20240912$20240923$20240923$PER$$US-RDY-SPO/USA/24/0013811$DR REDDYS$Agarwal A, Diaz A, Al-Dehneem R, Pineda RM, Khattri S. Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases. Journal of Drugs in Dermatology. 2023 Dec;22: 1183-1190. doi:10.36849/JDD.7500.$28$YR$A$F$Y$$$20240923$$HP$US$US
243490181$24349018$1$I$20240101$20240904$20240923$20240923$EXP$$US-SA-2024SA273824$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240923$$PH$US$US
243490191$24349019$1$I$20231201$20240911$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045770$AUROBINDO$$$$$$Y$$$20240923$$HP$GB$GB
243490201$24349020$1$I$$20240917$20240923$20240923$EXP$$US-BIOGEN-2024BI01283132$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
243490211$24349021$1$I$20240601$20240717$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000402$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
243490222$24349022$2$F$20240529$20240909$20240923$20240924$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469601$RANBAXY$$55$YR$$F$Y$$$20240924$$HP$IT$IT
243490231$24349023$1$I$20231201$20240917$20240923$20240923$EXP$$CA-BIOGEN-2024BI01283144$BIOGEN$$67$YR$$F$Y$$$20240923$$PH$CA$CA
243490241$24349024$1$I$$20240913$20240923$20240923$EXP$$AT-TEVA-VS-3243624$TEVA$$66$YR$$F$Y$$$20240923$$MD$AT$AT
243490251$24349025$1$I$$20240909$20240923$20240923$EXP$$US-SA-2024SA272190$SANOFI AVENTIS$$$$A$M$Y$$$20240923$$CN$US$US
243490261$24349026$1$I$20240824$20240912$20240923$20240923$EXP$$IT-AUROBINDO-AUR-APL-2024-046053$AUROBINDO$$90$YR$$M$Y$$$20240923$$MD$IT$IT
243490271$24349027$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012092$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240923$$CN$US$US
243490281$24349028$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012053$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243490291$24349029$1$I$20240901$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012681$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240923$$CN$US$US
243490301$24349030$1$I$20240901$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012570$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240923$$CN$US$US
243490311$24349031$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150059$BRISTOL MYERS SQUIBB$$6$DEC$A$M$Y$$$20240923$$MD$US$US
243490321$24349032$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188223$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243490331$24349033$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010459$APOTEX$$$$$M$Y$$$20240923$$HP$CA$CA
243490341$24349034$1$I$20240911$20240913$20240923$20240923$EXP$$CN-GE HEALTHCARE-2024CSU010611$GE HEALTHCARE$$79$YR$$F$Y$57.5$KG$20240923$$HP$CN$CN
243490351$24349035$1$I$20211123$20240911$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045419$AUROBINDO$$17$YR$$F$Y$$$20240923$$CN$GB$GB
243490362$24349036$2$F$20240901$20240920$20240923$20240925$PER$$US-ABBVIE-5933501$ABBVIE$$56$YR$$F$Y$$$20240925$$CN$US$US
243490371$24349037$1$I$20230301$20240913$20240923$20240923$EXP$$CA-GSK-CA2023089065$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$CA$GB
243490391$24349039$1$I$20240801$20240828$20240923$20240923$PER$$US-SA-2024SA238344$SANOFI AVENTIS$$13$YR$T$M$Y$47.27$KG$20240923$$MD$US$US
243490401$24349040$1$I$$20240905$20240923$20240923$PER$$US-SA-2024SA272950$SANOFI AVENTIS$$$$A$M$Y$$$20240923$$MD$US$US
243490421$24349042$1$I$$20240917$20240923$20240923$EXP$$US-SA-2024SA271455$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240923$$MD$US$US
243490431$24349043$1$I$$20240911$20240923$20240923$PER$$US-SA-2024SA273328$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240923$$CN$US$US
243490441$24349044$1$I$$20240902$20240923$20240923$PER$$US-SA-2024SA268409$SANOFI AVENTIS$$$$E$F$Y$55.7$KG$20240923$$MD$US$US
243490452$24349045$2$F$20240801$20240911$20240923$20240925$PER$$US-SA-2024SA271821$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240925$$CN$US$US
243490461$24349046$1$I$20211001$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-046042$AUROBINDO$$26$YR$$M$Y$$$20240923$$HP$FR$FR
243490471$24349047$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269441$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240923$$HP$US$US
243490481$24349048$1$I$20240909$20240909$20240923$20240923$PER$$US-SA-2024SA273309$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240923$$CN$US$US
243490491$24349049$1$I$20240716$20240717$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000403$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243490501$24349050$1$I$$20240912$20240923$20240923$EXP$$PT-AUROBINDO-AUR-APL-2024-045873$AUROBINDO$Vidal H, Salgado V, Alves P, Fonsecal NM, Frochot V, Ferreira A.. Calcium polystyrene sulfonate?induced colitis: advanced characterization of crystal nature with infrared spectroscopy. Clinical Kidney Journal. 2024;(8):No pagination (sfae210)$82$YR$$M$Y$$$20240923$$HP$PT$PT
243490511$24349051$1$I$$20240912$20240923$20240923$PER$$US-PHARMING-PHAUS2024000804$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243490521$24349052$1$I$20240531$20240918$20240923$20240923$EXP$IT-MINISAL02-1001840$IT-TEVA-VS-3244956$TEVA$$58$YR$$M$Y$$$20240923$$MD$IT$IT
243490531$24349053$1$I$20240901$20240918$20240923$20240923$EXP$$CA-ROCHE-10000086396$ROCHE$$98$YR$E$F$Y$$$20240923$$PH$CA$CA
243490541$24349054$1$I$20240901$20240906$20240923$20240923$PER$$US-JNJFOC-20240947389$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240923$$CN$US$US
243490551$24349055$1$I$20240101$20240919$20240923$20240923$EXP$$DE-ABBVIE-5933296$ABBVIE$$73$YR$$M$Y$$$20240923$$CN$DE$DE
243490561$24349056$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186995$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243490571$24349057$1$I$20240710$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-046139$AUROBINDO$$81$YR$$M$Y$$$20240923$$PH$FR$FR
243490581$24349058$1$I$20240801$20240826$20240923$20240923$PER$$US-SA-2024SA266828$SANOFI AVENTIS$$58$YR$A$F$Y$62.73$KG$20240923$$MD$US$US
243490591$24349059$1$I$$20240911$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045506$AUROBINDO$$$$$F$Y$$$20240923$$CN$GB$GB
243490601$24349060$1$I$20240101$20240916$20240923$20240923$EXP$SE-SEMPA-2024-006457$SE-TEVA-VS-3244144$TEVA$$$$$F$Y$$$20240923$$CN$SE$SE
243490611$24349061$1$I$20240130$20240911$20240923$20240923$EXP$$DE-AUROBINDO-AUR-APL-2024-045676$AUROBINDO$$59$YR$$M$Y$$$20240923$$MD$DE$DE
243490621$24349062$1$I$20240603$20240913$20240923$20240923$EXP$IT-MINISAL02-1001531$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-08676$HIKMA$$$$$$Y$$$20240923$$MD$IT$IT
243490631$24349063$1$I$$20240919$20240923$20240923$EXP$$US-TAKEDA-2024TUS086486$TAKEDA$$$$$M$Y$$$20240923$$CN$US$US
243490641$24349064$1$I$$20240909$20240923$20240923$EXP$$CA-APOTEX-2024AP010416$APOTEX$$$$$F$Y$$$20240923$$HP$CA$CA
243490651$24349065$1$I$$20240909$20240923$20240923$EXP$$CA-APOTEX-2024AP010371$APOTEX$$65$YR$$F$Y$34$KG$20240923$$CN$CA$CA
243490671$24349067$1$I$20230302$20240911$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045963$AUROBINDO$$80$YR$$F$Y$60$KG$20240923$$MD$FR$FR
243490681$24349068$1$I$$20240912$20240923$20240923$EXP$$US-Accord-447355$ACCORD$$$$$F$Y$$$20240923$$MD$US$US
243490691$24349069$1$I$$20240911$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045530$AUROBINDO$$$$$M$Y$72$KG$20240923$$HP$GB$GB
243490701$24349070$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188224$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243490711$24349071$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187472$AMGEN$$$$A$F$Y$$$20240923$$PH$US$US
243490721$24349072$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150201$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240923$$CN$US$US
243490731$24349073$1$I$$20240919$20240923$20240923$EXP$$JP-ABBVIE-5931122$ABBVIE$$14$YR$$$Y$$$20240923$$PH$JP$JP
243490741$24349074$1$I$$20240915$20240923$20240923$PER$$US-ABBVIE-5929269$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243490751$24349075$1$I$20240304$20240916$20240923$20240923$EXP$ES-AEMPS-1567653$ES-TEVA-VS-3244286$TEVA$$96$YR$$F$Y$$$20240923$$MD$ES$ES
243490761$24349076$1$I$$20240921$20240923$20240923$PER$$NVSC2024US188433$NOVARTIS$$$$$$Y$$$20240923$$CN$US$US
243490772$24349077$2$F$20240101$20240911$20240923$20240926$PER$$US-SA-2024SA273874$SANOFI AVENTIS$$$$E$M$Y$$$20240926$$CN$US$US
243490781$24349078$1$I$20240901$20240917$20240923$20240923$PER$$US-SA-2024SA270435$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240923$$HP$US$US
243490791$24349079$1$I$20240101$20240916$20240923$20240923$PER$$US-SA-2024SA269676$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240923$$HP$US$US
243490801$24349080$1$I$20240901$20240916$20240923$20240923$PER$$US-SA-2024SA268546$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240923$$MD$US$US
243490821$24349082$1$I$20240817$20240920$20240923$20240923$EXP$PT-INFARMED-R202408-760$PT-NORMON-202401245$NORMON$$80$YR$E$F$Y$$$20240923$$PH$PT$
243490831$24349083$1$I$20240516$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-046123$AUROBINDO$$31$YR$$M$Y$$$20240923$$PH$FR$FR
243490841$24349084$1$I$20240601$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-046125$AUROBINDO$$49$YR$$M$Y$96$KG$20240923$$MD$FR$FR
243490851$24349085$1$I$$20240912$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045811$AUROBINDO$$$$$M$Y$$$20240923$$MD$GB$GB
243490861$24349086$1$I$20240809$20240912$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045877$AUROBINDO$$77$YR$$M$Y$100$KG$20240923$$CN$GB$GB
243490871$24349087$1$I$20230404$20240913$20240923$20240923$EXP$FR-AFSSAPS-PB2023000595$FR-CELLTRION INC.-2024FR022391$CELLTRION$$$$$$Y$$$20240923$$MD$FR$FR
243490881$24349088$1$I$$20240920$20240923$20240923$PER$$US-HALEON-2197951$Haleon PLC$$$$$$Y$$$20240923$$CN$US$US
243490891$24349089$1$I$$20240912$20240923$20240923$PER$$US-ASTELLAS-2024-AER-006708$ASTELLAS$$$$$F$Y$$$20240923$$HP$US$US
243490901$24349090$1$I$$20240912$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045920$AUROBINDO$$37$YR$$F$Y$56$KG$20240923$$CN$GB$GB
243490911$24349091$1$I$$20240830$20240923$20240923$PER$$US-SA-2024SA272825$SANOFI AVENTIS$$$$T$M$Y$45$KG$20240923$$MD$US$US
243490921$24349092$1$I$20191125$20240912$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045815$AUROBINDO$$41$YR$$M$Y$144$KG$20240923$$CN$GB$GB
243490931$24349093$1$I$20240101$20240916$20240923$20240923$EXP$$US-SA-2024SA270600$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240923$$MD$US$US
243490941$24349094$1$I$20240822$20240829$20240923$20240923$PER$$US-SA-2024SA267642$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240923$$MD$US$US
243490951$24349095$1$I$20240919$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012814$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240923$$CN$US$US
243490961$24349096$1$I$$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013476$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240923$$CN$US$US
243490971$24349097$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013752$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240923$$CN$US$US
243490981$24349098$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012499$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240923$$CN$US$US
243490991$24349099$1$I$20240918$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012963$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240923$$CN$US$US
243491001$24349100$1$I$$20240830$20240923$20240923$PER$$US-SA-2024SA272000$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240923$$MD$US$US
243491011$24349101$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012747$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240923$$CN$US$US
243491021$24349102$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012651$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240923$$CN$US$US
243491031$24349103$1$I$20240914$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013461$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240923$$CN$US$US
243491041$24349104$1$I$$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013641$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240923$$CN$US$US
243491051$24349105$1$I$20240901$20240903$20240923$20240923$PER$$US-SA-2024SA273034$SANOFI AVENTIS$$27$YR$A$F$Y$81.82$KG$20240923$$HP$US$US
243491061$24349106$1$I$20220101$20240913$20240923$20240923$EXP$$US-HETERO-HET2024US03189$HETERO$$$$$F$Y$$$20240923$$CN$US$US
243491071$24349107$1$I$20240731$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045911$AUROBINDO$$59$YR$$M$Y$$$20240923$$PH$FR$FR
243491081$24349108$1$I$20230610$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045946$AUROBINDO$$16$YR$$F$Y$51$KG$20240923$$MD$FR$FR
243491091$24349109$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270181$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240923$$HP$US$US
243491101$24349110$1$I$$20240912$20240923$20240923$PER$$US-SA-2024SA273338$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240923$$CN$US$US
243491111$24349111$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150060$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240923$$PH$US$US
243491121$24349112$1$I$20240901$20240913$20240923$20240923$EXP$$GB-TEVA-VS-3244944$TEVA$$39$YR$$F$Y$$$20240923$$CN$GB$GB
243491132$24349113$2$F$20240916$20240924$20240923$20240930$PER$$US-AMGEN-USASP2024185085$AMGEN$$$$$$Y$$$20240930$$HP$US$US
243491142$24349114$2$F$20240920$20240923$20240923$20240924$PER$$US-AMGEN-USASP2024188510$AMGEN$$81$YR$E$M$Y$$$20240923$$CN$US$US
243491151$24349115$1$I$20240731$20240912$20240923$20240923$EXP$FR-AFSSAPS-AM2024000716$FR-Accord-447513$ACCORD$$20$YR$A$F$Y$80$KG$20240923$$MD$FR$FR
243491161$24349116$1$I$20240912$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024185947$AMGEN$$56$YR$A$F$Y$52$KG$20240923$$PH$US$US
243491171$24349117$1$I$20240914$20240916$20240923$20240923$EXP$$US-AMGEN-USASP2024184840$AMGEN$$73$YR$E$F$Y$$$20240923$$CN$US$US
243491192$24349119$2$F$20240920$20240923$20240923$20240924$PER$$US-AMGEN-USASP2024188793$AMGEN$$85$YR$E$F$Y$$$20240924$$CN$US$US
243491201$24349120$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188229$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243491221$24349122$1$I$20240101$20240919$20240923$20240923$PER$$US-ABBVIE-5933163$ABBVIE$$$$$$Y$$$20240923$$HP$US$US
243491231$24349123$1$I$20240301$20240918$20240923$20240923$EXP$$US-ABBVIE-5930052$ABBVIE$$71$YR$$F$Y$$$20240923$$CN$US$US
243491241$24349124$1$I$20240701$20240916$20240923$20240923$EXP$HR-HALMED-300086459$HR-TEVA-VS-3244324$TEVA$$59$YR$$M$Y$70$KG$20240923$$MD$HR$HR
243491251$24349125$1$I$$20240913$20240923$20240923$EXP$$US-BEH-2024178939$CSL BEHRING$$25$YR$A$F$Y$$$20240923$$CN$US$US
243491261$24349126$1$I$$20240828$20240923$20240923$PER$$US-SA-2024SA272166$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240923$$HP$US$US
243491271$24349127$1$I$$20240912$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005570$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243491281$24349128$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270013$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240923$$HP$US$US
243491291$24349129$1$I$20240909$20240912$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005556$ACADIA PHARMACEUTICALS$$62$YR$$M$Y$$$20240923$$CN$US$US
243491301$24349130$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA273241$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240923$$CN$US$US
243491311$24349131$1$I$20240103$20240910$20240923$20240923$EXP$$DE-CELLTRION INC.-2024DE022463$CELLTRION$$$$$$Y$$$20240923$$MD$DE$DE
243491321$24349132$1$I$20240915$20240919$20240923$20240923$PER$$US-ABBVIE-5931219$ABBVIE$$74$YR$$F$Y$96.1$KG$20240923$$CN$US$US
243491331$24349133$1$I$$20240911$20240923$20240923$EXP$$BR-Accord-447324$ACCORD$$57$YR$A$F$Y$$$20240923$$PH$BR$BR
243491341$24349134$1$I$20240101$20240917$20240923$20240923$PER$$US-ABBVIE-5930446$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243491351$24349135$1$I$20210301$20240918$20240923$20240923$EXP$NO-NOMAADVRE-PASRAPP-2024-Vp6b9x$NO-JNJFOC-20240949538$JOHNSON AND JOHNSON$$26$YR$A$M$Y$130$KG$20240923$$CN$NO$NO
243491361$24349136$1$I$20240912$20240916$20240923$20240923$EXP$$CO-RECORDATI RARE DISEASE INC.-2024007200$RECORDATI$$$$$$Y$$$20240923$$CN$CO$CO
243491381$24349138$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087707$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243491391$24349139$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087883$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243491401$24349140$1$I$$20240910$20240923$20240923$EXP$$CA-ROCHE-10000085916$ROCHE$$43$YR$A$F$Y$129$KG$20240923$$HP$CA$CA
243491411$24349141$1$I$20240903$20240912$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005602$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240923$$CN$US$US
243491421$24349142$1$I$$20240903$20240923$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08883$LUPIN$$$$$$Y$$$20240923$$CN$US$US
243491431$24349143$1$I$$20240916$20240923$20240923$EXP$$GB-ROCHE-10000086892$ROCHE$Paranavitane S, Harikrishnan S, Silber E, Brex P, William V, Falah Y, et al. Neutropaenia complicating anti-CD20 therapy in Multiple Sclerosis: A retrospective review of cases in South-East London and Kent (Abstract number: P1619/1653). Multiple Sclerosis Journal. 2024;30 (SUPP 3):1025-6.$$$$$Y$$$20240923$$HP$GB$GB
243491441$24349144$1$I$$20240918$20240923$20240923$PER$$US-ROCHE-10000085752$ROCHE$$69$YR$E$F$Y$$$20240923$$PH$US$US
243491471$24349147$1$I$$20240913$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005597$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243491481$24349148$1$I$20240910$20240913$20240923$20240923$PER$$US-GSK-US2024114330$GLAXOSMITHKLINE$$77$YR$$M$Y$$$20240923$$CN$US$US
243491491$24349149$1$I$20240901$20240916$20240923$20240923$EXP$$GB-ABBVIE-5927489$ABBVIE$$$$A$M$Y$$$20240923$$CN$GB$GB
243491501$24349150$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087808$ROCHE$$$$A$M$Y$$$20240923$$HP$US$US
243491511$24349151$1$I$20240611$20240911$20240923$20240923$EXP$$US-TAKEDA-2024TUS067044$TAKEDA$$21$YR$$M$Y$$$20240923$$CN$US$US
243491521$24349152$1$I$20240323$20240916$20240923$20240923$EXP$$CO-TAKEDA-2024TUS006231$TAKEDA$$47$YR$$M$Y$67$KG$20240923$$CN$CO$CO
243491531$24349153$1$I$$20240918$20240923$20240923$PER$$US-ABBVIE-5931351$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243491541$24349154$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150066$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240923$$CN$US$US
243491551$24349155$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147895$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240923$$CN$US$US
243491562$24349156$2$F$20240919$20240924$20240923$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149873$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240926$$HP$US$US
243491581$24349158$1$I$20240101$20240916$20240923$20240923$PER$$US-SA-2024SA269371$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240923$$MD$US$US
243491591$24349159$1$I$$20240912$20240923$20240923$PER$$US-SA-2024SA273365$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240923$$CN$US$US
243491601$24349160$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270190$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240923$$MD$US$US
243491611$24349161$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270012$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240923$$HP$US$US
243491621$24349162$1$I$20240801$20240904$20240923$20240923$PER$$US-SA-2024SA272540$SANOFI AVENTIS$$59$YR$A$M$Y$83.46$KG$20240923$$MD$US$US
243491631$24349163$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000088323$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243491641$24349164$1$I$$20240913$20240923$20240923$EXP$$IN-ROCHE-3427509$ROCHE$$83$YR$E$M$Y$$$20240923$$MD$IN$IN
243491651$24349165$1$I$20240901$20240918$20240923$20240923$EXP$$US-ABBVIE-5931381$ABBVIE$$51$YR$$F$Y$$$20240923$$CN$US$US
243491661$24349166$1$I$$20240918$20240923$20240923$EXP$$ES-TAKEDA-2024TUS093789$TAKEDA$$$$$$Y$$$20240923$$MD$ES$ES
243491671$24349167$1$I$$20240913$20240923$20240923$EXP$$NL-AMGEN-NLDSP2024184006$AMGEN$Von Dem Borne P. A.. The degree of HLA matching determines the incidence of cytokine release syndrome and associated non relapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia + Lymphoma. 2024;65 (9):1270-1280$$$A$$Y$$$20240923$$HP$NL$NL
243491681$24349168$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010514$APOTEX$$87$YR$$F$Y$$$20240923$$CN$CA$CA
243491701$24349170$1$I$$20240917$20240923$20240923$PER$$US-LEO Pharma-373625$LEO PHARM$$73$YR$$F$Y$$$20240923$$CN$US$US
243491721$24349172$1$I$$20240909$20240923$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09123$LUPIN$$$$$$Y$$$20240923$$MD$US$US
243491731$24349173$1$I$20230428$20240913$20240923$20240923$EXP$FR-AFSSAPS-DJ2023000671$FR-CELLTRION INC.-2024FR022407$CELLTRION$$$$$$Y$$$20240923$$MD$FR$FR
243491741$24349174$1$I$$20240911$20240923$20240923$EXP$$BR-TAKEDA-2024TUS091897$TAKEDA$$$$$F$Y$$$20240923$$CN$BR$BR
243491751$24349175$1$I$$20240912$20240923$20240923$EXP$$ES-AUROBINDO-AUR-APL-2024-045866$AUROBINDO$Salmons P G. Insights into new-onset arthritis in patients with hidradenitis suppurativa Garbayo-Salmons.. Acta Derm Venereol 2024. 2024;1-2$29$YR$$F$Y$$$20240923$$HP$ES$ES
243491761$24349176$1$I$20240101$20240917$20240923$20240923$EXP$$US-SA-2024SA271681$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240923$$HP$US$US
243491781$24349178$1$I$20240819$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-046041$AUROBINDO$$49$YR$$F$Y$$$20240923$$HP$FR$FR
243491791$24349179$1$I$20240801$20240828$20240923$20240923$PER$$US-SA-2024SA267119$SANOFI AVENTIS$$$$A$M$Y$71.21$KG$20240923$$MD$US$US
243491801$24349180$1$I$$20240922$20240923$20240923$PER$$NVSC2024US188618$NOVARTIS$$$$$$Y$$$20240923$$CN$US$US
243491812$24349181$2$F$$20240920$20240923$20240925$EXP$$AU-SANDOZ INC.-SDZ2024AU081950$SANDOZ$$$$$F$Y$$$20240925$$CN$AU$AU
243491821$24349182$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186924$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
243491831$24349183$1$I$20240701$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187694$AMGEN$$23$YR$A$F$Y$$$20240923$$CN$US$US
243491841$24349184$1$I$20220112$20240903$20240923$20240923$PER$$US-SA-2024SA272691$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240923$$MD$US$US
243491851$24349185$1$I$20240423$20240912$20240923$20240923$EXP$$NL-AUROBINDO-AUR-APL-2024-046146$AUROBINDO$$72$YR$$M$Y$70$KG$20240923$$PH$NL$NL
243491862$24349186$2$F$$20240920$20240923$20240928$EXP$$DE-AUROBINDO-AUR-APL-2024-046052$AUROBINDO$$$$A$$Y$$$20240928$$CN$DE$DE
243491871$24349187$1$I$$20240918$20240923$20240923$EXP$$US-TAKEDA-2023TUS012015$TAKEDA$$$$$F$Y$$$20240923$$MD$US$US
243491901$24349190$1$I$20240915$20240920$20240923$20240923$EXP$$CN-ROCHE-10000088110$ROCHE$$49$YR$A$F$Y$44$KG$20240923$$HP$CN$CN
243491921$24349192$1$I$20230501$20240913$20240923$20240923$EXP$FR-AFSSAPS-MP2023001033$FR-CELLTRION INC.-2024FR022403$CELLTRION$$$$$$Y$$$20240923$$PH$FR$FR
243491931$24349193$1$I$$20240912$20240923$20240923$PER$$US-ASTELLAS-2024-AER-006793$ASTELLAS$$47$YR$A$$Y$$$20240923$$HP$US$US
243491941$24349194$1$I$$20240909$20240923$20240923$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09176$LUPIN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Therapeutic Advances in Infectious Disease. 2022;9:1-10$36$YR$$M$Y$$$20240923$$HP$US$US
243491951$24349195$1$I$20240601$20240918$20240923$20240923$EXP$$US-ABBVIE-5930979$ABBVIE$$69$YR$$F$Y$$$20240923$$CN$US$US
243491961$24349196$1$I$20240901$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012771$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240923$$CN$US$US
243491971$24349197$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011739$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243491981$24349198$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012413$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240923$$CN$US$US
243491991$24349199$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012823$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243492001$24349200$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012938$ELI LILLY AND CO$$$$$M$Y$$$20240923$$CN$US$US
243492011$24349201$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012732$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240923$$CN$US$US
243492021$24349202$1$I$20240915$20240916$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010301$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240923$$CN$US$US
243492031$24349203$1$I$20240822$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012856$ELI LILLY AND CO$$16$YR$T$$Y$$$20240923$$CN$US$US
243492041$24349204$1$I$20240701$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011915$ELI LILLY AND CO$$25$YR$A$$Y$$$20240923$$CN$US$US
243492051$24349205$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012426$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240923$$CN$US$US
243492061$24349206$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012130$ELI LILLY AND CO$$$$A$F$Y$$$20240923$$CN$US$US
243492071$24349207$1$I$20231101$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012456$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240923$$CN$US$US
243492081$24349208$1$I$$20240909$20240923$20240923$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09180$LUPIN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of  Hansen^s disease (Leprosy): a case series  of multidrug therapy of monthly rifampin,  moxifloxacin, and minocycline (RMM) in the  United States. Therapeutic Advances in  Infectious Disease. 2022;9:1-10$20$YR$$M$Y$$$20240923$$HP$US$US
243492091$24349209$1$I$20240507$20240912$20240923$20240923$EXP$$DE-AUROBINDO-AUR-APL-2024-045999$AUROBINDO$$73$YR$$M$Y$$$20240923$$MD$DE$DE
243492101$24349210$1$I$20240601$20240920$20240923$20240923$EXP$FR-AFSSAPS-LY2024001431$NVSC2024FR187914$NOVARTIS$$56$YR$$F$Y$74$KG$20240923$$PH$FR$FR
243492111$24349211$1$I$$20240909$20240923$20240923$EXP$$US-TEYRO-2024-TY-000606$Teyro Labs$Oberstein PE, Dias Costa A, Kawaler EA, Cardot-Ruffino V, Rahma OE, Beri N, et.al.Blockade of IL1B and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.Cancer Immunol Res.2024;12(9):1221-1235$$$$F$Y$$$20240923$$HP$US$US
243492121$24349212$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150366$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240923$$CN$US$US
243492131$24349213$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150332$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240923$$CN$US$US
243492152$24349215$2$F$$20240918$20240923$20240927$EXP$$IT-AUROBINDO-AUR-APL-2024-045879$AUROBINDO$Manzon, L. Bisphosphonate therapy and osteonecrosis of the jaw complicated with a temporal abscess in an elderly woman with rheumatoid arthritis: a case report[J]. Clin Interv Aging. 2014;9:1409-1413$68$YR$$F$Y$$$20240927$$HP$IT$IT
243492162$24349216$2$F$20240920$20240923$20240923$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150270$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240924$$HP$US$US
243492171$24349217$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188234$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243492181$24349218$1$I$20240501$20240916$20240923$20240923$EXP$$US-TAKEDA-2024TUS092847$TAKEDA$$24$YR$$M$Y$$$20240923$$MD$US$US
243492191$24349219$1$I$20240829$20240917$20240923$20240923$EXP$FR-AFSSAPS-MP2024001367$FR-GSK-FR2024115531$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$PH$FR$FR
243492211$24349221$1$I$$20240920$20240923$20240923$EXP$$NVSC2024PT188250$NOVARTIS$$58$YR$$M$Y$$$20240923$$MD$PT$PT
243492221$24349222$1$I$$20240918$20240923$20240923$EXP$$JP-EXELIXIS-CABO-23065166$EXELIXIS$$68$YR$$M$Y$$$20240923$$MD$JP$JP
243492231$24349223$1$I$20240101$20240917$20240923$20240923$EXP$$US-AMGEN-USASP2024184519$AMGEN$$70$YR$E$F$Y$$$20240923$$PH$US$US
243492241$24349224$1$I$20240917$20240918$20240923$20240923$EXP$$US-ABBVIE-5931435$ABBVIE$$58$YR$$M$Y$$$20240923$$CN$US$US
243492251$24349225$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187219$AMGEN$$$$A$F$Y$$$20240923$$HP$US$US
243492261$24349226$1$I$$20240916$20240923$20240923$EXP$$AR-GSK-AR2024AMR115815$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$AR$AR
243492301$24349230$1$I$$20240918$20240923$20240923$EXP$$JP-EXELIXIS-EXL-2024-000415$EXELIXIS$$71$YR$$M$Y$$$20240923$$MD$JP$JP
243492311$24349231$1$I$$20240909$20240923$20240923$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09181$LUPIN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of  Hansen^s disease (Leprosy): a case series  of multidrug therapy of monthly rifampin,  moxifloxacin, and minocycline (RMM) in the  United States. Therapeutic Advances in Infectious Disease. 2022;9:1-10$27$YR$$M$Y$$$20240923$$HP$US$US
243492321$24349232$1$I$20240816$20240913$20240923$20240923$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-117545$REGENERON$$67$YR$$F$Y$$$20240923$$HP$CO$CO
243492331$24349233$1$I$$20240909$20240923$20240923$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09174$LUPIN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Therapeutic Advances in Infectious Disease. 2022;9:1-10$72$YR$$F$Y$$$20240923$$HP$US$US
243492341$24349234$1$I$$20240903$20240923$20240923$PER$$US-ABBVIE-5930891$ABBVIE$$$$$$Y$$$20240923$$HP$US$US
243492351$24349235$1$I$$20240918$20240923$20240923$EXP$$CA-ABBVIE-5930404$ABBVIE$$73$YR$$F$Y$$$20240923$$HP$CA$CA
243492361$24349236$1$I$$20240903$20240923$20240923$PER$$US-ABBVIE-5930893$ABBVIE$$$$$$Y$$$20240923$$HP$US$US
243492371$24349237$1$I$$20240909$20240923$20240923$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09178$LUPIN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Therapeutic Advances in Infectious Disease. 2022;9:1-10$39$YR$$M$Y$$$20240923$$HP$US$US
243492381$24349238$1$I$$20240909$20240923$20240923$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09173$LUPIN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al.. Novel approaches in the treatment of  Hansen^s disease (Leprosy): a case series  of multidrug therapy of monthly rifampin,  moxifloxacin, and minocycline (RMM) in the  United States. Therapeutic Advances in Infectious Disease. 2022;9:1-10$77$YR$$M$Y$$$20240923$$HP$US$US
243492391$24349239$1$I$20240803$20240913$20240923$20240923$EXP$$DE-TAKEDA-2020TUS048638$TAKEDA$$50$YR$$F$Y$$$20240923$$CN$DE$DE
243492401$24349240$1$I$20240901$20240917$20240923$20240923$PER$$US-SA-2024SA270198$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240923$$HP$US$US
243492411$24349241$1$I$20240301$20240917$20240923$20240923$PER$$US-SA-2024SA269066$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240923$$MD$US$US
243492421$24349242$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA271635$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240923$$MD$US$US
243492431$24349243$1$I$20240911$20240912$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005537$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240923$$CN$US$US
243492451$24349245$1$I$20240101$20240911$20240923$20240923$PER$$US-SA-2024SA266767$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240923$$HP$US$US
243492461$24349246$1$I$20220812$20240913$20240923$20240923$EXP$FR-AFSSAPS-AN20222365$FR-TEVA-2022-FR-2828150$TEVA$$66$YR$$F$Y$78$KG$20240923$$PH$FR$FR
243492471$24349247$1$I$20240101$20240920$20240923$20240923$EXP$$NVSC2024FI188090$NOVARTIS$$$$$$Y$$$20240923$$MD$FI$FI
243492491$24349249$1$I$$20240910$20240923$20240923$EXP$$TZ-862174955-ML2024-04914$MICRO LABS$Alphonce B, Komanya F, Magitta NF, Deodatus S, Sindato E. Amoxicillin-induced DRESS syndrome without eosinophilia. Clinical Case Reports. 2024;12: 1-4. doi:10.1002/ccr3.9333.$47$YR$A$F$Y$$$20240923$$HP$TZ$TZ
243492501$24349250$1$I$$20240910$20240923$20240923$EXP$$TN-862174955-ML2024-04915$MICRO LABS$Laroussi S, Bouattour N, Daoud S, Moalla KS, Sakka S, Damak M, et al. Reversible dementia and seizures due to metformin-induced vitamin B12 deficiency. Encephale. 2024;50(4): 474-477. doi:10.1016/j.encep.2023.11.030.$64$YR$A$F$Y$$$20240923$$HP$TN$TN
243492511$24349251$1$I$20191006$20240918$20240923$20240923$EXP$$US-TAKEDA-US201938743$TAKEDA$$76$YR$$M$Y$85$KG$20240923$$HP$US$US
243492521$24349252$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188249$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243492531$24349253$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188241$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243492541$24349254$1$I$20240918$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186775$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243492551$24349255$1$I$$20240909$20240923$20240923$EXP$$US-BAXTER-2024BAX024455$BAXTER$$$$$M$Y$$$20240923$$CN$US$US
243492561$24349256$1$I$20240828$20240909$20240923$20240923$EXP$CN-NMPACDR-6608011032345202400547$CN-BAXTER-2024BAX024569$BAXTER$$74$YR$$F$Y$48$KG$20240923$$MD$CN$CN
243492571$24349257$1$I$$20240909$20240923$20240923$EXP$$CA-APOTEX-2024AP010357$APOTEX$$65$YR$$F$Y$$$20240923$$MD$CA$CA
243492601$24349260$1$I$20240826$20240910$20240923$20240923$EXP$CN-NMPACDR-3704011509867202400770$CN-BAXTER-2024BAX024629$BAXTER$$51$YR$$F$Y$58$KG$20240923$$MD$CN$CN
243492611$24349261$1$I$20240101$20240903$20240923$20240923$PER$$US-TEVA-VS-3242062$TEVA$$63$YR$$F$Y$$$20240923$$CN$US$US
243492621$24349262$1$I$20230101$20240913$20240923$20240923$EXP$$CA-BEH-2024168737$CSL BEHRING$$68$YR$E$M$Y$58.7$KG$20240923$$CN$CA$CA
243492631$24349263$1$I$20200316$20240918$20240923$20240923$EXP$$US-TAKEDA-US202015455$TAKEDA$$77$YR$$M$Y$80$KG$20240923$$HP$US$US
243492641$24349264$1$I$$20240912$20240923$20240923$EXP$$NL-AUROBINDO-AUR-APL-2024-046074$AUROBINDO$$15$YR$$M$Y$80$KG$20240923$$CN$NL$NL
243492652$24349265$2$F$20240101$20240913$20240923$20240925$PER$$US-SA-2024SA273294$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240925$$CN$US$US
243492661$24349266$1$I$20240722$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045938$AUROBINDO$$70$YR$$F$Y$$$20240923$$PH$FR$FR
243492671$24349267$1$I$20240101$20240904$20240923$20240923$PER$$US-SA-2024SA273074$SANOFI AVENTIS$$$$$F$Y$$$20240923$$MD$US$US
243492681$24349268$1$I$20240101$20240831$20240923$20240923$PER$$US-SA-2024SA272931$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240923$$CN$US$US
243492691$24349269$1$I$$20240910$20240923$20240923$PER$$US-SA-2024SA273013$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240923$$CN$US$US
243492701$24349270$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA272887$SANOFI AVENTIS$$$$A$M$Y$$$20240923$$HP$US$US
243492711$24349271$1$I$$20240918$20240923$20240923$EXP$$NVSC2024FR188285$NOVARTIS$$$$E$$Y$$$20240923$$MD$FR$FR
243492721$24349272$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188248$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243492731$24349273$1$I$20240911$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150257$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240923$$CN$US$US
243492741$24349274$1$I$20211217$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149448$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243492751$24349275$1$I$$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149523$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243492761$24349276$1$I$20240807$20240912$20240923$20240923$EXP$$DE-AUROBINDO-AUR-APL-2024-045993$AUROBINDO$$77$YR$$F$Y$62$KG$20240923$$MD$DE$DE
243492772$24349277$2$F$$20240918$20240923$20240927$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-03465$AMNEAL$$$$$$Y$$$20240927$$PH$JP$JP
243492801$24349280$1$I$$20240909$20240923$20240923$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09177$LUPIN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Therapeutic Advances in Infectious Disease. 2022;9:1-10$17$YR$$M$Y$$$20240923$$HP$US$US
243492811$24349281$1$I$$20240915$20240923$20240923$EXP$$KR-JNJFOC-20240947808$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$KR$AU
243492821$24349282$1$I$20240918$20240919$20240923$20240923$EXP$GB-MHRA-MED-202409180915187920-KDJPT$GB-SANDOZ INC.-SDZ2024GB081944$SANDOZ$$37$YR$$F$Y$70$KG$20240923$$MD$GB$GB
243492832$24349283$2$F$$20240915$20240923$20240924$EXP$$US-JNJFOC-20240952294$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20240924$$HP$US$US
243492861$24349286$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000085216$ROCHE$$$$$M$Y$$$20240923$$CN$US$US
243492891$24349289$1$I$$20240920$20240923$20240923$PER$$US-HALEON-2197970$Haleon PLC$$$$$$Y$$$20240923$$CN$US$US
243492902$24349290$2$F$20240919$20240924$20240923$20240927$PER$$US-AMGEN-USASP2024188829$AMGEN$$67$YR$E$M$Y$$$20240927$$CN$US$US
243492911$24349291$1$I$$20240916$20240923$20240923$EXP$$ES-ROCHE-10000086354$ROCHE$Moral A, Ruiz R, Garc?a-Soto J, Et.al. efficacy and security of ocrelizumab in patients with remittent recurrent multiple sclerosis (rrms) in a tertiary care hospital multiple sclerosis unit.. Multiple Sclerosis Journal. 2024;30 (3S):1118.$$$$$Y$$$20240923$$HP$ES$ES
243492921$24349292$1$I$20240723$20240918$20240923$20240923$EXP$$US-ROCHE-10000085936$ROCHE$$47$YR$A$M$Y$$$20240923$$MD$US$US
243492931$24349293$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000084736$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243492951$24349295$1$I$20240801$20240906$20240923$20240923$PER$$US-SA-2024SA272962$SANOFI AVENTIS$$14$YR$T$M$Y$75$KG$20240923$$MD$US$US
243492961$24349296$1$I$20240501$20240918$20240923$20240923$EXP$GB-MHRA-MED-202409181943524990-MQWCG$GB-SA-2024SA271292$SANOFI AVENTIS$$$$$F$Y$71$KG$20240923$$CN$GB$GB
243492971$24349297$1$I$20240801$20240916$20240923$20240923$PER$$US-SA-2024SA269210$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240923$$MD$US$US
243492981$24349298$1$I$$20240917$20240923$20240923$PER$$US-SA-2023SA137509$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240923$$MD$US$US
243492991$24349299$1$I$20220101$20240915$20240923$20240923$EXP$$RS-009507513-2409SRB006346$MERCK$$$$A$F$Y$$$20240923$$MD$RS$RS
243493001$24349300$1$I$$20240916$20240923$20240923$EXP$CA-NEBO-669904$CA-NEBO-669904$PHARMACOSMOS$$44$YR$$F$Y$$$20240923$$HP$CA$CA
243493011$24349301$1$I$$20240917$20240923$20240923$EXP$$US-AMGEN-USASP2024186276$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
243493021$24349302$1$I$$20240909$20240923$20240923$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09175$LUPIN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Therapeutic Advances in Infectious Disease. 2022;9:1-10$37$YR$$M$Y$$$20240923$$HP$US$US
243493031$24349303$1$I$$20240919$20240923$20240923$EXP$$GB-SANDOZ INC.-SDZ2024GB081870$SANDOZ$$$$$M$Y$$$20240923$$CN$GB$GB
243493041$24349304$1$I$20240101$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187187$AMGEN$$67$YR$E$F$Y$$$20240923$$CN$US$US
243493051$24349305$1$I$20240806$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045935$AUROBINDO$$44$YR$$F$Y$58$KG$20240923$$MD$FR$FR
243493061$24349306$1$I$20240816$20240828$20240923$20240923$EXP$$TR-CELLTRION INC.-2024TR022480$CELLTRION$$$$$$Y$$$20240923$$HP$TR$TR
243493081$24349308$1$I$$20240918$20240923$20240923$PER$$US-ABBVIE-5931764$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243493091$24349309$1$I$$20240918$20240923$20240923$EXP$$CA-ROCHE-3524048$ROCHE$$$$A$M$Y$$$20240923$$CN$CA$CA
243493101$24349310$1$I$$20240920$20240923$20240923$PER$$NVSC2024US188865$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243493111$24349311$1$I$$20240910$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045444$AUROBINDO$Dotson AD, Fingert JH, Boese EA. Unsuccessful transscleral cyclophotocoagulation in oculocutaneous albinism.. Am-J-Ophthalmol-Case-Rep. 2024$35$YR$$F$Y$$$20240923$$HP$US$US
243493121$24349312$1$I$$20240913$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US081941$SANDOZ$$$$$$Y$$$20240923$$HP$US$US
243493131$24349313$1$I$20240101$20240919$20240923$20240923$EXP$$DE-SANDOZ INC.-SDZ2024DE081625$SANDOZ$$82$YR$$M$Y$$$20240923$$PH$DE$DE
243493141$24349314$1$I$$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013503$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240923$$CN$US$US
243493151$24349315$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012586$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243493161$24349316$1$I$20240919$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012563$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240923$$CN$US$US
243493171$24349317$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011941$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240923$$CN$US$US
243493181$24349318$1$I$20240901$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012577$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240923$$CN$US$US
243493191$24349319$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011024$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240923$$CN$US$US
243493201$24349320$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012184$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240923$$CN$US$US
243493211$24349321$1$I$$20240910$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409006694$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240923$$CN$US$US
243493221$24349322$1$I$20240817$20240912$20240923$20240923$EXP$FR-AFSSAPS-RN2024000956$FR-Accord-446845$ACCORD$$44$YR$A$F$Y$$$20240923$$MD$FR$FR
243493231$24349323$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA272379$SANOFI AVENTIS$$$$T$F$Y$65.7$KG$20240923$$MD$US$US
243493241$24349324$1$I$20240101$20240904$20240923$20240923$PER$$US-SA-2024SA272564$SANOFI AVENTIS$$33$YR$A$F$Y$68.18$KG$20240923$$MD$US$US
243493261$24349326$1$I$$20240918$20240923$20240923$PER$$US-JNJFOC-20240951757$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$CN$US$US
243493271$24349327$1$I$$20240912$20240923$20240923$EXP$$TW-JNJFOC-20240934268$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240923$$HP$TW$TW
243493281$24349328$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5931485$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243493291$24349329$1$I$$20240911$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005518$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243493311$24349331$1$I$$20240909$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-044968$AUROBINDO$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM, et al.. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis.. Semin-Arthritis-Rheum. 2024;67$58$YR$$M$Y$$$20240923$$HP$US$US
243493331$24349333$1$I$20240801$20240920$20240923$20240923$PER$$US-ROCHE-10000088409$ROCHE$$55$YR$A$M$Y$$$20240923$$CN$US$US
243493341$24349334$1$I$20240821$20240920$20240923$20240923$PER$$US-ABBVIE-5933749$ABBVIE$$38$YR$$F$Y$106$KG$20240923$$CN$US$US
243493351$24349335$1$I$$20240919$20240923$20240923$EXP$$CA-ROCHE-3301712$ROCHE$$$$A$F$Y$$$20240923$$CN$CA$CA
243493361$24349336$1$I$20240516$20240911$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045708$AUROBINDO$$71$YR$$M$Y$64$KG$20240923$$PH$FR$FR
243493371$24349337$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA269398$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240923$$HP$US$US
243493401$24349340$1$I$$20240907$20240923$20240923$PER$$US-ASTELLAS-2024-AER-006498$ASTELLAS$$$$$M$Y$$$20240923$$MD$US$US
243493411$24349341$1$I$$20240904$20240923$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08980$LUPIN$$$$$$Y$$$20240923$$CN$US$US
243493421$24349342$1$I$20240822$20240911$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005558$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240923$$CN$US$US
243493431$24349343$1$I$$20240917$20240923$20240923$EXP$$US-AMGEN-USASL2024187214$AMGEN$$72$YR$E$F$Y$61.3$KG$20240923$$HP$US$US
243493441$24349344$1$I$20230102$20240918$20240923$20240923$EXP$$KR-AMGEN-KORSP2024187253$AMGEN$Lee E.; Choi W. J.; Lee J. et al.. Outcomes of hematopoietic stem cell transplantation in patients with SARS-CoV-2 infection during the Omicron era. International Journal of Infectious Diseases. 2024;147:1-4$44$YR$A$M$Y$$$20240923$$HP$KR$KR
243493451$24349345$1$I$20220601$20240911$20240923$20240923$EXP$$RO-AUROBINDO-AUR-APL-2024-045690$AUROBINDO$$70$YR$$M$Y$$$20240923$$MD$RO$RO
243493461$24349346$1$I$$20240911$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045890$AUROBINDO$$$$$F$Y$$$20240923$$CN$US$US
243493471$24349347$1$I$20230331$20240916$20240923$20240923$EXP$$BR-TAKEDA-2023TUS036775$TAKEDA$$40$YR$$F$Y$$$20240923$$CN$BR$BR
243493481$24349348$1$I$$20240904$20240923$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08954$LUPIN$$$$$$Y$$$20240923$$CN$US$US
243493491$24349349$1$I$20240909$20240911$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005561$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240923$$CN$US$US
243493501$24349350$1$I$20240101$20240910$20240923$20240923$EXP$$CA-UCBSA-2024046112$UCB$$$$$F$Y$$$20240923$$CN$CA$CA
243493511$24349351$1$I$$20240912$20240923$20240923$PER$$US-Nobelpharma America, LLC-NPA-2024-01628$NOBELPHARMA$$15$YR$T$M$Y$$$20240923$$CN$COUNTRY NOT SPECIFIED$US
243493521$24349352$1$I$20230901$20240910$20240923$20240923$PER$$US-Nobelpharma America, LLC-NPA-2024-01627$NOBELPHARMA$$6$YR$C$M$Y$$$20240923$$PH$US$US
243493531$24349353$1$I$20240101$20240912$20240923$20240923$EXP$$US-INSMED, INC.-2024-03437-US$INSMED$$$$$F$Y$$$20240923$$CN$US$US
243493541$24349354$1$I$20231001$20240913$20240923$20240923$PER$$US-Nobelpharma America, LLC-NPA-2024-01648$NOBELPHARMA$$13$YR$T$F$Y$$$20240923$$PH$US$US
243493551$24349355$1$I$$20240919$20240923$20240923$EXP$$IT-AMGEN-ITASP2024188445$AMGEN$Modica R.; Benevento E.; Altieri B. et al.. Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis. International Journal of Molecular Sciences. 2024;25 (16):1-13$$$$$Y$$$20240923$$HP$IT$IT
243493561$24349356$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188196$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243493571$24349357$1$I$$20240913$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005580$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243493581$24349358$1$I$20200101$20240913$20240923$20240923$EXP$$ES-IPCA LABORATORIES LIMITED-IPC-2024-ES-002245$IPCA$Lucia Cobarro Galvez, Silvia Valbuena-Lopez, Elsa Prieto Moriche et al.. Hydroxychloroquine-induced cardiomyopathy: role of cardiac magnetic resonance for the diagnosis and follow-up of a very rare entity-a case report. European Heart Journal - Case Reports. 2024;8:1-5$$$$$Y$$$20240923$$HP$ES$ES
243493601$24349360$1$I$20240822$20240912$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045846$AUROBINDO$$71$YR$$F$Y$$$20240923$$CN$GB$GB
243493611$24349361$1$I$20240830$20240903$20240923$20240923$EXP$$US-SA-2024SA273125$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240923$$PH$US$US
243493621$24349362$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA269216$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240923$$MD$US$US
243493631$24349363$1$I$$20240910$20240923$20240923$PER$$US-SA-2024SA273247$SANOFI AVENTIS$$$$A$M$Y$$$20240923$$CN$US$US
243493641$24349364$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270033$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240923$$HP$US$US
243493661$24349366$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA181104$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240923$$MD$US$US
243493681$24349368$1$I$$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024185787$AMGEN$$$$$F$Y$$$20240923$$MD$US$US
243493691$24349369$1$I$$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024186894$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243493711$24349371$1$I$$20240912$20240923$20240923$PER$$US-ASTELLAS-2024-AER-006743$ASTELLAS$$71$YR$E$M$Y$$$20240923$$HP$US$US
243493731$24349373$1$I$20240831$20240916$20240923$20240923$EXP$$US-GSK-US2024AMR115829$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$US$US
243493741$24349374$1$I$20240101$20240918$20240923$20240923$EXP$$CA-ABBVIE-5930458$ABBVIE$$63$YR$$M$Y$$$20240923$$CN$CA$CA
243493751$24349375$1$I$$20240914$20240923$20240923$PER$$US-HALEON-2197147$Haleon PLC$$$$$$Y$$$20240923$$CN$US$US
243493771$24349377$1$I$20240801$20240913$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005603$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20240923$$CN$US$US
243493781$24349378$1$I$20240823$20240918$20240923$20240923$EXP$$NVSC2024CN187617$NOVARTIS$$83$YR$$F$Y$46$KG$20240923$$HP$CN$CN
243493801$24349380$1$I$$20240905$20240923$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08962$LUPIN$$$$$$Y$$$20240923$$CN$US$US
243493811$24349381$1$I$$20240913$20240923$20240923$EXP$$BR-TAKEDA-2024TUS092934$TAKEDA$$$$$M$Y$17$KG$20240923$$CN$BR$BR
243493831$24349383$1$I$$20240915$20240923$20240923$EXP$$US-JNJFOC-20240952298$JOHNSON AND JOHNSON$$19$YR$A$F$Y$$$20240923$$HP$US$US
243493841$24349384$1$I$$20240918$20240923$20240923$PER$$US-ABBVIE-5932706$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243493851$24349385$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114336$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243493861$24349386$1$I$20240901$20240913$20240923$20240923$PER$$US-ROCHE-10000082827$ROCHE$$30$YR$A$M$Y$68.04$KG$20240923$$CN$US$US
243493871$24349387$1$I$$20240916$20240923$20240923$EXP$$US-ROCHE-10000083570$ROCHE$$62$YR$A$M$Y$$$20240923$$CN$US$US
243493881$24349388$1$I$$20240913$20240923$20240923$EXP$$GB-CELLTRION INC.-2024GB022319$CELLTRION$$$$$$Y$$$20240923$$CN$GB$GB
243493892$24349389$2$F$20201001$20240917$20240923$20240926$EXP$$JP-ROCHE-10000085875$ROCHE$$4$DEC$A$F$Y$$$20240926$$MD$JP$JP
243493901$24349390$1$I$$20240917$20240923$20240923$EXP$$CA-TAKEDA-2024TUS093330$TAKEDA$$$$$F$Y$$$20240923$$CN$CA$CA
243493911$24349391$1$I$$20240910$20240923$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09100$LUPIN$$$$$$Y$$$20240923$$CN$US$US
243493931$24349393$1$I$20240508$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149408$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243493941$24349394$1$I$$20240917$20240923$20240923$EXP$US-MLMSERVICE-20240911-PI187763-00175-2$US-RDY-SPO/USA/24/0013734$DR REDDYS$Weinstein T, Altshuler D, Lafond E, Katz A. Elevated Anti-Xa in the Setting of Prophylactic Unfractionated Subcutaneous Heparin Administration. Journal of pharmacy practice. 2024;37(5):1209-13. DOI: 10.1177/08971900241228951.$85$YR$E$F$Y$57.9$KG$20240923$$PH$US$US
243493951$24349395$1$I$$20240913$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005612$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243493961$24349396$1$I$$20240913$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005620$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243493972$24349397$2$F$$20240916$20240923$20240927$EXP$$US-BEH-2024178804$CSL BEHRING$$19$YR$A$F$Y$112.47$KG$20240927$$CN$US$US
243493981$24349398$1$I$20240501$20240919$20240923$20240923$PER$$NVSC2024US188063$NOVARTIS$$$$$M$Y$$$20240923$$HP$US$US
243493991$24349399$1$I$$20240913$20240923$20240923$PER$$US-ABBVIE-5924303$ABBVIE$$$$A$$Y$$$20240923$$MD$US$US
243494011$24349401$1$I$20240527$20240916$20240923$20240923$EXP$FR-AFSSAPS-AVMA2024000395$FR-TEVA-VS-3244103$TEVA$$43$YR$$M$Y$$$20240923$$PH$FR$FR
243494021$24349402$1$I$20240901$20240913$20240923$20240923$PER$$US-ABBVIE-5924258$ABBVIE$$69$YR$$F$Y$$$20240923$$CN$US$US
243494031$24349403$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010513$APOTEX$$34$YR$$F$Y$81$KG$20240923$$MD$CA$CA
243494041$24349404$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114355$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243494051$24349405$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187153$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243494071$24349407$1$I$20240918$20240916$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010244$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240923$$CN$US$US
243494081$24349408$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012153$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240923$$CN$US$US
243494091$24349409$1$I$20240130$20240912$20240923$20240923$EXP$$CA-TAKEDA-2022TUS069136$TAKEDA$$49$YR$$M$Y$$$20240923$$CN$CA$CA
243494101$24349410$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011017$ELI LILLY AND CO$$23$YR$A$M$Y$$$20240923$$CN$US$US
243494121$24349412$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012788$ELI LILLY AND CO$$$$A$F$Y$$$20240923$$CN$US$US
243494131$24349413$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013368$ELI LILLY AND CO$$87$YR$E$M$Y$$$20240923$$CN$US$US
243494141$24349414$1$I$20240826$20240916$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012319$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240923$$CN$US$US
243494151$24349415$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011672$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240923$$CN$US$US
243494161$24349416$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012101$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243494172$24349417$2$F$20240501$20240916$20240923$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409012982$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240927$$CN$US$US
243494181$24349418$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012431$ELI LILLY AND CO$$$$$F$Y$$$20240923$$HP$US$US
243494191$24349419$1$I$20240101$20240829$20240923$20240923$PER$$US-SA-2024SA205798$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240923$$MD$US$US
243494201$24349420$1$I$20231001$20240919$20240923$20240923$EXP$$CA-TAKEDA-2024TUS093941$TAKEDA$$49$YR$$M$Y$$$20240923$$MD$CA$CA
243494211$24349421$1$I$$20240918$20240923$20240923$EXP$$CA-TAKEDA-2024TUS093587$TAKEDA$$$$$F$Y$$$20240923$$MD$CA$CA
243494221$24349422$1$I$$20240918$20240923$20240923$EXP$$CA-TAKEDA-2024TUS093461$TAKEDA$$$$$F$Y$$$20240923$$MD$CA$CA
243494232$24349423$2$F$$20240920$20240923$20240926$EXP$$CA-ABBVIE-5930041$ABBVIE$$$$A$F$Y$$$20240926$$HP$CA$CA
243494241$24349424$1$I$20240101$20240916$20240923$20240923$EXP$$DE-TAKEDA-2024TUS092018$TAKEDA$$$$$F$Y$$$20240923$$HP$DE$DE
243494251$24349425$1$I$20240917$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024185758$AMGEN$$41$YR$A$M$Y$$$20240923$$CN$US$US
243494261$24349426$1$I$$20240913$20240923$20240923$EXP$$CA-TAKEDA-2024TUS092577$TAKEDA$$$$$F$Y$$$20240923$$CN$CA$CA
243494271$24349427$1$I$$20240916$20240923$20240923$EXP$$CA-TAKEDA-2024TUS092833$TAKEDA$$$$$F$Y$$$20240923$$MD$CA$CA
243494282$24349428$2$F$20240920$20240923$20240923$20240924$PER$$US-AMGEN-USASP2024188466$AMGEN$$51$YR$A$F$Y$$$20240923$$CN$US$US
243494301$24349430$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010500$APOTEX$$52$YR$$F$Y$$$20240923$$HP$CA$CA
243494311$24349431$1$I$$20240912$20240923$20240923$PER$$US-ABBVIE-5924192$ABBVIE$$$$$M$Y$$$20240923$$HP$US$US
243494321$24349432$1$I$$20240917$20240923$20240923$EXP$$US-SA-2024SA270174$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240923$$MD$US$US
243494341$24349434$1$I$$20240915$20240923$20240923$EXP$$US-JNJFOC-20240952285$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240923$$HP$US$US
243494351$24349435$1$I$20240815$20240919$20240923$20240923$EXP$$CA-TAKEDA-2024TUS093960$TAKEDA$$67$YR$$M$Y$$$20240923$$MD$CA$CA
243494361$24349436$1$I$20240902$20240903$20240923$20240923$PER$$US-SA-2024SA272494$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240923$$MD$US$US
243494371$24349437$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114349$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240923$$CN$US$US
243494381$24349438$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA272725$SANOFI AVENTIS$$$$A$F$Y$84.55$KG$20240923$$MD$US$US
243494391$24349439$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA273113$SANOFI AVENTIS$$$$E$F$Y$$$20240923$$MD$US$US
243494401$24349440$1$I$$20240909$20240923$20240923$PER$$US-SA-2023SA213125$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240923$$HP$US$US
243494411$24349441$1$I$20240901$20240903$20240923$20240923$PER$$US-SA-2024SA273135$SANOFI AVENTIS$$58$YR$A$F$Y$63.64$KG$20240923$$MD$US$US
243494421$24349442$1$I$20240101$20240905$20240923$20240923$PER$$US-SA-2024SA272597$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240923$$MD$US$US
243494431$24349443$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA273128$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240923$$CN$US$US
243494441$24349444$1$I$$20240916$20240923$20240923$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001889$BLUEPRINT MEDICINES$$$$$M$Y$$$20240923$$CN$US$US
243494451$24349445$1$I$20240307$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149491$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243494461$24349446$1$I$20230821$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149426$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243494481$24349448$1$I$$20240914$20240923$20240923$EXP$$US-EMD Serono-2024049561$EMD SERONO INC$$72$YR$E$M$Y$$$20240923$$MD$US$US
243494491$24349449$1$I$20240827$20240912$20240923$20240923$EXP$$GB-BAXTER-2024BAX024610$BAXTER$$77$YR$$F$Y$58$KG$20240923$$MD$GB$GB
243494501$24349450$1$I$$20240829$20240923$20240923$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03196$AMNEAL$$$$$$Y$$$20240923$$CN$US$US
243494511$24349451$1$I$20240905$20240912$20240923$20240923$EXP$CN-NMPACDR-3708281020400202400643$CN-BAXTER-2024BAX024714$BAXTER$$52$YR$$M$Y$63$KG$20240923$$MD$CN$CN
243494521$24349452$1$I$$20240712$20240923$20240923$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02979$AMNEAL$$$$$$Y$$$20240923$$PH$US$US
243494531$24349453$1$I$$20240917$20240923$20240923$EXP$$JP-ASTELLAS-2024-AER-007275$ASTELLAS$$8$YR$C$F$Y$25$KG$20240923$$PH$JP$JP
243494551$24349455$1$I$$20240917$20240923$20240923$EXP$NL-LRB-01000899$NL-TEVA-VS-3244554$TEVA$$77$YR$$M$Y$80$KG$20240923$$MD$NL$NL
243494571$24349457$1$I$$20240919$20240923$20240923$PER$$US-ABBVIE-5932558$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243494581$24349458$1$I$$20240904$20240923$20240923$EXP$$US-MYLANLABS-2024M1085955$MYLAN$$34$YR$$F$Y$$$20240923$$CN$US$US
243494591$24349459$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114369$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243494601$24349460$1$I$$20240912$20240923$20240923$EXP$$US-INSMED-2023-04982-USAA$INSMED$$$$$F$Y$$$20240923$$CN$US$US
243494621$24349462$1$I$$20240917$20240923$20240923$EXP$$US-TAKEDA-2024TUS092905$TAKEDA$$$$$F$Y$$$20240923$$CN$US$US
243494641$24349464$1$I$20240919$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149748$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$109.77$KG$20240923$$CN$US$US
243494651$24349465$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150132$BRISTOL MYERS SQUIBB$$38$YR$A$F$Y$$$20240923$$HP$US$US
243494661$24349466$1$I$20230921$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149470$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243494671$24349467$1$I$20240918$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150095$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240923$$CN$US$US
243494682$24349468$2$F$20240919$20240919$20240923$20240927$PER$$US-AMGEN-USASP2024187998$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243494691$24349469$1$I$20240626$20240909$20240923$20240923$EXP$$IT-CIPLA LTD.-2024IT09978$CIPLA$$$$$$Y$$$20240923$$PH$IT$IT
243494701$24349470$1$I$$20240916$20240923$20240923$PER$$US-PHARMING-PHAUS2024000814$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243494711$24349471$1$I$$20240918$20240923$20240923$PER$$US-PHARMING-PHAUS2024000820$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243494722$24349472$2$F$$20240923$20240923$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150314$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$78.2$KG$20240926$$PH$US$US
243494731$24349473$1$I$$20240913$20240923$20240923$PER$$US-PHARMING-PHAUS2024000813$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243494741$24349474$1$I$$20240917$20240923$20240923$PER$$US-PHARMING-PHAUS2024000823$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243494751$24349475$1$I$$20240913$20240923$20240923$PER$$US-PHARMING-PHAUS2024000805$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243494761$24349476$1$I$$20240913$20240923$20240923$PER$$US-PHARMING-PHAUS2024000806$PHARMING GROUP$$$$$$Y$$$20240923$$MD$US$US
243494771$24349477$1$I$$20240913$20240923$20240923$PER$$US-PHARMING-PHAUS2024000811$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243494781$24349478$1$I$20240908$20240915$20240923$20240923$EXP$$CN-SANDOZ INC.-SDZ2024CN081730$SANDOZ$$67$YR$$M$Y$65$KG$20240923$$HP$CN$CN
243494791$24349479$1$I$$20240916$20240923$20240923$PER$$US-PHARMING-PHAUS2024000817$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243494801$24349480$1$I$$20240916$20240923$20240923$PER$$US-PHARMING-PHAUS2024000810$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243494811$24349481$1$I$$20240916$20240923$20240923$PER$$US-PHARMING-PHAUS2024000821$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243494821$24349482$1$I$$20240902$20240923$20240923$EXP$$AU-TEVA-VS-3211610$TEVA$$57$YR$$F$Y$$$20240923$$PH$AU$AU
243494831$24349483$1$I$20240831$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188992$AMGEN$$68$YR$E$M$Y$$$20240923$$CN$US$US
243494841$24349484$1$I$20240919$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187379$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243494851$24349485$1$I$20240903$20240913$20240923$20240923$EXP$$CN-TAKEDA-2024TUS093836$TAKEDA$$62$YR$$F$Y$80$KG$20240923$$MD$CN$CN
243494861$24349486$1$I$$20240913$20240923$20240923$PER$$US-PHARMING-PHAUS2024000815$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243494872$24349487$2$F$20240909$20240923$20240923$20240924$PER$$US-AMGEN-USASP2024188832$AMGEN$$90$YR$E$F$Y$$$20240924$$CN$US$US
243494881$24349488$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187690$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
243494891$24349489$1$I$20140101$20240918$20240923$20240923$EXP$$US-JNJFOC-20240953971$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$CN$US$US
243494901$24349490$1$I$20240101$20240912$20240923$20240923$EXP$$US-INSMED, INC.-2024-03714-US$INSMED$$$$$F$Y$$$20240923$$CN$US$US
243494911$24349491$1$I$20240101$20240919$20240923$20240923$PER$$US-BIOGEN-2024BI01283472$BIOGEN$$50$YR$$M$Y$$$20240923$$CN$US$US
243494921$24349492$1$I$20240726$20240916$20240923$20240923$PER$$US-PHARMING-PHAUS2024000812$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243494931$24349493$1$I$$20240913$20240923$20240923$EXP$$GR-CELLTRION INC.-2024GR022401$CELLTRION$$$$$$Y$$$20240923$$MD$GR$GR
243494961$24349496$1$I$20240730$20240912$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045830$AUROBINDO$$72$YR$$M$Y$$$20240923$$MD$GB$GB
243494981$24349498$1$I$20240826$20240904$20240923$20240923$PER$$US-SA-2024SA272992$SANOFI AVENTIS$$41$YR$A$F$Y$68.18$KG$20240923$$MD$US$US
243494991$24349499$1$I$$20240905$20240923$20240923$PER$$US-SA-2024SA273048$SANOFI AVENTIS$$$$E$F$Y$$$20240923$$MD$US$US
243495001$24349500$1$I$$20240905$20240923$20240923$PER$$US-SA-2024SA272914$SANOFI AVENTIS$$63$YR$A$M$Y$112.73$KG$20240923$$MD$US$US
243495011$24349501$1$I$20240101$20240917$20240923$20240923$PER$$US-SA-2024SA269960$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240923$$HP$US$US
243495021$24349502$1$I$20240101$20240909$20240923$20240923$PER$$US-SA-2024SA272472$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240923$$CN$US$US
243495031$24349503$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA269192$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240923$$MD$US$US
243495041$24349504$1$I$$20240912$20240923$20240923$EXP$$CA-APOTEX-2024AP010682$APOTEX$$60$YR$$F$Y$$$20240923$$HP$CA$CA
243495082$24349508$2$F$20240915$20240923$20240923$20240930$EXP$$CA-JNJFOC-20240954360$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240930$$HP$CA$CA
243495091$24349509$1$I$$20240910$20240923$20240923$EXP$$CA-ROCHE-10000084690$ROCHE$$65$YR$E$F$Y$34$KG$20240923$$HP$CA$CA
243495101$24349510$1$I$$20240916$20240923$20240923$EXP$$AR-GSK-AR2024AMR115883$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$AR$AR
243495121$24349512$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012476$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240923$$CN$US$US
243495131$24349513$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012634$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240923$$CN$US$US
243495141$24349514$1$I$20240101$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013378$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240923$$CN$US$US
243495151$24349515$1$I$20240917$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011824$ELI LILLY AND CO$$19$YR$A$M$Y$$$20240923$$CN$US$US
243495161$24349516$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012589$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240923$$CN$US$US
243495171$24349517$1$I$20240201$20240917$20240923$20240923$EXP$$US-UNITED THERAPEUTICS-UNT-2024-001591$UNITED THERAPEUTICS$$54$YR$$F$Y$88.435$KG$20240923$$$US$US
243495181$24349518$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012713$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243495201$24349520$1$I$20240913$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011544$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240923$$CN$US$US
243495212$24349521$2$F$20240914$20240923$20240923$20240926$PER$$US-BIOGEN-2024BI01283475$BIOGEN$$46$YR$$F$Y$$$20240926$$CN$US$US
243495221$24349522$1$I$$20240909$20240923$20240923$EXP$$IT-AUROBINDO-AUR-APL-2024-044975$AUROBINDO$Montalto S, Di Filippo M, Capra V, Manzitti C, Sementa AR, Sorrentino S, et al. Abdominal rhabdoid tumor presenting with symptomatic spinal epidural compression in a newborn. A case report.. Front-Pediatr. 2023;11:1337760 (1-6)$$$N$F$Y$3.1$KG$20240923$$HP$IT$IT
243495231$24349523$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA272870$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$MD$US$US
243495241$24349524$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272827$SANOFI AVENTIS$$$$A$F$Y$137.73$KG$20240923$$MD$US$US
243495251$24349525$1$I$20180828$20240903$20240923$20240923$PER$$US-SA-2024SA272492$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240923$$MD$US$US
243495261$24349526$1$I$$20240910$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024187496$AMGEN$MATSUOKA H, YOSHIDA K, NAKAI S, SUZUKI R, IMURA Y, TAKAMI H, et al.. Successful pazopanib treatment of undifferentiated pleomorphic sarcoma with coamplification of PDGFRA, VEGFR2 and KIT: A case report. Molecular and Clinical Oncology. 2024;21$51$YR$A$M$Y$$$20240923$$MD$JP$JP
243495271$24349527$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272919$SANOFI AVENTIS$$$$A$F$Y$66$KG$20240923$$MD$US$US
243495281$24349528$1$I$20240717$20240904$20240923$20240923$PER$$US-SA-2024SA272858$SANOFI AVENTIS$$30$YR$A$M$Y$95.45$KG$20240923$$MD$US$US
243495291$24349529$1$I$$20240830$20240923$20240923$PER$$US-SA-2024SA271678$SANOFI AVENTIS$$$$A$M$Y$86$KG$20240923$$MD$US$US
243495301$24349530$1$I$20230801$20240904$20240923$20240923$PER$$US-SA-2024SA272944$SANOFI AVENTIS$$37$YR$A$F$Y$162$KG$20240923$$CN$US$US
243495311$24349531$1$I$20240101$20240829$20240923$20240923$PER$$US-SA-2024SA266943$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240923$$MD$US$US
243495321$24349532$1$I$20240101$20240909$20240923$20240923$PER$$US-SA-2024SA273787$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240923$$CN$US$US
243495331$24349533$1$I$$20240913$20240923$20240923$PER$$US-SA-2024SA268023$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240923$$HP$US$US
243495341$24349534$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA271812$SANOFI AVENTIS$$$$$F$Y$$$20240923$$HP$US$US
243495351$24349535$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268775$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240923$$HP$US$US
243495361$24349536$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269996$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240923$$HP$US$US
243495371$24349537$1$I$20240801$20240905$20240923$20240923$PER$$US-SA-2024SA273301$SANOFI AVENTIS$$71$YR$E$M$Y$81.82$KG$20240923$$MD$US$US
243495381$24349538$1$I$$20240916$20240923$20240923$EXP$$CO-GSK-CO2024AMR115992$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$CO$CO
243495391$24349539$1$I$$20240912$20240923$20240923$EXP$$CA-TAKEDA-2022TUS041936$TAKEDA$$$$$F$Y$$$20240923$$MD$CA$CA
243495401$24349540$1$I$$20240912$20240923$20240923$EXP$$US-Accord-447351$ACCORD$$$$$M$Y$$$20240923$$PH$US$US
243495411$24349541$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149912$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240923$$HP$US$US
243495421$24349542$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150241$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240923$$HP$US$US
243495431$24349543$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150205$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$64.41$KG$20240923$$CN$US$US
243495441$24349544$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150216$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240923$$CN$US$US
243495451$24349545$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149586$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$82.55$KG$20240923$$CN$US$US
243495461$24349546$1$I$20240314$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149422$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243495471$24349547$1$I$$20240914$20240923$20240923$EXP$GB-MHRA-MED-202409132324583640-WTRCD$GB-JUBILANT PHARMA LTD-2024GB001323$JUBILANT$$82$YR$$F$Y$$$20240923$$CN$GB$GB
243495481$24349548$1$I$20240902$20240913$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146794$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240923$$PH$US$US
243495491$24349549$1$I$20240501$20240918$20240923$20240923$EXP$$US-ABBVIE-5930233$ABBVIE$$68$YR$$M$Y$$$20240923$$CN$US$US
243495501$24349550$1$I$$20240911$20240923$20240923$PER$$US-EMD Serono-2024048935$EMD SERONO INC$$49$YR$A$F$Y$$$20240923$$CN$US$US
243495511$24349551$1$I$20220506$20240913$20240923$20240923$EXP$$CA-TAKEDA-2024TUS091931$TAKEDA$$37$YR$$M$Y$$$20240923$$MD$CA$CA
243495521$24349552$1$I$20240901$20240913$20240923$20240923$EXP$$GB-TEVA-VS-3244539$TEVA$$48$YR$$M$Y$$$20240923$$CN$GB$GB
243495531$24349553$1$I$$20240910$20240923$20240923$EXP$$ES-NOVITIUMPHARMA-2024ESNVP01891$NOVITIUM PHARMA$Eduardo Rubio-Mora. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?.Transplant Infectious Disease.04-APR-2024;26(3):e14276$4$MON$I$F$Y$$$20240923$$HP$ES$ES
243495542$24349554$2$F$20240918$20240926$20240923$20240927$EXP$$US-ROCHE-10000085800$ROCHE$$49$YR$A$F$Y$$$20240927$$CN$US$US
243495551$24349555$1$I$20231115$20240919$20240923$20240923$EXP$$NL-ROCHE-3567469$ROCHE$$78$YR$E$M$Y$83$KG$20240923$$MD$NL$NL
243495561$24349556$1$I$$20240916$20240923$20240923$PER$$US-LEO Pharma-373565$LEO PHARM$$$$$F$Y$$$20240923$$CN$US$US
243495571$24349557$1$I$$20240912$20240923$20240923$EXP$$US-JNJFOC-20240933236$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$CN$US$US
243495581$24349558$1$I$$20240903$20240923$20240923$PER$$US-TEVA-VS-3240775$TEVA$$91$YR$$$Y$$$20240923$$PH$US$US
243495591$24349559$1$I$$20240920$20240923$20240923$PER$$US-ROCHE-10000088403$ROCHE$$$$$$Y$$$20240923$$HP$US$US
243495602$24349560$2$F$$20240915$20240923$20240923$EXP$$US-ROCHE-10000087162$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243495611$24349561$1$I$20240801$20240913$20240923$20240923$EXP$$US-ROCHE-10000065311$ROCHE$$69$YR$E$F$Y$$$20240923$$CN$US$US
243495621$24349562$1$I$$20240912$20240923$20240923$EXP$NL-LRB-01000888$NL-Accord-447155$ACCORD$$73$YR$E$F$Y$62$KG$20240923$$MD$NL$NL
243495641$24349564$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114366$GLAXOSMITHKLINE$$$$A$F$Y$$$20240923$$CN$US$US
243495651$24349565$1$I$20240901$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188448$AMGEN$$$$$M$Y$$$20240923$$CN$US$US
243495661$24349566$1$I$$20240917$20240923$20240923$EXP$$GB-TAKEDA-2024TUS093405$TAKEDA$$$$A$M$Y$$$20240923$$CN$GB$GB
243495672$24349567$2$F$$20240919$20240923$20240930$PER$$US-ABBVIE-5932188$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243495681$24349568$1$I$$20240912$20240923$20240923$EXP$$US-ROCHE-10000081294$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
243495691$24349569$1$I$$20240919$20240923$20240923$EXP$$CA-ROCHE-3367198$ROCHE$$69$YR$E$F$Y$$$20240923$$HP$CA$CA
243495701$24349570$1$I$$20240917$20240923$20240923$PER$US-MLMSERVICE-20240911-PI187763-00175-1$US-RDY-SPO/USA/24/0013728$DR REDDYS$Weinstein T, Altshuler D, Lafond E, Katz A. Elevated Anti-Xa in the Setting of Prophylactic Unfractionated Subcutaneous Heparin Administration. Journal of pharmacy practice. 2024;37(5):1209-13. DOI: 10.1177/08971900241228951.$66$YR$E$M$Y$66.2$KG$20240923$$PH$US$US
243495711$24349571$1$I$$20240917$20240923$20240923$PER$US-MLMSERVICE-20240911-PI187763-00175-3$US-RDY-SPO/USA/24/0013735$DR REDDYS$Weinstein T, Altshuler D, Lafond E, Katz A. Elevated Anti-Xa in the Setting of Prophylactic Unfractionated Subcutaneous Heparin Administration. Journal of pharmacy practice. 2024;37(5):1209-13. DOI: 10.1177/08971900241228951.$91$YR$E$F$Y$45.4$KG$20240923$$PH$US$US
243495721$24349572$1$I$20240703$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045933$AUROBINDO$$72$YR$$F$Y$$$20240923$$PH$FR$FR
243495731$24349573$1$I$$20240913$20240923$20240923$EXP$GB-MHRA-MED-202409131455273380-PCZSV$GB-TEVA-VS-3243836$TEVA$$$$$M$Y$$$20240923$$CN$GB$GB
243495741$24349574$1$I$20240309$20240423$20240923$20240923$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089374$GLENMARK$$$$$$Y$$$20240923$$CN$US$US
243495751$24349575$1$I$$20240703$20240923$20240923$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091424$GLENMARK$$$$$$Y$$$20240923$$CN$US$US
243495761$24349576$1$I$20240301$20240530$20240923$20240923$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090189$GLENMARK$$$$$$Y$$$20240923$$CN$US$US
243495781$24349578$1$I$20240801$20240923$20240923$20240923$EXP$FI-FIMEA-202403397$FI-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052758$BOEHRINGER INGELHEIM$$87$YR$E$M$Y$$$20240923$$MD$FI$FI
243495791$24349579$1$I$20240801$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045939$AUROBINDO$$73$YR$$F$Y$87$KG$20240923$$PH$FR$FR
243495811$24349581$1$I$$20240917$20240923$20240923$EXP$$US-ABBVIE-5929688$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243495821$24349582$1$I$$20240915$20240923$20240923$EXP$$US-JNJFOC-20240952275$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240923$$HP$US$US
243495831$24349583$1$I$20240401$20240913$20240923$20240923$EXP$$BR-TEVA-VS-3244727$TEVA$$64$YR$$F$Y$$$20240923$$CN$BR$BR
243495841$24349584$1$I$$20240919$20240923$20240923$PER$$US-BIOVITRUM-2024-US-012299$BIOVITRUM$$24$YR$$F$Y$$$20240923$$CN$US$US
243495851$24349585$1$I$$20240916$20240923$20240923$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001892$BLUEPRINT MEDICINES$$$$$F$Y$$$20240923$$CN$US$US
243495861$24349586$1$I$20240803$20240910$20240923$20240923$EXP$$US-UCBSA-2024046478$UCB$$59$YR$$M$Y$$$20240923$$CN$US$US
243495881$24349588$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150411$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240923$$CN$US$US
243495891$24349589$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148197$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240923$$CN$US$US
243495901$24349590$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188677$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243495931$24349593$1$I$20240831$20240912$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045915$AUROBINDO$$76$YR$$M$Y$$$20240923$$MD$GB$GB
243495941$24349594$1$I$20240528$20240913$20240923$20240923$EXP$IT-MINISAL02-1001862$IT-ASTELLAS-2024-AER-006901$ASTELLAS$$85$YR$E$M$Y$$$20240923$$MD$IT$IT
243495951$24349595$1$I$20240101$20240705$20240923$20240923$PER$$US-AJANTA-2024AJA00130$AJANTA PHARMA$$$$$$Y$$$20240921$$CN$US$US
243495971$24349597$1$I$$20240912$20240923$20240923$PER$$US-ASTELLAS-2024-AER-006715$ASTELLAS$$$$$F$Y$$$20240923$$MD$US$US
243495981$24349598$1$I$20240801$20240905$20240923$20240923$PER$$US-SA-2024SA273039$SANOFI AVENTIS$$35$YR$A$F$Y$68.64$KG$20240923$$MD$US$US
243495991$24349599$1$I$20240101$20240905$20240923$20240923$PER$$US-SA-2024SA273073$SANOFI AVENTIS$$43$YR$A$M$Y$81.82$KG$20240923$$MD$US$US
243496001$24349600$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150147$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240923$$CN$US$US
243496011$24349601$1$I$$20240913$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147253$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240923$$CN$US$US
243496021$24349602$1$I$$20240916$20240923$20240923$EXP$$JP-TAKEDA-2024TUS093187$TAKEDA$Fujiwara Y, Masago K, Matsuzawa R, Yamaguchi T, Watanabe N, Shimizu J, et al. Long-term response of lorlatinib to leptomeningeal metastasis in patients with anaplastic lymphoma kinase fusion positive non-small lung cancer: a case report. Case Reports in Oncology. 2024;17:942-49$35$YR$$M$Y$$$20240923$$MD$JP$JP
243496031$24349603$1$I$20230331$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045913$AUROBINDO$$81$YR$$F$Y$$$20240923$$PH$FR$FR
243496041$24349604$1$I$$20240919$20240923$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA082052$SANDOZ$$$$$M$Y$$$20240923$$MD$CA$CA
243496052$24349605$2$F$$20240918$20240923$20240924$EXP$$IN-MSNLABS-2024MSNLIT02044$MSN LABORATORIES$Malani SK, Chigullapalli S, Sujanyal S, Sharma V.Rosuvastatin-Induced Myopathy: A Case Series.Cureus.05-AUG-2024;16(8):e66180$$$$$Y$$$20240924$$MD$IN$IN
243496061$24349606$1$I$$20240905$20240923$20240923$PER$$US-SA-2024SA273260$SANOFI AVENTIS$$$$A$M$Y$88.18$KG$20240923$$MD$US$US
243496071$24349607$1$I$20240101$20240911$20240923$20240923$EXP$$SK-AUROBINDO-AUR-APL-2024-045548$AUROBINDO$$64$YR$$$Y$$$20240923$$MD$SK$SK
243496081$24349608$1$I$$20240919$20240923$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA081570$SANDOZ$$78$YR$$F$Y$$$20240923$$CN$CA$CA
243496091$24349609$1$I$$20240918$20240923$20240923$EXP$$ME-JNJFOC-20240954743$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$MD$ME$ME
243496101$24349610$1$I$$20240918$20240923$20240923$EXP$$ME-JNJFOC-20240954733$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$MD$ME$ME
243496111$24349611$1$I$20240719$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045937$AUROBINDO$$71$YR$$F$Y$73$KG$20240923$$MD$FR$FR
243496121$24349612$1$I$$20240919$20240923$20240923$EXP$$GR-JAZZ PHARMACEUTICALS-2024-GR-015678$JAZZ$$$$$$Y$$$20240922$$MD$GR$GR
243496131$24349613$1$I$$20240919$20240923$20240923$EXP$$GR-JAZZ PHARMACEUTICALS-2024-GR-015677$JAZZ$$$$$$Y$$$20240921$$MD$GR$GR
243496141$24349614$1$I$20230810$20240823$20240923$20240923$EXP$$KR-JAZZ PHARMACEUTICALS-2024-KR-015689$JAZZ$$67$YR$$F$Y$40$KG$20240922$$HP$KR$KR
243496152$24349615$2$F$20240701$20240919$20240923$20240925$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015612$JAZZ$$21$YR$$F$Y$$$20240924$$CN$US$US
243496161$24349616$1$I$$20240918$20240923$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015593$JAZZ$$$$$F$Y$$$20240922$$CN$US$US
243496171$24349617$1$I$$20240919$20240923$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015590$JAZZ$$$$$F$Y$$$20240922$$CN$US$US
243496191$24349619$1$I$$20240918$20240923$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015595$JAZZ$$$$$M$Y$20.408$KG$20240922$$CN$US$US
243496221$24349622$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188780$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243496231$24349623$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012852$ELI LILLY AND CO$$$$A$F$Y$$$20240923$$CN$US$US
243496241$24349624$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012498$ELI LILLY AND CO$$$$A$M$Y$$$20240923$$CN$US$US
243496251$24349625$1$I$$20240917$20240923$20240923$EXP$$DE-ABBVIE-5930912$ABBVIE$$$$$M$Y$$$20240923$$MD$DE$DE
243496261$24349626$1$I$20240820$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013370$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240923$$CN$US$US
243496271$24349627$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012783$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243496281$24349628$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012493$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243496291$24349629$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012927$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240923$$CN$US$US
243496301$24349630$1$I$$20240916$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011398$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240923$$CN$US$US
243496311$24349631$1$I$20240915$20240918$20240923$20240923$30DAY$$IT-SANDOZ INC.-SDZ2024IT081921$SANDOZ$$13$YR$$M$Y$42$KG$20240923$$CN$IT$IT
243496322$24349632$2$F$20240828$20240926$20240923$20240930$PER$$US-BIOVITRUM-2024-US-012298$BIOVITRUM$$63$YR$$F$Y$$$20240930$$CN$US$US
243496331$24349633$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150324$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$86.18$KG$20240923$$CN$US$US
243496341$24349634$1$I$$20240916$20240923$20240923$EXP$$RO-ABBVIE-5928190$ABBVIE$$56$YR$$M$Y$$$20240923$$MD$RO$RO
243496361$24349636$1$I$20240125$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149467$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243496371$24349637$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150125$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240923$$CN$US$US
243496391$24349639$1$I$20240909$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188812$AMGEN$$47$YR$A$M$Y$$$20240923$$CN$US$US
243496401$24349640$1$I$$20240915$20240923$20240923$EXP$$US-JNJFOC-20240952265$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240923$$HP$US$US
243496411$24349641$1$I$20160121$20240904$20240923$20240923$EXP$$US-SA-2024SA272538$SANOFI AVENTIS$$29$YR$A$M$Y$88.64$KG$20240923$$MD$US$US
243496421$24349642$1$I$$20240912$20240923$20240923$PER$$US-ASTELLAS-2024-AER-007037$ASTELLAS$$$$$F$Y$$$20240923$$MD$US$US
243496431$24349643$1$I$20240101$20240909$20240923$20240923$PER$$US-SA-2024SA273642$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240923$$CN$US$US
243496441$24349644$1$I$$20240911$20240923$20240923$PER$$US-SA-2024SA273314$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240923$$CN$US$US
243496451$24349645$1$I$$20240915$20240923$20240923$EXP$$US-JNJFOC-20240952295$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240923$$HP$US$US
243496461$24349646$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA273198$SANOFI AVENTIS$$$$$F$Y$88$KG$20240923$$MD$US$US
243496471$24349647$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268283$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240923$$MD$US$US
243496481$24349648$1$I$$20240916$20240923$20240923$EXP$$JP-TEVA-VS-3244603$TEVA$Ide S, Eguchi T, Matsuoka S, Miura K, Hamanaka K, Tani N, et al. Local Consolidative Therapy Conducted for Oligometastatic Non-small-cell Lung Cancer After Chemoimmunotherapy. [Japanese]. Haigan 2023; 63 (2): 115-121.; Ide S, Eguchi T, Matsuoka S, Miura K, Hamanaka K, Tani N, et al. Local Consolidative Therapy Conducted for Oligometastatic Non-small-cell Lung Cancer After Chemoimmunotherapy. [Japanese]. Haigan 2023; 63 (2): 115-121.$66$YR$$M$Y$$$20240923$$HP$JP$JP
243496491$24349649$1$I$$20240918$20240923$20240923$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-13065$IPSEN$$$$$M$Y$$$20240923$$CN$GB$GB
243496501$24349650$1$I$20240101$20240919$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149760$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$67.59$KG$20240923$$CN$US$US
243496511$24349651$1$I$20240101$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024186225$AMGEN$$39$YR$A$F$Y$$$20240923$$HP$US$US
243496521$24349652$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187848$AMGEN$Fountzilas C.; Boland P.M.; Mukherjee S. et al.. Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial. British Journal of Cancer. 2024;1-8$$$$$Y$$$20240923$$HP$US$US
243496531$24349653$1$I$20240610$20240917$20240923$20240923$EXP$$US-ABBVIE-5839784$ABBVIE$$52$YR$$F$Y$$$20240923$$CN$US$US
243496542$24349654$2$F$$20240918$20240923$20240924$EXP$$IN-MSNLABS-2024MSNLIT02045$MSN LABORATORIES$Malani SK, Chigullapalli S, Sujanyal S, Sharma V.Rosuvastatin-Induced Myopathy: A Case Series.Cureus.08-MAY-2024;16(8):e66180$$$$$Y$$$20240924$$MD$IN$IN
243496551$24349655$1$I$$20240916$20240923$20240923$EXP$CA-NEBO-669899$CA-NEBO-669899$PHARMACOSMOS$$73$YR$$F$Y$$$20240923$$HP$CA$CA
243496561$24349656$1$I$20240722$20240905$20240923$20240923$30DAY$$US-BECTON DICKINSON-US-BD-24-000551$BECTON DICKINSON$$$$$$Y$$$20240923$$CN$US$US
243496571$24349657$1$I$$20240917$20240923$20240923$EXP$$DE-JNJFOC-20240948168$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$HP$DE$DE
243496591$24349659$1$I$20240722$20240916$20240923$20240923$EXP$FR-AFSSAPS-RN2024000948$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112435$ZYDUS PHARM$$$$$$Y$$$20240923$$PH$FR$FR
243496601$24349660$1$I$20240501$20240909$20240923$20240923$EXP$FR-AFSSAPS-AVNT2024000669$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112133$ZYDUS PHARM$$$$$$Y$$$20240923$$PH$FR$FR
243496611$24349661$1$I$20240825$20240909$20240923$20240923$EXP$FR-AFSSAPS-BR2024000705$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112131$ZYDUS PHARM$$$$$$Y$$$20240923$$MD$FR$FR
243496621$24349662$1$I$$20240913$20240923$20240923$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112411$ZYDUS PHARM$Akhdar G.. MM-388 Navigating the Nexus: Lenalidomide-Associated Thrombotic Thrombocytopenic Purpura (TTP).. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl.):S555$$$$$Y$$$20240923$$MD$US$US
243496631$24349663$1$I$20230611$20240916$20240923$20240923$EXP$FR-AFSSAPS-AM2024000733$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112437$ZYDUS PHARM$$$$$$Y$$$20240923$$MD$FR$FR
243496641$24349664$1$I$20240601$20240918$20240923$20240923$EXP$$PR-ABBVIE-5930224$ABBVIE$$47$YR$$F$Y$76$KG$20240923$$CN$PR$PR
243496651$24349665$1$I$$20240910$20240923$20240923$EXP$$US-AUROBINDO-AUR-APL-2024-045653$AUROBINDO$Williams JA, Hrin ML, Bowers NL, Jorizzo JL, Feldman SR, Huang WW. Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients.. J-Am-Acad-Dermatol. 2024;90(3):642-644$43$YR$$M$Y$$$20240923$$MD$US$US
243496661$24349666$1$I$20240901$20240918$20240923$20240923$EXP$GB-SANDOZ-SDZ2024GB046893$GB-STRIDES ARCOLAB LIMITED-2024SP012133$STRIDES$$$$E$M$Y$$$20240923$$CN$GB$GB
243496671$24349667$1$I$20120717$20240912$20240923$20240923$EXP$$US-SA-2024SA272751$SANOFI AVENTIS$$41$YR$A$M$Y$86.1$KG$20240923$$MD$US$US
243496681$24349668$1$I$$20240117$20240923$20240923$PER$$US-ROCHE-3494417$ROCHE$$$$$M$Y$$$20240923$$HP$US$US
243496691$24349669$1$I$20231226$20240103$20240923$20240923$PER$$CN-ROCHE-3487207$ROCHE$$65$YR$E$F$Y$50$KG$20240923$$HP$CN$CN
243496701$24349670$1$I$20200422$20240117$20240923$20240923$PER$$RO-ROCHE-3490157$ROCHE$$56$YR$A$F$Y$74$KG$20240923$$MD$RO$RO
243496711$24349671$1$I$20231218$20240117$20240923$20240923$PER$$CN-ROCHE-3494418$ROCHE$$66$YR$E$M$Y$60$KG$20240923$$HP$CN$CN
243496721$24349672$1$I$20240812$20240910$20240923$20240923$EXP$FR-AFSSAPS-DJ2024000956$FR-TAKEDA-2024TUS090184$TAKEDA$$57$YR$$F$Y$67$KG$20240923$$HP$FR$FR
243496731$24349673$1$I$20231220$20231229$20240923$20240923$PER$$CN-ROCHE-3484703$ROCHE$$73$YR$E$M$Y$61$KG$20240923$$HP$CN$CN
243496741$24349674$1$I$20210831$20240126$20240923$20240923$PER$PT-INFARMED-T202109-226$PT-ROCHE-3499491$ROCHE$$70$YR$E$F$Y$81$KG$20240923$$PH$PT$PT
243496751$24349675$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5931042$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243496761$24349676$1$I$$20240919$20240923$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA081666$SANDOZ$$53$YR$$M$Y$103$KG$20240923$$HP$CA$CA
243496771$24349677$1$I$20240728$20240913$20240923$20240923$EXP$$JP-BEH-2024176471$CSL BEHRING$$$$$$Y$$$20240923$$MD$JP$JP
243496782$24349678$2$F$$20240918$20240923$20240924$EXP$$IN-MSNLABS-2024MSNLIT02046$MSN LABORATORIES$Malani SK, Chigullapalli S, Sujanyal S, Sharma V.Rosuvastatin-Induced Myopathy: A Case Series.Cureus.2024;16(8):e66180$$$$$Y$$$20240924$$MD$IN$IN
243496791$24349679$1$I$20231225$20240104$20240923$20240923$PER$$CN-ROCHE-3486488$ROCHE$$49$YR$A$F$Y$75$KG$20240923$$HP$CN$CN
243496801$24349680$1$I$$20240121$20240923$20240923$PER$$GB-ROCHE-3497005$ROCHE$$51$YR$A$F$Y$$$20240923$$CN$GB$GB
243496811$24349681$1$I$20240108$20240123$20240923$20240923$PER$$CN-ROCHE-3499220$ROCHE$$61$YR$A$F$Y$67.4$KG$20240923$$HP$CN$CN
243496821$24349682$1$I$20240106$20240115$20240923$20240923$PER$$CN-ROCHE-3492650$ROCHE$$55$YR$A$F$Y$80$KG$20240923$$HP$CN$CN
243496831$24349683$1$I$20240120$20240120$20240923$20240923$PER$$CA-ROCHE-3496404$ROCHE$$68$YR$E$M$Y$$$20240923$$HP$CA$CA
243496841$24349684$1$I$20230707$20240115$20240923$20240923$PER$$CN-ROCHE-3492647$ROCHE$$55$YR$A$F$Y$70$KG$20240923$$HP$CN$CN
243496851$24349685$1$I$20240112$20240122$20240923$20240923$PER$$CN-ROCHE-3496422$ROCHE$$49$YR$A$F$Y$$$20240923$$HP$CN$CN
243496861$24349686$1$I$$20231226$20240923$20240923$PER$$VN-ROCHE-3483238$ROCHE$$66$YR$E$F$Y$$$20240923$$MD$VN$VN
243496871$24349687$1$I$20190623$20240118$20240923$20240923$PER$$RO-ROCHE-3494373$ROCHE$$56$YR$A$F$Y$$$20240923$$MD$RO$RO
243496881$24349688$1$I$$20240118$20240923$20240923$PER$$NO-ROCHE-3495639$ROCHE$$$$$$Y$$$20240923$$MD$NO$NO
243496891$24349689$1$I$$20240112$20240923$20240923$PER$$CO-ROCHE-3492089$ROCHE$$56$YR$A$F$Y$$$20240923$$CN$CO$CO
243496911$24349691$1$I$$20240922$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150335$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$52.62$KG$20240923$$CN$US$US
243496921$24349692$1$I$20240801$20240914$20240923$20240923$PER$$US-SA-2024SA262175$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240923$$HP$US$US
243496931$24349693$1$I$20240903$20240904$20240923$20240923$PER$$US-SA-2024SA272372$SANOFI AVENTIS$$62$YR$A$F$Y$84.77$KG$20240923$$MD$US$US
243496941$24349694$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268425$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240923$$MD$US$US
243496951$24349695$1$I$20231211$20231229$20240923$20240923$PER$$CN-ROCHE-3485074$ROCHE$$51$YR$A$F$Y$56.5$KG$20240923$$HP$CN$CN
243496961$24349696$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64643$$FDA-CTU$$86$YR$$M$N$$$20240920$N$$US$
243496991$24349699$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64694$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243497001$24349700$1$I$$20240821$20240920$20240920$DIR$FDA-CDER-CTU-2024-64640$$FDA-CTU$$$$$F$N$$$20240821$N$HP$US$
243497031$24349703$1$I$20181219$20240117$20240923$20240923$PER$$RO-ROCHE-3494262$ROCHE$$56$YR$A$F$Y$74$KG$20240923$$HP$RO$RO
243497041$24349704$1$I$20191105$20240111$20240923$20240923$PER$$RO-ROCHE-3490133$ROCHE$$56$YR$A$F$Y$$$20240923$$MD$RO$RO
243497051$24349705$1$I$$20240108$20240923$20240923$PER$$US-ROCHE-3487840$ROCHE$$47$YR$A$F$Y$$$20240923$$PH$US$US
243497061$24349706$1$I$$20240117$20240923$20240923$PER$$CO-ROCHE-3494502$ROCHE$$42$YR$A$F$Y$$$20240923$$CN$CO$CO
243497071$24349707$1$I$$20240115$20240923$20240923$PER$$CO-ROCHE-3492780$ROCHE$$62$YR$A$F$Y$$$20240923$$CN$CO$CO
243497081$24349708$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114371$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243497091$24349709$1$I$$20240912$20240923$20240923$EXP$$PT-AUROBINDO-AUR-APL-2024-045867$AUROBINDO$Mateus JE, Silva C, Ferreira M, Porto J, Verissimo MT, Carvalho A.. Massive hemorrhage as complication of anticoagulant therapy. European Geriatric Medicine. 2019;10(Suppl 1)::S223$75$YR$$F$Y$$$20240923$$HP$PT$PT
243497101$24349710$1$I$$20240910$20240923$20240923$EXP$$NP-MACLEODS PHARMA-MAC2024049413$MACLEODS$Bade S, Bade S, Sharma G, Bhurtel N, Singh Y, Paudel S, et al..Transformative weight loss with Dulaglutide: A case report of success in a challenging patient profile of an ex sumo wrestler.Clinical case reports.2024;12(9):e9403$$$$$Y$$$20240923$$HP$NP$NP
243497111$24349711$1$I$$20240910$20240923$20240923$EXP$$JP-MACLEODS PHARMA-MAC2024049261$MACLEODS$$$$$$Y$$$20240923$$MD$JP$JP
243497131$24349713$1$I$20200930$20240910$20240923$20240923$EXP$$BE-MACLEODS PHARMA-MAC2024049411$MACLEODS$Ferdinande K, Declerck L, Melis C, Missiaen L, Seynhaeve L, De Vloo C, et al..CYP2D6 polymorphism may contribute to Trazodone-induced hepatotoxicity: a rare case of drug-drug-gene induced liver injury.Acta Gastro-Enterologica Belgica.2024;87(2):332-5$$$$$Y$$$20240923$$MD$BE$BE
243497141$24349714$1$I$$20240911$20240923$20240923$EXP$$FR-MACLEODS PHARMA-MAC2024049426$MACLEODS$Inouri T, Noel J, Blanchet B, Thomas-Schoemann A..Letter to the editor regarding the paper by A. Boileve et al.: Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti-VEGF agents: a retrospective study.Supportive Care in Cancer.10-SEP-2024;32(10):648$$$$$Y$$$20240923$$HP$FR$FR
243497151$24349715$1$I$20240911$20240911$20240923$20240923$EXP$$GB-MACLEODS PHARMA-MAC2024049420$MACLEODS$$$$$$Y$$$20240923$$HP$GB$GB
243497162$24349716$2$F$$20240917$20240923$20240926$EXP$$NL-MACLEODS PHARMA-MAC2024049415$MACLEODS$Brouwer M, Offermans M, van Nuil L, Poukens A, van Oijen B, Dormans T..Effective Extracorporeal Treatment of Metformin-Associated Lactic Acidosis using Continuous Venovenous Hemodiafiltration.European Journal of Case Reports in Internal Medicine.03-SEP-2024;11(9):004784$$$$$Y$$$20240926$$HP$NL$NL
243497171$24349717$1$I$20240910$20240911$20240923$20240923$EXP$GB-MHRA-MED-202409111649186280-GRTYV$GB-MACLEODS PHARMA-MAC2024049423$MACLEODS$$$$$$Y$$$20240923$$HP$GB$GB
243497181$24349718$1$I$$20240911$20240923$20240923$EXP$GB-MHRA-MED-202409111600130520-LCVQZ$GB-MACLEODS PHARMA-MAC2024049422$MACLEODS$$$$$$Y$$$20240923$$HP$GB$GB
243497191$24349719$1$I$20220401$20240911$20240923$20240923$EXP$$JP-MACLEODS PHARMA-MAC2024049414$MACLEODS$Mathis AT, Pietrowski JF, Ahn DY..Foreign Language Syndrome Following Extraction of Wisdom Teeth Under General Anesthesia: A Case Report.Journal of oral and maxillofacial surgery.2024;1-4$21$YR$A$F$Y$57$KG$20240923$$MD$JP$JP
243497201$24349720$1$I$20240809$20240918$20240923$20240923$EXP$$US-ABBVIE-5931212$ABBVIE$$61$YR$$F$Y$$$20240923$$CN$US$US
243497211$24349721$1$I$20240109$20240115$20240923$20240923$PER$$US-ROCHE-3492856$ROCHE$$54$YR$A$F$Y$$$20240923$$CN$US$US
243497221$24349722$1$I$20231013$20231222$20240923$20240923$PER$$CN-ROCHE-3486936$ROCHE$$53$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243497231$24349723$1$I$20231023$20231222$20240923$20240923$PER$$CN-ROCHE-3493238$ROCHE$$38$YR$A$F$Y$$$20240923$$HP$CN$CN
243497241$24349724$1$I$$20240104$20240923$20240923$PER$$NG-ROCHE-3486840$ROCHE$Achonu C, Olopade OB, Yusuf B, Fadeyi AA andFasanmade OA Case Report of Graves^ Disease in a 45-Year-Old Woman Secondary to Herceptin Treatment for Breast Cancer. Doi;10.1089/mab.2023.0011. Monoclonal antibodies in immunodiagnosis and immunotherapy 2023 Dec;42 (6):194-202.$43$YR$A$F$Y$$$20240923$$HP$NG$NG
243497251$24349725$1$I$$20231228$20240923$20240923$PER$$MY-ROCHE-3483140$ROCHE$$60$YR$A$F$Y$$$20240923$$PH$MY$MY
243497261$24349726$1$I$$20240103$20240923$20240923$PER$$CH-ROCHE-3485973$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243497271$24349727$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64655$$FDA-CTU$$80$YR$$F$N$$$20240920$N$$US$
243497281$24349728$1$I$20201101$20240111$20240923$20240923$PER$$BG-ROCHE-3490147$ROCHE$$73$YR$E$F$Y$$$20240923$$CN$BG$BG
243497291$24349729$1$I$20240112$20240115$20240923$20240923$PER$$CN-ROCHE-3492597$ROCHE$$49$YR$A$F$Y$$$20240923$$HP$CN$CN
243497301$24349730$1$I$20240911$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64724$$FDA-CTU$$56$YR$$F$N$$$20240920$N$HP$US$
243497311$24349731$1$I$20231221$20240124$20240923$20240923$PER$$CN-ROCHE-3498610$ROCHE$$66$YR$E$F$Y$52.4$KG$20240923$$HP$CN$CN
243497321$24349732$1$I$20231029$20240115$20240923$20240923$PER$$CN-ROCHE-3492580$ROCHE$$74$YR$E$F$Y$55$KG$20240923$$HP$CN$CN
243497331$24349733$1$I$$20240118$20240923$20240923$PER$$CH-ROCHE-3496081$ROCHE$$$$E$$Y$$$20240923$$MD$CH$CH
243497341$24349734$1$I$$20240118$20240923$20240923$PER$$CH-ROCHE-3495357$ROCHE$$$$A$$Y$$$20240923$$MD$CH$CH
243497361$24349736$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64656$$FDA-CTU$$52$YR$$M$N$102.06$KG$20240920$N$$US$
243497371$24349737$1$I$20240901$20240916$20240923$20240923$PER$$US-SA-2024SA268387$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240923$$MD$US$US
243497381$24349738$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269446$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240923$$HP$US$US
243497391$24349739$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64704$$FDA-CTU$$69$YR$$M$N$91.63$KG$20240920$N$$US$
243497401$24349740$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA272529$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240923$$CN$US$US
243497411$24349741$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA272868$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240923$$CN$US$US
243497421$24349742$1$I$$20231221$20240923$20240923$PER$$GB-ROCHE-3482783$ROCHE$$$$$F$Y$$$20240923$$HP$GB$GB
243497431$24349743$1$I$$20231221$20240923$20240923$PER$$GB-ROCHE-3482782$ROCHE$$$$$F$Y$$$20240923$$HP$GB$GB
243497441$24349744$1$I$$20231228$20240923$20240923$PER$$US-ROCHE-3484275$ROCHE$Iqbal Q, Sharma S, Romo K and Dendy J CONVERSION TO GRAVE^S DISEASE FROM HASHIMOTO^S THYROIDITIS - A RARE PHENOMENON! (POSTER 275). DOI: 10.1089/thy.2023.29156.abstracts. Thyroid 2023 Sep;33 (SUP 1):A-34-.$72$YR$E$F$Y$$$20240923$$HP$US$US
243497451$24349745$1$I$$20231221$20240923$20240923$PER$$GB-ROCHE-3482775$ROCHE$$$$$F$Y$$$20240923$$HP$GB$GB
243497461$24349746$1$I$$20231221$20240923$20240923$PER$$GB-ROCHE-3482776$ROCHE$$$$$F$Y$$$20240923$$HP$GB$GB
243497471$24349747$1$I$$20231221$20240923$20240923$PER$$GB-ROCHE-3482779$ROCHE$$$$$F$Y$$$20240923$$HP$GB$GB
243497481$24349748$1$I$$20231221$20240923$20240923$PER$$GB-ROCHE-3482777$ROCHE$$$$$F$Y$$$20240923$$HP$GB$GB
243497491$24349749$1$I$$20231221$20240923$20240923$PER$$GB-ROCHE-3482778$ROCHE$$$$$F$Y$$$20240923$$HP$GB$GB
243497501$24349750$1$I$$20240105$20240923$20240923$PER$$US-ROCHE-3487603$ROCHE$$$$$M$Y$$$20240923$$MD$US$US
243497511$24349751$1$I$20231207$20240104$20240923$20240923$PER$$CN-ROCHE-3486308$ROCHE$$61$YR$A$F$Y$56$KG$20240923$$HP$CN$CN
243497521$24349752$1$I$$20231221$20240923$20240923$PER$$GB-ROCHE-3482781$ROCHE$$$$$F$Y$$$20240923$$HP$GB$GB
243497531$24349753$1$I$20210616$20240117$20240923$20240923$PER$$RO-ROCHE-3490130$ROCHE$$58$YR$A$F$Y$74$KG$20240923$$MD$RO$RO
243497541$24349754$1$I$$20240916$20240923$20240923$EXP$$BR-TAKEDA-2024TUS020299$TAKEDA$$$$$F$Y$$$20240923$$CN$BR$BR
243497561$24349756$1$I$$20231221$20240923$20240923$PER$$GB-ROCHE-3482780$ROCHE$$$$$F$Y$$$20240923$$HP$GB$GB
243497571$24349757$1$I$20231201$20240117$20240923$20240923$PER$$US-ROCHE-3487434$ROCHE$$60$YR$A$F$Y$$$20240923$$CN$US$US
243497581$24349758$1$I$20231206$20240103$20240923$20240923$PER$$CN-ROCHE-3485726$ROCHE$$58$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243497591$24349759$1$I$20231227$20240109$20240923$20240923$PER$$US-ROCHE-3489514$ROCHE$$59$YR$A$F$Y$$$20240923$$HP$US$US
243497601$24349760$1$I$$20240106$20240923$20240923$PER$$FR-ROCHE-3488847$ROCHE$$$$A$F$Y$$$20240923$$CN$FR$FR
243497611$24349761$1$I$20240812$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045917$AUROBINDO$$55$YR$$M$Y$56$KG$20240923$$MD$FR$FR
243497621$24349762$1$I$$20240919$20240923$20240923$EXP$CA-MHPD-E2B_07214908$CA-Accord-447556$ACCORD$$$$$F$Y$5$KG$20240923$$HP$CA$CA
243497631$24349763$1$I$20240101$20240918$20240923$20240923$PER$$US-ORGANON-O2409USA001435$ORGANON$$$$$F$Y$$$20240923$$HP$US$US
243497641$24349764$1$I$$20231003$20240923$20240923$PER$$JP-ROCHE-3438937$ROCHE$$1$YR$I$$Y$$$20240923$$CN$JP$JP
243497651$24349765$1$I$20181017$20240111$20240923$20240923$PER$$RO-ROCHE-3491891$ROCHE$$56$YR$A$F$Y$74$KG$20240923$$MD$RO$RO
243497661$24349766$1$I$20231220$20240119$20240923$20240923$PER$$CN-ROCHE-3496044$ROCHE$$33$YR$A$F$Y$52.5$KG$20240923$$HP$CN$CN
243497671$24349767$1$I$$20240909$20240923$20240923$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01478$INTRA-CELLULAR THERAPIES$$8$DEC$$F$Y$$$20240923$$HP$US$US
243497681$24349768$1$I$20240501$20240909$20240923$20240923$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01477$INTRA-CELLULAR THERAPIES$$22$YR$$F$Y$$$20240923$$CN$US$US
243497691$24349769$1$I$20230928$20230929$20240923$20240923$PER$$JP-ROCHE-3434146$ROCHE$$8$YR$C$M$Y$$$20240923$$PH$JP$JP
243497701$24349770$1$I$20240109$20240126$20240923$20240923$PER$FR-AFSSAPS-PO2024000043$FR-ROCHE-3499489$ROCHE$$60$YR$A$F$Y$98$KG$20240923$$MD$FR$FR
243497711$24349771$1$I$20231116$20240102$20240923$20240923$PER$$CN-ROCHE-3485054$ROCHE$$65$YR$E$M$Y$73$KG$20240923$$HP$CN$CN
243497721$24349772$1$I$20231130$20240122$20240923$20240923$PER$$CN-ROCHE-3496731$ROCHE$$43$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243497731$24349773$1$I$20231215$20240111$20240923$20240923$PER$$CN-ROCHE-3491602$ROCHE$$32$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243497741$24349774$1$I$$20231031$20240923$20240923$PER$$JP-ROCHE-3455871$ROCHE$$$$C$$Y$$$20240923$$PH$JP$JP
243497751$24349775$1$I$$20240118$20240923$20240923$PER$$CH-ROCHE-3495350$ROCHE$$$$E$$Y$$$20240923$$MD$CH$CH
243497761$24349776$1$I$$20240123$20240923$20240923$PER$$CA-ROCHE-3484670$ROCHE$$$$A$M$Y$62$KG$20240923$$HP$CA$CA
243497771$24349777$1$I$20231218$20240102$20240923$20240923$PER$$CN-ROCHE-3485042$ROCHE$$60$YR$A$F$Y$$$20240923$$HP$CN$CN
243497781$24349778$1$I$$20240109$20240923$20240923$PER$$AU-ROCHE-3490891$ROCHE$Unknown. Immune targeting in HER2+ breast cancer. Australian LIMBIC 2024 Jan 09;ONCOLOGY:-.$$$$F$Y$$$20240923$$HP$AU$AU
243497791$24349779$1$I$$20240117$20240923$20240923$PER$$US-ROCHE-3492750$ROCHE$$80$YR$E$F$Y$$$20240923$$MD$US$US
243497801$24349780$1$I$20230101$20231101$20240923$20240923$PER$$JP-ROCHE-3456705$ROCHE$$7$YR$C$$Y$$$20240923$$CN$JP$JP
243497811$24349781$1$I$20211201$20240105$20240923$20240923$PER$$CN-ROCHE-3487760$ROCHE$WANG J, Zhu X, Chen J, Liu F and Tang X Successful treatment with trastuzumab plus chemotherapy as the first-line regimen in advanced small bowel adenocarcinoma harboring HER2 amplification: A report of two cases.Doi:10.3892/ol.2023.14197. Oncology Letters 2024;27 (2):1-7.$28$YR$A$M$Y$$$20240923$$HP$CN$CN
243497821$24349782$1$I$20240318$20240318$20240923$20240923$PER$$JP-ROCHE-3547515$ROCHE$$5$MON$I$F$Y$9.3$KG$20240923$$PH$JP$JP
243497831$24349783$1$I$20231007$20231010$20240923$20240923$PER$$JP-ROCHE-3440020$ROCHE$$4$YR$C$F$Y$$$20240923$$PH$JP$JP
243497841$24349784$1$I$20240121$20240130$20240923$20240923$PER$$JP-ROCHE-3507389$ROCHE$$10$MON$I$F$Y$$$20240923$$HP$JP$JP
243497851$24349785$1$I$$20240109$20240923$20240923$PER$$CN-ROCHE-3489270$ROCHE$$52$YR$A$F$Y$48$KG$20240923$$HP$CN$CN
243497861$24349786$1$I$20231222$20240112$20240923$20240923$PER$$CN-ROCHE-3491788$ROCHE$$62$YR$A$F$Y$$$20240923$$HP$CN$CN
243497871$24349787$1$I$$20231227$20240923$20240923$PER$$JP-ROCHE-3486340$ROCHE$$5$YR$C$$Y$$$20240923$$CN$JP$JP
243497881$24349788$1$I$$20231110$20240923$20240923$PER$$JP-ROCHE-3460526$ROCHE$$$$I$$Y$11$KG$20240923$$MD$JP$JP
243497891$24349789$1$I$20231030$20231109$20240923$20240923$PER$$JP-ROCHE-3460504$ROCHE$$5$YR$C$M$Y$$$20240923$$PH$JP$JP
243497901$24349790$1$I$20231211$20240102$20240923$20240923$PER$$CN-ROCHE-3485034$ROCHE$$60$YR$A$F$Y$$$20240923$$HP$CN$CN
243497911$24349791$1$I$$20240113$20240923$20240923$PER$$CN-ROCHE-3492035$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243497921$24349792$1$I$20240201$20240212$20240923$20240923$PER$$BG-ROCHE-3509703$ROCHE$$11$YR$C$M$Y$$$20240923$$CN$BG$BG
243497931$24349793$1$I$$20240122$20240923$20240923$PER$$CO-ROCHE-3497085$ROCHE$$65$YR$E$F$Y$$$20240923$$CN$CO$CO
243497941$24349794$1$I$20231224$20231227$20240923$20240923$PER$$BG-ROCHE-3483253$ROCHE$$3$YR$C$F$Y$$$20240923$$CN$BG$BG
243497951$24349795$1$I$20231224$20231227$20240923$20240923$PER$$CN-ROCHE-3482909$ROCHE$$52$YR$A$F$Y$$$20240923$$HP$CN$CN
243497961$24349796$1$I$$20240207$20240923$20240923$PER$$JP-ROCHE-3513333$ROCHE$$5$YR$C$F$Y$$$20240923$$PH$JP$JP
243497971$24349797$1$I$20231113$20231114$20240923$20240923$PER$$JP-ROCHE-3463969$ROCHE$$9$YR$C$F$Y$$$20240923$$PH$JP$JP
243497981$24349798$1$I$20231024$20231114$20240923$20240923$PER$$JP-ROCHE-3463970$ROCHE$$8$YR$C$F$Y$$$20240923$$PH$JP$JP
243497991$24349799$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000085556$ROCHE$$$$C$F$Y$$$20240923$$CN$US$US
243498001$24349800$1$I$$20240123$20240923$20240923$PER$$US-ROCHE-3497983$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243498011$24349801$1$I$$20240118$20240923$20240923$PER$$CH-ROCHE-3496717$ROCHE$$$$A$$Y$$$20240923$$MD$CH$CH
243498021$24349802$1$I$20240213$20240213$20240923$20240923$PER$$JP-ROCHE-3515527$ROCHE$$7$YR$C$M$Y$$$20240923$$PH$JP$JP
243498031$24349803$1$I$20231221$20231228$20240923$20240923$PER$$JP-ROCHE-3482764$ROCHE$$5$YR$C$F$Y$$$20240923$$PH$JP$JP
243498041$24349804$1$I$20240117$20240118$20240923$20240923$PER$$JP-ROCHE-3499055$ROCHE$$1$YR$I$M$Y$8.6$KG$20240923$$PH$JP$JP
243498051$24349805$1$I$20190515$20240118$20240923$20240923$PER$$RO-ROCHE-3491883$ROCHE$$56$YR$A$F$Y$$$20240923$$MD$RO$RO
243498061$24349806$1$I$20231221$20240102$20240923$20240923$PER$$CN-ROCHE-3485037$ROCHE$$62$YR$A$F$Y$$$20240923$$HP$CN$CN
243498071$24349807$1$I$$20240917$20240923$20240923$EXP$$IN-ROCHE-10000085520$ROCHE$$66$YR$E$M$Y$$$20240923$$CN$IN$IN
243498081$24349808$1$I$20231122$20231227$20240923$20240923$PER$$CN-ROCHE-3482903$ROCHE$$54$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243498091$24349809$1$I$20240119$20240123$20240923$20240923$PER$$CN-ROCHE-3497653$ROCHE$$68$YR$E$M$Y$58$KG$20240923$$HP$CN$CN
243498101$24349810$1$I$$20240912$20240923$20240923$EXP$$BR-MYLANLABS-2024M1083762$MYLAN$$$$$F$Y$57$KG$20240923$$CN$BR$BR
243498121$24349812$1$I$$20240912$20240923$20240923$EXP$$US-MYLANLABS-2024M1084897$MYLAN$Al Yacoub R, Brown K, Ladna M. Successful multidisciplinary treatment of the rare pathology of vulvar Crohn^s disease. BMJ-Case-Rep 2023; 16 (10): 1-4.$6$DEC$$F$Y$$$20240923$$HP$US$US
243498141$24349814$1$I$$20240911$20240923$20240923$EXP$$US-MYLANLABS-2024M1084277$MYLAN$Shah A, Kunkel H, Aghazadeh NM, Tollefson M. 54647 Efficacy of Colchicine Treatment for Aphthous Ulcers in Pediatric Patients. J-Am-Acad-Dermatol 2024; 91 (Suppl.) (3): AB36.$$$C$$Y$$$20240923$$HP$US$US
243498151$24349815$1$I$$20240909$20240923$20240923$EXP$$US-MYLANLABS-2024M1083733$MYLAN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen+#39;s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.$39$YR$$M$Y$$$20240923$$HP$US$US
243498161$24349816$1$I$$20240910$20240923$20240923$EXP$$FR-MYLANLABS-2024M1084241$MYLAN$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$31$YR$$M$Y$$$20240923$$HP$FR$FR
243498171$24349817$1$I$20180917$20240911$20240923$20240923$EXP$$CO-MYLANLABS-2024M1085162$MYLAN$$9$YR$$M$Y$15$KG$20240923$$CN$CO$CO
243498181$24349818$1$I$$20240909$20240923$20240923$EXP$$US-MYLANLABS-2024M1083506$MYLAN$Hernandez CL, Lynch DM, Golash AJ, Marquis K, Besz KM, Oxnard G, et al. Anaphylaxis and systemic mastocytosis controlled with KIT inhibitors in a patient with metastatic lung adenocarcinoma. Ann-Allergy-Asthma-Immunol 2023; 131 668-670.$58$YR$$F$Y$$$20240923$$MD$US$US
243498191$24349819$1$I$$20240911$20240923$20240923$EXP$$IT-MYLANLABS-2024M1075725$MYLAN$Cuniolo L, Gipponi M, Murelli F, Depaoli F, Cornacchia C, Franchelli S, et al. Multidisciplinary and Tailored Treatment of Locally Advanced Breast Cancer in Progression during Neoadjuvant Chemotherapy: Case Report. Current Oncology. 2024;31 (5):2856-6$55$YR$$F$Y$$$20240923$$HP$IT$IT
243498201$24349820$1$I$20240824$20240911$20240923$20240923$EXP$$TR-MYLANLABS-2024M1085995$MYLAN$$48$YR$$M$Y$79$KG$20240923$$CN$TR$TR
243498211$24349821$1$I$$20240913$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024106517$AMGEN$$$$$F$Y$$$20240923$$CN$JP$JP
243498221$24349822$1$I$$20240910$20240923$20240923$EXP$$GB-MYLANLABS-2024M1084178$MYLAN$Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP. A case of human T-lymphotropic virus-1-associated lichenoid dermatitis. Clin-Exp-Dermatol 2024; 49 (8): 916-918.$61$YR$$F$Y$$$20240923$$HP$GB$GB
243498231$24349823$1$I$20230201$20240909$20240923$20240923$EXP$$US-EPICPHARMA-US-2024EPCSPO01129$EPIC PHARM$$64$YR$A$M$Y$$$20240923$$CN$US$US
243498241$24349824$1$I$20240308$20240308$20240923$20240923$PER$$US-ROCHE-3524404$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243498251$24349825$1$I$20231124$20231222$20240923$20240923$PER$$CN-ROCHE-3492371$ROCHE$$66$YR$E$F$Y$55$KG$20240923$$HP$CN$CN
243498261$24349826$1$I$20240204$20240206$20240923$20240923$PER$$JP-ROCHE-3512586$ROCHE$$9$YR$C$M$Y$$$20240923$$PH$JP$JP
243498271$24349827$1$I$20231206$20240105$20240923$20240923$PER$$CN-ROCHE-3487007$ROCHE$$39$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243498281$24349828$1$I$$20231127$20240923$20240923$PER$$JP-ROCHE-3469948$ROCHE$$10$YR$C$M$Y$$$20240923$$PH$JP$JP
243498291$24349829$1$I$20240104$20240126$20240923$20240923$PER$$CN-ROCHE-3500411$ROCHE$$67$YR$E$F$Y$72$KG$20240923$$HP$CN$CN
243498301$24349830$1$I$20231210$20240102$20240923$20240923$PER$$CN-ROCHE-3484998$ROCHE$$52$YR$A$F$Y$$$20240923$$HP$CN$CN
243498311$24349831$1$I$20240110$20240119$20240923$20240923$PER$$CN-ROCHE-3496739$ROCHE$$58$YR$A$F$Y$$$20240923$$HP$CN$CN
243498321$24349832$1$I$$20240124$20240923$20240923$PER$$JP-ROCHE-3504259$ROCHE$$2$YR$C$F$Y$$$20240923$$PH$JP$JP
243498331$24349833$1$I$20231114$20231218$20240923$20240923$PER$$JP-ROCHE-3463860$ROCHE$$5$YR$C$F$Y$$$20240923$$PH$JP$JP
243498341$24349834$1$I$20231228$20240118$20240923$20240923$PER$IT-MINISAL02-965156$IT-ROCHE-3494227$ROCHE$$65$YR$E$F$Y$$$20240923$$MD$IT$IT
243498351$24349835$1$I$20240107$20240122$20240923$20240923$PER$$CN-ROCHE-3496747$ROCHE$$49$YR$A$F$Y$$$20240923$$HP$CN$CN
243498361$24349836$1$I$$20240124$20240923$20240923$PER$$JP-ROCHE-3506114$ROCHE$$2$YR$C$F$Y$$$20240923$$PH$JP$JP
243498371$24349837$1$I$20231019$20240104$20240923$20240923$PER$$CN-ROCHE-3486990$ROCHE$$36$YR$A$F$Y$50.5$KG$20240923$$HP$CN$CN
243498381$24349838$1$I$$20240130$20240923$20240923$PER$$JP-ROCHE-3509148$ROCHE$$$$C$$Y$$$20240923$$PH$JP$JP
243498391$24349839$1$I$20240311$20240311$20240923$20240923$PER$$JP-ROCHE-3541323$ROCHE$$3$YR$C$F$Y$$$20240923$$PH$JP$JP
243498402$24349840$2$F$$20240916$20240923$20240925$EXP$$US-SA-2024SA272746$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240925$$CN$US$US
243498411$24349841$1$I$20231130$20240122$20240923$20240923$PER$$CN-ROCHE-3496758$ROCHE$$51$YR$A$F$Y$70$KG$20240923$$HP$CN$CN
243498421$24349842$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64692$$FDA-CTU$$61$YR$$M$N$$$20240920$N$$US$
243498431$24349843$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64663$$FDA-CTU$$36$YR$$F$N$$$20240920$N$$US$
243498441$24349844$1$I$20240904$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64725$$FDA-CTU$$63$YR$$F$N$$$20240919$N$HP$US$
243498451$24349845$1$I$20220207$20240205$20240923$20240923$PER$$IT-ROCHE-3489025$ROCHE$$52$YR$A$F$Y$68$KG$20240923$$MD$IT$IT
243498461$24349846$1$I$20240314$20240315$20240923$20240923$PER$$JP-ROCHE-3544802$ROCHE$$$$C$$Y$$$20240923$$CN$JP$JP
243498471$24349847$1$I$20221031$20240122$20240923$20240923$PER$IT-MINISAL02-965689$IT-ROCHE-3496105$ROCHE$$79$YR$E$F$Y$76$KG$20240923$$MD$IT$IT
243498481$24349848$1$I$20231207$20231222$20240923$20240923$PER$$JP-ROCHE-3482819$ROCHE$$8$DEC$E$F$Y$$$20240923$$MD$JP$JP
243498491$24349849$1$I$$20240325$20240923$20240923$PER$$AU-ROCHE-3532607$ROCHE$$$$C$$Y$$$20240923$$PH$AU$AU
243498501$24349850$1$I$20231019$20240409$20240923$20240923$PER$$JP-ROCHE-3560597$ROCHE$$6$YR$C$M$Y$18$KG$20240923$$PH$JP$JP
243498511$24349851$1$I$$20240125$20240923$20240923$PER$$JP-ROCHE-3504945$ROCHE$$10$YR$C$M$Y$$$20240923$$PH$JP$JP
243498521$24349852$1$I$$20231226$20240923$20240923$PER$$JP-ROCHE-3484130$ROCHE$$7$DEC$E$F$Y$$$20240923$$MD$JP$JP
243498531$24349853$1$I$20190623$20240314$20240923$20240923$PER$$RO-ROCHE-3490146$ROCHE$$56$YR$A$F$Y$74$KG$20240923$$MD$RO$RO
243498541$24349854$1$I$$20240129$20240923$20240923$PER$$CA-ROCHE-3501520$ROCHE$$$$$$Y$$$20240923$$PH$CA$CA
243498551$24349855$1$I$$20240202$20240923$20240923$PER$$US-ROCHE-3504678$ROCHE$$$$$M$Y$12$KG$20240923$$PH$US$US
243498561$24349856$1$I$20240117$20240123$20240923$20240923$PER$$CN-ROCHE-3497635$ROCHE$$54$YR$A$F$Y$$$20240923$$CN$CN$CN
243498581$24349858$1$I$20231201$20231218$20240923$20240923$PER$$JP-ROCHE-3482090$ROCHE$$4$YR$C$M$Y$$$20240923$$PH$JP$JP
243498591$24349859$1$I$$20240318$20240923$20240923$PER$$JP-ROCHE-3547626$ROCHE$$$$C$$Y$$$20240923$$PH$JP$JP
243498601$24349860$1$I$20231212$20240119$20240923$20240923$PER$$CN-ROCHE-3495735$ROCHE$$50$YR$A$F$Y$$$20240923$$HP$CN$CN
243498611$24349861$1$I$20230928$20231110$20240923$20240923$PER$$JP-ROCHE-3459672$ROCHE$$6$DEC$A$F$Y$$$20240923$$PH$JP$JP
243498631$24349863$1$I$20240722$20240916$20240923$20240923$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001881$BLUEPRINT MEDICINES$$26$YR$A$F$Y$$$20240923$$CN$US$US
243498641$24349864$1$I$$20240920$20240923$20240923$PER$$US-HALEON-2198021$Haleon PLC$$$$$$Y$$$20240923$$CN$US$US
243498651$24349865$1$I$$20240403$20240923$20240923$PER$$JP-ROCHE-3555743$ROCHE$$1$YR$I$$Y$$$20240923$$CN$JP$JP
243498661$24349866$1$I$20231206$20240308$20240923$20240923$PER$$IT-ROCHE-3496622$ROCHE$$73$YR$E$F$Y$67$KG$20240923$$MD$IT$IT
243498671$24349867$1$I$$20240220$20240923$20240923$PER$$JP-ROCHE-3524555$ROCHE$$$$C$F$Y$$$20240923$$PH$JP$JP
243498681$24349868$1$I$20231101$20231207$20240923$20240923$PER$$JP-ROCHE-3471330$ROCHE$$7$YR$C$F$Y$$$20240923$$PH$JP$JP
243498691$24349869$1$I$20240209$20240221$20240923$20240923$PER$BG-BDA-26856$BG-ROCHE-3513696$ROCHE$$2$YR$C$F$Y$16$KG$20240923$$CN$BG$BG
243498701$24349870$1$I$$20240104$20240923$20240923$PER$$FR-ROCHE-3487517$ROCHE$$$$$$Y$$$20240923$$MD$FR$FR
243498711$24349871$1$I$$20240110$20240923$20240923$PER$$MY-ROCHE-3491866$ROCHE$$74$YR$E$M$Y$$$20240923$$PH$MY$MY
243498721$24349872$1$I$$20231122$20240923$20240923$PER$$JP-ROCHE-3467015$ROCHE$$5$YR$C$M$Y$$$20240923$$PH$JP$JP
243498731$24349873$1$I$$20231025$20240923$20240923$PER$$JP-ROCHE-3450245$ROCHE$$8$YR$C$F$Y$$$20240923$$PH$JP$JP
243498741$24349874$1$I$20240123$20240125$20240923$20240923$PER$$US-ROCHE-3497808$ROCHE$$16$YR$T$M$Y$$$20240923$$PH$US$US
243498751$24349875$1$I$$20240119$20240923$20240923$PER$$CN-ROCHE-3495928$ROCHE$$$$$$Y$$$20240923$$HP$CN$CN
243498761$24349876$1$I$$20240103$20240923$20240923$PER$$JP-ROCHE-3490583$ROCHE$$63$YR$A$F$Y$$$20240923$$MD$JP$JP
243498771$24349877$1$I$$20240110$20240923$20240923$PER$$RO-ROCHE-3491297$ROCHE$$68$YR$E$F$Y$67$KG$20240923$$CN$RO$RO
243498781$24349878$1$I$$20231127$20240923$20240923$PER$$JP-ROCHE-3469992$ROCHE$$1$YR$I$M$Y$$$20240923$$PH$JP$JP
243498791$24349879$1$I$$20231115$20240923$20240923$PER$$JP-ROCHE-3463940$ROCHE$$5$YR$C$F$Y$$$20240923$$PH$JP$JP
243498801$24349880$1$I$$20240112$20240923$20240923$PER$$CN-ROCHE-3491742$ROCHE$$66$YR$E$F$Y$$$20240923$$MD$CN$CN
243498811$24349881$1$I$20240201$20240201$20240923$20240923$PER$$JP-ROCHE-3510445$ROCHE$$10$YR$C$M$Y$$$20240923$$PH$JP$JP
243498821$24349882$1$I$20240111$20240123$20240923$20240923$PER$$CN-ROCHE-3500009$ROCHE$$67$YR$E$M$Y$65$KG$20240923$$HP$CN$CN
243498831$24349883$1$I$$20240408$20240923$20240923$PER$$AU-ROCHE-3541758$ROCHE$$3$YR$C$F$Y$$$20240923$$CN$AU$AU
243498841$24349884$1$I$$20240117$20240923$20240923$PER$$US-ROCHE-3493586$ROCHE$$50$YR$A$F$Y$$$20240923$$MD$US$US
243498851$24349885$1$I$$20240920$20240923$20240923$PER$$US-ROCHE-10000088649$ROCHE$$12$YR$T$F$Y$91$KG$20240923$$HP$US$US
243498861$24349886$1$I$$20240117$20240923$20240923$PER$$JP-ROCHE-3510468$ROCHE$$8$YR$C$M$Y$$$20240923$$PH$JP$JP
243498871$24349887$1$I$20240801$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012636$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240923$$CN$US$US
243498881$24349888$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012763$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240923$$CN$US$US
243498891$24349889$1$I$20240919$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012724$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240923$$CN$US$US
243498901$24349890$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012729$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240923$$CN$US$US
243498911$24349891$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012918$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240923$$CN$US$US
243498921$24349892$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010168$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240923$$CN$US$US
243498931$24349893$1$I$20240912$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012581$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240923$$CN$US$US
243498951$24349895$1$I$$20240117$20240923$20240923$PER$$PE-ROCHE-3494584$ROCHE$$43$YR$A$F$Y$$$20240923$$CN$PE$PE
243498961$24349896$1$I$20240915$20240918$20240923$20240923$EXP$$IN-ROCHE-3547334$ROCHE$$62$YR$A$M$Y$$$20240923$$MD$IN$IN
243498971$24349897$1$I$$20231226$20240923$20240923$PER$$US-ROCHE-3482564$ROCHE$$$$$$Y$$$20240923$$PH$US$US
243498981$24349898$1$I$20240120$20240315$20240923$20240923$PER$BG-BDA-26699$BG-ROCHE-3528409$ROCHE$$5$YR$C$F$Y$$$20240923$$CN$BG$BG
243498991$24349899$1$I$$20231229$20240923$20240923$PER$$IN-ROCHE-3484379$ROCHE$$$$$$Y$$$20240923$$HP$IN$IN
243499001$24349900$1$I$$20240820$20240923$20240923$EXP$$IN-HETERO-HET2024IN02797$HETERO$Malwade S, Dharmagadda A, Premkumar V.. Neonatal Abstinence Syndrome: A Case Series. Cureus. 2024;16(7):e64372$$$N$M$Y$1.5$KG$20240829$$MD$IN$IN
243499011$24349901$1$I$20220404$20240122$20240923$20240923$PER$IT-MINISAL02-965684$IT-ROCHE-3496094$ROCHE$$78$YR$E$F$Y$76$KG$20240923$$MD$IT$IT
243499021$24349902$1$I$20240229$20240229$20240923$20240923$PER$$JP-ROCHE-3535642$ROCHE$$5$YR$C$F$Y$$$20240923$$CN$JP$JP
243499031$24349903$1$I$$20240326$20240923$20240923$PER$$JP-ROCHE-3550858$ROCHE$$6$YR$C$M$Y$$$20240923$$PH$JP$JP
243499041$24349904$1$I$$20231006$20240923$20240923$PER$$JP-ROCHE-3439011$ROCHE$$$$C$F$Y$$$20240923$$PH$JP$JP
243499051$24349905$1$I$20231129$20240122$20240923$20240923$PER$$CN-ROCHE-3496774$ROCHE$$51$YR$A$F$Y$51$KG$20240923$$HP$CN$CN
243499061$24349906$1$I$$20231212$20240923$20240923$PER$$FR-ROCHE-3476098$ROCHE$$2$MON$I$F$Y$4.35$KG$20240923$$PH$FR$FR
243499071$24349907$1$I$20240223$20240423$20240923$20240923$PER$FR-AFSSAPS-DJ2024000554$FR-ROCHE-3551974$ROCHE$$11$YR$C$F$Y$34$KG$20240923$$CN$FR$FR
243499081$24349908$1$I$$20231229$20240923$20240923$PER$$US-ROCHE-3484410$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243499091$24349909$1$I$20240109$20240124$20240923$20240923$PER$$CN-ROCHE-3498159$ROCHE$$71$YR$E$F$Y$53$KG$20240923$$HP$CN$CN
243499101$24349910$1$I$$20240319$20240923$20240923$PER$$JP-ROCHE-3548424$ROCHE$$$$C$$Y$$$20240923$$PH$JP$JP
243499111$24349911$1$I$20231226$20240105$20240923$20240923$PER$$CN-ROCHE-3487375$ROCHE$$49$YR$A$M$Y$65$KG$20240923$$HP$CN$CN
243499121$24349912$1$I$$20231229$20240923$20240923$PER$$CN-ROCHE-3483687$ROCHE$$52$YR$A$F$Y$$$20240923$$MD$CN$CN
243499131$24349913$1$I$$20231127$20240923$20240923$PER$$JP-ROCHE-3469910$ROCHE$$6$YR$C$M$Y$$$20240923$$PH$JP$JP
243499141$24349914$1$I$20240206$20240215$20240923$20240923$PER$$FR-ROCHE-3508136$ROCHE$$3$YR$C$F$Y$13.1$KG$20240923$$PH$FR$FR
243499151$24349915$1$I$20231216$20240108$20240923$20240923$PER$$CN-ROCHE-3489246$ROCHE$$69$YR$E$F$Y$55$KG$20240923$$HP$CN$CN
243499161$24349916$1$I$$20240501$20240923$20240923$PER$$JP-ROCHE-3551012$ROCHE$$1$YR$I$M$Y$$$20240923$$PH$JP$JP
243499171$24349917$1$I$20240109$20240116$20240923$20240923$PER$$CN-ROCHE-3493402$ROCHE$$72$YR$E$F$Y$60$KG$20240923$$HP$CN$CN
243499181$24349918$1$I$$20240301$20240923$20240923$PER$$JP-ROCHE-3533572$ROCHE$$7$YR$C$M$Y$$$20240923$$CN$JP$JP
243499191$24349919$1$I$$20240806$20240923$20240923$EXP$$US-MIRUM PHARMACEUTICALS, INC.-US-MIR-24-00632$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243499201$24349920$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114353$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$HP$US$US
243499211$24349921$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114341$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240923$$CN$US$US
243499221$24349922$1$I$20240914$20240918$20240923$20240923$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-149789$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240923$$MD$DE$DE
243499231$24349923$1$I$$20240919$20240923$20240923$EXP$CA-MHPD-E2B_07214942$CA-Accord-447570$ACCORD$$$$$F$Y$6$KG$20240923$$HP$CA$CA
243499241$24349924$1$I$20240319$20240515$20240923$20240923$PER$$JP-ROCHE-3572195$ROCHE$$9$YR$C$M$Y$$$20240923$$PH$JP$JP
243499251$24349925$1$I$20231216$20240102$20240923$20240923$PER$$CN-ROCHE-3485114$ROCHE$$57$YR$A$F$Y$$$20240923$$HP$CN$CN
243499261$24349926$1$I$20231001$20231027$20240923$20240923$PER$$JP-ROCHE-3452511$ROCHE$$7$YR$C$M$Y$$$20240923$$PH$JP$JP
243499271$24349927$1$I$20240115$20240122$20240923$20240923$PER$$CN-ROCHE-3496755$ROCHE$$48$YR$A$F$Y$46$KG$20240923$$HP$CN$CN
243499281$24349928$1$I$20231213$20231229$20240923$20240923$PER$$CN-ROCHE-3485110$ROCHE$$55$YR$A$F$Y$66$KG$20240923$$HP$CN$CN
243499291$24349929$1$I$$20240508$20240923$20240923$PER$$JP-ROCHE-3566917$ROCHE$$1$YR$I$F$Y$$$20240923$$PH$JP$JP
243499302$24349930$2$F$$20240915$20240923$20240923$PER$$US-ROCHE-10000083250$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243499311$24349931$1$I$20231224$20231229$20240923$20240923$PER$$CN-ROCHE-3484547$ROCHE$$52$YR$A$F$Y$57$KG$20240923$$HP$CN$CN
243499321$24349932$1$I$$20231023$20240923$20240923$PER$$JP-ROCHE-3450181$ROCHE$$$$C$$Y$$$20240923$$CN$JP$JP
243499331$24349933$1$I$20210331$20240111$20240923$20240923$PER$$RO-ROCHE-3490165$ROCHE$$58$YR$A$F$Y$$$20240923$$MD$RO$RO
243499341$24349934$1$I$$20231229$20240923$20240923$PER$$US-ROCHE-3484252$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243499351$24349935$1$I$20231019$20231229$20240923$20240923$PER$$CN-ROCHE-3484534$ROCHE$$52$YR$A$F$Y$$$20240923$$HP$CN$CN
243499361$24349936$1$I$20231020$20231020$20240923$20240923$PER$$JP-ROCHE-3448435$ROCHE$$2$YR$C$F$Y$$$20240923$$PH$JP$JP
243499371$24349937$1$I$20231207$20231226$20240923$20240923$PER$$CN-ROCHE-3483940$ROCHE$$39$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243499381$24349938$1$I$$20240104$20240923$20240923$PER$$PK-ROCHE-3486257$ROCHE$$39$YR$A$F$Y$$$20240923$$CN$PK$PK
243499391$24349939$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64684$$FDA-CTU$$24$YR$$M$N$$$20240920$N$$US$
243499401$24349940$1$I$20221010$20240122$20240923$20240923$PER$IT-MINISAL02-965688$IT-ROCHE-3495990$ROCHE$$79$YR$E$F$Y$76$KG$20240923$$MD$IT$IT
243499411$24349941$1$I$$20231006$20240923$20240923$PER$$JP-ROCHE-3439008$ROCHE$$6$YR$C$M$Y$$$20240923$$PH$JP$JP
243499421$24349942$1$I$20230915$20231017$20240923$20240923$PER$$JP-ROCHE-3444938$ROCHE$$$$C$F$Y$$$20240923$$PH$JP$JP
243499431$24349943$1$I$$20240912$20240923$20240923$EXP$$IT-AUROBINDO-AUR-APL-2024-046234$AUROBINDO$Pessina E, Martini A, Raffone F, Martiadis V.. Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series. .. Front Psychiatry. 2023;14:1299368 (1-5)$$$$$Y$$$20240923$$HP$IT$IT
243499441$24349944$1$I$20240910$20240911$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005511$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240923$$CN$US$US
243499451$24349945$1$I$20231207$20240105$20240923$20240923$PER$$CN-ROCHE-3487382$ROCHE$$43$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243499461$24349946$1$I$$20240111$20240923$20240923$PER$$JP-ROCHE-3493869$ROCHE$$78$YR$E$M$Y$$$20240923$$PH$JP$JP
243499471$24349947$1$I$$20231227$20240923$20240923$PER$$CN-ROCHE-3483019$ROCHE$$41$YR$A$F$Y$$$20240923$$CN$CN$CN
243499481$24349948$1$I$$20240122$20240923$20240923$PER$$RO-ROCHE-3497156$ROCHE$$74$YR$E$F$Y$$$20240923$$CN$RO$RO
243499491$24349949$1$I$20240913$20240913$20240923$20240923$PER$$US-MYLANLABS-2024M1084635$MYLAN$$59$YR$$F$Y$$$20240923$$CN$US$US
243499501$24349950$1$I$$20240108$20240923$20240923$PER$$CN-ROCHE-3487815$ROCHE$$74$YR$E$M$Y$$$20240923$$CN$CN$CN
243499511$24349951$1$I$$20240125$20240923$20240923$PER$$US-ROCHE-3500586$ROCHE$Prasad A, Verghese D, Vijaya Rangan S and Sunadarajan N. Spontaneous tumour lysis secondary to gastric adenocarcinoma. DOI: 10.1136/bcr-2023-258369. BMJ Case Reports 2024 Jan 08;17 (1):1-5.$$$E$M$Y$$$20240923$$MD$US$US
243499521$24349952$1$I$$20240105$20240923$20240923$PER$$CA-ROCHE-3487801$ROCHE$$$$$$Y$$$20240923$$PH$CA$CA
243499531$24349953$1$I$20231115$20240111$20240923$20240923$PER$$CN-ROCHE-3491786$ROCHE$$58$YR$A$F$Y$66$KG$20240923$$HP$CN$CN
243499541$24349954$1$I$$20240102$20240923$20240923$PER$$BR-ROCHE-3485247$ROCHE$$58$YR$A$F$Y$$$20240923$$CN$BR$BR
243499551$24349955$1$I$20231226$20240111$20240923$20240923$PER$$CN-ROCHE-3491331$ROCHE$$52$YR$A$F$Y$71$KG$20240923$$HP$CN$CN
243499571$24349957$1$I$20240101$20240919$20240923$20240923$EXP$$CA-Orion Corporation ORION PHARMA-24_00031809$ORION$$32$YR$A$F$Y$$$20240923$$HP$CA$
243499581$24349958$1$I$20240913$20240916$20240923$20240923$EXP$$US-LEO Pharma-373569$LEO PHARM$$79$YR$$M$Y$$$20240923$$CN$US$US
243499591$24349959$1$I$$20240913$20240923$20240923$PER$$US-BEH-2024178837$CSL BEHRING$$$$A$F$Y$$$20240923$$HP$US$US
243499611$24349961$1$I$20240901$20240917$20240923$20240923$PER$$US-SA-2024SA269476$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240923$$HP$US$US
243499621$24349962$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010472$APOTEX$$76$YR$$M$Y$$$20240923$$CN$CA$CA
243499631$24349963$1$I$20240101$20240918$20240923$20240923$EXP$$NVSC2024AU169700$NOVARTIS$$$$$F$Y$$$20240923$$HP$AU$AU
243499642$24349964$2$F$$20240923$20240923$20240927$EXP$$NVSC2024US184854$NOVARTIS$$40$YR$$F$Y$$$20240927$$CN$US$US
243499651$24349965$1$I$20231208$20240124$20240923$20240923$PER$$US-ROCHE-3483319$ROCHE$$44$YR$A$M$Y$$$20240923$$CN$US$US
243499661$24349966$1$I$20240104$20240110$20240923$20240923$PER$$CN-ROCHE-3489936$ROCHE$$46$YR$A$F$Y$$$20240923$$HP$CN$CN
243499671$24349967$1$I$$20240104$20240923$20240923$PER$$FR-ROCHE-3486327$ROCHE$$$$$$Y$$$20240923$$MD$FR$FR
243499681$24349968$1$I$20231214$20240105$20240923$20240923$PER$$CN-ROCHE-3488597$ROCHE$$55$YR$A$F$Y$50$KG$20240923$$HP$CN$CN
243499691$24349969$1$I$20240106$20240109$20240923$20240923$PER$$CN-ROCHE-3489677$ROCHE$$50$YR$A$F$Y$64.5$KG$20240923$$HP$CN$CN
243499701$24349970$1$I$20181008$20240117$20240923$20240923$PER$$RO-ROCHE-3494268$ROCHE$$56$YR$A$F$Y$74$KG$20240923$$MD$RO$RO
243499711$24349971$1$I$$20240105$20240923$20240923$PER$$PK-ROCHE-3486501$ROCHE$$43$YR$A$F$Y$121$KG$20240923$$CN$PK$PK
243499721$24349972$1$I$$20240119$20240923$20240923$PER$$JP-ROCHE-3499283$ROCHE$$5$DEC$A$F$Y$$$20240923$$PH$JP$JP
243499741$24349974$1$I$20240117$20240122$20240923$20240923$PER$$CN-ROCHE-3496560$ROCHE$$64$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243499751$24349975$1$I$$20240915$20240923$20240923$EXP$$US-JNJFOC-20240952189$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240923$$HP$US$US
243499761$24349976$1$I$20231201$20240122$20240923$20240923$PER$$US-ROCHE-3498122$ROCHE$$68$YR$E$M$Y$$$20240923$$MD$US$US
243499771$24349977$1$I$20231220$20240126$20240923$20240923$PER$$CN-ROCHE-3500424$ROCHE$$71$YR$E$F$Y$62$KG$20240923$$HP$CN$CN
243499781$24349978$1$I$20240101$20240109$20240923$20240923$PER$$JP-ROCHE-3491505$ROCHE$$76$YR$E$F$Y$$$20240923$$MD$JP$JP
243499791$24349979$1$I$20231222$20240111$20240923$20240923$PER$$CN-ROCHE-3491791$ROCHE$$52$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243499801$24349980$1$I$20231108$20240123$20240923$20240923$PER$$CN-ROCHE-3497648$ROCHE$$50$YR$A$F$Y$$$20240923$$HP$CN$CN
243499811$24349981$1$I$$20240118$20240923$20240923$PER$$US-ROCHE-3495321$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243499821$24349982$1$I$$20240124$20240923$20240923$PER$$RU-ROCHE-3499617$ROCHE$$$$$F$Y$$$20240923$$CN$RU$RU
243499831$24349983$1$I$20240108$20240112$20240923$20240923$PER$$CN-ROCHE-3491781$ROCHE$$52$YR$A$F$Y$66$KG$20240923$$HP$CN$CN
243499841$24349984$1$I$20170404$20240110$20240923$20240923$PER$$IT-ROCHE-3489810$ROCHE$$76$YR$E$F$Y$88$KG$20240923$$MD$IT$IT
243499851$24349985$1$I$$20231229$20240923$20240923$PER$$US-ROCHE-3484304$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243499861$24349986$1$I$20230611$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045943$AUROBINDO$$15$YR$$M$Y$65$KG$20240923$$MD$FR$FR
243499871$24349987$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64660$$FDA-CTU$$81$YR$$F$N$63.5$KG$20240920$N$$US$
243499881$24349988$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64710$$FDA-CTU$$59$YR$$F$N$$$20240920$N$$US$
243499891$24349989$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64722$$FDA-CTU$$74$YR$$F$N$$$20240920$N$$US$
243499901$24349990$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64693$$FDA-CTU$$69$YR$$F$N$$$20240920$N$$US$
243499911$24349991$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64648$$FDA-CTU$$44$YR$$F$N$$$20240920$N$$US$
243499921$24349992$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64686$$FDA-CTU$$60$YR$$F$N$$$20240920$N$HP$US$
243499951$24349995$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64731$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243499961$24349996$1$I$20240916$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64734$$FDA-CTU$$31$YR$$F$N$$$20240920$N$$US$
243499971$24349997$1$I$$20240916$20240923$20240923$PER$$US-GSK-US2024114979$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$US$US
243499981$24349998$1$I$20240603$20240903$20240923$20240923$PER$$US-TEVA-VS-3240000$TEVA$$52$YR$$M$Y$88.45$KG$20240923$$CN$US$US
243499991$24349999$1$I$$20231228$20240923$20240923$PER$$CN-ROCHE-3484480$ROCHE$Zhang R, Liu X, Song G, Zhang Y and Liv H Trastuzumab Biosimilar (HLX02), Pertuzumab Plus Chemotherapy in Patients with HER2- Positive Metastatic Breast Cancer after Progression of Trastuzumab: A Prospective, Phase II Study. DOI: 10.4143/crt.2023.1151. Cancer research and treatment 2023;:-.$$$$$Y$$$20240923$$HP$CN$CN
243500001$24350000$1$I$20231128$20240108$20240923$20240923$PER$$CN-ROCHE-3488414$ROCHE$$62$YR$A$F$Y$32$KG$20240923$$HP$CN$CN
243500011$24350001$1$I$20231120$20240102$20240923$20240923$PER$$CN-ROCHE-3485660$ROCHE$$44$YR$A$F$Y$62$KG$20240923$$HP$CN$CN
243500021$24350002$1$I$$20240118$20240923$20240923$PER$$CH-ROCHE-3496261$ROCHE$$$$A$$Y$$$20240923$$MD$CH$CH
243500031$24350003$1$I$$20240104$20240923$20240923$PER$$PE-ROCHE-3486885$ROCHE$$74$YR$E$F$Y$$$20240923$$CN$PE$PE
243500051$24350005$1$I$$20231222$20240923$20240923$PER$$JP-ROCHE-3482735$ROCHE$$$$$F$Y$$$20240923$$PH$JP$JP
243500071$24350007$1$I$$20240105$20240923$20240923$PER$$US-ROCHE-3487455$ROCHE$$47$YR$A$F$Y$$$20240923$$CN$US$US
243500081$24350008$1$I$20231027$20240109$20240923$20240923$PER$$US-ROCHE-3489501$ROCHE$$69$YR$E$F$Y$$$20240923$$MD$US$US
243500101$24350010$1$I$20231127$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149409$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243500111$24350011$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114352$GLAXOSMITHKLINE$$89$YR$$F$Y$$$20240923$$CN$US$US
243500121$24350012$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114361$GLAXOSMITHKLINE$$57$YR$$M$Y$$$20240923$$CN$US$US
243500131$24350013$1$I$20240101$20240918$20240923$20240923$PER$$US-BAUSCH-BL-2024-014144$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240923$$CN$US$US
243500141$24350014$1$I$$20240918$20240923$20240923$EXP$$US-BAUSCH-BL-2024-014113$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240923$$CN$US$US
243500151$24350015$1$I$$20240125$20240923$20240923$PER$$US-ROCHE-3500276$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243500161$24350016$1$I$20240910$20240912$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005542$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240923$$CN$US$US
243500171$24350017$1$I$20240117$20240126$20240923$20240923$PER$$CN-ROCHE-3500467$ROCHE$$70$YR$E$F$Y$68$KG$20240923$$HP$CN$CN
243500181$24350018$1$I$20240111$20240125$20240923$20240923$PER$$CN-ROCHE-3500482$ROCHE$$53$YR$A$F$Y$57$KG$20240923$$HP$CN$CN
243500191$24350019$1$I$20240110$20240123$20240923$20240923$PER$$CN-ROCHE-3500041$ROCHE$$42$YR$A$F$Y$59$KG$20240923$$HP$CN$CN
243500201$24350020$1$I$$20240206$20240923$20240923$PER$$RO-ROCHE-3497144$ROCHE$$66$YR$E$F$Y$77$KG$20240923$$CN$RO$RO
243500211$24350021$1$I$20240109$20240201$20240923$20240923$PER$IT-MINISAL02-965993$IT-ROCHE-3496854$ROCHE$$79$YR$E$F$Y$75$KG$20240923$$PH$IT$IT
243500221$24350022$1$I$20240115$20240124$20240923$20240923$PER$$CN-ROCHE-3498628$ROCHE$$59$YR$A$F$Y$59$KG$20240923$$HP$CN$CN
243500231$24350023$1$I$20231008$20240920$20240923$20240923$EXP$IE-HPRA-2024-115457$IE-BAUSCH-BL-2024-014214$BAUSCH AND LOMB$$91$YR$$F$Y$$$20240923$$LW$IE$IE
243500241$24350024$1$I$20240818$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187825$AMGEN$$42$YR$A$M$Y$$$20240923$$MD$US$US
243500251$24350025$1$I$$20240216$20240923$20240923$PER$$US-ROCHE-3497961$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243500261$24350026$1$I$20231206$20240214$20240923$20240923$PER$$KR-ROCHE-3496144$ROCHE$$76$YR$E$$Y$$$20240923$$MD$KR$KR
243500271$24350027$1$I$$20240212$20240923$20240923$PER$$US-ROCHE-3492847$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243500281$24350028$1$I$$20240318$20240923$20240923$PER$$US-ROCHE-3495151$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243500291$24350029$1$I$$20240227$20240923$20240923$PER$$SI-ROCHE-3494783$ROCHE$Cavka L, Zakotnik B Capecitabine is effective as palliative chemotherapy in a patient with androgen receptor and HER2 positive metastatic salivary duct carcinoma. A case report. DOI: 10.4103/jcrt.jcrt_373_2. Journal of Cancer Research and Therapeutics 2023;19 (7):2048-51.$56$YR$A$M$Y$$$20240923$$HP$SI$SI
243500301$24350030$1$I$20220322$20240314$20240923$20240923$PER$$AT-ROCHE-3490789$ROCHE$$48$YR$A$F$Y$58$KG$20240923$$MD$AT$AT
243500311$24350031$1$I$$20240212$20240923$20240923$PER$$US-ROCHE-3498718$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243500321$24350032$1$I$20240103$20240221$20240923$20240923$PER$$MM-ROCHE-3489978$ROCHE$$64$YR$A$F$Y$48.25$KG$20240923$$CN$MM$MM
243500331$24350033$1$I$$20240402$20240923$20240923$PER$$US-ROCHE-3497201$ROCHE$$44$YR$A$M$Y$$$20240923$$MD$US$US
243500341$24350034$1$I$$20240909$20240923$20240923$PER$$US-COSETTE-CP2024US000247$COSETTE PHARMACEUTICALS$$55$YR$A$F$Y$$$20240923$$CN$US$US
243500353$24350035$3$F$20240803$20240930$20240923$20240930$EXP$$CN-BAYER-2024A128979$BAYER$$30$YR$A$F$Y$$$20240930$$MD$CN$CN
243500361$24350036$1$I$$20240919$20240923$20240923$EXP$$US-ABBVIE-5932417$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243500382$24350038$2$F$$20240919$20240923$20240927$EXP$$US-MYLANLABS-2024M1084810$MYLAN$$63$YR$$F$Y$$$20240927$$CN$US$US
243500411$24350041$1$I$$20240917$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024186119$AMGEN$$74$YR$E$F$Y$$$20240923$$PH$JP$JP
243500421$24350042$1$I$$20240522$20240923$20240923$PER$$CA-ROCHE-3494561$ROCHE$$$$A$F$Y$$$20240923$$CN$CA$CA
243500431$24350043$1$I$$20240115$20240923$20240923$PER$$CA-ROCHE-3493841$ROCHE$$$$E$F$Y$70$KG$20240923$$MD$CA$CA
243500441$24350044$1$I$$20240524$20240923$20240923$PER$$CA-ROCHE-3484846$ROCHE$$$$A$F$Y$83$KG$20240923$$HP$CA$CA
243500451$24350045$1$I$20230810$20240403$20240923$20240923$PER$$AT-ROCHE-3486796$ROCHE$$52$YR$A$$Y$$$20240923$$MD$AT$AT
243500511$24350051$1$I$$20240423$20240923$20240923$PER$$US-ROCHE-3486801$ROCHE$$72$YR$E$F$Y$123.38$KG$20240923$$MD$US$US
243500521$24350052$1$I$$20240117$20240923$20240923$PER$$FR-ROCHE-3494494$ROCHE$$69$YR$E$F$Y$$$20240923$$CN$FR$FR
243500531$24350053$1$I$$20240916$20240923$20240923$EXP$$ES-ROCHE-10000086311$ROCHE$Carvajal R, Rodriguez B, Garcia-Vasco L, Zabalza A, Arino H, Bollo L, et al. Secondary organizing pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies (abstract number: P1643/2079). Multiple Sclerosis Journal. 2024;30 (SUPP 3):1039-40.$$$$$Y$$$20240923$$HP$ES$ES
243500541$24350054$1$I$20240826$20240911$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005512$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240923$$CN$US$US
243500551$24350055$1$I$$20240117$20240923$20240923$PER$$CN-ROCHE-3494073$ROCHE$$$$$$Y$$$20240923$$MD$CN$CN
243500561$24350056$1$I$20230910$20240912$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045793$AUROBINDO$$62$YR$$M$Y$$$20240923$$MD$GB$GB
243500571$24350057$1$I$20240814$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045928$AUROBINDO$$98$YR$$F$Y$$$20240923$$MD$FR$FR
243500581$24350058$1$I$$20240909$20240923$20240923$EXP$$PL-PBT-009705$PANACEA BIOTEC$Wozna J, Korecka K, Bowszyc-Dmochowska M, Jalowska M. Porokeratosis of Mibelli Treated With Topical 2% Lovastatin/2% Cholesterol Ointment. Cureus. 2024 Jul 31;16(7):e65871. doi: 10.7759/cureus.65871.$56$YR$A$M$Y$$$20240923$$HP$PL$PL
243500591$24350059$1$I$$20240910$20240923$20240923$EXP$001092107$CA-USP-004901$USPHARMA$$5$WK$I$F$Y$$$20240923$$HP$CA$CA
243500601$24350060$1$I$$20240919$20240923$20240923$EXP$CA-MHPD-E2B_07214944$CA-Accord-447572$ACCORD$$$$$M$Y$4$KG$20240923$$HP$CA$CA
243500611$24350061$1$I$20240502$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149415$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243500621$24350062$1$I$$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149815$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240923$$CN$US$US
243500631$24350063$1$I$20240918$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188657$AMGEN$$70$YR$E$F$Y$$$20240923$$CN$US$US
243500651$24350065$1$I$20240101$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148600$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240923$$HP$US$US
243500661$24350066$1$I$20240508$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149411$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243500671$24350067$1$I$20240811$20240916$20240923$20240923$EXP$$US-TAKEDA-2024TUS036931$TAKEDA$$64$YR$$M$Y$$$20240923$$HP$US$US
243500681$24350068$1$I$$20240910$20240923$20240923$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-28036$SAMSUNG BIOEPIS$$$$$M$Y$64$KG$20240923$$HP$AU$AU
243500691$24350069$1$I$$20240822$20240923$20240923$EXP$$BR-SA-2024SA251470$SANOFI AVENTIS$$$$A$M$Y$$$20240923$$CN$BR$BR
243500701$24350070$1$I$20240909$20240911$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005525$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240923$$CN$US$US
243500711$24350071$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114342$GLAXOSMITHKLINE$$$$$M$Y$$$20240923$$CN$US$US
243500721$24350072$1$I$20190101$20240911$20240923$20240923$EXP$$US-BEH-2024178808$CSL BEHRING$$36$YR$A$M$Y$$$20240923$$CN$US$US
243500731$24350073$1$I$20240823$20240911$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005541$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240923$$CN$US$US
243500751$24350075$1$I$$20240918$20240923$20240923$EXP$$NVSC2024GB187501$NOVARTIS$$$$A$F$Y$$$20240923$$CN$GB$GB
243500761$24350076$1$I$$20240910$20240923$20240923$EXP$E2B_07229119$CA-USP-004900$USPHARMA$$65$YR$E$F$Y$$$20240923$$HP$CA$CA
243500771$24350077$1$I$$20240919$20240923$20240923$PER$$US-BIOGEN-2024BI01283420$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
243500781$24350078$1$I$20231107$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149438$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243500791$24350079$1$I$$20240917$20240923$20240923$EXP$$IL-GILEAD-2024-0688309$GILEAD$$30$YR$A$F$Y$$$20240923$$MD$IL$IL
243500801$24350080$1$I$20240704$20240917$20240923$20240923$EXP$DE-CADRBFARM-2024330354$DE-TEVA-VS-3244524$TEVA$$70$YR$$F$Y$$$20240923$$MD$DE$DE
243500811$24350081$1$I$$20240922$20240923$20240923$EXP$$DZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052680$BOEHRINGER INGELHEIM$$47$YR$A$F$Y$$$20240923$$MD$DZ$DZ
243500832$24350083$2$F$20240223$20240923$20240923$20240925$EXP$FR-AFSSAPS-NY2024001099$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052741$BOEHRINGER INGELHEIM$$90$YR$E$F$Y$60$KG$20240925$$MD$FR$FR
243500841$24350084$1$I$$20240913$20240923$20240923$EXP$GB-MHRA-MED-202409131322524410-MCGDB$GB-862174955-ML2024-04931$Unknown Manufacturer$$$$$$Y$$$20240923$$PH$GB$GB
243500861$24350086$1$I$$20240919$20240923$20240923$EXP$CA-MHPD-E2B_07214938$CA-Accord-447567$ACCORD$$$$$M$Y$9$KG$20240923$$HP$CA$CA
243500871$24350087$1$I$20231221$20231221$20240923$20240923$PER$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-23-00788$MELINTA THERAPEUTICS$$$$$$Y$$$20240904$$HP$US$US
243500881$24350088$1$I$20240101$20240912$20240923$20240923$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-22208$SAMSUNG BIOEPIS$$20$YR$A$F$Y$53$KG$20240923$$CN$CA$CA
243500891$24350089$1$I$20231002$20231002$20240923$20240923$PER$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-23-00545$MELINTA THERAPEUTICS$$$$$$Y$$$20240904$$HP$US$US
243500901$24350090$1$I$$20240724$20240923$20240923$PER$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00369$MELINTA THERAPEUTICS$$$$$M$Y$$$20240904$$HP$US$US
243500911$24350091$1$I$$20240530$20240923$20240923$PER$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00281$MELINTA THERAPEUTICS$$70$YR$$F$Y$$$20240904$$PH$US$US
243500931$24350093$1$I$20231228$20240425$20240923$20240923$PER$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00207$Unknown Manufacturer$$61$YR$$M$Y$123.83$KG$20240904$$HP$US$US
243500941$24350094$1$I$$20240724$20240923$20240923$PER$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00370$MELINTA THERAPEUTICS$$$$$M$Y$$$20240904$$HP$US$US
243500951$24350095$1$I$$20240911$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005553$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243500971$24350097$1$I$20240101$20240917$20240923$20240923$EXP$$US-ABBVIE-5929645$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243500981$24350098$1$I$20240816$20240916$20240923$20240923$EXP$$US-Vifor (International) Inc.-VIT-2024-08526$VIFOR$$58$YR$$F$Y$116.2$KG$20240923$$HP$US$US
243501001$24350100$1$I$20240901$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013485$ELI LILLY AND CO$$$$$M$Y$$$20240923$$CN$US$US
243501011$24350101$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012955$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243501021$24350102$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011016$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240923$$CN$US$US
243501031$24350103$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012614$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243501041$24350104$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA273057$SANOFI AVENTIS$$$$$M$Y$$$20240923$$PH$US$US
243501051$24350105$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268398$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240923$$MD$US$US
243501062$24350106$2$F$$20240911$20240923$20240926$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469054$RANBAXY$Kim N, Hance F, Barsi J. Septic Arthritis of the Pubic Symphysis in a 16-Year-Old Male Adolescent: A Case Report. JBJS Case Connect. 2023;Dec 4 ;13(4):e23.00475;1-4$16$YR$$M$Y$$$20240926$$HP$US$US
243501071$24350107$1$I$$20240915$20240923$20240923$EXP$$US-JNJFOC-20240949857$JOHNSON AND JOHNSON$$13$YR$T$F$Y$$$20240923$$HP$US$US
243501081$24350108$1$I$20220901$20240912$20240923$20240923$EXP$$ES-AUROBINDO-AUR-APL-2024-046135$AUROBINDO$$77$YR$$F$Y$77$KG$20240923$$MD$ES$ES
243501091$24350109$1$I$$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150589$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240923$$HP$US$US
243501101$24350110$1$I$20240201$20240917$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149331$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240923$$MD$US$US
243501111$24350111$1$I$20240101$20240913$20240923$20240923$PER$$US-TEVA-VS-3243889$TEVA$$$$$F$Y$$$20240923$$CN$US$US
243501121$24350112$1$I$$20240916$20240923$20240923$EXP$$US-GSK-US2024114932$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$US$US
243501131$24350113$1$I$20240823$20240915$20240923$20240923$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161916$JIANGSU HENGRUI MEDICINE$$53$YR$$M$Y$$$20240923$$MD$CN$CN
243501141$24350114$1$I$20240816$20240912$20240923$20240923$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161912$JIANGSU HENGRUI MEDICINE$$54$YR$$F$Y$47$KG$20240923$$MD$CN$CN
243501151$24350115$1$I$20240815$20240911$20240923$20240923$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161915$JIANGSU HENGRUI MEDICINE$$56$YR$$F$Y$$$20240923$$MD$CN$CN
243501161$24350116$1$I$$20240912$20240923$20240923$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161913$JIANGSU HENGRUI MEDICINE$$$$$$Y$$$20240923$$MD$CN$CN
243501171$24350117$1$I$$20240917$20240923$20240923$PER$$US-Mission Pharmacal Company-2161919$MISSION$$77$YR$$F$Y$$$20240923$$$US$US
243501181$24350118$1$I$20240902$20240914$20240923$20240923$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161910$JIANGSU HENGRUI MEDICINE$$77$YR$$M$Y$47$KG$20240923$$MD$CN$CN
243501201$24350120$1$I$$20240827$20240923$20240923$PER$$US-ITALFARMACO SPA-2161917$ITALFARMACO$$13$YR$$M$Y$35.5$KG$20240923$$$US$US
243501211$24350121$1$I$20240819$20240912$20240923$20240923$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2161914$JIANGSU HENGRUI MEDICINE$$79$YR$$M$Y$59$KG$20240923$$MD$CN$CN
243501221$24350122$1$I$20240101$20240912$20240923$20240923$EXP$$US-BAYER-2024A082152$BAYER$$48$YR$A$F$Y$$$20240923$$CN$US$US
243501231$24350123$1$I$20240626$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-046019$AUROBINDO$$35$YR$$M$Y$$$20240923$$PH$FR$FR
243501251$24350125$1$I$$20240913$20240923$20240923$EXP$$US-Vifor (International) Inc.-VIT-2024-08568$VIFOR$$$$E$F$Y$59.474$KG$20240923$$CN$US$US
243501261$24350126$1$I$$20240912$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-045813$AUROBINDO$$37$YR$$F$Y$57$KG$20240923$$CN$GB$GB
243501271$24350127$1$I$20240901$20240914$20240923$20240923$EXP$$CN-EMD Serono-2024049399$EMD SERONO INC$$41$YR$A$F$Y$62$KG$20240923$$HP$CN$CN
243501281$24350128$1$I$$20240913$20240923$20240923$EXP$$NVSC2024IT185612$NOVARTIS$Piolatto A, Gaglioti CM, Tesio N, Clemente MG, Culcasi M, Matrone A et al.. Deferasirox film-coated tablet-associated ulcerative colitis: An emerging pattern in thalassemia patients. BRITISH JOURNAL OF HAEMATOLOGY. 2024;205(2):719-21$24$YR$$F$Y$$$20240923$$HP$IT$IT
243501301$24350130$1$I$$20240917$20240923$20240923$EXP$$ZA-MYLANLABS-2024M1085254$MYLAN$$$$$M$Y$$$20240923$$HP$ZA$ZA
243501331$24350133$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114128$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$MD$US$US
243501341$24350134$1$I$20240727$20240911$20240923$20240923$PER$$GB-IDORSIA-008466-2024-GB$IDORSIA PHARMACEUTICALS$$62$YR$$F$Y$$$20240923$$CN$GB$GB
243501351$24350135$1$I$20240901$20240913$20240923$20240923$PER$$US-GSK-US2024114367$GLAXOSMITHKLINE$$53$YR$$F$Y$$$20240923$$CN$US$US
243501361$24350136$1$I$$20240916$20240923$20240923$EXP$$NVSC2024DE188298$NOVARTIS$$$$A$F$Y$$$20240923$$CN$DE$DE
243501371$24350137$1$I$$20240913$20240923$20240923$EXP$$NVSC2024IT185617$NOVARTIS$Piolatto A, Gaglioti CM, Tesio N, Clemente MG, Culcasi M, Matrone A, et al. Deferasirox film-coated tablet-associated ulcerative colitis: An emerging pattern in thalassemia patients. BRITISH JOURNAL OF HAEMATOLOGY. 2024;205 (2):719-21$50$YR$$M$Y$$$20240923$$HP$IT$IT
243501381$24350138$1$I$$20240913$20240923$20240923$PER$$PR-VIIV HEALTHCARE LIMITED-US2024AMR115067$VIIV$$$$$M$Y$$$20240923$$CN$PR$US
243501392$24350139$2$F$$20240923$20240923$20240924$PER$$US-JNJFOC-20240960120$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243501401$24350140$1$I$$20240917$20240923$20240923$EXP$$US-ABBVIE-5930411$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243501411$24350141$1$I$$20240914$20240923$20240923$EXP$$US-BAYER-2024A131610$BAYER$$$$$M$Y$$$20240923$$CN$US$US
243501421$24350142$1$I$$20240918$20240923$20240923$PER$$US-ABBVIE-5931590$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243501431$24350143$1$I$20130501$20240910$20240923$20240923$EXP$$GB-AUROBINDO-AUR-APL-2024-046047$AUROBINDO$$31$YR$$M$Y$$$20240923$$CN$GB$GB
243501452$24350145$2$F$20240920$20240923$20240923$20240924$PER$$US-AMGEN-USASP2024188705$AMGEN$$69$YR$E$M$Y$$$20240924$$CN$US$US
243501461$24350146$1$I$20200930$20240910$20240923$20240923$EXP$$BE-AUROBINDO-AUR-APL-2024-045266$AUROBINDO$Ferdinande K, Declerck L, Melis C, Missiaen L, Seynhaeve L, De Vloo C, et al.. CYP2D6 polymorphism may contribute to Trazodone-induced hepatotoxicity: a rare case of drug-drug-gene induced liver injury. Acta Gastro-Enterologica Belgica. 2024;87(2):332-5$46$YR$$F$Y$$$20240923$$MD$BE$BE
243501472$24350147$2$F$$20240923$20240923$20240926$EXP$$PL-MYLANLABS-2024M1085411$MYLAN$Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoeman H, Ljungman P, Kobbe G, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. AMERICAN JOURNAL OF TRANSPLANTATION. 2015;1-10$39$YR$$M$Y$$$20240926$$HP$PL$PL
243501501$24350150$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114368$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243501511$24350151$1$I$$20240912$20240923$20240923$EXP$$CA-TAKEDA-2020TUS016198$TAKEDA$$$$$M$Y$$$20240923$$CN$CA$CA
243501531$24350153$1$I$$20240215$20240923$20240923$PER$$AR-ROCHE-3500726$ROCHE$$61$YR$A$F$Y$$$20240923$$CN$AR$AR
243501541$24350154$1$I$20240326$20240404$20240921$20240921$DIR$FDA-CDER-CTU-2024-64746$$FDA-CTU$$35$MON$$M$N$17.8$KG$20240404$N$$US$
243501551$24350155$1$I$$20240913$20240923$20240923$EXP$GB-MHRA-MED-202409131511421900-MPKSC$GB-HETERO-AMR2024GB03173$HETERO$$$$$M$Y$$$20240923$$CN$GB$GB
243501561$24350156$1$I$$20240208$20240923$20240923$PER$$VN-ROCHE-3508522$ROCHE$$$$$$Y$$$20240923$$HP$VN$VN
243501571$24350157$1$I$$20240213$20240923$20240923$PER$$CO-ROCHE-3511578$ROCHE$$61$YR$A$F$Y$$$20240923$$CN$CO$CO
243501581$24350158$1$I$$20240215$20240923$20240923$PER$$US-ROCHE-3512196$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243501591$24350159$1$I$20240917$20240918$20240921$20240921$DIR$FDA-CDER-CTU-2024-64740$$FDA-CTU$$41$YR$$F$N$76.2$KG$20240918$N$$US$
243501601$24350160$1$I$20240218$20240820$20240921$20240921$DIR$FDA-CDER-CTU-2024-64739$$FDA-CTU$$66$YR$$F$N$63$KG$20240820$N$$US$
243501611$24350161$1$I$$20240215$20240923$20240923$PER$$US-ROCHE-3512197$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243501621$24350162$1$I$$20240606$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-029550$AUROBINDO$$54$YR$$M$Y$79.378$KG$20240923$$HP$US$US
243501631$24350163$1$I$20240919$20240920$20240921$20240921$DIR$FDA-CDER-CTU-2024-64738$$FDA-CTU$$67$YR$$M$N$108$KG$20240920$N$$US$
243501641$24350164$1$I$20240701$20240923$20240923$20240923$EXP$FR-AFSSAPS-RE2024000908$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052747$BOEHRINGER INGELHEIM$$47$YR$A$F$Y$59$KG$20240923$$MD$FR$FR
243501651$24350165$1$I$20240911$20240920$20240921$20240921$DIR$FDA-CDER-CTU-2024-64743$$FDA-CTU$$24$YR$$F$N$43.9$KG$20240920$N$$US$
243501671$24350167$1$I$20240123$20240129$20240923$20240923$PER$$CN-ROCHE-3501219$ROCHE$$68$YR$E$F$Y$$$20240923$$HP$CN$CN
243501681$24350168$1$I$20231101$20240916$20240923$20240923$EXP$$FR-JNJFOC-20240943184$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20240923$$CN$FR$FR
243501691$24350169$1$I$20231201$20240130$20240923$20240923$PER$IT-MINISAL02-967237$IT-ROCHE-3501090$ROCHE$$74$YR$E$F$Y$$$20240923$$MD$IT$IT
243501701$24350170$1$I$$20240215$20240923$20240923$PER$$US-ROCHE-3511194$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243501711$24350171$1$I$$20240130$20240923$20240923$PER$$CH-ROCHE-3501984$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243501731$24350173$1$I$$20240130$20240923$20240923$PER$$CH-ROCHE-3501981$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243501751$24350175$1$I$20231223$20240312$20240923$20240923$PER$$IT-ROCHE-3509858$ROCHE$$41$YR$A$F$Y$75$KG$20240923$$MD$IT$IT
243501761$24350176$1$I$$20240126$20240923$20240923$PER$$US-ROCHE-3500667$ROCHE$$68$YR$E$F$Y$$$20240923$$HP$US$US
243501771$24350177$1$I$$20240212$20240923$20240923$PER$$PT-ROCHE-3509666$ROCHE$$$$$$Y$$$20240923$$HP$PT$PT
243501781$24350178$1$I$20240112$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149492$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243501791$24350179$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024AMR114489$GLAXOSMITHKLINE$$37$YR$$F$Y$$$20240923$$HP$US$US
243501801$24350180$1$I$$20240919$20240923$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA081593$SANDOZ$$76$YR$$F$Y$73$KG$20240923$$MD$CA$CA
243501811$24350181$1$I$$20240116$20240923$20240923$PER$$CA-ROCHE-3511007$ROCHE$$$$A$F$Y$80$KG$20240923$$MD$CA$CA
243501821$24350182$1$I$$20240207$20240923$20240923$PER$$CL-ROCHE-3507195$ROCHE$$60$YR$A$F$Y$$$20240923$$CN$CL$CL
243501841$24350184$1$I$$20240208$20240923$20240923$PER$$CO-ROCHE-3508026$ROCHE$$65$YR$E$F$Y$$$20240923$$CN$CO$CO
243501851$24350185$1$I$20240115$20240129$20240923$20240923$PER$$CN-ROCHE-3501206$ROCHE$$66$YR$E$F$Y$$$20240923$$HP$CN$CN
243501861$24350186$1$I$$20240129$20240923$20240923$PER$$CA-ROCHE-3500857$ROCHE$$$$A$F$Y$64$KG$20240923$$MD$CA$CA
243501871$24350187$1$I$$20240124$20240923$20240923$PER$$BR-ROCHE-3500723$ROCHE$$$$$F$Y$$$20240923$$MD$BR$BR
243501881$24350188$1$I$$20240215$20240923$20240923$PER$$RO-ROCHE-3512494$ROCHE$$$$$F$Y$$$20240923$$CN$RO$RO
243501891$24350189$1$I$$20240201$20240923$20240923$PER$$CO-ROCHE-3503852$ROCHE$$52$YR$A$F$Y$$$20240923$$CN$CO$CO
243501901$24350190$1$I$20230916$20240205$20240923$20240923$PER$$IT-ROCHE-3504743$ROCHE$$58$YR$A$F$Y$$$20240923$$MD$IT$IT
243501911$24350191$1$I$$20240917$20240923$20240923$EXP$$CA-Orion Corporation ORION PHARMA-24_00031379$ORION$$69$YR$E$F$Y$$$20240923$$HP$CA$
243501922$24350192$2$F$20220101$20240923$20240923$20240926$EXP$$CA-AUROBINDO-AUR-APL-2024-046445$AUROBINDO$$$$$F$Y$$$20240926$$PH$CA$CA
243501931$24350193$1$I$$20240703$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-034163$AUROBINDO$$76$YR$$M$Y$92.971$KG$20240923$$MD$US$US
243501941$24350194$1$I$$20240221$20240923$20240923$PER$$CO-ROCHE-3514598$ROCHE$$58$YR$A$F$Y$$$20240923$$CN$CO$CO
243501951$24350195$1$I$$20240215$20240923$20240923$PER$$US-ROCHE-3512193$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243501961$24350196$1$I$20190725$20240205$20240923$20240923$PER$$IT-ROCHE-3505310$ROCHE$$76$YR$E$F$Y$70$KG$20240923$$MD$IT$IT
243501971$24350197$1$I$$20240215$20240923$20240923$PER$$US-ROCHE-3512195$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243501981$24350198$1$I$$20240215$20240923$20240923$PER$$US-ROCHE-3512194$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243501991$24350199$1$I$$20240214$20240923$20240923$PER$$CO-ROCHE-3511630$ROCHE$$36$YR$A$F$Y$$$20240923$$CN$CO$CO
243502011$24350201$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010460$APOTEX$$28$YR$$F$Y$$$20240923$$PH$CA$CA
243502021$24350202$1$I$$20240125$20240923$20240923$PER$$US-ROCHE-3502163$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243502031$24350203$1$I$20240111$20240130$20240923$20240923$PER$$CN-ROCHE-3502021$ROCHE$$62$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243502041$24350204$1$I$20240103$20240130$20240923$20240923$PER$IT-MINISAL02-967243$IT-ROCHE-3501092$ROCHE$$74$YR$E$F$Y$65$KG$20240923$$MD$IT$IT
243502051$24350205$1$I$20231201$20240130$20240923$20240923$PER$CH-SM-2024-10275$CH-ROCHE-3501377$ROCHE$$70$YR$E$F$Y$71$KG$20240923$$MD$CH$CH
243502061$24350206$1$I$20240126$20240126$20240923$20240923$PER$$CN-ROCHE-3501511$ROCHE$$51$YR$A$F$Y$$$20240923$$CN$CN$CN
243502071$24350207$1$I$$20240426$20240923$20240923$PER$$FR-ROCHE-3505597$ROCHE$de Bernardi A, Bachelot T and Larrouquere L. Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature DOI: 10.3389/fonc.2023.1210873. Frontiers in Oncology 2023;13:1-11.$38$YR$A$F$Y$$$20240923$$HP$FR$FR
243502081$24350208$1$I$20240101$20240131$20240923$20240923$PER$IT-MINISAL02-967442$IT-ROCHE-3502297$ROCHE$$51$YR$A$F$Y$58$KG$20240923$$MD$IT$IT
243502091$24350209$1$I$20240111$20240130$20240923$20240923$PER$IT-MINISAL02-966588$IT-ROCHE-3501148$ROCHE$$54$YR$A$F$Y$79$KG$20240923$$MD$IT$IT
243502101$24350210$1$I$20240102$20240126$20240923$20240923$PER$$CN-ROCHE-3501989$ROCHE$$53$YR$A$F$Y$69$KG$20240923$$HP$CN$CN
243502111$24350211$1$I$$20240125$20240923$20240923$PER$$US-ROCHE-3502165$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243502121$24350212$1$I$20240115$20240131$20240923$20240923$PER$$CN-ROCHE-3502101$ROCHE$$64$YR$A$F$Y$56$KG$20240923$$HP$CN$CN
243502131$24350213$1$I$$20240130$20240923$20240923$PER$$PE-ROCHE-3502412$ROCHE$$55$YR$A$F$Y$47$KG$20240923$$CN$PE$PE
243502141$24350214$1$I$$20240130$20240923$20240923$PER$$US-ROCHE-3501852$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243502151$24350215$1$I$20230731$20240911$20240921$20240921$DIR$FDA-CDER-CTU-2024-64745$$FDA-CTU$$82$YR$$F$N$91.6$KG$20240911$N$$US$
243502161$24350216$1$I$$20240128$20240923$20240923$PER$$CA-ROCHE-3501001$ROCHE$$$$A$F$Y$59$KG$20240923$$MD$CA$CA
243502171$24350217$1$I$20240917$20240919$20240921$20240921$DIR$FDA-CDER-CTU-2024-64741$$FDA-CTU$$$$$F$N$79.5$KG$20240919$N$$US$
243502181$24350218$1$I$20240911$20240919$20240921$20240921$DIR$FDA-CDER-CTU-2024-64742$$FDA-CTU$$6$YR$$F$N$27.4$KG$20240919$N$$US$
243502191$24350219$1$I$20230101$20240912$20240923$20240923$EXP$$US-BAYER-2024A131002$BAYER$$42$YR$A$F$Y$$$20240923$$CN$US$US
243502201$24350220$1$I$$20240131$20240923$20240923$PER$$NL-ROCHE-3502342$ROCHE$$$$$F$Y$$$20240923$$MD$NL$NL
243502211$24350221$1$I$20240908$20240920$20240921$20240921$DIR$FDA-CDER-CTU-2024-64744$$FDA-CTU$$6$YR$$F$N$21.1$KG$20240920$N$$US$
243502221$24350222$1$I$20221121$20240130$20240923$20240923$PER$IT-MINISAL02-966571$IT-ROCHE-3501286$ROCHE$$79$YR$E$F$Y$76$KG$20240923$$MD$IT$IT
243502231$24350223$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187845$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243502251$24350225$1$I$$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188808$AMGEN$$$$$F$Y$$$20240923$$HP$US$US
243502261$24350226$1$I$20240904$20240905$20240923$20240923$PER$$US-JNJFOC-20240913189$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240923$$CN$US$US
243502271$24350227$1$I$$20240920$20240921$20240921$DIR$FDA-CDER-CTU-2024-64747$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243502281$24350228$1$I$$20240920$20240921$20240921$DIR$FDA-CDER-CTU-2024-64751$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243502291$24350229$1$I$20240123$20240201$20240923$20240923$PER$IT-MINISAL02-967682$IT-ROCHE-3502836$ROCHE$$42$YR$A$M$Y$54$KG$20240923$$MD$IT$IT
243502301$24350230$1$I$20210527$20240909$20240923$20240923$EXP$FR-AFSSAPS-NY2024001015$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112094$ZYDUS PHARM$$$$$$Y$$$20240923$$MD$FR$FR
243502311$24350231$1$I$$20240920$20240921$20240921$DIR$FDA-CDER-CTU-2024-64750$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243502321$24350232$1$I$20240125$20240201$20240923$20240923$PER$$CN-ROCHE-3503622$ROCHE$$43$YR$A$F$Y$$$20240923$$HP$CN$CN
243502331$24350233$1$I$20240110$20240201$20240923$20240923$PER$$PK-ROCHE-3503596$ROCHE$$55$YR$A$F$Y$$$20240923$$CN$PK$PK
243502341$24350234$1$I$$20240123$20240923$20240923$PER$$JP-ROCHE-3502495$ROCHE$$$$$M$Y$$$20240923$$MD$JP$JP
243502351$24350235$1$I$$20240130$20240923$20240923$PER$$US-ROCHE-3503592$ROCHE$$75$YR$E$F$Y$$$20240923$$CN$US$US
243502361$24350236$1$I$$20240921$20240921$20240921$DIR$FDA-CDER-CTU-2024-64749$$FDA-CTU$$55$YR$$F$N$$$20240921$N$$US$
243502381$24350238$1$I$20240116$20240124$20240923$20240923$PER$$JP-ROCHE-3503321$ROCHE$$7$DEC$E$M$Y$$$20240923$$MD$JP$JP
243502391$24350239$1$I$20240112$20240202$20240923$20240923$PER$$CN-ROCHE-3503644$ROCHE$$63$YR$A$F$Y$59$KG$20240923$$HP$CN$CN
243502401$24350240$1$I$20240129$20240202$20240923$20240923$PER$$CN-ROCHE-3503617$ROCHE$$49$YR$A$F$Y$70$KG$20240923$$HP$CN$CN
243502411$24350241$1$I$$20240921$20240921$20240921$DIR$FDA-CDER-CTU-2024-64748$$FDA-CTU$$59$YR$$M$N$$$20240921$N$$US$
243502421$24350242$1$I$$20240129$20240923$20240923$PER$$CN-ROCHE-3502738$ROCHE$$57$YR$A$F$Y$$$20240923$$MD$CN$CN
243502431$24350243$1$I$$20240131$20240923$20240923$PER$$US-ROCHE-3503049$ROCHE$$$$E$F$Y$$$20240923$$HP$US$US
243502441$24350244$1$I$$20240916$20240923$20240923$PER$$US-GSK-US2024114948$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243502451$24350245$1$I$20240112$20240129$20240923$20240923$PER$$CN-ROCHE-3502879$ROCHE$$40$YR$A$F$Y$$$20240923$$HP$CN$CN
243502461$24350246$1$I$20240621$20240912$20240923$20240923$EXP$$CA-ROCHE-10000015091$ROCHE$$78$YR$E$F$Y$60$KG$20240923$$HP$CA$CA
243502471$24350247$1$I$$20240709$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-034845$AUROBINDO$$82$YR$$M$Y$81.65$KG$20240923$$MD$US$US
243502481$24350248$1$I$$20240204$20240923$20240923$PER$$CN-ROCHE-3504405$ROCHE$$56$YR$A$F$Y$$$20240923$$MD$CN$CN
243502491$24350249$1$I$$20240201$20240923$20240923$PER$$DE-ROCHE-3503847$ROCHE$$$$$$Y$$$20240923$$PH$DE$DE
243502501$24350250$1$I$20231123$20240129$20240923$20240923$PER$$CN-ROCHE-3503997$ROCHE$$39$YR$A$F$Y$$$20240923$$HP$CN$CN
243502511$24350251$1$I$$20240201$20240923$20240923$PER$$DK-ROCHE-3504182$ROCHE$$$$$$Y$$$20240923$$MD$DK$DK
243502521$24350252$1$I$$20240130$20240923$20240923$PER$$MY-ROCHE-3503735$ROCHE$$61$YR$A$M$Y$$$20240923$$HP$MY$MY
243502531$24350253$1$I$$20240201$20240923$20240923$PER$$VE-ROCHE-3503979$ROCHE$$$$$$Y$$$20240923$$MD$VE$VE
243502541$24350254$1$I$20231228$20240204$20240923$20240923$PER$$CN-ROCHE-3504139$ROCHE$$68$YR$E$F$Y$50$KG$20240923$$HP$CN$CN
243502551$24350255$1$I$$20240912$20240923$20240923$PER$$US-MYLANLABS-2024M1083774$MYLAN$$$$$M$Y$$$20240923$$CN$US$US
243502561$24350256$1$I$20240112$20240204$20240923$20240923$PER$$CN-ROCHE-3504116$ROCHE$$65$YR$E$M$Y$65$KG$20240923$$HP$CN$CN
243502571$24350257$1$I$20240115$20240204$20240923$20240923$PER$$CN-ROCHE-3504152$ROCHE$$53$YR$A$F$Y$$$20240923$$HP$CN$CN
243502581$24350258$1$I$20240121$20240205$20240923$20240923$PER$$CN-ROCHE-3504492$ROCHE$$61$YR$A$F$Y$51$KG$20240923$$HP$CN$CN
243502591$24350259$1$I$$20240131$20240923$20240923$PER$$US-ROCHE-3503646$ROCHE$$68$YR$E$F$Y$$$20240923$$MD$US$US
243502601$24350260$1$I$$20240917$20240923$20240923$EXP$CA-DRL-USA-SPO/CAN/24/0013682$CA-RDY-SPO/CAN/24/0013682$DR REDDYS$$73$YR$E$F$Y$66$KG$20240923$$HP$CA$CA
243502611$24350261$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150356$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240923$$HP$US$US
243502631$24350263$1$I$20240118$20240205$20240923$20240923$PER$IT-MINISAL02-967290$IT-ROCHE-3504547$ROCHE$$42$YR$A$F$Y$64$KG$20240923$$PH$IT$IT
243502641$24350264$1$I$$20240202$20240923$20240923$PER$$CN-ROCHE-3504348$ROCHE$$$$$$Y$$$20240923$$MD$CN$CN
243502651$24350265$1$I$20240127$20240204$20240923$20240923$PER$$CN-ROCHE-3504515$ROCHE$$67$YR$E$M$Y$50$KG$20240923$$HP$CN$CN
243502661$24350266$1$I$$20240201$20240923$20240923$PER$$VE-ROCHE-3504752$ROCHE$$$$$$Y$$$20240923$$MD$VE$VE
243502671$24350267$1$I$20231001$20240205$20240923$20240923$PER$IT-MINISAL02-966068$IT-ROCHE-3501182$ROCHE$$61$YR$A$F$Y$$$20240923$$MD$IT$IT
243502681$24350268$1$I$20230518$20240206$20240923$20240923$PER$IT-MINISAL02-968363$IT-ROCHE-3505285$ROCHE$$77$YR$E$F$Y$$$20240923$$MD$IT$IT
243502691$24350269$1$I$$20240131$20240923$20240923$PER$$DK-ROCHE-3504839$ROCHE$$$$$$Y$$$20240923$$PH$DK$DK
243502701$24350270$1$I$$20240117$20240923$20240923$PER$$PH-ROCHE-3504567$ROCHE$$$$E$F$Y$$$20240923$$HP$PH$PH
243502711$24350271$1$I$20240109$20240204$20240923$20240923$PER$$CN-ROCHE-3504511$ROCHE$$70$YR$E$F$Y$49$KG$20240923$$HP$CN$CN
243502721$24350272$1$I$20240201$20240206$20240923$20240923$PER$$CN-ROCHE-3505255$ROCHE$$61$YR$A$F$Y$68$KG$20240923$$HP$CN$CN
243502731$24350273$1$I$$20240131$20240923$20240923$PER$$US-ROCHE-3504864$ROCHE$$65$YR$E$F$Y$99.5$KG$20240923$$PH$US$US
243502741$24350274$1$I$$20240910$20240923$20240923$EXP$$NL-AUROBINDO-AUR-APL-2024-045767$AUROBINDO$Brouwer M, Offermans M, van Nuil L, Poukens A, van Oijen B, Dormans T.. Effective Extracorporeal Treatment of MetforminAssociated Lactic Acidosis using Continuous Venovenous Hemodiafiltration. European journal of case reports in internal medicine. 2024;11(9)$57$YR$$F$Y$$$20240923$$MD$NL$NL
243502752$24350275$2$F$$20240709$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-035046$AUROBINDO$$80$YR$$M$Y$$$20240923$$HP$US$US
243502771$24350277$1$I$20240715$20240917$20240923$20240923$PER$$US-ABBVIE-5930845$ABBVIE$$39$YR$$M$Y$102$KG$20240923$$CN$US$US
243502781$24350278$1$I$$20240205$20240923$20240923$PER$$PE-ROCHE-3505742$ROCHE$$47$YR$A$F$Y$53$KG$20240923$$CN$PE$PE
243502791$24350279$1$I$$20240201$20240923$20240923$PER$$SG-ROCHE-3505573$ROCHE$$72$YR$E$M$Y$$$20240923$$MD$SG$SG
243502801$24350280$1$I$$20240126$20240923$20240923$PER$$JP-ROCHE-3506152$ROCHE$$$$E$M$Y$$$20240923$$MD$JP$JP
243502811$24350281$1$I$20200420$20240207$20240923$20240923$PER$PL-URPL-1-1778-2020$PL-ROCHE-3506002$ROCHE$$79$YR$E$F$Y$74$KG$20240923$$MD$PL$PL
243502821$24350282$1$I$20240130$20240205$20240923$20240923$PER$$CN-ROCHE-3505402$ROCHE$$47$YR$A$F$Y$58$KG$20240923$$HP$CN$CN
243502831$24350283$1$I$20240107$20240207$20240923$20240923$PER$$CN-ROCHE-3506109$ROCHE$$55$YR$A$F$Y$68$KG$20240923$$HP$CN$CN
243502841$24350284$1$I$$20240201$20240923$20240923$PER$$VE-ROCHE-3505683$ROCHE$$$$$$Y$$$20240923$$MD$VE$VE
243502851$24350285$1$I$20240109$20240207$20240923$20240923$PER$$CN-ROCHE-3505949$ROCHE$$55$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243502871$24350287$1$I$20240723$20240912$20240923$20240923$EXP$$FR-AUROBINDO-AUR-APL-2024-045907$AUROBINDO$$53$YR$$F$Y$58$KG$20240923$$PH$FR$FR
243502891$24350289$1$I$$20240206$20240923$20240923$PER$$KR-ROCHE-3506312$ROCHE$$$$$$Y$$$20240923$$PH$KR$KR
243502901$24350290$1$I$$20240206$20240923$20240923$PER$$PE-ROCHE-3506425$ROCHE$$70$YR$E$F$Y$$$20240923$$CN$PE$PE
243502911$24350291$1$I$$20240207$20240923$20240923$PER$$CA-ROCHE-3506939$ROCHE$$$$A$F$Y$74$KG$20240923$$MD$CA$CA
243502921$24350292$1$I$$20240206$20240923$20240923$PER$$CA-ROCHE-3506593$ROCHE$$$$A$F$Y$78$KG$20240923$$MD$CA$CA
243502931$24350293$1$I$$20240207$20240923$20240923$PER$$IL-ROCHE-3506515$ROCHE$$$$A$F$Y$$$20240923$$HP$IL$IL
243502941$24350294$1$I$$20240207$20240923$20240923$PER$$CN-ROCHE-3506917$ROCHE$$61$YR$A$F$Y$$$20240923$$MD$CN$CN
243502951$24350295$1$I$$20240206$20240923$20240923$PER$$US-ROCHE-3506369$ROCHE$$$$E$F$Y$$$20240923$$HP$US$US
243502961$24350296$1$I$20240207$20240207$20240923$20240923$PER$$CN-ROCHE-3506854$ROCHE$$60$YR$A$F$Y$$$20240923$$MD$CN$CN
243502971$24350297$1$I$$20240206$20240923$20240923$PER$$CA-ROCHE-3506679$ROCHE$$$$E$F$Y$76$KG$20240923$$MD$CA$CA
243503001$24350300$1$I$$20240715$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-036134$AUROBINDO$$$$A$M$Y$83.914$KG$20240923$$MD$US$US
243503021$24350302$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64669$$FDA-CTU$$60$YR$$F$N$$$20240920$N$$US$
243503031$24350303$1$I$20240901$20240918$20240923$20240923$EXP$$US-SA-2024SA271357$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240923$$MD$US$US
243503041$24350304$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012489$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240923$$CN$US$US
243503051$24350305$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012683$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240923$$CN$US$US
243503061$24350306$1$I$20240831$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012537$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240923$$CN$US$US
243503071$24350307$1$I$20221101$20240206$20240923$20240923$PER$$US-ROCHE-3506311$ROCHE$$77$YR$E$F$Y$$$20240923$$MD$US$US
243503081$24350308$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64667$$FDA-CTU$$33$YR$$F$N$58.97$KG$20240920$N$HP$US$
243503091$24350309$1$I$$20240208$20240923$20240923$PER$$CH-ROCHE-3507823$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243503101$24350310$1$I$$20240920$20240921$20240921$DIR$FDA-CDER-CTU-2024-64755$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243503111$24350311$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012693$ELI LILLY AND CO$$$$$M$Y$$$20240923$$CN$US$US
243503121$24350312$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012907$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240923$$CN$US$US
243503131$24350313$1$I$$20240207$20240923$20240923$PER$$US-ROCHE-3507654$ROCHE$$53$YR$A$F$Y$$$20240923$$MD$US$US
243503141$24350314$1$I$$20240208$20240923$20240923$PER$$CH-ROCHE-3507712$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243503151$24350315$1$I$20220101$20240910$20240923$20240923$EXP$$US-LUNDBECK-DKLU4004263$LUNDBECK$$$$$$Y$$$20240923$$CN$US$US
243503161$24350316$1$I$20240820$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012127$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240923$$CN$US$US
243503171$24350317$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64713$$FDA-CTU$$29$YR$$F$N$67.59$KG$20240920$N$HP$US$
243503181$24350318$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64707$$FDA-CTU$$73$YR$$F$N$$$20240920$N$$US$
243503191$24350319$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64666$$FDA-CTU$$62$YR$$F$N$78.47$KG$20240920$N$$US$
243503201$24350320$1$I$$20240920$20240922$20240922$DIR$FDA-CDER-CTU-2024-64752$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243503211$24350321$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64716$$FDA-CTU$$48$YR$$F$N$$$20240920$N$$US$
243503221$24350322$1$I$$20240919$20240923$20240923$EXP$$CA-ROCHE-10000086358$ROCHE$$51$YR$A$F$Y$$$20240923$$HP$CA$CA
243503231$24350323$1$I$20240801$20240909$20240923$20240923$PER$$US-SA-2024SA273793$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240923$$CN$US$US
243503241$24350324$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272562$SANOFI AVENTIS$$$$A$F$Y$78.02$KG$20240923$$MD$US$US
243503251$24350325$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA272326$SANOFI AVENTIS$$$$A$M$Y$$$20240923$$MD$US$US
243503261$24350326$1$I$20240101$20240916$20240923$20240923$PER$$US-SA-2024SA270286$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240923$$HP$US$US
243503271$24350327$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA272612$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240923$$CN$US$US
243503281$24350328$1$I$$20240915$20240923$20240923$EXP$$US-JNJFOC-20240952299$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240923$$HP$US$US
243503291$24350329$1$I$$20240911$20240923$20240923$PER$$US-IMP-2024000732$Harrow Health$$$$A$F$Y$$$20240923$$CN$US$US
243503301$24350330$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150143$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240923$$CN$US$US
243503311$24350331$1$I$$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149152$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240923$$CN$US$US
243503321$24350332$1$I$$20240715$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-036240$AUROBINDO$$$$$M$Y$65.77$KG$20240923$$MD$US$US
243503331$24350333$1$I$20240101$20240916$20240923$20240923$PER$$US-SA-2024SA270245$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$HP$US$US
243503341$24350334$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA272368$SANOFI AVENTIS$$$$A$F$Y$84.09$KG$20240923$$MD$US$US
243503351$24350335$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA270566$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240923$$HP$US$US
243503361$24350336$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268484$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240923$$HP$US$US
243503371$24350337$1$I$20240701$20240918$20240923$20240923$EXP$$FR-REGENERON PHARMACEUTICALS, INC.-2024-127228$REGENERON$$$$$F$Y$$$20240923$$MD$FR$FR
243503381$24350338$1$I$20240701$20240916$20240923$20240923$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-125811$REGENERON$$71$YR$$M$Y$$$20240923$$HP$CO$CO
243503391$24350339$1$I$$20240716$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-036795$AUROBINDO$$74$YR$$M$Y$$$20240923$$HP$US$US
243503401$24350340$1$I$$20240911$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024187509$AMGEN$$$$$$Y$$$20240923$$PH$JP$JP
243503412$24350341$2$F$20240912$20240924$20240923$20240930$30DAY$$US-AMGEN-USASP2024185122$AMGEN$$71$YR$E$F$Y$104.31$KG$20240930$$PH$US$US
243503422$24350342$2$F$20240905$20240923$20240923$20240926$30DAY$$US-AMGEN-USASP2024178986$AMGEN$$82$YR$E$F$Y$76$KG$20240926$$PH$US$US
243503431$24350343$1$I$$20240917$20240923$20240923$EXP$$NVSC2024US187107$NOVARTIS$Fiocco C, Farooq F, Kaveney A. Acute disseminated intravascular coagulation precipitated by 177Lu-Dotatate in metastatic midgut neuroendocrine tumor: a case report. JOURNAL OF GASTROINTESTINAL CANCER. 2023;54:1370-2$73$YR$$M$Y$$$20240923$$HP$US$US
243503441$24350344$1$I$20230918$20240916$20240923$20240923$EXP$$JP-EXELIXIS-EXL-2024-000386$EXELIXIS$$62$YR$$M$Y$54$KG$20240923$$MD$JP$JP
243503461$24350346$1$I$$20240202$20240923$20240923$PER$$JP-ROCHE-3510398$ROCHE$$$$$$Y$$$20240923$$PH$JP$JP
243503471$24350347$1$I$20211213$20240205$20240923$20240923$PER$$NL-ROCHE-3508198$ROCHE$$$$$$Y$$$20240923$$MD$NL$NL
243503481$24350348$1$I$$20240208$20240923$20240923$PER$$US-ROCHE-3508014$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243503491$24350349$1$I$$20240208$20240923$20240923$PER$$CN-ROCHE-3507841$ROCHE$Cao T, Duan Z, Zhu J, Wu J, Chen J, Jiang M, Lu X and Li Y Case report: Urothelial injury in a female with breast cancer: a rare adverse event after the combination of paclitaxel and trastuzumab Doi: 10.3389/fonc.2023.1258474. Frontiers in Oncology 2024 Jan 18;13:1-5.$47$YR$A$F$Y$$$20240923$$HP$CN$CN
243503501$24350350$1$I$$20240208$20240923$20240923$PER$$IN-ROCHE-3508950$ROCHE$$50$YR$A$F$Y$$$20240923$$CN$IN$IN
243503511$24350351$1$I$$20240205$20240923$20240923$PER$$JP-ROCHE-3511966$ROCHE$Shimizu K, Tsuchida K, Mizutani M, Sakaguchi Y, Sahara K, Miyake M et al A case of HER2-positive gastric carcinoma with liver metastases which achieved pathological complete response to laparoscopic surgery after chemotherapy.. Japanese Journal of Cancer and Chemotherapy. 2023;50 (13):1801-3.$77$YR$E$M$Y$52.5$KG$20240923$$MD$JP$JP
243503521$24350352$1$I$20240101$20240131$20240923$20240923$PER$$JP-ROCHE-3509158$ROCHE$$63$YR$A$F$Y$$$20240923$$PH$JP$JP
243503531$24350353$1$I$20240104$20240209$20240923$20240923$PER$$CN-ROCHE-3508465$ROCHE$$57$YR$A$F$Y$61$KG$20240923$$HP$CN$CN
243503541$24350354$1$I$$20240209$20240923$20240923$PER$$DE-ROCHE-3507986$ROCHE$$39$YR$A$F$Y$61$KG$20240923$$PH$DE$DE
243503551$24350355$1$I$20240205$20240209$20240923$20240923$PER$$CN-ROCHE-3508474$ROCHE$$40$YR$A$F$Y$$$20240923$$HP$CN$CN
243503561$24350356$1$I$20240209$20240212$20240923$20240923$PER$$PE-ROCHE-3510944$ROCHE$$52$YR$A$F$Y$$$20240923$$CN$PE$PE
243503571$24350357$1$I$$20240208$20240923$20240923$PER$$US-ROCHE-3507947$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243503581$24350358$1$I$20240131$20240209$20240923$20240923$PER$$CN-ROCHE-3508462$ROCHE$$53$YR$A$M$Y$70$KG$20240923$$HP$CN$CN
243503591$24350359$1$I$$20240208$20240923$20240923$PER$$CH-ROCHE-3508291$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243503601$24350360$1$I$$20240208$20240923$20240923$PER$$US-ROCHE-3508313$ROCHE$$57$YR$A$F$Y$$$20240923$$MD$US$US
243503611$24350361$1$I$$20240216$20240923$20240923$PER$$US-ROCHE-3507875$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243503621$24350362$1$I$$20240212$20240923$20240923$PER$$US-ROCHE-3509616$ROCHE$$$$$F$Y$$$20240923$$PH$US$US
243503631$24350363$1$I$20240205$20240210$20240923$20240923$PER$$IN-ROCHE-3510437$ROCHE$$54$YR$A$F$Y$$$20240923$$CN$IN$IN
243503641$24350364$1$I$$20240206$20240923$20240923$PER$$MX-ROCHE-3507995$ROCHE$$78$YR$E$F$Y$$$20240923$$CN$MX$MX
243503651$24350365$1$I$$20240212$20240923$20240923$PER$$US-ROCHE-3509575$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243503661$24350366$1$I$$20240115$20240923$20240923$PER$$IT-ROCHE-3508139$ROCHE$$$$$F$Y$$$20240923$$CN$IT$IT
243503671$24350367$1$I$$20240209$20240923$20240923$PER$$ES-ROCHE-3508889$ROCHE$$$$$$Y$$$20240923$$MD$ES$ES
243503681$24350368$1$I$$20240212$20240923$20240923$PER$$US-ROCHE-3509552$ROCHE$$67$YR$E$M$Y$$$20240923$$MD$US$US
243503691$24350369$1$I$$20240216$20240923$20240923$PER$$RU-ROCHE-3512240$ROCHE$$32$YR$A$F$Y$$$20240923$$MD$RU$RU
243503701$24350370$1$I$$20240212$20240923$20240923$PER$$US-ROCHE-3509554$ROCHE$$78$YR$E$F$Y$$$20240923$$CN$US$US
243503711$24350371$1$I$$20240208$20240923$20240923$PER$$CH-ROCHE-3507862$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243503721$24350372$1$I$$20240218$20240923$20240923$PER$$CN-ROCHE-3512269$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243503731$24350373$1$I$20240130$20240209$20240923$20240923$PER$$CN-ROCHE-3508745$ROCHE$$76$YR$E$F$Y$$$20240923$$HP$CN$CN
243503741$24350374$1$I$20240118$20240201$20240923$20240923$PER$$JP-ROCHE-3509776$ROCHE$$8$DEC$E$M$Y$$$20240923$$MD$JP$JP
243503751$24350375$1$I$$20240212$20240923$20240923$PER$$US-ROCHE-3509436$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243503761$24350376$1$I$$20240207$20240923$20240923$PER$$US-ROCHE-3507895$ROCHE$$78$YR$E$F$Y$$$20240923$$MD$US$US
243503771$24350377$1$I$$20240116$20240923$20240923$PER$$CA-ROCHE-3511017$ROCHE$$$$A$F$Y$48$KG$20240923$$MD$CA$CA
243503781$24350378$1$I$$20240208$20240923$20240923$PER$$CH-ROCHE-3508282$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243503791$24350379$1$I$$20240920$20240922$20240922$DIR$FDA-CDER-CTU-2024-64753$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243503801$24350380$1$I$20240129$20240209$20240923$20240923$PER$$CN-ROCHE-3508661$ROCHE$$70$YR$E$F$Y$$$20240923$$HP$CN$CN
243503811$24350381$1$I$$20240213$20240923$20240923$PER$$BD-ROCHE-3508945$ROCHE$$50$YR$A$F$Y$$$20240923$$CN$BD$BD
243503821$24350382$1$I$$20240213$20240923$20240923$PER$$US-ROCHE-3510420$ROCHE$$68$YR$E$M$Y$$$20240923$$MD$US$US
243503841$24350384$1$I$$20240209$20240923$20240923$PER$$CA-ROCHE-3508909$ROCHE$$$$A$F$Y$56$KG$20240923$$MD$CA$CA
243503851$24350385$1$I$$20240116$20240923$20240923$PER$$CA-ROCHE-3511003$ROCHE$$$$A$F$Y$76$KG$20240923$$MD$CA$CA
243503861$24350386$1$I$$20240208$20240923$20240923$PER$$US-ROCHE-3507958$ROCHE$$76$YR$E$F$Y$$$20240923$$PH$US$US
243503871$24350387$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64651$$FDA-CTU$$47$YR$$F$N$44.45$KG$20240920$N$$US$
243503881$24350388$1$I$20240901$20240922$20240922$20240922$DIR$FDA-CDER-CTU-2024-64760$$FDA-CTU$$74$YR$$F$N$$$20240922$N$$US$
243503891$24350389$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64683$$FDA-CTU$$53$YR$$$N$78.02$KG$20240920$N$$US$
243503901$24350390$1$I$20240209$20240212$20240923$20240923$PER$$US-ROCHE-3509527$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243503911$24350391$1$I$20190101$20240912$20240923$20240923$PER$$US-MYLANLABS-2024M1084026$MYLAN$$$$$F$Y$81.64$KG$20240923$$CN$US$US
243503921$24350392$1$I$$20240218$20240923$20240923$PER$$US-ROCHE-3512477$ROCHE$$39$YR$A$F$Y$$$20240923$$CN$US$US
243503931$24350393$1$I$$20240219$20240923$20240923$PER$$US-ROCHE-3509194$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243503941$24350394$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64681$$FDA-CTU$$55$YR$$F$N$83.91$KG$20240920$N$$US$
243503951$24350395$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64647$$FDA-CTU$$53$YR$$M$N$$$20240920$N$$US$
243503961$24350396$1$I$$20240215$20240923$20240923$PER$$RU-ROCHE-3512429$ROCHE$$36$YR$A$F$Y$$$20240923$$MD$RU$RU
243503971$24350397$1$I$$20240216$20240923$20240923$PER$$RU-ROCHE-3512478$ROCHE$$34$YR$A$F$Y$$$20240923$$MD$RU$RU
243503981$24350398$1$I$20240901$20240918$20240922$20240922$DIR$FDA-CDER-CTU-2024-64754$$FDA-CTU$$8$YR$$M$N$$$20240918$N$HP$US$
243503991$24350399$1$I$20231207$20240207$20240923$20240923$PER$$JP-ROCHE-3512664$ROCHE$$$$E$F$Y$$$20240923$$MD$JP$JP
243504001$24350400$1$I$$20240216$20240923$20240923$PER$$RU-ROCHE-3512447$ROCHE$$43$YR$A$F$Y$$$20240923$$MD$RU$RU
243504011$24350401$1$I$$20240910$20240923$20240923$EXP$$CA-UCBSA-2024047376$UCB$$$$$F$Y$$$20240923$$HP$CA$CA
243504022$24350402$2$F$$20240918$20240923$20240923$PER$$US-GILEAD-2024-0688210$GILEAD$$35$YR$A$M$Y$$$20240923$$MD$US$US
243504031$24350403$1$I$$20240919$20240923$20240923$EXP$$NVSC2024IN188117$NOVARTIS$$$$A$M$Y$$$20240923$$MD$IN$IN
243504041$24350404$1$I$$20240724$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-038214$AUROBINDO$$49$YR$$M$Y$117.9$KG$20240923$$MD$US$US
243504051$24350405$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64699$$FDA-CTU$$16$YR$$F$N$102.06$KG$20240920$N$$US$
243504061$24350406$1$I$$20240903$20240922$20240922$DIR$FDA-CDER-CTU-2024-64757$$FDA-CTU$$$$$M$N$$$20240903$N$HP$US$
243504071$24350407$1$I$$20240903$20240922$20240922$DIR$FDA-CDER-CTU-2024-64756$$FDA-CTU$$$$$M$N$$$20240903$N$HP$US$
243504091$24350409$1$I$$20240914$20240923$20240923$PER$$US-JNJFOC-20240947502$JOHNSON AND JOHNSON$$75$YR$E$F$Y$69.8$KG$20240923$$CN$US$US
243504101$24350410$1$I$$20240913$20240923$20240923$PER$$US-IMP-2024000748$Harrow Health$$$$A$F$Y$$$20240923$$CN$US$US
243504111$24350411$1$I$$20240115$20240923$20240923$PER$$CA-ROCHE-3513355$ROCHE$$$$A$F$Y$57$KG$20240923$$MD$CA$CA
243504121$24350412$1$I$$20240219$20240923$20240923$PER$$US-ROCHE-3513048$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243504131$24350413$1$I$$20240220$20240923$20240923$PER$$CN-ROCHE-3513603$ROCHE$$56$YR$A$F$Y$$$20240923$$MD$CN$CN
243504141$24350414$1$I$20240109$20240220$20240923$20240923$PER$$CN-ROCHE-3512858$ROCHE$$53$YR$A$F$Y$51$KG$20240923$$HP$CN$CN
243504151$24350415$1$I$$20240216$20240923$20240923$PER$$RU-ROCHE-3512336$ROCHE$$$$$F$Y$$$20240923$$MD$RU$RU
243504181$24350418$1$I$20240207$20240219$20240923$20240923$PER$$CN-ROCHE-3512924$ROCHE$$53$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243504191$24350419$1$I$20240209$20240218$20240923$20240923$PER$$MM-ROCHE-3513029$ROCHE$$56$YR$A$F$Y$$$20240923$$CN$MM$MM
243504201$24350420$1$I$$20240220$20240923$20240923$PER$$CA-ROCHE-3513162$ROCHE$$$$A$F$Y$75$KG$20240923$$MD$CA$CA
243504211$24350421$1$I$$20240220$20240923$20240923$PER$$CA-ROCHE-3513151$ROCHE$$$$E$F$Y$100$KG$20240923$$MD$CA$CA
243504221$24350422$1$I$$20240913$20240923$20240923$EXP$$CA-ROCHE-10000082833$ROCHE$$$$A$M$Y$$$20240923$$CN$CA$CA
243504231$24350423$1$I$$20240115$20240923$20240923$PER$$CA-ROCHE-3513357$ROCHE$$$$A$F$Y$63$KG$20240923$$MD$CA$CA
243504241$24350424$1$I$20240218$20240220$20240923$20240923$PER$$CN-ROCHE-3512861$ROCHE$$47$YR$A$F$Y$74$KG$20240923$$HP$CN$CN
243504251$24350425$1$I$$20240216$20240923$20240923$PER$$RU-ROCHE-3512330$ROCHE$$$$$F$Y$$$20240923$$MD$RU$RU
243504261$24350426$1$I$20240217$20240220$20240923$20240923$PER$$CN-ROCHE-3513280$ROCHE$$61$YR$A$F$Y$51$KG$20240923$$HP$CN$CN
243504271$24350427$1$I$$20240221$20240923$20240923$PER$$PK-ROCHE-3513817$ROCHE$$70$YR$E$F$Y$$$20240923$$CN$PK$PK
243504281$24350428$1$I$20200312$20240222$20240923$20240923$PER$PL-URPL-1-1318-2020$PL-ROCHE-3514980$ROCHE$$37$YR$A$F$Y$60$KG$20240923$$MD$PL$PL
243504291$24350429$1$I$$20240222$20240923$20240923$PER$$US-ROCHE-3515032$ROCHE$$$$$$Y$$$20240923$$HP$US$US
243504301$24350430$1$I$20240103$20240222$20240923$20240923$PER$$CN-ROCHE-3514584$ROCHE$$52$YR$A$F$Y$$$20240923$$HP$CN$CN
243504311$24350431$1$I$20231231$20240222$20240923$20240923$PER$$CN-ROCHE-3514404$ROCHE$$67$YR$E$F$Y$$$20240923$$HP$CN$CN
243504321$24350432$1$I$20240125$20240221$20240923$20240923$PER$$CN-ROCHE-3515067$ROCHE$$52$YR$A$F$Y$54$KG$20240923$$HP$CN$CN
243504331$24350433$1$I$20240109$20240221$20240923$20240923$PER$$CN-ROCHE-3515042$ROCHE$$43$YR$A$F$Y$56$KG$20240923$$HP$CN$CN
243504341$24350434$1$I$$20240222$20240923$20240923$PER$IT-MINISAL02-971120$IT-ROCHE-3514991$ROCHE$$67$YR$E$F$Y$$$20240923$$MD$IT$IT
243504351$24350435$1$I$$20240220$20240923$20240923$PER$$US-ROCHE-3513774$ROCHE$$30$YR$A$F$Y$$$20240923$$HP$US$US
243504361$24350436$1$I$20240123$20240221$20240923$20240923$PER$$CN-ROCHE-3514358$ROCHE$$67$YR$E$F$Y$55$KG$20240923$$HP$CN$CN
243504371$24350437$1$I$$20240914$20240923$20240923$PER$$US-EMD Serono-2024049556$EMD SERONO INC$$$$A$$Y$$$20240923$$MD$US$US
243504381$24350438$1$I$$20240917$20240923$20240923$EXP$$ES-ASTELLAS-2024-AER-007588$ASTELLAS$$67$YR$E$M$Y$$$20240923$$MD$ES$ES
243504391$24350439$1$I$$20240920$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-040771$AUROBINDO$$49$YR$$M$Y$$$20240923$$MD$US$US
243504411$24350441$1$I$20240913$20240916$20240923$20240923$30DAY$$US-AMGEN-USASP2024185007$AMGEN$$28$YR$A$F$Y$61.23$KG$20240923$$HP$US$US
243504421$24350442$1$I$$20240917$20240923$20240923$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR116352$VIIV$$$$$M$Y$$$20240923$$CN$US$US
243504431$24350443$1$I$20220101$20240909$20240923$20240923$EXP$FR-AFSSAPS-SE2024000694$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112132$ZYDUS PHARM$$$$$$Y$$$20240923$$MD$FR$FR
243504441$24350444$1$I$$20240910$20240923$20240923$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112233$ZYDUS PHARM$Russe-Russe JR, Abdelhamid I, Meier R, Giblen G, Maheshwari A.. Rousing drug-induced liver injury through cytochrome p450 isoenzyme overload leading to fulminant liver failure. J-Liver-Transplant. 2024;14:100207$$$$$Y$$$20240923$$HP$US$US
243504451$24350445$1$I$20210826$20240311$20240923$20240923$PER$PT-INFARMED-T202108-3684$PT-ROCHE-3508891$ROCHE$$42$YR$A$F$Y$62$KG$20240923$$PH$PT$PT
243504461$24350446$1$I$$20240222$20240923$20240923$PER$$VN-ROCHE-3515210$ROCHE$$46$YR$A$F$Y$$$20240923$$MD$VN$VN
243504471$24350447$1$I$$20240303$20240923$20240923$PER$$IT-ROCHE-3515030$ROCHE$Bianchi G, Duca M, Sica L and Mariani G Metastatic breast cancer treated with lapatinib with a prolonged benefit: A case report and a review of therapeutic options available. DOI: 10.1177/030089161309900617. Tumori 2013 Dec;99 (6):E269-72.$53$YR$A$F$Y$$$20240923$$HP$IT$IT
243504481$24350448$1$I$20240209$20240301$20240923$20240923$PER$$CA-ROCHE-3508973$ROCHE$$68$YR$E$M$Y$63$KG$20240923$$HP$CA$CA
243504491$24350449$1$I$20210812$20240314$20240923$20240923$PER$$PT-ROCHE-3505235$ROCHE$$51$YR$A$F$Y$86$KG$20240923$$MD$PT$PT
243504501$24350450$1$I$20200313$20240223$20240923$20240923$PER$PL-URPL-1-2667-2020$PL-ROCHE-3515132$ROCHE$$60$YR$A$F$Y$$$20240923$$MD$PL$PL
243504511$24350451$1$I$$20240222$20240923$20240923$PER$$RU-ROCHE-3512382$ROCHE$$33$YR$A$F$Y$$$20240923$$MD$RU$RU
243504521$24350452$1$I$$20240419$20240923$20240923$PER$$US-ROCHE-3514130$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243504531$24350453$1$I$$20240207$20240923$20240923$PER$$CA-ROCHE-3507012$ROCHE$$$$A$F$Y$60$KG$20240923$$MD$CA$CA
243504541$24350454$1$I$$20240319$20240923$20240923$PER$$JP-ROCHE-3501825$ROCHE$$$$$F$Y$$$20240923$$MD$JP$JP
243504551$24350455$1$I$$20240318$20240923$20240923$PER$$US-ROCHE-3513783$ROCHE$$$$E$F$Y$$$20240923$$HP$US$US
243504561$24350456$1$I$20240101$20240306$20240923$20240923$PER$$JP-ROCHE-3505231$ROCHE$$$$E$F$Y$$$20240923$$PH$JP$JP
243504571$24350457$1$I$$20240513$20240923$20240923$PER$$US-ROCHE-3511561$ROCHE$$49$YR$A$F$Y$97.52$KG$20240923$$CN$US$US
243504581$24350458$1$I$20240129$20240605$20240923$20240923$PER$$KR-ROCHE-3511361$ROCHE$$27$YR$A$$Y$$$20240923$$MD$KR$KR
243504591$24350459$1$I$$20240312$20240923$20240923$PER$$JP-ROCHE-3506162$ROCHE$$$$E$F$Y$$$20240923$$MD$JP$JP
243504601$24350460$1$I$20221118$20240523$20240923$20240923$PER$$JP-ROCHE-3509387$ROCHE$$73$YR$E$M$Y$45$KG$20240923$$MD$JP$JP
243504621$24350462$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189042$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243504631$24350463$1$I$$20240315$20240923$20240923$PER$$US-ROCHE-3514419$ROCHE$$47$YR$A$F$Y$$$20240923$$MD$US$US
243504641$24350464$1$I$$20240812$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-041501$AUROBINDO$$60$YR$$F$Y$146.9$KG$20240923$$HP$US$US
243504651$24350465$1$I$$20240918$20240923$20240923$EXP$$CA-Orion Corporation ORION PHARMA-24_00031805$ORION$$67$YR$E$M$Y$$$20240923$$HP$CA$
243504661$24350466$1$I$20240901$20240912$20240923$20240923$PER$$US-ASTELLAS-2024-AER-007034$ASTELLAS$$$$$F$Y$$$20240923$$CN$US$US
243504671$24350467$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087654$ROCHE$$66$YR$E$M$Y$$$20240923$$CN$US$US
243504681$24350468$1$I$20240101$20240913$20240923$20240923$EXP$$BR-TEVA-VS-3244971$TEVA$$25$YR$$F$Y$$$20240923$$CN$BR$BR
243504691$24350469$1$I$20240101$20240917$20240923$20240923$EXP$SE-SEMPA-2024-006794$SE-JUBILANT CADISTA PHARMACEUTICALS-2024SE001332$JUBILANT$$51$YR$$F$Y$60$KG$20240923$$MD$SE$SE
243504701$24350470$1$I$20000101$20240913$20240923$20240923$EXP$SE-EMA-DD-20180103-negievprod-092302$SE-JUBILANT CADISTA PHARMACEUTICALS-2024SE001314$JUBILANT$$32$YR$$F$Y$39$KG$20240923$$MD$SE$SE
243504711$24350471$1$I$$20240813$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-041578$AUROBINDO$$41$YR$$F$Y$$$20240923$$MD$US$US
243504721$24350472$1$I$20240901$20240917$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148720$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$108.1$KG$20240923$$PH$US$US
243504761$24350476$1$I$20240911$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64733$$FDA-CTU$$78$YR$$F$N$$$20240920$N$$US$
243504781$24350478$1$I$$20240920$20240920$20240920$DIR$719290$$FDA-CTU$$69$YR$$F$N$54.45$KG$20240920$N$$US$
243504801$24350480$1$I$$20240919$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US081957$SANDOZ$$$$$$Y$$$20240923$$HP$US$US
243504811$24350481$1$I$20240808$20240813$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-041841$AUROBINDO$$59$YR$$M$Y$$$20240923$$MD$US$US
243504821$24350482$1$I$$20240822$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-042990$AUROBINDO$$76$YR$$M$Y$92.9$KG$20240923$$MD$US$US
243504831$24350483$1$I$20240101$20240913$20240923$20240923$EXP$$AR-AMGEN-ARGSP2024186391$AMGEN$$$$$$Y$$$20240923$$MD$AR$AR
243504841$24350484$1$I$20240806$20240916$20240923$20240923$EXP$$CN-ABBVIE-5932331$ABBVIE$$56$YR$$M$Y$80$KG$20240923$$HP$CN$CN
243504851$24350485$1$I$$20240913$20240923$20240923$PER$$US-ASTELLAS-2024-AER-007018$ASTELLAS$$$$$F$Y$$$20240923$$MD$US$US
243504861$24350486$1$I$20240918$20240919$20240923$20240923$EXP$$DE-ABBVIE-5933380$ABBVIE$$77$YR$$M$Y$$$20240923$$CN$DE$DE
243504871$24350487$1$I$$20240913$20240923$20240923$EXP$$NZ-MYLANLABS-2024M1085030$MYLAN$Bonnet LA, Evans KF. CMV neuroretinitis in a post-transplant patient. BMJ-Case-Rep 2023; 16 (12):.$5$DEC$$M$Y$$$20240923$$MD$NZ$NZ
243504881$24350488$1$I$20240901$20240917$20240923$20240923$EXP$$GB-MYLANLABS-2024M1083745$MYLAN$$32$YR$$M$Y$$$20240923$$HP$GB$GB
243504891$24350489$1$I$20240821$20240914$20240923$20240923$EXP$$CN-MYLANLABS-2024M1085400$MYLAN$$69$YR$$M$Y$85.5$KG$20240923$$HP$CN$CN
243504921$24350492$1$I$$20240913$20240923$20240923$EXP$$US-MYLANLABS-2024M1085040$MYLAN$Stark JE, Montgomery CM. Administering a Soda Beverage With the Hepatitis C Treatment Sofosbuvir/Velpatasvir and the Proton-Pump Inhibitor Pantoprazole: A Case Report. J-Pharm-Pract 2024; 37 (4): 1011-1014.$52$YR$$M$Y$$$20240923$$PH$US$US
243504941$24350494$1$I$20240818$20240826$20240923$20240923$PER$$US-AUROBINDO-AUR-APL-2024-043305$AUROBINDO$$82$YR$$M$Y$81.6$KG$20240923$$MD$US$US
243504951$24350495$1$I$20230919$20240412$20240923$20240923$PER$$CO-ROCHE-3515213$ROCHE$$48$YR$A$F$Y$$$20240923$$MD$CO$CO
243504961$24350496$1$I$$20240308$20240923$20240923$PER$$MA-ROCHE-3525737$ROCHE$$$$$$Y$$$20240923$$CN$MA$MA
243504981$24350498$1$I$20240126$20240411$20240923$20240923$PER$IT-MINISAL02-975271$IT-ROCHE-3529990$ROCHE$$33$YR$A$F$Y$$$20240923$$MD$IT$IT
243504991$24350499$1$I$$20240308$20240923$20240923$PER$$RO-ROCHE-3525412$ROCHE$$48$YR$A$F$Y$$$20240923$$CN$RO$RO
243505001$24350500$1$I$20210120$20240308$20240923$20240923$PER$$IT-ROCHE-3524128$ROCHE$$76$YR$E$F$Y$$$20240923$$MD$IT$IT
243505011$24350501$1$I$$20240912$20240923$20240923$EXP$$US-ROCHE-10000082902$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243505021$24350502$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64673$$FDA-CTU$$$$$M$N$$$20240920$N$HP$US$
243505031$24350503$1$I$$20240228$20240923$20240923$PER$$CA-ROCHE-3518604$ROCHE$$$$E$F$Y$$$20240923$$CN$CA$CA
243505051$24350505$1$I$$20240314$20240923$20240923$PER$$MY-ROCHE-3527242$ROCHE$$58$YR$A$F$Y$$$20240923$$HP$MY$MY
243505061$24350506$1$I$20240216$20240313$20240923$20240923$PER$IT-MINISAL02-974314$IT-ROCHE-3526808$ROCHE$$77$YR$E$F$Y$69$KG$20240923$$MD$IT$IT
243505071$24350507$1$I$20240901$20240909$20240923$20240923$EXP$$US-COOPERSURGICAL, INC.-2024CPS002764$COOPERSURGICAL$$52$YR$$F$Y$84.807$KG$20240923$$MD$US$US
243505081$24350508$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64668$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243505101$24350510$1$I$$20240909$20240923$20240923$EXP$$JP-MEDEXUS PHARMA, INC.-2024MED00399$MEDEXUS PHARMA$Ebisawa K, Iwashita T, Uchiyama K, Kitayama Y, Takeuchi T. Epstein?Barr virus-positive mucocutaneous ulcer resulting in severe Methotrexate intoxication: a case report. J. Med. Case Rep.. 2024;18(1)$$$E$M$Y$$$20240923$$HP$JP$JP
243505111$24350511$1$I$20240919$20240920$20240920$20240920$DIR$719245$$FDA-CTU$$47$YR$$M$N$162.3$KG$20240920$Y$HP$US$
243505121$24350512$1$I$20240917$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024186797$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
243505131$24350513$1$I$20240213$20240313$20240923$20240923$PER$$KR-ROCHE-3527307$ROCHE$$64$YR$A$$Y$$$20240923$$MD$KR$KR
243505141$24350514$1$I$20240920$20240920$20240920$20240920$DIR$719262$$FDA-CTU$$53$YR$$F$N$$$20240920$N$$US$
243505161$24350516$1$I$$20240920$20240920$20240920$DIR$719229$$FDA-CTU$$$$$UNK$N$$$20240920$N$CN$US$
243505171$24350517$1$I$20240207$20240226$20240923$20240923$PER$$CN-ROCHE-3516603$ROCHE$$70$YR$E$M$Y$$$20240923$$HP$CN$CN
243505181$24350518$1$I$20240103$20240222$20240923$20240923$PER$$CN-ROCHE-3515434$ROCHE$$60$YR$A$F$Y$$$20240923$$HP$CN$CN
243505191$24350519$1$I$$20240226$20240923$20240923$PER$$AE-ROCHE-3516447$ROCHE$$$$$F$Y$$$20240923$$CN$AE$AE
243505201$24350520$1$I$20240127$20240226$20240923$20240923$PER$$CN-ROCHE-3516610$ROCHE$$52$YR$A$F$Y$$$20240923$$HP$CN$CN
243505211$24350521$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64680$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243505221$24350522$1$I$$20240227$20240923$20240923$PER$$CA-ROCHE-3517777$ROCHE$$$$$F$Y$$$20240923$$CN$CA$CA
243505241$24350524$1$I$20231201$20240311$20240923$20240923$PER$$BR-ROCHE-3525184$ROCHE$$59$YR$A$F$Y$$$20240923$$MD$BR$BR
243505251$24350525$1$I$$20240226$20240923$20240923$PER$$CN-ROCHE-3516621$ROCHE$$56$YR$A$F$Y$$$20240923$$MD$CN$CN
243505261$24350526$1$I$$20240228$20240923$20240923$PER$$US-ROCHE-3518499$ROCHE$$77$YR$E$F$Y$70.31$KG$20240923$$CN$US$US
243505271$24350527$1$I$$20240226$20240923$20240923$PER$$CN-ROCHE-3516692$ROCHE$$50$YR$A$F$Y$$$20240923$$MD$CN$CN
243505281$24350528$1$I$20221101$20240918$20240923$20240923$EXP$FR-AFSSAPS-LM2024000507$FR-009507513-2409FRA006698$MERCK$$52$YR$$M$Y$72$KG$20240923$$MD$FR$FR
243505301$24350530$1$I$20240227$20240412$20240923$20240923$PER$$JP-ROCHE-3527055$ROCHE$$67$YR$E$F$Y$$$20240923$$HP$JP$JP
243505311$24350531$1$I$$20240219$20240923$20240923$PER$$JP-ROCHE-3515881$ROCHE$Kishimoto K, Murakami K, Takahashi Y, Kotani S, Oka A, Yazaki T Gastric Metastasis from Salivary Duct Carcinoma. doi:10.2169/internalmedicine.1965-23. Internal Medicine 2024;63 (3):373-8.$59$YR$A$M$Y$$$20240923$$MD$JP$JP
243505331$24350533$1$I$$20240213$20240923$20240923$PER$$CA-ROCHE-3516797$ROCHE$$$$A$F$Y$75$KG$20240923$$MD$CA$CA
243505341$24350534$1$I$20201027$20240918$20240923$20240923$EXP$$NVSC2024AU187369$NOVARTIS$$53$YR$$F$Y$$$20240923$$MD$AU$AU
243505351$24350535$1$I$20231228$20240223$20240923$20240923$PER$$CN-ROCHE-3517401$ROCHE$$60$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243505361$24350536$1$I$$20240212$20240923$20240923$PER$$CA-ROCHE-3517441$ROCHE$$$$A$F$Y$50$KG$20240923$$MD$CA$CA
243505371$24350537$1$I$$20240212$20240923$20240923$PER$$CA-ROCHE-3517438$ROCHE$$$$A$F$Y$80$KG$20240923$$MD$CA$CA
243505391$24350539$1$I$20231128$20240228$20240923$20240923$PER$IT-MINISAL02-972080$IT-ROCHE-3517509$ROCHE$$64$YR$A$F$Y$$$20240923$$PH$IT$IT
243505401$24350540$1$I$$20240226$20240923$20240923$PER$$US-ROCHE-3516943$ROCHE$$62$YR$A$F$Y$$$20240923$$HP$US$US
243505411$24350541$1$I$$20240223$20240923$20240923$PER$$US-ROCHE-3516924$ROCHE$$45$YR$A$F$Y$$$20240923$$MD$US$US
243505421$24350542$1$I$$20240223$20240923$20240923$PER$$PK-ROCHE-3517496$ROCHE$$46$YR$A$F$Y$78$KG$20240923$$CN$PK$PK
243505431$24350543$1$I$20240202$20240227$20240923$20240923$PER$$CN-ROCHE-3517356$ROCHE$$71$YR$E$M$Y$55$KG$20240923$$HP$CN$CN
243505441$24350544$1$I$20210306$20240222$20240923$20240923$PER$$MX-ROCHE-3516828$ROCHE$$49$YR$A$F$Y$$$20240923$$CN$MX$MX
243505451$24350545$1$I$$20240213$20240923$20240923$PER$$CA-ROCHE-3516791$ROCHE$$$$$F$Y$77$KG$20240923$$MD$CA$CA
243505461$24350546$1$I$$20240919$20240923$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA081712$SANDOZ$$41$YR$$M$Y$$$20240923$$PH$CA$CA
243505481$24350548$1$I$20240919$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012843$ELI LILLY AND CO$$$$A$F$Y$$$20240923$$CN$US$US
243505492$24350549$2$F$20240801$20240919$20240923$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409011000$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240929$$CN$US$US
243505501$24350550$1$I$$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013493$ELI LILLY AND CO$$84$YR$E$M$Y$$$20240923$$CN$US$US
243505511$24350551$1$I$20240920$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013874$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240923$$CN$US$US
243505521$24350552$1$I$20240913$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012627$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240923$$CN$US$US
243505531$24350553$1$I$20240917$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011232$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240923$$CN$US$US
243505541$24350554$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011091$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240923$$CN$US$US
243505551$24350555$1$I$$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013426$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243505561$24350556$1$I$20240904$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013355$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243505571$24350557$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012536$ELI LILLY AND CO$$29$YR$A$M$Y$$$20240923$$CN$US$US
243505581$24350558$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012540$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240923$$CN$US$US
243505591$24350559$1$I$20240919$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012676$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240923$$CN$US$US
243505601$24350560$1$I$20240901$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012475$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240923$$CN$US$US
243505611$24350561$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012748$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240923$$CN$US$US
243505621$24350562$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011690$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240923$$CN$US$US
243505631$24350563$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012744$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240923$$CN$US$US
243505641$24350564$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012887$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240923$$CN$US$US
243505651$24350565$1$I$$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013628$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240923$$CN$US$US
243505662$24350566$2$F$$20240925$20240923$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409012423$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240927$$CN$US$US
243505671$24350567$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012117$ELI LILLY AND CO$$$$A$M$Y$$$20240923$$CN$US$US
243505681$24350568$1$I$20231204$20240226$20240923$20240923$PER$$CN-ROCHE-3518321$ROCHE$$84$YR$E$F$Y$68$KG$20240923$$HP$CN$CN
243505691$24350569$1$I$20240910$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64737$$FDA-CTU$$62$YR$$F$N$$$20240920$Y$HP$US$
243505701$24350570$1$I$20240127$20240226$20240923$20240923$PER$$CN-ROCHE-3518331$ROCHE$$30$YR$A$F$Y$$$20240923$$HP$CN$CN
243505711$24350571$1$I$$20240212$20240923$20240923$PER$$CA-ROCHE-3518196$ROCHE$$$$A$F$Y$80$KG$20240923$$MD$CA$CA
243505721$24350572$1$I$$20240227$20240923$20240923$PER$$AT-ROCHE-3517662$ROCHE$$$$A$F$Y$$$20240923$$CN$AT$AT
243505731$24350573$1$I$$20240229$20240923$20240923$PER$$CN-ROCHE-3518271$ROCHE$$$$A$F$Y$$$20240923$$MD$CN$CN
243505741$24350574$1$I$20240202$20240226$20240923$20240923$PER$$CN-ROCHE-3518328$ROCHE$$60$YR$A$F$Y$57$KG$20240923$$HP$CN$CN
243505771$24350577$1$I$$20240205$20240923$20240923$PER$$CA-ROCHE-3518205$ROCHE$$$$A$F$Y$70$KG$20240923$$MD$CA$CA
243505781$24350578$1$I$$20240215$20240923$20240923$PER$$JP-ROCHE-3517928$ROCHE$$$$A$F$Y$$$20240923$$MD$JP$JP
243505791$24350579$1$I$$20240916$20240923$20240923$EXP$$US-BAYER-2024A132621$BAYER$$$$$F$Y$$$20240923$$CN$US$US
243505801$24350580$1$I$$20240227$20240923$20240923$PER$$US-ROCHE-3517727$ROCHE$$82$YR$E$F$Y$$$20240923$$MD$US$US
243505821$24350582$1$I$$20240228$20240923$20240923$PER$$US-ROCHE-3519002$ROCHE$$$$$$Y$$$20240923$$HP$US$US
243505831$24350583$1$I$20240101$20240227$20240923$20240923$PER$$MX-ROCHE-3518693$ROCHE$$44$YR$A$F$Y$$$20240923$$CN$MX$MX
243505841$24350584$1$I$$20240228$20240923$20240923$PER$$VN-ROCHE-3518507$ROCHE$$$$A$F$Y$$$20240923$$MD$VN$VN
243505851$24350585$1$I$$20240228$20240923$20240923$PER$$BS-ROCHE-3519489$ROCHE$$$$$$Y$$$20240923$$CN$BS$BS
243505861$24350586$1$I$20230630$20240229$20240923$20240923$PER$$CN-ROCHE-3519097$ROCHE$$35$YR$A$F$Y$52.5$KG$20240923$$HP$CN$CN
243505871$24350587$1$I$$20240920$20240923$20240923$PER$$US-JNJFOC-20240956580$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$US$US
243505881$24350588$1$I$$20240228$20240923$20240923$PER$$US-ROCHE-3518813$ROCHE$$71$YR$E$M$Y$$$20240923$$MD$US$US
243505901$24350590$1$I$20230815$20240229$20240923$20240923$PER$$CN-ROCHE-3519112$ROCHE$$56$YR$A$F$Y$73$KG$20240923$$HP$CN$CN
243505911$24350591$1$I$20231001$20240228$20240923$20240923$PER$$US-ROCHE-3518503$ROCHE$$82$YR$E$F$Y$$$20240923$$MD$US$US
243505921$24350592$1$I$$20240228$20240923$20240923$PER$$US-ROCHE-3519197$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243505931$24350593$1$I$$20240226$20240923$20240923$PER$$US-ROCHE-3518515$ROCHE$$$$$F$Y$$$20240923$$MD$US$US
243505941$24350594$1$I$$20240228$20240923$20240923$PER$$VN-ROCHE-3518516$ROCHE$$$$A$F$Y$$$20240923$$MD$VN$VN
243505951$24350595$1$I$20230523$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149499$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243505961$24350596$1$I$$20240828$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-138440$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240923$$CN$US$US
243505971$24350597$1$I$$20240919$20240923$20240923$EXP$$UA-PFIZER INC-202400260828$PFIZER$$45$YR$$F$Y$$$20240923$$CN$UA$UA
243505981$24350598$1$I$20240903$20240919$20240923$20240923$EXP$$DE-PFIZER INC-PV202400123370$PFIZER$$40$YR$$F$Y$49$KG$20240923$$MD$DE$DE
243505992$24350599$2$F$20240916$20240925$20240923$20240930$EXP$$US-PFIZER INC-202400251060$PFIZER$$65$YR$$F$Y$$$20240930$$HP$US$US
243506011$24350601$1$I$$20240916$20240923$20240923$EXP$CA-NEBO-669750$CA-NEBO-669750$PHARMACOSMOS$$50$YR$$F$Y$64$KG$20240923$$HP$CA$CA
243506021$24350602$1$I$20240821$20240918$20240923$20240923$EXP$$NVSC2024GB169645$NOVARTIS$$61$YR$$F$Y$69.1$KG$20240923$$HP$GB$GB
243506032$24350603$2$F$$20240917$20240923$20240924$EXP$$FR-PFIZER INC-202400258151$PFIZER$Dupont, J.. Chloramphenicol toxicity.. Prat Anesth Reanim.. 2024;28:243-249$56$YR$$M$Y$$$20240924$$HP$FR$FR
243506041$24350604$1$I$$20240229$20240923$20240923$PER$$RU-ROCHE-3520015$ROCHE$$60$YR$A$F$Y$$$20240923$$MD$RU$RU
243506051$24350605$1$I$20231002$20240304$20240923$20240923$PER$$CN-ROCHE-3520743$ROCHE$$62$YR$A$F$Y$57$KG$20240923$$HP$CN$CN
243506061$24350606$1$I$20240225$20240301$20240923$20240923$PER$$CN-ROCHE-3519941$ROCHE$$40$YR$A$F$Y$63$KG$20240923$$HP$CN$CN
243506071$24350607$1$I$20240222$20240301$20240923$20240923$PER$$CN-ROCHE-3519938$ROCHE$$37$YR$A$F$Y$82$KG$20240923$$HP$CN$CN
243506081$24350608$1$I$20240225$20240301$20240923$20240923$PER$$CN-ROCHE-3519592$ROCHE$$51$YR$A$F$Y$52$KG$20240923$$HP$CN$CN
243506091$24350609$1$I$20240128$20240301$20240923$20240923$PER$$CN-ROCHE-3519924$ROCHE$$54$YR$A$F$Y$$$20240923$$HP$CN$CN
243506101$24350610$1$I$20240221$20240301$20240923$20240923$PER$$CN-ROCHE-3519570$ROCHE$$58$YR$A$F$Y$$$20240923$$HP$CN$CN
243506111$24350611$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3519811$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243506121$24350612$1$I$20240223$20240301$20240923$20240923$PER$$CN-ROCHE-3519568$ROCHE$$47$YR$A$F$Y$75$KG$20240923$$HP$CN$CN
243506131$24350613$1$I$20240126$20240301$20240923$20240923$PER$$CN-ROCHE-3519950$ROCHE$$53$YR$A$F$Y$66$KG$20240923$$HP$CN$CN
243506141$24350614$1$I$$20240229$20240923$20240923$PER$$BE-ROCHE-3520319$ROCHE$$$$$$Y$$$20240923$$PH$BE$BE
243506162$24350616$2$F$$20240926$20240923$20240927$EXP$$NZ-MYLANLABS-2024M1086001$MYLAN$$$$$M$Y$$$20240927$$PH$NZ$NZ
243506171$24350617$1$I$$20240920$20240923$20240923$EXP$$AU-MYLANLABS-2024M1086004$MYLAN$$$$$M$Y$$$20240923$$HP$AU$AU
243506191$24350619$1$I$20240201$20240304$20240923$20240923$PER$$CN-ROCHE-3521532$ROCHE$$49$YR$A$F$Y$64$KG$20240923$$HP$CN$CN
243506201$24350620$1$I$20240219$20240304$20240923$20240923$PER$$CN-ROCHE-3521539$ROCHE$$60$YR$A$F$Y$56$KG$20240923$$HP$CN$CN
243506211$24350621$1$I$20240203$20240229$20240923$20240923$PER$$CN-ROCHE-3520681$ROCHE$$62$YR$A$F$Y$56$KG$20240923$$HP$CN$CN
243506221$24350622$1$I$20240224$20240304$20240923$20240923$PER$$CN-ROCHE-3520778$ROCHE$$39$YR$A$F$Y$56$KG$20240923$$HP$CN$CN
243506231$24350623$1$I$20240201$20240305$20240923$20240923$PER$$CN-ROCHE-3521734$ROCHE$$49$YR$A$F$Y$64$KG$20240923$$HP$CN$CN
243506241$24350624$1$I$$20240301$20240923$20240923$PER$$PH-ROCHE-3520889$ROCHE$$$$$F$Y$$$20240923$$CN$PH$PH
243506251$24350625$1$I$20240228$20240304$20240923$20240923$PER$$CN-ROCHE-3520809$ROCHE$$69$YR$E$F$Y$$$20240923$$HP$CN$CN
243506261$24350626$1$I$20240724$20240914$20240923$20240923$EXP$$CA-ROCHE-10000083334$ROCHE$$39$YR$A$F$Y$$$20240923$$CN$CA$CA
243506271$24350627$1$I$$20240305$20240923$20240923$PER$$CN-ROCHE-3520693$ROCHE$$77$YR$E$F$Y$$$20240923$$MD$CN$CN
243506281$24350628$1$I$20240301$20240304$20240923$20240923$PER$$US-ROCHE-3520836$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243506291$24350629$1$I$20240227$20240305$20240923$20240923$PER$$CN-ROCHE-3521587$ROCHE$$56$YR$A$F$Y$52$KG$20240923$$HP$CN$CN
243506301$24350630$1$I$$20240306$20240923$20240923$PER$$AU-ROCHE-3521672$ROCHE$$$$$M$Y$$$20240923$$MD$AU$AU
243506311$24350631$1$I$20240101$20240903$20240923$20240923$PER$$US-TEVA-VS-3240081$TEVA$$74$YR$$F$Y$53.98$KG$20240923$$CN$US$US
243506321$24350632$1$I$20240227$20240304$20240923$20240923$PER$$CN-ROCHE-3520769$ROCHE$$56$YR$A$F$Y$56$KG$20240923$$HP$CN$CN
243506331$24350633$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA273562$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$CN$US$US
243506341$24350634$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272635$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240923$$MD$US$US
243506351$24350635$1$I$20240904$20240913$20240923$20240923$PER$$US-GSK-US2024114153$GLAXOSMITHKLINE$$62$YR$$F$Y$$$20240923$$CN$US$US
243506371$24350637$1$I$$20240910$20240923$20240923$EXP$$US-APOTEX-2024AP010584$APOTEX$Tarantino MD, Hardesty B, Metjian A, Ortel TL, Chen J, Badejo K, et al. Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety study. Haemophilia. 2023;29 (5):1259-1268$$$E$F$Y$$$20240923$$HP$US$US
243506381$24350638$1$I$20240219$20240306$20240923$20240923$PER$$CN-ROCHE-3521829$ROCHE$$75$YR$E$M$Y$$$20240923$$HP$CN$CN
243506391$24350639$1$I$20220101$20240307$20240923$20240923$PER$$CN-ROCHE-3522315$ROCHE$$$$A$F$Y$75$KG$20240923$$HP$CN$CN
243506401$24350640$1$I$20240214$20240305$20240923$20240923$PER$$MM-ROCHE-3519335$ROCHE$$75$YR$E$F$Y$$$20240923$$CN$MM$MM
243506411$24350641$1$I$20240118$20240307$20240923$20240923$PER$IT-MINISAL02-973527$IT-ROCHE-3522219$ROCHE$$64$YR$A$F$Y$$$20240923$$MD$IT$IT
243506421$24350642$1$I$20240115$20240307$20240923$20240923$PER$$CN-ROCHE-3522325$ROCHE$$70$YR$E$F$Y$65$KG$20240923$$HP$CN$CN
243506431$24350643$1$I$20240302$20240304$20240923$20240923$PER$$PK-ROCHE-3521850$ROCHE$$59$YR$A$F$Y$$$20240923$$CN$PK$PK
243506441$24350644$1$I$20240226$20240306$20240923$20240923$PER$$CN-ROCHE-3522369$ROCHE$$64$YR$A$F$Y$66$KG$20240923$$HP$CN$CN
243506451$24350645$1$I$$20240303$20240923$20240923$PER$$GB-ROCHE-3522459$ROCHE$$$$$$Y$$$20240923$$HP$GB$GB
243506461$24350646$1$I$20240917$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64685$$FDA-CTU$$66$YR$$M$N$77.56$KG$20240920$Y$PH$US$
243506471$24350647$1$I$20240901$20240920$20240920$20240920$DIR$719260$$FDA-CTU$$73$YR$$F$N$63$KG$20240920$N$CN$CA$
243506481$24350648$1$I$$20240221$20240923$20240923$PER$$JP-ROCHE-3522049$ROCHE$$$$$F$Y$$$20240923$$CN$JP$JP
243506491$24350649$1$I$$20240916$20240923$20240923$30DAY$$US-PFIZER INC-202400257866$PFIZER$$67$YR$$F$Y$$$20240923$$CN$US$US
243506501$24350650$1$I$20240913$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64721$$FDA-CTU$$48$YR$$M$N$$$20240920$Y$HP$US$
243506511$24350651$1$I$$20240911$20240923$20240923$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08570$HIKMA$Schwetye KE, Nair LR, Boyle J, Barash JA.. Schwetye KE, Nair LR, Boyle J, Barash JA. Histopathologic correlates of opioid-associated injury in chanter syndrome: first report of a post-mortem examination.. Acta neuropathologica. 2024;148(1):33:/$45$YR$$M$Y$$$20240923$$MD$US$US
243506521$24350652$1$I$$20240917$20240923$20240923$30DAY$$US-PFIZER INC-202400258541$PFIZER$$6$YR$$F$Y$$$20240923$$CN$US$US
243506531$24350653$1$I$$20240911$20240923$20240923$PER$$US-SA-2024SA272907$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240923$$HP$US$US
243506543$24350654$3$F$$20240920$20240923$20240930$30DAY$$US-PFIZER INC-202400257495$PFIZER$$37$YR$$F$Y$$$20240930$$CN$US$US
243506551$24350655$1$I$$20240916$20240923$20240923$30DAY$$US-PFIZER INC-202400257648$PFIZER$$15$YR$$F$Y$52.16$KG$20240923$$CN$US$US
243506562$24350656$2$F$$20240926$20240923$20240930$30DAY$$US-PFIZER INC-202400259097$PFIZER$$11$YR$$F$Y$$$20240930$$CN$US$US
243506571$24350657$1$I$$20240916$20240923$20240923$30DAY$$US-PFIZER INC-202400257511$PFIZER$$9$YR$$M$Y$$$20240923$$MD$US$US
243506581$24350658$1$I$20240907$20240920$20240920$20240920$DIR$719236$$FDA-CTU$$86$YR$$F$N$58.8$KG$20240920$N$HP$US$
243506611$24350661$1$I$$20240910$20240923$20240923$PER$$US-SA-2024SA272961$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240923$$CN$US$US
243506621$24350662$1$I$20240101$20240917$20240923$20240923$EXP$$CA-PFIZER INC-202300401052$PFIZER$$14$YR$$F$Y$$$20240923$$MD$CA$CA
243506631$24350663$1$I$$20240913$20240923$20240923$30DAY$$US-PFIZER INC-202400255687$PFIZER$$16$YR$$M$Y$$$20240923$$CN$US$US
243506641$24350664$1$I$20240904$20240909$20240923$20240923$30DAY$$US-PFIZER INC-202400253492$PFIZER$$3$YR$$M$Y$$$20240923$$CN$US$US
243506651$24350665$1$I$20240909$20240911$20240920$20240920$DIR$FDA-CDER-CTU-2024-64662$$FDA-CTU$$66$YR$$F$N$$$20240911$N$PH$US$
243506661$24350666$1$I$20240617$20240919$20240923$20240923$EXP$SE-SEMPA-2024-006774$SE-PFIZER INC-202400259387$PFIZER$$69$YR$$F$Y$$$20240923$$MD$SE$SE
243506671$24350667$1$I$$20240911$20240923$20240923$30DAY$$US-PFIZER INC-202400255542$PFIZER$$12$YR$$M$Y$$$20240923$$CN$US$US
243506681$24350668$1$I$20240920$20240920$20240920$20240920$DIR$719234$$FDA-CTU$$87$YR$$F$N$$$20240920$N$HP$US$
243506691$24350669$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272815$SANOFI AVENTIS$$34$YR$A$$Y$$$20240923$$CN$US$US
243506711$24350671$1$I$$20240905$20240923$20240923$PER$$US-SA-2024SA273025$SANOFI AVENTIS$$$$E$F$Y$77.11$KG$20240923$$MD$US$US
243506741$24350674$1$I$20230901$20240917$20240923$20240923$30DAY$$US-PFIZER INC-PV202400044204$PFIZER$$$$$$Y$$$20240923$$HP$US$US
243506751$24350675$1$I$$20240910$20240923$20240923$PER$$US-SA-2024SA272875$SANOFI AVENTIS$$$$$F$Y$$$20240923$$MD$US$US
243506761$24350676$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA273153$SANOFI AVENTIS$$$$E$F$Y$54.55$KG$20240923$$MD$US$US
243506771$24350677$1$I$$20240916$20240923$20240923$30DAY$$CL-PFIZER INC-PV202400121326$PFIZER$$12$YR$$M$Y$$$20240923$$CN$CL$CL
243506781$24350678$1$I$20240909$20240909$20240923$20240923$PER$$US-SA-2024SA272532$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240923$$CN$US$US
243506791$24350679$1$I$20240801$20240903$20240923$20240923$PER$$US-SA-2024SA272549$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240923$$MD$US$US
243506801$24350680$1$I$$20240916$20240923$20240923$EXP$$NVSC2024US185340$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
243506811$24350681$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188374$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243506821$24350682$1$I$20240304$20240306$20240923$20240923$PER$$PE-ROCHE-3522543$ROCHE$$52$YR$A$F$Y$$$20240923$$CN$PE$PE
243506831$24350683$1$I$20240219$20240308$20240923$20240923$PER$$CN-ROCHE-3523749$ROCHE$$72$YR$E$F$Y$$$20240923$$HP$CN$CN
243506841$24350684$1$I$$20240308$20240923$20240923$PER$$CN-ROCHE-3523718$ROCHE$$45$YR$A$F$Y$$$20240923$$CN$CN$CN
243506851$24350685$1$I$20240122$20240307$20240923$20240923$PER$$CN-ROCHE-3523184$ROCHE$$45$YR$A$F$Y$$$20240923$$HP$CN$CN
243506861$24350686$1$I$$20240306$20240923$20240923$PER$$US-ROCHE-3522575$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243506871$24350687$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523744$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243506882$24350688$2$F$$20240916$20240923$20240927$EXP$$CA-BAUSCH-BL-2024-013926$BAUSCH AND LOMB$$3$DEC$$M$Y$$$20240927$$HP$CA$CA
243506901$24350690$1$I$$20240307$20240923$20240923$PER$$PK-ROCHE-3523101$ROCHE$$28$YR$A$F$Y$65$KG$20240923$$CN$PK$PK
243506911$24350691$1$I$$20240918$20240923$20240923$EXP$$GB-ROCHE-10000069709$ROCHE$$$$E$F$Y$$$20240923$$CN$GB$GB
243506921$24350692$1$I$$20240307$20240923$20240923$PER$$BA-ROCHE-3523370$ROCHE$Berendika J, Jungic S, Tubic B, Malcic Kecman G, Rakita I, Gojkovic Z, Vjestica M, Nikic G and Babic B Adjuvant Treatment of the Salivary Duct Carcinoma with Her2 Overexpression, Doi: 10.1159/000514850. Case Reports in Oncology 2021 Mar 29;14 (1):610-15.$55$YR$A$F$Y$$$20240923$$HP$BA$BA
243506931$24350693$1$I$20240207$20240307$20240923$20240923$PER$IT-MINISAL02-972793$IT-ROCHE-3519919$ROCHE$$64$YR$A$F$Y$$$20240923$$MD$IT$IT
243506941$24350694$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523924$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243506951$24350695$1$I$20240901$20240916$20240923$20240923$PER$$US-SA-2024SA268193$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240923$$CN$US$US
243506961$24350696$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA015145$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240923$$CN$US$US
243506971$24350697$1$I$$20240308$20240923$20240923$PER$$CN-ROCHE-3523719$ROCHE$$62$YR$A$F$Y$$$20240923$$CN$CN$CN
243506981$24350698$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270599$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240923$$CN$US$US
243506991$24350699$1$I$20240101$20240916$20240923$20240923$PER$$US-SA-2024SA270038$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240923$$MD$US$US
243507001$24350700$1$I$20240913$20240917$20240923$20240923$PER$$US-SA-2024SA269485$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240923$$HP$US$US
243507011$24350701$1$I$20230801$20240920$20240923$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US082144$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
243507021$24350702$1$I$$20240911$20240923$20240923$PER$$US-MYLANLABS-2024M1069503$MYLAN$$$$$F$Y$$$20240923$$CN$US$US
243507031$24350703$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523932$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507041$24350704$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523925$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507051$24350705$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523927$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507061$24350706$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523933$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507071$24350707$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523934$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507081$24350708$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523931$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507091$24350709$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523926$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507101$24350710$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523928$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507121$24350712$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523929$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507131$24350713$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523930$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507141$24350714$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150412$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240923$$MD$US$US
243507151$24350715$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150075$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240923$$HP$US$US
243507161$24350716$1$I$$20240917$20240923$20240923$EXP$$AU-PFIZER INC-202400257901$PFIZER$$34$YR$$F$Y$$$20240923$$CN$AU$AU
243507171$24350717$1$I$20240101$20240912$20240923$20240923$30DAY$$US-PFIZER INC-202400256015$PFIZER$$14$YR$$F$Y$30.84$KG$20240923$$CN$US$US
243507182$24350718$2$F$20231201$20240918$20240923$20240926$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-149742$BRISTOL MYERS SQUIBB$$62$YR$A$$Y$$$20240926$$HP$DE$DE
243507191$24350719$1$I$$20240918$20240923$20240923$30DAY$$US-PFIZER INC-202400259679$PFIZER$$12$YR$$F$Y$$$20240923$$CN$US$US
243507201$24350720$1$I$$20240911$20240923$20240923$30DAY$$US-PFIZER INC-PV202400119662$PFIZER$$$$$F$Y$$$20240923$$CN$US$US
243507211$24350721$1$I$20240916$20240917$20240923$20240923$30DAY$$US-PFIZER INC-202400258283$PFIZER$$14$YR$$M$Y$77.11$KG$20240923$$CN$US$US
243507221$24350722$1$I$$20240910$20240923$20240923$30DAY$$CA-PFIZER INC-202400254804$PFIZER$$66$YR$$M$Y$$$20240923$$CN$CA$CA
243507231$24350723$1$I$$20240919$20240923$20240923$EXP$GB-MHRA-MED-202409171608550330-GJPQL$GB-PFIZER INC-202400259805$PFIZER$$10$YR$$F$Y$32$KG$20240923$$MD$GB$GB
243507242$24350724$2$F$$20240923$20240923$20240926$30DAY$$US-PFIZER INC-202400258371$PFIZER$$14$YR$$M$Y$$$20240926$$CN$US$US
243507251$24350725$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523942$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507261$24350726$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523944$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507271$24350727$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523935$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507281$24350728$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523937$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507291$24350729$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523939$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507301$24350730$1$I$$20240912$20240923$20240923$EXP$$JP-JNJFOC-20240959250$JOHNSON AND JOHNSON$$60$YR$A$$Y$$$20240923$$MD$JP$JP
243507311$24350731$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523936$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507321$24350732$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523941$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507331$24350733$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523947$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507341$24350734$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523940$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507351$24350735$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523945$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507361$24350736$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523943$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507371$24350737$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523938$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507381$24350738$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523946$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507391$24350739$1$I$$20240918$20240923$20240923$EXP$$JP-UCBSA-2024047919$UCB$Kashiwazaki D, Tomita T, Hori E, Akioka N, Akai T, Noguchi K et al.. Frequency, Characteristics, and Preventability of Adverse Drug Reactions in Perioperative Neurosurgery: Analysis Over 11 Years. World Neurosurgery. 2024;189:e624-631$$$$$Y$$$20240923$$MD$JP$JP
243507402$24350740$2$F$20240401$20240920$20240923$20240924$PER$$US-ABBVIE-5931839$ABBVIE$$64$YR$$F$Y$72$KG$20240924$$CN$US$US
243507411$24350741$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114345$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243507421$24350742$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523949$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507431$24350743$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523954$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507441$24350744$1$I$$20240205$20240923$20240923$PER$$CA-ROCHE-3524687$ROCHE$$$$A$F$Y$75$KG$20240923$$MD$CA$CA
243507451$24350745$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523950$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507461$24350746$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523956$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507471$24350747$1$I$20240206$20240312$20240923$20240923$PER$$CN-ROCHE-3525281$ROCHE$$40$YR$A$F$Y$53$KG$20240923$$HP$CN$CN
243507481$24350748$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523951$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507491$24350749$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523955$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507501$24350750$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523953$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507511$24350751$1$I$$20240205$20240923$20240923$PER$$CA-ROCHE-3524700$ROCHE$$54$YR$A$F$Y$72$KG$20240923$$MD$CA$CA
243507521$24350752$1$I$20120521$20240304$20240923$20240923$PER$$JP-ROCHE-3524619$ROCHE$$62$YR$A$F$Y$$$20240923$$MD$JP$JP
243507531$24350753$1$I$$20240308$20240923$20240923$PER$$US-ROCHE-3525038$ROCHE$$75$YR$E$F$Y$$$20240923$$MD$US$US
243507541$24350754$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523948$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507551$24350755$1$I$$20240301$20240923$20240923$PER$$CN-ROCHE-3523952$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243507561$24350756$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188601$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243507571$24350757$1$I$20240213$20240226$20240923$20240923$PER$$JP-ROCHE-3524963$ROCHE$$9$DEC$E$M$Y$$$20240923$$MD$JP$JP
243507581$24350758$1$I$$20240119$20240923$20240923$PER$$CA-ROCHE-3526293$ROCHE$$$$E$F$Y$64$KG$20240923$$MD$CA$CA
243507591$24350759$1$I$20240307$20240312$20240923$20240923$PER$$CN-ROCHE-3525555$ROCHE$$58$YR$A$M$Y$62$KG$20240923$$HP$CN$CN
243507601$24350760$1$I$20091207$20240304$20240923$20240923$PER$$JP-ROCHE-3526112$ROCHE$$64$YR$A$F$Y$$$20240923$$MD$JP$JP
243507611$24350761$1$I$20240211$20240311$20240923$20240923$PER$$CO-ROCHE-3523506$ROCHE$$57$YR$A$F$Y$57$KG$20240923$$CN$CO$CO
243507621$24350762$1$I$$20240119$20240923$20240923$PER$$CA-ROCHE-3526279$ROCHE$$$$A$F$Y$56$KG$20240923$$MD$CA$CA
243507631$24350763$1$I$$20240122$20240923$20240923$PER$$CA-ROCHE-3525490$ROCHE$$$$A$F$Y$65$KG$20240923$$MD$CA$CA
243507641$24350764$1$I$20240112$20240311$20240923$20240923$PER$$CN-ROCHE-3524819$ROCHE$$49$YR$A$F$Y$52.5$KG$20240923$$HP$CN$CN
243507651$24350765$1$I$20230630$20240311$20240923$20240923$PER$$CN-ROCHE-3526437$ROCHE$$46$YR$A$F$Y$64$KG$20240923$$HP$CN$CN
243507661$24350766$1$I$20240229$20240312$20240923$20240923$PER$$CN-ROCHE-3525600$ROCHE$$75$YR$E$M$Y$59$KG$20240923$$HP$CN$CN
243507671$24350767$1$I$$20240910$20240923$20240923$EXP$$CA-ROCHE-10000085851$ROCHE$$78$YR$E$$Y$93$KG$20240923$$HP$CA$CA
243507681$24350768$1$I$$20240311$20240923$20240923$PER$$US-ROCHE-3526002$ROCHE$$66$YR$E$F$Y$$$20240923$$MD$US$US
243507691$24350769$1$I$20240308$20240312$20240923$20240923$PER$$CN-ROCHE-3525611$ROCHE$$58$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243507701$24350770$1$I$$20240307$20240923$20240923$PER$$PK-ROCHE-3524792$ROCHE$$63$YR$A$F$Y$$$20240923$$CN$PK$PK
243507711$24350771$1$I$$20240312$20240923$20240923$PER$$US-ROCHE-3525832$ROCHE$$$$$F$Y$$$20240923$$MD$US$US
243507721$24350772$1$I$$20240122$20240923$20240923$PER$$CA-ROCHE-3526276$ROCHE$$$$E$F$Y$50$KG$20240923$$MD$CA$CA
243507731$24350773$1$I$$20240310$20240923$20240923$PER$$CN-ROCHE-3524838$ROCHE$$46$YR$A$F$Y$$$20240923$$MD$CN$CN
243507741$24350774$1$I$$20240311$20240923$20240923$PER$$CN-ROCHE-3524849$ROCHE$$41$YR$A$F$Y$$$20240923$$CN$CN$CN
243507751$24350775$1$I$$20240311$20240923$20240923$PER$$US-ROCHE-3524892$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243507761$24350776$1$I$$20240115$20240923$20240923$PER$$CA-ROCHE-3525485$ROCHE$$59$YR$A$F$Y$$$20240923$$MD$CA$CA
243507771$24350777$1$I$20240227$20240312$20240923$20240923$PER$$CN-ROCHE-3525612$ROCHE$$56$YR$A$F$Y$52$KG$20240923$$HP$CN$CN
243507801$24350780$1$I$$20240918$20240923$20240923$EXP$$US-PFIZER INC-PV202400122612$PFIZER$Boitano, L.. The refractory effective of unfractionated heparin during an open aneurysm repair post-andexanet administration: A case report. Annals of Vascular Surgery - Brief Reports and Innovations. 2022;2(2):10.1016/j.avsurg.2022.100080$84$YR$$M$Y$97$KG$20240923$$HP$US$US
243507821$24350782$1$I$$20240912$20240923$20240923$30DAY$$US-PFIZER INC-202400256412$PFIZER$$8$YR$$M$Y$$$20240923$$CN$US$US
243507831$24350783$1$I$$20240918$20240923$20240923$EXP$$US-PFIZER INC-202400084559$PFIZER$$45$YR$$F$Y$48.63$KG$20240923$$MD$US$US
243507841$24350784$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269504$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240923$$HP$US$US
243507881$24350788$1$I$20240101$20240910$20240923$20240923$EXP$$US-APOTEX-2024AP010583$APOTEX$$$$$F$Y$$$20240923$$CN$US$US
243507891$24350789$1$I$20220805$20240918$20240923$20240923$EXP$$CO-UCBSA-2024048699$UCB$$77$YR$$M$Y$$$20240923$$CN$CO$CO
243507901$24350790$1$I$20240814$20240916$20240920$20240920$DIR$FDA-CDER-CTU-2024-64715$$FDA-CTU$$63$YR$$M$N$$$20240916$N$HP$US$
243507911$24350791$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64723$$FDA-CTU$$59$YR$$F$N$$$20240920$N$$US$
243507921$24350792$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024AMR114567$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243507931$24350793$1$I$20240823$20240919$20240923$20240923$EXP$FR-AFSSAPS-AM2024000748$NVSC2024FR187137$NOVARTIS$$32$YR$$M$Y$$$20240923$$PH$FR$FR
243507941$24350794$1$I$$20240311$20240923$20240923$PER$$JP-ROCHE-3528268$ROCHE$Takahashi I, Nakaji Y, Maruyama S, Matsukuma A, Kounoe S. OB13-2 Two cases of HER2 positive unresectable gastric cancer for which trastuzumab deruxtecan was effective. The 96th Annual Meeting of Japanese Gastric Cancer Association. 2024;:345-.$71$YR$E$M$Y$$$20240923$$MD$JP$JP
243507951$24350795$1$I$20240306$20240314$20240923$20240923$PER$$CN-ROCHE-3527293$ROCHE$$62$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243507961$24350796$1$I$$20240313$20240923$20240923$PER$$US-ROCHE-3527813$ROCHE$$$$$M$Y$$$20240923$$HP$US$US
243507971$24350797$1$I$$20240318$20240923$20240923$PER$$KR-ROCHE-3529634$ROCHE$$$$$$Y$$$20240923$$PH$KR$KR
243507981$24350798$1$I$20240220$20240318$20240923$20240923$PER$$CN-ROCHE-3528955$ROCHE$$58$YR$A$F$Y$51$KG$20240923$$HP$CN$CN
243507991$24350799$1$I$20230718$20240314$20240923$20240923$PER$$CN-ROCHE-3527283$ROCHE$$48$YR$A$F$Y$75$KG$20240923$$HP$CN$CN
243508001$24350800$1$I$20201105$20240315$20240923$20240923$PER$PL-URPL-1-3333-2020$PL-ROCHE-3527514$ROCHE$$58$YR$A$F$Y$46$KG$20240923$$MD$PL$PL
243508011$24350801$1$I$$20240917$20240923$20240923$EXP$$VN-ROCHE-10000086855$ROCHE$Hoang B, Chuong N, Luan D. Clinical, para-clinical characteristics and results of treatment of lupus enteritis at university medical center ho chi minh city. Vietnam Medical Journal. 2024-Aug;3:316-25. doi:10.51298/vmj.v541i3.10908.$$$$$Y$$$20240923$$HP$VN$VN
243508021$24350802$1$I$$20240315$20240923$20240923$PER$$CA-ROCHE-3527082$ROCHE$$$$A$F$Y$60$KG$20240923$$MD$CA$CA
243508031$24350803$1$I$20230727$20240314$20240923$20240923$PER$$CN-ROCHE-3527281$ROCHE$$70$YR$E$F$Y$66.5$KG$20240923$$HP$CN$CN
243508041$24350804$1$I$$20240318$20240923$20240923$PER$$ZA-ROCHE-3530137$ROCHE$$$$$F$Y$$$20240923$$CN$ZA$ZA
243508051$24350805$1$I$20221205$20240304$20240923$20240923$PER$$JP-ROCHE-3528002$ROCHE$$67$YR$E$F$Y$$$20240923$$MD$JP$JP
243508061$24350806$1$I$$20240313$20240923$20240923$PER$$BE-ROCHE-3528519$ROCHE$$$$$$Y$$$20240923$$PH$BE$BE
243508071$24350807$1$I$20230222$20240304$20240923$20240923$PER$$JP-ROCHE-3528026$ROCHE$$53$YR$A$F$Y$$$20240923$$MD$JP$JP
243508081$24350808$1$I$20240307$20240313$20240923$20240923$PER$$CN-ROCHE-3526466$ROCHE$$69$YR$E$F$Y$82.5$KG$20240923$$HP$CN$CN
243508091$24350809$1$I$20240205$20240313$20240923$20240923$PER$$CN-ROCHE-3526473$ROCHE$$53$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243508101$24350810$1$I$$20240115$20240923$20240923$PER$$CA-ROCHE-3527074$ROCHE$$$$$F$Y$$$20240923$$MD$CA$CA
243508111$24350811$1$I$20240308$20240314$20240923$20240923$PER$$CN-ROCHE-3527291$ROCHE$$53$YR$A$F$Y$78$KG$20240923$$HP$CN$CN
243508121$24350812$1$I$$20240315$20240923$20240923$PER$$US-ROCHE-3529120$ROCHE$$$$$F$Y$$$20240923$$MD$US$US
243508131$24350813$1$I$20220801$20240304$20240923$20240923$PER$$JP-ROCHE-3528357$ROCHE$$84$YR$E$F$Y$$$20240923$$MD$JP$JP
243508141$24350814$1$I$$20240913$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147234$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240923$$HP$US$US
243508161$24350816$1$I$20240301$20240318$20240923$20240923$PER$$CN-ROCHE-3530672$ROCHE$$84$YR$E$F$Y$55$KG$20240923$$HP$CN$CN
243508171$24350817$1$I$$20240205$20240923$20240923$PER$$CA-ROCHE-3530293$ROCHE$$$$A$F$Y$72$KG$20240923$$MD$CA$CA
243508181$24350818$1$I$20240110$20240319$20240923$20240923$PER$IT-MINISAL02-975501$IT-ROCHE-3528942$ROCHE$$54$YR$A$M$Y$84$KG$20240923$$MD$IT$IT
243508191$24350819$1$I$$20240320$20240923$20240923$PER$$US-ROCHE-3530597$ROCHE$$69$YR$E$F$Y$$$20240923$$HP$US$US
243508201$24350820$1$I$$20240315$20240923$20240923$PER$$IT-ROCHE-3529388$ROCHE$$$$$$Y$$$20240923$$MD$IT$IT
243508211$24350821$1$I$$20240320$20240923$20240923$PER$$US-ROCHE-3530867$ROCHE$$$$A$F$Y$$$20240923$$MD$US$US
243508221$24350822$1$I$20240301$20240321$20240923$20240923$PER$PT-INFARMED-T202403-244$PT-ROCHE-3530799$ROCHE$$53$YR$A$F$Y$90$KG$20240923$$PH$PT$PT
243508231$24350823$1$I$20230628$20240319$20240923$20240923$PER$IT-MINISAL02-975495$IT-ROCHE-3529076$ROCHE$$54$YR$A$M$Y$84$KG$20240923$$MD$IT$IT
243508241$24350824$1$I$$20240319$20240923$20240923$PER$$RU-ROCHE-3520082$ROCHE$$76$YR$E$F$Y$$$20240923$$MD$RU$RU
243508251$24350825$1$I$20210501$20240315$20240923$20240923$PER$FR-AFSSAPS-LL2024000426$FR-ROCHE-3528343$ROCHE$$52$YR$A$F$Y$57$KG$20240923$$MD$FR$FR
243508261$24350826$1$I$20240205$20240312$20240923$20240923$PER$$US-ROCHE-3525646$ROCHE$$$$A$F$Y$69.4$KG$20240923$$CN$US$US
243508271$24350827$1$I$$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188725$AMGEN$$$$A$F$Y$$$20240923$$HP$US$US
243508281$24350828$1$I$$20240412$20240923$20240923$PER$$JP-ROCHE-3527021$ROCHE$$67$YR$E$F$Y$$$20240923$$MD$JP$JP
243508291$24350829$1$I$20200126$20240402$20240923$20240923$PER$$IT-ROCHE-3524257$ROCHE$$40$YR$A$F$Y$$$20240923$$MD$IT$IT
243508301$24350830$1$I$20240917$20240918$20240923$20240923$EXP$$US-BAYER-2024A134269$BAYER$$57$YR$A$M$Y$78.458$KG$20240923$$CN$US$US
243508311$24350831$1$I$20240221$20240531$20240923$20240923$PER$$CA-ROCHE-3515345$ROCHE$$59$YR$A$F$Y$$$20240923$$HP$CA$CA
243508321$24350832$1$I$$20240603$20240923$20240923$PER$$NZ-ROCHE-3529155$ROCHE$$$$$F$Y$$$20240923$$CN$NZ$NZ
243508331$24350833$1$I$20210601$20240514$20240923$20240923$PER$$CO-ROCHE-3522582$ROCHE$$45$YR$A$F$Y$$$20240923$$MD$CO$CO
243508341$24350834$1$I$20240306$20240605$20240923$20240923$PER$$KR-ROCHE-3527046$ROCHE$$68$YR$E$$Y$$$20240923$$MD$KR$KR
243508351$24350835$1$I$20240531$20240910$20240923$20240923$EXP$$US-UCBSA-2024038359$UCB$$29$YR$$F$Y$$$20240923$$CN$US$US
243508361$24350836$1$I$20240801$20240918$20240923$20240923$EXP$$US-ABBVIE-5931046$ABBVIE$$51$YR$$M$Y$$$20240923$$CN$US$US
243508371$24350837$1$I$20240730$20240912$20240923$20240923$EXP$GB-MHRA-MED-202409121738305820-FBWNG$GB-TORRENT-00037959$TORRENT$$72$YR$E$M$Y$$$20240923$$MD$GB$GB
243508381$24350838$1$I$$20240912$20240923$20240923$EXP$GB-MHRA-MED-202409121849111340-YLCMH$GB-TORRENT-00037954$TORRENT$$34$YR$A$F$Y$$$20240923$$CN$GB$GB
243508391$24350839$1$I$$20240913$20240923$20240923$EXP$GB-MHRA-MED-202409132324583640-WTRCD$GB-TORRENT-00037969$TORRENT$$82$YR$E$F$Y$$$20240923$$CN$GB$GB
243508401$24350840$1$I$$20240912$20240923$20240923$EXP$$BR-TORRENT-00006262$TORRENT$$78$YR$E$F$Y$$$20240923$$HP$BR$BR
243508411$24350841$1$I$$20240913$20240923$20240923$EXP$GB-MHRA-MED-202409131731545670-ZPHJS$GB-TORRENT-00037967$TORRENT$$61$YR$A$M$Y$$$20240923$$HP$GB$GB
243508431$24350843$1$I$20240813$20240912$20240923$20240923$EXP$GB-MHRA-MED-202409121833150340-PHTWG$GB-TORRENT-00037973$TORRENT$$71$YR$E$F$Y$64$KG$20240923$$CN$GB$GB
243508441$24350844$1$I$$20240910$20240923$20240923$EXP$$US-TORRENT-00013752$TORRENT$$46$YR$A$M$Y$$$20240923$$CN$US$US
243508461$24350846$1$I$20240901$20240913$20240923$20240923$EXP$$US-TEVA-VS-3244363$TEVA$$$$$F$Y$$$20240923$$CN$US$US
243508481$24350848$1$I$$20240910$20240923$20240923$EXP$$US-Nova Laboratories Limited-2161920$NOVA LABORATORIES$Journal: Cancers?Author: Lucas BJ, Connors JS, Wang H, Conneely S, Cuglievan B, Garcia MB, et al.?Title: Observation and Management of Juvenile Myelomonocytic Leukemia and Noonan Syndrome-Associated Myeloproliferative?Disorder: A Real-World Experience?Volume: 16, 2749 Year: 2024 Pages: 1 to 16$3$YR$$M$Y$$$20240923$$$US$US
243508491$24350849$1$I$$20240916$20240923$20240923$EXP$$MX-ROCHE-10000085264$ROCHE$Hernandez-Lopez A, Reyna-Juarez Y, Ostos-Prado M, Alcala-Carmona B, Torres-Ruiz J, Mendez-Flores S, et al. Anti-synthetase and myelodysplastic syndromes with deep morphea: an example of shared immunopathogenesis? A case-based review. Rheumatology International. 2024; doi:10.1007/s00296-024-05717-y.$57$YR$A$M$Y$$$20240923$$HP$MX$MX
243508501$24350850$1$I$$20240913$20240923$20240923$PER$$US-TEVA-VS-3243846$TEVA$$52$YR$$M$Y$$$20240923$$CN$US$US
243508511$24350851$1$I$20240201$20240913$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147243$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$101.15$KG$20240923$$CN$US$US
243508521$24350852$1$I$20240806$20240916$20240923$20240923$EXP$IT-MINISAL02-1002644$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-148007$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$60$KG$20240923$$MD$IT$IT
243508531$24350853$1$I$$20240916$20240923$20240923$EXP$$US-BAYER-2024A127376$BAYER$$57$YR$A$M$Y$$$20240923$$CN$US$US
243508541$24350854$1$I$$20240920$20240923$20240923$PER$$US-JNJFOC-20240956649$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243508551$24350855$1$I$$20240910$20240923$20240923$EXP$$CA-B.Braun Medical Inc.-2161921$B BRAUN$Literature Article$31$YR$$F$Y$$$20240923$$$CA$CA
243508572$24350857$2$F$$20240927$20240923$20240927$EXP$NL-LRB-01003948$NL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052799$BOEHRINGER INGELHEIM$$86$YR$E$M$Y$83$KG$20240927$$CN$NL$NL
243508581$24350858$1$I$20240920$20240920$20240920$20240920$DIR$719235$$FDA-CTU$$$$$UNK$N$$$20240920$N$$US$
243508591$24350859$1$I$20240920$20240920$20240920$20240920$DIR$719237$$FDA-CTU$$68$YR$$F$N$54.45$KG$20240920$N$$US$
243508621$24350862$1$I$$20240920$20240920$20240920$DIR$719231$$FDA-CTU$$$$$UNK$N$$$20240920$N$CN$US$
243508631$24350863$1$I$20240829$20240920$20240920$20240920$DIR$719248$$FDA-CTU$$71$YR$$M$N$97.5$KG$20240920$N$HP$US$
243508661$24350866$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64726$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243508681$24350868$1$I$20240904$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64708$$FDA-CTU$$35$MON$$F$N$$$20240920$N$HP$US$
243508701$24350870$1$I$$20240913$20240923$20240923$EXP$GB-MHRA-MED-202409131322524410-MCGDB$GB-TEVA-VS-3243576$TEVA$$$$$$Y$$$20240923$$PH$GB$GB
243508711$24350871$1$I$20240101$20240917$20240923$20240923$EXP$$US-OTSUKA-2024_026041$OTSUKA$$$$$M$Y$99.79$KG$20240923$$HP$US$US
243508721$24350872$1$I$$20240918$20240923$20240923$EXP$$EG-TAKEDA-2024TUS093374$TAKEDA$$10$YR$$$Y$$$20240923$$CN$EG$EG
243508731$24350873$1$I$$20240913$20240923$20240923$PER$$US-ABBVIE-5925181$ABBVIE$$$$A$F$Y$$$20240923$$MD$US$US
243508741$24350874$1$I$$20240911$20240923$20240923$EXP$$ZA-GILEAD-2024-0687809$GILEAD$$$$$F$Y$$$20240923$$MD$ZA$ZA
243508751$24350875$1$I$$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64642$$FDA-CTU$$$$$F$N$$$20240919$N$HP$US$
243508761$24350876$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64678$$FDA-CTU$$46$YR$$F$N$79.38$KG$20240920$N$$US$
243508771$24350877$1$I$20180901$20240920$20240920$20240920$DIR$719246$$FDA-CTU$$39$YR$$M$N$92.25$KG$20240920$N$CN$US$
243508781$24350878$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64676$$FDA-CTU$$39$YR$$F$N$180$LBS$20240920$N$$US$
243508791$24350879$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012833$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243508801$24350880$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012952$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240923$$CN$US$US
243508811$24350881$1$I$20240901$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011619$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240923$$CN$US$US
243508821$24350882$1$I$20240919$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012718$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240923$$CN$US$US
243508831$24350883$1$I$20240830$20240918$20240923$20240923$EXP$$TW-ABBVIE-5929687$ABBVIE$$68$YR$$M$Y$71$KG$20240923$$MD$TW$TW
243508841$24350884$1$I$20240901$20240917$20240923$20240923$PER$$US-SA-2024SA270554$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240923$$HP$US$US
243508851$24350885$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64644$$FDA-CTU$$53$YR$$F$N$180$LBS$20240920$N$$US$
243508861$24350886$1$I$20240920$20240920$20240920$20240920$DIR$719249$$FDA-CTU$$31$YR$$M$N$76.5$KG$20240920$N$CN$US$
243508871$24350887$1$I$$20240917$20240923$20240923$EXP$$US-ABBVIE-5929058$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243508881$24350888$1$I$20120701$20240913$20240923$20240923$EXP$$US-JNJFOC-20240940354$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20240923$$LW$US$US
243508891$24350889$1$I$20240918$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64636$$FDA-CTU$$53$YR$$F$N$$$20240920$N$$US$
243508901$24350890$1$I$$20240910$20240923$20240923$PER$$US-SA-2024SA266125$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240923$$MD$US$US
243508911$24350891$1$I$20200621$20240918$20240923$20240923$EXP$FR-AFSSAPS-PC2024000713$FR-JNJFOC-20240959663$JOHNSON AND JOHNSON$$100$YR$E$F$Y$76$KG$20240923$$PH$FR$FR
243508921$24350892$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA274024$SANOFI AVENTIS$$$$T$F$Y$43.09$KG$20240923$$MD$US$US
243508931$24350893$1$I$$20240920$20240920$20240920$DIR$719266$$FDA-CTU$$$$$UNK$N$$$20240920$N$CN$US$
243508951$24350895$1$I$20240801$20240920$20240920$20240920$DIR$719252$$FDA-CTU$$72$YR$$F$N$63.9$KG$20240920$N$HP$US$
243508961$24350896$1$I$$20240321$20240923$20240923$PER$$IR-ROCHE-3531851$ROCHE$$$$$F$Y$$$20240923$$HP$IR$IR
243508971$24350897$1$I$$20240326$20240923$20240923$PER$$KR-ROCHE-3535655$ROCHE$$$$$$Y$$$20240923$$PH$KR$KR
243508981$24350898$1$I$$20240329$20240923$20240923$PER$$CN-ROCHE-3536234$ROCHE$$$$$$Y$$$20240923$$HP$CN$CN
243508991$24350899$1$I$$20240306$20240923$20240923$PER$$JP-ROCHE-3536183$ROCHE$$$$E$F$Y$$$20240923$$MD$JP$JP
243509001$24350900$1$I$$20240329$20240923$20240923$PER$$US-ROCHE-3536492$ROCHE$$65$YR$E$F$Y$$$20240923$$MD$US$US
243509011$24350901$1$I$20240302$20240321$20240923$20240923$PER$$CN-ROCHE-3531771$ROCHE$$56$YR$A$F$Y$57$KG$20240923$$HP$CN$CN
243509021$24350902$1$I$20240301$20240328$20240923$20240923$PER$$CN-ROCHE-3535531$ROCHE$$80$YR$E$F$Y$56$KG$20240923$$HP$CN$CN
243509031$24350903$1$I$$20240320$20240923$20240923$PER$$PK-ROCHE-3532068$ROCHE$$56$YR$A$F$Y$39$KG$20240923$$CN$PK$PK
243509041$24350904$1$I$20240303$20240325$20240923$20240923$PER$$CN-ROCHE-3533191$ROCHE$$46$YR$A$F$Y$57.5$KG$20240923$$HP$CN$CN
243509051$24350905$1$I$20230908$20240326$20240923$20240923$PER$$CN-ROCHE-3534623$ROCHE$$71$YR$E$F$Y$49.5$KG$20240923$$HP$CN$CN
243509061$24350906$1$I$20240321$20240328$20240923$20240923$PER$$CN-ROCHE-3535522$ROCHE$$46$YR$A$F$Y$59$KG$20240923$$HP$CN$CN
243509071$24350907$1$I$$20240321$20240923$20240923$PER$$CA-ROCHE-3531174$ROCHE$Dao A, Chung A and Gray G Metastatic Extramammary Paget^s Disease with near-complete response to trastuzumab and paclitaxel therapy.Doi:10.1007/s00404-024-07418-0. Archives of gynecology and obstetrics 2024 Mar 18;:1-3.$70$YR$E$F$Y$$$20240923$$HP$CA$CA
243509081$24350908$1$I$20240307$20240402$20240923$20240923$PER$IT-MINISAL02-977855$IT-ROCHE-3538118$ROCHE$$39$YR$A$F$Y$52$KG$20240923$$MD$IT$IT
243509091$24350909$1$I$20240314$20240327$20240923$20240923$PER$$CN-ROCHE-3535174$ROCHE$$33$YR$A$F$Y$74$KG$20240923$$HP$CN$CN
243509101$24350910$1$I$20100305$20240328$20240923$20240923$PER$GB-MHRA-MED-202403271437007620-KNJGF$GB-ROCHE-3535649$ROCHE$$64$YR$A$F$Y$$$20240923$$CN$GB$GB
243509111$24350911$1$I$20240321$20240328$20240923$20240923$PER$$CN-ROCHE-3534731$ROCHE$$63$YR$A$M$Y$63$KG$20240923$$HP$CN$CN
243509121$24350912$1$I$$20240301$20240923$20240923$PER$$JP-ROCHE-3532885$ROCHE$$$$A$F$Y$$$20240923$$MD$JP$JP
243509131$24350913$1$I$$20240325$20240923$20240923$PER$PL-URPL-1-3962-2020$PL-ROCHE-3532908$ROCHE$$40$YR$A$F$Y$78$KG$20240923$$HP$PL$PL
243509141$24350914$1$I$$20240911$20240923$20240923$PER$$US-ROCHE-10000083815$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243509151$24350915$1$I$20240229$20240329$20240923$20240923$PER$$CN-ROCHE-3536327$ROCHE$$64$YR$A$M$Y$60$KG$20240923$$HP$CN$CN
243509181$24350918$1$I$$20240318$20240923$20240923$PER$$VN-ROCHE-3531742$ROCHE$$57$YR$A$F$Y$$$20240923$$MD$VN$VN
243509191$24350919$1$I$20240322$20240328$20240923$20240923$PER$$CN-ROCHE-3535434$ROCHE$$56$YR$A$F$Y$50$KG$20240923$$HP$CN$CN
243509201$24350920$1$I$20240201$20240319$20240923$20240923$PER$$CO-ROCHE-3531080$ROCHE$$36$YR$A$F$Y$59$KG$20240923$$CN$CO$CO
243509211$24350921$1$I$20240327$20240329$20240923$20240923$PER$$CN-ROCHE-3536129$ROCHE$$75$YR$E$M$Y$60$KG$20240923$$HP$CN$CN
243509221$24350922$1$I$$20240402$20240923$20240923$PER$$CO-ROCHE-3538135$ROCHE$$60$YR$A$F$Y$$$20240923$$CN$CO$CO
243509231$24350923$1$I$$20240320$20240923$20240923$PER$$US-ROCHE-3531635$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243509241$24350924$1$I$20240916$20240912$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146614$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240923$$CN$US$US
243509251$24350925$1$I$$20240326$20240923$20240923$PER$$CN-ROCHE-3533896$ROCHE$$60$YR$A$F$Y$$$20240923$$MD$CN$CN
243509261$24350926$1$I$$20240307$20240923$20240923$PER$$BR-ROCHE-3531931$ROCHE$$$$$F$Y$$$20240923$$MD$BR$BR
243509271$24350927$1$I$20231206$20240327$20240923$20240923$PER$$CN-ROCHE-3535202$ROCHE$$56$YR$A$F$Y$58$KG$20240923$$HP$CN$CN
243509281$24350928$1$I$20240319$20240321$20240923$20240923$PER$$CN-ROCHE-3531778$ROCHE$$53$YR$A$F$Y$52$KG$20240923$$HP$CN$CN
243509301$24350930$1$I$$20240328$20240923$20240923$PER$$CN-ROCHE-3536347$ROCHE$$65$YR$E$M$Y$$$20240923$$MD$CN$CN
243509311$24350931$1$I$$20240329$20240923$20240923$PER$$US-ROCHE-3535964$ROCHE$$40$YR$A$M$Y$$$20240923$$PH$US$US
243509321$24350932$1$I$$20240327$20240923$20240923$PER$$US-ROCHE-3534751$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243509331$24350933$1$I$$20240327$20240923$20240923$PER$$US-ROCHE-3534907$ROCHE$$48$YR$A$M$Y$$$20240923$$MD$US$US
243509341$24350934$1$I$$20240327$20240923$20240923$PER$$CN-ROCHE-3532826$ROCHE$$74$YR$E$M$Y$$$20240923$$CN$CN$CN
243509351$24350935$1$I$$20240327$20240923$20240923$PER$$US-ROCHE-3534762$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243509361$24350936$1$I$20240314$20240322$20240923$20240923$PER$$CN-ROCHE-3532429$ROCHE$$45$YR$A$F$Y$56$KG$20240923$$HP$CN$CN
243509371$24350937$1$I$20230724$20240325$20240923$20240923$PER$$CN-ROCHE-3533935$ROCHE$$29$YR$A$F$Y$53$KG$20240923$$HP$CN$CN
243509381$24350938$1$I$20240226$20240327$20240923$20240923$PER$$CN-ROCHE-3534536$ROCHE$$60$YR$A$F$Y$74$KG$20240923$$HP$CN$CN
243509391$24350939$1$I$20240103$20240321$20240923$20240923$PER$$DE-ROCHE-3531281$ROCHE$$59$YR$A$M$Y$88$KG$20240923$$MD$DE$DE
243509401$24350940$1$I$$20240328$20240923$20240923$PER$$US-ROCHE-3536114$ROCHE$$$$$$Y$$$20240923$$HP$US$US
243509411$24350941$1$I$$20240328$20240923$20240923$PER$$CN-ROCHE-3535733$ROCHE$$38$YR$A$F$Y$$$20240923$$CN$CN$CN
243509421$24350942$1$I$$20240913$20240923$20240923$EXP$$NVSC2024IT185611$NOVARTIS$Piolatto A, Gaglioti CM, Tesio N, Clemente MG, Culcasi M, Matrone A, et al.. Deferasirox film-coated tablet-associated ulcerative colitis: An emerging pattern in thalassemia patients?. BRITISH JOURNAL OF HAEMATOLOGY. 2024;205 (2):719-21$50$YR$$F$Y$$$20240923$$HP$IT$IT
243509431$24350943$1$I$$20240327$20240923$20240923$PER$$PE-ROCHE-3536524$ROCHE$$36$YR$A$F$Y$$$20240923$$CN$PE$PE
243509441$24350944$1$I$$20240328$20240923$20240923$PER$$MX-ROCHE-3536627$ROCHE$$$$$$Y$$$20240923$$CN$MX$MX
243509451$24350945$1$I$20240312$20240401$20240923$20240923$PER$$CN-ROCHE-3536860$ROCHE$$56$YR$A$F$Y$$$20240923$$HP$CN$CN
243509461$24350946$1$I$20240319$20240401$20240923$20240923$PER$$CN-ROCHE-3536996$ROCHE$$58$YR$A$F$Y$50$KG$20240923$$HP$CN$CN
243509471$24350947$1$I$20240313$20240401$20240923$20240923$PER$$CN-ROCHE-3536870$ROCHE$$49$YR$A$F$Y$66$KG$20240923$$HP$CN$CN
243509481$24350948$1$I$20240327$20240401$20240923$20240923$PER$$CN-ROCHE-3536375$ROCHE$$51$YR$A$F$Y$$$20240923$$HP$CN$CN
243509491$24350949$1$I$$20240328$20240923$20240923$PER$$CN-ROCHE-3536066$ROCHE$$38$YR$A$F$Y$$$20240923$$CN$CN$CN
243509501$24350950$1$I$20240314$20240401$20240923$20240923$PER$$CN-ROCHE-3536861$ROCHE$$67$YR$E$F$Y$$$20240923$$HP$CN$CN
243509511$24350951$1$I$20240311$20240402$20240923$20240923$PER$$CN-ROCHE-3537008$ROCHE$$52$YR$A$M$Y$70$KG$20240923$$HP$CN$CN
243509521$24350952$1$I$$20240916$20240923$20240923$EXP$$RS-ROCHE-10000085579$ROCHE$$38$YR$A$F$Y$$$20240923$$MD$RS$RS
243509531$24350953$1$I$20240219$20240401$20240923$20240923$PER$$CN-ROCHE-3537006$ROCHE$$52$YR$A$F$Y$$$20240923$$HP$CN$CN
243509541$24350954$1$I$20240125$20240402$20240923$20240923$PER$IT-MINISAL02-977848$IT-ROCHE-3537137$ROCHE$$65$YR$E$F$Y$$$20240923$$MD$IT$IT
243509551$24350955$1$I$20230413$20240401$20240923$20240923$PER$$KR-ROCHE-3537243$ROCHE$$65$YR$E$F$Y$63$KG$20240923$$HP$KR$KR
243509561$24350956$1$I$20240827$20240910$20240923$20240923$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00886$Phathom Pharmaceuticals$$7$DEC$$M$Y$$$20240923$$MD$JP$JP
243509571$24350957$1$I$$20240916$20240923$20240923$EXP$$GB-MYLANLABS-2024M1085089$MYLAN$$$$$M$Y$$$20240923$$CN$GB$GB
243509581$24350958$1$I$$20240916$20240923$20240923$EXP$$US-MYLANLABS-2024M1043766$MYLAN$$$$$F$Y$91.218$KG$20240923$$HP$US$US
243509601$24350960$1$I$20221130$20240401$20240923$20240923$PER$$KR-ROCHE-3537494$ROCHE$$44$YR$A$F$Y$69$KG$20240923$$HP$KR$KR
243509611$24350961$1$I$20221216$20240401$20240923$20240923$PER$$KR-ROCHE-3537554$ROCHE$$78$YR$E$F$Y$48$KG$20240923$$HP$KR$KR
243509621$24350962$1$I$20221221$20240401$20240923$20240923$PER$$KR-ROCHE-3537556$ROCHE$$44$YR$A$F$Y$69$KG$20240923$$HP$KR$KR
243509631$24350963$1$I$20240320$20240401$20240923$20240923$PER$$CN-ROCHE-3537379$ROCHE$$83$YR$E$F$Y$50$KG$20240923$$HP$CN$CN
243509641$24350964$1$I$20221222$20240401$20240923$20240923$PER$$KR-ROCHE-3537569$ROCHE$$61$YR$A$F$Y$$$20240923$$HP$KR$KR
243509651$24350965$1$I$20221119$20240401$20240923$20240923$PER$$KR-ROCHE-3537536$ROCHE$$60$YR$A$F$Y$$$20240923$$HP$KR$KR
243509661$24350966$1$I$20221102$20240401$20240923$20240923$PER$$KR-ROCHE-3537731$ROCHE$$43$YR$A$F$Y$$$20240923$$HP$KR$KR
243509671$24350967$1$I$20221227$20240401$20240923$20240923$PER$$KR-ROCHE-3537708$ROCHE$$57$YR$A$F$Y$51.8$KG$20240923$$HP$KR$KR
243509681$24350968$1$I$20221130$20240401$20240923$20240923$PER$$KR-ROCHE-3537728$ROCHE$$52$YR$A$F$Y$$$20240923$$HP$KR$KR
243509691$24350969$1$I$20221216$20240401$20240923$20240923$PER$$KR-ROCHE-3537562$ROCHE$$45$YR$A$F$Y$54$KG$20240923$$HP$KR$KR
243509701$24350970$1$I$20221201$20240401$20240923$20240923$PER$$KR-ROCHE-3537737$ROCHE$$64$YR$A$F$Y$$$20240923$$HP$KR$KR
243509711$24350971$1$I$20221107$20240401$20240923$20240923$PER$$KR-ROCHE-3537723$ROCHE$$54$YR$A$F$Y$$$20240923$$CN$KR$KR
243509721$24350972$1$I$20221221$20240401$20240923$20240923$PER$$KR-ROCHE-3537748$ROCHE$$66$YR$E$F$Y$$$20240923$$HP$KR$KR
243509731$24350973$1$I$20221208$20240401$20240923$20240923$PER$$KR-ROCHE-3537740$ROCHE$$57$YR$A$F$Y$$$20240923$$HP$KR$KR
243509741$24350974$1$I$$20240329$20240923$20240923$PER$$US-ROCHE-3537744$ROCHE$$$$A$F$Y$$$20240923$$MD$US$US
243509751$24350975$1$I$20221221$20240401$20240923$20240923$PER$$KR-ROCHE-3537709$ROCHE$$52$YR$A$F$Y$$$20240923$$HP$KR$KR
243509771$24350977$1$I$20230104$20240401$20240923$20240923$PER$$KR-ROCHE-3537806$ROCHE$$56$YR$A$F$Y$$$20240923$$HP$KR$KR
243509781$24350978$1$I$20230119$20240401$20240923$20240923$PER$$KR-ROCHE-3537758$ROCHE$$46$YR$A$F$Y$55$KG$20240923$$HP$KR$KR
243509791$24350979$1$I$20221129$20240401$20240923$20240923$PER$$KR-ROCHE-3537745$ROCHE$$62$YR$A$F$Y$$$20240923$$HP$KR$KR
243509801$24350980$1$I$20230102$20240401$20240923$20240923$PER$$KR-ROCHE-3537750$ROCHE$$54$YR$A$M$Y$76.5$KG$20240923$$HP$KR$KR
243509811$24350981$1$I$20220626$20240401$20240923$20240923$PER$$KR-ROCHE-3537805$ROCHE$$56$YR$A$F$Y$63.3$KG$20240923$$HP$KR$KR
243509821$24350982$1$I$20240710$20240920$20240920$20240920$DIR$719269$$FDA-CTU$$58$YR$$F$N$76.5$KG$20240920$N$HP$US$
243509831$24350983$1$I$$20240330$20240923$20240923$PER$$JP-ROCHE-3535849$ROCHE$$$$$$Y$$$20240923$$HP$JP$JP
243509841$24350984$1$I$20220714$20240401$20240923$20240923$PER$$KR-ROCHE-3537772$ROCHE$$70$YR$E$F$Y$$$20240923$$HP$KR$KR
243509851$24350985$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268791$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240923$$MD$US$US
243509861$24350986$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64645$$FDA-CTU$$74$YR$$F$N$165$LBS$20240920$N$$US$
243509871$24350987$1$I$20230116$20240401$20240923$20240923$PER$$KR-ROCHE-3537789$ROCHE$$52$YR$A$F$Y$$$20240923$$HP$KR$KR
243509881$24350988$1$I$20240826$20240920$20240920$20240920$DIR$719254$$FDA-CTU$$55$YR$$F$N$78$KG$20240920$N$HP$US$
243509891$24350989$1$I$20240904$20240920$20240920$20240920$DIR$719268$$FDA-CTU$$56$YR$$M$N$107.55$KG$20240920$N$CN$US$
243509901$24350990$1$I$20240701$20240916$20240923$20240923$PER$$US-SA-2024SA268772$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240923$$HP$US$US
243509911$24350991$1$I$$20240905$20240923$20240923$PER$$US-SA-2024SA272924$SANOFI AVENTIS$$$$A$F$Y$75$KG$20240923$$MD$US$US
243509921$24350992$1$I$20240622$20240916$20240923$20240923$EXP$$NVSC2024BR134618$NOVARTIS$$37$YR$$M$Y$83$KG$20240923$$HP$BR$BR
243509931$24350993$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64650$$FDA-CTU$$47$YR$$F$N$$$20240920$N$$US$
243509941$24350994$1$I$20240730$20240920$20240920$20240920$DIR$719276$$FDA-CTU$$70$YR$$M$N$94.5$KG$20240920$N$CN$US$
243509961$24350996$1$I$20240726$20240916$20240923$20240923$EXP$FR-AFSSAPS-GR2024001087$FR-Waylis Therapeutics LLC-ATNAHS20240902630$Waylis$$21$YR$A$M$Y$86$KG$20240923$$PH$FR$FR
243509981$24350998$1$I$20230203$20240401$20240923$20240923$PER$$KR-ROCHE-3537963$ROCHE$$63$YR$A$M$Y$73.95$KG$20240923$$HP$KR$KR
243509991$24350999$1$I$20230112$20240401$20240923$20240923$PER$$KR-ROCHE-3537974$ROCHE$$62$YR$A$F$Y$$$20240923$$HP$KR$KR
243510001$24351000$1$I$20230220$20240401$20240923$20240923$PER$$KR-ROCHE-3537973$ROCHE$$50$YR$A$F$Y$$$20240923$$HP$KR$KR
243510011$24351001$1$I$20230125$20240401$20240923$20240923$PER$$KR-ROCHE-3537956$ROCHE$$61$YR$A$F$Y$66$KG$20240923$$HP$KR$KR
243510021$24351002$1$I$20230222$20240401$20240923$20240923$PER$$KR-ROCHE-3537989$ROCHE$$61$YR$A$F$Y$$$20240923$$HP$KR$KR
243510031$24351003$1$I$20230225$20240401$20240923$20240923$PER$$KR-ROCHE-3537982$ROCHE$$61$YR$A$F$Y$$$20240923$$HP$KR$KR
243510041$24351004$1$I$20230130$20240401$20240923$20240923$PER$$KR-ROCHE-3537808$ROCHE$$46$YR$A$F$Y$55$KG$20240923$$HP$KR$KR
243510051$24351005$1$I$$20240331$20240923$20240923$PER$$RU-ROCHE-3532446$ROCHE$$37$YR$A$F$Y$$$20240923$$MD$RU$RU
243510061$24351006$1$I$20180910$20240201$20240923$20240923$PER$$BG-ROCHE-2210730$ROCHE$$67$YR$E$F$Y$49$KG$20240923$$MD$BG$BG
243510071$24351007$1$I$20230112$20240401$20240923$20240923$PER$$KR-ROCHE-3537952$ROCHE$$77$YR$E$M$Y$47.6$KG$20240923$$HP$KR$KR
243510081$24351008$1$I$20220801$20240401$20240923$20240923$PER$$KR-ROCHE-3537988$ROCHE$$54$YR$A$F$Y$$$20240923$$HP$KR$KR
243510091$24351009$1$I$20210707$20231031$20240923$20240923$PER$$EG-ROCHE-2871830$ROCHE$$35$YR$A$F$Y$$$20240923$$MD$EG$EG
243510101$24351010$1$I$$20231205$20240923$20240923$PER$$US-ROCHE-2977323$ROCHE$$75$YR$E$F$Y$$$20240923$$HP$US$US
243510111$24351011$1$I$20240117$20240402$20240923$20240923$PER$IT-MINISAL02-977020$IT-ROCHE-3534371$ROCHE$$46$YR$A$F$Y$$$20240923$$MD$IT$IT
243510121$24351012$1$I$20191120$20231023$20240923$20240923$PER$$AT-ROCHE-2637400$ROCHE$$82$YR$E$F$Y$70$KG$20240923$$MD$AT$AT
243510131$24351013$1$I$20231101$20240923$20240923$20240923$EXP$FR-AFSSAPS-DJ2024001013$FR-ROCHE-10000088613$ROCHE$$78$YR$E$F$Y$56$KG$20240923$$MD$FR$FR
243510141$24351014$1$I$20190309$20231110$20240923$20240923$PER$$EG-ROCHE-2622119$ROCHE$$58$YR$A$F$Y$$$20240923$$MD$EG$EG
243510151$24351015$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010505$APOTEX$$52$YR$$F$Y$$$20240923$$HP$CA$CA
243510161$24351016$1$I$$20240913$20240923$20240923$PER$$US-MYLANLABS-2024M1085091$MYLAN$$$$$M$Y$$$20240923$$CN$US$US
243510181$24351018$1$I$20210429$20231004$20240923$20240923$PER$$PT-ROCHE-2883969$ROCHE$$57$YR$A$F$Y$62$KG$20240923$$MD$PT$PT
243510192$24351019$2$F$20240424$20240916$20240923$20240924$EXP$$US-INCYTE CORPORATION-2024IN009997$INCYTE$$$$$$Y$$$20240924$$HP$US$US
243510201$24351020$1$I$20240614$20240819$20240923$20240923$EXP$$JP-GALDERMA-JP2024010085$GALDERMA$$$$$$Y$$$20240923$$PH$JP$JP
243510211$24351021$1$I$20230331$20240401$20240923$20240923$PER$$KR-ROCHE-3538017$ROCHE$$54$YR$A$F$Y$63$KG$20240923$$HP$KR$KR
243510221$24351022$1$I$$20240402$20240923$20240923$PER$$GB-ROCHE-3538125$ROCHE$$$$$$Y$$$20240923$$PH$GB$GB
243510231$24351023$1$I$20230303$20240401$20240923$20240923$PER$$KR-ROCHE-3538006$ROCHE$$77$YR$E$F$Y$71$KG$20240923$$HP$KR$KR
243510241$24351024$1$I$$20240401$20240923$20240923$PER$$RU-ROCHE-3538084$ROCHE$$52$YR$A$F$Y$$$20240923$$MD$RU$RU
243510251$24351025$1$I$20240126$20240402$20240923$20240923$PER$IT-MINISAL02-977827$IT-ROCHE-3538115$ROCHE$$63$YR$A$F$Y$$$20240923$$MD$IT$IT
243510261$24351026$1$I$20230111$20240401$20240923$20240923$PER$$KR-ROCHE-3537996$ROCHE$$45$YR$A$F$Y$70$KG$20240923$$HP$KR$KR
243510271$24351027$1$I$20230309$20240401$20240923$20240923$PER$$KR-ROCHE-3538008$ROCHE$$71$YR$E$F$Y$$$20240923$$HP$KR$KR
243510281$24351028$1$I$20200801$20240117$20240923$20240923$PER$$AT-ROCHE-2877918$ROCHE$$84$YR$E$F$Y$82$KG$20240923$$MD$AT$AT
243510291$24351029$1$I$$20240403$20240923$20240923$PER$$US-ROCHE-3538297$ROCHE$$$$$$Y$$$20240923$$PH$US$US
243510301$24351030$1$I$20190601$20240205$20240923$20240923$PER$$AT-ROCHE-2543814$ROCHE$$64$YR$A$F$Y$80.4$KG$20240923$$MD$AT$AT
243510311$24351031$1$I$20200503$20240118$20240923$20240923$PER$$AT-ROCHE-2612941$ROCHE$$63$YR$A$F$Y$55$KG$20240923$$MD$AT$AT
243510321$24351032$1$I$20181109$20240315$20240923$20240923$PER$$RO-ROCHE-2519348$ROCHE$$85$YR$E$F$Y$85$KG$20240923$$MD$RO$RO
243510331$24351033$1$I$20230309$20240401$20240923$20240923$PER$$KR-ROCHE-3538314$ROCHE$$74$YR$E$F$Y$$$20240923$$HP$KR$KR
243510341$24351034$1$I$20230412$20240401$20240923$20240923$PER$$KR-ROCHE-3538011$ROCHE$$58$YR$A$F$Y$69$KG$20240923$$HP$KR$KR
243510351$24351035$1$I$20230220$20240401$20240923$20240923$PER$$KR-ROCHE-3538000$ROCHE$$57$YR$A$M$Y$61$KG$20240923$$HP$KR$KR
243510361$24351036$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114214$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243510371$24351037$1$I$20230227$20240401$20240923$20240923$PER$$KR-ROCHE-3538003$ROCHE$$53$YR$A$F$Y$$$20240923$$HP$KR$KR
243510381$24351038$1$I$20240101$20240917$20240923$20240923$EXP$$US-ABBVIE-5929970$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243510391$24351039$1$I$20230321$20240401$20240923$20240923$PER$$KR-ROCHE-3538372$ROCHE$$54$YR$A$F$Y$$$20240923$$HP$KR$KR
243510401$24351040$1$I$$20240912$20240923$20240923$PER$$US-INCYTE CORPORATION-2024IN009700$INCYTE$$$$$$Y$$$20240923$$CN$US$US
243510411$24351041$1$I$20200615$20240117$20240923$20240923$PER$$AT-ROCHE-2788134$ROCHE$$44$YR$A$F$Y$58$KG$20240923$$MD$AT$AT
243510421$24351042$1$I$20200224$20240117$20240923$20240923$PER$$AT-ROCHE-2788580$ROCHE$$68$YR$E$M$Y$93$KG$20240923$$MD$AT$AT
243510431$24351043$1$I$20230222$20240401$20240923$20240923$PER$$KR-ROCHE-3538337$ROCHE$$34$YR$A$F$Y$54.1$KG$20240923$$HP$KR$KR
243510441$24351044$1$I$20230320$20240401$20240923$20240923$PER$$KR-ROCHE-3538367$ROCHE$$73$YR$E$F$Y$60$KG$20240923$$HP$KR$KR
243510451$24351045$1$I$20191231$20240401$20240923$20240923$PER$$KR-ROCHE-3538373$ROCHE$$70$YR$E$F$Y$$$20240923$$PH$KR$KR
243510461$24351046$1$I$20210825$20231219$20240923$20240923$PER$$CO-ROCHE-2963427$ROCHE$$63$YR$A$F$Y$$$20240923$$MD$CO$CO
243510471$24351047$1$I$20190401$20240205$20240923$20240923$PER$$AT-ROCHE-2544127$ROCHE$$64$YR$A$F$Y$80.4$KG$20240923$$MD$AT$AT
243510481$24351048$1$I$20230329$20240401$20240923$20240923$PER$$KR-ROCHE-3538386$ROCHE$$50$YR$A$F$Y$$$20240923$$HP$KR$KR
243510491$24351049$1$I$20230227$20240401$20240923$20240923$PER$$KR-ROCHE-3538352$ROCHE$$51$YR$A$F$Y$$$20240923$$HP$KR$KR
243510501$24351050$1$I$20230323$20240401$20240923$20240923$PER$$KR-ROCHE-3538376$ROCHE$$60$YR$A$F$Y$$$20240923$$HP$KR$KR
243510511$24351051$1$I$20230327$20240401$20240923$20240923$PER$$KR-ROCHE-3538365$ROCHE$$69$YR$E$F$Y$$$20240923$$HP$KR$KR
243510521$24351052$1$I$20230128$20240401$20240923$20240923$PER$$KR-ROCHE-3538351$ROCHE$$39$YR$A$F$Y$$$20240923$$HP$KR$KR
243510531$24351053$1$I$20200315$20240314$20240923$20240923$PER$$IT-ROCHE-2608878$ROCHE$$37$YR$A$F$Y$64$KG$20240923$$MD$IT$IT
243510541$24351054$1$I$20230202$20240401$20240923$20240923$PER$$KR-ROCHE-3538350$ROCHE$$53$YR$A$M$Y$$$20240923$$HP$KR$KR
243510551$24351055$1$I$20230309$20240401$20240923$20240923$PER$$KR-ROCHE-3538349$ROCHE$$51$YR$A$F$Y$$$20240923$$HP$KR$KR
243510561$24351056$1$I$20230315$20240401$20240923$20240923$PER$$KR-ROCHE-3538385$ROCHE$$63$YR$A$F$Y$$$20240923$$HP$KR$KR
243510571$24351057$1$I$$20240921$20240923$20240923$EXP$$NVSC2024US188471$NOVARTIS$$$$I$M$Y$$$20240923$$CN$US$US
243510581$24351058$1$I$20230313$20240401$20240923$20240923$PER$$KR-ROCHE-3538360$ROCHE$$43$YR$A$F$Y$61$KG$20240923$$HP$KR$KR
243510591$24351059$1$I$20230912$20240402$20240923$20240923$PER$$DE-ROCHE-3538049$ROCHE$$59$YR$A$F$Y$$$20240923$$MD$DE$DE
243510601$24351060$1$I$20230320$20240401$20240923$20240923$PER$$KR-ROCHE-3538334$ROCHE$$54$YR$A$F$Y$$$20240923$$HP$KR$KR
243510611$24351061$1$I$20230412$20240401$20240923$20240923$PER$$KR-ROCHE-3538479$ROCHE$$59$YR$A$F$Y$$$20240923$$HP$KR$KR
243510621$24351062$1$I$20211018$20240401$20240923$20240923$PER$$KR-ROCHE-3538392$ROCHE$$72$YR$E$M$Y$60$KG$20240923$$HP$KR$KR
243510631$24351063$1$I$$20240920$20240920$20240920$DIR$719275$$FDA-CTU$$$$$UNK$N$$$20240920$$CN$US$
243510641$24351064$1$I$20190708$20240117$20240923$20240923$PER$$AT-ROCHE-2788542$ROCHE$$67$YR$E$M$Y$93$KG$20240923$$MD$AT$AT
243510651$24351065$1$I$20230315$20240401$20240923$20240923$PER$$KR-ROCHE-3538332$ROCHE$$63$YR$A$F$Y$$$20240923$$HP$KR$KR
243510661$24351066$1$I$20230417$20240401$20240923$20240923$PER$$KR-ROCHE-3538437$ROCHE$$70$YR$E$M$Y$44$KG$20240923$$HP$KR$KR
243510671$24351067$1$I$20230117$20240401$20240923$20240923$PER$$KR-ROCHE-3537944$ROCHE$$68$YR$E$F$Y$55.5$KG$20240923$$HP$KR$KR
243510681$24351068$1$I$20240830$20240920$20240920$20240920$DIR$719293$$FDA-CTU$$69$YR$$F$N$83.25$KG$20240920$N$CN$US$
243510691$24351069$1$I$20180402$20240227$20240923$20240923$PER$$BG-ROCHE-2320924$ROCHE$$56$YR$A$F$Y$62$KG$20240923$$HP$BG$BG
243510701$24351070$1$I$20191211$20240117$20240923$20240923$PER$$AT-ROCHE-2764458$ROCHE$$82$YR$E$F$Y$70$KG$20240923$$MD$AT$AT
243510711$24351071$1$I$20230417$20240401$20240923$20240923$PER$$KR-ROCHE-3538416$ROCHE$$61$YR$A$F$Y$59$KG$20240923$$HP$KR$KR
243510721$24351072$1$I$20200515$20240123$20240923$20240923$PER$$BG-ROCHE-2665380$ROCHE$$64$YR$A$F$Y$64$KG$20240923$$MD$BG$BG
243510731$24351073$1$I$$20240909$20240920$20240920$DIR$FDA-CDER-CTU-2024-64732$$FDA-CTU$$$$$F$N$$$20240909$N$HP$US$
243510741$24351074$1$I$$20240913$20240923$20240923$EXP$DE-EMBRYOTOX-202301709$DE-ROCHE-10000081745$ROCHE$$$$A$F$Y$55$KG$20240923$$MD$DE$DE
243510751$24351075$1$I$$20240402$20240923$20240923$PER$$US-ROCHE-3538148$ROCHE$$47$YR$A$F$Y$$$20240923$$PH$US$US
243510761$24351076$1$I$20230412$20240401$20240923$20240923$PER$$KR-ROCHE-3538415$ROCHE$$65$YR$E$F$Y$58$KG$20240923$$HP$KR$KR
243510771$24351077$1$I$20201118$20240222$20240923$20240923$PER$$PT-ROCHE-2813654$ROCHE$$56$YR$A$F$Y$56.8$KG$20240923$$MD$PT$PT
243510781$24351078$1$I$20230227$20240401$20240923$20240923$PER$$KR-ROCHE-3538359$ROCHE$$46$YR$A$F$Y$$$20240923$$HP$KR$KR
243510791$24351079$1$I$20240819$20240920$20240920$20240920$DIR$719250$$FDA-CTU$$52$YR$$M$N$90$KG$20240920$N$CN$US$
243510801$24351080$1$I$20190901$20240108$20240923$20240923$PER$$IT-ROCHE-2495084$ROCHE$$68$YR$E$F$Y$78$KG$20240923$$MD$IT$IT
243510821$24351082$1$I$20240905$20240914$20240923$20240923$EXP$$CN-BAUSCHBL-2024BNL033486$BAUSCH AND LOMB$$58$YR$$F$Y$$$20240923$$HP$CN$CN
243510831$24351083$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188955$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243510842$24351084$2$F$$20240919$20240923$20240926$PER$$US-AMGEN-USASP2024187695$AMGEN$$$$$$Y$$$20240926$$MD$US$US
243510851$24351085$1$I$$20240916$20240923$20240923$PER$$US-MYLANLABS-2024M1084741$MYLAN$$$$$F$Y$$$20240923$$CN$US$US
243510861$24351086$1$I$$20240916$20240923$20240923$PER$$US-ABBVIE-5928281$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243510871$24351087$1$I$20230504$20240401$20240923$20240923$PER$$KR-ROCHE-3538499$ROCHE$$62$YR$A$F$Y$55.7$KG$20240923$$HP$KR$KR
243510881$24351088$1$I$$20240118$20240923$20240923$PER$$RO-ROCHE-2561415$ROCHE$$54$YR$A$F$Y$93$KG$20240923$$CN$RO$RO
243510891$24351089$1$I$$20240405$20240923$20240923$PER$$PE-ROCHE-3538198$ROCHE$$47$YR$A$F$Y$52$KG$20240923$$CN$PE$PE
243510901$24351090$1$I$20230524$20240401$20240923$20240923$PER$$KR-ROCHE-3538509$ROCHE$$40$YR$A$F$Y$45$KG$20240923$$HP$KR$KR
243510911$24351091$1$I$20230601$20240401$20240923$20240923$PER$$KR-ROCHE-3538516$ROCHE$$42$YR$A$F$Y$$$20240923$$HP$KR$KR
243510921$24351092$1$I$20230509$20240401$20240923$20240923$PER$$KR-ROCHE-3538482$ROCHE$$57$YR$A$F$Y$$$20240923$$HP$KR$KR
243510931$24351093$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3536260$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243510941$24351094$1$I$20230511$20240401$20240923$20240923$PER$$KR-ROCHE-3538489$ROCHE$$60$YR$A$F$Y$69$KG$20240923$$HP$KR$KR
243510951$24351095$1$I$20230418$20240401$20240923$20240923$PER$$KR-ROCHE-3538486$ROCHE$$51$YR$A$F$Y$49$KG$20240923$$HP$KR$KR
243510961$24351096$1$I$20200615$20240117$20240923$20240923$PER$$AT-ROCHE-2789990$ROCHE$$61$YR$A$F$Y$65$KG$20240923$$MD$AT$AT
243510971$24351097$1$I$20181221$20240319$20240923$20240923$PER$$IT-ROCHE-2324392$ROCHE$$36$YR$A$F$Y$75$KG$20240923$$MD$IT$IT
243510981$24351098$1$I$20230516$20240401$20240923$20240923$PER$$KR-ROCHE-3538493$ROCHE$$58$YR$A$F$Y$$$20240923$$HP$KR$KR
243510991$24351099$1$I$20230419$20240401$20240923$20240923$PER$$KR-ROCHE-3538508$ROCHE$$65$YR$E$F$Y$$$20240923$$HP$KR$KR
243511001$24351100$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537087$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511011$24351101$1$I$$20240129$20240923$20240923$PER$$US-ROCHE-2862930$ROCHE$$53$YR$A$F$Y$76.66$KG$20240923$$MD$US$US
243511021$24351102$1$I$20190326$20231120$20240923$20240923$PER$$PT-ROCHE-2315385$ROCHE$$50$YR$A$F$Y$69$KG$20240923$$MD$PT$PT
243511031$24351103$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270326$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240923$$MD$US$US
243511042$24351104$2$F$20240907$20240909$20240923$20240924$PER$$US-SA-2024SA271476$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240924$$HP$US$US
243511051$24351105$1$I$20230201$20240910$20240923$20240923$PER$$US-SA-2024SA273024$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240923$$CN$US$US
243511061$24351106$1$I$20180409$20240205$20240923$20240923$PER$$IT-ROCHE-2220356$ROCHE$$64$YR$A$F$Y$75$KG$20240923$$MD$IT$IT
243511081$24351108$1$I$20240705$20240905$20240923$20240923$PER$$US-SA-2024SA272966$SANOFI AVENTIS$$46$YR$A$F$Y$94.09$KG$20240923$$MD$US$US
243511091$24351109$1$I$20240101$20240918$20240923$20240923$EXP$$US-SA-2024SA273925$SANOFI AVENTIS$$54$YR$A$F$Y$79.37$KG$20240923$$MD$US$US
243511101$24351110$1$I$20240909$20240912$20240923$20240923$PER$$US-BIOGEN-2024BI01282624$BIOGEN$$22$YR$$F$Y$$$20240923$$CN$US$US
243511111$24351111$1$I$20240828$20240828$20240923$20240923$PER$$US-CSL-2024-008171$CSL Plasma$$42$YR$$F$Y$$$20240923$$HP$US$US
243511121$24351112$1$I$$20240918$20240923$20240923$EXP$$US-BAYER-2024A133608$BAYER$$88$YR$E$M$Y$$$20240923$$CN$US$US
243511141$24351114$1$I$20240701$20240913$20240923$20240923$EXP$$BR-JNJFOC-20240941106$JOHNSON AND JOHNSON$$76$YR$E$M$Y$75$KG$20240923$$CN$BR$BR
243511151$24351115$1$I$20240101$20240920$20240923$20240923$PER$$US-JNJFOC-20240956648$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243511161$24351116$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537058$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511171$24351117$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537071$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511181$24351118$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537056$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511191$24351119$1$I$20210623$20231204$20240923$20240923$PER$$AR-ROCHE-2955671$ROCHE$$41$YR$A$F$Y$$$20240923$$MD$AR$AR
243511201$24351120$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537088$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511221$24351122$1$I$20200810$20240305$20240923$20240923$PER$$IT-ROCHE-2727644$ROCHE$$52$YR$A$F$Y$60$KG$20240923$$MD$IT$IT
243511231$24351123$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537060$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511241$24351124$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537057$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511251$24351125$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537072$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511261$24351126$1$I$20201215$20240117$20240923$20240923$PER$$BG-ROCHE-2830935$ROCHE$$70$YR$E$F$Y$49$KG$20240923$$MD$BG$BG
243511271$24351127$1$I$20190520$20231123$20240923$20240923$PER$$AT-ROCHE-2789456$ROCHE$$38$YR$A$F$Y$$$20240923$$MD$AT$AT
243511281$24351128$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537089$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511291$24351129$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537059$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511301$24351130$1$I$20190814$20231109$20240923$20240923$PER$$BG-ROCHE-2505199$ROCHE$$64$YR$A$F$Y$55$KG$20240923$$MD$BG$BG
243511311$24351131$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537073$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511321$24351132$1$I$20210719$20231205$20240923$20240923$PER$$CY-ROCHE-2914026$ROCHE$$36$YR$A$F$Y$74$KG$20240923$$MD$CY$CY
243511331$24351133$1$I$$20240919$20240923$20240923$EXP$$US-GILEAD-2024-0688364$GILEAD$$71$YR$E$M$Y$$$20240923$$MD$US$US
243511341$24351134$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537075$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511361$24351136$1$I$20180817$20240306$20240923$20240923$PER$$AT-ROCHE-2188909$ROCHE$$78$YR$E$F$Y$48$KG$20240923$$MD$AT$AT
243511381$24351138$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537067$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511391$24351139$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537079$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511401$24351140$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537078$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511411$24351141$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537077$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511421$24351142$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537074$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511431$24351143$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537061$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511441$24351144$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537081$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511451$24351145$1$I$20181115$20231121$20240923$20240923$PER$$AT-ROCHE-2239109$ROCHE$$70$YR$E$F$Y$52$KG$20240923$$MD$AT$AT
243511461$24351146$1$I$20180315$20240117$20240923$20240923$PER$$AT-ROCHE-2102044$ROCHE$$75$YR$E$F$Y$105$KG$20240923$$MD$AT$AT
243511471$24351147$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537062$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511481$24351148$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537065$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511491$24351149$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537076$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511501$24351150$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537063$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511511$24351151$1$I$20240905$20240919$20240923$20240923$EXP$$US-BAYER-2024A134855$BAYER$$85$YR$E$F$Y$$$20240923$$CN$US$US
243511521$24351152$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537093$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511531$24351153$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537084$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511561$24351156$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537090$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511571$24351157$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537095$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511581$24351158$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537096$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511591$24351159$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537086$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511601$24351160$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537082$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511611$24351161$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537094$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511621$24351162$1$I$20240107$20240920$20240920$20240920$DIR$719287$$FDA-CTU$$45$YR$$F$N$85.5$KG$20240920$N$CN$US$
243511631$24351163$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64639$$FDA-CTU$$62$YR$$M$N$$$20240920$N$$US$
243511641$24351164$1$I$$20240920$20240920$20240920$DIR$719258$$FDA-CTU$$$$$UNK$N$$$20240920$$CN$US$
243511651$24351165$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537083$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511661$24351166$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537085$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511671$24351167$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187564$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243511682$24351168$2$F$20240918$20240926$20240923$20240927$PER$$US-AMGEN-USASP2024187637$AMGEN$$93$YR$E$M$Y$$$20240927$$CN$US$US
243511701$24351170$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64709$$FDA-CTU$$75$YR$$F$N$195$LBS$20240920$N$$US$
243511711$24351171$1$I$20191215$20240205$20240923$20240923$PER$$AT-ROCHE-2565692$ROCHE$$62$YR$A$F$Y$80.4$KG$20240923$$MD$AT$AT
243511721$24351172$1$I$20170104$20240109$20240923$20240923$PER$$CY-ROCHE-2682855$ROCHE$$68$YR$E$F$Y$64$KG$20240923$$MD$CY$CY
243511731$24351173$1$I$20190429$20240118$20240923$20240923$PER$$AT-ROCHE-2320209$ROCHE$$67$YR$E$F$Y$89$KG$20240923$$MD$AT$AT
243511741$24351174$1$I$20191017$20240213$20240923$20240923$PER$$IT-ROCHE-2485370$ROCHE$$68$YR$E$F$Y$78$KG$20240923$$MD$IT$IT
243511751$24351175$1$I$20240917$20240920$20240920$20240920$DIR$719283$$FDA-CTU$$82$YR$$F$N$41.85$KG$20240920$N$CN$US$
243511761$24351176$1$I$20240913$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64665$$FDA-CTU$$52$YR$$F$N$115$KG$20240920$Y$PH$US$
243511771$24351177$1$I$$20240917$20240920$20240920$DIR$FDA-CDER-CTU-2024-64657$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243511781$24351178$1$I$20240910$20240920$20240923$20240923$EXP$$US-BAYER-2024A134784$BAYER$$85$YR$E$M$Y$$$20240923$$CN$US$US
243511791$24351179$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537069$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511801$24351180$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537064$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511811$24351181$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537097$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511821$24351182$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537066$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511831$24351183$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537068$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511841$24351184$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537092$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511851$24351185$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537091$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511861$24351186$1$I$20210502$20231113$20240923$20240923$PER$$EG-ROCHE-2852653$ROCHE$$45$YR$A$F$Y$$$20240923$$MD$EG$EG
243511871$24351187$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537070$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511881$24351188$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537080$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511891$24351189$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537099$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511901$24351190$1$I$20191028$20231005$20240923$20240923$PER$$AT-ROCHE-2563801$ROCHE$$83$YR$E$F$Y$63$KG$20240923$$MD$AT$AT
243511911$24351191$1$I$20191206$20240304$20240923$20240923$PER$$AT-ROCHE-2714395$ROCHE$$83$YR$E$F$Y$63$KG$20240923$$MD$AT$AT
243511921$24351192$1$I$20210704$20231031$20240923$20240923$PER$$EG-ROCHE-2957164$ROCHE$$35$YR$A$F$Y$$$20240923$$MD$EG$EG
243511931$24351193$1$I$20201228$20240123$20240923$20240923$PER$$AT-ROCHE-2827710$ROCHE$$47$YR$A$F$Y$58$KG$20240923$$MD$AT$AT
243511941$24351194$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537098$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511951$24351195$1$I$20240625$20240910$20240923$20240923$EXP$$NVSC2024CN182702$NOVARTIS$$86$YR$$F$Y$$$20240923$$HP$CN$CN
243511961$24351196$1$I$20200301$20240229$20240923$20240923$PER$$PT-ROCHE-2696852$ROCHE$$75$YR$E$F$Y$$$20240923$$MD$PT$PT
243511971$24351197$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5930933$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243511981$24351198$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537101$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243511991$24351199$1$I$$20240912$20240923$20240923$EXP$$US-UCBSA-2024047591$UCB$$$$$$Y$$$20240923$$CN$US$US
243512001$24351200$1$I$20220510$20231228$20240923$20240923$PER$$IT-ROCHE-2118594$ROCHE$$51$YR$A$F$Y$68$KG$20240923$$MD$IT$IT
243512011$24351201$1$I$20170302$20240308$20240923$20240923$PER$$AT-ROCHE-2024154$ROCHE$$62$YR$A$F$Y$68$KG$20240923$$MD$AT$AT
243512031$24351203$1$I$$20240321$20240923$20240923$PER$$GB-ROCHE-3532647$ROCHE$$$$$$Y$$$20240923$$HP$GB$GB
243512041$24351204$1$I$$20240321$20240923$20240923$PER$$IR-ROCHE-3531853$ROCHE$$$$$F$Y$$$20240923$$HP$IR$IR
243512061$24351206$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087543$ROCHE$$49$YR$A$F$Y$$$20240923$$CN$US$US
243512071$24351207$1$I$$20240515$20240923$20240923$PER$$IT-ROCHE-3538414$ROCHE$Staropoli N, Scionti F, Farenza V, Falcone F,  Luciano F, Renne M, Di Martino M, Ciliberto D, Tedesco L, Crispino A, Labanca C, Cuce M, Esposito S, Agapito G, Cannataro M, Tassone P, Tagliaferri P and  Arbitrio M Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience.  DOI : 10.1016/j.biopha.2024.116478. Biomedicine + pharmacotherapy = Biomedecine + pharmacotherapie 2024 Mar 27;174:1-8$61$YR$A$F$Y$$$20240923$$HP$IT$IT
243512081$24351208$1$I$20211008$20240311$20240923$20240923$PER$$UY-ROCHE-2932845$ROCHE$$55$YR$A$F$Y$$$20240923$$MD$UY$UY
243512091$24351209$1$I$$20240406$20240923$20240923$PER$$US-ROCHE-3537100$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243512101$24351210$1$I$20240401$20240515$20240923$20240923$PER$$CA-ROCHE-3537291$ROCHE$$41$YR$A$F$Y$68$KG$20240923$$HP$CA$CA
243512111$24351211$1$I$20240803$20240916$20240923$20240923$EXP$FR-AFSSAPS-LL2024001722$FR-FreseniusKabi-FK202413931$FRESENIUS KABI$$63$YR$A$M$Y$$$20240923$$PH$FR$FR
243512121$24351212$1$I$20240702$20240916$20240923$20240923$EXP$FR-AFSSAPS-PA2024001447$FR-FreseniusKabi-FK202413960$FRESENIUS KABI$$30$YR$A$F$Y$51$KG$20240923$$PH$FR$FR
243512131$24351213$1$I$$20240918$20240923$20240923$EXP$$DE-JNJFOC-20240959795$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$CN$DE$DE
243512141$24351214$1$I$20240822$20240917$20240923$20240923$PER$$JP-Eisai-EC-2024-174781$EISAI$$80$YR$E$F$Y$57$KG$20240923$$MD$JP$JP
243512151$24351215$1$I$$20240916$20240923$20240923$EXP$$CA-FreseniusKabi-FK202413985$FRESENIUS KABI$$73$YR$E$F$Y$$$20240923$$HP$CA$CA
243512161$24351216$1$I$$20240915$20240923$20240923$EXP$$US-JNJFOC-20240952289$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240923$$HP$US$US
243512172$24351217$2$F$20240901$20240918$20240923$20240927$PER$$US-GSK-US2024115638$GLAXOSMITHKLINE$$33$YR$$F$Y$$$20240927$$CN$US$US
243512181$24351218$1$I$$20240912$20240923$20240923$EXP$$US-UCBSA-2024047542$UCB$$$$$F$Y$$$20240923$$HP$US$US
243512191$24351219$1$I$20190501$20240122$20240923$20240923$PER$$AT-ROCHE-2788559$ROCHE$$67$YR$E$M$Y$93$KG$20240923$$MD$AT$AT
243512211$24351221$1$I$20190415$20240117$20240923$20240923$PER$$BG-ROCHE-2367370$ROCHE$$71$YR$E$F$Y$64$KG$20240923$$MD$BG$BG
243512221$24351222$1$I$20180220$20240215$20240923$20240923$PER$$IT-ROCHE-2220357$ROCHE$$57$YR$A$F$Y$61$KG$20240923$$MD$IT$IT
243512231$24351223$1$I$20190314$20240101$20240923$20240923$PER$$AT-ROCHE-2287698$ROCHE$$64$YR$A$F$Y$89$KG$20240923$$MD$AT$AT
243512241$24351224$1$I$$20240430$20240923$20240923$PER$$QA-ROCHE-3557796$ROCHE$$$$$F$Y$$$20240923$$MD$QA$QA
243512251$24351225$1$I$$20240321$20240923$20240923$PER$$IR-ROCHE-3532689$ROCHE$$$$$F$Y$$$20240923$$HP$IR$IR
243512261$24351226$1$I$20200327$20240103$20240923$20240923$PER$$BG-ROCHE-2683762$ROCHE$$60$YR$A$F$Y$80$KG$20240923$$MD$BG$BG
243512271$24351227$1$I$20170816$20240403$20240923$20240923$PER$$IT-ROCHE-2029733$ROCHE$$70$YR$E$F$Y$47$KG$20240923$$MD$IT$IT
243512281$24351228$1$I$20210116$20231027$20240923$20240923$PER$$EG-ROCHE-2885810$ROCHE$$62$YR$A$F$Y$$$20240923$$MD$EG$EG
243512301$24351230$1$I$$20240405$20240923$20240923$PER$$AU-ROCHE-3543678$ROCHE$$$$$F$Y$$$20240923$$MD$AU$AU
243512311$24351231$1$I$$20240424$20240923$20240923$PER$$ES-ROCHE-3553222$ROCHE$$$$E$F$Y$60$KG$20240923$$MD$ES$ES
243512321$24351232$1$I$20190715$20231120$20240923$20240923$PER$$AT-ROCHE-2790149$ROCHE$$38$YR$A$F$Y$$$20240923$$MD$AT$AT
243512331$24351233$1$I$20240124$20240521$20240923$20240923$PER$IT-MINISAL02-977843$IT-ROCHE-3537216$ROCHE$$71$YR$E$F$Y$$$20240923$$MD$IT$IT
243512341$24351234$1$I$20211115$20231027$20240923$20240923$PER$$EG-ROCHE-2967045$ROCHE$$62$YR$A$F$Y$$$20240923$$MD$EG$EG
243512351$24351235$1$I$$20240417$20240923$20240923$PER$$CO-ROCHE-3548978$ROCHE$$67$YR$E$F$Y$$$20240923$$CN$CO$CO
243512361$24351236$1$I$20230126$20240408$20240923$20240923$PER$$DE-ROCHE-3542011$ROCHE$$77$YR$E$F$Y$59$KG$20240923$$MD$DE$DE
243512371$24351237$1$I$20240118$20240422$20240923$20240923$PER$IT-MINISAL02-981351$IT-ROCHE-3550998$ROCHE$$62$YR$A$F$Y$$$20240923$$MD$IT$IT
243512381$24351238$1$I$$20240321$20240923$20240923$PER$$IR-ROCHE-3531858$ROCHE$$$$$F$Y$$$20240923$$HP$IR$IR
243512391$24351239$1$I$$20240321$20240923$20240923$PER$$IR-ROCHE-3531856$ROCHE$$$$$F$Y$$$20240923$$HP$IR$IR
243512401$24351240$1$I$20190605$20240105$20240923$20240923$PER$$GR-ROCHE-2433992$ROCHE$$64$YR$A$F$Y$80$KG$20240923$$MD$GR$GR
243512411$24351241$1$I$$20240321$20240923$20240923$PER$$IR-ROCHE-3532688$ROCHE$$$$$F$Y$$$20240923$$HP$IR$IR
243512421$24351242$1$I$$20240321$20240923$20240923$PER$$IR-ROCHE-3531857$ROCHE$$$$$F$Y$$$20240923$$HP$IR$IR
243512431$24351243$1$I$20240325$20240416$20240923$20240923$PER$$CA-ROCHE-3548196$ROCHE$$59$YR$A$F$Y$$$20240923$$CN$CA$CA
243512441$24351244$1$I$$20240501$20240923$20240923$PER$$US-ROCHE-3556937$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243512451$24351245$1$I$$20240321$20240923$20240923$PER$$IR-ROCHE-3532690$ROCHE$$$$$F$Y$$$20240923$$HP$IR$IR
243512461$24351246$1$I$20171231$20240117$20240923$20240923$PER$$AT-ROCHE-2077752$ROCHE$$30$YR$A$F$Y$62$KG$20240923$$MD$AT$AT
243512471$24351247$1$I$20181203$20240409$20240923$20240923$PER$$IT-ROCHE-2020613$ROCHE$$67$YR$E$F$Y$84$KG$20240923$$MD$IT$IT
243512481$24351248$1$I$$20240408$20240923$20240923$PER$$PE-ROCHE-3543747$ROCHE$$47$YR$A$F$Y$$$20240923$$CN$PE$PE
243512491$24351249$1$I$$20240522$20240923$20240923$PER$$JP-ROCHE-3537837$ROCHE$$70$YR$E$F$Y$$$20240923$$PH$JP$JP
243512501$24351250$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087572$ROCHE$$59$YR$A$M$Y$$$20240923$$CN$US$US
243512511$24351251$1$I$$20240419$20240923$20240923$PER$$CO-ROCHE-3550664$ROCHE$$57$YR$A$F$Y$$$20240923$$CN$CO$CO
243512521$24351252$1$I$$20240424$20240923$20240923$PER$$ES-ROCHE-3553220$ROCHE$$$$E$F$Y$70$KG$20240923$$MD$ES$ES
243512531$24351253$1$I$$20240321$20240923$20240923$PER$$IR-ROCHE-3532691$ROCHE$$$$$F$Y$$$20240923$$HP$IR$IR
243512541$24351254$1$I$$20231019$20240923$20240923$PER$$CH-ROCHE-2396345$ROCHE$$66$YR$E$$Y$$$20240923$$MD$CH$CH
243512551$24351255$1$I$$20240423$20240923$20240923$PER$$CA-ROCHE-3549688$ROCHE$$$$A$F$Y$$$20240923$$CN$CA$CA
243512561$24351256$1$I$20180605$20240221$20240923$20240923$PER$$AT-ROCHE-2333789$ROCHE$$51$YR$A$F$Y$72$KG$20240923$$MD$AT$AT
243512571$24351257$1$I$20190101$20240304$20240923$20240923$PER$$AT-ROCHE-2723956$ROCHE$$50$YR$A$F$Y$55$KG$20240923$$MD$AT$AT
243512581$24351258$1$I$$20240409$20240923$20240923$PER$$CO-ROCHE-3543855$ROCHE$$60$YR$A$F$Y$$$20240923$$CN$CO$CO
243512591$24351259$1$I$$20240415$20240923$20240923$PER$$US-ROCHE-3546510$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243512601$24351260$1$I$20191106$20240110$20240923$20240923$PER$$AT-ROCHE-2552166$ROCHE$$73$YR$E$F$Y$55$KG$20240923$$MD$AT$AT
243512611$24351261$1$I$20180522$20240103$20240923$20240923$PER$$AT-ROCHE-2155810$ROCHE$$53$YR$A$F$Y$75$KG$20240923$$MD$AT$AT
243512621$24351262$1$I$$20240404$20240923$20240923$PER$$CN-ROCHE-3538628$ROCHE$Zhu J, Wang Y, Xu B, Pu W, He P, Zhang J, Wang H and Chen H. Photodynamic therapy may salvage chemotherapy failure in gastric cancer: A case report and a literature review. DOI: 10.1016/j.pdpdt.2024.104038. Photodiagnosis and Photodynamic Therapy 2024 Apr;46:1-8.$56$YR$A$M$Y$$$20240923$$HP$CN$CN
243512631$24351263$1$I$20240103$20240429$20240923$20240923$PER$IT-MINISAL02-982502$IT-ROCHE-3555499$ROCHE$$79$YR$E$F$Y$$$20240923$$MD$IT$IT
243512641$24351264$1$I$$20240403$20240923$20240923$PER$$JP-ROCHE-3557754$ROCHE$$$$$F$Y$$$20240923$$MD$JP$JP
243512651$24351265$1$I$20180521$20240227$20240923$20240923$PER$$IT-ROCHE-2171491$ROCHE$$41$YR$A$F$Y$63$KG$20240923$$MD$IT$IT
243512661$24351266$1$I$20230605$20240401$20240923$20240923$PER$$KR-ROCHE-3538527$ROCHE$$58$YR$A$F$Y$$$20240923$$HP$KR$KR
243512671$24351267$1$I$20230525$20240401$20240923$20240923$PER$$KR-ROCHE-3538519$ROCHE$$28$YR$A$F$Y$$$20240923$$HP$KR$KR
243512681$24351268$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64730$$FDA-CTU$$73$YR$$F$N$68.5$KG$20240920$N$PH$US$
243512691$24351269$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64717$$FDA-CTU$$71$YR$$F$N$$$20240920$N$$US$
243512701$24351270$1$I$20210413$20231031$20240923$20240923$PER$$EG-ROCHE-2886822$ROCHE$$46$YR$A$F$Y$$$20240923$$MD$EG$EG
243512711$24351271$1$I$20211111$20231027$20240923$20240923$PER$$CA-ROCHE-2957540$ROCHE$$62$YR$A$F$Y$57$KG$20240923$$HP$CA$CA
243512731$24351273$1$I$$20240418$20240923$20240923$PER$$PE-ROCHE-3549817$ROCHE$$36$YR$A$F$Y$$$20240923$$CN$PE$PE
243512741$24351274$1$I$$20240917$20240923$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015436$JAZZ$$$$$F$Y$$$20240923$$CN$US$US
243512751$24351275$1$I$$20240917$20240923$20240923$EXP$$JP-PFIZER INC-PV202400121845$PFIZER$Ikunishi, S.. A case of methotrexate-associated lymphoproliferative disorders (MTX-LPD) in the liver. The 51st Annual Meeting of the Japan Society of Ultrasonics in Medicine, Kansai. 2024;51st:124$9$DEC$$F$Y$$$20240923$$HP$JP$JP
243512761$24351276$1$I$$20240917$20240923$20240923$EXP$$JP-PFIZER INC-PV202400121847$PFIZER$Nagata, M.. A case of iatrogenic immunodeficiency-related lymphoproliferative diseases in the mammary glands. The 51st Annual Meeting of the Japan Society of Ultrasonics in Medicine, Kansai. 2024;51st:144$6$DEC$$F$Y$$$20240923$$HP$JP$JP
243512781$24351278$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64670$$FDA-CTU$$60$YR$$F$N$$$20240920$N$$US$
243512791$24351279$1$I$20240910$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64711$$FDA-CTU$$81$YR$$F$N$$$20240920$N$HP$US$
243512801$24351280$1$I$$20240416$20240923$20240923$PER$$CO-ROCHE-3547793$ROCHE$$59$YR$A$F$Y$$$20240923$$CN$CO$CO
243512811$24351281$1$I$$20240917$20240923$20240923$EXP$$JP-PFIZER INC-PV202400122030$PFIZER$Takeuchi, Y.. A case of a patient with suspected severe asthmatic attack in which a heart-lung machine was removed under VV-ECMO. The 62nd Annual Meeting of the Kyushu Regional Conference, 2024 Branch Academic. 2024;62nd:29$50$YR$$M$Y$58$KG$20240923$$HP$JP$JP
243512821$24351282$1$I$$20240411$20240923$20240923$PER$$JP-ROCHE-3559168$ROCHE$$7$DEC$E$F$Y$$$20240923$$MD$JP$JP
243512831$24351283$1$I$$20240917$20240923$20240923$EXP$$JP-PFIZER INC-PV202400121822$PFIZER$Matsumoto, T.. A case of multiple solar keratosis and spinocellular carcinoma complicated with atypical fibroxanthoma and leiomyosarcoma after taking oral voriconazole. The 88th Annual Meeting of the East Division of the Japanese Dermatological. 2024;88th:130$76$YR$$M$Y$$$20240923$$HP$JP$JP
243512841$24351284$1$I$20220201$20240920$20240920$20240920$DIR$719284$$FDA-CTU$$41$YR$$M$N$$$20240920$N$CN$US$
243512851$24351285$1$I$20190515$20230928$20240923$20240923$PER$$AT-ROCHE-2486372$ROCHE$$38$YR$A$F$Y$$$20240923$$MD$AT$AT
243512861$24351286$1$I$20200513$20230925$20240923$20240923$PER$$AT-ROCHE-2726741$ROCHE$$58$YR$A$F$Y$44$KG$20240923$$MD$AT$AT
243512871$24351287$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64664$$FDA-CTU$$59$YR$$M$N$$$20240920$N$$US$
243512881$24351288$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64675$$FDA-CTU$$64$YR$$F$N$$$20240920$N$$US$
243512891$24351289$1$I$20240814$20240916$20240920$20240920$DIR$FDA-CDER-CTU-2024-64714$$FDA-CTU$$63$YR$$M$N$$$20240916$N$HP$US$
243512901$24351290$1$I$20230311$20240401$20240923$20240923$PER$$KR-ROCHE-3538533$ROCHE$$56$YR$A$F$Y$$$20240923$$PH$KR$KR
243512911$24351291$1$I$20221201$20240409$20240923$20240923$PER$$RO-ROCHE-3544702$ROCHE$$43$YR$A$F$Y$$$20240923$$MD$RO$RO
243512921$24351292$1$I$20230911$20240411$20240923$20240923$PER$$CO-ROCHE-3545553$ROCHE$$63$YR$A$F$Y$$$20240923$$MD$CO$CO
243512931$24351293$1$I$20180831$20231030$20240923$20240923$PER$$AT-ROCHE-2859953$ROCHE$$78$YR$E$F$Y$48$KG$20240923$$MD$AT$AT
243512941$24351294$1$I$$20240503$20240923$20240923$PER$$CH-ROCHE-3558611$ROCHE$$$$A$$Y$$$20240923$$MD$CH$CH
243512952$24351295$2$F$$20240930$20240923$20240930$EXP$$IR-SA-2024SA274221$SANOFI AVENTIS$$$$I$F$Y$$$20240930$$MD$IR$IR
243512961$24351296$1$I$$20240415$20240923$20240923$PER$$JP-ROCHE-3559137$ROCHE$$70$YR$E$F$Y$$$20240923$$HP$JP$JP
243512971$24351297$1$I$20181121$20231103$20240923$20240923$PER$$IT-ROCHE-2324472$ROCHE$$70$YR$E$F$Y$59$KG$20240923$$MD$IT$IT
243512981$24351298$1$I$20210227$20231031$20240923$20240923$PER$$EG-ROCHE-2899067$ROCHE$$40$YR$A$F$Y$$$20240923$$MD$EG$EG
243512991$24351299$1$I$$20240912$20240923$20240923$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18496$IPSEN$$$$$F$Y$$$20240923$$HP$US$US
243513001$24351300$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5930786$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243513021$24351302$1$I$20240920$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013624$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243513031$24351303$1$I$20230614$20240401$20240923$20240923$PER$$KR-ROCHE-3538544$ROCHE$$40$YR$A$F$Y$43$KG$20240923$$HP$KR$KR
243513041$24351304$1$I$20201231$20240401$20240923$20240923$PER$$KR-ROCHE-3539365$ROCHE$$67$YR$E$F$Y$106.5$KG$20240923$$HP$KR$KR
243513061$24351306$1$I$20200623$20231027$20240923$20240923$PER$$EG-ROCHE-2908404$ROCHE$$46$YR$A$F$Y$$$20240923$$MD$EG$EG
243513071$24351307$1$I$20180914$20231101$20240923$20240923$PER$$AT-ROCHE-2484960$ROCHE$$65$YR$E$F$Y$$$20240923$$MD$AT$AT
243513081$24351308$1$I$20190502$20231009$20240923$20240923$PER$$AT-ROCHE-2552678$ROCHE$$52$YR$A$F$Y$77$KG$20240923$$MD$AT$AT
243513091$24351309$1$I$$20240404$20240923$20240923$PER$$US-ROCHE-3538691$ROCHE$Sato M, Sato M, Han Q, Mori R, Mizuta K, Kang B, Morinaga S, Kobayash N, Ichikawa Y, Nakajima A and Hoffman R Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methio. Anticancer research. DOI: 10.21873/anticanres.16946 2024 Apr;44 (4):1499-1504.$66$YR$E$F$Y$$$20240923$$HP$US$US
243513101$24351310$1$I$20221209$20240401$20240923$20240923$PER$$KR-ROCHE-3539371$ROCHE$$66$YR$E$F$Y$62$KG$20240923$$HP$KR$KR
243513111$24351311$1$I$20230609$20240401$20240923$20240923$PER$$KR-ROCHE-3538537$ROCHE$$57$YR$A$F$Y$46.5$KG$20240923$$HP$KR$KR
243513121$24351312$1$I$$20240308$20240923$20240923$PER$$JP-ROCHE-3539065$ROCHE$$$$$F$Y$$$20240923$$MD$JP$JP
243513131$24351313$1$I$20230525$20240401$20240923$20240923$PER$$KR-ROCHE-3538560$ROCHE$$35$YR$A$F$Y$60$KG$20240923$$HP$KR$KR
243513141$24351314$1$I$20200716$20230927$20240923$20240923$PER$$AT-ROCHE-2715291$ROCHE$$72$YR$E$F$Y$53$KG$20240923$$MD$AT$AT
243513151$24351315$1$I$20230623$20240401$20240923$20240923$PER$$KR-ROCHE-3539370$ROCHE$$45$YR$A$F$Y$$$20240923$$HP$KR$KR
243513161$24351316$1$I$$20240130$20240923$20240923$PER$$CH-ROCHE-2006432$ROCHE$$$$A$$Y$$$20240923$$MD$CH$CH
243513171$24351317$1$I$20210915$20230925$20240923$20240923$PER$$BR-ROCHE-2974779$ROCHE$$56$YR$A$F$Y$$$20240923$$MD$BR$BR
243513181$24351318$1$I$$20240916$20240923$20240923$EXP$$GR-ROCHE-10000085005$ROCHE$Dimopoulos P, Sotirchos V, Rolston V, Jarnagin W, Moussa A, Yaeger R, et al. Gastrohepatic Fistula After Radiation Segmentectomy of a Left Hepatic Lobe Rectal Metastasis: A Case Report. CardioVascular and Interventional Radiology. 2024-Sep;47 (9):1296-1298. doi:10.1007/s00270-024-03796-9.$61$YR$A$M$Y$$$20240923$$HP$GR$GR
243513191$24351319$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269936$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240923$$MD$US$US
243513201$24351320$1$I$$20240914$20240923$20240923$PER$$US-SA-2024SA272401$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$CN$US$US
243513211$24351321$1$I$20230504$20240401$20240923$20240923$PER$$KR-ROCHE-3538729$ROCHE$$33$YR$A$F$Y$77.1$KG$20240923$$HP$KR$KR
243513221$24351322$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64720$$FDA-CTU$$54$YR$$M$N$$$20240920$N$$US$
243513231$24351323$1$I$$20240404$20240923$20240923$PER$$CN-ROCHE-3538912$ROCHE$Wu F, Chen M, Wang L, Li N, Wu X, Chen X, Hong Y, Li C, Lin L, Chen K, Huang W and Liu J The Efficacy and Safety of Inetetamab and Pyrotinib in Combination with Vinorelbine for Second-line Therapy and Beyond in HER2-positive Metastatic Breast Cancer: A Single institution Clinical Experience. DOI: 10.2174/0115680096248592231016065117. Current Cancer Drug Targets 2024;24 (5):490-500.$$$$$Y$$$20240923$$HP$CN$CN
243513241$24351324$1$I$20230613$20240401$20240923$20240923$PER$$KR-ROCHE-3538550$ROCHE$$59$YR$A$F$Y$$$20240923$$HP$KR$KR
243513251$24351325$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64641$$FDA-CTU$$52$YR$$M$N$$$20240920$N$$US$
243513261$24351326$1$I$$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64687$$FDA-CTU$$$$$F$N$$$20240919$N$HP$US$
243513271$24351327$1$I$$20240919$20240920$20240920$DIR$FDA-CDER-CTU-2024-64736$$FDA-CTU$$$$$M$N$$$20240919$N$HP$US$
243513281$24351328$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270104$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240923$$HP$US$US
243513302$24351330$2$F$$20240913$20240923$20240926$PER$$US-SA-2022SA006985$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240926$$CN$US$US
243513311$24351331$1$I$20201117$20231031$20240923$20240923$PER$$BR-ROCHE-2961714$ROCHE$$45$YR$A$F$Y$$$20240923$$HP$BR$BR
243513321$24351332$1$I$20240917$20240921$20240921$20240921$DIR$719340$$FDA-CTU$$60$YR$$F$N$65.25$KG$20240921$Y$CN$US$
243513331$24351333$1$I$20230608$20240401$20240923$20240923$PER$$KR-ROCHE-3538543$ROCHE$$58$YR$A$F$Y$$$20240923$$HP$KR$KR
243513341$24351334$1$I$20210503$20231104$20240923$20240923$PER$$PE-ROCHE-2953120$ROCHE$$36$YR$A$F$Y$$$20240923$$HP$PE$PE
243513351$24351335$1$I$$20240918$20240923$20240923$PER$$US-TAKEDA-2024TUS093406$TAKEDA$$$$$M$Y$$$20240923$$PH$US$US
243513361$24351336$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189119$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243513371$24351337$1$I$$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188486$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
243513381$24351338$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024188633$AMGEN$$$$$$Y$$$20240923$$MD$US$US
243513391$24351339$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187985$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243513401$24351340$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188141$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243513411$24351341$1$I$$20240919$20240923$20240923$PER$$US-BIOGEN-2024BI01283559$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
243513421$24351342$1$I$$20240920$20240923$20240923$PER$$US-JNJFOC-20240956559$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243513431$24351343$1$I$$20240916$20240923$20240923$PER$$US-IMP-2024000749$Harrow Health$$$$A$F$Y$$$20240923$$CN$US$US
243513441$24351344$1$I$$20240915$20240923$20240923$EXP$$US-JNJFOC-20240952290$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240923$$HP$US$US
243513451$24351345$1$I$$20240918$20240923$20240923$EXP$$CA-JNJFOC-20240820373$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240923$$HP$CA$CA
243513461$24351346$1$I$$20240919$20240923$20240923$EXP$$ES-PFIZER INC-202400259777$PFIZER$Lopez, M.. Cytokine release syndrome due to intravenous trastuzumab with tolerance of subcutaneous administration. European Academy of Allergy and Clinical Immunology (EAACI) Congress. 2024$68$YR$$F$Y$$$20240923$$HP$ES$ES
243513471$24351347$1$I$$20240919$20240923$20240923$EXP$$ES-PFIZER INC-202400259786$PFIZER$Lopez, M.. Cytokine release syndrome due to intravenous trastuzumab with tolerance of subcutaneous administration. European Academy of Allergy and Clinical Immunology (EAACI) Congress. 2024$84$YR$$F$Y$$$20240923$$HP$ES$ES
243513481$24351348$1$I$20230608$20240401$20240923$20240923$PER$$KR-ROCHE-3540054$ROCHE$$69$YR$E$F$Y$64$KG$20240923$$HP$KR$KR
243513491$24351349$1$I$$20240404$20240923$20240923$PER$$RS-ROCHE-3539962$ROCHE$Zelen T, Prica A and Jovisevic M. Early relapse of her2 positive breast cancer [Abstract number: PR125]. DOI: 10.1016/S0960-9776(23)00689-6. Breast 2023 Oct;71 (SUP: 1):S58-.$47$YR$A$F$Y$$$20240923$$HP$RS$RS
243513501$24351350$1$I$$20240403$20240923$20240923$PER$$GB-ROCHE-3539390$ROCHE$$$$$F$Y$$$20240923$$CN$GB$GB
243513511$24351351$1$I$20230524$20240401$20240923$20240923$PER$$KR-ROCHE-3540107$ROCHE$$52$YR$A$F$Y$52$KG$20240923$$HP$KR$KR
243513521$24351352$1$I$20221209$20240401$20240923$20240923$PER$$KR-ROCHE-3539374$ROCHE$$54$YR$A$F$Y$$$20240923$$HP$KR$KR
243513531$24351353$1$I$$20240219$20240923$20240923$PER$$US-ROCHE-2276829$ROCHE$$67$YR$E$M$Y$98.34$KG$20240923$$MD$US$US
243513541$24351354$1$I$$20240220$20240923$20240923$PER$$US-ROCHE-2104862$ROCHE$$74$YR$E$F$Y$$$20240923$$MD$US$US
243513551$24351355$1$I$20221103$20240401$20240923$20240923$PER$$KR-ROCHE-3540185$ROCHE$$35$YR$A$F$Y$$$20240923$$HP$KR$KR
243513561$24351356$1$I$20181227$20240314$20240923$20240923$PER$$AT-ROCHE-2275904$ROCHE$$78$YR$E$F$Y$58$KG$20240923$$MD$AT$AT
243513571$24351357$1$I$20190624$20231214$20240923$20240923$PER$$IT-ROCHE-2536744$ROCHE$$37$YR$A$F$Y$76$KG$20240923$$HP$IT$IT
243513581$24351358$1$I$20180807$20240228$20240923$20240923$PER$$AT-ROCHE-2217090$ROCHE$$42$YR$A$F$Y$58$KG$20240923$$MD$AT$AT
243513591$24351359$1$I$20221207$20240401$20240923$20240923$PER$$KR-ROCHE-3539381$ROCHE$$80$YR$E$F$Y$70$KG$20240923$$HP$KR$KR
243513601$24351360$1$I$20170904$20240206$20240923$20240923$PER$$BG-ROCHE-2027217$ROCHE$$48$YR$A$F$Y$55$KG$20240923$$MD$BG$BG
243513611$24351361$1$I$20230623$20240401$20240923$20240923$PER$$KR-ROCHE-3540116$ROCHE$$67$YR$E$F$Y$60$KG$20240923$$HP$KR$KR
243513621$24351362$1$I$20230616$20240401$20240923$20240923$PER$$KR-ROCHE-3540184$ROCHE$$55$YR$A$F$Y$55$KG$20240923$$HP$KR$KR
243513631$24351363$1$I$20230518$20240401$20240923$20240923$PER$$KR-ROCHE-3538728$ROCHE$$51$YR$A$F$Y$$$20240923$$HP$KR$KR
243513641$24351364$1$I$20210104$20240401$20240923$20240923$PER$$KR-ROCHE-3540172$ROCHE$$72$YR$E$M$Y$60$KG$20240923$$HP$KR$KR
243513651$24351365$1$I$20230620$20240401$20240923$20240923$PER$$KR-ROCHE-3540051$ROCHE$$70$YR$E$F$Y$$$20240923$$HP$KR$KR
243513661$24351366$1$I$20210317$20240401$20240923$20240923$PER$$KR-ROCHE-3540113$ROCHE$$42$YR$A$F$Y$68$KG$20240923$$HP$KR$KR
243513671$24351367$1$I$20240716$20240718$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000404$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243513681$24351368$1$I$20240101$20240912$20240923$20240923$EXP$$US-UCBSA-2024047340$UCB$$$$$F$Y$$$20240923$$HP$US$US
243513691$24351369$1$I$$20240912$20240923$20240923$PER$$US-INCYTE CORPORATION-2024IN009660$INCYTE$$$$$$Y$$$20240923$$CN$US$US
243513701$24351370$1$I$20190916$20240205$20240923$20240923$PER$$PT-ROCHE-2474812$ROCHE$$64$YR$A$F$Y$$$20240923$$MD$PT$PT
243513711$24351371$1$I$$20240402$20240923$20240923$PER$$RU-ROCHE-3540555$ROCHE$$56$YR$A$F$Y$$$20240923$$MD$RU$RU
243513721$24351372$1$I$20240311$20240311$20240923$20240923$PER$$JP-ROCHE-3542062$ROCHE$$$$$F$Y$$$20240923$$MD$JP$JP
243513731$24351373$1$I$20170805$20240104$20240923$20240923$PER$$PT-ROCHE-1998906$ROCHE$$29$YR$A$F$Y$53$KG$20240923$$MD$PT$PT
243513741$24351374$1$I$$20240922$20240920$20240920$DIR$FDA-CDER-CTU-2024-64638$$FDA-CTU$$$$$M$N$$$20240922$N$HP$US$
243513751$24351375$1$I$$20240918$20240920$20240920$DIR$FDA-CDER-CTU-2024-64679$$FDA-CTU$$$$$M$N$$$20240918$N$HP$US$
243513761$24351376$1$I$20211109$20240202$20240923$20240923$PER$$IT-ROCHE-2955785$ROCHE$$42$YR$A$F$Y$100$KG$20240923$$MD$IT$IT
243513771$24351377$1$I$20171111$20240205$20240923$20240923$PER$$IT-ROCHE-2086865$ROCHE$$68$YR$E$F$Y$64$KG$20240923$$MD$IT$IT
243513791$24351379$1$I$$20240404$20240923$20240923$PER$$US-ROCHE-3540406$ROCHE$$82$YR$E$M$Y$$$20240923$$MD$US$US
243513801$24351380$1$I$$20240401$20240923$20240923$PER$$JP-ROCHE-3541399$ROCHE$$$$A$F$Y$$$20240923$$MD$JP$JP
243513811$24351381$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64659$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243513841$24351384$1$I$$20240404$20240923$20240923$PER$$IT-ROCHE-3541445$ROCHE$$74$YR$E$F$Y$$$20240923$$HP$IT$IT
243513851$24351385$1$I$20240301$20240404$20240923$20240923$PER$$US-ROCHE-3540502$ROCHE$$49$YR$A$F$Y$$$20240923$$CN$US$US
243513861$24351386$1$I$20240328$20240408$20240923$20240923$PER$$CN-ROCHE-3541502$ROCHE$$55$YR$A$F$Y$52$KG$20240923$$HP$CN$CN
243513871$24351387$1$I$$20240403$20240923$20240923$PER$$RU-ROCHE-3541643$ROCHE$$67$YR$E$F$Y$$$20240923$$MD$RU$RU
243513881$24351388$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64700$$FDA-CTU$$82$YR$$M$N$$$20240920$N$$US$
243513891$24351389$1$I$20240901$20240921$20240921$20240921$DIR$719327$$FDA-CTU$$39$YR$$F$N$169.2$KG$20240921$N$CN$US$
243513901$24351390$1$I$$20240913$20240920$20240920$DIR$FDA-CDER-CTU-2024-64735$$FDA-CTU$$$$$M$N$77.11$KG$20240913$N$$US$
243513911$24351391$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64654$$FDA-CTU$$39$YR$$F$N$81.65$KG$20240920$N$$US$
243513921$24351392$1$I$20240319$20240403$20240923$20240923$PER$$CN-ROCHE-3540904$ROCHE$$51$YR$A$F$Y$63$KG$20240923$$HP$CN$CN
243513931$24351393$1$I$20240327$20240407$20240923$20240923$PER$$CN-ROCHE-3540917$ROCHE$$40$YR$A$F$Y$50$KG$20240923$$HP$CN$CN
243513941$24351394$1$I$20240101$20240819$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000406$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
243513951$24351395$1$I$20240701$20240723$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000409$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243513971$24351397$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64637$$FDA-CTU$$62$YR$$M$N$$$20240920$N$$US$
243513991$24351399$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64674$$FDA-CTU$$71$YR$$F$N$46.27$KG$20240920$N$HP$US$
243514001$24351400$1$I$20181218$20240205$20240923$20240923$PER$$AT-ROCHE-2487316$ROCHE$$64$YR$A$F$Y$80.4$KG$20240923$$MD$AT$AT
243514011$24351401$1$I$$20240718$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000405$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243514021$24351402$1$I$$20240410$20240923$20240923$PER$$GB-ROCHE-3544696$ROCHE$$$$$$Y$$$20240923$$HP$GB$GB
243514031$24351403$1$I$20240402$20240408$20240923$20240923$PER$$CN-ROCHE-3542202$ROCHE$$69$YR$E$F$Y$55$KG$20240923$$HP$CN$CN
243514041$24351404$1$I$20240327$20240405$20240923$20240923$PER$$IN-ROCHE-3543115$ROCHE$$66$YR$E$F$Y$$$20240923$$CN$IN$IN
243514051$24351405$1$I$20210112$20240207$20240923$20240923$PER$$PT-ROCHE-2802129$ROCHE$$$$E$F$Y$$$20240923$$MD$PT$PT
243514061$24351406$1$I$$20240401$20240923$20240923$PER$$JP-ROCHE-3544851$ROCHE$Nemoto K, Ishiba T, Adachi M, Nara M, Yonekura R and Aruga T. A case with difficulty in differentiating drug-induced pneumonia caused by T-DXd from pneumonia caused by SARSCoV- 2 infection.. Japanese Journal of Breast Cancer 2024;39 (1):93-8.$63$YR$A$F$Y$$$20240923$$HP$JP$JP
243514081$24351408$1$I$$20240312$20240923$20240923$PER$$JP-ROCHE-3543898$ROCHE$$82$YR$E$F$Y$$$20240923$$MD$JP$JP
243514091$24351409$1$I$20240403$20240411$20240923$20240923$PER$$CN-ROCHE-3544235$ROCHE$$60$YR$A$F$Y$$$20240923$$HP$CN$CN
243514101$24351410$1$I$20240315$20240409$20240923$20240923$PER$$CN-ROCHE-3542171$ROCHE$$77$YR$E$F$Y$62$KG$20240923$$HP$CN$CN
243514111$24351411$1$I$20190401$20240206$20240923$20240923$PER$$IT-ROCHE-2486856$ROCHE$$51$YR$A$F$Y$60$KG$20240923$$MD$IT$IT
243514121$24351412$1$I$$20240311$20240923$20240923$PER$$JP-ROCHE-3542105$ROCHE$Takenaka Y, Hirano K. An experience of treatment for primary gastric yolk sac tumor-like carcinoma.. The 96th Annual Meeting of Japanese Gastric Cancer Association. 2024;:405-.$74$YR$E$M$Y$$$20240923$$MD$JP$JP
243514131$24351413$1$I$$20240403$20240923$20240923$PER$$US-ROCHE-3541762$ROCHE$$44$YR$A$F$Y$$$20240923$$MD$US$US
243514141$24351414$1$I$20170529$20240207$20240923$20240923$PER$$PT-ROCHE-2822938$ROCHE$$72$YR$E$F$Y$$$20240923$$MD$PT$PT
243514151$24351415$1$I$20190501$20240404$20240923$20240923$PER$$RU-ROCHE-3542238$ROCHE$$36$YR$A$F$Y$$$20240923$$MD$RU$RU
243514161$24351416$1$I$20210126$20240207$20240923$20240923$PER$$BR-ROCHE-2946569$ROCHE$$49$YR$A$F$Y$$$20240923$$MD$BR$BR
243514171$24351417$1$I$20240321$20240408$20240923$20240923$PER$$CN-ROCHE-3542185$ROCHE$$61$YR$A$F$Y$$$20240923$$HP$CN$CN
243514181$24351418$1$I$20181105$20240206$20240923$20240923$PER$$IT-ROCHE-2245850$ROCHE$$50$YR$A$F$Y$60$KG$20240923$$HP$IT$IT
243514191$24351419$1$I$$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024189106$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243514201$24351420$1$I$20210625$20240912$20240923$20240923$EXP$$DE-HIKMA PHARMACEUTICALS-DE-H14001-24-08559$HIKMA$$$$E$F$Y$$$20240923$$MD$DE$DE
243514211$24351421$1$I$20240801$20240912$20240923$20240923$EXP$$US-UCBSA-2024047207$UCB$$37$YR$$F$Y$$$20240923$$HP$US$US
243514221$24351422$1$I$20240701$20240912$20240923$20240923$EXP$$DE-UCBSA-2024047098$UCB$$58$YR$$F$Y$96$KG$20240923$$MD$DE$DE
243514231$24351423$1$I$20190128$20240216$20240923$20240923$PER$$PT-ROCHE-2317757$ROCHE$$44$YR$A$F$Y$57$KG$20240923$$MD$PT$PT
243514241$24351424$1$I$$20240412$20240923$20240923$PER$$CN-ROCHE-3546038$ROCHE$$49$YR$A$F$Y$$$20240923$$MD$CN$CN
243514251$24351425$1$I$$20240411$20240923$20240923$PER$$US-ROCHE-3544885$ROCHE$$51$YR$A$F$Y$$$20240923$$HP$US$US
243514261$24351426$1$I$20240101$20240411$20240923$20240923$PER$$FR-ROCHE-3545540$ROCHE$$$$$F$Y$$$20240923$$PH$FR$FR
243514271$24351427$1$I$$20240209$20240923$20240923$PER$$US-ROCHE-2928822$ROCHE$$73$YR$E$F$Y$$$20240923$$MD$US$US
243514281$24351428$1$I$$20240411$20240923$20240923$PER$$US-ROCHE-3546294$ROCHE$$65$YR$E$F$Y$$$20240923$$MD$US$US
243514291$24351429$1$I$20240405$20240408$20240923$20240923$PER$$BR-ROCHE-3545576$ROCHE$$47$YR$A$F$Y$60$KG$20240923$$PH$BR$BR
243514301$24351430$1$I$$20240411$20240923$20240923$PER$$US-ROCHE-3545461$ROCHE$$40$YR$A$F$Y$$$20240923$$MD$US$US
243514311$24351431$1$I$$20240412$20240923$20240923$PER$$CN-ROCHE-3546023$ROCHE$$$$$$Y$$$20240923$$HP$CN$CN
243514321$24351432$1$I$$20240215$20240923$20240923$PER$$US-ROCHE-2932556$ROCHE$$59$YR$A$M$Y$$$20240923$$MD$US$US
243514331$24351433$1$I$$20240411$20240923$20240923$PER$$CH-ROCHE-3546704$ROCHE$$$$$$Y$$$20240923$$HP$CH$CH
243514341$24351434$1$I$20190313$20240208$20240923$20240923$PER$$RO-ROCHE-2519349$ROCHE$$61$YR$A$F$Y$62$KG$20240923$$MD$RO$RO
243514351$24351435$1$I$$20240411$20240923$20240923$PER$$VN-ROCHE-3545958$ROCHE$$83$YR$E$F$Y$$$20240923$$MD$VN$VN
243514361$24351436$1$I$20240404$20240408$20240923$20240923$PER$$BR-ROCHE-3545574$ROCHE$$55$YR$A$F$Y$67.4$KG$20240923$$PH$BR$BR
243514371$24351437$1$I$$20240410$20240923$20240923$PER$$RU-ROCHE-3546339$ROCHE$$59$YR$A$F$Y$$$20240923$$MD$RU$RU
243514381$24351438$1$I$20200501$20240216$20240923$20240923$PER$$IT-ROCHE-2718086$ROCHE$$55$YR$A$F$Y$68$KG$20240923$$MD$IT$IT
243514391$24351439$1$I$20191120$20240213$20240923$20240923$PER$$AT-ROCHE-2553955$ROCHE$$43$YR$A$F$Y$65$KG$20240923$$MD$AT$AT
243514401$24351440$1$I$$20240416$20240923$20240923$PER$$KE-ROCHE-3547994$ROCHE$$$$$$Y$$$20240923$$HP$KE$KE
243514411$24351441$1$I$$20240411$20240923$20240923$PER$$US-ROCHE-3546930$ROCHE$$41$YR$A$M$Y$$$20240923$$MD$US$US
243514421$24351442$1$I$20240111$20240417$20240923$20240923$PER$$CN-ROCHE-3547651$ROCHE$$61$YR$A$F$Y$75$KG$20240923$$HP$CN$CN
243514431$24351443$1$I$20190701$20240227$20240923$20240923$PER$$IT-ROCHE-2616593$ROCHE$$66$YR$E$F$Y$55$KG$20240923$$MD$IT$IT
243514441$24351444$1$I$$20240227$20240923$20240923$PER$$DE-ROCHE-2926599$ROCHE$$$$$F$Y$$$20240923$$CN$IE$DE
243514451$24351445$1$I$20191228$20240228$20240923$20240923$PER$$BG-ROCHE-2551074$ROCHE$$61$YR$A$F$Y$72$KG$20240923$$MD$BG$BG
243514461$24351446$1$I$20180426$20240215$20240923$20240923$PER$$IT-ROCHE-2087853$ROCHE$$69$YR$E$F$Y$64$KG$20240923$$MD$IT$IT
243514471$24351447$1$I$$20240110$20240923$20240923$PER$$US-ROCHE-2899592$ROCHE$$66$YR$E$M$Y$82.1$KG$20240923$$HP$US$US
243514481$24351448$1$I$20240313$20240415$20240923$20240923$PER$$CN-ROCHE-3546785$ROCHE$$48$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243514491$24351449$1$I$20240408$20240415$20240923$20240923$PER$$CN-ROCHE-3546782$ROCHE$$65$YR$E$F$Y$65$KG$20240923$$HP$CN$CN
243514501$24351450$1$I$$20240416$20240923$20240923$PER$$AU-ROCHE-3544442$ROCHE$$$$$$Y$$$20240923$$MD$AU$AU
243514511$24351451$1$I$20190214$20240227$20240923$20240923$PER$$AT-ROCHE-2328041$ROCHE$$41$YR$A$F$Y$60$KG$20240923$$MD$AT$AT
243514521$24351452$1$I$$20240417$20240923$20240923$PER$$US-ROCHE-3548317$ROCHE$$77$YR$E$F$Y$46.27$KG$20240923$$CN$US$US
243514531$24351453$1$I$$20240415$20240923$20240923$PER$$CH-ROCHE-3547697$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243514541$24351454$1$I$20210622$20240220$20240923$20240923$PER$$BR-ROCHE-2939703$ROCHE$$48$YR$A$F$Y$$$20240923$$HP$BR$BR
243514551$24351455$1$I$$20240415$20240923$20240923$PER$$CH-ROCHE-3548225$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243514561$24351456$1$I$$20240209$20240923$20240923$PER$$CA-ROCHE-3547606$ROCHE$$$$A$F$Y$48$KG$20240923$$MD$CA$CA
243514571$24351457$1$I$$20240415$20240923$20240923$PER$$CH-ROCHE-3547706$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243514581$24351458$1$I$20240823$20240919$20240923$20240923$EXP$$MX-ABBVIE-5933585$ABBVIE$$44$YR$$F$Y$$$20240923$$CN$MX$MX
243514591$24351459$1$I$$20240129$20240923$20240923$PER$$CA-ROCHE-3549170$ROCHE$$$$A$F$Y$60$KG$20240923$$MD$CA$CA
243514601$24351460$1$I$20230307$20240116$20240923$20240923$PER$$CA-ROCHE-3549179$ROCHE$$60$YR$A$F$Y$80$KG$20240923$$MD$CA$CA
243514611$24351461$1$I$20240801$20240912$20240920$20240920$DIR$FDA-CDER-CTU-2024-64649$$FDA-CTU$$34$MON$$M$N$$$20240912$N$HP$US$
243514621$24351462$1$I$$20240417$20240923$20240923$PER$$RU-ROCHE-3548718$ROCHE$$40$YR$A$F$Y$$$20240923$$MD$RU$RU
243514631$24351463$1$I$$20240207$20240923$20240923$PER$$CA-ROCHE-3548474$ROCHE$$$$A$F$Y$71$KG$20240923$$MD$CA$CA
243514641$24351464$1$I$$20240417$20240923$20240923$PER$$MY-ROCHE-3548938$ROCHE$$45$YR$A$F$Y$$$20240923$$HP$MY$MY
243514651$24351465$1$I$20190916$20240229$20240923$20240923$PER$$IT-ROCHE-2423044$ROCHE$$51$YR$A$F$Y$92$KG$20240923$$MD$IT$IT
243514661$24351466$1$I$20201006$20240306$20240923$20240923$PER$$AT-ROCHE-2825831$ROCHE$$65$YR$E$F$Y$68$KG$20240923$$MD$AT$AT
243514671$24351467$1$I$20210801$20240301$20240923$20240923$PER$$AT-ROCHE-2972458$ROCHE$$73$YR$E$F$Y$53$KG$20240923$$MD$AT$AT
243514681$24351468$1$I$$20240209$20240923$20240923$PER$$CA-ROCHE-3548467$ROCHE$$$$A$F$Y$68$KG$20240923$$MD$CA$CA
243514691$24351469$1$I$20170717$20240306$20240923$20240923$PER$$IT-ROCHE-2056089$ROCHE$$40$YR$A$F$Y$65$KG$20240923$$MD$IT$IT
243514701$24351470$1$I$$20240415$20240923$20240923$PER$$PE-ROCHE-3548968$ROCHE$$52$YR$A$F$Y$$$20240923$$CN$PE$PE
243514711$24351471$1$I$20240315$20240418$20240923$20240923$PER$IT-MINISAL02-981129$IT-ROCHE-3549058$ROCHE$$46$YR$A$F$Y$$$20240923$$MD$IT$IT
243514721$24351472$1$I$$20240417$20240923$20240923$PER$$PE-ROCHE-3540558$ROCHE$$76$YR$E$F$Y$$$20240923$$CN$PE$PE
243514731$24351473$1$I$20240401$20240417$20240923$20240923$PER$$CN-ROCHE-3548440$ROCHE$$51$YR$A$F$Y$62$KG$20240923$$HP$CN$CN
243514741$24351474$1$I$20180111$20240307$20240923$20240923$PER$$IT-ROCHE-2208291$ROCHE$$67$YR$E$F$Y$52$KG$20240923$$MD$IT$IT
243514751$24351475$1$I$$20240417$20240923$20240923$PER$$CO-ROCHE-3548991$ROCHE$$61$YR$A$F$Y$$$20240923$$CN$CO$CO
243514761$24351476$1$I$20160101$20240912$20240923$20240923$PER$$US-TAKEDA-2024TUS091489$TAKEDA$$$$$F$Y$70$KG$20240923$$MD$US$US
243514771$24351477$1$I$20240916$20240918$20240923$20240923$EXP$$US-ABBVIE-5931561$ABBVIE$$58$YR$$F$Y$$$20240923$$CN$US$US
243514781$24351478$1$I$$20240920$20240923$20240923$PER$$US-TAKEDA-2024TUS094021$TAKEDA$$59$YR$$F$Y$$$20240923$$CN$US$US
243514802$24351480$2$F$$20240925$20240923$20240930$EXP$$CA-JNJFOC-20240945869$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240930$$MD$CA$CA
243514811$24351481$1$I$20200714$20240311$20240923$20240923$PER$$AT-ROCHE-2690076$ROCHE$$65$YR$E$F$Y$68$KG$20240923$$MD$AT$AT
243514821$24351482$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010498$APOTEX$$52$YR$$F$Y$$$20240923$$HP$CA$CA
243514831$24351483$1$I$20230523$20240116$20240923$20240923$PER$$CA-ROCHE-3549889$ROCHE$$47$YR$A$F$Y$76$KG$20240923$$MD$CA$CA
243514841$24351484$1$I$$20240419$20240923$20240923$PER$$CH-ROCHE-3549966$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243514851$24351485$1$I$$20240419$20240923$20240923$PER$$CH-ROCHE-3550004$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243514861$24351486$1$I$$20240129$20240923$20240923$PER$$CA-ROCHE-3550333$ROCHE$$$$A$F$Y$83$KG$20240923$$MD$CA$CA
243514871$24351487$1$I$$20240419$20240923$20240923$PER$$CH-ROCHE-3550014$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243514881$24351488$1$I$20190304$20240313$20240923$20240923$PER$$RO-ROCHE-2519514$ROCHE$$59$YR$A$F$Y$55$KG$20240923$$MD$RO$RO
243514891$24351489$1$I$$20240418$20240923$20240923$PER$$US-ROCHE-3549561$ROCHE$$63$YR$A$F$Y$$$20240923$$MD$US$US
243514901$24351490$1$I$$20240419$20240923$20240923$PER$$CH-ROCHE-3550019$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243514911$24351491$1$I$20190426$20240308$20240923$20240923$PER$$IT-ROCHE-2361071$ROCHE$$59$YR$A$F$Y$70$KG$20240923$$MD$IT$IT
243514921$24351492$1$I$20190301$20240315$20240923$20240923$PER$$PT-ROCHE-2316201$ROCHE$$51$YR$A$F$Y$63$KG$20240923$$MD$PT$PT
243514931$24351493$1$I$$20240116$20240923$20240923$PER$$CA-ROCHE-3549888$ROCHE$$$$A$F$Y$48$KG$20240923$$MD$CA$CA
243514941$24351494$1$I$$20240115$20240923$20240923$PER$$CA-ROCHE-3550199$ROCHE$$$$A$F$Y$60$KG$20240923$$MD$CA$CA
243514951$24351495$1$I$20180209$20240307$20240923$20240923$PER$$IT-ROCHE-2217783$ROCHE$$54$YR$A$F$Y$65$KG$20240923$$MD$IT$IT
243514961$24351496$1$I$20231130$20240418$20240923$20240923$PER$$DE-ROCHE-3543432$ROCHE$$64$YR$A$F$Y$57$KG$20240923$$MD$DE$DE
243514971$24351497$1$I$20191101$20240307$20240923$20240923$PER$$AT-ROCHE-2563263$ROCHE$$83$YR$E$F$Y$63$KG$20240923$$MD$AT$AT
243514981$24351498$1$I$$20240115$20240923$20240923$PER$$CA-ROCHE-3550202$ROCHE$$$$A$F$Y$59$KG$20240923$$MD$CA$CA
243514991$24351499$1$I$$20240418$20240923$20240923$PER$$PH-ROCHE-3549442$ROCHE$$$$$$Y$$$20240923$$HP$PH$PH
243515011$24351501$1$I$20210108$20240311$20240923$20240923$PER$$BR-ROCHE-2750994$ROCHE$$43$YR$A$F$Y$$$20240923$$MD$BR$BR
243515021$24351502$1$I$20240407$20240423$20240923$20240923$PER$$CN-ROCHE-3552083$ROCHE$$60$YR$A$F$Y$58$KG$20240923$$HP$CN$CN
243515031$24351503$1$I$20211109$20240314$20240923$20240923$PER$$IT-ROCHE-2103499$ROCHE$$42$YR$A$F$Y$100$KG$20240923$$MD$IT$IT
243515041$24351504$1$I$$20240417$20240923$20240923$PER$$RU-ROCHE-3550646$ROCHE$$44$YR$A$F$Y$$$20240923$$MD$RU$RU
243515051$24351505$1$I$20240319$20240921$20240921$20240921$DIR$719319$$FDA-CTU$$64$YR$$M$N$78.75$KG$20240921$$CN$US$
243515061$24351506$1$I$20240301$20240326$20240923$20240923$PER$$JP-ROCHE-3550860$ROCHE$$7$DEC$E$F$Y$$$20240923$$PH$JP$JP
243515071$24351507$1$I$$20240326$20240923$20240923$PER$$JP-ROCHE-3550842$ROCHE$$6$DEC$A$F$Y$$$20240923$$PH$JP$JP
243515081$24351508$1$I$20240414$20240423$20240923$20240923$PER$GB-MHRA-MED-202404160422311940-DFTBW$GB-ROCHE-3551952$ROCHE$$44$YR$A$F$Y$$$20240923$$CN$GB$GB
243515091$24351509$1$I$20240404$20240423$20240923$20240923$PER$$CN-ROCHE-3552131$ROCHE$$40$YR$A$F$Y$86$KG$20240923$$HP$CN$CN
243515101$24351510$1$I$$20240419$20240923$20240923$PER$$CH-ROCHE-3551177$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243515111$24351511$1$I$20200406$20240314$20240923$20240923$PER$$PT-ROCHE-2714936$ROCHE$$37$YR$A$F$Y$52.3$KG$20240923$$MD$PT$PT
243515121$24351512$1$I$$20240325$20240923$20240923$PER$$US-ROCHE-2880538$ROCHE$$64$YR$A$F$Y$55$KG$20240923$$MD$US$US
243515131$24351513$1$I$20240911$20240921$20240921$20240921$DIR$719343$$FDA-CTU$$44$YR$$F$N$72$KG$20240921$N$CN$US$
243515141$24351514$1$I$$20240913$20240923$20240923$PER$$US-EMD Serono-2024049489$EMD SERONO INC$$$$A$F$Y$$$20240923$$HP$US$US
243515151$24351515$1$I$20210608$20240321$20240923$20240923$PER$$AT-ROCHE-2884918$ROCHE$$66$YR$E$F$Y$80.4$KG$20240923$$MD$AT$AT
243515161$24351516$1$I$20240402$20240423$20240923$20240923$PER$PT-INFARMED-F202404-378$PT-ROCHE-3551704$ROCHE$$61$YR$A$F$Y$56$KG$20240923$$PH$PT$PT
243515171$24351517$1$I$$20240423$20240923$20240923$PER$$CN-ROCHE-3551685$ROCHE$$66$YR$E$F$Y$66$KG$20240923$$HP$CN$CN
243515181$24351518$1$I$$20240327$20240923$20240923$PER$$JP-ROCHE-3551683$ROCHE$$80$YR$E$F$Y$$$20240923$$MD$JP$JP
243515191$24351519$1$I$$20240918$20240923$20240923$EXP$$CA-Orion Corporation ORION PHARMA-24_00031785$ORION$$73$YR$E$F$Y$$$20240923$$HP$CA$
243515211$24351521$1$I$20240501$20240918$20240923$20240923$EXP$$US-ABBVIE-5930118$ABBVIE$$61$YR$$F$Y$$$20240923$$CN$US$US
243515221$24351522$1$I$20240322$20240424$20240923$20240923$PER$$CN-ROCHE-3552949$ROCHE$$43$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243515231$24351523$1$I$$20240423$20240923$20240923$PER$$US-ROCHE-3552289$ROCHE$$40$YR$A$F$Y$$$20240923$$MD$US$US
243515241$24351524$1$I$20200305$20240326$20240923$20240923$PER$$AT-ROCHE-2732383$ROCHE$$62$YR$A$F$Y$55$KG$20240923$$MD$AT$AT
243515251$24351525$1$I$$20240422$20240923$20240923$PER$$RO-ROCHE-3553074$ROCHE$$$$$F$Y$$$20240923$$CN$RO$RO
243515261$24351526$1$I$$20240401$20240923$20240923$PER$$US-ROCHE-2537582$ROCHE$$72$YR$E$F$Y$$$20240923$$MD$US$US
243515271$24351527$1$I$$20240422$20240923$20240923$PER$$US-ROCHE-3552267$ROCHE$$57$YR$A$F$Y$52.2$KG$20240923$$MD$US$US
243515281$24351528$1$I$20240226$20240424$20240923$20240923$PER$$CN-ROCHE-3552908$ROCHE$$54$YR$A$F$Y$52.5$KG$20240923$$HP$CN$CN
243515291$24351529$1$I$20210609$20240514$20240923$20240923$PER$$CO-ROCHE-2962254$ROCHE$$47$YR$A$F$Y$$$20240923$$MD$CO$CO
243515301$24351530$1$I$$20240424$20240923$20240923$PER$$PE-ROCHE-3552500$ROCHE$$52$YR$A$F$Y$60$KG$20240923$$CN$PE$PE
243515311$24351531$1$I$20240416$20240424$20240923$20240923$PER$$CN-ROCHE-3552886$ROCHE$$69$YR$E$F$Y$85$KG$20240923$$HP$CN$CN
243515321$24351532$1$I$20240314$20240424$20240923$20240923$PER$$CN-ROCHE-3552940$ROCHE$$71$YR$E$F$Y$60$KG$20240923$$HP$CN$CN
243515331$24351533$1$I$20240408$20240424$20240923$20240923$PER$$CN-ROCHE-3552878$ROCHE$$79$YR$E$M$Y$56.3$KG$20240923$$HP$CN$CN
243515351$24351535$1$I$$20240521$20240923$20240923$PER$$PL-ROCHE-2751800$ROCHE$$$$$F$Y$$$20240923$$CN$PL$PL
243515361$24351536$1$I$20240329$20240424$20240923$20240923$PER$$CN-ROCHE-3552865$ROCHE$$60$YR$A$F$Y$44$KG$20240923$$HP$CN$CN
243515371$24351537$1$I$20240701$20240731$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000411$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243515381$24351538$1$I$20191004$20240514$20240923$20240923$PER$$AT-ROCHE-2475540$ROCHE$$79$YR$E$F$Y$48$KG$20240923$$MD$AT$AT
243515391$24351539$1$I$$20240920$20240923$20240923$PER$$US-TAKEDA-2024TUS093981$TAKEDA$$$$$F$Y$$$20240923$$CN$US$US
243515402$24351540$2$F$20240101$20240917$20240923$20240927$EXP$$US-UCBSA-2024016174$UCB$$$$$F$Y$$$20240927$$MD$US$US
243515411$24351541$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA273214$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240923$$CN$US$US
243515421$24351542$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA272965$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240923$$CN$US$US
243515431$24351543$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA274207$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$MD$US$US
243515441$24351544$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA273322$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240923$$CN$US$US
243515451$24351545$1$I$$20240905$20240923$20240923$PER$$US-SA-2024SA273283$SANOFI AVENTIS$$$$A$M$Y$71.36$KG$20240923$$MD$US$US
243515471$24351547$1$I$$20240910$20240923$20240923$PER$$US-SA-2024SA273163$SANOFI AVENTIS$$$$$$Y$$$20240923$$HP$US$US
243515481$24351548$1$I$20240101$20240904$20240923$20240923$PER$$US-SA-2024SA273275$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240923$$MD$US$US
243515491$24351549$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270404$SANOFI AVENTIS$$12$YR$T$M$Y$33.1$KG$20240923$$MD$US$US
243515501$24351550$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA273257$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240923$$CN$US$US
243515511$24351551$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272487$SANOFI AVENTIS$$$$T$M$Y$81.82$KG$20240923$$MD$US$US
243515521$24351552$1$I$$20240830$20240923$20240923$PER$$US-SA-2022SA405234$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240923$$MD$US$US
243515531$24351553$1$I$20220601$20240903$20240923$20240923$PER$$US-SA-2024SA272623$SANOFI AVENTIS$$51$YR$A$F$Y$68.18$KG$20240923$$MD$US$US
243515541$24351554$1$I$20180829$20240604$20240923$20240923$PER$$EG-ROCHE-2623525$ROCHE$$57$YR$A$F$Y$$$20240923$$MD$EG$EG
243515551$24351555$1$I$20240420$20240426$20240923$20240923$PER$$CN-ROCHE-3554448$ROCHE$$31$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243515561$24351556$1$I$$20240604$20240923$20240923$PER$$RO-ROCHE-2695639$ROCHE$$$$$F$Y$$$20240923$$CN$RO$RO
243515571$24351557$1$I$$20240426$20240923$20240923$PER$$CN-ROCHE-3554414$ROCHE$$42$YR$A$F$Y$$$20240923$$MD$CN$CN
243515581$24351558$1$I$20240409$20240425$20240923$20240923$PER$$CN-ROCHE-3553690$ROCHE$$72$YR$E$F$Y$$$20240923$$HP$CN$CN
243515591$24351559$1$I$$20240426$20240923$20240923$PER$$CN-ROCHE-3554411$ROCHE$$61$YR$A$F$Y$$$20240923$$MD$CN$CN
243515611$24351561$1$I$$20240424$20240923$20240923$PER$$FR-ROCHE-3555185$ROCHE$$72$YR$E$F$Y$62$KG$20240923$$MD$FR$FR
243515621$24351562$1$I$20240418$20240425$20240923$20240923$PER$$CN-ROCHE-3553723$ROCHE$$39$YR$A$F$Y$$$20240923$$HP$CN$CN
243515631$24351563$1$I$20240408$20240425$20240923$20240923$PER$$CN-ROCHE-3553683$ROCHE$$55$YR$A$F$Y$73$KG$20240923$$HP$CN$CN
243515641$24351564$1$I$20240408$20240426$20240923$20240923$PER$$CN-ROCHE-3554421$ROCHE$$60$YR$A$F$Y$54$KG$20240923$$HP$CN$CN
243515651$24351565$1$I$$20240730$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000423$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243515661$24351566$1$I$20240721$20240730$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000422$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243515671$24351567$1$I$20240622$20240726$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000417$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243515681$24351568$1$I$$20240917$20240923$20240923$EXP$$NVSC2024TR188108$NOVARTIS$$64$YR$$M$Y$$$20240923$$CN$TR$TR
243515691$24351569$1$I$20240627$20240723$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000412$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243515711$24351571$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA270516$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240923$$HP$US$US
243515721$24351572$1$I$20240910$20240910$20240923$20240923$EXP$$RU-BRAINTREE LABORATORIES, INC.-2024BTE00599$BRAINTREE$$30$YR$$F$Y$$$20240923$$CN$RU$RU
243515741$24351574$1$I$20240910$20240912$20240923$20240923$EXP$$US-NAPO PHARMACEUTICALS-2024US003098$PAREXEL$$$$$$Y$$$20240923$$HP$US$US
243515751$24351575$1$I$20240913$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187668$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243515761$24351576$1$I$20240901$20240916$20240923$20240923$PER$$US-AMGEN-USASP2024185090$AMGEN$$86$YR$E$M$Y$$$20240923$$HP$US$US
243515771$24351577$1$I$$20240903$20240923$20240923$PER$$US-TEVA-VS-3240587$TEVA$$$$$F$Y$$$20240923$$CN$US$US
243515781$24351578$1$I$20240424$20240430$20240923$20240923$PER$$CN-ROCHE-3557785$ROCHE$$40$YR$A$F$Y$57.5$KG$20240923$$HP$CN$CN
243515791$24351579$1$I$20181031$20240418$20240923$20240923$PER$$PT-ROCHE-3555522$ROCHE$$38$YR$A$F$Y$52.3$KG$20240923$$MD$PT$PT
243515811$24351581$1$I$$20240502$20240923$20240923$PER$$GB-ROCHE-3557802$ROCHE$$46$YR$A$F$Y$$$20240923$$MD$GB$GB
243515821$24351582$1$I$$20240426$20240923$20240923$PER$$US-ROCHE-3556529$ROCHE$Jacobs S, Wang Y, Abraham J, Feng H, Montero A, Lipchik C, Finnigan M, Jankowitz R, Salkeni M, Maley S, Puhalla S, Piette F, Quinn K, Chang K, Nagy R, Allegra C, Vehec K, Wolmark N, Lucas P, Srinivasan A and Pogue-Geile A NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer. DOI:10.1186/S13058-024-01823-8. Breast cancer research 2024 Apr 22;26 (1):1-13.$$$$$Y$$$20240923$$HP$US$US
243515831$24351583$1$I$20240326$20240502$20240923$20240923$PER$IT-MINISAL02-983111$IT-ROCHE-3557710$ROCHE$$70$YR$E$F$Y$$$20240923$$PH$IT$IT
243515841$24351584$1$I$$20240510$20240923$20240923$PER$$TR-ROCHE-3555441$ROCHE$$$$$$Y$$$20240923$$CN$TR$TR
243515851$24351585$1$I$20240423$20240505$20240923$20240923$PER$$CN-ROCHE-3559153$ROCHE$$58$YR$A$F$Y$$$20240923$$HP$CN$CN
243515861$24351586$1$I$20230921$20240430$20240923$20240923$PER$$EG-ROCHE-3556565$ROCHE$$57$YR$A$F$Y$$$20240923$$HP$EG$EG
243515871$24351587$1$I$$20240516$20240923$20240923$PER$$DE-ROCHE-3544798$ROCHE$Bugia L, Jungbauer F, Zaubitzer L, Horner C, Merx K, Yasser A, Germann T, Lammert A, Scherl C, Rotter N and  Affolter A Nivolumab as a Promising Treatment Option for Metastatic Salivary Duct Carcinoma. DOI: 10.1097/CJI.0000000000000513.. Journal of immunotherapy 2024 Mar 28;:1-5.$65$YR$E$M$Y$$$20240923$$HP$DE$DE
243515881$24351588$1$I$$20240515$20240923$20240923$PER$$IT-ROCHE-3541444$ROCHE$Staropoli N, Scionti F, Farenza V, Falcone F,  Luciano F, Renne M, Di Martino M, Ciliberto D, Tedesco L, Crispino A, Labanca C, Cuce M, Esposito S, Agapito G, Cannataro M, Tassone P, Tagliaferri P and  Arbitrio M Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience.  DOI : 10.1016/j.biopha.2024.116478. Biomedicine + pharmacotherapy 2024 Mar 27;174:1-8.$59$YR$A$F$Y$$$20240923$$HP$IT$IT
243515891$24351589$1$I$20240305$20240502$20240923$20240923$PER$IT-MINISAL02-983110$IT-ROCHE-3557706$ROCHE$$70$YR$E$F$Y$$$20240923$$PH$IT$IT
243515911$24351591$1$I$$20240527$20240923$20240923$PER$$AR-ROCHE-3544587$ROCHE$$60$YR$A$F$Y$$$20240923$$CN$AR$AR
243515921$24351592$1$I$20240403$20240428$20240923$20240923$PER$$CN-ROCHE-3555588$ROCHE$$58$YR$A$F$Y$58$KG$20240923$$HP$CN$CN
243515931$24351593$1$I$$20240503$20240923$20240923$PER$$PE-ROCHE-3558191$ROCHE$$$$$F$Y$$$20240923$$CN$PE$PE
243515941$24351594$1$I$$20240504$20240923$20240923$PER$$US-ROCHE-3558785$ROCHE$$54$YR$A$F$Y$$$20240923$$MD$US$US
243515951$24351595$1$I$20240420$20240524$20240923$20240923$PER$$IN-ROCHE-3554660$ROCHE$$74$YR$E$F$Y$$$20240923$$CN$IN$IN
243515961$24351596$1$I$20240416$20240428$20240923$20240923$PER$$CN-ROCHE-3555666$ROCHE$$49$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243515971$24351597$1$I$$20240503$20240923$20240923$PER$$PE-ROCHE-3558915$ROCHE$$53$YR$A$F$Y$$$20240923$$CN$PE$PE
243515981$24351598$1$I$$20240502$20240923$20240923$PER$$US-ROCHE-3557947$ROCHE$$$$$$Y$$$20240923$$MD$US$US
243515991$24351599$1$I$$20240430$20240923$20240923$PER$$US-ROCHE-3556700$ROCHE$$59$YR$A$M$Y$$$20240923$$MD$US$US
243516001$24351600$1$I$20240424$20240429$20240923$20240923$PER$$CN-ROCHE-3555580$ROCHE$$79$YR$E$F$Y$$$20240923$$HP$CN$CN
243516011$24351601$1$I$$20240527$20240923$20240923$PER$$IN-ROCHE-3557209$ROCHE$$54$YR$A$F$Y$$$20240923$$CN$IN$IN
243516021$24351602$1$I$20240801$20240916$20240923$20240923$PER$$US-IMP-2024000754$Harrow Health$$75$YR$E$F$Y$$$20240923$$CN$US$US
243516031$24351603$1$I$20240416$20240429$20240923$20240923$PER$$CN-ROCHE-3555547$ROCHE$$42$YR$A$F$Y$68$KG$20240923$$HP$CN$CN
243516041$24351604$1$I$20240322$20240502$20240923$20240923$PER$ES-AEMPS-1515148$ES-ROCHE-3558076$ROCHE$$52$YR$A$F$Y$$$20240923$$PH$ES$ES
243516051$24351605$1$I$$20240503$20240923$20240923$PER$$US-ROCHE-3558657$ROCHE$$69$YR$E$F$Y$$$20240923$$HP$US$US
243516061$24351606$1$I$20240422$20240427$20240923$20240923$PER$$PK-ROCHE-3555839$ROCHE$$73$YR$E$F$Y$$$20240923$$CN$PK$PK
243516071$24351607$1$I$20240317$20240428$20240923$20240923$PER$$CN-ROCHE-3555727$ROCHE$$59$YR$A$M$Y$70$KG$20240923$$HP$CN$CN
243516081$24351608$1$I$20240408$20240429$20240923$20240923$PER$$CN-ROCHE-3555953$ROCHE$$60$YR$A$F$Y$51$KG$20240923$$HP$CN$CN
243516091$24351609$1$I$20240427$20240430$20240923$20240923$PER$$CN-ROCHE-3556696$ROCHE$$44$YR$A$F$Y$70$KG$20240923$$HP$CN$CN
243516101$24351610$1$I$$20240516$20240923$20240923$PER$$IN-ROCHE-3557152$ROCHE$$71$YR$E$F$Y$$$20240923$$CN$IN$IN
243516111$24351611$1$I$$20240503$20240923$20240923$PER$$US-ROCHE-3558279$ROCHE$$$$$F$Y$$$20240923$$PH$US$US
243516121$24351612$1$I$20231226$20240430$20240923$20240923$PER$$EG-ROCHE-3556302$ROCHE$$58$YR$A$F$Y$$$20240923$$MD$EG$EG
243516131$24351613$1$I$20240917$20240917$20240923$20240923$EXP$$US-MYLANLABS-2024M1085552$MYLAN$$31$YR$$F$Y$$$20240923$$CN$US$US
243516141$24351614$1$I$20240813$20240917$20240923$20240923$EXP$FR-AFSSAPS-BR2024000745$FR-MYLANLABS-2024M1085200$MYLAN$$58$YR$$M$Y$$$20240923$$HP$FR$FR
243516151$24351615$1$I$$20240917$20240923$20240923$EXP$$FR-MYLANLABS-2024M1085371$MYLAN$Ikic A, Chatelus E, Epailly E, Kremer H, Sibilia J, Gottenberg J, et al. Heart transplantation in 6 patients with systemic sclerosis and a primary cardiac involvement. DEFAULT RECORD. 2014;S740$$$$M$Y$$$20240923$$HP$FR$FR
243516171$24351617$1$I$20240516$20240917$20240923$20240923$EXP$FR-AFSSAPS-GR2024001061$FR-MYLANLABS-2024M1084945$MYLAN$$31$YR$$M$Y$$$20240923$$PH$FR$FR
243516181$24351618$1$I$$20240920$20240923$20240923$DIR$FDA-CDER-CTU-2024-64906$$FDA-CTU$$$$$M$N$$$20240920$N$HP$US$
243516202$24351620$2$F$20240703$20240917$20240923$20240927$EXP$FR-AFSSAPS-RN2024000978$FR-MYLANLABS-2024M1084539$MYLAN$$68$YR$$F$Y$$$20240927$$PH$FR$FR
243516211$24351621$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5929968$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243516221$24351622$1$I$20240516$20240917$20240923$20240923$EXP$FR-AFSSAPS-AN2024001251$FR-MYLANLABS-2024M1084620$MYLAN$$71$YR$$M$Y$64$KG$20240923$$PH$FR$FR
243516231$24351623$1$I$$20240501$20240923$20240923$PER$$RU-ROCHE-3557396$ROCHE$Avgustinovich A, Afanasyev S, Spirina L, Kaygorodova E, Ermolenko R, Samtsov E, Frolova I and Cheremisina O. A case of pathological complete regression in combined modality treatment of resectable HER2/NEU-positive gastric cancer. DOI: 10.21294/1814-4861-2024-23-1-170-177. Siberian Journal of Oncology 2024;23 (1):170-7.$69$YR$E$M$Y$$$20240923$$HP$RU$RU
243516251$24351625$1$I$$20240531$20240923$20240923$PER$$IN-ROCHE-3555664$ROCHE$$44$YR$A$F$Y$$$20240923$$CN$IN$IN
243516271$24351627$1$I$20231024$20240529$20240923$20240923$PER$$JP-ROCHE-3548299$ROCHE$$6$DEC$A$F$Y$$$20240923$$MD$JP$JP
243516281$24351628$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189127$NOVARTIS$$$$$$Y$$$20240923$$MD$US$US
243516291$24351629$1$I$$20240918$20240923$20240923$EXP$$NVSC2024CA187228$NOVARTIS$$40$YR$$F$Y$$$20240923$$CN$CA$CA
243516301$24351630$1$I$$20240912$20240923$20240923$PER$$US-IMP-2024000738$Harrow Health$$$$E$F$Y$$$20240923$$CN$US$US
243516311$24351631$1$I$$20240916$20240923$20240923$PER$$US-IMP-2024000744$Harrow Health$$$$A$F$Y$$$20240923$$CN$US$US
243516331$24351633$1$I$$20240916$20240923$20240923$PER$$US-IMP-2024000746$Harrow Health$$$$E$F$Y$$$20240923$$CN$US$US
243516341$24351634$1$I$$20240913$20240923$20240923$EXP$$US-TEVA-VS-3243947$TEVA$$79$YR$$F$Y$$$20240923$$PH$US$US
243516351$24351635$1$I$20240101$20240916$20240923$20240923$PER$$US-DAIICHI SANKYO, INC.-DS-2024-100136-US$DAIICHI$$$$$F$Y$$$20240923$$CN$US$US
243516361$24351636$1$I$$20240916$20240923$20240923$PER$$US-IMP-2024000747$Harrow Health$$$$E$F$Y$$$20240923$$CN$US$US
243516371$24351637$1$I$20240816$20240918$20240923$20240923$EXP$$TW-JNJFOC-20240951985$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240923$$MD$TW$TW
243516381$24351638$1$I$$20240916$20240923$20240923$PER$$US-ABBVIE-5926619$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243516391$24351639$1$I$20240802$20240808$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000433$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243516401$24351640$1$I$20240731$20240802$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000430$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243516411$24351641$1$I$20240101$20240802$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000426$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243516421$24351642$1$I$20240101$20240805$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000432$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$CN$US$US
243516431$24351643$1$I$20240730$20240806$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000434$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243516441$24351644$1$I$20240913$20240913$20240923$20240923$PER$$US-GSK-US2024114269$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240923$$CN$US$US
243516461$24351646$1$I$$20240916$20240923$20240923$PER$$US-TAKEDA-2024TUS092825$TAKEDA$$36$YR$$F$Y$109$KG$20240923$$MD$US$US
243516471$24351647$1$I$$20240917$20240923$20240923$PER$$US-IMP-2024000755$Harrow Health$$$$A$F$Y$$$20240923$$CN$US$US
243516481$24351648$1$I$$20240507$20240923$20240923$PER$$KR-ROCHE-3560625$ROCHE$$$$$$Y$$$20240923$$HP$KR$KR
243516491$24351649$1$I$20240509$20240509$20240923$20240923$PER$$CN-ROCHE-3561588$ROCHE$$72$YR$E$F$Y$$$20240923$$CN$CN$CN
243516501$24351650$1$I$$20240506$20240923$20240923$PER$$US-ROCHE-3559554$ROCHE$$38$YR$A$F$Y$$$20240923$$HP$US$US
243516511$24351651$1$I$20240423$20240505$20240923$20240923$PER$$CN-ROCHE-3559350$ROCHE$$54$YR$A$F$Y$$$20240923$$HP$CN$CN
243516521$24351652$1$I$20240420$20240505$20240923$20240923$PER$$CN-ROCHE-3559244$ROCHE$$67$YR$E$F$Y$$$20240923$$HP$CN$CN
243516531$24351653$1$I$$20240415$20240923$20240923$PER$$JP-ROCHE-3559980$ROCHE$$$$E$F$Y$$$20240923$$MD$JP$JP
243516541$24351654$1$I$$20240507$20240923$20240923$PER$$US-ROCHE-3560168$ROCHE$$80$YR$E$F$Y$$$20240923$$MD$US$US
243516551$24351655$1$I$20240409$20240505$20240923$20240923$PER$$CN-ROCHE-3559260$ROCHE$$71$YR$E$F$Y$60$KG$20240923$$HP$CN$CN
243516561$24351656$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000085138$ROCHE$$$$$$Y$$$20240923$$MD$US$US
243516571$24351657$1$I$$20240509$20240923$20240923$PER$$BE-ROCHE-3561068$ROCHE$$$$$F$Y$$$20240923$$MD$BE$BE
243516581$24351658$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000084896$ROCHE$$$$$$Y$$$20240923$$MD$US$US
243516591$24351659$1$I$$20240416$20240923$20240923$PER$$JP-ROCHE-3559816$ROCHE$$75$YR$E$F$Y$$$20240923$$PH$JP$JP
243516601$24351660$1$I$$20240418$20240923$20240923$PER$$JP-ROCHE-3561451$ROCHE$$71$YR$E$F$Y$$$20240923$$HP$JP$JP
243516611$24351661$1$I$$20240509$20240923$20240923$PER$$MY-ROCHE-3561282$ROCHE$$45$YR$A$F$Y$$$20240923$$PH$MY$MY
243516621$24351662$1$I$$20240508$20240923$20240923$PER$$CH-ROCHE-3561200$ROCHE$$$$A$$Y$$$20240923$$MD$CH$CH
243516631$24351663$1$I$$20240507$20240923$20240923$PER$IT-MINISAL02-983815$IT-ROCHE-3560923$ROCHE$$59$YR$A$F$Y$$$20240923$$MD$IT$IT
243516641$24351664$1$I$20240509$20240509$20240923$20240923$PER$$US-ROCHE-3561663$ROCHE$$$$$$Y$$$20240923$$PH$US$US
243516651$24351665$1$I$20240408$20240505$20240923$20240923$PER$$CN-ROCHE-3559255$ROCHE$$45$YR$A$F$Y$80$KG$20240923$$HP$CN$CN
243516661$24351666$1$I$20240416$20240505$20240923$20240923$PER$$CN-ROCHE-3559305$ROCHE$$80$YR$E$F$Y$$$20240923$$HP$CN$CN
243516671$24351667$1$I$20240418$20240505$20240923$20240923$PER$$CN-ROCHE-3559250$ROCHE$$66$YR$E$M$Y$94$KG$20240923$$HP$CN$CN
243516681$24351668$1$I$20240425$20240507$20240923$20240923$PER$$CN-ROCHE-3560090$ROCHE$$65$YR$E$F$Y$60$KG$20240923$$HP$CN$CN
243516691$24351669$1$I$20240416$20240505$20240923$20240923$PER$$CN-ROCHE-3559419$ROCHE$$37$YR$A$F$Y$75$KG$20240923$$HP$CN$CN
243516701$24351670$1$I$20230823$20240505$20240923$20240923$PER$$CN-ROCHE-3560058$ROCHE$$71$YR$E$F$Y$65$KG$20240923$$HP$CN$CN
243516711$24351671$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000060916$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243516721$24351672$1$I$$20240508$20240923$20240923$PER$$CH-ROCHE-3561222$ROCHE$$$$A$$Y$$$20240923$$MD$CH$CH
243516731$24351673$1$I$$20240508$20240923$20240923$PER$$US-ROCHE-3561482$ROCHE$$71$YR$E$F$Y$$$20240923$$MD$US$US
243516741$24351674$1$I$20240201$20240416$20240923$20240923$PER$$JP-ROCHE-3560004$ROCHE$$6$DEC$A$F$Y$$$20240923$$MD$JP$JP
243516751$24351675$1$I$20240426$20240508$20240923$20240923$PER$$CN-ROCHE-3560932$ROCHE$$73$YR$E$F$Y$43$KG$20240923$$HP$CN$CN
243516761$24351676$1$I$$20240507$20240923$20240923$PER$$PL-ROCHE-3560508$ROCHE$$$$$F$Y$$$20240923$$MD$PL$PL
243516771$24351677$1$I$20240425$20240505$20240923$20240923$PER$$CN-ROCHE-3559266$ROCHE$$61$YR$A$F$Y$$$20240923$$HP$CN$CN
243516781$24351678$1$I$$20240917$20240923$20240923$PER$$US-IMP-2024000756$Harrow Health$$$$E$F$Y$$$20240923$$CN$US$US
243516791$24351679$1$I$20240506$20240508$20240923$20240923$PER$$CN-ROCHE-3561080$ROCHE$$57$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243516801$24351680$1$I$$20240506$20240923$20240923$PER$$US-ROCHE-3559544$ROCHE$$52$YR$A$F$Y$$$20240923$$MD$US$US
243516811$24351681$1$I$$20240921$20240923$20240923$EXP$FR-GERMAN-SPO/FRA/24/0013205$FR-ROCHE-10000088084$ROCHE$Haidar NA, Vaillant W, Salignon K, Jounblat Y, Borel C. ABCL-159 Successful Treatment of a Gray Zone Lymphoma With Immunotherapy: A Case Report. Clinical Lymphoma, Myeloma and Leukemia. 2024 Sep;24: S459. doi:10.1016/S2152-2650%2824%2901490-3.$66$YR$E$F$Y$$$20240923$$MD$FR$FR
243516821$24351682$1$I$20200313$20240508$20240923$20240923$PER$$KR-ROCHE-3561946$ROCHE$$51$YR$A$F$Y$$$20240923$$HP$KR$KR
243516831$24351683$1$I$$20240506$20240923$20240923$PER$$RO-ROCHE-3562252$ROCHE$$60$YR$A$F$Y$$$20240923$$MD$RO$RO
243516841$24351684$1$I$$20240507$20240923$20240923$PER$$IT-ROCHE-3562247$ROCHE$$$$$$Y$$$20240923$$MD$IT$IT
243516851$24351685$1$I$20210527$20240508$20240923$20240923$PER$$KR-ROCHE-3562070$ROCHE$$58$YR$A$F$Y$$$20240923$$HP$KR$KR
243516861$24351686$1$I$20240920$20240921$20240921$20240921$DIR$719336$$FDA-CTU$$45$YR$$F$N$65.7$KG$20240921$N$CN$US$
243516871$24351687$1$I$20201130$20240508$20240923$20240923$PER$$KR-ROCHE-3561949$ROCHE$$37$YR$A$F$Y$$$20240923$$HP$KR$KR
243516881$24351688$1$I$20200316$20240508$20240923$20240923$PER$$KR-ROCHE-3561951$ROCHE$$47$YR$A$F$Y$$$20240923$$HP$KR$KR
243516891$24351689$1$I$$20240509$20240923$20240923$PER$$IT-ROCHE-3562086$ROCHE$$$$$F$Y$$$20240923$$HP$IT$IT
243516911$24351691$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-64727$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243516921$24351692$1$I$20220504$20240508$20240923$20240923$PER$$KR-ROCHE-3561940$ROCHE$$53$YR$A$F$Y$$$20240923$$HP$KR$KR
243516931$24351693$1$I$$20240508$20240923$20240923$PER$$KR-ROCHE-3561948$ROCHE$$$$A$F$Y$$$20240923$$HP$KR$KR
243516941$24351694$1$I$20240501$20240509$20240923$20240923$PER$$CN-ROCHE-3561785$ROCHE$$45$YR$A$F$Y$52$KG$20240923$$HP$CN$CN
243516951$24351695$1$I$$20240918$20240923$20240923$EXP$$SA-PFIZER INC-PV202400122502$PFIZER$Iraqi, M.. Successful Treatment of Generalized Pustular Psoriasis with Adalimumab in a Pediatric Patient: a case report. International Journal of Dermatology and Venereology. 2024;10.1097/JD9.0000000000000288$3$YR$$F$Y$14.2$KG$20240923$$HP$SA$SA
243516961$24351696$1$I$20220623$20240508$20240923$20240923$PER$$KR-ROCHE-3561950$ROCHE$$48$YR$A$F$Y$$$20240923$$HP$KR$KR
243516971$24351697$1$I$20240702$20240913$20240923$20240923$EXP$GB-MHRA-MED-202409131219476770-BSYLP$GB-ELI_LILLY_AND_COMPANY-GB202409009583$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240923$$CN$GB$GB
243516981$24351698$1$I$20240703$20240912$20240923$20240923$EXP$FR-AFSSAPS-GR2024001066$FR-ELI_LILLY_AND_COMPANY-FR202409008684$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240923$$CN$FR$FR
243516991$24351699$1$I$20220628$20240508$20240923$20240923$PER$$KR-ROCHE-3561980$ROCHE$$61$YR$A$F$Y$$$20240923$$HP$KR$KR
243517001$24351700$1$I$20240813$20240911$20240923$20240923$EXP$FR-AFSSAPS-BR2024000745$FR-ELI_LILLY_AND_COMPANY-FR202409007938$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240923$$CN$FR$FR
243517011$24351701$1$I$20240601$20240910$20240923$20240923$EXP$FR-AFSSAPS-TS2024000971$FR-ELI_LILLY_AND_COMPANY-FR202409006860$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240923$$CN$FR$FR
243517021$24351702$1$I$$20240911$20240923$20240923$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202408015435$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240923$$CN$DE$DE
243517031$24351703$1$I$20240812$20240912$20240923$20240923$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409008530$ELI LILLY AND CO$$71$YR$E$F$Y$35$KG$20240923$$CN$CN$CN
243517041$24351704$1$I$20240723$20240912$20240923$20240923$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409009306$ELI LILLY AND CO$$53$YR$A$F$Y$58$KG$20240923$$CN$FR$FR
243517051$24351705$1$I$$20240910$20240923$20240923$EXP$$CA-PFIZER INC-202400259977$PFIZER$$44$YR$$F$Y$60$KG$20240923$$MD$CA$CA
243517061$24351706$1$I$20240918$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013498$ELI LILLY AND CO$$$$$M$Y$$$20240923$$CN$US$US
243517071$24351707$1$I$20240721$20240912$20240923$20240923$EXP$FR-AFSSAPS-GR2024001080$FR-ELI_LILLY_AND_COMPANY-FR202409009298$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240923$$CN$FR$FR
243517081$24351708$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013433$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240923$$MD$US$US
243517091$24351709$1$I$20240723$20240912$20240923$20240923$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409008545$ELI LILLY AND CO$$62$YR$A$M$Y$65$KG$20240923$$CN$CN$CN
243517101$24351710$1$I$20240803$20240911$20240923$20240923$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409007745$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240923$$CN$CN$CN
243517121$24351712$1$I$20240920$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013611$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240923$$CN$US$US
243517131$24351713$1$I$20240715$20240911$20240923$20240923$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409012878$ELI LILLY AND CO$$78$YR$E$F$Y$44$KG$20240923$$CN$DE$CN
243517141$24351714$1$I$20240104$20240911$20240923$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202409007637$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243517151$24351715$1$I$20240424$20240511$20240923$20240923$PER$$CN-ROCHE-3562632$ROCHE$$75$YR$E$F$Y$48$KG$20240923$$HP$CN$CN
243517162$24351716$2$F$20240101$20240912$20240923$20240925$EXP$$US-UCBSA-2024047060$UCB$$$$$M$Y$110.48$KG$20240925$$HP$US$US
243517181$24351718$1$I$20230712$20240513$20240923$20240923$PER$$JP-ROCHE-3559349$ROCHE$$48$YR$A$M$Y$68.6$KG$20240923$$MD$JP$JP
243517191$24351719$1$I$$20240509$20240923$20240923$PER$$US-ROCHE-3562429$ROCHE$He L, Shen X, Liu Y, Gao L, Wu J, Yu C. The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review. Transl-Cancer- Res 2022;11 (11):4206-217.$52$YR$A$F$Y$$$20240923$$HP$US$US
243517201$24351720$1$I$$20240509$20240923$20240923$PER$$BR-ROCHE-3562317$ROCHE$$$$$F$Y$$$20240923$$MD$BR$BR
243517211$24351721$1$I$20240508$20240511$20240923$20240923$PER$$CN-ROCHE-3563457$ROCHE$$39$YR$A$F$Y$70$KG$20240923$$HP$CN$CN
243517221$24351722$1$I$$20240920$20240923$20240923$PER$$US-DSJP-DS-2024-100945-US$DAIICHI$$$$$F$Y$$$20240923$$MD$US$US
243517231$24351723$1$I$20240424$20240511$20240923$20240923$PER$$CN-ROCHE-3563440$ROCHE$$57$YR$A$F$Y$58$KG$20240923$$HP$CN$CN
243517241$24351724$1$I$$20240917$20240923$20240923$EXP$$US-TAKEDA-2024TUS092940$TAKEDA$$22$YR$$M$Y$$$20240923$$CN$US$US
243517251$24351725$1$I$20240911$20240911$20240923$20240923$PER$$US-JNJFOC-20240929601$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240923$$CN$US$US
243517261$24351726$1$I$$20240916$20240923$20240923$EXP$$US-GILEAD-2024-0688048$GILEAD$$66$YR$E$F$Y$$$20240923$$CN$US$US
243517271$24351727$1$I$20240501$20240513$20240923$20240923$PER$$CN-ROCHE-3563486$ROCHE$$61$YR$A$M$Y$$$20240923$$HP$CN$CN
243517281$24351728$1$I$20220501$20240912$20240923$20240923$EXP$$TH-ROCHE-10000082000$ROCHE$$74$YR$E$M$Y$$$20240923$$MD$TH$TH
243517291$24351729$1$I$$20240509$20240923$20240923$PER$$US-ROCHE-3563503$ROCHE$He L, Shen X, Liu Y, Gao L, Wu J, Yu C. The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review. Transl-Cancer- Res 2022;11 (11):4206-217.$64$YR$A$F$Y$$$20240923$$HP$US$US
243517301$24351730$1$I$$20240509$20240923$20240923$PER$$IT-ROCHE-3564224$ROCHE$$$$$F$Y$$$20240923$$HP$IT$IT
243517311$24351731$1$I$20240509$20240513$20240923$20240923$PER$$CN-ROCHE-3563575$ROCHE$$51$YR$A$F$Y$67$KG$20240923$$HP$CN$CN
243517321$24351732$1$I$20240409$20240513$20240923$20240923$PER$$CN-ROCHE-3563609$ROCHE$$67$YR$E$F$Y$53$KG$20240923$$HP$CN$CN
243517331$24351733$1$I$$20240509$20240923$20240923$PER$$IT-ROCHE-3564226$ROCHE$$$$$F$Y$$$20240923$$HP$IT$IT
243517341$24351734$1$I$$20240509$20240923$20240923$PER$$IT-ROCHE-3564225$ROCHE$$$$$F$Y$$$20240923$$HP$IT$IT
243517351$24351735$1$I$20240503$20240514$20240923$20240923$PER$$CN-ROCHE-3564196$ROCHE$$58$YR$A$F$Y$76$KG$20240923$$HP$CN$CN
243517361$24351736$1$I$$20240509$20240923$20240923$PER$$PE-ROCHE-3563766$ROCHE$$37$YR$A$F$Y$$$20240923$$CN$PE$PE
243517371$24351737$1$I$$20240513$20240923$20240923$PER$$US-ROCHE-3563554$ROCHE$$50$YR$A$F$Y$$$20240923$$HP$US$US
243517381$24351738$1$I$20240214$20240513$20240923$20240923$PER$SI-JAZMP-NCPHV-2024SI0406_0406$SI-ROCHE-3564093$ROCHE$$75$YR$E$F$Y$$$20240923$$PH$SI$SI
243517391$24351739$1$I$20240429$20240513$20240923$20240923$PER$$CN-ROCHE-3563532$ROCHE$$65$YR$E$F$Y$65$KG$20240923$$HP$CN$CN
243517401$24351740$1$I$$20240509$20240923$20240923$PER$$IT-ROCHE-3564227$ROCHE$$$$$F$Y$$$20240923$$HP$IT$IT
243517411$24351741$1$I$20240509$20240514$20240923$20240923$PER$$CN-ROCHE-3564153$ROCHE$$72$YR$E$F$Y$54$KG$20240923$$HP$CN$CN
243517421$24351742$1$I$20240101$20240805$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000436$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243517431$24351743$1$I$20240723$20240918$20240923$20240923$EXP$FR-AFSSAPS-LL2024001748$FR-009507513-2409FRA006461$MERCK$$53$YR$$F$Y$58$KG$20240923$$PH$FR$FR
243517441$24351744$1$I$$20240911$20240923$20240923$PER$$US-009507513-2409USA004297$MERCK$$$$$F$Y$$$20240923$$CN$US$US
243517451$24351745$1$I$20240913$20240913$20240923$20240923$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-28299$SAMSUNG BIOEPIS$$35$YR$A$M$Y$$$20240923$$CN$CA$CA
243517461$24351746$1$I$20240423$20240515$20240923$20240923$PER$$CN-ROCHE-3565147$ROCHE$$68$YR$E$F$Y$63$KG$20240923$$HP$CN$CN
243517471$24351747$1$I$20240728$20240919$20240923$20240923$EXP$FR-AFSSAPS-PV2024000868$FR-009507513-2409FRA007094$MERCK$$56$YR$$M$Y$70$KG$20240923$$MD$FR$FR
243517481$24351748$1$I$$20240516$20240923$20240923$PER$$CN-ROCHE-3565150$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243517491$24351749$1$I$20240418$20240514$20240923$20240923$PER$$CN-ROCHE-3564275$ROCHE$$63$YR$A$M$Y$60$KG$20240923$$HP$CN$CN
243517501$24351750$1$I$$20240509$20240923$20240923$PER$$IT-ROCHE-3564232$ROCHE$$$$$F$Y$$$20240923$$HP$IT$IT
243517511$24351751$1$I$20240508$20240514$20240923$20240923$PER$$CN-ROCHE-3564310$ROCHE$$55$YR$A$F$Y$54$KG$20240923$$HP$CN$CN
243517521$24351752$1$I$$20240514$20240923$20240923$PER$$PK-ROCHE-3564551$ROCHE$$28$YR$A$F$Y$$$20240923$$MD$PK$PK
243517531$24351753$1$I$$20240509$20240923$20240923$PER$$IT-ROCHE-3564229$ROCHE$$$$$F$Y$$$20240923$$HP$IT$IT
243517541$24351754$1$I$$20240509$20240923$20240923$PER$$IT-ROCHE-3564231$ROCHE$$$$$F$Y$$$20240923$$HP$IT$IT
243517551$24351755$1$I$20240110$20240513$20240923$20240923$PER$IT-MINISAL02-984336$IT-ROCHE-3564435$ROCHE$$41$YR$A$F$Y$$$20240923$$MD$IT$IT
243517561$24351756$1$I$20240125$20240513$20240923$20240923$PER$IT-MINISAL02-984337$IT-ROCHE-3564278$ROCHE$$41$YR$A$F$Y$$$20240923$$MD$IT$IT
243517571$24351757$1$I$$20240509$20240923$20240923$PER$$IT-ROCHE-3564230$ROCHE$$$$$F$Y$$$20240923$$HP$IT$IT
243517581$24351758$1$I$$20240509$20240923$20240923$PER$$IT-ROCHE-3564228$ROCHE$$$$$F$Y$$$20240923$$HP$IT$IT
243517591$24351759$1$I$20230512$20240509$20240923$20240923$PER$$JP-ROCHE-3566650$ROCHE$$8$DEC$E$F$Y$$$20240923$$MD$JP$JP
243517611$24351761$1$I$20240419$20240515$20240923$20240923$PER$$CN-ROCHE-3565157$ROCHE$$58$YR$A$M$Y$87$KG$20240923$$HP$CN$CN
243517621$24351762$1$I$$20240515$20240923$20240923$PER$$RU-ROCHE-3566036$ROCHE$$68$YR$E$F$Y$$$20240923$$MD$RU$RU
243517631$24351763$1$I$20240410$20240515$20240923$20240923$PER$$CN-ROCHE-3565156$ROCHE$$54$YR$A$F$Y$52$KG$20240923$$HP$CN$CN
243517641$24351764$1$I$$20240507$20240923$20240923$PER$$US-ROCHE-3565338$ROCHE$$86$YR$E$F$Y$$$20240923$$MD$US$US
243517651$24351765$1$I$$20240515$20240923$20240923$PER$$CO-ROCHE-3565575$ROCHE$$41$YR$A$F$Y$$$20240923$$CN$CO$CO
243517661$24351766$1$I$20240508$20240515$20240923$20240923$PER$$CN-ROCHE-3565152$ROCHE$$55$YR$A$F$Y$54$KG$20240923$$HP$CN$CN
243517671$24351767$1$I$$20240516$20240923$20240923$PER$$CN-ROCHE-3566000$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243517681$24351768$1$I$$20240507$20240923$20240923$PER$$JP-ROCHE-3565822$ROCHE$$$$$F$Y$$$20240923$$MD$JP$JP
243517691$24351769$1$I$$20240514$20240923$20240923$PER$$ES-ROCHE-3566208$ROCHE$$68$YR$E$F$Y$61$KG$20240923$$MD$ES$ES
243517701$24351770$1$I$$20240917$20240923$20240923$EXP$$US-INCYTE CORPORATION-2024IN009865$INCYTE$$$$$$Y$$$20240923$$CN$US$US
243517721$24351772$1$I$$20240912$20240923$20240923$PER$$US-ABBVIE-5925128$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243517751$24351775$1$I$20240511$20240517$20240923$20240923$PER$$CN-ROCHE-3566815$ROCHE$$61$YR$A$F$Y$69$KG$20240923$$HP$CN$CN
243517771$24351777$1$I$$20240516$20240923$20240923$PER$$PE-ROCHE-3567903$ROCHE$$$$$$Y$$$20240923$$CN$PE$PE
243517781$24351778$1$I$$20240516$20240923$20240923$PER$$CN-ROCHE-3566760$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243517791$24351779$1$I$20240517$20240520$20240923$20240923$PER$$CN-ROCHE-3567587$ROCHE$$42$YR$A$F$Y$$$20240923$$MD$CN$CN
243517801$24351780$1$I$$20240918$20240923$20240923$EXP$$PT-PFIZER INC-202400259547$PFIZER$Ramalho, A.. POSA-110 - (4096) - INFECCION POR VIRUS RESPIRATORIO SINCITIAL (VRS) EN PACIENTE ADULTO MAYOR CON ASMA GRAVE LA IMPORTANCIA DE LA SENSIBILIZACION FUNGICA. Congresso Nacional de Medicina Interna. 2024;1183$93$YR$$F$Y$$$20240923$$MD$PT$PT
243517811$24351781$1$I$$20240509$20240923$20240923$PER$$JP-ROCHE-3567288$ROCHE$$$$$M$Y$$$20240923$$PH$JP$JP
243517821$24351782$1$I$$20240516$20240923$20240923$PER$$CN-ROCHE-3567956$ROCHE$Man X, Huang J, Sun S, Zhou D, Zhang B, Fang S, Zheng F, Li C, Wang X, Huang W, Wang L, He Q, Fu H, Zhang Y, Liu C, Dong L, Zhao X, Xu L, Sun X, Fan B, Song L, Zhou Z, Yu J, and Li H Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a s. Clinical and translational medicine 2024 May;14 (5):1-11.$$$$$Y$$$20240923$$HP$CN$CN
243517831$24351783$1$I$20240417$20240520$20240923$20240923$PER$$CN-ROCHE-3567507$ROCHE$$47$YR$A$F$Y$$$20240923$$HP$CN$CN
243517841$24351784$1$I$$20240520$20240923$20240923$PER$$CN-ROCHE-3567372$ROCHE$$36$YR$A$F$Y$$$20240923$$CN$CN$CN
243517851$24351785$1$I$$20240521$20240923$20240923$PER$$US-ROCHE-3567978$ROCHE$$88$YR$E$M$Y$$$20240923$$MD$US$US
243517861$24351786$1$I$$20240521$20240923$20240923$PER$$DE-ROCHE-3567681$ROCHE$$68$YR$E$M$Y$$$20240923$$CN$DE$DE
243517871$24351787$1$I$20240505$20240517$20240923$20240923$PER$$CN-ROCHE-3566791$ROCHE$$44$YR$A$F$Y$45$KG$20240923$$HP$CN$CN
243517881$24351788$1$I$$20240521$20240923$20240923$PER$$ES-ROCHE-3568418$ROCHE$$$$A$F$Y$74$KG$20240923$$MD$ES$ES
243517891$24351789$1$I$$20240918$20240923$20240923$EXP$$US-TAKEDA-2022TUS015327$TAKEDA$$$$$F$Y$81.6$KG$20240923$$HP$US$US
243517901$24351790$1$I$20240504$20240521$20240923$20240923$PER$$CN-ROCHE-3569111$ROCHE$$67$YR$E$F$Y$65$KG$20240923$$HP$CN$CN
243517911$24351791$1$I$$20240523$20240923$20240923$PER$$PT-ROCHE-3566002$ROCHE$Mendes A, Mendes A, Raimundo R, Cochicho J, Viana S, Parente R, Lessa J, Neves A, Suleac M, Lavadinho I and Soles I Trastuzumab, a lifesaver with a remarkably augmented risk for cardiovascular events [Abstract number: 1987].Doi: 10.12890/2019_V6Sup1.. European Journal of Case Reports in Internal Medicine 2019;6 (SUPPLEMENT 1):222-223.$60$YR$A$F$Y$$$20240923$$HP$PT$PT
243517921$24351792$1$I$20240501$20240522$20240923$20240923$PER$$CN-ROCHE-3569098$ROCHE$$59$YR$A$M$Y$65$KG$20240923$$HP$CN$CN
243517931$24351793$1$I$$20240517$20240923$20240923$PER$$UY-ROCHE-3569150$ROCHE$$$$$$Y$$$20240923$$HP$UY$UY
243517941$24351794$1$I$$20240522$20240923$20240923$PER$$CN-ROCHE-3569037$ROCHE$$$$$$Y$$$20240923$$MD$CN$CN
243517951$24351795$1$I$$20240521$20240923$20240923$PER$$ES-ROCHE-3566113$ROCHE$$$$$$Y$$$20240923$$PH$ES$ES
243517961$24351796$1$I$$20240521$20240923$20240923$PER$$ES-ROCHE-3568620$ROCHE$$$$A$F$Y$75$KG$20240923$$MD$ES$ES
243517971$24351797$1$I$20240806$20240917$20240923$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015478$JAZZ$$76$YR$$F$Y$$$20240923$$CN$US$US
243517981$24351798$1$I$20240501$20240521$20240923$20240923$PER$$CA-ROCHE-3568827$ROCHE$$35$YR$A$F$Y$76$KG$20240923$$HP$CA$CA
243517991$24351799$1$I$$20240909$20240923$20240923$EXP$$US-MYLANLABS-2024M1083729$MYLAN$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen+#39;s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.$27$YR$$M$Y$$$20240923$$HP$US$US
243518011$24351801$1$I$$20240521$20240923$20240923$PER$$PE-ROCHE-3568655$ROCHE$$55$YR$A$F$Y$$$20240923$$CN$PE$PE
243518021$24351802$1$I$20240913$20240917$20240923$20240923$PER$$US-ABBVIE-5930098$ABBVIE$$41$YR$$F$Y$$$20240923$$MD$US$US
243518052$24351805$2$F$20240916$20240920$20240923$20240926$EXP$$US-AMGEN-USASP2024186756$AMGEN$$77$YR$E$F$Y$$$20240926$$CN$US$US
243518061$24351806$1$I$$20240916$20240923$20240923$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-150278$BRISTOL MYERS SQUIBB$Kudu E, Akdag G, Yildirim ME. Evaluation of emergency department visits and immune-related adverse effects (irAEs) in patients treated with nivolumab. Supportive Care in Cancer. 2024 Sep 09;32(10):1-9. doi:10.1007/s00520-024-08856-x.$64$YR$A$M$Y$$$20240923$$MD$TR$TR
243518071$24351807$1$I$20240520$20240523$20240923$20240923$PER$$CN-ROCHE-3569819$ROCHE$$54$YR$A$F$Y$70$KG$20240923$$HP$CN$CN
243518081$24351808$1$I$20240101$20240917$20240923$20240923$EXP$$JP-OTSUKA-2024_026059$OTSUKA$$57$YR$$M$Y$$$20240923$$MD$JP$JP
243518091$24351809$1$I$$20240523$20240923$20240923$PER$$GB-ROCHE-3568706$ROCHE$$$$E$F$Y$$$20240923$$CN$GB$GB
243518101$24351810$1$I$$20240522$20240923$20240923$PER$$PE-ROCHE-3570358$ROCHE$$$$$F$Y$$$20240923$$CN$PE$PE
243518111$24351811$1$I$$20240523$20240923$20240923$PER$$CN-ROCHE-3569940$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243518121$24351812$1$I$$20240521$20240923$20240923$PER$$US-ROCHE-3569319$ROCHE$$$$A$F$Y$$$20240923$$HP$US$US
243518131$24351813$1$I$$20240522$20240923$20240923$PER$$AR-ROCHE-3562321$ROCHE$$41$YR$A$F$Y$$$20240923$$CN$AR$AR
243518141$24351814$1$I$20240219$20240523$20240923$20240923$PER$$US-ROCHE-3570050$ROCHE$$61$YR$A$F$Y$74.84$KG$20240923$$CN$US$US
243518151$24351815$1$I$20240429$20240521$20240923$20240923$PER$$IN-ROCHE-3566140$ROCHE$$52$YR$A$F$Y$$$20240923$$CN$IN$IN
243518161$24351816$1$I$$20240519$20240923$20240923$PER$$PL-ROCHE-3569502$ROCHE$$$$$F$Y$$$20240923$$CN$PL$PL
243518171$24351817$1$I$$20240905$20240923$20240923$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09077$LUPIN$$$$$$Y$$$20240923$$CN$US$US
243518181$24351818$1$I$$20240916$20240923$20240923$EXP$$CA-GSK-CA2023117887$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$HP$CA$CA
243518211$24351821$1$I$$20240920$20240923$20240923$PER$$US-JNJFOC-20240959783$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$CN$US$US
243518232$24351823$2$F$$20240913$20240923$20240928$PER$$US-JNJFOC-20240936918$JOHNSON AND JOHNSON$$$$$F$Y$$$20240928$$CN$US$US
243518241$24351824$1$I$$20240521$20240923$20240923$PER$$PE-ROCHE-3570361$ROCHE$$53$YR$A$F$Y$$$20240923$$CN$PE$PE
243518251$24351825$1$I$$20240524$20240923$20240923$PER$$US-ROCHE-3570755$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243518261$24351826$1$I$20240516$20240527$20240923$20240923$PER$$CN-ROCHE-3571691$ROCHE$$52$YR$A$F$Y$54$KG$20240923$$HP$CN$CN
243518271$24351827$1$I$20240514$20240524$20240923$20240923$PER$$CN-ROCHE-3570912$ROCHE$$48$YR$A$F$Y$52.5$KG$20240923$$HP$CN$CN
243518281$24351828$1$I$20240426$20240524$20240923$20240923$PER$$CN-ROCHE-3571257$ROCHE$$61$YR$A$F$Y$50$KG$20240923$$HP$CN$CN
243518291$24351829$1$I$20240524$20240524$20240923$20240923$PER$$CA-ROCHE-3571431$ROCHE$$65$YR$E$F$Y$57$KG$20240923$$HP$CA$CA
243518301$24351830$1$I$$20240524$20240923$20240923$PER$$CO-ROCHE-3571342$ROCHE$$50$YR$A$F$Y$$$20240923$$CN$CO$CO
243518311$24351831$1$I$20240912$20240921$20240921$20240921$DIR$719333$$FDA-CTU$$71$YR$$F$N$50.4$KG$20240921$N$CN$US$
243518331$24351833$1$I$20240517$20240527$20240923$20240923$PER$$CN-ROCHE-3571434$ROCHE$$50$YR$A$F$Y$80$KG$20240923$$HP$CN$CN
243518341$24351834$1$I$$20240523$20240923$20240923$PER$$PE-ROCHE-3571390$ROCHE$$48$YR$A$F$Y$$$20240923$$CN$PE$PE
243518351$24351835$1$I$$20240523$20240923$20240923$PER$$PL-ROCHE-3571224$ROCHE$$$$$$Y$$$20240923$$HP$PL$PL
243518361$24351836$1$I$20240428$20240528$20240923$20240923$PER$$CN-ROCHE-3572434$ROCHE$$42$YR$A$F$Y$$$20240923$$HP$CN$CN
243518371$24351837$1$I$20240517$20240517$20240923$20240923$PER$$JP-ROCHE-3572113$ROCHE$$7$DEC$E$F$Y$$$20240923$$MD$JP$JP
243518381$24351838$1$I$$20240527$20240923$20240923$PER$$CH-ROCHE-3571855$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243518391$24351839$1$I$20240508$20240527$20240923$20240923$PER$$CN-ROCHE-3571706$ROCHE$$60$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243518401$24351840$1$I$20240521$20240528$20240923$20240923$PER$$US-ROCHE-3572267$ROCHE$$55$YR$A$F$Y$$$20240923$$CN$US$US
243518411$24351841$1$I$20240520$20240528$20240923$20240923$PER$$CN-ROCHE-3572412$ROCHE$$44$YR$A$F$Y$64$KG$20240923$$HP$CN$CN
243518421$24351842$1$I$$20240528$20240923$20240923$PER$$US-ROCHE-3563335$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243518431$24351843$1$I$$20240502$20240923$20240923$PER$$JP-ROCHE-3572259$ROCHE$$73$YR$E$F$Y$$$20240923$$PH$JP$JP
243518441$24351844$1$I$20240517$20240527$20240923$20240923$PER$$CN-ROCHE-3571704$ROCHE$$44$YR$A$F$Y$56$KG$20240923$$HP$CN$CN
243518451$24351845$1$I$20240320$20240528$20240923$20240923$PER$$US-ROCHE-3560275$ROCHE$$79$YR$E$F$Y$$$20240923$$CN$US$US
243518461$24351846$1$I$20240518$20240528$20240923$20240923$PER$$CN-ROCHE-3572430$ROCHE$$45$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243518471$24351847$1$I$20240101$20240916$20240923$20240923$EXP$$US-SA-2024SA271086$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240923$$HP$US$US
243518481$24351848$1$I$20240507$20240528$20240923$20240923$PER$$CN-ROCHE-3572401$ROCHE$$57$YR$A$F$Y$$$20240923$$HP$CN$CN
243518501$24351850$1$I$$20240917$20240923$20240923$PER$$US-IMP-2024000752$Harrow Health$$$$E$F$Y$$$20240923$$CN$US$US
243518511$24351851$1$I$$20240528$20240923$20240923$PER$$GB-ROCHE-3572599$ROCHE$$$$$$Y$$$20240923$$CN$GB$GB
243518521$24351852$1$I$$20240517$20240923$20240923$PER$$JP-ROCHE-3573145$ROCHE$$$$E$F$Y$$$20240923$$PH$JP$JP
243518531$24351853$1$I$20240509$20240529$20240923$20240923$PER$$CN-ROCHE-3573313$ROCHE$$65$YR$E$F$Y$55$KG$20240923$$HP$CN$CN
243518551$24351855$1$I$$20240517$20240923$20240923$PER$$JP-ROCHE-3573217$ROCHE$$$$$$Y$$$20240923$$MD$JP$JP
243518561$24351856$1$I$20240910$20240911$20240923$20240923$EXP$$RU-BRAINTREE LABORATORIES, INC.-2024BTE00604$BRAINTREE$$25$YR$$F$Y$$$20240923$$CN$RU$RU
243518571$24351857$1$I$20240101$20240912$20240923$20240923$PER$$US-BAYER-2024A132212$BAYER$$57$YR$A$M$Y$327$KG$20240923$$CN$US$US
243518581$24351858$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA272485$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240923$$CN$US$US
243518591$24351859$1$I$$20240916$20240923$20240923$PER$$US-AMGEN-USASP2024187089$AMGEN$Butler C.L.; Choi S.; Qiuheng Z. et al.. Transplant outcomes in lung transplant candidates desensitized with a daratumumab based protocol. Human Immunology. 2024;85:38$$$$$Y$$$20240923$$HP$US$US
243518601$24351860$1$I$20240418$20240528$20240923$20240923$PER$$CA-ROCHE-3559699$ROCHE$$59$YR$A$F$Y$133$KG$20240923$$CN$CA$CA
243518611$24351861$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA271529$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$HP$US$US
243518621$24351862$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269600$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240923$$HP$US$US
243518631$24351863$1$I$20240801$20240828$20240923$20240923$PER$$US-SA-2024SA272821$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240923$$HP$US$US
243518641$24351864$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA273272$SANOFI AVENTIS$$$$$F$Y$$$20240923$$CN$US$US
243518651$24351865$1$I$20240901$20240913$20240923$20240923$PER$$US-SA-2024SA235778$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240923$$MD$US$US
243518661$24351866$1$I$$20240528$20240923$20240923$PER$$US-ROCHE-3571192$ROCHE$$$$$$Y$$$20240923$$HP$US$US
243518671$24351867$1$I$$20240529$20240923$20240923$PER$$KR-ROCHE-3574297$ROCHE$$$$$$Y$$$20240923$$HP$KR$KR
243518681$24351868$1$I$20240516$20240530$20240923$20240923$PER$$CN-ROCHE-3574194$ROCHE$$55$YR$A$F$Y$52$KG$20240923$$HP$CN$CN
243518691$24351869$1$I$20240401$20240529$20240923$20240923$PER$$CA-ROCHE-3559647$ROCHE$$31$YR$A$F$Y$74.4$KG$20240923$$CN$CA$CA
243518701$24351870$1$I$20240522$20240530$20240923$20240923$PER$$CN-ROCHE-3574179$ROCHE$$33$YR$A$F$Y$$$20240923$$HP$CN$CN
243518711$24351871$1$I$$20240520$20240923$20240923$PER$$JP-ROCHE-3573841$ROCHE$$9$DEC$E$M$Y$$$20240923$$PH$JP$JP
243518721$24351872$1$I$$20240530$20240923$20240923$PER$$US-ROCHE-3574239$ROCHE$Banda J, Donthireddy K Delay in diagnosis of locally advanced breast cancer during lactation ^case report^.(Abstract number: PO1-20-11). DOI:10.1158/1538-7445.SABCS23-PO1-20-11. Cancer Research 2024 May;84 (9):-.$$$$$Y$$$20240923$$HP$US$US
243518731$24351873$1$I$$20240530$20240923$20240923$PER$$US-ROCHE-3574021$ROCHE$Li Q, Lv D, Sun X, Wang M, Cai L, Liu F, Li C, Zhao J, Sun J, Shi Y and Ma F Inetetamab combined with sirolimus and chemotherapy in HER2 positive metastatic breast cancer patients with abnormal activation of Pi3k/Akt/mTOR pathway after trastuzumab treatment (Abstract number: PO5-04-01). DOI:10.1158/1538-7445.SABCS23-PO5-04-01. Cancer Research 2024 May;84 (9):-.$$$$$Y$$$20240923$$HP$US$US
243518741$24351874$1$I$20240227$20240530$20240923$20240923$PER$$CN-ROCHE-3574181$ROCHE$$53$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243518751$24351875$1$I$$20240913$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146589$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240923$$PH$US$US
243518761$24351876$1$I$$20240913$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146552$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240923$$CN$US$US
243518771$24351877$1$I$20240229$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149490$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243518781$24351878$1$I$20240101$20240826$20240923$20240923$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000180$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240923$$CN$US$US
243518791$24351879$1$I$$20240529$20240923$20240923$PER$$MY-ROCHE-3575401$ROCHE$$39$YR$A$F$Y$$$20240923$$CN$MY$MY
243518801$24351880$1$I$$20240531$20240923$20240923$PER$$RU-ROCHE-3575400$ROCHE$$65$YR$E$F$Y$$$20240923$$MD$RU$RU
243518811$24351881$1$I$$20240531$20240923$20240923$PER$$JP-ROCHE-3575435$ROCHE$$$$$$Y$$$20240923$$HP$JP$JP
243518821$24351882$1$I$20210801$20240531$20240923$20240923$PER$$RU-ROCHE-3575666$ROCHE$$60$YR$A$F$Y$$$20240923$$MD$RU$RU
243518831$24351883$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64911$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243518841$24351884$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64925$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243518861$24351886$1$I$$20240603$20240923$20240923$PER$$US-ROCHE-3575680$ROCHE$$$$$$Y$$$20240923$$PH$US$US
243518871$24351887$1$I$20240520$20240531$20240923$20240923$PER$$CN-ROCHE-3575358$ROCHE$$55$YR$A$F$Y$45$KG$20240923$$HP$CN$CN
243518891$24351889$1$I$20240507$20240531$20240923$20240923$PER$$CN-ROCHE-3575285$ROCHE$$55$YR$A$F$Y$$$20240923$$HP$CN$CN
243518901$24351890$1$I$$20240529$20240923$20240923$PER$$US-ROCHE-3575737$ROCHE$$39$YR$A$M$Y$$$20240923$$MD$US$US
243518911$24351891$1$I$$20240531$20240923$20240923$PER$$CA-ROCHE-3563732$ROCHE$$$$A$F$Y$46.7$KG$20240923$$CN$CA$CA
243518921$24351892$1$I$20240524$20240530$20240923$20240923$PER$$CN-ROCHE-3575368$ROCHE$$49$YR$A$F$Y$45$KG$20240923$$HP$CN$CN
243518931$24351893$1$I$20231216$20240531$20240923$20240923$PER$$CO-ROCHE-3566479$ROCHE$$54$YR$A$F$Y$$$20240923$$MD$CO$CO
243518941$24351894$1$I$20240525$20240531$20240923$20240923$PER$$CN-ROCHE-3575323$ROCHE$$68$YR$E$F$Y$90$KG$20240923$$HP$CN$CN
243518951$24351895$1$I$20240522$20240531$20240923$20240923$PER$$CN-ROCHE-3575326$ROCHE$$90$YR$E$F$Y$$$20240923$$HP$CN$CN
243518961$24351896$1$I$$20240916$20240923$20240923$EXP$$US-CHEPLA-2024011876$CHEPLAPHARM$$40$YR$$F$Y$61.9$KG$20240923$$MD$COUNTRY NOT SPECIFIED$US
243518971$24351897$1$I$$20240917$20240923$20240923$EXP$$AT-CHEPLA-2024011943$CHEPLAPHARM$$$$A$M$Y$$$20240923$$CN$COUNTRY NOT SPECIFIED$AT
243518981$24351898$1$I$20240519$20240916$20240923$20240923$EXP$FR-AFSSAPS-AVMA2024000392$FR-CHEPLA-2024011919$CHEPLAPHARM$$21$YR$$M$Y$$$20240923$$PH$COUNTRY NOT SPECIFIED$FR
243518991$24351899$1$I$$20240916$20240923$20240923$EXP$$US-CHEPLA-2024012036$CHEPLAPHARM$Salk G, Mangala YO, Onukogu ID, Meleveedu K. CML-751 Clonal Competition Between JAK2 and BCR-ABL in Myeloproliferative Neoplasm. Clinical lymphoma, myeloma and leukemia. 2024;24(S1):S384.$67$YR$$M$Y$$$20240923$$HP$COUNTRY NOT SPECIFIED$US
243519001$24351900$1$I$$20240917$20240923$20240923$EXP$$AU-CHEPLA-2024011939$CHEPLAPHARM$$19$YR$$M$Y$$$20240923$$CN$COUNTRY NOT SPECIFIED$AU
243519021$24351902$1$I$20240514$20240603$20240923$20240923$PER$$CN-ROCHE-3576257$ROCHE$$25$YR$A$F$Y$50$KG$20240923$$HP$CN$CN
243519031$24351903$1$I$$20240529$20240923$20240923$PER$$IN-ROCHE-3576164$ROCHE$$$$$$Y$$$20240923$$MD$IN$IN
243519041$24351904$1$I$20240507$20240601$20240923$20240923$PER$$CN-ROCHE-3576178$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243519051$24351905$1$I$$20240604$20240923$20240923$PER$$SE-ROCHE-3576082$ROCHE$$$$$F$Y$$$20240923$$HP$SE$SE
243519061$24351906$1$I$20240507$20240601$20240923$20240923$PER$$CN-ROCHE-3576181$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243519071$24351907$1$I$$20240527$20240923$20240923$PER$$JP-ROCHE-3564917$ROCHE$$$$$F$Y$$$20240923$$MD$JP$JP
243519081$24351908$1$I$20231219$20240522$20240923$20240923$PER$$JP-ROCHE-3575885$ROCHE$$$$E$F$Y$$$20240923$$PH$JP$JP
243519091$24351909$1$I$$20240531$20240923$20240923$PER$$IT-ROCHE-3575792$ROCHE$Chilelli M, Signorelli C, Giron Berrios J, Raso A, Nelli F and Ruggeri E Long-Term Complete Response and Survival in Metastatic Extramammary Paget^s Disease Treated With Trastuzumab Plus Paclitaxel: A Case Report.Doi;10.7759/cureus.58924. Cureus 2024 Apr 24;16 (4):1-7.$57$YR$A$M$Y$$$20240923$$HP$IT$IT
243519101$24351910$1$I$20240603$20240604$20240923$20240923$PER$$CN-ROCHE-3576153$ROCHE$$56$YR$A$F$Y$$$20240923$$MD$CN$CN
243519111$24351911$1$I$20240519$20240603$20240923$20240923$PER$$CN-ROCHE-3576224$ROCHE$$59$YR$A$M$Y$60$KG$20240923$$HP$CN$CN
243519121$24351912$1$I$20240422$20240603$20240923$20240923$PER$$CN-ROCHE-3576144$ROCHE$$44$YR$A$F$Y$$$20240923$$HP$CN$CN
243519131$24351913$1$I$$20240529$20240923$20240923$PER$$US-ROCHE-3575763$ROCHE$$46$YR$A$F$Y$$$20240923$$MD$US$US
243519141$24351914$1$I$20240801$20240912$20240923$20240923$EXP$$US-UCBSA-2024047507$UCB$$$$$F$Y$$$20240923$$MD$US$US
243519151$24351915$1$I$$20240916$20240923$20240923$EXP$FR-AFSSAPS-AVPO2024000177$FR-TEVA-VS-3244268$TEVA$$40$YR$$M$Y$$$20240923$$PH$FR$FR
243519161$24351916$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377392$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519171$24351917$1$I$$20240603$20240923$20240923$PER$$US-ROCHE-3576448$ROCHE$$76$YR$E$F$Y$63.5$KG$20240923$$CN$US$US
243519181$24351918$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376695$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519191$24351919$1$I$20240517$20240603$20240923$20240923$PER$$TR-ROCHE-3571663$ROCHE$$53$YR$A$F$Y$$$20240923$$PH$TR$TR
243519201$24351920$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376915$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519211$24351921$1$I$20240510$20240603$20240923$20240923$PER$$CN-ROCHE-3576282$ROCHE$$46$YR$A$F$Y$52$KG$20240923$$HP$CN$CN
243519221$24351922$1$I$20240520$20240603$20240923$20240923$PER$$CN-ROCHE-3576290$ROCHE$$48$YR$A$F$Y$61$KG$20240923$$HP$CN$CN
243519231$24351923$1$I$$20231017$20240923$20240923$PER$$GR-ROCHE-3235416$ROCHE$$$$$F$Y$$$20240923$$MD$GR$GR
243519241$24351924$1$I$$20240530$20240923$20240923$PER$$US-ROCHE-3573530$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519251$24351925$1$I$$20240603$20240923$20240923$PER$$TR-ROCHE-3571782$ROCHE$$$$A$F$Y$$$20240923$$PH$TR$TR
243519261$24351926$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377254$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519271$24351927$1$I$20211007$20240402$20240923$20240923$PER$$BG-ROCHE-2982198$ROCHE$$62$YR$A$F$Y$64$KG$20240923$$MD$BG$BG
243519281$24351928$1$I$20240328$20240603$20240923$20240923$PER$$TR-ROCHE-3571777$ROCHE$$39$YR$A$F$Y$$$20240923$$PH$TR$TR
243519291$24351929$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376684$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519311$24351931$1$I$20240101$20240904$20240923$20240923$PER$$US-SA-2024SA273053$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240923$$CN$US$US
243519321$24351932$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272941$SANOFI AVENTIS$$$$C$M$Y$19.09$KG$20240923$$MD$US$US
243519331$24351933$1$I$20240516$20240603$20240923$20240923$PER$$CN-ROCHE-3576314$ROCHE$$69$YR$E$M$Y$$$20240923$$HP$CN$CN
243519341$24351934$1$I$$20240531$20240923$20240923$PER$$RU-ROCHE-3576519$ROCHE$$$$A$F$Y$$$20240923$$CN$RU$RU
243519351$24351935$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377515$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519361$24351936$1$I$$20240531$20240923$20240923$PER$$US-ROCHE-3573664$ROCHE$Zhukova L, Polshina N. Successful outcome of locally advanced HR+HER2+ breast cancer treatment in a young female after pancreas kidney transplantation. 3-year follow-up (Abstract number: PO4-20-09). DOI: 10.1158/1538-7445.SABCS23-PO4-20-09. Cancer Research 2024 May;84 (9):-.$34$YR$A$F$Y$$$20240923$$HP$US$US
243519371$24351937$1$I$20240506$20240531$20240923$20240923$PER$$CO-ROCHE-3576656$ROCHE$$59$YR$A$F$Y$$$20240923$$CN$CO$CO
243519381$24351938$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377370$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519391$24351939$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376694$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519401$24351940$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377382$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519411$24351941$1$I$$20240604$20240923$20240923$PER$$ES-ROCHE-3567043$ROCHE$$$$A$F$Y$73$KG$20240923$$MD$ES$ES
243519421$24351942$1$I$$20240604$20240923$20240923$PER$$ES-ROCHE-3567030$ROCHE$$$$E$F$Y$78$KG$20240923$$MD$ES$ES
243519431$24351943$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376683$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519441$24351944$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376916$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519451$24351945$1$I$$20240530$20240923$20240923$PER$$AR-ROCHE-3576729$ROCHE$$$$$F$Y$$$20240923$$CN$AR$AR
243519461$24351946$1$I$20240308$20240530$20240923$20240923$PER$$US-ROCHE-3576651$ROCHE$$72$YR$E$M$Y$$$20240923$$MD$US$US
243519471$24351947$1$I$$20240529$20240923$20240923$PER$$HN-ROCHE-3572026$ROCHE$$$$$F$Y$$$20240923$$MD$HN$HN
243519481$24351948$1$I$$20231102$20240923$20240923$PER$$DE-ROCHE-3255242$ROCHE$$$$$$Y$$$20240923$$MD$DE$DE
243519491$24351949$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376864$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519501$24351950$1$I$$20240805$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000439$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243519511$24351951$1$I$$20240530$20240923$20240923$PER$$US-ROCHE-3573394$ROCHE$Kim Y, Coogan A and Madrigrano A. Paraneoplastic cerebellar degeneration in anti-Yo antibody and HER2-positive metastatic breast carcinoma (Abstract number: PO5-20-06). Doi: 10.1158/1538-7445.SABCS23-PO5-20-06. Cancer Research 2024 May;84 (9):1-2.$57$YR$A$F$Y$$$20240923$$HP$US$US
243519531$24351953$1$I$20230401$20240809$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000444$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$CN$US$US
243519541$24351954$1$I$20240101$20240805$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000438$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243519551$24351955$1$I$20240101$20240805$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000437$REVANCE THERAPEUTICS$$$$A$F$Y$$$20240923$$HP$US$US
243519561$24351956$1$I$20240101$20240805$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000440$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243519571$24351957$1$I$20240719$20240829$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000442$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243519581$24351958$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376840$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519591$24351959$1$I$$20240916$20240923$20240923$PER$$US-BAYER-2024A132306$BAYER$$$$$M$Y$$$20240923$$CN$US$US
243519611$24351961$1$I$20211219$20231027$20240923$20240923$PER$$EG-ROCHE-3015652$ROCHE$$55$YR$A$F$Y$$$20240923$$MD$EG$EG
243519621$24351962$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376863$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519631$24351963$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377524$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519641$24351964$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377362$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519661$24351966$1$I$20220928$20231020$20240923$20240923$PER$$AT-ROCHE-3283732$ROCHE$$50$YR$A$F$Y$60$KG$20240923$$MD$AT$AT
243519671$24351967$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377361$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519681$24351968$1$I$20191126$20240919$20240923$20240923$EXP$$CA-TAKEDA-2024TUS093992$TAKEDA$$34$YR$$M$Y$$$20240923$$CN$CA$CA
243519701$24351970$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64930$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243519711$24351971$1$I$$20240921$20240921$20240921$DIR$719313$$FDA-CTU$$30$YR$$F$N$58.5$KG$20240921$N$CN$US$
243519721$24351972$1$I$20240806$20240916$20240923$20240923$EXP$PT-INFARMED-E202408-275$PT-FreseniusKabi-FK202412766$FRESENIUS KABI$$52$YR$A$F$Y$$$20240923$$PH$PT$PT
243519731$24351973$1$I$$20240913$20240923$20240923$EXP$$CH-FreseniusKabi-FK202414090$FRESENIUS KABI$Jandus P, perez-codesido S, Virgini AA, Fertani S. Successful desensitization to etoposide in a patient after cardiac arrest. Journal of Oncology Pharmacy Practice. 2024;1-5. doi:DOI: 10.1177/10781552241280723.$61$YR$A$F$Y$$$20240923$$HP$CH$CH
243519741$24351974$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376919$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519751$24351975$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64922$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243519761$24351976$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64921$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243519772$24351977$2$F$20240729$20240919$20240923$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142955$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240924$$MD$US$US
243519781$24351978$1$I$20240817$20240916$20240923$20240923$EXP$$FR-FreseniusKabi-FK202411595$FRESENIUS KABI$$64$YR$A$M$Y$60$KG$20240923$$MD$FR$FR
243519791$24351979$1$I$$20231130$20240923$20240923$PER$$CN-ROCHE-3138658$ROCHE$Wang C. Elimination of Infusion-related Reactions after the Switch of Herceptin with Zercepac. DOI: 10.23736/S0026-4806.22.08214-3.. Minerva medica 2022 Jul 05;114 (5):742-3.$62$YR$A$F$Y$$$20240923$$HP$CN$CN
243519811$24351981$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377527$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519821$24351982$1$I$20230505$20240112$20240923$20240923$PER$$PH-ROCHE-3350764$ROCHE$$69$YR$E$F$Y$$$20240923$$MD$PH$PH
243519831$24351983$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376839$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519841$24351984$1$I$20230204$20240220$20240923$20240923$PER$$IT-ROCHE-3352141$ROCHE$$79$YR$E$F$Y$56$KG$20240923$$MD$IT$IT
243519851$24351985$1$I$$20240911$20240923$20240923$EXP$$NL-ROCHE-10000087141$ROCHE$$61$YR$A$F$Y$$$20240923$$MD$NL$NL
243519861$24351986$1$I$$20231103$20240923$20240923$PER$$DE-ROCHE-3373985$ROCHE$$33$YR$A$F$Y$$$20240923$$MD$DE$DE
243519871$24351987$1$I$$20231101$20240923$20240923$PER$$US-ROCHE-3177043$ROCHE$$62$YR$A$F$Y$150.9$KG$20240923$$MD$US$US
243519881$24351988$1$I$20240312$20240812$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000446$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243519891$24351989$1$I$20240812$20240812$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000445$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
243519901$24351990$1$I$20240801$20240813$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000448$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243519911$24351991$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3372527$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243519921$24351992$1$I$$20240916$20240923$20240923$PER$$US-BAYER-2024A132619$BAYER$$$$$$Y$$$20240923$$CN$US$US
243519931$24351993$1$I$$20231204$20240923$20240923$PER$$US-ROCHE-3036839$ROCHE$$45$YR$A$F$Y$$$20240923$$MD$US$US
243519941$24351994$1$I$$20240917$20240923$20240923$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-28401$SAMSUNG BIOEPIS$$36$YR$A$F$Y$$$20240923$$CN$GB$GB
243519951$24351995$1$I$$20240917$20240923$20240923$EXP$$TH-AMGEN-THASP2024186608$AMGEN$Sukharomana M.; Jittawattanarat B.; Charuvanij S. et al.. Prevalence of BLA-1327, clinical characteristics and treatment outcomes in children with enthesitis-related arthritis. BMC Pediatrics. 2024;24 (1):1-12$$$$$Y$$$20240923$$HP$TH$TH
243519961$24351996$1$I$$20240919$20240923$20240923$EXP$$GB-SANDOZ INC.-SDZ2024GB081587$SANDOZ$$$$$F$Y$$$20240923$$CN$GB$GB
243519971$24351997$1$I$20240101$20240916$20240923$20240923$EXP$$TR-AMGEN-TURSP2024184442$AMGEN$$60$YR$A$F$Y$$$20240923$$CN$TR$TR
243519981$24351998$1$I$$20240911$20240923$20240923$PER$$US-JNJFOC-20240935483$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240923$$CN$US$US
243519991$24351999$1$I$$20240830$20240923$20240923$PER$$US-JNJFOC-20240910693$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$CN$US$US
243520001$24352000$1$I$20220306$20231031$20240923$20240923$PER$$EG-ROCHE-3116516$ROCHE$$48$YR$A$F$Y$$$20240923$$MD$EG$EG
243520011$24352001$1$I$20171010$20240207$20240923$20240923$PER$$PT-ROCHE-2986452$ROCHE$$72$YR$E$F$Y$$$20240923$$MD$PT$PT
243520031$24352003$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087556$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243520041$24352004$1$I$20230501$20231114$20240923$20240923$PER$$GH-ROCHE-3376035$ROCHE$$$$A$F$Y$69$KG$20240923$$CN$GH$GH
243520051$24352005$1$I$20240115$20240201$20240923$20240923$PER$$CA-ROCHE-3363873$ROCHE$$53$YR$A$F$Y$76$KG$20240923$$CN$CA$CA
243520061$24352006$1$I$$20240920$20240923$20240923$PER$$US-ROCHE-10000088285$ROCHE$$48$YR$A$M$Y$$$20240923$$CN$US$US
243520071$24352007$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087823$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243520081$24352008$1$I$20210601$20231110$20240923$20240923$PER$$EG-ROCHE-2979031$ROCHE$$64$YR$A$F$Y$$$20240923$$MD$EG$EG
243520091$24352009$1$I$$20231204$20240923$20240923$PER$$JP-ROCHE-3357517$ROCHE$$$$$$Y$$$20240923$$MD$JP$JP
243520101$24352010$1$I$20201130$20231207$20240923$20240923$PER$$CL-ROCHE-3333595$ROCHE$$75$YR$E$F$Y$$$20240923$$MD$CL$CL
243520111$24352011$1$I$20221024$20240103$20240923$20240923$PER$$IT-ROCHE-3277863$ROCHE$$74$YR$E$F$Y$54$KG$20240923$$MD$IT$IT
243520131$24352013$1$I$20220715$20231205$20240923$20240923$PER$$CY-ROCHE-3156403$ROCHE$$37$YR$A$F$Y$74$KG$20240923$$MD$CY$CY
243520141$24352014$1$I$20240912$20240913$20240923$20240923$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08682$HIKMA$$56$YR$$F$Y$$$20240923$$CN$US$US
243520161$24352016$1$I$20220207$20231123$20240923$20240923$PER$$AT-ROCHE-3288648$ROCHE$$58$YR$A$F$Y$52$KG$20240923$$MD$AT$AT
243520171$24352017$1$I$20220928$20240119$20240923$20240923$PER$$AT-ROCHE-3200982$ROCHE$$82$YR$E$F$Y$58$KG$20240923$$MD$AT$AT
243520181$24352018$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189147$NOVARTIS$$$$$M$Y$$$20240923$$CN$US$US
243520191$24352019$1$I$$20240919$20240923$20240923$PER$$US-ABBVIE-5931534$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243520201$24352020$1$I$20211118$20230929$20240923$20240923$PER$$EG-ROCHE-3040014$ROCHE$$45$YR$A$F$Y$$$20240923$$MD$EG$EG
243520211$24352021$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376913$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520221$24352022$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377257$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520231$24352023$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377596$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520241$24352024$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377560$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520251$24352025$1$I$20210101$20240117$20240923$20240923$PER$$AT-ROCHE-3047430$ROCHE$$45$YR$A$F$Y$58$KG$20240923$$MD$AT$AT
243520261$24352026$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377562$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520271$24352027$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377262$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520281$24352028$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012983$ELI LILLY AND CO$$59$YR$A$$Y$$$20240923$$CN$US$US
243520291$24352029$1$I$20240918$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012550$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240923$$CN$US$US
243520301$24352030$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012782$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240923$$CN$US$US
243520311$24352031$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012453$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240923$$CN$US$US
243520321$24352032$1$I$20240918$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012708$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240923$$CN$US$US
243520331$24352033$1$I$$20240918$20240923$20240923$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-102702$REGENERON$$$$$F$Y$$$20240923$$CN$US$US
243520342$24352034$2$F$$20240917$20240923$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409009271$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240925$$CN$US$US
243520361$24352036$1$I$$20240917$20240923$20240923$EXP$$JP-PFIZER INC-202400259674$PFIZER$$$$$$Y$$$20240923$$MD$JP$JP
243520381$24352038$1$I$20240101$20240916$20240923$20240923$EXP$$FR-PFIZER INC-PV202400053189$PFIZER$$38$YR$$F$Y$$$20240923$$PH$FR$FR
243520391$24352039$1$I$$20240920$20240923$20240923$PER$$US-ROCHE-10000088075$ROCHE$$$$A$$Y$$$20240923$$MD$US$US
243520401$24352040$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376918$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520411$24352041$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376797$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520422$24352042$2$F$20220101$20240923$20240923$20240925$EXP$$GE-PFIZER INC-202400260246$PFIZER$Mulloy, L.. New onset diabetic ketoacidosis in a renal transplant recipient. The American journal of the medical sciences. 2024$38$YR$$M$Y$$$20240925$$MD$GE$GE
243520432$24352043$2$F$20191001$20240923$20240923$20240927$EXP$$IT-PFIZER INC-PV202400122578$PFIZER$Volzone, F.. Long-term complete remission in a patient with high-risk primary mediastinal B-cell lymphoma and iatrogenic symptomatic bradycardia after only two courses of DA-EPOCH-R followed by chemo-free treatment. Annals of Hematology. 2024;10.1007/s00277-024-05994-4$23$YR$$F$Y$$$20240927$$HP$IT$IT
243520441$24352044$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377393$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520451$24352045$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376796$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520461$24352046$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376865$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520471$24352047$1$I$$20240921$20240923$20240923$PER$$US-ROCHE-10000088286$ROCHE$$25$YR$A$F$Y$$$20240923$$CN$US$US
243520481$24352048$1$I$20240918$20240920$20240923$20240923$PER$$US-ROCHE-10000088368$ROCHE$$52$YR$A$F$Y$$$20240923$$CN$US$US
243520491$24352049$1$I$20230101$20240917$20240923$20240923$EXP$$CA-PFIZER INC-202300237360$PFIZER$$63$YR$$M$Y$$$20240923$$MD$CA$CA
243520501$24352050$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377358$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520511$24352051$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376794$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520521$24352052$1$I$$20231101$20240923$20240923$PER$$US-ROCHE-3000833$ROCHE$$78$YR$E$M$Y$$$20240923$$MD$US$US
243520531$24352053$1$I$20220827$20231005$20240923$20240923$PER$$AT-ROCHE-3193213$ROCHE$$74$YR$E$F$Y$53$KG$20240923$$MD$AT$AT
243520541$24352054$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377369$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520551$24352055$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377555$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520561$24352056$1$I$20240901$20240916$20240923$20240923$EXP$$US-AMGEN-USASP2024184605$AMGEN$$$$$F$Y$61.23$KG$20240923$$CN$US$US
243520571$24352057$1$I$$20240917$20240923$20240923$EXP$$US-AMGEN-USASP2024186806$AMGEN$Molmenti E..P.; Nair V.; Jandovitz N. et.al. COVID-19 in kidney transplant recipients. American Journal of Transplantation. 2020;20 (7):1819-1825$45$YR$A$M$Y$$$20240923$$HP$US$US
243520581$24352058$1$I$$20240918$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149201$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240923$$CN$US$US
243520601$24352060$1$I$$20240109$20240923$20240923$PER$$DE-ROCHE-3358711$ROCHE$$44$YR$A$F$Y$88$KG$20240923$$CN$DE$DE
243520611$24352061$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377516$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520621$24352062$1$I$20220516$20231027$20240923$20240923$PER$$EG-ROCHE-3151666$ROCHE$$62$YR$A$F$Y$$$20240923$$MD$EG$EG
243520631$24352063$1$I$20210206$20231031$20240923$20240923$PER$$EG-ROCHE-2979026$ROCHE$$46$YR$A$F$Y$$$20240923$$MD$EG$EG
243520641$24352064$1$I$$20240913$20240923$20240923$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR115729$VIIV$$34$YR$$M$Y$$$20240923$$MD$US$US
243520651$24352065$1$I$20240501$20240819$20240923$20240923$EXP$$GB-TEVA-VS-3236378$TEVA$$47$YR$$M$Y$$$20240923$$CN$GB$GB
243520661$24352066$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64923$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243520671$24352067$1$I$$20240910$20240923$20240923$PER$$US-GSK-US2024112677$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243520681$24352068$1$I$$20240920$20240923$20240923$EXP$$US-GILEAD-2024-0688497$GILEAD$$$$C$F$Y$$$20240923$$CN$US$US
243520711$24352071$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64931$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243520731$24352073$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377554$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520741$24352074$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377523$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520751$24352075$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377532$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520761$24352076$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377530$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520771$24352077$1$I$$20240214$20240923$20240923$PER$$IE-ROCHE-3306055$ROCHE$O^Mahony D, Power S and Power D Human epidermal growth factor receptor 2-positive metastatic gastric cancer in complete sustained remission with trastuzumab. DOI 10.1016/S0140-6736(23)00141-1. Lancet 2023 Mar 04;401 (10378):772-.$71$YR$E$F$Y$$$20240923$$MD$IE$IE
243520781$24352078$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377390$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520791$24352079$1$I$20210609$20240311$20240923$20240923$PER$$BR-ROCHE-3306558$ROCHE$$68$YR$E$F$Y$$$20240923$$MD$BR$BR
243520801$24352080$1$I$20220302$20231205$20240923$20240923$PER$$EG-ROCHE-3071470$ROCHE$$60$YR$A$F$Y$$$20240923$$MD$EG$EG
243520811$24352081$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377529$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520821$24352082$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376792$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520831$24352083$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377258$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520841$24352084$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377518$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520851$24352085$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376862$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520861$24352086$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377534$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520871$24352087$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377557$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520881$24352088$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377394$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520891$24352089$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376861$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520901$24352090$1$I$20200601$20240117$20240923$20240923$PER$$AT-ROCHE-3034058$ROCHE$$82$YR$E$F$Y$$$20240923$$MD$AT$AT
243520911$24352091$1$I$$20231128$20240923$20240923$PER$$CN-ROCHE-3317484$ROCHE$$51$YR$A$F$Y$49$KG$20240923$$CN$CN$CN
243520921$24352092$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376687$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520931$24352093$1$I$20201121$20240104$20240923$20240923$PER$$EG-ROCHE-2979030$ROCHE$$63$YR$A$F$Y$$$20240923$$MD$EG$EG
243520941$24352094$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA273068$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240923$$CN$US$US
243520951$24352095$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376693$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520961$24352096$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377561$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520971$24352097$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377553$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243520981$24352098$1$I$20220101$20231120$20240923$20240923$PER$$JP-ROCHE-3223540$ROCHE$Sugawara S, Morishita A. What Pharmacy Pharmacists Can Do: A Case of HER2-positive Breast Cancer. The 16th Annual Meeting of the Pharmacy Society of Japan. 2022;:79-.;. P0915-5-PM What Pharmacy Pharmacists Can Do: A Case of HER2-positive Breast Cancer. The 33rd Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences 2023;:1709-.$41$YR$A$F$Y$$$20240923$$PH$JP$JP
243520991$24352099$1$I$20240101$20240905$20240923$20240923$PER$$US-SA-2024SA273089$SANOFI AVENTIS$$62$YR$A$M$Y$113.64$KG$20240923$$HP$US$US
243521001$24352100$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA272750$SANOFI AVENTIS$$$$C$F$Y$52$KG$20240923$$MD$US$US
243521011$24352101$1$I$$20240910$20240923$20240923$EXP$$ES-MEITHEAL-2024MPLIT00291$MEITHEAL PHARMACEUTICALS$$27$YR$A$F$Y$$$20240923$$HP$ES$ES
243521021$24352102$1$I$20240801$20240913$20240923$20240923$EXP$$NVSC2024CO188014$NOVARTIS$$57$YR$$F$Y$$$20240923$$CN$CO$CO
243521031$24352103$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189160$NOVARTIS$$$$$F$Y$70$KG$20240923$$CN$US$US
243521041$24352104$1$I$20240101$20240905$20240923$20240923$PER$$US-SA-2024SA273140$SANOFI AVENTIS$$60$YR$A$F$Y$119.73$KG$20240923$$MD$US$US
243521051$24352105$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189181$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
243521061$24352106$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377259$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521071$24352107$1$I$$20230926$20240923$20240923$PER$$US-ROCHE-3135723$ROCHE$$75$YR$E$M$Y$$$20240923$$MD$US$US
243521081$24352108$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377522$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521091$24352109$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376685$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521101$24352110$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377594$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521111$24352111$1$I$$20240913$20240923$20240923$EXP$$GB-BAYER-2024A131320$BAYER$$$$A$M$Y$$$20240923$$HP$GB$GB
243521121$24352112$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377260$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521131$24352113$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377388$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521141$24352114$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376793$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521151$24352115$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377363$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521161$24352116$1$I$$20231010$20240923$20240923$PER$$GR-ROCHE-3129598$ROCHE$$$$$F$Y$$$20240923$$MD$GR$GR
243521171$24352117$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376843$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521181$24352118$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376688$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521191$24352119$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377519$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521201$24352120$1$I$$20240920$20240923$20240923$EXP$$US-GILEAD-2024-0688505$GILEAD$$$$A$F$Y$$$20240923$$HP$US$US
243521222$24352122$2$F$$20240916$20240923$20240927$EXP$$GB-ADVANZ PHARMA-202409007484$ADVANZ PHARMA$$$$$$Y$$$20240927$$MD$GB$GB
243521231$24352123$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376838$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521241$24352124$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376691$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521251$24352125$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376841$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521261$24352126$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64938$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243521271$24352127$1$I$20240921$20240921$20240921$20240921$DIR$719302$$FDA-CTU$$70$YR$$F$N$74.7$KG$20240921$N$CN$US$
243521281$24352128$1$I$$20240921$20240921$20240921$DIR$719325$$FDA-CTU$$$$$F$N$$$20240921$N$CN$US$
243521291$24352129$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377597$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521301$24352130$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376689$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521311$24352131$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377521$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521321$24352132$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64935$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243521341$24352134$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377261$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521351$24352135$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377360$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521361$24352136$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377531$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521371$24352137$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377365$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521381$24352138$1$I$$20231102$20240923$20240923$PER$$DE-ROCHE-3256977$ROCHE$$$$$$Y$$$20240923$$MD$DE$DE
243521391$24352139$1$I$20240101$20240909$20240923$20240923$EXP$$US-UCBSA-2024046372$UCB$$$$$F$Y$$$20240923$$CN$US$US
243521401$24352140$1$I$$20240828$20240923$20240923$30DAY$$US-Kaleo, Inc.-2024KL000043$KALEO$$25$YR$A$M$Y$$$20240920$$CN$US$US
243521411$24352141$1$I$$20240919$20240923$20240923$PER$$US-BAYER-2024A134197$BAYER$$33$YR$A$F$Y$$$20240923$$CN$US$US
243521421$24352142$1$I$20240901$20240917$20240923$20240923$EXP$$US-INCYTE CORPORATION-2024IN009839$INCYTE$$$$$$Y$$$20240923$$CN$US$US
243521431$24352143$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377255$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521441$24352144$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376922$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521451$24352145$1$I$20210512$20231103$20240923$20240923$PER$$RO-ROCHE-3201463$ROCHE$$57$YR$A$F$Y$75$KG$20240923$$MD$RO$RO
243521461$24352146$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377556$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521471$24352147$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376842$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521481$24352148$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377528$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521491$24352149$1$I$20210928$20231030$20240923$20240923$PER$$EG-ROCHE-3020005$ROCHE$$55$YR$A$F$Y$$$20240923$$MD$EG$EG
243521501$24352150$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377384$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521521$24352152$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376795$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521531$24352153$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114149$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$MD$US$US
243521541$24352154$1$I$20230101$20240919$20240923$20240923$PER$$US-BAYER-2024A134468$BAYER$$68$YR$E$F$Y$69$KG$20240923$$CN$US$US
243521561$24352156$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377256$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521571$24352157$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377385$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521581$24352158$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377387$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521591$24352159$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377389$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521601$24352160$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377533$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521611$24352161$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377595$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521621$24352162$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377563$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521631$24352163$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376921$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521641$24352164$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377386$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521651$24352165$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377371$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521661$24352166$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376686$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521671$24352167$1$I$$20240828$20240923$20240923$30DAY$$US-Kaleo, Inc.-2024KL000044$KALEO$$10$YR$C$F$Y$$$20240920$$CN$US$US
243521681$24352168$1$I$20240806$20240910$20240923$20240923$PER$$US-SA-2024SA273177$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240923$$CN$US$US
243521691$24352169$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA273055$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240923$$CN$US$US
243521701$24352170$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268706$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240923$$HP$US$US
243521711$24352171$1$I$$20240827$20240923$20240923$PER$$US-SA-2024SA269006$SANOFI AVENTIS$$$$E$M$Y$76.19$KG$20240923$$MD$US$US
243521721$24352172$1$I$20240101$20240912$20240923$20240923$PER$$US-SA-2024SA267845$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240923$$HP$US$US
243521731$24352173$1$I$20240101$20240909$20240923$20240923$PER$$US-SA-2024SA274247$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240923$$MD$US$US
243521741$24352174$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013950$BAUSCH AND LOMB$$79$YR$$M$Y$$$20240923$$HP$CA$CA
243521751$24352175$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013958$BAUSCH AND LOMB$$79$YR$$F$Y$$$20240923$$CN$CA$CA
243521761$24352176$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013959$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240923$$CN$CA$CA
243521771$24352177$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013953$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240923$$CN$CA$CA
243521781$24352178$1$I$$20240919$20240923$20240923$30DAY$$CO-PFIZER INC-PV202400122851$PFIZER$$10$YR$$M$Y$19.7$KG$20240923$$CN$CO$CO
243521791$24352179$1$I$20240919$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64944$$FDA-CTU$$81$YR$$F$N$$$20240923$N$$US$
243521801$24352180$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64945$$FDA-CTU$$62$YR$$M$N$73.03$KG$20240923$N$HP$US$
243521811$24352181$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377520$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521831$24352183$1$I$$20240918$20240918$20240918$DIR$FDA-CDER-CTU-2024-64919$$FDA-CTU$$$$$$N$$$20240918$$CN$US$
243521841$24352184$1$I$20230419$20231101$20240923$20240923$PER$$CA-ROCHE-3335393$ROCHE$$41$YR$A$F$Y$80$KG$20240923$$HP$CA$CA
243521851$24352185$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377525$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521861$24352186$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377535$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521871$24352187$1$I$$20231020$20240923$20240923$PER$$US-ROCHE-3314702$ROCHE$$68$YR$E$F$Y$$$20240923$$MD$US$US
243521881$24352188$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376799$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521891$24352189$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376844$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521901$24352190$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376914$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521911$24352191$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376800$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521921$24352192$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377368$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243521931$24352193$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013972$BAUSCH AND LOMB$$64$YR$$F$Y$$$20240923$$CN$CA$CA
243521941$24352194$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013975$BAUSCH AND LOMB$$64$YR$$M$Y$$$20240923$$CN$CA$CA
243521951$24352195$1$I$$20240920$20240923$20240923$EXP$$US-BAUSCH-BL-2024-014218$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240923$$CN$US$US
243521961$24352196$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013980$BAUSCH AND LOMB$$72$YR$$M$Y$$$20240923$$CN$CA$CA
243521971$24352197$1$I$$20240920$20240923$20240923$EXP$$ES-BAUSCH-BL-2024-014229$BAUSCH AND LOMB$$$$$F$Y$$$20240923$$MD$ES$ES
243521991$24352199$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010471$APOTEX$$76$YR$$M$Y$$$20240923$$PH$CA$CA
243522001$24352200$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013993$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240923$$CN$CA$CA
243522012$24352201$2$F$$20240920$20240923$20240927$PER$$US-BAYER-2024A134727$BAYER$$$$$F$Y$$$20240927$$CN$US$US
243522021$24352202$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377526$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522031$24352203$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376917$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522041$24352204$1$I$20200624$20231009$20240923$20240923$PER$$AT-ROCHE-3101043$ROCHE$$74$YR$E$F$Y$55$KG$20240923$$MD$AT$AT
243522051$24352205$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377391$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522061$24352206$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377366$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522071$24352207$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377559$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522081$24352208$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376682$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522091$24352209$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376798$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522111$24352211$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377367$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522121$24352212$1$I$20230823$20240912$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145938$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240923$$CN$US$US
243522132$24352213$2$F$20240915$20240923$20240923$20240924$PER$$US-AMGEN-USASP2024188665$AMGEN$$73$YR$E$M$Y$$$20240924$$CN$US$US
243522141$24352214$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-014008$BAUSCH AND LOMB$$69$YR$$M$Y$$$20240923$$CN$CA$CA
243522151$24352215$1$I$$20240911$20240923$20240923$EXP$$CA-BEH-2024178545$CSL BEHRING$$64$YR$A$F$Y$90.7$KG$20240923$$CN$CA$CA
243522161$24352216$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013961$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240923$$CN$CA$CA
243522171$24352217$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-014002$BAUSCH AND LOMB$$49$YR$$F$Y$$$20240923$$CN$CA$CA
243522181$24352218$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013999$BAUSCH AND LOMB$$69$YR$$M$Y$$$20240923$$CN$CA$CA
243522191$24352219$1$I$20240729$20240920$20240923$20240923$EXP$FR-AFSSAPS-GR2024001110$FR-BAUSCH-BL-2024-014212$BAUSCH AND LOMB$$79$YR$$M$Y$106$KG$20240923$$PH$FR$FR
243522201$24352220$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377517$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522221$24352222$1$I$$20240920$20240923$20240923$EXP$$HU-BAUSCH-BL-2024-014213$BAUSCH AND LOMB$$60$YR$$M$Y$$$20240923$$MD$HU$HU
243522231$24352223$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377383$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522241$24352224$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377558$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522251$24352225$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376690$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522261$24352226$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376920$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522271$24352227$1$I$20240801$20240815$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000455$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243522281$24352228$1$I$20240731$20240815$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000457$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243522291$24352229$1$I$20240718$20240816$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000456$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243522301$24352230$1$I$20240801$20240815$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000454$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243522311$24352231$1$I$20240801$20240814$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000450$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243522321$24352232$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377263$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522331$24352233$1$I$$20231011$20240923$20240923$PER$$ES-ROCHE-3360975$ROCHE$$$$A$F$Y$$$20240923$$MD$ES$ES
243522341$24352234$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377598$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522351$24352235$1$I$20230801$20231006$20240923$20240923$PER$$CA-ROCHE-3372257$ROCHE$$58$YR$A$F$Y$121$KG$20240923$$CN$CA$CA
243522361$24352236$1$I$20221117$20231010$20240923$20240923$PER$$EG-ROCHE-3286322$ROCHE$$60$YR$A$F$Y$$$20240923$$MD$EG$EG
243522371$24352237$1$I$20240101$20240909$20240923$20240923$EXP$$US-UCBSA-2024048446$UCB$$$$$F$Y$$$20240923$$CN$US$US
243522381$24352238$1$I$$20240829$20240923$20240923$30DAY$$US-Kaleo, Inc.-2024KL000045$KALEO$$19$YR$A$M$Y$$$20240920$$CN$US$US
243522391$24352239$1$I$$20240207$20240923$20240923$PER$$RO-ROCHE-3120722$ROCHE$$43$YR$A$F$Y$60$KG$20240923$$CN$RO$RO
243522401$24352240$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3376696$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522411$24352241$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377359$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522421$24352242$1$I$$20231019$20240923$20240923$PER$$US-ROCHE-3377364$ROCHE$$$$$F$Y$$$20240923$$HP$US$US
243522431$24352243$1$I$20240722$20240920$20240923$20240923$EXP$$NVSC2024US188224$NOVARTIS$$66$YR$$F$Y$$$20240923$$MD$US$US
243522441$24352244$1$I$20220416$20231027$20240923$20240923$PER$$EG-ROCHE-3096951$ROCHE$$62$YR$A$F$Y$$$20240923$$MD$EG$EG
243522451$24352245$1$I$$20240130$20240923$20240923$PER$$US-ROCHE-3029767$ROCHE$$47$YR$A$M$Y$74$KG$20240923$$MD$US$US
243522461$24352246$1$I$$20240920$20240923$20240923$PER$$US-BAYER-2024A135317$BAYER$$$$$$Y$$$20240923$$CN$US$US
243522471$24352247$1$I$$20240913$20240923$20240923$EXP$$CA-TEVA-VS-3246013$TEVA$$37$YR$$M$Y$$$20240923$$CN$CA$CA
243522481$24352248$1$I$20220722$20240216$20240923$20240923$PER$$AT-ROCHE-3347180$ROCHE$$76$YR$E$F$Y$55$KG$20240923$$MD$AT$AT
243522491$24352249$1$I$20220315$20240516$20240923$20240923$PER$$EG-ROCHE-3152082$ROCHE$$35$YR$A$F$Y$$$20240923$$MD$EG$EG
243522501$24352250$1$I$$20240305$20240923$20240923$PER$$US-ROCHE-3325620$ROCHE$$53$YR$A$M$Y$$$20240923$$MD$US$US
243522511$24352251$1$I$$20240304$20240923$20240923$PER$$US-ROCHE-3319680$ROCHE$$25$YR$A$F$Y$$$20240923$$MD$US$US
243522521$24352252$1$I$20230304$20240513$20240923$20240923$PER$$TH-ROCHE-3306380$ROCHE$$56$YR$A$F$Y$$$20240923$$PH$TH$TH
243522531$24352253$1$I$$20240529$20240923$20240923$PER$$US-ROCHE-3365466$ROCHE$$82$YR$E$M$Y$$$20240923$$MD$US$US
243522541$24352254$1$I$$20240417$20240923$20240923$PER$$US-ROCHE-3281194$ROCHE$$56$YR$A$F$Y$$$20240923$$HP$US$US
243522551$24352255$1$I$20230605$20240322$20240923$20240923$PER$$IT-ROCHE-3363045$ROCHE$$64$YR$A$F$Y$$$20240923$$MD$IT$IT
243522561$24352256$1$I$20211110$20240516$20240923$20240923$PER$$EG-ROCHE-3197348$ROCHE$$47$YR$A$F$Y$$$20240923$$MD$EG$EG
243522571$24352257$1$I$$20240909$20240923$20240923$EXP$$JP-SA-2024SA272704$SANOFI AVENTIS$$$$$F$Y$$$20240923$$HP$JP$JP
243522581$24352258$1$I$$20240918$20240923$20240923$EXP$$GB-BAUSCH-BL-2024-014134$BAUSCH AND LOMB$Abdalrazag O, Okoye A, Muniyappa S. Title to be provided. British Journal of Diabetes. 2024 JUN 01;24(1):. doi:10.15277/bjd.2024.454$77$YR$$M$Y$$$20240923$$HP$GB$GB
243522591$24352259$1$I$20220528$20240306$20240923$20240923$PER$$IT-ROCHE-3044733$ROCHE$$56$YR$A$F$Y$60$KG$20240923$$MD$IT$IT
243522611$24352261$1$I$$20240917$20240923$20240923$EXP$$NL-BAUSCH-BL-2024-014088$BAUSCH AND LOMB$Brouwer M, Offermans M, van Nuil L, Poukens A, van Oijen B, Dormans T. Effective Extracorporeal Treatment of Metformin-Associated Lactic Acidosis using Continuous Venovenous Hemodiafiltration. European journal of case reports in internal medicine. 2024 SEP 03;11(9):. doi:10.12890/2024_004784.$57$YR$$F$Y$$$20240923$$HP$NL$NL
243522621$24352262$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-014016$BAUSCH AND LOMB$$57$YR$$M$Y$$$20240923$$CN$CA$CA
243522631$24352263$1$I$20240101$20240918$20240923$20240923$PER$$US-BAUSCH-BL-2024-014106$BAUSCH AND LOMB$$79$YR$$M$Y$$$20240923$$CN$US$US
243522641$24352264$1$I$20240908$20240920$20240923$20240923$PER$$US-BAYER-2024A134763$BAYER$$16$YR$T$F$Y$$$20240923$$MD$US$US
243522652$24352265$2$F$20240101$20240916$20240923$20240927$EXP$$CA-BAUSCH-BL-2024-014037$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240927$$CN$CA$CA
243522661$24352266$1$I$$20240604$20240923$20240923$PER$$RO-ROCHE-3057955$ROCHE$$68$YR$E$F$Y$80$KG$20240923$$CN$RO$RO
243522671$24352267$1$I$20220201$20240606$20240923$20240923$PER$$DE-ROCHE-3115485$ROCHE$$72$YR$E$F$Y$103$KG$20240923$$MD$DE$DE
243522681$24352268$1$I$20240919$20240921$20240921$20240921$DIR$719305$$FDA-CTU$$55$YR$$F$N$65.25$KG$20240921$N$CN$US$
243522691$24352269$1$I$20240915$20240921$20240921$20240921$DIR$719309$$FDA-CTU$$44$YR$$M$N$130.5$KG$20240921$N$CN$US$
243522701$24352270$1$I$20240808$20240819$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000459$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
243522711$24352271$1$I$20240824$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010713$APOTEX$$43$YR$A$M$Y$$$20240923$$CN$CA$CA
243522721$24352272$1$I$20240905$20240906$20240923$20240923$PER$$US-PERRIGO-24US008416$PERRIGO$$$$$F$Y$$$20240923$$CN$US$US
243522731$24352273$1$I$$20240603$20240923$20240923$PER$$CN-ROCHE-3142871$ROCHE$Wang H, Shao B and DI L. Third-line Pyrotinib, Trastuzumab (Zercepac) and Vinorelbine for brain metastases of HER2-positive advanced breast cancer patient. DOI: 10.23736/S0026-4806.22.08236-2. Minerva medica 2024 Apr;115 (2):257-9.$62$YR$A$F$Y$$$20240923$$HP$CN$CN
243522741$24352274$1$I$20240614$20240619$20240923$20240923$PER$$US-PERRIGO-24US005935$PERRIGO$$59$YR$$F$Y$48.526$KG$20240923$$CN$US$US
243522751$24352275$1$I$20240622$20240624$20240923$20240923$PER$$US-PERRIGO-24US006076$PERRIGO$$69$YR$$F$Y$88.435$KG$20240923$$CN$US$US
243522761$24352276$1$I$20240801$20240823$20240923$20240923$PER$$US-PERRIGO-24US007967$PERRIGO$$66$YR$$F$Y$48.526$KG$20240923$$CN$US$US
243522771$24352277$1$I$20220317$20240729$20240923$20240923$PER$$US-PERRIGO-24US007190$PERRIGO$$68$YR$$F$Y$58.05$KG$20240923$$CN$US$US
243522781$24352278$1$I$20240817$20240818$20240923$20240923$PER$$US-PERRIGO-24US007779$PERRIGO$$$$A$$Y$$$20240923$$CN$US$US
243522791$24352279$1$I$20240624$20240626$20240923$20240923$PER$$US-PERRIGO-24US006138$PERRIGO$$67$YR$$M$Y$74.83$KG$20240923$$CN$US$US
243522801$24352280$1$I$20240812$20240813$20240923$20240923$PER$$US-PERRIGO-24US007652$PERRIGO$$$$$M$Y$$$20240923$$CN$US$US
243522811$24352281$1$I$20240101$20240807$20240923$20240923$PER$$US-PERRIGO-24US007460$PERRIGO$$81$YR$$F$Y$59.864$KG$20240923$$CN$US$US
243522821$24352282$1$I$$20240916$20240923$20240923$EXP$$PL-TEVA-VS-3244864$TEVA$Rybka J, Kuszczak B, Bogucka-Fedorczuk A. Treatment of primary central nervous system lymphoma (PCNSL) - single center experience and literature review. Acta-Haematol-Polon 2024; 55 (3): 151-156.$$$$$Y$$$20240923$$HP$PL$PL
243522831$24352283$1$I$$20240920$20240923$20240923$PER$$US-BAYER-2024A134805$BAYER$$$$$M$Y$$$20240923$$CN$US$US
243522841$24352284$1$I$20240424$20240913$20240923$20240923$EXP$$FR-FreseniusKabi-FK202413889$FRESENIUS KABI$$5$MON$I$F$Y$6.6$KG$20240923$$MD$FR$FR
243522851$24352285$1$I$$20240913$20240923$20240923$EXP$$US-VIVUS, Inc.-2024V1001122$VIVUS$$$$A$F$Y$$$20240919$$CN$US$US
243522861$24352286$1$I$$20240920$20240923$20240923$PER$$US-BAYER-2024A134850$BAYER$$46$YR$A$F$Y$$$20240923$$MD$US$US
243522871$24352287$1$I$$20240827$20240923$20240923$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000185$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240923$$CN$US$US
243522881$24352288$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189182$NOVARTIS$$$$$F$Y$$$20240923$$MD$US$US
243522891$24352289$1$I$20240813$20240920$20240923$20240923$EXP$FR-AFSSAPS-MA2024001497$NVSC2024FR188057$NOVARTIS$$68$YR$$F$Y$86$KG$20240923$$MD$FR$FR
243522911$24352291$1$I$$20240829$20240923$20240923$30DAY$$MX-JNJFOC-20240956557$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$MX$MX
243522931$24352293$1$I$20201126$20240917$20240923$20240923$EXP$PL-URPL-1-3245-2020$PL-TEVA-VS-3244711$TEVA$$28$YR$$F$Y$70$KG$20240923$$MD$PL$PL
243522941$24352294$1$I$$20240911$20240923$20240923$EXP$$US-FARMAPROD-202409-3250$DOMPE FARMACEUTICI$$$$A$M$Y$$$20240923$$CN$US$US
243522951$24352295$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011892$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240923$$CN$US$US
243522961$24352296$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012452$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240923$$CN$US$US
243522971$24352297$1$I$20240919$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010607$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240923$$CN$US$US
243522981$24352298$1$I$$20240916$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010061$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243523002$24352300$2$F$$20240926$20240923$20240927$EXP$$TW-SA-2024SA273411$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240927$$MD$TW$TW
243523011$24352301$1$I$20240101$20240902$20240923$20240923$PER$$US-SA-2024SA273156$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240923$$MD$US$US
243523021$24352302$1$I$$20240913$20240923$20240923$PER$$US-ABBVIE-5924579$ABBVIE$$$$A$M$Y$$$20240923$$MD$US$US
243523031$24352303$1$I$$20240910$20240923$20240923$PER$$US-FARMAPROD-202409-3243$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240923$$CN$US$US
243523042$24352304$2$F$$20240913$20240923$20240927$EXP$$NVSC2024BR187883$NOVARTIS$$$$$F$Y$$$20240927$$CN$BR$BR
243523061$24352306$1$I$20240730$20240921$20240921$20240921$DIR$719345$$FDA-CTU$$42$YR$$F$N$83.7$KG$20240921$N$CN$US$
243523101$24352310$1$I$20240917$20240921$20240921$20240921$DIR$719342$$FDA-CTU$$67$YR$$F$N$114.75$KG$20240921$N$CN$US$
243523111$24352311$1$I$20240825$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64946$$FDA-CTU$$64$YR$$F$N$$$20240923$N$$US$
243523121$24352312$1$I$$20240918$20240923$20240923$PER$$US-ROCHE-10000086525$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243523131$24352313$1$I$20240307$20240923$20240923$20240923$PER$$US-PROD-AS2-212756134-RB-087220-2024$RECKITT BENCKISER$$85$YR$$F$Y$$$20240923$$CN$US$US
243523141$24352314$1$I$$20240911$20240923$20240923$EXP$$CH-TAKEDA-2024TUS093687$TAKEDA$$$$$M$Y$$$20240923$$HP$CH$CH
243523151$24352315$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148118$BRISTOL MYERS SQUIBB$Phillipps J, Nassief G, Morecroft R, Adeyelu T, Elliott A, Abdulla F, et al. Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma. npj Precision Oncology. 2024;8(1):1-7. doi:10.1038/s41698-024-00684-w.$60$YR$A$M$Y$$$20240923$$HP$US$US
243523171$24352317$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150309$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$54.88$KG$20240923$$CN$US$US
243523181$24352318$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150319$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$95.25$KG$20240923$$CN$US$US
243523191$24352319$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150271$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$65.77$KG$20240923$$CN$US$US
243523201$24352320$1$I$20240912$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149726$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240923$$HP$US$US
243523221$24352322$1$I$20240801$20240920$20240923$20240923$PER$$US-BAYER-2024A135056$BAYER$$42$YR$A$F$Y$$$20240923$$MD$US$US
243523232$24352323$2$F$20240919$20240923$20240923$20240924$PER$$US-AMGEN-USASP2024188576$AMGEN$$34$YR$A$F$Y$$$20240924$$CN$US$US
243523241$24352324$1$I$$20240625$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003775$PAREXEL$$57$YR$$F$Y$$$20240923$$CN$US$US
243523251$24352325$1$I$20240706$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003966$PAREXEL$$60$YR$$F$Y$$$20240923$$CN$US$US
243523261$24352326$1$I$20240706$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003886$PAREXEL$$90$YR$$F$Y$$$20240923$$CN$US$US
243523271$24352327$1$I$$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003968$PAREXEL$$92$YR$$F$Y$$$20240923$$CN$US$US
243523281$24352328$1$I$20221205$20240921$20240921$20240921$DIR$719306$$FDA-CTU$$16$YR$$M$N$72$KG$20240921$N$CN$US$
243523291$24352329$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003427$PAREXEL$$68$YR$$F$Y$$$20240923$$CN$US$US
243523301$24352330$1$I$$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003994$PAREXEL$$59$YR$$F$Y$$$20240923$$CN$US$US
243523311$24352331$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003998$PAREXEL$$53$YR$$F$Y$$$20240923$$CN$US$US
243523321$24352332$1$I$$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003996$PAREXEL$$71$YR$$F$Y$$$20240923$$CN$US$US
243523331$24352333$1$I$$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003992$PAREXEL$$78$YR$$F$Y$$$20240923$$CN$US$US
243523341$24352334$1$I$$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003986$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243523351$24352335$1$I$20240714$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64947$$FDA-CTU$$56$YR$$M$N$$$20240923$Y$HP$US$
243523361$24352336$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64948$$FDA-CTU$$32$YR$$F$N$$$20240923$N$$US$
243523371$24352337$1$I$20240920$20240921$20240921$20240921$DIR$719326$$FDA-CTU$$80$YR$$F$N$$$20240921$N$HP$US$
243523381$24352338$1$I$20240706$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003755$PAREXEL$$46$YR$$F$Y$$$20240923$$CN$US$US
243523391$24352339$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004028$PAREXEL$$65$YR$$F$Y$$$20240923$$HP$US$US
243523401$24352340$1$I$$20240918$20240923$20240923$PER$$US-JNJFOC-20240954519$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$MD$US$US
243523411$24352341$1$I$$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004000$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243523421$24352342$1$I$$20240916$20240923$20240923$EXP$$US-EXELIXIS-CABO-23071729$EXELIXIS$$$$$M$Y$$$20240923$$CN$US$US
243523431$24352343$1$I$$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003790$PAREXEL$$74$YR$$F$Y$$$20240923$$CN$US$US
243523441$24352344$1$I$20240101$20240910$20240923$20240923$PER$$US-009507513-2409USA003463$MERCK$$$$$F$Y$$$20240923$$CN$US$US
243523451$24352345$1$I$$20240913$20240923$20240923$EXP$$BR-CHEPLA-2024012107$CHEPLAPHARM$$$$A$F$Y$59$KG$20240923$$CN$COUNTRY NOT SPECIFIED$BR
243523461$24352346$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269819$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240923$$HP$US$US
243523471$24352347$1$I$20240809$20240917$20240923$20240923$EXP$$US-AMERICAN REGENT INC-2024003560$AMERICAN REGENT$$66$YR$$F$Y$105$KG$20240923$$HP$US$US
243523481$24352348$1$I$20240826$20240913$20240923$20240923$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00948$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240923$$CN$US$US
243523491$24352349$1$I$$20240917$20240923$20240923$EXP$$US-ABBVIE-5933723$ABBVIE$$$$$$Y$$$20240923$$MD$US$US
243523501$24352350$1$I$20240901$20240913$20240923$20240923$EXP$$US-BRAINTREE LABORATORIES, INC.-2024BTE00600$BRAINTREE$$68$YR$$F$Y$$$20240923$$CN$US$US
243523531$24352353$1$I$$20240919$20240923$20240923$EXP$$US-ABBVIE-5931120$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243523541$24352354$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003978$PAREXEL$$80$YR$$F$Y$$$20240923$$CN$US$US
243523551$24352355$1$I$$20240911$20240923$20240923$EXP$$FR-TAKEDA-2024TUS092829$TAKEDA$$$$E$M$Y$$$20240923$$CN$FR$FR
243523561$24352356$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003769$PAREXEL$$68$YR$$F$Y$$$20240923$$CN$US$US
243523571$24352357$1$I$$20240705$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003977$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243523581$24352358$1$I$$20240705$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003974$PAREXEL$$68$YR$$F$Y$$$20240923$$CN$US$US
243523601$24352360$1$I$$20240705$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003964$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243523611$24352361$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003439$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243523621$24352362$1$I$$20240705$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003979$PAREXEL$$49$YR$$F$Y$$$20240923$$CN$US$US
243523631$24352363$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003908$PAREXEL$$54$YR$$F$Y$$$20240923$$CN$US$US
243523641$24352364$1$I$20240408$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003081$PAREXEL$$83$YR$$F$Y$$$20240923$$CN$US$US
243523651$24352365$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003889$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243523661$24352366$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003566$PAREXEL$$82$YR$$F$Y$$$20240923$$CN$US$US
243523671$24352367$1$I$$20240705$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003963$PAREXEL$$89$YR$$F$Y$$$20240923$$CN$US$US
243523681$24352368$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003137$PAREXEL$$49$YR$$F$Y$$$20240923$$CN$US$US
243523691$24352369$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003933$PAREXEL$$81$YR$$F$Y$$$20240923$$CN$US$US
243523701$24352370$1$I$$20240705$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003746$PAREXEL$$44$YR$$F$Y$$$20240923$$CN$US$US
243523711$24352371$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003985$PAREXEL$$52$YR$$F$Y$$$20240923$$HP$US$US
243523721$24352372$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003960$PAREXEL$$43$YR$$F$Y$$$20240923$$CN$US$US
243523731$24352373$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003987$PAREXEL$$61$YR$$F$Y$$$20240923$$CN$US$US
243523741$24352374$1$I$$20240705$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003288$PAREXEL$$31$YR$$F$Y$$$20240923$$CN$US$US
243523751$24352375$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002314$PAREXEL$$59$YR$$F$Y$$$20240923$$CN$US$US
243523761$24352376$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003981$PAREXEL$$46$YR$$F$Y$$$20240923$$HP$US$US
243523771$24352377$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003766$PAREXEL$$68$YR$$F$Y$$$20240923$$CN$US$US
243523781$24352378$1$I$$20240706$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003965$PAREXEL$$61$YR$$F$Y$$$20240923$$CN$US$US
243523791$24352379$1$I$$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003971$PAREXEL$$61$YR$$F$Y$$$20240923$$CN$US$US
243523801$24352380$1$I$20240626$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003837$PAREXEL$$37$YR$$F$Y$$$20240923$$CN$US$US
243523811$24352381$1$I$$20240704$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003901$PAREXEL$$51$YR$$F$Y$$$20240923$$CN$US$US
243523821$24352382$1$I$20240527$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003461$PAREXEL$$74$YR$$F$Y$$$20240923$$CN$US$US
243523831$24352383$1$I$20240706$20240708$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003948$PAREXEL$$76$YR$$F$Y$$$20240923$$CN$US$US
243523841$24352384$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114333$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$CN$US$US
243523871$24352387$1$I$20230901$20240918$20240923$20240923$EXP$FR-AFSSAPS-NY2024001060$FR-JNJFOC-20240959510$JOHNSON AND JOHNSON$$73$YR$E$M$Y$127$KG$20240923$$MD$FR$FR
243523881$24352388$1$I$20240916$20240916$20240923$20240923$EXP$$CO-JNJFOC-20240912054$JOHNSON AND JOHNSON$$67$YR$E$F$Y$90$KG$20240923$$HP$CO$CO
243523891$24352389$1$I$20240101$20240919$20240923$20240923$EXP$$US-ABBVIE-5931269$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243523901$24352390$1$I$20240918$20240918$20240923$20240923$EXP$$US-BAYER-2024A133564$BAYER$$85$YR$E$M$Y$$$20240923$$CN$US$US
243523911$24352391$1$I$20240101$20240919$20240923$20240923$EXP$$US-ABBVIE-5930907$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243523921$24352392$1$I$20240529$20240604$20240923$20240923$PER$$PK-ROCHE-3577082$ROCHE$$$$$$Y$$$20240923$$CN$PK$PK
243523931$24352393$1$I$$20240606$20240923$20240923$PER$$RU-ROCHE-3579064$ROCHE$$$$$F$Y$$$20240923$$HP$RU$RU
243523951$24352395$1$I$20240523$20240607$20240923$20240923$PER$$CN-ROCHE-3578738$ROCHE$$54$YR$A$F$Y$48$KG$20240923$$HP$CN$CN
243523961$24352396$1$I$$20240531$20240923$20240923$PER$$CN-ROCHE-3577120$ROCHE$$43$YR$A$F$Y$$$20240923$$MD$CN$CN
243523971$24352397$1$I$$20240604$20240923$20240923$PER$$PE-ROCHE-3579042$ROCHE$$56$YR$A$F$Y$$$20240923$$CN$PE$PE
243523981$24352398$1$I$$20240607$20240923$20240923$PER$$CN-ROCHE-3579424$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243523991$24352399$1$I$20240910$20240922$20240922$20240922$DIR$719371$$FDA-CTU$$37$YR$$M$N$$$20240922$Y$PH$US$
243524001$24352400$1$I$20240919$20240922$20240922$20240922$DIR$719370$$FDA-CTU$$67$YR$$F$N$$$20240922$Y$HP$US$
243524021$24352402$1$I$$20240606$20240923$20240923$PER$$MX-ROCHE-3578546$ROCHE$$$$$$Y$$$20240923$$HP$MX$MX
243524031$24352403$1$I$20240322$20240606$20240923$20240923$PER$IT-MINISAL02-988536$IT-ROCHE-3577882$ROCHE$$31$YR$A$F$Y$$$20240923$$PH$IT$IT
243524051$24352405$1$I$$20240603$20240923$20240923$PER$$CA-ROCHE-3576754$ROCHE$$$$A$F$Y$$$20240923$$CN$CA$CA
243524061$24352406$1$I$$20240607$20240923$20240923$PER$SE-SEMPA-2024-000502$SE-ROCHE-3578639$ROCHE$$58$YR$A$F$Y$83$KG$20240923$$CN$SE$SE
243524071$24352407$1$I$20240520$20240606$20240923$20240923$PER$$CO-ROCHE-3579817$ROCHE$$57$YR$A$F$Y$56$KG$20240923$$CN$CO$CO
243524091$24352409$1$I$20210310$20240606$20240923$20240923$PER$IT-MINISAL02-988487$IT-ROCHE-3577991$ROCHE$$68$YR$E$M$Y$$$20240923$$MD$IT$IT
243524101$24352410$1$I$20240524$20240603$20240923$20240923$PER$$US-ROCHE-3577587$ROCHE$$39$YR$A$M$Y$$$20240923$$MD$US$US
243524111$24352411$1$I$20240305$20240605$20240923$20240923$PER$$CN-ROCHE-3577997$ROCHE$$68$YR$E$F$Y$70$KG$20240923$$HP$CN$CN
243524121$24352412$1$I$$20240531$20240923$20240923$PER$$CN-ROCHE-3577045$ROCHE$$$$$$Y$$$20240923$$HP$CN$CN
243524131$24352413$1$I$$20240610$20240923$20240923$PER$$RU-ROCHE-3580169$ROCHE$$68$YR$E$F$Y$$$20240923$$MD$RU$RU
243524141$24352414$1$I$$20240607$20240923$20240923$PER$$CA-ROCHE-3579801$ROCHE$$$$A$F$Y$$$20240923$$CN$CA$CA
243524161$24352416$1$I$$20240528$20240923$20240923$PER$$JP-ROCHE-3577888$ROCHE$$71$YR$E$F$Y$$$20240923$$PH$JP$JP
243524171$24352417$1$I$20240101$20240918$20240923$20240923$EXP$$US-ABBVIE-5932427$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243524181$24352418$1$I$20240501$20240918$20240923$20240923$EXP$$US-ABBVIE-5932265$ABBVIE$$58$YR$$M$Y$$$20240923$$CN$US$US
243524191$24352419$1$I$20240523$20240610$20240923$20240923$PER$$CN-ROCHE-3580213$ROCHE$$44$YR$A$F$Y$75$KG$20240923$$HP$CN$CN
243524201$24352420$1$I$$20240916$20240923$20240923$DIR$FDA-CDER-CTU-2024-64950$$FDA-CTU$$$$$F$N$$$20240916$N$HP$US$
243524211$24352421$1$I$20240524$20240610$20240923$20240923$PER$$CN-ROCHE-3580209$ROCHE$$33$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243524221$24352422$1$I$20240520$20240610$20240923$20240923$PER$$CN-ROCHE-3580198$ROCHE$$57$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243524231$24352423$1$I$20240601$20240610$20240923$20240923$PER$$CN-ROCHE-3580201$ROCHE$$50$YR$A$F$Y$70$KG$20240923$$HP$CN$CN
243524241$24352424$1$I$20240604$20240610$20240923$20240923$PER$$CN-ROCHE-3580189$ROCHE$$31$YR$A$F$Y$52$KG$20240923$$HP$CN$CN
243524251$24352425$1$I$$20240603$20240923$20240923$PER$$JP-ROCHE-3579530$ROCHE$Ito A. A case in which Keishikashakuyakuto was effective for diarrhoea that developed during pharmacotherapy after breast cancer surgery. Kampo Medicine / The 74th Annual Meeting of the Japan Society for Oriental Medic. 2024;75 (S):211-.$52$YR$A$F$Y$$$20240923$$MD$JP$JP
243524261$24352426$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150193$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240923$$CN$US$US
243524281$24352428$1$I$$20240607$20240923$20240923$PER$$CN-ROCHE-3579828$ROCHE$$$$$F$Y$$$20240923$$HP$CN$CN
243524291$24352429$1$I$20240101$20240918$20240923$20240923$EXP$$CA-ABBVIE-5930808$ABBVIE$$$$A$F$Y$$$20240923$$CN$CA$CA
243524311$24352431$1$I$$20240916$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147747$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240923$$CN$US$US
243524321$24352432$1$I$$20240921$20240923$20240923$PER$$US-AMGEN-USASP2024189157$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243524331$24352433$1$I$$20240912$20240923$20240923$EXP$$CA-APOTEX-2024AP010679$APOTEX$$$$$F$Y$$$20240923$$MD$CA$CA
243524341$24352434$1$I$$20240913$20240923$20240923$EXP$$CA-TEVA-VS-3244339$TEVA$$53$YR$$M$Y$$$20240923$$HP$CA$CA
243524361$24352436$1$I$$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003919$PAREXEL$$54$YR$$F$Y$$$20240923$$HP$US$US
243524371$24352437$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003911$PAREXEL$$63$YR$$F$Y$$$20240923$$CN$US$US
243524381$24352438$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003891$PAREXEL$$67$YR$$F$Y$$$20240923$$CN$US$US
243524391$24352439$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003907$PAREXEL$$76$YR$$F$Y$$$20240923$$CN$US$US
243524401$24352440$1$I$$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003941$PAREXEL$$63$YR$$F$Y$$$20240923$$CN$US$US
243524411$24352441$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003893$PAREXEL$$67$YR$$F$Y$$$20240923$$CN$US$US
243524421$24352442$1$I$$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003867$PAREXEL$$62$YR$$F$Y$$$20240923$$CN$US$US
243524431$24352443$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003909$PAREXEL$$50$YR$$F$Y$$$20240923$$CN$US$US
243524441$24352444$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003892$PAREXEL$$52$YR$$F$Y$$$20240923$$CN$US$US
243524451$24352445$1$I$20240101$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003437$PAREXEL$$82$YR$$F$Y$$$20240923$$CN$US$US
243524461$24352446$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003895$PAREXEL$$67$YR$$F$Y$$$20240923$$CN$US$US
243524471$24352447$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003912$PAREXEL$$72$YR$$F$Y$$$20240923$$CN$US$US
243524481$24352448$1$I$$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003864$PAREXEL$$39$YR$$F$Y$$$20240923$$CN$US$US
243524491$24352449$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003650$PAREXEL$$57$YR$$F$Y$$$20240923$$CN$US$US
243524501$24352450$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003904$PAREXEL$$60$YR$$F$Y$$$20240923$$CN$US$US
243524511$24352451$1$I$20240630$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003887$PAREXEL$$71$YR$$F$Y$$$20240923$$CN$US$US
243524521$24352452$1$I$$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003940$PAREXEL$$56$YR$$F$Y$$$20240923$$CN$US$US
243524531$24352453$1$I$$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003875$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243524541$24352454$1$I$20240401$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003629$PAREXEL$$77$YR$$F$Y$$$20240923$$CN$US$US
243524551$24352455$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003590$PAREXEL$$74$YR$$F$Y$$$20240923$$CN$US$US
243524561$24352456$1$I$$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003585$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243524571$24352457$1$I$$20240703$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003890$PAREXEL$$39$YR$$F$Y$$$20240923$$CN$US$US
243524581$24352458$1$I$$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002855$PAREXEL$$54$YR$$F$Y$$$20240923$$CN$US$US
243524591$24352459$1$I$20240101$20240903$20240923$20240923$EXP$$US-SA-2024SA273595$SANOFI AVENTIS$$48$YR$A$M$Y$73.18$KG$20240923$$MD$US$US
243524601$24352460$1$I$20240723$20240821$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000469$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$CN$US$US
243524611$24352461$1$I$$20240821$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000470$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$CN$US$US
243524621$24352462$1$I$20240730$20240819$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000461$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243524631$24352463$1$I$20240707$20240822$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000471$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243524641$24352464$1$I$20240101$20240829$20240923$20240923$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005144$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240923$$CN$US$US
243524651$24352465$1$I$$20240916$20240923$20240923$EXP$$ES-TEVA-VS-3245922$TEVA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.; Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.$$$$$Y$$$20240923$$HP$ES$ES
243524661$24352466$1$I$$20240910$20240923$20240923$EXP$$JP-ADVANZ PHARMA-202409007611$ADVANZ PHARMA$$$$$$Y$$$20240923$$PH$JP$JP
243524671$24352467$1$I$20240308$20240901$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000472$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
243524681$24352468$1$I$20240801$20240822$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000475$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$MD$US$US
243524691$24352469$1$I$$20240918$20240923$20240923$EXP$$AU-AMGEN-AUSSP2024187154$AMGEN$$$$$F$Y$$$20240923$$HP$AU$AU
243524701$24352470$1$I$$20240916$20240923$20240923$PER$$US-AMGEN-USASP2024185054$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
243524711$24352471$1$I$$20240911$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024187097$AMGEN$$80$YR$E$$Y$$$20240923$$MD$JP$JP
243524721$24352472$1$I$20230908$20230927$20240923$20240923$PER$$CN-ROCHE-3430352$ROCHE$$74$YR$E$M$Y$62$KG$20240923$$HP$CN$CN
243524731$24352473$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380221$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243524741$24352474$1$I$$20230929$20240923$20240923$PER$$CN-ROCHE-3431367$ROCHE$$$$$$Y$$$20240923$$HP$CN$CN
243524751$24352475$1$I$$20231002$20240923$20240923$PER$$JP-ROCHE-3434770$ROCHE$$68$YR$E$F$Y$$$20240923$$PH$JP$JP
243524761$24352476$1$I$20230910$20230927$20240923$20240923$PER$$CN-ROCHE-3430359$ROCHE$$53$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243524771$24352477$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380209$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243524781$24352478$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380284$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243524791$24352479$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380360$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243524801$24352480$1$I$$20230927$20240923$20240923$PER$$JP-ROCHE-3432176$ROCHE$$76$YR$E$M$Y$$$20240923$$PH$JP$JP
243524821$24352482$1$I$$20240910$20240923$20240923$EXP$$CA-B.Braun Medical Inc.-2161927$B BRAUN$Literature Article$58$YR$$M$Y$$$20240923$$$CA$CA
243524831$24352483$1$I$$20240701$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003926$PAREXEL$$30$YR$$F$Y$$$20240923$$CN$US$US
243524841$24352484$1$I$$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003885$PAREXEL$$67$YR$$F$Y$$$20240923$$HP$US$US
243524851$24352485$1$I$20240915$20240922$20240922$20240922$DIR$719355$$FDA-CTU$$33$YR$$M$N$74.25$KG$20240922$N$CN$US$
243524871$24352487$1$I$20240916$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64951$$FDA-CTU$$81$YR$$F$N$$$20240923$N$$US$
243524881$24352488$1$I$$20240701$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003934$PAREXEL$$74$YR$$F$Y$$$20240923$$CN$US$US
243524891$24352489$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380358$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243524901$24352490$1$I$20240916$20240922$20240922$20240922$DIR$719373$$FDA-CTU$$39$YR$$F$N$$$20240922$Y$PH$US$
243524911$24352491$1$I$$20240701$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003923$PAREXEL$$40$YR$$F$Y$$$20240923$$CN$US$US
243524921$24352492$1$I$$20230925$20240923$20240923$PER$$DE-ROCHE-3428822$ROCHE$$$$$$Y$$$20240923$$HP$DE$DE
243524931$24352493$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380271$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243524951$24352495$1$I$$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003880$PAREXEL$$50$YR$$F$Y$$$20240923$$HP$US$US
243524961$24352496$1$I$$20240701$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003929$PAREXEL$$69$YR$$F$Y$$$20240923$$CN$US$US
243524971$24352497$1$I$$20240701$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003924$PAREXEL$$75$YR$$F$Y$$$20240923$$CN$US$US
243524991$24352499$1$I$$20240629$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003789$PAREXEL$$89$YR$$F$Y$$$20240923$$CN$US$US
243525001$24352500$1$I$$20240701$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003928$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243525011$24352501$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380273$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243525021$24352502$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380286$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243525031$24352503$1$I$20230904$20230926$20240923$20240923$PER$$CN-ROCHE-3429682$ROCHE$$60$YR$A$F$Y$43$KG$20240923$$HP$CN$CN
243525051$24352505$1$I$$20240701$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003922$PAREXEL$$69$YR$$F$Y$$$20240923$$CN$US$US
243525061$24352506$1$I$20230829$20231010$20240923$20240923$PER$$CA-ROCHE-3415149$ROCHE$$42$YR$A$F$Y$49.8$KG$20240923$$HP$CA$CA
243525071$24352507$1$I$$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003712$PAREXEL$$58$YR$$F$Y$$$20240923$$CN$US$US
243525081$24352508$1$I$20240301$20240702$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003884$PAREXEL$$65$YR$$F$Y$$$20240923$$HP$US$US
243525091$24352509$1$I$$20240629$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003906$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243525101$24352510$1$I$$20240701$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003536$PAREXEL$$57$YR$$F$Y$$$20240923$$CN$US$US
243525121$24352512$1$I$20240529$20240630$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003636$PAREXEL$$52$YR$$F$Y$$$20240923$$CN$US$US
243525131$24352513$1$I$20240101$20240701$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003146$PAREXEL$$76$YR$$F$Y$$$20240923$$CN$US$US
243525141$24352514$1$I$$20240701$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003917$PAREXEL$$60$YR$$F$Y$$$20240923$$CN$US$US
243525151$24352515$1$I$20230916$20230928$20240923$20240923$PER$$CN-ROCHE-3432478$ROCHE$$52$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243525161$24352516$1$I$$20230925$20240923$20240923$PER$$US-ROCHE-3422742$ROCHE$$50$YR$A$F$Y$$$20240923$$MD$US$US
243525171$24352517$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380211$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525191$24352519$1$I$$20240701$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003860$PAREXEL$$57$YR$$F$Y$$$20240923$$CN$US$US
243525212$24352521$2$F$20240913$20240918$20240923$20240925$EXP$$US-SA-2024SA273796$SANOFI AVENTIS$$$$A$$Y$$$20240925$$MD$AR$AR
243525221$24352522$1$I$$20240918$20240923$20240923$EXP$$JP-SA-2024SA272769$SANOFI AVENTIS$Sen M et al.. A case of transformation to high-grade medullary cancer after vandetanib and selpercatinib administration.. The 11th General Meeting of the Japanese Society of Thyroid Pathology. 2024;17:unk$62$YR$A$M$Y$$$20240923$$MD$JP$JP
243525241$24352524$1$I$$20240830$20240923$20240923$30DAY$$US-JNJFOC-20240881807$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$MD$US$US
243525251$24352525$1$I$20230919$20230926$20240923$20240923$PER$$JP-ROCHE-3431371$ROCHE$$$$$F$Y$$$20240923$$MD$JP$JP
243525261$24352526$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380218$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525271$24352527$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380341$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525281$24352528$1$I$$20230927$20240923$20240923$PER$$UY-ROCHE-3432400$ROCHE$$$$$F$Y$$$20240923$$HP$UY$UY
243525291$24352529$1$I$20230811$20231011$20240923$20240923$PER$$CA-ROCHE-3405457$ROCHE$$42$YR$A$F$Y$50.6$KG$20240923$$HP$CA$CA
243525301$24352530$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380346$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525311$24352531$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380280$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243525321$24352532$1$I$20220704$20230925$20240923$20240923$PER$IT-MINISAL02-944884$IT-ROCHE-3428288$ROCHE$$48$YR$A$F$Y$$$20240923$$MD$IT$IT
243525331$24352533$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380274$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243525341$24352534$1$I$$20231122$20240923$20240923$PER$$DE-ROCHE-3432533$ROCHE$Guthoff  R. Moeglichkeiten und aktuelle Grenzen - Korneale Bildgebung. Ophthalmologische Nachrichten 2023;9:6-8.$40$YR$A$F$Y$57$KG$20240923$$MD$DE$DE
243525351$24352535$1$I$20240101$20240905$20240923$20240923$PER$$US-SA-2024SA273020$SANOFI AVENTIS$$47$YR$A$M$Y$111$KG$20240923$$MD$US$US
243525361$24352536$1$I$$20240830$20240923$20240923$PER$$US-SA-2024SA097435$SANOFI AVENTIS$$$$A$F$Y$140.14$KG$20240923$$MD$US$US
243525371$24352537$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268395$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240923$$MD$US$US
243525381$24352538$1$I$20240901$20240919$20240923$20240923$EXP$$US-ABBVIE-5931123$ABBVIE$$65$YR$$F$Y$$$20240923$$CN$US$US
243525391$24352539$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012838$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243525401$24352540$1$I$20240918$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012012$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240923$$CN$US$US
243525411$24352541$1$I$$20240916$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010747$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243525421$24352542$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012587$ELI LILLY AND CO$$$$$M$Y$$$20240923$$CN$US$US
243525431$24352543$1$I$20240801$20240830$20240923$20240923$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000484$REVANCE THERAPEUTICS$$$$$$Y$$$20240923$$HP$US$US
243525441$24352544$1$I$20240101$20240916$20240923$20240923$PER$$US-BAYER-2024A132437$BAYER$$$$$F$Y$$$20240923$$CN$US$US
243525451$24352545$1$I$20180901$20240916$20240923$20240923$EXP$$US-BAYER-2024A134776$BAYER$Viscardi C.M.; Rho J.Y.; Blake C.R. Bilateral neovascular glaucoma associated with Radium-223 infusions for prostate cancer. American Journal of Ophthalmology Case Reports. 2024;36:Article Number: 102142$65$YR$E$M$Y$$$20240923$$HP$US$US
243525461$24352546$1$I$$20240916$20240923$20240923$EXP$$ES-TEVA-VS-3245920$TEVA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.; Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.$$$$$Y$$$20240923$$HP$ES$ES
243525471$24352547$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150684$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240923$$CN$US$US
243525481$24352548$1$I$20240528$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149527$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243525501$24352550$1$I$$20240916$20240923$20240923$EXP$$PL-TEVA-VS-3244840$TEVA$Rybka J, Kuszczak B, Bogucka-Fedorczuk A. Treatment of primary central nervous system lymphoma (PCNSL) - single center experience and literature review. Acta-Haematol-Polon 2024; 55 (3): 151-156.$$$$$Y$$$20240923$$HP$PL$PL
243525511$24352551$1$I$20240101$20240916$20240923$20240923$PER$$US-BAYER-2024A132646$BAYER$$22$YR$A$F$Y$$$20240923$$CN$US$US
243525521$24352552$1$I$20230803$20230926$20240923$20240923$PER$$CN-ROCHE-3429684$ROCHE$$67$YR$E$F$Y$67$KG$20240923$$HP$CN$CN
243525531$24352553$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380215$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525541$24352554$1$I$20191101$20231012$20240923$20240923$PER$$AT-ROCHE-3424524$ROCHE$$43$YR$A$F$Y$$$20240923$$MD$AT$AT
243525551$24352555$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380343$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525561$24352556$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380272$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243525571$24352557$1$I$$20231107$20240923$20240923$PER$$NZ-ROCHE-3420617$ROCHE$$40$YR$A$F$Y$166$KG$20240923$$HP$NZ$NZ
243525581$24352558$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380234$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525591$24352559$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380226$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525601$24352560$1$I$20230913$20231005$20240923$20240923$PER$IT-MINISAL02-945695$IT-ROCHE-3432633$ROCHE$$58$YR$A$M$Y$$$20240923$$MD$IT$IT
243525611$24352561$1$I$20221115$20240103$20240923$20240923$PER$$PT-ROCHE-3398998$ROCHE$$64$YR$A$F$Y$$$20240923$$MD$PT$PT
243525621$24352562$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380283$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243525631$24352563$1$I$20230611$20230927$20240923$20240923$PER$PT-INFARMED-T202307-159$PT-ROCHE-3390603$ROCHE$$51$YR$A$F$Y$55$KG$20240923$$PH$PT$PT
243525641$24352564$1$I$20230821$20230926$20240923$20240923$PER$$CN-ROCHE-3429701$ROCHE$$38$YR$A$F$Y$53$KG$20240923$$HP$CN$CN
243525651$24352565$1$I$$20231206$20240923$20240923$PER$$JP-ROCHE-3425809$ROCHE$$5$DEC$A$F$Y$$$20240923$$MD$JP$JP
243525661$24352566$1$I$$20231101$20240923$20240923$PER$$JP-ROCHE-3420064$ROCHE$$7$DEC$E$F$Y$$$20240923$$MD$JP$JP
243525671$24352567$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380353$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525681$24352568$1$I$20141201$20231205$20240923$20240923$PER$$PT-ROCHE-3427180$ROCHE$Vasconcelos de Matos L, Volovat S, Debiasi M and Cardoso F. Unfolding the role of the PI3K/AKT/MTOR pathway in male breast cancer: A pragmatic appraisal. DOI: 10.1016/j.breast.2023.103576.. Breast 2023;72:1-6.$73$YR$E$M$Y$$$20240923$$HP$PT$PT
243525701$24352570$1$I$$20231003$20240923$20240923$PER$$RO-ROCHE-3435315$ROCHE$$51$YR$A$F$Y$$$20240923$$MD$RO$RO
243525711$24352571$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380236$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525721$24352572$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380237$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525731$24352573$1$I$$20231212$20240923$20240923$PER$$JP-ROCHE-3415263$ROCHE$$64$YR$A$M$Y$$$20240923$$MD$JP$JP
243525741$24352574$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380213$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525751$24352575$1$I$20200618$20231110$20240923$20240923$PER$$JP-ROCHE-3381028$ROCHE$Watanabe K, Takeda H, Takamura M, Hashimoto K. A Case of Metachronous Bilateral Male Breast Cancer Contralaterally Developing during Therapy for Locally Advanced Breast Cancer. The 31st Annual Meeting of the Japanese Breast Cancer Society. 2023;:276-.$64$YR$A$M$Y$$$20240923$$MD$JP$JP
243525761$24352576$1$I$$20231216$20240923$20240923$PER$$TR-ROCHE-3433612$ROCHE$$47$YR$A$F$Y$$$20240923$$HP$TR$TR
243525771$24352577$1$I$20230724$20240103$20240923$20240923$PER$$AT-ROCHE-3419781$ROCHE$$49$YR$A$F$Y$64$KG$20240923$$MD$AT$AT
243525781$24352578$1$I$$20230925$20240923$20240923$PER$$CA-ROCHE-3422326$ROCHE$$$$E$F$Y$$$20240923$$CN$CA$CA
243525791$24352579$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380344$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525801$24352580$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380212$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243525811$24352581$1$I$20170101$20240909$20240923$20240923$EXP$$CZ-IBIGEN-2024-015734$ISTITUTO BICHIMICO ITALIANO GIOVANNI LORENZINI (IBIGEN)$Krupickova, Z.. Infectious endocarditis of valve replacement - long time story. Kapitoly z kardiologie pro prakticke lekare. 2017;9 (2):74$60$YR$$M$Y$$$20240909$$MD$CZ$CZ
243525821$24352582$1$I$$20231016$20240923$20240923$PER$$US-ROCHE-3395969$ROCHE$$67$YR$E$F$Y$$$20240923$$MD$US$US
243525831$24352583$1$I$20240913$20240922$20240922$20240922$DIR$719372$$FDA-CTU$$50$YR$$F$N$84.15$KG$20240922$N$HP$US$
243525841$24352584$1$I$$20230926$20240923$20240923$PER$$CN-ROCHE-3429686$ROCHE$$$$A$F$Y$$$20240923$$MD$CN$CN
243525851$24352585$1$I$20230907$20231009$20240923$20240923$PER$IT-MINISAL02-947091$IT-ROCHE-3434334$ROCHE$$42$YR$A$F$Y$54$KG$20240923$$MD$IT$IT
243525861$24352586$1$I$20230419$20230926$20240923$20240923$PER$$CN-ROCHE-3429669$ROCHE$$30$YR$A$F$Y$54.5$KG$20240923$$HP$CN$CN
243525871$24352587$1$I$$20231003$20240923$20240923$PER$$DE-ROCHE-3433295$ROCHE$$$$$F$Y$$$20240923$$MD$DE$DE
243525891$24352589$1$I$20230817$20231006$20240923$20240923$PER$$CN-ROCHE-3435672$ROCHE$$69$YR$E$F$Y$69$KG$20240923$$HP$CN$CN
243525901$24352590$1$I$$20240628$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003443$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243525911$24352591$1$I$$20240628$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003899$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243525921$24352592$1$I$$20240627$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003881$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243525931$24352593$1$I$20240921$20240922$20240922$20240922$DIR$719358$$FDA-CTU$$54$YR$$F$N$72$KG$20240922$N$CN$US$
243525941$24352594$1$I$20230922$20231006$20240923$20240923$PER$$CN-ROCHE-3435621$ROCHE$$69$YR$E$F$Y$$$20240923$$HP$CN$CN
243525951$24352595$1$I$$20240628$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003931$PAREXEL$$63$YR$$F$Y$$$20240923$$CN$US$US
243525961$24352596$1$I$$20240627$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003429$PAREXEL$$62$YR$$F$Y$$$20240923$$CN$US$US
243525971$24352597$1$I$$20240627$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003835$PAREXEL$$45$YR$$F$Y$$$20240923$$CN$US$US
243525981$24352598$1$I$$20240627$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003856$PAREXEL$$52$YR$$F$Y$$$20240923$$CN$US$US
243525991$24352599$1$I$$20240627$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003883$PAREXEL$$56$YR$$F$Y$$$20240923$$CN$US$US
243526001$24352600$1$I$$20240629$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003905$PAREXEL$$70$YR$$F$Y$$$20240923$$CN$US$US
243526011$24352601$1$I$$20240627$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002472$PAREXEL$$80$YR$$F$Y$$$20240923$$CN$US$US
243526021$24352602$1$I$$20240627$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003879$PAREXEL$$59$YR$$F$Y$$$20240923$$CN$US$US
243526031$24352603$1$I$$20240627$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003850$PAREXEL$$48$YR$$F$Y$$$20240923$$CN$US$US
243526041$24352604$1$I$$20240628$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003897$PAREXEL$$74$YR$$F$Y$$$20240923$$CN$US$US
243526051$24352605$1$I$$20240627$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003949$PAREXEL$$67$YR$$F$Y$$$20240923$$CN$US$US
243526061$24352606$1$I$20240601$20240918$20240923$20240923$EXP$$US-ABBVIE-5931091$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243526071$24352607$1$I$$20240628$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003478$PAREXEL$$65$YR$$F$Y$$$20240923$$HP$US$US
243526091$24352609$1$I$$20240913$20240923$20240923$EXP$$GB-TEVA-VS-3245151$TEVA$$64$YR$$F$Y$$$20240923$$CN$GB$GB
243526101$24352610$1$I$$20240917$20240923$20240923$EXP$$CA-AMGEN-CANSP2024186598$AMGEN$$77$YR$E$M$Y$$$20240923$$MD$CA$CA
243526111$24352611$1$I$$20231002$20240923$20240923$PER$$US-ROCHE-3433013$ROCHE$$$$E$F$Y$72.57$KG$20240923$$CN$US$US
243526121$24352612$1$I$20230917$20230927$20240923$20240923$PER$$CN-ROCHE-3430377$ROCHE$$54$YR$A$F$Y$47$KG$20240923$$HP$CN$CN
243526131$24352613$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380355$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526141$24352614$1$I$20230830$20230926$20240923$20240923$PER$$CN-ROCHE-3431941$ROCHE$$50$YR$A$F$Y$98$KG$20240923$$HP$CN$CN
243526151$24352615$1$I$20230921$20230927$20240923$20240923$PER$$CN-ROCHE-3430024$ROCHE$$56$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243526161$24352616$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380357$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526171$24352617$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380228$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526181$24352618$1$I$20230626$20231030$20240923$20240923$PER$$CN-ROCHE-3380706$ROCHE$$39$YR$A$F$Y$65$KG$20240923$$CN$CN$CN
243526201$24352620$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380191$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):755-56.$$$$F$Y$$$20240923$$MD$BE$BE
243526221$24352622$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380210$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526231$24352623$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380354$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526241$24352624$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380230$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526251$24352625$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380276$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243526271$24352627$1$I$20240101$20240916$20240923$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012228$JAZZ$$$$$F$Y$$$20240923$$CN$US$US
243526281$24352628$1$I$$20231219$20240923$20240923$PER$$US-ROCHE-3406393$ROCHE$$49$YR$A$F$Y$$$20240923$$HP$US$US
243526291$24352629$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380222$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526301$24352630$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380282$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243526311$24352631$1$I$$20240916$20240923$20240923$EXP$$US-BAYER-2024A134778$BAYER$Viscardi C.M.; Rho J.Y.; Blake C.R. Bilateral neovascular glaucoma associated with Radium-223 infusions for prostate cancer. American Journal of Ophthalmology Case Reports. 2024;36:Article Number: 102142$74$YR$E$M$Y$$$20240923$$HP$US$US
243526321$24352632$1$I$20190615$20231117$20240923$20240923$PER$$AT-ROCHE-3386821$ROCHE$$50$YR$A$F$Y$83$KG$20240923$$MD$AT$AT
243526331$24352633$1$I$20220101$20240829$20240923$20240923$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005188$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240923$$CN$US$US
243526341$24352634$1$I$$20240919$20240923$20240923$EXP$$US-VANTIVE-2024VAN019910$Vantive US Healthcare$$$$$F$Y$$$20240923$$HP$US$US
243526351$24352635$1$I$$20231215$20240923$20240923$PER$$US-ROCHE-3401231$ROCHE$$67$YR$E$F$Y$$$20240923$$MD$US$US
243526362$24352636$2$F$$20240918$20240923$20240926$EXP$$IN-VANTIVE-2024VAN019845$Vantive US Healthcare$$69$YR$$M$Y$$$20240926$$CN$IN$IN
243526371$24352637$1$I$20240913$20240913$20240923$20240923$EXP$$CN-VANTIVE-2024VAN019788$Vantive US Healthcare$$62$YR$$F$Y$57$KG$20240923$$CN$CN$CN
243526381$24352638$1$I$$20240916$20240923$20240923$EXP$$US-VANTIVE-2024VAN019829$Vantive US Healthcare$$$$$$Y$$$20240923$$HP$US$US
243526391$24352639$1$I$20240914$20240914$20240923$20240923$EXP$$CN-VANTIVE-2024VAN019795$Vantive US Healthcare$$63$YR$$F$Y$$$20240923$$CN$CN$CN
243526401$24352640$1$I$$20240914$20240923$20240923$EXP$$CN-VANTIVE-2024VAN019807$Vantive US Healthcare$$$$$F$Y$$$20240923$$CN$CN$CN
243526421$24352642$1$I$20240301$20240919$20240923$20240923$PER$$US-BAYER-2024A134816$BAYER$$29$YR$A$F$Y$$$20240923$$MD$US$US
243526441$24352644$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380352$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jun 14;:1-13.$$$$M$Y$$$20240923$$MD$BE$BE
243526451$24352645$1$I$$20231002$20240923$20240923$PER$$US-ROCHE-3428993$ROCHE$$46$YR$A$F$Y$$$20240923$$MD$US$US
243526461$24352646$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380224$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526471$24352647$1$I$$20230928$20240923$20240923$PER$$US-ROCHE-3431444$ROCHE$$39$YR$A$F$Y$$$20240923$$HP$US$US
243526481$24352648$1$I$$20231004$20240923$20240923$PER$$RO-ROCHE-3435289$ROCHE$$$$$F$Y$$$20240923$$CN$RO$RO
243526491$24352649$1$I$$20231008$20240923$20240923$PER$$CN-ROCHE-3435625$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243526501$24352650$1$I$20230914$20230926$20240923$20240923$PER$$JP-ROCHE-3431280$ROCHE$$$$$F$Y$$$20240923$$MD$JP$JP
243526511$24352651$1$I$20230413$20230927$20240923$20240923$PER$IT-MINISAL02-944960$IT-ROCHE-3428296$ROCHE$$59$YR$A$F$Y$90$KG$20240923$$MD$IT$IT
243526521$24352652$1$I$20230914$20231005$20240923$20240923$PER$IT-MINISAL02-947149$IT-ROCHE-3434364$ROCHE$$78$YR$E$F$Y$80$KG$20240923$$MD$IT$IT
243526531$24352653$1$I$$20240205$20240923$20240923$PER$$JP-ROCHE-3415299$ROCHE$Fujimoto T. A Case of HER 2-positive Breast Cancer with Liver Disorder -associated with Diffuse Metastases to Liver in Which Drug Therapy Could Be Continued. The 45th Annual Meeting of Japanese Society for Research of Loco-Regional Cancer 2023;105:-.;, Maeda N, Ioka T, Nagano H. A Case of HER 2-positive Advanced Breast Cancer with Liver Disorder -associated with Diffuse Metastases to Liver in Which Drug Therapy Could Be Continued. Japanese Journal of Cancer and Chemotherapy 2023;50 (13):1739-41.$49$YR$A$F$Y$65$KG$20240923$$MD$JP$JP
243526541$24352654$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380289$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243526551$24352655$1$I$$20230925$20240923$20240923$PER$$GE-ROCHE-3430408$ROCHE$$$$$F$Y$$$20240923$$HP$GE$GE
243526561$24352656$1$I$$20231128$20240923$20240923$PER$$NZ-ROCHE-3383970$ROCHE$$$$A$F$Y$$$20240923$$PH$NZ$NZ
243526571$24352657$1$I$$20230926$20240923$20240923$PER$$RU-ROCHE-3431397$ROCHE$$67$YR$E$F$Y$$$20240923$$MD$RU$RU
243526581$24352658$1$I$20210806$20230927$20240923$20240923$PER$IT-MINISAL02-945341$IT-ROCHE-3429611$ROCHE$$64$YR$A$F$Y$$$20240923$$MD$IT$IT
243526591$24352659$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5929698$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243526601$24352660$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380278$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243526611$24352661$1$I$$20240918$20240923$20240923$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005199$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240923$$HP$US$US
243526621$24352662$1$I$20230315$20231024$20240923$20240923$PER$$CN-ROCHE-3413893$ROCHE$$52$YR$A$F$Y$56$KG$20240923$$CN$CN$CN
243526631$24352663$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380270$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243526641$24352664$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380359$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526651$24352665$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380216$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526661$24352666$1$I$$20240919$20240923$20240923$PER$$US-BAYER-2024A134938$BAYER$$42$YR$A$F$Y$$$20240923$$MD$US$US
243526671$24352667$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380232$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526681$24352668$1$I$20230925$20230927$20240923$20240923$PER$$CN-ROCHE-3430402$ROCHE$$60$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243526691$24352669$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380220$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526701$24352670$1$I$$20230925$20240923$20240923$PER$$RO-ROCHE-3429142$ROCHE$$$$$F$Y$$$20240923$$CN$RO$RO
243526721$24352672$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380231$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526741$24352674$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380347$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526751$24352675$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380279$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243526761$24352676$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380229$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526771$24352677$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380361$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526781$24352678$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380281$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243526791$24352679$1$I$$20231005$20240923$20240923$PER$$US-ROCHE-3434947$ROCHE$$47$YR$A$F$Y$$$20240923$$CN$US$US
243526801$24352680$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64957$$FDA-CTU$$76$YR$$F$N$$$20240923$N$$US$
243526811$24352681$1$I$$20240919$20240923$20240923$DIR$FDA-CDER-CTU-2024-64958$$FDA-CTU$$$$$F$N$$$20240919$N$HP$US$
243526821$24352682$1$I$$20240916$20240923$20240923$DIR$FDA-CDER-CTU-2024-64960$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243526831$24352683$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380364$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526841$24352684$1$I$$20231004$20240923$20240923$PER$$US-ROCHE-3435316$ROCHE$$62$YR$A$M$Y$$$20240923$$PH$US$US
243526851$24352685$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380277$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243526861$24352686$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380345$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243526871$24352687$1$I$$20240919$20240923$20240923$DIR$FDA-CDER-CTU-2024-64959$$FDA-CTU$$$$$F$N$$$20240919$N$HP$US$
243526881$24352688$1$I$20210309$20230925$20240923$20240923$PER$IT-MINISAL02-944923$IT-ROCHE-3427993$ROCHE$$63$YR$A$F$Y$$$20240923$$MD$IT$IT
243526891$24352689$1$I$$20231030$20240923$20240923$PER$$US-ROCHE-3433959$ROCHE$$47$YR$A$F$Y$$$20240923$$CN$US$US
243526901$24352690$1$I$$20240626$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003839$PAREXEL$$81$YR$$F$Y$$$20240923$$HP$US$US
243526911$24352691$1$I$20240101$20240626$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003811$PAREXEL$$78$YR$$F$Y$$$20240923$$CN$US$US
243526921$24352692$1$I$$20240627$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003832$PAREXEL$$54$YR$$F$Y$$$20240923$$HP$US$US
243526931$24352693$1$I$$20240625$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003784$PAREXEL$$57$YR$$F$Y$$$20240923$$HP$US$US
243526941$24352694$1$I$$20240627$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003828$PAREXEL$$62$YR$$$Y$$$20240923$$CN$US$US
243526951$24352695$1$I$$20240626$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002316$PAREXEL$$72$YR$$F$Y$$$20240923$$CN$US$US
243526961$24352696$1$I$20240612$20240626$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003147$PAREXEL$$81$YR$$F$Y$$$20240923$$CN$US$US
243526971$24352697$1$I$$20240626$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003807$PAREXEL$$68$YR$$F$Y$$$20240923$$CN$US$US
243526981$24352698$1$I$20240626$20240626$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002228$PAREXEL$$54$YR$$F$Y$$$20240923$$CN$US$US
243526991$24352699$1$I$$20240627$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003942$PAREXEL$$69$YR$$F$Y$$$20240923$$CN$US$US
243527001$24352700$1$I$$20240626$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003817$PAREXEL$$77$YR$$F$Y$$$20240923$$HP$US$US
243527011$24352701$1$I$20240101$20240626$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003809$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243527021$24352702$1$I$20240904$20240919$20240923$20240923$EXP$$US-ABBVIE-5931159$ABBVIE$$72$YR$$F$Y$$$20240923$$CN$US$US
243527031$24352703$1$I$$20240626$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003805$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243527041$24352704$1$I$$20240626$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003136$PAREXEL$$57$YR$$F$Y$$$20240923$$CN$US$US
243527061$24352706$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189199$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243527081$24352708$1$I$20240624$20240625$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003797$PAREXEL$$77$YR$$F$Y$$$20240923$$HP$US$US
243527091$24352709$1$I$$20240912$20240923$20240923$PER$$US-JNJFOC-20240932537$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$CN$US$US
243527101$24352710$1$I$20230724$20231019$20240923$20240923$PER$IT-MINISAL02-946310$IT-ROCHE-3432754$ROCHE$$52$YR$A$F$Y$$$20240923$$MD$IT$IT
243527111$24352711$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380342$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527131$24352713$1$I$20220307$20240917$20240923$20240923$EXP$$CA-TAKEDA-2022TUS075353$TAKEDA$$66$YR$$F$Y$$$20240923$$CN$CA$CA
243527141$24352714$1$I$$20240917$20240923$20240923$EXP$$NVSC2024CA187385$NOVARTIS$$29$YR$$F$Y$$$20240923$$MD$CA$CA
243527151$24352715$1$I$20240913$20240920$20240923$20240923$EXP$$US-BAYER-2024A135068$BAYER$$34$YR$A$F$Y$$$20240923$$HP$US$US
243527161$24352716$1$I$20220509$20240920$20240923$20240923$EXP$$CN-BAYER-2024A135059$BAYER$$37$YR$A$F$Y$53.5$KG$20240923$$HP$CN$CN
243527171$24352717$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380356$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527181$24352718$1$I$20180530$20230925$20240923$20240923$PER$$KR-ROCHE-3428333$ROCHE$$53$YR$A$F$Y$$$20240923$$MD$KR$KR
243527191$24352719$1$I$20230718$20231011$20240923$20240923$PER$IT-MINISAL02-947087$IT-ROCHE-3434330$ROCHE$$40$YR$A$F$Y$60$KG$20240923$$MD$IT$IT
243527201$24352720$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380340$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527211$24352721$1$I$$20240912$20240923$20240923$PER$$US-ROCHE-10000080905$ROCHE$$$$$$Y$$$20240923$$HP$US$US
243527221$24352722$1$I$$20230927$20240923$20240923$PER$$CN-ROCHE-3430434$ROCHE$$44$YR$A$F$Y$$$20240923$$CN$CN$CN
243527231$24352723$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380225$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527241$24352724$1$I$$20230928$20240923$20240923$PER$$CN-ROCHE-3430444$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243527251$24352725$1$I$20231030$20231221$20240923$20240923$PER$$CN-ROCHE-3481779$ROCHE$$52$YR$A$F$Y$50$KG$20240923$$HP$CN$CN
243527261$24352726$1$I$20230223$20230927$20240923$20240923$PER$$CN-ROCHE-3430387$ROCHE$$51$YR$A$F$Y$63$KG$20240923$$HP$CN$CN
243527271$24352727$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380227$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527281$24352728$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3377834$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527291$24352729$1$I$20230920$20230926$20240923$20240923$PER$$AE-ROCHE-3431390$ROCHE$$54$YR$A$F$Y$$$20240923$$CN$AE$AE
243527301$24352730$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380365$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527311$24352731$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380351$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527321$24352732$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380214$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527331$24352733$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380275$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243527341$24352734$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380288$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243527351$24352735$1$I$$20231001$20240923$20240923$PER$$IN-ROCHE-3434402$ROCHE$$48$YR$A$F$Y$$$20240923$$CN$IN$IN
243527361$24352736$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380350$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527371$24352737$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380362$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527381$24352738$1$I$20230925$20230928$20240923$20240923$PER$$CN-ROCHE-3431315$ROCHE$$66$YR$E$F$Y$53$KG$20240923$$HP$CN$CN
243527391$24352739$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380223$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527401$24352740$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380235$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527411$24352741$1$I$20230907$20231018$20240923$20240923$PER$$CA-ROCHE-3406118$ROCHE$$41$YR$A$F$Y$74$KG$20240923$$CN$CA$CA
243527421$24352742$1$I$20231222$20231226$20240923$20240923$PER$$CN-ROCHE-3482315$ROCHE$$77$YR$E$F$Y$48$KG$20240923$$HP$CN$CN
243527431$24352743$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010494$APOTEX$$52$YR$$F$Y$$$20240923$$HP$CA$CA
243527441$24352744$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380348$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527451$24352745$1$I$$20231221$20240923$20240923$PER$$US-ROCHE-3480537$ROCHE$$$$$$Y$$$20240923$$HP$US$US
243527461$24352746$1$I$20230902$20231009$20240923$20240923$PER$IT-MINISAL02-946887$IT-ROCHE-3434315$ROCHE$$83$YR$E$F$Y$50$KG$20240923$$MD$IT$IT
243527471$24352747$1$I$$20240527$20240923$20240923$PER$$JP-ROCHE-3414522$ROCHE$Nakagawa T, Yamamoto Y, Yanagawa S, Takaya M, Amioka J, Kaneko Y, et al.. A Case of Recurrence-free Survival for Three and a Half Years after Chemotherapy for Stage IV Gastric Cancer with Multiple Metastases to Liver Followed by Resection of Primary Lesion.. The 45th Annual Meeting of Japanese Society for Research of Loco-Regional Cancer. 2023;51 (4):135-.;, Yamamoto Y, Yanagawa S, Shiozaki S, Kaneko Y, Watanabe A, Nishina M, Takei D, Sumi Y, Yamaki M, Kurayoshi M, Hashizume J, Oshita A, Nakahar$67$YR$E$M$Y$62$KG$20240923$$HP$JP$JP
243527481$24352748$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380219$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527491$24352749$1$I$20230405$20231220$20240923$20240923$PER$$CN-ROCHE-3480971$ROCHE$$51$YR$A$M$Y$$$20240923$$HP$CN$CN
243527501$24352750$1$I$$20231221$20240923$20240923$PER$$US-ROCHE-3480669$ROCHE$$$$$$Y$$$20240923$$HP$US$US
243527511$24352751$1$I$20231202$20231225$20240923$20240923$PER$$CN-ROCHE-3481690$ROCHE$$65$YR$E$F$Y$$$20240923$$HP$CN$CN
243527521$24352752$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380363$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527531$24352753$1$I$$20231226$20240923$20240923$PER$$CN-ROCHE-3482230$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243527551$24352755$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380217$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527561$24352756$1$I$$20231220$20240923$20240923$PER$$US-ROCHE-3479851$ROCHE$$$$A$M$Y$$$20240923$$HP$US$US
243527571$24352757$1$I$$20231219$20240923$20240923$PER$$IS-ROCHE-3480792$ROCHE$$$$$$Y$$$20240923$$PH$IS$IS
243527581$24352758$1$I$$20240105$20240923$20240923$PER$$US-ROCHE-3480784$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243527591$24352759$1$I$$20231002$20240923$20240923$PER$$JP-ROCHE-3434722$ROCHE$PRIVACY P, Itamura M, Hitaka T, Sasaki N, Sawada Y. 19 A case of HER2-positive Paget^s disease of the vulva treated with trastuzumab.. The 406th Fukuoka Regional Meeting of the Japanese Dermatological Association, commemorating the inauguration of Professor Yu Sawada, Department of Dermatology, University of Occupational and Environmental Health, Japan. 2023;21:-.$82$YR$E$M$Y$$$20240923$$MD$JP$JP
243527601$24352760$1$I$$20231222$20240923$20240923$PER$$IN-ROCHE-3480749$ROCHE$$75$YR$E$F$Y$$$20240923$$CN$IN$IN
243527611$24352761$1$I$$20231222$20240923$20240923$PER$$FR-ROCHE-3480447$ROCHE$$$$$F$Y$$$20240923$$PH$FR$FR
243527621$24352762$1$I$$20230929$20240923$20240923$PER$$CA-ROCHE-3426850$ROCHE$$$$$F$Y$$$20240923$$CN$CA$CA
243527631$24352763$1$I$$20231221$20240923$20240923$PER$$US-ROCHE-3480680$ROCHE$$$$$F$Y$$$20240923$$PH$US$US
243527641$24352764$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380339$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527651$24352765$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380269$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243527661$24352766$1$I$$20231220$20240923$20240923$PER$$US-ROCHE-3480059$ROCHE$$$$A$$Y$$$20240923$$MD$US$US
243527671$24352767$1$I$$20231222$20240923$20240923$PER$$CN-ROCHE-3482305$ROCHE$$$$$$Y$$$20240923$$CN$CN$CN
243527681$24352768$1$I$20231122$20231225$20240923$20240923$PER$$CN-ROCHE-3481874$ROCHE$$37$YR$A$F$Y$45$KG$20240923$$HP$CN$CN
243527691$24352769$1$I$20230804$20240305$20240923$20240923$PER$$IN-ROCHE-3401880$ROCHE$$70$YR$E$F$Y$$$20240923$$CN$IN$IN
243527701$24352770$1$I$$20240208$20240923$20240923$PER$$IN-ROCHE-3387730$ROCHE$Gupta R, Mason A, Batra A, Vinayak, Khanduri R and Kumar M Sarcoidosis associated with Trastuzumab in a young female with carcinoma of breast. DOI: 10.1016/j.ijtb.2023.06.009. The Indian journal of tuberculosis 2024 Jan;71 (1):96-8.$33$YR$A$F$Y$$$20240923$$HP$IN$IN
243527711$24352771$1$I$$20240418$20240923$20240923$PER$$BE-ROCHE-3426638$ROCHE$$$$$F$Y$$$20240923$$CN$BE$BE
243527721$24352772$1$I$20230909$20230925$20240923$20240923$PER$$JP-ROCHE-3430073$ROCHE$$$$E$F$Y$$$20240923$$MD$JP$JP
243527731$24352773$1$I$$20231221$20240923$20240923$PER$$GB-ROCHE-3480995$ROCHE$$$$$F$Y$$$20240923$$HP$GB$GB
243527741$24352774$1$I$20230313$20240322$20240923$20240923$PER$$IT-ROCHE-3388561$ROCHE$$63$YR$A$F$Y$$$20240923$$MD$IT$IT
243527751$24352775$1$I$$20231218$20240923$20240923$PER$$MY-ROCHE-3480703$ROCHE$$43$YR$A$F$Y$$$20240923$$CN$MY$MY
243527761$24352776$1$I$$20230927$20240923$20240923$PER$$TR-ROCHE-3431656$ROCHE$$$$$F$Y$$$20240923$$PH$TR$TR
243527771$24352777$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380285$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243527781$24352778$1$I$20230701$20230926$20240923$20240923$PER$IT-MINISAL02-945121$IT-ROCHE-3428953$ROCHE$$56$YR$A$F$Y$58$KG$20240923$$PH$IT$IT
243527791$24352779$1$I$$20231227$20240923$20240923$PER$$JP-ROCHE-3481160$ROCHE$$47$YR$A$F$Y$$$20240923$$MD$JP$JP
243527801$24352780$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380233$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527811$24352781$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380287$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$F$Y$$$20240923$$MD$BE$BE
243527821$24352782$1$I$$20231220$20240923$20240923$PER$$PE-ROCHE-3480145$ROCHE$$55$YR$A$F$Y$$$20240923$$CN$PE$PE
243527831$24352783$1$I$20240816$20240922$20240922$20240922$DIR$719356$$FDA-CTU$$55$YR$$F$N$143.8$KG$20240922$N$CN$US$
243527841$24352784$1$I$20231201$20231221$20240923$20240923$PER$$CN-ROCHE-3481102$ROCHE$$$$$F$Y$60$KG$20240923$$HP$CN$CN
243527851$24352785$1$I$$20231222$20240923$20240923$PER$$US-ROCHE-3481148$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243527861$24352786$1$I$$20240102$20240923$20240923$PER$$US-ROCHE-3480593$ROCHE$$54$YR$A$M$Y$$$20240923$$MD$US$US
243527871$24352787$1$I$$20230928$20240923$20240923$PER$$BE-ROCHE-3380349$ROCHE$Van Cutsem E, di Bartolomeo M, Smyth E, Chau I, Park H, Siena S, Lonardi S, Wainberg Z, Ajani J, Chao J, Janjigian Y, Qin A, Singh J, Barlaskar F, Kawaguchi Y and Ku G. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses.. The Lancet. Oncology. DOI 10.1016/S1470-2045(23)00215-2 2023 Jul;24 (7):744-56.$$$$M$Y$$$20240923$$MD$BE$BE
243527881$24352788$1$I$20230923$20230928$20240923$20240923$PER$$CN-ROCHE-3432559$ROCHE$$54$YR$A$F$Y$67$KG$20240923$$HP$CN$CN
243527891$24352789$1$I$$20240625$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003799$PAREXEL$$59$YR$$F$Y$$$20240923$$HP$US$US
243527901$24352790$1$I$$20240625$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003740$PAREXEL$$67$YR$$F$Y$$$20240923$$CN$US$US
243527911$24352791$1$I$$20240625$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003782$PAREXEL$$43$YR$$F$Y$$$20240923$$CN$US$US
243527921$24352792$1$I$$20240625$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003772$PAREXEL$$60$YR$$F$Y$$$20240923$$CN$US$US
243527931$24352793$1$I$20231207$20231226$20240923$20240923$PER$$CN-ROCHE-3482313$ROCHE$$49$YR$A$F$Y$98$KG$20240923$$HP$CN$CN
243527941$24352794$1$I$$20240625$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003779$PAREXEL$$62$YR$$F$Y$$$20240923$$CN$US$US
243527951$24352795$1$I$$20240213$20240923$20240923$PER$$JP-ROCHE-3482132$ROCHE$$8$DEC$E$F$Y$$$20240923$$MD$JP$JP
243527961$24352796$1$I$$20231220$20240923$20240923$PER$$GB-ROCHE-3481601$ROCHE$$$$A$F$Y$$$20240923$$CN$GB$GB
243527971$24352797$1$I$$20231229$20240923$20240923$PER$$CH-ROCHE-3481415$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243527981$24352798$1$I$20231202$20231220$20240923$20240923$PER$$CN-ROCHE-3480959$ROCHE$$50$YR$A$F$Y$62$KG$20240923$$HP$CN$CN
243527991$24352799$1$I$$20240625$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003851$PAREXEL$$56$YR$$F$Y$$$20240923$$CN$US$US
243528002$24352800$2$F$20240101$20240924$20240923$20240930$PER$$US-AMGEN-USASP2024187896$AMGEN$$56$YR$A$F$Y$$$20240930$$CN$US$US
243528011$24352801$1$I$$20240916$20240923$20240923$EXP$$US-GSK-US2024114826$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$US$US
243528022$24352802$2$F$20230901$20240920$20240923$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015427$JAZZ$$47$YR$$F$Y$$$20240926$$CN$US$US
243528031$24352803$1$I$20240101$20240903$20240923$20240923$PER$$CA-TOLMAR, INC.-24CA052436$TOLMAR$$$$$M$Y$$$20240923$$PH$CA$CA
243528041$24352804$1$I$20240903$20240903$20240923$20240923$PER$$CA-TOLMAR, INC.-24CA052392$TOLMAR$$71$YR$$M$Y$$$20240923$$CN$CA$CA
243528051$24352805$1$I$20240903$20240903$20240923$20240923$PER$$CA-TOLMAR, INC.-24CA052435$TOLMAR$$75$YR$$M$Y$$$20240923$$CN$CA$CA
243528071$24352807$1$I$20240823$20240903$20240923$20240923$PER$$FR-TOLMAR, INC.-24FR052119$TOLMAR$$$$$F$Y$$$20240923$$PH$FR$FR
243528081$24352808$1$I$$20240905$20240923$20240923$PER$$CA-TOLMAR, INC.-24CA052455$TOLMAR$$$$$M$Y$$$20240923$$CN$CA$CA
243528091$24352809$1$I$20240823$20240903$20240923$20240923$PER$$FR-TOLMAR, INC.-24FR052124$TOLMAR$$$$$F$Y$$$20240923$$PH$FR$FR
243528101$24352810$1$I$20240903$20240903$20240923$20240923$PER$$FR-TOLMAR, INC.-24FR052395$TOLMAR$$76$YR$$M$Y$$$20240923$$PH$FR$FR
243528111$24352811$1$I$$20240903$20240923$20240923$PER$$FR-TOLMAR, INC.-24FR052324$TOLMAR$$73$YR$$M$Y$$$20240923$$PH$FR$FR
243528121$24352812$1$I$$20240903$20240923$20240923$PER$$NL-TOLMAR, INC.-24NL052357$TOLMAR$$$$$M$Y$$$20240923$$CN$NL$NL
243528131$24352813$1$I$20240809$20240903$20240923$20240923$PER$$TR-TOLMAR, INC.-24TR052368$TOLMAR$$80$YR$$M$Y$$$20240923$$PH$TR$TR
243528141$24352814$1$I$20240709$20240903$20240923$20240923$PER$$NL-TOLMAR, INC.-24NL052344$TOLMAR$$66$YR$$M$Y$$$20240923$$CN$NL$NL
243528151$24352815$1$I$$20240903$20240923$20240923$PER$$NL-TOLMAR, INC.-24NL052367$TOLMAR$$$$$M$Y$$$20240923$$CN$NL$NL
243528161$24352816$1$I$20240201$20240903$20240923$20240923$PER$$GT-TOLMAR, INC.-24GT052318$TOLMAR$$74$YR$$M$Y$$$20240923$$CN$GT$GT
243528171$24352817$1$I$$20231212$20240923$20240923$PER$$FR-ROCHE-3476153$ROCHE$$$$E$F$Y$$$20240923$$MD$FR$FR
243528181$24352818$1$I$20240902$20240903$20240923$20240923$PER$$TR-TOLMAR, INC.-24TR052390$TOLMAR$$66$YR$$M$Y$$$20240923$$PH$TR$TR
243528191$24352819$1$I$$20231212$20240923$20240923$PER$$FR-ROCHE-3476145$ROCHE$$$$A$F$Y$$$20240923$$MD$FR$FR
243528201$24352820$1$I$20231212$20240122$20240923$20240923$PER$$US-ROCHE-3476753$ROCHE$$76$YR$E$F$Y$$$20240923$$CN$US$US
243528211$24352821$1$I$$20231129$20240923$20240923$PER$$US-ROCHE-3468384$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243528221$24352822$1$I$$20231212$20240923$20240923$PER$$FR-ROCHE-3476155$ROCHE$$$$A$F$Y$$$20240923$$MD$FR$FR
243528231$24352823$1$I$20231120$20231127$20240923$20240923$PER$$CN-ROCHE-3465619$ROCHE$$51$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243528241$24352824$1$I$$20231218$20240923$20240923$PER$$MA-ROCHE-3478331$ROCHE$$$$$M$Y$$$20240923$$MD$MA$MA
243528251$24352825$1$I$$20231125$20240923$20240923$PER$$RU-ROCHE-3465915$ROCHE$$83$YR$E$F$Y$59$KG$20240923$$CN$RU$RU
243528261$24352826$1$I$20240101$20240829$20240923$20240923$PER$$US-SA-2024SA267379$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240923$$MD$US$US
243528271$24352827$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268377$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240923$$MD$US$US
243528281$24352828$1$I$20240830$20240903$20240923$20240923$PER$$US-SA-2024SA270678$SANOFI AVENTIS$$14$YR$T$M$Y$109.09$KG$20240923$$MD$US$US
243528291$24352829$1$I$20240101$20240918$20240923$20240923$PER$$US-SA-2024SA271870$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240923$$MD$US$US
243528301$24352830$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268271$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240923$$MD$US$US
243528311$24352831$1$I$20240508$20240808$20240923$20240923$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000112$UROGEN PHARMA$$$$$$Y$$$20240923$$HP$US$US
243528331$24352833$1$I$$20240917$20240923$20240923$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005169$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240923$$CN$US$US
243528351$24352835$1$I$$20231127$20240923$20240923$PER$$FR-ROCHE-3467836$ROCHE$$$$E$F$Y$$$20240923$$MD$FR$FR
243528361$24352836$1$I$$20240807$20240923$20240923$PER$$US-UROGEN PHARMA LTD.-2024-UGN-000111$UROGEN PHARMA$$$$$$Y$$$20240923$$MD$US$US
243528371$24352837$1$I$20231121$20231130$20240923$20240923$PER$IT-MINISAL02-956644$IT-ROCHE-3467205$ROCHE$$70$YR$E$F$Y$60$KG$20240923$$MD$IT$IT
243528381$24352838$1$I$$20231207$20240923$20240923$PER$$IT-ROCHE-3472623$ROCHE$$$$$$Y$$$20240923$$HP$IT$IT
243528391$24352839$1$I$20231121$20231130$20240923$20240923$PER$$US-ROCHE-3468792$ROCHE$$73$YR$E$F$Y$81.65$KG$20240923$$CN$US$US
243528401$24352840$1$I$20230601$20231129$20240923$20240923$PER$$AE-ROCHE-3467011$ROCHE$$53$YR$A$F$Y$$$20240923$$MD$AE$AE
243528411$24352841$1$I$$20231205$20240923$20240923$PER$$US-ROCHE-3470944$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243528421$24352842$1$I$$20231208$20240923$20240923$PER$$US-ROCHE-3471164$ROCHE$$71$YR$E$F$Y$$$20240923$$MD$US$US
243528431$24352843$1$I$$20231128$20240923$20240923$PER$$ES-ROCHE-3467830$ROCHE$$54$YR$A$F$Y$70$KG$20240923$$MD$ES$ES
243528441$24352844$1$I$$20231124$20240923$20240923$PER$$CN-ROCHE-3465336$ROCHE$Zhao X, Chen Z, Zhang X, Zhu X, Zhang W, Qiu L, Wang C, Huang M, Zhang Z, Li W, Yang L and Guo W Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial. Doi: 10.20892/j.issn.2095-3941.2023.0112. Cancer Biology and Medicine 2023 Sep 15;20 (9):682-8.$$$$$Y$$$20240923$$HP$CN$CN
243528451$24352845$1$I$$20240209$20240923$20240923$PER$$US-ROCHE-3467753$ROCHE$$43$YR$A$F$Y$$$20240923$$MD$US$US
243528461$24352846$1$I$$20231130$20240923$20240923$PER$$IN-ROCHE-3467486$ROCHE$Patel K. Real-world data on the efficacy of T-DM1 biosimilar for the treatment of HER2- positive metastatic breast cancer patients: Outcomes from a single center retrospective study in India [Abstract number: 72P]. DOI:10.1016/j.annonc.2023.10.206. Annals of Oncology 2023 Nov;34 (SUP:4):S1493-.$$$$$Y$$$20240923$$HP$IN$IN
243528471$24352847$1$I$$20231128$20240923$20240923$PER$$ES-ROCHE-3467837$ROCHE$$$$A$F$Y$67$KG$20240923$$MD$ES$ES
243528481$24352848$1$I$$20231212$20240923$20240923$PER$$FR-ROCHE-3476949$ROCHE$$$$E$F$Y$$$20240923$$MD$FR$FR
243528491$24352849$1$I$$20231128$20240923$20240923$PER$$ES-ROCHE-3466819$ROCHE$$$$E$F$Y$67$KG$20240923$$MD$ES$ES
243528501$24352850$1$I$20230901$20231208$20240923$20240923$PER$$US-ROCHE-3473056$ROCHE$$74$YR$E$F$Y$53.52$KG$20240923$$CN$US$US
243528511$24352851$1$I$20240101$20240916$20240923$20240923$EXP$$US-ABBVIE-5928381$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243528521$24352852$1$I$$20240917$20240923$20240923$EXP$$CA-ABBVIE-5929966$ABBVIE$$$$A$M$Y$$$20240923$$CN$CA$CA
243528531$24352853$1$I$20240902$20240916$20240923$20240923$EXP$FR-AFSSAPS-SE2024000718$FR-FreseniusKabi-FK202414016$FRESENIUS KABI$$59$YR$A$F$Y$94$KG$20240923$$MD$FR$FR
243528541$24352854$1$I$$20240913$20240923$20240923$PER$$US-INCYTE CORPORATION-2024IN009732$INCYTE$$$$$$Y$$$20240923$$CN$US$US
243528551$24352855$1$I$$20231201$20240923$20240923$PER$$CN-ROCHE-3469200$ROCHE$$$$$$Y$$$20240923$$CN$CN$CN
243528561$24352856$1$I$20230929$20231128$20240923$20240923$PER$FR-AFSSAPS-MP2023002110$FR-ROCHE-3465742$ROCHE$$75$YR$E$F$Y$$$20240923$$HP$FR$FR
243528571$24352857$1$I$$20231128$20240923$20240923$PER$$RO-ROCHE-3467819$ROCHE$$$$$F$Y$$$20240923$$MD$RO$RO
243528581$24352858$1$I$$20230802$20240923$20240923$EXP$$US-Eisai-EC-2023-145984$EISAI$Craddock KE, McKee JL, Fitzgerald M, Ahrens-Niklas R, Aggarwal S. Neonatal Hypertonia and Progressive Respiratory Failure due to Novel Heterozygous Mutation in ATAD1. Pediatric Neurology. 2023 Feb 24;142: 56-57. doi:10.1016/j.pediatrneurol.2023.02.010.$2$MON$I$F$Y$$$20240923$$MD$US$US
243528591$24352859$1$I$$20240919$20240923$20240923$EXP$$CA-TAKEDA-2024TUS094005$TAKEDA$$$$$M$Y$$$20240923$$CN$CA$CA
243528601$24352860$1$I$$20240918$20240923$20240923$EXP$$CA-TAKEDA-2024TUS093134$TAKEDA$$82$YR$$M$Y$$$20240923$$HP$CA$CA
243528611$24352861$1$I$20231109$20231121$20240923$20240923$PER$$CO-ROCHE-3464353$ROCHE$$58$YR$A$F$Y$52$KG$20240923$$CN$CO$CO
243528621$24352862$1$I$$20231212$20240923$20240923$PER$$GB-ROCHE-3476111$ROCHE$$$$$F$Y$$$20240923$$PH$GB$GB
243528631$24352863$1$I$$20231128$20240923$20240923$PER$$US-ROCHE-3465917$ROCHE$$75$YR$E$F$Y$$$20240923$$MD$US$US
243528641$24352864$1$I$20240101$20240918$20240923$20240923$EXP$$CA-ABBVIE-5932362$ABBVIE$$$$A$M$Y$$$20240923$$CN$CA$CA
243528651$24352865$1$I$$20231127$20240923$20240923$PER$$CL-ROCHE-3468638$ROCHE$$$$$$Y$$$20240923$$MD$CL$CL
243528661$24352866$1$I$20231028$20231129$20240923$20240923$PER$IT-MINISAL02-956415$IT-ROCHE-3466206$ROCHE$$51$YR$A$F$Y$$$20240923$$MD$IT$IT
243528671$24352867$1$I$20231125$20231206$20240923$20240923$PER$$CN-ROCHE-3471053$ROCHE$$60$YR$A$F$Y$50$KG$20240923$$HP$CN$CN
243528681$24352868$1$I$$20231127$20240923$20240923$PER$$JP-ROCHE-3468956$ROCHE$Kamata A, Hino K, Kamiyama K, Takasaka Y, Tazawa K, Kojima A A case of HER2-positive cutaneous apocrine carcinoma which developed in axilla [Abstract number: P43-6]. The 85th Annual Congress of Japan Surgical Association 2023;:-.$61$YR$A$F$Y$$$20240923$$MD$JP$JP
243528691$24352869$1$I$20231214$20231220$20240923$20240923$PER$$CN-ROCHE-3479810$ROCHE$$70$YR$E$F$Y$98$KG$20240923$$HP$CN$CN
243528701$24352870$1$I$$20231127$20240923$20240923$PER$$PT-ROCHE-3466036$ROCHE$Ribeiro R, Pinho R, Ferrao D, Almeida J, Silva M Interstitial Pneumonitis Induced by Paclitaxel in Breast Cancer Treatment: a Case Report. REVISTA PORTUGUESA DE ONCOLOGIA 2023;6 (2):94-7.$72$YR$E$F$Y$$$20240923$$HP$PT$PT
243528711$24352871$1$I$20231103$20231130$20240923$20240923$PER$$CN-ROCHE-3468569$ROCHE$$43$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243528721$24352872$1$I$20231110$20231130$20240923$20240923$PER$$CN-ROCHE-3468568$ROCHE$$66$YR$E$F$Y$$$20240923$$HP$CN$CN
243528731$24352873$1$I$$20231124$20240923$20240923$PER$$ES-ROCHE-3465098$ROCHE$$$$A$F$Y$66$KG$20240923$$MD$ES$ES
243528741$24352874$1$I$20230110$20240118$20240923$20240923$PER$$CY-ROCHE-3470593$ROCHE$$37$YR$A$F$Y$74$KG$20240923$$MD$CY$CY
243528751$24352875$1$I$$20231127$20240923$20240923$PER$$FR-ROCHE-3468572$ROCHE$$$$E$F$Y$$$20240923$$MD$FR$FR
243528761$24352876$1$I$$20231205$20240923$20240923$PER$$AR-ROCHE-3472045$ROCHE$$63$YR$A$F$Y$$$20240923$$CN$AR$AR
243528771$24352877$1$I$$20240109$20240923$20240923$PER$$BE-ROCHE-3469552$ROCHE$$68$YR$E$M$Y$$$20240923$$MD$BE$BE
243528791$24352879$1$I$$20231127$20240923$20240923$PER$$ES-ROCHE-3465985$ROCHE$$48$YR$A$F$Y$64$KG$20240923$$MD$ES$ES
243528811$24352881$1$I$20230815$20240917$20240923$20240923$EXP$$VN-JNJFOC-20240951294$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240923$$HP$VN$VN
243528821$24352882$1$I$$20240906$20240923$20240923$30DAY$$IN-JNJFOC-20240940146$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$IN$IN
243528831$24352883$1$I$20240401$20240916$20240923$20240923$EXP$FI-FIMEA-202403256$FI-TEVA-VS-3244152$TEVA$$40$YR$$F$Y$$$20240923$$CN$FI$FI
243528851$24352885$1$I$20210212$20231221$20240923$20240923$PER$$BG-ROCHE-3479009$ROCHE$$51$YR$A$F$Y$111$KG$20240923$$MD$BG$BG
243528861$24352886$1$I$20200810$20231201$20240923$20240923$PER$$BG-ROCHE-3468944$ROCHE$$71$YR$E$F$Y$57$KG$20240923$$MD$BG$BG
243528871$24352887$1$I$$20231123$20240923$20240923$PER$$ES-ROCHE-3464802$ROCHE$$$$E$F$Y$57$KG$20240923$$MD$ES$ES
243528881$24352888$1$I$20231111$20231130$20240923$20240923$PER$$CN-ROCHE-3468245$ROCHE$$73$YR$E$M$Y$60$KG$20240923$$HP$CN$CN
243528891$24352889$1$I$20231109$20231206$20240923$20240923$PER$$CN-ROCHE-3470960$ROCHE$$30$YR$A$M$Y$48$KG$20240923$$HP$CN$CN
243528901$24352890$1$I$$20231221$20240923$20240923$PER$$PE-ROCHE-3472768$ROCHE$$58$YR$A$F$Y$$$20240923$$CN$PE$PE
243528911$24352891$1$I$$20231120$20240923$20240923$PER$$JP-ROCHE-3464658$ROCHE$Horikawa M. CP1-4 Gastric cancer -an approach considering the characteristics of cancers.. The 33rd Annual Meeting of the Japanese Society of Pharmaceutical Health Care 2023;:1212-.$9$DEC$E$M$Y$$$20240923$$PH$JP$JP
243528921$24352892$1$I$20231130$20231205$20240923$20240923$PER$$JP-ROCHE-3474705$ROCHE$$7$DEC$E$F$Y$$$20240923$$PH$JP$JP
243528931$24352893$1$I$$20231205$20240923$20240923$PER$$JP-ROCHE-3474600$ROCHE$$$$A$F$Y$$$20240923$$PH$JP$JP
243528941$24352894$1$I$$20231201$20240923$20240923$PER$NL-LRB-00931298$NL-ROCHE-3468040$ROCHE$$41$YR$A$F$Y$85$KG$20240923$$CN$NL$NL
243528951$24352895$1$I$20231112$20231220$20240923$20240923$PER$$CN-ROCHE-3479755$ROCHE$$63$YR$A$F$Y$49.4$KG$20240923$$HP$CN$CN
243528961$24352896$1$I$$20240916$20240923$20240923$EXP$$CA-TAKEDA-2024TUS092666$TAKEDA$$$$$M$Y$$$20240923$$CN$CA$CA
243528971$24352897$1$I$20240901$20240909$20240923$20240923$EXP$GB-MHRA-MED-202409091556086610-QTYGH$GB-ELI_LILLY_AND_COMPANY-GB202409005945$ELI LILLY AND CO$$27$YR$A$F$Y$73$KG$20240923$$CN$GB$GB
243528981$24352898$1$I$$20240916$20240923$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011222$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243528991$24352899$1$I$20160101$20240912$20240923$20240923$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409009279$ELI LILLY AND CO$$76$YR$E$M$Y$84$KG$20240923$$CN$CN$CN
243529001$24352900$1$I$$20240910$20240923$20240923$EXP$$BR-ELI_LILLY_AND_COMPANY-BR202409010268$ELI LILLY AND CO$$$$I$F$Y$$$20240923$$CN$BR$BR
243529011$24352901$1$I$20240729$20240910$20240923$20240923$EXP$FR-AFSSAPS-TS2024000973$FR-ELI_LILLY_AND_COMPANY-FR202409006889$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240923$$CN$FR$FR
243529021$24352902$1$I$20240412$20240911$20240923$20240923$EXP$GB-MHRA-MED-202409120157468240-NTZHK$GB-ELI_LILLY_AND_COMPANY-GB202409007857$ELI LILLY AND CO$$43$YR$A$F$Y$78$KG$20240923$$CN$GB$GB
243529031$24352903$1$I$$20240911$20240923$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202409008055$ELI LILLY AND CO$$49$YR$A$$Y$$$20240923$$LW$US$US
243529041$24352904$1$I$$20240908$20240923$20240923$EXP$GB-MHRA-MED-202409081741434740-LVJDP$GB-ELI_LILLY_AND_COMPANY-GB202409005024$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240923$$CN$GB$GB
243529051$24352905$1$I$$20240912$20240923$20240923$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409007834$ELI LILLY AND CO$$$$$M$Y$$$20240923$$CN$GB$GB
243529072$24352907$2$F$20240828$20240917$20240923$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009556$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240927$$CN$US$US
243529081$24352908$1$I$20240906$20240912$20240923$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009370$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240923$$CN$US$US
243529091$24352909$1$I$20240910$20240911$20240923$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202409007527$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240923$$CN$US$US
243529101$24352910$1$I$$20240916$20240923$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009834$ELI LILLY AND CO$$$$$M$Y$$$20240923$$CN$US$US
243529111$24352911$1$I$20240908$20240909$20240923$20240923$EXP$GB-MHRA-MED-202409091620467760-SLRDQ$GB-ELI_LILLY_AND_COMPANY-GB202409005942$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240923$$CN$GB$GB
243529121$24352912$1$I$20240908$20240911$20240923$20240923$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202409007600$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240923$$CN$ES$ES
243529131$24352913$1$I$20240919$20240922$20240922$20240922$DIR$719383$$FDA-CTU$$51$YR$$F$N$59.85$KG$20240922$N$CN$US$
243529141$24352914$1$I$$20240911$20240923$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202409008130$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240923$$CN$US$US
243529161$24352916$1$I$20230101$20240911$20240923$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202409007695$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243529171$24352917$1$I$20240701$20240922$20240922$20240922$DIR$719365$$FDA-CTU$$60$YR$$M$N$90$KG$20240922$N$CN$US$
243529181$24352918$1$I$$20240912$20240923$20240923$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202409009181$ELI LILLY AND CO$$$$$M$Y$$$20240923$$MD$AE$AE
243529192$24352919$2$F$20240829$20240918$20240923$20240930$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409010358$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240930$$CN$FR$FR
243529201$24352920$1$I$20230101$20240916$20240923$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202409010287$ELI LILLY AND CO$$71$YR$E$$Y$$$20240923$$CN$US$US
243529211$24352921$1$I$20240518$20240916$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409009967$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240923$$CN$US$US
243529221$24352922$1$I$20240803$20240911$20240923$20240923$EXP$GB-MHRA-MED-202409111538586210-CZRDS$GB-ELI_LILLY_AND_COMPANY-GB202409007883$ELI LILLY AND CO$$57$YR$A$F$Y$84$KG$20240923$$CN$GB$GB
243529231$24352923$1$I$$20240922$20240922$20240922$DIR$719349$$FDA-CTU$$39$YR$$F$N$70.2$KG$20240922$N$CN$US$
243529251$24352925$1$I$$20240916$20240923$20240923$EXP$$ES-TEVA-VS-3245928$TEVA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.; Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.$$$$$Y$$$20240923$$HP$ES$ES
243529261$24352926$1$I$$20231211$20240923$20240923$PER$$US-ROCHE-3474241$ROCHE$$79$YR$E$F$Y$$$20240923$$CN$US$US
243529271$24352927$1$I$$20231124$20240923$20240923$PER$$ES-ROCHE-3465147$ROCHE$$$$E$F$Y$72$KG$20240923$$MD$ES$ES
243529281$24352928$1$I$$20231204$20240923$20240923$PER$$JP-ROCHE-3474597$ROCHE$$79$YR$E$F$Y$$$20240923$$MD$JP$JP
243529291$24352929$1$I$20230101$20240917$20240923$20240923$EXP$$US-INCYTE CORPORATION-2024IN009836$INCYTE$$$$$$Y$$$20240923$$CN$US$US
243529301$24352930$1$I$20231106$20231128$20240923$20240923$PER$$BR-ROCHE-3466898$ROCHE$$$$$F$Y$$$20240923$$PH$BR$BR
243529311$24352931$1$I$$20231129$20240923$20240923$PER$$AE-ROCHE-3467758$ROCHE$$55$YR$A$F$Y$$$20240923$$MD$AE$AE
243529321$24352932$1$I$$20231124$20240923$20240923$PER$$ES-ROCHE-3465149$ROCHE$$38$YR$A$F$Y$63$KG$20240923$$MD$ES$ES
243529331$24352933$1$I$20231103$20231128$20240923$20240923$PER$FR-AFSSAPS-MP2023002113$FR-ROCHE-3465488$ROCHE$$58$YR$A$F$Y$$$20240923$$HP$FR$FR
243529341$24352934$1$I$$20231212$20240923$20240923$PER$$FR-ROCHE-3476945$ROCHE$$$$A$F$Y$$$20240923$$MD$FR$FR
243529351$24352935$1$I$20231030$20231206$20240923$20240923$PER$$CN-ROCHE-3471092$ROCHE$$47$YR$A$F$Y$$$20240923$$HP$CN$CN
243529361$24352936$1$I$$20231120$20240923$20240923$PER$$JP-ROCHE-3464588$ROCHE$Miyauchi Y, Sakurai J, Yajima K, Okada Y, Sasaki M and Sato S P0729-4-PM2 A case of curatively unresectable, advanced and/or recurrent HER2-positive colon cancer treated with pertuzumab plus trastuzumab combination therapy.. The 33rd Annual Meeting of the Japanese Society of Pharmaceutical Health Care an. 2023;:1041-.$68$YR$E$F$Y$$$20240923$$PH$JP$JP
243529371$24352937$1$I$$20231127$20240923$20240923$PER$$FR-ROCHE-3468585$ROCHE$$$$E$F$Y$$$20240923$$MD$FR$FR
243529381$24352938$1$I$$20231211$20240923$20240923$PER$$IN-ROCHE-3476754$ROCHE$$58$YR$A$F$Y$$$20240923$$CN$IN$IN
243529391$24352939$1$I$$20231211$20240923$20240923$PER$$RO-ROCHE-3475323$ROCHE$$73$YR$E$F$Y$63$KG$20240923$$CN$RO$RO
243529401$24352940$1$I$$20231208$20240923$20240923$PER$$VN-ROCHE-3473852$ROCHE$$50$YR$A$F$Y$$$20240923$$MD$VN$VN
243529411$24352941$1$I$20231111$20231218$20240923$20240923$PER$$CN-ROCHE-3479801$ROCHE$$42$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243529421$24352942$1$I$$20231205$20240923$20240923$PER$$CH-ROCHE-3471379$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243529431$24352943$1$I$20231114$20231207$20240923$20240923$PER$$CN-ROCHE-3472067$ROCHE$$72$YR$E$M$Y$52$KG$20240923$$HP$CN$CN
243529441$24352944$1$I$20231120$20231205$20240923$20240923$PER$$CN-ROCHE-3472901$ROCHE$$64$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243529451$24352945$1$I$$20240913$20240923$20240923$EXP$$US-BEH-2024179161$CSL BEHRING$$$$A$F$Y$$$20240923$$CN$US$US
243529461$24352946$1$I$$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148803$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240923$$HP$US$US
243529471$24352947$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149365$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240923$$CN$US$US
243529481$24352948$1$I$$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149096$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240923$$HP$US$US
243529491$24352949$1$I$20231015$20240119$20240923$20240923$PER$$AT-ROCHE-3478019$ROCHE$$75$YR$E$F$Y$53$KG$20240923$$MD$AT$AT
243529501$24352950$1$I$20240623$20240920$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150558$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240923$$HP$US$US
243529511$24352951$1$I$$20240920$20240923$20240923$EXP$$US-INCYTE CORPORATION-2024IN009998$INCYTE$$$$$$Y$$$20240923$$CN$US$US
243529521$24352952$1$I$$20231127$20240923$20240923$PER$$FR-ROCHE-3468559$ROCHE$$$$E$F$Y$$$20240923$$MD$FR$FR
243529531$24352953$1$I$20231130$20231130$20240923$20240923$PER$$US-ROCHE-3468881$ROCHE$$$$A$F$Y$$$20240923$$MD$US$US
243529541$24352954$1$I$20231211$20231219$20240923$20240923$PER$$CN-ROCHE-3478667$ROCHE$$76$YR$E$M$Y$66.4$KG$20240923$$HP$CN$CN
243529551$24352955$1$I$20230301$20231201$20240923$20240923$PER$NO-NOMAADVRE-PASRAPP-2023-Vpd6p3$NO-ROCHE-3468035$ROCHE$$46$YR$A$F$Y$70$KG$20240923$$CN$NO$NO
243529561$24352956$1$I$$20231218$20240923$20240923$PER$$RU-ROCHE-3478511$ROCHE$$73$YR$E$F$Y$$$20240923$$MD$RU$RU
243529571$24352957$1$I$$20231205$20240923$20240923$PER$$FR-ROCHE-3471967$ROCHE$$$$A$F$Y$$$20240923$$MD$FR$FR
243529581$24352958$1$I$20231114$20231121$20240923$20240923$PER$$JP-ROCHE-3465312$ROCHE$$7$DEC$E$F$Y$$$20240923$$MD$JP$JP
243529591$24352959$1$I$20231101$20240315$20240923$20240923$PER$$CA-ROCHE-3466888$ROCHE$$62$YR$A$F$Y$57$KG$20240923$$CN$CA$CA
243529601$24352960$1$I$20230131$20231123$20240923$20240923$PER$$CN-ROCHE-3465582$ROCHE$$55$YR$A$F$Y$$$20240923$$HP$CN$CN
243529611$24352961$1$I$20231124$20231213$20240923$20240923$PER$$CN-ROCHE-3475752$ROCHE$$62$YR$A$M$Y$83$KG$20240923$$HP$CN$CN
243529621$24352962$1$I$$20231218$20240923$20240923$PER$$US-ROCHE-3478426$ROCHE$$64$YR$A$F$Y$$$20240923$$CN$US$US
243529631$24352963$1$I$20220222$20231214$20240923$20240923$PER$PL-URPL-DML-MLP.4401.1.298.2022$PL-ROCHE-3475916$ROCHE$$49$YR$A$F$Y$79$KG$20240923$$HP$PL$PL
243529651$24352965$1$I$20181103$20231127$20240923$20240923$PER$PL-URPL-1-1124-2019$PL-ROCHE-3464718$ROCHE$$63$YR$A$F$Y$$$20240923$$HP$PL$PL
243529661$24352966$1$I$$20231127$20240923$20240923$PER$$FR-ROCHE-3467786$ROCHE$$$$A$F$Y$$$20240923$$MD$FR$FR
243529671$24352967$1$I$$20231130$20240923$20240923$PER$$JP-ROCHE-3471296$ROCHE$$$$$F$Y$$$20240923$$MD$JP$JP
243529681$24352968$1$I$$20231214$20240923$20240923$PER$$US-ROCHE-3477268$ROCHE$Vosoughi E, Nafissi N, Mahadevan A, Lee S, Parajuli K, Rijal N, Parajuli R and Mehta R Real-life experience of trastuzumab deruxtecan (T-DXd) in patients with heavily pretreated HER2 positive advanced breast cancer: A retrospective single institution study. DOI:10.1200/JCO.2023.41.16_SUPPL.E13035.. Journal of Clinical Oncology 2023 Jun;41 (SUP:16):E13035-.$$$$$Y$$$20240923$$HP$US$US
243529691$24352969$1$I$20231025$20231201$20240923$20240923$PER$$CN-ROCHE-3468824$ROCHE$$44$YR$A$F$Y$72$KG$20240923$$HP$CN$CN
243529701$24352970$1$I$20170818$20231130$20240923$20240923$PER$$IT-ROCHE-3474407$ROCHE$$71$YR$E$F$Y$67$KG$20240923$$MD$IT$IT
243529711$24352971$1$I$20231106$20231218$20240923$20240923$PER$$CN-ROCHE-3478237$ROCHE$$52$YR$A$F$Y$53$KG$20240923$$HP$CN$CN
243529721$24352972$1$I$$20231212$20240923$20240923$PER$$FR-ROCHE-3476132$ROCHE$$$$E$F$Y$$$20240923$$MD$FR$FR
243529741$24352974$1$I$20231025$20231201$20240923$20240923$PER$$CN-ROCHE-3469211$ROCHE$$52$YR$A$F$Y$52$KG$20240923$$HP$CN$CN
243529751$24352975$1$I$20231125$20231206$20240923$20240923$PER$$CN-ROCHE-3473216$ROCHE$$69$YR$E$F$Y$55$KG$20240923$$HP$CN$CN
243529771$24352977$1$I$20231121$20231208$20240923$20240923$PER$$CN-ROCHE-3473208$ROCHE$$52$YR$A$F$Y$49.5$KG$20240923$$HP$CN$CN
243529781$24352978$1$I$20230406$20240124$20240923$20240923$PER$$CY-ROCHE-3470117$ROCHE$$37$YR$A$F$Y$74$KG$20240923$$MD$CY$CY
243529791$24352979$1$I$$20231218$20240923$20240923$PER$$US-ROCHE-3478350$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243529801$24352980$1$I$20231113$20231117$20240923$20240923$PER$$GB-ROCHE-3467142$ROCHE$$52$YR$A$M$Y$78$KG$20240923$$HP$GB$GB
243529811$24352981$1$I$20231206$20231229$20240923$20240923$PER$IT-MINISAL02-960181$IT-ROCHE-3478104$ROCHE$$42$YR$A$F$Y$54$KG$20240923$$MD$IT$IT
243529821$24352982$1$I$20231206$20231211$20240923$20240923$PER$$US-ROCHE-3474204$ROCHE$$53$YR$A$F$Y$$$20240923$$CN$US$US
243529831$24352983$1$I$20231212$20231218$20240923$20240923$PER$$CN-ROCHE-3478835$ROCHE$$43$YR$A$F$Y$48.5$KG$20240923$$HP$CN$CN
243529841$24352984$1$I$20240918$20240919$20240923$20240923$EXP$$NVSC2024CN188918$NOVARTIS$$68$YR$$F$Y$70$KG$20240923$$HP$CN$CN
243529851$24352985$1$I$20240909$20240918$20240923$20240923$EXP$$CN-ASTELLAS-2024-AER-007558$ASTELLAS$$52$YR$A$M$Y$60$KG$20240923$$HP$CN$CN
243529871$24352987$1$I$$20231203$20240923$20240923$PER$$IT-ROCHE-3469657$ROCHE$$$$$F$Y$$$20240923$$CN$IT$IT
243529881$24352988$1$I$$20231205$20240923$20240923$PER$$FR-ROCHE-3471990$ROCHE$$$$A$F$Y$$$20240923$$MD$FR$FR
243529891$24352989$1$I$$20231130$20240923$20240923$PER$$US-ROCHE-3468342$ROCHE$$$$$$Y$$$20240923$$MD$US$US
243529921$24352992$1$I$20231115$20231129$20240923$20240923$PER$$CN-ROCHE-3467459$ROCHE$$46$YR$A$F$Y$67$KG$20240923$$HP$CN$CN
243529932$24352993$2$F$$20240923$20240923$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150097$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240925$$HP$US$US
243529941$24352994$1$I$20231116$20231218$20240923$20240923$PER$$CN-ROCHE-3479818$ROCHE$$43$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243529951$24352995$1$I$20231117$20231213$20240923$20240923$PER$$CN-ROCHE-3475777$ROCHE$$59$YR$A$F$Y$$$20240923$$HP$CN$CN
243529961$24352996$1$I$$20240917$20240923$20240923$EXP$$CA-TAKEDA-2023TUS081470$TAKEDA$$$$$M$Y$$$20240923$$CN$CA$CA
243529971$24352997$1$I$20231121$20231204$20240923$20240923$PER$$CN-ROCHE-3470861$ROCHE$$70$YR$E$M$Y$70$KG$20240923$$HP$CN$CN
243529981$24352998$1$I$$20231205$20240923$20240923$PER$$FR-ROCHE-3471992$ROCHE$$$$A$F$Y$$$20240923$$MD$FR$FR
243530001$24353000$1$I$20180602$20231129$20240923$20240923$PER$$BG-ROCHE-3467063$ROCHE$$54$YR$A$F$Y$65$KG$20240923$$MD$BG$BG
243530011$24353001$1$I$20231208$20231220$20240923$20240923$PER$$CN-ROCHE-3479837$ROCHE$$64$YR$A$F$Y$$$20240923$$HP$CN$CN
243530021$24353002$1$I$$20231219$20240923$20240923$PER$$US-ROCHE-3479208$ROCHE$$58$YR$A$F$Y$$$20240923$$CN$US$US
243530031$24353003$1$I$20230918$20231202$20240923$20240923$PER$$IN-ROCHE-3467677$ROCHE$$53$YR$A$F$Y$$$20240923$$CN$IN$IN
243530041$24353004$1$I$$20231213$20240923$20240923$PER$$US-ROCHE-3475989$ROCHE$$$$A$F$Y$100$KG$20240923$$PH$US$US
243530051$24353005$1$I$$20231127$20240923$20240923$PER$$JP-ROCHE-3468145$ROCHE$Shiyoji W, Matsumura N, Soma D, Tsukayama H, Saito H and Koyanagi G P60-4 A case of excision of synchronous double gastric and bile duct cancers. The 85th Annual Congress of Japan Surgical Association 2023;:-.$73$YR$E$M$Y$$$20240923$$MD$JP$JP
243530061$24353006$1$I$$20231204$20240923$20240923$PER$$JP-ROCHE-3477491$ROCHE$$$$$$Y$$$20240923$$MD$JP$JP
243530071$24353007$1$I$$20231205$20240923$20240923$PER$$FR-ROCHE-3471989$ROCHE$$$$E$F$Y$$$20240923$$MD$FR$FR
243530081$24353008$1$I$20231030$20231120$20240923$20240923$PER$$CN-ROCHE-3464228$ROCHE$$86$YR$E$F$Y$65$KG$20240923$$HP$CN$CN
243530091$24353009$1$I$$20231124$20240923$20240923$PER$$CO-ROCHE-3466850$ROCHE$$58$YR$A$F$Y$$$20240923$$CN$CO$CO
243530101$24353010$1$I$20231102$20231123$20240923$20240923$PER$$CN-ROCHE-3464206$ROCHE$$54$YR$A$F$Y$62.3$KG$20240923$$HP$CN$CN
243530111$24353011$1$I$$20240806$20240923$20240923$EXP$$ES-BIOGEN-2024BI01277524$BIOGEN$$$$$$Y$$$20240923$$MD$ES$ES
243530121$24353012$1$I$20240801$20240917$20240923$20240923$PER$$CA-Eisai-EC-2024-175107$EISAI$$88$YR$E$M$Y$$$20240923$$CN$CA$CA
243530131$24353013$1$I$$20231212$20240923$20240923$PER$$FR-ROCHE-3476942$ROCHE$$$$A$F$Y$$$20240923$$MD$FR$FR
243530151$24353015$1$I$$20231128$20240923$20240923$PER$$RO-ROCHE-3467813$ROCHE$$$$$F$Y$$$20240923$$MD$RO$RO
243530161$24353016$1$I$$20231213$20240923$20240923$PER$$CA-ROCHE-3477229$ROCHE$$$$A$F$Y$$$20240923$$CN$CA$CA
243530171$24353017$1$I$20231122$20231211$20240923$20240923$PER$$CN-ROCHE-3474662$ROCHE$$66$YR$E$F$Y$70$KG$20240923$$HP$CN$CN
243530181$24353018$1$I$$20231214$20240923$20240923$PER$$CO-ROCHE-3477911$ROCHE$$38$YR$A$F$Y$$$20240923$$CN$CO$CO
243530211$24353021$1$I$20240717$20240922$20240922$20240922$DIR$719394$$FDA-CTU$$71$YR$$F$N$78.75$KG$20240922$N$CN$US$
243530231$24353023$1$I$20240617$20240922$20240922$20240922$DIR$719364$$FDA-CTU$$68$YR$$F$N$62.1$KG$20240922$N$CN$US$
243530241$24353024$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64961$$FDA-CTU$$77$YR$$F$N$$$20240923$N$HP$US$
243530251$24353025$1$I$20240807$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64974$$FDA-CTU$$17$YR$$M$N$$$20240923$N$HP$US$
243530261$24353026$1$I$20240913$20240918$20240923$20240923$EXP$$CN-TAKEDA-2024TUS093377$TAKEDA$$60$YR$$F$Y$51$KG$20240923$$HP$CN$CN
243530271$24353027$1$I$$20240919$20240923$20240923$PER$$US-JNJFOC-20240951000$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243530281$24353028$1$I$$20240910$20240923$20240923$PER$$US-SA-2024SA273199$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240923$$CN$US$US
243530291$24353029$1$I$20240828$20240909$20240923$20240923$PER$$US-SA-2024SA273766$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240923$$CN$US$US
243530311$24353031$1$I$$20240919$20240923$20240923$PER$$NVSC2024US189183$NOVARTIS$$$$$M$Y$$$20240923$$CN$US$US
243530321$24353032$1$I$20240101$20240916$20240923$20240923$EXP$$US-SA-2024SA269458$SANOFI AVENTIS$$86$YR$E$F$Y$$$20240923$$MD$US$US
243530331$24353033$1$I$$20240917$20240923$20240923$EXP$$CZ-SA-2024SA271510$SANOFI AVENTIS$$$$A$F$Y$$$20240923$$CN$CZ$CZ
243530351$24353035$1$I$20240916$20240916$20240923$20240923$EXP$$NVSC2024DE188213$NOVARTIS$$43$YR$$F$Y$$$20240923$$HP$DE$DE
243530361$24353036$1$I$$20231121$20240923$20240923$PER$$AR-ROCHE-3466935$ROCHE$$66$YR$E$F$Y$$$20240923$$CN$AR$AR
243530371$24353037$1$I$$20231208$20240923$20240923$PER$$US-ROCHE-3474491$ROCHE$$77$YR$E$F$Y$$$20240923$$MD$US$US
243530381$24353038$1$I$$20231127$20240923$20240923$PER$$US-ROCHE-3465706$ROCHE$$56$YR$A$M$Y$$$20240923$$MD$US$US
243530391$24353039$1$I$20230801$20240514$20240923$20240923$PER$$CO-ROCHE-3465200$ROCHE$$56$YR$A$F$Y$$$20240923$$MD$CO$CO
243530401$24353040$1$I$20231128$20231208$20240923$20240923$PER$$CN-ROCHE-3474079$ROCHE$$53$YR$A$F$Y$68$KG$20240923$$HP$CN$CN
243530411$24353041$1$I$$20231123$20240923$20240923$PER$$AU-ROCHE-3464571$ROCHE$$45$YR$A$F$Y$76.35$KG$20240923$$HP$AU$AU
243530421$24353042$1$I$20231016$20231205$20240923$20240923$PER$$CN-ROCHE-3470816$ROCHE$$55$YR$A$F$Y$$$20240923$$HP$CN$CN
243530431$24353043$1$I$20231101$20231206$20240923$20240923$PER$$CO-ROCHE-3472729$ROCHE$$61$YR$A$F$Y$$$20240923$$CN$CO$CO
243530441$24353044$1$I$20231116$20231121$20240923$20240923$PER$$CN-ROCHE-3464547$ROCHE$$67$YR$E$F$Y$$$20240923$$HP$CN$CN
243530451$24353045$1$I$$20231129$20240923$20240923$PER$$IN-ROCHE-3468837$ROCHE$$58$YR$A$F$Y$$$20240923$$CN$IN$IN
243530461$24353046$1$I$$20231211$20240923$20240923$PER$$RU-ROCHE-3474919$ROCHE$$34$YR$A$F$Y$$$20240923$$MD$RU$RU
243530471$24353047$1$I$$20231204$20240923$20240923$PER$$JP-ROCHE-3472286$ROCHE$$$$$$Y$$$20240923$$MD$JP$JP
243530481$24353048$1$I$20231205$20231219$20240923$20240923$PER$IT-MINISAL02-960166$IT-ROCHE-3478349$ROCHE$$63$YR$A$F$Y$$$20240923$$MD$IT$IT
243530491$24353049$1$I$$20231128$20240923$20240923$PER$$RO-ROCHE-3467803$ROCHE$$$$$F$Y$$$20240923$$MD$RO$RO
243530501$24353050$1$I$20221101$20231205$20240923$20240923$PER$$PL-ROCHE-3469895$ROCHE$$$$$F$Y$$$20240923$$HP$PL$PL
243530511$24353051$1$I$20231109$20231129$20240923$20240923$PER$$CN-ROCHE-3467404$ROCHE$$64$YR$A$F$Y$64$KG$20240923$$HP$CN$CN
243530521$24353052$1$I$$20231128$20240923$20240923$PER$$IN-ROCHE-3468467$ROCHE$$56$YR$A$F$Y$$$20240923$$CN$IN$IN
243530531$24353053$1$I$20231116$20231129$20240923$20240923$PER$$CN-ROCHE-3467402$ROCHE$$60$YR$A$F$Y$85.8$KG$20240923$$HP$CN$CN
243530541$24353054$1$I$$20231212$20240923$20240923$PER$$FR-ROCHE-3476126$ROCHE$$$$E$F$Y$$$20240923$$MD$FR$FR
243530551$24353055$1$I$20190207$20240229$20240923$20240923$PER$$IT-ROCHE-3470192$ROCHE$$62$YR$A$F$Y$70$KG$20240923$$MD$IT$IT
243530561$24353056$1$I$$20231128$20240923$20240923$PER$$RU-ROCHE-3467499$ROCHE$$58$YR$A$F$Y$$$20240923$$MD$RU$RU
243530571$24353057$1$I$20231118$20240327$20240923$20240923$PER$$PE-ROCHE-3466063$ROCHE$$47$YR$A$F$Y$$$20240923$$CN$PE$PE
243530581$24353058$1$I$$20231214$20240923$20240923$PER$$CN-ROCHE-3476780$ROCHE$$$$$$Y$$$20240923$$HP$CN$CN
243530591$24353059$1$I$$20231213$20240923$20240923$PER$$US-ROCHE-3475951$ROCHE$$58$YR$A$M$Y$$$20240923$$MD$US$US
243530601$24353060$1$I$20231121$20231127$20240923$20240923$PER$$CN-ROCHE-3465381$ROCHE$$54$YR$A$F$Y$63$KG$20240923$$HP$CN$CN
243530611$24353061$1$I$20231124$20231211$20240923$20240923$PER$$CN-ROCHE-3474076$ROCHE$$33$YR$A$M$Y$$$20240923$$HP$CN$CN
243530621$24353062$1$I$$20231219$20240923$20240923$PER$$GB-ROCHE-3479367$ROCHE$$$$$$Y$$$20240923$$HP$GB$GB
243530631$24353063$1$I$$20231205$20240923$20240923$PER$$FR-ROCHE-3471966$ROCHE$$$$A$F$Y$$$20240923$$MD$FR$FR
243530641$24353064$1$I$$20231201$20240923$20240923$PER$$CN-ROCHE-3469129$ROCHE$$$$$$Y$$$20240923$$CN$CN$CN
243530651$24353065$1$I$20231106$20231124$20240923$20240923$PER$$CN-ROCHE-3464826$ROCHE$$78$YR$E$M$Y$65$KG$20240923$$HP$CN$CN
243530661$24353066$1$I$$20231130$20240923$20240923$PER$$US-ROCHE-3468428$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243530671$24353067$1$I$$20231212$20240923$20240923$PER$$FR-ROCHE-3476946$ROCHE$$$$E$F$Y$$$20240923$$MD$FR$FR
243530691$24353069$1$I$20231202$20231211$20240923$20240923$PER$$CN-ROCHE-3473476$ROCHE$$73$YR$E$F$Y$52$KG$20240923$$HP$CN$CN
243530701$24353070$1$I$20231129$20231219$20240923$20240923$PER$$CN-ROCHE-3479051$ROCHE$$62$YR$A$F$Y$62$KG$20240923$$HP$CN$CN
243530711$24353071$1$I$20240901$20240920$20240923$20240923$EXP$$US-BAYER-2024A134739$BAYER$$86$YR$E$M$Y$$$20240923$$CN$US$US
243530721$24353072$1$I$20240910$20240913$20240923$20240923$PER$$US-BAYER-2024A131488$BAYER$$66$YR$E$F$Y$$$20240923$$CN$US$US
243530731$24353073$1$I$20231127$20231206$20240923$20240923$PER$$CN-ROCHE-3471625$ROCHE$$73$YR$E$F$Y$49$KG$20240923$$HP$CN$CN
243530741$24353074$1$I$$20231207$20240923$20240923$PER$$RO-ROCHE-3472845$ROCHE$$58$YR$A$F$Y$70$KG$20240923$$CN$RO$RO
243530751$24353075$1$I$$20231220$20240923$20240923$PER$$AE-ROCHE-3479780$ROCHE$$61$YR$A$F$Y$$$20240923$$MD$AE$AE
243530761$24353076$1$I$20231101$20240605$20240923$20240923$PER$$KR-ROCHE-3464570$ROCHE$$48$YR$A$$Y$$$20240923$$HP$KR$KR
243530771$24353077$1$I$20231118$20231220$20240923$20240923$PER$$CN-ROCHE-3479756$ROCHE$$54$YR$A$F$Y$63$KG$20240923$$HP$CN$CN
243530781$24353078$1$I$$20231207$20240923$20240923$PER$$FR-ROCHE-3472007$ROCHE$$67$YR$E$F$Y$$$20240923$$CN$FR$FR
243530791$24353079$1$I$20231130$20231206$20240923$20240923$PER$$CN-ROCHE-3472840$ROCHE$$69$YR$E$F$Y$55$KG$20240923$$HP$CN$CN
243530801$24353080$1$I$$20231212$20240923$20240923$PER$$FR-ROCHE-3476139$ROCHE$$$$A$F$Y$$$20240923$$MD$FR$FR
243530811$24353081$1$I$20231110$20231124$20240923$20240923$PER$$CN-ROCHE-3464851$ROCHE$$59$YR$A$F$Y$58$KG$20240923$$HP$CN$CN
243530821$24353082$1$I$$20231123$20240923$20240923$PER$$US-ROCHE-3464671$ROCHE$Fernando A, Cheema R Nothing Great Comes Without Its Risks; A Rare Case Of Pembrolizumab Induced Hypophysitis. doi: 10.1210/jendso/bvad114.1275. Journal of the Endocrine Society 2023;7 [SUPP;1]:A681-.$64$YR$A$M$Y$$$20240923$$MD$US$US
243530831$24353083$1$I$$20231204$20240923$20240923$PER$$CN-ROCHE-3469852$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243530841$24353084$1$I$20231201$20231206$20240923$20240923$PER$$CN-ROCHE-3471623$ROCHE$$48$YR$A$F$Y$48$KG$20240923$$HP$CN$CN
243530851$24353085$1$I$$20231212$20240923$20240923$PER$$US-ROCHE-3474274$ROCHE$$59$YR$A$F$Y$$$20240923$$MD$US$US
243530861$24353086$1$I$$20240917$20240923$20240923$DIR$FDA-CDER-CTU-2024-64962$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243530871$24353087$1$I$20240913$20240922$20240922$20240922$DIR$719392$$FDA-CTU$$57$YR$$F$N$71.4$KG$20240922$N$HP$US$
243530901$24353090$1$I$20240401$20240909$20240923$20240923$EXP$$DE-NORDICGR-057385$NORDIC PHARMA$$7$YR$$F$Y$21$KG$20240923$$HP$DE$DE
243530911$24353091$1$I$20230425$20231123$20240923$20240923$PER$$CN-ROCHE-3464192$ROCHE$$45$YR$A$F$Y$$$20240923$$HP$CN$CN
243530921$24353092$1$I$$20231204$20240923$20240923$PER$$JP-ROCHE-3469817$ROCHE$$$$$F$Y$$$20240923$$MD$JP$JP
243530931$24353093$1$I$$20231208$20240923$20240923$PER$$EG-ROCHE-3472368$ROCHE$$$$$$Y$$$20240923$$HP$EG$EG
243530941$24353094$1$I$20240910$20240919$20240923$20240923$PER$$US-ABBVIE-5930763$ABBVIE$$63$YR$$M$Y$$$20240923$$CN$US$US
243530951$24353095$1$I$$20240918$20240923$20240923$EXP$$JP-009507513-2409JPN002910J$MERCK$$73$YR$$M$Y$$$20240923$$MD$JP$JP
243530961$24353096$1$I$$20231208$20240923$20240923$PER$$VN-ROCHE-3473841$ROCHE$$$$A$F$Y$$$20240923$$MD$VN$VN
243530971$24353097$1$I$20210819$20240319$20240923$20240923$PER$$BR-ROCHE-3471115$ROCHE$$61$YR$A$F$Y$$$20240923$$MD$BR$BR
243530981$24353098$1$I$$20240920$20240923$20240923$DIR$FDA-CDER-CTU-2024-64975$$FDA-CTU$$$$$M$N$$$20240920$N$HP$US$
243530991$24353099$1$I$20240923$20240923$20240923$20240923$DIR$719400$$FDA-CTU$$31$YR$$F$N$48.6$KG$20240923$N$CN$US$
243531001$24353100$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64976$$FDA-CTU$$72$YR$$F$N$$$20240923$N$$US$
243531011$24353101$1$I$20230801$20231127$20240923$20240923$PER$$CO-ROCHE-3467905$ROCHE$$56$YR$A$F$Y$57$KG$20240923$$CN$CO$CO
243531021$24353102$1$I$$20231212$20240923$20240923$PER$$FR-ROCHE-3476104$ROCHE$$$$A$F$Y$$$20240923$$MD$FR$FR
243531031$24353103$1$I$$20231211$20240923$20240923$PER$$CH-ROCHE-3475252$ROCHE$$$$E$$Y$$$20240923$$MD$CH$CH
243531041$24353104$1$I$$20240904$20240923$20240923$PER$$US-MYLANLABS-2024M1081970$MYLAN$$37$YR$$F$Y$$$20240923$$CN$US$US
243531051$24353105$1$I$20240920$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188783$AMGEN$$64$YR$A$F$Y$$$20240923$$CN$US$US
243531061$24353106$1$I$20240101$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186802$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243531071$24353107$1$I$20240801$20240917$20240923$20240923$EXP$$US-EXELIXIS-EXL-2024-000295$EXELIXIS$$70$YR$$F$Y$$$20240923$$CN$US$US
243531081$24353108$1$I$$20240913$20240923$20240923$PER$$US-VERTEX PHARMACEUTICALS-2024-014719$VERTEX$$$$C$$Y$$$20240923$$PH$US$US
243531091$24353109$1$I$$20240916$20240923$20240923$PER$$US-VERTEX PHARMACEUTICALS-2024-014829$VERTEX$$$$$$Y$$$20240923$$PH$US$US
243531101$24353110$1$I$$20240917$20240923$20240923$EXP$$AT-VERTEX PHARMACEUTICALS-2024-014835$VERTEX$$$$$$Y$$$20240923$$MD$AT$AT
243531111$24353111$1$I$20240101$20240918$20240923$20240923$PER$$US-VERTEX PHARMACEUTICALS-2024-014874$VERTEX$$13$YR$$F$Y$$$20240923$$CN$US$US
243531121$24353112$1$I$$20240918$20240923$20240923$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014855$VERTEX$$$$E$M$Y$$$20240923$$CN$GB$GB
243531131$24353113$1$I$$20240918$20240923$20240923$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014858$VERTEX$$$$T$M$Y$$$20240923$$CN$GB$GB
243531141$24353114$1$I$$20240916$20240923$20240923$PER$$US-VERTEX PHARMACEUTICALS-2024-014830$VERTEX$$$$$$Y$$$20240923$$PH$US$US
243531151$24353115$1$I$20240101$20240917$20240923$20240923$EXP$$US-ABBVIE-5929256$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243531171$24353117$1$I$$20240918$20240923$20240923$EXP$$CA-PFIZER INC-202400259968$PFIZER$$82$YR$$M$Y$$$20240923$$HP$CA$CA
243531191$24353119$1$I$$20240919$20240923$20240923$EXP$$US-PFIZER INC-202400260301$PFIZER$$80$YR$$M$Y$$$20240923$$CN$US$US
243531201$24353120$1$I$$20240919$20240923$20240923$EXP$$AE-PFIZER INC-PV202400123358$PFIZER$$80$YR$$F$Y$$$20240923$$MD$AE$AE
243531211$24353121$1$I$20240101$20240918$20240923$20240923$EXP$$CA-PFIZER INC-202300296274$PFIZER$$71$YR$$F$Y$$$20240923$$MD$CA$CA
243531221$24353122$1$I$$20240919$20240923$20240923$EXP$$JP-PFIZER INC-PV202400122704$PFIZER$$$$$$Y$$$20240923$$MD$JP$JP
243531231$24353123$1$I$20240905$20240914$20240923$20240923$EXP$$CN-JNJFOC-20240940305$JOHNSON AND JOHNSON$$64$YR$A$F$Y$72.5$KG$20240923$$HP$CN$CN
243531241$24353124$1$I$20180101$20240919$20240923$20240923$EXP$$CA-PFIZER INC-2018254640$PFIZER$$72$YR$$M$Y$$$20240923$$CN$CA$CA
243531251$24353125$1$I$20240828$20240917$20240923$20240923$EXP$$NVSC2024CN187859$NOVARTIS$$54$YR$$F$Y$60$KG$20240923$$HP$CN$CN
243531261$24353126$1$I$20240918$20240918$20240923$20240923$EXP$$US-PFIZER INC-PV202400117192$PFIZER$$29$YR$$M$Y$$$20240923$$HP$US$US
243531271$24353127$1$I$$20240917$20240923$20240923$EXP$$US-PFIZER INC-202300422370$PFIZER$$$$E$M$Y$$$20240923$$CN$US$US
243531281$24353128$1$I$$20240917$20240923$20240923$EXP$$JP-PFIZER INC-PV202400121888$PFIZER$Okumura, T.. A case of varicella in an elderly patient orally taking methotrexate sodium. The 245th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2024;245th$91$YR$$M$Y$$$20240923$$HP$JP$JP
243531291$24353129$1$I$20220101$20240919$20240923$20240923$EXP$$US-PFIZER INC-202400260819$PFIZER$$61$YR$$F$Y$$$20240923$$HP$US$US
243531311$24353131$1$I$$20240919$20240923$20240923$EXP$$US-PFIZER INC-PV202400123300$PFIZER$$56$YR$$F$Y$$$20240923$$HP$US$US
243531321$24353132$1$I$20240101$20240918$20240923$20240923$EXP$$CA-PFIZER INC-202400260436$PFIZER$$80$YR$$M$Y$$$20240923$$HP$CA$CA
243531331$24353133$1$I$20240214$20240918$20240923$20240923$EXP$$JP-PFIZER INC-PV202400103724$PFIZER$$60$YR$$M$Y$48.5$KG$20240923$$MD$JP$JP
243531341$24353134$1$I$20240918$20240918$20240923$20240923$EXP$$US-PFIZER INC-202400252295$PFIZER$$70$YR$$M$Y$$$20240923$$CN$US$US
243531351$24353135$1$I$20210101$20240918$20240923$20240923$EXP$$FR-PFIZER INC-202400259605$PFIZER$$22$YR$$F$Y$54$KG$20240923$$MD$FR$FR
243531361$24353136$1$I$20150101$20240918$20240923$20240923$EXP$$US-PFIZER INC-202400259843$PFIZER$$63$YR$$F$Y$81.19$KG$20240923$$CN$US$US
243531371$24353137$1$I$$20240919$20240923$20240923$EXP$$DE-PFIZER INC-202400260324$PFIZER$$$$$F$Y$$$20240923$$CN$DE$DE
243531381$24353138$1$I$20240601$20240919$20240923$20240923$EXP$FR-AFSSAPS-CN2024000752$FR-PFIZER INC-202400259550$PFIZER$$73$YR$$M$Y$64$KG$20240923$$MD$FR$FR
243531391$24353139$1$I$20230101$20240918$20240923$20240923$EXP$$CA-PFIZER INC-202300249364$PFIZER$$63$YR$$F$Y$$$20240923$$HP$CA$CA
243531401$24353140$1$I$$20240918$20240923$20240923$EXP$$DE-PFIZER INC-PV202400123405$PFIZER$$$$$F$Y$$$20240923$$HP$DE$DE
243531411$24353141$1$I$$20240917$20240923$20240923$EXP$$JP-PFIZER INC-PV202400122012$PFIZER$Arima, N.. A case of pancytopenia during methotrexate sodium treatment for rheumatoid arthritis, which was promptly treated with levofolinate. The 346th Kyushu Regional Meeting of the Japanese Society of Internal Medicine. 2024;346th$80$YR$$F$Y$$$20240923$$HP$JP$JP
243531421$24353142$1$I$20240901$20240919$20240923$20240923$EXP$$US-PFIZER INC-202400260739$PFIZER$$65$YR$$F$Y$$$20240923$$HP$US$US
243531431$24353143$1$I$20240911$20240919$20240923$20240923$EXP$$CN-PFIZER INC-PV202400123084$PFIZER$$35$YR$$F$Y$58$KG$20240923$$HP$CN$CN
243531441$24353144$1$I$$20240918$20240923$20240923$EXP$$US-PFIZER INC-202400260173$PFIZER$$71$YR$$M$Y$$$20240923$$CN$US$US
243531451$24353145$1$I$$20240919$20240923$20240923$EXP$$US-PFIZER INC-PV202400123483$PFIZER$$60$YR$$F$Y$$$20240923$$HP$US$US
243531461$24353146$1$I$$20240919$20240923$20240923$EXP$$IN-PFIZER INC-PV202400061612$PFIZER$$34$YR$$F$Y$$$20240923$$CN$IN$IN
243531471$24353147$1$I$20240905$20240918$20240923$20240923$EXP$$CN-PFIZER INC-PV202400122646$PFIZER$$72$YR$$F$Y$56$KG$20240923$$HP$CN$CN
243531481$24353148$1$I$$20240919$20240923$20240923$EXP$$US-PFIZER INC-PV202400123490$PFIZER$$37$YR$$F$Y$$$20240923$$HP$US$US
243531492$24353149$2$F$$20240920$20240923$20240925$EXP$$CA-PFIZER INC-202400259722$PFIZER$Shukla, V.. Developmental and epileptic encephalopathies after successful treatment of pediatric ALL: A case series and review of literature. Epileptic Disorders. 2024;1-10$6$YR$$M$Y$$$20240925$$HP$CA$CA
243531501$24353150$1$I$20240101$20240919$20240923$20240923$EXP$$US-PFIZER INC-202400260302$PFIZER$$$$$F$Y$$$20240923$$CN$US$US
243531511$24353151$1$I$$20240918$20240923$20240923$EXP$$GB-PFIZER INC-202400258909$PFIZER$$36$YR$$$Y$120$KG$20240923$$HP$GB$GB
243531521$24353152$1$I$$20240917$20240923$20240923$EXP$$US-PFIZER INC-PV202400121851$PFIZER$$$$$$Y$$$20240923$$CN$US$US
243531531$24353153$1$I$20240717$20240919$20240923$20240923$EXP$GB-MHRA-MED-202409171628133930-TYBLW$GB-PFIZER INC-202400259802$PFIZER$$30$YR$$F$Y$54$KG$20240923$$CN$GB$GB
243531542$24353154$2$F$20221001$20240919$20240923$20240925$EXP$$US-PFIZER INC-202400258616$PFIZER$Levi, D.. Safety of dexamethasone in transforaminal epidural steroid injections: A case of temporary paraplegia caused by injection of lidocaine and dexamethasone into a lumbar radiculomedullary artery, with no neurologic sequelae.. Interventional pain medicine. 2023;2(1):100240$76$YR$$M$Y$$$20240925$$MD$US$US
243531551$24353155$1$I$20240701$20240918$20240923$20240923$EXP$$US-PFIZER INC-202400260061$PFIZER$$63$YR$$F$Y$$$20240923$$HP$US$US
243531571$24353157$1$I$20240824$20240916$20240923$20240923$PER$$US-BAYER-2024A132820$BAYER$$29$YR$A$F$Y$$$20240923$$CN$US$US
243531581$24353158$1$I$20230710$20240918$20240923$20240923$EXP$$GB-PFIZER INC-202400258900$PFIZER$$64$YR$$F$Y$$$20240923$$HP$GB$GB
243531591$24353159$1$I$$20240916$20240923$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015240$JAZZ$$20$YR$$M$Y$$$20240923$$CN$US$US
243531601$24353160$1$I$$20240910$20240923$20240923$EXP$$US-MEITHEAL-2024MPLIT00286$MEITHEAL PHARMACEUTICALS$Erol LA, et al.Paraneoplastic Hyperthyroidism Secondary to a Chemotherapy-Induced Surge in beta-hCG in a Patient with Non-Seminomatous Germ Cell Tumor.Hawaii Journal of Health and Social Welfare.Feb-2024;83 (2):45-7$21$YR$A$M$Y$$$20240923$$MD$US$US
243531611$24353161$1$I$20240604$20240918$20240923$20240923$EXP$$US-AMERICAN REGENT INC-2024003563$AMERICAN REGENT$$71$YR$$M$Y$55$KG$20240923$$HP$US$US
243531621$24353162$1$I$$20240910$20240923$20240923$EXP$$GB-MEITHEAL-2024MPLIT00289$MEITHEAL PHARMACEUTICALS$Hall R, et al.Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin^s lymphoma, complicated by anthracycline-induced cardiomyopathy.BMJ Case Reports .14-AUG-2024;17 (8):1-5$3$DEC$A$F$Y$$$20240923$$MD$GB$GB
243531631$24353163$1$I$20240903$20240919$20240923$20240923$EXP$$NVSC2024CN188912$NOVARTIS$$88$YR$$F$Y$$$20240923$$HP$CN$CN
243531641$24353164$1$I$20240301$20240916$20240923$20240923$EXP$$NVSC2024ES139210$NOVARTIS$$$$A$F$Y$$$20240923$$MD$ES$ES
243531651$24353165$1$I$20100104$20240913$20240923$20240923$EXP$$FR-TEVA-VS-3243912$TEVA$$$$$F$Y$3.36$KG$20240923$$MD$FR$FR
243531661$24353166$1$I$$20240605$20240923$20240923$PER$$NVSC2024US119337$NOVARTIS$$81$YR$$M$Y$83.9$KG$20240923$$CN$US$US
243531671$24353167$1$I$$20240918$20240923$20240923$PER$$US-BAYER-2024A133812$BAYER$$54$YR$A$F$Y$$$20240923$$CN$US$US
243531681$24353168$1$I$$20240912$20240923$20240923$EXP$$GB-OTSUKA-2024_026178$OTSUKA$$$$$M$Y$$$20240923$$HP$GB$GB
243531691$24353169$1$I$20180101$20240917$20240923$20240923$EXP$$CA-ROCHE-3074077$ROCHE$$43$YR$A$F$Y$$$20240923$$CN$CA$CA
243531701$24353170$1$I$20240801$20240922$20240922$20240922$DIR$719376$$FDA-CTU$$63$YR$$M$N$83.25$KG$20240922$Y$CN$US$
243531711$24353171$1$I$20240728$20240923$20240923$20240923$DIR$719422$$FDA-CTU$$33$YR$$M$N$160.4$KG$20240923$N$HP$US$
243531721$24353172$1$I$20240725$20240923$20240923$20240923$DIR$719419$$FDA-CTU$$33$YR$$M$N$160.4$KG$20240923$N$HP$US$
243531741$24353174$1$I$20240517$20240919$20240923$20240923$EXP$$PL-BAYER-2024A135318$BAYER$$38$YR$A$F$Y$84$KG$20240923$$CN$PL$PL
243531751$24353175$1$I$$20240826$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202408016144$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243531761$24353176$1$I$20240801$20240914$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147005$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240923$$HP$US$US
243531771$24353177$1$I$20240908$20240912$20240923$20240923$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000952$PAREXEL$$$$$$Y$$$20240923$$HP$CN$CN
243531782$24353178$2$F$$20240920$20240923$20240925$EXP$$US-ROCHE-10000082797$ROCHE$$$$A$M$Y$$$20240925$$CN$US$US
243531791$24353179$1$I$$20240920$20240923$20240923$PER$$US-HALEON-2198039$Haleon PLC$$$$$F$Y$$$20240923$$CN$US$US
243531811$24353181$1$I$$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024189139$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243531821$24353182$1$I$$20240826$20240923$20240923$EXP$$US-SA-2024SA273747$SANOFI AVENTIS$$$$$M$Y$$$20240923$$CN$US$US
243531831$24353183$1$I$$20240920$20240923$20240923$EXP$$NVSC2024US089830$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
243531841$24353184$1$I$20240822$20240917$20240923$20240923$EXP$SE-SEMPA-2024-006597$SE-MYLANLABS-2024M1084987$MYLAN$$75$YR$$M$Y$58$KG$20240923$$CN$SE$SE
243531861$24353186$1$I$20240813$20240919$20240923$20240923$EXP$FR-AFSSAPS-NC2024001092$FR-PFIZER INC-202400259552$PFIZER$$40$YR$$M$Y$62.8$KG$20240923$$MD$FR$FR
243531871$24353187$1$I$$20240916$20240923$20240923$30DAY$$US-PFIZER INC-202400258004$PFIZER$$81$YR$$F$Y$55.34$KG$20240923$$CN$US$US
243531881$24353188$1$I$20240801$20240919$20240923$20240923$EXP$$CA-PFIZER INC-PV202300182434$PFIZER$$65$YR$$F$Y$$$20240923$$HP$CA$CA
243531891$24353189$1$I$20240101$20240918$20240923$20240923$EXP$$US-PFIZER INC-202400260060$PFIZER$$48$YR$$F$Y$$$20240923$$HP$US$US
243531931$24353193$1$I$20240831$20240919$20240923$20240923$EXP$FR-AFSSAPS-MA2024001471$FR-PFIZER INC-202400259388$PFIZER$$38$YR$$M$Y$61$KG$20240923$$PH$FR$FR
243531941$24353194$1$I$$20240917$20240923$20240923$EXP$$GT-JNJFOC-20240948529$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$MD$GT$GT
243531951$24353195$1$I$$20240920$20240923$20240923$PER$$US-GILEAD-2024-0688532$GILEAD$$$$A$M$Y$$$20240923$$CN$US$US
243531961$24353196$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA272988$SANOFI AVENTIS$$$$A$F$Y$90.91$KG$20240923$$MD$US$US
243531971$24353197$1$I$$20220926$20240923$20240923$EXP$$CA-SANDOZ INC.-NVSC2022CA217954$SANDOZ$$62$YR$$F$Y$$$20240923$$CN$CA$CA
243531981$24353198$1$I$$20240917$20240923$20240923$EXP$US-MLMSERVICE-20240916-PI188297-00221-5$US-RDY-SPO/USA/24/0013743$DR REDDYS$Hussein G, Krastev P, Mallari AJ, El Labban M, Yadav S, Hassan M, et al. Stone heart syndrome: A curious case of digoxin toxicity and calcium infusion. Clinical Case Reports. 2024;12(9). DOI:10.1002/ccr3.9376.$78$YR$E$F$Y$$$20240923$$MD$US$US
243531992$24353199$2$F$$20240919$20240923$20240924$EXP$$BR-GENMAB-2024-03255$GENMAB$$$$$M$Y$$$20240924$$MD$BR$BR
243532001$24353200$1$I$20230908$20231026$20240923$20240923$PER$$CN-ROCHE-3448684$ROCHE$$55$YR$A$F$Y$62$KG$20240923$$HP$CN$CN
243532011$24353201$1$I$$20231121$20240923$20240923$PER$$US-ROCHE-3462750$ROCHE$$54$YR$A$F$Y$$$20240923$$MD$US$US
243532021$24353202$1$I$20231016$20231114$20240923$20240923$PER$$CN-ROCHE-3460398$ROCHE$$65$YR$E$F$Y$77$KG$20240923$$HP$CN$CN
243532031$24353203$1$I$20231021$20231030$20240923$20240923$PER$$CN-ROCHE-3450484$ROCHE$$34$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243532041$24353204$1$I$$20231101$20240923$20240923$PER$$US-ROCHE-3451224$ROCHE$$62$YR$A$F$Y$$$20240923$$MD$US$US
243532051$24353205$1$I$20240912$20240913$20240923$20240923$EXP$$KR-SAMSUNG BIOEPIS-SB-2024-28519$SAMSUNG BIOEPIS$$79$YR$E$F$Y$37.5$KG$20240923$$MD$KR$KR
243532061$24353206$1$I$$20231027$20240923$20240923$PER$$PE-ROCHE-3449984$ROCHE$$35$YR$A$F$Y$$$20240923$$CN$PE$PE
243532071$24353207$1$I$20231015$20231113$20240923$20240923$PER$$CN-ROCHE-3457403$ROCHE$$52$YR$A$F$Y$68$KG$20240923$$HP$CN$CN
243532081$24353208$1$I$20230322$20231110$20240923$20240923$PER$$RU-ROCHE-3457077$ROCHE$$63$YR$A$$Y$$$20240923$$MD$RU$RU
243532091$24353209$1$I$20231025$20231101$20240923$20240923$PER$$CN-ROCHE-3451171$ROCHE$$69$YR$E$M$Y$61$KG$20240923$$HP$CN$CN
243532101$24353210$1$I$$20240920$20240923$20240923$EXP$$PT-TAKEDA-2024TUS093656$TAKEDA$$69$YR$$F$Y$$$20240923$$HP$PT$PT
243532111$24353211$1$I$$20231228$20240923$20240923$PER$$JP-ROCHE-3463965$ROCHE$$7$DEC$E$F$Y$$$20240923$$MD$JP$JP
243532121$24353212$1$I$20231102$20231107$20240923$20240923$PER$$CN-ROCHE-3454521$ROCHE$$35$YR$A$F$Y$50$KG$20240923$$HP$CN$CN
243532131$24353213$1$I$20230915$20231122$20240923$20240923$PER$$KR-ROCHE-3448818$ROCHE$$62$YR$A$$Y$$$20240923$$MD$KR$KR
243532141$24353214$1$I$$20231027$20240923$20240923$PER$$US-ROCHE-3449060$ROCHE$$54$YR$A$F$Y$$$20240923$$MD$US$US
243532151$24353215$1$I$20231028$20231107$20240923$20240923$PER$$CN-ROCHE-3454515$ROCHE$$60$YR$A$F$Y$85$KG$20240923$$HP$CN$CN
243532161$24353216$1$I$$20231109$20240923$20240923$PER$$US-ROCHE-3456143$ROCHE$$$$$$Y$$$20240923$$MD$US$US
243532181$24353218$1$I$$20231113$20240923$20240923$PER$$NL-ROCHE-3457598$ROCHE$$68$YR$E$F$Y$$$20240923$$CN$NL$NL
243532191$24353219$1$I$$20231110$20240923$20240923$PER$$CN-ROCHE-3456910$ROCHE$$62$YR$A$F$Y$$$20240923$$CN$CN$CN
243532202$24353220$2$F$$20240903$20240923$20240924$PER$$US-SA-2024SA271056$SANOFI AVENTIS$$$$A$F$Y$74.84$KG$20240924$$MD$US$US
243532211$24353221$1$I$20231120$20231122$20240923$20240923$PER$$US-ROCHE-3463481$ROCHE$$52$YR$A$F$Y$$$20240923$$CN$US$US
243532221$24353222$1$I$$20231108$20240923$20240923$PER$$ES-ROCHE-3456272$ROCHE$$74$YR$E$F$Y$53$KG$20240923$$MD$ES$ES
243532241$24353224$1$I$20231105$20231108$20240923$20240923$PER$$CN-ROCHE-3455207$ROCHE$$64$YR$A$F$Y$57$KG$20240923$$HP$CN$CN
243532251$24353225$1$I$$20240129$20240923$20240923$PER$$NL-ROCHE-3457293$ROCHE$de Weger V, Schutte T, Konings I and Menke-van der Houven van Oordt C Successful Trastuzumab-Deruxtecan Rechallenge After Interstitial Lung Disease: A Case Report. Doi: 10.4048/jbc.2023.26.e38. Journal of breast cancer 2023 Oct;26 (5):519-23.$39$YR$A$F$Y$$$20240923$$HP$NL$NL
243532261$24353226$1$I$20231024$20231128$20240923$20240923$PER$$DE-ROCHE-3462054$ROCHE$$77$YR$E$F$Y$$$20240923$$MD$DE$DE
243532271$24353227$1$I$$20231120$20240923$20240923$PER$$ES-ROCHE-3462908$ROCHE$$64$YR$A$F$Y$54$KG$20240923$$MD$ES$ES
243532281$24353228$1$I$20231013$20231107$20240923$20240923$PER$$CN-ROCHE-3454570$ROCHE$$$$$F$Y$62$KG$20240923$$HP$CN$CN
243532291$24353229$1$I$$20231113$20240923$20240923$PER$$TR-ROCHE-3459342$ROCHE$$$$$$Y$$$20240923$$HP$TR$TR
243532301$24353230$1$I$20231106$20231113$20240923$20240923$PER$$JP-ROCHE-3460533$ROCHE$$$$A$F$Y$$$20240923$$MD$JP$JP
243532321$24353232$1$I$20231018$20231107$20240923$20240923$PER$$CN-ROCHE-3454559$ROCHE$$58$YR$A$F$Y$56$KG$20240923$$HP$CN$CN
243532331$24353233$1$I$20231108$20231114$20240923$20240923$PER$$CN-ROCHE-3458313$ROCHE$$62$YR$A$F$Y$$$20240923$$HP$CN$CN
243532341$24353234$1$I$$20231228$20240923$20240923$PER$$JP-ROCHE-3463945$ROCHE$$7$DEC$E$F$Y$$$20240923$$MD$JP$JP
243532351$24353235$1$I$$20240921$20240923$20240923$PER$$US-AMGEN-USASP2024189136$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243532361$24353236$1$I$$20231115$20240923$20240923$PER$$ES-ROCHE-3459567$ROCHE$$61$YR$A$F$Y$65$KG$20240923$$MD$ES$ES
243532371$24353237$1$I$$20231121$20240923$20240923$PER$$MY-ROCHE-3460095$ROCHE$$$$$$Y$$$20240923$$CN$MY$MY
243532381$24353238$1$I$$20231120$20240923$20240923$PER$$JP-ROCHE-3453275$ROCHE$Tsujiyama S, Shiyokawa T, Fujii T, Yamae K, Amioka M, Nitsuta K et al.. P5-6 Administration experience of SGLT-2 inhibitors for CTRCD due to HER2 inhibitors. The 6th Annual Meeting of the Japanese Onco-Cardiology Society 2023;:114-.$8$DEC$E$F$Y$$$20240923$$MD$JP$JP
243532391$24353239$1$I$$20240923$20240923$20240923$DIR$719428$$FDA-CTU$$$$$UNK$N$$$20240923$$CN$US$
243532401$24353240$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64978$$FDA-CTU$$47$YR$$F$N$$$20240923$N$HP$US$
243532411$24353241$1$I$$20240923$20240923$20240923$DIR$719430$$FDA-CTU$$$$$UNK$N$$$20240923$N$CN$US$
243532432$24353243$2$F$20240901$20240923$20240923$20240925$EXP$$US-PFIZER INC-PV202400123747$PFIZER$$77$YR$$M$Y$$$20240925$$CN$US$US
243532451$24353245$1$I$20240801$20240920$20240923$20240923$EXP$$TW-PFIZER INC-PV202400123360$PFIZER$$$$E$F$Y$$$20240923$$HP$TW$TW
243532461$24353246$1$I$20240901$20240917$20240923$20240923$EXP$$US-ABBVIE-5928524$ABBVIE$$81$YR$$M$Y$$$20240923$$CN$US$US
243532471$24353247$1$I$20231014$20231108$20240923$20240923$PER$$CN-ROCHE-3455201$ROCHE$$54$YR$A$F$Y$62$KG$20240923$$HP$CN$CN
243532481$24353248$1$I$$20231120$20240923$20240923$PER$NL-LRB-00924510$NL-ROCHE-3461844$ROCHE$$54$YR$A$F$Y$89$KG$20240923$$CN$NL$NL
243532491$24353249$1$I$$20240916$20240923$20240923$EXP$$CL-ROCHE-10000086293$ROCHE$Canto A, Garcia L, Aylwin E, Jurgensen L, Guzman I, Gutierrez L, et al. Real-World evidence of treatment with ocrelizumab in Chilean patients with Multiple Sclerosis 4-years follow up. [Abstract number:P1702/395]. Multiple Sclerosis Journal. 2024;30 (3 (SUP)):1075-6.$$$$$Y$$$20240923$$HP$CL$CL
243532501$24353250$1$I$$20231121$20240923$20240923$PER$$AE-ROCHE-3462422$ROCHE$$62$YR$A$F$Y$$$20240923$$MD$AE$AE
243532511$24353251$1$I$20231110$20231121$20240923$20240923$PER$$CN-ROCHE-3464179$ROCHE$$42$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243532521$24353252$1$I$20231110$20231115$20240923$20240923$PER$$CN-ROCHE-3459255$ROCHE$$$$$F$Y$65$KG$20240923$$HP$CN$CN
243532531$24353253$1$I$20231020$20231123$20240923$20240923$PER$$CN-ROCHE-3463824$ROCHE$$51$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243532541$24353254$1$I$$20231107$20240923$20240923$PER$$CA-ROCHE-3454962$ROCHE$$$$$$Y$$$20240923$$HP$CA$CA
243532551$24353255$1$I$$20231102$20240923$20240923$PER$$US-ROCHE-3453441$ROCHE$Collins M, Hadden R and Shahnoor N Primary perineuritis, a rare but treatable neuropathy: Review of perineurial anatomy, clinicopathological features, and differential diagnosis. DOI:10.1002/mus.27949. Muscle and Nerve 2023;68 (5):696-713.$63$YR$A$F$Y$$$20240923$$MD$US$US
243532561$24353256$1$I$$20231113$20240923$20240923$PER$$CN-ROCHE-3457450$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243532571$24353257$1$I$$20231109$20240923$20240923$PER$$BE-ROCHE-3449020$ROCHE$$$$$F$Y$$$20240923$$MD$BE$BE
243532581$24353258$1$I$20190213$20231109$20240923$20240923$PER$$PL-ROCHE-3455039$ROCHE$$52$YR$A$F$Y$$$20240923$$MD$PL$PL
243532591$24353259$1$I$$20231113$20240923$20240923$PER$$TR-ROCHE-3457852$ROCHE$$$$$$Y$$$20240923$$HP$TR$TR
243532601$24353260$1$I$$20231114$20240923$20240923$PER$$CA-ROCHE-3458016$ROCHE$$$$A$F$Y$$$20240923$$CN$CA$CA
243532611$24353261$1$I$$20231122$20240923$20240923$PER$$CD-ROCHE-3462113$ROCHE$$$$$$Y$$$20240923$$MD$CD$CD
243532621$24353262$1$I$20230525$20231120$20240923$20240923$PER$$CO-ROCHE-3457978$ROCHE$$58$YR$A$F$Y$58$KG$20240923$$CN$CO$CO
243532631$24353263$1$I$20231109$20231114$20240923$20240923$PER$$CN-ROCHE-3458321$ROCHE$$60$YR$A$F$Y$$$20240923$$HP$CN$CN
243532641$24353264$1$I$$20231122$20240923$20240923$PER$$CG-ROCHE-3462123$ROCHE$$$$$$Y$$$20240923$$MD$CG$CG
243532651$24353265$1$I$20231020$20231108$20240923$20240923$PER$$CN-ROCHE-3455204$ROCHE$$61$YR$A$F$Y$53$KG$20240923$$HP$CN$CN
243532661$24353266$1$I$$20231114$20240923$20240923$PER$$ES-ROCHE-3458711$ROCHE$$$$A$F$Y$77$KG$20240923$$MD$ES$ES
243532671$24353267$1$I$$20231124$20240923$20240923$PER$$CN-ROCHE-3464100$ROCHE$$$$$F$Y$$$20240923$$MD$CN$CN
243532681$24353268$1$I$$20240104$20240923$20240923$PER$$CA-ROCHE-3459529$ROCHE$$$$A$F$Y$$$20240923$$CN$CA$CA
243532691$24353269$1$I$$20240122$20240923$20240923$PER$$JP-ROCHE-3456718$ROCHE$Tabei Y, Tada Y, Nakazato I, Ishikawa H, Suma T, Oyama K et al. Intrathecal injection of trastuzumab for meningeal carcinomatosis from HER2 positive salivary gland cancer (Abstract number: P07-3). The 82nd Annual Meeting of the Japan Neurosurgical Society 2023;:1137-.$46$YR$A$M$Y$$$20240923$$MD$JP$JP
243532701$24353270$1$I$20240918$20240918$20240923$20240923$EXP$$US-OTSUKA-2024_019034$OTSUKA$$34$YR$$F$Y$$$20240923$$CN$US$US
243532711$24353271$1$I$20240401$20240919$20240923$20240923$PER$$US-BIOGEN-2024BI01261949$BIOGEN$$31$YR$$F$Y$$$20240923$$CN$US$US
243532721$24353272$1$I$20231108$20231115$20240923$20240923$PER$$CN-ROCHE-3459289$ROCHE$$59$YR$A$F$Y$$$20240923$$HP$CN$CN
243532731$24353273$1$I$20231116$20231120$20240923$20240923$PER$$CN-ROCHE-3463441$ROCHE$$45$YR$A$F$Y$66$KG$20240923$$HP$CN$CN
243532741$24353274$1$I$20231021$20231123$20240923$20240923$PER$$CN-ROCHE-3463806$ROCHE$$61$YR$A$F$Y$$$20240923$$HP$CN$CN
243532751$24353275$1$I$$20240114$20240923$20240923$PER$$TH-ROCHE-3453770$ROCHE$$49$YR$A$F$Y$$$20240923$$CN$TH$TH
243532761$24353276$1$I$20231018$20231103$20240923$20240923$PER$$CN-ROCHE-3452746$ROCHE$$56$YR$A$F$Y$65$KG$20240923$$HP$CN$CN
243532771$24353277$1$I$20230717$20231117$20240923$20240923$PER$$CN-ROCHE-3460701$ROCHE$$55$YR$A$F$Y$$$20240923$$HP$CN$CN
243532781$24353278$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188623$AMGEN$$$$$M$Y$$$20240923$$MD$US$US
243532801$24353280$1$I$20231113$20231122$20240923$20240923$PER$$CN-ROCHE-3463420$ROCHE$$78$YR$E$F$Y$70$KG$20240923$$HP$CN$CN
243532811$24353281$1$I$20231107$20231117$20240923$20240923$PER$$CN-ROCHE-3460804$ROCHE$$72$YR$E$F$Y$59$KG$20240923$$HP$CN$CN
243532831$24353283$1$I$$20231106$20240923$20240923$PER$$JP-ROCHE-3458054$ROCHE$Hamanaka T. A case in which online drug administration guidance was useful in confirming adverse events during chemotherapy [Abstract Number: O57-1]. The 61st Annual Meeting of Japan Society of Clinical Oncology. 2023;1036:-.$6$DEC$A$F$Y$$$20240923$$PH$JP$JP
243532841$24353284$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64980$$FDA-CTU$$72$YR$$F$N$60.78$KG$20240923$N$$US$
243532851$24353285$1$I$$20231114$20240923$20240923$PER$$PK-ROCHE-3457827$ROCHE$$65$YR$E$F$Y$93$KG$20240923$$CN$PK$PK
243532861$24353286$1$I$20231103$20231114$20240923$20240923$PER$$CN-ROCHE-3458389$ROCHE$$68$YR$E$M$Y$50$KG$20240923$$HP$CN$CN
243532871$24353287$1$I$20230316$20231122$20240923$20240923$PER$$CN-ROCHE-3463425$ROCHE$$45$YR$A$F$Y$$$20240923$$HP$CN$CN
243532881$24353288$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64979$$FDA-CTU$$68$YR$$M$N$$$20240923$N$$US$
243532891$24353289$1$I$20240816$20240910$20240923$20240923$PER$$US-JNJFOC-20240930239$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$CN$US$US
243532901$24353290$1$I$20240101$20240801$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002909$PAREXEL$$$$$$Y$$$20240923$$CN$US$US
243532911$24353291$1$I$$20240806$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000072$PAREXEL$$$$$$Y$$$20240923$$CN$US$US
243532921$24353292$1$I$$20240731$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003615$PAREXEL$$59$YR$$F$Y$$$20240923$$CN$US$US
243532931$24353293$1$I$$20240814$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002938$PAREXEL$$52$YR$$F$Y$$$20240923$$CN$US$US
243532941$24353294$1$I$$20240731$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004267$PAREXEL$$70$YR$$F$Y$$$20240923$$CN$US$US
243532951$24353295$1$I$$20240731$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004295$PAREXEL$$49$YR$$F$Y$$$20240923$$CN$US$US
243532961$24353296$1$I$20240101$20240805$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000052$PAREXEL$$$$$$Y$$$20240923$$CN$US$US
243532971$24353297$1$I$20240730$20240807$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000094$PAREXEL$$$$$$Y$$$20240923$$CN$US$US
243532981$24353298$1$I$$20240731$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003969$PAREXEL$$$$$F$Y$63.56$KG$20240923$$CN$US$US
243532991$24353299$1$I$20240601$20240802$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000022$PAREXEL$$$$$$Y$$$20240923$$CN$US$US
243533001$24353300$1$I$$20240731$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004279$PAREXEL$$73$YR$$F$Y$$$20240923$$CN$US$US
243533011$24353301$1$I$$20240731$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004256$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243533021$24353302$1$I$$20240731$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004269$PAREXEL$$78$YR$$F$Y$$$20240923$$CN$US$US
243533031$24353303$1$I$20231009$20231103$20240923$20240923$PER$$CN-ROCHE-3452760$ROCHE$$68$YR$E$F$Y$45$KG$20240923$$HP$CN$CN
243533041$24353304$1$I$$20231103$20240923$20240923$PER$$RU-ROCHE-3452988$ROCHE$$48$YR$A$F$Y$$$20240923$$MD$RU$RU
243533051$24353305$1$I$20231027$20231031$20240923$20240923$PER$$CN-ROCHE-3450404$ROCHE$$35$YR$A$F$Y$70$KG$20240923$$HP$CN$CN
243533061$24353306$1$I$$20231031$20240923$20240923$PER$$VE-ROCHE-3450857$ROCHE$$$$$F$Y$$$20240923$$MD$VE$VE
243533071$24353307$1$I$20231027$20231101$20240923$20240923$PER$$CN-ROCHE-3451213$ROCHE$$29$YR$A$F$Y$51.5$KG$20240923$$HP$CN$CN
243533081$24353308$1$I$$20231030$20240923$20240923$PER$$CA-ROCHE-3449143$ROCHE$$$$A$F$Y$$$20240923$$CN$CA$CA
243533091$24353309$1$I$$20231025$20240923$20240923$PER$$BR-ROCHE-3449184$ROCHE$$51$YR$A$F$Y$60$KG$20240923$$MD$BR$BR
243533101$24353310$1$I$20230720$20231101$20240923$20240923$PER$$CN-ROCHE-3451218$ROCHE$$62$YR$A$F$Y$47$KG$20240923$$HP$CN$CN
243533111$24353311$1$I$$20231101$20240923$20240923$PER$$US-ROCHE-3451503$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243533121$24353312$1$I$20231024$20231031$20240923$20240923$PER$$CO-ROCHE-3452238$ROCHE$$54$YR$A$F$Y$59$KG$20240923$$CN$CO$CO
243533131$24353313$1$I$$20231107$20240923$20240923$PER$$RU-ROCHE-3453840$ROCHE$$$$$F$Y$$$20240923$$MD$RU$RU
243533141$24353314$1$I$20240101$20240905$20240923$20240923$PER$$US-SA-2024SA273107$SANOFI AVENTIS$$9$YR$C$M$Y$27.36$KG$20240923$$MD$US$US
243533151$24353315$1$I$$20240905$20240923$20240923$PER$$US-SA-2024SA273295$SANOFI AVENTIS$$$$A$M$Y$$$20240923$$MD$US$US
243533161$24353316$1$I$20240911$20240911$20240923$20240923$PER$$US-ALKERMES INC.-ALK-2024-002378$ALKERMES$$58$YR$$M$Y$$$20240923$$HP$US$US
243533171$24353317$1$I$20231006$20231103$20240923$20240923$PER$$CN-ROCHE-3452368$ROCHE$$61$YR$A$F$Y$49$KG$20240923$$HP$CN$CN
243533181$24353318$1$I$$20231103$20240923$20240923$PER$$RO-ROCHE-3451928$ROCHE$$67$YR$E$F$Y$$$20240923$$HP$RO$RO
243533191$24353319$1$I$20230908$20231027$20240923$20240923$PER$$CN-ROCHE-3448772$ROCHE$$46$YR$A$F$Y$$$20240923$$HP$CN$CN
243533201$24353320$1$I$20231030$20231103$20240923$20240923$PER$$CN-ROCHE-3452359$ROCHE$$61$YR$A$F$Y$56$KG$20240923$$HP$CN$CN
243533211$24353321$1$I$20231103$20231107$20240923$20240923$PER$$CN-ROCHE-3454184$ROCHE$$58$YR$A$F$Y$$$20240923$$HP$CN$CN
243533221$24353322$1$I$$20231103$20240923$20240923$PER$$US-ROCHE-3452236$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243533231$24353323$1$I$20231029$20231103$20240923$20240923$PER$$CN-ROCHE-3452366$ROCHE$$65$YR$E$M$Y$55$KG$20240923$$HP$CN$CN
243533241$24353324$1$I$$20231114$20240923$20240923$PER$$GB-ROCHE-3460219$ROCHE$$$$$M$Y$$$20240923$$PH$GB$GB
243533251$24353325$1$I$$20231102$20240923$20240923$PER$$HR-ROCHE-3451640$ROCHE$$$$$$Y$$$20240923$$HP$HR$HR
243533262$24353326$2$F$20240101$20240917$20240923$20240925$EXP$$US-JNJFOC-20240951284$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240925$$CN$US$US
243533271$24353327$1$I$$20231122$20240923$20240923$PER$$US-ROCHE-3463644$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243533281$24353328$1$I$$20231122$20240923$20240923$PER$$CN-ROCHE-3463463$ROCHE$$35$YR$A$$Y$$$20240923$$MD$CN$CN
243533291$24353329$1$I$20231110$20231120$20240923$20240923$PER$$CN-ROCHE-3461799$ROCHE$$60$YR$A$F$Y$56.4$KG$20240923$$HP$CN$CN
243533301$24353330$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3451774$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243533311$24353331$1$I$$20231113$20240923$20240923$PER$$RU-ROCHE-3458582$ROCHE$$$$A$F$Y$$$20240923$$MD$RU$RU
243533321$24353332$1$I$20231026$20231109$20240923$20240923$PER$$CN-ROCHE-3455982$ROCHE$$43$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243533331$24353333$1$I$20231113$20231120$20240923$20240923$PER$IT-MINISAL02-954904$IT-ROCHE-3461874$ROCHE$$47$YR$A$F$Y$80$KG$20240923$$MD$IT$IT
243533341$24353334$1$I$$20231120$20240923$20240923$PER$$CN-ROCHE-3460697$ROCHE$$36$YR$A$F$Y$$$20240923$$CN$CN$CN
243533351$24353335$1$I$$20240923$20240923$20240923$DIR$719405$$FDA-CTU$$$$$UNK$N$$$20240923$N$CN$US$
243533361$24353336$1$I$$20231207$20240923$20240923$PER$$ES-ROCHE-3457484$ROCHE$Munoz S, Sanchez Espinosa A, Ortiz Gonzalez A, Guillen Saorin E, Perez Parra D, Capozzi  C, Acosta Ortega J and Sanchez De las Matas Garre  M Nonnecrotising granulomatous lymphadenitis in the context of autoimmune pseudosarcoidotic reaction.(Abstract number:E-PS-02-012). Doi: 10.1007/s00428-023-03602-w. Virchows Archiv 2023 Sep;483 (SUPPLEMENT 1):S155-.$36$YR$A$F$Y$$$20240923$$HP$ES$ES
243533371$24353337$1$I$20230630$20240322$20240923$20240923$PER$$PT-ROCHE-3453644$ROCHE$$67$YR$E$F$Y$62$KG$20240923$$MD$PT$PT
243533381$24353338$1$I$$20231112$20240923$20240923$PER$$CN-ROCHE-3456812$ROCHE$$41$YR$A$F$Y$$$20240923$$CN$CN$CN
243533391$24353339$1$I$20231108$20231115$20240923$20240923$PER$$CN-ROCHE-3459178$ROCHE$$60$YR$A$F$Y$50$KG$20240923$$HP$CN$CN
243533401$24353340$1$I$$20231109$20240923$20240923$PER$$IT-ROCHE-3456080$ROCHE$$$$$$Y$$$20240923$$HP$IT$IT
243533411$24353341$1$I$20240814$20240916$20240923$20240923$EXP$FR-AFSSAPS-CN2024000836$FR-MYLANLABS-2024M1084335$MYLAN$$75$YR$$M$Y$$$20240923$$PH$FR$FR
243533421$24353342$1$I$20230701$20240916$20240923$20240923$EXP$FR-AFSSAPS-LM2024000494$FR-MYLANLABS-2024M1084251$MYLAN$$58$YR$$M$Y$$$20240923$$MD$FR$FR
243533431$24353343$1$I$$20240916$20240923$20240923$EXP$$GB-MYLANLABS-2024M1084476$MYLAN$$$$$M$Y$$$20240923$$CN$GB$GB
243533441$24353344$1$I$20240705$20240917$20240923$20240923$EXP$FR-AFSSAPS-CN2024000854$FR-MYLANLABS-2024M1085344$MYLAN$$53$YR$$M$Y$104$KG$20240923$$MD$FR$FR
243533451$24353345$1$I$$20240910$20240923$20240923$EXP$$US-MYLANLABS-2024M1084085$MYLAN$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. J-Oncol-Pharm-Pract 2024; 0 (0):.$69$YR$$F$Y$$$20240923$$HP$US$US
243533461$24353346$1$I$20240101$20240916$20240923$20240923$EXP$$FR-MYLANLABS-2024M1084261$MYLAN$$33$YR$$M$Y$$$20240923$$MD$FR$FR
243533471$24353347$1$I$$20240911$20240923$20240923$EXP$$CN-INCYTE CORPORATION-2024IN009911$INCYTE$Yan W, Zhao F, Gu M, Liu N, Guo X, Xu X. Ruxolitinib Treatment of Steroid-Refractory Graft-versus-Host Disease in Children: A Case Series and Review of the Literature. PEDIATRIC DRUGS. 2023;25:577-84$$$$$Y$$$20240923$$HP$CN$CN
243533481$24353348$1$I$20240606$20240915$20240923$20240923$PER$$CN-BRACCO-2024CN05829$BRACCO$$61$YR$$M$Y$$$20240923$$HP$CN$CN
243533491$24353349$1$I$20240830$20240916$20240923$20240923$EXP$$BR-TAKEDA-2024TUS093550$TAKEDA$$76$YR$$F$Y$$$20240923$$CN$BR$BR
243533501$24353350$1$I$20231114$20231116$20240923$20240923$PER$$CN-ROCHE-3459988$ROCHE$$53$YR$A$F$Y$63$KG$20240923$$HP$CN$CN
243533511$24353351$1$I$$20231122$20240923$20240923$PER$$US-ROCHE-3463962$ROCHE$$$$$$Y$$$20240923$$HP$US$US
243533521$24353352$1$I$20231110$20231120$20240923$20240923$PER$IT-MINISAL02-954892$IT-ROCHE-3461601$ROCHE$$54$YR$A$F$Y$54$KG$20240923$$MD$IT$IT
243533531$24353353$1$I$$20231116$20240923$20240923$PER$$JP-ROCHE-3463898$ROCHE$$39$YR$A$F$Y$$$20240923$$PH$JP$JP
243533541$24353354$1$I$$20231117$20240923$20240923$PER$$RO-ROCHE-3459718$ROCHE$$48$YR$A$F$Y$$$20240923$$HP$RO$RO
243533551$24353355$1$I$20231011$20231115$20240923$20240923$PER$$CN-ROCHE-3459230$ROCHE$$59$YR$A$F$Y$59$KG$20240923$$HP$CN$CN
243533561$24353356$1$I$20240801$20240919$20240923$20240923$EXP$$NVSC2024GD188258$NOVARTIS$$53$YR$$M$Y$$$20240923$$MD$GD$GD
243533571$24353357$1$I$20240902$20240919$20240923$20240923$EXP$FR-AFSSAPS-PO2024000988$FR-009507513-2409FRA006994$MERCK$$83$YR$$M$Y$65$KG$20240923$$MD$FR$FR
243533581$24353358$1$I$20240816$20240909$20240923$20240923$EXP$$US-ITALFARMACO SPA-2161929$ITALFARMACO$$49$YR$$M$Y$$$20240923$$$US$US
243533591$24353359$1$I$20240917$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187135$AMGEN$$77$YR$E$F$Y$$$20240923$$PH$US$US
243533601$24353360$1$I$20231018$20231115$20240923$20240923$PER$$CN-ROCHE-3459184$ROCHE$$39$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243533611$24353361$1$I$20231103$20231120$20240923$20240923$PER$$CN-ROCHE-3461765$ROCHE$$49$YR$A$F$Y$$$20240923$$HP$CN$CN
243533621$24353362$1$I$$20231120$20240923$20240923$PER$$PK-ROCHE-3463640$ROCHE$$63$YR$A$F$Y$$$20240923$$CN$PK$PK
243533631$24353363$1$I$20230825$20231109$20240923$20240923$PER$$CO-ROCHE-3456212$ROCHE$$74$YR$E$F$Y$64$KG$20240923$$CN$CO$CO
243533641$24353364$1$I$$20231120$20240923$20240923$PER$$CN-ROCHE-3461866$ROCHE$$$$$$Y$$$20240923$$CN$CN$CN
243533651$24353365$1$I$$20231109$20240923$20240923$PER$$MY-ROCHE-3457361$ROCHE$$42$YR$A$F$Y$$$20240923$$PH$MY$MY
243533661$24353366$1$I$20230310$20231031$20240923$20240923$PER$$EG-ROCHE-3450167$ROCHE$$62$YR$A$F$Y$$$20240923$$MD$EG$EG
243533671$24353367$1$I$20231030$20231115$20240923$20240923$PER$$CN-ROCHE-3459204$ROCHE$$60$YR$A$M$Y$$$20240923$$HP$CN$CN
243533681$24353368$1$I$20231117$20240105$20240923$20240923$PER$$CA-ROCHE-3461682$ROCHE$$55$YR$A$F$Y$58$KG$20240923$$HP$CA$CA
243533691$24353369$1$I$20231011$20231115$20240923$20240923$PER$$CN-ROCHE-3459202$ROCHE$$43$YR$A$F$Y$48$KG$20240923$$HP$CN$CN
243533701$24353370$1$I$20231025$20231123$20240923$20240923$PER$$CN-ROCHE-3464185$ROCHE$$69$YR$E$M$Y$61$KG$20240923$$HP$CN$CN
243533711$24353371$1$I$$20231121$20240923$20240923$PER$$US-ROCHE-3460007$ROCHE$$53$YR$A$F$Y$$$20240923$$CN$US$US
243533721$24353372$1$I$$20231116$20240923$20240923$PER$$CN-ROCHE-3459412$ROCHE$Shang P, Lou C, Yin L, Tao C, Dong Y, Yang G and Yuan Z Advanced renal pelvis carcinoma patient with an ERBB2 insertion mutation: a case report. DOI: 10.1177/03000605231204502. The Journal of international medical research 2023 Nov 01;51 (11):1-8.$6$DEC$A$M$Y$$$20240923$$HP$CN$CN
243533731$24353373$1$I$20231107$20231120$20240923$20240923$PER$$CN-ROCHE-3461281$ROCHE$$54$YR$A$F$Y$$$20240923$$HP$CN$CN
243533741$24353374$1$I$$20231117$20240923$20240923$PER$$US-ROCHE-3461600$ROCHE$$$$$F$Y$$$20240923$$PH$US$US
243533751$24353375$1$I$20230917$20231110$20240923$20240923$PER$$CN-ROCHE-3456915$ROCHE$$55$YR$A$F$Y$61.2$KG$20240923$$HP$CN$CN
243533761$24353376$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004044$PAREXEL$$82$YR$$F$Y$$$20240923$$CN$US$US
243533771$24353377$1$I$20231016$20231115$20240923$20240923$PER$$CN-ROCHE-3459187$ROCHE$$60$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243533781$24353378$1$I$$20240731$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004275$PAREXEL$$79$YR$$F$Y$$$20240923$$CN$US$US
243533791$24353379$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004290$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243533801$24353380$1$I$$20240731$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000002$PAREXEL$$$$$$Y$$$20240923$$CN$US$US
243533811$24353381$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004204$PAREXEL$$61$YR$$F$Y$$$20240923$$CN$US$US
243533821$24353382$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004137$PAREXEL$$78$YR$$F$Y$$$20240923$$CN$US$US
243533831$24353383$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004161$PAREXEL$$43$YR$$F$Y$$$20240923$$HP$US$US
243533841$24353384$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004292$PAREXEL$$63$YR$$F$Y$$$20240923$$CN$US$US
243533851$24353385$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004186$PAREXEL$$96$YR$$F$Y$$$20240923$$CN$US$US
243533861$24353386$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004281$PAREXEL$$44$YR$$F$Y$$$20240923$$CN$US$US
243533871$24353387$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004177$PAREXEL$$79$YR$$F$Y$$$20240923$$CN$US$US
243533881$24353388$1$I$$20240731$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004277$PAREXEL$$68$YR$$F$Y$$$20240923$$CN$US$US
243533891$24353389$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004185$PAREXEL$$74$YR$$F$Y$$$20240923$$CN$US$US
243533901$24353390$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003647$PAREXEL$$46$YR$$M$Y$$$20240923$$CN$US$US
243533911$24353391$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004027$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243533921$24353392$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004286$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243533931$24353393$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004136$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243533941$24353394$1$I$20240101$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003364$PAREXEL$$61$YR$$F$Y$$$20240923$$CN$US$US
243533951$24353395$1$I$$20240731$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004212$PAREXEL$$73$YR$$F$Y$$$20240923$$HP$US$US
243533961$24353396$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004176$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243533971$24353397$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004265$PAREXEL$$29$YR$$F$Y$$$20240923$$CN$US$US
243533981$24353398$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003882$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243533991$24353399$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004225$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243534001$24353400$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004153$PAREXEL$$48$YR$$F$Y$$$20240923$$CN$US$US
243534011$24353401$1$I$20240729$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004263$PAREXEL$$70$YR$$F$Y$$$20240923$$CN$US$US
243534021$24353402$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013376$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240923$$MD$US$US
243534031$24353403$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012897$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240923$$CN$US$US
243534041$24353404$1$I$$20231114$20240923$20240923$PER$$FR-ROCHE-3455537$ROCHE$$87$YR$E$M$Y$$$20240923$$PH$FR$FR
243534051$24353405$1$I$20231114$20231117$20240923$20240923$PER$$CN-ROCHE-3460379$ROCHE$$56$YR$A$M$Y$63$KG$20240923$$HP$CN$CN
243534061$24353406$1$I$20231108$20231114$20240923$20240923$PER$$CN-ROCHE-3459968$ROCHE$$60$YR$A$F$Y$45$KG$20240923$$HP$CN$CN
243534071$24353407$1$I$$20231102$20240923$20240923$PER$$RU-ROCHE-3452943$ROCHE$$75$YR$E$F$Y$$$20240923$$HP$RU$RU
243534081$24353408$1$I$20231022$20231108$20240923$20240923$PER$$CO-ROCHE-3457085$ROCHE$$$$$$Y$$$20240923$$CN$CO$CO
243534091$24353409$1$I$20240814$20240913$20240923$20240923$EXP$$US-ROCHE-10000083284$ROCHE$$42$YR$A$M$Y$$$20240923$$CN$US$US
243534111$24353411$1$I$20231028$20231108$20240923$20240923$PER$$CN-ROCHE-3456528$ROCHE$$46$YR$A$F$Y$50$KG$20240923$$HP$CN$CN
243534121$24353412$1$I$$20231121$20240923$20240923$PER$$US-ROCHE-3462822$ROCHE$$56$YR$A$F$Y$$$20240923$$MD$US$US
243534131$24353413$1$I$20231024$20231031$20240923$20240923$PER$$JP-ROCHE-3454222$ROCHE$$$$A$F$Y$$$20240923$$MD$JP$JP
243534141$24353414$1$I$$20231108$20240923$20240923$PER$$RO-ROCHE-3457141$ROCHE$$64$YR$A$F$Y$$$20240923$$PH$RO$RO
243534151$24353415$1$I$$20231109$20240923$20240923$PER$$MY-ROCHE-3457024$ROCHE$$51$YR$A$F$Y$$$20240923$$PH$MY$MY
243534161$24353416$1$I$$20231109$20240923$20240923$PER$$CN-ROCHE-3456406$ROCHE$Jiang F, Lai J,  Zhuo X, Liu L, Yang Y, Zhang J Zhao  J, Xu W, Wang J, Wang C and Fu G HER2-positive breast cancer progresses rapidly after pyrotinib resistance: Acquired RET gene fusion and TP53 gene mutation are potential reasons. Anti-Cancer Drugs 2023 Nov 01;34.10:1196-1201.$46$YR$A$F$Y$$$20240923$$HP$CN$CN
243534171$24353417$1$I$20240918$20240920$20240923$20240923$EXP$$JP-PFIZER INC-202400260310$PFIZER$$65$YR$$F$Y$$$20240923$$PH$JP$JP
243534182$24353418$2$F$$20240923$20240923$20240924$EXP$$US-PFIZER INC-PV202400123754$PFIZER$$52$YR$$F$Y$$$20240924$$HP$US$US
243534191$24353419$1$I$$20240917$20240923$20240923$PER$$US-PFIZER INC-202400258262$PFIZER$$35$YR$$F$Y$$$20240923$$HP$US$US
243534201$24353420$1$I$$20240920$20240923$20240923$EXP$$US-PFIZER INC-202400261152$PFIZER$$42$YR$$F$Y$$$20240923$$CN$US$US
243534211$24353421$1$I$20240902$20240920$20240923$20240923$EXP$$IN-PFIZER INC-PV202400123881$PFIZER$$63$YR$$F$Y$$$20240923$$CN$IN$IN
243534221$24353422$1$I$20240801$20240910$20240923$20240923$PER$$US-JNJFOC-20240924241$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240923$$CN$US$US
243534231$24353423$1$I$$20231117$20240923$20240923$PER$$RO-ROCHE-3459871$ROCHE$$47$YR$A$F$Y$$$20240923$$HP$RO$RO
243534241$24353424$1$I$$20240917$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147878$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240923$$CN$US$US
243534251$24353425$1$I$$20231108$20240923$20240923$PER$$GB-ROCHE-3455587$ROCHE$$57$YR$A$M$Y$$$20240923$$MD$GB$GB
243534261$24353426$1$I$20231104$20231123$20240923$20240923$PER$$CN-ROCHE-3464177$ROCHE$$49$YR$A$F$Y$75$KG$20240923$$HP$CN$CN
243534271$24353427$1$I$$20240920$20240923$20240923$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-150166$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240923$$MD$IT$IT
243534281$24353428$1$I$$20231121$20240923$20240923$PER$$PE-ROCHE-3463783$ROCHE$$55$YR$A$F$Y$48$KG$20240923$$CN$PE$PE
243534291$24353429$1$I$20230325$20240415$20240923$20240923$PER$$EG-ROCHE-3450777$ROCHE$$63$YR$A$F$Y$$$20240923$$MD$EG$EG
243534301$24353430$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64986$$FDA-CTU$$61$YR$$F$N$$$20240923$N$$US$
243534311$24353431$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150449$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240923$$CN$US$US
243534321$24353432$1$I$$20231117$20240923$20240923$PER$$RO-ROCHE-3459788$ROCHE$$58$YR$A$F$Y$$$20240923$$HP$RO$RO
243534331$24353433$1$I$$20231101$20240923$20240923$PER$$US-ROCHE-3451436$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243534341$24353434$1$I$20230718$20231123$20240923$20240923$PER$$CN-ROCHE-3464180$ROCHE$$47$YR$A$F$Y$67$KG$20240923$$HP$CN$CN
243534351$24353435$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64987$$FDA-CTU$$69$YR$$F$N$$$20240923$N$$US$
243534361$24353436$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452808$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534371$24353437$1$I$20231017$20231106$20240923$20240923$PER$$CN-ROCHE-3453696$ROCHE$$64$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243534381$24353438$1$I$20240912$20240913$20240923$20240923$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18676$IPSEN$$60$YR$A$F$Y$84.36$KG$20240923$$CN$US$US
243534391$24353439$1$I$20231104$20231123$20240923$20240923$PER$$CN-ROCHE-3464186$ROCHE$$48$YR$A$F$Y$$$20240923$$HP$CN$CN
243534401$24353440$1$I$20240916$20240918$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149204$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$81.19$KG$20240923$$HP$US$US
243534411$24353441$1$I$$20240918$20240923$20240923$PER$$US-LEO Pharma-373643$LEO PHARM$$27$YR$$F$Y$$$20240923$$CN$US$US
243534421$24353442$1$I$20231006$20231031$20240923$20240923$PER$$CN-ROCHE-3450438$ROCHE$$50$YR$A$F$Y$$$20240923$$HP$CN$CN
243534432$24353443$2$F$$20240918$20240923$20240923$PER$$US-PFIZER INC-PV202400122602$PFIZER$$54$YR$$F$Y$$$20240923$$CN$US$US
243534441$24353444$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452795$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534451$24353445$1$I$$20231103$20240923$20240923$PER$$CN-ROCHE-3451693$ROCHE$$$$$F$Y$$$20240923$$CN$CN$CN
243534461$24353446$1$I$20231010$20231030$20240923$20240923$PER$$CN-ROCHE-3449952$ROCHE$$75$YR$E$F$Y$65$KG$20240923$$HP$CN$CN
243534471$24353447$1$I$20231019$20231103$20240923$20240923$PER$$CN-ROCHE-3452757$ROCHE$$53$YR$A$F$Y$63.5$KG$20240923$$HP$CN$CN
243534481$24353448$1$I$$20231030$20240923$20240923$PER$$US-ROCHE-3449461$ROCHE$$$$$$Y$$$20240923$$PH$US$US
243534491$24353449$1$I$20230812$20231027$20240923$20240923$PER$$CN-ROCHE-3448792$ROCHE$$55$YR$A$M$Y$71$KG$20240923$$HP$CN$CN
243534501$24353450$1$I$$20231030$20240923$20240923$PER$$CH-ROCHE-3451494$ROCHE$$$$$$Y$$$20240923$$MD$CH$CH
243534511$24353451$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452812$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534521$24353452$1$I$$20231106$20240923$20240923$PER$$PT-ROCHE-3453728$ROCHE$$$$$F$Y$$$20240923$$MD$PT$PT
243534531$24353453$1$I$$20231030$20240923$20240923$PER$$RU-ROCHE-3449946$ROCHE$$44$YR$A$F$Y$$$20240923$$MD$RU$RU
243534541$24353454$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452809$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534552$24353455$2$F$$20240917$20240923$20240923$EXP$$NVSC2024US160518$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
243534561$24353456$1$I$20240709$20240917$20240923$20240923$EXP$HR-HALMED-300086476$HR-TEVA-VS-3244517$TEVA$$40$YR$$F$Y$$$20240923$$MD$HR$HR
243534571$24353457$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452813$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534581$24353458$1$I$$20231025$20240923$20240923$PER$$VN-ROCHE-3449082$ROCHE$$36$YR$A$F$Y$$$20240923$$MD$VN$VN
243534591$24353459$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452801$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534601$24353460$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452803$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534611$24353461$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452800$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534621$24353462$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452802$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534631$24353463$1$I$20231006$20231027$20240923$20240923$PER$$CN-ROCHE-3448803$ROCHE$$57$YR$A$F$Y$71$KG$20240923$$HP$CN$CN
243534651$24353465$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452804$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534661$24353466$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452814$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534671$24353467$1$I$20231007$20231031$20240923$20240923$PER$$CN-ROCHE-3450172$ROCHE$$72$YR$E$M$Y$$$20240923$$HP$CN$CN
243534681$24353468$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452815$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534691$24353469$1$I$20221004$20231031$20240923$20240923$PER$$JP-ROCHE-3453344$ROCHE$$7$DEC$E$F$Y$$$20240923$$MD$JP$JP
243534701$24353470$1$I$20231027$20231103$20240923$20240923$PER$$CN-ROCHE-3452769$ROCHE$$61$YR$A$F$Y$56$KG$20240923$$HP$CN$CN
243534711$24353471$1$I$$20240916$20240923$20240923$EXP$$PL-TEVA-VS-3244862$TEVA$Rybka J, Kuszczak B, Bogucka-Fedorczuk A. Treatment of primary central nervous system lymphoma (PCNSL) - single center experience and literature review. Acta-Haematol-Polon 2024; 55 (3): 151-156.$$$$$Y$$$20240923$$HP$PL$PL
243534721$24353472$1$I$20210623$20240916$20240923$20240923$EXP$$US-EXELIXIS-CABO-24079592$EXELIXIS$$60$YR$$F$Y$$$20240923$$CN$US$US
243534731$24353473$1$I$$20240913$20240923$20240923$EXP$$US-CHIESI-2024CHF06163$CHIESI$$57$YR$$M$Y$$$20240923$$MD$US$US
243534741$24353474$1$I$20240101$20240916$20240923$20240923$EXP$$US-EXELIXIS-EXL-2024-000300$EXELIXIS$$$$$F$Y$$$20240923$$CN$US$US
243534751$24353475$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452805$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534761$24353476$1$I$20231007$20231101$20240923$20240923$PER$$CN-ROCHE-3451133$ROCHE$$43$YR$A$F$Y$55$KG$20240923$$HP$CN$CN
243534771$24353477$1$I$$20231031$20240923$20240923$PER$$US-ROCHE-3450560$ROCHE$$67$YR$E$F$Y$$$20240923$$MD$US$US
243534781$24353478$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452807$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534791$24353479$1$I$20230619$20231031$20240923$20240923$PER$IT-MINISAL02-951221$IT-ROCHE-3449385$ROCHE$$52$YR$A$F$Y$$$20240923$$HP$IT$IT
243534801$24353480$1$I$20231027$20231027$20240923$20240923$PER$$JP-ROCHE-3450960$ROCHE$$6$DEC$A$F$Y$$$20240923$$MD$JP$JP
243534811$24353481$1$I$20231024$20231030$20240923$20240923$PER$$CN-ROCHE-3449654$ROCHE$$46$YR$A$F$Y$62.5$KG$20240923$$HP$CN$CN
243534821$24353482$1$I$$20231101$20240923$20240923$PER$$US-ROCHE-3451338$ROCHE$$67$YR$E$F$Y$$$20240923$$MD$US$US
243534831$24353483$1$I$20230429$20231027$20240923$20240923$PER$$CN-ROCHE-3448427$ROCHE$$51$YR$A$F$Y$67$KG$20240923$$HP$CN$CN
243534841$24353484$1$I$20231017$20231027$20240923$20240923$PER$$CN-ROCHE-3448423$ROCHE$$58$YR$A$M$Y$63$KG$20240923$$HP$CN$CN
243534851$24353485$1$I$$20231102$20240923$20240923$PER$$CN-ROCHE-3452806$ROCHE$Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H and Li H Dalpiciclib and pyrotinib in womenwith HER2-positive advanced breast cancer: a single-arm phase II trial. DOI:10.1038/s41467-023-41955-7. Nature Communications 2023;14 (1):1-8.$$$$F$Y$$$20240923$$HP$CN$CN
243534861$24353486$1$I$20240101$20240916$20240923$20240923$EXP$$US-TEVA-VS-3245661$TEVA$$17$YR$$M$Y$$$20240923$$MD$US$US
243534871$24353487$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004246$PAREXEL$$57$YR$$F$Y$$$20240923$$CN$US$US
243534881$24353488$1$I$20240812$20240916$20240923$20240923$EXP$$CA-JNJFOC-20240949836$JOHNSON AND JOHNSON$$27$YR$A$F$Y$$$20240923$$HP$CA$CA
243534891$24353489$1$I$20240706$20240919$20240923$20240923$EXP$FR-AFSSAPS-NT2024001117$FR-Accord-448117$ACCORD$$33$YR$A$M$Y$82$KG$20240923$$MD$FR$FR
243534901$24353490$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004122$PAREXEL$$45$YR$$F$Y$$$20240923$$CN$US$US
243534911$24353491$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004273$PAREXEL$$62$YR$$F$Y$$$20240923$$CN$US$US
243534921$24353492$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004152$PAREXEL$$64$YR$$F$Y$$$20240923$$HP$US$US
243534931$24353493$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004215$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243534941$24353494$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003989$PAREXEL$$69$YR$$F$Y$$$20240923$$CN$US$US
243534951$24353495$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004217$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243534961$24353496$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004206$PAREXEL$$86$YR$$F$Y$$$20240923$$CN$US$US
243534971$24353497$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004234$PAREXEL$$58$YR$$F$Y$$$20240923$$CN$US$US
243534981$24353498$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004247$PAREXEL$$85$YR$$F$Y$$$20240923$$HP$US$US
243534991$24353499$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004119$PAREXEL$$69$YR$$F$Y$$$20240923$$HP$US$US
243535001$24353500$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004159$PAREXEL$$45$YR$$F$Y$$$20240923$$HP$US$US
243535011$24353501$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004202$PAREXEL$$78$YR$$F$Y$$$20240923$$CN$US$US
243535021$24353502$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004172$PAREXEL$$63$YR$$F$Y$$$20240923$$CN$US$US
243535031$24353503$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003888$PAREXEL$$56$YR$$F$Y$$$20240923$$CN$US$US
243535041$24353504$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004252$PAREXEL$$54$YR$$F$Y$$$20240923$$CN$US$US
243535061$24353506$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004227$PAREXEL$$54$YR$$F$Y$$$20240923$$CN$US$US
243535071$24353507$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004223$PAREXEL$$58$YR$$F$Y$$$20240923$$HP$US$US
243535081$24353508$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004230$PAREXEL$$74$YR$$F$Y$$$20240923$$CN$US$US
243535091$24353509$1$I$20240727$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004244$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243535101$24353510$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004168$PAREXEL$$68$YR$$F$Y$$$20240923$$CN$US$US
243535111$24353511$1$I$$20240730$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004166$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243535121$24353512$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004287$PAREXEL$$61$YR$$F$Y$$$20240923$$CN$US$US
243535131$24353513$1$I$20230523$20231027$20240923$20240923$PER$$CN-ROCHE-3448425$ROCHE$$54$YR$A$F$Y$61$KG$20240923$$HP$CN$CN
243535141$24353514$1$I$$20231117$20240923$20240923$PER$$CN-ROCHE-3460435$ROCHE$$$$$F$Y$47.5$KG$20240923$$HP$CN$CN
243535151$24353515$1$I$$20231027$20240923$20240923$PER$$CN-ROCHE-3448741$ROCHE$$$$$$Y$$$20240923$$HP$CN$CN
243535161$24353516$1$I$$20240915$20240923$20240923$EXP$$NVSC2024IL186371$NOVARTIS$$$$$F$Y$$$20240923$$MD$IL$IL
243535171$24353517$1$I$$20240917$20240923$20240923$EXP$$NVSC2024CA188165$NOVARTIS$$60$YR$$F$Y$$$20240923$$CN$CA$CA
243535191$24353519$1$I$$20240923$20240923$20240923$PER$$NVSC2024US189226$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243535201$24353520$1$I$$20240921$20240923$20240923$PER$$US-PFIZER INC-202400261603$PFIZER$$40$YR$$M$Y$$$20240923$$CN$US$US
243535211$24353521$1$I$$20240920$20240923$20240923$EXP$$IT-ABBVIE-5933191$ABBVIE$$73$YR$$M$Y$$$20240923$$CN$IT$IT
243535222$24353522$2$F$$20240920$20240923$20240924$PER$$US-PFIZER INC-PV202400123680$PFIZER$$79$YR$$F$Y$$$20240924$$HP$US$US
243535231$24353523$1$I$20240917$20240920$20240923$20240923$PER$$US-PFIZER INC-202400261157$PFIZER$$$$A$M$Y$$$20240923$$CN$US$US
243535241$24353524$1$I$20240916$20240920$20240923$20240923$PER$$US-PFIZER INC-202400260745$PFIZER$$83$YR$$F$Y$$$20240923$$PH$US$US
243535251$24353525$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-PV202400123770$PFIZER$$43$YR$$F$Y$$$20240923$$HP$US$US
243535261$24353526$1$I$20240921$20240922$20240923$20240923$PER$$US-PFIZER INC-202400261251$PFIZER$$50$YR$$F$Y$$$20240923$$HP$US$US
243535271$24353527$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-PV202400123952$PFIZER$$65$YR$$F$Y$$$20240923$$HP$US$US
243535281$24353528$1$I$$20240922$20240923$20240923$PER$$US-PFIZER INC-202400261040$PFIZER$$61$YR$$F$Y$$$20240923$$CN$US$US
243535291$24353529$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-PV202400123514$PFIZER$$51$YR$$F$Y$$$20240923$$HP$US$US
243535301$24353530$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-202400260115$PFIZER$$46$YR$$F$Y$$$20240923$$HP$US$US
243535311$24353531$1$I$20240101$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260905$PFIZER$$65$YR$$F$Y$$$20240923$$HP$US$US
243535321$24353532$1$I$20240918$20240920$20240923$20240923$PER$$US-PFIZER INC-202400261532$PFIZER$$52$YR$$F$Y$$$20240923$$CN$US$US
243535331$24353533$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-PV202400123763$PFIZER$$47$YR$$F$Y$$$20240923$$HP$US$US
243535341$24353534$1$I$20240921$20240922$20240923$20240923$PER$$US-PFIZER INC-202400260992$PFIZER$$46$YR$$F$Y$$$20240923$$CN$US$US
243535352$24353535$2$F$20240826$20240924$20240923$20240924$PER$$US-PFIZER INC-202400261576$PFIZER$$66$YR$$F$Y$$$20240924$$HP$US$US
243535361$24353536$1$I$20240101$20240919$20240923$20240923$PER$$US-PFIZER INC-PV202400123453$PFIZER$$59$YR$$F$Y$$$20240923$$HP$US$US
243535371$24353537$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-202400261037$PFIZER$$$$A$M$Y$$$20240923$$CN$US$US
243535401$24353540$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-PV202400123551$PFIZER$$72$YR$$F$Y$$$20240923$$CN$US$US
243535411$24353541$1$I$20240918$20240921$20240923$20240923$PER$$US-PFIZER INC-202400261597$PFIZER$$33$YR$$F$Y$$$20240923$$CN$US$US
243535431$24353543$1$I$20240921$20240921$20240923$20240923$PER$$US-PFIZER INC-202400261573$PFIZER$$59$YR$$F$Y$$$20240923$$CN$US$US
243535441$24353544$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-202400260714$PFIZER$$$$T$M$Y$$$20240923$$HP$US$US
243535451$24353545$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-PV202400123115$PFIZER$$70$YR$$F$Y$$$20240923$$CN$US$US
243535461$24353546$1$I$20240901$20240920$20240923$20240923$PER$$US-PFIZER INC-202400261249$PFIZER$$41$YR$$F$Y$$$20240923$$CN$US$US
243535471$24353547$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260892$PFIZER$$65$YR$$M$Y$$$20240923$$CN$US$US
243535482$24353548$2$F$$20240920$20240923$20240924$PER$$US-PFIZER INC-PV202400123768$PFIZER$$61$YR$$F$Y$$$20240924$$HP$US$US
243535491$24353549$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260432$PFIZER$$58$YR$$F$Y$$$20240923$$CN$US$US
243535501$24353550$1$I$20240920$20240920$20240920$20240920$DIR$719255$$FDA-CTU$$66$YR$$UNK$N$$$20240920$N$HP$US$
243535511$24353551$1$I$20240919$20240920$20240923$20240923$EXP$$US-PFIZER INC-202400261035$PFIZER$$19$YR$$F$Y$$$20240923$$CN$US$US
243535521$24353552$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-PV202400123758$PFIZER$$75$YR$$M$Y$$$20240923$$CN$US$US
243535531$24353553$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-PV202400123788$PFIZER$$61$YR$$F$Y$$$20240923$$HP$US$US
243535541$24353554$1$I$20240101$20240920$20240923$20240923$PER$$US-PFIZER INC-202400261058$PFIZER$$28$YR$$M$Y$$$20240923$$CN$US$US
243535573$24353557$3$F$20240914$20240926$20240923$20240930$PER$$US-PFIZER INC-202400261127$PFIZER$$69$YR$$F$Y$$$20240930$$CN$US$US
243535581$24353558$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-PV202400123186$PFIZER$$65$YR$$F$Y$$$20240923$$CN$US$US
243535592$24353559$2$F$20220901$20240923$20240923$20240925$PER$$US-PFIZER INC-202400260879$PFIZER$$58$YR$$F$Y$$$20240925$$HP$US$US
243535601$24353560$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-202400260976$PFIZER$$60$YR$$M$Y$$$20240923$$CN$US$US
243535611$24353561$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-PV202300082534$PFIZER$$82$YR$$F$Y$61.23$KG$20240923$$HP$US$US
243535622$24353562$2$F$$20240926$20240923$20240927$PER$$US-PFIZER INC-PV202300130908$PFIZER$$$$C$M$Y$45.805$KG$20240927$$CN$US$US
243535631$24353563$1$I$20240914$20240921$20240923$20240923$PER$$US-PFIZER INC-202400261584$PFIZER$$79$YR$$F$Y$$$20240923$$CN$US$US
243535641$24353564$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-PV202400123712$PFIZER$$74$YR$$F$Y$$$20240923$$CN$US$US
243535661$24353566$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-202400260977$PFIZER$$61$YR$$M$Y$$$20240923$$CN$US$US
243535671$24353567$1$I$$20240920$20240923$20240923$PER$$US-PFIZER INC-202400261170$PFIZER$$$$$M$Y$$$20240923$$CN$US$US
243535681$24353568$1$I$20240921$20240921$20240923$20240923$PER$$US-PFIZER INC-202400261604$PFIZER$$76$YR$$F$Y$$$20240923$$CN$US$US
243535691$24353569$1$I$$20240826$20240923$20240923$EXP$$US-Vifor (International) Inc.-VIT-2024-07750$VIFOR$$$$$$Y$$$20240923$$HP$US$US
243535701$24353570$1$I$$20240918$20240923$20240923$EXP$$BR-BIOMARINAP-BR-2024-160709$BIOMARIN$$$$$$Y$$$20240923$$CN$BR$BR
243535711$24353571$1$I$20240901$20240911$20240923$20240923$PER$$US-BIOMARINAP-US-2024-160549$BIOMARIN$$$$$$Y$$$20240923$$CN$US$US
243535721$24353572$1$I$$20240916$20240923$20240923$PER$$DE-Blueprint Medicines Corporation-SP-DE-2024-001896$BLUEPRINT MEDICINES$$$$$$Y$$$20240923$$MD$DE$DE
243535731$24353573$1$I$$20240920$20240923$20240923$EXP$$US-ABBVIE-5933496$ABBVIE$$$$$F$Y$$$20240923$$HP$US$US
243535752$24353575$2$F$$20240918$20240923$20240930$EXP$$DE-GUERBET / LLC-DE-20240043$GUERBET$Cardinal von Widdern J. Persisting Cutaneous Pancreatic Fistula in a Patient With Necrotizing Pancreatitis: A Novel Approach ofTransfistulous Histoacryl Occlusion. ACG Case Rep J. 2024 Aug 22;11(e01456): 1-5. doi:10.14309/crj.0000000000001456..$39$YR$A$M$Y$$$20240930$$MD$DE$DE
243535761$24353576$1$I$$20231121$20240923$20240923$PER$$ES-ROCHE-3463740$ROCHE$$$$E$F$Y$61$KG$20240923$$MD$ES$ES
243535771$24353577$1$I$$20231102$20240923$20240923$PER$$RU-ROCHE-3451963$ROCHE$Kolomiets K, Isaev I, Kovalev V, Grishchenko N, Kokovihina D, Morozova A, Torosyan A, Shashkova V and Snegireva P Multidisciplinary approach to treatment of a patient with unresectable metastatic liver lesion spawned by her2+ gastric adenocarcinoma giving. DOI: 10.24075/brsmu.2023.031. Bulletin of Russian State Medical University 2023;4:16-20.$$$$M$Y$$$20240923$$HP$RU$RU
243535781$24353578$1$I$$20231117$20240923$20240923$PER$$US-ROCHE-3462178$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243535791$24353579$1$I$$20231121$20240923$20240923$PER$$US-ROCHE-3462751$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243535801$24353580$1$I$$20240130$20240923$20240923$PER$$JP-ROCHE-3450361$ROCHE$$55$YR$A$F$Y$81.6$KG$20240923$$HP$JP$JP
243535811$24353581$1$I$20231028$20240201$20240923$20240923$PER$$BE-ROCHE-3461046$ROCHE$$61$YR$A$F$Y$$$20240923$$PH$BE$BE
243535821$24353582$1$I$$20240918$20240923$20240923$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001905$BLUEPRINT MEDICINES$$$$$F$Y$$$20240923$$CN$US$US
243535841$24353584$1$I$$20240905$20240923$20240923$PER$$US-SA-2024SA273259$SANOFI AVENTIS$$67$YR$E$$Y$$$20240923$$CN$US$US
243535851$24353585$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268486$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240923$$HP$US$US
243535861$24353586$1$I$$20240918$20240923$20240923$PER$$US-SA-2024SA271894$SANOFI AVENTIS$$$$T$F$Y$$$20240923$$MD$US$US
243535871$24353587$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004155$PAREXEL$$$$$F$Y$$$20240923$$MD$US$US
243535881$24353588$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004145$PAREXEL$$74$YR$$F$Y$$$20240923$$CN$US$US
243535891$24353589$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004164$PAREXEL$$84$YR$$F$Y$$$20240923$$MD$US$US
243535901$24353590$1$I$$20240725$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004135$PAREXEL$$40$YR$$F$Y$$$20240923$$CN$US$US
243535911$24353591$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004157$PAREXEL$$84$YR$$F$Y$$$20240923$$CN$US$US
243535921$24353592$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004146$PAREXEL$$87$YR$$F$Y$$$20240923$$CN$US$US
243535931$24353593$1$I$$20240725$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004231$PAREXEL$$73$YR$$F$Y$$$20240923$$CN$US$US
243535941$24353594$1$I$20240101$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003148$PAREXEL$$56$YR$$F$Y$$$20240923$$CN$US$US
243535951$24353595$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004253$PAREXEL$$57$YR$$F$Y$$$20240923$$CN$US$US
243535961$24353596$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004143$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243535971$24353597$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004121$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243535981$24353598$1$I$$20240725$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004285$PAREXEL$$71$YR$$F$Y$$$20240923$$MD$US$US
243535991$24353599$1$I$$20240725$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004195$PAREXEL$$57$YR$$F$Y$$$20240923$$CN$US$US
243536001$24353600$1$I$20240531$20240725$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003561$PAREXEL$$46$YR$$F$Y$$$20240923$$CN$US$US
243536011$24353601$1$I$$20240725$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004150$PAREXEL$$60$YR$$F$Y$$$20240923$$CN$US$US
243536021$24353602$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004124$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243536031$24353603$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004257$PAREXEL$$58$YR$$F$Y$$$20240923$$CN$US$US
243536041$24353604$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004139$PAREXEL$$53$YR$$F$Y$$$20240923$$CN$US$US
243536051$24353605$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004110$PAREXEL$$46$YR$$F$Y$$$20240923$$HP$US$US
243536061$24353606$1$I$$20240725$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004239$PAREXEL$$63$YR$$F$Y$$$20240923$$CN$US$US
243536071$24353607$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004272$PAREXEL$$53$YR$$F$Y$$$20240923$$HP$US$US
243536081$24353608$1$I$$20240727$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004188$PAREXEL$$45$YR$$F$Y$$$20240923$$CN$US$US
243536091$24353609$1$I$$20240725$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004154$PAREXEL$$59$YR$$F$Y$$$20240923$$CN$US$US
243536101$24353610$1$I$$20240726$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004251$PAREXEL$$61$YR$$F$Y$$$20240923$$CN$US$US
243536111$24353611$1$I$$20240729$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004117$PAREXEL$$55$YR$$F$Y$$$20240923$$CN$US$US
243536121$24353612$1$I$$20240923$20240923$20240923$EXP$$CN-PFIZER INC-PV202400124011$PFIZER$$$$A$F$Y$$$20240923$$CN$CN$CN
243536131$24353613$1$I$20240919$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150485$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$HP$US$US
243536141$24353614$1$I$$20240916$20240923$20240923$EXP$$BE-BEH-2024174628$CSL BEHRING$$$$A$M$Y$$$20240923$$HP$BE$BE
243536151$24353615$1$I$20201126$20240916$20240923$20240923$EXP$PL-URPL-1-3245-2020$PL-MYLANLABS-2024M1084553$MYLAN$$28$YR$$F$Y$70$KG$20240923$$MD$PL$PL
243536161$24353616$1$I$20240905$20240916$20240923$20240923$EXP$FR-AFSSAPS-AN2024001258$FR-MYLANLABS-2024M1084730$MYLAN$$77$YR$$M$Y$78$KG$20240923$$PH$FR$FR
243536171$24353617$1$I$20141114$20240916$20240923$20240923$EXP$$FR-MYLANLABS-2024M1084636$MYLAN$$$$$$Y$$$20240923$$MD$FR$FR
243536181$24353618$1$I$20240801$20240916$20240923$20240923$EXP$$FI-MYLANLABS-2024M1084607$MYLAN$$79$YR$$M$Y$$$20240923$$CN$FI$FI
243536192$24353619$2$F$20211111$20240916$20240923$20240925$EXP$ES-AEMPS-1568222$ES-MYLANLABS-2024M1084551$MYLAN$$37$YR$$F$Y$77$KG$20240925$$PH$ES$ES
243536201$24353620$1$I$20240829$20240916$20240923$20240923$EXP$FR-AFSSAPS-LY2024001394$FR-MYLANLABS-2024M1084572$MYLAN$$$$$M$Y$3.6$KG$20240923$$MD$FR$FR
243536211$24353621$1$I$20240801$20240916$20240923$20240923$EXP$ES-AEMPS-1567656$ES-MYLANLABS-2024M1084726$MYLAN$$89$YR$$F$Y$$$20240923$$MD$ES$ES
243536221$24353622$1$I$$20240916$20240923$20240923$PER$$US-ROCHE-10000082402$ROCHE$Nieto-Patlan A, Fernandez Davila N, Wang Y, Zelnick M, Muscal E, Curry M, et al. Case Report: p40 phox deficiency underlying pediatric-onset systemic lupus erythematosus. Frontiers in Pediatrics. 2024-Jan;12:1-6. doi:10.3389/fped.2024.1425874.$18$YR$A$F$Y$$$20240923$$HP$US$US
243536231$24353623$1$I$20240621$20240909$20240923$20240923$EXP$FR-AFSSAPS-DJ2024000994$FR-GENMAB-2024-03370$GENMAB$$63$YR$$M$Y$82$KG$20240923$$MD$FR$FR
243536241$24353624$1$I$$20240724$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004125$PAREXEL$$81$YR$$F$Y$$$20240923$$CN$US$US
243536251$24353625$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004158$PAREXEL$$61$YR$$F$Y$$$20240923$$CN$US$US
243536261$24353626$1$I$$20240724$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004116$PAREXEL$$67$YR$$F$Y$$$20240923$$CN$US$US
243536271$24353627$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003600$PAREXEL$$60$YR$$F$Y$$$20240923$$CN$US$US
243536291$24353629$1$I$$20240724$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004101$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243536301$24353630$1$I$$20240724$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004118$PAREXEL$$64$YR$$F$Y$$$20240923$$HP$US$US
243536311$24353631$1$I$20240920$20240920$20240920$20240920$DIR$719295$$FDA-CTU$$27$YR$$F$N$$$20240920$Y$PH$US$
243536321$24353632$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004043$PAREXEL$$52$YR$$F$Y$$$20240923$$CN$US$US
243536331$24353633$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004069$PAREXEL$$55$YR$$F$Y$$$20240923$$HP$US$US
243536341$24353634$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003093$PAREXEL$$77$YR$$F$Y$$$20240923$$CN$US$US
243536351$24353635$1$I$$20240724$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004284$PAREXEL$$68$YR$$F$Y$$$20240923$$CN$US$US
243536361$24353636$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004089$PAREXEL$$73$YR$$F$Y$$$20240923$$CN$US$US
243536371$24353637$1$I$$20240724$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002114$PAREXEL$$$$$$Y$$$20240923$$CN$US$US
243536381$24353638$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004238$PAREXEL$$69$YR$$F$Y$$$20240923$$CN$US$US
243536391$24353639$1$I$$20240724$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003967$PAREXEL$$77$YR$$F$Y$$$20240923$$CN$US$US
243536401$24353640$1$I$$20240724$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004071$PAREXEL$$54$YR$$F$Y$$$20240923$$CN$US$US
243536411$24353641$1$I$20240717$20240725$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004167$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243536421$24353642$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004242$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243536431$24353643$1$I$$20240725$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004171$PAREXEL$$79$YR$$F$Y$$$20240923$$CN$US$US
243536441$24353644$1$I$20240623$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003780$PAREXEL$$49$YR$$F$Y$$$20240923$$CN$US$US
243536451$24353645$1$I$$20240725$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004156$PAREXEL$$40$YR$$F$Y$$$20240923$$CN$US$US
243536461$24353646$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004021$PAREXEL$$43$YR$$F$Y$$$20240923$$CN$US$US
243536471$24353647$1$I$$20240724$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004076$PAREXEL$$72$YR$$F$Y$$$20240923$$CN$US$US
243536481$24353648$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004053$PAREXEL$$42$YR$$F$Y$$$20240923$$CN$US$US
243536491$24353649$1$I$$20240724$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004123$PAREXEL$$56$YR$$F$Y$$$20240923$$CN$US$US
243536501$24353650$1$I$$20240916$20240923$20240923$EXP$$US-MYLANLABS-2024M1085414$MYLAN$$$$$M$Y$97.05$KG$20240923$$PH$US$US
243536511$24353651$1$I$$20240916$20240923$20240923$EXP$$GB-MYLANLABS-2024M1085087$MYLAN$$52$YR$$F$Y$$$20240923$$CN$GB$GB
243536521$24353652$1$I$$20240919$20240923$20240923$EXP$$NVSC2024CO173521$NOVARTIS$$$$$M$Y$82$KG$20240923$$CN$CO$CO
243536531$24353653$1$I$20240912$20240918$20240923$20240923$EXP$$NVSC2024CN187989$NOVARTIS$$77$YR$$M$Y$63$KG$20240923$$HP$CN$CN
243536541$24353654$1$I$$20240916$20240923$20240923$EXP$$GB-UCBSA-2024047824$UCB$Dhawan S, Musa AH, Mantripragada K. Novel Mitochondrial Cytopathy Causing Mitochondrial Encephalomyopathy With Lactic Acidosis and Stroke-Like Episodes Syndrome and Tubulointerstitial Nephropathy. Cureus. 2024;16(8):1-8$5$DEC$$M$Y$$$20240923$$HP$GB$GB
243536551$24353655$1$I$$20240919$20240923$20240923$PER$$AU-Eisai-EC-2024-175071$EISAI$$$$$F$Y$$$20240923$$HP$AU$AU
243536571$24353657$1$I$$20240909$20240923$20240923$EXP$$US-SMPA-2024SPA002552$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243536591$24353659$1$I$$20240909$20240923$20240923$EXP$$US-SMPA-2024SPA002573$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243536601$24353660$1$I$$20240909$20240923$20240923$EXP$$US-SMPA-2024SPA002540$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243536611$24353661$1$I$20240101$20240917$20240923$20240923$EXP$SE-SEMPA-2024-006643$SE-MYLANLABS-2024M1084921$MYLAN$$89$YR$$F$Y$$$20240923$$MD$SE$SE
243536621$24353662$1$I$$20240909$20240923$20240923$EXP$$US-SMPA-2024SPA002521$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243536631$24353663$1$I$20240411$20240917$20240923$20240923$EXP$FR-AFSSAPS-AN2024001250$FR-MYLANLABS-2024M1085258$MYLAN$$69$YR$$M$Y$$$20240923$$PH$FR$FR
243536641$24353664$1$I$20231019$20240909$20240923$20240923$EXP$$US-SMPA-2023MYSCI1000805$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243536661$24353666$1$I$$20240909$20240923$20240923$EXP$$US-SMPA-2024SPA002527$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243536671$24353667$1$I$20240301$20240916$20240923$20240923$EXP$IT-MINISAL02-1001743$IT-TEVA-VS-3244020$TEVA$$35$YR$$F$Y$$$20240923$$MD$IT$IT
243536681$24353668$1$I$20240829$20240919$20240923$20240923$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005224$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240923$$CN$US$US
243536701$24353670$1$I$20240920$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011882$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240923$$CN$US$US
243536711$24353671$1$I$20240919$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012778$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240923$$CN$US$US
243536721$24353672$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012522$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240923$$CN$US$US
243536731$24353673$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013910$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240923$$CN$US$US
243536741$24353674$1$I$$20240913$20240923$20240923$EXP$$US-AIMMUNE THERAPEUTICS, INC.-2024AIMT01346$AIMMUNE$$$$$$Y$$$20240923$$MD$US$US
243536751$24353675$1$I$$20240917$20240923$20240923$DIR$FDA-CDER-CTU-2024-64991$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243536761$24353676$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004226$PAREXEL$$73$YR$$F$Y$$$20240923$$CN$US$US
243536771$24353677$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004120$PAREXEL$$72$YR$$F$Y$$$20240923$$CN$US$US
243536781$24353678$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004096$PAREXEL$$77$YR$$F$Y$$$20240923$$CN$US$US
243536791$24353679$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004065$PAREXEL$$60$YR$$F$Y$$$20240923$$CN$US$US
243536801$24353680$1$I$$20240720$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004085$PAREXEL$$69$YR$$F$Y$$$20240923$$CN$US$US
243536811$24353681$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003400$PAREXEL$$73$YR$$F$Y$$$20240923$$CN$US$US
243536821$24353682$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004093$PAREXEL$$60$YR$$F$Y$$$20240923$$CN$US$US
243536831$24353683$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004086$PAREXEL$$69$YR$$F$Y$$$20240923$$CN$US$US
243536841$24353684$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004098$PAREXEL$$$$$F$Y$$$20240923$$CN$US$US
243536851$24353685$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004063$PAREXEL$$89$YR$$F$Y$$$20240923$$CN$US$US
243536861$24353686$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004243$PAREXEL$$93$YR$$F$Y$$$20240923$$CN$US$US
243536871$24353687$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004051$PAREXEL$$73$YR$$F$Y$$$20240923$$CN$US$US
243536881$24353688$1$I$$20240720$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004081$PAREXEL$$62$YR$$F$Y$$$20240923$$CN$US$US
243536891$24353689$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004080$PAREXEL$$77$YR$$F$Y$$$20240923$$CN$US$US
243536901$24353690$1$I$20240715$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004103$PAREXEL$$58$YR$$F$Y$$$20240923$$CN$US$US
243536911$24353691$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004088$PAREXEL$$58$YR$$F$Y$$$20240923$$CN$US$US
243536921$24353692$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004074$PAREXEL$$51$YR$$F$Y$$$20240923$$CN$US$US
243536931$24353693$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004104$PAREXEL$$84$YR$$F$Y$$$20240923$$CN$US$US
243536941$24353694$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004113$PAREXEL$$86$YR$$F$Y$$$20240923$$CN$US$US
243536951$24353695$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004262$PAREXEL$$43$YR$$$Y$$$20240923$$HP$US$US
243536961$24353696$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004036$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243536971$24353697$1$I$20240601$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003939$PAREXEL$$86$YR$$F$Y$$$20240923$$CN$US$US
243536981$24353698$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004228$PAREXEL$$74$YR$$F$Y$$$20240923$$CN$US$US
243536991$24353699$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004046$PAREXEL$$80$YR$$F$Y$$$20240923$$HP$US$US
243537001$24353700$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004091$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243537021$24353702$1$I$$20240723$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004029$PAREXEL$$68$YR$$F$Y$$$20240923$$CN$US$US
243537031$24353703$1$I$$20240917$20240923$20240923$PER$$US-BIOVITRUM-2024-US-012215$BIOVITRUM$$68$YR$$M$Y$$$20240923$$CN$US$US
243537041$24353704$1$I$20240101$20240918$20240923$20240923$EXP$$US-SA-2024SA273899$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240923$$CN$US$US
243537051$24353705$1$I$$20240916$20240923$20240923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-149920$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$JP$JP
243537061$24353706$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA272452$SANOFI AVENTIS$$51$YR$A$F$Y$67$KG$20240923$$MD$US$US
243537071$24353707$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA269530$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240923$$CN$US$US
243537081$24353708$1$I$$20240923$20240923$20240923$PER$$NVSC2024US189228$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243537092$24353709$2$F$20240913$20240924$20240923$20240927$EXP$$JP-009507513-2409JPN005296$MERCK$$94$YR$$F$Y$$$20240927$$PH$JP$JP
243537102$24353710$2$F$$20240923$20240923$20240930$EXP$FR-AFSSAPS-AVPO2024000176$FR-TEVA-VS-3244121$TEVA$$37$YR$$M$Y$$$20240930$$PH$FR$FR
243537121$24353712$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189216$NOVARTIS$$$$$$Y$$$20240923$$MD$US$US
243537131$24353713$1$I$$20240916$20240923$20240923$EXP$$FR-MYLANLABS-2024M1084332$MYLAN$Kanitakis J, Karayannopoulou G, Petruzzo P, Lanzetta M.. Graft vasculopathy in the skin of a human hand allograft: implications for diagnosis of rejection of vascularized composite allografts. American journal of transplantation. 2014;1:1-6$35$YR$$M$Y$$$20240923$$HP$FR$FR
243537151$24353715$1$I$$20240916$20240923$20240923$EXP$$DE-MYLANLABS-2024M1084644$MYLAN$Harmel, P., Schlunk, F., Harms, L.. Fulminant rebound of relapsing-remitting multiple sclerosis after discontinuation of dimethyl fumarate: a case report.. Mult. Scler.. 2018;24(8):1131?1133$38$YR$$M$Y$$$20240923$$HP$DE$DE
243537161$24353716$1$I$$20240916$20240923$20240923$EXP$$DE-MYLANLABS-2024M1084382$MYLAN$Brueckner I, Welter-Luedeke J, Zangl A, Graw M, Paul LD.. Alpha-Pyrrolidinohexanophenone (Alpha-PHP) vs. Alpha-pyrrolidinoisohexanophenone (Alpha-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases. J Anal Toxicol.. 2024;48 (5):299-313$41$YR$$F$Y$$$20240923$$HP$DE$DE
243537171$24353717$1$I$$20240916$20240923$20240923$EXP$$BE-MYLANLABS-2024M1084796$MYLAN$Balthasar Y, Gheysens T, Loos C, de Picker L.. Reversible cerebral vasoconstrictionsyndrome: case study and the role ofsubstance use, covid-19, and psychotropic drugs. Psychiatry and covid-19. 2024;66(6):296-300$27$YR$$M$Y$$$20240923$$MD$BE$BE
243537181$24353718$1$I$$20240916$20240923$20240923$EXP$$BE-MYLANLABS-2024M1085176$MYLAN$Nortier JL, Roumeguere T, Broeders N, Jayaswal A, Rorive S, Quackels T, et al. Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropa. TRANSPLANT INTERNATIONAL. 2014;1-7$$$$F$Y$$$20240923$$HP$BE$BE
243537191$24353719$1$I$$20240916$20240923$20240923$EXP$$BE-JNJFOC-20240943606$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$MD$BE$BE
243537201$24353720$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA272689$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240923$$CN$US$US
243537211$24353721$1$I$$20240719$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004068$PAREXEL$$68$YR$$F$Y$$$20240923$$CN$US$US
243537221$24353722$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004035$PAREXEL$$69$YR$$F$Y$$$20240923$$CN$US$US
243537231$24353723$1$I$$20240719$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004073$PAREXEL$$37$YR$$F$Y$$$20240923$$CN$US$US
243537241$24353724$1$I$$20240912$20240923$20240923$PER$$US-INCYTE CORPORATION-2024IN009714$INCYTE$$$$$$Y$$$20240923$$MD$US$US
243537251$24353725$1$I$$20240719$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004070$PAREXEL$$51$YR$$F$Y$$$20240923$$CN$US$US
243537261$24353726$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004039$PAREXEL$$48$YR$$F$Y$$$20240923$$CN$US$US
243537271$24353727$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004219$PAREXEL$$59$YR$$F$Y$$$20240923$$MD$US$US
243537281$24353728$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004003$PAREXEL$$60$YR$$F$Y$$$20240923$$HP$US$US
243537291$24353729$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004059$PAREXEL$$67$YR$$F$Y$$$20240923$$CN$US$US
243537301$24353730$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003624$PAREXEL$$56$YR$$F$Y$$$20240923$$CN$US$US
243537311$24353731$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004042$PAREXEL$$57$YR$$F$Y$$$20240923$$CN$US$US
243537321$24353732$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004211$PAREXEL$$63$YR$$F$Y$$$20240923$$CN$US$US
243537331$24353733$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004199$PAREXEL$$67$YR$$F$Y$$$20240923$$CN$US$US
243537341$24353734$1$I$20240710$20240719$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004050$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243537351$24353735$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004205$PAREXEL$$65$YR$$F$Y$$$20240923$$MD$US$US
243537361$24353736$1$I$$20240719$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004064$PAREXEL$$52$YR$$F$Y$$$20240923$$CN$US$US
243537371$24353737$1$I$20240414$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003122$PAREXEL$$86$YR$$F$Y$$$20240923$$CN$US$US
243537381$24353738$1$I$$20240721$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004075$PAREXEL$$62$YR$$F$Y$$$20240923$$CN$US$US
243537391$24353739$1$I$$20240722$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004095$PAREXEL$$54$YR$$F$Y$$$20240923$$CN$US$US
243537401$24353740$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004221$PAREXEL$$72$YR$$F$Y$$$20240923$$CN$US$US
243537411$24353741$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004214$PAREXEL$$68$YR$$F$Y$$$20240923$$CN$US$US
243537421$24353742$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004048$PAREXEL$$55$YR$$F$Y$$$20240923$$HP$US$US
243537441$24353744$1$I$20240204$20240920$20240920$20240920$DIR$719289$$FDA-CTU$$73$YR$$F$N$101.25$KG$20240920$N$CN$US$
243537451$24353745$1$I$20240819$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64996$$FDA-CTU$$87$YR$$M$N$$$20240923$Y$HP$US$
243537461$24353746$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004208$PAREXEL$$48$YR$$F$Y$$$20240923$$CN$US$US
243537471$24353747$1$I$$20240720$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004077$PAREXEL$$70$YR$$F$Y$$$20240923$$CN$US$US
243537481$24353748$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64992$$FDA-CTU$$41$YR$$F$N$79.38$KG$20240923$N$$US$
243537491$24353749$1$I$$20240719$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003792$PAREXEL$$62$YR$$F$Y$$$20240923$$CN$US$US
243537501$24353750$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64993$$FDA-CTU$$87$YR$$M$N$$$20240923$N$$US$
243537521$24353752$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004200$PAREXEL$$89$YR$$M$Y$$$20240923$$CN$US$US
243537531$24353753$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64994$$FDA-CTU$$61$YR$$M$N$$$20240923$N$$US$
243537541$24353754$1$I$$20240918$20240923$20240923$EXP$$FR-AMGEN-FRASP2024186421$AMGEN$$$$A$F$Y$64$KG$20240923$$CN$FR$FR
243537551$24353755$1$I$$20240917$20240923$20240923$EXP$$FR-MYLANLABS-2024M1085428$MYLAN$Ikic A, Chatelus E, Epailly E, Kremer H, Sibilia J, Gottenberg J, et al.. Heart transplantation in 6 patients with systemic sclerosis and a primary cardiac involvement. DEFAULT RECORD. 2014;1$$$$F$Y$$$20240923$$HP$FR$FR
243537561$24353756$1$I$$20240917$20240923$20240923$EXP$NL-LRB-01001136$NL-MYLANLABS-2024M1084976$MYLAN$$70$YR$$M$Y$99$KG$20240923$$CN$NL$NL
243537571$24353757$1$I$20240901$20240918$20240923$20240923$EXP$$US-ABBVIE-5930960$ABBVIE$$62$YR$$M$Y$$$20240923$$CN$US$US
243537581$24353758$1$I$$20240920$20240920$20240920$DIR$719238$$FDA-CTU$$$$$UNK$N$$$20240920$N$PH$US$
243537601$24353760$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64997$$FDA-CTU$$20$YR$$F$N$$$20240923$N$$US$
243537611$24353761$1$I$20240501$20240920$20240920$20240920$DIR$719279$$FDA-CTU$$69$YR$$M$N$$$20240920$N$HP$US$
243537621$24353762$1$I$$20240916$20240923$20240923$DIR$FDA-CDER-CTU-2024-64998$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243537631$24353763$1$I$$20240912$20240923$20240923$PER$$US-INCYTE CORPORATION-2024IN009711$INCYTE$$$$$$Y$$$20240923$$CN$US$US
243537641$24353764$1$I$20240301$20240913$20240923$20240923$EXP$$US-AMGEN-USASP2024185762$AMGEN$$61$YR$A$F$Y$$$20240923$$HP$US$US
243537652$24353765$2$F$20190101$20240920$20240923$20240926$EXP$$NVSC2024AU187589$NOVARTIS$$77$YR$$M$Y$$$20240926$$MD$AU$AU
243537662$24353766$2$F$$20240918$20240923$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US081618$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
243537681$24353768$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004232$PAREXEL$$73$YR$$F$Y$$$20240923$$CN$US$US
243537691$24353769$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004174$PAREXEL$$62$YR$$F$Y$$$20240923$$CN$US$US
243537701$24353770$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004196$PAREXEL$$51$YR$$F$Y$$$20240923$$MD$US$US
243537711$24353771$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004249$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243537721$24353772$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004213$PAREXEL$$54$YR$$F$Y$$$20240923$$CN$US$US
243537731$24353773$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004245$PAREXEL$$72$YR$$F$Y$$$20240923$$CN$US$US
243537741$24353774$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004033$PAREXEL$$59$YR$$F$Y$$$20240923$$CN$US$US
243537751$24353775$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004175$PAREXEL$$58$YR$$F$Y$$$20240923$$CN$US$US
243537761$24353776$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004047$PAREXEL$$57$YR$$F$Y$$$20240923$$CN$US$US
243537771$24353777$1$I$20230725$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2023-STML-US002294$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243537781$24353778$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004260$PAREXEL$$63$YR$$F$Y$$$20240923$$CN$US$US
243537791$24353779$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004128$PAREXEL$$77$YR$$F$Y$$$20240923$$CN$US$US
243537801$24353780$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004034$PAREXEL$$55$YR$$F$Y$$$20240923$$CN$US$US
243537811$24353781$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004182$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243537821$24353782$1$I$$20240718$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004041$PAREXEL$$75$YR$$F$Y$$$20240923$$CN$US$US
243537831$24353783$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004197$PAREXEL$$54$YR$$F$Y$$$20240923$$CN$US$US
243537841$24353784$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004216$PAREXEL$$59$YR$$F$Y$$$20240923$$CN$US$US
243537851$24353785$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004134$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243537861$24353786$1$I$20240503$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004147$PAREXEL$$78$YR$$F$Y$$$20240923$$CN$US$US
243537871$24353787$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004181$PAREXEL$$74$YR$$F$Y$$$20240923$$CN$US$US
243537881$24353788$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004130$PAREXEL$$64$YR$$F$Y$$$20240923$$HP$US$US
243537891$24353789$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004151$PAREXEL$$54$YR$$F$Y$$$20240923$$CN$US$US
243537901$24353790$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004233$PAREXEL$$81$YR$$F$Y$$$20240923$$CN$US$US
243537911$24353791$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004220$PAREXEL$$70$YR$$F$Y$$$20240923$$CN$US$US
243537921$24353792$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004224$PAREXEL$$61$YR$$F$Y$$$20240923$$CN$US$US
243537932$24353793$2$F$20240825$20240923$20240923$20240924$PER$$US-AMGEN-USASP2024188499$AMGEN$$72$YR$E$F$Y$$$20240924$$CN$US$US
243537941$24353794$1$I$$20240913$20240923$20240923$PER$$US-ROCHE-10000085189$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
243537951$24353795$1$I$$20240912$20240923$20240923$PER$$US-ROCHE-10000083211$ROCHE$$$$$F$Y$$$20240923$$CN$US$US
243537961$24353796$1$I$$20240717$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004264$PAREXEL$$48$YR$$F$Y$$$20240923$$CN$US$US
243537971$24353797$1$I$$20240913$20240923$20240923$PER$$US-INCYTE CORPORATION-2024IN009751$INCYTE$$$$$$Y$$$20240923$$HP$US$US
243537982$24353798$2$F$20240901$20240919$20240923$20240926$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-28582$SAMSUNG BIOEPIS$$81$YR$E$F$Y$$$20240926$$CN$CA$CA
243537991$24353799$1$I$20240519$20240918$20240923$20240923$EXP$GB-MHRA-MED-202409182331166280-PBYTC$GB-SANDOZ INC.-SDZ2024GB081586$SANDOZ$$$$$F$Y$$$20240923$$CN$GB$GB
243538001$24353800$1$I$$20240917$20240923$20240923$EXP$$JP-GSK-JP2024116691$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$JP$JP
243538012$24353801$2$F$$20240919$20240923$20240924$PER$$US-ROCHE-10000086560$ROCHE$$49$YR$A$F$Y$$$20240924$$CN$US$US
243538031$24353803$1$I$$20240916$20240923$20240923$PER$$US-ROCHE-10000085358$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243538051$24353805$1$I$$20240916$20240923$20240923$PER$$US-ROCHE-10000085283$ROCHE$$55$YR$A$F$Y$$$20240923$$CN$US$US
243538061$24353806$1$I$20240825$20240918$20240923$20240923$EXP$$NVSC2024CN187988$NOVARTIS$$64$YR$$M$Y$$$20240923$$HP$CN$CN
243538071$24353807$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-64999$$FDA-CTU$$62$YR$$M$N$$$20240923$N$$US$
243538081$24353808$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000085406$ROCHE$$43$YR$A$F$Y$$$20240923$$CN$US$US
243538091$24353809$1$I$$20240921$20240921$20240921$DIR$719339$$FDA-CTU$$$$$F$N$$$20240921$N$CN$US$
243538101$24353810$1$I$$20240919$20240923$20240923$EXP$$PL-SANDOZ INC.-SDZ2024PL082074$SANDOZ$$33$YR$$M$Y$$$20240923$$HP$PL$PL
243538121$24353812$1$I$$20240918$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US081776$SANDOZ$$$$$F$Y$48.18$KG$20240923$$CN$US$US
243538131$24353813$1$I$$20240913$20240923$20240923$PER$$US-INCYTE CORPORATION-2024IN009748$INCYTE$$$$$$Y$$$20240923$$CN$US$US
243538141$24353814$1$I$20240801$20240918$20240923$20240923$EXP$$JP-009507513-2409JPN002881J$MERCK$$73$YR$$F$Y$$$20240923$$PH$JP$JP
243538151$24353815$1$I$$20240918$20240923$20240923$EXP$$GB-TAKEDA-2022TUS017290$TAKEDA$$$$$F$Y$$$20240923$$CN$GB$GB
243538161$24353816$1$I$$20240919$20240923$20240923$PER$$US-TAKEDA-2024TUS093517$TAKEDA$$$$$$Y$$$20240923$$CN$US$US
243538171$24353817$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004209$PAREXEL$$81$YR$$F$Y$$$20240923$$CN$US$US
243538181$24353818$1$I$$20240715$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004090$PAREXEL$$64$YR$$F$Y$$$20240923$$MD$US$US
243538191$24353819$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004222$PAREXEL$$85$YR$$F$Y$$$20240923$$CN$US$US
243538201$24353820$1$I$$20240713$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004072$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243538211$24353821$1$I$20240916$20240917$20240923$20240923$PER$$US-ROCHE-10000085343$ROCHE$$68$YR$E$F$Y$83.91$KG$20240923$$CN$US$US
243538221$24353822$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003852$PAREXEL$$70$YR$$F$Y$$$20240923$$CN$US$US
243538231$24353823$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004207$PAREXEL$$83$YR$$F$Y$$$20240923$$CN$US$US
243538241$24353824$1$I$$20240715$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004097$PAREXEL$$75$YR$$F$Y$$$20240923$$CN$US$US
243538251$24353825$1$I$$20240715$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004148$PAREXEL$$49$YR$$F$Y$$$20240923$$CN$US$US
243538261$24353826$1$I$$20240715$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004165$PAREXEL$$82$YR$$F$Y$$$20240923$$CN$US$US
243538271$24353827$1$I$20240711$20240715$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004203$PAREXEL$$75$YR$$F$Y$$$20240923$$CN$US$US
243538281$24353828$1$I$$20240713$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004111$PAREXEL$$63$YR$$F$Y$$$20240923$$CN$US$US
243538291$24353829$1$I$$20240715$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004201$PAREXEL$$65$YR$$F$Y$$$20240923$$CN$US$US
243538301$24353830$1$I$$20240715$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004114$PAREXEL$$42$YR$$F$Y$$$20240923$$CN$US$US
243538311$24353831$1$I$$20240715$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004082$PAREXEL$$54$YR$$F$Y$$$20240923$$CN$US$US
243538321$24353832$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003482$PAREXEL$$85$YR$$F$Y$$$20240923$$CN$US$US
243538331$24353833$1$I$20240510$20240713$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003454$PAREXEL$$73$YR$$F$Y$$$20240923$$CN$US$US
243538341$24353834$1$I$20240514$20240715$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2023-STML-US002157$PAREXEL$$62$YR$$F$Y$$$20240923$$CN$US$US
243538351$24353835$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003614$PAREXEL$$81$YR$$F$Y$$$20240923$$CN$US$US
243538361$24353836$1$I$$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004235$PAREXEL$$57$YR$$F$Y$$$20240923$$HP$US$US
243538371$24353837$1$I$$20240715$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004187$PAREXEL$$63$YR$$F$Y$$$20240923$$HP$US$US
243538381$24353838$1$I$$20240713$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004108$PAREXEL$$84$YR$$F$Y$$$20240923$$CN$US$US
243538391$24353839$1$I$20240705$20240716$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004045$PAREXEL$$82$YR$$F$Y$$$20240923$$CN$US$US
243538401$24353840$1$I$$20240715$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004127$PAREXEL$$56$YR$$F$Y$$$20240923$$CN$US$US
243538411$24353841$1$I$20240807$20240912$20240923$20240923$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18633$IPSEN$$37$YR$A$F$Y$61.23$KG$20240923$$HP$US$US
243538421$24353842$1$I$$20240715$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004184$PAREXEL$$62$YR$$F$Y$$$20240923$$CN$US$US
243538431$24353843$1$I$20240101$20240911$20240923$20240923$PER$$US-SA-2024SA266661$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240923$$MD$US$US
243538441$24353844$1$I$$20240911$20240923$20240923$EXP$$NVSC2024RU186240$NOVARTIS$Marchenko M.V., Klimova O.U., Anikina E.V., Lapina A.V., Rudakova T.A., Ksenzova T.I., et al.. Ingibitor komplementa S3 u pacientov s paroksizmal^noj nochnoj gemoglobinuriej pri suboptimal^nom otvete na terapiyu ingibitorom S5 [Complement C3 inhibitor in patients with paroxysmal nocturnal hemoglobinuria with suboptimal response to C5 inhibitor therapy]. ONCOHEMATOLOGY. 2024;19(3):68-78$24$YR$$F$Y$$$20240923$$HP$RU$RU
243538451$24353845$1$I$20240909$20240919$20240923$20240923$EXP$GB-MHRA-MED-202409161222572420-TMDZF$GB-MYLANLABS-2024M1085431$MYLAN$$53$YR$$M$Y$100$KG$20240923$$CN$GB$GB
243538461$24353846$1$I$20240917$20240919$20240923$20240923$EXP$GB-MHRA-MED-202409170839014500-CVQBL$GB-MYLANLABS-2024M1085748$MYLAN$$65$YR$$F$Y$75$KG$20240923$$MD$GB$GB
243538471$24353847$1$I$20240814$20240919$20240923$20240923$EXP$GB-MHRA-MED-202409190538139840-WVMPN$GB-MYLANLABS-2024M1085478$MYLAN$$21$YR$$M$Y$$$20240923$$CN$GB$GB
243538481$24353848$1$I$20240922$20240922$20240923$20240923$EXP$GB-MHRA-MED-202409221118204180-DLKYH$GB-MYLANLABS-2024M1086158$MYLAN$$59$YR$$M$Y$80$KG$20240923$$MD$GB$GB
243538491$24353849$1$I$20240713$20240918$20240923$20240923$EXP$$NVSC2024US177289$NOVARTIS$$77$YR$$M$Y$$$20240923$$CN$US$US
243538501$24353850$1$I$$20240919$20240923$20240923$EXP$$AU-MYLANLABS-2024M1085808$MYLAN$$$$$M$Y$$$20240923$$PH$AU$AU
243538511$24353851$1$I$$20240919$20240923$20240923$PER$$US-BAYER-2024A134771$BAYER$$$$$F$Y$$$20240923$$CN$US$US
243538521$24353852$1$I$20240910$20240914$20240923$20240923$PER$$CN-Eisai-EC-2024-174434$EISAI$$58$YR$A$F$Y$60$KG$20240923$$HP$CN$CN
243538531$24353853$1$I$$20240916$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US080862$SANDOZ$File B, Hari A.. Discrepancy in PD-L1 expression between primary and metastatic tumors in two patients with recurrent cervical cancer. Gynecologic Oncology Reports. 2024$42$YR$$F$Y$$$20240923$$HP$US$US
243538541$24353854$1$I$20230627$20240919$20240923$20240923$EXP$$JP-ASTELLAS-2024-AER-008031$ASTELLAS$$68$YR$E$M$Y$48.7$KG$20240923$$PH$JP$JP
243538551$24353855$1$I$$20240913$20240923$20240923$EXP$$CA-TEVA-VS-3244337$TEVA$$51$YR$$M$Y$$$20240923$$HP$CA$CA
243538561$24353856$1$I$20240923$20240923$20240923$20240923$PER$$US-BAYER-2024A135447$BAYER$$33$YR$A$F$Y$$$20240923$$MD$US$US
243538571$24353857$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114277$GLAXOSMITHKLINE$$$$$M$Y$$$20240923$$CN$US$US
243538581$24353858$1$I$$20240913$20240923$20240923$EXP$$CA-TEVA-VS-3244317$TEVA$$$$$F$Y$$$20240923$$CN$CA$CA
243538591$24353859$1$I$$20240916$20240923$20240923$EXP$$US-GILEAD-2024-0685141$GILEAD$$$$A$F$Y$$$20240923$$CN$US$US
243538601$24353860$1$I$$20240909$20240923$20240923$EXP$$CA-BAXTER-2024BAX024583$BAXTER$$34$YR$$M$Y$$$20240923$$CN$CA$CA
243538611$24353861$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189233$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243538621$24353862$1$I$20240301$20240916$20240923$20240923$EXP$$GB-GSK-GB2024EME042297$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$GB$GB
243538631$24353863$1$I$20240618$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003995$PAREXEL$$51$YR$$F$Y$$$20240923$$CN$US$US
243538641$24353864$1$I$$20240916$20240923$20240923$EXP$$FR-JNJFOC-20240959825$JOHNSON AND JOHNSON$Soria A, Kurihara F, Amsler E, Brehon A, Autegarden JE, Barbaud A.. Paradoxical urticaria to H1-antihistamines. Journal of the European Academy of Dermatology and Venereology. 2024;00:1-6. doi:10.1111/jdv.20330$40$YR$A$F$Y$$$20240923$$HP$FR$FR
243538651$24353865$1$I$$20240711$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004007$PAREXEL$$72$YR$$F$Y$$$20240923$$CN$US$US
243538661$24353866$1$I$$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003622$PAREXEL$$59$YR$$F$Y$$$20240923$$CN$US$US
243538671$24353867$1$I$$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004010$PAREXEL$$69$YR$$F$Y$$$20240923$$CN$US$US
243538681$24353868$1$I$$20240711$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004025$PAREXEL$$74$YR$$F$Y$$$20240923$$HP$US$US
243538691$24353869$1$I$$20240711$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004023$PAREXEL$$60$YR$$F$Y$$$20240923$$CN$US$US
243538701$24353870$1$I$$20240711$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003250$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243538711$24353871$1$I$$20240712$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003795$PAREXEL$$73$YR$$F$Y$$$20240923$$CN$US$US
243538721$24353872$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087951$ROCHE$$61$YR$A$F$Y$$$20240923$$CN$US$US
243538731$24353873$1$I$$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004005$PAREXEL$$62$YR$$F$Y$$$20240923$$CN$US$US
243538741$24353874$1$I$$20240713$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004109$PAREXEL$$70$YR$$F$Y$$$20240923$$CN$US$US
243538751$24353875$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087779$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243538761$24353876$1$I$$20240712$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004102$PAREXEL$$69$YR$$F$Y$$$20240923$$CN$US$US
243538771$24353877$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087747$ROCHE$$65$YR$E$F$Y$$$20240923$$CN$US$US
243538781$24353878$1$I$$20240711$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003141$PAREXEL$$59$YR$$F$Y$$$20240923$$CN$US$US
243538791$24353879$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087677$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243538811$24353881$1$I$$20240918$20240923$20240923$PER$$US-ROCHE-10000086531$ROCHE$$51$YR$A$F$Y$$$20240923$$CN$US$US
243538821$24353882$1$I$$20240711$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004038$PAREXEL$$60$YR$$F$Y$$$20240923$$CN$US$US
243538831$24353883$1$I$$20240711$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004057$PAREXEL$$73$YR$$F$Y$$$20240923$$CN$US$US
243538841$24353884$1$I$20240709$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003927$PAREXEL$$78$YR$$F$Y$$$20240923$$CN$US$US
243538851$24353885$1$I$$20240711$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004026$PAREXEL$$60$YR$$F$Y$$$20240923$$CN$US$US
243538861$24353886$1$I$$20240711$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004040$PAREXEL$$79$YR$$F$Y$$$20240923$$CN$US$US
243538871$24353887$1$I$$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002224$PAREXEL$$53$YR$$F$Y$$$20240923$$CN$US$US
243538881$24353888$1$I$$20240712$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004030$PAREXEL$$61$YR$$F$Y$$$20240923$$CN$US$US
243538891$24353889$1$I$$20240711$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004049$PAREXEL$$54$YR$$F$Y$$$20240923$$HP$US$US
243538901$24353890$1$I$$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004024$PAREXEL$$62$YR$$F$Y$$$20240923$$CN$US$US
243538911$24353891$1$I$20240711$20240712$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004106$PAREXEL$$52$YR$$F$Y$$$20240923$$CN$US$US
243538921$24353892$1$I$$20240711$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003802$PAREXEL$$64$YR$$F$Y$$$20240923$$CN$US$US
243538931$24353893$1$I$$20240712$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004055$PAREXEL$$74$YR$$F$Y$$$20240923$$CN$US$US
243538941$24353894$1$I$$20240920$20240923$20240923$PER$$US-TAKEDA-2024TUS094008$TAKEDA$$$$$F$Y$$$20240923$$CN$US$US
243538951$24353895$1$I$20240901$20240912$20240923$20240923$EXP$$CN-TAKEDA-2024TUS093622$TAKEDA$$54$YR$$F$Y$55$KG$20240923$$HP$CN$CN
243538961$24353896$1$I$$20240713$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004079$PAREXEL$$40$YR$$F$Y$$$20240923$$CN$US$US
243538971$24353897$1$I$$20240916$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US081804$SANDOZ$File B, Hari A.. Discrepancy in PD-L1 expression between primary and metastatic tumors in two patients with recurrent cervical cancer. Gynecologic Oncology Reports. 2024$36$YR$$F$Y$$$20240923$$HP$US$US
243538981$24353898$1$I$$20240712$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004062$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243538991$24353899$1$I$20240319$20240922$20240923$20240923$EXP$GB-MHRA-MED-202409220831067940-BCQNJ$GB-SANDOZ INC.-SDZ2024GB082027$SANDOZ$$66$YR$$F$Y$62$KG$20240923$$CN$GB$GB
243539011$24353901$1$I$$20240917$20240923$20240923$EXP$$GT-ABBVIE-5931899$ABBVIE$$$$$M$Y$$$20240923$$MD$GT$GT
243539021$24353902$1$I$$20240910$20240923$20240923$EXP$$CA-B.Braun Medical Inc.-2161930$B BRAUN$Literature Article$19$YR$$F$Y$$$20240923$$$CA$CA
243539031$24353903$1$I$$20240920$20240923$20240923$PER$$US-ROCHE-10000087692$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243539041$24353904$1$I$$20240920$20240923$20240923$EXP$$RO-SANDOZ INC.-SDZ2024RO080814$SANDOZ$$73$YR$$M$Y$$$20240923$$HP$RO$RO
243539051$24353905$1$I$20240916$20240921$20240921$20240921$DIR$719301$$FDA-CTU$$$$$F$N$$$20240921$N$CN$US$
243539061$24353906$1$I$$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024189191$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243539081$24353908$1$I$$20240920$20240923$20240923$PER$$US-ROCHE-10000087359$ROCHE$$$$E$F$Y$$$20240923$$CN$US$US
243539091$24353909$1$I$20240707$20240916$20240923$20240923$EXP$FR-AFSSAPS-MA2024001324$FR-TEVA-VS-3244368$TEVA$$49$YR$$F$Y$$$20240923$$CN$FR$FR
243539101$24353910$1$I$$20230920$20240923$20240923$EXP$$NVSC2023IT205804$NOVARTIS$$$$$M$Y$$$20240923$$HP$IT$IT
243539111$24353911$1$I$20240624$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004017$PAREXEL$$44$YR$$F$Y$$$20240923$$CN$US$US
243539121$24353912$1$I$$20240822$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004193$PAREXEL$$69$YR$$F$Y$$$20240923$$CN$US$US
243539131$24353913$1$I$$20240815$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004309$PAREXEL$$$$$$Y$$$20240923$$CN$US$US
243539141$24353914$1$I$$20240810$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US000175$PAREXEL$$$$$$Y$$$20240923$$CN$US$US
243539151$24353915$1$I$$20240821$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004020$PAREXEL$$$$$F$Y$72$KG$20240923$$CN$US$US
243539161$24353916$1$I$$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004060$PAREXEL$$60$YR$$F$Y$$$20240923$$HP$US$US
243539171$24353917$1$I$$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004061$PAREXEL$$63$YR$$F$Y$$$20240923$$CN$US$US
243539181$24353918$1$I$$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003103$PAREXEL$$66$YR$$F$Y$$$20240923$$CN$US$US
243539191$24353919$1$I$$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004037$PAREXEL$$46$YR$$F$Y$$$20240923$$HP$US$US
243539201$24353920$1$I$20240101$20240816$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003152$PAREXEL$$$$$$Y$$$20240923$$CN$US$US
243539211$24353921$1$I$20240101$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2023-STML-US004644$PAREXEL$$55$YR$$F$Y$54.48$KG$20240923$$CN$US$US
243539221$24353922$1$I$20240626$20240814$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003841$PAREXEL$$$$$$Y$$$20240923$$CN$US$US
243539231$24353923$1$I$$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004015$PAREXEL$$75$YR$$F$Y$$$20240923$$MD$US$US
243539241$24353924$1$I$$20240710$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004018$PAREXEL$$90$YR$$F$Y$$$20240923$$CN$US$US
243539251$24353925$1$I$$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004058$PAREXEL$$82$YR$$F$Y$$$20240923$$CN$US$US
243539261$24353926$1$I$$20240918$20240923$20240923$EXP$$VN-SANDOZ INC.-SDZ2024VN082048$SANDOZ$Dang Nguyen TB, Huynh MV. Ghep te bao goc dong loai lan hai trong dieu tr? cac truong hop thai ghep/tai phat t?i benh vien tmhh tp.hcm [The second allogeneic hematopoietic stem cell transplantation in treatment of relapse/rejection cases at blood transfusion hematology hospital, ho chi minh city]. VIETNAM MEDICAL JOURNAL. 2022;520:51-7$39$YR$$M$Y$$$20240923$$HP$VN$VN
243539271$24353927$1$I$$20240709$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004056$PAREXEL$$86$YR$$F$Y$$$20240923$$CN$US$US
243539281$24353928$1$I$$20240913$20240923$20240923$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004258$PAREXEL$$$$$F$Y$72.5$KG$20240923$$CN$US$US
243539291$24353929$1$I$$20240918$20240923$20240923$EXP$$BE-GENMAB-2024-03464$GENMAB$$$$$F$Y$$$20240923$$PH$BE$BE
243539301$24353930$1$I$20240101$20240612$20240923$20240923$PER$$US-ARDELYX-2024ARDX004323$ARDELYX$$$$$M$Y$$$20240922$$CN$US$US
243539311$24353931$1$I$20240909$20240917$20240923$20240923$EXP$$CA-ABBVIE-5929990$ABBVIE$$77$YR$$F$Y$$$20240923$$CN$CA$CA
243539321$24353932$1$I$$20240625$20240923$20240923$PER$$US-ARDELYX-2024ARDX004641$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243539331$24353933$1$I$20240501$20240613$20240923$20240923$PER$$US-ARDELYX-2024ARDX004370$ARDELYX$$46$YR$$M$Y$62$KG$20240922$$PH$US$US
243539341$24353934$1$I$$20240625$20240923$20240923$PER$$US-ARDELYX-2024ARDX004644$ARDELYX$$$$$F$Y$$$20240922$$HP$US$US
243539351$24353935$1$I$20231109$20240920$20240923$20240923$EXP$$NVSC2020IN294364$NOVARTIS$$88$YR$$M$Y$$$20240923$$MD$IN$IN
243539361$24353936$1$I$$20240627$20240923$20240923$PER$$US-ARDELYX-2024ARDX004714$ARDELYX$$$$$$Y$$$20240922$$HP$US$US
243539371$24353937$1$I$20240101$20240918$20240923$20240923$EXP$$US-ABBVIE-5841536$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243539381$24353938$1$I$$20240916$20240923$20240923$PER$$US-AMGEN-USASP2024184686$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
243539391$24353939$1$I$$20240903$20240923$20240923$EXP$$US-SA-2024SA271691$SANOFI AVENTIS$$$$E$F$Y$63.64$KG$20240923$$MD$US$US
243539401$24353940$1$I$20240530$20240917$20240923$20240923$EXP$$FR-AMGEN-FRASP2024116448$AMGEN$$68$YR$E$F$Y$$$20240923$$MD$FR$FR
243539411$24353941$1$I$$20240702$20240923$20240923$PER$$US-ARDELYX-2024ARDX004863$ARDELYX$$$$$F$Y$$$20240922$$HP$US$US
243539421$24353942$1$I$20230101$20240918$20240923$20240923$EXP$$JP-SANDOZ INC.-SDZ2024JP081932$SANDOZ$$80$YR$$F$Y$$$20240923$$CN$JP$JP
243539431$24353943$1$I$$20240807$20240923$20240923$PER$$US-ARDELYX-2024ARDX005214$ARDELYX$$$$$$Y$$$20240922$$HP$US$US
243539441$24353944$1$I$20240611$20240705$20240923$20240923$PER$$US-ARDELYX-2024ARDX005054$ARDELYX$$29$YR$$M$Y$120.4$KG$20240922$$HP$US$US
243539451$24353945$1$I$$20240911$20240923$20240923$EXP$$ALC2024US004225$ALCON$$$$$F$Y$$$20240923$$CN$US$US
243539461$24353946$1$I$$20240911$20240923$20240923$PER$$US-BEH-2024178810$CSL BEHRING$$$$$$Y$$$20240923$$MD$US$US
243539471$24353947$1$I$20240101$20240821$20240923$20240923$PER$$US-ARDELYX-2024ARDX005385$ARDELYX$$$$$F$Y$$$20240922$$PH$US$US
243539481$24353948$1$I$$20240919$20240923$20240923$EXP$$GB-SANDOZ INC.-NVSC2020GB120015$SANDOZ$$$$$M$Y$$$20240923$$CN$GB$GB
243539491$24353949$1$I$$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148050$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$47.17$KG$20240923$$HP$US$US
243539501$24353950$1$I$$20240916$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147565$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240923$$CN$US$US
243539511$24353951$1$I$$20240920$20240923$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA081971$SANDOZ$$95$YR$$F$Y$55.45$KG$20240923$$CN$CA$CA
243539521$24353952$1$I$$20240816$20240923$20240923$PER$$US-ARDELYX-2024ARDX005607$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243539531$24353953$1$I$$20240724$20240923$20240923$PER$$US-ARDELYX-2024ARDX005676$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243539541$24353954$1$I$20240501$20240722$20240923$20240923$PER$$US-ARDELYX-2024ARDX005577$ARDELYX$$43$YR$$$Y$$$20240922$$HP$US$US
243539551$24353955$1$I$$20240916$20240923$20240923$EXP$$US-JNJFOC-20240949933$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$HP$US$US
243539561$24353956$1$I$20220101$20240918$20240923$20240923$EXP$$DE-AMGEN-DEUSP2024186932$AMGEN$$60$YR$A$F$Y$$$20240923$$MD$DE$DE
243539571$24353957$1$I$20240701$20240822$20240923$20240923$PER$$US-ARDELYX-2024ARDX005756$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243539581$24353958$1$I$$20240916$20240923$20240923$PER$$US-ROCHE-10000084588$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243539591$24353959$1$I$20240101$20240730$20240923$20240923$EXP$$US-ARDELYX-2024ARDX005859$ARDELYX$$$$E$F$Y$$$20240922$$MD$US$US
243539601$24353960$1$I$$20240919$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US081692$SANDOZ$$$$$M$Y$$$20240923$$HP$US$US
243539611$24353961$1$I$20240101$20240829$20240923$20240923$PER$$US-ARDELYX-2024ARDX005818$ARDELYX$$$$$M$Y$145.6$KG$20240922$$PH$US$US
243539621$24353962$1$I$$20240819$20240923$20240923$PER$$US-ARDELYX-2024ARDX006015$ARDELYX$$50$YR$$M$Y$$$20240922$$HP$US$US
243539631$24353963$1$I$$20240820$20240923$20240923$PER$$US-ARDELYX-2024ARDX006017$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243539641$24353964$1$I$$20240807$20240923$20240923$EXP$$US-ARDELYX-2024ARDX006042$ARDELYX$$$$$$Y$$$20240922$$HP$US$US
243539651$24353965$1$I$20240701$20240919$20240923$20240923$EXP$$IN-SANDOZ INC.-SDZ2024IN081984$SANDOZ$$65$YR$$M$Y$$$20240923$$CN$IN$IN
243539661$24353966$1$I$20090517$20240916$20240923$20240923$EXP$$US-GSK-US2024AMR115366$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$US$US
243539671$24353967$1$I$20240709$20240821$20240923$20240923$PER$$US-ARDELYX-2024ARDX006045$ARDELYX$$22$YR$$M$Y$$$20240922$$CN$US$US
243539681$24353968$1$I$$20240916$20240923$20240923$EXP$$GB-TAKEDA-2024TUS093279$TAKEDA$$$$$F$Y$$$20240923$$CN$GB$GB
243539701$24353970$1$I$$20240919$20240923$20240923$EXP$$HU-MYLANLABS-2016M1037599$MYLAN$Ruszkai Z,Szombath A,Bokretas G,Bartha P,Molnar et al. E. Serotonine: A source of joy for some people but brain-racking and hustle for others.. Anesthesiology and Intensive Therapy Supplement. 2016;2:47$27$YR$$F$Y$$$20240923$$MD$HU$HU
243539711$24353971$1$I$$20240917$20240923$20240923$EXP$$AT-ABBVIE-5926825$ABBVIE$$$$$F$Y$$$20240923$$MD$AT$AT
243539722$24353972$2$F$$20240919$20240923$20240926$EXP$$GB-GENMAB-2024-03466$GENMAB$$67$YR$$M$Y$$$20240926$$MD$GB$GB
243539731$24353973$1$I$$20240808$20240923$20240923$PER$$US-ARDELYX-2024ARDX006080$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243539741$24353974$1$I$$20240919$20240923$20240923$PER$$US-SA-2024SA272204$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240923$$HP$US$US
243539751$24353975$1$I$20240101$20240807$20240923$20240923$PER$$US-ARDELYX-2024ARDX006050$ARDELYX$$$$$F$Y$59$KG$20240922$$PH$US$US
243539761$24353976$1$I$20240101$20240918$20240923$20240923$PER$$US-SA-2024SA271896$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240923$$MD$US$US
243539771$24353977$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268462$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240923$$MD$US$US
243539781$24353978$1$I$$20240909$20240923$20240923$PER$$US-SA-2024SA273072$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240923$$CN$US$US
243539791$24353979$1$I$20240722$20240813$20240923$20240923$PER$$US-ARDELYX-2024ARDX006155$ARDELYX$$61$YR$$F$Y$$$20240922$$CN$US$US
243539801$24353980$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5931647$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243539811$24353981$1$I$20220615$20240921$20240921$20240921$DIR$719330$$FDA-CTU$$28$YR$$M$N$51.52$KG$20240921$N$PH$US$
243539831$24353983$1$I$$20240814$20240923$20240923$PER$$US-ARDELYX-2024ARDX006183$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243539841$24353984$1$I$$20240919$20240923$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA081693$SANDOZ$$$$$M$Y$$$20240923$$PH$CA$CA
243539851$24353985$1$I$$20240917$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US081400$SANDOZ$Yuting Huang. Hepatic Adenomatosis in a Transgender Man onGender-Affirming Testosterone Therapy. ACG CASE REPORTS JOURNAL. 2024$22$YR$$M$Y$$$20240923$$MD$US$US
243539861$24353986$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010710$APOTEX$$$$A$M$Y$$$20240923$$CN$CA$CA
243539871$24353987$1$I$$20240912$20240923$20240923$PER$$US-JNJFOC-20240933103$JOHNSON AND JOHNSON$$11$YR$C$F$Y$29.51$KG$20240923$$HP$US$US
243539881$24353988$1$I$$20240814$20240923$20240923$PER$$US-ARDELYX-2024ARDX006192$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243539891$24353989$1$I$$20240916$20240923$20240923$EXP$$ES-TEVA-VS-3245929$TEVA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.; Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.$$$$$Y$$$20240923$$HP$ES$ES
243539901$24353990$1$I$$20240912$20240923$20240923$PER$$US-JNJFOC-20240933218$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$MD$US$US
243539911$24353991$1$I$$20240814$20240923$20240923$PER$$US-ARDELYX-2024ARDX006196$ARDELYX$$$$$$Y$$$20240922$$MD$US$US
243539921$24353992$1$I$$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024189154$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243539931$24353993$1$I$20240101$20240919$20240923$20240923$EXP$$US-ABBVIE-5931148$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243539941$24353994$1$I$20240101$20240828$20240923$20240923$PER$$US-ARDELYX-2024ARDX006197$ARDELYX$$$$$F$Y$$$20240922$$CN$US$US
243539951$24353995$1$I$20240901$20240916$20240923$20240923$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001885$BLUEPRINT MEDICINES$$88$YR$E$M$Y$$$20240923$$CN$US$US
243539961$24353996$1$I$20240101$20240815$20240923$20240923$PER$$US-ARDELYX-2024ARDX006225$ARDELYX$$$$$F$Y$$$20240922$$HP$US$US
243539981$24353998$1$I$20240701$20240816$20240923$20240923$PER$$US-ARDELYX-2024ARDX006241$ARDELYX$$48$YR$$F$Y$$$20240922$$CN$US$US
243539991$24353999$1$I$20240101$20240815$20240923$20240923$PER$$US-ARDELYX-2024ARDX006236$ARDELYX$$$$$M$Y$$$20240922$$PH$US$US
243540001$24354000$1$I$$20240913$20240923$20240923$PER$$US-ROCHE-10000082640$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
243540031$24354003$1$I$$20240916$20240923$20240923$EXP$$US-RDY-SPO/USA/24/0013643$DR REDDYS$$45$YR$A$M$Y$$$20240923$$MD$US$US
243540051$24354005$1$I$$20240917$20240923$20240923$EXP$$AU-RDY-SPO/AUS/24/0013696$DR REDDYS$$45$YR$A$F$Y$$$20240923$$CN$AU$AU
243540061$24354006$1$I$$20240918$20240923$20240923$EXP$$CN-ABBVIE-5930402$ABBVIE$$$$$$Y$$$20240923$$MD$CN$CN
243540072$24354007$2$F$$20240924$20240923$20240925$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052777$BOEHRINGER INGELHEIM$$40$YR$A$F$Y$$$20240926$$MD$PL$PL
243540081$24354008$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000088095$ROCHE$$$$C$M$Y$$$20240923$$CN$US$US
243540091$24354009$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087372$ROCHE$$$$T$M$Y$$$20240923$$CN$US$US
243540101$24354010$1$I$$20240916$20240923$20240923$EXP$$US-BIOGEN-2024BI01282947$BIOGEN$$$$$$Y$$$20240923$$CN$US$US
243540111$24354011$1$I$$20240920$20240923$20240923$PER$$US-ROCHE-10000087649$ROCHE$$$$$$Y$$$20240923$$CN$US$US
243540121$24354012$1$I$$20240909$20240923$20240923$DIR$FDA-CDER-CTU-2024-65000$$FDA-CTU$$$$$M$N$$$20240909$N$HP$US$
243540131$24354013$1$I$20240916$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65001$$FDA-CTU$$48$YR$$M$N$$$20240923$N$HP$US$
243540141$24354014$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65002$$FDA-CTU$$59$YR$$F$N$104.33$KG$20240923$N$$US$
243540151$24354015$1$I$20240801$20240909$20240923$20240923$PER$$US-SA-2024SA274278$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240923$$MD$US$US
243540161$24354016$1$I$$20240919$20240923$20240923$EXP$$US-ABBVIE-5931103$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243540181$24354018$1$I$20240611$20240913$20240923$20240923$EXP$$JP-GALDERMA-JP2024010640$GALDERMA$$$$$$Y$$$20240923$$MD$JP$JP
243540191$24354019$1$I$20240501$20240920$20240923$20240923$PER$$US-ROCHE-10000087587$ROCHE$$7$YR$C$M$Y$$$20240923$$CN$US$US
243540201$24354020$1$I$$20240920$20240923$20240923$PER$$US-ROCHE-10000088068$ROCHE$$$$T$M$Y$$$20240923$$CN$US$US
243540211$24354021$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087486$ROCHE$$$$A$M$Y$$$20240923$$CN$US$US
243540221$24354022$1$I$20240823$20240919$20240923$20240923$PER$$US-ROCHE-10000087545$ROCHE$$1$YR$I$M$Y$$$20240923$$CN$US$US
243540231$24354023$1$I$20240101$20240916$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147381$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240923$$CN$US$US
243540241$24354024$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150306$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$50.8$KG$20240923$$HP$US$US
243540251$24354025$1$I$20240125$20240919$20240923$20240923$EXP$$US-TAKEDA-2024TUS007737$TAKEDA$$58$YR$$F$Y$$$20240923$$HP$US$US
243540271$24354027$1$I$$20240913$20240923$20240923$EXP$$AR-JNJFOC-20240941751$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$MD$AR$AR
243540281$24354028$1$I$$20240917$20240923$20240923$EXP$$JP-GSK-JP2024116692$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$JP$JP
243540291$24354029$1$I$$20240917$20240923$20240923$EXP$$JP-GSK-JP2024116686$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$JP$JP
243540301$24354030$1$I$20240919$20240920$20240923$20240923$PER$$US-ROCHE-10000087496$ROCHE$$5$YR$C$M$Y$16.33$KG$20240923$$CN$US$US
243540311$24354031$1$I$20220101$20240913$20240923$20240923$EXP$$IT-OTSUKA-2024_025816$OTSUKA$$63$YR$$F$Y$$$20240923$$CN$IT$IT
243540321$24354032$1$I$$20240918$20240923$20240923$PER$$US-ROCHE-10000086305$ROCHE$$$$$M$Y$$$20240923$$CN$US$US
243540331$24354033$1$I$20240911$20240920$20240923$20240923$PER$$US-ROCHE-10000087725$ROCHE$$18$YR$A$M$Y$$$20240923$$CN$US$US
243540341$24354034$1$I$20240917$20240919$20240923$20240923$PER$$US-ROCHE-10000087698$ROCHE$$58$YR$A$M$Y$$$20240923$$CN$US$US
243540351$24354035$1$I$20240816$20240920$20240923$20240923$PER$$US-ROCHE-10000087753$ROCHE$$31$YR$A$M$Y$$$20240923$$CN$US$US
243540371$24354037$1$I$$20240918$20240923$20240923$EXP$$GB-SANDOZ INC.-SDZ2024GB019550$SANDOZ$$$$$F$Y$$$20240923$$CN$GB$GB
243540381$24354038$1$I$20160501$20240918$20240923$20240923$EXP$$CA-SANDOZ INC.-NVSC2016CA002675$SANDOZ$$47$YR$$F$Y$$$20240923$$CN$CA$CA
243540391$24354039$1$I$$20240918$20240923$20240923$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-19039$IPSEN$$$$$F$Y$$$20240923$$CN$GB$GB
243540401$24354040$1$I$$20240914$20240923$20240923$EXP$$AU-TAKEDA-2024TUS092759$TAKEDA$$$$A$F$Y$$$20240923$$CN$AU$AU
243540411$24354041$1$I$20240101$20240903$20240923$20240923$EXP$$US-SA-2024SA272107$SANOFI AVENTIS$$70$YR$E$M$Y$87.73$KG$20240923$$MD$US$US
243540421$24354042$1$I$$20240816$20240923$20240923$PER$$US-ARDELYX-2024ARDX006317$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243540431$24354043$1$I$$20240816$20240923$20240923$PER$$US-ARDELYX-2024ARDX006318$ARDELYX$$$$$F$Y$$$20240922$$HP$US$US
243540441$24354044$1$I$$20240816$20240923$20240923$PER$$US-ARDELYX-2024ARDX006319$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243540451$24354045$1$I$20240715$20240816$20240923$20240923$PER$$US-ARDELYX-2024ARDX006244$ARDELYX$$53$YR$$M$Y$$$20240922$$CN$US$US
243540461$24354046$1$I$$20240816$20240923$20240923$PER$$US-ARDELYX-2024ARDX006320$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243540471$24354047$1$I$$20240816$20240923$20240923$PER$$US-ARDELYX-2024ARDX006321$ARDELYX$$$$$F$Y$$$20240922$$HP$US$US
243540491$24354049$1$I$$20240816$20240923$20240923$PER$$US-ARDELYX-2024ARDX006322$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243540511$24354051$1$I$$20240821$20240923$20240923$PER$$US-ARDELYX-2024ARDX006355$ARDELYX$$53$YR$$M$Y$$$20240922$$HP$US$US
243540531$24354053$1$I$$20240816$20240923$20240923$PER$$US-ARDELYX-2024ARDX006323$ARDELYX$$$$$M$Y$$$20240922$$HP$US$US
243540541$24354054$1$I$$20240918$20240923$20240923$30DAY$$GB-MYLANLABS-2024M1085454$MYLAN$$$$$M$Y$$$20240923$$CN$GB$GB
243540561$24354056$1$I$20240807$20240822$20240923$20240923$PER$$US-ARDELYX-2024ARDX006356$ARDELYX$$61$YR$$M$Y$78.47$KG$20240923$$CN$US$US
243540571$24354057$1$I$$20240918$20240923$20240923$30DAY$$GB-MYLANLABS-2024M1085365$MYLAN$$$$$$Y$$$20240923$$CN$GB$GB
243540581$24354058$1$I$$20240917$20240923$20240923$EXP$US-MLMSERVICE-20240911-PI187763-00175-5$US-RDY-SPO/USA/24/0013737$DR REDDYS$Weinstein T, Altshuler D, Lafond E, Katz A. Elevated Anti-Xa in the Setting of Prophylactic Unfractionated Subcutaneous Heparin Administration. Journal of pharmacy practice. 2024;37(5):1209-13. DOI: 10.1177/08971900241228951.$89$YR$E$M$Y$76.3$KG$20240923$$PH$US$US
243540591$24354059$1$I$$20240917$20240923$20240923$PER$US-MLMSERVICE-20240910-PI188845-00285-1$US-RDY-SPO/USA/24/0013727$DR REDDYS$Obeidat A, Al-Moussally F, Abdallah W. Successful Treatment of Risperidone-Induced Hypothermia With Aripiprazole: A Brief Case Report and a Literature Review. Cureus. 2024;16(8):e66464. DOI:10.7759/cureus.66464.$68$YR$E$M$Y$$$20240923$$MD$US$US
243540601$24354060$1$I$20240101$20240730$20240923$20240923$EXP$$US-ARDELYX-2024ARDX003088$ARDELYX$$$$$F$Y$92$KG$20240923$$HP$US$US
243540611$24354061$1$I$$20240823$20240923$20240923$PER$$US-ARDELYX-2024ARDX006391$ARDELYX$$$$$M$Y$65$KG$20240923$$CN$US$US
243540621$24354062$1$I$20240821$20240822$20240923$20240923$PER$$US-ARDELYX-2024ARDX006393$ARDELYX$$80$YR$$M$Y$89.36$KG$20240923$$PH$US$US
243540631$24354063$1$I$$20240920$20240923$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US082127$SANDOZ$$$$$$Y$$$20240923$$HP$US$US
243540641$24354064$1$I$20240101$20240827$20240923$20240923$PER$$US-ARDELYX-2024ARDX006546$ARDELYX$$$$$M$Y$$$20240923$$CN$US$US
243540651$24354065$1$I$20240101$20240823$20240923$20240923$PER$$US-ARDELYX-2024ARDX006374$ARDELYX$$$$$F$Y$169$KG$20240923$$CN$US$US
243540661$24354066$1$I$$20240826$20240923$20240923$PER$$US-ARDELYX-2024ARDX006573$ARDELYX$$$$$$Y$$$20240923$$HP$US$US
243540671$24354067$1$I$$20240920$20240923$20240923$EXP$$NVSC2024CA146606$NOVARTIS$$$$$M$Y$$$20240923$$CN$CA$CA
243540681$24354068$1$I$20240604$20240827$20240923$20240923$PER$$US-ARDELYX-2024ARDX006593$ARDELYX$$94$YR$$M$Y$$$20240923$$PH$US$US
243540691$24354069$1$I$20240801$20240909$20240923$20240923$PER$$US-ARDELYX-2024ARDX006548$ARDELYX$$70$YR$$M$Y$$$20240923$$CN$US$US
243540701$24354070$1$I$20240806$20240829$20240923$20240923$PER$$US-ARDELYX-2024ARDX006612$ARDELYX$$39$YR$$M$Y$$$20240923$$CN$US$US
243540711$24354071$1$I$$20240911$20240923$20240923$EXP$$US-Walmart-2161932$WALMART$$$$$M$Y$$$20240923$$$US$US
243540721$24354072$1$I$$20240903$20240923$20240923$PER$$US-ARDELYX-2024ARDX006694$ARDELYX$$$$$M$Y$$$20240923$$HP$US$US
243540731$24354073$1$I$20240630$20240919$20240923$20240923$EXP$$DE-SANDOZ INC.-SDZ2024DE081634$SANDOZ$$58$YR$$M$Y$71$KG$20240923$$MD$DE$DE
243540741$24354074$1$I$20240101$20240916$20240923$20240923$EXP$DK-DKMA-30730650$DK-TEVA-VS-3244002$TEVA$$79$YR$$M$Y$$$20240923$$MD$DK$DK
243540751$24354075$1$I$$20240904$20240923$20240923$PER$$US-ARDELYX-2024ARDX006732$ARDELYX$$$$$$Y$$$20240923$$HP$US$US
243540761$24354076$1$I$20240829$20240829$20240923$20240923$PER$$US-ARDELYX-2024ARDX006615$ARDELYX$$58$YR$$M$Y$$$20240923$$CN$US$US
243540771$24354077$1$I$20240101$20240904$20240923$20240923$PER$$US-ARDELYX-2024ARDX006730$ARDELYX$$$$$M$Y$$$20240923$$HP$US$US
243540781$24354078$1$I$$20240919$20240923$20240923$PER$$US-BIOGEN-2024BI01283457$BIOGEN$$$$$F$Y$$$20240923$$CN$US$US
243540791$24354079$1$I$$20240922$20240923$20240923$DIR$FDA-CDER-CTU-2024-65003$$FDA-CTU$$$$$F$N$$$20240922$N$HP$US$
243540801$24354080$1$I$20240101$20240916$20240923$20240923$EXP$$GB-BIOGEN-2024BI01283111$BIOGEN$$62$YR$$M$Y$$$20240923$$CN$GB$GB
243540811$24354081$1$I$20200901$20240916$20240923$20240923$EXP$$DE-BIOGEN-2020BI00916961$BIOGEN$$33$YR$$F$Y$69$KG$20240923$$CN$DE$DE
243540821$24354082$1$I$$20240919$20240923$20240923$PER$$US-ABBVIE-5932327$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243540842$24354084$2$F$$20240920$20240923$20240925$EXP$$CA-PFIZER INC-202400259721$PFIZER$Shukla, V.. Developmental and epileptic encephalopathies after successful treatment of pediatric ALL: A case series and review of literature. Epileptic Disorders. 2024;1-10$7$YR$$M$Y$$$20240925$$HP$CA$CA
243540852$24354085$2$F$20200101$20240920$20240923$20240925$EXP$$AU-PFIZER INC-202400258565$PFIZER$Poon, J.. Sum of the parts: a cascade of adverse effects. Australian Prescriber. 2024;47(4):125-128$55$YR$$M$Y$$$20240925$$HP$AU$AU
243540861$24354086$1$I$$20240916$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148582$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240923$$CN$US$US
243540871$24354087$1$I$20240911$20240919$20240923$20240923$EXP$$RU-AMERICAN REGENT INC-2024003586$AMERICAN REGENT$$44$YR$$F$Y$62$KG$20240923$$HP$RU$RU
243540881$24354088$1$I$20240516$20240916$20240923$20240923$EXP$$CA-GSK-CA2024115441$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$CA$CA
243540891$24354089$1$I$20240101$20240920$20240923$20240923$PER$$NVSC2024US189022$NOVARTIS$$35$YR$$F$Y$$$20240923$$HP$US$US
243540901$24354090$1$I$$20240916$20240923$20240923$EXP$$AR-TEVA-VS-3245019$TEVA$Soriano D, Santos Chocler G, Varela MA, Coronel MF. Chemotherapy-induced neuropathy and pain in pediatric oncology patients: impact of combination therapies. Eur-J-Pediatr 2024; 183 (9): 3749-3756.; Soriano D, Santos Chocler G, Varela MA, Coronel MF. Chemotherapy-induced neuropathy and pain in pediatric oncology patients: impact of combination therapies. Eur-J-Pediatr 2024; 183 (9): 3749-3756.$$$C$M$Y$$$20240923$$HP$AR$AR
243540911$24354091$1$I$$20240921$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150477$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$79.8$KG$20240923$$CN$US$US
243540921$24354092$1$I$$20240916$20240923$20240923$EXP$$NVSC2024BR102168$NOVARTIS$$$$$F$Y$93$KG$20240923$$CN$BR$BR
243540931$24354093$1$I$$20240916$20240923$20240923$PER$$US-AMGEN-USASP2024185137$AMGEN$$$$$$Y$$$20240923$$MD$US$US
243540941$24354094$1$I$$20240911$20240923$20240923$PER$$US-BEH-2024178731$CSL BEHRING$$$$$$Y$$$20240923$$PH$US$US
243540951$24354095$1$I$$20240920$20240923$20240923$EXP$$ES-INCYTE CORPORATION-2024IN009999$INCYTE$$$$$$Y$$$20240923$$MD$ES$ES
243540961$24354096$1$I$20240701$20240917$20240923$20240923$EXP$AU-ROCHE-10000040490$AU-SANDOZ INC.-SDZ2024AU081437$SANDOZ$$23$YR$$M$Y$$$20240923$$HP$AU$AU
243540971$24354097$1$I$$20240918$20240923$20240923$PER$$US-ROCHE-10000086002$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243540981$24354098$1$I$20240912$20240920$20240923$20240923$EXP$$RU-AMERICAN REGENT INC-2024003604$AMERICAN REGENT$$29$YR$$F$Y$74$KG$20240923$$MD$RU$RU
243540991$24354099$1$I$$20240910$20240923$20240923$EXP$$US-SA-2024SA273281$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240923$$CN$US$US
243541021$24354102$1$I$$20240919$20240923$20240923$EXP$$US-AMGEN-USASP2024188348$AMGEN$Bharat A.; Kurihara C.; Kaiho T. et al.. Contrasting predictors of severe primary graft dysfunction following transplant for chronic and acute respiratory failure. Journal of Thoracic Disease. 2024;16 (8):5050-5062$$$$$Y$$$20240923$$HP$US$US
243541031$24354103$1$I$$20240917$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US081305$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
243541041$24354104$1$I$20230101$20240917$20240923$20240923$EXP$US-MLMSERVICE-20240910-PI188113-00125-1$US-RDY-SPO/USA/24/0013732$DR REDDYS$Gwynn N, Lindenmayer J, Boes T, Pitalo C. Late Recognition of Cholinergic Delirium in Patient on Donepezil Combination Treatment. Journal of Clinical Psychopharmacology. 2024;44(5):521-2. DOI:10.1097/JCP.0000000000001901.$70$YR$E$M$Y$$$20240923$$MD$US$US
243541051$24354105$1$I$$20240912$20240923$20240923$PER$$US-ABBVIE-5925071$ABBVIE$$$$$M$Y$$$20240923$$HP$US$US
243541061$24354106$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187141$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243541071$24354107$1$I$20240701$20240916$20240923$20240923$EXP$$CZ-GSK-CZ2024EME115296$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$CZ$CZ
243541081$24354108$1$I$$20240917$20240923$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US081384$SANDOZ$$$$$$Y$$$20240923$$CN$US$US
243541091$24354109$1$I$$20240919$20240923$20240923$EXP$$US-ABBVIE-5931665$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243541101$24354110$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013960$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240923$$CN$CA$CA
243541111$24354111$1$I$$20240919$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-014236$BAUSCH AND LOMB$$67$YR$$F$Y$$$20240923$$PH$CA$CA
243541121$24354112$1$I$$20240920$20240923$20240923$PER$$US-BAUSCH-BL-2024-014234$BAUSCH AND LOMB$$$$$F$Y$$$20240923$$HP$US$US
243541131$24354113$1$I$20240101$20240919$20240923$20240923$EXP$$US-ABBVIE-5931098$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243541141$24354114$1$I$$20240919$20240923$20240923$EXP$$US-ABBVIE-5931661$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243541151$24354115$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013971$BAUSCH AND LOMB$$57$YR$$F$Y$$$20240923$$CN$CA$CA
243541161$24354116$1$I$20231101$20240921$20240923$20240923$EXP$$DE-BAUSCH-BL-2024-014244$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240923$$MD$DE$DE
243541171$24354117$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013973$BAUSCH AND LOMB$$82$YR$$F$Y$$$20240923$$CN$CA$CA
243541181$24354118$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013979$BAUSCH AND LOMB$$80$YR$$M$Y$$$20240923$$CN$CA$CA
243541191$24354119$1$I$$20240920$20240923$20240923$EXP$$IT-AMERICAN REGENT INC-2024003596$AMERICAN REGENT$$$$A$M$Y$$$20240923$$MD$IT$IT
243541201$24354120$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012821$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243541211$24354121$1$I$20240902$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013364$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240923$$CN$US$US
243541221$24354122$1$I$20240101$20240830$20240923$20240923$PER$$US-SA-2024SA271600$SANOFI AVENTIS$$66$YR$E$M$Y$74.55$KG$20240923$$MD$US$US
243541241$24354124$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013985$BAUSCH AND LOMB$$74$YR$$M$Y$$$20240923$$CN$CA$CA
243541251$24354125$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-014009$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240923$$CN$CA$CA
243541261$24354126$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-014001$BAUSCH AND LOMB$$48$YR$$F$Y$$$20240923$$CN$CA$CA
243541271$24354127$1$I$$20240916$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147670$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240923$$PH$US$US
243541281$24354128$1$I$20230929$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149440$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243541301$24354130$1$I$20240601$20240918$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149262$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$63.5$KG$20240923$$CN$US$US
243541311$24354131$1$I$$20240917$20240923$20240923$EXP$$JP-EXELIXIS-EXL-2024-000375$EXELIXIS$$$$$M$Y$$$20240923$$MD$JP$JP
243541331$24354133$1$I$20060101$20240912$20240923$20240923$EXP$$CH-JNJFOC-A-CH2009-28308$JOHNSON AND JOHNSON$$$$N$F$Y$2.76$KG$20240923$$MD$CH$CH
243541341$24354134$1$I$$20240919$20240923$20240923$PER$$US-BIOVITRUM-2024-US-012348$BIOVITRUM$$68$YR$$F$Y$$$20240923$$CN$US$US
243541351$24354135$1$I$20240701$20240917$20240923$20240923$EXP$$FR-JNJFOC-20240422760$JOHNSON AND JOHNSON$$$$$F$Y$82$KG$20240923$$PH$FR$FR
243541361$24354136$1$I$$20240919$20240923$20240923$EXP$$US-BIOVITRUM-CTI2024US04480$BIOVITRUM$Shih AH, Handa S, Farina KA, Becker M, Kelly B, Yu A, et al. Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights. JCO Precision Oncology. 2024 Jan 31;8: 1-5. doi:doi: 10.1200/PO.23.00234.$70$YR$$F$Y$$$20240923$$MD$US$US
243541371$24354137$1$I$$20240910$20240923$20240923$EXP$$US-BAYER-2024A129665$BAYER$$56$YR$A$M$Y$136.05$KG$20240923$$CN$US$US
243541381$24354138$1$I$20230923$20240916$20240923$20240923$EXP$$CA-GSK-CA2023131678$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$HP$CA$CA
243541391$24354139$1$I$$20240919$20240923$20240923$PER$$US-TAKEDA-2024TUS094067$TAKEDA$$$$A$F$Y$$$20240923$$CN$US$US
243541401$24354140$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002022$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541411$24354141$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002020$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541421$24354142$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002046$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541431$24354143$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002062$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541441$24354144$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002037$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541451$24354145$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002056$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541461$24354146$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002069$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541471$24354147$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002059$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541481$24354148$1$I$20240101$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002008$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541491$24354149$1$I$$20240826$20240923$20240923$PER$$US-SMPA-2024SPA001947$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541511$24354151$1$I$$20240826$20240923$20240923$PER$$US-SMPA-2024SPA001949$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541531$24354153$1$I$20240101$20240827$20240923$20240923$PER$$US-SMPA-2024SPA001993$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541541$24354154$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002033$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541551$24354155$1$I$$20240826$20240923$20240923$PER$$US-SMPA-2024SPA001948$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541561$24354156$1$I$20240826$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002044$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541571$24354157$1$I$20240101$20240827$20240923$20240923$PER$$US-SMPA-2024SPA001996$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541591$24354159$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002064$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541601$24354160$1$I$$20240826$20240923$20240923$PER$$US-SMPA-2024SPA001953$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541611$24354161$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002031$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541621$24354162$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002038$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541631$24354163$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA000852$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541641$24354164$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002142$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541651$24354165$1$I$20240823$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002050$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541661$24354166$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002042$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541681$24354168$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002023$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541691$24354169$1$I$20240101$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002051$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541701$24354170$1$I$$20240826$20240923$20240923$PER$$US-SMPA-2024SPA001955$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541711$24354171$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002045$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541721$24354172$1$I$20240501$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002032$SUNOVION$$$$$$Y$$$20240923$$PH$US$US
243541731$24354173$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002095$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541741$24354174$1$I$20240101$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002054$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541751$24354175$1$I$20240101$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002016$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541761$24354176$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002058$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541771$24354177$1$I$20240101$20240827$20240923$20240923$PER$$US-SMPA-2024SPA001994$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541781$24354178$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024SPA002043$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541791$24354179$1$I$$20240916$20240923$20240923$EXP$$DE-BIOGEN-2018BI00578224$BIOGEN$$38$YR$$M$Y$$$20240923$$HP$US$DE
243541801$24354180$1$I$$20240827$20240923$20240923$PER$$US-SMPA-2024MYSCI0501139$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541821$24354182$1$I$$20240920$20240923$20240923$PER$$US-BIOVITRUM-2024-US-012332$BIOVITRUM$$66$YR$$M$Y$$$20240923$$CN$US$US
243541831$24354183$1$I$$20240913$20240923$20240923$PER$$US-SMPA-2024SPA000673$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541841$24354184$1$I$20240601$20240912$20240923$20240923$PER$$US-SMPA-2024MYSCI0601121$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541851$24354185$1$I$20240417$20240913$20240923$20240923$EXP$FR-AFSSAPS-AVMA2024000383$FR-TEVA-VS-3243641$TEVA$$41$YR$$M$Y$$$20240923$$PH$FR$FR
243541861$24354186$1$I$$20240909$20240923$20240923$PER$$US-SMPA-2024SPA000223$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541871$24354187$1$I$$20240910$20240923$20240923$PER$$US-SMPA-2024MYSCI0300961$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541881$24354188$1$I$20240101$20240916$20240923$20240923$PER$$US-SMPA-2024SPA001008$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541891$24354189$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA000335$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541901$24354190$1$I$20101201$20240921$20240921$20240921$DIR$719316$$FDA-CTU$$54$YR$$F$N$69.75$KG$20240921$N$CN$US$
243541911$24354191$1$I$$20240903$20240923$20240923$PER$$US-SMPA-2024SPA000929$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541931$24354193$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA000206$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541941$24354194$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA000192$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541951$24354195$1$I$$20240830$20240923$20240923$PER$$US-SMPA-2024MYSCI0700449$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243541961$24354196$1$I$20240901$20240920$20240923$20240923$EXP$$US-ABBVIE-5933507$ABBVIE$$1$YR$$M$Y$$$20240923$$CN$US$US
243541971$24354197$1$I$$20240918$20240923$20240923$PER$$US-009507513-2409USA006737$MERCK$$$$$F$Y$87.1$KG$20240923$$CN$US$US
243541981$24354198$1$I$20240101$20240919$20240923$20240923$PER$$AU-Eisai-EC-2024-174989$EISAI$$$$$M$Y$$$20240923$$HP$AU$AU
243541991$24354199$1$I$$20240917$20240923$20240923$EXP$$US-TAKEDA-2024TUS092706$TAKEDA$$$$$F$Y$38.5$KG$20240923$$CN$US$US
243542001$24354200$1$I$20240823$20240916$20240923$20240923$EXP$BE-JNJFOC-20240913166$BE-GSK-BE2024114732$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$BE$BE
243542021$24354202$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268469$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240923$$MD$US$US
243542031$24354203$1$I$20240101$20240917$20240923$20240923$PER$$US-SA-2024SA269563$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240923$$HP$US$US
243542041$24354204$1$I$20240301$20240918$20240923$20240923$EXP$$US-SA-2024SA272994$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240923$$HP$US$US
243542052$24354205$2$F$20220101$20240921$20240923$20240924$EXP$$US-PURDUE PHARMA-USA-2024-0312095$PURDUE$$16$YR$$M$Y$$$20240924$$CN$US$US
243542071$24354207$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-PV202400123296$PFIZER$$$$$F$Y$$$20240923$$CN$US$US
243542081$24354208$1$I$20240901$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260913$PFIZER$$53$YR$$M$Y$$$20240923$$HP$US$US
243542091$24354209$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-PV202400122762$PFIZER$$$$$$Y$$$20240923$$CN$US$US
243542101$24354210$1$I$20240901$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260420$PFIZER$$$$$F$Y$$$20240923$$CN$US$US
243542111$24354211$1$I$20240801$20240919$20240923$20240923$PER$$US-PFIZER INC-202400259993$PFIZER$$$$$F$Y$$$20240923$$HP$US$US
243542131$24354213$1$I$20230109$20240917$20240923$20240923$PER$$US-PFIZER INC-202300015752$PFIZER$$79$YR$$M$Y$$$20240923$$CN$US$US
243542141$24354214$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260752$PFIZER$$$$$$Y$$$20240923$$CN$US$US
243542151$24354215$1$I$20240920$20240919$20240923$20240923$PER$$US-PFIZER INC-202400259971$PFIZER$$82$YR$$F$Y$106.59$KG$20240923$$CN$US$US
243542161$24354216$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-202400260381$PFIZER$$50$YR$$F$Y$$$20240923$$HP$US$US
243542171$24354217$1$I$20240918$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260484$PFIZER$$41$YR$$F$Y$$$20240923$$CN$US$US
243542181$24354218$1$I$20240101$20240919$20240923$20240923$PER$$US-PFIZER INC-202400087880$PFIZER$$48$YR$$F$Y$$$20240923$$HP$US$US
243542191$24354219$1$I$20240101$20240919$20240923$20240923$PER$$US-PFIZER INC-PV202400123498$PFIZER$$44$YR$$F$Y$$$20240923$$HP$US$US
243542201$24354220$1$I$20240501$20240917$20240923$20240923$PER$$US-PFIZER INC-202400191371$PFIZER$$50$YR$$F$Y$$$20240923$$HP$US$US
243542211$24354221$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260325$PFIZER$$$$$$Y$$$20240923$$CN$US$US
243542221$24354222$1$I$20240101$20240918$20240923$20240923$PER$$US-PFIZER INC-PV202400122837$PFIZER$$64$YR$$M$Y$$$20240923$$HP$US$US
243542231$24354223$1$I$20240101$20240919$20240923$20240923$PER$$US-PFIZER INC-PV202400123510$PFIZER$$64$YR$$M$Y$$$20240923$$HP$US$US
243542241$24354224$1$I$20240801$20240918$20240923$20240923$PER$$US-PFIZER INC-202400260021$PFIZER$$$$$F$Y$$$20240923$$MD$US$US
243542261$24354226$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-PV202400123508$PFIZER$$$$A$F$Y$$$20240923$$CN$US$US
243542271$24354227$1$I$20240919$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260435$PFIZER$$58$YR$$F$Y$$$20240923$$CN$US$US
243542301$24354230$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260443$PFIZER$$73$YR$$F$Y$$$20240923$$CN$US$US
243542311$24354231$1$I$$20240917$20240923$20240923$PER$$US-PFIZER INC-PV202400122773$PFIZER$$77$YR$$M$Y$$$20240923$$MD$US$US
243542321$24354232$1$I$20240915$20240917$20240923$20240923$PER$$US-PFIZER INC-202400258531$PFIZER$$66$YR$$F$Y$56.236$KG$20240923$$CN$US$US
243542331$24354233$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-PV202400108781$PFIZER$$68$YR$$F$Y$$$20240923$$MD$US$US
243542341$24354234$1$I$20240909$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260901$PFIZER$$21$YR$$M$Y$$$20240923$$HP$US$US
243542351$24354235$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260013$PFIZER$$$$$F$Y$$$20240923$$HP$US$US
243542361$24354236$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400202410$PFIZER$$72$YR$$F$Y$$$20240923$$CN$US$US
243542371$24354237$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260070$PFIZER$$76$YR$$F$Y$$$20240923$$CN$US$US
243542381$24354238$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-202400260139$PFIZER$$70$YR$$F$Y$$$20240923$$MD$US$US
243542391$24354239$1$I$20240101$20240919$20240923$20240923$PER$$US-PFIZER INC-PV202400123253$PFIZER$$18$YR$$F$Y$$$20240923$$HP$US$US
243542401$24354240$1$I$20240101$20240919$20240923$20240923$PER$$US-PFIZER INC-PV202400123259$PFIZER$$53$YR$$M$Y$$$20240923$$HP$US$US
243542411$24354241$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260799$PFIZER$$$$$$Y$$$20240923$$HP$US$US
243542431$24354243$1$I$$20240917$20240923$20240923$PER$$US-PFIZER INC-202400258737$PFIZER$$$$$F$Y$$$20240923$$MD$US$US
243542441$24354244$1$I$20240801$20240918$20240923$20240923$PER$$US-PFIZER INC-202400259628$PFIZER$$86$YR$$F$Y$61.224$KG$20240923$$CN$US$US
243542451$24354245$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-PV202400109154$PFIZER$$84$YR$$F$Y$$$20240923$$MD$US$US
243542472$24354247$2$F$$20240919$20240923$20240924$PER$$US-PFIZER INC-PV202400122202$PFIZER$$96$YR$$M$Y$69.4$KG$20240924$$MD$US$US
243542481$24354248$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260877$PFIZER$$54$YR$$F$Y$$$20240923$$HP$US$US
243542491$24354249$1$I$$20240917$20240923$20240923$PER$$US-PFIZER INC-202400258763$PFIZER$$81$YR$$F$Y$$$20240923$$CN$US$US
243542501$24354250$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260887$PFIZER$$66$YR$$F$Y$$$20240923$$HP$US$US
243542511$24354251$1$I$20240901$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260891$PFIZER$$57$YR$$F$Y$$$20240923$$HP$US$US
243542521$24354252$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260875$PFIZER$$66$YR$$F$Y$$$20240923$$HP$US$US
243542531$24354253$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-202400259502$PFIZER$$48$YR$$M$Y$$$20240923$$MD$US$US
243542541$24354254$1$I$20240501$20240919$20240923$20240923$PER$$US-PFIZER INC-PV202400100298$PFIZER$$58$YR$$F$Y$$$20240923$$HP$US$US
243542551$24354255$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-PV202400122701$PFIZER$$$$$$Y$$$20240923$$CN$US$US
243542562$24354256$2$F$$20240918$20240923$20240924$PER$$US-PFIZER INC-PV202400122700$PFIZER$$51$YR$$F$Y$$$20240924$$CN$US$US
243542571$24354257$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-PV202400122707$PFIZER$$67$YR$$M$Y$73.03$KG$20240923$$CN$US$US
243542581$24354258$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-PV202400122959$PFIZER$$18$YR$$F$Y$$$20240923$$CN$US$US
243542591$24354259$1$I$$20240919$20240923$20240923$PER$$US-PFIZER INC-202400260442$PFIZER$$65$YR$$F$Y$$$20240923$$CN$US$US
243542601$24354260$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-PV202400056077$PFIZER$$72$YR$$F$Y$$$20240923$$CN$US$US
243542611$24354261$1$I$20240729$20240911$20240923$20240923$PER$$US-PFIZER INC-202400259094$PFIZER$$81$YR$$F$Y$$$20240923$$HP$US$US
243542631$24354263$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-202400259736$PFIZER$$29$YR$$F$Y$$$20240923$$CN$US$US
243542641$24354264$1$I$20240101$20240919$20240923$20240923$PER$$US-PFIZER INC-PV202400123459$PFIZER$$48$YR$$M$Y$$$20240923$$HP$US$US
243542651$24354265$1$I$$20240918$20240923$20240923$PER$$US-PFIZER INC-202400260195$PFIZER$$64$YR$$M$Y$$$20240923$$HP$US$US
243542661$24354266$1$I$20231113$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149463$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243542671$24354267$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150383$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$59.42$KG$20240923$$CN$US$US
243542681$24354268$1$I$20240101$20240905$20240923$20240923$PER$$US-SA-2024SA273032$SANOFI AVENTIS$$24$YR$A$M$Y$65.91$KG$20240923$$MD$US$US
243542691$24354269$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270578$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240923$$MD$US$US
243542701$24354270$1$I$20240910$20240916$20240923$20240923$EXP$$CO-JNJFOC-20240951437$JOHNSON AND JOHNSON$$77$YR$E$M$Y$70$KG$20240923$$HP$CO$CO
243542721$24354272$1$I$20240703$20240922$20240922$20240922$DIR$719388$$FDA-CTU$$72$YR$$F$N$56.7$KG$20240922$N$HP$US$
243542731$24354273$1$I$$20240916$20240923$20240923$EXP$$AR-GSK-AR2024AMR115870$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$AR$AR
243542741$24354274$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189232$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243542752$24354275$2$F$$20240924$20240923$20240926$EXP$$NVSC2024US187724$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
243542761$24354276$1$I$20240910$20240916$20240923$20240923$PER$$US-ABBVIE-5928241$ABBVIE$$38$YR$$F$Y$$$20240923$$MD$US$US
243542771$24354277$1$I$$20240919$20240923$20240923$PER$$US-ABBVIE-5934009$ABBVIE$$$$$F$Y$$$20240923$$MD$US$US
243542781$24354278$1$I$$20240918$20240923$20240923$EXP$$JP-009507513-2409JPN002915J$MERCK$$78$YR$$M$Y$$$20240923$$MD$JP$JP
243542791$24354279$1$I$20240509$20240913$20240923$20240923$EXP$$GB-TEVA-VS-3243697$TEVA$$85$YR$$F$Y$$$20240923$$MD$GB$GB
243542801$24354280$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189256$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243542811$24354281$1$I$$20240923$20240923$20240923$EXP$$BE-GILEAD-2024-0688585$GILEAD$$$$$$Y$$$20240923$$CN$BE$BE
243542821$24354282$1$I$20240101$20240919$20240923$20240923$EXP$$DE-MYLANLABS-2024M1085391$MYLAN$$$$$M$Y$$$20240923$$MD$DE$DE
243542831$24354283$1$I$$20240920$20240923$20240923$EXP$$CA-GILEAD-2024-0688514$GILEAD$$54$YR$A$M$Y$$$20240923$$HP$CA$CA
243542841$24354284$1$I$20240909$20240920$20240923$20240923$EXP$$NVSC2024CN188932$NOVARTIS$$73$YR$$F$Y$55$KG$20240923$$HP$CN$CN
243542851$24354285$1$I$20240418$20240913$20240923$20240923$EXP$FR-AFSSAPS-AVMA2024000384$FR-TEVA-VS-3243924$TEVA$$37$YR$$F$Y$$$20240923$$PH$FR$FR
243542861$24354286$1$I$20240920$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013513$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240923$$CN$US$US
243542871$24354287$1$I$20240909$20240912$20240923$20240923$EXP$$US-ORGANON-O2409USA000976$ORGANON$$71$YR$$M$Y$$$20240923$$CN$US$US
243542881$24354288$1$I$20231001$20240913$20240923$20240923$EXP$GB-MHRA-MED-202409081235422870-CVGBF$GB-TEVA-VS-3243824$TEVA$$85$YR$$F$Y$80$KG$20240923$$PH$GB$GB
243542891$24354289$1$I$20240601$20240913$20240923$20240923$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18616$IPSEN$$77$YR$E$F$Y$$$20240923$$HP$US$US
243542901$24354290$1$I$$20240918$20240923$20240923$EXP$$DE-009507513-2409DEU007398$MERCK$$$$E$F$Y$$$20240923$$CN$DE$DE
243542911$24354291$1$I$$20240918$20240923$20240923$EXP$$JP-009507513-2409JPN002917J$MERCK$$54$YR$$M$Y$$$20240923$$MD$JP$JP
243542921$24354292$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150552$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$47.63$KG$20240923$$CN$US$US
243542931$24354293$1$I$20240815$20240912$20240923$20240923$EXP$CN-NMPACDR-3301091036826202400583$CN-BAXTER-2024BAX024711$BAXTER$$50$YR$$F$Y$68$KG$20240923$$MD$CN$CN
243542941$24354294$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187144$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243542951$24354295$1$I$$20240909$20240923$20240923$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09102$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240923$$MD$US$US
243542961$24354296$1$I$20240801$20240918$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US081332$SANDOZ$$$$$$Y$$$20240923$$HP$US$US
243542971$24354297$1$I$$20240919$20240923$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA081810$SANDOZ$$43$YR$$M$Y$$$20240923$$HP$CA$CA
243542981$24354298$1$I$$20240919$20240923$20240923$EXP$$JP-OTSUKA-2024_026162$OTSUKA$$4$DEC$$F$Y$$$20240923$$MD$JP$JP
243543001$24354300$1$I$$20240917$20240923$20240923$PER$$US-SA-2024SA270522$SANOFI AVENTIS$$17$YR$T$F$Y$56.7$KG$20240923$$MD$US$US
243543012$24354301$2$F$20240911$20240913$20240923$20240927$PER$$US-SA-2024SA267447$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240927$$MD$US$US
243543021$24354302$1$I$20240801$20240828$20240923$20240923$PER$$US-SA-2024SA272595$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240923$$HP$US$US
243543031$24354303$1$I$$20240913$20240923$20240923$PER$$US-SA-2024SA274141$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240923$$CN$US$US
243543042$24354304$2$F$$20240923$20240923$20240924$PER$$US-JNJFOC-20240960513$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243543051$24354305$1$I$20240501$20240912$20240923$20240923$PER$$US-JNJFOC-20240932012$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$CN$US$US
243543061$24354306$1$I$20210625$20240912$20240923$20240923$EXP$$DE-BAXTER-2024BAX024676$BAXTER$$$$$F$Y$$$20240923$$MD$DE$DE
243543081$24354308$1$I$$20240912$20240923$20240923$PER$$US-ROCHE-10000084469$ROCHE$$6$YR$C$$Y$$$20240923$$HP$US$US
243543091$24354309$1$I$20240302$20240916$20240923$20240923$EXP$$TW-GSK-TW2024APC115770$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$TW$TW
243543111$24354311$1$I$$20240917$20240923$20240923$EXP$$DZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051887$BOEHRINGER INGELHEIM$$40$YR$A$F$Y$$$20240923$$MD$DZ$DZ
243543121$24354312$1$I$$20240913$20240923$20240923$PER$$US-ROCHE-10000085215$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243543131$24354313$1$I$20230101$20240910$20240923$20240923$EXP$$GR-PERRIGO-24GR008676$PERRIGO$Kalfoutzou A, Petroulakis P, Tsiouri E, Fafoutis T, Mylonakis A, Dimitrakoudi M, et al. Ibuprofen: The Hidden Culprit Behind Aseptic Meningitis. Cureus. 2024;16(8):e65936. DOI: 10.7759/cureus.65936.$53$YR$$M$Y$$$20240923$$MD$GR$GR
243543142$24354314$2$F$$20240918$20240923$20240926$EXP$$US-SANDOZ INC.-NVSC2022US237157$SANDOZ$$$$$F$Y$$$20240926$$CN$US$US
243543151$24354315$1$I$$20240916$20240923$20240923$EXP$$CA-GSK-CA2024115496$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$CA$CA
243543161$24354316$1$I$20240911$20240917$20240923$20240923$PER$$US-BAYER-2024A132660$BAYER$$37$YR$A$M$Y$$$20240923$$CN$US$US
243543171$24354317$1$I$$20240917$20240923$20240923$PER$$US-ROCHE-10000086764$ROCHE$$$$A$F$Y$$$20240923$$CN$US$US
243543181$24354318$1$I$20240920$20240922$20240922$20240922$DIR$719393$$FDA-CTU$$94$YR$$M$N$65.25$KG$20240922$N$HP$US$
243543191$24354319$1$I$$20240916$20240923$20240923$EXP$$DE-INCYTE CORPORATION-2024IN010000$INCYTE$$$$$$Y$$$20240923$$CN$DE$DE
243543201$24354320$1$I$$20240918$20240923$20240923$PER$$US-ROCHE-10000086056$ROCHE$$58$YR$A$F$Y$$$20240923$$CN$US$US
243543211$24354321$1$I$20240914$20240917$20240923$20240923$PER$$US-ROCHE-10000085789$ROCHE$$14$YR$T$F$Y$$$20240923$$CN$US$US
243543221$24354322$1$I$$20240917$20240923$20240923$EXP$$CA-ROCHE-10000084843$ROCHE$$50$YR$A$F$Y$68$KG$20240923$$HP$CA$CA
243543241$24354324$1$I$20240101$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150049$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240923$$CN$US$US
243543251$24354325$1$I$20240901$20240920$20240923$20240923$EXP$$IL-AMERICAN REGENT INC-2024003606$AMERICAN REGENT$$15$YR$$F$Y$$$20240923$$PH$IL$IL
243543261$24354326$1$I$$20240916$20240923$20240923$EXP$$US-INCYTE CORPORATION-2024IN010009$INCYTE$Ritter A, Kensey N, Higgs J, Zainah H.. Cavitary lung lesions caused by Pneumocystis jirovecii in a patient with myelofibrosis on ruxolitinib.. BMJ CASE REPORTS. 2024;17:e258468:1-5$$$$$Y$$$20240923$$HP$US$US
243543282$24354328$2$F$$20240919$20240923$20240926$EXP$$IN-VANTIVE-2024VAN019862$Vantive US Healthcare$$52$YR$$F$Y$$$20240926$$CN$IN$IN
243543291$24354329$1$I$$20240917$20240923$20240923$EXP$$IN-VANTIVE-2024VAN019891$Vantive US Healthcare$$65$YR$$M$Y$$$20240923$$CN$IN$IN
243543301$24354330$1$I$$20240911$20240923$20240923$PER$$US-ABBVIE-5923970$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243543321$24354332$1$I$$20240918$20240923$20240923$PER$$US-ROCHE-10000086143$ROCHE$$72$YR$E$F$Y$$$20240923$$CN$US$US
243543341$24354334$1$I$20240828$20240919$20240923$20240923$EXP$FR-AFSSAPS-RS2024000863$FR-GSK-FR2024116485$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$MD$FR$FR
243543352$24354335$2$F$20240911$20240920$20240923$20240926$PER$$US-AMGEN-USASP2024182025$AMGEN$$64$YR$A$F$Y$65$KG$20240926$$PH$US$US
243543361$24354336$1$I$$20240916$20240923$20240923$PER$$US-AMGEN-USASP2024185792$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243543371$24354337$1$I$$20240916$20240923$20240923$EXP$$GB-JNJFOC-20240954724$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240923$$PH$GB$GB
243543381$24354338$1$I$20230209$20240914$20240923$20240923$EXP$$IN-INCYTE CORPORATION-2023IN007291$INCYTE$$$$$$Y$$$20240923$$CN$IN$IN
243543392$24354339$2$F$20240916$20240919$20240923$20240927$PER$$US-ROCHE-10000088137$ROCHE$$84$YR$E$F$Y$$$20240927$$CN$US$US
243543401$24354340$1$I$20240125$20240916$20240923$20240923$EXP$IT-MINISAL02-1001580$IT-TEVA-VS-3244340$TEVA$$58$YR$$F$Y$$$20240923$$MD$IT$IT
243543411$24354341$1$I$$20240917$20240923$20240923$EXP$$FR-MYLANLABS-2024M1085174$MYLAN$$75$YR$$M$Y$$$20240923$$MD$FR$FR
243543421$24354342$1$I$20240801$20240917$20240923$20240923$EXP$FR-AFSSAPS-AVTO2024000128$FR-MYLANLABS-2024M1085707$MYLAN$$16$YR$$F$Y$$$20240923$$MD$FR$FR
243543431$24354343$1$I$$20240917$20240923$20240923$EXP$$KR-MYLANLABS-2024M1085686$MYLAN$Punsalan MTS, Kim J-M, Kang DW. Recurrent cerebral infarction due to carotid atherosclerosis and cardioembolism during dual antiplatelet treatment: a case report. Neurol-Sci 2023; 44 4121-4123.$80$YR$$M$Y$$$20240923$$HP$KR$KR
243543451$24354345$1$I$20240727$20240920$20240923$20240923$EXP$$RU-AMERICAN REGENT INC-2024003605$AMERICAN REGENT$$20$YR$$F$Y$55$KG$20240923$$MD$RU$RU
243543462$24354346$2$F$$20240919$20240923$20240923$EXP$$US-ROCHE-10000087604$ROCHE$$80$YR$E$M$Y$$$20240923$$HP$US$US
243543471$24354347$1$I$$20240917$20240923$20240923$EXP$$US-INCYTE CORPORATION-2024IN009852$INCYTE$$$$$$Y$$$20240923$$CN$US$US
243543482$24354348$2$F$$20240924$20240923$20240925$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052776$BOEHRINGER INGELHEIM$$40$YR$A$F$Y$$$20240926$$MD$PL$PL
243543491$24354349$1$I$20210801$20240916$20240923$20240923$EXP$$NVSC2022EG034147$NOVARTIS$$70$YR$$F$Y$85$KG$20240923$$CN$EG$EG
243543501$24354350$1$I$$20240919$20240923$20240923$EXP$$US-Taiho Oncology Inc-2024-007735$TAIHO ONCOLOGY INC$$52$YR$A$M$Y$$$20240923$$CN$US$US
243543521$24354352$1$I$$20240913$20240923$20240923$EXP$$RU-ROCHE-10000083193$ROCHE$$$$A$F$Y$$$20240923$$MD$RU$RU
243543531$24354353$1$I$20240907$20240921$20240923$20240923$EXP$FR-AFSSAPS-TO2024001762$FR-BAUSCH-BL-2024-014242$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240923$$MD$FR$FR
243543541$24354354$1$I$$20240912$20240923$20240923$PER$$US-JNJFOC-20240933339$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243543551$24354355$1$I$20240916$20240917$20240923$20240923$EXP$$FR-FERRINGPH-2024FE05299$FERRING$$$$$$Y$$$20240923$$MD$FR$FR
243543561$24354356$1$I$20240619$20240917$20240923$20240923$EXP$$JP-FERRINGPH-2024FE04658$FERRING$$$$$$Y$$$20240923$$HP$JP$JP
243543571$24354357$1$I$20240101$20240918$20240923$20240923$EXP$$US-FERRINGPH-2024FE05311$FERRING$$$$$$Y$$$20240923$$HP$US$US
243543581$24354358$1$I$$20240911$20240923$20240923$EXP$$US-BIOGEN-2024BI01282342$BIOGEN$$$$$F$Y$$$20240923$$HP$US$US
243543591$24354359$1$I$$20240911$20240923$20240923$EXP$$US-BIOGEN-2024BI01282340$BIOGEN$$$$$F$Y$$$20240923$$HP$US$US
243543621$24354362$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012503$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240923$$CN$US$US
243543631$24354363$1$I$$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013790$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240923$$CN$US$US
243543643$24354364$3$F$$20240923$20240923$20240924$PER$$NVSC2024US189204$NOVARTIS$$$$$F$Y$$$20240925$$HP$US$US
243543651$24354365$1$I$$20240919$20240923$20240923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-150348$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240923$$PH$JP$JP
243543661$24354366$1$I$$20240916$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148163$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240923$$HP$US$US
243543671$24354367$1$I$20240101$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149947$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240923$$CN$US$US
243543681$24354368$1$I$20240821$20240916$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148110$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$93$KG$20240923$$PH$US$US
243543691$24354369$1$I$20240101$20240920$20240923$20240923$PER$$US-JNJFOC-20240956815$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243543701$24354370$1$I$$20240913$20240923$20240923$EXP$$US-BIOGEN-2024BI01282737$BIOGEN$$$$$F$Y$$$20240923$$HP$US$US
243543711$24354371$1$I$20240101$20240918$20240923$20240923$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-126238$REGENERON$$$$$F$Y$$$20240923$$HP$US$US
243543721$24354372$1$I$20240918$20240919$20240923$20240923$EXP$$US-KYOWAKIRIN-2024KK021741$KYOWA$$$$$$Y$$$20240923$$HP$US$US
243543731$24354373$1$I$20240705$20240920$20240923$20240923$EXP$GB-MHRA-MED-202409171353166980-SJGRP$GB-GSK-GB2024116922$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$PH$GB$GB
243543741$24354374$1$I$$20240919$20240923$20240923$EXP$FR-AFSSAPS-AN2024001269$FR-MYLANLABS-2024M1085345$MYLAN$$29$YR$$F$Y$79$KG$20240923$$MD$FR$FR
243543751$24354375$1$I$20240901$20240911$20240923$20240923$EXP$$US-BIOGEN-2024BI01282482$BIOGEN$$32$YR$$F$Y$$$20240923$$HP$US$US
243543771$24354377$1$I$$20240919$20240923$20240923$EXP$$RO-TAKEDA-2024TUS093933$TAKEDA$$73$YR$$M$Y$$$20240923$$HP$RO$RO
243543781$24354378$1$I$$20240917$20240923$20240923$EXP$$IQ-ROCHE-10000087120$ROCHE$$61$YR$A$$Y$$$20240923$$MD$IQ$IQ
243543791$24354379$1$I$20230501$20240916$20240923$20240923$EXP$$NVSC2024RO187314$NOVARTIS$$67$YR$$M$Y$$$20240923$$MD$RO$RO
243543801$24354380$1$I$20240710$20240918$20240923$20240923$EXP$$NVSC2024CN188104$NOVARTIS$$54$YR$$F$Y$64$KG$20240923$$MD$CN$CN
243543811$24354381$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268424$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240923$$MD$US$US
243543821$24354382$1$I$20240908$20240908$20240923$20240923$PER$$US-RDY-SPO/USA/24/0013357$DR REDDYS$$$$$$Y$$$20240923$$CN$US$US
243543841$24354384$1$I$20240911$20240913$20240923$20240923$EXP$GB-MHRA-MED-202409131532497230-DCHYK$GB-NOVOPROD-1283966$NOVO NORDISK$$30$YR$$M$Y$$$20240923$$MD$GB$GB
243543851$24354385$1$I$$20240909$20240923$20240923$EXP$$JP-NOVOPROD-1284212$NOVO NORDISK$Yuki Tsuchida , et al.. Early diagnosis of euDKA was difficult in a patient with type II diabetes mellitus, who was orally taking an SGLT2 inhibitor and self-discontinued insulin therapy. 695th Kanto Regional Meeting of Japanese Society of Internal Medicine$64$YR$$F$Y$$$20240923$$MD$JP$JP
243543861$24354386$1$I$$20240916$20240923$20240923$PER$$US-AMGEN-USASP2024185801$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243543881$24354388$1$I$$20240923$20240923$20240923$DIR$719431$$FDA-CTU$$$$$UNK$N$$$20240923$N$CN$US$
243543891$24354389$1$I$$20240902$20240923$20240923$PER$$AU-TOLMAR, INC.-24AU052328$TOLMAR$$$$$M$Y$$$20240923$$CN$AU$AU
243543901$24354390$1$I$$20240902$20240923$20240923$PER$$AU-TOLMAR, INC.-24AU052362$TOLMAR$$$$$M$Y$$$20240923$$CN$AU$AU
243543911$24354391$1$I$$20240903$20240923$20240923$PER$$AU-TOLMAR, INC.-24AU052384$TOLMAR$$$$$M$Y$$$20240923$$CN$AU$AU
243543921$24354392$1$I$20240902$20240902$20240923$20240923$PER$$BR-TOLMAR, INC.-24BR052345$TOLMAR$$11$YR$$F$Y$$$20240923$$CN$BR$BR
243543931$24354393$1$I$$20240903$20240923$20240923$PER$$AU-TOLMAR, INC.-24AU052385$TOLMAR$$$$$M$Y$$$20240923$$CN$AU$AU
243543942$24354394$2$F$$20240912$20240923$20240923$EXP$$US-ASTELLAS-2024-AER-006821$ASTELLAS$$60$YR$A$F$Y$$$20240923$$MD$US$US
243543961$24354396$1$I$$20240911$20240923$20240923$EXP$$FR-TAKEDA-2024TUS092747$TAKEDA$$$$E$F$Y$$$20240923$$CN$FR$FR
243543971$24354397$1$I$$20240913$20240923$20240923$30DAY$$FI-MYLANLABS-2024M1084619$MYLAN$$$$$$Y$$$20240923$$CN$FI$FI
243543982$24354398$2$F$$20240918$20240923$20240923$EXP$$US-ROCHE-10000086123$ROCHE$$$$$F$Y$$$20240923$$MD$US$US
243543992$24354399$2$F$$20240920$20240923$20240927$EXP$$CA-TAKEDA-2024TUS093671$TAKEDA$$$$$M$Y$$$20240927$$MD$CA$CA
243544001$24354400$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150424$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240923$$CN$US$US
243544011$24354401$1$I$$20240920$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150426$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240923$$MD$US$US
243544022$24354402$2$F$$20240926$20240923$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150400$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$72.12$KG$20240927$$CN$US$US
243544031$24354403$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150380$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240923$$HP$US$US
243544041$24354404$1$I$20240101$20240918$20240923$20240923$EXP$$CA-PFIZER INC-202400256391$PFIZER$$83$YR$$M$Y$$$20240923$$MD$CA$CA
243544051$24354405$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010510$APOTEX$$80$YR$$F$Y$$$20240923$$CN$CA$CA
243544061$24354406$1$I$20240825$20240919$20240923$20240923$EXP$GB-MHRA-MED-202409161541022990-LWNFY$GB-PFIZER INC-202400259755$PFIZER$$41$YR$$F$Y$121$KG$20240923$$MD$GB$GB
243544072$24354407$2$F$20240801$20240925$20240923$20240930$EXP$$CA-PFIZER INC-202400250303$PFIZER$$66$YR$$F$Y$$$20240930$$HP$CA$CA
243544081$24354408$1$I$20240101$20240918$20240923$20240923$EXP$$JP-009507513-2409JPN002863J$MERCK$$84$YR$$M$Y$$$20240923$$MD$JP$JP
243544091$24354409$1$I$20240907$20240923$20240923$20240923$PER$$US-BAYER-2024A135516$BAYER$$47$YR$A$F$Y$$$20240923$$MD$US$US
243544101$24354410$1$I$20240701$20240916$20240923$20240923$EXP$$AU-GSK-AU2024APC114681$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$HP$AU$AU
243544111$24354411$1$I$20240918$20240920$20240923$20240923$PER$$US-BAYER-2024A134847$BAYER$$95$YR$E$F$Y$$$20240923$$CN$US$US
243544121$24354412$1$I$$20240919$20240923$20240923$EXP$$DE-PURDUE-USA-2024-0311968$PURDUE$Jahn F., Kuch M., Meyer S.. Coffee party with unexpected consequences: A rare cause of fever-associated status epilepticus in a toddler- A case report. Monatsschr Kinderheilkd. 2024$20$MON$$M$Y$$$20240923$$MD$DE$DE
243544131$24354413$1$I$20211001$20240919$20240923$20240923$EXP$$FR-PURDUE-USA-2024-0312111$PURDUE$$26$YR$$M$Y$$$20240923$$HP$FR$FR
243544151$24354415$1$I$$20240916$20240923$20240923$EXP$$DE-ABBVIE-5929809$ABBVIE$$20$YR$$M$Y$$$20240923$$MD$DE$DE
243544161$24354416$1$I$$20240917$20240923$20240923$EXP$$US-PURDUE-USA-2024-0312071$PURDUE$Hicks K, Graf J, Zafar S, Waguespack SG.. Case 3: Psychiatric Distress, Hypertension, and Weight Gain in an Adolescent Male. Pediatrics in Review. 2024;45(9):513- 517$14$YR$$M$Y$101.5$KG$20240923$$MD$US$US
243544171$24354417$1$I$$20240920$20240923$20240923$EXP$NL-LRB-01000148$NVSC2024NL188158$NOVARTIS$$50$YR$$F$Y$$$20240923$$PH$NL$NL
243544182$24354418$2$F$20240701$20240924$20240923$20240926$EXP$$NVSC2024SK188174$NOVARTIS$$$$A$M$Y$$$20240926$$MD$SK$SK
243544191$24354419$1$I$$20240916$20240923$20240923$EXP$GB-MHRA-MED-202409142302073110-RQNDG$GB-OTSUKA-2024_025908$OTSUKA$$29$YR$$F$Y$$$20240923$$CN$GB$GB
243544201$24354420$1$I$$20240917$20240923$20240923$EXP$$NVSC2024GB186466$NOVARTIS$$$$A$F$Y$$$20240923$$CN$GB$GB
243544211$24354421$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268749$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240923$$HP$US$US
243544241$24354424$1$I$20240913$20240919$20240923$20240923$EXP$$CN-PFIZER INC-PV202400123023$PFIZER$$2$YR$$M$Y$14.4$KG$20240923$$HP$CN$CN
243544251$24354425$1$I$20240101$20240919$20240923$20240923$EXP$$AE-PFIZER INC-PV202400122805$PFIZER$$48$YR$$F$Y$$$20240923$$MD$AE$AE
243544262$24354426$2$F$20230525$20240924$20240923$20240926$EXP$$US-PFIZER INC-2023SGN07375$PFIZER$$$$$F$Y$$$20240926$$MD$US$US
243544271$24354427$1$I$20240828$20240917$20240923$20240923$EXP$$CN-ASTELLAS-2024-AER-007360$ASTELLAS$$73$YR$E$F$Y$49$KG$20240923$$HP$CN$CN
243544281$24354428$1$I$$20240917$20240923$20240923$EXP$$AU-RDY-SPO/AUS/24/0013770$DR REDDYS$$54$YR$A$F$Y$$$20240923$$CN$AU$AU
243544291$24354429$1$I$$20240913$20240923$20240923$PER$$US-RDY-SPO/USA/24/0013697$DR REDDYS$$25$YR$A$F$Y$$$20240923$$MD$US$US
243544301$24354430$1$I$20240906$20240911$20240923$20240923$EXP$GB-MHRA-MED-202409111640291450-QHKWR$GB-ETHYPHARM-2024002462$ETHYPHARM$$$$$$Y$$$20240920$$HP$GB$
243544311$24354431$1$I$20240524$20240913$20240923$20240923$EXP$EU-AFSSAPS-AVCN2024000682$EU-ETHYPHARM-2024002484$ETHYPHARM$$$$$$Y$$$20240920$$MD$EU$EU
243544322$24354432$2$F$$20240924$20240923$20240925$EXP$$MA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052628$BOEHRINGER INGELHEIM$$$$E$M$Y$$$20240925$$HP$MA$MA
243544331$24354433$1$I$20240824$20240916$20240923$20240923$EXP$$CN-OTSUKA-2024_025952$OTSUKA$$77$YR$$F$Y$62$KG$20240923$$HP$CN$CN
243544341$24354434$1$I$20221201$20240918$20240923$20240923$EXP$$NVSC2024AU187622$NOVARTIS$$58$YR$$F$Y$$$20240923$$MD$AU$AU
243544351$24354435$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189231$NOVARTIS$$$$$M$Y$$$20240923$$CN$US$US
243544361$24354436$1$I$20240911$20240913$20240923$20240923$PER$$US-GSK-US2024114359$GLAXOSMITHKLINE$$85$YR$$F$Y$$$20240923$$CN$US$US
243544371$24354437$1$I$20240423$20240918$20240923$20240923$EXP$NL-LRB-01003223$NL-MYLANLABS-2024M1085007$MYLAN$$72$YR$$M$Y$70$KG$20240923$$PH$NL$NL
243544381$24354438$1$I$20240324$20240918$20240923$20240923$EXP$FR-AFSSAPS-TO2024001731$FR-MYLANLABS-2024M1084972$MYLAN$$75$YR$$M$Y$$$20240923$$PH$FR$FR
243544391$24354439$1$I$$20240918$20240923$20240923$EXP$$US-MYLANLABS-2024M1085612$MYLAN$$$$$M$Y$$$20240923$$MD$US$US
243544401$24354440$1$I$20230601$20240918$20240923$20240923$EXP$$NO-MYLANLABS-2024M1085856$MYLAN$$85$YR$$F$Y$$$20240923$$MD$NO$NO
243544411$24354441$1$I$20230101$20240918$20240923$20240923$EXP$$DE-MYLANLABS-2024M1085449$MYLAN$$$$$F$Y$$$20240923$$CN$DE$DE
243544421$24354442$1$I$20220701$20240920$20240923$20240923$EXP$$US-GILEAD-2024-0688511$GILEAD$$38$YR$A$M$Y$$$20240923$$CN$US$US
243544431$24354443$1$I$20230331$20240918$20240923$20240923$EXP$FR-AFSSAPS-AN2024001256$FR-MYLANLABS-2024M1085151$MYLAN$$81$YR$$F$Y$$$20240923$$PH$FR$FR
243544441$24354444$1$I$20240507$20240918$20240923$20240923$EXP$$DE-MYLANLABS-2024M1085049$MYLAN$$73$YR$$M$Y$$$20240923$$MD$DE$DE
243544451$24354445$1$I$20240917$20240918$20240923$20240923$EXP$GB-MHRA-TPP34151120C7250651YC1726561553341$GB-MYLANLABS-2024M1085334$MYLAN$$55$YR$$F$Y$89$KG$20240923$$MD$GB$GB
243544461$24354446$1$I$20240801$20240919$20240923$20240923$PER$$US-009507513-2409USA007208$MERCK$$$$A$F$Y$$$20240923$$HP$US$US
243544471$24354447$1$I$20240101$20240917$20240923$20240923$EXP$$IT-ORGANON-O2409ITA001295$ORGANON$$$$$F$Y$$$20240923$$CN$IT$IT
243544481$24354448$1$I$$20240917$20240923$20240923$30DAY$$FI-PFIZER INC-202400259711$PFIZER$$$$$$Y$$$20240923$$PH$FI$FI
243544491$24354449$1$I$$20240801$20240923$20240923$EXP$$JP-009507513-2409JPN005085$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$35$YR$$F$Y$$$20240923$$HP$JP$JP
243544501$24354450$1$I$$20240913$20240923$20240923$EXP$GB-MHRA-MED-202409131731545670-ZPHJS$GB-TEVA-VS-3243916$TEVA$$61$YR$$M$Y$$$20240923$$HP$GB$GB
243544511$24354451$1$I$20240918$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012565$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240923$$CN$US$US
243544521$24354452$1$I$20240918$20240918$20240923$20240923$PER$$US-ORGANON-O2409USA001453$ORGANON$$$$$$Y$$$20240923$$CN$US$US
243544531$24354453$1$I$$20240922$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150414$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$82.1$KG$20240923$$CN$US$US
243544541$24354454$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150555$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240923$$CN$US$US
243544551$24354455$1$I$20240425$20240912$20240923$20240923$EXP$$IL-BAXTER-2024BAX024679$BAXTER$$68$YR$$M$Y$$$20240923$$HP$IL$IL
243544561$24354456$1$I$20240424$20240916$20240923$20240923$EXP$$US-OTSUKA-2024_026038$OTSUKA$$75$YR$$M$Y$$$20240923$$HP$US$US
243544571$24354457$1$I$20240919$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150602$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240923$$CN$US$US
243544581$24354458$1$I$$20240922$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150382$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$62.14$KG$20240923$$CN$US$US
243544601$24354460$1$I$$20240919$20240923$20240923$PER$$US-BIOMARINAP-US-2024-160690$BIOMARIN$$$$$$Y$$$20240923$$CN$US$US
243544611$24354461$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087348$ROCHE$$59$YR$A$F$Y$$$20240923$$HP$US$US
243544641$24354464$1$I$$20240920$20240923$20240923$PER$$US-BIOMARINAP-US-2024-160699$BIOMARIN$$$$$$Y$$$20240923$$CN$US$US
243544651$24354465$1$I$20221021$20240916$20240923$20240923$EXP$$CA-TAKEDA-2024TUS065309$TAKEDA$$72$YR$$M$Y$$$20240923$$CN$CA$CA
243544661$24354466$1$I$$20240917$20240923$20240923$EXP$US-MLMSERVICE-20240911-PI187763-00175-4$US-RDY-SPO/USA/24/0013736$DR REDDYS$Weinstein T, Altshuler D, Lafond E, Katz A. Elevated Anti-Xa in the Setting of Prophylactic Unfractionated Subcutaneous Heparin Administration. Journal of pharmacy practice. 2024;37(5):1209-13. DOI: 10.1177/08971900241228951.$32$YR$A$F$Y$50.4$KG$20240923$$PH$US$US
243544671$24354467$1$I$$20240919$20240923$20240923$EXP$GB-MHRA-MED-202409130914122390-YLHTD$GB-SANDOZ INC.-SDZ2024GB081826$SANDOZ$$29$YR$$M$Y$86$KG$20240923$$HP$GB$GB
243544682$24354468$2$F$$20240924$20240923$20240930$EXP$$US-TRAVERE-2024TVT00907$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243544691$24354469$1$I$$20240916$20240923$20240923$EXP$$US-TRAVERE-2024TVT00922$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240923$$CN$US$US
243544702$24354470$2$F$20240921$20240926$20240923$20240926$EXP$$UA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052839$BOEHRINGER INGELHEIM$$80$YR$E$F$Y$74$KG$20240926$$MD$UA$UA
243544721$24354472$1$I$$20240919$20240923$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US057072$SANDOZ$$$$$$Y$$$20240923$$CN$US$US
243544751$24354475$1$I$$20240919$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150631$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240923$$CN$US$US
243544761$24354476$1$I$20240621$20240912$20240923$20240923$EXP$CN-NMPACDR-3301091036826202400590$CN-BAXTER-2024BAX024712$BAXTER$$70$YR$$F$Y$47$KG$20240923$$MD$CN$CN
243544771$24354477$1$I$20240301$20240916$20240923$20240923$EXP$$CA-GSK-CA2024114923$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$CN$CA$CA
243544781$24354478$1$I$20230814$20240916$20240923$20240923$EXP$$RU-MYLANLABS-2024M1085797$MYLAN$Shalaeva D.D., Pereverzeva K.G., Fomina O.A., Yakushin S.S.. BRASH syndrome: ? case report. Ration. Pharmacother. Cardiol.. 2024;20(3):367-373$$$$F$Y$$$20240923$$HP$RU$RU
243544791$24354479$1$I$$20240919$20240923$20240923$PER$$US-ROCHE-10000087371$ROCHE$$$$A$M$Y$$$20240923$$HP$US$US
243544801$24354480$1$I$$20240912$20240923$20240923$EXP$$US-UCBSA-2024047222$UCB$$$$$F$Y$$$20240923$$HP$US$US
243544811$24354481$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA271025$SANOFI AVENTIS$$$$A$F$Y$71$KG$20240923$$MD$US$US
243544821$24354482$1$I$20190612$20240919$20240923$20240923$EXP$$AU-SA-2024SA170729$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240923$$MD$AU$AU
243544831$24354483$1$I$$20240903$20240923$20240923$PER$$US-SA-2024SA273158$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240923$$CN$US$US
243544841$24354484$1$I$$20240919$20240923$20240923$EXP$FR-AFSSAPS-AVPO2024000183$FR-MYLANLABS-2024M1085368$MYLAN$$51$YR$$F$Y$$$20240923$$PH$FR$FR
243544851$24354485$1$I$20240827$20240919$20240923$20240923$EXP$FR-AFSSAPS-AM2024000738$FR-MYLANLABS-2024M1085404$MYLAN$$53$YR$$F$Y$87$KG$20240923$$HP$FR$FR
243544862$24354486$2$F$$20240906$20240923$20240925$PER$$US-SA-2024SA272329$SANOFI AVENTIS$$$$E$M$Y$92.07$KG$20240925$$MD$US$US
243544871$24354487$1$I$$20240801$20240923$20240923$EXP$$JP-009507513-2409JPN005086$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$68$YR$$M$Y$$$20240923$$HP$JP$JP
243544882$24354488$2$F$20240101$20240920$20240923$20240927$EXP$$US-AMGEN-USASP2024187765$AMGEN$$83$YR$E$F$Y$$$20240927$$PH$US$US
243544891$24354489$1$I$$20240918$20240923$20240923$EXP$$US-MYLANLABS-2024M1085975$MYLAN$$$$$F$Y$68.6$KG$20240923$$CN$US$US
243544911$24354491$1$I$$20240914$20240923$20240923$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009774$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240923$$CN$US$US
243544921$24354492$1$I$20240904$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012984$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243544931$24354493$1$I$$20240911$20240923$20240923$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409007686$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$CN$CN
243544941$24354494$1$I$$20240913$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409009407$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240923$$CN$US$US
243544961$24354496$1$I$$20240912$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409008341$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240923$$CN$US$US
243544971$24354497$1$I$20240901$20240911$20240923$20240923$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409007922$ELI LILLY AND CO$$51$YR$A$F$Y$95$KG$20240923$$MD$DE$DE
243544981$24354498$1$I$20240912$20240919$20240923$20240923$EXP$$DE-KYOWAKIRIN-2024KK021732$KYOWA$$$$$$Y$$$20240923$$HP$DE$DE
243544991$24354499$1$I$20240801$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149091$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240923$$CN$US$US
243545001$24354500$1$I$$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149176$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240923$$CN$US$US
243545011$24354501$1$I$$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149080$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240923$$HP$US$US
243545021$24354502$1$I$20240913$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149027$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$70.53$KG$20240923$$PH$US$US
243545031$24354503$1$I$20240729$20240917$20240923$20240923$EXP$$US-OTSUKA-2024_025821$OTSUKA$$78$YR$$F$Y$$$20240923$$CN$US$US
243545041$24354504$1$I$$20240913$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146916$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240923$$HP$US$US
243545051$24354505$1$I$20240914$20240916$20240923$20240923$EXP$GB-MHRA-MED-202409151713236650-NHTBF$GB-Ipsen Biopharmaceuticals, Inc.-2024-18609$IPSEN$$45$YR$A$F$Y$94$KG$20240923$$CN$GB$GB
243545061$24354506$1$I$20240916$20240916$20240923$20240923$EXP$$US-JNJFOC-20240951215$JOHNSON AND JOHNSON$$57$YR$A$M$Y$88.9$KG$20240923$$HP$US$US
243545081$24354508$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA273237$SANOFI AVENTIS$$49$YR$A$F$Y$73.18$KG$20240923$$MD$US$US
243545091$24354509$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272855$SANOFI AVENTIS$$18$YR$A$F$Y$52.16$KG$20240923$$MD$US$US
243545101$24354510$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268502$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240923$$MD$US$US
243545111$24354511$1$I$$20240909$20240923$20240923$EXP$$IL-SA-2024SA274266$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240923$$MD$IL$IL
243545121$24354512$1$I$20180101$20240910$20240923$20240923$PER$$US-SA-2024SA273424$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240923$$CN$US$US
243545131$24354513$1$I$$20240905$20240923$20240923$PER$$US-SA-2024SA273280$SANOFI AVENTIS$$$$A$F$Y$77.27$KG$20240923$$MD$US$US
243545141$24354514$1$I$20230101$20240917$20240923$20240923$PER$$US-SA-2024SA269615$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240923$$HP$US$US
243545151$24354515$1$I$20240901$20240916$20240923$20240923$PER$$US-SA-2024SA268474$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240923$$CN$US$US
243545161$24354516$1$I$$20240916$20240923$20240923$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-150281$BRISTOL MYERS SQUIBB$Kudu E, Akdag G, Yildirim ME. Evaluation of emergency department visits and immune-related adverse effects (irAEs) in patients treated with nivolumab. Supportive Care in Cancer. 2024 Sep 09;32(10):1-9. doi:10.1007/s00520-024-08856-x.$76$YR$E$M$Y$$$20240923$$MD$TR$TR
243545171$24354517$1$I$20240826$20240911$20240923$20240923$EXP$$MY-BRISTOL-MYERS SQUIBB COMPANY-2024-150261$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$63$KG$20240923$$CN$MY$MY
243545181$24354518$1$I$20240714$20240902$20240923$20240923$30DAY$$US-JNJFOC-20240753538$JOHNSON AND JOHNSON$$$$$F$Y$$$20240923$$CN$US$US
243545191$24354519$1$I$20240201$20240918$20240923$20240923$EXP$$PH-OTSUKA-2024_026189$OTSUKA$$45$YR$$F$Y$$$20240923$$CN$PH$PH
243545201$24354520$1$I$$20240918$20240923$20240923$EXP$$US-OTSUKA-2024_026142$OTSUKA$$$$$M$Y$$$20240923$$HP$US$US
243545211$24354521$1$I$$20240920$20240923$20240923$EXP$$PL-BEIGENE-BGN-2024-015057$BEIGENE$$$$$$Y$$$20240923$$MD$PL$PL
243545221$24354522$1$I$$20240711$20240923$20240923$PER$$US-ABBVIE-5930793$ABBVIE$$$$$$Y$$$20240923$$CN$US$CA
243545241$24354524$1$I$20230801$20240911$20240923$20240923$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18652$IPSEN$$$$$F$Y$$$20240923$$MD$US$US
243545251$24354525$1$I$20240101$20240920$20240923$20240923$PER$$US-PFIZER INC-202400094675$PFIZER$$33$YR$$M$Y$$$20240923$$CN$US$US
243545261$24354526$1$I$$20240923$20240923$20240923$PER$$US-PFIZER INC-2021SGN00236$PFIZER$$$$$$Y$$$20240923$$MD$US$US
243545271$24354527$1$I$$20240922$20240923$20240923$PER$$US-PFIZER INC-202400261223$PFIZER$$61$YR$$F$Y$$$20240923$$MD$US$US
243545281$24354528$1$I$20240820$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149099$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240923$$CN$US$US
243545291$24354529$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149366$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240923$$HP$US$US
243545301$24354530$1$I$$20240920$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150326$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240923$$MD$US$US
243545311$24354531$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150468$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240923$$CN$US$US
243545321$24354532$1$I$$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150535$BRISTOL MYERS SQUIBB$$19$YR$A$M$Y$$$20240923$$HP$US$US
243545331$24354533$1$I$20240921$20240923$20240923$20240923$DIR$719439$$FDA-CTU$$70$YR$$F$N$60.75$KG$20240923$N$CN$US$
243545361$24354536$1$I$20240105$20240919$20240923$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2023-US-025516$JAZZ$$57$YR$$M$Y$$$20240923$$HP$US$US
243545371$24354537$1$I$$20240916$20240923$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015318$JAZZ$$$$$M$Y$$$20240923$$CN$US$US
243545381$24354538$1$I$$20240917$20240923$20240923$EXP$$ES-MYLANLABS-2024M1001898$MYLAN$Ruano-Zaragoza M, Torrent-Rodriguez A, Araujo-Sanchez G, Ribo P, Loli-Ausejo D, Solis K, et al.. Successful oral dasatinib desensitization in immediate hypersensitivity. Journal of Investigational Allergology + Clinical Immunology. 2023;34(4):1-8$53$YR$$F$Y$$$20240923$$MD$ES$ES
243545391$24354539$1$I$$20240923$20240923$20240923$DIR$719452$$FDA-CTU$$$$$UNK$N$$$20240923$N$CN$US$
243545401$24354540$1$I$20240903$20240903$20240923$20240923$PER$$US-SA-2024SA272799$SANOFI AVENTIS$$83$YR$E$F$Y$106.14$KG$20240923$$MD$US$US
243545411$24354541$1$I$20180620$20240913$20240923$20240923$EXP$$CA-TAKEDA-2018TUS013792$TAKEDA$$48$YR$$F$Y$$$20240923$$CN$CA$CA
243545421$24354542$1$I$20231129$20240918$20240923$20240923$EXP$$US-OTSUKA-2024_026160$OTSUKA$$95$YR$$F$Y$$$20240923$$CN$US$US
243545431$24354543$1$I$20210301$20240919$20240923$20240923$EXP$FR-AFSSAPS-AVPO2024000182$FR-MYLANLABS-2024M1085361$MYLAN$$57$YR$$M$Y$$$20240923$$PH$FR$FR
243545441$24354544$1$I$$20240918$20240923$20240923$PER$$US-VIIV HEALTHCARE LIMITED-US2024116042$VIIV$$$$$M$Y$$$20240923$$MD$US$US
243545451$24354545$1$I$20240101$20240904$20240923$20240923$EXP$$US-SA-2024SA272698$SANOFI AVENTIS$$55$YR$A$F$Y$118$KG$20240923$$MD$US$US
243545462$24354546$2$F$$20240920$20240923$20240926$EXP$$US-SANDOZ INC.-SDZ2024US081238$SANDOZ$$$$$M$Y$$$20240926$$CN$US$US
243545471$24354547$1$I$$20240912$20240923$20240923$EXP$GB-MHRA-MED-202409121205117390-CTVMR$GB-ELI_LILLY_AND_COMPANY-GB202409008803$ELI LILLY AND CO$$$$$F$Y$81$KG$20240923$$CN$GB$GB
243545481$24354548$1$I$$20240912$20240923$20240923$EXP$GB-MHRA-MED-202409121159412570-NHVWC$GB-ELI_LILLY_AND_COMPANY-GB202409008800$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$GB$GB
243545491$24354549$1$I$$20240903$20240923$20240923$PER$$US-TEVA-VS-3240079$TEVA$$$$$M$Y$$$20240923$$CN$US$US
243545512$24354551$2$F$$20240916$20240923$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409011457$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240926$$CN$US$US
243545521$24354552$1$I$20221110$20240920$20240923$20240923$EXP$$US-PFIZER INC-2022SGN10774$PFIZER$$$$$F$Y$$$20240923$$MD$US$US
243545531$24354553$1$I$20240909$20240919$20240923$20240923$EXP$FR-AFSSAPS-BR2024000757$FR-PFIZER INC-202400259557$PFIZER$$72$YR$$M$Y$63$KG$20240923$$MD$FR$FR
243545551$24354555$1$I$20240501$20240923$20240923$20240923$EXP$$RU-PFIZER INC-PV202400123898$PFIZER$$51$YR$$M$Y$$$20240923$$MD$RU$RU
243545561$24354556$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150474$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240923$$HP$US$US
243545571$24354557$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150608$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240923$$CN$US$US
243545581$24354558$1$I$$20240918$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149371$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240923$$HP$US$US
243545621$24354562$1$I$20240101$20240911$20240923$20240923$PER$$US-009507513-2409USA004471$MERCK$$$$$F$Y$$$20240923$$CN$US$US
243545631$24354563$1$I$20240715$20240920$20240923$20240923$EXP$FR-AFSSAPS-AN2024001292$FR-PFIZER INC-202400260290$PFIZER$$43$YR$$F$Y$85$KG$20240923$$MD$FR$FR
243545641$24354564$1$I$$20240918$20240923$20240923$EXP$$US-PFIZER INC-202400073115$PFIZER$$77$YR$$M$Y$$$20240923$$PH$US$US
243545651$24354565$1$I$20240828$20240917$20240923$20240923$EXP$IT-MINISAL02-1001958$IT-BAYER-2024A132358$BAYER$$54$YR$A$M$Y$69$KG$20240923$$MD$IT$IT
243545661$24354566$1$I$$20240918$20240923$20240923$PER$$US-ROCHE-10000086402$ROCHE$$$$$$Y$$$20240923$$HP$US$US
243545671$24354567$1$I$20240920$20240923$20240923$20240923$DIR$719424$$FDA-CTU$$57$YR$$M$N$$$20240923$Y$PH$US$
243545681$24354568$1$I$$20240918$20240923$20240923$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-28548$SAMSUNG BIOEPIS$$83$YR$E$F$Y$$$20240923$$CN$GB$GB
243545691$24354569$1$I$20240920$20240923$20240923$20240923$DIR$719443$$FDA-CTU$$$$$UNK$N$$$20240923$N$CN$US$
243545701$24354570$1$I$$20240920$20240923$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US082160$SANDOZ$$$$$$Y$$$20240923$$CN$US$US
243545711$24354571$1$I$$20240913$20240923$20240923$EXP$$IT-BIOMARINAP-IT-2024-160667$BIOMARIN$$$$$$Y$$$20240923$$CN$IT$IT
243545721$24354572$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114238$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$HP$US$US
243545731$24354573$1$I$$20240916$20240923$20240923$EXP$$US-VIIV HEALTHCARE LIMITED-US2024114982$VIIV$$$$$$Y$$$20240923$$CN$US$US
243545741$24354574$1$I$20240724$20240917$20240923$20240923$EXP$FR-AFSSAPS-BR2024000702$FR-MYLANLABS-2024M1085628$MYLAN$$49$YR$$M$Y$96$KG$20240923$$MD$FR$FR
243545751$24354575$1$I$20210301$20240917$20240923$20240923$EXP$$RO-MYLANLABS-2024M1085017$MYLAN$$79$YR$$M$Y$$$20240923$$MD$RO$RO
243545761$24354576$1$I$$20240917$20240923$20240923$EXP$$GB-MYLANLABS-2024M1085170$MYLAN$$$$A$F$Y$$$20240923$$CN$GB$GB
243545771$24354577$1$I$20240101$20240917$20240923$20240923$PER$$US-SA-2024SA269795$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240923$$MD$US$US
243545781$24354578$1$I$$20240917$20240923$20240923$EXP$$US-ANIPHARMA-2024-US-050431$ANI$$$$$F$Y$$$20240923$$HP$US$US
243545791$24354579$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149605$BRISTOL MYERS SQUIBB$$22$YR$A$M$Y$$$20240923$$HP$US$US
243545801$24354580$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150683$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240923$$PH$US$US
243545811$24354581$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150571$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240923$$CN$US$US
243545821$24354582$1$I$20240111$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149443$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243545841$24354584$1$I$$20240918$20240923$20240923$PER$$US-BAUSCH-BL-2024-014124$BAUSCH AND LOMB$$$$$F$Y$$$20240923$$CN$US$US
243545851$24354585$1$I$$20240920$20240923$20240923$EXP$$GB-TEVA-VS-3246247$TEVA$$79$YR$$F$Y$64$KG$20240923$$PH$GB$GB
243545861$24354586$1$I$$20240918$20240923$20240923$EXP$$US-BAUSCH-BL-2024-014110$BAUSCH AND LOMB$$68$YR$$F$Y$$$20240923$$CN$US$US
243545871$24354587$1$I$20240101$20240919$20240923$20240923$EXP$$US-BAUSCH-BL-2024-014205$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240923$$CN$US$US
243545881$24354588$1$I$20240905$20240919$20240923$20240923$EXP$$MX-BAYER-2024A135431$BAYER$$53$YR$A$M$Y$$$20240923$$CN$MX$MX
243545891$24354589$1$I$$20240913$20240923$20240923$EXP$$NVSC2024CN185622$NOVARTIS$Zhang X, Huang D, Lou D, Si X, Mao J. Stevens-Johnson Syndrome/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review. BMC ENDOCRINE DISORDERS. 2024;24(172):1-6$73$YR$$F$Y$$$20240923$$HP$CN$CN
243545901$24354590$1$I$20240101$20240918$20240923$20240923$EXP$$SE-PURDUE-USA-2024-0312108$PURDUE$$89$YR$$F$Y$$$20240923$$MD$SE$SE
243545911$24354591$1$I$20240904$20240919$20240923$20240923$EXP$$SE-PURDUE-USA-2024-0312113$PURDUE$$80$YR$$M$Y$$$20240923$$MD$SE$SE
243545921$24354592$1$I$20240830$20240918$20240923$20240923$EXP$$FR-PURDUE-USA-2024-0312101$PURDUE$$28$YR$$M$Y$$$20240923$$PH$FR$FR
243545931$24354593$1$I$$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149410$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243545941$24354594$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-014003$BAUSCH AND LOMB$$45$YR$$F$Y$95$KG$20240923$$HP$CA$CA
243545951$24354595$1$I$20240904$20240917$20240923$20240923$EXP$$JP-Eisai-EC-2024-174565$EISAI$$$$E$M$Y$$$20240923$$MD$JP$JP
243545961$24354596$1$I$$20240909$20240923$20240923$PER$$US-Eisai-EC-2024-174075$EISAI$$$$$F$Y$$$20240923$$MD$US$US
243545971$24354597$1$I$$20240916$20240923$20240923$EXP$$PL-TEVA-VS-3245014$TEVA$Richert-Przygonska M, Milewska M, Debski R, Cisek J, Czyzewski K. Sclerodermatous manifestation of chronic graft-versus-host disease: therapy challenges. Acta-Haematol-Polon 2023; 54 (5): 308-312.$14$YR$$M$Y$$$20240923$$HP$PL$PL
243545981$24354598$1$I$$20240923$20240923$20240923$DIR$719440$$FDA-CTU$$$$$UNK$N$$$20240923$N$CN$US$
243545991$24354599$1$I$20240919$20240923$20240923$20240923$DIR$719444$$FDA-CTU$$28$YR$$F$N$63.5$KG$20240923$N$HP$US$
243546021$24354602$1$I$20240613$20240916$20240923$20240923$EXP$IT-MINISAL02-1001534$IT-TEVA-VS-3244190$TEVA$$71$YR$$F$Y$$$20240923$$MD$IT$IT
243546031$24354603$1$I$20240913$20240922$20240923$20240923$EXP$SE-SEMPA-2024-006895$SE-BAUSCH-BL-2024-014273$BAUSCH AND LOMB$$50$YR$$F$Y$$$20240923$$MD$SE$SE
243546041$24354604$1$I$20240701$20240921$20240923$20240923$EXP$FR-AFSSAPS-MP2024001443$FR-BAUSCH-BL-2024-014246$BAUSCH AND LOMB$$89$YR$$F$Y$$$20240923$$PH$FR$FR
243546051$24354605$1$I$$20240916$20240923$20240923$EXP$NL-LRB-01000584$NL-TEVA-VS-3244017$TEVA$$77$YR$$F$Y$75$KG$20240923$$CN$NL$NL
243546061$24354606$1$I$20190718$20240916$20240923$20240923$EXP$PL-URPL-2-1162-2020$PL-TEVA-VS-3244112$TEVA$$33$YR$$M$Y$70$KG$20240923$$CN$PL$PL
243546071$24354607$1$I$20240501$20240916$20240923$20240923$EXP$IT-MINISAL02-1001426$IT-TEVA-VS-3244266$TEVA$$47$YR$$M$Y$$$20240923$$MD$IT$IT
243546091$24354609$1$I$$20240911$20240923$20240923$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409007855$ELI LILLY AND CO$$49$YR$A$F$Y$78$KG$20240923$$CN$GB$GB
243546101$24354610$1$I$20240101$20240830$20240923$20240923$PER$$US-SA-2024SA267969$SANOFI AVENTIS$$$$T$F$Y$53.64$KG$20240923$$MD$US$US
243546111$24354611$1$I$20240101$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150603$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240923$$PH$US$US
243546121$24354612$1$I$20240328$20240916$20240923$20240923$EXP$DE-CADRBFARM-2024330314$DE-TEVA-VS-3244326$TEVA$$71$YR$$M$Y$76$KG$20240923$$CN$DE$DE
243546131$24354613$1$I$$20240919$20240923$20240923$EXP$GB-MHRA-MED-202409192155176390-PRNVD$GB-MYLANLABS-2024M1085820$MYLAN$$$$$F$Y$$$20240923$$CN$GB$GB
243546142$24354614$2$F$20231229$20240924$20240923$20240927$EXP$$NVSC2024AR007566$NOVARTIS$$38$YR$$F$Y$$$20240927$$CN$AR$AR
243546151$24354615$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024114354$GLAXOSMITHKLINE$$$$$F$Y$$$20240923$$HP$US$US
243546161$24354616$1$I$20240904$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188743$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243546171$24354617$1$I$$20240916$20240923$20240923$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-150277$BRISTOL MYERS SQUIBB$Kudu E, Akdag G, Yildirim ME. Evaluation of emergency department visits and immune-related adverse effects (irAEs) in patients treated with nivolumab. Supportive Care in Cancer. 2024 Sep 09;32(10):1-9. doi:10.1007/s00520-024-08856-x.$56$YR$A$M$Y$$$20240923$$MD$TR$TR
243546181$24354618$1$I$20240118$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149453$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240923$$MD$PT$PT
243546191$24354619$1$I$20240101$20240711$20240923$20240923$PER$$US-VISTAPHARM-2024-US-038078$VISTAPHARM$$$$$F$Y$$$20240923$$CN$US$US
243546201$24354620$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150623$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240923$$CN$US$US
243546211$24354621$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150036$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$70.31$KG$20240923$$CN$US$US
243546221$24354622$1$I$$20240916$20240923$20240923$EXP$$NVSC2024DE188232$NOVARTIS$$$$A$M$Y$$$20240923$$CN$DE$DE
243546231$24354623$1$I$$20240920$20240923$20240923$PER$$US-PHARMING-PHAUS2024000824$PHARMING GROUP$$$$$$Y$$$20240923$$CN$US$US
243546241$24354624$1$I$20240726$20240913$20240923$20240923$PER$$US-MYLANLABS-2024M1084647$MYLAN$$58$YR$$F$Y$$$20240923$$CN$US$US
243546251$24354625$1$I$20230330$20240916$20240923$20240923$EXP$$NVSC2023IN084863$NOVARTIS$$56$YR$$M$Y$$$20240923$$CN$IN$IN
243546261$24354626$1$I$20240923$20240923$20240923$20240923$DIR$719446$$FDA-CTU$$$$$UNK$N$$$20240923$N$CN$US$
243546291$24354629$1$I$20230908$20240923$20240923$20240923$DIR$719414$$FDA-CTU$$33$YR$$F$N$125.1$KG$20240923$N$CN$US$
243546301$24354630$1$I$$20240923$20240923$20240923$DIR$719453$$FDA-CTU$$75$YR$$F$N$$$20240923$N$PH$US$
243546311$24354631$1$I$20240921$20240923$20240923$20240923$DIR$719456$$FDA-CTU$$7$YR$$M$N$36$KG$20240923$N$CN$US$
243546331$24354633$1$I$$20240910$20240923$20240923$PER$$US-JNJFOC-20240959953$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240923$$CN$US$US
243546341$24354634$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149843$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240923$$HP$US$US
243546351$24354635$1$I$$20240918$20240923$20240923$EXP$$JP-009507513-2409JPN002903J$MERCK$$76$YR$$M$Y$$$20240923$$MD$JP$JP
243546361$24354636$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149942$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240923$$HP$US$US
243546371$24354637$1$I$20240101$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148027$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240923$$HP$US$US
243546381$24354638$1$I$20240101$20240916$20240923$20240923$PER$$US-MYLANLABS-2024M1085177$MYLAN$$$$$$Y$$$20240923$$CN$US$US
243546391$24354639$1$I$20240920$20240923$20240923$20240923$DIR$719450$$FDA-CTU$$43$YR$$F$N$100$KG$20240923$Y$HP$US$
243546401$24354640$1$I$20240727$20240923$20240923$20240923$DIR$719423$$FDA-CTU$$54$YR$$F$N$94.5$KG$20240923$N$CN$US$
243546413$24354641$3$F$$20240925$20240923$20240927$EXP$$US-PFIZER INC-PV202400001189$PFIZER$$87$YR$$F$Y$$$20240927$$CN$US$US
243546421$24354642$1$I$20240101$20240917$20240923$20240923$EXP$$JP-009507513-2408JPN000912J$MERCK$$76$YR$$M$Y$$$20240923$$MD$JP$JP
243546431$24354643$1$I$20240909$20240919$20240923$20240923$EXP$$US-PFIZER INC-202400260445$PFIZER$$86$YR$$M$Y$$$20240923$$PH$US$US
243546441$24354644$1$I$20240921$20240923$20240923$20240923$DIR$719420$$FDA-CTU$$81$YR$$M$N$80.1$KG$20240923$N$HP$US$
243546451$24354645$1$I$$20240912$20240923$20240923$PER$$US-RDY-SPO/USA/24/0013610$DR REDDYS$$88$YR$E$M$Y$$$20240923$$MD$US$US
243546461$24354646$1$I$$20240914$20240923$20240923$PER$$JP-Eisai-EC-2024-174505$EISAI$Matsumura Noriomi. Cases of Pembro + Lenva administration at our hospital (cases of administration for 2 months or more). Uterine cancer online lecture.$$$E$F$Y$$$20240923$$MD$JP$JP
243546471$24354647$1$I$20240721$20240917$20240923$20240923$EXP$FR-AFSSAPS-PP2024001006$FR-Eisai-EC-2024-174483$EISAI$$37$YR$A$F$Y$$$20240923$$MD$FR$FR
243546481$24354648$1$I$$20240918$20240923$20240923$EXP$$US-OTSUKA-2024_026137$OTSUKA$$$$$F$Y$$$20240923$$HP$US$US
243546491$24354649$1$I$$20240909$20240923$20240923$EXP$$NVSC2024IT174394$NOVARTIS$Caorsi R, Bertoni A, Matucci-Cerinic C, Natoli V, Palmeri S, Rosina S et al.. Long-term efficacy of MAS825, a bispecic anti-IL1beta and IL-18 monoclonal antibody, in two patients with sJIA and recurrent episodes of MAS. RHEUMATOLOGY. 2024;1-6$10$YR$$F$Y$$$20240923$$HP$IT$IT
243546511$24354651$1$I$$20240923$20240923$20240923$DIR$719438$$FDA-CTU$$$$$UNK$N$$$20240923$N$CN$US$
243546521$24354652$1$I$20240730$20240923$20240923$20240923$DIR$719441$$FDA-CTU$$59$YR$$M$N$93.39$KG$20240923$N$HP$US$
243546531$24354653$1$I$$20240904$20240923$20240923$EXP$$US-SA-2024SA273132$SANOFI AVENTIS$$$$A$F$Y$99.09$KG$20240923$$HP$US$US
243546551$24354655$1$I$$20240917$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010388$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240923$$CN$US$US
243546561$24354656$1$I$$20240801$20240923$20240923$EXP$$JP-009507513-2409JPN005087$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$67$YR$$M$Y$$$20240923$$HP$JP$JP
243546571$24354657$1$I$$20240917$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148376$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240923$$MD$US$US
243546591$24354659$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150381$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240923$$CN$US$US
243546601$24354660$1$I$20240707$20240916$20240923$20240923$EXP$$AU-009507513-2409AUS006066$MERCK$$78$YR$$M$Y$$$20240923$$HP$AU$AU
243546611$24354661$1$I$$20240911$20240923$20240923$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09169$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240923$$HP$US$US
243546622$24354662$2$F$20240906$20240918$20240923$20240925$EXP$$US-INTERCEPT-PM2024001862$INTERCEPT PHARMACEUTICALS$$91$YR$$F$Y$$$20240925$$CN$US$US
243546641$24354664$1$I$$20240919$20240923$20240923$PER$$US-ABBVIE-5932750$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243546652$24354665$2$F$$20240919$20240923$20240927$30DAY$$GT-PFIZER INC-PV202400122824$PFIZER$$14$YR$$M$Y$$$20240927$$HP$GT$GT
243546661$24354666$1$I$$20240818$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001056$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240923$$HP$US$US
243546671$24354667$1$I$20240917$20240920$20240923$20240923$PER$$US-BIOMARINAP-US-2024-160705$BIOMARIN$$$$$$Y$$$20240923$$CN$US$US
243546681$24354668$1$I$$20240816$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001040$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240923$$CN$US$US
243546691$24354669$1$I$$20240822$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001073$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240923$$CN$US$US
243546701$24354670$1$I$$20240820$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001044$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240923$$CN$US$US
243546711$24354671$1$I$20240101$20240913$20240923$20240923$EXP$$US-TEVA-VS-3195421$TEVA$$70$YR$$F$Y$$$20240923$$CN$US$US
243546721$24354672$1$I$20240101$20240918$20240923$20240923$EXP$$JP-009507513-2409JPN002868J$MERCK$$7$DEC$$M$Y$$$20240923$$MD$JP$JP
243546731$24354673$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272885$SANOFI AVENTIS$$$$A$F$Y$73.18$KG$20240923$$MD$US$US
243546741$24354674$1$I$$20240917$20240923$20240923$PER$$US-JNJFOC-20240947545$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$US$US
243546751$24354675$1$I$20240801$20240920$20240923$20240923$PER$$US-JNJFOC-20240957045$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$CN$US$US
243546761$24354676$1$I$20240901$20240911$20240923$20240923$PER$$US-JNJFOC-20240931628$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243546771$24354677$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189254$NOVARTIS$$$$$M$Y$$$20240923$$CN$US$US
243546781$24354678$1$I$20240101$20240921$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150497$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240923$$PH$US$US
243546791$24354679$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150455$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240923$$CN$US$US
243546801$24354680$1$I$$20240903$20240923$20240923$PER$$US-TEVA-VS-3240084$TEVA$$77$YR$$M$Y$79.38$KG$20240923$$CN$US$US
243546811$24354681$1$I$$20240919$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149671$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240923$$CN$US$US
243546822$24354682$2$F$20240827$20240925$20240923$20240930$EXP$$US-AMGEN-USASP2024187070$AMGEN$$65$YR$E$M$Y$$$20240930$$MD$US$US
243546831$24354683$1$I$20240920$20240923$20240923$20240923$DIR$719415$$FDA-CTU$$15$YR$$M$N$$$20240923$Y$PH$US$
243546851$24354685$1$I$$20240913$20240923$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015085$JAZZ$$6$YR$$$Y$$$20240923$$CN$US$US
243546861$24354686$1$I$$20240917$20240923$20240923$PER$$JP-BRACCO-2024JP05907$BRACCO$Tomita Y, Kawaguchi Y, Kobayashi W, Hakamada S, Takazawa Y, Masuda S.. MO27-3 A case of Kounis syndrome presenting with rash and very late stent thrombi after contrast-enhanced CT scan. The 32nd Annual Meeting of the Japanese Association of Cardiovascular Interven. 2024;772$74$YR$$M$Y$$$20240923$$HP$JP$JP
243546871$24354687$1$I$20240705$20240918$20240923$20240923$EXP$FR-AFSSAPS-CF2024000465$FR-MYLANLABS-2024M1085158$MYLAN$$52$YR$$M$Y$57$KG$20240923$$MD$FR$FR
243546881$24354688$1$I$20240831$20240917$20240923$20240923$EXP$$BE-MYLANLABS-2024M1084910$MYLAN$$22$YR$$F$Y$$$20240923$$PH$BE$BE
243546891$24354689$1$I$20220601$20240917$20240923$20240923$EXP$$RO-MYLANLABS-2024M1085181$MYLAN$$70$YR$$M$Y$$$20240923$$MD$RO$RO
243546901$24354690$1$I$$20240918$20240923$20240923$EXP$$NVSC2024AR188228$NOVARTIS$$$$$F$Y$$$20240923$$MD$AR$AR
243546911$24354691$1$I$$20240906$20240923$20240923$PER$$US-SA-2024SA271667$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240923$$CN$US$US
243546921$24354692$1$I$20240902$20240916$20240923$20240923$EXP$$GB-TEVA-VS-3244392$TEVA$$67$YR$$M$Y$76$KG$20240923$$CN$GB$GB
243546931$24354693$1$I$$20240816$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001028$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240923$$HP$US$US
243546942$24354694$2$F$20240101$20240918$20240923$20240925$EXP$$JP-009507513-2402JPN002478J$MERCK$$71$YR$$M$Y$$$20240925$$MD$JP$JP
243546951$24354695$1$I$$20240823$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001075$FRESENIUS MEDICAL CARE$$87$YR$E$M$Y$73$KG$20240923$$HP$US$US
243546961$24354696$1$I$20240910$20240911$20240923$20240923$EXP$$US-FMCRTG-FMC-2409-001147$FRESENIUS MEDICAL CARE$$62$YR$A$M$Y$88$KG$20240923$$HP$US$US
243546971$24354697$1$I$20240822$20240826$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001071$FRESENIUS MEDICAL CARE$$86$YR$E$M$Y$93.9$KG$20240923$$HP$US$US
243546981$24354698$1$I$$20240816$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001032$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240923$$CN$US$US
243546991$24354699$1$I$$20240814$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001022$FRESENIUS MEDICAL CARE$$60$YR$A$M$Y$$$20240923$$CN$US$US
243547001$24354700$1$I$$20240825$20240923$20240923$PER$$US-FMCRTG-FMC-2409-001087$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240923$$CN$US$US
243547011$24354701$1$I$20240816$20240826$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001066$FRESENIUS MEDICAL CARE$$76$YR$E$M$Y$$$20240923$$HP$US$US
243547021$24354702$1$I$20240814$20240821$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001051$FRESENIUS MEDICAL CARE$$69$YR$E$F$Y$98.6$KG$20240923$$HP$US$US
243547031$24354703$1$I$$20240827$20240923$20240923$PER$$US-FMCRTG-FMC-2409-001085$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240923$$HP$US$US
243547041$24354704$1$I$$20240825$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001080$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240923$$CN$US$US
243547051$24354705$1$I$20240810$20240826$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001067$FRESENIUS MEDICAL CARE$$49$YR$A$M$Y$$$20240923$$HP$US$US
243547061$24354706$1$I$20240818$20240823$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001070$FRESENIUS MEDICAL CARE$$58$YR$A$F$Y$$$20240923$$HP$US$US
243547071$24354707$1$I$$20240910$20240923$20240923$EXP$$US-FMCRTG-FMC-2409-001139$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240923$$CN$US$US
243547081$24354708$1$I$20240812$20240815$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001026$FRESENIUS MEDICAL CARE$$88$YR$E$F$Y$$$20240923$$HP$US$US
243547091$24354709$1$I$$20240816$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001031$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240923$$HP$US$US
243547101$24354710$1$I$$20240816$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001037$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240923$$CN$US$US
243547111$24354711$1$I$20240818$20240823$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001058$FRESENIUS MEDICAL CARE$$66$YR$E$M$Y$$$20240923$$HP$US$US
243547121$24354712$1$I$$20240815$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001029$FRESENIUS MEDICAL CARE$$49$YR$A$F$Y$$$20240923$$HP$US$US
243547131$24354713$1$I$$20240814$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001012$FRESENIUS MEDICAL CARE$$73$YR$E$M$Y$78$KG$20240923$$HP$US$US
243547141$24354714$1$I$$20240823$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001069$FRESENIUS MEDICAL CARE$$49$YR$A$M$Y$$$20240923$$HP$US$US
243547151$24354715$1$I$20240627$20240821$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001050$FRESENIUS MEDICAL CARE$$71$YR$E$M$Y$113$KG$20240923$$HP$US$US
243547161$24354716$1$I$20240805$20240814$20240923$20240923$PER$$US-FMCRTG-FMC-2408-001018$FRESENIUS MEDICAL CARE$$70$YR$E$M$Y$77$KG$20240923$$HP$US$US
243547181$24354718$1$I$20240626$20240918$20240923$20240923$EXP$FR-AFSSAPS-AVCF2024000599$FR-MYLANLABS-2024M1085610$MYLAN$$49$YR$$M$Y$$$20240923$$HP$FR$FR
243547191$24354719$1$I$20231101$20240917$20240923$20240923$EXP$$DE-MYLANLABS-2024M1085271$MYLAN$$75$YR$$M$Y$$$20240923$$MD$DE$DE
243547211$24354721$1$I$20240824$20240914$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409010120$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243547221$24354722$1$I$20240101$20240912$20240923$20240923$PER$$US-BIOGEN-2024BI01247392$BIOGEN$$31$YR$$F$Y$$$20240923$$CN$US$US
243547231$24354723$1$I$20240915$20240920$20240923$20240923$PER$$US-AMGEN-USASP2024188989$AMGEN$$76$YR$E$$Y$$$20240923$$CN$US$US
243547241$24354724$1$I$$20240913$20240923$20240923$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015079$JAZZ$$8$YR$$$Y$$$20240923$$CN$US$US
243547251$24354725$1$I$$20240920$20240923$20240923$PER$$US-PURDUE PHARMA-USA-2024-0312093$PURDUE$$$$$M$Y$$$20240923$$CN$US$US
243547261$24354726$1$I$20240703$20240918$20240923$20240923$EXP$FR-AFSSAPS-AM2024000727$FR-009507513-2409FRA007246$MERCK$$66$YR$$F$Y$72$KG$20240923$$PH$FR$FR
243547271$24354727$1$I$20240923$20240923$20240923$20240923$DIR$719457$$FDA-CTU$$49$YR$$F$N$62.1$KG$20240923$N$HP$US$
243547281$24354728$1$I$$20240923$20240923$20240923$DIR$719417$$FDA-CTU$$69$YR$$F$N$$$20240923$N$$US$
243547291$24354729$1$I$$20240920$20240923$20240923$PER$$US-PURDUE PHARMA-USA-2024-0312096$PURDUE$$44$YR$$F$Y$$$20240923$$CN$US$US
243547302$24354730$2$F$20220101$20240921$20240923$20240924$PER$$US-PURDUE PHARMA-USA-2024-0312094$PURDUE$$26$YR$$M$Y$$$20240924$$CN$US$US
243547311$24354731$1$I$$20240920$20240923$20240923$PER$$US-PURDUE-USA-2024-0312097$PURDUE$$47$YR$$M$Y$$$20240923$$CN$US$US
243547321$24354732$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272764$SANOFI AVENTIS$$$$A$F$Y$43.18$KG$20240923$$MD$US$US
243547331$24354733$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149474$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240923$$CN$US$US
243547341$24354734$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149614$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240923$$HP$US$US
243547351$24354735$1$I$$20240916$20240923$20240923$EXP$$US-Calliditas-2024CAL01919$CALLIDITAS THERAPEUTICS$$60$YR$A$M$Y$$$20240923$$CN$US$US
243547361$24354736$1$I$20230701$20240916$20240923$20240923$EXP$$NVSC2023CA030707$NOVARTIS$$44$YR$$F$Y$$$20240923$$CN$CA$CA
243547381$24354738$1$I$$20240909$20240923$20240923$PER$$US-JNJFOC-20240951924$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$HP$US$US
243547391$24354739$1$I$20210126$20240913$20240923$20240923$PER$$US-VERTEX PHARMACEUTICALS-2021-012423$VERTEX$$31$YR$$F$Y$58$KG$20240923$$HP$US$US
243547401$24354740$1$I$20240901$20240913$20240923$20240923$PER$$US-ABBVIE-5925634$ABBVIE$$68$YR$$M$Y$$$20240923$$MD$US$US
243547411$24354741$1$I$$20240918$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US056429$SANDOZ$$$$$F$Y$$$20240923$$CN$US$US
243547421$24354742$1$I$$20240801$20240923$20240923$EXP$$JP-009507513-2409JPN005088$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$49$YR$$M$Y$$$20240923$$HP$JP$JP
243547432$24354743$2$F$20240710$20240924$20240923$20240927$EXP$$AT-REGENERON PHARMACEUTICALS, INC.-2024-127116$REGENERON$$45$YR$$F$Y$$$20240927$$MD$AT$AT
243547441$24354744$1$I$$20240917$20240923$20240923$EXP$$NVSC2024CA187523$NOVARTIS$$$$$F$Y$$$20240923$$MD$CA$CA
243547451$24354745$1$I$20240807$20240918$20240923$20240923$EXP$$DE-009507513-2409DEU007412$MERCK$$61$YR$$F$Y$$$20240923$$MD$DE$DE
243547461$24354746$1$I$$20240917$20240923$20240923$PER$$US-JNJFOC-20240947769$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240923$$MD$US$US
243547471$24354747$1$I$20240910$20240917$20240923$20240923$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000196$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240923$$MD$US$US
243547481$24354748$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189113$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
243547491$24354749$1$I$$20240913$20240923$20240923$PER$$US-GSK-US2024AMR114617$GLAXOSMITHKLINE$$$$$M$Y$$$20240923$$CN$US$US
243547501$24354750$1$I$$20240923$20240923$20240923$PER$$NVSC2024US189308$NOVARTIS$$$$$$Y$$$20240923$$HP$US$US
243547511$24354751$1$I$$20240919$20240923$20240923$PER$$US-JNJFOC-20240952750$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$PH$US$US
243547521$24354752$1$I$20100101$20240921$20240923$20240923$PER$$NVSC2024US188902$NOVARTIS$$$$$M$Y$$$20240923$$CN$US$US
243547531$24354753$1$I$$20240801$20240923$20240923$EXP$$JP-009507513-2409JPN005089$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$66$YR$$F$Y$$$20240923$$HP$JP$JP
243547552$24354755$2$F$$20240913$20240923$20240926$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004517$Unknown Manufacturer$Meng Y, Li L, Wang H, Chen X, Yue Y, Wang M, Meng L, Li B, Li X. Pralsetinib for the treatment of a RET-positive advanced non-small-cell lung cancer patient harboring both ANK-RET and CCDC6-RET fusions with coronary heart disease: a case report. Annals of Translational Medicine. 2022;10(8):1-6$$$$$Y$$$20240926$$HP$CN$CN
243547561$24354756$1$I$20240801$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149851$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240923$$CN$US$US
243547571$24354757$1$I$20080101$20240918$20240923$20240923$EXP$$CO-LUNDBECK-DKLU4004464$LUNDBECK$$$$$$Y$$$20240923$$CN$CO$CO
243547581$24354758$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149826$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240923$$CN$US$US
243547591$24354759$1$I$$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150354$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240923$$HP$US$US
243547601$24354760$1$I$$20240807$20240923$20240923$PER$$US-LUNDBECK-DKLU4003195$LUNDBECK$$$$$$Y$$$20240923$$CN$US$US
243547611$24354761$1$I$20240501$20240916$20240923$20240923$EXP$FR-AFSSAPS-BX2024001795$FR-ABBVIE-5924874$ABBVIE$$76$YR$$F$Y$$$20240923$$PH$FR$FR
243547621$24354762$1$I$20191207$20240916$20240923$20240923$EXP$GB-MHRA-MED-202409141425377270-JTYGR$GB-TEVA-VS-3244274$TEVA$$26$YR$$M$Y$97$KG$20240923$$CN$GB$GB
243547631$24354763$1$I$$20240904$20240923$20240923$PER$$US-SA-2024SA272571$SANOFI AVENTIS$$$$A$M$Y$90$KG$20240923$$MD$US$US
243547641$24354764$1$I$20240101$20240916$20240923$20240923$EXP$$RS-009507513-2409SRB007121$MERCK$$71$YR$$F$Y$$$20240923$$HP$RS$RS
243547651$24354765$1$I$$20240917$20240923$20240923$EXP$$US-BAUSCH-BL-2024-014086$BAUSCH AND LOMB$Hussein G, Krastev P, Mallari A, El Labban M, Yadav S, Hassan M, Warsame M, Zoesch G, Trnka J, Vojjala N, Jain S, Surani S, Khan S. Stone heart syndrome: A curious case of digoxin toxicity and calcium infusion. Clinical Case Reports.. 2024;12(9):. doi:10.1002/ccr3.9376$78$YR$$F$Y$$$20240923$$HP$US$US
243547661$24354766$1$I$$20240913$20240923$20240923$PER$$US-JNJFOC-20240936813$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$CN$US$US
243547671$24354767$1$I$$20240807$20240923$20240923$PER$$US-LUNDBECK-DKLU4002863$LUNDBECK$$$$$$Y$$$20240923$$CN$US$US
243547682$24354768$2$F$$20240917$20240923$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409011361$ELI LILLY AND CO$$56$YR$A$$Y$$$20240926$$LW$US$US
243547692$24354769$2$F$$20240916$20240923$20240930$EXP$$CA-BAUSCH-BL-2023-013666$BAUSCH AND LOMB$Trollip E, Hawkins K, Kwek I, Dewart K, Qureshi M, Senaratne J. Bupivacaine and morphine epidural use for refractory neuropathic pain relief in a Guillain-Barre syndrome patient. Clinical Case Reports. 2023;11:1-6. doi:10.1002/ccr3.7221$3$DEC$$M$Y$$$20240930$$HP$CA$CA
243547701$24354770$1$I$20240101$20240916$20240923$20240923$EXP$$NVSC2024DE188216$NOVARTIS$$$$$F$Y$$$20240923$$PH$DE$DE
243547711$24354771$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150263$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240923$$CN$US$US
243547721$24354772$1$I$$20240903$20240923$20240923$PER$$US-TEVA-VS-3242498$TEVA$$$$$$Y$$$20240923$$CN$US$US
243547731$24354773$1$I$$20240920$20240923$20240923$PER$$US-BIOMARINAP-US-2024-160707$BIOMARIN$$$$$$Y$$$20240923$$CN$US$US
243547741$24354774$1$I$$20240917$20240923$20240923$EXP$$US-BIOMARINAP-US-2024-160631$BIOMARIN$$$$$$Y$$$20240923$$CN$US$US
243547751$24354775$1$I$20240708$20240920$20240923$20240923$EXP$$NVSC2024US188901$NOVARTIS$$$$$M$Y$$$20240923$$CN$US$US
243547761$24354776$1$I$20240917$20240918$20240923$20240923$PER$$US-BIOMARINAP-US-2024-160637$BIOMARIN$$$$$$Y$$$20240923$$CN$US$US
243547771$24354777$1$I$20240914$20240918$20240923$20240923$PER$$US-Millicent Holdings Ltd.-MILL20241160$MILLICENT HOLDINGS$$69$YR$E$F$Y$$$20240923$$CN$US$US
243547781$24354778$1$I$20220101$20240903$20240923$20240923$PER$$US-SA-2024SA272972$SANOFI AVENTIS$$$$$M$Y$$$20240923$$CN$US$US
243547791$24354779$1$I$20240829$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150320$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240923$$HP$US$US
243547801$24354780$1$I$$20240913$20240923$20240923$EXP$$CA-HLS-202402334$HLS THERAPEUTICS$$$$A$F$Y$$$20240923$$PH$CA$CA
243547811$24354781$1$I$20240902$20240916$20240923$20240923$EXP$$CN-009507513-2409CHN007111$MERCK$$92$YR$$M$Y$70$KG$20240923$$HP$CN$CN
243547821$24354782$1$I$$20240913$20240923$20240923$PER$$US-JNJFOC-20240960724$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240923$$MD$US$US
243547831$24354783$1$I$$20240917$20240923$20240923$PER$$US-JNJFOC-20240960553$JOHNSON AND JOHNSON$$$$$M$Y$$$20240923$$CN$US$US
243547841$24354784$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150512$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240923$$PH$US$US
243547851$24354785$1$I$20240712$20240914$20240923$20240923$EXP$$CN-009507513-2409CHN006538$MERCK$$94$YR$$F$Y$73.5$KG$20240923$$HP$CN$CN
243547861$24354786$1$I$$20240918$20240923$20240923$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-28661$SAMSUNG BIOEPIS$$68$YR$E$M$Y$$$20240923$$CN$GB$GB
243547871$24354787$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189109$NOVARTIS$$$$$F$Y$$$20240923$$CN$US$US
243547881$24354788$1$I$20240101$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188076$AMGEN$$83$YR$E$F$Y$$$20240923$$PH$US$US
243547891$24354789$1$I$$20240909$20240923$20240923$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09061$NEUROCRINE BIOSCIENCES$$54$YR$$F$Y$$$20240923$$HP$US$US
243547901$24354790$1$I$20240902$20240921$20240923$20240923$EXP$$NVSC2024CN189084$NOVARTIS$$39$YR$$F$Y$$$20240923$$HP$CN$CN
243547911$24354791$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA273653$SANOFI AVENTIS$$$$$F$Y$$$20240923$$CN$US$US
243547921$24354792$1$I$20240801$20240911$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000368$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243547931$24354793$1$I$20240101$20240912$20240923$20240923$EXP$$CA-RIGEL-20240900106$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240923$$MD$CA$CA
243547941$24354794$1$I$20240829$20240912$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000353$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243547951$24354795$1$I$20240801$20240903$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000355$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243547961$24354796$1$I$20240701$20240904$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000356$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243547971$24354797$1$I$20240811$20240905$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000358$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243547981$24354798$1$I$20240830$20240906$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000360$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243547991$24354799$1$I$20240819$20240827$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000348$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243548001$24354800$1$I$20240801$20240826$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000343$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243548011$24354801$1$I$20240101$20240830$20240923$20240923$PER$$US-009507513-2409USA000515$MERCK$$$$$F$Y$117.9$KG$20240923$$CN$US$US
243548021$24354802$1$I$20240901$20240918$20240923$20240923$EXP$$CN-009507513-2409CHN007423$MERCK$$93$YR$$F$Y$48$KG$20240923$$HP$CN$CN
243548031$24354803$1$I$20240801$20240827$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000350$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243548041$24354804$1$I$20240101$20240903$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000352$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243548061$24354806$1$I$$20240903$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000272$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243548071$24354807$1$I$20240601$20240903$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000232$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243548081$24354808$1$I$20240101$20240904$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000357$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243548101$24354810$1$I$$20240806$20240923$20240923$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000310$Unknown Manufacturer$$$$$$Y$$$20240923$$CN$US$US
243548121$24354812$1$I$20230801$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013791$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240923$$CN$US$US
243548131$24354813$1$I$$20240913$20240923$20240923$EXP$$CA-HLS-202402332$HLS THERAPEUTICS$$$$E$M$Y$$$20240923$$HP$CA$CA
243548141$24354814$1$I$$20240801$20240923$20240923$EXP$$JP-009507513-2409JPN005090$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$51$YR$$M$Y$$$20240923$$HP$JP$JP
243548151$24354815$1$I$20231001$20240917$20240923$20240923$EXP$$CA-APELLIS-2024-APL-0000838$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240923$$PH$CA$CA
243548162$24354816$2$F$$20240926$20240923$20240926$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052942$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240926$$CN$US$US
243548171$24354817$1$I$$20240919$20240923$20240923$EXP$IT-MINISAL02-1002471$IT-009507513-2409ITA007354$MERCK$$79$YR$$F$Y$$$20240923$$MD$IT$IT
243548181$24354818$1$I$20240101$20240922$20240923$20240923$EXP$$IL-KARYOPHARM-2024KPT001566$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240923$$MD$IL$IL
243548201$24354820$1$I$20240904$20240911$20240923$20240923$PER$$US-SA-2024SA271750$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240923$$MD$US$US
243548211$24354821$1$I$20240101$20240903$20240923$20240923$PER$$US-SA-2024SA272499$SANOFI AVENTIS$$62$YR$A$F$Y$50$KG$20240923$$MD$US$US
243548231$24354823$1$I$$20240911$20240923$20240923$PER$$US-009507513-2409USA005336$MERCK$$45$YR$$F$Y$$$20240923$$CN$US$US
243548241$24354824$1$I$20240901$20240917$20240923$20240923$PER$$US-Millicent Holdings Ltd.-MILL20241163$MILLICENT HOLDINGS$$$$$F$Y$$$20240923$$CN$US$US
243548251$24354825$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011378$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240923$$HP$US$US
243548271$24354827$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189259$NOVARTIS$$$$$M$Y$70.31$KG$20240923$$CN$US$US
243548281$24354828$1$I$$20240918$20240923$20240923$EXP$$JP-009507513-2409JPN002914J$MERCK$$80$YR$$M$Y$$$20240923$$MD$JP$JP
243548301$24354830$1$I$$20240801$20240923$20240923$EXP$$JP-009507513-2409JPN005091$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$82$YR$$F$Y$$$20240923$$HP$JP$JP
243548311$24354831$1$I$20240917$20240918$20240923$20240923$PER$$US-ABBVIE-5930995$ABBVIE$$$$$F$Y$$$20240923$$HP$US$US
243548321$24354832$1$I$$20240920$20240923$20240923$PER$$US-JNJFOC-20240957025$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$US$US
243548331$24354833$1$I$20240601$20240909$20240923$20240923$PER$$US-SA-2024SA271675$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240924$$MD$US$US
243548341$24354834$1$I$20240917$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65036$$FDA-CTU$$58$YR$$M$N$$$20240919$N$HP$US$
243548351$24354835$1$I$$20240801$20240923$20240923$EXP$$JP-009507513-2409JPN005068$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$78$YR$$M$Y$$$20240923$$HP$JP$JP
243548361$24354836$1$I$$20240918$20240923$20240923$PER$$US-JNJFOC-20240949863$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240923$$HP$US$US
243548371$24354837$1$I$$20240918$20240923$20240923$PER$$US-JNJFOC-20240949747$JOHNSON AND JOHNSON$$$$$$Y$$$20240923$$HP$US$US
243548381$24354838$1$I$20240122$20240919$20240923$20240923$EXP$$DE-APELLIS-2024-APL-0001023$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240923$$MD$DE$DE
243548392$24354839$2$F$20240508$20240924$20240923$20240930$EXP$$NVSC2024US188044$NOVARTIS$$54$YR$$M$Y$86$KG$20240930$$PH$US$US
243548401$24354840$1$I$20240907$20240918$20240923$20240923$EXP$$IL-TAKEDA-2024TUS093080$TAKEDA$$$$E$F$Y$$$20240923$$MD$IL$IL
243548421$24354842$1$I$$20240801$20240923$20240923$EXP$$JP-009507513-2409JPN005069$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$81$YR$$M$Y$$$20240923$$HP$JP$JP
243548431$24354843$1$I$$20240923$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409014058$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240923$$CN$US$US
243548441$24354844$1$I$$20240912$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409008736$ELI LILLY AND CO$$$$$F$Y$$$20240923$$CN$US$US
243548451$24354845$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150725$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240923$$CN$US$US
243548462$24354846$2$F$20240101$20240924$20240923$20240926$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052820$BOEHRINGER INGELHEIM$$53$YR$A$M$Y$$$20240926$$CN$CA$CA
243548471$24354847$1$I$$20240917$20240923$20240923$EXP$$NVSC2024CA187494$NOVARTIS$$$$$F$Y$$$20240924$$MD$CA$CA
243548481$24354848$1$I$$20240916$20240923$20240923$EXP$$US-009507513-2409USA005741$MERCK$$$$$M$Y$$$20240923$$HP$US$US
243548491$24354849$1$I$$20240920$20240923$20240923$EXP$$NVSC2024DE187772$NOVARTIS$$$$$$Y$$$20240924$$MD$DE$DE
243548501$24354850$1$I$20240919$20240919$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150727$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240923$$CN$US$US
243548511$24354851$1$I$$20240919$20240923$20240923$EXP$$IT-TAKEDA-2024TUS094263$TAKEDA$$$$$F$Y$$$20240923$$CN$GB$IT
243548521$24354852$1$I$20240101$20240916$20240923$20240923$PER$$US-DAIICHI SANKYO, INC.-DS-2024-100212-US$DAIICHI$$$$$M$Y$$$20240923$$MD$US$US
243548531$24354853$1$I$$20240918$20240923$20240923$PER$$US-DAIICHI SANKYO, INC.-DS-2024-100939-US$DAIICHI$$$$$F$Y$$$20240923$$CN$US$US
243548541$24354854$1$I$20240919$20240920$20240923$20240923$PER$$US-DSJP-DS-2024-100947-US$DAIICHI$$$$$M$Y$$$20240923$$CN$US$US
243548551$24354855$1$I$$20240918$20240923$20240923$EXP$$CA-TAKEDA-2024TUS094194$TAKEDA$$$$$$Y$$$20240923$$MD$CA$CA
243548561$24354856$1$I$$20240920$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150744$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240923$$CN$US$US
243548571$24354857$1$I$20240909$20240918$20240923$20240923$PER$$US-BIOMARINAP-US-2024-160635$BIOMARIN$$$$$$Y$$$20240923$$CN$US$US
243548581$24354858$1$I$$20240917$20240923$20240923$PER$$US-BIOMARINAP-US-2024-160614$BIOMARIN$$$$$$Y$$$20240923$$CN$US$US
243548591$24354859$1$I$$20240910$20240923$20240923$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09143$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240923$$HP$US$US
243548601$24354860$1$I$$20240910$20240923$20240923$PER$$US-SA-2024SA274321$SANOFI AVENTIS$$$$E$M$Y$$$20240924$$HP$US$US
243548611$24354861$1$I$$20240920$20240923$20240923$PER$$NVSC2024US189227$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243548621$24354862$1$I$$20240911$20240923$20240923$EXP$$US-ZENPEP LLC-2024AIMT01334$AIMMUNE$$$$$$Y$$$20240923$$CN$US$US
243548631$24354863$1$I$20240120$20240911$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-019831$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$76.5$KG$20240923$$CN$US$US
243548641$24354864$1$I$20240901$20240903$20240923$20240923$PER$$US-KARYOPHARM-2024KPT001505$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240923$$CN$US$US
243548651$24354865$1$I$20240101$20240903$20240923$20240923$PER$$US-KARYOPHARM-2024KPT001498$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240923$$CN$US$US
243548681$24354868$1$I$$20240913$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024188102$AMGEN$$$$$$Y$$$20240923$$MD$JP$JP
243548691$24354869$1$I$20240908$20240920$20240923$20240923$EXP$$PR-ABBVIE-5934283$ABBVIE$$66$YR$$M$Y$$$20240923$$CN$PR$PR
243548702$24354870$2$F$$20240924$20240923$20240924$EXP$$NVSJ2024JP011107$NOVARTIS$$75$YR$$M$Y$$$20240925$$MD$JP$JP
243548711$24354871$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013995$BAUSCH AND LOMB$$59$YR$$F$Y$$$20240923$$CN$CA$CA
243548721$24354872$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-014000$BAUSCH AND LOMB$$66$YR$$M$Y$$$20240923$$CN$CA$CA
243548731$24354873$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013941$BAUSCH AND LOMB$$79$YR$$M$Y$$$20240923$$CN$CA$CA
243548741$24354874$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-014017$BAUSCH AND LOMB$$63$YR$$$Y$$$20240923$$CN$CA$CA
243548751$24354875$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-014010$BAUSCH AND LOMB$$60$YR$$M$Y$$$20240923$$CN$CA$CA
243548771$24354877$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-014195$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240923$$CN$CA$CA
243548781$24354878$1$I$20230101$20240909$20240923$20240923$EXP$$US-HLS-202401178$HLS THERAPEUTICS$$42$YR$A$F$Y$$$20240923$$MD$AE$US
243548791$24354879$1$I$$20240910$20240923$20240923$EXP$$CA-HLS-202402276$HLS THERAPEUTICS$$45$YR$A$M$Y$$$20240923$$HP$CA$CA
243548801$24354880$1$I$$20240918$20240923$20240923$EXP$$NVSJ2024JP011103$NOVARTIS$$71$YR$$M$Y$$$20240924$$MD$JP$JP
243548811$24354881$1$I$$20240916$20240923$20240923$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001882$BLUEPRINT MEDICINES$$$$$$Y$$$20240924$$MD$US$US
243548821$24354882$1$I$$20240910$20240923$20240923$EXP$$CA-HLS-202402277$HLS THERAPEUTICS$$59$YR$A$M$Y$$$20240923$$HP$CA$CA
243548841$24354884$1$I$$20240919$20240923$20240923$EXP$$AT-SANDOZ INC.-SDZ2024AT081987$SANDOZ$$$$$M$Y$$$20240923$$CN$AT$AT
243548861$24354886$1$I$$20240910$20240923$20240923$EXP$$CA-HLS-202402279$HLS THERAPEUTICS$$$$$F$Y$$$20240923$$HP$CA$CA
243548871$24354887$1$I$$20240910$20240923$20240923$EXP$$CA-SANDOZ INC.-SDZ2024CA081439$SANDOZ$$65$YR$$F$Y$$$20240923$$HP$CA$CA
243548891$24354889$1$I$20170101$20240917$20240923$20240923$EXP$$US-009507513-2409USA005843$MERCK$$66$YR$$F$Y$$$20240923$$CN$US$US
243548901$24354890$1$I$$20240919$20240923$20240923$EXP$$US-SANDOZ INC.-SDZ2024US082126$SANDOZ$$$$$$Y$$$20240923$$HP$US$US
243548911$24354891$1$I$$20240910$20240923$20240923$EXP$$CA-HLS-202402280$HLS THERAPEUTICS$$58$YR$A$F$Y$$$20240923$$HP$CA$CA
243548931$24354893$1$I$20240915$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024185626$AMGEN$$78$YR$E$F$Y$$$20240923$$HP$US$US
243548941$24354894$1$I$$20240918$20240923$20240923$EXP$$IL-JNJFOC-20240960959$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240924$$HP$IL$IL
243548951$24354895$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA268736$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240924$$HP$US$US
243548961$24354896$1$I$$20240919$20240923$20240923$EXP$$JP-TAKEDA-2024TJP013931$TAKEDA$$$$$$Y$$$20240923$$MD$JP$JP
243548981$24354898$1$I$20240811$20240913$20240923$20240923$EXP$DE-BFARM-24006421$DE-ORGANON-O2409DEU001603$ORGANON$$33$YR$$F$Y$$$20240923$$MD$DE$DE
243549001$24354900$1$I$$20240916$20240923$20240923$PER$$US-SA-2024SA269246$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240924$$MD$US$US
243549011$24354901$1$I$$20240923$20240923$20240923$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052930$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240924$$CN$US$US
243549021$24354902$1$I$$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187166$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243549031$24354903$1$I$20240901$20240916$20240923$20240923$PER$$US-SA-2024SA269305$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240924$$HP$US$US
243549041$24354904$1$I$$20240917$20240923$20240923$EXP$$NVSJ2024JP011010$NOVARTIS$$98$YR$$F$Y$$$20240924$$PH$JP$JP
243549061$24354906$1$I$20240905$20240912$20240923$20240923$EXP$$CO-JNJFOC-20240937945$JOHNSON AND JOHNSON$$20$YR$A$M$Y$70$KG$20240924$$HP$CO$CO
243549071$24354907$1$I$$20240919$20240923$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US081887$SANDOZ$$$$$M$Y$$$20240923$$CN$US$US
243549081$24354908$1$I$$20240910$20240923$20240923$EXP$$CA-APOTEX-2024AP010495$APOTEX$$72$YR$$F$Y$66.667$KG$20240923$$PH$CA$CA
243549091$24354909$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5931224$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243549102$24354910$2$F$$20240923$20240923$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409012738$ELI LILLY AND CO$$$$$F$Y$$$20240927$$HP$US$US
243549111$24354911$1$I$$20240920$20240923$20240923$EXP$$US-JNJFOC-20240960898$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243549121$24354912$1$I$$20240916$20240923$20240923$EXP$$CA-BAUSCH-BL-2024-013994$BAUSCH AND LOMB$$60$YR$$F$Y$$$20240924$$HP$CA$CA
243549131$24354913$1$I$20240910$20240919$20240923$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US081843$SANDOZ$$68$YR$$F$Y$$$20240923$$CN$US$US
243549141$24354914$1$I$20240701$20240921$20240923$20240923$EXP$$MA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052707$BOEHRINGER INGELHEIM$$63$YR$A$F$Y$$$20240924$$HP$MA$MA
243549151$24354915$1$I$$20240909$20240923$20240923$30DAY$$US-JNJFOC-20240940312$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243549161$24354916$1$I$$20240909$20240923$20240923$EXP$$CN-RK PHARMA, INC-20240900053$RK PHARMA$Xiaofang Zhang. Stevens-Johnson Syndrome/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review. BMC Endocrine Disorders. 2024;24(1):172$$$$$Y$$$20240923$$HP$CN$CN
243549171$24354917$1$I$$20240917$20240923$20240923$PER$$US-AMGEN-USASP2024186319$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243549181$24354918$1$I$20240901$20240918$20240923$20240923$EXP$$US-JNJFOC-20240948810$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240924$$CN$US$US
243549191$24354919$1$I$20240101$20240920$20240923$20240923$EXP$$US-ABBVIE-5933762$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243549201$24354920$1$I$$20240918$20240923$20240923$EXP$$JP-TAKEDA-2024TJP013866$TAKEDA$$1$YR$$$Y$$$20240923$$MD$JP$JP
243549221$24354922$1$I$$20240917$20240923$20240923$EXP$$JP-SMPA-2024SMP013302$SUNOVION$$$$$$Y$$$20240923$$CN$JP$JP
243549231$24354923$1$I$$20240920$20240923$20240923$30DAY$$US-SANDOZ INC.-SDZ2024US082232$SANDOZ$$$$$M$Y$$$20240923$$HP$US$US
243549241$24354924$1$I$20221209$20240913$20240923$20240923$EXP$$CN-SMPA-2024SMP013264$SUNOVION$$$$$$Y$$$20240923$$CN$CN$CN
243549271$24354927$1$I$20240915$20240916$20240923$20240923$PER$$US-BAUSCHBL-2024BNL033509$BAUSCH AND LOMB$$82$YR$$M$Y$$$20240924$$CN$US$US
243549281$24354928$1$I$20240905$20240913$20240923$20240923$PER$$US-BAUSCHBL-2024BNL033445$BAUSCH AND LOMB$$69$YR$$F$Y$$$20240924$$CN$US$US
243549291$24354929$1$I$20240915$20240916$20240923$20240923$EXP$GB-MHRA-MED-202409152155173570-LJKGB$GB-JNJFOC-20240946603$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240924$$CN$GB$GB
243549301$24354930$1$I$$20240911$20240923$20240923$EXP$$CA-APOTEX-2024AP010558$APOTEX$$83$YR$$F$Y$$$20240923$$HP$CA$CA
243549311$24354931$1$I$20200212$20240911$20240923$20240923$EXP$$CN-TAKEDA-2024TUS093912$TAKEDA$$62$YR$$F$Y$$$20240923$$HP$CN$CN
243549321$24354932$1$I$20240913$20240913$20240923$20240923$PER$$US-BAUSCHBL-2024BNL033457$BAUSCH AND LOMB$$$$$F$Y$$$20240924$$CN$US$US
243549331$24354933$1$I$20240913$20240916$20240923$20240923$PER$$US-BAUSCHBL-2024BNL033541$BAUSCH AND LOMB$$$$$F$Y$$$20240924$$CN$US$US
243549351$24354935$1$I$20240101$20240923$20240923$20240923$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052981$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240924$$CN$US$US
243549361$24354936$1$I$20240706$20240917$20240923$20240923$EXP$$JP-GSK-JP2024JPN115045$GLAXOSMITHKLINE$$$$$$Y$$$20240923$$PH$JP$JP
243549372$24354937$2$F$$20240924$20240923$20240927$EXP$$CN-BEIGENE-BGN-2024-015036$BEIGENE$$$$$$Y$$$20240927$$MD$CN$CN
243549381$24354938$1$I$$20240910$20240923$20240923$PER$$US-SMPA-2024SPA002631$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549391$24354939$1$I$$20240906$20240923$20240923$PER$$US-SMPA-2024SPA002535$SUNOVION$$$$$$Y$$$20240923$$MD$US$US
243549411$24354941$1$I$$20240913$20240923$20240923$PER$$US-SMPA-2024SPA002852$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549421$24354942$1$I$$20240906$20240923$20240923$PER$$US-SMPA-2024SPA002456$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549441$24354944$1$I$$20240905$20240923$20240923$PER$$US-SMPA-2024SPA002427$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549451$24354945$1$I$$20240911$20240923$20240923$PER$$US-SMPA-2024SPA002731$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549461$24354946$1$I$$20240906$20240923$20240923$PER$$US-SMPA-2024SPA002489$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549471$24354947$1$I$$20240910$20240923$20240923$PER$$US-SMPA-2024SPA002643$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549481$24354948$1$I$$20240910$20240923$20240923$PER$$US-SMPA-2024SPA002588$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549491$24354949$1$I$$20240913$20240923$20240923$PER$$US-SMPA-2024SPA002899$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549501$24354950$1$I$$20240910$20240923$20240923$PER$$US-SMPA-2024SPA002592$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549511$24354951$1$I$$20240910$20240923$20240923$PER$$US-SMPA-2024SPA002605$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549521$24354952$1$I$$20240918$20240923$20240923$PER$$US-SMPA-2024SPA003039$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549531$24354953$1$I$$20240911$20240923$20240923$PER$$US-SMPA-2024SPA002611$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549541$24354954$1$I$$20240911$20240923$20240923$PER$$US-SMPA-2024SPA002664$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549561$24354956$1$I$$20240910$20240923$20240923$PER$$US-SMPA-2024SPA002614$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549571$24354957$1$I$$20240909$20240923$20240923$PER$$US-SMPA-2024SPA002576$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549581$24354958$1$I$$20240910$20240923$20240923$PER$$US-SMPA-2024SPA002634$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549591$24354959$1$I$$20240911$20240923$20240923$PER$$US-SMPA-2024SPA002596$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549601$24354960$1$I$$20240911$20240923$20240923$PER$$US-SMPA-2024SPA002660$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549611$24354961$1$I$$20240909$20240923$20240923$PER$$US-SMPA-2024SPA002549$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549621$24354962$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002713$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549631$24354963$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002175$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549641$24354964$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002163$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549651$24354965$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002193$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549661$24354966$1$I$$20240903$20240923$20240923$PER$$US-SMPA-2024SPA002283$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549671$24354967$1$I$20230914$20240916$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148165$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$89.8$KG$20240924$$PH$US$US
243549691$24354969$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002710$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549701$24354970$1$I$$20240918$20240923$20240923$PER$$US-SMPA-2024SPA003026$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549711$24354971$1$I$$20240911$20240923$20240923$PER$$US-SMPA-2024SPA002685$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549721$24354972$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002179$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549731$24354973$1$I$20240801$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002123$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549742$24354974$2$F$$20240911$20240923$20240925$PER$$US-SMPA-2024SPA002672$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243549751$24354975$1$I$$20240911$20240923$20240923$PER$$US-SMPA-2024SPA002624$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549761$24354976$1$I$$20240916$20240923$20240923$PER$$US-SMPA-2024SPA002946$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549771$24354977$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002131$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549781$24354978$1$I$$20240903$20240923$20240923$PER$$US-SMPA-2024SPA002294$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549791$24354979$1$I$$20240913$20240923$20240923$PER$$US-SMPA-2024SPA002878$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549801$24354980$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002143$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549821$24354982$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002101$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549831$24354983$1$I$20240801$20240917$20240923$20240923$PER$$US-SMPA-2024SPA002955$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549841$24354984$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002097$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549851$24354985$1$I$$20240912$20240923$20240923$PER$$US-SMPA-2024SPA002671$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549861$24354986$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002118$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549871$24354987$1$I$$20240830$20240923$20240923$PER$$US-SMPA-2024SPA002209$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549881$24354988$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002151$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549891$24354989$1$I$$20240830$20240923$20240923$PER$$US-SMPA-2024SPA002195$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549901$24354990$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002127$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549921$24354992$1$I$$20240916$20240923$20240923$PER$$US-SMPA-2024SPA002953$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549931$24354993$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002134$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549941$24354994$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002079$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549951$24354995$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002167$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549961$24354996$1$I$$20240911$20240923$20240923$PER$$US-SMPA-2024SPA002657$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549971$24354997$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002166$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549981$24354998$1$I$$20240909$20240923$20240923$PER$$US-SMPA-2024SPA002533$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243549991$24354999$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002161$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550001$24355000$1$I$$20240916$20240923$20240923$PER$$US-SMPA-2024SPA002929$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550021$24355002$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002071$SUNOVION$$$$$$Y$$$20240923$$$US$US
243550031$24355003$1$I$$20240830$20240923$20240923$PER$$US-SMPA-2024SPA002162$SUNOVION$$$$$$Y$$$20240923$$MD$US$US
243550041$24355004$1$I$$20240903$20240923$20240923$PER$$US-SMPA-2024SPA002277$SUNOVION$$$$$$Y$$$20240923$$HP$US$US
243550051$24355005$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002070$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550061$24355006$1$I$20240801$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002126$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550071$24355007$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002104$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550081$24355008$1$I$$20240916$20240923$20240923$PER$$US-SMPA-2024SPA002965$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550091$24355009$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002210$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550101$24355010$1$I$$20240917$20240923$20240923$PER$$US-SMPA-2024MYSCI0500010$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550121$24355012$1$I$20240827$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002076$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550141$24355014$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002174$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550151$24355015$1$I$$20240903$20240923$20240923$PER$$US-SMPA-2024SPA002275$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550161$24355016$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002137$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550171$24355017$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002120$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550181$24355018$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002180$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550221$24355022$1$I$$20240830$20240923$20240923$PER$$US-SMPA-2024SPA002208$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550231$24355023$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002063$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550241$24355024$1$I$20240801$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002119$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550251$24355025$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002087$SUNOVION$$$$$$Y$$$20240923$$HP$US$US
243550261$24355026$1$I$$20240911$20240923$20240923$PER$$US-SMPA-2024SPA002696$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550271$24355027$1$I$$20240913$20240923$20240923$PER$$US-SMPA-2024SPA002856$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550281$24355028$1$I$$20240913$20240923$20240923$PER$$US-SMPA-2024SPA002868$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550301$24355030$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002145$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550311$24355031$1$I$$20240912$20240923$20240923$PER$$US-SMPA-2024SPA002740$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550331$24355033$1$I$$20240903$20240923$20240923$PER$$US-SMPA-2024SPA002288$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550341$24355034$1$I$$20240903$20240923$20240923$PER$$US-SMPA-2024SPA002306$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550351$24355035$1$I$$20240830$20240923$20240923$PER$$US-SMPA-2024SPA002187$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550361$24355036$1$I$$20240829$20240923$20240923$PER$$US-SMPA-2024SPA002218$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550372$24355037$2$F$$20240830$20240923$20240927$PER$$US-SMPA-2024SPA002205$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243550382$24355038$2$F$$20240919$20240923$20240930$PER$$US-SMPA-2024SPA002232$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243550391$24355039$1$I$$20240903$20240923$20240923$PER$$US-SMPA-2024SPA002303$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550421$24355042$1$I$$20240911$20240923$20240923$PER$$US-SMPA-2024SPA002666$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550431$24355043$1$I$$20240912$20240923$20240923$PER$$US-SMPA-2024SPA002669$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550451$24355045$1$I$$20240904$20240923$20240923$PER$$US-SMPA-2024SPA002362$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550471$24355047$1$I$$20240830$20240923$20240923$PER$$US-SMPA-2024SPA002271$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550481$24355048$1$I$$20240830$20240923$20240923$PER$$US-SMPA-2024SPA002189$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550491$24355049$1$I$$20240910$20240923$20240923$PER$$US-SMPA-2024SPA002649$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550501$24355050$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002078$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550511$24355051$1$I$20240801$20240830$20240923$20240923$PER$$US-SMPA-2024SPA002322$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550521$24355052$1$I$$20240906$20240923$20240923$PER$$US-SMPA-2024SPA002512$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550541$24355054$1$I$$20240828$20240923$20240923$PER$$US-SMPA-2024SPA002706$SUNOVION$$$$$$Y$$$20240923$$CN$US$US
243550552$24355055$2$F$$20240919$20240923$20240930$PER$$US-SMPA-2024SPA002350$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243550561$24355056$1$I$20240912$20240912$20240923$20240923$PER$$US-BAUSCHBL-2024BNL033406$BAUSCH AND LOMB$$28$YR$$F$Y$$$20240924$$CN$US$US
243550571$24355057$1$I$20200201$20240916$20240923$20240923$EXP$$US-JNJFOC-20240951793$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20240924$$MD$US$US
243550581$24355058$1$I$$20240922$20240923$20240923$PER$$US-ABBVIE-5935071$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243550592$24355059$2$F$20240901$20240923$20240923$20240927$EXP$$US-ABBVIE-5925163$ABBVIE$$61$YR$$M$Y$$$20240927$$CN$US$US
243550601$24355060$1$I$$20240906$20240923$20240923$30DAY$$JP-JNJFOC-20240939707$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$PH$JP$JP
243550611$24355061$1$I$20240801$20240919$20240923$20240923$PER$$US-BAUSCHBL-2024BNL033845$BAUSCH AND LOMB$$77$YR$$F$Y$$$20240924$$CN$US$US
243550631$24355063$1$I$20240909$20240910$20240923$20240923$EXP$$CO-ABBVIE-5930611$ABBVIE$$68$YR$$M$Y$63$KG$20240923$$HP$CO$CO
243550641$24355064$1$I$20240911$20240911$20240923$20240923$PER$$US-JNJFOC-20240938593$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240924$$HP$US$US
243550651$24355065$1$I$20240908$20240918$20240923$20240923$EXP$$US-ABBVIE-5929888$ABBVIE$$64$YR$$M$Y$$$20240923$$CN$US$US
243550661$24355066$1$I$20240101$20240916$20240923$20240923$EXP$$US-ABBVIE-5927563$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243550681$24355068$1$I$$20240919$20240923$20240923$PER$$US-GILEAD-2024-0688420$GILEAD$$$$A$M$Y$$$20240923$$HP$US$US
243550701$24355070$1$I$$20240917$20240923$20240923$EXP$$PL-JNJFOC-20240955889$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$HP$PL$PL
243550711$24355071$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012559$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240923$$CN$US$US
243550721$24355072$1$I$$20240909$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409006898$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240923$$CN$US$US
243550731$24355073$1$I$$20240918$20240923$20240923$EXP$$CA-JNJFOC-20240960108$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240924$$PH$CA$CA
243550741$24355074$1$I$$20240918$20240923$20240923$EXP$$CH-AMGEN-CHENI2024187753$AMGEN$$$$E$M$Y$$$20240923$$MD$CH$CH
243550751$24355075$1$I$$20240916$20240923$20240923$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-150284$BRISTOL MYERS SQUIBB$Kudu E, Akdag G, Yildirim ME. Evaluation of emergency department visits and immune-related adverse effects (irAEs) in patients treated with nivolumab. Supportive Care in Cancer. 2024 Sep 09;32(10):1-9. doi:10.1007/s00520-024-08856-x.$70$YR$E$M$Y$$$20240924$$MD$TR$TR
243550761$24355076$1$I$20240901$20240918$20240923$20240923$EXP$$DE-ABBVIE-5930854$ABBVIE$$$$$M$Y$$$20240923$$MD$DE$DE
243550771$24355077$1$I$$20240919$20240923$20240923$EXP$$US-ABBVIE-5931371$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243550781$24355078$1$I$$20231121$20240923$20240923$PER$$US-CIPLA LTD.-2023US07457$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243550791$24355079$1$I$20240917$20240918$20240923$20240923$EXP$$TR-ABBVIE-5930841$ABBVIE$$69$YR$$M$Y$$$20240923$$MD$TR$TR
243550801$24355080$1$I$$20231109$20240923$20240923$PER$$US-CIPLA LTD.-2023US07247$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243550811$24355081$1$I$20231010$20231120$20240923$20240923$PER$$US-CIPLA LTD.-2023US07466$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243550821$24355082$1$I$20231208$20231208$20240923$20240923$PER$$US-CIPLA LTD.-2023US07887$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243550831$24355083$1$I$$20231219$20240923$20240923$PER$$US-CIPLA LTD.-2023US08485$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243550841$24355084$1$I$$20240108$20240923$20240923$PER$$US-CIPLA LTD.-2023US08171$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243550851$24355085$1$I$20240901$20240918$20240923$20240923$EXP$$US-ABBVIE-5932840$ABBVIE$$50$YR$$F$Y$$$20240923$$MD$US$US
243550861$24355086$1$I$20230101$20240228$20240923$20240923$PER$$US-CIPLA LTD.-2023US08707$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243550871$24355087$1$I$$20240525$20240923$20240923$PER$$US-CIPLA LTD.-2024US05571$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243550881$24355088$1$I$$20240516$20240923$20240923$PER$$US-CIPLA LTD.-2024US05837$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243550891$24355089$1$I$$20240918$20240923$20240923$EXP$$US-ABBVIE-5932429$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243550901$24355090$1$I$20240901$20240916$20240923$20240923$EXP$$US-AMGEN-USASP2024185948$AMGEN$$$$E$F$Y$$$20240923$$HP$US$US
243550911$24355091$1$I$20240918$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187612$AMGEN$$61$YR$A$F$Y$$$20240923$$CN$US$US
243550922$24355092$2$F$$20240923$20240923$20240925$PER$$US-AMGEN-USASP2024188753$AMGEN$$59$YR$A$F$Y$$$20240925$$HP$US$US
243550941$24355094$1$I$20240601$20240920$20240923$20240923$EXP$$CA-ABBVIE-5933782$ABBVIE$$$$E$F$Y$$$20240923$$CN$CA$CA
243550951$24355095$1$I$20240901$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024186699$AMGEN$$$$$F$Y$$$20240923$$MD$US$US
243550961$24355096$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188163$AMGEN$$$$$$Y$$$20240923$$CN$US$US
243550971$24355097$1$I$20240101$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187696$AMGEN$$53$YR$A$F$Y$$$20240923$$CN$US$US
243550981$24355098$1$I$$20240920$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150187$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240924$$HP$US$US
243550991$24355099$1$I$20240901$20240917$20240923$20240923$EXP$$US-JNJFOC-20240950254$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240924$$CN$US$US
243551001$24355100$1$I$20240101$20240919$20240923$20240923$PER$$US-ABBVIE-5932173$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243551011$24355101$1$I$20240101$20240919$20240923$20240923$PER$$US-ABBVIE-5933273$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243551021$24355102$1$I$$20240911$20240923$20240923$EXP$$GB-Unichem Pharmaceuticals (USA) Inc-UCM202409-001165$UNICHEM$$77$WK$I$M$Y$$$20240924$$HP$GB$
243551031$24355103$1$I$$20240919$20240923$20240923$PER$$US-ABBVIE-5932910$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243551041$24355104$1$I$$20240916$20240923$20240923$EXP$$US-ABBVIE-5926468$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243551051$24355105$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012553$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240923$$CN$US$US
243551061$24355106$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409013030$ELI LILLY AND CO$$$$$$Y$$$20240923$$CN$US$US
243551071$24355107$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409014150$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240923$$CN$US$US
243551091$24355109$1$I$20240801$20240913$20240923$20240923$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00344$PRINSTON PHARMACEUTICAL$$74$YR$$F$Y$68.946$KG$20240923$$CN$US$US
243551101$24355110$1$I$20240101$20240920$20240923$20240923$EXP$$US-ABBVIE-5933804$ABBVIE$$$$$F$Y$$$20240923$$MD$US$US
243551111$24355111$1$I$$20240920$20240923$20240923$PER$$US-ABBVIE-5934601$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243551121$24355112$1$I$20240911$20240917$20240923$20240923$EXP$$US-JNJFOC-20240953852$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240924$$CN$US$US
243551131$24355113$1$I$$20240917$20240923$20240923$PER$$US-ABBVIE-5929164$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243551141$24355114$1$I$20240401$20240828$20240923$20240923$PER$$US-BEIGENE-BGN-2024-013702$BEIGENE$$$$$$Y$$$20240923$$CN$US$US
243551151$24355115$1$I$20240828$20240830$20240923$20240923$PER$$US-BEIGENE-BGN-2024-013856$BEIGENE$$$$$$Y$$$20240923$$CN$US$US
243551161$24355116$1$I$20240916$20240918$20240923$20240923$EXP$$CA-BIOGEN-2024BI01283425$BIOGEN$$68$YR$$M$Y$$$20240923$$PH$CA$CA
243551172$24355117$2$F$$20240924$20240923$20240928$EXP$$US-ABBVIE-5928519$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243551181$24355118$1$I$20240522$20240919$20240923$20240923$EXP$FR-AFSSAPS-BS2024000646$FR-JNJFOC-20240960436$JOHNSON AND JOHNSON$$81$YR$E$M$Y$68$KG$20240924$$MD$FR$FR
243551191$24355119$1$I$20240701$20240911$20240923$20240923$PER$$US-ABBVIE-5922561$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243551201$24355120$1$I$20211001$20240909$20240923$20240923$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019389$VALIDUS$$$$$$Y$$$20240923$$CN$US$US
243551211$24355121$1$I$$20240913$20240923$20240923$EXP$$JP-VALIDUS PHARMACEUTICALS LLC-JP-VDP-2024-019400$VALIDUS$Ishizaki Y, Murakami T, Ohno Y, Yagishita A, Ikari Y. Takotsubo syndrome complicated by cardiogenic shock due to left ventricular outflow tract obstruction, acute mitral regurgitation, and atrial fibrillation: a case report.. European Heart Journal - Case Reports.. 2024;8(8):1-5$$$$$Y$$$20240923$$MD$JP$JP
243551231$24355123$1$I$20240701$20240917$20240923$20240923$EXP$$BR-BIOGEN-2024BI01283150$BIOGEN$$32$YR$$M$Y$105$KG$20240923$$CN$BR$BR
243551242$24355124$2$F$20230101$20240924$20240923$20240930$EXP$$US-ABBVIE-5932418$ABBVIE$$$$$F$Y$73$KG$20240929$$CN$US$US
243551251$24355125$1$I$$20240919$20240923$20240923$EXP$$CA-ABBVIE-5933627$ABBVIE$$$$E$F$Y$$$20240923$$HP$CA$CA
243551261$24355126$1$I$$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149203$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240924$$MD$US$US
243551281$24355128$1$I$20240101$20240916$20240923$20240923$EXP$$US-ABBVIE-5932316$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243551291$24355129$1$I$$20240905$20240923$20240923$PER$$US-JNJFOC-20240911937$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243551301$24355130$1$I$$20240917$20240923$20240923$EXP$$JP-009507513-2409JPN002709J$MERCK$$$$$F$Y$$$20240923$$MD$JP$JP
243551311$24355131$1$I$20240624$20240919$20240923$20240923$EXP$FR-AFSSAPS-RN2024000997$FR-JNJFOC-20240960873$JOHNSON AND JOHNSON$$76$YR$E$F$Y$80$KG$20240924$$MD$FR$FR
243551321$24355132$1$I$$20240923$20240923$20240923$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052997$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240924$$CN$US$US
243551331$24355133$1$I$$20240919$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012630$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240923$$CN$US$US
243551341$24355134$1$I$$20240920$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409014158$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240923$$CN$US$US
243551351$24355135$1$I$20240901$20240920$20240923$20240923$EXP$$US-ABBVIE-5933761$ABBVIE$$74$YR$$M$Y$$$20240923$$CN$US$US
243551361$24355136$1$I$$20240923$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150792$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240924$$CN$US$US
243551371$24355137$1$I$$20240916$20240923$20240923$EXP$$US-ABBVIE-5927403$ABBVIE$$$$$M$Y$$$20240923$$CN$US$US
243551381$24355138$1$I$$20240912$20240923$20240923$EXP$$JP-AMGEN-JPNSP2024188583$AMGEN$$$$$$Y$$$20240923$$MD$JP$JP
243551391$24355139$1$I$20180701$20240917$20240923$20240923$PER$$US-009507513-2409USA006818$MERCK$$71$YR$$M$Y$71.08$KG$20240923$$MD$US$US
243551401$24355140$1$I$$20240920$20240923$20240923$PER$$US-HALEON-2198064$Haleon PLC$$$$$$Y$$$20240923$$CN$US$US
243551411$24355141$1$I$20240701$20240911$20240923$20240923$PER$$US-ABBVIE-5922110$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243551421$24355142$1$I$$20240918$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409012077$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240923$$CN$US$US
243551441$24355144$1$I$20240901$20240918$20240923$20240923$PER$$US-AMGEN-USASP2024187094$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243551461$24355146$1$I$$20240916$20240923$20240923$PER$$US-ELI_LILLY_AND_COMPANY-US202409011298$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240923$$MD$US$US
243551471$24355147$1$I$$20240917$20240923$20240923$EXP$$US-JNJFOC-20240955257$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243551481$24355148$1$I$$20240916$20240923$20240923$EXP$$US-JNJFOC-20240940679$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20240924$$CN$US$US
243551491$24355149$1$I$20240901$20240917$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148763$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$79.4$KG$20240924$$PH$US$US
243551501$24355150$1$I$20240901$20240919$20240923$20240923$EXP$$PR-ABBVIE-5931558$ABBVIE$$82$YR$$M$Y$$$20240923$$CN$PR$PR
243551512$24355151$2$F$20230531$20240920$20240923$20240928$PER$$US-AMGEN-USASP2024188480$AMGEN$$45$YR$A$F$Y$$$20240928$$HP$US$US
243551531$24355153$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024187776$AMGEN$Bona R. D.; Gu S. X.; Butt A. et al.. Phenotypic and genotypic evaluation of bleeding diagnostic dilemmas: Two case studies. Blood Cells, Molecules, and Diseases. 2024;110:1-5$26$YR$A$F$Y$$$20240923$$HP$US$US
243551541$24355154$1$I$$20240918$20240923$20240923$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149189$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240924$$MD$US$US
243551551$24355155$1$I$20240101$20240911$20240923$20240923$PER$$US-ABBVIE-5931096$ABBVIE$$$$$F$Y$$$20240923$$CN$US$US
243551571$24355157$1$I$$20240920$20240923$20240923$EXP$$US-ABBVIE-5933526$ABBVIE$$$$$$Y$$$20240923$$CN$US$US
243551591$24355159$1$I$$20240919$20240923$20240923$PER$$US-AMGEN-USASP2024188303$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243551601$24355160$1$I$20240901$20240921$20240923$20240923$PER$$US-AMGEN-USASP2024189072$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
243551611$24355161$1$I$20240101$20240917$20240923$20240923$EXP$$US-JNJFOC-20240950061$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240924$$HP$US$US
243551631$24355163$1$I$$20240916$20240923$20240923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147072$BRISTOL MYERS SQUIBB$Sakunchotpanit G, Rohan TZ, Moran J, Russell-Goldman E, Walters M, Nambudiri VE. Cutaneous scedosporium apiospermum infection in a patient with metastatic renal cell carcinoma. JAAD Case Reports. 2024;52:60-2. doi:10.1016/j.jdcr.2024.07.013.$68$YR$E$M$Y$$$20240924$$HP$US$US
243551641$24355164$1$I$20231228$20240915$20240923$20240923$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149502$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$MD$PT$PT
243551651$24355165$1$I$20240801$20240916$20240924$20240924$EXP$$AT-TAKEDA-2024TUS093667$TAKEDA$$32$YR$$F$Y$$$20240923$$HP$AT$AT
243551661$24355166$1$I$20240801$20240918$20240924$20240924$EXP$$US-ABBVIE-5930739$ABBVIE$$61$YR$$F$Y$$$20240924$$CN$US$US
243551681$24355168$1$I$20240901$20240918$20240924$20240924$EXP$$ES-ABBVIE-5930931$ABBVIE$$73$YR$$F$Y$$$20240924$$CN$ES$ES
243551691$24355169$1$I$20240725$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024186722$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243551702$24355170$2$F$20230122$20240926$20240924$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409014171$ELI LILLY AND CO$$15$YR$T$F$Y$42.63$KG$20240930$$CN$US$US
243551711$24355171$1$I$20240501$20240912$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409008686$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240923$$CN$US$US
243551731$24355173$1$I$$20240919$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150736$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240924$$CN$US$US
243551752$24355175$2$F$$20240917$20240924$20240926$EXP$GR-MLMSERVICE-20240906-PI186138-00270-1$GR-STRIDES ARCOLAB LIMITED-2024SP012069$STRIDES$Kitsios K, Trakatelli C-M.. Diabetic ketoacidosis in a patient with type 2 diabetes induced by multiple triggers: a case report and implications for clinical practice.. Practical Diabetes. 2024;41(3):27-30$58$YR$$M$Y$$$20240926$$MD$GR$GR
243551761$24355176$1$I$$20240917$20240924$20240924$EXP$$US-TAKEDA-2024TUS030993$TAKEDA$$$$$F$Y$61$KG$20240924$$HP$US$US
243551771$24355177$1$I$$20240918$20240924$20240924$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03472$AMNEAL$$70$YR$$M$Y$$$20240924$$CN$US$US
243551791$24355179$1$I$$20240920$20240924$20240924$EXP$$CA-ABBVIE-5933860$ABBVIE$$$$A$M$Y$$$20240924$$HP$CA$CA
243551801$24355180$1$I$20240607$20240801$20240924$20240924$EXP$$CA-ABBVIE-5933629$ABBVIE$$82$YR$$M$Y$$$20240924$$MD$CA$CA
243551811$24355181$1$I$20240101$20240918$20240924$20240924$EXP$$US-ABBVIE-5933813$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243551821$24355182$1$I$20240823$20240919$20240924$20240924$EXP$$US-ABBVIE-5933725$ABBVIE$$76$YR$$F$Y$$$20240924$$MD$US$US
243551841$24355184$1$I$20240917$20240918$20240924$20240924$EXP$$FR-ABBVIE-5933314$ABBVIE$$85$YR$$F$Y$$$20240924$$CN$FR$FR
243551861$24355186$1$I$$20240919$20240924$20240924$EXP$GB-MHRA-MED-202409162354189920-VPRYH$GB-CHATTEMPRD-2024OHG032815$CHATTEM$$48$YR$A$M$Y$64$KG$20240924$$CN$GB$GB
243551881$24355188$1$I$20240914$20240918$20240924$20240924$EXP$$GB-CHATTEMPRD-2024OHG032685$CHATTEM$$75$YR$E$F$Y$74$KG$20240924$$PH$GB$GB
243551891$24355189$1$I$$20240918$20240924$20240924$EXP$$US-ABBVIE-5930080$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243551901$24355190$1$I$20190101$20240917$20240924$20240924$EXP$$US-ABBVIE-5918796$ABBVIE$$$$$F$Y$48.08$KG$20240924$$CN$US$US
243551911$24355191$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150072$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240924$$CN$US$US
243551921$24355192$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150333$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$47.6$KG$20240924$$CN$US$US
243551931$24355193$1$I$20230101$20240916$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147276$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240924$$CN$US$US
243551941$24355194$1$I$$20240919$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150740$BRISTOL MYERS SQUIBB$$37$YR$A$F$Y$$$20240924$$CN$US$US
243551951$24355195$1$I$$20240916$20240924$20240924$EXP$$US-AMGEN-USASP2024184888$AMGEN$Lin P.; Huang L.; Flaxel C. et.al. Two Cases of Chronic Central Serous Chorioretinopathy Successfully Treated with Systemic Interferon Alpha. Ocular Immunology and Inflammation. 2024;32 (7):1465-1474$48$YR$A$M$Y$$$20240923$$MD$US$US
243551961$24355196$1$I$20240920$20240920$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US082105$SANDOZ$$2$YR$$$Y$$$20240924$$CN$US$US
243551971$24355197$1$I$20240101$20240916$20240924$20240924$EXP$$US-ABBVIE-5917272$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243551981$24355198$1$I$$20240917$20240924$20240924$EXP$$US-CHATTEMPRD-2024OHG032619$CHATTEM$$$$$$Y$$$20240924$$CN$US$US
243551991$24355199$1$I$20240918$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024187628$AMGEN$$76$YR$E$M$Y$$$20240923$$CN$US$US
243552001$24355200$1$I$$20240916$20240924$20240924$EXP$$US-ABBVIE-5927848$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243552011$24355201$1$I$$20240917$20240924$20240924$PER$$US-ABBVIE-5929340$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243552021$24355202$1$I$$20240920$20240924$20240924$PER$$NVSC2024US189409$NOVARTIS$$$$$M$Y$$$20240924$$CN$US$US
243552031$24355203$1$I$20240909$20240919$20240924$20240924$EXP$$US-ABBVIE-5931332$ABBVIE$$36$YR$$F$Y$$$20240924$$CN$US$US
243552041$24355204$1$I$$20240912$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409008870$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240924$$CN$US$US
243552051$24355205$1$I$20240917$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012169$ELI LILLY AND CO$$$$A$F$Y$$$20240924$$CN$US$US
243552061$24355206$1$I$20240909$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012167$ELI LILLY AND CO$$66$YR$E$$Y$$$20240924$$CN$US$US
243552071$24355207$1$I$$20240919$20240924$20240924$EXP$$US-TAKEDA-2024TUS083403$TAKEDA$$$$$M$Y$$$20240924$$CN$US$US
243552081$24355208$1$I$$20240919$20240924$20240924$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-029700$UNITED THERAPEUTICS$$78$YR$$M$Y$$$20240924$$$JP$JP
243552091$24355209$1$I$20240101$20240917$20240924$20240924$EXP$$US-ABBVIE-5930161$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243552101$24355210$1$I$20240919$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188173$AMGEN$$79$YR$E$F$Y$$$20240923$$CN$US$US
243552111$24355211$1$I$20240915$20240918$20240924$20240924$EXP$$US-ABBVIE-5930549$ABBVIE$$60$YR$$M$Y$$$20240924$$CN$US$US
243552121$24355212$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5931146$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243552131$24355213$1$I$$20240919$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150749$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240924$$CN$US$US
243552141$24355214$1$I$20240601$20240830$20240924$20240924$PER$$US-ARDELYX-2024ARDX004926$ARDELYX$$55$YR$$F$Y$55$KG$20240923$$HP$US$US
243552151$24355215$1$I$$20240904$20240924$20240924$EXP$$US-ARDELYX-2024ARDX006733$ARDELYX$$$$$$Y$$$20240923$$HP$US$US
243552161$24355216$1$I$20240808$20240820$20240924$20240924$PER$$US-ARDELYX-2024ARDX006291$ARDELYX$$65$YR$$F$Y$$$20240923$$HP$US$US
243552171$24355217$1$I$$20240905$20240924$20240924$PER$$US-ARDELYX-2024ARDX006769$ARDELYX$$$$$M$Y$$$20240923$$HP$US$US
243552181$24355218$1$I$$20240905$20240924$20240924$PER$$US-ARDELYX-2024ARDX006771$ARDELYX$$$$$F$Y$$$20240923$$HP$US$US
243552191$24355219$1$I$20240720$20240812$20240924$20240924$PER$$US-ARDELYX-2024ARDX006235$ARDELYX$$59$YR$$M$Y$$$20240923$$PH$US$US
243552201$24355220$1$I$$20240916$20240924$20240924$EXP$$AU-STRIDES ARCOLAB LIMITED-2024SP012191$STRIDES$Cotter F, Shi M, Sathianathen N, Thevarajah G, Cheng J, Gyomber D, et al.. Corpus cavernosum abscess complicating distal shunt procedures for priapism.. J-Clin-Urol. 2024;17 (1):96-103$36$YR$$M$Y$$$20240924$$HP$AU$AU
243552211$24355221$1$I$20240826$20240913$20240924$20240924$EXP$$US-ARDELYX-2024ARDX006558$ARDELYX$$40$YR$$M$Y$$$20240923$$PH$US$US
243552221$24355222$1$I$20240701$20240917$20240924$20240924$PER$$US-ARDELYX-2024ARDX006188$ARDELYX$$29$YR$$M$Y$$$20240923$$PH$US$US
243552231$24355223$1$I$$20240905$20240924$20240924$PER$$US-ARDELYX-2024ARDX006789$ARDELYX$$$$$F$Y$$$20240923$$CN$US$US
243552241$24355224$1$I$20240815$20240906$20240924$20240924$PER$$US-ARDELYX-2024ARDX006794$ARDELYX$$27$YR$$F$Y$$$20240923$$CN$US$US
243552251$24355225$1$I$20240716$20240906$20240924$20240924$PER$$US-ARDELYX-2024ARDX006829$ARDELYX$$31$YR$$M$Y$$$20240923$$CN$US$US
243552261$24355226$1$I$20240601$20240905$20240924$20240924$PER$$US-ARDELYX-2024ARDX006788$ARDELYX$$46$YR$$F$Y$$$20240923$$CN$US$US
243552271$24355227$1$I$20240801$20240905$20240924$20240924$PER$$US-ARDELYX-2024ARDX006808$ARDELYX$$61$YR$$M$Y$78$KG$20240923$$CN$US$US
243552281$24355228$1$I$20240101$20240917$20240924$20240924$PER$$US-AMGEN-USASP2024185904$AMGEN$$48$YR$A$M$Y$$$20240923$$CN$US$US
243552291$24355229$1$I$20240622$20240910$20240924$20240924$PER$$US-ARDELYX-2024ARDX006863$ARDELYX$$63$YR$$M$Y$$$20240923$$PH$US$US
243552301$24355230$1$I$20240906$20240909$20240924$20240924$PER$$US-ARDELYX-2024ARDX006849$ARDELYX$$46$YR$$F$Y$97$KG$20240923$$PH$US$US
243552312$24355231$2$F$$20240924$20240924$20240927$PER$$US-AMGEN-USASP2024187428$AMGEN$$$$$F$Y$$$20240927$$CN$US$US
243552332$24355233$2$F$$20240919$20240924$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015277$JAZZ$$$$$F$Y$135.6$KG$20240926$$CN$US$US
243552341$24355234$1$I$20240404$20240918$20240924$20240924$EXP$$US-ABBVIE-5932420$ABBVIE$$69$YR$$F$Y$$$20240924$$CN$US$US
243552351$24355235$1$I$20240409$20240918$20240924$20240924$EXP$$GB-ABBVIE-5930894$ABBVIE$$61$YR$$F$Y$91$KG$20240924$$HP$GB$GB
243552361$24355236$1$I$20240811$20240920$20240924$20240924$EXP$$CA-ABBVIE-5933628$ABBVIE$$77$YR$$M$Y$$$20240924$$CN$CA$CA
243552371$24355237$1$I$20240901$20240920$20240924$20240924$EXP$$JP-TAKEDA-2024TJP013938$TAKEDA$$$$E$M$Y$$$20240924$$MD$JP$JP
243552382$24355238$2$F$20240701$20240923$20240924$20240925$PER$$US-AMGEN-USASP2024188628$AMGEN$$69$YR$E$F$Y$$$20240924$$CN$US$US
243552391$24355239$1$I$$20240919$20240924$20240924$EXP$$CA-ABBVIE-5933786$ABBVIE$$$$E$M$Y$$$20240924$$CN$CA$CA
243552401$24355240$1$I$$20240916$20240924$20240924$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-150280$BRISTOL MYERS SQUIBB$Kudu E, Akdag G, Yildirim ME. Evaluation of emergency department visits and immune-related adverse effects (irAEs) in patients treated with nivolumab. Supportive Care in Cancer. 2024 Sep 09;32(10):1-9. doi:10.1007/s00520-024-08856-x.$83$YR$E$M$Y$$$20240924$$MD$TR$TR
243552411$24355241$1$I$20240919$20240919$20240924$20240924$EXP$$US-ABBVIE-5931523$ABBVIE$$53$YR$$F$Y$$$20240924$$CN$US$US
243552421$24355242$1$I$$20240916$20240924$20240924$EXP$$JP-GENMAB-2024-03405$GENMAB$$84$YR$$F$Y$$$20240924$$MD$JP$JP
243552431$24355243$1$I$20210101$20240916$20240924$20240924$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP012184$STRIDES$Rustom DS, Wall BM, Talwar M.. Malakoplakia in kidney transplant causing severe hydronephrosis and successful treatment with antibiotics and lowering immunosuppression.. Transpl-Infect-Dis. 2023;25:e14158$$$$$Y$$$20240924$$HP$US$US
243552451$24355245$1$I$$20240917$20240924$20240924$EXP$$US-ABBVIE-5929893$ABBVIE$$$$$$Y$$$20240924$$MD$US$US
243552461$24355246$1$I$20240912$20240912$20240924$20240924$PER$$US-GLK-002377$GLAUKOS$$$$$$Y$$$20240924$$MD$US$US
243552471$24355247$1$I$20240907$20240919$20240924$20240924$EXP$$CA-ABBVIE-5935178$ABBVIE$$81$YR$$F$Y$$$20240924$$HP$CA$CA
243552481$24355248$1$I$20240801$20240920$20240924$20240924$EXP$$TR-ABBVIE-5933429$ABBVIE$$69$YR$$M$Y$$$20240924$$CN$TR$TR
243552491$24355249$1$I$$20240917$20240924$20240924$EXP$$US-ABBVIE-5929059$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243552502$24355250$2$F$20240911$20240923$20240924$20240926$PER$$US-AMGEN-USASP2024187565$AMGEN$$$$$$Y$$$20240926$$HP$US$US
243552511$24355251$1$I$20240912$20240919$20240924$20240924$EXP$$US-AMGEN-USASP2024188042$AMGEN$$82$YR$E$M$Y$$$20240923$$CN$US$US
243552531$24355253$1$I$20240101$20240917$20240924$20240924$EXP$$JP-JNJFOC-20240962264$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240924$$MD$JP$JP
243552541$24355254$1$I$$20240917$20240924$20240924$EXP$$JP-GSK-JP2024116680$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
243552551$24355255$1$I$$20240919$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150830$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240924$$CN$US$US
243552571$24355257$1$I$20240911$20240920$20240924$20240924$EXP$$CN-ABBVIE-5934477$ABBVIE$$79$YR$$F$Y$45$KG$20240924$$MD$CN$CN
243552581$24355258$1$I$$20240910$20240924$20240924$30DAY$$JP-JNJFOC-20240946671$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$PH$JP$JP
243552591$24355259$1$I$$20240917$20240924$20240924$EXP$$JP-GSK-JP2024116690$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
243552601$24355260$1$I$$20240917$20240924$20240924$EXP$$JP-GSK-JP2024116695$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
243552611$24355261$1$I$$20240917$20240924$20240924$EXP$$JP-GSK-JP2024116693$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
243552621$24355262$1$I$20240919$20240919$20240924$20240924$EXP$$GB-JNJFOC-20240954574$JOHNSON AND JOHNSON$$57$YR$A$F$Y$70$KG$20240924$$PH$GB$GB
243552631$24355263$1$I$20240810$20240913$20240924$20240924$EXP$$US-ABBVIE-5924366$ABBVIE$$44$YR$$F$Y$$$20240924$$CN$US$US
243552641$24355264$1$I$$20240918$20240924$20240924$EXP$$US-ABBVIE-5848503$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243552651$24355265$1$I$$20240923$20240924$20240924$EXP$$CA-ORGANON-O2409CAN001660$ORGANON$$$$$F$Y$$$20240924$$HP$CA$CA
243552671$24355267$1$I$20220101$20240916$20240924$20240924$EXP$$CO-ABBVIE-5929632$ABBVIE$$$$$F$Y$37$KG$20240924$$CN$CO$CO
243552691$24355269$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189467$NOVARTIS$$$$$$Y$$$20240924$$HP$US$US
243552711$24355271$1$I$20240909$20240913$20240924$20240924$EXP$$US-BEH-2024178876$CSL BEHRING$$66$YR$E$F$Y$172.34$KG$20240924$$CN$US$US
243552721$24355272$1$I$$20240917$20240924$20240924$PER$$US-ROCHE-10000084831$ROCHE$$13$YR$T$M$Y$$$20240924$$CN$US$US
243552731$24355273$1$I$20240809$20240912$20240924$20240924$PER$$US-ROCHE-10000055687$ROCHE$$$$$$Y$$$20240924$$HP$US$US
243552742$24355274$2$F$$20240923$20240924$20240925$PER$$US-ROCHE-10000088010$ROCHE$$78$YR$E$F$Y$$$20240925$$MD$US$US
243552761$24355276$1$I$20240901$20240911$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409007789$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240924$$CN$US$US
243552771$24355277$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013712$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240924$$CN$US$US
243552781$24355278$1$I$$20240912$20240924$20240924$EXP$$DE-AUROBINDO-AUR-APL-2024-045789$AUROBINDO$Bello,A, Fleischmann,B, Jain,S. Teclistamab Success in CAR-T Refractory Multiple Myeloma . A Case Presentation.. Clinical Lymphoma Myeloma and Leukemia. 2024;24:S536-S536$53$YR$$F$Y$$$20240924$$MD$DE$DE
243552811$24355281$1$I$20240101$20240912$20240924$20240924$PER$$US-ABBVIE-5923593$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243552821$24355282$1$I$$20240911$20240924$20240924$EXP$$US-NOVOPROD-1284961$NOVO NORDISK$$$$A$F$Y$$$20240924$$CN$US$US
243552831$24355283$1$I$20230901$20240912$20240924$20240924$EXP$$US-NOVOPROD-1284861$NOVO NORDISK$$74$YR$$M$Y$$$20240924$$CN$US$US
243552841$24355284$1$I$20240628$20240912$20240924$20240924$EXP$$US-NOVOPROD-1274954$NOVO NORDISK$$52$YR$$F$Y$$$20240924$$CN$US$US
243552851$24355285$1$I$$20240912$20240924$20240924$EXP$$US-NOVOPROD-1285150$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$US$US
243552861$24355286$1$I$20240807$20240912$20240924$20240924$EXP$$US-NOVOPROD-1284818$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$US$US
243552871$24355287$1$I$$20240912$20240924$20240924$EXP$$AU-NOVOPROD-1283236$NOVO NORDISK$$$$$M$Y$$$20240924$$MD$AU$AU
243552881$24355288$1$I$20240819$20240912$20240924$20240924$EXP$$US-NOVOPROD-1284978$NOVO NORDISK$$68$YR$$M$Y$$$20240924$$CN$US$US
243552891$24355289$1$I$$20240911$20240924$20240924$EXP$$US-NOVOPROD-1286655$NOVO NORDISK$$$$E$F$Y$$$20240924$$CN$US$US
243552901$24355290$1$I$20240101$20240910$20240924$20240924$EXP$$US-NOVOPROD-1283270$NOVO NORDISK$$64$YR$$F$Y$$$20240924$$CN$US$US
243552911$24355291$1$I$$20240911$20240924$20240924$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP012056$STRIDES$Blush RR. ?-Adrenergic Agonist-Induced Lactic Acidosis: A Case Report.. AACN advanced critical care.. 2024;35(3):222-7$54$YR$$F$Y$$$20240924$$HP$US$US
243552921$24355292$1$I$20231212$20240918$20240924$20240924$EXP$$NVSC2024US160638$NOVARTIS$$88$YR$$F$Y$$$20240924$$CN$US$US
243552931$24355293$1$I$20240627$20240912$20240924$20240924$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002327$Alvotech$$80$YR$$F$Y$$$20240924$$MD$CA$CA
243552941$24355294$1$I$$20240830$20240924$20240924$PER$$US-CHATTEMPRD-2024OHG032812$CHATTEM$$$$A$F$Y$$$20240924$$CN$US$US
243552952$24355295$2$F$20240301$20240916$20240924$20240926$EXP$$US-NOVOPROD-1284514$NOVO NORDISK$$$$A$F$Y$$$20240926$$CN$US$US
243552961$24355296$1$I$$20240912$20240924$20240924$EXP$$DO-NOVOPROD-1283697$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$DO$DO
243552971$24355297$1$I$$20240912$20240924$20240924$EXP$$JP-NOVOPROD-1283237$NOVO NORDISK$$88$YR$$M$Y$$$20240924$$PH$JP$JP
243552981$24355298$1$I$$20240912$20240924$20240924$EXP$$BR-NOVOPROD-1283307$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$BR$BR
243552991$24355299$1$I$20240909$20240912$20240924$20240924$EXP$$US-NOVOPROD-1284768$NOVO NORDISK$$76$YR$$M$Y$$$20240924$$CN$US$US
243553001$24355300$1$I$$20240912$20240924$20240924$EXP$$GB-NOVOPROD-1283260$NOVO NORDISK$$26$YR$$F$Y$$$20240924$$CN$GB$GB
243553021$24355302$1$I$$20240912$20240924$20240924$EXP$$TR-NOVOPROD-1284250$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$TR$TR
243553031$24355303$1$I$$20240912$20240924$20240924$EXP$$TR-NOVOPROD-1284065$NOVO NORDISK$$$$$M$Y$$$20240924$$CN$TR$TR
243553041$24355304$1$I$$20240912$20240924$20240924$EXP$$DE-NOVOPROD-1283572$NOVO NORDISK$$$$$M$Y$$$20240924$$CN$DE$DE
243553051$24355305$1$I$$20240912$20240924$20240924$EXP$$AU-NOVOPROD-1283477$NOVO NORDISK$$74$YR$$F$Y$$$20240924$$MD$AU$AU
243553061$24355306$1$I$$20240912$20240924$20240924$EXP$$US-NOVOPROD-1284763$NOVO NORDISK$$60$YR$$M$Y$$$20240924$$PH$US$US
243553071$24355307$1$I$$20240912$20240924$20240924$EXP$$US-NOVOPROD-1284542$NOVO NORDISK$$26$YR$$F$Y$$$20240924$$CN$US$US
243553091$24355309$1$I$$20240912$20240924$20240924$EXP$$US-NOVOPROD-1284765$NOVO NORDISK$$47$YR$$$Y$$$20240924$$CN$US$US
243553101$24355310$1$I$$20240912$20240924$20240924$EXP$$US-NOVOPROD-1284798$NOVO NORDISK$$49$YR$$$Y$$$20240924$$CN$US$US
243553111$24355311$1$I$$20240912$20240924$20240924$EXP$$JP-NOVOPROD-1283324$NOVO NORDISK$$7$DEC$$F$Y$$$20240924$$PH$JP$JP
243553121$24355312$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5933438$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243553131$24355313$1$I$20240904$20240920$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150795$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240924$$CN$US$US
243553141$24355314$1$I$$20240917$20240924$20240924$EXP$$US-JNJFOC-20240945323$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240924$$PH$US$US
243553151$24355315$1$I$$20240830$20240924$20240924$PER$$US-CHATTEMPRD-2024OHG031645$CHATTEM$$$$A$F$Y$$$20240924$$CN$US$US
243553161$24355316$1$I$$20240920$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150837$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240924$$CN$US$US
243553171$24355317$1$I$20240918$20240919$20240924$20240924$PER$$US-ROCHE-10000087521$ROCHE$$16$YR$T$M$Y$$$20240924$$CN$US$US
243553181$24355318$1$I$$20240909$20240924$20240924$EXP$$US-CIPLA LTD.-2024US10379$CIPLA$Reddy TP, Safdar Z, Barrios R, Bernicker E, Qian W, Chang J.. Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension. Pulmonary Circulation. 2024;4(3):e12426.:1 to 8$$$$$Y$$$20240924$$HP$US$US
243553191$24355319$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000087676$ROCHE$$$$A$M$Y$$$20240924$$CN$US$US
243553201$24355320$1$I$$20240918$20240924$20240924$PER$$US-ROCHE-10000086057$ROCHE$$$$E$M$Y$$$20240924$$CN$US$US
243553211$24355321$1$I$$20240916$20240924$20240924$PER$$US-ROCHE-10000085490$ROCHE$$$$E$M$Y$$$20240924$$CN$US$US
243553231$24355323$1$I$$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188822$AMGEN$$$$$$Y$$$20240923$$MD$US$US
243553241$24355324$1$I$$20240917$20240924$20240924$PER$$US-AMGEN-USASP2024186373$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243553251$24355325$1$I$20240112$20240919$20240924$20240924$EXP$AT-BASGAGES-2024-006759$AT-AMGEN-AUTSP2024187436$AMGEN$$54$YR$A$F$Y$$$20240923$$CN$AT$AT
243553261$24355326$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189487$NOVARTIS$$$$$$Y$$$20240924$$HP$US$US
243553271$24355327$1$I$20240801$20240912$20240924$20240924$EXP$GB-MHRA-MED-202409120743382770-DNZSH$GB-Accord-448100$ACCORD$$34$YR$A$M$Y$91$KG$20240924$$CN$GB$GB
243553281$24355328$1$I$$20240920$20240924$20240924$PER$$US-ROCHE-10000087990$ROCHE$$$$E$F$Y$$$20240924$$CN$US$US
243553291$24355329$1$I$$20240909$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005492$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243553301$24355330$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189410$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243553311$24355331$1$I$20240401$20240918$20240924$20240924$EXP$$CA-PFIZER INC-202400070586$PFIZER$$65$YR$$F$Y$$$20240924$$MD$CA$CA
243553322$24355332$2$F$$20240924$20240924$20240927$EXP$$JP-SANDOZ INC.-SDZ2024JP081012$SANDOZ$$76$YR$$M$Y$$$20240927$$MD$JP$JP
243553331$24355333$1$I$$20240918$20240924$20240924$EXP$$CA-ROCHE-10000084883$ROCHE$$$$$M$Y$$$20240924$$HP$CA$CA
243553361$24355336$1$I$$20240912$20240924$20240924$EXP$CA-MHPD-E2B_06712983$CA-Accord-404817$ACCORD$$35$YR$A$F$Y$$$20240924$$HP$CA$
243553381$24355338$1$I$$20240917$20240924$20240924$PER$$US-ROCHE-10000084866$ROCHE$$$$A$F$Y$$$20240924$$CN$US$US
243553392$24355339$2$F$20240922$20240923$20240924$20240927$PER$$US-AMGEN-USASP2024189292$AMGEN$$84$YR$E$F$Y$$$20240927$$CN$US$US
243553411$24355341$1$I$$20240912$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005572$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
243553422$24355342$2$F$20240801$20240917$20240924$20240925$EXP$$NZ-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-043919$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$94$KG$20240925$$HP$NZ$NZ
243553431$24355343$1$I$$20240916$20240924$20240924$PER$$US-ROCHE-10000085404$ROCHE$$$$$F$Y$$$20240924$$MD$US$US
243553441$24355344$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000088456$ROCHE$$$$$$Y$$$20240924$$CN$US$US
243553471$24355347$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013437$ELI LILLY AND CO$$$$A$$Y$$$20240924$$CN$US$US
243553481$24355348$1$I$$20240916$20240924$20240924$EXP$$CA-TAKEDA-2024TUS089946$TAKEDA$$$$$F$Y$$$20240924$$CN$CA$CA
243553491$24355349$1$I$20240919$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188227$AMGEN$$70$YR$E$M$Y$$$20240923$$CN$US$US
243553501$24355350$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013860$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240924$$CN$US$US
243553511$24355351$1$I$20240825$20240915$20240924$20240924$EXP$$CN-BEIGENE-BGN-2024-014751$BEIGENE$$$$$$Y$$$20240924$$HP$CN$CN
243553522$24355352$2$F$$20240923$20240924$20240925$PER$$US-AMGEN-USASP2024188469$AMGEN$$$$$F$Y$$$20240925$$CN$US$US
243553531$24355353$1$I$$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024187982$AMGEN$$$$$F$Y$$$20240923$$CN$US$US
243553541$24355354$1$I$20240101$20240819$20240924$20240924$PER$$US-ENDO USA, INC.-2024-003273$ENDO$$$$$M$Y$$$20240924$$CN$US$US
243553561$24355356$1$I$20240917$20240918$20240924$20240924$PER$$US-ABBVIE-5933010$ABBVIE$$46$YR$$F$Y$$$20240924$$HP$US$US
243553581$24355358$1$I$$20240912$20240924$20240924$EXP$$US-Accord-446968$ACCORD$$$$$M$Y$$$20240924$$HP$US$US
243553591$24355359$1$I$20240901$20240910$20240924$20240924$PER$$US-JNJFOC-20240925284$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240924$$CN$US$US
243553601$24355360$1$I$$20240912$20240924$20240924$EXP$$US-Accord-447342$ACCORD$$$$$F$Y$102.51$KG$20240924$$HP$US$US
243553611$24355361$1$I$20240910$20240918$20240924$20240924$EXP$$CN-ROCHE-10000085754$ROCHE$$40$YR$A$M$Y$80$KG$20240924$$HP$CN$CN
243553621$24355362$1$I$20240722$20240905$20240924$20240924$30DAY$$US-BECTON DICKINSON-US-BD-24-000552$BECTON DICKINSON$$$$$$Y$$$20240924$$CN$US$US
243553631$24355363$1$I$$20240906$20240924$20240924$30DAY$$US-BECTON DICKINSON-US-BD-24-000553$BECTON DICKINSON$$$$$$Y$$$20240924$$CN$US$US
243553642$24355364$2$F$20240913$20240924$20240924$20240927$PER$$US-AMGEN-USASP2024184774$AMGEN$$32$YR$A$F$Y$$$20240926$$HP$US$US
243553651$24355365$1$I$20240717$20240912$20240924$20240924$EXP$$GB-AUROBINDO-AUR-APL-2024-045797$AUROBINDO$$27$YR$$M$Y$96$KG$20240924$$MD$GB$GB
243553661$24355366$1$I$20220101$20240904$20240924$20240924$EXP$$CN-AVS-000017$AAVIS PHARMACEUTICALS$Lei Y, Zhang X, Liu H, Xu Z, Xu P. Amyotrophic lateral sclerosis associated with Sjogren^s syndrome: a case report. BMC Neurol. 2024 Aug 28;24(1):300. doi: 10.1186/s12883-024-03775-0.$56$YR$A$M$Y$$$20240917$$HP$CN$CN
243553671$24355367$1$I$20240901$20240912$20240924$20240924$EXP$$US-Accord-447345$ACCORD$$64$YR$A$F$Y$$$20240924$$HP$US$US
243553681$24355368$1$I$$20240913$20240924$20240924$EXP$$US-ROCHE-10000084565$ROCHE$$78$YR$E$F$Y$$$20240924$$CN$US$US
243553691$24355369$1$I$20220101$20240917$20240924$20240924$EXP$$RO-ABBVIE-5927355$ABBVIE$$46$YR$$$Y$$$20240924$$MD$RO$RO
243553711$24355371$1$I$$20240918$20240924$20240924$EXP$$CA-ALVOTECHPMS-2023-ALVOTECHPMS-000971$Alvotech$$52$YR$$F$Y$$$20240924$$PH$CA$CA
243553721$24355372$1$I$$20240920$20240924$20240924$PER$$US-ABBVIE-5935320$ABBVIE$$$$$$Y$$$20240924$$HP$US$US
243553741$24355374$1$I$$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188867$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243553751$24355375$1$I$$20240916$20240924$20240924$EXP$$US-AMGEN-USASP2024184869$AMGEN$$$$$M$Y$90.71$KG$20240923$$CN$US$US
243553761$24355376$1$I$20240717$20240916$20240924$20240924$EXP$$US-AMGEN-USASP2024184841$AMGEN$$52$YR$A$F$Y$$$20240923$$CN$US$US
243553771$24355377$1$I$$20240916$20240924$20240924$PER$$US-AMGEN-USASP2024187078$AMGEN$$22$YR$A$M$Y$$$20240923$$MD$US$US
243553781$24355378$1$I$20240101$20240919$20240924$20240924$EXP$$US-JNJFOC-20240958851$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240924$$HP$US$US
243553791$24355379$1$I$20240701$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005220$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240924$$CN$US$US
243553801$24355380$1$I$$20240912$20240924$20240924$EXP$$JP-Accord-446773$ACCORD$Yamamoto Y, Iino K, Kitazawa M, Nakahara M, Nakabori H, Ueda H, et al. Fibrin-associated diffuse large B-cell lymphoma in the aortic valve and ascending aorta. Journal of Cardiology Cases. 2024;30(3):94-6.$$$A$F$Y$$$20240924$$MD$JP$JP
243553821$24355382$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005224$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243553831$24355383$1$I$$20240917$20240924$20240924$EXP$$GB-JAZZ PHARMACEUTICALS-2024-GB-015401$JAZZ$$9$YR$$M$Y$$$20240923$$HP$GB$GB
243553841$24355384$1$I$20240920$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013571$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240924$$CN$US$US
243553851$24355385$1$I$20240919$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012527$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240924$$CN$US$US
243553861$24355386$1$I$$20240913$20240924$20240924$EXP$$IT-AUROBINDO-AUR-APL-2024-046247$AUROBINDO$Marcon, G.. Visual Hallucinations With Sertraline.. Journal of Clinical Psychiatry.. 2004;65 (3):446-447$70$YR$$F$Y$$$20240924$$MD$IT$IT
243553871$24355387$1$I$$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409131322524410-MCGDB$GB-Accord-447010$ACCORD$$$$$$Y$$$20240924$$PH$GB$GB
243553891$24355389$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000088501$ROCHE$$$$A$M$Y$$$20240924$$CN$US$US
243553901$24355390$1$I$$20240905$20240924$20240924$PER$$US-JNJFOC-20240912711$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243553911$24355391$1$I$$20240913$20240924$20240924$EXP$$US-ABBVIE-5926387$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243553921$24355392$1$I$$20240917$20240924$20240924$EXP$$US-JNJFOC-20240945504$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$MD$US$US
243553931$24355393$1$I$$20240920$20240924$20240924$PER$$US-ROCHE-10000087364$ROCHE$$$$A$F$Y$$$20240924$$CN$US$US
243553941$24355394$1$I$20240911$20240920$20240924$20240924$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-127167$REGENERON$$$$$F$Y$$$20240924$$CN$CA$CA
243553951$24355395$1$I$$20240918$20240924$20240924$EXP$$TW-AMGEN-TWNSP2024188736$AMGEN$$$$E$F$Y$$$20240923$$HP$TW$TW
243553961$24355396$1$I$20240830$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188137$AMGEN$$70$YR$E$F$Y$$$20240923$$CN$US$US
243553971$24355397$1$I$$20240916$20240924$20240924$PER$$US-AMGEN-USASP2024186055$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243553981$24355398$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024187519$AMGEN$$$$$$Y$$$20240923$$HP$US$US
243553991$24355399$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005212$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
243554001$24355400$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005205$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243554011$24355401$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005213$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243554021$24355402$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005219$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243554041$24355404$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005215$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$HP$US$US
243554051$24355405$1$I$20240101$20240913$20240924$20240924$EXP$SE-SEMPA-2024-006426$SE-Accord-447171$ACCORD$$$$$F$Y$$$20240924$$CN$SE$SE
243554061$24355406$1$I$$20240920$20240924$20240924$PER$$US-ROCHE-10000088270$ROCHE$$$$$$Y$$$20240924$$CN$US$US
243554081$24355408$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003863$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243554091$24355409$1$I$20240919$20240920$20240924$20240924$EXP$$US-AMGEN-USASP2024188890$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243554101$24355410$1$I$$20240912$20240924$20240924$PER$$US-ABBVIE-5926392$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243554111$24355411$1$I$$20240921$20240924$20240924$PER$$NVSC2024US189031$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
243554121$24355412$1$I$$20240913$20240924$20240924$PER$$US-CHATTEMPRD-2024OHG032125$CHATTEM$$41$YR$A$F$Y$$$20240924$$HP$US$US
243554141$24355414$1$I$$20240913$20240924$20240924$PER$$US-JNJFOC-20240940053$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243554151$24355415$1$I$$20240919$20240924$20240924$EXP$$GB-JNJFOC-20240959935$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$HP$GB$GB
243554161$24355416$1$I$$20240919$20240924$20240924$EXP$$LU-JNJFOC-20240959711$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$MD$LU$LU
243554171$24355417$1$I$20230101$20240920$20240924$20240924$PER$$US-ROCHE-10000088127$ROCHE$$79$YR$E$M$Y$83.91$KG$20240924$$CN$US$US
243554181$24355418$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189532$NOVARTIS$$$$$$Y$$$20240924$$HP$US$US
243554191$24355419$1$I$20240701$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409131510347000-FHCDP$GB-Accord-446738$ACCORD$$28$YR$A$F$Y$58$KG$20240924$$HP$GB$GB
243554201$24355420$1$I$$20240918$20240924$20240924$PER$$US-CHATTEMPRD-2024OHG032710$CHATTEM$$$$$M$Y$$$20240924$$CN$US$US
243554211$24355421$1$I$20240302$20240910$20240924$20240924$EXP$$GB-AMGEN-GBRSP2024188509$AMGEN$$80$YR$E$F$Y$67$KG$20240923$$HP$GB$GB
243554221$24355422$1$I$$20240919$20240924$20240924$PER$$US-CHATTEMPRD-2024OHG032790$CHATTEM$$$$$F$Y$$$20240924$$HP$US$US
243554231$24355423$1$I$$20240912$20240924$20240924$EXP$$US-NOVOPROD-1285825$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$US$US
243554241$24355424$1$I$$20240913$20240924$20240924$EXP$$US-NOVOPROD-1285684$NOVO NORDISK$$$$$M$Y$$$20240924$$CN$US$US
243554251$24355425$1$I$$20240829$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000525$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240923$$PH$US$US
243554261$24355426$1$I$$20240820$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000403$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243554271$24355427$1$I$$20240828$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000516$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240923$$CN$US$US
243554281$24355428$1$I$$20240914$20240924$20240924$PER$$US-EMD Serono-2024049431$EMD SERONO INC$$$$A$F$Y$$$20240924$$HP$US$US
243554291$24355429$1$I$$20240912$20240924$20240924$EXP$$IN-Accord-447421$ACCORD$Shinde V, Penmetsa P, Nair KR, Dixit Y. A Neuropathy Mimic: Statin-Induced Myopathy Presenting as Guillain-Barre Syndrome. Cureus. 2024 Aug 8;16(8):e66483. doi: 10.7759/cureus.66483.$$$$F$Y$$$20240924$$HP$IN$IN
243554301$24355430$1$I$20240905$20240912$20240924$20240924$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03421$AMNEAL$$58$YR$$F$Y$$$20240924$$HP$US$US
243554321$24355432$1$I$$20240916$20240924$20240924$EXP$$US-TAKEDA-2024TUS093087$TAKEDA$$$$$M$Y$$$20240924$$CN$US$US
243554331$24355433$1$I$20240520$20240920$20240924$20240924$EXP$$ES-ROCHE-10000087704$ROCHE$$49$YR$A$M$Y$$$20240924$$MD$ES$ES
243554341$24355434$1$I$$20240918$20240924$20240924$PER$$US-ABBVIE-5932656$ABBVIE$$$$$$Y$$$20240924$$HP$US$US
243554351$24355435$1$I$20240622$20240918$20240924$20240924$EXP$$JP-SA-2024SA254363$SANOFI AVENTIS$$9$YR$C$M$Y$28$KG$20240924$$MD$JP$JP
243554361$24355436$1$I$$20240920$20240924$20240924$EXP$$JP-SAKK-2024SA271900AA$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240924$$MD$JP$JP
243554371$24355437$1$I$$20240904$20240924$20240924$PER$$AU-TOLMAR, INC.-24AU052383$TOLMAR$$$$$M$Y$$$20240923$$CN$AU$AU
243554381$24355438$1$I$20240701$20240919$20240924$20240924$EXP$$US-SA-2024SA273263$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240924$$MD$US$US
243554391$24355439$1$I$$20240906$20240924$20240924$PER$$AU-TOLMAR, INC.-24AU052474$TOLMAR$$$$$M$Y$$$20240923$$CN$AU$AU
243554401$24355440$1$I$$20240904$20240924$20240924$PER$$AU-TOLMAR, INC.-24AU052407$TOLMAR$$$$$M$Y$$$20240923$$CN$AU$AU
243554411$24355441$1$I$$20240905$20240924$20240924$PER$$BR-TOLMAR, INC.-24BR052493$TOLMAR$$$$$F$Y$$$20240923$$CN$BR$BR
243554421$24355442$1$I$20240101$20240905$20240924$20240924$PER$$BR-TOLMAR, INC.-24BR052310$TOLMAR$$$$$F$Y$$$20240923$$CN$BR$BR
243554431$24355443$1$I$20240101$20240905$20240924$20240924$PER$$BR-TOLMAR, INC.-24BR052501$TOLMAR$$$$$M$Y$$$20240923$$CN$BR$BR
243554441$24355444$1$I$20240824$20240914$20240924$20240924$EXP$CN-NMPA-3308811037326202400173$CN-NOVOPROD-1284632$NOVO NORDISK$$71$YR$$M$Y$$$20240924$$HP$CN$CN
243554451$24355445$1$I$$20240913$20240924$20240924$EXP$$RO-NOVOPROD-1284101$NOVO NORDISK$$26$YR$$F$Y$60$KG$20240924$$CN$RO$RO
243554461$24355446$1$I$20240301$20240913$20240924$20240924$EXP$$RO-NOVOPROD-1284107$NOVO NORDISK$$61$YR$$F$Y$$$20240924$$MD$RO$RO
243554481$24355448$1$I$20240907$20240913$20240924$20240924$EXP$$AR-NOVOPROD-1284113$NOVO NORDISK$$$$$M$Y$$$20240924$$CN$AR$AR
243554491$24355449$1$I$$20240914$20240924$20240924$EXP$$CN-NOVOPROD-1284084$NOVO NORDISK$$50$YR$$M$Y$$$20240924$$CN$CN$CN
243554501$24355450$1$I$20240817$20240913$20240924$20240924$EXP$CN-NMPA-3604011018746202400788$CN-NOVOPROD-1284238$NOVO NORDISK$$43$YR$$M$Y$74$KG$20240924$$HP$CN$CN
243554521$24355452$1$I$$20240920$20240924$20240924$PER$$US-ROCHE-10000088173$ROCHE$$$$A$F$Y$$$20240924$$CN$US$US
243554531$24355453$1$I$$20240917$20240924$20240924$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2024115319$VIIV$$$$$$Y$$$20240924$$PH$JP$JP
243554541$24355454$1$I$20240811$20240913$20240924$20240924$EXP$FR-AFSSAPS-CN2024000839$FR-Accord-447288$ACCORD$$16$YR$T$M$Y$$$20240924$$MD$FR$FR
243554551$24355455$1$I$$20240918$20240924$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015540$JAZZ$$28$YR$$F$Y$$$20240923$$CN$US$US
243554561$24355456$1$I$20240829$20240913$20240924$20240924$EXP$$GB-LAURUS LABS LIMITED-2024LAU000067$LAURUS LABS LIMITED$$50$YR$$F$Y$93$KG$20240924$$HP$GB$GB
243554571$24355457$1$I$20230901$20230922$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004748$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240615$$HP$US$US
243554581$24355458$1$I$$20240110$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004726$AZURITY PHARMACEUTICALS$$50$YR$A$F$Y$$$20240615$$CN$US$US
243554591$24355459$1$I$20230101$20231213$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB005033$AZURITY PHARMACEUTICALS$$$$$F$Y$$$20240615$$CN$US$US
243554601$24355460$1$I$20240601$20240624$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000809$AZURITY PHARMACEUTICALS$$24$YR$A$M$Y$36$KG$20240809$$PH$US$US
243554611$24355461$1$I$$20240917$20240924$20240924$PER$$US-CHATTEMPRD-2024OHG032611$CHATTEM$$$$$$Y$$$20240924$$CN$US$US
243554621$24355462$1$I$$20230901$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2023ARB004673$AZURITY PHARMACEUTICALS$$50$YR$A$F$Y$$$20240615$$CN$US$US
243554631$24355463$1$I$$20240917$20240924$20240924$PER$$US-CHATTEMPRD-2024OHG032674$CHATTEM$$$$A$$Y$$$20240924$$CN$US$US
243554641$24355464$1$I$20240905$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409132124506250-RFNMH$GB-NOVOPROD-1283963$NOVO NORDISK$$57$YR$$$Y$$$20240924$$PH$GB$GB
243554651$24355465$1$I$20231029$20240913$20240924$20240924$EXP$NO-NOMAADVRE-RELISSO-2024-V5k6pk$NO-NOVOPROD-1282946$NOVO NORDISK$$27$YR$$F$Y$100$KG$20240924$$MD$NO$NO
243554661$24355466$1$I$20240909$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409131208134840-SFKLD$GB-NOVOPROD-1283968$NOVO NORDISK$$62$YR$$F$Y$94$KG$20240924$$MD$GB$GB
243554671$24355467$1$I$20240701$20240913$20240924$20240924$EXP$SE-SEMPA-2024-006610$SE-NOVOPROD-1282962$NOVO NORDISK$$82$YR$$M$Y$$$20240924$$MD$SE$SE
243554681$24355468$1$I$$20240913$20240924$20240924$EXP$$NO-NOVOPROD-1283582$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$NO$NO
243554701$24355470$1$I$20240902$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409131615114730-ZRWKH$GB-NOVOPROD-1283965$NOVO NORDISK$$34$YR$$F$Y$$$20240924$$PH$GB$GB
243554711$24355471$1$I$$20240910$20240924$20240924$EXP$$JP-APCER-AZR202409-000655$AZURITY PHARMACEUTICALS$$$$$F$Y$$$20240923$$PH$JP$JP
243554721$24355472$1$I$$20240725$20240924$20240924$EXP$$GB-AZURITY PHARMACEUTICALS, INC.-AZR202407-000662$AZURITY PHARMACEUTICALS$$83$YR$$$Y$$$20240923$$PH$GB$GB
243554731$24355473$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024187334$AMGEN$$$$$M$Y$$$20240923$$CN$US$US
243554741$24355474$1$I$$20240920$20240924$20240924$EXP$$CA-ROCHE-10000087928$ROCHE$$$$A$F$Y$$$20240924$$CN$CA$CA
243554751$24355475$1$I$$20240909$20240924$20240924$PER$$US-JNJFOC-20240927532$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243554761$24355476$1$I$20201209$20240913$20240924$20240924$EXP$ES-AEMPS-1260903$ES-Accord-447092$ACCORD$$90$YR$E$F$Y$$$20240924$$MD$ES$ES
243554771$24355477$1$I$20240901$20240902$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000493$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$MD$US$US
243554781$24355478$1$I$$20240920$20240924$20240924$PER$$US-HALEON-2198110$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
243554791$24355479$1$I$20240801$20240830$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000486$REVANCE THERAPEUTICS$$$$$F$Y$$$20240924$$HP$US$US
243554801$24355480$1$I$20240818$20240830$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000487$REVANCE THERAPEUTICS$$$$$F$Y$$$20240924$$HP$US$US
243554811$24355481$1$I$20240817$20240831$20240924$20240924$EXP$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000489$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$MD$US$US
243554821$24355482$1$I$20240101$20240903$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000495$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$HP$US$US
243554831$24355483$1$I$20240801$20240904$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000496$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$MD$US$US
243554841$24355484$1$I$$20240830$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000491$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$MD$US$US
243554851$24355485$1$I$20240101$20240903$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000494$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$HP$US$US
243554861$24355486$1$I$20240822$20240920$20240924$20240924$PER$$US-ROCHE-10000088208$ROCHE$$47$YR$A$F$Y$104.33$KG$20240924$$CN$US$US
243554871$24355487$1$I$20240817$20240830$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000485$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$HP$US$US
243554881$24355488$1$I$$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011040$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240924$$CN$US$US
243554891$24355489$1$I$20240917$20240918$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011715$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240924$$CN$US$US
243554901$24355490$1$I$20240920$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013619$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240924$$CN$US$US
243554911$24355491$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013569$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240924$$CN$US$US
243554921$24355492$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013644$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243554931$24355493$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014276$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243554951$24355495$1$I$20240913$20240923$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150777$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$$$20240924$$CN$US$US
243554961$24355496$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005237$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
243554971$24355497$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150871$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240924$$HP$US$US
243554982$24355498$2$F$$20240923$20240924$20240924$PER$$US-ROCHE-10000088481$ROCHE$$$$$F$Y$$$20240924$$MD$US$US
243554991$24355499$1$I$20240917$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024186999$AMGEN$$80$YR$E$F$Y$$$20240923$$CN$US$US
243555001$24355500$1$I$20240909$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024189302$AMGEN$$$$$$Y$$$20240923$$PH$US$US
243555011$24355501$1$I$20240916$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024187513$AMGEN$$50$YR$A$F$Y$$$20240923$$CN$US$US
243555021$24355502$1$I$$20240922$20240924$20240924$PER$$US-ROCHE-10000088351$ROCHE$$$$$$Y$$$20240924$$MD$US$US
243555031$24355503$1$I$20180101$20240916$20240924$20240924$EXP$$NL-CELLTRION INC.-2024NL022461$CELLTRION$$$$$$Y$$$20240924$$HP$NL$NL
243555041$24355504$1$I$$20240826$20240924$20240924$PER$$US-ROCHE-10000018552$ROCHE$$34$YR$A$F$Y$$$20240924$$MD$US$US
243555061$24355506$1$I$20240830$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005238$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20240924$$CN$US$US
243555071$24355507$1$I$20240902$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409101300091540-GRMQV$GB-Accord-446815$ACCORD$$90$YR$E$F$Y$36$KG$20240924$$HP$GB$GB
243555081$24355508$1$I$20230501$20240913$20240924$20240924$EXP$DE-EMBRYOTOX-202301709-B$DE-ROCHE-10000081911$ROCHE$$1$DY$N$F$Y$1.91$KG$20240924$$MD$DE$DE
243555091$24355509$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005242$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243555101$24355510$1$I$$20240921$20240924$20240924$PER$$NVSC2024US189072$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
243555121$24355512$1$I$$20240912$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147012$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240924$$CN$US$US
243555131$24355513$1$I$20240101$20240904$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000501$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$CN$US$US
243555141$24355514$1$I$$20240906$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000506$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$MD$US$US
243555151$24355515$1$I$20240712$20240904$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000497$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$HP$US$US
243555161$24355516$1$I$20240101$20240905$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000503$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$HP$US$US
243555171$24355517$1$I$20240827$20240905$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000502$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$HP$US$US
243555181$24355518$1$I$$20240611$20240924$20240924$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000337$REVANCE THERAPEUTICS$$$$$$Y$$$20240924$$CN$US$US
243555191$24355519$1$I$20240828$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005234$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240924$$CN$US$US
243555201$24355520$1$I$20220517$20240913$20240924$20240924$EXP$$DE-JNJFOC-20240944324$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240924$$MD$DE$DE
243555211$24355521$1$I$20230101$20240919$20240924$20240924$EXP$$US-JNJFOC-20240953336$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243555221$24355522$1$I$20240814$20240913$20240924$20240924$EXP$FR-AFSSAPS-AM2024000719$FR-Accord-447264$ACCORD$$63$YR$A$F$Y$$$20240924$$PH$FR$FR
243555231$24355523$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005259$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
243555252$24355525$2$F$20240922$20240924$20240924$20240925$PER$$US-AMGEN-USASP2024189232$AMGEN$$77$YR$E$M$Y$$$20240925$$CN$US$US
243555261$24355526$1$I$20240623$20240911$20240924$20240924$EXP$$CN-ABBVIE-5910949$ABBVIE$$58$YR$$F$Y$48$KG$20240924$$MD$CN$CN
243555271$24355527$1$I$$20240916$20240924$20240924$PER$$US-BIOGEN-2024BI01282925$BIOGEN$$$$$$Y$$$20240924$$MD$US$US
243555281$24355528$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005261$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
243555301$24355530$1$I$$20240918$20240924$20240924$PER$$US-ROCHE-10000085788$ROCHE$$$$$$Y$$$20240924$$CN$US$US
243555321$24355532$1$I$$20240920$20240924$20240924$EXP$$BG-ABBVIE-5933269$ABBVIE$$45$YR$$M$Y$$$20240924$$CN$BG$BG
243555331$24355533$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005262$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
243555351$24355535$1$I$$20240916$20240924$20240924$EXP$$CA-TOLMAR, INC.-24CA052619$TOLMAR$$$$$M$Y$$$20240924$$CN$CA$CA
243555362$24355536$2$F$20240524$20240911$20240924$20240925$EXP$$CN-ABBVIE-5910927$ABBVIE$$50$YR$$F$Y$52$KG$20240925$$HP$CN$CN
243555371$24355537$1$I$$20240916$20240924$20240924$EXP$$CA-TOLMAR, INC.-24CA052616$TOLMAR$$$$$M$Y$$$20240924$$PH$CA$CA
243555381$24355538$1$I$$20240916$20240924$20240924$EXP$$CA-TOLMAR, INC.-24CA052646$TOLMAR$$$$$M$Y$$$20240924$$CN$CA$CA
243555392$24355539$2$F$$20240919$20240924$20240925$EXP$$JP-JNJFOC-20240959255$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240925$$PH$JP$JP
243555401$24355540$1$I$20240919$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013967$ELI LILLY AND CO$$$$$F$Y$$$20240924$$CN$US$US
243555412$24355541$2$F$$20240923$20240924$20240924$30DAY$$US-ELI_LILLY_AND_COMPANY-US202409013582$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240924$$PH$US$US
243555421$24355542$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013822$ELI LILLY AND CO$$$$A$M$Y$$$20240924$$CN$US$US
243555431$24355543$1$I$20240917$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012840$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240924$$CN$US$US
243555441$24355544$1$I$20240919$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013960$ELI LILLY AND CO$$$$$F$Y$$$20240924$$CN$US$US
243555452$24355545$2$F$$20240924$20240924$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409011931$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240926$$CN$US$US
243555461$24355546$1$I$20240801$20240917$20240924$20240924$PER$$US-AMGEN-USASP2024186108$AMGEN$$68$YR$E$F$Y$$$20240923$$HP$US$US
243555471$24355547$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189553$NOVARTIS$$$$$$Y$$$20240924$$HP$US$US
243555481$24355548$1$I$$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024187783$AMGEN$$70$YR$E$F$Y$$$20240923$$CN$US$US
243555491$24355549$1$I$$20240919$20240924$20240924$EXP$$DE-ROCHE-10000088667$ROCHE$$$$A$F$Y$$$20240924$$MD$DE$DE
243555501$24355550$1$I$$20240910$20240924$20240924$EXP$$US-SPECGX-T202401901$SPECGX$Ghalayni R, Kalaji BA, Malik K. From friend to foe: A case of naloxone-induced pulmonary edema. Hospital Pharmacy. 2024;59(4):407-10$66$YR$$F$Y$$$20240924$$HP$US$US
243555511$24355551$1$I$$20240910$20240924$20240924$EXP$$US-SPECGX-T202401898$SPECGX$Carmona H, Town J. Positive pressure, negative consequences: Treating naloxone-induced pulmonary edema in the setting of pneumomediastinum and pneumopericardium. Am J Respir Crit Care Med. 2020;201(C37):A4950$25$YR$$M$Y$$$20240924$$HP$US$US
243555522$24355552$2$F$20240913$20240919$20240924$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029193$UNITED THERAPEUTICS$$80$YR$$F$Y$72.562$KG$20240927$$$US$US
243555531$24355553$1$I$$20240904$20240924$20240924$PER$$US-JNJFOC-20240912206$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$PH$US$US
243555541$24355554$1$I$20231101$20240913$20240924$20240924$EXP$$CO-NOVOPROD-1285259$NOVO NORDISK$$64$YR$$F$Y$$$20240924$$CN$CO$CO
243555551$24355555$1$I$$20240913$20240924$20240924$EXP$$BR-NOVOPROD-1284741$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$BR$BR
243555561$24355556$1$I$$20240913$20240924$20240924$EXP$$BE-NOVOPROD-1284921$NOVO NORDISK$$$$$F$Y$$$20240924$$MD$BE$BE
243555571$24355557$1$I$20240801$20240913$20240924$20240924$EXP$$US-NOVOPROD-1285857$NOVO NORDISK$$68$YR$$F$Y$$$20240924$$CN$US$US
243555581$24355558$1$I$$20240913$20240924$20240924$EXP$$BR-NOVOPROD-1284736$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$BR$BR
243555591$24355559$1$I$$20240913$20240924$20240924$EXP$$BR-NOVOPROD-1284731$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$BR$BR
243555601$24355560$1$I$20230601$20240913$20240924$20240924$EXP$$US-NOVOPROD-1285238$NOVO NORDISK$$68$YR$$M$Y$$$20240924$$CN$US$US
243555611$24355561$1$I$$20240913$20240924$20240924$EXP$$TR-NOVOPROD-1284922$NOVO NORDISK$$$$$M$Y$$$20240924$$CN$TR$TR
243555621$24355562$1$I$$20240913$20240924$20240924$EXP$$CA-NOVOPROD-1284746$NOVO NORDISK$$$$$$Y$$$20240924$$CN$CA$CA
243555641$24355564$1$I$$20240916$20240924$20240924$EXP$$ES-ROCHE-10000089012$ROCHE$Somovilla A, Aguirre C G. Organizing Pneumonia in Multiple Sclerosis Patients Treated with Ocrelizumab following SARS-CoV-2 Infection: A Case Series Report (Abstract number: P1153/2242). Multiple Sclerosis Journal. 2024;30 (3(S)):763.$49$YR$A$M$Y$$$20240924$$HP$ES$ES
243555651$24355565$1$I$20240101$20240920$20240924$20240924$EXP$$NVSC2024GT189356$NOVARTIS$$$$$M$Y$$$20240924$$MD$GT$GT
243555661$24355566$1$I$20240913$20240914$20240924$20240924$EXP$$CO-NOVOPROD-1285465$NOVO NORDISK$$$$$F$Y$50$KG$20240924$$CN$CO$CO
243555671$24355567$1$I$20240101$20240912$20240924$20240924$EXP$$CA-TAKEDA-2024TUS091504$TAKEDA$$41$YR$$F$Y$80$KG$20240924$$MD$CA$CA
243555681$24355568$1$I$$20240913$20240924$20240924$EXP$$US-NOVOPROD-1285829$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$US$US
243555691$24355569$1$I$$20240913$20240924$20240924$EXP$$BR-NOVOPROD-1286339$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$BR$BR
243555701$24355570$1$I$$20240913$20240924$20240924$EXP$$BR-NOVOPROD-1285878$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$BR$BR
243555711$24355571$1$I$$20240913$20240924$20240924$EXP$$US-NOVOPROD-1285552$NOVO NORDISK$$$$A$F$Y$$$20240924$$CN$US$US
243555721$24355572$1$I$$20240913$20240924$20240924$EXP$$US-NOVOPROD-1285575$NOVO NORDISK$$44$YR$$F$Y$$$20240924$$CN$US$US
243555741$24355574$1$I$20240514$20240913$20240924$20240924$EXP$$US-NOVOPROD-1285631$NOVO NORDISK$$57$YR$$F$Y$$$20240924$$CN$US$US
243555751$24355575$1$I$20230501$20240913$20240924$20240924$EXP$$US-NOVOPROD-1285574$NOVO NORDISK$$79$YR$$F$Y$$$20240924$$CN$US$US
243555761$24355576$1$I$$20240913$20240924$20240924$EXP$$US-NOVOPROD-1285597$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$US$US
243555771$24355577$1$I$20220901$20240913$20240924$20240924$EXP$$US-NOVOPROD-1285572$NOVO NORDISK$$76$YR$$F$Y$$$20240924$$CN$US$US
243555781$24355578$1$I$$20240913$20240924$20240924$EXP$$BR-NOVOPROD-1286078$NOVO NORDISK$$$$$F$Y$$$20240924$$CN$BR$BR
243555791$24355579$1$I$20240825$20240913$20240924$20240924$EXP$FR-AFSSAPS-BR2024000705$FR-Accord-447169$ACCORD$$64$YR$A$F$Y$66$KG$20240924$$MD$FR$FR
243555801$24355580$1$I$$20240909$20240924$20240924$PER$$US-JNJFOC-20240939772$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243555812$24355581$2$F$20240921$20240923$20240924$20240925$PER$$US-AMGEN-USASP2024189480$AMGEN$$29$YR$A$F$Y$$$20240925$$CN$US$US
243555821$24355582$1$I$20240701$20240920$20240924$20240924$EXP$FR-AFSSAPS-PP2024001005$FR-TAKEDA-2024TUS093568$TAKEDA$$69$YR$$M$Y$93$KG$20240924$$HP$FR$FR
243555831$24355583$1$I$$20240919$20240924$20240924$EXP$$DE-TAKEDA-2024TUS093809$TAKEDA$$$$$M$Y$$$20240924$$CN$GB$DE
243555841$24355584$1$I$20240801$20240920$20240924$20240924$EXP$$US-AMGEN-USASP2024188458$AMGEN$$$$E$F$Y$$$20240923$$CN$US$US
243555851$24355585$1$I$$20240916$20240924$20240924$EXP$$JP-TEVA-VS-3244666$TEVA$Amemiya T, Suzuki H. Retrospective analysis of risk factors for levofloxacin-induced liver injury. J-Chemother 2023; 35 707-711.$$$$$Y$$$20240924$$HP$JP$JP
243555861$24355586$1$I$20240529$20240916$20240924$20240924$EXP$$CA-TAKEDA-2024TUS041875$TAKEDA$$52$YR$$M$Y$$$20240924$$CN$CA$CA
243555871$24355587$1$I$$20240916$20240924$20240924$EXP$$CA-CELLTRION INC.-2024CA022170$CELLTRION$$$$$$Y$$$20240924$$CN$CA$CA
243555881$24355588$1$I$20240301$20240916$20240924$20240924$EXP$$CA-CELLTRION INC.-2024CA004458$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
243555891$24355589$1$I$20240101$20240918$20240924$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-028011$UNITED THERAPEUTICS$$$$$F$Y$73.469$KG$20240924$$$US$US
243555901$24355590$1$I$$20240913$20240924$20240924$PER$$US-ASTELLAS-2024-AER-006952$ASTELLAS$$80$YR$E$F$Y$$$20240924$$CN$US$US
243555911$24355591$1$I$20240101$20240917$20240924$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-023929$UNITED THERAPEUTICS$$$$$M$Y$63.492$KG$20240924$$$US$US
243555921$24355592$1$I$$20240916$20240924$20240924$EXP$$JP-TEVA-VS-3244663$TEVA$Amemiya T, Suzuki H. Retrospective analysis of risk factors for levofloxacin-induced liver injury. J-Chemother 2023; 35 707-711.$$$$$Y$$$20240924$$HP$JP$JP
243555931$24355593$1$I$20240905$20240906$20240924$20240924$PER$$US-JNJFOC-20240916475$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240924$$CN$US$US
243555941$24355594$1$I$20220101$20240909$20240924$20240924$EXP$$BR-CIPLA LTD.-2024BR10365$CIPLA$Morau MV, Moriel P, Seguin CS, Junior MWP, Dagli-Hernandez C, Pincinato EdC. Gefitinib-induced severe dermatological adverse reactions: A case report and pharmacogenetic profile. Pharmaceuticals. 2024;17,1040:1 to 8$$$$$Y$$$20240924$$HP$BR$BR
243555951$24355595$1$I$20240711$20240918$20240924$20240924$EXP$ES-AEMPS-1568908$ES-ROCHE-10000084785$ROCHE$$46$YR$A$F$Y$$$20240924$$MD$ES$ES
243555961$24355596$1$I$20240914$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024187902$AMGEN$$71$YR$E$F$Y$$$20240923$$CN$US$US
243555971$24355597$1$I$20240904$20240905$20240924$20240924$PER$$US-JNJFOC-20240912662$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240924$$CN$US$US
243555981$24355598$1$I$$20240920$20240924$20240924$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052792$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240924$$CN$US$US
243555991$24355599$1$I$$20240917$20240924$20240924$PER$$US-GSK-US2024AMR115368$GLAXOSMITHKLINE$$28$YR$$F$Y$69.8$KG$20240924$$CN$US$US
243556001$24355600$1$I$$20240920$20240924$20240924$PER$$NVSC2024US189435$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243556011$24355601$1$I$20240707$20240913$20240924$20240924$EXP$FR-AFSSAPS-MA2024001324$FR-Accord-447151$ACCORD$$49$YR$A$F$Y$$$20240924$$CN$FR$FR
243556021$24355602$1$I$$20240916$20240924$20240924$EXP$$ES-Bion-013874$BIONPHARMA$$$$$$Y$$$20240924$$HP$ES$ES
243556041$24355604$1$I$20230504$20240913$20240924$20240924$EXP$FR-AFSSAPS-PC2024000689$FR-Accord-447083$ACCORD$$28$YR$A$F$Y$57$KG$20240924$$PH$FR$FR
243556051$24355605$1$I$20240101$20240912$20240924$20240924$EXP$$US-UCBSA-2024047232$UCB$$$$$M$Y$$$20240924$$HP$US$US
243556061$24355606$1$I$20240922$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014326$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240924$$CN$US$US
243556071$24355607$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013678$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240924$$CN$US$US
243556081$24355608$1$I$$20240916$20240924$20240924$EXP$$ES-Bion-013880$BIONPHARMA$$$$$$Y$$$20240924$$HP$ES$ES
243556091$24355609$1$I$$20240917$20240924$20240924$EXP$$ES-Bion-013884$BIONPHARMA$$53$YR$A$M$Y$$$20240924$$HP$ES$ES
243556101$24355610$1$I$$20240904$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09006$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243556111$24355611$1$I$20240701$20240916$20240924$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-019834$UNITED THERAPEUTICS$$69$YR$$F$Y$74.376$KG$20240924$$$US$US
243556132$24355613$2$F$20240101$20240924$20240924$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-029746$UNITED THERAPEUTICS$$$$$M$Y$108.84$KG$20240928$$$US$US
243556141$24355614$1$I$$20240911$20240924$20240924$EXP$$CA-HALEON-2197636$Haleon PLC$$29$YR$$F$Y$$$20240923$$HP$CA$CA
243556151$24355615$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150572$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240924$$CN$US$US
243556161$24355616$1$I$$20240917$20240924$20240924$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01996$NOVITIUM PHARMA$Tong Zou.Vaginal delivery of triplets after emergency transvaginal cerclage: A case report and literature review.Medicine.15-MAR-2024;103(11):1-6$$$N$F$Y$$$20240924$$HP$CN$CN
243556171$24355617$1$I$$20240919$20240924$20240924$PER$$US-ABBVIE-5932680$ABBVIE$$$$$$Y$$$20240924$$HP$US$US
243556181$24355618$1$I$20221215$20240916$20240924$20240924$EXP$ES-AEMPS-1374466$ES-CELLTRION INC.-2024ES022393$CELLTRION$$$$$$Y$$$20240924$$MD$ES$ES
243556191$24355619$1$I$20240501$20240913$20240924$20240924$EXP$IT-MINISAL02-1001426$IT-Accord-447211$ACCORD$$47$YR$A$M$Y$$$20240924$$MD$IT$IT
243556201$24355620$1$I$20240125$20240913$20240924$20240924$EXP$IT-MINISAL02-1001580$IT-Accord-447226$ACCORD$$58$YR$A$F$Y$$$20240924$$MD$IT$IT
243556211$24355621$1$I$$20240915$20240924$20240924$EXP$$US-VKT-000593$VKT PHARMA PRIVATE LIMITED$$27$YR$A$M$Y$$$20240918$$MD$US$US
243556231$24355623$1$I$20240801$20240912$20240924$20240924$EXP$$US-UCBSA-2024047296$UCB$$54$YR$$F$Y$$$20240924$$HP$US$US
243556241$24355624$1$I$20120101$20240919$20240924$20240924$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052211$BOEHRINGER INGELHEIM$Saxena H. GP^s ex-wife sues him for mismanaging her cardiac risk factors during their marriage. AusDoc.$$$$F$Y$$$20240924$$HP$AU$AU
243556251$24355625$1$I$$20240919$20240924$20240924$EXP$$JP-GSK-JP2024JPN116655$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
243556261$24355626$1$I$$20240907$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09096$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243556271$24355627$1$I$$20240923$20240924$20240924$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052973$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240924$$CN$CA$CA
243556281$24355628$1$I$20240701$20240913$20240924$20240924$EXP$HR-HALMED-300086459$HR-Accord-447256$ACCORD$$59$YR$A$M$Y$70$KG$20240924$$MD$HR$HR
243556291$24355629$1$I$$20240919$20240924$20240924$EXP$$CN-ROCHE-10000086455$ROCHE$Zheng C, Yang Y, Yang H. Impact of oxaliplatin and trastuzumab combination therapy on tumor markers and T lymphocyte subsets for advanced gastric cancer. World Journal of Gastrointestinal Oncology. 2024;16 (9):3905-12. doi:10.4251/wjgo.v16.i9.3905.$$$$$Y$$$20240924$$HP$CN$CN
243556301$24355630$1$I$20240828$20240919$20240924$20240924$EXP$IT-MINISAL02-1002238$IT-JNJFOC-20240959742$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240924$$PH$IT$IT
243556311$24355631$1$I$$20240906$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09038$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243556321$24355632$1$I$$20240917$20240924$20240924$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01997$NOVITIUM PHARMA$Tong Zou.Vaginal delivery of triplets after emergency transvaginal cerclage: A case report and literature review.Medicine.15-MAR-2024;103(11):1-6$$$N$M$Y$$$20240924$$HP$CN$CN
243556331$24355633$1$I$$20240920$20240924$20240924$EXP$$CN-BEIGENE-BGN-2024-014977$BEIGENE$Li Pang, Wen-Rui Wu, Lei-Bo Xu, Chao Liu. Fatal graft-versus-host disease in recipient with pretransplant exposure to immune checkpoint inhibitors and donor-dominant one-way HLA matching after liver transplantation: A case report. International Journal of Surgery Case Reports. 2024;123:110267$$$$$Y$$$20240924$$MD$CN$CN
243556341$24355634$1$I$$20240903$20240924$20240924$EXP$$US-SA-2024SA273556$SANOFI AVENTIS$$$$$F$Y$$$20240924$$MD$US$US
243556351$24355635$1$I$$20240918$20240924$20240924$EXP$$ZW-CIPLA LTD.-2024ZW08707$CIPLA$Bishop MD, Frenkel LM, Korutaro V, Boyce CL, Beck IA, Styrchak SM et al.. Characterizing HIV drug resistance in cases of vertical transmission in the VesTed randomized antiretroviral treatment trial. J Acquir Immune Defic Syndr. 2024;96 (4):385 to 392$$$$$Y$$$20240924$$HP$ZW$ZW
243556361$24355636$1$I$20240301$20240919$20240924$20240924$EXP$FR-AFSSAPS-CN2024000360$FR-009507513-2409FRA007076$MERCK$$67$YR$$F$Y$85$KG$20240924$$MD$FR$FR
243556371$24355637$1$I$$20240910$20240924$20240924$EXP$$DE-INSMED, INC.-2024-03661-DE$INSMED$$70$YR$$M$Y$$$20240924$$CN$DE$DE
243556381$24355638$1$I$$20240904$20240924$20240924$EXP$$US-SA-2024SA273136$SANOFI AVENTIS$$$$A$F$Y$82$KG$20240924$$MD$US$US
243556391$24355639$1$I$20240904$20240919$20240924$20240924$EXP$$CA-JNJFOC-20240957757$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240924$$HP$CA$CA
243556401$24355640$1$I$20240101$20240919$20240924$20240924$PER$$US-BIOGEN-2024BI01283545$BIOGEN$$$$$$Y$$$20240924$$CN$US$US
243556411$24355641$1$I$$20240904$20240924$20240924$PER$$US-TEVA-VS-3241770$TEVA$$34$YR$$F$Y$$$20240924$$CN$US$US
243556421$24355642$1$I$$20240906$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09002$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243556431$24355643$1$I$20240101$20240918$20240924$20240924$PER$$US-DAIICHI SANKYO, INC.-DS-2024-100761-US$DAIICHI$$$$$F$Y$$$20240924$$HP$US$US
243556441$24355644$1$I$$20240919$20240924$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015758$JAZZ$$$$$M$Y$$$20240923$$HP$US$US
243556451$24355645$1$I$$20240920$20240924$20240924$PER$$US-GILEAD-2024-0688576$GILEAD$$$$$F$Y$$$20240923$$MD$US$US
243556461$24355646$1$I$20240902$20240903$20240924$20240924$30DAY$$GR-JNJFOC-20240905802$JOHNSON AND JOHNSON$$78$YR$E$F$Y$58$KG$20240924$$CN$GR$GR
243556471$24355647$1$I$20240909$20240912$20240924$20240924$EXP$$US-SA-2024SA273118$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$MD$US$US
243556481$24355648$1$I$20210201$20240913$20240924$20240924$EXP$DE-EMA-2024221-AUTODUP-1708555013362$DE-Accord-413082$ACCORD$$$$A$M$Y$$$20240924$$MD$DE$DE
243556491$24355649$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000087571$ROCHE$$$$E$F$Y$$$20240924$$CN$US$US
243556511$24355651$1$I$$20240920$20240924$20240924$EXP$$NVSC2024US188363$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
243556531$24355653$1$I$$20240912$20240924$20240924$PER$$US-ROCHE-10000082712$ROCHE$$$$$F$Y$$$20240924$$MD$US$US
243556541$24355654$1$I$$20240917$20240924$20240924$EXP$$FR-SA-2024SA272006$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240924$$CN$FR$FR
243556551$24355655$1$I$$20240912$20240924$20240924$EXP$$US-ROCHE-10000081632$ROCHE$$68$YR$E$F$Y$$$20240924$$CN$US$US
243556561$24355656$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005265$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243556581$24355658$1$I$20220101$20240918$20240924$20240924$EXP$$DE-AMGEN-DEUSP2024186297$AMGEN$$$$$F$Y$$$20240924$$CN$DE$DE
243556591$24355659$1$I$20240916$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013024$ELI LILLY AND CO$$$$A$F$Y$$$20240924$$CN$US$US
243556601$24355660$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013823$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240924$$CN$US$US
243556611$24355661$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013939$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240924$$CN$US$US
243556621$24355662$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014136$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240924$$CN$US$US
243556631$24355663$1$I$20240919$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013946$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240924$$CN$US$US
243556641$24355664$1$I$20230115$20240913$20240924$20240924$EXP$FR-AFSSAPS-PC2024000698$FR-Accord-447075$ACCORD$$74$YR$E$M$Y$78$KG$20240924$$PH$FR$FR
243556651$24355665$1$I$$20240919$20240924$20240924$EXP$$JP-SA-2024SA270469$SANOFI AVENTIS$$$$$F$Y$$$20240924$$CN$JP$JP
243556661$24355666$1$I$20240101$20240918$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149547$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240924$$CN$US$US
243556671$24355667$1$I$$20240916$20240924$20240924$EXP$$JP-TEVA-VS-3244667$TEVA$Amemiya T, Suzuki H. Retrospective analysis of risk factors for levofloxacin-induced liver injury. J-Chemother 2023; 35 707-711.$$$$$Y$$$20240924$$HP$JP$JP
243556681$24355668$1$I$$20240911$20240924$20240924$EXP$$CA-APOTEX-2024AP010573$APOTEX$$87$YR$$F$Y$$$20240924$$HP$CA$CA
243556691$24355669$1$I$20240920$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150654$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$HP$US$US
243556701$24355670$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150899$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240924$$HP$US$US
243556711$24355671$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150910$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240924$$HP$US$US
243556722$24355672$2$F$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150895$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240924$$CN$US$US
243556731$24355673$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005269$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
243556741$24355674$1$I$$20231004$20240924$20240924$PER$$US-CIPLA LTD.-2023US06206$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243556751$24355675$1$I$20230901$20231003$20240924$20240924$PER$$US-CIPLA LTD.-2023US06183$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243556761$24355676$1$I$$20231229$20240924$20240924$PER$$US-CIPLA LTD.-2023US07010$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243556771$24355677$1$I$20231004$20240215$20240924$20240924$PER$$US-CIPLA LTD.-2023US06593$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243556781$24355678$1$I$20231001$20231013$20240924$20240924$PER$$US-CIPLA LTD.-2023US06588$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243556791$24355679$1$I$$20231105$20240924$20240924$PER$$US-CIPLA LTD.-2023US07066$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243556801$24355680$1$I$20231010$20231010$20240924$20240924$PER$$US-CIPLA LTD.-2023US06481$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243556811$24355681$1$I$20231018$20231018$20240924$20240924$PER$$US-CIPLA LTD.-2023US06714$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243556821$24355682$1$I$20240801$20240830$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052277$TOLMAR$$$$$M$Y$$$20240923$$CN$CA$CA
243556831$24355683$1$I$20240828$20240828$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052265$TOLMAR$$66$YR$$M$Y$$$20240923$$CN$CA$CA
243556841$24355684$1$I$$20240828$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052268$TOLMAR$$$$$M$Y$$$20240923$$CN$CA$CA
243556851$24355685$1$I$20240829$20240829$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052280$TOLMAR$$79$YR$$M$Y$$$20240923$$CN$CA$CA
243556861$24355686$1$I$20240829$20240829$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052279$TOLMAR$$81$YR$$M$Y$$$20240923$$CN$CA$CA
243556871$24355687$1$I$20231006$20231006$20240924$20240924$PER$$US-CIPLA LTD.-2023US06429$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243556881$24355688$1$I$$20240829$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052281$TOLMAR$$$$$M$Y$$$20240923$$CN$CA$CA
243556891$24355689$1$I$$20240919$20240924$20240924$PER$$US-BIOGEN-2024BI01283570$BIOGEN$$$$$$Y$$$20240924$$CN$US$US
243556901$24355690$1$I$20240830$20240830$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052348$TOLMAR$$69$YR$$M$Y$$$20240923$$CN$CA$CA
243556911$24355691$1$I$20240911$20240912$20240924$20240924$PER$$US-TAKEDA-2024TUS091134$TAKEDA$$$$$F$Y$$$20240924$$CN$US$US
243556921$24355692$1$I$$20240913$20240924$20240924$EXP$$CA-APOTEX-2024AP010725$APOTEX$$42$YR$$M$Y$$$20240924$$HP$CA$CA
243556931$24355693$1$I$20240905$20240919$20240924$20240924$EXP$$US-ROCHE-10000087776$ROCHE$$74$YR$E$M$Y$$$20240924$$CN$US$US
243556941$24355694$1$I$$20240618$20240924$20240924$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-453276$RANBAXY$$$$$F$Y$$$20240924$$CN$US$US
243556951$24355695$1$I$$20240920$20240924$20240924$PER$$US-JNJFOC-20240956592$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243556961$24355696$1$I$$20240918$20240924$20240924$EXP$$US-JNJFOC-20240951455$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$HP$US$US
243556981$24355698$1$I$$20231002$20240924$20240924$PER$$US-CIPLA LTD.-2023US06099$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243556991$24355699$1$I$$20240923$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150950$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240924$$CN$US$US
243557001$24355700$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000087838$ROCHE$$40$YR$A$M$Y$$$20240924$$MD$US$US
243557011$24355701$1$I$$20240920$20240924$20240924$PER$$US-TAKEDA-2024TUS094231$TAKEDA$$$$$M$Y$47$KG$20240924$$MD$US$US
243557021$24355702$1$I$20240213$20240913$20240924$20240924$EXP$$GB-AUROBINDO-AUR-APL-2024-046113$AUROBINDO$$4$YR$$M$Y$$$20240924$$CN$GB$GB
243557031$24355703$1$I$$20240830$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005273$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
243557041$24355704$1$I$$20240917$20240924$20240924$PER$$US-GILEAD-2024-0688099$GILEAD$$$$$M$Y$$$20240924$$HP$US$US
243557061$24355706$1$I$$20240911$20240924$20240924$EXP$$CA-APOTEX-2024AP010577$APOTEX$$67$YR$$F$Y$$$20240924$$CN$CA$CA
243557071$24355707$1$I$20231201$20240912$20240924$20240924$EXP$$NZ-ABBVIE-5931936$ABBVIE$$73$YR$$$Y$$$20240924$$MD$NZ$NZ
243557081$24355708$1$I$20240920$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188501$AMGEN$$$$$F$Y$$$20240924$$PH$US$US
243557091$24355709$1$I$20240915$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188954$AMGEN$$$$$M$Y$$$20240924$$CN$US$US
243557101$24355710$1$I$20201107$20240913$20240924$20240924$EXP$$ES-AUROBINDO-AUR-APL-2021-028285$AUROBINDO$$41$YR$$F$Y$70$KG$20240924$$MD$ES$ES
243557111$24355711$1$I$$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188935$AMGEN$$$$$$Y$$$20240924$$HP$US$US
243557122$24355712$2$F$$20240921$20240924$20240926$PER$$NVSC2024US189417$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
243557131$24355713$1$I$20221201$20240913$20240924$20240924$EXP$$BR-CELLTRION INC.-2023BR005383$CELLTRION$$$$$$Y$$$20240924$$CN$BR$BR
243557141$24355714$1$I$$20240909$20240924$20240924$PER$$US-APOTEX-2024AP010617$APOTEX$Hudson J, Kaeberlein T, Mahal A, Wong N, Ghorbanifarajzadeh M, Radella F, et al.. Evaluation of off-label rapamycin use on oral health.. Geroscience. 2024;46 (5):4135-4146$$$A$M$Y$$$20240924$$HP$US$US
243557151$24355715$1$I$$20240919$20240924$20240924$PER$$US-GSK-US2024116630$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243557162$24355716$2$F$$20240920$20240924$20240930$PER$$US-GSK-US2024AMR116857$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$MD$US$US
243557171$24355717$1$I$$20240916$20240924$20240924$EXP$CA-NEBO-669585$CA-NEBO-669585$PHARMACOSMOS$$64$YR$$M$Y$113$KG$20240924$$HP$CA$CA
243557181$24355718$1$I$20240908$20240919$20240924$20240924$EXP$$DE-ABBVIE-5933358$ABBVIE$$38$YR$$M$Y$$$20240924$$CN$DE$DE
243557191$24355719$1$I$20240904$20240912$20240924$20240924$EXP$$US-Accord-447357$ACCORD$$59$YR$A$F$Y$56.7$KG$20240924$$HP$US$US
243557212$24355721$2$F$20240101$20240923$20240924$20240926$PER$$US-AMGEN-USASP2024188767$AMGEN$$69$YR$E$F$Y$$$20240926$$CN$US$US
243557221$24355722$1$I$20240101$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188779$AMGEN$$77$YR$E$F$Y$$$20240924$$CN$US$US
243557231$24355723$1$I$$20240916$20240924$20240924$EXP$$JP-TEVA-VS-3244668$TEVA$Amemiya T, Suzuki H. Retrospective analysis of risk factors for levofloxacin-induced liver injury. J-Chemother 2023; 35 707-711.$$$$$Y$$$20240924$$HP$JP$JP
243557241$24355724$1$I$20240909$20240910$20240924$20240924$EXP$$GB-MSNLABS-2024MSNSPO02017$MSN LABORATORIES$$$$$$Y$$$20240924$$HP$GB$GB
243557251$24355725$1$I$$20240913$20240924$20240924$EXP$$CA-APOTEX-2024AP010724$APOTEX$$3$DEC$$M$Y$$$20240924$$HP$CA$CA
243557261$24355726$1$I$$20240914$20240924$20240924$EXP$GB-MHRA-MED-202409131738386140-YDRGS$GB-AMAROX PHARMA-AMR2024GB03174$HETERO$$58$YR$$M$Y$$$20240924$$HP$GB$GB
243557271$24355727$1$I$$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188762$AMGEN$$$$$F$Y$$$20240924$$HP$US$US
243557281$24355728$1$I$$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150741$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240924$$CN$US$US
243557291$24355729$1$I$$20240916$20240924$20240924$EXP$$JP-TEVA-VS-3244671$TEVA$Amemiya T, Suzuki H. Retrospective analysis of risk factors for levofloxacin-induced liver injury. J-Chemother 2023; 35 707-711.$$$$$Y$$$20240924$$HP$JP$JP
243557301$24355730$1$I$$20240916$20240924$20240924$EXP$$US-ROCHE-10000086595$ROCHE$Moral A, Ruiz R, Garcia-Soto J, Ramirez E, Insenser M, Luque J. Efficacy and security of ocrelizumab in patients with primary progressive multiple sclerosis (ppms) in a tertiary care hospital multiple sclerosis unit [Abstract: P1765/1483]. Multiple Sclerosis Journal. 2024;30 (3S):1113.$$$$$Y$$$20240924$$HP$US$US
243557311$24355731$1$I$$20240919$20240924$20240924$EXP$$US-JNJFOC-20240959035$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$HP$US$US
243557322$24355732$2$F$$20240923$20240924$20240925$PER$$US-HALEON-2198124$Haleon PLC$$$$$F$Y$$$20240925$$CN$US$US
243557331$24355733$1$I$20200930$20240913$20240924$20240924$EXP$$PL-AUROBINDO-AUR-APL-2024-046471$AUROBINDO$$31$YR$$F$Y$60$KG$20240924$$MD$PL$PL
243557341$24355734$1$I$$20240912$20240924$20240924$EXP$$JP-BEH-2024178740$CSL BEHRING$$$$$$Y$95$KG$20240924$$PH$JP$JP
243557351$24355735$1$I$$20240918$20240924$20240924$PER$$US-JNJFOC-20240954996$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$MD$US$US
243557361$24355736$1$I$20240501$20240918$20240924$20240924$EXP$$CO-JNJFOC-20240952449$JOHNSON AND JOHNSON$$43$YR$A$F$Y$63$KG$20240924$$HP$CO$CO
243557371$24355737$1$I$20201001$20240913$20240924$20240924$EXP$$PL-AUROBINDO-AUR-APL-2024-046329$AUROBINDO$$23$YR$$F$Y$65$KG$20240924$$PH$PL$PL
243557381$24355738$1$I$20230919$20240916$20240924$20240924$EXP$IT-MINISAL02-978064$IT-CELLTRION INC.-2024IT022459$CELLTRION$$$$$$Y$$$20240924$$PH$IT$IT
243557391$24355739$1$I$$20240923$20240924$20240924$EXP$DE-BFARM-24006324$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052751$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$98$KG$20240924$$CN$DE$DE
243557401$24355740$1$I$$20240923$20240924$20240924$EXP$DE-SANDOZ-SDZ2024DE080522$DE-UCBSA-2024048806$UCB$$$$$M$Y$$$20240924$$PH$DE$DE
243557411$24355741$1$I$$20240917$20240924$20240924$PER$$US-CHATTEMPRD-2024OHG032678$CHATTEM$$$$$F$Y$$$20240924$$CN$US$US
243557421$24355742$1$I$$20240909$20240924$20240924$EXP$$CA-APOTEX-2024AP010401$APOTEX$$65$YR$$F$Y$$$20240924$$HP$CA$CA
243557431$24355743$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000087987$ROCHE$$54$YR$A$F$Y$$$20240924$$HP$US$US
243557441$24355744$1$I$$20240912$20240924$20240924$EXP$GB-MHRA-MED-202409091536034100-TGZWJ$GB-ROCHE-10000080930$ROCHE$$77$YR$E$F$Y$$$20240924$$MD$GB$GB
243557451$24355745$1$I$$20240916$20240924$20240924$EXP$$GB-CELLTRION INC.-2024GB022493$CELLTRION$$$$$$Y$$$20240924$$CN$GB$GB
243557461$24355746$1$I$$20240913$20240924$20240924$EXP$$IT-AUROBINDO-AUR-APL-2020-024354$AUROBINDO$Corti C, Faiola S, Lanna M, Castoldi F, Lista G, Nespoli L, Mannarino S and Rustico M. Monochorionic diamniotic twin pregnancy complicated by discordant premature closure of ductus arteriosus.. Clinical Case Reports. 2020;8(4):685-9.$$$N$F$Y$2.205$KG$20240924$$MD$IT$IT
243557481$24355748$1$I$$20240919$20240924$20240924$EXP$$US-AMGEN-USASP2024187777$AMGEN$$72$YR$E$F$Y$$$20240924$$MD$US$US
243557491$24355749$1$I$$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188639$AMGEN$$$$$$Y$$$20240924$$PH$US$US
243557501$24355750$1$I$$20240115$20240924$20240924$PER$$US-CIPLA LTD.-2024US00774$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243557511$24355751$1$I$$20240205$20240924$20240924$PER$$US-CIPLA LTD.-2024US01748$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243557521$24355752$1$I$20240205$20240205$20240924$20240924$PER$$US-CIPLA LTD.-2024US01706$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243557531$24355753$1$I$20210101$20240229$20240924$20240924$PER$$US-CIPLA LTD.-2024US02471$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243557541$24355754$1$I$$20240102$20240924$20240924$PER$$US-CIPLA LTD.-2024US00231$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243557551$24355755$1$I$$20240206$20240924$20240924$PER$$US-CIPLA LTD.-2024US01814$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243557561$24355756$1$I$$20231227$20240924$20240924$PER$$US-CIPLA LTD.-2023US08712$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243557571$24355757$1$I$$20240217$20240924$20240924$PER$$US-CIPLA LTD.-2024US02181$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243557581$24355758$1$I$$20240220$20240924$20240924$PER$$US-CIPLA LTD.-2024US02232$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243557591$24355759$1$I$$20240115$20240924$20240924$PER$$US-CIPLA LTD.-2024US00800$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243557601$24355760$1$I$$20240914$20240924$20240924$EXP$$JP-ROCHE-10000088262$ROCHE$Satake T, Sakaeda H, Murakawa K, Machida A, Kitaoka M, Okada M. A case of drug-induced liver injury after the administration of tocilizumab for adult Stills disease. Kanzo/Acta Hepatologica Japonica. 2024;65 (8):397-406. doi:10.2957/kanzo.65.397.$71$YR$E$M$Y$$$20240924$$MD$JP$JP
243557611$24355761$1$I$20240821$20240918$20240924$20240924$PER$$NVSC2024US189157$NOVARTIS$$42$YR$$M$Y$150$KG$20240924$$CN$US$US
243557621$24355762$1$I$$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188862$AMGEN$$$$$$Y$$$20240924$$PH$US$US
243557631$24355763$1$I$20231226$20240915$20240924$20240924$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149472$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$MD$PT$PT
243557641$24355764$1$I$$20240915$20240924$20240924$EXP$$US-JNJFOC-20240952300$JOHNSON AND JOHNSON$$13$YR$T$$Y$$$20240924$$HP$US$US
243557651$24355765$1$I$$20240913$20240924$20240924$EXP$$GB-AUROBINDO-AUR-APL-2024-046024$AUROBINDO$$58$YR$$M$Y$$$20240924$$HP$GB$GB
243557661$24355766$1$I$$20240913$20240924$20240924$PER$$US-BEH-2024178967$CSL BEHRING$$37$YR$A$F$Y$$$20240924$$HP$US$US
243557671$24355767$1$I$$20240918$20240924$20240924$PER$$US-GSK-US2024116151$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243557681$24355768$1$I$$20240911$20240924$20240924$PER$$US-HALEON-2196705$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
243557692$24355769$2$F$$20240920$20240924$20240926$EXP$$PL-AUROBINDO-AUR-APL-2024-046438$AUROBINDO$Mozdzen K, Murawska A.. Status epilepticus in pregnant patients - description of two cases and review of the literature. POLSKI PRZEGL?D NEUROLOGICZNY. 2024;20(2):115-28$$$N$$Y$2.48$KG$20240926$$MD$PL$PL
243557701$24355770$1$I$$20240913$20240924$20240924$EXP$$ID-ROCHE-10000082363$ROCHE$$$$$$Y$$$20240924$$MD$ID$ID
243557711$24355771$1$I$20240909$20240912$20240924$20240924$EXP$$US-ARGENX-2024-ARGX-US007754$ARGENX BVBA$$$$$$Y$$$20240924$$MD$US$US
243557724$24355772$4$F$20240918$20240924$20240924$20240930$EXP$$JP-JNJFOC-20240962909$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240930$$HP$JP$JP
243557731$24355773$1$I$20240901$20240919$20240924$20240924$EXP$$CA-JNJFOC-20240957126$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20240924$$HP$CA$CA
243557741$24355774$1$I$$20240912$20240924$20240924$EXP$DE-ELI_LILLY_AND_COMPANY-DE202407013607$DE-ROCHE-10000080179$ROCHE$$$$$M$Y$102$KG$20240924$$CN$DE$DE
243557751$24355775$1$I$20131128$20240916$20240924$20240924$EXP$$IT-AUROBINDO-AUR-APL-2014-00495$AUROBINDO$$94$YR$$F$Y$$$20240924$$PH$IT$IT
243557761$24355776$1$I$20240908$20240923$20240924$20240924$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-050688$BOEHRINGER INGELHEIM$$74$YR$E$M$Y$67$KG$20240924$$CN$US$US
243557771$24355777$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024187782$AMGEN$$$$$$Y$$$20240924$$CN$US$US
243557781$24355778$1$I$$20240916$20240924$20240924$PER$$US-LEO Pharma-373611$LEO PHARM$$29$YR$$F$Y$66$KG$20240924$$HP$US$US
243557791$24355779$1$I$20230530$20240916$20240924$20240924$EXP$$IT-CELLTRION INC.-2023IT014918$CELLTRION$$$$$$Y$$$20240924$$MD$IT$IT
243557801$24355780$1$I$$20240902$20240924$20240924$PER$$US-JNJFOC-20240906571$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243557811$24355781$1$I$20240701$20240918$20240924$20240924$EXP$$AR-JNJFOC-20240958355$JOHNSON AND JOHNSON$$44$YR$A$F$Y$67$KG$20240924$$CN$AR$AR
243557821$24355782$1$I$$20240912$20240924$20240924$EXP$$US-JNJFOC-20240939737$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$HP$US$US
243557832$24355783$2$F$20240831$20240904$20240924$20240925$30DAY$$US-JNJFOC-20240914188$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240925$$CN$US$US
243557841$24355784$1$I$$20240916$20240924$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-029393$UNITED THERAPEUTICS$$$$$F$Y$97.506$KG$20240924$$$US$US
243557851$24355785$1$I$$20240919$20240924$20240924$PER$$US-ABBVIE-5932649$ABBVIE$$$$$F$Y$$$20240924$$HP$US$US
243557861$24355786$1$I$$20240918$20240924$20240924$EXP$$US-HALEON-2197618$Haleon PLC$$$$$$Y$$$20240923$$CN$US$US
243557871$24355787$1$I$$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150868$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$CN$US$US
243557881$24355788$1$I$$20240916$20240924$20240924$EXP$$CA-JNJFOC-20240708877$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240924$$HP$CA$CA
243557891$24355789$1$I$$20240922$20240924$20240924$PER$$US-ABBVIE-5934934$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243557901$24355790$1$I$$20240912$20240924$20240924$EXP$$JP-BEH-2024178736$CSL BEHRING$$$$$M$Y$$$20240924$$CN$JP$JP
243557921$24355792$1$I$20240828$20240916$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013668$DR REDDYS$$71$YR$E$F$Y$$$20240924$$HP$US$US
243557931$24355793$1$I$$20240911$20240924$20240924$EXP$$FR-AUROBINDO-AUR-APL-2024-045734$AUROBINDO$Haidar NA, Vaillant W, Salignon K, Jounblat Y, Borel C. ABCL159 Successful Treatment of a Gray Zone Lymphoma With Immunotherapy: A Case Report. Clinical Lymphoma, Myeloma and Leukemia. 2024;24 (Suppl.):S459$66$YR$$F$Y$$$20240924$$MD$FR$FR
243557941$24355794$1$I$$20240917$20240924$20240924$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01998$NOVITIUM PHARMA$Tong Zou.Vaginal delivery of triplets after emergency transvaginal cerclage: A case report and literature review.Medicine.15-MAR-2024;103(11):1-6$$$N$M$Y$$$20240924$$HP$CN$CN
243557971$24355797$1$I$$20240915$20240924$20240924$EXP$$US-JNJFOC-20240952297$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240924$$HP$US$US
243557981$24355798$1$I$20240913$20240913$20240924$20240924$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US004948$PAREXEL$$$$$$Y$$$20240924$$CN$US$US
243557991$24355799$1$I$$20240916$20240924$20240924$EXP$$CA-HALEON-2197799$Haleon PLC$$48$YR$$F$Y$68$KG$20240924$$HP$CA$CA
243558001$24355800$1$I$$20240916$20240924$20240924$EXP$$JP-CELLTRION INC.-2024JP022357$CELLTRION$Rinka K, Fujii H, Hagihara A, Kawamura E, Enomoto M, Kawada N.. A case of secondary immune thrombocytopenia induced by atezolizumab plus bevacizumab therapy for hepatocellular carcinoma resulting in death from intracranial hemorrhage. Nihon Shokakibyo Gakkai Zasshi. 2024;121(9):754-762$$$$$Y$$$20240924$$HP$JP$JP
243558011$24355801$1$I$$20240912$20240924$20240924$EXP$$CA-APOTEX-2024AP010680$APOTEX$$$$$F$Y$$$20240924$$MD$CA$CA
243558021$24355802$1$I$20240816$20240913$20240924$20240924$EXP$IT-MINISAL02-1001391$IT-Accord-447197$ACCORD$$47$YR$A$M$Y$$$20240924$$MD$IT$IT
243558031$24355803$1$I$$20240917$20240924$20240924$EXP$$CA-HALEON-2197620$Haleon PLC$$44$YR$$F$Y$$$20240924$$HP$CA$CA
243558041$24355804$1$I$$20240915$20240924$20240924$EXP$$US-JNJFOC-20240952293$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240924$$HP$US$US
243558051$24355805$1$I$$20240913$20240924$20240924$EXP$$TR-JNJFOC-20240935362$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20240924$$HP$TR$TR
243558061$24355806$1$I$$20240919$20240924$20240924$EXP$$US-JNJFOC-20240959950$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243558091$24355809$1$I$20240723$20240909$20240924$20240924$PER$$US-EPICPHARMA-US-2024EPCSPO01130$EPIC PHARM$$82$YR$E$F$Y$71$KG$20240924$$MD$US$US
243558101$24355810$1$I$20211117$20240917$20240924$20240924$EXP$$AU-TAKEDA-2024TUS093985$TAKEDA$$73$YR$$M$Y$$$20240924$$MD$AU$AU
243558121$24355812$1$I$20220630$20240919$20240924$20240924$EXP$$JP-GSK-JP2023047351$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
243558132$24355813$2$F$$20240916$20240924$20240930$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-21432$ALKEM$Farzaei A, Mehrabi Nasab E, Jenab Y, Amirzadegan A, Khodayari Javazm A, Eisvand M, Hajzeinolabedini F, Bozorgi A.. An interesting case series of ticagrelor induced long QTc. International Journal of Cardiology Cardiovascular Risk and Prevention. 2024;22:200311$70$YR$$M$Y$$$20240930$$HP$IR$IR
243558142$24355814$2$F$$20240916$20240924$20240930$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-21430$ALKEM$Farzaei A, Mehrabi Nasab E, Jenab Y, Amirzadegan A, Khodayari Javazm A, Eisvand M, Hajzeinolabedini F, Bozorgi A.. An interesting case series of ticagrelor induced long QTc. International Journal of Cardiology Cardiovascular Risk and Prevention. 2024;22:200311$64$YR$$F$Y$$$20240930$$HP$IR$IR
243558152$24355815$2$F$$20240916$20240924$20240930$EXP$$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-21429$ALKEM$Farzaei A, Mehrabi Nasab E, Jenab Y, Amirzadegan A, Khodayari Javazm A, Eisvand M, Hajzeinolabedini F, Bozorgi A.. An interesting case series of ticagrelor induced long QTc. International Journal of Cardiology Cardiovascular Risk and Prevention. 2024;22:200311$72$YR$$M$Y$$$20240930$$HP$IR$IR
243558171$24355817$1$I$20220101$20240905$20240924$20240924$EXP$$US-PROCTER+GAMBLE-PH24007070$PROCTER AND GAMBLE$Grosso D, Wagner JL, OConnor A, Keck K, Huang Y, Wang ZX, Mehler H, Leiby B, Flomenberg P, Gergis U, Nikbakht N, Morris M, Karp J, Peedin A, Flomenberg N. Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19. Blood advances. 2024;8 (15):4113-24$83$YR$$F$Y$$$20240924$$HP$US$US
243558181$24355818$1$I$20240907$20240909$20240924$20240924$EXP$GB-MHRA-MED-202409090049162670-PWQTR$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21270$ALKEM$$43$YR$$F$Y$$$20240924$$CN$GB$GB
243558192$24355819$2$F$20240725$20240919$20240924$20240927$PER$$US-AMGEN-USASP2024187507$AMGEN$$79$YR$E$F$Y$$$20240927$$HP$US$US
243558201$24355820$1$I$$20240906$20240924$20240924$EXP$$SE-AMGEN-SWESP2024188497$AMGEN$$$$$$Y$$$20240924$$MD$SE$SE
243558211$24355821$1$I$$20240913$20240924$20240924$PER$$US-ASTELLAS-2024-AER-006964$ASTELLAS$$$$$M$Y$$$20240924$$MD$US$US
243558221$24355822$1$I$$20240919$20240924$20240924$EXP$$US-JNJFOC-20240951989$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243558232$24355823$2$F$$20240916$20240924$20240930$EXP$IR-MLMSERVICE-20240904-PI184440-00291-1$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2024-21519$ALKEM$Atapour A, Momenzadeh M, Panahishokouh M, Badri S.. Rosuvastatin-Induced Rhabdomyolysis as a Result of Drug Interaction With Sitagliptin: A Case Report. Clinical Medicine Insights: Case Reports. 2024;17:1-4$64$YR$$F$Y$65$KG$20240930$$PH$IR$IR
243558241$24355824$1$I$20240101$20240911$20240924$20240924$EXP$$DE-ALVOGEN-2024095493$ALVOGEN$$71$YR$$F$Y$$$20240924$$PH$DE$DE
243558261$24355826$1$I$$20240923$20240924$20240924$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053016$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240924$$CN$US$US
243558271$24355827$1$I$$20240912$20240924$20240924$PER$$US-ABBVIE-5930173$ABBVIE$$$$$F$Y$$$20240924$$MD$US$US
243558281$24355828$1$I$20210825$20240917$20240924$20240924$EXP$$CO-TAKEDA-CO202005262$TAKEDA$$38$YR$$M$Y$80$KG$20240924$$CN$CO$CO
243558291$24355829$1$I$$20240920$20240924$20240924$EXP$$AU-ABBVIE-5933090$ABBVIE$$$$$F$Y$$$20240924$$MD$AU$AU
243558311$24355831$1$I$$20240917$20240924$20240924$EXP$$JP-009507513-2409JPN002639J$MERCK$$$$$F$Y$$$20240924$$MD$JP$JP
243558321$24355832$1$I$20230418$20240913$20240924$20240924$EXP$FR-AFSSAPS-PC2024000688$FR-Accord-447238$ACCORD$$62$YR$A$F$Y$73$KG$20240924$$PH$FR$FR
243558331$24355833$1$I$$20240916$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147287$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240924$$CN$US$US
243558341$24355834$1$I$20231121$20240915$20240924$20240924$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149483$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$MD$PT$PT
243558361$24355836$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150815$BRISTOL MYERS SQUIBB$$38$YR$A$M$Y$$$20240924$$HP$US$US
243558371$24355837$1$I$$20240917$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147994$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240924$$CN$US$US
243558391$24355839$1$I$$20240920$20240924$20240924$PER$$NVSC2024US189577$NOVARTIS$$$$$F$Y$72$KG$20240924$$CN$US$US
243558401$24355840$1$I$$20240910$20240924$20240924$EXP$$US-UCBSA-2024046554$UCB$$$$$F$Y$$$20240924$$CN$US$US
243558411$24355841$1$I$$20240910$20240924$20240924$EXP$$US-LEADINGPHARMA-US-2024LEALIT00427$LEADING PHARMA$S Mukherji.Brief case report: A case of FOLFIRI-Induced psychosis.Psycho-Oncology.OCT-2023;32 (No.10):1625-1627$72$YR$E$M$Y$$$20240924$$HP$US$US
243558421$24355842$1$I$20231025$20240905$20240924$20240924$EXP$$US-SA-2024SA273126$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240924$$CN$US$US
243558431$24355843$1$I$20230101$20240917$20240924$20240924$EXP$$CO-AMGEN-COLSP2024188708$AMGEN$$$$$$Y$$$20240924$$CN$CO$CO
243558441$24355844$1$I$$20240918$20240924$20240924$EXP$$US-AMGEN-USASP2024186638$AMGEN$$32$YR$A$F$Y$$$20240924$$MD$US$US
243558451$24355845$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150748$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240924$$CN$US$US
243558461$24355846$1$I$$20240923$20240924$20240924$PER$$US-JNJFOC-20240962291$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$HP$US$US
243558471$24355847$1$I$$20240923$20240924$20240924$EXP$$US-AMGEN-USASP2024189077$AMGEN$Monroe I.; Isern R.; Witherspoon K. et al.. HYPERCALCEMIC CRISIS DUE TO GRANULOMATOUS BONE MARROW INFECTION: A RARE PRESENTATION OF DISSEMINATED MYCOBACTERIUM GENAVENSE IN AN IMMUNOCOMPETENT PATIENT. Chest. 2024;166 (4):A959-A960$83$YR$E$M$Y$$$20240924$$HP$US$US
243558481$24355848$1$I$$20240914$20240924$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-029114$UNITED THERAPEUTICS$$$$$F$Y$76.644$KG$20240924$$$US$US
243558491$24355849$1$I$20230428$20240916$20240924$20240924$EXP$FR-AFSSAPS-MP2023000987$FR-CELLTRION INC.-2024FR022415$CELLTRION$$$$$$Y$$$20240924$$MD$FR$FR
243558501$24355850$1$I$$20240919$20240924$20240924$EXP$$CA-TAKEDA-2024TUS093859$TAKEDA$$$$$M$Y$$$20240924$$CN$CA$CA
243558511$24355851$1$I$$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188160$AMGEN$$$$$$Y$$$20240924$$CN$US$US
243558521$24355852$1$I$20221012$20240920$20240924$20240924$EXP$$JP-TAKEDA-2024TJP002012$TAKEDA$$54$YR$$M$Y$$$20240924$$MD$JP$JP
243558531$24355853$1$I$20240101$20240916$20240924$20240924$EXP$FR-AFSSAPS-AVLY2024000178$FR-TEVA-VS-3244239$TEVA$$35$YR$$M$Y$70$KG$20240924$$MD$FR$FR
243558541$24355854$1$I$$20240919$20240924$20240924$EXP$JP-MMM-WEJSL8RD$JP-GSK-JP2024116377$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$PH$JP$JP
243558562$24355856$2$F$20160101$20240919$20240924$20240927$EXP$$US-ABBVIE-5931361$ABBVIE$$52$YR$$M$Y$$$20240927$$CN$US$US
243558571$24355857$1$I$20240101$20240918$20240924$20240924$EXP$$US-ABBVIE-5924168$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243558581$24355858$1$I$$20240910$20240924$20240924$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08572$HIKMA$Au-Yeung NM, Regennitter NS, Stepherson J, Seele J, Rosenblatt E, Carter W. Au-Yeung NM, Regennitter NS, Stepherson J, Seele J, Rosenblatt E, Carter W. Folate Deficiency and Medication-Induced Severe Pancytopenia in a Bilateral Lung Transplantee. Cureus. 2024;16(7):e65780:1-8$74$YR$$M$Y$$$20240924$$MD$US$US
243558591$24355859$1$I$$20240918$20240924$20240924$EXP$$US-ABBVIE-5931181$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243558611$24355861$1$I$20240727$20240919$20240924$20240924$EXP$$US-BEIGENE-BGN-2024-015054$BEIGENE$$$$$$Y$$$20240924$$CN$US$US
243558631$24355863$1$I$$20240917$20240924$20240924$PER$$US-JNJFOC-20240955543$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$HP$US$US
243558641$24355864$1$I$20240811$20240916$20240924$20240924$EXP$FR-AFSSAPS-CN2024000839$FR-TEVA-VS-3244300$TEVA$$16$YR$$M$Y$$$20240924$$MD$FR$FR
243558651$24355865$1$I$20240916$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150770$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240924$$MD$US$US
243558661$24355866$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150864$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240924$$HP$US$US
243558671$24355867$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150957$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240924$$HP$US$US
243558683$24355868$3$F$20240901$20240927$20240924$20240930$PER$$US-AMGEN-USASP2024189648$AMGEN$$66$YR$$F$Y$$$20240930$$CN$US$US
243558691$24355869$1$I$$20240915$20240924$20240924$EXP$$HK-JNJFOC-20240947819$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$HP$HK$HK
243558701$24355870$1$I$20240917$20240917$20240924$20240924$PER$$US-AMGEN-USASP2024185936$AMGEN$$80$YR$E$F$Y$58.503$KG$20240924$$PH$US$US
243558711$24355871$1$I$20240903$20240917$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148498$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$126.1$KG$20240924$$PH$US$US
243558721$24355872$1$I$$20240912$20240924$20240924$EXP$CA-MHPD-E2B_07241360$CA-Accord-447034$ACCORD$$80$YR$E$M$Y$69$KG$20240924$$HP$CA$CA
243558731$24355873$1$I$$20240910$20240924$20240924$EXP$$US-LEADINGPHARMA-US-2024LEALIT00429$LEADING PHARMA$AM Torrie.Apparent Reversal of a Successful Peripheral Neural Blockade With Intravenous Lipid Emulsion After Treatment for Local Anesthetic Systemic Toxicity: A Case Report.A and A Practice .NOV-2020;14$42$YR$A$F$Y$56.7$KG$20240924$$HP$US$US
243558741$24355874$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150951$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$67.59$KG$20240924$$HP$US$US
243558751$24355875$1$I$$20240923$20240924$20240924$EXP$$US-TAKEDA-2024TUS094353$TAKEDA$$$$$F$Y$$$20240924$$CN$US$US
243558761$24355876$1$I$$20240913$20240924$20240924$EXP$$IT-AUROBINDO-AUR-APL-2024-046407$AUROBINDO$Airoldi L, Rossi L, Giubertoni A, Bacchini  S, Panizza A, Cumitini L, et al. Late pleuro-pericardial effusion after atrial fibrillation radiofrequency ablation. European Heart Journal. 2021;23(Suppl G):G166$57$YR$$F$Y$$$20240924$$HP$IT$IT
243558771$24355877$1$I$$20240919$20240924$20240924$EXP$$BR-TAKEDA-2024TUS094114$TAKEDA$$$$$F$Y$$$20240924$$CN$BR$BR
243558781$24355878$1$I$$20240914$20240924$20240924$EXP$GB-MHRA-MED-202409131731545670-ZPHJS$GB-HETERO-AMR2024GB03178$HETERO$$61$YR$$M$Y$$$20240924$$HP$GB$GB
243558801$24355880$1$I$$20240918$20240924$20240924$EXP$$US-CHATTEMPRD-2024OHG032702$CHATTEM$$$$$M$Y$$$20240924$$LW$US$US
243558811$24355881$1$I$$20240910$20240924$20240924$EXP$$CN-LEADINGPHARMA-CN-2024LEALIT00431$LEADING PHARMA$J Tang.Death due to severe hypoglycemia caused by diclofenac sodium and lidocaine injection .Adverse drug reactions journal.2021;23:324-325$53$YR$A$M$Y$$$20240924$$HP$CN$CN
243558831$24355883$1$I$$20240916$20240924$20240924$EXP$$GB-ROCHE-10000083253$ROCHE$$$$A$M$Y$$$20240924$$HP$GB$GB
243558842$24355884$2$F$$20240923$20240924$20240926$PER$$US-ROCHE-10000088560$ROCHE$OROZCO L,  MASSIVE HEMOPTYSIS FOLLOWING COVID-19. Chest. 2024;166 (4):898A-9. doi:10.1016/j.chest.2024.06.609.$65$YR$E$F$Y$$$20240926$$HP$US$US
243558851$24355885$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5931072$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243558861$24355886$1$I$20240801$20240918$20240924$20240924$EXP$$US-ROCHE-10000085943$ROCHE$$55$YR$A$F$Y$$$20240924$$MD$US$US
243558871$24355887$1$I$20240901$20240918$20240924$20240924$EXP$$US-ABBVIE-5931279$ABBVIE$$68$YR$$M$Y$$$20240924$$CN$US$US
243558881$24355888$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150675$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20240924$$HP$US$US
243558891$24355889$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150946$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240924$$CN$US$US
243558901$24355890$1$I$$20240918$20240924$20240924$EXP$$US-ABBVIE-5931457$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243558911$24355891$1$I$$20240913$20240924$20240924$EXP$$IN-ROCHE-3547364$ROCHE$$59$YR$A$F$Y$$$20240924$$CN$IN$IN
243558921$24355892$1$I$20240830$20240918$20240924$20240924$EXP$$PK-ROCHE-10000085340$ROCHE$$46$YR$A$M$Y$$$20240924$$CN$PK$PK
243558931$24355893$1$I$$20240918$20240924$20240924$EXP$$US-CHATTEMPRD-2024OHG032708$CHATTEM$$$$$F$Y$$$20240924$$LW$US$US
243558941$24355894$1$I$20151103$20240911$20240924$20240924$EXP$$US-ROCHE-10000083235$ROCHE$$46$YR$A$M$Y$95.3$KG$20240924$$HP$US$US
243558951$24355895$1$I$$20240917$20240924$20240924$EXP$$JP-GSK-JP2024JPN115723$GLAXOSMITHKLINE$Maeda M, Yoshizaki S, Kainaga M, Uchibori A, Oishi C, Kobayashi E, et al. B-22 A case of a 29-year-old female patient who presented with severe Guillain-Barre syndrome during chronic phase of oral corticosteroid treatment for drug-induced hypersensitivity syndrome due to lamotrigine.. The 250th Kanto-Koshinetsu Regional Meeting of Japanese Neurological Society. 7$$$$$Y$$$20240924$$MD$JP$JP
243558961$24355896$1$I$20240830$20240916$20240924$20240924$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004966$PAREXEL$$$$$$Y$$$20240924$$CN$US$US
243558971$24355897$1$I$20240416$20240912$20240924$20240924$EXP$$CO-JNJFOC-20240463500$JOHNSON AND JOHNSON$$46$YR$A$M$Y$65$KG$20240924$$HP$CO$CO
243558983$24355898$3$F$20220101$20240920$20240924$20240927$EXP$$BR-JNJFOC-20240955701$JOHNSON AND JOHNSON$$$$E$F$Y$50$KG$20240927$$HP$BR$BR
243558991$24355899$1$I$20240919$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188464$AMGEN$$72$YR$E$F$Y$$$20240924$$CN$US$US
243559001$24355900$1$I$$20240910$20240924$20240924$EXP$$CA-ROCHE-10000085839$ROCHE$$65$YR$E$F$Y$$$20240924$$MD$CA$CA
243559011$24355901$1$I$$20240918$20240924$20240924$PER$$US-JNJFOC-20240951576$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$MD$US$US
243559021$24355902$1$I$$20240906$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09005$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243559031$24355903$1$I$$20240918$20240924$20240924$EXP$$US-ABBVIE-5931549$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243559041$24355904$1$I$$20240906$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09064$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243559051$24355905$1$I$$20240910$20240924$20240924$EXP$$TW-LEADINGPHARMA-TW-2024LEALIT00428$LEADING PHARMA$Zhi-Fu Wu.Self-limiting Skin Rash Found in a Patient with Suspected Malignant Hyperthermia Attack A Case Report.Journal of Medical Sciences.12-APR-2024;44(4):185-187$3$YR$C$F$Y$13.6$KG$20240924$$HP$TW$TW
243559071$24355907$1$I$$20240922$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US082241$SANDOZ$$$$$$Y$$$20240924$$CN$US$US
243559081$24355908$1$I$$20240914$20240924$20240924$PER$$US-GSK-US2024AMR115309$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243559091$24355909$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013464$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240924$$CN$US$US
243559101$24355910$1$I$$20240921$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013547$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240924$$CN$US$US
243559111$24355911$1$I$20240901$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014331$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240924$$CN$US$US
243559121$24355912$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013570$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240924$$CN$US$US
243559131$24355913$1$I$$20240916$20240924$20240924$PER$$US-AMGEN-USASP2024187627$AMGEN$Maharaj S.; Edwards B.; Senapati S.G. et al.. Mixed autolmmune hemolytic anemia as the initial presentation of systemic lupus erythematosus: A case report and review. eJHaem. 2024;1-4$22$YR$A$F$Y$$$20240924$$HP$US$US
243559141$24355914$1$I$20240909$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013705$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240924$$CN$US$US
243559151$24355915$1$I$$20240906$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09065$LUPIN$$$$$$Y$$$20240924$$PH$US$US
243559161$24355916$1$I$$20240917$20240924$20240924$PER$$US-AMGEN-USASP2024186899$AMGEN$Santoro J.D.; Ahsan S.; Lafarpour S. et.al. Anti-CD20 Therapy in Children With Severe Epstein-Barr Virus-Associated Meningoencephalitis.. Journal of Child Neurology. 2024;1-6$16$YR$T$F$Y$$$20240924$$MD$US$US
243559171$24355917$1$I$$20240916$20240924$20240924$EXP$$CA-SANDOZ INC.-SDZ2024CA080999$SANDOZ$$$$$F$Y$$$20240924$$CN$CA$CA
243559182$24355918$2$F$20240917$20240924$20240924$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148430$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240926$$PH$US$US
243559191$24355919$1$I$$20240918$20240924$20240924$EXP$$VN-SANDOZ INC.-SDZ2024VN082068$SANDOZ$$40$YR$$F$Y$$$20240924$$MD$VN$VN
243559201$24355920$1$I$$20240921$20240924$20240924$PER$$US-ABBVIE-5935138$ABBVIE$$$$A$F$Y$$$20240924$$HP$US$US
243559211$24355921$1$I$20220916$20240909$20240924$20240924$EXP$FR-AFSSAPS-CF20221585$FR-BAXTER-2024BAX024398$BAXTER$$57$YR$$F$Y$$$20240924$$PH$FR$FR
243559231$24355923$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5933259$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243559241$24355924$1$I$$20240906$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09016$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243559251$24355925$1$I$$20240918$20240924$20240924$EXP$$US-ABBVIE-5874013$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243559261$24355926$1$I$20240101$20240917$20240924$20240924$EXP$$CA-ABBVIE-5929071$ABBVIE$$$$A$F$Y$65.7$KG$20240924$$CN$CA$CA
243559271$24355927$1$I$20240101$20240919$20240924$20240924$EXP$$US-ABBVIE-5931488$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243559281$24355928$1$I$$20240919$20240924$20240924$EXP$$CA-SANDOZ INC.-SDZ2024CA081655$SANDOZ$$49$YR$$F$Y$$$20240924$$HP$CA$CA
243559291$24355929$1$I$20240814$20240919$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US081813$SANDOZ$$5$YR$$M$Y$$$20240924$$CN$US$US
243559301$24355930$1$I$$20240917$20240924$20240924$EXP$$TH-SANDOZ INC.-NVSC2022TH132951$SANDOZ$$$$$F$Y$53$KG$20240924$$CN$TH$TH
243559311$24355931$1$I$$20240920$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US082162$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243559322$24355932$2$F$$20240923$20240924$20240926$EXP$$US-SANDOZ INC.-SDZ2024US082286$SANDOZ$$$$$F$Y$$$20240926$$CN$US$US
243559332$24355933$2$F$$20240924$20240924$20240925$PER$$US-AMGEN-USASP2024189595$AMGEN$$$$$F$Y$$$20240925$$CN$US$US
243559341$24355934$1$I$20240917$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188963$AMGEN$$$$$F$Y$$$20240924$$CN$US$US
243559351$24355935$1$I$$20240919$20240924$20240924$EXP$$US-AMGEN-USASP2024187906$AMGEN$$$$$F$Y$$$20240924$$MD$US$US
243559361$24355936$1$I$20230808$20240918$20240924$20240924$EXP$$US-CHATTEMPRD-2024OHG032695$CHATTEM$$$$$M$Y$$$20240924$$LW$US$US
243559371$24355937$1$I$$20240919$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US081844$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243559381$24355938$1$I$20240801$20240918$20240924$20240924$EXP$$US-ABBVIE-5930546$ABBVIE$$81$YR$$F$Y$$$20240924$$CN$US$US
243559391$24355939$1$I$$20240918$20240924$20240924$EXP$$US-ABBVIE-5930457$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243559412$24355941$2$F$20240918$20240923$20240924$20240930$EXP$$NVSC2024DE188589$NOVARTIS$$37$YR$$M$Y$$$20240930$$MD$DE$DE
243559421$24355942$1$I$20240902$20240902$20240924$20240924$30DAY$$CN-JNJFOC-20240904009$JOHNSON AND JOHNSON$$27$YR$A$M$Y$75$KG$20240924$$CN$CN$CN
243559431$24355943$1$I$20240918$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024186773$AMGEN$$52$YR$A$F$Y$$$20240924$$PH$US$US
243559441$24355944$1$I$$20240917$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US081738$SANDOZ$$$$$M$Y$$$20240924$$CN$US$US
243559451$24355945$1$I$$20240919$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US082090$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243559462$24355946$2$F$20240919$20240919$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US081783$SANDOZ$$68$YR$$F$Y$$$20240924$$CN$US$US
243559471$24355947$1$I$$20240916$20240924$20240924$PER$$US-TAKEDA-2024TUS092105$TAKEDA$$$$$$Y$$$20240924$$CN$US$US
243559482$24355948$2$F$$20240918$20240924$20240924$EXP$$AU-SANDOZ INC.-SDZ2024AU081637$SANDOZ$$45$YR$$F$Y$$$20240924$$HP$AU$AU
243559491$24355949$1$I$20240819$20240918$20240924$20240924$EXP$$AU-SANDOZ INC.-SDZ2024AU081201$SANDOZ$$55$YR$$M$Y$96.5$KG$20240924$$MD$AU$AU
243559501$24355950$1$I$$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409132324583640-WTRCD$GB-Accord-446797$ACCORD$$82$YR$E$F$Y$$$20240924$$CN$GB$GB
243559531$24355953$1$I$20240920$20240921$20240924$20240924$EXP$$US-ABBVIE-5935316$ABBVIE$$91$YR$$M$Y$$$20240924$$CN$US$US
243559541$24355954$1$I$20240101$20240919$20240924$20240924$EXP$$US-ABBVIE-5933419$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243559551$24355955$1$I$20240911$20240919$20240924$20240924$EXP$$DO-ABBVIE-5935353$ABBVIE$$76$YR$$F$Y$71$KG$20240924$$HP$DO$DO
243559561$24355956$1$I$20240915$20240919$20240924$20240924$EXP$$US-TAKEDA-2024TUS093669$TAKEDA$$10$YR$$M$Y$$$20240924$$MD$US$US
243559571$24355957$1$I$20230411$20240916$20240924$20240924$EXP$FR-AFSSAPS-TS2023000664$FR-CELLTRION INC.-2024FR022424$CELLTRION$$$$$$Y$$$20240924$$MD$FR$FR
243559581$24355958$1$I$$20240920$20240924$20240924$EXP$$AR-ABBVIE-5933104$ABBVIE$$$$$F$Y$$$20240924$$MD$AR$AR
243559591$24355959$1$I$$20240909$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09029$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243559601$24355960$1$I$$20240917$20240924$20240924$EXP$$NVSC2024BR188606$NOVARTIS$$$$$F$Y$$$20240924$$CN$BR$BR
243559611$24355961$1$I$$20240916$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US080825$SANDOZ$Mahadevia HJ, Al-Obaidi A, Cossor F. Visual Hallucinations With Arsenic TrioxideTherapy in Acute Promyelocytic Leukemia. CUREUS. 2024$69$YR$$M$Y$$$20240924$$HP$US$US
243559632$24355963$2$F$20240908$20240919$20240924$20240930$EXP$$CA-ABBVIE-5935272$ABBVIE$$74$YR$$F$Y$$$20240930$$HP$CA$CA
243559651$24355965$1$I$20240101$20240919$20240924$20240924$EXP$$US-ABBVIE-5933301$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243559671$24355967$1$I$$20240917$20240924$20240924$EXP$$VN-SANDOZ INC.-SDZ2024VN082314$SANDOZ$Truong PHD, Suzanne MTT, Tran TT, Lam MH, Le PD, Nguyen TBU et al. al. Buoc dau danh gia hieu qua va doc tinh cua phac do dieu kien hoa BeEAM tren benh nhan u lympho deuc ghep te bao goc tu than t?i benh vien cho ray [Initial evaluation the safety and efficiency of BeEAM conditioning regimen in lymphoma patients undergoing autologous stem cell transplantation at Cho Ray hospital]. VIETNAM MEDICAL JOURNAL. 2022;520(11):430-37$$$$$Y$$$20240924$$HP$VN$VN
243559681$24355968$1$I$20240901$20240916$20240924$20240924$EXP$$US-SA-2024SA074765$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240924$$MD$US$US
243559691$24355969$1$I$20240910$20240910$20240924$20240924$PER$$US-JNJFOC-20240931663$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240924$$CN$US$US
243559711$24355971$1$I$20240911$20240911$20240924$20240924$PER$$US-JNJFOC-20240929666$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243559731$24355973$1$I$$20240912$20240924$20240924$EXP$$US-GRAVITIPHARMA-GRA-2409-US-LIT-0415$GRAVITI PHARMACEUTICALS$Laird J, Falk RH, Coyle M, Cuddy SAM.Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone.JACC-Case-Rep.2020;2(15):2372-2375$85$YR$E$F$Y$$$20240924$$MD$US$US
243559741$24355974$1$I$20240912$20240916$20240924$20240924$PER$$US-AMGEN-USASP2024185081$AMGEN$$66$YR$E$M$Y$44.9$KG$20240924$$PH$US$US
243559751$24355975$1$I$20240814$20240917$20240924$20240924$EXP$IT-MINISAL02-1001802$IT-TEVA-VS-3244845$TEVA$$56$YR$$F$Y$55$KG$20240924$$PH$IT$IT
243559761$24355976$1$I$20240101$20240919$20240924$20240924$EXP$$US-AMGEN-USASP2024187652$AMGEN$$31$YR$A$F$Y$$$20240924$$HP$US$US
243559781$24355978$1$I$20240915$20240919$20240924$20240924$EXP$$US-ABBVIE-5931663$ABBVIE$$60$YR$$F$Y$$$20240924$$CN$US$US
243559791$24355979$1$I$$20240920$20240924$20240924$PER$$US-ABBVIE-5934975$ABBVIE$$$$$M$Y$$$20240924$$HP$US$US
243559801$24355980$1$I$20240910$20240911$20240924$20240924$PER$$US-TEVA-VS-3243192$TEVA$$36$YR$$F$Y$$$20240924$$CN$US$US
243559831$24355983$1$I$$20240918$20240924$20240924$PER$$US-JNJFOC-20240953390$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243559841$24355984$1$I$$20240920$20240924$20240924$PER$$US-JNJFOC-20240959646$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243559851$24355985$1$I$20230113$20240916$20240924$20240924$EXP$FR-AFSSAPS-RN2023000532$FR-CELLTRION INC.-2024FR022427$CELLTRION$$$$$$Y$$$20240924$$MD$FR$FR
243559861$24355986$1$I$$20240912$20240924$20240924$EXP$$US-GRAVITIPHARMA-GRA-2409-US-LIT-0397$GRAVITI PHARMACEUTICALS$Khalaf SA.Daptomycin induced rhabdomyolysis. When drug-drug interactions play a crucial rule.J-Invest-Med.2021;69(5):1123-1124$54$YR$A$F$Y$$$20240924$$HP$US$US
243559871$24355987$1$I$$20240916$20240924$20240924$EXP$$IE-ASPEN-GLO2024IE006461$ASPEN$$$$$$Y$$$20240924$$MD$IE$IE
243559881$24355988$1$I$20240101$20240916$20240924$20240924$EXP$$GB-ASPEN-GLO2024GB006429$ASPEN$$$$$$Y$$$20240924$$MD$GB$GB
243559891$24355989$1$I$$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188660$AMGEN$$$$$$Y$$$20240924$$PH$US$US
243559901$24355990$1$I$20240918$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188195$AMGEN$$71$YR$E$M$Y$$$20240924$$CN$US$US
243559911$24355991$1$I$20240901$20240917$20240924$20240924$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051997$BOEHRINGER INGELHEIM$$61$YR$A$F$Y$$$20240924$$CN$US$US
243559921$24355992$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5933308$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243559931$24355993$1$I$20240913$20240913$20240924$20240924$PER$$US-ASTELLAS-2024-AER-006933$ASTELLAS$$69$YR$E$M$Y$$$20240924$$PH$US$US
243559951$24355995$1$I$$20240910$20240924$20240924$EXP$$US-UCBSA-2024046599$UCB$$$$$M$Y$$$20240924$$CN$US$US
243559961$24355996$1$I$$20240909$20240924$20240924$PER$$US-JNJFOC-20240925914$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240924$$CN$US$US
243559971$24355997$1$I$$20240915$20240924$20240924$EXP$$US-JNJFOC-20240952292$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240924$$HP$US$US
243559981$24355998$1$I$20240701$20240916$20240924$20240924$EXP$$SG-ROCHE-10000083756$ROCHE$$$$$M$Y$$$20240924$$CN$SG$SG
243559991$24355999$1$I$20240910$20240919$20240924$20240924$EXP$$CN-ROCHE-10000086188$ROCHE$$49$YR$A$F$Y$58.5$KG$20240924$$HP$CN$CN
243560001$24356000$1$I$$20240916$20240924$20240924$EXP$FR-ABBVIE-5909974$FR-ROCHE-10000082591$ROCHE$$$$E$F$Y$$$20240924$$MD$FR$FR
243560021$24356002$1$I$$20240919$20240924$20240924$EXP$$CA-ROCHE-10000086139$ROCHE$$75$YR$E$F$Y$$$20240924$$PH$CA$CA
243560031$24356003$1$I$$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409131511421900-MPKSC$GB-Accord-446852$ACCORD$$$$$M$Y$$$20240924$$CN$GB$GB
243560041$24356004$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189660$NOVARTIS$$$$$F$Y$$$20240924$$MD$US$US
243560051$24356005$1$I$$20240916$20240924$20240924$EXP$$CA-TAKEDA-2024TUS088283$TAKEDA$$$$$F$Y$$$20240924$$CN$CA$CA
243560061$24356006$1$I$$20231025$20240924$20240924$EXP$$ID-ROCHE-10000086523$ROCHE$$$$$$Y$$$20240924$$CN$ID$ID
243560071$24356007$1$I$$20240919$20240924$20240924$EXP$$US-ROCHE-10000087318$ROCHE$$67$YR$E$M$Y$$$20240924$$CN$US$US
243560081$24356008$1$I$$20240918$20240924$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015538$JAZZ$$35$YR$$F$Y$63.6$KG$20240924$$CN$US$US
243560101$24356010$1$I$20240723$20240918$20240924$20240924$EXP$$US-CHATTEMPRD-2024OHG032688$CHATTEM$$63$YR$A$F$Y$$$20240924$$LW$US$US
243560111$24356011$1$I$20240916$20240917$20240924$20240924$EXP$$US-BEH-2024179020$CSL BEHRING$$35$YR$A$F$Y$$$20240924$$HP$US$US
243560122$24356012$2$F$20240903$20240924$20240924$20240928$EXP$$US-ABBVIE-5930516$ABBVIE$$19$YR$$M$Y$104$KG$20240928$$CN$US$US
243560132$24356013$2$F$$20240915$20240924$20240925$EXP$$US-JNJFOC-20240952291$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240925$$HP$US$US
243560141$24356014$1$I$$20240917$20240924$20240924$PER$$US-ABBVIE-5928563$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243560151$24356015$1$I$$20240913$20240924$20240924$PER$$US-ABBVIE-5924531$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243560161$24356016$1$I$20240722$20240913$20240924$20240924$EXP$$CZ-CELLTRION INC.-2024CZ022337$CELLTRION$$$$$$Y$$$20240924$$MD$CZ$CZ
243560171$24356017$1$I$$20240913$20240924$20240924$PER$$US-ABBVIE-5925832$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243560181$24356018$1$I$$20240903$20240924$20240924$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005266$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243560201$24356020$1$I$20240917$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188540$AMGEN$$$$$M$Y$$$20240924$$HP$US$US
243560212$24356021$2$F$20240901$20240924$20240924$20240926$PER$$US-AMGEN-USASP2024189636$AMGEN$$62$YR$A$M$Y$$$20240926$$CN$US$US
243560221$24356022$1$I$$20240917$20240924$20240924$EXP$NL-LRB-01001052$NL-TEVA-VS-3244599$TEVA$$71$YR$$F$Y$$$20240924$$MD$NL$NL
243560242$24356024$2$F$20210101$20240920$20240924$20240926$EXP$$DE-BIOGEN-2024BI01283398$BIOGEN$$$$$F$Y$$$20240926$$CN$DE$DE
243560251$24356025$1$I$$20240916$20240924$20240924$EXP$$AU-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001344$ALEMBIC$$$$$$Y$$$20240924$$HP$AU$AU
243560262$24356026$2$F$$20240923$20240924$20240925$PER$$US-AMGEN-USASP2024189227$AMGEN$$$$$F$Y$$$20240925$$PH$US$US
243560271$24356027$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024188233$AMGEN$$72$YR$E$$Y$$$20240924$$MD$US$US
243560281$24356028$1$I$$20240915$20240924$20240924$EXP$$US-JNJFOC-20240952288$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240924$$HP$US$US
243560291$24356029$1$I$$20240917$20240924$20240924$EXP$$JP-009507513-2409JPN002861J$MERCK$$57$YR$$$Y$$$20240924$$MD$JP$JP
243560301$24356030$1$I$20240101$20240923$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151107$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240924$$CN$US$US
243560311$24356031$1$I$$20240912$20240924$20240924$PER$$US-ABBVIE-5926132$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243560321$24356032$1$I$$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188582$AMGEN$$$$$$Y$$$20240924$$CN$US$US
243560331$24356033$1$I$$20240915$20240924$20240924$EXP$$US-JNJFOC-20240952287$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240924$$HP$US$US
243560341$24356034$1$I$$20240917$20240924$20240924$PER$$US-JNJFOC-20240954511$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$HP$US$US
243560351$24356035$1$I$20231201$20240916$20240924$20240924$EXP$FR-AFSSAPS-MA2024001285$FR-EMD Serono-2024049523$EMD SERONO INC$$35$YR$A$F$Y$$$20240924$$MD$FR$FR
243560361$24356036$1$I$$20240920$20240924$20240924$EXP$$NVSC2024ZA188754$NOVARTIS$$81$YR$$M$Y$$$20240924$$CN$ZA$ZA
243560371$24356037$1$I$20240916$20240916$20240924$20240924$EXP$$US-RDY-SPO/USA/24/0013745$DR REDDYS$$48$YR$A$M$Y$$$20240924$$MD$US$US
243560381$24356038$1$I$$20240911$20240924$20240924$PER$$US-GSK-US2024AMR114102$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243560391$24356039$1$I$20190924$20240917$20240924$20240924$EXP$FR-AFSSAPS-MP20191337$FR-TEVA-VS-3244754$TEVA$$68$YR$$M$Y$$$20240924$$MD$FR$FR
243560401$24356040$1$I$$20240915$20240924$20240924$EXP$$US-JNJFOC-20240952286$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240924$$HP$US$US
243560411$24356041$1$I$20240101$20240918$20240924$20240924$EXP$$US-ABBVIE-5843453$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243560442$24356044$2$F$$20240924$20240924$20240926$PER$$US-AMGEN-USASP2024189642$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243560451$24356045$1$I$$20240910$20240924$20240924$EXP$$AT-ASCENT-2024ASLIT00033$ASCENT$Scorza CA, et al..Takotsubo syndrome is triggered by hypoactive delirium and recognized by increased catecholamine requirement in the ICU.Clinics (Sao Paulo, Brazil).2024;79 (1):1-2$60$YR$A$F$Y$75$KG$20240924$$HP$AT$AT
243560471$24356047$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151073$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20240924$$CN$US$US
243560481$24356048$1$I$$20240918$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149004$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240924$$HP$US$US
243560491$24356049$1$I$$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149361$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240924$$HP$US$US
243560501$24356050$1$I$$20240917$20240924$20240924$EXP$$US-TAKEDA-2017BLT001285$TAKEDA$$$$$F$Y$$$20240924$$CN$US$US
243560511$24356051$1$I$20180802$20240914$20240924$20240924$EXP$$AU-TAKEDA-2024TUS094271$TAKEDA$$55$YR$$M$Y$$$20240924$$MD$AU$AU
243560521$24356052$1$I$20240820$20240920$20240924$20240924$EXP$$JP-TAKEDA-2024TJP014008$TAKEDA$$$$C$$Y$$$20240924$$MD$JP$JP
243560531$24356053$1$I$$20240910$20240924$20240924$EXP$$US-UCBSA-2024046615$UCB$$$$$F$Y$$$20240924$$CN$US$US
243560541$24356054$1$I$$20240910$20240924$20240924$EXP$$GB-ASCENT-2024ASLIT00034$ASCENT$Johnson N, et al..Non-steroidal anti-inflammatory drug induced intestinal stricturing: diaphragm disease.Journal of Surgical Case Reports.JAN-2024;1 (1):1-4$41$YR$A$M$Y$$$20240924$$HP$GB$GB
243560551$24356055$1$I$20240701$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409131805504950-CYFVB$GB-Accord-447244$ACCORD$$30$YR$A$F$Y$70$KG$20240924$$CN$GB$GB
243560561$24356056$1$I$20180101$20190118$20240924$20240924$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2019US001480$JUBILANT$$$$$F$Y$$$20240924$$CN$US$US
243560571$24356057$1$I$$20221024$20240924$20240924$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2022US000780$JUBILANT$Tuttle M, Wells L, Corcoran J, Theobald J. Elective cannulation to venoarterial extracorporeal membrane oxygenation (VA ECMO) in a teenager with vasoplegia following amlodipine ingestion. Clinical Toxicology. 2022;60(2):135$17$YR$$F$Y$61.224$KG$20240924$$HP$US$US
243560581$24356058$1$I$$20240922$20240924$20240924$PER$$NVSC2024US189390$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
243560591$24356059$1$I$$20240917$20240924$20240924$EXP$$NL-IPCA LABORATORIES LIMITED-IPC-2024-NL-002246$IPCA$Medea Brouwer, Mandy Offermans, Lisanne van Nuil et al.. Effective extracorporeal treatment of metformin-associated lactic acidosis using continuous venovenous hemodiafiltration. European Journal of Case Reports in Internal Medicine. 2024;11(9)$$$$$Y$$$20240924$$HP$NL$NL
243560601$24356060$1$I$20230101$20240917$20240924$20240924$EXP$$JP-TAKEDA-2024TUS094312$TAKEDA$$77$YR$$F$Y$$$20240924$$MD$JP$JP
243560611$24356061$1$I$$20240918$20240924$20240924$EXP$$US-TAKEDA-2024TUS093392$TAKEDA$$21$YR$$M$Y$$$20240924$$CN$US$US
243560621$24356062$1$I$20210701$20230124$20240924$20240924$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2022US000803$JUBILANT$Essink J, Berg S, Montange J, Sankey A, Taylor V, Salomon J. Single-Pass Albumin Dialysis as Rescue Therapy for Pediatric Calcium Channel Blocker Overdose. Journal of Investigative Medicine High Impact Case Reports. 2022;10:1-5$17$YR$$F$Y$102.95$KG$20240924$$MD$US$US
243560631$24356063$1$I$$20240910$20240924$20240924$EXP$$US-ASCENT-2024ASLIT00035$ASCENT$Hennen M-A, et al..An unwelcome side-effect of trazodone use in a trans-male.Psychiatry and Clinical Neurosciences.2024;78(6):376-8$24$YR$A$$Y$$$20240924$$HP$US$US
243560642$24356064$2$F$20240101$20240924$20240924$20240927$EXP$$US-ABBVIE-5931456$ABBVIE$$58$YR$$F$Y$88.904$KG$20240927$$CN$US$US
243560651$24356065$1$I$$20240911$20240924$20240924$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK094059$GLENMARK$Pelletier JH, Nagaraj S, Gbadegesin R, Wigfall D, McGann KA, Foreman J.. Neutropenic enterocolitis (typhlitis) in a pediatric renal transplant patient. A case report and review of the literature.. Pediatric Transplantation.. 2017;21(6):e13022$$$$$Y$$$20240924$$MD$US$US
243560661$24356066$1$I$20240101$20240919$20240924$20240924$EXP$$US-ABBVIE-5931238$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243560681$24356068$1$I$$20240919$20240924$20240924$EXP$$US-TAKEDA-2024TUS094204$TAKEDA$$$$$F$Y$$$20240924$$MD$US$US
243560701$24356070$1$I$$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409130956002900-GBVFD$GB-Accord-446746$ACCORD$$4$YR$C$M$Y$$$20240924$$CN$GB$GB
243560711$24356071$1$I$$20240917$20240924$20240924$EXP$$GB-NOVITIUMPHARMA-2024GBNVP01970$NOVITIUM PHARMA$Khawar Hussain.A case of human T-lymphotropic virus-1-associated lichenoid dermatitis.Clinical and Experimental Dermatology.AUG-2024;49(8):916-918$61$YR$A$F$Y$$$20240924$$HP$GB$GB
243560721$24356072$1$I$20240702$20240920$20240924$20240924$EXP$FR-AFSSAPS-RE2024000891$NVSC2024FR187775$NOVARTIS$$77$YR$$F$Y$64$KG$20240924$$MD$FR$FR
243560731$24356073$1$I$20240901$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012548$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240924$$CN$US$US
243560741$24356074$1$I$20240919$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013738$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240924$$CN$US$US
243560751$24356075$1$I$20240901$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014256$ELI LILLY AND CO$$$$$M$Y$$$20240924$$CN$US$US
243560761$24356076$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013838$ELI LILLY AND CO$$$$A$F$Y$$$20240924$$CN$US$US
243560771$24356077$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013584$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240924$$CN$US$US
243560781$24356078$1$I$$20240919$20240924$20240924$PER$$US-GSK-US2024116636$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243560791$24356079$1$I$$20240920$20240924$20240924$PER$$US-HALEON-2198118$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
243560801$24356080$1$I$$20240919$20240924$20240924$PER$$US-ABBVIE-5932879$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243560811$24356081$1$I$$20240918$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150643$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240924$$MD$US$US
243560821$24356082$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150255$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$76.66$KG$20240924$$CN$US$US
243560831$24356083$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150575$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240924$$HP$US$US
243560841$24356084$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150297$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240924$$HP$US$US
243560851$24356085$1$I$$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150542$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240924$$HP$US$US
243560861$24356086$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150872$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240924$$HP$US$US
243560871$24356087$1$I$$20240919$20240924$20240924$PER$$NVSC2024US189683$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
243560881$24356088$1$I$$20240918$20240924$20240924$EXP$$NVSC2024CN187907$NOVARTIS$Wen S, He L, Zhang S, Zhu P. Clinical study on Xintong Granules combined with sacubactril valsartan in treatment of chronic heart failure with ejection fraction preservation. DRUGS + CLINIC. 2024;39(9):1-5$$$A$$Y$$$20240924$$HP$CN$CN
243560901$24356090$1$I$20240730$20240919$20240924$20240924$EXP$IT-MINISAL02-1002103$IT-TEVA-VS-3245996$TEVA$$63$YR$$M$Y$$$20240924$$PH$IT$IT
243560912$24356091$2$F$20240814$20240918$20240924$20240927$EXP$$MX-SANDOZ INC.-SDZ2024MX082281$SANDOZ$$88$YR$$M$Y$$$20240927$$CN$MX$MX
243560921$24356092$1$I$$20240918$20240924$20240924$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-28587$SAMSUNG BIOEPIS$$73$YR$E$F$Y$$$20240924$$MD$CA$CA
243560931$24356093$1$I$$20240919$20240924$20240924$EXP$$FR-SANDOZ INC.-PHHY2015FR020263$SANDOZ$$6$YR$$F$Y$$$20240924$$MD$FR$FR
243560941$24356094$1$I$20240901$20240914$20240924$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-029046$UNITED THERAPEUTICS$$56$YR$$M$Y$86.621$KG$20240924$$$US$US
243560951$24356095$1$I$20240917$20240918$20240924$20240924$PER$$US-ABBVIE-5934431$ABBVIE$$$$$F$Y$$$20240924$$MD$US$US
243560962$24356096$2$F$20240101$20240923$20240924$20240926$PER$$US-AMGEN-USASP2024188814$AMGEN$$57$YR$A$M$Y$$$20240926$$CN$US$US
243560971$24356097$1$I$20240418$20240923$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151039$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240924$$CN$US$US
243560981$24356098$1$I$$20240910$20240924$20240924$EXP$$US-LEADINGPHARMA-US-2024LEALIT00430$LEADING PHARMA$M-A Hennen.An unwelcome side-effect of trazodone use in a trans-male.Psychiatry and Clinical Neurosciences.JUN-2024;78:376$24$YR$A$$Y$$$20240924$$HP$US$US
243560991$24356099$1$I$$20240917$20240924$20240924$PER$$US-VIIV HEALTHCARE LIMITED-US2024116049$VIIV$$$$$M$Y$$$20240924$$CN$US$US
243561001$24356100$1$I$$20240923$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151014$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240924$$CN$US$US
243561011$24356101$1$I$20240909$20240917$20240924$20240924$EXP$$CA-GSK-CA2024115593$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$CA$CA
243561021$24356102$1$I$20240201$20240919$20240924$20240924$EXP$$US-ABBVIE-5931277$ABBVIE$$66$YR$$M$Y$$$20240924$$CN$US$US
243561041$24356104$1$I$$20240913$20240924$20240924$EXP$FR-AFSSAPS-RN2024000970$FR-Accord-447167$ACCORD$$68$YR$E$M$Y$69$KG$20240924$$PH$FR$FR
243561071$24356107$1$I$20240901$20240918$20240924$20240924$EXP$$CN-ROCHE-10000085765$ROCHE$$68$YR$E$F$Y$50$KG$20240924$$HP$CN$CN
243561081$24356108$1$I$$20240916$20240924$20240924$PER$$US-ROCHE-10000084428$ROCHE$$$$A$F$Y$$$20240924$$CN$US$US
243561091$24356109$1$I$20240913$20240919$20240924$20240924$EXP$$TH-ROCHE-10000087315$ROCHE$$36$YR$A$$Y$$$20240924$$CN$TH$TH
243561101$24356110$1$I$$20240917$20240924$20240924$EXP$$US-ROCHE-10000084485$ROCHE$Campos Ramos M, Chao Z, Orozco R, Reiter K, Glass J, Vigil A. Rheumatoid arthritis associated vasculitis: a rare entity; case and review. Journal of Surgical Case Reports. 2024;8:1-4. doi:10.1093/jscr/rjae446.$60$YR$A$M$Y$$$20240924$$HP$US$US
243561111$24356111$1$I$$20240903$20240924$20240924$30DAY$$US-JNJFOC-20240927735$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$PH$US$US
243561122$24356112$2$F$$20240919$20240924$20240925$EXP$$US-JNJFOC-20240960152$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243561131$24356113$1$I$20220901$20240923$20240924$20240924$EXP$$AT-GILEAD-2024-0688119$GILEAD$$51$YR$A$F$Y$$$20240924$$MD$AT$AT
243561141$24356114$1$I$$20240912$20240924$20240924$EXP$$US-SA-2024SA274149$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240924$$HP$US$US
243561151$24356115$1$I$$20240915$20240924$20240924$PER$$US-ABBVIE-5925950$ABBVIE$$$$A$F$Y$$$20240924$$CN$US$US
243561161$24356116$1$I$$20240910$20240924$20240924$EXP$$US-UCBSA-2024046692$UCB$$$$$$Y$$$20240924$$CN$US$US
243561171$24356117$1$I$$20240904$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08937$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243561191$24356119$1$I$$20240910$20240924$20240924$EXP$$ES-PRAXGEN-2024PPLIT00050$PRAXGEN PHARMACEUTICALS$$27$YR$A$F$Y$$$20240924$$HP$ES$ES
243561221$24356122$1$I$$20240917$20240924$20240924$EXP$$US-JNJFOC-20240949977$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240924$$HP$US$US
243561231$24356123$1$I$20240901$20240920$20240924$20240924$EXP$$CA-JNJFOC-20240959854$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240924$$HP$CA$CA
243561251$24356125$1$I$$20240916$20240924$20240924$EXP$$US-INTERCEPT-PM2024001580$INTERCEPT PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
243561271$24356127$1$I$20240819$20240911$20240924$20240924$EXP$$CN-AUROBINDO-AUR-APL-2024-046091$AUROBINDO$$77$YR$$F$Y$$$20240924$$HP$CN$CN
243561281$24356128$1$I$$20240918$20240924$20240924$EXP$$JP-SA-2024SA270454$SANOFI AVENTIS$$$$$$Y$$$20240924$$HP$JP$JP
243561292$24356129$2$F$20240914$20240921$20240924$20240930$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029213$UNITED THERAPEUTICS$$65$YR$$M$Y$50.794$KG$20240930$$PH$US$US
243561311$24356131$1$I$$20240912$20240924$20240924$EXP$$CA-APOTEX-2024AP010659$APOTEX$$$$$F$Y$$$20240924$$MD$CA$CA
243561321$24356132$1$I$$20240916$20240924$20240924$EXP$$US-JNJFOC-20240961491$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240924$$CN$US$US
243561341$24356134$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024187562$AMGEN$$$$$$Y$$$20240924$$PH$US$US
243561351$24356135$1$I$20240920$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189649$AMGEN$$74$YR$E$M$Y$$$20240924$$CN$US$US
243561371$24356137$1$I$20240101$20240912$20240924$20240924$EXP$$CA-APOTEX-2024AP010733$APOTEX$$$$E$M$Y$$$20240924$$CN$CA$CA
243561383$24356138$3$F$$20240920$20240924$20240926$EXP$$US-SANDOZ INC.-SDZ2024US082263$SANDOZ$$39$YR$$M$Y$$$20240926$$CN$US$US
243561391$24356139$1$I$20240101$20240911$20240924$20240924$EXP$$US-JNJFOC-20240959729$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240924$$CN$US$US
243561401$24356140$1$I$$20240909$20240924$20240924$PER$$US-APOTEX-2024AP010527$APOTEX$Ward J, Portnof J, Barreto V, Freedman P, Reich R, Kerpel S. T. Two cases of imatinib induced oral pigmentation affecting the palate. ORAL AND MAXILLOFACIAL PATHOLOGY. 2024;138 (4):e79-e84$69$YR$$F$Y$$$20240924$$MD$US$US
243561411$24356141$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024189197$AMGEN$$$$$M$Y$$$20240924$$CN$US$US
243561431$24356143$1$I$20240917$20240919$20240924$20240924$EXP$$US-AMGEN-USASP2024187807$AMGEN$$$$$$Y$$$20240924$$PH$US$US
243561441$24356144$1$I$20240809$20240920$20240924$20240924$EXP$$CN-ROCHE-10000088062$ROCHE$$61$YR$A$F$Y$$$20240924$$CN$CN$CN
243561481$24356148$1$I$$20240905$20240924$20240924$30DAY$$GB-JNJFOC-20240937574$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$GB$GB
243561491$24356149$1$I$20240101$20240919$20240924$20240924$EXP$$KR-JNJFOC-20240958914$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240924$$HP$KR$KR
243561501$24356150$1$I$20240903$20240911$20240924$20240924$PER$$US-GSK-US2024113166$GLAXOSMITHKLINE$$70$YR$$F$Y$$$20240924$$CN$US$US
243561511$24356151$1$I$$20240917$20240924$20240924$PER$$US-ABBVIE-5928463$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243561531$24356153$1$I$$20240919$20240924$20240924$EXP$$CA-TAKEDA-2024TUS094100$TAKEDA$$$$$F$Y$$$20240924$$MD$CA$CA
243561541$24356154$1$I$$20240913$20240924$20240924$PER$$US-ASTELLAS-2024-AER-007255$ASTELLAS$$67$YR$E$F$Y$$$20240924$$CN$US$US
243561551$24356155$1$I$$20240919$20240924$20240924$EXP$BE-FAMHP-DHH-N2024-122607$BE-TEVA-VS-3246145$TEVA$$$$$M$Y$$$20240924$$CN$BE$BE
243561581$24356158$1$I$20240916$20240919$20240924$20240924$EXP$$AU-SA-2024SA272955$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240924$$HP$AU$AU
243561591$24356159$1$I$$20240910$20240924$20240924$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-21534$ALKEM$Karpos PA, Jones CK, McNamara MJ, Spengler DM.. Persistent leakage of cerebrospinal fluid after intrathecal administration of Morphine in an operation on the lumbar spine. A report of two cases. The Journal of bone and joint surgery American. 1994;76:916-8$27$YR$$F$Y$$$20240924$$HP$US$US
243561601$24356160$1$I$$20240910$20240924$20240924$EXP$$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2024-21561$ALKEM$de Gans J, van der Heide H.. Purulent meningitis caused by Pseudomonas aeruginosa following an operation of the aortic bifurcation, presumably related to intrathecal analgesia. Nederlands Tijdschrift Voor Geneeskunde. 1983;127:377-81$61$YR$$M$Y$$$20240924$$HP$NL$NL
243561611$24356161$1$I$$20240910$20240924$20240924$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-21535$ALKEM$Karpos PA, Jones CK, McNamara MJ, Spengler DM.. Persistent leakage of cerebrospinal fluid after intrathecal administration of Morphine in an operation on the lumbar spine. A report of two cases. The Journal of bone and joint surgery American. 1994;76:916-8$34$YR$$F$Y$$$20240924$$HP$US$US
243561621$24356162$1$I$$20240910$20240924$20240924$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21537$ALKEM$Ip Yam C, Salt J. Transient ischaemic attack following carbon dioxide retention due to intrathecal morphine. Anaesthesia. 1992;47:1098$76$YR$$M$Y$$$20240924$$HP$GB$GB
243561631$24356163$1$I$$20240910$20240924$20240924$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-21568$ALKEM$Ryan KF, Price JW, Warriner CB, Choi PT.. Persistent hypothermia after intrathecal morphine: case report and literature review. Can J Anaesth. 2012;59:384-8$57$YR$$F$Y$$$20240924$$HP$CA$CA
243561641$24356164$1$I$$20240910$20240924$20240924$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-19871$ALKEM$Satirer O, Henes JC, Doring M, Lesk T, Benseler S, Kuemmerle-Deschner JB.. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. Rheumatic and Musculoskeletal Diseases Open. 2024;10(3):e004381$6$YR$$F$Y$$$20240924$$HP$DE$DE
243561651$24356165$1$I$$20240910$20240924$20240924$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-21579$ALKEM$Satirer O, Henes JC, D?ring M, Lesk T, Benseler S, Kuemmerle-Deschner JB. Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD Open. 2024;10(3):unk$6$YR$$M$Y$$$20240924$$HP$DE$DE
243561661$24356166$1$I$20240820$20240913$20240924$20240924$EXP$ES-AEMPS-1567709$ES-Accord-447194$ACCORD$$52$YR$A$F$Y$$$20240924$$PH$ES$ES
243561681$24356168$1$I$$20240910$20240924$20240924$EXP$$AT-ALKEM LABORATORIES LIMITED-AT-ALKEM-2024-21560$ALKEM$Krenn H, Jellinek H, Haumer H, Oczenski W, Fitzgerald R.. Naloxone-resistant respiratory depression and neurological eye symptoms after intrathecal morphine. Anesthesia and Analgesia. 2000;91:432-423$72$YR$$F$Y$$$20240924$$HP$AT$AT
243561691$24356169$1$I$$20240910$20240924$20240924$EXP$$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2024-21543$ALKEM$Eran A, Barak M.. Posterior reversible encephalopathy syndrome after combined general and spinal anesthesia with intrathecal morphine.. Anesth Analg. 2009;108:609-12$51$YR$$F$Y$$$20240924$$HP$IL$IL
243561701$24356170$1$I$20240628$20240911$20240924$20240924$EXP$FR-AFSSAPS-PA2024001358$FR-Axellia-005363$XELLIA PHARMACEUTICALS$$36$YR$A$M$Y$72.9$KG$20240924$$MD$FR$FR
243561711$24356171$1$I$20240909$20240910$20240924$20240924$EXP$GB-MHRA-TPP2245943C22576978YC1725887365955$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21397$ALKEM$$82$YR$$F$Y$74$KG$20240924$$MD$GB$GB
243561721$24356172$1$I$20230901$20240910$20240924$20240924$EXP$GB-MHRA-MED-202409091928410690-VLMKN$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21391$ALKEM$$38$YR$$F$Y$91$KG$20240924$$CN$GB$GB
243561741$24356174$1$I$$20240919$20240924$20240924$PER$$US-GSK-US2024116639$GLAXOSMITHKLINE$$$$$M$Y$$$20240924$$CN$US$US
243561751$24356175$1$I$20240809$20240911$20240924$20240924$EXP$FR-AFSSAPS-ST2024001355$FR-Axellia-005368$XELLIA PHARMACEUTICALS$$84$YR$E$F$Y$60$KG$20240924$$MD$FR$FR
243561761$24356176$1$I$$20240910$20240924$20240924$EXP$GB-MHRA-TPP23178954C9770265YC1725720115107$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21401$ALKEM$$43$YR$$M$Y$80$KG$20240924$$MD$GB$GB
243561771$24356177$1$I$$20240916$20240924$20240924$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-148754$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240924$$MD$DE$DE
243561781$24356178$1$I$20240812$20240918$20240924$20240924$EXP$$CN-ROCHE-10000086303$ROCHE$$39$YR$A$F$Y$50.3$KG$20240924$$HP$CN$CN
243561791$24356179$1$I$$20240917$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US081334$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243561801$24356180$1$I$$20240910$20240924$20240924$EXP$$US-UCBSA-2024046697$UCB$$$$$M$Y$$$20240924$$HP$US$US
243561811$24356181$1$I$20240702$20240920$20240924$20240924$EXP$$CN-ROCHE-10000088123$ROCHE$$53$YR$A$M$Y$$$20240924$$CN$CN$CN
243561821$24356182$1$I$20240801$20240904$20240924$20240924$PER$$US-TEVA-VS-3240468$TEVA$$85$YR$$F$Y$68.04$KG$20240924$$CN$US$US
243561831$24356183$1$I$$20240919$20240924$20240924$EXP$$US-JNJFOC-20240960012$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243561841$24356184$1$I$$20240909$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09027$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243561851$24356185$1$I$20240901$20240919$20240924$20240924$EXP$$CA-ABBVIE-5933154$ABBVIE$$$$A$F$Y$$$20240924$$CN$CA$CA
243561861$24356186$1$I$$20240917$20240924$20240924$EXP$$US-VIIV HEALTHCARE LIMITED-US2024116035$VIIV$$$$$$Y$$$20240924$$MD$US$US
243561871$24356187$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5932314$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243561881$24356188$1$I$$20240910$20240924$20240924$EXP$$US-UCBSA-2024046761$UCB$$$$$$Y$$$20240924$$CN$US$US
243561891$24356189$1$I$20240916$20240920$20240924$20240924$EXP$GB-MHRA-MIDB-fb834542-3658-4c43-822c-ba64be4f155e$GB-SANDOZ INC.-SDZ2024GB082039$SANDOZ$$$$$F$Y$$$20240924$$PH$GB$GB
243561901$24356190$1$I$20240914$20240916$20240924$20240924$EXP$$US-PTC THERAPEUTICS INC.-US-2024PTC001238$PTC THERAPEUTICS$$17$YR$$M$Y$$$20240924$$HP$US$US
243561921$24356192$1$I$$20240920$20240924$20240924$PER$$US-ROCHE-10000087631$ROCHE$$40$YR$A$F$Y$$$20240924$$HP$US$US
243561931$24356193$1$I$$20240911$20240924$20240924$PER$$US-APOTEX-2024AP010581$APOTEX$$$$$F$Y$$$20240924$$CN$US$US
243561941$24356194$1$I$20230101$20240919$20240924$20240924$EXP$$JP-GILEAD-2024-0688343$GILEAD$$64$YR$A$M$Y$$$20240924$$MD$JP$JP
243561951$24356195$1$I$20240801$20240918$20240924$20240924$EXP$$US-ABBVIE-5930939$ABBVIE$$45$YR$$M$Y$$$20240924$$CN$US$US
243561961$24356196$1$I$20240101$20240918$20240924$20240924$EXP$$US-ABBVIE-5931470$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243561981$24356198$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024188142$AMGEN$$$$$$Y$$$20240924$$MD$US$US
243561991$24356199$1$I$$20240917$20240924$20240924$PER$$US-ROCHE-10000085243$ROCHE$$20$YR$A$M$Y$$$20240924$$CN$US$US
243562001$24356200$1$I$$20240919$20240924$20240924$EXP$$TH-ROCHE-10000087295$ROCHE$$62$YR$A$M$Y$$$20240924$$HP$TH$TH
243562011$24356201$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150392$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$107.5$KG$20240924$$PH$US$US
243562021$24356202$1$I$20240901$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150680$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$68.6$KG$20240924$$PH$US$US
243562031$24356203$1$I$$20240919$20240924$20240924$EXP$$TH-ROCHE-10000086543$ROCHE$$$$$F$Y$$$20240924$$CN$TH$TH
243562041$24356204$1$I$20240727$20240918$20240924$20240924$EXP$$PK-ROCHE-10000085492$ROCHE$$62$YR$A$M$Y$$$20240924$$CN$PK$PK
243562051$24356205$1$I$$20240917$20240924$20240924$EXP$$CA-GSK-CA2023147233$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$CA$CA
243562061$24356206$1$I$$20240916$20240924$20240924$EXP$$CA-GSK-CA2024115438$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$CA$CA
243562071$24356207$1$I$$20240916$20240924$20240924$EXP$$CA-ROCHE-10000085897$ROCHE$$42$YR$A$F$Y$$$20240924$$MD$CA$CA
243562081$24356208$1$I$$20240916$20240924$20240924$EXP$$HU-CELLTRION INC.-2024HU022432$CELLTRION$Krivan G, Kallay K, Sinko J, Goda V, Remenyi P, Kassa C, et al.. Who dares wins! - A rare case of EBV infection. Gyermekgyogyaszat. 2018;3$$$$$Y$$$20240924$$MD$HU$HU
243562091$24356209$1$I$$20240919$20240924$20240924$PER$$US-BIOGEN-2024BI01260076$BIOGEN$$$$$M$Y$$$20240924$$CN$US$US
243562101$24356210$1$I$20240916$20240919$20240924$20240924$EXP$$US-ABBVIE-5932710$ABBVIE$$57$YR$$M$Y$$$20240924$$CN$US$US
243562111$24356211$1$I$$20240913$20240924$20240924$EXP$$GB-AUROBINDO-AUR-APL-2024-046009$AUROBINDO$$61$YR$$M$Y$$$20240924$$HP$GB$GB
243562121$24356212$1$I$$20240905$20240924$20240924$30DAY$$US-JNJFOC-20240939784$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243562131$24356213$1$I$20240815$20240921$20240924$20240924$EXP$$IN-ROCHE-10000089010$ROCHE$$70$YR$E$F$Y$$$20240924$$CN$IN$IN
243562141$24356214$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150251$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240924$$CN$US$US
243562151$24356215$1$I$$20240918$20240924$20240924$EXP$$IN-ROCHE-10000087311$ROCHE$$73$YR$E$F$Y$$$20240924$$CN$IN$IN
243562161$24356216$1$I$20220105$20240916$20240924$20240924$EXP$$IN-ROCHE-3001627$ROCHE$$63$YR$A$M$Y$$$20240924$$CN$IN$IN
243562171$24356217$1$I$20240101$20240918$20240924$20240924$EXP$$US-AMGEN-USASP2024187163$AMGEN$$$$$M$Y$$$20240924$$HP$US$US
243562181$24356218$1$I$20240730$20240913$20240924$20240924$EXP$$FR-AUROBINDO-AUR-APL-2024-046461$AUROBINDO$$79$YR$$M$Y$110$KG$20240924$$MD$FR$FR
243562201$24356220$1$I$20240919$20240919$20240924$20240924$EXP$$JP-ABBVIE-5932633$ABBVIE$$$$$$Y$$$20240924$$MD$JP$JP
243562211$24356221$1$I$20240920$20240920$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US082205$SANDOZ$$14$YR$$$Y$$$20240924$$CN$US$US
243562221$24356222$1$I$$20240829$20240924$20240924$PER$$US-009507513-2409USA007220$MERCK$Marvin-Peek J, Sasaki K, Kontoyiannis D, Adachi J, Ohanian M, Takahashi K, et al. Nontuberculosis mycobacteria (NTM) infections in patients with leukemia: a single center case series. Frontiers in Medicine. 2024;11$72$YR$$M$Y$$$20240924$$HP$US$US
243562231$24356223$1$I$$20240919$20240924$20240924$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001917$BLUEPRINT MEDICINES$$$$$M$Y$$$20240924$$HP$US$US
243562241$24356224$1$I$$20240912$20240924$20240924$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001372$ALEMBIC$$$$$$Y$$$20240924$$CN$US$US
243562251$24356225$1$I$20240329$20240915$20240924$20240924$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149505$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$MD$PT$PT
243562261$24356226$1$I$20240101$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151026$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240924$$HP$US$US
243562271$24356227$1$I$$20240912$20240924$20240924$EXP$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001375$ALEMBIC$Gwynn N, Lindenmayer J.-P, Boes T, Pitalo C. Late Recognition of Cholinergic Delirium in Patient on Donepezil Combination Treatment. Journal of Clinical Psychopharmacology. 2024;44 (5):521-522$$$$$Y$$$20240924$$HP$US$US
243562281$24356228$1$I$$20240917$20240924$20240924$EXP$$JP-AMGEN-JPNSP2024187001$AMGEN$$$$$$Y$$$20240924$$MD$JP$JP
243562291$24356229$1$I$$20240913$20240924$20240924$EXP$$CA-AMGEN-CANNI2024186791$AMGEN$$$$$F$Y$$$20240924$$CN$CA$CA
243562301$24356230$1$I$$20240911$20240924$20240924$EXP$$US-APOTEX-2024AP010640$APOTEX$Neisewander B, Trapp N. Electroconvulsive therapy complicated by ventricular fibrillation: A case report. Annals of Clinical Psychiatry. 2023;35 (2):133-134$37$YR$$F$Y$$$20240924$$MD$US$US
243562311$24356231$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5934383$ABBVIE$$$$$M$Y$$$20240924$$MD$US$US
243562321$24356232$1$I$20230801$20240916$20240924$20240924$EXP$FR-AFSSAPS-MA2024001261$FR-EMD Serono-2024049529$EMD SERONO INC$$33$YR$A$F$Y$$$20240924$$MD$FR$FR
243562331$24356233$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150955$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240924$$HP$US$US
243562341$24356234$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150853$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240924$$HP$US$US
243562351$24356235$1$I$20240919$20240919$20240924$20240924$EXP$$US-ABBVIE-5933598$ABBVIE$$70$YR$$F$Y$$$20240924$$CN$US$US
243562361$24356236$1$I$$20240909$20240924$20240924$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469308$RANBAXY$Abe T, Sagara A, Suzuki T, Okada D, Matsuzaka K, Nakayama T. Infusion Reactions in HER2-Positive Gastric Cancer: Switching from Trastuzumab to Its Biosimilar. Biol Pharm Bull. 2024;47 (8):1452-1455$52$YR$$F$Y$$$20240924$$HP$JP$JP
243562371$24356237$1$I$$20240909$20240924$20240924$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469314$RANBAXY$Van Breusegem P, Verswijvel G, Fransis S, Van der Speeten K. Peritoneal Surface Malignancies Originating From Urachal Carcinoma: Case Reports and Review of the Literature. Ind J Surg Oncol. 2023;Mar; 14 (Suppl):S109-S121$42$YR$$F$Y$$$20240924$$HP$BE$BE
243562381$24356238$1$I$$20240909$20240924$20240924$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469569$RANBAXY$Kinoshita K, Matsumoto Y, Hayano K, Kurata Y, Otsuka R, Hayashi H, et al. Chemotherapy Strategy in a Case of MSI-High Patients with Gastric Cancer-Case Report. Gan To Kagaku Ryoho. 2024;51 (5):553-555$73$YR$$F$Y$$$20240924$$HP$JP$JP
243562391$24356239$1$I$20240101$20240910$20240924$20240924$EXP$$CA-UCBSA-2024046881$UCB$$$$$M$Y$$$20240924$$CN$CA$CA
243562401$24356240$1$I$20240101$20240920$20240924$20240924$EXP$$CA-ABBVIE-5933716$ABBVIE$$73$YR$$F$Y$$$20240924$$CN$CA$CA
243562411$24356241$1$I$20240415$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469371$RANBAXY$$76$YR$$M$Y$$$20240924$$PH$FR$FR
243562431$24356243$1$I$20240714$20240916$20240924$20240924$EXP$FR-AFSSAPS-LL2024001723$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112368$ZYDUS PHARM$$$$$$Y$$$20240924$$MD$FR$FR
243562441$24356244$1$I$20240829$20240916$20240924$20240924$EXP$FR-AFSSAPS-MP2024001367$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112507$ZYDUS PHARM$$$$$$Y$$$20240924$$PH$FR$FR
243562451$24356245$1$I$$20240909$20240924$20240924$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469715$RANBAXY$$$$$F$Y$$$20240924$$CN$GB$GB
243562461$24356246$1$I$20240619$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469551$RANBAXY$$84$YR$$F$Y$57.9$KG$20240924$$MD$FR$FR
243562471$24356247$1$I$$20240909$20240924$20240924$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469277$RANBAXY$Zou T, Wu Y-C, Yao  Q. Vaginal delivery of triplets after emergency transvaginal cerclage A case report and literature review. Medicine. 2024;103 (11):E37262$33$YR$$F$Y$$$20240924$$MD$CN$CN
243562481$24356248$1$I$20240726$20240916$20240924$20240924$EXP$FR-AFSSAPS-GR2024001087$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112483$ZYDUS PHARM$$$$$$Y$$$20240924$$PH$FR$FR
243562491$24356249$1$I$20240720$20240916$20240924$20240924$EXP$FR-AFSSAPS-AN2024001217$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112402$ZYDUS PHARM$$$$$$Y$$$20240924$$MD$FR$FR
243562501$24356250$1$I$20240626$20240909$20240924$20240924$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469300$RANBAXY$$91$YR$$M$Y$79$KG$20240924$$MD$DE$DE
243562511$24356251$1$I$20230515$20240916$20240924$20240924$EXP$FR-AFSSAPS-AM2024000731$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112465$ZYDUS PHARM$$$$$$Y$$$20240924$$MD$FR$FR
243562521$24356252$1$I$$20240910$20240924$20240924$EXP$001112167$CA-USP-004903$USPHARMA$$71$YR$E$F$Y$$$20240924$$CN$CA$CA
243562531$24356253$1$I$$20240910$20240924$20240924$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112199$ZYDUS PHARM$Thaliath L, Berg H, Edmund J. AML-101 Bone Marrow Necrosis in APML. Clin-Lymphoma- Myeloma-Leuk. 2024;24 (Suppl. 1):S293-S294 abstr. AML-101$$$$$Y$$$20240924$$MD$US$US
243562541$24356254$1$I$$20240912$20240924$20240924$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112364$ZYDUS PHARM$Popat D, Sanghavi N, Singh A, Sawhney R.. MM-657 Parsonage Turner Syndrome Complicating Multiple Myeloma Therapy: ^Nothing to Shrug your Shoulders at^. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl.):S578.$$$$$Y$$$20240924$$MD$US$US
243562551$24356255$1$I$$20240909$20240924$20240924$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469382$RANBAXY$$85$YR$$F$Y$$$20240924$$MD$NL$NL
243562561$24356256$1$I$$20240909$20240924$20240924$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469310$RANBAXY$Van Breusegem P, Verswijvel G, Fransis S, Van der Speeten K. Peritoneal Surface Malignancies Originating From Urachal Carcinoma: Case Reports and Review of the Literature. Ind J Surg Oncol. 2023;14 (Suppl 1):S109-S121$49$YR$$M$Y$$$20240924$$HP$BE$BE
243562571$24356257$1$I$$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469334$RANBAXY$$14$YR$$M$Y$$$20240924$$MD$FR$FR
243562581$24356258$1$I$$20240909$20240924$20240924$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469127$RANBAXY$Shukla K, Chaudhari R, Asgharpour A. Spontaneous Hepatic Hemorrhage Causing Acute Liver Failure Requiring Liver Transplant. ACG Case Rep J. 2024;Feb;11:E01268$59$YR$$F$Y$$$20240924$$MD$US$US
243562591$24356259$1$I$$20240909$20240924$20240924$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469320$RANBAXY$Abe T, Sagara A, Suzuki T, Okada D, Matsuzaka K, Nakayama T. Infusion Reactions in HER2-Positive Gastric Cancer: Switching from Trastuzumab to Its Biosimilar. Biol Pharm Bull. 2024;47 (8):1452-1455$57$YR$$F$Y$$$20240924$$HP$JP$JP
243562601$24356260$1$I$$20240909$20240924$20240924$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469412$RANBAXY$$66$YR$$F$Y$69$KG$20240924$$CN$NL$NL
243562611$24356261$1$I$$20240909$20240924$20240924$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469354$RANBAXY$Rybka J, Kuszczak B, Bogucka-Fedorczuk A. Treatment of primary central nervous system lymphoma(PCNSL) - single center experience and literature review. Acta Haematol Polon. 2024;55 (3):151-156$$$$$Y$$$20240924$$HP$PL$PL
243562621$24356262$1$I$20240119$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469359$RANBAXY$$55$YR$$M$Y$69$KG$20240924$$MD$FR$FR
243562631$24356263$1$I$$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469403$RANBAXY$$41$YR$$M$Y$76$KG$20240924$$PH$FR$FR
243562641$24356264$1$I$$20240909$20240924$20240924$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469335$RANBAXY$Su C-S, Kao C-L. Stevens-Johnson syndrome?toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report. J Med Case Rep. 2024;18 (1):1-5$82$YR$$F$Y$$$20240924$$HP$CN$CN
243562651$24356265$1$I$20240418$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469349$RANBAXY$$34$YR$$M$Y$$$20240924$$PH$FR$FR
243562661$24356266$1$I$20240816$20240909$20240924$20240924$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469709$RANBAXY$$60$YR$$M$Y$$$20240924$$PH$GB$GB
243562671$24356267$1$I$20240615$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469726$RANBAXY$$89$YR$$F$Y$$$20240924$$MD$FR$FR
243562681$24356268$1$I$$20240909$20240924$20240924$EXP$$MY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469511$RANBAXY$Foo JC, Mun KS, Tae SK, Chang KTE. H3-AND IDH-WILDTYPE DIFFUSE PAEDIATRIC-TYPE HIGH-GRADE GLIOMA WITH MYCN-AMPLIFICATION: AN INDICATION CRITERION FOR LIFRAUMENI SYNDROME TESTING. Neuro Oncol. 2024;Jun;26 (Suppl.):iv90 (NOAE064.303)$5$YR$$M$Y$$$20240924$$HP$MY$MY
243562691$24356269$1$I$$20240909$20240924$20240924$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469327$RANBAXY$Abe T, Sagara A, Suzuki T, Okada D, Matsuzaka K, Nakayama T. Infusion Reactions in HER2-Positive Gastric Cancer: Switching from Trastuzumab to Its Biosimilar. Biol Pharm Bull. 2024;47 (8):1452-1455$75$YR$$M$Y$$$20240924$$HP$JP$JP
243562701$24356270$1$I$20240415$20240909$20240924$20240924$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469379$RANBAXY$$17$YR$$F$Y$$$20240924$$MD$IT$IT
243562711$24356271$1$I$$20240909$20240924$20240924$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469069$RANBAXY$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J Acad Consult Liaison Psychiatry. 2024;65 (1):33-38$44$YR$$M$Y$$$20240924$$MD$US$US
243562721$24356272$1$I$$20240909$20240924$20240924$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469261$RANBAXY$Majumder S, Chattaraj S, Roy S, Saha S. Medication reconciliation to minimise medication errors: Iatrogenic hypercalcaemia as a case report. Indian J Physiol Pharmacol. 2024;Apr-Jun, 68 (2):172-175$74$YR$$F$Y$$$20240924$$HP$IN$IN
243562731$24356273$1$I$$20240909$20240924$20240924$EXP$$MY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468270$RANBAXY$Loy JS, Khoo CC, Arumugam T, Ngian GH, Ismail AK. Rhabdomyolysis due to unidentified jellyfish envenomation in west Malaysian waters. Toxicon X. 2024;21:1-3$9$YR$$$Y$$$20240924$$HP$MY$MY
243562741$24356274$1$I$$20240909$20240924$20240924$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469311$RANBAXY$Abe T, Sagara A, Suzuki T, Okada D, Matsuzaka K, Nakayama T. Infusion Reactions in HER2-Positive Gastric Cancer: Switching from Trastuzumab to Its Biosimilar. Biol Pharm Bull. 2024;47 (8):1452-1455$71$YR$$M$Y$$$20240924$$HP$JP$JP
243562751$24356275$1$I$20230327$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469405$RANBAXY$$39$YR$$F$Y$110$KG$20240924$$MD$FR$FR
243562761$24356276$1$I$$20240909$20240924$20240924$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469280$RANBAXY$Zou T, Wu Y-C, Yao  Q. Vaginal delivery of triplets after emergency transvaginal cerclage A case report and literature review. Medicine. 2024;103 (11):E37262$$$$F$Y$$$20240924$$MD$CN$CN
243562771$24356277$1$I$20240629$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469630$RANBAXY$$76$YR$$F$Y$77.6$KG$20240924$$MD$FR$FR
243562781$24356278$1$I$$20240909$20240924$20240924$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469323$RANBAXY$Abe T, Sagara A, Suzuki T, Okada D, Matsuzaka K, Nakayama T. Infusion Reactions in HER2-Positive Gastric Cancer: Switching from Trastuzumab to Its Biosimilar. Biol Pharm Bull. 2024;47 (8):1452-1455$81$YR$$F$Y$$$20240924$$HP$JP$JP
243562791$24356279$1$I$$20240909$20240924$20240924$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469328$RANBAXY$Abe T, Sagara A, Suzuki T, Okada D, Matsuzaka K, Nakayama T. Infusion Reactions in HER2-Positive Gastric Cancer: Switching from Trastuzumab to Its Biosimilar. Biol Pharm Bull. 2024;47 (8):1452-1455$81$YR$$F$Y$$$20240924$$HP$JP$JP
243562801$24356280$1$I$$20240909$20240924$20240924$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469214$RANBAXY$$92$YR$$F$Y$$$20240924$$PH$GB$GB
243562811$24356281$1$I$$20240909$20240924$20240924$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469282$RANBAXY$Zou T, Wu Y-C, Yao  Q. Vaginal delivery of triplets after emergency transvaginal cerclage A case report and literature review. Medicine. 2024;103(11):E37262$$$$M$Y$$$20240924$$MD$CN$CN
243562821$24356282$1$I$20240607$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469286$RANBAXY$$93$YR$$M$Y$$$20240924$$PH$FR$FR
243562831$24356283$1$I$$20240909$20240924$20240924$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469165$RANBAXY$Richert-Przygonska M, Milewska M, Debski R, Cisek J, Czyzewski K. Sclerodermatous manifestation of chronic graft-versus-host disease: therapy challenges. 2023;545):308-312$14$YR$$M$Y$$$20240924$$HP$PL$PL
243562841$24356284$1$I$$20240909$20240924$20240924$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469406$RANBAXY$Posado-Dominguez L, Figuero-Perez L, Arnazazu Amores-Martin M, Reguera-Puertas P, Martin-Galache M, Del Barco-Morillo E et al. COMPLICATIONS SECONDARY TO THE USE OF SGLT2 INHIBITORS IN ONCOLOGICAL PATIENTS:A SERIES OF 5 CASES. Eur J Case Rep Intern Med. 2024;Dec;10:no pagination$60$YR$$F$Y$$$20240924$$HP$ES$ES
243562851$24356285$1$I$20220822$20240909$20240924$20240924$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469423$RANBAXY$$68$YR$$F$Y$$$20240924$$MD$ES$ES
243562861$24356286$1$I$20230101$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469556$RANBAXY$$34$YR$$M$Y$$$20240924$$MD$FR$FR
243562871$24356287$1$I$$20240909$20240924$20240924$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469315$RANBAXY$Abe T, Sagara A, Suzuki T, Okada D, Matsuzaka K, Nakayama T. Infusion Reactions in HER2-Positive Gastric Cancer: Switching from Trastuzumab to Its Biosimilar. Biol Pharm Bull. 2024;47 (8):1452-1455$85$YR$$M$Y$$$20240924$$HP$JP$JP
243562881$24356288$1$I$$20240909$20240924$20240924$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469142$RANBAXY$Lester SC, Johnson EF, Breen WG, Khurana A. Taming the Lion: A Report of Pencil Beam Scanning Proton Therapy for Severe Leonine Facies. Adv Radiat Oncol. 2024;9(9):1-13$70$YR$$M$Y$$$20240924$$MD$US$US
243562891$24356289$1$I$20240224$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469633$RANBAXY$$15$YR$$M$Y$57$KG$20240924$$PH$FR$FR
243562901$24356290$1$I$$20240909$20240924$20240924$EXP$$ET-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469409$RANBAXY$Diriba A, Tilahun T, Gonfaa L, Gebi J, Lemi B, Fyera J, et al. Concordant fatal congenital anomaly in twin pregnancy: a case report and reviewof the literature. J Med Case Rep. 2024;18 (1):406$22$YR$$F$Y$$$20240924$$HP$ET$ET
243562911$24356291$1$I$$20240913$20240924$20240924$PER$$US-GSK-US2024114766$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243562921$24356292$1$I$$20240909$20240924$20240924$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-450106$RANBAXY$$$$E$M$Y$$$20240924$$CN$US$US
243562931$24356293$1$I$20200414$20240909$20240924$20240924$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469640$RANBAXY$$17$YR$$M$Y$67.3$KG$20240924$$MD$PL$PL
243562941$24356294$1$I$$20240909$20240924$20240924$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469284$RANBAXY$Zou T, Wu Y-C, Yao  Q. Vaginal delivery of triplets after emergency transvaginal cerclage A case report and literature review. Medicine. 2024;103(11):E37262$$$$M$Y$$$20240924$$MD$CN$CN
243562951$24356295$1$I$$20240909$20240924$20240924$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469645$RANBAXY$$94$YR$$M$Y$$$20240924$$MD$IT$IT
243562961$24356296$1$I$20240620$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469627$RANBAXY$$59$YR$$M$Y$53$KG$20240924$$PH$FR$FR
243562971$24356297$1$I$20240508$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469647$RANBAXY$$58$YR$$M$Y$$$20240924$$MD$FR$FR
243562981$24356298$1$I$20240909$20240909$20240924$20240924$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469690$RANBAXY$$72$YR$$F$Y$60$KG$20240924$$HP$GB$GB
243562991$24356299$1$I$$20240909$20240924$20240924$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469641$RANBAXY$Dasara M, Dono F, Evangelista G, Quintieri P, Liviello D, Cipollone S, et al.. Status epilepticus as a complication of SARS-CoV-2 vaccination: Two case reports and systematic review with individual patients^ data analysis. Seizure. 2024;121(0):8-16$80$YR$$F$Y$$$20240924$$HP$IT$IT
243563001$24356300$1$I$20210201$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469560$RANBAXY$$32$YR$$M$Y$$$20240924$$MD$FR$FR
243563011$24356301$1$I$20240620$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469592$RANBAXY$$38$YR$$F$Y$$$20240924$$HP$FR$FR
243563021$24356302$1$I$20240605$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469624$RANBAXY$$75$YR$$M$Y$$$20240924$$PH$FR$FR
243563031$24356303$1$I$20240621$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469612$RANBAXY$$39$YR$$M$Y$125$KG$20240924$$MD$FR$FR
243563041$24356304$1$I$20240620$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469610$RANBAXY$$24$YR$$M$Y$85$KG$20240924$$MD$FR$FR
243563051$24356305$1$I$$20240918$20240924$20240924$PER$$US-LEO Pharma-373699$LEO PHARM$$34$YR$$F$Y$$$20240924$$PH$US$US
243563061$24356306$1$I$20240916$20240920$20240924$20240924$PER$$US-ABBVIE-5934814$ABBVIE$$31$YR$$F$Y$$$20240924$$MD$US$US
243563101$24356310$1$I$20240101$20240903$20240924$20240924$EXP$$AU-SA-2024SA273519$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240924$$MD$AU$AU
243563112$24356311$2$F$$20240924$20240924$20240925$PER$$US-AMGEN-USASP2024189216$AMGEN$$$$$M$Y$$$20240925$$CN$US$US
243563121$24356312$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-102469$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$89.36$KG$20240924$$CN$US$US
243563131$24356313$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150445$BRISTOL MYERS SQUIBB$$22$YR$A$M$Y$$$20240924$$HP$US$US
243563141$24356314$1$I$$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150756$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$54.88$KG$20240924$$CN$US$US
243563151$24356315$1$I$$20240909$20240924$20240924$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469047$RANBAXY$Xiong L, Kwan KJS, Wei G-G, Xu X, Lu ZQ. Postoperative Renal Abscess Following Tip Flexible Suctioning Ureteral Access Sheath  and Digital Ureteroscopic Lithotripsy: A Case Report. Am J Case Rep. 2024;25 (0):e944782$57$YR$$F$Y$$$20240924$$HP$CN$CN
243563162$24356316$2$F$$20240919$20240924$20240924$EXP$$US-ROCHE-10000087582$ROCHE$$$$$F$Y$$$20240924$$HP$US$US
243563171$24356317$1$I$20240510$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469430$RANBAXY$$79$YR$$F$Y$52$KG$20240924$$MD$FR$FR
243563181$24356318$1$I$20240606$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469550$RANBAXY$$$$$F$Y$2.7$KG$20240924$$MD$FR$FR
243563191$24356319$1$I$$20240909$20240924$20240924$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469712$RANBAXY$$$$$F$Y$101$KG$20240924$$MD$GB$GB
243563201$24356320$1$I$$20240909$20240924$20240924$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469072$RANBAXY$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J Acad Consult Liaison Psychiatry. 2024;65 (1):33-38$53$YR$$F$Y$$$20240924$$MD$US$US
243563211$24356321$1$I$$20240909$20240924$20240924$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469189$RANBAXY$Dasara M, Dono F, Evangelista G, Quintieri P, Liviello D, Cipollone S, et al. Status epilepticus as a complication of SARS-CoV-2 vaccination: Two case reports and systematic review with individual patients data analysis. Seizure. 2024;121 (0):8-16$79$YR$$M$Y$$$20240924$$HP$IT$IT
243563221$24356322$1$I$20240101$20240909$20240924$20240924$EXP$$BG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469313$RANBAXY$$78$YR$$F$Y$$$20240924$$CN$BG$BG
243563231$24356323$1$I$20230116$20240909$20240924$20240924$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469553$RANBAXY$$40$YR$$F$Y$76$KG$20240924$$MD$SE$SE
243563241$24356324$1$I$$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469433$RANBAXY$$68$YR$$M$Y$$$20240924$$MD$FR$FR
243563251$24356325$1$I$20240501$20240909$20240924$20240924$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469208$RANBAXY$$$$$F$Y$$$20240924$$CN$GB$GB
243563261$24356326$1$I$20240301$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469722$RANBAXY$$80$YR$$F$Y$60$KG$20240924$$MD$FR$FR
243563271$24356327$1$I$$20240909$20240924$20240924$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469319$RANBAXY$Abe T, Sagara A, Suzuki T, Okada D, Matsuzaka K, Nakayama T. Infusion Reactions in HER2-Positive Gastric Cancer: Switching from Trastuzumab to Its Biosimilar. Biol Pharm Bull. 2024;47 (8):1452-1455$70$YR$$M$Y$$$20240924$$HP$JP$JP
243563282$24356328$2$F$$20240911$20240924$20240926$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469184$RANBAXY$Neves Briard J, Duquette A, Cayrol R, Lapalme-Remis S. Refractory Status Epilepticus in a Patient With Aducanumab-Induced Amyloid-Related Imaging Abnormalities. Neurology. 2024;Sep 10; 103 (5):e209582(1)-e209582(5)$75$YR$$F$Y$$$20240926$$MD$CA$CA
243563291$24356329$1$I$$20240909$20240924$20240924$EXP$$JO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469217$RANBAXY$Alzibdeh A, Mohamad I, Al-Hussaini M, Salah S, Jaradat A, Abuhijlih R, et al. Significance of Beta Human Chorionic Gonadotropin in Predicting Disease Progression in Uterine Leiomyosarcoma. World J Oncol. 2024;15 (1):143-148$44$YR$$F$Y$$$20240924$$HP$JO$JO
243563301$24356330$1$I$$20240909$20240924$20240924$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469267$RANBAXY$Kesav P, Vishnu VY, Khurana D. Fatal disseminated neurobrucellosis. QJM. 2014;107;Jun:321-322$59$YR$$M$Y$$$20240924$$HP$IN$IN
243563311$24356331$1$I$20240710$20240909$20240924$20240924$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469384$RANBAXY$$57$YR$$F$Y$$$20240924$$MD$ES$ES
243563321$24356332$1$I$20240614$20240909$20240924$20240924$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469415$RANBAXY$$94$YR$$M$Y$67.5$KG$20240924$$MD$FR$FR
243563331$24356333$1$I$$20240909$20240924$20240924$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469158$RANBAXY$Richert-Przygonska M, Milewska M, Debski R, Cisek J, Czyzewski K. Sclerodermatous manifestation of chronic graft-versus-host disease: therapy challenges. Acta Haematol Polon. 2023;54 (5):308-312$16$YR$$M$Y$$$20240924$$HP$PL$PL
243563341$24356334$1$I$$20240909$20240924$20240924$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469360$RANBAXY$Ishizawa K, Komori T, Shimazaki R, Nakata Y, Tamaru JI Sasaki A, et al. Primary cauda equina lymphoma confirmed by autopsy: A case report. Neuropathology. 2024;44 (2):147-153$70$YR$$F$Y$$$20240924$$MD$JP$JP
243563351$24356335$1$I$$20240909$20240924$20240924$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469316$RANBAXY$Abe T, Sagara A, Suzuki T, Okada D, Matsuzaka K, Nakayama T. Infusion Reactions in HER2-Positive Gastric Cancer: Switching from Trastuzumab to Its Biosimilar. Biol Pharm Bull. 2024;47 (8):1452-1455$79$YR$$M$Y$$$20240924$$HP$JP$JP
243563361$24356336$1$I$$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188943$AMGEN$$$$$M$Y$$$20240924$$CN$US$US
243563371$24356337$1$I$$20240917$20240924$20240924$EXP$$US-AMGEN-USASL2024150724$AMGEN$$61$YR$A$M$Y$$$20240924$$CN$US$US
243563381$24356338$1$I$20240913$20240919$20240924$20240924$EXP$$US-AMGEN-USASP2024187898$AMGEN$$86$YR$E$F$Y$$$20240924$$HP$US$US
243563391$24356339$1$I$20240901$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188573$AMGEN$$$$$F$Y$$$20240924$$PH$US$US
243563401$24356340$1$I$20231001$20240916$20240924$20240924$EXP$$SK-STRIDES ARCOLAB LIMITED-2024SP012215$STRIDES$Sucik M, Rosolanka R, Nosakova L, Simekova K, Krkoska D.. Isoniazid induced liver injury associated with jaundice. [Slovak].. Gastroenterologie-a-Hepatologie. 2024;78 (2):156-164$64$YR$$F$Y$$$20240924$$HP$SK$SK
243563411$24356341$1$I$$20240917$20240924$20240924$EXP$$CA-ROCHE-10000084420$ROCHE$$76$YR$E$M$Y$$$20240924$$CN$CA$CA
243563421$24356342$1$I$20240817$20240917$20240924$20240924$EXP$FR-AFSSAPS-MP2024001394$FR-ROCHE-10000084002$ROCHE$$85$YR$E$M$Y$74$KG$20240924$$HP$FR$FR
243563431$24356343$1$I$20240913$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409131907486120-VZYSR$GB-Accord-447015$ACCORD$$$$$$Y$$$20240924$$HP$GB$GB
243563441$24356344$1$I$20240906$20240916$20240924$20240924$EXP$$US-SA-2024SA274564$SANOFI AVENTIS$$50$YR$A$F$Y$44.09$KG$20240924$$MD$US$US
243563451$24356345$1$I$$20240917$20240924$20240924$EXP$$BE-STRIDES ARCOLAB LIMITED-2024SP012221$STRIDES$Mastrodicasa E.. SULFURIC ACID INGESTION: MAY THE SEVERITY OF THE METABOLIC ACIDOSIS BE CONSIDERED AS A PREDICTIVE SIGN OF LATE DAMAGE TO THE GASTROINTESTINAL TRACT.. Eur-J-Case-Rep-Intern-Med. 2024;11 (5)$66$YR$$F$Y$$$20240924$$HP$BE$BE
243563471$24356347$1$I$20240806$20240919$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149875$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240924$$HP$US$US
243563481$24356348$1$I$$20240918$20240924$20240924$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP012212$STRIDES$Manuel S L, Sapone J, Lin F. Tacrolimus-Induced Recurrent Acute Coronary Syndrome Due to an Unknown Mechanism.. Cureus. 2024;16(6):e63266$8$DEC$$F$Y$$$20240924$$HP$US$US
243563491$24356349$1$I$$20240916$20240924$20240924$EXP$$US-EMD Serono-2024039298$EMD SERONO INC$$$$A$M$Y$$$20240924$$CN$US$US
243563501$24356350$1$I$20240906$20240918$20240924$20240924$EXP$$CN-SA-2024SA272517$SANOFI AVENTIS$$29$YR$A$F$Y$58$KG$20240924$$HP$CN$CN
243563511$24356351$1$I$$20240916$20240924$20240924$EXP$$GB-TAKEDA-2024TUS093935$TAKEDA$$$$A$$Y$$$20240924$$MD$GB$GB
243563531$24356353$1$I$20240101$20240912$20240924$20240924$PER$$US-TAKEDA-2024TUS091466$TAKEDA$$5$YR$$M$Y$$$20240924$$MD$US$US
243563541$24356354$1$I$$20240917$20240924$20240924$PER$$US-GSK-US2024AMR115782$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243563551$24356355$1$I$$20240919$20240924$20240924$PER$$US-TAKEDA-2024TUS093470$TAKEDA$$$$$M$Y$$$20240924$$MD$US$US
243563561$24356356$1$I$$20240913$20240924$20240924$PER$$US-TAKEDA-2024TUS091487$TAKEDA$$$$$F$Y$$$20240924$$CN$US$US
243563571$24356357$1$I$20240101$20240910$20240924$20240924$EXP$$US-UCBSA-2024047106$UCB$$$$$F$Y$54.4$KG$20240924$$CN$US$US
243563581$24356358$1$I$20240901$20240919$20240924$20240924$EXP$$US-SA-2024SA274284$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240924$$HP$US$US
243563601$24356360$1$I$$20240913$20240924$20240924$PER$$US-BEH-2024178974$CSL BEHRING$$$$$$Y$80$KG$20240924$$MD$US$US
243563611$24356361$1$I$$20240912$20240924$20240924$EXP$$US-BEH-2024178790$CSL BEHRING$$$$A$F$Y$$$20240924$$HP$US$US
243563621$24356362$1$I$20240805$20240913$20240924$20240924$EXP$DE-SAMSUNG BIOEPIS-SB-2024-24612$DE-ROCHE-10000081893$ROCHE$$76$YR$E$M$Y$86.2$KG$20240924$$MD$DE$DE
243563641$24356364$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014299$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240924$$CN$US$US
243563651$24356365$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013597$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243563661$24356366$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014445$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240924$$CN$US$US
243563671$24356367$1$I$20240920$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013827$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240924$$CN$US$US
243563681$24356368$1$I$20240920$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013677$ELI LILLY AND CO$$25$YR$A$$Y$$$20240924$$CN$US$US
243563691$24356369$1$I$$20240916$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409010001$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240924$$CN$US$US
243563701$24356370$1$I$$20240912$20240924$20240924$EXP$$US-UCBSA-2024047764$UCB$$$$$$Y$$$20240924$$CN$US$US
243563711$24356371$1$I$20240601$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013606$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240924$$CN$US$US
243563721$24356372$1$I$20240919$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013533$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240924$$CN$US$US
243563731$24356373$1$I$20240101$20240912$20240924$20240924$EXP$$US-UCBSA-2024043658$UCB$$$$$F$Y$$$20240924$$CN$US$US
243563741$24356374$1$I$$20240912$20240924$20240924$EXP$$US-UCBSA-2024047364$UCB$$$$$M$Y$$$20240924$$HP$US$US
243563751$24356375$1$I$20240914$20240923$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151066$BRISTOL MYERS SQUIBB$$97$YR$E$F$Y$$$20240924$$MD$US$US
243563761$24356376$1$I$$20240920$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150992$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240924$$CN$US$US
243563771$24356377$1$I$20240523$20240919$20240924$20240924$EXP$FR-AFSSAPS-LL2024001770$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-150137$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240924$$PH$FR$FR
243563781$24356378$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150824$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$87.09$KG$20240924$$PH$US$US
243563791$24356379$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150808$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240924$$HP$US$US
243563801$24356380$1$I$$20240917$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149192$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240924$$CN$US$US
243563811$24356381$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151028$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240924$$CN$US$US
243563831$24356383$1$I$20240814$20240920$20240924$20240924$EXP$$IN-ROCHE-10000088728$ROCHE$$48$YR$A$M$Y$$$20240924$$CN$IN$IN
243563841$24356384$1$I$$20240913$20240924$20240924$PER$$US-JNJFOC-20240939884$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243563851$24356385$1$I$$20240920$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US082179$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243563861$24356386$1$I$20240904$20240914$20240924$20240924$EXP$$CN-TAKEDA-2024TUS094276$TAKEDA$$63$YR$$F$Y$45$KG$20240924$$HP$CN$CN
243563871$24356387$1$I$20240201$20240917$20240924$20240924$EXP$$BR-GSK-BR2024AMR092926$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$BR$BR
243563881$24356388$1$I$20240314$20240916$20240924$20240924$EXP$FR-AFSSAPS-PV2024000273$FR-CELLTRION INC.-2024FR022476$CELLTRION$$$$$$Y$$$20240924$$MD$FR$FR
243563891$24356389$1$I$20240315$20240920$20240924$20240924$EXP$GB-MHRA-MED-202409200810225960-FCHTQ$GB-GSK-GB2024116839$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$GB$GB
243563912$24356391$2$F$20240921$20240924$20240924$20240925$PER$$US-AMGEN-USASP2024189605$AMGEN$$65$YR$E$F$Y$$$20240925$$CN$US$US
243563921$24356392$1$I$20240901$20240916$20240924$20240924$EXP$$DE-ROCHE-10000083973$ROCHE$$55$YR$A$M$Y$$$20240924$$MD$DE$DE
243563931$24356393$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150948$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240924$$HP$US$US
243563941$24356394$1$I$$20240918$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149473$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240924$$CN$US$US
243563951$24356395$1$I$20240909$20240917$20240924$20240924$EXP$$US-ROCHE-10000085374$ROCHE$$76$YR$E$M$Y$$$20240924$$CN$US$US
243563971$24356397$1$I$$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188281$AMGEN$$$$$$Y$$$20240924$$HP$US$US
243563981$24356398$1$I$20240920$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188274$AMGEN$$41$YR$A$F$Y$$$20240924$$CN$US$US
243563991$24356399$1$I$$20240917$20240924$20240924$EXP$$CA-APOTEX-2024AP011113$APOTEX$$69$YR$$F$Y$$$20240924$$PH$CA$CA
243564001$24356400$1$I$$20240920$20240924$20240924$PER$$US-HALEON-2198093$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
243564011$24356401$1$I$20240913$20240913$20240924$20240924$PER$$US-ABBVIE-5932330$ABBVIE$$44$YR$$F$Y$$$20240924$$CN$US$US
243564022$24356402$2$F$$20240920$20240924$20240927$EXP$$GB-TEVA-VS-3245794$TEVA$$39$YR$$M$Y$$$20240927$$CN$GB$GB
243564031$24356403$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150782$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240924$$HP$US$US
243564041$24356404$1$I$20240802$20240917$20240924$20240924$EXP$FR-AFSSAPS-NC2024001102$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-148677$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$76$KG$20240924$$MD$FR$FR
243564052$24356405$2$F$20240905$20240925$20240924$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150688$BRISTOL MYERS SQUIBB$$$$E$F$Y$$$20240927$$HP$US$US
243564071$24356407$1$I$$20240919$20240924$20240924$PER$$US-ABBVIE-5933538$ABBVIE$$62$YR$$F$Y$$$20240924$$MD$US$US
243564081$24356408$1$I$20240101$20240912$20240924$20240924$EXP$$US-UCBSA-2024027761$UCB$$$$$F$Y$$$20240924$$CN$US$US
243564091$24356409$1$I$20240614$20240913$20240924$20240924$EXP$$US-UCBSA-2024030790$UCB$$11$YR$$F$Y$42.7$KG$20240924$$CN$US$US
243564102$24356410$2$F$20240905$20240919$20240924$20240925$EXP$$CN-JNJFOC-20240960412$JOHNSON AND JOHNSON$$1$YR$I$M$Y$10$KG$20240925$$HP$CN$CN
243564111$24356411$1$I$20240101$20240905$20240924$20240924$PER$$US-JNJFOC-20240913141$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$PH$US$US
243564121$24356412$1$I$20240101$20240909$20240924$20240924$EXP$$US-ADAMAS Pharma-ADM202409-003389$ADAMAS PHARMA$$82$YR$$M$Y$$$20240924$$$COUNTRY NOT SPECIFIED$
243564131$24356413$1$I$$20240912$20240924$20240924$PER$$US-ASTELLAS-2024-AER-006998$ASTELLAS$$$$$F$Y$$$20240924$$HP$US$US
243564141$24356414$1$I$$20240916$20240924$20240924$EXP$$CA-APOTEX-2024AP011000$APOTEX$$$$$M$Y$$$20240924$$HP$CA$CA
243564151$24356415$1$I$20240810$20240917$20240924$20240924$EXP$FR-AFSSAPS-GR2024001072$FR-ROCHE-10000083695$ROCHE$$91$YR$E$F$Y$70$KG$20240924$$MD$FR$FR
243564161$24356416$1$I$20240701$20240916$20240924$20240924$EXP$$CO-ROCHE-10000089293$ROCHE$$$$$F$Y$$$20240924$$CN$CO$CO
243564171$24356417$1$I$$20240913$20240924$20240924$EXP$$US-Accord-447395$ACCORD$$$$$M$Y$112.5$KG$20240924$$PH$US$US
243564181$24356418$1$I$20230601$20240916$20240924$20240924$EXP$FR-AFSSAPS-MA2024001286$FR-EMD Serono-2024049598$EMD SERONO INC$$37$YR$A$F$Y$$$20240924$$MD$FR$FR
243564191$24356419$1$I$20240920$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188433$AMGEN$$86$YR$E$$Y$$$20240924$$CN$US$US
243564201$24356420$1$I$20240101$20240904$20240924$20240924$PER$$US-TEVA-VS-3240459$TEVA$$76$YR$$F$Y$42.18$KG$20240924$$CN$US$US
243564211$24356421$1$I$$20240912$20240924$20240924$EXP$$US-UCBSA-2024047754$UCB$$$$$$Y$$$20240924$$CN$US$US
243564221$24356422$1$I$20240901$20240912$20240924$20240924$EXP$$US-UCBSA-2024047055$UCB$$64$YR$$F$Y$$$20240924$$CN$US$US
243564241$24356424$1$I$20231101$20240918$20240924$20240924$EXP$IT-MINISAL02-969550$IT-TEVA-VS-3165215$TEVA$$29$YR$$M$Y$80$KG$20240924$$CN$IT$IT
243564251$24356425$1$I$20240906$20240917$20240924$20240924$EXP$$AU-GSK-AU2024115251$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$AU$AU
243564271$24356427$1$I$20240808$20240913$20240924$20240924$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08620$HIKMA$$$$$M$Y$85.5$KG$20240924$$HP$US$US
243564281$24356428$1$I$$20240911$20240924$20240924$EXP$$GB-ABBVIE-5934802$ABBVIE$Ibrahim H, Chean CS, Kalakonda AJM, Kwan J, Kumar P, Williams S, et al. Ibrutinib-related uveitis: a case series from two tertiary centres in the united kingdom. Ocular Immunology and Inflammation. 2024;1-6.$84$YR$$M$Y$$$20240924$$HP$GB$GB
243564291$24356429$1$I$$20240914$20240924$20240924$EXP$$CN-ROCHE-10000082217$ROCHE$$75$YR$E$M$Y$$$20240924$$CN$CN$CN
243564301$24356430$1$I$$20240913$20240924$20240924$EXP$$US-TAKEDA-2024TUS092375$TAKEDA$$$$$M$Y$$$20240924$$CN$US$US
243564311$24356431$1$I$20240909$20240913$20240924$20240924$EXP$CN-HENLIUS-24CN017217$CN-Accord-447802$ACCORD$$35$YR$A$F$Y$60$KG$20240924$$MD$CN$CN
243564331$24356433$1$I$$20240919$20240924$20240924$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-126704$REGENERON$$$$$F$Y$$$20240924$$HP$US$US
243564341$24356434$1$I$20240909$20240919$20240924$20240924$EXP$$US-ABBVIE-5933113$ABBVIE$$61$YR$$F$Y$$$20240924$$HP$US$US
243564351$24356435$1$I$$20240909$20240924$20240924$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468650$RANBAXY$$65$YR$$F$Y$$$20240924$$MD$US$US
243564361$24356436$1$I$$20230824$20240924$20240924$PER$$US-CELLTRION INC.-2023US016891$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
243564371$24356437$1$I$$20240913$20240924$20240924$EXP$$US-Accord-447396$ACCORD$$$$$M$Y$$$20240924$$HP$US$US
243564381$24356438$1$I$20240101$20240919$20240924$20240924$EXP$GB-MHRA-MED-202409171553492210-ZKVJC$GB-ABBVIE-5931902$ABBVIE$$38$YR$$M$Y$72$KG$20240924$$MD$GB$GB
243564401$24356440$1$I$20240913$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188447$AMGEN$$34$YR$A$F$Y$$$20240924$$MD$US$US
243564411$24356441$1$I$$20240329$20240924$20240924$PER$$US-GSK-US2024AMR117323$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$US$US
243564441$24356444$1$I$20240904$20240916$20240924$20240924$PER$$US-AMGEN-USASP2024184717$AMGEN$$70$YR$E$M$Y$93.197$KG$20240924$$HP$US$US
243564461$24356446$1$I$$20231103$20240924$20240924$PER$$US-CELLTRION INC.-2023US017520$CELLTRION$$$$$$Y$$$20240924$$MD$US$US
243564471$24356447$1$I$20240529$20240916$20240924$20240924$EXP$$DE-ROCHE-10000025569$ROCHE$$87$YR$E$F$Y$$$20240924$$MD$DE$DE
243564481$24356448$1$I$20240824$20240916$20240924$20240924$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-20373$SAMSUNG BIOEPIS$$73$YR$E$F$Y$$$20240924$$PH$CA$CA
243564492$24356449$2$F$$20240923$20240924$20240926$PER$$US-ROCHE-10000089004$ROCHE$Gandhi A, Yedidi R, Singh K, Pasha A, Ware A. Interstitial lung disease in antisynthetase syndrome. Chest. 2024;166 (4):A5375-6. doi:10.1016/j.chest.2024.06.3198.$69$YR$E$F$Y$$$20240926$$HP$US$US
243564501$24356450$1$I$20210101$20240917$20240924$20240924$EXP$$US-ABBVIE-5932358$ABBVIE$$$$$F$Y$107.95$KG$20240924$$CN$US$US
243564511$24356451$1$I$$20240829$20240924$20240924$PER$$US-SCIEGENP-2024SCSPO00362$SCIEGEN$$65$YR$E$M$Y$165$KG$20240924$$CN$US$US
243564531$24356453$1$I$20240913$20240913$20240924$20240924$EXP$$US-Accord-447148$ACCORD$$57$YR$A$M$Y$$$20240924$$PH$US$US
243564541$24356454$1$I$$20240920$20240924$20240924$PER$$US-HALEON-2198058$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
243564551$24356455$1$I$20240601$20240913$20240924$20240924$EXP$$US-UCBSA-2024047582$UCB$$41$YR$$F$Y$$$20240924$$HP$US$US
243564561$24356456$1$I$20240917$20240917$20240924$20240924$PER$$US-ROCHE-10000085638$ROCHE$$37$YR$A$F$Y$113.4$KG$20240924$$CN$US$US
243564582$24356458$2$F$20240920$20240923$20240924$20240925$PER$$US-AMGEN-USASP2024188797$AMGEN$$83$YR$E$F$Y$$$20240924$$CN$US$US
243564591$24356459$1$I$$20240916$20240924$20240924$EXP$$US-ROCHE-10000083531$ROCHE$$31$YR$A$F$Y$97.52$KG$20240924$$CN$US$US
243564601$24356460$1$I$20240101$20240917$20240924$20240924$PER$$US-AMGEN-USASP2024185795$AMGEN$$$$$F$Y$$$20240924$$MD$US$US
243564612$24356461$2$F$20240917$20240923$20240924$20240930$PER$$US-ROCHE-10000087074$ROCHE$$41$YR$A$F$Y$98.88$KG$20240930$$MD$US$US
243564621$24356462$1$I$$20240917$20240924$20240924$PER$$US-ROCHE-10000083730$ROCHE$$$$A$F$Y$$$20240924$$CN$US$US
243564631$24356463$1$I$$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149653$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240924$$HP$US$US
243564641$24356464$1$I$$20240918$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149196$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240924$$HP$US$US
243564651$24356465$1$I$$20240916$20240924$20240924$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP012200$STRIDES$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, et al.. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases.. Ann-Rheum-Dis. 2022;81 (2):289-291$$$$$Y$$$20240924$$MD$US$US
243564661$24356466$1$I$20230801$20240919$20240924$20240924$EXP$$MX-ROCHE-10000065231$ROCHE$$66$YR$E$F$Y$70$KG$20240924$$CN$MX$MX
243564671$24356467$1$I$$20240919$20240924$20240924$EXP$$US-GILEAD-2024-0688325$GILEAD$$$$E$F$Y$$$20240924$$CN$US$US
243564681$24356468$1$I$20240101$20240919$20240924$20240924$EXP$$GB-AMICUS THERAPEUTICS, INC.-AMI_3398$AMICUS THERAPEUTICS$$74$YR$$M$Y$$$20240924$$PH$GB$GB
243564691$24356469$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3244436$TEVA$$$$$F$Y$$$20240924$$MD$US$US
243564701$24356470$1$I$$20240826$20240924$20240924$PER$$US-ARDELYX-2024ARDX006571$ARDELYX$$$$$$Y$$$20240924$$HP$US$US
243564711$24356471$1$I$20240806$20240830$20240924$20240924$PER$$US-ARDELYX-2024ARDX006638$ARDELYX$$76$YR$$M$Y$$$20240924$$PH$US$US
243564731$24356473$1$I$20240901$20240918$20240924$20240924$PER$$US-ABBVIE-5930163$ABBVIE$$64$YR$$M$Y$$$20240924$$CN$US$US
243564741$24356474$1$I$20240905$20240906$20240924$20240924$30DAY$$GB-JNJFOC-20240916940$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240924$$CN$GB$GB
243564751$24356475$1$I$20240830$20240910$20240924$20240924$PER$$US-AMGEN-USASP2024189804$AMGEN$$75$YR$E$F$Y$$$20240924$$PH$US$US
243564761$24356476$1$I$$20240917$20240924$20240924$EXP$$JP-GSK-JP2024116694$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
243564771$24356477$1$I$20240801$20240909$20240924$20240924$PER$$US-JNJFOC-20240931219$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240924$$CN$US$US
243564781$24356478$1$I$$20240910$20240924$20240924$EXP$$FR-LEADINGPHARMA-FR-2024LEALIT00426$LEADING PHARMA$A Baudriller.Deaths related to pharmacobezoars: A report on two cases.Toxicologie Analytique et Clinique.JAN-2024$55$YR$A$F$Y$$$20240924$$HP$FR$FR
243564791$24356479$1$I$20240829$20240919$20240924$20240924$PER$$US-GSK-US2024116666$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$MD$US$US
243564801$24356480$1$I$$20240917$20240924$20240924$PER$$US-GSK-US2024115666$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243564811$24356481$1$I$$20240919$20240924$20240924$EXP$$GB-SANDOZ INC.-SDZ2024GB082308$SANDOZ$$$$$M$Y$$$20240924$$HP$GB$GB
243564821$24356482$1$I$$20240917$20240924$20240924$EXP$$CA-ROCHE-10000083925$ROCHE$$$$$M$Y$$$20240924$$HP$CA$CA
243564831$24356483$1$I$20240814$20240918$20240924$20240924$EXP$AU-009507513-2311AUS000224$AU-SANDOZ INC.-SDZ2024AU081488$SANDOZ$$36$YR$$F$Y$$$20240924$$MD$AU$AU
243564841$24356484$1$I$20240821$20240913$20240924$20240924$EXP$$US-Accord-447397$ACCORD$$37$YR$A$F$Y$$$20240924$$MD$US$US
243564861$24356486$1$I$$20240917$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148578$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240924$$HP$US$US
243564871$24356487$1$I$20240905$20240920$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150549$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240924$$HP$US$US
243564882$24356488$2$F$20240101$20240919$20240924$20240927$PER$$US-AMGEN-USASP2024187506$AMGEN$$73$YR$E$F$Y$$$20240927$$CN$US$US
243564891$24356489$1$I$20231114$20240917$20240924$20240924$EXP$$JP-ROCHE-3474887$ROCHE$$76$YR$E$M$Y$64$KG$20240924$$MD$JP$JP
243564901$24356490$1$I$$20240917$20240924$20240924$EXP$$JP-GSK-JP2024116704$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$JP$JP
243564911$24356491$1$I$20240830$20240917$20240924$20240924$EXP$IT-MINISAL02-1002182$IT-GSK-IT2024115478$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$IT$IT
243564921$24356492$1$I$$20240919$20240924$20240924$PER$$US-HALEON-2198134$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
243564931$24356493$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000088320$ROCHE$$15$YR$T$M$Y$$$20240924$$CN$US$US
243564961$24356496$1$I$$20240913$20240924$20240924$PER$$US-JNJFOC-20240946840$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$HP$US$US
243564981$24356498$1$I$$20240915$20240924$20240924$EXP$$TW-JNJFOC-20240948160$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$HP$TW$TW
243564991$24356499$1$I$$20240918$20240924$20240924$EXP$$GB-SANDOZ INC.-SDZ2024GB041246$SANDOZ$$$$$F$Y$$$20240924$$CN$GB$GB
243565001$24356500$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000087691$ROCHE$$9$YR$C$F$Y$$$20240924$$CN$US$US
243565011$24356501$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000088518$ROCHE$$11$YR$C$M$Y$$$20240924$$CN$US$US
243565021$24356502$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000088131$ROCHE$$65$YR$E$M$Y$$$20240924$$CN$US$US
243565031$24356503$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000087905$ROCHE$$$$T$M$Y$$$20240924$$CN$US$US
243565041$24356504$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024187629$AMGEN$$$$$M$Y$$$20240924$$CN$US$US
243565051$24356505$1$I$20240923$20240923$20240924$20240924$EXP$$US-GILEAD-2024-0688640$GILEAD$$64$YR$A$M$Y$$$20240924$$MD$US$US
243565061$24356506$1$I$20240829$20240918$20240924$20240924$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-18999$IPSEN$$61$YR$A$M$Y$$$20240924$$CN$US$US
243565071$24356507$1$I$$20240912$20240924$20240924$EXP$$US-MYLANLABS-2024M1084900$MYLAN$Agarwal A, Diaz A, Al-Dehneem R, Pineda RM, Khattri S. Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases. J-Drugs-Dermatol 2023; 22 1183-1190.$75$YR$$F$Y$$$20240924$$MD$US$US
243565081$24356508$1$I$$20240912$20240924$20240924$EXP$$US-MYLANLABS-2024M1084930$MYLAN$Agarwal A, Diaz A, Al-Dehneem R, Pineda RM, Khattri S. Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases. J-Drugs-Dermatol 2023; 22 1183-1190.$35$YR$$F$Y$$$20240924$$MD$US$US
243565091$24356509$1$I$$20240912$20240924$20240924$EXP$$US-MYLANLABS-2024M1084886$MYLAN$Agarwal A, Diaz A, Al-Dehneem R, Pineda RM, Khattri S. Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases. J-Drugs-Dermatol 2023; 22 1183-1190.$59$YR$$M$Y$$$20240924$$MD$US$US
243565101$24356510$1$I$$20240912$20240924$20240924$EXP$$US-MYLANLABS-2024M1084887$MYLAN$Agarwal A, Diaz A, Al-Dehneem R, Pineda RM, Khattri S. Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases. J-Drugs-Dermatol 2023; 22 1183-1190.$30$YR$$F$Y$$$20240924$$MD$US$US
243565111$24356511$1$I$$20240911$20240924$20240924$EXP$$GB-MYLANLABS-2024M1083616$MYLAN$Abdalrazag OA, Okoye AO, Muniyappa SM. Title to be provided. Br-J-Diabetes 2024; 24 (1): abstr. 512.$77$YR$$M$Y$$$20240924$$HP$GB$GB
243565121$24356512$1$I$$20240912$20240924$20240924$EXP$$US-MYLANLABS-2024M1084892$MYLAN$Agarwal A, Diaz A, Al-Dehneem R, Pineda RM, Khattri S. Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases. J-Drugs-Dermatol 2023; 22 1183-1190.$35$YR$$F$Y$$$20240924$$MD$US$US
243565131$24356513$1$I$$20240916$20240924$20240924$PER$$US-ABBVIE-5929763$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243565141$24356514$1$I$20200706$20240910$20240924$20240924$EXP$$US-COOPERSURGICAL, INC.-2024CPS002794$COOPERSURGICAL$$$$$F$Y$$$20240924$$LW$US$US
243565151$24356515$1$I$20240701$20240918$20240924$20240924$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-127322$REGENERON$$80$YR$$M$Y$$$20240924$$CN$CO$CO
243565161$24356516$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013785$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240924$$CN$US$US
243565171$24356517$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014204$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240924$$CN$US$US
243565181$24356518$1$I$$20240920$20240924$20240924$PER$$US-ROCHE-10000087643$ROCHE$$76$YR$E$F$Y$$$20240924$$CN$US$US
243565211$24356521$1$I$20240101$20240917$20240924$20240924$EXP$$US-AMGEN-USASP2024185558$AMGEN$$79$YR$E$F$Y$$$20240924$$CN$US$US
243565222$24356522$2$F$$20240916$20240924$20240927$EXP$$FR-MYLANLABS-2024M1085422$MYLAN$$71$YR$$M$Y$$$20240927$$HP$FR$FR
243565231$24356523$1$I$$20240917$20240924$20240924$EXP$$US-TAKEDA-2024TUS093329$TAKEDA$$$$$M$Y$$$20240924$$CN$US$US
243565242$24356524$2$F$20240101$20240925$20240924$20240927$PER$$US-ABBVIE-5934170$ABBVIE$$$$$M$Y$104.32$KG$20240927$$CN$US$US
243565251$24356525$1$I$$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150484$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240924$$MD$US$US
243565262$24356526$2$F$20240917$20240919$20240924$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148585$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$78.47$KG$20240925$$CN$US$US
243565281$24356528$1$I$20240701$20240919$20240924$20240924$EXP$$US-ABBVIE-5932815$ABBVIE$$43$YR$$F$Y$$$20240924$$CN$US$US
243565291$24356529$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000088294$ROCHE$$$$A$F$Y$$$20240924$$HP$US$US
243565301$24356530$1$I$20240101$20240918$20240924$20240924$EXP$$US-AMGEN-USASP2024186701$AMGEN$$80$YR$E$M$Y$$$20240924$$MD$US$US
243565311$24356531$1$I$$20240920$20240924$20240924$EXP$$US-GILEAD-2024-0688590$GILEAD$$$$E$M$Y$$$20240924$$CN$US$US
243565321$24356532$1$I$20240901$20240918$20240924$20240924$EXP$$US-ABBVIE-5930144$ABBVIE$$59$YR$$M$Y$$$20240924$$CN$US$US
243565331$24356533$1$I$$20240923$20240924$20240924$PER$$US-ROCHE-10000089544$ROCHE$$32$YR$A$F$Y$$$20240924$$CN$US$US
243565341$24356534$1$I$$20240917$20240924$20240924$EXP$$US-TAKEDA-2024TUS084612$TAKEDA$$$$$M$Y$$$20240924$$CN$US$US
243565351$24356535$1$I$20240101$20240919$20240924$20240924$EXP$$US-ABBVIE-5932348$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243565361$24356536$1$I$$20240910$20240924$20240924$EXP$$GB-CADILA HEALTHCARE LIMITED-GB-ZYDUS-112316$ZYDUS PHARM$$$$$$Y$$$20240924$$MD$GB$GB
243565371$24356537$1$I$$20240910$20240924$20240924$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112365$ZYDUS PHARM$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B, et al.. AML-713 Hematological Malignancies and Pregnancy: A Single-Institution Experience.. Clinical Lymphoma, Myeloma + Leukemia. 2024;24 (Suppl. 1):S333-S334$$$$$Y$$$20240924$$MD$US$US
243565381$24356538$1$I$$20240910$20240924$20240924$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112301$ZYDUS PHARM$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum. 2024;67$$$$$Y$$$20240924$$HP$US$US
243565391$24356539$1$I$$20240910$20240924$20240924$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112299$ZYDUS PHARM$Wallwork RS, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO, Wigley FM. Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Semin-Arthritis-Rheum. 2024;67:no pagination$$$$$Y$$$20240924$$HP$US$US
243565401$24356540$1$I$20240912$20240918$20240924$20240924$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-127549$REGENERON$$33$YR$$M$Y$$$20240924$$HP$CO$CO
243565411$24356541$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150581$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$46.72$KG$20240924$$CN$US$US
243565421$24356542$1$I$$20240917$20240924$20240924$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-149213$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240924$$MD$CH$CH
243565441$24356544$1$I$20240101$20240905$20240924$20240924$PER$$US-FDC-2024USSPO00705$FDC LIMITED$$60$YR$A$M$Y$92.9$KG$20240924$$CN$US$US
243565451$24356545$1$I$$20240920$20240924$20240924$PER$$US-HALEON-2198120$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
243565461$24356546$1$I$$20240919$20240924$20240924$EXP$$AT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052302$BOEHRINGER INGELHEIM$$49$YR$A$M$Y$$$20240924$$MD$AT$AT
243565471$24356547$1$I$20240301$20240916$20240924$20240924$EXP$$AR-JNJFOC-20240951288$JOHNSON AND JOHNSON$$68$YR$E$F$Y$59$KG$20240924$$CN$AR$AR
243565481$24356548$1$I$$20240923$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US082376$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243565491$24356549$1$I$20240101$20240913$20240924$20240924$EXP$$DE-UCBSA-2024037721$UCB$$$$$M$Y$93$KG$20240924$$MD$DE$DE
243565501$24356550$1$I$$20240916$20240924$20240924$EXP$$US-BAYER-2024A132781$BAYER$$74$YR$E$F$Y$77.551$KG$20240924$$CN$US$US
243565511$24356551$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65202$$FDA-CTU$$46$YR$$F$N$$$20240923$N$$US$
243565521$24356552$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65200$$FDA-CTU$$51$YR$$F$N$$$20240923$N$$US$
243565531$24356553$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65158$$FDA-CTU$$41$YR$$F$N$$$20240923$N$$US$
243565541$24356554$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65174$$FDA-CTU$$80$YR$$F$N$$$20240923$N$$US$
243565551$24356555$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65182$$FDA-CTU$$55$YR$$M$N$116.12$KG$20240923$N$$US$
243565561$24356556$1$I$$20240921$20240923$20240923$DIR$FDA-CDER-CTU-2024-65183$$FDA-CTU$$$$$M$N$$$20240921$N$HP$US$
243565571$24356557$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65053$$FDA-CTU$$$$$$N$$$20240919$N$CN$US$
243565581$24356558$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65037$$FDA-CTU$$$$$$N$$$20240919$N$CN$US$
243565591$24356559$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65031$$FDA-CTU$$$$$$N$$$20240919$N$CN$US$
243565601$24356560$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65041$$FDA-CTU$$$$$$N$$$20240919$N$CN$US$
243565611$24356561$1$I$20240918$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65019$$FDA-CTU$$$$$$N$$$20240919$N$CN$US$
243565621$24356562$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65030$$FDA-CTU$$$$$$N$$$20240919$N$CN$US$
243565631$24356563$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65055$$FDA-CTU$$$$$$N$$$20240919$N$CN$US$
243565641$24356564$1$I$20240801$20240918$20240924$20240924$PER$$US-ROCHE-10000086177$ROCHE$$$$$M$Y$$$20240924$$MD$US$US
243565651$24356565$1$I$$20240918$20240924$20240924$PER$$US-ROCHE-10000086085$ROCHE$$$$$$Y$$$20240924$$CN$US$US
243565661$24356566$1$I$$20240913$20240924$20240924$EXP$$JP-ASTELLAS-2024-AER-007627$ASTELLAS$$4$YR$C$F$Y$$$20240924$$MD$JP$JP
243565672$24356567$2$F$$20240320$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019172$VALIDUS$$$$$F$Y$$$20240924$$CN$US$US
243565682$24356568$2$F$$20240320$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019174$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243565692$24356569$2$F$$20240202$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019115$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243565701$24356570$1$I$20231210$20231210$20240924$20240924$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2023-019055$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243565711$24356571$1$I$$20240311$20240924$20240924$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019165$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243565722$24356572$2$F$$20240202$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019114$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243565731$24356573$1$I$$20231025$20240924$20240924$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2023-018233$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243565742$24356574$2$F$$20240227$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019147$VALIDUS$$$$$$Y$$$20240924$$MD$US$US
243565751$24356575$1$I$$20230831$20240924$20240924$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2023-016259$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243565762$24356576$2$F$$20240115$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019087$VALIDUS$$$$$$Y$$$20240924$$MD$US$US
243565772$24356577$2$F$$20240319$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019170$VALIDUS$$$$$$Y$$$20240924$$MD$US$US
243565782$24356578$2$F$$20240327$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019185$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243565792$24356579$2$F$$20240321$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019179$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243565802$24356580$2$F$$20240401$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019195$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243565812$24356581$2$F$$20240320$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019173$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243565821$24356582$1$I$20240101$20240906$20240924$20240924$EXP$$US-SA-2024SA273938$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240924$$MD$US$US
243565831$24356583$1$I$$20240918$20240924$20240924$PER$$US-HALEON-2197422$Haleon PLC$$58$YR$$F$Y$$$20240924$$CN$US$US
243565841$24356584$1$I$20240801$20240916$20240924$20240924$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-148616$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240924$$MD$PL$PL
243565861$24356586$1$I$20240101$20240916$20240924$20240924$EXP$$US-TEVA-VS-3245728$TEVA$$23$YR$$F$Y$$$20240924$$HP$US$US
243565871$24356587$1$I$20240425$20240920$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150178$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240924$$CN$US$US
243565881$24356588$1$I$$20240919$20240924$20240924$EXP$GB-MHRA-MED-202409171227195190-CSJRY$GB-ROCHE-10000086924$ROCHE$$26$YR$A$M$Y$$$20240924$$MD$GB$GB
243565891$24356589$1$I$20240918$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024189205$AMGEN$$$$A$$Y$$$20240924$$HP$US$US
243565901$24356590$1$I$$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188844$AMGEN$$$$$F$Y$$$20240924$$CN$US$US
243565911$24356591$1$I$$20240918$20240924$20240924$PER$$US-GSK-US2024116165$GLAXOSMITHKLINE$$$$A$F$Y$$$20240924$$CN$US$US
243565921$24356592$1$I$20240918$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65022$$FDA-CTU$$$$$$N$$$20240919$N$CN$US$
243565931$24356593$1$I$20240918$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65025$$FDA-CTU$$35$YR$$F$N$130$LBS$20240919$Y$CN$US$
243565941$24356594$1$I$19981108$20240909$20240924$20240924$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469392$RANBAXY$$63$YR$$M$Y$65$KG$20240924$$MD$DE$DE
243565951$24356595$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65027$$FDA-CTU$$$$$$N$$$20240919$$CN$US$
243565961$24356596$1$I$20240919$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65033$$FDA-CTU$$59$YR$$F$N$$$20240919$N$PH$US$
243565972$24356597$2$F$$20240516$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019263$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243565982$24356598$2$F$$20240429$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019238$VALIDUS$$$$$$Y$$$20240924$$HP$US$US
243565992$24356599$2$F$$20240419$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019225$VALIDUS$$$$$$Y$$$20240924$$MD$US$US
243566002$24356600$2$F$$20240425$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019232$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566012$24356601$2$F$$20240403$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019200$VALIDUS$$$$$$Y$$$20240924$$MD$US$US
243566022$24356602$2$F$$20240513$20240924$20240924$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019253$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566032$24356603$2$F$20240501$20240520$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019266$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566041$24356604$1$I$20240919$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65020$$FDA-CTU$$$$$$N$$$20240919$N$CN$US$
243566051$24356605$1$I$20240918$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65059$$FDA-CTU$$34$YR$$F$N$$$20240919$N$HP$US$
243566062$24356606$2$F$$20240506$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019245$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566072$24356607$2$F$$20240502$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019243$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566082$24356608$2$F$$20240424$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019229$VALIDUS$$$$$$Y$$$20240924$$MD$US$US
243566091$24356609$1$I$$20240426$20240924$20240924$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019236$VALIDUS$$$$$$Y$$$20240924$$HP$US$US
243566102$24356610$2$F$$20240502$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019242$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566111$24356611$1$I$$20240402$20240924$20240924$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019197$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566122$24356612$2$F$$20240411$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019213$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566131$24356613$1$I$$20240610$20240924$20240924$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019226$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566142$24356614$2$F$$20240425$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019233$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566151$24356615$1$I$$20240918$20240924$20240924$EXP$$FR-ROCHE-10000083671$ROCHE$$80$YR$E$M$Y$$$20240924$$PH$FR$FR
243566162$24356616$2$F$$20240521$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019257$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566172$24356617$2$F$$20240523$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019272$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566182$24356618$2$F$20240322$20240506$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019246$VALIDUS$$$$$$Y$$$20240924$$HP$US$US
243566191$24356619$1$I$20240914$20240918$20240924$20240924$PER$$US-GSK-US2024116163$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20240924$$CN$US$US
243566201$24356620$1$I$$20240917$20240924$20240924$EXP$$BR-GSK-BR2024AMR088556$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$BR$BR
243566211$24356621$1$I$20240916$20240917$20240924$20240924$PER$$US-GSK-US2024115614$GLAXOSMITHKLINE$$68$YR$$F$Y$63.96$KG$20240924$$CN$US$US
243566221$24356622$1$I$20240918$20240919$20240924$20240924$PER$$US-ABBVIE-5931844$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243566231$24356623$1$I$20230101$20240509$20240924$20240924$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-06854$HIKMA$Lorenzon L, Campisi A, Di Paolo A, Giuliante F, Buttitta F, D^Ugo D.. Lorenzon L, Campisi A, Di Paolo A, Giuliante F, Buttitta F, D^Ugo D. Case Report: The molecular fingerprint and the clinical implication of an exceptional response to neoadjuvant therapy in a metastatic cardia adenocarcinoma. Frontiers in Surgery. 2024;11:1297083:1-8$52$YR$$M$Y$$$20240924$$MD$IT$IT
243566241$24356624$1$I$$20240910$20240924$20240924$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08571$HIKMA$Ahmed A, Ammar H, Mageau R.. Ahmed A, Ammar H, Mageau R.- Challenging illness scripts: a case of pernicious anaemia and axonal neuropathy.. BMJ Case Rep. 2024;17(8):e260967:1-5$4$DEC$$M$Y$$$20240924$$MD$US$US
243566251$24356625$1$I$$20240910$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09099$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243566261$24356626$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000087872$ROCHE$$54$YR$A$F$Y$$$20240924$$HP$US$US
243566271$24356627$1$I$$20240916$20240924$20240924$EXP$$US-BAYER-2024A133273$BAYER$$59$YR$A$M$Y$61.224$KG$20240924$$CN$US$US
243566281$24356628$1$I$20240804$20240913$20240924$20240924$EXP$$FR-AUROBINDO-AUR-APL-2024-046158$AUROBINDO$$60$YR$$F$Y$80$KG$20240924$$PH$FR$FR
243566291$24356629$1$I$$20240919$20240924$20240924$PER$$US-TAKEDA-2024TUS093821$TAKEDA$$$$$M$Y$$$20240924$$MD$US$US
243566302$24356630$2$F$20240916$20240924$20240924$20240925$PER$$US-AMGEN-USASP2024189641$AMGEN$$80$YR$E$F$Y$$$20240925$$CN$US$US
243566311$24356631$1$I$$20240916$20240924$20240924$PER$$US-TAKEDA-2024TUS092521$TAKEDA$$$$$F$Y$$$20240924$$CN$US$US
243566322$24356632$2$F$$20240725$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019336$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566332$24356633$2$F$$20240626$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019303$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566342$24356634$2$F$$20240722$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019329$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566352$24356635$2$F$$20240605$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019280$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566362$24356636$2$F$$20240719$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019326$VALIDUS$$$$$$Y$$$20240924$$HP$US$US
243566372$24356637$2$F$$20240722$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019330$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566382$24356638$2$F$$20240628$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019307$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566391$24356639$1$I$$20240624$20240924$20240924$EXP$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019298$VALIDUS$$$$$$Y$$$20240924$$HP$US$US
243566402$24356640$2$F$$20240607$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019282$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566412$24356641$2$F$$20240703$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019308$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566422$24356642$2$F$$20240723$20240924$20240924$PER$$US-VALIDUS PHARMACEUTICALS LLC-US-VDP-2024-019332$VALIDUS$$$$$$Y$$$20240924$$CN$US$US
243566431$24356643$1$I$$20240905$20240924$20240924$PER$$US-FDC-2024USSPO00708$FDC LIMITED$$$$$M$Y$$$20240924$$CN$US$US
243566441$24356644$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151050$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240924$$CN$US$US
243566451$24356645$1$I$$20240916$20240924$20240924$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-148780$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240924$$MD$PL$PL
243566461$24356646$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150909$BRISTOL MYERS SQUIBB$$97$YR$E$F$Y$59$KG$20240924$$CN$US$US
243566471$24356647$1$I$$20240912$20240924$20240924$EXP$$CA-RDY-CLI/CAN/24/0013871$DR REDDYS$$71$YR$E$F$Y$$$20240924$$CN$CA$CA
243566481$24356648$1$I$$20240912$20240924$20240924$EXP$$MX-STERISCIENCE B.V.-2024-ST-001447$Steriscience PTE$Baquero-Ospina P, Cantu-Rosales C, Concha-Del-Rio LE.. GOOD SYNDROME: CYTOMEGALOVIRUS RETINITIS CASE CHALLENGE.. Retin-Cases-Brief-Rep. 2024;18 (1):112-115$71$YR$$F$Y$$$20240924$$MD$MX$MX
243566501$24356650$1$I$$20240904$20240924$20240924$PER$$US-TEVA-VS-3240223$TEVA$$72$YR$$F$Y$$$20240924$$CN$US$US
243566511$24356651$1$I$20240901$20240923$20240924$20240924$PER$$US-ROCHE-10000089344$ROCHE$$$$$F$Y$$$20240924$$HP$US$US
243566521$24356652$1$I$20240801$20240923$20240924$20240924$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053044$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240924$$CN$US$US
243566531$24356653$1$I$20240830$20240910$20240924$20240924$EXP$CN-NMPACDR-3307831038956202400537$CN-BAXTER-2024BAX024623$BAXTER$$12$YR$$F$Y$34$KG$20240924$$MD$CN$CN
243566541$24356654$1$I$20110101$20240916$20240924$20240924$EXP$SE-SEMPA-2024-006616$SE-Merz Pharmaceuticals GmbH-2024090000129$MERZ$$$$$$Y$$$20240924$$CN$SE$SE
243566561$24356656$1$I$20231201$20240917$20240924$20240924$EXP$$CA-GSK-CA2023174502$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$CA$CA
243566571$24356657$1$I$20240904$20240913$20240924$20240924$EXP$CN-HENLIUS-24CN017236$CN-Accord-448191$ACCORD$$56$YR$A$F$Y$50$KG$20240924$$MD$CN$CN
243566581$24356658$1$I$$20240911$20240924$20240924$EXP$$IR-STERISCIENCE B.V.-2024-ST-001454$Steriscience PTE$Mohammadi M, Varpaei HA, Hosseini SA, Emami KH, Mousaeinejad N. Posterior Reversible Encephalopathy Syndrome in a Hospitalized Pregnant Woman with SARS-CoV-2 Infection: A Case Report. Arch-Neurosci. 2023;10 (4)$31$YR$$F$Y$$$20240924$$HP$IR$IR
243566592$24356659$2$F$20240912$20240925$20240924$20240927$30DAY$$US-ELI_LILLY_AND_COMPANY-US202409013805$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240927$$CN$US$US
243566601$24356660$1$I$20240201$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013572$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240924$$CN$US$US
243566611$24356661$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012976$ELI LILLY AND CO$$$$$M$Y$$$20240924$$CN$US$US
243566621$24356662$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013501$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243566631$24356663$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013782$ELI LILLY AND CO$$$$$F$Y$$$20240924$$CN$US$US
243566641$24356664$1$I$20240705$20240912$20240924$20240924$EXP$$GB-AUROBINDO-AUR-APL-2024-045854$AUROBINDO$$59$YR$$F$Y$$$20240924$$MD$GB$GB
243566651$24356665$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014544$ELI LILLY AND CO$$59$YR$A$$Y$$$20240924$$CN$US$US
243566661$24356666$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013787$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240924$$CN$US$US
243566671$24356667$1$I$$20240919$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149667$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240924$$HP$US$US
243566701$24356670$1$I$$20240918$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149660$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240924$$CN$US$US
243566711$24356671$1$I$20190925$20240918$20240924$20240924$EXP$$CO-UCBSA-2024048720$UCB$$68$YR$$F$Y$$$20240924$$CN$CO$CO
243566721$24356672$1$I$20240906$20240910$20240924$20240924$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468271$RANBAXY$$54$YR$A$M$Y$$$20240924$$MD$PL$PL
243566731$24356673$1$I$20240910$20240910$20240924$20240924$EXP$$CA-ALVOTECHPMS-2024-ALVOTECHPMS-002325$Alvotech$$75$YR$$M$Y$$$20240924$$MD$CA$CA
243566741$24356674$1$I$$20240911$20240924$20240924$EXP$$RO-STERISCIENCE B.V.-2024-ST-001457$Steriscience PTE$Dulamea OA, Arbune AA, Andronache A, Zurini LG, Anghel D.. Exploring the diverse phenotypes of anti-GAD 65 encephalitis, diagnosis and treatment challenges. Rom-J-Neurol. 2024;23 (2):111-118.$71$YR$$F$Y$$$20240924$$HP$RO$RO
243566761$24356676$1$I$$20240403$20240924$20240924$PER$$US-CIPLA LTD.-2024US03572$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243566771$24356677$1$I$20240401$20240415$20240924$20240924$PER$$US-CIPLA LTD.-2024US04004$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243566781$24356678$1$I$$20240330$20240924$20240924$PER$$US-CIPLA LTD.-2024US03445$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243566791$24356679$1$I$$20240311$20240924$20240924$PER$$US-CIPLA LTD.-2024US02867$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243566801$24356680$1$I$$20240312$20240924$20240924$PER$$US-CIPLA LTD.-2024US02816$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243566821$24356682$1$I$20240101$20240423$20240924$20240924$PER$$US-CIPLA LTD.-2024US04347$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243566831$24356683$1$I$$20240325$20240924$20240924$PER$$US-CIPLA LTD.-2024US03225$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243566841$24356684$1$I$$20240329$20240924$20240924$PER$$US-CIPLA LTD.-2024US03446$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243566861$24356686$1$I$$20240423$20240924$20240924$PER$$US-CIPLA LTD.-2024US04215$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243566881$24356688$1$I$20230701$20240917$20240924$20240924$EXP$$US-SA-2024SA271556$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240924$$MD$US$US
243566891$24356689$1$I$$20240903$20240924$20240924$PER$$US-FDC-2024USSPO00698$FDC LIMITED$$$$$F$Y$$$20240924$$CN$US$US
243566901$24356690$1$I$20240801$20240917$20240924$20240924$EXP$$CA-GSK-CA2024115538$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$CA$CA
243566911$24356691$1$I$20240201$20240313$20240924$20240924$PER$$US-CIPLA LTD.-2024US02926$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243566921$24356692$1$I$20240101$20240913$20240924$20240924$EXP$$CA-ABBVIE-5926162$ABBVIE$$$$A$M$Y$$$20240924$$MD$CA$CA
243566931$24356693$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65185$$FDA-CTU$$69$YR$$M$N$$$20240923$N$$US$
243566941$24356694$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65047$$FDA-CTU$$$$$$N$$$20240919$$CN$US$
243566951$24356695$1$I$$20240912$20240924$20240924$EXP$$CA-APOTEX-2024AP010648$APOTEX$$30$YR$$F$Y$99$KG$20240924$$HP$CA$CA
243566961$24356696$1$I$$20240918$20240924$20240924$EXP$$JP-ROCHE-10000089302$ROCHE$$73$YR$E$F$Y$$$20240924$$MD$JP$JP
243566971$24356697$1$I$$20240917$20240924$20240924$EXP$$NL-MYLANLABS-2004036594$MYLAN$Lesterhuis W, M.D.. Acute Generalised Exanthematous Pustulosis Mimicking Septic Shock. The American Journal of Medicine. 2004;116:574 - 575$63$YR$$M$Y$$$20240924$$MD$NL$NL
243566981$24356698$1$I$$20240913$20240924$20240924$PER$$US-GSK-US2024AMR114541$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243566991$24356699$1$I$$20240917$20240924$20240924$EXP$$US-SA-2024SA272925$SANOFI AVENTIS$$$$A$F$Y$58.32$KG$20240924$$MD$US$US
243567001$24356700$1$I$$20240917$20240924$20240924$PER$$US-JNJFOC-20240945163$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243567011$24356701$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65024$$FDA-CTU$$$$$$N$$$20240919$$CN$US$
243567021$24356702$1$I$20240101$20240914$20240924$20240924$PER$$US-JNJFOC-20240950465$JOHNSON AND JOHNSON$$65$YR$E$F$Y$72.6$KG$20240924$$CN$US$US
243567041$24356704$1$I$20240920$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65209$$FDA-CTU$$67$YR$$M$N$$$20240923$N$HP$US$
243567051$24356705$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65061$$FDA-CTU$$$$$$N$$$20240919$$CN$US$
243567061$24356706$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65186$$FDA-CTU$$45$YR$$F$N$74.84$KG$20240923$N$$US$
243567071$24356707$1$I$$20240921$20240924$20240924$PER$$US-ROCHE-10000088428$ROCHE$$26$YR$A$$Y$$$20240924$$CN$US$US
243567081$24356708$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65169$$FDA-CTU$$72$YR$$M$N$100.24$KG$20240923$N$$US$
243567091$24356709$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65187$$FDA-CTU$$53$YR$$F$N$$$20240923$N$$US$
243567101$24356710$1$I$$20240920$20240923$20240923$DIR$FDA-CDER-CTU-2024-65155$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243567111$24356711$1$I$20240801$20240916$20240924$20240924$EXP$FR-AFSSAPS-TS2024000979$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112419$ZYDUS PHARM$$$$$$Y$$$20240924$$MD$FR$FR
243567122$24356712$2$F$20240101$20240923$20240924$20240930$PER$$US-ABBVIE-5933779$ABBVIE$$50$YR$$F$Y$$$20240930$$CN$US$US
243567141$24356714$1$I$20240801$20240917$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013834$DR REDDYS$$65$YR$E$F$Y$$$20240924$$MD$US$US
243567151$24356715$1$I$20240916$20240917$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013755$DR REDDYS$$26$YR$A$M$Y$$$20240924$$HP$US$US
243567161$24356716$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151086$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$65.32$KG$20240924$$CN$US$US
243567171$24356717$1$I$20240916$20240917$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013806$DR REDDYS$$24$YR$A$F$Y$$$20240924$$MD$US$US
243567181$24356718$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150791$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240924$$CN$US$US
243567191$24356719$1$I$20240101$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150822$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240924$$CN$US$US
243567201$24356720$1$I$20240801$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151134$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240924$$HP$US$US
243567211$24356721$1$I$20231110$20240917$20240924$20240924$EXP$$GB-AUROBINDO-AUR-APL-2024-046225$AUROBINDO$$75$YR$$$Y$105$KG$20240924$$CN$GB$GB
243567221$24356722$1$I$20240501$20240917$20240924$20240924$EXP$FR-AFSSAPS-GR2024001056$FR-MYLANLABS-2024M1085255$MYLAN$$69$YR$$F$Y$$$20240924$$PH$FR$FR
243567231$24356723$1$I$20240730$20240917$20240924$20240924$EXP$$US-TAKEDA-2024TUS078429$TAKEDA$$59$YR$$F$Y$58.05$KG$20240924$$MD$US$US
243567241$24356724$1$I$20240912$20240917$20240924$20240924$PER$$US-GSK-US2024115549$GLAXOSMITHKLINE$$58$YR$$F$Y$$$20240924$$CN$US$US
243567251$24356725$1$I$$20240918$20240924$20240924$EXP$$US-SA-2024SA274289$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240924$$CN$US$US
243567261$24356726$1$I$$20240912$20240924$20240924$EXP$$IE-STERISCIENCE B.V.-2024-ST-001462$Steriscience PTE$Soh BWT, Salim A, O^Riordan R, Owens P, Matiullah S.. Unveiling the devastations of Streptococcus sanguinis infective endocarditis masquerading as iron deficiency anaemia: A case report.. Eur-Heart-J-Case-Rep. 2024;8 (8)$19$YR$$F$Y$$$20240924$$HP$IE$IE
243567281$24356728$1$I$20240801$20240919$20240924$20240924$EXP$$US-SA-2024SA272528$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240924$$MD$US$US
243567291$24356729$1$I$20240901$20240919$20240924$20240924$EXP$$US-SA-2024SA273979$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240924$$CN$US$US
243567301$24356730$1$I$$20240912$20240924$20240924$EXP$$IN-Accord-447026$ACCORD$Malani SK, Chigullapalli S, Sujanyal S, Sharma V. Rosuvastatin-Induced Myopathy: A Case Series. Cureus. 2024 Aug 5;16(8):e66180.$78$YR$E$F$Y$$$20240924$$HP$IN$IN
243567311$24356731$1$I$20240501$20240919$20240924$20240924$EXP$$FR-SANDOZ INC.-SDZ2024FR081594$SANDOZ$$55$YR$$F$Y$$$20240924$$MD$FR$FR
243567321$24356732$1$I$20010101$20240921$20240924$20240924$PER$$US-BIOGEN-2024BI01283821$BIOGEN$$$$$M$Y$$$20240924$$HP$US$US
243567331$24356733$1$I$20240707$20240923$20240924$20240924$EXP$$US-TAKEDA-2024TUS094354$TAKEDA$$64$YR$$F$Y$$$20240924$$CN$US$US
243567341$24356734$1$I$20190101$20240917$20240924$20240924$EXP$$US-TAKEDA-2019TUS012489$TAKEDA$$$$$M$Y$$$20240924$$MD$US$US
243567351$24356735$1$I$$20240913$20240924$20240924$EXP$$US-Accord-447215$ACCORD$$$$$M$Y$$$20240924$$HP$US$US
243567361$24356736$1$I$$20240913$20240924$20240924$EXP$$IT-Accord-432046$ACCORD$Ricchiuto A, Antenora F, Valzano I, Montanaro V, Giorgio A, Manco A, et al.?Diffuse alveolar hemorrhage associated with apixaban therapy. Respiration.?2023 Sep 01;102(8):704. doi:10.1159/000531211.$58$YR$A$M$Y$$$20240924$$HP$IT$IT
243567371$24356737$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151149$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240924$$HP$US$US
243567381$24356738$1$I$$20240923$20240924$20240924$EXP$$CA-ORGANON-O2409CAN001723$ORGANON$$43$YR$$F$Y$68$KG$20240924$$HP$CA$CA
243567392$24356739$2$F$20240910$20240924$20240924$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151123$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240926$$HP$US$US
243567401$24356740$1$I$20240912$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150120$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240924$$CN$US$US
243567411$24356741$1$I$20150601$20240913$20240924$20240924$EXP$$IT-AUROBINDO-AUR-APL-2024-046363$AUROBINDO$Sapuppo G.; Giusti M. A.; Arico D. et al. Recurrent parathyromatosis in a patient with concomitant MENI and CASR gene alterations: Clinical management of a case report and literature review.. Frontiers in Endocrinology. 2023;14:1-8$52$YR$$F$Y$$$20240924$$HP$IT$IT
243567421$24356742$1$I$20240101$20240916$20240924$20240924$EXP$$DE-TEVA-VS-3246245$TEVA$$54$YR$$F$Y$$$20240924$$MD$DE$DE
243567431$24356743$1$I$20240621$20240913$20240924$20240924$EXP$$JP-ROCHE-10000022415$ROCHE$$63$YR$A$F$Y$56.6$KG$20240924$$MD$JP$JP
243567441$24356744$1$I$$20240916$20240924$20240924$EXP$$NL-ROCHE-10000088389$ROCHE$$34$YR$A$F$Y$$$20240924$$MD$NL$NL
243567451$24356745$1$I$20240101$20240922$20240924$20240924$PER$$US-AMGEN-USASP2024189539$AMGEN$$33$YR$A$M$Y$$$20240924$$HP$US$US
243567461$24356746$1$I$$20240913$20240924$20240924$EXP$$IN-TAKEDA-2024TUS080301$TAKEDA$$$$$F$Y$$$20240924$$MD$IN$IN
243567471$24356747$1$I$$20240916$20240924$20240924$PER$$US-GSK-US2024114827$GLAXOSMITHKLINE$$$$$M$Y$$$20240924$$MD$US$US
243567481$24356748$1$I$20220201$20240919$20240924$20240924$EXP$$PR-GSK-US2024116617$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$PR$US
243567491$24356749$1$I$20200110$20240921$20240924$20240924$EXP$GB-MHRA-MED-202409211823125570-MGLRN$GB-GSK-GB2024117202$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$PH$GB$GB
243567501$24356750$1$I$$20240920$20240924$20240924$PER$$US-ROCHE-10000087831$ROCHE$$66$YR$E$F$Y$$$20240924$$HP$US$US
243567511$24356751$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65192$$FDA-CTU$$31$YR$$M$N$$$20240923$N$$US$
243567531$24356753$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65189$$FDA-CTU$$55$YR$$M$N$$$20240923$N$$US$
243567551$24356755$1$I$$20240913$20240924$20240924$EXP$$US-Accord-447147$ACCORD$$$$$F$Y$97.98$KG$20240924$$MD$US$US
243567561$24356756$1$I$$20240912$20240924$20240924$EXP$$IN-Accord-447024$ACCORD$Malani SK, Chigullapalli S, Sujanyal S, Sharma V. Rosuvastatin-Induced Myopathy: A Case Series. Cureus. 2024;16(8):e66180.$62$YR$A$M$Y$$$20240924$$HP$IN$IN
243567571$24356757$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65212$$FDA-CTU$$80$YR$$F$N$$$20240923$N$$US$
243567581$24356758$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65205$$FDA-CTU$$66$YR$$F$N$$$20240923$N$$US$
243567591$24356759$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65172$$FDA-CTU$$71$YR$$F$N$72.57$KG$20240923$N$$US$
243567611$24356761$1$I$20200517$20240917$20240924$20240924$EXP$PL-URPL-1-1651-2020$PL-MYLANLABS-2024M1084944$MYLAN$$12$YR$$F$Y$85$KG$20240924$$PH$PL$PL
243567621$24356762$1$I$20240101$20240917$20240924$20240924$EXP$SE-SEMPA-2024-006607$SE-MYLANLABS-2024M1084879$MYLAN$$64$YR$$M$Y$$$20240924$$MD$SE$SE
243567631$24356763$1$I$$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149501$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240924$$CN$US$US
243567641$24356764$1$I$$20231001$20240924$20240924$PER$$US-CELLTRION INC.-2023US017154$CELLTRION$$$$$$Y$$$20240924$$MD$US$US
243567651$24356765$1$I$20240919$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150509$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$102.06$KG$20240924$$CN$US$US
243567671$24356767$1$I$20240905$20240918$20240924$20240924$EXP$NO-NOMAADVRE-PASRAPP-2024-Vaaxed$NO-BAYER-2024A133136$BAYER$$34$YR$A$F$Y$$$20240924$$CN$NO$NO
243567681$24356768$1$I$$20240913$20240924$20240924$EXP$$CA-APOTEX-2024AP010720$APOTEX$$85$YR$$F$Y$58.957$KG$20240924$$CN$CA$CA
243567691$24356769$1$I$$20240919$20240924$20240924$EXP$$JP-ASTELLAS-2024-AER-007963$ASTELLAS$$$$E$$Y$$$20240924$$MD$JP$JP
243567711$24356771$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65197$$FDA-CTU$$59$YR$$F$N$$$20240923$N$$US$
243567721$24356772$1$I$$20240916$20240924$20240924$EXP$$US-RDY-SPO/USA/24/0013804$DR REDDYS$$43$YR$A$M$Y$$$20240924$$HP$US$US
243567731$24356773$1$I$$20240920$20240924$20240924$PER$$US-ROCHE-10000088396$ROCHE$$$$$$Y$$$20240924$$CN$US$US
243567742$24356774$2$F$$20240924$20240924$20240930$EXP$$JP-ROCHE-10000084940$ROCHE$$80$YR$E$F$Y$$$20240930$$MD$JP$JP
243567751$24356775$1$I$20130101$20240911$20240924$20240924$EXP$$GB-AUROBINDO-AUR-APL-2024-046098$AUROBINDO$$31$YR$$M$Y$$$20240924$$CN$GB$GB
243567761$24356776$1$I$$20240914$20240924$20240924$EXP$$US-ASTELLAS-2024-AER-007012$ASTELLAS$$$$E$M$Y$$$20240924$$MD$US$US
243567771$24356777$1$I$20231104$20240923$20240924$20240924$EXP$IE-HPRA-2023-108660$IE-UCBSA-2024048953$UCB$$33$YR$$F$Y$$$20240924$$CN$IE$IE
243567781$24356778$1$I$20240912$20240918$20240924$20240924$PER$$US-GSK-US2024116018$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240924$$CN$US$US
243567791$24356779$1$I$$20240910$20240924$20240924$EXP$$FR-DEXPHARM-2024-3187$DEXCEL$Tardy C, Puszkiel A, Boudou-Rouquette P, De Percin S, Alexandre J, Berge M, et al. Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection. Cancer Chemotherapy and Pharmacology. 2023 Aug 24;93(2):169?75. doi:10.1007/s00280-023-04574-z$55$YR$A$M$Y$86$KG$20240924$$HP$FR$FR
243567811$24356781$1$I$$20240910$20240924$20240924$EXP$$FR-DEXPHARM-2024-3200$DEXCEL$Tardy C, Puszkiel A, Boudou-Rouquette P, De Percin S, Alexandre J, Berge M, et al. Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection. Cancer Chemotherapy and Pharmacology. 2023 Aug 24;93(2):169?75. doi:10.1007/s00280-023-04574-z$50$YR$A$F$Y$135$KG$20240924$$HP$FR$FR
243567821$24356782$1$I$$20240909$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09031$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243567841$24356784$1$I$$20240916$20240924$20240924$EXP$$JP-TEVA-VS-3244661$TEVA$Amemiya T, Suzuki H. Retrospective analysis of risk factors for levofloxacin-induced liver injury. J-Chemother 2023; 35 707-711.$$$$$Y$$$20240924$$HP$JP$JP
243567851$24356785$1$I$20240101$20240913$20240924$20240924$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00273$CATALYST PHARMA$$$$$F$Y$$$20240924$$CN$US$US
243567861$24356786$1$I$$20240717$20240924$20240924$PER$$US-Ascend Therapeutics US, LLC-2161939$ASCEND$$$$$$Y$$$20240924$$$US$US
243567871$24356787$1$I$$20240910$20240924$20240924$EXP$DE-SA-2021SA284932$DE-PBT-001315$PANACEA BIOTEC$Affeldt P, Di CV, Grundmann F, Wirtz M, Kaiser R, Benzing T, et al. Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation. Immun Inflamm Dis.. 2021;9(2):513-20.. doi:10.1002/iid3.411$$$$M$Y$$$20240924$$HP$DE$DE
243567881$24356788$1$I$$20240916$20240924$20240924$EXP$$CA-GSK-CA2024115553$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$CA$CA
243567891$24356789$1$I$20230101$20240916$20240924$20240924$EXP$$IT-AMGEN-ITASP2024185823$AMGEN$$39$YR$A$F$Y$$$20240924$$MD$IT$IT
243567901$24356790$1$I$$20240916$20240924$20240924$EXP$$JP-TEVA-VS-3244662$TEVA$Amemiya T, Suzuki H. Retrospective analysis of risk factors for levofloxacin-induced liver injury. J-Chemother 2023; 35 707-711.$$$$$Y$$$20240924$$HP$JP$JP
243567911$24356791$1$I$20240909$20240909$20240924$20240924$EXP$$US-Fagron Sterile Services-2161952$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$29$YR$$F$Y$99$KG$20240924$$PH$US$US
243567921$24356792$1$I$20240919$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188734$AMGEN$$70$YR$E$F$Y$$$20240924$$CN$US$US
243567931$24356793$1$I$20240909$20240909$20240924$20240924$EXP$$US-Fagron Sterile Services-2161948$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$39$YR$$M$Y$68$KG$20240924$$PH$US$US
243567941$24356794$1$I$$20240909$20240924$20240924$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09094$LUPIN$$$$$$Y$$$20240924$$CN$US$US
243567961$24356796$1$I$20240903$20240910$20240924$20240924$EXP$$US-Fagron Sterile Services-2161955$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$$$$$Y$$$20240924$$$US$US
243567971$24356797$1$I$$20240920$20240924$20240924$PER$$US-ROCHE-10000088538$ROCHE$$10$YR$C$M$Y$$$20240924$$MD$US$US
243567981$24356798$1$I$$20240913$20240924$20240924$EXP$$JP-ASTELLAS-2024-AER-007626$ASTELLAS$$2$YR$C$M$Y$$$20240924$$MD$JP$JP
243568001$24356800$1$I$20240101$20240917$20240924$20240924$EXP$$US-TEVA-VS-3245914$TEVA$$15$YR$$F$Y$$$20240924$$HP$US$US
243568011$24356801$1$I$$20240916$20240924$20240924$EXP$$JP-TEVA-VS-3244664$TEVA$Amemiya T, Suzuki H. Retrospective analysis of risk factors for levofloxacin-induced liver injury. J-Chemother 2023; 35 707-711.$$$$$Y$$$20240924$$HP$JP$JP
243568021$24356802$1$I$$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65217$$FDA-CTU$$$$$$N$$$20240919$N$CN$US$
243568031$24356803$1$I$20240917$20240919$20240924$20240924$PER$GB-MHRA-MED-202409191136567810-YKDJL$GB-IDORSIA-008502-2024-GB$IDORSIA PHARMACEUTICALS$$83$YR$$M$Y$47$KG$20240924$$MD$GB$GB
243568041$24356804$1$I$$20240916$20240924$20240924$EXP$$JP-TEVA-VS-3244665$TEVA$Amemiya T, Suzuki H. Retrospective analysis of risk factors for levofloxacin-induced liver injury. J-Chemother 2023; 35 707-711.$$$$$Y$$$20240924$$HP$JP$JP
243568081$24356808$1$I$20240918$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65214$$FDA-CTU$$57$YR$$F$N$$$20240923$Y$HP$US$
243568091$24356809$1$I$$20240913$20240924$20240924$EXP$$FR-AUROBINDO-AUR-APL-2024-046166$AUROBINDO$$59$YR$$M$Y$$$20240924$$MD$FR$FR
243568101$24356810$1$I$$20240910$20240924$20240924$EXP$$GB-B.Braun Medical Inc.-2161940$B BRAUN$$66$YR$$F$Y$98$KG$20240924$$$GB$GB
243568111$24356811$1$I$$20240923$20240924$20240924$EXP$$CO-Air Products and Chemicals-2161951$AIR PRODUCTS$$$$$F$Y$$$20240924$$PH$CO$CO
243568121$24356812$1$I$$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-65058$$FDA-CTU$$$$$$N$$$20240920$N$CN$US$
243568131$24356813$1$I$20240901$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-65048$$FDA-CTU$$$$$M$N$$$20240920$N$$US$
243568141$24356814$1$I$20240917$20240919$20240919$20240919$DIR$FDA-CDER-CTU-2024-65050$$FDA-CTU$$67$YR$$M$N$77$KG$20240919$Y$HP$US$
243568161$24356816$1$I$$20240918$20240924$20240924$EXP$$BR-TAKEDA-2024TUS093425$TAKEDA$$$$$$Y$$$20240924$$CN$BR$BR
243568181$24356818$1$I$$20240910$20240924$20240924$EXP$$CN-B.Braun Medical Inc.-2161944$B BRAUN$Literature Article$69$YR$$M$Y$$$20240924$$$CN$CN
243568191$24356819$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65162$$FDA-CTU$$46$YR$$F$N$71.67$KG$20240923$N$$US$
243568201$24356820$1$I$$20240909$20240924$20240924$EXP$$US-PERRIGO-24US008850$PERRIGO$$$$A$$Y$$$20240924$$CN$US$US
243568211$24356821$1$I$20240101$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189435$AMGEN$$$$A$F$Y$$$20240924$$CN$US$US
243568221$24356822$1$I$$20240724$20240924$20240924$PER$$US-Ascend Therapeutics US, LLC-2161943$ASCEND$$$$$F$Y$$$20240924$$$US$US
243568231$24356823$1$I$20240801$20240920$20240924$20240924$EXP$$CA-SANDOZ INC.-NVSC2022CA235896$SANDOZ$$84$YR$$M$Y$81.633$KG$20240924$$MD$CA$CA
243568241$24356824$1$I$20240721$20240918$20240924$20240924$EXP$FR-AFSSAPS-NC2024001065$FR-MYLANLABS-2024M1085278$MYLAN$$27$YR$$F$Y$60$KG$20240924$$MD$FR$FR
243568251$24356825$1$I$20240903$20240916$20240924$20240924$EXP$FR-AFSSAPS-LY2024001407$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112371$ZYDUS PHARM$$$$$$Y$$$20240924$$PH$FR$FR
243568262$24356826$2$F$$20240913$20240924$20240925$EXP$IR-MLMSERVICE-20240904-PI184440-00291-1$IR-STRIDES ARCOLAB LIMITED-2024SP011985$STRIDES$Atapour A, Momenzadeh M, Panahishokouh M, Badri S. Rosuvastatin-Induced Rhabdomyolysis as a Result of Drug Interaction With Sitagliptin: A Case Report. Clinical Medicine Insights: Case Reports. 2024;17:1-4$$$$F$Y$65$KG$20240925$$PH$IR$IR
243568271$24356827$1$I$$20240917$20240924$20240924$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-127686$REGENERON$$$$$F$Y$$$20240924$$CN$CA$CA
243568281$24356828$1$I$$20240918$20240924$20240924$EXP$$GB-MYLANLABS-2024M1085276$MYLAN$$$$$M$Y$$$20240924$$PH$GB$GB
243568291$24356829$1$I$20240911$20240917$20240924$20240924$EXP$$MX-AMGEN-MEXSP2024187346$AMGEN$$$$E$F$Y$$$20240924$$CN$MX$MX
243568301$24356830$1$I$20240101$20240923$20240924$20240924$EXP$$SE-Hill Dermaceuticals, Inc.-2161941$HILL DERM$$75$YR$$F$Y$$$20240924$$MD$SE$SE
243568311$24356831$1$I$20240907$20240909$20240924$20240924$EXP$$US-Fagron Sterile Services-2161953$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$34$YR$$M$Y$61.1$KG$20240924$$PH$US$US
243568321$24356832$1$I$$20240910$20240924$20240924$EXP$$CN-B.Braun Medical Inc.-2161950$B BRAUN$Literature Article$78$YR$$M$Y$$$20240924$$$CN$CN
243568331$24356833$1$I$20240911$20240911$20240924$20240924$EXP$$US-Jiangsu Hengrui Medicine Co., Ltd.-2161979$JIANGSU HENGRUI MEDICINE$$38$YR$$F$Y$72.562$KG$20240924$$$US$US
243568351$24356835$1$I$20230515$20240920$20240924$20240924$EXP$$FR-Hill Dermaceuticals, Inc.-2161945$HILL DERM$$51$YR$$M$Y$74$KG$20240924$$$FR$FR
243568361$24356836$1$I$$20240911$20240924$20240924$EXP$$US-Oxford Pharmaceuticals, LLC-2161977$OXFORD PHARMACEUTICALS$Source document$52$YR$$M$Y$$$20240924$$$US$US
243568371$24356837$1$I$$20240910$20240924$20240924$EXP$$TN-Zhejiang Jingxin Pharmaceutical Co., Ltd-2161973$ZHEJIANG JINGXIN PHARMACEUTICAL$Full text$20$YR$$M$Y$$$20240924$$$TN$TN
243568381$24356838$1$I$$20240920$20240924$20240924$EXP$$TW-ASTELLAS-2024-AER-008125$ASTELLAS$$$$$F$Y$$$20240924$$MD$TW$TW
243568391$24356839$1$I$$20240910$20240924$20240924$EXP$$GB-WES Pharma Inc-2161971$WES PHARMA$Full text$75$YR$$M$Y$$$20240924$$$GB$GB
243568401$24356840$1$I$20240905$20240916$20240924$20240924$PER$$US-GSK-US2024114815$GLAXOSMITHKLINE$$81$YR$$M$Y$$$20240924$$CN$US$US
243568411$24356841$1$I$20240710$20240918$20240924$20240924$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2161980$JIANGSU HANSOH PHARMACEUTICAL$$$$$M$Y$$$20240924$$MD$CN$CN
243568421$24356842$1$I$$20240910$20240924$20240924$EXP$$US-Oxford Pharmaceuticals, LLC-2161978$OXFORD PHARMACEUTICALS$Source document$56$YR$$F$Y$$$20240924$$$US$US
243568431$24356843$1$I$$20231109$20240924$20240924$PER$$US-CELLTRION INC.-2023US018220$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
243568441$24356844$1$I$$20240911$20240924$20240924$EXP$$ES-Eywa Pharma Inc.-2161975$EYWA PHARMA$Abstract$$$$$Y$$$20240924$$$ES$ES
243568451$24356845$1$I$$20240917$20240924$20240924$EXP$$US-GSK-US2024115672$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$US$US
243568461$24356846$1$I$20240914$20240916$20240924$20240924$EXP$$CO-GSK-CO2023AMR160362$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$CO$CO
243568471$24356847$1$I$20240101$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188436$AMGEN$$$$$M$Y$$$20240924$$MD$US$US
243568481$24356848$1$I$$20240919$20240924$20240924$EXP$$CN-JNJFOC-20240605277$JOHNSON AND JOHNSON$$24$YR$A$M$Y$90$KG$20240924$$CN$CN$CN
243568491$24356849$1$I$$20240912$20240924$20240924$30DAY$$FR-JNJFOC-20240956535$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$PH$FR$FR
243568501$24356850$1$I$20240829$20240918$20240924$20240924$EXP$$PK-ROCHE-10000085529$ROCHE$$46$YR$A$M$Y$$$20240924$$CN$PK$PK
243568511$24356851$1$I$$20240910$20240924$20240924$EXP$$CN-Guardian Drug Company-2161970$GUARDIAN PHARMACEUTICALS$Abstract$4$YR$$F$Y$$$20240924$$$CN$CN
243568521$24356852$1$I$$20240911$20240924$20240924$EXP$$ES-Eywa Pharma Inc.-2161976$EYWA PHARMA$Abstract$$$$$Y$$$20240924$$$ES$ES
243568531$24356853$1$I$20240501$20240920$20240924$20240924$EXP$GB-MHRA-MED-202409201520553610-WLDRJ$GB-TAKEDA-2024TUS093872$TAKEDA$$67$YR$$M$Y$91$KG$20240924$$HP$GB$GB
243568541$24356854$1$I$20180315$20240917$20240924$20240924$EXP$$CA-TAKEDA-2018TUS006790$TAKEDA$$80$YR$$M$Y$$$20240924$$CN$CA$CA
243568551$24356855$1$I$20240101$20240918$20240924$20240924$EXP$$NVSC2024DE188277$NOVARTIS$$$$A$M$Y$$$20240924$$MD$DE$DE
243568561$24356856$1$I$$20240918$20240924$20240924$EXP$$NVSJ2024JP011111$NOVARTIS$Nishiguchi T, Yamazaki D, Okano R, Sonoda A, Sakawa M, Iwamoto S, et al.. A Case of Posterior Reversible Encephalopathy Syndrome during Ciclosporin Therapy for Ulcerative Colitis. The 379th Annual Meeting of the Kanto Branch of the Japanese Society of Gastroen. 2024;18$$$A$F$Y$$$20240924$$HP$JP$JP
243568582$24356858$2$F$$20240916$20240924$20240926$EXP$$GB-CELLTRION INC.-2024GB022508$CELLTRION$$$$$$Y$$$20240926$$CN$GB$GB
243568591$24356859$1$I$$20240920$20240924$20240924$EXP$$NVSC2024US189245$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243568601$24356860$1$I$$20240910$20240924$20240924$EXP$$FR-WES Pharma Inc-2161972$WES PHARMA$Abstract$55$YR$$F$Y$$$20240924$$$FR$FR
243568611$24356861$1$I$20151023$20240913$20240924$20240924$EXP$$PT-AUROBINDO-AUR-APL-2024-046467$AUROBINDO$Cota-Medeiros, Fabio.. A CASE OF ENDOCARDITIS COMPLICATED BY DRESS SYNDROME.. 22nd Congresso de Medicina Interna. 2016;287$$$A$F$Y$$$20240924$$MD$PT$PT
243568621$24356862$1$I$$20240920$20240924$20240924$EXP$$NVSC2024US189242$NOVARTIS$$$$$F$Y$$$20240924$$HP$US$US
243568631$24356863$1$I$$20240918$20240924$20240924$PER$$NVSC2024US187393$NOVARTIS$$$$$F$Y$65.7$KG$20240924$$HP$US$US
243568641$24356864$1$I$20240901$20240913$20240924$20240924$EXP$$NVSC2024DE186692$NOVARTIS$$57$YR$$F$Y$$$20240924$$CN$DE$DE
243568651$24356865$1$I$20240817$20240923$20240924$20240924$EXP$SE-SEMPA-2024-006599$NVSC2024SE188629$NOVARTIS$$35$YR$$F$Y$$$20240924$$MD$SE$SE
243568661$24356866$1$I$$20240919$20240924$20240924$EXP$$NVSC2024US060301$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243568671$24356867$1$I$20240810$20240923$20240924$20240924$EXP$$NVSC2024DE188825$NOVARTIS$$82$YR$$F$Y$$$20240924$$MD$DE$DE
243568681$24356868$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65210$$FDA-CTU$$66$YR$$F$N$$$20240923$N$$US$
243568691$24356869$1$I$$20240910$20240924$20240924$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09454$LUPIN$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al. Clinical characteristics and HLA associations of Azithromycin-induced liver injury. Alimentary Pharmacology and Therapeutics. 2024;60:787-795$$$A$$Y$$$20240924$$HP$US$US
243568701$24356870$1$I$$20240916$20240924$20240924$EXP$$NVSC2024ZA186992$NOVARTIS$$80$YR$$M$Y$$$20240924$$HP$ZA$ZA
243568711$24356871$1$I$$20240918$20240924$20240924$EXP$$CA-Orion Corporation ORION PHARMA-24_00031819$ORION$$63$YR$A$F$Y$$$20240924$$CN$CA$
243568721$24356872$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65159$$FDA-CTU$$55$YR$$F$N$87.09$KG$20240923$N$$US$
243568731$24356873$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65176$$FDA-CTU$$63$YR$$M$N$121.11$KG$20240923$N$$US$
243568753$24356875$3$F$20240214$20240920$20240924$20240930$EXP$$NVSC2024DE076451$NOVARTIS$$45$YR$$M$Y$112$KG$20240930$$MD$DE$DE
243568761$24356876$1$I$$20240923$20240923$20240923$DIR$719514$$FDA-CTU$$$$$UNK$N$$$20240923$N$$US$
243568771$24356877$1$I$$20240920$20240924$20240924$EXP$$NVSC2024MY188309$NOVARTIS$$$$$$Y$$$20240924$$MD$MY$MY
243568791$24356879$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65157$$FDA-CTU$$55$YR$$M$N$$$20240923$N$$US$
243568801$24356880$1$I$20240914$20240918$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149237$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240924$$CN$US$US
243568811$24356881$1$I$20240825$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-65054$$FDA-CTU$$61$YR$$M$N$95.4$KG$20240920$Y$MD$US$
243568821$24356882$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65165$$FDA-CTU$$44$YR$$F$N$66.68$KG$20240923$N$$US$
243568831$24356883$1$I$$20240912$20240924$20240924$EXP$$US-NOVOPROD-1285628$NOVO NORDISK$$$$A$F$Y$$$20240924$$CN$US$US
243568841$24356884$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189812$NOVARTIS$$$$$$Y$$$20240924$$HP$US$US
243568851$24356885$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189773$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243568861$24356886$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65163$$FDA-CTU$$62$YR$$F$N$$$20240923$N$$US$
243568871$24356887$1$I$20240806$20240920$20240924$20240924$EXP$FR-AFSSAPS-RN2024001012$NVSC2024FR187816$NOVARTIS$$45$YR$$M$Y$$$20240924$$MD$FR$FR
243568881$24356888$1$I$$20240920$20240924$20240924$PER$$NVSC2024US189241$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
243568901$24356890$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189720$NOVARTIS$$$$A$M$Y$$$20240924$$PH$US$US
243568911$24356891$1$I$$20240918$20240924$20240924$EXP$$NVSC2024AT161850$NOVARTIS$$81$YR$$F$Y$$$20240924$$MD$AT$AT
243568921$24356892$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189852$NOVARTIS$$$$$$Y$$$20240924$$MD$US$US
243568931$24356893$1$I$20240101$20240923$20240924$20240924$EXP$FR-AFSSAPS-SE2024000729$NVSC2024FR188960$NOVARTIS$$70$YR$$F$Y$$$20240924$$MD$FR$FR
243568941$24356894$1$I$$20240916$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013657$DR REDDYS$$36$YR$A$M$Y$$$20240924$$HP$US$US
243568951$24356895$1$I$$20240916$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013797$DR REDDYS$$17$YR$T$F$Y$$$20240924$$MD$US$US
243568961$24356896$1$I$$20240917$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013904$DR REDDYS$$71$YR$E$F$Y$$$20240924$$HP$US$US
243568971$24356897$1$I$20220101$20240917$20240924$20240924$PER$US-MLMSERVICE-20240910-PI188113-00246-2$US-RDY-SPO/USA/24/0013729$DR REDDYS$Gwynn N, Lindenmayer J, Boes T, Pitalo C. Late Recognition of Cholinergic Delirium in Patient on Donepezil Combination Treatment. Journal of Clinical Psychopharmacology. 2024;44(5):521-2. DOI:10.1097/JCP.0000000000001901.$69$YR$E$M$Y$$$20240924$$MD$US$US
243568981$24356898$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189794$NOVARTIS$$$$$$Y$$$20240924$$HP$US$US
243568991$24356899$1$I$20240903$20240904$20240924$20240924$PER$$US-TOLMAR, INC.-24US052396$TOLMAR$$62$YR$$M$Y$$$20240924$$HP$US$US
243569002$24356900$2$F$$20240924$20240924$20240925$PER$$US-AMGEN-USASP2024189623$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243569021$24356902$1$I$20240904$20240904$20240924$20240924$PER$$US-TOLMAR, INC.-24US052442$TOLMAR$$82$YR$$M$Y$$$20240924$$PH$US$US
243569031$24356903$1$I$20240905$20240906$20240924$20240924$PER$$US-TOLMAR, INC.-24US052457$TOLMAR$$69$YR$$M$Y$$$20240924$$HP$US$US
243569041$24356904$1$I$20230901$20240923$20240924$20240924$EXP$SE-SEMPA-2024-006897$NVSC2024SE188738$NOVARTIS$$26$YR$$F$Y$66$KG$20240924$$MD$SE$SE
243569051$24356905$1$I$$20240905$20240924$20240924$PER$$US-TOLMAR, INC.-24US052464$TOLMAR$$$$$$Y$$$20240924$$HP$US$US
243569061$24356906$1$I$20240801$20240904$20240924$20240924$PER$$US-TOLMAR, INC.-24US052468$TOLMAR$$$$$M$Y$$$20240924$$HP$US$US
243569071$24356907$1$I$$20240905$20240924$20240924$PER$$US-TOLMAR, INC.-24US052469$TOLMAR$$$$$M$Y$$$20240924$$HP$US$US
243569081$24356908$1$I$20240906$20240906$20240924$20240924$PER$$US-TOLMAR, INC.-24US052509$TOLMAR$$86$YR$$M$Y$$$20240924$$HP$US$US
243569091$24356909$1$I$$20240919$20240924$20240924$EXP$$NVSC2024US188801$NOVARTIS$$$$$F$Y$$$20240924$$HP$US$US
243569111$24356911$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189839$NOVARTIS$$$$$$Y$$$20240924$$HP$US$US
243569121$24356912$1$I$20240506$20240917$20240924$20240924$EXP$$NVSC2024DE156357$NOVARTIS$$77$YR$$M$Y$78$KG$20240924$$CN$DE$DE
243569131$24356913$1$I$$20240920$20240924$20240924$EXP$$US-BAYER-2024A135476$BAYER$$89$YR$E$F$Y$$$20240924$$CN$US$US
243569141$24356914$1$I$$20240910$20240924$20240924$EXP$$TR-GLANDPHARMA-TR-2024GLNLIT00763$GLAND PHARMA$Gozdem Kayki.Dexmedetomidine Use for Analgesia In Preterm Babies . BMJ Paediatrics Open.2024;8:A19$$$I$$Y$$$20240924$$HP$TR$TR
243569151$24356915$1$I$$20240904$20240924$20240924$PER$$US-TEVA-VS-3242094$TEVA$$67$YR$$F$Y$$$20240924$$CN$US$US
243569161$24356916$1$I$$20240917$20240924$20240924$PER$$US-AMGEN-USASP2024186316$AMGEN$$$$$$Y$$$20240924$$HP$US$US
243569182$24356918$2$F$$20240923$20240924$20240926$EXP$$US-BAYER-2024A135547$BAYER$$$$$$Y$$$20240926$$CN$US$US
243569191$24356919$1$I$$20240912$20240924$20240924$30DAY$$FR-JNJFOC-20240956525$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$PH$FR$FR
243569201$24356920$1$I$$20240923$20240924$20240924$EXP$$US-GILEAD-2024-0688643$GILEAD$$$$A$F$Y$$$20240924$$CN$US$US
243569221$24356922$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65160$$FDA-CTU$$51$YR$$F$N$81.65$KG$20240923$N$$US$
243569232$24356923$2$F$$20240919$20240924$20240924$PER$$US-ROCHE-10000087737$ROCHE$$80$YR$E$M$Y$$$20240924$$HP$US$US
243569241$24356924$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65194$$FDA-CTU$$56$YR$$F$N$63.96$KG$20240923$N$$US$
243569251$24356925$1$I$$20240918$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012648$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240924$$CN$US$US
243569261$24356926$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013566$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243569271$24356927$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013680$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240924$$CN$US$US
243569282$24356928$2$F$$20240923$20240924$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409013518$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240926$$CN$US$US
243569291$24356929$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014499$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240924$$CN$US$US
243569301$24356930$1$I$20240923$20240923$20240923$20240923$DIR$719475$$FDA-CTU$$80$YR$$UNK$N$$$20240923$N$$US$
243569311$24356931$1$I$20240912$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013527$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240924$$CN$US$US
243569321$24356932$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014247$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240924$$CN$US$US
243569331$24356933$1$I$$20240918$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013538$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243569341$24356934$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014508$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240924$$CN$US$US
243569351$24356935$1$I$20240913$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013598$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240924$$CN$US$US
243569371$24356937$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65196$$FDA-CTU$$72$YR$$F$N$$$20240923$N$$US$
243569381$24356938$1$I$$20240911$20240924$20240924$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP012057$STRIDES$Mansour H, Ali J, Swamy A, Leahy A.. case of haemorrhagic emphysematous gastritis.. Cureus. 2024;16(8):e66084$70$YR$$F$Y$$$20240924$$MD$GB$GB
243569391$24356939$1$I$$20240918$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149066$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$68.49$KG$20240924$$CN$US$US
243569411$24356941$1$I$$20240922$20240924$20240924$EXP$$US-BAYER-2024A135414$BAYER$$$$$$Y$$$20240924$$CN$US$US
243569421$24356942$1$I$20240724$20240917$20240924$20240924$EXP$$JP-AMGEN-JPNSP2024147002$AMGEN$$78$YR$E$M$Y$$$20240924$$MD$JP$JP
243569431$24356943$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189866$NOVARTIS$$$$$$Y$$$20240924$$HP$US$US
243569441$24356944$1$I$$20240917$20240924$20240924$EXP$$NVSC2024BR188439$NOVARTIS$$$$$F$Y$$$20240924$$MD$BR$BR
243569461$24356946$1$I$$20240916$20240924$20240924$EXP$$AU-MYLANLABS-2024M1085691$MYLAN$Cotter F, Shi M, Sathianathen N, Thevarajah G, Cheng J, Gyomber D, et al. Corpus cavernosum abscess complicating distal shunt procedures for priapism. J-Clin-Urol 2024; 17 (1): 96-103.$36$YR$$M$Y$$$20240924$$HP$AU$AU
243569471$24356947$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65173$$FDA-CTU$$38$YR$$M$N$$$20240923$N$$US$
243569481$24356948$1$I$$20240916$20240924$20240924$EXP$$US-MYLANLABS-2024M1085511$MYLAN$O^Dell BL, Kochhar K, Johnson A. Vasopressor-Induced Peripheral Gangrene Secondary to COVID-19: A Case Report. J-Am-Podiatr-Med-Assoc 2024; 114 (3): 1-6.$37$YR$$M$Y$$$20240924$$MD$US$US
243569491$24356949$1$I$$20240916$20240924$20240924$EXP$$US-MYLANLABS-2024M1086160$MYLAN$Lanier C, Fuller M, Reece BA. Novel Drug-Drug Interaction of Potential Rifabutin-Induced Edoxaban Failure: A Case Report. J-Pharm-Pract 2024; 37 (5): 1199-1204.$76$YR$$M$Y$$$20240924$$PH$US$US
243569501$24356950$1$I$$20240917$20240924$20240924$EXP$$FR-MYLANLABS-2024M1085289$MYLAN$Franchi V, Labussiere-Wallet H, Chouik Y,Heiblig M, Larcher M.. UBTF-TD AML complicated by post-allograft Veno-occlusive disease (VOD) treated by liver transplantation. Correspondances en Onco-Hematologie.. 2023;XVIII(6):349-51$$$A$M$Y$$$20240924$$MD$FR$FR
243569511$24356951$1$I$$20240916$20240924$20240924$EXP$$GR-MYLANLABS-2024M1085463$MYLAN$Ozdogan M, Papadopoulou E, Metaxa-Mariatou V, Kapetsis G, Meintani A, Florou-Chatzigiannidou C, et al. Case report: Immunotherapy guided by molecular profiling of tumors: illustrative cases and literature review. Front-Med 2024; 11 (0).$62$YR$$M$Y$$$20240924$$HP$GR$GR
243569521$24356952$1$I$$20240917$20240924$20240924$EXP$$US-MYLANLABS-2024M1085921$MYLAN$Robinson W, McLellan BN. Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus. JAAD-Case-Rep 2023; 42 31-34.$68$YR$$M$Y$$$20240924$$MD$US$US
243569531$24356953$1$I$$20240917$20240924$20240924$EXP$$PT-MYLANLABS-2024M1084933$MYLAN$Dias, L.. EP-062 - Encephalitis: a double-edged sword. national congress of neurology - 2022. e-posters.. Synapse. 2022;23 (1):292$$$$M$Y$$$20240924$$HP$PT$PT
243569541$24356954$1$I$$20240917$20240924$20240924$EXP$$BE-MYLANLABS-2024M1085659$MYLAN$Mastrodicasa E. Sulfuric acid ingestion: may the severity of the metabolic acidosis be considered as a predictive sign of late damage to the gastrointestinal tract? Eur-J-Case-Rep-Intern-Med 2024; 11 (5).$66$YR$$F$Y$$$20240924$$HP$BE$BE
243569551$24356955$1$I$$20240917$20240924$20240924$EXP$$US-MYLANLABS-2024M1085684$MYLAN$Prasad A, Verghese D, Vijaya Rangan S, Sunadarajan N. Spontaneous tumour lysis secondary to gastric adenocarcinoma. BMJ-Case-Rep 2024; 17 (1):.$8$DEC$$M$Y$$$20240924$$HP$US$US
243569562$24356956$2$F$$20240923$20240924$20240927$PER$$US-ROCHE-10000088014$ROCHE$$43$YR$A$F$Y$$$20240927$$CN$US$US
243569571$24356957$1$I$$20240916$20240924$20240924$EXP$$CN-MYLANLABS-2024M1086180$MYLAN$Li W, Fu Y, Wang W. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. Ann-Hematol 2024; 103 (8): 3207-3217.$84$YR$$M$Y$$$20240924$$HP$CN$CN
243569581$24356958$1$I$$20240917$20240924$20240924$EXP$$SG-MYLANLABS-2024M1085911$MYLAN$Lee BH, Leong YH, Kwek Beng Kee E. Atypical Presentation of Klebsiella pneumoniae Necrotizing Fasciitis of the Lower Extremities: Silent but Deadly: A Case Report. JBJS-Case-Connect 2023; 13.$50$YR$$F$Y$$$20240924$$MD$SG$SG
243569591$24356959$1$I$$20240916$20240924$20240924$EXP$$EG-MYLANLABS-2024M1085857$MYLAN$Ali HT, Khalil SA, Caprara ALF, Rissardo JP. Pregabalin-Induced Parkinsonism: Case Report and Review of the Literature. [Review]. J-Pharm-Pract 2024; 37 (5): 1220-1224.$48$YR$$F$Y$$$20240924$$HP$EG$EG
243569601$24356960$1$I$$20240916$20240924$20240924$EXP$$IN-MYLANLABS-2024M1085753$MYLAN$Prakash S, Patel H, Shah CS. Medication-overuse headache overlapping with serotonin syndrome. BMJ-Case-Rep 2024; 17 (1):.$$$A$F$Y$$$20240924$$MD$IN$IN
243569611$24356961$1$I$20240603$20240910$20240924$20240924$EXP$$CN-ABBVIE-5910942$ABBVIE$$55$YR$$F$Y$47.5$KG$20240924$$CN$CN$CN
243569621$24356962$1$I$$20240916$20240924$20240924$EXP$$IN-MYLANLABS-2024M1085666$MYLAN$Bhowmick SS. Metabolic Opsoclonus Myoclonus Syndrome in a Patient of Crohn^s Disease: Lessons Learnt. Ann-Indian-Acad-Neurol 2023; 26 (5): 793-794.$51$YR$$M$Y$$$20240924$$MD$IN$IN
243569631$24356963$1$I$20230525$20240913$20240924$20240924$EXP$$GB-UCBSA-2024047861$UCB$$73$YR$$M$Y$80$KG$20240924$$MD$GB$GB
243569641$24356964$1$I$$20231005$20240924$20240924$PER$$US-CELLTRION INC.-2023US016318$CELLTRION$$$$$$Y$$$20240924$$HP$US$US
243569651$24356965$1$I$20240909$20240916$20240924$20240924$EXP$$US-VANTIVE-2024VAN019830$Vantive US Healthcare$$$$$M$Y$$$20240924$$HP$US$US
243569661$24356966$1$I$$20240918$20240924$20240924$EXP$$US-VANTIVE-2024VAN019873$Vantive US Healthcare$$$$$M$Y$$$20240924$$HP$US$US
243569671$24356967$1$I$20240911$20240916$20240924$20240924$EXP$$US-VANTIVE-2024VAN019833$Vantive US Healthcare$$79$YR$$F$Y$$$20240924$$HP$US$US
243569681$24356968$1$I$$20240918$20240924$20240924$PER$$US-GSK-US2024116166$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240924$$PH$US$US
243569691$24356969$1$I$20240915$20240923$20240924$20240924$EXP$GB-MHRA-WEBRADR-202409230605498500-JBFTZ$GB-SANDOZ INC.-SDZ2024GB082135$SANDOZ$$27$YR$$M$Y$$$20240924$$PH$GB$GB
243569701$24356970$1$I$20230413$20240916$20240924$20240924$EXP$LT-SMCA-4686$LT-CELLTRION INC.-2024LT022413$CELLTRION$$$$$$Y$$$20240924$$MD$LT$LT
243569711$24356971$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150423$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$94.8$KG$20240924$$CN$US$US
243569721$24356972$1$I$$20240916$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147552$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240924$$CN$US$US
243569751$24356975$1$I$20240913$20240913$20240924$20240924$EXP$$US-UCBSA-2024047538$UCB$$60$YR$$F$Y$$$20240924$$CN$US$US
243569761$24356976$1$I$20240815$20240923$20240924$20240924$EXP$$CN-ROCHE-10000089605$ROCHE$$33$YR$A$F$Y$54$KG$20240924$$HP$CN$CN
243569771$24356977$1$I$$20240912$20240924$20240924$EXP$$IN-Accord-447025$ACCORD$Malani SK, Chigullapalli S, Sujanyal S, Sharma V. Rosuvastatin-Induced Myopathy: A Case Series. Cureus. 2024;16(8):e66180$70$YR$E$F$Y$$$20240924$$HP$IN$IN
243569791$24356979$1$I$20240915$20240922$20240924$20240924$PER$$US-AMGEN-USASP2024189256$AMGEN$$54$YR$A$F$Y$$$20240924$$CN$US$US
243569801$24356980$1$I$$20240918$20240924$20240924$EXP$$NVSC2024VN187904$NOVARTIS$$71$YR$$F$Y$$$20240924$$MD$VN$VN
243569811$24356981$1$I$$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024187910$AMGEN$$$$$F$Y$$$20240924$$CN$US$US
243569821$24356982$1$I$$20240916$20240924$20240924$EXP$$NL-CELLTRION INC.-2024NL022472$CELLTRION$Kreuger AL, Jolink H, Halkes CJM, von dem Borne PA, Veelken H, Lankester AC, et al.. Allogene stamceltransplantatie bij volwassen patianten met een primaire immuundeficiantie. Nederlands Tijdschrift voor Hematologie. 2024;21/2:30-36$$$$$Y$$$20240924$$MD$NL$NL
243569831$24356983$1$I$$20240912$20240924$20240924$EXP$$CA-APOTEX-2024AP010647$APOTEX$$82$YR$$F$Y$$$20240924$$PH$CA$CA
243569841$24356984$1$I$20240901$20240917$20240924$20240924$EXP$$US-CHIESI-2024CHF06173$CHIESI$$43$YR$$F$Y$$$20240924$$CN$US$US
243569851$24356985$1$I$20231201$20240917$20240924$20240924$EXP$$US-CHIESI-2024CHF06190$CHIESI$$17$YR$$F$Y$56$KG$20240924$$HP$US$US
243569871$24356987$1$I$$20240912$20240924$20240924$EXP$$PT-MACLEODS PHARMA-MAC2024049437$MACLEODS$Silva SP, Eugenio G, Pinto M, Barcelos A..Clinical and persistent remission in anti-HMGCR immune-mediated necrotizing myopathy to a single cycle of rituximab - a case-based review.ARP Rheumatology.18-MAY-2024;1-11$$$$$Y$$$20240924$$HP$PT$PT
243569881$24356988$1$I$$20240912$20240924$20240924$EXP$GB-MHRA-MED-202409121633045170-MFKQT$GB-MACLEODS PHARMA-MAC2024049444$MACLEODS$$$$$$Y$$$20240924$$MD$GB$GB
243569891$24356989$1$I$$20240913$20240924$20240924$EXP$$DK-MACLEODS PHARMA-MAC2024049447$MACLEODS$Hoeck PR, Kessing LV, Pagsberg AK, Andersen M.15-year-old with bipolar affective disorder treated with ECT.Ugeskrift Laeger.2024;186:V02240137$$$$$Y$$$20240924$$MD$DK$DK
243569901$24356990$1$I$$20240913$20240924$20240924$EXP$$ES-MACLEODS PHARMA-MAC2019020414$MACLEODS$$$$$$Y$$$20240924$$HP$ES$ES
243569911$24356991$1$I$$20240916$20240924$20240924$PER$$US-GSK-US2024115670$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243569921$24356992$1$I$20240706$20240917$20240924$20240924$EXP$FR-AFSSAPS-PP2024000963$FR-GSK-FR2024115399$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$FR$FR
243569931$24356993$1$I$20190816$20240919$20240924$20240924$EXP$$CO-UCBSA-2024048998$UCB$$77$YR$$M$Y$$$20240924$$CN$CO$CO
243569941$24356994$1$I$$20240920$20240924$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151190$BRISTOL MYERS SQUIBB$$9$DEC$E$$Y$$$20240924$$MD$JP$JP
243569951$24356995$1$I$$20240913$20240924$20240924$EXP$$ID-MACLEODS PHARMA-MAC2024049445$MACLEODS$Auerkari AN, Sedono R, Pryambodho P..Severe Neuropathic Back Pain as the Initial Presentation in Angiostrongylus cantonensis Infection: The Role of ICU Management in Overcoming Diagnostic and Analgosedation Challenges..Archives of Clinical Infectious Diseases.2024;19(4):e135637$$$$$Y$$$20240924$$MD$ID$ID
243569961$24356996$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150546$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240924$$CN$US$US
243569981$24356998$1$I$20240918$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024187669$AMGEN$$$$$$Y$$$20240924$$PH$US$US
243569991$24356999$1$I$$20240919$20240924$20240924$EXP$$CA-SANDOZ INC.-SDZ2024CA081548$SANDOZ$$$$$M$Y$$$20240924$$CN$CA$CA
243570001$24357000$1$I$20240801$20240913$20240924$20240924$EXP$$US-UCBSA-2024047600$UCB$$60$YR$$F$Y$$$20240924$$HP$US$US
243570021$24357002$1$I$$20240923$20240924$20240924$EXP$$CA-BAYER-2024A135863$BAYER$$49$YR$A$F$Y$67$KG$20240924$$HP$CA$CA
243570041$24357004$1$I$20240905$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65211$$FDA-CTU$$47$YR$$M$N$$$20240923$Y$HP$US$
243570051$24357005$1$I$20240902$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65064$$FDA-CTU$$78$YR$$F$N$$$20240923$Y$PH$US$
243570061$24357006$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65215$$FDA-CTU$$20$YR$$F$N$$$20240923$N$$US$
243570071$24357007$1$I$20240916$20240923$20240923$20240923$DIR$719547$$FDA-CTU$$43$YR$$F$N$$$20240923$Y$HP$US$
243570091$24357009$1$I$20240912$20240917$20240924$20240924$DIR$FDA-CDER-CTU-2024-65220$$FDA-CTU$$$$$F$N$62.6$KG$20240917$N$$US$
243570101$24357010$1$I$20240919$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65223$$FDA-CTU$$62$YR$$M$N$$$20240924$N$$US$
243570111$24357011$1$I$20240921$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65218$$FDA-CTU$$$$$M$N$79.4$KG$20240923$N$$US$
243570121$24357012$1$I$20240923$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65204$$FDA-CTU$$75$YR$$F$N$$$20240923$Y$HP$US$
243570131$24357013$1$I$20230701$20240709$20240924$20240924$DIR$FDA-CDER-CTU-2024-65221$$FDA-CTU$$$$$F$N$96.9$KG$20240709$N$$US$
243570141$24357014$1$I$20231212$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65216$$FDA-CTU$$$$$M$N$75.3$KG$20240923$N$$US$
243570151$24357015$1$I$20240920$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65219$$FDA-CTU$$$$$F$N$50.3$KG$20240923$N$$US$
243570161$24357016$1$I$20240220$20240918$20240924$20240924$DIR$FDA-CDER-CTU-2024-65222$$FDA-CTU$$$$$M$N$46.65$KG$20240918$N$$US$
243570171$24357017$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65175$$FDA-CTU$$79$YR$$M$N$$$20240923$N$$US$
243570181$24357018$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65154$$FDA-CTU$$51$YR$$F$N$110.22$KG$20240923$N$$US$
243570191$24357019$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65152$$FDA-CTU$$67$YR$$F$N$$$20240923$N$$US$
243570201$24357020$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65065$$FDA-CTU$$68$YR$$F$N$$$20240923$N$$US$
243570211$24357021$1$I$20240920$20240923$20240923$20240923$DIR$719536$$FDA-CTU$$19$WK$$M$N$6.75$KG$20240923$N$HP$US$
243570221$24357022$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65166$$FDA-CTU$$81$YR$$M$N$$$20240923$N$$US$
243570231$24357023$1$I$20240720$20240924$20240924$20240924$EXP$HU-OGYI-0116424$NVSC2024HU189694$NOVARTIS$$9$YR$$F$Y$59$KG$20240924$$MD$HU$HU
243570241$24357024$1$I$$20240919$20240924$20240924$EXP$$NVSC2024US188162$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
243570251$24357025$1$I$$20240923$20240924$20240924$EXP$$PT-TAKEDA-2024TUS094337$TAKEDA$$14$YR$$M$Y$$$20240924$$HP$PT$PT
243570261$24357026$1$I$$20240923$20240924$20240924$EXP$CZ-CZSUKL-24002562$CZ-BAYER-2024A135321$BAYER$$33$YR$A$F$Y$55$KG$20240924$$CN$CZ$CZ
243570271$24357027$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65167$$FDA-CTU$$35$YR$$F$N$117.93$KG$20240923$N$$US$
243570281$24357028$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65151$$FDA-CTU$$60$YR$$F$N$127.46$KG$20240923$N$$US$
243570291$24357029$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65153$$FDA-CTU$$72$YR$$F$N$$$20240923$N$$US$
243570301$24357030$1$I$20240201$20240920$20240924$20240924$EXP$RU-RZN-2570279$RU-SANDOZ INC.-SDZ2024RU082102$SANDOZ$$$$$F$Y$68$KG$20240924$$MD$RU$RU
243570311$24357031$1$I$$20230911$20240924$20240924$PER$$US-CELLTRION INC.-2023US017881$CELLTRION$Lee R.V., Melstrom K.A, Mannan R., Idos G.E., Kidambi T.. Severe Immune-Mediated Colitis Induced by Checkpoint Inhibitors in an Adolescent With Lynch Syndrome. Cureus. 2023;15(8):1-7$$$$$Y$$$20240924$$HP$US$US
243570321$24357032$1$I$$20240923$20240923$20240923$DIR$719480$$FDA-CTU$$$$$M$N$$$20240923$N$HP$US$
243570331$24357033$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65170$$FDA-CTU$$79$YR$$M$N$$$20240923$N$$US$
243570341$24357034$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65179$$FDA-CTU$$69$YR$$F$N$$$20240923$N$$US$
243570351$24357035$1$I$20240801$20240910$20240924$20240924$EXP$$US-UCBSA-2024046694$UCB$$63$YR$$F$Y$$$20240924$$HP$US$US
243570361$24357036$1$I$$20240913$20240924$20240924$EXP$$DE-UCBSA-2024047511$UCB$$$$A$M$Y$$$20240924$$PH$DE$DE
243570371$24357037$1$I$20240101$20240912$20240924$20240924$PER$$US-JNJFOC-20240960321$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$HP$US$US
243570381$24357038$1$I$20231120$20240916$20240924$20240924$EXP$$TW-TAKEDA-2023TUS114756$TAKEDA$$73$YR$$M$Y$$$20240924$$CN$TW$TW
243570391$24357039$1$I$$20240909$20240924$20240924$EXP$$DE-SA-2024SA274648$SANOFI AVENTIS$$$$$$Y$$$20240924$$CN$DE$DE
243570401$24357040$1$I$$20240909$20240924$20240924$EXP$$US-SA-2024SA275239$SANOFI AVENTIS$$$$E$F$Y$$$20240924$$CN$US$US
243570411$24357041$1$I$20240809$20240909$20240924$20240924$EXP$$US-SA-2024SA275030$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240924$$MD$US$US
243570422$24357042$2$F$$20240920$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US082202$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243570431$24357043$1$I$20230824$20230825$20240924$20240924$PER$$US-CELLTRION INC.-2023US016943$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
243570441$24357044$1$I$20240829$20240921$20240924$20240924$EXP$$IN-ROCHE-10000089106$ROCHE$$81$YR$E$F$Y$$$20240924$$CN$IN$IN
243570451$24357045$1$I$$20240919$20240924$20240924$PER$$US-HALEON-2198032$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
243570461$24357046$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151127$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240924$$CN$US$US
243570471$24357047$1$I$$20240917$20240924$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-029667$UNITED THERAPEUTICS$$$$$F$Y$60.317$KG$20240924$$$US$US
243570491$24357049$1$I$20240101$20240913$20240924$20240924$EXP$$US-UCBSA-2024048562$UCB$$$$$F$Y$$$20240924$$CN$US$US
243570501$24357050$1$I$20230101$20240911$20240924$20240924$EXP$$CA-UCBSA-2023041823$UCB$$$$$F$Y$$$20240924$$CN$CA$CA
243570511$24357051$1$I$20240909$20240918$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149126$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$63.5$KG$20240924$$HP$US$US
243570531$24357053$1$I$$20240908$20240924$20240924$PER$$NVSC2024US182357$NOVARTIS$$37$YR$$F$Y$$$20240924$$MD$US$US
243570541$24357054$1$I$$20230829$20240924$20240924$PER$$US-CELLTRION INC.-2023US017317$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
243570551$24357055$1$I$20230501$20230925$20240924$20240924$PER$$US-CELLTRION INC.-2023US018191$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
243570561$24357056$1$I$20240901$20240917$20240924$20240924$PER$$US-UNITED THERAPEUTICS-UNT-2024-029511$UNITED THERAPEUTICS$$44$YR$$F$Y$54.422$KG$20240924$$$US$US
243570571$24357057$1$I$20240831$20240912$20240924$20240924$EXP$$US-UCBSA-2024047242$UCB$$14$YR$$M$Y$$$20240924$$CN$US$US
243570581$24357058$1$I$20240916$20240918$20240924$20240924$PER$$US-VIIV HEALTHCARE LIMITED-US2024116116$VIIV$$31$YR$$M$Y$$$20240924$$HP$US$US
243570591$24357059$1$I$$20240916$20240924$20240924$PER$$US-VIIV HEALTHCARE LIMITED-US2024114803$VIIV$$$$$F$Y$131.45$KG$20240924$$HP$US$US
243570601$24357060$1$I$$20240909$20240924$20240924$30DAY$$DE-JNJFOC-20240945578$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$DE$DE
243570611$24357061$1$I$$20240919$20240924$20240924$EXP$$US-LUNDBECK-DKLU4004456$LUNDBECK$$$$$$Y$$$20240924$$PH$US$US
243570621$24357062$1$I$$20240916$20240924$20240924$EXP$$CA-TAKEDA-2024TUS092665$TAKEDA$$$$$F$Y$$$20240924$$MD$CA$CA
243570631$24357063$1$I$20240101$20240912$20240924$20240924$EXP$$US-SA-2024SA273902$SANOFI AVENTIS$$$$$F$Y$$$20240924$$CN$US$US
243570651$24357065$1$I$20191220$20240917$20240924$20240924$EXP$$BR-TAKEDA-BR201940102$TAKEDA$$13$YR$$M$Y$101$KG$20240924$$CN$BR$BR
243570661$24357066$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65193$$FDA-CTU$$60$YR$$F$N$$$20240923$N$HP$US$
243570671$24357067$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65191$$FDA-CTU$$88$YR$$M$N$$$20240923$N$$US$
243570681$24357068$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65178$$FDA-CTU$$25$YR$$M$N$$$20240923$N$$US$
243570691$24357069$1$I$$20240912$20240924$20240924$EXP$$JP-EMD Serono-2024050521$EMD SERONO INC$$44$YR$A$M$Y$67$KG$20240924$$MD$JP$JP
243570701$24357070$1$I$20240815$20240916$20240924$20240924$EXP$$AR-MYLANLABS-2024M1082069$MYLAN$$28$YR$$M$Y$$$20240924$$CN$AR$AR
243570711$24357071$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65207$$FDA-CTU$$91$YR$$M$N$$$20240923$N$$US$
243570721$24357072$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65201$$FDA-CTU$$50$YR$$F$N$62.14$KG$20240923$N$$US$
243570741$24357074$1$I$$20240916$20240924$20240924$EXP$$CN-MYLANLABS-2024M1086208$MYLAN$Li W, Fu Y, Wang W. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. Ann-Hematol 2024; 103 (8): 3207-3217.$66$YR$$F$Y$79.37$KG$20240924$$HP$CN$CN
243570751$24357075$1$I$$20240912$20240924$20240924$EXP$$US-MYLANLABS-2024M1084895$MYLAN$Viacava FM, Bandres MV, Mishkin A. A case of skin and soft tissue infection in a lung transplant recipient. Transpl-Infect-Dis 2024; 26 (1):.$65$YR$$M$Y$$$20240924$$HP$US$US
243570761$24357076$1$I$20200512$20240918$20240924$20240924$EXP$FR-AFSSAPS-NC2024001105$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-149363$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$61$KG$20240924$$MD$FR$FR
243570771$24357077$1$I$20240916$20240917$20240924$20240924$EXP$$CA-TAKEDA-2024TUS070364$TAKEDA$$75$YR$$F$Y$$$20240924$$CN$CA$CA
243570791$24357079$1$I$20240919$20240920$20240924$20240924$EXP$$US-ORGANON-O2409USA001691$ORGANON$$41$YR$$F$Y$114.29$KG$20240924$$MD$US$US
243570801$24357080$1$I$$20240919$20240924$20240924$EXP$$US-TAKEDA-2021TUS030427$TAKEDA$$$$$M$Y$68$KG$20240924$$HP$US$US
243570811$24357081$1$I$$20240916$20240924$20240924$EXP$$US-LUNDBECK-DKLU4004376$LUNDBECK$$$$$$Y$$$20240924$$HP$US$US
243570821$24357082$1$I$20240801$20240912$20240924$20240924$EXP$$US-UCBSA-2024047590$UCB$$65$YR$$M$Y$$$20240924$$HP$US$US
243570831$24357083$1$I$20221031$20240920$20240924$20240924$EXP$$CA-TAKEDA-2024TUS094437$TAKEDA$$46$YR$$F$Y$$$20240924$$MD$CA$CA
243570841$24357084$1$I$20230101$20231018$20240924$20240924$PER$$US-CELLTRION INC.-2023US017555$CELLTRION$$$$$$Y$$$20240924$$MD$US$US
243570851$24357085$1$I$$20240815$20240924$20240924$EXP$$US-TEVA-VS-3245000$TEVA$$54$YR$$M$Y$$$20240924$$PH$US$US
243570861$24357086$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65171$$FDA-CTU$$79$YR$$M$N$$$20240923$N$$US$
243570871$24357087$1$I$20240919$20240923$20240924$20240924$EXP$$CN-BAYER-2024A135695$BAYER$$61$YR$A$M$Y$57.9$KG$20240924$$HP$CN$CN
243570881$24357088$1$I$20240901$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65164$$FDA-CTU$$83$YR$$M$N$$$20240923$N$PH$US$
243570891$24357089$1$I$$20231020$20240924$20240924$PER$$US-CELLTRION INC.-2023US018113$CELLTRION$$$$$$Y$$$20240924$$MD$US$US
243570902$24357090$2$F$$20240923$20240924$20240925$PER$$NVSC2024US189641$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
243570911$24357091$1$I$20240804$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65168$$FDA-CTU$$66$YR$$M$N$$$20240923$N$$US$
243570921$24357092$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65177$$FDA-CTU$$$$$F$N$$$20240923$N$HP$US$
243570931$24357093$1$I$20240920$20240923$20240923$20240923$DIR$719524$$FDA-CTU$$82$YR$$M$N$$$20240923$Y$PH$US$
243570941$24357094$1$I$20240716$20240923$20240924$20240924$EXP$GB-MHRA-MED-202409230929473980-TRJFN$GB-SANDOZ INC.-SDZ2024GB082357$SANDOZ$$24$YR$$M$Y$$$20240924$$MD$GB$GB
243570951$24357095$1$I$20240101$20240917$20240924$20240924$EXP$FR-AFSSAPS-LL2024001720$FR-TEVA-VS-3244624$TEVA$$33$YR$$M$Y$$$20240924$$MD$FR$FR
243570961$24357096$1$I$$20240918$20240924$20240924$PER$$US-ROCHE-10000086132$ROCHE$$$$$M$Y$$$20240924$$CN$US$US
243570971$24357097$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65161$$FDA-CTU$$27$YR$$M$N$$$20240923$N$$US$
243570981$24357098$1$I$20240903$20240918$20240924$20240924$EXP$$GB-BEH-2024178325$CSL BEHRING$$73$YR$E$M$Y$$$20240924$$CN$GB$GB
243570991$24357099$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65184$$FDA-CTU$$57$YR$$F$N$128.37$KG$20240923$N$$US$
243571001$24357100$1$I$$20240916$20240924$20240924$EXP$$CH-TEVA-VS-3245073$TEVA$Zwimpfer TA, Scherer K, Schotzau A, Heinzelmann-Schwarz V, Hartmann K, Vetter M, et al. Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers. Cancer-Med 2024; 13 (1): e6840.; Zwimpfer TA, Scherer K, Schotzau A, Heinzelmann-Schwarz V, Hartmann K, Vetter M, et al. Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers. Cancer-Med 2024; 13 (1): e6840.$$$$F$Y$$$20240924$$HP$CH$CH
243571011$24357101$1$I$$20240909$20240924$20240924$EXP$PL-EMA-DD-20240903-7482689-182719$PL-SERVIER-S24011329$SERVIER$Gawle-Krawczyk K, Stanczak-Bujnicka E, Matysiak M. Posterior reversible encephalopathy syndrome in a boy undergoing therapy for acute lymphoblastic leukaemia. Pediatria Polska. 2016;91:168-71$$$$$Y$$$20240924$$HP$PL$PL
243571021$24357102$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65213$$FDA-CTU$$81$YR$$F$N$0$KG$20240923$N$HP$US$
243571031$24357103$1$I$$20240916$20240924$20240924$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-2024-150274$BRISTOL MYERS SQUIBB$Kudu E, Akdag G, Yildirim ME. Evaluation of emergency department visits and immune-related adverse effects (irAEs) in patients treated with nivolumab. Supportive Care in Cancer. 2024 Sep 09;32(10):1-9. doi:10.1007/s00520-024-08856-x.$66$YR$E$F$Y$$$20240924$$MD$TR$TR
243571041$24357104$1$I$20240921$20240923$20240924$20240924$EXP$$CN-BAYER-2024A135755$BAYER$$53$YR$A$M$Y$60$KG$20240924$$HP$CN$CN
243571051$24357105$1$I$20240919$20240922$20240923$20240923$DIR$FDA-CDER-CTU-2024-65195$$FDA-CTU$$30$YR$$M$N$$$20240922$N$HP$US$
243571061$24357106$1$I$$20240920$20240924$20240924$PER$$US-BAYER-2024A125882$BAYER$$20$YR$A$F$Y$$$20240924$$HP$US$US
243571071$24357107$1$I$$20240916$20240924$20240924$EXP$$GR-SA-2024SA275129$SANOFI AVENTIS$Kofopoulos E.. RARE GASTROINTESTINAL ANASTOMOTIC LEAKAGE COMPLICATION AFTER RECEIVING CHEMOTHERAPY.. 33rd PANHELLENIC SURGICAL CONGRESS AND INTERNATIONAL SURGICAL FORUM. 2023;470:Unknown$67$YR$E$F$Y$$$20240924$$MD$GR$GR
243571081$24357108$1$I$20240903$20240923$20240923$20240923$DIR$719481$$FDA-CTU$$65$YR$$M$N$87.6$KG$20240923$N$PH$US$
243571091$24357109$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65199$$FDA-CTU$$74$YR$$F$N$62.6$KG$20240923$N$$US$
243571101$24357110$1$I$20240917$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65198$$FDA-CTU$$48$YR$$F$N$$$20240923$N$CN$US$
243571111$24357111$1$I$20231201$20240916$20240924$20240924$PER$$US-GSK-US2024114822$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240924$$CN$US$US
243571131$24357113$1$I$$20240919$20240924$20240924$PER$$US-BAYER-2024A134203$BAYER$$$$E$M$Y$$$20240924$$CN$US$US
243571141$24357114$1$I$$20240912$20240924$20240924$EXP$$CA-APOTEX-2024AP010650$APOTEX$$88$YR$$M$Y$$$20240924$$PH$CA$CA
243571151$24357115$1$I$$20240909$20240924$20240924$30DAY$$JP-JNJFOC-20240944744$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$HP$JP$JP
243571161$24357116$1$I$$20240909$20240924$20240924$30DAY$$JP-JNJFOC-20240944578$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$PH$JP$JP
243571181$24357118$1$I$$20240914$20240924$20240924$EXP$$US-ASTELLAS-2024-AER-007008$ASTELLAS$$$$E$M$Y$$$20240924$$MD$US$US
243571211$24357121$1$I$20240912$20240913$20240924$20240924$30DAY$$IT-UCBSA-2024048981$UCB$$$$$$Y$$$20240924$$PH$IT$IT
243571221$24357122$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189929$NOVARTIS$$$$$$Y$$$20240924$$HP$US$US
243571231$24357123$1$I$$20240920$20240924$20240924$PER$$US-BIOVITRUM-2024-US-012360$BIOVITRUM$$75$YR$$M$Y$$$20240924$$CN$US$US
243571241$24357124$1$I$$20240918$20240924$20240924$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015583$JAZZ$$$$$M$Y$$$20240924$$CN$US$US
243571251$24357125$1$I$$20240919$20240924$20240924$PER$$US-BAYER-2024A134214$BAYER$$40$YR$A$F$Y$$$20240924$$MD$US$US
243571271$24357127$1$I$20240909$20240923$20240924$20240924$EXP$$CN-BAYER-2024A135770$BAYER$$50$YR$A$F$Y$65$KG$20240924$$HP$CN$CN
243571281$24357128$1$I$20240812$20240913$20240924$20240924$EXP$$US-BEH-2024178771$CSL BEHRING$$80$YR$E$F$Y$$$20240924$$HP$US$US
243571291$24357129$1$I$20240911$20240919$20240924$20240924$EXP$$CN-SA-2024SA274718$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240924$$HP$CN$CN
243571301$24357130$1$I$$20240911$20240924$20240924$EXP$$CA-ALCON LABORATORIES-ALC2023CA001482$ALCON$$71$YR$$F$Y$69$KG$20240924$$CN$COUNTRY NOT SPECIFIED$CA
243571311$24357131$1$I$20240801$20240913$20240924$20240924$EXP$$JP-UCBSA-2024048047$UCB$$5$DEC$$M$Y$130$KG$20240924$$HP$JP$JP
243571331$24357133$1$I$20240904$20240906$20240924$20240924$PER$$US-JNJFOC-20240916397$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240924$$CN$US$US
243571341$24357134$1$I$20231208$20240910$20240924$20240924$EXP$$GB-AMGEN-GBRSP2024188515$AMGEN$$70$YR$E$M$Y$73$KG$20240924$$HP$GB$GB
243571351$24357135$1$I$20240806$20240923$20240923$20240923$DIR$719533$$FDA-CTU$$62$YR$$M$N$78$KG$20240923$N$MD$US$
243571381$24357138$1$I$$20240918$20240924$20240924$EXP$$ZA-ROCHE-10000086969$ROCHE$$$$E$M$Y$$$20240924$$MD$ZA$ZA
243571392$24357139$2$F$$20240923$20240924$20240926$PER$$US-ROCHE-10000088931$ROCHE$Liotta N, Derienzo V, Cardamone L. Adjunctive chemotherapy for the treatment of HLH: A case report from the intensive care unit. Chest. 2024;166 (4S):A2900-1. doi:10.1016/j.chest.2024.06.1751.$49$YR$A$F$Y$$$20240926$$HP$US$US
243571401$24357140$1$I$20240902$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65228$$FDA-CTU$$70$YR$$M$N$$$20240924$N$$US$
243571421$24357142$1$I$20240920$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188674$AMGEN$$71$YR$E$F$Y$$$20240924$$HP$US$US
243571431$24357143$1$I$20240917$20240917$20240924$20240924$EXP$$US-ASTELLAS-2024-AER-007591$ASTELLAS$$87$YR$E$M$Y$$$20240924$$CN$US$US
243571451$24357145$1$I$$20240920$20240924$20240924$EXP$$US-GILEAD-2024-0688181$GILEAD$$$$E$F$Y$$$20240924$$CN$US$US
243571461$24357146$1$I$$20240920$20240924$20240924$EXP$GB-MHRA-MED-202409190858508500-DQSTH$GB-LUNDBECK-DKLU4004438$LUNDBECK$$$$$$Y$$$20240924$$HP$GB$GB
243571471$24357147$1$I$20220101$20240912$20240924$20240924$EXP$$US-ROCHE-10000081642$ROCHE$$49$YR$A$M$Y$99.79$KG$20240924$$CN$US$US
243571481$24357148$1$I$20230401$20240917$20240924$20240924$EXP$$US-AMGEN-USASP2024186065$AMGEN$$53$YR$A$F$Y$$$20240924$$CN$US$US
243571511$24357151$1$I$$20240911$20240924$20240924$PER$$US-JNJFOC-20240935579$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243571521$24357152$1$I$$20240913$20240924$20240924$EXP$$US-MYLANLABS-2024M1085033$MYLAN$Purt B, Nugent A, Wu PS, Paulus YM. Sub-Tenon Triamcinolone and Anti-HIV Medication-Induced Cushing Syndrome. JAMA-Ophthalmol 2024;.$82$YR$$M$Y$$$20240924$$MD$US$US
243571531$24357153$1$I$20240101$20240919$20240924$20240924$PER$$US-BAYER-2024A134773$BAYER$$$$$F$Y$$$20240924$$CN$US$US
243571541$24357154$1$I$20240923$20240923$20240924$20240924$EXP$GB-MHRA-MED-202409230657427290-HPGML$GB-MYLANLABS-2024M1086270$MYLAN$$57$YR$$M$Y$80$KG$20240924$$MD$GB$GB
243571551$24357155$1$I$20240918$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013454$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240924$$CN$US$US
243571561$24357156$1$I$20240829$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012595$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243571571$24357157$1$I$20230101$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014526$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240924$$CN$US$US
243571581$24357158$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65232$$FDA-CTU$$$$$M$N$$$20240923$N$HP$US$
243571592$24357159$2$F$20240916$20240918$20240924$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409012401$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240926$$HP$US$US
243571601$24357160$1$I$$20240912$20240924$20240924$EXP$$US-UCBSA-2024047873$UCB$$$$$$Y$$$20240924$$CN$US$US
243571611$24357161$1$I$20240701$20240913$20240924$20240924$EXP$$US-UCBSA-2024047571$UCB$$21$YR$$F$Y$$$20240924$$CN$US$US
243571621$24357162$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65230$$FDA-CTU$$86$YR$$M$N$$$20240924$N$$US$
243571631$24357163$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65231$$FDA-CTU$$$$$M$N$$$20240923$N$HP$US$
243571641$24357164$1$I$20231201$20240918$20240924$20240924$EXP$$US-LUNDBECK-DKLU4004395$LUNDBECK$$$$$$Y$$$20240924$$CN$US$US
243571651$24357165$1$I$20240110$20240916$20240924$20240924$EXP$$FR-AUROBINDO-AUR-APL-2024-046100$AUROBINDO$$67$YR$$M$Y$$$20240924$$CN$FR$FR
243571661$24357166$1$I$$20240919$20240924$20240924$PER$$US-BAYER-2024A134777$BAYER$$$$$F$Y$$$20240924$$HP$US$US
243571671$24357167$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3245894$TEVA$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.; Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.$60$YR$$F$Y$$$20240924$$MD$US$US
243571681$24357168$1$I$$20240910$20240924$20240924$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08573$HIKMA$Mena S, Raj A, Caldwell W, Kaushal A.. Mena S, Raj A, Caldwell W, Kaushal A. The annoyance of singultus: a case report of a rare adverse effect after epidural steroid injection.. BMC anesthesiology. 2024;24(1):302.:1-27$49$YR$$M$Y$$$20240924$$MD$US$US
243571691$24357169$1$I$$20240913$20240924$20240924$EXP$$CN-ROCHE-10000005949$ROCHE$$71$YR$E$M$Y$$$20240924$$MD$CN$CN
243571701$24357170$1$I$$20240916$20240924$20240924$EXP$$CA-BAUSCH-BL-2024-013962$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240924$$CN$CA$CA
243571711$24357171$1$I$$20240920$20240924$20240924$PER$$US-BAUSCH-BL-2024-014203$BAUSCH AND LOMB$$$$$F$Y$$$20240924$$CN$US$US
243571722$24357172$2$F$$20240927$20240924$20240930$EXP$$AT-BAUSCH-BL-2024-014257$BAUSCH AND LOMB$$54$YR$$M$Y$$$20240930$$MD$AT$AT
243571731$24357173$1$I$$20240918$20240924$20240924$PER$$US-BAUSCH-BL-2024-014196$BAUSCH AND LOMB$$59$YR$$F$Y$$$20240924$$HP$US$US
243571741$24357174$1$I$20240101$20240919$20240924$20240924$PER$$US-BAUSCH-BL-2024-014157$BAUSCH AND LOMB$$$$$F$Y$$$20240924$$CN$US$US
243571751$24357175$1$I$20230901$20240912$20240924$20240924$EXP$$MX-ROCHE-10000083117$ROCHE$$29$YR$A$M$Y$69$KG$20240924$$CN$MX$MX
243571761$24357176$1$I$$20240917$20240924$20240924$EXP$$US-BAUSCH-BL-2024-014182$BAUSCH AND LOMB$$60$YR$$F$Y$$$20240924$$CN$US$US
243571771$24357177$1$I$$20240830$20240924$20240924$PER$$US-CELLTRION INC.-2023US016889$CELLTRION$$$$$$Y$$$20240924$$PH$US$US
243571781$24357178$1$I$20240627$20240917$20240924$20240924$EXP$$US-Vifor (International) Inc.-VIT-2024-08600$VIFOR$$62$YR$$M$Y$104.5$KG$20240924$$HP$US$US
243571791$24357179$1$I$20230115$20240922$20240924$20240924$EXP$$DE-BAUSCH-BL-2023-004627$BAUSCH AND LOMB$$75$YR$$M$Y$$$20240924$$HP$DE$DE
243571801$24357180$1$I$$20240918$20240924$20240924$PER$$US-BAUSCH-BL-2024-014198$BAUSCH AND LOMB$$78$YR$$M$Y$$$20240924$$CN$US$US
243571811$24357181$1$I$$20240923$20240924$20240924$EXP$$US-BAUSCH-BL-2024-014300$BAUSCH AND LOMB$$21$YR$$M$Y$$$20240924$$HP$US$US
243571821$24357182$1$I$20240910$20240916$20240924$20240924$EXP$$ZA-Vifor (International) Inc.-VIT-2024-08513$VIFOR$$69$YR$$M$Y$$$20240924$$HP$ZA$ZA
243571831$24357183$1$I$$20240923$20240924$20240924$EXP$$US-BAUSCH-BL-2024-014283$BAUSCH AND LOMB$$57$YR$$M$Y$$$20240924$$HP$US$US
243571842$24357184$2$F$$20240923$20240924$20240926$EXP$$US-BAUSCH-BL-2024-014294$BAUSCH AND LOMB$$68$YR$$F$Y$$$20240926$$CN$US$US
243571851$24357185$1$I$$20240916$20240924$20240924$EXP$$ZA-Vifor (International) Inc.-VIT-2024-08509$VIFOR$$$$E$M$Y$$$20240924$$HP$ZA$ZA
243571862$24357186$2$F$20240814$20240916$20240924$20240924$PER$$US-ROCHE-10000083954$ROCHE$$48$YR$A$M$Y$$$20240924$$CN$US$US
243571871$24357187$1$I$$20240920$20240924$20240924$PER$$US-BAYER-2024A134848$BAYER$$38$YR$A$F$Y$$$20240924$$MD$US$US
243571891$24357189$1$I$20240718$20240918$20240924$20240924$EXP$$SA-GILEAD-2024-0688120$GILEAD$$$$$F$Y$$$20240924$$MD$SA$SA
243571911$24357191$1$I$$20240914$20240924$20240924$EXP$$CN-009507513-2409CHN007698$MERCK$$94$YR$$F$Y$73.5$KG$20240924$$HP$CN$CN
243571921$24357192$1$I$20240401$20240830$20240924$20240924$PER$$US-009507513-2409USA007520$MERCK$$75$YR$$F$Y$$$20240924$$CN$US$US
243571931$24357193$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3245893$TEVA$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.; Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.$53$YR$$F$Y$$$20240924$$MD$US$US
243571941$24357194$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151071$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240924$$CN$US$US
243571951$24357195$1$I$$20240915$20240924$20240924$EXP$$AU-JNJFOC-20240947886$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$HP$AU$AU
243571961$24357196$1$I$$20240912$20240924$20240924$EXP$$CA-APOTEX-2024AP010674$APOTEX$$29$YR$$F$Y$$$20240924$$CN$CA$CA
243571981$24357198$1$I$20240910$20240917$20240924$20240924$EXP$$US-RDY-SPO/USA/24/0013818$DR REDDYS$$59$YR$A$F$Y$$$20240924$$PH$US$US
243571991$24357199$1$I$$20240917$20240924$20240924$EXP$$US-RDY-SPO/USA/24/0013809$DR REDDYS$$42$YR$A$$Y$$$20240924$$HP$US$US
243572002$24357200$2$F$$20240923$20240924$20240930$PER$$US-RDY-SPO/USA/24/0013805$DR REDDYS$$16$YR$T$M$Y$$$20240929$$HP$US$US
243572011$24357201$1$I$20240917$20240917$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013844$DR REDDYS$$59$YR$A$M$Y$$$20240924$$HP$US$US
243572021$24357202$1$I$$20240917$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013753$DR REDDYS$$47$YR$A$M$Y$$$20240924$$PH$US$US
243572031$24357203$1$I$20231025$20240917$20240924$20240924$EXP$$BE-TAKEDA-2024TUS094369$TAKEDA$$53$YR$$$Y$$$20240924$$MD$BE$BE
243572041$24357204$1$I$$20240920$20240924$20240924$PER$$US-BAYER-2024A134849$BAYER$$17$YR$T$F$Y$$$20240924$$MD$US$US
243572051$24357205$1$I$$20240917$20240924$20240924$EXP$$US-RDY-SPO/USA/24/0013824$DR REDDYS$$56$YR$A$F$Y$$$20240924$$HP$US$US
243572081$24357208$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65190$$FDA-CTU$$70$YR$$F$N$71.21$KG$20240923$N$$US$
243572121$24357212$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65238$$FDA-CTU$$26$YR$$F$N$$$20240924$N$HP$US$
243572131$24357213$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65236$$FDA-CTU$$64$YR$$M$N$$$20240924$N$$US$
243572141$24357214$1$I$$20240912$20240924$20240924$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08600$HIKMA$$$$$F$Y$$$20240924$$MD$US$US
243572152$24357215$2$F$$20240925$20240924$20240925$EXP$$US-PFIZER INC-PV202400122496$PFIZER$Gikandi, A.. Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest. Perfusion. 2024;1-4$67$YR$$M$Y$$$20240925$$HP$US$US
243572161$24357216$1$I$$20240923$20240924$20240924$EXP$$US-PFIZER INC-PV202400124132$PFIZER$Thompson, J.. THE CRISIS OF POLYAUTOIMMUNITY: ANTIGLOMERULAR BASEMENT MEMBRANE DISEASE COMPLICATED BY ANTIPHOSPHOLIPID SYNDROME. Chest. 2024;166(4 Suppl):A3102-A3103$26$YR$$F$Y$$$20240924$$HP$US$US
243572182$24357218$2$F$$20240923$20240924$20240926$EXP$$JP-PFIZER INC-202400261218$PFIZER$Tada, Y.. Usefulness of Sarilumab in Patients with Rheumatoid Arthritis after Regression of Lymphoproliferative Disorders. Case reports in rheumatology. 2023;10.1155/2023/5780733$76$YR$$M$Y$$$20240926$$MD$JP$JP
243572191$24357219$1$I$$20240919$20240924$20240924$EXP$$CN-PFIZER INC-PV202400123194$PFIZER$Fang, J.. A case report of adult-onset Still^s disease complicated with interstitial lung disease?. Clinical Education of General Practice. 2024;22(8):754-755$58$YR$$M$Y$$$20240924$$HP$CN$CN
243572201$24357220$1$I$$20240916$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2023US064715$SANDOZ$$$$E$F$Y$$$20240924$$CN$US$US
243572211$24357221$1$I$$20240920$20240924$20240924$PER$$US-BAYER-2024A134851$BAYER$$$$$$Y$$$20240924$$CN$US$US
243572221$24357222$1$I$$20240916$20240924$20240924$EXP$$GB-MYLANLABS-2024M1085670$MYLAN$Thapaliya S, Whiskey E, Firdosi M. Effective and safe use of intramuscular clozapine in a patient presenting with catatonia and thrombocytopenia. BMJ-Case-Rep 2024; 17 (8): 1-4.$5$DEC$$F$Y$$$20240924$$HP$GB$GB
243572231$24357223$1$I$20240919$20240919$20240924$20240924$EXP$$CO-ABBVIE-5935352$ABBVIE$$63$YR$$M$Y$50$KG$20240924$$HP$CO$CO
243572241$24357224$1$I$20240801$20240913$20240924$20240924$EXP$$US-UCBSA-2024047624$UCB$$29$YR$$F$Y$$$20240924$$HP$US$US
243572252$24357225$2$F$$20240916$20240924$20240924$PER$$US-ROCHE-10000083402$ROCHE$$$$C$M$Y$$$20240924$$CN$US$US
243572261$24357226$1$I$$20231109$20240924$20240924$PER$$US-CELLTRION INC.-2023US017375$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
243572271$24357227$1$I$20240911$20240912$20240924$20240924$EXP$$IE-ROCHE-10000080910$ROCHE$$$$$F$Y$$$20240924$$CN$IE$IE
243572281$24357228$1$I$$20240916$20240924$20240924$EXP$$CA-ROCHE-10000083361$ROCHE$$$$E$F$Y$$$20240924$$PH$CA$CA
243572291$24357229$1$I$$20240914$20240924$20240924$PER$$US-GSK-US2023129631$GLAXOSMITHKLINE$$$$E$F$Y$$$20240924$$CN$US$US
243572301$24357230$1$I$$20240917$20240924$20240924$EXP$$JP-TAKEDA-2024TUS094316$TAKEDA$$58$YR$$M$Y$$$20240924$$MD$JP$JP
243572311$24357231$1$I$$20240923$20240924$20240924$EXP$$US-GILEAD-2024-0688647$GILEAD$$73$YR$E$M$Y$$$20240924$$CN$US$US
243572321$24357232$1$I$$20240916$20240924$20240924$EXP$$CA-ROCHE-10000087125$ROCHE$$43$YR$A$M$Y$$$20240924$$MD$CA$CA
243572341$24357234$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150317$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240924$$CN$US$US
243572351$24357235$1$I$20240903$20240916$20240924$20240924$PER$$US-GSK-US2024114824$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240924$$CN$US$US
243572361$24357236$1$I$$20240913$20240924$20240924$EXP$$JP-UCBSA-2024047966$UCB$$$$$$Y$$$20240924$$PH$JP$JP
243572371$24357237$1$I$$20240920$20240924$20240924$PER$$US-BAYER-2024A134947$BAYER$$$$$F$Y$$$20240924$$CN$US$US
243572381$24357238$1$I$$20240919$20240924$20240924$EXP$$JP-JNJFOC-20240959212$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$JP$JP
243572391$24357239$1$I$$20240920$20240924$20240924$PER$$US-BAYER-2024A134952$BAYER$$$$$F$Y$$$20240924$$CN$US$US
243572411$24357241$1$I$$20240916$20240924$20240924$EXP$$GB-TEVA-VS-3244445$TEVA$$76$YR$$M$Y$74$KG$20240924$$PH$GB$GB
243572421$24357242$1$I$20240901$20240916$20240924$20240924$EXP$$GB-TEVA-VS-3244369$TEVA$$$$E$M$Y$$$20240924$$CN$GB$GB
243572431$24357243$1$I$20240701$20240913$20240924$20240924$EXP$$SG-ROCHE-10000082963$ROCHE$$62$YR$A$F$Y$$$20240924$$CN$SG$SG
243572442$24357244$2$F$$20240917$20240924$20240924$EXP$$US-ROCHE-10000084662$ROCHE$$$$A$M$Y$$$20240924$$CN$US$US
243572461$24357246$1$I$$20231110$20240924$20240924$PER$$US-CELLTRION INC.-2023US018272$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
243572471$24357247$1$I$20240919$20240919$20240924$20240924$EXP$$US-JNJFOC-20240954657$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240924$$MD$US$US
243572481$24357248$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5932366$ABBVIE$$67$YR$$M$Y$$$20240924$$MD$US$US
243572501$24357250$1$I$20240807$20240808$20240924$20240924$PER$$US-LUNDBECK-DKLU4002853$LUNDBECK$$$$$$Y$$$20240924$$CN$US$US
243572511$24357251$1$I$$20240923$20240924$20240924$PER$$US-GILEAD-2024-0688680$GILEAD$$70$YR$E$M$Y$$$20240924$$HP$US$US
243572531$24357253$1$I$20231105$20240918$20240924$20240924$EXP$$NVSC2023US259738$NOVARTIS$$80$YR$$F$Y$$$20240924$$CN$US$US
243572552$24357255$2$F$$20240916$20240924$20240926$EXP$$NVSC2021AU287700$NOVARTIS$Ennis S, Plit M, Malouf M. Epstein-barr virus associated smoothmuscle neoplasm postlung transplantation. TRANSPLANT INFECTIOUS DISEASE. 2021;1-2$43$YR$$F$Y$$$20240926$$HP$AU$AU
243572561$24357256$1$I$$20240920$20240924$20240924$PER$$NVSC2024US189799$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243572571$24357257$1$I$20220101$20240912$20240924$20240924$EXP$$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-08755$HIKMA$S. Sorella, G. MA, Gianna MD, Giorgia A, Matteo T, Renata C, Leonardo B, Fabio P, M. M, I. DG. S. S, G. MA, Gianna MD, Giorgia A, Matteo T, Renata C, et al. A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD, Leukemia and Lymphoma.. Leukemia + Lymphoma. 2024;27:1-8pgs$71$YR$$M$Y$$$20240924$$MD$IT$IT
243572581$24357258$1$I$$20240808$20240924$20240924$PER$$US-LUNDBECK-DKLU4002854$LUNDBECK$$$$$$Y$$$20240924$$CN$US$US
243572621$24357262$1$I$20240922$20240923$20240923$20240923$DIR$719572$$FDA-CTU$$68$YR$$M$N$96.75$KG$20240923$N$CN$US$
243572631$24357263$1$I$$20240919$20240924$20240924$EXP$$JP-009507513-2409JPN003039J$MERCK$$10$DEC$$$Y$$$20240924$$MD$JP$JP
243572641$24357264$1$I$$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188857$AMGEN$$$$$$Y$$$20240924$$MD$US$US
243572651$24357265$1$I$$20240923$20240923$20240923$DIR$719529$$FDA-CTU$$66$YR$$F$N$75.6$KG$20240923$N$HP$US$
243572691$24357269$1$I$20240201$20240920$20240924$20240924$EXP$$NVSC2024IE188717$NOVARTIS$$55$YR$$F$Y$$$20240924$$HP$IE$IE
243572711$24357271$1$I$$20240920$20240924$20240924$EXP$$NVSC2024BR189468$NOVARTIS$$2$YR$$$Y$$$20240924$$MD$BR$BR
243572721$24357272$1$I$20240918$20240918$20240924$20240924$PER$$US-JNJFOC-20240955664$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240924$$HP$US$US
243572731$24357273$1$I$$20240918$20240924$20240924$PER$$US-BAYER-2024A133861$BAYER$$92$YR$E$M$Y$$$20240924$$CN$US$US
243572741$24357274$1$I$$20240912$20240924$20240924$EXP$$US-FARMAPROD-202409-3268$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240924$$CN$US$US
243572751$24357275$1$I$$20240919$20240924$20240924$EXP$$NL-MYLANLABS-2024M1086157$MYLAN$Brouwer M, Offermans M, van Nuil L, Poukens A, van Oijen B, Dormans T. Effective extracorporeal treatment of metformin-associated lactic acidosis using continuous venovenous hemodiafiltration. Eur-J-Case-Rep-Intern-Med 2024; 11 (9).$57$YR$$F$Y$$$20240924$$HP$NL$NL
243572761$24357276$1$I$20220901$20240918$20240924$20240924$EXP$$ES-MYLANLABS-2024M1085873$MYLAN$$77$YR$$F$Y$77$KG$20240924$$MD$ES$ES
243572771$24357277$1$I$20240821$20240918$20240924$20240924$EXP$FR-AFSSAPS-AVCF2024000582$FR-MYLANLABS-2024M1085155$MYLAN$$19$YR$$F$Y$$$20240924$$HP$FR$FR
243572781$24357278$1$I$$20240909$20240924$20240924$EXP$$CA-ROCHE-10000088386$ROCHE$$65$YR$E$F$Y$34$KG$20240924$$HP$CA$CA
243572791$24357279$1$I$$20240919$20240924$20240924$EXP$$IT-MYLANLABS-2024M1086201$MYLAN$Levi V, Stanziano M, Pinto C, Zibordi F, Fedeli D, Caldiera V, et al. Bilateral Simultaneous Magnetic Resonance-Guided Focused Ultrasound Pallidotomy for Life-Threatening Status Dystonicus. Mov-Disord 2024; 39 (8): 1408-1412.$6$YR$$M$Y$$$20240924$$MD$IT$IT
243572812$24357281$2$F$$20240916$20240924$20240926$EXP$$GB-ROCHE-RCA4853502$ROCHE$$$$E$F$Y$$$20240926$$CN$GB$GB
243572821$24357282$1$I$20210101$20240916$20240924$20240924$EXP$$NVSC2024US187278$NOVARTIS$Rustom DS, Wall BM, Talwar M. Malakoplakia in kidney transplant causing severe hydronephrosis and successful treatment with antibiotics and lowering immunosuppression. TRANSPLANT INFECTIOUS DISEASE. 2023;25 (e14158):1-3$55$YR$$M$Y$$$20240924$$HP$US$US
243572831$24357283$1$I$20230101$20240918$20240924$20240924$EXP$$NVSC2023IN264555$NOVARTIS$$$$$F$Y$$$20240924$$CN$IN$IN
243572851$24357285$1$I$20240101$20240808$20240924$20240924$PER$$US-TEVA-VS-3244771$TEVA$$70$YR$$F$Y$$$20240924$$CN$US$US
243572861$24357286$1$I$20240819$20240912$20240924$20240924$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08664$HIKMA$$76$YR$$M$Y$$$20240924$$HP$US$US
243572871$24357287$1$I$20240921$20240923$20240923$20240923$DIR$719559$$FDA-CTU$$25$YR$$F$N$$$20240923$N$CN$US$
243572881$24357288$1$I$20220812$20240503$20240924$20240924$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-06574$HIKMA$Patel EJ, Ahmad M, Schwartz BS, van Zante A, Kersten R, Loftus P.. Patel EJ, Ahmad M, Schwartz BS, van Zante A, Kersten R, Loftus P. Invasive Fungal Sinusitis in an Immunocompetent Patient After Sinus Surgery for Chronic Rhinosinusitis with Nasal Polyps and a Mycetoma. Laryngoscope. Laryngoscope. 2024;1-4$38$YR$$F$Y$$$20240924$$MD$US$US
243572902$24357290$2$F$20240918$20240924$20240924$20240925$PER$$US-AMGEN-USASP2024189278$AMGEN$$75$YR$E$F$Y$$$20240925$$CN$US$US
243572911$24357291$1$I$$20240911$20240924$20240924$PER$$US-JNJFOC-20240931271$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243572921$24357292$1$I$$20240920$20240924$20240924$PER$$US-BAYER-2024A134862$BAYER$$77$YR$E$M$Y$$$20240924$$CN$US$US
243572931$24357293$1$I$20240702$20240920$20240924$20240924$EXP$$US-DSJP-DSU-2024-130700$DAIICHI$$52$YR$$F$Y$$$20240924$$MD$US$US
243572942$24357294$2$F$20240801$20240924$20240924$20240928$EXP$$US-ABBVIE-5931556$ABBVIE$$70$YR$$M$Y$59$KG$20240928$$CN$US$US
243572951$24357295$1$I$$20240912$20240924$20240924$EXP$$CH-JNJFOC-A-CH2009-28304$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240924$$MD$CH$CH
243572962$24357296$2$F$$20240922$20240924$20240927$PER$$US-ROCHE-10000087507$ROCHE$$50$YR$A$F$Y$$$20240927$$CN$US$US
243572971$24357297$1$I$$20240911$20240924$20240924$EXP$$CA-APOTEX-2024AP010576$APOTEX$$$$$F$Y$$$20240924$$CN$CA$CA
243572981$24357298$1$I$$20240918$20240924$20240924$EXP$$JP-GILEAD-2024-0688153$GILEAD$$$$$M$Y$$$20240924$$MD$JP$JP
243572991$24357299$1$I$$20240922$20240924$20240924$PER$$US-ABBVIE-5934913$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243573001$24357300$1$I$20240101$20240910$20240924$20240924$EXP$$US-UCBSA-2024046567$UCB$$$$$F$Y$$$20240924$$CN$US$US
243573011$24357301$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3245895$TEVA$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.; Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.$20$YR$$F$Y$$$20240924$$MD$US$US
243573021$24357302$1$I$20230105$20240920$20240924$20240924$EXP$FR-AFSSAPS-AN2023000052$FR-ABBVIE-2303762US$ABBVIE$$59$YR$$F$Y$$$20240924$$PH$FR$FR
243573032$24357303$2$F$20240906$20240925$20240924$20240926$EXP$$US-ABBVIE-5933364$ABBVIE$$83$YR$$M$Y$$$20240926$$CN$US$US
243573041$24357304$1$I$$20240920$20240924$20240924$PER$$US-BAYER-2024A134868$BAYER$$$$$$Y$$$20240924$$CN$US$US
243573051$24357305$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3245984$TEVA$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.; Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.$61$YR$$M$Y$$$20240924$$MD$US$US
243573081$24357308$1$I$$20240910$20240924$20240924$EXP$$GB-CIPLA LTD.-2024GB10041$CIPLA$$$$$$Y$$$20240924$$HP$GB$GB
243573091$24357309$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024187566$AMGEN$$$$$$Y$$$20240924$$PH$US$US
243573101$24357310$1$I$$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024187992$AMGEN$$$$A$$Y$$$20240924$$CN$US$US
243573111$24357311$1$I$$20240910$20240924$20240924$EXP$$GB-CIPLA LTD.-2024GB10061$CIPLA$$$$$$Y$$$20240924$$HP$GB$GB
243573121$24357312$1$I$$20240917$20240924$20240924$EXP$$NVSC2024US186806$NOVARTIS$$$$$M$Y$$$20240924$$PH$US$US
243573131$24357313$1$I$20240516$20240917$20240924$20240924$EXP$FR-AFSSAPS-AN2024001251$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-08783$HIKMA$$71$YR$$M$Y$64$KG$20240924$$PH$FR$FR
243573141$24357314$1$I$20240101$20240920$20240924$20240924$PER$$US-BIOGEN-2024BI01262832$BIOGEN$$$$$F$Y$$$20240924$$CN$US$US
243573151$24357315$1$I$$20240922$20240924$20240924$PER$$US-BAYER-2024A135721$BAYER$$$$$F$Y$$$20240924$$CN$US$US
243573161$24357316$1$I$20240922$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150866$BRISTOL MYERS SQUIBB$$$$A$F$Y$$$20240924$$CN$US$US
243573171$24357317$1$I$$20240808$20240924$20240924$PER$$US-LUNDBECK-DKLU4002856$LUNDBECK$$$$$$Y$$$20240924$$CN$US$US
243573182$24357318$2$F$20240801$20240918$20240924$20240925$EXP$$US-009507513-2408USA003906$MERCK$$58$YR$$M$Y$$$20240925$$HP$US$US
243573191$24357319$1$I$$20240910$20240924$20240924$EXP$$CA-UCBSA-2024046858$UCB$$$$$F$Y$$$20240924$$CN$CA$CA
243573201$24357320$1$I$$20240910$20240924$20240924$EXP$$US-CIPLA LTD.-2024US10328$CIPLA$Au-Yeung NM, Regennitter NS, Stepherson J, Seele J, Rosenblatt E, Carter W.. Folate deficiency and medication-induced severe pancytopenia in a bilateral lung transplantee. Cureus. 2024;16(7):e65780$$$$$Y$$$20240924$$MD$US$US
243573211$24357321$1$I$20240101$20240918$20240924$20240924$EXP$SE-SEMPA-2024-006607$SE-TEVA-VS-3245004$TEVA$$64$YR$$M$Y$$$20240924$$MD$SE$SE
243573221$24357322$1$I$$20240913$20240924$20240924$EXP$$US-BEH-2024178980$CSL BEHRING$$$$$F$Y$$$20240924$$MD$US$US
243573231$24357323$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5932277$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243573241$24357324$1$I$$20240912$20240924$20240924$EXP$$US-CIPLA LTD.-2024US10333$CIPLA$Barkhordarian M, Grijalva M, Lee A, Jarri A, Belyayeva A, Weissman S.. Statin-induced autoimmune myopathy: A diagnostic challenge in muscle weakness. American Journal of Case Reports. 2024;25:e944261$$$$$Y$$$20240924$$MD$US$US
243573261$24357326$1$I$$20240917$20240924$20240924$EXP$$SI-JNJFOC-20240958857$JOHNSON AND JOHNSON$$22$YR$A$F$Y$$$20240924$$MD$SI$SI
243573271$24357327$1$I$20030711$20240912$20240924$20240924$EXP$$IE-JNJFOC-A-CH2003-03900$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20240924$$PH$IE$IE
243573291$24357329$1$I$20240923$20240923$20240923$20240923$DIR$719541$$FDA-CTU$$36$YR$$F$N$128.02$KG$20240923$N$CN$US$
243573301$24357330$1$I$20240924$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65242$$FDA-CTU$$64$YR$$$N$63.6$KG$20240924$N$PH$US$
243573311$24357331$1$I$20240801$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65243$$FDA-CTU$$56$YR$$F$N$92.3$KG$20240923$N$PH$US$
243573321$24357332$1$I$20240919$20240923$20240923$20240923$DIR$719532$$FDA-CTU$$54$YR$$F$N$$$20240923$N$HP$US$
243573351$24357335$1$I$20240801$20240923$20240923$20240923$DIR$719566$$FDA-CTU$$41$YR$$F$N$52.2$KG$20240923$N$CN$US$
243573381$24357338$1$I$20240923$20240923$20240923$20240923$DIR$719517$$FDA-CTU$$$$$UNK$N$$$20240923$N$CN$US$
243573401$24357340$1$I$$20240910$20240924$20240924$EXP$$GB-CIPLA LTD.-2024GB10034$CIPLA$$$$$$Y$$$20240924$$HP$GB$GB
243573412$24357341$2$F$$20240923$20240924$20240925$PER$$NVSC2024US189954$NOVARTIS$$35$YR$$F$Y$$$20240925$$HP$US$US
243573421$24357342$1$I$20240910$20240910$20240924$20240924$EXP$$CA-UCBSA-2024046884$UCB$$57$YR$$M$Y$$$20240924$$CN$CA$CA
243573431$24357343$1$I$$20240920$20240924$20240924$PER$$US-BAYER-2024A135261$BAYER$$81$YR$E$M$Y$$$20240924$$CN$US$US
243573441$24357344$1$I$20240101$20240906$20240924$20240924$EXP$$TW-SA-2024SA273639$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240924$$CN$TW$TW
243573451$24357345$1$I$$20240917$20240924$20240924$EXP$$CO-TAKEDA-2024TUS012205$TAKEDA$$$$$F$Y$45.6$KG$20240924$$HP$CO$CO
243573461$24357346$1$I$$20240923$20240924$20240924$PER$$US-BAYER-2024A135541$BAYER$$22$YR$A$F$Y$$$20240924$$HP$US$US
243573472$24357347$2$F$20240101$20240919$20240924$20240926$EXP$$ES-ABBVIE-5930930$ABBVIE$$$$$M$Y$$$20240926$$CN$ES$ES
243573481$24357348$1$I$20240923$20240923$20240923$20240923$DIR$719469$$FDA-CTU$$58$YR$$M$N$$$20240923$N$$US$
243573491$24357349$1$I$$20240917$20240924$20240924$EXP$$IN-ROCHE-10000085435$ROCHE$$$$A$M$Y$$$20240924$$MD$IN$IN
243573501$24357350$1$I$20240902$20240923$20240923$20240923$DIR$719531$$FDA-CTU$$61$YR$$F$N$$$20240923$Y$HP$US$
243573511$24357351$1$I$20240228$20240919$20240924$20240924$EXP$GB-MHRA-MED-202409171124586580-FTHPR$GB-MYLANLABS-2024M1085764$MYLAN$$63$YR$$M$Y$99$KG$20240924$$PH$GB$GB
243573521$24357352$1$I$20240101$20240919$20240924$20240924$EXP$$GB-MYLANLABS-2024M1085814$MYLAN$$$$$F$Y$$$20240924$$CN$GB$GB
243573531$24357353$1$I$$20240919$20240924$20240924$EXP$$AU-MYLANLABS-2024M1085774$MYLAN$$79$YR$$M$Y$$$20240924$$HP$AU$AU
243573541$24357354$1$I$$20240919$20240924$20240924$EXP$GB-MHRA-MED-202409171915049240-NJFRC$GB-MYLANLABS-2024M1085822$MYLAN$$$$E$M$Y$$$20240924$$CN$GB$GB
243573561$24357356$1$I$20221001$20240912$20240924$20240924$PER$$US-INCYTE CORPORATION-2024IN009657$INCYTE$$$$$$Y$$$20240924$$CN$US$US
243573571$24357357$1$I$$20240910$20240924$20240924$EXP$$US-SHIELD THERAPEUTICS-US-STX-24-00252$IRON THERAPEUTICS$$76$YR$$F$Y$$$20240924$$CN$US$US
243573581$24357358$1$I$20240910$20240919$20240924$20240924$EXP$GB-MHRA-MED-202409171003251260-HZLKY$GB-MYLANLABS-2024M1085786$MYLAN$$22$YR$$F$Y$69$KG$20240924$$CN$GB$GB
243573591$24357359$1$I$$20240919$20240924$20240924$EXP$$AT-MYLANLABS-2024M1085747$MYLAN$$$$$M$Y$$$20240924$$CN$AT$AT
243573601$24357360$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189863$NOVARTIS$$$$$$Y$$$20240924$$HP$US$US
243573611$24357361$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189948$NOVARTIS$$$$$M$Y$$$20240924$$MD$US$US
243573621$24357362$1$I$$20240916$20240924$20240924$EXP$$US-GSK-US2023042960$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$PH$US$US
243573631$24357363$1$I$$20240911$20240924$20240924$EXP$$US-SA-2024SA266728$SANOFI AVENTIS$$$$A$M$Y$$$20240924$$MD$US$US
243573643$24357364$3$F$20240923$20240925$20240924$20240926$PER$$US-AMGEN-USASP2024189574$AMGEN$$73$YR$E$F$Y$$$20240926$$CN$US$US
243573651$24357365$1$I$$20240920$20240924$20240924$PER$$US-BAYER-2024A135399$BAYER$$$$$$Y$$$20240924$$CN$US$US
243573661$24357366$1$I$$20240919$20240924$20240924$EXP$$US-LUNDBECK-DKLU4004436$LUNDBECK$$$$$$Y$$$20240924$$CN$US$US
243573671$24357367$1$I$20240701$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013964$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240924$$CN$US$US
243573702$24357370$2$F$20240901$20240923$20240924$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409013852$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240926$$CN$US$US
243573711$24357371$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014288$ELI LILLY AND CO$$$$$M$Y$$$20240924$$CN$US$US
243573731$24357373$1$I$20240701$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013382$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240924$$CN$US$US
243573741$24357374$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014222$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240924$$HP$US$US
243573751$24357375$1$I$$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012871$ELI LILLY AND CO$$50$YR$A$M$Y$$$20240924$$CN$US$US
243573761$24357376$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013436$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240924$$CN$US$US
243573771$24357377$1$I$$20240921$20240924$20240924$PER$$US-BAYER-2024A134846$BAYER$$$$$M$Y$$$20240924$$CN$US$US
243573781$24357378$1$I$$20240729$20240924$20240924$PER$$US-Lavipharm SA-2161984$LAVIPHARM$$$$$M$Y$$$20240924$$$US$US
243573791$24357379$1$I$20240101$20240917$20240924$20240924$EXP$$US-SA-2024SA274773$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240924$$MD$US$US
243573821$24357382$1$I$20240101$20240919$20240924$20240924$EXP$$US-SA-2024SA274425$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240924$$CN$US$US
243573831$24357383$1$I$20240101$20240920$20240924$20240924$EXP$$US-SA-2024SA274439$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240924$$MD$US$US
243573841$24357384$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3246305$TEVA$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.; Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug...$27$YR$$M$Y$$$20240924$$HP$US$US
243573861$24357386$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024188155$AMGEN$$$$$$Y$$$20240924$$CN$US$US
243573872$24357387$2$F$20240911$20240919$20240924$20240930$PER$$US-AMGEN-USASP2024187811$AMGEN$$59$YR$A$F$Y$$$20240929$$CN$US$US
243573881$24357388$1$I$20240818$20240923$20240923$20240923$DIR$719565$$FDA-CTU$$78$YR$$F$N$61.65$KG$20240923$N$CN$US$
243573891$24357389$1$I$20240922$20240923$20240923$20240923$DIR$719540$$FDA-CTU$$46$YR$$M$N$83.25$KG$20240923$$CN$US$
243573921$24357392$1$I$$20240923$20240923$20240923$DIR$719512$$FDA-CTU$$$$$UNK$N$$$20240923$$CN$US$
243573941$24357394$1$I$$20240913$20240924$20240924$PER$$US-TAKEDA-2024TUS093754$TAKEDA$$$$$$Y$$$20240924$$HP$US$US
243573951$24357395$1$I$$20240918$20240924$20240924$EXP$$US-TAKEDA-2024TUS093724$TAKEDA$$30$YR$$M$Y$$$20240924$$CN$US$US
243573961$24357396$1$I$$20240913$20240924$20240924$EXP$$US-MYLANLABS-2024M1085369$MYLAN$Harper KK, Mutch V, Safran JP, Wu D, Aggarwal N, Maheshwari E, et al. Leukemia cutis and anterior uveitis associated with chronic myelomonocytic leukemia. JAAD-Case-Rep 2024; 52 21-24.$76$YR$$F$Y$$$20240924$$HP$US$US
243573971$24357397$1$I$20220607$20240920$20240924$20240924$EXP$$CA-MYLANLABS-2024M1064877$MYLAN$$57$YR$$M$Y$118.4$KG$20240924$$HP$CA$CA
243573981$24357398$1$I$$20240922$20240924$20240924$PER$$US-BAYER-2024A135405$BAYER$$58$YR$A$M$Y$$$20240924$$HP$US$US
243573991$24357399$1$I$20230302$20240918$20240924$20240924$EXP$FR-AFSSAPS-CF2023000330$FR-TEVA-VS-3244916$TEVA$$80$YR$$F$Y$60$KG$20240924$$MD$FR$FR
243574001$24357400$1$I$$20240802$20240924$20240924$PER$$US-Lavipharm SA-2161985$LAVIPHARM$$$$$M$Y$$$20240924$$$US$US
243574011$24357401$1$I$20230901$20240918$20240924$20240924$EXP$$US-ABBVIE-5931047$ABBVIE$$72$YR$$M$Y$$$20240924$$CN$US$US
243574021$24357402$1$I$$20240920$20240924$20240924$EXP$$GB-ABBVIE-5935766$ABBVIE$$$$A$M$Y$$$20240924$$HP$GB$GB
243574041$24357404$1$I$20240624$20240917$20240924$20240924$EXP$$NL-ABBVIE-5502668$ABBVIE$$72$YR$$M$Y$$$20240924$$HP$NL$NL
243574052$24357405$2$F$20200116$20240930$20240924$20240930$EXP$$FI-CHEPLA-1500139242$CHEPLAPHARM$$31$YR$$M$Y$$$20240930$$PH$COUNTRY NOT SPECIFIED$FI
243574061$24357406$1$I$20240801$20240916$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147882$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240924$$CN$US$US
243574071$24357407$1$I$$20240917$20240924$20240924$EXP$$AU-CHEPLA-2024011937$CHEPLAPHARM$$38$YR$$F$Y$$$20240924$$HP$COUNTRY NOT SPECIFIED$AU
243574081$24357408$1$I$20240808$20240919$20240924$20240924$EXP$FR-AFSSAPS-RN2024000984$FR-CHEPLA-2024012046$CHEPLAPHARM$$58$YR$$F$Y$$$20240924$$MD$COUNTRY NOT SPECIFIED$FR
243574091$24357409$1$I$$20240916$20240924$20240924$EXP$$ES-TEVA-VS-3245930$TEVA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.; Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.$$$$$Y$$$20240924$$HP$ES$ES
243574101$24357410$1$I$20240518$20240923$20240924$20240924$PER$$US-BAYER-2024A135517$BAYER$$$$$M$Y$$$20240924$$MD$US$US
243574111$24357411$1$I$$20240916$20240924$20240924$EXP$$ES-TEVA-VS-3245916$TEVA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.; Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.$$$$$Y$$$20240924$$HP$ES$ES
243574121$24357412$1$I$20240824$20240916$20240924$20240924$EXP$FR-AFSSAPS-MP2024001357$FR-TEVA-VS-3244631$TEVA$$90$YR$$M$Y$60$KG$20240924$$PH$FR$FR
243574141$24357414$1$I$$20240911$20240924$20240924$EXP$$GB-ABBVIE-5934681$ABBVIE$Ibrahim H, Chean CS, Kalakonda AJM, Kwan J, Kumar P, Williams S, et al. Ibrutinib-related uveitis: a case series from two tertiary centres in the united kingdom. Ocular Immunology and Inflammation. 2024;1-6.$68$YR$$M$Y$$$20240924$$HP$GB$GB
243574151$24357415$1$I$$20240911$20240924$20240924$EXP$$GB-ABBVIE-5934657$ABBVIE$Ibrahim H, Chean CS, Kalakonda AJM, Kwan J, Kumar P, Williams S, et al. Ibrutinib-related uveitis: a case series from two tertiary centres in the united-kingdom. Ocular Immunology and Inflammation. 2024;1-6.$68$YR$$F$Y$$$20240924$$HP$GB$GB
243574161$24357416$1$I$$20240917$20240924$20240924$EXP$$CN-ROCHE-10000083509$ROCHE$Su Y, Su Y, Yu Y, Yan Z, Zhao Y, Lou J, et al. Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review. Diagnostic pathology. 2024-Sep-07;19 (1):1-10. doi:10.1186/s13000-024-01544-8.$45$YR$A$M$Y$$$20240924$$HP$CN$CN
243574171$24357417$1$I$20240806$20240923$20240924$20240924$EXP$$DE-ABBVIE-5934516$ABBVIE$$85$YR$$F$Y$$$20240924$$MD$DE$DE
243574181$24357418$1$I$$20240923$20240924$20240924$PER$$US-BAYER-2024A135621$BAYER$$$$$F$Y$$$20240924$$CN$US$US
243574191$24357419$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189922$NOVARTIS$$$$$M$Y$$$20240924$$HP$US$US
243574201$24357420$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189944$NOVARTIS$$$$$F$Y$53$KG$20240924$$CN$US$US
243574211$24357421$1$I$$20240919$20240924$20240924$EXP$$GB-MYLANLABS-2024M1083482$MYLAN$$$$$M$Y$$$20240924$$CN$GB$GB
243574221$24357422$1$I$$20240919$20240924$20240924$EXP$$GB-MYLANLABS-2024M1085712$MYLAN$$32$YR$$M$Y$46$KG$20240924$$CN$GB$GB
243574231$24357423$1$I$20240711$20240919$20240924$20240924$EXP$ES-AEMPS-1568908$ES-MYLANLABS-2024M1085443$MYLAN$$46$YR$$F$Y$$$20240924$$MD$ES$ES
243574241$24357424$1$I$20240910$20240923$20240924$20240924$PER$$US-BAYER-2024A135543$BAYER$$33$YR$A$F$Y$$$20240924$$MD$US$US
243574252$24357425$2$F$$20240919$20240924$20240930$EXP$$BA-MYLANLABS-2024M1085668$MYLAN$$69$YR$$M$Y$$$20240930$$MD$BA$BA
243574261$24357426$1$I$$20240923$20240924$20240924$PER$$US-BAYER-2024A135637$BAYER$$46$YR$A$F$Y$$$20240924$$CN$US$US
243574271$24357427$1$I$20240909$20240919$20240924$20240924$EXP$GB-MHRA-MED-202409181114112600-QNPRF$GB-MYLANLABS-2024M1085745$MYLAN$$$$$F$Y$$$20240924$$MD$GB$GB
243574281$24357428$1$I$20240919$20240919$20240924$20240924$EXP$$GB-MYLANLABS-2024M1085445$MYLAN$$57$YR$$F$Y$70$KG$20240924$$PH$GB$GB
243574291$24357429$1$I$$20240918$20240924$20240924$EXP$$DE-REGENERON PHARMACEUTICALS, INC.-2024-127774$REGENERON$$$$$$Y$$$20240924$$HP$DE$DE
243574301$24357430$1$I$$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024189548$AMGEN$$$$$$Y$$$20240924$$HP$US$US
243574311$24357431$1$I$20240823$20240923$20240924$20240924$PER$$US-BAYER-2024A135703$BAYER$$$$$F$Y$$$20240924$$CN$US$US
243574321$24357432$1$I$20240920$20240923$20240924$20240924$PER$$US-BAYER-2024A135573$BAYER$$37$YR$A$F$Y$$$20240924$$MD$US$US
243574331$24357433$1$I$20240918$20240919$20240924$20240924$EXP$$IL-BAYER-2024A135166$BAYER$$$$$M$Y$$$20240924$$HP$IL$IL
243574341$24357434$1$I$$20240923$20240923$20240923$DIR$719508$$FDA-CTU$$$$$UNK$N$$$20240923$N$CN$US$
243574351$24357435$1$I$20240923$20240924$20240924$20240924$DIR$719602$$FDA-CTU$$0$YR$$F$N$$$20240924$N$$US$
243574361$24357436$1$I$$20230828$20240924$20240924$PER$$US-CELLTRION INC.-2023US017207$CELLTRION$Polanco EG, Borowitz S. Delayed Hypersensitivity Reaction to Infliximab Due to Mammalian Meat Allergy. JPGN Reports. 2023;4:3(e322)$$$$$Y$$$20240924$$MD$US$US
243574371$24357437$1$I$$20240919$20240924$20240924$30DAY$$GB-PFIZER INC-PV202400122751$PFIZER$$16$YR$$M$Y$$$20240924$$CN$GB$GB
243574381$24357438$1$I$$20240917$20240924$20240924$30DAY$$GR-PFIZER INC-PV202400122129$PFIZER$$11$YR$$F$Y$28$KG$20240924$$CN$GR$GR
243574392$24357439$2$F$20240916$20240918$20240924$20240925$30DAY$$US-PFIZER INC-202400259630$PFIZER$$8$YR$$F$Y$$$20240925$$CN$US$US
243574401$24357440$1$I$$20240917$20240924$20240924$30DAY$$US-PFIZER INC-202400258461$PFIZER$$16$YR$$M$Y$$$20240924$$CN$US$US
243574412$24357441$2$F$20240901$20240920$20240924$20240925$30DAY$$US-PFIZER INC-202400259383$PFIZER$$12$YR$$F$Y$$$20240925$$CN$US$US
243574431$24357443$1$I$$20240912$20240924$20240924$30DAY$$CO-PFIZER INC-PV202400120560$PFIZER$$12$YR$$F$Y$$$20240924$$CN$CO$CO
243574441$24357444$1$I$20240902$20240913$20240924$20240924$EXP$$RU-BEH-2024178935$CSL BEHRING$$63$YR$A$F$Y$72$KG$20240924$$CN$RU$RU
243574451$24357445$1$I$20240916$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189653$AMGEN$$67$YR$E$F$Y$$$20240924$$HP$US$US
243574461$24357446$1$I$$20230913$20240924$20240924$PER$$US-CELLTRION INC.-2023US017998$CELLTRION$$$$$$Y$$$20240924$$MD$US$US
243574471$24357447$1$I$$20240919$20240924$20240924$EXP$$US-PFIZER INC-PV202400122855$PFIZER$Sood, S.. Segmental retinal arteritis in a case of presumed bilateral rifabutin-associated hypopyon uveitis. American Journal of Ophthalmology Case Reports. 2024;36:1-5$63$YR$$F$Y$62.3$KG$20240924$$HP$US$US
243574481$24357448$1$I$$20240918$20240924$20240924$30DAY$$US-PFIZER INC-202400259862$PFIZER$$16$YR$$M$Y$$$20240924$$CN$US$US
243574491$24357449$1$I$20240923$20240923$20240924$20240924$PER$$US-BAYER-2024A135719$BAYER$$88$YR$E$F$Y$$$20240924$$CN$US$US
243574501$24357450$1$I$20240423$20240911$20240924$20240924$EXP$ES-AEMPS-1567228$ES-GUERBET / LLC-ES-20240040$GUERBET$$33$YR$A$M$Y$$$20240924$$MD$ES$ES
243574511$24357451$1$I$$20240913$20240924$20240924$EXP$$ID-HQ SPECIALTY-ID-2024INT000086$INTERCHEM$Auerkari A, Sedona R.. Severe Neuropathic Back Pain as the Initial Presentation in Angiostrongylus cantonensis Infection: The Role of ICU Management in Overcoming Diagnostic and Analgosedation Challenges. 2024$$$$$Y$$$20240924$$MD$ID$ID
243574521$24357452$1$I$$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409131738386140-YDRGS$GB-TORRENT-00037974$TORRENT$$58$YR$A$M$Y$$$20240924$$HP$GB$GB
243574531$24357453$1$I$20240213$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409130956002900-GBVFD$GB-TORRENT-00037979$TORRENT$$4$YR$C$M$Y$$$20240924$$CN$GB$GB
243574551$24357455$1$I$$20240913$20240924$20240924$EXP$$IN-TORRENT-00003667$TORRENT$$70$YR$E$F$Y$$$20240924$$MD$IN$IN
243574581$24357458$1$I$20240909$20240923$20240923$20240923$DIR$719468$$FDA-CTU$$62$YR$$F$N$73.7$KG$20240923$N$PH$US$
243574601$24357460$1$I$$20240913$20240924$20240924$EXP$$US-TORRENT-00013753$TORRENT$$20$YR$A$F$Y$$$20240924$$MD$US$US
243574612$24357461$2$F$$20240925$20240924$20240927$EXP$GB-MHRA-MED-202409131322524410-MCGDB$GB-PERRIGO-24GB008624$PERRIGO$$$$$$Y$$$20240927$$PH$GB$GB
243574622$24357462$2$F$$20240925$20240924$20240927$EXP$GB-TAKEDA-2023TUS104891$GB-PERRIGO-24GB008625$PERRIGO$$$$E$M$Y$$$20240927$$HP$GB$GB
243574631$24357463$1$I$$20240913$20240924$20240924$EXP$$BE-PERRIGO-24BE008585$PERRIGO$Balthasar Y, Gheysens T, Loos C, de Picker L. Reversible Cerebral VasoconstrictionSyndrome: Case Study and the Role ofSubstance Use, COVID-19, and Psychotropic Drugs. PSYCHIATRY AND COVID-19. 2024;66(6):296-300$27$YR$$M$Y$$$20240924$$MD$BE$BE
243574661$24357466$1$I$20240703$20240918$20240924$20240924$EXP$FR-AFSSAPS-RN2024000978$FR-TEVA-VS-3245179$TEVA$$68$YR$$F$Y$$$20240924$$PH$FR$FR
243574671$24357467$1$I$20240823$20240916$20240924$20240924$EXP$$CA-REGENERON PHARMACEUTICALS, INC.-2024-127847$REGENERON$$$$$M$Y$$$20240924$$HP$CA$CA
243574681$24357468$1$I$$20240911$20240924$20240924$EXP$$GB-ADVANZ PHARMA-202409007528$ADVANZ PHARMA$$$$$$Y$$$20240924$$MD$GB$GB
243574691$24357469$1$I$$20240919$20240924$20240924$30DAY$$US-PFIZER INC-PV202400123127$PFIZER$$$$$$Y$$$20240924$$CN$US$US
243574711$24357471$1$I$$20240918$20240924$20240924$30DAY$$US-PFIZER INC-202400259895$PFIZER$$12$YR$$M$Y$$$20240924$$CN$US$US
243574721$24357472$1$I$$20240918$20240924$20240924$30DAY$$US-PFIZER INC-PV202400122609$PFIZER$$5$YR$$F$Y$13.61$KG$20240924$$CN$US$US
243574732$24357473$2$F$$20240919$20240924$20240925$30DAY$$US-PFIZER INC-202400260689$PFIZER$$13$YR$$M$Y$$$20240925$$CN$US$US
243574741$24357474$1$I$$20240918$20240924$20240924$30DAY$$FR-PFIZER INC-202400258935$PFIZER$$$$$$Y$$$20240924$$PH$FR$FR
243574751$24357475$1$I$20240923$20240923$20240923$20240923$DIR$719523$$FDA-CTU$$44$YR$$F$N$71$KG$20240923$N$CN$GB$
243574771$24357477$1$I$20240902$20240923$20240923$20240923$DIR$719556$$FDA-CTU$$54$YR$$F$N$49.5$KG$20240923$N$HP$US$
243574781$24357478$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013457$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240924$$CN$US$US
243574791$24357479$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013492$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240924$$CN$US$US
243574803$24357480$3$F$20240901$20240919$20240924$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409012909$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240930$$CN$US$US
243574811$24357481$1$I$20240921$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014295$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240924$$CN$US$US
243574821$24357482$1$I$20240911$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013626$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240924$$CN$US$US
243574831$24357483$1$I$20240913$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013688$ELI LILLY AND CO$$18$YR$A$F$Y$$$20240924$$CN$US$US
243574841$24357484$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014037$ELI LILLY AND CO$$$$A$F$Y$$$20240924$$CN$US$US
243574851$24357485$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013497$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243574861$24357486$1$I$$20240918$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011990$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240924$$CN$US$US
243574871$24357487$1$I$20240917$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013592$ELI LILLY AND CO$$25$YR$A$M$Y$$$20240924$$CN$US$US
243574881$24357488$1$I$20240301$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013708$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240924$$CN$US$US
243574891$24357489$1$I$20230521$20240916$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409010414$ELI LILLY AND CO$$43$YR$A$$Y$$$20240924$$CN$US$US
243574901$24357490$1$I$20240701$20240910$20240924$20240924$EXP$$GB-CARA THERAPEUTICS, INC.-2024-00424-GB$CARA THERAPEUTICS$$76$YR$$M$Y$$$20240924$$CN$GB$GB
243574911$24357491$1$I$20240912$20240923$20240924$20240924$PER$$US-BAYER-2024A135824$BAYER$$$$$F$Y$$$20240924$$HP$US$US
243574931$24357493$1$I$$20240913$20240924$20240924$PER$$US-TEVA-VS-3244347$TEVA$$45$YR$$$Y$$$20240924$$CN$US$US
243574942$24357494$2$F$20230527$20240916$20240924$20240926$EXP$ES-AEMPS-1375861$ES-CELLTRION INC.-2024ES022408$CELLTRION$$$$$$Y$$$20240926$$PH$ES$ES
243574951$24357495$1$I$$20240923$20240924$20240924$PER$$US-BAYER-2024A135763$BAYER$$$$$$Y$$$20240924$$CN$US$US
243574961$24357496$1$I$$20240828$20240924$20240924$PER$$US-009507513-2408USA010502$MERCK$$$$$M$Y$$$20240924$$CN$US$US
243574971$24357497$1$I$$20240917$20240924$20240924$PER$$US-ROCHE-10000084922$ROCHE$$$$E$M$Y$$$20240924$$MD$US$US
243574991$24357499$1$I$$20240923$20240924$20240924$PER$$US-BAYER-2024A135901$BAYER$$$$$F$Y$$$20240924$$HP$US$US
243575001$24357500$1$I$$20240905$20240924$20240924$30DAY$$CN-JNJFOC-20240939668$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$CN$CN
243575011$24357501$1$I$20240701$20240913$20240924$20240924$EXP$$US-JNJFOC-20240936188$JOHNSON AND JOHNSON$$57$YR$$F$Y$$$20240924$$CN$US$US
243575021$24357502$1$I$$20240921$20240924$20240924$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052704$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240924$$CN$DE$DE
243575031$24357503$1$I$20240901$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151241$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$55.8$KG$20240924$$HP$US$US
243575041$24357504$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150172$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240924$$CN$US$US
243575051$24357505$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150762$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240924$$HP$US$US
243575061$24357506$1$I$$20240917$20240924$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-149767$BRISTOL MYERS SQUIBB$$7$DEC$E$M$Y$$$20240924$$MD$JP$JP
243575071$24357507$1$I$20240801$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150557$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$HP$US$US
243575081$24357508$1$I$$20240919$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149518$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240924$$CN$US$US
243575091$24357509$1$I$$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150693$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$72$KG$20240924$$PH$US$US
243575111$24357511$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150562$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240924$$CN$US$US
243575121$24357512$1$I$20240701$20240923$20240924$20240924$EXP$SE-SEMPA-2024-006906$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-150847$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240924$$MD$SE$SE
243575131$24357513$1$I$20240901$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150480$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$70.31$KG$20240924$$CN$US$US
243575141$24357514$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150112$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240924$$HP$US$US
243575151$24357515$1$I$20240920$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151182$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$PH$US$US
243575161$24357516$1$I$$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150538$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$MD$US$US
243575181$24357518$1$I$$20240904$20240924$20240924$PER$$US-TEVA-VS-3240414$TEVA$$79$YR$$F$Y$44.444$KG$20240924$$PH$US$US
243575191$24357519$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3245986$TEVA$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.; Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.$69$YR$$M$Y$$$20240924$$MD$US$US
243575201$24357520$1$I$20240101$20240909$20240924$20240924$PER$$US-INSUD PHARMA-2409US07043$INSUD PHARMA$$$$$$Y$$$20240924$$CN$US$US
243575211$24357521$1$I$$20240909$20240924$20240924$PER$$US-INSUD PHARMA-2409US07040$INSUD PHARMA$$$$$$Y$$$20240924$$HP$US$US
243575221$24357522$1$I$$20240909$20240924$20240924$PER$$US-INSUD PHARMA-2409US07039$INSUD PHARMA$$$$$$Y$$$20240924$$CN$US$US
243575231$24357523$1$I$20240907$20240909$20240924$20240924$PER$$US-INSUD PHARMA-2409US07041$INSUD PHARMA$$$$$$Y$$$20240924$$CN$US$US
243575241$24357524$1$I$$20240923$20240924$20240924$PER$$US-BAYER-2024A135759$BAYER$$34$YR$A$M$Y$$$20240924$$CN$US$US
243575251$24357525$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3245987$TEVA$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.; Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.$32$YR$$F$Y$$$20240924$$MD$US$US
243575261$24357526$1$I$20240921$20240923$20240923$20240923$DIR$719550$$FDA-CTU$$62$YR$$F$N$54.4$KG$20240923$N$HP$US$
243575271$24357527$1$I$20240922$20240923$20240923$20240923$DIR$719527$$FDA-CTU$$39$YR$$F$N$18.9$KG$20240923$N$CN$US$
243575281$24357528$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65250$$FDA-CTU$$72$YR$$F$N$90.72$KG$20240924$N$$US$
243575311$24357531$1$I$20240919$20240923$20240923$20240923$DIR$719522$$FDA-CTU$$63$YR$$F$N$$$20240923$N$HP$US$
243575321$24357532$1$I$20240913$20240923$20240923$20240923$DIR$719459$$FDA-CTU$$62$YR$$F$N$58.5$KG$20240923$N$CN$US$
243575341$24357534$1$I$20240101$20240913$20240924$20240924$EXP$FR-AFSSAPS-LL2024001720$FR-BAXTER-2024BAX024670$BAXTER$$33$YR$$M$Y$$$20240924$$MD$FR$FR
243575351$24357535$1$I$20240623$20240923$20240924$20240924$PER$$US-BAYER-2024A135783$BAYER$$$$$F$Y$$$20240924$$MD$US$US
243575361$24357536$1$I$20240910$20240910$20240924$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-147437$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240924$$CN$JP$JP
243575371$24357537$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151328$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240924$$MD$US$US
243575381$24357538$1$I$$20240910$20240924$20240924$EXP$$NVSC2024IN185312$NOVARTIS$$$$$M$Y$$$20240924$$CN$IN$IN
243575391$24357539$1$I$$20240911$20240924$20240924$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240900123$UPSHER SMITH LABORATORIES$$$$$F$Y$56.689$KG$20240924$$MD$US$US
243575401$24357540$1$I$20240901$20240916$20240924$20240924$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006525$AURINIA PHARMACEUTICALS$$46$YR$$F$Y$$$20240924$$CN$US$US
243575411$24357541$1$I$$20240826$20240924$20240924$EXP$$BR-INCYTE CORPORATION-2024IN010062$INCYTE$$$$$$Y$$$20240924$$MD$BR$BR
243575421$24357542$1$I$20240418$20240923$20240924$20240924$PER$$US-BAYER-2024A135860$BAYER$$$$$M$Y$$$20240924$$MD$US$US
243575451$24357545$1$I$$20240913$20240924$20240924$PER$$US-TAKEDA-2024TUS092815$TAKEDA$$$$$F$Y$$$20240924$$CN$US$US
243575461$24357546$1$I$20240101$20240910$20240924$20240924$EXP$$CA-UCBSA-2024047167$UCB$$$$$F$Y$$$20240924$$CN$CA$CA
243575471$24357547$1$I$$20240919$20240924$20240924$EXP$$US-AMGEN-USASP2024187418$AMGEN$$$$$F$Y$$$20240924$$CN$US$US
243575481$24357548$1$I$20240915$20240916$20240924$20240924$PER$$US-AMGEN-USASP2024184575$AMGEN$$$$$$Y$$$20240924$$PH$US$US
243575491$24357549$1$I$$20240918$20240924$20240924$EXP$$US-TAKEDA-2024TUS093707$TAKEDA$$15$YR$$M$Y$$$20240924$$CN$US$US
243575502$24357550$2$F$20240701$20240919$20240924$20240925$30DAY$$US-PFIZER INC-202400260391$PFIZER$$11$YR$$F$Y$$$20240925$$CN$US$US
243575511$24357551$1$I$20240917$20240917$20240924$20240924$30DAY$$JP-PFIZER INC-PV202400121730$PFIZER$$$$$$Y$$$20240924$$CN$JP$JP
243575521$24357552$1$I$$20240911$20240924$20240924$EXP$$US-UCBSA-2024046888$UCB$$$$$M$Y$$$20240924$$CN$US$US
243575531$24357553$1$I$20190121$20240918$20240924$20240924$PER$PL-URPL-1-398-2019$PL-BRACCO-2019PL07233$BRACCO$$73$YR$$M$Y$$$20240924$$HP$PL$PL
243575541$24357554$1$I$$20240920$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151238$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240924$$CN$US$US
243575551$24357555$1$I$20240913$20240916$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013661$DR REDDYS$$53$YR$A$M$Y$$$20240924$$HP$US$US
243575561$24357556$1$I$20240909$20240923$20240924$20240924$EXP$$CN-ROCHE-10000089672$ROCHE$$55$YR$A$F$Y$55$KG$20240924$$HP$CN$CN
243575571$24357557$1$I$20240709$20240917$20240924$20240924$EXP$$DE-BEH-2024179028$CSL BEHRING$$76$YR$E$F$Y$48$KG$20240924$$MD$DE$DE
243575581$24357558$1$I$$20240920$20240924$20240924$EXP$$US-PFIZER INC-202400261092$PFIZER$$62$YR$$F$Y$$$20240924$$HP$US$US
243575591$24357559$1$I$20240221$20240918$20240924$20240924$EXP$$US-ABBVIE-5931410$ABBVIE$$76$YR$$F$Y$$$20240924$$CN$US$US
243575601$24357560$1$I$20240913$20240920$20240924$20240924$EXP$$US-PFIZER INC-202400261172$PFIZER$$93$YR$$M$Y$$$20240924$$CN$US$US
243575611$24357561$1$I$20240328$20240920$20240924$20240924$EXP$$CA-PFIZER INC-202400201255$PFIZER$$61$YR$$F$Y$$$20240924$$HP$CA$CA
243575631$24357563$1$I$20240901$20240920$20240924$20240924$EXP$$AR-PFIZER INC-PV202400124143$PFIZER$$82$YR$$M$Y$$$20240924$$MD$AR$AR
243575641$24357564$1$I$$20240920$20240924$20240924$EXP$GB-MHRA-MED-202409201309469970-JYNKV$GB-PFIZER INC-202400260856$PFIZER$$$$$F$Y$$$20240924$$HP$GB$GB
243575651$24357565$1$I$20240518$20240920$20240924$20240924$EXP$$CN-PFIZER INC-PV202400123649$PFIZER$$55$YR$$F$Y$46$KG$20240924$$HP$CN$CN
243575661$24357566$1$I$20240915$20240919$20240924$20240924$EXP$$US-PFIZER INC-202400260245$PFIZER$$57$YR$$F$Y$$$20240924$$CN$US$US
243575681$24357568$1$I$$20240920$20240924$20240924$EXP$$US-PFIZER INC-PV202300173738$PFIZER$$73$YR$$F$Y$$$20240924$$CN$US$US
243575691$24357569$1$I$$20240920$20240924$20240924$EXP$$CA-PFIZER INC-202400254565$PFIZER$$80$YR$$M$Y$$$20240924$$MD$CA$CA
243575711$24357571$1$I$20240702$20240923$20240923$20240923$DIR$719553$$FDA-CTU$$63$YR$$F$N$48.6$KG$20240923$N$CN$US$
243575721$24357572$1$I$$20240913$20240924$20240924$30DAY$$US-PFIZER INC-202400262261$PFIZER$$$$$M$Y$$$20240924$$CN$US$US
243575731$24357573$1$I$$20240923$20240924$20240924$EXP$$US-PFIZER INC-202400261774$PFIZER$$76$YR$$F$Y$$$20240924$$CN$US$US
243575741$24357574$1$I$$20240923$20240924$20240924$EXP$$PL-PFIZER INC-202400261420$PFIZER$$64$YR$$$Y$$$20240924$$MD$PL$PL
243575751$24357575$1$I$20210904$20240921$20240921$20240921$DIR$FDA-CDER-CTU-2024-64633$$FDA-CTU$$43$YR$$F$N$81.65$KG$20240924$N$CN$US$
243575761$24357576$1$I$$20240917$20240924$20240924$EXP$$US-INCYTE CORPORATION-2024IN009824$INCYTE$$$$$$Y$$$20240924$$CN$US$US
243575771$24357577$1$I$20240101$20240911$20240924$20240924$PER$$US-JNJFOC-20240931465$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243575782$24357578$2$F$$20240919$20240924$20240925$EXP$$DE-009507513-2409DEU007345$MERCK$$$$$M$Y$$$20240925$$MD$DE$DE
243575791$24357579$1$I$$20240917$20240924$20240924$EXP$$US-ROCHE-10000086588$ROCHE$$28$YR$A$F$Y$$$20240924$$CN$US$US
243575801$24357580$1$I$20240101$20240918$20240924$20240924$EXP$$BR-EMD Serono-2024050526$EMD SERONO INC$$73$YR$E$F$Y$$$20240924$$MD$BR$BR
243575811$24357581$1$I$$20240921$20240924$20240924$PER$$US-AMGEN-USASP2024189200$AMGEN$$$$$$Y$$$20240924$$PH$US$US
243575821$24357582$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3246306$TEVA$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.; Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug...$36$YR$$M$Y$$$20240924$$HP$US$US
243575831$24357583$1$I$$20240917$20240924$20240924$EXP$$US-APELLIS-2024-APL-0001013$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240924$$MD$US$US
243575842$24357584$2$F$20231201$20240927$20240924$20240927$EXP$$BR-BAYER-2024A136328$BAYER$$$$$F$Y$$$20240927$$CN$BR$BR
243575851$24357585$1$I$20240801$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151161$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240924$$HP$US$US
243575861$24357586$1$I$20240919$20240923$20240923$20240923$DIR$719487$$FDA-CTU$$98$YR$$F$N$$$20240923$N$HP$US$
243575881$24357588$1$I$$20230810$20240924$20240924$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-404669$RANBAXY$$$$$F$Y$$$20240924$$CN$US$US
243575891$24357589$1$I$$20240627$20240924$20240924$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-455702$RANBAXY$$$$$M$Y$$$20240924$$CN$US$US
243575901$24357590$1$I$$20240909$20240924$20240924$EXP$$RU-ORGANON-O2409RUS001624$ORGANON$$$$$F$Y$$$20240924$$MD$RU$RU
243575911$24357591$1$I$$20240921$20240924$20240924$EXP$GB-MHRA-MED-202409201442135780-GSWCR$GB-ORGANON-O2409GBR001639$ORGANON$$$$$M$Y$$$20240924$$CN$GB$GB
243575931$24357593$1$I$$20240923$20240923$20240923$DIR$719479$$FDA-CTU$$$$$M$N$$$20240923$Y$$US$
243575941$24357594$1$I$20240923$20240923$20240923$20240923$DIR$719462$$FDA-CTU$$24$YR$$F$N$80.1$KG$20240923$N$CN$US$
243575951$24357595$1$I$$20240923$20240923$20240923$DIR$719464$$FDA-CTU$$$$$M$N$$$20240923$N$$US$
243575961$24357596$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65246$$FDA-CTU$$$$$F$N$100.7$KG$20240923$N$$US$
243575971$24357597$1$I$$20240826$20240924$20240924$PER$$US-LEX-000462$LEXICON PHARMACEUTICALS$$63$YR$$M$Y$$$20240924$$CN$US$US
243575981$24357598$1$I$20240420$20240916$20240924$20240924$EXP$$CA-CELLTRION INC.-2024CA011023$CELLTRION$$$$$$Y$$$20240924$$HP$CA$CA
243575991$24357599$1$I$$20240918$20240924$20240924$EXP$$CA-TAKEDA-2024TUS093794$TAKEDA$$23$YR$$F$Y$84$KG$20240924$$HP$CA$CA
243576001$24357600$1$I$20240911$20240919$20240924$20240924$EXP$$CN-BAYER-2024A134394$BAYER$$69$YR$E$F$Y$56$KG$20240924$$HP$CN$CN
243576011$24357601$1$I$$20240906$20240924$20240924$30DAY$$US-ABBVIE-5930131$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243576021$24357602$1$I$20240620$20240919$20240924$20240924$EXP$$US-ABBVIE-5827524$ABBVIE$$55$YR$$F$Y$$$20240924$$CN$US$US
243576031$24357603$1$I$$20240904$20240924$20240924$PER$$US-TEVA-VS-3242479$TEVA$$61$YR$$F$Y$$$20240924$$CN$US$US
243576041$24357604$1$I$20240101$20240918$20240924$20240924$EXP$$US-TG THERAPEUTICS INC.-TGT004021$TG THERAPEUTICS$$$$$$Y$$$20240924$$CN$US$US
243576051$24357605$1$I$20240916$20240920$20240924$20240924$EXP$$US-BAYER-2024A135052$BAYER$$6$YR$C$M$Y$$$20240924$$CN$US$US
243576061$24357606$1$I$20240909$20240916$20240924$20240924$EXP$$US-BAYER-2024A132242$BAYER$$69$YR$E$F$Y$$$20240924$$CN$US$US
243576071$24357607$1$I$20240617$20240912$20240924$20240924$PER$$US-JNJFOC-20240933205$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20240924$$CN$US$US
243576081$24357608$1$I$20240909$20240918$20240924$20240924$EXP$$CA-JNJFOC-20240869182$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240924$$HP$CA$CA
243576091$24357609$1$I$$20240917$20240924$20240924$EXP$$US-JNJFOC-20240955202$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240924$$HP$US$US
243576101$24357610$1$I$$20240916$20240924$20240924$PER$$US-JNJFOC-20240953658$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$HP$US$US
243576111$24357611$1$I$$20240919$20240924$20240924$EXP$$CA-JNJFOC-20240960790$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$HP$CA$CA
243576131$24357613$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3246307$TEVA$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.; Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug...$77$YR$$M$Y$$$20240924$$HP$US$US
243576151$24357615$1$I$$20240920$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150214$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$85.73$KG$20240924$$HP$US$US
243576161$24357616$1$I$20240605$20240915$20240924$20240924$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149534$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$MD$PT$PT
243576171$24357617$1$I$20240705$20240918$20240924$20240924$EXP$FR-AFSSAPS-NC2024001063$FR-009507513-2409FRA006355$MERCK$$62$YR$$M$Y$$$20240924$$MD$FR$FR
243576192$24357619$2$F$20240923$20240923$20240924$20240930$PER$$US-AMGEN-USASP2024189845$AMGEN$$63$YR$A$F$Y$$$20240930$$CN$US$US
243576201$24357620$1$I$$20240912$20240924$20240924$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-09448$LUPIN$$$$$$Y$$$20240924$$HP$CA$CA
243576211$24357621$1$I$20240815$20240924$20240924$20240924$DIR$719608$$FDA-CTU$$66$YR$$F$N$67.95$KG$20240924$N$CN$US$
243576221$24357622$1$I$20240901$20240924$20240924$20240924$DIR$719600$$FDA-CTU$$$$$UNK$N$$$20240924$N$CN$US$
243576231$24357623$1$I$20240813$20240923$20240923$20240923$DIR$719543$$FDA-CTU$$35$YR$$M$N$73.1$KG$20240923$N$HP$US$
243576261$24357626$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65252$$FDA-CTU$$27$YR$$M$N$88.9$KG$20240924$N$$US$
243576281$24357628$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65253$$FDA-CTU$$81$YR$$M$N$$$20240924$N$$US$
243576291$24357629$1$I$20240904$20240923$20240923$20240923$DIR$719511$$FDA-CTU$$53$YR$$F$N$85.05$KG$20240923$N$CN$US$
243576301$24357630$1$I$$20240923$20240923$20240923$DIR$719465$$FDA-CTU$$38$YR$$F$N$133.2$KG$20240923$N$CN$US$
243576311$24357631$1$I$20240626$20240923$20240923$20240923$DIR$719463$$FDA-CTU$$49$YR$$F$N$73.8$KG$20240923$N$CN$US$
243576321$24357632$1$I$20240916$20240923$20240923$20240923$DIR$719412$$FDA-CTU$$69$YR$$M$N$104.85$KG$20240923$N$HP$US$
243576331$24357633$1$I$20240920$20240923$20240923$20240923$DIR$719516$$FDA-CTU$$48$YR$$F$N$$$20240923$Y$PH$US$
243576341$24357634$1$I$20240801$20240909$20240924$20240924$PER$$US-JNJFOC-20240921029$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243576361$24357636$1$I$$20240905$20240924$20240924$PER$$US-JNJFOC-20240925050$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$PH$US$US
243576371$24357637$1$I$$20240918$20240924$20240924$PER$$US-JNJFOC-20240955291$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243576381$24357638$1$I$20230511$20240916$20240924$20240924$EXP$$AU-TAKEDA-2023TUS054667$TAKEDA$$35$YR$$M$Y$$$20240924$$CN$AU$AU
243576391$24357639$1$I$$20240916$20240924$20240924$EXP$$CH-ROCHE-10000084534$ROCHE$$$$$F$Y$$$20240924$$MD$CH$CH
243576401$24357640$1$I$20240307$20240923$20240923$20240923$DIR$719552$$FDA-CTU$$67$YR$$UNK$N$$$20240923$Y$PH$US$
243576411$24357641$1$I$20230101$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189475$AMGEN$$53$YR$A$F$Y$$$20240924$$CN$US$US
243576421$24357642$1$I$20240421$20240918$20240924$20240924$EXP$FR-AFSSAPS-NT2024001099$FR-TEVA-VS-3244917$TEVA$$44$YR$$F$Y$$$20240924$$MD$FR$FR
243576431$24357643$1$I$20240823$20240918$20240924$20240924$EXP$FR-AFSSAPS-RE2024000866$FR-TEVA-VS-3245386$TEVA$$68$YR$$M$Y$107$KG$20240924$$MD$FR$FR
243576441$24357644$1$I$20240801$20240919$20240924$20240924$PER$$PR-BIOGEN-2024BI01283628$BIOGEN$$36$YR$$F$Y$40.86$KG$20240924$$CN$PR$PR
243576451$24357645$1$I$20240903$20240920$20240924$20240924$EXP$$CN-BAYER-2024A135615$BAYER$$72$YR$E$F$Y$45$KG$20240924$$HP$CN$CN
243576461$24357646$1$I$$20240917$20240924$20240924$PER$$US-ROCHE-10000084568$ROCHE$$$$$$Y$$$20240924$$HP$US$US
243576481$24357648$1$I$20240701$20240916$20240924$20240924$EXP$GB-MHRA-MED-202409130944585940-GDHMZ$GB-TEVA-VS-3244204$TEVA$$$$$M$Y$$$20240924$$CN$GB$GB
243576491$24357649$1$I$$20240917$20240924$20240924$EXP$FR-AFSSAPS-AVPO2024000178$FR-TEVA-VS-3244579$TEVA$$55$YR$$F$Y$$$20240924$$PH$FR$FR
243576501$24357650$1$I$$20240910$20240924$20240924$PER$$US-KARYOPHARM-2024KPT001528$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240924$$CN$US$US
243576511$24357651$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013848$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240924$$CN$US$US
243576521$24357652$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014363$ELI LILLY AND CO$$$$$F$Y$$$20240924$$HP$US$US
243576531$24357653$1$I$$20240922$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151404$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$CN$US$US
243576541$24357654$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014756$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240924$$CN$US$US
243576551$24357655$1$I$$20240919$20240924$20240924$PER$$US-ABBVIE-5932896$ABBVIE$$$$$F$Y$$$20240924$$HP$US$US
243576561$24357656$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013683$ELI LILLY AND CO$$77$YR$E$$Y$$$20240924$$CN$US$US
243576571$24357657$1$I$$20240914$20240924$20240924$PER$$US-ASTELLAS-2024-AER-007007$ASTELLAS$$$$$F$Y$$$20240924$$MD$US$US
243576591$24357659$1$I$$20240918$20240924$20240924$EXP$$DE-MYLANLABS-2024M1085308$MYLAN$$73$YR$$$Y$$$20240924$$MD$DE$DE
243576601$24357660$1$I$$20240918$20240924$20240924$EXP$NL-LRB-01003378$NL-MYLANLABS-2024M1085629$MYLAN$$15$YR$$M$Y$80$KG$20240924$$CN$NL$NL
243576611$24357661$1$I$$20240918$20240924$20240924$EXP$$DE-MYLANLABS-2024M1085408$MYLAN$$56$YR$$F$Y$$$20240924$$CN$DE$DE
243576621$24357662$1$I$20240911$20240916$20240924$20240924$PER$$US-GSK-US2024114742$GLAXOSMITHKLINE$$65$YR$$M$Y$$$20240924$$CN$US$US
243576641$24357664$1$I$$20240919$20240924$20240924$EXP$$US-AMGEN-USASP2024188842$AMGEN$$$$$F$Y$$$20240924$$MD$US$US
243576651$24357665$1$I$$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188795$AMGEN$$$$$$Y$$$20240924$$HP$US$US
243576661$24357666$1$I$$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188593$AMGEN$$$$$$Y$$$20240924$$HP$US$US
243576671$24357667$1$I$20240821$20240911$20240924$20240924$30DAY$$US-AMGEN-USASP2024183253$AMGEN$$71$YR$E$M$Y$$$20240924$$PH$US$US
243576701$24357670$1$I$20240916$20240923$20240923$20240923$DIR$719471$$FDA-CTU$$46$YR$$F$N$89.55$KG$20240923$N$CN$US$
243576711$24357671$1$I$20220201$20240924$20240924$20240924$DIR$719578$$FDA-CTU$$28$YR$$F$N$$$20240924$N$CN$US$
243576731$24357673$1$I$20040101$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65254$$FDA-CTU$$64$YR$$F$N$58.51$KG$20240924$N$CN$US$
243576741$24357674$1$I$20240301$20240923$20240923$20240923$DIR$719575$$FDA-CTU$$71$YR$$F$N$60.3$KG$20240923$N$CN$US$
243576751$24357675$1$I$20240923$20240924$20240924$20240924$DIR$719603$$FDA-CTU$$69$YR$$F$N$63$KG$20240924$Y$CN$US$
243576761$24357676$1$I$$20240923$20240923$20240923$DIR$719497$$FDA-CTU$$$$$UNK$N$$$20240923$$CN$US$
243576781$24357678$1$I$$20240919$20240924$20240924$EXP$$US-ASTELLAS-2024-AER-008090$ASTELLAS$$82$YR$E$M$Y$$$20240924$$CN$US$US
243576791$24357679$1$I$$20230825$20240924$20240924$PER$$US-CELLTRION INC.-2023US016929$CELLTRION$$$$$$Y$$$20240924$$MD$US$US
243576821$24357682$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65255$$FDA-CTU$$76$YR$$F$N$$$20240923$N$CN$US$
243576831$24357683$1$I$20240319$20240920$20240924$20240924$EXP$ES-AEMPS-1570726$ES-PFIZER INC-202400260357$PFIZER$$51$YR$$F$Y$$$20240924$$MD$ES$ES
243576841$24357684$1$I$$20240924$20240924$20240924$DIR$719615$$FDA-CTU$$34$YR$$F$N$$$20240924$N$CN$US$
243576851$24357685$1$I$20240919$20240920$20240924$20240924$EXP$$US-PFIZER INC-202400260832$PFIZER$$87$YR$$F$Y$79.365$KG$20240924$$CN$US$US
243576861$24357686$1$I$$20240918$20240924$20240924$EXP$$IT-PFIZER INC-202400258744$PFIZER$$70$YR$$F$Y$$$20240924$$MD$IT$IT
243576871$24357687$1$I$20240902$20240923$20240924$20240924$EXP$$MA-PFIZER INC-PV202400124583$PFIZER$$$$$F$Y$$$20240924$$CN$MA$MA
243576881$24357688$1$I$$20240920$20240924$20240924$EXP$$IN-PFIZER INC-PV202400026317$PFIZER$$70$YR$$F$Y$$$20240924$$CN$IN$IN
243576891$24357689$1$I$20240101$20240912$20240924$20240924$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18785$IPSEN$$$$$$Y$$$20240924$$HP$US$US
243576901$24357690$1$I$$20240916$20240924$20240924$EXP$$NVSC2024DE184824$NOVARTIS$Aicher A, Sindrilaru A, Crisan D, Thaiss W, Steinacker J, Beer M et al.. Short-interval, low-dose peptide receptor radionuclide therapy in combination with PD-1 checkpoint immunotherapy induces remission in immunocompromised patients with metastatic Merkel cell carcinoma. PHARMACEUTICS. 14:1466$82$YR$$M$Y$$$20240924$$HP$DE$DE
243576911$24357691$1$I$$20240922$20240924$20240924$EXP$$CA-ASTELLAS-2024-AER-008266$ASTELLAS$$63$YR$A$M$Y$$$20240924$$HP$CA$CA
243576921$24357692$1$I$20220815$20240913$20240924$20240924$EXP$$JP-AKEBIA THERAPEUTICS, INC.-JP-AKEB-24-000622$AKEBIA THERAPEUTICS$$89$YR$$F$Y$40.9$KG$20240924$$MD$JP$JP
243576931$24357693$1$I$20240827$20240916$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013655$DR REDDYS$$64$YR$A$M$Y$$$20240924$$HP$US$US
243576941$24357694$1$I$20240820$20240916$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013738$DR REDDYS$$54$YR$A$M$Y$$$20240924$$MD$US$US
243576951$24357695$1$I$$20240917$20240924$20240924$PER$US-MLMSERVICE-20240911-PI181883-00289-3$US-RDY-SPO/USA/24/0013739$DR REDDYS$Coutinho PB, Johnson KA, Seritan AL, Galifianakis NB, Coleman R, Wang D, et al. Elevated Mood Induced by Subthalamic Nucleus Deep Brain Stimulation: A Video-Recorded Case Report. Tremor and Other Hyperkinetic Movements. 2024;14(1):1-8. DOI:10.5334/tohm.900$73$YR$E$M$Y$72.1$KG$20240924$$MD$US$US
243576961$24357696$1$I$$20240916$20240924$20240924$PER$$US-ASTELLAS-2024-AER-007342$ASTELLAS$$$$$F$Y$$$20240924$$HP$US$US
243576972$24357697$2$F$$20240923$20240924$20240925$30DAY$$KW-PFIZER INC-202400257387$PFIZER$$$$$$Y$$$20240925$$PH$KW$KW
243576981$24357698$1$I$20240601$20240917$20240924$20240924$EXP$$CA-PFIZER INC-202200808500$PFIZER$$61$YR$$M$Y$$$20240924$$HP$CA$CA
243577001$24357700$1$I$$20240919$20240924$20240924$EXP$$US-PFIZER INC-PV202400123463$PFIZER$$14$YR$$M$Y$$$20240924$$MD$US$US
243577011$24357701$1$I$$20240920$20240924$20240924$EXP$$CA-PFIZER INC-202400260769$PFIZER$$$$$M$Y$$$20240924$$HP$CA$CA
243577021$24357702$1$I$$20240911$20240924$20240924$30DAY$$NL-PFIZER INC-202400255160$PFIZER$$$$$F$Y$$$20240924$$PH$NL$NL
243577031$24357703$1$I$$20240912$20240924$20240924$30DAY$$CO-PFIZER INC-202400256367$PFIZER$$$$$M$Y$$$20240924$$CN$CO$CO
243577052$24357705$2$F$20240101$20240924$20240924$20240927$PER$$CA-PFIZER INC-202400174136$PFIZER$$68$YR$$F$Y$$$20240927$$CN$CA$CA
243577061$24357706$1$I$$20240920$20240924$20240924$EXP$$US-PFIZER INC-PV202400124021$PFIZER$$$$$$Y$$$20240924$$CN$US$US
243577071$24357707$1$I$$20240909$20240924$20240924$30DAY$$JO-PFIZER INC-202400108189$PFIZER$$$$$$Y$$$20240924$$CN$JO$JO
243577081$24357708$1$I$$20240918$20240924$20240924$EXP$$US-PFIZER INC-PV202400122594$PFIZER$$84$YR$$F$Y$58.5$KG$20240924$$CN$US$US
243577091$24357709$1$I$20240101$20240807$20240924$20240924$PER$$US-LUNDBECK-DKLU4002903$LUNDBECK$$$$$$Y$$$20240924$$HP$US$US
243577101$24357710$1$I$20240801$20240916$20240924$20240924$EXP$$US-JNJFOC-20240842126$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240924$$HP$US$US
243577111$24357711$1$I$20240906$20240913$20240924$20240924$PER$$US-ABBVIE-5926405$ABBVIE$$59$YR$$F$Y$$$20240924$$CN$US$US
243577121$24357712$1$I$20240802$20240918$20240924$20240924$PER$$US-JNJFOC-20240958360$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$MD$US$US
243577131$24357713$1$I$20240727$20240913$20240924$20240924$EXP$$CN-JNJFOC-20240938937$JOHNSON AND JOHNSON$$68$YR$E$F$Y$70$KG$20240924$$HP$CN$CN
243577141$24357714$1$I$20240101$20240917$20240924$20240924$EXP$$CA-ABBVIE-5929206$ABBVIE$$35$YR$$M$Y$$$20240924$$PH$CA$CA
243577151$24357715$1$I$$20240917$20240924$20240924$30DAY$$NZ-PFIZER INC-202400258337$PFIZER$$$$$F$Y$$$20240924$$PH$NZ$NZ
243577161$24357716$1$I$20240101$20240917$20240924$20240924$EXP$$US-LEX-000485$LEXICON PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243577171$24357717$1$I$20240828$20240913$20240924$20240924$PER$$US-ABBVIE-5926361$ABBVIE$$62$YR$$$Y$$$20240924$$CN$US$US
243577191$24357719$1$I$$20240610$20240924$20240924$EXP$$BR-INCYTE CORPORATION-2024IN010061$INCYTE$$$$$$Y$$$20240924$$MD$BR$BR
243577201$24357720$1$I$$20240914$20240924$20240924$PER$$US-GSK-US2024114451$GLAXOSMITHKLINE$$3$DEC$$F$Y$$$20240924$$MD$US$US
243577241$24357724$1$I$20240727$20240919$20240924$20240924$EXP$$RO-009507513-2409ROU007546$MERCK$$77$YR$$$Y$$$20240924$$MD$RO$RO
243577251$24357725$1$I$20230701$20231002$20240924$20240924$PER$$US-CELLTRION INC.-2023US017535$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
243577261$24357726$1$I$20240712$20240918$20240924$20240924$EXP$FR-AFSSAPS-PA2024001510$FR-TEVA-VS-3245258$TEVA$$33$YR$$F$Y$$$20240924$$CN$FR$FR
243577271$24357727$1$I$20240806$20240919$20240924$20240924$EXP$FR-AFSSAPS-LY2024001322$FR-ABBVIE-5935265$ABBVIE$$31$YR$$F$Y$42$KG$20240924$$PH$FR$FR
243577281$24357728$1$I$$20240919$20240924$20240924$EXP$GB-MHRA-MED-202409181057302110-HYPVT$GB-TEVA-VS-3245889$TEVA$$$$$F$Y$$$20240924$$HP$GB$GB
243577291$24357729$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150301$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240924$$HP$US$US
243577301$24357730$1$I$20240917$20240919$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149631$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240924$$MD$US$US
243577311$24357731$1$I$20240920$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151261$BRISTOL MYERS SQUIBB$$37$YR$A$M$Y$$$20240924$$CN$US$US
243577321$24357732$1$I$$20240923$20240924$20240924$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-151036$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$78.02$KG$20240924$$CN$PR$PR
243577341$24357734$1$I$20240810$20240916$20240924$20240924$EXP$$GB-TEVA-VS-3244413$TEVA$$59$YR$$M$Y$$$20240924$$MD$GB$GB
243577351$24357735$1$I$$20240917$20240924$20240924$EXP$$US-BEH-2024179041$CSL BEHRING$$$$A$F$Y$$$20240924$$HP$US$US
243577391$24357739$1$I$$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189833$AMGEN$$$$$$Y$$$20240924$$CN$US$US
243577401$24357740$1$I$$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189402$AMGEN$$$$$M$Y$$$20240924$$CN$US$US
243577411$24357741$1$I$20240912$20240917$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013831$DR REDDYS$$15$YR$T$F$Y$$$20240924$$HP$US$US
243577421$24357742$1$I$20240910$20240918$20240924$20240924$PER$$CN-Eisai-EC-2024-174828$EISAI$$49$YR$A$F$Y$58.5$KG$20240924$$HP$CN$CN
243577431$24357743$1$I$$20240917$20240924$20240924$EXP$$US-RDY-SPO/USA/24/0013817$DR REDDYS$$29$YR$A$M$Y$$$20240924$$HP$US$US
243577441$24357744$1$I$$20240916$20240924$20240924$PER$$US-ROCHE-10000084363$ROCHE$$$$$$Y$$$20240924$$CN$US$US
243577451$24357745$1$I$$20240920$20240924$20240924$PER$$US-009507513-2409USA007690$MERCK$$$$$M$Y$$$20240924$$CN$US$US
243577462$24357746$2$F$20240914$20240924$20240924$20240930$PER$$US-Eisai-EC-2024-175013$EISAI$$68$YR$E$F$Y$$$20240930$$CN$US$US
243577471$24357747$1$I$$20240910$20240924$20240924$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00787$GLAND PHARMA$Tatsuhiko Azegami.False-positive Serum Antiglomerular Basement Membrane Antibody due to Bovine Serum Albumin-containing Surgical Adhesive: A Case Report .Kidney Medicine.25-JUL-2024;6:1-3$6$DEC$A$M$Y$$$20240924$$MD$JP$JP
243577481$24357748$1$I$$20240923$20240924$20240924$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053100$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240924$$MD$DE$DE
243577491$24357749$1$I$20240924$20240924$20240924$20240924$EXP$GB-MHRA-MED-202409241027545650-JFSNR$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053096$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240924$$HP$GB$GB
243577501$24357750$1$I$$20240708$20240924$20240924$EXP$$US-APCER-AZR202407-000057$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240924$$CN$US$US
243577511$24357751$1$I$$20240719$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202407-000192$AZURITY PHARMACEUTICALS$$4$MON$$$Y$$$20240924$$HP$US$US
243577521$24357752$1$I$$20240813$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202408-000355$AZURITY PHARMACEUTICALS$$$$$$Y$$$20240924$$PH$US$US
243577531$24357753$1$I$$20240531$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000692$AZURITY PHARMACEUTICALS$$$$$M$Y$$$20240615$$CN$US$US
243577541$24357754$1$I$$20240613$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000755$AZURITY PHARMACEUTICALS$$8$YR$C$M$Y$$$20240809$$HP$US$US
243577551$24357755$1$I$20240101$20240621$20240924$20240924$EXP$$US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000801$AZURITY PHARMACEUTICALS$$$$$$Y$$$20240809$$PH$US$US
243577561$24357756$1$I$20240910$20240916$20240924$20240924$EXP$GB-MHRA-MED-202409141549540490-SGTMD$GB-TEVA-VS-3244235$TEVA$$13$YR$$M$Y$64$KG$20240924$$CN$GB$GB
243577571$24357757$1$I$$20240919$20240924$20240924$EXP$$JP-PFIZER INC-PV202400122931$PFIZER$$$$$$Y$$$20240924$$MD$JP$JP
243577601$24357760$1$I$20240701$20240919$20240924$20240924$EXP$$US-PFIZER INC-202400260881$PFIZER$$76$YR$$F$Y$$$20240924$$HP$US$US
243577611$24357761$1$I$$20240920$20240924$20240924$EXP$$IE-PFIZER INC-202400260390$PFIZER$$63$YR$$M$Y$$$20240924$$MD$IE$IE
243577621$24357762$1$I$20200331$20240917$20240924$20240924$EXP$$US-PFIZER INC-202400258510$PFIZER$$42$YR$$M$Y$$$20240924$$CN$US$US
243577631$24357763$1$I$20240130$20240920$20240924$20240924$EXP$$CN-PFIZER INC-PV202400123647$PFIZER$$60$YR$$M$Y$70$KG$20240924$$HP$CN$CN
243577641$24357764$1$I$$20240918$20240924$20240924$EXP$$MK-PFIZER INC-202400260754$PFIZER$$$$$$Y$$$20240924$$MD$MK$MK
243577661$24357766$1$I$$20240913$20240924$20240924$30DAY$$US-PFIZER INC-202400256410$PFIZER$$9$YR$$F$Y$$$20240924$$CN$US$US
243577672$24357767$2$F$20240101$20240923$20240924$20240925$EXP$$CA-PFIZER INC-202400261692$PFIZER$$59$YR$$M$Y$$$20240925$$CN$CA$CA
243577681$24357768$1$I$$20240920$20240924$20240924$EXP$$CA-PFIZER INC-202400032426$PFIZER$$52$YR$$F$Y$$$20240924$$HP$CA$CA
243577691$24357769$1$I$20240901$20240920$20240924$20240924$EXP$$DE-PFIZER INC-202400260368$PFIZER$$53$YR$$F$Y$$$20240924$$MD$DE$DE
243577702$24357770$2$F$$20240920$20240924$20240926$30DAY$$US-PFIZER INC-202400256498$PFIZER$$17$YR$$M$Y$$$20240926$$CN$US$US
243577711$24357771$1$I$$20240918$20240924$20240924$EXP$$MK-PFIZER INC-202400260676$PFIZER$$$$$$Y$$$20240924$$MD$MK$MK
243577721$24357772$1$I$$20240918$20240924$20240924$PER$$US-ROCHE-10000085945$ROCHE$$67$YR$E$F$Y$56.69$KG$20240924$$CN$US$US
243577731$24357773$1$I$$20240919$20240924$20240924$EXP$$GB-PFIZER INC-202400259639$PFIZER$$$$$F$Y$$$20240924$$HP$GB$GB
243577741$24357774$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3246308$TEVA$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.; Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug...$72$YR$$F$Y$$$20240924$$HP$US$US
243577761$24357776$1$I$$20240919$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149810$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240924$$HP$US$US
243577781$24357778$1$I$$20240912$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146493$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240924$$CN$US$US
243577791$24357779$1$I$$20240912$20240924$20240924$30DAY$$US-PFIZER INC-202400256441$PFIZER$$6$YR$$M$Y$$$20240924$$CN$US$US
243577801$24357780$1$I$$20240501$20240924$20240924$PER$$US-CIPLA LTD.-2024US04534$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243577811$24357781$1$I$20240401$20240427$20240924$20240924$PER$$US-CIPLA LTD.-2024US04371$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243577821$24357782$1$I$20240916$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65268$$FDA-CTU$$60$YR$$F$N$$$20240923$N$HP$US$
243577831$24357783$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65267$$FDA-CTU$$31$YR$$F$N$$$20240924$N$$US$
243577841$24357784$1$I$$20240910$20240924$20240924$EXP$$TN-GLANDPHARMA-TN-2024GLNLIT00765$GLAND PHARMA$Khouloud Razki.^From levetiracetam to lithium^: A journey of hope to manage suicidality and depression.Journal of the Neurological Sciences.2023;455:119-120$20$YR$A$M$Y$$$20240924$$HP$TN$TN
243577851$24357785$1$I$$20231020$20240924$20240924$PER$$US-CELLTRION INC.-2023US018283$CELLTRION$$$$$$Y$$$20240924$$MD$US$US
243577861$24357786$1$I$$20240503$20240924$20240924$PER$$US-CIPLA LTD.-2024US04628$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243577871$24357787$1$I$20231201$20240506$20240924$20240924$PER$$US-CIPLA LTD.-2024US04743$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243577881$24357788$1$I$20240914$20240916$20240924$20240924$EXP$GB-MHRA-MED-202409161417307220-FTKJG$GB-TEVA-VS-3244388$TEVA$$$$$$Y$$$20240924$$PH$GB$GB
243577891$24357789$1$I$20240501$20240514$20240924$20240924$PER$$US-CIPLA LTD.-2024US04547$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243577901$24357790$1$I$20240701$20240918$20240924$20240924$EXP$FR-AFSSAPS-TS2024000989$FR-MYLANLABS-2024M1085298$MYLAN$$50$YR$$M$Y$62$KG$20240924$$MD$FR$FR
243577911$24357791$1$I$20240806$20240918$20240924$20240924$EXP$FR-AFSSAPS-NC2024001061$FR-MYLANLABS-2024M1085138$MYLAN$$44$YR$$F$Y$58$KG$20240924$$MD$FR$FR
243577921$24357792$1$I$$20240916$20240924$20240924$EXP$$ES-TEVA-VS-3245881$TEVA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.; Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.$$$$$Y$$$20240924$$HP$ES$ES
243577931$24357793$1$I$20230104$20240923$20240924$20240924$EXP$$US-BIOVITRUM-2024-US-012374$BIOVITRUM$$75$YR$$F$Y$$$20240924$$CN$US$US
243577941$24357794$1$I$$20240919$20240924$20240924$EXP$$GB-MYLANLABS-2024M1086122$MYLAN$$$$$F$Y$$$20240924$$CN$GB$GB
243577951$24357795$1$I$20221103$20240919$20240924$20240924$EXP$$AR-MYLANLABS-2024M1086124$MYLAN$$17$YR$$F$Y$$$20240924$$CN$AR$AR
243577961$24357796$1$I$$20240512$20240924$20240924$PER$$US-CIPLA LTD.-2024US04992$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243577971$24357797$1$I$20240707$20240723$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003749$PAREXEL$$65$YR$$F$Y$$$20240924$$CN$US$US
243577982$24357798$2$F$20240921$20240924$20240924$20240926$PER$$US-AMGEN-USASP2024189570$AMGEN$$64$YR$A$F$Y$$$20240926$$CN$US$US
243577991$24357799$1$I$20240101$20240515$20240924$20240924$PER$$US-CIPLA LTD.-2024US05121$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243578001$24357800$1$I$$20240910$20240924$20240924$EXP$$US-GLANDPHARMA-US-2024GLNLIT00785$GLAND PHARMA$M Shaikh.Wide QRS tachycardia in a patient with atrial fibrillation: A case report and approach to diagnosis.European Heart Journal - Case Reports.2024;1-6:8$87$YR$E$M$Y$$$20240924$$HP$US$US
243578011$24357801$1$I$$20240919$20240924$20240924$EXP$$BE-JNJFOC-20240959232$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20240924$$MD$BE$BE
243578021$24357802$1$I$$20240919$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150016$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$89.36$KG$20240924$$CN$US$US
243578031$24357803$1$I$20240915$20240920$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150351$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240924$$HP$US$US
243578041$24357804$1$I$$20240919$20240924$20240924$EXP$$US-TAKEDA-2024TUS093964$TAKEDA$$$$$M$Y$$$20240924$$CN$US$US
243578051$24357805$1$I$$20240918$20240924$20240924$EXP$$MK-PFIZER INC-202400260763$PFIZER$$$$$$Y$$$20240924$$MD$MK$MK
243578061$24357806$1$I$$20240918$20240924$20240924$EXP$$MK-PFIZER INC-202400260768$PFIZER$$$$$$Y$$$20240924$$MD$MK$MK
243578071$24357807$1$I$$20240918$20240924$20240924$EXP$$MK-PFIZER INC-202400260781$PFIZER$$$$$$Y$$$20240924$$MD$MK$MK
243578081$24357808$1$I$20220505$20240918$20240924$20240924$EXP$ES-AEMPS-1570471$ES-PFIZER INC-202400258614$PFIZER$$69$YR$$F$Y$$$20240924$$PH$ES$ES
243578101$24357810$1$I$$20240522$20240924$20240924$PER$$US-CIPLA LTD.-2024US05481$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243578111$24357811$1$I$$20240516$20240924$20240924$PER$$US-CIPLA LTD.-2024US05136$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243578121$24357812$1$I$$20240522$20240924$20240924$PER$$US-CIPLA LTD.-2024US05505$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243578131$24357813$1$I$$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024189291$AMGEN$$$$$M$Y$$$20240924$$CN$US$US
243578141$24357814$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024186573$AMGEN$$$$$M$Y$$$20240924$$CN$US$US
243578151$24357815$1$I$$20240910$20240924$20240924$PER$$US-GSK-US2024112665$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243578201$24357820$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65269$$FDA-CTU$$63$YR$$F$N$$$20240924$N$$US$
243578221$24357822$1$I$20240101$20240916$20240924$20240924$PER$$US-VERTEX PHARMACEUTICALS-2024-014779$VERTEX$$$$I$F$Y$$$20240924$$CN$US$US
243578231$24357823$1$I$$20240919$20240924$20240924$PER$$US-VERTEX PHARMACEUTICALS-2024-014920$VERTEX$$$$$$Y$$$20240924$$CN$US$US
243578241$24357824$1$I$$20240717$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004132$PAREXEL$$53$YR$$F$Y$$$20240924$$CN$US$US
243578251$24357825$1$I$$20240715$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004144$PAREXEL$$62$YR$$F$Y$$$20240924$$CN$US$US
243578261$24357826$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65270$$FDA-CTU$$$$$F$N$$$20240923$N$HP$US$
243578271$24357827$1$I$20230613$20240916$20240924$20240924$EXP$FR-AFSSAPS-CF2023000328$FR-FreseniusKabi-FK202413965$FRESENIUS KABI$$$$I$M$Y$$$20240924$$HP$FR$FR
243578281$24357828$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65271$$FDA-CTU$$73$YR$$F$N$81.65$KG$20240924$N$$US$
243578291$24357829$1$I$20240908$20240918$20240924$20240924$EXP$$US-BEH-2024179054$CSL BEHRING$$64$YR$A$M$Y$$$20240924$$HP$US$US
243578301$24357830$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000087879$ROCHE$$61$YR$A$F$Y$$$20240924$$CN$US$US
243578311$24357831$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000087081$ROCHE$$$$$$Y$$$20240924$$HP$US$US
243578321$24357832$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151237$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240924$$CN$US$US
243578331$24357833$1$I$$20240919$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149635$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240924$$CN$US$US
243578341$24357834$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150790$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240924$$CN$US$US
243578351$24357835$1$I$20240801$20240923$20240924$20240924$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-151030$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$78.02$KG$20240924$$CN$PR$PR
243578361$24357836$1$I$$20240910$20240924$20240924$EXP$$IT-GLANDPHARMA-IT-2024GLNLIT00758$GLAND PHARMA$Clara Ugolini.^Incidental^ lipoadenoma of the parathyroid gland: A case report of a rare entity.Journal of Clinical and Translational Endocrinology: Case Reports.SEP-2024;33:1-3$48$YR$A$M$Y$$$20240924$$HP$IT$IT
243578371$24357837$1$I$$20240918$20240924$20240924$PER$$US-LEO Pharma-373668$LEO PHARM$$54$YR$$F$Y$$$20240924$$PH$US$US
243578382$24357838$2$F$20240901$20240924$20240924$20240926$PER$$US-ABBVIE-5935531$ABBVIE$$$$$$Y$$$20240926$$CN$US$US
243578391$24357839$1$I$$20240919$20240924$20240924$PER$$US-BIOGEN-2024BI01283527$BIOGEN$$$$$F$Y$$$20240924$$CN$US$US
243578401$24357840$1$I$$20240919$20240924$20240924$PER$$US-BIOGEN-2024BI01283678$BIOGEN$$$$$M$Y$$$20240924$$CN$US$US
243578421$24357842$1$I$$20240919$20240924$20240924$PER$$US-TAKEDA-2024TUS093416$TAKEDA$$$$$M$Y$$$20240924$$HP$US$US
243578431$24357843$1$I$20231001$20240917$20240924$20240924$EXP$$CA-GSK-CA2023147833$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$CA$CA
243578441$24357844$1$I$$20240919$20240924$20240924$EXP$$US-GILEAD-2024-0684889$GILEAD$$$$E$F$Y$$$20240924$$CN$US$US
243578451$24357845$1$I$$20240916$20240924$20240924$EXP$$CA-PERRIGO-24CA008804$PERRIGO$$88$YR$$M$Y$$$20240924$$PH$CA$CA
243578471$24357847$1$I$$20240920$20240924$20240924$PER$$US-ROCHE-10000088023$ROCHE$$$$A$F$Y$$$20240924$$CN$US$US
243578491$24357849$1$I$$20240910$20240924$20240924$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00779$GLAND PHARMA$Naoki Fujimoto.Takotsubo syndrome in a cancer patient treated with a combination of anti-cancer drugs including immune checkpoint inhibitors: A case report.European Heart Journal - Case Reports.AUG-2024; 8: No. 8:1-5$66$YR$A$F$Y$$$20240924$$HP$JP$JP
243578501$24357850$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189991$NOVARTIS$$$$$$Y$$$20240924$$MD$US$US
243578511$24357851$1$I$20240207$20240923$20240924$20240924$EXP$$NVSC2024IN189827$NOVARTIS$$76$YR$$F$Y$$$20240924$$CN$IN$IN
243578521$24357852$1$I$20240807$20240807$20240924$20240924$PER$$US-LUNDBECK-DKLU4002905$LUNDBECK$$$$$$Y$$$20240924$$CN$US$US
243578541$24357854$1$I$20220601$20240916$20240924$20240924$EXP$$RO-FreseniusKabi-FK202413875$FRESENIUS KABI$$70$YR$E$M$Y$$$20240924$$MD$RO$RO
243578551$24357855$1$I$20240918$20240918$20240924$20240924$EXP$$US-PFIZER INC-PV202400123101$PFIZER$$87$YR$$M$Y$67.6$KG$20240924$$MD$US$US
243578561$24357856$1$I$20200101$20240910$20240924$20240924$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00793$GLAND PHARMA$Kazuhisa Nakashima.Cytokine Release Syndrome More than Two Years after Pembrolizumab Introduction.Internal Medicine.2024;63:2163-2166$71$YR$E$M$Y$$$20240924$$HP$JP$JP
243578571$24357857$1$I$$20240916$20240924$20240924$EXP$$SK-FreseniusKabi-FK202101920$FRESENIUS KABI$$$$E$F$Y$$$20240924$$HP$SK$GB
243578581$24357858$1$I$20230222$20240918$20240924$20240924$EXP$$CN-TEVA-VS-3244752$TEVA$$71$YR$$M$Y$$$20240924$$HP$CN$CN
243578591$24357859$1$I$$20240918$20240924$20240924$EXP$$DE-PFIZER INC-PV202400123404$PFIZER$$$$E$M$Y$$$20240924$$HP$DE$DE
243578611$24357861$1$I$$20240923$20240924$20240924$PER$$US-BAYER-2024A135985$BAYER$$$$$F$Y$$$20240924$$CN$US$US
243578621$24357862$1$I$20240914$20240923$20240924$20240924$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-151003$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$68.95$KG$20240924$$CN$PR$PR
243578631$24357863$1$I$20240823$20240912$20240924$20240924$EXP$GB-MHRA-MED-202409121439038150-RYGDW$GB-ELI_LILLY_AND_COMPANY-GB202409008809$ELI LILLY AND CO$$25$YR$A$F$Y$108$KG$20240924$$CN$GB$GB
243578641$24357864$1$I$$20240918$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149010$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240924$$PH$US$US
243578651$24357865$1$I$$20240919$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409014437$ELI LILLY AND CO$$45$YR$A$$Y$$$20240924$$LW$US$US
243578661$24357866$1$I$$20240912$20240924$20240924$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409008572$ELI LILLY AND CO$$90$YR$E$M$Y$$$20240924$$CN$DE$DE
243578681$24357868$1$I$$20240912$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409008256$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240924$$CN$US$US
243578691$24357869$1$I$20240909$20240913$20240924$20240924$EXP$GB-MHRA-MED-202409132033034210-SNWZC$GB-ELI_LILLY_AND_COMPANY-GB202409009465$ELI LILLY AND CO$$38$YR$A$F$Y$90$KG$20240924$$CN$GB$GB
243578701$24357870$1$I$20240707$20240911$20240924$20240924$EXP$GB-MHRA-MED-202409111044307490-PNJLR$GB-ELI_LILLY_AND_COMPANY-GB202409007820$ELI LILLY AND CO$$42$YR$A$F$Y$73$KG$20240924$$CN$GB$GB
243578711$24357871$1$I$$20240913$20240924$20240924$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202409009974$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240924$$CN$BE$BE
243578721$24357872$1$I$$20240913$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009029$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240924$$CN$US$US
243578731$24357873$1$I$$20240918$20240924$20240924$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409012725$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$JP$JP
243578741$24357874$1$I$$20240912$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409008843$ELI LILLY AND CO$$79$YR$E$F$Y$$$20240924$$CN$US$US
243578751$24357875$1$I$20240913$20240913$20240924$20240924$PER$$US-JNJFOC-20240936732$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240924$$CN$US$US
243578761$24357876$1$I$20240916$20240919$20240924$20240924$EXP$$US-ROCHE-10000087164$ROCHE$$$$$M$Y$$$20240924$$CN$US$US
243578781$24357878$1$I$20240918$20240919$20240924$20240924$EXP$$AU-BEH-2024179069$CSL BEHRING$$63$YR$A$F$Y$67.8$KG$20240924$$HP$AU$AU
243578791$24357879$1$I$$20240910$20240924$20240924$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00768$GLAND PHARMA$Zhou Xiaohui.Childhood acute lymphoblastic leukemia complicated with cytokine release syndrome: report of 1 case and review of the literature.Journal of Leukemia and Lymphoma.25-DEC-2022;31:730-733$71$DY$I$F$Y$6$KG$20240924$$HP$CN$CN
243578801$24357880$1$I$$20240917$20240924$20240924$EXP$$US-BAYER-2024A064530$BAYER$$71$YR$E$M$Y$$$20240924$$CN$US$US
243578811$24357881$1$I$20240907$20240918$20240924$20240924$EXP$$CN-ORGANON-O2409CHN001541$ORGANON$$61$YR$$F$Y$65$KG$20240924$$HP$CN$CN
243578821$24357882$1$I$$20240719$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004054$PAREXEL$$65$YR$$F$Y$$$20240924$$CN$US$US
243578831$24357883$1$I$$20240723$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004014$PAREXEL$$70$YR$$F$Y$$$20240924$$CN$US$US
243578841$24357884$1$I$$20240719$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004052$PAREXEL$$46$YR$$F$Y$$$20240924$$HP$US$US
243578851$24357885$1$I$$20231022$20240924$20240924$PER$$US-CELLTRION INC.-2023US018041$CELLTRION$$$$$$Y$$$20240924$$MD$US$US
243578861$24357886$1$I$$20240923$20240924$20240924$PER$$US-BAUSCH-BL-2024-014282$BAUSCH AND LOMB$$$$$F$Y$$$20240924$$CN$US$US
243578871$24357887$1$I$$20230919$20240924$20240924$PER$$US-CELLTRION INC.-2023US017244$CELLTRION$$$$$$Y$$$20240924$$MD$US$US
243578881$24357888$1$I$$20240918$20240924$20240924$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001912$BLUEPRINT MEDICINES$$$$$F$Y$$$20240924$$CN$US$US
243578891$24357889$1$I$20240914$20240917$20240924$20240924$EXP$$US-Vifor (International) Inc.-VIT-2024-08607$VIFOR$$62$YR$$F$Y$87$KG$20240924$$HP$US$US
243578911$24357891$1$I$$20240910$20240924$20240924$EXP$$JP-GLANDPHARMA-JP-2024GLNLIT00773$GLAND PHARMA$M Kamimura.Anthracyclines for acute promyelocytic leukemia in a female with congenital long QT syndrome.Pediatric Blood and Cancer .JAN-2023;70, No.8:e30323$16$YR$T$F$Y$$$20240924$$HP$JP$JP
243578921$24357892$1$I$20240101$20240913$20240924$20240924$EXP$$FR-JNJFOC-20240940437$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240924$$MD$FR$FR
243578931$24357893$1$I$$20240921$20240924$20240924$PER$$US-ROCHE-10000089105$ROCHE$$$$$$Y$$$20240924$$CN$US$US
243578941$24357894$1$I$$20240913$20240924$20240924$EXP$$KZ-TAKEDA-2024TUS093129$TAKEDA$$$$A$M$Y$$$20240924$$CN$KZ$KZ
243578951$24357895$1$I$$20240902$20240924$20240924$EXP$$BG-JNJFOC-20240960192$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240924$$MD$BG$BG
243578971$24357897$1$I$$20240921$20240924$20240924$PER$$US-HALEON-2198137$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
243578981$24357898$1$I$$20240916$20240924$20240924$EXP$$CA-BAUSCH-BL-2024-014012$BAUSCH AND LOMB$$36$YR$$F$Y$$$20240924$$HP$CA$CA
243578991$24357899$1$I$20240830$20240913$20240924$20240924$EXP$CN-NMPACDR-6401061025926202400185$CN-BAXTER-2024BAX024811$BAXTER$$62$YR$$F$Y$60$KG$20240924$$MD$CN$CN
243579001$24357900$1$I$$20240910$20240924$20240924$EXP$$NO-DEXPHARM-2024-3212$DEXCEL$Reitan Riibe, S.; Heitmann, K.; Schjott, J.; Riedel, B.  Healthcare professionals^ information need related to antiseizure medication use in breastfeeding patients with epilepsy. Retrospective analysis of enquiries to Norwegian medicines information and pharmacovigilance centers. Epilepsy and Behavior Reports 2023, V24, PJan 2023.$3$MON$C$$Y$$$20240924$$HP$NO$NO
243579011$24357901$1$I$20240829$20240913$20240924$20240924$EXP$CN-NMPACDR-5224001038336202400161$CN-BAXTER-2024BAX024810$BAXTER$$54$YR$$M$Y$53$KG$20240924$$MD$CN$CN
243579021$24357902$1$I$$20240917$20240924$20240924$30DAY$$CO-PFIZER INC-202400258987$PFIZER$$14$YR$$M$Y$$$20240924$$CN$CO$CO
243579031$24357903$1$I$$20240919$20240924$20240924$30DAY$$KR-PFIZER INC-PV202400122963$PFIZER$$13$YR$$F$Y$$$20240924$$CN$KR$KR
243579041$24357904$1$I$20240301$20240924$20240924$20240924$DIR$719577$$FDA-CTU$$71$YR$$F$N$60.3$KG$20240924$N$CN$US$
243579051$24357905$1$I$20091206$20240923$20240923$20240923$DIR$719568$$FDA-CTU$$59$YR$$M$N$95.85$KG$20240923$N$CN$US$
243579061$24357906$1$I$$20240918$20240924$20240924$EXP$$US-INCYTE CORPORATION-2024IN009902$INCYTE$$$$$$Y$$$20240924$$CN$US$US
243579071$24357907$1$I$20240829$20240905$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052472$TOLMAR$$70$YR$$M$Y$$$20240923$$CN$CA$CA
243579081$24357908$1$I$20240904$20240904$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052465$TOLMAR$$18$YR$$F$Y$$$20240923$$CN$CA$CA
243579091$24357909$1$I$20240906$20240906$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052500$TOLMAR$$72$YR$$M$Y$$$20240923$$CN$CA$CA
243579111$24357911$1$I$20240905$20240905$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052503$TOLMAR$$87$YR$$M$Y$$$20240923$$CN$CA$CA
243579131$24357913$1$I$$20240909$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052518$TOLMAR$$$$$M$Y$$$20240923$$CN$CA$CA
243579141$24357914$1$I$20240906$20240906$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052539$TOLMAR$$85$YR$$M$Y$$$20240923$$CN$CA$CA
243579151$24357915$1$I$$20240906$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052540$TOLMAR$$$$$M$Y$$$20240923$$CN$CA$CA
243579161$24357916$1$I$20240701$20240909$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA052521$TOLMAR$$54$YR$$M$Y$$$20240923$$CN$CA$CA
243579181$24357918$1$I$20240821$20240904$20240924$20240924$PER$$CO-TOLMAR, INC.-24CO052511$TOLMAR$$9$YR$$F$Y$$$20240923$$CN$CO$CO
243579191$24357919$1$I$$20240906$20240924$20240924$PER$$DE-TOLMAR, INC.-24DE052471$TOLMAR$$$$$$Y$$$20240923$$CN$DE$DE
243579201$24357920$1$I$$20240905$20240924$20240924$PER$$DE-TOLMAR, INC.-24DE052498$TOLMAR$$$$$$Y$$$20240923$$MD$DE$DE
243579211$24357921$1$I$20240827$20240905$20240924$20240924$PER$$FR-TOLMAR, INC.-24FR052241$TOLMAR$$90$YR$$M$Y$$$20240923$$PH$FR$FR
243579221$24357922$1$I$$20240910$20240924$20240924$EXP$$NO-DEXPHARM-2024-3213$DEXCEL$Reitan Riibe, S.; Heitmann, K.; Schjott, J.; Riedel, B.  Healthcare           professionals^ information need related to antiseizure medication use           in breastfeeding patients with epilepsy. Retrospective analysis of           enquiries to Norwegian medicines information and pharmacovigilance           centers. Epilepsy and Behavior Reports 2023, V24, PJan 2023$$$I$$Y$$$20240924$$HP$NO$NO
243579231$24357923$1$I$20240605$20240913$20240924$20240924$PER$$CA-Eisai-EC-2024-174680$EISAI$$73$YR$E$M$Y$$$20240924$$HP$CA$CA
243579241$24357924$1$I$20240823$20240917$20240924$20240924$EXP$$CN-GSK-CN2024GSK116941$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$CN$CN
243579251$24357925$1$I$20240307$20240919$20240924$20240924$EXP$RO-EMA-DD-20240918-7482679-082626$RO-RDY-SPO/ROU/24/0013819$DR REDDYS$Desiderio G, Maria FD, Alkojok A, Galizia V, Arena G, Macarie I et al. Progresses And Challenges In The Management Of Multiple Myeloma: Navigating Through A Relapsing-Remitting Course. Medical Journal of Mariensis. 2024; Vol. 70, Suppl. 3:194$58$YR$A$M$Y$$$20240924$$HP$RO$RO
243579261$24357926$1$I$$20240313$20240924$20240924$EXP$$US-TAKEDA-2024TUS093204$TAKEDA$Yetiskul E, Nisar A, Khan S, Qaqish F, Khan D, Bershadskiy A. A case of acute myocardial infarction in a patient with essential thrombocythaemia treated with anagrelide. European Journal Of Case Reports In Internal Medicine. 2024;11(3):1-4$60$YR$$F$Y$$$20240924$$HP$US$US
243579271$24357927$1$I$$20240916$20240924$20240924$EXP$$NVSC2024US187974$NOVARTIS$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L et al.. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. ANN RHEUM DIS. 2022;81(2):289-91$$$A$$Y$$$20240924$$HP$US$US
243579282$24357928$2$F$$20240923$20240924$20240926$EXP$$NVSC2024US141418$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
243579291$24357929$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3246309$TEVA$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.; Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug...$37$YR$$M$Y$$$20240924$$HP$US$US
243579301$24357930$1$I$$20240910$20240924$20240924$EXP$$NO-DEXPHARM-2024-3214$DEXCEL$Reitan Riibe, S.; Heitmann, K.; Schjott, J.; Riedel, B.  Healthcare           professionals^ information need related to antiseizure medication use           in breastfeeding patients with epilepsy. Retrospective analysis of           enquiries to Norwegian medicines information and pharmacovigilance           centers. Epilepsy and Behavior Reports 2023, V24, PJan 2023$5$DY$N$$Y$$$20240924$$HP$NO$NO
243579311$24357931$1$I$$20240910$20240924$20240924$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00759$GLAND PHARMA$Ping Wang.Tumor necrosis factor-alpha inhibitor for successful treatment of toxic epidermal necrolysis with severe infection: a case series.Journal of International Medical Research.JAN-2024;52, No.1:1-9$24$YR$A$M$Y$$$20240924$$HP$CN$CN
243579321$24357932$1$I$20240603$20240919$20240924$20240924$EXP$GB-MHRA-MED-202408101728371230-ZVCRD$GB-Ipsen Biopharmaceuticals, Inc.-2024-15999$IPSEN$$77$YR$E$F$Y$$$20240924$$CN$GB$GB
243579381$24357938$1$I$20240809$20240923$20240923$20240923$DIR$719539$$FDA-CTU$$69$YR$$M$N$87.5$KG$20240923$N$HP$US$
243579391$24357939$1$I$20240101$20240903$20240924$20240924$EXP$$US-SA-2024SA272926$SANOFI AVENTIS$$63$YR$A$F$Y$54.422$KG$20240924$$MD$US$US
243579401$24357940$1$I$$20240923$20240924$20240924$EXP$$US-ABBVIE-5935865$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243579421$24357942$1$I$20240705$20240917$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148809$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$72.57$KG$20240924$$HP$US$US
243579431$24357943$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150189$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240924$$HP$US$US
243579441$24357944$1$I$$20240919$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149809$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240924$$HP$US$US
243579451$24357945$1$I$$20240916$20240924$20240924$EXP$$ES-TEVA-VS-3245919$TEVA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.; Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.$$$$$Y$$$20240924$$HP$ES$ES
243579461$24357946$1$I$$20240918$20240924$20240924$EXP$$PT-INCYTE CORPORATION-2024IN009897$INCYTE$$$$$$Y$$$20240924$$MD$PT$PT
243579491$24357949$1$I$20240718$20240917$20240924$20240924$EXP$$AU-BEH-2024179062$CSL BEHRING$$16$YR$T$F$Y$58.7$KG$20240924$$HP$AU$AU
243579501$24357950$1$I$$20240916$20240924$20240924$EXP$$US-BIOGEN-2024BI01282759$BIOGEN$$$$$M$Y$$$20240924$$CN$US$US
243579511$24357951$1$I$$20240923$20240924$20240924$EXP$$CA-BAYER-2024A135970$BAYER$$61$YR$A$F$Y$$$20240924$$HP$CA$CA
243579521$24357952$1$I$20240915$20240923$20240924$20240924$EXP$$US-BAYER-2024A135839$BAYER$$60$YR$A$M$Y$$$20240924$$CN$US$US
243579541$24357954$1$I$$20240910$20240924$20240924$EXP$$MY-GLANDPHARMA-MY-2024GLNLIT00766$GLAND PHARMA$CH Ding.Septicaemia due to Vibrio vulnificus: A tropical infection not to be taken lightly.Tropical Biomedicine.JUN-2024;41, No.2:157-159$67$YR$A$M$Y$$$20240924$$HP$MY$MY
243579551$24357955$1$I$20230611$20240918$20240924$20240924$EXP$FR-AFSSAPS-AM2024000733$FR-MYLANLABS-2024M1085159$MYLAN$$15$YR$$M$Y$65$KG$20240924$$MD$FR$FR
243579561$24357956$1$I$20240701$20240712$20240924$20240924$PER$$US-CIPLA LTD.-2024US07745$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243579571$24357957$1$I$$20240826$20240924$20240924$PER$$US-CIPLA LTD.-2024US07883$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243579581$24357958$1$I$$20240702$20240924$20240924$PER$$US-CIPLA LTD.-2024US07309$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243579591$24357959$1$I$$20240708$20240924$20240924$PER$$US-CIPLA LTD.-2024US07467$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243579601$24357960$1$I$20220101$20240918$20240924$20240924$EXP$$IT-MYLANLABS-2024M1086175$MYLAN$De Novellis D, Raimondo A, Serio B, Baldi C, Giudice V, Lembo S, et al. Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B. Photodermatol-Photoimmunol-Photomed 2024; 40 (3):.$55$YR$$M$Y$$$20240924$$HP$IT$IT
243579611$24357961$1$I$20240809$20240918$20240924$20240924$EXP$FR-AFSSAPS-LM2024000502$FR-MYLANLABS-2024M1085149$MYLAN$$96$YR$$F$Y$$$20240924$$MD$FR$FR
243579621$24357962$1$I$20240101$20240704$20240924$20240924$PER$$US-CIPLA LTD.-2024US07315$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243579631$24357963$1$I$20231001$20240712$20240924$20240924$PER$$US-CIPLA LTD.-2024US07692$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243579642$24357964$2$F$20240908$20240924$20240924$20240924$PER$$US-AMGEN-USASP2024189830$AMGEN$$68$YR$E$M$Y$$$20240924$$CN$US$US
243579651$24357965$1$I$$20240915$20240924$20240924$EXP$$TR-BAXTER-2024BAX024851$BAXTER$$23$YR$$M$Y$95$KG$20240924$$HP$TR$TR
243579671$24357967$1$I$$20240923$20240924$20240924$EXP$$CA-ORGANON-O2409CAN001697$ORGANON$$$$$F$Y$$$20240924$$HP$CA$CA
243579681$24357968$1$I$$20240917$20240924$20240924$PER$$US-ROCHE-10000085303$ROCHE$$32$YR$A$F$Y$$$20240924$$HP$US$US
243579691$24357969$1$I$20240801$20240918$20240924$20240924$EXP$$US-ABBVIE-5931130$ABBVIE$$70$YR$$M$Y$$$20240924$$CN$US$US
243579701$24357970$1$I$$20240723$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004067$PAREXEL$$77$YR$$F$Y$$$20240924$$CN$US$US
243579721$24357972$1$I$$20240917$20240924$20240924$EXP$$CH-PERRIGO-24CH008900$PERRIGO$Ziaka M, Liakoni E, Mani-Weber U, Exadaktylos A. Probable drug-induced systemic reaction without blood eosinophilia and rash- utility of eosinophilic cationic protein for diagnosis. International Journal of Immunopathology and Pharmacology. 2024;38:1-7. DOI: 10.1177/03946320241271712.$53$YR$$M$Y$$$20240924$$MD$CH$CH
243579731$24357973$1$I$$20240723$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004282$PAREXEL$$79$YR$$F$Y$$$20240924$$CN$US$US
243579741$24357974$1$I$20240905$20240905$20240924$20240924$PER$$CA-TOLMAR, INC.-24CA049692$TOLMAR$$79$YR$$M$Y$$$20240924$$CN$CA$CA
243579751$24357975$1$I$$20240917$20240924$20240924$EXP$$US-009507513-2409USA005895$MERCK$Phillipps J, Nassief G Morecroft R, Adeyelu T, Elliott A, Abdulla F, et al.. Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma. npj Precision Oncology. 2024;8 (1)::1-7$60$YR$$M$Y$$$20240924$$HP$US$US
243579761$24357976$1$I$20240801$20240919$20240924$20240924$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001913$BLUEPRINT MEDICINES$$31$YR$A$F$Y$$$20240924$$CN$US$US
243579781$24357978$1$I$$20240916$20240924$20240924$EXP$$BE-SA-2024SA274538$SANOFI AVENTIS$$$$A$$Y$$$20240924$$MD$BE$BE
243579791$24357979$1$I$20230401$20240920$20240924$20240924$EXP$$US-OTSUKA-2023_002064$OTSUKA$$93$YR$$F$Y$62.14$KG$20240924$$CN$US$US
243579801$24357980$1$I$20240805$20240924$20240924$20240924$EXP$FR-AFSSAPS-PO2024001005$FR-BAYER-2024A135840$BAYER$$24$YR$A$M$Y$$$20240924$$PH$FR$FR
243579811$24357981$1$I$20240823$20240918$20240924$20240924$EXP$$US-BAYER-2024A124066$BAYER$$59$YR$A$F$Y$$$20240924$$CN$US$US
243579821$24357982$1$I$20210101$20240919$20240924$20240924$EXP$$US-BAUSCH-BL-2023-011205$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240924$$CN$US$US
243579831$24357983$1$I$$20240912$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013640$DR REDDYS$$$$$F$Y$$$20240924$$CN$US$US
243579841$24357984$1$I$$20240913$20240924$20240924$EXP$$US-BEH-2024178843$CSL BEHRING$$$$A$M$Y$$$20240924$$HP$US$US
243579851$24357985$1$I$20240822$20240917$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013754$DR REDDYS$$45$YR$A$F$Y$$$20240924$$HP$US$US
243579861$24357986$1$I$$20240912$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013572$DR REDDYS$$26$YR$A$F$Y$$$20240924$$HP$US$US
243579871$24357987$1$I$20240913$20240916$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013663$DR REDDYS$$31$YR$A$F$Y$$$20240924$$MD$US$US
243579891$24357989$1$I$$20240821$20240924$20240924$PER$$US-Eisai-EC-2024-172470$EISAI$$$$$$Y$$$20240924$$HP$US$US
243579901$24357990$1$I$$20240917$20240924$20240924$EXP$$US-GSK-US2024115569$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$US$US
243579911$24357991$1$I$20240905$20240918$20240924$20240924$EXP$$US-SA-2024SA274662$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240924$$MD$US$US
243579921$24357992$1$I$20240101$20240916$20240924$20240924$EXP$SE-SEMPA-2024-006605$SE-FreseniusKabi-FK202413865$FRESENIUS KABI$$68$YR$E$F$Y$$$20240924$$MD$SE$SE
243579941$24357994$1$I$$20240918$20240924$20240924$EXP$$US-SA-2024SA272920$SANOFI AVENTIS$$$$E$F$Y$45.91$KG$20240924$$MD$US$US
243579951$24357995$1$I$$20240916$20240924$20240924$EXP$$NVSC2024US188024$NOVARTIS$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L et al.. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. ANN RHEUM DIS. 2022;81(2):289-91$$$A$$Y$$$20240924$$HP$US$US
243579961$24357996$1$I$$20231018$20240924$20240924$PER$$US-CELLTRION INC.-2023US017597$CELLTRION$$$$$$Y$$$20240924$$MD$US$US
243579971$24357997$1$I$20240829$20240919$20240924$20240924$EXP$FR-AFSSAPS-MP2024001367$FR-MYLANLABS-2024M1085518$MYLAN$$80$YR$$M$Y$82$KG$20240924$$PH$FR$FR
243579991$24357999$1$I$20240719$20240919$20240924$20240924$EXP$HR-HALMED-300086534$HR-MYLANLABS-2024M1085527$MYLAN$$$$A$F$Y$$$20240924$$MD$HR$HR
243580001$24358000$1$I$$20240917$20240924$20240924$PER$$US-PFIZER INC-202400259069$PFIZER$$15$YR$$M$Y$$$20240924$$CN$US$US
243580011$24358001$1$I$20230515$20240919$20240924$20240924$EXP$FR-AFSSAPS-AM2024000731$FR-MYLANLABS-2024M1085623$MYLAN$$18$YR$$M$Y$105$KG$20240924$$MD$FR$FR
243580021$24358002$1$I$20240913$20240921$20240924$20240924$EXP$GB-MHRA-MED-202409211856209780-FZLGM$GB-SA-2024SA274262$SANOFI AVENTIS$$22$YR$A$F$Y$53$KG$20240924$$CN$GB$GB
243580031$24358003$1$I$$20240919$20240924$20240924$EXP$$US-SA-2024SA275355$SANOFI AVENTIS$$65$YR$E$F$Y$57.73$KG$20240924$$MD$US$US
243580041$24358004$1$I$$20240919$20240924$20240924$EXP$$US-BAUSCH-BL-2024-014128$BAUSCH AND LOMB$Wang C, Ferreira J, Placek A, Aguayo-Hiraldo P, Raca G, Wood B, Miller K, Coates T, Freyer D, Kovach A. A de novo germline RUNX1 variant preceding development of concurrent T-lymphoblastic leukemia and myelodysplastic syndrome. Leukemia + Lymphoma. 2024;65(9):1357-1361. doi:10.1080/10428194.2024.2347577$12$YR$$F$Y$$$20240924$$HP$US$US
243580051$24358005$1$I$$20240919$20240924$20240924$EXP$GB-MHRA-MIDB-73e607ff-63a0-478b-ae93-0a66590b78ba$GB-SA-2024SA272601$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240924$$PH$GB$GB
243580061$24358006$1$I$20240916$20240916$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147804$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$MD$US$US
243580071$24358007$1$I$$20240918$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149144$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240924$$HP$US$US
243580081$24358008$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151046$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$$$20240924$$CN$US$US
243580091$24358009$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013774$ELI LILLY AND CO$$$$$M$Y$$$20240924$$CN$US$US
243580101$24358010$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013614$ELI LILLY AND CO$$37$YR$A$$Y$$$20240924$$CN$US$US
243580111$24358011$1$I$$20240918$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149397$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$PH$US$US
243580121$24358012$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014734$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240924$$CN$US$US
243580131$24358013$1$I$$20240912$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013607$ELI LILLY AND CO$$$$$$Y$$$20240924$$LW$US$US
243580141$24358014$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013559$ELI LILLY AND CO$$19$YR$A$M$Y$$$20240924$$CN$US$US
243580151$24358015$1$I$20240920$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013589$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240924$$CN$US$US
243580161$24358016$1$I$20240904$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013976$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240924$$CN$US$US
243580171$24358017$1$I$$20240918$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011981$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240924$$CN$US$US
243580181$24358018$1$I$$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011117$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240924$$CN$US$US
243580191$24358019$1$I$$20240909$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409005600$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240924$$CN$US$US
243580201$24358020$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013949$ELI LILLY AND CO$$75$YR$E$$Y$$$20240924$$CN$US$US
243580211$24358021$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013735$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243580221$24358022$1$I$20240920$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014355$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240924$$CN$US$US
243580232$24358023$2$F$$20240919$20240924$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409014339$ELI LILLY AND CO$$$$$$Y$$$20240930$$CN$US$US
243580241$24358024$1$I$20240922$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014418$ELI LILLY AND CO$$$$$M$Y$$$20240924$$CN$US$US
243580251$24358025$1$I$20240801$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011124$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240924$$CN$US$US
243580261$24358026$1$I$20240913$20240913$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409009065$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240924$$CN$US$US
243580271$24358027$1$I$$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409010734$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243580281$24358028$1$I$20240919$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013502$ELI LILLY AND CO$$21$YR$A$F$Y$$$20240924$$CN$US$US
243580291$24358029$1$I$$20240918$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011599$ELI LILLY AND CO$$$$$F$Y$$$20240924$$MD$US$US
243580301$24358030$1$I$$20240918$20240924$20240924$PER$$US-PFIZER INC-202400259268$PFIZER$$15$YR$$M$Y$$$20240924$$CN$US$US
243580311$24358031$1$I$$20240724$20240924$20240924$PER$$US-Ascend Therapeutics US, LLC-2161992$ASCEND$$$$$$Y$$$20240924$$$US$US
243580341$24358034$1$I$$20240916$20240924$20240924$EXP$$CA-BAUSCH-BL-2024-013954$BAUSCH AND LOMB$$63$YR$$M$Y$$$20240924$$CN$CA$CA
243580351$24358035$1$I$$20240920$20240924$20240924$PER$$US-HALEON-2198105$Haleon PLC$$80$WK$$M$Y$$$20240924$$CN$US$US
243580371$24358037$1$I$20150625$20240920$20240924$20240924$PER$$US-BIOGEN-2023BI01231132$BIOGEN$$17$YR$$M$Y$$$20240924$$HP$US$US
243580391$24358039$1$I$20191124$20240918$20240924$20240924$EXP$$HU-PERRIGO-21HU034931$PERRIGO$Aniko L, Agnes L, Monika K, Matyas M, Attila M. Tragic consequences of paracetamol therapy in chronic liver disease. Orvosi Hetilap. 2020;161(40):1720-3. DOI: 10.1556/650.2020.31752.$34$YR$$M$Y$$$20240924$$HP$HU$HU
243580401$24358040$1$I$20240506$20240912$20240924$20240924$PER$$JP-BRACCO-2024JP05862$BRACCO$$60$YR$$M$Y$$$20240924$$HP$JP$JP
243580411$24358041$1$I$20240919$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188848$AMGEN$$85$YR$E$M$Y$$$20240924$$PH$US$US
243580421$24358042$1$I$20240101$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189407$AMGEN$$$$A$F$Y$$$20240924$$CN$US$US
243580431$24358043$1$I$20220615$20240924$20240924$20240924$EXP$$JP-BAYER-2024A135859$BAYER$$67$YR$E$M$Y$$$20240924$$MD$JP$JP
243580441$24358044$1$I$$20240923$20240924$20240924$PER$$US-BAYER-2024A135598$BAYER$$$$$F$Y$$$20240924$$CN$US$US
243580481$24358048$1$I$$20240916$20240924$20240924$EXP$$CA-TAKEDA-2024TUS086065$TAKEDA$$$$$F$Y$$$20240924$$CN$CA$CA
243580491$24358049$1$I$$20240916$20240924$20240924$EXP$$CA-TAKEDA-2024TUS092723$TAKEDA$$$$$F$Y$$$20240924$$MD$CA$CA
243580501$24358050$1$I$$20240923$20240924$20240924$EXP$$CN-TAKEDA-2024TUS094603$TAKEDA$$$$$F$Y$$$20240924$$CN$CN$CN
243580511$24358051$1$I$$20240910$20240924$20240924$EXP$$US-GLANDPHARMA-US-2024GLNLIT00784$GLAND PHARMA$Gabriel Heering.Side Effects of Stem Cell Transplant Mimicking Symptoms of Known Amyloidosis.Case Reports in Gastroenterology.MAY-2024;18:273-278$67$YR$E$F$Y$$$20240924$$HP$US$US
243580521$24358052$1$I$$20240919$20240924$20240924$EXP$$US-JNJFOC-20240955007$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243580531$24358053$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-PV202400124690$PFIZER$$57$YR$$F$Y$$$20240924$$HP$US$US
243580541$24358054$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-PV202400124405$PFIZER$$$$$$Y$$$20240924$$CN$US$US
243580551$24358055$1$I$20240901$20240923$20240924$20240924$PER$$US-PFIZER INC-202400262637$PFIZER$$56$YR$$F$Y$83.91$KG$20240924$$CN$US$US
243580561$24358056$1$I$$20240921$20240924$20240924$PER$$US-PFIZER INC-PV202400124189$PFIZER$$$$$$Y$$$20240924$$CN$US$US
243580571$24358057$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-202400261735$PFIZER$$$$$M$Y$$$20240924$$MD$US$US
243580581$24358058$1$I$$20240921$20240924$20240924$PER$$US-PFIZER INC-PV202400123835$PFIZER$$59$YR$$F$Y$$$20240924$$HP$US$US
243580591$24358059$1$I$20240916$20240924$20240924$20240924$PER$$US-PFIZER INC-202400262756$PFIZER$$69$YR$$F$Y$$$20240924$$CN$US$US
243580602$24358060$2$F$20220101$20240923$20240924$20240927$PER$$US-PFIZER INC-202400261126$PFIZER$Liu, C.. Successful treatment of persistent symptomatic coronavirus disease 19 infection with extended-duration nirmatrelvir-ritonavir among outpatients with hematologic cancer. Open Forum Infectious Diseases. 2023;10(6):10.1093/ofid/ofad306$34$YR$$M$Y$$$20240927$$MD$US$US
243580611$24358061$1$I$20240922$20240923$20240924$20240924$PER$$US-PFIZER INC-202400262658$PFIZER$$61$YR$$M$Y$$$20240924$$CN$US$US
243580621$24358062$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-202400261834$PFIZER$$$$$F$Y$$$20240924$$CN$US$US
243580631$24358063$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-202400262097$PFIZER$$37$YR$$F$Y$$$20240924$$CN$US$US
243580651$24358065$1$I$20240317$20240924$20240924$20240924$DIR$719619$$FDA-CTU$$66$YR$$F$N$57.15$KG$20240924$N$PH$US$
243580671$24358067$1$I$$20240923$20240923$20240923$DIR$719530$$FDA-CTU$$$$$UNK$N$$$20240923$N$$US$
243580691$24358069$1$I$20240920$20240923$20240924$20240924$PER$$US-PFIZER INC-202400261907$PFIZER$$41$YR$$F$Y$$$20240924$$CN$US$US
243580701$24358070$1$I$20240921$20240922$20240924$20240924$PER$$US-PFIZER INC-202400261148$PFIZER$$$$$$Y$$$20240924$$CN$US$US
243580711$24358071$1$I$$20240921$20240924$20240924$PER$$US-PFIZER INC-PV202400124186$PFIZER$$$$$$Y$$$20240924$$CN$US$US
243580721$24358072$1$I$20240921$20240923$20240924$20240924$PER$$US-PFIZER INC-202400262654$PFIZER$$64$YR$$M$Y$$$20240924$$CN$US$US
243580741$24358074$1$I$$20240923$20240923$20240923$DIR$719435$$FDA-CTU$$$$$UNK$N$$$20240923$$CN$US$
243580751$24358075$1$I$20240923$20240923$20240924$20240924$PER$$US-PFIZER INC-202400262266$PFIZER$$54$YR$$F$Y$$$20240924$$CN$US$US
243580761$24358076$1$I$20240101$20240923$20240924$20240924$PER$$US-PFIZER INC-PV202400124512$PFIZER$$80$YR$$M$Y$$$20240924$$CN$US$US
243580771$24358077$1$I$20240923$20240923$20240924$20240924$PER$$US-PFIZER INC-202400262697$PFIZER$$69$YR$$F$Y$$$20240924$$CN$US$US
243580782$24358078$2$F$20220101$20240923$20240924$20240927$PER$$US-PFIZER INC-202400261144$PFIZER$Liu, C.. Successful treatment of persistent symptomatic coronavirus disease 19 infection with extended-duration nirmatrelvir-ritonavir among outpatients with hematologic cancer. Open Forum Infectious Diseases. 2023;10(6):10.1093/ofid/ofad306$55$YR$$M$Y$$$20240927$$MD$US$US
243580791$24358079$1$I$20240921$20240923$20240924$20240924$PER$$US-PFIZER INC-202400261970$PFIZER$$68$YR$$F$Y$$$20240924$$CN$US$US
243580811$24358081$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-202400262093$PFIZER$$$$$$Y$$$20240924$$CN$US$US
243580821$24358082$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-202400262108$PFIZER$$68$YR$$F$Y$$$20240924$$CN$US$US
243580831$24358083$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-202400262098$PFIZER$$$$$F$Y$$$20240924$$CN$US$US
243580841$24358084$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-202400261875$PFIZER$$69$YR$$F$Y$$$20240924$$CN$US$US
243580851$24358085$1$I$20240920$20240920$20240924$20240924$PER$$US-PFIZER INC-202400261592$PFIZER$$40$YR$$F$Y$$$20240924$$CN$US$US
243580871$24358087$1$I$20240923$20240923$20240924$20240924$PER$$US-PFIZER INC-202400262274$PFIZER$$46$YR$$M$Y$$$20240924$$CN$US$US
243580891$24358089$1$I$$20240917$20240924$20240924$EXP$$JP-OTSUKA-2024_024548$OTSUKA$$8$DEC$$F$Y$$$20240924$$PH$JP$JP
243580901$24358090$1$I$20230607$20240917$20240924$20240924$EXP$$CZ-GSK-CZ2024EME116235$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$CZ$CZ
243580911$24358091$1$I$$20240823$20240924$20240924$EXP$$NVSC2024FR175266$NOVARTIS$$56$YR$$M$Y$$$20240924$$HP$FR$FR
243580921$24358092$1$I$20240917$20240915$20240924$20240924$EXP$$CA-TAKEDA-2024TUS092241$TAKEDA$$40$YR$$F$Y$$$20240924$$CN$CA$CA
243580951$24358095$1$I$$20240917$20240924$20240924$EXP$$CA-ABBVIE-5929975$ABBVIE$$$$A$M$Y$$$20240924$$CN$CA$CA
243580961$24358096$1$I$$20240923$20240924$20240924$PER$$US-HALEON-2198447$Haleon PLC$$68$YR$$F$Y$$$20240924$$HP$US$US
243580971$24358097$1$I$$20240910$20240924$20240924$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00761$GLAND PHARMA$Zhenshun Cheng.Epstein-Barr virus (EBV) induced pneumonitis in a patient with breast cancer receiving neoadjuvant chemotherapy: A case report.Respiratory Medicine Case Reports.JAN-2023;45:1-5$52$YR$A$F$Y$$$20240924$$HP$CN$CN
243580981$24358098$1$I$$20240923$20240924$20240924$PER$$US-BAYER-2024A135758$BAYER$$77$YR$E$F$Y$$$20240924$$CN$US$US
243580991$24358099$1$I$$20240918$20240924$20240924$EXP$$US-ABBVIE-5931013$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243581001$24358100$1$I$20220227$20240912$20240924$20240924$EXP$$JP-RECORDATI RARE DISEASE INC.-2024007346$RECORDATI$$$$$$Y$$$20240924$$MD$JP$JP
243581011$24358101$1$I$$20240912$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145606$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240924$$CN$US$US
243581021$24358102$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150981$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240924$$HP$US$US
243581031$24358103$1$I$20220328$20240918$20240924$20240924$EXP$$NVSC2022IN076570$NOVARTIS$$60$YR$$M$Y$$$20240924$$CN$IN$IN
243581041$24358104$1$I$20240701$20240916$20240924$20240924$PER$$US-BAYER-2024A132331$BAYER$$66$YR$E$F$Y$$$20240924$$CN$US$US
243581061$24358106$1$I$$20240919$20240924$20240924$EXP$$US-OTSUKA-2024_026259$OTSUKA$$$$$F$Y$$$20240924$$MD$US$US
243581071$24358107$1$I$$20240919$20240924$20240924$EXP$$NVSC2024US188711$NOVARTIS$$$$$$Y$$$20240924$$MD$US$US
243581081$24358108$1$I$20240830$20240923$20240924$20240924$EXP$PT-INFARMED-J202409-281$NVSC2024PT188690$NOVARTIS$$42$YR$$F$Y$$$20240924$$HP$PT$PT
243581091$24358109$1$I$$20240911$20240924$20240924$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-09128$LUPIN$Jangid NC, Choudhary AN, Shah BJ, Shah SR, Vyas HR, Mistry D. Clinico-therapeutic study of Stevens Johnson syndrome-toxic epidermal necrolysis and prognostic significance of SCORTEN in Indian patients. Journal of Dermatology. 2024;69 (1):24-31$$$$$Y$$$20240924$$MD$IN$IN
243581101$24358110$1$I$$20240920$20240924$20240924$EXP$$NVSC2024BE188896$NOVARTIS$$$$A$M$Y$$$20240924$$MD$BE$BE
243581111$24358111$1$I$$20240910$20240924$20240924$EXP$$IN-GLANDPHARMA-IN-2024GLNLIT00777$GLAND PHARMA$Somarajan Anandan.A Very Rare Side Effect of a Very Commonly Used Drug:  Pantoprazole-induced Seizure.Journal of the Association of Physicians of India.AUG-2024;72:89$69$YR$A$F$Y$$$20240924$$HP$IN$IN
243581121$24358112$1$I$20220526$20240904$20240924$20240924$EXP$$AR-BIOMARINAP-AR-2024-160734$BIOMARIN$$$$$$Y$$$20240924$$CN$AR$AR
243581131$24358113$1$I$20240826$20240919$20240924$20240924$EXP$$US-OTSUKA-2024_023634$OTSUKA$$$$$M$Y$$$20240924$$HP$US$US
243581141$24358114$1$I$20240919$20240919$20240924$20240924$EXP$$US-OTSUKA-2024_026239$OTSUKA$$$$$M$Y$$$20240924$$CN$US$US
243581151$24358115$1$I$20240909$20240913$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013790$DR REDDYS$$42$YR$A$F$Y$$$20240924$$CN$US$US
243581171$24358117$1$I$$20240918$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013895$DR REDDYS$$70$YR$E$M$Y$$$20240924$$CN$US$US
243581181$24358118$1$I$$20240923$20240924$20240924$EXP$$CA-ORGANON-O2409CAN001680$ORGANON$$$$$F$Y$$$20240924$$HP$CA$CA
243581191$24358119$1$I$20240817$20240920$20240924$20240924$EXP$FR-AFSSAPS-PV2024000827$FR-TAKEDA-2024TUS094382$TAKEDA$$19$YR$$M$Y$$$20240924$$HP$FR$FR
243581201$24358120$1$I$$20240916$20240924$20240924$EXP$$ES-TEVA-VS-3245882$TEVA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.; Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.$$$$$Y$$$20240924$$HP$ES$ES
243581212$24358121$2$F$20240629$20240918$20240924$20240927$EXP$$US-ROCHE-10000077406$ROCHE$$53$YR$A$F$Y$77.11$KG$20240927$$CN$US$US
243581231$24358123$1$I$$20240910$20240924$20240924$EXP$$IL-GLANDPHARMA-IL-2024GLNLIT00764$GLAND PHARMA$Rotem Liran.A Severe Acute Kidney Injury Following Zoledronic Acid Therapy Leading to Chronic Hemodialysis Treatment: A Case Report.Israel Medical Association Journal: Imaj.DEC-2023;25:828-829$78$YR$E$F$Y$$$20240924$$MD$IL$IL
243581241$24358124$1$I$$20240705$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003389$PAREXEL$$78$YR$$F$Y$$$20240924$$CN$US$US
243581261$24358126$1$I$20240828$20240919$20240924$20240924$EXP$$AR-MYLANLABS-2024M1083500$MYLAN$$73$YR$$F$Y$$$20240924$$CN$AR$AR
243581281$24358128$1$I$$20240717$20240924$20240924$PER$$US-Ascend Therapeutics US, LLC-2161993$ASCEND$$$$$$Y$$$20240924$$$US$US
243581291$24358129$1$I$$20240920$20240924$20240924$EXP$$CY-PERRIGO-24CY008908$PERRIGO$Vougiouklakis G, Agouridis AP, Alexakis K, Mamilos A, Spernovasilis N. Herpes Simplex Virus Esophagitis in a Patient Receiving Long-Term Nasal Corticosteroids: A Rare Case. Cureus. 2024;16(8):e66631. DOI:10.7759/cureus.66631.$35$YR$$M$Y$$$20240924$$MD$CY$CY
243581321$24358132$1$I$20220723$20240916$20240924$20240924$EXP$$ID-009507513-2409IDN007125$MERCK$$49$YR$$M$Y$$$20240924$$MD$ID$ID
243581331$24358133$1$I$$20240911$20240924$20240924$EXP$$CA-APOTEX-2024AP010534$APOTEX$$48$YR$$M$Y$$$20240924$$HP$CA$CA
243581341$24358134$1$I$20240917$20240923$20240924$20240924$PER$$US-BAYER-2024A135450$BAYER$$25$YR$A$F$Y$$$20240924$$MD$US$US
243581351$24358135$1$I$$20240910$20240924$20240924$EXP$$IT-GLANDPHARMA-IT-2024GLNLIT00762$GLAND PHARMA$N Ragone.Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case.International Clinical Psychopharmacology.MAR-2024;39(2):117-119$64$YR$A$F$Y$$$20240924$$HP$IT$IT
243581361$24358136$1$I$$20240920$20240924$20240924$EXP$$GB-ABBVIE-5935605$ABBVIE$$$$E$F$Y$$$20240924$$PH$GB$GB
243581371$24358137$1$I$$20240920$20240924$20240924$EXP$$AU-MYLANLABS-2024M1086029$MYLAN$$$$$M$Y$$$20240924$$PH$AU$AU
243581381$24358138$1$I$20240815$20240912$20240924$20240924$EXP$$CN-ROCHE-10000086067$ROCHE$$56$YR$A$F$Y$$$20240924$$HP$CN$CN
243581391$24358139$1$I$20230110$20240919$20240924$20240924$EXP$FR-AFSSAPS-PC2024000719$FR-009507513-2409FRA006980$MERCK$$67$YR$$M$Y$94$KG$20240924$$PH$FR$FR
243581401$24358140$1$I$$20240916$20240924$20240924$EXP$$CA-BAUSCH-BL-2024-014011$BAUSCH AND LOMB$$$$$F$Y$$$20240924$$HP$CA$CA
243581411$24358141$1$I$$20240919$20240924$20240924$EXP$$RO-AMGEN-ROUSP2024187422$AMGEN$$59$YR$A$M$Y$$$20240924$$MD$RO$RO
243581431$24358143$1$I$$20240917$20240924$20240924$EXP$$JP-JNJFOC-A-CH2020-202626$JOHNSON AND JOHNSON$$$$I$F$Y$$$20240924$$MD$JP$JP
243581441$24358144$1$I$$20240916$20240924$20240924$EXP$$CA-BAUSCH-BL-2024-014028$BAUSCH AND LOMB$$$$$F$Y$$$20240924$$HP$CA$CA
243581451$24358145$1$I$$20240916$20240924$20240924$EXP$$CA-BAUSCH-BL-2024-014022$BAUSCH AND LOMB$$58$YR$$F$Y$$$20240924$$HP$CA$CA
243581461$24358146$1$I$$20240924$20240924$20240924$DIR$719623$$FDA-CTU$$$$$UNK$N$$$20240924$$CN$US$
243581471$24358147$1$I$20240909$20240923$20240923$20240923$DIR$719426$$FDA-CTU$$54$YR$$F$N$46.8$KG$20240923$N$CN$US$
243581481$24358148$1$I$20231101$20240924$20240924$20240924$DIR$719606$$FDA-CTU$$67$YR$$M$N$67.5$KG$20240924$N$CN$US$
243581491$24358149$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65272$$FDA-CTU$$$$$F$N$$$20240923$N$HP$US$
243581501$24358150$1$I$20240923$20240923$20240923$20240923$DIR$719498$$FDA-CTU$$$$$UNK$N$$$20240923$N$CN$US$
243581511$24358151$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65273$$FDA-CTU$$75$YR$$F$N$$$20240924$N$$US$
243581531$24358153$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65274$$FDA-CTU$$65$YR$$F$N$$$20240924$N$$US$
243581551$24358155$1$I$$20240917$20240924$20240924$EXP$$FR-GSK-FR2024EME116294$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$MD$FR$FR
243581561$24358156$1$I$20240901$20240919$20240924$20240924$EXP$$FR-ABBVIE-5935415$ABBVIE$$$$$$Y$$$20240924$$MD$FR$FR
243581571$24358157$1$I$20230920$20240917$20240924$20240924$EXP$FR-AFSSAPS-TS2024000974$FR-TEVA-VS-3244506$TEVA$$$$$M$Y$1.805$KG$20240924$$MD$FR$FR
243581581$24358158$1$I$$20240920$20240924$20240924$PER$$US-PFIZER INC-2022SGN10346$PFIZER$$60$YR$$F$Y$$$20240924$$CN$US$US
243581591$24358159$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65287$$FDA-CTU$$76$YR$$F$N$$$20240924$N$$US$
243581601$24358160$1$I$$20240923$20240923$20240923$DIR$719491$$FDA-CTU$$$$$UNK$N$$$20240923$N$CN$US$
243581611$24358161$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65275$$FDA-CTU$$56$YR$$F$N$$$20240924$N$CN$US$
243581621$24358162$1$I$20240725$20240920$20240924$20240924$EXP$FR-AFSSAPS-TO2024001441$FR-LUNDBECK-DKLU4003675$LUNDBECK$$$$$$Y$$$20240924$$PH$FR$FR
243581631$24358163$1$I$20240721$20240923$20240923$20240923$DIR$719489$$FDA-CTU$$16$YR$$M$N$76.5$KG$20240923$N$CN$US$
243581641$24358164$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65279$$FDA-CTU$$$$$F$N$$$20240923$N$HP$US$
243581651$24358165$1$I$$20240919$20240924$20240924$PER$$US-TAKEDA-2024TUS093510$TAKEDA$$$$$M$Y$72$KG$20240924$$MD$US$US
243581661$24358166$1$I$20240923$20240924$20240924$20240924$PER$$US-BAYER-2024A136511$BAYER$$40$YR$A$F$Y$$$20240924$$HP$US$US
243581671$24358167$1$I$$20240923$20240924$20240924$EXP$$US-VANTIVE-2024VAN019980$Vantive US Healthcare$$$$$F$Y$$$20240924$$HP$US$US
243581682$24358168$2$F$20240913$20240924$20240924$20240926$EXP$$VN-VANTIVE-2024VAN019905$Vantive US Healthcare$$$$A$F$Y$$$20240926$$MD$VN$VN
243581712$24358171$2$F$$20240923$20240924$20240930$EXP$$IN-VANTIVE-2024VAN019931$Vantive US Healthcare$$67$YR$$M$Y$$$20240930$$CN$IN$IN
243581721$24358172$1$I$$20240920$20240924$20240924$EXP$$NVSC2024US130758$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243581733$24358173$3$F$$20240919$20240924$20240927$PER$$NVSC2024US190035$NOVARTIS$$52$YR$$F$Y$$$20240927$$HP$US$US
243581741$24358174$1$I$$20240919$20240924$20240924$EXP$$CN-VANTIVE-2024VAN019919$Vantive US Healthcare$$$$$M$Y$$$20240924$$CN$CN$CN
243581751$24358175$1$I$20240913$20240923$20240924$20240924$EXP$$SG-VANTIVE-2024VAN019968$Vantive US Healthcare$$86$YR$$M$Y$$$20240924$$CN$SG$SG
243581761$24358176$1$I$$20240919$20240924$20240924$PER$$NVSC2024US188311$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243581771$24358177$1$I$$20240919$20240924$20240924$EXP$$IN-VANTIVE-2024VAN019929$Vantive US Healthcare$$77$YR$$M$Y$$$20240924$$CN$IN$IN
243581781$24358178$1$I$20240906$20240920$20240924$20240924$EXP$$SG-VANTIVE-2024VAN019909$Vantive US Healthcare$$74$YR$$M$Y$$$20240924$$CN$SG$SG
243581791$24358179$1$I$$20240805$20240924$20240924$EXP$$FR-VANTIVE-2024VAN019851$Vantive US Healthcare$$$$$$Y$$$20240924$$HP$FR$FR
243581801$24358180$1$I$20211221$20240919$20240924$20240924$EXP$$JP-LUNDBECK-DKLU4004516$LUNDBECK$$$$$$Y$$$20240924$$MD$JP$JP
243581812$24358181$2$F$20240916$20240926$20240924$20240926$30DAY$$US-PFIZER INC-202400258273$PFIZER$$$$$M$Y$$$20240926$$CN$US$US
243581823$24358182$3$F$$20240924$20240924$20240927$30DAY$$US-PFIZER INC-202400258733$PFIZER$$13$YR$$F$Y$$$20240927$$HP$US$US
243581831$24358183$1$I$$20240917$20240924$20240924$30DAY$$US-PFIZER INC-202400258388$PFIZER$$12$YR$$M$Y$40.82$KG$20240924$$CN$US$US
243581841$24358184$1$I$20240101$20240917$20240924$20240924$30DAY$$US-PFIZER INC-202400258496$PFIZER$$12$YR$$M$Y$$$20240924$$CN$US$US
243581852$24358185$2$F$20240901$20240924$20240924$20240927$30DAY$$US-PFIZER INC-202400258384$PFIZER$$14$YR$$M$Y$$$20240927$$CN$US$US
243581861$24358186$1$I$20240101$20240917$20240924$20240924$30DAY$$US-PFIZER INC-202400258675$PFIZER$$8$YR$$M$Y$$$20240924$$CN$US$US
243581871$24358187$1$I$$20240918$20240924$20240924$EXP$$GB-AMGEN-GBRSP2024186617$AMGEN$Chavda S. J.. Real World Analysis of the Incidence and Impact of Hypertension and Cardiac Toxicity Associated with Carfilzomib for Patients with Multiple Myeloma. Blood. 2018;132 (1):3255$$$$$Y$$$20240924$$MD$GB$GB
243581882$24358188$2$F$$20240924$20240924$20240927$PER$$NVSC2024US190041$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
243581892$24358189$2$F$20240801$20240920$20240924$20240926$EXP$$US-JNJFOC-20240956249$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240926$$CN$US$US
243581901$24358190$1$I$$20240918$20240924$20240924$EXP$$US-TAKEDA-2024TUS093759$TAKEDA$$67$YR$$M$Y$$$20240924$$CN$US$US
243581911$24358191$1$I$$20240919$20240924$20240924$EXP$$US-KYOWAKIRIN-2024KK021793$KYOWA$$$$$$Y$$$20240924$$HP$US$US
243581922$24358192$2$F$$20240923$20240924$20240926$EXP$$CA-TAKEDA-2024TUS089037$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
243581941$24358194$1$I$$20240918$20240924$20240924$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-19126$IPSEN$$10$YR$C$M$Y$37.1$KG$20240924$$CN$US$US
243581951$24358195$1$I$$20240917$20240924$20240924$30DAY$$US-PFIZER INC-202400258540$PFIZER$$58$YR$$F$Y$$$20240924$$CN$US$US
243581962$24358196$2$F$20240915$20240919$20240924$20240926$30DAY$$US-PFIZER INC-202400257624$PFIZER$$11$YR$$M$Y$$$20240926$$CN$US$US
243581971$24358197$1$I$20240915$20240916$20240924$20240924$30DAY$$US-PFIZER INC-202400257524$PFIZER$$14$YR$$M$Y$45.351$KG$20240924$$CN$US$US
243581981$24358198$1$I$20240824$20240918$20240924$20240924$EXP$FR-AFSSAPS-MP2024001357$FR-009507513-2409FRA006481$MERCK$$90$YR$$M$Y$60$KG$20240924$$PH$FR$FR
243581991$24358199$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3246310$TEVA$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.; Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug...$17$YR$$M$Y$$$20240924$$HP$US$US
243582001$24358200$1$I$$20240920$20240924$20240924$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-151416$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$HP$CO$CO
243582012$24358201$2$F$20240701$20240923$20240924$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151064$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240925$$PH$US$US
243582021$24358202$1$I$20240904$20240909$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150793$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240924$$HP$US$US
243582031$24358203$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151274$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240924$$HP$US$US
243582041$24358204$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150706$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240924$$CN$US$US
243582061$24358206$1$I$$20240916$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147971$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$59$KG$20240924$$PH$US$US
243582071$24358207$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150690$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240924$$CN$US$US
243582081$24358208$1$I$20240904$20240913$20240924$20240924$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409009171$ELI LILLY AND CO$$60$YR$A$F$Y$76$KG$20240924$$CN$CN$CN
243582091$24358209$1$I$$20240917$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409010616$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243582101$24358210$1$I$20240904$20240911$20240924$20240924$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409007448$ELI LILLY AND CO$$68$YR$E$F$Y$67$KG$20240924$$CN$CN$CN
243582111$24358211$1$I$20240620$20240620$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202406014768$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240924$$CN$US$US
243582121$24358212$1$I$20240703$20240911$20240924$20240924$EXP$IT-MINISAL02-1001876$IT-ELI_LILLY_AND_COMPANY-IT202409008695$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240924$$CN$IT$IT
243582131$24358213$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151033$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240924$$MD$US$US
243582141$24358214$1$I$$20240912$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409008526$ELI LILLY AND CO$$84$YR$E$F$Y$$$20240924$$CN$US$US
243582161$24358216$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014033$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240924$$CN$US$US
243582171$24358217$1$I$$20240918$20240924$20240924$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409012403$ELI LILLY AND CO$$$$E$F$Y$$$20240924$$CN$JP$JP
243582181$24358218$1$I$20240101$20240918$20240924$20240924$EXP$$CR-ELI_LILLY_AND_COMPANY-CR202409013388$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240924$$CN$CR$CR
243582191$24358219$1$I$20240903$20240912$20240924$20240924$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202409008490$ELI LILLY AND CO$$60$YR$A$$Y$$$20240924$$MD$BE$BE
243582201$24358220$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013472$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240924$$CN$US$US
243582212$24358221$2$F$20240910$20240919$20240924$20240926$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409010105$ELI LILLY AND CO$$25$YR$A$M$Y$$$20240926$$CN$JP$JP
243582221$24358222$1$I$20240905$20240914$20240924$20240924$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409010242$ELI LILLY AND CO$$69$YR$E$M$Y$50$KG$20240924$$CN$DE$CN
243582231$24358223$1$I$20240905$20240913$20240924$20240924$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409008900$ELI LILLY AND CO$$59$YR$A$M$Y$72$KG$20240924$$CN$CN$CN
243582241$24358224$1$I$20240202$20240916$20240924$20240924$EXP$IT-MINISAL02-1001823$IT-ELI_LILLY_AND_COMPANY-IT202409010824$ELI LILLY AND CO$$73$YR$E$F$Y$65$KG$20240924$$CN$DE$IT
243582251$24358225$1$I$20221101$20240912$20240924$20240924$EXP$FR-AFSSAPS-LM2024000507$FR-ELI_LILLY_AND_COMPANY-FR202409009338$ELI LILLY AND CO$$52$YR$A$M$Y$72$KG$20240924$$CN$FR$FR
243582261$24358226$1$I$$20240913$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009982$ELI LILLY AND CO$$$$$M$Y$$$20240924$$CN$US$US
243582271$24358227$1$I$20240517$20240913$20240924$20240924$EXP$FR-AFSSAPS-AM2024000717$FR-ELI_LILLY_AND_COMPANY-FR202409009564$ELI LILLY AND CO$$82$YR$E$M$Y$61$KG$20240924$$CN$FR$FR
243582291$24358229$1$I$20240827$20240912$20240924$20240924$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409009531$ELI LILLY AND CO$$44$YR$A$$Y$$$20240924$$CN$FR$FR
243582311$24358231$1$I$20240702$20240913$20240924$20240924$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409010344$ELI LILLY AND CO$$$$$$Y$$$20240924$$HP$GB$GB
243582321$24358232$1$I$20240904$20240912$20240924$20240924$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409009744$ELI LILLY AND CO$$54$YR$A$M$Y$62$KG$20240924$$CN$DE$CN
243582331$24358233$1$I$20240905$20240914$20240924$20240924$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409011112$ELI LILLY AND CO$$48$YR$A$F$Y$50$KG$20240924$$CN$CN$CN
243582341$24358234$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151053$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240924$$HP$US$US
243582361$24358236$1$I$20240805$20240919$20240924$20240924$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409014184$ELI LILLY AND CO$$86$YR$E$F$Y$$$20240924$$CN$JP$JP
243582371$24358237$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65285$$FDA-CTU$$62$YR$$F$N$35.83$KG$20240924$N$$US$
243582381$24358238$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65290$$FDA-CTU$$23$YR$$F$N$$$20240924$N$$US$
243582391$24358239$1$I$20240923$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65283$$FDA-CTU$$23$YR$$F$N$$$20240924$N$HP$US$
243582401$24358240$1$I$20230224$20240913$20240924$20240924$EXP$$FR-JNJFOC-20240850853$JOHNSON AND JOHNSON$$67$YR$E$M$Y$82$KG$20240924$$HP$FR$FR
243582411$24358241$1$I$20240101$20240904$20240924$20240924$PER$$US-009507513-2409USA001848$MERCK$$$$$M$Y$$$20240924$$CN$US$US
243582421$24358242$1$I$20240914$20240916$20240924$20240924$EXP$$US-GENMAB-2024-03351$GENMAB$$66$YR$$F$Y$80.272$KG$20240924$$CN$US$US
243582431$24358243$1$I$$20240920$20240924$20240924$EXP$$MX-BAYER-2024A136481$BAYER$$78$YR$E$M$Y$$$20240924$$CN$MX$MX
243582441$24358244$1$I$20240901$20240916$20240924$20240924$PER$$US-ABBVIE-5926573$ABBVIE$$$$A$F$Y$$$20240924$$HP$US$US
243582451$24358245$1$I$$20240917$20240924$20240924$EXP$$JP-TAKEDA-2024TUS094314$TAKEDA$$66$YR$$F$Y$$$20240924$$MD$JP$JP
243582461$24358246$1$I$$20240917$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024PT081875$SANDOZ$NehemiasGuevara- Rodriguez. A rare adverse event of atorvastatin inducingleukocytoclastic vasculitis with ANCA-negative(Anti- Neutrophil cytoplasmic antibody) case report andliterature review. Clinical case report. 2023;11:e7030.$55$YR$$F$Y$$$20240924$$HP$US$PT
243582471$24358247$1$I$$20240919$20240924$20240924$EXP$GB-MHRA-MED-202409190800175420-JHKMS$GB-TEVA-VS-3245865$TEVA$$$$$F$Y$$$20240924$$CN$GB$GB
243582481$24358248$1$I$20240914$20240921$20240924$20240924$EXP$$IN-ROCHE-10000089043$ROCHE$$58$YR$A$M$Y$$$20240924$$CN$IN$IN
243582491$24358249$1$I$$20240917$20240924$20240924$PER$$US-BIOVITRUM-2024-US-010852$BIOVITRUM$$78$YR$$F$Y$$$20240924$$CN$US$US
243582501$24358250$1$I$20240922$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150840$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240924$$CN$US$US
243582511$24358251$1$I$$20240922$20240924$20240924$EXP$$CA-BIOVITRUM-2024-CA-012359$BIOVITRUM$$59$YR$$F$Y$$$20240924$$HP$CA$CA
243582521$24358252$1$I$20220314$20240920$20240924$20240924$EXP$$CA-SANDOZ INC.-NVSC2022CA135050$SANDOZ$$66$YR$$M$Y$$$20240924$$MD$CA$CA
243582531$24358253$1$I$20240101$20240910$20240924$20240924$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240100120$UPSHER SMITH LABORATORIES$$$$$F$Y$$$20240924$$$US$US
243582541$24358254$1$I$20240904$20240918$20240924$20240924$EXP$$US-OTSUKA-2024_026127$OTSUKA$$$$$F$Y$$$20240924$$CN$US$US
243582551$24358255$1$I$$20240816$20240924$20240924$PER$$US-Eisai-EC-2024-172329$EISAI$$$$$$Y$$$20240924$$MD$US$US
243582561$24358256$1$I$$20240923$20240924$20240924$EXP$$CA-ORGANON-O2409CAN001706$ORGANON$$43$YR$$F$Y$$$20240924$$HP$CA$CA
243582571$24358257$1$I$$20240919$20240924$20240924$EXP$$GB-SANDOZ INC.-SDZ2024GB082194$SANDOZ$$$$$F$Y$$$20240924$$CN$GB$GB
243582581$24358258$1$I$20240522$20240909$20240924$20240924$EXP$$FR-PIERREL S.P.A.-2024PIR00058$PIERREL$$8$YR$$M$Y$$$20240924$$CN$FR$FR
243582601$24358260$1$I$$20240919$20240924$20240924$EXP$$NVSC2024DE189482$NOVARTIS$$$$$M$Y$$$20240924$$MD$DE$DE
243582611$24358261$1$I$$20240911$20240924$20240924$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240600122$UPSHER SMITH LABORATORIES$$$$$F$Y$$$20240924$$MD$US$US
243582621$24358262$1$I$$20240819$20240924$20240924$PER$$US-Ascend Therapeutics US, LLC-2161994$ASCEND$$$$$F$Y$$$20240924$$$US$US
243582631$24358263$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65291$$FDA-CTU$$$$$F$N$$$20240923$N$HP$US$
243582641$24358264$1$I$20240911$20240917$20240924$20240924$PER$$US-Vifor (International) Inc.-VIT-2024-08602$VIFOR$$74$YR$$M$Y$67.5$KG$20240924$$HP$US$US
243582651$24358265$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65292$$FDA-CTU$$62$YR$$F$N$$$20240924$N$$US$
243582661$24358266$1$I$20240923$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65288$$FDA-CTU$$72$YR$$F$N$$$20240924$Y$HP$US$
243582671$24358267$1$I$20240701$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65294$$FDA-CTU$$12$YR$$M$N$$$20240924$N$PH$US$
243582681$24358268$1$I$20240912$20240917$20240924$20240924$PER$$US-Vifor (International) Inc.-VIT-2024-08595$VIFOR$$62$YR$$F$Y$61$KG$20240924$$HP$US$US
243582692$24358269$2$F$$20240915$20240924$20240924$PER$$US-ROCHE-10000082961$ROCHE$$$$$$Y$$$20240924$$CN$US$US
243582701$24358270$1$I$20240808$20240923$20240923$20240923$DIR$719504$$FDA-CTU$$50$YR$$M$N$80.64$KG$20240923$N$HP$US$
243582721$24358272$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150929$BRISTOL MYERS SQUIBB$$94$YR$E$M$Y$78.02$KG$20240924$$HP$US$US
243582731$24358273$1$I$$20240919$20240924$20240924$EXP$$CA-SANDOZ INC.-NVSC2022CA190523$SANDOZ$$$$$M$Y$$$20240924$$CN$CA$CA
243582741$24358274$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151009$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240924$$HP$US$US
243582751$24358275$1$I$20240912$20240918$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US081358$SANDOZ$$56$YR$$M$Y$$$20240924$$CN$US$US
243582761$24358276$1$I$$20240910$20240924$20240924$EXP$$CA-HLS-202402281$HLS THERAPEUTICS$$54$YR$A$M$Y$$$20240924$$HP$CA$CA
243582771$24358277$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65293$$FDA-CTU$$77$YR$$M$N$$$20240924$N$$US$
243582781$24358278$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65286$$FDA-CTU$$$$$M$N$$$20240924$N$HP$US$
243582791$24358279$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65284$$FDA-CTU$$$$$F$N$$$20240923$N$HP$US$
243582801$24358280$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65289$$FDA-CTU$$$$$M$N$$$20240923$N$HP$US$
243582811$24358281$1$I$$20240911$20240924$20240924$EXP$$GB-SA-2024SA274351$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240924$$CN$GB$GB
243582831$24358283$1$I$$20240913$20240924$20240924$EXP$$US-SA-2024SA275225$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$MD$US$US
243582841$24358284$1$I$$20240924$20240924$20240924$EXP$$ES-SANDOZ INC.-SDZ2024ES082392$SANDOZ$$39$YR$$F$Y$$$20240924$$HP$ES$ES
243582851$24358285$1$I$$20231006$20240924$20240924$PER$$US-CELLTRION INC.-2023US017056$CELLTRION$$$$$$Y$$$20240924$$MD$US$US
243582861$24358286$1$I$$20240923$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US082522$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243582871$24358287$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150845$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240924$$CN$US$US
243582881$24358288$1$I$$20240917$20240924$20240924$EXP$$US-SA-2024SA274122$SANOFI AVENTIS$$2$YR$C$$Y$$$20240924$$MD$US$US
243582891$24358289$1$I$20221101$20240924$20240924$20240924$EXP$GR-009507513-2409GRC003917$GR-SANDOZ INC.-SDZ2024GR082414$SANDOZ$$73$YR$$M$Y$$$20240924$$MD$GR$GR
243582901$24358290$1$I$20240901$20240924$20240924$20240924$EXP$$DE-SANDOZ INC.-SDZ2024DE082411$SANDOZ$$53$YR$$F$Y$$$20240924$$MD$DE$DE
243582911$24358291$1$I$20240823$20240917$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013841$DR REDDYS$$18$YR$A$M$Y$$$20240924$$HP$US$US
243582921$24358292$1$I$$20240911$20240924$20240924$EXP$AU-GUERBET / ASPEN AUSTRALIA-AU-20240064$AU-GUERBET / LLC-AU-20240064$GUERBET$$33$YR$A$M$Y$$$20240924$$HP$AU$AU
243582931$24358293$1$I$20221230$20240918$20240924$20240924$EXP$$CN-TEVA-VS-3245288$TEVA$$66$YR$$M$Y$$$20240924$$HP$CN$CN
243582941$24358294$1$I$$20240816$20240924$20240924$PER$$US-Eisai-EC-2024-172333$EISAI$$$$$F$Y$$$20240924$$HP$US$US
243582952$24358295$2$F$$20240925$20240924$20240926$PER$$US-AMGEN-USASP2024189608$AMGEN$$$$$F$Y$$$20240926$$HP$US$US
243582961$24358296$1$I$$20240816$20240924$20240924$PER$$US-Eisai-EC-2024-172630$EISAI$$$$$M$Y$$$20240924$$CN$US$US
243582971$24358297$1$I$20240922$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189829$AMGEN$$69$YR$E$M$Y$$$20240924$$CN$US$US
243582982$24358298$2$F$20240830$20240923$20240924$20240930$EXP$FR-AFSSAPS-AN2024001268$FR-SA-2024SA275335$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240930$$PH$FR$FR
243583001$24358300$1$I$20240914$20240918$20240924$20240924$EXP$$CO-TAKEDA-2024TUS093904$TAKEDA$$44$YR$$M$Y$65$KG$20240924$$CN$CO$CO
243583011$24358301$1$I$$20230906$20240924$20240924$PER$$US-CELLTRION INC.-2023US017631$CELLTRION$$$$$$Y$$$20240924$$CN$US$US
243583021$24358302$1$I$20240822$20240917$20240924$20240924$EXP$FR-AFSSAPS-RE2024000867$FR-TEVA-VS-3244609$TEVA$$34$YR$$F$Y$59$KG$20240924$$MD$FR$FR
243583031$24358303$1$I$20240101$20240923$20240924$20240924$EXP$$US-SA-2024SA269865$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240924$$MD$US$US
243583041$24358304$1$I$$20240913$20240924$20240924$PER$$US-DAIICHI SANKYO, INC.-DS-2024-100243-US$DAIICHI$$62$YR$$F$Y$$$20240924$$MD$US$US
243583051$24358305$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014749$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240924$$CN$US$US
243583061$24358306$1$I$$20240918$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012041$ELI LILLY AND CO$$48$YR$A$$Y$$$20240924$$CN$US$US
243583071$24358307$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012617$ELI LILLY AND CO$$$$$F$Y$$$20240924$$CN$US$US
243583081$24358308$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014273$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240924$$CN$US$US
243583091$24358309$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013959$ELI LILLY AND CO$$49$YR$A$$Y$$$20240924$$HP$US$US
243583101$24358310$1$I$$20240922$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014290$ELI LILLY AND CO$$$$$M$Y$$$20240924$$CN$US$US
243583111$24358311$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013821$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240924$$CN$US$US
243583131$24358313$1$I$20240101$20240912$20240924$20240924$PER$$US-JNJFOC-20240932076$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243583141$24358314$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013453$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240924$$CN$US$US
243583151$24358315$1$I$20240901$20240909$20240924$20240924$PER$$US-JNJFOC-20240937735$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$MD$US$US
243583161$24358316$1$I$$20240918$20240924$20240924$EXP$$IN-SANDOZ INC.-SDZ2024IN081981$SANDOZ$$$$$M$Y$$$20240924$$CN$IN$IN
243583191$24358319$1$I$20240802$20240919$20240924$20240924$EXP$PT-INFARMED-T202409-152$PT-009507513-2409PRT007093$MERCK$$83$YR$$M$Y$60$KG$20240924$$PH$PT$PT
243583201$24358320$1$I$$20240904$20240924$20240924$PER$$US-TEVA-VS-3240501$TEVA$$$$$F$Y$$$20240924$$CN$US$US
243583211$24358321$1$I$$20240920$20240924$20240924$EXP$$GB-ABBVIE-5933772$ABBVIE$$$$$F$Y$$$20240924$$HP$GB$GB
243583221$24358322$1$I$20240829$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65305$$FDA-CTU$$7$YR$$F$N$$$20240924$N$HP$US$
243583251$24358325$1$I$$20240917$20240924$20240924$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-24942$SAMSUNG BIOEPIS$$61$YR$A$M$Y$$$20240924$$CN$GB$GB
243583261$24358326$1$I$20230309$20240919$20240924$20240924$EXP$FR-AFSSAPS-PC2024000718$FR-009507513-2409FRA007192$MERCK$$75$YR$$M$Y$78$KG$20240924$$PH$FR$FR
243583271$24358327$1$I$20240902$20240911$20240924$20240924$EXP$GB-MHRA-MED-202409111945085200-JDNPH$GB-GUERBET / LLC-GB-20240126$GUERBET$$59$YR$A$$Y$67$KG$20240924$$HP$GB$GB
243583291$24358329$1$I$20240818$20240919$20240924$20240924$EXP$$SE-TAKEDA-2024TUS093455$TAKEDA$$39$YR$$F$Y$$$20240924$$HP$SE$SE
243583301$24358330$1$I$$20240919$20240924$20240924$EXP$$CA-SANDOZ INC.-SDZ2024CA081511$SANDOZ$$77$YR$$F$Y$$$20240924$$HP$CA$CA
243583321$24358332$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65307$$FDA-CTU$$39$YR$$F$N$44$KG$20240924$N$$US$
243583331$24358333$1$I$20230905$20240917$20240924$20240924$EXP$FR-AFSSAPS-MP2024001389$FR-GSK-FR2024115530$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$PH$FR$FR
243583341$24358334$1$I$20190301$20240909$20240924$20240924$EXP$$BG-BAXTER-2024BAX025166$BAXTER$$60$YR$$F$Y$$$20240924$$HP$BG$BG
243583351$24358335$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65312$$FDA-CTU$$72$YR$$F$N$$$20240924$N$$US$
243583361$24358336$1$I$$20240919$20240924$20240924$EXP$$JP-JNJFOC-20240962649$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$PH$JP$JP
243583371$24358337$1$I$$20240920$20240924$20240924$EXP$$US-JNJFOC-20240960198$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243583381$24358338$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024187886$AMGEN$$80$YR$E$M$Y$$$20240924$$MD$US$US
243583391$24358339$1$I$20240822$20240920$20240924$20240924$EXP$$NVSC2024CN189809$NOVARTIS$$73$YR$$F$Y$60$KG$20240924$$HP$CN$CN
243583401$24358340$1$I$20240613$20240919$20240924$20240924$PER$$US-ABBVIE-5933450$ABBVIE$$46$YR$$F$Y$96$KG$20240924$$MD$US$US
243583411$24358341$1$I$$20240911$20240924$20240924$EXP$$GB-ABBVIE-5934850$ABBVIE$brahim H, Kalakonda A, Kwan J, Kumar P, Williams S, Beare N, Chean C. Ibrutinib-Related Uveitis A Case Series from Two Tertiary Centres in the United Kingdom. Ocul Immunol Inflamm. 2024 AUG 19;1-10. doi:https://doi.org/10.1080/09273948.2024.2396007$55$YR$$M$Y$$$20240924$$HP$GB$GB
243583421$24358342$1$I$20221209$20240921$20240924$20240924$EXP$$US-PURDUE PHARMA-USA-2024-0312118$PURDUE$$26$YR$$M$Y$$$20240924$$CN$US$US
243583431$24358343$1$I$20230101$20240923$20240924$20240924$EXP$$US-PURDUE PHARMA-USA-2024-0312123$PURDUE$$20$YR$$M$Y$$$20240924$$CN$US$US
243583441$24358344$1$I$20240508$20240920$20240924$20240924$EXP$$CA-SANDOZ INC.-NVSC2022CA223545$SANDOZ$$88$YR$$F$Y$$$20240924$$CN$CA$CA
243583451$24358345$1$I$20240101$20240918$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US082150$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243583461$24358346$1$I$20240920$20240920$20240924$20240924$EXP$$NVSC2024GB189413$NOVARTIS$$54$YR$$M$Y$$$20240924$$HP$GB$GB
243583471$24358347$1$I$20240101$20240916$20240924$20240924$PER$$US-ABBVIE-5926675$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243583481$24358348$1$I$$20240905$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-142763$BRISTOL MYERS SQUIBB$$25$YR$A$F$Y$61.23$KG$20240924$$CN$US$US
243583491$24358349$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65308$$FDA-CTU$$77$YR$$F$N$$$20240924$N$$US$
243583501$24358350$1$I$20240923$20240924$20240924$20240924$DIR$719636$$FDA-CTU$$82$YR$$UNK$N$$$20240924$N$HP$US$
243583511$24358351$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65311$$FDA-CTU$$69$YR$$M$N$92.99$KG$20240924$N$$US$
243583531$24358353$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65319$$FDA-CTU$$61$YR$$F$N$$$20240924$N$$US$
243583541$24358354$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65338$$FDA-CTU$$54$YR$$F$N$83.91$KG$20240924$N$$US$
243583571$24358357$1$I$$20240911$20240924$20240924$EXP$$US-ABBVIE-5935042$ABBVIE$Fernandez Turizo MJ, Kim E, Zhang C, Yankama T, Von Keudell G, Sermer DJ, et al. Pre-existing cardiovascular disease is associated with an increased risk of cardiovascular events during Bruton tyrosine kinase inhibitor therapy. The Oncologist. 2024;oyae229.$$$$$Y$$$20240924$$MD$US$US
243583581$24358358$1$I$20230701$20240920$20240924$20240924$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053058$BOEHRINGER INGELHEIM$$66$YR$E$M$Y$$$20240924$$MD$JP$JP
243583601$24358360$1$I$$20240909$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409007437$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240924$$CN$US$US
243583611$24358361$1$I$$20240916$20240924$20240924$EXP$$US-TEVA-VS-3246311$TEVA$Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther-Adv-Infect-Dis 2022; 9 1-10.; Franco-Paredes C, Garcia-Creighton E, Henao-Martinez A, Kallgren DL, Banjade R, Dyer JA, et al. Novel approaches in the treatment of Hansen^s disease (Leprosy): a case series of multidrug...$39$YR$$M$Y$$$20240924$$HP$US$US
243583622$24358362$2$F$$20240924$20240924$20240926$PER$$US-AMGEN-USASP2024189788$AMGEN$$$$A$M$Y$$$20240926$$CN$US$US
243583633$24358363$3$F$$20240923$20240924$20240928$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-18880$IPSEN$$8$YR$C$M$Y$$$20240928$$CN$US$US
243583641$24358364$1$I$$20240918$20240924$20240924$PER$$US-AMGEN-USASP2024188999$AMGEN$$45$YR$A$F$Y$$$20240924$$HP$US$US
243583662$24358366$2$F$20240801$20240923$20240924$20240926$PER$$US-AMGEN-USASP2024190079$AMGEN$$$$$F$Y$$$20240925$$CN$US$US
243583671$24358367$1$I$20240915$20240920$20240924$20240924$PER$$US-009507513-2409USA007777$MERCK$$52$YR$$M$Y$$$20240924$$CN$US$US
243583691$24358369$1$I$20240701$20240917$20240924$20240924$EXP$$US-GSK-US2024115665$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$CN$US$US
243583701$24358370$1$I$$20240920$20240924$20240924$EXP$$NVSC2024IT189529$NOVARTIS$$$$A$M$Y$$$20240924$$MD$IT$IT
243583711$24358371$1$I$20130101$20240917$20240924$20240924$EXP$$PHHY2013MX016380$NOVARTIS$$61$YR$$F$Y$60$KG$20240924$$CN$MX$MX
243583722$24358372$2$F$$20240916$20240924$20240925$EXP$$IN-SANDOZ INC.-SDZ2024IN081366$SANDOZ$$$$$M$Y$$$20240925$$CN$IN$IN
243583731$24358373$1$I$$20240531$20240924$20240924$PER$$US-CIPLA LTD.-2024US05874$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243583751$24358375$1$I$$20240920$20240924$20240924$30DAY$$AU-MYLANLABS-2024M1086230$MYLAN$$$$$$Y$$$20240924$$CN$AU$AU
243583781$24358378$1$I$$20240918$20240924$20240924$EXP$$JP-PFIZER INC-202400261103$PFIZER$$73$YR$$F$Y$45$KG$20240924$$MD$JP$JP
243583791$24358379$1$I$20240801$20240918$20240924$20240924$EXP$$BR-PFIZER INC-202400259943$PFIZER$$35$YR$$F$Y$$$20240924$$MD$BR$BR
243583811$24358381$1$I$$20240918$20240924$20240924$EXP$$JP-PFIZER INC-202400258682$PFIZER$$$$$$Y$$$20240924$$MD$JP$JP
243583823$24358382$3$F$20240101$20240926$20240924$20240927$EXP$$US-PFIZER INC-202400260907$PFIZER$$65$YR$$F$Y$$$20240927$$MD$US$US
243583831$24358383$1$I$20240208$20240919$20240924$20240924$EXP$FR-AFSSAPS-PP2024000997$FR-PFIZER INC-202400259569$PFIZER$$71$YR$$M$Y$65$KG$20240924$$MD$FR$FR
243583841$24358384$1$I$$20240919$20240924$20240924$EXP$$US-PFIZER INC-202400259955$PFIZER$$76$YR$$F$Y$90.249$KG$20240924$$MD$US$US
243583852$24358385$2$F$20161030$20240923$20240924$20240926$EXP$$AU-PFIZER INC-PV202400123133$PFIZER$$10$YR$$F$Y$$$20240926$$HP$AU$AU
243583861$24358386$1$I$20240912$20240919$20240924$20240924$EXP$$US-PFIZER INC-202400260371$PFIZER$$60$YR$$M$Y$$$20240924$$PH$US$US
243583871$24358387$1$I$20240824$20240919$20240924$20240924$EXP$FR-AFSSAPS-MP2024001395$FR-PFIZER INC-202400260705$PFIZER$$78$YR$$F$Y$49$KG$20240924$$PH$FR$FR
243583881$24358388$1$I$$20240918$20240924$20240924$EXP$$MK-PFIZER INC-202400260775$PFIZER$$$$$$Y$$$20240924$$MD$MK$MK
243583891$24358389$1$I$20240901$20240919$20240924$20240924$EXP$$CN-PFIZER INC-PV202400122750$PFIZER$$20$YR$$M$Y$85$KG$20240924$$CN$CN$CN
243583901$24358390$1$I$20240828$20240918$20240924$20240924$EXP$$ZA-Vifor (International) Inc.-VIT-2024-08597$VIFOR$$$$A$M$Y$$$20240924$$CN$ZA$ZA
243583911$24358391$1$I$$20240918$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013896$DR REDDYS$$20$YR$A$F$Y$$$20240924$$CN$US$US
243583921$24358392$1$I$$20240916$20240924$20240924$EXP$$GB-JNJFOC-20240959548$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240924$$CN$GB$GB
243583931$24358393$1$I$$20240919$20240924$20240924$EXP$$PE-JNJFOC-20240952612$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240924$$CN$PE$PE
243583941$24358394$1$I$20240601$20240602$20240924$20240924$PER$$US-CIPLA LTD.-2024US05920$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243583952$24358395$2$F$$20240924$20240924$20240926$EXP$$CA-JNJFOC-20240959889$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240926$$MD$CA$CA
243583961$24358396$1$I$$20240919$20240924$20240924$EXP$$CA-SANDOZ INC.-SDZ2024CA081713$SANDOZ$$15$YR$$M$Y$38$KG$20240924$$MD$CA$CA
243583971$24358397$1$I$$20240606$20240924$20240924$PER$$US-CIPLA LTD.-2024US06064$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243583981$24358398$1$I$$20240603$20240924$20240924$PER$$US-CIPLA LTD.-2024US05944$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243583991$24358399$1$I$$20240606$20240924$20240924$PER$$US-CIPLA LTD.-2024US06110$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243584001$24358400$1$I$$20240917$20240924$20240924$EXP$$BA-SANDOZ INC.-SDZ2024BA082116$SANDOZ$$64$YR$$M$Y$$$20240924$$HP$BA$BA
243584012$24358401$2$F$$20240920$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US057180$SANDOZ$$$$$F$Y$$$20240924$$HP$US$US
243584021$24358402$1$I$20240709$20240916$20240924$20240924$EXP$FR-AFSSAPS-GR2024001073$FR-FreseniusKabi-FK202413969$FRESENIUS KABI$$73$YR$E$F$Y$$$20240924$$PH$FR$FR
243584031$24358403$1$I$$20240603$20240924$20240924$PER$$US-CIPLA LTD.-2024US05957$CIPLA$$$$$$Y$$$20240924$$CN$US$US
243584041$24358404$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65309$$FDA-CTU$$41$YR$$F$N$$$20240924$N$$US$
243584051$24358405$1$I$$20240919$20240924$20240924$EXP$$US-SANDOZ INC.-NVSC2021US279069$SANDOZ$$$$$F$Y$90.703$KG$20240924$$CN$US$US
243584061$24358406$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65361$$FDA-CTU$$52$YR$$F$N$$$20240924$N$$US$
243584081$24358408$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65306$$FDA-CTU$$78$YR$$F$N$$$20240924$N$$US$
243584091$24358409$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65372$$FDA-CTU$$16$YR$$F$N$60.33$KG$20240924$N$$US$
243584111$24358411$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65373$$FDA-CTU$$52$YR$$F$N$93.89$KG$20240924$N$$US$
243584121$24358412$1$I$20240531$20240920$20240924$20240924$EXP$$IE-PFIZER INC-PV202400106560$PFIZER$$11$YR$$M$Y$38.4$KG$20240924$$MD$IE$IE
243584132$24358413$2$F$$20240926$20240924$20240927$EXP$$CN-PFIZER INC-PV202400123318$PFIZER$$9$YR$$M$Y$$$20240927$$CN$CN$CN
243584141$24358414$1$I$20240914$20240916$20240924$20240924$30DAY$$GR-PFIZER INC-PV202400121596$PFIZER$$14$YR$$M$Y$38$KG$20240924$$CN$GR$GR
243584151$24358415$1$I$20240716$20240920$20240924$20240924$EXP$$IN-SANDOZ INC.-SDZ2024IN082227$SANDOZ$$54$YR$$M$Y$$$20240924$$CN$IN$IN
243584161$24358416$1$I$20240920$20240920$20240924$20240924$EXP$$BE-GILEAD-2024-0688512$GILEAD$$$$$$Y$$$20240924$$MD$BE$BE
243584171$24358417$1$I$$20240919$20240924$20240924$EXP$$NVSC2024US187910$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243584181$24358418$1$I$$20240911$20240924$20240924$EXP$$GB-ABBVIE-5935159$ABBVIE$Ibrahim H, Chean CS, Kalakonda AJM, Kwan J, Kumar P, Williams S, et al. Ibrutinib-related uveitis: a case series from two tertiary centres in the united kingdom. Ocular Immunology and Inflammation. 2024;1-6.$76$YR$$M$Y$$$20240924$$HP$GB$GB
243584191$24358419$1$I$$20240924$20240924$20240924$PER$$US-ROCHE-10000089402$ROCHE$$63$YR$A$M$Y$$$20240924$$CN$US$US
243584201$24358420$1$I$$20240830$20240924$20240924$EXP$$US-KYOWAKIRIN-2024KK021801$KYOWA$Horrillo R, Estrella J, Zhang HC.. Mogamulizumab-Induced Cholangiopathy in a Patient With Cutaneous T-Cell Lymphoma A Case Study. American Journal of Gastroenterology. 2023;118:S2359-S2360$$$$$Y$$$20240924$$HP$US$US
243584211$24358421$1$I$$20240917$20240924$20240924$EXP$$US-BIOGEN-2024BI01283138$BIOGEN$$$$$F$Y$$$20240924$$HP$US$US
243584231$24358423$1$I$20230925$20240919$20240924$20240924$EXP$$US-ABBVIE-5931433$ABBVIE$$58$YR$$F$Y$$$20240924$$CN$US$US
243584241$24358424$1$I$$20240912$20240924$20240924$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09226$NEUROCRINE BIOSCIENCES$$38$YR$$M$Y$$$20240924$$CN$US$US
243584251$24358425$1$I$20240914$20240924$20240924$20240924$DIR$719621$$FDA-CTU$$60$YR$$M$N$126$KG$20240924$N$$US$
243584261$24358426$1$I$$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189338$AMGEN$$$$$M$Y$$$20240924$$CN$US$US
243584271$24358427$1$I$$20240920$20240924$20240924$PER$$US-HALEON-2198074$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
243584281$24358428$1$I$$20240917$20240924$20240924$EXP$$US-RDY-SPO/USA/24/0013801$DR REDDYS$$$$$F$Y$$$20240924$$CN$US$US
243584291$24358429$1$I$20240901$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65374$$FDA-CTU$$73$YR$$M$N$$$20240924$N$PH$US$
243584301$24358430$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65375$$FDA-CTU$$66$YR$$F$N$$$20240924$N$$US$
243584311$24358431$1$I$$20240924$20240924$20240924$DIR$719647$$FDA-CTU$$$$$UNK$N$$$20240924$$CN$US$
243584321$24358432$1$I$20240901$20240920$20240924$20240924$EXP$FI-FIMEA-202403393$FI-JNJFOC-20240960954$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20240924$$CN$FI$FI
243584331$24358433$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65310$$FDA-CTU$$72$YR$$F$N$$$20240924$N$$US$
243584341$24358434$1$I$20240917$20240918$20240924$20240924$EXP$$US-AMGEN-USASP2024186966$AMGEN$$88$YR$E$M$Y$$$20240924$$CN$US$US
243584351$24358435$1$I$20240701$20240913$20240924$20240924$EXP$$DE-JNJFOC-20240940342$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240924$$MD$DE$DE
243584361$24358436$1$I$20240826$20240918$20240924$20240924$PER$$US-JNJFOC-20240953877$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$HP$US$US
243584372$24358437$2$F$20240908$20240920$20240924$20240930$EXP$GB-MHRA-MED-202409141639538120-SMYKB$GB-TEVA-VS-3244223$TEVA$$39$YR$$F$Y$$$20240930$$CN$GB$GB
243584381$24358438$1$I$$20240920$20240924$20240924$EXP$$CA-PFIZER INC-202400260638$PFIZER$$75$YR$$F$Y$$$20240924$$CN$CA$CA
243584391$24358439$1$I$20240911$20240916$20240924$20240924$EXP$GB-MHRA-MED-202409141644302610-KFVZN$GB-TEVA-VS-3244227$TEVA$$39$YR$$F$Y$$$20240924$$CN$GB$GB
243584401$24358440$1$I$$20240904$20240924$20240924$PER$$US-TEVA-VS-3241776$TEVA$$63$YR$$F$Y$$$20240924$$HP$US$US
243584411$24358441$1$I$20240101$20240916$20240924$20240924$EXP$$GB-TEVA-VS-3244251$TEVA$$74$YR$$$Y$$$20240924$$MD$GB$GB
243584431$24358443$1$I$20240919$20240924$20240924$20240924$DIR$719638$$FDA-CTU$$53$YR$$F$N$116$KG$20240924$N$PH$US$
243584441$24358444$1$I$20240913$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65313$$FDA-CTU$$90$YR$$M$N$$$20240924$N$$US$
243584471$24358447$1$I$20240915$20240924$20240924$20240924$DIR$719625$$FDA-CTU$$7$YR$$M$N$$$20240924$N$PH$US$
243584481$24358448$1$I$$20240920$20240924$20240924$EXP$$NVSC2024GR189260$NOVARTIS$$69$YR$$M$Y$$$20240924$$MD$GR$GR
243584491$24358449$1$I$20240101$20240919$20240924$20240924$EXP$$NVSC2024DE189404$NOVARTIS$$37$YR$$F$Y$$$20240924$$MD$DE$DE
243584501$24358450$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014572$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240924$$CN$US$US
243584511$24358451$1$I$$20240916$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148403$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240924$$CN$US$US
243584521$24358452$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014576$ELI LILLY AND CO$$$$$F$Y$$$20240924$$CN$US$US
243584531$24358453$1$I$20240701$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012303$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240924$$CN$US$US
243584541$24358454$1$I$$20240911$20240924$20240924$EXP$$GB-ABBVIE-5934883$ABBVIE$Ibrahim H, Kalakonda A, Kwan J, Kumar P, Williams S, Beare N, Chean C. Ibrutinib-Related Uveitis: A Case Series from Two Tertiary Centres in the United Kingdom. Ocul Immunol Inflamm$54$YR$$M$Y$$$20240924$$HP$GB$GB
243584551$24358455$1$I$$20240920$20240924$20240924$EXP$$CA-SANDOZ INC.-SDZ2024CA082332$SANDOZ$$$$$F$Y$$$20240924$$MD$CA$CA
243584571$24358457$1$I$20240913$20240917$20240924$20240924$EXP$GB-MHRA-MED-202409170717375770-RJVPC$GB-TEVA-VS-3244490$TEVA$$$$$$Y$$$20240924$$CN$GB$GB
243584581$24358458$1$I$$20240920$20240924$20240924$EXP$$NVSC2024ID189653$NOVARTIS$$23$YR$$F$Y$$$20240924$$MD$ID$ID
243584591$24358459$1$I$$20240913$20240924$20240924$EXP$$US-BIOGEN-2024BI01282814$BIOGEN$$$$$F$Y$$$20240924$$MD$US$US
243584602$24358460$2$F$20240918$20240919$20240924$20240930$PER$$US-AMGEN-USASP2024187651$AMGEN$$58$YR$A$F$Y$$$20240930$$PH$US$US
243584611$24358461$1$I$20240601$20240909$20240924$20240924$PER$$US-JNJFOC-20240921974$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240924$$HP$US$US
243584621$24358462$1$I$$20240913$20240924$20240924$PER$$US-ABBVIE-5927291$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243584631$24358463$1$I$$20240922$20240924$20240924$PER$$US-HALEON-2198382$Haleon PLC$$$$$$Y$$$20240924$$CN$US$US
243584641$24358464$1$I$20240604$20240923$20240924$20240924$30DAY$$IT-SANDOZ INC.-SDZ2024IT056446$SANDOZ$$66$YR$$F$Y$57$KG$20240924$$CN$IT$IT
243584651$24358465$1$I$$20240917$20240924$20240924$EXP$$JP-PFIZER INC-202400262036$PFIZER$$10$DEC$$F$Y$$$20240924$$MD$JP$JP
243584661$24358466$1$I$$20240919$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US081895$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243584671$24358467$1$I$$20240917$20240924$20240924$EXP$$JP-PFIZER INC-202400262069$PFIZER$$8$DEC$$M$Y$$$20240924$$MD$JP$JP
243584681$24358468$1$I$$20240911$20240924$20240924$EXP$$GB-ABBVIE-5935148$ABBVIE$Ibrahim H, Chean CS, Kalakonda AJM, Kwan J, Kumar P, Williams S, et al. Ibrutinib-related uveitis: a case series from two tertiary centres in the united kingdom. Ocular Immunology and Inflammation. 2024;1-6.$69$YR$$M$Y$$$20240924$$HP$GB$GB
243584691$24358469$1$I$20240101$20240819$20240924$20240924$PER$$US-Eisai-EC-2024-172441$EISAI$$$$$F$Y$$$20240924$$CN$US$US
243584701$24358470$1$I$$20240920$20240924$20240924$PER$$US-FreseniusKabi-FK202414122$FRESENIUS KABI$$$$$$Y$$$20240924$$PH$US$US
243584711$24358471$1$I$20240816$20240919$20240924$20240924$30DAY$$US-AMGEN-USASP2024187830$AMGEN$$29$YR$A$M$Y$$$20240924$$HP$US$US
243584721$24358472$1$I$$20240920$20240924$20240924$PER$$US-FreseniusKabi-FK202414121$FRESENIUS KABI$$$$$$Y$$$20240924$$PH$US$US
243584731$24358473$1$I$$20240918$20240924$20240924$EXP$$CA-FreseniusKabi-FK202414050$FRESENIUS KABI$$$$$$Y$$$20240924$$PH$CA$CA
243584741$24358474$1$I$$20240913$20240924$20240924$EXP$$US-BIOGEN-2024BI01282812$BIOGEN$$$$$F$Y$$$20240924$$MD$US$US
243584751$24358475$1$I$$20240917$20240924$20240924$EXP$$US-BIOGEN-2024BI01283019$BIOGEN$$$$$F$Y$$$20240924$$CN$US$US
243584761$24358476$1$I$$20240919$20240924$20240924$EXP$$CA-GILEAD-2024-0688369$GILEAD$$$$A$M$Y$$$20240924$$CN$CA$CA
243584781$24358478$1$I$20240825$20240924$20240924$20240924$EXP$FR-AFSSAPS-PP2024001032$NVSC2024FR189651$NOVARTIS$$71$YR$$F$Y$69$KG$20240924$$MD$FR$FR
243584791$24358479$1$I$$20240923$20240924$20240924$EXP$$CA-SANDOZ INC.-NVSC2023CA136447$SANDOZ$$$$$F$Y$$$20240924$$HP$CA$CA
243584801$24358480$1$I$$20240919$20240924$20240924$EXP$$SI-009507513-2409SVN007837$MERCK$$$$$F$Y$$$20240924$$MD$SI$SI
243584811$24358481$1$I$$20240918$20240924$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151184$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240924$$MD$JP$JP
243584821$24358482$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151349$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240924$$CN$US$US
243584831$24358483$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151176$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240924$$HP$US$US
243584841$24358484$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150892$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240924$$CN$US$US
243584851$24358485$1$I$20240101$20240923$20240924$20240924$EXP$$DE-ABBVIE-5935567$ABBVIE$$85$YR$$M$Y$$$20240924$$MD$DE$DE
243584861$24358486$1$I$$20240912$20240924$20240924$PER$$US-GSK-US2024113778$GLAXOSMITHKLINE$$$$$F$Y$$$20240924$$CN$US$US
243584901$24358490$1$I$20240721$20240924$20240924$20240924$DIR$719655$$FDA-CTU$$32$YR$$M$N$67.05$KG$20240924$N$PH$US$
243584911$24358491$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65377$$FDA-CTU$$$$$M$N$$$20240924$N$HP$US$
243584921$24358492$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65378$$FDA-CTU$$44$YR$$F$N$156.49$KG$20240924$N$$US$
243584931$24358493$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65379$$FDA-CTU$$40$YR$$F$N$114.31$KG$20240924$N$$US$
243584951$24358495$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65383$$FDA-CTU$$60$YR$$F$N$$$20240924$N$$US$
243584961$24358496$1$I$20240917$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-65318$$FDA-CTU$$38$YR$$F$N$81.65$KG$20240920$Y$HP$US$
243584971$24358497$1$I$20240920$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-65331$$FDA-CTU$$37$YR$$F$N$81.65$KG$20240920$N$CN$US$
243584991$24358499$1$I$20240915$20240920$20240920$20240920$DIR$FDA-CDER-CTU-2024-65333$$FDA-CTU$$20$YR$$F$N$129.27$KG$20240920$Y$CN$US$
243585001$24358500$1$I$20180101$20240918$20240924$20240924$EXP$$JP-ASTELLAS-2024JP004967$ASTELLAS$$94$YR$E$M$Y$$$20240924$$PH$JP$JP
243585011$24358501$1$I$20220901$20240917$20240924$20240924$EXP$$US-BIOGEN-2024BI01283659$BIOGEN$$41$YR$$F$Y$$$20240924$$CN$US$US
243585021$24358502$1$I$$20240909$20240924$20240924$EXP$$JP-JNJFOC-20240931716$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$HP$JP$JP
243585031$24358503$1$I$20240714$20240917$20240924$20240924$EXP$FR-AFSSAPS-LL2024001723$FR-TEVA-VS-3244591$TEVA$$85$YR$$M$Y$$$20240924$$MD$FR$FR
243585041$24358504$1$I$20240923$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189765$AMGEN$$63$YR$A$M$Y$$$20240924$$CN$US$US
243585051$24358505$1$I$20201212$20240916$20240924$20240924$EXP$$CA-TAKEDA-CA202028711$TAKEDA$$64$YR$$F$Y$$$20240924$$CN$CA$CA
243585061$24358506$1$I$20240101$20240919$20240924$20240924$EXP$$US-SA-2024SA274052$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240924$$MD$US$US
243585071$24358507$1$I$20240228$20240915$20240924$20240924$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149493$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$MD$PT$PT
243585081$24358508$1$I$$20240922$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150495$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$93.44$KG$20240924$$CN$US$US
243585091$24358509$1$I$20240920$20240923$20240924$20240924$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-151010$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$95.25$KG$20240924$$CN$PR$PR
243585101$24358510$1$I$20240801$20240917$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151141$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240924$$CN$US$US
243585111$24358511$1$I$20240809$20240919$20240924$20240924$EXP$$US-KYOWAKIRIN-2024KK021829$KYOWA$$$$$$Y$$$20240924$$HP$US$US
243585121$24358512$1$I$$20240923$20240924$20240924$EXP$$US-SA-2024SA274373$SANOFI AVENTIS$Viswanathan S, Vaughan W, Gadalla M.. Eosinophilic Granulomatosis With Polyangiitis Post Dupilumab Infusions.. Chest. 2024;166(4):A5397-8.$50$YR$A$M$Y$$$20240924$$HP$US$US
243585131$24358513$1$I$20240913$20240919$20240924$20240924$EXP$$US-SA-2024SA275384$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240924$$MD$US$US
243585151$24358515$1$I$20240810$20240917$20240924$20240924$PER$$US-ROCHE-10000085039$ROCHE$$23$YR$A$M$Y$$$20240924$$CN$US$US
243585161$24358516$1$I$20240909$20240918$20240924$20240924$EXP$IT-MINISAL02-1002404$IT-FreseniusKabi-FK202414046$FRESENIUS KABI$$70$YR$E$F$Y$66$KG$20240924$$MD$IT$IT
243585171$24358517$1$I$20240826$20240920$20240924$20240924$EXP$$DE-FreseniusKabi-FK202414109$FRESENIUS KABI$$$$$F$Y$90$KG$20240924$$MD$DE$DE
243585191$24358519$1$I$20240906$20240917$20240924$20240924$PER$$US-Eisai-EC-2024-174897$EISAI$$63$YR$A$F$Y$$$20240924$$CN$US$US
243585201$24358520$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000087975$ROCHE$$$$T$M$Y$$$20240924$$CN$US$US
243585221$24358522$1$I$20240801$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188745$AMGEN$$57$YR$A$F$Y$$$20240924$$CN$US$US
243585231$24358523$1$I$$20240911$20240924$20240924$PER$$US-JNJFOC-20240933714$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243585241$24358524$1$I$20240822$20240917$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151297$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240924$$MD$US$US
243585251$24358525$1$I$20240923$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151414$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$122.47$KG$20240924$$CN$US$US
243585261$24358526$1$I$20240101$20240915$20240924$20240924$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-2024-149932$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$MD$PT$PT
243585271$24358527$1$I$20240724$20240912$20240924$20240924$EXP$$AR-ELI_LILLY_AND_COMPANY-AR202408010209$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240924$$CN$DE$AR
243585281$24358528$1$I$20240916$20240919$20240924$20240924$PER$$US-ROCHE-10000087403$ROCHE$$18$YR$A$F$Y$$$20240924$$CN$US$US
243585291$24358529$1$I$$20240920$20240924$20240924$PER$$US-ROCHE-10000088890$ROCHE$$$$T$M$Y$$$20240924$$CN$US$US
243585301$24358530$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000087392$ROCHE$$$$A$M$Y$$$20240924$$CN$US$US
243585311$24358531$1$I$20210914$20240919$20240924$20240924$EXP$$US-MYLANLABS-2024M1086343$MYLAN$$25$YR$$F$Y$$$20240924$$MD$US$US
243585321$24358532$1$I$$20240923$20240924$20240924$PER$$US-ROCHE-10000089536$ROCHE$$$$A$M$Y$$$20240924$$CN$US$US
243585331$24358533$1$I$$20240923$20240924$20240924$PER$$US-ROCHE-10000089471$ROCHE$$$$A$M$Y$$$20240924$$CN$US$US
243585351$24358535$1$I$20240901$20240919$20240924$20240924$EXP$$BR-BIOGEN-2024BI01283622$BIOGEN$$29$YR$$F$Y$76$KG$20240924$$HP$BR$BR
243585361$24358536$1$I$$20240607$20240924$20240924$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090802$GLENMARK$$$$$$Y$$$20240924$$CN$US$US
243585371$24358537$1$I$$20240911$20240924$20240924$EXP$$GB-ABBVIE-5934861$ABBVIE$Ibrahim H, Chean CS, Kalakonda AJM, Kwan J, Kumar P, Williams S, et al. Ibrutinib-related uveitis: a case series from two tertiary centres in the united kingdom. Ocular Immunology and Inflammation. 2024;1-6.$60$YR$$M$Y$$$20240924$$MD$GB$GB
243585381$24358538$1$I$20240801$20240924$20240924$20240924$DIR$719669$$FDA-CTU$$67$YR$$F$N$103.5$KG$20240924$N$CN$US$
243585401$24358540$1$I$$20240923$20240924$20240924$EXP$$CA-ORGANON-O2409CAN001689$ORGANON$$44$YR$$F$Y$78$KG$20240924$$HP$CA$CA
243585411$24358541$1$I$20240911$20240921$20240921$20240921$DIR$FDA-CDER-CTU-2024-65340$$FDA-CTU$$7$YR$$F$N$19.6$KG$20240921$N$HP$US$
243585431$24358543$1$I$$20240924$20240924$20240924$DIR$719670$$FDA-CTU$$64$YR$$F$N$51.75$KG$20240924$N$CN$US$
243585451$24358545$1$I$20240903$20240918$20240924$20240924$EXP$$JP-009507513-2409JPN002894J$MERCK$$8$DEC$$F$Y$$$20240924$$PH$JP$JP
243585462$24358546$2$F$20240811$20240918$20240924$20240925$EXP$$ES-009507513-2409ESP008256$MERCK$$50$YR$$M$Y$$$20240925$$MD$ES$ES
243585471$24358547$1$I$$20240910$20240924$20240924$EXP$$CA-HLS-202402285$HLS THERAPEUTICS$$$$$M$Y$$$20240924$$HP$CA$CA
243585481$24358548$1$I$$20240918$20240924$20240924$EXP$$JP-PFIZER INC-202400261095$PFIZER$$77$YR$$M$Y$59.2$KG$20240924$$MD$JP$JP
243585491$24358549$1$I$$20240923$20240924$20240924$EXP$$PE-PFIZER INC-PV202400124762$PFIZER$$$$E$F$Y$$$20240924$$CN$PE$PE
243585501$24358550$1$I$20240923$20240924$20240924$20240924$DIR$719653$$FDA-CTU$$43$YR$$M$N$65.8$KG$20240924$Y$PH$US$
243585511$24358551$1$I$20240920$20240924$20240924$20240924$DIR$719668$$FDA-CTU$$54$YR$$F$N$87.3$KG$20240924$N$CN$US$
243585531$24358553$1$I$$20240919$20240924$20240924$EXP$$DE-PFIZER INC-202400259917$PFIZER$$48$YR$$M$Y$$$20240924$$CN$DE$DE
243585541$24358554$1$I$20240301$20240920$20240924$20240924$EXP$ES-AEMPS-1570725$ES-PFIZER INC-202400260356$PFIZER$$75$YR$$M$Y$$$20240924$$MD$ES$ES
243585551$24358555$1$I$20240905$20240920$20240924$20240924$EXP$$US-PFIZER INC-PV202300125511$PFIZER$$81$YR$$F$Y$$$20240924$$CN$US$US
243585561$24358556$1$I$20100101$20240919$20240924$20240924$EXP$$US-PFIZER INC-202400260140$PFIZER$$67$YR$$F$Y$$$20240924$$MD$US$US
243585571$24358557$1$I$20240717$20240919$20240924$20240924$EXP$FR-AFSSAPS-NC2024001093$FR-PFIZER INC-202400259384$PFIZER$$72$YR$$M$Y$51$KG$20240924$$MD$FR$FR
243585581$24358558$1$I$$20240919$20240924$20240924$EXP$$PL-PFIZER INC-PV202400122800$PFIZER$$45$YR$$M$Y$$$20240924$$MD$PL$PL
243585591$24358559$1$I$$20240920$20240924$20240924$EXP$$US-PFIZER INC-PV202400124167$PFIZER$$44$YR$$F$Y$$$20240924$$HP$US$US
243585611$24358561$1$I$$20240919$20240924$20240924$EXP$$JP-PFIZER INC-202400259664$PFIZER$$8$DEC$$F$Y$$$20240924$$MD$JP$JP
243585621$24358562$1$I$20240826$20240920$20240924$20240924$EXP$$CA-PFIZER INC-202400261813$PFIZER$$86$YR$$M$Y$$$20240924$$CN$CA$CA
243585631$24358563$1$I$20240101$20240919$20240924$20240924$EXP$$US-PFIZER INC-202400173175$PFIZER$$5$YR$$M$Y$$$20240924$$CN$US$US
243585661$24358566$1$I$20240801$20240919$20240924$20240924$EXP$$US-PFIZER INC-202400260672$PFIZER$$83$YR$$F$Y$$$20240924$$CN$US$US
243585681$24358568$1$I$20240901$20240920$20240924$20240924$EXP$$ZA-PFIZER INC-PV202400124003$PFIZER$$20$YR$$F$Y$$$20240924$$MD$ZA$ZA
243585703$24358570$3$F$$20240926$20240924$20240926$EXP$GB-MHRA-MED-202409171452358370-VCHJZ$GB-PFIZER INC-202400259783$PFIZER$$66$YR$$M$Y$$$20240926$$MD$GB$GB
243585711$24358571$1$I$$20240919$20240924$20240924$EXP$$JP-PFIZER INC-202400259641$PFIZER$$$$$$Y$$$20240924$$PH$JP$JP
243585721$24358572$1$I$20240823$20240919$20240924$20240924$EXP$FR-AFSSAPS-AM2024000748$FR-PFIZER INC-202400259566$PFIZER$$32$YR$$M$Y$$$20240924$$PH$FR$FR
243585731$24358573$1$I$20240808$20240913$20240924$20240924$EXP$$US-BAXTER-2024BAX024725$BAXTER$$$$$M$Y$85.5$KG$20240924$$HP$US$US
243585741$24358574$1$I$20240731$20240916$20240924$20240924$EXP$ES-AEMPS-1567482$ES-FreseniusKabi-FK202413886$FRESENIUS KABI$$56$YR$A$M$Y$$$20240924$$MD$ES$ES
243585751$24358575$1$I$20240904$20240918$20240924$20240924$EXP$SE-SEMPA-2024-006671$SE-MYLANLABS-2024M1085238$MYLAN$$31$YR$$M$Y$$$20240924$$MD$SE$SE
243585771$24358577$1$I$20240820$20240918$20240924$20240924$EXP$$GB-MYLANLABS-2024M1085385$MYLAN$$$$$F$Y$$$20240924$$HP$GB$GB
243585781$24358578$1$I$$20240918$20240924$20240924$EXP$$ES-MYLANLABS-2024M1085638$MYLAN$Sanchez CF, Torre EA. La polifarmacia no es inocua. Family doctors. 2024;41$45$YR$$M$Y$$$20240924$$MD$ES$ES
243585791$24358579$1$I$20240826$20240919$20240924$20240924$EXP$$CN-ROCHE-10000088809$ROCHE$$80$YR$E$M$Y$$$20240924$$HP$CN$CN
243585801$24358580$1$I$20240612$20240918$20240924$20240924$EXP$FR-AFSSAPS-AVMA2024000398$FR-MYLANLABS-2024M1085312$MYLAN$$$$$M$Y$$$20240924$$MD$FR$FR
243585811$24358581$1$I$20230610$20240918$20240924$20240924$EXP$FR-AFSSAPS-AM2024000730$FR-MYLANLABS-2024M1085353$MYLAN$$16$YR$$F$Y$51$KG$20240924$$MD$FR$FR
243585821$24358582$1$I$$20240911$20240924$20240924$EXP$CA-002147023-NVSC2023CA026955$CA-IMP-2023000062$Harrow Health$$61$YR$A$F$Y$86$KG$20240924$$PH$CA$CA
243585841$24358584$1$I$20240907$20240913$20240924$20240924$PER$$US-JNJFOC-20240940131$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243585851$24358585$1$I$$20240918$20240924$20240924$PER$$US-BIOMARINAP-US-2024-160692$BIOMARIN$$$$$$Y$$$20240924$$CN$US$US
243585861$24358586$1$I$20240902$20240923$20240924$20240924$PER$$US-BIOMARINAP-US-2024-160743$BIOMARIN$$$$$$Y$$$20240924$$CN$US$US
243585871$24358587$1$I$$20240923$20240924$20240924$EXP$$US-PFIZER INC-2019SGN00835$PFIZER$$17$YR$$F$Y$$$20240924$$MD$US$US
243585881$24358588$1$I$$20240919$20240924$20240924$EXP$$CA-PFIZER INC-202400260730$PFIZER$$90$YR$$M$Y$$$20240924$$HP$CA$CA
243585901$24358590$1$I$20240922$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189669$AMGEN$$55$YR$A$F$Y$$$20240924$$CN$US$US
243585911$24358591$1$I$$20240917$20240924$20240924$PER$$US-IMP-2024000753$Harrow Health$$$$E$F$Y$$$20240924$$CN$US$US
243585921$24358592$1$I$$20240920$20240924$20240924$PER$$US-ABBVIE-5934458$ABBVIE$$$$$$Y$$$20240924$$HP$US$US
243585931$24358593$1$I$20240101$20240806$20240924$20240924$PER$$US-Ascend Therapeutics US, LLC-2161998$ASCEND$$$$$M$Y$$$20240924$$$US$US
243585941$24358594$1$I$$20240918$20240924$20240924$PER$$US-IMP-2024000759$Harrow Health$$$$E$M$Y$$$20240924$$CN$US$US
243585951$24358595$1$I$$20240916$20240924$20240924$PER$$US-IMP-2024000764$Harrow Health$$$$E$F$Y$$$20240924$$CN$US$US
243585961$24358596$1$I$$20240918$20240924$20240924$EXP$$US-TAKEDA-2024TUS093773$TAKEDA$$21$YR$$F$Y$$$20240924$$CN$US$US
243585971$24358597$1$I$$20240917$20240924$20240924$EXP$$US-GSK-US2024GSK117490$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$US$US
243585981$24358598$1$I$20240620$20240912$20240924$20240924$EXP$$CN-ASTELLAS-2024-AER-008243$ASTELLAS$$69$YR$E$M$Y$61$KG$20240924$$HP$CN$CN
243585991$24358599$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151052$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240924$$HP$US$US
243586001$24358600$1$I$$20240920$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150478$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$110.68$KG$20240924$$CN$US$US
243586011$24358601$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150757$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240924$$HP$US$US
243586021$24358602$1$I$20240830$20240919$20240924$20240924$EXP$FR-AFSSAPS-CN2024000880$FR-PFIZER INC-202400259555$PFIZER$$89$YR$$F$Y$87$KG$20240924$$PH$FR$FR
243586031$24358603$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150718$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240924$$HP$US$US
243586041$24358604$1$I$20240916$20240924$20240924$20240924$PER$$US-BAYER-2024A136533$BAYER$$44$YR$A$F$Y$$$20240924$$HP$US$US
243586051$24358605$1$I$$20240919$20240924$20240924$EXP$$ES-GILEAD-2024-0688304$GILEAD$$$$$$Y$$$20240924$$CN$ES$ES
243586061$24358606$1$I$$20240920$20240924$20240924$EXP$$NVSC2024US188924$NOVARTIS$$$$$M$Y$$$20240924$$CN$US$US
243586081$24358608$1$I$20240601$20240918$20240924$20240924$EXP$$US-MYLANLABS-2024M1086105$MYLAN$$85$YR$$F$Y$54.43$KG$20240924$$CN$US$US
243586091$24358609$1$I$20240715$20240918$20240924$20240924$EXP$IT-MINISAL02-1002104$IT-MYLANLABS-2024M1085234$MYLAN$$64$YR$$M$Y$$$20240924$$MD$IT$IT
243586101$24358610$1$I$20240605$20240918$20240924$20240924$EXP$FR-AFSSAPS-AVMA2024000399$FR-MYLANLABS-2024M1085161$MYLAN$$36$YR$$M$Y$$$20240924$$MD$FR$FR
243586111$24358611$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000088007$ROCHE$$$$E$F$Y$$$20240924$$MD$US$US
243586131$24358613$1$I$$20240916$20240924$20240924$30DAY$$CL-PFIZER INC-PV202400121305$PFIZER$$12$YR$$F$Y$$$20240924$$CN$CL$CL
243586141$24358614$1$I$20240919$20240923$20240924$20240924$PER$$NVSC2024US190042$NOVARTIS$$63$YR$$M$Y$$$20240924$$HP$US$US
243586171$24358617$1$I$20230101$20240917$20240924$20240924$EXP$$NVSC2022BR259545$NOVARTIS$$$$$F$Y$$$20240924$$CN$BR$BR
243586181$24358618$1$I$$20240916$20240924$20240924$PER$$US-JNJFOC-20240947139$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243586191$24358619$1$I$$20240910$20240924$20240924$EXP$$CA-HLS-202402284$HLS THERAPEUTICS$$$$$M$Y$$$20240924$$HP$CA$CA
243586201$24358620$1$I$$20240916$20240924$20240924$EXP$$NVSC2024TW188139$NOVARTIS$Wu CY, Chen CC, Liou SW, Yen JC. Bilateral optic disc edema and serous retinal detachment as initial ocular manifestations of systemic lymphoma: a case report and literature review. TAIWAN J OPHTHALMOL. 2024;14:448-53$29$YR$$M$Y$$$20240924$$HP$TW$TW
243586211$24358621$1$I$$20240904$20240924$20240924$PER$$US-TEVA-VS-3241070$TEVA$$23$YR$$F$Y$$$20240924$$CN$US$US
243586231$24358623$1$I$20240912$20240920$20240924$20240924$EXP$$CA-GILEAD-2024-0688465$GILEAD$$76$YR$E$M$Y$$$20240924$$HP$CA$CA
243586241$24358624$1$I$20240922$20240924$20240924$20240924$DIR$719662$$FDA-CTU$$11$YR$$M$N$21.15$KG$20240924$Y$CN$US$
243586261$24358626$1$I$20240813$20240918$20240924$20240924$EXP$FR-AFSSAPS-BR2024000745$FR-TEVA-VS-3245177$TEVA$$58$YR$$M$Y$$$20240924$$HP$FR$FR
243586271$24358627$1$I$20220601$20240916$20240924$20240924$EXP$$DE-FreseniusKabi-FK202413920$FRESENIUS KABI$$34$YR$A$F$Y$$$20240924$$MD$DE$DE
243586281$24358628$1$I$20220101$20240923$20240924$20240924$EXP$$RO-FreseniusKabi-FK202414207$FRESENIUS KABI$$59$YR$A$$Y$$$20240924$$MD$RO$RO
243586291$24358629$1$I$20240801$20240822$20240924$20240924$PER$$US-Eisai-EC-2024-172828$EISAI$$58$YR$A$F$Y$$$20240924$$CN$US$US
243586301$24358630$1$I$$20240916$20240924$20240924$EXP$$CA-TEVA-VS-3244710$TEVA$$63$YR$$M$Y$$$20240924$$HP$CA$CA
243586311$24358631$1$I$$20240821$20240924$20240924$PER$$US-Eisai-EC-2024-172642$EISAI$$$$$F$Y$$$20240924$$HP$US$US
243586321$24358632$1$I$20240101$20240827$20240924$20240924$PER$$US-Eisai-EC-2024-173744$EISAI$$67$YR$E$F$Y$$$20240924$$CN$US$US
243586331$24358633$1$I$$20240916$20240924$20240924$EXP$$CA-TEVA-VS-3244669$TEVA$$61$YR$$F$Y$55$KG$20240924$$PH$CA$CA
243586341$24358634$1$I$20240201$20240918$20240924$20240924$EXP$$PR-Eisai-EC-2024-161350$EISAI$$65$YR$E$F$Y$48.6$KG$20240924$$CN$PR$PR
243586351$24358635$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5913556$ABBVIE$$$$$$Y$$$20240924$$HP$US$US
243586361$24358636$1$I$$20240918$20240924$20240924$EXP$$US-PFIZER INC-202400259462$PFIZER$Wang, C.. A de novo germline RUNX1 variant preceding development of concurrent T-lymphoblastic leukemia and myelodysplastic syndrome. Leukemia and Lymphoma. 2024;65(9):1357-1361$12$YR$$F$Y$$$20240924$$MD$US$US
243586371$24358637$1$I$$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188640$AMGEN$$$$$F$Y$$$20240924$$CN$US$US
243586381$24358638$1$I$$20240916$20240924$20240924$EXP$$CA-TEVA-VS-3244705$TEVA$$75$YR$$F$Y$$$20240924$$HP$CA$CA
243586391$24358639$1$I$$20240916$20240924$20240924$EXP$$CA-TEVA-VS-3244652$TEVA$$41$YR$$F$Y$$$20240924$$CN$CA$CA
243586401$24358640$1$I$20240914$20240916$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409010424$ELI LILLY AND CO$$$$A$M$Y$$$20240924$$CN$US$US
243586411$24358641$1$I$20240919$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013835$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240924$$CN$US$US
243586421$24358642$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014347$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243586431$24358643$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014468$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240924$$CN$US$US
243586442$24358644$2$F$$20240926$20240924$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409013629$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240930$$CN$US$US
243586451$24358645$1$I$$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409010393$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240924$$CN$US$US
243586461$24358646$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014622$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240924$$CN$US$US
243586471$24358647$1$I$20240923$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014678$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240924$$CN$US$US
243586481$24358648$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013943$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240924$$CN$US$US
243586491$24358649$1$I$20240919$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013578$ELI LILLY AND CO$$95$YR$E$F$Y$$$20240924$$CN$US$US
243586501$24358650$1$I$$20240918$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012268$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240924$$CN$US$US
243586511$24358651$1$I$$20240916$20240924$20240924$EXP$$CA-TEVA-VS-3244689$TEVA$$$$$$Y$$$20240924$$CN$CA$CA
243586521$24358652$1$I$$20240918$20240924$20240924$EXP$$US-TAKEDA-2024TUS093806$TAKEDA$$56$YR$$M$Y$$$20240924$$CN$US$US
243586531$24358653$1$I$$20240919$20240924$20240924$EXP$$KR-009507513-2409KOR007714$MERCK$$$$$F$Y$$$20240924$$HP$KR$KR
243586541$24358654$1$I$20240917$20240918$20240924$20240924$EXP$$US-ABBVIE-5930021$ABBVIE$$85$YR$$F$Y$$$20240924$$CN$US$US
243586551$24358655$1$I$20210401$20240917$20240924$20240924$EXP$$US-ABBVIE-5531318$ABBVIE$$62$YR$$M$Y$$$20240924$$CN$US$US
243586561$24358656$1$I$20240101$20240916$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147891$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$110.22$KG$20240924$$CN$US$US
243586571$24358657$1$I$20240826$20240912$20240924$20240924$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-19128$IPSEN$$$$$F$Y$$$20240924$$HP$US$US
243586581$24358658$1$I$20240901$20240924$20240924$20240924$DIR$719641$$FDA-CTU$$51$YR$$M$N$103.5$KG$20240924$N$CN$US$
243586591$24358659$1$I$20240901$20240911$20240924$20240924$PER$$US-MYLANLABS-2024M1083750$MYLAN$$$$$M$Y$$$20240924$$CN$US$US
243586601$24358660$1$I$20240804$20240916$20240924$20240924$EXP$$US-GILEAD-2024-0687136$GILEAD$$29$YR$A$F$Y$$$20240924$$HP$US$US
243586611$24358661$1$I$$20240924$20240924$20240924$DIR$719650$$FDA-CTU$$$$$UNK$N$$$20240924$N$CN$US$
243586621$24358662$1$I$20240219$20240919$20240924$20240924$EXP$FR-AFSSAPS-NC2024001104$FR-REGENERON PHARMACEUTICALS, INC.-2024-127117$REGENERON$$66$YR$$M$Y$$$20240924$$MD$FR$FR
243586631$24358663$1$I$20240905$20240919$20240924$20240924$EXP$$CN-009507513-2409CHN007892$MERCK$$59$YR$$M$Y$80$KG$20240924$$HP$CN$CN
243586641$24358664$1$I$$20240916$20240924$20240924$PER$$US-EMD Serono-2024049867$EMD SERONO INC$$$$$F$Y$$$20240924$$HP$US$US
243586651$24358665$1$I$20240912$20240913$20240924$20240924$EXP$$US-Fagron Sterile Services-2162000$FAGRON COMPOUNDING SERVICES D/B/A FAGRON STERILE SERVICES, WICHITA, KS$$$$$F$Y$76.7$KG$20240924$$PH$US$US
243586661$24358666$1$I$20240801$20240823$20240924$20240924$PER$$US-Eisai-EC-2024-172993$EISAI$$$$$F$Y$$$20240924$$HP$US$US
243586671$24358667$1$I$$20240910$20240924$20240924$EXP$$CA-HLS-202402283$HLS THERAPEUTICS$$84$YR$E$F$Y$$$20240924$$HP$CA$CA
243586681$24358668$1$I$$20240823$20240924$20240924$PER$$US-Eisai-EC-2024-172776$EISAI$$$$E$F$Y$$$20240924$$HP$US$US
243586691$24358669$1$I$$20240919$20240924$20240924$EXP$$FR-009507513-2409FRA007811$MERCK$$40$YR$$F$Y$$$20240924$$MD$FR$FR
243586701$24358670$1$I$$20240922$20240924$20240924$PER$$NVSC2024US189230$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
243586711$24358671$1$I$$20240920$20240924$20240924$EXP$$NVSC2024US189095$NOVARTIS$$$$$$Y$$$20240924$$CN$US$US
243586731$24358673$1$I$20240909$20240920$20240924$20240924$EXP$$US-KYOWAKIRIN-2024KK021914$KYOWA$$$$$$Y$$$20240924$$HP$US$US
243586741$24358674$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5935634$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243586751$24358675$1$I$20230306$20240920$20240924$20240924$EXP$$GR-ABBVIE-5935195$ABBVIE$$80$YR$$M$Y$81$KG$20240924$$MD$GR$GR
243586762$24358676$2$F$20240923$20240924$20240924$20240927$PER$$US-AMGEN-USASP2024189757$AMGEN$$46$YR$A$M$Y$$$20240927$$PH$US$US
243586771$24358677$1$I$$20240918$20240924$20240924$EXP$$AU-SANDOZ INC.-SDZ2024AU081421$SANDOZ$$64$YR$$M$Y$$$20240924$$MD$AU$AU
243586791$24358679$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5933929$ABBVIE$$47$YR$$F$Y$$$20240924$$HP$US$US
243586801$24358680$1$I$$20240919$20240924$20240924$EXP$FR-AFSSAPS-AVMA2024000412$FR-MYLANLABS-2024M1085621$MYLAN$$$$A$M$Y$$$20240924$$MD$FR$FR
243586811$24358681$1$I$20240313$20240919$20240924$20240924$EXP$$GB-MYLANLABS-2024M1025042$MYLAN$$$$$M$Y$$$20240924$$PH$GB$GB
243586821$24358682$1$I$20240621$20240919$20240924$20240924$EXP$FR-AFSSAPS-DJ2024000980$FR-MYLANLABS-2024M1085459$MYLAN$$76$YR$$M$Y$71$KG$20240924$$MD$FR$FR
243586831$24358683$1$I$20220331$20240919$20240924$20240924$EXP$$NL-MYLANLABS-2024M1086053$MYLAN$$51$YR$$F$Y$$$20240924$$MD$NL$NL
243586841$24358684$1$I$$20240918$20240924$20240924$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005191$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240924$$CN$US$US
243586851$24358685$1$I$$20240917$20240924$20240924$EXP$$US-AMGEN-USASL2024187630$AMGEN$$$$$F$Y$$$20240924$$CN$US$US
243586861$24358686$1$I$$20240823$20240924$20240924$EXP$$BR-TEVA-VS-3246886$TEVA$$34$YR$$M$Y$$$20240924$$CN$BR$BR
243586871$24358687$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150481$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240924$$CN$US$US
243586881$24358688$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151478$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240924$$HP$US$US
243586891$24358689$1$I$20240913$20240916$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013519$DR REDDYS$$57$YR$A$M$Y$$$20240924$$HP$US$US
243586901$24358690$1$I$20240826$20240911$20240924$20240924$PER$$US-JNJFOC-20240934337$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243586911$24358691$1$I$$20240911$20240924$20240924$PER$$US-JNJFOC-20240934374$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243586921$24358692$1$I$20240923$20240924$20240924$20240924$PER$$US-BAYER-2024A136565$BAYER$$79$YR$E$M$Y$$$20240924$$CN$US$US
243586931$24358693$1$I$$20240919$20240924$20240924$PER$$US-ROCHE-10000087155$ROCHE$$$$$F$Y$$$20240924$$HP$US$US
243586941$24358694$1$I$20240828$20240924$20240924$20240924$DIR$719616$$FDA-CTU$$94$YR$$F$N$51.3$KG$20240924$N$CN$US$
243586951$24358695$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150699$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$120.66$KG$20240924$$PH$US$US
243586961$24358696$1$I$$20240918$20240924$20240924$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409011809AA$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$JP$JP
243586971$24358697$1$I$20240919$20240919$20240924$20240924$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409014153$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$JP$JP
243586981$24358698$1$I$$20240923$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US082394$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243586991$24358699$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151002$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240924$$CN$US$US
243587001$24358700$1$I$$20240920$20240924$20240924$PER$$US-BAYER-2024A135277$BAYER$$79$YR$E$F$Y$$$20240924$$CN$US$US
243587011$24358701$1$I$$20240904$20240924$20240924$PER$$US-TEVA-VS-3241178$TEVA$$76$YR$$M$Y$$$20240924$$CN$US$US
243587021$24358702$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5934066$ABBVIE$$17$YR$$M$Y$$$20240924$$HP$US$US
243587032$24358703$2$F$20240501$20240923$20240924$20240926$PER$$US-AMGEN-USASP2024189741$AMGEN$$76$YR$E$F$Y$$$20240926$$CN$US$US
243587041$24358704$1$I$20201226$20240918$20240924$20240924$EXP$FR-AFSSAPS-PV2024000673$FR-TEVA-VS-3244988$TEVA$$15$DY$$M$Y$0.8$KG$20240924$$MD$FR$FR
243587071$24358707$1$I$$20240919$20240924$20240924$PER$$US-PFIZER INC-PV202400123149$PFIZER$$45$YR$$F$Y$$$20240924$$CN$US$US
243587081$24358708$1$I$$20240919$20240924$20240924$PER$$US-PFIZER INC-202400260889$PFIZER$$81$YR$$F$Y$$$20240924$$CN$US$US
243587091$24358709$1$I$20220101$20240920$20240924$20240924$PER$$US-PFIZER INC-PV202400123560$PFIZER$$31$YR$$F$Y$$$20240924$$HP$US$US
243587102$24358710$2$F$$20240925$20240924$20240927$PER$$US-PFIZER INC-2022SGN09732$PFIZER$$18$YR$$F$Y$$$20240927$$MD$US$US
243587111$24358711$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-PV202400124487$PFIZER$$15$YR$$F$Y$$$20240924$$MD$US$US
243587121$24358712$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-2022SGN04151$PFIZER$$39$YR$$F$Y$$$20240924$$PH$US$US
243587141$24358714$1$I$20240812$20240920$20240924$20240924$PER$$US-PFIZER INC-202400261018$PFIZER$$64$YR$$F$Y$$$20240924$$CN$US$US
243587151$24358715$1$I$20240920$20240920$20240924$20240924$PER$$US-PFIZER INC-202400260899$PFIZER$$88$YR$$F$Y$$$20240924$$CN$US$US
243587161$24358716$1$I$20240701$20240920$20240924$20240924$PER$$US-PFIZER INC-202400017504$PFIZER$$63$YR$$F$Y$$$20240924$$CN$US$US
243587171$24358717$1$I$$20240920$20240924$20240924$PER$$US-PFIZER INC-PV202400123795$PFIZER$$51$YR$$F$Y$$$20240924$$HP$US$US
243587181$24358718$1$I$$20240920$20240924$20240924$PER$$US-PFIZER INC-202400262090$PFIZER$$50$YR$$F$Y$$$20240924$$HP$US$US
243587191$24358719$1$I$$20240920$20240924$20240924$PER$$US-PFIZER INC-PV202400123546$PFIZER$$67$YR$$F$Y$$$20240924$$CN$US$US
243587201$24358720$1$I$20230901$20240920$20240924$20240924$PER$$US-PFIZER INC-202400261512$PFIZER$$$$A$F$Y$$$20240924$$CN$US$US
243587212$24358721$2$F$$20240923$20240924$20240926$PER$$US-PFIZER INC-PV202400123977$PFIZER$$61$YR$$F$Y$47.075$KG$20240926$$MD$US$US
243587231$24358723$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-2019SGN00185$PFIZER$$$$$$Y$$$20240924$$MD$US$US
243587241$24358724$1$I$20240901$20240919$20240924$20240924$PER$$US-PFIZER INC-202400260884$PFIZER$$54$YR$$M$Y$$$20240924$$CN$US$US
243587251$24358725$1$I$$20240920$20240924$20240924$PER$$US-PFIZER INC-PV202300079030$PFIZER$$59$YR$$F$Y$$$20240924$$CN$US$US
243587261$24358726$1$I$20200101$20240920$20240924$20240924$PER$$US-PFIZER INC-PV202400017331$PFIZER$$48$YR$$F$Y$$$20240924$$HP$US$US
243587271$24358727$1$I$20240901$20240920$20240924$20240924$PER$$US-PFIZER INC-PV202400123683$PFIZER$$10$YR$$M$Y$$$20240924$$CN$US$US
243587281$24358728$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-202400261775$PFIZER$$$$$F$Y$$$20240924$$CN$US$US
243587301$24358730$1$I$$20240919$20240924$20240924$PER$$US-PFIZER INC-PV202400030810$PFIZER$$80$YR$$M$Y$82.54$KG$20240924$$MD$US$US
243587311$24358731$1$I$$20240919$20240924$20240924$PER$$US-PFIZER INC-PV202400123388$PFIZER$$79$YR$$F$Y$$$20240924$$HP$US$US
243587321$24358732$1$I$$20240920$20240924$20240924$PER$$US-PFIZER INC-PV202400123765$PFIZER$$63$YR$$F$Y$$$20240924$$HP$US$US
243587341$24358734$1$I$20240701$20240919$20240924$20240924$PER$$US-PFIZER INC-202400260886$PFIZER$$37$YR$$F$Y$$$20240924$$HP$US$US
243587351$24358735$1$I$$20240919$20240924$20240924$EXP$$JP-BAYER-2024A134561$BAYER$$77$YR$E$M$Y$$$20240924$$MD$JP$JP
243587361$24358736$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-2023SGN03736$PFIZER$$$$$F$Y$$$20240924$$HP$US$US
243587371$24358737$1$I$20230501$20240918$20240924$20240924$PER$$US-PFIZER INC-202400260069$PFIZER$$63$YR$$F$Y$$$20240924$$HP$US$US
243587381$24358738$1$I$$20240918$20240924$20240924$PER$$US-PFIZER INC-202400196841$PFIZER$$17$YR$$F$Y$111$KG$20240924$$CN$US$US
243587401$24358740$1$I$$20240920$20240924$20240924$PER$$US-PFIZER INC-202400239807$PFIZER$$47$YR$$F$Y$$$20240924$$HP$US$US
243587411$24358741$1$I$$20240918$20240924$20240924$PER$$US-PFIZER INC-PV202400123181$PFIZER$$54$YR$$F$Y$$$20240924$$CN$US$US
243587421$24358742$1$I$$20240919$20240924$20240924$PER$$US-PFIZER INC-202400260059$PFIZER$$66$YR$$F$Y$$$20240924$$CN$US$US
243587441$24358744$1$I$$20240918$20240924$20240924$PER$$US-PFIZER INC-202400262033$PFIZER$$67$YR$$M$Y$73.03$KG$20240924$$CN$US$US
243587451$24358745$1$I$20240918$20240919$20240924$20240924$PER$$US-PFIZER INC-PV202400123192$PFIZER$$60$YR$$F$Y$$$20240924$$HP$US$US
243587461$24358746$1$I$$20240919$20240924$20240924$PER$$US-PFIZER INC-PV202400123117$PFIZER$$73$YR$$F$Y$$$20240924$$HP$US$US
243587471$24358747$1$I$$20240920$20240924$20240924$PER$$US-PFIZER INC-202400262083$PFIZER$$73$YR$$F$Y$$$20240924$$HP$US$US
243587481$24358748$1$I$$20240920$20240924$20240924$PER$$US-PFIZER INC-202400261033$PFIZER$$69$YR$$F$Y$$$20240924$$CN$US$US
243587491$24358749$1$I$20240601$20240920$20240924$20240924$PER$$US-PFIZER INC-202400262106$PFIZER$$38$YR$$F$Y$$$20240924$$HP$US$US
243587501$24358750$1$I$$20240920$20240924$20240924$PER$$US-PFIZER INC-202400260833$PFIZER$$$$$F$Y$$$20240924$$PH$US$US
243587521$24358752$1$I$$20240919$20240924$20240924$PER$$US-PFIZER INC-202400260203$PFIZER$$15$YR$$F$Y$$$20240924$$HP$US$US
243587541$24358754$1$I$$20240918$20240924$20240924$PER$$US-PFIZER INC-202400260036$PFIZER$$59$YR$$F$Y$$$20240924$$HP$US$US
243587551$24358755$1$I$20240920$20240920$20240924$20240924$PER$$US-PFIZER INC-202400260861$PFIZER$$68$YR$$M$Y$$$20240924$$HP$US$US
243587561$24358756$1$I$$20240920$20240924$20240924$PER$$US-PFIZER INC-202400260975$PFIZER$$88$YR$$$Y$$$20240924$$CN$US$US
243587571$24358757$1$I$20240918$20240919$20240924$20240924$PER$$US-PFIZER INC-202400260468$PFIZER$$67$YR$$F$Y$$$20240924$$CN$US$US
243587591$24358759$1$I$$20240921$20240924$20240924$EXP$$NVSC2024DK189264$NOVARTIS$$$$$F$Y$$$20240924$$CN$DK$DK
243587602$24358760$2$F$$20240923$20240924$20240926$PER$$NVSC2024US189807$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
243587611$24358761$1$I$20240801$20240821$20240924$20240924$PER$$US-Eisai-EC-2024-172634$EISAI$$72$YR$E$F$Y$$$20240924$$CN$US$US
243587621$24358762$1$I$$20240823$20240924$20240924$PER$$US-Eisai-EC-2024-172793$EISAI$$$$$M$Y$$$20240924$$MD$US$US
243587631$24358763$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65362$$FDA-CTU$$$$$F$N$$$20240923$N$HP$US$
243587641$24358764$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65317$$FDA-CTU$$$$$$N$$$20240923$$CN$US$
243587651$24358765$1$I$20240920$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65359$$FDA-CTU$$77$YR$$F$N$52.7$KG$20240923$N$$US$
243587661$24358766$1$I$20240903$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65357$$FDA-CTU$$46$YR$$F$N$81.1$KG$20240923$N$PH$US$
243587671$24358767$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65370$$FDA-CTU$$$$$$N$$$20240923$$CN$US$
243587681$24358768$1$I$20240920$20240924$20240924$20240924$DIR$719618$$FDA-CTU$$62$YR$$F$N$138.6$KG$20240924$N$HP$US$
243587691$24358769$1$I$$20240924$20240924$20240924$DIR$719674$$FDA-CTU$$$$$UNK$N$$$20240924$N$CN$US$
243587701$24358770$1$I$20240101$20240910$20240924$20240924$EXP$$CN-SA-2024SA275502$SANOFI AVENTIS$$$$$$Y$$$20240924$$MD$CN$CN
243587711$24358771$1$I$$20240923$20240924$20240924$EXP$$CA-ABBVIE-5936455$ABBVIE$$$$E$F$Y$$$20240924$$PH$CA$CA
243587721$24358772$1$I$$20240920$20240924$20240924$EXP$$BR-TAKEDA-2024TUS094506$TAKEDA$$$$$F$Y$$$20240924$$CN$BR$BR
243587751$24358775$1$I$$20240916$20240924$20240924$EXP$$US-GENMAB-2024-03352$GENMAB$$7$DEC$$F$Y$$$20240924$$PH$US$US
243587761$24358776$1$I$20240617$20240923$20240924$20240924$EXP$$CA-HLS-202402403$HLS THERAPEUTICS$$73$YR$E$F$Y$$$20240924$$PH$CA$CA
243587771$24358777$1$I$$20240913$20240924$20240924$EXP$$JP-KYOWAKIRIN-2024KK021371$KYOWA$$8$DEC$$M$Y$$$20240924$$PH$JP$JP
243587781$24358778$1$I$20240829$20240920$20240924$20240924$EXP$$JP-PFIZER INC-202400260230$PFIZER$$8$DEC$$M$Y$$$20240924$$MD$JP$JP
243587792$24358779$2$F$20220901$20240923$20240924$20240926$EXP$$US-PFIZER INC-2022SGN10419$PFIZER$$$$$M$Y$$$20240926$$PH$US$US
243587811$24358781$1$I$$20240920$20240924$20240924$EXP$$CA-PFIZER INC-202400260756$PFIZER$$51$YR$$F$Y$72$KG$20240924$$CN$CA$CA
243587821$24358782$1$I$20240909$20240920$20240924$20240924$EXP$$CN-PFIZER INC-PV202400123639$PFIZER$$23$YR$$F$Y$85$KG$20240924$$HP$CN$CN
243587841$24358784$1$I$20221213$20240919$20240924$20240924$EXP$$CA-PFIZER INC-202200275506$PFIZER$$44$YR$$M$Y$$$20240924$$MD$CA$CA
243587851$24358785$1$I$20220101$20240920$20240924$20240924$EXP$$US-PFIZER INC-2022SGN09381$PFIZER$$71$YR$$F$Y$$$20240924$$HP$US$US
243587861$24358786$1$I$20240710$20240920$20240924$20240924$EXP$PT-INFARMED-R202409-340$PT-PFIZER INC-202400260415$PFIZER$$74$YR$$F$Y$$$20240924$$PH$PT$PT
243587871$24358787$1$I$20210602$20240920$20240924$20240924$EXP$FR-AFSSAPS-MA2024001358$FR-PFIZER INC-202400260281$PFIZER$$75$YR$$F$Y$$$20240924$$PH$FR$FR
243587881$24358788$1$I$$20240919$20240924$20240924$EXP$$IE-PFIZER INC-PV202400123400$PFIZER$$$$$F$Y$$$20240924$$MD$IE$IE
243587891$24358789$1$I$$20240921$20240924$20240924$EXP$$IN-PFIZER INC-PV202400110296$PFIZER$$60$YR$$M$Y$$$20240924$$CN$IN$IN
243587902$24358790$2$F$20181018$20240926$20240924$20240927$EXP$$US-PFIZER INC-2018SGN02724$PFIZER$$51$YR$$M$Y$$$20240927$$HP$US$US
243587921$24358792$1$I$20240101$20240918$20240924$20240924$EXP$$PT-ORGANON-O2409PRT001737$ORGANON$$$$$$Y$$$20240924$$MD$PT$PT
243587931$24358793$1$I$$20240918$20240924$20240924$EXP$$US-AMGEN-USASP2024187284$AMGEN$Ragheb J.M.; Ton A.; Bell J.A. et al.. Risk of Subsequent Hip Fractures across Varying Treatment Patterns for Index Vertebral Compression Fractures. Journal of Clinical Medicine. 2024;13 (16):1-8$$$$$Y$$$20240924$$HP$US$US
243587941$24358794$1$I$$20240920$20240924$20240924$EXP$$US-AMGEN-USASP2024188375$AMGEN$Sofocleous C.T.; Dimopoulos P.M.; Sotirchos V.S. et al.. Gastrohepatic Fistula After Radiation Segmentectomy of a Left Hepatic Lobe Rectal Metastasis: A Case Report. CardioVascular and Interventional Radiology. 2024;47 (9):1296-1298$61$YR$A$M$Y$$$20240924$$HP$US$US
243587951$24358795$1$I$20210101$20240909$20240924$20240924$EXP$$US-NOVOPROD-1178645$NOVO NORDISK$$$$$F$Y$66.667$KG$20240924$$CN$US$US
243587961$24358796$1$I$$20231003$20240924$20240924$EXP$$US-NOVOPROD-1135659$NOVO NORDISK$$$$A$F$Y$$$20240924$$CN$US$US
243587971$24358797$1$I$20240101$20240919$20240924$20240924$EXP$$CA-ABBVIE-5933788$ABBVIE$$89$YR$$M$Y$$$20240924$$HP$CA$CA
243587981$24358798$1$I$20240101$20240826$20240924$20240924$PER$$US-Eisai-EC-2024-172967$EISAI$$80$YR$E$M$Y$$$20240924$$CN$US$US
243587991$24358799$1$I$20190406$20240919$20240924$20240924$EXP$$DE-MYLANLABS-2020M1007463$MYLAN$$$$$$Y$$$20240924$$MD$DE$DE
243588001$24358800$1$I$20240807$20240924$20240924$20240924$DIR$719687$$FDA-CTU$$77$YR$$M$N$113.3$KG$20240924$N$HP$US$
243588012$24358801$2$F$20240801$20240924$20240924$20240927$PER$$US-AMGEN-USASP2024189756$AMGEN$$73$YR$E$M$Y$$$20240927$$CN$US$US
243588031$24358803$1$I$20240806$20240924$20240924$20240924$DIR$719686$$FDA-CTU$$77$YR$$M$N$111.9$KG$20240924$N$HP$US$
243588041$24358804$1$I$$20240917$20240924$20240924$EXP$$US-AMGEN-USASP2024186809$AMGEN$Molmenti E.P.; Nair V.; Jandovitz N. et.al. COVID-19 in kidney transplant recipients. American Journal of Transplantation. 2020;20 (7):1819-1825$$$$$Y$$$20240924$$HP$US$US
243588051$24358805$1$I$20240712$20240924$20240924$20240924$EXP$FR-AFSSAPS-GR2024001135$NVSC2024FR189676$NOVARTIS$$57$YR$$F$Y$$$20240924$$PH$FR$FR
243588061$24358806$1$I$20240526$20240918$20240924$20240924$EXP$FR-AFSSAPS-NT2024001098$FR-TEVA-VS-3245248$TEVA$$33$YR$$F$Y$$$20240924$$PH$FR$FR
243588081$24358808$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151294$BRISTOL MYERS SQUIBB$$31$YR$A$M$Y$$$20240924$$CN$US$US
243588091$24358809$1$I$20210429$20230214$20240924$20240924$EXP$$GB-BIOCRYST PHARMACEUTICALS, INC.-2023BCR00149$BIOCRYST PHARMACEUTICALS$$21$YR$$F$Y$$$20240924$$MD$GB$GB
243588102$24358810$2$F$20240301$20240917$20240924$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409010390$ELI LILLY AND CO$$23$YR$A$M$Y$$$20240927$$CN$US$US
243588111$24358811$1$I$$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012316$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240924$$CN$US$US
243588121$24358812$1$I$20240922$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014879$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240924$$CN$US$US
243588131$24358813$1$I$20240706$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013836$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240924$$CN$US$US
243588141$24358814$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014672$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240924$$CN$US$US
243588151$24358815$1$I$20240922$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014662$ELI LILLY AND CO$$81$YR$E$M$Y$$$20240924$$CN$US$US
243588161$24358816$1$I$20240920$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014031$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240924$$CN$US$US
243588171$24358817$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013692$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240924$$CN$US$US
243588181$24358818$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014465$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240924$$CN$US$US
243588191$24358819$1$I$20240101$20240920$20240924$20240924$EXP$$US-ABBVIE-5935330$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243588201$24358820$1$I$20231213$20240924$20240924$20240924$DIR$719685$$FDA-CTU$$41$YR$$M$N$99$KG$20240924$Y$CN$US$
243588211$24358821$1$I$20240913$20240913$20240924$20240924$PER$$US-ALKERMES INC.-ALK-2024-002400$ALKERMES$$66$YR$$M$Y$101.59$KG$20240924$$HP$US$US
243588221$24358822$1$I$$20240920$20240924$20240924$EXP$$NVSC2024US188737$NOVARTIS$$$$$F$Y$48.53$KG$20240924$$CN$US$US
243588231$24358823$1$I$20240101$20240916$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148638$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240924$$MD$US$US
243588241$24358824$1$I$$20240919$20240924$20240924$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-150710$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240924$$CN$DE$DE
243588251$24358825$1$I$20230418$20240917$20240924$20240924$EXP$FR-AFSSAPS-NC2024001084$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-148772$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$65$KG$20240924$$CN$FR$FR
243588261$24358826$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151327$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240924$$HP$US$US
243588271$24358827$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151329$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240924$$HP$US$US
243588291$24358829$1$I$$20240917$20240924$20240924$EXP$GB-MHRA-MIDB-e4b01613-0849-4c9e-85e2-6564741a3d9b$GB-TEVA-VS-3244527$TEVA$$78$YR$$M$Y$$$20240924$$PH$GB$GB
243588311$24358831$1$I$$20240920$20240924$20240924$PER$$US-Taiho Oncology Inc-2024-008921$TAIHO ONCOLOGY INC$$55$YR$A$M$Y$45.36$KG$20240924$$HP$US$US
243588321$24358832$1$I$20240801$20240826$20240924$20240924$PER$$US-Eisai-EC-2024-172969$EISAI$$77$YR$E$M$Y$$$20240924$$CN$US$US
243588331$24358833$1$I$20240903$20240918$20240924$20240924$EXP$FR-AFSSAPS-BX2024001758$FR-TEVA-VS-3245260$TEVA$$2$YR$$F$Y$$$20240924$$HP$FR$FR
243588341$24358834$1$I$20231227$20240920$20240924$20240924$EXP$$CA-TAKEDA-2024TUS094486$TAKEDA$$59$YR$$F$Y$$$20240924$$CN$CA$CA
243588351$24358835$1$I$$20240916$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003810$PAREXEL$$$$$$Y$$$20240924$$CN$US$US
243588361$24358836$1$I$$20240913$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003865$PAREXEL$$$$$$Y$$$20240924$$CN$US$US
243588371$24358837$1$I$20240601$20240909$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004129$PAREXEL$$$$$$Y$$$20240924$$CN$US$US
243588381$24358838$1$I$20240919$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188841$AMGEN$$87$YR$E$F$Y$$$20240924$$CN$US$US
243588391$24358839$1$I$$20240917$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US004266$PAREXEL$$$$$$Y$$$20240924$$CN$US$US
243588401$24358840$1$I$$20240710$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003567$PAREXEL$$60$YR$$F$Y$$$20240924$$CN$US$US
243588411$24358841$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151076$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240924$$CN$US$US
243588421$24358842$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151312$BRISTOL MYERS SQUIBB$$33$YR$A$F$Y$$$20240924$$HP$US$US
243588431$24358843$1$I$$20240917$20240924$20240924$PER$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US003962$PAREXEL$$$$$$Y$$$20240924$$CN$US$US
243588441$24358844$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150938$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240924$$HP$US$US
243588451$24358845$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151345$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240924$$CN$US$US
243588461$24358846$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151208$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240924$$CN$US$US
243588471$24358847$1$I$$20240911$20240924$20240924$EXP$$CO-TAKEDA-2024TUS094554$TAKEDA$$$$$F$Y$$$20240924$$HP$CO$CO
243588481$24358848$1$I$20240912$20240913$20240924$20240924$PER$$US-ABBVIE-5926354$ABBVIE$$37$YR$$F$Y$$$20240924$$CN$US$US
243588501$24358850$1$I$$20240917$20240924$20240924$EXP$$NVSC2024BR189816$NOVARTIS$$$$$F$Y$$$20240924$$CN$BR$BR
243588511$24358851$1$I$20240101$20240920$20240924$20240924$EXP$$US-BAUSCH-BL-2024-014297$BAUSCH AND LOMB$$65$YR$$M$Y$$$20240924$$CN$US$US
243588521$24358852$1$I$$20240923$20240924$20240924$PER$$US-ABBVIE-5935877$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243588532$24358853$2$F$20240813$20240926$20240924$20240930$EXP$$US-BAUSCH-BL-2024-014317$BAUSCH AND LOMB$$79$YR$$F$Y$$$20240930$$CN$US$US
243588541$24358854$1$I$$20240923$20240924$20240924$EXP$$US-BAUSCH-BL-2024-005869$BAUSCH AND LOMB$$76$YR$$F$Y$$$20240924$$CN$US$US
243588551$24358855$1$I$$20240917$20240924$20240924$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-18916$IPSEN$Carey, Alexandra, Fialkowski, Allison, Broyles, Kathryn, et al. ^Achieving Enteral Autonomy in Children with Intestinal Failure Following Inpatient Admission: A Case Series^, The Journal of Pediatrics, 2024, Vol. 275.0, Iss. nan, Pp. 114226. doi:10.1016/j.jpeds.2024.114226$2$YR$C$F$Y$$$20240924$$MD$US$US
243588561$24358856$1$I$$20240916$20240924$20240924$EXP$$CA-JNJFOC-20240952392$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$HP$CA$CA
243588581$24358858$1$I$20240918$20240924$20240924$20240924$DIR$719628$$FDA-CTU$$59$YR$$M$N$$$20240924$N$PH$US$
243588591$24358859$1$I$20240923$20240924$20240924$20240924$DIR$719677$$FDA-CTU$$$$$UNK$N$$$20240924$N$CN$US$
243588601$24358860$1$I$20240923$20240924$20240924$20240924$DIR$719680$$FDA-CTU$$$$$UNK$N$$$20240924$N$HP$US$
243588611$24358861$1$I$20240814$20240917$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013756$DR REDDYS$$17$YR$T$F$Y$$$20240924$$HP$US$US
243588621$24358862$1$I$$20240916$20240924$20240924$PER$US-MLMSERVICE-20240909-PI186962-00077-1$US-RDY-SPO/USA/24/0013648$DR REDDYS$Mahtani R, Harpalani N, Yan F, Phiel K, Kovalenko I. Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series. Frontiers in Oncology. 2024;14:1419246. DOI: 10.3389/fonc.2024.1419246.$72$YR$E$F$Y$$$20240924$$MD$US$US
243588631$24358863$1$I$$20240923$20240924$20240924$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053201$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240924$$CN$US$US
243588641$24358864$1$I$20240916$20240920$20240924$20240924$EXP$$NVSC2024CN189820$NOVARTIS$$44$YR$$F$Y$105$KG$20240924$$HP$CN$CN
243588651$24358865$1$I$20221109$20240919$20240924$20240924$EXP$FR-AFSSAPS-MA2024001511$FR-Eisai-EC-2024-174737$EISAI$$70$YR$E$F$Y$$$20240924$$HP$FR$FR
243588661$24358866$1$I$20221108$20240919$20240924$20240924$EXP$FR-AFSSAPS-MA2024001509$FR-Eisai-EC-2024-174943$EISAI$$74$YR$E$F$Y$$$20240924$$HP$FR$FR
243588671$24358867$1$I$$20240917$20240924$20240924$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-18731$IPSEN$$49$YR$A$F$Y$$$20240924$$CN$CA$CA
243588681$24358868$1$I$$20240919$20240924$20240924$EXP$$CA-TAKEDA-2024TUS093805$TAKEDA$$$$$M$Y$$$20240924$$HP$CA$CA
243588691$24358869$1$I$20240820$20240920$20240924$20240924$EXP$$AU-TAKEDA-2024TUS093590$TAKEDA$$53$YR$$M$Y$$$20240924$$HP$AU$AU
243588701$24358870$1$I$$20240920$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150750$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240924$$CN$US$US
243588711$24358871$1$I$20240815$20240909$20240924$20240924$EXP$$JO-JNJFOC-20240939005$JOHNSON AND JOHNSON$$64$YR$A$F$Y$77$KG$20240924$$MD$JO$JO
243588722$24358872$2$F$20240101$20240924$20240924$20240927$EXP$$US-ABBVIE-5934610$ABBVIE$$$$$F$Y$68$KG$20240927$$CN$US$US
243588731$24358873$1$I$$20240917$20240924$20240924$EXP$$US-BAYER-2024A133505$BAYER$$46$YR$A$M$Y$102.95$KG$20240924$$CN$US$US
243588741$24358874$1$I$$20240919$20240924$20240924$EXP$$US-MYLANLABS-2024M1086687$MYLAN$$$$$M$Y$$$20240924$$CN$US$US
243588751$24358875$1$I$$20240918$20240924$20240924$EXP$$US-TAKEDA-2024TUS093746$TAKEDA$$45$YR$$M$Y$$$20240924$$CN$US$US
243588761$24358876$1$I$20240101$20240919$20240924$20240924$EXP$$TH-Eisai-EC-2024-175054$EISAI$$47$YR$A$M$Y$$$20240924$$CN$TH$TH
243588771$24358877$1$I$20240101$20240826$20240924$20240924$PER$$US-Eisai-EC-2024-172984$EISAI$$$$$F$Y$$$20240924$$CN$US$US
243588781$24358878$1$I$20240730$20240919$20240924$20240924$EXP$FR-AFSSAPS-AM2024000734$FR-MYLANLABS-2024M1085624$MYLAN$$79$YR$$M$Y$110$KG$20240924$$MD$FR$FR
243588791$24358879$1$I$$20240919$20240924$20240924$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052364$BOEHRINGER INGELHEIM$Surani S, Hussein G, Krastev P, Mallari AJ, Labban ME, Yadav S. Stone heart syndrome: a curious case of digoxin toxicity and calcium infusion.. Clinical Case Reports. 2024;12(9): e9376. doi:10.1002/ccr3.9376.$78$YR$E$F$Y$$$20240924$$HP$US$US
243588801$24358880$1$I$$20240922$20240924$20240924$PER$$US-AMGEN-USASP2024189774$AMGEN$$$$$$Y$$$20240924$$CN$US$US
243588811$24358881$1$I$20240201$20240916$20240924$20240924$PER$$US-RDY-SPO/USA/24/0013714$DR REDDYS$$$$$F$Y$55$KG$20240924$$CN$US$US
243588821$24358882$1$I$20240725$20240923$20240924$20240924$EXP$FR-AFSSAPS-GR2024001116$NVSC2024FR189567$NOVARTIS$$85$YR$$M$Y$87$KG$20240924$$MD$FR$FR
243588831$24358883$1$I$20240903$20240924$20240924$20240924$DIR$719676$$FDA-CTU$$62$YR$$M$N$115$KG$20240924$N$PH$US$
243588851$24358885$1$I$20231006$20240920$20240924$20240924$EXP$FR-AFSSAPS-NT2024001160$FR-PFIZER INC-202400260453$PFIZER$$5$YR$$M$Y$18$KG$20240924$$PH$FR$FR
243588862$24358886$2$F$$20240925$20240924$20240927$EXP$$US-PFIZER INC-2019SGN01716$PFIZER$$$$$$Y$$$20240927$$HP$US$US
243588871$24358887$1$I$20240918$20240919$20240924$20240924$EXP$$DE-PFIZER INC-PV202400123393$PFIZER$$$$$F$Y$$$20240924$$MD$DE$DE
243588882$24358888$2$F$$20240925$20240924$20240927$EXP$$US-PFIZER INC-2019SGN00544$PFIZER$$$$$M$Y$$$20240927$$MD$US$US
243588891$24358889$1$I$$20240923$20240924$20240924$PER$$US-PFIZER INC-202400262327$PFIZER$$$$E$M$Y$$$20240924$$MD$US$US
243588901$24358890$1$I$$20240923$20240924$20240924$EXP$$CA-PFIZER INC-202400261945$PFIZER$$67$YR$$M$Y$$$20240924$$HP$CA$CA
243588911$24358891$1$I$20240620$20240919$20240924$20240924$EXP$$CN-PFIZER INC-PV202400123046$PFIZER$$38$YR$$F$Y$$$20240924$$HP$CN$CN
243588922$24358892$2$F$$20240926$20240924$20240930$EXP$$US-PFIZER INC-2019SGN00383$PFIZER$$$$$M$Y$$$20240930$$MD$US$US
243588931$24358893$1$I$$20240920$20240924$20240924$EXP$$JP-PFIZER INC-202400260535$PFIZER$$$$$$Y$$$20240924$$MD$JP$JP
243588941$24358894$1$I$20240603$20240919$20240924$20240924$EXP$FR-AFSSAPS-PP2024000996$FR-INCYTE CORPORATION-2024IN010006$INCYTE$$$$$$Y$$$20240924$$MD$FR$FR
243588951$24358895$1$I$20230101$20240916$20240924$20240924$PER$$US-ABBVIE-5926003$ABBVIE$$$$$M$Y$136.07$KG$20240924$$CN$US$US
243588961$24358896$1$I$20240411$20240918$20240924$20240924$EXP$FR-AFSSAPS-AN2024001250$FR-TEVA-VS-3244966$TEVA$$69$YR$$M$Y$$$20240924$$PH$FR$FR
243588971$24358897$1$I$$20240919$20240924$20240924$EXP$$NVSC2024DE189483$NOVARTIS$$$$$F$Y$$$20240924$$MD$DE$DE
243588991$24358899$1$I$$20240919$20240924$20240924$EXP$$JP-009507513-2409JPN003038J$MERCK$$$$E$$Y$$$20240924$$MD$JP$JP
243589011$24358901$1$I$20240705$20240918$20240924$20240924$EXP$FR-AFSSAPS-CN2024000854$FR-TEVA-VS-3245235$TEVA$$53$YR$$M$Y$104$KG$20240924$$MD$FR$FR
243589021$24358902$1$I$20140101$20240911$20240924$20240924$PER$$US-JNJFOC-20240931184$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240924$$CN$US$US
243589031$24358903$1$I$$20240919$20240924$20240924$EXP$$GB-TEVA-VS-3245939$TEVA$$$$$F$Y$$$20240924$$HP$GB$GB
243589051$24358905$1$I$20240101$20240923$20240924$20240924$EXP$$HR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052791$BOEHRINGER INGELHEIM$$73$YR$E$M$Y$$$20240924$$MD$HR$HR
243589071$24358907$1$I$$20240919$20240924$20240924$EXP$$NVSC2024US188147$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243589081$24358908$1$I$$20240904$20240924$20240924$PER$$US-SMPA-2024SPA002330$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589111$24358911$1$I$$20240919$20240924$20240924$PER$$US-SMPA-2024SPA003074$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589121$24358912$1$I$$20240917$20240924$20240924$PER$$US-SMPA-2024SPA002972$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589131$24358913$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA000789$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589141$24358914$1$I$$20240916$20240924$20240924$PER$$US-SMPA-2024SPA002950$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589151$24358915$1$I$$20240904$20240924$20240924$PER$$US-SMPA-2024SPA000770$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589161$24358916$1$I$$20240904$20240924$20240924$PER$$US-SMPA-2024SPA002342$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589171$24358917$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002316$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589181$24358918$1$I$$20240828$20240924$20240924$PER$$US-SMPA-2024SPA002085$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589191$24358919$1$I$$20240905$20240924$20240924$PER$$US-SMPA-2024SPA002400$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589201$24358920$1$I$$20240918$20240924$20240924$PER$$US-SMPA-2024SPA003063$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589211$24358921$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002241$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589232$24358923$2$F$$20240916$20240924$20240930$PER$$US-SMPA-2024SPA002590$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243589241$24358924$1$I$$20240916$20240924$20240924$PER$$US-SMPA-2024SPA002986$SUNOVION$$$$$$Y$$$20240924$$HP$US$US
243589251$24358925$1$I$$20240916$20240924$20240924$PER$$US-SMPA-2024SPA002925$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589271$24358927$1$I$$20240916$20240924$20240924$PER$$US-SMPA-2024SPA002911$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589282$24358928$2$F$$20240830$20240924$20240927$PER$$US-SMPA-2024SPA002348$SUNOVION$$$$$$Y$$$20240927$$MD$US$US
243589291$24358929$1$I$$20240916$20240924$20240924$PER$$US-SMPA-2024SPA002931$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589301$24358930$1$I$$20240904$20240924$20240924$PER$$US-SMPA-2024SPA002357$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589311$24358931$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002255$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589321$24358932$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024MYSCI0700179$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589331$24358933$1$I$$20240916$20240924$20240924$PER$$US-SMPA-2024SPA002923$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589341$24358934$1$I$$20240905$20240924$20240924$PER$$US-SMPA-2024SPA002363$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589351$24358935$1$I$$20240905$20240924$20240924$PER$$US-SMPA-2024SPA002380$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589361$24358936$1$I$$20240827$20240924$20240924$PER$$US-SMPA-2024SPA002072$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589371$24358937$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002256$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589381$24358938$1$I$$20240920$20240924$20240924$PER$$US-SMPA-2024SPA003154$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589391$24358939$1$I$$20240916$20240924$20240924$PER$$US-SMPA-2024SPA002905$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589401$24358940$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002317$SUNOVION$$$$$$Y$$$20240924$$MD$US$US
243589411$24358941$1$I$$20240904$20240924$20240924$PER$$US-SMPA-2024SPA002341$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589421$24358942$1$I$$20240919$20240924$20240924$PER$$US-SMPA-2024SPA003101$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589431$24358943$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002279$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589441$24358944$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002244$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589451$24358945$1$I$$20240916$20240924$20240924$PER$$US-SMPA-2024SPA002979$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589461$24358946$1$I$$20240904$20240924$20240924$PER$$US-SMPA-2024SPA002329$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589471$24358947$1$I$$20240905$20240924$20240924$PER$$US-SMPA-2024SPA002398$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589491$24358949$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002262$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589501$24358950$1$I$$20240830$20240924$20240924$PER$$US-SMPA-2024SPA002190$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589511$24358951$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA000618$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589521$24358952$1$I$$20240830$20240924$20240924$PER$$US-SMPA-2024SPA002202$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589531$24358953$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA001091$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589551$24358955$1$I$$20240916$20240924$20240924$PER$$US-SMPA-2024SPA002934$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589561$24358956$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002261$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589571$24358957$1$I$$20240902$20240924$20240924$PER$$US-SMPA-2024SPA002230$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589581$24358958$1$I$$20240904$20240924$20240924$PER$$US-SMPA-2024SPA000483$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589591$24358959$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002272$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589621$24358962$1$I$$20240912$20240924$20240924$PER$$US-SMPA-2024SPA002716$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589631$24358963$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002240$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589641$24358964$1$I$$20240904$20240924$20240924$PER$$US-SMPA-2024SPA002353$SUNOVION$$$$$$Y$$$20240924$$MD$US$US
243589651$24358965$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002252$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589661$24358966$1$I$$20240912$20240924$20240924$PER$$US-SMPA-2024SPA002689$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589671$24358967$1$I$$20240917$20240924$20240924$PER$$US-SMPA-2024SPA002944$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589681$24358968$1$I$20240401$20240903$20240924$20240924$PER$$US-SMPA-2024MYSCI0401110$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589691$24358969$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002270$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589701$24358970$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002264$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589711$24358971$1$I$$20240829$20240924$20240924$PER$$US-SMPA-2024SPA002132$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589721$24358972$1$I$$20240917$20240924$20240924$PER$$US-SMPA-2024SPA002980$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589731$24358973$1$I$$20240916$20240924$20240924$PER$$US-SMPA-2024SPA002904$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589741$24358974$1$I$$20240904$20240924$20240924$PER$$US-SMPA-2024SPA001209$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589751$24358975$1$I$$20240917$20240924$20240924$PER$$US-SMPA-2024SPA002982$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589761$24358976$1$I$$20240917$20240924$20240924$PER$$US-SMPA-2024SPA002957$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589771$24358977$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002274$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589781$24358978$1$I$20150101$20240916$20240924$20240924$PER$$US-SMPA-2024SPA002891$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589791$24358979$1$I$$20240909$20240924$20240924$PER$$US-INCYTE CORPORATION-2024IN009521$INCYTE$$$$$$Y$$$20240924$$CN$US$US
243589811$24358981$1$I$$20240830$20240924$20240924$PER$$US-SMPA-2024SPA002165$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589821$24358982$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002338$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589831$24358983$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002335$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589841$24358984$1$I$$20240917$20240924$20240924$PER$$US-SMPA-2024SPA002966$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589861$24358986$1$I$$20240905$20240924$20240924$PER$$US-SMPA-2024SPA002392$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589871$24358987$1$I$$20240916$20240924$20240924$PER$$US-SMPA-2024SPA002974$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589881$24358988$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002289$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589891$24358989$1$I$$20240904$20240924$20240924$PER$$US-SMPA-2024SPA002334$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589901$24358990$1$I$$20240913$20240924$20240924$PER$$US-SMPA-2024SPA002753$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589911$24358991$1$I$$20240901$20240924$20240924$PER$$US-SMPA-2024SPA002223$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589921$24358992$1$I$$20240917$20240924$20240924$PER$$US-SMPA-2024SPA002991$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589931$24358993$1$I$$20240828$20240924$20240924$PER$$US-SMPA-2024SPA002140$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589941$24358994$1$I$$20240903$20240924$20240924$PER$$US-SMPA-2024SPA002251$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589951$24358995$1$I$$20240905$20240924$20240924$PER$$US-SMPA-2024SPA002407$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243589971$24358997$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014574$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240924$$CN$US$US
243589981$24358998$1$I$$20240913$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009064$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240924$$CN$US$US
243589991$24358999$1$I$$20240923$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409014056$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240924$$CN$US$US
243590001$24359000$1$I$20240701$20240919$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409012768$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240924$$MD$US$US
243590011$24359001$1$I$$20240915$20240924$20240924$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202409010906$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240924$$MD$SA$SA
243590021$24359002$1$I$20240917$20240917$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011721$ELI LILLY AND CO$$12$YR$C$M$Y$41.27$KG$20240924$$CN$US$US
243590031$24359003$1$I$$20240913$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009069$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240924$$CN$US$US
243590041$24359004$1$I$$20240916$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009970$ELI LILLY AND CO$$$$$M$Y$$$20240924$$CN$US$US
243590051$24359005$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013921$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240924$$CN$US$US
243590071$24359007$1$I$20240918$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013610$ELI LILLY AND CO$$$$$F$Y$$$20240924$$CN$US$US
243590081$24359008$1$I$20000605$20240912$20240924$20240924$EXP$$US-ELI_LILLY_AND_COMPANY-US202409008477$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240924$$CN$US$US
243590091$24359009$1$I$$20240912$20240924$20240924$PER$$US-INCYTE CORPORATION-2024IN009686$INCYTE$$$$$$Y$$$20240924$$CN$US$US
243590101$24359010$1$I$$20240922$20240924$20240924$PER$$US-JNJFOC-20240960710$JOHNSON AND JOHNSON$$$$$$Y$$$20240924$$CN$US$US
243590111$24359011$1$I$$20240910$20240924$20240924$EXP$$US-SMPA-2024MYSCI0700605$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243590121$24359012$1$I$$20240910$20240924$20240924$EXP$$US-SMPA-2024SPA002575$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243590131$24359013$1$I$$20240910$20240924$20240924$EXP$$US-SMPA-2024SPA002574$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243590141$24359014$1$I$20240618$20240917$20240924$20240924$EXP$SE-SEMPA-2024-006549$SE-TEVA-VS-3244735$TEVA$$57$YR$$M$Y$$$20240924$$MD$SE$SE
243590161$24359016$1$I$20230401$20240917$20240924$20240924$EXP$$CA-009507513-2409USA006057$MERCK$$$$$F$Y$$$20240924$$MD$CA$CA
243590171$24359017$1$I$20240907$20240916$20240924$20240924$PER$$US-JNJFOC-20240947284$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20240924$$CN$US$US
243590181$24359018$1$I$$20240912$20240924$20240924$PER$$US-INCYTE CORPORATION-2024IN009680$INCYTE$$$$$$Y$$$20240924$$CN$US$US
243590191$24359019$1$I$20240624$20240923$20240924$20240924$EXP$BE-EMA-DD-20240821-7482647-171149$NVSC2024BE188622$NOVARTIS$$85$YR$$M$Y$$$20240924$$HP$BE$BE
243590211$24359021$1$I$20240515$20240915$20240924$20240924$EXP$$KW-AMRYT PHARMACEUTICALS DAC-AEGR007171$AEGERION$$$$$$Y$$$20240924$$CN$KW$KW
243590221$24359022$1$I$20240701$20240920$20240924$20240924$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052696$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240924$$CN$US$US
243590231$24359023$1$I$20240501$20240918$20240924$20240924$EXP$FR-AFSSAPS-GR2024001056$FR-TEVA-VS-3245246$TEVA$$69$YR$$F$Y$$$20240924$$PH$FR$FR
243590241$24359024$1$I$20240815$20240827$20240924$20240924$PER$$US-Eisai-EC-2024-173098$EISAI$$76$YR$E$F$Y$$$20240924$$HP$US$US
243590251$24359025$1$I$$20240827$20240924$20240924$PER$$US-Eisai-EC-2024-173117$EISAI$$$$$$Y$$$20240924$$MD$US$US
243590261$24359026$1$I$$20240918$20240924$20240924$EXP$NL-LRB-01001136$NL-TEVA-VS-3245046$TEVA$$70$YR$$M$Y$99$KG$20240924$$CN$NL$NL
243590271$24359027$1$I$20240803$20240917$20240924$20240924$EXP$FR-AFSSAPS-LL2024001722$FR-TEVA-VS-3244531$TEVA$$63$YR$$M$Y$$$20240924$$PH$FR$FR
243590291$24359029$1$I$20201027$20240918$20240924$20240924$EXP$PL-URPL-1-2545-2020$PL-TEVA-VS-3245210$TEVA$$33$YR$$M$Y$$$20240924$$MD$PL$PL
243590301$24359030$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151112$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$77.11$KG$20240924$$HP$US$US
243590311$24359031$1$I$$20240917$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148549$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$107.95$KG$20240924$$CN$US$US
243590321$24359032$1$I$$20240919$20240924$20240924$PER$$US-009507513-2409USA007761$MERCK$$23$YR$$M$Y$$$20240924$$MD$US$US
243590341$24359034$1$I$20230420$20240918$20240924$20240924$EXP$FR-AFSSAPS-CF2023000344$FR-TEVA-VS-3244899$TEVA$$29$YR$$F$Y$$$20240924$$MD$FR$FR
243590361$24359036$1$I$20240101$20240917$20240924$20240924$EXP$FR-AFSSAPS-RN2024000891$FR-TEVA-VS-3244726$TEVA$$57$YR$$M$Y$$$20240924$$MD$FR$FR
243590372$24359037$2$F$$20240923$20240924$20240926$PER$$US-AMGEN-USASP2024189482$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243590381$24359038$1$I$20240801$20240917$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US082513$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243590391$24359039$1$I$20240902$20240917$20240924$20240924$EXP$FR-AFSSAPS-LL2024001724$FR-TEVA-VS-3244731$TEVA$$71$YR$$M$Y$$$20240924$$MD$FR$FR
243590411$24359041$1$I$$20240910$20240924$20240924$EXP$$US-SMPA-2024SPA002678$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243590421$24359042$1$I$20240101$20240910$20240924$20240924$EXP$$US-SMPA-2024SPA002623$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243590431$24359043$1$I$20240906$20240910$20240924$20240924$EXP$$US-SMPA-2024SPA002584$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243590441$24359044$1$I$$20240910$20240924$20240924$EXP$$US-SMPA-2024SPA002659$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243590451$24359045$1$I$$20240910$20240924$20240924$EXP$$US-SMPA-2024SPA002648$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243590461$24359046$1$I$$20231120$20240924$20240924$PER$$US-PERRIGO-23US013479$PERRIGO$$$$$F$Y$$$20240924$$CN$US$US
243590471$24359047$1$I$20240724$20240725$20240924$20240924$PER$$US-PERRIGO-24US007125$PERRIGO$$18$YR$$F$Y$47.619$KG$20240924$$CN$US$US
243590481$24359048$1$I$$20240923$20240924$20240924$EXP$$CO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053183$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240924$$HP$CO$CO
243590491$24359049$1$I$20240908$20240909$20240924$20240924$EXP$$CO-MYLANLABS-2024M1086719$MYLAN$$6$YR$$F$Y$$$20240924$$CN$CO$CO
243590501$24359050$1$I$20240425$20240917$20240924$20240924$EXP$FR-AFSSAPS-SE2024000695$FR-TEVA-VS-3244714$TEVA$$49$YR$$F$Y$$$20240924$$MD$FR$FR
243590531$24359053$1$I$20190101$20240919$20240924$20240924$EXP$$US-JAZZ-2022-US-004188$JAZZ$$$$$M$Y$89.796$KG$20240924$$MD$US$US
243590541$24359054$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014833$ELI LILLY AND CO$$$$$F$Y$$$20240924$$CN$US$US
243590571$24359057$1$I$20240410$20240528$20240924$20240924$EXP$$NZ-BLUEPRINT MEDICINES CORPORATION-2024BUS000079$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$NZ$NZ
243590581$24359058$1$I$20240228$20240306$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004382$Unknown Manufacturer$$$$$$Y$$$20240924$$HP$CN$CN
243590591$24359059$1$I$20240612$20240814$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004476$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243590601$24359060$1$I$20240326$20240423$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000010$Unknown Manufacturer$$$$$$Y$$$20240924$$HP$CN$CN
243590621$24359062$1$I$20240801$20240812$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004469$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243590631$24359063$1$I$20240707$20240918$20240924$20240924$EXP$HR-HALMED-300086462$HR-TEVA-VS-3245224$TEVA$$18$YR$$F$Y$$$20240924$$MD$HR$HR
243590641$24359064$1$I$20240601$20240705$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS003984$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243590651$24359065$1$I$$20240920$20240924$20240924$EXP$$NVSC2024US189477$NOVARTIS$$$$$M$Y$$$20240924$$HP$US$US
243590671$24359067$1$I$20240701$20240918$20240924$20240924$EXP$HR-HALMED-300086460$HR-TEVA-VS-3245233$TEVA$$17$YR$$F$Y$$$20240924$$MD$HR$HR
243590681$24359068$1$I$20240524$20240917$20240924$20240924$EXP$FR-AFSSAPS-AVCN2024000682$FR-TEVA-VS-3244583$TEVA$$38$YR$$M$Y$$$20240924$$MD$FR$FR
243590701$24359070$1$I$$20240910$20240924$20240924$PER$$US-INCYTE CORPORATION-2024IN009590$INCYTE$$$$$$Y$$$20240924$$CN$US$US
243590712$24359071$2$F$20240920$20240920$20240924$20240925$PER$$US-JNJFOC-20240956408$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$US$US
243590721$24359072$1$I$$20240910$20240924$20240924$PER$$US-INCYTE CORPORATION-2024IN009580$INCYTE$$$$$$Y$$$20240924$$CN$US$US
243590732$24359073$2$F$20240801$20240919$20240924$20240925$EXP$$US-Eisai-EC-2024-173613$EISAI$$84$YR$E$F$Y$$$20240925$$CN$US$US
243590741$24359074$1$I$$20240920$20240924$20240924$PER$$US-ABBVIE-5935663$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243590751$24359075$1$I$$20240910$20240924$20240924$PER$$US-INCYTE CORPORATION-2024IN009576$INCYTE$$$$$$Y$$$20240924$$CN$US$US
243590771$24359077$1$I$20231027$20240530$20240924$20240924$EXP$$RO-BLUEPRINT MEDICINES CORPORATION-2024BUS000092$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$RO$RO
243590781$24359078$1$I$20240422$20240815$20240924$20240924$EXP$$AR-BLUEPRINT MEDICINES CORPORATION-2024BUS000037$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$AR$AR
243590801$24359080$1$I$20230825$20240619$20240924$20240924$EXP$$MD-BLUEPRINT MEDICINES CORPORATION-2024BUS000123$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$MD$MD
243590831$24359083$1$I$20240724$20240807$20240924$20240924$EXP$$KR-BLUEPRINT MEDICINES CORPORATION-2024BUS004431$Unknown Manufacturer$$$$$$Y$$$20240924$$HP$KR$KR
243590861$24359086$1$I$20240901$20240920$20240924$20240924$EXP$$JP-009507513-2409JPN003080J$MERCK$$$$$M$Y$$$20240924$$CN$JP$JP
243590871$24359087$1$I$$20240417$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000034$Unknown Manufacturer$$$$$$Y$$$20240924$$PH$FR$FR
243590881$24359088$1$I$$20240911$20240924$20240924$EXP$$JP-ABBVIE-5930938$ABBVIE$$66$YR$$F$Y$$$20240924$$CN$JP$JP
243590901$24359090$1$I$$20240917$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147970$BRISTOL MYERS SQUIBB$Rodriguez JA, Bonnano C, Khatiwada P, Roa AA, Mayer D, Eckardt PA. Covid-19 coinfection with mycobacterium abscessus in a patient with multiple myeloma. Case Reports in Infectious Diseases. 2021 Jan 19;2021:1-5. doi:10.1155/2021/8840536.$84$YR$E$M$Y$$$20240924$$HP$US$US
243590911$24359091$1$I$$20240422$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000002$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243590921$24359092$1$I$$20240418$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000008$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243590931$24359093$1$I$$20240422$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000021$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243590941$24359094$1$I$$20240502$20240924$20240924$EXP$$BE-BLUEPRINT MEDICINES CORPORATION-2024BUS000044$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$BE$BE
243590951$24359095$1$I$$20240422$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000059$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243590961$24359096$1$I$$20240422$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000009$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243590971$24359097$1$I$20230101$20240423$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000053$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243590981$24359098$1$I$$20240430$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000027$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$US$US
243590991$24359099$1$I$$20240430$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000036$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243591001$24359100$1$I$$20240923$20240924$20240924$EXP$$US-ABBVIE-5936573$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243591011$24359101$1$I$$20240916$20240924$20240924$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00510$XERIS PHARMACEUTICALS$$$$$F$Y$$$20240924$$HP$US$US
243591021$24359102$1$I$$20240425$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000012$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243591041$24359104$1$I$20240901$20240918$20240924$20240924$PER$$US-BRIAN CONNER SVP QUALITY AND CHIEF COMPLIANCE OFFICER-2024XER00519$XERIS PHARMACEUTICALS$$52$YR$$M$Y$133.81$KG$20240924$$CN$US$US
243591071$24359107$1$I$$20240819$20240924$20240924$EXP$$IT-BLUEPRINT MEDICINES CORPORATION-2024BUS000135$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$IT$IT
243591081$24359108$1$I$20240626$20240827$20240924$20240924$EXP$$RO-BLUEPRINT MEDICINES CORPORATION-2024BUS000128$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$RO$RO
243591091$24359109$1$I$$20240923$20240924$20240924$PER$$NVSC2024US190031$NOVARTIS$$$$$F$Y$$$20240924$$CN$US$US
243591101$24359110$1$I$20240101$20240917$20240924$20240924$PER$$US-009507513-2409USA006211$MERCK$$67$YR$$F$Y$$$20240924$$CN$US$US
243591111$24359111$1$I$20240701$20240917$20240924$20240924$EXP$$CA-GSK-CA2024004494$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$HP$CA$CA
243591121$24359112$1$I$20230901$20240516$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000054$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243591131$24359113$1$I$$20240520$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000084$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243591141$24359114$1$I$$20240521$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000083$Unknown Manufacturer$$$$$$Y$$$20240924$$HP$US$US
243591151$24359115$1$I$$20240502$20240924$20240924$EXP$$CL-BLUEPRINT MEDICINES CORPORATION-2024BUS000035$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CL$CL
243591161$24359116$1$I$$20240515$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000066$Unknown Manufacturer$$$$$$Y$$$20240924$$PH$FR$FR
243591171$24359117$1$I$20230401$20240516$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000057$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243591181$24359118$1$I$20220201$20240516$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000052$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243591191$24359119$1$I$20240410$20240517$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000103$Unknown Manufacturer$$$$$$Y$$$20240924$$HP$CN$CN
243591201$24359120$1$I$20240620$20240923$20240924$20240924$EXP$FR-AFSSAPS-PC2024000754$NVSC2024FR188974$NOVARTIS$$65$YR$$M$Y$70$KG$20240924$$MD$FR$FR
243591211$24359121$1$I$20240923$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014412$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240924$$CN$US$US
243591221$24359122$1$I$$20240507$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000043$Unknown Manufacturer$$$$$$Y$$$20240924$$PH$FR$FR
243591231$24359123$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014808$ELI LILLY AND CO$$$$$M$Y$$$20240924$$CN$US$US
243591241$24359124$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151240$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240924$$CN$US$US
243591251$24359125$1$I$$20240918$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149009$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240924$$CN$US$US
243591261$24359126$1$I$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151125$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240924$$CN$US$US
243591271$24359127$1$I$$20240528$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000086$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243591291$24359129$1$I$$20240920$20240924$20240924$EXP$$GB-PFIZER INC-PV202400123447$PFIZER$$$$$$Y$$$20240924$$HP$GB$GB
243591301$24359130$1$I$20240621$20240923$20240924$20240924$EXP$ES-AEMPS-1569931$ES-PFIZER INC-202400261466$PFIZER$$34$YR$$F$Y$$$20240924$$PH$ES$ES
243591311$24359131$1$I$$20240920$20240924$20240924$EXP$$GB-PFIZER INC-PV202400123424$PFIZER$$$$$$Y$$$20240924$$MD$GB$GB
243591321$24359132$1$I$20230901$20240920$20240924$20240924$EXP$$CA-PFIZER INC-2016446709$PFIZER$$52$YR$$F$Y$$$20240924$$CN$CA$CA
243591341$24359134$1$I$$20240528$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000007$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243591351$24359135$1$I$$20240529$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000085$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243591361$24359136$1$I$20220101$20240603$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000117$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243591371$24359137$1$I$$20240613$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000140$Unknown Manufacturer$$$$$$Y$$$20240924$$PH$FR$FR
243591381$24359138$1$I$$20240528$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000081$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243591391$24359139$1$I$20230101$20240530$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000019$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243591401$24359140$1$I$20231201$20240606$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000118$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243591411$24359141$1$I$$20240611$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000131$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$FR$FR
243591421$24359142$1$I$$20240603$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000093$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243591431$24359143$1$I$$20240611$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000137$Unknown Manufacturer$$$$$$Y$$$20240924$$PH$FR$FR
243591451$24359145$1$I$$20240312$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004393$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$CN$CN
243591461$24359146$1$I$20231001$20240311$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004404$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$CN$CN
243591491$24359149$1$I$20220817$20230410$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000323$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243591511$24359151$1$I$20230215$20230302$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000892$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$CN$CN
243591521$24359152$1$I$20230901$20240424$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000013$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243591531$24359153$1$I$20230801$20240513$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000056$Unknown Manufacturer$Barsouk A, Elghawy O, Stone S, Singh A. Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition. Anti-cancer drugs. 2024;1-5$$$$$Y$$$20240924$$MD$US$US
243591541$24359154$1$I$20240220$20240918$20240924$20240924$EXP$FR-AFSSAPS-PB2024000976$FR-009507513-2409FRA007303$MERCK$$46$YR$$F$Y$48$KG$20240924$$HP$FR$FR
243591551$24359155$1$I$20231012$20240920$20240924$20240924$EXP$$KR-009507513-2409KOR007030$MERCK$$$$$M$Y$44$KG$20240924$$PH$KR$KR
243591561$24359156$1$I$20231001$20240923$20240924$20240924$EXP$$US-PURDUE PHARMA-USA-2024-0312124$PURDUE$$52$YR$$M$Y$$$20240924$$CN$US$US
243591571$24359157$1$I$$20240920$20240924$20240924$EXP$$SI-PURDUE PHARMA-USA-2021-0288788$PURDUE$Razinger, Gasper, Grenc, Damjan, Pezdir, Tomaz, Kranvogl, Roman, Brvar, Miran. Severe rhabdomyolysis and acute kidney failure due to synthetic opioid brorphine exposure in combination with chronic sertraline therapy. European Journal of Clinical Pharmacology. 2021;77(11):1759-1761$45$YR$$M$Y$$$20240924$$HP$SI$SI
243591581$24359158$1$I$20201010$20240923$20240924$20240924$EXP$$US-PURDUE PHARMA-USA-2024-0312125$PURDUE$$$$$F$Y$$$20240924$$CN$US$US
243591591$24359159$1$I$$20240919$20240924$20240924$EXP$$GB-MYLANLABS-2024M1085741$MYLAN$$$$$F$Y$$$20240924$$MD$GB$GB
243591621$24359162$1$I$$20240520$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000076$Unknown Manufacturer$Shinkyo Yoon, Hyun-Min Ryu, Sang-We Kim, Kang-Seo Park, Dae Ho Lee. Pralsetinib induces opportunistic infection in RET fusion-positive NSCLC patients via inhibition of IL2 production by blocking Jak3-Stat5 activation. Cancer Res. 2024;84(6_Suppl):4998$$$$$Y$$$20240924$$HP$US$US
243591631$24359163$1$I$$20240516$20240924$20240924$EXP$$IT-BLUEPRINT MEDICINES CORPORATION-2024BUS000077$Unknown Manufacturer$Cognigni V, Giudice G, Bozzetti F, Milanese G, Moschini I, Casali M, Mazzaschi G and Tiseo M. Successful treatment with selpercatinib after pralsetinib-related pneumonitis and intracranial failure in a patient with RET-rearranged nonsmall cell lung cancer. Anti-Cancer Drugs. 2024;Vol 35 No 6:1-4$$$$$Y$$$20240924$$HP$IT$IT
243591641$24359164$1$I$$20240820$20240924$20240924$EXP$$SE-BLUEPRINT MEDICINES CORPORATION-2024BUS004494$Unknown Manufacturer$$$$$$Y$$$20240924$$HP$SE$SE
243591651$24359165$1$I$$20240620$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000139$Unknown Manufacturer$$$$$$Y$$$20240924$$PH$FR$FR
243591661$24359166$1$I$20220601$20230310$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS001073$Unknown Manufacturer$$$$$F$Y$$$20240924$$CN$CN$CN
243591671$24359167$1$I$$20221108$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS002040$Unknown Manufacturer$$62$YR$$F$Y$$$20240924$$CN$US$US
243591681$24359168$1$I$20240809$20240917$20240924$20240924$EXP$$US-BIOGEN-2024BI01282984$BIOGEN$$24$YR$$M$Y$$$20240924$$HP$US$US
243591691$24359169$1$I$$20240523$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000033$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$FR$FR
243591701$24359170$1$I$$20240321$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004405$Unknown Manufacturer$$85$YR$$M$Y$$$20240924$$MD$US$US
243591711$24359171$1$I$$20230517$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000203$Unknown Manufacturer$$$$$M$Y$128$KG$20240924$$PH$FR$FR
243591721$24359172$1$I$20240114$20240215$20240924$20240924$EXP$$BG-BLUEPRINT MEDICINES CORPORATION-2024BUS004383$Unknown Manufacturer$$43$YR$$F$Y$$$20240924$$MD$BG$BG
243591731$24359173$1$I$20231001$20240219$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004385$Unknown Manufacturer$$$$A$M$Y$$$20240924$$CN$CN$CN
243591741$24359174$1$I$20240118$20240227$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004395$Unknown Manufacturer$$44$YR$$F$Y$$$20240924$$MD$CN$CN
243591751$24359175$1$I$$20240229$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004400$Unknown Manufacturer$$$$$F$Y$$$20240924$$MD$CN$CN
243591761$24359176$1$I$$20240229$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004410$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243591771$24359177$1$I$20230901$20240229$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004408$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243591782$24359178$2$F$20240918$20240924$20240924$20240930$EXP$$GB-MYLANLABS-2024M1052556$MYLAN$$$$$M$Y$$$20240930$$MD$GB$GB
243591791$24359179$1$I$$20240311$20240924$20240924$EXP$$IT-BLUEPRINT MEDICINES CORPORATION-2024BUS004389$Unknown Manufacturer$$58$YR$$F$Y$$$20240924$$HP$IT$IT
243591801$24359180$1$I$20240103$20240919$20240924$20240924$EXP$$CH-009507513-2409CHE007862$MERCK$$$$$M$Y$$$20240924$$CN$CH$CH
243591811$24359181$1$I$$20240921$20240924$20240924$PER$$US-PURDUE PHARMA-USA-2024-0312116$PURDUE$$83$YR$$$Y$$$20240924$$CN$US$US
243591822$24359182$2$F$20231201$20240924$20240924$20240927$PER$$US-PURDUE PHARMA-USA-2024-0312127$PURDUE$$65$YR$$F$Y$79.38$KG$20240927$$CN$US$US
243591831$24359183$1$I$$20240921$20240924$20240924$PER$$US-PURDUE PHARMA-USA-2024-0312115$PURDUE$$65$YR$$$Y$$$20240924$$CN$US$US
243591841$24359184$1$I$$20240921$20240924$20240924$PER$$US-PURDUE PHARMA-USA-2024-0312117$PURDUE$$26$YR$$F$Y$$$20240924$$CN$US$US
243591851$24359185$1$I$$20240923$20240924$20240924$PER$$US-PURDUE-USA-2024-0312122$PURDUE$$$$$F$Y$$$20240924$$PH$US$US
243591861$24359186$1$I$$20240919$20240924$20240924$PER$$US-JNJFOC-20240954689$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243591871$24359187$1$I$$20240726$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004443$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243591881$24359188$1$I$$20240716$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000101$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$FR$FR
243591891$24359189$1$I$$20240708$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004450$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243591901$24359190$1$I$20090101$20240917$20240924$20240924$PER$$US-PURDUE-USA-2024-0312144$PURDUE$$$$$M$Y$$$20240924$$CN$US$US
243591911$24359191$1$I$$20240718$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004449$Unknown Manufacturer$$$$$$Y$$$20240924$$PH$US$US
243591931$24359193$1$I$20240801$20240819$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004479$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243591941$24359194$1$I$$20240704$20240924$20240924$EXP$$CA-BLUEPRINT MEDICINES CORPORATION-2024BUS004433$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CA$CA
243591951$24359195$1$I$$20240710$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000042$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$FR$FR
243591961$24359196$1$I$$20240719$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004437$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243591971$24359197$1$I$$20240702$20240924$20240924$EXP$$NZ-BLUEPRINT MEDICINES CORPORATION-2024BUS000151$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$NZ$NZ
243591981$24359198$1$I$$20240716$20240924$20240924$EXP$$IL-BLUEPRINT MEDICINES CORPORATION-2024BUS004439$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$IL$IL
243591991$24359199$1$I$$20240723$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004440$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592001$24359200$1$I$20240416$20240701$20240924$20240924$EXP$$KR-BLUEPRINT MEDICINES CORPORATION-2024BUS000145$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$KR$KR
243592011$24359201$1$I$$20240716$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS004412$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$FR$FR
243592021$24359202$1$I$$20240722$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000024$Unknown Manufacturer$$$$$$Y$$$20240924$$PH$FR$FR
243592041$24359204$1$I$$20240705$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000068$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$FR$FR
243592051$24359205$1$I$20210101$20240917$20240924$20240924$EXP$$CN-MYLANLABS-2024M1085954$MYLAN$Li G, Liu Z.. Pharmaceutical care of phantom limb pain after hemipelvic amputation for osteosarcoma.. Journal of China Prescription Drug. 22(8):40-42$60$YR$$M$Y$72$KG$20240924$$MD$CN$CN
243592061$24359206$1$I$$20240917$20240924$20240924$EXP$$NO-MYLANLABS-2024M1085864$MYLAN$Janeras L, Breivik H, Lundeland B, Ringstad GA, Stubhaug A. Long-term intrathecal infusion of low-dose morphine effectively relieves symptoms of severe restless legs syndrome/Willis-Ekbom disease without inducing opioid tolerance. Pain 2024; 1-5.$7$DEC$$M$Y$$$20240924$$HP$NO$NO
243592071$24359207$1$I$20240615$20240618$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000142$Unknown Manufacturer$$$$$$Y$$$20240924$$HP$CN$CN
243592081$24359208$1$I$20240619$20240620$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000143$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243592091$24359209$1$I$$20240624$20240924$20240924$EXP$$IT-BLUEPRINT MEDICINES CORPORATION-2024BUS000133$BLUEPRINT MEDICINES$$$$$$Y$$$20240924$$MD$IT$IT
243592101$24359210$1$I$$20240624$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS000121$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592111$24359211$1$I$$20240626$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000152$Unknown Manufacturer$$$$$$Y$$$20240924$$PH$FR$FR
243592121$24359212$1$I$20231101$20240701$20240924$20240924$EXP$$KR-BLUEPRINT MEDICINES CORPORATION-2024BUS000015$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$KR$KR
243592131$24359213$1$I$20230503$20240613$20240924$20240924$EXP$$SI-BLUEPRINT MEDICINES CORPORATION-2024BUS000113$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$SI$SI
243592141$24359214$1$I$$20240620$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS003982$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592151$24359215$1$I$20240201$20240625$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000114$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243592161$24359216$1$I$$20240812$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004473$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592171$24359217$1$I$$20240312$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004390$Unknown Manufacturer$$$$A$F$Y$$$20240924$$CN$CN$CN
243592181$24359218$1$I$$20240423$20240924$20240924$EXP$$SE-BLUEPRINT MEDICINES CORPORATION-2024BUS000011$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$SE$SE
243592191$24359219$1$I$20220501$20240312$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004424$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243592201$24359220$1$I$$20240722$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000129$Unknown Manufacturer$$$$$$Y$$$20240924$$PH$FR$FR
243592211$24359221$1$I$$20240307$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004425$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$CN$CN
243592221$24359222$1$I$20240813$20240820$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004483$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592231$24359223$1$I$$20240730$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004453$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592241$24359224$1$I$$20240802$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004457$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592251$24359225$1$I$$20240725$20240924$20240924$EXP$$TH-BLUEPRINT MEDICINES CORPORATION-2024BUS000026$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$TH$TH
243592261$24359226$1$I$$20240731$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004454$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592271$24359227$1$I$$20240805$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004460$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592281$24359228$1$I$$20240807$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004466$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592291$24359229$1$I$$20240320$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004401$Unknown Manufacturer$$$$$M$Y$$$20240924$$CN$CN$CN
243592301$24359230$1$I$$20240329$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004413$Unknown Manufacturer$$68$YR$$M$Y$$$20240924$$HP$US$US
243592311$24359231$1$I$$20240405$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004421$Unknown Manufacturer$$$$$F$Y$$$20240924$$MD$US$US
243592321$24359232$1$I$$20240415$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000061$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243592331$24359233$1$I$$20240807$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004465$Unknown Manufacturer$$$$$$Y$$$20240924$$PH$US$US
243592341$24359234$1$I$$20240314$20240924$20240924$EXP$$RU-BLUEPRINT MEDICINES CORPORATION-2024BUS004396$Unknown Manufacturer$$$$A$$Y$$$20240924$$MD$RU$RU
243592351$24359235$1$I$$20240322$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004406$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243592361$24359236$1$I$$20240401$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004422$Unknown Manufacturer$$$$$$Y$$$20240924$$HP$US$US
243592371$24359237$1$I$$20240404$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004420$BLUEPRINT MEDICINES$$$$$$Y$$$20240924$$CN$US$US
243592381$24359238$1$I$$20240409$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000020$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243592391$24359239$1$I$20240101$20240416$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS000060$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243592401$24359240$1$I$20240701$20240726$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004441$Unknown Manufacturer$$$$$$Y$$$20240924$$HP$US$US
243592411$24359241$1$I$$20240806$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004462$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592431$24359243$1$I$$20240729$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004444$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592471$24359247$1$I$20240809$20240919$20240924$20240924$EXP$$CN-SA-2024SA274143$SANOFI AVENTIS$$67$YR$E$M$Y$65$KG$20240924$$HP$CN$CN
243592481$24359248$1$I$20240101$20240828$20240924$20240924$PER$$US-SA-2024SA253604$SANOFI AVENTIS$$52$YR$A$F$Y$65.91$KG$20240924$$MD$US$US
243592491$24359249$1$I$$20240812$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004474$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243592501$24359250$1$I$$20240812$20240924$20240924$EXP$$SG-BLUEPRINT MEDICINES CORPORATION-2024BUS004489$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$SG$SG
243592511$24359251$1$I$$20240813$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004475$BLUEPRINT MEDICINES$$$$$$Y$$$20240924$$CN$US$US
243592521$24359252$1$I$20240401$20240816$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004507$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243592531$24359253$1$I$20240802$20240813$20240924$20240924$EXP$$KR-BLUEPRINT MEDICINES CORPORATION-2024BUS004486$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$KR$KR
243592541$24359254$1$I$20240301$20240814$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004504$Unknown Manufacturer$$79$YR$$F$Y$$$20240924$$CN$CN$CN
243592551$24359255$1$I$$20240809$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004463$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243592561$24359256$1$I$$20240820$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004484$BLUEPRINT MEDICINES$$$$$$Y$$$20240924$$CN$US$US
243592571$24359257$1$I$$20240830$20240924$20240924$PER$$US-SA-2024SA270622$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$HP$US$US
243592581$24359258$1$I$$20240812$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004470$BLUEPRINT MEDICINES$$$$$$Y$$$20240924$$CN$US$US
243592591$24359259$1$I$$20240830$20240924$20240924$PER$$US-SA-2024SA272270$SANOFI AVENTIS$$$$A$M$Y$$$20240924$$MD$US$US
243592602$24359260$2$F$20240101$20240830$20240924$20240924$PER$$US-SA-2024SA268140$SANOFI AVENTIS$$$$A$M$Y$98$KG$20240924$$MD$US$US
243592611$24359261$1$I$$20240829$20240924$20240924$PER$$US-SA-2024SA266892$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240924$$HP$US$US
243592621$24359262$1$I$20240701$20240812$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004446$BLUEPRINT MEDICINES$$$$$$Y$$$20240924$$PH$US$US
243592631$24359263$1$I$$20240830$20240924$20240924$PER$$US-SA-2024SA225865$SANOFI AVENTIS$$$$A$M$Y$92$KG$20240924$$MD$US$US
243592641$24359264$1$I$20240101$20240830$20240924$20240924$PER$$US-SA-2024SA274209$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$CN$US$US
243592651$24359265$1$I$20240829$20240829$20240924$20240924$PER$$US-SA-2024SA271645$SANOFI AVENTIS$$57$YR$A$F$Y$88.64$KG$20240924$$MD$US$US
243592661$24359266$1$I$$20240901$20240924$20240924$PER$$US-SA-2024SA264035$SANOFI AVENTIS$$$$A$F$Y$59.09$KG$20240924$$MD$US$US
243592671$24359267$1$I$$20240830$20240924$20240924$PER$$US-SA-2024SA270627$SANOFI AVENTIS$$$$T$F$Y$42$KG$20240924$$MD$US$US
243592681$24359268$1$I$$20240830$20240924$20240924$PER$$US-SA-2024SA273892$SANOFI AVENTIS$$$$E$F$Y$$$20240924$$MD$US$US
243592691$24359269$1$I$$20240830$20240924$20240924$PER$$US-SA-2024SA271319$SANOFI AVENTIS$$$$C$M$Y$$$20240924$$MD$US$US
243592701$24359270$1$I$$20240903$20240924$20240924$PER$$US-SA-2024SA270628$SANOFI AVENTIS$$$$A$F$Y$90$KG$20240924$$MD$US$US
243592711$24359271$1$I$20240101$20240903$20240924$20240924$PER$$US-SA-2024SA270946$SANOFI AVENTIS$$41$YR$A$M$Y$96$KG$20240924$$MD$US$US
243592721$24359272$1$I$$20240903$20240924$20240924$PER$$US-SA-2024SA270706$SANOFI AVENTIS$$$$A$M$Y$96.6$KG$20240924$$MD$US$US
243592731$24359273$1$I$20240101$20240904$20240924$20240924$PER$$US-SA-2024SA273061$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240924$$CN$US$US
243592741$24359274$1$I$20240101$20240904$20240924$20240924$PER$$US-SA-2024SA272347$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240924$$MD$US$US
243592751$24359275$1$I$20240101$20240903$20240924$20240924$PER$$US-SA-2024SA271017$SANOFI AVENTIS$$68$YR$E$M$Y$61.36$KG$20240924$$MD$US$US
243592761$24359276$1$I$20240901$20240903$20240924$20240924$PER$$US-SA-2024SA272866$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240924$$MD$US$US
243592771$24359277$1$I$20240101$20240903$20240924$20240924$PER$$US-SA-2024SA272668$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240924$$MD$US$US
243592781$24359278$1$I$20240101$20240903$20240924$20240924$PER$$US-SA-2024SA271623$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240924$$MD$US$US
243592791$24359279$1$I$$20240903$20240924$20240924$PER$$US-SA-2024SA272133$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240924$$CN$US$US
243592801$24359280$1$I$$20240903$20240924$20240924$PER$$US-SA-2024SA272956$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240924$$PH$US$US
243592811$24359281$1$I$20240101$20240904$20240924$20240924$PER$$US-SA-2024SA272059$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240924$$MD$US$US
243592821$24359282$1$I$20240101$20240903$20240924$20240924$PER$$US-SA-2024SA272548$SANOFI AVENTIS$$3$YR$C$M$Y$18.095$KG$20240924$$MD$US$US
243592831$24359283$1$I$20231201$20240903$20240924$20240924$PER$$US-SA-2024SA272427$SANOFI AVENTIS$$66$YR$E$F$Y$49$KG$20240924$$MD$US$US
243592841$24359284$1$I$$20240904$20240924$20240924$PER$$US-SA-2024SA272599$SANOFI AVENTIS$$$$E$F$Y$88.889$KG$20240924$$MD$US$US
243592851$24359285$1$I$$20240903$20240924$20240924$PER$$US-SA-2024SA271749$SANOFI AVENTIS$$$$E$F$Y$61.2$KG$20240924$$MD$US$US
243592871$24359287$1$I$20240101$20240904$20240924$20240924$PER$$US-SA-2024SA272384$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240924$$MD$US$US
243592891$24359289$1$I$$20240903$20240924$20240924$PER$$US-SA-2024SA272524$SANOFI AVENTIS$$$$A$M$Y$75$KG$20240924$$MD$US$US
243592901$24359290$1$I$20240831$20240904$20240924$20240924$PER$$US-SA-2024SA271587$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240924$$MD$US$US
243592911$24359291$1$I$20240101$20240903$20240924$20240924$PER$$US-SA-2024SA270889$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240924$$CN$US$US
243592921$24359292$1$I$20240101$20240904$20240924$20240924$PER$$US-SA-2024SA272833$SANOFI AVENTIS$$60$YR$A$F$Y$84.09$KG$20240924$$MD$US$US
243592931$24359293$1$I$20240101$20240904$20240924$20240924$PER$$US-SA-2024SA272565$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240924$$CN$US$US
243592941$24359294$1$I$$20240903$20240924$20240924$PER$$US-SA-2024SA272567$SANOFI AVENTIS$$$$A$F$Y$101.82$KG$20240924$$MD$US$US
243592951$24359295$1$I$20240101$20240904$20240924$20240924$PER$$US-SA-2024SA272969$SANOFI AVENTIS$$52$YR$A$M$Y$81.91$KG$20240924$$MD$US$US
243592961$24359296$1$I$$20240903$20240924$20240924$PER$$US-SA-2024SA272498$SANOFI AVENTIS$$43$YR$A$F$Y$65.91$KG$20240924$$MD$US$US
243592971$24359297$1$I$20240801$20240903$20240924$20240924$PER$$US-SA-2024SA272420$SANOFI AVENTIS$$$$A$M$Y$80.45$KG$20240924$$MD$US$US
243592981$24359298$1$I$20240902$20240903$20240924$20240924$PER$$US-SA-2024SA271875$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240924$$MD$US$US
243592991$24359299$1$I$20240801$20240903$20240924$20240924$PER$$US-SA-2024SA270558$SANOFI AVENTIS$$$$$F$Y$$$20240924$$CN$US$US
243593001$24359300$1$I$20240901$20240903$20240924$20240924$PER$$US-SA-2024SA271145$SANOFI AVENTIS$$$$A$M$Y$97.52$KG$20240924$$MD$US$US
243593011$24359301$1$I$$20240904$20240924$20240924$PER$$US-SA-2024SA271553$SANOFI AVENTIS$$$$E$F$Y$$$20240924$$MD$US$US
243593021$24359302$1$I$20240101$20240903$20240924$20240924$PER$$US-SA-2024SA272935$SANOFI AVENTIS$$19$YR$A$F$Y$70.45$KG$20240924$$MD$US$US
243593031$24359303$1$I$20190101$20240911$20240924$20240924$PER$$US-SA-2024SA273737$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240924$$CN$US$US
243593041$24359304$1$I$20240101$20240906$20240924$20240924$PER$$US-SA-2024SA275203$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240924$$HP$US$US
243593051$24359305$1$I$$20240906$20240924$20240924$PER$$US-SA-2024SA273523$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240924$$CN$US$US
243593061$24359306$1$I$20240911$20240911$20240924$20240924$PER$$US-SA-2024SA273588$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240924$$CN$US$US
243593071$24359307$1$I$$20240910$20240924$20240924$PER$$US-SA-2021SA325036$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240924$$CN$US$US
243593081$24359308$1$I$20240827$20240910$20240924$20240924$PER$$US-SA-2024SA272536$SANOFI AVENTIS$$$$$M$Y$$$20240924$$CN$US$US
243593091$24359309$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273615$SANOFI AVENTIS$$$$$$Y$$$20240924$$HP$US$US
243593101$24359310$1$I$20240101$20240906$20240924$20240924$PER$$US-SA-2024SA274528$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240924$$MD$US$US
243593111$24359311$1$I$$20240909$20240924$20240924$PER$$US-SA-2024SA274975$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240924$$CN$US$US
243593121$24359312$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273582$SANOFI AVENTIS$$$$$F$Y$$$20240924$$MD$US$US
243593131$24359313$1$I$20200405$20240911$20240924$20240924$PER$$US-SA-2024SA274419$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240924$$CN$US$US
243593141$24359314$1$I$20240101$20240905$20240924$20240924$PER$$US-SA-2024SA273141$SANOFI AVENTIS$$39$YR$A$F$Y$93.18$KG$20240924$$MD$US$US
243593151$24359315$1$I$$20240911$20240924$20240924$PER$$US-SA-2024SA273334$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240924$$CN$US$US
243593161$24359316$1$I$20240101$20240905$20240924$20240924$PER$$US-SA-2024SA273086$SANOFI AVENTIS$$61$YR$A$F$Y$76.82$KG$20240924$$MD$US$US
243593171$24359317$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273572$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240924$$CN$US$US
243593181$24359318$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA272991$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240924$$CN$US$US
243593191$24359319$1$I$20240301$20240910$20240924$20240924$PER$$US-INCYTE CORPORATION-2024IN009574$INCYTE$$$$$$Y$$$20240924$$CN$US$US
243593201$24359320$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273412$SANOFI AVENTIS$$$$$F$Y$$$20240924$$CN$US$US
243593211$24359321$1$I$20240906$20240909$20240924$20240924$PER$$US-SA-2024SA275094$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240924$$PH$US$US
243593221$24359322$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA266289$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240924$$MD$US$US
243593231$24359323$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273325$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240924$$CN$US$US
243593241$24359324$1$I$20240101$20240909$20240924$20240924$PER$$US-SA-2024SA275081$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240924$$CN$US$US
243593251$24359325$1$I$$20240909$20240924$20240924$PER$$US-SA-2024SA275463$SANOFI AVENTIS$$76$YR$E$$Y$$$20240924$$CN$US$US
243593261$24359326$1$I$20240910$20240910$20240924$20240924$PER$$US-SA-2024SA273346$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240924$$CN$US$US
243593271$24359327$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA274642$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240924$$PH$US$US
243593281$24359328$1$I$$20240911$20240924$20240924$PER$$US-SA-2024SA273429$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240924$$CN$US$US
243593291$24359329$1$I$$20240909$20240924$20240924$PER$$US-SA-2024SA274533$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$MD$US$US
243593311$24359331$1$I$20240911$20240911$20240924$20240924$PER$$US-SA-2024SA273045$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240924$$MD$US$US
243593321$24359332$1$I$$20240909$20240924$20240924$PER$$US-SA-2024SA275135$SANOFI AVENTIS$$54$YR$A$$Y$$$20240924$$CN$US$US
243593331$24359333$1$I$$20240911$20240924$20240924$PER$$US-SA-2024SA272909$SANOFI AVENTIS$$$$A$M$Y$$$20240924$$MD$US$US
243593341$24359334$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273669$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240924$$CN$US$US
243593351$24359335$1$I$20240907$20240910$20240924$20240924$PER$$US-SA-2024SA273425$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240924$$HP$US$US
243593361$24359336$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273614$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240924$$CN$US$US
243593371$24359337$1$I$20240801$20240910$20240924$20240924$PER$$US-SA-2024SA275388$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240924$$CN$US$US
243593381$24359338$1$I$20240101$20240911$20240924$20240924$PER$$US-SA-2024SA272826$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240924$$CN$US$US
243593392$24359339$2$F$$20240910$20240924$20240925$PER$$US-SA-2024SA273624$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240925$$CN$US$US
243593401$24359340$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273179$SANOFI AVENTIS$$$$$F$Y$$$20240924$$PH$US$US
243593411$24359341$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA266185$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240924$$MD$US$US
243593421$24359342$1$I$20240907$20240910$20240924$20240924$PER$$US-SA-2024SA273685$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240924$$CN$US$US
243593431$24359343$1$I$$20240909$20240924$20240924$PER$$US-SA-2024SA275484$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$MD$US$US
243593441$24359344$1$I$20240131$20240820$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004508$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243593451$24359345$1$I$20240301$20240829$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004529$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243593461$24359346$1$I$$20240903$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004500$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243593471$24359347$1$I$20240712$20240903$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004498$BLUEPRINT MEDICINES$$$$$$Y$$$20240924$$CN$US$US
243593481$24359348$1$I$$20240822$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004442$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$US$US
243593491$24359349$1$I$20230927$20240906$20240924$20240924$EXP$$GR-BLUEPRINT MEDICINES CORPORATION-2024BUS000110$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$GR$GR
243593501$24359350$1$I$$20240903$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004499$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$US$US
243593511$24359351$1$I$$20240826$20240924$20240924$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004519$Unknown Manufacturer$$$$$$Y$$$20240924$$CN$CN$CN
243593521$24359352$1$I$20240909$20240910$20240924$20240924$PER$$US-SA-2024SA273511$SANOFI AVENTIS$$$$$F$Y$$$20240924$$CN$US$US
243593531$24359353$1$I$20240101$20240909$20240924$20240924$PER$$US-SA-2024SA274951$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240924$$MD$US$US
243593541$24359354$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273330$SANOFI AVENTIS$$$$A$M$Y$$$20240924$$CN$US$US
243593561$24359356$1$I$20240101$20240910$20240924$20240924$PER$$US-SA-2024SA273321$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240924$$CN$US$US
243593571$24359357$1$I$20240909$20240910$20240924$20240924$PER$$US-SA-2024SA274549$SANOFI AVENTIS$$10$YR$C$F$Y$30$KG$20240924$$CN$US$US
243593581$24359358$1$I$$20240909$20240924$20240924$PER$$US-SA-2024SA275181$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240924$$PH$US$US
243593591$24359359$1$I$20220101$20240911$20240924$20240924$PER$$US-SA-2024SA273308$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240924$$CN$US$US
243593601$24359360$1$I$20240907$20240910$20240924$20240924$PER$$US-SA-2024SA273564$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240924$$CN$US$US
243593621$24359362$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273726$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240924$$CN$US$US
243593631$24359363$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273554$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240924$$MD$US$US
243593641$24359364$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273517$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240924$$CN$US$US
243593651$24359365$1$I$20240101$20240911$20240924$20240924$PER$$US-SA-2024SA273447$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240924$$MD$US$US
243593661$24359366$1$I$$20240911$20240924$20240924$PER$$US-SA-2024SA274484$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240924$$CN$US$US
243593671$24359367$1$I$20240910$20240911$20240924$20240924$PER$$US-SA-2024SA273245$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240924$$CN$US$US
243593681$24359368$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273324$SANOFI AVENTIS$$$$E$F$Y$$$20240924$$CN$US$US
243593691$24359369$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273611$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240924$$CN$US$US
243593701$24359370$1$I$20240821$20240909$20240924$20240924$PER$$US-SA-2024SA275461$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240924$$HP$US$US
243593711$24359371$1$I$$20240911$20240924$20240924$PER$$US-SA-2024SA272680$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240924$$HP$US$US
243593721$24359372$1$I$20240827$20240911$20240924$20240924$PER$$US-SA-2024SA273440$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240924$$CN$US$US
243593731$24359373$1$I$20240801$20240910$20240924$20240924$PER$$US-SA-2024SA274147$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240924$$HP$US$US
243593741$24359374$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273618$SANOFI AVENTIS$$$$$F$Y$$$20240924$$CN$US$US
243593751$24359375$1$I$20230101$20240910$20240924$20240924$PER$$US-SA-2024SA275126$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240924$$CN$US$US
243593761$24359376$1$I$$20240909$20240924$20240924$PER$$US-SA-2024SA274673$SANOFI AVENTIS$$$$E$F$Y$$$20240924$$MD$US$US
243593771$24359377$1$I$$20240911$20240924$20240924$PER$$US-SA-2024SA272958$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240924$$CN$US$US
243593781$24359378$1$I$20240816$20240910$20240924$20240924$PER$$US-SA-2024SA271832$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240924$$PH$US$US
243593791$24359379$1$I$$20240909$20240924$20240924$PER$$US-SA-2024SA275155$SANOFI AVENTIS$$$$$F$Y$$$20240924$$CN$US$US
243593802$24359380$2$F$20240910$20240910$20240924$20240925$PER$$US-SA-2024SA273522$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240925$$HP$US$US
243593811$24359381$1$I$20240101$20240910$20240924$20240924$PER$$US-SA-2024SA273320$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240924$$CN$US$US
243593821$24359382$1$I$20190101$20240910$20240924$20240924$PER$$US-SA-2024SA273866$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240924$$CN$US$US
243593831$24359383$1$I$20240824$20240911$20240924$20240924$PER$$US-SA-2024SA272849$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240924$$MD$US$US
243593841$24359384$1$I$20240101$20240909$20240924$20240924$PER$$US-SA-2024SA274319$SANOFI AVENTIS$$43$YR$A$M$Y$73.18$KG$20240924$$MD$US$US
243593851$24359385$1$I$20240101$20240911$20240924$20240924$PER$$US-SA-2024SA274292$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240924$$CN$US$US
243593861$24359386$1$I$$20240913$20240924$20240924$PER$$US-SA-2024SA255952$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240924$$HP$US$US
243593871$24359387$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA274250$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240924$$CN$US$US
243593891$24359389$1$I$20210901$20240911$20240924$20240924$PER$$US-SA-2024SA273137$SANOFI AVENTIS$$$$C$M$Y$$$20240924$$MD$US$US
243593901$24359390$1$I$20240912$20240912$20240924$20240924$PER$$US-SA-2024SA274166$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240924$$CN$US$US
243593921$24359392$1$I$$20240912$20240924$20240924$PER$$US-SA-2024SA273368$SANOFI AVENTIS$$$$$M$Y$$$20240924$$CN$US$US
243593931$24359393$1$I$$20240917$20240924$20240924$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-18741$IPSEN$$51$YR$A$F$Y$136$KG$20240924$$CN$CA$CA
243593941$24359394$1$I$$20240912$20240924$20240924$PER$$US-SA-2024SA267343$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240924$$HP$US$US
243593951$24359395$1$I$$20240912$20240924$20240924$PER$$US-SA-2024SA267285$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240924$$HP$US$US
243593961$24359396$1$I$20240301$20240912$20240924$20240924$PER$$US-SA-2024SA274333$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240924$$MD$US$US
243593971$24359397$1$I$20240910$20240912$20240924$20240924$PER$$US-SA-2024SA273980$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240924$$MD$US$US
243593981$24359398$1$I$$20240911$20240924$20240924$PER$$US-SA-2024SA273586$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240924$$CN$US$US
243593991$24359399$1$I$$20240911$20240924$20240924$PER$$US-SA-2024SA273448$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240924$$CN$US$US
243594001$24359400$1$I$20240910$20240912$20240924$20240924$PER$$US-SA-2024SA274316$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240924$$CN$US$US
243594011$24359401$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA273634$SANOFI AVENTIS$$$$A$M$Y$$$20240924$$HP$US$US
243594031$24359403$1$I$$20240912$20240924$20240924$PER$$US-SA-2024SA274364$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240924$$CN$US$US
243594041$24359404$1$I$$20240910$20240924$20240924$PER$$US-SA-2024SA274161$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240924$$HP$US$US
243594051$24359405$1$I$20240801$20240910$20240924$20240924$PER$$US-SA-2024SA273372$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240924$$CN$US$US
243594061$24359406$1$I$20240901$20240911$20240924$20240924$PER$$US-SA-2024SA272947$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240924$$CN$US$US
243594071$24359407$1$I$$20240913$20240924$20240924$PER$$US-SA-2024SA269002$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240924$$HP$US$US
243594081$24359408$1$I$20240501$20240913$20240924$20240924$PER$$US-SA-2024SA267521$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240924$$HP$US$US
243594091$24359409$1$I$$20240913$20240924$20240924$PER$$US-SA-2024SA268217$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240924$$HP$US$US
243594101$24359410$1$I$20240101$20240913$20240924$20240924$PER$$US-SA-2024SA272611$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240924$$HP$US$US
243594111$24359411$1$I$20240101$20240913$20240924$20240924$PER$$US-SA-2024SA268017$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240924$$MD$US$US
243594121$24359412$1$I$$20240913$20240924$20240924$PER$$US-SA-2024SA269816$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240924$$MD$US$US
243594131$24359413$1$I$20240913$20240913$20240924$20240924$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000033$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240924$$MD$US$US
243594141$24359414$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270966$SANOFI AVENTIS$$$$C$F$Y$$$20240924$$HP$US$US
243594151$24359415$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271352$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240924$$HP$US$US
243594161$24359416$1$I$20240101$20240918$20240924$20240924$PER$$US-SA-2024SA271391$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240924$$MD$US$US
243594171$24359417$1$I$20240901$20240918$20240924$20240924$PER$$US-SA-2024SA271341$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240924$$MD$US$US
243594181$24359418$1$I$20240801$20240917$20240924$20240924$PER$$US-SA-2024SA271019$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240924$$HP$US$US
243594191$24359419$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA268751$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240924$$MD$US$US
243594201$24359420$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270378$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240924$$MD$US$US
243594211$24359421$1$I$20240917$20240917$20240924$20240924$PER$$US-SA-2024SA274542$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240924$$MD$US$US
243594221$24359422$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA270940$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240924$$MD$US$US
243594231$24359423$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270818$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240924$$HP$US$US
243594241$24359424$1$I$20240801$20240918$20240924$20240924$PER$$US-SA-2024SA271296$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240924$$MD$US$US
243594251$24359425$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271559$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$HP$US$US
243594261$24359426$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271331$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240924$$HP$US$US
243594271$24359427$1$I$20240101$20240915$20240924$20240924$PER$$US-SA-2024SA274819$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240924$$CN$US$US
243594281$24359428$1$I$20240901$20240915$20240924$20240924$PER$$US-SA-2024SA270184$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240924$$HP$US$US
243594291$24359429$1$I$20240903$20240915$20240924$20240924$PER$$US-SA-2024SA274714$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240924$$CN$US$US
243594301$24359430$1$I$20240901$20240917$20240924$20240924$PER$$US-SA-2024SA270941$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240924$$MD$US$US
243594311$24359431$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270765$SANOFI AVENTIS$$93$YR$E$M$Y$$$20240924$$MD$US$US
243594321$24359432$1$I$20240917$20240918$20240924$20240924$PER$$US-SA-2024SA270778$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240924$$HP$US$US
243594331$24359433$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA271152$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$CN$US$US
243594351$24359435$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA271735$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$HP$US$US
243594361$24359436$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270577$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240924$$HP$US$US
243594381$24359438$1$I$20240701$20240917$20240924$20240924$PER$$US-SA-2024SA271543$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240924$$MD$US$US
243594391$24359439$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271654$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240924$$MD$US$US
243594411$24359441$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270475$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240924$$HP$US$US
243594421$24359442$1$I$20240801$20240916$20240924$20240924$PER$$US-SA-2023SA358246$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240924$$HP$US$US
243594431$24359443$1$I$20240101$20240916$20240924$20240924$PER$$US-SA-2024SA270729$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240924$$MD$US$US
243594441$24359444$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271642$SANOFI AVENTIS$$36$YR$A$F$Y$78$KG$20240924$$MD$US$US
243594451$24359445$1$I$20240911$20240916$20240924$20240924$PER$$US-SA-2024SA270594$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240924$$HP$US$US
243594471$24359447$1$I$20240601$20240917$20240924$20240924$PER$$US-SA-2024SA270886$SANOFI AVENTIS$$$$A$M$Y$$$20240924$$HP$US$US
243594481$24359448$1$I$20240501$20240917$20240924$20240924$PER$$US-SA-2024SA271325$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240924$$HP$US$US
243594491$24359449$1$I$20240612$20240912$20240924$20240924$EXP$$JP-shionogi-202400000047$SHIONOGI$$9$DEC$E$M$Y$64.4$KG$20240924$$MD$JP$JP
243594501$24359450$1$I$20240701$20240917$20240924$20240924$PER$$US-SA-2024SA270762$SANOFI AVENTIS$$$$E$F$Y$$$20240924$$MD$US$US
243594521$24359452$1$I$20240101$20240916$20240924$20240924$PER$$US-SA-2024SA269611$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240924$$MD$US$US
243594531$24359453$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271500$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240924$$MD$US$US
243594541$24359454$1$I$20240101$20240918$20240924$20240924$PER$$US-SA-2024SA271471$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240924$$HP$US$US
243594551$24359455$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270875$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240924$$MD$US$US
243594561$24359456$1$I$20240701$20240917$20240924$20240924$PER$$US-SA-2024SA271052$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240924$$MD$US$US
243594571$24359457$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA269832$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240924$$MD$US$US
243594581$24359458$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271099$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240924$$HP$US$US
243594591$24359459$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA269920$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240924$$HP$US$US
243594601$24359460$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA270839$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240924$$HP$US$US
243594611$24359461$1$I$20240901$20240918$20240924$20240924$PER$$US-SA-2024SA271611$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240924$$MD$US$US
243594621$24359462$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA269881$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240924$$HP$US$US
243594631$24359463$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271186$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240924$$HP$US$US
243594641$24359464$1$I$20240813$20240916$20240924$20240924$PER$$US-SA-2024SA270608$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240924$$$US$US
243594651$24359465$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA268401$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240924$$MD$US$US
243594661$24359466$1$I$20240803$20240917$20240924$20240924$PER$$US-SA-2024SA271444$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240924$$MD$US$US
243594671$24359467$1$I$20240901$20240917$20240924$20240924$PER$$US-SA-2024SA270853$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240924$$MD$US$US
243594681$24359468$1$I$20240101$20240918$20240924$20240924$PER$$US-SA-2024SA271498$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240924$$HP$US$US
243594691$24359469$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270756$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240924$$HP$US$US
243594701$24359470$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA269848$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240924$$HP$US$US
243594711$24359471$1$I$20240101$20240916$20240924$20240924$PER$$US-SA-2024SA270659$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240924$$MD$US$US
243594721$24359472$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270139$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240924$$HP$US$US
243594731$24359473$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270987$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240924$$CN$US$US
243594741$24359474$1$I$20240801$20240917$20240924$20240924$PER$$US-SA-2024SA270758$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240924$$CN$US$US
243594751$24359475$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270804$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240924$$HP$US$US
243594771$24359477$1$I$20240101$20240916$20240924$20240924$PER$$US-SA-2024SA269325$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240924$$MD$US$US
243594781$24359478$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270408$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240924$$MD$US$US
243594791$24359479$1$I$20240101$20240918$20240924$20240924$PER$$US-SA-2024SA271532$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240924$$HP$US$US
243594801$24359480$1$I$$20240307$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004384$BLUEPRINT MEDICINES$$$$$$Y$$$20240924$$MD$US$US
243594811$24359481$1$I$$20240531$20240924$20240924$EXP$$GB-BLUEPRINT MEDICINES CORPORATION-2024BUS000096$BLUEPRINT MEDICINES$$$$$$Y$$$20240924$$HP$GB$GB
243594821$24359482$1$I$$20240613$20240924$20240924$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS000127$BLUEPRINT MEDICINES$$$$$$Y$$$20240924$$HP$FR$FR
243594831$24359483$1$I$$20240311$20240924$20240924$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004388$BLUEPRINT MEDICINES$$$$$$Y$$$20240924$$PH$US$US
243594841$24359484$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271090$SANOFI AVENTIS$$$$E$M$Y$$$20240924$$HP$US$US
243594851$24359485$1$I$20240901$20240918$20240924$20240924$PER$$US-SA-2024SA271637$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240924$$HP$US$US
243594861$24359486$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA270701$SANOFI AVENTIS$$$$C$F$Y$$$20240924$$MD$US$US
243594871$24359487$1$I$20240101$20240916$20240924$20240924$PER$$US-SA-2024SA270645$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$HP$US$US
243594881$24359488$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271251$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240924$$HP$US$US
243594891$24359489$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271546$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240924$$HP$US$US
243594901$24359490$1$I$$20240916$20240924$20240924$PER$$US-SA-2023SA164375$SANOFI AVENTIS$$$$C$M$Y$$$20240924$$HP$US$US
243594911$24359491$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA270773$SANOFI AVENTIS$$$$A$M$Y$$$20240924$$HP$US$US
243594921$24359492$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271291$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240924$$CN$US$US
243594931$24359493$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA271004$SANOFI AVENTIS$$$$E$F$Y$$$20240924$$HP$US$US
243594941$24359494$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271458$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240924$$MD$US$US
243594951$24359495$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271552$SANOFI AVENTIS$$$$T$M$Y$$$20240924$$HP$US$US
243594961$24359496$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270347$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240924$$HP$US$US
243594971$24359497$1$I$20240914$20240916$20240924$20240924$PER$$US-SA-2024SA270545$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240924$$MD$US$US
243594981$24359498$1$I$20240901$20240916$20240924$20240924$PER$$US-SA-2024SA268471$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240924$$MD$US$US
243594991$24359499$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA270589$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240924$$HP$US$US
243595001$24359500$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271055$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240924$$MD$US$US
243595011$24359501$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270415$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240924$$CN$US$US
243595021$24359502$1$I$20240901$20240918$20240924$20240924$PER$$US-SA-2024SA271609$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240924$$HP$US$US
243595031$24359503$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270963$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240924$$HP$US$US
243595041$24359504$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270945$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240924$$CN$US$US
243595051$24359505$1$I$20240101$20240918$20240924$20240924$PER$$US-SA-2024SA271297$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240924$$HP$US$US
243595061$24359506$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271573$SANOFI AVENTIS$$$$A$M$Y$$$20240924$$HP$US$US
243595071$24359507$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271261$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240924$$HP$US$US
243595081$24359508$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271106$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240924$$HP$US$US
243595091$24359509$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270337$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240924$$HP$US$US
243595101$24359510$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271080$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240924$$MD$US$US
243595111$24359511$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270962$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240924$$HP$US$US
243595121$24359512$1$I$20240901$20240917$20240924$20240924$PER$$US-SA-2024SA271626$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240924$$MD$US$US
243595131$24359513$1$I$20240901$20240918$20240924$20240924$PER$$US-SA-2024SA271266$SANOFI AVENTIS$$$$$M$Y$$$20240924$$MD$US$US
243595141$24359514$1$I$20240901$20240918$20240924$20240924$PER$$US-SA-2024SA271533$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240924$$HP$US$US
243595151$24359515$1$I$20240701$20240916$20240924$20240924$PER$$US-SA-2024SA270903$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240924$$MD$US$US
243595161$24359516$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA269947$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240924$$HP$US$US
243595171$24359517$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA273656$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$MD$US$US
243595181$24359518$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA271400$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240924$$HP$US$US
243595191$24359519$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA184532$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240924$$CN$US$US
243595201$24359520$1$I$20240801$20240917$20240924$20240924$PER$$US-SA-2024SA271464$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240924$$MD$US$US
243595211$24359521$1$I$20240901$20240918$20240924$20240924$PER$$US-SA-2024SA271612$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240924$$HP$US$US
243595221$24359522$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270619$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240924$$MD$US$US
243595231$24359523$1$I$20240828$20240918$20240924$20240924$PER$$US-SA-2024SA271504$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240924$$HP$US$US
243595241$24359524$1$I$$20240924$20240924$20240924$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053217$BOEHRINGER INGELHEIM$$$$$$Y$$$20240924$$MD$US$US
243595251$24359525$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA272563$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240924$$HP$US$US
243595261$24359526$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA270564$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240924$$HP$US$US
243595271$24359527$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271457$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240924$$HP$US$US
243595281$24359528$1$I$20240101$20240916$20240924$20240924$PER$$US-SA-2024SA270865$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240924$$HP$US$US
243595291$24359529$1$I$20240801$20240917$20240924$20240924$PER$$US-SA-2024SA270363$SANOFI AVENTIS$$$$C$F$Y$$$20240924$$CN$US$US
243595301$24359530$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270750$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240924$$HP$US$US
243595311$24359531$1$I$20240101$20240916$20240924$20240924$PER$$US-SA-2024SA269249$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240924$$MD$US$US
243595321$24359532$1$I$20240101$20240918$20240924$20240924$PER$$US-SA-2024SA270936$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240924$$MD$US$US
243595331$24359533$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA200460$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240924$$HP$US$US
243595341$24359534$1$I$20240901$20240916$20240924$20240924$PER$$US-SA-2024SA268448$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240924$$MD$US$US
243595351$24359535$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA269359$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240924$$MD$US$US
243595361$24359536$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270533$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240924$$MD$US$US
243595371$24359537$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270525$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240924$$MD$US$US
243595381$24359538$1$I$20240901$20240917$20240924$20240924$PER$$US-SA-2024SA271021$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240924$$HP$US$US
243595391$24359539$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271371$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240924$$MD$US$US
243595401$24359540$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA271011$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240924$$MD$US$US
243595411$24359541$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA271259$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240924$$HP$US$US
243595421$24359542$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA269341$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240924$$HP$US$US
243595431$24359543$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271745$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240924$$MD$US$US
243595441$24359544$1$I$20200401$20240916$20240924$20240924$PER$$US-SA-2024SA270612$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240924$$HP$US$US
243595451$24359545$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271281$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240924$$HP$US$US
243595461$24359546$1$I$20240901$20240916$20240924$20240924$PER$$US-SA-2024SA268713$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240924$$HP$US$US
243595471$24359547$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270720$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240924$$HP$US$US
243595481$24359548$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270837$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240924$$HP$US$US
243595491$24359549$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271596$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240924$$MD$US$US
243595501$24359550$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA270997$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240924$$MD$US$US
243595511$24359551$1$I$20240901$20240918$20240924$20240924$PER$$US-SA-2024SA270840$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240924$$MD$US$US
243595521$24359552$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271230$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240924$$HP$US$US
243595531$24359553$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA275040$SANOFI AVENTIS$$$$E$M$Y$72.8$KG$20240924$$MD$US$US
243595541$24359554$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA270144$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240924$$MD$US$US
243595551$24359555$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA270761$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240924$$HP$US$US
243595561$24359556$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA271414$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$MD$US$US
243595571$24359557$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270855$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240924$$HP$US$US
243595581$24359558$1$I$20240101$20240918$20240924$20240924$PER$$US-SA-2024SA271628$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240924$$MD$US$US
243595591$24359559$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA187620$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240924$$MD$US$US
243595601$24359560$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA270800$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240924$$MD$US$US
243595611$24359561$1$I$20240913$20240916$20240924$20240924$PER$$US-SA-2024SA270667$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240924$$MD$US$US
243595621$24359562$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270581$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240924$$MD$US$US
243595631$24359563$1$I$20240901$20240916$20240924$20240924$PER$$US-SA-2024SA269318$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240924$$MD$US$US
243595641$24359564$1$I$20231201$20240917$20240924$20240924$PER$$US-SA-2024SA270934$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240924$$HP$US$US
243595651$24359565$1$I$20230101$20240916$20240924$20240924$PER$$US-SA-2024SA268582$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240924$$HP$US$US
243595661$24359566$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270623$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240924$$MD$US$US
243595671$24359567$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271100$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240924$$HP$US$US
243595681$24359568$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270874$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240924$$HP$US$US
243595691$24359569$1$I$20240915$20240917$20240924$20240924$PER$$US-SA-2024SA270598$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240924$$CN$US$US
243595701$24359570$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270424$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240924$$HP$US$US
243595711$24359571$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA270587$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240924$$HP$US$US
243595721$24359572$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA269910$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240924$$MD$US$US
243595731$24359573$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA269349$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240924$$HP$US$US
243595741$24359574$1$I$20240901$20240918$20240924$20240924$PER$$US-SA-2024SA270663$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240924$$HP$US$US
243595751$24359575$1$I$20240916$20240916$20240924$20240924$PER$$US-SA-2024SA270734$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240924$$HP$US$US
243595761$24359576$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271111$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240924$$MD$US$US
243595771$24359577$1$I$20240101$20240916$20240924$20240924$PER$$US-SA-2024SA269043$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240924$$HP$US$US
243595781$24359578$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA270573$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$MD$US$US
243595791$24359579$1$I$20240813$20240917$20240924$20240924$PER$$US-SA-2024SA269903$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240924$$MD$US$US
243595801$24359580$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270656$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$HP$US$US
243595811$24359581$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271397$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240924$$HP$US$US
243595821$24359582$1$I$20240901$20240916$20240924$20240924$PER$$US-SA-2024SA268696$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240924$$HP$US$US
243595831$24359583$1$I$20230220$20240917$20240924$20240924$PER$$US-SA-2024SA270816$SANOFI AVENTIS$$6$YR$C$M$Y$40.5$KG$20240924$$HP$US$US
243595841$24359584$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA270949$SANOFI AVENTIS$$$$A$F$Y$$$20240924$$MD$US$US
243595851$24359585$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270588$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240924$$HP$US$US
243595861$24359586$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271329$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240924$$HP$US$US
243595871$24359587$1$I$20240901$20240918$20240924$20240924$PER$$US-SA-2024SA271234$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240924$$MD$US$US
243595881$24359588$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA269659$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240924$$MD$US$US
243595891$24359589$1$I$$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014811$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243595901$24359590$1$I$20240901$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014366$ELI LILLY AND CO$$62$YR$A$$Y$$$20240924$$CN$US$US
243595911$24359591$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA271361$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240924$$HP$US$US
243595921$24359592$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270870$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240924$$HP$US$US
243595931$24359593$1$I$20240901$20240916$20240924$20240924$PER$$US-SA-2024SA268745$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240924$$HP$US$US
243595941$24359594$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA269909$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240924$$MD$US$US
243595951$24359595$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271614$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240924$$HP$US$US
243595961$24359596$1$I$20240701$20240917$20240924$20240924$PER$$US-SA-2024SA271342$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240924$$HP$US$US
243595971$24359597$1$I$20240901$20240918$20240924$20240924$PER$$US-SA-2024SA270789$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240924$$HP$US$US
243595981$24359598$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA270638$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240924$$MD$US$US
243595991$24359599$1$I$20240901$20240916$20240924$20240924$PER$$US-SA-2024SA270565$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240924$$HP$US$US
243596001$24359600$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA271606$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240924$$CN$US$US
243596011$24359601$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA268198$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240924$$MD$US$US
243596021$24359602$1$I$20240919$20240919$20240924$20240924$PER$$US-SA-2024SA273171$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240924$$HP$US$US
243596031$24359603$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA268192$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240924$$CN$US$US
243596041$24359604$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271452$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240924$$MD$US$US
243596051$24359605$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271479$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240924$$MD$US$US
243596061$24359606$1$I$$20240916$20240924$20240924$PER$$US-SA-2024SA268336$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240924$$MD$US$US
243596071$24359607$1$I$$20240917$20240924$20240924$PER$$US-SA-2024SA271389$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240924$$HP$US$US
243596081$24359608$1$I$$20240919$20240924$20240924$PER$$US-SA-2024SA275221$SANOFI AVENTIS$$$$A$$Y$$$20240924$$MD$US$US
243596091$24359609$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271378$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240924$$HP$US$US
243596101$24359610$1$I$20240922$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014629$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240924$$CN$US$US
243596111$24359611$1$I$20240909$20240913$20240924$20240924$PER$$US-BAUSCHBL-2024BNL033489$BAUSCH AND LOMB$$49$YR$$M$Y$$$20240924$$MD$US$US
243596121$24359612$1$I$$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409010426$ELI LILLY AND CO$$29$YR$A$M$Y$$$20240924$$CN$US$US
243596131$24359613$1$I$20240919$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024190088$AMGEN$$81$YR$E$F$Y$$$20240924$$CN$US$US
243596141$24359614$1$I$$20240912$20240924$20240924$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09239$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240924$$HP$US$US
243596161$24359616$1$I$$20240919$20240924$20240924$EXP$$US-009507513-2409USA007462$MERCK$$$$$F$Y$$$20240924$$CN$US$US
243596171$24359617$1$I$$20240923$20240924$20240924$PER$$NVSC2024US190044$NOVARTIS$$$$$M$Y$$$20240924$$MD$US$US
243596181$24359618$1$I$$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409010389$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240924$$CN$US$US
243596191$24359619$1$I$20240920$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014015$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240924$$CN$US$US
243596202$24359620$2$F$20240918$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012419$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243596211$24359621$1$I$$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011365$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243596221$24359622$1$I$$20240917$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011376$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240924$$CN$US$US
243596231$24359623$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013645$ELI LILLY AND CO$$26$YR$A$M$Y$$$20240924$$CN$US$US
243596241$24359624$1$I$20240901$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012868$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240924$$CN$US$US
243596251$24359625$1$I$20240923$20240923$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014803$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240924$$CN$US$US
243596271$24359627$1$I$20240916$20240917$20240924$20240924$PER$$US-ABBVIE-5927956$ABBVIE$$28$YR$$F$Y$$$20240924$$HP$US$US
243596281$24359628$1$I$20230401$20240913$20240924$20240924$PER$$US-SA-2024SA269570$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240924$$MD$US$US
243596292$24359629$2$F$$20240924$20240924$20240926$PER$$NVSC2024US189959$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
243596301$24359630$1$I$$20240918$20240924$20240924$PER$$US-BAUSCH-BL-2024-014102$BAUSCH AND LOMB$$$$$M$Y$$$20240924$$CN$US$US
243596311$24359631$1$I$$20240801$20240924$20240924$EXP$$JP-009507513-2409JPN005074$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$54$YR$$F$Y$$$20240924$$HP$JP$JP
243596321$24359632$1$I$$20240923$20240924$20240924$PER$$NVSC2024US190030$NOVARTIS$$$$$M$Y$$$20240924$$HP$US$US
243596331$24359633$1$I$$20240919$20240924$20240924$PER$$US-GILEAD-2024-0688378$GILEAD$$$$A$M$Y$$$20240924$$CN$US$US
243596341$24359634$1$I$$20240913$20240924$20240924$PER$$US-SA-2024SA268289$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240924$$HP$US$US
243596362$24359636$2$F$$20240919$20240924$20240927$EXP$$PT-009507513-2409PRT007288$MERCK$$$$$F$Y$$$20240927$$MD$PT$PT
243596371$24359637$1$I$20240101$20240915$20240924$20240924$EXP$$US-RADIUS HEALTH, INC.-2024US007300$RADIUS PHARM$$$$$F$Y$$$20240924$$CN$US$US
243596381$24359638$1$I$$20240918$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012264$ELI LILLY AND CO$$25$YR$A$$Y$$$20240924$$HP$US$US
243596391$24359639$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409014025$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240924$$CN$US$US
243596401$24359640$1$I$$20240801$20240924$20240924$EXP$$JP-009507513-2409JPN005073$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$72$YR$$M$Y$$$20240924$$HP$JP$JP
243596421$24359642$1$I$$20240919$20240924$20240924$PER$$AU-Eisai-EC-2024-175075$EISAI$$$$$F$Y$$$20240924$$HP$AU$AU
243596431$24359643$1$I$$20240918$20240924$20240924$EXP$$US-APELLIS-2024-APL-0001029$APELLIS PHARMACEUTICALS$George Jiao, MD, Daniel Zhu, MD, Jeffrey L. Shakin, MD, and Albert S. Li, MD. Haemophilus influenzae Endophthalmitis?Associated With Intravitreal Pegcetacoplan?Injection.Journal of VitreoRetinal Diseases . 2024;00(0):1?4. doi:10.1177/24741264241276594$$$$$Y$$$20240923$$MD$US$US
243596441$24359644$1$I$$20240920$20240924$20240924$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053203$BOEHRINGER INGELHEIM$$78$YR$E$M$Y$$$20240924$$MD$US$US
243596451$24359645$1$I$20240815$20240909$20240924$20240924$EXP$$BR-TAKEDA-2024TUS090793$TAKEDA$$51$YR$$F$Y$$$20240924$$CN$BR$BR
243596461$24359646$1$I$$20240918$20240924$20240924$PER$$US-TAKEDA-2024TUS093490$TAKEDA$$$$$$Y$$$20240924$$HP$US$US
243596481$24359648$1$I$$20240801$20240924$20240924$EXP$$JP-009507513-2409JPN005070$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$66$YR$$M$Y$$$20240924$$HP$JP$JP
243596491$24359649$1$I$$20240923$20240924$20240924$PER$$US-ABBVIE-5937301$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243596501$24359650$1$I$$20240923$20240924$20240924$PER$$US-TAKEDA-2024TUS094630$TAKEDA$$$$$F$Y$$$20240924$$CN$US$US
243596511$24359651$1$I$$20240918$20240924$20240924$EXP$$JP-009507513-2409JPN002905J$MERCK$$57$YR$$M$Y$$$20240924$$MD$JP$JP
243596521$24359652$1$I$$20240801$20240924$20240924$EXP$$JP-009507513-2409JPN005071$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$81$YR$$M$Y$$$20240924$$HP$JP$JP
243596531$24359653$1$I$$20240913$20240924$20240924$PER$$PR-JNJFOC-20240960504$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20240924$$CN$PR$US
243596541$24359654$1$I$20240918$20240918$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012289$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243596551$24359655$1$I$$20240918$20240924$20240924$EXP$$US-TAKEDA-2024TUS093388$TAKEDA$$44$YR$$M$Y$$$20240924$$CN$US$US
243596561$24359656$1$I$$20240801$20240924$20240924$EXP$$JP-009507513-2409JPN005072$MERCK$Maruyama S, Wada D, Kanayama S, Shimazu H, Miyano Y, Inoue A, et al.. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody. BMC Infectious Diseases. 2024;24(715)$39$YR$$M$Y$$$20240924$$HP$JP$JP
243596592$24359659$2$F$$20240923$20240924$20240926$EXP$$AU-TAKEDA-2024TUS094653$TAKEDA$$$$$M$Y$$$20240926$$CN$GB$AU
243596611$24359661$1$I$$20240920$20240924$20240924$EXP$$IT-TAKEDA-2024TUS094742$TAKEDA$$$$$M$Y$$$20240924$$CN$GB$IT
243596621$24359662$1$I$$20240919$20240924$20240924$PER$$US-JNJFOC-20240957806$JOHNSON AND JOHNSON$$$$$F$Y$$$20240924$$CN$US$US
243596631$24359663$1$I$$20240919$20240924$20240924$PER$$US-JNJFOC-20240958038$JOHNSON AND JOHNSON$$$$$M$Y$$$20240924$$CN$US$US
243596641$24359664$1$I$20240918$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012416$ELI LILLY AND CO$$$$$$Y$$$20240924$$CN$US$US
243596651$24359665$1$I$20240807$20240916$20240924$20240924$EXP$$US-ASTELLAS-2024-AER-007346$ASTELLAS$$74$YR$E$M$Y$57$KG$20240924$$MD$US$US
243596671$24359667$1$I$$20240921$20240924$20240924$PER$$US-PURDUE PHARMA-USA-2024-0312114$PURDUE$$70$YR$$$Y$$$20240924$$CN$US$US
243596691$24359669$1$I$20240913$20240913$20240924$20240924$PER$$US-JNJFOC-20240959822$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240924$$CN$US$US
243596701$24359670$1$I$$20240917$20240924$20240924$PER$$US-ASTELLAS-2024-AER-007624$ASTELLAS$$$$$M$Y$$$20240924$$MD$US$US
243596711$24359671$1$I$$20240912$20240924$20240924$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09211$NEUROCRINE BIOSCIENCES$$$$$M$Y$$$20240924$$HP$US$US
243596721$24359672$1$I$20240101$20240918$20240924$20240924$EXP$$DE-TAKEDA-2024TUS026172$TAKEDA$$58$YR$$F$Y$63.7$KG$20240924$$HP$DE$DE
243596731$24359673$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150751$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240924$$PH$US$US
243596741$24359674$1$I$20240921$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151468$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240924$$CN$US$US
243596752$24359675$2$F$$20240923$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151442$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240924$$CN$US$US
243596761$24359676$1$I$20240901$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150367$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$74.93$KG$20240924$$PH$US$US
243596771$24359677$1$I$20240901$20240914$20240924$20240924$PER$$CN-Eisai-EC-2024-174440$EISAI$$58$YR$A$F$Y$36$KG$20240924$$HP$CN$CN
243596781$24359678$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150773$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240924$$PH$US$US
243596791$24359679$1$I$$20240923$20240924$20240924$EXP$$US-TAKEDA-2024TUS031210$TAKEDA$$$$$M$Y$$$20240924$$CN$US$US
243596801$24359680$1$I$$20240923$20240924$20240924$PER$$US-DAIICHI SANKYO, INC.-DS-2024-101080-US$DAIICHI$$$$$F$Y$$$20240924$$CN$US$US
243596811$24359681$1$I$$20240923$20240924$20240924$PER$$US-DAIICHI SANKYO, INC.-DS-2024-101073-US$DAIICHI$$$$$F$Y$$$20240924$$CN$US$US
243596821$24359682$1$I$$20240913$20240924$20240924$EXP$$US-BEH-2024178934$CSL BEHRING$$$$$F$Y$$$20240924$$CN$US$US
243596831$24359683$1$I$20240830$20240911$20240924$20240924$EXP$$CA-HLS-202402319$HLS THERAPEUTICS$$71$YR$E$M$Y$$$20240924$$HP$CA$CA
243596842$24359684$2$F$20240820$20240911$20240924$20240926$EXP$$US-FMCRTG-FMC-2409-001148$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240926$$HP$US$US
243596851$24359685$1$I$$20240812$20240924$20240924$PER$$US-FMCRTG-FMC-2408-000998$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240924$$CN$US$US
243596861$24359686$1$I$$20240913$20240924$20240924$EXP$$US-FMCRTG-FMC-2409-001150$FRESENIUS MEDICAL CARE$$73$YR$E$F$Y$47$KG$20240924$$HP$US$US
243596871$24359687$1$I$$20240831$20240924$20240924$PER$$US-FMCRTG-FMC-2409-001097$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240924$$HP$US$US
243596881$24359688$1$I$$20240911$20240924$20240924$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09155$NEUROCRINE BIOSCIENCES$$$$$F$Y$$$20240924$$HP$US$US
243596891$24359689$1$I$$20240911$20240924$20240924$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09157$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240924$$HP$US$US
243596901$24359690$1$I$20230801$20240911$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409007593$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240924$$CN$US$US
243596921$24359692$1$I$20240101$20240918$20240924$20240924$EXP$$PT-ORGANON-O2409PRT001586$ORGANON$$30$YR$$F$Y$$$20240924$$MD$PT$PT
243596931$24359693$1$I$$20240916$20240924$20240924$PER$$US-BIOGEN-2024BI01282899$BIOGEN$$$$$F$Y$$$20240924$$PH$US$US
243596941$24359694$1$I$20240101$20240917$20240924$20240924$EXP$$US-009507513-2409USA006287$MERCK$$66$YR$$M$Y$$$20240924$$CN$US$US
243596951$24359695$1$I$$20240920$20240924$20240924$EXP$$IT-TAKEDA-2024TUS094752$TAKEDA$$$$$M$Y$$$20240924$$CN$GB$IT
243596981$24359698$1$I$$20240920$20240924$20240924$EXP$$NVSC2024GB189288$NOVARTIS$$$$A$$Y$$$20240925$$HP$GB$GB
243596991$24359699$1$I$20240101$20240918$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149999$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240925$$PH$US$US
243597011$24359701$1$I$$20240918$20240924$20240924$EXP$$US-ALKERMES INC.-ALK-2024-002412$ALKERMES$$$$$F$Y$$$20240925$$CN$US$US
243597021$24359702$1$I$20240101$20240917$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US082616$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243597031$24359703$1$I$20230101$20240918$20240924$20240924$EXP$$US-ALKERMES INC.-ALK-2024-002436$ALKERMES$$3$DEC$$M$Y$$$20240925$$PH$US$US
243597041$24359704$1$I$$20240910$20240924$20240924$EXP$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01564$TARO$R. M. Puthumana, J. Mintz, M. Perez, S. Gaddipati, D. Gorman. Too Much of a Good Thing: A Case of Beta Blocker and WarfarinToxicity. Am J Respir Crit Care Med. 2024;209:A5692$$$$$Y$$$20240925$$HP$US$US
243597051$24359705$1$I$$20240924$20240924$20240924$EXP$$CA-ROCHE-10000089713$ROCHE$$40$YR$A$F$Y$$$20240925$$CN$CA$CA
243597061$24359706$1$I$20240601$20240919$20240924$20240924$EXP$$GR-ABBVIE-5932296$ABBVIE$$74$YR$$M$Y$$$20240924$$CN$GR$GR
243597071$24359707$1$I$20240916$20240917$20240924$20240924$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001901$BLUEPRINT MEDICINES$$90$YR$E$F$Y$$$20240925$$CN$US$US
243597091$24359709$1$I$20240904$20240924$20240924$20240924$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053252$BOEHRINGER INGELHEIM$$87$YR$E$F$Y$$$20240925$$CN$US$US
243597102$24359710$2$F$$20240920$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US082108$SANDOZ$$41$YR$$$Y$$$20240924$$HP$US$US
243597111$24359711$1$I$20240201$20240923$20240924$20240924$EXP$$US-ABBVIE-5936031$ABBVIE$$82$YR$$M$Y$$$20240924$$CN$US$US
243597121$24359712$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013923$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240924$$CN$US$US
243597131$24359713$1$I$20220601$20240924$20240924$20240924$EXP$$NVSJ2024JP011207$NOVARTIS$$$$$$Y$$$20240925$$MD$JP$JP
243597152$24359715$2$F$20240821$20240924$20240924$20240926$30DAY$$US-AMGEN-USASP2024185640$AMGEN$$69$YR$E$M$Y$92.3$KG$20240926$$HP$US$US
243597161$24359716$1$I$20240730$20240918$20240924$20240924$EXP$$JP-GSK-JP2024JPN115715$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$PH$JP$JP
243597191$24359719$1$I$20240914$20240915$20240924$20240924$PER$$US-JNJFOC-20240939390$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240925$$CN$US$US
243597201$24359720$1$I$20240101$20240920$20240924$20240924$EXP$$CN-JNJFOC-20240964039$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240925$$HP$CN$CN
243597211$24359721$1$I$20240101$20240919$20240924$20240924$PER$$US-ABBVIE-5932947$ABBVIE$$83$YR$$F$Y$$$20240924$$MD$US$US
243597221$24359722$1$I$$20240923$20240924$20240924$PER$$NVSC2024US190133$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
243597231$24359723$1$I$20240914$20240916$20240924$20240924$EXP$$CA-JNJFOC-20240946375$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240925$$CN$CA$CA
243597241$24359724$1$I$$20240923$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US082337$SANDOZ$$$$$$Y$$$20240924$$CN$US$US
243597251$24359725$1$I$20230301$20240917$20240924$20240924$EXP$$CA-JNJFOC-20230375042$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240925$$CN$CA$CA
243597261$24359726$1$I$20240101$20240910$20240924$20240924$PER$$US-009507513-2409USA003522$MERCK$$$$$M$Y$$$20240924$$CN$US$US
243597271$24359727$1$I$$20240902$20240924$20240924$30DAY$$GR-JNJFOC-20240902851$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$GR$GR
243597281$24359728$1$I$20210601$20240911$20240924$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-110452$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$65.7$KG$20240925$$MD$JP$JP
243597291$24359729$1$I$$20240918$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409011921$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240924$$CN$US$US
243597301$24359730$1$I$$20240918$20240924$20240924$EXP$$US-TAKEDA-2024TUS093698$TAKEDA$$$$$M$Y$$$20240924$$MD$US$US
243597311$24359731$1$I$20240805$20240924$20240924$20240924$EXP$FR-AFSSAPS-GR2024001121$FR-ROCHE-10000089899$ROCHE$$56$YR$A$F$Y$$$20240925$$PH$FR$FR
243597321$24359732$1$I$20240917$20240922$20240924$20240924$PER$$US-AMGEN-USASP2024189257$AMGEN$$54$YR$A$F$Y$$$20240924$$CN$US$US
243597331$24359733$1$I$$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189603$AMGEN$$$$$M$Y$$$20240924$$CN$US$US
243597341$24359734$1$I$$20240918$20240924$20240924$EXP$$US-ABBVIE-5932662$ABBVIE$$61$YR$$F$Y$$$20240924$$HP$US$US
243597351$24359735$1$I$20240913$20240913$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147006$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240925$$CN$US$US
243597361$24359736$1$I$20240905$20240923$20240924$20240924$EXP$$CN-ROCHE-10000089541$ROCHE$$57$YR$A$F$Y$46.4$KG$20240925$$HP$CN$CN
243597371$24359737$1$I$$20240917$20240924$20240924$EXP$$US-TAKEDA-2024TUS093189$TAKEDA$$$$$M$Y$$$20240924$$CN$US$US
243597381$24359738$1$I$20240919$20240919$20240924$20240924$PER$$US-ABBVIE-5931538$ABBVIE$$65$YR$$F$Y$$$20240924$$HP$US$US
243597391$24359739$1$I$20240829$20240919$20240924$20240924$EXP$$CA-ABBVIE-5931075$ABBVIE$$$$A$F$Y$$$20240924$$CN$CA$CA
243597401$24359740$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5930859$ABBVIE$$$$$F$Y$$$20240924$$HP$US$US
243597411$24359741$1$I$$20240916$20240924$20240924$EXP$$ES-JNJFOC-20240944230$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$MD$ES$ES
243597422$24359742$2$F$$20240920$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US056231$SANDOZ$$$$$F$Y$$$20240924$$PH$US$US
243597431$24359743$1$I$$20240913$20240924$20240924$EXP$$CA-ABBVIE-5933560$ABBVIE$$$$$M$Y$$$20240924$$HP$CA$CA
243597441$24359744$1$I$20240101$20240919$20240924$20240924$EXP$$US-ABBVIE-5932394$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243597451$24359745$1$I$20240601$20240919$20240924$20240924$EXP$$CA-ABBVIE-5933156$ABBVIE$$44$YR$$F$Y$$$20240924$$CN$CA$CA
243597461$24359746$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5933981$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243597471$24359747$1$I$20240101$20240918$20240924$20240924$EXP$$ZA-ABBVIE-5931283$ABBVIE$$53$YR$$F$Y$$$20240924$$CN$ZA$ZA
243597481$24359748$1$I$20240903$20240903$20240924$20240924$30DAY$$CA-JNJFOC-20240911877$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240925$$HP$CA$CA
243597491$24359749$1$I$20240404$20240920$20240924$20240924$EXP$$US-ABBVIE-5933630$ABBVIE$$42$YR$$F$Y$$$20240924$$CN$US$US
243597501$24359750$1$I$20240919$20240920$20240924$20240924$PER$$US-ABBVIE-5933502$ABBVIE$$20$YR$$F$Y$53$KG$20240924$$HP$US$US
243597511$24359751$1$I$20230101$20240919$20240924$20240924$EXP$$US-ABBVIE-5933261$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243597541$24359754$1$I$20240906$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188609$AMGEN$$72$YR$E$F$Y$$$20240924$$CN$US$US
243597553$24359755$3$F$20240911$20240927$20240924$20240930$PER$$US-AMGEN-USASP2024188680$AMGEN$$81$YR$E$F$Y$$$20240929$$CN$US$US
243597561$24359756$1$I$20240101$20240923$20240924$20240924$EXP$$ZA-ABBVIE-5936491$ABBVIE$$38$YR$$F$Y$$$20240924$$MD$ZA$ZA
243597571$24359757$1$I$20240101$20240917$20240924$20240924$PER$$US-SA-2024SA271066$SANOFI AVENTIS$$$$C$F$Y$$$20240925$$HP$US$US
243597581$24359758$1$I$$20240918$20240924$20240924$EXP$$GB-ABBVIE-5933131$ABBVIE$$$$A$M$Y$$$20240924$$CN$GB$GB
243597601$24359760$1$I$$20240918$20240924$20240924$EXP$$GR-SANDOZ INC.-SDZ2024GR082211$SANDOZ$$20$YR$$M$Y$$$20240924$$CN$GR$GR
243597611$24359761$1$I$20240701$20240917$20240924$20240924$PER$$US-SA-2024SA271666$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240925$$HP$US$US
243597621$24359762$1$I$$20240921$20240924$20240924$EXP$GB-MHRA-MED-202409202127308070-KLQDR$GB-ORGANON-O2409GBR001636$ORGANON$$$$$M$Y$94$KG$20240924$$CN$GB$GB
243597631$24359763$1$I$$20240917$20240924$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-149109$BRISTOL MYERS SQUIBB$Yamada H, et al. A case of acute-onset type 1 diabetes mellitus considered as delayed-onset nivolumab-induced irAE. The 694th Kanto Regional Meeting of the Japanese Society of Internal Medicine. 2024;13.$82$YR$E$F$Y$$$20240925$$MD$JP$JP
243597641$24359764$1$I$$20240919$20240924$20240924$EXP$$BG-JNJFOC-20240964073$JOHNSON AND JOHNSON$Tchernev G.; Ivanov L.. MUSTARDE ROTATION FLAP AS ADEQUATE OPTION FOR HIGH-RISK BCC NEAR THE LOWER EYE LID: THE ADDITIONAL INTAKE OF N-NITROSO-FOLIC-ACID AND N-NITROSO-RIVOROXABAN AS COFACTORS/TRIGGERS OF THE METABOLIC REPROGRAMMING OF THE FUTURE CANCER CELL. Georgian medical news. 2024;351:131-137$74$YR$E$F$Y$$$20240925$$HP$BG$BG
243597651$24359765$1$I$20240201$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013739$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240924$$CN$US$US
243597661$24359766$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013765$ELI LILLY AND CO$$42$YR$A$$Y$$$20240924$$CN$US$US
243597671$24359767$1$I$20240101$20240910$20240924$20240924$EXP$$US-SMPA-2024SPA002927$SUNOVION$$$$$$Y$$$20240924$$CN$US$US
243597681$24359768$1$I$20240101$20240919$20240924$20240924$EXP$$US-ABBVIE-5933062$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243597691$24359769$1$I$20240920$20240923$20240924$20240924$EXP$$RO-ABBVIE-5936633$ABBVIE$$82$YR$$M$Y$$$20240924$$CN$RO$RO
243597701$24359770$1$I$20230826$20240917$20240924$20240924$EXP$$CA-ABBVIE-5468293$ABBVIE$$56$YR$$F$Y$$$20240924$$HP$CA$CA
243597711$24359771$1$I$20240101$20240909$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151553$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$79.38$KG$20240925$$CN$US$US
243597721$24359772$1$I$20240101$20240905$20240924$20240924$PER$$US-SA-2024SA273079$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240925$$MD$US$US
243597732$24359773$2$F$$20240912$20240924$20240926$PER$$US-SA-2024SA112175$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240926$$CN$US$US
243597741$24359774$1$I$20240601$20240913$20240924$20240924$PER$$US-SA-2024SA267418$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240925$$MD$US$US
243597781$24359778$1$I$20240919$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024187977$AMGEN$$79$YR$E$F$Y$$$20240924$$CN$US$US
243597801$24359780$1$I$$20240918$20240924$20240924$EXP$$US-ABBVIE-5824371$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243597811$24359781$1$I$20240914$20240917$20240924$20240924$EXP$$US-SANDOZ INC.-SDZ2024US082385$SANDOZ$$$$$F$Y$$$20240924$$CN$US$US
243597821$24359782$1$I$$20240920$20240924$20240924$EXP$$US-ABBVIE-5933791$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243597831$24359783$1$I$20240831$20240919$20240924$20240924$EXP$$US-ABBVIE-5931970$ABBVIE$$77$YR$$F$Y$$$20240924$$CN$US$US
243597851$24359785$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5933150$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243597861$24359786$1$I$$20240912$20240924$20240924$EXP$$BG-Unichem Pharmaceuticals (USA) Inc-UCM202409-001173$UNICHEM$$$$$F$Y$$$20240925$$HP$BG$
243597871$24359787$1$I$20240701$20240831$20240924$20240924$PER$$US-SA-2024SA268098$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
243597891$24359789$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5932477$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243597901$24359790$1$I$20240101$20240920$20240924$20240924$EXP$$ZA-ABBVIE-5933081$ABBVIE$$$$A$F$Y$$$20240924$$HP$ZA$ZA
243597911$24359791$1$I$$20240917$20240924$20240924$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029456$UNITED THERAPEUTICS$$$$$M$Y$77.098$KG$20240924$$$US$US
243597931$24359793$1$I$20240101$20240910$20240924$20240924$PER$$US-009507513-2409USA003849$MERCK$$$$$M$Y$$$20240924$$CN$US$US
243597941$24359794$1$I$20240101$20240918$20240924$20240924$EXP$$GB-ABBVIE-5933213$ABBVIE$$31$YR$$M$Y$$$20240924$$CN$GB$GB
243597951$24359795$1$I$20240801$20240918$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149585$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240925$$CN$US$US
243597961$24359796$1$I$$20240919$20240924$20240924$EXP$$GB-ABBVIE-5933417$ABBVIE$$$$A$M$Y$$$20240924$$CN$GB$GB
243597971$24359797$1$I$20240701$20240919$20240924$20240924$EXP$$CA-ABBVIE-5933781$ABBVIE$$80$YR$$M$Y$$$20240924$$CN$CA$CA
243597981$24359798$1$I$20240901$20240918$20240924$20240924$EXP$$CA-ABBVIE-5933787$ABBVIE$$82$YR$$F$Y$$$20240924$$CN$CA$CA
243597991$24359799$1$I$$20240910$20240924$20240924$EXP$$GB-CIPLA LTD.-2024GB10060$CIPLA$$$$$$Y$$$20240925$$HP$GB$GB
243598001$24359800$1$I$$20240919$20240924$20240924$PER$$US-JNJFOC-20240960343$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243598011$24359801$1$I$20240916$20240920$20240924$20240924$EXP$$ES-ABBVIE-5927163$ABBVIE$$73$YR$$F$Y$$$20240924$$CN$ES$ES
243598021$24359802$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151588$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240925$$CN$US$US
243598031$24359803$1$I$$20240920$20240924$20240924$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151569$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240925$$CN$US$US
243598041$24359804$1$I$$20240923$20240924$20240924$EXP$$US-ABBVIE-5936057$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243598051$24359805$1$I$20240901$20240920$20240924$20240924$EXP$$US-ABBVIE-5933071$ABBVIE$$67$YR$$F$Y$$$20240924$$CN$US$US
243598071$24359807$1$I$20240306$20240916$20240924$20240924$PER$$US-AMGEN-USASP2024185109$AMGEN$$69$YR$E$F$Y$79.8$KG$20240924$$HP$US$US
243598091$24359809$1$I$$20240913$20240924$20240924$PER$$US-SA-2024SA270456$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240925$$HP$US$US
243598101$24359810$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA270881$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240925$$HP$US$US
243598111$24359811$1$I$$20240916$20240924$20240924$EXP$$BR-NOVITIUMPHARMA-2024BRNVP01958$NOVITIUM PHARMA$Clara Alice Lima Leal.AMPUTACAO DE PE POR ACTINOMICETOMA: UM RELATO DE CASO DE DIAGNOSTICO E TRATAMENTO DESAFIADORES.The Brazilian Journal of Infectious Diseases.14-NOV-2023;27(1):103496$59$YR$A$M$Y$$$20240925$$HP$BR$BR
243598121$24359812$1$I$20240304$20240920$20240924$20240924$EXP$$JP-SAKK-2024SA127268AA$SANOFI AVENTIS$$78$YR$E$F$Y$37$KG$20240925$$MD$JP$JP
243598131$24359813$1$I$20240917$20240919$20240924$20240924$EXP$RU-RZN- 2566843$RU-SANDOZ INC.-SDZ2024RU082218$SANDOZ$$$$$M$Y$$$20240924$$MD$RU$RU
243598141$24359814$1$I$20240911$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024187430$AMGEN$$78$YR$E$F$Y$$$20240924$$CN$US$US
243598151$24359815$1$I$20230101$20240917$20240924$20240924$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151285$BRISTOL MYERS SQUIBB$$7$DEC$E$F$Y$$$20240925$$MD$JP$JP
243598161$24359816$1$I$$20240917$20240924$20240924$EXP$$CA-ABBVIE-5930671$ABBVIE$$70$YR$$M$Y$$$20240924$$CN$CA$CA
243598171$24359817$1$I$20240830$20240920$20240924$20240924$PER$$US-AMGEN-USASP2024188859$AMGEN$$$$$$Y$$$20240924$$PH$US$US
243598181$24359818$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5932313$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243598191$24359819$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5932359$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243598201$24359820$1$I$$20240904$20240924$20240924$30DAY$$GB-JNJFOC-20240913390$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$GB$GB
243598211$24359821$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5932108$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243598222$24359822$2$F$20240911$20240919$20240924$20240925$EXP$$US-BEIGENE-BGN-2024-014892$BEIGENE$$$$$$Y$$$20240925$$CN$US$US
243598231$24359823$1$I$20240901$20240918$20240924$20240924$PER$$US-SA-2024SA270904$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240925$$HP$US$US
243598242$24359824$2$F$20240501$20240924$20240924$20240927$EXP$$NVSJ2024JP011081$NOVARTIS$$43$YR$$F$Y$$$20240927$$MD$JP$JP
243598251$24359825$1$I$20240101$20240917$20240924$20240924$EXP$$US-ABBVIE-5930153$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243598261$24359826$1$I$$20240916$20240924$20240924$EXP$$US-ABBVIE-5927040$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243598271$24359827$1$I$20230101$20240918$20240924$20240924$EXP$$US-ABBVIE-5932432$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243598281$24359828$1$I$20240922$20240923$20240924$20240924$PER$$US-AMGEN-USASP2024189584$AMGEN$$74$YR$E$F$Y$$$20240924$$CN$US$US
243598291$24359829$1$I$20240919$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188130$AMGEN$$75$YR$E$F$Y$$$20240924$$HP$US$US
243598321$24359832$1$I$$20240920$20240924$20240924$EXP$$US-ABBVIE-5933064$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243598331$24359833$1$I$20240911$20240918$20240924$20240924$EXP$$US-AMGEN-USASL2024186646$AMGEN$$59$YR$A$M$Y$$$20240924$$CN$US$US
243598341$24359834$1$I$$20240919$20240924$20240924$EXP$$AR-SANDOZ INC.-SDZ2024AR082256$SANDOZ$$$$$M$Y$32$KG$20240924$$CN$AR$AR
243598351$24359835$1$I$20240907$20240916$20240924$20240924$EXP$$CN-BEIGENE-BGN-2024-014749$BEIGENE$$$$$$Y$$$20240924$$HP$CN$CN
243598361$24359836$1$I$$20240920$20240924$20240924$EXP$$US-ABBVIE-5933511$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243598381$24359838$1$I$20240917$20240918$20240924$20240924$EXP$$CO-BIOGEN-2024BI01283601$BIOGEN$$2$YR$$M$Y$9.2$KG$20240924$$CN$CO$CO
243598391$24359839$1$I$20240910$20240920$20240924$20240924$EXP$$US-ABBVIE-5933740$ABBVIE$$70$YR$$F$Y$$$20240924$$CN$US$US
243598401$24359840$1$I$$20240916$20240924$20240924$EXP$$AU-TAKEDA-2024TUS079178$TAKEDA$$82$YR$$M$Y$$$20240924$$HP$AU$AU
243598411$24359841$1$I$20240721$20240923$20240924$20240924$EXP$IT-MINISAL02-1002619$IT-JNJFOC-20240964235$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240925$$MD$IT$IT
243598421$24359842$1$I$$20240918$20240924$20240924$EXP$$BR-TAKEDA-2024TUS094018$TAKEDA$$$$$M$Y$$$20240924$$CN$BR$BR
243598431$24359843$1$I$$20240920$20240924$20240924$EXP$$RO-SANDOZ INC.-SDZ2024RO081760$SANDOZ$$41$YR$$M$Y$$$20240924$$HP$RO$RO
243598441$24359844$1$I$20240101$20240918$20240924$20240924$PER$$US-ABBVIE-5931937$ABBVIE$$$$$$Y$$$20240924$$CN$US$US
243598451$24359845$1$I$20240717$20240910$20240924$20240924$EXP$$GB-CIPLA (EU) LIMITED-2024GB10058$CIPLA$$$$$$Y$$$20240925$$HP$GB$GB
243598462$24359846$2$F$20240101$20240923$20240924$20240927$PER$$US-ABBVIE-5934948$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243598472$24359847$2$F$20240914$20240926$20240924$20240930$30DAY$$US-AMGEN-USASP2024186042$AMGEN$$41$YR$A$M$Y$97.959$KG$20240930$$PH$US$US
243598481$24359848$1$I$20240918$20240919$20240924$20240924$PER$$US-AMGEN-USASP2024188726$AMGEN$$$$$$Y$$$20240924$$CN$US$US
243598491$24359849$1$I$20240118$20240919$20240924$20240924$EXP$$DE-ROCHE-10000089116$ROCHE$$29$YR$A$F$Y$65$KG$20240925$$MD$DE$DE
243598501$24359850$1$I$20240722$20240910$20240924$20240924$EXP$$FR-CIPLA LTD.-2024FR10326$CIPLA$$$$$$Y$$$20240925$$PH$FR$FR
243598521$24359852$1$I$$20240918$20240924$20240924$EXP$$US-BIOGEN-2024BI01276481$BIOGEN$$$$$F$Y$$$20240924$$HP$US$US
243598531$24359853$1$I$20180801$20240919$20240924$20240924$EXP$HR-HALMED-300086518$HR-TAKEDA-2024TUS093414$TAKEDA$$45$YR$$M$Y$$$20240924$$HP$HR$HR
243598541$24359854$1$I$$20240918$20240924$20240924$EXP$$US-BIOGEN-2024BI01283444$BIOGEN$$$$$F$Y$$$20240924$$CN$US$US
243598551$24359855$1$I$20240901$20240916$20240924$20240924$EXP$$US-JNJFOC-20240942218$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$HP$US$US
243598561$24359856$1$I$$20240920$20240924$20240924$EXP$$US-ABBVIE-5933705$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243598571$24359857$1$I$20240101$20240917$20240924$20240924$EXP$$US-ABBVIE-5928866$ABBVIE$$$$$F$Y$$$20240924$$CN$US$US
243598581$24359858$1$I$$20240918$20240924$20240924$EXP$$GB-ABBVIE-5933185$ABBVIE$$$$E$F$Y$$$20240924$$CN$GB$GB
243598591$24359859$1$I$$20240905$20240924$20240924$PER$$US-SA-2024SA273042$SANOFI AVENTIS$$$$T$M$Y$$$20240925$$MD$US$US
243598601$24359860$1$I$20240101$20240917$20240924$20240924$EXP$$CA-ABBVIE-5930605$ABBVIE$$34$YR$$F$Y$$$20240924$$CN$CA$CA
243598621$24359862$1$I$$20240919$20240924$20240924$EXP$$US-ABBVIE-5933516$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243598631$24359863$1$I$$20240917$20240924$20240924$EXP$$US-ABBVIE-5890465$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243598641$24359864$1$I$20240818$20240905$20240924$20240924$30DAY$$FR-JNJFOC-20240911148$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240925$$CN$FR$FR
243598661$24359866$1$I$$20240923$20240924$20240924$30DAY$$US-SANDOZ INC.-SDZ2024US082480$SANDOZ$$62$YR$$M$Y$$$20240924$$HP$US$US
243598671$24359867$1$I$20200220$20240917$20240924$20240924$EXP$$ES-CELLTRION INC.-2023ES010972$CELLTRION$$$$$$Y$$$20240925$$MD$ES$ES
243598681$24359868$1$I$$20240920$20240924$20240924$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151336$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240925$$CN$US$US
243598691$24359869$1$I$$20240912$20240924$20240924$PER$$US-SA-2024SA274712$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240925$$CN$US$US
243598701$24359870$1$I$20240816$20240917$20240924$20240924$EXP$$CA-TAKEDA-2024TUS093114$TAKEDA$$66$YR$$M$Y$$$20240924$$MD$CA$CA
243598711$24359871$1$I$$20240913$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409009607$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240924$$CN$US$US
243598721$24359872$1$I$20240301$20240919$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409012688$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240924$$CN$US$US
243598731$24359873$1$I$$20240920$20240924$20240924$PER$$US-ELI_LILLY_AND_COMPANY-US202409013783$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240924$$HP$US$US
243598741$24359874$1$I$20240301$20240918$20240924$20240924$PER$$US-SA-2024SA272526$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240925$$MD$US$US
243598751$24359875$1$I$$20240923$20240924$20240924$PER$$NVSC2024US189908$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
243598761$24359876$1$I$20240912$20240921$20240924$20240924$EXP$$PL-ABBVIE-5935532$ABBVIE$$76$YR$$M$Y$$$20240924$$HP$PL$PL
243598771$24359877$1$I$20240101$20240920$20240924$20240924$EXP$$CO-ABBVIE-5935603$ABBVIE$$$$$F$Y$$$20240924$$CN$CO$CO
243598781$24359878$1$I$$20240923$20240924$20240924$EXP$$US-ABBVIE-5935987$ABBVIE$$$$$F$Y$$$20240924$$HP$US$US
243598801$24359880$1$I$$20240910$20240924$20240924$EXP$$GB-CIPLA LTD.-2024GB10059$CIPLA$$$$$$Y$$$20240925$$HP$GB$GB
243598811$24359881$1$I$$20240910$20240924$20240924$EXP$$GB-CIPLA LTD.-2024GB10063$CIPLA$$$$$$Y$$$20240925$$HP$GB$GB
243598821$24359882$1$I$$20240918$20240924$20240924$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00266$AMNEAL$$$$$F$Y$$$20240925$$CN$US$US
243598831$24359883$1$I$$20240910$20240924$20240924$EXP$$GB-CIPLA LTD.-2024GB10039$CIPLA$$$$$$Y$$$20240925$$HP$GB$GB
243598841$24359884$1$I$$20240910$20240924$20240924$EXP$$GB-CIPLA LTD.-2024GB10062$CIPLA$$$$$$Y$$$20240925$$HP$GB$GB
243598851$24359885$1$I$20240409$20240919$20240924$20240924$EXP$$JP-GSK-JP2024JPN074500$GLAXOSMITHKLINE$$$$$$Y$$$20240924$$PH$JP$JP
243598861$24359886$1$I$20240101$20240904$20240924$20240924$PER$$US-SA-2024SA273139$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240925$$MD$US$US
243598871$24359887$1$I$$20240813$20240924$20240924$EXP$$US-ABBVIE-5936464$ABBVIE$Bragg K, Miller H, Buckshaw R, Simon LV, King C. Testosterone therapy as an isolated risk factor for venous thrombosis: a case report. Cureus. 2024;16(7):1-5.$3$DEC$$M$Y$$$20240924$$MD$US$US
243598881$24359888$1$I$20240717$20240718$20240924$20240924$PER$$US-CIPLA LTD.-2024US07948$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243598891$24359889$1$I$$20240718$20240924$20240924$PER$$US-CIPLA LTD.-2024US07910$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243598901$24359890$1$I$$20231010$20240924$20240924$PER$$US-CIPLA LTD.-2023US06482$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243598911$24359891$1$I$$20240729$20240924$20240924$PER$$US-CIPLA LTD.-2024US08351$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243598921$24359892$1$I$$20240723$20240924$20240924$PER$$US-CIPLA LTD.-2024US08092$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243598931$24359893$1$I$$20240918$20240924$20240924$EXP$$US-TAKEDA-2024TUS093390$TAKEDA$$24$YR$$M$Y$$$20240924$$CN$US$US
243598941$24359894$1$I$$20240918$20240924$20240924$EXP$$US-TAKEDA-2024TUS093742$TAKEDA$$30$YR$$M$Y$$$20240924$$CN$US$US
243598951$24359895$1$I$$20240918$20240924$20240924$PER$$US-SA-2024SA272632$SANOFI AVENTIS$$$$A$M$Y$$$20240925$$MD$US$US
243598971$24359897$1$I$20240101$20240919$20240924$20240924$EXP$$US-ABBVIE-5932756$ABBVIE$$$$$M$Y$$$20240924$$CN$US$US
243598981$24359898$1$I$20240722$20240923$20240924$20240924$EXP$FR-AFSSAPS-RS2024000884$FR-JNJFOC-20240963362$JOHNSON AND JOHNSON$$44$YR$A$M$Y$79$KG$20240925$$MD$FR$FR
243598991$24359899$1$I$$20240910$20240924$20240924$EXP$$GB-CIPLA LTD.-2024GB10042$CIPLA$$$$$$Y$$$20240925$$HP$GB$GB
243599011$24359901$1$I$$20240916$20240925$20240925$PER$$US-AMGEN-USASP2024187832$AMGEN$Suliman A.; Srinivasan A.; Li Y. et al.. Successful third transplant for recurrent leukemia after TLI-ATG conditioning and despite EBV-associated mixed donor chimerism. Human Immunology. 2024;85:33-34$14$YR$T$M$Y$$$20240924$$HP$US$US
243599021$24359902$1$I$$20240917$20240925$20240925$PER$$US-AMGEN-USASP2024189926$AMGEN$$60$YR$A$M$Y$$$20240924$$MD$US$US
243599031$24359903$1$I$$20240917$20240925$20240925$EXP$$US-AMGEN-USASP2024186778$AMGEN$Molmenti E.P.; Nair V.; Jandovitz N. et.al. COVID-19 in kidney transplant recipients. American Journal of Transplantation. 2020;20 (7):1819-1825$50$YR$A$M$Y$$$20240924$$HP$US$US
243599041$24359904$1$I$$20240917$20240925$20240925$EXP$$US-AMGEN-USASP2024186562$AMGEN$Narasimhan S.; Galetta K.M.; Castillo J.J. et al.. Paraneoplastic myelitis associated with Waldenstrom macroglobulinemia responsive to treatment with ibrutinib - venetoclax: A case report. eNeurologicaISci. 2024;37:1-4$68$YR$E$M$Y$$$20240924$$HP$US$US
243599051$24359905$1$I$$20240918$20240925$20240925$EXP$$US-AZURITY PHARMACEUTICALS, INC.-AZR202409-000679$AZURITY PHARMACEUTICALS$$$$$F$Y$$$20240924$$CN$US$US
243599061$24359906$1$I$$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151314$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240925$$CN$US$US
243599071$24359907$1$I$$20240921$20240925$20240925$PER$$NVSC2024US190115$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
243599081$24359908$1$I$$20240918$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149228$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240925$$MD$US$US
243599091$24359909$1$I$$20230907$20240925$20240925$PER$$US-CIPLA LTD.-2023US05493$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243599101$24359910$1$I$$20240919$20240925$20240925$EXP$$DE-ABBVIE-5933447$ABBVIE$$$$E$M$Y$$$20240925$$HP$DE$DE
243599111$24359911$1$I$20240101$20240920$20240925$20240925$EXP$$US-ABBVIE-5933664$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243599121$24359912$1$I$20240101$20240920$20240925$20240925$EXP$$US-ABBVIE-5933603$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243599131$24359913$1$I$20221204$20240918$20240925$20240925$EXP$$KR-AMGEN-KORSP2024187244$AMGEN$Lee E.; Choi W. J.; Lee J. et al.. Outcomes of hematopoietic stem cell transplantation in patients with SARS-CoV-2 infection during the Omicron era. International Journal of Infectious Diseases. 2024;147:1-4$40$YR$A$M$Y$$$20240924$$HP$KR$KR
243599142$24359914$2$F$20240824$20240925$20240925$20240926$PER$$US-AMGEN-USASP2024190237$AMGEN$$67$YR$E$F$Y$$$20240926$$CN$US$US
243599151$24359915$1$I$$20240916$20240925$20240925$PER$$US-AMGEN-USASP2024187653$AMGEN$Park D. J.; Harary P. M.; Hori Y. S. et al.. KEAP1-mutant atypical meningioma: illustrative case. Journal of neurosurgery Case lessons. 2024;8(11):1-7$40$YR$A$F$Y$$$20240924$$HP$US$US
243599161$24359916$1$I$$20240919$20240925$20240925$PER$$US-AMGEN-USASP2024189006$AMGEN$Fowler N.; Benningfield M.; Vyas A. et al.. Foveal eversion as a prognostic biomarker for eyes with macular edema. Investigative Ophthalmology + Visual Science. 2024;65 (9):PB0067$$$$$Y$$$20240924$$HP$US$US
243599171$24359917$1$I$$20240918$20240925$20240925$EXP$$US-ENDO USA, INC.-2024-003498$ENDO$$$$$F$Y$$$20240925$$CN$US$US
243599181$24359918$1$I$$20231018$20240925$20240925$PER$$US-CIPLA LTD.-2023US06767$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243599192$24359919$2$F$$20240925$20240925$20240926$PER$$US-AMGEN-USASP2024188651$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243599201$24359920$1$I$$20240923$20240925$20240925$EXP$$US-ABBVIE-5936258$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243599211$24359921$1$I$$20240919$20240925$20240925$PER$$US-ABBVIE-5932684$ABBVIE$$$$$F$Y$$$20240925$$HP$US$US
243599221$24359922$1$I$$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151389$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240925$$CN$US$US
243599231$24359923$1$I$20240912$20240918$20240925$20240925$EXP$$CN-SA-2024SA272507$SANOFI AVENTIS$$74$YR$E$F$Y$65$KG$20240925$$HP$CN$CN
243599241$24359924$1$I$20240813$20240905$20240925$20240925$30DAY$$BR-JNJFOC-20240918045$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$BR$BR
243599251$24359925$1$I$$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093288$TAKEDA$$$$$F$Y$69.66$KG$20240925$$MD$US$US
243599261$24359926$1$I$20230310$20240916$20240925$20240925$EXP$DE-PEI-CADR2023319233$DE-CELLTRION INC.-2024DE022386$CELLTRION$$$$$$Y$$$20240925$$CN$DE$DE
243599271$24359927$1$I$$20240903$20240925$20240925$PER$$US-SA-2024SA273273$SANOFI AVENTIS$$$$A$M$Y$$$20240925$$MD$US$US
243599281$24359928$1$I$20240909$20240918$20240925$20240925$EXP$GB-MHRA-MED-202409181137080160-CZTLG$GB-GSK-GB2024115939$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$GB$GB
243599291$24359929$1$I$20240801$20240919$20240925$20240925$EXP$$PR-ABBVIE-5924018$ABBVIE$$70$YR$$M$Y$77$KG$20240925$$CN$PR$PR
243599301$24359930$1$I$20240916$20240917$20240925$20240925$PER$$US-AMGEN-USASP2024185785$AMGEN$$$$$F$Y$$$20240924$$HP$US$US
243599311$24359931$1$I$$20240917$20240925$20240925$PER$$US-VIIV HEALTHCARE LIMITED-US2024115550$VIIV$$$$$M$Y$$$20240925$$CN$US$US
243599321$24359932$1$I$20230101$20240807$20240925$20240925$PER$$US-CIPLA LTD.-2024US07952$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243599331$24359933$1$I$20240913$20240920$20240925$20240925$EXP$FR-AFSSAPS-RS2024000886$FR-JNJFOC-20240964140$JOHNSON AND JOHNSON$$10$YR$C$M$Y$31.1$KG$20240925$$MD$FR$FR
243599341$24359934$1$I$$20240919$20240925$20240925$EXP$$CO-ABBVIE-5935221$ABBVIE$$$$$M$Y$69$KG$20240925$$HP$CO$CO
243599351$24359935$1$I$20240901$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012865$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240925$$CN$US$US
243599361$24359936$1$I$$20240902$20240925$20240925$EXP$$GB-SA-2024SA270950$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240925$$CN$GB$GB
243599381$24359938$1$I$20240812$20240904$20240925$20240925$PER$$US-SA-2024SA272717$SANOFI AVENTIS$$86$YR$E$$Y$$$20240925$$CN$US$US
243599391$24359939$1$I$$20240911$20240925$20240925$PER$$US-SA-2024SA274357$SANOFI AVENTIS$$20$YR$A$F$Y$54.43$KG$20240925$$CN$US$US
243599401$24359940$1$I$$20240920$20240925$20240925$EXP$$US-ABBVIE-5933260$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243599412$24359941$2$F$20240921$20240923$20240925$20240926$EXP$$GB-ABBVIE-5936062$ABBVIE$$79$YR$$M$Y$$$20240926$$HP$GB$GB
243599422$24359942$2$F$$20240923$20240925$20240928$EXP$$GB-ABBVIE-5933575$ABBVIE$$$$A$F$Y$$$20240928$$CN$GB$GB
243599431$24359943$1$I$20231201$20240923$20240925$20240925$EXP$$US-ABBVIE-5936139$ABBVIE$$89$YR$$M$Y$$$20240925$$CN$US$US
243599441$24359944$1$I$20240801$20240923$20240925$20240925$EXP$$US-ABBVIE-5936668$ABBVIE$$86$YR$$F$Y$$$20240925$$CN$US$US
243599451$24359945$1$I$20240815$20240822$20240925$20240925$EXP$$CA-ABBVIE-5935669$ABBVIE$$79$YR$$M$Y$$$20240925$$MD$CA$CA
243599461$24359946$1$I$$20240916$20240925$20240925$EXP$$TR-AMGEN-TURSP2024187020$AMGEN$Yavuz S.; Erol M. K.; Kucuk M. F. et al.. Do intravitreal anti-VEGF injections have an effect on corneal endothelial remodeling in children with premature retinopathy. European journal of ophthalmology. 2024;34 (5):1393-1399$$$$$Y$$$20240924$$HP$TR$TR
243599471$24359947$1$I$20240908$20240920$20240925$20240925$EXP$$US-GILEAD-2024-0688624$GILEAD$$49$YR$A$M$Y$$$20240924$$CN$US$US
243599481$24359948$1$I$$20240920$20240925$20240925$EXP$$AU-ABBVIE-5935757$ABBVIE$$$$$M$Y$$$20240925$$CN$AU$AU
243599491$24359949$1$I$$20240910$20240925$20240925$30DAY$$GB-JNJFOC-20240930412$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240925$$HP$GB$GB
243599511$24359951$1$I$$20240918$20240925$20240925$PER$$US-VIIV HEALTHCARE LIMITED-US2024116122$VIIV$$$$$$Y$$$20240925$$HP$US$US
243599521$24359952$1$I$20240801$20240916$20240925$20240925$PER$$US-VIIV HEALTHCARE LIMITED-US2024115439$VIIV$$39$YR$$M$Y$$$20240925$$CN$US$US
243599541$24359954$1$I$20240101$20240829$20240925$20240925$PER$$US-SA-2024SA268949$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240925$$MD$US$US
243599551$24359955$1$I$20231025$20240918$20240925$20240925$EXP$$RU-ABBVIE-5932426$ABBVIE$$5$YR$$F$Y$19$KG$20240925$$MD$RU$RU
243599561$24359956$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012202$STRIDES$Zhang Z, Zhu Y, Wang Z, Zeng Z, Wen L, Zhang L, et al.. Case Report: A novel FGFR1 fusion in acute B-lymphoblastic leukemia identified by RNA sequencing.. Front-Oncol. 2023;13$28$YR$$M$Y$$$20240925$$HP$CN$CN
243599571$24359957$1$I$20240910$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151640$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240925$$CN$US$US
243599581$24359958$1$I$$20240917$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149571$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240925$$CN$US$US
243599591$24359959$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150703$BRISTOL MYERS SQUIBB$$95$YR$E$F$Y$$$20240925$$CN$US$US
243599601$24359960$1$I$20240923$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151617$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240925$$CN$US$US
243599611$24359961$1$I$20240601$20240918$20240925$20240925$EXP$$IL-ABBVIE-5831345$ABBVIE$$$$$F$Y$$$20240925$$CN$IL$IL
243599621$24359962$1$I$20240922$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189857$AMGEN$$66$YR$E$M$Y$$$20240924$$CN$US$US
243599631$24359963$1$I$20240601$20240918$20240925$20240925$EXP$$EG-SANDOZ INC.-SDZ2024EG082390$SANDOZ$$26$YR$$F$Y$78$KG$20240925$$CN$EG$EG
243599641$24359964$1$I$$20240917$20240925$20240925$EXP$$US-SANDOZ INC.-SDZ2024US082538$SANDOZ$$$$$$Y$$$20240925$$PH$US$US
243599671$24359967$1$I$$20240918$20240925$20240925$EXP$$US-ABBVIE-5930980$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243599681$24359968$1$I$$20240920$20240925$20240925$EXP$$US-TAKEDA-2022TUS016458$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
243599691$24359969$1$I$$20240915$20240925$20240925$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000331$EMCURE$Kim O, Sergi Z, Yu G, Yamamoto K, Quezado M, Abdullaev Z et;al. A patient-derived cell model for malignant transformation in IDH-mutant glioma. Acta neuropathologica communications. 2024;12(1):148$$$$F$Y$$$20240925$$HP$US$US
243599701$24359970$1$I$20240915$20240916$20240925$20240925$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000330$EMCURE$$$$$$Y$$$20240925$$CN$US$US
243599711$24359971$1$I$$20240916$20240925$20240925$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP012189$STRIDES$Prakash S, Patel H, Shah CS.. Medication-overuse headache overlapping with serotonin syndrome.. BMJ-Case-Rep. 2024;17(1)$$$A$F$Y$$$20240925$$MD$IN$IN
243599721$24359972$1$I$$20240915$20240925$20240925$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000332$EMCURE$Racharla L, Gitzel L, Joseph M, Guthier D, Hawwa N.. Ivabradine and Milrinone-Bridge to Recovery in New HFrEF With Low-Output Heart Failure.. Case Reports in Cardiology. 2024;2024:5278240$44$YR$$M$Y$$$20240925$$HP$US$US
243599731$24359973$1$I$20231101$20240919$20240925$20240925$EXP$$US-ABBVIE-5932347$ABBVIE$$21$YR$$F$Y$$$20240925$$CN$US$US
243599741$24359974$1$I$20240301$20240919$20240925$20240925$EXP$$US-ABBVIE-5915463$ABBVIE$$69$YR$$M$Y$$$20240925$$CN$US$US
243599751$24359975$1$I$20240501$20240919$20240925$20240925$EXP$$US-ABBVIE-5807968$ABBVIE$$87$YR$$M$Y$87$KG$20240925$$CN$US$US
243599761$24359976$1$I$20240912$20240923$20240925$20240925$PER$$US-ROCHE-10000089609$ROCHE$$57$YR$A$F$Y$$$20240925$$CN$US$US
243599771$24359977$1$I$$20240920$20240925$20240925$EXP$$US-CHATTEMPRD-2024OHG033019$CHATTEM$$$$$F$Y$$$20240925$$LW$US$US
243599781$24359978$1$I$$20240917$20240925$20240925$EXP$$US-AVET LIFESCIENCES LTD-2024-AVET-000336$EMCURE$Henson JC, Morehead L, Hagood J, Wijewardane N, Paydak H. Oral theophylline corrects sinus node dysfunction in acute on chronic lithium toxicity: case report and systematic review of lithium-induced Sinus node dysfunction. Frontiers in cardiovascular medicines. 2024;11:1412376$73$YR$$F$Y$$$20240925$$HP$US$US
243599801$24359980$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012278$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$60$YR$$F$Y$63.4$KG$20240925$$HP$CN$CN
243599811$24359981$1$I$$20240919$20240925$20240925$EXP$$HR-JAZZ PHARMACEUTICALS-2024-HR-015906$JAZZ$$$$$$Y$$$20240924$$HP$HR$HR
243599821$24359982$1$I$$20240919$20240925$20240925$EXP$$CA-GILEAD-2024-0688605$GILEAD$$77$YR$E$F$Y$$$20240924$$CN$CA$CA
243599831$24359983$1$I$20240706$20240918$20240925$20240925$EXP$$AT-ABBVIE-5838020$ABBVIE$$62$YR$$M$Y$$$20240925$$CN$AT$AT
243599852$24359985$2$F$20240905$20240905$20240925$20240930$30DAY$$US-JNJFOC-20240911833$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240930$$CN$US$US
243599861$24359986$1$I$20240101$20240916$20240925$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-027719$UNITED THERAPEUTICS$$$$$F$Y$39.909$KG$20240925$$$US$US
243599871$24359987$1$I$$20240904$20240925$20240925$PER$$US-SA-2024SA274471$SANOFI AVENTIS$$$$A$M$Y$$$20240925$$MD$US$US
243599882$24359988$2$F$20240924$20240927$20240925$20240930$EXP$$JP-JNJFOC-20240963549$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20241001$$PH$JP$JP
243599891$24359989$1$I$20230101$20240919$20240925$20240925$EXP$$US-ABBVIE-5932630$ABBVIE$$84$YR$$F$Y$$$20240925$$CN$US$US
243599921$24359992$1$I$$20240915$20240925$20240925$EXP$$US-CATALENT PHARMA SOLUTIONS-CAT-001385-2024$CATALENT PHARMA$Nesiama E Mirembe L Weber K Isaac S Trammell D Obokhare I.Massive Gastrointestinal Bleeding Related to NSAID Use in a Patient with Ileorectal Anastomosis.Case Reports in Surgery.30-AUG-2024;2024:4619458$52$YR$A$F$Y$$$20240925$$HP$US$US
243599931$24359993$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272706$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240925$$MD$US$US
243599941$24359994$1$I$$20240906$20240925$20240925$PER$$US-SA-2024SA273292$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240925$$CN$US$US
243599951$24359995$1$I$20240101$20240830$20240925$20240925$PER$$US-SA-2024SA271408$SANOFI AVENTIS$$57$YR$A$M$Y$125$KG$20240925$$MD$US$US
243599961$24359996$1$I$20240801$20240917$20240925$20240925$PER$$US-SA-2024SA271430$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240925$$MD$US$US
243599971$24359997$1$I$$20240913$20240925$20240925$30DAY$$GB-SANDOZ INC.-NVSC2021GB047707$SANDOZ$$$$$M$Y$$$20240925$$CN$GB$GB
243599981$24359998$1$I$$20240919$20240925$20240925$EXP$$KR-NOVITIUMPHARMA-2024KRNVP01994$NOVITIUM PHARMA$S. Lee.Management of newborns and healthcare workers exposed to isoniazid-resistant congenital tuberculosis in the neonatal intensive care unit.Journal of Hospital Infection.01-MAR-2024;147:40-46$$$N$M$Y$$$20240925$$HP$KR$KR
243599991$24359999$1$I$20240911$20240912$20240925$20240925$30DAY$$JP-JNJFOC-20240949497$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$PH$JP$JP
243600001$24360000$1$I$20240829$20240919$20240925$20240925$EXP$$US-ABBVIE-5935751$ABBVIE$$88$YR$$M$Y$$$20240925$$MD$US$US
243600011$24360001$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150966$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$$$20240925$$HP$US$US
243600021$24360002$1$I$$20240918$20240925$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029696$UNITED THERAPEUTICS$$$$$F$Y$53.515$KG$20240925$$$US$US
243600031$24360003$1$I$$20240919$20240925$20240925$EXP$$US-AMGEN-USASP2024187879$AMGEN$$42$YR$A$M$Y$$$20240924$$HP$US$US
243600041$24360004$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012280$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$77$YR$$M$Y$79.7$KG$20240925$$HP$CN$CN
243600051$24360005$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA271784$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240925$$MD$US$US
243600061$24360006$1$I$20240922$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189828$AMGEN$$62$YR$A$F$Y$$$20240924$$CN$US$US
243600072$24360007$2$F$20211201$20240925$20240925$20240930$EXP$$US-ABBVIE-5933559$ABBVIE$$72$YR$$F$Y$73$KG$20240930$$HP$US$US
243600081$24360008$1$I$$20240917$20240925$20240925$EXP$$US-AMGEN-USASP2024186804$AMGEN$Molmenti E.P.; Nair V.; Jandovitz N. et.al.. COVID-19 in kidney transplant recipients. American Journal of Transplantation. 2020;20 (7):1819-1825$30$YR$A$F$Y$$$20240924$$HP$US$US
243600091$24360009$1$I$$20240913$20240925$20240925$EXP$$US-ABBVIE-5927906$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243600101$24360010$1$I$20240101$20240711$20240925$20240925$PER$$US-IMP-2024000497$Harrow Health$$76$YR$E$F$Y$$$20240925$$CN$US$US
243600111$24360011$1$I$20240101$20240919$20240925$20240925$EXP$$US-ABBVIE-5933980$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243600121$24360012$1$I$20240917$20240918$20240925$20240925$EXP$$US-ABBVIE-5931557$ABBVIE$$83$YR$$F$Y$$$20240925$$CN$US$US
243600131$24360013$1$I$20240704$20240913$20240925$20240925$EXP$SE-SEMPA-2024-006564$SE-Accord-447234$ACCORD$$70$YR$E$F$Y$$$20240925$$MD$SE$SE
243600141$24360014$1$I$$20240919$20240925$20240925$EXP$$US-ABBVIE-5933593$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243600151$24360015$1$I$$20240910$20240925$20240925$EXP$$GB-CIPLA LTD.-2024GB10064$CIPLA$$$$$$Y$$$20240925$$HP$GB$GB
243600161$24360016$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013612$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243600171$24360017$1$I$$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013383$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240925$$CN$US$US
243600181$24360018$1$I$20240801$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014724$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240925$$CN$US$US
243600191$24360019$1$I$$20240917$20240925$20240925$EXP$$IE-CELLTRION INC.-2024IE022505$CELLTRION$$$$$$Y$$$20240925$$CN$IE$IE
243600201$24360020$1$I$20240101$20240905$20240925$20240925$EXP$$US-SA-2024SA273890$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240925$$MD$US$US
243600211$24360021$1$I$$20230913$20240925$20240925$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-407412$RANBAXY$$$$$$Y$$$20240925$$HP$US$US
243600221$24360022$1$I$$20240919$20240925$20240925$PER$$US-AMGEN-USASP2024188710$AMGEN$$$$$F$Y$$$20240924$$CN$US$US
243600231$24360023$1$I$20240922$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189564$AMGEN$$55$YR$A$M$Y$$$20240924$$CN$US$US
243600241$24360024$1$I$$20240917$20240925$20240925$EXP$$MY-Umedica-000106$UMEDICA LABS$Zakaria ER, Wan Ghazali WS, Sazali H, Shahril NS, Md Salleh S, Mohd Nawi SN. Acrocyanosis as a rare presentation of drug-induced cutaneous vasculitis: a case report. BMC Rheumatol. 2024 Sep 10;8(1):41. doi: 10.1186/s41927-024-00413-7. PMID: 39256797; PMCID: PMC11384702.$68$YR$$M$Y$$$20240924$$MD$MY$
243600251$24360025$1$I$$20240916$20240925$20240925$EXP$$CN-Bion-013873$BIONPHARMA$$$$N$F$Y$$$20240925$$HP$CN$CN
243600261$24360026$1$I$$20240916$20240925$20240925$EXP$$CN-Bion-013882$BIONPHARMA$$$$N$M$Y$$$20240925$$HP$CN$CN
243600271$24360027$1$I$$20240916$20240925$20240925$EXP$$CN-Bion-013883$BIONPHARMA$$$$N$M$Y$$$20240925$$HP$CN$CN
243600281$24360028$1$I$20240101$20240918$20240925$20240925$EXP$$US-BIOGEN-2024BI01280986$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243600291$24360029$1$I$$20240918$20240925$20240925$EXP$$US-BIOGEN-2024BI01283392$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243600301$24360030$1$I$20230222$20240917$20240925$20240925$EXP$FR-AFSSAPS-DJ2023000705$FR-CELLTRION INC.-2024FR022511$CELLTRION$$$$$$Y$$$20240925$$MD$FR$FR
243600311$24360031$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA272330$SANOFI AVENTIS$$$$$F$Y$$$20240925$$CN$US$US
243600321$24360032$1$I$$20240916$20240925$20240925$PER$$US-SA-2024SA270088$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240925$$HP$US$US
243600342$24360034$2$F$20240918$20240925$20240925$20240926$PER$$US-AMGEN-USASP2024190200$AMGEN$$71$YR$E$M$Y$$$20240926$$CN$US$US
243600351$24360035$1$I$20240922$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189567$AMGEN$$50$YR$A$F$Y$$$20240924$$HP$US$US
243600361$24360036$1$I$$20240917$20240925$20240925$EXP$$US-GSK-US2024116190$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
243600371$24360037$1$I$20240301$20240918$20240925$20240925$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052375$BOEHRINGER INGELHEIM$$69$YR$E$F$Y$$$20240925$$MD$PL$PL
243600381$24360038$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012284$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$72$YR$$F$Y$68$KG$20240925$$HP$CN$CN
243600391$24360039$1$I$$20240919$20240925$20240925$EXP$$AU-TAKEDA-2024TUS094626$TAKEDA$$$$$M$Y$$$20240925$$CN$GB$AU
243600401$24360040$1$I$20240919$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024188870$AMGEN$$$$$$Y$$$20240924$$HP$US$US
243600411$24360041$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012294$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$72$YR$$F$Y$69$KG$20240925$$HP$CN$CN
243600421$24360042$1$I$$20240906$20240925$20240925$PER$$US-SA-2024SA273751$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240925$$CN$US$US
243600431$24360043$1$I$20240915$20240918$20240925$20240925$PER$$US-SA-2024SA270751$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240925$$HP$US$US
243600441$24360044$1$I$$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024188813$AMGEN$$$$$$Y$$$20240924$$PH$US$US
243600451$24360045$1$I$20240902$20240909$20240925$20240925$PER$$US-SA-2024SA275943$SANOFI AVENTIS$$34$YR$A$M$Y$129.55$KG$20240925$$MD$US$US
243600461$24360046$1$I$20240918$20240919$20240925$20240925$PER$$US-GSK-US2024116641$GLAXOSMITHKLINE$$19$YR$$M$Y$$$20240925$$CN$US$US
243600481$24360048$1$I$20240101$20240917$20240925$20240925$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000811$DECIPHERA PHARMACEUTICALS$$65$YR$A$F$Y$60.9$KG$20240925$$PH$US$US
243600501$24360050$1$I$$20240923$20240925$20240925$PER$$US-ABBVIE-5936267$ABBVIE$$$$$$Y$$$20240925$$HP$US$US
243600511$24360051$1$I$20200101$20240919$20240925$20240925$PER$$US-ABBVIE-5931811$ABBVIE$$$$$F$Y$104.32$KG$20240925$$CN$US$US
243600531$24360053$1$I$$20240923$20240925$20240925$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053076$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240925$$CN$US$US
243600541$24360054$1$I$$20240918$20240925$20240925$EXP$$JP-SANDOZ INC.-SDZ2024JP081009$SANDOZ$$$$$$Y$$$20240925$$PH$JP$JP
243600551$24360055$1$I$$20240911$20240925$20240925$EXP$DE-BFARM-24006127$DE-MSNLABS-2024MSNSPO02020$MSN LABORATORIES$$$$$$Y$$$20240925$$MD$DE$DE
243600571$24360057$1$I$20240826$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014793$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240925$$CN$US$US
243600591$24360059$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013768$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240925$$CN$US$US
243600601$24360060$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013506$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240925$$CN$US$US
243600611$24360061$1$I$$20240630$20240925$20240925$PER$$US-ROCHE-10000016671$ROCHE$$$$$$Y$$$20240925$$CN$US$US
243600621$24360062$1$I$$20240916$20240925$20240925$EXP$$ES-ROCHE-10000090273$ROCHE$Pereiro P, Munoz-Vendrell A, Lejarreta S, Vicens-Zygmunt V, Leon S, Laura B, et al. Organizing pneumonia following SARS-CoV2 infection in patients with multiple sclerosis treated with ocrelizumab: a case series [Abstract number: P1650/2448]. Multiple Sclerosis Journal. 2024;30 (3 (SUP)):1044-5.$$$A$M$Y$$$20240925$$HP$ES$ES
243600631$24360063$1$I$$20240916$20240925$20240925$EXP$$ES-ROCHE-10000088139$ROCHE$Pereiro P, Munoz-Vendrell A, Lejarreta S, Vicens-Zygmunt V, Leon S, Laura B, et al. Organizing pneumonia following SARS-CoV2 infection in patients with multiple sclerosis treated with ocrelizumab: a case series [Abstract number: P1650/2448]. Multiple Sclerosis Journal. 2024;30 (3 (SUP)):1044-5.$$$A$F$Y$$$20240925$$HP$ES$ES
243600641$24360064$1$I$$20240919$20240925$20240925$PER$$US-ROCHE-10000087068$ROCHE$$$$$$Y$$$20240925$$HP$US$US
243600661$24360066$1$I$$20240919$20240925$20240925$PER$$US-ROCHE-10000087067$ROCHE$$$$$$Y$$$20240925$$CN$US$US
243600671$24360067$1$I$$20240916$20240925$20240925$EXP$$ES-ROCHE-10000087943$ROCHE$Moral A, Rocio LR J. Efficacy and security of ocrelizumab in patients with primary progressive multiple sclerosis (ppms) in a tertiary care hospital multiple sclerosis unit (Abstract:P1765/1483). Multiple sclerosis journal. 2024;3S (30):1113.$$$$$Y$$$20240925$$HP$ES$ES
243600681$24360068$1$I$$20240923$20240925$20240925$EXP$$US-PFIZER INC-202400261940$PFIZER$$77$YR$$M$Y$$$20240925$$CN$US$US
243600691$24360069$1$I$$20240916$20240925$20240925$EXP$$ES-ROCHE-10000090272$ROCHE$Pereiro P, Munoz-Vendrell A, Lejarreta S, Vicens-Zygmunt V, Leon S, Laura B, et al. Organizing pneumonia following SARS-CoV2 infection in patients with multiple sclerosis treated with ocrelizumab: a case series [Abstract number: P1650/2448]. Multiple Sclerosis Journal. 2024;30 (3 (SUP)):1044-5.$$$A$F$Y$$$20240925$$HP$ES$ES
243600701$24360070$1$I$20221201$20240919$20240925$20240925$EXP$$US-ROCHE-10000087681$ROCHE$$47$YR$A$M$Y$102.05$KG$20240925$$CN$US$US
243600711$24360071$1$I$$20240923$20240925$20240925$EXP$$CO-PFIZER INC-202400261920$PFIZER$$$$$M$Y$$$20240925$$MD$CO$CO
243600721$24360072$1$I$$20240920$20240925$20240925$EXP$$US-PFIZER INC-202400260759$PFIZER$$79$YR$$M$Y$$$20240925$$CN$US$US
243600731$24360073$1$I$$20240918$20240925$20240925$EXP$$CA-PFIZER INC-202300442944$PFIZER$$30$YR$$M$Y$$$20240925$$MD$CA$CA
243600741$24360074$1$I$20240101$20240920$20240925$20240925$EXP$$US-PFIZER INC-202400261056$PFIZER$$72$YR$$F$Y$$$20240925$$HP$US$US
243600751$24360075$1$I$20240914$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151510$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240925$$CN$US$US
243600761$24360076$1$I$20240101$20240913$20240925$20240925$EXP$SE-SEMPA-2024-006457$SE-Accord-447352$ACCORD$$$$$F$Y$$$20240925$$CN$SE$SE
243600771$24360077$1$I$20240913$20240916$20240925$20240925$EXP$$US-BIOGEN-2024BI01283513$BIOGEN$$32$YR$$F$Y$$$20240925$$CN$US$US
243600781$24360078$1$I$20240801$20240918$20240925$20240925$PER$$US-SA-2024SA270712$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240925$$HP$US$US
243600791$24360079$1$I$20240901$20240917$20240925$20240925$PER$$US-SA-2024SA270100$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240925$$HP$US$US
243600802$24360080$2$F$20240803$20240916$20240925$20240930$PER$$US-SA-2024SA272878$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240930$$CN$US$US
243600811$24360081$1$I$$20240913$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046004$AUROBINDO$$$$$M$Y$$$20240925$$CN$GB$GB
243600821$24360082$1$I$20240901$20240917$20240925$20240925$PER$$US-SA-2024SA271036$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240925$$MD$US$US
243600831$24360083$1$I$$20240916$20240925$20240925$PER$$US-SA-2024SA268353$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240925$$CN$US$US
243600841$24360084$1$I$$20240918$20240925$20240925$PER$$US-AMGEN-USASP2024188695$AMGEN$$$$$$Y$$$20240924$$CN$US$US
243600851$24360085$1$I$$20240918$20240925$20240925$EXP$$JP-SANDOZ INC.-SDZ2024JP081337$SANDOZ$Nakagawa S, Kobayashi K, Naruse S, Kawashima S, Mimuro S, Nakajima Y. A case of labor epidural analgesia for a patient with suspected lidocaine allergy. The 22nd Annual Meeting of the Tokai-Hokuriku Branch of the Japanese Society of. 2024;P15-05$3$DEC$$F$Y$$$20240925$$MD$JP$JP
243600861$24360086$1$I$$20240904$20240925$20240925$PER$$US-SA-2024SA273742$SANOFI AVENTIS$$42$YR$A$M$Y$83.9$KG$20240925$$MD$US$US
243600871$24360087$1$I$$20240923$20240925$20240925$EXP$GB-MHRA-MED-202409231111127210-SFDKN$GB-TAKEDA-2024TUS094338$TAKEDA$$41$YR$$F$Y$$$20240925$$HP$GB$GB
243600881$24360088$1$I$$20240916$20240925$20240925$PER$$US-ASTELLAS-2024-AER-007289$ASTELLAS$$$$$M$Y$$$20240925$$HP$US$US
243600891$24360089$1$I$$20240917$20240925$20240925$EXP$$US-SANDOZ INC.-SDZ2024US082582$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
243600901$24360090$1$I$$20240910$20240925$20240925$PER$$CA-TOLMAR, INC.-24CA052170$TOLMAR$$$$$M$Y$$$20240925$$CN$CA$CA
243600911$24360091$1$I$20240422$20240911$20240925$20240925$EXP$$GB-MSNLABS-2024MSNSPO02032$MSN LABORATORIES$$$$$$Y$$$20240925$$PH$GB$GB
243600921$24360092$1$I$20240101$20240910$20240925$20240925$PER$$CA-TOLMAR, INC.-24CA052283$TOLMAR$$$$$M$Y$$$20240925$$CN$CA$CA
243600931$24360093$1$I$20240901$20240910$20240925$20240925$PER$$CA-TOLMAR, INC.-24CA052347$TOLMAR$$79$YR$$M$Y$$$20240925$$CN$CA$CA
243600941$24360094$1$I$$20240910$20240925$20240925$PER$$CA-TOLMAR, INC.-24CA052516$TOLMAR$$$$$M$Y$$$20240925$$CN$CA$CA
243600961$24360096$1$I$20240910$20240910$20240925$20240925$PER$$CA-TOLMAR, INC.-24CA052559$TOLMAR$$74$YR$$M$Y$$$20240925$$CN$CA$CA
243600981$24360098$1$I$$20240826$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032949$CHATTEM$$$$A$M$Y$$$20240925$$CN$US$US
243600991$24360099$1$I$$20240917$20240925$20240925$EXP$GB-MHRA-MIDB-3c878ed0-5fd9-4b44-ae2d-19eae366651c$GB-CELLTRION INC.-2024GB022574$CELLTRION$$$$$$Y$$$20240925$$PH$GB$GB
243601001$24360100$1$I$$20240827$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032950$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243601011$24360101$1$I$$20240913$20240925$20240925$EXP$$DE-Accord-447699$ACCORD$Riedhammer C, Dull J, Kestler C, Kadel S, Franz F, Weis P, et al. Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma. Annals of Hematology. 2024 Apr;103(4): 1327-1332.$59$YR$A$M$Y$$$20240925$$HP$DE$DE
243601021$24360102$1$I$20240807$20240904$20240925$20240925$PER$$US-JNJFOC-20240912722$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$US$US
243601031$24360103$1$I$$20240918$20240925$20240925$EXP$$BE-JNJFOC-20240957419$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$MD$BE$BE
243601041$24360104$1$I$$20240910$20240925$20240925$PER$$US-ASTELLAS-2024-AER-008516$ASTELLAS$$$$$F$Y$$$20240925$$HP$US$US
243601051$24360105$1$I$$20240911$20240925$20240925$EXP$GB-MHRA-MED-202409101642449390-TPHCK$GB-MSNLABS-2024MSNSPO02035$MSN LABORATORIES$$$$$$Y$$$20240925$$CN$GB$GB
243601061$24360106$1$I$20240919$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189779$AMGEN$$$$$M$Y$$$20240924$$CN$US$US
243601072$24360107$2$F$$20240829$20240925$20240930$PER$$US-CHATTEMPRD-2024OHG032954$CHATTEM$$$$A$F$Y$$$20240930$$CN$US$US
243601091$24360109$1$I$20240830$20240923$20240925$20240925$PER$$NVSC2024US190126$NOVARTIS$$70$YR$$M$Y$108.6$KG$20240925$$CN$US$US
243601101$24360110$1$I$$20240916$20240925$20240925$EXP$$US-TEVA-VS-3245985$TEVA$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.; Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.$53$YR$$M$Y$$$20240925$$MD$US$US
243601111$24360111$1$I$20240910$20240912$20240925$20240925$EXP$$CN-JNJFOC-20240935028$JOHNSON AND JOHNSON$$39$YR$A$F$Y$60.3$KG$20240925$$HP$CN$CN
243601121$24360112$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150506$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240925$$HP$US$US
243601141$24360114$1$I$$20240829$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032849$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243601151$24360115$1$I$$20240912$20240925$20240925$EXP$GB-MHRA-MED-202409111408560500-SGTCZ$GB-MSNLABS-2024MSNSPO02050$MSN LABORATORIES$$$$$$Y$$$20240925$$PH$GB$GB
243601161$24360116$1$I$20240917$20240923$20240925$20240925$PER$$NVSC2024US190208$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
243601171$24360117$1$I$$20240912$20240925$20240925$EXP$$JP-AMGEN-JPNSP2024187858$AMGEN$$$$$$Y$$$20240924$$MD$JP$JP
243601191$24360119$1$I$$20240829$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032872$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243601201$24360120$1$I$$20240918$20240925$20240925$EXP$$US-AMGEN-USASP2024187684$AMGEN$Fountzilas C.; Boland P. M.; Mukherjee S. et al.. TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial. British Journal of Cancer. 2024;1-8$$$$$Y$$$20240924$$HP$US$US
243601211$24360121$1$I$$20240919$20240925$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA081610$SANDOZ$$79$YR$$F$Y$$$20240925$$HP$CA$CA
243601221$24360122$1$I$20191125$20240912$20240925$20240925$EXP$GB-MHRA-MED-202409120729514340-FMSJY$GB-MSNLABS-2024MSNSPO02051$MSN LABORATORIES$$$$$$Y$$$20240925$$CN$GB$GB
243601231$24360123$1$I$$20240830$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032882$CHATTEM$$$$A$M$Y$$$20240925$$CN$US$US
243601241$24360124$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244546$TEVA$$$$$F$Y$$$20240925$$MD$CA$CA
243601251$24360125$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244794$TEVA$$68$YR$$M$Y$$$20240925$$HP$CA$CA
243601261$24360126$1$I$$20240830$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032972$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243601271$24360127$1$I$$20240830$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032892$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243601281$24360128$1$I$$20240917$20240925$20240925$EXP$$AU-TOLMAR, INC.-24AU052618$TOLMAR$$$$$M$Y$$$20240925$$CN$AU$AU
243601291$24360129$1$I$$20240917$20240925$20240925$EXP$$CA-TOLMAR, INC.-24CA052652$TOLMAR$$$$$M$Y$$$20240925$$HP$CA$CA
243601311$24360131$1$I$20240101$20240919$20240925$20240925$EXP$$US-ABBVIE-5856611$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243601331$24360133$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244791$TEVA$$54$YR$$M$Y$74$KG$20240925$$HP$CA$CA
243601341$24360134$1$I$20201026$20240922$20240925$20240925$EXP$$IL-ABBVIE-21K-082-3866977-00$ABBVIE$$81$YR$$M$Y$73$KG$20240925$$MD$IL$IL
243601351$24360135$1$I$$20240911$20240925$20240925$EXP$$LB-AUROBINDO-AUR-APL-2024-045709$AUROBINDO$Achkar Z, Fakhoury R, Zein Deen O, Shayya A. CT-613 Tirofiban-Induced Profound Thrombocytopenia. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl.):S611 abstr. CT-613$57$YR$$M$Y$$$20240925$$HP$LB$LB
243601361$24360136$1$I$20240922$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189515$AMGEN$$23$YR$A$F$Y$$$20240924$$CN$US$US
243601371$24360137$1$I$20240913$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189681$AMGEN$$69$YR$E$F$Y$$$20240924$$CN$US$US
243601381$24360138$1$I$20240921$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189978$AMGEN$$83$YR$E$M$Y$$$20240924$$CN$US$US
243601391$24360139$1$I$$20240918$20240925$20240925$EXP$$GB-AMGEN-GBRSP2024188900$AMGEN$$86$YR$E$M$Y$$$20240924$$PH$GB$GB
243601401$24360140$1$I$$20240830$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032890$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243601411$24360141$1$I$20240401$20240924$20240925$20240925$EXP$FR-AFSSAPS-DJ2024001056$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-151628$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$68$KG$20240925$$MD$FR$FR
243601421$24360142$1$I$$20240919$20240925$20240925$EXP$$US-AMGEN-USASP2024188078$AMGEN$Gilmore R. M.; Abernathy K.; Shultes K. et al.. Rituximab Case Report- Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia. Bone Marrow Transplantation. 2024;59 (9):1275-1279$$$$$Y$$$20240924$$HP$US$US
243601431$24360143$1$I$20240920$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014372$ELI LILLY AND CO$$$$E$M$Y$$$20240925$$CN$US$US
243601441$24360144$1$I$20230101$20240916$20240925$20240925$EXP$$BR-SANDOZ INC.-SDZ2024BR049612$SANDOZ$$$$$F$Y$$$20240925$$CN$BR$BR
243601451$24360145$1$I$$20240830$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032891$CHATTEM$$$$A$M$Y$$$20240925$$CN$US$US
243601461$24360146$1$I$20240826$20240914$20240925$20240925$EXP$CN-HENLIUS-24CN017247$CN-Accord-448201$ACCORD$$46$YR$A$F$Y$$$20240925$$HP$CN$CN
243601471$24360147$1$I$$20240830$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032881$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243601481$24360148$1$I$20240921$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189571$AMGEN$$69$YR$E$M$Y$$$20240924$$CN$US$US
243601491$24360149$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024190080$AMGEN$$$$$$Y$$$20240924$$CN$US$US
243601501$24360150$1$I$20240921$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189429$AMGEN$$84$YR$E$F$Y$$$20240924$$CN$US$US
243601521$24360152$1$I$$20240913$20240925$20240925$PER$$US-SA-2024SA268171$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240925$$MD$US$US
243601531$24360153$1$I$$20240912$20240925$20240925$PER$$US-SA-2024SA275984$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240925$$CN$US$US
243601541$24360154$1$I$$20240830$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032967$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243601551$24360155$1$I$$20240911$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-045446$AUROBINDO$Shiroky J.. Dermatopathology cinches the diagnosis for spor(E)adic fevers.. Journal of General Internal Medicine.. 2020;35(1):S440-1.$63$YR$$F$Y$$$20240925$$MD$US$US
243601561$24360156$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012296$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$74$YR$$F$Y$50$KG$20240925$$HP$CN$CN
243601571$24360157$1$I$$20240918$20240925$20240925$EXP$$TR-NOVITIUMPHARMA-2024TRNVP01986$NOVITIUM PHARMA$Mehmet Sabanci.Managing recurrent parvovirus B19-associated anemia after a pediatric kidney transplant.Pediatric Nephrology.22-MAY-2024;39:2923-2925$13$YR$C$F$Y$40$KG$20240925$$HP$TR$TR
243601581$24360158$1$I$$20240916$20240925$20240925$EXP$GB-MHRA-TPP5725192C10406417YC1726214894287$GB-Accord-447062$ACCORD$$76$YR$E$M$Y$74$KG$20240925$$PH$GB$GB
243601591$24360159$1$I$$20240830$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032970$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243601601$24360160$1$I$$20240806$20240925$20240925$PER$$US-TEVA-VS-3227475$TEVA$$40$YR$$F$Y$58$KG$20240925$$CN$US$US
243601611$24360161$1$I$$20240919$20240925$20240925$PER$$US-ABBVIE-5931782$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243601621$24360162$1$I$$20240911$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-045894$AUROBINDO$Anghelescu DL, Heyman HM, Alberts NM, Rees M, Puri L, Frett MJ. COVID-19 infection and pain in adolescents with sickle cell disease: A case series. EJHaem. 2022;3(4):1310-1315$14$YR$$F$Y$$$20240925$$HP$US$US
243601632$24360163$2$F$20240923$20240924$20240925$20240926$PER$$US-AMGEN-USASP2024189816$AMGEN$$72$YR$E$F$Y$$$20240925$$CN$US$US
243601641$24360164$1$I$20240923$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189666$AMGEN$$77$YR$E$F$Y$$$20240924$$PH$US$US
243601651$24360165$1$I$$20240906$20240925$20240925$EXP$$US-SA-2024SA272817$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240925$$CN$US$US
243601661$24360166$1$I$$20240916$20240925$20240925$EXP$$CA-APOTEX-2024AP011002$APOTEX$$$$$F$Y$$$20240925$$MD$CA$CA
243601671$24360167$1$I$$20240912$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145949$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240925$$CN$US$US
243601681$24360168$1$I$20240911$20240916$20240925$20240925$EXP$GB-MHRA-MED-202409141644302610-KFVZN$GB-Accord-447445$ACCORD$$39$YR$A$F$Y$$$20240925$$CN$GB$GB
243601691$24360169$1$I$20240101$20240916$20240925$20240925$EXP$$US-Axsome Therapeutics, Inc.-AXS202409-001478$AXSOME THERAPEUTICS$$28$YR$A$F$Y$69.8$KG$20240925$$CN$US$
243601701$24360170$1$I$20240918$20240918$20240925$20240925$PER$$US-GSK-US2024116169$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240925$$CN$US$US
243601711$24360171$1$I$$20240917$20240925$20240925$EXP$$CA-HALEON-2197673$Haleon PLC$$44$YR$$F$Y$$$20240924$$HP$CA$CA
243601721$24360172$1$I$$20240917$20240925$20240925$PER$$US-PCCINC-2024-PPL-000697$PIRAMAL$$$$$$Y$$$20240925$$HP$US$US
243601731$24360173$1$I$20240922$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189327$AMGEN$$$$$F$Y$$$20240924$$MD$US$US
243601741$24360174$1$I$20240908$20240913$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-045992$AUROBINDO$$42$YR$$F$Y$60$KG$20240925$$MD$GB$GB
243601751$24360175$1$I$20240830$20240912$20240925$20240925$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005601$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20240925$$CN$US$US
243601761$24360176$1$I$20240826$20240914$20240925$20240925$EXP$$BR-Accord-447480$ACCORD$$67$YR$E$F$Y$58.6$KG$20240925$$PH$BR$BR
243601781$24360178$1$I$20240101$20240911$20240925$20240925$EXP$$RO-SPC-000493$SOLARIS PHARMA$Balas-Maftei B, Florea CE, Obreja M, Rotaru A, Miftode L, Miftode E, et al. Diagnosis and treatment challenges in a rare Clostridium infection: A case report. Biomed Rep. 2024 Aug 19;21(5):149. doi: 10.3892/br.2024.1837.$70$YR$E$M$Y$$$20240925$$HP$RO$RO
243601791$24360179$1$I$$20240913$20240925$20240925$EXP$$DE-AUROBINDO-AUR-APL-2024-046397$AUROBINDO$Frohling S.; Maria-veronica T.; Fuss C. T. et al. Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling. Molecular Oncology. 2023;17 (7):1343-1355$51$YR$$M$Y$$$20240925$$HP$DE$DE
243601801$24360180$1$I$20240918$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024188852$AMGEN$$74$YR$E$M$Y$$$20240924$$CN$US$US
243601811$24360181$1$I$$20240916$20240925$20240925$EXP$$US-TEVA-VS-3246198$TEVA$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.; Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.$48$YR$$F$Y$$$20240925$$MD$US$US
243601821$24360182$1$I$$20240917$20240925$20240925$EXP$$US-Umedica-000107$UMEDICA LABS$Singh G, Canton C, Langworthy D. Probable chlorthalidone-induced hypokalemic rhabdomyolysis. J Am Pharm Assoc (2003). 2024 Sep 13:102249. doi: 10.1016/j.japh.2024.102249.$52$YR$$M$Y$$$20240924$$HP$US$
243601831$24360183$1$I$$20240806$20240925$20240925$EXP$$US-GSK-US2024097997$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
243601841$24360184$1$I$$20240920$20240925$20240925$EXP$$US-SA-2024SA274721$SANOFI AVENTIS$$$$C$M$Y$$$20240925$$MD$US$US
243601851$24360185$1$I$$20240917$20240925$20240925$PER$$US-PCCINC-2024-PPL-000699$PIRAMAL$$$$$$Y$$$20240925$$HP$US$US
243601861$24360186$1$I$$20240920$20240925$20240925$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015823$JAZZ$$$$$M$Y$$$20240924$$HP$US$US
243601871$24360187$1$I$$20240916$20240925$20240925$EXP$$US-TEVA-VS-3246199$TEVA$Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.; Janowski JPB, Suarez L, Allen ND, Sampson SM. A Case Series of 11 Patients With Subacute Serotonin Syndrome. J-Acad-Consult-Liaison-Psychiatry 2024; 65 (1): 33-38.$64$YR$$M$Y$$$20240925$$MD$US$US
243601881$24360188$1$I$$20240918$20240925$20240925$EXP$$US-NOVITIUMPHARMA-2024USNVP01985$NOVITIUM PHARMA$Scott C. Lester.Taming the Lion: A Report of Pencil Beam Scanning Proton Therapy for Severe Leonine Facies.Advances in Radiation Oncology.29-JUN-2024;9:1-4$70$YR$E$M$Y$$$20240925$$HP$US$US
243601891$24360189$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013495$ELI LILLY AND CO$$66$YR$E$M$Y$$$20240925$$CN$US$US
243601901$24360190$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014542$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240925$$CN$US$US
243601911$24360191$1$I$20240906$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014778$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240925$$CN$US$US
243601921$24360192$1$I$20240920$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014551$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240925$$CN$US$US
243601931$24360193$1$I$$20240917$20240925$20240925$EXP$$CA-HALEON-2197587$Haleon PLC$$$$$F$Y$$$20240924$$HP$CA$CA
243601941$24360194$1$I$$20240917$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409011270$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240925$$CN$US$US
243601951$24360195$1$I$20240916$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013806$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240925$$CN$US$US
243601971$24360197$1$I$20240920$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013542$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240925$$CN$US$US
243601981$24360198$1$I$20240820$20240913$20240925$20240925$EXP$$US-UCBSA-2024048002$UCB$$17$YR$$F$Y$53$KG$20240925$$MD$US$US
243601991$24360199$1$I$20240903$20240924$20240925$20240925$EXP$$EG-SANDOZ INC.-SDZ2024EG082466$SANDOZ$$32$YR$$F$Y$69$KG$20240925$$HP$EG$EG
243602001$24360200$1$I$$20240906$20240925$20240925$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005428$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240925$$CN$US$US
243602011$24360201$1$I$$20240918$20240925$20240925$PER$$US-ABBVIE-5932087$ABBVIE$$91$YR$$$Y$$$20240925$$CN$US$US
243602021$24360202$1$I$$20240916$20240925$20240925$EXP$$MY-Encube-001338$ENCUBE ETHICALS$Zakaria ER, Wan Ghazali WS, Sazali H, Shahril NS, Md Salleh S, Mohd Nawi SN. Acrocyanosis as a rare presentation of drug-induced cutaneous vasculitis: a case report. BMC Rheumatol. 2024 Sep 10;8(1):41. doi: 10.1186/s41927-024-00413-7.$68$YR$E$M$Y$$$20240924$$MD$MY$
243602031$24360203$1$I$$20240923$20240925$20240925$PER$$US-ROCHE-10000089466$ROCHE$$$$$$Y$$$20240925$$CN$US$US
243602041$24360204$1$I$$20240921$20240925$20240925$PER$$US-ROCHE-10000088338$ROCHE$$51$YR$A$M$Y$95.3$KG$20240925$$CN$US$US
243602051$24360205$1$I$20240901$20240918$20240925$20240925$PER$$US-ROCHE-10000085784$ROCHE$$4$YR$C$F$Y$$$20240925$$CN$US$US
243602061$24360206$1$I$$20240918$20240925$20240925$EXP$$US-ROCHE-10000085967$ROCHE$$$$A$F$Y$$$20240925$$CN$US$US
243602071$24360207$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189867$AMGEN$$64$YR$A$M$Y$$$20240924$$CN$US$US
243602091$24360209$1$I$20240922$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189629$AMGEN$$57$YR$A$F$Y$$$20240924$$CN$US$US
243602101$24360210$1$I$$20240906$20240925$20240925$EXP$$PT-CELLTRION INC.-2024PT022642$CELLTRION$$$$$$Y$$$20240925$$MD$PT$PT
243602111$24360211$1$I$$20240919$20240925$20240925$PER$$US-ABBVIE-5935538$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243602121$24360212$1$I$$20240920$20240925$20240925$PER$$US-ROCHE-10000089447$ROCHE$$$$A$M$Y$$$20240925$$CN$US$US
243602141$24360214$1$I$$20240917$20240925$20240925$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2024US001340$JUBILANT$Hussein G, Krastev P, Mallari AJ, El Labban M, Yadav S, Hassan M, et al.. Stone heart syndrome: A curious case of digoxin toxicity and calcium infusion.. Clinical Case Reports. 2024;12(9):e9376$78$YR$$F$Y$$$20240925$$MD$US$US
243602151$24360215$1$I$$20240916$20240925$20240925$EXP$NL-LRB-01003454$NL-JUBILANT PHARMA LTD-2024NL001329$JUBILANT$$30$YR$$M$Y$70$KG$20240925$$MD$NL$NL
243602161$24360216$1$I$$20230125$20240925$20240925$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2023US001732$JUBILANT$Tahir T, Heck D, Knapp B, Kumar R, Junqueira M. CALCIUM CHANNEL BLOCKER TOXICITY TREATED WITH METHYLENE BLUE AND LIPID EMULSION: A RARE SURVIVOR. Critical Care Medicine. 2023;51(1) Suppl.:622$67$YR$$F$Y$$$20240925$$MD$US$US
243602171$24360217$1$I$$20230125$20240925$20240925$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2023US001733$JUBILANT$Kondriuk I, Long J, Waqas Q.. BLUE, INSIDE AND OUT: METHYLENE BLUE AS THE RESCUE THERAPY FOR REFRACTORY DISTRIBUTIVE SHOCK.. Critical Care Medicine.. 2023;51 (1) Supple:625$54$YR$$M$Y$$$20240925$$MD$US$US
243602181$24360218$1$I$$20240913$20240925$20240925$EXP$$ID-JUBILANT CADISTA PHARMACEUTICALS-2024ID001325$JUBILANT$Auerkari AN, Sedono R, Pryambodho P. Severe Neuropathic Back Pain as the Initial Presentation in Angiostrongylus cantonensis Infection: The Role of ICU Management in Overcoming Diagnostic and Analgosedation Challenges.. Archives of Clinical Infectious Diseases. 2024;19(4):e135637$27$YR$$F$Y$$$20240925$$MD$ID$ID
243602191$24360219$1$I$20240901$20240920$20240925$20240925$PER$$US-ABBVIE-5934426$ABBVIE$$78$YR$$F$Y$$$20240925$$CN$US$US
243602201$24360220$1$I$20220101$20240911$20240925$20240925$EXP$$US-NOVOPROD-1284443$NOVO NORDISK$$76$YR$$F$Y$$$20240925$$CN$US$US
243602211$24360221$1$I$$20240913$20240925$20240925$EXP$$US-NOVOPROD-1285627$NOVO NORDISK$$$$$M$Y$$$20240925$$CN$US$US
243602221$24360222$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA275956$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240925$$MD$US$US
243602231$24360223$1$I$$20240904$20240925$20240925$PER$$US-SA-2024SA272838$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
243602241$24360224$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA270930$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240925$$HP$US$US
243602252$24360225$2$F$20240101$20240916$20240925$20240930$PER$$US-SA-2024SA230363$SANOFI AVENTIS$$9$YR$C$M$Y$38$KG$20240930$$HP$US$US
243602261$24360226$1$I$$20240916$20240925$20240925$PER$$US-SA-2024SA274803$SANOFI AVENTIS$$$$C$M$Y$$$20240925$$MD$US$US
243602271$24360227$1$I$20240904$20240904$20240925$20240925$PER$$US-SA-2024SA272124$SANOFI AVENTIS$$45$YR$A$M$Y$84$KG$20240925$$MD$US$US
243602281$24360228$1$I$20240901$20240918$20240925$20240925$PER$$US-SA-2024SA270908$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240925$$HP$US$US
243602293$24360229$3$F$20240915$20240930$20240925$20240930$PER$$US-AMGEN-USASP2024189843$AMGEN$$83$YR$E$F$Y$$$20240930$$CN$US$US
243602301$24360230$1$I$$20240831$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032829$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243602311$24360231$1$I$20240912$20240913$20240925$20240925$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03389$AMNEAL$$73$YR$$M$Y$$$20240925$$CN$US$US
243602321$24360232$1$I$$20240919$20240925$20240925$PER$$US-ROCHE-10000087916$ROCHE$$62$YR$A$F$Y$$$20240925$$CN$US$US
243602331$24360233$1$I$$20240917$20240925$20240925$EXP$$US-INTERCEPT-PM2024001867$INTERCEPT PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
243602342$24360234$2$F$20240918$20240924$20240925$20240930$PER$$US-ROCHE-10000088924$ROCHE$$57$YR$A$F$Y$$$20240930$$CN$US$US
243602351$24360235$1$I$$20240911$20240925$20240925$EXP$$US-MSNLABS-2024MSNLIT02029$MSN LABORATORIES$Zou H, Rau A, Thompson L, Henderson D.Pancytopenia Concurrent With Metabolic Encephalopathy.Cureus.2024;16(8):e67963$$$$$Y$$$20240925$$MD$US$US
243602361$24360236$1$I$$20240831$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032910$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243602371$24360237$1$I$$20240831$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032928$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243602381$24360238$1$I$$20240918$20240925$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-150977$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$PH$JP$JP
243602391$24360239$1$I$$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151158$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240925$$CN$US$US
243602401$24360240$1$I$$20240915$20240925$20240925$EXP$$US-NOVOPROD-1286075$NOVO NORDISK$$$$$$Y$$$20240925$$CN$US$US
243602411$24360241$1$I$$20240916$20240925$20240925$EXP$$US-NOVOPROD-1285862$NOVO NORDISK$$$$$M$Y$$$20240925$$HP$US$US
243602431$24360243$1$I$$20240916$20240925$20240925$EXP$$US-NOVOPROD-1286411$NOVO NORDISK$$64$YR$$F$Y$$$20240925$$CN$US$US
243602441$24360244$1$I$$20240915$20240925$20240925$EXP$$IL-NOVOPROD-1286444$NOVO NORDISK$$73$YR$$M$Y$$$20240925$$MD$IL$IL
243602451$24360245$1$I$20230301$20240916$20240925$20240925$EXP$$US-NOVOPROD-1286380$NOVO NORDISK$$$$$F$Y$$$20240925$$CN$US$US
243602461$24360246$1$I$$20240916$20240925$20240925$EXP$$US-NOVOPROD-1286401$NOVO NORDISK$$$$$F$Y$49.887$KG$20240925$$CN$US$US
243602471$24360247$1$I$$20240916$20240925$20240925$EXP$$US-NOVOPROD-1288283$NOVO NORDISK$$$$$M$Y$$$20240925$$CN$US$US
243602481$24360248$1$I$20240601$20240916$20240925$20240925$EXP$$CO-NOVOPROD-1287167$NOVO NORDISK$$47$YR$$F$Y$69$KG$20240925$$CN$CO$CO
243602491$24360249$1$I$20240808$20240914$20240925$20240925$EXP$$CO-NOVOPROD-1282504$NOVO NORDISK$$37$YR$$$Y$54$KG$20240925$$CN$CO$CO
243602501$24360250$1$I$20230918$20240912$20240925$20240925$EXP$$US-NOVOPROD-1270659$NOVO NORDISK$$53$YR$$F$Y$$$20240925$$CN$US$US
243602511$24360251$1$I$$20240915$20240925$20240925$EXP$$CN-NOVOPROD-1285681$NOVO NORDISK$$$$$M$Y$$$20240925$$CN$CN$CN
243602521$24360252$1$I$$20240916$20240925$20240925$EXP$$DE-ROCHE-10000084495$ROCHE$$$$A$F$Y$$$20240925$$MD$DE$DE
243602531$24360253$1$I$$20240916$20240925$20240925$EXP$$TR-NOVOPROD-1287774$NOVO NORDISK$$$$$F$Y$$$20240925$$CN$TR$TR
243602541$24360254$1$I$$20240920$20240925$20240925$EXP$$JP-009507513-2402JPN001227J$MERCK$$5$DEC$$F$Y$$$20240925$$MD$JP$JP
243602551$24360255$1$I$$20240831$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032799$CHATTEM$$$$A$M$Y$$$20240925$$CN$US$US
243602562$24360256$2$F$$20240923$20240925$20240927$PER$$NVSC2024US189878$NOVARTIS$$$$$$Y$$$20240927$$CN$US$US
243602571$24360257$1$I$$20240831$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032831$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243602581$24360258$1$I$$20240831$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032923$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243602591$24360259$1$I$$20240913$20240925$20240925$PER$$US-ABBVIE-5924811$ABBVIE$$$$$$Y$$$20240925$$HP$US$US
243602601$24360260$1$I$$20240912$20240925$20240925$EXP$$CA-APOTEX-2024AP010667$APOTEX$$$$$M$Y$$$20240925$$HP$CA$CA
243602611$24360261$1$I$20240101$20240913$20240925$20240925$EXP$DK-DKMA-30738335$DK-Accord-447149$ACCORD$$13$WK$I$$Y$$$20240925$$MD$DK$DK
243602621$24360262$1$I$$20240916$20240925$20240925$EXP$$AU-NOVOPROD-1284924$NOVO NORDISK$$55$YR$$F$Y$$$20240925$$MD$AU$AU
243602631$24360263$1$I$20240401$20240916$20240925$20240925$EXP$NO-NOMAADVRE-RELISV-2024-Vzg3p6$NO-NOVOPROD-1283725$NOVO NORDISK$$73$YR$$M$Y$$$20240925$$MD$NO$NO
243602641$24360264$1$I$$20240916$20240925$20240925$EXP$$US-NOVOPROD-1285752$NOVO NORDISK$$$$$F$Y$$$20240925$$CN$US$US
243602651$24360265$1$I$20240904$20240916$20240925$20240925$EXP$CN-NMPA-3311811048727202400117$CN-NOVOPROD-1285304$NOVO NORDISK$$69$YR$$F$Y$80$KG$20240925$$HP$CN$CN
243602661$24360266$1$I$20240815$20240916$20240925$20240925$EXP$$US-NOVOPROD-1274597$NOVO NORDISK$$83$YR$$M$Y$$$20240925$$CN$US$US
243602671$24360267$1$I$20240913$20240916$20240925$20240925$EXP$$US-NOVOPROD-1285828$NOVO NORDISK$$76$YR$$F$Y$$$20240925$$CN$US$US
243602681$24360268$1$I$$20240916$20240925$20240925$EXP$$CZ-NOVOPROD-1283878$NOVO NORDISK$$$$$F$Y$$$20240925$$CN$CZ$CZ
243602691$24360269$1$I$20240201$20240918$20240925$20240925$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR000634$CURRAX PHARMACEUTICALS$$57$YR$$F$Y$$$20240925$$CN$CA$CA
243602701$24360270$1$I$20240915$20240916$20240925$20240925$EXP$$EE-NOVOPROD-1284778$NOVO NORDISK$$63$YR$$M$Y$$$20240925$$HP$EE$EE
243602721$24360272$1$I$$20240831$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032905$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243602731$24360273$1$I$$20240918$20240925$20240925$EXP$$US-JNJFOC-20240959290$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$CN$US$US
243602751$24360275$1$I$20240908$20240909$20240925$20240925$PER$$US-JNJFOC-20240921915$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20240925$$HP$US$US
243602761$24360276$1$I$20240701$20240917$20240925$20240925$EXP$$MX-EMD Serono-2024049990$EMD SERONO INC$$15$YR$T$M$Y$$$20240925$$CN$MX$MX
243602771$24360277$1$I$$20240916$20240925$20240925$PER$$US-JNJFOC-20240941850$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$CN$US$US
243602781$24360278$1$I$$20240923$20240925$20240925$PER$$US-ROCHE-10000089665$ROCHE$$$$E$F$Y$$$20240925$$CN$US$US
243602791$24360279$1$I$20240525$20240924$20240925$20240925$EXP$GB-MHRA-MED-202409241050587910-WSGVF$GB-JNJFOC-20240963959$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$PH$GB$GB
243602801$24360280$1$I$$20240902$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032920$CHATTEM$$$$A$M$Y$$$20240925$$CN$US$US
243602811$24360281$1$I$$20240909$20240925$20240925$PER$$US-JNJFOC-20240930699$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$HP$US$US
243602821$24360282$1$I$$20240902$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032819$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243602831$24360283$1$I$$20240831$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032801$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243602841$24360284$1$I$20240901$20240920$20240925$20240925$EXP$GB-MHRA-MED-202409201502422900-WMPHY$GB-BIOGEN-2024BI01283681$BIOGEN$$50$YR$$F$Y$$$20240925$$HP$GB$GB
243602852$24360285$2$F$20240919$20240923$20240925$20240926$EXP$$US-BIOGEN-2024BI01283757$BIOGEN$$62$YR$$F$Y$$$20240926$$CN$US$US
243602861$24360286$1$I$20240902$20240912$20240925$20240925$30DAY$$US-NOVOPROD-1285461$NOVO NORDISK$$41$YR$$M$Y$$$20240925$$CN$US$US
243602871$24360287$1$I$20170101$20240916$20240925$20240925$EXP$$US-NOVOPROD-1260749$NOVO NORDISK$$$$$M$Y$102.95$KG$20240925$$MD$US$US
243602881$24360288$1$I$20240401$20240916$20240925$20240925$EXP$$US-NOVOPROD-1286400$NOVO NORDISK$$$$$M$Y$$$20240925$$CN$US$US
243602891$24360289$1$I$20230502$20240917$20240925$20240925$EXP$FR-AFSSAPS-PP2023000869$FR-CELLTRION INC.-2024FR022549$CELLTRION$$$$$$Y$$$20240925$$MD$FR$FR
243602901$24360290$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012297$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$69$YR$$F$Y$53.5$KG$20240925$$HP$CN$CN
243602921$24360292$1$I$20240918$20240919$20240925$20240925$EXP$$US-JNJFOC-20240959696$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240925$$HP$US$US
243602931$24360293$1$I$20240916$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189740$AMGEN$$64$YR$A$F$Y$$$20240924$$CN$US$US
243602961$24360296$1$I$$20240920$20240925$20240925$PER$$US-JNJFOC-20240956624$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243602971$24360297$1$I$$20240918$20240925$20240925$PER$$US-JNJFOC-20240955909$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243602981$24360298$1$I$$20240902$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032919$CHATTEM$$$$A$F$Y$$$20240925$$CN$US$US
243603001$24360300$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012300$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$72$YR$$F$Y$53.523$KG$20240925$$HP$CN$CN
243603011$24360301$1$I$$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093781$TAKEDA$$40$YR$$M$Y$$$20240925$$CN$US$US
243603021$24360302$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014504$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240925$$CN$US$US
243603031$24360303$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014384$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240925$$CN$US$US
243603041$24360304$1$I$20240915$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014769$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240925$$CN$US$US
243603051$24360305$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014782$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240925$$CN$US$US
243603061$24360306$1$I$$20240916$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032666$CHATTEM$$44$YR$A$F$Y$$$20240925$$HP$US$US
243603071$24360307$1$I$$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151296$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240925$$CN$US$US
243603081$24360308$1$I$$20240918$20240925$20240925$EXP$$NVSC2023IN280273$NOVARTIS$$$$$F$Y$$$20240925$$CN$IN$IN
243603091$24360309$1$I$$20240916$20240925$20240925$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP012316$STRIDES$Ray AK, Mitra S.. A Case Series on Complexities in Recognition and Management of Tourette Syndrome with Variable Behavioral Presentations: Comorbidity Versus Umbrella Construct.. J-Indian-Assoc-Child-Adolesc-Ment-Health. 2024;20 (3):264-268$14$YR$$M$Y$$$20240925$$HP$IN$IN
243603111$24360311$1$I$$20240920$20240925$20240925$EXP$$US-BIOGEN-2024BI01283914$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243603121$24360312$1$I$$20240920$20240925$20240925$EXP$$US-BIOGEN-2024BI01283768$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243603131$24360313$1$I$$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093800$TAKEDA$$31$YR$$F$Y$$$20240925$$CN$US$US
243603141$24360314$1$I$20230901$20240911$20240925$20240925$EXP$ES-AEMPS-1565908$ES-MSNLABS-2024MSNSPO02018$MSN LABORATORIES$$$$$$Y$$$20240925$$MD$ES$ES
243603151$24360315$1$I$20100101$20240916$20240925$20240925$EXP$$GB-STRIDES ARCOLAB LIMITED-2024SP012299$STRIDES$Grice S, Hammond S, Hampson L, Wagner A, Naisbitt DJ.. Omeprazole-Associated Atypical Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in a Patient with Positive In Vitro Diagnostic Testing to Multiple Proton Pump Inhibitors.. Chem-Res-Toxicol. 2024;37 (9):1484-1487$6$DEC$$M$Y$$$20240925$$HP$GB$GB
243603161$24360316$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012239$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$64$YR$$M$Y$$$20240925$$HP$CN$CN
243603171$24360317$1$I$20240101$20240911$20240925$20240925$EXP$$US-INSMED, INC.-2024-03686-US$INSMED$$$$$F$Y$$$20240925$$CN$US$US
243603181$24360318$1$I$$20240912$20240925$20240925$EXP$$CA-APOTEX-2024AP010656$APOTEX$$54$YR$$F$Y$$$20240925$$HP$CA$CA
243603201$24360320$1$I$$20240916$20240925$20240925$EXP$$CA-APOTEX-2024AP011042$APOTEX$$47$YR$$M$Y$$$20240925$$HP$CA$CA
243603211$24360321$1$I$$20240916$20240925$20240925$PER$$US-ASTELLAS-2024US022558$ASTELLAS$$82$YR$E$F$Y$$$20240925$$CN$US$US
243603221$24360322$1$I$$20240917$20240925$20240925$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP012311$STRIDES$Kitazawa T, Yamamoto A, Nakayama S, Kawase K, Wakabayashi Y.. Disseminated Nontuberculous Mycobacterium Infection During Treatment of Multiple Myeloma: A Case Report and Review of the Literature.. Intern-Med. 2024;1-5$$$E$M$Y$$$20240925$$HP$JP$JP
243603231$24360323$1$I$$20240917$20240925$20240925$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP012254$STRIDES$Alfredo MAC, Schmitt JV, Miola AC, Milagres SP, Lastoria JC.. Cardiovascular events associated with thalidomide and prednisone in leprosy type 2 reaction.. Anais-Brasil-Dermatol. 2022;99:53-56$45$YR$$M$Y$$$20240925$$HP$BR$BR
243603241$24360324$1$I$$20240918$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032932$CHATTEM$$$$$$Y$$$20240925$$CN$US$US
243603251$24360325$1$I$$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093814$TAKEDA$$34$YR$$M$Y$$$20240925$$CN$US$US
243603271$24360327$1$I$20240501$20240918$20240925$20240925$EXP$$CZ-ABBVIE-5935140$ABBVIE$$$$$M$Y$46$KG$20240925$$MD$CZ$CZ
243603281$24360328$1$I$$20240917$20240925$20240925$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP012253$STRIDES$Alfredo MAC, Schmitt JV, Miola AC, Milagres SP, Lastoria JC.. Cardiovascular events associated with thalidomide and prednisone in leprosy type 2 reaction.. Anais-Brasil-Dermatol. 2022;99:53-56$49$YR$$M$Y$$$20240925$$HP$BR$BR
243603301$24360330$1$I$$20240919$20240925$20240925$PER$$US-CHATTEMPRD-2024OHG032800$CHATTEM$$$$$$Y$$$20240925$$CN$US$US
243603311$24360331$1$I$$20240917$20240925$20240925$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP012244$STRIDES$Alfredo MAC, Schmitt JV, Miola AC, Milagres SP, Lastoria JC.. Cardiovascular events associated with thalidomide and prednisone in leprosy type 2 reaction.. Anais-Brasil-Dermatol. 2022;99:53-56$38$YR$$F$Y$$$20240925$$HP$BR$BR
243603321$24360332$1$I$20240101$20240920$20240925$20240925$PER$$US-BIOGEN-2024BI01276841$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243603351$24360335$1$I$$20240917$20240925$20240925$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP012250$STRIDES$Alfredo MAC, Schmitt JV, Miola AC, Milagres SP, Lastoria JC.. Cardiovascular events associated with thalidomide and prednisone in leprosy type 2 reaction.. Anais-Brasil-Dermatol. 2022;99:53-56$54$YR$$M$Y$$$20240925$$HP$BR$BR
243603362$24360336$2$F$$20240928$20240925$20240930$PER$$US-HALEON-2198088$Haleon PLC$$$$$M$Y$88.451$KG$20240930$$CN$US$US
243603381$24360338$1$I$$20240917$20240925$20240925$EXP$$BR-STRIDES ARCOLAB LIMITED-2024SP012251$STRIDES$Alfredo MAC, Schmitt JV, Miola AC, Milagres SP, Lastoria JC.. Cardiovascular events associated with thalidomide and prednisone in leprosy type 2 reaction.. Anais-Brasil-Dermatol. 2022;99:53-56$68$YR$$M$Y$$$20240925$$HP$BR$BR
243603391$24360339$1$I$$20240910$20240925$20240925$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09461$LUPIN$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al. Clinical characteristics and HLA associations of Azithromycin-induced liver injury. Alimentary Pharmacology and Therapeutics. 2024;60:787-795$$$A$$Y$$$20240925$$HP$US$US
243603401$24360340$1$I$20231101$20231201$20240925$20240925$PER$$US-CIPLA LTD.-2023US07787$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243603411$24360341$1$I$20240917$20240920$20240925$20240925$EXP$GB-MHRA-MED-202409181720390300-VDQSL$GB-STRIDES ARCOLAB LIMITED-2024SP012249$STRIDES$$84$YR$$M$Y$$$20240925$$HP$GB$GB
243603421$24360342$1$I$20230912$20230918$20240925$20240925$PER$$US-TARO PHARMACEUTICALS USA INC.-2023TAR00995$TARO$$$$$$Y$$$20240925$$CN$US$US
243603431$24360343$1$I$$20240527$20240925$20240925$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00686$TARO$$$$$$Y$$$20240925$$CN$US$US
243603441$24360344$1$I$20240612$20240612$20240925$20240925$PER$$US-TARO PHARMACEUTICALS USA INC.-2024TAR00797$TARO$$$$$$Y$$$20240925$$CN$US$US
243603451$24360345$1$I$20240101$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189698$AMGEN$$71$YR$E$F$Y$$$20240924$$CN$US$US
243603461$24360346$1$I$20240101$20240916$20240925$20240925$EXP$FR-AFSSAPS-LL2024001720$FR-Accord-447425$ACCORD$$33$YR$A$M$Y$$$20240925$$MD$FR$FR
243603481$24360348$1$I$20240101$20240911$20240925$20240925$EXP$$US-MALLINCKRODT-MNK202405147$MALLINCKRODT$$$$$F$Y$$$20240925$$CN$US$US
243603491$24360349$1$I$20240905$20240906$20240925$20240925$PER$$US-JNJFOC-20240919884$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240925$$PH$US$US
243603501$24360350$1$I$$20240911$20240925$20240925$EXP$$US-MALLINCKRODT-MNK202405141$MALLINCKRODT$$$$$M$Y$$$20240925$$CN$US$US
243603511$24360351$1$I$20240828$20240916$20240925$20240925$PER$$US-GSK-US2024114975$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20240925$$CN$US$US
243603521$24360352$1$I$$20240916$20240925$20240925$PER$$US-ASTELLAS-2024-AER-007930$ASTELLAS$$$$E$F$Y$$$20240925$$MD$US$US
243603531$24360353$1$I$$20240920$20240925$20240925$PER$$NVSC2024US190103$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
243603541$24360354$1$I$$20240913$20240925$20240925$EXP$$CA-APOTEX-2024AP010726$APOTEX$$3$DEC$$M$Y$$$20240925$$HP$CA$CA
243603551$24360355$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014336$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240925$$CN$US$US
243603561$24360356$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014575$ELI LILLY AND CO$$$$$M$Y$$$20240925$$CN$US$US
243603571$24360357$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014513$ELI LILLY AND CO$$$$$$Y$$$20240925$$CN$US$US
243603581$24360358$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014618$ELI LILLY AND CO$$25$YR$A$M$Y$$$20240925$$CN$US$US
243603591$24360359$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015176$ELI LILLY AND CO$$$$$$Y$$$20240925$$CN$US$US
243603601$24360360$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014414$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240925$$CN$US$US
243603611$24360361$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014489$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240925$$CN$US$US
243603621$24360362$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014283$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240925$$CN$US$US
243603631$24360363$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014514$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240925$$CN$US$US
243603641$24360364$1$I$20240921$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014714$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240925$$CN$US$US
243603651$24360365$1$I$20240911$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013699$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240925$$CN$US$US
243603661$24360366$1$I$$20240918$20240925$20240925$PER$$US-AMGEN-USASP2024187775$AMGEN$$$$$$Y$$$20240924$$PH$US$US
243603671$24360367$1$I$$20240920$20240925$20240925$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015920$JAZZ$$$$$M$Y$$$20240924$$CN$US$US
243603681$24360368$1$I$$20240913$20240925$20240925$EXP$$IT-AUROBINDO-AUR-APL-2024-044778$AUROBINDO$Guerrieri S, Rubin M, Gattuso I, Zanetta C, Genchi A, Preziosa P et al.. Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series. JOURNAL OF NEUROLOGY. 2024;271(6):3678-81$38$YR$$M$Y$$$20240925$$HP$IT$IT
243603691$24360369$1$I$20240813$20240916$20240925$20240925$EXP$FR-AFSSAPS-BR2024000745$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112421$ZYDUS PHARM$$$$$$Y$$$20240925$$HP$FR$FR
243603701$24360370$1$I$20240221$20240916$20240925$20240925$EXP$FR-AFSSAPS-BR2024000754$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112489$ZYDUS PHARM$$$$$$Y$$$20240925$$MD$FR$FR
243603711$24360371$1$I$20240101$20240916$20240925$20240925$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112629$ZYDUS PHARM$$$$$$Y$$$20240925$$HP$US$US
243603721$24360372$1$I$$20240911$20240925$20240925$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112294$ZYDUS PHARM$Salk G, Mangala YO, Onukogu ID, Meleveedu K.. ALL-747 Methotrexate-Induced Neurotoxicity Due to Ommaya Reservoir Malfunction in a Patient with Acute Lymphoblastic Leukemia.. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S282-S283 abstr. ALL-747.$$$$$Y$$$20240925$$MD$US$US
243603732$24360373$2$F$$20240926$20240925$20240927$PER$$US-DSJP-DS-2024-101004-US$DAIICHI$Chengappa NK, Babu AD, Bhutta T, Ali F, Singh S.. SPECTRUM OF ADVERSE EFFECTS WITH EDOXABAN IN A PATIENT WITH RENAL TRANSPLANTS: A CASE REPORT. CHEST. 2024;166(4):2469A-2470A$84$YR$$M$Y$$$20240927$$HP$US$US
243603741$24360374$1$I$$20240920$20240925$20240925$EXP$$BR-TAKEDA-2024TUS094305$TAKEDA$$$$$$Y$$$20240925$$CN$BR$BR
243603751$24360375$1$I$20240824$20240918$20240925$20240925$EXP$$US-RDY-SPO/USA/24/0013927$DR REDDYS$$80$YR$E$F$Y$$$20240925$$HP$US$US
243603761$24360376$1$I$$20240910$20240925$20240925$EXP$$BG-RISINGPHARMA-BG-2024RISLIT00340$RISING PHARMACEUTICALS$G Tchernev.Multiple keratinocytic cancers after intake of antihypertensives (lisinopril/ bisoprolol/hct) and antiarrhytmics (propafenone): the important new links to the nitroso-contamination and the metabolic  reprogramming of the future cancer cell.Georgian Med News.2024;351:65-71$87$YR$E$F$Y$$$20240925$$HP$BG$BG
243603781$24360378$1$I$$20240919$20240925$20240925$PER$$US-JNJFOC-20240952715$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$HP$US$US
243603801$24360380$1$I$20240607$20240910$20240925$20240925$EXP$$GB-AMGEN-GBRNI2024188514$AMGEN$$31$YR$A$F$Y$150$KG$20240924$$HP$GB$GB
243603811$24360381$1$I$20240918$20240919$20240925$20240925$PER$$US-AMGEN-USASP2024188050$AMGEN$$61$YR$A$F$Y$66.213$KG$20240924$$PH$US$US
243603821$24360382$1$I$$20240911$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-045395$AUROBINDO$Blush RR. ?-Adrenergic Agonist-Induced Lactic Acidosis: A Case Report. AACN advanced critical care. 2024;35(3):222-7$54$YR$$F$Y$$$20240925$$HP$US$US
243603831$24360383$1$I$$20240910$20240925$20240925$PER$$US-CASPERPHARMA-US-2024RISSPO00342$CASPER PHARMA$$21$YR$A$M$Y$$$20240925$$HP$US$US
243603841$24360384$1$I$$20240911$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-045724$AUROBINDO$Haliyur R, Johnson TJ, Johnson MW. Poor response of solitary optic disc retinal capillary hemangioblastoma to intravitreal propranolol. Can-J-Ophthalmol. 2024;59 (1):e92-e94$56$YR$$M$Y$$$20240925$$MD$US$US
243603851$24360385$1$I$$20240918$20240925$20240925$EXP$$US-CHATTEMPRD-2024OHG032675$CHATTEM$$$$$M$Y$$$20240925$$LW$US$US
243603861$24360386$1$I$20240604$20240606$20240925$20240925$PER$$US-CIPLA LTD.-2024US06156$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243603871$24360387$1$I$20240612$20240613$20240925$20240925$PER$$US-CIPLA LTD.-2024US06519$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243603881$24360388$1$I$$20240923$20240925$20240925$EXP$$CN-TAKEDA-2024TUS094580$TAKEDA$$$$$M$Y$$$20240925$$CN$CN$CN
243603891$24360389$1$I$$20240621$20240925$20240925$PER$$US-CIPLA LTD.-2024US06787$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243603901$24360390$1$I$20240922$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189665$AMGEN$$68$YR$E$F$Y$$$20240924$$CN$US$US
243603911$24360391$1$I$20240729$20240729$20240925$20240925$PER$$US-CIPLA LTD.-2024US07031$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243603921$24360392$1$I$20240622$20240622$20240925$20240925$PER$$US-CIPLA LTD.-2024US06803$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243603931$24360393$1$I$20240628$20240628$20240925$20240925$PER$$US-CIPLA LTD.-2024US07008$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243603941$24360394$1$I$$20240910$20240925$20240925$PER$$US-RISINGPHARMA-US-2024RISSPO00341$RISING PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
243603961$24360396$1$I$20240801$20240916$20240925$20240925$EXP$$DE-AUROBINDO-AUR-APL-2024-046883$AUROBINDO$$$$A$F$Y$59$KG$20240925$$MD$DE$DE
243603981$24360398$1$I$$20240911$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-045826$AUROBINDO$Beltran LP, Benken J, Jou J, Benedetti E, Nishioka H, Alamreia E, et al.. Efficacy and Safety of Perioperative Angiotensin IIVersus Phenylephrine as a First-Line Continuous Infusion Vasopressor in Kidney Transplant Recipients.. Clin-Transplant. 2024;38:e15432$$$A$$Y$$$20240925$$HP$US$US
243603991$24360399$1$I$$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093769$TAKEDA$$26$YR$$M$Y$$$20240925$$CN$US$US
243604001$24360400$1$I$$20240919$20240925$20240925$EXP$$CA-JNJFOC-20240960405$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240925$$HP$CA$CA
243604011$24360401$1$I$$20240917$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046050$AUROBINDO$Serris A, Rahi M, Rioux C, Fidouh N, Joly V, Boutolleau D.. Refractory anti-viral resistant CMV retinitis in an immunological non responder person living with HIV. International Journal of Infectious Diseases. 2024;1-13$43$YR$$F$Y$$$20240925$$HP$FR$FR
243604021$24360402$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151665$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$62.6$KG$20240925$$CN$US$US
243604031$24360403$1$I$$20240918$20240925$20240925$EXP$$JP-009507513-2408JPN000904J$MERCK$$9$DEC$$M$Y$$$20240925$$MD$JP$JP
243604041$24360404$1$I$$20240917$20240925$20240925$EXP$$DE-CELLTRION INC.-2024DE022625$CELLTRION$Sprengel MA, Krumrey-langkammerer, Haas JP, et al.. Occult protein-losing enteropathy as cause of treatment resistance of noninfectious uveitis-Case report. Monthly journal Pediatrics. 2024;1-5$$$$$Y$$$20240925$$MD$DE$DE
243604051$24360405$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013862$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240925$$CN$US$US
243604061$24360406$1$I$20240920$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014707$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240925$$CN$US$US
243604072$24360407$2$F$20240913$20240924$20240925$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151124$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$76.7$KG$20240926$$PH$US$US
243604081$24360408$1$I$$20240923$20240925$20240925$EXP$$CA-HALEON-2197976$Haleon PLC$$22$YR$$F$Y$$$20240924$$HP$CA$CA
243604091$24360409$1$I$$20240922$20240925$20240925$PER$$US-JNJFOC-20240960353$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243604101$24360410$1$I$$20240916$20240925$20240925$EXP$$US-JNJFOC-20240964064$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$HP$US$US
243604112$24360411$2$F$$20240924$20240925$20240925$PER$$US-JNJFOC-20240965587$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243604121$24360412$1$I$$20240905$20240925$20240925$30DAY$$AU-JNJFOC-20240914080$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$PH$AU$AU
243604141$24360414$1$I$$20240923$20240925$20240925$PER$$US-HALEON-2198315$Haleon PLC$$$$$$Y$$$20240925$$CN$US$US
243604151$24360415$1$I$$20240916$20240925$20240925$EXP$$US-HETERO-HET2024US03191$HETERO$$$$$$Y$$$20240925$$CN$US$US
243604161$24360416$1$I$$20240916$20240925$20240925$EXP$CA-MHPD-001094530$CA-Accord-447011$ACCORD$$76$YR$E$M$Y$$$20240925$$PH$CA$CA
243604171$24360417$1$I$20240101$20240918$20240925$20240925$EXP$$JP-AMGEN-JPNSP2024188888$AMGEN$$92$YR$E$F$Y$$$20240925$$MD$JP$JP
243604181$24360418$1$I$20240915$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189411$AMGEN$$72$YR$E$F$Y$$$20240925$$CN$US$US
243604192$24360419$2$F$20240921$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024189652$AMGEN$$67$YR$E$M$Y$$$20240925$$MD$US$US
243604211$24360421$1$I$20231124$20231124$20240925$20240925$PER$$US-CIPLA LTD.-2023US07560$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243604221$24360422$1$I$$20231206$20240925$20240925$PER$$US-CIPLA LTD.-2023US07972$CIPLA$$$$$$Y$$$20240925$$CN$US$US
243604231$24360423$1$I$$20240916$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013793$DR REDDYS$$16$YR$T$$Y$$$20240925$$MD$US$US
243604241$24360424$1$I$$20240916$20240925$20240925$EXP$$US-HETERO-HET2024US03192$HETERO$$$$$F$Y$$$20240925$$PH$US$US
243604251$24360425$1$I$20240917$20240917$20240925$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029605$UNITED THERAPEUTICS$$85$YR$$F$Y$56.236$KG$20240925$$$US$US
243604261$24360426$1$I$$20240916$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046064$AUROBINDO$$$$$F$Y$$$20240925$$CN$GB$GB
243604271$24360427$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151675$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240925$$CN$US$US
243604281$24360428$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151032$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240925$$HP$US$US
243604291$24360429$1$I$20240901$20240919$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150175$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240925$$CN$US$US
243604301$24360430$1$I$$20240916$20240925$20240925$EXP$$DE-AUROBINDO-AUR-APL-2024-046623$AUROBINDO$$$$$M$Y$$$20240925$$CN$DE$DE
243604321$24360432$1$I$$20240912$20240925$20240925$PER$$US-JNJFOC-20240935095$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243604331$24360433$1$I$20240911$20240916$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147757$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240925$$HP$US$US
243604341$24360434$1$I$$20240918$20240925$20240925$PER$$US-JNJFOC-20240951149$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$HP$US$US
243604351$24360435$1$I$$20240916$20240925$20240925$EXP$CA-MHPD-E2B_07248377$CA-Accord-447063$ACCORD$$51$YR$A$M$Y$$$20240925$$HP$CA$CA
243604361$24360436$1$I$$20240913$20240925$20240925$EXP$$PT-AUROBINDO-AUR-APL-2024-046420$AUROBINDO$Silva Cunha M.; De Sousa X.; Simoes J... Bilateral Mastodynia: An Unusual Presentation of Calciphylaxis.. Acta medica portuguesa.. 2019;32(1):86$62$YR$$F$Y$$$20240925$$HP$PT$PT
243604371$24360437$1$I$20210302$20240911$20240925$20240925$EXP$$GB-LUPIN PHARMACEUTICALS INC.-2024-09073$LUPIN$$68$YR$$M$Y$$$20240925$$MD$GB$GB
243604381$24360438$1$I$$20240912$20240925$20240925$PER$$US-GSK-US2024113764$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
243604391$24360439$1$I$$20240912$20240925$20240925$EXP$$CA-APOTEX-2024AP010999$APOTEX$$$$A$M$Y$$$20240925$$PH$CA$CA
243604401$24360440$1$I$20240829$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046152$AUROBINDO$$80$YR$$M$Y$82$KG$20240925$$PH$FR$FR
243604412$24360441$2$F$20240831$20240916$20240925$20240926$EXP$$HU-ROCHE-10000083771$ROCHE$$40$YR$A$F$Y$$$20240926$$MD$HU$HU
243604421$24360442$1$I$20240701$20240919$20240925$20240925$PER$$US-AMGEN-USASP2024188011$AMGEN$$63$YR$A$F$Y$$$20240925$$CN$US$US
243604431$24360443$1$I$$20240918$20240925$20240925$PER$$US-BIOGEN-2021BI00975006$BIOGEN$$$$$F$Y$22.7$KG$20240925$$CN$US$US
243604441$24360444$1$I$20240711$20240917$20240925$20240925$EXP$$FR-AMGEN-FRANI2024185545$AMGEN$$51$YR$A$M$Y$$$20240925$$HP$FR$FR
243604451$24360445$1$I$20240101$20240917$20240925$20240925$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2024CUR003505$CURRAX PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$CA$CA
243604461$24360446$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244793$TEVA$$57$YR$$M$Y$84$KG$20240925$$HP$CA$CA
243604471$24360447$1$I$$20240916$20240925$20240925$EXP$$MY-DEXPHARM-2024-3182$DEXCEL$Zakaria ER, Wan Ghazali WS, Sazali H, Shahril NS, Md Salleh S, Mohd Nawi SN. Acrocyanosis as a rare presentation of drug-induced cutaneous vasculitis: A case report. BMC Rheumatology. 2024 Sept 10;8(1). doi:10.1186/s41927-024-00413-7$68$YR$A$M$Y$$$20240925$$CN$MY$MY
243604481$24360448$1$I$$20240916$20240925$20240925$EXP$$HR-EMA-20111024-mkevhumanwt-131629912$Haleon PLC$Vrabec Matkovic D, Budisin V, Pahic R. Failure in long term treatment of chronic pain in cervical spondylotic myelopathy. Medicinski Glasnik 2011 Aug 1;8(2):309-311.; Vrabec-Matkovic D..Failure in long term treatment of chronic pain in cervical spondylotic myelopathy.Medicinski Glasnik.2011.8(2).309-311; Vrabec Matkovic D, Budisin V, Pahic R.Failure in long-term treatment of chronic pain in cervical spondylotic myelopathy..Medicinski Glasnik.2011.8(2).309-311; Vrabec-Matkovic D.Failure in lon...$31$YR$$F$Y$$$20240925$$MD$HR$HR
243604491$24360449$1$I$$20240916$20240925$20240925$EXP$$IT-DEXPHARM-2024-3205$DEXCEL$Corbelli E, Fantaguzzi F, Iuliano L, Knutsson KA, Bandello F. Corneal descemetocele following nd:YAG laser capsulotomy in a patient with Steven Johnson Syndrome: A case report. American Journal of Ophthalmology Case Reports. 2024 Dec;36:102150. doi:10.1016/j.ajoc.2024.102150$52$YR$A$M$Y$$$20240925$$CN$IT$IT
243604501$24360450$1$I$20240714$20240917$20240925$20240925$EXP$$US-JNJFOC-20240757541$JOHNSON AND JOHNSON$$69$YR$E$M$Y$70$KG$20240925$$HP$US$US
243604511$24360451$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244621$TEVA$$60$YR$$F$Y$$$20240925$$HP$CA$CA
243604521$24360452$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244790$TEVA$$50$YR$$M$Y$83$KG$20240925$$HP$CA$CA
243604531$24360453$1$I$20240918$20240919$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046714$AUROBINDO$$57$YR$$F$Y$70$KG$20240925$$CN$GB$GB
243604541$24360454$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014921$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240925$$CN$US$US
243604551$24360455$1$I$20240902$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014493$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240925$$CN$US$US
243604581$24360458$1$I$20240823$20240906$20240925$20240925$PER$$US-TOLMAR, INC.-24US052218$TOLMAR$$$$$$Y$$$20240925$$HP$US$US
243604591$24360459$1$I$20240828$20240906$20240925$20240925$PER$$US-TOLMAR, INC.-24US052204$TOLMAR$$95$YR$$M$Y$$$20240925$$HP$US$US
243604601$24360460$1$I$20240101$20240905$20240925$20240925$PER$$US-TOLMAR, INC.-24US052305$TOLMAR$$$$$M$Y$$$20240925$$HP$US$US
243604611$24360461$1$I$$20240916$20240925$20240925$EXP$$FR-ROCHE-10000084051$ROCHE$Bettacchioli E, Foulquier J, Chevet B, Cornec-Le Gall E, Hanrotel C, Lanfranco L, et al. Dual MPO/PR3 ANCA positivity and vasculitis: Insights from a 7-cases study and an AI-powered literature review. Rheumatology (United Kingdom). 2024-Sep-01;63 (9):2557-2568. doi:10.1093/rheumatology/keae170.$81$YR$E$M$Y$$$20240925$$HP$FR$FR
243604621$24360462$1$I$$20240905$20240925$20240925$PER$$US-TOLMAR, INC.-24US052359$TOLMAR$$$$$M$Y$$$20240925$$CN$US$US
243604631$24360463$1$I$$20240919$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150409$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240925$$PH$US$US
243604641$24360464$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151571$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240925$$CN$US$US
243604651$24360465$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151531$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240925$$CN$US$US
243604661$24360466$1$I$$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024189663$AMGEN$$$$$F$Y$$$20240925$$HP$US$US
243604671$24360467$1$I$$20240918$20240925$20240925$EXP$$PH-AMGEN-PHLSP2024187296$AMGEN$Carolino D. D.; Tud A. R.. Functional Outcomes of Limb Salvage Surgery in Patients with Giant Cell Tumor of Bone of the Lower Extremities: A Cross-sectional Comparative Study. Acta medica Philippina. 2024;58 (14):34-40$$$$$Y$$$20240925$$MD$PH$PH
243604681$24360468$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244593$TEVA$$11$YR$$F$Y$$$20240925$$HP$CA$CA
243604691$24360469$1$I$$20240920$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-047000$AUROBINDO$$$$$M$Y$94$KG$20240925$$CN$GB$GB
243604701$24360470$1$I$$20240917$20240925$20240925$EXP$$CN-ROCHE-10000084472$ROCHE$Chen X, Liang Y, Jiang S. Clinical characteristics, treatment and prognosis of children with SARS-CoV-2 infection complicated with severe neurological dysfunctions in Foshan, China. Frontiers in Pediatrics. 2024-Jan;12: doi:10.3389/fped.2024.1414023.$1$YR$I$F$Y$$$20240925$$HP$CN$CN
243604711$24360471$1$I$20230504$20240913$20240925$20240925$EXP$ES-AEMPS-1365813$ES-CELLTRION INC.-2024ES022645$CELLTRION$$$$$$Y$$$20240925$$MD$ES$ES
243604731$24360473$1$I$20240914$20240916$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046199$AUROBINDO$$38$YR$$F$Y$70$KG$20240925$$MD$GB$GB
243604741$24360474$1$I$20240909$20240916$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046206$AUROBINDO$$$$$$Y$$$20240925$$PH$GB$GB
243604751$24360475$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244617$TEVA$$58$YR$$M$Y$$$20240925$$HP$CA$CA
243604761$24360476$1$I$$20240916$20240925$20240925$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK094133$GLENMARK$$$$$$Y$$$20240925$$PH$GB$GB
243604771$24360477$1$I$20230816$20240916$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046205$AUROBINDO$$62$YR$$F$Y$80$KG$20240925$$CN$GB$GB
243604781$24360478$1$I$$20240918$20240925$20240925$PER$$US-JNJFOC-20240949542$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$US$US
243604791$24360479$1$I$20240912$20240915$20240925$20240925$EXP$FI-FIMEA-202403333$FI-GE HEALTHCARE-2024CSU010573$GE HEALTHCARE$$77$YR$$F$Y$$$20240925$$MD$FI$FI
243604801$24360480$1$I$$20240913$20240925$20240925$EXP$$IT-AUROBINDO-AUR-APL-2024-046257$AUROBINDO$Matrone A.; Brancatella A.; Marchetti P. et.al.. patient with MEN 1 and end-stage chronic kidney disease due to alport syndrome: Decision making on the eligibility of transplantation. Molecular and Clinical Oncology. 2018;8:449-452$36$YR$$M$Y$$$20240925$$MD$IT$IT
243604811$24360481$1$I$20240824$20240916$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046678$AUROBINDO$$78$YR$$F$Y$49$KG$20240925$$PH$FR$FR
243604821$24360482$1$I$20130103$20240916$20240925$20240925$PER$$US-JNJFOC-20240943731$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240925$$HP$US$US
243604841$24360484$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151593$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240925$$HP$US$US
243604851$24360485$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151537$BRISTOL MYERS SQUIBB$$36$YR$A$F$Y$$$20240925$$HP$US$US
243604861$24360486$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151225$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240925$$CN$US$US
243604871$24360487$1$I$20240819$20240925$20240925$20240925$EXP$FR-AFSSAPS-PP2024001014$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053310$BOEHRINGER INGELHEIM$$55$YR$A$M$Y$$$20240925$$PH$FR$FR
243604891$24360489$1$I$20230901$20240918$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046951$AUROBINDO$$19$YR$$M$Y$71.4$KG$20240925$$PH$FR$FR
243604901$24360490$1$I$$20240913$20240925$20240925$EXP$$PT-AUROBINDO-AUR-APL-2024-046433$AUROBINDO$Manique I.; Cortez L.; Silva-nunes J.. PARATHYROID CARCINOMA: A RARE DIAGNOSIS AND AN UNCOMMON PRESENTATION.. Congresso Portugues de Endocrinologia / 74 ^a Reuniao Anual da SPEDM.. 2023;18:55$49$YR$$M$Y$$$20240925$$HP$PT$PT
243604911$24360491$1$I$$20240913$20240925$20240925$EXP$$IT-AUROBINDO-AUR-APL-2024-046505$AUROBINDO$Cetani F.; Elena P.; Torregrossa L. et al.. Approach to the Patient With Parathyroid Carcinoma.. The Journal of clinical endocrinology and metabolism.. 2023;1-43$50$YR$$M$Y$$$20240925$$HP$IT$IT
243604921$24360492$1$I$$20240918$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-039279$AUROBINDO$Suheyla k, Azmaeen Z, Alesia T, Muhammed H.. Transient haemoptysis after taking sildenafil. BMJ Case Rep. 2024;17(7):e258050 (1-3)$$$E$M$Y$$$20240925$$HP$US$US
243604941$24360494$1$I$$20240913$20240925$20240925$PER$$US-JNJFOC-20240942706$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243604951$24360495$1$I$20240821$20240821$20240925$20240925$PER$$US-ABBVIE-5936029$ABBVIE$$40$YR$$$Y$$$20240925$$MD$US$US
243604961$24360496$1$I$$20240911$20240925$20240925$PER$$US-JNJFOC-20240933723$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243604991$24360499$1$I$$20240916$20240925$20240925$EXP$GB-MHRA-MED-202409142302073110-RQNDG$GB-Accord-447270$ACCORD$$29$YR$A$F$Y$$$20240925$$CN$GB$GB
243605001$24360500$1$I$20240801$20240916$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-040796$AUROBINDO$$78$YR$$F$Y$51$KG$20240925$$PH$FR$FR
243605011$24360501$1$I$$20240919$20240925$20240925$EXP$$US-AMGEN-USASP2024188257$AMGEN$$$$$$Y$$$20240925$$MD$US$US
243605021$24360502$1$I$$20240915$20240925$20240925$PER$$US-HALEON-2197149$Haleon PLC$$$$$$Y$$$20240925$$CN$US$US
243605031$24360503$1$I$$20240919$20240925$20240925$EXP$$GB-ROCHE-10000086816$ROCHE$$76$YR$E$F$Y$$$20240925$$HP$GB$GB
243605051$24360505$1$I$$20240920$20240925$20240925$EXP$$DE-AUROBINDO-AUR-APL-2024-046824$AUROBINDO$$71$YR$$F$Y$98$KG$20240925$$CN$DE$DE
243605061$24360506$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014613$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240925$$CN$US$US
243605071$24360507$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014443$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240925$$CN$US$US
243605081$24360508$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014666$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240925$$CN$US$US
243605091$24360509$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013690$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243605101$24360510$1$I$20240922$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015212$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240925$$CN$US$US
243605111$24360511$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014589$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240925$$CN$US$US
243605121$24360512$1$I$20240910$20240910$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409009790$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240925$$CN$US$US
243605131$24360513$1$I$20240601$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014712$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240925$$CN$US$US
243605141$24360514$1$I$20240921$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014893$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240925$$CN$US$US
243605151$24360515$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015357$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240925$$HP$US$US
243605161$24360516$1$I$20240917$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014536$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240925$$CN$US$US
243605171$24360517$1$I$20240715$20240913$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046305$AUROBINDO$$72$YR$$M$Y$66$KG$20240925$$CN$GB$GB
243605181$24360518$1$I$$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024188769$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243605191$24360519$1$I$20240921$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151289$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$56.6$KG$20240925$$PH$US$US
243605201$24360520$1$I$$20240831$20240925$20240925$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005236$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240925$$CN$US$US
243605211$24360521$1$I$20200801$20240920$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-047033$AUROBINDO$$30$YR$$F$Y$79$KG$20240925$$CN$GB$GB
243605221$24360522$1$I$20211101$20240910$20240925$20240925$EXP$$DE-GLANDPHARMA-DE-2024GLNLIT00772$GLAND PHARMA$Roch C.Successful use of Rectal Pregabalin for the Treatment of Chemotherapy-Induced Neuropathic Pain-a Case Report.Journal of Palliative Care.JAN-2023;38:412-415$65$YR$A$F$Y$$$20240925$$HP$DE$DE
243605231$24360523$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024190164$AMGEN$$$$$F$Y$$$20240925$$CN$US$US
243605241$24360524$1$I$20240923$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189856$AMGEN$$61$YR$A$F$Y$$$20240925$$CN$US$US
243605261$24360526$1$I$20240524$20240903$20240925$20240925$30DAY$$BR-JNJFOC-20240916280$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$PH$BR$BR
243605271$24360527$1$I$$20240917$20240925$20240925$EXP$$GB-JAZZ PHARMACEUTICALS-2024-GB-015408$JAZZ$$7$YR$$M$Y$$$20240925$$HP$GB$GB
243605281$24360528$1$I$$20240913$20240925$20240925$EXP$$IT-AUROBINDO-AUR-APL-2024-046260$AUROBINDO$Giuliani C.; Di Dalmazi G.; Napolitano G.. Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism.. Frontiers in Endocrinology.. 2018;9(777):1-6$80$YR$$M$Y$$$20240925$$HP$IT$IT
243605292$24360529$2$F$20240829$20240905$20240925$20240930$30DAY$$US-JNJFOC-20240913185$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240930$$CN$US$US
243605301$24360530$1$I$$20240917$20240925$20240925$EXP$$NVSC2024US188088$NOVARTIS$Vandolah H, Crossley JR, Kim HJ. Three cases of uncommon medication?associated osteonecrosis of temporal bone. WORLD JOURNAL OF OTORHINOLARYNGOLOGY - HEAD AND NECK SURGERY. 2024;10:237?40$60$YR$$M$Y$$$20240925$$HP$US$US
243605331$24360533$1$I$$20240910$20240925$20240925$EXP$$US-GLANDPHARMA-US-2024GLNLIT00767$GLAND PHARMA$Credo R.Acute Intermittent Porphyria in a Burn Patient.Journal of Burn Care and Research.JAN-2024;45:790-795$60$YR$A$M$Y$$$20240925$$HP$US$US
243605341$24360534$1$I$$20240916$20240925$20240925$EXP$$CA-APOTEX-2024AP011011$APOTEX$$55$YR$$F$Y$$$20240925$$HP$CA$CA
243605361$24360536$1$I$$20240916$20240925$20240925$EXP$$SK-CELLTRION INC.-2023SK007674$CELLTRION$$$$$$Y$$$20240925$$MD$SK$SK
243605371$24360537$1$I$$20240918$20240925$20240925$PER$$US-GSK-US2024116154$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
243605381$24360538$1$I$20240101$20240919$20240925$20240925$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-150923$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240925$$CN$DE$DE
243605391$24360539$1$I$$20240919$20240925$20240925$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03470$AMNEAL$$$$$M$Y$$$20240925$$CN$US$US
243605412$24360541$2$F$$20240913$20240925$20240926$EXP$$PL-AUROBINDO-AUR-APL-2024-046404$AUROBINDO$Gorska M. Diffuse alveolar hemorrhage in a chronically hemodialyzed patient with progressive necrotic skin lesions as a manifestation of calciphylaxis. Polish Archives of Internal Medicine. 2023;133 (6)::1-3.$49$YR$$F$Y$$$20240926$$MD$PL$PL
243605421$24360542$1$I$20240920$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189864$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243605431$24360543$1$I$20240921$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189886$AMGEN$$73$YR$E$F$Y$$$20240925$$CN$US$US
243605461$24360546$1$I$$20240918$20240925$20240925$PER$$US-ABBVIE-5930382$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243605471$24360547$1$I$20240914$20240917$20240925$20240925$EXP$$GB-JNJFOC-20240960119$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20240925$$CN$GB$GB
243605481$24360548$1$I$$20240911$20240925$20240925$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09254$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243605491$24360549$1$I$20240704$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046149$AUROBINDO$$57$YR$$$Y$57$KG$20240925$$PH$FR$FR
243605501$24360550$1$I$$20240911$20240925$20240925$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-09126$LUPIN$Jangid NC, Choudhary AN, Shah BJ, Shah SR, Vyas HR, Mistry D. Clinico-therapeutic study of Stevens Johnson syndrome-toxic epidermal necrolysis and prognostic significance of SCORTEN in Indian patients. Indian Journal of Dermatology. 2024;69 (1):24-31$$$$$Y$$$20240925$$MD$IN$IN
243605511$24360551$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189478$AMGEN$$$$$M$Y$$$20240925$$CN$US$US
243605521$24360552$1$I$20240904$20240905$20240925$20240925$EXP$$US-SA-2024SA273677$SANOFI AVENTIS$$59$YR$A$F$Y$93.64$KG$20240925$$MD$US$US
243605531$24360553$1$I$$20240917$20240925$20240925$EXP$$IT-CELLTRION INC.-2024DE022563$CELLTRION$Barberio B, Verstockt B, Fumery M, Pugliese D, Bertani L, Buda A, et al.. Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series. J Crohns Colitis. 2022;16:1845-1852$$$$$Y$$$20240925$$MD$IT$DE
243605541$24360554$1$I$20240101$20240919$20240925$20240925$EXP$$US-ABBVIE-5932797$ABBVIE$$$$A$F$Y$$$20240925$$MD$US$US
243605551$24360555$1$I$20240906$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014393$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240925$$CN$US$US
243605561$24360556$1$I$20240912$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014577$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240925$$CN$US$US
243605581$24360558$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014297$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240925$$CN$US$US
243605591$24360559$1$I$20240801$20240916$20240925$20240925$EXP$$GT-JNJFOC-20240947773$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240925$$HP$GT$GT
243605601$24360560$1$I$20240907$20240916$20240925$20240925$EXP$$CA-JNJFOC-20240927346$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240925$$CN$CA$CA
243605611$24360561$1$I$20240907$20240916$20240925$20240925$EXP$$US-JNJFOC-20240943699$JOHNSON AND JOHNSON$$30$YR$A$$Y$$$20240925$$CN$US$US
243605621$24360562$1$I$$20240812$20240925$20240925$EXP$$BE-EXELIXIS-CABO-23063342$EXELIXIS$$$$$$Y$$$20240925$$HP$BE$BE
243605631$24360563$1$I$20230101$20240910$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-144433$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240925$$MD$US$US
243605641$24360564$1$I$$20240514$20240925$20240925$EXP$$CA-HALEON-2197899$Haleon PLC$$58$YR$$F$Y$$$20240924$$CN$CA$CA
243605661$24360566$1$I$$20240919$20240925$20240925$PER$$US-AMGEN-USASP2024187922$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243605671$24360567$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244493$TEVA$$47$YR$$F$Y$$$20240925$$HP$CA$CA
243605681$24360568$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244489$TEVA$$48$YR$$F$Y$$$20240925$$HP$CA$CA
243605691$24360569$1$I$20240101$20240917$20240925$20240925$EXP$$US-AMGEN-USASP2024186024$AMGEN$$84$YR$E$F$Y$$$20240925$$HP$US$US
243605701$24360570$1$I$20240919$20240923$20240925$20240925$EXP$$US-TAKEDA-2024TUS094788$TAKEDA$$69$YR$$F$Y$$$20240925$$CN$US$US
243605711$24360571$1$I$$20240916$20240925$20240925$EXP$GB-MHRA-MIDB-d6b2a154-f451-4c48-b949-b491b3fb136f$GB-DEXPHARM-2024-3216$DEXCEL$$$$A$$Y$$$20240925$$HP$GB$GB
243605721$24360572$1$I$$20240918$20240925$20240925$EXP$$US-AMGEN-USASP2024187667$AMGEN$Peekea J.; Tang-Wai R.; Robison A.et.al. Rasmussen^s encephalitis in a pediatric patient with subtle early MRI changes: A case report. Radiology Case Reports. 2024;19:5496-5500$5$YR$C$F$Y$$$20240925$$HP$US$US
243605731$24360573$1$I$$20240923$20240925$20240925$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015968$JAZZ$$$$$M$Y$52.154$KG$20240925$$HP$US$US
243605741$24360574$1$I$$20240918$20240925$20240925$PER$$US-GSK-US2024AMR116339$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
243605751$24360575$1$I$$20240917$20240925$20240925$PER$$US-ABBVIE-5930012$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243605771$24360577$1$I$$20240913$20240925$20240925$EXP$$DE-AUROBINDO-AUR-APL-2024-046324$AUROBINDO$Frohling S, Teleanu M. V, Fuss C. T. et al. Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling. Molecular Oncology. 2023;17 (7):1343-1355$82$YR$$F$Y$$$20240925$$HP$DE$DE
243605781$24360578$1$I$20201201$20240916$20240925$20240925$EXP$$US-ABBVIE-5930049$ABBVIE$$70$YR$$M$Y$108$KG$20240925$$HP$US$US
243605791$24360579$1$I$$20240918$20240925$20240925$EXP$$TW-AMGEN-TWNSP2024187691$AMGEN$Sheu B.C.; Huang K.J.; Chang W.C. et al.. Urine Protein to Creatinine Ratio for the Assessment of Bevacizumab-Associated Proteinuria in Patients with Gynecologic Cancers: A Diagnostic and Quality Improvement Study. Diagnostics. 2024;14 (17):1-10$$$$$Y$$$20240925$$HP$TW$TW
243605802$24360580$2$F$$20240918$20240925$20240925$PER$$US-AMGEN-USASP2024188727$AMGEN$Nauffal M.; Eng S.; Lin A. et al.. Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation. Case Reports in Hematology. 2024;1-4$75$YR$E$F$Y$$$20240925$$HP$US$US
243605811$24360581$1$I$$20240919$20240925$20240925$EXP$$IN-AMGEN-INDSP2024188416$AMGEN$Garg K.; Kale S.S.: Mishra S. et al.. Surgical Management of Extradural Tumors at the Craniovertebral Junction - Insights from a Tertiary Care  Center. World Neurosurgery. 2024;189:e652-e661$4$YR$C$M$Y$$$20240925$$HP$IN$IN
243605821$24360582$1$I$$20240918$20240925$20240925$EXP$$TW-AMGEN-TWNSP2024187672$AMGEN$Sheu B.C.; Huang K.J.; Chang W.C. et al.. Urine Protein to Creatinine Ratio for the Assessment of Bevacizumab-Associated Proteinuria in Patients with Gynecologic Cancers: A Diagnostic and Quality Improvement Study. Diagnostics. 2024;14 (17):1-10$$$$$Y$$$20240925$$HP$TW$TW
243605831$24360583$1$I$20240313$20240913$20240925$20240925$EXP$$IT-AUROBINDO-AUR-APL-2024-046373$AUROBINDO$$46$YR$$F$Y$$$20240925$$MD$IT$IT
243605841$24360584$1$I$$20240919$20240925$20240925$EXP$$BE-ABBVIE-5933439$ABBVIE$$$$$F$Y$$$20240925$$PH$BE$BE
243605851$24360585$1$I$$20240916$20240925$20240925$EXP$$ES-TAKEDA-2024TUS094674$TAKEDA$$77$YR$$F$Y$77$KG$20240925$$MD$ES$ES
243605861$24360586$1$I$20240101$20240905$20240925$20240925$PER$$US-TEVA-VS-3242329$TEVA$$87$YR$$M$Y$$$20240925$$CN$US$US
243605871$24360587$1$I$20240901$20240920$20240925$20240925$EXP$$CA-JNJFOC-20240960007$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20240925$$HP$CA$CA
243605881$24360588$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150142$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240925$$HP$US$US
243605891$24360589$1$I$20240922$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150855$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240925$$CN$US$US
243605901$24360590$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151493$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240925$$CN$US$US
243605911$24360591$1$I$$20240918$20240925$20240925$EXP$$ES-TAKEDA-2024TUS094728$TAKEDA$$$$$$Y$$$20240925$$CN$ES$ES
243605921$24360592$1$I$20240801$20240917$20240925$20240925$EXP$$ZA-AMGEN-ZAFSP2024188242$AMGEN$$75$YR$E$M$Y$75$KG$20240925$$MD$ZA$ZA
243605931$24360593$1$I$20240901$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189931$AMGEN$$56$YR$A$F$Y$$$20240925$$CN$US$US
243605941$24360594$1$I$20120101$20240916$20240925$20240925$PER$$US-JNJFOC-20240958282$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240925$$HP$US$US
243605951$24360595$1$I$$20240910$20240925$20240925$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00791$GLAND PHARMA$H Chen.Efficacy and toxicity of simultaneous integrated boost intensity modulated radiation therapy combined with concurrent chemotherapy in patients with locally advanced thoracic esophageal squamous cell carcinoma.Journal of Practical Oncology.JAN-2023;38(1):46-53$$$$$Y$$$20240925$$HP$CN$CN
243605961$24360596$1$I$20240917$20240918$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013848$DR REDDYS$$64$YR$A$F$Y$$$20240925$$MD$US$US
243605971$24360597$1$I$20240921$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024190029$AMGEN$$84$YR$E$M$Y$$$20240925$$CN$US$US
243605981$24360598$1$I$20240817$20240919$20240925$20240925$EXP$IT-MINISAL02-1001645$IT-TEVA-VS-3246158$TEVA$$62$YR$$M$Y$$$20240925$$MD$IT$IT
243605991$24360599$1$I$20240618$20240916$20240925$20240925$EXP$SE-SEMPA-2024-006549$SE-Accord-447443$ACCORD$$57$YR$A$M$Y$$$20240925$$MD$SE$SE
243606001$24360600$1$I$20240922$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189673$AMGEN$$62$YR$A$F$Y$$$20240925$$CN$US$US
243606011$24360601$1$I$$20240919$20240925$20240925$EXP$$SE-TAKEDA-2024TUS094722$TAKEDA$$75$YR$$M$Y$$$20240925$$HP$SE$SE
243606021$24360602$1$I$20230420$20240916$20240925$20240925$EXP$FR-AFSSAPS-CF2023000344$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112423$ZYDUS PHARM$$$$$$Y$$$20240925$$MD$FR$FR
243606031$24360603$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014605$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240925$$CN$US$US
243606041$24360604$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015090$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240925$$CN$US$US
243606051$24360605$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014598$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240925$$CN$US$US
243606061$24360606$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014370$ELI LILLY AND CO$$64$YR$A$$Y$$$20240925$$CN$US$US
243606071$24360607$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014561$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240925$$CN$US$US
243606081$24360608$1$I$20240921$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014676$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240925$$CN$US$US
243606101$24360610$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014726$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240925$$CN$US$US
243606111$24360611$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014646$ELI LILLY AND CO$$$$$$Y$$$20240925$$CN$US$US
243606121$24360612$1$I$20240920$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014486$ELI LILLY AND CO$$35$YR$A$$Y$$$20240925$$CN$US$US
243606131$24360613$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014722$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240925$$HP$US$US
243606141$24360614$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014556$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240925$$CN$US$US
243606151$24360615$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015129$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240925$$CN$US$US
243606161$24360616$1$I$20240630$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014733$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240925$$CN$US$US
243606171$24360617$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014593$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240925$$CN$US$US
243606181$24360618$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014509$ELI LILLY AND CO$$62$YR$A$$Y$$$20240925$$CN$US$US
243606191$24360619$1$I$20240719$20240917$20240925$20240925$EXP$$BR-JNJFOC-20240742496$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240925$$CN$BR$BR
243606201$24360620$1$I$20240101$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151385$BRISTOL MYERS SQUIBB$$78$YR$E$$Y$$$20240925$$CN$US$US
243606211$24360621$1$I$$20240910$20240925$20240925$EXP$$DK-GLANDPHARMA-DK-2024GLNLIT00781$GLAND PHARMA$Torjus Skajaa.Acute kidney injury in a child treated with cisplatin and amphotericin B.Cancer Chemotherapy and Pharmacology.07-AUG-2024$17$YR$T$F$Y$$$20240925$$HP$DK$DK
243606221$24360622$1$I$20240101$20240913$20240925$20240925$EXP$$US-INSMED, INC.-2024-03722-US$INSMED$$$$$F$Y$$$20240925$$CN$US$US
243606231$24360623$1$I$$20240916$20240925$20240925$EXP$$CA-APOTEX-2024AP011001$APOTEX$$32$YR$$F$Y$$$20240925$$CN$CA$CA
243606241$24360624$1$I$20240801$20240913$20240925$20240925$EXP$$US-UCBSA-2024047604$UCB$$41$YR$$F$Y$$$20240925$$HP$US$US
243606251$24360625$1$I$$20240910$20240925$20240925$EXP$$ES-GLANDPHARMA-ES-2024GLNLIT00770$GLAND PHARMA$Josu Erquicia Peralt.An acute coronary syndrome in an unusual  patient: analysing cisplatin toxicity-a case  report and review of the literature.European Heart Journal - Case Reports.AUG-2024;8:365$23$YR$A$M$Y$$$20240925$$HP$ES$ES
243606261$24360626$1$I$20240913$20240913$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046018$AUROBINDO$$53$YR$$M$Y$75$KG$20240925$$MD$GB$GB
243606271$24360627$1$I$20240801$20240912$20240925$20240925$EXP$$JP-AMGEN-JPNSP2024174059$AMGEN$$8$DEC$E$$Y$72.1$KG$20240925$$MD$JP$JP
243606281$24360628$1$I$20240918$20240918$20240925$20240925$PER$$US-AMGEN-USASP2024187059$AMGEN$$$$$$Y$$$20240925$$PH$US$US
243606291$24360629$1$I$20240921$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189898$AMGEN$$71$YR$E$F$Y$$$20240925$$CN$US$US
243606301$24360630$1$I$$20240912$20240925$20240925$EXP$$PL-AUROBINDO-AUR-APL-2024-044868$AUROBINDO$Mo?d?e? K, Murawska A, Hypnar J, P?dziwiatr E, Po?piech J, Bosak M. Status epilepticus in pregnant patients - two case reports and literature review. POLSKI PRZEGL?D NEUROLOGICZNY (Polish Neurological Review). 2024;20(2):115-128$28$YR$$F$Y$$$20240925$$HP$PL$PL
243606321$24360632$1$I$20210211$20240913$20240925$20240925$EXP$$DE-AUROBINDO-AUR-APL-2024-046476$AUROBINDO$$49$YR$$F$Y$$$20240925$$MD$DE$DE
243606331$24360633$1$I$20240626$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046495$AUROBINDO$$49$YR$$M$Y$$$20240925$$HP$FR$FR
243606341$24360634$1$I$$20240916$20240925$20240925$EXP$$CA-JNJFOC-20240947910$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$PH$CA$CA
243606351$24360635$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150769$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$77.56$KG$20240925$$HP$US$US
243606361$24360636$1$I$$20240920$20240925$20240925$EXP$$US-ABBVIE-5934253$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243606371$24360637$1$I$20221201$20240913$20240925$20240925$EXP$FR-AFSSAPS-LL2023000720$FR-CELLTRION INC.-2024FR022657$CELLTRION$$$$$$Y$$$20240925$$MD$FR$FR
243606381$24360638$1$I$$20240913$20240925$20240925$EXP$$DE-AUROBINDO-AUR-APL-2024-046474$AUROBINDO$Valor-Mendez L.; Atzinger A.; Reis P. et al.. Clinical Images: Increased bone metabolism in secondary hyperparathyroidism.. Arthritis + Rheumatology.. 2023;75 (6):1072$47$YR$$M$Y$$$20240925$$MD$DE$DE
243606391$24360639$1$I$20240816$20240921$20240925$20240925$EXP$$CN-HALEON-2197957$Haleon PLC$$33$YR$$F$Y$45$KG$20240925$$HP$CN$CN
243606401$24360640$1$I$20240831$20240922$20240925$20240925$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015947$JAZZ$$88$YR$$F$Y$$$20240925$$CN$US$US
243606411$24360641$1$I$20220912$20240919$20240925$20240925$EXP$$CO-UCBSA-2024048939$UCB$$49$YR$$M$Y$$$20240925$$CN$CO$CO
243606431$24360643$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189806$AMGEN$$$$$F$Y$$$20240925$$HP$US$US
243606441$24360644$1$I$20240917$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024190113$AMGEN$$77$YR$E$F$Y$$$20240925$$CN$US$US
243606461$24360646$1$I$$20240913$20240925$20240925$EXP$$ES-AUROBINDO-AUR-APL-2024-035417$AUROBINDO$Neacsu ED, Montalban EM, de Miguel BM. Resolution of a rare case of hypercalcemia in a PTHrpproducing pancreatic neuroendocrine tumor using selective internal radiation therapy with 90Y microspheres. Ann-Pancreat-Cancer. 2024;7:5:1-7$7$DEC$$F$Y$$$20240925$$HP$ES$ES
243606471$24360647$1$I$$20240910$20240925$20240925$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09464$LUPIN$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al. Clinical characteristics and HLA associations of Azithromycin-induced liver injury. Alimentary Pharmacology and Therapeutics. 2024;60:787-795$$$A$$Y$$$20240925$$HP$US$US
243606481$24360648$1$I$$20240925$20240925$20240925$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053285$BOEHRINGER INGELHEIM$Tokuhide Kimura, Jiro Kamiyama, Kazuki Hasegawa, Motohiro Tsuboi, Hajime Suzuki, Masashi Gokita, Shigemasa Taguchi, Koichi Yasaka, Kazuya Kiyota; O9-6 A case of euglycemic ketoacidosis with buttock abscess and decreased blood pressure during oral administration of SGLT2 inhibitor; 75$55$YR$A$M$Y$67.5$KG$20240925$$MD$JP$JP
243606491$24360649$1$I$$20240917$20240925$20240925$EXP$$CA-ROCHE-10000084382$ROCHE$$60$YR$A$F$Y$$$20240925$$HP$CA$CA
243606501$24360650$1$I$20240101$20240920$20240925$20240925$EXP$$CA-ABBVIE-5933837$ABBVIE$$$$E$F$Y$$$20240925$$HP$CA$CA
243606511$24360651$1$I$$20240919$20240925$20240925$PER$$US-AMGEN-USASP2024188825$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243606521$24360652$1$I$$20240913$20240925$20240925$EXP$$JP-AMGEN-JPNSP2024189275$AMGEN$$$$$$Y$$$20240925$$MD$JP$JP
243606531$24360653$1$I$20160101$20240913$20240925$20240925$EXP$$NL-AUROBINDO-AUR-APL-2024-046400$AUROBINDO$Prins RHN, Moolenaar WVT... Primary cutaneous cos+ aggressive epidermotropic cytotoxic T-cel lymphoma, as post-transplant lymphoproliferative disorder (PTLD) after kidney transplantation: a case study.. 2024;21:283-7. Dutch Journal for Hematology.. 2024;21:283-7$35$YR$$M$Y$$$20240925$$HP$NL$NL
243606541$24360654$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013675$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240925$$CN$US$US
243606551$24360655$1$I$20230128$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013557$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240925$$CN$US$US
243606561$24360656$1$I$$20240919$20240925$20240925$PER$$US-ABBVIE-5931732$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243606571$24360657$1$I$20240830$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014220$ELI LILLY AND CO$$$$$$Y$$$20240925$$CN$US$US
243606581$24360658$1$I$20240919$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014907$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240925$$CN$US$US
243606591$24360659$1$I$$20240921$20240925$20240925$PER$$US-HALEON-2198310$Haleon PLC$$$$$$Y$$$20240925$$CN$US$US
243606601$24360660$1$I$20240901$20240919$20240925$20240925$EXP$$US-ABBVIE-5933114$ABBVIE$$58$YR$$F$Y$$$20240925$$CN$US$US
243606611$24360661$1$I$20240821$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151682$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$102.51$KG$20240925$$PH$US$US
243606621$24360662$1$I$20240101$20240917$20240925$20240925$EXP$$US-JNJFOC-20240950981$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240925$$CN$US$US
243606631$24360663$1$I$20240901$20240919$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151315$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$84.37$KG$20240925$$CN$US$US
243606651$24360665$1$I$20240509$20240913$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-045925$AUROBINDO$$85$YR$$F$Y$$$20240925$$MD$GB$GB
243606661$24360666$1$I$20240913$20240913$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-045998$AUROBINDO$$$$$$Y$$$20240925$$HP$GB$GB
243606671$24360667$1$I$$20231128$20240925$20240925$PER$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67782$HIKMA$$$$$$Y$$$20240925$$MD$US$US
243606681$24360668$1$I$20240701$20240913$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-045990$AUROBINDO$$71$YR$$F$Y$58$KG$20240925$$PH$GB$GB
243606691$24360669$1$I$$20240917$20240925$20240925$EXP$$JP-EXELIXIS-EXL-2024-000441$EXELIXIS$$$$$M$Y$$$20240925$$MD$JP$JP
243606701$24360670$1$I$$20240917$20240925$20240925$EXP$$JP-EXELIXIS-EXL-2024-000438$EXELIXIS$$$$$M$Y$$$20240925$$MD$JP$JP
243606711$24360671$1$I$$20240913$20240925$20240925$EXP$$DE-AUROBINDO-AUR-APL-2024-046328$AUROBINDO$$70$YR$$M$Y$$$20240925$$MD$DE$DE
243606731$24360673$1$I$$20240916$20240925$20240925$PER$$US-JNJFOC-20240959388$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240925$$CN$US$US
243606741$24360674$1$I$$20240916$20240925$20240925$PER$$US-JNJFOC-20240959384$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$CN$US$US
243606751$24360675$1$I$$20240906$20240925$20240925$30DAY$$KR-JNJFOC-20240934943$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$KR$KR
243606761$24360676$1$I$$20240917$20240925$20240925$PER$$US-JNJFOC-20240955434$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$US$US
243606771$24360677$1$I$20240801$20240913$20240925$20240925$EXP$$US-UCBSA-2024047514$UCB$$35$YR$$F$Y$$$20240925$$HP$US$US
243606781$24360678$1$I$20240801$20240921$20240925$20240925$EXP$$EG-ABBVIE-5935167$ABBVIE$$39$YR$$F$Y$$$20240925$$CN$EG$EG
243606801$24360680$1$I$20240901$20240916$20240925$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029348$UNITED THERAPEUTICS$$62$YR$$F$Y$96.145$KG$20240925$$$US$US
243606811$24360681$1$I$20240101$20240925$20240925$20240925$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053329$BOEHRINGER INGELHEIM$$80$YR$E$M$Y$$$20240925$$HP$SG$SG
243606841$24360684$1$I$$20240923$20240925$20240925$EXP$$US-ABBVIE-5936997$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243606851$24360685$1$I$$20240914$20240925$20240925$EXP$$US-UCBSA-2024048004$UCB$$$$A$F$Y$$$20240925$$CN$US$US
243606861$24360686$1$I$$20240923$20240925$20240925$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015971$JAZZ$$29$YR$$M$Y$$$20240925$$CN$US$US
243606871$24360687$1$I$$20240918$20240925$20240925$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053200$BOEHRINGER INGELHEIM$$62$YR$A$F$Y$$$20240925$$CN$US$US
243606901$24360690$1$I$20240906$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024188644$AMGEN$$67$YR$E$M$Y$$$20240925$$CN$US$US
243606911$24360691$1$I$20240101$20240919$20240925$20240925$PER$$US-AMGEN-USASP2024187712$AMGEN$$75$YR$E$F$Y$$$20240925$$HP$US$US
243606931$24360693$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151773$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$78.47$KG$20240925$$CN$US$US
243606941$24360694$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150739$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240925$$CN$US$US
243606951$24360695$1$I$$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150482$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240925$$CN$US$US
243606961$24360696$1$I$20240701$20240923$20240925$20240925$EXP$SE-SEMPA-2024-006908$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-151390$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240925$$MD$SE$SE
243606971$24360697$1$I$$20240917$20240925$20240925$EXP$$MX-JNJFOC-20240956472$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240925$$CN$MX$MX
243606981$24360698$1$I$$20240918$20240925$20240925$PER$$US-JNJFOC-20240948777$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$CN$US$US
243607001$24360700$1$I$20240101$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190262$AMGEN$$$$$F$Y$$$20240925$$HP$US$US
243607011$24360701$1$I$$20240917$20240925$20240925$EXP$$BR-SANDOZ INC.-SDZ2024BR081604$SANDOZ$$$$$F$Y$$$20240925$$CN$BR$BR
243607021$24360702$1$I$20140101$20240923$20240925$20240925$EXP$$DE-SANDOZ INC.-SDZ2024DE082114$SANDOZ$$37$YR$$F$Y$63$KG$20240925$$MD$DE$DE
243607031$24360703$1$I$20240905$20240925$20240925$20240925$EXP$$SG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053322$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240925$$HP$SG$SG
243607041$24360704$1$I$$20240916$20240925$20240925$PER$US-MLMSERVICE-20240906-PI186745-00232-1$US-ROCHE-10000083436$ROCHE$Shrestha P, Shrestha P, Garrahy I, Rahimian S. Eosinophilic granulomatosis with polyangiitis (EGPA) on remission with a new neuropathy a rare case of mycophenolate induced primary CNS lymphoproliferative disease. Journal Journal Of Community Hospital Internal Medicine Perspectives. 2020;10 (6):600-3. doi:10.1080/20009666.2020.1811066.$81$YR$E$F$Y$$$20240925$$MD$US$US
243607051$24360705$1$I$20240801$20240910$20240925$20240925$EXP$$US-RECORDATI RARE DISEASES-2024007072$RECORDATI$$$$$$Y$$$20240925$$CN$US$US
243607071$24360707$1$I$$20240920$20240925$20240925$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053205$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240925$$MD$US$US
243607081$24360708$1$I$$20240911$20240925$20240925$EXP$$PT-AUROBINDO-AUR-APL-2024-045713$AUROBINDO$Silva JC, Gaspar M, Fernandes V, Verdasca F, Pinheiro M. HERPETIC RETINITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS.. Eur-J-Case-Rep-Intern-Med. 2024;11 (Suppl. 1):1040-1041 abstr. 1957$30$YR$$F$Y$$$20240925$$HP$PT$PT
243607091$24360709$1$I$$20240919$20240925$20240925$EXP$$US-SANDOZ INC.-SDZ2024US081839$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
243607101$24360710$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014794$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240925$$CN$US$US
243607111$24360711$1$I$20240101$20240918$20240925$20240925$EXP$$GB-SANDOZ INC.-SDZ2024GB081352$SANDOZ$$$$A$M$Y$73$KG$20240925$$MD$GB$GB
243607121$24360712$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014373$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240925$$CN$US$US
243607131$24360713$1$I$20240913$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015242$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240925$$CN$US$US
243607141$24360714$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409009007$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240925$$CN$US$US
243607151$24360715$1$I$20240913$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014219$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240925$$CN$US$US
243607162$24360716$2$F$$20240920$20240925$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409014209$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240927$$MD$US$US
243607171$24360717$1$I$$20240911$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-045825$AUROBINDO$Beltran LP, Benken J, Jou J, Benedetti E, Nishioka H, Alamreia E, et al. Efficacy and Safety of Perioperative Angiotensin IIVersus Phenylephrine as a First-Line Continuous Infusion Vasopressor in Kidney Transplant Recipients. Clinical Transplantation. 2024;38:e15432$$$A$$Y$$$20240925$$HP$US$US
243607181$24360718$1$I$20240915$20240919$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149449$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240925$$CN$US$US
243607191$24360719$1$I$20240922$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151488$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$86.18$KG$20240925$$CN$US$US
243607201$24360720$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151586$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240925$$HP$US$US
243607211$24360721$1$I$$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015173$ELI LILLY AND CO$$50$YR$A$F$Y$88.435$KG$20240925$$CN$US$US
243607231$24360723$1$I$20240101$20240922$20240925$20240925$PER$$US-AMGEN-USASP2024189818$AMGEN$$64$YR$A$M$Y$$$20240925$$CN$US$US
243607241$24360724$1$I$20240923$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189632$AMGEN$$61$YR$A$F$Y$$$20240925$$CN$US$US
243607271$24360727$1$I$20240701$20240920$20240925$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151355$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$61.8$KG$20240925$$PH$JP$JP
243607281$24360728$1$I$20240420$20240920$20240925$20240925$EXP$$US-SANDOZ INC.-SDZ2024US056216$SANDOZ$$$$$$Y$$$20240925$$PH$US$US
243607301$24360730$1$I$$20240916$20240925$20240925$EXP$$CA-CELLTRION INC.-2024CA022579$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
243607311$24360731$1$I$20240311$20240905$20240925$20240925$EXP$ES-AEMPS-1500789$ES-CELLTRION INC.-2024ES022593$CELLTRION$$$$$$Y$$$20240925$$MD$ES$ES
243607351$24360735$1$I$20220901$20240916$20240925$20240925$EXP$$BR-ROCHE-10000084390$ROCHE$$67$YR$E$F$Y$$$20240925$$MD$BR$BR
243607361$24360736$1$I$20240805$20240921$20240925$20240925$EXP$FR-AFSSAPS-GR2024001133$FR-BEIGENE-BGN-2024-015117$BEIGENE$$$$$$Y$$$20240925$$PH$FR$FR
243607371$24360737$1$I$20240612$20240923$20240925$20240925$EXP$$US-GILEAD-2024-0688677$GILEAD$$19$YR$A$F$Y$$$20240925$$CN$US$US
243607381$24360738$1$I$$20240916$20240925$20240925$EXP$$CA-APOTEX-2024AP011004$APOTEX$$67$YR$$F$Y$64.853$KG$20240925$$MD$CA$CA
243607391$24360739$1$I$20240918$20240919$20240925$20240925$30DAY$$US-AMGEN-USASP2024187532$AMGEN$$66$YR$E$F$Y$64.9$KG$20240925$$HP$US$US
243607411$24360741$1$I$20240919$20240919$20240925$20240925$PER$$US-AMGEN-USASP2024187505$AMGEN$$$$$$Y$$$20240925$$HP$US$US
243607421$24360742$1$I$$20240911$20240925$20240925$PER$$US-JNJFOC-20240935478$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240925$$CN$US$US
243607432$24360743$2$F$20240615$20240923$20240925$20240930$30DAY$$US-AMGEN-USASP2024187748$AMGEN$$65$YR$E$M$Y$79$KG$20240930$$PH$US$US
243607441$24360744$1$I$$20240916$20240925$20240925$PER$$US-TAKEDA-2024TUS092856$TAKEDA$$$$$F$Y$$$20240925$$MD$US$US
243607451$24360745$1$I$$20240916$20240925$20240925$EXP$CA-MHPD-001093729$CA-Accord-447158$ACCORD$$48$YR$A$M$Y$$$20240925$$HP$CA$CA
243607471$24360747$1$I$20240101$20240920$20240925$20240925$EXP$$PR-SA-2024SA275345$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240925$$MD$PR$PR
243607481$24360748$1$I$20240828$20240913$20240925$20240925$EXP$$ES-AUROBINDO-AUR-APL-2024-046283$AUROBINDO$$67$YR$$M$Y$87$KG$20240925$$MD$ES$ES
243607491$24360749$1$I$$20240913$20240925$20240925$EXP$$PL-AUROBINDO-AUR-APL-2024-046430$AUROBINDO$Kaminska D, Koscielska-Kasprzak K, Myszka M, Banasik M, Chelmonski A, Boratynska M et al.,.. Significant infections after hand transplantation in a polish population. TRANSPLANTATION PROCEEDINGS. 2014;46:2887-9$$$A$M$Y$$$20240925$$HP$PL$PL
243607501$24360750$1$I$20201201$20240920$20240925$20240925$EXP$PL-EMA-DD-20240916-7482677-114845$PL-SANDOZ INC.-SDZ2024PL081774$SANDOZ$$49$YR$$M$Y$$$20240925$$HP$PL$PL
243607511$24360751$1$I$$20240916$20240925$20240925$EXP$CA-MHPD-E2B_001092143$CA-Accord-447045$ACCORD$$11$YR$C$F$Y$$$20240925$$HP$CA$CA
243607521$24360752$1$I$$20240918$20240925$20240925$EXP$$IN-ROCHE-10000086919$ROCHE$$56$YR$A$M$Y$$$20240925$$CN$IN$IN
243607531$24360753$1$I$20240615$20240922$20240925$20240925$EXP$$ES-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00497$VELOXIS PHARMACEUTICALS$$57$YR$$M$Y$$$20240925$$MD$ES$ES
243607551$24360755$1$I$20240901$20240916$20240925$20240925$EXP$$US-ORPHANEU-2024007263$RECORDATI$$$$$$Y$$$20240925$$CN$US$US
243607561$24360756$1$I$$20240918$20240925$20240925$EXP$$CA-ROCHE-10000086252$ROCHE$$$$$F$Y$$$20240925$$HP$CA$CA
243607571$24360757$1$I$$20240923$20240925$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US082330$SANDOZ$$$$$M$Y$$$20240925$$CN$US$US
243607581$24360758$1$I$20240901$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150342$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240925$$HP$US$US
243607591$24360759$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150260$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240925$$CN$US$US
243607601$24360760$1$I$20240907$20240924$20240925$20240925$EXP$FR-AFSSAPS-RS2024000882$FR-SANDOZ INC.-SDZ2024FR082597$SANDOZ$$69$YR$$M$Y$76$KG$20240925$$MD$FR$FR
243607611$24360761$1$I$$20240916$20240925$20240925$EXP$$US-ROCHE-10000084359$ROCHE$$$$$$Y$$$20240925$$CN$US$US
243607621$24360762$1$I$20210101$20240919$20240925$20240925$EXP$$US-BIOGEN-2024BI01283575$BIOGEN$$$$$F$Y$$$20240925$$HP$US$US
243607631$24360763$1$I$$20240918$20240925$20240925$EXP$$CO-SANDOZ INC.-SDZ2024CO081643$SANDOZ$$$$$F$Y$$$20240925$$CN$CO$CO
243607641$24360764$1$I$$20240920$20240925$20240925$EXP$$US-BIOGEN-2024BI01282991$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243607651$24360765$1$I$20240101$20240916$20240925$20240925$EXP$FR-AFSSAPS-NY2024000881$FR-Accord-447426$ACCORD$$83$YR$E$M$Y$$$20240925$$MD$FR$FR
243607671$24360767$1$I$20240125$20240911$20240925$20240925$EXP$$US-UCBSA-2024008068$UCB$$70$YR$$M$Y$74.8$KG$20240925$$CN$US$US
243607681$24360768$1$I$$20240921$20240925$20240925$EXP$$JP-ABBVIE-5936460$ABBVIE$$80$YR$$M$Y$$$20240925$$MD$JP$JP
243607701$24360770$1$I$$20240918$20240925$20240925$EXP$$NVSC2024EG189088$NOVARTIS$$$$$M$Y$$$20240925$$CN$EG$EG
243607711$24360771$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024190016$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243607721$24360772$1$I$$20240429$20240925$20240925$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-01532$AMNEAL$$31$YR$$F$Y$$$20240925$$CN$US$US
243607731$24360773$1$I$$20231110$20240925$20240925$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03547$AMNEAL$$$$$$Y$$$20240925$$HP$US$US
243607741$24360774$1$I$$20240108$20240925$20240925$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00071$AMNEAL$$$$$F$Y$$$20240925$$CN$US$US
243607751$24360775$1$I$$20240422$20240925$20240925$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-00880$AMNEAL$$$$$F$Y$$$20240925$$MD$US$US
243607761$24360776$1$I$$20240919$20240925$20240925$EXP$$CA-ABBVIE-5933186$ABBVIE$$$$E$M$Y$$$20240925$$CN$CA$CA
243607771$24360777$1$I$20240101$20240919$20240925$20240925$EXP$$US-ABBVIE-5724793$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243607781$24360778$1$I$$20240919$20240925$20240925$EXP$$US-ABBVIE-5932551$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243607791$24360779$1$I$20240911$20240912$20240925$20240925$PER$$US-AMGEN-USASP2024189101$AMGEN$$44$YR$A$F$Y$110.9$KG$20240925$$HP$US$US
243607801$24360780$1$I$20231201$20240919$20240925$20240925$EXP$$US-ABBVIE-5933218$ABBVIE$$74$YR$$F$Y$$$20240925$$CN$US$US
243607811$24360781$1$I$20120801$20240913$20240925$20240925$EXP$$BE-AUROBINDO-AUR-APL-2024-046208$AUROBINDO$Valdes-socin H, Almanza MR, Fernandez-ladreda MT, Daele DV, Polus M, Chavez M et al. Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor. Arch Endocrinol Metab. 2017;61(5):506-509$52$YR$$M$Y$92$KG$20240925$$MD$BE$BE
243607831$24360783$1$I$$20240904$20240925$20240925$30DAY$$CN-JNJFOC-20240929531$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$CN$CN
243607841$24360784$1$I$$20240916$20240925$20240925$PER$$US-HALEON-2197418$Haleon PLC$$$$$F$Y$$$20240925$$CN$US$US
243607852$24360785$2$F$20230601$20240918$20240925$20240927$EXP$ES-AEMPS-1380376$ES-CELLTRION INC.-2024ES022534$CELLTRION$$$$$$Y$$$20240927$$MD$ES$ES
243607861$24360786$1$I$20240917$20240919$20240925$20240925$PER$$US-AMGEN-USASP2024187275$AMGEN$$72$YR$E$F$Y$$$20240925$$CN$US$US
243607871$24360787$1$I$$20240924$20240925$20240925$EXP$$CA-HALEON-2198298$Haleon PLC$$85$YR$$F$Y$$$20240925$$PH$CA$CA
243607881$24360788$1$I$$20240823$20240925$20240925$PER$$US-IMP-2024000669$Harrow Health$$$$$F$Y$$$20240925$$CN$US$US
243607891$24360789$1$I$20240911$20240919$20240925$20240925$EXP$$JP-ASTELLAS-2024-AER-007741$ASTELLAS$$76$YR$E$M$Y$$$20240925$$PH$JP$JP
243607901$24360790$1$I$$20240920$20240925$20240925$EXP$$US-ABBVIE-5933525$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243607911$24360791$1$I$20240828$20240904$20240925$20240925$PER$$US-IMP-2024000713$Harrow Health$$71$YR$E$F$Y$61.6$KG$20240925$$CN$US$US
243607921$24360792$1$I$20240916$20240920$20240925$20240925$EXP$$US-ABBVIE-5936887$ABBVIE$$86$YR$$F$Y$$$20240925$$CN$US$US
243607931$24360793$1$I$20240101$20240920$20240925$20240925$EXP$$US-ABBVIE-5811821$ABBVIE$$48$YR$$F$Y$107$KG$20240925$$CN$US$US
243607941$24360794$1$I$20221001$20240916$20240925$20240925$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK094139$GLENMARK$Levi D, Horn S, Murphy J, Levin J.. Safety of dexamethasone in transforaminal epidural steroid injections: A case of temporary paraplegia caused by injection of lidocaine and dexamethasone into a lumbar radiculomedullary artery, with no neurologic sequelae.. Interventional pain medicine.. 2023;2 (1):100240$$$$$Y$$$20240925$$MD$US$US
243607951$24360795$1$I$20240826$20240919$20240925$20240925$EXP$IT-MINISAL02-1002058$IT-TEVA-VS-3246111$TEVA$$32$YR$$F$Y$$$20240925$$MD$IT$IT
243607961$24360796$1$I$$20240913$20240925$20240925$EXP$$IT-AUROBINDO-AUR-APL-2024-046295$AUROBINDO$Caturano M.; Magro V.. A surprising surprise in a patient already complex.. Italian Journal of Medicine. 2019;13 (Suppl 2):69$79$YR$$$Y$$$20240925$$HP$IT$IT
243607971$24360797$1$I$$20240913$20240925$20240925$EXP$$PT-AUROBINDO-AUR-APL-2024-046432$AUROBINDO$Joao P. A.; Carneiro J.; Grilo J. et al. Wunderlich Syndrome in a Peritoneal Dialysis Patient with Warfarin latrogenic Coagulopathy: Should We Really be so Aggressive on Cardioembolic Events Prevention. Portuguese Journal of Nephrology + Hypertension. 2023;37 (2):106-111$68$YR$$M$Y$$$20240925$$HP$PT$PT
243607981$24360798$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014292$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240925$$CN$US$US
243607991$24360799$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014395$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240925$$CN$US$US
243608001$24360800$1$I$20240919$20240923$20240925$20240925$EXP$$PR-ABBVIE-5936947$ABBVIE$$69$YR$$F$Y$$$20240925$$HP$PR$PR
243608021$24360802$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014532$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240925$$CN$US$US
243608031$24360803$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151678$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240925$$HP$US$US
243608041$24360804$1$I$20240101$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151324$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240925$$HP$US$US
243608051$24360805$1$I$20240823$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151524$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$132$KG$20240925$$HP$US$US
243608061$24360806$1$I$$20240910$20240925$20240925$EXP$$US-BAXTER-2024BAX024538$BAXTER$$$$$M$Y$$$20240925$$CN$US$US
243608071$24360807$1$I$20240911$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190333$AMGEN$$64$YR$A$F$Y$$$20240925$$HP$US$US
243608081$24360808$1$I$$20240913$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046025$AUROBINDO$$$$$$Y$$$20240925$$PH$GB$GB
243608091$24360809$1$I$$20240918$20240925$20240925$PER$$US-GSK-US2024AMR115827$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$HP$US$US
243608101$24360810$1$I$$20240916$20240925$20240925$EXP$FR-ADIENNEP-2024AD000720$FR-ROCHE-10000082933$ROCHE$Franchi V, Labussiere-Wallet H, Chouik Y, Heiblig M, Larcher M. LAM UBTF-TD compliquee de MVO post-allogreffe traitee par transplantation hepatique [Liver transplantation for VOD/SOS after HSCT in a UBTF-TD AML].. Correspondances en Onco-Hematologie. 2023;18 (6):349-51.$$$A$M$Y$$$20240925$$MD$FR$FR
243608111$24360811$1$I$$20240916$20240925$20240925$EXP$NL-LRB-01000693$NL-TEVA-VS-3244109$TEVA$$72$YR$$F$Y$98.5$KG$20240925$$MD$NL$NL
243608121$24360812$1$I$20140101$20240917$20240925$20240925$EXP$$US-ABBVIE-5678527$ABBVIE$$$$$M$Y$99$KG$20240925$$CN$US$US
243608131$24360813$1$I$20240919$20240920$20240925$20240925$EXP$$CO-UCBSA-2024049134$UCB$$51$YR$$F$Y$$$20240925$$CN$CO$CO
243608141$24360814$1$I$$20240916$20240925$20240925$EXP$$CA-APOTEX-2024AP011030$APOTEX$$39$YR$$F$Y$$$20240925$$HP$CA$CA
243608151$24360815$1$I$$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046402$AUROBINDO$Bernardor J.; Flammier S.; Zagozdzon I. et al. Safety and Efficacy of Cinacalcet in Children Aged Under 3 Years on Maintenance Dialysis. Kidney International Reports. 2024;1-14$28$MON$$$Y$11.1$KG$20240925$$HP$FR$FR
243608161$24360816$1$I$$20240913$20240925$20240925$EXP$$NL-AUROBINDO-AUR-APL-2024-046377$AUROBINDO$Ziemer, M. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: A descriptive study of 17 cases from a national registry and review of the literature. British Journal of Dermatology.. 2012;66 (3):575-600$27$YR$$F$Y$$$20240925$$HP$NL$NL
243608172$24360817$2$F$20160628$20240920$20240925$20240930$EXP$$CA-CHIESI-2024CHF06204$CHIESI$$55$YR$$M$Y$74$KG$20240930$$PH$CA$CA
243608181$24360818$1$I$$20240924$20240925$20240925$EXP$$CA-HALEON-2198300$Haleon PLC$$65$YR$$F$Y$$$20240925$$MD$CA$CA
243608191$24360819$1$I$20240918$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189727$AMGEN$$42$YR$A$F$Y$$$20240925$$CN$US$US
243608201$24360820$1$I$20240912$20240913$20240925$20240925$EXP$$CA-APOTEX-2024AP010732$APOTEX$$75$YR$E$M$Y$$$20240925$$HP$CA$CA
243608211$24360821$1$I$$20240921$20240925$20240925$PER$$US-TAKEDA-2024TUS094402$TAKEDA$$$$$$Y$$$20240925$$CN$US$US
243608221$24360822$1$I$$20240921$20240925$20240925$PER$$US-TAKEDA-2024TUS094782$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
243608231$24360823$1$I$20231207$20240920$20240925$20240925$EXP$$JP-MFDS-2021000061-2409JPN008536$MERCK$$70$YR$$M$Y$$$20240925$$MD$JP$JP
243608241$24360824$1$I$20240821$20240903$20240925$20240925$PER$$US-REVANCE THERAPEUTICS INC.-US-REV-2024-000492$REVANCE THERAPEUTICS$$$$$$Y$$$20240925$$HP$US$US
243608251$24360825$1$I$$20240917$20240925$20240925$PER$$US-JNJFOC-20240947680$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$MD$US$US
243608261$24360826$1$I$20230301$20240913$20240925$20240925$EXP$FR-AFSSAPS-PP2023000737$FR-CELLTRION INC.-2024FR022641$CELLTRION$$$$$$Y$$$20240925$$MD$FR$FR
243608273$24360827$3$F$20240101$20240919$20240925$20240928$EXP$$US-AMGEN-USASP2024187375$AMGEN$$70$YR$E$F$Y$$$20240928$$CN$US$US
243608281$24360828$1$I$$20240918$20240925$20240925$EXP$$CA-ROCHE-10000085603$ROCHE$$$$$M$Y$$$20240925$$HP$CA$CA
243608291$24360829$1$I$$20240912$20240925$20240925$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-09413$LUPIN$$$$$$Y$$$20240925$$CN$CA$CA
243608301$24360830$1$I$20240923$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024190050$AMGEN$$74$YR$E$F$Y$$$20240925$$CN$US$US
243608311$24360831$1$I$$20240916$20240925$20240925$EXP$CA-MHPD-E2B_001090715$CA-Accord-447255$ACCORD$$71$YR$E$$Y$$$20240925$$PH$CA$CA
243608321$24360832$1$I$20240815$20240923$20240925$20240925$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-151421$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$70$KG$20240925$$MD$DE$DE
243608331$24360833$1$I$$20240917$20240925$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-129165$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240925$$PH$JP$JP
243608341$24360834$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150997$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240925$$CN$US$US
243608351$24360835$1$I$$20240911$20240925$20240925$EXP$$CA-UCBSA-2024046928$UCB$$$$$F$Y$$$20240925$$CN$CA$CA
243608361$24360836$1$I$$20240920$20240925$20240925$PER$$US-ABBVIE-5934836$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243608391$24360839$1$I$20220101$20240918$20240925$20240925$EXP$$US-ABBVIE-5930785$ABBVIE$$18$YR$$F$Y$$$20240925$$CN$US$US
243608401$24360840$1$I$$20240924$20240925$20240925$EXP$$DE-SANDOZ INC.-SDZ2024DE082559$SANDOZ$$$$A$$Y$$$20240925$$HP$DE$DE
243608411$24360841$1$I$20240813$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046362$AUROBINDO$$92$YR$$F$Y$70$KG$20240925$$MD$FR$FR
243608421$24360842$1$I$$20240913$20240925$20240925$EXP$$PT-Accord-447212$ACCORD$Brites FM, Ferreira CA. Howell-Jolly Body like Inclusions in Neutrophils and Monocytes. Laboratory Medicine Magazine. 2024;5:82.$58$YR$A$F$Y$$$20240925$$MD$PT$PT
243608431$24360843$1$I$$20240916$20240925$20240925$EXP$$CA-CELLTRION INC.-2024CA022158$CELLTRION$$$$$$Y$$$20240925$$CN$CA$CA
243608441$24360844$1$I$20240912$20240918$20240925$20240925$PER$$US-ABBVIE-5930035$ABBVIE$$28$YR$$F$Y$67$KG$20240925$$MD$US$US
243608451$24360845$1$I$$20240916$20240925$20240925$PER$$US-JNJFOC-20240941629$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$PH$US$US
243608461$24360846$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189676$AMGEN$$$$$F$Y$$$20240925$$HP$US$US
243608472$24360847$2$F$$20240919$20240925$20240925$EXP$$US-AMGEN-USASP2024188039$AMGEN$$$$A$M$Y$$$20240925$$HP$US$US
243608482$24360848$2$F$20240901$20240925$20240925$20240930$PER$$US-AMGEN-USASP2024189241$AMGEN$$57$YR$A$M$Y$$$20240930$$CN$US$US
243608491$24360849$1$I$20240101$20240805$20240925$20240925$PER$$US-IMP-2024000596$Harrow Health$$$$E$$Y$$$20240925$$CN$US$US
243608501$24360850$1$I$20220315$20240923$20240925$20240925$EXP$ES-AEMPS-1570733$ES-009507513-2409ESP008082$MERCK$$72$YR$$M$Y$$$20240925$$MD$ES$ES
243608511$24360851$1$I$$20240923$20240925$20240925$EXP$$NVSC2024US190055$NOVARTIS$$$$$M$Y$$$20240925$$HP$US$US
243608521$24360852$1$I$$20240920$20240925$20240925$EXP$$NZ-ROCHE-10000087944$ROCHE$$$$$$Y$$$20240925$$PH$NZ$NZ
243608531$24360853$1$I$20240101$20240923$20240925$20240925$EXP$$ZA-ABBVIE-5935001$ABBVIE$$77$YR$$F$Y$$$20240925$$MD$ZA$ZA
243608541$24360854$1$I$20240917$20240918$20240925$20240925$EXP$$US-AMGEN-USASP2024187258$AMGEN$$77$YR$E$F$Y$$$20240925$$CN$US$US
243608551$24360855$1$I$$20240918$20240925$20240925$PER$$US-AMGEN-USASP2024188324$AMGEN$$$$E$F$Y$$$20240925$$CN$US$US
243608561$24360856$1$I$20220101$20240918$20240925$20240925$EXP$$EG-ABBVIE-5930922$ABBVIE$$29$YR$$M$Y$$$20240925$$CN$EG$EG
243608571$24360857$1$I$$20240913$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046033$AUROBINDO$$82$YR$$F$Y$$$20240925$$CN$GB$GB
243608581$24360858$1$I$$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046333$AUROBINDO$Penit, A... Community-acquired Clostridium difficile infections.. Medecine Et Maladies Infectieuses. 2016;46 (3):131-139$69$YR$$F$Y$$$20240925$$HP$FR$FR
243608591$24360859$1$I$20240711$20240913$20240925$20240925$EXP$$ES-AUROBINDO-AUR-APL-2024-046281$AUROBINDO$$46$YR$$F$Y$$$20240925$$MD$ES$ES
243608601$24360860$1$I$20200101$20240916$20240925$20240925$EXP$$US-AMGEN-USASP2024187929$AMGEN$Ok M.T.; Googe P.; Sayed C. et al.. The Successful Use of Upadacitinib as Monotherapy for Hidradenitis Suppurativa and Ulcerative Colitis in the Setting of Refractory Disease. Pediatric Dermatology. 2024;1-5$15$YR$T$F$Y$$$20240925$$HP$US$US
243608611$24360861$1$I$20240901$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024188910$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243608621$24360862$1$I$$20240923$20240925$20240925$PER$$US-Taiho Oncology Inc-2024-008968$TAIHO ONCOLOGY INC$$52$YR$A$F$Y$48.53$KG$20240925$$CN$US$US
243608631$24360863$1$I$20220520$20240913$20240925$20240925$EXP$$ES-AUROBINDO-AUR-APL-2024-046282$AUROBINDO$$57$YR$$F$Y$$$20240925$$PH$ES$ES
243608641$24360864$1$I$$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046169$AUROBINDO$$51$YR$$F$Y$$$20240925$$PH$FR$FR
243608651$24360865$1$I$20230911$20240913$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-045980$AUROBINDO$$$$E$M$Y$$$20240925$$CN$GB$GB
243608681$24360868$1$I$$20240910$20240925$20240925$EXP$$US-GLANDPHARMA-US-2024GLNLIT00769$GLAND PHARMA$Lindsay A. Erol.Paraneoplastic Hyperthyroidism Secondary to a Chemotherapy-Induced Surge in beta-hCG in a Patient with Non-Seminomatous Germ Cell Tumor.Hawaii Journal of Health and Social Welfare.FEB-2024;83 (No.2):45-47$21$YR$A$M$Y$$$20240925$$MD$US$US
243608691$24360869$1$I$$20240913$20240925$20240925$EXP$$BE-AUROBINDO-AUR-APL-2024-046466$AUROBINDO$Scheers I.; Sokal E.; Limaye N. et al.. Cinacalcet sustainedly prevents pancreatitis in a child with a compound heterozygous SPINK1/AP2S1 mutation.. Pancreatology.. 2019;1-4$13$YR$$F$Y$$$20240925$$HP$BE$BE
243608701$24360870$1$I$$20240916$20240925$20240925$EXP$$CA-APOTEX-2024AP011019$APOTEX$$73$YR$$M$Y$$$20240925$$HP$CA$CA
243608721$24360872$1$I$$20240916$20240925$20240925$EXP$CA-MHPD-E2B_001092792$CA-Accord-447156$ACCORD$$73$YR$E$M$Y$$$20240925$$MD$CA$CA
243608731$24360873$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014823$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240925$$CN$US$US
243608741$24360874$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015272$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240925$$CN$US$US
243608751$24360875$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014636$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240925$$CN$US$US
243608761$24360876$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014584$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243608771$24360877$1$I$20240728$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012901$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240925$$CN$US$US
243608781$24360878$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151476$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240925$$CN$US$US
243608791$24360879$1$I$20240501$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151471$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240925$$CN$US$US
243608801$24360880$1$I$$20240913$20240925$20240925$EXP$$ID-Accord-447023$ACCORD$Auerkari AN, Sedono R, Pryambodho P. Severe Neuropathic Back Pain as the Initial Presentation in Angiostrongylus cantonensis Infection: The Role of ICU Management in Overcoming Diagnostic and Analgosedation Challenges. Archives of Clinical Infectious Diseases. 2024;19(4):e135637. DOI: 10.5812/archcid-135637.$27$YR$A$F$Y$$$20240925$$MD$ID$ID
243608811$24360881$1$I$$20240917$20240925$20240925$EXP$$CA-HALEON-2197844$Haleon PLC$$50$YR$$F$Y$$$20240925$$HP$CA$CA
243608821$24360882$1$I$20240907$20240920$20240925$20240925$PER$$US-BIOVITRUM-2024-US-012380$BIOVITRUM$$59$YR$$F$Y$$$20240925$$CN$US$US
243608831$24360883$1$I$$20240913$20240925$20240925$EXP$$RU-ROCHE-10000082853$ROCHE$$$$A$M$Y$$$20240925$$MD$RU$RU
243608841$24360884$1$I$20230530$20240917$20240925$20240925$EXP$FR-AFSSAPS-RN2023000583$FR-CELLTRION INC.-2024FR022564$CELLTRION$$$$$$Y$$$20240925$$MD$FR$FR
243608852$24360885$2$F$20240701$20240923$20240925$20240927$EXP$$US-ABBVIE-5929090$ABBVIE$$37$YR$$F$Y$68.945$KG$20240927$$CN$US$US
243608861$24360886$1$I$$20240923$20240925$20240925$EXP$GB-MHRA-MIDB-fe068b56-0690-4c08-b396-62ba8c2b1a2f$GB-HALEON-2198168$Haleon PLC$$74$YR$$M$Y$$$20240925$$PH$GB$GB
243608871$24360887$1$I$$20240912$20240925$20240925$EXP$$US-UCBSA-2024047763$UCB$$$$$$Y$$$20240925$$CN$US$US
243608881$24360888$1$I$20230614$20240919$20240925$20240925$EXP$$US-BIOVITRUM-2024-US-012311$BIOVITRUM$$70$YR$$F$Y$$$20240925$$CN$US$US
243608891$24360889$1$I$$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046456$AUROBINDO$Bernardor J.; Flammier S.; Zagozdzon I. et al.. Safety and Efficacy of Cinacalcet in Children Aged Under 3 Years on Maintenance Dialysis.. Kidney International Reports.. 2024;14$$$$F$Y$$$20240925$$HP$FR$FR
243608901$24360890$1$I$$20240924$20240925$20240925$EXP$$CN-ROCHE-10000089704$ROCHE$$$$$M$Y$$$20240925$$CN$CN$CN
243608911$24360891$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151100$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240925$$CN$US$US
243608921$24360892$1$I$20240909$20240918$20240925$20240925$EXP$GB-MHRA-MED-202409181137080160-CZTLG$GB-TEVA-VS-3245168$TEVA$$28$YR$$F$Y$$$20240925$$CN$GB$GB
243608931$24360893$1$I$$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150959$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240925$$CN$US$US
243608941$24360894$1$I$20240101$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151230$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240925$$CN$US$US
243608951$24360895$1$I$$20240920$20240925$20240925$EXP$$NVSJ2024JP011172$NOVARTIS$$70$YR$$M$Y$$$20240925$$MD$JP$JP
243608971$24360897$1$I$$20240910$20240925$20240925$EXP$$SG-GLANDPHARMA-SG-2024GLNLIT00778$GLAND PHARMA$AJK Chua .Osteoradionecrosis of the lamina papyracea leading to recurrent orbital infections A case study.International Forum of Allergy and Rhinology.JUN-2023;13(6):1055-1057$66$YR$E$F$Y$$$20240925$$HP$SG$SG
243608981$24360898$1$I$20240101$20240918$20240925$20240925$EXP$$US-AMGEN-USASL2024186669$AMGEN$$83$YR$E$M$Y$$$20240925$$CN$US$US
243608991$24360899$1$I$$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024188889$AMGEN$$$$$F$Y$$$20240925$$PH$US$US
243609001$24360900$1$I$$20240921$20240925$20240925$PER$$US-AMGEN-USASP2024189493$AMGEN$$$$$M$Y$$$20240925$$CN$US$US
243609011$24360901$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024190123$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243609021$24360902$1$I$$20240919$20240925$20240925$EXP$$US-SANDOZ INC.-SDZ2024US082181$SANDOZ$$$$$M$Y$$$20240925$$HP$US$US
243609031$24360903$1$I$$20240913$20240925$20240925$EXP$$BE-AUROBINDO-AUR-APL-2024-046354$AUROBINDO$$65$YR$$F$Y$$$20240925$$MD$BE$BE
243609041$24360904$1$I$20240101$20240911$20240925$20240925$EXP$$US-JNJFOC-20240939363$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240925$$CN$US$US
243609051$24360905$1$I$20240408$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65462$$FDA-CTU$$52$YR$$F$N$$$20240924$N$HP$US$
243609061$24360906$1$I$$20230102$20240925$20240925$EXP$$DE-SANDOZ INC.-NVSC2023DE002419$SANDOZ$$$$$$Y$$$20240925$$PH$DE$DE
243609071$24360907$1$I$$20240916$20240925$20240925$PER$$US-GSK-US2024114947$GLAXOSMITHKLINE$$$$$M$Y$$$20240925$$CN$US$US
243609081$24360908$1$I$20240919$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024188588$AMGEN$$61$YR$A$M$Y$$$20240925$$CN$US$US
243609091$24360909$1$I$$20240920$20240925$20240925$EXP$$GB-AMGEN-GBRSP2024188197$AMGEN$$$$$M$Y$$$20240925$$CN$GB$GB
243609101$24360910$1$I$$20240904$20240925$20240925$EXP$$US-SA-2024SA272220$SANOFI AVENTIS$$$$E$M$Y$$$20240925$$MD$US$US
243609112$24360911$2$F$20240101$20240923$20240925$20240928$EXP$$US-ABBVIE-5832223$ABBVIE$$$$$M$Y$111$KG$20240928$$CN$US$US
243609121$24360912$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151840$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240925$$CN$US$US
243609131$24360913$1$I$$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046452$AUROBINDO$Sabbah N.; Demar M.; Sogbo F. et.al.. Recurrent vomiting and confusion in pregnancy: hypercalcaemia due to parathyroid adenoma.. Lancet. 2023;402 (10395):62-63$32$YR$$F$Y$$$20240925$$MD$FR$FR
243609141$24360914$1$I$$20240918$20240925$20240925$EXP$$DE-AMGEN-DEUSP2024186665$AMGEN$$$$$M$Y$$$20240925$$PH$DE$DE
243609151$24360915$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024190255$AMGEN$$$$$$Y$$$20240925$$PH$US$US
243609161$24360916$1$I$$20240919$20240925$20240925$EXP$$JP-AMGEN-JPNSP2024187893$AMGEN$$$$$$Y$$$20240925$$MD$JP$JP
243609171$24360917$1$I$20240919$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024188391$AMGEN$$49$YR$A$F$Y$$$20240925$$CN$US$US
243609181$24360918$1$I$$20240919$20240925$20240925$EXP$$US-ROCHE-10000088618$ROCHE$$$$I$F$Y$$$20240925$$CN$US$US
243609191$24360919$1$I$20240101$20240920$20240925$20240925$EXP$$US-ABBVIE-5933898$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243609211$24360921$1$I$20240829$20240919$20240925$20240925$EXP$$US-ABBVIE-5932293$ABBVIE$$71$YR$$F$Y$$$20240925$$CN$US$US
243609221$24360922$1$I$$20240919$20240925$20240925$EXP$$US-ABBVIE-5932312$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243609231$24360923$1$I$20240909$20240913$20240925$20240925$EXP$$US-FARMAPROD-202408-3008$DOMPE FARMACEUTICI$$75$YR$E$F$Y$$$20240925$$CN$US$US
243609251$24360925$1$I$20191126$20221202$20240925$20240925$EXP$$GB-SANDOZ INC.-SDZ2022GB000455$SANDOZ$$59$YR$$M$Y$62$KG$20240925$$MD$GB$GB
243609261$24360926$1$I$20220819$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65483$$FDA-CTU$$28$YR$$F$N$$$20240924$N$PH$US$
243609271$24360927$1$I$20240904$20240918$20240924$20240924$DIR$FDA-CDER-CTU-2024-65505$$FDA-CTU$$75$YR$$F$N$$$20240918$N$HP$US$
243609281$24360928$1$I$$20240823$20240925$20240925$PER$$US-IMP-2024000680$Harrow Health$$67$YR$E$F$Y$$$20240925$$MD$US$US
243609291$24360929$1$I$$20240919$20240925$20240925$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001915$BLUEPRINT MEDICINES$$$$$F$Y$$$20240925$$CN$US$US
243609301$24360930$1$I$20240620$20240924$20240925$20240925$EXP$FR-AFSSAPS-LM2024000526$NVSC2024FR189687$NOVARTIS$$68$YR$$M$Y$75$KG$20240925$$MD$FR$FR
243609311$24360931$1$I$20240820$20240918$20240925$20240925$EXP$FR-AFSSAPS-MP2024001350$FR-TEVA-VS-3245257$TEVA$$63$YR$$M$Y$88$KG$20240925$$PH$FR$FR
243609321$24360932$1$I$20060101$20240913$20240925$20240925$EXP$$ES-AUROBINDO-AUR-APL-2024-046695$AUROBINDO$Arenas M. D.; Gil M. T.; Gutierrez M. D.; et. al... Management of calcific uremic arteriolopathy (calciphylaxis) with a combination of treatments including hyperbaric oxygen therapy.. Clinical Nephrology. 2008;70(3):261-264$67$YR$$F$Y$$$20240925$$MD$ES$ES
243609341$24360934$1$I$20240909$20240919$20240925$20240925$PER$$NVSC2024US189858$NOVARTIS$$64$YR$$F$Y$$$20240925$$CN$US$US
243609351$24360935$1$I$20240914$20240916$20240925$20240925$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00958$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240925$$CN$US$US
243609361$24360936$1$I$20240801$20240913$20240925$20240925$EXP$$US-UCBSA-2024047548$UCB$$37$YR$$F$Y$$$20240925$$HP$US$US
243609371$24360937$1$I$$20240918$20240925$20240925$PER$$US-ROCHE-10000086441$ROCHE$$$$E$F$Y$$$20240925$$CN$US$US
243609381$24360938$1$I$$20240910$20240925$20240925$EXP$$US-GLANDPHARMA-US-2024GLNLIT00775$GLAND PHARMA$Mukherji S.Brief case report: A case of FOLFIRI-Induced psychosis.Psycho-Oncology .OCT-2023;32:1625-1627$72$YR$E$M$Y$$$20240925$$HP$US$US
243609391$24360939$1$I$20240806$20240911$20240925$20240925$PER$$US-JNJFOC-20240928091$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240925$$MD$US$US
243609401$24360940$1$I$$20240916$20240925$20240925$EXP$CA-MHPD-001092715$CA-Accord-447275$ACCORD$$83$YR$E$F$Y$77$KG$20240925$$HP$CA$CA
243609411$24360941$1$I$$20240919$20240925$20240925$EXP$$US-ABBVIE-5933523$ABBVIE$$$$$$Y$$$20240925$$MD$US$US
243609421$24360942$1$I$$20240918$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012090$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240925$$CN$US$US
243609431$24360943$1$I$20240923$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015433$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240925$$CN$US$US
243609441$24360944$1$I$20240629$20240923$20240925$20240925$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-151359$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240925$$CN$TW$TW
243609461$24360946$1$I$$20240919$20240925$20240925$EXP$$CA-ABBVIE-5933255$ABBVIE$$$$A$M$Y$$$20240925$$CN$CA$CA
243609472$24360947$2$F$$20240920$20240925$20240925$EXP$$US-AMGEN-USASP2024188879$AMGEN$$55$YR$A$F$Y$$$20240925$$MD$US$US
243609481$24360948$1$I$$20240910$20240925$20240925$PER$$US-GILEAD-2024-0687521$GILEAD$$75$YR$E$F$Y$$$20240925$$HP$US$US
243609501$24360950$1$I$20240701$20240910$20240925$20240925$PER$$US-COSETTE-CP2024US000255$COSETTE PHARMACEUTICALS$$49$YR$$F$Y$$$20240925$$CN$US$US
243609511$24360951$1$I$20230728$20240923$20240925$20240925$EXP$$KR-ROCHE-10000088736$ROCHE$$64$YR$A$M$Y$$$20240925$$HP$KR$KR
243609522$24360952$2$F$20210226$20240924$20240925$20240930$EXP$$CA-JNJFOC-20240947746$JOHNSON AND JOHNSON$$26$YR$A$F$Y$118$KG$20240929$$HP$CA$CA
243609531$24360953$1$I$$20240919$20240925$20240925$EXP$$CA-GSK-CA2024116561$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$CA$CA
243609541$24360954$1$I$20240814$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046463$AUROBINDO$$66$YR$$M$Y$90$KG$20240925$$PH$FR$FR
243609561$24360956$1$I$$20240916$20240925$20240925$EXP$$US-UCBSA-2024047779$UCB$$$$$F$Y$$$20240925$$HP$US$US
243609572$24360957$2$F$20220101$20240916$20240925$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR115927$VIIV$$$$$M$Y$$$20240926$$CN$US$US
243609581$24360958$1$I$$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151485$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240925$$CN$US$US
243609601$24360960$1$I$$20240910$20240925$20240925$EXP$$US-GLANDPHARMA-US-2024GLNLIT00776$GLAND PHARMA$SC Cromack.Prostaglandin Injection for Myoma Expulsion (PRIME): Case Series of a Novel Approach to Hysteroscopic Resection of FIGO Type 2 Myomas.Journal of Minimally Invasive Gynecology.JUL-2024;31, No.7:613-619$$$$F$Y$$$20240925$$HP$US$US
243609611$24360961$1$I$$20240918$20240925$20240925$EXP$$US-RDY-SPO/USA/24/0013828$DR REDDYS$$49$YR$A$M$Y$$$20240925$$MD$US$US
243609621$24360962$1$I$$20240918$20240925$20240925$EXP$$US-RDY-SPO/USA/24/0013838$DR REDDYS$$42$YR$A$M$Y$$$20240925$$MD$US$US
243609641$24360964$1$I$20240916$20240918$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013854$DR REDDYS$$17$YR$T$M$Y$$$20240925$$HP$US$US
243609651$24360965$1$I$20210301$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046349$AUROBINDO$$57$YR$$M$Y$$$20240925$$PH$FR$FR
243609661$24360966$1$I$$20240921$20240925$20240925$EXP$$ZA-HALEON-2198236$Haleon PLC$$$$$$Y$$$20240925$$CN$ZA$ZA
243609701$24360970$1$I$20240916$20240919$20240925$20240925$PER$$US-GSK-US2024116612$GLAXOSMITHKLINE$$47$YR$$F$Y$$$20240925$$CN$US$US
243609711$24360971$1$I$$20240919$20240925$20240925$EXP$$US-LEO Pharma-373710$LEO PHARM$$77$YR$$F$Y$$$20240925$$CN$US$US
243609721$24360972$1$I$20240801$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046462$AUROBINDO$$65$YR$$F$Y$42$KG$20240925$$PH$FR$FR
243609731$24360973$1$I$$20240913$20240925$20240925$EXP$$ES-AUROBINDO-AUR-APL-2024-046134$AUROBINDO$Mora Mora M.T.; Marin Alvarez J.P.. Exophthalmos and hyperparathyroidism.. NEFROLOGIA. 2017;37(4):429-449$27$YR$$F$Y$$$20240925$$HP$ES$ES
243609741$24360974$1$I$20230405$20240913$20240925$20240925$EXP$FR-AFSSAPS-TO2023000822$FR-CELLTRION INC.-2024FR022659$CELLTRION$$$$$$Y$$$20240925$$MD$FR$FR
243609751$24360975$1$I$20200512$20240920$20240925$20240925$EXP$PL-URPL-1-2723-2020$PL-TAKEDA-2024TUS094875$TAKEDA$$67$YR$$M$Y$$$20240925$$HP$PL$PL
243609782$24360978$2$F$$20240923$20240925$20240928$PER$$US-ABBVIE-5935706$ABBVIE$$$$$F$Y$$$20240928$$MD$US$US
243609791$24360979$1$I$$20240911$20240925$20240925$PER$$US-COSETTE-CP2024US000254$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
243609811$24360981$1$I$$20240920$20240925$20240925$PER$$NVSC2024US190209$NOVARTIS$$$$$M$Y$$$20240925$$MD$US$US
243609821$24360982$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151691$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240925$$CN$US$US
243609831$24360983$1$I$$20240918$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148774$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240925$$HP$US$US
243609851$24360985$1$I$$20240916$20240925$20240925$EXP$$ZA-ROCHE-10000084426$ROCHE$$$$A$F$Y$$$20240925$$CN$ZA$ZA
243609861$24360986$1$I$20240801$20240920$20240925$20240925$EXP$$IT-ABBVIE-5933449$ABBVIE$$63$YR$$M$Y$$$20240925$$CN$IT$IT
243609882$24360988$2$F$$20240927$20240925$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151178$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240930$$CN$US$US
243609901$24360990$1$I$$20240913$20240925$20240925$EXP$$ES-AUROBINDO-AUR-APL-2024-046304$AUROBINDO$Montoro-ronsano J.; Perez-ricart A.; Galicia-basart M.; et.al.. Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism. Kidney Research and Clinical Practice. 2019;00:1-10$$$$$Y$$$20240925$$HP$ES$ES
243609911$24360991$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150890$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240925$$CN$US$US
243609921$24360992$1$I$$20240910$20240925$20240925$EXP$$US-GLANDPHARMA-US-2024GLNLIT00780$GLAND PHARMA$Samuel Reinfeld.Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: A case series.CNS spectrums.22-DEC-2022;28(5):587-591$15$YR$T$M$Y$$$20240925$$HP$US$US
243609951$24360995$1$I$20240901$20240920$20240925$20240925$EXP$$CA-BAUSCH-BL-2024-014296$BAUSCH AND LOMB$$61$YR$$F$Y$$$20240925$$CN$CA$CA
243609961$24360996$1$I$$20240917$20240925$20240925$PER$$US-ABBVIE-5935292$ABBVIE$$$$$F$Y$$$20240925$$MD$US$US
243609981$24360998$1$I$$20240910$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09117$LUPIN$$$$$$Y$$$20240925$$HP$US$US
243609991$24360999$1$I$$20240916$20240925$20240925$EXP$$US-ROCHE-10000083410$ROCHE$$$$$F$Y$$$20240925$$CN$US$US
243610001$24361000$1$I$$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046374$AUROBINDO$Laradi A.; Babinet F.; Lanoiselee S. Bilateral Breast Pyoderma Gangrenosum in an Hemodialyzed Patient Cured by Corticosteroids with Wound Care. Journal of the American Society of Nephrology. 2016;27:977A$62$YR$$F$Y$$$20240925$$HP$FR$FR
243610012$24361001$2$F$$20240913$20240925$20240925$PER$$US-ROCHE-10000082988$ROCHE$$78$YR$E$M$Y$96.2$KG$20240925$$CN$US$US
243610022$24361002$2$F$20231227$20240923$20240925$20240927$EXP$$NVSC2024US190284$NOVARTIS$$78$YR$$M$Y$84.82$KG$20240927$$MD$US$US
243610031$24361003$1$I$20240101$20240917$20240925$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-029816$UNITED THERAPEUTICS$$$$$M$Y$65.306$KG$20240925$$$US$US
243610041$24361004$1$I$20240101$20240911$20240925$20240925$EXP$$GB-UCBSA-2024047125$UCB$$$$A$F$Y$$$20240925$$CN$GB$GB
243610051$24361005$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015308$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240925$$CN$US$US
243610061$24361006$1$I$$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014305$ELI LILLY AND CO$$$$A$F$Y$$$20240925$$HP$US$US
243610071$24361007$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014818$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240925$$CN$US$US
243610081$24361008$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015559$ELI LILLY AND CO$$66$YR$E$$Y$$$20240925$$CN$US$US
243610091$24361009$1$I$$20240919$20240925$20240925$PER$$US-ABBVIE-5936922$ABBVIE$$$$$$Y$$$20240925$$CN$US$US
243610101$24361010$1$I$$20240914$20240925$20240925$EXP$$CA-TAKEDA-2024TUS092292$TAKEDA$$$$$M$Y$$$20240925$$CN$CA$CA
243610131$24361013$1$I$20240913$20240921$20240925$20240925$EXP$$IN-ROCHE-3538032$ROCHE$$35$YR$A$M$Y$$$20240925$$MD$IN$IN
243610141$24361014$1$I$20240901$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189749$AMGEN$$55$YR$A$F$Y$$$20240925$$CN$US$US
243610151$24361015$1$I$$20240919$20240925$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-029848$UNITED THERAPEUTICS$$$$$F$Y$47.891$KG$20240925$$PH$US$US
243610161$24361016$1$I$20240522$20240919$20240925$20240925$PER$$US-ABBVIE-5932610$ABBVIE$$58$YR$$F$Y$91$KG$20240925$$CN$US$US
243610171$24361017$1$I$20240501$20240919$20240925$20240925$EXP$$JP-ASTELLAS-2024-AER-007956$ASTELLAS$$7$DEC$A$M$Y$$$20240925$$MD$JP$JP
243610181$24361018$1$I$$20240923$20240925$20240925$PER$$US-ABBVIE-5936008$ABBVIE$$$$$F$Y$$$20240925$$HP$US$US
243610221$24361022$1$I$$20240920$20240925$20240925$PER$$US-JNJFOC-20240956609$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243610231$24361023$1$I$$20240913$20240925$20240925$EXP$$CA-ROCHE-10000082047$ROCHE$$$$A$M$Y$$$20240925$$CN$CA$CA
243610241$24361024$1$I$20240914$20240919$20240925$20240925$EXP$$CN-ROCHE-10000086211$ROCHE$$30$YR$A$F$Y$36$KG$20240925$$HP$CN$CN
243610251$24361025$1$I$$20240923$20240925$20240925$EXP$$US-JNJFOC-20240962092$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$HP$US$US
243610261$24361026$1$I$$20240906$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09013$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243610271$24361027$1$I$$20240923$20240925$20240925$EXP$$US-GILEAD-2024-0688691$GILEAD$$$$A$M$Y$$$20240925$$CN$US$US
243610281$24361028$1$I$$20240916$20240925$20240925$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US003975$PAREXEL$$$$$$Y$$$20240925$$CN$US$US
243610291$24361029$1$I$$20240918$20240925$20240925$EXP$$CN-ROCHE-10000085882$ROCHE$$31$YR$A$F$Y$$$20240925$$CN$CN$CN
243610301$24361030$1$I$20200101$20240919$20240925$20240925$EXP$$US-ABBVIE-5932395$ABBVIE$$53$YR$$F$Y$$$20240925$$CN$US$US
243610311$24361031$1$I$20240701$20240919$20240925$20240925$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052506$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$$$20240925$$CN$US$US
243610321$24361032$1$I$$20240921$20240925$20240925$EXP$$IN-ROCHE-10000089073$ROCHE$$78$YR$E$M$Y$$$20240925$$CN$IN$IN
243610341$24361034$1$I$$20240919$20240925$20240925$EXP$$US-ABBVIE-5932480$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243610351$24361035$1$I$20240909$20240919$20240925$20240925$EXP$GB-MHRA-MED-202409181114112600-QNPRF$GB-RDY-SPO/GBR/24/0013912$DR REDDYS$$$$$F$Y$$$20240925$$MD$GB$GB
243610361$24361036$1$I$20240902$20240903$20240925$20240925$PER$$TR-TOLMAR, INC.-24TR052405$TOLMAR$$75$YR$$M$Y$$$20240925$$HP$TR$TR
243610381$24361038$1$I$20240715$20240903$20240925$20240925$PER$$US-TOLMAR, INC.-24US052156$TOLMAR$$66$YR$$M$Y$$$20240925$$HP$US$US
243610391$24361039$1$I$20240903$20240903$20240925$20240925$PER$$US-TOLMAR, INC.-24US052370$TOLMAR$$79$YR$$M$Y$$$20240925$$PH$US$US
243610401$24361040$1$I$$20240924$20240925$20240925$EXP$$NVSC2024AT189669$NOVARTIS$$21$YR$$F$Y$$$20240925$$MD$AT$AT
243610441$24361044$1$I$20240918$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093732$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
243610451$24361045$1$I$20240801$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093583$TAKEDA$$34$YR$$$Y$$$20240925$$MD$US$US
243610461$24361046$1$I$$20240920$20240925$20240925$EXP$$US-ABBVIE-5933041$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243610471$24361047$1$I$20240101$20240919$20240925$20240925$EXP$$US-ABBVIE-5933928$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243610481$24361048$1$I$$20240919$20240925$20240925$EXP$$US-TAKEDA-2024TUS059488$TAKEDA$$$$$F$Y$81$KG$20240925$$HP$US$US
243610491$24361049$1$I$20240922$20240923$20240925$20240925$EXP$$US-ABBVIE-5936953$ABBVIE$$76$YR$$M$Y$$$20240925$$CN$US$US
243610502$24361050$2$F$$20240920$20240925$20240926$EXP$$US-ABBVIE-5932787$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243610511$24361051$1$I$20240801$20240911$20240925$20240925$EXP$$US-UCBSA-2024046738$UCB$$34$YR$$F$Y$$$20240925$$CN$US$US
243610521$24361052$1$I$$20240906$20240925$20240925$PER$$US-JNJFOC-20240932760$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243610531$24361053$1$I$20240101$20240917$20240925$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-029871$UNITED THERAPEUTICS$$$$$M$Y$72.562$KG$20240925$$$US$US
243610541$24361054$1$I$$20240905$20240925$20240925$PER$$US-JNJFOC-20240912459$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$MD$US$US
243610551$24361055$1$I$$20240919$20240925$20240925$PER$$US-GSK-US2024116572$GLAXOSMITHKLINE$$$$$M$Y$$$20240925$$CN$US$US
243610561$24361056$1$I$$20240910$20240925$20240925$EXP$$TR-GLANDPHARMA-TR-2024GLNLIT00771$GLAND PHARMA$Erensu Baysa.Acute laryngeal dystonia: a case report.Psychiatry and Clinical Psychopharmacology.JAN-2019;29:259$21$YR$A$M$Y$$$20240925$$HP$TR$TR
243610571$24361057$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151667$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$86.64$KG$20240925$$CN$US$US
243610581$24361058$1$I$$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093676$TAKEDA$$16$YR$$M$Y$$$20240925$$CN$US$US
243610601$24361060$1$I$20240806$20240912$20240925$20240925$EXP$FR-AFSSAPS-CN2024000797$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08635$HIKMA$$70$YR$$F$Y$56.6$KG$20240925$$PH$FR$FR
243610621$24361062$1$I$$20240909$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09050$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243610641$24361064$1$I$$20240105$20240925$20240925$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202401-000025$UNICHEM$$$$$F$Y$$$20240925$$CN$US$
243610651$24361065$1$I$$20240411$20240925$20240925$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202404-000405$UNICHEM$$$$$M$Y$$$20240925$$PH$US$
243610661$24361066$1$I$20240101$20240522$20240925$20240925$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202405-000625$UNICHEM$$43$YR$A$F$Y$59$KG$20240925$$MD$US$
243610671$24361067$1$I$20240516$20240523$20240925$20240925$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202405-000666$UNICHEM$$65$YR$E$F$Y$$$20240925$$CN$US$
243610681$24361068$1$I$20240301$20240325$20240925$20240925$PER$$US-Unichem Pharmaceuticals (USA) Inc-UCM202403-000282$UNICHEM$$83$YR$E$F$Y$$$20240925$$CN$US$
243610691$24361069$1$I$20240101$20240920$20240925$20240925$PER$$US-BIOGEN-2024BI01283730$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243610711$24361071$1$I$20240401$20240917$20240925$20240925$EXP$$GR-TAKEDA-2024TUS093828$TAKEDA$$77$YR$$F$Y$$$20240925$$CN$GR$GR
243610721$24361072$1$I$20240912$20240913$20240925$20240925$PER$$US-ROCHE-10000082404$ROCHE$$$$$$Y$$$20240925$$CN$US$US
243610731$24361073$1$I$20240920$20240916$20240925$20240925$EXP$$CA-TAKEDA-2019TUS012376$TAKEDA$$64$YR$$F$Y$$$20240925$$CN$CA$CA
243610751$24361075$1$I$$20240919$20240925$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-029920$UNITED THERAPEUTICS$$$$$M$Y$67.12$KG$20240925$$$US$US
243610761$24361076$1$I$$20240918$20240925$20240925$EXP$$CA-ROCHE-10000085886$ROCHE$$$$$F$Y$$$20240925$$HP$CA$CA
243610771$24361077$1$I$$20240830$20240925$20240925$PER$$US-Vifor (International) Inc.-VIT-2024-07864$VIFOR$$43$YR$$F$Y$$$20240925$$HP$US$US
243610781$24361078$1$I$20240201$20240919$20240925$20240925$EXP$$US-ABBVIE-5931554$ABBVIE$$68$YR$$F$Y$$$20240925$$CN$US$US
243610791$24361079$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151685$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240925$$CN$US$US
243610801$24361080$1$I$$20240909$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09044$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243610811$24361081$1$I$20240226$20240920$20240925$20240925$EXP$SE-SEMPA-2024-006803$SE-TAKEDA-2024TUS093629$TAKEDA$$33$YR$$F$Y$85$KG$20240925$$HP$SE$SE
243610821$24361082$1$I$$20240920$20240925$20240925$EXP$$US-TAKEDA-2024TUS036862$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
243610831$24361083$1$I$20240921$20240923$20240925$20240925$EXP$$US-GILEAD-2024-0688682$GILEAD$$40$YR$A$F$Y$$$20240925$$CN$US$US
243610841$24361084$1$I$20240901$20240919$20240925$20240925$EXP$$US-ABBVIE-5932564$ABBVIE$$73$YR$$M$Y$$$20240925$$CN$US$US
243610851$24361085$1$I$$20240920$20240925$20240925$EXP$$US-ABBVIE-5933873$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243610873$24361087$3$F$20240901$20240923$20240925$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-029932$UNITED THERAPEUTICS$$82$YR$$F$Y$72.109$KG$20240928$$$US$US
243610881$24361088$1$I$20240801$20240919$20240925$20240925$EXP$$US-ABBVIE-5933030$ABBVIE$$75$YR$$M$Y$$$20240925$$CN$US$US
243610911$24361091$1$I$20240405$20240919$20240925$20240925$EXP$$CA-TAKEDA-2024TUS050875$TAKEDA$$60$YR$$M$Y$114$KG$20240925$$CN$CA$CA
243610921$24361092$1$I$20180226$20240919$20240925$20240925$EXP$$BE-AMGEN-BELNI2024180044$AMGEN$$81$YR$E$M$Y$64.8$KG$20240925$$MD$BE$BE
243610931$24361093$1$I$$20240917$20240925$20240925$EXP$$GB-TAKEDA-2024TUS093662$TAKEDA$$$$$M$Y$$$20240925$$HP$GB$GB
243610941$24361094$1$I$$20240920$20240925$20240925$PER$$US-LEO Pharma-373724$LEO PHARM$$33$YR$$F$Y$$$20240925$$CN$US$US
243610951$24361095$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190560$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
243610961$24361096$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189913$AMGEN$$$$$F$Y$$$20240925$$CN$US$US
243610971$24361097$1$I$$20240909$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09043$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243610981$24361098$1$I$$20231017$20240925$20240925$PER$$US-CELLTRION INC.-2023US018519$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243610991$24361099$1$I$20240729$20240917$20240925$20240925$EXP$FR-AFSSAPS-TS2024000973$FR-TEVA-VS-3244513$TEVA$$56$YR$$M$Y$$$20240925$$MD$FR$FR
243611001$24361100$1$I$$20240924$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151751$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240925$$HP$US$US
243611011$24361101$1$I$$20240924$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151713$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240925$$CN$US$US
243611021$24361102$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151796$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$71.67$KG$20240925$$CN$US$US
243611031$24361103$1$I$20240101$20240919$20240925$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-029974$UNITED THERAPEUTICS$$$$$M$Y$87.075$KG$20240925$$$US$US
243611051$24361105$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015376$ELI LILLY AND CO$$87$YR$E$M$Y$$$20240925$$CN$US$US
243611061$24361106$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014421$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240925$$CN$US$US
243611071$24361107$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014713$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240925$$CN$US$US
243611081$24361108$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014649$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240925$$CN$US$US
243611091$24361109$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014428$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240925$$CN$US$US
243611101$24361110$1$I$20240208$20240918$20240925$20240925$EXP$$CA-TAKEDA-2024TUS003828$TAKEDA$$19$YR$$M$Y$$$20240925$$CN$CA$CA
243611111$24361111$1$I$$20240917$20240925$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-029915$UNITED THERAPEUTICS$$$$$F$Y$63.039$KG$20240925$$$US$US
243611121$24361112$1$I$$20231006$20240925$20240925$PER$$US-CELLTRION INC.-2023US019627$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243611131$24361113$1$I$$20240909$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09028$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243611141$24361114$1$I$20231212$20240919$20240925$20240925$EXP$$US-ABBVIE-5933631$ABBVIE$$49$YR$$F$Y$62$KG$20240925$$MD$US$US
243611151$24361115$1$I$20240901$20240916$20240925$20240925$EXP$$CA-CELLTRION INC.-2024CA022561$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
243611161$24361116$1$I$$20240910$20240925$20240925$PER$$US-EPICPHARMA-US-2024EPCSPO01133$EPIC PHARM$$74$YR$E$M$Y$$$20240925$$CN$US$US
243611171$24361117$1$I$$20240916$20240925$20240925$EXP$$TR-ROCHE-10000088341$ROCHE$Akyol G, Unsal SE, Mandaci NS, Keklik M, Unal A. CT-249 Treatment of Hematopoietic Stem Cell Transplant-Associated Microangiopathy with Eculizumab. Clinical Lymphoma, Myeloma and Leukemia. 2024; 24(S594), Sup 1. DOI: 10.1016/S2152-2650(24)01754-3.$62$YR$A$F$Y$$$20240925$$MD$TR$TR
243611181$24361118$1$I$$20240918$20240925$20240925$EXP$$AT-AMGEN-AUTSP2024189007$AMGEN$Strasser B.; Kranewitter W.; Hofer H. et al.. Bone marrow reinvestigation leading to the diagnosis of VEXAS syndrome. Laboratory Medicine. 2024;55 (5):655-657$46$YR$A$M$Y$$$20240925$$MD$AT$AT
243611191$24361119$1$I$$20240316$20240925$20240925$PER$$US-ENDO PHARMACEUTICALS INC-2024-001396$ENDO$$$$$F$Y$$$20240925$$CN$US$US
243611201$24361120$1$I$$20231126$20240925$20240925$PER$$US-CELLTRION INC.-2023US020432$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243611211$24361121$1$I$$20240921$20240925$20240925$PER$$US-AMGEN-USASP2024189262$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243611221$24361122$1$I$20240920$20240920$20240925$20240925$30DAY$$US-AMGEN-USASP2024188831$AMGEN$$63$YR$A$$Y$$$20240925$$HP$US$US
243611232$24361123$2$F$20240920$20240923$20240925$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150171$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240928$$HP$US$US
243611241$24361124$1$I$20240625$20240920$20240925$20240925$EXP$$CN-009507513-2409CHN008490$MERCK$$65$YR$$M$Y$$$20240925$$MD$CN$CN
243611251$24361125$1$I$$20240909$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09033$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243611271$24361127$1$I$$20240910$20240925$20240925$PER$$US-EPICPHARMA-US-2024EPCSPO01127$EPIC PHARM$$$$$$Y$$$20240925$$CN$US$US
243611281$24361128$1$I$$20240918$20240925$20240925$EXP$$US-RDY-SPO/USA/24/0013836$DR REDDYS$$65$YR$E$F$Y$$$20240925$$MD$US$US
243611291$24361129$1$I$20240916$20240923$20240925$20240925$EXP$$NVSC2024GB189528$NOVARTIS$$$$$M$Y$$$20240925$$CN$GB$GB
243611301$24361130$1$I$$20240919$20240925$20240925$PER$$US-ROCHE-10000088140$ROCHE$$$$$$Y$$$20240925$$CN$US$US
243611331$24361133$1$I$$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024189576$AMGEN$$$$$M$Y$$$20240925$$CN$US$US
243611341$24361134$1$I$$20240918$20240925$20240925$EXP$$US-VIIV HEALTHCARE LIMITED-US2024116664$VIIV$$$$$$Y$$$20240925$$MD$US$US
243611361$24361136$1$I$20240115$20240918$20240925$20240925$EXP$$BR-TAKEDA-2024TUS093942$TAKEDA$$16$YR$$M$Y$$$20240925$$CN$BR$BR
243611371$24361137$1$I$$20240923$20240925$20240925$EXP$$NVSC2024US189905$NOVARTIS$$$$$F$Y$54.43$KG$20240925$$CN$US$US
243611381$24361138$1$I$$20240909$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09032$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243611391$24361139$1$I$$20231221$20240925$20240925$PER$$US-CELLTRION INC.-2023US021626$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243611411$24361141$1$I$20240101$20240909$20240925$20240925$EXP$$US-SA-2024SA276004$SANOFI AVENTIS$$10$YR$C$M$Y$30.839$KG$20240925$$MD$US$US
243611421$24361142$1$I$20240910$20240911$20240925$20240925$EXP$$US-SA-2024SA274733$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240925$$CN$US$US
243611471$24361147$1$I$$20240919$20240925$20240925$PER$$US-ABBVIE-5932523$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243611481$24361148$1$I$$20240911$20240925$20240925$EXP$$BR-CADILA HEALTHCARE LIMITED-BR-ZYDUS-112230$ZYDUS PHARM$$$$$$Y$$$20240925$$CN$BR$BR
243611491$24361149$1$I$20240801$20240823$20240925$20240925$PER$$US-SERVIER-S24010798$SERVIER$$$$$$Y$$$20240925$$CN$US$US
243611501$24361150$1$I$20240101$20240916$20240925$20240925$EXP$DK-DKMA-30738335$DK-TEVA-VS-3244376$TEVA$$$$$$Y$$$20240925$$MD$DK$DK
243611521$24361152$1$I$$20240920$20240925$20240925$PER$$US-LEO Pharma-373707$LEO PHARM$$$$$M$Y$$$20240925$$MD$US$US
243611531$24361153$1$I$$20240911$20240925$20240925$PER$$US-JNJFOC-20240933911$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$CN$US$US
243611541$24361154$1$I$20110101$20240918$20240925$20240925$PER$$US-JNJFOC-20240953652$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240925$$HP$US$US
243611551$24361155$1$I$20240101$20240917$20240925$20240925$PER$$US-JNJFOC-20240955722$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240925$$HP$US$US
243611561$24361156$1$I$$20240918$20240925$20240925$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029779$UNITED THERAPEUTICS$$$$$M$Y$83.9$KG$20240925$$$US$US
243611571$24361157$1$I$20230816$20240916$20240925$20240925$EXP$$DE-JNJFOC-20240959879$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240925$$MD$DE$DE
243611581$24361158$1$I$20240830$20240906$20240925$20240925$PER$$US-JNJFOC-20240915950$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240925$$HP$US$US
243611591$24361159$1$I$$20240918$20240925$20240925$EXP$$US-SA-2024SA271617$SANOFI AVENTIS$$97$YR$E$M$Y$$$20240925$$HP$US$US
243611601$24361160$1$I$20240801$20240913$20240925$20240925$EXP$$US-UCBSA-2024047486$UCB$$44$YR$$F$Y$$$20240925$$HP$US$US
243611611$24361161$1$I$$20240923$20240925$20240925$PER$$US-HALEON-2198412$Haleon PLC$$$$$$Y$$$20240925$$CN$US$US
243611621$24361162$1$I$$20240920$20240925$20240925$EXP$CZ-EMA-DD-20240919-7482650-063850$CZ-RDY-SPO/CZE/24/0013964$DR REDDYS$Weinbergerova B, Mayer J, Kabut T, Sperr WR, Stevkova J, Jonasova A, et al. Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis. Br J Haematol. 2024 Jul 23. doi: 10.1111/bjh.19670.$78$YR$E$$Y$$$20240925$$HP$CZ$CZ
243611631$24361163$1$I$20240826$20240919$20240925$20240925$EXP$$JP-EXELIXIS-EXL-2024-000517$EXELIXIS$$8$DEC$$M$Y$$$20240925$$MD$JP$JP
243611651$24361165$1$I$20240823$20240826$20240925$20240925$PER$$US-Eisai-EC-2024-173000$EISAI$$$$$M$Y$$$20240925$$HP$US$US
243611661$24361166$1$I$20240101$20240826$20240925$20240925$PER$$US-Eisai-EC-2024-172999$EISAI$$81$YR$E$F$Y$70$KG$20240925$$CN$US$US
243611671$24361167$1$I$$20240918$20240925$20240925$PER$$US-GSK-US2024AMR116343$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
243611681$24361168$1$I$20240918$20240918$20240925$20240925$PER$$US-AMGEN-USASP2024190238$AMGEN$$64$YR$A$F$Y$$$20240925$$CN$US$US
243611691$24361169$1$I$$20240916$20240925$20240925$EXP$$US-ROCHE-10000083929$ROCHE$$75$YR$E$F$Y$$$20240925$$CN$US$US
243611701$24361170$1$I$20240825$20240918$20240925$20240925$EXP$$CN-JNJFOC-20240954448$JOHNSON AND JOHNSON$$53$YR$A$M$Y$52$KG$20240925$$HP$CN$CN
243611712$24361171$2$F$20240901$20240923$20240925$20240930$EXP$$GB-MYLANLABS-2024M1086214$MYLAN$$$$$M$Y$$$20240930$$CN$GB$GB
243611721$24361172$1$I$20240828$20240918$20240925$20240925$EXP$$CN-ROCHE-10000086549$ROCHE$$$$$F$Y$$$20240925$$HP$CN$CN
243611732$24361173$2$F$20240808$20240923$20240925$20240927$EXP$ES-AEMPS-1570668$ES-JNJFOC-20240964084$JOHNSON AND JOHNSON$$61$YR$A$M$Y$87$KG$20240927$$MD$ES$ES
243611741$24361174$1$I$20240822$20240924$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151756$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240925$$CN$US$US
243611751$24361175$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150857$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240925$$CN$US$US
243611761$24361176$1$I$$20240918$20240925$20240925$EXP$$CN-ROCHE-10000084799$ROCHE$Zhang J, Yu J, Yang D, Jiang L, Dong X, Liu Z, et al. Bevacizumab reduces cerebral radiation necrosis due to stereotactic radiotherapy in non-small cell lung cancer patients with brain metastases: an inverse probability of treatment weighting analysis. Frontiers in immunology. 2024-Aug-27;15:1-10. doi:10.3389/fimmu.2024.1399613.$$$$$Y$$$20240925$$HP$CN$CN
243611781$24361178$1$I$$20240918$20240925$20240925$EXP$$IE-ROCHE-10000086736$ROCHE$$$$A$F$Y$$$20240925$$MD$IE$IE
243611801$24361180$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014624$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240925$$CN$US$US
243611811$24361181$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014398$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240925$$CN$US$US
243611821$24361182$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015320$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240925$$CN$US$US
243611831$24361183$1$I$20240917$20240918$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012329$ELI LILLY AND CO$$$$A$F$Y$$$20240925$$CN$US$US
243611841$24361184$1$I$$20240923$20240925$20240925$PER$$US-ROCHE-10000089885$ROCHE$$45$YR$A$M$Y$$$20240925$$MD$US$US
243611851$24361185$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014738$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240925$$CN$US$US
243611861$24361186$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014902$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240925$$CN$US$US
243611871$24361187$1$I$$20240923$20240925$20240925$PER$$US-ROCHE-10000090044$ROCHE$$49$YR$A$F$Y$$$20240925$$MD$US$US
243611881$24361188$1$I$$20240919$20240925$20240925$EXP$$CA-JNJFOC-20240962629$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240925$$CN$CA$CA
243611911$24361191$1$I$$20240917$20240925$20240925$EXP$$US-TAKEDA-2022TUS091824$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
243611921$24361192$1$I$$20240912$20240925$20240925$EXP$$AR-TAKEDA-2024TUS093621$TAKEDA$$5$YR$$$Y$$$20240925$$CN$AR$AR
243611931$24361193$1$I$20240830$20240918$20240925$20240925$EXP$$CN-SANDOZ INC.-SDZ2024CN082346$SANDOZ$$76$YR$$F$Y$50.3$KG$20240925$$HP$CN$CN
243611941$24361194$1$I$20240821$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046167$AUROBINDO$$73$YR$$M$Y$54$KG$20240925$$PH$FR$FR
243611951$24361195$1$I$$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093776$TAKEDA$$30$YR$$F$Y$$$20240925$$CN$US$US
243611961$24361196$1$I$$20240918$20240925$20240925$PER$$US-TAKEDA-2024TUS093380$TAKEDA$$$$$$Y$$$20240925$$CN$US$US
243611971$24361197$1$I$$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093751$TAKEDA$$53$YR$$F$Y$$$20240925$$CN$US$US
243612011$24361201$1$I$$20240916$20240925$20240925$EXP$$FR-TEVA-VS-3245753$TEVA$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$27$YR$$M$Y$$$20240925$$HP$FR$FR
243612021$24361202$1$I$$20240917$20240925$20240925$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP012328$STRIDES$Mann I, Morado-Aramburo O, Hasbun R.. Emerging shadows: HHV-8-associated encephalitis unveiled in a solid organ transplant recipient.. Transpl-Infect-Dis. 2024;26 (4):1-3$$$$$Y$$$20240925$$HP$US$US
243612031$24361203$1$I$$20240911$20240925$20240925$EXP$$AT-CELLTRION INC.-2024AT022737$CELLTRION$$$$$$Y$$$20240925$$MD$AT$AT
243612041$24361204$1$I$$20240910$20240925$20240925$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09463$LUPIN$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al. Clinical characteristics and HLA associations of Azithromycin-induced liver injury. Alimentary Pharmacology and Therapeutics. 2024;60:787-795$$$A$$Y$$$20240925$$HP$US$US
243612051$24361205$1$I$20240101$20240916$20240925$20240925$EXP$$US-TEVA-VS-3245226$TEVA$$56$YR$$F$Y$$$20240925$$CN$US$US
243612061$24361206$1$I$20240910$20240913$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013616$DR REDDYS$$$$$M$Y$$$20240925$$CN$US$US
243612071$24361207$1$I$20240830$20240913$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013565$DR REDDYS$$46$YR$A$M$Y$$$20240925$$MD$US$US
243612081$24361208$1$I$20240916$20240916$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013885$DR REDDYS$$15$YR$T$F$Y$$$20240925$$CN$US$US
243612091$24361209$1$I$$20240912$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013611$DR REDDYS$$15$YR$T$$Y$$$20240925$$MD$US$US
243612101$24361210$1$I$$20240909$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013378$DR REDDYS$$$$$F$Y$$$20240925$$CN$US$US
243612111$24361211$1$I$$20240916$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013795$DR REDDYS$$19$YR$A$F$Y$$$20240925$$MD$US$US
243612121$24361212$1$I$$20240916$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013711$DR REDDYS$$68$YR$E$F$Y$$$20240925$$MD$US$US
243612131$24361213$1$I$$20240920$20240925$20240925$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052837$BOEHRINGER INGELHEIM$$84$YR$E$F$Y$$$20240925$$MD$PL$PL
243612141$24361214$1$I$20230515$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046159$AUROBINDO$$18$YR$$M$Y$105$KG$20240925$$MD$FR$FR
243612151$24361215$1$I$$20240912$20240925$20240925$EXP$$US-GRAVITIPHARMA-GRA-2409-US-LIT-0394$GRAVITI PHARMACEUTICALS$Hussain R, Bokhari A, Sadiq S.RHABDOMYOLYSIS WITH CONCURRENT ATROVASTATIN AND SITAGLIPTIN IN THE SETTING OF VITAMIN D DEFICIENCY.Chest.2021;160 (4):A217$69$YR$A$M$Y$$$20240925$$HP$US$US
243612161$24361216$1$I$$20240918$20240925$20240925$EXP$$CN-RDY-SPO/CHN/24/0013843$DR REDDYS$Xiaomin Z, Fang W, Su T. A case of mixed psychoactive drug overdose. Chinese Journal of Industrial Medicine. 2024 Aug;37(4): doi:10.13631/j.cnki.zggyyx.2024.04.039.$22$YR$A$M$Y$$$20240925$$MD$CN$CN
243612171$24361217$1$I$20240912$20240917$20240925$20240925$PER$$US-TAKEDA-2024TUS092389$TAKEDA$$31$YR$$F$Y$$$20240925$$PH$US$US
243612181$24361218$1$I$$20240911$20240925$20240925$EXP$GB-MHRA-MED-202409102349253270-YZNMC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21499$ALKEM$$$$$M$Y$$$20240925$$CN$GB$GB
243612191$24361219$1$I$$20240913$20240925$20240925$EXP$$NL-AUROBINDO-AUR-APL-2024-046473$AUROBINDO$Coopmans E. C.; Langerak A. W.; Budel L. M. et al. Woman from Suriname with refractory hypercalcemia and ascites. Dutch Journal of Hematology. 2024;21(4):73-83$60$YR$$F$Y$$$20240925$$MD$NL$NL
243612201$24361220$1$I$$20240916$20240925$20240925$PER$$US-GSK-US2024AMR115383$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
243612211$24361221$1$I$20240830$20240911$20240925$20240925$EXP$GB-MHRA-TPP30349237C3169167YC1725881408288$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21464$ALKEM$$40$YR$$F$Y$56$KG$20240925$$MD$GB$GB
243612231$24361223$1$I$20210302$20240911$20240925$20240925$EXP$$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21466$ALKEM$$68$YR$$M$Y$$$20240925$$MD$GB$GB
243612241$24361224$1$I$$20240916$20240925$20240925$PER$$US-GSK-US2024114946$GLAXOSMITHKLINE$$$$$M$Y$$$20240925$$CN$US$US
243612261$24361226$1$I$20240812$20240914$20240925$20240925$EXP$CN-HENLIUS-24CN017260$CN-Accord-448197$ACCORD$$39$YR$A$F$Y$50.3$KG$20240925$$MD$CN$CN
243612271$24361227$1$I$$20240923$20240925$20240925$EXP$$US-ABBVIE-5936115$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243612281$24361228$1$I$$20240919$20240925$20240925$EXP$$US-ROCHE-10000087273$ROCHE$$$$C$M$Y$$$20240925$$MD$US$US
243612291$24361229$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151498$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240925$$CN$US$US
243612301$24361230$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151486$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240925$$CN$US$US
243612311$24361231$1$I$20240914$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151567$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240925$$HP$US$US
243612322$24361232$2$F$$20240926$20240925$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151521$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240927$$HP$US$US
243612331$24361233$1$I$$20240923$20240925$20240925$EXP$$CA-CHATTEMPRD-2021SA227034$CHATTEM$$58$YR$A$F$Y$$$20240925$$HP$CA$CA
243612341$24361234$1$I$$20240911$20240925$20240925$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-21179$ALKEM$Kato Y, Kuriyama A, Hata R, Ikegami T. Extracorporeal Membrane Oxygenation for Hypokalemia and Refractory Ventricular Fibrillation Associated with Caffeine Intoxication. The Journal of Emergency Medicine. 2020;58 (1):59-62$43$YR$$F$Y$81$KG$20240925$$MD$JP$JP
243612351$24361235$1$I$$20240919$20240925$20240925$EXP$$TR-GILEAD-2024-0688321$GILEAD$$$$$F$Y$$$20240925$$MD$TR$TR
243612361$24361236$1$I$$20240924$20240925$20240925$PER$$US-ABBVIE-5938439$ABBVIE$$$$$$Y$$$20240925$$MD$US$US
243612371$24361237$1$I$20240901$20240916$20240925$20240925$PER$$US-ABBVIE-5927812$ABBVIE$$$$$$Y$$$20240925$$CN$US$US
243612391$24361239$1$I$$20240916$20240925$20240925$PER$$US-TAKEDA-2024TUS092255$TAKEDA$$$$$$Y$$$20240925$$PH$US$US
243612401$24361240$1$I$$20240911$20240925$20240925$EXP$$GB-UCBSA-2024047109$UCB$$$$$F$Y$$$20240925$$CN$GB$GB
243612411$24361241$1$I$$20240917$20240925$20240925$EXP$$IN-ROCHE-10000054832$ROCHE$$71$YR$E$M$Y$$$20240925$$CN$IN$IN
243612421$24361242$1$I$$20240923$20240925$20240925$EXP$$NVSC2024US190051$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
243612431$24361243$1$I$$20240913$20240925$20240925$EXP$$PL-JNJFOC-20240940086$JOHNSON AND JOHNSON$$84$YR$E$$Y$$$20240925$$MD$PL$PL
243612451$24361245$1$I$$20240923$20240925$20240925$EXP$$US-GILEAD-2024-0688702$GILEAD$$66$YR$E$F$Y$$$20240925$$CN$US$US
243612461$24361246$1$I$$20230829$20240925$20240925$PER$$US-CELLTRION INC.-2023US017138$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243612471$24361247$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3246102$TEVA$$77$YR$$F$Y$$$20240925$$CN$CA$CA
243612481$24361248$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244657$TEVA$$41$YR$$F$Y$$$20240925$$HP$CA$CA
243612491$24361249$1$I$$20240725$20240925$20240925$PER$$US-ROCHE-10000022997$ROCHE$$$$$$Y$$$20240925$$CN$US$US
243612511$24361251$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151727$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$98.88$KG$20240925$$CN$US$US
243612521$24361252$1$I$$20240924$20240925$20240925$EXP$$DE-SANDOZ INC.-SDZ2024DE082553$SANDOZ$$$$A$$Y$$$20240925$$HP$DE$DE
243612531$24361253$1$I$20240411$20240917$20240925$20240925$EXP$$FR-HIKMA PHARMACEUTICALS-FR-H14001-24-08779$HIKMA$$69$YR$$M$Y$$$20240925$$PH$FR$FR
243612541$24361254$1$I$$20231116$20240925$20240925$PER$$US-CELLTRION INC.-2023US022299$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243612551$24361255$1$I$20240901$20240916$20240925$20240925$PER$$US-GSK-US2024114980$GLAXOSMITHKLINE$$85$YR$$M$Y$$$20240925$$CN$US$US
243612561$24361256$1$I$20240923$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015152$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243612571$24361257$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014099$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240925$$CN$US$US
243612581$24361258$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014323$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240925$$CN$US$US
243612591$24361259$1$I$$20240923$20240925$20240925$PER$$US-ABBVIE-5935868$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243612601$24361260$1$I$20230922$20240117$20240925$20240925$PER$$US-CELLTRION INC.-2023US022331$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243612621$24361262$1$I$$20240916$20240925$20240925$PER$$US-GSK-US2024114925$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
243612632$24361263$2$F$$20240923$20240925$20240926$PER$$US-BIOGEN-2024BI01283634$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243612641$24361264$1$I$20240401$20240627$20240925$20240925$PER$$US-TEVA-VS-3214570$TEVA$$59$YR$$F$Y$83.91$KG$20240925$$CN$US$US
243612651$24361265$1$I$$20240917$20240925$20240925$EXP$$FR-MYLANLABS-2024M1085891$MYLAN$Sakhi H, Reverdito G, Soulat G, Mousseaux E. Cardiovascular magnetic resonance in the identification of extra-cardiac causes of myocarditis: a case series. Eur-Heart-J-Case-Rep 2024; 8 (5): 1-5.$54$YR$$F$Y$$$20240925$$HP$FR$FR
243612661$24361266$1$I$$20240916$20240925$20240925$EXP$$US-MYLANLABS-2024M1085675$MYLAN$Oyama G, Maling N, Avila-Thompson A, Zeilman PR, Foote KD, Malaty IA, et al. Rescue GPi-DBS for a stroke-associated hemiballism in a patient with STN-DBS. Tremor-Other-Hyperkinet-Mov 2014; 4 1-5.$38$YR$$M$Y$$$20240925$$HP$US$US
243612671$24361267$1$I$20240908$20240910$20240925$20240925$EXP$$US-GLANDPHARMA-US-2024GLNSPO00789$GLAND PHARMA$$70$YR$E$F$Y$$$20240925$$PH$US$US
243612681$24361268$1$I$$20240917$20240925$20240925$EXP$$IT-MYLANLABS-2024M1085673$MYLAN$Cecchi R, Pavesi M, Bartoli L, Brunetti L. Successful treatment of localized pyoderma gangrenosum with topical pimecrolimus. J-Cutan-Med-Surg 2012; 16 (5): 295-297.$56$YR$$F$Y$$$20240925$$HP$IT$IT
243612691$24361269$1$I$$20240916$20240925$20240925$EXP$$US-MYLANLABS-2024M1085693$MYLAN$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann-Rheum-Dis 2022; 81 (2): 289-291.$$$A$$Y$$$20240925$$MD$US$US
243612701$24361270$1$I$$20240916$20240925$20240925$EXP$$US-MYLANLABS-2024M1085704$MYLAN$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann-Rheum-Dis 2022; 81 (2): 289-291.$$$A$$Y$$$20240925$$MD$US$US
243612711$24361271$1$I$20240101$20240916$20240925$20240925$PER$$US-ABBVIE-5926892$ABBVIE$$37$YR$$M$Y$$$20240925$$CN$US$US
243612721$24361272$1$I$$20231209$20240925$20240925$PER$$US-CELLTRION INC.-2023US017737$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243612731$24361273$1$I$$20240909$20240925$20240925$PER$$US-009507513-2409USA003576$MERCK$$$$$F$Y$$$20240925$$CN$US$US
243612741$24361274$1$I$$20240924$20240925$20240925$PER$$US-HALEON-2198549$Haleon PLC$$87$YR$$F$Y$$$20240925$$CN$US$US
243612751$24361275$1$I$20240101$20240917$20240925$20240925$EXP$$CA-JNJFOC-20240419859$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20240925$$HP$CA$CA
243612761$24361276$1$I$20240909$20240916$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046207$AUROBINDO$$$$$$Y$$$20240925$$PH$GB$GB
243612771$24361277$1$I$20240914$20240918$20240925$20240925$EXP$GB-MHRA-TPP18008578C8751311YC1726635626245$GB-RDY-SPO/GBR/24/0013794$DR REDDYS$$75$YR$E$F$Y$74$KG$20240925$$PH$GB$GB
243612781$24361278$1$I$20240830$20240910$20240925$20240925$EXP$$US-GLANDPHARMA-US-2024GLNSPO00786$GLAND PHARMA$$17$YR$T$M$Y$$$20240925$$PH$US$US
243612791$24361279$1$I$20221001$20240918$20240925$20240925$EXP$$CN-RDY-SPO/CHN/24/0013875$DR REDDYS$Yang T, Yu B, Wang Y. Clinical pharmacist involvement in the pharmaceutical practice of severe drug eruption and deep vein thrombosis in a patient with multiple myeloma. CHINESE JOURNAL OF CLINICAL PHARMACY. 2024;33(8): 632. doi:10.19577/j.1007-4406.2024.08.016.$67$YR$E$F$Y$43$KG$20240925$$HP$CN$CN
243612801$24361280$1$I$$20240917$20240925$20240925$EXP$$US-RDY-SPO/USA/24/0013803$DR REDDYS$$$$$$Y$$$20240925$$HP$US$US
243612812$24361281$2$F$20240801$20240925$20240925$20240926$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053361$BOEHRINGER INGELHEIM$$54$YR$A$F$Y$$$20240926$$CN$US$US
243612821$24361282$1$I$$20240912$20240925$20240925$EXP$$US-GRAVITIPHARMA-GRA-2409-US-LIT-0393$GRAVITI PHARMACEUTICALS$Edjiu N, Rajan S.Doacs and emergent craniotomy for intracranial hemorrhage: Current laboratory testing and reversal options..J-Neurosurg-Anesthesiol.2021;33 (4):405$69$YR$A$F$Y$$$20240925$$HP$US$US
243612831$24361283$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190570$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
243612841$24361284$1$I$20220101$20231103$20240925$20240925$PER$$US-CELLTRION INC.-2023US019278$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243612851$24361285$1$I$$20240919$20240925$20240925$EXP$$CA-ROCHE-10000086414$ROCHE$$53$YR$A$F$Y$63$KG$20240925$$HP$CA$CA
243612861$24361286$1$I$$20240911$20240925$20240925$EXP$$CA-BAXTER-2024BAX024758$BAXTER$$70$YR$$F$Y$$$20240925$$CN$CA$CA
243612871$24361287$1$I$$20240918$20240925$20240925$PER$$US-GSK-US2024116148$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
243612881$24361288$1$I$20240910$20240923$20240925$20240925$EXP$ES-AEMPS-1571046$ES-GILEAD-2024-0688633$GILEAD$$22$YR$A$M$Y$$$20240925$$PH$ES$ES
243612891$24361289$1$I$20240919$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150256$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240925$$HP$US$US
243612901$24361290$1$I$$20240912$20240925$20240925$EXP$$US-GRAVITIPHARMA-GRA-2409-US-LIT-0398$GRAVITI PHARMACEUTICALS$Abudalou M, Mohamed AS, Vega EA, Sbihi AA.Colchicine-induced rhabdomyolysis: a review of 83 cases.BMJ-Case-Rep.2021;14:7$74$YR$E$M$Y$$$20240925$$HP$US$US
243612911$24361291$1$I$$20240919$20240925$20240925$PER$$US-GSK-US2024116589$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$HP$US$US
243612921$24361292$1$I$$20231012$20240925$20240925$PER$$US-CELLTRION INC.-2023US019994$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243612931$24361293$1$I$20221001$20240913$20240925$20240925$EXP$$PL-AUROBINDO-AUR-APL-2024-046645$AUROBINDO$Tubek S.; Gajewska E.; Kuzyszyn Z. et al.. Metastatic lung calcifications in end-stage renal failure with coexisting short bowel syndrome. Unknown$53$YR$$F$Y$$$20240925$$MD$PL$PL
243612941$24361294$1$I$$20240918$20240925$20240925$EXP$$US-ABBVIE-5931296$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243612951$24361295$1$I$20240922$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189600$AMGEN$$56$YR$A$F$Y$$$20240925$$CN$US$US
243612961$24361296$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18242$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS.. Prasugrel is effective and safe for neurointerventional procedures. J Neurointervent Surg. 2013;5:332-336$60$YR$$$Y$$$20240925$$HP$US$US
243612971$24361297$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18252$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS.. Prasugrel is effective and safe for neurointerventional procedures. J Neurointervent Surg. 2013;5:332-336$59$YR$$$Y$$$20240925$$HP$US$US
243612982$24361298$2$F$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18227$ALKEM$Akbari SH, Reynolds MR, Kadkhodayan Y, Cross DT, Moran CJ.. Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J NeuroIntervent Surg. 2013;5:337-343$6$DEC$$M$Y$$$20240925$$HP$US$US
243612991$24361299$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18246$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS. Prasugrel is effective and safe for neurointerventional procedures. J NeuroIntervent Surg. 2013;5:332-336$57$YR$$$Y$$$20240925$$HP$US$US
243613001$24361300$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18256$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS.. Prasugrel is effective and safe for neurointerventional procedures. J Neurointervt Surg. 2013;5:332-336$72$YR$$$Y$$$20240925$$HP$US$US
243613011$24361301$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18210$ALKEM$Davis K, Morrison C.. Ticagrelor for Neuroendovascular Procedures: A Case Series. Journal of Pharmacy Practice. 2018;31(1):115-119$36$YR$$M$Y$$$20240925$$HP$US$US
243613021$24361302$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18243$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS. Prasugrel is effective and safe for neurointerventional procedures. J NeuroIntervent Surg. 2013;5:332-336$53$YR$$$Y$$$20240925$$HP$US$US
243613031$24361303$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18208$ALKEM$Davis K, Morrison C.. Ticagrelor for Neuroendovascular Procedures: A Case Series. Journal of Pharmacy Practice. 2018;31(1):115-119$63$YR$$F$Y$$$20240925$$HP$US$US
243613042$24361304$2$F$$20240717$20240925$20240925$EXP$$VN-ALKEM LABORATORIES LIMITED-VN-ALKEM-2024-16657$ALKEM$Ton MD, Phuong DV, Tho PQ, Dung NT, Tuan TA, Thien NT. Management of ruptured aneurysmal subarachnoid hemorrhage with multiple basilar trunk aneurysms using a flow-diverter stent: A case report. Radiology Case Reports. 2024;19:2629-2632$35$YR$$F$Y$$$20240925$$HP$VN$VN
243613051$24361305$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18249$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS.. Prasugrel is effective and safe for neurointerventional procedures. J Neurointervent Surg. 2013;5:332-336$51$YR$$$Y$$$20240925$$HP$US$US
243613061$24361306$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18257$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS.. Prasugrel is effective and safe for neurointerventional procedures. J Neurointervent Surg. 2013;5:332-336$52$YR$$$Y$$$20240925$$HP$US$US
243613071$24361307$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18248$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS. Prasugrel is effective and safe for neurointerventional procedures. J NeuroIntervent Surg. 2013;5:332-336$53$YR$$$Y$$$20240925$$HP$US$US
243613081$24361308$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18254$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS.. Prasugrel is effective and safe for neurointerventional procedures. J Neurointervent Surg. 2013;5:332-336$61$YR$$$Y$$$20240925$$HP$US$US
243613091$24361309$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18250$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS.. Prasugrel is effective and safe for neurointerventional procedures. J Neurointervent Surg. 2013;5:332-336$64$YR$$$Y$$$20240925$$HP$US$US
243613101$24361310$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18251$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS.. Prasugrel is effective and safe for neurointerventional procedures. J Neurointervent Surg. 2013;5:332-336$41$YR$$$Y$$$20240925$$HP$US$US
243613111$24361311$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18247$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS.. Prasugrel is effective and safe for neurointerventional procedures. J Neurointervent Surg. 2013;5:332-336$78$YR$$$Y$$$20240925$$HP$US$US
243613121$24361312$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18223$ALKEM$Akbari SH, Reynolds MR, Kadkhodayan Y, Cross DT 3rd, Moran CJ.. Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J NeuroIntervent Surg. 2013;5:337-343$8$DEC$$F$Y$$$20240925$$HP$US$US
243613131$24361313$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18245$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS.. Prasugrel is effective and safe for neurointerventional procedures. J Neurointervent Surg. 2013;5:332-336$48$YR$$$Y$$$20240925$$HP$US$US
243613141$24361314$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18255$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS.. Prasugrel is effective and safe for neurointerventional procedures. J Neurointervent Surg. 2013;5:332-336$56$YR$$$Y$$$20240925$$HP$US$US
243613151$24361315$1$I$$20240726$20240925$20240925$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-17816$ALKEM$Kim B, Kim K, Jeon P, Kim S, Kim H, Byun H, Cha J, Hong S, Jo K.. Thromboembolic complications in patients with clopidogrel resistance after coil embolization for unruptured intracranial aneurysms. AJNR Am J Neuroradiol. 2014;35 (9):1786-1792$74$YR$$F$Y$$$20240925$$HP$KR$KR
243613161$24361316$1$I$$20240801$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-18240$ALKEM$Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS.. Prasugrel is effective and safe for neurointerventional procedures. J Neurointervent Surg. 2013;5:332-336$63$YR$$$Y$$$20240925$$HP$US$US
243613171$24361317$1$I$$20240726$20240925$20240925$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-17815$ALKEM$Kim B, Kim K, Jeon P, Kim S, Kim H, Byun H, Cha J, Hong S, Jo K.. Thromboembolic complications in patients with clopidogrel resistance after coil embolization for unruptured intracranial aneurysms. AJNR Am J Neuroradiol. 2014;35(9):1786-1792$59$YR$$F$Y$$$20240925$$HP$KR$KR
243613181$24361318$1$I$$20240717$20240925$20240925$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-16745$ALKEM$Song J, Yeon JY, Kim JS, Hong SC, Kim KH, Jeon P.. Delayed thromboembolic events more than 30 days after self expandable intracranial stent-assisted embolization of unruptured intracranial aneurysms. Clinical Neurology and Neurosurgery. 2015;135:73-78$65$YR$$F$Y$$$20240925$$HP$KR$KR
243613191$24361319$1$I$$20240723$20240925$20240925$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-16986$ALKEM$Laurent D, Dodd WS, Small C, Gooch MR, Ghosh R, Goutnik M, Blatt T, Porche K, Geh N, Adamczak S, Polifka AJ, Brzezicki G, Hoh B, Chalouhi N.. Ticagrelor resistance: a case series and algorithm for management of non-responders. J NeuroIntervent Surg. 2022;14:179-183$$$$$Y$$$20240925$$HP$US$US
243613201$24361320$1$I$$20240717$20240925$20240925$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-16747$ALKEM$Song J, Yeon JY, Kim JS, Hong SC, Kim KH, Jeon P.. Delayed thromboembolic events more than 30 days after self expandable intracranial stent-assisted embolization of unruptured intracranial aneurysms. Clinical Neurology and Neurosurgery. 2015;135:73-78$61$YR$$F$Y$$$20240925$$HP$KR$KR
243613211$24361321$1$I$$20240717$20240925$20240925$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-16751$ALKEM$Song J, Yeon JY, Kim JS, Hong SC, Kim KH, Jeon P.. Delayed thromboembolic events more than 30 days after self expandable intracranial stent-assisted embolization of unruptured intracranial aneurysms. Clinical Neurology and Neurosurgery. 2015;135:73-78$70$YR$$M$Y$$$20240925$$HP$KR$KR
243613221$24361322$1$I$$20240723$20240925$20240925$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-16923$ALKEM$Fujikawa T, Noda T, Tada S, Tanaka A.. Intractable intraoperative bleeding requiring platelet transfusion during emergent cholecystectomy in a patient with dual antiplatelet therapy after drug-eluting coronary stent implantation (with video). BMJ Case Rep Published online. 2013;unk:1-4$76$YR$$M$Y$$$20240925$$HP$JP$JP
243613231$24361323$1$I$$20240626$20240925$20240925$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14209$ALKEM$$$$$M$Y$$$20240925$$HP$AU$AU
243613241$24361324$1$I$$20240726$20240925$20240925$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-17814$ALKEM$Kim B, Kim K, Jeon P, Kim S, Kim H, Byun H, Cha J, Hong S, Jo K.. Thromboembolic complications in patients with clopidogrel resistance after coil embolization for unruptured intracranial aneurysms. AJNR Am J Neuroradiol. 2014;35(9):1786-1792$75$YR$$F$Y$$$20240925$$HP$KR$KR
243613251$24361325$1$I$$20240717$20240925$20240925$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-16739$ALKEM$Song J, Yeon JY, Kim JS, Hong SC, Kim KH, Jeon P.. Delayed thromboembolic events more than 30 days after self expandable intracranial stent-assisted embolization of unruptured intracranial aneurysms. Clinical Neurology and Neurosurgery. 2015;135:73-78$46$YR$$F$Y$$$20240925$$HP$KR$KR
243613261$24361326$1$I$$20240626$20240925$20240925$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14201$ALKEM$$$$$M$Y$$$20240925$$HP$AU$AU
243613271$24361327$1$I$$20240903$20240925$20240925$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-19235$ALKEM$Du X, Guo X, Zhou X.. Recovery of nonketotic hyperglycaemic hemichorea -hemiballismus due to acute ischemic stroke in the contralateral supplementary motor area: a case report and literature review. Folia Neuropathol.. 2024;62 (1):1-6$83$YR$$F$Y$$$20240925$$HP$CN$CN
243613281$24361328$1$I$$20240705$20240925$20240925$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-15720$ALKEM$Shoda K, Enomoto Y, Egashira Y, Kinoshita T, Mizutani D, Iwama T. Long-term complications after stent assist coiling dependent on clopidogrel response. BMC Neurology. 2021;21:247$$$$$Y$$$20240925$$HP$JP$JP
243613291$24361329$1$I$$20240626$20240925$20240925$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14215$ALKEM$$66$YR$$F$Y$$$20240925$$HP$AU$AU
243613301$24361330$1$I$$20240705$20240925$20240925$EXP$$JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2024-15715$ALKEM$Shoda K, Enomoto Y, Egashira Y, Kinoshita T, Mizutani D, Iwama T.. Long-term complications after stent assist coiling dependent on clopidogrel response. BMC Neurology. 2021;21:247$$$$$Y$$$20240925$$HP$JP$JP
243613311$24361331$1$I$$20240911$20240925$20240925$EXP$$CA-UCBSA-2024047186$UCB$$$$$M$Y$$$20240925$$CN$CA$CA
243613321$24361332$1$I$$20240626$20240925$20240925$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-14216$ALKEM$$74$YR$$M$Y$$$20240925$$HP$AU$AU
243613331$24361333$1$I$$20240619$20240925$20240925$EXP$$AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-13799$ALKEM$$71$YR$$F$Y$$$20240925$$HP$AU$AU
243613341$24361334$1$I$$20240717$20240925$20240925$EXP$$KR-ALKEM LABORATORIES LIMITED-KR-ALKEM-2024-16740$ALKEM$Song J, Yeon JY, Kim JS, Hong SC, Kim KH, Jeon P.. Delayed thromboembolic events more than 30 days after self expandable intracranial stent-assisted embolization of unruptured intracranial aneurysms. Clinical Neurology and Neurosurgery. 2015;135:73-78$62$YR$$M$Y$$$20240925$$HP$KR$KR
243613351$24361335$1$I$20240501$20240920$20240925$20240925$EXP$$DE-SANDOZ INC.-SDZ2024DE081952$SANDOZ$$51$YR$$M$Y$$$20240925$$CN$DE$DE
243613361$24361336$1$I$$20240911$20240925$20240925$EXP$$GB-CIPLA LTD.-2024GB10073$CIPLA$$$$$$Y$$$20240925$$CN$GB$GB
243613371$24361337$1$I$$20240919$20240925$20240925$EXP$$AU-TAKEDA-2024TUS094269$TAKEDA$$$$$F$Y$$$20240925$$CN$GB$AU
243613391$24361339$1$I$$20240118$20240925$20240925$PER$$US-CELLTRION INC.-2023US020882$CELLTRION$$$$$$Y$$$20240925$$HP$US$US
243613401$24361340$1$I$$20240913$20240925$20240925$EXP$$IT-AUROBINDO-AUR-APL-2024-046361$AUROBINDO$Messa P.; Regalia A.; Alfieri C.M. et al.. Current indications to parathyroidectomy in CKD patients before and after renal transplantation.. JN Journal of Nephrology.. 2013;26(6):1025-1032$46$YR$$M$Y$$$20240925$$HP$IT$IT
243613421$24361342$1$I$20210101$20240919$20240925$20240925$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-2024-150026$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$MD$ES$ES
243613431$24361343$1$I$$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151101$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$65.32$KG$20240925$$CN$US$US
243613441$24361344$1$I$20240921$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189758$AMGEN$$79$YR$E$F$Y$$$20240925$$CN$US$US
243613471$24361347$1$I$20240101$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151490$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240925$$CN$US$US
243613481$24361348$1$I$$20240913$20240925$20240925$EXP$$IN-ROCHE-10000083104$ROCHE$$72$YR$E$M$Y$$$20240925$$CN$IN$IN
243613491$24361349$1$I$20240501$20240918$20240925$20240925$EXP$$CA-GSK-CA2023175224$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$CA$CA
243613501$24361350$1$I$20240729$20240909$20240925$20240925$PER$$US-009507513-2409USA003582$MERCK$$50$YR$$F$Y$$$20240925$$HP$US$US
243613511$24361351$1$I$$20240918$20240925$20240925$EXP$$BR-ROCHE-10000089303$ROCHE$$$$$$Y$$$20240925$$MD$BR$BR
243613521$24361352$1$I$20231101$20231222$20240925$20240925$PER$$US-CELLTRION INC.-2023US022021$CELLTRION$$$$$$Y$$$20240925$$HP$US$US
243613531$24361353$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190651$NOVARTIS$$$$$$Y$$$20240925$$HP$US$US
243613551$24361355$1$I$$20240916$20240925$20240925$PER$$US-GSK-US2024114964$GLAXOSMITHKLINE$$$$$M$Y$$$20240925$$CN$US$US
243613561$24361356$1$I$20220101$20240916$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046730$AUROBINDO$$28$YR$$M$Y$95$KG$20240925$$CN$FR$FR
243613571$24361357$1$I$20240101$20240925$20240925$20240925$EXP$$TH-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053354$BOEHRINGER INGELHEIM$$58$YR$A$M$Y$$$20240925$$CN$TH$TH
243613581$24361358$1$I$$20240917$20240925$20240925$PER$$US-TAKEDA-2024TUS093404$TAKEDA$$$$$$Y$$$20240925$$CN$US$US
243613591$24361359$1$I$$20240916$20240925$20240925$EXP$$PL-AUROBINDO-AUR-APL-2024-046779$AUROBINDO$Bleszynska-Marunowska E, Jagiello K, Wierucki L, Renke M, Grodzicki T, Kalarus Z et al.. Potentially Inappropriate Medications Involved in Drug-Drug Interactions in a Polish Population over 80 Years Old: An Observational, Cross-Sectional Study. Pharmaceuticals. 2024;17 (8)::1-9$$$E$$Y$$$20240925$$HP$PL$PL
243613601$24361360$1$I$$20240916$20240925$20240925$EXP$$DE-AUROBINDO-AUR-APL-2024-046620$AUROBINDO$Cicinnati V, Kabar I, Wolters H, Anthoni C, Schmidt H, Beckebaum S et.al.. Small bowel transplantation complicated by cytomegalovirus tissue invasive disease without viremia.. J. Clin. Virol.. 2014;60:177-180$52$YR$$F$Y$$$20240925$$MD$DE$DE
243613622$24361362$2$F$$20240924$20240925$20240927$PER$$US-ROCHE-10000089306$ROCHE$Rodriguez Castro J, Devine A, Gonzalez garcia G, Danckers M, Diaz R. Potential link between pulse dose steroids, pneumothorax, and pneumomediastinum in rapidly progressive interstitial lung disease: a case study. Chest. 2024-Oct;166 (4):3257A-8. doi:10.1016/j.chest.2024.06.1950.$55$YR$A$M$Y$$$20240927$$HP$US$US
243613631$24361363$1$I$$20240918$20240925$20240925$EXP$$CA-ROCHE-10000087994$ROCHE$$33$YR$A$M$Y$$$20240925$$MD$CA$CA
243613641$24361364$1$I$20240101$20240919$20240925$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA066243$SANDOZ$$$$$F$Y$$$20240925$$CN$CA$CA
243613651$24361365$1$I$$20240921$20240925$20240925$EXP$$CA-ROCHE-10000087471$ROCHE$$$$$F$Y$$$20240925$$HP$CA$CA
243613661$24361366$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014547$ELI LILLY AND CO$$34$YR$A$M$Y$$$20240925$$CN$US$US
243613671$24361367$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014385$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240925$$CN$US$US
243613681$24361368$1$I$20240915$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014728$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240925$$CN$US$US
243613691$24361369$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013828$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240925$$CN$US$US
243613701$24361370$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014506$ELI LILLY AND CO$$53$YR$A$$Y$$$20240925$$CN$US$US
243613711$24361371$1$I$$20240921$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014405$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240925$$CN$US$US
243613721$24361372$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014383$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240925$$PH$US$US
243613731$24361373$1$I$$20240913$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409009533$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240925$$CN$US$US
243613741$24361374$1$I$$20240919$20240925$20240925$EXP$$JP-ARGENX-2024-ARGX-JP008028AA$ARGENX BVBA$$$$$$Y$$$20240925$$MD$JP$JP
243613751$24361375$1$I$$20240916$20240925$20240925$EXP$$US-MYLANLABS-2024M1085679$MYLAN$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann-Rheum-Dis 2022; 81 (2): 289-291.$$$A$$Y$$$20240925$$MD$US$US
243613761$24361376$1$I$$20240916$20240925$20240925$EXP$$US-MYLANLABS-2024M1085706$MYLAN$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann-Rheum-Dis 2022; 81 (2): 289-291.$$$A$$Y$$$20240925$$MD$US$US
243613771$24361377$1$I$20230101$20240918$20240925$20240925$EXP$$FR-MYLANLABS-2024M1086479$MYLAN$Roger P-M, Sichez-Com H, Ollier J, Boumezber S, Bataille S. Oral clindamycin for peritonitis due to Brevibacterium casei and Bacillus cereus in two successive patients undergoing peritoneal dialysis. JAC-Antimicrob-Resist 2024; 6 (4): 1-2.$75$YR$$M$Y$$$20240925$$HP$FR$FR
243613781$24361378$1$I$$20240918$20240925$20240925$EXP$$IN-MYLANLABS-2024M1086482$MYLAN$Chinchure SD, Kataria V. Carotid Stump Syndrome: Rare Cause of Recurrent Stroke Post-Ipsilateral Carotid Occlusion - A Case Report. Ann-Indian-Acad-Neurol 2024; 27 (4): 426-429.$53$YR$$F$Y$$$20240925$$HP$IN$IN
243613801$24361380$1$I$20230101$20240918$20240925$20240925$EXP$$FR-MYLANLABS-2024M1086514$MYLAN$Roger P-M, Sichez-Com H, Ollier J, Boumezber S, Bataille S. Oral clindamycin for peritonitis due to Brevibacterium casei and Bacillus cereus in two successive patients undergoing peritoneal dialysis. JAC-Antimicrob-Resist 2024; 6 (4): 1-2.$77$YR$$M$Y$$$20240925$$HP$FR$FR
243613811$24361381$1$I$20230907$20240923$20240925$20240925$EXP$$KR-009507513-2409KOR007630$MERCK$$$$E$M$Y$$$20240925$$HP$KR$KR
243613821$24361382$1$I$$20240923$20240925$20240925$PER$$US-JNJFOC-20240962844$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$MD$US$US
243613831$24361383$1$I$$20240917$20240925$20240925$PER$$US-AMGEN-USASP2024188389$AMGEN$Hawwa, N. lvabradine and Milrinone-Bridge to Recovery in New HFrEF With Low-Output Heart Failure. Case Reports in Cardiology. 2024;2024:1-13$47$YR$A$F$Y$$$20240925$$HP$US$US
243613841$24361384$1$I$20240923$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190605$AMGEN$$$$$$Y$$$20240925$$PH$US$US
243613851$24361385$1$I$$20230921$20240925$20240925$PER$$US-CELLTRION INC.-2023US018525$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243613861$24361386$1$I$$20240916$20240925$20240925$EXP$$US-UCBSA-2024038413$UCB$$$$$F$Y$$$20240925$$HP$US$US
243613871$24361387$1$I$20240917$20240918$20240925$20240925$EXP$$CN-ROCHE-10000089084$ROCHE$$$$$$Y$$$20240925$$MD$CN$CN
243613881$24361388$1$I$20200101$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012290$STRIDES$Hu Y, Wang Z, Ma J, Wang N, Meng J, Dong S, et al.. The early and rapid response to daratumumab in children with chronic refractory immune thrombocytopenia from a referral single centre of China.. Br-J-Haematol. 2024;205 (1)$2$YR$$F$Y$$$20240925$$HP$CN$CN
243613891$24361389$1$I$$20240923$20240925$20240925$PER$$NVSC2024US190653$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
243613901$24361390$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012276$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$66$YR$$F$Y$79.37$KG$20240925$$HP$CN$CN
243613911$24361391$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012277$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$68$YR$$F$Y$76$KG$20240925$$HP$CN$CN
243613921$24361392$1$I$$20240923$20240925$20240925$EXP$$US-ABBVIE-5936551$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243613931$24361393$1$I$20240923$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189902$AMGEN$$$$$F$Y$$$20240925$$CN$US$US
243613941$24361394$1$I$20240921$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189739$AMGEN$$63$YR$A$M$Y$$$20240925$$CN$US$US
243613961$24361396$1$I$$20240916$20240925$20240925$PER$$US-GSK-US2024AMR115211$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
243613971$24361397$1$I$20240901$20240919$20240925$20240925$PER$$US-ABBVIE-5934590$ABBVIE$$$$$$Y$$$20240925$$CN$US$US
243613981$24361398$1$I$$20240923$20240925$20240925$EXP$$KR-AMGEN-KORSP2024189186$AMGEN$$$$$F$Y$$$20240925$$CN$KR$KR
243613991$24361399$1$I$20220708$20240920$20240925$20240925$EXP$$CO-UCBSA-2024049062$UCB$$16$YR$$M$Y$$$20240925$$CN$CO$CO
243614001$24361400$1$I$$20240919$20240925$20240925$EXP$$US-AMGEN-USASP2024188313$AMGEN$Beatty N. L.; Correa N. J.; Vijay A. et al.. Case Report: Disseminated Histoplasmosis of the Tongue Presenting Decades after Exposure in Latin America. The American journal of tropical medicine and hygiene. 2024;1-5$72$YR$E$M$Y$$$20240925$$HP$US$US
243614011$24361401$1$I$$20240923$20240925$20240925$EXP$$CA-ORGANON-O2409CAN001721$ORGANON$$43$YR$$F$Y$68$KG$20240925$$CN$CA$CA
243614031$24361403$1$I$20240911$20240916$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046056$AUROBINDO$$39$YR$$F$Y$$$20240925$$CN$GB$GB
243614041$24361404$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012238$STRIDES$Li W, Fu Y, Wang W. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$63$YR$$M$Y$94$KG$20240925$$HP$CN$CN
243614051$24361405$1$I$$20240917$20240925$20240925$EXP$$AU-RDY-SPO/AUS/24/0013733$DR REDDYS$$53$YR$A$F$Y$$$20240925$$CN$AU$AU
243614061$24361406$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012240$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$$$$F$Y$57.6$KG$20240925$$HP$CN$CN
243614071$24361407$1$I$20230721$20231102$20240925$20240925$PER$$US-CELLTRION INC.-2023US018973$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243614081$24361408$1$I$20231107$20231207$20240925$20240925$PER$$US-CELLTRION INC.-2023US021807$CELLTRION$$$$$$Y$$$20240925$$HP$US$US
243614091$24361409$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012281$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$68$YR$$M$Y$62$KG$20240925$$HP$CN$CN
243614101$24361410$1$I$20240919$20240919$20240925$20240925$EXP$$US-RDY-SPO/USA/24/0013868$DR REDDYS$$67$YR$E$$Y$$$20240925$$PH$US$US
243614111$24361411$1$I$$20231117$20240925$20240925$PER$$US-CELLTRION INC.-2023US019694$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243614121$24361412$1$I$20240611$20240913$20240925$20240925$EXP$$JP-AMGEN-JPNSP2024187143$AMGEN$$10$DEC$E$F$Y$$$20240925$$PH$JP$JP
243614131$24361413$1$I$$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151594$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240925$$CN$US$US
243614141$24361414$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151242$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240925$$HP$US$US
243614151$24361415$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012283$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$73$YR$$M$Y$63.3$KG$20240925$$HP$CN$CN
243614161$24361416$1$I$$20240916$20240925$20240925$EXP$$EG-STRIDES ARCOLAB LIMITED-2024SP012247$STRIDES$Ali HT, Khalil SA, Caprara ALF, Rissardo JP.. Pregabalin-Induced Parkinsonism: Case Report and Review of the Literature. [Review].. J-Pharm-Pract. 2024;37 (5):1220-1224$48$YR$$F$Y$$$20240925$$HP$EG$EG
243614171$24361417$1$I$$20240918$20240925$20240925$EXP$$BG-MYLANLABS-2024M1086533$MYLAN$Yancheva-Petrova N, Grozdeva R, Ivanov D, Strashimirov D. HPV-associated oropharyngeal carcinomas in patients living with HIV on long-term antiretroviral therapy: Case reports. Int-J-STD-AIDS 2024; 35 (8): 654-657.$59$YR$$M$Y$$$20240925$$HP$BG$BG
243614181$24361418$1$I$20240919$20240924$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151801$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240925$$PH$US$US
243614191$24361419$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244496$TEVA$$65$YR$$M$Y$81$KG$20240925$$HP$CA$CA
243614201$24361420$1$I$$20230920$20240925$20240925$PER$$US-CELLTRION INC.-2023US018466$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243614211$24361421$1$I$$20230928$20240925$20240925$PER$$US-CELLTRION INC.-2023US019287$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243614221$24361422$1$I$$20240108$20240925$20240925$PER$$US-CELLTRION INC.-2023US019935$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243614231$24361423$1$I$$20240923$20240925$20240925$EXP$$US-TAKEDA-2024TUS094681$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
243614241$24361424$1$I$20240701$20240918$20240925$20240925$EXP$$US-TAKEDA-2020TUS020715$TAKEDA$$68$YR$$M$Y$$$20240925$$MD$US$US
243614251$24361425$1$I$$20240917$20240925$20240925$EXP$$CA-STRIDES ARCOLAB LIMITED-2024SP012305$STRIDES$D^Souza R, Soete E, Silversides CK, Zaffar N, Van Mieghem T, Van Cleemput J, et al.. Pregnancy Outcomes Following Cardiac Transplantation.. J-Obstet-Gynaecol-Can. 2018;40 (5):566-571$$$$$Y$$$20240925$$MD$CA$CA
243614261$24361426$1$I$$20240920$20240925$20240925$PER$$US-PCCINC-2024-PPL-000698$PIRAMAL$$$$$$Y$$$20240925$$HP$US$US
243614271$24361427$1$I$$20240919$20240925$20240925$EXP$$US-ABBVIE-5932261$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243614281$24361428$1$I$$20231004$20240925$20240925$PER$$US-CELLTRION INC.-2023US019521$CELLTRION$$$$$$Y$$$20240925$$HP$US$US
243614291$24361429$1$I$$20231105$20240925$20240925$PER$$US-CELLTRION INC.-2023US018633$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243614301$24361430$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012304$STRIDES$Wang Y, Fang Y, Yan Z, Xia R, Zeng W, Deng W, et al.. Fatal BK polyomavirus-associated pneumonia: report of two cases with literature review. BMC-Infect-Dis. 2023;23:1-9$6$YR$$M$Y$$$20240925$$HP$CN$CN
243614311$24361431$1$I$20240904$20240905$20240925$20240925$EXP$$US-SA-2024SA274670$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240925$$MD$US$US
243614321$24361432$1$I$20240907$20240914$20240925$20240925$EXP$$US-UCBSA-2024047767$UCB$$17$YR$$M$Y$29.9$KG$20240925$$MD$US$US
243614331$24361433$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012256$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$70$YR$$F$Y$$$20240925$$HP$CN$CN
243614341$24361434$1$I$$20240917$20240925$20240925$EXP$$CA-STRIDES ARCOLAB LIMITED-2024SP012307$STRIDES$D^Souza R, Soete E, Silversides CK, Zaffar N, Van Mieghem T, Van Cleemput J, et al.. Pregnancy Outcomes Following Cardiac Transplantation.. J-Obstet-Gynaecol-Can. 2018;40 (5):566-571$$$$$Y$$$20240925$$MD$CA$CA
243614351$24361435$1$I$$20240919$20240925$20240925$EXP$$FR-ABBVIE-5935694$ABBVIE$$$$$$Y$$$20240925$$MD$FR$FR
243614361$24361436$1$I$20230331$20240918$20240925$20240925$EXP$$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08820$HIKMA$$81$YR$$F$Y$$$20240925$$PH$FR$FR
243614371$24361437$1$I$20240911$20240918$20240925$20240925$EXP$$JP-ABBVIE-5927919$ABBVIE$$80$YR$$M$Y$$$20240925$$PH$JP$JP
243614381$24361438$1$I$$20240911$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-045769$AUROBINDO$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B, et al. AML-713 Hematological Malignancies and Pregnancy: A Single-Institution Experience. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S333-S334 abstr. AML-713$$$$F$Y$$$20240925$$HP$US$US
243614391$24361439$1$I$$20240918$20240925$20240925$EXP$$US-GSK-US2024116054$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
243614401$24361440$1$I$$20240918$20240925$20240925$EXP$$US-GSK-US2024116171$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
243614411$24361441$1$I$20240901$20240919$20240925$20240925$EXP$$CO-UCBSA-2024048915$UCB$$61$YR$$M$Y$$$20240925$$CN$CO$CO
243614421$24361442$1$I$20240917$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189747$AMGEN$$84$YR$E$F$Y$57.152$KG$20240925$$CN$US$US
243614432$24361443$2$F$$20240913$20240925$20240927$PER$$US-ROCHE-10000082762$ROCHE$$$$A$M$Y$$$20240927$$CN$US$US
243614441$24361444$1$I$$20240917$20240925$20240925$EXP$$CA-STRIDES ARCOLAB LIMITED-2024SP012289$STRIDES$D^Souza R, Soete E, Silversides CK, Zaffar N, Van Mieghem T, Van Cleemput J, et al.. Pregnancy Outcomes Following Cardiac Transplantation.. J-Obstet-Gynaecol-Can. 2018;40 (5):566-571$$$$F$Y$$$20240925$$MD$CA$CA
243614451$24361445$1$I$$20231108$20240925$20240925$PER$$US-CELLTRION INC.-2023US020029$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243614461$24361446$1$I$$20231018$20240925$20240925$PER$$US-CELLTRION INC.-2023US020687$CELLTRION$Dittrich A.. A CAVITARY CONUNDRUM. Chest. 2023;164:A5598-A5599$$$$$Y$$$20240925$$HP$US$US
243614471$24361447$1$I$$20231016$20240925$20240925$PER$$US-CELLTRION INC.-2023US020475$CELLTRION$Dantas M A.S, Graneiro AL, Cavalcante R, Felipez LM.. A Challenging Case of Oral Ulcers and Gastrointestinal Bleeding: Crohn^s or Behcet^s Disease. Case Reports in Pediatrics. 2023;Volume 2023:6 pages$$$$$Y$$$20240925$$HP$US$US
243614481$24361448$1$I$$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093808$TAKEDA$$40$YR$$F$Y$$$20240925$$CN$US$US
243614491$24361449$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012259$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$84$YR$$M$Y$$$20240925$$HP$CN$CN
243614501$24361450$1$I$$20240924$20240925$20240925$EXP$$US-GILEAD-2024-0688751$GILEAD$$$$A$M$Y$$$20240925$$CN$US$US
243614511$24361451$1$I$$20240920$20240925$20240925$PER$$US-JNJFOC-20240959701$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20240925$$CN$US$US
243614531$24361453$1$I$20240801$20240911$20240925$20240925$EXP$$US-UCBSA-2024047067$UCB$$23$YR$$F$Y$$$20240925$$HP$US$US
243614541$24361454$1$I$$20240924$20240925$20240925$EXP$$US-SANDOZ INC.-SDZ2024US082728$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
243614551$24361455$1$I$$20240913$20240925$20240925$EXP$$BE-SA-2024SA274232$SANOFI AVENTIS$$$$$$Y$$$20240925$$MD$BE$BE
243614561$24361456$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012235$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217.$76$YR$$F$Y$68.8$KG$20240925$$HP$CN$CN
243614571$24361457$1$I$$20240917$20240925$20240925$EXP$$NO-STRIDES ARCOLAB LIMITED-2024SP012312$STRIDES$Janeras L, Breivik H, Lundeland B, Ringstad GA, Stubhaug A.. Long-term intrathecal infusion of low-dose morphine effectively relieves symptoms of severe restless legs syndrome/Willis-Ekbom disease without inducing opioid tolerance.. Pain. 2024;1-5.$7$DEC$$M$Y$$$20240925$$HP$NO$NO
243614581$24361458$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014540$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240925$$CN$US$US
243614591$24361459$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014452$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240925$$CN$US$US
243614601$24361460$1$I$20240920$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015651$ELI LILLY AND CO$$68$YR$E$M$Y$$$20240925$$CN$US$US
243614611$24361461$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202403001985$ELI LILLY AND CO$$$$$$Y$$$20240925$$CN$US$US
243614621$24361462$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014411$ELI LILLY AND CO$$$$$$Y$$$20240925$$CN$US$US
243614631$24361463$1$I$20240924$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015255$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240925$$CN$US$US
243614641$24361464$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014481$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240925$$CN$US$US
243614651$24361465$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015697$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240925$$CN$US$US
243614661$24361466$1$I$$20240913$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409010102$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240925$$CN$US$US
243614671$24361467$1$I$20240919$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013866$ELI LILLY AND CO$$$$E$F$Y$$$20240925$$CN$US$US
243614681$24361468$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014651$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240925$$CN$US$US
243614691$24361469$1$I$$20240918$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012706$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240925$$CN$US$US
243614701$24361470$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014449$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240925$$CN$US$US
243614711$24361471$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151472$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240925$$CN$US$US
243614721$24361472$1$I$$20240913$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151503$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$CN$US$US
243614731$24361473$1$I$$20240917$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148047$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240925$$HP$US$US
243614741$24361474$1$I$20240702$20240918$20240925$20240925$EXP$$US-BAYER-2024A107827$BAYER$$36$YR$A$M$Y$113.38$KG$20240925$$CN$US$US
243614751$24361475$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012236$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$48$YR$$M$Y$120.9$KG$20240925$$HP$CN$CN
243614761$24361476$1$I$$20240913$20240925$20240925$EXP$GB-MHRA-MED-202409131731545670-ZPHJS$GB-MACLEODS PHARMA-MAC2024049457$MACLEODS$$$$$$Y$$$20240925$$HP$GB$GB
243614771$24361477$1$I$$20240913$20240925$20240925$EXP$GB-MHRA-MED-202409131738386140-YDRGS$GB-MACLEODS PHARMA-MAC2024049458$MACLEODS$$$$$$Y$$$20240925$$HP$GB$GB
243614781$24361478$1$I$20240715$20240913$20240925$20240925$EXP$GB-MHRA-MED-202408161236046940-MTNSF$GB-MACLEODS PHARMA-MAC2024048974$MACLEODS$$$$$$Y$$$20240925$$CN$GB$GB
243614791$24361479$1$I$$20240913$20240925$20240925$EXP$GB-MHRA-MED-202409132324583640-WTRCD$GB-MACLEODS PHARMA-MAC2024049459$MACLEODS$$$$$$Y$$$20240925$$CN$GB$GB
243614801$24361480$1$I$20240824$20240918$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046919$AUROBINDO$$61$YR$$M$Y$49.6$KG$20240925$$PH$FR$FR
243614811$24361481$1$I$$20231117$20240925$20240925$PER$$US-CELLTRION INC.-2023US020186$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243614821$24361482$1$I$$20231108$20240925$20240925$PER$$US-CELLTRION INC.-2023US020929$CELLTRION$$$$$$Y$$$20240925$$HP$US$US
243614831$24361483$1$I$$20231117$20240925$20240925$PER$$US-CELLTRION INC.-2023US019736$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243614861$24361486$1$I$20220621$20240913$20240925$20240925$EXP$$KR-ASTELLAS-2024-AER-008192$ASTELLAS$$$$A$M$Y$$$20240925$$PH$KR$KR
243614871$24361487$1$I$$20240917$20240925$20240925$EXP$$US-TEVA-VS-3245737$TEVA$$62$YR$$F$Y$$$20240925$$CN$US$US
243614891$24361489$1$I$$20240824$20240925$20240925$PER$$US-CELLTRION INC.-2023US021777$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243614901$24361490$1$I$20230605$20240919$20240925$20240925$EXP$$US-ASTELLAS-2023US023408$ASTELLAS$$81$YR$E$M$Y$$$20240925$$CN$US$US
243614921$24361492$1$I$$20240917$20240925$20240925$EXP$$FR-STRIDES ARCOLAB LIMITED-2024SP012318$STRIDES$Sakhi H, Reverdito G, Soulat G, Mousseaux E.. Cardiovascular magnetic resonance in the identification of extra-cardiac causes of myocarditis: a case series.. Eur-Heart-J-Case-Rep. 2024;8 (5):1-5$54$YR$$F$Y$$$20240925$$HP$FR$FR
243614931$24361493$1$I$$20231207$20240925$20240925$PER$$US-CELLTRION INC.-2023US021258$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243614951$24361495$1$I$20240924$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65412$$FDA-CTU$$52$YR$$F$N$$$20240924$Y$HP$US$
243614961$24361496$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65434$$FDA-CTU$$$$$F$N$$$20240923$N$HP$US$
243614971$24361497$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65429$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243614981$24361498$1$I$20240917$20240919$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046696$AUROBINDO$$65$YR$$F$Y$75$KG$20240925$$MD$GB$GB
243614991$24361499$1$I$20230629$20240924$20240925$20240925$EXP$$US-SANDOZ INC.-SDZ2023US003907$SANDOZ$$81$YR$$F$Y$$$20240925$$CN$US$US
243615001$24361500$1$I$$20240924$20240925$20240925$EXP$$CA-ORGANON-O2409CAN001813$ORGANON$$88$YR$$M$Y$$$20240925$$PH$CA$CA
243615011$24361501$1$I$20230502$20240919$20240925$20240925$EXP$$KR-ROCHE-10000021444$ROCHE$$65$YR$E$$Y$$$20240925$$MD$KR$KR
243615021$24361502$1$I$$20240917$20240925$20240925$EXP$$US-TAKEDA-2024TUS093694$TAKEDA$$$$$M$Y$$$20240925$$MD$US$US
243615031$24361503$1$I$$20240111$20240925$20240925$PER$$US-CELLTRION INC.-2023US022049$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243615041$24361504$1$I$$20240917$20240924$20240924$DIR$FDA-CDER-CTU-2024-65437$$FDA-CTU$$$$$M$N$$$20240917$N$HP$US$
243615051$24361505$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65407$$FDA-CTU$$46$YR$$F$N$$$20240924$N$$US$
243615061$24361506$1$I$20240911$20240920$20240925$20240925$EXP$$SG-MYLANLABS-2024M1085876$MYLAN$$70$YR$$M$Y$$$20240925$$HP$SG$SG
243615081$24361508$1$I$$20240920$20240925$20240925$PER$$US-HALEON-2197987$Haleon PLC$$$$$F$Y$$$20240925$$CN$US$US
243615091$24361509$1$I$$20240919$20240925$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-029754$UNITED THERAPEUTICS$$$$$F$Y$56.236$KG$20240925$$$US$US
243615101$24361510$1$I$$20231018$20240925$20240925$PER$$US-CELLTRION INC.-2023US020480$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243615111$24361511$1$I$$20240219$20240925$20240925$PER$$US-CELLTRION INC.-2023US021971$CELLTRION$$$$$$Y$$$20240925$$PH$US$US
243615131$24361513$1$I$20240524$20240916$20240925$20240925$EXP$$CA-CELLTRION INC.-2024CA013980$CELLTRION$$$$$$Y$$$20240925$$HP$CA$CA
243615141$24361514$1$I$20240806$20240918$20240925$20240925$EXP$$TR-SA-2024SA274065$SANOFI AVENTIS$$31$YR$A$M$Y$70$KG$20240925$$MD$TR$TR
243615151$24361515$1$I$$20240918$20240925$20240925$EXP$$US-GSK-US2024AMR117293$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
243615161$24361516$1$I$$20240917$20240925$20240925$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP012260$STRIDES$Sasidharanpillai S, David EM, Jishna P, Khader A, George N, Sabnam CP, et al.. Antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS): A cross-sectional study.. Indian-J-Dermatol-Venereol-Leprol. 2024;90 (3)$$$$$Y$$$20240925$$HP$IN$IN
243615181$24361518$1$I$$20240916$20240925$20240925$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012237$STRIDES$Li W, Fu Y, Wang W.. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors.. Ann-Hematol. 2024;103 (8):3207-3217$59$YR$$M$Y$58$KG$20240925$$HP$CN$CN
243615191$24361519$1$I$20200108$20240920$20240925$20240925$EXP$$CO-UCBSA-2024048927$UCB$$77$YR$$M$Y$$$20240925$$CN$CO$CO
243615202$24361520$2$F$20240919$20240923$20240925$20240928$PER$$US-AMGEN-USASP2024190108$AMGEN$$63$YR$A$F$Y$$$20240928$$CN$US$US
243615211$24361521$1$I$20230320$20240918$20240925$20240925$EXP$$RO-ROCHE-10000086558$ROCHE$Moarcas M, Mihailescu-Marin M. Advanceed cervical cancer in palliative care- a demon we could prevent: case report. Paliatia - Journal of Paliative Care. 2024-Jul;17 (3):43-8.$34$YR$A$F$Y$$$20240925$$MD$RO$RO
243615231$24361523$1$I$20240901$20240917$20240925$20240925$EXP$$CL-JNJFOC-20240948582$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240925$$CN$CL$CL
243615251$24361525$1$I$20240101$20240920$20240925$20240925$EXP$$CA-Orion Corporation ORION PHARMA-23_00026612$ORION$$52$YR$A$M$Y$62$KG$20240925$$MD$CA$
243615261$24361526$1$I$$20240921$20240925$20240925$EXP$$US-TAKEDA-2024TUS015611$TAKEDA$$$$$M$Y$$$20240925$$CN$US$US
243615271$24361527$1$I$$20240919$20240925$20240925$EXP$$US-ASTELLAS-2024-AER-008049$ASTELLAS$$$$E$M$Y$$$20240925$$CN$US$US
243615291$24361529$1$I$20230101$20240916$20240925$20240925$EXP$$AU-CELLTRION INC.-2024AU022620$CELLTRION$$$$$$Y$$$20240925$$HP$AU$AU
243615301$24361530$1$I$20240101$20240920$20240925$20240925$EXP$$US-SA-2024SA275116$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240925$$HP$US$US
243615311$24361531$1$I$$20240919$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151731$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$73.48$KG$20240925$$CN$US$US
243615321$24361532$1$I$20230101$20240917$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148212$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240925$$CN$US$US
243615331$24361533$1$I$$20240920$20240925$20240925$EXP$$RO-AMGEN-ROUSP2024189265$AMGEN$$$$$F$Y$$$20240925$$MD$RO$RO
243615341$24361534$1$I$$20240916$20240925$20240925$EXP$$US-PROCTER_AND_GAMBLE-PH24007409$PROCTER AND GAMBLE$Gale AM, Nachreiner D, Kumar A, Sell P, Gauguet S. Acute Toxic Cerebellar Leukoencephalopathy in an Eight-Year-Old Child Following Illicit Fentanyl and Cocaine Ingestion: A Case Report of Full Clinical Recovery. Cureus. 2024;16(8):e66573$8$YR$$$Y$$$20240925$$HP$US$US
243615371$24361537$1$I$$20240917$20240925$20240925$EXP$$CA-STRIDES ARCOLAB LIMITED-2024SP012263$STRIDES$D^Souza R, Soete E, Silversides CK, Zaffar N, Van Mieghem T, Van Cleemput J, et al.. Pregnancy Outcomes Following Cardiac Transplantation.. J-Obstet-Gynaecol-Can. 2018;40 (5):566-571.$$$$F$Y$$$20240925$$MD$CA$CA
243615381$24361538$1$I$$20240916$20240925$20240925$EXP$$FR-TEVA-VS-3245758$TEVA$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$47$YR$$M$Y$$$20240925$$HP$FR$FR
243615391$24361539$1$I$20240701$20240920$20240925$20240925$EXP$$US-SA-2024SA275556$SANOFI AVENTIS$$64$YR$A$F$Y$52.27$KG$20240925$$HP$US$US
243615401$24361540$1$I$$20240917$20240925$20240925$EXP$$CA-APOTEX-2024AP011112$APOTEX$$79$YR$$M$Y$93$KG$20240925$$MD$CA$CA
243615421$24361542$1$I$$20240920$20240925$20240925$EXP$$US-SA-2024SA274169$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240925$$MD$US$US
243615431$24361543$1$I$20191125$20240916$20240925$20240925$EXP$$CA-TAKEDA-CA202005891$TAKEDA$$39$YR$$F$Y$76.2$KG$20240925$$CN$CA$CA
243615441$24361544$1$I$20201001$20240922$20240925$20240925$EXP$GB-MHRA-MED-202409220922534550-BQHWR$GB-TAKEDA-2024TUS094960$TAKEDA$$34$YR$$F$Y$$$20240925$$HP$GB$GB
243615451$24361545$1$I$$20240917$20240925$20240925$PER$$US-ASTELLAS-2024-AER-007991$ASTELLAS$$50$YR$A$F$Y$$$20240925$$MD$US$US
243615461$24361546$1$I$$20240916$20240925$20240925$EXP$$IN-ROCHE-10000069646$ROCHE$$88$YR$E$F$Y$50$KG$20240925$$MD$IN$IN
243615471$24361547$1$I$$20240920$20240925$20240925$EXP$$AU-MYLANLABS-2024M1086028$MYLAN$$$$$M$Y$$$20240925$$HP$AU$AU
243615481$24361548$1$I$$20240918$20240925$20240925$EXP$$US-BAYER-2024A133523$BAYER$$41$YR$A$F$Y$$$20240925$$HP$US$US
243615491$24361549$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65402$$FDA-CTU$$79$YR$$M$N$$$20240924$N$$US$
243615501$24361550$1$I$20200801$20240920$20240925$20240925$EXP$GB-MHRA-MED-202409201203388880-KMYJL$GB-MYLANLABS-2024M1086034$MYLAN$$30$YR$$F$Y$79$KG$20240925$$CN$GB$GB
243615511$24361551$1$I$$20240916$20240925$20240925$EXP$$FR-TEVA-VS-3245960$TEVA$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$32$YR$$M$Y$$$20240925$$HP$FR$FR
243615521$24361552$1$I$$20240916$20240925$20240925$EXP$$PL-AUROBINDO-AUR-APL-2024-046941$AUROBINDO$K. Mozdzen, A. Murawska, J. Hypnar, E. Pedziwiatr, J. Pospiech, M. Bosak.. Status epilepticus in pregnant patients two case reports and literature review. Polish Neurological Review. 2024;20(2):115-128$34$YR$$F$Y$$$20240925$$HP$PL$PL
243615541$24361554$1$I$20240101$20240923$20240925$20240925$EXP$$US-ABBVIE-5936083$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243615551$24361555$1$I$$20240917$20240925$20240925$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP012241$STRIDES$Sasidharanpillai S, David EM, Jishna P, Khader A, George N, Sabnam CP, et al.. Antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS): A cross-sectional study. Indian-J-Dermatol-Venereol-Leprol. 2024;90 (3)$$$$$Y$$$20240925$$HP$IN$IN
243615561$24361556$1$I$$20240916$20240925$20240925$EXP$$US-HIKMA PHARMACEUTICALS-US-H14001-24-08713$HIKMA$Mahtani R, Harpalani N, Yan F, Phiel K, Kovalenko I. Mahtani R, Harpalani N, Yan F, Phiel K, Kovalenko I. Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series.. Frontiers in Oncology.. 2024;14:1419246$$$$F$Y$$$20240925$$MD$US$US
243615571$24361557$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190682$NOVARTIS$$$$$$Y$$$20240925$$HP$US$US
243615581$24361558$1$I$20240906$20240914$20240925$20240925$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2162016$JIANGSU HENGRUI MEDICINE$$37$YR$$M$Y$$$20240925$$MD$CN$CN
243615591$24361559$1$I$$20240919$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046792$AUROBINDO$$$$$F$Y$$$20240925$$CN$GB$GB
243615601$24361560$1$I$$20240919$20240925$20240925$PER$$US-ABBVIE-5934001$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243615611$24361561$1$I$20130701$20240918$20240925$20240925$EXP$$TN-OrBion Pharmaceuticals Private Limited-2162012$ORBION PHARMACEUTICALS$Charfi O, Lakhoua G, Sahnoun R, El Aidli S, Daghfous R, Kastalli S, Za?em A. Multiple drug intolerance syndrome in an epileptic woman. Therapie. 2023 Sep-Oct; 78(5S):S85-S86. Doi: 10.2515/therapie/2015052.$50$YR$$F$Y$$$20240925$$MD$TN$TN
243615621$24361562$1$I$$20240916$20240925$20240925$PER$$US-ROCHE-10000083383$ROCHE$$$$$F$Y$$$20240925$$MD$US$US
243615651$24361565$1$I$$20240917$20240924$20240924$DIR$FDA-CDER-CTU-2024-65399$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243615661$24361566$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65440$$FDA-CTU$$51$YR$$F$N$$$20240924$N$$US$
243615671$24361567$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65406$$FDA-CTU$$66$YR$$F$N$79.38$KG$20240924$N$$US$
243615681$24361568$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65420$$FDA-CTU$$63$YR$$F$N$$$20240924$N$$US$
243615691$24361569$1$I$$20240906$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09037$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243615701$24361570$1$I$20240514$20240918$20240925$20240925$EXP$$AU-GILEAD-2024-0673044$GILEAD$$67$YR$E$F$Y$$$20240925$$HP$AU$AU
243615711$24361571$1$I$$20240923$20240925$20240925$PER$$US-Mission Pharmacal Company-2162005$MISSION$$39$YR$$F$Y$$$20240925$$$US$US
243615721$24361572$1$I$$20240912$20240925$20240925$PER$$US-ROCHE-10000082275$ROCHE$$$$$$Y$$$20240925$$CN$US$US
243615731$24361573$1$I$$20240911$20240925$20240925$EXP$$US-Appco Pharma LLC-2162022$APPCO PHARMA$Initial$35$YR$$M$Y$$$20240925$$MD$US$US
243615741$24361574$1$I$20240905$20240905$20240925$20240925$PER$$US-JNJFOC-20240912634$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20240925$$CN$US$US
243615751$24361575$1$I$$20240917$20240925$20240925$EXP$$CO-ROCHE-10000088264$ROCHE$$$$$$Y$$$20240925$$MD$CO$CO
243615761$24361576$1$I$$20240911$20240925$20240925$EXP$$US-Appco Pharma LLC-2162027$APPCO PHARMA$Initial$82$YR$$$Y$$$20240925$$$US$US
243615771$24361577$1$I$$20240911$20240925$20240925$EXP$$NG-OrBion Pharmaceuticals Private Limited-2162011$ORBION PHARMACEUTICALS$Mmerem JI, Johnson SM, Iroezindu MO. Monkeypox and chickenpox co-infection in a person living with Human Immunodeficiency Virus. J Infect Dev Ctries. 2024 Jul 29; 18(7):1152-1156. doi: 10.3855/jidc.18318.$30$YR$$M$Y$$$20240925$$MD$NG$NG
243615781$24361578$1$I$$20240918$20240925$20240925$EXP$$IT-STRIDES ARCOLAB LIMITED-2024SP012317$STRIDES$Mannelli F, Crupi F, Zanotti R, Pagano L, Rapezzi D, Tanasi I, et al.. The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis.. Ther-Adv-Hematol. 2023;14:no pagination$61$YR$$M$Y$$$20240925$$HP$IT$IT
243615791$24361579$1$I$$20240912$20240925$20240925$EXP$$JP-AJANTA-2024AJA00157$AJANTA PHARMA$Kitazawa T, Yamamoto A, Nakayama S, Kawase K, Wakabayashi Y.Disseminated Nontuberculous Mycobacterium Infection During Treatment of Multiple Myeloma: A Case Report and Review of the Literature.Internal Medicine.04-SEP-2024$74$YR$E$M$Y$$$20240925$$HP$JP$JP
243615801$24361580$1$I$$20240911$20240925$20240925$EXP$$FR-Appco Pharma LLC-2162026$APPCO PHARMA$Initial$55$YR$$F$Y$$$20240925$$$FR$FR
243615811$24361581$1$I$$20240921$20240925$20240925$PER$$US-AMGEN-USASP2024189267$AMGEN$$$$$F$Y$$$20240925$$CN$US$US
243615821$24361582$1$I$20240920$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189987$AMGEN$$77$YR$E$M$Y$$$20240925$$CN$US$US
243615831$24361583$1$I$$20240911$20240925$20240925$EXP$$CN-Appco Pharma LLC-2162020$APPCO PHARMA$Initial$24$YR$$M$Y$$$20240925$$$CN$CN
243615841$24361584$1$I$20220317$20240920$20240925$20240925$EXP$$DE-002147023-NVSC2022DE073177$Haleon PLC$$60$YR$$M$Y$82.6$KG$20240925$$HP$DE$DE
243615861$24361586$1$I$$20240911$20240925$20240925$EXP$$FR-Appco Pharma LLC-2162023$APPCO PHARMA$Initial$24$YR$$M$Y$$$20240925$$MD$FR$FR
243615871$24361587$1$I$$20240911$20240925$20240925$EXP$$DE-Appco Pharma LLC-2162021$APPCO PHARMA$Initial$55$YR$$F$Y$$$20240925$$$DE$DE
243615881$24361588$1$I$$20240912$20240925$20240925$EXP$$US-Avondale Pharmaceuticals, LLC-2162028$AVONDALE PHARMACEUTICALS$Initial$$$$M$Y$$$20240925$$MD$US$US
243615891$24361589$1$I$$20240911$20240925$20240925$EXP$$US-Appco Pharma LLC-2162024$APPCO PHARMA$Initial$69$YR$$$Y$$$20240925$$$US$US
243615901$24361590$1$I$20240101$20240917$20240925$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-029137$UNITED THERAPEUTICS$$$$$F$Y$65.76$KG$20240925$$$US$US
243615911$24361591$1$I$$20240923$20240925$20240925$PER$$US-Mission Pharmacal Company-2162025$MISSION$$39$YR$$F$Y$$$20240925$$$US$US
243615931$24361593$1$I$$20240919$20240925$20240925$EXP$$US-ROCHE-10000087335$ROCHE$$85$YR$E$F$Y$$$20240925$$CN$US$US
243615942$24361594$2$F$20240916$20240927$20240925$20240930$EXP$$BR-BAYER-2024A134725$BAYER$$$$$F$Y$$$20240930$$HP$BR$BR
243615961$24361596$1$I$20240824$20240913$20240925$20240925$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2162018$JIANGSU HENGRUI MEDICINE$$36$YR$$F$Y$60$KG$20240925$$MD$CN$CN
243615971$24361597$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014628$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240925$$CN$US$US
243615981$24361598$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015279$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240925$$CN$US$US
243615991$24361599$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014494$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243616001$24361600$1$I$20240901$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014751$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240925$$CN$US$US
243616011$24361601$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014658$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240925$$CN$US$US
243616021$24361602$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014745$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240925$$CN$US$US
243616031$24361603$1$I$20230118$20230125$20240925$20240925$EXP$$NVSC2023RU018182$NOVARTIS$$26$YR$$F$Y$80$KG$20240925$$HP$RU$RU
243616041$24361604$1$I$$20240920$20240925$20240925$EXP$$NVSC2024CA099732$NOVARTIS$$67$YR$$F$Y$$$20240925$$CN$CA$CA
243616051$24361605$1$I$$20240911$20240925$20240925$EXP$$SA-OrBion Pharmaceuticals Private Limited-2162008$ORBION PHARMACEUTICALS$Sayed J, Nasir A, Sayed AG, Alghamdi OA, Alsharif EJ. A case report of MoCD etiology in a neonate: A novel homozygous MoCS2 variant. Clin Case Rep. 2024 Jul 11; 12(7):e9169. Doi: 10.1002/ccr3.9169.$$$$M$Y$$$20240925$$MD$SA$SA
243616061$24361606$1$I$$20240920$20240925$20240925$EXP$$ID-PFIZER INC-PV202400123725$PFIZER$Alidris, R.. Hypokalemic Periodic Paralysis Masquerading as Guillain-Barre Syndrome in 36-Years-Old Woman: Case Report. NEURONA. 2023;40 No 2 (2023):1-4$36$YR$$F$Y$$$20240925$$MD$ID$ID
243616071$24361607$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65395$$FDA-CTU$$51$YR$$M$N$$$20240924$N$$US$
243616082$24361608$2$F$20231101$20240919$20240925$20240927$EXP$$US-ROCHE-10000087099$ROCHE$$57$YR$A$M$Y$$$20240927$$CN$US$US
243616091$24361609$1$I$$20240911$20240925$20240925$EXP$$US-OrBion Pharmaceuticals Private Limited-2162010$ORBION PHARMACEUTICALS$Bierly JJ, Peterson BL. Distribution of donepezil in postmortem casework. J Forensic Leg Med. 2024 Jan; 101: 102625. Doi: 10.1016/j.jflm.2023.102625.$61$YR$$$Y$$$20240925$$MD$US$US
243616101$24361610$1$I$20240903$20240924$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151797$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240925$$CN$US$US
243616111$24361611$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65405$$FDA-CTU$$65$YR$$F$N$$$20240924$N$$US$
243616121$24361612$1$I$$20240917$20240924$20240924$DIR$FDA-CDER-CTU-2024-65426$$FDA-CTU$$$$$F$N$$$20240917$N$HP$US$
243616131$24361613$1$I$$20240918$20240925$20240925$EXP$$RO-STRIDES ARCOLAB LIMITED-2024SP012385$STRIDES$Galos F, Ionescu MI, Mirea MDL, Boboc AA, Ioan A, Boboc C.. Trends in Upper Gastrointestinal Bleeding in Children: The Impact of Helicobacter pylori Infection and Non-Steroidal Anti-Inflammatory Drug Use.. Antibiotics-(Basel). 2024;13 (8)$$$C$$Y$$$20240925$$HP$RO$RO
243616141$24361614$1$I$$20240916$20240924$20240924$DIR$FDA-CDER-CTU-2024-65425$$FDA-CTU$$$$$M$N$$$20240916$N$HP$US$
243616151$24361615$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65450$$FDA-CTU$$64$YR$$F$N$$$20240924$N$$US$
243616161$24361616$1$I$$20240923$20240925$20240925$PER$$US-HALEON-2198647$Haleon PLC$$37$YR$$F$Y$$$20240925$$HP$US$US
243616171$24361617$1$I$20230101$20240922$20240925$20240925$EXP$$US-ABBVIE-5929881$ABBVIE$$$$$M$Y$58$KG$20240925$$CN$US$US
243616191$24361619$1$I$20240101$20240919$20240925$20240925$EXP$$US-ABBVIE-5932765$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243616201$24361620$1$I$20170419$20240919$20240925$20240925$EXP$FR-AFSSAPS-RN20171105$FR-TEVA-VS-3245965$TEVA$$52$YR$$F$Y$$$20240925$$CN$FR$FR
243616211$24361621$1$I$20210101$20240917$20240925$20240925$EXP$$US-AMGEN-USASP2024186683$AMGEN$Stern R.; Bibi M.; Keltz M.D. et al.. Premature Ovarian Insufficiency After Coronavirus Disease 2019 (COVID-19). Obstetrics + Gynecology. 2024;143 (6):e149-e152$31$YR$A$F$Y$$$20240925$$HP$US$US
243616221$24361622$1$I$20240916$20240923$20240925$20240925$EXP$$NVSC2024US189992$NOVARTIS$$52$YR$$F$Y$$$20240925$$CN$US$US
243616241$24361624$1$I$20240822$20240918$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-047080$AUROBINDO$$51$YR$$M$Y$$$20240925$$MD$FR$FR
243616261$24361626$1$I$$20240702$20240925$20240925$30DAY$$US-PFIZER INC-202400205738$PFIZER$$13$YR$$M$Y$$$20240925$$CN$US$US
243616271$24361627$1$I$$20240919$20240925$20240925$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP012262$STRIDES$Nakako S, Koh H, Sogabe N, Kuno M, Makuuchi Y, Takakuwa T, et al.. Successful treatment with mesenchymal stem cells for steroid-refractory late-onset idiopathic pneumonia syndrome following allogeneic hematopoietic cell transplantation.. Transpl-Immunol. 2024;86$55$YR$$M$Y$$$20240925$$HP$JP$JP
243616291$24361629$1$I$20230727$20240919$20240925$20240925$PER$$CO-REGENERON PHARMACEUTICALS, INC.-2024-127674$REGENERON$$52$YR$$M$Y$$$20240925$$CN$CO$CO
243616301$24361630$1$I$20240919$20240920$20240925$20240925$EXP$$US-BAYER-2024A135112$BAYER$$5$YR$C$M$Y$$$20240925$$HP$US$US
243616311$24361631$1$I$20240701$20240920$20240925$20240925$EXP$FI-FIMEA-202403351$FI-BAYER-2024A134536$BAYER$$34$YR$A$F$Y$$$20240925$$CN$FI$FI
243616321$24361632$1$I$$20240923$20240925$20240925$EXP$$GB-SANDOZ INC.-NVSC2020GB029574$SANDOZ$$$$$M$Y$$$20240925$$CN$GB$GB
243616361$24361636$1$I$$20240917$20240925$20240925$EXP$$CA-TAKEDA-2024TUS093218$TAKEDA$$$$$F$Y$$$20240925$$CN$CA$CA
243616371$24361637$1$I$20231101$20240918$20240925$20240925$EXP$$US-ABBVIE-5477587$ABBVIE$$78$YR$$M$Y$$$20240925$$MD$US$US
243616411$24361641$1$I$$20240916$20240925$20240925$PER$$US-Calliditas-2024CAL01910$CALLIDITAS THERAPEUTICS$$61$YR$A$F$Y$$$20240924$$MD$US$US
243616421$24361642$1$I$20190702$20240919$20240925$20240925$PER$$DE-Eisai-EC-2019-058766$EISAI$$78$YR$E$M$Y$60$KG$20240925$$MD$DE$DE
243616431$24361643$1$I$$20240916$20240925$20240925$PER$$US-Calliditas-2024CAL01921$CALLIDITAS THERAPEUTICS$$31$YR$A$M$Y$$$20240924$$HP$US$US
243616451$24361645$1$I$20240913$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65441$$FDA-CTU$$68$YR$$F$N$82.55$KG$20240924$N$PH$US$
243616461$24361646$1$I$20240920$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65439$$FDA-CTU$$73$YR$$M$N$$$20240924$N$HP$US$
243616471$24361647$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65410$$FDA-CTU$$$$$F$N$$$20240923$N$HP$US$
243616481$24361648$1$I$20240830$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65413$$FDA-CTU$$68$YR$$M$N$$$20240924$Y$PH$US$
243616491$24361649$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65403$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243616501$24361650$1$I$20240301$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65411$$FDA-CTU$$58$YR$$M$N$$$20240923$N$HP$US$
243616521$24361652$1$I$$20240923$20240925$20240925$PER$$US-HALEON-2198425$Haleon PLC$$46$YR$$F$Y$$$20240925$$CN$US$US
243616531$24361653$1$I$$20240920$20240925$20240925$EXP$$US-TAKEDA-2024TUS093730$TAKEDA$$$$A$M$Y$70$KG$20240925$$HP$US$US
243616541$24361654$1$I$20240307$20240911$20240925$20240925$EXP$$DE-OCTA-GAM28724$OCTAPHARMA$$77$YR$E$M$Y$96$KG$20240924$$MD$EU$EU
243616551$24361655$1$I$20240813$20240916$20240925$20240925$EXP$FR-AFSSAPS-TO2024001713$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112452$ZYDUS PHARM$$$$$$Y$$$20240925$$MD$FR$FR
243616561$24361656$1$I$20240804$20240916$20240925$20240925$EXP$FR-AFSSAPS-AM2024000737$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112455$ZYDUS PHARM$$$$$$Y$$$20240925$$PH$FR$FR
243616581$24361658$1$I$$20240912$20240925$20240925$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112307$ZYDUS PHARM$$$$$$Y$$$20240925$$HP$US$US
243616601$24361660$1$I$$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024189303$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243616611$24361661$1$I$$20240918$20240925$20240925$EXP$$US-GSK-US2024116160$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
243616621$24361662$1$I$20231227$20240913$20240925$20240925$EXP$$KR-Accord-447471$ACCORD$$64$YR$A$F$Y$$$20240925$$HP$KR$KR
243616631$24361663$1$I$20240910$20240913$20240925$20240925$EXP$$CN-OCTA-ALB15724$OCTAPHARMA$$$$E$M$Y$60$KG$20240924$$HP$CN$CN
243616641$24361664$1$I$20240924$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65447$$FDA-CTU$$71$YR$$F$N$$$20240924$Y$HP$US$
243616651$24361665$1$I$20240819$20240912$20240925$20240925$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000970$PAREXEL$$$$$$Y$$$20240925$$HP$CN$CN
243616661$24361666$1$I$20240830$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65397$$FDA-CTU$$83$YR$$F$N$$$20240924$Y$HP$US$
243616671$24361667$1$I$20140711$20240920$20240925$20240925$EXP$$CA-BAYER-2024A135841$BAYER$$32$YR$A$F$Y$$$20240925$$CN$CA$CA
243616681$24361668$1$I$$20240911$20240925$20240925$EXP$$DE-AUROBINDO-AUR-APL-2024-045559$AUROBINDO$Obermaier B, Braun C, Hensen L, Ahmad O, Faul C, Lang P et al.. Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection ? A single-center experience. Transplant Infectious Disease. 2024;26:e14296$42$YR$$$Y$$$20240925$$HP$DE$DE
243616691$24361669$1$I$$20240905$20240925$20240925$EXP$$NVSC2024BE190043$NOVARTIS$$$$E$M$Y$$$20240925$$MD$BE$BE
243616703$24361670$3$F$20240920$20240926$20240925$20240930$PER$$US-AMGEN-USASP2024188605$AMGEN$$73$YR$E$F$Y$$$20240929$$CN$US$US
243616711$24361671$1$I$20240901$20240920$20240925$20240925$EXP$$US-BAYER-2024A135730$BAYER$$71$YR$E$F$Y$65.17$KG$20240925$$CN$US$US
243616721$24361672$1$I$20240911$20240923$20240925$20240925$EXP$$CN-ROCHE-10000089415$ROCHE$$64$YR$A$F$Y$50.5$KG$20240925$$HP$CN$CN
243616741$24361674$1$I$$20240911$20240925$20240925$EXP$$PT-AUROBINDO-AUR-APL-2024-045762$AUROBINDO$Farinha I, Ferreira PG. Salvage use of tofacitinib in sarcoidosis patient with refractory multiorgan involvement. Sarccoidosis-Vasc-Diffuse-Lung-Dis. 2024;41 (2):e2024019$44$YR$$M$Y$$$20240925$$HP$PT$PT
243616751$24361675$1$I$$20240911$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-045774$AUROBINDO$Angeli A, Blazek A, Stephenson C.. 64-Year-Old Woman With Fevers and Abdominal Pain. MAYO CLINIC PROCEEDINGS. 2024;99(8):1312-1316$64$YR$$F$Y$$$20240925$$MD$US$US
243616761$24361676$1$I$$20240920$20240925$20240925$EXP$GB-MHRA-MED-202409202127308070-KLQDR$GB-MYLANLABS-2024M1086023$MYLAN$$$$$M$Y$94$KG$20240925$$CN$GB$GB
243616781$24361678$1$I$20240806$20240920$20240925$20240925$EXP$$GB-MYLANLABS-2024M1086036$MYLAN$$68$YR$$F$Y$115$KG$20240925$$PH$GB$GB
243616791$24361679$1$I$$20240919$20240925$20240925$EXP$$CA-GSK-CA2024105418$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$CA$CA
243616801$24361680$1$I$$20240911$20240925$20240925$EXP$$IT-AUROBINDO-AUR-APL-2024-045743$AUROBINDO$IannoneLF, Vigani G, Boccalini A, De Cesaris F, Mannaioni G, Chiarugi A, et al.. Rimegepant as an acute treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations.. Cephalalgia Reports. 2024;7:1?6$56$YR$$F$Y$$$20240925$$HP$IT$IT
243616811$24361681$1$I$$20240911$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-045471$AUROBINDO$Reddy TP, Barrios R, Bernicker E, Qian W, Chang J, Safdar Z. Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension. Pulmonary circulation. 2024;14(3):e12426$52$YR$$F$Y$$$20240925$$MD$US$US
243616821$24361682$1$I$$20231006$20240925$20240925$PER$$US-CELLTRION INC.-2023US018493$CELLTRION$$$$$$Y$$$20240925$$PH$US$US
243616831$24361683$1$I$20240908$20240920$20240925$20240925$EXP$$US-BAYER-2024A136846$BAYER$$49$YR$A$M$Y$92.971$KG$20240925$$CN$US$US
243616841$24361684$1$I$$20240923$20240925$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US082388$SANDOZ$$$$$M$Y$$$20240925$$CN$US$US
243616851$24361685$1$I$$20240913$20240925$20240925$EXP$$CH-STERISCIENCE B.V.-2024-ST-001473$Steriscience PTE$Nagele K, Battig V, Gosert R, Walti CS, Prince SS, Halter J, et al.. Revealing the unseen: next generation sequencing for early detection of drug-resistant cytomegalovirus variants upon letermovir prophylaxis failure.. J-Infect-Dis. 2024$63$YR$$M$Y$$$20240925$$HP$CH$CH
243616861$24361686$1$I$$20240923$20240925$20240925$EXP$GB-MHRA-MIDB-GB-MHRA-MIDB-fd53304b-68f8-4620-a7a6-bd883841f054$GB-ORGANON-O2409GBR001753$ORGANON$$79$YR$$$Y$$$20240925$$PH$GB$GB
243616871$24361687$1$I$$20240918$20240925$20240925$EXP$$NVSC2024TW188251$NOVARTIS$Su Y, Liu W, Lin C, Chien H, Yang K. Bisphosphonate-related osteonecrosis of the jaw: Is the medication duration related to advanced disease stage?. FORMOSAN JOURNAL OF SURGERY. 2024;57(4):151-6$80$YR$$F$Y$$$20240925$$HP$TW$TW
243616881$24361688$1$I$$20240918$20240925$20240925$EXP$$NVSC2024TW188254$NOVARTIS$Su Y, Liu W, Lin C, Chien H, Yang K. Bisphosphonate-related osteonecrosis of the jaw: Is the medication duration related to advanced disease stage?. FORMOSAN JOURNAL OF SURGERY. 2024;57(4):151-6$60$YR$$F$Y$$$20240925$$HP$TW$TW
243616891$24361689$1$I$20240901$20240923$20240925$20240925$EXP$FR-AFSSAPS-PA2024001558$NVSC2024FR188982$NOVARTIS$$66$YR$$M$Y$98$KG$20240925$$PH$FR$FR
243616911$24361691$1$I$$20240923$20240925$20240925$EXP$$US-ABBVIE-5936867$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243616921$24361692$1$I$20240822$20240923$20240925$20240925$EXP$$CN-ROCHE-10000089245$ROCHE$$70$YR$E$F$Y$50$KG$20240925$$HP$CN$CN
243616941$24361694$1$I$20240913$20240919$20240925$20240925$EXP$$GB-MYLANLABS-2024M1086097$MYLAN$$$$$M$Y$$$20240925$$PH$GB$GB
243616961$24361696$1$I$$20240919$20240925$20240925$EXP$$IE-MYLANLABS-2024M1085981$MYLAN$$$$$M$Y$$$20240925$$CN$IE$IE
243616971$24361697$1$I$$20240919$20240925$20240925$EXP$$GB-MYLANLABS-2024M1085752$MYLAN$$$$$M$Y$$$20240925$$HP$GB$GB
243616991$24361699$1$I$$20240920$20240925$20240925$EXP$GB-MHRA-MED-202409201446341410-QFLZB$GB-MYLANLABS-2024M1086070$MYLAN$$42$YR$$M$Y$102$KG$20240925$$CN$GB$GB
243617001$24361700$1$I$$20240919$20240925$20240925$EXP$$GB-MYLANLABS-2024M1086096$MYLAN$$$$$M$Y$$$20240925$$CN$GB$GB
243617011$24361701$1$I$$20240920$20240925$20240925$EXP$GB-MHRA-MED-202409201442135780-GSWCR$GB-MYLANLABS-2024M1086067$MYLAN$$$$$M$Y$$$20240925$$CN$GB$GB
243617021$24361702$1$I$20240901$20240920$20240925$20240925$EXP$GB-MHRA-MED-202409201502422900-WMPHY$GB-MYLANLABS-2024M1086064$MYLAN$$50$YR$$F$Y$$$20240925$$HP$GB$GB
243617031$24361703$1$I$$20240919$20240925$20240925$EXP$$GB-MYLANLABS-2024M1085914$MYLAN$$$$$F$Y$$$20240925$$PH$GB$GB
243617041$24361704$1$I$$20240919$20240925$20240925$EXP$$AR-MYLANLABS-2024M1086044$MYLAN$$$$$F$Y$$$20240925$$MD$AR$AR
243617051$24361705$1$I$20240924$20240924$20240925$20240925$EXP$GB-MHRA-MED-202409240827089000-NQYKC$GB-MYLANLABS-2024M1086683$MYLAN$$62$YR$$M$Y$87$KG$20240925$$CN$GB$GB
243617061$24361706$1$I$20240920$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024190033$AMGEN$$75$YR$E$M$Y$$$20240925$$CN$US$US
243617071$24361707$1$I$20080101$20240912$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-045637$AUROBINDO$Ehrhardt C, M?kinen KK, Cobb CM.. Development of Root Caries Associated With the Use of Sugar-Free Nicotine Lozenges: A Long-Term Case Report. Case reports in dentistry. 2024;6635130.. Case Reports in Dentistry. 2024;2024:1-8$59$YR$$M$Y$81$KG$20240925$$MD$US$US
243617081$24361708$1$I$20240101$20240916$20240925$20240925$EXP$$BR-JNJFOC-20240948707$JOHNSON AND JOHNSON$$72$YR$E$M$Y$86$KG$20240925$$CN$BR$BR
243617091$24361709$1$I$$20240920$20240925$20240925$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-28760$SAMSUNG BIOEPIS$$60$YR$A$M$Y$$$20240925$$CN$GB$GB
243617101$24361710$1$I$$20240912$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-045952$AUROBINDO$Malani KA, Finn A. Metformin-associated lactic acidosis: a serious complication of a common drug. BMJ case reports. 2024;17(9):e260592$8$DEC$$M$Y$$$20240925$$MD$US$US
243617111$24361711$1$I$$20240911$20240925$20240925$EXP$$US-AUROBINDO-AUR-APL-2024-045901$AUROBINDO$Heyman HM, Alberts NM, Rees M, Puri L, Frett MJ, Anghelescu DL.. COVID-19 infection and pain in adolescents with sickle cell disease: A case series. EJHaem. 2022;3(4):1310-1315$17$YR$$F$Y$$$20240925$$HP$US$US
243617121$24361712$1$I$$20240918$20240925$20240925$PER$$US-MYLANLABS-2024M1086102$MYLAN$$$$$F$Y$67.13$KG$20240925$$CN$US$US
243617141$24361714$1$I$$20240911$20240925$20240925$EXP$$NO-Axellia-005362$XELLIA PHARMACEUTICALS$Sommerfelt H, Sandvik LF, Bachmann IM, Brekke RL, Svendsen HL, Guttormsen AB. Toxic epidermal necrolysis after immune checkpoint inhibition, case report, and review of the literature. Acta Oncologica. 2022;61(10):1295-1299.$34$YR$A$M$Y$$$20240925$$HP$NO$NO
243617151$24361715$1$I$20230401$20240912$20240925$20240925$EXP$$JP-Axellia-005370$XELLIA PHARMACEUTICALS$Nakazawa Y, Ishida M, Sekine K, Shimada F, Suzuki T, Hirose Y. Massive chylous pleural effusion and protein-losing enteropathy caused by mesenteric panniculitis: A case report. Biomed Rep. 2024 Aug 19;21(5):148.$56$YR$A$M$Y$$$20240925$$HP$JP$JP
243617161$24361716$1$I$20240101$20240916$20240925$20240925$EXP$$US-UCBSA-2024047834$UCB$$$$$M$Y$$$20240925$$HP$US$US
243617171$24361717$1$I$$20240916$20240925$20240925$EXP$$FR-TEVA-VS-3245961$TEVA$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$38$YR$$M$Y$$$20240925$$HP$FR$FR
243617181$24361718$1$I$20240902$20240917$20240925$20240925$EXP$$JP-009507513-2409JPN002688J$MERCK$$$$$F$Y$$$20240925$$MD$JP$JP
243617191$24361719$1$I$$20231227$20240925$20240925$PER$$US-CELLTRION INC.-2023US019545$CELLTRION$$$$$$Y$$$20240925$$PH$US$US
243617211$24361721$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65432$$FDA-CTU$$74$YR$$F$N$$$20240924$N$HP$US$
243617221$24361722$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65419$$FDA-CTU$$63$YR$$M$N$$$20240924$N$$US$
243617231$24361723$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65416$$FDA-CTU$$39$YR$$M$N$92.99$KG$20240924$N$$US$
243617241$24361724$1$I$20231212$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65451$$FDA-CTU$$80$YR$$M$N$75.3$KG$20240924$N$$US$
243617251$24361725$1$I$20240916$20240918$20240925$20240925$DIR$FDA-CDER-CTU-2024-65415$$FDA-CTU$$57$YR$$M$N$87.1$KG$20240918$N$$US$
243617261$24361726$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013661$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240925$$CN$US$US
243617271$24361727$1$I$20240712$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65448$$FDA-CTU$$79$YR$$M$N$$$20240924$Y$HP$US$
243617281$24361728$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65445$$FDA-CTU$$62$YR$$M$N$$$20240924$N$$US$
243617291$24361729$1$I$20240901$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014701$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240925$$CN$US$US
243617301$24361730$1$I$$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013379$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240925$$CN$US$US
243617311$24361731$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65418$$FDA-CTU$$79$YR$$F$N$$$20240924$N$PH$US$
243617321$24361732$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65422$$FDA-CTU$$80$YR$$M$N$$$20240924$N$$US$
243617331$24361733$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65421$$FDA-CTU$$76$YR$$F$N$$$20240923$N$HP$US$
243617341$24361734$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014659$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240925$$CN$US$US
243617351$24361735$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014709$ELI LILLY AND CO$$$$$M$Y$$$20240925$$CN$US$US
243617361$24361736$1$I$20240921$20240921$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014313$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243617371$24361737$1$I$$20240722$20240925$20240925$EXP$$CA-CURRAX PHARMACEUTICALS LLC-CA-2024CUR004219$CURRAX PHARMACEUTICALS$$42$YR$$M$Y$$$20240925$$CN$CA$CA
243617391$24361739$1$I$20240909$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65436$$FDA-CTU$$85$YR$$M$N$$$20240924$N$HP$US$
243617401$24361740$1$I$$20240917$20240925$20240925$PER$$US-ROCHE-10000084900$ROCHE$$$$A$M$Y$$$20240925$$CN$US$US
243617411$24361741$1$I$$20240924$20240925$20240925$EXP$$US-BAYER-2024A136617$BAYER$$53$YR$A$M$Y$$$20240925$$CN$US$US
243617421$24361742$1$I$$20240913$20240925$20240925$EXP$$BE-AUROBINDO-AUR-APL-2024-046376$AUROBINDO$Devresse A.; Foguenne M.; Mourad M. et al.. Acute and Severe Hypercalcemia Early After Kidney Transplantation in a Patient Previously Treated With Etelcalcetide.. Transplant International. 2023;1-2.$68$YR$$M$Y$$$20240925$$HP$BE$BE
243617431$24361743$1$I$20240801$20240917$20240925$20240925$EXP$$IL-IMMUNOCORE, LTD.-2024-IMC-002930$IMMUNOCORE$$$$$$Y$$$20240925$$MD$IL$IL
243617441$24361744$1$I$$20240917$20240925$20240925$PER$$US-JNJFOC-20240953759$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20240925$$CN$US$US
243617451$24361745$1$I$$20240918$20240925$20240925$EXP$$CA-TEVA-VS-3245855$TEVA$$$$$$Y$$$20240925$$HP$CA$CA
243617461$24361746$1$I$$20240916$20240925$20240925$EXP$$CN-TEYRO-2024-TY-000629$Teyro Labs$Liu X, Peng X, Yang S, Liu H, Zhang S, Li Y, et al..Salvage chemotherapy regimens with arsenic trioxide for relapsed or refractory neuroblastoma: a promising approach..BMC Cancer.2024;24:1140$$$$$Y$$$20240925$$HP$CN$CN
243617471$24361747$1$I$20240703$20240917$20240925$20240925$EXP$$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08782$HIKMA$$68$YR$$F$Y$$$20240925$$PH$FR$FR
243617481$24361748$1$I$$20240924$20240925$20240925$EXP$$CA-BAYER-2024A136623$BAYER$$80$YR$E$M$Y$$$20240925$$CN$CA$CA
243617491$24361749$1$I$$20240913$20240925$20240925$EXP$$IT-AUROBINDO-AUR-APL-2024-046360$AUROBINDO$Conzo G; Napolitano S.; Mauriello C. et al... Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report. . 2012;6:417. Journal of medical case reports. 2012;6:417$41$YR$$M$Y$$$20240925$$HP$IT$IT
243617501$24361750$1$I$$20240917$20240925$20240925$EXP$$US-IMMUNOCORE, LTD-2024-IMC-003137$IMMUNOCORE$$$$$F$Y$69.388$KG$20240925$$HP$US$US
243617511$24361751$1$I$$20240919$20240925$20240925$EXP$$CA-ROCHE-10000086807$ROCHE$$40$YR$A$F$Y$$$20240925$$HP$CA$CA
243617521$24361752$1$I$$20240923$20240925$20240925$EXP$$NVSC2024US189941$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
243617551$24361755$1$I$20230201$20240919$20240925$20240925$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-149986$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240925$$MD$DE$DE
243617561$24361756$1$I$$20240919$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150500$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240925$$CN$US$US
243617571$24361757$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150721$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$90.72$KG$20240925$$CN$US$US
243617581$24361758$1$I$$20240918$20240925$20240925$EXP$$NVSC2024PE189365$NOVARTIS$$86$YR$$F$Y$$$20240925$$CN$PE$PE
243617591$24361759$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151612$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$82.55$KG$20240925$$CN$US$US
243617601$24361760$1$I$$20231230$20240925$20240925$PER$$US-CELLTRION INC.-2023US020266$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243617611$24361761$1$I$$20240912$20240925$20240925$EXP$$US-Avondale Pharmaceuticals, LLC-2162031$AVONDALE PHARMACEUTICALS$Initial$17$YR$$F$Y$$$20240925$$$US$US
243617621$24361762$1$I$$20240913$20240925$20240925$EXP$$CN-ROCHE-3099772$ROCHE$Meng Y, Li L, Wang H, Chen X, Yue Y, Wang M, Meng L, Li B and Li X. Pralsetinib for the treatment of a RET-positive advanced non-small-cell lung cancer patient harboring both ANK-RET and CCDC6-RET fusions with coronary heart disease: a case report. Doi: 10.21037/atm-22-1237. Annals of Translational Medicine 2022 Apr;10 (8):1-6.$64$YR$A$M$Y$$$20240925$$HP$CN$CN
243617631$24361763$1$I$20220216$20240919$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-USA-20220301338$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$84.82$KG$20240925$$CN$US$US
243617641$24361764$1$I$20240910$20240919$20240925$20240925$EXP$$US-RDY-SPO/USA/24/0013855$DR REDDYS$$73$YR$E$M$Y$$$20240925$$HP$US$US
243617651$24361765$1$I$$20240917$20240925$20240925$PER$$US-GSK-US2024115651$GLAXOSMITHKLINE$$$$$F$Y$$$20240925$$CN$US$US
243617661$24361766$1$I$20240909$20240919$20240925$20240925$EXP$GB-MHRA-MED-202409181114112600-QNPRF$GB-TEVA-VS-3245913$TEVA$$$$$F$Y$$$20240925$$MD$GB$GB
243617671$24361767$1$I$$20240918$20240925$20240925$EXP$US-MLMSERVICE-20240903-PI182232-00323-1$US-RDY-SPO/USA/24/0013802$DR REDDYS$Purt B, Nugent A, Wu PS, Paulus YM. Sub-tenon triamcinolone and anti-HIV medication-induced Cushing syndrome. JAMA ophthalmology. 2024. DOI: 10.1001/jamaophthalmol.2024.3284.$82$YR$E$M$Y$$$20240925$$MD$US$US
243617681$24361768$1$I$20240101$20240916$20240925$20240925$EXP$$US-UCBSA-2024047860$UCB$$$$$F$Y$$$20240925$$CN$US$US
243617691$24361769$1$I$20240913$20240919$20240925$20240925$EXP$$GB-TEVA-VS-3246019$TEVA$$53$YR$$F$Y$101$KG$20240925$$CN$GB$GB
243617701$24361770$1$I$$20240918$20240925$20240925$PER$$US-AMGEN-USASP2024186690$AMGEN$$80$YR$E$M$Y$$$20240925$$MD$US$US
243617712$24361771$2$F$20240101$20240919$20240925$20240925$PER$$US-ABBVIE-5931669$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243617721$24361772$1$I$$20240921$20240925$20240925$PER$$US-BIOGEN-2024BI01283806$BIOGEN$$$$$F$Y$$$20240925$$HP$US$US
243617741$24361774$1$I$20240914$20240919$20240925$20240925$EXP$GB-MHRA-MED-202409161424553710-WZRYN$GB-TEVA-VS-3246021$TEVA$$$$$$Y$$$20240925$$PH$GB$GB
243617751$24361775$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65435$$FDA-CTU$$69$YR$$M$N$$$20240924$N$$US$
243617761$24361776$1$I$20240911$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65404$$FDA-CTU$$72$YR$$F$N$$$20240923$N$HP$US$
243617771$24361777$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65442$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243617781$24361778$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65433$$FDA-CTU$$77$YR$$F$N$$$20240924$N$$US$
243617791$24361779$1$I$20240905$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65417$$FDA-CTU$$35$YR$$F$N$$$20240924$N$HP$US$
243617801$24361780$1$I$$20240919$20240925$20240925$EXP$$JP-009507513-2409JPN003111J$MERCK$$73$YR$$F$Y$$$20240925$$MD$JP$JP
243617821$24361782$1$I$20240916$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65409$$FDA-CTU$$77$YR$$F$N$$$20240923$N$HP$US$
243617831$24361783$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65444$$FDA-CTU$$10$YR$$M$N$41.73$KG$20240924$N$$US$
243617841$24361784$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65438$$FDA-CTU$$$$$M$N$$$20240924$N$HP$US$
243617851$24361785$1$I$20220908$20240920$20240925$20240925$EXP$$CO-UCBSA-2024048978$UCB$$79$YR$$M$Y$$$20240925$$CN$CO$CO
243617861$24361786$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65414$$FDA-CTU$$42$YR$$M$N$$$20240924$N$$US$
243617871$24361787$1$I$$20240920$20240925$20240925$EXP$$US-ROCHE-10000087924$ROCHE$$14$YR$T$F$Y$20.5$KG$20240925$$CN$US$US
243617881$24361788$1$I$$20240922$20240925$20240925$EXP$$US-BAYER-2024A135769$BAYER$$$$$$Y$$$20240925$$CN$US$US
243617891$24361789$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65408$$FDA-CTU$$61$YR$$F$N$150$LBS$20240924$N$$US$
243617901$24361790$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65446$$FDA-CTU$$40$YR$$F$N$$$20240924$N$$US$
243617911$24361791$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65431$$FDA-CTU$$$$$M$N$$$20240923$N$HP$US$
243617921$24361792$1$I$$20240916$20240925$20240925$EXP$$CN-TEYRO-2024-TY-000671$Teyro Labs$Li K, Zhong W, Fan J, Wang S, Yu D, Huang J, et.al.Neoadjuvant gemcitabine-cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial..Nat Cancer..2024$$$$$Y$$$20240925$$HP$CN$CN
243617931$24361793$1$I$$20240919$20240925$20240925$EXP$$FR-JNJFOC-20240954701$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$MD$FR$FR
243617941$24361794$1$I$20210514$20240916$20240925$20240925$EXP$$PT-AUROBINDO-AUR-APL-2024-046114$AUROBINDO$$24$YR$$M$Y$$$20240925$$MD$PT$PT
243617961$24361796$1$I$$20240923$20240924$20240924$DIR$FDA-CDER-CTU-2024-65396$$FDA-CTU$$$$$M$N$$$20240923$N$HP$US$
243617971$24361797$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65427$$FDA-CTU$$66$YR$$M$N$$$20240924$N$$US$
243617981$24361798$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65449$$FDA-CTU$$38$YR$$F$N$$$20240924$N$$US$
243617991$24361799$1$I$20230725$20240910$20240924$20240924$DIR$FDA-CDER-CTU-2024-65401$$FDA-CTU$$67$YR$$F$N$48.99$KG$20240910$N$CN$US$
243618001$24361800$1$I$20240716$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65516$$FDA-CTU$$55$YR$$F$N$$$20240924$N$HP$US$
243618011$24361801$1$I$20240921$20240924$20240924$20240924$DIR$719729$$FDA-CTU$$72$YR$$F$N$$$20240924$N$$US$
243618021$24361802$1$I$20240924$20240924$20240924$20240924$DIR$719779$$FDA-CTU$$43$YR$$F$N$$$20240924$N$$US$
243618031$24361803$1$I$$20240917$20240925$20240925$PER$$US-GSK-US2024115659$GLAXOSMITHKLINE$$$$$M$Y$$$20240925$$CN$US$US
243618041$24361804$1$I$$20240903$20240925$20240925$EXP$$SE-SA-2024SA274652$SANOFI AVENTIS$$$$$$Y$$$20240925$$CN$SE$SE
243618051$24361805$1$I$20240501$20240923$20240925$20240925$PER$$US-TAKEDA-2024TUS094768$TAKEDA$$$$C$F$Y$$$20240925$$CN$US$US
243618061$24361806$1$I$20230905$20240913$20240925$20240925$EXP$$FR-AUROBINDO-AUR-APL-2024-046151$AUROBINDO$$38$YR$$M$Y$72$KG$20240925$$PH$FR$FR
243618071$24361807$1$I$20240801$20240916$20240925$20240925$EXP$$US-UCBSA-2024047773$UCB$$62$YR$$F$Y$$$20240925$$HP$US$US
243618082$24361808$2$F$$20240924$20240925$20240927$EXP$$US-PFIZER INC-202400261217$PFIZER$Yang, L.. Hepatic Adenomatosis in a Transgender Man on Gender-Affirming Testosterone Therapy. ACG case reports journal. 2024;11(9):e01483$22$YR$$F$Y$$$20240927$$MD$US$US
243618091$24361809$1$I$$20240920$20240925$20240925$EXP$$US-PFIZER INC-202400260337$PFIZER$Brenner, B.. Heparin insensitivity and thrombotic risk associated with sequential uses of prothrombin complex concentrate and andexanet alfa for apixaban reversal during acute type a aortic dissection repair: a case report. A + A Practice. 2022;16 (11):e01636$76$YR$$F$Y$67$KG$20240925$$MD$US$US
243618111$24361811$1$I$20240101$20240916$20240925$20240925$PER$$US-ABBVIE-5927555$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243618121$24361812$1$I$$20240918$20240925$20240925$EXP$$NVSC2024AU187366$NOVARTIS$$$$$F$Y$$$20240925$$MD$AU$AU
243618131$24361813$1$I$20240917$20240920$20240925$20240925$PER$$US-ROCHE-10000087948$ROCHE$$1$MON$I$M$Y$$$20240925$$CN$US$US
243618141$24361814$1$I$$20240921$20240925$20240925$EXP$$US-TAKEDA-2024TUS094804$TAKEDA$$16$YR$$M$Y$$$20240925$$CN$US$US
243618151$24361815$1$I$$20240916$20240925$20240925$EXP$$CN-TEYRO-2024-TY-000628$Teyro Labs$Liu X, Peng X, Yang S, Liu H, Zhang S, Li Y,et al..Salvage chemotherapy regimens with arsenic trioxide for relapsed or refractory neuroblastoma: a promising approach..BMC Cancer.2024;24:1140$$$$$Y$$$20240925$$HP$CN$CN
243618161$24361816$1$I$$20231102$20240925$20240925$PER$$US-CELLTRION INC.-2023US021309$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243618171$24361817$1$I$20240918$20240919$20240925$20240925$EXP$$CA-UNITED THERAPEUTICS-UNT-2024-029822$UNITED THERAPEUTICS$$72$YR$$F$Y$$$20240925$$$CA$CA
243618181$24361818$1$I$$20240924$20240925$20240925$EXP$$FR-AMGEN-FRASP2024190135$AMGEN$$$$C$$Y$$$20240925$$PH$FR$FR
243618192$24361819$2$F$$20240918$20240925$20240927$EXP$$US-UCBSA-2024047984$UCB$$$$$F$Y$75.283$KG$20240927$$HP$US$US
243618201$24361820$1$I$20240101$20240916$20240925$20240925$EXP$$DE-AUROBINDO-AUR-APL-2024-046675$AUROBINDO$$82$YR$$M$Y$$$20240925$$PH$DE$DE
243618211$24361821$1$I$$20240922$20240925$20240925$EXP$$DE-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005031$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240925$$MD$DE$DE
243618221$24361822$1$I$20240906$20240920$20240925$20240925$EXP$$US-AMGEN-USASP2024188550$AMGEN$$$$$M$Y$$$20240925$$CN$US$US
243618231$24361823$1$I$$20240923$20240925$20240925$PER$$US-JNJFOC-20240964113$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240925$$CN$US$US
243618241$24361824$1$I$20240101$20240911$20240925$20240925$EXP$$US-SA-2024SA275063$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240925$$MD$US$US
243618251$24361825$1$I$20240607$20240916$20240925$20240925$EXP$$EG-HIKMA PHARMACEUTICALS USA INC.-EG-H14001-24-08686$HIKMA$$$$$$Y$$$20240925$$PH$EG$EG
243618261$24361826$1$I$20240630$20240916$20240925$20240925$EXP$$DE-AUROBINDO-AUR-APL-2024-044471$AUROBINDO$$58$YR$$M$Y$71$KG$20240925$$MD$DE$DE
243618271$24361827$1$I$20240501$20240916$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147887$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$75$KG$20240925$$PH$US$US
243618281$24361828$1$I$$20240916$20240925$20240925$EXP$GB-MHRA-MIDB-63c10a59-fb78-409f-a2ce-89d9c954c635$GB-BAXTER-2024BAX024838$BAXTER$$33$YR$$$Y$$$20240925$$HP$GB$GB
243618291$24361829$1$I$$20240912$20240925$20240925$30DAY$$US-PFIZER INC-202400256026$PFIZER$$5$YR$$M$Y$$$20240925$$CN$US$US
243618301$24361830$1$I$20240918$20240919$20240925$20240925$30DAY$$US-PFIZER INC-202400260234$PFIZER$$14$YR$$M$Y$$$20240925$$CN$US$US
243618312$24361831$2$F$20230101$20240924$20240925$20240927$EXP$$CA-PFIZER INC-202300014742$PFIZER$$26$YR$$M$Y$$$20240927$$MD$CA$CA
243618321$24361832$1$I$$20240916$20240925$20240925$30DAY$$US-PFIZER INC-202400257657$PFIZER$$13$YR$$M$Y$$$20240925$$CN$US$US
243618341$24361834$1$I$20240901$20240913$20240925$20240925$30DAY$$US-PFIZER INC-202400256284$PFIZER$$$$$M$Y$$$20240925$$CN$US$US
243618361$24361836$1$I$$20240916$20240925$20240925$30DAY$$US-PFIZER INC-202400257625$PFIZER$$7$YR$$M$Y$$$20240925$$CN$US$US
243618371$24361837$1$I$$20240917$20240925$20240925$30DAY$$CO-PFIZER INC-PV202400122216$PFIZER$$$$$$Y$$$20240925$$CN$CO$CO
243618391$24361839$1$I$$20240913$20240925$20240925$30DAY$$CN-PFIZER INC-PV202400120803$PFIZER$$$$C$M$Y$$$20240925$$CN$CN$CN
243618411$24361841$1$I$$20240919$20240925$20240925$30DAY$$US-PFIZER INC-202400260504$PFIZER$$9$YR$$M$Y$$$20240925$$CN$US$US
243618421$24361842$1$I$$20240920$20240925$20240925$EXP$$CA-PFIZER INC-202400260847$PFIZER$$13$YR$$F$Y$$$20240925$$HP$CA$CA
243618431$24361843$1$I$$20240913$20240925$20240925$30DAY$$US-PFIZER INC-202400257605$PFIZER$$14$YR$$M$Y$$$20240925$$CN$US$US
243618441$24361844$1$I$20220607$20240923$20240925$20240925$EXP$$CA-PFIZER INC-202200819460$PFIZER$$79$YR$$F$Y$$$20240925$$MD$CA$CA
243618461$24361846$1$I$$20240916$20240925$20240925$EXP$$CN-TEYRO-2024-TY-000627$Teyro Labs$Liu X, Peng X, Yang S, Liu H, Zhang S, Wang J,et al..Salvage chemotherapy regimens with arsenic trioxide for relapsed or refractory neuroblastoma: a promising approach..BMC Cancer.2024;24:1140$$$$$Y$$$20240925$$HP$CN$CN
243618471$24361847$1$I$20240101$20240913$20240925$20240925$EXP$$US-SA-2024SA275372$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240925$$MD$US$US
243618481$24361848$1$I$$20240912$20240925$20240925$PER$$US-FARMAPROD-202407-2592$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240925$$CN$US$US
243618511$24361851$1$I$20240924$20240924$20240924$20240924$DIR$719753$$FDA-CTU$$3$MON$$F$N$$$20240924$N$$US$
243618521$24361852$1$I$20240701$20240916$20240925$20240925$EXP$$US-UCBSA-2024038619$UCB$$7$YR$$M$Y$$$20240925$$CN$US$US
243618531$24361853$1$I$$20240910$20240925$20240925$PER$$US-MYLANLABS-2024M1083054$MYLAN$$$$$$Y$$$20240925$$CN$US$US
243618542$24361854$2$F$$20240929$20240925$20240930$EXP$$CA-BAYER-2024A136974$BAYER$$$$$F$Y$$$20240930$$HP$CA$CA
243618551$24361855$1$I$20240621$20240917$20240925$20240925$EXP$$US-SA-2024SA269855$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240925$$CN$US$US
243618561$24361856$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014824$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240925$$CN$US$US
243618571$24361857$1$I$20240916$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014216$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240925$$CN$US$US
243618581$24361858$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015389$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240925$$CN$US$US
243618591$24361859$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014592$ELI LILLY AND CO$$53$YR$A$$Y$$$20240925$$CN$US$US
243618601$24361860$1$I$$20240619$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015345$ELI LILLY AND CO$$$$$M$Y$$$20240925$$CN$US$US
243618611$24361861$1$I$$20240724$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015583$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243618621$24361862$1$I$$20240910$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409006436$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240925$$CN$US$US
243618631$24361863$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014491$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240925$$CN$US$US
243618641$24361864$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014495$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240925$$CN$US$US
243618651$24361865$1$I$20130107$20240916$20240925$20240925$EXP$$GB-AUROBINDO-AUR-APL-2024-046068$AUROBINDO$$30$YR$$M$Y$70$KG$20240925$$CN$GB$GB
243618661$24361866$1$I$20240811$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151627$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240925$$CN$US$US
243618671$24361867$1$I$$20240923$20240925$20240925$EXP$$CL-BRISTOL-MYERS SQUIBB COMPANY-2024-151411$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$MD$CL$CL
243618681$24361868$1$I$$20240918$20240925$20240925$30DAY$$US-PFIZER INC-202400259250$PFIZER$$10$YR$$F$Y$$$20240925$$CN$US$US
243618691$24361869$1$I$$20240911$20240925$20240925$30DAY$$US-PFIZER INC-202400255052$PFIZER$$10$YR$$M$Y$$$20240925$$CN$US$US
243618701$24361870$1$I$$20240916$20240925$20240925$30DAY$$US-PFIZER INC-202400257854$PFIZER$$7$YR$$F$Y$$$20240925$$CN$US$US
243618711$24361871$1$I$$20240920$20240925$20240925$30DAY$$US-PFIZER INC-202400261022$PFIZER$$13$YR$$M$Y$$$20240925$$CN$US$US
243618721$24361872$1$I$$20240916$20240925$20240925$EXP$$CN-TEYRO-2024-TY-000626$Teyro Labs$Liu X, Peng X, Yang S, Liu H, Zhang S, Yang L,et al..Salvage chemotherapy regimens with arsenic trioxide for relapsed or refractory neuroblastoma: a promising approach..BMC Cancer.2024;24:1140$$$$$Y$$$20240925$$HP$CN$CN
243618731$24361873$1$I$20240915$20240920$20240925$20240925$PER$$US-VIIV HEALTHCARE LIMITED-US2024117112$VIIV$$36$YR$$M$Y$$$20240925$$MD$US$US
243618741$24361874$1$I$$20240916$20240925$20240925$EXP$$AE-ROCHE-10000083855$ROCHE$$$$A$F$Y$$$20240925$$CN$AE$AE
243618751$24361875$1$I$$20240923$20240925$20240925$EXP$$CA-ORGANON-O2409CAN001733$ORGANON$$$$$F$Y$$$20240925$$HP$CA$CA
243618761$24361876$1$I$20240716$20240920$20240925$20240925$EXP$$NVSC2024IN190128$NOVARTIS$$54$YR$$M$Y$$$20240925$$CN$IN$IN
243618771$24361877$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244497$TEVA$$65$YR$$M$Y$81$KG$20240925$$HP$CA$CA
243618791$24361879$1$I$20240101$20240920$20240925$20240925$EXP$$US-SA-2024SA275170$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240925$$MD$US$US
243618801$24361880$1$I$20240101$20240827$20240925$20240925$PER$$US-SLATERUN-2024SRSPO00144$SLATE RUN$$$$$F$Y$$$20240925$$CN$US$US
243618821$24361882$1$I$$20240913$20240925$20240925$EXP$BE-MLMSERVICE-20240905-PI181491-00155-3$BE-STRIDES ARCOLAB LIMITED-2024SP012077$STRIDES$De Vleeschhauwer F, Casteels K, Hoffman I, Proesmans M, Rochtus A. Systemic Adverse Events Associated with Locally Administered Corticosteroids.. Children. 2024;11(8):951$9$YR$$M$Y$$$20240925$$MD$BE$BE
243618831$24361883$1$I$20240101$20240828$20240925$20240925$PER$$US-SLATERUN-2024SRSPO00145$SLATE RUN$$36$YR$A$F$Y$160$KG$20240925$$CN$US$US
243618841$24361884$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189554$AMGEN$$$$A$M$Y$$$20240925$$HP$US$US
243618851$24361885$1$I$$20240919$20240925$20240925$EXP$$SI-AMGEN-SVNSP2024188395$AMGEN$$$$$F$Y$$$20240925$$MD$SI$SI
243618861$24361886$1$I$20240101$20240919$20240925$20240925$EXP$$SI-AMGEN-SVNSP2024187860$AMGEN$$82$YR$E$F$Y$$$20240925$$MD$SI$SI
243618871$24361887$1$I$20240807$20240924$20240924$20240924$DIR$719698$$FDA-CTU$$54$YR$$M$N$90.8$KG$20240924$N$HP$US$
243618881$24361888$1$I$20240805$20240924$20240924$20240924$DIR$719690$$FDA-CTU$$52$YR$$M$N$98.2$KG$20240924$N$HP$US$
243618891$24361889$1$I$20240807$20240924$20240924$20240924$DIR$719694$$FDA-CTU$$52$YR$$M$N$97.6$KG$20240924$N$HP$US$
243618901$24361890$1$I$20240917$20240924$20240924$20240924$DIR$719715$$FDA-CTU$$44$YR$$F$N$94.05$KG$20240924$N$CN$US$
243618921$24361892$1$I$20220101$20240917$20240925$20240925$PER$$US-BAYER-2024A133777$BAYER$$17$YR$T$F$Y$$$20240925$$HP$US$US
243618931$24361893$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151638$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$77.56$KG$20240925$$CN$US$US
243618941$24361894$1$I$20240101$20240923$20240925$20240925$PER$$US-ORGANON-O2409USA000465$ORGANON$$$$$F$Y$56.78$KG$20240925$$HP$US$US
243618951$24361895$1$I$$20240923$20240925$20240925$EXP$$GB-PFIZER INC-PV202400124098$PFIZER$$69$YR$$F$Y$$$20240925$$CN$GB$GB
243618962$24361896$2$F$20240912$20240917$20240925$20240925$EXP$$US-ROCHE-10000085100$ROCHE$$64$YR$A$F$Y$57.15$KG$20240925$$CN$US$US
243618971$24361897$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65518$$FDA-CTU$$69$YR$$F$N$$$20240925$N$HP$US$
243618981$24361898$1$I$$20240924$20240924$20240924$DIR$719691$$FDA-CTU$$$$$UNK$N$$$20240924$N$CN$US$
243618991$24361899$1$I$$20240920$20240925$20240925$EXP$$US-SA-2024SA273952$SANOFI AVENTIS$$$$$$Y$$$20240925$$MD$US$US
243619001$24361900$1$I$$20240916$20240925$20240925$EXP$$CN-TEYRO-2024-TY-000625$Teyro Labs$Liu X, Peng X, Yang S, Liu H, Zhang S, Li Y, et al..Salvage chemotherapy regimens with arsenic trioxide for relapsed or refractory neuroblastoma: a promising approach..BMC Cancer.2024;24:1140$$$$$Y$$$20240925$$HP$CN$CN
243619011$24361901$1$I$20240916$20240924$20240924$20240924$DIR$719704$$FDA-CTU$$51$YR$$F$N$73.6$KG$20240924$Y$HP$US$
243619031$24361903$1$I$$20240924$20240924$20240924$DIR$719696$$FDA-CTU$$80$YR$$F$N$$$20240924$N$PH$US$
243619041$24361904$1$I$20240923$20240924$20240924$20240924$DIR$719710$$FDA-CTU$$$$$UNK$N$$$20240924$N$CN$US$
243619061$24361906$1$I$20230101$20240917$20240925$20240925$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-128035$REGENERON$$66$YR$$F$Y$$$20240925$$HP$CO$CO
243619071$24361907$1$I$$20240916$20240925$20240925$EXP$$IT-AUROBINDO-AUR-APL-2024-004133$AUROBINDO$Suanno G, Pederzolli M, Lasagni Vitar R, Fonteyne P, Ferrari G.. Topical fosaprepitant for the treatment of ocular pain and inflammation.. American Journal of Ophthalmology Case Reports.. 2023;32:1-6$82$YR$$F$Y$$$20240925$$HP$IT$IT
243619081$24361908$1$I$$20240916$20240925$20240925$PER$$US-ABBVIE-5927061$ABBVIE$$$$$M$Y$$$20240925$$HP$US$US
243619091$24361909$1$I$20240603$20240918$20240925$20240925$EXP$$JP-AMGEN-JPNSP2024112761$AMGEN$$36$YR$A$F$Y$$$20240925$$MD$JP$JP
243619101$24361910$1$I$20240918$20240920$20240925$20240925$EXP$$NVSC2024US189141$NOVARTIS$$33$YR$$F$Y$$$20240925$$CN$US$US
243619111$24361911$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151812$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240925$$HP$US$US
243619121$24361912$1$I$$20240919$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150000$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$77.56$KG$20240925$$HP$US$US
243619132$24361913$2$F$$20240910$20240925$20240925$EXP$$CA-ROCHE-10000016279$ROCHE$$63$YR$A$F$Y$$$20240925$$HP$CA$CA
243619141$24361914$1$I$20240914$20240918$20240925$20240925$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000971$PAREXEL$$$$$$Y$$$20240925$$HP$CN$CN
243619151$24361915$1$I$20240917$20240917$20240925$20240925$PER$$US-BAYER-2024A136568$BAYER$$30$YR$A$F$Y$$$20240925$$CN$US$US
243619162$24361916$2$F$$20240927$20240925$20240930$PER$$US-BAYER-2024A135274$BAYER$$62$YR$A$F$Y$$$20240930$$CN$US$US
243619171$24361917$1$I$20240919$20240919$20240925$20240925$EXP$$US-AMGEN-USASP2024187970$AMGEN$$83$YR$E$F$Y$$$20240925$$CN$US$US
243619181$24361918$1$I$$20240910$20240925$20240925$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469485$RANBAXY$Aerts L, den Uijl DW, Luermans JGL, Maesen B. Temporary sinus node dysfunction following ablation of atrial fibrillation in patients with aberrancy of the sinus node artery: a case series. Interdiscip Cardiovasc Thorac Surg. 2024;39(1):ivae135; 1-4$59$YR$$M$Y$$$20240925$$HP$NL$NL
243619191$24361919$1$I$$20240910$20240925$20240925$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469482$RANBAXY$Aerts L, den Uijl DW, Luermans JGL, Maesen B. Temporary sinus node dysfunction following ablation of atrial fibrillation in patients with aberrancy of the sinus node artery: a case series. Interdisciplinary CardioVascular and Thoracic Surgery. 2024;39(1):ivae135; 1-4$72$YR$$M$Y$$$20240925$$HP$NL$NL
243619201$24361920$1$I$$20240910$20240925$20240925$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469475$RANBAXY$Miller CG, Brucker AJ, Perry LM, Kim BJ, Martin ME, Frey NV, et al. OUTER RETINOPATHY and MICROANGIOPATHY in ACUTE MYELOGENOUS LEUKEMIA. Retin Cases Brief Rep. 2023;17:683-689$23$YR$$F$Y$$$20240925$$MD$US$US
243619221$24361922$1$I$$20240910$20240925$20240925$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469343$RANBAXY$Porragas-Paseiro HS, Johnson S, Brubaker L, Sanders BE. Pneumocystis jirovecii pneumonia complicating methotrexate treatment in a patient with low-risk post-molar gestational trophoblastic neoplasia: A case report and review of the literature. Gynecol Oncol Rep. 2023;50 (0):101286(1-6)$35$YR$$F$Y$$$20240925$$HP$US$US
243619231$24361923$1$I$$20240910$20240925$20240925$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469480$RANBAXY$Conlon C, Li YJ, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Aliment Pharmacol Ther. 2024;60:787-795$$$$$Y$$$20240925$$HP$US$US
243619241$24361924$1$I$$20240910$20240925$20240925$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469500$RANBAXY$Ferdinande K, Declerck L, Melis C, Missiaen L, Seynhaeve L, De Vloo C, et al. CYP2D6 polymorphism may contribute to Trazodone-induced hepatotoxicity: a rare case of drug-drug-gene induced liver injury. Acta Gastroenterol Belg. 2024;87 (2):332-335$46$YR$$F$Y$$$20240925$$HP$BE$BE
243619251$24361925$1$I$$20240916$20240925$20240925$EXP$$CA-UCBSA-2024048413$UCB$$$$$F$Y$$$20240925$$MD$CA$CA
243619261$24361926$1$I$$20240910$20240925$20240925$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469465$RANBAXY$Qian Y, Zhi Z, Ai J, Kang L, Qiu G, Huang X, et al. Immune related intestinal pseudo-obstruction caused by immune checkpoint inhibitors: case report. Front Oncol. 2024;14 (0):1415117 (01-06)$64$YR$$M$Y$$$20240925$$HP$CN$CN
243619271$24361927$1$I$$20240910$20240925$20240925$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467372$RANBAXY$$12$YR$$F$Y$50$KG$20240925$$HP$GB$GB
243619291$24361929$1$I$$20240910$20240925$20240925$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-310677$RANBAXY$$$$E$F$Y$$$20240925$$HP$US$US
243619301$24361930$1$I$$20240910$20240925$20240925$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469549$RANBAXY$Wilson I, Qiu M, Itchins M, Wang B, Huang ML, Grimison P. Metastatic Non-Myofibroblastic Sarcoma Harbouring EML4-ALK Fusion-Dramatic Response to ALK Tyrosine Kinase Inhibitors and Development of Resistance Mutations. Cancer Rep. 2024;7 (8):e2164$58$YR$$M$Y$$$20240925$$HP$AU$AU
243619321$24361932$1$I$$20240910$20240925$20240925$EXP$$SD-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469559$RANBAXY$Yosif AA, Bakhiet SM, Abdalla TH, Mhmoud NA, Siddig EE, Fahal AH.. Invasive, aggressive mastoid bone eumycetoma: a treatment challenge.. Trans R Soc Trop Med Hyg. 2021;115 (4):431-435$8$YR$$M$Y$$$20240925$$HP$SD$SD
243619331$24361933$1$I$$20240910$20240925$20240925$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469705$RANBAXY$Bennett GD, Rosmalen-Brinkley K, Johnstone K, Messina G.. Two instances of successful oral desensitisation following hypersensitivity reaction in a patient receiving osimertinib: a case report. Journal of Pharmacy Practice and Research. 2024;54 (4):328-332$70$YR$$F$Y$$$20240925$$HP$AU$AU
243619341$24361934$1$I$$20240917$20240925$20240925$PER$$US-ASTELLAS-2024-AER-007635$ASTELLAS$$7$DEC$E$F$Y$$$20240925$$MD$US$US
243619351$24361935$1$I$$20240910$20240925$20240925$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469761$RANBAXY$$85$YR$$F$Y$$$20240925$$CN$GB$GB
243619381$24361938$1$I$$20240910$20240925$20240925$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469440$RANBAXY$Malyshev SM, Popov KD, Simakov KV, Marichev AO, Topuzova MP, Smirnova AY, et al. Status epilepticus in a pregnant patient with a previously unrecognized POLG-associated disease. Zh Nevropatol Psikhiatr Im S S Korsakova. 2023;123:129-135$$$$F$Y$$$20240925$$HP$RU$RU
243619391$24361939$1$I$$20240910$20240925$20240925$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469884$RANBAXY$Thompson G, Bundell C, Lucas M. Paracetamol allergy in clinical practice. AJGP. 2019;48 (4):216-219$19$YR$$F$Y$$$20240925$$HP$AU$AU
243619401$24361940$1$I$$20240910$20240925$20240925$EXP$$LB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-468470$RANBAXY$Achkar Z, Fakhoury R, Zein Deen O, Shayya A. CT-613 Tirofiban-Induced Profound Thrombocytopenia. Clin Lymphoma Myeloma Leuk. 2024;24$57$YR$$M$Y$$$20240925$$HP$LB$LB
243619411$24361941$1$I$$20240910$20240925$20240925$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468725$RANBAXY$Tanashyan MM, Antonova KV, Lagoda OV, Raskurazhev A A, Panina AA. Cerebrometabolic Cognitive Dysfunction: Approaches to Multitarget Therapy. Current issues of neurology. 2023;15 (1):18-27$62$YR$$F$Y$$$20240925$$HP$RU$RU
243619421$24361942$1$I$$20240910$20240925$20240925$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469486$RANBAXY$Djerbi N, Zimmermann K, Roncador M, Becker MO, Manz MG, Balabanov S. Intrapatient competition of VEXAS syndrome and CML clones. Blood Adv. 2023;Nov 28;7(22):6815-6818$48$YR$$M$Y$$$20240925$$HP$CH$CH
243619431$24361943$1$I$$20240910$20240925$20240925$EXP$$RU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466432$RANBAXY$Tanashyan MM, Antonova KV, Lagoda OV, Raskurazhev A A, Panina AA. Cerebrometabolic Cognitive Dysfunction: Approaches to Multitarget Therapy. Current issues of neurology. 2023;15 (1):18-27$67$YR$$$Y$$$20240925$$HP$RU$RU
243619441$24361944$1$I$20240402$20240910$20240925$20240925$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469059$RANBAXY$$49$YR$$F$Y$$$20240925$$MD$ES$ES
243619461$24361946$1$I$$20240910$20240925$20240925$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469580$RANBAXY$$36$YR$$$Y$$$20240925$$PH$GB$GB
243619471$24361947$1$I$$20240910$20240925$20240925$EXP$$PH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468531$RANBAXY$Legaspi LAE, Ondinee-Igot M, Fernando G. Rare metastatic primary intra-abdominal follicular dendritic cell sarcoma poorly responsive to chemotherapy: A case report. Phil J Intern Med. 2024;Jan-Mar;62 (1):308-313$33$YR$$F$Y$$$20240925$$HP$PH$PH
243619481$24361948$1$I$$20240910$20240925$20240925$EXP$$SA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469718$RANBAXY$Alzamil AA, Alhajress RI, Bakri E. Isolated nasal and periocular necrotizing fasciitis caused by Klebsiella pneumoniae: Case report. Otolaryngol Case Rep. 2024;30:no info$79$YR$$M$Y$$$20240925$$HP$SA$SA
243619491$24361949$1$I$20240916$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65520$$FDA-CTU$$52$YR$$M$N$$$20240924$N$HP$US$
243619511$24361951$1$I$$20240910$20240925$20240925$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469391$RANBAXY$Liu Y, Li Y, Yu Z, Wang R and Jing Y. Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: a case report and literature review. Front Oncol. 2024;14:1341682 (1-9)$23$YR$$F$Y$$$20240925$$HP$CN$CN
243619521$24361952$1$I$$20240910$20240925$20240925$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469448$RANBAXY$Suanno G, Pederzolli M, Lasagni Vitar RM, Fonteyne P, Ferrari G. Topical fosaprepitant for the treatment of ocular pain and inflammation. Am J Ophthalmol Case Rep. 2023;32:101964$82$YR$$F$Y$$$20240925$$HP$IT$IT
243619531$24361953$1$I$$20240910$20240925$20240925$EXP$$TW-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469264$RANBAXY$Hsu YT and Chen CH. Progression of fertility-sparing treatment for atypical endometrial hyperplasia in a woman with lynch syndrome: a case report and review of the literature. Front Oncol. 2024;14 (0):1422006 (1-7)$39$YR$$F$Y$$$20240925$$HP$TW$TW
243619541$24361954$1$I$$20240910$20240925$20240925$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468078$RANBAXY$$$$$M$Y$$$20240925$$CN$IN$IN
243619551$24361955$1$I$20240916$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65517$$FDA-CTU$$52$YR$$M$N$$$20240924$N$HP$US$
243619561$24361956$1$I$20240902$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65519$$FDA-CTU$$70$YR$$F$N$$$20240924$N$HP$US$
243619571$24361957$1$I$20210302$20240910$20240925$20240925$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469747$RANBAXY$$68$YR$$M$Y$$$20240925$$MD$GB$GB
243619581$24361958$1$I$$20240910$20240925$20240925$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469714$RANBAXY$Kruszelnicka M, Kulus K, Machnicka B, Kasprzak M. Dietary support in hyperhomocysteinemia. Acta Angiol. 2024;30 (2):92-96$8$DEC$$M$Y$$$20240925$$HP$PL$PL
243619591$24361959$1$I$$20240910$20240925$20240925$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469499$RANBAXY$Li Q, Guan W, Zhang J, Chen M, Zou Y. Anti-Infection of Nasopharyngeal Carcinoma Combined with Non-Tuberculous Mycobacteria : A Case Report and Literature Review. Infect Drug Resist. 2024;17 (0):3527-3535$58$YR$$M$Y$$$20240925$$HP$CN$CN
243619601$24361960$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65521$$FDA-CTU$$54$YR$$F$N$$$20240925$N$HP$US$
243619611$24361961$1$I$$20240919$20240925$20240925$EXP$$KR-009507513-2409KOR008074$MERCK$$$$$M$Y$$$20240925$$HP$KR$KR
243619621$24361962$1$I$$20240910$20240925$20240925$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469752$RANBAXY$$72$YR$$M$Y$77$KG$20240925$$PH$GB$GB
243619631$24361963$1$I$$20240910$20240925$20240925$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469456$RANBAXY$Macit B, Arora A, Reginato AM, Qureshi AA. Cerebral toxoplasmosis in a patient with systemic sclerosis under thalidomide treatment: A case report. JAAD Case Rep. 2024;51:100-103$49$YR$$F$Y$$$20240925$$MD$US$US
243619641$24361964$1$I$20240501$20240920$20240925$20240925$EXP$FR-AFSSAPS-NT2024001162$FR-JNJFOC-20240964041$JOHNSON AND JOHNSON$$75$YR$E$M$Y$66$KG$20240925$$MD$FR$FR
243619651$24361965$1$I$$20240922$20240925$20240925$PER$$US-BAYER-2024A135727$BAYER$$$$$F$Y$$$20240925$$CN$US$US
243619661$24361966$1$I$$20240919$20240925$20240925$EXP$$US-TAKEDA-2024TUS094441$TAKEDA$$30$YR$$F$Y$$$20240925$$CN$US$US
243619671$24361967$1$I$20240916$20240918$20240925$20240925$EXP$$NVSC2024DE188597$NOVARTIS$$$$$M$Y$$$20240925$$MD$DE$DE
243619681$24361968$1$I$20070101$20240919$20240925$20240925$EXP$$US-ORGANON-O2409USA001511$ORGANON$$$$$M$Y$$$20240925$$CN$US$US
243619691$24361969$1$I$20240919$20240924$20240924$20240924$DIR$719770$$FDA-CTU$$75$YR$$F$N$58.5$KG$20240924$N$CN$US$
243619701$24361970$1$I$20240923$20240924$20240924$20240924$DIR$719782$$FDA-CTU$$$$$UNK$N$$$20240924$$CN$US$
243619711$24361971$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65522$$FDA-CTU$$60$YR$$F$N$$$20240925$N$$US$
243619721$24361972$1$I$20240917$20240924$20240924$20240924$DIR$719778$$FDA-CTU$$71$YR$$M$N$107$KG$20240924$N$HP$US$
243619731$24361973$1$I$$20240923$20240925$20240925$DIR$FDA-CDER-CTU-2024-65523$$FDA-CTU$$$$$M$N$$$20240923$N$HP$US$
243619741$24361974$1$I$20240813$20240919$20240925$20240925$EXP$FR-AFSSAPS-TO2024001713$FR-MYLANLABS-2024M1085611$MYLAN$$92$YR$$F$Y$70$KG$20240925$$MD$FR$FR
243619751$24361975$1$I$20240827$20240919$20240925$20240925$EXP$FR-AFSSAPS-AVCF2024000588$FR-MYLANLABS-2024M1085625$MYLAN$$41$YR$$F$Y$$$20240925$$HP$FR$FR
243619761$24361976$1$I$$20240919$20240925$20240925$EXP$$GB-MYLANLABS-2024M1085690$MYLAN$$39$YR$$M$Y$$$20240925$$CN$GB$GB
243619771$24361977$1$I$20230905$20240919$20240925$20240925$EXP$FR-AFSSAPS-MP2024001389$FR-MYLANLABS-2024M1085522$MYLAN$$38$YR$$M$Y$72$KG$20240925$$PH$FR$FR
243619781$24361978$1$I$$20240916$20240925$20240925$EXP$$FR-TEVA-VS-3245977$TEVA$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$50$YR$$M$Y$$$20240925$$HP$FR$FR
243619791$24361979$1$I$$20240913$20240925$20240925$PER$$US-JNJFOC-20240937308$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$CN$US$US
243619801$24361980$1$I$20240909$20240910$20240925$20240925$30DAY$$GB-BECTON DICKINSON-GB-BD-24-000554$BECTON DICKINSON$$$$$$Y$$$20240925$$CN$GB$GB
243619811$24361981$1$I$20240801$20240916$20240925$20240925$EXP$$BR-JNJFOC-20240947358$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240925$$CN$BR$BR
243619821$24361982$1$I$$20240922$20240925$20240925$PER$$US-BAYER-2024A135941$BAYER$$$$$F$Y$$$20240925$$CN$US$US
243619831$24361983$1$I$$20240919$20240925$20240925$PER$$US-TAKEDA-2024TUS093729$TAKEDA$$$$$M$Y$61$KG$20240925$$MD$US$US
243619841$24361984$1$I$20240922$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024189418$AMGEN$$69$YR$E$M$Y$$$20240925$$CN$US$US
243619851$24361985$1$I$20240101$20240921$20240925$20240925$PER$$US-AMGEN-USASP2024189541$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243619872$24361987$2$F$20240922$20240927$20240925$20240930$EXP$$US-GILEAD-2024-0688723$GILEAD$$78$YR$E$F$Y$$$20240930$$CN$US$US
243619881$24361988$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014871$ELI LILLY AND CO$$$$$F$Y$$$20240925$$PH$US$US
243619891$24361989$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014448$ELI LILLY AND CO$$29$YR$A$$Y$$$20240925$$CN$US$US
243619901$24361990$1$I$$20240919$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149911$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240925$$CN$US$US
243619911$24361991$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014687$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240925$$CN$US$US
243619921$24361992$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151504$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240925$$CN$US$US
243619931$24361993$1$I$20240907$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150650$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$67.6$KG$20240925$$PH$US$US
243619941$24361994$1$I$$20240923$20240925$20240925$PER$$ZA-REGENERON PHARMACEUTICALS, INC.-2024-127677$REGENERON$$$$$M$Y$$$20240925$$MD$ZA$ZA
243619951$24361995$1$I$$20240924$20240925$20240925$EXP$$GB-SANDOZ INC.-SDZ2024GB007693$SANDOZ$$$$$M$Y$$$20240925$$CN$GB$GB
243619961$24361996$1$I$20240918$20240923$20240925$20240925$PER$$US-BAYER-2024A135493$BAYER$$40$YR$A$F$Y$$$20240925$$MD$US$US
243619971$24361997$1$I$$20240919$20240925$20240925$PER$$US-TAKEDA-2024TUS094236$TAKEDA$$$$$$Y$$$20240925$$CN$US$US
243619981$24361998$1$I$20211201$20240917$20240925$20240925$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-149704$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240925$$MD$DE$DE
243619991$24361999$1$I$$20240917$20240925$20240925$PER$$US-ASTELLAS-2024-AER-007890$ASTELLAS$$$$E$M$Y$$$20240925$$MD$US$US
243620011$24362001$1$I$$20240912$20240925$20240925$EXP$$IL-REGENERON PHARMACEUTICALS, INC.-2024-128250$REGENERON$$$$$F$Y$$$20240925$$MD$IL$IL
243620021$24362002$1$I$20240506$20240911$20240925$20240925$EXP$GB-MHRA-MED-202408072019074410-NTCRP$GB-AMGEN-GBRSP2024189032$AMGEN$$68$YR$E$F$Y$51$KG$20240925$$MD$GB$GB
243620041$24362004$1$I$$20240918$20240925$20240925$EXP$$NVSC2024TW188242$NOVARTIS$Su Y, Liu W, Lin C, Chien H, Yang K. Bisphosphonate-related osteonecrosis of the jaw: Is the medication duration related to advanced disease stage?. FORMOSAN JOURNAL OF SURGERY. 2024;57(4):151-6$59$YR$$F$Y$$$20240925$$HP$TW$TW
243620051$24362005$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65527$$FDA-CTU$$82$YR$$F$N$$$20240925$N$HP$US$
243620061$24362006$1$I$$20240918$20240925$20240925$EXP$$NVSC2024VN187021$NOVARTIS$Dang Nguyen TB, Huynh MV. Ghep te bao goc dong loai lan hai trong dieu tr? cac truong hop thai ghep/tai phat t?i benh vien tmhh tp.hcm [The second allogeneic hematopoietic stem cell transplantation in treatment of relapse/rejection cases at blood transfusion hematology hospital, ho chi minh city]. VIETNAM MEDICAL JOURNAL. 2022;520:51-7$10$YR$$F$Y$$$20240925$$HP$VN$VN
243620071$24362007$1$I$20240910$20240924$20240925$20240925$PER$$US-BAYER-2024A136609$BAYER$$43$YR$A$F$Y$$$20240925$$MD$US$US
243620081$24362008$1$I$$20240916$20240925$20240925$EXP$$US-TEVA-VS-3246121$TEVA$Wang M, Reynolds KL, Montazeri K, Schaefer EA, Sullivan RJ, Dougan M. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clin-Gastroenterol-Hepatol 2024; 22 (7): 1539-1541.e2.; Wang M, Reynolds KL, Montazeri K, Schaefer EA, Sullivan RJ, Dougan M. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clin-Gastroenterol-Hepatol 2024; 22 (7): 1539-1541.e2.$63$YR$$M$Y$$$20240925$$HP$US$US
243620091$24362009$1$I$$20240809$20240925$20240925$EXP$$DE-DSJP-DSJ-2024-144871$DAIICHI$$$$$F$Y$$$20240925$$MD$DE$DE
243620101$24362010$1$I$$20240917$20240925$20240925$EXP$$NZ-JNJFOC-20240957485$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$MD$NZ$NZ
243620111$24362011$1$I$20240801$20240917$20240925$20240925$EXP$$DE-ABBVIE-5929064$ABBVIE$$52$YR$$M$Y$$$20240925$$CN$DE$DE
243620121$24362012$1$I$$20240923$20240925$20240925$EXP$$US-GILEAD-2024-0688675$GILEAD$$$$A$$Y$$$20240925$$HP$US$US
243620131$24362013$1$I$$20240915$20240925$20240925$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-029212$UNITED THERAPEUTICS$Kato J, Yamada S, Takise Y, Sekiya Y, Masuda Y, Misonoo Y, et al.. Neuraxial anesthesia for patients with severe pulmonary arterial hypertension undergoing urgent open abdominal surgeries: two case reports. JA Clin Rep. 2024;10:52:1-6$25$YR$$F$Y$42$KG$20240925$$$JP$JP
243620142$24362014$2$F$20240101$20240920$20240925$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-028469$UNITED THERAPEUTICS$$$$$M$Y$74.83$KG$20240928$$$US$US
243620151$24362015$1$I$$20240923$20240925$20240925$EXP$$CA-PFIZER INC-202400261930$PFIZER$$46$YR$$F$Y$$$20240925$$HP$CA$CA
243620161$24362016$1$I$$20240915$20240925$20240925$PER$$US-ABBVIE-5926945$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243620171$24362017$1$I$$20240906$20240925$20240925$PER$$US-TEVA-VS-3242273$TEVA$$54$YR$$F$Y$$$20240925$$CN$US$US
243620181$24362018$1$I$20220101$20240918$20240925$20240925$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-128103$REGENERON$$62$YR$$M$Y$$$20240925$$HP$CO$CO
243620191$24362019$1$I$20240923$20240924$20240925$20240925$PER$$US-BAYER-2024A136741$BAYER$$44$YR$A$F$Y$$$20240925$$HP$US$US
243620201$24362020$1$I$$20240920$20240925$20240925$EXP$$US-RDY-SPO/USA/24/0013936$DR REDDYS$$23$YR$A$M$Y$$$20240925$$CN$US$US
243620211$24362021$1$I$$20240916$20240925$20240925$EXP$$FR-TEVA-VS-3245742$TEVA$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$49$YR$$M$Y$$$20240925$$HP$FR$FR
243620221$24362022$1$I$20240728$20240911$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09207$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243620231$24362023$1$I$20240702$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65528$$FDA-CTU$$66$YR$$F$N$$$20240924$N$HP$US$
243620241$24362024$1$I$20240101$20240920$20240925$20240925$PER$$US-JNJFOC-20240960018$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243620261$24362026$1$I$$20240924$20240925$20240925$PER$$US-BAYER-2024A136770$BAYER$$$$$F$Y$$$20240925$$HP$US$US
243620271$24362027$1$I$20240101$20240919$20240925$20240925$EXP$$CA-ABBVIE-5933124$ABBVIE$$51$YR$$F$Y$$$20240925$$CN$CA$CA
243620291$24362029$1$I$20240501$20240918$20240925$20240925$EXP$$CN-ASTELLAS-2024-AER-007547$ASTELLAS$$82$YR$E$F$Y$$$20240925$$CN$CN$CN
243620301$24362030$1$I$$20240924$20240925$20240925$PER$$US-BAYER-2024A136783$BAYER$$$$$F$Y$$$20240925$$CN$US$US
243620311$24362031$1$I$$20240920$20240925$20240925$EXP$$IT-AMGEN-ITASP2024188630$AMGEN$$$$E$F$Y$$$20240925$$MD$IT$IT
243620321$24362032$1$I$$20240918$20240925$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-029933$UNITED THERAPEUTICS$$$$$F$Y$53.515$KG$20240925$$$US$US
243620331$24362033$1$I$$20240918$20240925$20240925$PER$$US-UNITED THERAPEUTICS-UNT-2024-029777$UNITED THERAPEUTICS$$$$$M$Y$62.585$KG$20240925$$$US$US
243620341$24362034$1$I$20240425$20240918$20240925$20240925$EXP$$US-KYOWAKIRIN-2024KK021712$KYOWA$$$$$$Y$$$20240925$$PH$US$US
243620351$24362035$1$I$20240922$20240924$20240924$20240924$DIR$719767$$FDA-CTU$$45$YR$$F$N$65.7$KG$20240924$N$CN$US$
243620361$24362036$1$I$$20240924$20240924$20240924$DIR$719746$$FDA-CTU$$$$$UNK$N$$$20240924$$CN$US$
243620371$24362037$1$I$$20240916$20240925$20240925$EXP$$FR-TEVA-VS-3245761$TEVA$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$25$YR$$M$Y$$$20240925$$HP$FR$FR
243620381$24362038$1$I$20240820$20240924$20240925$20240925$PER$$US-BAYER-2024A136784$BAYER$$30$YR$A$F$Y$$$20240925$$MD$US$US
243620391$24362039$1$I$20240916$20240924$20240924$20240924$DIR$719713$$FDA-CTU$$81$YR$$M$N$83.25$KG$20240924$Y$HP$US$
243620401$24362040$1$I$20231228$20240919$20240925$20240925$EXP$$CN-ALCON LABORATORIES-ALC2024CN004336$ALCON$$61$YR$$F$Y$$$20240925$$HP$CN$CN
243620411$24362041$1$I$$20240910$20240925$20240925$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469131$RANBAXY$Acharya P, Nyamagoud SB, Netalakar A, Umarani TJ, Hiremath N, Dayana BM, et al. Autoimmune Unraveling: Phenobarbital-Associated Pemphigus Vulgaris Case Report. J Young Pharm. 2024;Jul-Sep;16(3):597-600$22$YR$$F$Y$56$KG$20240925$$HP$IN$IN
243620421$24362042$1$I$$20240921$20240925$20240925$PER$$US-HALEON-2198136$Haleon PLC$$$$$$Y$$$20240925$$CN$US$US
243620431$24362043$1$I$$20240924$20240925$20240925$EXP$$TR-GILEAD-2024-0688734$GILEAD$$$$$F$Y$$$20240925$$MD$TR$TR
243620441$24362044$1$I$$20240923$20240925$20240925$EXP$$US-UCBSA-2024048889$UCB$Cherabuddi M, Aljbour Almajali D, Chao S, Cohen A. Can Methotrexate Toxicity Occur Despite A Low-Dose Regimen And Normal Therapeutic Levels?. Chest. 2024;166(4):A2779-80$$$E$M$Y$$$20240925$$HP$US$US
243620472$24362047$2$F$$20240919$20240925$20240926$EXP$$SG-REGENERON PHARMACEUTICALS, INC.-2024-127313$REGENERON$$$$$M$Y$$$20240926$$MD$SG$SG
243620481$24362048$1$I$$20240924$20240925$20240925$PER$$US-BAYER-2024A136793$BAYER$$$$$F$Y$$$20240925$$HP$US$US
243620491$24362049$1$I$20221111$20240924$20240925$20240925$EXP$DE-CADRBFARM-2024330564$DE-SANDOZ INC.-SDZ2024DE082605$SANDOZ$$49$YR$$F$Y$53$KG$20240925$$CN$DE$DE
243620501$24362050$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189930$AMGEN$$$$$F$Y$$$20240925$$HP$US$US
243620522$24362052$2$F$$20240924$20240925$20240930$PER$$US-AGIOS-2409US03890$AGIOS PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243620531$24362053$1$I$20240919$20240919$20240925$20240925$EXP$GB-MHRA-TPP55220572C9802744YC1726732613565$GB-RDY-SPO/GBR/24/0013974$DR REDDYS$$57$YR$A$F$Y$70$KG$20240925$$PH$GB$GB
243620561$24362056$1$I$$20240919$20240925$20240925$EXP$GB-MHRA-MED-202409191035255390-MZQTK$GB-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2409GB07244$INSUD PHARMA$$46$YR$$F$Y$$$20240925$$CN$GB$GB
243620571$24362057$1$I$$20240923$20240925$20240925$EXP$$US-BAYER-2024A135646$BAYER$$$$$$Y$$$20240925$$CN$US$US
243620581$24362058$1$I$20240905$20240914$20240925$20240925$PER$$US-009507513-2409USA008428$MERCK$$$$A$F$Y$$$20240925$$MD$US$US
243620591$24362059$1$I$20240829$20240917$20240925$20240925$EXP$FR-AFSSAPS-LY2024001394$FR-TEVA-VS-3244508$TEVA$$$$$M$Y$3.6$KG$20240925$$MD$FR$FR
243620601$24362060$1$I$$20240918$20240925$20240925$EXP$GB-MHRA-MED-202409181355589180-TBDKM$GB-LABORATORIOS LICONSA S.A.-2409GB07238$INSUD PHARMA$$70$YR$$M$Y$79$KG$20240925$$CN$GB$GB
243620611$24362061$1$I$20221004$20240918$20240925$20240925$EXP$FR-AFSSAPS-PC2024000700$FR-009507513-2409FRA006360$MERCK$$58$YR$$F$Y$47$KG$20240925$$PH$FR$FR
243620621$24362062$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014289$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240925$$CN$US$US
243620631$24362063$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013608$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240925$$CN$US$US
243620641$24362064$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014695$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240925$$HP$US$US
243620651$24362065$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015313$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243620661$24362066$1$I$20240915$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015509$ELI LILLY AND CO$$58$YR$A$M$Y$$$20240925$$CN$US$US
243620671$24362067$1$I$20240917$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013789$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240925$$CN$US$US
243620682$24362068$2$F$$20240927$20240925$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015518$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240930$$CN$US$US
243620691$24362069$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014675$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240925$$CN$US$US
243620701$24362070$1$I$$20240918$20240925$20240925$EXP$$NVSC2024TW188248$NOVARTIS$Su Y, Liu W, Lin C, Chien H, Yang K. Bisphosphonate-related osteonecrosis of the jaw: Is the medication duration related to advanced disease stage?. FORMOSAN JOURNAL OF SURGERY. 2024;57(4):151-6$40$YR$$M$Y$$$20240925$$HP$TW$TW
243620711$24362071$1$I$$20240923$20240925$20240925$EXP$$NVSC2024US189656$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
243620721$24362072$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151739$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$MD$US$US
243620731$24362073$1$I$20240101$20240919$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150033$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$92.53$KG$20240925$$PH$US$US
243620741$24362074$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152141$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240925$$CN$US$US
243620752$24362075$2$F$$20240917$20240925$20240926$EXP$$NVSC2024CA189054$NOVARTIS$D^Souza R, Soete E, Silversides CK, Zaffar N, Van Mieghem T, Van Cleemput J, et al. Pregnancy Outcomes Following Cardiac Transplantation. J OBSTET GYNAECOL CAN. 2018;40(5):566-71$$$$F$Y$$$20240926$$HP$CA$CA
243620761$24362076$1$I$20240916$20240924$20240924$20240924$DIR$719772$$FDA-CTU$$79$YR$$F$N$54.45$KG$20240924$N$CN$US$
243620801$24362080$1$I$$20240916$20240925$20240925$EXP$$FR-TEVA-VS-3245978$TEVA$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$41$YR$$M$Y$$$20240925$$HP$FR$FR
243620811$24362081$1$I$$20240920$20240925$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA082403$SANDOZ$$$$$F$Y$$$20240925$$MD$CA$CA
243620821$24362082$1$I$$20240911$20240925$20240925$EXP$$US-Innogenix, LLC-2162034$INNOGENIX$Full text$26$YR$$M$Y$$$20240925$$$US$US
243620831$24362083$1$I$$20240919$20240925$20240925$PER$$US-MYLANLABS-2024M1085977$MYLAN$$$$$M$Y$$$20240925$$CN$US$US
243620842$24362084$2$F$$20240920$20240925$20240930$EXP$$FR-MYLANLABS-2024M1086480$MYLAN$Ghanem R, Glaisner S, Bobin A, Ronchetti A-M, Cereja S, Joly B, et al. Posterior reversible encephalopathy syndrome (PRES) and myeloma. Leukemia-Research-Reports 2024; 21.$53$YR$$F$Y$$$20240930$$HP$FR$FR
243620851$24362085$1$I$$20240916$20240925$20240925$EXP$$US-MYLANLABS-2024M1085694$MYLAN$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann-Rheum-Dis 2022; 81 (2): 289-291.$$$A$$Y$$$20240925$$MD$US$US
243620861$24362086$1$I$$20240920$20240925$20240925$EXP$$NVSC2024DE190155$NOVARTIS$$$$A$F$Y$$$20240925$$HP$DE$DE
243620871$24362087$1$I$$20240923$20240925$20240925$EXP$$NVSC2024CA189744$NOVARTIS$$$$$F$Y$$$20240925$$MD$CA$CA
243620881$24362088$1$I$$20240916$20240925$20240925$EXP$$CA-LUNDBECK-DKLU4004397$LUNDBECK$$$$$$Y$$$20240925$$CN$CA$CA
243620891$24362089$1$I$20161101$20240916$20240925$20240925$EXP$$US-MYLANLABS-2024M1084389$MYLAN$$64$YR$$M$Y$87.08$KG$20240925$$LW$US$US
243620901$24362090$1$I$$20240910$20240925$20240925$EXP$$BG-MELINTA THERAPEUTICS, LLC-BG-MLNT-24-00448$Unknown Manufacturer$Kordeva S, Ivanov L, Alexandrov A, Simon AC. Henry CS. Joseph JM. et al.. Keratinocyte cancers, dysplastic nevi and cutaneous melanoma development after intake of potentially nitrosamine/NDSRIs contaminated drugs: new data. Important links to photo-(nitroso-) carcinogenesis and pharmacooncogenesis. Medical Review. 2024;60(5):62-72$$$$$Y$$$20240925$$MD$BG$BG
243620911$24362091$1$I$$20240917$20240925$20240925$EXP$$US-MYLANLABS-2024M1086165$MYLAN$Patel S, Sivananthan M. Hypersensitivity to Psychotropic Medications in a Patient With 17q12 Microdeletion Syndrome: A Case Report. J-Clin-Psychopharmacol 2024; 44 69-71.$29$YR$$M$Y$$$20240925$$MD$US$US
243620921$24362092$1$I$$20240916$20240925$20240925$EXP$$US-RDY-SPO/USA/23/0177068$DR REDDYS$$63$YR$A$M$Y$$$20240925$$MD$US$US
243620931$24362093$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189692$AMGEN$$$$$F$Y$$$20240925$$MD$US$US
243620961$24362096$1$I$20240813$20240916$20240925$20240925$EXP$FR-AFSSAPS-MP2024001369$FR-PFM-2024-05084$PIERRE FABRE MEDICAMENT$$17$YR$$F$Y$$$20240923$$MD$FR$FR
243620971$24362097$1$I$20170419$20240918$20240925$20240925$EXP$FR-AFSSAPS-RN20171105$FR-PFM-2024-05111$PIERRE FABRE MEDICAMENT$$52$YR$$F$Y$$$20240925$$$FR$FR
243620981$24362098$1$I$20240901$20240913$20240925$20240925$EXP$$US-TORRENT-00013751$TORRENT$$38$YR$A$F$Y$108$KG$20240925$$HP$US$US
243620991$24362099$1$I$$20240915$20240925$20240925$EXP$$AU-TORRENT-00000562$TORRENT$$$$$F$Y$$$20240925$$CN$AU$AU
243621001$24362100$1$I$20231101$20240918$20240925$20240925$EXP$SE-SEMPA-2024-006695$SE-PFM-2024-05059$PIERRE FABRE MEDICAMENT$$81$YR$$F$Y$$$20240923$$MD$SE$SE
243621011$24362101$1$I$20240101$20240918$20240925$20240925$EXP$NO-NOMAADVRE-PASRAPP-2024-Vbgmgz$NO-PFM-2024-05060$PIERRE FABRE MEDICAMENT$$33$YR$$F$Y$$$20240923$$$NO$NO
243621021$24362102$1$I$$20240920$20240925$20240925$PER$$US-ABBVIE-5936235$ABBVIE$$$$$$Y$$$20240925$$CN$US$US
243621031$24362103$1$I$20240101$20240907$20240925$20240925$EXP$$US-SA-2024SA275219$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240925$$CN$US$US
243621041$24362104$1$I$$20240916$20240925$20240925$EXP$$FR-TEVA-VS-3245979$TEVA$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$31$YR$$M$Y$$$20240925$$HP$FR$FR
243621061$24362106$1$I$20240725$20240905$20240925$20240925$EXP$$US-SA-2024SA275439$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240925$$MD$US$US
243621071$24362107$1$I$20240101$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3246848$TEVA$$$$$F$Y$$$20240925$$CN$CA$CA
243621081$24362108$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190574$NOVARTIS$$$$$$Y$$$20240925$$HP$US$US
243621091$24362109$1$I$$20240918$20240925$20240925$EXP$$NVSC2024TW188253$NOVARTIS$Su Y, Liu W, Lin C, Chien H, Yang K. Bisphosphonate-related osteonecrosis of the jaw: Is the medication duration related to advanced disease stage?. FORMOSAN JOURNAL OF SURGERY. 2024;57(4):151-6$83$YR$$F$Y$$$20240925$$HP$TW$TW
243621101$24362110$1$I$$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190742$AMGEN$$$$$M$Y$$$20240925$$CN$US$US
243621111$24362111$1$I$20160101$20240918$20240925$20240925$EXP$$BR-AMGEN-BRASP2024187925$AMGEN$$69$YR$E$F$Y$$$20240925$$CN$BR$BR
243621121$24362112$1$I$$20240917$20240925$20240925$EXP$$GB-Alcon Laboratories-ALC2024GB004342$ALCON$$7$DEC$$M$Y$$$20240925$$CN$COUNTRY NOT SPECIFIED$GB
243621151$24362115$1$I$20240924$20240924$20240924$20240924$DIR$719780$$FDA-CTU$$45$YR$$F$N$74.25$KG$20240924$N$CN$US$
243621201$24362120$1$I$$20240829$20240925$20240925$EXP$$DE-LUNDBECK-DKLU4004547$LUNDBECK$$$$$$Y$$$20240925$$PH$DE$DE
243621211$24362121$1$I$$20240918$20240925$20240925$EXP$$NVSC2024TW188236$NOVARTIS$Su Y, Liu W, Lin C, Chien H, Yang K. Bisphosphonate-related osteonecrosis of the jaw: Is the medication duration related to advanced disease stage?. FORMOSAN JOURNAL OF SURGERY. 2024;57(4):151-6$58$YR$$F$Y$$$20240925$$HP$TW$TW
243621231$24362123$1$I$$20240919$20240925$20240925$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-19095$IPSEN$$$$$F$Y$90$KG$20240925$$CN$US$US
243621241$24362124$1$I$20240828$20240919$20240925$20240925$EXP$$GB-TEVA-VS-3246276$TEVA$$51$YR$$M$Y$80$KG$20240925$$HP$GB$GB
243621251$24362125$1$I$20240914$20240924$20240925$20240925$EXP$$CN-BAYER-2024A136847$BAYER$$74$YR$E$F$Y$65$KG$20240925$$HP$CN$CN
243621261$24362126$1$I$20240919$20240919$20240925$20240925$EXP$$GB-TEVA-VS-3246291$TEVA$$56$YR$$F$Y$124$KG$20240925$$MD$GB$GB
243621271$24362127$1$I$20240909$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150714$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$95.25$KG$20240925$$PH$US$US
243621281$24362128$1$I$$20240916$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147019$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240925$$MD$US$US
243621291$24362129$1$I$20160101$20240909$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151591$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$78.02$KG$20240925$$CN$US$US
243621301$24362130$1$I$$20240919$20240925$20240925$EXP$$GB-TEVA-VS-3246330$TEVA$$64$YR$$M$Y$$$20240925$$CN$GB$GB
243621311$24362131$1$I$20240827$20240827$20240925$20240925$PER$$US-Eisai-EC-2024-173362$EISAI$$$$$$Y$$$20240925$$HP$US$US
243621321$24362132$1$I$20240828$20240828$20240925$20240925$PER$$US-Eisai-EC-2024-173364$EISAI$$76$YR$E$M$Y$66$KG$20240925$$CN$US$US
243621331$24362133$1$I$20240820$20240827$20240925$20240925$PER$$US-Eisai-EC-2024-173728$EISAI$$76$YR$E$F$Y$$$20240925$$CN$US$US
243621341$24362134$1$I$$20240918$20240925$20240925$EXP$$HR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051986$BOEHRINGER INGELHEIM$$62$YR$A$M$Y$$$20240925$$MD$HR$HR
243621351$24362135$1$I$$20240916$20240925$20240925$EXP$$DE-TEVA-VS-3237762$TEVA$$86$YR$$M$Y$$$20240925$$CN$DE$DE
243621381$24362138$1$I$$20240923$20240925$20240925$PER$$US-ABBVIE-5935769$ABBVIE$$$$$$Y$$$20240925$$CN$US$US
243621391$24362139$1$I$$20240808$20240925$20240925$PER$$US-LUNDBECK-DKLU4002857$LUNDBECK$$$$$$Y$$$20240925$$CN$US$US
243621401$24362140$1$I$20240714$20240924$20240924$20240924$DIR$719777$$FDA-CTU$$67$YR$$F$N$67.5$KG$20240924$N$CN$US$
243621411$24362141$1$I$$20240917$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148960$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240925$$CN$US$US
243621421$24362142$1$I$20240825$20240923$20240925$20240925$EXP$FI-FIMEA-202403460$FI-BRISTOL-MYERS SQUIBB COMPANY-2024-150901$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240925$$MD$FI$FI
243621431$24362143$1$I$20240807$20240808$20240925$20240925$PER$$US-LUNDBECK-DKLU4002851$LUNDBECK$$$$$$Y$$$20240925$$CN$US$US
243621441$24362144$1$I$$20240923$20240925$20240925$EXP$$CA-JNJFOC-20240965162$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240925$$PH$CA$CA
243621451$24362145$1$I$20231201$20240920$20240925$20240925$EXP$$US-ABBVIE-5933309$ABBVIE$$65$YR$$F$Y$54$KG$20240925$$CN$US$US
243621461$24362146$1$I$20231218$20231221$20240925$20240925$EXP$$KR-JNJFOC-20240963215$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20240925$$MD$KR$KR
243621481$24362148$1$I$20240910$20240924$20240924$20240924$DIR$719774$$FDA-CTU$$46$YR$$F$N$120.6$KG$20240924$N$CN$US$
243621491$24362149$1$I$20240924$20240924$20240924$20240924$DIR$719745$$FDA-CTU$$42$YR$$M$N$85$KG$20240924$N$PH$US$
243621501$24362150$1$I$$20240916$20240925$20240925$EXP$$US-APOTEX-2024AP011135$APOTEX$D^Annibale D, Lewiecki EM, Ekanayake P. Bone health ECHO case report: Orbital inflammation after zoledronate infusion. Journal of Clinical Densitometry. 2024;27(4): 101519:1-3$73$YR$$F$Y$$$20240925$$HP$US$US
243621511$24362151$1$I$$20240920$20240925$20240925$EXP$$US-ABBVIE-5934296$ABBVIE$Ferdous T, Holtzapple Z, Al-Tkrit A, Assaly R. Inhaled Anesthetic Sevoflurane-Associated Diffuse Alveolar Hemorrhage. Am J Ther. 2024;31(5): e591-e593.$44$YR$$M$Y$$$20240925$$MD$US$US
243621521$24362152$1$I$20240915$20240916$20240925$20240925$PER$$US-ABBVIE-5927839$ABBVIE$$66$YR$$F$Y$$$20240925$$CN$US$US
243621531$24362153$1$I$20240910$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189503$AMGEN$$$$$$Y$$$20240925$$PH$US$US
243621541$24362154$1$I$$20240918$20240925$20240925$EXP$$FR-GILEAD-2024-0688320$GILEAD$$$$A$$Y$$$20240925$$HP$FR$FR
243621551$24362155$1$I$$20240910$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09103$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243621561$24362156$1$I$20240924$20240924$20240924$20240924$DIR$719766$$FDA-CTU$$60$YR$$F$N$$$20240924$N$HP$US$
243621571$24362157$1$I$$20240820$20240925$20240925$PER$$US-Eisai-EC-2024-172465$EISAI$$$$E$M$Y$$$20240925$$MD$US$US
243621581$24362158$1$I$20240814$20240827$20240925$20240925$PER$$US-Eisai-EC-2024-173735$EISAI$$70$YR$E$M$Y$$$20240925$$CN$US$US
243621601$24362160$1$I$$20240917$20240925$20240925$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-051847$BOEHRINGER INGELHEIM$Poon J, Coombes F, Coombes I. Sum of the parts: a cascade of adverse effects. Australian Prescriber. 2024 Aug;47(4): 125-128. doi:10.18773/austprescr.2024.031.$58$YR$A$M$Y$$$20240925$$HP$AU$AU
243621611$24362161$1$I$$20240911$20240925$20240925$EXP$$US-UCBSA-2024047199$UCB$$$$$$Y$$$20240925$$CN$US$US
243621621$24362162$1$I$20240712$20240919$20240925$20240925$EXP$FR-AFSSAPS-NC2024001068$FR-TEVA-VS-3245763$TEVA$$85$YR$$M$Y$$$20240925$$MD$FR$FR
243621651$24362165$1$I$20240801$20240918$20240925$20240925$EXP$$US-ROCHE-10000085774$ROCHE$$62$YR$A$F$Y$47.62$KG$20240925$$CN$US$US
243621661$24362166$1$I$$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093434$TAKEDA$$$$A$F$Y$$$20240925$$CN$US$US
243621671$24362167$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151875$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$76.66$KG$20240925$$CN$US$US
243621691$24362169$1$I$$20240914$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147885$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240925$$CN$US$US
243621701$24362170$1$I$$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151473$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240925$$CN$US$US
243621711$24362171$1$I$$20240920$20240925$20240925$EXP$$US-BAYER-2024A135604$BAYER$$76$YR$E$M$Y$$$20240925$$CN$US$US
243621721$24362172$1$I$20240714$20240925$20240925$20240925$EXP$FR-AFSSAPS-GR2024001114$FR-BAYER-2024A136877$BAYER$$87$YR$E$F$Y$72$KG$20240925$$PH$FR$FR
243621731$24362173$1$I$$20240914$20240925$20240925$EXP$$US-JNJFOC-20240940349$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$HP$US$US
243621741$24362174$1$I$$20240918$20240925$20240925$EXP$NL-LRB-01003167$NL-TEVA-VS-3245244$TEVA$$45$YR$$M$Y$73.4$KG$20240925$$CN$NL$NL
243621751$24362175$1$I$$20240919$20240925$20240925$EXP$$CA-JNJFOC-20240962905$JOHNSON AND JOHNSON$$60$YR$A$F$Y$35$KG$20240925$$HP$CA$CA
243621761$24362176$1$I$20240920$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150537$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$109.77$KG$20240925$$HP$US$US
243621771$24362177$1$I$20240101$20240919$20240925$20240925$EXP$$TR-ABBVIE-5933277$ABBVIE$$34$YR$$F$Y$$$20240925$$MD$TR$TR
243621781$24362178$1$I$$20240925$20240925$20240925$EXP$$TH-ROCHE-10000090558$ROCHE$$70$YR$E$F$Y$$$20240925$$MD$TH$TH
243621791$24362179$1$I$$20240918$20240925$20240925$EXP$$CA-TAKEDA-2024TUS093820$TAKEDA$$28$YR$$M$Y$68$KG$20240925$$HP$CA$CA
243621801$24362180$1$I$$20231227$20240925$20240925$PER$$US-CELLTRION INC.-2023US019336$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243621811$24362181$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190641$NOVARTIS$$59$YR$$F$Y$$$20240925$$HP$US$US
243621821$24362182$1$I$$20240911$20240925$20240925$EXP$$US-UCBSA-2024047374$UCB$$$$$M$Y$$$20240925$$HP$US$US
243621831$24362183$1$I$20240906$20240917$20240925$20240925$EXP$$CA-JNJFOC-20240947354$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240925$$HP$CA$CA
243621841$24362184$1$I$20240912$20240924$20240924$20240924$DIR$719776$$FDA-CTU$$65$YR$$M$N$175.8$KG$20240924$N$PH$US$
243621851$24362185$1$I$$20240924$20240924$20240924$DIR$719721$$FDA-CTU$$$$$UNK$N$$$20240924$$CN$US$
243621861$24362186$1$I$20240814$20240924$20240924$20240924$DIR$719693$$FDA-CTU$$47$YR$$F$N$142.8$KG$20240924$N$HP$US$
243621871$24362187$1$I$20240510$20240924$20240924$20240924$DIR$719773$$FDA-CTU$$43$YR$$F$N$104.85$KG$20240924$N$CN$US$
243621881$24362188$1$I$$20231012$20240925$20240925$PER$$US-CELLTRION INC.-2023US020030$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243621891$24362189$1$I$20240829$20240902$20240925$20240925$EXP$$BR-INCYTE CORPORATION-2024IN010116$INCYTE$$$$$$Y$$$20240925$$PH$BR$BR
243621901$24362190$1$I$$20240916$20240925$20240925$EXP$$ES-HIKMA PHARMACEUTICALS USA INC.-ES-H14001-24-08694$HIKMA$$$$$$Y$$$20240925$$MD$ES$ES
243621911$24362191$1$I$20240801$20240829$20240925$20240925$PER$$US-Eisai-EC-2024-173456$EISAI$$61$YR$A$F$Y$$$20240925$$HP$US$US
243621941$24362194$1$I$$20240919$20240925$20240925$PER$$US-VERTEX PHARMACEUTICALS-2024-014921$VERTEX$$$$$$Y$$$20240925$$CN$US$US
243621951$24362195$1$I$$20240912$20240925$20240925$EXP$$CA-LUPIN HEALTHCARE (UK) LIMITED-2024-09420$LUPIN$$$$$$Y$$$20240925$$CN$CA$CA
243621961$24362196$1$I$20240911$20240919$20240925$20240925$EXP$$US-VERTEX PHARMACEUTICALS-2024-014827$VERTEX$$15$YR$$F$Y$$$20240925$$CN$US$US
243621971$24362197$1$I$$20240919$20240925$20240925$EXP$$US-VERTEX PHARMACEUTICALS-2024-013830$VERTEX$$$$$$Y$$$20240925$$CN$US$US
243621981$24362198$1$I$$20240920$20240925$20240925$EXP$$US-VERTEX PHARMACEUTICALS-2024-014977$VERTEX$$$$$$Y$$$20240925$$CN$US$US
243621991$24362199$1$I$20240904$20240916$20240925$20240925$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18884$IPSEN$$30$YR$A$F$Y$$$20240925$$HP$US$US
243622001$24362200$1$I$20240522$20240911$20240925$20240925$EXP$$AT-GENMAB-2024-02151$GENMAB$$70$YR$$M$Y$100$KG$20240925$$HP$AT$AT
243622011$24362201$1$I$$20240903$20240925$20240925$PER$$US-TOLMAR, INC.-24US051994$TOLMAR$$$$$$Y$$$20240925$$MD$US$US
243622031$24362203$1$I$$20240903$20240925$20240925$PER$$US-TOLMAR, INC.-24US052051$TOLMAR$$$$$$Y$$$20240925$$MD$US$US
243622041$24362204$1$I$$20240830$20240925$20240925$PER$$US-TOLMAR, INC.-24US052331$TOLMAR$$$$$$Y$$$20240925$$HP$US$US
243622051$24362205$1$I$$20240903$20240925$20240925$PER$$US-TOLMAR, INC.-24US052377$TOLMAR$$$$$F$Y$$$20240925$$MD$US$US
243622061$24362206$1$I$$20240920$20240925$20240925$PER$$US-009507513-2409USA008100$MERCK$$$$$F$Y$$$20240925$$CN$US$US
243622071$24362207$1$I$20240909$20240909$20240925$20240925$PER$$CA-TOLMAR, INC.-24CA052523$TOLMAR$$77$YR$$M$Y$$$20240924$$CN$CA$CA
243622081$24362208$1$I$20231201$20240920$20240925$20240925$EXP$FR-AFSSAPS-PB2024000986$FR-VERTEX PHARMACEUTICALS-2024-014923$VERTEX$$39$YR$$F$Y$55.5$KG$20240925$$HP$FR$FR
243622091$24362209$1$I$20240909$20240909$20240925$20240925$PER$$CA-TOLMAR, INC.-24CA052525$TOLMAR$$77$YR$$M$Y$$$20240924$$CN$CA$CA
243622101$24362210$1$I$20240909$20240909$20240925$20240925$PER$$CA-TOLMAR, INC.-24CA052533$TOLMAR$$87$YR$$M$Y$$$20240924$$CN$CA$CA
243622111$24362211$1$I$20240101$20240909$20240925$20240925$PER$$CA-TOLMAR, INC.-24CA052535$TOLMAR$$$$$M$Y$$$20240924$$CN$CA$CA
243622121$24362212$1$I$20240902$20240909$20240925$20240925$PER$$FR-TOLMAR, INC.-24FR052365$TOLMAR$$73$YR$$M$Y$$$20240924$$PH$FR$FR
243622141$24362214$1$I$20240906$20240909$20240925$20240925$PER$$NI-TOLMAR, INC.-24NI052569$TOLMAR$$78$YR$$M$Y$$$20240924$$CN$NI$NI
243622151$24362215$1$I$20240515$20240909$20240925$20240925$PER$$NL-TOLMAR, INC.-24NL052483$TOLMAR$$84$YR$$M$Y$$$20240924$$CN$NL$NL
243622161$24362216$1$I$$20240909$20240925$20240925$PER$$NL-TOLMAR, INC.-24NL052606$TOLMAR$$$$$M$Y$$$20240924$$HP$NL$NL
243622171$24362217$1$I$$20240909$20240925$20240925$PER$$NL-TOLMAR, INC.-24NL052607$TOLMAR$$$$$M$Y$$$20240924$$HP$NL$NL
243622191$24362219$1$I$20240909$20240909$20240925$20240925$PER$$TR-TOLMAR, INC.-24TR052507$TOLMAR$$70$YR$$M$Y$$$20240924$$MD$TR$TR
243622201$24362220$1$I$20240919$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013609$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240925$$CN$US$US
243622211$24362221$1$I$$20240913$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409009149$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240925$$CN$US$US
243622221$24362222$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015275$ELI LILLY AND CO$$64$YR$A$$Y$$$20240925$$CN$US$US
243622241$24362224$1$I$20240801$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150377$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240925$$HP$US$US
243622251$24362225$1$I$$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151326$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240925$$CN$US$US
243622261$24362226$1$I$$20240917$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148617$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240925$$CN$US$US
243622271$24362227$1$I$20231003$20240919$20240925$20240925$EXP$LV-SAM-2024098335$LV-MYLANLABS-2024M1085892$MYLAN$$82$YR$$F$Y$$$20240925$$MD$LV$LV
243622281$24362228$1$I$20240720$20240913$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009760$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243622291$24362229$1$I$$20240919$20240925$20240925$EXP$$SE-MYLANLABS-2024M1086629$MYLAN$Boberg E, Hedman A, Hollenberg J. Pulmonary embolism with paradoxical embolization to right coronary artery in the presence of a large patent foramen ovale: a case report. Eur-Heart-J-Case-Rep 2024; 8 (4):.$64$YR$$M$Y$$$20240925$$HP$SE$SE
243622301$24362230$1$I$$20240920$20240925$20240925$EXP$$CN-JNJFOC-20240960993$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$CN$CN
243622321$24362232$1$I$$20240910$20240925$20240925$EXP$$CN-GLANDPHARMA-CN-2024GLNLIT00792$GLAND PHARMA$Xing Ye Wu.The appearing and disappearing ascites in the treatment of colorectal cancer: a case report.Frontiers in Oncology.27-JUN-2024;14:1-7$65$YR$A$M$Y$$$20240925$$HP$CN$CN
243622331$24362233$1$I$$20240924$20240924$20240924$DIR$719695$$FDA-CTU$$$$$M$N$$$20240924$N$HP$US$
243622341$24362234$1$I$$20240924$20240924$20240924$DIR$719697$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243622351$24362235$1$I$$20240923$20240925$20240925$PER$$US-JNJFOC-20240963941$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243622361$24362236$1$I$$20240924$20240925$20240925$PER$$US-BIOVITRUM-2024-US-007212$BIOVITRUM$$61$YR$$F$Y$$$20240925$$CN$US$US
243622371$24362237$1$I$$20240922$20240925$20240925$PER$$US-VERTEX PHARMACEUTICALS-2024-015019$VERTEX$$$$$$Y$$$20240925$$CN$US$US
243622381$24362238$1$I$20240910$20240911$20240925$20240925$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09256$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243622391$24362239$1$I$$20240919$20240925$20240925$EXP$$JP-OTSUKA-2024_026398$OTSUKA$$4$DEC$$F$Y$$$20240925$$MD$JP$JP
243622411$24362241$1$I$$20240925$20240925$20240925$DIR$719582$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243622421$24362242$1$I$20240101$20240923$20240925$20240925$PER$$US-009507513-2409USA008238$MERCK$$$$$M$Y$$$20240925$$CN$US$US
243622431$24362243$1$I$20240922$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189392$AMGEN$$82$YR$E$F$Y$$$20240925$$CN$US$US
243622441$24362244$1$I$20240923$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024190086$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243622451$24362245$1$I$$20240925$20240925$20240925$DIR$719804$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243622481$24362248$1$I$$20240924$20240925$20240925$EXP$$US-GILEAD-2024-0688743$GILEAD$$65$YR$E$F$Y$$$20240925$$MD$US$US
243622491$24362249$1$I$$20240925$20240925$20240925$DIR$719590$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243622501$24362250$1$I$20240915$20240923$20240925$20240925$EXP$$US-GILEAD-2024-0688602$GILEAD$$64$YR$A$$Y$$$20240925$$HP$US$US
243622511$24362251$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190810$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
243622521$24362252$1$I$20240409$20240924$20240925$20240925$EXP$$NVSC2024GT190168$NOVARTIS$$7$YR$$M$Y$$$20240925$$CN$GT$GT
243622531$24362253$1$I$20240914$20240920$20240925$20240925$EXP$$CN-FreseniusKabi-FK202414150$FRESENIUS KABI$$81$YR$E$M$Y$38$KG$20240925$$HP$CN$CN
243622561$24362256$1$I$$20240910$20240925$20240925$EXP$$BR-GLANDPHARMA-BR-2024GLNLIT00788$GLAND PHARMA$Luiz Euribel Prestes-Carneiro.Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report.Pathogens.12-SEP-2023;12 No.9:1-8$33$YR$A$M$Y$$$20240925$$HP$BR$BR
243622571$24362257$1$I$20231026$20231108$20240925$20240925$PER$$US-CELLTRION INC.-2023US020980$CELLTRION$$$$$$Y$$$20240925$$PH$US$US
243622601$24362260$1$I$20231015$20240925$20240925$20240925$DIR$719791$$FDA-CTU$$33$YR$$F$N$63$KG$20240925$N$CN$US$
243622621$24362262$1$I$20240923$20240924$20240925$20240925$EXP$$US-GILEAD-2024-0688815$GILEAD$$48$YR$A$F$Y$$$20240925$$CN$US$US
243622651$24362265$1$I$$20240916$20240925$20240925$PER$$US-ROCHE-10000083445$ROCHE$$$$$$Y$$$20240925$$MD$US$US
243622661$24362266$1$I$$20231115$20240925$20240925$PER$$US-CELLTRION INC.-2023US022152$CELLTRION$$$$$$Y$$$20240925$$CN$US$US
243622671$24362267$1$I$20240821$20240919$20240925$20240925$EXP$FR-AFSSAPS-AVCF2024000582$FR-TEVA-VS-3246147$TEVA$$19$YR$$F$Y$$$20240925$$HP$FR$FR
243622681$24362268$1$I$$20240917$20240925$20240925$EXP$$US-JNJFOC-20240955229$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243622691$24362269$1$I$$20240916$20240925$20240925$PER$$US-JNJFOC-20240946020$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243622711$24362271$1$I$20240806$20240917$20240925$20240925$EXP$$JP-AMGEN-JPNNI2024189737$AMGEN$$5$YR$C$M$Y$16.8$KG$20240925$$MD$JP$JP
243622731$24362273$1$I$$20240917$20240925$20240925$EXP$$DE-ROCHE-3571345$ROCHE$$30$YR$A$M$Y$$$20240925$$MD$DE$DE
243622741$24362274$1$I$20240822$20240920$20240925$20240925$EXP$$CN-PFIZER INC-PV202400123634$PFIZER$$51$YR$$M$Y$63$KG$20240925$$HP$CN$CN
243622751$24362275$1$I$20240920$20240925$20240925$20240925$DIR$719799$$FDA-CTU$$31$YR$$F$N$70.65$KG$20240925$N$CN$US$
243622761$24362276$1$I$20240819$20240925$20240925$20240925$DIR$719595$$FDA-CTU$$64$YR$$M$N$99.1$KG$20240925$N$$US$
243622771$24362277$1$I$$20240912$20240925$20240925$PER$$US-ROCHE-10000079726$ROCHE$Kaya S, Lam F, Stevenson M, Motiei-Langroudi R, Kasper E. Intramedullary Metastases to Conus Medullaris: A Review of the Literature with a Case Illustration. Brain Sciences. 2024-Aug;14 (8):1-13. doi:10.3390/brainsci14080761.$51$YR$A$F$Y$$$20240925$$MD$US$US
243622781$24362278$1$I$20230901$20240925$20240925$20240925$DIR$719797$$FDA-CTU$$45$YR$$M$N$110.25$KG$20240925$N$HP$US$
243622801$24362280$1$I$20240910$20240920$20240925$20240925$EXP$$CN-PFIZER INC-PV202400123675$PFIZER$$50$YR$$F$Y$57$KG$20240925$$HP$CN$CN
243622821$24362282$1$I$20240915$20240925$20240925$20240925$DIR$719788$$FDA-CTU$$71$YR$$M$N$74.25$KG$20240925$N$CN$US$
243622832$24362283$2$F$20240907$20240926$20240925$20240927$EXP$$CN-PFIZER INC-PV202400123007$PFIZER$$29$YR$$F$Y$99$KG$20240927$$HP$CN$CN
243622851$24362285$1$I$20240907$20240920$20240925$20240925$EXP$$CN-PFIZER INC-PV202400123643$PFIZER$$49$YR$$M$Y$55$KG$20240925$$HP$CN$CN
243622861$24362286$1$I$20240722$20240921$20240925$20240925$EXP$$US-PFIZER INC-202400261558$PFIZER$$50$YR$$F$Y$$$20240925$$CN$US$US
243622892$24362289$2$F$20220314$20240923$20240925$20240926$EXP$$CA-PFIZER INC-202101828631$PFIZER$$81$YR$$M$Y$95$KG$20240926$$MD$CA$CA
243622921$24362292$1$I$20240725$20240920$20240925$20240925$EXP$FR-AFSSAPS-LL2024001767$FR-PFIZER INC-202400260464$PFIZER$$63$YR$$M$Y$$$20240925$$PH$FR$FR
243622931$24362293$1$I$20070101$20240920$20240925$20240925$EXP$FR-AFSSAPS-PV2024000888$FR-PFIZER INC-202400260454$PFIZER$$66$YR$$M$Y$68.5$KG$20240925$$MD$FR$FR
243622941$24362294$1$I$20230222$20240920$20240925$20240925$EXP$$CN-PFIZER INC-PV202400123650$PFIZER$$29$YR$$F$Y$55$KG$20240925$$HP$CN$CN
243622951$24362295$1$I$$20240920$20240925$20240925$EXP$$HU-PFIZER INC-202400260397$PFIZER$$60$YR$$M$Y$$$20240925$$MD$HU$HU
243622961$24362296$1$I$20240723$20240921$20240925$20240925$EXP$GB-MHRA-MED-202409211054303200-RQCVT$GB-PFIZER INC-202400260916$PFIZER$$63$YR$$F$Y$49$KG$20240925$$CN$GB$GB
243622971$24362297$1$I$20221125$20240920$20240925$20240925$EXP$FR-AFSSAPS-MA2024001360$FR-PFIZER INC-202400260457$PFIZER$$41$YR$$F$Y$61$KG$20240925$$PH$FR$FR
243622981$24362298$1$I$$20240920$20240925$20240925$EXP$$ZA-PFIZER INC-202400261488$PFIZER$$65$YR$$M$Y$$$20240925$$CN$ZA$ZA
243622991$24362299$1$I$20170101$20240920$20240925$20240925$EXP$$SE-PFIZER INC-2019SGN01287$PFIZER$Fang, M.. Compound heterozygous mutations of IL2-Inducible T cell kinase in a swedish patient: the importance of early genetic diagnosis. Journal of Clinical Immunology. 2019;39:131-134$36$YR$$F$Y$$$20240925$$HP$SE$SE
243623001$24362300$1$I$20230601$20240921$20240925$20240925$EXP$$US-PFIZER INC-202400261519$PFIZER$$31$YR$$F$Y$$$20240925$$HP$US$US
243623031$24362303$1$I$20200101$20240920$20240925$20240925$EXP$$CA-PFIZER INC-PV202400123766$PFIZER$$$$$F$Y$$$20240925$$LW$CA$CA
243623041$24362304$1$I$20231019$20240920$20240925$20240925$EXP$FR-AFSSAPS-AN2024001284$FR-PFIZER INC-202400260449$PFIZER$$67$YR$$F$Y$56$KG$20240925$$MD$FR$FR
243623051$24362305$1$I$$20240917$20240925$20240925$EXP$$US-PFIZER INC-202400263095$PFIZER$Hussein, G.. Stone heart syndrome: A curious case of digoxin toxicity and calcium infusion. Clinical Case Reports. 2024;12(9):10.1002/ccr3.9376$78$YR$$F$Y$$$20240925$$HP$US$US
243623061$24362306$1$I$20240801$20240920$20240925$20240925$EXP$GB-MHRA-MED-202409191834544870-JCKLP$GB-PFIZER INC-202400260661$PFIZER$$84$YR$$M$Y$$$20240925$$MD$GB$GB
243623101$24362310$1$I$20240707$20240920$20240925$20240925$EXP$FR-AFSSAPS-MA2024001388$FR-PFIZER INC-202400260472$PFIZER$$26$YR$$M$Y$$$20240925$$MD$FR$FR
243623111$24362311$1$I$20240806$20240922$20240925$20240925$EXP$$CN-PFIZER INC-PV202400123715$PFIZER$$72$YR$$F$Y$$$20240925$$HP$CN$CN
243623122$24362312$2$F$20240916$20240924$20240925$20240926$EXP$$JP-PFIZER INC-202400261077$PFIZER$$75$YR$$M$Y$$$20240926$$HP$JP$JP
243623141$24362314$1$I$20240807$20240919$20240925$20240925$EXP$FR-AFSSAPS-PB2024000984$FR-PFIZER INC-202400259372$PFIZER$$74$YR$$F$Y$63.5$KG$20240925$$HP$FR$FR
243623151$24362315$1$I$20240701$20240920$20240925$20240925$EXP$FR-AFSSAPS-GR2024001103$FR-PFIZER INC-202400260469$PFIZER$$78$YR$$F$Y$$$20240925$$PH$FR$FR
243623161$24362316$1$I$$20240920$20240925$20240925$EXP$$CA-PFIZER INC-202400086341$PFIZER$$56$YR$$F$Y$$$20240925$$HP$CA$CA
243623171$24362317$1$I$$20240919$20240925$20240925$EXP$$JP-PFIZER INC-PV202400123267$PFIZER$$51$YR$$F$Y$$$20240925$$MD$JP$JP
243623181$24362318$1$I$20230809$20240918$20240925$20240925$EXP$$PL-PFIZER INC-2023SGN13260$PFIZER$$23$YR$$M$Y$59$KG$20240925$$MD$PL$PL
243623191$24362319$1$I$20240902$20240914$20240925$20240925$EXP$CN-NMPACDR-4413011007956202400696$CN-BAXTER-2024BAX024804$BAXTER$$57$YR$$F$Y$61.5$KG$20240925$$MD$CN$CN
243623201$24362320$1$I$$20240923$20240925$20240925$EXP$$IN-ROCHE-10000089852$ROCHE$$25$YR$A$F$Y$$$20240925$$CN$IN$IN
243623221$24362322$1$I$$20240920$20240925$20240925$PER$$US-HALEON-2198114$Haleon PLC$$$$$F$Y$$$20240925$$CN$US$US
243623251$24362325$1$I$20240725$20240923$20240925$20240925$EXP$FR-AFSSAPS-LL2024001767$FR-FreseniusKabi-FK202414303$FRESENIUS KABI$$63$YR$A$M$Y$$$20240925$$PH$FR$FR
243623261$24362326$1$I$$20240923$20240925$20240925$EXP$$CA-FreseniusKabi-FK202414223$FRESENIUS KABI$$65$YR$E$M$Y$76$KG$20240925$$HP$CA$CA
243623271$24362327$1$I$$20240923$20240925$20240925$EXP$$CA-FreseniusKabi-FK202414242$FRESENIUS KABI$$1$YR$I$M$Y$$$20240925$$HP$CA$CA
243623281$24362328$1$I$$20240912$20240925$20240925$EXP$GB-MHRA-MED-202409121426155180-YVMGP$GB-ADVANZ PHARMA-202409007578$ADVANZ PHARMA$$$$$$Y$$$20240925$$HP$GB$GB
243623291$24362329$1$I$20240326$20240920$20240925$20240925$EXP$$US-TAKEDA-2024TUS093961$TAKEDA$$12$YR$$F$Y$$$20240925$$HP$US$US
243623301$24362330$1$I$$20240921$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014677$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240925$$CN$US$US
243623311$24362331$1$I$$20240923$20240925$20240925$EXP$$CA-FreseniusKabi-FK202414254$FRESENIUS KABI$$29$YR$A$F$Y$76$KG$20240925$$PH$CA$CA
243623321$24362332$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015270$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240925$$CN$US$US
243623331$24362333$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014990$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240925$$CN$US$US
243623341$24362334$1$I$20240901$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012742$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240925$$CN$US$US
243623351$24362335$1$I$20240917$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012622$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240925$$CN$US$US
243623361$24362336$1$I$$20240918$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409011980$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240925$$CN$US$US
243623381$24362338$1$I$$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65547$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243623391$24362339$1$I$20240912$20240912$20240925$20240925$EXP$$CO-AMICUS THERAPEUTICS, INC.-AMI_3383$AMICUS THERAPEUTICS$$48$YR$$M$Y$75$KG$20240925$$CN$CO$CO
243623411$24362341$1$I$$20240917$20240925$20240925$EXP$$US-EMD Serono-2024050113$EMD SERONO INC$$$$E$F$Y$$$20240925$$CN$US$US
243623431$24362343$1$I$20240913$20240920$20240925$20240925$EXP$$CO-UCBSA-2024049133$UCB$$23$YR$$F$Y$$$20240925$$CN$CO$CO
243623441$24362344$1$I$$20240916$20240925$20240925$PER$$US-DAIICHI SANKYO, INC.-DS-2024-100258-US$DAIICHI$$$$$F$Y$$$20240925$$MD$US$US
243623451$24362345$1$I$$20240919$20240925$20240925$EXP$$CA-TAKEDA-2024TUS094211$TAKEDA$$66$YR$$F$Y$$$20240925$$HP$CA$CA
243623481$24362348$1$I$$20240910$20240925$20240925$EXP$$ET-GLANDPHARMA-ET-2024GLNLIT00795$GLAND PHARMA$Amanuel Yegnanew Adela.Acute brachial artery occlusion following cisplatin-based chemotherapy: case report..SAGE Open Medical Case Reports.JAN-2024;12:1-5$50$YR$A$M$Y$$$20240925$$HP$ET$ET
243623491$24362349$1$I$$20240919$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150063$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240925$$PH$US$US
243623511$24362351$1$I$$20240919$20240925$20240925$EXP$$US-AMGEN-USASP2024187670$AMGEN$Kaur V.; Ladwa A.; Elghawy O.. Single Institution Experience with Immune Checkpoint Inhibitors in Vulvar and Vaginal Melanomas. Obstetrics and Gynecology International. 2024;1-6$53$YR$A$F$Y$$$20240925$$HP$US$US
243623521$24362352$1$I$$20240917$20240925$20240925$30DAY$$US-PFIZER INC-PV202400119914$PFIZER$$8$YR$$M$Y$22.1$KG$20240925$$CN$US$US
243623531$24362353$1$I$$20240923$20240925$20240925$EXP$$RU-PFIZER INC-PV202400124071$PFIZER$$54$YR$$M$Y$$$20240925$$MD$RU$RU
243623551$24362355$1$I$$20240923$20240925$20240925$EXP$$CA-FreseniusKabi-FK202414269$FRESENIUS KABI$$22$YR$A$M$Y$$$20240925$$CN$CA$CA
243623561$24362356$1$I$20210702$20240923$20240925$20240925$EXP$PL-URPL-DML-MLP.4401.1.5074.2021$PL-FreseniusKabi-FK202414282$FRESENIUS KABI$$36$YR$A$F$Y$60$KG$20240925$$MD$PL$PL
243623571$24362357$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244574$TEVA$$81$YR$$F$Y$$$20240925$$PH$CA$CA
243623621$24362362$1$I$20240902$20240925$20240925$20240925$DIR$719591$$FDA-CTU$$63$YR$$F$N$111.5$KG$20240925$N$PH$US$
243623651$24362365$1$I$20240722$20240925$20240925$20240925$DIR$719807$$FDA-CTU$$9$YR$$M$N$43.2$KG$20240925$N$$US$
243623661$24362366$1$I$20240917$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65549$$FDA-CTU$$32$YR$$F$N$$$20240924$N$HP$US$
243623671$24362367$1$I$$20240925$20240925$20240925$DIR$719800$$FDA-CTU$$$$$UNK$N$$$20240925$N$MD$US$
243623681$24362368$1$I$20240922$20240923$20240925$20240925$DIR$FDA-CDER-CTU-2024-65553$$FDA-CTU$$83$YR$$F$N$52.62$KG$20240923$N$$US$
243623691$24362369$1$I$20240919$20240925$20240925$20240925$DIR$719594$$FDA-CTU$$79$YR$$M$N$$$20240925$N$PH$US$
243623711$24362371$1$I$20240906$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65555$$FDA-CTU$$58$YR$$M$N$$$20240925$N$HP$US$
243623721$24362372$1$I$$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65556$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243623741$24362374$1$I$$20240919$20240925$20240925$DIR$FDA-CDER-CTU-2024-65554$$FDA-CTU$$$$$F$N$76$KG$20240919$N$$US$
243623751$24362375$1$I$20240911$20240925$20240925$20240925$DIR$719802$$FDA-CTU$$71$YR$$F$N$67.5$KG$20240925$N$CN$US$
243623761$24362376$1$I$$20240925$20240925$20240925$DIR$719584$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243623771$24362377$1$I$$20240913$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009743$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243623781$24362378$1$I$20240604$20240918$20240925$20240925$PER$$US-009507513-2409USA006603$MERCK$$$$$F$Y$$$20240925$$CN$US$US
243623791$24362379$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244704$TEVA$$67$YR$$F$Y$$$20240925$$PH$CA$CA
243623801$24362380$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65557$$FDA-CTU$$71$YR$$F$N$$$20240925$N$$US$
243623811$24362381$1$I$$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65558$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243623821$24362382$1$I$20240901$20240920$20240925$20240925$PER$$US-ABBVIE-5933773$ABBVIE$$50$YR$$F$Y$$$20240925$$CN$US$US
243623851$24362385$1$I$20240916$20240918$20240925$20240925$EXP$$PK-ROCHE-10000085499$ROCHE$$39$YR$A$F$Y$$$20240925$$CN$PK$PK
243623862$24362386$2$F$20240830$20240923$20240925$20240926$EXP$$CN-PFIZER INC-PV202400124277$PFIZER$$58$YR$$M$Y$68$KG$20240926$$HP$CN$CN
243623871$24362387$1$I$20240910$20240923$20240925$20240925$EXP$$CN-PFIZER INC-PV202400124268$PFIZER$$79$YR$$F$Y$$$20240925$$HP$CN$CN
243623881$24362388$1$I$20240101$20240923$20240925$20240925$EXP$$CA-PFIZER INC-202400262913$PFIZER$$92$YR$$M$Y$$$20240925$$HP$CA$CA
243623901$24362390$1$I$20240801$20240922$20240925$20240925$EXP$$US-PFIZER INC-202400261065$PFIZER$$63$YR$$M$Y$$$20240925$$CN$US$US
243623911$24362391$1$I$20240919$20240923$20240925$20240925$EXP$$GB-PFIZER INC-202400261662$PFIZER$$$$$F$Y$$$20240925$$CN$GB$GB
243623921$24362392$1$I$$20240923$20240925$20240925$EXP$$US-PFIZER INC-202101391473$PFIZER$$68$YR$$F$Y$$$20240925$$CN$US$US
243623931$24362393$1$I$$20240919$20240925$20240925$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-126752$REGENERON$$$$$M$Y$$$20240925$$CN$US$US
243623941$24362394$1$I$$20240920$20240925$20240925$PER$$US-BAYER-2024A134864$BAYER$$$$$F$Y$$$20240925$$CN$US$US
243623951$24362395$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244724$TEVA$$$$$F$Y$$$20240925$$HP$CA$CA
243623961$24362396$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244532$TEVA$$84$YR$$M$Y$$$20240925$$PH$CA$CA
243623971$24362397$1$I$$20240909$20240925$20240925$PER$$US-JNJFOC-20240921418$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$CN$US$US
243623981$24362398$1$I$$20240920$20240925$20240925$PER$$US-BIOGEN-2024BI01283674$BIOGEN$$$$$M$Y$$$20240925$$CN$US$US
243624001$24362400$1$I$$20240923$20240925$20240925$PER$$US-BIOGEN-2021BI00983722$BIOGEN$$$$$M$Y$$$20240925$$CN$US$US
243624011$24362401$1$I$20190101$20240913$20240925$20240925$EXP$$US-TAKEDA-2024TUS086710$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
243624021$24362402$1$I$$20240910$20240925$20240925$EXP$$US-GLANDPHARMA-US-2024GLNLIT00790$GLAND PHARMA$Farrah N. Gaston.Spontaneous Iliac Artery Dissection in a 66-Year Old Male Complicated By Hemorrhage, GI Bleeding, and Bilateral DVT/PE.Blood.NOV-2023;142 (Suppl. 1)$66$YR$E$M$Y$$$20240925$$MD$US$US
243624031$24362403$1$I$$20240913$20240925$20240925$EXP$$US-SA-2024SA275008$SANOFI AVENTIS$$$$E$M$Y$$$20240925$$MD$US$US
243624041$24362404$1$I$$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65559$$FDA-CTU$$$$$F$N$108$LBS$20240924$N$HP$US$
243624062$24362406$2$F$$20240925$20240925$20240927$EXP$$US-PFIZER INC-2021SGN00272$PFIZER$$$$$M$Y$$$20240927$$HP$US$US
243624071$24362407$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151281$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$75.3$KG$20240925$$HP$US$US
243624081$24362408$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65560$$FDA-CTU$$19$YR$$F$N$165$LBS$20240925$N$$US$
243624091$24362409$1$I$$20240923$20240925$20240925$EXP$$US-PFIZER INC-PV202400124521$PFIZER$$57$YR$$F$Y$$$20240925$$CN$US$US
243624101$24362410$1$I$20240101$20240923$20240925$20240925$EXP$$US-PFIZER INC-202400261742$PFIZER$$77$YR$$M$Y$$$20240925$$CN$US$US
243624112$24362411$2$F$$20240926$20240925$20240928$PER$$US-AMGEN-USASP2024190809$AMGEN$$$$$$Y$$$20240928$$CN$US$US
243624121$24362412$1$I$20240913$20240916$20240925$20240925$EXP$$PA-DSJP-DS-2024-100484-PA$DAIICHI$$$$$F$Y$$$20240925$$CN$PA$PA
243624131$24362413$1$I$$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024189021$AMGEN$Chen J.S.; Korn B.S.; Carey A.R. et al.. Looking beyond blurred margins. Survey of Ophthalmology. 2024;69 (5):842-846$60$YR$A$M$Y$$$20240925$$HP$US$US
243624141$24362414$1$I$20240726$20240905$20240925$20240925$PER$$US-JNJFOC-20240917576$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20240925$$CN$US$US
243624151$24362415$1$I$20240612$20240914$20240925$20240925$EXP$CN-NMPACDR-3101141011142202400176$CN-BAXTER-2024BAX024817$BAXTER$$73$YR$$F$Y$40$KG$20240925$$MD$CN$CN
243624171$24362417$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150079$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240925$$HP$US$US
243624181$24362418$1$I$20240801$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150145$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240925$$HP$US$US
243624191$24362419$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152004$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240925$$CN$US$US
243624201$24362420$1$I$$20240923$20240925$20240925$EXP$$CA-PFIZER INC-202400262457$PFIZER$$65$YR$$M$Y$$$20240925$$MD$CA$CA
243624211$24362421$1$I$20240619$20240923$20240925$20240925$EXP$SE-SEMPA-2024-006735$SE-PFIZER INC-202400261492$PFIZER$$88$YR$$F$Y$$$20240925$$MD$SE$SE
243624231$24362423$1$I$$20240923$20240925$20240925$EXP$$US-PFIZER INC-PV202400124855$PFIZER$$88$YR$$M$Y$$$20240925$$HP$US$US
243624241$24362424$1$I$$20240917$20240925$20240925$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00968$BIOCRYST PHARMACEUTICALS$$$$$F$Y$$$20240925$$MD$US$US
243624251$24362425$1$I$$20240913$20240925$20240925$EXP$GB-MHRA-MED-202409112158055820-SRTQY$GB-NORDICGR-057440$NORDIC PHARMA$$$$$F$Y$$$20240924$$CN$GB$GB
243624281$24362428$1$I$20240918$20240923$20240925$20240925$EXP$$US-SA-2024SA275427$SANOFI AVENTIS$$92$YR$E$M$Y$$$20240925$$HP$US$US
243624291$24362429$1$I$20240917$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190757$AMGEN$$87$YR$E$F$Y$$$20240925$$CN$US$US
243624301$24362430$1$I$$20240917$20240925$20240925$EXP$$BR-JNJFOC-20240955901$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20240925$$CN$BR$BR
243624311$24362431$1$I$$20240910$20240925$20240925$EXP$$US-GLANDPHARMA-US-2024GLNLIT00783$GLAND PHARMA$Yichi Zhang.Acute and chronic infectious complications following gunshot injuries: a case comparison.Southern Medical Journal.APR-2022;115:561$25$YR$A$M$Y$$$20240925$$HP$US$US
243624331$24362433$1$I$$20231019$20240925$20240925$PER$$US-CELLTRION INC.-2023US018867$CELLTRION$Siegel CA. Determining the appropriate treatment for patients with UC: The role of tofacitinib$$$$$Y$$$20240925$$MD$US$US
243624341$24362434$1$I$20240301$20240917$20240925$20240925$EXP$$DE-TEVA-VS-3246051$TEVA$$69$YR$$F$Y$$$20240925$$HP$DE$DE
243624361$24362436$1$I$$20240923$20240925$20240925$DIR$FDA-CDER-CTU-2024-65562$$FDA-CTU$$$$$F$N$$$20240923$N$HP$US$
243624371$24362437$1$I$20240730$20240920$20240925$20240925$EXP$$CN-Merck Healthcare KGaA-2024050696$MERCK KGAA$$61$YR$A$M$Y$83$KG$20240925$$HP$CN$CN
243624381$24362438$1$I$20240824$20240920$20240925$20240925$EXP$$US-CHEPLA-2024012103$CHEPLAPHARM$$82$YR$$M$Y$$$20240925$$CN$COUNTRY NOT SPECIFIED$US
243624391$24362439$1$I$20240701$20240919$20240925$20240925$EXP$HR-HALMED-300086451$HR-CHEPLA-2024011998$CHEPLAPHARM$$39$YR$$F$Y$$$20240925$$MD$COUNTRY NOT SPECIFIED$HR
243624401$24362440$1$I$$20240917$20240925$20240925$30DAY$$US-PFIZER INC-202400251257$PFIZER$$15$YR$$M$Y$$$20240925$$CN$US$US
243624411$24362441$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65563$$FDA-CTU$$63$YR$$F$N$139$LBS$20240925$N$$US$
243624421$24362442$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65564$$FDA-CTU$$69$YR$$M$N$$$20240925$N$$US$
243624431$24362443$1$I$20240831$20240920$20240925$20240925$DIR$FDA-CDER-CTU-2024-65565$$FDA-CTU$$62$YR$$F$N$$$20240920$N$HP$US$
243624441$24362444$1$I$$20240919$20240925$20240925$EXP$$CN-PFIZER INC-PV202400122724$PFIZER$$$$A$M$Y$$$20240925$$CN$CN$CN
243624451$24362445$1$I$$20240916$20240925$20240925$30DAY$$DE-PFIZER INC-202400261902$PFIZER$$$$$$Y$$$20240925$$HP$DE$DE
243624461$24362446$1$I$20240801$20240827$20240925$20240925$PER$$US-Eisai-EC-2024-173199$EISAI$$72$YR$E$F$Y$$$20240925$$CN$US$US
243624471$24362447$1$I$$20240827$20240925$20240925$PER$$US-Eisai-EC-2024-173225$EISAI$$$$$$Y$$$20240925$$MD$US$US
243624491$24362449$1$I$20240921$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189281$AMGEN$$62$YR$A$M$Y$$$20240925$$CN$US$US
243624502$24362450$2$F$20240901$20240905$20240925$20240927$30DAY$$US-JNJFOC-20240911980$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20240927$$CN$US$US
243624511$24362451$1$I$$20240923$20240925$20240925$PER$$NVSC2024US190648$NOVARTIS$$$$$F$Y$$$20240925$$CN$US$US
243624531$24362453$1$I$20240901$20240920$20240925$20240925$EXP$$NVSC2024US189202$NOVARTIS$$71$YR$$M$Y$$$20240925$$CN$US$US
243624541$24362454$1$I$$20240923$20240925$20240925$EXP$$CA-ORGANON-O2409CAN001666$ORGANON$$43$YR$$F$Y$$$20240925$$HP$CA$CA
243624551$24362455$1$I$20240101$20240913$20240925$20240925$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1824$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240925$$CN$US$US
243624561$24362456$1$I$20240101$20240913$20240925$20240925$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1854$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240925$$CN$US$US
243624571$24362457$1$I$$20231110$20240925$20240925$PER$$US-CELLTRION INC.-2023US019907$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243624582$24362458$2$F$20240922$20240924$20240925$20240927$PER$$US-AMGEN-USASP2024189590$AMGEN$$53$YR$A$M$Y$$$20240927$$CN$US$US
243624591$24362459$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151859$BRISTOL MYERS SQUIBB$$21$YR$A$M$Y$$$20240925$$HP$US$US
243624602$24362460$2$F$20240918$20240926$20240925$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149219$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240927$$PH$US$US
243624611$24362461$1$I$20240916$20240916$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149982$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240925$$CN$US$US
243624621$24362462$1$I$20240919$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151358$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240925$$MD$US$US
243624631$24362463$1$I$$20240827$20240925$20240925$30DAY$$US-BAXTER-2024BAX024764$BAXTER$$$$$$Y$$$20240925$$HP$US$US
243624641$24362464$1$I$$20240916$20240925$20240925$EXP$$CA-HLS-202402344$HLS THERAPEUTICS$$$$A$F$Y$$$20240925$$HP$CA$CA
243624651$24362465$1$I$$20240917$20240925$20240925$PER$$US-ROCHE-10000085218$ROCHE$$$$$M$Y$$$20240925$$PH$US$US
243624661$24362466$1$I$20240901$20240910$20240925$20240925$EXP$$US-GLANDPHARMA-US-2024GLNSPO00774$GLAND PHARMA$$57$YR$A$F$Y$$$20240925$$PH$US$US
243624671$24362467$1$I$20230101$20240917$20240925$20240925$EXP$$US-TEVA-VS-3244762$TEVA$$72$YR$$F$Y$59.87$KG$20240925$$CN$US$US
243624681$24362468$1$I$$20240910$20240925$20240925$EXP$$US-TARO PHARMACEUTICALS USA INC.-2024TAR01569$TARO$Homiack DR, Yan LE, Petry LG, Lloyd JR, Najjar F, Cook EH.. Successful Electroconvulsive Therapy in a Patient with Catatonia and Maternal Duplication 15q11-13 Syndrome.. J ECT. 2024;0(0)$$$$$Y$$$20240925$$HP$US$US
243624691$24362469$1$I$$20240916$20240925$20240925$PER$$US-EMD Serono-2024049862$EMD SERONO INC$$37$YR$A$F$Y$$$20240925$$CN$US$US
243624701$24362470$1$I$20240913$20240923$20240925$20240925$EXP$$NVSC2024US189752$NOVARTIS$$61$YR$$F$Y$$$20240925$$CN$US$US
243624711$24362471$1$I$20240819$20240828$20240925$20240925$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00887$BIOCRYST PHARMACEUTICALS$$66$YR$$F$Y$$$20240925$$CN$US$US
243624721$24362472$1$I$$20240923$20240925$20240925$PER$$NVSC2024US189817$NOVARTIS$$$$$$Y$$$20240925$$CN$US$US
243624731$24362473$1$I$$20240923$20240925$20240925$EXP$$CA-ORGANON-O2409CAN001726$ORGANON$$$$$F$Y$$$20240925$$HP$CA$CA
243624771$24362477$1$I$20240924$20240925$20240925$20240925$DIR$719810$$FDA-CTU$$47$YR$$M$N$$$20240925$Y$PH$US$
243624791$24362479$1$I$20240601$20240919$20240925$20240925$EXP$$CN-JNJFOC-20240959235$JOHNSON AND JOHNSON$$13$YR$T$F$Y$$$20240925$$HP$CN$CN
243624801$24362480$1$I$$20240910$20240925$20240925$30DAY$$KR-JNJFOC-20240951136$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$KR$KR
243624811$24362481$1$I$$20240917$20240925$20240925$EXP$$US-MYLANLABS-2024M1086135$MYLAN$Shah M, Green J, Hudacko R, Cohen AJ. Clinical Response to Olaparib in a Patient with Leptomeningeal Carcinomatosis in Newly Diagnosed Breast Cancer with Germline BRCA2 Mutation. JCO-Precis-Oncol 2024; 8.$38$YR$$F$Y$$$20240925$$MD$US$US
243624821$24362482$1$I$$20240916$20240925$20240925$EXP$$DE-MYLANLABS-2024M1085832$MYLAN$Rechtien L, Sollfrank L, Foerster Y, Berking C, Sticherling M. Case Report: The many faces of bullous pemphigoid. Front-Immunol 2023; 14 1-5.$25$YR$$M$Y$$$20240925$$HP$DE$DE
243624831$24362483$1$I$20231106$20240920$20240925$20240925$EXP$$AU-MYLANLABS-2024M1078151$MYLAN$$47$YR$$M$Y$$$20240925$$HP$AU$AU
243624841$24362484$1$I$$20240923$20240925$20240925$EXP$$US-009507513-2409USA008255$MERCK$$17$YR$$$Y$$$20240925$$HP$US$US
243624851$24362485$1$I$20240729$20240920$20240925$20240925$EXP$$US-TAKEDA-2024TUS094408$TAKEDA$$75$YR$$F$Y$54$KG$20240925$$MD$US$US
243624861$24362486$1$I$$20240912$20240925$20240925$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-09233$LUPIN$Gupta DD, Keny SJ, Kakodkar UC. Study of adverse drug reactions during the treatment of drug-resistant tuberculosis. Indian Journal Of Tuberculosis. 2024;71:S136-S140$$$$$Y$$$20240925$$HP$IN$IN
243624871$24362487$1$I$20240906$20240913$20240925$20240925$EXP$GB-MHRA-MED-202409131452577990-WVZLY$GB-ELI_LILLY_AND_COMPANY-GB202409009477$ELI LILLY AND CO$$54$YR$A$F$Y$96$KG$20240925$$CN$GB$GB
243624881$24362488$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015203$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240925$$CN$US$US
243624891$24362489$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013423$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240925$$CN$US$US
243624901$24362490$1$I$20180101$20240910$20240925$20240925$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409007662$ELI LILLY AND CO$$72$YR$E$$Y$50$KG$20240925$$CN$CN$CN
243624911$24362491$1$I$$20240916$20240925$20240925$EXP$$CA-HLS-202402356$HLS THERAPEUTICS$$$$E$M$Y$$$20240925$$HP$CA$CA
243624921$24362492$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150635$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240925$$CN$US$US
243624931$24362493$1$I$$20231125$20240925$20240925$PER$$US-CELLTRION INC.-2023US020557$CELLTRION$$$$$$Y$$$20240925$$HP$US$US
243624941$24362494$1$I$$20240924$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151746$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20240925$$PH$US$US
243624951$24362495$1$I$$20240923$20240925$20240925$EXP$$CA-ORGANON-O2409CAN001747$ORGANON$$43$YR$$F$Y$$$20240925$$MD$CA$CA
243624961$24362496$1$I$$20240924$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151761$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$106.59$KG$20240925$$CN$US$US
243624971$24362497$1$I$$20240920$20240925$20240925$EXP$$US-Indivior Limited- INDV-156560-2024$RECKITT BENCKISER$$$$$$Y$$$20240925$$CN$US$US
243624991$24362499$1$I$$20240910$20240925$20240925$EXP$$CN-AFAXYS PHARMA, LLC-2024AFX00012$AFAXYS$Han M, Xia J, Zhang M. et al.. Is Dosage Adjustment Based on Age Necessary for Intravenous Lidocaine in Patients Undergoing General Anesthesia: A Prospective Multi-Arm Comparative Study.. J. Pharm. Sci. 2024. 2024;113(9):2922-2932$78$YR$$M$Y$$$20240925$$HP$CN$CN
243625001$24362500$1$I$20240822$20240916$20240925$20240925$EXP$$CA-HLS-202402349$HLS THERAPEUTICS$$38$YR$A$F$Y$$$20240925$$HP$CA$CA
243625011$24362501$1$I$20240613$20240916$20240925$20240925$EXP$$CA-VER-202400484$VERITY PHARMACEUTICALS$$82$YR$E$M$Y$$$20240925$$CN$CA$CA
243625021$24362502$1$I$$20240910$20240925$20240925$EXP$$CN-AFAXYS PHARMA, LLC-2024AFX00011$AFAXYS$Han M, Xia J, Zhang M. et al.. Is Dosage Adjustment Based on Age Necessary for Intravenous Lidocaine in Patients Undergoing General Anesthesia: A Prospective Multi-Arm Comparative Study.. J. Pharm. Sci.. 2024;113(9):2922-2932$$$A$M$Y$$$20240925$$HP$CN$CN
243625041$24362504$1$I$$20240918$20240925$20240925$PER$$US-ASTELLAS-2024-AER-007791$ASTELLAS$$$$$F$Y$$$20240925$$CN$US$US
243625051$24362505$1$I$20240801$20240917$20240925$20240925$EXP$$CA-OTSUKA-2024_026205$OTSUKA$$$$N$$Y$$$20240925$$HP$CA$CA
243625061$24362506$1$I$20240801$20240919$20240925$20240925$EXP$$US-Eisai-EC-2024-175024$EISAI$$69$YR$E$F$Y$$$20240925$$CN$US$US
243625071$24362507$1$I$$20240917$20240925$20240925$EXP$$CA-INDIVIOR US-INDV-156526-2024$RECKITT BENCKISER$Rafizadeh, Reza, Azarbar, Ataa, Hestvik, Lukas, Clune, Jennifer, Mathew, Nickie. Substance-Related Withdrawal Catatonia in Co-occurring Disorders. Journal of clinical psychopharmacology. 2024;44(5):524-527$46$YR$$M$Y$$$20240925$$HP$CA$CA
243625091$24362509$1$I$20240821$20240829$20240925$20240925$PER$$US-Eisai-EC-2024-173365$EISAI$$80$YR$E$F$Y$$$20240925$$CN$US$US
243625111$24362511$1$I$20240822$20240919$20240925$20240925$PER$IT-MINISAL02-1003311$IT-Eisai-EC-2024-175083$EISAI$$55$YR$A$F$Y$$$20240925$$HP$IT$IT
243625121$24362512$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65568$$FDA-CTU$$71$YR$$F$N$$$20240925$N$HP$US$
243625141$24362514$1$I$$20240921$20240925$20240925$EXP$$US-ASTELLAS-2024-AER-008672$ASTELLAS$Somu K. Invasive pulmonary aspergillosis in a post-lung transplant patient. Chest. 2024;166(4): A1458-9.$52$YR$A$M$Y$$$20240925$$HP$US$US
243625151$24362515$1$I$$20240917$20240925$20240925$EXP$$CA-ROCHE-10000083886$ROCHE$$10$YR$C$F$Y$47$KG$20240925$$PH$CA$CA
243625161$24362516$1$I$20240901$20240916$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150341$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$87.09$KG$20240925$$PH$US$US
243625171$24362517$1$I$$20240921$20240925$20240925$PER$$US-ROCHE-10000088507$ROCHE$$78$YR$E$F$Y$$$20240925$$CN$US$US
243625181$24362518$1$I$20240921$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024190089$AMGEN$$81$YR$E$F$Y$$$20240925$$CN$US$US
243625191$24362519$1$I$$20231109$20240925$20240925$PER$$US-CELLTRION INC.-2023US021894$CELLTRION$$$$$$Y$$$20240925$$MD$US$US
243625201$24362520$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150747$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$CN$US$US
243625211$24362521$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151637$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$122.47$KG$20240925$$CN$US$US
243625221$24362522$1$I$20240503$20240919$20240925$20240925$EXP$$BE-BRISTOL-MYERS SQUIBB COMPANY-2024-151598$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$58$KG$20240925$$MD$BE$BE
243625231$24362523$1$I$$20240909$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09035$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243625241$24362524$1$I$$20240919$20240925$20240925$EXP$$TH-ROCHE-10000087555$ROCHE$$$$E$M$Y$$$20240925$$MD$TH$TH
243625252$24362525$2$F$20240501$20240923$20240925$20240930$PER$$US-AMGEN-USASP2024189356$AMGEN$$74$YR$E$$Y$$$20240930$$CN$US$US
243625261$24362526$1$I$$20240915$20240925$20240925$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202409010907$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240925$$MD$SA$SA
243625271$24362527$1$I$20240919$20240919$20240925$20240925$EXP$$US-ELI_LILLY_AND_COMPANY-US202409013646$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243625281$24362528$1$I$20240913$20240919$20240925$20240925$EXP$GB-MHRA-MED-202409191214251670-HNSKV$GB-ELI_LILLY_AND_COMPANY-GB202409013309$ELI LILLY AND CO$$59$YR$A$F$Y$76$KG$20240925$$CN$GB$GB
243625301$24362530$1$I$$20240918$20240925$20240925$EXP$$US-ELI_LILLY_AND_COMPANY-US202409012086$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240925$$CN$US$US
243625311$24362531$1$I$$20240913$20240925$20240925$EXP$GB-MHRA-MED-202409131025547360-TNBVS$GB-ELI_LILLY_AND_COMPANY-GB202409009581$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$GB$GB
243625321$24362532$1$I$$20240924$20240925$20240925$EXP$SE-SEMPA-2024-006925$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-151609$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240925$$MD$SE$SE
243625331$24362533$1$I$20240912$20240913$20240925$20240925$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009442$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240925$$CN$US$US
243625341$24362534$1$I$$20240923$20240925$20240925$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202409013411$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240925$$CN$AU$AU
243625371$24362537$1$I$$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS093344$TAKEDA$$$$$M$Y$79$KG$20240925$$MD$US$US
243625381$24362538$1$I$$20240921$20240925$20240925$PER$$US-BIOGEN-2022BI01088716$BIOGEN$$$$$F$Y$$$20240925$$MD$US$US
243625391$24362539$1$I$$20240916$20240925$20240925$EXP$$CA-AZURITY PHARMACEUTICALS, INC.-AZR202409-000671$AZURITY PHARMACEUTICALS$Shukla V, Cheng S, Hukin J, Huh L, Datta AN. Developmental and epileptic encephalopathies after successful treatment of pediatric ALL: A case series and review of literature.. Epileptic Disord.. 2024;00:1-10$$$$M$Y$$$20240925$$HP$CA$CA
243625401$24362540$1$I$$20240916$20240925$20240925$EXP$$CA-AZURITY PHARMACEUTICALS, INC.-AZR202409-000670$AZURITY PHARMACEUTICALS$Shukla V, Cheng S, Hukin J, Huh L, Datta AN.. Developmental and epileptic encephalopathies after successful treatment of pediatric ALL: A case series and review of literature.. Epileptic Disord.. 2024;00:1-10$$$$M$Y$$$20240925$$HP$CA$CA
243625411$24362541$1$I$20240101$20240919$20240925$20240925$EXP$$US-BAUSCH-BL-2024-014153$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240925$$CN$US$US
243625421$24362542$1$I$$20240919$20240925$20240925$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001916$BLUEPRINT MEDICINES$$$$$F$Y$$$20240925$$CN$US$US
243625441$24362544$1$I$20240801$20240919$20240925$20240925$EXP$$ZA-Vifor (International) Inc.-VIT-2024-08713$VIFOR$$76$YR$$F$Y$$$20240925$$HP$ZA$ZA
243625451$24362545$1$I$20240903$20240919$20240925$20240925$EXP$$JP-Vifor (International) Inc.-VIT-2024-08714$VIFOR$$73$YR$$F$Y$$$20240925$$PH$JP$JP
243625461$24362546$1$I$20240101$20240920$20240925$20240925$EXP$$JP-BAUSCH-BL-2024-014363$BAUSCH AND LOMB$$54$YR$$F$Y$$$20240925$$HP$JP$JP
243625471$24362547$1$I$$20240920$20240925$20240925$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001922$BLUEPRINT MEDICINES$$$$$F$Y$$$20240925$$CN$US$US
243625481$24362548$1$I$$20240917$20240925$20240925$EXP$$CA-BAUSCHBL-2024BNL033579$BAUSCH AND LOMB$$61$YR$$F$Y$58$KG$20240925$$HP$CA$CA
243625491$24362549$1$I$$20240918$20240925$20240925$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001908$BLUEPRINT MEDICINES$$$$$F$Y$$$20240925$$CN$US$US
243625501$24362550$1$I$20231101$20240921$20240925$20240925$EXP$$EU-BAUSCHBL-2024BNL033848$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240925$$MD$EU$EU
243625511$24362551$1$I$20240922$20240924$20240925$20240925$EXP$$US-BAUSCH-BL-2024-014389$BAUSCH AND LOMB$$85$YR$$M$Y$$$20240925$$CN$US$US
243625521$24362552$1$I$$20240915$20240925$20240925$EXP$$US-Aprecia Pharmaceuticals-APRE20241155$APRECIA PHARMACEUTICALS$Romero K, O^Brien M, Agrawal A, Hasan I. Creatine Kinase Surge: Levetiracetam-Induced Rhabdomyolysis. Cureus. 2024 AUG 12;16(8): E66715:1-5. doi:10.7759/cureus.66715$27$YR$A$M$Y$$$20240925$$HP$US$US
243625531$24362553$1$I$$20240919$20240925$20240925$PER$$US-BAUSCH-BL-2024-014175$BAUSCH AND LOMB$$88$YR$$M$Y$$$20240925$$CN$US$US
243625541$24362554$1$I$20240810$20240819$20240925$20240925$EXP$$DE-SERVIER-S24010591$SERVIER$$$$$$Y$$$20240925$$MD$DE$DE
243625551$24362555$1$I$$20240923$20240925$20240925$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001937$BLUEPRINT MEDICINES$$$$$F$Y$$$20240925$$CN$US$US
243625561$24362556$1$I$20240901$20240920$20240925$20240925$EXP$$US-ABBVIE-5933609$ABBVIE$$43$YR$$F$Y$$$20240925$$CN$US$US
243625571$24362557$1$I$20240101$20240920$20240925$20240925$EXP$$US-ABBVIE-5933574$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243625581$24362558$1$I$20240917$20240917$20240925$20240925$PER$$US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001380$ALEMBIC$$$$$$Y$$$20240925$$CN$US$US
243625591$24362559$1$I$20240101$20240920$20240925$20240925$EXP$$US-ABBVIE-5933633$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243625611$24362561$1$I$$20240919$20240925$20240925$EXP$$US-ORGANON-O2409USA001694$ORGANON$$$$$F$Y$$$20240925$$CN$US$US
243625621$24362562$1$I$20240915$20240917$20240925$20240925$EXP$$ES-ABBVIE-5937312$ABBVIE$$75$YR$$M$Y$$$20240925$$CN$ES$ES
243625631$24362563$1$I$20240913$20240925$20240925$20240925$DIR$719812$$FDA-CTU$$46$YR$$F$N$$$20240925$N$HP$US$
243625641$24362564$1$I$20240627$20240917$20240925$20240925$EXP$$JP-ROCHE-10000016126$ROCHE$$8$DEC$E$M$Y$$$20240925$$MD$JP$JP
243625651$24362565$1$I$20240101$20240920$20240925$20240925$EXP$$CA-ABBVIE-5933845$ABBVIE$$52$YR$$F$Y$$$20240925$$CN$CA$CA
243625661$24362566$1$I$20240924$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190819$AMGEN$$67$YR$E$F$Y$$$20240925$$CN$US$US
243625671$24362567$1$I$$20240924$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151670$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240925$$CN$US$US
243625681$24362568$1$I$20240918$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150891$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240925$$CN$US$US
243625691$24362569$1$I$20240916$20240923$20240925$20240925$EXP$$US-DENDREON PHARMACEUTICAL LLC-2024DEN000297$DENDREON$$$$$$Y$$$20240925$$HP$US$US
243625701$24362570$1$I$$20240920$20240925$20240925$EXP$$BG-ABBVIE-5933470$ABBVIE$$$$$M$Y$$$20240925$$CN$BG$BG
243625741$24362574$1$I$$20240918$20240925$20240925$EXP$$US-OTSUKA-2024_026159$OTSUKA$$$$A$F$Y$$$20240925$$HP$US$US
243625751$24362575$1$I$$20240920$20240925$20240925$PER$$US-BIOGEN-2024BI01283690$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243625761$24362576$1$I$$20240918$20240925$20240925$EXP$$CA-GSK-CA2024116097$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$CA$CA
243625771$24362577$1$I$20240801$20240920$20240925$20240925$EXP$$US-SA-2024SA274812$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240925$$HP$US$US
243625781$24362578$1$I$20220101$20240917$20240925$20240925$EXP$$JP-SA-2024SA276835$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240925$$CN$JP$JP
243625811$24362581$1$I$$20240916$20240925$20240925$EXP$$US-TAKEDA-2024TUS092610$TAKEDA$$$$$$Y$$$20240925$$CN$US$US
243625821$24362582$1$I$$20240919$20240925$20240925$EXP$$US-SA-2024SA276052$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240925$$HP$US$US
243625841$24362584$1$I$20240601$20240910$20240925$20240925$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1151$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240925$$MD$US$US
243625851$24362585$1$I$20240908$20240919$20240925$20240925$EXP$FR-AFSSAPS-AVCF2024000612$FR-MYLANLABS-2024M1085759$MYLAN$$26$YR$$F$Y$$$20240925$$HP$FR$FR
243625871$24362587$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015587$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240925$$CN$US$US
243625881$24362588$1$I$20240920$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014757$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240925$$CN$US$US
243625891$24362589$1$I$20240923$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015377$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240925$$CN$US$US
243625901$24362590$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014521$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240925$$CN$US$US
243625911$24362591$1$I$$20240913$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409010702$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240925$$CN$US$US
243625921$24362592$1$I$20240920$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014314$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240925$$CN$US$US
243625931$24362593$1$I$$20240912$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409008501$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240925$$CN$US$US
243625941$24362594$1$I$20240901$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012765$ELI LILLY AND CO$$50$YR$A$$Y$$$20240925$$CN$US$US
243625951$24362595$1$I$20240801$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014857$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240925$$CN$US$US
243625961$24362596$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014698$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240925$$CN$US$US
243625971$24362597$1$I$$20240923$20240925$20240925$EXP$$CN-FERRINGPH-2024FE05374$FERRING$$$$$$Y$$$20240925$$CN$CN$CN
243625981$24362598$1$I$20240101$20240918$20240925$20240925$EXP$$US-FERRINGPH-2024FE05308$FERRING$$$$$$Y$$$20240925$$PH$US$US
243625991$24362599$1$I$$20240920$20240925$20240925$EXP$$US-ABBVIE-5933755$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243626001$24362600$1$I$20240805$20240916$20240925$20240925$EXP$FR-AFSSAPS-NY2024001045$FR-FERRINGPH-2024FE05265$FERRING$$$$$$Y$$$20240925$$MD$FR$FR
243626011$24362601$1$I$$20240919$20240925$20240925$EXP$$SA-TAKEDA-2024TUS081554$TAKEDA$$$$$F$Y$$$20240925$$CN$SA$SA
243626021$24362602$1$I$20240914$20240920$20240925$20240925$EXP$GB-MHRA-TPP27037237C20797556YC1726572370543$GB-MYLANLABS-2024M1086035$MYLAN$$11$YR$$F$Y$37$KG$20240925$$PH$GB$GB
243626031$24362603$1$I$$20240920$20240925$20240925$EXP$$US-INCYTE CORPORATION-2024IN010004$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243626041$24362604$1$I$$20240917$20240925$20240925$EXP$GB-MHRA-MIDB-453b32be-2e4d-4cc4-8a91-04dfebc18a89$GB-TEVA-VS-3244889$TEVA$$92$YR$$F$Y$$$20240925$$HP$GB$GB
243626051$24362605$1$I$$20240918$20240925$20240925$EXP$$NVSC2024VN188926$NOVARTIS$Dang Nguyen TB, Huynh MV. Ghep te bao goc dong loai lan hai trong dieu tri cac truong hop thai ghep/tai phat tai benh vien tmhh tp hcm [The second allogeneic hematopoietic stem cell transplantation in treatment of relapse/rejection cases at blood transfusion hematology hospital, ho chi minh city]. VIETNAM MEDICAL JOURNAL. 2022;520:51-7$36$YR$$F$Y$$$20240925$$HP$VN$VN
243626071$24362607$1$I$$20240920$20240925$20240925$EXP$$US-INCYTE CORPORATION-2024IN010002$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243626082$24362608$2$F$$20240917$20240925$20240926$PER$$US-JNJFOC-20240935795$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
243626091$24362609$1$I$$20240917$20240925$20240925$PER$$US-AMGEN-USASP2024187041$AMGEN$Santoro J.D.; Ahsan S.; Lafarpour S. et.al. Anti-CD20 Therapy in Children With Severe Epstein-Barr Virus-Associated Meningoencephalitis.. Journal of Child Neurology. 2024;1-6$16$YR$T$M$Y$$$20240925$$MD$US$US
243626111$24362611$1$I$20240821$20240924$20240925$20240925$EXP$$GB-JNJFOC-20240964620$JOHNSON AND JOHNSON$$36$YR$A$F$Y$114$KG$20240925$$MD$GB$GB
243626131$24362613$1$I$20240924$20240924$20240924$20240924$DIR$719642$$FDA-CTU$$54$YR$$F$N$135$KG$20240924$N$HP$US$
243626141$24362614$1$I$20240923$20240924$20240924$20240924$DIR$719665$$FDA-CTU$$73$YR$$F$N$$$20240924$N$PH$US$
243626151$24362615$1$I$20240924$20240924$20240924$20240924$DIR$719684$$FDA-CTU$$50$YR$$F$N$$$20240924$N$$US$
243626161$24362616$1$I$20240921$20240925$20240925$20240925$DIR$719811$$FDA-CTU$$44$YR$$F$N$70.65$KG$20240925$N$CN$US$
243626171$24362617$1$I$$20240918$20240925$20240925$EXP$$CA-TAKEDA-2024TUS093526$TAKEDA$$$$$F$Y$$$20240925$$MD$CA$CA
243626181$24362618$1$I$20240916$20240919$20240925$20240925$EXP$$US-JNJFOC-20240956321$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$US$US
243626201$24362620$1$I$$20240911$20240925$20240925$PER$$US-JNJFOC-20240964598$JOHNSON AND JOHNSON$$$$E$M$Y$$$20240925$$MD$US$US
243626211$24362621$1$I$20240915$20240923$20240925$20240925$EXP$$GB-PFIZER INC-202400261689$PFIZER$$27$YR$$M$Y$$$20240925$$PH$GB$GB
243626231$24362623$1$I$$20240925$20240925$20240925$EXP$$TH-PFIZER INC-PV202400125400$PFIZER$$$$$$Y$$$20240925$$CN$TH$TH
243626241$24362624$1$I$20240912$20240924$20240925$20240925$EXP$$CN-PFIZER INC-PV202400124933$PFIZER$$36$YR$$F$Y$95$KG$20240925$$HP$CN$CN
243626271$24362627$1$I$$20240924$20240925$20240925$EXP$$AU-PFIZER INC-202400262314$PFIZER$$71$YR$$M$Y$$$20240925$$MD$AU$AU
243626291$24362629$1$I$20240401$20240924$20240925$20240925$EXP$$NP-PFIZER INC-PV202400124728$PFIZER$$49$YR$$F$Y$$$20240925$$MD$NP$NP
243626301$24362630$1$I$20240906$20240923$20240925$20240925$EXP$$US-PFIZER INC-PV202400031411$PFIZER$$79$YR$$M$Y$$$20240925$$CN$US$US
243626311$24362631$1$I$$20240923$20240925$20240925$EXP$$US-PFIZER INC-202400262642$PFIZER$$$$E$M$Y$$$20240925$$MD$US$US
243626321$24362632$1$I$20240918$20240923$20240925$20240925$EXP$$CN-PFIZER INC-PV202400124348$PFIZER$$4$YR$$M$Y$23$KG$20240925$$HP$CN$CN
243626331$24362633$1$I$20240101$20240924$20240925$20240925$EXP$$TR-PFIZER INC-PV202400125204$PFIZER$$48$YR$$M$Y$$$20240925$$MD$TR$TR
243626351$24362635$1$I$$20240920$20240925$20240925$30DAY$$FR-PFIZER INC-202400260574$PFIZER$$15$YR$$M$Y$$$20240925$$CN$FR$FR
243626361$24362636$1$I$20240810$20240923$20240925$20240925$EXP$$FR-PFIZER INC-202400261436$PFIZER$$78$YR$$M$Y$112$KG$20240925$$MD$FR$FR
243626371$24362637$1$I$$20240924$20240925$20240925$EXP$$CA-PFIZER INC-202400262979$PFIZER$$73$YR$$M$Y$$$20240925$$MD$CA$CA
243626381$24362638$1$I$20240828$20240829$20240925$20240925$PER$$US-Eisai-EC-2024-173363$EISAI$$78$YR$E$F$Y$$$20240925$$CN$US$US
243626391$24362639$1$I$$20240920$20240925$20240925$EXP$$NVSC2024PL188073$NOVARTIS$Basak GW, Wiktor-jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G et al.. Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT. AMERICAN JOURNAL OF TRANSPLANTATION. 2015;15:705?14$12$YR$$F$Y$$$20240925$$HP$PL$PL
243626401$24362640$1$I$$20240917$20240925$20240925$PER$$JP-Eisai-EC-2024-174715$EISAI$Ayaka Takashima. A case of head hemangiosarcoma with metastases to gastrointestinal tract. Proceedings of the 76th Annual Meeting of the Western Division of Japanese Dermatological Association. 2024; -(-): 54-.$82$YR$E$F$Y$$$20240925$$MD$JP$JP
243626411$24362641$1$I$20240901$20240917$20240925$20240925$EXP$$CH-Eisai-EC-2024-174669$EISAI$$79$YR$E$F$Y$70$KG$20240925$$MD$CH$CH
243626431$24362643$1$I$$20240919$20240925$20240925$PER$$US-ROCHE-10000087586$ROCHE$$$$A$M$Y$$$20240925$$CN$US$US
243626441$24362644$1$I$$20240914$20240925$20240925$EXP$$CN-ROCHE-10000081662$ROCHE$Dong G, Gao P, Shi F, Yu J, Zhu J. Acute kidney injury associated with thrombotic microangiopathy Characterization, prevalence, and prognosis. Medicine (United States). 2024-Aug-30;103 (35):1-6. doi:10.1097/MD.0000000000039431.$$$$$Y$$$20240925$$HP$CN$CN
243626451$24362645$1$I$$20240923$20240925$20240925$PER$$US-ROCHE-10000089794$ROCHE$$$$C$M$Y$$$20240925$$CN$US$US
243626461$24362646$1$I$$20240911$20240925$20240925$EXP$$DE-SCIEGENP-2024SCLIT00370$SCIEGEN$Shamseldin M, et al.Anatomic locations of ureterovascular  fstulae: a review of 532 patients in the literature  and a new series of 8 patients.CVIR Endovascular.14-Aug-2024;7 (1):01-15$80$YR$E$F$Y$$$20240925$$HP$DE$DE
243626471$24362647$1$I$20230101$20240916$20240925$20240925$EXP$$CO-ABBVIE-5903041$ABBVIE$$$$$F$Y$73$KG$20240925$$CN$CO$CO
243626481$24362648$1$I$$20240923$20240925$20240925$PER$$US-ROCHE-10000089649$ROCHE$$$$$$Y$$$20240925$$PH$US$US
243626491$24362649$1$I$$20240919$20240925$20240925$EXP$$US-INCYTE CORPORATION-2024IN009949$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243626501$24362650$1$I$20240829$20240924$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151699$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$63.5$KG$20240925$$MD$US$US
243626521$24362652$1$I$$20240911$20240925$20240925$EXP$$DE-SCIEGENP-2024SCLIT00371$SCIEGEN$Shamseldin M, et al.Anatomic locations of ureterovascular  fstulae: a review of 532 patients in the literature  and a new series of 8 patients.CVIR Endovascular.14-Aug-2024;7 (1):01-15$84$YR$E$M$Y$$$20240925$$HP$DE$DE
243626531$24362653$1$I$20240919$20240920$20240925$20240925$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000973$PAREXEL$$$$$$Y$$$20240925$$HP$CN$CN
243626541$24362654$1$I$$20240911$20240925$20240925$EXP$$US-SCIEGENP-2024SCLIT00368$SCIEGEN$Hennen M-A, et al.An unwelcome side-effect of trazodone use in a trans-male.Psychiatry and Clinical Neurosciences.2024;78(6):376-8$24$YR$A$M$Y$$$20240925$$HP$US$US
243626551$24362655$1$I$$20240917$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009871$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243626561$24362656$1$I$$20240918$20240925$20240925$EXP$$CN-TAKEDA-2024TUS093367$TAKEDA$$$$$M$Y$$$20240925$$CN$CN$CN
243626571$24362657$1$I$$20240919$20240925$20240925$PER$$US-TAKEDA-2024TUS093495$TAKEDA$$$$$M$Y$$$20240925$$CN$US$US
243626581$24362658$1$I$20240910$20240924$20240925$20240925$PER$$US-ROCHE-10000090624$ROCHE$$16$YR$T$M$Y$$$20240925$$CN$US$US
243626591$24362659$1$I$20240101$20240917$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009858$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243626611$24362661$1$I$$20240924$20240925$20240925$PER$$US-ROCHE-10000090467$ROCHE$$50$YR$A$M$Y$$$20240925$$PH$US$US
243626621$24362662$1$I$20210501$20240917$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009857$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243626631$24362663$1$I$$20240922$20240925$20240925$EXP$$EG-TAKEDA-2024TUS094433$TAKEDA$$$$$$Y$$$20240925$$MD$EG$EG
243626641$24362664$1$I$$20240913$20240925$20240925$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015108$JAZZ$$16$YR$$$Y$$$20240925$$CN$US$US
243626651$24362665$1$I$$20240909$20240925$20240925$30DAY$$AE-JNJFOC-20240949858$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$AE$AE
243626661$24362666$1$I$$20240911$20240925$20240925$EXP$$US-Axsome Therapeutics, Inc.-AXS202409-001433$AXSOME THERAPEUTICS$$$$$M$Y$$$20240925$$HP$US$
243626681$24362668$1$I$$20240924$20240924$20240924$DIR$719644$$FDA-CTU$$$$$UNK$N$$$20240924$$CN$US$
243626711$24362671$1$I$$20240923$20240925$20240925$EXP$$US-BIOVITRUM-2024-US-012408$BIOVITRUM$Tuffy KM, Ahani B, Domachowske JB, Furuno K, Ji H, Madhi SA, et al. Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab. Vaccine. 2024;42(24): 1-12. doi:10.1016/j.vaccine.2024.126276.$$$I$$Y$$$20240925$$HP$US$US
243626721$24362672$1$I$$20240920$20240925$20240925$EXP$$US-PURDUE PHARMA-USA-2024-0312120$PURDUE$$$$$M$Y$$$20240925$$CN$US$US
243626741$24362674$1$I$$20240920$20240925$20240925$EXP$$DK-PURDUE-USA-2024-0312137$PURDUE$Plaehn G, Fuglsang T, Hindersson P, Breindahl T.. Adverse effects from counterfeit and mislabeled medicine containing tapentadol and carisoprodol. Clin-Case-Rep.. 2024;12(8):1-6$16$YR$$$Y$$$20240925$$HP$DK$DK
243626761$24362676$1$I$$20240920$20240925$20240925$PER$$US-Blueprint Medicines Corporation-SO-US-2024-001924$BLUEPRINT MEDICINES$$34$YR$A$M$Y$$$20240925$$MD$US$US
243626772$24362677$2$F$$20240924$20240925$20240926$EXP$$IN-VANTIVE-2024VAN020005$Vantive US Healthcare$$50$YR$$F$Y$$$20240926$$CN$IN$IN
243626781$24362678$1$I$$20240916$20240925$20240925$EXP$$GR-VANTIVE-2024VAN019901$Vantive US Healthcare$$$$$F$Y$$$20240925$$CN$GR$GR
243626791$24362679$1$I$$20240917$20240925$20240925$EXP$$FR-VANTIVE-2024VAN019882$Vantive US Healthcare$$$$$$Y$$$20240925$$MD$FR$FR
243626801$24362680$1$I$$20240919$20240925$20240925$EXP$$GR-VANTIVE-2024VAN020000$Vantive US Healthcare$$$$$F$Y$$$20240925$$CN$GR$GR
243626811$24362681$1$I$20240830$20240920$20240925$20240925$EXP$$SG-VANTIVE-2024VAN019907$Vantive US Healthcare$$57$YR$$F$Y$$$20240925$$CN$SG$SG
243626821$24362682$1$I$$20240730$20240925$20240925$PER$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00797$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240925$$CN$US$US
243626831$24362683$1$I$20240801$20240828$20240925$20240925$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00883$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240925$$CN$US$US
243626841$24362684$1$I$$20240917$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009819$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243626851$24362685$1$I$$20240920$20240925$20240925$EXP$PL-URPL-1-4342-2020$PL-JNJFOC-20240960184$JOHNSON AND JOHNSON$$28$YR$A$M$Y$92$KG$20240925$$MD$PL$PL
243626861$24362686$1$I$$20240919$20240925$20240925$EXP$$CA-PURDUE-USA-2024-0312142$PURDUE$$41$YR$$F$Y$$$20240925$$HP$CA$CA
243626881$24362688$1$I$20240923$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190505$AMGEN$$51$YR$A$F$Y$$$20240925$$CN$US$US
243626891$24362689$1$I$$20240917$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009497$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243626901$24362690$1$I$20240828$20240915$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009757$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243626921$24362692$1$I$20240831$20240920$20240925$20240925$EXP$$US-ABBVIE-5937290$ABBVIE$$81$YR$$M$Y$$$20240925$$CN$US$US
243626931$24362693$1$I$$20240923$20240925$20240925$EXP$$CA-JNJFOC-20240965827$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$PH$CA$CA
243626951$24362695$1$I$$20240918$20240925$20240925$EXP$$CA-HLS-202402362$HLS THERAPEUTICS$$$$E$F$Y$$$20240925$$HP$CA$CA
243626961$24362696$1$I$$20240916$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009792$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243626971$24362697$1$I$$20240911$20240925$20240925$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09155$LUPIN$$$$$$Y$$$20240925$$CN$US$US
243626981$24362698$1$I$$20240916$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009804$INCYTE$$$$$$Y$$$20240925$$MD$US$US
243626991$24362699$1$I$$20240918$20240925$20240925$EXP$$US-BIOMARINAP-US-2024-160665$BIOMARIN$$$$$$Y$$$20240925$$CN$US$US
243627001$24362700$1$I$20240628$20240918$20240925$20240925$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000966$PAREXEL$$$$$$Y$$$20240925$$HP$CN$CN
243627021$24362702$1$I$$20240920$20240925$20240925$EXP$$NVSC2024GB188304$NOVARTIS$$$$A$$Y$$$20240925$$CN$GB$GB
243627031$24362703$1$I$20240911$20240919$20240925$20240925$EXP$$JP-Eisai-EC-2024-174982$EISAI$$$$E$M$Y$$$20240925$$MD$JP$JP
243627041$24362704$1$I$20240902$20240919$20240925$20240925$EXP$$US-BIOMARINAP-US-2024-160720$BIOMARIN$$$$$$Y$$$20240925$$CN$US$US
243627061$24362706$1$I$$20240916$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009805$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243627071$24362707$1$I$20240829$20240917$20240925$20240925$DIR$FDA-CDER-CTU-2024-65632$$FDA-CTU$$76$YR$$M$N$$$20240917$N$HP$US$
243627081$24362708$1$I$$20240918$20240925$20240925$DIR$FDA-CDER-CTU-2024-65576$$FDA-CTU$$$$$M$N$$$20240918$N$HP$US$
243627091$24362709$1$I$$20240920$20240925$20240925$EXP$$US-SENTISSAG-2024SAGLIT-00018$Sentiss Pharma$Blush RR.Beta-Adrenergic Agonist-Induced Lactic Acidosis: A Case Report.AACN Advanced Critical Care.15-SEP-2024;35(3):222-227$54$YR$A$F$Y$$$20240925$$HP$US$US
243627101$24362710$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65588$$FDA-CTU$$63$YR$$M$N$$$20240925$N$$US$
243627111$24362711$1$I$$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65581$$FDA-CTU$$$$$M$N$$$20240924$N$HP$US$
243627131$24362713$1$I$20240912$20240912$20240925$20240925$DIR$FDA-CDER-CTU-2024-65578$$FDA-CTU$$68$YR$$M$N$$$20240912$N$HP$US$
243627141$24362714$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65685$$FDA-CTU$$35$YR$$F$N$$$20240925$N$$US$
243627151$24362715$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65688$$FDA-CTU$$63$YR$$F$N$$$20240925$N$$US$
243627171$24362717$1$I$$20240911$20240925$20240925$30DAY$$CA-JNJFOC-20240949419$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$CA$CA
243627181$24362718$1$I$20240801$20240917$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148416$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240925$$CN$US$US
243627191$24362719$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152064$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240925$$CN$US$US
243627201$24362720$1$I$20240908$20240914$20240925$20240925$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000964$PAREXEL$$$$$$Y$$$20240925$$HP$CN$CN
243627241$24362724$1$I$$20240919$20240925$20240925$PER$$US-PFIZER INC-PV202400123170$PFIZER$$39$YR$$F$Y$$$20240925$$CN$US$US
243627251$24362725$1$I$$20240919$20240925$20240925$PER$$US-PFIZER INC-202400260785$PFIZER$$5$YR$$M$Y$$$20240925$$CN$US$US
243627281$24362728$1$I$20240216$20240918$20240925$20240925$PER$$US-PFIZER INC-PV202400123135$PFIZER$$14$YR$$M$Y$76$KG$20240925$$MD$US$US
243627291$24362729$1$I$$20240816$20240925$20240925$DIR$FDA-CDER-CTU-2024-65687$$FDA-CTU$$$$$M$N$$$20240816$N$HP$US$
243627301$24362730$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65580$$FDA-CTU$$17$YR$$F$N$$$20240925$N$$US$
243627311$24362731$1$I$$20240923$20240925$20240925$PER$$US-ROCHE-10000090767$ROCHE$$$$A$F$Y$$$20240925$$CN$US$US
243627321$24362732$1$I$20240324$20240919$20240925$20240925$EXP$FR-AFSSAPS-NC2024001071$FR-MYLANLABS-2024M1085816$MYLAN$$15$YR$$F$Y$127$KG$20240925$$MD$FR$FR
243627331$24362733$1$I$$20240919$20240925$20240925$EXP$$NL-MYLANLABS-2024M1086033$MYLAN$Berghuis D, Mehyar LS, Abu-Arja R, Albert MH, Barnum JL, von Bernuth H et al.. Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study. J Clin Immunol.. 2024;44(8):182$$$T$M$Y$$$20240925$$MD$NL$NL
243627341$24362734$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65587$$FDA-CTU$$43$YR$$F$N$$$20240925$N$$US$
243627351$24362735$1$I$$20240910$20240925$20240925$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01483$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240925$$HP$US$US
243627391$24362739$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65575$$FDA-CTU$$$$$F$N$$$20240925$N$HP$US$
243627401$24362740$1$I$$20240917$20240925$20240925$30DAY$$CL-PFIZER INC-202400262988$PFIZER$$$$$$Y$$$20240925$$CN$CL$CL
243627421$24362742$1$I$$20240919$20240925$20240925$EXP$$US-PFIZER INC-PV202400123381$PFIZER$Keil, E.. Salvage treatment of Pneumocystis jirovecii pneumonia with micafungin and clindamycin: a case report. AME Medical Journal. 2024;10 (7):10.21037/amj-23-131$76$YR$$M$Y$81$KG$20240925$$PH$US$US
243627441$24362744$1$I$$20240918$20240925$20240925$EXP$$JP-009507513-2409JPN003105J$MERCK$$7$DEC$$M$Y$$$20240925$$MD$JP$JP
243627451$24362745$1$I$$20240921$20240925$20240925$PER$$DE-Blueprint Medicines Corporation-SO-DE-2024-001936$BLUEPRINT MEDICINES$$$$$$Y$$$20240925$$HP$DE$DE
243627471$24362747$1$I$$20240921$20240925$20240925$PER$$DE-Blueprint Medicines Corporation-SO-DE-2024-001938$BLUEPRINT MEDICINES$$$$$$Y$$$20240925$$HP$DE$DE
243627481$24362748$1$I$$20240920$20240925$20240925$PER$$US-BAYER-2024A135072$BAYER$$35$YR$A$F$Y$$$20240925$$HP$US$US
243627491$24362749$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190628$NOVARTIS$$$$$F$Y$$$20240925$$HP$US$US
243627501$24362750$1$I$$20240917$20240925$20240925$EXP$$US-PERRIGO-24US008987$PERRIGO$$$$A$$Y$$$20240925$$CN$US$US
243627511$24362751$1$I$$20240920$20240925$20240925$PER$$US-BAYER-2024A134768$BAYER$$26$YR$A$F$Y$$$20240925$$MD$US$US
243627521$24362752$1$I$$20240916$20240925$20240925$PER$$US-BAYER-2024A134614$BAYER$$$$$$Y$$$20240925$$CN$US$US
243627531$24362753$1$I$$20240913$20240925$20240925$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202409008708$ELI LILLY AND CO$$$$$$Y$$$20240925$$CN$ES$ES
243627541$24362754$1$I$20240601$20240917$20240925$20240925$EXP$$CO-JNJFOC-20240754663$JOHNSON AND JOHNSON$$57$YR$A$F$Y$51$KG$20240925$$HP$CO$CO
243627551$24362755$1$I$$20240913$20240925$20240925$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409009503$ELI LILLY AND CO$$$$$M$Y$$$20240925$$CN$FR$FR
243627561$24362756$1$I$20240904$20240914$20240925$20240925$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409009811$ELI LILLY AND CO$$63$YR$A$F$Y$45$KG$20240925$$CN$DE$CN
243627571$24362757$1$I$20240902$20240912$20240925$20240925$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202409008473$ELI LILLY AND CO$$76$YR$E$$Y$$$20240925$$CN$BE$BE
243627581$24362758$1$I$$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013951$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240925$$CN$US$US
243627591$24362759$1$I$20220101$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014362$ELI LILLY AND CO$$53$YR$A$$Y$$$20240925$$CN$US$US
243627601$24362760$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014865$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240925$$CN$US$US
243627611$24362761$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014400$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240925$$CN$US$US
243627621$24362762$1$I$20240711$20240913$20240925$20240925$EXP$GB-MHRA-MED-202409131415236910-ZLFPV$GB-ELI_LILLY_AND_COMPANY-GB202409009586$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240925$$CN$GB$GB
243627631$24362763$1$I$$20240913$20240925$20240925$EXP$$US-ELI_LILLY_AND_COMPANY-US202409009777$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240925$$CN$US$US
243627641$24362764$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015291$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240925$$CN$US$US
243627652$24362765$2$F$20240913$20240917$20240925$20240927$PER$$US-JNJFOC-20240940661$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$CN$US$US
243627661$24362766$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014702$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240925$$CN$US$US
243627671$24362767$1$I$$20240911$20240925$20240925$30DAY$$HR-JNJFOC-20240949264$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$HR$HR
243627681$24362768$1$I$20240916$20240923$20240925$20240925$EXP$$US-ROCHE-10000089373$ROCHE$$70$YR$E$M$Y$$$20240925$$CN$US$US
243627711$24362771$1$I$20240401$20240919$20240925$20240925$EXP$FR-AFSSAPS-PB2024000983$FR-009507513-2409FRA006863$MERCK$$47$YR$$F$Y$87$KG$20240925$$HP$FR$FR
243627721$24362772$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65693$$FDA-CTU$$49$YR$$F$N$$$20240925$N$$US$
243627731$24362773$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65589$$FDA-CTU$$71$YR$$M$N$275$LBS$20240925$N$$US$
243627741$24362774$1$I$$20240914$20240925$20240925$EXP$$US-JNJFOC-20240940318$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$US$US
243627751$24362775$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65672$$FDA-CTU$$23$YR$$M$N$$$20240925$N$$US$
243627771$24362777$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65585$$FDA-CTU$$65$YR$$F$N$$$20240925$N$$US$
243627791$24362779$1$I$20240917$20240923$20240925$20240925$EXP$$DE-JNJFOC-20240966015$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240925$$CN$DE$DE
243627821$24362782$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65689$$FDA-CTU$$90$YR$$F$N$132$LBS$20240925$N$$US$
243627831$24362783$1$I$$20240918$20240925$20240925$EXP$$EG-EMD Serono-2024050223$EMD SERONO INC$$44$YR$A$F$Y$$$20240925$$CN$EG$EG
243627841$24362784$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65691$$FDA-CTU$$60$YR$$F$N$171$LBS$20240925$N$$US$
243627851$24362785$1$I$20240101$20240920$20240925$20240925$EXP$$BR-ORGANON-O2409BRA001777$ORGANON$$16$YR$$F$Y$$$20240925$$CN$BR$BR
243627861$24362786$1$I$20240904$20240911$20240925$20240925$EXP$GB-MHRA-MED-202409111602459140-PBRKZ$GB-BAXTER-2024BAX024604$BAXTER$$55$YR$$M$Y$84$KG$20240925$$PH$GB$GB
243627871$24362787$1$I$$20240923$20240925$20240925$EXP$$NVSC2024US189555$NOVARTIS$$$$$$Y$$$20240925$$HP$US$US
243627881$24362788$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65695$$FDA-CTU$$49$YR$$F$N$200$LBS$20240925$N$$US$
243627911$24362791$1$I$$20240924$20240925$20240925$EXP$$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053130$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240925$$CN$GB$GB
243627921$24362792$1$I$$20240913$20240925$20240925$PER$$US-ABBVIE-5930869$ABBVIE$$$$$F$Y$$$20240925$$MD$US$US
243627931$24362793$1$I$20240101$20240918$20240925$20240925$EXP$$JP-Eisai-EC-2024-174731$EISAI$$84$YR$E$M$Y$$$20240925$$MD$JP$JP
243627951$24362795$1$I$$20240913$20240925$20240925$EXP$$BE-ACRAF SpA-2024-035841$SK LIFE SCIENCE$$$$$$Y$$$20240925$$MD$BE$BE
243627961$24362796$1$I$20240829$20240921$20240925$20240925$EXP$$CN-DSJP-DS-2024-100992-CN$DAIICHI$$39$YR$$F$Y$52$KG$20240925$$HP$CN$CN
243627981$24362798$1$I$20240901$20240916$20240925$20240925$PER$$US-JNJFOC-20240940748$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240925$$PH$US$US
243627991$24362799$1$I$20240101$20240918$20240925$20240925$PER$$US-JNJFOC-20240948337$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240925$$CN$US$US
243628001$24362800$1$I$$20240918$20240925$20240925$EXP$$US-JNJFOC-20240948430$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$US$US
243628011$24362801$1$I$20240101$20240906$20240925$20240925$EXP$$US-SA-2024SA275190$SANOFI AVENTIS$$54$YR$A$F$Y$84$KG$20240925$$MD$US$US
243628022$24362802$2$F$$20240925$20240925$20240927$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006776$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243628041$24362804$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65584$$FDA-CTU$$53$YR$$F$N$$$20240925$N$$US$
243628061$24362806$1$I$$20240923$20240925$20240925$EXP$$US-SA-2024SA276140$SANOFI AVENTIS$SAAD E, ABDALLA M, SOROUR L, TRUONG H, GOGIA S, SINGH A.. A RARE CASE OF UNILATERAL PHRENIC NERVE PALSY IN ASSOCIATION WITH PLATINUM-BASED CHEMOTHERAPY.. Chest.. 2024;166(4):A6122-3.$77$YR$E$F$Y$$$20240925$$HP$US$US
243628071$24362807$1$I$20240917$20240917$20240925$20240925$EXP$$ES-SA-2024SA275776$SANOFI AVENTIS$$60$YR$A$F$Y$115.7$KG$20240925$$MD$ES$ES
243628081$24362808$1$I$$20240918$20240925$20240925$EXP$$US-ALKERMES INC.-ALK-2024-002422$ALKERMES$$2$DEC$$F$Y$$$20240925$$HP$US$US
243628091$24362809$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65690$$FDA-CTU$$90$YR$$F$N$$$20240925$N$$US$
243628151$24362815$1$I$20240909$20240913$20240925$20240925$DIR$FDA-CDER-CTU-2024-65577$$FDA-CTU$$16$YR$$M$N$$$20240913$N$HP$US$
243628161$24362816$1$I$20240918$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65615$$FDA-CTU$$79$YR$$M$N$$$20240925$N$CN$US$
243628171$24362817$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65651$$FDA-CTU$$63$YR$$F$N$133$LBS$20240925$N$$US$
243628181$24362818$1$I$20240914$20240924$20240924$20240924$DIR$719689$$FDA-CTU$$29$YR$$F$N$$$20240924$N$HP$US$
243628191$24362819$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65708$$FDA-CTU$$54$YR$$F$N$144$LBS$20240925$N$$US$
243628201$24362820$1$I$$20240913$20240925$20240925$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18805$IPSEN$$$$$$Y$$$20240925$$HP$US$US
243628211$24362821$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244788$TEVA$$57$YR$$M$Y$76$KG$20240925$$HP$CA$CA
243628221$24362822$1$I$20240101$20240911$20240925$20240925$PER$$US-MRZWEB-2024090000092$MERZ$$$$$$Y$$$20240925$$MD$US$US
243628231$24362823$1$I$$20240920$20240925$20240925$PER$$US-BIOGEN-2024BI01283881$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243628241$24362824$1$I$$20240920$20240925$20240925$PER$$DE-Blueprint Medicines Corporation-SO-DE-2024-001932$BLUEPRINT MEDICINES$$$$$$Y$$$20240925$$HP$DE$DE
243628251$24362825$1$I$20240923$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65631$$FDA-CTU$$$$$$N$$$20240923$N$CN$US$
243628261$24362826$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65709$$FDA-CTU$$65$YR$$F$N$$$20240925$N$$US$
243628271$24362827$1$I$$20240917$20240925$20240925$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18715$IPSEN$$$$$M$Y$$$20240925$$HP$US$US
243628281$24362828$1$I$$20240920$20240925$20240925$EXP$$US-PERRIGO-24US008951$PERRIGO$$$$$M$Y$$$20240925$$CN$US$US
243628291$24362829$1$I$20240801$20240923$20240925$20240925$EXP$CZ-CZSUKL-24002584$CZ-GSK-CZ2024117932$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$PH$CZ$CZ
243628301$24362830$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65710$$FDA-CTU$$79$YR$$M$N$$$20240925$N$$US$
243628311$24362831$1$I$20240502$20240923$20240925$20240925$EXP$$CN-BAYER-2024A135751$BAYER$$19$YR$A$F$Y$50$KG$20240925$$HP$CN$CN
243628331$24362833$1$I$20240828$20240919$20240925$20240925$EXP$FR-AFSSAPS-CN2024000856$FR-TEVA-VS-3246005$TEVA$$81$YR$$M$Y$87$KG$20240925$$PH$FR$FR
243628351$24362835$1$I$$20240920$20240925$20240925$EXP$$US-ABBVIE-5934205$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243628371$24362837$1$I$20240904$20240918$20240925$20240925$EXP$$EG-EMD Serono-2024050273$EMD SERONO INC$$31$YR$A$F$Y$$$20240925$$CN$EG$EG
243628391$24362839$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65713$$FDA-CTU$$58$YR$$F$N$159$LBS$20240925$N$$US$
243628421$24362842$1$I$$20240924$20240925$20240925$EXP$$US-SANDOZ INC.-SDZ2024US082743$SANDOZ$$$$$F$Y$$$20240925$$HP$US$US
243628431$24362843$1$I$$20240924$20240924$20240924$DIR$719719$$FDA-CTU$$$$$UNK$N$$$20240924$$CN$US$
243628451$24362845$1$I$$20240917$20240925$20240925$EXP$$MX-SANDOZ INC.-SDZ2024MX082254$SANDOZ$$91$YR$$M$Y$$$20240925$$CN$MX$MX
243628461$24362846$1$I$$20240913$20240925$20240925$EXP$$NVSC2024US190602$NOVARTIS$$29$YR$$F$Y$84.354$KG$20240925$$CN$US$US
243628471$24362847$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65612$$FDA-CTU$$$$$$N$$$20240923$$CN$US$
243628481$24362848$1$I$$20240921$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014890$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240925$$CN$US$US
243628501$24362850$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151120$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240925$$CN$US$US
243628511$24362851$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151928$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240925$$CN$US$US
243628521$24362852$1$I$20240101$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151245$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240925$$CN$US$US
243628531$24362853$1$I$20240823$20240917$20240925$20240925$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013836$JAZZ$$49$YR$$F$Y$$$20240925$$CN$US$US
243628541$24362854$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65604$$FDA-CTU$$$$$$N$$$20240923$N$CN$US$
243628551$24362855$1$I$20240409$20240919$20240925$20240925$EXP$$IN-PFIZER INC-202200764319$PFIZER$$45$YR$$M$Y$$$20240925$$CN$IN$IN
243628561$24362856$1$I$20240816$20240919$20240925$20240925$EXP$$CN-PFIZER INC-PV202400123037$PFIZER$$7$YR$$M$Y$25$KG$20240925$$HP$CN$CN
243628571$24362857$1$I$20240920$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024188688$AMGEN$$25$YR$A$F$Y$$$20240925$$CN$US$US
243628581$24362858$1$I$$20240918$20240925$20240925$EXP$$BR-TAKEDA-2021TUS021024$TAKEDA$$$$$F$Y$$$20240925$$MD$BR$BR
243628591$24362859$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244734$TEVA$$43$YR$$F$Y$89$KG$20240925$$HP$CA$CA
243628601$24362860$1$I$20240904$20240911$20240925$20240925$EXP$$US-BAYER-2024A131033$BAYER$$16$YR$T$M$Y$$$20240925$$CN$US$US
243628611$24362861$1$I$20230101$20240917$20240925$20240925$EXP$$MX-INCYTE CORPORATION-2024IN009518$INCYTE$$$$$$Y$$$20240925$$CN$MX$MX
243628621$24362862$1$I$$20240924$20240925$20240925$EXP$$US-SANDOZ INC.-SDZ2024US082751$SANDOZ$$$$$M$Y$$$20240925$$CN$US$US
243628631$24362863$1$I$$20240923$20240925$20240925$EXP$$US-BAYER-2024A135852$BAYER$$75$YR$E$M$Y$$$20240925$$CN$US$US
243628641$24362864$1$I$20171101$20240914$20240925$20240925$EXP$$CA-SANDOZ INC.-PHHY2018CA017698$SANDOZ$$60$YR$$F$Y$73$KG$20240925$$CN$CA$CA
243628651$24362865$1$I$20220101$20240919$20240925$20240925$EXP$GE-MLMSERVICE-20240903-PI182589-00306-1$GE-ROCHE-10000086320$ROCHE$Skalak HM, Haas K, Laub M, Mulloy LL. New onset diabetic ketoacidosis in a renal transplant recipient. The American journal of the medical sciences. 2024. DOI:10.1016/j.amjms.2024.08.023.$38$YR$A$M$Y$$$20240925$$HP$GE$GE
243628671$24362867$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65716$$FDA-CTU$$55$YR$$F$N$265$LBS$20240925$N$$US$
243628681$24362868$1$I$20240805$20240924$20240924$20240924$DIR$719708$$FDA-CTU$$49$YR$$F$N$71.4$KG$20240924$N$PH$US$
243628691$24362869$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65712$$FDA-CTU$$51$YR$$F$N$46$LBS$20240925$N$$US$
243628711$24362871$1$I$$20240924$20240924$20240924$DIR$719700$$FDA-CTU$$$$$UNK$N$$$20240924$$CN$US$
243628721$24362872$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65613$$FDA-CTU$$$$$$N$$$20240923$$CN$US$
243628731$24362873$1$I$20240925$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65717$$FDA-CTU$$34$YR$$F$N$$$20240925$Y$PH$US$
243628741$24362874$1$I$20231216$20240924$20240924$20240924$DIR$719781$$FDA-CTU$$37$YR$$F$N$81$KG$20240924$N$CN$US$
243628751$24362875$1$I$20230920$20240924$20240924$20240924$DIR$719783$$FDA-CTU$$69$YR$$M$N$87.75$KG$20240924$N$CN$US$
243628761$24362876$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65640$$FDA-CTU$$$$$$N$$$20240923$$CN$US$
243628771$24362877$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65599$$FDA-CTU$$$$$$N$$$20240923$N$CN$US$
243628781$24362878$1$I$20240909$20240925$20240925$20240925$DIR$719825$$FDA-CTU$$69$YR$$M$N$$$20240925$N$PH$US$
243628791$24362879$1$I$20240910$20240914$20240925$20240925$DIR$FDA-CDER-CTU-2024-65545$$FDA-CTU$$73$YR$$M$N$170$LBS$20240914$N$CN$US$
243628801$24362880$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65607$$FDA-CTU$$$$$$N$$$20240923$$CN$US$
243628811$24362881$1$I$20240922$20240925$20240925$20240925$DIR$719826$$FDA-CTU$$64$YR$$F$N$$$20240925$N$HP$US$
243628821$24362882$1$I$20240821$20240925$20240925$20240925$DIR$719813$$FDA-CTU$$54$YR$$F$N$83.7$KG$20240925$N$CN$US$
243628831$24362883$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65643$$FDA-CTU$$$$$$N$$$20240923$$CN$US$
243628841$24362884$1$I$20220814$20240924$20240925$20240925$EXP$FR-AFSSAPS-AN20222554$FR-SANDOZ INC.-NVSC2022FR291780$SANDOZ$$34$YR$$F$Y$78.9$KG$20240925$$PH$FR$FR
243628851$24362885$1$I$20231201$20240917$20240925$20240925$EXP$$CO-SANDOZ INC.-SDZ2024CO082598$SANDOZ$$53$YR$$F$Y$72$KG$20240925$$CN$CO$CO
243628861$24362886$1$I$$20240920$20240925$20240925$EXP$$CN-SANDOZ INC.-SDZ2024CN081788$SANDOZ$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. West China Journal of Stomatology. 2024;1-7$63$YR$$M$Y$$$20240925$$HP$CN$CN
243628871$24362887$1$I$$20240919$20240925$20240925$EXP$$US-TAKEDA-2024TUS093456$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
243628881$24362888$1$I$20200109$20240919$20240925$20240925$EXP$$CA-TAKEDA-2024TUS094001$TAKEDA$$55$YR$$M$Y$$$20240925$$MD$CA$CA
243628891$24362889$1$I$20240918$20240918$20240925$20240925$EXP$$CN-GSK-CN2024APC116237$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$CN$CN
243628911$24362891$1$I$20230101$20240920$20240925$20240925$PER$$US-JNJFOC-20240956618$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243628921$24362892$1$I$20240907$20240920$20240925$20240925$EXP$$US-ABBVIE-5934195$ABBVIE$$77$YR$$M$Y$$$20240925$$CN$US$US
243628931$24362893$1$I$$20240916$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150227$BRISTOL MYERS SQUIBB$Adkins K, Williams RJ, Esteso P, Kobayashi R, Gauvreau K, VanderPluym C, et al. Real-world use and outcomes of apixaban for early post-surgical fontan thromboprophylaxis. Pediatric Cardiology. 2024 Sep 12;doi:10.1007/s00246-024-03641-3.$$$C$$Y$$$20240925$$HP$US$US
243628941$24362894$1$I$20240921$20240921$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150931$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240925$$PH$US$US
243628951$24362895$1$I$$20240920$20240925$20240925$EXP$$US-PFIZER INC-2022SGN08754$PFIZER$$30$YR$$M$Y$$$20240925$$MD$US$US
243628961$24362896$1$I$20240730$20240924$20240925$20240925$EXP$GB-MHRA-MED-202409241412470800-VFZRK$GB-SANDOZ INC.-SDZ2024GB082816$SANDOZ$$76$YR$$F$Y$89$KG$20240925$$MD$GB$GB
243628971$24362897$1$I$20240812$20240920$20240925$20240925$EXP$$US-ABBVIE-5933606$ABBVIE$$79$YR$$M$Y$$$20240925$$CN$US$US
243628981$24362898$1$I$$20240920$20240925$20240925$EXP$$CN-SANDOZ INC.-SDZ2024CN082496$SANDOZ$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. West China Journal of Stomatology. 2024;1-7$$$$F$Y$$$20240925$$HP$CN$CN
243628991$24362899$1$I$$20240918$20240925$20240925$EXP$$CA-GSK-CA2024AMR117244$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$CA$CA
243629001$24362900$1$I$$20240920$20240925$20240925$EXP$$CA-SANDOZ INC.-NVSC2023CA130830$SANDOZ$$$$$F$Y$$$20240925$$CN$CA$CA
243629011$24362901$1$I$20240912$20240923$20240925$20240925$EXP$GB-MHRA-WEBRADR-202409232130526760-BTRHN$GB-SANDOZ INC.-SDZ2024GB082458$SANDOZ$$45$YR$$F$Y$74$KG$20240925$$CN$GB$GB
243629021$24362902$1$I$$20240830$20240925$20240925$PER$$US-Eisai-EC-2024-173519$EISAI$$$$$$Y$$$20240925$$HP$US$US
243629031$24362903$1$I$$20240920$20240925$20240925$PER$$US-JNJFOC-20240956596$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243629041$24362904$1$I$$20240916$20240925$20240925$PER$$US-JNJFOC-20240945975$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$US$US
243629051$24362905$1$I$$20240916$20240925$20240925$PER$$US-JNJFOC-20240941898$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243629061$24362906$1$I$$20240924$20240925$20240925$EXP$$DE-SANDOZ INC.-SDZ2024DE082744$SANDOZ$$$$A$$Y$$$20240925$$HP$DE$DE
243629071$24362907$1$I$$20240923$20240925$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US082319$SANDOZ$$$$$M$Y$$$20240925$$HP$US$US
243629081$24362908$1$I$20240904$20240919$20240925$20240925$EXP$$PK-ROCHE-10000086908$ROCHE$$65$YR$E$M$Y$$$20240925$$CN$PK$PK
243629091$24362909$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151757$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240925$$HP$US$US
243629101$24362910$1$I$$20240920$20240925$20240925$EXP$$DE-TAKEDA-2024TUS094675$TAKEDA$$$$$M$Y$$$20240925$$CN$GB$DE
243629111$24362911$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151918$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240925$$CN$US$US
243629121$24362912$1$I$20240811$20240914$20240925$20240925$PER$$CA-TOLMAR, INC.-24CA051806$TOLMAR$$67$YR$$M$Y$$$20240924$$CN$CA$CA
243629131$24362913$1$I$$20240923$20240925$20240925$EXP$$CA-SANDOZ INC.-SDZ2023CA055436$SANDOZ$$$$$F$Y$$$20240925$$CN$CA$CA
243629141$24362914$1$I$20240101$20240924$20240925$20240925$EXP$IE-HPRA-2024-114610$IE-SANDOZ INC.-SDZ2024IE070789$SANDOZ$$77$YR$$F$Y$$$20240925$$CN$IE$IE
243629151$24362915$1$I$$20240924$20240925$20240925$PER$$US-ABBVIE-5938258$ABBVIE$$$$$$Y$$$20240925$$CN$US$US
243629161$24362916$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190822$NOVARTIS$$$$$$Y$$$20240925$$HP$US$US
243629181$24362918$1$I$20240207$20240925$20240925$20240925$DIR$719814$$FDA-CTU$$49$YR$$F$N$101.2$KG$20240925$N$PH$US$
243629191$24362919$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190827$NOVARTIS$$$$$$Y$$$20240925$$HP$US$US
243629201$24362920$1$I$$20240924$20240925$20240925$EXP$$ES-SANDOZ INC.-SDZ2024ES082470$SANDOZ$$50$YR$$M$Y$$$20240925$$HP$ES$ES
243629211$24362921$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65624$$FDA-CTU$$$$$$N$$$20240923$$CN$US$
243629221$24362922$1$I$20240826$20240925$20240925$20240925$DIR$719815$$FDA-CTU$$51$YR$$F$N$88.8$KG$20240925$N$HP$US$
243629241$24362924$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-202400246882$PFIZER$$83$YR$$F$Y$$$20240925$$CN$US$US
243629251$24362925$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-PV202400124573$PFIZER$$55$YR$$F$Y$$$20240925$$HP$US$US
243629261$24362926$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-202400262418$PFIZER$$71$YR$$F$Y$$$20240925$$CN$US$US
243629271$24362927$1$I$$20240920$20240925$20240925$PER$$US-PFIZER INC-202400262264$PFIZER$$67$YR$$M$Y$$$20240925$$CN$US$US
243629281$24362928$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-202400261969$PFIZER$$$$E$M$Y$$$20240925$$MD$US$US
243629291$24362929$1$I$20240923$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65594$$FDA-CTU$$75$YR$$F$N$$$20240923$N$HP$US$
243629301$24362930$1$I$20240924$20240925$20240925$20240925$DIR$719816$$FDA-CTU$$76$YR$$M$N$$$20240925$Y$PH$US$
243629311$24362931$1$I$$20240917$20240925$20240925$EXP$$JP-ROCHE-10000089990$ROCHE$$60$YR$A$F$Y$$$20240925$$HP$JP$JP
243629321$24362932$1$I$$20240920$20240925$20240925$PER$$US-PFIZER INC-PV202400124769$PFIZER$$87$YR$$M$Y$$$20240925$$HP$US$US
243629341$24362934$1$I$$20240925$20240925$20240925$DIR$719823$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243629351$24362935$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-202400030283$PFIZER$$70$YR$$M$Y$$$20240925$$CN$US$US
243629361$24362936$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-202400262427$PFIZER$$$$$F$Y$$$20240925$$HP$US$US
243629371$24362937$1$I$$20240920$20240925$20240925$PER$$US-PFIZER INC-PV202400123801$PFIZER$$$$$F$Y$$$20240925$$HP$US$US
243629381$24362938$1$I$20240920$20240923$20240925$20240925$PER$$US-PFIZER INC-202400261916$PFIZER$$86$YR$$F$Y$91.63$KG$20240925$$CN$US$US
243629391$24362939$1$I$20240901$20240923$20240925$20240925$PER$$US-PFIZER INC-202400262263$PFIZER$$23$YR$$M$Y$$$20240925$$CN$US$US
243629401$24362940$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65719$$FDA-CTU$$73$YR$$F$N$$$20240925$N$HP$US$
243629411$24362941$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-202400263051$PFIZER$$24$YR$$F$Y$$$20240925$$CN$US$US
243629431$24362943$1$I$20221210$20240920$20240925$20240925$PER$$US-PFIZER INC-2022SGN11798$PFIZER$$$$$M$Y$$$20240925$$MD$US$US
243629441$24362944$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-PV202400125062$PFIZER$$49$YR$$F$Y$$$20240925$$HP$US$US
243629451$24362945$1$I$$20240920$20240925$20240925$EXP$$CN-SANDOZ INC.-SDZ2024CN082498$SANDOZ$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. West China Journal of Stomatology. 2024;1-7$70$YR$$M$Y$$$20240925$$HP$CN$CN
243629461$24362946$1$I$$20240920$20240925$20240925$PER$$US-PFIZER INC-PV202400116215$PFIZER$$80$YR$$F$Y$$$20240925$$HP$US$US
243629471$24362947$1$I$20240923$20240923$20240925$20240925$PER$$US-PFIZER INC-202400262260$PFIZER$$$$$$Y$$$20240925$$CN$US$US
243629482$24362948$2$F$$20240925$20240925$20240925$PER$$US-PFIZER INC-PV202400125048$PFIZER$$51$YR$$F$Y$$$20240925$$HP$US$US
243629501$24362950$1$I$20240101$20240923$20240925$20240925$PER$$US-PFIZER INC-PV202400124674$PFIZER$$54$YR$$M$Y$$$20240925$$HP$US$US
243629511$24362951$1$I$20240923$20240923$20240925$20240925$PER$$US-PFIZER INC-202400262707$PFIZER$$68$YR$$M$Y$$$20240925$$CN$US$US
243629521$24362952$1$I$$20240920$20240925$20240925$PER$$US-PFIZER INC-PV202400124386$PFIZER$$31$YR$$M$Y$$$20240925$$HP$US$US
243629541$24362954$1$I$$20240920$20240925$20240925$PER$$US-PFIZER INC-202400189280$PFIZER$$21$YR$$F$Y$$$20240925$$CN$US$US
243629551$24362955$1$I$20240101$20240923$20240925$20240925$PER$$US-PFIZER INC-202400263104$PFIZER$$74$YR$$F$Y$$$20240925$$HP$US$US
243629571$24362957$1$I$20240922$20240923$20240925$20240925$PER$$US-PFIZER INC-202400261984$PFIZER$$48$YR$$M$Y$$$20240925$$CN$US$US
243629581$24362958$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-PV202300165241$PFIZER$$57$YR$$F$Y$$$20240925$$CN$US$US
243629601$24362960$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-PV202400035794$PFIZER$$83$YR$$F$Y$$$20240925$$CN$US$US
243629611$24362961$1$I$20240901$20240922$20240925$20240925$PER$$US-PFIZER INC-202400261475$PFIZER$$71$YR$$F$Y$$$20240925$$CN$US$US
243629621$24362962$1$I$20240911$20240920$20240925$20240925$PER$$US-PFIZER INC-PV202400123618$PFIZER$$22$YR$$F$Y$$$20240925$$HP$US$US
243629631$24362963$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-202400262309$PFIZER$$39$YR$$F$Y$$$20240925$$MD$US$US
243629641$24362964$1$I$20240912$20240920$20240925$20240925$PER$$US-PFIZER INC-PV202400123691$PFIZER$$41$YR$$F$Y$$$20240925$$HP$US$US
243629651$24362965$1$I$$20240920$20240925$20240925$PER$$US-PFIZER INC-PV202400123544$PFIZER$$58$YR$$F$Y$$$20240925$$HP$US$US
243629661$24362966$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-PV202400124361$PFIZER$$$$$F$Y$$$20240925$$CN$US$US
243629671$24362967$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-202400262275$PFIZER$$$$$M$Y$$$20240925$$CN$US$US
243629681$24362968$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-202400262216$PFIZER$$27$YR$$M$Y$$$20240925$$CN$US$US
243629691$24362969$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-202400261891$PFIZER$$66$YR$$M$Y$$$20240925$$CN$US$US
243629701$24362970$1$I$$20240917$20240925$20240925$EXP$$AU-BAYER-2024A134356$BAYER$$67$YR$E$M$Y$104$KG$20240925$$HP$AU$AT
243629711$24362971$1$I$20240101$20240923$20240925$20240925$PER$$US-PFIZER INC-PV202400124628$PFIZER$$73$YR$$M$Y$$$20240925$$HP$US$US
243629721$24362972$1$I$20240920$20240923$20240925$20240925$PER$$US-PFIZER INC-202400261914$PFIZER$$45$YR$$F$Y$$$20240925$$CN$US$US
243629731$24362973$1$I$20240920$20240921$20240925$20240925$PER$$US-PFIZER INC-PV202400123961$PFIZER$$27$YR$$F$Y$90.703$KG$20240925$$CN$US$US
243629741$24362974$1$I$20240919$20240922$20240925$20240925$PER$$US-PFIZER INC-202400261804$PFIZER$$75$YR$$F$Y$127.01$KG$20240925$$CN$US$US
243629751$24362975$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-PV202400124647$PFIZER$$51$YR$$F$Y$68.934$KG$20240925$$HP$US$US
243629761$24362976$1$I$20240301$20240920$20240925$20240925$PER$$US-PFIZER INC-PV202400036108$PFIZER$$76$YR$$M$Y$$$20240925$$CN$US$US
243629771$24362977$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-PV202300141671$PFIZER$$65$YR$$F$Y$$$20240925$$CN$US$US
243629781$24362978$1$I$$20240920$20240925$20240925$EXP$$US-LUNDBECK-DKLU4004510$LUNDBECK$$$$$$Y$$$20240925$$CN$US$US
243629791$24362979$1$I$$20240918$20240925$20240925$EXP$SE-TEVA-VS-3176362$SE-GSK-SE2024116271$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$SE$SE
243629801$24362980$1$I$$20240923$20240925$20240925$EXP$$CA-ABBVIE-5935597$ABBVIE$$71$YR$$F$Y$54$KG$20240925$$HP$CA$CA
243629811$24362981$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65720$$FDA-CTU$$72$YR$$F$N$$$20240925$N$$US$
243629821$24362982$1$I$20210906$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65605$$FDA-CTU$$67$DY$$M$N$$$20240923$N$$US$
243629831$24362983$1$I$20240719$20240925$20240925$20240925$DIR$719830$$FDA-CTU$$20$YR$$F$N$67.5$KG$20240925$N$CN$US$
243629841$24362984$1$I$$20240828$20240925$20240925$DIR$FDA-CDER-CTU-2024-65721$$FDA-CTU$$$$$F$N$$$20240828$N$HP$US$
243629851$24362985$1$I$$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65618$$FDA-CTU$$$$$$N$$$20240923$$CN$US$
243629861$24362986$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65722$$FDA-CTU$$24$YR$$F$N$$$20240925$N$$US$
243629881$24362988$1$I$$20240917$20240925$20240925$EXP$$US-EMD Serono-2024050110$EMD SERONO INC$$$$A$F$Y$$$20240925$$MD$US$US
243629891$24362989$1$I$20240831$20240831$20240925$20240925$PER$$US-CSL-2024-008451$CSL Plasma$$36$YR$$F$Y$$$20240925$$HP$US$US
243629901$24362990$1$I$20220401$20240913$20240925$20240925$EXP$$US-GSK-US2024060169$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
243629911$24362991$1$I$$20240920$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013942$DR REDDYS$$17$YR$T$F$Y$$$20240925$$MD$US$US
243629921$24362992$1$I$20240720$20240918$20240925$20240925$EXP$HR-HALMED-300086543$HR-GSK-HR2024115956$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$MD$HR$HR
243629931$24362993$1$I$$20240924$20240925$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA082773$SANDOZ$$$$$M$Y$$$20240925$$MD$CA$CA
243629941$24362994$1$I$$20240913$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009738$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243629951$24362995$1$I$20240101$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189573$AMGEN$$$$$M$Y$$$20240925$$HP$US$US
243629961$24362996$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015239$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240925$$CN$US$US
243629971$24362997$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015029$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240925$$CN$US$US
243629981$24362998$1$I$20240924$20240925$20240925$20240925$DIR$719838$$FDA-CTU$$54$YR$$F$N$68.4$KG$20240925$N$CN$US$
243629991$24362999$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65723$$FDA-CTU$$86$YR$$M$N$$$20240925$N$$US$
243630001$24363000$1$I$20240918$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65616$$FDA-CTU$$$$$$N$$$20240923$Y$HP$US$
243630011$24363001$1$I$20240920$20240920$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014357$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240925$$CN$US$US
243630021$24363002$1$I$20240101$20240919$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150073$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240925$$CN$US$US
243630031$24363003$1$I$$20240919$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149946$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$HP$US$US
243630061$24363006$1$I$20240808$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65617$$FDA-CTU$$$$$$N$$$20240923$Y$HP$US$
243630071$24363007$1$I$$20240917$20240925$20240925$EXP$$AU-LUNDBECK-DKLU4004545$LUNDBECK$$$$$$Y$$$20240925$$CN$AU$AU
243630091$24363009$1$I$20240924$20240925$20240925$20240925$DIR$719841$$FDA-CTU$$31$YR$$M$N$$$20240925$N$HP$US$
243630111$24363011$1$I$20240923$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65619$$FDA-CTU$$$$$$N$$$20240923$Y$HP$US$
243630121$24363012$1$I$$20240924$20240925$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA082626$SANDOZ$$$$$M$Y$$$20240925$$CN$CA$CA
243630132$24363013$2$F$20240101$20240923$20240925$20240926$PER$$US-ABBVIE-5935650$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243630141$24363014$1$I$20240501$20240920$20240925$20240925$EXP$$US-BAYER-2024A080751$BAYER$$94$YR$E$M$Y$$$20240925$$CN$US$US
243630151$24363015$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190823$NOVARTIS$$64$YR$$F$Y$$$20240925$$CN$US$US
243630172$24363017$2$F$$20240925$20240925$20240930$PER$$US-PFIZER INC-2020SGN05334$PFIZER$$$$$$Y$$$20240930$$MD$US$US
243630191$24363019$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-202400262777$PFIZER$$$$$$Y$$$20240925$$MD$US$US
243630201$24363020$1$I$20240901$20240923$20240925$20240925$PER$$US-PFIZER INC-PV202400124564$PFIZER$$19$YR$$F$Y$$$20240925$$HP$US$US
243630211$24363021$1$I$20240923$20240923$20240925$20240925$PER$$US-PFIZER INC-202400261872$PFIZER$$69$YR$$F$Y$46.27$KG$20240925$$CN$US$US
243630221$24363022$1$I$$20240920$20240925$20240925$PER$$US-PFIZER INC-2020SGN05323$PFIZER$$$$$$Y$$$20240925$$MD$US$US
243630231$24363023$1$I$$20240920$20240925$20240925$PER$$US-PFIZER INC-2018SGN02722$PFIZER$$60$YR$$F$Y$$$20240925$$HP$US$US
243630241$24363024$1$I$$20240916$20240925$20240925$EXP$$US-ALKERMES INC.-ALK-2024-002407$ALKERMES$$$$$M$Y$97.959$KG$20240925$$CN$US$US
243630251$24363025$1$I$$20240916$20240925$20240925$EXP$$ES-TEVA-VS-3245884$TEVA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.; Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.$$$$$Y$$$20240925$$HP$ES$ES
243630261$24363026$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152156$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240925$$CN$US$US
243630271$24363027$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151937$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240925$$CN$US$US
243630281$24363028$1$I$20190101$20240919$20240925$20240925$EXP$$US-VERTEX PHARMACEUTICALS-2024-015013$VERTEX$$$$A$F$Y$$$20240925$$CN$US$US
243630291$24363029$1$I$$20240919$20240925$20240925$PER$$US-VERTEX PHARMACEUTICALS-2024-015007$VERTEX$$2$YR$$M$Y$$$20240925$$CN$US$US
243630301$24363030$1$I$20220101$20240913$20240925$20240925$EXP$$JP-JNJFOC-20240126610$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240925$$HP$JP$JP
243630311$24363031$1$I$$20240904$20240925$20240925$PER$$US-SMPA-2024SPA002311$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630321$24363032$1$I$$20240919$20240925$20240925$EXP$$JP-BAYER-2024A134552$BAYER$$72$YR$E$M$Y$$$20240925$$MD$JP$JP
243630331$24363033$1$I$$20240919$20240925$20240925$PER$$US-SMPA-2024SPA003067$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630341$24363034$1$I$$20240907$20240925$20240925$PER$$US-SMPA-2024SPA002583$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630351$24363035$1$I$$20240909$20240925$20240925$PER$$US-SMPA-2024SPA000632$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630371$24363037$1$I$$20240904$20240925$20240925$PER$$US-SMPA-2024SPA002312$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630381$24363038$1$I$$20240919$20240925$20240925$PER$$US-SMPA-2024SPA003106$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630391$24363039$1$I$$20240917$20240925$20240925$PER$$US-SMPA-2024SPA003006$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630401$24363040$1$I$$20240908$20240925$20240925$PER$$US-SMPA-2024SPA002498$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630411$24363041$1$I$$20240905$20240925$20240925$PER$$US-SMPA-2024SPA002371$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630431$24363043$1$I$$20240905$20240925$20240925$PER$$US-SMPA-2024SPA002366$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630441$24363044$1$I$$20240905$20240925$20240925$PER$$US-SMPA-2024SPA002406$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630451$24363045$1$I$$20240916$20240925$20240925$PER$$US-SMPA-2024SPA002975$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630461$24363046$1$I$$20240917$20240925$20240925$PER$$US-SMPA-2024SPA002958$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630471$24363047$1$I$$20240829$20240925$20240925$PER$$US-SMPA-2024SPA003111$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630481$24363048$1$I$$20240906$20240925$20240925$PER$$US-SMPA-2024SPA002444$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630491$24363049$1$I$20240923$20240923$20240923$20240923$DIR$FDA-CDER-CTU-2024-65595$$FDA-CTU$$$$$$N$$$20240923$Y$HP$US$
243630501$24363050$1$I$$20240917$20240925$20240925$PER$$US-SMPA-2024SPA002942$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630511$24363051$1$I$$20240909$20240925$20240925$PER$$US-SMPA-2024SPA002518$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630521$24363052$1$I$$20240916$20240925$20240925$PER$$US-SMPA-2024SPA002893$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630541$24363054$1$I$$20240917$20240925$20240925$PER$$US-SMPA-2024SPA002969$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630551$24363055$1$I$$20240917$20240925$20240925$PER$$US-SMPA-2024SPA002984$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630561$24363056$1$I$$20240904$20240925$20240925$PER$$US-SMPA-2024SPA002302$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630571$24363057$1$I$$20240913$20240925$20240925$PER$$US-SMPA-2024SPA002860$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630581$24363058$1$I$$20240909$20240925$20240925$PER$$US-SMPA-2024SPA002434$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630591$24363059$1$I$$20240923$20240925$20240925$PER$$US-SMPA-2024SPA003214$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630611$24363061$1$I$$20240907$20240925$20240925$PER$$US-SMPA-2024SPA002464$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630621$24363062$1$I$$20240905$20240925$20240925$PER$$US-SMPA-2024SPA002437$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630631$24363063$1$I$$20240916$20240925$20240925$PER$$US-SMPA-2024SPA002985$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630641$24363064$1$I$$20240916$20240925$20240925$PER$$US-SMPA-2024SPA002998$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630652$24363065$2$F$$20240920$20240925$20240930$PER$$US-SMPA-2024SPA002310$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243630671$24363067$1$I$$20240920$20240925$20240925$PER$$US-SMPA-2024SPA003182$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630681$24363068$1$I$$20240909$20240925$20240925$PER$$US-SMPA-2024SPA000227$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630691$24363069$1$I$$20240917$20240925$20240925$PER$$US-SMPA-2024SPA002930$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630701$24363070$1$I$$20240904$20240925$20240925$PER$$US-SMPA-2024SPA002293$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630711$24363071$1$I$$20240906$20240925$20240925$PER$$US-SMPA-2024SPA002509$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630721$24363072$1$I$$20240917$20240925$20240925$PER$$US-SMPA-2024SPA002948$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630741$24363074$1$I$$20240918$20240925$20240925$PER$$US-SMPA-2024SPA003041$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630761$24363076$1$I$$20240916$20240925$20240925$PER$$US-SMPA-2024SPA003004$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630771$24363077$1$I$$20240909$20240925$20240925$PER$$US-SMPA-2024SPA002516$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630781$24363078$1$I$$20240912$20240925$20240925$PER$$US-SMPA-2024SPA002726$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630791$24363079$1$I$$20240919$20240925$20240925$PER$$US-SMPA-2024SPA003107$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630801$24363080$1$I$$20240917$20240925$20240925$PER$$US-SMPA-2024SPA002938$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630811$24363081$1$I$$20240911$20240925$20240925$PER$$US-SMPA-2024SPA001207$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630821$24363082$1$I$$20240904$20240925$20240925$PER$$US-SMPA-2024SPA002469$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630851$24363085$1$I$$20240909$20240925$20240925$PER$$US-SMPA-2024SPA002526$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630861$24363086$1$I$$20240909$20240925$20240925$PER$$US-SMPA-2024SPA002550$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630871$24363087$1$I$$20240905$20240925$20240925$PER$$US-SMPA-2024SPA001200$SUNOVION$$$$$$Y$$$20240925$$MD$US$US
243630881$24363088$1$I$$20240918$20240925$20240925$PER$$US-SMPA-2024SPA003045$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630891$24363089$1$I$$20240904$20240925$20240925$PER$$US-SMPA-2024SPA002321$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630901$24363090$1$I$$20240905$20240925$20240925$PER$$US-SMPA-2024SPA002415$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630911$24363091$1$I$$20240905$20240925$20240925$PER$$US-SMPA-2024SPA002431$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630931$24363093$1$I$$20240917$20240925$20240925$PER$$US-SMPA-2024SPA002990$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630941$24363094$1$I$$20240919$20240925$20240925$PER$$US-SMPA-2024SPA003108$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630951$24363095$1$I$$20240917$20240925$20240925$PER$$US-SMPA-2024SPA003018$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630961$24363096$1$I$$20240904$20240925$20240925$PER$$US-SMPA-2024SPA002381$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630971$24363097$1$I$$20240904$20240925$20240925$PER$$US-SMPA-2024SPA002299$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630981$24363098$1$I$$20240920$20240925$20240925$PER$$US-SMPA-2024SPA003179$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243630991$24363099$1$I$$20240919$20240925$20240925$PER$$US-SMPA-2024SPA003109$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243631001$24363100$1$I$20240624$20240918$20240925$20240925$EXP$$EG-EMD Serono-2024050293$EMD SERONO INC$$33$YR$A$F$Y$$$20240925$$CN$EG$EG
243631011$24363101$1$I$$20240916$20240925$20240925$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001876$BLUEPRINT MEDICINES$$$$$F$Y$$$20240925$$CN$US$US
243631021$24363102$1$I$20170407$20240918$20240925$20240925$EXP$$US-TAKEDA-2024TUS092565$TAKEDA$$$$E$F$Y$42.9$KG$20240925$$MD$US$US
243631031$24363103$1$I$20240912$20240923$20240925$20240925$EXP$GB-MHRA-MED-202409230834355300-JFWBT$GB-ABBVIE-5935366$ABBVIE$$45$YR$$M$Y$$$20240925$$HP$GB$GB
243631041$24363104$1$I$$20240918$20240925$20240925$PER$$US-SMPA-2024SPA003047$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243631051$24363105$1$I$$20240906$20240925$20240925$PER$$US-SMPA-2024SPA002442$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243631061$24363106$1$I$$20240917$20240925$20240925$PER$$US-SMPA-2024SPA002977$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243631071$24363107$1$I$$20240920$20240925$20240925$PER$$US-SMPA-2024SPA003151$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243631081$24363108$1$I$$20240905$20240925$20240925$PER$$US-SMPA-2024SPA002382$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243631091$24363109$1$I$$20240919$20240925$20240925$PER$$US-SMPA-2024SPA003086$SUNOVION$$$$$$Y$$$20240925$$CN$US$US
243631101$24363110$1$I$20160101$20240911$20240925$20240925$EXP$$US-ALCON LABORATORIES-ALC2023US001236$ALCON$$85$YR$$F$Y$49.9$KG$20240925$$CN$US$US
243631111$24363111$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190781$NOVARTIS$$$$$$Y$$$20240925$$MD$US$US
243631121$24363112$1$I$$20240911$20240925$20240925$EXP$$US-JNJFOC-20240964224$JOHNSON AND JOHNSON$$$$$M$Y$70.8$KG$20240925$$MD$US$US
243631131$24363113$1$I$$20240917$20240925$20240925$PER$$US-JNJFOC-20240945048$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$CN$US$US
243631141$24363114$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151941$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240925$$CN$US$US
243631151$24363115$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151788$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240925$$CN$US$US
243631161$24363116$1$I$20240101$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152147$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240925$$HP$US$US
243631171$24363117$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151890$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$73.03$KG$20240925$$CN$US$US
243631181$24363118$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151732$BRISTOL MYERS SQUIBB$$31$YR$A$F$Y$$$20240925$$HP$US$US
243631191$24363119$1$I$$20240917$20240925$20240925$EXP$$GB-VER-202400011$VERITY PHARMACEUTICALS$$83$YR$E$$Y$$$20240925$$PH$GB$GB
243631201$24363120$1$I$$20240920$20240925$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US082195$SANDOZ$$$$$M$Y$$$20240925$$CN$US$US
243631211$24363121$1$I$$20240918$20240925$20240925$EXP$$CA-GSK-CA2024028324$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$HP$CA$CA
243631221$24363122$1$I$20240801$20240917$20240925$20240925$EXP$$JP-GALDERMA-JP2024014167$GALDERMA$$$$$$Y$$$20240925$$MD$JP$JP
243631231$24363123$1$I$20240709$20240917$20240925$20240925$EXP$$AU-BEH-2024179058$CSL BEHRING$$12$YR$T$M$Y$37.2$KG$20240925$$HP$AU$AU
243631241$24363124$1$I$$20240924$20240925$20240925$EXP$$CN-BAYER-2024A136010$BAYER$$$$$M$Y$$$20240925$$CN$CN$CN
243631251$24363125$1$I$20240901$20240919$20240925$20240925$EXP$$US-ABBVIE-5932309$ABBVIE$$52$YR$$F$Y$$$20240925$$CN$US$US
243631261$24363126$1$I$$20240917$20240925$20240925$EXP$$US-TAKEDA-2024TUS093011$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
243631271$24363127$1$I$20240918$20240920$20240925$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA082735$SANDOZ$$70$YR$$M$Y$$$20240925$$MD$CA$CA
243631281$24363128$1$I$$20240924$20240925$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US082718$SANDOZ$$$$$M$Y$$$20240925$$HP$US$US
243631291$24363129$1$I$20240523$20240801$20240925$20240925$EXP$FR-AFSSAPS-LL2024001359$FR-ROCHE-10000047211$ROCHE$$40$YR$A$M$Y$$$20240925$$MD$FR$FR
243631301$24363130$1$I$20240901$20240919$20240925$20240925$EXP$$JP-009507513-2409JPN003034J$MERCK$$75$YR$$$Y$$$20240925$$MD$JP$JP
243631321$24363132$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65656$$FDA-CTU$$$$$$N$$$20240924$$CN$US$
243631331$24363133$1$I$20240101$20240918$20240925$20240925$EXP$$CA-JNJFOC-20240548219$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240925$$HP$CA$CA
243631341$24363134$1$I$20240101$20240903$20240925$20240925$PER$$US-Eisai-EC-2024-173867$EISAI$$$$$F$Y$$$20240925$$HP$US$US
243631351$24363135$1$I$20240824$20240903$20240925$20240925$PER$$US-Eisai-EC-2024-173697$EISAI$$77$YR$E$F$Y$$$20240925$$CN$US$US
243631361$24363136$1$I$$20240920$20240925$20240925$EXP$$CN-SANDOZ INC.-SDZ2024CN082500$SANDOZ$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. West China Journal of Stomatology. 2024;1-7$$$$M$Y$$$20240925$$HP$CN$CN
243631381$24363138$1$I$$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190315$AMGEN$$$$$F$Y$$$20240925$$CN$US$US
243631391$24363139$1$I$20230901$20240920$20240925$20240925$EXP$$TR-AMGEN-TURSP2024177133$AMGEN$$83$YR$E$F$Y$$$20240925$$MD$TR$TR
243631401$24363140$1$I$$20240923$20240925$20240925$EXP$$US-AMGEN-USASP2024190244$AMGEN$Blunt D.; Arcalas C.; Day J. et al.. Fluorescein Angiographic Changes of Retinopathy of Prematurity and Recurrence After Bevacizumab Injections. Investigative Ophthalmology + Visual Science. 2024;65(7):1-3$$$$$Y$$$20240925$$HP$US$US
243631411$24363141$1$I$20240831$20240906$20240925$20240925$EXP$$CN-SANDOZ INC.-SDZ2024CN082703$SANDOZ$$69$YR$$M$Y$44.5$KG$20240925$$MD$CN$CN
243631421$24363142$1$I$20240919$20240919$20240925$20240925$PER$$US-AMGEN-USASP2024188067$AMGEN$$41$YR$A$F$Y$57.143$KG$20240925$$HP$US$US
243631431$24363143$1$I$20240918$20240919$20240925$20240925$EXP$$IT-APELLIS-2024-APL-0001051$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240925$$MD$IT$IT
243631441$24363144$1$I$$20240924$20240925$20240925$EXP$$DE-SANDOZ INC.-SDZ2024DE082528$SANDOZ$$$$A$$Y$$$20240925$$HP$DE$DE
243631451$24363145$1$I$$20240917$20240925$20240925$PER$$US-ABBVIE-5930430$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243631461$24363146$1$I$20240801$20240919$20240925$20240925$EXP$$JP-009507513-2409JPN002918J$MERCK$$$$$F$Y$$$20240925$$MD$JP$JP
243631471$24363147$1$I$20240901$20240924$20240925$20240925$PER$$US-PFIZER INC-PV202400125198$PFIZER$$56$YR$$M$Y$$$20240925$$HP$US$US
243631481$24363148$1$I$20240924$20240924$20240925$20240925$PER$$US-PFIZER INC-202400263205$PFIZER$$64$YR$$F$Y$$$20240925$$CN$US$US
243631491$24363149$1$I$$20240923$20240925$20240925$PER$$US-PFIZER INC-PV202400125163$PFIZER$$64$YR$$M$Y$$$20240925$$HP$US$US
243631501$24363150$1$I$20240901$20240923$20240925$20240925$PER$$US-PFIZER INC-202400261876$PFIZER$$$$$F$Y$$$20240925$$CN$US$US
243631511$24363151$1$I$$20240924$20240925$20240925$PER$$US-PFIZER INC-202400263279$PFIZER$$68$YR$$F$Y$$$20240925$$MD$US$US
243631521$24363152$1$I$$20240924$20240925$20240925$PER$$US-PFIZER INC-202400263152$PFIZER$$52$YR$$M$Y$$$20240925$$MD$US$US
243631531$24363153$1$I$$20240924$20240925$20240925$PER$$US-PFIZER INC-PV202400125111$PFIZER$$66$YR$$F$Y$$$20240925$$HP$US$US
243631541$24363154$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65623$$FDA-CTU$$$$$$N$$$20240924$$CN$US$
243631571$24363157$1$I$$20240924$20240925$20240925$PER$$US-PFIZER INC-PV202400125144$PFIZER$$$$$F$Y$$$20240925$$CN$US$US
243631581$24363158$1$I$20220101$20240924$20240925$20240925$PER$$US-PFIZER INC-PV202400125052$PFIZER$$$$T$M$Y$$$20240925$$HP$US$US
243631591$24363159$1$I$$20240924$20240925$20240925$PER$$US-PFIZER INC-PV202300202333$PFIZER$$66$YR$$F$Y$$$20240925$$MD$US$US
243631601$24363160$1$I$$20240916$20240925$20240925$EXP$$ES-TEVA-VS-3245885$TEVA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.; Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.$$$$$Y$$$20240925$$HP$ES$ES
243631611$24363161$1$I$20240724$20240918$20240925$20240925$EXP$$DZ-BAYER-2024A133253$BAYER$$50$YR$A$M$Y$$$20240925$$CN$DZ$DZ
243631621$24363162$1$I$20240401$20240924$20240925$20240925$PER$$US-PFIZER INC-202400263587$PFIZER$$$$T$F$Y$$$20240925$$CN$US$US
243631631$24363163$1$I$$20240924$20240925$20240925$PER$$US-PFIZER INC-202400263253$PFIZER$$63$YR$$F$Y$$$20240925$$PH$US$US
243631641$24363164$1$I$20240617$20240924$20240925$20240925$PER$$US-PFIZER INC-PV202400125088$PFIZER$$55$YR$$F$Y$$$20240925$$HP$US$US
243631661$24363166$1$I$20240101$20240924$20240925$20240925$PER$$US-PFIZER INC-PV202400125072$PFIZER$$50$YR$$F$Y$$$20240925$$HP$US$US
243631671$24363167$1$I$20240923$20240924$20240925$20240925$PER$$US-PFIZER INC-202400263256$PFIZER$$50$YR$$F$Y$$$20240925$$CN$US$US
243631681$24363168$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015353$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240925$$CN$US$US
243631691$24363169$1$I$20240826$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014918$ELI LILLY AND CO$$56$YR$A$$Y$$$20240925$$CN$US$US
243631701$24363170$1$I$$20240918$20240925$20240925$EXP$$US-ELI_LILLY_AND_COMPANY-US202409012072$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240925$$CN$US$US
243631711$24363171$1$I$$20240919$20240925$20240925$EXP$$NL-ELI_LILLY_AND_COMPANY-NL202409013387$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240925$$CN$NL$NL
243631721$24363172$1$I$20240922$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014324$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240925$$CN$US$US
243631731$24363173$1$I$$20240918$20240925$20240925$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409014182$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$JP$JP
243631741$24363174$1$I$20240501$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014458$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240925$$HP$US$US
243631751$24363175$1$I$20240914$20240918$20240925$20240925$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409012980$ELI LILLY AND CO$$57$YR$A$F$Y$81$KG$20240925$$CN$DE$CN
243631771$24363177$1$I$20240901$20240918$20240925$20240925$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011688$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240925$$CN$US$US
243631781$24363178$1$I$20240816$20240913$20240925$20240925$EXP$GB-MHRA-MED-202409131019224030-BMZKC$GB-ELI_LILLY_AND_COMPANY-GB202409009580$ELI LILLY AND CO$$34$YR$A$M$Y$84$KG$20240925$$CN$GB$GB
243631791$24363179$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015650$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240925$$CN$US$US
243631801$24363180$1$I$20240725$20240918$20240925$20240925$EXP$FR-AFSSAPS-LL2024001767$FR-ELI_LILLY_AND_COMPANY-FR202409012197$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240925$$CN$FR$FR
243631811$24363181$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014755$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240925$$HP$US$US
243631831$24363183$1$I$$20240918$20240925$20240925$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202409011461$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240925$$CN$AU$AU
243631841$24363184$1$I$20210201$20240917$20240925$20240925$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409011480$ELI LILLY AND CO$$72$YR$E$M$Y$51$KG$20240925$$CN$JP$JP
243631851$24363185$1$I$$20240919$20240925$20240925$EXP$$US-JNJFOC-20240958350$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$HP$US$US
243631861$24363186$1$I$$20240916$20240925$20240925$EXP$$IL-TEVA-VS-3245599$TEVA$$77$YR$$F$Y$$$20240925$$HP$IL$IL
243631871$24363187$1$I$$20240915$20240925$20240925$EXP$$IN-JNJFOC-20240943631$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20240925$$MD$IN$US
243631881$24363188$1$I$20240919$20240919$20240925$20240925$EXP$$TR-GILEAD-2024-0688307$GILEAD$$$$$F$Y$$$20240925$$MD$TR$TR
243631891$24363189$1$I$$20240916$20240925$20240925$EXP$$ES-TEVA-VS-3245886$TEVA$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.; Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver-Int 2024; 44 (2): 286-292.$$$$$Y$$$20240925$$HP$ES$ES
243631901$24363190$1$I$$20240910$20240925$20240925$EXP$$LB-OSMOTICA PHARMACEUTICALS-2024ALO00463$Alora Pharma$Khattab N W, Razzouk R, Tanios B, et al.. Pulmonary Edema Following Nifedipine Use in Pregnancy: A Case Report.. Cureus. 2024;16(9)$24$YR$$F$Y$$$20240925$$HP$LB$LB
243631911$24363191$1$I$20200101$20240924$20240925$20240925$EXP$$DE-SANDOZ INC.-SDZ2024DE082422$SANDOZ$$32$YR$$F$Y$$$20240925$$MD$DE$DE
243631931$24363193$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244512$TEVA$$72$YR$$F$Y$54$KG$20240925$$PH$CA$CA
243631941$24363194$1$I$$20240920$20240925$20240925$EXP$$CN-SANDOZ INC.-SDZ2024CN082501$SANDOZ$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. West China Journal of Stomatology. 2024;1-7$73$YR$$M$Y$$$20240925$$HP$CN$CN
243631951$24363195$1$I$20240816$20240924$20240925$20240925$EXP$FR-AFSSAPS-BX2024001810$FR-SANDOZ INC.-SDZ2024FR082609$SANDOZ$$22$YR$$M$Y$$$20240925$$PH$FR$FR
243631961$24363196$1$I$$20240919$20240925$20240925$EXP$$DE-009507513-2409DEU008092$MERCK$$$$E$M$Y$$$20240925$$MD$DE$DE
243631981$24363198$1$I$$20240912$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009706$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243631991$24363199$1$I$20240909$20240919$20240925$20240925$EXP$GB-MHRA-MED-202409161222572420-TMDZF$GB-TEVA-VS-3245942$TEVA$$53$YR$$M$Y$100$KG$20240925$$CN$GB$GB
243632001$24363200$1$I$$20240919$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149596$BRISTOL MYERS SQUIBB$$49$YR$A$M$Y$$$20240925$$CN$US$US
243632011$24363201$1$I$$20240920$20240925$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151091$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240925$$MD$JP$JP
243632031$24363203$1$I$$20240924$20240925$20240925$EXP$$DE-SANDOZ INC.-SDZ2024DE082529$SANDOZ$$$$A$$Y$$$20240925$$HP$DE$DE
243632041$24363204$1$I$$20240919$20240925$20240925$EXP$GB-MHRA-MED-202409171415308560-ZPFTB$GB-TEVA-VS-3245966$TEVA$$66$YR$$F$Y$$$20240925$$CN$GB$GB
243632051$24363205$1$I$20230101$20240920$20240925$20240925$EXP$$DE-APELLIS-APL-2023-002924$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240925$$PH$DE$DE
243632061$24363206$1$I$20240924$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-65657$$FDA-CTU$$76$YR$$F$N$$$20240924$N$$US$
243632071$24363207$1$I$20240717$20240916$20240925$20240925$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-120641$BRISTOL MYERS SQUIBB$$$$$M$Y$113$KG$20240925$$MD$DE$DE
243632081$24363208$1$I$$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150976$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240925$$CN$US$US
243632091$24363209$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151677$BRISTOL MYERS SQUIBB$$31$YR$A$F$Y$$$20240925$$HP$US$US
243632101$24363210$1$I$$20240924$20240925$20240925$EXP$$RO-SANDOZ INC.-SDZ2024RO082551$SANDOZ$$25$YR$$M$Y$$$20240925$$HP$RO$RO
243632121$24363212$1$I$$20240916$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151139$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$61.9$KG$20240925$$CN$US$US
243632141$24363214$1$I$20240819$20240918$20240925$20240925$EXP$$AU-SANDOZ INC.-SDZ2024AU081209$SANDOZ$$77$YR$$M$Y$$$20240925$$MD$AU$AU
243632161$24363216$1$I$$20240918$20240925$20240925$EXP$$CA-ROCHE-10000085455$ROCHE$$43$YR$A$F$Y$$$20240925$$CN$CA$CA
243632171$24363217$1$I$$20240919$20240925$20240925$EXP$GB-MHRA-MED-202409170920428330-QRVDJ$GB-TEVA-VS-3245993$TEVA$$$$$F$Y$$$20240925$$HP$GB$GB
243632181$24363218$1$I$20240902$20240919$20240925$20240925$EXP$$GB-TEVA-VS-3246006$TEVA$$39$YR$$M$Y$108$KG$20240925$$MD$GB$GB
243632191$24363219$1$I$20240801$20240919$20240925$20240925$EXP$GB-MHRA-MED-202409162105320240-RTMDY$GB-TEVA-VS-3245998$TEVA$$76$YR$$M$Y$58$KG$20240925$$MD$GB$GB
243632201$24363220$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244553$TEVA$$6$DEC$$M$Y$$$20240925$$HP$CA$CA
243632211$24363221$1$I$$20240923$20240925$20240925$EXP$$CA-ORGANON-O2409CAN001677$ORGANON$$67$YR$$F$Y$73$KG$20240925$$MD$CA$CA
243632241$24363224$1$I$$20240925$20240925$20240925$DIR$719844$$FDA-CTU$$$$$UNK$N$$$20240925$$CN$US$
243632251$24363225$1$I$20240919$20240925$20240925$20240925$DIR$719845$$FDA-CTU$$21$YR$$F$N$45$KG$20240925$N$HP$US$
243632261$24363226$1$I$20240902$20240920$20240925$20240925$EXP$$CN-PFIZER INC-PV202400123677$PFIZER$$4$YR$$M$Y$16.3$KG$20240925$$HP$CN$CN
243632281$24363228$1$I$$20240816$20240925$20240925$30DAY$$CL-PFIZER INC-202400261925$PFIZER$$$$$M$Y$$$20240925$$CN$CL$CL
243632291$24363229$1$I$20221012$20240920$20240925$20240925$EXP$$US-PFIZER INC-2022SGN09642$PFIZER$$$$$$Y$$$20240925$$HP$US$US
243632301$24363230$1$I$20240101$20240912$20240925$20240925$PER$$US-KARYOPHARM-2024KPT001533$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240925$$CN$US$US
243632311$24363231$1$I$$20240913$20240925$20240925$PER$$US-KARYOPHARM-2024KPT001540$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240925$$CN$US$US
243632321$24363232$1$I$20230525$20240920$20240925$20240925$EXP$$US-PFIZER INC-2023SGN05586$PFIZER$$79$YR$$F$Y$$$20240925$$CN$US$US
243632331$24363233$1$I$20240101$20240914$20240925$20240925$PER$$US-KARYOPHARM-2024KPT001542$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240925$$MD$US$US
243632351$24363235$1$I$$20240918$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150011$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240925$$CN$US$US
243632361$24363236$1$I$20240101$20240917$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150164$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240925$$HP$US$US
243632371$24363237$1$I$$20240918$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150316$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240925$$HP$US$US
243632391$24363239$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150456$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240925$$CN$US$US
243632411$24363241$1$I$20240319$20240922$20240925$20240925$EXP$GB-MHRA-MED-202409220831067940-BCQNJ$GB-MYLANLABS-2024M1086136$MYLAN$$66$YR$$F$Y$62$KG$20240925$$CN$GB$GB
243632421$24363242$1$I$20240801$20240809$20240925$20240925$PER$$US-LUNDBECK-DKLU4002847$LUNDBECK$$$$$$Y$$$20240925$$CN$US$US
243632441$24363244$1$I$$20240715$20240925$20240925$EXP$$BR-INCYTE CORPORATION-2024IN010115$INCYTE$$$$$$Y$$$20240925$$MD$BR$BR
243632451$24363245$1$I$20160101$20240919$20240925$20240925$EXP$$NL-MYLANLABS-2024M1086171$MYLAN$Prins RHN, Moolenaar WVT. Primary cutaneous cos+ aggressive epidermotropic cytotoxic T-cel lymphoma, as post-transplant lymphoproliferative disorder (PTLD) after kidney transplantation: a case study. Dutch Journal for Hematology. 2024;21:283-7$35$YR$$M$Y$$$20240925$$HP$NL$NL
243632461$24363246$1$I$20240914$20240917$20240925$20240925$EXP$$IL-TAKEDA-2024TUS093233$TAKEDA$$87$YR$$F$Y$$$20240925$$MD$IL$IL
243632471$24363247$1$I$$20240919$20240925$20240925$EXP$$US-ABBVIE-5931446$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243632491$24363249$1$I$20140829$20240920$20240925$20240925$PER$$US-BIOGEN-2014BI110167$BIOGEN$$54$YR$$F$Y$$$20240925$$HP$US$US
243632501$24363250$1$I$20140201$20240916$20240925$20240925$EXP$$US-BIOGEN-2014BI087852$BIOGEN$$41$YR$$F$Y$$$20240925$$CN$US$US
243632511$24363251$1$I$20240911$20240913$20240925$20240925$PER$$US-JNJFOC-20240950898$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243632521$24363252$1$I$20240901$20240919$20240925$20240925$EXP$$CA-JNJFOC-20240959166$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20240925$$CN$CA$CA
243632531$24363253$1$I$$20240919$20240925$20240925$EXP$$JP-BEH-2024179110$CSL BEHRING$$64$YR$A$M$Y$$$20240925$$MD$JP$JP
243632541$24363254$1$I$$20240808$20240925$20240925$PER$$US-LUNDBECK-DKLU4002792$LUNDBECK$$$$$$Y$$$20240925$$PH$US$US
243632551$24363255$1$I$20240301$20240920$20240925$20240925$EXP$$US-ORGANON-O2409USA001832$ORGANON$$51$YR$$M$Y$$$20240925$$CN$US$US
243632562$24363256$2$F$20240916$20240925$20240925$20240930$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005243$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240930$$CN$US$US
243632571$24363257$1$I$20240924$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190459$AMGEN$$67$YR$E$F$Y$$$20240925$$CN$US$US
243632581$24363258$1$I$$20240920$20240925$20240925$EXP$$AR-PFIZER INC-202400261847$PFIZER$$76$YR$$F$Y$$$20240925$$CN$AR$AR
243632591$24363259$1$I$20240806$20240920$20240925$20240925$EXP$FR-AFSSAPS-MA2024001361$FR-PFIZER INC-202400260463$PFIZER$$58$YR$$M$Y$$$20240925$$MD$FR$FR
243632601$24363260$1$I$20240916$20240919$20240925$20240925$EXP$$CN-MYLANLABS-2024M1085846$MYLAN$$53$YR$$F$Y$56$KG$20240925$$HP$CN$CN
243632611$24363261$1$I$20240714$20240919$20240925$20240925$EXP$IE-HPRA-2024-115352$IE-MYLANLABS-2024M1086046$MYLAN$$64$YR$$F$Y$74.4$KG$20240925$$CN$IE$IE
243632621$24363262$1$I$$20240919$20240925$20240925$EXP$$GR-MYLANLABS-2024M1086013$MYLAN$Thomas, D.. 031. Papillary glioneuronal tumor: a rare case of brain tumor. 35th panhellenic congress on neurology. 2024;39$18$YR$$F$Y$$$20240925$$MD$GR$GR
243632631$24363263$1$I$$20240911$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009670$INCYTE$$$$$$Y$$$20240925$$HP$US$US
243632641$24363264$1$I$20240901$20240919$20240925$20240925$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202409014112$ELI LILLY AND CO$$$$$$Y$$$20240925$$CN$CO$CO
243632651$24363265$1$I$$20240920$20240925$20240925$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409014162$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240925$$CN$JP$JP
243632661$24363266$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151214$BRISTOL MYERS SQUIBB$$57$YR$A$M$Y$$$20240925$$HP$US$US
243632671$24363267$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150839$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240925$$CN$US$US
243632681$24363268$1$I$20240901$20240923$20240925$20240925$EXP$ES-AEMPS-1571781$ES-ELI_LILLY_AND_COMPANY-ES202409015019$ELI LILLY AND CO$$57$YR$A$F$Y$58.8$KG$20240925$$CN$ES$ES
243632691$24363269$1$I$$20240920$20240925$20240925$EXP$$DE-PFIZER INC-202400260354$PFIZER$$$$$F$Y$$$20240925$$CN$DE$DE
243632701$24363270$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151934$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240925$$CN$US$US
243632711$24363271$1$I$$20240918$20240925$20240925$EXP$$CA-HLS-202402366$HLS THERAPEUTICS$$$$A$F$Y$$$20240925$$HP$CA$CA
243632721$24363272$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152197$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240925$$CN$US$US
243632731$24363273$1$I$$20240920$20240925$20240925$EXP$$US-TAKEDA-2024TUS093919$TAKEDA$$$$E$M$Y$70.8$KG$20240925$$MD$US$US
243632751$24363275$1$I$$20240918$20240925$20240925$EXP$$NL-TEVA-VS-3246490$TEVA$$56$YR$$F$Y$$$20240925$$CN$NL$NL
243632761$24363276$1$I$20240924$20240925$20240925$20240925$DIR$719863$$FDA-CTU$$53$YR$$F$N$$$20240925$N$HP$US$
243632771$24363277$1$I$20240910$20240925$20240925$20240925$DIR$719850$$FDA-CTU$$72$YR$$F$N$77.85$KG$20240925$N$PH$US$
243632781$24363278$1$I$20240417$20240925$20240925$20240925$DIR$719855$$FDA-CTU$$57$YR$$F$N$99$KG$20240925$N$CN$US$
243632791$24363279$1$I$20240724$20240919$20240925$20240925$EXP$IT-MINISAL02-1002092$IT-TEVA-VS-3245992$TEVA$$78$YR$$F$Y$60$KG$20240925$$PH$IT$IT
243632801$24363280$1$I$$20240808$20240925$20240925$PER$$US-LUNDBECK-DKLU4002837$LUNDBECK$$$$$$Y$$$20240925$$HP$US$US
243632811$24363281$1$I$$20240916$20240925$20240925$EXP$$CA-TEVA-VS-3244792$TEVA$$55$YR$$F$Y$63$KG$20240925$$HP$CA$CA
243632831$24363283$1$I$20240925$20240925$20240925$20240925$DIR$719870$$FDA-CTU$$67$YR$$F$N$$$20240925$N$$US$
243632851$24363285$1$I$20240918$20240925$20240925$20240925$DIR$719834$$FDA-CTU$$40$YR$$M$N$80$KG$20240925$N$PH$US$
243632861$24363286$1$I$$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151491$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240925$$CN$US$US
243632881$24363288$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151082$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240925$$HP$US$US
243632891$24363289$1$I$$20240916$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152123$BRISTOL MYERS SQUIBB$Barlowe TS, Saxena-Beem S, Ishizawar RC, Herfarth H, Moon AM. Multiple gastrointestinal immune related adverse events from immune checkpoint inhibitor therapy. Clinical and Translational Gastroenterology. 2024 Sep 12;doi:10.14309/ctg.0000000000000768.$26$YR$A$F$Y$$$20240925$$MD$US$US
243632901$24363290$1$I$20240810$20240919$20240925$20240925$EXP$$CN-MYLANLABS-2024M1085839$MYLAN$$84$YR$$F$Y$58$KG$20240925$$HP$CN$CN
243632911$24363291$1$I$20211206$20240919$20240925$20240925$EXP$DE-BFARM-24006315$DE-MYLANLABS-2024M1084767$MYLAN$$63$YR$$M$Y$100$KG$20240925$$CN$DE$DE
243632921$24363292$1$I$20240921$20240923$20240925$20240925$EXP$$NVSC2024CN190640$NOVARTIS$$61$YR$$F$Y$67$KG$20240925$$HP$CN$CN
243632931$24363293$1$I$20240902$20240919$20240925$20240925$EXP$FR-AFSSAPS-LL2024001749$FR-TEVA-VS-3246154$TEVA$$77$YR$$F$Y$$$20240925$$MD$FR$FR
243632941$24363294$1$I$20240701$20240923$20240925$20240925$PER$$US-JNJFOC-20240963507$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243632951$24363295$1$I$20240201$20240913$20240925$20240925$PER$$US-JNJFOC-20240936783$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240925$$CN$US$US
243632961$24363296$1$I$$20240822$20240925$20240925$PER$$US-LUNDBECK-DKLU4003404$LUNDBECK$$$$$$Y$$$20240925$$CN$US$US
243632971$24363297$1$I$$20240918$20240925$20240925$PER$$US-IMP-2024000761$Harrow Health$$$$E$F$Y$$$20240925$$CN$US$US
243632981$24363298$1$I$$20240918$20240925$20240925$PER$$US-IMP-2024000762$Harrow Health$$$$E$F$Y$$$20240925$$CN$US$US
243632991$24363299$1$I$20240901$20240919$20240925$20240925$PER$$US-BAUSCH-BL-2024-014230$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240925$$CN$US$US
243633001$24363300$1$I$20200101$20240920$20240925$20240925$EXP$$FI-BAUSCH-BL-2024-014248$BAUSCH AND LOMB$Lindstrom M, UNKNOWN. Tyoikaisen laihduttajan kavelyvaikeus-osa 1. Laakarilehti. 2024;VSK 79:34-35.$59$YR$$M$Y$$$20240925$$MD$FI$FI
243633011$24363301$1$I$20240923$20240924$20240925$20240925$EXP$$US-BAUSCH-BL-2024-014387$BAUSCH AND LOMB$$76$YR$$M$Y$$$20240925$$CN$US$US
243633021$24363302$1$I$20240921$20240924$20240925$20240925$EXP$$NVSC2024US190645$NOVARTIS$$55$YR$$M$Y$$$20240925$$HP$US$US
243633041$24363304$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190826$NOVARTIS$$$$$M$Y$$$20240925$$HP$US$US
243633051$24363305$1$I$$20240920$20240925$20240925$PER$$US-BIOGEN-2024BI01283671$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243633061$24363306$1$I$20240909$20240916$20240925$20240925$PER$$US-BIOGEN-2024BI01282834$BIOGEN$$46$YR$$F$Y$$$20240925$$CN$US$US
243633071$24363307$1$I$$20240919$20240925$20240925$EXP$$CA-ROCHE-10000086753$ROCHE$$$$$F$Y$$$20240925$$CN$CA$CA
243633081$24363308$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2023-179642$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240925$$CN$US$US
243633091$24363309$1$I$20240701$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152070$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240925$$CN$US$US
243633101$24363310$1$I$$20240925$20240925$20240925$DIR$719888$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243633112$24363311$2$F$$20240926$20240925$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151276$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240927$$CN$US$US
243633121$24363312$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151367$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240925$$CN$US$US
243633131$24363313$1$I$20230822$20240920$20240925$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151674$BRISTOL MYERS SQUIBB$$7$DEC$E$$Y$$$20240925$$HP$JP$JP
243633141$24363314$1$I$$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151465$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240925$$CN$US$US
243633151$24363315$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152085$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240925$$CN$US$US
243633161$24363316$1$I$$20240923$20240925$20240925$EXP$$US-SANDOZ INC.-NVSC2023US097078$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
243633181$24363318$1$I$$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151147$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$75.3$KG$20240925$$HP$US$US
243633191$24363319$1$I$$20240920$20240925$20240925$EXP$PT-INFARMED-J202408-693$PT-TAKEDA-2024TUS094887$TAKEDA$$66$YR$$F$Y$$$20240925$$HP$PT$PT
243633201$24363320$1$I$20240901$20240917$20240925$20240925$EXP$GB-MHRA-MED-202409141739528290-YVQSK$GB-BAUSCH-BL-2024-014409$BAUSCH AND LOMB$$44$YR$$F$Y$65$KG$20240925$$CN$GB$GB
243633211$24363321$1$I$$20240923$20240925$20240925$PER$$US-JNJFOC-20240963571$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243633221$24363322$1$I$$20240916$20240925$20240925$EXP$$CA-JNJFOC-20240849881$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240925$$HP$CA$CA
243633231$24363323$1$I$$20130109$20240925$20240925$PER$$NVSC2013US013666$NOVARTIS$$$$$M$Y$$$20240925$$CN$US$US
243633241$24363324$1$I$$20240916$20240925$20240925$EXP$$FR-DSJP-DSE-2024-144634$DAIICHI$$$$A$F$Y$$$20240925$$MD$FR$FR
243633251$24363325$1$I$$20240918$20240925$20240925$PER$$US-IMP-2024000757$Harrow Health$$$$E$F$Y$$$20240925$$CN$US$US
243633261$24363326$1$I$20240901$20240918$20240925$20240925$PER$$US-IMP-2024000758$Harrow Health$$78$YR$E$F$Y$$$20240925$$CN$US$US
243633281$24363328$1$I$$20240919$20240925$20240925$PER$$US-IMP-2024000766$Harrow Health$$$$E$F$Y$$$20240925$$CN$US$US
243633291$24363329$1$I$20240920$20240920$20240925$20240925$EXP$$US-OTSUKA-2024_026350$OTSUKA$$$$$$Y$$$20240925$$CN$US$US
243633301$24363330$1$I$$20240913$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009733$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243633311$24363331$1$I$20240101$20240920$20240925$20240925$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-122608$REGENERON$$$$$M$Y$$$20240925$$MD$US$US
243633321$24363332$1$I$20240916$20240916$20240925$20240925$EXP$$AU-GUERBET / LLC-AU-20240067$GUERBET$$61$YR$A$M$Y$90$KG$20240925$$HP$AU$AU
243633331$24363333$1$I$20240901$20240919$20240925$20240925$EXP$$CN-JNJFOC-20240962769$JOHNSON AND JOHNSON$$4$YR$C$M$Y$18$KG$20240925$$HP$CN$CN
243633341$24363334$1$I$$20240827$20240925$20240925$30DAY$$US-BAXTER-2024BAX024762$BAXTER$$$$$$Y$$$20240925$$HP$US$US
243633351$24363335$1$I$20240101$20240917$20240925$20240925$EXP$$JP-009507513-2406JPN001749J$MERCK$$6$DEC$$M$Y$$$20240925$$MD$JP$JP
243633361$24363336$1$I$$20240916$20240925$20240925$PER$$US-MYLANLABS-2024M1085562$MYLAN$$$$$M$Y$$$20240925$$CN$US$US
243633371$24363337$1$I$20240924$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190469$AMGEN$$63$YR$A$F$Y$$$20240925$$CN$US$US
243633381$24363338$1$I$20240904$20240918$20240925$20240925$PER$$US-Eisai-EC-2024-174785$EISAI$$$$$M$Y$$$20240925$$CN$US$US
243633391$24363339$1$I$$20240921$20240925$20240925$PER$$US-IMP-2024000769$Harrow Health$$$$E$F$Y$$$20240925$$CN$US$US
243633401$24363340$1$I$$20240919$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150041$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240925$$CN$US$US
243633411$24363341$1$I$$20240916$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147131$BRISTOL MYERS SQUIBB$Barlowe TS, Saxena-Beem S, Ishizawar RC, Herfarth H, Moon AM. Multiple gastrointestinal immune related adverse events from immune checkpoint inhibitor therapy. Clinical and Translational Gastroenterology. 2024 Sep 12;doi:10.14309/ctg.0000000000000768.$70$YR$E$M$Y$$$20240925$$MD$US$US
243633421$24363342$1$I$$20240822$20240925$20240925$PER$$US-SA-2024SA272206$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$PH$US$US
243633431$24363343$1$I$20240829$20240925$20240925$20240925$DIR$719889$$FDA-CTU$$51$YR$$M$N$$$20240925$N$PH$US$
243633441$24363344$1$I$$20240925$20240925$20240925$DIR$719890$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243633451$24363345$1$I$20240920$20240925$20240925$20240925$DIR$719892$$FDA-CTU$$84$YR$$M$N$60.75$KG$20240925$N$CN$US$
243633461$24363346$1$I$$20240827$20240925$20240925$PER$$US-SA-2024SA272816$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240925$$CN$US$US
243633471$24363347$1$I$$20240827$20240925$20240925$PER$$US-SA-2024SA268931$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
243633481$24363348$1$I$20240801$20240830$20240925$20240925$PER$$US-SA-2024SA270585$SANOFI AVENTIS$$90$YR$E$M$Y$72.57$KG$20240925$$MD$US$US
243633491$24363349$1$I$$20240913$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409009691$ELI LILLY AND CO$$$$$M$Y$$$20240925$$CN$US$US
243633501$24363350$1$I$20240923$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014705$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240925$$CN$US$US
243633511$24363351$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014528$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240925$$CN$US$US
243633521$24363352$1$I$$20240903$20240925$20240925$PER$$US-Eisai-EC-2024-173657$EISAI$$$$$F$Y$$$20240925$$MD$US$US
243633531$24363353$1$I$20240101$20240903$20240925$20240925$PER$$US-Eisai-EC-2024-173651$EISAI$$66$YR$E$F$Y$$$20240925$$CN$US$US
243633541$24363354$1$I$$20240913$20240925$20240925$30DAY$$GB-MYLANLABS-2024M1084580$MYLAN$$6$YR$$M$Y$21$KG$20240925$$CN$GB$GB
243633551$24363355$1$I$20240823$20240830$20240925$20240925$PER$$US-SA-2024SA270699$SANOFI AVENTIS$$66$YR$E$F$Y$72.73$KG$20240925$$MD$US$US
243633571$24363357$1$I$20240101$20240904$20240925$20240925$PER$$US-SA-2024SA273195$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240925$$MD$US$US
243633581$24363358$1$I$$20240904$20240925$20240925$PER$$US-SA-2024SA272853$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240925$$HP$US$US
243633591$24363359$1$I$$20240831$20240925$20240925$PER$$US-SA-2024SA272052$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240925$$HP$US$US
243633601$24363360$1$I$20240801$20240904$20240925$20240925$PER$$US-SA-2024SA272450$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240925$$HP$US$US
243633611$24363361$1$I$20240101$20240830$20240925$20240925$PER$$US-SA-2024SA271170$SANOFI AVENTIS$$48$YR$A$F$Y$75.45$KG$20240925$$MD$US$US
243633621$24363362$1$I$$20240904$20240925$20240925$PER$$US-SA-2024SA272892$SANOFI AVENTIS$$63$YR$A$M$Y$95.2$KG$20240925$$MD$US$US
243633631$24363363$1$I$20240101$20240903$20240925$20240925$PER$$US-SA-2024SA270823$SANOFI AVENTIS$$14$YR$T$M$Y$42$KG$20240925$$MD$US$US
243633641$24363364$1$I$$20240830$20240925$20240925$PER$$US-SA-2024SA271627$SANOFI AVENTIS$$$$A$F$Y$58.91$KG$20240925$$MD$US$US
243633661$24363366$1$I$$20240903$20240925$20240925$PER$$US-SA-2024SA271603$SANOFI AVENTIS$$$$A$M$Y$90.91$KG$20240925$$MD$US$US
243633671$24363367$1$I$$20240903$20240925$20240925$PER$$US-SA-2024SA272332$SANOFI AVENTIS$$$$A$M$Y$125$KG$20240925$$MD$US$US
243633681$24363368$1$I$20240801$20240903$20240925$20240925$PER$$US-SA-2024SA271069$SANOFI AVENTIS$$35$YR$A$M$Y$100$KG$20240925$$MD$US$US
243633691$24363369$1$I$20240830$20240904$20240925$20240925$PER$$US-SA-2024SA274525$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240925$$MD$US$US
243633701$24363370$1$I$$20240904$20240925$20240925$PER$$US-SA-2024SA271848$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240925$$HP$US$US
243633711$24363371$1$I$20240101$20240903$20240925$20240925$PER$$US-SA-2024SA261630$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240925$$HP$US$US
243633721$24363372$1$I$20240101$20240903$20240925$20240925$PER$$US-SA-2024SA239925$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240925$$MD$US$US
243633741$24363374$1$I$$20240904$20240925$20240925$PER$$US-SA-2024SA271439$SANOFI AVENTIS$$$$E$F$Y$$$20240925$$MD$US$US
243633751$24363375$1$I$20240101$20240904$20240925$20240925$PER$$US-SA-2024SA272465$SANOFI AVENTIS$$37$YR$A$F$Y$63.64$KG$20240925$$MD$US$US
243633761$24363376$1$I$20240801$20240903$20240925$20240925$PER$$US-SA-2024SA270386$SANOFI AVENTIS$$8$YR$C$M$Y$29$KG$20240925$$MD$US$US
243633771$24363377$1$I$$20240923$20240925$20240925$EXP$$US-JNJFOC-20240964341$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$HP$US$US
243633781$24363378$1$I$$20240905$20240925$20240925$PER$$US-SA-2024SA272823$SANOFI AVENTIS$$49$YR$A$$Y$$$20240925$$CN$US$US
243633821$24363382$1$I$20240101$20240906$20240925$20240925$PER$$US-SA-2024SA276349$SANOFI AVENTIS$$66$YR$E$M$Y$88.64$KG$20240925$$MD$US$US
243633831$24363383$1$I$20240818$20240903$20240925$20240925$PER$$US-SA-2024SA253974$SANOFI AVENTIS$$19$YR$A$F$Y$86.18$KG$20240925$$MD$US$US
243633841$24363384$1$I$$20240904$20240925$20240925$PER$$US-SA-2024SA272585$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240925$$MD$US$US
243633851$24363385$1$I$20240101$20240905$20240925$20240925$PER$$US-SA-2024SA272712$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240925$$MD$US$US
243633861$24363386$1$I$$20240904$20240925$20240925$PER$$US-SA-2024SA176927$SANOFI AVENTIS$$$$E$F$Y$70.3$KG$20240925$$MD$US$US
243633871$24363387$1$I$20240101$20240902$20240925$20240925$PER$$US-SA-2024SA273599$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240925$$HP$US$US
243633881$24363388$1$I$$20240904$20240925$20240925$PER$$US-SA-2024SA272773$SANOFI AVENTIS$$$$E$M$Y$79.3$KG$20240925$$MD$US$US
243633891$24363389$1$I$$20240906$20240925$20240925$PER$$US-SA-2024SA276333$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240925$$CN$US$US
243633901$24363390$1$I$20240101$20240903$20240925$20240925$PER$$US-SA-2024SA272516$SANOFI AVENTIS$$76$YR$E$F$Y$47.73$KG$20240925$$MD$US$US
243633911$24363391$1$I$20240904$20240905$20240925$20240925$PER$$US-SA-2024SA274485$SANOFI AVENTIS$$11$YR$C$M$Y$34.47$KG$20240925$$MD$US$US
243633921$24363392$1$I$20240101$20240903$20240925$20240925$PER$$US-SA-2024SA273695$SANOFI AVENTIS$$70$YR$E$M$Y$99.8$KG$20240925$$MD$US$US
243633941$24363394$1$I$20240101$20240903$20240925$20240925$PER$$US-SA-2024SA273551$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240925$$MD$US$US
243633951$24363395$1$I$$20240905$20240925$20240925$PER$$US-SA-2024SA274914$SANOFI AVENTIS$$$$$F$Y$$$20240925$$CN$US$US
243633961$24363396$1$I$$20240905$20240925$20240925$PER$$US-SA-2024SA276406$SANOFI AVENTIS$$57$YR$A$$Y$$$20240925$$CN$US$US
243633971$24363397$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA275913$SANOFI AVENTIS$$$$E$M$Y$$$20240925$$MD$US$US
243633981$24363398$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276346$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240925$$MD$US$US
243633991$24363399$1$I$20240801$20240910$20240925$20240925$PER$$US-SA-2024SA276412$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240925$$PH$US$US
243634001$24363400$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA277056$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240925$$MD$US$US
243634011$24363401$1$I$20240815$20240910$20240925$20240925$PER$$US-SA-2024SA277382$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240925$$CN$US$US
243634021$24363402$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276243$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240925$$CN$US$US
243634031$24363403$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276413$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240925$$MD$US$US
243634041$24363404$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276032$SANOFI AVENTIS$$50$YR$A$$Y$$$20240925$$MD$US$US
243634051$24363405$1$I$$20240906$20240925$20240925$PER$$US-SA-2024SA274646$SANOFI AVENTIS$$79$YR$E$$Y$$$20240925$$CN$US$US
243634061$24363406$1$I$$20240911$20240925$20240925$PER$$US-SA-2024SA273604$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240925$$CN$US$US
243634072$24363407$2$F$20240101$20240911$20240925$20240926$PER$$US-SA-2024SA276644$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240926$$MD$US$US
243634081$24363408$1$I$$20240925$20240925$20240925$DIR$719893$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243634091$24363409$1$I$20240801$20240910$20240925$20240925$PER$$US-SA-2024SA276040$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240925$$MD$US$US
243634101$24363410$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276469$SANOFI AVENTIS$$65$YR$E$$Y$$$20240925$$CN$US$US
243634111$24363411$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276120$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240925$$PH$US$US
243634121$24363412$1$I$$20240925$20240925$20240925$DIR$719895$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243634131$24363413$1$I$20240101$20240910$20240925$20240925$PER$$US-SA-2024SA276385$SANOFI AVENTIS$$50$YR$A$F$Y$95.45$KG$20240925$$MD$US$US
243634141$24363414$1$I$20240101$20240906$20240925$20240925$PER$$US-SA-2024SA272980$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240925$$MD$US$US
243634151$24363415$1$I$$20240911$20240925$20240925$PER$$US-SA-2024SA273348$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240925$$CN$US$US
243634161$24363416$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA275868$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240925$$MD$US$US
243634171$24363417$1$I$20240809$20240909$20240925$20240925$PER$$US-SA-2024SA275709$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240925$$MD$US$US
243634181$24363418$1$I$20240901$20240910$20240925$20240925$PER$$US-SA-2024SA275852$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240925$$HP$US$US
243634191$24363419$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276285$SANOFI AVENTIS$$71$YR$E$$Y$$$20240925$$CN$US$US
243634201$24363420$1$I$20240828$20240911$20240925$20240925$PER$$US-SA-2024SA274873$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240925$$MD$US$US
243634211$24363421$1$I$$20240918$20240925$20240925$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-26459$SAMSUNG BIOEPIS$$30$YR$A$M$Y$88.45$KG$20240925$$CN$CA$CA
243634221$24363422$1$I$$20240911$20240925$20240925$PER$$US-SA-2024SA266706$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240925$$HP$US$US
243634231$24363423$1$I$20240101$20240911$20240925$20240925$PER$$US-SA-2024SA273719$SANOFI AVENTIS$$3$YR$C$F$Y$12.5$KG$20240925$$PH$US$US
243634241$24363424$1$I$20240909$20240910$20240925$20240925$PER$$PR-SA-2024SA275835$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240925$$MD$PR$PR
243634251$24363425$1$I$20240401$20240911$20240925$20240925$PER$$US-SA-2024SA274936$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240925$$MD$US$US
243634261$24363426$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA273455$SANOFI AVENTIS$$$$$$Y$$$20240925$$MD$US$US
243634281$24363428$1$I$20240601$20240910$20240925$20240925$PER$$US-SA-2024SA274960$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240925$$CN$US$US
243634291$24363429$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276343$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240925$$CN$US$US
243634301$24363430$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276825$SANOFI AVENTIS$$19$YR$A$$Y$$$20240925$$CN$US$US
243634311$24363431$1$I$$20240909$20240925$20240925$PER$$US-SA-2024SA276289$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
243634321$24363432$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA275806$SANOFI AVENTIS$$43$YR$A$$Y$$$20240925$$CN$US$US
243634331$24363433$1$I$20240601$20240910$20240925$20240925$PER$$US-SA-2024SA276822$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240925$$MD$US$US
243634341$24363434$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276597$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
243634351$24363435$1$I$20240819$20240910$20240925$20240925$PER$$US-SA-2024SA277027$SANOFI AVENTIS$$11$YR$C$M$Y$42.09$KG$20240925$$MD$US$US
243634361$24363436$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276362$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240925$$MD$US$US
243634371$24363437$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA275855$SANOFI AVENTIS$$65$YR$E$$Y$$$20240925$$MD$US$US
243634381$24363438$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA275915$SANOFI AVENTIS$$72$YR$E$$Y$$$20240925$$CN$US$US
243634391$24363439$1$I$20240911$20240911$20240925$20240925$PER$$US-SA-2024SA273623$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240925$$HP$US$US
243634401$24363440$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA275898$SANOFI AVENTIS$$35$YR$A$$Y$$$20240925$$CN$US$US
243634411$24363441$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276709$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$CN$US$US
243634421$24363442$1$I$20240101$20240910$20240925$20240925$PER$$US-SA-2024SA277044$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240925$$MD$US$US
243634441$24363444$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276935$SANOFI AVENTIS$$$$T$F$Y$$$20240925$$MD$US$US
243634451$24363445$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276542$SANOFI AVENTIS$$$$$$Y$$$20240925$$CN$US$US
243634461$24363446$1$I$$20240911$20240925$20240925$PER$$US-SA-2024SA275723$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240925$$CN$US$US
243634471$24363447$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276864$SANOFI AVENTIS$$58$YR$A$$Y$$$20240925$$MD$US$US
243634481$24363448$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276342$SANOFI AVENTIS$$79$YR$E$$Y$$$20240925$$MD$US$US
243634491$24363449$1$I$$20240911$20240925$20240925$PER$$US-SA-2024SA276139$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240925$$HP$US$US
243634501$24363450$1$I$$20240911$20240925$20240925$PER$$US-SA-2024SA274771$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240925$$CN$US$US
243634512$24363451$2$F$$20240916$20240925$20240930$EXP$$IQ-ROCHE-10000089298$ROCHE$$55$YR$A$M$Y$$$20240930$$PH$IQ$IQ
243634521$24363452$1$I$20240908$20240911$20240925$20240925$PER$$US-SA-2024SA274778$SANOFI AVENTIS$$$$E$M$Y$$$20240925$$CN$US$US
243634532$24363453$2$F$20240101$20240911$20240925$20240926$PER$$US-SA-2024SA275104$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240926$$MD$US$US
243634541$24363454$1$I$20240101$20240911$20240925$20240925$PER$$US-SA-2024SA275413$SANOFI AVENTIS$$$$$M$Y$$$20240925$$MD$US$US
243634551$24363455$1$I$20230101$20240912$20240925$20240925$PER$$US-SA-2024SA275960$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240925$$MD$US$US
243634561$24363456$1$I$$20240912$20240925$20240925$PER$$US-SA-2024SA273110$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240925$$CN$US$US
243634571$24363457$1$I$$20240912$20240925$20240925$PER$$US-SA-2024SA275986$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240925$$MD$US$US
243634581$24363458$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276319$SANOFI AVENTIS$$$$E$M$Y$$$20240925$$HP$US$US
243634591$24363459$1$I$$20240912$20240925$20240925$PER$$US-SA-2024SA273808$SANOFI AVENTIS$$3$YR$C$$Y$$$20240925$$HP$US$US
243634601$24363460$1$I$$20240912$20240925$20240925$PER$$US-SA-2024SA274837$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$CN$US$US
243634611$24363461$1$I$20240501$20240912$20240925$20240925$PER$$US-SA-2024SA275064$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240925$$CN$US$US
243634621$24363462$1$I$20240829$20240912$20240925$20240925$PER$$US-SA-2024SA275932$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240925$$CN$US$US
243634631$24363463$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA277164$SANOFI AVENTIS$$$$A$M$Y$$$20240925$$MD$US$US
243634641$24363464$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276679$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$CN$US$US
243634651$24363465$1$I$20240101$20240912$20240925$20240925$PER$$US-SA-2024SA270833$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240925$$CN$US$US
243634661$24363466$1$I$20240401$20240910$20240925$20240925$PER$$US-SA-2024SA275894$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240925$$HP$US$US
243634671$24363467$1$I$$20240912$20240925$20240925$PER$$US-SA-2024SA275158$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240925$$CN$US$US
243634681$24363468$1$I$$20240912$20240925$20240925$PER$$US-SA-2024SA273009$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240925$$HP$US$US
243634691$24363469$1$I$$20240909$20240925$20240925$PER$$US-SA-2024SA275980$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
243634711$24363471$1$I$20240911$20240911$20240925$20240925$PER$$US-SA-2024SA272888$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240925$$CN$US$US
243634721$24363472$1$I$20240901$20240912$20240925$20240925$PER$$US-SA-2024SA275934$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240925$$HP$US$US
243634731$24363473$1$I$20240911$20240912$20240925$20240925$PER$$US-SA-2024SA275947$SANOFI AVENTIS$$14$YR$T$F$Y$97$KG$20240925$$MD$US$US
243634741$24363474$1$I$$20240912$20240925$20240925$PER$$US-SA-2024SA273816$SANOFI AVENTIS$$$$$F$Y$$$20240925$$CN$US$US
243634751$24363475$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276350$SANOFI AVENTIS$$67$YR$E$$Y$$$20240925$$CN$US$US
243634761$24363476$1$I$20240820$20240910$20240925$20240925$PER$$US-SA-2024SA275769$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240925$$MD$US$US
243634781$24363478$1$I$$20240913$20240925$20240925$PER$$US-SA-2024SA275189$SANOFI AVENTIS$$$$$$Y$$$20240925$$MD$US$US
243634791$24363479$1$I$$20240913$20240925$20240925$PER$$US-SA-2024SA274908$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240925$$CN$US$US
243634801$24363480$1$I$20240911$20240913$20240925$20240925$PER$$US-SA-2024SA275078$SANOFI AVENTIS$$92$YR$E$F$Y$$$20240925$$CN$US$US
243634811$24363481$1$I$$20240913$20240925$20240925$PER$$US-SA-2024SA274943$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240925$$CN$US$US
243634821$24363482$1$I$$20240913$20240925$20240925$PER$$US-SA-2024SA270373$SANOFI AVENTIS$$$$$$Y$$$20240925$$HP$US$US
243634831$24363483$1$I$20240911$20240913$20240925$20240925$PER$$US-SA-2024SA274840$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240925$$CN$US$US
243634841$24363484$1$I$$20240913$20240925$20240925$PER$$US-SA-2024SA275780$SANOFI AVENTIS$$64$YR$A$$Y$$$20240925$$CN$US$US
243634851$24363485$1$I$$20240919$20240925$20240925$EXP$$US-Indivior Limited-INDV-156520-2024$RECKITT BENCKISER$$$$$$Y$$$20240925$$CN$US$US
243634861$24363486$1$I$20230501$20240918$20240925$20240925$EXP$FR-AFSSAPS-AVCN2024000723$FR-INDIVIOR UK LIMITED-INDV-156493-2024$RECKITT BENCKISER$$$$$$Y$$$20240925$$MD$FR$FR
243634871$24363487$1$I$20240924$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190335$AMGEN$$$$$F$Y$$$20240925$$HP$US$US
243634881$24363488$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA271580$SANOFI AVENTIS$$$$T$F$Y$$$20240925$$MD$US$US
243634891$24363489$1$I$20240901$20240918$20240925$20240925$PER$$US-SA-2024SA271030$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240925$$HP$US$US
243634901$24363490$1$I$$20240913$20240925$20240925$PER$$US-SA-2024SA274801$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240925$$CN$US$US
243634911$24363491$1$I$$20240913$20240925$20240925$PER$$US-SA-2024SA275153$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240925$$CN$US$US
243634921$24363492$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271732$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240925$$HP$US$US
243634931$24363493$1$I$$20240916$20240925$20240925$PER$$US-SA-2024SA268415$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240925$$CN$US$US
243634941$24363494$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272681$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240925$$HP$US$US
243634951$24363495$1$I$20240901$20240917$20240925$20240925$PER$$US-SA-2024SA270437$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240925$$HP$US$US
243634961$24363496$1$I$20240101$20240917$20240925$20240925$PER$$US-SA-2024SA271428$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240925$$MD$US$US
243634971$24363497$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA271702$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240925$$HP$US$US
243634981$24363498$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA271837$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240925$$MD$US$US
243634991$24363499$1$I$20240325$20240925$20240925$20240925$DIR$719896$$FDA-CTU$$71$YR$$F$N$83.25$KG$20240925$N$CN$US$
243635001$24363500$1$I$20240101$20240917$20240925$20240925$PER$$US-SA-2024SA274518$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240925$$MD$US$US
243635031$24363503$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA270103$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240925$$MD$US$US
243635041$24363504$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA273012$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240925$$HP$US$US
243635051$24363505$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA271095$SANOFI AVENTIS$$$$C$M$Y$$$20240925$$MD$US$US
243635061$24363506$1$I$20240901$20240918$20240925$20240925$PER$$US-SA-2024SA271699$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240925$$MD$US$US
243635071$24363507$1$I$20240901$20240918$20240925$20240925$PER$$US-SA-2024SA271797$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240925$$HP$US$US
243635081$24363508$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA272335$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$HP$US$US
243635091$24363509$1$I$20240901$20240918$20240925$20240925$PER$$US-SA-2024SA272948$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240925$$HP$US$US
243635101$24363510$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272122$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240925$$HP$US$US
243635111$24363511$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272423$SANOFI AVENTIS$$$$C$F$Y$$$20240925$$HP$US$US
243635131$24363513$1$I$20240817$20240917$20240925$20240925$PER$$US-SA-2024SA271459$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240925$$MD$US$US
243635141$24363514$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA270753$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240925$$HP$US$US
243635151$24363515$1$I$20240828$20240916$20240925$20240925$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18852$IPSEN$$40$YR$A$F$Y$$$20240925$$MD$US$US
243635161$24363516$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272053$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240925$$MD$US$US
243635171$24363517$1$I$20240101$20240916$20240925$20240925$PER$$US-SA-2024SA270635$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240925$$MD$US$US
243635181$24363518$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA271608$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
243635191$24363519$1$I$20240101$20240916$20240925$20240925$PER$$US-SA-2024SA276472$SANOFI AVENTIS$$$$$$Y$$$20240925$$MD$US$US
243635201$24363520$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272074$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240925$$MD$US$US
243635211$24363521$1$I$20240101$20240917$20240925$20240925$PER$$US-SA-2024SA271684$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240925$$HP$US$US
243635221$24363522$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272678$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
243635231$24363523$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272180$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240925$$HP$US$US
243635241$24363524$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272770$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240925$$HP$US$US
243635252$24363525$2$F$20240908$20240918$20240925$20240927$PER$$US-SA-2024SA276326$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240927$$CN$US$US
243635261$24363526$1$I$20240801$20240918$20240925$20240925$PER$$US-SA-2024SA271982$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240925$$MD$US$US
243635271$24363527$1$I$20240825$20240919$20240925$20240925$EXP$$KR-SAMSUNG BIOEPIS-SB-2024-26110$SAMSUNG BIOEPIS$$65$YR$E$M$Y$76.6$KG$20240925$$MD$KR$KR
243635281$24363528$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271703$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240925$$HP$US$US
243635291$24363529$1$I$20240401$20240917$20240925$20240925$PER$$US-SA-2024SA271038$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240925$$MD$US$US
243635301$24363530$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272837$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240925$$MD$US$US
243635311$24363531$1$I$20240101$20240916$20240925$20240925$PER$$US-SA-2024SA268373$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240925$$MD$US$US
243635321$24363532$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271232$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240925$$HP$US$US
243635331$24363533$1$I$$20240916$20240925$20240925$PER$$US-SA-2024SA276551$SANOFI AVENTIS$$21$YR$A$M$Y$$$20240925$$CN$US$US
243635341$24363534$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271844$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240925$$MD$US$US
243635351$24363535$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA272553$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240925$$HP$US$US
243635361$24363536$1$I$20230101$20240917$20240925$20240925$PER$$US-SA-2024SA271522$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240925$$MD$US$US
243635371$24363537$1$I$20240901$20240918$20240925$20240925$PER$$US-SA-2024SA272361$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240925$$MD$US$US
243635381$24363538$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA270769$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240925$$HP$US$US
243635391$24363539$1$I$20240822$20240916$20240925$20240925$PER$$US-SA-2024SA270752$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240925$$MD$US$US
243635401$24363540$1$I$20240916$20240918$20240925$20240925$PER$$US-SA-2024SA272715$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240925$$MD$US$US
243635411$24363541$1$I$$20240916$20240925$20240925$PER$$US-SA-2024SA268241$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240925$$MD$US$US
243635421$24363542$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271139$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240925$$MD$US$US
243635431$24363543$1$I$$20240916$20240925$20240925$PER$$US-SA-2024SA198226$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240925$$HP$US$US
243635441$24363544$1$I$20240101$20240917$20240925$20240925$PER$$US-SA-2024SA271519$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240925$$MD$US$US
243635451$24363545$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271307$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240925$$MD$US$US
243635461$24363546$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271754$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240925$$CN$US$US
243635471$24363547$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA271690$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240925$$HP$US$US
243635481$24363548$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA272030$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240925$$HP$US$US
243635491$24363549$1$I$$20240916$20240925$20240925$PER$$US-SA-2024SA275051$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
243635501$24363550$1$I$20240601$20240917$20240925$20240925$PER$$US-SA-2024SA271438$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240925$$MD$US$US
243635511$24363551$1$I$20240101$20240917$20240925$20240925$PER$$US-SA-2024SA271648$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240925$$HP$US$US
243635521$24363552$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA271910$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240925$$MD$US$US
243635531$24363553$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA271584$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240925$$MD$US$US
243635541$24363554$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272393$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240925$$MD$US$US
243635551$24363555$1$I$20240101$20240917$20240925$20240925$PER$$US-SA-2024SA270777$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240925$$MD$US$US
243635561$24363556$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA270955$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240925$$CN$US$US
243635571$24363557$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA271751$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240925$$MD$US$US
243635582$24363558$2$F$20240101$20240917$20240925$20240930$PER$$US-SA-2024SA271372$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240930$$MD$US$US
243635591$24363559$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA271424$SANOFI AVENTIS$$$$E$M$Y$$$20240925$$MD$US$US
243635601$24363560$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA271560$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240925$$MD$US$US
243635611$24363561$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271161$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240925$$HP$US$US
243635621$24363562$1$I$20240619$20240916$20240925$20240925$PER$$US-SA-2024SA274768$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240925$$MD$US$US
243635631$24363563$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA273486$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240925$$MD$US$US
243635641$24363564$1$I$20240901$20240903$20240925$20240925$PER$$US-Eisai-EC-2024-173619$EISAI$$$$$F$Y$$$20240925$$CN$US$US
243635651$24363565$1$I$$20240830$20240925$20240925$PER$$US-Eisai-EC-2024-173521$EISAI$$$$$F$Y$$$20240925$$HP$US$US
243635661$24363566$1$I$$20240917$20240925$20240925$EXP$$AU-RDY-SPO/AUS/24/0013761$DR REDDYS$$53$YR$A$F$Y$$$20240925$$CN$AU$AU
243635671$24363567$1$I$20240101$20240917$20240925$20240925$PER$$US-SA-2024SA271539$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240925$$MD$US$US
243635681$24363568$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271053$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240925$$HP$US$US
243635691$24363569$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA271568$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240925$$CN$US$US
243635701$24363570$1$I$20240901$20240918$20240925$20240925$PER$$US-SA-2024SA272642$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240925$$HP$US$US
243635711$24363571$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA272449$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240925$$HP$US$US
243635721$24363572$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA270711$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240925$$HP$US$US
243635731$24363573$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271794$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240925$$HP$US$US
243635741$24363574$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272370$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240925$$MD$US$US
243635751$24363575$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA270399$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240925$$MD$US$US
243635761$24363576$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272607$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240925$$HP$US$US
243635771$24363577$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA271286$SANOFI AVENTIS$$$$C$M$Y$$$20240925$$CN$US$US
243635781$24363578$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272455$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240925$$MD$US$US
243635791$24363579$1$I$20240801$20240918$20240925$20240925$PER$$US-SA-2024SA272489$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240925$$HP$US$US
243635801$24363580$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA270632$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240925$$MD$US$US
243635811$24363581$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA272236$SANOFI AVENTIS$$$$E$M$Y$$$20240925$$HP$US$US
243635821$24363582$1$I$$20240916$20240925$20240925$PER$$US-SA-2024SA270283$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240925$$HP$US$US
243635831$24363583$1$I$20240101$20240917$20240925$20240925$PER$$US-SA-2024SA271713$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240925$$HP$US$US
243635841$24363584$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272163$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240925$$MD$US$US
243635851$24363585$1$I$20240101$20240917$20240925$20240925$PER$$US-SA-2024SA271567$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240925$$MD$US$US
243635861$24363586$1$I$20240901$20240917$20240925$20240925$PER$$US-SA-2024SA271530$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240925$$MD$US$US
243635871$24363587$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271092$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240925$$MD$US$US
243635881$24363588$1$I$$20240916$20240925$20240925$PER$$US-SA-2024SA276298$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240925$$CN$US$US
243635891$24363589$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271196$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240925$$MD$US$US
243635901$24363590$1$I$20240901$20240917$20240925$20240925$PER$$US-SA-2024SA271490$SANOFI AVENTIS$$$$C$M$Y$$$20240925$$HP$US$US
243635911$24363591$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA270888$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240925$$MD$US$US
243635921$24363592$1$I$20240901$20240918$20240925$20240925$PER$$US-SA-2024SA270814$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240925$$MD$US$US
243635931$24363593$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA271985$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240925$$HP$US$US
243635941$24363594$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA270922$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240925$$HP$US$US
243635951$24363595$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA271830$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240925$$MD$US$US
243635961$24363596$1$I$20240901$20240918$20240925$20240925$PER$$US-SA-2024SA272711$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240925$$HP$US$US
243635971$24363597$1$I$20240902$20240917$20240925$20240925$EXP$$AU-GUERBET / LLC-AU-20240068$GUERBET$$77$YR$E$F$Y$64$KG$20240925$$HP$AU$AU
243635981$24363598$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA272736$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240925$$HP$US$US
243635991$24363599$1$I$20240416$20240917$20240925$20240925$PER$$US-SA-2024SA271376$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240925$$HP$US$US
243636001$24363600$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272228$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240925$$HP$US$US
243636011$24363601$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272436$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240925$$HP$US$US
243636021$24363602$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA272464$SANOFI AVENTIS$$$$A$M$Y$$$20240925$$HP$US$US
243636031$24363603$1$I$20240901$20240917$20240925$20240925$PER$$US-SA-2024SA270896$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240925$$MD$US$US
243636041$24363604$1$I$20240909$20240918$20240925$20240925$PER$$US-SA-2024SA272581$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240925$$HP$US$US
243636051$24363605$1$I$20240901$20240918$20240925$20240925$PER$$US-SA-2024SA270925$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240925$$HP$US$US
243636061$24363606$1$I$$20240916$20240925$20240925$PER$$US-SA-2024SA268347$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240925$$HP$US$US
243636071$24363607$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271709$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240925$$HP$US$US
243636081$24363608$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA270328$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240925$$HP$US$US
243636091$24363609$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272448$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240925$$HP$US$US
243636101$24363610$1$I$20240301$20240918$20240925$20240925$PER$$US-SA-2024SA272671$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240925$$HP$US$US
243636111$24363611$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271789$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$HP$US$US
243636121$24363612$1$I$20240803$20240917$20240925$20240925$PER$$US-SA-2024SA271109$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240925$$MD$US$US
243636131$24363613$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272385$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240925$$HP$US$US
243636141$24363614$1$I$20240914$20240918$20240925$20240925$PER$$US-SA-2024SA272235$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240925$$HP$US$US
243636151$24363615$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272098$SANOFI AVENTIS$$$$C$F$Y$$$20240925$$HP$US$US
243636161$24363616$1$I$20240301$20240923$20240925$20240925$PER$$US-JNJFOC-20240963811$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243636171$24363617$1$I$20240802$20240916$20240925$20240925$PER$$US-JNJFOC-20240944258$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$HP$US$US
243636181$24363618$1$I$20240901$20240913$20240925$20240925$PER$$US-JNJFOC-20240937283$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$CN$US$US
243636191$24363619$1$I$20240101$20240917$20240925$20240925$PER$$US-SA-2024SA270977$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240925$$HP$US$US
243636201$24363620$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA271385$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240925$$HP$US$US
243636211$24363621$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA271589$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240925$$HP$US$US
243636221$24363622$1$I$20240901$20240918$20240925$20240925$PER$$US-SA-2024SA271765$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240925$$HP$US$US
243636241$24363624$1$I$20240601$20240917$20240925$20240925$PER$$US-SA-2024SA271304$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240925$$HP$US$US
243636251$24363625$1$I$20240918$20240918$20240925$20240925$PER$$US-SA-2024SA271131$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240925$$HP$US$US
243636261$24363626$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA271698$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240925$$HP$US$US
243636271$24363627$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271182$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240925$$MD$US$US
243636281$24363628$1$I$20240901$20240917$20240925$20240925$PER$$US-SA-2024SA270937$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240925$$MD$US$US
243636291$24363629$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA271369$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240925$$HP$US$US
243636301$24363630$1$I$20240901$20240919$20240925$20240925$PER$$US-SA-2024SA272745$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240925$$MD$US$US
243636311$24363631$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA272934$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240925$$HP$US$US
243636321$24363632$1$I$20240101$20240919$20240925$20240925$PER$$US-SA-2024SA272415$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240925$$MD$US$US
243636331$24363633$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA272846$SANOFI AVENTIS$$$$A$M$Y$$$20240925$$MD$US$US
243636341$24363634$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA272044$SANOFI AVENTIS$$$$E$F$Y$$$20240925$$HP$US$US
243636361$24363636$1$I$20240101$20240919$20240925$20240925$PER$$US-SA-2024SA272774$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240925$$MD$US$US
243636371$24363637$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272541$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240925$$HP$US$US
243636381$24363638$1$I$20240801$20240918$20240925$20240925$PER$$US-SA-2024SA272451$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240925$$MD$US$US
243636391$24363639$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272684$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240925$$HP$US$US
243636401$24363640$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272749$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240925$$MD$US$US
243636411$24363641$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA270421$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240925$$HP$US$US
243636421$24363642$1$I$$20240917$20240925$20240925$PER$$US-SA-2024SA271601$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240925$$MD$US$US
243636431$24363643$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA272638$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240925$$HP$US$US
243636441$24363644$1$I$20240101$20240918$20240925$20240925$PER$$US-SA-2024SA272600$SANOFI AVENTIS$$$$A$M$Y$$$20240925$$HP$US$US
243636451$24363645$1$I$20240828$20240919$20240925$20240925$EXP$$AU-GUERBET / LLC-AU-20240069$GUERBET$$26$YR$A$F$Y$103$KG$20240925$$HP$AU$AU
243636461$24363646$1$I$20240701$20240919$20240925$20240925$PER$$US-SA-2024SA271808$SANOFI AVENTIS$$92$YR$E$F$Y$$$20240925$$HP$US$US
243636471$24363647$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272570$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240925$$MD$US$US
243636481$24363648$1$I$20240501$20240919$20240925$20240925$PER$$US-SA-2024SA272213$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240925$$HP$US$US
243636491$24363649$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272466$SANOFI AVENTIS$$$$E$M$Y$$$20240925$$HP$US$US
243636501$24363650$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272662$SANOFI AVENTIS$$93$YR$E$F$Y$$$20240925$$HP$US$US
243636511$24363651$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272234$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240925$$CN$US$US
243636521$24363652$1$I$20240901$20240919$20240925$20240925$PER$$US-SA-2024SA272381$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240925$$MD$US$US
243636531$24363653$1$I$20240101$20240919$20240925$20240925$PER$$US-SA-2024SA272157$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240925$$HP$US$US
243636541$24363654$1$I$20240101$20240919$20240925$20240925$PER$$US-SA-2024SA272224$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240925$$HP$US$US
243636551$24363655$1$I$20240101$20240919$20240925$20240925$PER$$US-SA-2024SA272776$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240925$$HP$US$US
243636561$24363656$1$I$20240501$20240919$20240925$20240925$PER$$US-SA-2024SA272661$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240925$$HP$US$US
243636571$24363657$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272288$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240925$$HP$US$US
243636581$24363658$1$I$20240101$20240919$20240925$20240925$PER$$US-SA-2024SA272260$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240925$$HP$US$US
243636591$24363659$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272742$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240925$$MD$US$US
243636601$24363660$1$I$20240901$20240919$20240925$20240925$PER$$US-SA-2024SA272584$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240925$$HP$US$US
243636611$24363661$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272181$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240925$$HP$US$US
243636621$24363662$1$I$$20240923$20240925$20240925$EXP$$BR-ROCHE-10000089651$ROCHE$$$$E$M$Y$$$20240925$$HP$BR$BR
243636631$24363663$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65663$$FDA-CTU$$$$$$N$$$20240925$N$$US$
243636641$24363664$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272245$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240925$$MD$US$US
243636651$24363665$1$I$$20240924$20240925$20240925$EXP$$CA-ORGANON-O2409CAN001841$ORGANON$$50$YR$$F$Y$$$20240925$$HP$CA$CA
243636661$24363666$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272741$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240925$$MD$US$US
243636671$24363667$1$I$20240918$20240919$20240925$20240925$PER$$US-SA-2024SA272879$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240925$$CN$US$US
243636681$24363668$1$I$20240901$20240919$20240925$20240925$PER$$US-SA-2024SA272319$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240925$$HP$US$US
243636691$24363669$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272587$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240925$$HP$US$US
243636701$24363670$1$I$20240901$20240919$20240925$20240925$PER$$US-SA-2024SA272636$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240925$$HP$US$US
243636711$24363671$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272573$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240925$$HP$US$US
243636721$24363672$1$I$$20240920$20240925$20240925$EXP$$DE-ABBVIE-5933472$ABBVIE$$$$E$F$Y$$$20240925$$CN$DE$DE
243636731$24363673$1$I$20210801$20240920$20240925$20240925$PER$$US-SA-2024SA275844$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240925$$MD$US$US
243636741$24363674$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65683$$FDA-CTU$$$$$$N$$$20240925$N$CN$US$
243636751$24363675$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65684$$FDA-CTU$$$$$$N$$$20240925$N$CN$US$
243636761$24363676$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272461$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240925$$MD$US$US
243636771$24363677$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272762$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240925$$HP$US$US
243636781$24363678$1$I$20240901$20240919$20240925$20240925$PER$$US-SA-2024SA272263$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240925$$HP$US$US
243636791$24363679$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272512$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240925$$MD$US$US
243636801$24363680$1$I$20240101$20240919$20240925$20240925$PER$$US-SA-2024SA272626$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240925$$HP$US$US
243636811$24363681$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272169$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240925$$CN$US$US
243636821$24363682$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272434$SANOFI AVENTIS$$$$A$M$Y$$$20240925$$MD$US$US
243636831$24363683$1$I$20230101$20240920$20240925$20240925$PER$$US-SA-2024SA274678$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240925$$MD$US$US
243636841$24363684$1$I$20240101$20240919$20240925$20240925$PER$$US-SA-2024SA272591$SANOFI AVENTIS$$$$A$M$Y$$$20240925$$HP$US$US
243636851$24363685$1$I$20240901$20240923$20240925$20240925$PER$$US-SA-2024SA275238$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240925$$HP$US$US
243636861$24363686$1$I$20240619$20240923$20240925$20240925$PER$$US-SA-2024SA275784$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240925$$MD$US$US
243636871$24363687$1$I$20240101$20240919$20240925$20240925$PER$$US-SA-2024SA272657$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240925$$MD$US$US
243636881$24363688$1$I$20240829$20240923$20240925$20240925$PER$$US-SA-2024SA275457$SANOFI AVENTIS$$59$YR$A$F$Y$74$KG$20240925$$CN$US$US
243636891$24363689$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272624$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240925$$HP$US$US
243636901$24363690$1$I$20240919$20240919$20240925$20240925$PER$$US-SA-2024SA272239$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240925$$HP$US$US
243636911$24363691$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272305$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240925$$HP$US$US
243636921$24363692$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272559$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240925$$HP$US$US
243636931$24363693$1$I$20240101$20240919$20240925$20240925$PER$$US-SA-2024SA272543$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240925$$HP$US$US
243636941$24363694$1$I$20240901$20240919$20240925$20240925$PER$$US-SA-2024SA272378$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240925$$MD$US$US
243636961$24363696$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150621$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240925$$MD$US$US
243636971$24363697$1$I$20240902$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151339$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240925$$CN$US$US
243636981$24363698$1$I$$20240919$20240925$20240925$PER$$US-ABBVIE-5933289$ABBVIE$$$$$$Y$$$20240925$$CN$US$US
243636991$24363699$1$I$$20240913$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009735$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243637001$24363700$1$I$20240911$20240924$20240925$20240925$EXP$$US-KYOWAKIRIN-2024KK021982$KYOWA$$$$$$Y$$$20240925$$HP$US$US
243637011$24363701$1$I$20240101$20240918$20240925$20240925$EXP$$US-SA-2023SA276715$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240925$$HP$US$US
243637021$24363702$1$I$$20240918$20240925$20240925$EXP$$GB-SA-2024SA134519$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$CN$GB$GB
243637031$24363703$1$I$20240911$20240919$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149457$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$56.25$KG$20240925$$CN$US$US
243637041$24363704$1$I$$20240918$20240925$20240925$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-28516$SAMSUNG BIOEPIS$$$$$M$Y$$$20240925$$CN$GB$GB
243637051$24363705$1$I$20240505$20240919$20240925$20240925$EXP$FR-AFSSAPS-TS2024001012$FR-SA-2024SA276525$SANOFI AVENTIS$$78$YR$E$F$Y$55$KG$20240925$$MD$FR$FR
243637061$24363706$1$I$$20240917$20240925$20240925$EXP$$US-ROCHE-10000085470$ROCHE$$$$E$M$Y$$$20240925$$CN$US$US
243637071$24363707$1$I$20240101$20240920$20240925$20240925$EXP$$US-SA-2024SA275703$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240925$$MD$US$US
243637081$24363708$1$I$$20240920$20240925$20240925$EXP$$DE-TAKEDA-2024TUS094718$TAKEDA$$$$$M$Y$$$20240925$$CN$GB$DE
243637091$24363709$1$I$20240901$20240904$20240925$20240925$EXP$$US-SA-2024SA274857$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240925$$MD$US$US
243637101$24363710$1$I$20240913$20240920$20240925$20240925$EXP$$US-SA-2024SA275873$SANOFI AVENTIS$$18$YR$A$M$Y$$$20240925$$MD$US$US
243637111$24363711$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA277156$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240925$$HP$US$US
243637121$24363712$1$I$$20240910$20240925$20240925$PER$$US-SA-2024SA276962$SANOFI AVENTIS$$$$A$M$Y$100.91$KG$20240925$$HP$US$US
243637131$24363713$1$I$20240101$20240910$20240925$20240925$PER$$US-SA-2024SA277097$SANOFI AVENTIS$$17$YR$T$F$Y$57.73$KG$20240925$$MD$US$US
243637141$24363714$1$I$$20240904$20240925$20240925$PER$$US-SA-2024SA272850$SANOFI AVENTIS$$9$YR$C$M$Y$22.2$KG$20240925$$MD$US$US
243637151$24363715$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272723$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240925$$MD$US$US
243637161$24363716$1$I$20240101$20240913$20240925$20240925$PER$$US-SA-2024SA267312$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240925$$MD$US$US
243637181$24363718$1$I$20240901$20240919$20240925$20240925$PER$$US-SA-2024SA272515$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240925$$MD$US$US
243637191$24363719$1$I$$20240918$20240925$20240925$PER$$PR-SA-2024SA276286$SANOFI AVENTIS$$$$E$F$Y$$$20240925$$MD$PR$PR
243637201$24363720$1$I$20240903$20240912$20240925$20240925$PER$$US-SA-2024SA273898$SANOFI AVENTIS$$85$YR$E$M$Y$$$20240925$$CN$US$US
243637211$24363721$1$I$20231101$20240916$20240925$20240925$PER$$US-SA-2023SA372200$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240925$$HP$US$US
243637221$24363722$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA086193$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240925$$MD$US$US
243637231$24363723$1$I$20240101$20240913$20240925$20240925$PER$$US-SA-2024SA271682$SANOFI AVENTIS$$$$$M$Y$$$20240925$$CN$US$US
243637241$24363724$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271501$SANOFI AVENTIS$$$$A$F$Y$$$20240925$$MD$US$US
243637251$24363725$1$I$$20240918$20240925$20240925$PER$$US-GILEAD-2024-0688233$GILEAD$$$$$M$Y$$$20240925$$HP$US$US
243637261$24363726$1$I$$20240917$20240925$20240925$PER$$US-ABBVIE-5928057$ABBVIE$$40$YR$$M$Y$$$20240925$$CN$US$US
243637271$24363727$1$I$20240101$20240919$20240925$20240925$PER$$US-SA-2024SA272737$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240925$$HP$US$US
243637281$24363728$1$I$20240910$20240912$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013788$DR REDDYS$$54$YR$A$F$Y$$$20240925$$HP$US$US
243637291$24363729$1$I$$20240912$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013605$DR REDDYS$$53$YR$A$F$Y$$$20240925$$MD$US$US
243637321$24363732$1$I$20240801$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151630$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240925$$HP$US$US
243637331$24363733$1$I$$20240920$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151474$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240925$$CN$US$US
243637341$24363734$1$I$$20240916$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152122$BRISTOL MYERS SQUIBB$Barlowe TS, Saxena-Beem S, Ishizawar RC, Herfarth H, Moon AM. Multiple gastrointestinal immune related adverse events from immune checkpoint inhibitor therapy. Clinical and Translational Gastroenterology. 2024 Sep 12;doi:10.14309/ctg.0000000000000768.$48$YR$A$F$Y$$$20240925$$MD$US$US
243637351$24363735$1$I$20240901$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152024$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$99.79$KG$20240925$$CN$US$US
243637361$24363736$1$I$$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012260$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240925$$CN$US$US
243637371$24363737$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014262$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243637381$24363738$1$I$20240701$20240916$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409010072$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240925$$CN$US$US
243637391$24363739$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014761$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240925$$CN$US$US
243637401$24363740$1$I$20240617$20240918$20240925$20240925$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-127707$REGENERON$$$$$M$Y$$$20240925$$MD$CA$CA
243637411$24363741$1$I$$20240912$20240925$20240925$EXP$$US-SA-2024SA275347$SANOFI AVENTIS$$$$E$F$Y$76.36$KG$20240925$$MD$US$US
243637421$24363742$1$I$20231006$20240919$20240925$20240925$EXP$$CA-ABBVIE-5933986$ABBVIE$$47$YR$$M$Y$72$KG$20240925$$HP$CA$CA
243637431$24363743$1$I$$20240923$20240925$20240925$EXP$$US-TAKEDA-2024TUS095106$TAKEDA$$$$$F$Y$$$20240925$$CN$US$US
243637441$24363744$1$I$$20240809$20240925$20240925$PER$$US-LUNDBECK-DKLU4002848$LUNDBECK$$$$$$Y$$$20240925$$CN$US$US
243637451$24363745$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152020$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$59.8$KG$20240925$$PH$US$US
243637471$24363747$1$I$$20240919$20240925$20240925$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015770$JAZZ$$$$$F$Y$$$20240925$$CN$US$US
243637481$24363748$1$I$$20240925$20240925$20240925$DIR$719903$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243637491$24363749$1$I$$20240913$20240925$20240925$EXP$$GR-Calliditas-2024CAL02040$CALLIDITAS THERAPEUTICS$$55$YR$A$M$Y$$$20240925$$MD$GR$GR
243637501$24363750$1$I$20240701$20240918$20240925$20240925$PER$$US-Calliditas-2024CAL01336$CALLIDITAS THERAPEUTICS$$63$YR$A$M$Y$$$20240925$$CN$US$US
243637511$24363751$1$I$20240829$20240830$20240925$20240925$PER$$US-Eisai-EC-2024-173523$EISAI$$$$$F$Y$$$20240925$$HP$US$US
243637521$24363752$1$I$20240912$20240913$20240925$20240925$EXP$$FR-GUERBET / LLC-FR-20240337$GUERBET$$43$YR$A$F$Y$90$KG$20240925$$HP$FR$FR
243637531$24363753$1$I$$20240913$20240925$20240925$PER$$US-JNJFOC-20240940355$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$CN$US$US
243637541$24363754$1$I$20240913$20240916$20240925$20240925$PER$$US-JNJFOC-20240940798$JOHNSON AND JOHNSON$$52$YR$A$F$Y$79$KG$20240925$$PH$US$US
243637551$24363755$1$I$$20240923$20240925$20240925$PER$$US-JNJFOC-20240963851$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243637561$24363756$1$I$20240917$20240918$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148979$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240925$$CN$US$US
243637571$24363757$1$I$$20240917$20240925$20240925$EXP$$US-TAKEDA-US201826061$TAKEDA$$$$$F$Y$123$KG$20240925$$HP$US$US
243637581$24363758$1$I$20240901$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151901$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$87.09$KG$20240925$$PH$US$US
243637601$24363760$1$I$20240901$20240909$20240925$20240925$PER$$US-SA-2024SA275813$SANOFI AVENTIS$$13$YR$T$F$Y$70.91$KG$20240925$$MD$US$US
243637611$24363761$1$I$20240601$20240917$20240925$20240925$PER$$US-SA-2024SA271084$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240925$$HP$US$US
243637621$24363762$1$I$20240901$20240919$20240925$20240925$PER$$US-SA-2024SA272824$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240925$$MD$US$US
243637631$24363763$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272688$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240925$$HP$US$US
243637641$24363764$1$I$20240913$20240919$20240925$20240925$EXP$$US-TAKEDA-2024TUS093538$TAKEDA$$65$YR$$F$Y$$$20240925$$MD$US$US
243637651$24363765$1$I$$20240923$20240925$20240925$EXP$GB-MHRA-MIDB-d6dcb5f6-ed78-4806-976f-1b1eb79b3850$GB-SA-2024SA276341$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240925$$PH$GB$GB
243637661$24363766$1$I$20240501$20240916$20240925$20240925$EXP$$BR-JNJFOC-20240949113$JOHNSON AND JOHNSON$$65$YR$E$F$Y$62$KG$20240925$$CN$BR$BR
243637671$24363767$1$I$$20240916$20240925$20240925$PER$$US-JNJFOC-20240941810$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243637681$24363768$1$I$$20240917$20240925$20240925$PER$$US-BIOGEN-2024BI01282963$BIOGEN$$$$C$M$Y$$$20240925$$CN$US$US
243637691$24363769$1$I$$20240920$20240925$20240925$EXP$$US-TAKEDA-2024TUS094136$TAKEDA$$$$$F$Y$$$20240925$$HP$US$US
243637701$24363770$1$I$20240907$20240919$20240925$20240925$EXP$$US-OTSUKA-2024_026262$OTSUKA$$$$$F$Y$$$20240925$$CN$US$US
243637731$24363773$1$I$20240328$20240912$20240925$20240925$EXP$$JP-shionogi-202400000148$SHIONOGI$$6$DEC$A$F$Y$61.2$KG$20240925$$MD$JP$JP
243637742$24363774$2$F$20240909$20240917$20240925$20240930$EXP$$US-ROCHE-10000084762$ROCHE$$63$YR$A$M$Y$98.4$KG$20240930$$PH$US$US
243637751$24363775$1$I$20240904$20240916$20240925$20240925$EXP$$DE-DSJP-DS-2024-100511-DE$DAIICHI$$44$YR$$F$Y$$$20240925$$MD$DE$DE
243637761$24363776$1$I$$20240919$20240925$20240925$PER$$US-AMGEN-USASP2024188914$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243637771$24363777$1$I$20240923$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189979$AMGEN$$67$YR$E$F$Y$$$20240925$$CN$US$US
243637782$24363778$2$F$20240922$20240925$20240925$20240926$PER$$US-AMGEN-USASP2024190354$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243637791$24363779$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014466$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240925$$CN$US$US
243637801$24363780$1$I$$20240910$20240925$20240925$EXP$$JP-EAGLE PHARMACEUTICALS, INC.-JP-2024EAG000219$EAGLE$Keita I, et al.. Two cases of follicular lymphoma with persistent aplasia pure red cell after combination therapy with bendamustine and obinutuzumab.. The 20th Meeting of Kanto- Koshinetsu Branch of the Japanese Society of Hematolo. 2024;58$77$YR$$F$Y$$$20240925$$MD$JP$JP
243637811$24363781$1$I$20240921$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014374$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240925$$CN$US$US
243637831$24363783$1$I$$20240917$20240925$20240925$EXP$$RU-ABBVIE-5937912$ABBVIE$$75$YR$$$Y$$$20240925$$MD$RU$RU
243637851$24363785$1$I$20240909$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151382$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$141.07$KG$20240925$$HP$US$US
243637871$24363787$1$I$20240501$20240918$20240925$20240925$EXP$$US-SANDOZ INC.-SDZ2024US081584$SANDOZ$$47$YR$$F$Y$$$20240925$$CN$US$US
243637881$24363788$1$I$$20240919$20240925$20240925$EXP$$JP-BAUSCH-BL-2024-014365$BAUSCH AND LOMB$$66$YR$$F$Y$$$20240925$$PH$JP$JP
243637891$24363789$1$I$20230210$20240919$20240925$20240925$EXP$$JP-BAUSCH-BL-2024-014362$BAUSCH AND LOMB$$52$YR$$F$Y$$$20240925$$PH$JP$JP
243637901$24363790$1$I$$20240910$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009573$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243637911$24363791$1$I$$20240923$20240925$20240925$EXP$$US-BAUSCH-BL-2024-014332$BAUSCH AND LOMB$$74$YR$$F$Y$$$20240925$$CN$US$US
243637921$24363792$1$I$$20240923$20240925$20240925$EXP$$US-BAUSCH-BL-2024-014286$BAUSCH AND LOMB$$$$$$Y$$$20240925$$MD$US$US
243637931$24363793$1$I$$20240921$20240925$20240925$EXP$$ZA-PFIZER INC-202400260959$PFIZER$$$$A$M$Y$$$20240925$$CN$ZA$ZA
243637941$24363794$1$I$$20240920$20240925$20240925$EXP$$CA-PFIZER INC-202400260810$PFIZER$$29$YR$$F$Y$62.6$KG$20240925$$HP$CA$CA
243637951$24363795$1$I$$20240923$20240925$20240925$EXP$$US-PFIZER INC-2022SGN04276$PFIZER$$$$$F$Y$$$20240925$$MD$US$US
243637961$24363796$1$I$20240917$20240920$20240925$20240925$EXP$$CN-PFIZER INC-PV202400123589$PFIZER$$18$YR$$F$Y$40.7$KG$20240925$$HP$CN$CN
243637972$24363797$2$F$$20240925$20240925$20240927$EXP$$US-PFIZER INC-2019SGN00848$PFIZER$$$$$$Y$$$20240927$$HP$US$US
243638001$24363800$1$I$$20240923$20240925$20240925$EXP$$JP-PFIZER INC-PV202400124440$PFIZER$$39$YR$$F$Y$$$20240925$$MD$JP$JP
243638011$24363801$1$I$20190601$20240923$20240925$20240925$EXP$$US-PFIZER INC-2019SGN02046$PFIZER$$51$YR$$F$Y$$$20240925$$MD$US$US
243638021$24363802$1$I$$20240913$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009750$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243638031$24363803$1$I$$20240912$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009678$INCYTE$$$$$$Y$$$20240925$$PH$US$US
243638041$24363804$1$I$20240625$20240913$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009747$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243638052$24363805$2$F$20240101$20240913$20240925$20240927$EXP$$CA-ABBVIE-5927933$ABBVIE$$42$YR$$F$Y$$$20240927$$CN$CA$CA
243638061$24363806$1$I$$20240913$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009742$INCYTE$$$$$$Y$$$20240925$$HP$US$US
243638081$24363808$1$I$20240901$20240925$20240925$20240925$EXP$ES-AEMPS-1572919$ES-PFIZER INC-202400263524$PFIZER$$89$YR$$F$Y$$$20240925$$MD$ES$ES
243638091$24363809$1$I$20240911$20240925$20240925$20240925$DIR$719905$$FDA-CTU$$64$YR$$M$N$84$KG$20240925$N$HP$US$
243638101$24363810$1$I$20240924$20240925$20240925$20240925$DIR$719904$$FDA-CTU$$46$YR$$F$N$98.1$KG$20240925$N$CN$US$
243638111$24363811$1$I$$20240919$20240925$20240925$EXP$$BE-MYLANLABS-2024M1086219$MYLAN$$65$YR$$F$Y$$$20240925$$MD$BE$BE
243638121$24363812$1$I$$20240925$20240925$20240925$EXP$$PL-PFIZER INC-202400263679$PFIZER$$$$$F$Y$$$20240925$$MD$PL$PL
243638131$24363813$1$I$20240911$20240923$20240925$20240925$EXP$$US-PFIZER INC-202400262742$PFIZER$$45$YR$$M$Y$$$20240925$$CN$US$US
243638141$24363814$1$I$$20240924$20240925$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US082712$SANDOZ$$$$$M$Y$$$20240925$$CN$US$US
243638151$24363815$1$I$$20240924$20240925$20240925$EXP$$GB-PFIZER INC-PV202400125396$PFIZER$$77$YR$$F$Y$$$20240925$$CN$GB$GB
243638171$24363817$1$I$$20240923$20240925$20240925$PER$$US-ABBVIE-5936041$ABBVIE$$$$$F$Y$$$20240925$$HP$US$US
243638181$24363818$1$I$20240922$20240923$20240925$20240925$EXP$$US-BAYER-2024A135537$BAYER$$67$YR$E$F$Y$$$20240925$$CN$US$US
243638191$24363819$1$I$20240201$20240925$20240925$20240925$DIR$719906$$FDA-CTU$$62$YR$$F$N$$$20240925$Y$PH$US$
243638201$24363820$1$I$$20240925$20240925$20240925$DIR$719908$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243638221$24363822$1$I$20240730$20240911$20240925$20240925$EXP$$US-GERON CORPORATION-US-GER-24-000096$GERON CORP$$$$E$F$Y$$$20240925$$HP$US$US
243638231$24363823$1$I$20240701$20240919$20240925$20240925$PER$FR-AFSSAPS-RE2024000908$FR-Eisai-EC-2024-175000$EISAI$$47$YR$A$F$Y$59$KG$20240925$$MD$FR$FR
243638241$24363824$1$I$20240830$20240923$20240925$20240925$PER$$CN-Eisai-EC-2024-175239$EISAI$$78$YR$E$F$Y$63$KG$20240925$$HP$CN$CN
243638251$24363825$1$I$20221110$20240916$20240925$20240925$EXP$FR-AFSSAPS-MA2024001487$FR-Eisai-EC-2024-174387$EISAI$$85$YR$E$F$Y$$$20240925$$HP$FR$FR
243638261$24363826$1$I$20240520$20240911$20240925$20240925$EXP$$PT-SMPA-2024SPA000099$SUNOVION$$$$$$Y$$$20240925$$MD$KR$KR
243638271$24363827$1$I$20230101$20240911$20240925$20240925$EXP$$PT-SMPA-2023SUN000933$SUNOVION$$$$$$Y$$$20240925$$MD$KR$KR
243638281$24363828$1$I$$20240923$20240925$20240925$PER$$US-JNJFOC-20240963921$JOHNSON AND JOHNSON$$$$$F$Y$$$20240925$$CN$US$US
243638291$24363829$1$I$$20240923$20240925$20240925$EXP$$NL-PFIZER INC-202400261485$PFIZER$Peeters, W.. Skin and soft tissue infections due to non-tuberculous mycobacteria... Journal of infectious diseases. 2024;19(3):100-107$65$YR$$F$Y$$$20240925$$HP$NL$NL
243638302$24363830$2$F$20240101$20240924$20240925$20240930$EXP$$DE-PFIZER INC-PV202400124743$PFIZER$$83$YR$$M$Y$$$20240930$$MD$DE$DE
243638311$24363831$1$I$$20240923$20240925$20240925$EXP$$FR-PFIZER INC-202400261453$PFIZER$$$$$M$Y$$$20240925$$MD$FR$FR
243638321$24363832$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152041$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240925$$CN$US$US
243638331$24363833$1$I$20240328$20240919$20240925$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-098559$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240925$$MD$JP$JP
243638341$24363834$1$I$$20240918$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149673$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$$$20240925$$HP$US$US
243638361$24363836$1$I$$20240923$20240925$20240925$PER$$US-ROCHE-10000089742$ROCHE$$$$A$F$Y$$$20240925$$CN$US$US
243638381$24363838$1$I$$20240918$20240925$20240925$PER$$US-SA-2024SA271228$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240925$$HP$US$US
243638391$24363839$1$I$20240901$20240919$20240925$20240925$PER$$US-SA-2024SA272694$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240925$$HP$US$US
243638401$24363840$1$I$20240101$20240913$20240925$20240925$PER$$US-SA-2024SA267924$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240925$$CN$US$US
243638411$24363841$1$I$$20240923$20240925$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US082518$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
243638422$24363842$2$F$20240101$20240918$20240925$20240928$EXP$$CA-TEVA-VS-3244019$TEVA$$60$YR$$M$Y$$$20240928$$CN$CA$CA
243638431$24363843$1$I$$20240923$20240925$20240925$EXP$$US-ABBVIE-5937595$ABBVIE$Haag AL, Chen E, Mccarver SC. Hyperammonemia in the icu: a case of fatal discovery. CHEST. 2024;166(4):A1874-A1875.$65$YR$$M$Y$$$20240925$$HP$US$US
243638441$24363844$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272739$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240925$$HP$US$US
243638452$24363845$2$F$$20240920$20240925$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US031293$SANDOZ$$$$$M$Y$$$20240925$$CN$US$US
243638471$24363847$1$I$$20240919$20240925$20240925$EXP$$DE-MYLANLABS-2019M1116855$MYLAN$$$$$M$Y$63$KG$20240925$$CN$DE$DE
243638481$24363848$1$I$$20240916$20240925$20240925$EXP$$US-MYLANLABS-2024M1084829$MYLAN$$$$$F$Y$$$20240925$$CN$US$US
243638491$24363849$1$I$20240901$20240919$20240925$20240925$EXP$$US-Vifor (International) Inc.-VIT-2024-08683$VIFOR$$$$$F$Y$$$20240925$$HP$US$US
243638501$24363850$1$I$20230610$20240916$20240925$20240925$PER$$JP-Eisai-EC-2024-174566$EISAI$$71$YR$E$F$Y$42$KG$20240925$$MD$JP$JP
243638511$24363851$1$I$20240904$20240917$20240925$20240925$EXP$$JP-009507513-2409JPN002655J$MERCK$$7$DEC$$M$Y$$$20240925$$MD$JP$JP
243638521$24363852$1$I$20230101$20240917$20240925$20240925$PER$$JP-Eisai-EC-2023-139298$EISAI$Sazuka T. RCC Seminar ~Rethinking surgery and drug therapy. RCC Seminar ~Rethinking surgery and drug therapy.$$$E$F$Y$$$20240925$$MD$JP$JP
243638531$24363853$1$I$$20240917$20240925$20240925$EXP$$JP-Eisai-EC-2024-174729$EISAI$Takahiko Okano. A case of small intestinal perforation due to pembrolizumab + lenvatinib therapy. The 872nd Surgical Society, program and abstracts. 2024: 53(P30)-.$77$YR$E$M$Y$$$20240925$$MD$JP$JP
243638541$24363854$1$I$$20240919$20240925$20240925$PER$$US-BIOMARINAP-US-2024-160717$BIOMARIN$$$$$$Y$$$20240925$$CN$US$US
243638551$24363855$1$I$20240101$20240912$20240925$20240925$EXP$$CO-ABBVIE-5930075$ABBVIE$$$$$M$Y$105$KG$20240925$$CN$CO$CO
243638561$24363856$1$I$20240923$20240923$20240925$20240925$PER$$US-PFIZER INC-202400262659$PFIZER$$63$YR$$F$Y$$$20240925$$MD$US$US
243638571$24363857$1$I$$20240912$20240925$20240925$PER$$US-SA-2024SA275024$SANOFI AVENTIS$$$$A$$Y$$$20240925$$MD$US$US
243638581$24363858$1$I$$20240919$20240925$20240925$PER$$US-SA-2024SA272740$SANOFI AVENTIS$$$$A$M$Y$$$20240925$$HP$US$US
243638591$24363859$1$I$$20240913$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009740$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243638601$24363860$1$I$$20240918$20240925$20240925$PER$$US-BIOMARINAP-US-2024-160693$BIOMARIN$$$$$$Y$$$20240925$$CN$US$US
243638611$24363861$1$I$20240705$20240919$20240925$20240925$PER$$US-Calliditas-2024CAL01720$CALLIDITAS THERAPEUTICS$$43$YR$A$M$Y$82.1$KG$20240925$$CN$US$US
243638621$24363862$1$I$20240101$20240919$20240925$20240925$EXP$$US-ABBVIE-5932763$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243638631$24363863$1$I$20240919$20240920$20240925$20240925$EXP$$CA-ROCHE-10000089152$ROCHE$$39$YR$A$F$Y$$$20240925$$CN$CA$CA
243638641$24363864$1$I$$20240905$20240925$20240925$PER$$US-TEVA-VS-3240891$TEVA$$83$YR$$F$Y$$$20240925$$CN$US$US
243638651$24363865$1$I$$20240613$20240925$20240925$PER$$US-RIGEL-20240600017$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240925$$CN$US$US
243638661$24363866$1$I$$20240628$20240925$20240925$PER$$US-RIGEL-20240700011$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240925$$CN$US$US
243638671$24363867$1$I$20240101$20240710$20240925$20240925$PER$$US-RIGEL-20240700056$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
243638681$24363868$1$I$20240101$20240815$20240925$20240925$PER$$US-RIGEL-20240800077$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
243638691$24363869$1$I$20240917$20240918$20240925$20240925$30DAY$$US-AMGEN-USASP2024186642$AMGEN$$63$YR$A$F$Y$82.5$KG$20240925$$PH$US$US
243638701$24363870$1$I$20240101$20240711$20240925$20240925$PER$$US-RIGEL-20240700080$RIGEL PHARMACEUTICALS$$$$$F$Y$68.039$KG$20240925$$CN$US$US
243638711$24363871$1$I$$20240715$20240925$20240925$PER$$US-RIGEL-20240700065$RIGEL PHARMACEUTICALS$$$$$F$Y$58.06$KG$20240925$$CN$US$US
243638721$24363872$1$I$$20240921$20240925$20240925$EXP$$US-ASTELLAS-2024-AER-008662$ASTELLAS$Nathani A. Kaposi sarcoma in two lung transplant recipients: a single-center experience. Transplantation Proceedings. 2024;56(7): 1639-45. doi: 10.1016/j.transproceed.2024.07.004.$69$YR$E$F$Y$$$20240925$$HP$US$US
243638731$24363873$1$I$20240101$20240605$20240925$20240925$PER$$US-RIGEL-2024OLU000056$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240925$$MD$US$US
243638751$24363875$1$I$$20240917$20240925$20240925$PER$$JP-Eisai-EC-2024-174735$EISAI$$$$$F$Y$$$20240925$$MD$JP$JP
243638761$24363876$1$I$20240923$20240923$20240925$20240925$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053289$BOEHRINGER INGELHEIM$$61$YR$A$F$Y$$$20240925$$CN$US$US
243638771$24363877$1$I$20240221$20240613$20240925$20240925$PER$$US-RIGEL-20240600007$RIGEL PHARMACEUTICALS$$36$YR$$M$Y$97.522$KG$20240925$$CN$US$US
243638791$24363879$1$I$$20240920$20240925$20240925$EXP$$JP-PERRIGO-24JP008906$PERRIGO$Maezumi S, Okada T, Kishida T, Ogawa Y, Tsukahara K. Renal Immune-Related Adverse Event Difficult to Diagnose during Nivolumab Treatment for Hypopharyngeal Carcinoma: Case Report. Case Reports in Oncology. 2024;17:966-72. DOI: 10.1159/000540373.$64$YR$$M$Y$$$20240925$$MD$JP$JP
243638801$24363880$1$I$20240911$20240919$20240925$20240925$PER$$CN-Eisai-EC-2024-175002$EISAI$$72$YR$E$F$Y$53$KG$20240925$$HP$CN$CN
243638811$24363881$1$I$$20240705$20240925$20240925$PER$$US-RIGEL-20240700040$RIGEL PHARMACEUTICALS$$$$$F$Y$$$20240925$$CN$US$US
243638821$24363882$1$I$$20240912$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009679$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243638831$24363883$1$I$20240101$20240621$20240925$20240925$PER$$US-RIGEL-20240600068$RIGEL PHARMACEUTICALS$$$$$M$Y$60.781$KG$20240925$$CN$US$US
243638841$24363884$1$I$20240611$20240707$20240925$20240925$PER$$US-RIGEL-20240700046$RIGEL PHARMACEUTICALS$$47$YR$$F$Y$81.65$KG$20240925$$HP$US$US
243638851$24363885$1$I$20240709$20240716$20240925$20240925$PER$$US-RIGEL-20240700069$RIGEL PHARMACEUTICALS$$35$YR$$M$Y$82.554$KG$20240925$$CN$US$US
243638861$24363886$1$I$20240517$20240919$20240925$20240925$EXP$FR-AFSSAPS-AM2024000717$FR-MYLANLABS-2024M1085622$MYLAN$$82$YR$$M$Y$61$KG$20240925$$PH$FR$FR
243638871$24363887$1$I$$20240912$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009685$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243638881$24363888$1$I$$20240922$20240925$20240925$PER$$US-JNJFOC-20240963734$JOHNSON AND JOHNSON$$$$$$Y$$$20240925$$CN$US$US
243638891$24363889$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152067$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$MD$US$US
243638901$24363890$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151855$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240925$$CN$US$US
243638911$24363891$1$I$20240806$20240920$20240925$20240925$EXP$FR-AFSSAPS-PP2024001008$FR-ELI_LILLY_AND_COMPANY-FR202409014869$ELI LILLY AND CO$$59$YR$A$M$Y$68$KG$20240925$$CN$DE$FR
243638921$24363892$1$I$$20240923$20240925$20240925$EXP$$CA-Eisai-EC-2024-175203$EISAI$$67$YR$E$M$Y$94$KG$20240925$$HP$CA$CA
243638931$24363893$1$I$$20240924$20240925$20240925$EXP$$CA-SANDOZ INC.-SDZ2024CA082646$SANDOZ$$$$$F$Y$54$KG$20240925$$CN$CA$CA
243638941$24363894$1$I$20240101$20240729$20240925$20240925$PER$$US-RIGEL-20240700121$RIGEL PHARMACEUTICALS$$$$$M$Y$60.781$KG$20240925$$CN$US$US
243638951$24363895$1$I$20240917$20240918$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012262$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240925$$CN$US$US
243638961$24363896$1$I$$20240919$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409013380$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240925$$CN$US$US
243638971$24363897$1$I$$20240913$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009737$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243638981$24363898$1$I$20240101$20240918$20240925$20240925$EXP$$US-ANIPHARMA-2024-US-050706$ANI$$84$YR$$F$Y$78.47$KG$20240925$$CN$US$US
243638991$24363899$1$I$$20240913$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009734$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243639001$24363900$1$I$$20240924$20240925$20240925$PER$$US-ROCHE-10000090677$ROCHE$$78$YR$E$M$Y$$$20240925$$CN$US$US
243639011$24363901$1$I$$20240919$20240925$20240925$EXP$$US-MYLANLABS-2024M1086107$MYLAN$$$$$$Y$$$20240925$$CN$US$US
243639021$24363902$1$I$$20240912$20240925$20240925$PER$$US-MYLANLABS-2024M1084337$MYLAN$$35$YR$$F$Y$$$20240925$$CN$US$US
243639031$24363903$1$I$$20240924$20240925$20240925$PER$$US-ABBVIE-5938292$ABBVIE$$$$$$Y$$$20240925$$HP$US$US
243639041$24363904$1$I$$20240911$20240925$20240925$PER$$US-INCYTE CORPORATION-2024IN009625$INCYTE$$$$$$Y$$$20240925$$CN$US$US
243639051$24363905$1$I$$20240920$20240925$20240925$EXP$$US-MYLANLABS-2024M1086806$MYLAN$$$$$M$Y$$$20240925$$CN$US$US
243639061$24363906$1$I$$20240921$20240925$20240925$EXP$$US-ASTELLAS-2024-AER-008680$ASTELLAS$FUJIUCHI B. Infection-related glomerulonephritis in a patient with bilateral endocarditis and legionnaires disease. Chest Infections Case Reports Posters (H). 2024;166(4): A1590-1.$48$YR$A$M$Y$$$20240925$$HP$US$US
243639071$24363907$1$I$$20240920$20240925$20240925$EXP$$US-JNJFOC-20240963207$JOHNSON AND JOHNSON$$$$$M$Y$$$20240925$$CN$US$US
243639081$24363908$1$I$20220503$20240920$20240925$20240925$EXP$ES-AEMPS-1570755$ES-PFIZER INC-202400260361$PFIZER$$55$YR$$F$Y$$$20240925$$PH$ES$ES
243639092$24363909$2$F$20231101$20240926$20240925$20240930$EXP$FR-AFSSAPS-DJ2024001013$FR-PFIZER INC-202400260461$PFIZER$$78$YR$$F$Y$56$KG$20240930$$MD$FR$FR
243639101$24363910$1$I$20240312$20240924$20240925$20240925$EXP$$US-PFIZER INC-PV202400036732$PFIZER$$78$YR$$F$Y$$$20240925$$HP$US$US
243639111$24363911$1$I$$20240920$20240925$20240925$EXP$$US-PFIZER INC-2023SGN05818$PFIZER$$$$$M$Y$$$20240925$$HP$US$US
243639121$24363912$1$I$$20240920$20240925$20240925$EXP$$US-PFIZER INC-2023SGN00881$PFIZER$$$$$$Y$$$20240925$$HP$US$US
243639141$24363914$1$I$$20240917$20240925$20240925$EXP$$US-MYLANLABS-2024M1085506$MYLAN$Fiocco C, Farooq F, Kaveney A. Acute Disseminated Intravascular Coagulation Precipitated by 177Lu-Dotatate in Metastatic Midgut Neuroendocrine Tumor: A Case Report. J-Gastrointest-Can 2023; 54 1370-1372.$73$YR$$M$Y$$$20240925$$HP$US$US
243639161$24363916$1$I$20240909$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151782$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240925$$CN$US$US
243639171$24363917$1$I$$20240911$20240925$20240925$PER$$US-SA-2024SA275648$SANOFI AVENTIS$$$$A$M$Y$$$20240925$$MD$US$US
243639181$24363918$1$I$20240904$20240924$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151709$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240925$$HP$US$US
243639191$24363919$1$I$20240901$20240919$20240925$20240925$EXP$CN-91110000556821568D-2024DRL001806$CN-RDY-SPO/CHN/24/0013983$DR REDDYS$$72$YR$E$M$Y$60$KG$20240925$$HP$CN$CN
243639201$24363920$1$I$20240910$20240918$20240925$20240925$EXP$CN-91110000556821568D-2024DRL001790$CN-RDY-SPO/CHN/24/0013933$DR REDDYS$$53$YR$A$F$Y$71$KG$20240925$$HP$CN$CN
243639211$24363921$1$I$20240918$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151573$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240925$$PH$US$US
243639221$24363922$1$I$$20240918$20240925$20240925$PER$$US-DSJP-DS-2024-101354-US$DAIICHI$$$$$F$Y$$$20240925$$MD$US$US
243639231$24363923$1$I$$20240918$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012288$ELI LILLY AND CO$$$$$M$Y$$$20240925$$CN$US$US
243639241$24363924$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014748$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240925$$CN$US$US
243639251$24363925$1$I$20240918$20240918$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012369$ELI LILLY AND CO$$$$A$$Y$$$20240925$$CN$US$US
243639261$24363926$1$I$$20240528$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015065$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243639271$24363927$1$I$$20240920$20240925$20240925$EXP$$PL-GILEAD-2024-0688473$GILEAD$$$$$F$Y$$$20240925$$HP$PL$PL
243639281$24363928$1$I$20240827$20240911$20240925$20240925$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00449$Unknown Manufacturer$$$$$$Y$$$20240925$$CN$BR$BR
243639291$24363929$1$I$$20240924$20240925$20240925$EXP$DE-EMA-DD-20200926-abdul_j-133355$DE-SANDOZ INC.-NVSC2020DE265933$SANDOZ$$37$YR$$F$Y$$$20240925$$MD$DE$DE
243639301$24363930$1$I$$20240920$20240925$20240925$PER$$US-ROCHE-10000088065$ROCHE$$43$YR$A$F$Y$$$20240925$$CN$US$US
243639312$24363931$2$F$$20240925$20240925$20240930$PER$$US-BIOMARINAP-US-2024-160740$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243639321$24363932$1$I$$20240923$20240925$20240925$PER$$US-ROCHE-10000089394$ROCHE$$$$A$$Y$$$20240925$$CN$US$US
243639332$24363933$2$F$$20240925$20240925$20240927$PER$$US-ROCHE-10000089324$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243639341$24363934$1$I$$20240923$20240925$20240925$PER$$US-ROCHE-10000089567$ROCHE$$$$$F$Y$$$20240925$$MD$US$US
243639351$24363935$1$I$20240101$20240916$20240925$20240925$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053300$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240925$$CN$US$US
243639361$24363936$1$I$20240923$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190454$AMGEN$$84$YR$E$F$Y$$$20240925$$CN$US$US
243639371$24363937$1$I$$20240913$20240925$20240925$EXP$$PT-MYLANLABS-2024M1071984$MYLAN$$44$YR$$M$Y$$$20240925$$MD$PT$PT
243639381$24363938$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151909$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240925$$HP$US$US
243639391$24363939$1$I$$20240924$20240925$20240925$EXP$$JP-BAYER-2024A135832$BAYER$$$$$M$Y$$$20240925$$MD$JP$JP
243639411$24363941$1$I$20240527$20240925$20240925$20240925$EXP$FR-AFSSAPS-DJ2024001001$FR-BAYER-2024A136925$BAYER$$64$YR$A$M$Y$$$20240925$$MD$FR$FR
243639421$24363942$1$I$20240101$20240923$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151080$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240925$$HP$US$US
243639431$24363943$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151373$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240925$$CN$US$US
243639441$24363944$1$I$20240924$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015826$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240925$$CN$US$US
243639461$24363946$1$I$$20240913$20240925$20240925$PER$$US-MYLANLABS-2024M1084696$MYLAN$$$$$$Y$$$20240925$$CN$US$US
243639471$24363947$1$I$$20240918$20240925$20240925$EXP$$CA-HLS-202402373$HLS THERAPEUTICS$$$$A$F$Y$$$20240925$$HP$CA$CA
243639481$24363948$1$I$20240409$20240924$20240925$20240925$EXP$$US-OTSUKA-2024_026542$OTSUKA$$83$YR$$$Y$$$20240925$$HP$US$US
243639491$24363949$1$I$20240101$20240906$20240925$20240925$PER$$US-RIGEL-20240800066$RIGEL PHARMACEUTICALS$$$$$F$Y$74.843$KG$20240925$$CN$US$US
243639501$24363950$1$I$$20240919$20240925$20240925$EXP$$CA-HLS-202402375$HLS THERAPEUTICS$$$$A$F$Y$$$20240925$$PH$CA$CA
243639511$24363951$1$I$20240101$20240730$20240925$20240925$PER$$US-RIGEL-20240700019$RIGEL PHARMACEUTICALS$$$$$M$Y$86.5$KG$20240925$$CN$US$US
243639521$24363952$1$I$$20240924$20240925$20240925$PER$$US-PURDUE PHARMA-USA-2024-0312149$PURDUE$$31$YR$$M$Y$$$20240925$$CN$US$US
243639532$24363953$2$F$20211117$20240925$20240925$20240926$PER$$US-PURDUE PHARMA-USA-2024-0312148$PURDUE$$32$YR$$M$Y$$$20240926$$CN$US$US
243639541$24363954$1$I$20090101$20240917$20240925$20240925$PER$$US-PURDUE-USA-2024-0312129$PURDUE$$45$YR$$F$Y$$$20240925$$CN$US$US
243639551$24363955$1$I$$20240924$20240925$20240925$PER$$US-PURDUE PHARMA-USA-2024-0312156$PURDUE$$$$$F$Y$$$20240925$$HP$US$US
243639561$24363956$1$I$$20240924$20240925$20240925$PER$$US-PURDUE-USA-2024-0312150$PURDUE$$$$$F$Y$$$20240925$$CN$US$US
243639572$24363957$2$F$$20240925$20240925$20240927$PER$$US-PURDUE PHARMA-USA-2024-0312152$PURDUE$$23$YR$$M$Y$$$20240927$$CN$US$US
243639581$24363958$1$I$$20240924$20240925$20240925$PER$$US-PURDUE PHARMA-USA-2024-0312154$PURDUE$$42$YR$$M$Y$$$20240925$$CN$US$US
243639591$24363959$1$I$20240903$20240918$20240925$20240925$PER$$CN-Eisai-EC-2024-174650$EISAI$$59$YR$A$M$Y$$$20240925$$MD$CN$CN
243639631$24363963$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151128$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240925$$CN$US$US
243639641$24363964$1$I$20240912$20240912$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-145864$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20240925$$CN$US$US
243639651$24363965$1$I$20240729$20240919$20240925$20240925$EXP$$CA-HLS-202402378$HLS THERAPEUTICS$$56$YR$A$M$Y$$$20240925$$HP$CA$CA
243639661$24363966$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151982$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240925$$CN$US$US
243639671$24363967$1$I$$20240918$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409012261$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240925$$CN$US$US
243639681$24363968$1$I$$20240922$20240925$20240925$EXP$$US-BAUSCH-BL-2024-014293$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240925$$CN$US$US
243639701$24363970$1$I$20240101$20240913$20240925$20240925$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0936$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240925$$CN$US$US
243639721$24363972$1$I$20240601$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151454$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240925$$CN$US$US
243639731$24363973$1$I$20240921$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152165$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$90.72$KG$20240925$$CN$US$US
243639741$24363974$1$I$20240101$20240905$20240925$20240925$PER$$US-MRZWEB-2024090000078$MERZ$$$$$$Y$$$20240925$$MD$US$US
243639751$24363975$1$I$$20240910$20240925$20240925$PER$$US-MRZWEB-2024090000079$MERZ$$$$$$Y$$$20240925$$HP$US$US
243639761$24363976$1$I$20240101$20240909$20240925$20240925$PER$$US-MRZWEB-2024090000090$MERZ$$$$$$Y$$$20240925$$HP$US$US
243639771$24363977$1$I$$20240906$20240925$20240925$PER$$US-Merz Pharmaceuticals GmbH-2024090000094$MERZ$$$$$$Y$$$20240925$$CN$US$US
243639781$24363978$1$I$$20240924$20240925$20240925$EXP$$US-009507513-2409USA008401$MERCK$Bhandari J, Sanjel C, Dang S, Draytsel D, Devakumar S, Sapna F. A RARE ADVERSE REACTION: PEMBROLIZUMAB-INDUCED ANGIOEDEMA. Chest. 2024;92A-93A$58$YR$$M$Y$$$20240925$$HP$US$US
243639792$24363979$2$F$20240911$20240923$20240925$20240927$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005075$SAREPTA THERAPEUTICS$$14$YR$$M$Y$26.2$KG$20240927$$HP$US$US
243639801$24363980$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152151$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240925$$PH$US$US
243639811$24363981$1$I$20230324$20240924$20240925$20240925$EXP$$ES-GILEAD-2024-0688762$GILEAD$$$$$M$Y$$$20240925$$CN$ES$ES
243639821$24363982$1$I$$20240924$20240925$20240925$EXP$$US-PURDUE PHARMA-USA-2024-0312158$PURDUE$$21$YR$$M$Y$$$20240925$$CN$US$US
243639842$24363984$2$F$20240501$20240925$20240925$20240926$EXP$$US-PURDUE PHARMA-USA-2024-0312151$PURDUE$$57$YR$$F$Y$$$20240926$$CN$US$US
243639851$24363985$1$I$20210101$20240924$20240925$20240925$EXP$$US-PURDUE PHARMA-USA-2024-0312153$PURDUE$$25$YR$$M$Y$$$20240925$$CN$US$US
243639871$24363987$1$I$20231012$20240920$20240925$20240925$EXP$$KR-009507513-2409KOR007026$MERCK$$$$A$F$Y$$$20240925$$PH$KR$KR
243639881$24363988$1$I$20240923$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015835$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240925$$HP$US$US
243639891$24363989$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015597$ELI LILLY AND CO$$76$YR$E$M$Y$$$20240925$$CN$US$US
243639901$24363990$1$I$$20240920$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150242$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$68.95$KG$20240925$$CN$US$US
243639911$24363991$1$I$20240717$20240909$20240925$20240925$PER$$US-SA-2024SA275699$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240925$$MD$US$US
243639921$24363992$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015444$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240925$$CN$US$US
243639931$24363993$1$I$20240923$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190627$AMGEN$$71$YR$E$F$Y$$$20240925$$CN$US$US
243639941$24363994$1$I$20240101$20240920$20240925$20240925$EXP$$DE-AMGEN-DEUSP2024091817$AMGEN$$80$YR$E$F$Y$$$20240925$$CN$DE$DE
243639961$24363996$1$I$$20240816$20240925$20240925$30DAY$$CL-PFIZER INC-202400261926$PFIZER$$$$$F$Y$$$20240925$$CN$CL$CL
243639971$24363997$1$I$20240101$20240823$20240925$20240925$PER$$US-LUNDBECK-DKLU4003461$LUNDBECK$$$$$$Y$$$20240925$$CN$US$US
243639981$24363998$1$I$$20240816$20240925$20240925$30DAY$$CL-PFIZER INC-202400260830$PFIZER$$$$$F$Y$$$20240925$$CN$CL$CL
243639991$24363999$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151870$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$$$20240925$$CN$US$US
243640001$24364000$1$I$20220901$20240918$20240925$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151018$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$74.5$KG$20240925$$PH$JP$JP
243640011$24364001$1$I$20240901$20240916$20240925$20240925$EXP$$PT-BLUEPRINT MEDICINES CORPORATION-2024BUS004521$Unknown Manufacturer$$$$$$Y$$$20240924$$MD$PT$PT
243640021$24364002$1$I$20240801$20240920$20240925$20240925$EXP$$US-BLUEPRINT MEDICINES CORPORATION-2024BUS004534$Unknown Manufacturer$$$$$$Y$$$20240925$$PH$US$US
243640051$24364005$1$I$$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151820$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$60.33$KG$20240925$$CN$US$US
243640061$24364006$1$I$20240501$20240913$20240925$20240925$EXP$$US-TAKEDA-2024TUS092184$TAKEDA$$58$YR$$F$Y$$$20240925$$CN$US$US
243640071$24364007$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152080$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240925$$CN$US$US
243640081$24364008$1$I$$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015605$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240925$$CN$US$US
243640101$24364010$1$I$20240923$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190313$AMGEN$$73$YR$E$F$Y$$$20240925$$CN$US$US
243640111$24364011$1$I$20240904$20240924$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151856$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$88$KG$20240925$$PH$US$US
243640121$24364012$1$I$$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152120$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240925$$CN$US$US
243640132$24364013$2$F$$20240925$20240925$20240926$PER$$US-AMGEN-USASP2024190631$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243640141$24364014$1$I$$20240813$20240925$20240925$PER$$US-LUNDBECK-DKLU4002997$LUNDBECK$$$$$$Y$$$20240925$$CN$US$US
243640152$24364015$2$F$20240915$20240925$20240925$20240926$PER$$US-AMGEN-USASP2024190502$AMGEN$$75$YR$E$F$Y$$$20240926$$CN$US$US
243640161$24364016$1$I$20240723$20240919$20240925$20240925$EXP$FR-AFSSAPS-LL2024001748$FR-TEVA-VS-3245983$TEVA$$53$YR$$F$Y$58$KG$20240925$$PH$FR$FR
243640171$24364017$1$I$20240906$20240919$20240925$20240925$EXP$FR-AFSSAPS-CN2024000872$FR-TEVA-VS-3246108$TEVA$$63$YR$$M$Y$110$KG$20240925$$MD$FR$FR
243640181$24364018$1$I$20221205$20240919$20240925$20240925$PER$FR-AFSSAPS-MA2024001510$FR-Eisai-EC-2024-174988$EISAI$$71$YR$E$F$Y$$$20240925$$HP$FR$FR
243640191$24364019$1$I$20240912$20240918$20240925$20240925$EXP$$JP-Eisai-EC-2024-174929$EISAI$$$$E$F$Y$$$20240925$$MD$JP$JP
243640201$24364020$1$I$20240814$20240919$20240925$20240925$EXP$FR-AFSSAPS-NC2024001067$FR-TEVA-VS-3245756$TEVA$$98$YR$$F$Y$$$20240925$$MD$FR$FR
243640211$24364021$1$I$$20240919$20240925$20240925$EXP$$ES-GILEAD-2024-0688305$GILEAD$$$$$$Y$$$20240925$$CN$ES$ES
243640221$24364022$1$I$20240101$20240923$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152061$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240925$$CN$US$US
243640231$24364023$1$I$20240812$20240919$20240925$20240925$EXP$FR-AFSSAPS-NT2024001130$FR-TEVA-VS-3245818$TEVA$$55$YR$$M$Y$56$KG$20240925$$MD$FR$FR
243640241$24364024$1$I$20240905$20240919$20240925$20240925$EXP$IT-MINISAL02-1002060$IT-TEVA-VS-3246107$TEVA$$28$YR$$M$Y$85$KG$20240925$$MD$IT$IT
243640251$24364025$1$I$20240702$20240918$20240925$20240925$EXP$FR-AFSSAPS-PA2024001447$FR-TEVA-VS-3244986$TEVA$$30$YR$$F$Y$51$KG$20240925$$PH$FR$FR
243640261$24364026$1$I$20210101$20240919$20240925$20240925$EXP$IE-HPRA-2024-115284$IE-TEVA-VS-3246050$TEVA$$$$$F$Y$$$20240925$$CN$IE$IE
243640271$24364027$1$I$$20240917$20240925$20240925$EXP$NL-LRB-01000876$NL-TEVA-VS-3244545$TEVA$$56$YR$$F$Y$58$KG$20240925$$CN$NL$NL
243640281$24364028$1$I$20240516$20240918$20240925$20240925$EXP$FR-AFSSAPS-AN2024001251$FR-TEVA-VS-3245255$TEVA$$71$YR$$M$Y$64$KG$20240925$$PH$FR$FR
243640291$24364029$1$I$20240720$20240918$20240925$20240925$EXP$FR-AFSSAPS-AN2024001217$FR-TEVA-VS-3244959$TEVA$$80$YR$$F$Y$70.5$KG$20240925$$MD$FR$FR
243640301$24364030$1$I$20240516$20240919$20240925$20240925$EXP$FR-AFSSAPS-GR2024001061$FR-TEVA-VS-3246020$TEVA$$31$YR$$M$Y$$$20240925$$PH$FR$FR
243640311$24364031$1$I$20230610$20240919$20240925$20240925$EXP$FR-AFSSAPS-AM2024000730$FR-TEVA-VS-3246093$TEVA$$16$YR$$F$Y$51$KG$20240925$$MD$FR$FR
243640321$24364032$1$I$20230101$20240912$20240925$20240925$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-00363$SAMSUNG BIOEPIS$$18$YR$A$F$Y$79$KG$20240925$$CN$CA$CA
243640341$24364034$1$I$$20240919$20240925$20240925$EXP$NL-LRB-01000577$NL-TEVA-VS-3246057$TEVA$$76$YR$$F$Y$65$KG$20240925$$MD$NL$NL
243640351$24364035$1$I$$20240917$20240925$20240925$EXP$FR-AFSSAPS-AVNT2024000679$FR-TEVA-VS-3244709$TEVA$$45$YR$$M$Y$$$20240925$$PH$FR$FR
243640371$24364037$1$I$20240923$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015722$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240925$$CN$US$US
243640381$24364038$1$I$20240903$20240903$20240925$20240925$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-26993$SAMSUNG BIOEPIS$$37$YR$A$M$Y$$$20240925$$HP$CA$CA
243640391$24364039$1$I$$20240914$20240925$20240925$EXP$$CN-ROCHE-10000082938$ROCHE$$66$YR$E$M$Y$$$20240925$$CN$CN$CN
243640401$24364040$1$I$20181101$20240923$20240925$20240925$EXP$$CA-PFIZER INC-2018481987$PFIZER$$58$YR$$M$Y$$$20240925$$CN$CA$CA
243640411$24364041$1$I$$20240920$20240925$20240925$EXP$$US-PFIZER INC-PV202200112805$PFIZER$$85$YR$$M$Y$77.11$KG$20240925$$CN$US$US
243640421$24364042$1$I$20220701$20240923$20240925$20240925$EXP$$ZA-PFIZER INC-202400098284$PFIZER$$68$YR$$F$Y$64$KG$20240925$$MD$ZA$ZA
243640431$24364043$1$I$$20240923$20240925$20240925$EXP$$US-PFIZER INC-PV202400122473$PFIZER$$73$YR$$$Y$$$20240925$$CN$US$US
243640441$24364044$1$I$20240807$20240924$20240925$20240925$EXP$$US-PFIZER INC-PV202300132382$PFIZER$$75$YR$$F$Y$77.11$KG$20240925$$CN$US$US
243640451$24364045$1$I$20240730$20240920$20240925$20240925$EXP$$CN-PFIZER INC-PV202400123671$PFIZER$$4$YR$$F$Y$15.5$KG$20240925$$HP$CN$CN
243640461$24364046$1$I$20240820$20240916$20240925$20240925$EXP$ES-AEMPS-1567709$ES-TEVA-VS-3244389$TEVA$$52$YR$$F$Y$$$20240925$$PH$ES$ES
243640471$24364047$1$I$20210101$20240916$20240925$20240925$EXP$FR-AFSSAPS-BR2024000710$FR-TEVA-VS-3244108$TEVA$$13$YR$$F$Y$$$20240925$$MD$FR$FR
243640481$24364048$1$I$20240519$20240916$20240925$20240925$EXP$FR-AFSSAPS-AVMA2024000392$FR-TEVA-VS-3244273$TEVA$$21$YR$$M$Y$$$20240925$$PH$FR$FR
243640491$24364049$1$I$20240902$20240917$20240925$20240925$EXP$SE-SEMPA-2024-006595$SE-TEVA-VS-3244685$TEVA$$37$YR$$F$Y$$$20240925$$MD$SE$SE
243640501$24364050$1$I$$20240923$20240925$20240925$EXP$$CA-GILEAD-2024-0688741$GILEAD$$76$YR$E$F$Y$$$20240925$$MD$CA$CA
243640521$24364052$1$I$20240924$20240925$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015975$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240925$$CN$US$US
243640531$24364053$1$I$$20240911$20240925$20240925$EXP$$CA-HLS-202402313$HLS THERAPEUTICS$$$$A$F$Y$$$20240925$$MD$CA$CA
243640541$24364054$1$I$20230828$20240917$20240925$20240925$EXP$$BR-TAKEDA-2023TUS103428$TAKEDA$$43$YR$$F$Y$$$20240925$$CN$BR$BR
243640551$24364055$1$I$$20240917$20240925$20240925$EXP$$PT-GILEAD-2024-0687993$GILEAD$$$$E$$Y$$$20240925$$HP$PT$PT
243640581$24364058$1$I$$20240918$20240925$20240925$EXP$$JP-MTPC-MTPC2024-0019923$Unknown Manufacturer$Hiramine K, Miyashita F, Yamashita Y, Okada T, Watanabe O, Sato M, et al.. CC2-3 A case of ischemic vertebral artery dissection with subarachnoid hemorrhage. The 5th Annual Meeting of the Japan Society of Vascular and. 2024;52$50$YR$$F$Y$$$20240925$$MD$JP$JP
243640591$24364059$1$I$20240918$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014826$ELI LILLY AND CO$$$$$F$Y$$$20240925$$CN$US$US
243640601$24364060$1$I$$20240906$20240925$20240925$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202408007514$ELI LILLY AND CO$$$$$$Y$$$20240925$$CN$JP$JP
243640611$24364061$1$I$$20240912$20240925$20240925$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09197$NEUROCRINE BIOSCIENCES$$6$DEC$$F$Y$$$20240925$$HP$US$US
243640631$24364063$1$I$20230206$20240923$20240925$20240925$EXP$FR-AFSSAPS-MA2024001359$FR-GILEAD-2024-0688616$GILEAD$$50$YR$A$F$Y$55$KG$20240925$$PH$FR$FR
243640641$24364064$1$I$20240514$20240916$20240925$20240925$PER$$US-DAIICHI SANKYO, INC.-DS-2024-100230-US$DAIICHI$$$$$F$Y$$$20240925$$MD$US$US
243640651$24364065$1$I$20231130$20240918$20240925$20240925$EXP$$NVSC2023GB251206$NOVARTIS$$$$$F$Y$$$20240926$$CN$GB$GB
243640661$24364066$1$I$20240618$20240921$20240925$20240925$EXP$$NVSC2024CN190604$NOVARTIS$$53$YR$$M$Y$61$KG$20240926$$HP$CN$CN
243640671$24364067$1$I$$20240923$20240925$20240925$PER$$NVSC2024US189802$NOVARTIS$$$$$F$Y$$$20240926$$HP$US$US
243640681$24364068$1$I$20240715$20240920$20240925$20240925$EXP$$NVSC2024AU190669$NOVARTIS$$71$YR$$F$Y$$$20240926$$CN$AU$AU
243640691$24364069$1$I$20240101$20240912$20240925$20240925$EXP$$US-MALLINCKRODT-MNK202405709$MALLINCKRODT$$28$YR$A$F$Y$$$20240925$$HP$US$US
243640701$24364070$1$I$$20240912$20240925$20240925$EXP$$US-MALLINCKRODT-MNK202405808$MALLINCKRODT$$$$$F$Y$$$20240925$$CN$US$US
243640711$24364071$1$I$20240101$20240912$20240925$20240925$EXP$$US-MALLINCKRODT-MNK202405286$MALLINCKRODT$$$$$F$Y$$$20240925$$HP$US$US
243640721$24364072$1$I$$20240912$20240925$20240925$EXP$$US-MALLINCKRODT-MNK202405728$MALLINCKRODT$$$$$F$Y$$$20240925$$HP$US$US
243640741$24364074$1$I$20200101$20240918$20240925$20240925$EXP$$JP-AMGEN-JPNSP2024190638$AMGEN$Fujimura K.. A patient of multiple fractures including nontraumatic distal tibial pseudoarthrosis; Joint surgery. The 53rd Annual Meeting of the Japan Society for Rheumatism and Joint Surgery. 2024;51:69$$$E$F$Y$$$20240925$$MD$JP$JP
243640751$24364075$1$I$20240915$20240916$20240925$20240925$PER$$US-ASTELLAS-2024-AER-007294$ASTELLAS$$80$YR$E$$Y$$$20240925$$MD$US$US
243640761$24364076$1$I$$20240920$20240925$20240925$PER$$US-PFIZER INC-2023SGN07376$PFIZER$$$$$M$Y$$$20240925$$CN$US$US
243640781$24364078$1$I$20240920$20240923$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409014567$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240925$$HP$US$US
243640791$24364079$1$I$$20240912$20240925$20240925$EXP$$CA-HLS-202402324$HLS THERAPEUTICS$$$$A$M$Y$$$20240925$$HP$CA$CA
243640801$24364080$1$I$20240917$20240924$20240925$20240925$EXP$$US-ABBVIE-5938574$ABBVIE$$79$YR$$F$Y$$$20240925$$CN$US$US
243640811$24364081$1$I$20240825$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015233$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240925$$CN$US$US
243640821$24364082$1$I$20240904$20240925$20240925$20240925$EXP$IT-MINISAL02-1003488$NVSC2024IT190523$NOVARTIS$$71$YR$$M$Y$$$20240926$$PH$IT$IT
243640831$24364083$1$I$$20240924$20240925$20240925$PER$$US-JNJFOC-20240965296$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243640841$24364084$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190793$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
243640851$24364085$1$I$20240917$20240917$20240925$20240925$EXP$$US-JNJFOC-20240955293$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240926$$MD$US$US
243640861$24364086$1$I$$20240919$20240925$20240925$EXP$$US-009507513-2409USA007306$MERCK$$$$$F$Y$$$20240925$$CN$US$US
243640871$24364087$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190821$NOVARTIS$$$$$$Y$$$20240926$$MD$US$US
243640882$24364088$2$F$$20240918$20240925$20240930$EXP$$NVSC2024AU189501$NOVARTIS$$$$$F$Y$$$20240930$$MD$AU$AU
243640891$24364089$1$I$20240301$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015246$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240925$$CN$US$US
243640901$24364090$1$I$$20240920$20240925$20240925$EXP$$NVSC2024FR190184$NOVARTIS$$37$YR$$M$Y$$$20240926$$CN$FR$FR
243640911$24364091$1$I$20240921$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189735$AMGEN$$58$YR$A$F$Y$$$20240925$$CN$US$US
243640921$24364092$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189906$AMGEN$$$$E$F$Y$$$20240925$$MD$US$US
243640931$24364093$1$I$20240902$20240923$20240925$20240925$EXP$$NVSC2024CN190630$NOVARTIS$$66$YR$$M$Y$62$KG$20240926$$HP$CN$CN
243640941$24364094$1$I$$20240924$20240925$20240925$EXP$$NVSC2024GR190787$NOVARTIS$$$$$M$Y$$$20240926$$MD$GR$GR
243640951$24364095$1$I$$20240922$20240925$20240925$EXP$$NVSC2024PT190196$NOVARTIS$$$$$$Y$$$20240926$$MD$PT$PT
243640961$24364096$1$I$20240915$20240924$20240925$20240925$EXP$$NVSC2024US190774$NOVARTIS$$74$YR$$M$Y$$$20240926$$CN$US$US
243640971$24364097$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190875$NOVARTIS$$$$$F$Y$$$20240926$$PH$US$US
243640981$24364098$1$I$$20240923$20240925$20240925$PER$$NVSC2024US190048$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
243640991$24364099$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190843$NOVARTIS$$$$$F$Y$$$20240926$$HP$US$US
243641002$24364100$2$F$$20240924$20240925$20240926$PER$$NVSC2024US190853$NOVARTIS$$$$$$Y$$$20240926$$MD$US$US
243641011$24364101$1$I$$20240918$20240925$20240925$EXP$$US-JNJFOC-20240948668$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$MD$US$US
243641021$24364102$1$I$20240918$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189687$AMGEN$$74$YR$E$F$Y$$$20240925$$CN$US$US
243641031$24364103$1$I$$20240925$20240925$20240925$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053521$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240926$$CN$US$US
243641041$24364104$1$I$20240909$20240923$20240925$20240925$EXP$$US-009507513-2409USA007972$MERCK$$80$YR$$M$Y$$$20240925$$HP$US$US
243641051$24364105$1$I$$20240924$20240925$20240925$PER$$NVSC2024US190799$NOVARTIS$$$$$$Y$$$20240926$$CN$US$US
243641061$24364106$1$I$$20240919$20240925$20240925$PER$$US-JNJFOC-20240959690$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$MD$US$US
243641071$24364107$1$I$20240904$20240905$20240925$20240925$PER$$US-SA-2024SA274430$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240926$$MD$US$US
243641082$24364108$2$F$$20240918$20240925$20240926$EXP$$BR-SANDOZ INC.-SDZ2024BR077799$SANDOZ$$$$$M$Y$62$KG$20240926$$CN$BR$BR
243641093$24364109$3$F$$20240925$20240925$20240930$PER$$NVSC2024US190802$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
243641101$24364110$1$I$$20240924$20240925$20240925$EXP$$PT-SANDOZ INC.-SDZ2024PT082813$SANDOZ$$19$YR$$M$Y$$$20240925$$MD$PT$PT
243641121$24364112$1$I$$20240923$20240925$20240925$EXP$$IT-ABBVIE-5936978$ABBVIE$$77$YR$$F$Y$$$20240925$$CN$IT$IT
243641131$24364113$1$I$20240829$20240912$20240925$20240925$PER$$US-JNJFOC-20240932957$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20240926$$CN$US$US
243641141$24364114$1$I$$20240917$20240925$20240925$PER$$US-JNJFOC-20240955703$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243641151$24364115$1$I$$20240923$20240925$20240925$EXP$$NVSC2024CN190759$NOVARTIS$$62$YR$$M$Y$$$20240926$$CN$CN$CN
243641161$24364116$1$I$20240728$20240919$20240925$20240925$EXP$$CA-ABBVIE-5880237$ABBVIE$$$$E$M$Y$$$20240925$$CN$CA$CA
243641171$24364117$1$I$20240101$20240917$20240925$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-132961$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240926$$MD$JP$JP
243641181$24364118$1$I$$20240919$20240925$20240925$PER$$US-ROCHE-10000088048$ROCHE$$$$$$Y$$$20240926$$HP$US$US
243641191$24364119$1$I$20191124$20240924$20240925$20240925$EXP$$HU-SANDOZ INC.-SDZ2024HU082584$SANDOZ$$34$YR$$M$Y$$$20240925$$HP$HU$HU
243641211$24364121$1$I$$20240923$20240925$20240925$PER$$US-ROCHE-10000084008$ROCHE$El Labban M, El Zibaoui R, Amadi A, Zareen T, Khan S. Life-Threatening tPA-Associated Angioedema: A Rare Case Report and Critical Review. The American journal of case reports. 2024-Sep-14;25:e944221-1-e944221-5. doi:10.12659/AJCR.944221.$79$YR$E$M$Y$$$20240926$$HP$US$US
243641221$24364122$1$I$$20240924$20240925$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US082863$SANDOZ$$$$$$Y$$$20240925$$CN$US$US
243641231$24364123$1$I$$20240916$20240925$20240925$PER$$US-JNJFOC-20240941946$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$MD$US$US
243641261$24364126$1$I$$20240911$20240925$20240925$PER$$US-JNJFOC-20240939519$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243641272$24364127$2$F$20240920$20240923$20240925$20240930$PER$$US-AMGEN-USASP2024189837$AMGEN$$69$YR$E$M$Y$$$20240930$$CN$US$US
243641281$24364128$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189371$AMGEN$$$$$F$Y$$$20240925$$CN$US$US
243641291$24364129$1$I$20240501$20240912$20240925$20240925$EXP$$US-UCBSA-2024032606$UCB$$61$YR$$M$Y$$$20240926$$HP$US$US
243641301$24364130$1$I$$20240923$20240925$20240925$EXP$$CA-ORGANON-O2409CAN001700$ORGANON$$50$YR$$F$Y$$$20240925$$HP$CA$CA
243641311$24364131$1$I$20240709$20240918$20240925$20240925$EXP$$CN-BEIGENE-BGN-2024-014834$BEIGENE$$$$$$Y$$$20240925$$HP$CN$CN
243641321$24364132$1$I$20240805$20240916$20240925$20240925$PER$$TR-Blueprint Medicines Corporation-SO-TR-2024-001878$BLUEPRINT MEDICINES$$59$YR$A$M$Y$$$20240926$$MD$TR$TR
243641331$24364133$1$I$$20240924$20240925$20240925$EXP$$IT-SANDOZ INC.-SDZ2024IT018539$SANDOZ$$$$$$Y$$$20240925$$HP$IT$IT
243641341$24364134$1$I$$20240920$20240925$20240925$PER$$US-JNJFOC-20240966614$JOHNSON AND JOHNSON$$$$A$M$Y$70$KG$20240926$$HP$US$US
243641351$24364135$1$I$$20240924$20240925$20240925$EXP$$NVSJ2024JP011261$NOVARTIS$$$$$$Y$$$20240926$$MD$JP$JP
243641371$24364137$1$I$20240101$20240912$20240925$20240925$PER$$US-JNJFOC-20240939373$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240926$$CN$US$US
243641381$24364138$1$I$$20240916$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152126$BRISTOL MYERS SQUIBB$Barlowe TS, Saxena-Beem S, Ishizawar RC, Herfarth H, Moon AM. Multiple gastrointestinal immune related adverse events from immune checkpoint inhibitor therapy. Clinical and Translational Gastroenterology. 2024 Sep 12;doi:10.14309/ctg.0000000000000768.$21$YR$A$F$Y$$$20240926$$MD$US$US
243641391$24364139$1$I$$20240925$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152307$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240926$$CN$US$US
243641401$24364140$1$I$20240905$20240917$20240925$20240925$EXP$$CN-JNJFOC-20240951016$JOHNSON AND JOHNSON$$56$YR$A$F$Y$77.5$KG$20240926$$HP$CN$CN
243641411$24364141$1$I$20240918$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189981$AMGEN$$66$YR$E$F$Y$$$20240925$$CN$US$US
243641421$24364142$1$I$20240304$20240917$20240925$20240925$EXP$$BR-BIOGEN-2024BI01283412$BIOGEN$$0$YR$$M$Y$3.35$KG$20240925$$CN$BR$BR
243641431$24364143$1$I$$20240920$20240925$20240925$EXP$$US-BAUSCHBL-2024BNL033920$BAUSCH AND LOMB$$61$YR$$F$Y$$$20240926$$CN$US$US
243641441$24364144$1$I$$20240912$20240925$20240925$EXP$$US-UCBSA-2024047758$UCB$$$$$$Y$$$20240926$$CN$US$US
243641461$24364146$1$I$20240924$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024190907$AMGEN$$41$YR$A$F$Y$$$20240925$$CN$US$US
243641471$24364147$1$I$20140101$20240918$20240925$20240925$EXP$$US-BIOGEN-2024BI01283505$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243641491$24364149$1$I$$20240919$20240925$20240925$EXP$$US-JNJFOC-20240960227$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240926$$MD$US$US
243641511$24364151$1$I$20240922$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024190083$AMGEN$$79$YR$E$F$Y$$$20240925$$CN$US$US
243641521$24364152$1$I$$20240923$20240925$20240925$EXP$$US-SANDOZ INC.-SDZ2024US082610$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
243641531$24364153$1$I$20240901$20240920$20240925$20240925$EXP$$US-JNJFOC-20240966493$JOHNSON AND JOHNSON$$71$YR$E$F$Y$65.17$KG$20240926$$CN$US$US
243641541$24364154$1$I$$20240916$20240925$20240925$PER$$US-BAUSCHBL-2024BNL033603$BAUSCH AND LOMB$$$$$$Y$$$20240926$$CN$US$US
243641551$24364155$1$I$20240901$20240916$20240925$20240925$PER$$US-BAUSCHBL-2024BNL033545$BAUSCH AND LOMB$$80$YR$$M$Y$$$20240926$$CN$US$US
243641561$24364156$1$I$$20240916$20240925$20240925$PER$$US-BAUSCHBL-2024BNL033550$BAUSCH AND LOMB$$$$$F$Y$$$20240926$$CN$US$US
243641571$24364157$1$I$$20240924$20240925$20240925$EXP$$JP-TAKEDA-2024TJP014057$TAKEDA$$$$$$Y$$$20240925$$MD$JP$JP
243641581$24364158$1$I$$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189260$AMGEN$$$$$F$Y$$$20240925$$CN$US$US
243641591$24364159$1$I$20240815$20240920$20240925$20240925$EXP$$US-ABBVIE-5935632$ABBVIE$$67$YR$$F$Y$$$20240925$$MD$US$US
243641601$24364160$1$I$$20240923$20240925$20240925$EXP$$CA-ORGANON-O2409CAN001754$ORGANON$$50$YR$$F$Y$$$20240925$$HP$CA$CA
243641611$24364161$1$I$20240906$20240918$20240925$20240925$EXP$$CN-BEIGENE-BGN-2024-014829$BEIGENE$$$$$$Y$$$20240925$$HP$CN$CN
243641621$24364162$1$I$$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024188629$AMGEN$$74$YR$E$M$Y$$$20240925$$CN$US$US
243641631$24364163$1$I$$20240918$20240925$20240925$EXP$$US-ABBVIE-5931157$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243641641$24364164$1$I$20240701$20240918$20240925$20240925$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001909$BLUEPRINT MEDICINES$$53$YR$A$F$Y$$$20240926$$CN$US$US
243641651$24364165$1$I$20240421$20240923$20240925$20240925$EXP$IT-MINISAL02-1003457$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-152089$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240926$$MD$IT$IT
243641661$24364166$1$I$$20240923$20240925$20240925$EXP$$US-SANDOZ INC.-SDZ2024US082625$SANDOZ$$$$$F$Y$$$20240925$$CN$US$US
243641671$24364167$1$I$$20240920$20240925$20240925$EXP$$US-ABBVIE-5933746$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243641681$24364168$1$I$$20240920$20240925$20240925$EXP$$US-ABBVIE-5933760$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243641691$24364169$1$I$20240901$20240919$20240925$20240925$EXP$$US-ABBVIE-5933982$ABBVIE$$74$YR$$M$Y$$$20240925$$CN$US$US
243641701$24364170$1$I$20240606$20240924$20240925$20240925$PER$$US-AMGEN-USASP2024191009$AMGEN$$71$YR$E$F$Y$$$20240925$$CN$US$US
243641711$24364171$1$I$20240901$20240918$20240925$20240925$PER$$US-ABBVIE-5930919$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243641731$24364173$1$I$$20240917$20240925$20240925$EXP$$US-JNJFOC-20240943976$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$PH$US$US
243641741$24364174$1$I$20240923$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189772$AMGEN$$72$YR$E$F$Y$$$20240925$$CN$US$US
243641751$24364175$1$I$20240916$20240920$20240925$20240925$EXP$$DE-ABBVIE-5933728$ABBVIE$$35$YR$$M$Y$$$20240925$$CN$DE$DE
243641761$24364176$1$I$20240801$20240916$20240925$20240925$EXP$$TW-JNJFOC-20240965447$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240926$$MD$TW$TW
243641771$24364177$1$I$$20240918$20240925$20240925$PER$$US-JNJFOC-20240959554$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$LW$US$US
243641781$24364178$1$I$$20240911$20240925$20240925$EXP$$US-CIPLA LTD.-2024US10385$CIPLA$Blush RR. ?-adrenergic agonist-induced lactic acidosis: A case report. AACN advanced critical care. 2024;35(3):222 to 227$$$$$Y$$$20240926$$HP$US$US
243641861$24364186$1$I$$20240916$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152127$BRISTOL MYERS SQUIBB$Barlowe TS, Saxena-Beem S, Ishizawar RC, Herfarth H, Moon AM. Multiple gastrointestinal immune related adverse events from immune checkpoint inhibitor therapy. Clinical and Translational Gastroenterology. 2024 Sep 12;doi:10.14309/ctg.0000000000000768.$58$YR$A$F$Y$$$20240926$$MD$US$US
243641881$24364188$1$I$20240101$20240910$20240925$20240925$EXP$$CA-ABBVIE-5937304$ABBVIE$$$$E$M$Y$$$20240925$$CN$CA$CA
243641891$24364189$1$I$$20240917$20240925$20240925$EXP$$ZA-ABBVIE-5935145$ABBVIE$$67$YR$$F$Y$$$20240925$$CN$ZA$ZA
243641901$24364190$1$I$20240909$20240924$20240925$20240925$EXP$$US-ABBVIE-5938107$ABBVIE$$73$YR$$F$Y$$$20240925$$CN$US$US
243641911$24364191$1$I$$20240917$20240925$20240925$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001897$BLUEPRINT MEDICINES$$$$$F$Y$$$20240926$$CN$US$US
243641921$24364192$1$I$$20240920$20240925$20240925$EXP$$CN-SANDOZ INC.-SDZ2024CN082499$SANDOZ$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. West China Journal of Stomatology. 2024;1-7$$$$M$Y$$$20240925$$HP$CN$CN
243641931$24364193$1$I$$20240924$20240925$20240925$EXP$$ES-SANDOZ INC.-SDZ2024ES082542$SANDOZ$$52$YR$$M$Y$$$20240925$$HP$ES$ES
243641941$24364194$1$I$$20240920$20240925$20240925$EXP$$CN-SANDOZ INC.-SDZ2024CN082505$SANDOZ$Gao N, Tian M, Sun Y, Wang D, Sun G. Application of bone perforation in the surgery of medication-related osteonecrosis of the jaw in stage II. West China Journal of Stomatology. 2024;1-7$65$YR$$M$Y$$$20240925$$HP$CN$CN
243641951$24364195$1$I$20240101$20240923$20240925$20240925$PER$$US-DSJP-DS-2024-101223-US$DAIICHI$$$$$F$Y$$$20240926$$MD$US$US
243641961$24364196$1$I$20240920$20240922$20240925$20240925$EXP$$FR-ABBVIE-5937148$ABBVIE$$86$YR$$M$Y$$$20240925$$HP$FR$FR
243641981$24364198$1$I$20240917$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189378$AMGEN$$66$YR$E$F$Y$$$20240925$$CN$US$US
243641991$24364199$1$I$20240923$20240923$20240925$20240925$PER$$US-AMGEN-USASP2024189701$AMGEN$$67$YR$E$F$Y$$$20240925$$CN$US$US
243642031$24364203$1$I$$20240918$20240925$20240925$PER$$NVSC2024US190894$NOVARTIS$$$$$F$Y$$$20240926$$MD$US$US
243642041$24364204$1$I$$20240920$20240925$20240925$EXP$$CN-SANDOZ INC.-SDZ2024CN082495$SANDOZ$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. West China Journal of Stomatology. 2024;1-7$64$YR$$F$Y$$$20240925$$HP$CN$CN
243642052$24364205$2$F$$20240925$20240925$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US082734$SANDOZ$$$$$M$Y$$$20240926$$CN$US$US
243642061$24364206$1$I$20240101$20240920$20240925$20240925$PER$$US-AMGEN-USASP2024188863$AMGEN$$55$YR$A$M$Y$$$20240925$$HP$US$US
243642071$24364207$1$I$20230501$20240911$20240925$20240925$EXP$$US-CIPLA LTD.-2024US10477$CIPLA$Gwynn N, Lindenmayer J, Boes T, Pitalo C. Late recognition of cholinergic delirium in patient on Donepezil combination treatment. Journal of Clinical Psychopharmacology. 2024;44 (5):521 to 522$$$$$Y$$$20240926$$MD$US$US
243642111$24364211$1$I$$20240920$20240925$20240925$EXP$$CN-SANDOZ INC.-SDZ2024CN082504$SANDOZ$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. West China Journal of Stomatology. 2024;1-7$79$YR$$M$Y$$$20240925$$HP$CN$CN
243642121$24364212$1$I$$20240920$20240925$20240925$EXP$$CN-SANDOZ INC.-SDZ2024CN082503$SANDOZ$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. West China Journal of Stomatology. 2024;1-7$62$YR$$M$Y$$$20240925$$HP$CN$CN
243642131$24364213$1$I$20240101$20240920$20240925$20240925$EXP$$US-ABBVIE-5887862$ABBVIE$$$$$M$Y$81$KG$20240925$$CN$US$US
243642201$24364220$1$I$20240101$20240920$20240925$20240925$PER$$US-ABBVIE-5934830$ABBVIE$$$$$F$Y$$$20240925$$HP$US$US
243642211$24364221$1$I$$20240918$20240925$20240925$EXP$$AR-JNJFOC-20240952609$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$MD$AR$AR
243642221$24364222$1$I$$20240919$20240925$20240925$PER$$US-JNJFOC-20240957936$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
243642241$24364224$1$I$$20240909$20240925$20240925$PER$$US-SA-2024SA276017$SANOFI AVENTIS$$$$A$M$Y$$$20240926$$CN$US$US
243642251$24364225$1$I$20240906$20240906$20240925$20240925$PER$$US-SA-2024SA275302$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240926$$MD$US$US
243642261$24364226$1$I$$20240917$20240925$20240925$EXP$GB-MHRA-MIDB-4b8290cd-80eb-4ec1-aa88-b5f47becbf3a$GB-TEVA-VS-3244876$TEVA$$73$YR$$F$Y$$$20240925$$PH$GB$GB
243642271$24364227$1$I$$20240924$20240925$20240925$PER$$US-ELI_LILLY_AND_COMPANY-US202409015781$ELI LILLY AND CO$$$$$$Y$$$20240925$$CN$US$US
243642281$24364228$1$I$$20240924$20240925$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151925$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$MD$JP$JP
243642291$24364229$1$I$$20240916$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152129$BRISTOL MYERS SQUIBB$Barlowe TS, Saxena-Beem S, Ishizawar RC, Herfarth H, Moon AM. Multiple gastrointestinal immune related adverse events from immune checkpoint inhibitor therapy. Clinical and Translational Gastroenterology. 2024 Sep 12;doi:10.14309/ctg.0000000000000768.$27$YR$A$F$Y$$$20240926$$MD$US$US
243642311$24364231$1$I$$20240918$20240925$20240925$PER$$US-JNJFOC-20240949331$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243642321$24364232$1$I$20201101$20240916$20240925$20240925$EXP$$DE-ABBVIE-5931023$ABBVIE$$75$YR$$M$Y$100$KG$20240925$$MD$DE$DE
243642331$24364233$1$I$20240912$20240918$20240925$20240925$EXP$$CN-AMGEN-CHNSP2024188182$AMGEN$$11$YR$C$M$Y$26$KG$20240925$$HP$CN$CN
243642341$24364234$1$I$$20240920$20240925$20240925$EXP$$NVSJ2024JP011191$NOVARTIS$$$$$$Y$$$20240926$$PH$JP$JP
243642352$24364235$2$F$20240901$20240919$20240925$20240926$EXP$$US-AMGEN-USASP2024189064$AMGEN$$$$T$M$Y$$$20240926$$HP$US$US
243642421$24364242$1$I$20240728$20240918$20240925$20240925$EXP$$CN-BEIGENE-BGN-2024-014821$BEIGENE$$$$$$Y$$$20240925$$HP$CN$CN
243642431$24364243$1$I$20240828$20240920$20240925$20240925$EXP$$CN-ABBVIE-5935404$ABBVIE$$54$YR$$F$Y$54$KG$20240925$$HP$CN$CN
243642441$24364244$1$I$$20240924$20240925$20240925$30DAY$$US-SANDOZ INC.-SDZ2024US082864$SANDOZ$$$$$$Y$$$20240925$$CN$US$US
243642451$24364245$1$I$20240101$20240920$20240925$20240925$EXP$$US-ABBVIE-5933547$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243642461$24364246$1$I$20240101$20240920$20240925$20240925$EXP$$US-ABBVIE-5933915$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243642471$24364247$1$I$20240101$20240919$20240925$20240925$EXP$$US-ABBVIE-5916321$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243642481$24364248$1$I$20240101$20240923$20240925$20240925$EXP$$US-ABBVIE-5773771$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243642491$24364249$1$I$20240101$20240918$20240925$20240925$EXP$$US-ABBVIE-5931024$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243642501$24364250$1$I$20240820$20240923$20240925$20240925$EXP$$US-ABBVIE-5936882$ABBVIE$$84$YR$$F$Y$$$20240925$$HP$US$US
243642511$24364251$1$I$20240825$20240918$20240925$20240925$EXP$$CN-BEIGENE-BGN-2024-014826$BEIGENE$$$$$$Y$$$20240925$$HP$CN$CN
243642521$24364252$1$I$20230101$20240919$20240925$20240925$EXP$$CO-ABBVIE-5933418$ABBVIE$$$$$M$Y$82$KG$20240925$$CN$CO$CO
243642532$24364253$2$F$$20240911$20240925$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152095$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240926$$CN$US$US
243642611$24364261$1$I$20220101$20240918$20240925$20240925$EXP$$FR-009507513-2311FRA007742$MERCK$$$$$M$Y$$$20240925$$MD$FR$FR
243642621$24364262$1$I$20240912$20240925$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152379$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240926$$CN$US$US
243642641$24364264$1$I$$20240918$20240925$20240925$EXP$$US-JNJFOC-20240948517$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
243642651$24364265$1$I$$20240923$20240925$20240925$PER$$NVSC2024US190984$NOVARTIS$$$$$F$Y$$$20240926$$PH$US$US
243642671$24364267$1$I$20240919$20240920$20240925$20240925$EXP$$US-ABBVIE-5933499$ABBVIE$$59$YR$$F$Y$$$20240925$$CN$US$US
243642681$24364268$1$I$$20240924$20240925$20240925$PER$$US-JNJFOC-20240965270$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243642691$24364269$1$I$$20240918$20240925$20240925$EXP$$US-JNJFOC-20240953928$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$HP$US$US
243642701$24364270$1$I$$20240919$20240925$20240925$EXP$$GT-ABBVIE-5937680$ABBVIE$$$$$M$Y$78$KG$20240925$$HP$GT$GT
243642711$24364271$1$I$$20240923$20240925$20240925$EXP$$US-ABBVIE-5936356$ABBVIE$$$$$F$Y$$$20240925$$HP$US$US
243642721$24364272$1$I$$20240923$20240925$20240925$EXP$$CA-ORGANON-O2409CAN001751$ORGANON$$$$$F$Y$$$20240925$$HP$CA$CA
243642731$24364273$1$I$$20240916$20240925$20240925$EXP$$US-BIOGEN-2024BI01282998$BIOGEN$$$$$F$Y$$$20240925$$HP$US$US
243642741$24364274$1$I$$20240924$20240925$20240925$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053550$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240926$$CN$US$US
243642751$24364275$1$I$20240709$20240713$20240925$20240925$EXP$GB-MHRA-MED-202407132227098760-DMYKB$GB-SMPA-2024SPA003291$SUNOVION$$$$$$Y$$$20240925$$CN$GB$GB
243642761$24364276$1$I$20240910$20240920$20240925$20240925$EXP$$US-009507513-2409USA007577$MERCK$$43$YR$$F$Y$$$20240925$$CN$US$US
243642781$24364278$1$I$20231010$20240922$20240925$20240925$EXP$$GR-ABBVIE-5935405$ABBVIE$$73$YR$$M$Y$$$20240925$$MD$GR$GR
243642821$24364282$1$I$20240101$20240917$20240925$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-150958$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$CN$JP$JP
243642831$24364283$1$I$20160901$20240918$20240925$20240925$EXP$$US-GSK-US2024116048$GLAXOSMITHKLINE$$$$$$Y$$$20240925$$CN$US$US
243642841$24364284$1$I$20240913$20240919$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150613$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$72.57$KG$20240926$$HP$US$US
243642851$24364285$1$I$20240906$20240923$20240925$20240925$EXP$$CA-TAKEDA-2024TUS095013$TAKEDA$$79$YR$$F$Y$$$20240925$$CN$CA$CA
243642861$24364286$1$I$20240827$20240918$20240925$20240925$EXP$$US-JNJFOC-20240952546$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240926$$MD$US$US
243642871$24364287$1$I$$20240918$20240925$20240925$EXP$$US-BIOGEN-2024BI01283484$BIOGEN$$$$$F$Y$$$20240925$$HP$US$US
243642881$24364288$1$I$20240914$20240917$20240925$20240925$EXP$$US-BIOGEN-2024BI01283003$BIOGEN$$20$YR$$F$Y$$$20240925$$CN$US$US
243642891$24364289$1$I$$20240919$20240925$20240925$EXP$$US-BIOGEN-2024BI01283504$BIOGEN$$$$$F$Y$$$20240925$$CN$US$US
243642901$24364290$1$I$$20240924$20240925$20240925$EXP$$US-TAKEDA-2024TUS013604$TAKEDA$$$$$M$Y$$$20240925$$CN$US$US
243642921$24364292$1$I$20240101$20240919$20240925$20240925$PER$$US-SA-2024SA272606$SANOFI AVENTIS$$13$YR$T$F$Y$$$20240926$$MD$US$US
243642931$24364293$1$I$20240709$20240918$20240925$20240925$EXP$$UY-ABBVIE-5852363$ABBVIE$$51$YR$$M$Y$$$20240925$$CN$UY$UY
243642941$24364294$1$I$$20240909$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013385$DR REDDYS$$15$YR$T$$Y$$$20240926$$HP$US$US
243642951$24364295$1$I$20240909$20240920$20240925$20240925$PER$$US-RDY-SPO/USA/24/0013940$DR REDDYS$$71$YR$E$M$Y$$$20240926$$MD$US$US
243642971$24364297$1$I$20240909$20240918$20240925$20240925$EXP$$BR-TAKEDA-2024TUS094607$TAKEDA$$80$YR$$F$Y$$$20240925$$CN$BR$BR
243642991$24364299$1$I$$20240917$20240925$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-150985$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240926$$MD$JP$JP
243643001$24364300$1$I$20240911$20240925$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152286$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240926$$CN$US$US
243643011$24364301$1$I$20240618$20240925$20240925$20240925$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152259$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240926$$HP$US$US
243643021$24364302$1$I$20171218$20240918$20240925$20240925$EXP$$CA-JNJFOC-20240954032$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240926$$HP$CA$CA
243643031$24364303$1$I$20240801$20240920$20240925$20240925$EXP$$US-ABBVIE-5935276$ABBVIE$$80$YR$$F$Y$$$20240925$$CN$US$US
243643051$24364305$1$I$$20240924$20240925$20240925$EXP$$US-ABBVIE-5938522$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243643061$24364306$1$I$$20240918$20240925$20240925$EXP$$US-ABBVIE-5932434$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243643071$24364307$1$I$20240709$20240923$20240925$20240925$EXP$$CA-ABBVIE-5936923$ABBVIE$$87$YR$$M$Y$$$20240925$$CN$CA$CA
243643081$24364308$1$I$20240919$20240920$20240925$20240925$EXP$$US-ABBVIE-5933913$ABBVIE$$72$YR$$F$Y$$$20240925$$CN$US$US
243643091$24364309$1$I$20240101$20240920$20240925$20240925$EXP$$FR-ABBVIE-5935371$ABBVIE$$$$A$F$Y$$$20240925$$MD$FR$FR
243643101$24364310$1$I$20240101$20240918$20240925$20240925$EXP$$US-ABBVIE-5930911$ABBVIE$$42$YR$$M$Y$$$20240925$$CN$US$US
243643111$24364311$1$I$20230101$20240920$20240925$20240925$EXP$$US-ABBVIE-5933768$ABBVIE$$$$$M$Y$$$20240925$$CN$US$US
243643122$24364312$2$F$$20240924$20240925$20240926$PER$$NVSC2024US190851$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
243643131$24364313$1$I$$20240917$20240925$20240925$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-148936$BRISTOL MYERS SQUIBB$Suezawa Y, Makihira Y, Kawano K, Ono H, Fukumoto T, Onishi H. A case of Ph+ acute lymphoblastic leukemia achieving MRD-negative remission by dasatinib + hyper-CVAD therapy followed by dasatinib + blinatumomab therapy administered as consolidation chemotherapy. The 63rd Meeting of the Japanese Society of Hematology Chugoku-Shikoku Association (Programs and Abstracts). 2024; 29$58$YR$A$F$Y$$$20240926$$MD$JP$JP
243643141$24364314$1$I$20240101$20240925$20240925$20240925$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152249$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240926$$HP$US$US
243643151$24364315$1$I$20240101$20240920$20240925$20240925$EXP$$US-JNJFOC-20240960183$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20240926$$HP$US$US
243643171$24364317$1$I$$20240918$20240925$20240925$EXP$$AT-AMGEN-AUTSP2024186613$AMGEN$$73$YR$E$F$Y$75$KG$20240925$$MD$AT$AT
243643181$24364318$1$I$20240101$20240920$20240925$20240925$EXP$$US-ABBVIE-5933536$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243643191$24364319$1$I$$20240920$20240925$20240925$EXP$$US-ABBVIE-5933552$ABBVIE$$$$$F$Y$$$20240925$$CN$US$US
243643201$24364320$1$I$20230331$20240918$20240926$20240926$EXP$$NVSC2024US190282$NOVARTIS$$72$YR$$M$Y$103$KG$20240926$$HP$US$US
243643211$24364321$1$I$$20240918$20240926$20240926$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP012383$STRIDES$Fiske HW, Roussel B, Winkler M, Hall B.. A case report of lactobacillus bacteremia in a patient on chronic parenteral nutrition.. Clin-Nutr-ESPEN. 2024;60:281-284$$$$$Y$$$20240926$$HP$US$US
243643221$24364322$1$I$20220101$20240917$20240926$20240926$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012285$STRIDES$Zhang H, Yang L.. Ureaplasma urealyticum infection following organ transplantation: a case report and narrative review.. Ren-Fail. 2024;46 (2):1-11$65$YR$$M$Y$$$20240926$$HP$CN$CN
243643231$24364323$1$I$$20240919$20240926$20240926$EXP$$US-ABBVIE-5932400$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243643241$24364324$1$I$$20240912$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-146109$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240926$$HP$US$US
243643251$24364325$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015482$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240925$$CN$US$US
243643261$24364326$1$I$$20240918$20240926$20240926$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012373$STRIDES$Wei C, Zhai F, Jia C, Zhang W, Zhou D, Zhang Y.. Immunochemotherapy triggered reversible cerebral vasoconstriction syndrome in a patient with intravascular large B-cell lymphoma.. Leuk-Lymphoma. 2024;65 (6):848-851$43$YR$$F$Y$$$20240926$$HP$CN$CN
243643281$24364328$1$I$$20240917$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409011394$ELI LILLY AND CO$$27$YR$A$M$Y$$$20240925$$CN$US$US
243643291$24364329$1$I$$20240919$20240926$20240926$EXP$$NO-STRIDES ARCOLAB LIMITED-2024SP012264$STRIDES$Ehrnstrom B, Haugan MS, Andreasen JB, Ellingsen A.. Immunocompromised teenager with meningitis caused by Ureaplasma parvum.. BMJ-Case-Rep. 2024;17 (3)$$$$F$Y$$$20240926$$MD$NO$NO
243643301$24364330$1$I$20240911$20240912$20240926$20240926$PER$$US-SA-2024SA273860$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240926$$CN$US$US
243643311$24364331$1$I$$20240912$20240926$20240926$EXP$$CA-HLS-202401652$HLS THERAPEUTICS$$$$E$M$Y$$$20240926$$PH$CA$CA
243643331$24364333$1$I$20240101$20240919$20240926$20240926$EXP$$CA-ABBVIE-5933166$ABBVIE$$$$A$F$Y$$$20240926$$CN$CA$CA
243643341$24364334$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5933930$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243643351$24364335$1$I$20240917$20240923$20240926$20240926$EXP$GB-MHRA-MED-202409180947199770-YMGQC$GB-STRIDES ARCOLAB LIMITED-2024SP012354$STRIDES$$38$YR$$M$Y$73$KG$20240926$$CN$GB$GB
243643361$24364336$1$I$$20240904$20240926$20240926$PER$$US-BEIGENE-BGN-2024-014033$BEIGENE$$$$$$Y$$$20240926$$CN$US$US
243643381$24364338$1$I$20210907$20240917$20240926$20240926$EXP$$DE-CELLTRION INC.-2024DE022713$CELLTRION$$$$$$Y$$$20240926$$MD$DE$DE
243643392$24364339$2$F$20240801$20240923$20240926$20240928$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012850$JAZZ$$36$YR$$F$Y$$$20240928$$CN$US$US
243643401$24364340$1$I$$20240918$20240926$20240926$PER$$US-SA-2024SA252396$SANOFI AVENTIS$$85$YR$E$F$Y$$$20240926$$HP$US$US
243643411$24364341$1$I$$20240909$20240926$20240926$PER$$US-SA-2024SA275646$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240926$$PH$US$US
243643421$24364342$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA271805$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240926$$HP$US$US
243643431$24364343$1$I$20200101$20240920$20240926$20240926$EXP$$US-ABBVIE-5933543$ABBVIE$$52$YR$$F$Y$$$20240926$$CN$US$US
243643451$24364345$1$I$20240916$20240923$20240926$20240926$EXP$GB-MHRA-TPP9261499C8184078YC1726486617017$GB-STRIDES ARCOLAB LIMITED-2024SP012368$STRIDES$$61$YR$$M$Y$81$KG$20240926$$MD$GB$GB
243643461$24364346$1$I$20240101$20240828$20240926$20240926$PER$$US-AMGEN-USASP2024187837$AMGEN$$72$YR$E$F$Y$$$20240925$$CN$US$US
243643471$24364347$1$I$20240701$20240919$20240926$20240926$EXP$$US-ABBVIE-5908834$ABBVIE$$75$YR$$F$Y$90$KG$20240926$$CN$US$US
243643491$24364349$1$I$$20240917$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409011429$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240926$$CN$US$US
243643501$24364350$1$I$$20240920$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015989$ELI LILLY AND CO$$53$YR$A$M$Y$$$20240926$$CN$US$US
243643511$24364351$1$I$20230901$20240920$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152069$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240926$$MD$US$US
243643521$24364352$1$I$$20240920$20240926$20240926$EXP$$DE-ABBVIE-5935317$ABBVIE$$$$E$F$Y$$$20240926$$CN$DE$DE
243643531$24364353$1$I$20240918$20240919$20240926$20240926$EXP$$NL-ABBVIE-5933727$ABBVIE$$64$YR$$F$Y$$$20240926$$MD$NL$NL
243643541$24364354$1$I$20240719$20240919$20240926$20240926$EXP$$US-ABBVIE-5932629$ABBVIE$$78$YR$$F$Y$$$20240926$$CN$US$US
243643551$24364355$1$I$20240729$20240920$20240926$20240926$EXP$$US-ABBVIE-5933767$ABBVIE$$64$YR$$M$Y$$$20240926$$CN$US$US
243643561$24364356$1$I$$20240917$20240926$20240926$EXP$$CA-AMNEAL PHARMACEUTICALS-2024-AMRX-03467$AMNEAL$Faragalla K, Cohen-Lyons D, Parvinnejad N, Wang H, Liu JN.. Fosfomycin-induced liver injury: A case report and literature review. Can. Liver J.. 2024;7(3):377-82$64$YR$$F$Y$$$20240926$$MD$CA$CA
243643571$24364357$1$I$20240101$20240923$20240926$20240926$EXP$$US-ABBVIE-5936230$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243643581$24364358$1$I$20240101$20240920$20240926$20240926$EXP$$US-ABBVIE-5933814$ABBVIE$$$$$F$Y$74$KG$20240926$$CN$US$US
243643591$24364359$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5933764$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243643601$24364360$1$I$20240101$20240919$20240926$20240926$PER$$US-SA-2024SA272700$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240926$$HP$US$US
243643621$24364362$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA272018$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240926$$HP$US$US
243643631$24364363$1$I$20240101$20240909$20240926$20240926$PER$$US-JNJFOC-20240920992$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243643642$24364364$2$F$$20240918$20240926$20240926$PER$$US-JNJFOC-20240932233$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243643651$24364365$1$I$20240917$20240917$20240926$20240926$EXP$$US-JNJFOC-20240955527$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240926$$HP$US$US
243643661$24364366$1$I$20240614$20240918$20240926$20240926$EXP$$CN-BEIGENE-BGN-2024-014820$BEIGENE$$$$$$Y$$$20240926$$HP$CN$CN
243643681$24364368$1$I$20240101$20240918$20240926$20240926$EXP$$US-JNJFOC-20240963103$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240926$$CN$US$US
243643701$24364370$1$I$$20240917$20240926$20240926$EXP$$US-JNJFOC-20240945344$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243643711$24364371$1$I$$20240918$20240926$20240926$EXP$$CA-JNJFOC-20240954876$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$PH$CA$CA
243643721$24364372$1$I$20240827$20240912$20240926$20240926$EXP$$CN-JNJFOC-20240937930$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240926$$HP$CN$CN
243643731$24364373$1$I$$20240916$20240926$20240926$PER$$US-BIOGEN-2024BI01283777$BIOGEN$$$$A$$Y$$$20240926$$MD$US$US
243643741$24364374$1$I$$20240920$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2024US082439$SANDOZ$$$$$$Y$$$20240926$$PH$US$US
243643751$24364375$1$I$$20240923$20240926$20240926$EXP$$NVSC2024US189919$NOVARTIS$$$$$$Y$$$20240926$$CN$US$US
243643761$24364376$1$I$20190101$20240920$20240926$20240926$EXP$$US-CHATTEMPRD-2024OHG033256$CHATTEM$$$$$$Y$$$20240926$$CN$US$US
243643771$24364377$1$I$20240101$20240918$20240926$20240926$EXP$$GB-SANDOZ INC.-SDZ2024GB081867$SANDOZ$$$$$F$Y$$$20240926$$HP$GB$GB
243643781$24364378$1$I$20240422$20240919$20240926$20240926$EXP$$HU-TAKEDA-2024TUS053419$TAKEDA$$50$YR$$F$Y$54$KG$20240926$$CN$HU$HU
243643791$24364379$1$I$$20240921$20240926$20240926$EXP$$IE-BRISTOL-MYERS SQUIBB COMPANY-2024-151936$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240926$$CN$IE$IE
243643801$24364380$1$I$$20240922$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151332$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240926$$CN$US$US
243643811$24364381$1$I$$20240923$20240926$20240926$EXP$$NVSC2024US190138$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
243643821$24364382$1$I$$20240922$20240926$20240926$PER$$US-JNJFOC-20240960081$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243643831$24364383$1$I$$20240917$20240926$20240926$PER$$US-JNJFOC-20240951469$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243643841$24364384$1$I$$20240923$20240926$20240926$EXP$$US-JNJFOC-20240962958$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
243643851$24364385$1$I$20240101$20240920$20240926$20240926$EXP$$US-JNJFOC-20240960177$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240926$$CN$US$US
243643861$24364386$1$I$$20240920$20240926$20240926$EXP$$US-JNJFOC-20240956431$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$PH$US$US
243643871$24364387$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA273474$SANOFI AVENTIS$$$$A$$Y$$$20240926$$HP$US$US
243643881$24364388$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA275339$SANOFI AVENTIS$$$$C$F$Y$$$20240926$$MD$US$US
243643891$24364389$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA277096$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240926$$CN$US$US
243643901$24364390$1$I$$20240911$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10484$CIPLA$Poon J, Coombes F, Coombes I. Sum of the parts: a cascade of adverse effects. Australian Prescriber. 2024;47:4:125 to 8$$$$$Y$$$20240926$$HP$AU$AU
243643911$24364391$1$I$$20240917$20240926$20240926$EXP$$FR-ABBVIE-5901217$ABBVIE$$75$YR$$M$Y$$$20240926$$MD$FR$FR
243643921$24364392$1$I$20240828$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189789$AMGEN$$81$YR$E$F$Y$$$20240925$$CN$US$US
243643931$24364393$1$I$20240523$20240918$20240926$20240926$EXP$$CN-BEIGENE-BGN-2024-014830$BEIGENE$$$$$$Y$$$20240926$$HP$CN$CN
243643941$24364394$1$I$$20240916$20240926$20240926$PER$$US-ABBVIE-5934658$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243643951$24364395$1$I$20240101$20240906$20240926$20240926$PER$$US-TEVA-VS-3241359$TEVA$$75$YR$$F$Y$$$20240926$$CN$US$US
243643961$24364396$1$I$$20240911$20240926$20240926$EXP$$GB-CIPLA LTD.-2024GB10338$CIPLA$$$$$$Y$$$20240926$$HP$GB$GB
243643971$24364397$1$I$20240915$20240918$20240926$20240926$PER$$US-AMGEN-USASP2024187003$AMGEN$$67$YR$E$M$Y$$$20240925$$CN$US$US
243643991$24364399$1$I$20240910$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152356$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240926$$CN$US$US
243644001$24364400$1$I$20240901$20240916$20240926$20240926$EXP$$US-INSMED, INC.-2024-03633-US$INSMED$$75$YR$$M$Y$$$20240926$$CN$US$US
243644012$24364401$2$F$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240963830$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240926$$HP$US$US
243644021$24364402$1$I$20240910$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014553$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240926$$CN$US$US
243644031$24364403$1$I$20240916$20240917$20240926$20240926$PER$$US-JNJFOC-20240945817$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243644041$24364404$1$I$$20240919$20240926$20240926$EXP$$US-ABBVIE-5937661$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243644051$24364405$1$I$$20240903$20240926$20240926$PER$$US-SA-2021SA207458$SANOFI AVENTIS$$$$T$M$Y$59.09$KG$20240926$$MD$US$US
243644061$24364406$1$I$20240101$20240917$20240926$20240926$PER$$US-SA-2024SA041523$SANOFI AVENTIS$$84$YR$E$F$Y$$$20240926$$HP$US$US
243644071$24364407$1$I$$20240919$20240926$20240926$EXP$$US-BIOGEN-2024BI01283672$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243644081$24364408$1$I$20240101$20240919$20240926$20240926$EXP$$DE-BIOGEN-2024BI01283679$BIOGEN$$$$$F$Y$$$20240926$$PH$DE$DE
243644091$24364409$1$I$20240828$20240918$20240926$20240926$EXP$$US-BIOGEN-2024BI01283585$BIOGEN$$33$YR$$F$Y$$$20240926$$CN$US$US
243644101$24364410$1$I$20240101$20240920$20240926$20240926$EXP$$US-ABBVIE-5933567$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243644111$24364411$1$I$20240916$20240919$20240926$20240926$PER$$US-ABBVIE-5935351$ABBVIE$$35$YR$$F$Y$$$20240926$$MD$US$US
243644131$24364413$1$I$$20240917$20240926$20240926$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-014878$JAZZ$$74$YR$$F$Y$$$20240925$$MD$JP$JP
243644142$24364414$2$F$20240924$20240926$20240926$20240930$PER$$US-AMGEN-USASP2024190852$AMGEN$$20$YR$A$F$Y$$$20240929$$HP$US$US
243644151$24364415$1$I$$20240920$20240926$20240926$PER$$US-AMGEN-USASP2024189918$AMGEN$$79$YR$E$F$Y$$$20240925$$PH$US$US
243644161$24364416$1$I$20240916$20240919$20240926$20240926$EXP$$US-ABBVIE-5933765$ABBVIE$$82$YR$$F$Y$$$20240926$$CN$US$US
243644181$24364418$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024191000$AMGEN$$$$$F$Y$$$20240925$$HP$US$US
243644191$24364419$1$I$$20240917$20240926$20240926$EXP$$US-JNJFOC-20240949983$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243644201$24364420$1$I$20240918$20240920$20240926$20240926$EXP$$US-BIOGEN-2024BI01283741$BIOGEN$$77$YR$$F$Y$$$20240926$$CN$US$US
243644211$24364421$1$I$20240828$20240920$20240926$20240926$30DAY$$US-AMGEN-USASP2024188750$AMGEN$$$$$$Y$$$20240925$$PH$US$US
243644221$24364422$1$I$20240101$20240923$20240926$20240926$EXP$$US-ABBVIE-5936414$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243644231$24364423$1$I$$20240917$20240926$20240926$EXP$$BE-TAKEDA-2024TUS094727$TAKEDA$$75$YR$$F$Y$$$20240926$$MD$BE$BE
243644241$24364424$1$I$20230101$20231220$20240926$20240926$PER$$US-ENDO PHARMACEUTICALS INC-2023-006244$ENDO$$$$$F$Y$$$20240926$$CN$US$US
243644251$24364425$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152376$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$$$20240926$$CN$US$US
243644261$24364426$1$I$$20240923$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151987$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240926$$CN$US$US
243644271$24364427$1$I$20210101$20230927$20240926$20240926$PER$$US-ENDO PHARMACEUTICALS INC-2023-005201$ENDO$$$$$M$Y$$$20240926$$CN$US$US
243644281$24364428$1$I$$20240915$20240926$20240926$EXP$$US-Accord-447925$ACCORD$Romero KN, O^Brien MC, Agrawal A, Hasan I. Creatine Kinase Surge: Levetiracetam-Induced Rhabdomyolysis. Cureus. 2024 Aug 12;16(8):e66715. doi: 10.7759/cureus.66715.$27$YR$A$M$Y$$$20240926$$MD$US$US
243644291$24364429$1$I$$20240923$20240926$20240926$EXP$$US-TAKEDA-2024TUS094827$TAKEDA$$14$YR$$M$Y$$$20240926$$CN$US$US
243644301$24364430$1$I$20240801$20240923$20240926$20240926$PER$$US-ABBVIE-5937915$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243644311$24364431$1$I$$20240916$20240926$20240926$EXP$$ES-ROCHE-10000089013$ROCHE$Somovilla A, Aguirre C G. Organizing Pneumonia in Multiple Sclerosis Patients Treated with Ocrelizumab following SARS-CoV-2 Infection: A Case Series Report (Abstract number: P1153/2242). Multiple Sclerosis Journal. 2024;30 (3(S)):763.$59$YR$A$M$Y$$$20240926$$HP$ES$ES
243644321$24364432$1$I$20240801$20240920$20240926$20240926$EXP$$US-ABBVIE-5933742$ABBVIE$$55$YR$$F$Y$$$20240926$$CN$US$US
243644331$24364433$1$I$20240601$20240920$20240926$20240926$EXP$$US-ABBVIE-5933546$ABBVIE$$35$YR$$F$Y$$$20240926$$CN$US$US
243644341$24364434$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA277340$SANOFI AVENTIS$$64$YR$A$$Y$$$20240926$$CN$US$US
243644351$24364435$1$I$20240101$20240919$20240926$20240926$PER$$US-SA-2024SA272707$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240926$$MD$US$US
243644361$24364436$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000090922$ROCHE$$81$YR$E$F$Y$$$20240926$$MD$US$US
243644371$24364437$1$I$20240917$20240924$20240926$20240926$PER$$US-ROCHE-10000090815$ROCHE$$76$YR$E$M$Y$108.86$KG$20240926$$CN$US$US
243644381$24364438$1$I$$20240909$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005467$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243644391$24364439$1$I$20240913$20240920$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014816$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240926$$CN$US$US
243644401$24364440$1$I$20240101$20240923$20240926$20240926$EXP$$US-ABBVIE-5935960$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243644411$24364441$1$I$$20240923$20240926$20240926$EXP$$NVSC2024GB189971$NOVARTIS$$$$$M$Y$$$20240926$$CN$GB$GB
243644421$24364442$1$I$$20240919$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409012872$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240926$$CN$US$US
243644431$24364443$1$I$$20240917$20240926$20240926$PER$$US-AMGEN-USASP2024186662$AMGEN$Stern R.; Bibi M.; Keltz M.D. et al.. Premature Ovarian Insufficiency After Coronavirus Disease 2019 (COVID-19). Obstetrics + Gynecology. 2024;143 (6):e149-e152$38$YR$A$F$Y$$$20240925$$HP$US$US
243644451$24364445$1$I$$20240923$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-016110$JAZZ$$$$$F$Y$$$20240925$$HP$US$US
243644462$24364446$2$F$$20240918$20240926$20240926$EXP$$CA-JNJFOC-20240955910$JOHNSON AND JOHNSON$$16$YR$T$M$Y$60$KG$20240926$$HP$CA$CA
243644471$24364447$1$I$20240910$20240917$20240926$20240926$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-28681$SAMSUNG BIOEPIS$$$$$F$Y$$$20240926$$CN$GB$GB
243644481$24364448$1$I$$20240923$20240926$20240926$PER$$US-ROCHE-10000089633$ROCHE$$$$A$M$Y$$$20240926$$HP$US$US
243644491$24364449$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191030$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
243644501$24364450$1$I$20240913$20240923$20240926$20240926$PER$$US-ROCHE-10000090025$ROCHE$$14$YR$T$M$Y$$$20240926$$CN$US$US
243644511$24364451$1$I$$20240924$20240926$20240926$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053163$BOEHRINGER INGELHEIM$Chua JL, VINTCH JR, YEE N. Sweet but sour: the bitter truth behind SGLT2 inhibitors and DKA. Chest. 2024;166(4): 2431A-2432A. doi:10.1016/j.chest.2024.06.1485.$48$YR$A$F$Y$$$20240926$$HP$US$US
243644521$24364452$1$I$$20240924$20240926$20240926$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053145$BOEHRINGER INGELHEIM$ALLEN S, WALKER CB, ISLAM SU. ANATOMY-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION FOR MEDIASTINAL FLUID COLLECTION IN THE ICU. Chest. 2024;166: 5249. doi:10.1016/j.chest.2024.06.3124.$69$YR$E$F$Y$$$20240926$$HP$US$US
243644531$24364453$1$I$$20240913$20240926$20240926$PER$$US-SA-2024SA274843$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240926$$MD$US$US
243644541$24364454$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA271788$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240926$$MD$US$US
243644551$24364455$1$I$$20240903$20240926$20240926$PER$$US-SA-2024SA273443$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
243644561$24364456$1$I$20240921$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189657$AMGEN$$57$YR$A$M$Y$$$20240925$$CN$US$US
243644571$24364457$1$I$$20240920$20240926$20240926$EXP$$US-BIOGEN-2024BI01283760$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243644581$24364458$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001744$ORGANON$$44$YR$$F$Y$97$KG$20240926$$HP$CA$CA
243644592$24364459$2$F$20240924$20240925$20240926$20240928$PER$$US-AMGEN-USASP2024191037$AMGEN$$77$YR$E$F$Y$$$20240928$$CN$US$US
243644601$24364460$1$I$$20240916$20240926$20240926$EXP$CA-MHPD-E2B_07198031$CA-Accord-447173$ACCORD$$$$E$F$Y$$$20240926$$HP$CA$CA
243644611$24364461$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3246138$TEVA$Haider A, Taveras S, Memushaj L, Esquenazi Y, Chen PR, Rios A. AML-738 Myeloid Sarcoma and Lymphoid Sarcoma of the Brain: A Case Series. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl.) S335-S336.$44$YR$$F$Y$$$20240926$$MD$US$US
243644621$24364462$1$I$20240705$20240709$20240926$20240926$PER$$US-TEVA-VS-3240771$TEVA$$70$YR$$M$Y$142.02$KG$20240926$$PH$US$US
243644631$24364463$1$I$$20240920$20240926$20240926$EXP$$ES-AUROBINDO-AUR-APL-2024-047282$AUROBINDO$Albert-Lopez E, Villafranca CM, Acosta AR, Benayas IB, De Ciurana Montiel E... CHECKPOINT INHIBITORS, A MILESTONE. BUT WHAT ABOUT COMPLICATIONS?.. Eur-J-Case-Rep-Intern-Med.. 2024;11 (Suppl.):988-989$52$YR$$M$Y$$$20240926$$HP$ES$ES
243644641$24364464$1$I$$20240916$20240926$20240926$EXP$$PL-AUROBINDO-AUR-APL-2024-046773$AUROBINDO$$$$$M$Y$$$20240926$$CN$PL$PL
243644651$24364465$1$I$20240910$20240920$20240926$20240926$EXP$$CN-ORGANON-O2409CHN001854$ORGANON$$78$YR$$M$Y$$$20240926$$HP$CN$CN
243644661$24364466$1$I$$20240912$20240926$20240926$EXP$$US-GRAVITIPHARMA-GRA-2409-US-LIT-0395$GRAVITI PHARMACEUTICALS$Fawole O, Bola A, Kladney M.Statin-induced myopathy and hepatitis after ticagrelor initiation.Gen-Intern-Med.2021;36(Suppl. 1):S354$75$YR$E$M$Y$$$20240926$$HP$US$US
243644671$24364467$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP009275$APOTEX$$$$$F$Y$$$20240926$$HP$CA$CA
243644681$24364468$1$I$$20240915$20240926$20240926$EXP$$US-QILU PHARMACEUTICAL CO.LTD.-QLU-000191-2024$QILU PHARMACEUTICAL$Zafar SJ Wynne Z John T Buzzalino LG Shishido AA Riedel DJ.Cefazolin-induced hemolytic anemia in septic arthritis: A case report.IDCases.09-AUG-2024;37:1-3$50$YR$A$F$Y$54.4$KG$20240926$$HP$US$US
243644691$24364469$1$I$20220410$20240918$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2022-059877$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240926$$MD$JP$JP
243644701$24364470$1$I$20240407$20240923$20240926$20240926$EXP$$US-BIOGEN-2024BI01283894$BIOGEN$$76$YR$$M$Y$$$20240926$$CN$US$US
243644711$24364471$1$I$20240801$20240919$20240926$20240926$EXP$$US-BIOGEN-2024BI01282293$BIOGEN$$60$YR$$F$Y$$$20240926$$HP$US$US
243644721$24364472$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000090448$ROCHE$$$$C$$Y$$$20240926$$CN$US$US
243644731$24364473$1$I$20240701$20240919$20240926$20240926$EXP$$BR-BIOGEN-2024BI01283748$BIOGEN$$40$YR$$M$Y$90$KG$20240926$$CN$BR$BR
243644741$24364474$1$I$20240915$20240920$20240926$20240926$EXP$$US-ABBVIE-5936557$ABBVIE$$90$YR$$F$Y$$$20240926$$CN$US$US
243644771$24364477$1$I$20240101$20240916$20240926$20240926$EXP$$NL-AUROBINDO-AUR-APL-2024-046755$AUROBINDO$$$$E$F$Y$58$KG$20240926$$HP$NL$NL
243644781$24364478$1$I$20240101$20240912$20240926$20240926$PER$$US-SA-2024SA276000$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240926$$CN$US$US
243644791$24364479$1$I$20240917$20240920$20240926$20240926$EXP$$CN-QILU PHARMACEUTICAL CO.LTD.-QLU-000202-2024$QILU PHARMACEUTICAL$$49$YR$A$F$Y$65$KG$20240926$$HP$CN$CN
243644801$24364480$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014535$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240926$$CN$US$US
243644811$24364481$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA272238$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240926$$MD$US$US
243644821$24364482$1$I$20240101$20240903$20240926$20240926$PER$$US-SA-2024SA273363$SANOFI AVENTIS$$33$YR$A$F$Y$104.55$KG$20240926$$MD$US$US
243644831$24364483$1$I$20240701$20240917$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-022625$UNITED THERAPEUTICS$$58$YR$$F$Y$53.061$KG$20240926$$$US$US
243644851$24364485$1$I$$20240918$20240926$20240926$PER$$US-ASTELLAS-2024-AER-007815$ASTELLAS$$56$YR$A$F$Y$$$20240926$$MD$US$US
243644861$24364486$1$I$20240916$20240916$20240926$20240926$EXP$$US-JNJFOC-20240941652$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240926$$CN$US$US
243644891$24364489$1$I$$20240916$20240926$20240926$EXP$$TW-SANDOZ INC.-SDZ2024TW082709$SANDOZ$Wu CY, Chen CC, Liou SW, Yen JC. Bilateral optic disc edema and serous retinal detachment as initial ocular manifestations of systemic lymphoma: a case report and literature review. TAIWAN J OPHTHALMOL. 2024;14:448-53$29$YR$$M$Y$$$20240926$$HP$TW$TW
243644901$24364490$1$I$$20240924$20240926$20240926$EXP$$GB-SANDOZ INC.-SDZ2024GB082909$SANDOZ$$$$$F$Y$$$20240926$$CN$GB$GB
243644911$24364491$1$I$$20240916$20240926$20240926$EXP$$PT-AUROBINDO-AUR-APL-2024-046783$AUROBINDO$Anesthetic Management of Maternal Brain Tumor Diagnosed During Pregnancy. A Case Report. Supplement of Journal of the Portuguese Society of Anesthesiology. 2024;33$38$YR$$F$Y$$$20240926$$MD$PT$PT
243644921$24364492$1$I$$20240924$20240926$20240926$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053315$BOEHRINGER INGELHEIM$Dhamsania C, PAEZ W, RIPA R, SOUSA D. Bronchodilator betrayal: a case of albuteroland ipratropium-induced paradoxical bronchospasm.. Chest. 2024;166(4): 4710A-4711A. doi:10.1016/j.ches t.2024.06.2838.$79$YR$E$M$Y$$$20240926$$HP$US$US
243644931$24364493$1$I$$20240912$20240926$20240926$PER$$US-RDY-SPO/USA/23/0180860$DR REDDYS$$70$YR$E$F$Y$$$20240926$$HP$US$US
243644941$24364494$1$I$20230908$20240916$20240926$20240926$PER$$US-RDY-SPO/USA/23/0179523$DR REDDYS$$63$YR$A$M$Y$$$20240926$$HP$US$US
243644951$24364495$1$I$20240101$20240917$20240926$20240926$PER$$US-ABBVIE-5934230$ABBVIE$$47$YR$$F$Y$$$20240926$$MD$US$US
243644971$24364497$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5937059$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243644981$24364498$1$I$20240101$20240920$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-030014$UNITED THERAPEUTICS$$$$$F$Y$81.179$KG$20240926$$$US$US
243644991$24364499$1$I$20220101$20240924$20240926$20240926$EXP$$DE-TAKEDA-2023TUS029341$TAKEDA$$55$YR$$M$Y$$$20240926$$HP$DE$DE
243645002$24364500$2$F$20240101$20240923$20240926$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-029970$UNITED THERAPEUTICS$$$$$F$Y$80.726$KG$20240928$$$US$US
243645011$24364501$1$I$20240101$20240922$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-029989$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240926$$$US$US
243645021$24364502$1$I$$20240920$20240926$20240926$EXP$$BR-JNJFOC-20240967462$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$BR$BR
243645031$24364503$1$I$20210526$20240918$20240926$20240926$EXP$$JP-SANDOZ INC.-SDZ2024JP082782$SANDOZ$Goda S, Kimura Y, Ando Y and Shirabe H. A. Patient Diagnosed with Drug-induced Interstitial Pneumonia with KL-6 increased after Treatment with Secukinumab for Pustular Psoriasis.. Program (Abstracts) for the 489th Osaka Regional Meeting of Japanese Dermatologi. 2022;NP$64$YR$$F$Y$$$20240926$$MD$JP$JP
243645041$24364504$1$I$$20240917$20240926$20240926$EXP$$CA-CELLTRION INC.-2024CA022619$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243645051$24364505$1$I$20240829$20240916$20240926$20240926$EXP$$PT-AUROBINDO-AUR-APL-2024-046784$AUROBINDO$$67$YR$$M$Y$$$20240926$$MD$PT$PT
243645071$24364507$1$I$20240722$20240918$20240926$20240926$EXP$$CN-BEIGENE-BGN-2024-014832$BEIGENE$$$$$$Y$$$20240926$$HP$CN$CN
243645081$24364508$1$I$$20240917$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR116443$VIIV$$$$$M$Y$$$20240926$$CN$US$US
243645101$24364510$1$I$$20240916$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-046210$AUROBINDO$$76$YR$$$Y$$$20240926$$PH$GB$GB
243645111$24364511$1$I$20240701$20240903$20240926$20240926$PER$$US-SA-2024SA260103$SANOFI AVENTIS$$14$YR$T$F$Y$59.73$KG$20240926$$MD$US$US
243645121$24364512$1$I$$20240912$20240926$20240926$EXP$$US-GRAVITIPHARMA-GRA-2409-US-LIT-0396$GRAVITI PHARMACEUTICALS$Tran TX, Khoo D.Atorvastatin induced polymyositis.J-Gen-Intern-Med.2021;36(Suppl. 1):S279$61$YR$A$M$Y$$$20240926$$HP$US$US
243645131$24364513$1$I$20240910$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190267$AMGEN$$62$YR$A$F$Y$$$20240925$$CN$US$US
243645141$24364514$1$I$$20240917$20240926$20240926$EXP$$CA-JNJFOC-20240613301$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240926$$HP$CA$CA
243645151$24364515$1$I$20240919$20240920$20240926$20240926$EXP$$US-AMGEN-USASP2024188345$AMGEN$$80$YR$E$M$Y$$$20240925$$HP$US$US
243645161$24364516$1$I$$20240916$20240926$20240926$EXP$CA-MHPD-E2B_07253848$CA-Accord-447065$ACCORD$$53$YR$A$M$Y$$$20240926$$HP$CA$CA
243645171$24364517$1$I$20240901$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151575$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240926$$CN$US$US
243645181$24364518$1$I$20240726$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046810$AUROBINDO$$21$YR$$M$Y$86$KG$20240926$$PH$FR$FR
243645191$24364519$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272275$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240926$$MD$US$US
243645201$24364520$1$I$$20240916$20240926$20240926$PER$$US-RDY-SPO/USA/24/0013646$DR REDDYS$$65$YR$E$F$Y$$$20240926$$HP$US$US
243645211$24364521$1$I$20230919$20240916$20240926$20240926$PER$$US-RDY-SPO/USA/23/0179638$DR REDDYS$$62$YR$A$M$Y$$$20240926$$HP$US$US
243645221$24364522$1$I$20240101$20240920$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-023976$UNITED THERAPEUTICS$$$$$M$Y$107.48$KG$20240926$$$US$US
243645231$24364523$1$I$$20240916$20240926$20240926$EXP$CA-MHPD-001092648$CA-Accord-447271$ACCORD$$80$YR$E$M$Y$68$KG$20240926$$HP$CA$CA
243645241$24364524$1$I$20240721$20240916$20240926$20240926$EXP$$IT-AUROBINDO-AUR-APL-2024-046708$AUROBINDO$$80$YR$$M$Y$$$20240926$$MD$IT$IT
243645251$24364525$1$I$20240901$20240918$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409009218$ELI LILLY AND CO$$23$YR$A$F$Y$$$20240926$$CN$US$US
243645261$24364526$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015223$ELI LILLY AND CO$$$$A$F$Y$$$20240926$$CN$US$US
243645271$24364527$1$I$20240901$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014904$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240926$$CN$US$US
243645281$24364528$1$I$$20240917$20240926$20240926$EXP$$US-EMD Serono-2024050084$EMD SERONO INC$$$$$F$Y$$$20240926$$CN$US$US
243645291$24364529$1$I$20240801$20240916$20240926$20240926$EXP$FR-AFSSAPS-TS2024000979$FR-ROCHE-10000082629$ROCHE$$15$YR$T$F$Y$53$KG$20240926$$MD$FR$FR
243645301$24364530$1$I$$20240919$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-030113$UNITED THERAPEUTICS$$$$$F$Y$49.887$KG$20240926$$$US$US
243645311$24364531$1$I$$20240918$20240926$20240926$PER$$US-ASTELLAS-2024-AER-007871$ASTELLAS$$59$YR$A$M$Y$$$20240926$$HP$US$US
243645321$24364532$1$I$$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152184$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240926$$CN$US$US
243645331$24364533$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152304$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240926$$CN$US$US
243645341$24364534$1$I$$20240920$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150610$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$81$KG$20240926$$PH$US$US
243645351$24364535$1$I$$20240913$20240926$20240926$EXP$$US-AUROBINDO-AUR-APL-2024-046416$AUROBINDO$$21$YR$$F$Y$46.2$KG$20240926$$CN$US$US
243645361$24364536$1$I$20240108$20240916$20240926$20240926$EXP$$PT-AUROBINDO-AUR-APL-2024-042896$AUROBINDO$$52$YR$$F$Y$$$20240926$$MD$PT$PT
243645371$24364537$1$I$$20240918$20240926$20240926$PER$$US-ASTELLAS-2024-AER-007879$ASTELLAS$$86$YR$E$M$Y$$$20240926$$HP$US$US
243645391$24364539$1$I$$20240911$20240926$20240926$PER$$US-AVS-000018$AAVIS PHARMACEUTICALS$Mcknight M, Cutshall BT, Sakaan S, Al Hommos NA, Wells DA. Hydroxychloroquine-Induced Hypoglycemia in a Patient Without Diabetes. J Pharm Pract. 2024 Oct;37(5):1205-1208. doi: 10.1177/08971900241228762.$55$YR$A$F$Y$$$20240924$$PH$US$US
243645401$24364540$1$I$$20240909$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09095$LUPIN$$$$$$Y$$$20240926$$MD$US$US
243645411$24364541$1$I$20240101$20240920$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-029955$UNITED THERAPEUTICS$$$$$F$Y$55.329$KG$20240926$$$US$US
243645421$24364542$1$I$$20240911$20240926$20240926$PER$$US-AVS-000019$AAVIS PHARMACEUTICALS$Azad AD, Chiou CA, Stagner AM, Freitag SK. Slate Grey Eyelid Pigmentation in a Patient With Hemochromatosis and Prior Hydroxychloroquine Use. Ophthalmic Plast Reconstr Surg. 2024 Sep-Oct 01;40(5):e190. doi: 10.1097/IOP.0000000000002609.$55$YR$A$F$Y$$$20240924$$MD$US$US
243645431$24364543$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA273056$SANOFI AVENTIS$$$$$F$Y$$$20240926$$CN$US$US
243645441$24364544$1$I$$20240924$20240926$20240926$EXP$$US-HALEON-2198575$Haleon PLC$$$$$$Y$$$20240925$$CN$US$US
243645451$24364545$1$I$$20240905$20240926$20240926$PER$$US-TEVA-VS-3242266$TEVA$$39$YR$$F$Y$$$20240926$$CN$US$US
243645461$24364546$1$I$$20240916$20240926$20240926$EXP$$US-CIPLA (EU) LIMITED-2024US10421$CIPLA$Zreik J, LaPage MJ, Zreik H. Congenital long QT syndrome unmasked by Albuterol in an adolescent with asthma. The Journal of emergency medicine. 2024$$$$$Y$$$20240926$$MD$US$US
243645471$24364547$1$I$20240920$20240920$20240926$20240926$PER$$US-BIOGEN-2024BI01283627$BIOGEN$$55$YR$$F$Y$$$20240926$$CN$US$US
243645492$24364549$2$F$$20240925$20240926$20240927$30DAY$$DE-UCBSA-2024049130$UCB$$$$$$Y$$$20240927$$PH$DE$DE
243645502$24364550$2$F$20240101$20240922$20240926$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-026624$UNITED THERAPEUTICS$$$$$F$Y$79.365$KG$20240928$$$US$US
243645511$24364551$1$I$$20240916$20240926$20240926$EXP$CA-MHPD-001093959$CA-Accord-447160$ACCORD$$51$YR$A$F$Y$54$KG$20240926$$HP$CA$CA
243645521$24364552$1$I$$20240918$20240926$20240926$EXP$$AU-TOLMAR, INC.-24AU052655$TOLMAR$$$$$M$Y$$$20240926$$CN$AU$AU
243645531$24364553$1$I$$20240916$20240926$20240926$EXP$CA-MHPD-001090808$CA-Accord-447254$ACCORD$$66$YR$E$F$Y$$$20240926$$PH$CA$CA
243645541$24364554$1$I$20240501$20240919$20240926$20240926$PER$$CA-TOLMAR, INC.-24CA052534$TOLMAR$$83$YR$$M$Y$$$20240926$$PH$CA$CA
243645551$24364555$1$I$$20240920$20240926$20240926$EXP$$CA-TOLMAR, INC.-24CA052795$TOLMAR$$$$$M$Y$$$20240926$$CN$CA$CA
243645561$24364556$1$I$$20240829$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032878$CHATTEM$$$$A$M$Y$$$20240926$$CN$US$US
243645571$24364557$1$I$$20240829$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032876$CHATTEM$$$$A$F$Y$$$20240926$$CN$US$US
243645581$24364558$1$I$$20240829$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032873$CHATTEM$$$$A$M$Y$$$20240926$$CN$US$US
243645592$24364559$2$F$20240101$20240920$20240926$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-027276$UNITED THERAPEUTICS$$$$$F$Y$74.83$KG$20240927$$$US$US
243645601$24364560$1$I$$20240916$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147695$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$74.39$KG$20240926$$CN$US$US
243645621$24364562$1$I$20230825$20240917$20240926$20240926$EXP$$CA-CELLTRION INC.-2023CA020828$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243645631$24364563$1$I$20240919$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151511$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240926$$PH$US$US
243645641$24364564$1$I$$20240829$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032875$CHATTEM$$$$A$F$Y$$$20240926$$CN$US$US
243645651$24364565$1$I$20220101$20240923$20240926$20240926$PER$$US-BIOGEN-2022BI01101032$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243645661$24364566$1$I$20240828$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046813$AUROBINDO$$45$YR$$F$Y$$$20240926$$PH$FR$FR
243645671$24364567$1$I$20240401$20240924$20240926$20240926$PER$$NVSC2024US191035$NOVARTIS$$50$YR$$F$Y$$$20240926$$HP$US$US
243645681$24364568$1$I$$20240911$20240926$20240926$EXP$$IN-CADILA HEALTHCARE LIMITED-IN-ZYDUS-102490$ZYDUS PHARM$Haritha S, Lakshmanan S, Sowmini PR, Mugundhan K.. Anticoagulant Induced Spinal Epidural Hematoma with Spontaneous Recovery.. Ann-Indian-Acad-Neurol. 2023;26 (Suppl. 2):S148$$$$$Y$$$20240926$$HP$IN$IN
243645691$24364569$1$I$$20240909$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09122$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243645701$24364570$1$I$$20240916$20240926$20240926$EXP$$DE-AMAROX PHARMA-AMR2024DE03185$HETERO$$$$$M$Y$$$20240926$$CN$DE$DE
243645711$24364571$1$I$$20240910$20240926$20240926$PER$$US-SA-2024SA276103$SANOFI AVENTIS$$$$$F$Y$$$20240926$$HP$US$US
243645721$24364572$1$I$20240819$20240916$20240926$20240926$EXP$$DE-AUROBINDO-AUR-APL-2024-046643$AUROBINDO$$$$$F$Y$$$20240926$$CN$DE$DE
243645731$24364573$1$I$$20240921$20240926$20240926$EXP$GB-MHRA-MED-202409211221223950-KJTDZ$GB-PFIZER INC-202400260921$PFIZER$$25$YR$$F$Y$$$20240926$$CN$GB$GB
243645741$24364574$1$I$$20240919$20240926$20240926$EXP$$JP-PFIZER INC-PV202400123270$PFIZER$$$$$$Y$$$20240926$$MD$JP$JP
243645751$24364575$1$I$$20240920$20240926$20240926$EXP$$CN-PFIZER INC-PV202400088816$PFIZER$$30$YR$$F$Y$$$20240926$$CN$CN$CN
243645761$24364576$1$I$20240817$20240916$20240926$20240926$EXP$$ES-PFIZER INC-202400263103$PFIZER$$68$YR$$M$Y$90.6$KG$20240926$$HP$ES$ES
243645771$24364577$1$I$20201116$20240918$20240926$20240926$PER$$US-ROCHE-10000085825$ROCHE$$40$YR$A$F$Y$$$20240926$$HP$US$US
243645781$24364578$1$I$20240801$20240920$20240926$20240926$PER$$US-BIOGEN-2024BI01283474$BIOGEN$$61$YR$$F$Y$$$20240926$$CN$US$US
243645792$24364579$2$F$$20240925$20240926$20240927$PER$$NVSC2024US190772$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
243645801$24364580$1$I$$20240923$20240926$20240926$PER$$US-BIOGEN-2024BI01283928$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243645811$24364581$1$I$20130101$20240923$20240926$20240926$PER$$US-BIOGEN-2015BI033267$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243645821$24364582$1$I$$20240830$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032884$CHATTEM$$$$A$F$Y$$$20240926$$CN$US$US
243645832$24364583$2$F$20230902$20240926$20240926$20240930$PER$$US-BIOGEN-2024BI01283865$BIOGEN$$71$YR$$M$Y$$$20240930$$CN$US$US
243645841$24364584$1$I$$20240923$20240926$20240926$PER$$US-BIOGEN-2024BI01283973$BIOGEN$$$$$$Y$$$20240926$$CN$US$US
243645851$24364585$1$I$$20240924$20240926$20240926$PER$$NVSC2024US190986$NOVARTIS$$$$$M$Y$$$20240926$$MD$US$US
243645861$24364586$1$I$$20240906$20240926$20240926$PER$$US-TEVA-VS-3241784$TEVA$$74$YR$$F$Y$$$20240926$$PH$US$US
243645871$24364587$1$I$$20240830$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032893$CHATTEM$$$$A$F$Y$$$20240926$$CN$US$US
243645881$24364588$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014327$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$US$US
243645891$24364589$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015632$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240926$$CN$US$US
243645901$24364590$1$I$20240915$20240918$20240926$20240926$EXP$GB-MHRA-MED-202409161108196690-DMGKT$GB-TEVA-VS-3245219$TEVA$$63$YR$$M$Y$$$20240926$$MD$GB$GB
243645911$24364591$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152255$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240926$$CN$US$US
243645931$24364593$1$I$$20240916$20240926$20240926$EXP$CA-MHPD-E2B_07253443$CA-Accord-447049$ACCORD$$16$YR$T$F$Y$$$20240926$$HP$CA$CA
243645941$24364594$1$I$$20240918$20240926$20240926$PER$$US-SA-2024SA272616$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240926$$HP$US$US
243645951$24364595$1$I$$20240920$20240926$20240926$PER$$US-LEO Pharma-373716$LEO PHARM$$39$YR$$M$Y$$$20240926$$PH$US$US
243645961$24364596$1$I$20240913$20240920$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024117107$VIIV$$19$YR$$M$Y$$$20240926$$MD$US$US
243645971$24364597$1$I$20230101$20240923$20240926$20240926$PER$$US-BIOGEN-2023BI01215819$BIOGEN$$$$$M$Y$$$20240926$$CN$US$US
243645981$24364598$1$I$20240823$20240916$20240926$20240926$EXP$ES-AEMPS-1565724$ES-Accord-447952$ACCORD$$79$YR$E$F$Y$$$20240926$$MD$ES$ES
243645991$24364599$1$I$20170101$20240916$20240926$20240926$EXP$$CN-JNJFOC-20240951657$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240926$$HP$CN$CN
243646001$24364600$1$I$20240913$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046692$AUROBINDO$$30$YR$$M$Y$$$20240926$$CN$FR$FR
243646011$24364601$1$I$$20240916$20240926$20240926$EXP$CA-MHPD-E2B_07214626$CA-Accord-447183$ACCORD$$48$YR$A$M$Y$$$20240926$$HP$CA$CA
243646021$24364602$1$I$20240801$20240916$20240926$20240926$EXP$$US-UCBSA-2024047771$UCB$$59$YR$$F$Y$$$20240926$$HP$US$US
243646031$24364603$1$I$$20240918$20240926$20240926$EXP$$US-AMGEN-USASP2024186660$AMGEN$$$$$$Y$$$20240925$$CN$US$US
243646041$24364604$1$I$20240923$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189762$AMGEN$$64$YR$A$F$Y$$$20240925$$CN$US$US
243646051$24364605$1$I$$20240920$20240926$20240926$EXP$$US-WW-2024-38883175$WOODWARD PHARMA SERVICES$Stratman S, et al. Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic symptoms. JAAD Case Rep. 2024;49:36-9. doi: 10.1016/j.jdcr.2024.04.028.$77$YR$$F$Y$$$20240926$$MD$US$US
243646061$24364606$1$I$$20240920$20240926$20240926$EXP$$CA-TAKEDA-2024TUS094222$TAKEDA$$$$$$Y$$$20240926$$HP$CA$CA
243646081$24364608$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5936334$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243646091$24364609$1$I$$20240830$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032888$CHATTEM$$$$A$F$Y$$$20240926$$CN$US$US
243646101$24364610$1$I$$20240924$20240926$20240926$PER$$US-HALEON-2198606$Haleon PLC$$$$$$Y$$$20240926$$CN$US$US
243646111$24364611$1$I$20240620$20240917$20240926$20240926$EXP$FR-AFSSAPS-AN2024001221$FR-Accord-447902$ACCORD$$63$YR$A$M$Y$74$KG$20240926$$MD$FR$FR
243646121$24364612$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA272484$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240926$$MD$US$US
243646131$24364613$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA274513$SANOFI AVENTIS$$$$$F$Y$$$20240926$$CN$US$US
243646141$24364614$1$I$20200401$20240924$20240926$20240926$EXP$$AT-SANDOZ INC.-NVSC2023AT127845$SANDOZ$$51$YR$$M$Y$73$KG$20240926$$MD$AT$AT
243646151$24364615$1$I$$20240830$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032883$CHATTEM$$$$A$F$Y$$$20240926$$CN$US$US
243646161$24364616$1$I$$20240916$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-029460$UNITED THERAPEUTICS$$$$$F$Y$$$20240926$$$US$US
243646181$24364618$1$I$20221221$20240920$20240926$20240926$EXP$$CO-UCBSA-2024049288$UCB$$67$YR$$F$Y$$$20240926$$CN$CO$CO
243646191$24364619$1$I$$20231204$20240926$20240926$PER$$US-CIPLA LTD.-2023US07868$CIPLA$$$$$$Y$$$20240926$$CN$US$US
243646201$24364620$1$I$20240519$20240912$20240926$20240926$EXP$$US-JNJFOC-20240939685$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240926$$HP$US$US
243646211$24364621$1$I$$20240916$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-029656$UNITED THERAPEUTICS$$$$$F$Y$98.866$KG$20240926$$$US$US
243646231$24364623$1$I$$20240924$20240926$20240926$PER$$NVSC2024US191029$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
243646241$24364624$1$I$$20240913$20240926$20240926$PER$$US-RDY-SPO/USA/24/0013621$DR REDDYS$$37$YR$A$M$Y$$$20240926$$HP$US$US
243646251$24364625$1$I$20240612$20240920$20240926$20240926$EXP$$CN-SA-2024SA275231$SANOFI AVENTIS$$66$YR$E$M$Y$60$KG$20240926$$HP$CN$CN
243646261$24364626$1$I$$20240831$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032907$CHATTEM$$$$A$M$Y$$$20240926$$CN$US$US
243646271$24364627$1$I$20240830$20240920$20240926$20240926$EXP$$US-ABBVIE-5934293$ABBVIE$$63$YR$$M$Y$$$20240926$$CN$US$US
243646281$24364628$1$I$$20240831$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032906$CHATTEM$$$$A$F$Y$$$20240926$$CN$US$US
243646291$24364629$1$I$$20240919$20240926$20240926$EXP$$US-ABBVIE-5933223$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243646301$24364630$1$I$$20240831$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032930$CHATTEM$$$$A$F$Y$$$20240926$$CN$US$US
243646311$24364631$1$I$20230807$20240919$20240926$20240926$EXP$$NVSC2024IN189350$NOVARTIS$$$$$M$Y$$$20240926$$CN$IN$IN
243646321$24364632$1$I$$20240913$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-148989$BRISTOL MYERS SQUIBB$$6$DEC$A$F$Y$$$20240926$$MD$JP$JP
243646331$24364633$1$I$20240910$20240923$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150972$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240926$$CN$US$US
243646341$24364634$1$I$20240915$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152272$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240926$$CN$US$US
243646351$24364635$1$I$$20240831$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032911$CHATTEM$$$$A$F$Y$$$20240926$$CN$US$US
243646371$24364637$1$I$20240923$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014423$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240926$$CN$US$US
243646381$24364638$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015545$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$US$US
243646391$24364639$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014271$ELI LILLY AND CO$$$$$$Y$$$20240926$$PH$US$US
243646401$24364640$1$I$20240924$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015319$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240926$$CN$US$US
243646411$24364641$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015326$ELI LILLY AND CO$$24$YR$A$$Y$$$20240926$$CN$US$US
243646421$24364642$1$I$20240201$20240909$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409006235$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240926$$CN$US$US
243646431$24364643$1$I$20240924$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015543$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$US$US
243646441$24364644$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA271861$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240926$$MD$US$US
243646451$24364645$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA272093$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240926$$MD$US$US
243646461$24364646$1$I$20240913$20240913$20240926$20240926$PER$$US-SA-2024SA274611$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240926$$CN$US$US
243646471$24364647$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5933931$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243646481$24364648$1$I$20240101$20240912$20240926$20240926$EXP$$US-UCBSA-2024044049$UCB$$$$$F$Y$$$20240926$$CN$US$US
243646491$24364649$1$I$20240901$20240922$20240926$20240926$EXP$$CH-ABBVIE-5935271$ABBVIE$$58$YR$$M$Y$$$20240926$$HP$CH$CH
243646501$24364650$1$I$$20240916$20240926$20240926$EXP$$ES-AMAROX PHARMA-AMR2024ES03315$HETERO$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E et al.. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver International. 2024;44(2):286-292$$$$$Y$$$20240926$$HP$ES$ES
243646511$24364651$1$I$20240101$20240923$20240926$20240926$EXP$$US-ABBVIE-5937783$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243646521$24364652$1$I$$20240831$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032929$CHATTEM$$$$A$F$Y$$$20240926$$CN$US$US
243646531$24364653$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005370$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243646541$24364654$1$I$$20240916$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024114972$VIIV$$$$$$Y$$$20240926$$HP$US$US
243646551$24364655$1$I$$20240917$20240926$20240926$EXP$NL-LRB-00885795$NL-CELLTRION INC.-2024NL022554$CELLTRION$$$$$$Y$$$20240926$$MD$NL$NL
243646561$24364656$1$I$20240801$20240916$20240926$20240926$EXP$$US-NOVOPROD-1286422$NOVO NORDISK$$50$YR$$F$Y$$$20240926$$CN$US$US
243646571$24364657$1$I$$20240916$20240926$20240926$EXP$$US-NOVOPROD-1286291$NOVO NORDISK$$55$YR$$F$Y$$$20240926$$HP$US$US
243646581$24364658$1$I$$20240916$20240926$20240926$EXP$$US-NOVOPROD-1285851$NOVO NORDISK$$75$YR$$M$Y$$$20240926$$CN$US$US
243646591$24364659$1$I$$20240913$20240926$20240926$EXP$$BR-NOVOPROD-1287033$NOVO NORDISK$$$$$F$Y$$$20240926$$CN$BR$BR
243646601$24364660$1$I$20220401$20240916$20240926$20240926$EXP$$BR-NOVOPROD-1286395$NOVO NORDISK$$52$YR$$F$Y$103$KG$20240926$$CN$BR$BR
243646611$24364661$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3245971$TEVA$Hernandez CL, Lynch DM, Golash AJ, Marquis K, Besz KM, Oxnard G, et al. Anaphylaxis and systemic mastocytosis controlled with KIT inhibitors in a patient with metastatic lung adenocarcinoma. Ann-Allergy-Asthma-Immunol 2023; 131 668-670.$58$YR$$F$Y$$$20240926$$MD$US$US
243646631$24364663$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA272143$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240926$$HP$US$US
243646641$24364664$1$I$20240101$20240919$20240926$20240926$PER$$US-SA-2024SA272696$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240926$$HP$US$US
243646651$24364665$1$I$$20240911$20240926$20240926$EXP$$CA-HALEON-2197656$Haleon PLC$$$$$F$Y$$$20240925$$HP$CA$CA
243646661$24364666$1$I$$20240918$20240926$20240926$EXP$GB-MHRA-MED-202409181355589180-TBDKM$GB-TEVA-VS-3245801$TEVA$$70$YR$$M$Y$79$KG$20240926$$CN$GB$GB
243646671$24364667$1$I$$20240821$20240926$20240926$PER$$US-SA-2024SA227039$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240926$$CN$US$US
243646681$24364668$1$I$$20240918$20240926$20240926$PER$$US-SA-2024SA269179$SANOFI AVENTIS$$17$YR$T$F$Y$56.4$KG$20240926$$MD$US$US
243646691$24364669$1$I$$20240911$20240926$20240926$PER$$US-GSK-US2024AMR113401$GLAXOSMITHKLINE$$$$$M$Y$$$20240926$$CN$US$US
243646701$24364670$1$I$20220101$20240917$20240926$20240926$PER$$US-GSK-US2024115601$GLAXOSMITHKLINE$$$$$F$Y$97.52$KG$20240926$$CN$US$US
243646711$24364671$1$I$$20240919$20240926$20240926$EXP$$US-ABBVIE-5938136$ABBVIE$$$$$F$Y$$$20240926$$MD$US$US
243646721$24364672$1$I$20240222$20240920$20240926$20240926$EXP$$GB-ABBVIE-5937430$ABBVIE$$56$YR$$M$Y$$$20240926$$HP$GB$GB
243646731$24364673$1$I$20240822$20240916$20240926$20240926$EXP$$US-NOVOPROD-1286426$NOVO NORDISK$$56$YR$$M$Y$$$20240926$$CN$US$US
243646741$24364674$1$I$20210201$20240916$20240926$20240926$EXP$$US-NOVOPROD-1286508$NOVO NORDISK$$66$YR$$F$Y$$$20240926$$CN$US$US
243646751$24364675$1$I$$20240916$20240926$20240926$EXP$$US-NOVOPROD-1286575$NOVO NORDISK$$68$YR$$F$Y$$$20240926$$CN$US$US
243646761$24364676$1$I$20240728$20240916$20240926$20240926$EXP$$US-NOVOPROD-1263858$NOVO NORDISK$$72$YR$$M$Y$$$20240926$$CN$US$US
243646771$24364677$1$I$$20240917$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032668$CHATTEM$$$$A$$Y$$$20240926$$CN$US$US
243646781$24364678$1$I$20240101$20240923$20240926$20240926$EXP$$US-ABBVIE-5936159$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243646791$24364679$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152256$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240926$$HP$US$US
243646801$24364680$1$I$$20240917$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032604$CHATTEM$$$$$F$Y$$$20240926$$CN$US$US
243646811$24364681$1$I$20231206$20240919$20240926$20240926$EXP$$CA-NALPROPION PHARMACEUTICALS INC.-CA-2023CUR005402$CURRAX PHARMACEUTICALS$$62$YR$$F$Y$$$20240926$$CN$CA$CA
243646821$24364682$1$I$20240601$20240916$20240926$20240926$EXP$DK-DKMA-30737675$DK-NOVOPROD-1283720$NOVO NORDISK$$69$YR$$F$Y$86$KG$20240926$$MD$DK$DK
243646831$24364683$1$I$$20240916$20240926$20240926$EXP$$US-NOVOPROD-1286602$NOVO NORDISK$$$$$F$Y$$$20240926$$CN$US$US
243646841$24364684$1$I$$20240916$20240926$20240926$EXP$$AU-NOVOPROD-1284940$NOVO NORDISK$$65$YR$$M$Y$125$KG$20240926$$HP$AU$AU
243646851$24364685$1$I$20240915$20240916$20240926$20240926$EXP$CN-NMPA-3203061050205202400243$CN-NOVOPROD-1285306$NOVO NORDISK$$42$YR$$M$Y$86$KG$20240926$$HP$CN$CN
243646861$24364686$1$I$$20240916$20240926$20240926$EXP$$AU-NOVOPROD-1284821$NOVO NORDISK$$$$$M$Y$$$20240926$$MD$AU$AU
243646871$24364687$1$I$20240413$20240916$20240926$20240926$EXP$EG-EDA-300264524$EG-NOVOPROD-1284046$NOVO NORDISK$$39$YR$$F$Y$60$KG$20240926$$HP$EG$EG
243646881$24364688$1$I$20240723$20240916$20240926$20240926$EXP$$US-NOVOPROD-1285850$NOVO NORDISK$$62$YR$$F$Y$$$20240926$$CN$US$US
243646891$24364689$1$I$$20240916$20240926$20240926$EXP$$US-NOVOPROD-1285625$NOVO NORDISK$$75$YR$$F$Y$$$20240926$$CN$US$US
243646901$24364690$1$I$$20240916$20240926$20240926$EXP$$AU-NOVOPROD-1284931$NOVO NORDISK$$$$E$M$Y$$$20240926$$MD$AU$AU
243646911$24364691$1$I$20240901$20240916$20240926$20240926$EXP$$US-NOVOPROD-1286637$NOVO NORDISK$$44$YR$$M$Y$$$20240926$$CN$US$US
243646921$24364692$1$I$20240101$20240920$20240926$20240926$EXP$$CA-JNJFOC-20240959272$JOHNSON AND JOHNSON$$76$YR$E$F$Y$49$KG$20240926$$PH$CA$CA
243646941$24364694$1$I$$20240919$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG033184$CHATTEM$$$$$F$Y$$$20240926$$CN$US$US
243646951$24364695$1$I$$20240915$20240926$20240926$EXP$$US-AMAROX PHARMA-HET2024US03236$HETERO$Romero K N, O^Brien M C, Agrawal A, et al.. Creatine Kinase Surge: Levetiracetam-Induced Rhabdomyolysis. Cureus. 2024;16(8): e66715:1-5$27$YR$$M$Y$$$20240926$$MD$US$US
243646961$24364696$1$I$$20240923$20240926$20240926$EXP$$US-ROCHE-10000089554$ROCHE$$$$I$M$Y$$$20240926$$CN$US$US
243646971$24364697$1$I$$20240919$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG032793$CHATTEM$$$$$$Y$$$20240926$$CN$US$US
243646981$24364698$1$I$$20240918$20240926$20240926$PER$$US-GSK-US2024AMR117218$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
243646991$24364699$1$I$20240722$20240916$20240926$20240926$EXP$AER# 24137825$US-NOVOPROD-1288398$NOVO NORDISK$$$$$F$Y$$$20240926$$HP$US$US
243647001$24364700$1$I$20240101$20240916$20240926$20240926$EXP$$US-UCBSA-2024047862$UCB$$$$$F$Y$112.9$KG$20240926$$HP$US$US
243647011$24364701$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114988$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243647021$24364702$1$I$$20240917$20240926$20240926$EXP$GB-MHRA-TPP16567279C10739351YC1726388059041$GB-ESPERIONTHERAPEUTICS-2024GBR01477$ESPERION THERAPEUTICS$$60$YR$$M$Y$81$KG$20240926$$MD$GB$GB
243647031$24364703$1$I$20240701$20240917$20240926$20240926$EXP$GB-MHRA-MED-202409161212436360-WVBDJ$GB-NOVOPROD-1285516$NOVO NORDISK$$50$YR$$F$Y$$$20240926$$CN$GB$GB
243647041$24364704$1$I$20240811$20240917$20240926$20240926$EXP$$JP-NOVOPROD-1285041$NOVO NORDISK$$76$YR$$M$Y$$$20240926$$MD$JP$JP
243647051$24364705$1$I$20240101$20240918$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-026649$UNITED THERAPEUTICS$$$$$F$Y$53.061$KG$20240926$$$US$US
243647061$24364706$1$I$$20240918$20240926$20240926$EXP$GB-MHRA-MIDB-c15ad200-01ce-41f1-bf31-95c7fe85a7cd$GB-ESPERIONTHERAPEUTICS-2024GBR01474$ESPERION THERAPEUTICS$$54$YR$$$Y$$$20240926$$HP$GB$GB
243647071$24364707$1$I$20240723$20240917$20240926$20240926$EXP$$US-NOVOPROD-1284982$NOVO NORDISK$$$$$M$Y$$$20240926$$CN$US$US
243647091$24364709$1$I$$20240920$20240926$20240926$EXP$$FR-BEIGENE-BGN-2024-015065$BEIGENE$$$$$$Y$$$20240926$$MD$FR$FR
243647101$24364710$1$I$20231101$20240916$20240926$20240926$EXP$GB-MHRA-MED-202409152026278000-LQSFK$GB-ESPERIONTHERAPEUTICS-2024GBR01460$ESPERION THERAPEUTICS$$66$YR$$F$Y$57$KG$20240926$$CN$GB$GB
243647111$24364711$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015252$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240926$$CN$US$US
243647121$24364712$1$I$20240901$20240919$20240926$20240926$EXP$$CN-ABBVIE-5931660$ABBVIE$$50$YR$$M$Y$54$KG$20240926$$MD$CN$CN
243647131$24364713$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA272946$SANOFI AVENTIS$$35$YR$A$F$Y$103.18$KG$20240926$$HP$US$US
243647141$24364714$1$I$20240901$20240919$20240926$20240926$PER$$US-SA-2024SA272341$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240926$$HP$US$US
243647151$24364715$1$I$20240701$20240917$20240926$20240926$PER$$US-SA-2024SA271708$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240926$$HP$US$US
243647161$24364716$1$I$$20240920$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG033094$CHATTEM$$68$YR$E$F$Y$$$20240926$$CN$US$US
243647171$24364717$1$I$$20240920$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015570$JAZZ$$$$$F$Y$$$20240925$$CN$US$US
243647182$24364718$2$F$20240906$20240924$20240926$20240927$PER$$US-HALEON-2197941$Haleon PLC$$64$YR$$F$Y$$$20240927$$CN$US$US
243647191$24364719$1$I$$20240917$20240926$20240926$EXP$$US-NOVOPROD-1287211$NOVO NORDISK$$$$$F$Y$$$20240926$$HP$US$US
243647201$24364720$1$I$20240801$20240916$20240926$20240926$EXP$$US-UCBSA-2024047976$UCB$$52$YR$$F$Y$$$20240926$$HP$US$US
243647211$24364721$1$I$20240916$20240918$20240926$20240926$EXP$$CN-BEIGENE-BGN-2024-014825$BEIGENE$$$$$$Y$$$20240926$$HP$CN$CN
243647221$24364722$1$I$20230101$20240912$20240926$20240926$EXP$$US-UCBSA-2024045852$UCB$$$$$F$Y$$$20240926$$CN$US$US
243647231$24364723$1$I$$20240918$20240926$20240926$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-28748$SAMSUNG BIOEPIS$$46$YR$A$F$Y$$$20240926$$CN$CA$CA
243647241$24364724$1$I$$20240923$20240926$20240926$EXP$$US-GSK-US2024117568$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
243647251$24364725$1$I$20240101$20240919$20240926$20240926$EXP$$US-ABBVIE-5934188$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243647271$24364727$1$I$$20240917$20240926$20240926$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01978$NOVITIUM PHARMA$Mina Yoshida.Toxic shock like syndrome caused by Streptococcus agalactiae bacteremia during treatment for multiple myeloma.Journal of Infection and Chemotherapy.APR-2023;29(4):407-409$74$YR$E$F$Y$$$20240926$$HP$JP$JP
243647281$24364728$1$I$20240101$20240919$20240926$20240926$EXP$$US-ABBVIE-5933568$ABBVIE$$22$YR$$F$Y$$$20240926$$CN$US$US
243647302$24364730$2$F$$20240924$20240926$20240930$PER$$US-ROCHE-10000089858$ROCHE$$$$A$F$Y$$$20240930$$CN$US$US
243647311$24364731$1$I$$20240923$20240926$20240926$PER$$US-ABBVIE-5936363$ABBVIE$$$$$$Y$$$20240926$$HP$US$US
243647321$24364732$1$I$20240101$20240910$20240926$20240926$PER$$US-JNJFOC-20240927689$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
243647332$24364733$2$F$20240911$20240918$20240926$20240930$EXP$$JP-JNJFOC-20240964158$JOHNSON AND JOHNSON$$70$YR$E$M$Y$72.6$KG$20240930$$MD$JP$JP
243647341$24364734$1$I$20230101$20240912$20240926$20240926$EXP$$GB-UCBSA-2024046935$UCB$$$$$F$Y$$$20240926$$CN$GB$GB
243647351$24364735$1$I$$20240920$20240926$20240926$EXP$$JP-GSK-JP2024JPN116744$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$PH$JP$JP
243647361$24364736$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240958380$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240926$$CN$US$US
243647371$24364737$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152269$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$$$20240926$$CN$US$US
243647381$24364738$1$I$20240922$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015309$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240926$$CN$US$US
243647391$24364739$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015474$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240926$$CN$US$US
243647401$24364740$1$I$20240921$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015613$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240926$$CN$US$US
243647411$24364741$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015799$ELI LILLY AND CO$$$$$M$Y$$$20240926$$CN$US$US
243647421$24364742$1$I$20240922$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014483$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240926$$CN$US$US
243647431$24364743$1$I$20240924$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015408$ELI LILLY AND CO$$38$YR$A$$Y$$$20240926$$CN$US$US
243647441$24364744$1$I$$20240921$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014868$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240926$$CN$US$US
243647451$24364745$1$I$20240922$20240923$20240926$20240926$EXP$$CA-HALEON-2198309$Haleon PLC$$56$YR$$F$Y$$$20240926$$CN$CA$CA
243647461$24364746$1$I$$20240918$20240926$20240926$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-09487$LUPIN$$$$$$Y$$$20240926$$CN$AU$AU
243647471$24364747$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152372$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240926$$HP$US$US
243647481$24364748$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152369$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$70.76$KG$20240926$$PH$US$US
243647491$24364749$1$I$20240901$20240923$20240926$20240926$EXP$$ES-AUROBINDO-AUR-APL-2024-047363$AUROBINDO$$57$YR$$F$Y$58.8$KG$20240926$$MD$ES$ES
243647501$24364750$1$I$$20240806$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152223$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240926$$CN$US$US
243647511$24364751$1$I$20240924$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151792$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$59.2$KG$20240926$$PH$US$US
243647521$24364752$1$I$20240101$20240911$20240926$20240926$EXP$$NL-ABBVIE-5933351$ABBVIE$$76$YR$$F$Y$$$20240926$$CN$NL$NL
243647532$24364753$2$F$20240201$20240924$20240926$20240930$EXP$$US-ABBVIE-5933497$ABBVIE$$$$$F$Y$108.86$KG$20240930$$CN$US$US
243647541$24364754$1$I$20240730$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046769$AUROBINDO$$73$YR$$M$Y$107$KG$20240926$$MD$FR$FR
243647551$24364755$1$I$$20240919$20240926$20240926$EXP$$US-GSK-US2024AMR116745$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
243647561$24364756$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272495$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240926$$MD$US$US
243647571$24364757$1$I$20240814$20240904$20240926$20240926$PER$$US-SA-2024SA273060$SANOFI AVENTIS$$13$YR$T$M$Y$36.27$KG$20240926$$MD$US$US
243647582$24364758$2$F$$20240926$20240926$20240930$EXP$$US-ABBVIE-5938611$ABBVIE$$$$$F$Y$72$KG$20240930$$CN$US$US
243647591$24364759$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5935968$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243647611$24364761$1$I$20240101$20240916$20240926$20240926$EXP$$DE-AUROBINDO-AUR-APL-2024-046631$AUROBINDO$$82$YR$$M$Y$$$20240926$$PH$DE$DE
243647621$24364762$1$I$$20240919$20240926$20240926$EXP$$NVSJ2024JP011125$NOVARTIS$$$$$$Y$$$20240926$$MD$JP$JP
243647631$24364763$1$I$$20240919$20240926$20240926$PER$$US-GILEAD-2024-0688335$GILEAD$$44$YR$A$M$Y$$$20240926$$MD$US$US
243647641$24364764$1$I$$20240917$20240926$20240926$EXP$$CL-NOVITIUMPHARMA-2024CLNVP01969$NOVITIUM PHARMA$Isabel Folatre.Pseudohiponatremia secondary to hypertriglyceridemia during the treatment of lymphoblastic lymphoma with corticoids and L-asparaginase.Andes Pediatrica.31-MAY-2024;95(4):442-448$14$YR$T$M$Y$$$20240926$$HP$CL$CL
243647651$24364765$1$I$$20240920$20240926$20240926$PER$$US-HALEON-2198044$Haleon PLC$$$$$$Y$$$20240926$$CN$US$US
243647661$24364766$1$I$20240922$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152000$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240926$$PH$US$US
243647671$24364767$1$I$20240101$20240912$20240926$20240926$EXP$$US-UCBSA-2024047143$UCB$$$$$F$Y$$$20240926$$CN$US$US
243647701$24364770$1$I$20221001$20240916$20240926$20240926$EXP$$US-ASPIRO-ASP2024US03195$ASPIRO PHARMA$Levi D, Horn S, Murphy J, Levin J.. Safety of dexamethasone in transforaminal epidural steroid  injections: A case of temporary paraplegia caused by injection of lidocaine and dexamethasone  into a lumbar radiculomedullary artery, with no neurologic sequelae. Interventional pain medicine.. 2023;2(1):100240$76$YR$$M$Y$$$20240926$$MD$US$US
243647711$24364771$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000091124$ROCHE$$63$YR$A$F$Y$$$20240926$$MD$US$US
243647721$24364772$1$I$$20240918$20240926$20240926$EXP$$DE-JNJFOC-20240953955$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$DE$DE
243647741$24364774$1$I$20240911$20240911$20240926$20240926$PER$$US-SA-2024SA274892$SANOFI AVENTIS$$89$YR$E$F$Y$136.08$KG$20240926$$CN$US$US
243647751$24364775$1$I$20240909$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046806$AUROBINDO$$72$YR$$M$Y$63$KG$20240926$$MD$FR$FR
243647761$24364776$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA273063$SANOFI AVENTIS$$$$$$Y$$$20240926$$MD$US$US
243647771$24364777$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272699$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240926$$HP$US$US
243647781$24364778$1$I$20240601$20240913$20240926$20240926$PER$$US-SA-2024SA272369$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240926$$MD$US$US
243647791$24364779$1$I$20240801$20240918$20240926$20240926$PER$$US-SA-2024SA272193$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240926$$MD$US$US
243647801$24364780$1$I$$20240913$20240926$20240926$PER$$US-SA-2024SA274465$SANOFI AVENTIS$$$$A$$Y$$$20240926$$MD$US$US
243647811$24364781$1$I$$20240919$20240926$20240926$PER$$US-CHATTEMPRD-2024OHG033096$CHATTEM$$85$YR$E$F$Y$$$20240926$$CN$US$US
243647821$24364782$1$I$$20240923$20240926$20240926$PER$$US-BIOGEN-2024BI01283909$BIOGEN$$$$$F$Y$$$20240926$$HP$US$US
243647831$24364783$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152348$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$54.88$KG$20240926$$CN$US$US
243647841$24364784$1$I$$20240912$20240926$20240926$EXP$$GB-UCBSA-2024047175$UCB$$$$$F$Y$$$20240926$$CN$GB$GB
243647852$24364785$2$F$$20240924$20240926$20240930$PER$$NVSC2024US191034$NOVARTIS$$$$$$Y$$$20240930$$CN$US$US
243647861$24364786$1$I$20240101$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046842$AUROBINDO$$80$YR$$M$Y$$$20240926$$MD$FR$FR
243647871$24364787$1$I$$20240918$20240926$20240926$EXP$$CN-NOVITIUMPHARMA-2024CNNVP01989$NOVITIUM PHARMA$Yimeng Qian.Immune-related intestinal pseudo-obstruction caused by immune checkpoint inhibitors: case report.Frontiers in Oncology.14-AUG-2024;14:1-6$64$YR$A$M$Y$$$20240926$$HP$CN$CN
243647881$24364788$1$I$$20240916$20240926$20240926$EXP$$CA-JNJFOC-20240951973$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20240926$$PH$CA$CA
243647891$24364789$1$I$$20240912$20240926$20240926$EXP$$CA-UCBSA-2024047166$UCB$$$$$M$Y$$$20240926$$CN$CA$CA
243647901$24364790$1$I$20240701$20240923$20240926$20240926$EXP$$US-ABBVIE-5936839$ABBVIE$$73$YR$$F$Y$$$20240926$$CN$US$US
243647911$24364791$1$I$20240101$20240912$20240926$20240926$PER$$US-SA-2024SA276383$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$CN$US$US
243647921$24364792$1$I$20240801$20240906$20240926$20240926$EXP$$US-SA-2024SA276659$SANOFI AVENTIS$$92$YR$E$F$Y$51.82$KG$20240926$$MD$US$US
243647931$24364793$1$I$$20240916$20240926$20240926$EXP$$CA-CELLTRION INC.-2024CA022779$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243647941$24364794$1$I$20240826$20240906$20240926$20240926$PER$$US-SA-2024SA275399$SANOFI AVENTIS$$$$$$Y$$$20240926$$HP$US$US
243647951$24364795$1$I$20240719$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046731$AUROBINDO$$66$YR$$F$Y$49$KG$20240926$$MD$FR$FR
243647961$24364796$1$I$$20240922$20240926$20240926$EXP$$ZA-HALEON-2198541$Haleon PLC$$$$$M$Y$$$20240925$$CN$ZA$ZA
243647971$24364797$1$I$$20240917$20240926$20240926$EXP$$HR-CELLTRION INC.-2024HR022716$CELLTRION$Fotez L, Dodig VM, Fotez L, Bobek D.. From Lumbar Pain to Bamboo Spine: A Case Report of Ankylosing Spondylitis in a 29- year-old Male. Medical Journal. 2023;7(Supp 7):38-39$$$$$Y$$$20240926$$HP$HR$HR
243647991$24364799$1$I$$20240909$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09105$LUPIN$$$$$$Y$$$20240926$$PH$US$US
243648001$24364800$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015794$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240926$$CN$US$US
243648011$24364801$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015591$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240926$$CN$US$US
243648021$24364802$1$I$20240920$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015447$ELI LILLY AND CO$$21$YR$A$$Y$$$20240926$$PH$US$US
243648031$24364803$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015600$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240926$$CN$US$US
243648041$24364804$1$I$$20240918$20240926$20240926$EXP$$US-EMD Serono-2024050370$EMD SERONO INC$$68$YR$E$M$Y$$$20240926$$CN$US$US
243648051$24364805$1$I$20240829$20240910$20240926$20240926$PER$$US-JNJFOC-20240926570$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243648061$24364806$1$I$20220701$20240920$20240926$20240926$EXP$$US-ABBVIE-5283565$ABBVIE$$71$YR$$F$Y$$$20240926$$CN$US$US
243648071$24364807$1$I$20240601$20240918$20240926$20240926$EXP$$MX-EMD Serono-2024050477$EMD SERONO INC$$35$YR$A$F$Y$$$20240926$$CN$MX$MX
243648091$24364809$1$I$$20240919$20240926$20240926$EXP$$TW-NOVITIUMPHARMA-2024TWNVP02008$NOVITIUM PHARMA$Chi-Sheng Su.Stevens-Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report.Journal of Medical Case Reports.28-JUL-2024;18(1):1-5$82$YR$E$F$Y$$$20240926$$HP$TW$TW
243648101$24364810$1$I$$20240916$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-046116$AUROBINDO$$33$YR$$$Y$$$20240926$$HP$GB$GB
243648111$24364811$1$I$$20240924$20240926$20240926$PER$$US-GILEAD-2024-0688776$GILEAD$$$$A$M$Y$$$20240926$$PH$US$US
243648121$24364812$1$I$$20240917$20240926$20240926$EXP$$NL-AUROBINDO-AUR-APL-2024-046848$AUROBINDO$$63$YR$$M$Y$70$KG$20240926$$CN$NL$NL
243648131$24364813$1$I$$20240924$20240926$20240926$EXP$GB-MHRA-MIDB-df9a5f5d-17a8-4fdd-860d-51aec1628f1f$GB-JNJFOC-20240965813$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240926$$PH$GB$GB
243648141$24364814$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011044$APOTEX$$60$YR$$F$Y$$$20240926$$HP$CA$CA
243648151$24364815$1$I$$20240918$20240926$20240926$EXP$$JP-ROCHE-10000090854$ROCHE$$2$DEC$A$M$Y$$$20240926$$MD$JP$JP
243648161$24364816$1$I$$20240915$20240926$20240926$EXP$$KR-Accord-447830$ACCORD$Hong G, Han SJ, Kim KH, Park D, Chung C. Cytomegalovirus tracheobronchitis mimicking lung cancer progression in a patient with lung adenocarcinoma: A case report. Thorac Cancer. 2024 Sep 14.$60$YR$A$M$Y$$$20240926$$HP$KR$KR
243648171$24364817$1$I$$20240919$20240926$20240926$EXP$$CA-JNJFOC-20240962625$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240926$$MD$CA$CA
243648181$24364818$1$I$$20240924$20240926$20240926$EXP$$NVSC2024MX190938$NOVARTIS$$$$$M$Y$$$20240926$$MD$MX$MX
243648191$24364819$1$I$20240903$20240918$20240926$20240926$PER$$US-ABBVIE-5932912$ABBVIE$$50$YR$$F$Y$$$20240926$$HP$US$US
243648201$24364820$1$I$20230601$20240624$20240926$20240926$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053403$BOEHRINGER INGELHEIM$$66$YR$E$F$Y$$$20240926$$MD$JP$JP
243648211$24364821$1$I$$20240906$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-143234$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240926$$CN$US$US
243648221$24364822$1$I$20240910$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046814$AUROBINDO$$91$YR$$F$Y$67$KG$20240926$$MD$FR$FR
243648231$24364823$1$I$20240901$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046661$AUROBINDO$$94$YR$$F$Y$62$KG$20240926$$MD$FR$FR
243648242$24364824$2$F$20240101$20240919$20240926$20240926$EXP$$US-ABBVIE-5931571$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243648251$24364825$1$I$20230816$20240916$20240926$20240926$EXP$GB-MHRA-MED-202409150949206770-TCDRY$GB-Accord-447037$ACCORD$$62$YR$A$F$Y$80$KG$20240926$$CN$GB$GB
243648261$24364826$1$I$$20240924$20240926$20240926$EXP$$CA-HALEON-2198444$Haleon PLC$$75$YR$$F$Y$$$20240926$$HP$CA$CA
243648271$24364827$1$I$$20240917$20240926$20240926$EXP$$US-NOVOPROD-1287238$NOVO NORDISK$$$$$F$Y$$$20240926$$CN$US$US
243648281$24364828$1$I$$20240917$20240926$20240926$EXP$$US-NOVOPROD-1287509$NOVO NORDISK$$$$A$M$Y$$$20240926$$CN$US$US
243648291$24364829$1$I$$20240917$20240926$20240926$EXP$$US-NOVOPROD-1288741$NOVO NORDISK$$$$$F$Y$$$20240926$$MD$US$US
243648301$24364830$1$I$20180224$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046751$AUROBINDO$$69$YR$$M$Y$109$KG$20240926$$MD$FR$FR
243648311$24364831$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152236$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240926$$HP$US$US
243648321$24364832$1$I$$20240916$20240926$20240926$EXP$$IT-AUROBINDO-AUR-APL-2024-046589$AUROBINDO$Pengo V, Bracco A, Denas G, Iliceto S.. Coronary Thrombosis with Distal Embolization in a Young Patient after Orthopaedic Surgery: An Informative Case Report.. Semin Thromb Hemost.. 2023;50 (6):894-896$40$YR$$M$Y$$$20240926$$HP$IT$IT
243648341$24364834$1$I$20240923$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189367$AMGEN$$70$YR$E$M$Y$$$20240926$$HP$US$US
243648351$24364835$1$I$20240201$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046801$AUROBINDO$$38$YR$$F$Y$125$KG$20240926$$MD$FR$FR
243648361$24364836$1$I$20230822$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046706$AUROBINDO$$51$YR$$M$Y$98.4$KG$20240926$$MD$FR$FR
243648371$24364837$1$I$$20240916$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-046188$AUROBINDO$$76$YR$$M$Y$74$KG$20240926$$PH$GB$GB
243648381$24364838$1$I$20240724$20240918$20240926$20240926$EXP$$GB-NOVOPROD-1285518$NOVO NORDISK$$66$YR$$F$Y$91$KG$20240926$$PH$GB$GB
243648391$24364839$1$I$20240910$20240918$20240926$20240926$EXP$ES-AEMPS-1570274$ES-NOVOPROD-1284913$NOVO NORDISK$$49$YR$$F$Y$115$KG$20240926$$MD$ES$ES
243648401$24364840$1$I$20231215$20240918$20240926$20240926$EXP$$TR-NOVOPROD-1166519$NOVO NORDISK$$815$MON$$M$Y$60$KG$20240926$$CN$TR$TR
243648411$24364841$1$I$$20240921$20240926$20240926$PER$$US-HALEON-2198128$Haleon PLC$$$$$$Y$$$20240926$$CN$US$US
243648421$24364842$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5936773$ABBVIE$$$$$F$Y$$$20240926$$HP$US$US
243648441$24364844$1$I$20231002$20240923$20240926$20240926$EXP$FR-AFSSAPS-NY2024001070$FR-JNJFOC-20240967010$JOHNSON AND JOHNSON$$73$YR$E$M$Y$91$KG$20240926$$MD$FR$FR
243648451$24364845$1$I$20240909$20240910$20240926$20240926$30DAY$$GB-JNJFOC-20240928019$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240926$$CN$GB$GB
243648461$24364846$1$I$20240826$20240916$20240926$20240926$EXP$$IT-AUROBINDO-AUR-APL-2024-046625$AUROBINDO$$74$YR$$F$Y$$$20240926$$MD$IT$IT
243648481$24364848$1$I$$20240918$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151200$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240926$$PH$JP$JP
243648491$24364849$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152298$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240926$$CN$US$US
243648501$24364850$1$I$$20240911$20240926$20240926$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK094032$GLENMARK$$$$$$Y$$$20240926$$CN$US$US
243648511$24364851$1$I$$20240909$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09055$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243648521$24364852$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014819$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$US$US
243648531$24364853$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015979$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240926$$CN$US$US
243648541$24364854$1$I$$20240920$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409013652$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240926$$CN$US$US
243648551$24364855$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016092$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240926$$CN$US$US
243648561$24364856$1$I$20240101$20240920$20240926$20240926$EXP$$CA-ABBVIE-5933777$ABBVIE$$71$YR$$F$Y$$$20240926$$CN$CA$CA
243648571$24364857$1$I$20240101$20240920$20240926$20240926$EXP$$US-ABBVIE-5934322$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243648581$24364858$1$I$$20240918$20240926$20240926$EXP$GB-MHRA-MED-202409181408556790-PWNDJ$GB-GE HEALTHCARE-2024CSU010727$GE HEALTHCARE$$29$YR$$F$Y$$$20240926$$HP$GB$GB
243648591$24364859$1$I$20240912$20240919$20240926$20240926$EXP$GB-MHRA-MED-202409162048293620-SGBJY$GB-GE HEALTHCARE-2024CSU010733$GE HEALTHCARE$$$$$F$Y$$$20240926$$HP$GB$GB
243648601$24364860$1$I$$20240909$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09057$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243648611$24364861$1$I$20240919$20240923$20240926$20240926$EXP$$US-ABBVIE-5936076$ABBVIE$$64$YR$$F$Y$$$20240926$$CN$US$US
243648621$24364862$1$I$$20240924$20240926$20240926$EXP$$US-ABBVIE-5938029$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243648631$24364863$1$I$20240705$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046575$AUROBINDO$$31$YR$$M$Y$$$20240926$$MD$FR$FR
243648641$24364864$1$I$$20240917$20240926$20240926$EXP$$CA-APOTEX-2024AP011114$APOTEX$$84$YR$$$Y$$$20240926$$PH$CA$CA
243648651$24364865$1$I$$20240920$20240926$20240926$PER$$US-ABBVIE-5935635$ABBVIE$$$$$F$Y$$$20240926$$HP$US$US
243648671$24364867$1$I$20240807$20240923$20240926$20240926$EXP$ES-ESTEVE-2024-01266$ES-UCBSA-2024048810$UCB$$46$YR$$M$Y$$$20240926$$MD$ES$ES
243648701$24364870$1$I$$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046715$AUROBINDO$Dupont J, Corsia B, Le Cam E, Abdennour L, Bleibtreu A, Weiss N, et al.. Chloramphenicol toxicity. Prat Anesth Reanim. 2024;28:243-249$56$YR$$M$Y$$$20240926$$HP$FR$FR
243648711$24364871$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005255$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243648721$24364872$1$I$20240916$20240917$20240926$20240926$PER$$US-TRIS PHARMA, INC.-24US011648$TRIS PHARM$$$$$$Y$$$20240926$$CN$US$US
243648751$24364875$1$I$20240524$20240919$20240926$20240926$EXP$$JP-ROCHE-10000090745$ROCHE$$$$$M$Y$$$20240926$$MD$JP$JP
243648761$24364876$1$I$$20240918$20240926$20240926$EXP$$JP-ROCHE-10000088387$ROCHE$$$$E$$Y$$$20240926$$MD$JP$JP
243648771$24364877$1$I$$20240916$20240926$20240926$EXP$$GB-TEVA-VS-3245162$TEVA$Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP. A case of human T-lymphotropic virus-1-associated lichenoid dermatitis. Clin-Exp-Dermatol 2024; 49 (8): 916-918.; Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP. A case of human T-lymphotropic virus-1-associated lichenoid dermatitis. Clin-Exp-Dermatol 2024; 49 (8): 916-918.$61$YR$$F$Y$$$20240926$$HP$GB$GB
243648781$24364878$1$I$20190307$20240911$20240926$20240926$EXP$$FR-JNJFOC-20240960975$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240926$$HP$FR$FR
243648791$24364879$1$I$20240619$20240925$20240926$20240926$EXP$$TH-ROCHE-10000090822$ROCHE$$66$YR$E$F$Y$$$20240926$$CN$TH$TH
243648811$24364881$1$I$20240101$20240910$20240926$20240926$PER$$US-APOTEX-2024AP010503$APOTEX$$$$$$Y$$$20240926$$PH$US$US
243648821$24364882$1$I$20240101$20240918$20240926$20240926$PER$$US-BEH-2024179100$CSL BEHRING$$$$$F$Y$$$20240926$$MD$US$US
243648831$24364883$1$I$$20240919$20240926$20240926$EXP$$FR-MIRUM PHARMACEUTICALS, INC.-FR-MIR-24-00874$Unknown Manufacturer$$$$$$Y$$$20240926$$MD$FR$FR
243648841$24364884$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011015$APOTEX$$52$YR$$M$Y$$$20240926$$HP$CA$CA
243648851$24364885$1$I$20240130$20240911$20240926$20240926$EXP$ES-AEMPS-1503582$ES-CELLTRION INC.-2024ES022867$CELLTRION$$$$$$Y$$$20240926$$PH$ES$ES
243648861$24364886$1$I$$20240918$20240926$20240926$EXP$$JP-TEVA-VS-3246542$TEVA$$49$YR$$F$Y$$$20240926$$MD$JP$JP
243648871$24364887$1$I$$20240916$20240926$20240926$EXP$$US-ROCHE-10000083812$ROCHE$$75$YR$E$F$Y$$$20240926$$CN$US$US
243648881$24364888$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005268$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243648891$24364889$1$I$$20240918$20240926$20240926$EXP$$US-TEVA-VS-3245189$TEVA$$16$YR$$F$Y$$$20240926$$CN$US$US
243648901$24364890$1$I$$20240919$20240926$20240926$EXP$$US-ABBVIE-5931426$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243648911$24364891$1$I$$20240909$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09080$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243648921$24364892$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006968$BIOCON$$$$$$Y$$$20240926$$HP$CA$CA
243648931$24364893$1$I$$20240918$20240926$20240926$PER$$US-TEVA-VS-3246313$TEVA$$45$YR$$F$Y$$$20240926$$HP$US$US
243648941$24364894$1$I$20240519$20240918$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-046340$AUROBINDO$$$$$F$Y$$$20240926$$CN$GB$GB
243648951$24364895$1$I$$20240917$20240926$20240926$EXP$$US-APOTEX-2024AP011258$APOTEX$Patel S, Sivananthan M.. Hypersensitivity to Psychotropic Medications in a Patient With 17q12 Microdeletion Syndrome: A Case Report. Journal of Clinical Psychopharmacology. 2024;44 (1):69-71$29$YR$$M$Y$$$20240926$$MD$US$US
243648961$24364896$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005271$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240926$$CN$US$US
243648971$24364897$1$I$$20240918$20240926$20240926$EXP$$CA-ASTELLAS-2024-AER-007855$ASTELLAS$$63$YR$A$$Y$73$KG$20240926$$PH$CA$CA
243648991$24364899$1$I$$20240920$20240926$20240926$EXP$$JP-ASTELLAS-2024-AER-007976$ASTELLAS$$89$YR$E$M$Y$$$20240926$$PH$JP$JP
243649001$24364900$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5934251$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243649011$24364901$1$I$20240723$20240918$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046984$AUROBINDO$$68$YR$$M$Y$$$20240926$$PH$FR$FR
243649021$24364902$1$I$20240601$20240920$20240926$20240926$EXP$$US-ABBVIE-5763076$ABBVIE$$60$YR$$M$Y$$$20240926$$CN$US$US
243649031$24364903$1$I$$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152103$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240926$$CN$US$US
243649041$24364904$1$I$$20240916$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152128$BRISTOL MYERS SQUIBB$Barlowe TS, Saxena-Beem S, Ishizawar RC, Herfarth H, Moon AM. Multiple gastrointestinal immune related adverse events from immune checkpoint inhibitor therapy. Clinical and Translational Gastroenterology. 2024 Sep 12;doi:10.14309/ctg.0000000000000768.$47$YR$A$M$Y$$$20240926$$MD$US$US
243649051$24364905$1$I$20240916$20240916$20240926$20240926$PER$$US-GSK-US2024114958$GLAXOSMITHKLINE$$83$YR$$F$Y$$$20240926$$CN$US$US
243649071$24364907$1$I$$20240916$20240926$20240926$EXP$CA-MHPD-E2B_07222188$CA-Accord-447016$ACCORD$$76$YR$E$M$Y$$$20240926$$HP$CA$CA
243649081$24364908$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015268$ELI LILLY AND CO$$50$YR$A$$Y$$$20240926$$CN$US$US
243649091$24364909$1$I$$20240920$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409013600$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240926$$CN$US$US
243649101$24364910$1$I$20211201$20240918$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409013635$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240926$$CN$US$US
243649111$24364911$1$I$20240901$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015190$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$US$US
243649121$24364912$1$I$20240916$20240918$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409011693$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240926$$HP$US$US
243649131$24364913$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015318$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240926$$CN$US$US
243649141$24364914$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003628$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243649151$24364915$1$I$20200613$20240916$20240926$20240926$EXP$$BR-TAKEDA-2020TUS027634$TAKEDA$$29$YR$$F$Y$$$20240926$$CN$BR$BR
243649161$24364916$1$I$20220101$20240909$20240926$20240926$EXP$$SK-CELLTRION INC.-2024SK022770$CELLTRION$$$$$$Y$$$20240926$$MD$SK$SK
243649171$24364917$1$I$20240801$20240903$20240926$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005240$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240926$$CN$US$US
243649181$24364918$1$I$20240610$20240712$20240926$20240926$EXP$$US-TEVA-VS-3221948$TEVA$$21$YR$$F$Y$$$20240926$$MD$US$US
243649191$24364919$1$I$$20240912$20240926$20240926$EXP$US-MLMSERVICE-20170914-0885468-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2017-02049$ALKEM$Pelletier JH, Nagaraj S, Gbadegesin R, Wigfall D and et al.. Neutropenic enterocolitis (typhlitis) in a pediatric renal transplant patient. A case report and review of the literature. Pediatric Transplantation.. 2017;21:1-3$15$YR$$M$Y$$$20240926$$HP$US$US
243649211$24364921$1$I$$20240920$20240926$20240926$EXP$$CW-JNJFOC-20240961606$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$MD$CW$CW
243649221$24364922$1$I$$20240912$20240926$20240926$EXP$GB-MHRA-MED-202409111600130520-LCVQZ$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21583$ALKEM$$$$$M$Y$72$KG$20240926$$HP$GB$GB
243649231$24364923$1$I$$20240912$20240926$20240926$EXP$$CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2024-21928$ALKEM$Yue J, Xu F, Zhang Y, Wen J, Zhou Q.. Diagnosis of light-chain deposition disease after renal transplantation: A case report and literature review. Experimental and Therapeutic Medicine. 2024;28:339$49$YR$$M$Y$$$20240926$$HP$CN$CN
243649241$24364924$1$I$$20240912$20240926$20240926$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-21824$ALKEM$Hussein G, Krastev P, Mallari AJP, El Labban M, Yadav S, Hassan M, Warsame M, Zoesch G, Trnka J, Vojjala N, Jain SM, Surani S, Khan SA. Stone heart syndrome: A curious case of digoxin toxicity and calcium infusion. Clinical Case Reports. 2024;unk:unk$78$YR$$F$Y$$$20240926$$HP$US$US
243649251$24364925$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114809$GLAXOSMITHKLINE$$$$$M$Y$$$20240926$$MD$US$US
243649262$24364926$2$F$20240917$20240920$20240926$20240926$EXP$$US-ROCHE-10000087584$ROCHE$$83$YR$E$M$Y$$$20240926$$MD$US$US
243649271$24364927$1$I$20240801$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005239$ACADIA PHARMACEUTICALS$$24$YR$$F$Y$$$20240926$$CN$US$US
243649281$24364928$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152421$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$81.65$KG$20240926$$CN$US$US
243649291$24364929$1$I$$20240916$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152124$BRISTOL MYERS SQUIBB$Barlowe TS, Saxena-Beem S, Ishizawar RC, Herfarth H, Moon AM. Multiple gastrointestinal immune related adverse events from immune checkpoint inhibitor therapy. Clinical and Translational Gastroenterology. 2024 Sep 12;doi:10.14309/ctg.0000000000000768.$40$YR$A$M$Y$$$20240926$$MD$US$US
243649301$24364930$1$I$$20240918$20240926$20240926$EXP$$GB-TAKEDA-2024TUS094032$TAKEDA$$$$$F$Y$$$20240926$$CN$GB$GB
243649311$24364931$1$I$$20240921$20240926$20240926$EXP$$US-ABBVIE-5935410$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243649321$24364932$1$I$$20240916$20240926$20240926$PER$$US-ABBVIE-5928193$ABBVIE$$$$A$M$Y$$$20240926$$HP$US$US
243649341$24364934$1$I$$20240924$20240926$20240926$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053459$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240926$$MD$US$US
243649351$24364935$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005277$ACADIA PHARMACEUTICALS$$$$$$Y$$$20240926$$CN$US$US
243649361$24364936$1$I$$20240919$20240926$20240926$PER$$US-ABBVIE-5935356$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243649371$24364937$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005244$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243649381$24364938$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005279$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243649391$24364939$1$I$$20240916$20240926$20240926$EXP$$GB-TEVA-VS-3245902$TEVA$Katis G, Srinivasan S, Eleftheriou P, Walker M, Demetriades P. Characterizing left ventricular systolic dysfunction in sickle cell disease: three contrasting case reports. Eur-Heart-J-Case-Rep 2024; 8 (8):.$52$YR$$M$Y$$$20240926$$HP$GB$GB
243649401$24364940$1$I$20240829$20240904$20240926$20240926$PER$$FR-TOLMAR, INC.-24FR052317$TOLMAR$$77$YR$$M$Y$$$20240926$$PH$FR$FR
243649411$24364941$1$I$20240904$20240904$20240926$20240926$PER$$FR-TOLMAR, INC.-24FR052437$TOLMAR$$88$YR$$M$Y$$$20240926$$PH$FR$FR
243649421$24364942$1$I$$20240906$20240926$20240926$PER$$NO-TOLMAR, INC.-24NO052404$TOLMAR$$$$$$Y$$$20240926$$HP$NO$NO
243649431$24364943$1$I$20240828$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005275$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240926$$CN$US$US
243649441$24364944$1$I$20240814$20240904$20240926$20240926$PER$$NL-TOLMAR, INC.-24NL052412$TOLMAR$$90$YR$$M$Y$$$20240926$$CN$NL$NL
243649461$24364946$1$I$$20240904$20240926$20240926$PER$$PA-TOLMAR, INC.-24PA052429$TOLMAR$$$$$M$Y$$$20240926$$CN$PA$PA
243649471$24364947$1$I$$20240904$20240926$20240926$PER$$TR-TOLMAR, INC.-24TR052444$TOLMAR$$84$YR$$M$Y$$$20240926$$HP$TR$TR
243649481$24364948$1$I$20240816$20240905$20240926$20240926$PER$$TR-TOLMAR, INC.-24TR052499$TOLMAR$$75$YR$$M$Y$$$20240926$$PH$TR$TR
243649491$24364949$1$I$$20240916$20240926$20240926$EXP$GB-MHRA-MED-202409140958417690-DKJSH$GB-Accord-447294$ACCORD$$$$$F$Y$$$20240926$$CN$GB$GB
243649501$24364950$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152430$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240926$$CN$US$US
243649511$24364951$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152374$BRISTOL MYERS SQUIBB$$65$YR$A$F$Y$$$20240926$$HP$US$US
243649522$24364952$2$F$$20240923$20240926$20240927$EXP$$US-ABBVIE-5935654$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243649531$24364953$1$I$20240915$20240919$20240926$20240926$EXP$$US-GSK-US2024116516$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
243649541$24364954$1$I$20240801$20240916$20240926$20240926$PER$$US-GSK-US2024114816$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20240926$$CN$US$US
243649561$24364956$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191242$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
243649571$24364957$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005247$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243649581$24364958$1$I$$20240916$20240926$20240926$EXP$$ES-AMAROX PHARMA-AMR2024ES03349$HETERO$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E et al.. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver International. 2024;44(2):286-292$$$$$Y$$$20240926$$HP$ES$ES
243649591$24364959$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005245$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243649611$24364961$1$I$20240902$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005248$ACADIA PHARMACEUTICALS$$16$YR$$F$Y$$$20240926$$CN$US$US
243649621$24364962$1$I$20230101$20240916$20240926$20240926$EXP$$NL-ABBVIE-5938350$ABBVIE$Burger D, Wttewaal E, Oosterhof P, Stalenhoef J. Concomitant use of anabolic androgen steroids and cabotegravir/rilpivirine leading to virological failure and development of two-class resistance. AIDS. 2024;38(11):1728-9.$27$YR$$M$Y$$$20240926$$MD$NL$NL
243649631$24364963$1$I$20240916$20240918$20240926$20240926$EXP$$JP-ROCHE-10000089371$ROCHE$$77$YR$E$M$Y$$$20240926$$MD$JP$JP
243649641$24364964$1$I$20240801$20240912$20240926$20240926$EXP$$US-UCBSA-2024041850$UCB$$30$YR$$M$Y$$$20240926$$CN$US$US
243649651$24364965$1$I$$20240921$20240926$20240926$PER$$US-JNJFOC-20240962777$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243649671$24364967$1$I$20240725$20240918$20240926$20240926$EXP$$CA-JNJFOC-20240774911$JOHNSON AND JOHNSON$$35$YR$A$F$Y$94$KG$20240926$$HP$CA$CA
243649681$24364968$1$I$20240917$20240918$20240926$20240926$EXP$GB-MHRA-MED-202409181720390300-VDQSL$GB-TEVA-VS-3245793$TEVA$$84$YR$$M$Y$$$20240926$$HP$GB$GB
243649691$24364969$1$I$$20240920$20240926$20240926$EXP$$CA-JNJFOC-20240960126$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$HP$CA$CA
243649701$24364970$1$I$20230920$20240916$20240926$20240926$EXP$FR-AFSSAPS-TS2024000974$FR-Accord-447428$ACCORD$$0$DY$N$M$Y$1.805$KG$20240926$$MD$FR$FR
243649711$24364971$1$I$$20240916$20240926$20240926$EXP$$BG-TWI PHARMACEUTICAL, INC-20240900127$TWI PHARMACEUTICALS$Tchernev G.; Ivanov L.; Broshtilova V.. MULTIPLE KERATINOCYTIC CANCERS AFTER INTAKE OF ANTIHYPERTENSIVES (LISINOPRIL/BISOPROLOL/HCT) AND ANTIARRHYTMICS (PROPAFENONE): THE IMPORTANT NEW LINKS TO THE NITROSO-CONTAMINATION AND THE METABOLIC REPROGRAMMING OF THE FUTURE CANCER CELL. Georgian Med. News. 2024;351:65-71$87$YR$$F$Y$$$20240920$$$BG$BG
243649721$24364972$1$I$20231001$20240919$20240926$20240926$EXP$$CA-GSK-CA2023147143$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$CA$CA
243649731$24364973$1$I$$20240919$20240926$20240926$PER$$US-JNJFOC-20240953267$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$PH$US$US
243649741$24364974$1$I$$20240916$20240926$20240926$PER$$US-JNJFOC-20240965811$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243649751$24364975$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191255$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
243649761$24364976$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014690$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240926$$CN$US$US
243649771$24364977$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016157$ELI LILLY AND CO$$43$YR$A$$Y$$$20240926$$LW$US$US
243649781$24364978$1$I$20240301$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015553$ELI LILLY AND CO$$28$YR$A$F$Y$$$20240926$$CN$US$US
243649791$24364979$1$I$20240910$20240920$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409013469$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240926$$CN$US$US
243649801$24364980$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151601$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$83.01$KG$20240926$$HP$US$US
243649811$24364981$1$I$$20240921$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150642$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$CN$US$US
243649821$24364982$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152440$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240926$$CN$US$US
243649831$24364983$1$I$20240923$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152054$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240926$$CN$US$US
243649841$24364984$1$I$$20240916$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147476$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240926$$HP$US$US
243649851$24364985$1$I$20240920$20240920$20240926$20240926$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-151749$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240926$$CN$DE$DE
243649861$24364986$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005284$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243649871$24364987$1$I$$20240923$20240926$20240926$EXP$GB-MHRA-MIDB-54838065-87e0-40b7-8258-f03aab871750$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-151341$BRISTOL MYERS SQUIBB$$65$YR$E$$Y$$$20240926$$HP$GB$GB
243649881$24364988$1$I$$20240909$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09063$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243649891$24364989$1$I$20240621$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005249$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240926$$CN$US$US
243649901$24364990$1$I$$20240917$20240926$20240926$EXP$$AU-CELLTRION INC.-2024AU022565$CELLTRION$$$$$$Y$$$20240926$$HP$AU$AU
243649911$24364991$1$I$20240904$20240919$20240926$20240926$EXP$$CO-UCBSA-2024047464$UCB$$46$YR$$F$Y$$$20240926$$CN$CO$CO
243649921$24364992$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114994$GLAXOSMITHKLINE$$$$$M$Y$$$20240926$$CN$US$US
243649931$24364993$1$I$20240101$20240916$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147791$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$113.4$KG$20240926$$CN$US$US
243649941$24364994$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152228$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$PH$US$US
243649951$24364995$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152396$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$65.32$KG$20240926$$CN$US$US
243649961$24364996$1$I$20240801$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152403$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240926$$HP$US$US
243649981$24364998$1$I$$20240924$20240926$20240926$PER$$NVSC2024US190791$NOVARTIS$$69$YR$$F$Y$$$20240926$$CN$US$US
243650001$24365000$1$I$20240716$20240917$20240926$20240926$EXP$$US-TEVA-VS-3246053$TEVA$$58$YR$$M$Y$95.3$KG$20240926$$HP$US$US
243650011$24365001$1$I$20240101$20240917$20240926$20240926$PER$$US-ABBVIE-5929166$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243650021$24365002$1$I$$20240910$20240926$20240926$PER$$US-APOTEX-2024AP010708$APOTEX$$$$E$M$Y$$$20240926$$CN$US$US
243650031$24365003$1$I$20240101$20240924$20240926$20240926$EXP$$NVSC2024RU190947$NOVARTIS$$42$YR$$M$Y$$$20240926$$MD$RU$RU
243650051$24365005$1$I$20240825$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005286$ACADIA PHARMACEUTICALS$$51$YR$$M$Y$$$20240926$$CN$US$US
243650061$24365006$1$I$20240801$20240920$20240926$20240926$EXP$$JP-GSK-JP2024JPN116750$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$PH$JP$JP
243650071$24365007$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152263$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240926$$HP$US$US
243650081$24365008$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152252$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240926$$HP$US$US
243650091$24365009$1$I$20240601$20240805$20240926$20240926$PER$$US-TWI PHARMACEUTICAL, INC-20240700053$TWI PHARMACEUTICALS$$49$YR$$F$Y$$$20240916$$CN$US$US
243650101$24365010$1$I$20240910$20240911$20240926$20240926$PER$$US-APOTEX-2024AP010688$APOTEX$$$$$F$Y$$$20240926$$CN$US$US
243650111$24365011$1$I$$20240920$20240926$20240926$EXP$$US-TAKEDA-2024TUS093914$TAKEDA$$$$$F$Y$$$20240926$$CN$US$US
243650121$24365012$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005287$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243650131$24365013$1$I$$20240923$20240926$20240926$EXP$$US-ROCHE-10000090203$ROCHE$$$$A$M$Y$$$20240926$$MD$US$US
243650141$24365014$1$I$$20240920$20240926$20240926$EXP$$JP-ASTELLAS-2024-AER-008433$ASTELLAS$$7$DEC$E$M$Y$$$20240926$$MD$JP$JP
243650151$24365015$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005295$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243650161$24365016$1$I$20240810$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005252$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20240926$$CN$US$US
243650171$24365017$1$I$$20240917$20240926$20240926$EXP$$JP-EMD Serono-2024050610$EMD SERONO INC$$75$YR$E$F$Y$$$20240926$$MD$JP$JP
243650181$24365018$1$I$20240722$20240919$20240926$20240926$EXP$FR-AFSSAPS-RN2024000948$FR-TEVA-VS-3246112$TEVA$$70$YR$$F$Y$$$20240926$$PH$FR$FR
243650191$24365019$1$I$$20240920$20240926$20240926$EXP$$TR-BIOGEN-2024BI01283770$BIOGEN$$$$$$Y$$$20240926$$MD$TR$TR
243650201$24365020$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152423$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240926$$CN$US$US
243650211$24365021$1$I$20240801$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152268$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$$$20240926$$HP$US$US
243650221$24365022$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005288$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243650231$24365023$1$I$$20240905$20240926$20240926$EXP$$ES-CELLTRION INC.-2024ES022765$CELLTRION$$$$$$Y$$$20240926$$MD$ES$ES
243650251$24365025$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005302$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243650261$24365026$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024007010$BIOCON$$$$$$Y$$$20240926$$CN$CA$CA
243650271$24365027$1$I$$20240919$20240926$20240926$EXP$$US-GSK-US2024116585$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
243650281$24365028$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005303$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243650291$24365029$1$I$20240612$20240917$20240926$20240926$EXP$$GB-CELLTRION INC.-2024GB022803$CELLTRION$$$$$$Y$$$20240926$$CN$GB$GB
243650301$24365030$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015639$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240926$$CN$US$US
243650311$24365031$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014368$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240926$$CN$US$US
243650321$24365032$1$I$20240920$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015758$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240926$$CN$US$US
243650331$24365033$1$I$20240922$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015725$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240926$$CN$US$US
243650341$24365034$1$I$$20240920$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014555$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240926$$CN$US$US
243650351$24365035$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015269$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240926$$MD$US$US
243650361$24365036$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005306$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243650371$24365037$1$I$$20240917$20240926$20240926$EXP$$US-EMD Serono-2024050316$EMD SERONO INC$$72$YR$E$F$Y$$$20240926$$CN$US$US
243650381$24365038$1$I$$20240916$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR118385$VIIV$$$$$$Y$$$20240926$$HP$US$US
243650391$24365039$1$I$$20240913$20240926$20240926$PER$$US-FARMAPROD-202409-3289$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240926$$CN$US$US
243650401$24365040$1$I$$20240916$20240926$20240926$PER$$US-TEVA-VS-3246219$TEVA$$$$$$Y$$$20240926$$CN$US$US
243650411$24365041$1$I$20240916$20240917$20240926$20240926$PER$$US-ABBVIE-5930645$ABBVIE$$44$YR$$F$Y$$$20240926$$MD$US$US
243650421$24365042$1$I$20240806$20240918$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046987$AUROBINDO$$45$YR$$M$Y$$$20240926$$MD$FR$FR
243650431$24365043$1$I$20240616$20240903$20240926$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005307$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20240926$$CN$US$US
243650441$24365044$1$I$20240918$20240918$20240926$20240926$EXP$$JP-EMD Serono-2024050132$EMD SERONO INC$$82$YR$E$M$Y$$$20240926$$MD$JP$JP
243650451$24365045$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005296$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243650471$24365047$1$I$20201102$20240916$20240926$20240926$EXP$$PL-AUROBINDO-AUR-APL-2024-046821$AUROBINDO$$66$YR$$F$Y$83.6$KG$20240926$$HP$PL$PL
243650491$24365049$1$I$$20240919$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-046484$AUROBINDO$$$$$F$Y$$$20240926$$PH$GB$GB
243650501$24365050$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152281$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240926$$HP$US$US
243650511$24365051$1$I$$20240916$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR118381$VIIV$$$$$$Y$$$20240926$$HP$US$US
243650521$24365052$1$I$20240901$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152303$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$68.04$KG$20240926$$CN$US$US
243650531$24365053$1$I$$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151993$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$MD$US$US
243650541$24365054$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152605$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240926$$CN$US$US
243650551$24365055$1$I$$20240919$20240926$20240926$EXP$$GB-GSK-GB2024EME117287$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$GB$GB
243650561$24365056$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152355$BRISTOL MYERS SQUIBB$$27$YR$A$M$Y$$$20240926$$HP$US$US
243650571$24365057$1$I$20240901$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005308$ACADIA PHARMACEUTICALS$$58$YR$$M$Y$$$20240926$$CN$US$US
243650581$24365058$1$I$20210405$20240918$20240926$20240926$EXP$$IT-TAKEDA-2021TUS022734$TAKEDA$$48$YR$$F$Y$$$20240926$$CN$IT$IT
243650591$24365059$1$I$20191111$20240923$20240926$20240926$EXP$GR-GREOF-202401006$GR-ORGANON-O2409GRC001837$ORGANON$$64$YR$$M$Y$$$20240926$$MD$GR$GR
243650601$24365060$1$I$$20240819$20240926$20240926$PER$$US-SERVIER-S24010603$SERVIER$$$$$$Y$$$20240926$$MD$US$US
243650611$24365061$1$I$20200301$20240918$20240926$20240926$EXP$$AU-TAKEDA-2024TUS095065$TAKEDA$$65$YR$$M$Y$$$20240926$$MD$AU$AU
243650621$24365062$1$I$$20240924$20240926$20240926$EXP$$US-TAKEDA-2024TUS095060$TAKEDA$$$$$F$Y$$$20240926$$CN$US$US
243650631$24365063$1$I$$20240910$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09084$LUPIN$$$$$$Y$$$20240926$$PH$US$US
243650641$24365064$1$I$$20240920$20240926$20240926$PER$$US-ROCHE-10000088433$ROCHE$$$$$$Y$$$20240926$$HP$US$US
243650651$24365065$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005311$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243650671$24365067$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005251$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243650681$24365068$1$I$20240821$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005298$ACADIA PHARMACEUTICALS$$66$YR$$F$Y$$$20240926$$MD$US$US
243650691$24365069$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005317$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243650701$24365070$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005301$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243650711$24365071$1$I$20240917$20240918$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-150962$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$MD$JP$JP
243650721$24365072$1$I$20240819$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005278$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20240926$$CN$US$US
243650731$24365073$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960190$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240926$$MD$US$US
243650741$24365074$1$I$$20240916$20240926$20240926$EXP$$DE-TEVA-VS-3244813$TEVA$Traidl S, Wedi B. Case of a multiple drug hypersensitivity syndrom - challange of allergological diagnostics. [German]. Allergologie 2023; 46 (2): 94-98.$52$YR$$M$Y$$$20240926$$MD$DE$DE
243650751$24365075$1$I$$20240912$20240926$20240926$PER$$US-JNJFOC-20240933167$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243650761$24365076$1$I$$20240906$20240926$20240926$EXP$$AU-JNJFOC-20240926119$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20240926$$MD$AU$AU
243650771$24365077$1$I$20240801$20240917$20240926$20240926$PER$$US-JNJFOC-20240953617$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
243650781$24365078$1$I$$20240913$20240926$20240926$EXP$$US-FDC-2024USSPO00731$FDC LIMITED$$$$$F$Y$53.5$KG$20240926$$CN$US$US
243650791$24365079$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005331$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$HP$US$US
243650801$24365080$1$I$20240903$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005309$ACADIA PHARMACEUTICALS$$69$YR$$F$Y$$$20240926$$MD$US$US
243650811$24365081$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005312$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243650821$24365082$1$I$$20240920$20240926$20240926$EXP$$US-ASTELLAS-2024-AER-008301$ASTELLAS$$$$E$M$Y$$$20240926$$CN$US$US
243650831$24365083$1$I$$20240924$20240926$20240926$EXP$$US-ABBVIE-5938921$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243650841$24365084$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005344$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243650861$24365086$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000091331$ROCHE$$81$YR$E$F$Y$$$20240926$$MD$US$US
243650871$24365087$1$I$$20240916$20240926$20240926$EXP$CA-MHPD-001093626$CA-Accord-447247$ACCORD$$53$YR$A$F$Y$$$20240926$$HP$CA$CA
243650881$24365088$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005334$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243650891$24365089$1$I$$20240917$20240926$20240926$EXP$$US-RDY-SPO/USA/24/0013998$DR REDDYS$Patel S, Sivananthan M. Hypersensitivity to Psychotropic Medications in a Patient With 17q12 Microdeletion Syndrome: A Case Report. Journal of Clinical Psychopharmacology. 2024 Jan 01;44: 69-71. doi:10.1097/JCP.0000000000001797.$29$YR$A$M$Y$$$20240926$$HP$US$US
243650902$24365090$2$F$20240812$20240925$20240926$20240930$EXP$$US-ORGANON-O2409USA001936$ORGANON$$32$YR$$F$Y$76.19$KG$20240930$$CN$US$US
243650911$24365091$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191295$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
243650921$24365092$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015375$ELI LILLY AND CO$$85$YR$E$$Y$$$20240926$$CN$US$US
243650931$24365093$1$I$$20240910$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09083$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243650941$24365094$1$I$20240904$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005347$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240926$$CN$US$US
243650951$24365095$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015719$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240926$$CN$US$US
243650961$24365096$1$I$20240901$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015307$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240926$$CN$US$US
243650971$24365097$1$I$20240923$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015422$ELI LILLY AND CO$$59$YR$A$$Y$$$20240926$$CN$US$US
243650981$24365098$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151883$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240926$$CN$US$US
243650991$24365099$1$I$$20240918$20240926$20240926$EXP$$CA-APOTEX-2024AP011187$APOTEX$$49$YR$$F$Y$$$20240926$$CN$CA$CA
243651001$24365100$1$I$$20240923$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151950$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240926$$CN$US$US
243651011$24365101$1$I$$20240916$20240926$20240926$EXP$$NL-CELLTRION INC.-2024NL022754$CELLTRION$Haanen J. B.; Borgers J. S.; Van Schijndel A. W. et al.. Clinical presentation of cardiac symptoms following treatment with tumor-infiltrating lymphocytes: diagnostic challenges and lessons learned. ESMO Open. 2024;9(2):1-12$$$$$Y$$$20240926$$HP$NL$NL
243651021$24365102$1$I$20240919$20240917$20240926$20240926$EXP$$CA-TAKEDA-2024TUS084550$TAKEDA$$37$YR$$F$Y$$$20240926$$CN$CA$CA
243651031$24365103$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-003735$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243651041$24365104$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005281$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243651051$24365105$1$I$20210101$20240916$20240926$20240926$EXP$$US-APOTEX-2024AP011137$APOTEX$Rustom D, Wall B, Talwar M. Malakoplakia in kidney transplant causing severe hydronephrosis and successful treatment with antibiotics and lowering immunosuppression. Transplant Infectious Disease. 2023;25:e14158:1-3$55$YR$$M$Y$$$20240926$$HP$US$US
243651081$24365108$1$I$$20240923$20240926$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029944$UNITED THERAPEUTICS$$$$$M$Y$$$20240926$$$US$US
243651101$24365110$1$I$$20240920$20240926$20240926$EXP$$JP-GSK-JP2024JPN116746$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$PH$JP$JP
243651111$24365111$1$I$$20240912$20240926$20240926$PER$$US-APOTEX-2024AP010991$APOTEX$Hussain SA, Berenji R, Faisal S, Ali L, Knavel A.. A rare case of symmetrical drug-related intertriginous and flexural erythema with tamoxifen use.. Clinical case reports. 2024;12(9) e9401:1-3$48$YR$$F$Y$$$20240926$$HP$US$US
243651121$24365112$1$I$$20240923$20240926$20240926$PER$$US-ROCHE-10000088746$ROCHE$Nayak V, Nayak V, Desai H, And Szlembarski S.. Norovirus-triggered small vessel vasculitis flare complicated by massive, life-threatening epistaxis, successfully treated with tocilizumab. Chest. 2024;166 (4):A2545-6. doi:10.1016/j.chest.2024.06.1548.$7$DEC$E$M$Y$$$20240926$$HP$US$US
243651131$24365113$1$I$$20240918$20240926$20240926$EXP$$CA-APOTEX-2024AP011209$APOTEX$$79$YR$$M$Y$$$20240926$$CN$CA$CA
243651141$24365114$1$I$$20240910$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09079$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243651151$24365115$1$I$$20240924$20240926$20240926$EXP$$JP-SANDOZ INC.-SDZ2024JP082532$SANDOZ$$16$YR$$F$Y$$$20240926$$MD$JP$JP
243651161$24365116$1$I$20230306$20240918$20240926$20240926$EXP$$US-SANDOZ INC.-NVSC2023US130406$SANDOZ$$65$YR$$M$Y$108$KG$20240926$$PH$US$US
243651171$24365117$1$I$$20240925$20240926$20240926$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053593$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240926$$MD$IT$IT
243651181$24365118$1$I$$20240924$20240926$20240926$EXP$PL-HALEON-2196304$PL-SANDOZ INC.-SDZ2024PL082673$SANDOZ$$76$YR$$F$Y$$$20240926$$HP$PL$PL
243651191$24365119$1$I$20240826$20240923$20240926$20240926$EXP$$CN-ROCHE-10000089255$ROCHE$$50$YR$A$F$Y$65$KG$20240926$$HP$CN$CN
243651201$24365120$1$I$20240902$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005283$ACADIA PHARMACEUTICALS$$16$YR$$F$Y$$$20240926$$CN$US$US
243651211$24365121$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152497$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240926$$CN$US$US
243651221$24365122$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152410$BRISTOL MYERS SQUIBB$$39$YR$A$M$Y$$$20240926$$HP$US$US
243651231$24365123$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152395$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$63.05$KG$20240926$$CN$US$US
243651241$24365124$1$I$$20240917$20240926$20240926$EXP$$GB-ROCHE-3492105$ROCHE$$$$E$M$Y$$$20240926$$CN$GB$GB
243651251$24365125$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5934064$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243651261$24365126$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005154$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243651271$24365127$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5934346$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243651281$24365128$1$I$$20240911$20240926$20240926$PER$$US-JNJFOC-20240931724$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243651291$24365129$1$I$$20240918$20240926$20240926$EXP$$US-JNJFOC-20240953262$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$HP$US$US
243651301$24365130$1$I$$20240924$20240926$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE082831$SANDOZ$$$$A$$Y$$$20240926$$HP$DE$DE
243651311$24365131$1$I$20240101$20240924$20240926$20240926$EXP$$US-009507513-2409USA008505$MERCK$$$$$F$Y$$$20240926$$HP$US$US
243651321$24365132$1$I$$20240917$20240926$20240926$EXP$$VN-SANDOZ INC.-SDZ2024VN082976$SANDOZ$Truong PHD, Suzanne MTT, Tran TT, Lam MH, Le PD, Nguyen TBU et al. . Buoc dau danh gia hieu qua va doc tinh cua phac do dieu kien hoa beeam tren benh nhan u lympho duoc ghep te bao goc tu than t?i benh vien cho ray [initial evaluation the safety and efficiency of beeam conditioning regimen in lymphoma patients undergoing autologous stem cell transplantation at cho ray hospital]. VIETNAM MEDICAL JOURNAL. 2022;520 (11):430-37$$$$$Y$$$20240926$$HP$VN$VN
243651331$24365133$1$I$$20240916$20240926$20240926$EXP$CA-MHPD-E2B_07215538$CA-Accord-447182$ACCORD$$64$YR$A$M$Y$$$20240926$$HP$CA$CA
243651341$24365134$1$I$$20240918$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2024US082923$SANDOZ$$$$$$Y$$$20240926$$CN$US$US
243651351$24365135$1$I$20240901$20240925$20240926$20240926$PER$$US-ROCHE-10000091699$ROCHE$$$$T$F$Y$$$20240926$$MD$US$US
243651361$24365136$1$I$20240701$20240918$20240926$20240926$EXP$$US-SA-2024SA276091$SANOFI AVENTIS$$35$YR$A$F$Y$79.55$KG$20240926$$MD$US$US
243651371$24365137$1$I$$20240920$20240926$20240926$EXP$$CA-ABBVIE-5933715$ABBVIE$$$$E$M$Y$$$20240926$$HP$CA$CA
243651381$24365138$1$I$20220501$20240918$20240926$20240926$EXP$$US-SA-2024SA272874$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240926$$MD$US$US
243651391$24365139$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5933876$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243651401$24365140$1$I$20240419$20240919$20240926$20240926$EXP$$US-ABBVIE-5781659$ABBVIE$$41$YR$$F$Y$$$20240926$$CN$US$US
243651411$24365141$1$I$$20240917$20240926$20240926$EXP$$IT-CELLTRION INC.-2024IT022811$CELLTRION$Accardo V.; Pagnini I.; Maccora I. et.al.. Safety and efficacy of biologic immunosuppressive treatment in juvenile idiopathic arthritis associated with inborn errors of immunity. Frontiers in Pediatrics. 2024;12:1-5$$$$$Y$$$20240926$$HP$IT$IT
243651421$24365142$1$I$$20240916$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR118391$VIIV$$$$$$Y$$$20240926$$HP$US$US
243651431$24365143$1$I$$20240924$20240926$20240926$EXP$GB-MHRA-MIDB-df9a5f5d-17a8-4fdd-860d-51aec1628f1f$GB-SANDOZ INC.-SDZ2024GB082963$SANDOZ$$66$YR$$F$Y$$$20240926$$PH$GB$GB
243651441$24365144$1$I$20240905$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046544$AUROBINDO$$8$YR$$F$Y$20$KG$20240926$$MD$FR$FR
243651451$24365145$1$I$$20240916$20240926$20240926$PER$$US-APOTEX-2024AP011138$APOTEX$Vannatta M, Grier L, Khan MH, Pinargote Cornejo P, Alam M, Moussa SH. In Vivo Emergence of Pandrug-Resistant Acinetobacter baumannii Strain: Comprehensive Resistance Characterization and Compassionate Use of Sulbactam-Durlobactam. Open Forum Infectious Diseases. 2023;10:1-5$44$YR$$M$Y$$$20240926$$HP$US$US
243651461$24365146$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005342$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243651471$24365147$1$I$20240923$20240924$20240926$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US082812$SANDOZ$$14$YR$$M$Y$$$20240926$$CN$US$US
243651481$24365148$1$I$$20240919$20240926$20240926$EXP$$AT-SANDOZ INC.-SDZ2024AT082987$SANDOZ$$$$$M$Y$$$20240926$$CN$AT$AT
243651491$24365149$1$I$20240901$20240920$20240926$20240926$PER$$US-ABBVIE-5934297$ABBVIE$$54$YR$$M$Y$$$20240926$$CN$US$US
243651501$24365150$1$I$20231201$20240919$20240926$20240926$EXP$$US-ABBVIE-5591502$ABBVIE$$60$YR$$F$Y$$$20240926$$CN$US$US
243651511$24365151$1$I$$20240917$20240926$20240926$PER$$US-GSK-US2024115640$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243651521$24365152$1$I$$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046922$AUROBINDO$Ikic A, Chatelus E, Epailly E, Kremer H, Sibilia J, Gottenberg J, et al.,. Heart transplantation in 6 patients with systemic sclerosis and a primary cardiac involvement.. Default Record. 2014;1$$$$F$Y$$$20240926$$HP$FR$FR
243651531$24365153$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005335$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243651551$24365155$1$I$$20240912$20240926$20240926$PER$$US-APOTEX-2024AP010998$APOTEX$Chen CB, Badri M, Kelly E.. Case report: dyslipidaemia-dramatic increase in haemoglobin A1c following statin initiation. European Heart Journal - Case Reports. 2024;8 (8):ytae436 (1-3)$52$YR$$M$Y$$$20240926$$MD$US$US
243651571$24365157$1$I$$20240924$20240926$20240926$PER$GB-MHRA-MED-202409241449055030-ZYPRD$GB-IDORSIA-008517-2024-GB$IDORSIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$MD$GB$GB
243651581$24365158$1$I$20240221$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046576$AUROBINDO$$80$YR$$M$Y$79$KG$20240926$$MD$FR$FR
243651592$24365159$2$F$20240505$20240923$20240926$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US057352$SANDOZ$$$$$F$Y$$$20240926$$CN$US$US
243651601$24365160$1$I$$20240924$20240926$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE082483$SANDOZ$$$$$F$Y$$$20240926$$CN$DE$DE
243651611$24365161$1$I$$20240920$20240926$20240926$EXP$$CA-ABBVIE-5933775$ABBVIE$$$$A$F$Y$$$20240926$$CN$CA$CA
243651621$24365162$1$I$$20240924$20240926$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE082560$SANDOZ$$$$A$$Y$$$20240926$$HP$DE$DE
243651641$24365164$1$I$20240412$20240916$20240926$20240926$EXP$$ES-AUROBINDO-AUR-APL-2024-046641$AUROBINDO$$83$YR$$F$Y$$$20240926$$MD$ES$ES
243651651$24365165$1$I$20240917$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015395$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240926$$CN$US$US
243651661$24365166$1$I$20240923$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015327$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240926$$CN$US$US
243651671$24365167$1$I$20240919$20240919$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014545$ELI LILLY AND CO$$$$E$F$Y$$$20240926$$CN$US$US
243651681$24365168$1$I$20240101$20240827$20240926$20240926$PER$$US-009507513-2408USA009882$MERCK$$$$$$Y$$$20240926$$CN$US$US
243651691$24365169$1$I$$20240923$20240926$20240926$EXP$$CA-TAKEDA-2024TUS094866$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
243651701$24365170$1$I$20240901$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152166$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240926$$CN$US$US
243651711$24365171$1$I$20231113$20240923$20240926$20240926$EXP$$MY-SANDOZ INC.-SDZ2023MY056613$SANDOZ$$59$YR$$M$Y$73.5$KG$20240926$$MD$MY$MY
243651721$24365172$1$I$20230101$20240920$20240926$20240926$EXP$ES-AEMPS-1503565$ES-TAKEDA-2024TUS094503$TAKEDA$$$$A$F$Y$$$20240926$$HP$ES$ES
243651741$24365174$1$I$20240101$20240920$20240926$20240926$EXP$$US-ABBVIE-5933607$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243651751$24365175$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5936050$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243651761$24365176$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000091259$ROCHE$$75$YR$E$F$Y$$$20240926$$HP$US$US
243651771$24365177$1$I$20230414$20240919$20240926$20240926$EXP$$HR-ABBVIE-5933809$ABBVIE$$67$YR$$F$Y$$$20240926$$MD$HR$HR
243651781$24365178$1$I$20230527$20240917$20240926$20240926$EXP$FR-AFSSAPS-TS2023000742$FR-CELLTRION INC.-2024FR022540$CELLTRION$$$$$$Y$$$20240926$$PH$FR$FR
243651801$24365180$1$I$$20240923$20240926$20240926$EXP$$US-ROCHE-10000089468$ROCHE$$$$A$M$Y$$$20240926$$CN$US$US
243651811$24365181$1$I$$20240918$20240926$20240926$EXP$$CA-SANDOZ INC.-SDZ2023CA028290$SANDOZ$$$$$M$Y$$$20240926$$CN$CA$CA
243651821$24365182$1$I$20240728$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046574$AUROBINDO$$56$YR$$M$Y$70$KG$20240926$$MD$FR$FR
243651831$24365183$1$I$20240126$20240906$20240926$20240926$EXP$IT-MINISAL02-977113$IT-CELLTRION INC.-2024IT022783$CELLTRION$$$$$$Y$$$20240926$$MD$IT$IT
243651841$24365184$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5936869$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243651852$24365185$2$F$$20240925$20240926$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US035553$SANDOZ$$$$$M$Y$$$20240929$$CN$US$US
243651861$24365186$1$I$20240921$20240924$20240926$20240926$EXP$$US-ABBVIE-5937386$ABBVIE$$78$YR$$M$Y$$$20240926$$CN$US$US
243651871$24365187$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151603$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$108.41$KG$20240926$$CN$US$US
243651881$24365188$1$I$20240101$20240923$20240926$20240926$EXP$$US-ABBVIE-5936009$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243651891$24365189$1$I$20240606$20240923$20240926$20240926$EXP$FR-AFSSAPS-TO2024001192$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-152169$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240926$$PH$FR$FR
243651901$24365190$1$I$20240829$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046657$AUROBINDO$$68$YR$$F$Y$$$20240926$$MD$FR$FR
243651911$24365191$1$I$20231025$20240916$20240926$20240926$EXP$$DE-AUROBINDO-AUR-APL-2023-067794$AUROBINDO$$58$YR$$M$Y$56$KG$20240926$$MD$DE$DE
243651921$24365192$1$I$20240810$20240923$20240926$20240926$EXP$$AR-ABBVIE-5935536$ABBVIE$$61$YR$$F$Y$$$20240926$$CN$AR$AR
243651931$24365193$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5936666$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243651951$24365195$1$I$$20240923$20240926$20240926$PER$$US-JNJFOC-20240962828$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$MD$US$US
243651961$24365196$1$I$20240807$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005350$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240926$$CN$US$US
243651971$24365197$1$I$20240324$20240919$20240926$20240926$EXP$FR-AFSSAPS-TO2024001731$FR-TEVA-VS-3245823$TEVA$$75$YR$$M$Y$$$20240926$$PH$FR$FR
243651981$24365198$1$I$$20240924$20240926$20240926$PER$$US-HALEON-2198662$Haleon PLC$$$$$$Y$$$20240926$$CN$US$US
243651991$24365199$1$I$$20240924$20240926$20240926$PER$$NVSC2024US191127$NOVARTIS$$64$YR$$F$Y$105$KG$20240926$$PH$US$US
243652001$24365200$1$I$20230901$20240911$20240926$20240926$EXP$CZ-CZSUKL-24000785$CZ-CELLTRION INC.-2024CZ022866$CELLTRION$$$$$$Y$$$20240926$$MD$CZ$CZ
243652011$24365201$1$I$20240806$20240916$20240926$20240926$EXP$$BR-Accord-447618$ACCORD$$9$YR$C$M$Y$38$KG$20240926$$PH$BR$BR
243652021$24365202$1$I$$20240902$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005256$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243652031$24365203$1$I$20240919$20240923$20240926$20240926$EXP$$AR-ABBVIE-5935585$ABBVIE$$61$YR$$F$Y$$$20240926$$CN$AR$AR
243652041$24365204$1$I$20240923$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152567$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240926$$CN$US$US
243652061$24365206$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152362$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240926$$HP$US$US
243652081$24365208$1$I$$20240924$20240926$20240926$PER$$US-ABBVIE-5939295$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243652091$24365209$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005338$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243652101$24365210$1$I$20240101$20240917$20240926$20240926$EXP$$US-TEVA-VS-3246225$TEVA$$30$YR$$M$Y$77.4$KG$20240926$$CN$US$US
243652111$24365211$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960314$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20240926$$MD$US$US
243652121$24365212$1$I$$20240924$20240926$20240926$EXP$$US-GILEAD-2024-0682970$GILEAD$$$$E$F$Y$$$20240926$$CN$US$US
243652141$24365214$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005340$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243652151$24365215$1$I$$20240917$20240926$20240926$EXP$$IT-CELLTRION INC.-2024IT022813$CELLTRION$Accardo V, Pagnini I, Maccora I, et.al.. Safety and efficacy of biologic immunosuppressive treatment in juvenile idiopathic arthritis associated with inborn errors of immunity. Frontiers in Pediatrics. 2024;12:1-5$$$$$Y$$$20240926$$HP$IT$IT
243652171$24365217$1$I$$20240910$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09078$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243652181$24365218$1$I$20240701$20240913$20240926$20240926$EXP$$CA-ABBVIE-5938388$ABBVIE$$77$YR$$M$Y$$$20240926$$MD$CA$CA
243652191$24365219$1$I$20240916$20240919$20240926$20240926$EXP$$AR-BIOGEN-2024BI01283617$BIOGEN$$71$YR$$F$Y$$$20240926$$CN$AR$AR
243652201$24365220$1$I$20240902$20240914$20240926$20240926$EXP$$CN-NOVAST LABORATORIES INC.-2024NOV000303$NOVAST$$$$$$Y$$$20240926$$HP$CN$CN
243652211$24365221$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005246$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243652221$24365222$1$I$$20240919$20240926$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005732$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243652231$24365223$1$I$20240901$20240920$20240926$20240926$EXP$$US-ABBVIE-5933687$ABBVIE$$82$YR$$M$Y$$$20240926$$CN$US$US
243652241$24365224$1$I$20240916$20240916$20240926$20240926$PER$$US-GSK-US2024114878$GLAXOSMITHKLINE$$30$YR$$F$Y$$$20240926$$CN$US$US
243652251$24365225$1$I$20240101$20240919$20240926$20240926$EXP$$IE-EMD Serono-2024050661$EMD SERONO INC$$16$YR$T$M$Y$$$20240926$$CN$IE$IE
243652261$24365226$1$I$20240809$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046800$AUROBINDO$$78$YR$$F$Y$$$20240926$$MD$FR$FR
243652271$24365227$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000091055$ROCHE$$$$T$F$Y$$$20240926$$CN$US$US
243652281$24365228$1$I$$20240919$20240926$20240926$EXP$$US-PADAGIS-2024PAD01513$PADAGIS$$$$$$Y$$$20240926$$MD$US$US
243652291$24365229$1$I$$20240919$20240926$20240926$EXP$$US-PADAGIS-2024PAD01524$PADAGIS$$$$$$Y$$$20240926$$HP$US$US
243652301$24365230$1$I$20240918$20240920$20240926$20240926$EXP$$US-PADAGIS-2024PAD01529$PADAGIS$$$$$$Y$$$20240926$$CN$US$US
243652311$24365231$1$I$20240814$20240912$20240926$20240926$EXP$$US-PADAGIS-2024PAD01488$PADAGIS$$$$$$Y$$$20240926$$CN$US$US
243652321$24365232$1$I$$20240924$20240926$20240926$PER$$US-HALEON-2198624$Haleon PLC$$$$$$Y$$$20240926$$CN$US$US
243652331$24365233$1$I$$20240919$20240926$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005787$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$HP$US$US
243652341$24365234$1$I$20240101$20240920$20240926$20240926$EXP$$US-ABBVIE-5933110$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243652351$24365235$1$I$20240701$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005341$ACADIA PHARMACEUTICALS$$68$YR$$F$Y$$$20240926$$CN$US$US
243652381$24365238$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152058$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240926$$CN$US$US
243652391$24365239$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152176$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240926$$HP$US$US
243652401$24365240$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152312$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240926$$CN$US$US
243652411$24365241$1$I$20240901$20240920$20240926$20240926$PER$$US-GSK-US2024117168$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$MD$US$US
243652421$24365242$1$I$20240501$20240918$20240926$20240926$PER$$NVSC2024US191070$NOVARTIS$$47$YR$$F$Y$$$20240926$$CN$US$US
243652431$24365243$1$I$20240701$20240917$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409011412$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240926$$CN$US$US
243652451$24365245$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005371$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243652461$24365246$1$I$20230701$20240917$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409011155$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240926$$CN$US$US
243652471$24365247$1$I$20240801$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005285$ACADIA PHARMACEUTICALS$$2$YR$$F$Y$$$20240926$$CN$US$US
243652481$24365248$1$I$20240101$20240917$20240926$20240926$EXP$$US-RECORDATI-2024007326$RECORDATI$$$$$$Y$$$20240926$$CN$US$US
243652501$24365250$1$I$$20240923$20240926$20240926$PER$$US-HALEON-2198643$Haleon PLC$CHITRASK RK, SANCHEZJUAN, BRAHMAKULAMFG. BARBELL BLUES: A CASE OF POST-DEADLIFT PNEUMOTHORAX. Chest; 166(4 Supplement): A3763. DOI: 10.1016/j.chest.2024.06.2255.; RAJESHKUMARCHITRASK, SANCHEZJUAN, BRAHMAKULAMFG. BARBELL BLUES: A CASE OF POST-?DEAD?LIFT PNEUMOTHORAX.?Chest?.#PY#;166(4 Supplement):A3763.?https://dx.doi.org/10.1016/j.chest.2024.06.2255$16$YR$$M$Y$$$20240926$$HP$US$US
243652511$24365251$1$I$$20240924$20240926$20240926$EXP$$KZ-TAKEDA-2024TUS095040$TAKEDA$$73$YR$$F$Y$$$20240926$$CN$KZ$KZ
243652521$24365252$1$I$20240813$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046841$AUROBINDO$$40$YR$$M$Y$62.8$KG$20240926$$MD$FR$FR
243652531$24365253$1$I$$20240916$20240926$20240926$PER$$US-JNJFOC-20240944119$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243652541$24365254$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024007015$BIOCON$$$$$$Y$$$20240926$$CN$CA$CA
243652551$24365255$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005374$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243652561$24365256$1$I$20240823$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046888$AUROBINDO$$$$A$M$Y$$$20240926$$PH$FR$FR
243652572$24365257$2$F$20240601$20240917$20240926$20240926$PER$$US-ROCHE-10000084893$ROCHE$$90$YR$E$M$Y$71.7$KG$20240926$$CN$US$US
243652581$24365258$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3246184$TEVA$Salk G, Onkarappa Mangala Y, David Onukogu I, Meleveedu K. CML-751 Clonal Competition Between JAK2 and BCR-ABL in Myeloproliferative Neoplasm. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl. 1) S384.$67$YR$$M$Y$$$20240926$$MD$US$US
243652601$24365260$1$I$20240806$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046795$AUROBINDO$$31$YR$$F$Y$41.5$KG$20240926$$PH$FR$FR
243652611$24365261$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960536$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240926$$MD$US$US
243652621$24365262$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011029$APOTEX$$$$$M$Y$78$KG$20240926$$HP$CA$CA
243652641$24365264$1$I$20240912$20240923$20240926$20240926$EXP$$US-ABBVIE-5937382$ABBVIE$$76$YR$$M$Y$$$20240926$$CN$US$US
243652651$24365265$1$I$$20240913$20240926$20240926$EXP$$US-GILEAD-2024-0684308$GILEAD$$$$C$F$Y$$$20240926$$CN$US$US
243652661$24365266$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005373$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243652671$24365267$1$I$$20240918$20240926$20240926$EXP$$US-TAKEDA-2024TUS093076$TAKEDA$$$$$F$Y$64$KG$20240926$$CN$US$US
243652681$24365268$1$I$20240917$20240917$20240926$20240926$EXP$$CA-TAKEDA-2024TUS021189$TAKEDA$$35$YR$$F$Y$$$20240926$$HP$CA$CA
243652691$24365269$1$I$$20240919$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-029066$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240926$$$US$US
243652701$24365270$1$I$$20240919$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-029898$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240926$$$US$US
243652711$24365271$1$I$$20240914$20240926$20240926$EXP$$CN-ROCHE-10000015632$ROCHE$$70$YR$E$M$Y$$$20240926$$CN$CN$CN
243652721$24365272$1$I$$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151164$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240926$$CN$US$US
243652731$24365273$1$I$$20240920$20240926$20240926$PER$$US-TAKEDA-2024TUS094348$TAKEDA$$16$YR$$M$Y$$$20240926$$CN$US$US
243652741$24365274$1$I$$20240920$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-030034$UNITED THERAPEUTICS$$$$$M$Y$52.608$KG$20240926$$$US$US
243652751$24365275$1$I$20240830$20240916$20240926$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005623$ACADIA PHARMACEUTICALS$$9$YR$$F$Y$$$20240926$$CN$US$US
243652761$24365276$1$I$$20240916$20240926$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005646$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$HP$US$US
243652771$24365277$1$I$$20240920$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015911$JAZZ$$$$$M$Y$$$20240926$$CN$US$US
243652781$24365278$1$I$20240729$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046846$AUROBINDO$$26$YR$$F$Y$48$KG$20240926$$MD$FR$FR
243652801$24365280$1$I$$20240918$20240926$20240926$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08770$HIKMA$Jones J, Mallory P.. Jones J, Mallory P. Ventilation/Perfusion Mismatch in a Child Following Cocaine Ingestion: Case Report.. SN Comprehensive Clinical Medicine. 2024;6(1):92$19$MON$$M$Y$11.5$KG$20240926$$MD$US$US
243652811$24365281$1$I$20240101$20240923$20240926$20240926$EXP$$US-ABBVIE-5936144$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243652821$24365282$1$I$$20240917$20240926$20240926$EXP$$CA-ROCHE-10000084818$ROCHE$$$$E$F$Y$$$20240926$$CN$CA$CA
243652831$24365283$1$I$$20240916$20240926$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005662$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243652851$24365285$1$I$20240801$20240924$20240926$20240926$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-151652$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$68.49$KG$20240926$$CN$PR$PR
243652861$24365286$1$I$20240820$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046844$AUROBINDO$$35$YR$$M$Y$72$KG$20240926$$PH$FR$FR
243652881$24365288$1$I$20180701$20240913$20240926$20240926$EXP$GB-MHRA-MED-202409121632016080-FNSLB$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21684$ALKEM$$70$YR$$M$Y$115$KG$20240926$$CN$GB$GB
243652901$24365290$1$I$20230910$20240913$20240926$20240926$EXP$GB-MHRA-MED-202409092211043050-VNYST$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21674$ALKEM$$62$YR$$M$Y$$$20240926$$MD$GB$GB
243652931$24365293$1$I$$20240923$20240926$20240926$PER$$US-ROCHE-10000089866$ROCHE$$87$YR$E$M$Y$$$20240926$$CN$US$US
243652951$24365295$1$I$$20240913$20240926$20240926$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-05983$ALKEM$Weise J, Schomerus G and Speerforck S. Add-on Cariprazine in Patients with Long-term Clozapine Treatment and Treatment Resistant Schizophrenia: Two Cases of Psychotic Deterioration and Pisa Syndrome. Clinical Psychopharmacology and Neuroscience. 2022;20(2):398-401$41$YR$$F$Y$$$20240926$$HP$DE$DE
243652971$24365297$1$I$20240912$20240913$20240926$20240926$EXP$GB-MHRA-TPP8092725C11764064YC1726158115206$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21690$ALKEM$$47$YR$$F$Y$69$KG$20240926$$MD$GB$GB
243652981$24365298$1$I$20240916$20240916$20240926$20240926$PER$$US-GSK-US2024114966$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
243652991$24365299$1$I$20240717$20240913$20240926$20240926$EXP$GB-MHRA-TPP12177260C9106323YC1726069479678$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21691$ALKEM$$27$YR$$M$Y$96$KG$20240926$$MD$GB$GB
243653001$24365300$1$I$20240822$20240916$20240926$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005667$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240926$$CN$US$US
243653011$24365301$1$I$$20240913$20240926$20240926$EXP$$CL-FDC-2024CLLIT00724$FDC LIMITED$Alberto fica.Infectious disease evaluations in a psychiatric unit, an observational study.Revista Medica de Chile.OCT-2023;151:1271-1280$$$$$Y$$$20240926$$HP$CL$CL
243653021$24365302$1$I$20240918$20240918$20240926$20240926$EXP$$CA-BEH-2024174904$CSL BEHRING$$68$YR$E$F$Y$74$KG$20240926$$CN$CA$CA
243653041$24365304$1$I$$20240915$20240926$20240926$EXP$$GB-VKT-000592$VKT PHARMA PRIVATE LIMITED$$$$A$M$Y$$$20240917$$MD$GB$GB
243653051$24365305$1$I$$20240916$20240926$20240926$EXP$CA-MHPD-001093820$CA-Accord-447159$ACCORD$$70$YR$E$M$Y$62$KG$20240926$$HP$CA$CA
243653061$24365306$1$I$$20240920$20240926$20240926$EXP$$NVSC2024US046943$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
243653071$24365307$1$I$20240101$20240920$20240926$20240926$EXP$$US-ABBVIE-5933780$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243653081$24365308$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014786$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240926$$CN$US$US
243653091$24365309$1$I$20240923$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014241$ELI LILLY AND CO$$74$YR$E$$Y$$$20240926$$CN$US$US
243653101$24365310$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015580$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240926$$CN$US$US
243653111$24365311$1$I$20240920$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015575$ELI LILLY AND CO$$49$YR$A$$Y$$$20240926$$CN$US$US
243653121$24365312$1$I$$20240921$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015618$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240926$$MD$US$US
243653131$24365313$1$I$20240921$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015167$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240926$$CN$US$US
243653151$24365315$1$I$$20240917$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148599$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240926$$CN$US$US
243653161$24365316$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152328$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$62.6$KG$20240926$$CN$US$US
243653171$24365317$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152526$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240926$$CN$US$US
243653181$24365318$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152418$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240926$$CN$US$US
243653191$24365319$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152203$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$125.19$KG$20240926$$CN$US$US
243653201$24365320$1$I$$20240910$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09082$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243653211$24365321$1$I$$20240918$20240926$20240926$EXP$$CA-TAKEDA-2024TUS093537$TAKEDA$$$$$M$Y$101.8$KG$20240926$$HP$CA$CA
243653221$24365322$1$I$$20240917$20240926$20240926$EXP$$US-ROCHE-10000084060$ROCHE$Sharma M, Stevens S, Maeng M, Nagornaya N, Bhatia R, Wester S. Erdheim-Chester Disease With Eyelid and Orbital Involvement: A Review of Treatment Modalities at One Institution From 2014 to 2022. Ophthalmic plastic and reconstructive surgery. 2024-Sep-01;40 (5):497-503. doi:10.1097/IOP.0000000000002619.$35$YR$A$$Y$$$20240926$$HP$US$US
243653231$24365323$1$I$20220101$20240917$20240926$20240926$EXP$$CA-CELLTRION INC.-2024CA022626$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243653241$24365324$1$I$20240801$20240924$20240926$20240926$EXP$$US-TAKEDA-2024TUS095083$TAKEDA$$29$YR$$M$Y$$$20240926$$MD$US$US
243653251$24365325$1$I$20240905$20240910$20240926$20240926$PER$$TR-TOLMAR, INC.-24TR052553$TOLMAR$$78$YR$$M$Y$$$20240926$$HP$TR$TR
243653261$24365326$1$I$20240214$20240917$20240926$20240926$EXP$IT-MINISAL02-978197$IT-CELLTRION INC.-2024IT022879$CELLTRION$$$$$$Y$$$20240926$$MD$IT$IT
243653271$24365327$1$I$20240208$20240719$20240926$20240926$EXP$$KR-JNJFOC-20240963210$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20240926$$MD$KR$KR
243653291$24365329$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151830$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240926$$HP$US$US
243653301$24365330$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152056$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240926$$CN$US$US
243653321$24365332$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152038$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240926$$CN$US$US
243653331$24365333$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152152$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240926$$CN$US$US
243653341$24365334$1$I$$20240925$20240926$20240926$EXP$$CA-HALEON-2198564$Haleon PLC$$43$YR$$M$Y$$$20240926$$HP$CA$CA
243653351$24365335$1$I$$20240917$20240926$20240926$EXP$$US-TAKEDA-2023TUS098145$TAKEDA$$$$$F$Y$$$20240926$$HP$US$US
243653361$24365336$1$I$$20240917$20240926$20240926$EXP$$US-EMD Serono-2024050091$EMD SERONO INC$$$$E$F$Y$$$20240926$$CN$US$US
243653371$24365337$1$I$$20240920$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015791$JAZZ$$$$$M$Y$$$20240926$$CN$US$US
243653381$24365338$1$I$$20240920$20240926$20240926$EXP$$JP-ROCHE-10000090565$ROCHE$$$$A$F$Y$$$20240926$$MD$JP$JP
243653391$24365339$1$I$20230331$20240919$20240926$20240926$EXP$FR-AFSSAPS-AN2024001256$FR-TEVA-VS-3246174$TEVA$$81$YR$$F$Y$$$20240926$$PH$FR$FR
243653401$24365340$1$I$20240601$20240919$20240926$20240926$EXP$$IN-CIPLA LTD.-2024IN10497$CIPLA$$$$$$Y$$$20240926$$MD$IN$IN
243653411$24365341$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005375$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243653421$24365342$1$I$$20240918$20240926$20240926$EXP$$US-JNJFOC-20240953753$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243653431$24365343$1$I$$20240919$20240926$20240926$EXP$$US-EXELIXIS-EXL-2024-000408$EXELIXIS$$$$$M$Y$$$20240926$$CN$US$US
243653441$24365344$1$I$$20240918$20240926$20240926$PER$$US-BEH-2024179113$CSL BEHRING$$$$$M$Y$$$20240926$$HP$US$US
243653451$24365345$1$I$$20240910$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09090$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243653461$24365346$1$I$$20240919$20240926$20240926$EXP$$JP-EXELIXIS-EXL-2024-000413$EXELIXIS$$67$YR$$M$Y$$$20240926$$PH$JP$JP
243653481$24365348$1$I$$20240919$20240926$20240926$EXP$$JP-EXELIXIS-EXL-2024-000515$EXELIXIS$$8$DEC$$M$Y$$$20240926$$MD$JP$JP
243653491$24365349$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005376$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243653501$24365350$1$I$20240901$20240920$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015788$JAZZ$$38$YR$$F$Y$$$20240926$$CN$US$US
243653521$24365352$1$I$20220107$20240913$20240926$20240926$EXP$$CA-ROCHE-2999297$ROCHE$$29$YR$A$F$Y$$$20240926$$HP$CA$CA
243653531$24365353$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005327$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243653541$24365354$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005326$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243653551$24365355$1$I$20240701$20240918$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046403$AUROBINDO$$66$YR$$M$Y$68.5$KG$20240926$$MD$FR$FR
243653561$24365356$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005336$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243653571$24365357$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005378$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243653581$24365358$1$I$20240901$20240916$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024114866$VIIV$$29$YR$$M$Y$$$20240926$$CN$US$US
243653591$24365359$1$I$20240501$20240916$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR115718$VIIV$$36$YR$$M$Y$$$20240926$$HP$US$US
243653601$24365360$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005339$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243653611$24365361$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3246126$TEVA$Wang M, Reynolds KL, Montazeri K, Schaefer EA, Sullivan RJ, Dougan M. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clin-Gastroenterol-Hepatol 2024; 22 (7): 1539-1541.e2.; Wang M, Reynolds KL, Montazeri K, Schaefer EA, Sullivan RJ, Dougan M. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clin-Gastroenterol-Hepatol 2024; 22 (7): 1539-1541.e2.$61$YR$$F$Y$$$20240926$$HP$US$US
243653621$24365362$1$I$$20240924$20240926$20240926$EXP$$AT-SANDOZ INC.-SDZ2024AT082754$SANDOZ$$54$YR$$M$Y$$$20240926$$MD$AT$AT
243653641$24365364$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005382$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243653651$24365365$1$I$20240420$20240923$20240926$20240926$EXP$$US-ROCHE-10000089437$ROCHE$$66$YR$E$M$Y$68.03$KG$20240926$$CN$US$US
243653661$24365366$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011351$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243653671$24365367$1$I$$20240910$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09102$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243653681$24365368$1$I$$20240922$20240926$20240926$PER$$US-JNJFOC-20240963924$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243653691$24365369$1$I$$20240923$20240926$20240926$EXP$$CA-JNJFOC-20240965765$JOHNSON AND JOHNSON$$22$YR$A$F$Y$59.02$KG$20240926$$CN$CA$CA
243653701$24365370$1$I$$20240918$20240926$20240926$EXP$$GB-JNJFOC-20240960051$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240926$$CN$GB$GB
243653711$24365371$1$I$$20240917$20240926$20240926$EXP$$BE-JNJFOC-20240957424$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240926$$MD$BE$BE
243653721$24365372$1$I$$20240917$20240926$20240926$PER$$US-ROCHE-10000086169$ROCHE$$$$$$Y$$$20240926$$MD$US$US
243653731$24365373$1$I$20240806$20240917$20240926$20240926$EXP$$CA-CELLTRION INC.-2024CA022632$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243653741$24365374$1$I$20230601$20240922$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-047145$AUROBINDO$$$$$$Y$$$20240926$$CN$GB$GB
243653751$24365375$1$I$20240101$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152561$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240926$$HP$US$US
243653761$24365376$1$I$$20240923$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-047306$AUROBINDO$$$$$F$Y$$$20240926$$MD$GB$GB
243653771$24365377$1$I$$20240922$20240926$20240926$PER$$NVSC2024US188993$NOVARTIS$$$$$$Y$$$20240926$$CN$US$US
243653781$24365378$1$I$$20240911$20240926$20240926$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112293$ZYDUS PHARM$Sasidharan Pillai S, Robilliard R, Fredette ME, Serrano-Gonzalez M, Scully KJ.. Persistent hypercalcemia mimicking hypophosphatasia after discontinuation of a ketogenic diet: a case report.. J-Pediatr-Endocrinol-Metab. 2023;36 (11):1109-1113$$$$$Y$$$20240926$$HP$US$US
243653791$24365379$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000090493$ROCHE$$$$A$M$Y$92.53$KG$20240926$$CN$US$US
243653801$24365380$1$I$20210709$20240917$20240926$20240926$EXP$$CA-CELLTRION INC.-2021CA010483$CELLTRION$$$$$$Y$$$20240926$$MD$CA$CA
243653811$24365381$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005310$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243653831$24365383$1$I$20230929$20240917$20240926$20240926$PER$$US-RDY-OTH/USA/23/0181892$DR REDDYS$$68$YR$E$M$Y$$$20240926$$MD$US$US
243653841$24365384$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005383$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243653861$24365386$1$I$20230725$20240920$20240926$20240926$EXP$$US-CHATTEMPRD-2024OHG033027$CHATTEM$$$$T$M$Y$$$20240926$$LW$US$US
243653871$24365387$1$I$20240808$20240917$20240926$20240926$EXP$$CA-JNJFOC-20240852972$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240926$$HP$CA$CA
243653881$24365388$1$I$20240901$20240923$20240926$20240926$EXP$$IN-ROCHE-10000089914$ROCHE$$68$YR$E$M$Y$$$20240926$$CN$IN$IN
243653891$24365389$1$I$20240101$20240923$20240926$20240926$PER$$US-BIOGEN-2024BI01256661$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243653901$24365390$1$I$20050218$20240925$20240926$20240926$EXP$$DE-ABBVIE-5938313$ABBVIE$$59$YR$$M$Y$$$20240926$$MD$DE$DE
243653911$24365391$1$I$20240827$20240920$20240926$20240926$EXP$FR-AFSSAPS-AVCF2024000588$FR-TEVA-VS-3246568$TEVA$$41$YR$$F$Y$$$20240926$$HP$FR$FR
243653921$24365392$1$I$$20240919$20240926$20240926$EXP$$BE-ROCHE-10000087801$ROCHE$$$$$$Y$$$20240926$$MD$BE$BE
243653931$24365393$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152060$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240926$$HP$US$US
243653941$24365394$1$I$$20240917$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148807$BRISTOL MYERS SQUIBB$Weiss ME, Perzia BM, Sinard JH, Tran TT, Maeng MM. Primary treatment of eyelid conjunctival melanoma with immunotherapy: a case report. Ophthalmic Plastic and Reconstructive Surgery. 2024 Sep 06;e1-4.doi:10.1097/IOP.0000000000002776.$59$YR$A$M$Y$$$20240926$$HP$US$US
243653961$24365396$1$I$20240101$20240917$20240926$20240926$EXP$$CA-CELLTRION INC.-2024CA022004$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243653971$24365397$1$I$$20240923$20240926$20240926$EXP$$US-ROCHE-10000089681$ROCHE$$37$YR$A$F$Y$$$20240926$$CN$US$US
243653991$24365399$1$I$$20240920$20240926$20240926$EXP$$NVSC2024DE190203$NOVARTIS$$$$$$Y$$$20240926$$MD$DE$DE
243654001$24365400$1$I$$20240923$20240926$20240926$EXP$$US-SA-2024SA276133$SANOFI AVENTIS$DURDEVIC M, MORKEVICIUS M, DURDEVIC D, GRUEN D, JEVTIC D, LEKIC I et al.. ACUTE RESPIRATORY FAILURE DUE TO OCCULT INTRABRONCHIAL HEMORRHAGE.. Chest.. 2024;166(4):A4434-5.$75$YR$E$M$Y$$$20240926$$HP$US$US
243654011$24365401$1$I$$20240912$20240926$20240926$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112366$ZYDUS PHARM$Pacilio RM, Dalack GW. Asthma and Atypical Antipsychotics: A Systematic Literature Review and Case Report of Respiratory Side Effects with Lurasidone, Cariprazine, and Lumateperone. J-Clin- Psychopharmacol. 2024;44(4):436-437$$$$$Y$$$20240926$$MD$US$US
243654021$24365402$1$I$$20240920$20240926$20240926$EXP$$US-JNJFOC-20240962715$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243654031$24365403$1$I$$20240917$20240926$20240926$PER$$US-JNJFOC-20240953735$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243654041$24365404$1$I$$20240918$20240926$20240926$EXP$$GB-ROCHE-10000087005$ROCHE$$$$E$F$Y$$$20240926$$CN$GB$GB
243654051$24365405$1$I$$20240923$20240926$20240926$PER$$US-BIOGEN-2024BI01259318$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243654061$24365406$1$I$20240919$20240920$20240926$20240926$EXP$GB-MHRA-MED-202409201232237680-FYSQB$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-08846$HIKMA$$$$$$Y$$$20240926$$MD$GB$GB
243654071$24365407$1$I$$20240918$20240926$20240926$PER$$US-ROCHE-10000085911$ROCHE$$$$$$Y$$$20240926$$HP$US$US
243654081$24365408$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152336$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240926$$CN$US$US
243654101$24365410$1$I$$20240912$20240926$20240926$EXP$$US-GRAVITIPHARMA-GRA-2409-US-LIT-0407$GRAVITI PHARMACEUTICALS$Snipes GM, Hafeez A, Marek G, Winchester DE.Sinus bradycardia with haemodynamic compromise following lithium intoxication.BMJ-Case-Rep .2021;14:e242946:1 to 4$7$DEC$$M$Y$$$20240926$$MD$US$US
243654111$24365411$1$I$$20240423$20240926$20240926$PER$US-MLMSERVICE-20240415-PI027300-00251-1$US-STRIDES ARCOLAB LIMITED-2024SP004787$STRIDES$Wright M, Rosenblum D.. Use of dicyclomine and mirabegron in neurogenic detrusor overactivity following traumatic spinal cord injury: a case report.. Archives of Physical Medicine and Rehabilitation. 2024;105 (4):e191$42$YR$$M$Y$$$20240926$$HP$US$US
243654121$24365412$1$I$$20240923$20240926$20240926$EXP$$UA-ROCHE-10000089879$ROCHE$$37$YR$A$M$Y$$$20240926$$MD$UA$UA
243654131$24365413$1$I$20240401$20240919$20240926$20240926$EXP$DE-PEI-CADR2024330603$DE-STALCOR-2024-AER-02133$Unknown Manufacturer$$8$YR$C$M$Y$28$KG$20240926$$MD$DE$DE
243654141$24365414$1$I$$20240919$20240926$20240926$EXP$$CA-GSK-CA2024005596$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$CA$CA
243654151$24365415$1$I$20240701$20240919$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-047133$AUROBINDO$$89$YR$$F$Y$$$20240926$$PH$FR$FR
243654161$24365416$1$I$$20240924$20240926$20240926$EXP$$CA-SANDOZ INC.-NVSC2023CA056213$SANDOZ$$$$$M$Y$$$20240926$$CN$CA$CA
243654171$24365417$1$I$20240101$20240918$20240926$20240926$PER$$US-JNJFOC-20240959764$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240926$$CN$US$US
243654181$24365418$1$I$$20240912$20240926$20240926$EXP$$CA-UCBSA-2024047320$UCB$$$$$F$Y$$$20240926$$CN$CA$CA
243654191$24365419$1$I$$20240917$20240926$20240926$PER$$US-STRIDES ARCOLAB LIMITED-2024SP012175$STRIDES$Huang J, Shah N, Bailon R, Trammel S.. Chronic Penile Pain: A Poorly Researched and Managed Life-Debilitating Condition. Cureus. 2023;15(12):e49776$37$YR$$M$Y$$$20240926$$HP$US$US
243654201$24365420$1$I$20240222$20240905$20240926$20240926$EXP$FR-AFSSAPS-CN2024000300$FR-CELLTRION INC.-2024FR022778$CELLTRION$$$$$$Y$$$20240926$$MD$FR$FR
243654211$24365421$1$I$$20240924$20240926$20240926$EXP$$SA-TAKEDA-2024TUS095036$TAKEDA$$$$$$Y$$$20240926$$MD$SA$SA
243654221$24365422$1$I$$20240916$20240926$20240926$EXP$$ES-ROCHE-10000087791$ROCHE$Somovilla A, Aguirre C, Gallego M, Vivancos J. Organizing Pneumonia in Multiple Sclerosis Patients Treated with Ocrelizumab following SARS-CoV-2 Infection: A Case Series Report [Abstract No: P1153/2242]. Multiple Sclerosis Journal. 2024;30 (3S):681-1137.$49$YR$A$M$Y$$$20240926$$HP$ES$ES
243654231$24365423$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006966$BIOCON$$$$$$Y$$$20240926$$HP$CA$CA
243654241$24365424$1$I$20240831$20240920$20240926$20240926$EXP$FR-AFSSAPS-AVCF2024000593$FR-TEVA-VS-3246149$TEVA$$51$YR$$F$Y$$$20240926$$HP$FR$FR
243654251$24365425$1$I$20240208$20240917$20240926$20240926$EXP$$DE-ROCHE-3525872$ROCHE$$39$YR$A$F$Y$$$20240926$$CN$DE$DE
243654261$24365426$1$I$$20240919$20240926$20240926$EXP$$CO-TAKEDA-2024TUS094725$TAKEDA$$$$$F$Y$10$KG$20240926$$CN$CO$CO
243654271$24365427$1$I$$20240918$20240926$20240926$EXP$$JP-NOVITIUMPHARMA-2024JPNVP01988$NOVITIUM PHARMA$Chiho Furuya.Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases.Frontiers in Immunology.25-JAN-2024;15:1-5$78$YR$E$M$Y$$$20240926$$HP$JP$JP
243654281$24365428$1$I$$20240912$20240926$20240926$EXP$$US-GRAVITIPHARMA-GRA-2409-US-LIT-0413$GRAVITI PHARMACEUTICALS$$70$YR$E$M$Y$$$20240926$$HP$US$US
243654291$24365429$1$I$$20240923$20240926$20240926$EXP$$CA-TAKEDA-2024TUS086078$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
243654301$24365430$1$I$20240101$20240917$20240926$20240926$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-029617$UNITED THERAPEUTICS$$58$YR$$F$Y$$$20240926$$$JP$JP
243654311$24365431$1$I$$20240918$20240926$20240926$EXP$$US-TAKEDA-2024TUS093370$TAKEDA$$$$$M$Y$105$KG$20240926$$CN$US$US
243654321$24365432$1$I$$20240923$20240926$20240926$EXP$$CA-TAKEDA-2024TUS094844$TAKEDA$$$$$F$Y$$$20240926$$MD$CA$CA
243654341$24365434$1$I$$20240921$20240926$20240926$EXP$$US-JNJFOC-20240962729$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243654351$24365435$1$I$$20240923$20240926$20240926$PER$$US-BIOGEN-2024BI01283938$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243654361$24365436$1$I$20240101$20240923$20240926$20240926$PER$$US-BIOGEN-2024BI01283926$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243654371$24365437$1$I$$20240923$20240926$20240926$PER$$US-BIOGEN-2024BI01283794$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243654381$24365438$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5933718$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243654391$24365439$1$I$$20240924$20240926$20240926$EXP$$NVSC2024US190748$NOVARTIS$$$$$$Y$$$20240926$$CN$US$US
243654401$24365440$1$I$$20240919$20240926$20240926$PER$$US-ROCHE-10000087946$ROCHE$$$$$F$Y$90.72$KG$20240926$$CN$US$US
243654411$24365441$1$I$20240903$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005313$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240926$$CN$US$US
243654421$24365442$1$I$$20240918$20240926$20240926$EXP$$CA-APOTEX-2024AP011169$APOTEX$$64$YR$$M$Y$$$20240926$$CN$CA$CA
243654431$24365443$1$I$$20240916$20240926$20240926$EXP$$PT-CELLTRION INC.-2024PT022682$CELLTRION$Costa MA, Lima SA, Peixoto AT, Martinez E.. Sacroileite Infecciosa em Paciente com Doenca de Crohn: Relato de Caso. CUF Academic Center, Gazeta M?dica; Ahead of Print$$$$$Y$$$20240926$$HP$PT$PT
243654441$24365444$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5933706$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243654451$24365445$1$I$20230801$20240918$20240926$20240926$EXP$$SE-EMD Serono-2024050062$EMD SERONO INC$$43$YR$A$M$Y$$$20240926$$HP$SE$SE
243654461$24365446$1$I$20220301$20240924$20240926$20240926$PER$$US-ROCHE-10000090641$ROCHE$$68$YR$E$F$Y$78.92$KG$20240926$$CN$US$US
243654471$24365447$1$I$$20240925$20240926$20240926$PER$$US-ROCHE-10000091003$ROCHE$$$$$$Y$$$20240926$$CN$US$US
243654481$24365448$1$I$20210918$20240919$20240926$20240926$EXP$$US-PROD-AS2-212756134-20-24-USA-RB-0007933$RECKITT BENCKISER$$$$$M$Y$$$20240926$$CN$US$US
243654491$24365449$1$I$$20240921$20240926$20240926$EXP$$US-GRAVITIPHARMA-GRA-2409-US-LIT-0392$GRAVITI PHARMACEUTICALS$Benoit SW, Khandelwal P, Grimley MS.Novel use of daratumumab for post-hematopoietic cell transplant membranous nephropathy..J-Am-Soc-Nephrol.2021;NA:32571$16$YR$T$F$Y$$$20240926$$HP$US$US
243654501$24365450$1$I$$20240916$20240926$20240926$EXP$$US-CELLTRION INC.-2024US022694$CELLTRION$File B, Hari A. Discrepancy in PD-L1 expression between primary and metastatic tumors in two patients with recurrent cervical cancer. Gynecologic Oncology Reports. 2024;55 (101484)$$$$$Y$$$20240926$$HP$US$US
243654511$24365451$1$I$$20240918$20240926$20240926$EXP$$CA-APOTEX-2024AP011231$APOTEX$$68$YR$$M$Y$$$20240926$$CN$CA$CA
243654521$24365452$1$I$20240827$20240916$20240926$20240926$PER$$US-GSK-US2024114938$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240926$$CN$US$US
243654531$24365453$1$I$20240909$20240919$20240926$20240926$EXP$FR-AFSSAPS-BR2024000757$FR-HBP-2024FR031267$HELSINN HEALTHCARE$$72$YR$$M$Y$63$KG$20240926$$MD$FR$FR
243654541$24365454$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005316$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243654551$24365455$1$I$$20240923$20240926$20240926$PER$$US-ABBVIE-5937619$ABBVIE$$$$$$Y$$$20240926$$HP$US$US
243654561$24365456$1$I$$20240920$20240926$20240926$EXP$JP-MMM-69YRK8OM$JP-GSK-JP2024117013$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$JP$JP
243654571$24365457$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011355$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243654581$24365458$1$I$20240301$20240918$20240926$20240926$EXP$$AU-EMD Serono-2024050149$EMD SERONO INC$$72$YR$E$F$Y$$$20240926$$CN$AU$AU
243654592$24365459$2$F$20240901$20240924$20240926$20240930$EXP$$US-ROCHE-10000090580$ROCHE$$49$YR$A$F$Y$$$20240930$$CN$US$US
243654601$24365460$1$I$20240915$20240920$20240926$20240926$EXP$$CN-ROCHE-10000088116$ROCHE$$59$YR$A$F$Y$45$KG$20240926$$HP$CN$CN
243654611$24365461$1$I$20240918$20240920$20240926$20240926$EXP$$CA-ROCHE-10000087579$ROCHE$$43$YR$A$F$Y$$$20240926$$CN$CA$CA
243654621$24365462$1$I$$20240919$20240926$20240926$EXP$$CN-GSK-CN2024APC116344$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CN$CN
243654631$24365463$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015774$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240926$$CN$US$US
243654641$24365464$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015286$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240926$$CN$US$US
243654651$24365465$1$I$$20240916$20240926$20240926$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP012190$STRIDES$Prakash S, Patel H, Shah CS.. Medication-overuse headache overlapping with serotonin syndrome.. BMJ-Case-Rep. 2024;17 (1)$$$A$F$Y$$$20240926$$MD$IN$IN
243654661$24365466$1$I$$20240920$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014224$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240926$$CN$US$US
243654701$24365470$1$I$20240101$20240918$20240926$20240926$EXP$$CA-JNJFOC-20240845885$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$$$20240926$$HP$CA$CA
243654711$24365471$1$I$20240801$20240920$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-012905$JAZZ$$43$YR$$F$Y$$$20240926$$CN$US$US
243654721$24365472$1$I$$20240925$20240926$20240926$PER$$US-HALEON-2198830$Haleon PLC$$$$$$Y$$$20240926$$CN$US$US
243654741$24365474$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005352$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243654751$24365475$1$I$$20240916$20240926$20240926$EXP$PT-EMA-DD-20190306-chopra_i-130436$PT-Accord-123605$ACCORD$Pereira L, Meng C, Guedes L, Marques S, Nunes A, Sampaio S, et al. Infective endocarditis in renal transplant recipients: one center experience. Portuguese Journal of Nephrology and Hypertension 2018,32(4):337 TO 341.$39$YR$A$F$Y$$$20240926$$MD$PT$PT
243654761$24365476$1$I$20240906$20240919$20240926$20240926$EXP$$NVSC2024US188671$NOVARTIS$$77$YR$$F$Y$$$20240926$$CN$US$US
243654771$24365477$1$I$20240906$20240917$20240926$20240926$PER$$US-TAKEDA-2024TUS092913$TAKEDA$$50$YR$$F$Y$$$20240926$$HP$US$US
243654781$24365478$1$I$20240801$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005354$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240926$$CN$US$US
243654791$24365479$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005353$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243654801$24365480$1$I$20240826$20240917$20240926$20240926$EXP$$AU-BEH-2024179096$CSL BEHRING$$78$YR$E$M$Y$$$20240926$$HP$AU$AU
243654811$24365481$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3246130$TEVA$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. J-Oncol-Pharm-Pract 2024; 0 (0):.$61$YR$$M$Y$$$20240926$$HP$US$US
243654821$24365482$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000090774$ROCHE$$$$A$M$Y$$$20240926$$HP$US$US
243654831$24365483$1$I$$20240916$20240926$20240926$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP012320$STRIDES$Ray AK, Mitra S.. A Case Series on Complexities in Recognition and Management of Tourette Syndrome with Variable Behavioral Presentations: Comorbidity Versus Umbrella Construct.. J-Indian-Assoc-Child-Adolesc-Ment-Health. 2024;20 (3):264-268$10$YR$$M$Y$$$20240926$$HP$IN$IN
243654861$24365486$1$I$20240919$20240923$20240926$20240926$PER$$US-JNJFOC-20240962105$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243654871$24365487$1$I$$20240918$20240926$20240926$EXP$$US-JNJFOC-20240966384$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240926$$MD$US$US
243654881$24365488$1$I$$20240918$20240926$20240926$EXP$$RS-GILEAD-2024-0688476$GILEAD$$69$YR$E$F$Y$$$20240926$$MD$RS$RS
243654891$24365489$1$I$$20240924$20240926$20240926$EXP$$US-GILEAD-2024-0688874$GILEAD$$$$A$M$Y$$$20240926$$CN$US$US
243654901$24365490$1$I$20240101$20240917$20240926$20240926$EXP$$CA-CELLTRION INC.-2024CA012943$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243654911$24365491$1$I$$20240918$20240926$20240926$EXP$$JP-STRIDES ARCOLAB LIMITED-2024SP012287$STRIDES$Sato K, Suzuki T, Akaike K, Uchihara D, Ichii O, Tai M, et al.. A case of gallbladder neuroendocrine carcinoma complicated by ectopic adrenocorticotropic hormone syndrome and resulting in rapid fetal outcomes due to sepsis.. Clin-J-Gastroenterol. 2024;17(4):724-730.$52$YR$$F$Y$$$20240926$$HP$JP$JP
243654921$24365492$1$I$$20240917$20240926$20240926$EXP$$JP-ROCHE-10000089971$ROCHE$$8$DEC$E$M$Y$$$20240926$$PH$JP$JP
243654931$24365493$1$I$$20231113$20240926$20240926$PER$$US-ALCON LABORATORIES-ALC2023US005158$ALCON$$$$$M$Y$$$20240926$$CN$US$US
243654941$24365494$1$I$$20240918$20240926$20240926$EXP$$IN-STRIDES ARCOLAB LIMITED-2024SP012374$STRIDES$Reddy NA, Raj K, Lashkari HP.. Norovirus Infection in Children with Acute Lymphoblastic Leukemia.. Infect-Chemotherap. 2023;55 (3):403-407$22$MON$$M$Y$$$20240926$$MD$IN$IN
243654951$24365495$1$I$20240731$20240924$20240926$20240926$EXP$$CN-ROCHE-10000090598$ROCHE$$51$YR$A$F$Y$56$KG$20240926$$HP$CN$CN
243654961$24365496$1$I$$20240529$20240926$20240926$PER$$US-ALCON LABORATORIES-ALC2024US002759$ALCON$$$$$M$Y$$$20240926$$CN$US$US
243654971$24365497$1$I$20240415$20240622$20240926$20240926$PER$$US-ALCON LABORATORIES-ALC2024US002368$ALCON$$59$YR$$M$Y$$$20240926$$CN$US$US
243654982$24365498$2$F$$20240923$20240926$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US057343$SANDOZ$$$$$M$Y$$$20240926$$CN$US$US
243654991$24365499$1$I$$20240919$20240926$20240926$EXP$$IQ-STRIDES ARCOLAB LIMITED-2024SP012303$STRIDES$Al-Jumaily U, Habeeb Rjeib HD, Al-Mosawy S, Faraj S, Metzger M.. Response-Based Approach for Pediatric Hodgkin Lymphoma in Nations with Restricted Resources.. Int-J-Hematol-Oncol-Bone-Marrow-Transpl. 2024;18 (3):285-296$$$C$M$Y$$$20240926$$HP$IQ$IQ
243655001$24365500$1$I$20210204$20240916$20240926$20240926$EXP$$DE-AUROBINDO-AUR-APL-2021-043835$AUROBINDO$$42$YR$$F$Y$$$20240926$$CN$DE$DE
243655021$24365502$1$I$$20240910$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09111$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243655031$24365503$1$I$$20240725$20240926$20240926$EXP$$US-PTA-005734$BANNER$$54$YR$A$M$Y$$$20240926$$CN$US$
243655041$24365504$1$I$$20240713$20240926$20240926$EXP$$US-PTA-005725$BANNER$$$$$$Y$$$20240926$$CN$US$
243655051$24365505$1$I$$20240710$20240926$20240926$EXP$$US-PTA-005711$BANNER$$50$YR$A$F$Y$$$20240926$$CN$US$
243655061$24365506$1$I$20230801$20240819$20240926$20240926$EXP$$US-PTA-005761$BANNER$$78$YR$$M$Y$$$20240926$$CN$US$
243655071$24365507$1$I$$20240726$20240926$20240926$EXP$$US-PTA-005743$BANNER$$$$$$Y$$$20240926$$CN$US$US
243655081$24365508$1$I$20230501$20240916$20240926$20240926$EXP$$PT-AUROBINDO-AUR-APL-2024-046676$AUROBINDO$$70$YR$$F$Y$$$20240926$$MD$PT$PT
243655091$24365509$1$I$$20240909$20240926$20240926$EXP$$US-PTA-005779$BANNER$$$$$$Y$$$20240926$$CN$US$
243655101$24365510$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011368$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243655121$24365512$1$I$$20240918$20240926$20240926$EXP$$BR-TAKEDA-2024TUS094559$TAKEDA$$$$$F$Y$77$KG$20240926$$CN$BR$BR
243655131$24365513$1$I$$20240918$20240926$20240926$PER$$US-BEH-2024179134$CSL BEHRING$$$$$F$Y$$$20240926$$MD$US$US
243655142$24365514$2$F$20240725$20240924$20240926$20240927$EXP$GB-MHRA-MED-202409240518135490-QNWVK$GB-ABBVIE-5937757$ABBVIE$$52$YR$$F$Y$$$20240927$$CN$GB$GB
243655161$24365516$1$I$20240101$20240918$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-024640$UNITED THERAPEUTICS$$$$$F$Y$64.853$KG$20240926$$$US$US
243655171$24365517$1$I$$20240918$20240926$20240926$EXP$$US-ABBVIE-5932566$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243655181$24365518$1$I$$20240916$20240926$20240926$EXP$$US-RDY-SPO/USA/24/0013879$DR REDDYS$Oyama G, Maling N, Avila-Thompson A, Zeilman PR, Foote KD, Malaty IA, et al. Rescue GPi-DBS for a stroke-associated hemiballism in a patient with STN-DBS. Tremor and Other Hyperkinetic Movements. 2014;1-5. doi:10.7916/D8XP72WF.$38$YR$A$M$Y$$$20240926$$HP$US$US
243655191$24365519$1$I$20240301$20240918$20240926$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005708$ACADIA PHARMACEUTICALS$$33$YR$$F$Y$25$KG$20240926$$CN$US$US
243655201$24365520$1$I$20240805$20240916$20240926$20240926$EXP$$PT-AUROBINDO-AUR-APL-2024-046111$AUROBINDO$$60$YR$$F$Y$53$KG$20240926$$PH$PT$PT
243655211$24365521$1$I$$20240915$20240926$20240926$EXP$$CA-Accord-448226$ACCORD$Shukla V, Cheng S, Hukin J, Huh L, Datta AN. Developmental and epileptic encephalopathies after successful treatment of pediatric ALL: A case series and review of literature. Epileptic Disorders. 2024:1-10.$6$YR$C$M$Y$$$20240926$$HP$CA$CA
243655221$24365522$1$I$$20240918$20240926$20240926$PER$$US-ROCHE-10000085940$ROCHE$$$$$$Y$$$20240926$$CN$US$US
243655231$24365523$1$I$$20240918$20240926$20240926$EXP$$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-08771$HIKMA$Traidl S, Wedi B.. Traidl S, Wedi B. Case of multiple drug Hypersensitivity syndromes - Challenges allergological diagnostics. Allergology. 2023;46(2):94-8$52$YR$$M$Y$$$20240926$$MD$DE$DE
243655241$24365524$1$I$20240101$20240919$20240926$20240926$EXP$$IN-CIPLA LTD.-2024IN10499$CIPLA$$$$$$Y$$$20240926$$MD$IN$IN
243655251$24365525$1$I$20240611$20240923$20240926$20240926$EXP$$IN-ROCHE-10000089895$ROCHE$$67$YR$E$M$Y$$$20240926$$CN$IN$IN
243655261$24365526$1$I$20240904$20240920$20240926$20240926$EXP$SE-SEMPA-2024-006723$SE-TEVA-VS-3246521$TEVA$$16$YR$$F$Y$$$20240926$$MD$SE$SE
243655271$24365527$1$I$$20240916$20240926$20240926$EXP$$NL-AUROBINDO-AUR-APL-2024-046648$AUROBINDO$$30$YR$$M$Y$70$KG$20240926$$MD$NL$NL
243655281$24365528$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016463$ELI LILLY AND CO$$$$$$Y$$$20240926$$CN$US$US
243655291$24365529$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015448$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240926$$CN$US$US
243655301$24365530$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015204$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240926$$PH$US$US
243655311$24365531$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016392$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240926$$CN$US$US
243655331$24365533$1$I$20240917$20240920$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409013558$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240926$$CN$US$US
243655351$24365535$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011371$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243655361$24365536$1$I$20240101$20240920$20240926$20240926$EXP$SE-SEMPA-2024-006721$SE-TEVA-VS-3246641$TEVA$$83$YR$$F$Y$$$20240926$$MD$SE$SE
243655381$24365538$1$I$$20240917$20240926$20240926$EXP$CA-MHPD-E2B_07197201$CA-Accord-447563$ACCORD$$72$YR$E$M$Y$$$20240926$$MD$CA$CA
243655391$24365539$1$I$20240312$20240906$20240926$20240926$EXP$IT-MINISAL02-977139$IT-CELLTRION INC.-2024IT022784$CELLTRION$$$$$$Y$$$20240926$$MD$IT$IT
243655401$24365540$1$I$$20240924$20240926$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE082478$SANDOZ$$$$A$$Y$$$20240926$$HP$DE$DE
243655411$24365541$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5936385$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243655421$24365542$1$I$20240914$20240916$20240926$20240926$PER$$US-GSK-US2024114987$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240926$$CN$US$US
243655431$24365543$1$I$$20240924$20240926$20240926$PER$$NVSC2024US190999$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
243655441$24365544$1$I$$20240916$20240926$20240926$EXP$$IN-HALEON-INCH2024APC005000$Haleon PLC$Prakash S, Patel H, Shah CS, Medication-overuse headache overlapping with serotonin syndrome. Bmj case rep 2024; 17: 1-5.; Prakash S, Patel H, Shah CS.Medication-overuse headache overlapping with serotonin syndrome.BMJ Case Reports.2024.17(1)$4$DEC$$F$Y$$$20240926$$HP$IN$IN
243655461$24365546$1$I$20240630$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046662$AUROBINDO$$27$YR$$M$Y$57$KG$20240926$$MD$FR$FR
243655471$24365547$1$I$$20240917$20240926$20240926$EXP$CA-MHPD-E2B_07234120$CA-Accord-447309$ACCORD$$60$YR$A$F$Y$$$20240926$$CN$CA$CA
243655491$24365549$1$I$20240729$20240916$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046092$AUROBINDO$$82$YR$$M$Y$63.2$KG$20240926$$PH$FR$FR
243655501$24365550$1$I$20240902$20240916$20240926$20240926$PER$$US-GSK-US2024115591$GLAXOSMITHKLINE$$76$YR$$F$Y$$$20240926$$CN$US$US
243655511$24365551$1$I$$20240916$20240926$20240926$EXP$$US-RDY-SPO/USA/24/0013874$DR REDDYS$Schweinitz BV, Gros BJ. Case Report of the Use of an Intravascular Cooling Device in the Management of Malignant Hyperthermia. Therapeutic Hypothermia and Temperature Management. 2024 Jun 14;14(2): 125-127. doi:10.1089/ther.2024.0004.$29$YR$A$M$Y$$$20240926$$MD$US$US
243655521$24365552$1$I$$20240917$20240926$20240926$EXP$$FR-RDY-SPO/FRA/24/0013995$DR REDDYS$Beaumont A, Mestre F, Decaux S, Bertin C, Duval X, Iung B, et al. Long-term Oral Suppressive Antimicrobial Therapy in Infective Endocarditis (SATIE Study): An Observational Study. Open Forum Infectious Diseases. 2024 May;11(5): doi:10.1093/ofid/ofae194.$31$YR$A$$Y$$$20240926$$HP$FR$FR
243655531$24365553$1$I$$20240917$20240926$20240926$EXP$$FR-RDY-SPO/FRA/24/0014014$DR REDDYS$Beaumont A, Mestre F, Decaux S, Bertin C, Duval X, Iung B, et al. Long-term Oral Suppressive Antimicrobial Therapy in Infective Endocarditis (SATIE Study): An Observational Study. Open Forum Infectious Diseases. 2024 May;11(5): doi:10.1093/ofid/ofae194.$48$YR$A$$Y$$$20240926$$HP$FR$FR
243655541$24365554$1$I$$20240916$20240926$20240926$EXP$$FR-RDY-SPO/FRA/24/0013987$DR REDDYS$Dufraigne A, Perinel-Ragey S, Guitton J, Cohen S, Thiery G, Launay M. Monitoring of Tissue and Plasma Imipenem Concentrations for the Treatment of Necrotizing Fasciitis With Carbapenem-Resistant Enterobacteriaceae-A Letter to the Editor. Therapeutic Drug Monitoring. 2024 Aug;46(4): 552-553. doi:10.1097/FTD.0000000000001193.$64$YR$A$M$Y$80$KG$20240926$$MD$FR$FR
243655551$24365555$1$I$$20240923$20240926$20240926$EXP$IE-Pharmaand-2024000936$IE-ROCHE-10000088623$ROCHE$$63$YR$A$M$Y$$$20240926$$MD$IE$IE
243655561$24365556$1$I$20240601$20240923$20240926$20240926$PER$$US-BIOGEN-2024BI01277643$BIOGEN$$36$YR$$M$Y$$$20240926$$CN$US$US
243655571$24365557$1$I$$20240925$20240926$20240926$EXP$$GB-MYLANLABS-2024M1058229$MYLAN$$$$$M$Y$$$20240926$$MD$GB$GB
243655581$24365558$1$I$20240101$20240920$20240926$20240926$EXP$$CA-ABBVIE-5935020$ABBVIE$$$$$F$Y$$$20240926$$CN$CA$CA
243655591$24365559$1$I$20240920$20240920$20240926$20240926$EXP$$FR-ABBVIE-5935304$ABBVIE$$69$YR$$M$Y$$$20240926$$HP$FR$FR
243655601$24365560$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5936405$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243655621$24365562$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3246133$TEVA$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. J-Oncol-Pharm-Pract 2024; 0 (0):.$34$YR$$F$Y$$$20240926$$HP$US$US
243655631$24365563$1$I$$20240920$20240926$20240926$EXP$JP-MMM-CENG9BHM$JP-GSK-JP2024117139$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$JP$JP
243655641$24365564$1$I$20240901$20240910$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09116$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243655651$24365565$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3246060$TEVA$Horblitt A, Jain D, Kabra N, Jolly G, Gupta S, Dhaduk K. SYNTHETIC ANGIOTENSIN II EXACERBATION OF SEPTIC MYOCARDITIS, CAUTIOUS UTILIZATION OF NOVEL VASOPRESSOR PHARMACEUTICALS. J-Am-Coll-Cardiol 2019; 73 (Suppl.) (9): 2600.$33$YR$$M$Y$$$20240926$$HP$US$US
243655661$24365566$1$I$$20240911$20240926$20240926$EXP$$IT-GRANULES-IT-2024GRALIT00415$GRANULES INDIA$L Bernasconi.Clinical characteristics of acute lacosamide poisoning: Pavia Poison Control Centre experience..British Journal of Clinical Pharmacology.JAN-2023$$$$$Y$$$20240926$$HP$IT$IT
243655671$24365567$1$I$$20240915$20240926$20240926$EXP$$CA-Accord-448227$ACCORD$Shukla V, Cheng S, Hukin J, Huh L, Datta AN. Developmental and epileptic encephalopathies after successful treatment of pediatric ALL: A case series and review of literature. Epileptic Disorders. 2024:1-10.$4$YR$C$M$Y$$$20240926$$HP$CA$CA
243655691$24365569$1$I$20221001$20240917$20240926$20240926$EXP$FR-AFSSAPS-MP2023001133$FR-CELLTRION INC.-2024FR022536$CELLTRION$$$$$$Y$$$20240926$$MD$FR$FR
243655701$24365570$1$I$20230301$20240917$20240926$20240926$EXP$FR-AFSSAPS-AM2023000510$FR-CELLTRION INC.-2024FR022512$CELLTRION$$$$$$Y$$$20240926$$PH$FR$FR
243655711$24365571$1$I$$20240916$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-029392$UNITED THERAPEUTICS$$$$$F$Y$52.154$KG$20240926$$$US$US
243655721$24365572$1$I$$20240911$20240926$20240926$EXP$$CA-SANDOZ INC.-PHHY2019CA065565$SANDOZ$$29$YR$$F$Y$$$20240926$$CN$CA$CA
243655741$24365574$1$I$$20240920$20240926$20240926$EXP$$US-ROCHE-10000088434$ROCHE$$$$A$F$Y$$$20240926$$CN$US$US
243655751$24365575$1$I$$20240919$20240926$20240926$EXP$$CA-ROCHE-10000086999$ROCHE$$51$YR$A$F$Y$$$20240926$$HP$CA$CA
243655761$24365576$1$I$$20240914$20240926$20240926$EXP$$SK-ALKEM LABORATORIES LIMITED-SK-ALKEM-2024-22358$ALKEM$Necpal J, Skorvanek M.. Opsoclonus-myoclonus ataxia syndrome secondary to venlafaxine intoxication. J Neurol Sci.. 2017;372:19-20$$$$$Y$$$20240926$$HP$SK$SK
243655771$24365577$1$I$$20240914$20240926$20240926$EXP$GB-MHRA-MED-202409131511421900-MPKSC$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21884$ALKEM$$$$$M$Y$$$20240926$$CN$GB$GB
243655781$24365578$1$I$$20240914$20240926$20240926$EXP$$ES-ALKEM LABORATORIES LIMITED-ES-ALKEM-2024-22300$ALKEM$Trigo Lopez J, Martinez Pias E, Carrancho Garcia A, Pedraza Hueso MI.. Opsoclonus-myoclonus syndrome secondary to duloxetine poisoning. Neurology. 2021;36:241-252$44$YR$$F$Y$$$20240926$$HP$ES$ES
243655791$24365579$1$I$20240509$20240914$20240926$20240926$EXP$GB-MHRA-TPP13367089C8456410YC1715258564975$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21894$ALKEM$$85$YR$$F$Y$$$20240926$$MD$GB$GB
243655801$24365580$1$I$$20240914$20240926$20240926$EXP$GB-MHRA-MED-202409131322524410-MCGDB$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-21881$ALKEM$$$$$$Y$$$20240926$$PH$GB$GB
243655812$24365581$2$F$$20240917$20240926$20240926$PER$$US-ROCHE-10000085254$ROCHE$$57$YR$A$F$Y$$$20240926$$CN$US$US
243655821$24365582$1$I$$20240910$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09101$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243655831$24365583$1$I$20220303$20240923$20240926$20240926$EXP$$CA-ROCHE-3046431$ROCHE$$53$YR$A$F$Y$52.6$KG$20240926$$CN$CA$CA
243655841$24365584$1$I$20101223$20240924$20240926$20240926$EXP$$DE-ORGANON-O2409DEU001924$ORGANON$$43$YR$$F$Y$65$KG$20240926$$HP$DE$DE
243655851$24365585$1$I$20240626$20240923$20240926$20240926$EXP$$DE-UCBSA-2024048800$UCB$$37$YR$$F$Y$96$KG$20240926$$CN$DE$DE
243655861$24365586$1$I$20240910$20240919$20240926$20240926$EXP$GB-MHRA-MED-202409171003251260-HZLKY$GB-TEVA-VS-3245333$TEVA$$22$YR$$F$Y$69$KG$20240926$$CN$GB$GB
243655881$24365588$1$I$20230920$20240917$20240926$20240926$EXP$FR-AFSSAPS-TS2024000974$FR-ABBVIE-5938578$ABBVIE$$$$$M$Y$1.9$KG$20240926$$MD$FR$FR
243655891$24365589$1$I$$20240923$20240926$20240926$PER$$US-ABBVIE-5937551$ABBVIE$$$$$$Y$$$20240926$$HP$US$US
243655901$24365590$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152626$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240926$$CN$US$US
243655911$24365591$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151738$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240926$$HP$US$US
243655921$24365592$1$I$$20240924$20240926$20240926$EXP$$IT-SANDOZ INC.-SDZ2024IT082990$SANDOZ$DUSIS, KAITERISA, SHAHD, et al. A DEADLY COCKTAIL: BRASH SYNDROME IN THE SETTING OF POLYPHARMACY. Chest. 2024$63$YR$$M$Y$$$20240926$$HP$IT$IT
243655931$24365593$1$I$$20240917$20240926$20240926$EXP$$CA-APOTEX-2022AP014324$APOTEX$$37$YR$$F$Y$$$20240926$$HP$CA$CA
243655941$24365594$1$I$$20240828$20240926$20240926$PER$$AU-TOLMAR, INC.-24AU052214$TOLMAR$$$$$M$Y$$$20240926$$CN$AU$AU
243655951$24365595$1$I$$20240830$20240926$20240926$PER$$AU-TOLMAR, INC.-24AU052036$TOLMAR$$$$$M$Y$$$20240926$$CN$AU$AU
243655961$24365596$1$I$$20240828$20240926$20240926$PER$$AU-TOLMAR, INC.-24AU052250$TOLMAR$$$$$M$Y$$$20240926$$CN$AU$AU
243655981$24365598$1$I$$20240830$20240926$20240926$PER$$CA-TOLMAR, INC.-24CA052009$TOLMAR$$$$$M$Y$$$20240926$$CN$CA$CA
243655992$24365599$2$F$20240901$20240926$20240926$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152055$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240928$$CN$US$US
243656001$24365600$1$I$$20240830$20240926$20240926$PER$$CA-TOLMAR, INC.-24CA052034$TOLMAR$$$$$M$Y$$$20240926$$CN$CA$CA
243656011$24365601$1$I$$20240828$20240926$20240926$PER$$CA-TOLMAR, INC.-24CA052205$TOLMAR$$$$$M$Y$$$20240926$$CN$CA$CA
243656021$24365602$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005321$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243656031$24365603$1$I$$20230907$20240926$20240926$PER$$US-AUROBINDO-AUR-APL-2023-058710$AUROBINDO$$$$$$Y$$$20240926$$CN$US$US
243656041$24365604$1$I$$20240919$20240926$20240926$PER$$US-ABBVIE-5933987$ABBVIE$$$$$$Y$$$20240926$$CN$US$US
243656051$24365605$1$I$$20240919$20240926$20240926$EXP$$CA-TAKEDA-2024TUS089842$TAKEDA$$$$$F$Y$$$20240926$$CN$CA$CA
243656061$24365606$1$I$$20240225$20240926$20240926$PER$$US-AUROBINDO-AUR-APL-2024-010483$AUROBINDO$$$$$F$Y$$$20240926$$CN$US$US
243656071$24365607$1$I$$20240916$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR116347$VIIV$$$$$F$Y$$$20240926$$CN$US$US
243656081$24365608$1$I$$20240923$20240926$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US031137$SANDOZ$$$$$$Y$$$20240926$$HP$US$US
243656091$24365609$1$I$$20240614$20240926$20240926$PER$$US-AUROBINDO-AUR-APL-2024-016553$AUROBINDO$$$$$F$Y$$$20240926$$CN$US$US
243656101$24365610$1$I$$20240924$20240926$20240926$EXP$$US-ABBVIE-5938737$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243656111$24365611$1$I$20240918$20240919$20240926$20240926$EXP$$US-BANNER LIFE SCIENCES-USBAN24000141$BANNER$$$$$$Y$$$20240926$$CN$US$US
243656121$24365612$1$I$$20240919$20240926$20240926$EXP$$CA-TAKEDA-2024TUS090638$TAKEDA$$$$$F$Y$$$20240926$$CN$CA$CA
243656131$24365613$1$I$20240401$20240924$20240926$20240926$EXP$$NVSC2024GT190936$NOVARTIS$$71$YR$$F$Y$$$20240926$$CN$GT$GT
243656141$24365614$1$I$20231101$20240916$20240926$20240926$EXP$FR-AFSSAPS-MA2024001258$FR-EMD Serono-2024049573$EMD SERONO INC$$39$YR$A$F$Y$$$20240926$$MD$FR$FR
243656151$24365615$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152371$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240926$$CN$US$US
243656161$24365616$1$I$$20240916$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152125$BRISTOL MYERS SQUIBB$Barlowe TS, Saxena-Beem S, Ishizawar RC, Herfarth H, Moon AM. Multiple gastrointestinal immune related adverse events from immune checkpoint inhibitor therapy. Clinical and Translational Gastroenterology. 2024 Sep 12;doi:10.14309/ctg.0000000000000768.$46$YR$A$F$Y$$$20240926$$MD$US$US
243656171$24365617$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152009$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$PH$US$US
243656181$24365618$1$I$20240915$20240920$20240926$20240926$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-151725$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240926$$CN$CN$CN
243656211$24365621$1$I$$20240911$20240926$20240926$EXP$$TN-GRANULES-TN-2024GRALIT00412$GRANULES INDIA$Khouloud Razki.^From levetiracetam to lithium^: A journey of hope to manage suicidality and depression.Journal of the Neurological Sciences.DEC-2023;455:119-120$20$YR$A$M$Y$$$20240926$$HP$TN$TN
243656221$24365622$1$I$20240101$20240916$20240926$20240926$EXP$$US-ROCHE-10000083932$ROCHE$$73$YR$E$M$Y$58.96$KG$20240926$$CN$US$US
243656241$24365624$1$I$$20240412$20240926$20240926$PER$$US-AUROBINDO-AUR-APL-2024-016748$AUROBINDO$$$$$$Y$$$20240926$$HP$US$US
243656251$24365625$1$I$20240101$20240916$20240926$20240926$PER$$US-UNITED THERAPEUTICS-UNT-2024-029400$UNITED THERAPEUTICS$$$$$F$Y$76.19$KG$20240926$$$US$US
243656261$24365626$1$I$$20240918$20240926$20240926$EXP$$CN-ROCHE-10000090960$ROCHE$Deng Y, Niu T, Li X, Liu Y, Zhou Y, Lei D. Systemic analysis of adverse drug events in patients with diabetes complicated by cataract treated with rizumab after surgery. CHIN J DRUG APPL AND MONIT. 2024;21(4):494-8. doi:10.3969/j.issn.1672-8157.2024.04.042$$$$$Y$$$20240926$$HP$CN$CN
243656271$24365627$1$I$20181023$20240919$20240926$20240926$EXP$$CA-TAKEDA-2018TUS035725$TAKEDA$$57$YR$$F$Y$$$20240926$$CN$CA$CA
243656281$24365628$1$I$$20240918$20240926$20240926$EXP$$CA-APOTEX-2024AP011232$APOTEX$$61$YR$$M$Y$$$20240926$$CN$CA$CA
243656291$24365629$1$I$$20240903$20240926$20240926$PER$$AU-TOLMAR, INC.-24AU052386$TOLMAR$$$$$M$Y$$$20240926$$CN$AU$AU
243656301$24365630$1$I$20240801$20240903$20240926$20240926$PER$$BR-TOLMAR, INC.-24BR052406$TOLMAR$$$$$$Y$$$20240926$$CN$BR$BR
243656311$24365631$1$I$20240903$20240903$20240926$20240926$PER$$BR-TOLMAR, INC.-24BR052408$TOLMAR$$9$YR$$F$Y$$$20240926$$CN$BR$BR
243656331$24365633$1$I$$20240921$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-016126$JAZZ$$$$$F$Y$$$20240926$$CN$US$US
243656341$24365634$1$I$20180129$20240925$20240926$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE082877$SANDOZ$$16$YR$$F$Y$65$KG$20240926$$MD$DE$DE
243656351$24365635$1$I$$20240412$20240926$20240926$PER$$US-AUROBINDO-AUR-APL-2024-016808$AUROBINDO$$$$$F$Y$$$20240926$$HP$US$US
243656361$24365636$1$I$20240905$20240920$20240926$20240926$PER$$US-ABBVIE-5936095$ABBVIE$$70$YR$$M$Y$$$20240926$$CN$US$US
243656371$24365637$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001718$ORGANON$$44$YR$$F$Y$$$20240926$$HP$CA$CA
243656381$24365638$1$I$$20240924$20240926$20240926$EXP$$CA-ABBVIE-5938555$ABBVIE$$21$YR$$F$Y$$$20240926$$HP$CA$CA
243656391$24365639$1$I$$20240911$20240926$20240926$EXP$$TR-GRANULES-TR-2024GRALIT00419$GRANULES INDIA$Nur Seda Gulcu Ustun.Sertraline-induced visual hallucination in an adolescent girl.Dusunen Adam.20-MAR-2024;37:111-113$16$YR$T$F$Y$$$20240926$$HP$TR$TR
243656401$24365640$1$I$$20240924$20240926$20240926$EXP$$US-JNJFOC-20240966406$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243656412$24365641$2$F$$20240919$20240926$20240926$PER$$US-ROCHE-10000087524$ROCHE$$$$$F$Y$$$20240926$$MD$US$US
243656421$24365642$1$I$$20240923$20240926$20240926$PER$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005260$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240926$$CN$US$US
243656431$24365643$1$I$$20240917$20240926$20240926$PER$$US-TAKEDA-2024TUS092742$TAKEDA$$$$$F$Y$54$KG$20240926$$MD$US$US
243656441$24365644$1$I$20240429$20240502$20240926$20240926$PER$$US-AUROBINDO-AUR-APL-2024-022348$AUROBINDO$$77$YR$$F$Y$$$20240926$$CN$US$US
243656451$24365645$1$I$20240702$20240917$20240926$20240926$EXP$FR-AFSSAPS-PA2024001447$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08791$HIKMA$$30$YR$$F$Y$51$KG$20240926$$PH$FR$FR
243656461$24365646$1$I$20240902$20240916$20240926$20240926$PER$$US-GSK-US2024114843$GLAXOSMITHKLINE$$38$YR$$F$Y$$$20240926$$CN$US$US
243656472$24365647$2$F$20240912$20240924$20240926$20240927$EXP$$HU-ABBVIE-5933731$ABBVIE$$76$YR$$F$Y$$$20240927$$HP$HU$HU
243656481$24365648$1$I$$20240916$20240926$20240926$EXP$CA-MHPD-001095618$CA-Accord-447850$ACCORD$$63$YR$A$M$Y$86$KG$20240926$$HP$CA$CA
243656491$24365649$1$I$20240101$20240924$20240926$20240926$PER$$US-ABBVIE-5939200$ABBVIE$$71$YR$$M$Y$$$20240926$$HP$US$US
243656511$24365651$1$I$20231123$20240911$20240926$20240926$EXP$$GB-BAXTER-2024BAX024276$BAXTER$$$$E$F$Y$89$KG$20240926$$CN$GB$GB
243656521$24365652$1$I$$20240917$20240926$20240926$EXP$$CA-VANTIVE-2024VAN019896$Vantive US Healthcare$$$$$M$Y$$$20240926$$HP$CA$CA
243656531$24365653$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5934302$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243656541$24365654$1$I$$20240827$20240926$20240926$PER$$US-009507513-2408USA009459$MERCK$Aguilera D, Janss A, Schniederjan M, Goldman-Yassen A, Velazquez J, Mazewski C, et al.. ANAPLASTIC TRANSFORMATION OF DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMORS: TWO PEDIATRIC CASES. Neuro-Oncology. 2024;26 (Suppl. 4):iv199$$$$M$Y$$$20240926$$HP$US$US
243656561$24365656$1$I$$20240919$20240926$20240926$PER$$US-TAKEDA-2024TUS093908$TAKEDA$$$$$$Y$$$20240926$$PH$US$US
243656571$24365657$1$I$$20240627$20240926$20240926$PER$$US-AUROBINDO-AUR-APL-2024-028664$AUROBINDO$$65$YR$$F$Y$70.76$KG$20240926$$CN$US$US
243656582$24365658$2$F$$20240924$20240926$20240928$EXP$$CA-ROCHE-10000090358$ROCHE$$$$A$F$Y$$$20240928$$CN$CA$CA
243656591$24365659$1$I$20240924$20240925$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152520$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240926$$HP$US$US
243656601$24365660$1$I$20240522$20240924$20240926$20240926$EXP$FR-AFSSAPS-DJ2024001063$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-152300$BRISTOL MYERS SQUIBB$$65$YR$A$M$Y$101$KG$20240926$$MD$FR$FR
243656611$24365661$1$I$20240208$20240916$20240926$20240926$EXP$$DE-AUROBINDO-AUR-APL-2024-046555$AUROBINDO$$87$YR$$M$Y$70$KG$20240926$$MD$DE$DE
243656631$24365663$1$I$$20240924$20240926$20240926$EXP$$NVSC2024DO190969$NOVARTIS$$$$$F$Y$$$20240926$$CN$DO$DO
243656641$24365664$1$I$$20240906$20240926$20240926$PER$$US-TEVA-VS-3241315$TEVA$$$$$M$Y$$$20240926$$HP$US$US
243656651$24365665$1$I$$20240528$20240926$20240926$PER$$US-AUROBINDO-AUR-APL-2024-034710$AUROBINDO$$$$A$F$Y$$$20240926$$HP$US$US
243656661$24365666$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5936810$ABBVIE$$$$$M$Y$$$20240926$$HP$US$US
243656671$24365667$1$I$20240915$20240916$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024114800$VIIV$$34$YR$$M$Y$$$20240926$$HP$US$US
243656691$24365669$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001727$ORGANON$$44$YR$$F$Y$$$20240926$$HP$CA$CA
243656701$24365670$1$I$$20240913$20240926$20240926$EXP$$US-CIPLA LTD.-2024US10472$CIPLA$$$$$$Y$$$20240926$$CN$US$US
243656711$24365671$1$I$20230101$20240924$20240926$20240926$PER$$NVSC2024US191443$NOVARTIS$$$$$M$Y$$$20240926$$HP$US$US
243656721$24365672$1$I$$20240923$20240926$20240926$EXP$$NVSC2024US189662$NOVARTIS$$$$$$Y$$$20240926$$CN$US$US
243656741$24365674$1$I$20240921$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014920$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240926$$CN$US$US
243656751$24365675$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015594$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240926$$CN$US$US
243656761$24365676$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015762$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240926$$CN$US$US
243656771$24365677$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015183$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240926$$CN$US$US
243656781$24365678$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152261$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240926$$CN$US$US
243656791$24365679$1$I$20240101$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152496$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240926$$CN$US$US
243656801$24365680$1$I$20240601$20240617$20240926$20240926$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108885$ZYDUS PHARM$$$$$$Y$$$20240926$$CN$US$US
243656811$24365681$1$I$20240907$20240923$20240926$20240926$EXP$FR-AFSSAPS-RS2024000882$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112669$ZYDUS PHARM$$$$$$Y$$$20240926$$MD$FR$FR
243656821$24365682$1$I$$20240914$20240926$20240926$EXP$$FR-ROCHE-10000088255$ROCHE$Tomomi Satake, Hiroshi Sakaeda, Kazuya Murakawa, Ayaka Machida, Mayuko Kitaoka, Mitsuo Okada et al.. A case of drug-induced liver injury after the administration of tocilizumab for adult Still?s disease. Acta Hepatologica Japonica. 2024;65(8):397-406. doi:10.2957/kanzo.65.397$69$YR$E$F$Y$$$20240926$$HP$FR$FR
243656831$24365683$1$I$20240722$20240723$20240926$20240926$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-110513$ZYDUS PHARM$$$$$$Y$$$20240926$$CN$US$US
243656841$24365684$1$I$$20240912$20240926$20240926$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112353$ZYDUS PHARM$Goel AR, Sylvester C, Avidan OR, Gilvaz VJ.. Psoriasis and psoriatic arthritis following use of dostarlimab for endometrial cancer.. BMJ-Case-Rep. 2024;17 No 8:1-5$$$$$Y$$$20240926$$MD$US$US
243656862$24365686$2$F$$20240925$20240926$20240927$PER$$NVSC2024US191450$NOVARTIS$$$$$$Y$$$20240927$$MD$US$US
243656871$24365687$1$I$$20240923$20240926$20240926$EXP$$DE-UCBSA-2024048808$UCB$$78$YR$$F$Y$$$20240926$$CN$DE$DE
243656881$24365688$1$I$20240917$20240917$20240926$20240926$EXP$$CN-MYLANLABS-2024M1085109$MYLAN$$56$YR$$M$Y$$$20240926$$HP$CN$CN
243656891$24365689$1$I$$20240918$20240926$20240926$EXP$$ES-MYLANLABS-2024M1086558$MYLAN$Rojas-Medina LM, Esteban-Fernandez L, Ruiz EB, Cancela AA, Perez MP, Urzaiz LL. The Tractography a Useful Tool in Brain Asymmetry. Stereotac-Funct-Neurosurg 2024; 102 (Suppl. 1) 115-116 abstr. P027.$$$A$M$Y$$$20240926$$HP$ES$ES
243656901$24365690$1$I$$20240917$20240926$20240926$EXP$$JP-MYLANLABS-2024M1086419$MYLAN$Sakamoto T, Obara N, Maruyama Y, Kato T, Kurita N, Hattori K, et al. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia. Eur-J-Haematol 2023; 111 (5): 768-776.. 2023;111 (5):768-776$54$YR$$M$Y$$$20240926$$HP$JP$JP
243656911$24365691$1$I$$20240917$20240926$20240926$EXP$$US-MYLANLABS-2024M1085733$MYLAN$Catalano TD, Orza D, Orza FM. Repeat, Bilateral Femoral Nerve Blocks With Liposomal Bupivacaine for Analgesia in a Patient With Calciphylaxis: A Case Report. A-A-Pract 2023; 17 e01717.$36$YR$$F$Y$$$20240926$$MD$US$US
243656921$24365692$1$I$$20240918$20240926$20240926$EXP$$IT-MYLANLABS-2024M1086196$MYLAN$Mannelli F, Crupi F, Zanotti R, Pagano L, Rapezzi D, Tanasi I, et al. The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis. Ther-Adv-Hematol 2023; 14.$55$YR$$F$Y$$$20240926$$HP$IT$IT
243656931$24365693$1$I$$20240917$20240926$20240926$EXP$$US-MYLANLABS-2024M1085922$MYLAN$Hall J, Edmundowicz D, Cronin E. Advanced Interatrial block induced by flecainide. J-Electrocardiol 2024; 86.$84$YR$$F$Y$$$20240926$$MD$US$US
243656941$24365694$1$I$$20240918$20240926$20240926$EXP$$JP-MYLANLABS-2024M1086429$MYLAN$Umemoto D, Hara S, Nishioka H. Infective endocarditis and septic arthritis caused by Corynebacterium striatum. J-Infect-Chemother 2024; 30 (7): 655-658.. 2024;30 (7):655-658$85$YR$$F$Y$$$20240926$$HP$JP$JP
243656951$24365695$1$I$$20240917$20240926$20240926$EXP$$US-MYLANLABS-2024M1086153$MYLAN$Mena S, Raj A, Caldwell W, Kaushal A. The annoyance of singultus: a case report of a rare adverse effect after epidural steroid injection. BMC-Anesthesiol 2024; 24 (1): 302.$49$YR$$M$Y$$$20240926$$HP$US$US
243656971$24365697$1$I$20240101$20240919$20240926$20240926$EXP$$PR-ABBVIE-5931543$ABBVIE$$$$$F$Y$$$20240926$$CN$PR$PR
243656982$24365698$2$F$20240901$20240916$20240926$20240926$EXP$$US-JNJFOC-20240940973$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243656991$24365699$1$I$20240914$20240919$20240926$20240926$EXP$GB-MHRA-MED-202409161420374990-ZFWGV$GB-TEVA-VS-3245788$TEVA$$$$$$Y$$$20240926$$PH$GB$GB
243657001$24365700$1$I$$20240918$20240926$20240926$EXP$$US-MYLANLABS-2024M1086497$MYLAN$Finkel KA, Jung H, Kim H, Coleman DT. Protracted anaphylaxis and cytokine release syndrome 6 days after rituximab desensitization. Ann-Allergy-Asthma-Immunol 2024; 133 (1): 112-114.$54$YR$$F$Y$$$20240926$$MD$US$US
243657011$24365701$1$I$$20240918$20240926$20240926$EXP$$CA-APOTEX-2024AP011202$APOTEX$$57$YR$$M$Y$$$20240926$$CN$CA$CA
243657021$24365702$1$I$20240919$20240920$20240926$20240926$EXP$$JP-GSK-JP2024117955$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$JP$JP
243657031$24365703$1$I$$20240918$20240926$20240926$EXP$$CA-TAKEDA-2024TUS093546$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
243657051$24365705$1$I$20240831$20240917$20240926$20240926$EXP$$DE-AUROBINDO-AUR-APL-2024-046829$AUROBINDO$$64$YR$$F$Y$45$KG$20240926$$MD$DE$DE
243657061$24365706$1$I$20240712$20240923$20240926$20240926$EXP$$IN-ROCHE-10000047385$ROCHE$$44$YR$A$F$Y$$$20240926$$MD$IN$IN
243657081$24365708$1$I$20240916$20240916$20240926$20240926$PER$$US-JNJFOC-20240940695$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20240926$$CN$US$US
243657091$24365709$1$I$$20240909$20240926$20240926$PER$$US-JNJFOC-20240922356$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243657101$24365710$1$I$$20240917$20240926$20240926$EXP$$DE-MYLANLABS-2024M1085900$MYLAN$Bieneck V, Decker A, Schmitt-Graeff A, Kreisel W, Schauer F. Remission of refractory esophageal lichen planus induced by tofacitinib. Z-Gastroenterol 2024; 62 (9): 1384-1388.$56$YR$$F$Y$$$20240926$$HP$DE$DE
243657111$24365711$1$I$20240101$20240918$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046415$AUROBINDO$$67$YR$$F$Y$56$KG$20240926$$MD$FR$FR
243657132$24365713$2$F$$20240924$20240926$20240926$PER$$US-ROCHE-10000090827$ROCHE$$56$YR$A$F$Y$$$20240926$$HP$US$US
243657141$24365714$1$I$$20240919$20240926$20240926$EXP$$JP-Ipsen Biopharmaceuticals, Inc.-2024-19383$IPSEN$$80$YR$E$M$Y$$$20240926$$MD$JP$JP
243657151$24365715$1$I$$20240919$20240926$20240926$PER$$US-ASTELLAS-2024-AER-008104$ASTELLAS$$$$A$F$Y$$$20240926$$MD$US$US
243657161$24365716$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3246129$TEVA$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. J-Oncol-Pharm-Pract 2024; 0 (0):.$69$YR$$F$Y$$$20240926$$HP$US$US
243657171$24365717$1$I$$20240917$20240926$20240926$PER$$US-GSK-US2024115637$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243657181$24365718$1$I$$20240920$20240926$20240926$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-19119$IPSEN$$77$YR$E$F$Y$$$20240926$$HP$US$US
243657191$24365719$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000091396$ROCHE$$42$YR$A$F$Y$$$20240926$$MD$US$US
243657201$24365720$1$I$$20240924$20240926$20240926$EXP$$CA-ROCHE-10000091571$ROCHE$$$$A$M$Y$$$20240926$$CN$CA$CA
243657211$24365721$1$I$20240802$20240918$20240926$20240926$EXP$$DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-24-08825$HIKMA$$49$YR$$F$Y$63$KG$20240926$$PH$DE$DE
243657221$24365722$1$I$$20240924$20240926$20240926$EXP$$DE-ORGANON-O2409DEU001882$ORGANON$$80$YR$$M$Y$69$KG$20240926$$HP$DE$DE
243657241$24365724$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001729$ORGANON$$44$YR$$F$Y$$$20240926$$HP$CA$CA
243657251$24365725$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65935$$FDA-CTU$$77$YR$$M$N$$$20240925$N$$US$
243657261$24365726$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65774$$FDA-CTU$$66$YR$$M$N$107.95$KG$20240925$N$$US$
243657301$24365730$1$I$20240204$20240917$20240926$20240926$EXP$$CA-JNJFOC-20231201283$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240926$$CN$CA$CA
243657311$24365731$1$I$20240101$20240916$20240926$20240926$PER$$US-JNJFOC-20240947225$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243657321$24365732$1$I$$20240923$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-047218$AUROBINDO$$79$YR$$$Y$$$20240926$$PH$GB$GB
243657331$24365733$1$I$20231114$20240911$20240926$20240926$EXP$$DE-CELLTRION INC.-2024DE022772$CELLTRION$$$$$$Y$$$20240926$$MD$DE$DE
243657341$24365734$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65921$$FDA-CTU$$68$YR$$M$N$$$20240925$N$HP$US$
243657361$24365736$1$I$20231006$20240923$20240926$20240926$EXP$FR-AFSSAPS-NT2024001160$FR-ROCHE-10000088629$ROCHE$$5$YR$C$M$Y$18$KG$20240926$$PH$FR$FR
243657371$24365737$1$I$$20240918$20240926$20240926$EXP$$CA-APOTEX-2024AP011243$APOTEX$$70$YR$$F$Y$$$20240926$$CN$CA$CA
243657381$24365738$1$I$$20240918$20240926$20240926$EXP$$UA-TAKEDA-2024TUS094175$TAKEDA$$$$$F$Y$$$20240926$$HP$UA$UA
243657391$24365739$1$I$20240101$20240926$20240926$20240926$EXP$$NVSC2024DE191256$NOVARTIS$$38$YR$$M$Y$$$20240926$$MD$DE$DE
243657401$24365740$1$I$20240915$20240923$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-047364$AUROBINDO$$27$YR$$M$Y$$$20240926$$PH$GB$GB
243657411$24365741$1$I$$20240923$20240926$20240926$PER$$US-HALEON-2198421$Haleon PLC$$$$$$Y$$$20240926$$CN$US$US
243657431$24365743$1$I$20231215$20240920$20240926$20240926$EXP$$CA-TAKEDA-2023TUS122334$TAKEDA$$71$YR$$F$Y$$$20240926$$CN$CA$CA
243657441$24365744$1$I$$20240916$20240926$20240926$EXP$$NL-CELLTRION INC.-2024NL022764$CELLTRION$Fine S.. PULMONARY HISTOPLASMOSIS IN A PATIENT WITH CROHN^S DISEASE ON ANTI-TNF INHIBITOR THERAPY.. Gastroenterology. 2024$$$$$Y$$$20240926$$HP$NL$NL
243657451$24365745$1$I$20231130$20240905$20240926$20240926$EXP$FR-AFSSAPS-TO2024000467$FR-CELLTRION INC.-2024FR022777$CELLTRION$$$$$$Y$$$20240926$$PH$FR$FR
243657462$24365746$2$F$$20240923$20240926$20240926$PER$$US-ROCHE-10000089881$ROCHE$$$$E$F$Y$$$20240926$$CN$US$US
243657471$24365747$1$I$$20240915$20240926$20240926$PER$$US-JNJFOC-20240946007$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243657481$24365748$1$I$$20240903$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005304$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$HP$US$US
243657491$24365749$1$I$$20240904$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005325$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243657521$24365752$1$I$20201001$20240920$20240926$20240926$EXP$PL-URPL-1-1998-2020$PL-TEVA-VS-3246632$TEVA$$23$YR$$F$Y$65$KG$20240926$$PH$PL$PL
243657531$24365753$1$I$20240522$20240916$20240926$20240926$EXP$$CA-TAKEDA-2024TUS053064$TAKEDA$$70$YR$$F$Y$66.3$KG$20240926$$CN$CA$CA
243657541$24365754$1$I$$20240919$20240926$20240926$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR117068$VIIV$$$$$$Y$$$20240926$$CN$US$US
243657551$24365755$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011346$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243657561$24365756$1$I$20240914$20240914$20240926$20240926$EXP$$US-BAYER-2024A132183$BAYER$$24$MON$C$M$Y$$$20240926$$CN$US$US
243657571$24365757$1$I$20210101$20240918$20240926$20240926$EXP$$US-ROCHE-10000085801$ROCHE$$61$YR$A$F$Y$49.9$KG$20240926$$CN$US$US
243657581$24365758$1$I$$20220924$20240926$20240926$PER$$US-BAYER-2024A136963$BAYER$$$$$$Y$$$20240926$$CN$US$US
243657591$24365759$1$I$20240604$20240919$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-047190$AUROBINDO$$42$YR$$M$Y$$$20240926$$PH$FR$FR
243657601$24365760$1$I$$20240920$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150907$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$HP$US$US
243657611$24365761$1$I$20240901$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015343$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240926$$CN$US$US
243657621$24365762$1$I$20240901$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015195$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240926$$CN$US$US
243657641$24365764$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5933878$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243657651$24365765$1$I$$20240923$20240926$20240926$EXP$$CA-ROCHE-10000088615$ROCHE$$59$YR$A$M$Y$70$KG$20240926$$HP$CA$CA
243657661$24365766$1$I$$20240925$20240926$20240926$PER$$US-ROCHE-10000091445$ROCHE$$37$YR$A$F$Y$$$20240926$$PH$US$US
243657671$24365767$1$I$$20240925$20240926$20240926$PER$$US-ROCHE-10000092098$ROCHE$$$$A$M$Y$$$20240926$$CN$US$US
243657681$24365768$1$I$$20240918$20240926$20240926$EXP$$BD-ROCHE-10000085500$ROCHE$$52$YR$A$F$Y$80$KG$20240926$$CN$BD$BD
243657691$24365769$1$I$20240701$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046750$AUROBINDO$$69$YR$$M$Y$93$KG$20240926$$MD$FR$FR
243657701$24365770$1$I$20240828$20240920$20240926$20240926$EXP$ES-AEMPS-1569549$ES-TEVA-VS-3246564$TEVA$$67$YR$$M$Y$87$KG$20240926$$MD$ES$ES
243657711$24365771$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3246123$TEVA$Wang M, Reynolds KL, Montazeri K, Schaefer EA, Sullivan RJ, Dougan M. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clin-Gastroenterol-Hepatol 2024; 22 (7): 1539-1541.e2.; Wang M, Reynolds KL, Montazeri K, Schaefer EA, Sullivan RJ, Dougan M. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clin-Gastroenterol-Hepatol 2024; 22 (7): 1539-1541.e2.$46$YR$$F$Y$$$20240926$$HP$US$US
243657721$24365772$1$I$$20240918$20240926$20240926$EXP$$CA-APOTEX-2024AP011148$APOTEX$$61$YR$$F$Y$$$20240926$$CN$CA$CA
243657731$24365773$1$I$$20240911$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09120$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243657741$24365774$1$I$20240822$20240916$20240926$20240926$PER$$US-ABBVIE-5928056$ABBVIE$$53$YR$$F$Y$$$20240926$$CN$US$US
243657751$24365775$1$I$20240813$20240917$20240926$20240926$EXP$$DE-AUROBINDO-AUR-APL-2024-046797$AUROBINDO$$81$YR$$M$Y$52$KG$20240926$$MD$DE$DE
243657761$24365776$1$I$20240101$20240919$20240926$20240926$EXP$$IN-CIPLA LTD.-2024IN10498$CIPLA$$$$$$Y$$$20240926$$MD$IN$IN
243657771$24365777$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001717$ORGANON$$40$YR$$F$Y$$$20240926$$HP$CA$CA
243657811$24365781$1$I$$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65757$$FDA-CTU$$$$$M$N$$$20240924$N$HP$US$
243657821$24365782$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65782$$FDA-CTU$$28$YR$$F$N$$$20240925$N$$US$
243657831$24365783$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65821$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243657841$24365784$1$I$$20240921$20240925$20240925$DIR$FDA-CDER-CTU-2024-65905$$FDA-CTU$$$$$F$N$$$20240921$N$HP$US$
243657851$24365785$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65767$$FDA-CTU$$91$YR$$F$N$$$20240925$N$$US$
243657871$24365787$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65811$$FDA-CTU$$65$YR$$F$N$49.9$KG$20240925$N$$US$
243657881$24365788$1$I$$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65806$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243657891$24365789$1$I$20240910$20240910$20240925$20240925$DIR$FDA-CDER-CTU-2024-65776$$FDA-CTU$$58$YR$$M$N$$$20240910$N$PH$US$
243657901$24365790$1$I$$20240918$20240926$20240926$EXP$$CA-APOTEX-2024AP011254$APOTEX$$72$YR$$M$Y$$$20240926$$CN$CA$CA
243657911$24365791$1$I$$20240916$20240926$20240926$EXP$$PT-MACLEODS PHARMA-MAC2024049464$MACLEODS$Mestre D, Gil F..Central Venous Catheter Misplacement Presenting With Parotid Gland Swelling: A Case Report..Cureus.2024;16(8):e66245$$$$$Y$$$20240926$$MD$PT$PT
243657921$24365792$1$I$20221001$20240916$20240926$20240926$EXP$$US-MACLEODS PHARMA-MAC2024049463$MACLEODS$Levi D, Horn S, Murphy J, Levin J..Safety of dexamethasone in transforaminal epidural steroid injections: A case of temporary paraplegia caused by injection of lidocaine and dexamethasone into a lumbar radiculomedullary artery, with no neurologic sequelae.Interventional pain medicine.2023;2(1):100240$$$$$Y$$$20240926$$MD$US$US
243657931$24365793$1$I$$20240916$20240926$20240926$EXP$$US-MACLEODS PHARMA-MAC2024049460$MACLEODS$$$$$$Y$$$20240926$$MD$GB$US
243657941$24365794$1$I$$20240917$20240926$20240926$EXP$$US-MACLEODS PHARMA-MAC2024049500$MACLEODS$Malani KA, Finn A..Metformin-associated lactic acidosis: a serious complication of a common drug.BMJ Case Reports.2024;17(9):e260592$$$$$Y$$$20240926$$MD$US$US
243657951$24365795$1$I$20240721$20240916$20240926$20240926$EXP$IT-MINISAL02-1002619$IT-MACLEODS PHARMA-MAC2024049466$MACLEODS$$$$$$Y$$$20240926$$MD$IT$IT
243657961$24365796$1$I$$20240916$20240926$20240926$EXP$GB-MHRA-MED-202409142302073110-RQNDG$GB-MACLEODS PHARMA-MAC2024049469$MACLEODS$$$$$$Y$$$20240926$$CN$GB$GB
243657971$24365797$1$I$20240810$20240916$20240926$20240926$EXP$$GB-MACLEODS PHARMA-MAC2024049473$MACLEODS$$$$$$Y$$$20240926$$MD$GB$GB
243657981$24365798$1$I$20230101$20240917$20240926$20240926$EXP$$AU-MACLEODS PHARMA-MAC2024049488$MACLEODS$Poon J, Coombes F, Coombes I.Sum of the parts: a cascade of adverse effects.Australian Prescriber.2024;47(4):125-8$$$$$Y$$$20240926$$HP$AU$AU
243657991$24365799$1$I$$20240924$20240926$20240926$EXP$$CA-ROCHE-10000091487$ROCHE$$$$A$F$Y$$$20240926$$CN$CA$CA
243658001$24365800$1$I$$20240916$20240926$20240926$EXP$$JP-MACLEODS PHARMA-MAC2024049476$MACLEODS$Kaneko M, Akimoto T, Nagata D..Fluoroquinolone-Associated Tendinopathy: An Important Complication of Cyst Infection Management in Polycystic Kidney Disease.International Medical Case Reports Journal.16-SEP-2024;17:777-781$$$$$Y$$$20240926$$HP$JP$JP
243658011$24365801$1$I$20240906$20240920$20240926$20240926$EXP$$CN-ROCHE-10000088564$ROCHE$$62$YR$A$F$Y$57$KG$20240926$$HP$CN$CN
243658021$24365802$1$I$$20240917$20240926$20240926$EXP$$NL-AUROBINDO-AUR-APL-2024-046831$AUROBINDO$$80$YR$$F$Y$72.2$KG$20240926$$MD$NL$NL
243658041$24365804$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191476$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
243658051$24365805$1$I$$20240925$20240926$20240926$PER$$US-ROCHE-10000090997$ROCHE$$64$YR$A$F$Y$$$20240926$$CN$US$US
243658061$24365806$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005359$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243658071$24365807$1$I$20240102$20240917$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046263$AUROBINDO$$62$YR$$M$Y$$$20240926$$MD$FR$FR
243658081$24365808$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114977$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
243658091$24365809$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011347$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243658101$24365810$1$I$$20240911$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09139$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243658111$24365811$1$I$20240401$20240911$20240926$20240926$EXP$$LV-GRANULES-LV-2024GRALIT00411$GRANULES INDIA$https://dx.doi.org/10.3389/fpsyt.2024.1456455.Sertraline induced acute hepatocellular liver injury in patient with major depressive disorder: a case report.Frontiers in Psychiatry.01-AUG-2024;15:1-7$36$YR$A$F$Y$$$20240926$$HP$LV$LV
243658121$24365812$1$I$20231218$20240924$20240926$20240926$EXP$$NVSC2024US190627$NOVARTIS$$84$YR$$F$Y$$$20240926$$MD$US$US
243658131$24365813$1$I$$20240912$20240926$20240926$EXP$$JP-MARKSANS PHARMA LIMITED-MPL202400062$MARKSANS$Ariga M, Hagita J, Soda M, Oida Y, Teramachi H and Kitaichi K. Daily dose of metformin caused acute kidney injury with lactic acidosis: a case report. Journal of Medical Case Reports. 2023;17:393$60$YR$$M$Y$69.3$KG$20240926$$HP$JP$JP
243658141$24365814$1$I$$20240916$20240926$20240926$EXP$$US-BAYER-2024A133985$BAYER$$$$$$Y$$$20240926$$CN$US$US
243658162$24365816$2$F$$20240923$20240926$20240927$EXP$$NVSC2024DE189014$NOVARTIS$Aicher A, Sindrilaru A, Crisan D, Thaiss W, Steinacker J, Beer M et al.. Scharffetter-Kochanek K, Beer AJ, Prasad V.. Short-Interval, Low-Dose Peptide Receptor Radionuclide Therapy in Combination with PD-1 Checkpoint Immunotherapy Induces Remission in Immunocompromised Patients with Metastatic Merkel Cell Carcinoma. PHARMACEUTICS. 2022;14:1466$85$YR$$F$Y$$$20240927$$HP$DE$DE
243658171$24365817$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011360$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243658181$24365818$1$I$20240924$20240924$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-047454$AUROBINDO$$62$YR$$M$Y$87$KG$20240926$$CN$GB$GB
243658192$24365819$2$F$$20240926$20240926$20240927$PER$$NVSC2024US191481$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
243658201$24365820$1$I$$20240911$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09140$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243658211$24365821$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011311$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243658221$24365822$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011348$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243658231$24365823$1$I$$20240916$20240926$20240926$EXP$$CN-TEYRO-2024-TY-000663$Teyro Labs$Li K, Zhong W, Fan J, Wang S, Yu D, Huang J, et.al.Neoadjuvant gemcitabine-cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial..Nat Cancer..2024$$$$$Y$$$20240926$$HP$CN$CN
243658251$24365825$1$I$$20240916$20240926$20240926$EXP$$ES-IPCA LABORATORIES LIMITED-IPC-2024-ES-002273$IPCA$Luis Mariano Rojas-Medina, Lucia Esteban-Fernandez, Estrella Barrero Ruiz, et al. The tractography a useful tool in brain asymmetry. Stereotact Funct Neurosurg. 2024;102 (suppl 1):115-116$$$$$Y$$$20240926$$HP$ES$ES
243658261$24365826$1$I$20240721$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10515$CIPLA$$$$$$Y$$$20240926$$HP$AU$AU
243658271$24365827$1$I$$20240911$20240926$20240926$EXP$$TR-GRANULES-TR-2024GRALIT00410$GRANULES INDIA$Dudu Demiroz.Isotretinoin-related depression: a case report.Psychiatry and Clinical Psychopharmacology.JAN-2019;29:251-252$20$YR$A$F$Y$$$20240926$$HP$TR$TR
243658281$24365828$1$I$$20240918$20240926$20240926$EXP$$BR-AUROBINDO-AUR-APL-2024-046646$AUROBINDO$Pinheiro MM, de Souza LG, Nunes GP, Martin IF, de Oliveira YU, Pinheiro FMM, et al. The first report of leukocytoclastic vasculitis induced by once-weekly subcutaneous semaglutide. Curr-MedRes-Opin. 2024;40(9):1525-1531$73$YR$$M$Y$$$20240926$$HP$BR$BR
243658291$24365829$1$I$20240201$20240913$20240926$20240926$EXP$GB-MHRA-MED-202409130956002900-GBVFD$GB-GLENMARK PHARMACEUTICALS-2024GMK094096$GLENMARK$$$$$$Y$$$20240926$$CN$GB$GB
243658301$24365830$1$I$$20240827$20240926$20240926$PER$$US-009507513-2409USA008263$MERCK$Aguilera D, Janss A, Schniederjan M, Goldman-Yassen A, Velazquez J, Mazewski C, et al.. ANAPLASTIC TRANSFORMATION OF DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMORS: TWO PEDIATRIC CASES. Neuro-Oncology. 2024;26 (Suppl. 4):iv199$$$C$M$Y$$$20240926$$HP$US$US
243658321$24365832$1$I$20240525$20240920$20240926$20240926$EXP$IT-MINISAL02-1002210$IT-TEVA-VS-3246168$TEVA$$71$YR$$M$Y$$$20240926$$PH$IT$IT
243658331$24365833$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114954$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243658341$24365834$1$I$20240501$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152500$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240926$$CN$US$US
243658351$24365835$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005360$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243658361$24365836$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011372$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243658371$24365837$1$I$$20240925$20240926$20240926$EXP$$GR-TAKEDA-2024TUS095114$TAKEDA$$71$YR$$M$Y$$$20240926$$HP$GR$GR
243658381$24365838$1$I$$20240922$20240926$20240926$EXP$$CA-ASTELLAS-2024-AER-008539$ASTELLAS$$40$YR$A$F$Y$$$20240926$$HP$CA$CA
243658401$24365840$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65936$$FDA-CTU$$77$YR$$M$N$$$20240925$N$$US$
243658411$24365841$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65812$$FDA-CTU$$32$YR$$F$N$$$20240925$N$$US$
243658431$24365843$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65803$$FDA-CTU$$71$YR$$F$N$$$20240925$N$$US$
243658441$24365844$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65927$$FDA-CTU$$65$YR$$F$N$$$20240925$N$$US$
243658451$24365845$1$I$$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65760$$FDA-CTU$$$$$M$N$$$20240924$N$HP$US$
243658461$24365846$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65929$$FDA-CTU$$73$YR$$M$N$$$20240925$N$$US$
243658491$24365849$1$I$$20240911$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09143$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243658501$24365850$1$I$$20240916$20240926$20240926$EXP$$CN-TEYRO-2024-TY-000632$Teyro Labs$Liu X, Peng X, Yang S, Liu H, Zhang S, Li Yet al..Salvage chemotherapy regimens with arsenic trioxide for relapsed or refractory neuroblastoma: a promising approach..BMC Cancer.2024;24:1140$$$$$Y$$$20240926$$HP$CN$CN
243658511$24365851$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005364$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243658521$24365852$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10575$CIPLA$Geara S, Hwang Y, Elias A, Liu W. Medication or illness? Antiviral induced encephalopathy. J-Neurol-Sci. 2023;455 (Suppl.)$$$$$Y$$$20240926$$HP$AU$AU
243658531$24365853$1$I$$20240917$20240926$20240926$EXP$$JP-ROCHE-10000090003$ROCHE$Saito A, Kodama K, Kuronuma K, Chiba H. 2 A case of pulmonary aspergilloma which was formed within lung cysts after the patient contracted COVID-19. The 2nd Annual Meeting of Hokkaido Medical Mycology Society. 2024;15$7$DEC$E$F$Y$$$20240926$$MD$JP$JP
243658541$24365854$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005365$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243658551$24365855$1$I$$20240924$20240926$20240926$EXP$$CA-ABBVIE-5937133$ABBVIE$$58$YR$$F$Y$$$20240926$$HP$CA$CA
243658562$24365856$2$F$20240208$20240917$20240926$20240928$EXP$PT-INFARMED-B202403-757$PT-CELLTRION INC.-2024PT022738$CELLTRION$$$$$$Y$$$20240928$$MD$PT$PT
243658571$24365857$1$I$$20240911$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09146$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243658581$24365858$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65819$$FDA-CTU$$38$YR$$F$N$$$20240925$N$$US$
243658601$24365860$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65786$$FDA-CTU$$61$YR$$F$N$89.81$KG$20240925$N$$US$
243658611$24365861$1$I$20240924$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015383$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240926$$CN$US$US
243658621$24365862$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU08538$CIPLA$Buckling H, Barlow T, Zielinski R, Karve S. Lorlatinib induced severe hyperlipidaemia: A case report. Heart-Lung-Circ. 2024;33 (Suppl. 4):S302$$$$$Y$$$20240926$$HP$AU$AU
243658631$24365863$1$I$20240916$20240916$20240926$20240926$PER$$US-BIOGEN-2024BI01282881$BIOGEN$$45$YR$$F$Y$$$20240926$$CN$US$US
243658641$24365864$1$I$$20240923$20240926$20240926$EXP$$US-ROCHE-10000089583$ROCHE$$77$YR$E$M$Y$$$20240926$$HP$US$US
243658651$24365865$1$I$20240923$20240923$20240926$20240926$PER$$US-ABBVIE-5938016$ABBVIE$$17$YR$$$Y$$$20240926$$HP$US$US
243658661$24365866$1$I$20240910$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152291$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240926$$HP$US$US
243658671$24365867$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65886$$FDA-CTU$$45$YR$$F$N$$$20240925$N$$US$
243658681$24365868$1$I$20240914$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65799$$FDA-CTU$$77$YR$$F$N$37.19$KG$20240925$N$PH$US$
243658691$24365869$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65801$$FDA-CTU$$$$$F$N$$$20240925$N$HP$US$
243658701$24365870$1$I$$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150489$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$58.97$KG$20240926$$HP$US$US
243658711$24365871$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65854$$FDA-CTU$$47$YR$$F$N$267$LBS$20240925$N$HP$US$
243658731$24365873$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65770$$FDA-CTU$$53$YR$$F$N$82.55$KG$20240925$N$$US$
243658751$24365875$1$I$$20240916$20240926$20240926$EXP$$US-BAYER-2024A137321$BAYER$$$$$$Y$$$20240926$$CN$US$US
243658761$24365876$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000091184$ROCHE$$$$$$Y$$$20240926$$HP$US$US
243658771$24365877$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65932$$FDA-CTU$$61$YR$$F$N$$$20240925$N$$US$
243658781$24365878$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10581$CIPLA$$$$$$Y$$$20240926$$CN$AU$AU
243658791$24365879$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011373$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243658801$24365880$1$I$$20240916$20240926$20240926$EXP$$CN-TEYRO-2024-TY-000630$Teyro Labs$Liu X, Peng X, Yang S, Liu H, Zhang S, Li Y, et al..Salvage chemotherapy regimens with arsenic trioxide for relapsed or refractory neuroblastoma: a promising approach..BMC Cancer.2024;24:1140$$$$$Y$$$20240926$$HP$CN$CN
243658811$24365881$1$I$$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1085500$MYLAN$Ritter A, Kensey N, Higgs J, Zainah H. Cavitary lung lesions caused by Pneumocystis jirovecii in a patient with myelofibrosis on ruxolitinib. BMJ-Case-Rep 2024; 17 (8): 1-5.$7$DEC$$F$Y$$$20240926$$MD$US$US
243658821$24365882$1$I$$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1085714$MYLAN$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann-Rheum-Dis 2022; 81 (2): 289-291.$$$A$$Y$$$20240926$$MD$US$US
243658831$24365883$1$I$$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1085678$MYLAN$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann-Rheum-Dis 2022; 81 (2): 289-291.$$$A$$Y$$$20240926$$MD$US$US
243658841$24365884$1$I$$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1085702$MYLAN$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann-Rheum-Dis 2022; 81 (2): 289-291.$$$A$$Y$$$20240926$$MD$US$US
243658851$24365885$1$I$$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1085364$MYLAN$Timtim E, Barahimi B, Mawn LA, Sobel RK. Sebaceous carcinoma masquerading as ocular mucous membrane pemphigoid. Orbit 2024; 43 (4): 531-534.$60$YR$$F$Y$$$20240926$$HP$US$US
243658861$24365886$1$I$$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1085338$MYLAN$Timtim E, Barahimi B, Mawn LA, Sobel RK. Sebaceous carcinoma masquerading as ocular mucous membrane pemphigoid. Orbit 2024; 43 (4): 531-534.$95$YR$$F$Y$$$20240926$$HP$US$US
243658871$24365887$1$I$$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1085669$MYLAN$Gabbay JM, Place AE, Ilowite M, Zhu J. Use of the osmolal gap in diagnosing mixed physiology hyponatremia in a child with B-cell acute lymphoblastic leukemia. Clin-Case-Rep 2023; 11 (6):.$12$YR$$M$Y$$$20240926$$HP$US$US
243658891$24365889$1$I$$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1085713$MYLAN$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann-Rheum-Dis 2022; 81 (2): 289-291.$$$E$$Y$$$20240926$$MD$US$US
243658901$24365890$1$I$$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1085682$MYLAN$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann-Rheum-Dis 2022; 81 (2): 289-291.$$$A$$Y$$$20240926$$MD$US$US
243658911$24365891$1$I$$20240916$20240926$20240926$EXP$$FR-MYLANLABS-2024M1086140$MYLAN$Dufraigne A, Perinel-Ragey S, Guitton J, Cohen S, Thiery G, Launay M. Monitoring of Tissue and Plasma Imipenem Concentrations for the Treatment of Necrotizing Fasciitis With Carbapenem-Resistant Enterobacteriaceae-A Letter to the Editor. Ther-Drug-Monit 2024; 46 (4): 552-553.$64$YR$$M$Y$$$20240926$$MD$FR$FR
243658921$24365892$1$I$$20240916$20240926$20240926$EXP$$JP-MYE-2024M1086410AA$MYLAN$Kimura M, Fujiwara S, Kuroda H, Kanamori M, Kawamoto M. Choroid plexitis caused by Burkholderia cepacia complex after COVID-19. Int-J-Infect-Dis 2024; 147.. 2024;147$67$YR$$F$Y$$$20240926$$HP$JP$JP
243658931$24365893$1$I$$20240923$20240926$20240926$EXP$$US-BAYER-2024A135545$BAYER$$$$$$Y$$$20240926$$CN$US$US
243658941$24365894$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191490$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
243658951$24365895$1$I$20230914$20240919$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-046506$AUROBINDO$$56$YR$$M$Y$75$KG$20240926$$CN$GB$GB
243658961$24365896$1$I$20210101$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1085509$MYLAN$Rustom DS, Wall BM, Talwar M. Malakoplakia in kidney transplant causing severe hydronephrosis and successful treatment with antibiotics and lowering immunosuppression. Transpl-Infect-Dis 2023; 25 e14158.$55$YR$$M$Y$$$20240926$$HP$US$US
243658971$24365897$1$I$$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1085677$MYLAN$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, et al. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann-Rheum-Dis 2022; 81 (2): 289-291.$$$E$$Y$$$20240926$$MD$US$US
243658991$24365899$1$I$$20240911$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09147$LUPIN$$$$$$Y$$$20240926$$CN$US$US
243659001$24365900$1$I$$20240916$20240926$20240926$EXP$$PT-IPCA LABORATORIES LIMITED-IPC-2024-PT-002244$IPCA$David Mistre and Francisco Gil. Central Venous Catheter Misplacement Presenting With Parotid Gland Swelling: A Case Report. Cureus. 2024;16(8):e66245:1-5$$$$$Y$$$20240926$$MD$PT$PT
243659031$24365903$1$I$$20240917$20240926$20240926$PER$$US-ASTELLAS-2024-AER-008229$ASTELLAS$$$$A$M$Y$88$KG$20240926$$HP$US$US
243659041$24365904$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011354$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243659051$24365905$1$I$$20240911$20240926$20240926$EXP$$CN-GRANULES-CN-2024GRALIT00409$GRANULES INDIA$H Xin.Efficacy and safety of dupilumab in the treatment of 123 cases of atopic dermatitis..Chinese Journal of Dermatology.JAN-2022;55:486-493$4$YR$C$F$Y$$$20240926$$HP$CN$CN
243659061$24365906$1$I$20240109$20240919$20240926$20240926$EXP$GB-MHRA-MED-202409191157153090-GQMPY$GB-TEVA-VS-3245904$TEVA$$35$YR$$F$Y$55$KG$20240926$$CN$GB$GB
243659071$24365907$1$I$$20240919$20240926$20240926$EXP$$NVSC2024TR190093$NOVARTIS$Saridas F, Koc ER, Ozkaya G, Turan OF. Fingolimod real life experience in non-naive multiple sclerosis patients. THE EUROPEAN RESEARCH JOURNAL. 2024;10 (5):430-8$$$$$Y$$$20240926$$HP$TR$TR
243659081$24365908$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191492$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
243659091$24365909$1$I$20240101$20240917$20240926$20240926$PER$$US-ASTELLAS-2024-AER-007638$ASTELLAS$$$$$F$Y$$$20240926$$HP$US$US
243659101$24365910$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024AMR115360$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243659111$24365911$1$I$$20240916$20240926$20240926$EXP$$CN-TEYRO-2024-TY-000631$Teyro Labs$Liu X, Peng X, Yang S, Liu H, Zhang S, ]Li Y, et al..Salvage chemotherapy regimens with arsenic trioxide for relapsed or refractory neuroblastoma: a promising approach..BMC Cancer.2024;24:1140$$$$$Y$$$20240926$$HP$CN$CN
243659121$24365912$1$I$$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150163$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240926$$HP$US$US
243659131$24365913$1$I$20230101$20240916$20240926$20240926$EXP$$US-TEVA-VS-3246081$TEVA$Hosseini R, Brooks SP, Gadelha E, Schaap R, Cook J, Husan A. Effective Treatment of Methotrexate Induced Oral Mucositis With a Morphine Mouthwash Solution: A Case Report. J-Pharm-Pract 2024;.; Hosseini R, Brooks SP, Gadelha E, Schaap R, Cook J, Husan A. Effective Treatment of Methotrexate Induced Oral Mucositis With a Morphine Mouthwash Solution: A Case Report. J-Pharm-Pract 2024;.$67$YR$$F$Y$$$20240926$$PH$US$US
243659141$24365914$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011367$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243659151$24365915$1$I$$20240924$20240926$20240926$PER$$US-HALEON-2198666$Haleon PLC$$$$$$Y$$$20240926$$CN$US$US
243659161$24365916$1$I$$20240924$20240926$20240926$PER$$US-HALEON-2198668$Haleon PLC$$$$$M$Y$$$20240926$$CN$US$US
243659171$24365917$1$I$20240801$20240916$20240926$20240926$PER$$US-ASTELLAS-2024-AER-007356$ASTELLAS$$77$YR$E$M$Y$$$20240926$$CN$US$US
243659191$24365919$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005366$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243659201$24365920$1$I$$20240920$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-046867$AUROBINDO$$79$YR$$F$Y$64$KG$20240926$$PH$GB$GB
243659211$24365921$1$I$$20240916$20240926$20240926$PER$$US-ABBVIE-5927377$ABBVIE$$$$$$Y$$$20240926$$CN$US$US
243659251$24365925$1$I$20240501$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65938$$FDA-CTU$$76$YR$$M$N$$$20240925$N$PH$US$
243659281$24365928$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65925$$FDA-CTU$$9$YR$$F$N$28.58$KG$20240925$N$HP$US$
243659291$24365929$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65813$$FDA-CTU$$63$YR$$F$N$$$20240925$N$$US$
243659301$24365930$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65772$$FDA-CTU$$66$YR$$M$N$203$LBS$20240925$N$HP$US$
243659311$24365931$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65778$$FDA-CTU$$61$YR$$F$N$198$LBS$20240925$N$$US$
243659321$24365932$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65779$$FDA-CTU$$$$$F$N$$$20240925$N$HP$US$
243659371$24365937$1$I$$20240916$20240926$20240926$EXP$$US-ROCHE-10000086772$ROCHE$Chumakova A, Thai G, Demetriou M, Bierman A, Sy M. Multiplex serum biomarker testing provides insights into nature of hypogammaglobulinemia patients with multiple sclerosis on B-cell depleting agents. (Abstract no: P1603/1446). Multiple Sclerosis Journal. 2024;30 (3s):1015.$$$$$Y$$$20240926$$HP$US$US
243659381$24365938$1$I$$20240918$20240925$20240925$DIR$FDA-CDER-CTU-2024-65755$$FDA-CTU$$$$$M$N$$$20240918$N$HP$US$
243659391$24365939$1$I$20240724$20240913$20240926$20240926$EXP$$DE-UCBSA-2024040010$UCB$$62$YR$$F$Y$$$20240926$$HP$DE$DE
243659411$24365941$1$I$20240801$20240913$20240926$20240926$EXP$$US-UCBSA-2024047741$UCB$$44$YR$$M$Y$$$20240926$$HP$US$US
243659431$24365943$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000090529$ROCHE$$$$A$F$Y$$$20240926$$CN$US$US
243659441$24365944$1$I$20240917$20240917$20240926$20240926$PER$$US-BIOGEN-2024BI01283100$BIOGEN$$24$YR$$M$Y$$$20240926$$CN$US$US
243659461$24365946$1$I$$20240913$20240926$20240926$EXP$$DE-AUROBINDO-AUR-APL-2024-046437$AUROBINDO$Todliche kombi: loperamid und tonic. APOTHEKE ADHOC (PHARMACY ADHOC). 2024$25$YR$$F$Y$$$20240926$$HP$DE$DE
243659471$24365947$1$I$$20240919$20240926$20240926$EXP$$CA-GSK-CA2023159014$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CA$CA
243659481$24365948$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65900$$FDA-CTU$$55$YR$$F$N$$$20240925$N$$US$
243659501$24365950$1$I$20240815$20240924$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-047469$AUROBINDO$$74$YR$$M$Y$74$KG$20240926$$MD$GB$GB
243659521$24365952$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005368$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243659531$24365953$1$I$20240101$20240920$20240926$20240926$EXP$$CA-JNJFOC-20240958344$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20240926$$PH$CA$CA
243659541$24365954$1$I$20240919$20240919$20240926$20240926$PER$$US-JNJFOC-20240960032$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20240926$$CN$US$US
243659561$24365956$1$I$20240101$20240914$20240926$20240926$EXP$$US-UCBSA-2024048015$UCB$$$$$F$Y$$$20240926$$HP$US$US
243659571$24365957$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65824$$FDA-CTU$$65$YR$$F$N$$$20240925$N$$US$
243659581$24365958$1$I$20230101$20240920$20240926$20240926$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-01055$CATALYST PHARMA$$$$$F$Y$$$20240926$$CN$US$US
243659591$24365959$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65804$$FDA-CTU$$60$YR$$F$N$$$20240925$N$$US$
243659601$24365960$1$I$20240101$20240918$20240926$20240926$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-00099$CATALYST PHARMA$$$$$F$Y$67.8$KG$20240926$$CN$US$US
243659621$24365962$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65846$$FDA-CTU$$77$YR$$F$N$119.29$KG$20240925$N$$US$
243659631$24365963$1$I$20240909$20240918$20240926$20240926$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-01045$CATALYST PHARMA$$40$YR$$M$Y$92.971$KG$20240926$$CN$US$US
243659641$24365964$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011352$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243659651$24365965$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65805$$FDA-CTU$$59$YR$$M$N$$$20240925$N$$US$
243659671$24365967$1$I$20230918$20240917$20240926$20240926$EXP$$BR-TAKEDA-2023TUS093654$TAKEDA$$80$YR$$F$Y$$$20240926$$CN$BR$BR
243659691$24365969$1$I$$20240920$20240926$20240926$EXP$$GB-MYLANLABS-2024M1086231$MYLAN$$$$$F$Y$$$20240926$$PH$GB$GB
243659712$24365971$2$F$$20240924$20240926$20240930$PER$$NVSC2024US190955$NOVARTIS$$$$$F$Y$$$20240930$$HP$US$US
243659721$24365972$1$I$$20240918$20240926$20240926$EXP$$JP-EXELIXIS-EXL-2024-000526$EXELIXIS$$68$YR$$M$Y$$$20240926$$MD$JP$JP
243659731$24365973$1$I$20240719$20240926$20240926$20240926$EXP$FR-AFSSAPS-DJ2024001060$NVSC2024FR191272$NOVARTIS$$20$YR$$M$Y$54$KG$20240926$$MD$FR$FR
243659741$24365974$1$I$$20240924$20240926$20240926$PER$$NVSC2024US191039$NOVARTIS$$$$$F$Y$$$20240926$$MD$US$US
243659751$24365975$1$I$$20240919$20240926$20240926$EXP$$MY-ASTELLAS-2024-AER-008061$ASTELLAS$$$$A$$Y$$$20240926$$MD$MY$MY
243659761$24365976$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001683$ORGANON$$$$$F$Y$$$20240926$$HP$CA$CA
243659771$24365977$1$I$$20240917$20240926$20240926$PER$$US-GSK-US2024AMR117445$GLAXOSMITHKLINE$$31$YR$$F$Y$$$20240926$$CN$GB$US
243659781$24365978$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114953$GLAXOSMITHKLINE$$$$$M$Y$$$20240926$$CN$US$US
243659801$24365980$1$I$$20240918$20240926$20240926$EXP$$JP-EXELIXIS-EXL-2024-000527$EXELIXIS$$58$YR$$M$Y$$$20240926$$MD$JP$JP
243659811$24365981$1$I$$20240916$20240926$20240926$EXP$$US-STERISCIENCE B.V.-2024-ST-001474$Steriscience PTE$Vannatta M, Grier L, Khan MH, Pinargote Cornejo P, Alam M, Moussa SH, et al.. In Vivo Emergence of Pandrug-Resistant Acinetobacter baumannii Strain: Comprehensive Resistance Characterization and Compassionate Use of Sulbactam-Durlobactam.. Open-Forum-Infect-Dis. 2023;10 (10):no pagination.$44$YR$$M$Y$$$20240926$$HP$US$US
243659831$24365983$1$I$$20240918$20240926$20240926$EXP$$JP-EXELIXIS-EXL-2024-000537$EXELIXIS$$59$YR$$M$Y$$$20240926$$MD$JP$JP
243659841$24365984$1$I$$20240916$20240926$20240926$EXP$$IN-STERISCIENCE B.V.-2024-ST-001478$Steriscience PTE$Bhowmick SS. Metabolic Opsoclonus Myoclonus Syndrome in a Patient of Crohn^s Disease: Lessons Learnt. Ann-Indian-Acad-Neurol. 2023;26 (5):793-794.$51$YR$$M$Y$$$20240926$$MD$IN$IN
243659851$24365985$1$I$$20240923$20240926$20240926$PER$$US-BIOGEN-2023BI01226900$BIOGEN$$$$$F$Y$$$20240926$$MD$US$US
243659861$24365986$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152600$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$56.7$KG$20240926$$CN$US$US
243659871$24365987$1$I$$20240916$20240926$20240926$EXP$$CN-TEYRO-2024-TY-000659$Teyro Labs$Li K, Zhong W, Fan J, Wang S, Yu D, Huang J, et.al.Neoadjuvant gemcitabine-cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial..Nat Cancer..2024$$$$$Y$$$20240926$$HP$CN$CN
243659891$24365989$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152658$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$$$20240926$$CN$US$US
243659901$24365990$1$I$20240910$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150733$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$66.22$KG$20240926$$PH$US$US
243659911$24365991$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152052$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240926$$CN$US$US
243659921$24365992$1$I$$20240916$20240926$20240926$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005678$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240926$$CN$US$US
243659941$24365994$1$I$20240801$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152574$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240926$$HP$US$US
243659951$24365995$1$I$$20240814$20240926$20240926$30DAY$$US-PFIZER INC-202400237251$PFIZER$$9$YR$$M$Y$$$20240926$$CN$US$US
243659961$24365996$1$I$20240826$20240919$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-152093$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240926$$MD$JP$JP
243659971$24365997$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152413$BRISTOL MYERS SQUIBB$$29$YR$A$M$Y$$$20240926$$CN$US$US
243659981$24365998$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151866$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240926$$PH$US$US
243659991$24365999$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011362$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243660001$24366000$1$I$$20240916$20240926$20240926$EXP$$US-UCBSA-2024047815$UCB$$$$$F$Y$60.317$KG$20240926$$HP$US$US
243660011$24366001$1$I$20240901$20240916$20240926$20240926$EXP$$US-UCBSA-2024047854$UCB$$37$YR$$F$Y$$$20240926$$HP$US$US
243660031$24366003$1$I$20240814$20240916$20240926$20240926$EXP$$US-UCBSA-2024047753$UCB$$35$YR$$M$Y$110.39$KG$20240926$$HP$US$US
243660041$24366004$1$I$$20240924$20240926$20240926$EXP$$NVSC2024US190720$NOVARTIS$$$$$F$Y$$$20240926$$HP$US$US
243660051$24366005$1$I$$20240916$20240926$20240926$EXP$$CN-STERISCIENCE B.V.-2024-ST-001482$Steriscience PTE$Wang Y, Fang Y, Yan Z, Xia R, Zeng W, Deng W, et al.. Fatal BK polyomavirus-associated pneumonia: report of two cases with literature review.. BMC-Infect-Dis. 2023;23:1-9$6$YR$$M$Y$$$20240926$$HP$CN$CN
243660061$24366006$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011359$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243660071$24366007$1$I$20240831$20240923$20240926$20240926$EXP$$EG-SANDOZ INC.-SDZ2024EG082857$SANDOZ$$37$YR$$F$Y$79$KG$20240926$$PH$EG$EG
243660081$24366008$1$I$20240627$20240920$20240926$20240926$EXP$PT-INFARMED-T202409-292$PT-TEVA-VS-3246400$TEVA$$79$YR$$M$Y$$$20240926$$MD$PT$PT
243660091$24366009$1$I$20231020$20240923$20240926$20240926$EXP$ES-AEMPS-1568186$ES-Orion Corporation ORION PHARMA-24_00031836$ORION$$66$YR$E$M$Y$$$20240926$$PH$ES$
243660101$24366010$1$I$$20240916$20240926$20240926$EXP$$FR-UCBSA-2024048005$UCB$$$$E$F$Y$$$20240926$$MD$FR$FR
243660111$24366011$1$I$$20240913$20240926$20240926$EXP$$ES-AUROBINDO-AUR-APL-2024-046300$AUROBINDO$Ligero-Lopez J, Villagrasa-Boli P, Bularca E, Portillo A, Oteo JA, Lopez-Alonso B, et al.. Emerging challenges: An imported case of Leishmania mexicana with Pseudomonas aeruginosa superinfection. Diagnostic Microbiology + Infectious Disease. 2024;110 (1):116431$44$YR$$M$Y$$$20240926$$HP$ES$ES
243660121$24366012$1$I$20230101$20240922$20240926$20240926$EXP$$RO-009507513-2409ROU008734$MERCK$$37$YR$$M$Y$$$20240926$$MD$RO$RO
243660131$24366013$1$I$$20240916$20240926$20240926$30DAY$$CA-JNJFOC-20240951009$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$PH$CA$CA
243660141$24366014$1$I$$20240918$20240926$20240926$EXP$$JP-JNJFOC-20240963997$JOHNSON AND JOHNSON$$10$YR$C$F$Y$$$20240926$$CN$JP$JP
243660151$24366015$1$I$20240901$20240922$20240926$20240926$PER$$US-JNJFOC-20240960151$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243660161$24366016$1$I$$20240916$20240926$20240926$EXP$$CN-STERISCIENCE B.V.-2024-ST-001483$Steriscience PTE$Wang Y, Fang Y, Yan Z, Xia R, Zeng W, Deng W, et al.. Fatal BK polyomavirus-associated pneumonia: report of two cases with literature review.. BMC-Infect-Dis. 2023;23:1-9$19$YR$$M$Y$$$20240926$$HP$CN$CN
243660181$24366018$1$I$20240916$20240920$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-047043$AUROBINDO$$39$YR$$F$Y$$$20240926$$PH$GB$GB
243660191$24366019$1$I$$20240919$20240926$20240926$EXP$$NVSC2024TR190088$NOVARTIS$Saridas F, Koc ER, Ozkaya G, Turan OF. Fingolimod real life experience in non-naive multiple sclerosis patients. THE EUROPEAN RESEARCH JOURNAL. 2024;10 (5):430-8$$$$$Y$$$20240926$$HP$TR$TR
243660201$24366020$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011353$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243660211$24366021$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191472$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
243660221$24366022$1$I$20240923$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015346$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240926$$CN$US$US
243660231$24366023$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016241$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240926$$CN$US$US
243660241$24366024$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015628$ELI LILLY AND CO$$75$YR$E$$Y$$$20240926$$CN$US$US
243660251$24366025$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015602$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240926$$CN$US$US
243660261$24366026$1$I$20240923$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015432$ELI LILLY AND CO$$57$YR$A$$Y$$$20240926$$CN$US$US
243660271$24366027$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152483$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240926$$CN$US$US
243660281$24366028$1$I$$20240923$20240926$20240926$PER$$US-PFIZER INC-PV202400124255$PFIZER$$72$YR$$F$Y$$$20240926$$HP$US$US
243660291$24366029$1$I$$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150253$BRISTOL MYERS SQUIBB$$21$YR$A$F$Y$$$20240926$$HP$US$US
243660301$24366030$1$I$$20240923$20240926$20240926$PER$$US-PFIZER INC-PV202300038551$PFIZER$$64$YR$$M$Y$$$20240926$$HP$US$US
243660311$24366031$1$I$20240918$20240919$20240926$20240926$PER$$US-PFIZER INC-202400260151$PFIZER$$15$MON$$M$Y$$$20240926$$CN$US$US
243660321$24366032$1$I$20240901$20240923$20240926$20240926$PER$$US-PFIZER INC-202400263225$PFIZER$$44$YR$$F$Y$$$20240926$$HP$US$US
243660341$24366034$1$I$$20240923$20240926$20240926$PER$$US-PFIZER INC-202400262679$PFIZER$$45$YR$$F$Y$$$20240926$$MD$US$US
243660351$24366035$1$I$$20240923$20240926$20240926$PER$$US-PFIZER INC-202400262430$PFIZER$$62$YR$$M$Y$$$20240926$$CN$US$US
243660372$24366037$2$F$$20240925$20240926$20240926$PER$$PR-PFIZER INC-202400263328$PFIZER$$59$YR$$F$Y$$$20240926$$CN$PR$PR
243660381$24366038$1$I$$20240923$20240926$20240926$PER$$US-PFIZER INC-PV202400124558$PFIZER$$$$$F$Y$$$20240926$$CN$US$US
243660391$24366039$1$I$20220101$20240920$20240926$20240926$PER$$US-PFIZER INC-202400262535$PFIZER$$77$YR$$F$Y$$$20240926$$HP$US$US
243660401$24366040$1$I$$20240920$20240926$20240926$PER$$US-PFIZER INC-202400261452$PFIZER$$$$$M$Y$$$20240926$$PH$US$US
243660431$24366043$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001705$ORGANON$$43$YR$$F$Y$68$KG$20240926$$CN$CA$CA
243660441$24366044$1$I$20240523$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65928$$FDA-CTU$$74$YR$$M$N$$$20240925$Y$PH$US$
243660461$24366046$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65814$$FDA-CTU$$75$YR$$F$N$55.79$KG$20240925$N$$US$
243660481$24366048$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65826$$FDA-CTU$$36$YR$$F$N$$$20240925$N$$US$
243660501$24366050$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65894$$FDA-CTU$$63$YR$$F$N$$$20240925$N$$US$
243660511$24366051$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65891$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243660521$24366052$1$I$$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65850$$FDA-CTU$$$$$M$N$$$20240924$N$HP$US$
243660531$24366053$1$I$20240919$20240924$20240926$20240926$EXP$$NVSC2024IE190767$NOVARTIS$$50$YR$$M$Y$$$20240926$$CN$IE$IE
243660541$24366054$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65873$$FDA-CTU$$81$YR$$F$N$$$20240925$N$$US$
243660551$24366055$1$I$$20240918$20240926$20240926$PER$$US-ROCHE-10000086609$ROCHE$$$$T$M$Y$$$20240926$$CN$US$US
243660561$24366056$1$I$20240919$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65897$$FDA-CTU$$56$YR$$M$N$$$20240925$Y$PH$US$
243660571$24366057$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65866$$FDA-CTU$$62$YR$$F$N$119.75$KG$20240925$N$$US$
243660581$24366058$1$I$$20240919$20240926$20240926$EXP$$AU-ANIPHARMA-2024-AU-000359$ANI$$83$YR$$F$Y$$$20240926$$CN$AU$AU
243660591$24366059$1$I$20240801$20240918$20240926$20240926$EXP$$ES-Blueprint Medicines Corporation-SP-ES-2024-001902$BLUEPRINT MEDICINES$$80$YR$E$F$Y$$$20240926$$MD$ES$ES
243660601$24366060$1$I$20240925$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65926$$FDA-CTU$$55$YR$$F$N$$$20240925$Y$PH$US$
243660621$24366062$1$I$20240812$20240917$20240926$20240926$EXP$$IT-AUROBINDO-AUR-APL-2024-046847$AUROBINDO$$73$YR$$M$Y$80$KG$20240926$$MD$IT$IT
243660632$24366063$2$F$$20240923$20240926$20240930$EXP$$PT-ROCHE-10000090362$ROCHE$Carrilho M, Nobre M, Santos M, Silva R, Martins J. Miocardite a CMV (abstract number: CO-0062 - (4147). Infectious and Parasitic Diseases.162.$72$YR$E$F$Y$$$20240930$$HP$PT$PT
243660641$24366064$1$I$20240913$20240919$20240926$20240926$EXP$GB-MHRA-MED-202409191653360440-WBLYK$GB-TEVA-VS-3246425$TEVA$$60$YR$$F$Y$$$20240926$$HP$GB$GB
243660651$24366065$1$I$$20240917$20240926$20240926$EXP$$NVSC2024BR190620$NOVARTIS$$$$$F$Y$$$20240926$$CN$BR$BR
243660661$24366066$1$I$20240901$20240917$20240926$20240926$EXP$$NVSC2024US186681$NOVARTIS$$68$YR$$F$Y$$$20240926$$CN$US$US
243660671$24366067$1$I$20240101$20240912$20240926$20240926$EXP$$US-UCBSA-2024047245$UCB$$$$$M$Y$79.365$KG$20240926$$HP$US$US
243660681$24366068$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114985$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243660691$24366069$1$I$$20240916$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024114998$VIIV$$$$$$Y$$$20240926$$PH$US$US
243660711$24366071$1$I$$20240911$20240926$20240926$EXP$$NO-GRANULES-NO-2024GRALIT00421$GRANULES INDIA$Joachim Frost.Detoxification after using new drugs from  the internet.Journal of the Norwegian Medical.16-JAN-2024;144:1-6$4$DEC$A$M$Y$$$20240926$$HP$NO$NO
243660731$24366073$1$I$20240925$20240925$20240926$20240926$PER$$US-ROCHE-10000091624$ROCHE$$34$YR$A$F$Y$$$20240926$$CN$US$US
243660742$24366074$2$F$$20240919$20240926$20240927$EXP$$NVSC2024FR190034$NOVARTIS$De Alcubierre D, Gkasdaris G, Mordrel M, Joncour A, Briet C, Almairac F et al.. BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2024;191 (2):251-61$53$YR$$F$Y$$$20240927$$HP$FR$FR
243660751$24366075$1$I$20240701$20240923$20240926$20240926$EXP$FR-AFSSAPS-RE2024000908$NVSC2024FR188748$NOVARTIS$$47$YR$$F$Y$59$KG$20240926$$MD$FR$FR
243660761$24366076$1$I$$20240922$20240926$20240926$EXP$$NVSC2024DE190849$NOVARTIS$$6$MON$$F$Y$$$20240926$$CN$DE$DE
243660771$24366077$1$I$$20240924$20240926$20240926$EXP$$NVSC2024US190812$NOVARTIS$$$$$F$Y$$$20240926$$HP$US$US
243660781$24366078$1$I$20240801$20240917$20240926$20240926$EXP$$US-UCBSA-2024047973$UCB$$35$YR$$F$Y$$$20240926$$HP$US$US
243660801$24366080$1$I$20240826$20240917$20240926$20240926$EXP$FR-AFSSAPS-PV2024000829$FR-TEVA-VS-3244648$TEVA$$12$YR$$F$Y$61$KG$20240926$$MD$FR$FR
243660821$24366082$1$I$$20240918$20240926$20240926$PER$$US-TAKEDA-2024TUS093321$TAKEDA$$$$$M$Y$78$KG$20240926$$MD$US$US
243660831$24366083$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65784$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243660841$24366084$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65781$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243660861$24366086$1$I$$20240912$20240926$20240926$PER$$US-JNJFOC-20240932392$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243660871$24366087$1$I$20240523$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65930$$FDA-CTU$$74$YR$$M$N$$$20240925$Y$PH$US$
243660881$24366088$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65759$$FDA-CTU$$$$$F$N$$$20240925$N$HP$US$
243660891$24366089$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65764$$FDA-CTU$$$$$F$N$$$20240925$N$HP$US$
243660901$24366090$1$I$20230101$20240919$20240926$20240926$EXP$$CA-CELLTRION INC.-2023CA020164$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243660911$24366091$1$I$20240826$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65841$$FDA-CTU$$63$YR$$M$N$$$20240924$N$HP$US$
243660921$24366092$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65859$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243660941$24366094$1$I$$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65787$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243660961$24366096$1$I$20190501$20240911$20240926$20240926$EXP$PL-URPL-2-1203-2020$PL-MELINTA THERAPEUTICS, LLC-PL-MLNT-24-00453$Unknown Manufacturer$$$$$$Y$$$20240926$$CN$PL$PL
243660971$24366097$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191496$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
243660981$24366098$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65847$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243660991$24366099$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011361$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243661001$24366100$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400116043$PFIZER$$70$YR$$F$Y$$$20240926$$CN$US$US
243661012$24366101$2$F$$20240925$20240926$20240930$PER$$US-PFIZER INC-202400264050$PFIZER$$75$YR$$F$Y$79.365$KG$20240930$$CN$US$US
243661021$24366102$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-202400263387$PFIZER$$75$YR$$F$Y$$$20240926$$CN$US$US
243661031$24366103$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-202400263384$PFIZER$$74$YR$$F$Y$$$20240926$$CN$US$US
243661041$24366104$1$I$20240101$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400125107$PFIZER$$58$YR$$F$Y$$$20240926$$HP$US$US
243661051$24366105$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001715$ORGANON$$40$YR$$F$Y$$$20240926$$HP$CA$CA
243661091$24366109$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-202400263562$PFIZER$$64$YR$$M$Y$$$20240926$$CN$US$US
243661101$24366110$1$I$20240701$20240924$20240926$20240926$PER$$US-PFIZER INC-202400262965$PFIZER$$$$$F$Y$$$20240926$$HP$US$US
243661111$24366111$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400125597$PFIZER$$62$YR$$M$Y$$$20240926$$HP$US$US
243661121$24366112$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-202400263491$PFIZER$$101$YR$$F$Y$$$20240926$$CN$US$US
243661142$24366114$2$F$$20240925$20240926$20240930$PER$$US-PFIZER INC-202400263379$PFIZER$$79$YR$$F$Y$$$20240930$$HP$US$US
243661151$24366115$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400125331$PFIZER$$68$YR$$F$Y$$$20240926$$CN$US$US
243661171$24366117$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-202400263981$PFIZER$$43$YR$$M$Y$$$20240926$$CN$US$US
243661181$24366118$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-202400241773$PFIZER$$67$YR$$M$Y$$$20240926$$CN$US$US
243661191$24366119$1$I$$20240919$20240926$20240926$EXP$$US-GSK-US2024116506$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
243661201$24366120$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114956$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243661212$24366121$2$F$20240916$20240924$20240926$20240930$PER$$US-PFIZER INC-202400263392$PFIZER$$50$YR$$F$Y$$$20240930$$PH$US$US
243661221$24366122$1$I$$20240917$20240926$20240926$EXP$$AU-CELLTRION INC.-2024AU022569$CELLTRION$$$$$$Y$$$20240926$$HP$AU$AU
243661241$24366124$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400125237$PFIZER$$68$YR$$F$Y$$$20240926$$HP$US$US
243661251$24366125$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024007011$BIOCON$$$$$$Y$$$20240926$$HP$CA$CA
243661261$24366126$1$I$20240101$20240917$20240926$20240926$EXP$$CA-UCBSA-2024048014$UCB$$$$$M$Y$$$20240926$$HP$CA$CA
243661271$24366127$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65777$$FDA-CTU$$62$YR$$M$N$$$20240925$N$$US$
243661281$24366128$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65858$$FDA-CTU$$68$YR$$F$N$$$20240925$N$$US$
243661291$24366129$1$I$$20240920$20240925$20240925$DIR$FDA-CDER-CTU-2024-65871$$FDA-CTU$$$$$M$N$$$20240920$N$HP$US$
243661301$24366130$1$I$20240918$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65903$$FDA-CTU$$63$YR$$F$N$$$20240925$Y$PH$US$
243661321$24366132$1$I$$20240920$20240926$20240926$EXP$$FR-MYLANLABS-2024M1086477$MYLAN$Ghanem R, Glaisner S, Bobin A, Ronchetti A-M, Cereja S, Joly B, et al. Posterior reversible encephalopathy syndrome (PRES) and myeloma. Leukemia-Research-Reports 2024; 21.$73$YR$$F$Y$$$20240926$$HP$FR$FR
243661331$24366133$1$I$20240624$20240920$20240926$20240926$EXP$$AR-MYLANLABS-2024M1071592$MYLAN$$23$YR$$M$Y$$$20240926$$MD$AR$AR
243661341$24366134$1$I$20240901$20240918$20240926$20240926$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029664$UNITED THERAPEUTICS$$62$YR$$F$Y$65.76$KG$20240926$$$US$US
243661351$24366135$1$I$20240916$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65835$$FDA-CTU$$73$YR$$F$N$$$20240925$N$HP$US$
243661371$24366137$1$I$20240916$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65831$$FDA-CTU$$73$YR$$F$N$$$20240925$N$HP$US$
243661391$24366139$1$I$$20240831$20240925$20240925$DIR$FDA-CDER-CTU-2024-65809$$FDA-CTU$$$$$F$N$$$20240831$N$HP$US$
243661401$24366140$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65828$$FDA-CTU$$61$YR$$F$N$90.72$KG$20240925$N$$US$
243661411$24366141$1$I$$20240925$20240925$20240925$DIR$719915$$FDA-CTU$$$$$F$N$$$20240925$N$HP$US$
243661431$24366143$1$I$$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65780$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243661451$24366145$1$I$$20240925$20240925$20240925$DIR$719954$$FDA-CTU$$$$$UNK$N$$$20240925$$CN$US$
243661471$24366147$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65941$$FDA-CTU$$58$YR$$F$N$$$20240925$N$$US$
243661481$24366148$1$I$20240922$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65924$$FDA-CTU$$70$YR$$M$N$$$20240924$N$HP$US$
243661491$24366149$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65908$$FDA-CTU$$53$YR$$F$N$111$LBS$20240925$N$$US$
243661501$24366150$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65893$$FDA-CTU$$79$YR$$F$N$$$20240925$N$$US$
243661521$24366152$1$I$20240101$20240917$20240926$20240926$EXP$FR-AFSSAPS-LL2024001723$FR-009507513-2409FRA009087$MERCK$$85$YR$$M$Y$$$20240926$$MD$FR$FR
243661531$24366153$1$I$20231214$20240920$20240926$20240926$EXP$$AU-TAKEDA-2023TUS120869$TAKEDA$$69$YR$$M$Y$$$20240926$$CN$AU$AU
243661561$24366156$1$I$$20240917$20240926$20240926$PER$$US-ABBVIE-5929447$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243661571$24366157$1$I$$20240917$20240926$20240926$EXP$$CA-UCBSA-2024048101$UCB$$$$$F$Y$$$20240926$$CN$CA$CA
243661581$24366158$1$I$20240802$20240916$20240926$20240926$EXP$$US-UCBSA-2024047629$UCB$$59$YR$$F$Y$$$20240926$$CN$US$US
243661591$24366159$1$I$$20240917$20240926$20240926$EXP$$BE-JNJFOC-20240957705$JOHNSON AND JOHNSON$$53$YR$A$$Y$$$20240926$$MD$BE$BE
243661601$24366160$1$I$$20240920$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-152609$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240926$$MD$JP$JP
243661611$24366161$1$I$$20240917$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149323$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240926$$CN$US$US
243661631$24366163$1$I$$20240923$20240926$20240926$EXP$$NVSC2024US189842$NOVARTIS$$$$$$Y$$$20240926$$CN$US$US
243661641$24366164$1$I$20240316$20240919$20240926$20240926$EXP$$NVSC2024RU182237$NOVARTIS$$$$$F$Y$$$20240926$$MD$RU$RU
243661651$24366165$1$I$$20240911$20240926$20240926$EXP$$JP-SA-2024SA277988$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240926$$CN$JP$JP
243661661$24366166$1$I$20240101$20240923$20240926$20240926$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005271$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240926$$CN$US$US
243661691$24366169$1$I$$20240916$20240926$20240926$PER$$US-TAKEDA-2024TUS094336$TAKEDA$$$$$$Y$$$20240926$$HP$US$US
243661701$24366170$1$I$20240329$20240919$20240926$20240926$EXP$$US-CHIESI-2024CHF06278$CHIESI$$51$YR$$F$Y$$$20240926$$MD$US$US
243661711$24366171$1$I$20240709$20240920$20240926$20240926$EXP$$US-Taiho Oncology Inc-2023-008597$TAIHO ONCOLOGY INC$$53$YR$A$F$Y$$$20240926$$CN$US$US
243661721$24366172$1$I$$20240911$20240926$20240926$EXP$$GB-GRANULES-GB-2024GRALIT00413$GRANULES INDIA$Rishabh Sehgal.Non-steroidal anti-inf lammatory drug induced intestinal stricturing: diaphragm disease.Journal of Surgical Case Reports.2024;1:1-4$41$YR$A$M$Y$$$20240926$$HP$GB$GB
243661731$24366173$1$I$$20240914$20240926$20240926$PER$$US-JNJFOC-20240940479$JOHNSON AND JOHNSON$$46$YR$A$$Y$$$20240926$$CN$US$US
243661741$24366174$1$I$$20240913$20240926$20240926$30DAY$$US-JNJFOC-20240948112$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243661751$24366175$1$I$20231201$20240916$20240926$20240926$EXP$FR-AFSSAPS-MA2024001263$FR-EMD Serono-2024049594$EMD SERONO INC$$32$YR$A$F$Y$$$20240926$$MD$FR$FR
243661761$24366176$1$I$$20240920$20240926$20240926$EXP$GB-MHRA-MED-202409201446341410-QFLZB$GB-ABBVIE-5938499$ABBVIE$$42$YR$$M$Y$$$20240926$$CN$GB$GB
243661771$24366177$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409001600$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240926$$CN$US$US
243661781$24366178$1$I$20240830$20240916$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024114807$VIIV$$24$YR$$M$Y$60.28$KG$20240926$$HP$US$US
243661791$24366179$1$I$$20240923$20240926$20240926$EXP$$US-ROCHE-10000089247$ROCHE$$48$YR$A$F$Y$$$20240926$$CN$US$US
243661801$24366180$1$I$20240801$20240920$20240926$20240926$EXP$$MX-ROCHE-10000090290$ROCHE$$33$YR$A$M$Y$$$20240926$$CN$MX$MX
243661811$24366181$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65797$$FDA-CTU$$69$YR$$F$N$$$20240925$N$$US$
243661821$24366182$1$I$$20240916$20240926$20240926$EXP$$ES-ROCHE-10000091323$ROCHE$Somovilla A, Aguirre C, Gallego M, Vivancos J. Organizing Pneumonia in Multiple Sclerosis Patients Treated with Ocrelizumab following SARS-CoV-2 Infection: A Case Series Report [Abstract No: P1153/2242]. Multiple Sclerosis Journal. 2024;30 (3S):681-1137.$38$YR$A$F$Y$$$20240926$$HP$ES$ES
243661831$24366183$1$I$$20240921$20240926$20240926$EXP$$GB-MYLANLABS-2024M1086125$MYLAN$$10$DEC$$F$Y$$$20240926$$CN$GB$GB
243661841$24366184$1$I$$20240911$20240926$20240926$EXP$$US-BAXTER-2024BAX024595$BAXTER$$$$$$Y$$$20240926$$HP$US$US
243661851$24366185$1$I$$20240917$20240926$20240926$EXP$$GB-BAXTER-2024BAX024893$BAXTER$$32$YR$$F$Y$87$KG$20240926$$MD$GB$GB
243661861$24366186$1$I$$20240923$20240926$20240926$EXP$$US-ROCHE-10000089983$ROCHE$$61$YR$A$F$Y$$$20240926$$HP$US$US
243661871$24366187$1$I$20221001$20240916$20240926$20240926$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08756$HIKMA$Levi D, Horn S, Murphy J, Levin J.. Levi D, Horn S, Murphy J, Levin J. Safety of dexamethasone in transforaminal epidural steroid injections: A case of temporary paraplegia caused by injection of lidocaine and dexamethasone into a lumbar radiculomedullary artery, with no neurologic sequelae. Interventional pain medicine.. Interventional pain medicine. 2023;2(1):100240$76$YR$$M$Y$$$20240926$$MD$US$US
243661881$24366188$1$I$$20240912$20240926$20240926$EXP$$US-SMPA-2024SPA002736$SUNOVION$$$$$$Y$$$20240926$$CN$US$US
243661891$24366189$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65856$$FDA-CTU$$68$YR$$F$N$$$20240925$N$$US$
243661901$24366190$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65827$$FDA-CTU$$54$YR$$F$N$$$20240925$N$$US$
243661911$24366191$1$I$$20240923$20240926$20240926$EXP$$GB-MYLANLABS-2024M1086854$MYLAN$$$$$F$Y$$$20240926$$CN$GB$GB
243661921$24366192$1$I$$20240923$20240926$20240926$EXP$$GB-MYLANLABS-2024M1086500$MYLAN$$$$$M$Y$$$20240926$$MD$GB$GB
243661931$24366193$1$I$20230601$20240922$20240926$20240926$EXP$GB-MHRA-MED-202409221001033100-JTNKS$GB-MYLANLABS-2024M1086151$MYLAN$$$$$$Y$$$20240926$$CN$GB$GB
243661941$24366194$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65913$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243661951$24366195$1$I$$20240923$20240926$20240926$EXP$GB-MHRA-MED-202409230720093430-PKWFQ$GB-MYLANLABS-2024M1086282$MYLAN$$64$YR$$F$Y$69$KG$20240926$$CN$GB$GB
243661961$24366196$1$I$$20240925$20240925$20240925$DIR$719928$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243661971$24366197$1$I$$20240923$20240926$20240926$EXP$GB-MHRA-MIDB-2296d7fc-595e-4c4d-ba09-75b4c72d24ae$GB-MYLANLABS-2024M1086583$MYLAN$$74$YR$$$Y$$$20240926$$PH$GB$GB
243662001$24366200$1$I$20240326$20240924$20240926$20240926$EXP$$US-ROCHE-10000090568$ROCHE$$59$YR$A$F$Y$76.2$KG$20240926$$CN$US$US
243662011$24366201$1$I$20190529$20240918$20240926$20240926$EXP$$CA-TAKEDA-2024TUS063683$TAKEDA$$65$YR$$M$Y$$$20240926$$MD$CA$CA
243662021$24366202$1$I$$20240923$20240926$20240926$EXP$GB-MHRA-MIDB-GB-MHRA-MIDB-fd53304b-68f8-4620-a7a6-bd883841f054$GB-MYLANLABS-2024M1086571$MYLAN$$79$YR$$$Y$$$20240926$$PH$GB$GB
243662031$24366203$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65898$$FDA-CTU$$32$YR$$F$N$205$LBS$20240925$N$$US$
243662041$24366204$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65796$$FDA-CTU$$39$YR$$M$N$$$20240925$N$$US$
243662061$24366206$1$I$$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65829$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243662071$24366207$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65916$$FDA-CTU$$33$YR$$M$N$$$20240925$N$$US$
243662081$24366208$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65758$$FDA-CTU$$56$YR$$M$N$$$20240925$N$$US$
243662101$24366210$1$I$$20240831$20240925$20240925$DIR$FDA-CDER-CTU-2024-65807$$FDA-CTU$$$$$F$N$$$20240831$N$HP$US$
243662151$24366215$1$I$$20240925$20240926$20240926$PER$$US-HALEON-2198843$Haleon PLC$$$$$$Y$$$20240926$$CN$US$US
243662161$24366216$1$I$$20240918$20240926$20240926$PER$$US-TEVA-VS-3247116$TEVA$$52$YR$$F$Y$$$20240926$$CN$US$US
243662171$24366217$1$I$20171214$20240911$20240926$20240926$EXP$$FR-JNJFOC-20240960683$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20240926$$HP$FR$FR
243662181$24366218$1$I$$20240923$20240926$20240926$EXP$$CA-ROCHE-10000088469$ROCHE$$$$$F$Y$$$20240926$$MD$CA$CA
243662191$24366219$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114968$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243662201$24366220$1$I$20240916$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151905$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240926$$CN$US$US
243662211$24366221$1$I$$20240911$20240926$20240926$EXP$$IN-GRANULES-IN-2024GRALIT00418$GRANULES INDIA$Somarajan Anandan.A Very Rare Side Effect of a Very Commonly Used Drug:  Pantoprazole-induced Seizure.Journal of the Association of Physicians of India.22-APR-2024;72:89$69$YR$E$F$Y$$$20240926$$HP$IN$IN
243662221$24366222$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151983$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240926$$CN$US$US
243662241$24366224$1$I$20240911$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151595$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$58.06$KG$20240926$$CN$US$US
243662251$24366225$1$I$20240901$20240919$20240926$20240926$EXP$$GB-TEVA-VS-3246364$TEVA$$35$YR$$F$Y$$$20240926$$CN$GB$GB
243662271$24366227$1$I$20240719$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10536$CIPLA$$$$$$Y$$$20240926$$MD$AU$AU
243662281$24366228$1$I$20240101$20240903$20240926$20240926$PER$$GB-REGENERON PHARMACEUTICALS, INC.-2024-098057$REGENERON$$40$YR$$F$Y$$$20240926$$CN$GB$GB
243662291$24366229$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011366$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240926$$HP$CA$CA
243662301$24366230$1$I$$20240916$20240926$20240926$EXP$$GB-TEVA-VS-3244954$TEVA$Mon A, Shanmuganathan S, Uddin A. Late dysfunction of a mechanical aortic valve after long-term low molecular weight heparin therapy: a case report. Eur-Heart-J-Case-Rep 2024; 8 (8):.$$$A$M$Y$$$20240926$$HP$GB$GB
243662311$24366231$1$I$20240921$20240925$20240925$20240925$DIR$719964$$FDA-CTU$$52$YR$$F$N$94.5$KG$20240925$N$CN$US$
243662321$24366232$1$I$20240801$20240917$20240926$20240926$EXP$$US-UCBSA-2024048036$UCB$$34$YR$$F$Y$$$20240926$$HP$US$US
243662331$24366233$1$I$20240801$20240920$20240926$20240926$EXP$$NVSC2024RU190200$NOVARTIS$$51$YR$$F$Y$62$KG$20240926$$HP$RU$RU
243662351$24366235$1$I$$20240916$20240926$20240926$PER$$US-ABBVIE-5927700$ABBVIE$$$$$$Y$$$20240926$$HP$US$US
243662361$24366236$1$I$20200907$20240926$20240926$20240926$EXP$PL-URPL-1-3873-2020$NVSC2024PL191233$NOVARTIS$$50$YR$$M$Y$90$KG$20240926$$MD$PL$PL
243662401$24366240$1$I$$20240920$20240926$20240926$EXP$GB-MHRA-MED-202409201442135780-GSWCR$GB-RDY-SPO/GBR/24/0014015$DR REDDYS$$$$$M$Y$$$20240926$$CN$GB$GB
243662411$24366241$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65933$$FDA-CTU$$77$YR$$M$N$$$20240925$N$$US$
243662421$24366242$1$I$20230501$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10529$CIPLA$$$$$$Y$$$20240926$$MD$AU$AU
243662431$24366243$1$I$20230522$20240916$20240926$20240926$EXP$$BR-CELLTRION INC.-2023BR010832$CELLTRION$$$$$$Y$$$20240926$$CN$BR$BR
243662441$24366244$1$I$$20240924$20240926$20240926$PER$$US-ABBVIE-5938140$ABBVIE$$$$$$Y$$$20240926$$CN$US$US
243662451$24366245$1$I$20240101$20240917$20240926$20240926$EXP$$CA-UCBSA-2024025627$UCB$$$$$M$Y$$$20240926$$CN$CA$CA
243662461$24366246$1$I$$20240830$20240926$20240926$30DAY$$DE-JNJFOC-20240965111$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$PH$DE$DE
243662481$24366248$1$I$$20240821$20240926$20240926$PER$$US-MYLANLABS-2024M1086726$MYLAN$$$$$F$Y$$$20240926$$CN$US$US
243662491$24366249$1$I$$20240919$20240926$20240926$EXP$$IN-MYLANLABS-2024M1086899$MYLAN$Buch Z, Hegde S, Lakshmi A, Bhat S. Classical ayurveda management of TCH (taxane, carboplatin, and herceptin) based chemotherapy induced peripheral neuropathy- A case report. J-Ayurveda-Integrat-Med 2024; 15 (5): no pagination.$50$YR$$F$Y$68.5$KG$20240926$$HP$IN$IN
243662501$24366250$1$I$20151210$20240920$20240926$20240926$EXP$$JP-JNJFOC-A-CH2016-137745$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240926$$MD$JP$JP
243662511$24366251$1$I$$20240919$20240926$20240926$EXP$$NZ-MYLANLABS-2024M1086711$MYLAN$Dick M, Innes-Jones K, Arri S. A rare presentation of acute myocarditis as a manifestation of adult-onset Still^s disease: a case report. Eur-Heart-J-Case-Rep 2023; 7 (11):.$22$YR$$M$Y$$$20240926$$HP$NZ$NZ
243662521$24366252$1$I$20240621$20240919$20240926$20240926$EXP$$GB-MYLANLABS-2024M1086970$MYLAN$$$$$F$Y$$$20240926$$CN$GB$GB
243662531$24366253$1$I$$20240919$20240926$20240926$EXP$$TW-MYLANLABS-2024M1086994$MYLAN$Chu C, Liang H-Y, Lien M-Y, Wu H-P. Immune Checkpoint Inhibitor-Related Myocarditis: A Case Series and Literature Review. Acta-Cardiol-Sin 2024; 40 (4): 445-450.$65$YR$$M$Y$$$20240926$$MD$TW$TW
243662541$24366254$1$I$20230301$20240920$20240926$20240926$EXP$$RO-PFIZER INC-PV202400123411$PFIZER$$$$$M$Y$$$20240926$$MD$RO$RO
243662551$24366255$1$I$$20240913$20240925$20240925$DIR$FDA-CDER-CTU-2024-65789$$FDA-CTU$$$$$F$N$$$20240913$N$HP$US$
243662561$24366256$1$I$$20240923$20240926$20240926$EXP$GB-MHRA-MED-202409231412099040-RVBLG$GB-PFIZER INC-202400261739$PFIZER$$90$YR$$F$Y$37$KG$20240926$$MD$GB$GB
243662571$24366257$1$I$20230101$20240923$20240926$20240926$EXP$$CA-PFIZER INC-202201212918$PFIZER$$41$YR$$F$Y$$$20240926$$MD$CA$CA
243662581$24366258$1$I$$20240921$20240926$20240926$EXP$$AU-PFIZER INC-PV202400123738$PFIZER$$12$YR$$M$Y$90$KG$20240926$$MD$AU$AU
243662591$24366259$1$I$20240720$20240918$20240926$20240926$EXP$FR-AFSSAPS-BX2024001745$FR-PFIZER INC-202400263984$PFIZER$$37$YR$$F$Y$54$KG$20240926$$MD$FR$FR
243662601$24366260$1$I$$20240919$20240926$20240926$EXP$$US-MYLANLABS-2024M1086888$MYLAN$Wachuku CI, Barrera T, Jackson T, Sow Y, Mollanazar N, Taylor SC. Upadacitinib as a treatment for chronic pruritus secondary to polycythemia vera after failure with dupilumab. JAAD-Case-Rep 2023; 35 87-89.$40$YR$$F$Y$$$20240926$$MD$US$US
243662611$24366261$1$I$$20240921$20240926$20240926$EXP$$US-BAYER-2024A134951$BAYER$$12$YR$C$M$Y$$$20240926$$CN$US$US
243662621$24366262$1$I$20231029$20240923$20240926$20240926$EXP$$CA-PFIZER INC-202200183825$PFIZER$$60$YR$$M$Y$$$20240926$$MD$CA$CA
243662641$24366264$1$I$20240912$20240923$20240926$20240926$EXP$$US-PFIZER INC-PV202400124417$PFIZER$$66$YR$$M$Y$$$20240926$$HP$US$US
243662651$24366265$1$I$20240101$20240920$20240926$20240926$EXP$$US-PFIZER INC-202400262293$PFIZER$$76$YR$$M$Y$$$20240926$$HP$US$US
243662661$24366266$1$I$$20240920$20240926$20240926$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001926$BLUEPRINT MEDICINES$$$$$F$Y$$$20240926$$CN$US$US
243662671$24366267$1$I$20240801$20240917$20240926$20240926$EXP$$US-UCBSA-2024047797$UCB$$31$YR$$F$Y$$$20240926$$CN$US$US
243662681$24366268$1$I$20240513$20240924$20240926$20240926$EXP$$US-SA-2024SA265295$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240926$$MD$US$US
243662691$24366269$1$I$20240917$20240919$20240926$20240926$EXP$GB-MHRA-MED-202409192231435280-VGZBH$GB-TEVA-VS-3246469$TEVA$$39$YR$$F$Y$$$20240926$$CN$GB$GB
243662701$24366270$1$I$20240801$20240917$20240926$20240926$EXP$$US-UCBSA-2024048194$UCB$$32$YR$$M$Y$$$20240926$$HP$US$US
243662721$24366272$1$I$20240925$20240925$20240926$20240926$PER$$US-ROCHE-10000091617$ROCHE$$51$YR$A$F$Y$$$20240926$$CN$US$US
243662731$24366273$1$I$20240806$20240924$20240926$20240926$EXP$FR-AFSSAPS-MA2024001361$FR-SANDOZ INC.-SDZ2024FR082667$SANDOZ$$58$YR$$M$Y$$$20240926$$MD$FR$FR
243662741$24366274$1$I$$20240916$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR118382$VIIV$$$$$$Y$$$20240926$$HP$US$US
243662751$24366275$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114983$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243662761$24366276$1$I$$20240919$20240926$20240926$PER$$US-JNJFOC-20240954812$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
243662771$24366277$1$I$$20240917$20240926$20240926$PER$$US-GSK-US2024115649$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243662781$24366278$1$I$$20240919$20240926$20240926$30DAY$$US-PFIZER INC-202400260205$PFIZER$$8$YR$$F$Y$$$20240926$$CN$US$US
243662791$24366279$1$I$$20240918$20240926$20240926$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-150339$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240926$$CN$GB$GB
243662811$24366281$1$I$20240918$20240920$20240926$20240926$30DAY$$US-PFIZER INC-202400261069$PFIZER$$13$YR$$F$Y$$$20240926$$CN$US$US
243662821$24366282$1$I$$20240913$20240926$20240926$30DAY$$US-PFIZER INC-PV202400112405$PFIZER$$74$YR$$M$Y$$$20240926$$HP$US$US
243662831$24366283$1$I$$20240924$20240926$20240926$30DAY$$CO-PFIZER INC-PV202400124830$PFIZER$$13$YR$$M$Y$$$20240926$$CN$CO$CO
243662841$24366284$1$I$$20240918$20240926$20240926$30DAY$$GB-PFIZER INC-PV202400122169$PFIZER$$$$$$Y$$$20240926$$MD$GB$GB
243662852$24366285$2$F$20240101$20240923$20240926$20240930$30DAY$$US-PFIZER INC-202400262326$PFIZER$$12$YR$$M$Y$$$20240930$$CN$US$US
243662871$24366287$1$I$20240916$20240925$20240925$20240925$DIR$719963$$FDA-CTU$$39$YR$$F$N$89.1$KG$20240925$N$PH$US$
243662881$24366288$1$I$$20240919$20240926$20240926$30DAY$$US-PFIZER INC-202400260544$PFIZER$$13$YR$$F$Y$$$20240926$$CN$US$US
243662891$24366289$1$I$20240915$20240919$20240926$20240926$30DAY$$US-PFIZER INC-202400260531$PFIZER$$16$YR$$M$Y$54.43$KG$20240926$$CN$US$US
243662911$24366291$1$I$$20240925$20240925$20240925$DIR$719935$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243662921$24366292$1$I$$20240925$20240925$20240925$DIR$719911$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243662931$24366293$1$I$20240101$20240920$20240926$20240926$PER$$US-ABBVIE-5933783$ABBVIE$$$$$$Y$$$20240926$$CN$US$US
243662941$24366294$1$I$$20240911$20240926$20240926$EXP$$US-GRANULES-US-2024GRALIT00416$GRANULES INDIA$Hennen M-A.An unwelcome side-effect of trazodone use in a trans-male.Psychiatry and Clinical Neurosciences.JUN-2024;78 (6):376$24$YR$A$$Y$$$20240926$$HP$US$US
243662951$24366295$1$I$20240101$20240917$20240926$20240926$EXP$$US-UCBSA-2024048245$UCB$$$$$F$Y$$$20240926$$CN$US$US
243662991$24366299$1$I$20240101$20240925$20240925$20240925$DIR$720014$$FDA-CTU$$53$YR$$F$N$180$KG$20240925$N$CN$AU$
243663001$24366300$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65884$$FDA-CTU$$89$YR$$M$N$$$20240925$N$HP$US$
243663011$24366301$1$I$20240601$20240919$20240926$20240926$EXP$$ES-OTSUKA-2024_026199$OTSUKA$$19$YR$$M$Y$$$20240926$$MD$ES$ES
243663021$24366302$1$I$$20240922$20240926$20240926$PER$$US-ROCHE-10000089470$ROCHE$$$$$$Y$$$20240926$$CN$US$US
243663031$24366303$1$I$$20240829$20240926$20240926$PER$$US-009507513-2408USA010520$MERCK$Cupit-Link M, Hagiwara K, Nagy M, Koo S, Orr B, Ruppin E, et al.. Response to PARP Inhibition in BARD1-Mutated Refractory Neuroblastoma. The New England journal of medicine. 2024;391 (7):659-61$$$C$F$Y$$$20240926$$MD$US$US
243663041$24366304$1$I$20240701$20240923$20240926$20240926$EXP$FR-AFSSAPS-PV2024000888$FR-ROCHE-10000088622$ROCHE$$66$YR$E$M$Y$68.5$KG$20240926$$MD$FR$FR
243663051$24366305$1$I$$20240916$20240926$20240926$EXP$$TH-STRIDES ARCOLAB LIMITED-2024SP012224$STRIDES$Nithirungruang P, Tanpowpong P, Getsuwan S, Boonsathorn S. Disseminated Macrolide-Resistant Mycobacterium intracellulare Infection in a Child with Autoimmune Lymphoproliferative Disorder: A Case Report and Literature Review. The American journal of tropical medicine and hygiene. 2024;1-5$4$YR$$F$Y$$$20240926$$MD$TH$TH
243663061$24366306$1$I$$20240923$20240926$20240926$EXP$NL-LRB-01003454$NL-MYLANLABS-2024M1086238$MYLAN$$30$YR$$M$Y$70$KG$20240926$$MD$NL$NL
243663091$24366309$1$I$$20240924$20240926$20240926$EXP$$JP-GILEAD-2024-0687454$GILEAD$$8$DEC$E$M$Y$$$20240926$$PH$JP$JP
243663101$24366310$1$I$20240917$20240918$20240926$20240926$EXP$$GB-TEVA-VS-3245059$TEVA$$55$YR$$F$Y$89$KG$20240926$$MD$GB$GB
243663121$24366312$1$I$$20240920$20240926$20240926$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409015567$ELI LILLY AND CO$$$$E$M$Y$$$20240926$$CN$JP$JP
243663131$24366313$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016135$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240926$$CN$US$US
243663151$24366315$1$I$20240918$20240920$20240926$20240926$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409013894$ELI LILLY AND CO$$45$YR$A$F$Y$59$KG$20240926$$CN$CN$CN
243663161$24366316$1$I$20240229$20240923$20240926$20240926$EXP$FR-AFSSAPS-BS2024000660$FR-ELI_LILLY_AND_COMPANY-FR202409014905$ELI LILLY AND CO$$18$YR$A$F$Y$45$KG$20240926$$CN$FR$FR
243663171$24366317$1$I$20240922$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015507$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240926$$CN$US$US
243663181$24366318$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016408$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240926$$CN$US$US
243663191$24366319$1$I$20240828$20240916$20240926$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011458$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240926$$CN$US$US
243663201$24366320$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015483$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240926$$CN$US$US
243663211$24366321$1$I$20240729$20240917$20240926$20240926$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409010812$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240926$$CN$JP$JP
243663221$24366322$1$I$$20240921$20240926$20240926$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409013918$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240926$$CN$DE$DE
243663232$24366323$2$F$20240901$20240925$20240926$20240927$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409016059$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240927$$CN$JP$JP
243663241$24366324$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016638$ELI LILLY AND CO$$82$YR$E$$Y$45.359$KG$20240926$$CN$US$US
243663251$24366325$1$I$20240920$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015393$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240926$$CN$US$US
243663261$24366326$1$I$20240917$20240917$20240926$20240926$EXP$$JP-ROCHE-10000089632$ROCHE$$7$DEC$E$F$Y$$$20240926$$MD$JP$JP
243663281$24366328$1$I$20231213$20240925$20240925$20240925$DIR$720009$$FDA-CTU$$49$YR$$F$N$65.25$KG$20240925$N$CN$US$
243663291$24366329$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65902$$FDA-CTU$$$$$M$N$59.87$KG$20240925$N$HP$US$
243663301$24366330$1$I$20240921$20240926$20240926$20240926$PER$$US-PFIZER INC-202400264491$PFIZER$$41$YR$$F$Y$$$20240926$$HP$US$US
243663311$24366331$1$I$$20240919$20240926$20240926$30DAY$$US-PFIZER INC-202400260118$PFIZER$$6$YR$$M$Y$$$20240926$$CN$US$US
243663321$24366332$1$I$20240808$20240924$20240926$20240926$EXP$FR-AFSSAPS-PB2024001016$FR-PFIZER INC-202400262522$PFIZER$$87$YR$$F$Y$53.8$KG$20240926$$MD$FR$FR
243663351$24366335$1$I$$20240925$20240925$20240925$DIR$719960$$FDA-CTU$$73$YR$$F$N$$$20240925$N$PH$US$
243663361$24366336$1$I$20240801$20240924$20240925$20240925$DIR$FDA-CDER-CTU-2024-65802$$FDA-CTU$$$$$F$N$71.67$KG$20240924$N$HP$US$
243663371$24366337$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65790$$FDA-CTU$$75$YR$$F$N$69.4$KG$20240925$N$$US$
243663381$24366338$1$I$20240101$20240925$20240926$20240926$PER$$US-PFIZER INC-PV202400125823$PFIZER$$65$YR$$F$Y$$$20240926$$HP$US$US
243663391$24366339$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400125389$PFIZER$$$$$$Y$$$20240926$$CN$US$US
243663401$24366340$1$I$20230815$20240924$20240926$20240926$EXP$FR-AFSSAPS-RN2024001039$FR-PFIZER INC-202400262662$PFIZER$$79$YR$$F$Y$$$20240926$$MD$FR$FR
243663411$24366341$1$I$20240801$20240923$20240926$20240926$EXP$$CA-PFIZER INC-202400263351$PFIZER$$83$YR$$F$Y$$$20240926$$HP$CA$CA
243663432$24366343$2$F$20240830$20240924$20240926$20240930$PER$$US-PFIZER INC-202400263496$PFIZER$$76$YR$$M$Y$$$20240930$$PH$US$US
243663451$24366345$1$I$20240925$20240925$20240926$20240926$PER$$US-PFIZER INC-202400264370$PFIZER$$54$YR$$F$Y$$$20240926$$CN$US$US
243663461$24366346$1$I$20240101$20240923$20240926$20240926$EXP$$CA-PFIZER INC-202400249444$PFIZER$$69$YR$$F$Y$$$20240926$$HP$CA$CA
243663471$24366347$1$I$20240101$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400125596$PFIZER$$30$YR$$F$Y$$$20240926$$HP$US$US
243663501$24366350$1$I$20240806$20240923$20240926$20240926$EXP$FR-AFSSAPS-RN2024001012$FR-PFIZER INC-202400263640$PFIZER$$45$YR$$M$Y$$$20240926$$MD$FR$FR
243663511$24366351$1$I$20240201$20240923$20240926$20240926$EXP$$CA-PFIZER INC-202400047695$PFIZER$$68$YR$$F$Y$$$20240926$$HP$CA$CA
243663521$24366352$1$I$$20240925$20240926$20240926$PER$$US-PFIZER INC-202400264008$PFIZER$$63$YR$$F$Y$$$20240926$$CN$US$US
243663531$24366353$1$I$20240101$20240923$20240926$20240926$EXP$$GB-PFIZER INC-202400262787$PFIZER$$$$$F$Y$$$20240926$$CN$GB$GB
243663541$24366354$1$I$20240911$20240923$20240926$20240926$EXP$$CN-PFIZER INC-PV202400124275$PFIZER$$34$YR$$F$Y$55$KG$20240926$$HP$CN$CN
243663551$24366355$1$I$20240101$20240923$20240926$20240926$EXP$$US-PFIZER INC-202400244031$PFIZER$$63$YR$$F$Y$$$20240926$$CN$US$US
243663561$24366356$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400125258$PFIZER$$56$YR$$F$Y$$$20240926$$MD$US$US
243663571$24366357$1$I$20240924$20240925$20240926$20240926$PER$$US-PFIZER INC-202400264394$PFIZER$$44$YR$$F$Y$$$20240926$$CN$US$US
243663581$24366358$1$I$20240924$20240925$20240926$20240926$PER$$US-PFIZER INC-202400264403$PFIZER$$62$YR$$F$Y$$$20240926$$CN$US$US
243663591$24366359$1$I$20240922$20240925$20240926$20240926$PER$$US-PFIZER INC-202400263964$PFIZER$$37$YR$$F$Y$$$20240926$$CN$US$US
243663601$24366360$1$I$19840813$20240923$20240926$20240926$EXP$$AU-PFIZER INC-PV202400124479$PFIZER$$$$$F$Y$$$20240926$$HP$AU$AU
243663621$24366362$1$I$$20240925$20240926$20240926$PER$$US-PFIZER INC-202400263945$PFIZER$$$$E$F$Y$$$20240926$$MD$US$US
243663631$24366363$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202300208248$PFIZER$$82$YR$$F$Y$$$20240926$$CN$US$US
243663651$24366365$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400125585$PFIZER$$65$YR$$M$Y$$$20240926$$HP$US$US
243663661$24366366$1$I$20240923$20240925$20240926$20240926$PER$$US-PFIZER INC-202400263979$PFIZER$$61$YR$$M$Y$$$20240926$$CN$US$US
243663671$24366367$1$I$$20240918$20240926$20240926$30DAY$$US-PFIZER INC-PV202400122973$PFIZER$$$$$$Y$$$20240926$$CN$US$US
243663681$24366368$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400125209$PFIZER$$84$YR$$F$Y$$$20240926$$CN$US$US
243663701$24366370$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400125547$PFIZER$$61$YR$$F$Y$$$20240926$$HP$US$US
243663711$24366371$1$I$$20240924$20240926$20240926$EXP$$US-PFIZER INC-202400263571$PFIZER$$76$YR$$F$Y$$$20240926$$CN$US$US
243663721$24366372$1$I$$20240911$20240926$20240926$EXP$$US-GRANULES-US-2024GRALIT00420$GRANULES INDIA$Shawn M. Varney.An Analysis of Clinical Outcomes of Exploratory Pediatric Metformin Ingestions Reported to the Texas Poison Center Network From 2011 to 2021.Hospital Pharmacy.2024;59:465-470$$$$$Y$$$20240926$$HP$US$US
243663731$24366373$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3245872$TEVA$Soliman S, Li N, Taveras S, Newman R, Blackwell S, Sibai B, et al. AML-713 Hematological Malignancies and Pregnancy: A Single-Institution Experience. Clin-Lymphoma-Myeloma-Leuk 2024; 24 (Suppl. 1) S333-S334 abstr. AML-713.$$$$F$Y$$$20240926$$MD$US$US
243663741$24366374$1$I$$20240924$20240926$20240926$PER$$US-ABBVIE-5938870$ABBVIE$$$$$$Y$$$20240926$$MD$US$US
243663751$24366375$1$I$$20240917$20240926$20240926$EXP$$JP-ROCHE-10000091665$ROCHE$$15$YR$T$F$Y$$$20240926$$MD$JP$JP
243663771$24366377$1$I$20240101$20240923$20240926$20240926$EXP$$CA-Orion Corporation ORION PHARMA-24_00031858$ORION$$54$YR$A$F$Y$$$20240926$$MD$CA$
243663781$24366378$1$I$20240601$20240916$20240926$20240926$EXP$$US-UCBSA-2024034054$UCB$$63$YR$$F$Y$$$20240926$$HP$US$US
243663791$24366379$1$I$$20240917$20240926$20240926$EXP$$JP-UCBSA-2024048365$UCB$$$$$$Y$$$20240926$$PH$JP$JP
243663801$24366380$1$I$20230711$20240918$20240926$20240926$EXP$$FR-AUROBINDO-AUR-APL-2024-046423$AUROBINDO$$66$YR$$F$Y$81$KG$20240926$$MD$FR$FR
243663821$24366382$1$I$20240920$20240920$20240926$20240926$PER$$US-ABBVIE-5938122$ABBVIE$$24$YR$$F$Y$$$20240926$$HP$US$US
243663831$24366383$1$I$$20240912$20240926$20240926$EXP$$JP-MARKSANS PHARMA LIMITED-MPL202400064$MARKSANS$Sakamoto N, Hamada S, Takahashi H, Satou R, Suzuki M, Maeno T. Improvement of Intestinal Pseudo-Obstruction by Total Parenteral Nutrition in a Young Woman With Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes A Case Report. Cureus. 2023;15(12):e50075$20$YR$$F$Y$$$20240926$$HP$JP$JP
243663851$24366385$1$I$$20240912$20240926$20240926$EXP$$JP-MARKSANS PHARMA LIMITED-MPL202400063$MARKSANS$Fukuda M, Hirayu N, Nabeta M, Goto M, Takasu O. Metformin-Associated Lactic Acidosis in Individuals Without Chronic Kidney Disease on Therapeutic Dose A Case Report. Cureus. 2023;15(11):e48683$77$YR$$M$Y$$$20240926$$HP$JP$JP
243663861$24366386$1$I$$20240924$20240926$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE082836$SANDOZ$$$$A$$Y$$$20240926$$HP$DE$DE
243663872$24366387$2$F$20210101$20240924$20240926$20240930$PER$$US-BIOGEN-2024BI01284071$BIOGEN$$$$$F$Y$98.972$KG$20240930$$CN$US$US
243663881$24366388$1$I$20240601$20240912$20240926$20240926$30DAY$$AR-JNJFOC-20240944259$JOHNSON AND JOHNSON$$70$YR$E$F$Y$52$KG$20240926$$CN$AR$AR
243663891$24366389$1$I$$20240923$20240926$20240926$PER$$US-BIOGEN-2023BI01184016$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243663901$24366390$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-PV202400124710$PFIZER$Ghnaima, H.. BEYOND THE NORM: PEGFILGRASTIM-INDUCED TOXIC NEUTROPHILIA LEADING TO HYPERVISCOSITY-LINKED NON-ST ELEVATION MYOCARDIAL INFARCTION IN CHRONIC MYELOMONOCYTIC LEUKEMIA. Chest. 2024;166(4S):2742A-2743A$86$YR$$M$Y$$$20240926$$HP$US$US
243663911$24366391$1$I$20240901$20240918$20240926$20240926$30DAY$$US-PFIZER INC-202400259491$PFIZER$$12$YR$$F$Y$33.7$KG$20240926$$CN$US$US
243663921$24366392$1$I$20230101$20240923$20240926$20240926$PER$$US-BIOGEN-2023BI01196841$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243663931$24366393$1$I$$20240920$20240926$20240926$30DAY$$US-PFIZER INC-202400261472$PFIZER$$14$YR$$M$Y$$$20240926$$CN$US$US
243663941$24366394$1$I$20240901$20240924$20240926$20240926$EXP$$CL-PFIZER INC-PV202400124832$PFIZER$$18$YR$$M$Y$$$20240926$$CN$CL$CL
243663951$24366395$1$I$$20240919$20240926$20240926$30DAY$$CA-PFIZER INC-202400259981$PFIZER$$34$YR$$F$Y$$$20240926$$PH$CA$CA
243663961$24366396$1$I$$20240918$20240926$20240926$30DAY$$US-PFIZER INC-PV202400123107$PFIZER$$16$YR$$M$Y$$$20240926$$MD$US$US
243663971$24366397$1$I$20240918$20240923$20240926$20240926$EXP$$US-ABBVIE-5935402$ABBVIE$$62$YR$$F$Y$$$20240926$$CN$US$US
243663981$24366398$1$I$$20240920$20240926$20240926$EXP$DE-BFARM-24006414$DE-TEVA-VS-3246527$TEVA$$$$A$M$Y$98$KG$20240926$$CN$DE$DE
243663992$24366399$2$F$$20240920$20240926$20240926$EXP$$US-PFIZER INC-2022SGN10897$PFIZER$$75$YR$$F$Y$$$20240926$$CN$US$US
243664002$24366400$2$F$$20240922$20240926$20240926$PER$$US-ROCHE-10000089160$ROCHE$$45$YR$A$F$Y$$$20240926$$HP$US$US
243664011$24366401$1$I$20240722$20240920$20240926$20240926$EXP$$US-OTSUKA-2024_025119$OTSUKA$$88$YR$$F$Y$$$20240926$$MD$US$US
243664021$24366402$1$I$20240718$20240916$20240926$20240926$EXP$GB-MHRA-MED-202409151541129150-HSZFD$GB-TORRENT-00037998$TORRENT$$73$YR$E$M$Y$105$KG$20240926$$MD$GB$GB
243664031$24366403$1$I$$20240916$20240926$20240926$EXP$GB-MHRA-MED-202409142302073110-RQNDG$GB-TORRENT-00037997$TORRENT$$29$YR$A$F$Y$$$20240926$$CN$GB$GB
243664042$24366404$2$F$20240908$20240920$20240926$20240930$EXP$GB-MHRA-MED-202409141639538120-SMYKB$GB-TORRENT-00037996$TORRENT$$39$YR$A$F$Y$$$20240930$$CN$GB$GB
243664051$24366405$1$I$$20240916$20240926$20240926$EXP$GB-MHRA-TPP5725192C10406417YC1726214894287$GB-TORRENT-00037999$TORRENT$$76$YR$E$M$Y$74$KG$20240926$$PH$GB$GB
243664061$24366406$1$I$$20240925$20240925$20240925$DIR$719940$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243664071$24366407$1$I$$20240917$20240926$20240926$EXP$$US-UCBSA-2024047983$UCB$$$$$F$Y$$$20240926$$MD$US$US
243664081$24366408$1$I$$20240918$20240926$20240926$EXP$$US-UCBSA-2024033539$UCB$$$$$M$Y$$$20240926$$MD$US$US
243664091$24366409$1$I$$20240924$20240926$20240926$EXP$$NVSC2024KE190954$NOVARTIS$$26$YR$$M$Y$$$20240926$$HP$KE$KE
243664101$24366410$1$I$20240301$20240917$20240926$20240926$EXP$$US-ROCHE-10000084667$ROCHE$$$$$F$Y$$$20240926$$CN$US$US
243664121$24366412$1$I$20240922$20240922$20240926$20240926$EXP$$GB-AUROBINDO-AUR-APL-2024-047150$AUROBINDO$$59$YR$$M$Y$80$KG$20240926$$MD$GB$GB
243664161$24366416$1$I$$20240918$20240926$20240926$EXP$$JP-BEH-2024179210$CSL BEHRING$$71$YR$E$M$Y$$$20240926$$HP$JP$JP
243664171$24366417$1$I$$20240911$20240926$20240926$EXP$$US-GRANULES-US-2024GRALIT00417$GRANULES INDIA$Ravi Salgia.Clinical features associated with immune checkpoint inhibitor  nephritis: a single-center clinical case series.Cancer Immunology Immunotherapy.06-AUG-2024;73:1-9$69$YR$A$M$Y$$$20240926$$HP$US$US
243664181$24366418$1$I$20240401$20240923$20240926$20240926$EXP$FR-AFSSAPS-BX2024001826$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-151616$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240926$$PH$FR$FR
243664191$24366419$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152196$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$86.64$KG$20240926$$CN$US$US
243664201$24366420$1$I$20240901$20240923$20240926$20240926$EXP$$CA-PFIZER INC-202400262892$PFIZER$$73$YR$$F$Y$$$20240926$$HP$CA$CA
243664211$24366421$1$I$$20240911$20240926$20240926$30DAY$$CA-PFIZER INC-202400254694$PFIZER$$$$$$Y$$$20240926$$CN$CA$CA
243664221$24366422$1$I$$20240924$20240926$20240926$EXP$$GB-PFIZER INC-PV202400124789$PFIZER$$$$E$F$Y$$$20240926$$CN$GB$GB
243664231$24366423$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-202400263840$PFIZER$$$$$$Y$$$20240926$$CN$US$US
243664251$24366425$1$I$$20240917$20240926$20240926$30DAY$$US-PFIZER INC-202400258415$PFIZER$$14$YR$$M$Y$56.7$KG$20240926$$CN$US$US
243664271$24366427$1$I$$20240917$20240926$20240926$EXP$$DE-UCBSA-2024048092$UCB$$$$$$Y$$$20240926$$MD$DE$DE
243664281$24366428$1$I$20240101$20240919$20240926$20240926$EXP$$US-ABBVIE-5901842$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243664291$24366429$1$I$$20240923$20240926$20240926$EXP$$US-BAYER-2024A136854$BAYER$$80$YR$E$F$Y$$$20240926$$CN$US$US
243664301$24366430$1$I$20240916$20240924$20240926$20240926$EXP$$NVSC2024CN191315$NOVARTIS$$71$YR$$M$Y$60$KG$20240926$$HP$CN$CN
243664321$24366432$1$I$$20240917$20240926$20240926$PER$$US-ABBVIE-5927776$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243664331$24366433$1$I$20230501$20240923$20240926$20240926$EXP$$US-BBU-2024000278$BIOGEN$FAKUNLE I, CHAN V, BAIG SH. CAVITARY LUNG INFECTION WITH MYCOBACTERIUM ABSCESSUS IN AN IMMUNOCOMPROMISED HOST. CHEST. 166 (4S):1259A-60A. doi:10.1016/j.chest.2024.06.817$79$YR$$F$Y$$$20240926$$HP$US$US
243664341$24366434$1$I$20240722$20240925$20240925$20240925$DIR$720007$$FDA-CTU$$84$YR$$F$N$49.5$KG$20240925$N$PH$US$
243664361$24366436$1$I$20171216$20240919$20240926$20240926$EXP$$JP-LUNDBECK-DKLU3041151$LUNDBECK$$$$$$Y$$$20240926$$MD$JP$JP
243664371$24366437$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65914$$FDA-CTU$$79$YR$$M$N$$$20240925$N$CN$US$
243664381$24366438$1$I$$20240925$20240925$20240925$DIR$719955$$FDA-CTU$$$$$UNK$N$$$20240925$$CN$US$
243664391$24366439$1$I$$20240925$20240925$20240925$DIR$719948$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243664401$24366440$1$I$$20240918$20240926$20240926$EXP$$CN-ROCHE-10000090901$ROCHE$Deng Y, Niu T, Li X, Liu Y, Zhou Y, Lei D. Systemic analysis of adverse drug events in patients with diabetes complicated by cataract treated with rizumab after surgery. CHIN J DRUG APPL AND MONIT. 2024;21 (4):494-8. doi:10.3969/j.issn.1672-8157.2024.04.042.$$$$$Y$$$20240926$$HP$CN$CN
243664411$24366441$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65794$$FDA-CTU$$80$YR$$M$N$$$20240925$N$$US$
243664431$24366443$1$I$20240923$20240923$20240926$20240926$DIR$FDA-CDER-CTU-2024-65985$$FDA-CTU$$19$YR$$M$N$$$20240923$N$$US$
243664441$24366444$1$I$$20240919$20240926$20240926$EXP$$RO-PFIZER INC-2018392144$MYLAN$Popescu, E.. Sertraline induced psychosis in a patient with obsessive compulsive disorder (OCD) and anxiety disorder. Psihiatru.ro. 2018;14 (3):44-46$33$YR$$F$Y$$$20240926$$HP$RO$RO
243664451$24366445$1$I$$20240920$20240926$20240926$PER$$US-ASTELLAS-2024-AER-008285$ASTELLAS$$$$$F$Y$$$20240926$$CN$US$US
243664461$24366446$1$I$20240101$20240923$20240926$20240926$PER$$US-ABBVIE-5936775$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243664471$24366447$1$I$$20240925$20240925$20240925$DIR$719943$$FDA-CTU$$$$$M$N$$$20240925$$CN$US$
243664481$24366448$1$I$20240920$20240923$20240926$20240926$EXP$$US-BAYER-2024A137138$BAYER$$77$YR$E$F$Y$77.098$KG$20240926$$CN$US$US
243664491$24366449$1$I$$20240906$20240926$20240926$PER$$US-TEVA-VS-3242490$TEVA$$67$YR$$F$Y$$$20240926$$CN$US$US
243664501$24366450$1$I$$20240920$20240926$20240926$EXP$PT-INFARMED-J202409-122$PT-HIKMA PHARMACEUTICALS-PT-H14001-24-08856$HIKMA$$56$YR$$M$Y$$$20240926$$HP$PT$PT
243664521$24366452$1$I$20220923$20240916$20240926$20240926$EXP$$DE-BIOCON BIOLOGICS LIMITED-BBL2024005869$BIOCON$$$$$$Y$$$20240926$$HP$DE$DE
243664531$24366453$1$I$$20240923$20240926$20240926$EXP$$US-BAYER-2024A137320$BAYER$$84$YR$E$F$Y$105.67$KG$20240926$$CN$US$US
243664541$24366454$1$I$$20240911$20240926$20240926$EXP$$CA-HALEON-2197242$Haleon PLC$$40$YR$$F$Y$96$KG$20240926$$CN$CA$CA
243664561$24366456$1$I$20240510$20240919$20240926$20240926$EXP$FR-AFSSAPS-DJ2024000943$FR-009507513-2409FRA006901$MERCK$$70$YR$$M$Y$59$KG$20240926$$MD$FR$FR
243664571$24366457$1$I$20240910$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011140$APOTEX$$58$YR$A$F$Y$$$20240926$$CN$CA$CA
243664581$24366458$1$I$$20240916$20240926$20240926$PER$$US-MYLANLABS-2024M1085503$MYLAN$$$$$$Y$$$20240926$$CN$US$US
243664591$24366459$1$I$20240101$20240918$20240926$20240926$PER$$US-ABBVIE-5932099$ABBVIE$$$$$F$Y$95.254$KG$20240926$$CN$US$US
243664601$24366460$1$I$$20240919$20240926$20240926$PER$$US-MYLANLABS-2024M1085550$MYLAN$$$$$F$Y$$$20240926$$CN$US$US
243664611$24366461$1$I$20240101$20240923$20240926$20240926$PER$$US-Eisai-EC-2024-174649$EISAI$$68$YR$E$F$Y$$$20240926$$MD$US$US
243664621$24366462$1$I$20240901$20240923$20240926$20240926$EXP$$PR-Eisai-EC-2024-175254$EISAI$$54$YR$A$F$Y$59$KG$20240926$$CN$PR$US
243664631$24366463$1$I$20240101$20240923$20240926$20240926$EXP$$US-Eisai-EC-2024-175310$EISAI$$55$YR$A$M$Y$84.3$KG$20240926$$CN$US$US
243664641$24366464$1$I$$20240920$20240926$20240926$EXP$$CN-SANDOZ INC.-SDZ2024CN082497$SANDOZ$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. West China Journal of Stomatology. 2024;1-7$$$$M$Y$$$20240926$$HP$CN$CN
243664651$24366465$1$I$20231101$20240924$20240926$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE082615$SANDOZ$$75$YR$$F$Y$$$20240926$$MD$DE$DE
243664671$24366467$1$I$$20240924$20240926$20240926$EXP$$JP-GILEAD-2024-0688635$GILEAD$$80$YR$E$M$Y$$$20240926$$PH$JP$JP
243664691$24366469$1$I$20220101$20240917$20240926$20240926$EXP$$AT-BEH-2024179047$CSL BEHRING$$40$YR$A$M$Y$$$20240926$$CN$AT$AT
243664701$24366470$1$I$20240318$20240918$20240926$20240926$EXP$SE-SEMPA-2024-006679$SE-Merck Healthcare KGaA-2024050105$MERCK KGAA$$73$YR$E$F$Y$63$KG$20240926$$CN$SE$SE
243664711$24366471$1$I$20240901$20240922$20240926$20240926$EXP$$NVSC2024IE190210$NOVARTIS$$72$YR$$F$Y$$$20240926$$CN$IE$IE
243664721$24366472$1$I$$20240924$20240926$20240926$EXP$$NVSC2024AU190708$NOVARTIS$$$$$$Y$$$20240926$$MD$AU$AU
243664731$24366473$1$I$20240913$20240916$20240926$20240926$EXP$$US-IOVANCE BIOTHERAPEUTICS, INC-2024IOV000081$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240926$$CN$US$US
243664741$24366474$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245187$TEVA$$87$YR$$M$Y$$$20240926$$HP$CA$CA
243664751$24366475$1$I$20240807$20240916$20240926$20240926$PER$$US-MYLANLABS-2024M1085592$MYLAN$$60$YR$$M$Y$$$20240926$$CN$US$US
243664761$24366476$1$I$20240909$20240917$20240926$20240926$PER$$US-IGSA-BIG0030763$GRIFOLS$$45$YR$$F$Y$$$20240926$$CN$US$US
243664771$24366477$1$I$20240817$20240917$20240926$20240926$EXP$$ZA-Vifor (International) Inc.-VIT-2024-08557$VIFOR$$70$YR$$M$Y$$$20240926$$HP$ZA$ZA
243664781$24366478$1$I$$20240925$20240926$20240926$EXP$GB-MHRA-MED-202409241914457570-HRVFM$GB-ORGANON-O2409GBR001889$ORGANON$$$$$M$Y$$$20240926$$CN$GB$GB
243664791$24366479$1$I$20201006$20240923$20240926$20240926$PER$PL-URPL-1-3647-2020$PL-BRACCO-2020PL05774$BRACCO$$74$YR$$F$Y$$$20240926$$HP$PL$PL
243664801$24366480$1$I$20201111$20240919$20240926$20240926$EXP$$NVSC2024TH187902$NOVARTIS$$73$YR$$F$Y$$$20240926$$MD$TH$TH
243664811$24366481$1$I$20240801$20240917$20240926$20240926$EXP$$US-UCBSA-2024048028$UCB$$38$YR$$F$Y$$$20240926$$HP$US$US
243664821$24366482$1$I$$20240917$20240926$20240926$EXP$$US-UCBSA-2024048010$UCB$$$$$F$Y$$$20240926$$HP$US$US
243664831$24366483$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152250$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240926$$HP$US$US
243664841$24366484$1$I$$20240920$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150590$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240926$$HP$US$US
243664851$24366485$1$I$$20240924$20240926$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE083126$SANDOZ$$80$YR$$M$Y$69$KG$20240926$$HP$DE$DE
243664861$24366486$1$I$$20240917$20240926$20240926$EXP$$CA-UCBSA-2024047974$UCB$$33$YR$$M$Y$$$20240926$$HP$CA$CA
243664881$24366488$1$I$$20240917$20240926$20240926$PER$$US-GSK-US2024115658$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243664891$24366489$1$I$20240923$20240923$20240926$20240926$DIR$FDA-CDER-CTU-2024-65931$$FDA-CTU$$45$YR$$M$N$59$KG$20240923$N$$US$
243664901$24366490$1$I$20240101$20240916$20240926$20240926$EXP$$US-ANIPHARMA-2024-US-050193$ANI$$54$YR$$F$Y$90.72$KG$20240926$$HP$US$US
243664911$24366491$1$I$$20240911$20240926$20240926$EXP$$CA-HALEON-2197780$Haleon PLC$$$$$F$Y$$$20240926$$HP$CA$CA
243664921$24366492$1$I$20240430$20240916$20240926$20240926$EXP$$CA-TAKEDA-2024TUS035132$TAKEDA$$77$YR$$F$Y$$$20240926$$MD$CA$CA
243664931$24366493$1$I$$20240924$20240926$20240926$EXP$DE-ABBVIE-5927179$DE-SANDOZ INC.-SDZ2024DE082832$SANDOZ$$$$A$$Y$$$20240926$$HP$DE$DE
243664941$24366494$1$I$$20240918$20240926$20240926$EXP$$US-TEVA-VS-3246204$TEVA$$$$$F$Y$$$20240926$$CN$US$US
243664951$24366495$1$I$$20240923$20240926$20240926$EXP$$CA-ROCHE-10000088599$ROCHE$$58$YR$A$M$Y$110$KG$20240926$$HP$CA$CA
243664962$24366496$2$F$20240910$20240918$20240926$20240930$EXP$$DE-UCBSA-2024048035$UCB$$70$YR$$F$Y$55$KG$20240930$$MD$DE$DE
243664971$24366497$1$I$$20240918$20240926$20240926$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08761$HIKMA$$$$$$Y$$$20240926$$CN$US$US
243664981$24366498$1$I$$20240918$20240926$20240926$EXP$$GB-TAKEDA-2024TUS094126$TAKEDA$$$$$M$Y$$$20240926$$CN$GB$GB
243664991$24366499$1$I$20240920$20240925$20240926$20240926$EXP$$CN-BAYER-2024A137558$BAYER$$73$YR$E$F$Y$50$KG$20240926$$HP$CN$CN
243665001$24366500$1$I$$20240917$20240926$20240926$EXP$$CA-HALEON-2197860$Haleon PLC$$50$YR$$F$Y$$$20240926$$HP$CA$CA
243665011$24366501$1$I$$20240920$20240926$20240926$EXP$PT-EMA-DD-20240912-7482655-071711$PT-TEVA-VS-3246583$TEVA$$62$YR$$M$Y$$$20240926$$HP$PT$PT
243665021$24366502$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245191$TEVA$$73$YR$$M$Y$$$20240926$$MD$CA$CA
243665031$24366503$1$I$20160216$20240916$20240926$20240926$EXP$$BE-ABBVIE-5939767$ABBVIE$$67$YR$$M$Y$$$20240926$$HP$BE$BE
243665041$24366504$1$I$$20240920$20240926$20240926$EXP$$NVSC2024VU189497$NOVARTIS$$$$$M$Y$$$20240926$$MD$VU$VU
243665061$24366506$1$I$$20240925$20240925$20240925$DIR$719914$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243665071$24366507$1$I$20240918$20240919$20240926$20240926$PER$$US-ASTELLAS-2024-AER-008062$ASTELLAS$$49$YR$A$F$Y$$$20240926$$MD$US$US
243665081$24366508$1$I$$20240913$20240926$20240926$PER$$US-JNJFOC-20240958141$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243665091$24366509$1$I$$20240920$20240926$20240926$EXP$$US-ASTELLAS-2024-AER-008389$ASTELLAS$$$$$M$Y$$$20240926$$MD$US$US
243665102$24366510$2$F$20240913$20240917$20240926$20240926$PER$$US-JNJFOC-20240942002$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240926$$CN$US$US
243665111$24366511$1$I$$20240916$20240926$20240926$EXP$GB-MHRA-MED-202409152025222850-GSVKF$GB-JNJFOC-20240966622$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240926$$CN$GB$GB
243665141$24366514$1$I$20240919$20240925$20240925$20240925$DIR$720013$$FDA-CTU$$66$YR$$F$N$69$KG$20240925$N$CN$US$
243665161$24366516$1$I$20240726$20240926$20240926$20240926$DIR$720016$$FDA-CTU$$23$YR$$M$N$60.75$KG$20240926$N$CN$US$
243665171$24366517$1$I$20240907$20240926$20240926$20240926$DIR$720077$$FDA-CTU$$40$YR$$M$N$94.5$KG$20240926$N$CN$US$
243665191$24366519$1$I$20240905$20240926$20240926$20240926$DIR$720018$$FDA-CTU$$42$YR$$M$N$91.35$KG$20240926$N$CN$US$
243665211$24366521$1$I$$20240925$20240925$20240925$DIR$719949$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243665221$24366522$1$I$$20240925$20240925$20240925$DIR$719936$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243665231$24366523$1$I$20240914$20240920$20240926$20240926$EXP$$CN-ASTELLAS-2024-AER-008232$ASTELLAS$$24$YR$A$M$Y$64$KG$20240926$$HP$CN$CN
243665251$24366525$1$I$20240101$20240917$20240926$20240926$EXP$$CA-CELLTRION INC.-2024CA018874$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243665281$24366528$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3246061$TEVA$Tarantino MD, Hardesty B, Metjian A, Ortel TL, Chen J, Badejo K, et al. Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety study. Haemophilia 2023; 29 (5): 1259-1268.$$$E$F$Y$$$20240926$$HP$US$US
243665292$24366529$2$F$20240924$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024190799$AMGEN$$$$$$Y$$$20240926$$HP$US$US
243665311$24366531$1$I$20240416$20240924$20240926$20240926$EXP$$GB-UCBSA-2024049033$UCB$$45$YR$$M$Y$90.85$KG$20240926$$HP$GB$GB
243665321$24366532$1$I$$20240911$20240926$20240926$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468289$RANBAXY$$$$$F$Y$$$20240926$$CN$BR$BR
243665331$24366533$1$I$$20240911$20240926$20240926$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469528$RANBAXY$Kim HM, Lee J, Kim S, Lee JW, Kim H-J, Cho Y-S.. Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease. Blood Res. 2023;Sep: 58(3):145-148$52$YR$$F$Y$$$20240926$$HP$KR$KR
243665351$24366535$1$I$$20240911$20240926$20240926$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469927$RANBAXY$$62$YR$$F$Y$76$KG$20240926$$CN$NL$NL
243665361$24366536$1$I$$20240911$20240926$20240926$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469938$RANBAXY$$$$$M$Y$$$20240926$$PH$GB$GB
243665371$24366537$1$I$20240109$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469770$RANBAXY$$41$YR$$M$Y$92$KG$20240926$$PH$FR$FR
243665381$24366538$1$I$$20240911$20240926$20240926$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469740$RANBAXY$Iwamoto M, Tsubamoto H, Yoshiyasu K, Wakimoto Y, Nakagawa K, Shibahara H. Fertility sparing management of stage IIIC serous borderline ovarian tumor: A case report of a 20 year follow up. J Obstet Gynaecol Res. 2023;49:2761-2765$19$YR$$F$Y$$$20240926$$HP$JP$JP
243665391$24366539$1$I$$20240911$20240926$20240926$EXP$$CA-BAXTER-2024BAX024757$BAXTER$$68$YR$$F$Y$73$KG$20240926$$HP$CA$CA
243665401$24366540$1$I$20240614$20240911$20240926$20240926$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469911$RANBAXY$$90$YR$$M$Y$53$KG$20240926$$MD$ES$ES
243665411$24366541$1$I$$20240911$20240926$20240926$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469788$RANBAXY$$24$YR$$F$Y$76$KG$20240926$$MD$PL$PL
243665421$24366542$1$I$$20240911$20240926$20240926$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469649$RANBAXY$Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Huang BJ et al. Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies. Pediatr Blood Cancer. 2023;70:e30335 (1-9)$10$YR$$M$Y$$$20240926$$HP$US$US
243665431$24366543$1$I$20240718$20240911$20240926$20240926$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469945$RANBAXY$$63$YR$$F$Y$$$20240926$$MD$DE$DE
243665441$24366544$1$I$$20240911$20240926$20240926$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469653$RANBAXY$Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Huang BJ et al. Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies. Pediatr Blood Cancer. 2023;70:e30335 (1-9)$20$YR$$F$Y$$$20240926$$HP$US$US
243665451$24366545$1$I$$20240911$20240926$20240926$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469525$RANBAXY$Kim HM, Lee J, Kim S, Lee JW, Kim H-J, Cho Y-S.. Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease. Blood Res. 2023;Sep: 58(3):145-148$39$YR$$F$Y$$$20240926$$HP$KR$KR
243665461$24366546$1$I$$20240911$20240926$20240926$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469524$RANBAXY$Kim HM, Lee J, Kim S, Lee JW, Kim H-J, Cho Y-S.. Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease. Blood Res. 2023;Sep: 58(3):145-148$31$YR$$F$Y$$$20240926$$HP$KR$KR
243665471$24366547$1$I$$20240911$20240926$20240926$EXP$$NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469827$RANBAXY$$71$YR$$F$Y$54$KG$20240926$$CN$NL$NL
243665481$24366548$1$I$20230712$20240911$20240926$20240926$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469850$RANBAXY$$60$YR$$F$Y$$$20240926$$MD$ES$ES
243665491$24366549$1$I$20240625$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469995$RANBAXY$$57$YR$$M$Y$$$20240926$$PH$FR$FR
243665501$24366550$1$I$20240530$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469902$RANBAXY$$16$YR$$M$Y$$$20240926$$MD$FR$FR
243665511$24366551$1$I$$20240925$20240926$20240926$PER$$US-GILEAD-2024-0688928$GILEAD$$47$YR$A$M$Y$$$20240926$$PH$US$US
243665531$24366553$1$I$$20240911$20240926$20240926$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469586$RANBAXY$Maffione AM, Rampin L, Chondrogiannis S, Marzola MC, Colletti PM, Rubello D. 18F-FDG PET/CT of Brown Adipose Tissue 18F-FDG PET/CT of Brown Adipose Tissue Paraganglioma. Clinical Nuclear Medicine. 2017;Dec, 42 (12):950-951$32$YR$$F$Y$$$20240926$$MD$IT$IT
243665541$24366554$1$I$$20240911$20240926$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469635$RANBAXY$Shi M, Wang S, Ren Y, Zhao L, Liu M, Yang L et al. Pegylated-interferon alpha (PEGIFN?)-induced interstitial lung disease in a patient with chronic hepatitis B: A case report and literature review. Int J Clin Pharmacol. 2024;62(8):386-394$61$YR$$M$Y$$$20240926$$HP$CN$CN
243665551$24366555$1$I$20240501$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469957$RANBAXY$$61$YR$$F$Y$47$KG$20240926$$MD$FR$FR
243665561$24366556$1$I$$20240911$20240926$20240926$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469536$RANBAXY$Cuniolo L, Gipponi M, Murelli F, Depaoli F, Cornacchia C, Franchelli S, et al. Multidisciplinary and Tailored Treatment of Locally Advanced Breast Cancer in Progression during Neoadjuvant Chemotherapy : Case Report. Curr Oncol. 2024;31 (5):2856-2866$55$YR$$F$Y$$$20240926$$HP$IT$IT
243665571$24366557$1$I$20240702$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469914$RANBAXY$$42$YR$$M$Y$110$KG$20240926$$MD$FR$FR
243665581$24366558$1$I$$20240911$20240926$20240926$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469976$RANBAXY$Uehara Y, Ikeda S, Kim KH, Lim HJ, Adashek JJ, Persha HE, et al. Targeting the FGF/FGFR axis and its co-alteration allies. ESMO Open. 2022;7(6):100647;1-13$78$YR$$M$Y$$$20240926$$HP$JP$JP
243665591$24366559$1$I$20240625$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469659$RANBAXY$$74$YR$$F$Y$$$20240926$$PH$FR$FR
243665601$24366560$1$I$$20240911$20240926$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470035$RANBAXY$He H, Hou N, Chen X, Song Y, Qiang W, Liu J, et al. An open-label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome. Br J Haematol. 2024;205 (2):478-482$61$YR$$M$Y$$$20240926$$HP$CN$CN
243665611$24366561$1$I$20240615$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469656$RANBAXY$$39$YR$$F$Y$59$KG$20240926$$MD$FR$FR
243665621$24366562$1$I$$20240911$20240926$20240926$EXP$DE-EMA-DD-20240718-7482645-080313$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469901$RANBAXY$$35$YR$$M$Y$$$20240926$$HP$DE$DE
243665631$24366563$1$I$$20240911$20240926$20240926$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469665$RANBAXY$Buckley S, Mallik R, Mukuba D, Casabar M, Chakraborty R, Ali O, et al. Safety and efficacy of the use of sodium-glucose co-transporter inhibitors (SGLT2i) in kidney transplant recipients at the Royal London Hospital. Br J Diabetes. 2024;24 (1):Abstract ID: 524$$$$$Y$$$20240926$$HP$GB$GB
243665641$24366564$1$I$20240711$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469958$RANBAXY$$26$YR$$F$Y$$$20240926$$MD$FR$FR
243665651$24366565$1$I$$20240911$20240926$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469875$RANBAXY$He H, Hou N, Chen X, Song Y, Qiang W, Liu J, et al. An open-label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome. Br J Haematol. 2024;205 (2):478-482$37$YR$$M$Y$$$20240926$$HP$CN$CN
243665661$24366566$1$I$20240313$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469458$RANBAXY$$23$YR$$M$Y$51$KG$20240926$$MD$FR$FR
243665671$24366567$1$I$$20240917$20240926$20240926$EXP$CA-DRL-USA-SPO/CAN/24/0013690$CA-RDY-SPO/CAN/24/0013690$DR REDDYS$$$$$F$Y$$$20240926$$HP$CA$CA
243665681$24366568$1$I$$20240911$20240926$20240926$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469583$RANBAXY$Lin AK. Pulmonary cryptococcus (case series, Regional VIC, Australia). Respirat Med Case Report. 2023;46:1-4$34$YR$$M$Y$$$20240926$$HP$AU$AU
243665691$24366569$1$I$$20240911$20240926$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469680$RANBAXY$Xu S, Wu X, Chen E, Ying K. Anti-Helicobacter pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review of the Literature. Clin Respir J. 2024;18(8):e13816;1-6$35$YR$$F$Y$$$20240926$$HP$CN$CN
243665701$24366570$1$I$20240920$20240925$20240925$20240925$DIR$719971$$FDA-CTU$$69$YR$$M$N$122.4$KG$20240925$N$CN$US$
243665711$24366571$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-65991$$FDA-CTU$$68$YR$$M$N$$$20240926$N$$US$
243665721$24366572$1$I$$20240911$20240926$20240926$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469697$RANBAXY$Schieve B, Belovs L, Potter B, Lannan FM. Severe complication after microwave thermoablation of a residual limb: multifocal full thickness cutaneous necrosis and deep venous thrombosis. BMJ Case Rep. 2023;16:e256693(1-5)$4$DEC$$F$Y$$$20240926$$HP$US$US
243665731$24366573$1$I$$20240911$20240926$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469684$RANBAXY$Xu S, Wu X, Chen E, Ying K. Anti-Helicobacter pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review of the Literature. Clin Respir J. 2024;18(8):e13816;1-6$52$YR$$F$Y$$$20240926$$HP$CN$CN
243665741$24366574$1$I$20201123$20240911$20240926$20240926$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469468$RANBAXY$$19$YR$$F$Y$70$KG$20240926$$MD$PL$PL
243665751$24366575$1$I$20240313$20240917$20240926$20240926$DIR$FDA-CDER-CTU-2024-65948$$FDA-CTU$$74$YR$$M$N$99.3$KG$20240917$N$$US$
243665761$24366576$1$I$$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-65979$$FDA-CTU$$$$$F$N$$$20240925$N$HP$US$
243665771$24366577$1$I$$20240911$20240926$20240926$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469706$RANBAXY$Hernandez CL, Lynch DM, Golash AJ, Marquis K, Besz KM, Oxnard G, et al. Anaphylaxis and systemic mastocytosis controlled with KIT inhibitors in a patient with metastatic lung adenocarcinoma. Ann Allergy Asthma Immunol. 2023;131:668-670$58$YR$$F$Y$$$20240926$$MD$US$US
243665781$24366578$1$I$$20240911$20240926$20240926$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469716$RANBAXY$Hill RC, Wang Y, Shaikh B, Ong M, Christos PJ, Lipner SR. Spironolactone treatment for dermatologic indications is not associated with clinically significant hypotension in a single-center retrospective study. J Am Acad Dermatol. 2024;Sep;91 (sp3):AB316(50516)$$$$F$Y$$$20240926$$HP$US$US
243665791$24366579$1$I$$20240911$20240926$20240926$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469663$RANBAXY$Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Huang BJ et al. Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies. Pediatr Blood Cancer. 2023;70 (6):e30335$15$YR$$F$Y$$$20240926$$HP$US$US
243665801$24366580$1$I$$20240911$20240926$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469683$RANBAXY$Xu S, Wu X, Chen E, Ying K. Anti-Helicobacter pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review of the Literature. Clin Respir J. 2024;18(8):e13816;1-6$57$YR$$F$Y$$$20240926$$HP$CN$CN
243665811$24366581$1$I$20240501$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469959$RANBAXY$$63$YR$$$Y$$$20240926$$MD$FR$FR
243665821$24366582$1$I$20240614$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469596$RANBAXY$$21$YR$$M$Y$$$20240926$$MD$FR$FR
243665831$24366583$1$I$20240514$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469894$RANBAXY$$51$YR$$F$Y$68$KG$20240926$$PH$FR$FR
243665841$24366584$1$I$20240701$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469717$RANBAXY$$78$YR$$F$Y$$$20240926$$MD$FR$FR
243665851$24366585$1$I$20231201$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469473$RANBAXY$$74$YR$$$Y$$$20240926$$MD$FR$FR
243665861$24366586$1$I$20230907$20240911$20240926$20240926$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469838$RANBAXY$$92$YR$$M$Y$$$20240926$$MD$IT$IT
243665871$24366587$1$I$$20240911$20240926$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469537$RANBAXY$Pan S, Moming Z, Tuerxun M, Chong Y, Zhu J.. A case of drug fever in the treatment of Brucella arthritis in a child: a case report. BMC Infect Dis. 2024;24 (1):877;1-4$4$YR$$M$Y$15$KG$20240926$$HP$CN$CN
243665891$24366589$1$I$$20240911$20240926$20240926$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469527$RANBAXY$Kim HM, Lee J, Kim S, Lee JW, Kim H-J, Cho Y-S.. Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease. Blood Res. 2023;Sep: 58(3):145-148$48$YR$$F$Y$$$20240926$$HP$KR$KR
243665901$24366590$1$I$20240629$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469960$RANBAXY$$57$YR$$M$Y$90$KG$20240926$$MD$FR$FR
243665911$24366591$1$I$$20240911$20240926$20240926$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469674$RANBAXY$Wallace CE, Tam I, Beveridge MG. Cyclosporine for Recalcitrant Bullous Pemphigoid Induced by Nivolumab Therapy for Malignant Melanoma. Cutis. 2024;Jul;14(1):E21-E23$41$YR$$M$Y$$$20240926$$HP$US$US
243665921$24366592$1$I$20231121$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469906$RANBAXY$$78$YR$$M$Y$100$KG$20240926$$MD$FR$FR
243665931$24366593$1$I$$20240911$20240926$20240926$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469538$RANBAXY$Abdalrazag OA, Okoye AO, Muniyappa SM. Title to be provided.. Br J Diabetes. 2024;24 (1):No pagination$77$YR$$M$Y$$$20240926$$HP$GB$GB
243665941$24366594$1$I$$20240911$20240926$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469681$RANBAXY$Xu S, Wu X, Chen E, Ying K. Anti-Helicobacter pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review of the Literature. Clin Respir J. 2024;18(8):e13816;1-6$34$YR$$F$Y$$$20240926$$HP$CN$CN
243665951$24366595$1$I$20240921$20240924$20240926$20240926$EXP$$NVSC2024DO190914$NOVARTIS$$64$YR$$F$Y$$$20240926$$CN$DO$DO
243665961$24366596$1$I$$20240920$20240926$20240926$EXP$$NVSC2024US190867$NOVARTIS$$$$$M$Y$$$20240926$$MD$US$US
243665971$24366597$1$I$$20240924$20240926$20240926$EXP$$US-GILEAD-2024-0688889$GILEAD$$$$E$F$Y$$$20240926$$CN$US$US
243665981$24366598$1$I$$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469991$RANBAXY$$9$YR$$M$Y$$$20240926$$HP$FR$FR
243665991$24366599$1$I$$20240923$20240926$20240926$EXP$$US-SA-2024SA276141$SANOFI AVENTIS$GEE J, QURESHI H.. IDIOPATHIC SPONTANEOUS RETROPERITONEAL HEMORRHAGE CAUSING BLOODY TROUBLE.. Chest.. 2024;166(4):A1861-2.$65$YR$E$F$Y$$$20240926$$HP$US$US
243666001$24366600$1$I$20170727$20240923$20240926$20240926$EXP$$DE-SA-2024SA275438$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240926$$HP$DE$DE
243666011$24366601$1$I$20240101$20240919$20240926$20240926$EXP$$US-ABBVIE-5932544$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243666021$24366602$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016255$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240926$$CN$US$US
243666031$24366603$1$I$20240611$20240919$20240926$20240926$EXP$$SA-GSK-SA2024EME109085$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$SA$SA
243666041$24366604$1$I$$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152074$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240926$$CN$US$US
243666051$24366605$1$I$$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150527$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$77$KG$20240926$$CN$US$US
243666061$24366606$1$I$$20240916$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR115257$VIIV$$$$$$Y$$$20240926$$CN$US$US
243666071$24366607$1$I$$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1084361$MYLAN$$$$$$Y$$$20240926$$LW$US$US
243666081$24366608$1$I$20210824$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1084631$MYLAN$$52$YR$$M$Y$95.25$KG$20240926$$LW$US$US
243666091$24366609$1$I$$20240920$20240926$20240926$EXP$$FR-MYLANLABS-2024M1086512$MYLAN$Ghanem R, Glaisner S, Bobin A, Ronchetti A-M, Cereja S, Joly B, et al. Posterior reversible encephalopathy syndrome (PRES) and myeloma. Leukemia-Research-Reports 2024; 21.$62$YR$$F$Y$$$20240926$$HP$FR$FR
243666101$24366610$1$I$20181001$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1084387$MYLAN$$68$YR$$M$Y$106.59$KG$20240926$$LW$US$US
243666111$24366611$1$I$$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1084360$MYLAN$$$$$$Y$$$20240926$$LW$US$US
243666121$24366612$1$I$20190101$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1084375$MYLAN$$$$$M$Y$95.25$KG$20240926$$LW$US$US
243666131$24366613$1$I$$20240924$20240926$20240926$PER$$US-DAIICHI SANKYO, INC.-DS-2024-101199-US$DAIICHI$$$$$F$Y$$$20240926$$HP$US$US
243666141$24366614$1$I$20230701$20240917$20240926$20240926$EXP$$MX-JNJFOC-20240948172$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20240926$$CN$MX$MX
243666151$24366615$1$I$$20240920$20240926$20240926$PER$$US-JNJFOC-20240959750$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243666161$24366616$1$I$$20240911$20240926$20240926$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469639$RANBAXY$Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Huang BJ et al. Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies. Pediatr Blood Cancer. 2023;70:e30335 (1-9)$17$YR$$F$Y$$$20240926$$HP$US$US
243666171$24366617$1$I$20240628$20240911$20240926$20240926$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470045$RANBAXY$$18$YR$$M$Y$$$20240926$$MD$IT$IT
243666181$24366618$1$I$20220104$20240916$20240926$20240926$EXP$$US-MYLANLABS-2024M1084640$MYLAN$$67$YR$$M$Y$95.25$KG$20240926$$LW$US$US
243666191$24366619$1$I$20240512$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469769$RANBAXY$$6$YR$$M$Y$$$20240926$$CN$FR$FR
243666201$24366620$1$I$$20240911$20240926$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470041$RANBAXY$He H, Hou N, Chen X, Song Y, Qiang W, Liu J, et al. An open-label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome. Br J Haematol. 2024;205 (2):478-482$74$YR$$M$Y$$$20240926$$HP$CN$CN
243666211$24366621$1$I$20240909$20240911$20240926$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468278$RANBAXY$$23$YR$$M$Y$71$KG$20240926$$CN$CN$CN
243666221$24366622$1$I$$20240911$20240926$20240926$EXP$$PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469792$RANBAXY$$23$YR$$M$Y$100$KG$20240926$$MD$PL$PL
243666231$24366623$1$I$20240702$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470029$RANBAXY$$79$YR$$F$Y$71$KG$20240926$$MD$FR$FR
243666241$24366624$1$I$$20240911$20240926$20240926$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469672$RANBAXY$Wang D, Li C, Turabi A. Atypical refractory occipital neuralgia treated with a unilateral dual-lead occipital nerve stimulator: a case report. Pain Manag. 2024;14(5-6):241-246$53$YR$$M$Y$$$20240926$$HP$US$US
243666251$24366625$1$I$$20240911$20240926$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469620$RANBAXY$Li D, Yu H, Zhou M, Fan W, Guan Q, Li L. Case report: Chronic inflammatory demyelinating polyneuropathy superimposed on Charcot?Marie-tooth type 1A disease after SARS-CoV-2 vaccination and COVID-19 infection. Front Neurol. 2024;15 (0):1358881 (1-6)$42$YR$$M$Y$80$KG$20240926$$HP$CN$CN
243666261$24366626$1$I$20240627$20240911$20240926$20240926$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469606$RANBAXY$$81$YR$$F$Y$63.5$KG$20240926$$PH$FR$FR
243666271$24366627$1$I$$20240916$20240926$20240926$PER$$US-ROCHE-10000084243$ROCHE$$$$$$Y$$$20240926$$CN$US$US
243666281$24366628$1$I$$20240717$20240926$20240926$PER$$US-009507513-2409USA009105$MERCK$Ni B, Wolfe CR, Arif S, Carugati M, Heldman MR, Messina JA, et al.. Real-World Experience with Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients. Open Forum Infectious Diseases. 2024;11(11)$41$YR$$M$Y$$$20240926$$MD$US$US
243666291$24366629$1$I$20240101$20240917$20240926$20240926$EXP$$US-TEVA-VS-3246289$TEVA$$33$YR$$F$Y$$$20240926$$HP$US$US
243666301$24366630$1$I$20240101$20240926$20240926$20240926$EXP$$JP-BAYER-2024A137633$BAYER$$71$YR$E$M$Y$$$20240926$$MD$JP$JP
243666311$24366631$1$I$$20240917$20240926$20240926$EXP$$AU-MYLANLABS-2024M1086187$MYLAN$Poon J, Coombes F, Coombes I. Sum of the parts: a cascade of adverse effects. Aust-Prescr 2024; 47 (4): 125-128.$58$YR$$M$Y$$$20240926$$HP$AU$AU
243666341$24366634$1$I$20240828$20240925$20240925$20240925$DIR$719946$$FDA-CTU$$70$YR$$F$N$72$KG$20240925$N$CN$US$
243666361$24366636$1$I$20240831$20240926$20240926$20240926$DIR$720022$$FDA-CTU$$56$YR$$F$N$85.95$KG$20240926$N$CN$US$
243666371$24366637$1$I$20240914$20240916$20240926$20240926$PER$$US-ABBVIE-5928601$ABBVIE$$62$YR$$F$Y$$$20240926$$CN$US$US
243666381$24366638$1$I$$20240717$20240926$20240926$PER$$US-009507513-2409USA009108$MERCK$Ni B, Wolfe CR, Arif S, Carugati M, Heldman MR, Messina JA, et al.. Real-World Experience with Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients. Open Forum Infectious Diseases. 2024;11(11)$76$YR$$M$Y$$$20240926$$MD$US$US
243666391$24366639$1$I$$20240916$20240926$20240926$EXP$$CA-TAKEDA-2024TUS092771$TAKEDA$$$$$M$Y$$$20240926$$CN$CA$CA
243666401$24366640$1$I$20240703$20240920$20240926$20240926$EXP$NO-NOMAADVRE-PASRAPP-2024-V374ew$NO-TAKEDA-2024TUS094384$TAKEDA$$38$YR$$F$Y$$$20240926$$HP$NO$NO
243666411$24366641$1$I$20240913$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-65934$$FDA-CTU$$27$YR$$F$N$65.1$KG$20240925$N$$US$
243666421$24366642$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-65968$$FDA-CTU$$59$YR$$M$N$$$20240926$N$$US$
243666431$24366643$1$I$$20240919$20240926$20240926$PER$$US-BAYER-2024A134233$BAYER$$$$$$Y$$$20240926$$CN$US$US
243666441$24366644$1$I$20240101$20240920$20240926$20240926$EXP$$US-ABBVIE-5933751$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243666452$24366645$2$F$$20240923$20240926$20240930$EXP$$US-CHATTEMPRD-2024OHG033292$CHATTEM$$$$$F$Y$$$20240930$$CN$US$US
243666461$24366646$1$I$20240101$20240923$20240926$20240926$EXP$$CA-ABBVIE-5937011$ABBVIE$$67$YR$$M$Y$$$20240926$$CN$CA$CA
243666471$24366647$1$I$20240316$20240919$20240926$20240926$EXP$FR-AFSSAPS-PB2024000982$FR-009507513-2409FRA006841$MERCK$$38$YR$$F$Y$60$KG$20240926$$HP$FR$FR
243666481$24366648$1$I$20240301$20240923$20240926$20240926$EXP$$US-ABBVIE-5936422$ABBVIE$$62$YR$$F$Y$$$20240926$$CN$US$US
243666491$24366649$1$I$20240913$20240913$20240926$20240926$EXP$$CA-CELLTRION INC.-2024CA022660$CELLTRION$$$$$$Y$$$20240926$$HP$CA$CA
243666501$24366650$1$I$$20240923$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152170$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240926$$PH$US$US
243666521$24366652$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152113$BRISTOL MYERS SQUIBB$$58$YR$A$$Y$$$20240926$$HP$US$US
243666531$24366653$1$I$$20240917$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148328$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240926$$CN$US$US
243666541$24366654$1$I$20240913$20240920$20240926$20240926$PER$$US-BAYER-2024A134974$BAYER$$73$YR$E$M$Y$$$20240926$$CN$US$US
243666551$24366655$1$I$$20240916$20240926$20240926$EXP$$US-UCBSA-2024047628$UCB$$$$$F$Y$$$20240926$$CN$US$US
243666561$24366656$1$I$$20240912$20240926$20240926$EXP$$JP-JNJFOC-A-CH2018-170307$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240926$$MD$JP$JP
243666571$24366657$1$I$20230601$20240924$20240926$20240926$EXP$$DE-MYLANLABS-2024M1086721$MYLAN$$$$$F$Y$$$20240926$$CN$DE$DE
243666581$24366658$1$I$$20240918$20240926$20240926$EXP$$AU-Bion-013901$BIONPHARMA$$5$WK$I$M$Y$$$20240926$$HP$AU$AU
243666601$24366660$1$I$$20240923$20240926$20240926$EXP$$NVSC2024ES191011$NOVARTIS$$$$$F$Y$$$20240926$$MD$ES$ES
243666611$24366661$1$I$$20240919$20240926$20240926$EXP$$CA-Bion-013915$BIONPHARMA$$61$YR$A$F$Y$$$20240926$$HP$CA$CA
243666621$24366662$1$I$$20240917$20240926$20240926$EXP$$CA-Bion-013888$BIONPHARMA$$75$YR$E$F$Y$$$20240926$$HP$CA$CA
243666631$24366663$1$I$$20240918$20240926$20240926$EXP$$CL-Bion-013896$BIONPHARMA$$14$YR$T$M$Y$$$20240926$$HP$CL$CL
243666641$24366664$1$I$$20240916$20240926$20240926$EXP$$US-UCBSA-2024048439$UCB$$$$$F$Y$$$20240926$$HP$US$US
243666651$24366665$1$I$20201105$20240918$20240926$20240926$EXP$$BR-TAKEDA-BR202028928$TAKEDA$$9$YR$$M$Y$26$KG$20240926$$CN$BR$BR
243666661$24366666$1$I$20240830$20240918$20240926$20240926$EXP$$CN-BEIGENE-BGN-2024-014843$BEIGENE$$$$$$Y$$$20240926$$HP$CN$CN
243666681$24366668$1$I$20211013$20240920$20240926$20240926$EXP$$ES-009507513-2409ESP007808$MERCK$$53$YR$$M$Y$101.8$KG$20240926$$MD$ES$ES
243666691$24366669$1$I$20240901$20240918$20240926$20240926$EXP$$US-TEVA-VS-3244933$TEVA$$67$YR$$F$Y$$$20240926$$CN$US$US
243666701$24366670$1$I$$20240918$20240926$20240926$EXP$$CN-Bion-013894$BIONPHARMA$$73$YR$E$F$Y$$$20240926$$HP$CN$CN
243666711$24366671$1$I$$20240924$20240926$20240926$PER$$US-BAYER-2024A136953$BAYER$$$$$$Y$$$20240926$$CN$US$US
243666721$24366672$1$I$$20240717$20240926$20240926$PER$$US-009507513-2409USA009107$MERCK$Ni B, Wolfe CR, Arif S, Carugati M, Heldman MR, Messina JA, et al.. Real-World Experience with Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients. Open Forum Infectious Diseases. 2024;11(11)$65$YR$$M$Y$$$20240926$$MD$US$US
243666731$24366673$1$I$$20240918$20240926$20240926$EXP$$MG-Bion-013893$BIONPHARMA$$37$YR$A$M$Y$$$20240926$$HP$MG$MG
243666741$24366674$1$I$20240924$20240925$20240925$20240925$DIR$719965$$FDA-CTU$$37$YR$$M$N$118.35$KG$20240925$N$$US$
243666751$24366675$1$I$20240920$20240925$20240925$20240925$DIR$719970$$FDA-CTU$$57$YR$$F$N$81.4$KG$20240925$N$PH$US$
243666761$24366676$1$I$20240727$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-65945$$FDA-CTU$$$$$M$N$90.3$KG$20240925$N$$US$
243666771$24366677$1$I$$20240925$20240925$20240925$DIR$719939$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243666781$24366678$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-65984$$FDA-CTU$$50$YR$$F$N$$$20240926$N$$US$
243666791$24366679$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-65981$$FDA-CTU$$79$YR$$F$N$$$20240926$N$$US$
243666811$24366681$1$I$$20240919$20240926$20240926$EXP$$IT-Bion-013918$BIONPHARMA$$45$YR$A$F$Y$$$20240926$$HP$IT$IT
243666821$24366682$1$I$$20240919$20240926$20240926$PER$$US-RDY-SPO/USA/24/0013856$DR REDDYS$$29$YR$A$F$Y$$$20240926$$HP$US$US
243666831$24366683$1$I$20220520$20240917$20240926$20240926$PER$$US-RDY-OTH/USA/23/0177959$DR REDDYS$$63$YR$A$M$Y$$$20240926$$MD$US$US
243666841$24366684$1$I$$20240918$20240926$20240926$EXP$$JP-Bion-013899$BIONPHARMA$$$$$$Y$$$20240926$$HP$JP$JP
243666851$24366685$1$I$20240918$20240919$20240926$20240926$PER$$US-RDY-SPO/USA/24/0013862$DR REDDYS$$43$YR$A$M$Y$$$20240926$$PH$US$US
243666871$24366687$1$I$$20240913$20240926$20240926$EXP$GB-MHRA-MED-202409132324583640-WTRCD$GB-CPL-004615$CADILA$$82$YR$E$F$Y$$$20240926$$CN$GB$GB
243666881$24366688$1$I$$20240925$20240926$20240926$EXP$$GR-TAKEDA-2024TUS095117$TAKEDA$$28$YR$$F$Y$$$20240926$$HP$GR$GR
243666891$24366689$1$I$20240912$20240919$20240926$20240926$EXP$GB-MHRA-MED-202409161320523930-VNDRT$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-08805$HIKMA$$23$YR$$F$Y$126$KG$20240926$$MD$GB$GB
243666901$24366690$1$I$20240925$20240925$20240926$20240926$PER$$US-BAYER-2024A137330$BAYER$$42$YR$A$F$Y$$$20240926$$HP$US$US
243666912$24366691$2$F$$20240927$20240926$20240927$EXP$$CA-BAYER-2024A134241$BAYER$$$$$F$Y$$$20240927$$MD$CA$CA
243666921$24366692$1$I$20210825$20240916$20240926$20240926$EXP$PL-URPL-DML-MLP.4401.1.5072.2021$PL-BAXTER-2024BAX024848$BAXTER$$42$YR$$F$Y$63$KG$20240926$$MD$PL$PL
243666931$24366693$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015690$ELI LILLY AND CO$$47$YR$A$$Y$$$20240926$$CN$US$US
243666941$24366694$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015374$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240926$$CN$US$US
243666951$24366695$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015511$ELI LILLY AND CO$$29$YR$A$M$Y$$$20240926$$CN$US$US
243666961$24366696$1$I$$20240921$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014667$ELI LILLY AND CO$$$$$$Y$$$20240926$$CN$US$US
243666971$24366697$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014652$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$US$US
243666981$24366698$1$I$$20240924$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2023-117351$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240926$$MD$JP$JP
243666991$24366699$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114951$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243667001$24366700$1$I$$20240920$20240926$20240926$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005278$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240926$$MD$FR$FR
243667011$24366701$1$I$20240815$20240916$20240926$20240926$EXP$$US-RADIUS HEALTH INC.-2024US007317$RADIUS PHARM$$70$YR$$F$Y$$$20240926$$CN$US$US
243667021$24366702$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152471$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240926$$CN$US$US
243667031$24366703$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152474$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240926$$HP$US$US
243667041$24366704$1$I$$20240924$20240926$20240926$EXP$$BE-GILEAD-2024-0688826$GILEAD$$72$YR$E$F$Y$$$20240926$$HP$BE$BE
243667051$24366705$1$I$$20240917$20240926$20240926$EXP$$US-MYLANLABS-2024M1086149$MYLAN$Mann I, Morado-Aramburo O, Hasbun R. Emerging shadows: HHV-8-associated encephalitis unveiled in a solid organ transplant recipient. Transpl-Infect-Dis 2024; 26 (4): 1-3.$73$YR$$F$Y$$$20240926$$HP$US$US
243667061$24366706$1$I$$20240913$20240926$20240926$EXP$$GB-CIPLA LTD.-2024GB10466$CIPLA$$$$$$Y$$$20240926$$MD$GB$GB
243667071$24366707$1$I$20240912$20240914$20240926$20240926$EXP$$NVSC2024CN186217$NOVARTIS$$71$YR$$M$Y$50$KG$20240926$$HP$CN$CN
243667092$24366709$2$F$$20240918$20240926$20240930$EXP$$NVSC2023US269954$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
243667101$24366710$1$I$20240621$20240923$20240926$20240926$EXP$$ES-SANDOZ INC.-SDZ2024ES082586$SANDOZ$$78$YR$$F$Y$$$20240926$$MD$ES$ES
243667111$24366711$1$I$$20240924$20240926$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE082509$SANDOZ$$$$A$$Y$$$20240926$$HP$DE$DE
243667121$24366712$1$I$$20240717$20240926$20240926$PER$$US-009507513-2409USA009106$MERCK$Ni B, Wolfe CR, Arif S, Carugati M, Heldman MR, Messina JA, et al.. Real-World Experience with Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients. Open Forum Infectious Diseases. 2024;11(11)$61$YR$$M$Y$$$20240926$$MD$US$US
243667142$24366714$2$F$20240920$20240929$20240926$20240930$EXP$$ZA-BAYER-2024A137083$BAYER$$36$YR$A$F$Y$$$20240930$$MD$ZA$ZA
243667161$24366716$1$I$$20240918$20240926$20240926$EXP$$GR-MYLANLABS-2024M1082854$MYLAN$Moutzourounis A, Pitiragkas E, Hotura A, Erentistis A, Zaganas I. Developmental Epileptic Encephalopathy in the Context of Arginase-1 Deficiency. 35th Panhellenic congress on neurology. 2024;233$24$YR$$M$Y$$$20240926$$MD$GR$GR
243667171$24366717$1$I$$20240924$20240926$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE082753$SANDOZ$$$$A$$Y$$$20240926$$HP$DE$DE
243667181$24366718$1$I$$20240829$20240926$20240926$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03189$AMNEAL$$$$$$Y$$$20240926$$CN$US$US
243667191$24366719$1$I$20240901$20240918$20240926$20240926$EXP$$JP-Eisai-EC-2024-174959$EISAI$$75$YR$E$F$Y$$$20240926$$MD$JP$JP
243667201$24366720$1$I$$20240920$20240926$20240926$EXP$$US-FreseniusKabi-FK202414120$FRESENIUS KABI$$$$$M$Y$$$20240926$$CN$US$US
243667211$24366721$1$I$$20240717$20240926$20240926$PER$$US-009507513-2409USA009104$MERCK$Ni B, Wolfe CR, Arif S, Carugati M, Heldman MR, Messina JA, et al.. Real-World Experience with Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients. Open Forum Infectious Diseases. 2024;11(11)$59$YR$$M$Y$$$20240926$$MD$US$US
243667221$24366722$1$I$$20240923$20240926$20240926$EXP$$CA-FreseniusKabi-FK202414192$FRESENIUS KABI$$67$YR$E$M$Y$98$KG$20240926$$HP$CA$CA
243667232$24366723$2$F$20240717$20240916$20240926$20240926$30DAY$$US-JNJFOC-20240944002$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$HP$US$US
243667241$24366724$1$I$20240101$20240911$20240926$20240926$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK094036$GLENMARK$$$$$$Y$$$20240926$$CN$US$US
243667251$24366725$1$I$20240824$20240916$20240926$20240926$DIR$FDA-CDER-CTU-2024-65943$$FDA-CTU$$$$$F$N$39.7$KG$20240916$N$$US$
243667281$24366728$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66003$$FDA-CTU$$67$YR$$F$N$$$20240926$N$$US$
243667291$24366729$1$I$20240723$20240925$20240925$20240925$DIR$720012$$FDA-CTU$$84$YR$$F$N$49.5$KG$20240925$N$PH$US$
243667331$24366733$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-65951$$FDA-CTU$$17$YR$$M$N$$$20240926$N$$US$
243667341$24366734$1$I$$20240925$20240925$20240925$DIR$719932$$FDA-CTU$$$$$F$N$$$20240925$Y$CN$US$
243667351$24366735$1$I$20240922$20240925$20240925$20240925$DIR$719950$$FDA-CTU$$58$YR$$M$N$$$20240925$N$PH$US$
243667371$24366737$1$I$20240824$20240918$20240926$20240926$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006741$AURINIA PHARMACEUTICALS$$55$YR$$F$Y$$$20240926$$CN$US$US
243667381$24366738$1$I$20240701$20240920$20240926$20240926$EXP$$US-ABBVIE-5934310$ABBVIE$$70$YR$$F$Y$$$20240926$$CN$US$US
243667391$24366739$1$I$20240916$20240925$20240926$20240926$PER$$US-BAYER-2024A137395$BAYER$$76$YR$E$F$Y$$$20240926$$CN$US$US
243667401$24366740$1$I$$20240920$20240926$20240926$PER$$US-TAKEDA-2024TUS093970$TAKEDA$$31$YR$$F$Y$$$20240926$$CN$US$US
243667411$24366741$1$I$$20240920$20240926$20240926$PER$$US-TAKEDA-2024TUS094773$TAKEDA$$$$$$Y$$$20240926$$CN$US$US
243667421$24366742$1$I$$20240925$20240926$20240926$PER$$US-BIOGEN-2016BI00312575$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243667431$24366743$1$I$20220301$20240924$20240926$20240926$PER$$US-BIOGEN-2022BI01108538$BIOGEN$$65$YR$$F$Y$$$20240926$$CN$US$US
243667441$24366744$1$I$$20240923$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152003$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240926$$CN$US$US
243667452$24366745$2$F$$20240926$20240926$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151351$BRISTOL MYERS SQUIBB$Terasawa R, Hirata A, Aoki C, Kimura K, Morita S, Hayashi M. A case of recurrent breast cancer with delayed wound healing induced by bevacizumab. Japanese Journal of Cancer and Chemotherapy. 2024 Mar;51(3):287-9.$5$DEC$A$F$Y$$$20240930$$MD$JP$JP
243667461$24366746$1$I$$20240917$20240926$20240926$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-2024-148631$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240926$$MD$CH$CH
243667471$24366747$1$I$$20240924$20240926$20240926$EXP$$US-ABBVIE-5938963$ABBVIE$$$$$F$Y$$$20240926$$HP$US$US
243667481$24366748$1$I$$20240919$20240926$20240926$EXP$$US-GSK-US2024116536$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
243667491$24366749$1$I$$20240925$20240926$20240926$PER$$US-BAYER-2024A137545$BAYER$$84$YR$E$M$Y$$$20240926$$CN$US$US
243667501$24366750$1$I$$20240921$20240926$20240926$EXP$$US-CHEPLA-2024012088$CHEPLAPHARM$Posadas K, Ankola A, Yang Z, Yee N. Tumor Molecular Profiling for an Individualized Approach to the Treatment of Hepatocellular Carcinoma: A Patient Case Study. Biomedicines. 2018;6 (46):1-11. doi:10.3390/biomedicines6020046.$65$YR$$M$Y$$$20240926$$HP$COUNTRY NOT SPECIFIED$US
243667511$24366751$1$I$20240719$20240920$20240926$20240926$EXP$HR-HALMED-300086534$HR-CHEPLA-2024012078$CHEPLAPHARM$$$$A$F$Y$$$20240926$$MD$COUNTRY NOT SPECIFIED$HR
243667521$24366752$1$I$20230518$20240924$20240926$20240926$EXP$$ES-GILEAD-2024-0688760$GILEAD$$$$$$Y$$$20240926$$HP$ES$ES
243667531$24366753$1$I$20240919$20240925$20240925$20240925$DIR$719937$$FDA-CTU$$39$YR$$F$N$76.3$KG$20240925$Y$MD$US$
243667541$24366754$1$I$$20240923$20240926$20240926$EXP$PL-URPL-1-4234-2020$PL-CHEPLA-2024012142$CHEPLAPHARM$$24$YR$$F$Y$94$KG$20240926$$MD$COUNTRY NOT SPECIFIED$PL
243667561$24366756$1$I$20240612$20240919$20240926$20240926$EXP$FR-AFSSAPS-PV2024000839$FR-CHEPLA-2024012116$CHEPLAPHARM$$10$YR$$F$Y$28$KG$20240926$$PH$COUNTRY NOT SPECIFIED$FR
243667571$24366757$1$I$20240922$20240925$20240925$20240925$DIR$719931$$FDA-CTU$$59$YR$$M$N$$$20240925$N$$US$
243667581$24366758$1$I$20240306$20240920$20240926$20240926$EXP$FR-AFSSAPS-AVBX2024000519$FR-CHEPLA-2024012135$CHEPLAPHARM$$59$YR$$M$Y$$$20240926$$MD$COUNTRY NOT SPECIFIED$FR
243667591$24366759$1$I$$20240717$20240926$20240926$PER$$US-009507513-2409USA009103$MERCK$Ni B, Wolfe CR, Arif S, Carugati M, Heldman MR, Messina JA, et al.. Real-World Experience with Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients. Open Forum Infectious Diseases. 2024;11(11)$54$YR$$M$Y$$$20240926$$MD$US$US
243667601$24366760$1$I$$20240919$20240926$20240926$EXP$$AR-TAKEDA-2024TUS093744$TAKEDA$$$$$$Y$$$20240926$$MD$AR$AR
243667621$24366762$1$I$$20240919$20240926$20240926$EXP$$US-KYOWAKIRIN-2024KK021851$KYOWA$$$$$$Y$$$20240926$$HP$US$US
243667631$24366763$1$I$20240901$20240917$20240926$20240926$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052110$BOEHRINGER INGELHEIM$$64$YR$A$M$Y$$$20240926$$MD$CA$CA
243667641$24366764$1$I$$20240919$20240926$20240926$PER$$US-TAKEDA-2024TUS094253$TAKEDA$$$$$$Y$$$20240926$$PH$US$US
243667651$24366765$1$I$$20240923$20240926$20240926$EXP$$CA-FreseniusKabi-FK202414189$FRESENIUS KABI$$2$YR$C$F$Y$13$KG$20240926$$HP$CA$CA
243667661$24366766$1$I$20220916$20240916$20240926$20240926$EXP$$US-BAYER-2024A134869$BAYER$$$$$M$Y$$$20240926$$CN$US$US
243667671$24366767$1$I$20221224$20240913$20240926$20240926$EXP$$GB-JNJFOC-20240771685$JOHNSON AND JOHNSON$$66$YR$E$M$Y$68$KG$20240926$$MD$GB$GB
243667681$24366768$1$I$$20240916$20240926$20240926$EXP$$ES-CELLTRION INC.-2024ES022762$CELLTRION$$$$$$Y$$$20240926$$HP$ES$ES
243667691$24366769$1$I$20220513$20240925$20240926$20240926$EXP$NL-LRB-01003949$NL-BAYER-2024A136915$BAYER$$17$YR$T$F$Y$$$20240926$$MD$NL$NL
243667701$24366770$1$I$$20240913$20240926$20240926$EXP$$US-UCBSA-2024047365$UCB$$$$$M$Y$$$20240926$$CN$US$US
243667711$24366771$1$I$$20240920$20240926$20240926$30DAY$$GB-MYLANLABS-2024M1086553$MYLAN$$$$$$Y$$$20240926$$PH$GB$GB
243667721$24366772$1$I$20240917$20240918$20240926$20240926$EXP$$US-BAYER-2024A133361$BAYER$$85$YR$E$F$Y$$$20240926$$CN$US$US
243667731$24366773$1$I$$20240717$20240926$20240926$PER$$US-009507513-2409USA009102$MERCK$Ni B, Wolfe CR, Arif S, Carugati M, Heldman MR, Messina JA, et al.. Real-World Experience with Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients. Open Forum Infectious Diseases. 2024;11(11)$72$YR$$M$Y$$$20240926$$MD$US$US
243667741$24366774$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10534$CIPLA$$$$$$Y$$$20240926$$CN$AU$AU
243667751$24366775$1$I$20240924$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015314$ELI LILLY AND CO$$48$YR$A$M$Y$$$20240926$$CN$US$US
243667761$24366776$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10486$CIPLA$Koo RM, Wong E, Davis JE, Perera T, Lim A, Koldej RM et al.. A phase 1 dose-escalation study of low-dose Lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome. Bone Marrow Transplantation. 2024;59(7):1025 to 1027$$$$$Y$$$20240926$$HP$AU$AU
243667771$24366777$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10538$CIPLA$$$$$$Y$$$20240926$$MD$AU$AU
243667781$24366778$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10577$CIPLA$$$$$$Y$$$20240926$$HP$AU$AU
243667791$24366779$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10560$CIPLA$$$$$$Y$$$20240926$$HP$AU$AU
243667801$24366780$1$I$20240913$20240924$20240926$20240926$EXP$$JP-REGENERON PHARMACEUTICALS, INC.-2024-128993$REGENERON$$70$YR$$M$Y$$$20240926$$MD$JP$JP
243667811$24366781$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10570$CIPLA$$$$$$Y$$$20240926$$CN$AU$AU
243667821$24366782$1$I$20190101$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10487$CIPLA$$$$$$Y$$$20240926$$MD$AU$AU
243667831$24366783$1$I$20240227$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10505$CIPLA$$$$$$Y$$$20240926$$HP$AU$AU
243667841$24366784$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152182$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$87.54$KG$20240926$$CN$US$US
243667851$24366785$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152582$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240926$$CN$US$US
243667861$24366786$1$I$$20240923$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151489$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240926$$CN$US$US
243667871$24366787$1$I$$20240912$20240926$20240926$EXP$$IN-B.Braun Medical Inc.-2162054$B BRAUN$Literature Article$74$YR$$M$Y$$$20240926$$$IN$IN
243667881$24366788$1$I$20240925$20240925$20240925$20240925$DIR$719919$$FDA-CTU$$53$YR$$M$N$$$20240925$N$HP$US$
243667901$24366790$1$I$$20240923$20240926$20240926$PER$$US-ROCHE-10000091362$ROCHE$Unknown ,  A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibit. Postgrad Med J. 2024-Aug-14;qgae104.$44$YR$A$M$Y$$$20240926$$HP$US$US
243667911$24366791$1$I$20240814$20240919$20240926$20240926$PER$FR-AFSSAPS-GR2024001122$FR-Waylis Therapeutics LLC-ATNAHS20240902663$Waylis$$62$YR$A$M$Y$67$KG$20240926$$PH$FR$FR
243667921$24366792$1$I$$20240912$20240926$20240926$EXP$$FR-B.Braun Medical Inc.-2162063$B BRAUN$$19$YR$$M$Y$$$20240926$$$FR$FR
243667931$24366793$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU09149$CIPLA$Bosi I, Wong WK, Mohammad S, Britton P, Hsu P. Unusual manifestations of APECED. J-Clin-Immunol. 2024;44$$$$$Y$$$20240926$$HP$AU$AU
243667941$24366794$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10491$CIPLA$Kam I, Prentice D, Kho LK, Dharsono F.. Inflammatory epilepsy (FIRES) and haemophagocytic lymphohistiocytosis (HLH): An adult case. BMJ-Case-Rep. 2023;16 (1):1 to 4$$$$$Y$$$20240926$$HP$AU$AU
243667951$24366795$1$I$20240101$20240918$20240926$20240926$EXP$SE-SEMPA-2024-006643$SE-TEVA-VS-3245236$TEVA$$89$YR$$F$Y$$$20240926$$MD$SE$SE
243667961$24366796$1$I$$20240912$20240926$20240926$EXP$$JP-B.Braun Medical Inc.-2162053$B BRAUN$Literature Article$91$YR$$F$Y$$$20240926$$$JP$JP
243667971$24366797$1$I$$20240911$20240926$20240926$EXP$$US-Eywa Pharma Inc.-2162038$EYWA PHARMA$Full text$59$YR$$F$Y$$$20240926$$$US$US
243667982$24366798$2$F$20240830$20240923$20240926$20240927$EXP$FR-AFSSAPS-TO2024001754$FR-009507513-2409FRA008364$MERCK$$49$YR$$M$Y$$$20240927$$PH$FR$FR
243667991$24366799$1$I$$20240923$20240926$20240926$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-18897$IPSEN$$$$$M$Y$$$20240926$$CN$GB$GB
243668001$24366800$1$I$20240905$20240919$20240926$20240926$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-19093$IPSEN$$66$YR$E$F$Y$$$20240926$$CN$US$US
243668011$24366801$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3245058$TEVA$$41$YR$$F$Y$$$20240926$$CN$US$US
243668021$24366802$1$I$20240904$20240920$20240926$20240926$EXP$GR-GREOF-202401004$GR-TEVA-VS-3246165$TEVA$$53$YR$$M$Y$82$KG$20240926$$MD$GR$GR
243668031$24366803$1$I$20240330$20240918$20240926$20240926$EXP$$US-TAKEDA-2024TUS030849$TAKEDA$$30$YR$$M$Y$$$20240926$$CN$US$US
243668041$24366804$1$I$$20240918$20240926$20240926$EXP$$US-RECORDATI RARE DISEASE INC.-2024007282$RECORDATI$$$$$$Y$$$20240926$$CN$US$US
243668051$24366805$1$I$$20240912$20240926$20240926$EXP$$FR-B.Braun Medical Inc.-2162061$B BRAUN$$82$YR$$M$Y$85$KG$20240926$$$FR$FR
243668071$24366807$1$I$$20240924$20240926$20240926$PER$$NVSC2024US191550$NOVARTIS$$50$YR$$F$Y$$$20240926$$HP$US$US
243668081$24366808$1$I$$20240912$20240926$20240926$EXP$$US-B.Braun Medical Inc.-2162058$B BRAUN$Literature Article$2$MON$$M$Y$$$20240926$$$US$US
243668091$24366809$1$I$$20240912$20240926$20240926$EXP$$FR-B.Braun Medical Inc.-2162044$B BRAUN$Literature Article$14$MON$$$Y$$$20240926$$$FR$FR
243668101$24366810$1$I$$20240717$20240926$20240926$PER$$US-009507513-2409USA008864$MERCK$Ni B, Wolfe CR, Arif S, Carugati M, Heldman MR, Messina JA, et al.. Real-World Experience with Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients. Open Forum Infectious Diseases. 2024;11(11)$57$YR$$M$Y$$$20240926$$MD$US$US
243668111$24366811$1$I$$20240717$20240926$20240926$PER$$US-009507513-2409USA009101$MERCK$Ni B, Wolfe CR, Arif S, Carugati M, Heldman MR, Messina JA, et al.. Real-World Experience with Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients. Open Forum Infectious Diseases. 2024;11(11)$53$YR$$F$Y$$$20240926$$MD$US$US
243668121$24366812$1$I$$20240922$20240926$20240926$EXP$$CA-ASTELLAS-2024-AER-008600$ASTELLAS$$37$YR$A$M$Y$$$20240926$$CN$CA$CA
243668131$24366813$1$I$$20240912$20240926$20240926$EXP$$JP-B.Braun Medical Inc.-2162057$B BRAUN$Literature Article$3$YR$$M$Y$$$20240926$$$JP$JP
243668141$24366814$1$I$$20240925$20240926$20240926$EXP$$US-TAKEDA-2024TUS095441$TAKEDA$$$$$F$Y$$$20240926$$CN$US$US
243668151$24366815$1$I$20240502$20240917$20240926$20240926$EXP$$BR-TAKEDA-2023TUS118777$TAKEDA$$43$YR$$F$Y$$$20240926$$CN$BR$BR
243668162$24366816$2$F$20240301$20240923$20240926$20240926$PER$$US-ABBVIE-5936311$ABBVIE$$75$YR$$F$Y$$$20240926$$MD$US$US
243668181$24366818$1$I$$20240816$20240926$20240926$EXP$$JP-TEVA-VS-3238917$TEVA$$72$YR$$F$Y$$$20240926$$CN$JP$JP
243668191$24366819$1$I$$20240711$20240926$20240926$PER$$US-Nostrum Laboratories, Inc.-2162069$NOSTRUM$$71$YR$$F$Y$$$20240926$$$US$US
243668211$24366821$1$I$20240201$20240923$20240926$20240926$EXP$FR-AFSSAPS-NY2024001053$FR-FreseniusKabi-FK202414299$FRESENIUS KABI$$38$YR$A$F$Y$125$KG$20240926$$MD$FR$FR
243668221$24366822$1$I$20240914$20240923$20240926$20240926$EXP$FR-AFSSAPS-TO2024001752$FR-FreseniusKabi-FK202414304$FRESENIUS KABI$$24$YR$A$F$Y$48$KG$20240926$$MD$FR$FR
243668231$24366823$1$I$20240716$20240923$20240926$20240926$EXP$FR-AFSSAPS-PO2024000983$FR-FreseniusKabi-FK202414301$FRESENIUS KABI$$47$YR$A$F$Y$77$KG$20240926$$MD$FR$FR
243668241$24366824$1$I$20240620$20240913$20240926$20240926$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2162080$JIANGSU HANSOH PHARMACEUTICAL$$64$YR$$F$Y$55$KG$20240926$$MD$CN$CN
243668251$24366825$1$I$$20240912$20240926$20240926$EXP$$SA-B.Braun Medical Inc.-2162045$B BRAUN$Literature Article$$$$F$Y$$$20240926$$$SA$SA
243668261$24366826$1$I$$20240912$20240926$20240926$EXP$$TR-B.Braun Medical Inc.-2162060$B BRAUN$Literature Article$56$YR$$M$Y$$$20240926$$$TR$TR
243668271$24366827$1$I$$20240917$20240926$20240926$EXP$$AT-CELLTRION INC.-2024AT022673$CELLTRION$$$$$$Y$$$20240926$$MD$AT$AT
243668281$24366828$1$I$$20240912$20240926$20240926$PER$$US-P+L Developments of Newyork Corporation-2162074$PL DEVELOPMENTS$$$$$$Y$$$20240926$$$US$US
243668291$24366829$1$I$20240603$20240918$20240926$20240926$EXP$FR-AFSSAPS-AVMA2024000416$FR-Waylis Therapeutics LLC-ATNAHS20240902653$Waylis$$32$YR$A$M$Y$$$20240925$$MD$FR$FR
243668304$24366830$4$F$$20240923$20240926$20240928$EXP$$US-ROCHE-10000088610$ROCHE$Reddy A, Kong A, Michael C, Abdulfattah O. HSV pneumonitis: the COVID Masquerader. Chest. 2024-Oct;166 (4):A1078-9. doi:10.1016/j.chest.2024.06.710.$59$YR$A$M$Y$$$20240928$$HP$US$US
243668331$24366833$1$I$$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66017$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243668341$24366834$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66012$$FDA-CTU$$51$YR$$F$N$76.66$KG$20240926$N$$US$
243668351$24366835$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66009$$FDA-CTU$$75$YR$$F$N$86.18$KG$20240926$N$$US$
243668371$24366837$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-65660$$FDA-CTU$$$$$$N$$$20240925$N$CN$US$
243668411$24366841$1$I$$20240911$20240926$20240926$PER$$US-P+L Developments of Newyork Corporation-2162075$PL DEVELOPMENTS$$$$$M$Y$$$20240926$$$US$US
243668421$24366842$1$I$$20240913$20240926$20240926$EXP$$US-Kindeva Drug Delivery L.P.-2162040$KINDEVA DRUG DELIVERY$$30$YR$$M$Y$$$20240926$$$US$US
243668431$24366843$1$I$$20240911$20240926$20240926$EXP$$RU-Eywa Pharma Inc.-2162081$EYWA PHARMA$Abstract$33$YR$$F$Y$$$20240926$$$RU$RU
243668451$24366845$1$I$$20240912$20240926$20240926$EXP$$DE-JNJFOC-20240840924$JOHNSON AND JOHNSON$$58$YR$A$F$Y$90$KG$20240926$$PH$DE$DE
243668471$24366847$1$I$$20240917$20240926$20240926$EXP$$RU-Oxford Pharmaceuticals, LLC-2162084$OXFORD PHARMACEUTICALS$Source document$34$YR$$M$Y$$$20240926$$$RU$RU
243668481$24366848$1$I$$20240924$20240926$20240926$EXP$$DE-GILEAD-2024-0688414$GILEAD$$$$$M$Y$$$20240926$$MD$DE$DE
243668491$24366849$1$I$$20240916$20240926$20240926$EXP$$US-RADIUS HEALTH INC.-2024US007296$RADIUS PHARM$$$$$F$Y$$$20240926$$CN$US$US
243668501$24366850$1$I$20240923$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152714$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240926$$CN$US$US
243668511$24366851$1$I$20240906$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150689$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240926$$PH$US$US
243668521$24366852$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152673$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$78.93$KG$20240926$$CN$US$US
243668531$24366853$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152668$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240926$$CN$US$US
243668541$24366854$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191600$NOVARTIS$$$$$$Y$$$20240926$$MD$US$US
243668551$24366855$1$I$$20240911$20240926$20240926$EXP$$US-Innogenix, LLC-2162077$INNOGENIX$Abstract$74$YR$$M$Y$$$20240926$$$US$US
243668561$24366856$1$I$20240901$20240922$20240926$20240926$EXP$$NVSC2024US189742$NOVARTIS$$75$YR$$F$Y$$$20240926$$CN$US$US
243668571$24366857$1$I$20240901$20240913$20240926$20240926$PER$$US-P+L Developments of Newyork Corporation-2162076$PL DEVELOPMENTS$$$$$F$Y$$$20240926$$$US$US
243668581$24366858$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191617$NOVARTIS$$$$$$Y$$$20240926$$HP$US$US
243668591$24366859$1$I$$20240910$20240926$20240926$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03407$AMNEAL$$$$$$Y$$$20240926$$PH$US$US
243668601$24366860$1$I$$20240911$20240926$20240926$EXP$$TR-Innogenix, LLC-2162079$INNOGENIX$Full text$21$YR$$M$Y$$$20240926$$$TR$TR
243668611$24366861$1$I$20240828$20240911$20240926$20240926$EXP$$IT-ITALFARMACO SPA-2162085$ITALFARMACO$$69$YR$$M$Y$70$KG$20240926$$MD$IT$IT
243668621$24366862$1$I$$20240910$20240926$20240926$PER$$US-Nova Laboratories Limited-2162087$NOVA LABORATORIES$Journal: Cancers?Author: Lucas BJ, Connors JS, Wang H, Conneely S, Cuglievan B, Garcia MB, et al.?Title: Observation and Management of Juvenile Myelomonocytic Leukemia and Noonan Syndrome-Associated Myeloproliferative?Disorder: A Real-World Experience?Volume: 16, 2749 Year: 2024 Pages: 1 to 16$12$MON$$M$Y$$$20240926$$$US$US
243668631$24366863$1$I$$20240923$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151031$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$63.96$KG$20240926$$CN$US$US
243668641$24366864$1$I$$20240920$20240926$20240926$PER$$US-BAYER-2024A134790$BAYER$$19$YR$A$F$Y$$$20240926$$MD$US$US
243668651$24366865$1$I$$20240910$20240926$20240926$PER$$US-Nova Laboratories Limited-2162089$NOVA LABORATORIES$Author: Lucas BJ, Connors JS, Wang H, Conneely S, Cuglievan B, Garcia MB, et al.?Title: Observation and Management of Juvenile Myelomonocytic Leukemia and Noonan Syndrome-Associated Myeloproliferative?Disorder: A Real-World Experience?Volume: 16, 2749 Year: 2024 Pages: 1 to 16$14$MON$$F$Y$$$20240926$$$US$US
243668661$24366866$1$I$$20240910$20240926$20240926$PER$$US-Nova Laboratories Limited-2162090$NOVA LABORATORIES$Journal: Cancers?Author: Lucas BJ, Connors JS, Wang H, Conneely S, Cuglievan B, Garcia MB, et al.?Title: Observation and Management of Juvenile Myelomonocytic Leukemia and Noonan Syndrome-Associated Myeloproliferative?Disorder: A Real-World Experience?Volume: 16, 2749 Year: 2024 Pages: 1 to 16$4$MON$$F$Y$$$20240926$$$US$US
243668671$24366867$1$I$$20240912$20240926$20240926$EXP$$US-Apozeal Pharmaceuticals-2162082$Apozeal Pharmaceuticals$Abstract$60$YR$$M$Y$$$20240926$$$US$US
243668681$24366868$1$I$$20240815$20240926$20240926$EXP$$US-TEVA-VS-3235681$TEVA$$$$$M$Y$$$20240926$$HP$US$US
243668691$24366869$1$I$$20240910$20240926$20240926$PER$$US-Nova Laboratories Limited-2162088$NOVA LABORATORIES$Journal: Cancers?Author: Lucas BJ, Connors JS, Wang H, Conneely S, Cuglievan B, Garcia MB, et al.?Title: Observation and Management of Juvenile Myelomonocytic Leukemia and Noonan Syndrome-Associated Myeloproliferative?Disorder: A Real-World Experience?Volume: 16, 2749 Year: 2024 Pages: 1to16$17$MON$$F$Y$$$20240926$$$US$US
243668701$24366870$1$I$$20240923$20240926$20240926$EXP$$US-ROCHE-10000088833$ROCHE$Hwang S, Kingsley C. A rare and rapid development of a penetrating thoracic aortic ulcer following exposure to chemotherapy. Chest. 2024-Oct;166 (4): doi:10.1016/j.chest.2024.06.199.$74$YR$E$F$Y$$$20240926$$HP$US$US
243668711$24366871$1$I$$20240911$20240926$20240926$EXP$$US-Innogenix, LLC-2162078$INNOGENIX$Abstract$68$YR$$M$Y$$$20240926$$$US$US
243668721$24366872$1$I$20240101$20240907$20240926$20240926$EXP$$US-SA-2024SA277138$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240926$$CN$US$US
243668731$24366873$1$I$$20240924$20240926$20240926$PER$$US-009507513-2409USA008713$MERCK$$$$$F$Y$$$20240926$$CN$US$US
243668741$24366874$1$I$20240910$20240919$20240926$20240926$EXP$$GB-009507513-2409GBR007740$MERCK$$$$$M$Y$$$20240926$$HP$GB$GB
243668751$24366875$1$I$20240901$20240918$20240926$20240926$PER$$US-ABBVIE-5931501$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243668761$24366876$1$I$$20240918$20240926$20240926$PER$$US-JNJFOC-20240966881$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243668771$24366877$1$I$$20240920$20240926$20240926$EXP$$NVSC2024BE189450$NOVARTIS$$$$$F$Y$$$20240926$$HP$BE$BE
243668781$24366878$1$I$20240101$20240910$20240926$20240926$EXP$$US-SA-2024SA276623$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240926$$CN$US$US
243668791$24366879$1$I$$20240911$20240926$20240926$EXP$$JP-SA-2024SA278422$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240926$$CN$JP$JP
243668801$24366880$1$I$$20240911$20240926$20240926$EXP$$JP-SA-2024SA278041$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240926$$CN$JP$JP
243668811$24366881$1$I$20240722$20240920$20240926$20240926$EXP$CH-SM-2024-15548$CH-Waylis Therapeutics LLC-ATNAHS20240902683$Waylis$$24$YR$A$M$Y$$$20240926$$PH$CH$CH
243668821$24366882$1$I$$20240912$20240926$20240926$PER$$US-JNJFOC-20240963461$JOHNSON AND JOHNSON$$$$A$M$Y$79$KG$20240926$$MD$US$US
243668851$24366885$1$I$20240909$20240910$20240926$20240926$PER$$US-TOLMAR, INC.-24US052519$TOLMAR$$60$YR$$M$Y$$$20240926$$HP$US$US
243668861$24366886$1$I$20240821$20240923$20240926$20240926$PER$$US-TOLMAR, INC.-24US052520$TOLMAR$$91$YR$$M$Y$$$20240926$$HP$US$US
243668881$24366888$1$I$20240910$20240910$20240926$20240926$PER$$US-TOLMAR, INC.-24US052603$TOLMAR$$61$YR$$M$Y$$$20240926$$PH$US$US
243668901$24366890$1$I$$20240912$20240926$20240926$EXP$$US-SA-2024SA276207$SANOFI AVENTIS$$$$A$M$Y$94.82$KG$20240926$$MD$US$US
243668911$24366891$1$I$$20240923$20240926$20240926$PER$$US-HALEON-2198649$Haleon PLC$COCHRANK, MELLGARDG, MINSUGI. A BLEEDING HEART: HEMORRHAGIC TAMPONADE AND RECURRENT IDIOPATHIC PERICARDITIS TREATED WITH ANAKINRA. Chest. 166(4):A526.?DOI: 10.1016/j.chest.2024.06.367; COCHRANK, MELLGARDG, MINSUGI. A BLEEDING HEART: HEMORRHAGIC TAMPONADE AND RECURRENT IDIOPATHIC PERICARDITISTREATED WITH ANAKINRA.?Chest?. #PY#;166(4 Supplement):A526.?https://dx.doi.org/10.1016/j.chest.2024.06.367$25$YR$$F$Y$$$20240926$$HP$US$US
243668921$24366892$1$I$20220501$20240918$20240926$20240926$EXP$$IT-RDY-SPO/ITA/24/0013999$DR REDDYS$Novellis DD, Raimondo A, Serio B, Baldi C, Giudice V, Lembo S, et al. Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B. Photodermatology Photoimmunology and Photomedicine. 2024;40(3): doi:10.1111/phpp.12965.$55$YR$A$M$Y$$$20240926$$HP$IT$IT
243668931$24366893$1$I$$20240916$20240926$20240926$EXP$$GR-PFM-2024-05076$PIERRE FABRE MEDICAMENT$Kitsios K, Trakatelli CM. Diabetic ketoacidosis in a patient with type 2 diabetes induced by multiple triggers: a case report and implications for clinical practice. PRACTICAL DIABETES. 2024;41(3):27-30$58$YR$$M$Y$$$20240926$$MD$GR$GR
243668941$24366894$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960271$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240926$$MD$US$US
243668951$24366895$1$I$$20240913$20240926$20240926$EXP$$US-SA-2024SA276987$SANOFI AVENTIS$$65$YR$E$M$Y$95.45$KG$20240926$$MD$US$US
243668961$24366896$1$I$20230601$20240918$20240926$20240926$EXP$$CA-ABBVIE-5931071$ABBVIE$$66$YR$$M$Y$$$20240926$$CN$CA$CA
243668971$24366897$1$I$$20240916$20240926$20240926$EXP$$ES-PFM-2024-05081$PIERRE FABRE MEDICAMENT$Rojas-Medina LM, Fern?ndez LE, Ru?z EB, Cancela AA,  P?rez MP,  Urzaiz LL. The Tractography a Useful Tool in Brain  Asymmetry. Stereotact Funct Neurosurg. 2024;102(1):1-167$52$YR$$M$Y$$$20240926$$$ES$ES
243668981$24366898$1$I$20240606$20240912$20240926$20240926$EXP$$AU-SAMSUNG BIOEPIS-SB-2024-27926$SAMSUNG BIOEPIS$$17$DY$N$F$Y$$$20240926$$HP$AU$AU
243668991$24366899$1$I$20240901$20240918$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149339$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240926$$CN$US$US
243669001$24366900$1$I$20211101$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151541$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$CN$US$US
243669011$24366901$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015644$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240926$$CN$US$US
243669021$24366902$1$I$20240501$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015512$ELI LILLY AND CO$$51$YR$A$$Y$$$20240926$$CN$US$US
243669031$24366903$1$I$20240924$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015386$ELI LILLY AND CO$$69$YR$E$M$Y$$$20240926$$CN$US$US
243669051$24366905$1$I$$20240916$20240926$20240926$EXP$$US-Calliditas-2024CAL01367$CALLIDITAS THERAPEUTICS$$67$YR$E$M$Y$60.8$KG$20240926$$CN$US$US
243669061$24366906$1$I$20240801$20240924$20240926$20240926$EXP$FR-AFSSAPS-BR2024000768$FR-ORGANON-O2409FRA001935$ORGANON$$39$YR$$F$Y$$$20240926$$MD$FR$FR
243669071$24366907$1$I$$20240918$20240926$20240926$EXP$$JP-ABBVIE-5937734$ABBVIE$$$$$$Y$$$20240926$$MD$JP$JP
243669081$24366908$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151514$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240926$$HP$US$US
243669091$24366909$1$I$20240101$20240920$20240926$20240926$EXP$$US-ABBVIE-5934288$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243669111$24366911$1$I$20240101$20240920$20240926$20240926$EXP$$US-ABBVIE-5933561$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243669121$24366912$1$I$20240101$20240918$20240926$20240926$EXP$$US-JNJFOC-20240954659$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240926$$HP$US$US
243669131$24366913$1$I$$20240918$20240926$20240926$EXP$$CA-JNJFOC-20240950365$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$PH$CA$CA
243669141$24366914$1$I$$20240911$20240926$20240926$PER$$US-JNJFOC-20240929575$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243669151$24366915$1$I$20220101$20240921$20240926$20240926$EXP$$US-ABBVIE-5934214$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243669161$24366916$1$I$$20240916$20240926$20240926$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-128950$REGENERON$$89$YR$$F$Y$$$20240926$$MD$US$US
243669181$24366918$1$I$$20240923$20240926$20240926$EXP$$IN-MYLANLABS-2024M1087203$MYLAN$Chatterji P,  Mukherjee Y. Sigmoid Sinus Thrombosis In A Child With Unsafe Type Of Chronic Otitis Media. Nepal-J-Neurosci 2024; 21 (2): 59-60.$10$YR$$M$Y$$$20240926$$HP$IN$IN
243669191$24366919$1$I$20240801$20240924$20240926$20240926$EXP$ES-AEMPS-1570720$ES-MYLANLABS-2024M1086598$MYLAN$$28$YR$$M$Y$$$20240926$$MD$ES$ES
243669211$24366921$1$I$20240918$20240924$20240926$20240926$DIR$FDA-CDER-CTU-2024-66022$$FDA-CTU$$27$YR$$F$N$$$20240924$N$PH$US$
243669221$24366922$1$I$$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66026$$FDA-CTU$$$$$F$N$$$20240925$N$HP$US$
243669252$24366925$2$F$20240924$20240925$20240926$20240930$PER$$NVSC2024US191459$NOVARTIS$$39$YR$$F$Y$$$20240930$$CN$US$US
243669291$24366929$1$I$$20240919$20240926$20240926$EXP$$RO-ROCHE-10000087687$ROCHE$$79$YR$E$F$Y$$$20240926$$CN$RO$RO
243669301$24366930$1$I$$20240903$20240926$20240926$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03244$AMNEAL$$$$$$Y$$$20240926$$PH$US$US
243669311$24366931$1$I$20240829$20240911$20240926$20240926$PER$$US-JNJFOC-20240929339$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20240926$$CN$US$US
243669321$24366932$1$I$20240909$20240921$20240926$20240926$EXP$$CN-JNJFOC-20240960552$JOHNSON AND JOHNSON$$39$YR$A$M$Y$65$KG$20240926$$HP$CN$CN
243669331$24366933$1$I$20240910$20240917$20240926$20240926$EXP$$IE-JNJFOC-20240954233$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20240926$$HP$IE$IE
243669341$24366934$1$I$20240101$20240917$20240926$20240926$EXP$$US-JNJFOC-20240951557$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240926$$CN$US$US
243669371$24366937$1$I$$20240916$20240926$20240926$EXP$$BE-TEVA-VS-3244902$TEVA$Van Breusegem P, Verswijvel G, Fransis S, Van der Speeten K. Peritoneal Surface Malignancies Originating From Urachal Carcinoma: Case Reports and Review of the Literature. Ind-J-Surg-Oncol 2023; 14 S109-S121.; Van Breusegem P, Verswijvel G, Fransis S, Van der Speeten K. Peritoneal Surface Malignancies Originating From Urachal Carcinoma: Case Reports and Review of the Literature. Ind-J-Surg-Oncol 2023; 14 S109-S121.$49$YR$$M$Y$$$20240926$$HP$BE$BE
243669381$24366938$1$I$$20240918$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152277$BRISTOL MYERS SQUIBB$$95$YR$E$M$Y$$$20240926$$HP$US$US
243669391$24366939$1$I$20240809$20240917$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-128084$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240926$$CN$US$US
243669401$24366940$1$I$$20240910$20240926$20240926$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09093$LUPIN$$$$$$Y$$$20240926$$MD$US$US
243669411$24366941$1$I$20240912$20240917$20240926$20240926$PER$$NVSC2024US185871$NOVARTIS$$$$$F$Y$$$20240926$$HP$US$US
243669421$24366942$1$I$20230319$20240918$20240926$20240926$EXP$$DE-ROCHE-10000087526$ROCHE$$47$YR$A$F$Y$80$KG$20240926$$MD$DE$DE
243669431$24366943$1$I$20240921$20240923$20240926$20240926$PER$$US-BAYER-2024A136736$BAYER$$19$YR$A$F$Y$$$20240926$$CN$US$US
243669441$24366944$1$I$$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151547$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240926$$CN$US$US
243669451$24366945$1$I$$20240924$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001846$ORGANON$$45$YR$$F$Y$95$KG$20240926$$HP$CA$CA
243669471$24366947$1$I$$20240911$20240926$20240926$EXP$$HR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469535$RANBAXY$Belancic A, Pavesic Radonja A, Ganoc L, Vitezic D, Bozina N. Challenging pharmacotherapy management of a psychotic disorder due to a delicate pharmacogenetic profile and drug-drug interactions: a case report and literature review. Croat Med J.. 2024;65 (4):383-395$31$YR$$F$Y$$$20240926$$HP$HR$HR
243669481$24366948$1$I$$20240920$20240926$20240926$EXP$$GB-VERTEX PHARMACEUTICALS-2024-014996$VERTEX$$$$A$F$Y$$$20240926$$CN$GB$GB
243669491$24366949$1$I$20240901$20240923$20240926$20240926$EXP$$GB-VERTEX PHARMACEUTICALS-2024-015077$VERTEX$$$$A$F$Y$$$20240926$$CN$GB$GB
243669501$24366950$1$I$$20240911$20240926$20240926$EXP$$CA-002147023-NVSC2021CA274775$Haleon PLC$$52$YR$$F$Y$$$20240926$$CN$CA$CA
243669511$24366951$1$I$20231108$20240920$20240926$20240926$EXP$FR-AFSSAPS-LL2024001762$FR-VERTEX PHARMACEUTICALS-2024-014925$VERTEX$$1$DY$$F$Y$$$20240926$$MD$FR$FR
243669521$24366952$1$I$20240501$20240919$20240926$20240926$EXP$FR-AFSSAPS-MA2024001481$FR-VERTEX PHARMACEUTICALS-2024-014902$VERTEX$$4$YR$$F$Y$17$KG$20240926$$MD$FR$FR
243669531$24366953$1$I$$20240924$20240926$20240926$EXP$$CO-VERTEX PHARMACEUTICALS-2024-015147$VERTEX$$23$YR$$F$Y$57$KG$20240926$$CN$CO$CO
243669541$24366954$1$I$20240918$20240920$20240926$20240926$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001923$BLUEPRINT MEDICINES$$79$YR$E$F$Y$$$20240926$$CN$US$US
243669551$24366955$1$I$$20240924$20240926$20240926$PER$$US-BAYER-2024A137028$BAYER$$24$YR$A$F$Y$$$20240926$$CN$US$US
243669561$24366956$1$I$$20240920$20240926$20240926$EXP$$US-Calliditas-2024CAL02036$CALLIDITAS THERAPEUTICS$$82$YR$E$F$Y$$$20240926$$MD$US$US
243669571$24366957$1$I$$20240918$20240926$20240926$EXP$$US-Calliditas-2024CAL01957$CALLIDITAS THERAPEUTICS$$$$$$Y$$$20240926$$MD$US$US
243669581$24366958$1$I$20240901$20240916$20240926$20240926$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006721$AURINIA PHARMACEUTICALS$$25$YR$$F$Y$$$20240926$$CN$US$US
243669591$24366959$1$I$$20240916$20240926$20240926$PER$$US-MYLANLABS-2024M1085461$MYLAN$$$$$$Y$$$20240926$$CN$US$US
243669601$24366960$1$I$$20240705$20240926$20240926$PER$$US-AMRYT PHARMACEUTICALS DAC-AEGR007266$AEGERION$$$$$$Y$$$20240926$$CN$US$US
243669611$24366961$1$I$20240905$20240913$20240926$20240926$DIR$FDA-CDER-CTU-2024-66024$$FDA-CTU$$20$YR$$F$N$$$20240913$N$HP$US$
243669641$24366964$1$I$20240923$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66066$$FDA-CTU$$77$YR$$M$N$$$20240926$N$$US$
243669651$24366965$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-65997$$FDA-CTU$$41$YR$$F$N$$$20240926$N$$US$
243669661$24366966$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-65996$$FDA-CTU$$68$YR$$F$N$$$20240926$N$$US$
243669671$24366967$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-65994$$FDA-CTU$$57$YR$$$N$$$20240926$N$$US$
243669681$24366968$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-65999$$FDA-CTU$$53$YR$$M$N$59.42$KG$20240926$N$$US$
243669691$24366969$1$I$$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66018$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243669701$24366970$1$I$$20240918$20240926$20240926$EXP$$TW-KOWA-24JP002325AA$KOWA PHARM$Po-Sheng Chen et al.. Risk of Hemorrhagic Stroke among Patients Treated with High Intensity Statins versus Pitavastatin-Ezetimibe: A Population Based Study. Tohoku J. Exp. Med. 2024;263:105-113$$$A$$Y$$$20240926$$MD$TW$TW
243669711$24366971$1$I$$20240830$20240926$20240926$PER$$US-Eisai-EC-2024-173947$EISAI$$$$E$F$Y$$$20240926$$CN$US$US
243669721$24366972$1$I$$20240924$20240926$20240926$PER$$US-BAYER-2024A137602$BAYER$$30$YR$A$F$Y$$$20240926$$CN$US$US
243669731$24366973$1$I$20240806$20240923$20240926$20240926$EXP$FR-AFSSAPS-MA2024001361$FR-FreseniusKabi-FK202414307$FRESENIUS KABI$$58$YR$A$M$Y$$$20240926$$MD$FR$FR
243669741$24366974$1$I$$20240917$20240926$20240926$EXP$$FR-CELLTRION INC.-2024FR022510$CELLTRION$H Ghesquieres. Therapeutic strategies for refractory or relapsed cerebral lymphomas. Correspondences in Onco-Hematology. 2023;XVIII (2):102-105$$$$$Y$$$20240926$$HP$FR$FR
243669761$24366976$1$I$20240924$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015541$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240926$$CN$US$US
243669771$24366977$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015385$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240926$$CN$US$US
243669781$24366978$1$I$20240922$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014670$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240926$$CN$US$US
243669791$24366979$1$I$20240101$20240920$20240926$20240926$EXP$$CA-ABBVIE-5933805$ABBVIE$$19$YR$$M$Y$$$20240926$$MD$CA$CA
243669802$24366980$2$F$$20240926$20240926$20240930$EXP$$US-PFIZER INC-PV202400124403$PFIZER$Luo, K.. UNVEILING DELAYED LUNG INJURY: A UNIQUE CASE OF ATG-INDUCED ACUTE LUNG INJURY WITH PROLONGED PROGRESSION. Chest. 2024;166(4 Supplemen:A3181-A3182$57$YR$$F$Y$$$20240930$$HP$US$US
243669811$24366981$1$I$20240924$20240925$20240926$20240926$PER$$US-BAYER-2024A137405$BAYER$$32$YR$A$F$Y$$$20240926$$MD$US$US
243669821$24366982$1$I$20240101$20240920$20240926$20240926$EXP$$MX-ABBVIE-5937501$ABBVIE$$$$$M$Y$106$KG$20240926$$CN$MX$MX
243669831$24366983$1$I$$20240916$20240926$20240926$EXP$$CN-TEYRO-2024-TY-000693$Teyro Labs$Li K, Zhong W, Fan J, Wang S, Yu D, Huang J, et.al.Neoadjuvant gemcitabine-cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial..Nat Cancer..2024$$$$$Y$$$20240926$$HP$CN$CN
243669841$24366984$1$I$20201016$20240920$20240926$20240926$EXP$$US-CHIESI-2024CHF06314$CHIESI$$78$YR$$M$Y$86.6$KG$20240926$$CN$US$US
243669851$24366985$1$I$$20240920$20240926$20240926$EXP$$SK-ASTELLAS-2024-AER-008401$ASTELLAS$Timea B, Patricia K. Diagnostic methods in the determination of immunological risk in a patient before kidney transplantation. Acta Medica Martiniana. 2024;24(2): 49-54. doi:10.2478/acm-2024-0007.$33$YR$A$F$Y$$$20240926$$HP$SK$SK
243669871$24366987$1$I$20230101$20240926$20240926$20240926$EXP$CZ-TEVA-VS-3244157$CZ-ROCHE-10000091896$ROCHE$$$$$M$Y$$$20240926$$MD$CZ$CZ
243669881$24366988$1$I$20240920$20240925$20240926$20240926$EXP$$US-INCYTE CORPORATION-2024IN010179$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243669891$24366989$1$I$20240101$20240924$20240926$20240926$EXP$$US-INCYTE CORPORATION-2024IN010076$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243669901$24366990$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001730$ORGANON$$44$YR$$F$Y$$$20240926$$HP$CA$CA
243669921$24366992$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011041$APOTEX$$$$$F$Y$$$20240926$$HP$CA$CA
243669931$24366993$1$I$$20240920$20240926$20240926$EXP$$US-PROD-AS2-212756134-20-24-USA-RB-0007948$RECKITT BENCKISER$$55$YR$$F$Y$$$20240926$$CN$US$US
243669951$24366995$1$I$$20240923$20240926$20240926$EXP$$AT-PFIZER INC-202400261415$PFIZER$$$$A$M$Y$$$20240926$$MD$AT$AT
243669961$24366996$1$I$20240101$20240924$20240926$20240926$EXP$$FR-PFIZER INC-202400262529$PFIZER$$86$YR$$F$Y$$$20240926$$MD$FR$FR
243669972$24366997$2$F$$20240920$20240926$20240927$EXP$$US-PFIZER INC-PV202400123988$PFIZER$$71$YR$$F$Y$57.7$KG$20240927$$MD$US$US
243669981$24366998$1$I$20240901$20240924$20240926$20240926$EXP$$US-PFIZER INC-202400263276$PFIZER$$52$YR$$F$Y$$$20240926$$HP$US$US
243669991$24366999$1$I$20240425$20240921$20240926$20240926$EXP$$IN-PFIZER INC-PV202400043855$PFIZER$$54$YR$$M$Y$76.2$KG$20240926$$CN$IN$IN
243670001$24367000$1$I$$20240925$20240926$20240926$EXP$$CA-PFIZER INC-202400263924$PFIZER$$43$YR$$F$Y$$$20240926$$CN$CA$CA
243670031$24367003$1$I$20230501$20240920$20240926$20240926$EXP$$PT-PFIZER INC-202400260413$PFIZER$$70$YR$$F$Y$$$20240926$$MD$PT$PT
243670041$24367004$1$I$$20240923$20240926$20240926$EXP$$RU-PFIZER INC-PV202400124079$PFIZER$$$$$$Y$$$20240926$$MD$RU$RU
243670051$24367005$1$I$20240502$20240924$20240926$20240926$EXP$FR-AFSSAPS-TO2024001766$FR-PFIZER INC-202400262649$PFIZER$$76$YR$$F$Y$$$20240926$$PH$FR$FR
243670061$24367006$1$I$20240915$20240924$20240926$20240926$EXP$$CN-PFIZER INC-PV202400124999$PFIZER$$68$YR$$M$Y$$$20240926$$HP$CN$CN
243670071$24367007$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-65990$$FDA-CTU$$75$YR$$F$N$$$20240926$N$$US$
243670101$24367010$1$I$20240730$20240924$20240926$20240926$EXP$$US-PFIZER INC-PV202400125043$PFIZER$$59$YR$$F$Y$$$20240926$$HP$US$US
243670111$24367011$1$I$20220419$20240924$20240926$20240926$EXP$$KR-PFIZER INC-202400262101$PFIZER$$54$YR$$F$Y$$$20240926$$PH$KR$KR
243670121$24367012$1$I$20230901$20240924$20240926$20240926$EXP$$US-PFIZER INC-PV202400125044$PFIZER$$39$YR$$M$Y$$$20240926$$HP$US$US
243670131$24367013$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-PV202400124438$PFIZER$$45$YR$$F$Y$$$20240926$$MD$US$US
243670141$24367014$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-65992$$FDA-CTU$$82$YR$$F$N$$$20240926$N$$US$
243670151$24367015$1$I$$20240925$20240926$20240926$EXP$$CA-PFIZER INC-202400263921$PFIZER$$60$YR$$F$Y$$$20240926$$CN$CA$CA
243670161$24367016$1$I$20220814$20240920$20240926$20240926$EXP$FR-AFSSAPS-AN20222554$FR-PFIZER INC-202300032501$PFIZER$$34$YR$$F$Y$78.9$KG$20240926$$PH$FR$FR
243670171$24367017$1$I$$20240925$20240926$20240926$EXP$$PT-PFIZER INC-202400263489$PFIZER$$$$A$F$Y$$$20240926$$MD$PT$PT
243670181$24367018$1$I$20240624$20240924$20240926$20240926$EXP$FR-AFSSAPS-PP2024001025$FR-PFIZER INC-202400262664$PFIZER$$72$YR$$F$Y$101$KG$20240926$$MD$FR$FR
243670191$24367019$1$I$20010621$20240923$20240926$20240926$EXP$$AU-PFIZER INC-PV202400124501$PFIZER$$80$YR$$F$Y$$$20240926$$HP$AU$AU
243670201$24367020$1$I$$20240925$20240926$20240926$EXP$$AR-PFIZER INC-202400263852$PFIZER$$84$YR$$M$Y$$$20240926$$CN$AR$AR
243670211$24367021$1$I$$20240920$20240926$20240926$EXP$$US-INCYTE CORPORATION-2024IN010026$INCYTE$$$$$$Y$$$20240926$$MD$US$US
243670231$24367023$1$I$$20240923$20240926$20240926$EXP$$CA-FreseniusKabi-FK202414266$FRESENIUS KABI$$33$YR$A$$Y$42$KG$20240926$$PH$CA$CA
243670241$24367024$1$I$20240916$20240923$20240926$20240926$EXP$PT-INFARMED-J202409-476$PT-FreseniusKabi-FK202414250$FRESENIUS KABI$$55$YR$A$F$Y$60.4$KG$20240926$$PH$PT$PT
243670251$24367025$1$I$$20240916$20240926$20240926$PER$$US-RDY-SPO/USA/24/0013888$DR REDDYS$$22$YR$A$F$Y$$$20240926$$MD$US$US
243670261$24367026$1$I$20240918$20240918$20240926$20240926$PER$$US-RDY-SPO/USA/24/0013827$DR REDDYS$$38$YR$A$M$Y$$$20240926$$MD$US$US
243670271$24367027$1$I$20240916$20240920$20240926$20240926$EXP$$CN-PFIZER INC-PV202400123626$PFIZER$$49$YR$$F$Y$63$KG$20240926$$HP$CN$CN
243670281$24367028$1$I$$20240916$20240926$20240926$EXP$$CN-TEYRO-2024-TY-000687$Teyro Labs$Li K, Zhong W, Fan J, Wang S, Yu D, Huang J, et.al.Neoadjuvant gemcitabine-cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial..Nat Cancer..2024$$$$$Y$$$20240926$$HP$CN$CN
243670291$24367029$1$I$20240630$20240916$20240926$20240926$PER$$US-RDY-SPO/USA/24/0013886$DR REDDYS$$39$YR$A$$Y$$$20240926$$CN$US$US
243670301$24367030$1$I$20240905$20240920$20240926$20240926$EXP$$NVSC2024RU190259$NOVARTIS$$16$YR$$F$Y$$$20240926$$HP$RU$RU
243670311$24367031$1$I$20240901$20240919$20240926$20240926$EXP$$CN-009507513-2409CHN007936$MERCK$$59$YR$$F$Y$47$KG$20240926$$HP$CN$CN
243670321$24367032$1$I$$20240913$20240926$20240926$EXP$FR-AFSSAPS-DJ2023000421$FR-CELLTRION INC.-2024FR022760$CELLTRION$$$$$$Y$$$20240926$$MD$FR$FR
243670331$24367033$1$I$20220115$20240919$20240926$20240926$EXP$ES-002147023-NVSC2022ES023431$ES-RDY-CLI/SPN/22/0150312$DR REDDYS$$72$YR$E$M$Y$50$KG$20240926$$MD$ES$ES
243670401$24367040$1$I$$20240917$20240926$20240926$EXP$$US-VANDA PHARMACEUTICALS, INC-2024ILOUS001970$VANDA PHARMACEUTICALS$$$$$F$Y$$$20240926$$HP$US$US
243670411$24367041$1$I$$20240918$20240926$20240926$EXP$$IT-HALEON-2197700$Haleon PLC$$23$YR$$M$Y$$$20240926$$CN$IT$IT
243670421$24367042$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152773$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240926$$CN$US$US
243670431$24367043$1$I$$20240920$20240926$20240926$EXP$$US-INCYTE CORPORATION-2024IN010011$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243670441$24367044$1$I$20240910$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152645$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$82.4$KG$20240926$$PH$US$US
243670451$24367045$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152458$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240926$$CN$US$US
243670471$24367047$1$I$$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66023$$FDA-CTU$$$$$F$N$$$20240925$N$HP$US$
243670491$24367049$1$I$20240922$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-65982$$FDA-CTU$$62$YR$$F$N$$$20240925$N$HP$US$
243670501$24367050$1$I$$20240919$20240926$20240926$EXP$$FR-ROCHE-10000090339$ROCHE$$$$$$Y$$$20240926$$MD$FR$FR
243670511$24367051$1$I$$20240925$20240926$20240926$EXP$$US-BAUSCH-BL-2024-014435$BAUSCH AND LOMB$$39$YR$$M$Y$$$20240926$$CN$US$US
243670522$24367052$2$F$$20240911$20240926$20240926$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03379$AMNEAL$$$$$$Y$$$20240926$$PH$US$US
243670531$24367053$1$I$20240807$20240920$20240926$20240926$EXP$FR-AFSSAPS-PB2024000984$FR-009507513-2409FRA007613$MERCK$$74$YR$$F$Y$63.5$KG$20240926$$HP$FR$FR
243670541$24367054$1$I$$20240925$20240926$20240926$EXP$$NVSC2024GB190960$NOVARTIS$$$$$F$Y$$$20240926$$CN$GB$GB
243670561$24367056$1$I$$20240923$20240926$20240926$EXP$$US-BAYER-2024A137233$BAYER$$46$YR$A$F$Y$190.48$KG$20240926$$HP$US$US
243670571$24367057$1$I$20240815$20240923$20240926$20240926$EXP$$US-KARYOPHARM-2024KPT001573$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240926$$HP$US$US
243670581$24367058$1$I$$20240909$20240926$20240926$PER$$US-JNJFOC-20240922540$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
243670591$24367059$1$I$$20240920$20240926$20240926$PER$$US-JNJFOC-20240965929$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243670601$24367060$1$I$20240901$20240916$20240926$20240926$PER$$US-JNJFOC-20240941659$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243670611$24367061$1$I$20240904$20240911$20240926$20240926$PER$$US-JNJFOC-20240929347$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243670621$24367062$1$I$$20240911$20240926$20240926$PER$$US-JNJFOC-20240929329$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
243670631$24367063$1$I$20240801$20240920$20240926$20240926$PER$$US-BAUSCH-BL-2024-014239$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240926$$CN$US$US
243670641$24367064$1$I$20240901$20240920$20240926$20240926$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001930$BLUEPRINT MEDICINES$$45$YR$A$M$Y$$$20240926$$CN$US$US
243670651$24367065$1$I$20240801$20240916$20240926$20240926$PER$$US-GSK-US2024114907$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243670661$24367066$1$I$$20240919$20240926$20240926$EXP$$DE-GSK-DE2024EME116758$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$DE$DE
243670681$24367068$1$I$$20240918$20240926$20240926$EXP$$HR-BAUSCH-BL-2024-014433$BAUSCH AND LOMB$$$$A$M$Y$$$20240926$$MD$HR$HR
243670701$24367070$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191635$NOVARTIS$$$$$$Y$$$20240926$$MD$US$US
243670711$24367071$1$I$$20240925$20240926$20240926$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053519$BOEHRINGER INGELHEIM$$$$$$Y$$$20240926$$MD$US$US
243670721$24367072$1$I$$20240917$20240926$20240926$PER$$US-INCYTE CORPORATION-2024IN009917$INCYTE$$$$$$Y$$$20240926$$PH$US$US
243670731$24367073$1$I$$20240923$20240926$20240926$EXP$$CA-BAUSCH-BL-2024-014349$BAUSCH AND LOMB$$48$YR$$M$Y$$$20240926$$HP$CA$CA
243670741$24367074$1$I$$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66073$$FDA-CTU$$$$$F$N$$$20240925$N$HP$US$
243670761$24367076$1$I$$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66075$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243670791$24367079$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016317$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240926$$CN$US$US
243670801$24367080$1$I$$20240920$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409013599$ELI LILLY AND CO$$35$YR$A$$Y$$$20240926$$CN$US$US
243670811$24367081$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015493$ELI LILLY AND CO$$33$YR$A$F$Y$$$20240926$$CN$US$US
243670821$24367082$1$I$20240923$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015648$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240926$$CN$US$US
243670831$24367083$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016380$ELI LILLY AND CO$$$$$$Y$$$20240926$$CN$US$US
243670841$24367084$1$I$$20240917$20240926$20240926$PER$$US-INCYTE CORPORATION-2024IN009873$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243670852$24367085$2$F$20240917$20240925$20240926$20240930$PER$$US-KARYOPHARM-2024KPT001560$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240930$$CN$US$US
243670861$24367086$1$I$20240827$20240912$20240926$20240926$EXP$CN-NMPA-3505021027230202401764$CN-NOVOPROD-1284233$NOVO NORDISK$$59$YR$$F$Y$50.5$KG$20240926$$HP$CN$CN
243670871$24367087$1$I$20240911$20240918$20240926$20240926$EXP$$US-UROGEN PHARMA LTD.-2024-UGN-000137$UROGEN PHARMA$$$$$$Y$$$20240926$$CN$US$US
243670881$24367088$1$I$$20240917$20240926$20240926$EXP$$JP-ROCHE-10000091286$ROCHE$Tokunaga Y,  A case of baloxavir marboxil-related ischaemic enterocolitis.. The 697th Kanto Regional Meeting of the Japanese Society of Internal Medicine, Abstracts (hybrid meeting held on 14-JUL-202. 2024-Jul-14;53.$27$YR$A$M$Y$$$20240926$$HP$JP$JP
243670891$24367089$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152684$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240926$$CN$US$US
243670901$24367090$1$I$20240901$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152238$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240926$$PH$US$US
243670911$24367091$1$I$$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150592$BRISTOL MYERS SQUIBB$$27$YR$A$F$Y$$$20240926$$HP$US$US
243670921$24367092$1$I$20240101$20240924$20240926$20240926$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-151947$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240926$$CN$PR$PR
243670931$24367093$1$I$20210805$20240916$20240926$20240926$PER$$US-INCYTE CORPORATION-2024IN009812$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243670941$24367094$1$I$$20240912$20240926$20240926$PER$$US-JNJFOC-20240932005$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243670951$24367095$1$I$$20240911$20240926$20240926$PER$$US-JNJFOC-20240929281$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243670961$24367096$1$I$$20240916$20240926$20240926$EXP$$CA-RDY-CLI/CAN/24/0013876$DR REDDYS$$70$YR$E$M$Y$$$20240926$$CN$CA$CA
243670971$24367097$1$I$20240912$20240925$20240926$20240926$PER$$US-BAYER-2024A137332$BAYER$$61$YR$A$F$Y$$$20240926$$HP$US$US
243670981$24367098$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191603$NOVARTIS$$$$$M$Y$$$20240926$$HP$US$US
243671001$24367100$1$I$20240819$20240920$20240926$20240926$EXP$$NVSC2024AU190753$NOVARTIS$$77$YR$$M$Y$80$KG$20240926$$MD$AU$AU
243671011$24367101$1$I$20240920$20240924$20240926$20240926$30DAY$$US-ALKERMES INC.-ALK-2024-002467$ALKERMES$$$$$$Y$$$20240926$$HP$US$US
243671021$24367102$1$I$20240920$20240920$20240926$20240926$PER$$US-ROCHE-10000089219$ROCHE$$44$YR$A$M$Y$92.08$KG$20240926$$HP$US$US
243671031$24367103$1$I$$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66076$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243671041$24367104$1$I$20240923$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66079$$FDA-CTU$$37$YR$$M$N$$$20240926$N$$US$
243671061$24367106$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66067$$FDA-CTU$$$$$F$N$$$20240926$N$HP$US$
243671071$24367107$1$I$20240920$20240924$20240926$20240926$EXP$$US-ABBVIE-5938668$ABBVIE$$89$YR$$M$Y$$$20240926$$CN$US$US
243671081$24367108$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001731$ORGANON$$48$YR$$F$Y$68$KG$20240926$$HP$CA$CA
243671091$24367109$1$I$20240813$20240920$20240926$20240926$EXP$FR-AFSSAPS-PV2024000788$FR-MYLANLABS-2024M1086133$MYLAN$$1$MON$$F$Y$3.4$KG$20240926$$MD$FR$FR
243671101$24367110$1$I$20240909$20240920$20240926$20240926$EXP$FR-AFSSAPS-BR2024000757$FR-MYLANLABS-2024M1086246$MYLAN$$72$YR$$M$Y$63$KG$20240926$$MD$FR$FR
243671111$24367111$1$I$20240831$20240924$20240926$20240926$EXP$$DE-MYLANLABS-2024M1086713$MYLAN$$64$YR$$F$Y$45$KG$20240926$$MD$DE$DE
243671121$24367112$1$I$$20240924$20240926$20240926$EXP$$US-BIOVITRUM-2024-US-012437$BIOVITRUM$Percic N, Mucha, et.al. RSV-MEDIATED HLH IN THE SETTING OF MULTIPLE MYELOMA: A DIAGNOSTIC AND THERAPEUTIC CONUNDRUM. Chest. 166(4): A2071. doi:10.1016/j.chest.2024.06.1282.$59$YR$$M$Y$$$20240926$$HP$US$US
243671141$24367114$1$I$20240901$20240923$20240926$20240926$EXP$FR-AFSSAPS-LY2024001419$FR-MYLANLABS-2024M1086363$MYLAN$$80$YR$$M$Y$$$20240926$$PH$FR$FR
243671161$24367116$1$I$$20240923$20240926$20240926$EXP$$CA-FreseniusKabi-FK202414267$FRESENIUS KABI$$41$YR$A$M$Y$$$20240926$$HP$CA$CA
243671171$24367117$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245092$TEVA$$51$YR$$F$Y$77$KG$20240926$$HP$CA$CA
243671181$24367118$1$I$$20240924$20240926$20240926$EXP$$US-JNJFOC-20240966701$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243671191$24367119$1$I$20240904$20240919$20240926$20240926$EXP$$CN-JNJFOC-20240960389$JOHNSON AND JOHNSON$$49$YR$A$M$Y$74.7$KG$20240926$$HP$CN$CN
243671201$24367120$1$I$20240901$20240913$20240926$20240926$PER$$US-JNJFOC-20240937150$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243671211$24367121$1$I$20240801$20240920$20240926$20240926$EXP$$US-JNJFOC-20240959749$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240926$$HP$US$US
243671241$24367124$1$I$20240913$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66007$$FDA-CTU$$70$YR$$F$N$$$20240926$N$$US$
243671281$24367128$1$I$$20240920$20240926$20240926$DIR$FDA-CDER-CTU-2024-66082$$FDA-CTU$$$$$F$N$$$20240920$N$HP$US$
243671301$24367130$1$I$20240819$20240823$20240926$20240926$EXP$$CH-OPKO PHARMACEUTICALS, LLC.-2024OPK00248$OPKO HEALTH$$75$YR$$M$Y$94.4$KG$20240924$$CN$CH$DE
243671311$24367131$1$I$$20240919$20240926$20240926$EXP$$CN-INFO-20240296$INFORLIFE$Ning Y, Xiao M, Perlin DS, Zhao Y, Lu M, Li YI et al. Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China. Emerging microbes + infections. 2023;12(1):2153086. DOI:10.1080/22221751.2022.2153086.$$$I$M$Y$$$20240920$$MD$CN$
243671321$24367132$1$I$$20240916$20240926$20240926$EXP$$ES-ROCHE-10000091324$ROCHE$Somovilla A, Aguirre C, Gallego M, Vivancos J. Organizing Pneumonia in Multiple Sclerosis Patients Treated with Ocrelizumab following SARS-CoV-2 Infection: A Case Series Report [Abstract No: P1153/2242]. Multiple Sclerosis Journal. 2024;30 (3S):681-1137.$59$YR$A$M$Y$$$20240926$$HP$ES$ES
243671341$24367134$1$I$$20240826$20240926$20240926$PER$$US-GSK-US2024118262$GLAXOSMITHKLINE$$$$$M$Y$$$20240926$$CN$US$US
243671351$24367135$1$I$20240101$20240909$20240926$20240926$EXP$$US-SA-2024SA277115$SANOFI AVENTIS$$62$YR$A$F$Y$86.36$KG$20240926$$MD$US$US
243671361$24367136$1$I$$20240916$20240926$20240926$EXP$$CA-APOTEX-2024AP011046$APOTEX$$$$$M$Y$$$20240926$$HP$CA$CA
243671371$24367137$1$I$20240501$20240913$20240926$20240926$PER$$US-JNJFOC-20240937069$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243671381$24367138$1$I$20240911$20240911$20240926$20240926$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470095$RANBAXY$$65$YR$$M$Y$78$KG$20240926$$CN$GB$GB
243671391$24367139$1$I$$20240911$20240926$20240926$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470125$RANBAXY$Imataki O, Uemura M.. Bifidobacterium Bloodstream Infection in a Lymphoma Patient Undergoing Chemotherapy: A Case Study and Implications for Probiotic Use. American Journal of Case Reports. 2024;25 (0):no pagination$75$YR$$F$Y$$$20240926$$HP$JP$JP
243671401$24367140$1$I$$20240911$20240926$20240926$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470091$RANBAXY$Aiba M, Okada K, Funakoshi T, Nozu R, Takahashi T, Ozu S, et al. Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma. J Infect Chemother. 2024;30 (10):1065-1068$6$DEC$$F$Y$$$20240926$$HP$JP$JP
243671411$24367141$1$I$$20240923$20240926$20240926$EXP$$CA-FreseniusKabi-FK202414225$FRESENIUS KABI$$69$YR$E$M$Y$70$KG$20240926$$PH$CA$CA
243671421$24367142$1$I$$20240911$20240926$20240926$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470096$RANBAXY$$$$$M$Y$72$KG$20240926$$HP$GB$GB
243671431$24367143$1$I$$20240923$20240926$20240926$EXP$$CA-FreseniusKabi-FK202414325$FRESENIUS KABI$$5$DEC$A$F$Y$$$20240926$$CN$CA$CA
243671441$24367144$1$I$$20240918$20240926$20240926$EXP$$ZA-TAKEDA-2024TUS091886$TAKEDA$$$$$F$Y$$$20240926$$MD$ZA$ZA
243671451$24367145$1$I$20240911$20240923$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150903$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240926$$CN$US$US
243671461$24367146$1$I$$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151096$BRISTOL MYERS SQUIBB$$48$YR$A$M$Y$$$20240926$$HP$US$US
243671471$24367147$1$I$$20240920$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150534$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240926$$CN$US$US
243671481$24367148$1$I$$20240916$20240926$20240926$EXP$$RU-TEVA-VS-3244905$TEVA$Nadeeva EYu, Kulibaba EV. ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND ACUTE RECURRENT MYOCARDIAL INFARCTION. [Russian]. Eksp-Klin-Farmakol 2024; 87 (6): 8-12.$72$YR$$M$Y$$$20240926$$HP$RU$RU
243671491$24367149$1$I$$20240920$20240926$20240926$EXP$$NVSC2024AU191340$NOVARTIS$$$$$$Y$$$20240926$$PH$AU$AU
243671501$24367150$1$I$$20240919$20240926$20240926$PER$$US-JNJFOC-20240953345$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$MD$US$US
243671511$24367151$1$I$$20240912$20240926$20240926$EXP$$CN-B.Braun Medical Inc.-2162096$B BRAUN$$59$YR$$F$Y$40$KG$20240926$$$CN$CN
243671551$24367155$1$I$20240701$20240913$20240926$20240926$PER$$US-JNJFOC-20240936790$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243671561$24367156$1$I$$20240916$20240926$20240926$EXP$$CN-TEYRO-2024-TY-000677$Teyro Labs$Li K, Zhong W, Fan J, Wang S, Yu D, Huang J, et.al.Neoadjuvant gemcitabine-cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial..Nat Cancer..2024$$$$$Y$$$20240926$$HP$CN$CN
243671571$24367157$1$I$$20240924$20240926$20240926$EXP$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000975$PAREXEL$$$$$$Y$$$20240926$$CN$US$US
243671581$24367158$1$I$$20240919$20240926$20240926$EXP$$US-SA-2024SA277263$SANOFI AVENTIS$$$$$M$Y$$$20240926$$HP$US$US
243671591$24367159$1$I$$20240911$20240926$20240926$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470043$RANBAXY$He H, Hou N, Chen X, Song Y, Qiang W, Liu J, et al. An open-label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome. Br J Haematol. 2024;205 (2):478-482$54$YR$$M$Y$$$20240926$$HP$CN$CN
243671601$24367160$1$I$20240902$20240923$20240926$20240926$EXP$$US-SA-2024SA276543$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240926$$MD$US$US
243671611$24367161$1$I$20240919$20240919$20240926$20240926$EXP$$US-SA-2024SA276482$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240926$$CN$US$US
243671621$24367162$1$I$20240601$20240919$20240926$20240926$EXP$FR-AFSSAPS-CN2024000752$FR-SA-2024SA278397$SANOFI AVENTIS$$73$YR$E$M$Y$64$KG$20240926$$MD$FR$FR
243671651$24367165$1$I$$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66085$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243671671$24367167$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152285$BRISTOL MYERS SQUIBB$$32$YR$A$M$Y$$$20240926$$HP$US$US
243671681$24367168$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151550$BRISTOL MYERS SQUIBB$$44$YR$A$F$Y$$$20240926$$CN$US$US
243671691$24367169$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152729$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240926$$CN$US$US
243671701$24367170$1$I$$20240910$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152630$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$69.72$KG$20240926$$CN$US$US
243671711$24367171$1$I$$20240923$20240926$20240926$EXP$$US-SA-2024SA276130$SANOFI AVENTIS$Vellore JR, Sharma A, Chaudary NA.. From tumor lysis to hemo lysis: a case of rasburicase-induced methemoglobinemia.. Chest.. 2024;166(4):A2369-70$41$YR$A$M$Y$$$20240926$$HP$US$US
243671731$24367173$1$I$20240903$20240913$20240926$20240926$PER$$US-JNJFOC-20240936654$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243671741$24367174$1$I$$20240913$20240926$20240926$PER$$US-JNJFOC-20240935744$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243671751$24367175$1$I$$20240912$20240926$20240926$PER$$US-JNJFOC-20240963392$JOHNSON AND JOHNSON$$$$$M$Y$55.8$KG$20240926$$MD$US$US
243671761$24367176$1$I$20210101$20240919$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-008027$JAZZ$$$$$F$Y$$$20240926$$CN$US$US
243671771$24367177$1$I$$20240923$20240926$20240926$EXP$$NL-SA-2024SA275828$SANOFI AVENTIS$LUO K, MENDPARA R, CAMAC ER, SHRAKE K.. UNVEILING DELAYED LUNG INJURY: A UNIQUE CASE OF ATG-INDUCED ACUTE LUNG INJURY WITH PROLONGED PROGRESSION. Chest. 2024;166(4):A3181-2$57$YR$A$F$Y$$$20240926$$HP$NL$NL
243671781$24367178$1$I$$20240915$20240926$20240926$DIR$FDA-CDER-CTU-2024-66086$$FDA-CTU$$$$$F$N$$$20240915$N$HP$US$
243671791$24367179$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245131$TEVA$$74$YR$$F$Y$$$20240926$$HP$CA$CA
243671811$24367181$1$I$20240913$20240925$20240925$20240925$DIR$719944$$FDA-CTU$$24$YR$$F$N$$$20240925$N$CN$US$
243671822$24367182$2$F$20240801$20240925$20240926$20240930$EXP$$US-SA-2024SA277169$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240930$$HP$US$US
243671831$24367183$1$I$20240913$20240925$20240925$20240925$DIR$719944$$FDA-CTU$$$$$$N$$$20240925$N$CN$US$
243671841$24367184$1$I$20240401$20240909$20240926$20240926$EXP$$US-ACS-20240356$ACS DOBFAR$$71$YR$$M$Y$$$20240912$$CN$US$
243671851$24367185$1$I$$20240918$20240926$20240926$EXP$$US-FreseniusKabi-FK202414383$FRESENIUS KABI$Measer J, Gray A, Braehler M. Subdural Spread of Local Anesthetic Mimicking Cerebrovascular Accident: A Case Report of Horner?s Syndrome, Upper Limb Paresthesia, and Motor Weakness After Thoracic Epidural Analgesia. A + A PRACTICE. 2024 Jul;18(7): 1-3. doi:10.1213/XAA.0000000000001812.$53$YR$A$F$Y$$$20240926$$MD$US$US
243671861$24367186$1$I$$20240919$20240926$20240926$EXP$$US-ACS-20240377$ACS DOBFAR$$$$E$F$Y$$$20240920$$CN$US$
243671871$24367187$1$I$$20240915$20240926$20240926$EXP$$US-ACS-20240366$ACS DOBFAR$Zafar SJ, Wynne Z, John T, Buzzalino LG, Shishido AA, Riedel DJ. Cefazolin-induced hemolytic anemia in septic arthritis: A case report. IDCases. 2024 Aug 9;37:e02057. doi: 10.1016/j.idcr.2024.e02057.$50$YR$$F$Y$$$20240919$$MD$US$
243671882$24367188$2$F$$20240926$20240926$20240930$PER$$US-HALEON-2198814$Haleon PLC$$$$$$Y$$$20240930$$CN$US$US
243671891$24367189$1$I$20240701$20240917$20240926$20240926$PER$$US-MYLANLABS-2024M1085203$MYLAN$$$$$F$Y$$$20240926$$CN$US$US
243671901$24367190$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152205$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240926$$MD$US$US
243671911$24367191$1$I$$20240919$20240926$20240926$EXP$$GB-MYLANLABS-2024M1086154$MYLAN$$$$$M$Y$$$20240926$$MD$GB$GB
243671921$24367192$1$I$20240801$20240917$20240926$20240926$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-027473$UNITED THERAPEUTICS$$91$YR$$F$Y$$$20240926$$$JP$JP
243671941$24367194$1$I$20240831$20240924$20240926$20240926$EXP$GB-MHRA-MED-202409241057389150-NSRYW$GB-BAYER-2024A136478$BAYER$$78$YR$E$M$Y$94$KG$20240926$$HP$GB$GB
243671951$24367195$1$I$20240701$20240920$20240926$20240926$EXP$$JP-009507513-2407JPN003206J$MERCK$$8$DEC$$M$Y$$$20240926$$PH$JP$JP
243671961$24367196$1$I$$20240912$20240926$20240926$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000374$Unknown Manufacturer$$$$$$Y$$$20240926$$CN$US$US
243671971$24367197$1$I$$20240916$20240926$20240926$EXP$$ES-AMAROX PHARMA-AMR2024ES03308$HETERO$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E et al. Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital. Liver International. 2024;44(2):286-292$$$$$Y$$$20240926$$HP$ES$ES
243671981$24367198$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245079$TEVA$$65$YR$$F$Y$81$KG$20240926$$PH$CA$CA
243671991$24367199$1$I$$20240924$20240926$20240926$EXP$$NVSC2024CN191418$NOVARTIS$$90$YR$$M$Y$$$20240926$$CN$CN$CN
243672001$24367200$1$I$$20240924$20240926$20240926$EXP$$US-ASTELLAS-2024-AER-009049$ASTELLAS$$62$YR$A$M$Y$$$20240926$$HP$US$US
243672011$24367201$1$I$$20240920$20240926$20240926$PER$$DE-Blueprint Medicines Corporation-SO-DE-2024-001933$BLUEPRINT MEDICINES$$$$$$Y$$$20240926$$HP$DE$DE
243672031$24367203$1$I$20240101$20240916$20240926$20240926$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-129064$REGENERON$$79$YR$$F$Y$$$20240926$$MD$US$US
243672042$24367204$2$F$20210211$20240926$20240926$20240930$EXP$$US-PFIZER INC-2021SGN00794$PFIZER$$26$YR$$F$Y$$$20240930$$PH$US$US
243672051$24367205$1$I$20190211$20240923$20240926$20240926$EXP$$US-PFIZER INC-2019SGN00537$PFIZER$$$$$F$Y$$$20240926$$MD$US$US
243672062$24367206$2$F$20190701$20240927$20240926$20240927$EXP$$US-PFIZER INC-2019SGN02497$PFIZER$$60$YR$$F$Y$$$20240927$$PH$US$US
243672071$24367207$1$I$$20240902$20240926$20240926$EXP$$JP-AMGEN-JPNSP2024175261$AMGEN$$$$$M$Y$$$20240926$$CN$JP$JP
243672081$24367208$1$I$$20240912$20240926$20240926$PER$$US-JNJFOC-20240933431$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243672101$24367210$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-66052$$FDA-CTU$$$$$$N$$$20240924$N$CN$US$
243672111$24367211$1$I$$20240925$20240925$20240925$DIR$719951$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243672141$24367214$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-66030$$FDA-CTU$$$$$$N$$$20240924$N$CN$US$
243672161$24367216$1$I$$20240925$20240925$20240925$DIR$719945$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243672171$24367217$1$I$20240924$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-66045$$FDA-CTU$$$$$$N$$$20240924$N$CN$US$
243672181$24367218$1$I$20231101$20240911$20240926$20240926$EXP$$US-COOPERSURGICAL, INC.-2024CPS002908$COOPERSURGICAL$$0$YR$$F$Y$2.721$KG$20240926$$CN$US$US
243672191$24367219$1$I$20230101$20240911$20240926$20240926$EXP$$US-COOPERSURGICAL, INC.-2024CPS001255$COOPERSURGICAL$$$$$F$Y$89.796$KG$20240926$$CN$US$US
243672201$24367220$1$I$$20240920$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-013990$JAZZ$$$$$M$Y$$$20240926$$CN$US$US
243672211$24367221$1$I$$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024190603$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243672221$24367222$1$I$$20240912$20240926$20240926$EXP$$US-BAXTER-2024BAX024653$BAXTER$$$$$F$Y$$$20240926$$CN$US$US
243672232$24367223$2$F$20230101$20240924$20240926$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151769$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240930$$CN$US$US
243672241$24367224$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151662$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240926$$CN$US$US
243672251$24367225$1$I$$20240911$20240926$20240926$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00910$Phathom Pharmaceuticals$$88$YR$$F$Y$$$20240926$$MD$JP$JP
243672261$24367226$1$I$$20240916$20240926$20240926$EXP$$CA-BAXTER-2024BAX024852$BAXTER$$16$YR$$F$Y$$$20240926$$HP$CA$CA
243672271$24367227$1$I$$20240921$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151360$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240926$$MD$US$US
243672281$24367228$1$I$$20240924$20240926$20240926$EXP$$US-BAYER-2024A136959$BAYER$$$$$M$Y$$$20240926$$HP$US$US
243672291$24367229$1$I$$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152210$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$84$KG$20240926$$MD$US$US
243672301$24367230$1$I$$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151344$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240926$$PH$US$US
243672311$24367231$1$I$$20240916$20240926$20240926$EXP$$CA-BAXTER-2024BAX024861$BAXTER$$9$YR$$M$Y$$$20240926$$CN$CA$CA
243672321$24367232$1$I$$20240916$20240926$20240926$EXP$$CA-BAXTER-2024BAX024913$BAXTER$$52$YR$$M$Y$$$20240926$$HP$CA$CA
243672331$24367233$1$I$$20240916$20240926$20240926$EXP$$CA-BAXTER-2024BAX024860$BAXTER$$89$YR$$M$Y$75$KG$20240926$$HP$CA$CA
243672341$24367234$1$I$$20240911$20240926$20240926$EXP$$GB-BAXTER-2024BAX024649$BAXTER$$$$$M$Y$$$20240926$$CN$GB$GB
243672352$24367235$2$F$20240901$20240923$20240926$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015317$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240930$$CN$US$US
243672361$24367236$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014739$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240926$$CN$US$US
243672371$24367237$1$I$20240604$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015607$ELI LILLY AND CO$$$$$$Y$$$20240926$$CN$US$US
243672381$24367238$1$I$$20240925$20240926$20240926$PER$$US-GILEAD-2024-0688919$GILEAD$$23$YR$A$$Y$$$20240926$$PH$US$US
243672391$24367239$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014798$ELI LILLY AND CO$$41$YR$A$$Y$$$20240926$$CN$US$US
243672401$24367240$1$I$$20240912$20240926$20240926$EXP$$US-SMPA-2024SPA001385$SUNOVION$$$$$$Y$$$20240926$$CN$US$US
243672421$24367242$1$I$$20240918$20240926$20240926$PER$$US-ABBVIE-5929867$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243672431$24367243$1$I$20240901$20240923$20240926$20240926$PER$$US-BIOGEN-2024BI01283841$BIOGEN$$57$YR$$F$Y$$$20240926$$CN$US$US
243672441$24367244$1$I$$20240905$20240926$20240926$PER$$US-B.Braun Medical Inc.-2162097$B BRAUN$$78$YR$$F$Y$75$KG$20240926$$$US$US
243672451$24367245$1$I$$20240916$20240926$20240926$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK094177$GLENMARK$$$$$$Y$$$20240926$$HP$US$US
243672461$24367246$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114986$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243672471$24367247$1$I$20240916$20240916$20240926$20240926$EXP$$US-GSK-US2024114981$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
243672481$24367248$1$I$20240801$20240916$20240926$20240926$EXP$$US-UCBSA-2024046988$UCB$$72$YR$$F$Y$$$20240926$$CN$US$US
243672491$24367249$1$I$$20240924$20240926$20240926$EXP$$NVSC2024CA190900$NOVARTIS$$$$$M$Y$$$20240926$$MD$CA$CA
243672501$24367250$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245124$TEVA$$70$YR$$F$Y$$$20240926$$HP$CA$CA
243672511$24367251$1$I$$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189326$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243672521$24367252$1$I$$20240925$20240925$20240925$DIR$719947$$FDA-CTU$$$$$UNK$N$$$20240925$N$CN$US$
243672531$24367253$1$I$20240513$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-66035$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243672541$24367254$1$I$$20240924$20240926$20240926$EXP$$GB-TEVA-VS-3247258$TEVA$$40$YR$$F$Y$126$KG$20240926$$MD$GB$GB
243672551$24367255$1$I$20240101$20240920$20240926$20240926$PER$$US-AMGEN-USASP2024189229$AMGEN$$$$$F$Y$$$20240926$$MD$US$US
243672561$24367256$1$I$20220801$20240918$20240926$20240926$EXP$$AR-AMGEN-ARGSP2022153769$AMGEN$$69$YR$E$F$Y$$$20240926$$CN$AR$AR
243672571$24367257$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152475$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240926$$CN$US$US
243672581$24367258$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152712$BRISTOL MYERS SQUIBB$$14$YR$T$M$Y$$$20240926$$HP$US$US
243672591$24367259$1$I$20240905$20240922$20240926$20240926$EXP$$GB-AMGEN-GBRSP2024189155$AMGEN$$72$YR$E$F$Y$$$20240926$$CN$GB$GB
243672611$24367261$1$I$20240807$20240918$20240926$20240926$EXP$$GB-JNJFOC-20240965934$JOHNSON AND JOHNSON$$61$YR$A$M$Y$80.3$KG$20240926$$HP$GB$GB
243672631$24367263$1$I$20240922$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190685$AMGEN$$69$YR$E$M$Y$$$20240926$$CN$US$US
243672641$24367264$1$I$$20240917$20240926$20240926$PER$$US-RDY-SPO/USA/24/0013887$DR REDDYS$$75$YR$E$F$Y$$$20240926$$CN$US$US
243672651$24367265$1$I$$20240920$20240926$20240926$PER$$JP-Eisai-EC-2024-175187$EISAI$Junichi Aratake et al.. [Original Article] Does the number of prior regimens affect treatment response in combination therapy with lenvatinib and pembrolizumab for advanced recurrent endometrial cancer?  - A single-center experience with 21 patients -. Advances in Obstetrics and Gynecology. 2024; 76(3): 222-228.$$$$F$Y$$$20240926$$MD$JP$JP
243672671$24367267$1$I$20240704$20240918$20240926$20240926$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000976$PAREXEL$$$$$$Y$$$20240926$$HP$CN$CN
243672681$24367268$1$I$$20240925$20240926$20240926$EXP$$IL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053581$BOEHRINGER INGELHEIM$$50$YR$A$F$Y$$$20240926$$MD$IL$IL
243672691$24367269$1$I$20230801$20240924$20240926$20240926$PER$$RU-Eisai-EC-2024-175333$EISAI$$46$YR$A$M$Y$$$20240926$$MD$RU$RU
243672701$24367270$1$I$20240801$20240926$20240926$20240926$EXP$$MA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053626$BOEHRINGER INGELHEIM$$$$E$F$Y$$$20240926$$HP$MA$MA
243672711$24367271$1$I$$20240215$20240926$20240926$PER$$US-TEVA-VS-3159042$TEVA$$$$$F$Y$$$20240926$$CN$US$US
243672721$24367272$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66094$$FDA-CTU$$58$YR$$F$N$94.35$KG$20240926$N$$US$
243672731$24367273$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66090$$FDA-CTU$$48$YR$$F$N$$$20240926$N$$US$
243672741$24367274$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66098$$FDA-CTU$$54$YR$$F$N$318$LBS$20240926$N$$US$
243672751$24367275$1$I$19940114$20240925$20240925$20240925$DIR$719924$$FDA-CTU$$$$$F$N$62.55$KG$20240925$Y$CN$US$
243672761$24367276$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66101$$FDA-CTU$$25$YR$$M$N$$$20240926$N$$US$
243672791$24367279$1$I$20240924$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-66038$$FDA-CTU$$$$$$N$$$20240924$N$CN$US$
243672812$24367281$2$F$20240924$20240926$20240926$20240930$PER$$US-AMGEN-USASP2024191209$AMGEN$$60$YR$A$F$Y$$$20240930$$CN$US$US
243672821$24367282$1$I$20240803$20240925$20240926$20240926$EXP$$NVSC2024EG190926$NOVARTIS$$25$YR$$M$Y$53$KG$20240926$$CN$EG$EG
243672833$24367283$3$F$20240801$20240918$20240926$20240930$PER$$US-ASTELLAS-2024-AER-007875$ASTELLAS$$58$YR$A$F$Y$$$20240930$$CN$US$US
243672841$24367284$1$I$20240924$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190853$AMGEN$$72$YR$E$F$Y$$$20240926$$CN$US$US
243672851$24367285$1$I$$20240920$20240926$20240926$PER$$US-AMGEN-USASP2024188838$AMGEN$$$$$M$Y$$$20240926$$PH$US$US
243672861$24367286$1$I$$20240921$20240926$20240926$EXP$$US-AMGEN-USASP2024189138$AMGEN$$$$$F$Y$$$20240926$$HP$US$US
243672872$24367287$2$F$20240101$20240924$20240926$20240930$PER$$US-AMGEN-USASP2024189390$AMGEN$$63$YR$A$M$Y$$$20240930$$PH$US$US
243672881$24367288$1$I$$20240912$20240926$20240926$EXP$$DE-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2409DE07134$INSUD PHARMA$$$$$F$Y$$$20240926$$MD$DE$DE
243672901$24367290$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66095$$FDA-CTU$$40$YR$$F$N$71.67$KG$20240926$N$PH$US$
243672921$24367292$1$I$$20240919$20240926$20240926$30DAY$$US-PFIZER INC-202400264553$PFIZER$$$$$$Y$$$20240926$$CN$US$US
243672951$24367295$1$I$$20240913$20240926$20240926$30DAY$$GB-PFIZER INC-PV202400120469$PFIZER$$79$YR$$M$Y$$$20240926$$CN$GB$GB
243672961$24367296$1$I$20240921$20240923$20240926$20240926$30DAY$$KR-PFIZER INC-PV202400124433$PFIZER$$11$YR$$M$Y$$$20240926$$CN$KR$KR
243672971$24367297$1$I$$20240923$20240926$20240926$30DAY$$US-PFIZER INC-202400261922$PFIZER$$64$YR$$F$Y$$$20240926$$CN$US$US
243673001$24367300$1$I$20240917$20240925$20240925$20240925$DIR$719929$$FDA-CTU$$64$YR$$M$N$112.1$KG$20240925$N$PH$US$
243673011$24367301$1$I$$20240919$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150640$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$CN$US$US
243673021$24367302$1$I$20240922$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152730$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$$$20240926$$HP$US$US
243673031$24367303$1$I$$20240923$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152208$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240926$$CN$US$US
243673041$24367304$1$I$$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150887$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$PH$US$US
243673051$24367305$1$I$20240907$20240924$20240926$20240926$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-151636$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$84$KG$20240926$$MD$DE$DE
243673061$24367306$1$I$$20240923$20240926$20240926$PER$$US-ABBVIE-5938842$ABBVIE$$$$$$Y$$$20240926$$HP$US$US
243673081$24367308$1$I$$20240919$20240926$20240926$PER$$US-JNJFOC-20240953152$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243673091$24367309$1$I$$20240912$20240926$20240926$PER$$US-JNJFOC-20240932731$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243673111$24367311$1$I$20240708$20240923$20240926$20240926$EXP$$US-KYOWAKIRIN-2024KK021976$KYOWA$$$$$$Y$$$20240926$$HP$US$US
243673121$24367312$1$I$$20240905$20240926$20240926$PER$$US-B.Braun Medical Inc.-2162098$B BRAUN$$71$YR$$F$Y$95.455$KG$20240926$$$US$US
243673131$24367313$1$I$$20240919$20240926$20240926$EXP$$CA-GSK-CA2024116975$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CA$CA
243673141$24367314$1$I$20231201$20240919$20240926$20240926$EXP$$CA-GSK-CA2023169577$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$CA$CA
243673161$24367316$1$I$$20240910$20240926$20240926$30DAY$$US-PFIZER INC-202400254052$PFIZER$$$$$$Y$$$20240926$$CN$US$US
243673171$24367317$1$I$$20240916$20240926$20240926$30DAY$$GB-PFIZER INC-PV202400121269$PFIZER$$42$YR$$M$Y$$$20240926$$CN$GB$GB
243673181$24367318$1$I$20240401$20240919$20240926$20240926$EXP$$US-GSK-US2024116613$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
243673202$24367320$2$F$20240911$20240926$20240926$20240927$PER$$US-AMGEN-USASP2024191439$AMGEN$$68$YR$E$F$Y$$$20240927$$CN$US$US
243673221$24367322$1$I$20240921$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024191133$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243673231$24367323$1$I$$20240918$20240926$20240926$EXP$$CN-AMGEN-CHNSP2024186953$AMGEN$Wang F.. Intravenous immunoglobulin improves live birth rates in patients with unexplained recurrent pregnancy loss. Journal of Reproductive Immunology. 2024;166:1-7$$$$$Y$$$20240926$$HP$CN$CN
243673241$24367324$1$I$$20240917$20240926$20240926$PER$$US-RDY-SPO/USA/24/0013820$DR REDDYS$$33$YR$A$M$Y$$$20240926$$MD$US$US
243673251$24367325$1$I$20240917$20240917$20240926$20240926$EXP$$US-RDY-SPO/USA/24/0013825$DR REDDYS$$40$YR$A$F$Y$$$20240926$$HP$US$US
243673261$24367326$1$I$$20240917$20240926$20240926$EXP$$US-RDY-SPO/USA/24/0013988$DR REDDYS$$82$YR$E$F$Y$$$20240926$$MD$US$US
243673271$24367327$1$I$$20240917$20240926$20240926$EXP$$FR-RDY-SPO/FRA/24/0013992$DR REDDYS$Sakhi H, Reverdito G, Soulat G, Mousseaux E. Cardiovascular magnetic resonance in the identification of extra-cardiac causes of myocarditis: a case series. European Heart Journal -Case Reports. 2024 May 01;8(5): 1-5. doi:10.1093/ehjcr/ytae232.$54$YR$A$F$Y$$$20240926$$HP$FR$FR
243673281$24367328$1$I$20240901$20240919$20240926$20240926$PER$$US-JNJFOC-20240953419$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240926$$CN$US$US
243673291$24367329$1$I$$20240917$20240926$20240926$EXP$$US-RDY-SPO/USA/24/0013877$DR REDDYS$Taylor E, Wershba E. Rash, Pedal Edema, and Severe Anemia in a 17-year-old Male. Pediatrics in Review. 2024 Aug 01;8(45): 472-475. doi:10.1542/pir.2022-005667.$17$YR$T$M$Y$$$20240926$$MD$US$US
243673311$24367331$1$I$20240923$20240923$20240926$20240926$EXP$$US-AMGEN-USASP2024189667$AMGEN$$77$YR$E$M$Y$$$20240926$$CN$US$US
243673331$24367333$1$I$$20240919$20240926$20240926$PER$$US-ROCHE-10000086591$ROCHE$Nauffal M, Eng S, Lin A, Chan A, Mazzerella K, Giralt S, et al. Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation. Case Reports in Hematology. 2024-Jan;2024:1-4. doi:10.1155/2024/5790011.$75$YR$E$F$Y$$$20240926$$HP$US$US
243673341$24367334$1$I$$20240919$20240926$20240926$PER$$US-AMGEN-USASP2024188222$AMGEN$$$$$F$Y$$$20240926$$MD$US$US
243673351$24367335$1$I$20240911$20240920$20240926$20240926$EXP$$CN-AMGEN-CHNSP2024190208$AMGEN$$47$YR$A$F$Y$52$KG$20240926$$HP$CN$CN
243673361$24367336$1$I$$20240919$20240926$20240926$EXP$$IT-AMGEN-ITASP2024187452$AMGEN$$$$A$F$Y$$$20240926$$MD$IT$IT
243673381$24367338$1$I$$20240923$20240926$20240926$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001941$BLUEPRINT MEDICINES$$$$$F$Y$$$20240926$$CN$US$US
243673391$24367339$1$I$20230101$20240920$20240926$20240926$EXP$$BG-AMGEN-BGRSP2024188619$AMGEN$$77$YR$E$M$Y$$$20240926$$MD$BG$BG
243673401$24367340$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024191018$AMGEN$$$$$$Y$$$20240926$$HP$US$US
243673411$24367341$1$I$20240827$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024190112$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243673421$24367342$1$I$20240924$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190656$AMGEN$$66$YR$E$F$Y$$$20240926$$CN$US$US
243673431$24367343$1$I$$20240918$20240926$20240926$EXP$$DK-AMGEN-DNKSP2024186815$AMGEN$$80$YR$E$F$Y$$$20240926$$MD$DK$DK
243673451$24367345$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66114$$FDA-CTU$$69$YR$$M$N$$$20240926$N$$US$
243673471$24367347$1$I$20240505$20240925$20240925$20240925$DIR$719989$$FDA-CTU$$16$YR$$F$N$65.25$KG$20240925$N$CN$US$
243673481$24367348$1$I$20200101$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189842$AMGEN$$91$YR$E$F$Y$$$20240926$$CN$US$US
243673491$24367349$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152757$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240926$$HP$US$US
243673511$24367351$1$I$$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150785$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240926$$HP$US$US
243673521$24367352$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66117$$FDA-CTU$$54$YR$$F$N$$$20240926$N$$US$
243673531$24367353$1$I$$20240812$20240926$20240926$DIR$FDA-CDER-CTU-2024-66116$$FDA-CTU$$$$$M$N$$$20240812$N$HP$US$
243673541$24367354$1$I$20240909$20240925$20240925$20240925$DIR$720011$$FDA-CTU$$36$YR$$F$N$$$20240925$N$CN$US$
243673551$24367355$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006931$BIOCON$$$$$$Y$$$20240926$$HP$CA$CA
243673561$24367356$1$I$$20240923$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151577$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$54.43$KG$20240926$$CN$US$US
243673591$24367359$1$I$$20240918$20240926$20240926$PER$$US-INCYTE CORPORATION-2024IN009921$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243673601$24367360$1$I$20240907$20240917$20240926$20240926$EXP$$EG-GE HEALTHCARE-2024CSU010853$GE HEALTHCARE$$$$$F$Y$$$20240926$$HP$EG$EG
243673611$24367361$1$I$$20240918$20240926$20240926$PER$$US-INCYTE CORPORATION-2024IN009928$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243673621$24367362$1$I$$20240924$20240926$20240926$EXP$$JP-BAYER-2024A136886$BAYER$$$$$M$Y$$$20240926$$MD$JP$JP
243673631$24367363$1$I$$20240919$20240926$20240926$EXP$$BR-TAKEDA-2023TUS054978$TAKEDA$$$$$F$Y$$$20240926$$MD$BR$BR
243673651$24367365$1$I$$20240919$20240926$20240926$EXP$$CA-AMGEN-CANSL2024187598$AMGEN$$$$$M$Y$$$20240926$$CN$CA$CA
243673661$24367366$1$I$20240919$20240920$20240926$20240926$PER$$US-ROCHE-10000087522$ROCHE$$64$YR$A$M$Y$$$20240926$$CN$US$US
243673671$24367367$1$I$$20240924$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2023US001776$SANDOZ$$$$$$Y$$$20240926$$CN$US$US
243673681$24367368$1$I$20240923$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189425$AMGEN$$78$YR$E$F$Y$$$20240926$$CN$US$US
243673701$24367370$1$I$$20240917$20240926$20240926$PER$$US-JNJFOC-20240944681$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$HP$US$US
243673711$24367371$1$I$20211001$20240917$20240926$20240926$EXP$$DE-AMGEN-DEUSP2024186558$AMGEN$Schaefers C.. BCMA x CD3 T-cell engager in a patient with penta-refractory multiple myeloma and HIV: a clinical and immunological report. Haematologica. 2024;109 (9):3071-3077$54$YR$A$M$Y$$$20240926$$HP$DE$DE
243673721$24367372$1$I$$20240923$20240926$20240926$EXP$$BR-BAYER-2024A137264$BAYER$$67$YR$E$M$Y$$$20240926$$CN$BR$BR
243673741$24367374$1$I$$20240918$20240926$20240926$PER$$US-AMGEN-USASP2024186949$AMGEN$$$$$M$Y$$$20240926$$HP$US$US
243673761$24367376$1$I$20240919$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190338$AMGEN$$68$YR$E$F$Y$$$20240926$$CN$US$US
243673771$24367377$1$I$$20240918$20240926$20240926$EXP$$TW-AMGEN-TWNSP2024188975$AMGEN$$70$YR$E$F$Y$$$20240926$$HP$TW$TW
243673781$24367378$1$I$20240821$20240912$20240926$20240926$30DAY$$US-AMGEN-USASP2024183348$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243673791$24367379$1$I$20240916$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190230$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243673801$24367380$1$I$$20240905$20240926$20240926$PER$$US-B.Braun Medical Inc.-2162100$B BRAUN$$79$YR$$F$Y$67.727$KG$20240926$$$US$US
243673811$24367381$1$I$20240907$20240923$20240926$20240926$30DAY$$US-AMGEN-USASP2024189929$AMGEN$$67$YR$E$F$Y$68.9$KG$20240926$$HP$US$US
243673821$24367382$1$I$20240901$20240923$20240926$20240926$30DAY$$US-AMGEN-USASP2024189939$AMGEN$$75$YR$E$F$Y$92$KG$20240926$$HP$US$US
243673831$24367383$1$I$20240920$20240923$20240926$20240926$30DAY$$US-AMGEN-USASP2024190015$AMGEN$$65$YR$E$F$Y$56.88$KG$20240926$$PH$US$US
243673841$24367384$1$I$$20240924$20240926$20240926$EXP$$JP-BAYER-2024A136888$BAYER$$$$$M$Y$$$20240926$$MD$JP$JP
243673851$24367385$1$I$$20240925$20240926$20240926$EXP$$NVSC2024ZA190679$NOVARTIS$$$$$M$Y$$$20240926$$CN$ZA$ZA
243673861$24367386$1$I$20190715$20240919$20240926$20240926$EXP$$CA-TAKEDA-2018TUS025661$TAKEDA$$73$YR$$F$Y$$$20240926$$CN$CA$CA
243673881$24367388$1$I$$20240924$20240926$20240926$EXP$$JP-BAYER-2024A136890$BAYER$$$$$M$Y$$$20240926$$MD$JP$JP
243673901$24367390$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66119$$FDA-CTU$$62$YR$$F$N$162$LBS$20240926$N$$US$
243673911$24367391$1$I$20240923$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024191090$AMGEN$$88$YR$E$M$Y$$$20240926$$CN$US$US
243673921$24367392$1$I$20240906$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190177$AMGEN$$50$YR$A$M$Y$$$20240926$$CN$US$US
243673931$24367393$1$I$$20240919$20240926$20240926$30DAY$$US-AMGEN-USASP2024188045$AMGEN$$$$$$Y$$$20240926$$PH$US$US
243673941$24367394$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66088$$FDA-CTU$$74$YR$$M$N$$$20240926$N$$US$
243673951$24367395$1$I$20240919$20240919$20240926$20240926$30DAY$$US-AMGEN-USASP2024187809$AMGEN$$81$YR$E$M$Y$93.5$KG$20240926$$PH$US$US
243673961$24367396$1$I$20240924$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191446$AMGEN$$$$$$Y$$$20240926$$HP$US$US
243673971$24367397$1$I$20240827$20240904$20240926$20240926$PER$$US-Eisai-EC-2024-173823$EISAI$$70$YR$E$M$Y$$$20240926$$CN$US$US
243673981$24367398$1$I$$20240923$20240926$20240926$EXP$RO-AMGEN-ROUSP2024180899$RO-Taiho Oncology Inc-2024-008982$TAIHO ONCOLOGY INC$$59$YR$A$$Y$$$20240926$$MD$RO$RO
243673991$24367399$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000090894$ROCHE$$$$A$M$Y$$$20240926$$CN$US$US
243674001$24367400$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000090494$ROCHE$$45$YR$A$$Y$$$20240926$$CN$US$US
243674011$24367401$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000090906$ROCHE$$$$A$F$Y$$$20240926$$CN$US$US
243674021$24367402$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000090530$ROCHE$$$$A$M$Y$$$20240926$$CN$US$US
243674031$24367403$1$I$$20240924$20240926$20240926$PER$$US-ROCHE-10000090740$ROCHE$$$$A$M$Y$$$20240926$$CN$US$US
243674041$24367404$1$I$$20240917$20240926$20240926$EXP$$CA-ROCHE-10000084347$ROCHE$$$$$$Y$$$20240926$$CN$CA$CA
243674051$24367405$1$I$$20240925$20240926$20240926$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053529$BOEHRINGER INGELHEIM$$84$YR$E$F$Y$$$20240926$$MD$JP$JP
243674071$24367407$1$I$20240914$20240926$20240926$20240926$DIR$720017$$FDA-CTU$$38$WK$$F$N$$$20240926$N$CN$CA$
243674081$24367408$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-66037$$FDA-CTU$$$$$$N$$$20240924$$CN$US$
243674091$24367409$1$I$20240817$20240925$20240925$20240925$DIR$719923$$FDA-CTU$$53$YR$$F$N$76.5$KG$20240925$N$CN$US$
243674101$24367410$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-66044$$FDA-CTU$$$$$$N$$$20240924$N$PH$US$
243674121$24367412$1$I$$20240919$20240926$20240926$PER$$US-GSK-US2024116432$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243674131$24367413$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190663$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243674141$24367414$1$I$20240923$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190671$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243674151$24367415$1$I$20240904$20240916$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152783$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$105$KG$20240926$$PH$US$US
243674161$24367416$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152718$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240926$$CN$US$US
243674171$24367417$1$I$20240923$20240924$20240926$20240926$PER$$NVSC2024US191672$NOVARTIS$$46$YR$$$Y$$$20240926$$HP$US$US
243674181$24367418$1$I$$20240924$20240926$20240926$EXP$$JP-ASTELLAS-2023JP004485$ASTELLAS$$$$E$$Y$$$20240926$$MD$JP$JP
243674201$24367420$1$I$$20240925$20240926$20240926$PER$$US-ROCHE-10000091786$ROCHE$$$$A$M$Y$$$20240926$$CN$US$US
243674211$24367421$1$I$20240817$20240923$20240926$20240926$EXP$$ES-009507513-2409ESP004363$MERCK$$68$YR$$M$Y$90.6$KG$20240926$$HP$ES$ES
243674221$24367422$1$I$20190227$20240919$20240926$20240926$EXP$$CA-TAKEDA-2019TUS000098$TAKEDA$$26$YR$$M$Y$$$20240926$$CN$CA$CA
243674231$24367423$1$I$20190601$20240924$20240926$20240926$EXP$$US-TAKEDA-US201921460$TAKEDA$$63$YR$$F$Y$97.506$KG$20240926$$HP$US$US
243674241$24367424$1$I$$20240910$20240926$20240926$30DAY$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03350$AMNEAL$$$$$$Y$$$20240926$$PH$US$US
243674251$24367425$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191538$NOVARTIS$$$$$$Y$$$20240926$$MD$US$US
243674271$24367427$1$I$$20240918$20240926$20240926$EXP$$JP-AMGEN-JPNSP2024188729$AMGEN$$$$$F$Y$$$20240926$$CN$JP$JP
243674281$24367428$1$I$20240919$20240920$20240926$20240926$30DAY$$US-AMGEN-USASP2024188796$AMGEN$$28$YR$A$F$Y$70.748$KG$20240926$$PH$US$US
243674291$24367429$1$I$$20240911$20240926$20240926$EXP$$US-SA-2024SA278513$SANOFI AVENTIS$$30$YR$A$F$Y$123.81$KG$20240926$$MD$US$US
243674301$24367430$1$I$$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189377$AMGEN$$$$$M$Y$$$20240926$$CN$US$US
243674322$24367432$2$F$20240924$20240927$20240926$20240928$PER$$US-AMGEN-USASP2024190192$AMGEN$$77$YR$E$M$Y$$$20240928$$CN$US$US
243674331$24367433$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005390$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243674351$24367435$1$I$$20240923$20240926$20240926$PER$$US-JNJFOC-20240962816$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243674361$24367436$1$I$20240922$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190504$AMGEN$$66$YR$E$M$Y$$$20240926$$CN$US$US
243674371$24367437$1$I$20240923$20240923$20240926$20240926$EXP$$US-PFIZER INC-202400261966$PFIZER$$6$DEC$$$Y$$$20240926$$CN$US$US
243674381$24367438$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-2019SGN02521$PFIZER$$35$YR$$F$Y$$$20240926$$HP$US$US
243674391$24367439$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-66029$$FDA-CTU$$$$$$N$$$20240924$N$$US$
243674401$24367440$1$I$$20240924$20240924$20240924$DIR$FDA-CDER-CTU-2024-66051$$FDA-CTU$$$$$$N$$$20240924$$CN$US$
243674422$24367442$2$F$$20240924$20240926$20240930$EXP$$US-PFIZER INC-202400261227$PFIZER$Romero, K.. Creatine Kinase Surge: Levetiracetam-Induced Rhabdomyolysis. Cureus. 2024;16(8):10.7759/cureus.66715$27$YR$$M$Y$$$20240930$$MD$US$US
243674432$24367443$2$F$20230901$20240926$20240926$20240930$EXP$$US-PFIZER INC-PV202400124621$PFIZER$$15$YR$$F$Y$$$20240930$$MD$US$US
243674441$24367444$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-PV202400124210$PFIZER$Usman, S.. A FATAL CASE OF MALIGNANT HYPERTHERMIA AFTER INTUBATION WITH ROCURONIUM. Chest. 2024;166(4 Supple):A3153-A3154$47$YR$$M$Y$$$20240926$$HP$US$US
243674451$24367445$1$I$$20240925$20240926$20240926$EXP$$HU-PFIZER INC-202400263506$PFIZER$$63$YR$$$Y$$$20240926$$MD$HU$HU
243674461$24367446$1$I$20240101$20240924$20240926$20240926$EXP$$DE-PFIZER INC-202400241626$PFIZER$$66$YR$$M$Y$$$20240926$$MD$DE$DE
243674481$24367448$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-202400262295$PFIZER$$$$A$F$Y$$$20240926$$HP$US$US
243674501$24367450$1$I$20240101$20240924$20240926$20240926$EXP$$US-PFIZER INC-PV202400125084$PFIZER$$72$YR$$F$Y$$$20240926$$HP$US$US
243674511$24367451$1$I$20240913$20240923$20240926$20240926$EXP$GR-GREOF-202401035$GR-PFIZER INC-202400261297$PFIZER$$85$YR$$F$Y$40$KG$20240926$$PH$GR$GR
243674521$24367452$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-PV202400124819$PFIZER$Delgadillo, B.. Left Pubic Symphysis Fracture With Undiagnosed Ipsilateral Femoral Neck Fracture in an Elderly Female With Osteoporosis: A Case Report. Cureus. 2024;16(9):10.7759/cureus.69203$68$YR$$F$Y$$$20240926$$HP$US$US
243674531$24367453$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-PV202400124208$PFIZER$Dhamsania, R.. RARE CASE OF THERAPY-RELATED ACUTE MYELOID LEUKEMIA FROM BREAST CARCINOMA MANAGEMENT WITH PALBOCICLIB. Chest. 2024;166 (4 Supple):4247A-4248A$67$YR$$F$Y$$$20240926$$HP$US$US
243674541$24367454$1$I$20100201$20240920$20240926$20240926$EXP$$GB-PFIZER INC-202400260789$PFIZER$$43$YR$$M$Y$$$20240926$$PH$GB$GB
243674551$24367455$1$I$20231201$20240920$20240926$20240926$EXP$$CA-PFIZER INC-202400049029$PFIZER$$77$YR$$F$Y$$$20240926$$HP$CA$CA
243674561$24367456$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114991$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243674571$24367457$1$I$$20240905$20240926$20240926$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005393$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240926$$CN$US$US
243674581$24367458$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190674$AMGEN$$$$$$Y$$$20240926$$HP$US$US
243674591$24367459$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190672$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243674601$24367460$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190397$AMGEN$$70$YR$E$F$Y$$$20240926$$CN$US$US
243674611$24367461$1$I$$20240920$20240926$20240926$PER$$US-AMGEN-USASP2024188376$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243674621$24367462$1$I$20240201$20240904$20240926$20240926$PER$$US-Eisai-EC-2024-174029$EISAI$$77$YR$E$F$Y$$$20240926$$CN$US$US
243674631$24367463$1$I$20240827$20240904$20240926$20240926$PER$$US-Eisai-EC-2024-173861$EISAI$$64$YR$A$F$Y$$$20240926$$CN$US$US
243674641$24367464$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190990$AMGEN$$$$$$Y$$$20240926$$PH$US$US
243674661$24367466$1$I$20221101$20240918$20240926$20240926$EXP$$CH-JNJFOC-20240967778$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240926$$MD$CH$CH
243674672$24367467$2$F$20240921$20240924$20240926$20240930$PER$$US-AMGEN-USASP2024190353$AMGEN$$5$YR$C$M$Y$24.036$KG$20240930$$PH$US$US
243674681$24367468$1$I$$20240923$20240926$20240926$EXP$$US-AMGEN-USASP2024190549$AMGEN$Chen E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$$$$$Y$$$20240926$$HP$US$US
243674701$24367470$1$I$20040505$20240913$20240926$20240926$EXP$$TW-AMGEN-TWNSP2024188697$AMGEN$$$$E$F$Y$$$20240926$$HP$TW$TW
243674711$24367471$1$I$$20240923$20240926$20240926$EXP$$US-AMGEN-USASP2024190550$AMGEN$Chen E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$$$$$Y$$$20240926$$HP$US$US
243674721$24367472$1$I$20240923$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024190106$AMGEN$$73$YR$E$F$Y$$$20240926$$CN$US$US
243674731$24367473$1$I$$20240923$20240926$20240926$EXP$$US-AMGEN-USASP2024189609$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243674741$24367474$1$I$$20240918$20240926$20240926$EXP$$NVSC2024US129473$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
243674751$24367475$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006962$BIOCON$$$$$$Y$$$20240926$$HP$CA$CA
243674761$24367476$1$I$20240101$20240906$20240926$20240926$PER$$US-TEVA-VS-3241209$TEVA$$$$$M$Y$$$20240926$$CN$US$US
243674771$24367477$1$I$$20240918$20240926$20240926$EXP$$CA-TAKEDA-2024TUS086626$TAKEDA$$$$$M$Y$$$20240926$$MD$CA$CA
243674781$24367478$1$I$20240923$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014159$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240926$$CN$US$US
243674791$24367479$1$I$20240917$20240918$20240926$20240926$EXP$$ES-VANTIVE-2024VAN019860$Vantive US Healthcare$$62$YR$$M$Y$$$20240926$$HP$ES$ES
243674801$24367480$1$I$20240825$20240913$20240926$20240926$EXP$$CH-BAXTER-2024BAX024113$BAXTER$$$$$$Y$$$20240926$$PH$CH$CH
243674811$24367481$1$I$20240101$20240919$20240926$20240926$EXP$$TW-AMGEN-TWNSP2024187928$AMGEN$$70$YR$E$F$Y$$$20240926$$CN$TW$TW
243674831$24367483$1$I$20240901$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024191010$AMGEN$$70$YR$E$F$Y$$$20240926$$CN$US$US
243674841$24367484$1$I$$20240919$20240926$20240926$PER$$US-AMGEN-USASP2024188201$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243674851$24367485$1$I$20240901$20240919$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149662$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$69.85$KG$20240926$$CN$US$US
243674861$24367486$1$I$20240912$20240924$20240926$20240926$PER$$US-BIOGEN-2024BI01284005$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243674871$24367487$1$I$$20240924$20240926$20240926$EXP$$US-GILEAD-2024-0684232$GILEAD$$$$E$F$Y$$$20240926$$CN$US$US
243674881$24367488$1$I$$20240923$20240926$20240926$EXP$$US-KYOWAKIRIN-2024KK021990$KYOWA$$$$$$Y$$$20240926$$HP$US$US
243674891$24367489$1$I$20240901$20240917$20240926$20240926$PER$$US-VIIV HEALTHCARE LIMITED-US2024115556$VIIV$$27$YR$$M$Y$$$20240926$$CN$US$US
243674901$24367490$1$I$$20240919$20240926$20240926$EXP$$MX-VIIV HEALTHCARE LIMITED-MX2024AMR111701$VIIV$$$$$$Y$$$20240926$$MD$MX$MX
243674911$24367491$1$I$$20240920$20240926$20240926$PER$$US-Prasco Laboratories-PRAS20241164$PRASCO$$$$$F$Y$$$20240926$$CN$US$US
243674921$24367492$1$I$20240901$20240919$20240926$20240926$EXP$$US-AMGEN-USASP2024187618$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243674931$24367493$1$I$$20240923$20240926$20240926$EXP$$US-AMGEN-USASP2024190551$AMGEN$Chen E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$$$$$Y$$$20240926$$HP$US$US
243674941$24367494$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190879$AMGEN$$$$$$Y$$$20240926$$HP$US$US
243674951$24367495$1$I$$20240923$20240926$20240926$EXP$$US-AMGEN-USASP2024190552$AMGEN$Chen E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$$$$$Y$$$20240926$$HP$US$US
243674971$24367497$1$I$20240901$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191638$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243674981$24367498$1$I$$20240923$20240926$20240926$EXP$$US-AMGEN-USASP2024190553$AMGEN$Chen E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$$$$$Y$$$20240926$$HP$US$US
243674992$24367499$2$F$20240920$20240925$20240926$20240930$PER$$US-AMGEN-USASP2024188830$AMGEN$$62$YR$A$M$Y$3$KG$20240930$$PH$US$US
243675011$24367501$1$I$20240901$20240919$20240926$20240926$EXP$$US-AMGEN-USASP2024187878$AMGEN$$$$$M$Y$$$20240926$$PH$US$US
243675021$24367502$1$I$$20240920$20240926$20240926$PER$$US-AMGEN-USASP2024189529$AMGEN$$69$YR$E$F$Y$$$20240926$$CN$US$US
243675031$24367503$1$I$$20240918$20240926$20240926$EXP$$IL-TAKEDA-2024TUS076755$TAKEDA$$$$$M$Y$$$20240926$$CN$IL$IL
243675042$24367504$2$F$20240201$20240923$20240926$20240930$PER$$US-JNJFOC-20240966904$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240929$$CN$US$US
243675061$24367506$1$I$$20240917$20240926$20240926$EXP$$US-RDY-SPO/USA/24/0013993$DR REDDYS$Smith CN, Eisenschenk S, Wang Y. Tiagabine-induced encephalopathy suppressed by vagus nerve stimulation: A case report. Epilepsy and Behavior Reports. 2024;(28): doi:10.1016/j.ebr.2024.100709.$27$YR$A$M$Y$$$20240926$$HP$US$US
243675071$24367507$1$I$20240925$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191537$AMGEN$$$$$$Y$$$20240926$$PH$US$US
243675091$24367509$1$I$$20240924$20240926$20240926$EXP$$US-Taiho Oncology Inc-2024-008984$TAIHO ONCOLOGY INC$$41$YR$A$F$Y$$$20240926$$CN$US$US
243675101$24367510$1$I$20240101$20240912$20240926$20240926$EXP$$US-MALLINCKRODT-MNK202405490$MALLINCKRODT$$57$YR$A$F$Y$191$KG$20240926$$CN$US$US
243675111$24367511$1$I$20240906$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191536$AMGEN$$70$YR$E$F$Y$$$20240926$$CN$US$US
243675121$24367512$1$I$20240921$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189714$AMGEN$$69$YR$E$M$Y$$$20240926$$CN$US$US
243675131$24367513$1$I$20240828$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190693$AMGEN$$74$YR$E$F$Y$$$20240926$$CN$US$US
243675141$24367514$1$I$$20240921$20240926$20240926$EXP$$US-AMGEN-USASP2024189456$AMGEN$Klein A.L.; Majid M.; Rosenzveig A. et al.. Long-Standing Chronic Recurrent Pericarditis Managed With Advanced Diagnostic and Therapeutic Methods. JACC: Case Reports. 2024;29 (18):1-3$65$YR$E$F$Y$$$20240926$$MD$US$US
243675161$24367516$1$I$20240922$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190765$AMGEN$$73$YR$E$M$Y$$$20240926$$CN$US$US
243675171$24367517$1$I$20240925$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191843$AMGEN$$75$YR$E$M$Y$$$20240926$$CN$US$US
243675191$24367519$1$I$20240924$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191574$AMGEN$$50$YR$A$F$Y$$$20240926$$CN$US$US
243675201$24367520$1$I$$20240918$20240926$20240926$EXP$$US-AMGEN-USASP2024187638$AMGEN$Luckett K.M.; Hall A.D.; Huaman M.A. et.al. Case Report: Disseminated Tuberculosis After Kidney Transplantation. American journal of tropical medicine and hygiene. 2024;111 (3):535-539$54$YR$A$F$Y$$$20240926$$HP$US$US
243675211$24367521$1$I$$20240916$20240926$20240926$PER$$US-GSK-US2024114961$GLAXOSMITHKLINE$$$$$F$Y$$$20240926$$CN$US$US
243675221$24367522$1$I$20240922$20240925$20240926$20240926$EXP$$PL-GILEAD-2024-0688861$GILEAD$$70$YR$E$M$Y$$$20240926$$HP$PL$PL
243675231$24367523$1$I$20240101$20240919$20240926$20240926$EXP$$US-TEVA-VS-3246750$TEVA$$20$YR$$M$Y$$$20240926$$HP$US$US
243675241$24367524$1$I$$20240828$20240926$20240926$PER$$US-LEX-000464$LEXICON PHARMACEUTICALS$$51$YR$$F$Y$$$20240926$$CN$US$US
243675251$24367525$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024007027$BIOCON$$$$$$Y$$$20240926$$HP$CA$CA
243675271$24367527$1$I$20240925$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191789$AMGEN$$88$YR$E$F$Y$$$20240926$$CN$US$US
243675281$24367528$1$I$20240920$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190920$AMGEN$$59$YR$A$M$Y$$$20240926$$CN$US$US
243675291$24367529$1$I$20230101$20240920$20240926$20240926$EXP$$US-AMGEN-USASP2024189496$AMGEN$Borja-montes O.F.; Toro-pedroza A.; Horton D.D. et.al. MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA POST-RITUXIMAB TBERAPY: A CASE SERIES. European journal of case reports in internal medicine. 2024;11$63$YR$A$M$Y$$$20240926$$HP$US$US
243675301$24367530$1$I$20240909$20240923$20240926$20240926$EXP$ES-AEMPS-1571605$ES-ABBVIE-5934916$ABBVIE$$15$YR$$F$Y$78$KG$20240926$$PH$ES$ES
243675311$24367531$1$I$20190401$20240920$20240926$20240926$EXP$$US-AMGEN-USASP2024189483$AMGEN$Borja-montes O.F.; Toro-pedroza A.; Horton D.D. et.al. MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA POST-RITUXIMAB TBERAPY: A CASE SERIES. European journal of case reports in internal medicine. 2024;11$56$YR$A$M$Y$$$20240926$$HP$US$US
243675322$24367532$2$F$20240101$20240926$20240926$20240927$PER$$US-AMGEN-USASP2024191460$AMGEN$$33$YR$A$F$Y$$$20240926$$HP$US$US
243675341$24367534$1$I$$20240923$20240926$20240926$EXP$$US-JNJFOC-20240964097$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243675352$24367535$2$F$20240917$20240917$20240926$20240930$PER$$US-JNJFOC-20240945702$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240930$$CN$US$US
243675361$24367536$1$I$$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191210$AMGEN$$$$$M$Y$$$20240926$$CN$US$US
243675371$24367537$1$I$20240924$20240925$20240926$20240926$EXP$$US-BAYER-2024A137288$BAYER$$93$YR$E$M$Y$$$20240926$$CN$US$US
243675391$24367539$1$I$$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024191156$AMGEN$$42$YR$A$M$Y$$$20240926$$MD$US$US
243675401$24367540$1$I$$20240916$20240926$20240926$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000193$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240926$$CN$US$US
243675431$24367543$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-PV202400124528$PFIZER$Maiorino, V.. FEMALE WITH CORNELIA DE LANGE SYNDROME AND COMPLICATED HOSPITAL COURSE. Chest. 2024;166(4 Supple):A3067-A3068$20$YR$$F$Y$22$KG$20240926$$HP$US$US
243675451$24367545$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-PV202400124383$PFIZER$Donovan, S.. SIMULTANEOUS DISSEMINATED NOCARDIOSIS AND ASPERGILLOSIS IN AN IMMUNOCOMPROMISED PATIENT. Chest. 2024;166(4 Supplemen:A3028-A3029$38$YR$$M$Y$$$20240926$$HP$US$US
243675461$24367546$1$I$20240901$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152325$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240926$$CN$US$US
243675471$24367547$1$I$20240805$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152816$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240926$$HP$US$US
243675481$24367548$1$I$20240101$20240920$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150544$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240926$$MD$US$US
243675491$24367549$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152853$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240926$$CN$US$US
243675501$24367550$1$I$$20240918$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151994$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240926$$PH$JP$JP
243675511$24367551$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152656$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240926$$HP$US$US
243675521$24367552$1$I$20240101$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191680$AMGEN$$$$$M$Y$$$20240926$$CN$US$US
243675531$24367553$1$I$20240918$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191783$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243675541$24367554$1$I$$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191597$AMGEN$$$$$$Y$$$20240926$$MD$US$US
243675551$24367555$1$I$20240917$20240920$20240926$20240926$EXP$$TW-AMGEN-TWNSP2024190501$AMGEN$$$$A$M$Y$$$20240926$$HP$TW$TW
243675561$24367556$1$I$20240923$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190792$AMGEN$$75$YR$E$F$Y$$$20240926$$CN$US$US
243675571$24367557$1$I$20240101$20240918$20240926$20240926$EXP$$JP-AMGEN-JPNSP2024187050$AMGEN$$$$$$Y$$$20240926$$MD$JP$JP
243675581$24367558$1$I$20240925$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191452$AMGEN$$55$YR$A$M$Y$$$20240926$$CN$US$US
243675591$24367559$1$I$20240926$20240926$20240926$20240926$DIR$720104$$FDA-CTU$$42$YR$$M$N$76.5$KG$20240926$N$HP$US$
243675601$24367560$1$I$20240926$20240926$20240926$20240926$DIR$720133$$FDA-CTU$$76$YR$$UNK$N$$$20240926$N$$US$
243675611$24367561$1$I$$20240920$20240926$20240926$EXP$$GB-ROCHE-10000087971$ROCHE$$$$A$F$Y$87.3$KG$20240926$$MD$GB$GB
243675621$24367562$1$I$20230111$20240924$20240926$20240926$EXP$$ES-GILEAD-2024-0688937$GILEAD$$$$$$Y$$$20240926$$HP$ES$ES
243675631$24367563$1$I$20240507$20240924$20240926$20240926$EXP$$ES-GILEAD-2024-0688941$GILEAD$$$$$$Y$$$20240926$$HP$ES$ES
243675641$24367564$1$I$20240901$20240911$20240926$20240926$PER$$US-JNJFOC-20240936512$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
243675661$24367566$1$I$$20240917$20240926$20240926$EXP$$AU-RDY-SPO/AUS/24/0007548$DR REDDYS$$$$$$Y$$$20240926$$CN$AU$AU
243675671$24367567$1$I$$20240917$20240926$20240926$PER$$US-Eisai-EC-2024-174645$EISAI$$79$YR$E$F$Y$$$20240926$$HP$US$US
243675681$24367568$1$I$20240916$20240925$20240926$20240926$EXP$$US-BAYER-2024A137387$BAYER$$85$YR$E$M$Y$$$20240926$$CN$US$US
243675691$24367569$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024191175$AMGEN$$$$$M$Y$$$20240926$$CN$US$US
243675701$24367570$1$I$20240924$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191602$AMGEN$$77$YR$E$M$Y$$$20240926$$CN$US$US
243675711$24367571$1$I$20240921$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024191112$AMGEN$$60$YR$A$F$Y$$$20240926$$HP$US$US
243675721$24367572$1$I$20240914$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191591$AMGEN$$76$YR$E$M$Y$$$20240926$$CN$US$US
243675751$24367575$1$I$20240911$20240912$20240926$20240926$PER$$US-GSK-US2024AMR113848$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20240926$$CN$US$US
243675761$24367576$1$I$$20240917$20240926$20240926$EXP$$JP-TEVA-VS-3245566$TEVA$$84$YR$$F$Y$$$20240926$$MD$JP$JP
243675771$24367577$1$I$20240925$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152597$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240926$$PH$US$US
243675781$24367578$1$I$20240923$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152821$BRISTOL MYERS SQUIBB$$15$YR$T$M$Y$$$20240926$$HP$US$US
243675791$24367579$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152985$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240926$$CN$US$US
243675801$24367580$1$I$$20240926$20240926$20240926$DIR$720086$$FDA-CTU$$$$$UNK$N$$$20240926$$CN$US$
243675811$24367581$1$I$$20240919$20240926$20240926$EXP$$JP-BAYER-2024A134557$BAYER$$67$YR$E$M$Y$$$20240926$$MD$JP$JP
243675831$24367583$1$I$20240925$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191804$AMGEN$$26$YR$A$F$Y$$$20240926$$CN$US$US
243675841$24367584$1$I$$20240923$20240926$20240926$EXP$$US-AMGEN-USASP2024189872$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243675861$24367586$1$I$$20240926$20240926$20240926$DIR$720132$$FDA-CTU$$$$$UNK$N$$$20240926$$CN$US$
243675872$24367587$2$F$20240924$20240926$20240926$20240927$PER$$US-AMGEN-USASP2024191441$AMGEN$$86$YR$E$F$Y$$$20240927$$CN$US$US
243675881$24367588$1$I$$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191873$AMGEN$$$$$$Y$$$20240926$$PH$US$US
243675891$24367589$1$I$20240101$20240920$20240926$20240926$EXP$$CA-BAUSCH-BL-2024-014288$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240926$$CN$CA$CA
243675901$24367590$1$I$$20240920$20240926$20240926$EXP$$US-BAUSCH-BL-2024-014247$BAUSCH AND LOMB$Malani K, Arkadiy F. Metformin-associated lactic acidosis: a serious complication of a common drug. BMJ case reports. 2024 AUG 30;17(9):. doi:10.1136/bcr-2024-260592$8$DEC$$M$Y$$$20240926$$HP$US$US
243675911$24367591$1$I$20240805$20240918$20240926$20240926$PER$$US-TEVA-VS-3231614$TEVA$$61$YR$$F$Y$$$20240926$$CN$US$US
243675921$24367592$1$I$$20240924$20240926$20240926$EXP$$US-SANDOZ INC.-NVSC2022US185238$SANDOZ$$$$$F$Y$$$20240926$$CN$US$US
243675931$24367593$1$I$$20240905$20240926$20240926$PER$$US-B.Braun Medical Inc.-2162101$B BRAUN$$67$YR$$M$Y$77.273$KG$20240926$$$US$US
243675941$24367594$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190562$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243675961$24367596$1$I$20240923$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189959$AMGEN$$$$$M$Y$$$20240926$$CN$US$US
243675971$24367597$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190518$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243676001$24367600$1$I$$20240925$20240926$20240926$EXP$$ES-GILEAD-2024-0688886$GILEAD$$$$$$Y$$$20240926$$MD$ES$ES
243676011$24367601$1$I$$20240920$20240926$20240926$30DAY$$US-AMGEN-USASP2024188667$AMGEN$$$$$$Y$$$20240926$$PH$US$US
243676021$24367602$1$I$20240917$20240923$20240926$20240926$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-19328$IPSEN$$82$YR$E$F$Y$$$20240926$$CN$CA$CA
243676041$24367604$1$I$20240901$20240919$20240926$20240926$PER$$US-JNJFOC-20240953213$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20240926$$CN$US$US
243676051$24367605$1$I$$20240924$20240926$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE082778$SANDOZ$$$$A$$Y$$$20240926$$HP$DE$DE
243676061$24367606$1$I$20240620$20240913$20240926$20240926$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK094120$GLENMARK$$$$$$Y$$$20240926$$CN$US$US
243676071$24367607$1$I$20240917$20240920$20240926$20240926$EXP$$PT-ROCHE-10000090013$ROCHE$$47$YR$A$F$Y$$$20240926$$MD$PT$PT
243676081$24367608$1$I$20220106$20240918$20240926$20240926$EXP$$US-RDY-SPO/USA/24/0013821$DR REDDYS$$65$YR$E$F$Y$$$20240926$$HP$US$US
243676091$24367609$1$I$20231205$20240922$20240926$20240926$30DAY$$IL-SANDOZ INC.-SDZ2023IL066860$SANDOZ$$13$YR$$F$Y$$$20240926$$CN$IL$IL
243676121$24367612$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006935$BIOCON$$$$$$Y$$$20240926$$HP$CA$CA
243676131$24367613$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001720$ORGANON$$50$YR$$F$Y$$$20240926$$HP$CA$CA
243676141$24367614$1$I$20240925$20240926$20240926$20240926$DIR$720122$$FDA-CTU$$$$$UNK$N$$$20240926$N$CN$US$
243676151$24367615$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006932$BIOCON$$$$$$Y$$$20240926$$HP$CA$CA
243676161$24367616$1$I$20240913$20240925$20240926$20240926$EXP$$JP-BAYER-2024A137431$BAYER$$9$DEC$E$M$Y$$$20240926$$MD$JP$JP
243676171$24367617$1$I$$20240924$20240926$20240926$PER$$CA-REGENERON PHARMACEUTICALS, INC.-2024-089152$REGENERON$$$$$M$Y$$$20240926$$CN$CA$CA
243676211$24367621$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-202400263891$PFIZER$$$$$$Y$$$20240926$$MD$US$US
243676221$24367622$1$I$$20240923$20240926$20240926$PER$$US-PFIZER INC-202400261820$PFIZER$$$$$M$Y$$$20240926$$CN$US$US
243676231$24367623$1$I$$20240925$20240926$20240926$PER$$US-PFIZER INC-PV202400125910$PFIZER$$60$YR$$F$Y$$$20240926$$HP$US$US
243676241$24367624$1$I$$20240925$20240926$20240926$PER$$US-PFIZER INC-202400264036$PFIZER$$62$YR$$F$Y$$$20240926$$CN$US$US
243676251$24367625$1$I$$20240925$20240926$20240926$PER$$US-PFIZER INC-202400209780$PFIZER$$49$YR$$M$Y$$$20240926$$CN$US$US
243676261$24367626$1$I$20240920$20240925$20240926$20240926$PER$$US-PFIZER INC-202400264175$PFIZER$$30$YR$$F$Y$$$20240926$$CN$US$US
243676271$24367627$1$I$$20240924$20240926$20240926$PER$$PR-PFIZER INC-202400263419$PFIZER$$73$YR$$F$Y$$$20240926$$HP$PR$PR
243676291$24367629$1$I$$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400124902$PFIZER$$$$$F$Y$$$20240926$$HP$US$US
243676301$24367630$1$I$$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150345$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240926$$CN$US$US
243676311$24367631$1$I$20240830$20240923$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151523$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240926$$PH$US$US
243676321$24367632$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152427$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240926$$HP$US$US
243676331$24367633$1$I$20240901$20240920$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-015918$JAZZ$$48$YR$$F$Y$$$20240926$$CN$US$US
243676341$24367634$1$I$20240101$20240916$20240926$20240926$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000194$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240926$$CN$US$US
243676351$24367635$1$I$$20240924$20240926$20240926$EXP$$JP-SANDOZ INC.-SDZ2024JP083108$SANDOZ$$$$$$Y$$$20240926$$CN$JP$JP
243676361$24367636$1$I$20240901$20240918$20240926$20240926$PER$$US-ABBVIE-5932294$ABBVIE$$$$A$F$Y$$$20240926$$CN$US$US
243676371$24367637$1$I$$20240918$20240926$20240926$EXP$$US-AMGEN-USASP2024187045$AMGEN$$$$A$$Y$$$20240926$$MD$US$US
243676391$24367639$1$I$20240920$20240924$20240926$20240926$EXP$$IT-ABBVIE-5938974$ABBVIE$$70$YR$$M$Y$$$20240926$$CN$IT$IT
243676401$24367640$1$I$20240820$20240923$20240926$20240926$EXP$$US-ABBVIE-5936725$ABBVIE$$59$YR$$F$Y$$$20240926$$CN$US$US
243676411$24367641$1$I$20240917$20240917$20240926$20240926$PER$$US-JNJFOC-20240945280$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240926$$PH$US$US
243676421$24367642$1$I$20240913$20240917$20240926$20240926$PER$$US-JNJFOC-20240944828$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240926$$CN$US$US
243676431$24367643$1$I$$20240917$20240926$20240926$PER$$US-JNJFOC-20240945372$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243676441$24367644$1$I$$20240916$20240926$20240926$PER$$US-JNJFOC-20240943905$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$HP$US$US
243676451$24367645$1$I$$20240917$20240926$20240926$PER$$US-JNJFOC-20240945067$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243676461$24367646$1$I$$20240924$20240926$20240926$EXP$$NVSC2024US190868$NOVARTIS$$$$$$Y$$$20240926$$MD$US$US
243676471$24367647$1$I$20240826$20240829$20240926$20240926$PER$$US-LEX-000466$LEXICON PHARMACEUTICALS$$68$YR$$F$Y$$$20240926$$CN$US$US
243676481$24367648$1$I$20240101$20240921$20240926$20240926$EXP$$US-PUMA BIOTECHNOLOGY, INC.-2024-PUM-US001276$PUMA$$$$$$Y$$$20240926$$HP$US$US
243676491$24367649$1$I$$20240912$20240926$20240926$30DAY$$JP-JNJFOC-20240954499$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$PH$JP$JP
243676501$24367650$1$I$20240917$20240917$20240926$20240926$PER$$US-JNJFOC-20240945316$JOHNSON AND JOHNSON$$18$YR$A$F$Y$$$20240926$$CN$US$US
243676511$24367651$1$I$$20240923$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2024US082664$SANDOZ$$$$$F$Y$$$20240926$$CN$US$US
243676522$24367652$2$F$$20240927$20240926$20240930$EXP$$US-PFIZER INC-2019SGN00382$PFIZER$$$$$M$Y$$$20240930$$MD$US$US
243676531$24367653$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-2021SGN00060$PFIZER$$7$DEC$$F$Y$$$20240926$$MD$US$US
243676541$24367654$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152694$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240926$$CN$US$US
243676561$24367656$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-PV202400124124$PFIZER$Faizee, F.. THE MYSTERIOUS VISITOR: A CHILLING ENCOUNTER WITH ELIZABETHKINGIA MIRICOLA. Chest. 2024;166(4 Suppl):A1210-A1211$40$YR$$F$Y$$$20240926$$HP$US$US
243676571$24367657$1$I$20240801$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151753$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240926$$HP$US$US
243676581$24367658$1$I$$20240919$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150040$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$PH$US$US
243676591$24367659$1$I$$20240917$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-152164$BRISTOL MYERS SQUIBB$Yokoyama T, et al. Myelodysplastic syndrome with poor glycemic control after azacitidine monotherapy. The 245th Kinki Regional Meeting of the Japanese Society of Internal Medicine.$90$YR$E$M$Y$$$20240926$$HP$JP$JP
243676601$24367660$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152522$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$93.89$KG$20240926$$CN$US$US
243676621$24367662$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016508$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240926$$CN$US$US
243676631$24367663$1$I$20200101$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014462$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240926$$CN$US$US
243676641$24367664$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-PV202400124505$PFIZER$Jarosz, M.. MDA-5 Mediated ILD: Dermatomyositis to Rapidly Progressive Interstitial Lung Disease. Chest. 2024;166(4):A3371-A3372$47$YR$$F$Y$$$20240926$$HP$US$US
243676651$24367665$1$I$20240910$20240919$20240926$20240926$EXP$$US-GSK-US2024116490$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
243676661$24367666$1$I$20231001$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015592$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240926$$CN$US$US
243676671$24367667$1$I$$20240924$20240926$20240926$EXP$$DE-SANDOZ INC.-SDZ2024DE082837$SANDOZ$$$$A$$Y$$$20240926$$HP$DE$DE
243676681$24367668$1$I$20240615$20240926$20240926$20240926$DIR$720023$$FDA-CTU$$53$YR$$F$N$55$KG$20240926$Y$CN$AU$
243676701$24367670$1$I$$20240925$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2023US001932$SANDOZ$$$$$$Y$$$20240926$$CN$US$US
243676711$24367671$1$I$$20240923$20240926$20240926$EXP$$US-INCYTE CORPORATION-2024IN010065$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243676731$24367673$1$I$$20240920$20240926$20240926$EXP$$ZA-ABBVIE-5937774$ABBVIE$$57$YR$$F$Y$$$20240926$$CN$ZA$ZA
243676741$24367674$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006930$BIOCON$$$$$$Y$$$20240926$$HP$CA$CA
243676751$24367675$1$I$$20240923$20240926$20240926$EXP$$US-INCYTE CORPORATION-2024IN010064$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243676761$24367676$1$I$20240814$20240920$20240926$20240926$EXP$$BR-BAYER-2024A119730$BAYER$$$$$F$Y$$$20240926$$CN$BR$BR
243676771$24367677$1$I$20240101$20240918$20240926$20240926$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000197$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240926$$CN$US$US
243676781$24367678$1$I$$20240919$20240926$20240926$PER$$US-INCYTE CORPORATION-2024IN009920$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243676791$24367679$1$I$20240811$20240823$20240926$20240926$PER$$US-FMCRTG-FMC-2408-001076$FRESENIUS MEDICAL CARE$$65$YR$E$F$Y$$$20240926$$HP$US$US
243676812$24367681$2$F$20240921$20240926$20240926$20240927$PER$$US-AMGEN-USASP2024191303$AMGEN$$87$YR$E$F$Y$$$20240927$$HP$US$US
243676821$24367682$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245527$TEVA$$78$YR$$M$Y$93$KG$20240926$$HP$CA$CA
243676831$24367683$1$I$$20240924$20240926$20240926$EXP$$US-JNJFOC-20240967663$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240926$$CN$US$US
243676841$24367684$1$I$20240925$20240926$20240926$20240926$DIR$720115$$FDA-CTU$$58$YR$$M$N$$$20240926$N$PH$US$
243676851$24367685$1$I$$20240925$20240926$20240926$EXP$$IT-SANDOZ INC.-SDZ2024IT082898$SANDOZ$$83$YR$$F$Y$$$20240926$$MD$IT$IT
243676861$24367686$1$I$$20240911$20240926$20240926$EXP$$IN-CMP PHARMA-2024CMP00055$CMP PHARMA$Janapreethi P, Sryma P.B, Subramanian M., Vijay G.. Isoniazid?induced cerebellitis in a patient with renal dysfunction. Lung India.. 2024;41(5):392-393$7$DEC$$F$Y$$$20240926$$HP$IN$IN
243676871$24367687$1$I$$20240924$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2024US083080$SANDOZ$Somu K, Adla Jala SR. Invasive pulmonary aspergilossis in a ost lung transplant patient. chest. 2024;166(4):A1458$52$YR$$M$Y$$$20240926$$HP$US$US
243676891$24367689$1$I$20230822$20240919$20240926$20240926$EXP$$US-GSK-US2024AMR117246$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$US$US
243676901$24367690$1$I$$20240925$20240926$20240926$PER$$US-PFIZER INC-PV202400126072$PFIZER$$54$YR$$M$Y$$$20240926$$HP$US$US
243676911$24367691$1$I$$20240925$20240926$20240926$PER$$US-PFIZER INC-202400264262$PFIZER$$44$YR$$F$Y$77.11$KG$20240926$$CN$US$US
243676921$24367692$1$I$20240822$20240924$20240926$20240926$PER$$US-PFIZER INC-PV202400125103$PFIZER$$58$YR$$F$Y$$$20240926$$HP$US$US
243676931$24367693$1$I$20240922$20240924$20240926$20240926$PER$$US-PFIZER INC-202400262941$PFIZER$$69$YR$$M$Y$$$20240926$$CN$US$US
243676941$24367694$1$I$$20240922$20240926$20240926$PER$$US-PFIZER INC-2021SGN00782$PFIZER$$18$YR$$F$Y$120$KG$20240926$$MD$US$US
243676951$24367695$1$I$$20240923$20240926$20240926$PER$$US-PFIZER INC-PV202400125104$PFIZER$$38$YR$$F$Y$$$20240926$$CN$US$US
243676961$24367696$1$I$$20240925$20240926$20240926$PER$$US-PFIZER INC-202400264584$PFIZER$$54$YR$$M$Y$$$20240926$$CN$US$US
243676971$24367697$1$I$20240910$20240925$20240926$20240926$PER$$US-PFIZER INC-202400264118$PFIZER$$55$YR$$F$Y$$$20240926$$MD$US$US
243676991$24367699$1$I$20240919$20240919$20240926$20240926$PER$$US-PFIZER INC-PV202400124928$PFIZER$$64$YR$$$Y$$$20240926$$HP$US$US
243677001$24367700$1$I$$20240925$20240926$20240926$PER$$US-PFIZER INC-PV202400125857$PFIZER$$71$YR$$F$Y$$$20240926$$HP$US$US
243677011$24367701$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151834$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240926$$CN$US$US
243677021$24367702$1$I$$20240908$20240926$20240926$EXP$$IE-GILEAD-2024-0688003$GILEAD$$69$YR$E$F$Y$$$20240926$$MD$IE$IE
243677031$24367703$1$I$20240915$20240916$20240926$20240926$EXP$$US-BIOGEN-2024BI01283021$BIOGEN$$31$YR$$F$Y$$$20240926$$CN$US$US
243677041$24367704$1$I$$20240918$20240926$20240926$EXP$$CA-PFIZER INC-202400261221$PFIZER$Datta, A.. Developmental and epileptic encephalopathies after successful treatment of pediatric ALL: A case series and review of literature. Epileptic Disorders. 2024;1-10$4$YR$$M$Y$$$20240926$$MD$CA$CA
243677051$24367705$1$I$$20240917$20240926$20240926$EXP$$IL-TAKEDA-2024TUS094022$TAKEDA$$$$$M$Y$$$20240926$$CN$IL$IL
243677061$24367706$1$I$$20240911$20240926$20240926$EXP$$JP-SA-2024SA278259$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240926$$CN$JP$JP
243677071$24367707$1$I$20240101$20240921$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2024US082916$SANDOZ$$$$$$Y$$$20240926$$CN$US$US
243677081$24367708$1$I$$20240919$20240926$20240926$EXP$$CA-TAKEDA-2024TUS094075$TAKEDA$$82$YR$$F$Y$83$KG$20240926$$HP$CA$CA
243677101$24367710$1$I$20240915$20240926$20240926$20240926$DIR$720021$$FDA-CTU$$75$YR$$M$N$85.5$KG$20240926$N$CN$US$
243677121$24367712$1$I$20240926$20240926$20240926$20240926$DIR$720100$$FDA-CTU$$37$YR$$M$N$$$20240926$N$MD$US$
243677131$24367713$1$I$20240904$20240926$20240926$20240926$DIR$720110$$FDA-CTU$$72$YR$$M$N$77$KG$20240926$N$MD$US$
243677151$24367715$1$I$$20240921$20240926$20240926$EXP$$DE-INCYTE CORPORATION-2024IN010178$INCYTE$$$$$$Y$$$20240926$$CN$DE$DE
243677161$24367716$1$I$$20240925$20240926$20240926$EXP$$US-TAKEDA-2024TUS095330$TAKEDA$$$$$$Y$$$20240926$$CN$US$US
243677171$24367717$1$I$$20240923$20240926$20240926$EXP$$US-SHIRE-US201925842$TAKEDA$$$$$F$Y$$$20240926$$HP$US$US
243677181$24367718$1$I$$20240918$20240926$20240926$EXP$$BR-TAKEDA-2023TUS038717$TAKEDA$$$$$M$Y$$$20240926$$CN$BR$BR
243677191$24367719$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960264$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240926$$MD$US$US
243677201$24367720$1$I$20240801$20240902$20240926$20240926$30DAY$$CN-JNJFOC-20240903677$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$CN$CN
243677221$24367722$1$I$20220813$20240925$20240926$20240926$EXP$$CA-SANDOZ INC.-NVSC2022CA071471$SANDOZ$$79$YR$$F$Y$$$20240926$$CN$CA$CA
243677231$24367723$1$I$$20240716$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2024US082378$SANDOZ$$$$$F$Y$102$KG$20240926$$CN$US$US
243677261$24367726$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024007026$BIOCON$$$$$$Y$$$20240926$$CN$CA$CA
243677271$24367727$1$I$$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151399$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240926$$CN$US$US
243677281$24367728$1$I$20240101$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152747$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240926$$PH$US$US
243677291$24367729$1$I$$20240918$20240926$20240926$EXP$$ZA-TAKEDA-2024TUS094254$TAKEDA$$$$$M$Y$$$20240926$$CN$ZA$ZA
243677301$24367730$1$I$20240101$20240919$20240926$20240926$EXP$$US-SA-2024SA276086$SANOFI AVENTIS$$9$YR$C$M$Y$19.09$KG$20240926$$HP$US$US
243677311$24367731$1$I$20240701$20240917$20240926$20240926$EXP$$US-UCBSA-2024047982$UCB$$52$YR$$M$Y$84.399$KG$20240926$$HP$US$US
243677321$24367732$1$I$20240801$20240919$20240926$20240926$EXP$$RU-SA-2024SA277011$SANOFI AVENTIS$$$$E$F$Y$$$20240926$$MD$RU$RU
243677331$24367733$1$I$20230501$20240923$20240926$20240926$EXP$$AR-MYLANLABS-2024M1087194$MYLAN$$16$YR$$F$Y$$$20240926$$MD$AR$AR
243677341$24367734$1$I$20240921$20240926$20240926$20240926$DIR$720118$$FDA-CTU$$64$YR$$F$N$77.6$KG$20240926$N$PH$US$
243677351$24367735$1$I$20240923$20240909$20240926$20240926$PER$$US-Calliditas-2024CAL01644$CALLIDITAS THERAPEUTICS$$39$YR$A$F$Y$$$20240926$$CN$US$US
243677361$24367736$1$I$20240920$20240926$20240926$20240926$DIR$720119$$FDA-CTU$$35$YR$$F$N$118.8$KG$20240926$N$CN$US$
243677371$24367737$1$I$$20240923$20240926$20240926$EXP$$DE-MYLANLABS-2024M1086574$MYLAN$$$$$F$Y$$$20240926$$CN$DE$DE
243677381$24367738$1$I$$20240923$20240926$20240926$EXP$$GB-MYLANLABS-2024M1086526$MYLAN$$$$$M$Y$$$20240926$$HP$GB$GB
243677391$24367739$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5938346$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243677401$24367740$1$I$20240213$20240918$20240926$20240926$EXP$$NZ-TAKEDA-2024TUS095305$TAKEDA$$71$YR$$M$Y$$$20240926$$MD$NZ$NZ
243677411$24367741$1$I$$20240923$20240926$20240926$EXP$$BG-MYLANLABS-2024M1086320$MYLAN$$62$YR$$M$Y$$$20240926$$HP$BG$BG
243677421$24367742$1$I$20240910$20240913$20240926$20240926$PER$$US-BAYER-2024A131556$BAYER$$74$YR$E$M$Y$$$20240926$$CN$US$US
243677431$24367743$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151845$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240926$$HP$US$US
243677441$24367744$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016633$ELI LILLY AND CO$$81$YR$E$F$Y$$$20240926$$CN$US$US
243677451$24367745$1$I$$20240920$20240926$20240926$EXP$$RO-PFIZER INC-202400260502$PFIZER$Tapirdea, A.. Multiple-Focused Analysis of Breast Cancer Late Recurrence - A Case Report and Literature Review. Journal of Medical and Radiation Oncology. 2024;IV(1):45-50$76$YR$$F$Y$$$20240926$$MD$RO$RO
243677461$24367746$1$I$20240501$20240917$20240926$20240926$EXP$FR-IPSEN Group, Research and Development-2024-08158$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-076253$BRISTOL MYERS SQUIBB$$64$YR$E$M$Y$95$KG$20240926$$PH$FR$FR
243677471$24367747$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151633$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240926$$CN$US$US
243677481$24367748$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015329$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240926$$CN$US$US
243677491$24367749$1$I$$20240919$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014078$ELI LILLY AND CO$$$$$$Y$$$20240926$$CN$US$US
243677501$24367750$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015290$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240926$$CN$US$US
243677511$24367751$1$I$20240801$20240919$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409013342$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240926$$CN$US$US
243677521$24367752$1$I$$20240918$20240926$20240926$PER$$US-AMGEN-USASP2024187563$AMGEN$$$$$$Y$$$20240926$$PH$US$US
243677532$24367753$2$F$20240714$20240915$20240926$20240926$PER$$US-GILEAD-2024-0687800$GILEAD$$$$$F$Y$$$20240926$$MD$US$US
243677541$24367754$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190760$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243677551$24367755$1$I$$20240916$20240926$20240926$EXP$$US-TAKEDA-2024TUS092859$TAKEDA$$$$$M$Y$$$20240926$$CN$US$US
243677561$24367756$1$I$$20240924$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2023US003571$SANDOZ$$$$$$Y$$$20240926$$CN$US$US
243677571$24367757$1$I$$20240917$20240926$20240926$EXP$$GB-TAKEDA-2024TUS093618$TAKEDA$$65$YR$$M$Y$$$20240926$$MD$GB$GB
243677591$24367759$1$I$20240925$20240926$20240926$20240926$DIR$720121$$FDA-CTU$$$$$UNK$N$$$20240926$N$CN$US$
243677611$24367761$1$I$20240801$20240919$20240926$20240926$EXP$$CA-KARYOPHARM-2024KPT001583$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240926$$CN$CA$CA
243677621$24367762$1$I$20240916$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190632$AMGEN$$55$YR$A$M$Y$$$20240926$$CN$US$US
243677641$24367764$1$I$$20240919$20240926$20240926$EXP$$US-GSK-US2024116625$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$US$US
243677651$24367765$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3246200$TEVA$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Aliment-Pharmacol-Ther 2024; 60 (6): 787-795.; Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Aliment-Pharmacol-Ther 2024; 60 (6): 787-795.$$$$$Y$$$20240926$$HP$US$US
243677661$24367766$1$I$20240922$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191500$AMGEN$$80$YR$E$F$Y$$$20240926$$CN$US$US
243677671$24367767$1$I$20240923$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190404$AMGEN$$22$YR$A$F$Y$$$20240926$$CN$US$US
243677681$24367768$1$I$20240516$20240926$20240926$20240926$DIR$720123$$FDA-CTU$$38$YR$$F$N$60.75$KG$20240926$Y$CN$US$
243677691$24367769$1$I$20240916$20240926$20240926$20240926$DIR$720130$$FDA-CTU$$55$YR$$F$N$68.85$KG$20240926$Y$CN$US$
243677711$24367771$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-65986$$FDA-CTU$$$$$$N$$$20240926$N$$US$
243677721$24367772$1$I$$20240923$20240926$20240926$EXP$$FR-PURDUE-USA-2024-0312170$PURDUE$$$$$M$Y$$$20240926$$CN$FR$FR
243677731$24367773$1$I$$20240917$20240926$20240926$EXP$$US-PURDUE-USA-2024-0312135$PURDUE$$58$YR$$F$Y$$$20240926$$CN$US$US
243677741$24367774$1$I$20240904$20240916$20240926$20240926$EXP$LU-ALMPS-202404306$LU-TEVA-VS-3243995$TEVA$$49$YR$$F$Y$58.7$KG$20240926$$PH$LU$LU
243677751$24367775$1$I$$20240919$20240926$20240926$EXP$US-MLMSERVICE-20240912-PI190122-00145-1$US-RDY-SPO/USA/24/0013954$DR REDDYS$Gale AM, Nachreiner D, Kumar A, Sell P, Gauguet S. Acute Toxic Cerebellar Leukoencephalopathy in an Eight-Year-Old Child Following Illicit Fentanyl and Cocaine Ingestion: A Case Report of Full Clinical Recovery. Cureus. 2024;16(8):e66573. DOI: 10.7759/cureus.66573.$8$YR$C$$Y$$$20240926$$MD$US$US
243677761$24367776$1$I$20240804$20240918$20240926$20240926$EXP$$AR-JNJFOC-20240952171$JOHNSON AND JOHNSON$$72$YR$E$F$Y$80$KG$20240926$$CN$AR$AR
243677771$24367777$1$I$20110601$20240920$20240926$20240926$EXP$$NVSC2024AU191299$NOVARTIS$$$$$$Y$$$20240926$$MD$AU$AU
243677781$24367778$1$I$$20240923$20240926$20240926$PER$$US-KARYOPHARM-2024KPT001570$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240926$$HP$US$US
243677801$24367780$1$I$20240923$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190657$AMGEN$$79$YR$E$M$Y$$$20240926$$CN$US$US
243677812$24367781$2$F$20240923$20240927$20240926$20240928$PER$$US-AMGEN-USASP2024190872$AMGEN$$71$YR$E$F$Y$$$20240928$$CN$US$US
243677821$24367782$1$I$$20240918$20240926$20240926$EXP$$NVSC2024US114651$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
243677831$24367783$1$I$$20240923$20240926$20240926$EXP$$NVSC2024US191181$NOVARTIS$$$$$F$Y$$$20240926$$CN$US$US
243677841$24367784$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245534$TEVA$$73$YR$$F$Y$$$20240926$$MD$CA$CA
243677851$24367785$1$I$$20240916$20240926$20240926$EXP$$US-TEVA-VS-3246201$TEVA$Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Aliment-Pharmacol-Ther 2024; 60 (6): 787-795.; Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, et al. Clinical characteristics and HLA associations of azithromycin-induced liver injury. Aliment-Pharmacol-Ther 2024; 60 (6): 787-795.$$$C$$Y$$$20240926$$HP$US$US
243677861$24367786$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245155$TEVA$$65$YR$$F$Y$$$20240926$$MD$CA$CA
243677871$24367787$1$I$$20240916$20240926$20240926$EXP$$FR-TEVA-VS-3245955$TEVA$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$26$YR$$M$Y$$$20240926$$HP$FR$FR
243677881$24367788$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245205$TEVA$$$$$$Y$$$20240926$$MD$CA$CA
243677891$24367789$1$I$$20240913$20240926$20240926$PER$$US-ABBVIE-5928086$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243677901$24367790$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245281$TEVA$$$$A$F$Y$$$20240926$$HP$CA$CA
243677911$24367791$1$I$$20240917$20240926$20240926$PER$$US-ABBVIE-5929157$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243677921$24367792$1$I$20240916$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190347$AMGEN$$66$YR$E$M$Y$$$20240926$$CN$US$US
243677931$24367793$1$I$$20240923$20240926$20240926$PER$$US-HALEON-2198679$Haleon PLC$$68$YR$$F$Y$$$20240926$$HP$US$US
243677941$24367794$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245256$TEVA$$$$$F$Y$$$20240926$$HP$CA$CA
243677951$24367795$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245261$TEVA$$89$YR$$F$Y$$$20240926$$HP$CA$CA
243677961$24367796$1$I$$20240813$20240926$20240926$PER$$US-LUNDBECK-DKLU4002895$LUNDBECK$$$$$$Y$$$20240926$$HP$US$US
243677971$24367797$1$I$$20240920$20240926$20240926$PER$$US-AMGEN-USASP2024189481$AMGEN$$$$$$Y$$$20240926$$PH$US$US
243677981$24367798$1$I$20240828$20240912$20240926$20240926$EXP$$DE-BAXTER-2024BAX024677$BAXTER$$$$$$Y$$$20240926$$PH$DE$DE
243678011$24367801$1$I$$20240926$20240926$20240926$DIR$720136$$FDA-CTU$$$$$UNK$N$$$20240926$N$CN$US$
243678031$24367803$1$I$20240913$20240926$20240926$20240926$DIR$720143$$FDA-CTU$$41$YR$$F$N$102.8$KG$20240926$N$PH$US$
243678041$24367804$1$I$20240922$20240926$20240926$20240926$DIR$720145$$FDA-CTU$$58$YR$$M$N$$$20240926$N$PH$US$
243678051$24367805$1$I$20240926$20240926$20240926$20240926$DIR$720144$$FDA-CTU$$74$YR$$F$N$81$KG$20240926$N$CN$US$
243678061$24367806$1$I$20240925$20240926$20240926$20240926$DIR$720146$$FDA-CTU$$28$YR$$F$N$$$20240926$Y$HP$US$
243678071$24367807$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245265$TEVA$$89$YR$$F$Y$$$20240926$$HP$CA$CA
243678081$24367808$1$I$$20240916$20240926$20240926$EXP$$US-RDY-SPO/USA/24/0013989$DR REDDYS$Guy DR, Mizes A, Richardson CT. Rapid response of omalizumab-resistant chronic urticaria to acalabrutinib. JAAD Case Reports. 2024 May;47: 47-49. doi:10.1016/j.jdcr.2024.03.004.$49$YR$A$F$Y$$$20240926$$HP$US$US
243678091$24367809$1$I$20240809$20240919$20240926$20240926$EXP$$CA-TAKEDA-2024TUS093948$TAKEDA$$46$YR$$M$Y$$$20240926$$CN$CA$CA
243678101$24367810$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245520$TEVA$$71$YR$$M$Y$$$20240926$$HP$CA$CA
243678111$24367811$1$I$$20240926$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2023US060099$SANDOZ$$$$$$Y$$$20240926$$CN$US$US
243678121$24367812$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5937463$ABBVIE$Patel A, Noll J, Hivick D, Musse J, Orabella CM, Lanka K. Can guselkumab cause diffuse alveolar hemorrhage in an 84-year-old female with psoriasis? CHEST. 2024;166(4):A3475-A3476.$84$YR$$F$Y$$$20240926$$HP$US$US
243678131$24367813$1$I$20240701$20240920$20240926$20240926$PER$$US-AMGEN-USASP2024188478$AMGEN$$68$YR$E$F$Y$$$20240926$$CN$US$US
243678141$24367814$1$I$$20240916$20240926$20240926$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024006933$BIOCON$$$$$$Y$$$20240926$$HP$CA$CA
243678151$24367815$1$I$20240919$20240920$20240926$20240926$PER$$US-AMGEN-USASP2024188899$AMGEN$$$$$$Y$$$20240926$$HP$US$US
243678181$24367818$1$I$$20240925$20240926$20240926$EXP$$US-PFIZER INC-2022SGN03275$PFIZER$$40$YR$$M$Y$$$20240926$$MD$US$US
243678201$24367820$1$I$$20240925$20240926$20240926$EXP$$US-PFIZER INC-PV202400125748$PFIZER$$61$YR$$F$Y$$$20240926$$HP$US$US
243678211$24367821$1$I$20240910$20240925$20240926$20240926$EXP$$ZA-PFIZER INC-PV202400125498$PFIZER$$70$YR$$M$Y$$$20240926$$CN$ZA$ZA
243678221$24367822$1$I$$20240923$20240926$20240926$EXP$$CA-PFIZER INC-202400263919$PFIZER$$58$YR$$F$Y$62$KG$20240926$$HP$CA$CA
243678231$24367823$1$I$$20240925$20240926$20240926$EXP$$US-PFIZER INC-202400264434$PFIZER$$68$YR$$F$Y$$$20240926$$CN$US$US
243678241$24367824$1$I$$20240923$20240926$20240926$EXP$$BE-PFIZER INC-PV202400124843$PFIZER$Ducobu, J.. Budd-chiari syndrome in a patient with systemic lupus erythematosus. Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine. 1987;42(6):450-456$28$YR$$F$Y$$$20240926$$HP$BE$BE
243678271$24367827$1$I$20240923$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015496$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240926$$CN$US$US
243678281$24367828$1$I$20240919$20240919$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409012318$ELI LILLY AND CO$$$$$M$Y$$$20240926$$CN$US$US
243678291$24367829$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014075$ELI LILLY AND CO$$$$$M$Y$$$20240926$$CN$US$US
243678301$24367830$1$I$20240920$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014079$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240926$$CN$US$US
243678311$24367831$1$I$$20240918$20240926$20240926$EXP$$US-ALXN-202409USA000397US$ALEXION PHARMACEUTICALS$$69$YR$$$Y$$$20240926$$$US$US
243678321$24367832$1$I$20240322$20240920$20240926$20240926$EXP$$NVSC2024US181430$NOVARTIS$$81$YR$$F$Y$71$KG$20240926$$MD$US$US
243678331$24367833$1$I$20130101$20240920$20240926$20240926$EXP$$US-ORGANON-O2409USA001695$ORGANON$$$$$M$Y$$$20240926$$CN$US$US
243678341$24367834$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190730$AMGEN$$$$$$Y$$$20240926$$PH$US$US
243678351$24367835$1$I$$20240923$20240926$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US082415$SANDOZ$$$$$F$Y$$$20240926$$CN$US$US
243678361$24367836$1$I$20240909$20240918$20240926$20240926$PER$$NVSC2024US191500$NOVARTIS$$69$YR$$$Y$$$20240926$$HP$US$US
243678371$24367837$1$I$$20240925$20240926$20240926$EXP$$FR-GILEAD-2024-0688859$GILEAD$$$$$$Y$$$20240926$$MD$FR$FR
243678381$24367838$1$I$$20240921$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2024US082271$SANDOZ$$$$$$Y$$$20240926$$CN$US$US
243678401$24367840$1$I$$20240926$20240926$20240926$DIR$720152$$FDA-CTU$$$$$UNK$N$$$20240926$$CN$US$
243678411$24367841$1$I$$20240918$20240926$20240926$EXP$$US-SAMSUNG BIOEPIS-SB-2024-28668$SAMSUNG BIOEPIS$$30$YR$A$F$Y$$$20240926$$HP$US$US
243678421$24367842$1$I$20230201$20240918$20240926$20240926$EXP$$US-SANDOZ INC.-NVSC2022US278258$SANDOZ$$29$YR$$F$Y$$$20240926$$MD$US$US
243678431$24367843$1$I$20240926$20240926$20240926$20240926$DIR$720142$$FDA-CTU$$22$YR$$F$N$$$20240926$N$$US$
243678441$24367844$1$I$$20240918$20240926$20240926$PER$$US-JNJFOC-20240948921$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$MD$US$US
243678461$24367846$1$I$20240423$20240916$20240926$20240926$EXP$NL-LRB-01003223$NL-PERRIGO-24NL008685$PERRIGO$$72$YR$$M$Y$70$KG$20240926$$PH$NL$NL
243678471$24367847$1$I$20240912$20240916$20240926$20240926$EXP$GB-MHRA-MED-202409140850397650-CRJPK$GB-PERRIGO-24GB008701$PERRIGO$$$$$F$Y$$$20240926$$CN$GB$GB
243678481$24367848$1$I$$20240919$20240926$20240926$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-28844$SAMSUNG BIOEPIS$$$$$M$Y$$$20240926$$CN$CA$CA
243678491$24367849$1$I$20240101$20240917$20240926$20240926$EXP$$NL-PERRIGO-24NL008753$PERRIGO$$$$E$F$Y$58$KG$20240926$$CN$NL$NL
243678501$24367850$1$I$20230101$20240925$20240926$20240926$PER$$US-PFIZER INC-2023SGN09091$PFIZER$$6$DEC$$F$Y$$$20240926$$HP$US$US
243678521$24367852$1$I$$20240920$20240926$20240926$EXP$$NVSC2024DE190698$NOVARTIS$$$$$$Y$$$20240926$$MD$DE$DE
243678531$24367853$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024191191$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243678541$24367854$1$I$$20240919$20240926$20240926$EXP$$ES-TAKEDA-2024TUS093489$TAKEDA$$$$$$Y$$$20240926$$CN$ES$ES
243678561$24367856$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-2023SGN02398$PFIZER$$31$YR$$F$Y$$$20240926$$CN$US$US
243678572$24367857$2$F$20240101$20240924$20240926$20240927$EXP$$US-PFIZER INC-PV202400096516$PFIZER$$84$YR$$M$Y$$$20240927$$HP$US$US
243678581$24367858$1$I$$20240924$20240926$20240926$EXP$$CA-PFIZER INC-202400262917$PFIZER$$65$YR$$F$Y$$$20240926$$MD$CA$CA
243678591$24367859$1$I$$20240924$20240926$20240926$EXP$$US-PFIZER INC-202400263255$PFIZER$$68$YR$$F$Y$$$20240926$$MD$US$US
243678611$24367861$1$I$20240718$20240924$20240926$20240926$EXP$$US-PFIZER INC-202400099126$PFIZER$$74$YR$$M$Y$$$20240926$$HP$US$US
243678621$24367862$1$I$20240823$20240924$20240926$20240926$EXP$$IT-PFIZER INC-202400262693$PFIZER$$54$YR$$F$Y$55$KG$20240926$$HP$IT$IT
243678631$24367863$1$I$$20240917$20240926$20240926$EXP$$CA-PFIZER INC-202300430262$PFIZER$$53$YR$$F$Y$$$20240926$$CN$CA$CA
243678641$24367864$1$I$$20240924$20240926$20240926$EXP$$HU-MYLANLABS-2024M1086661$MYLAN$$60$YR$$M$Y$$$20240926$$MD$HU$HU
243678651$24367865$1$I$20240919$20240920$20240926$20240926$EXP$GB-MHRA-MED-202409201102579480-DSCFR$GB-BIOGEN-2024BI01283683$BIOGEN$$36$YR$$F$Y$$$20240926$$HP$GB$GB
243678661$24367866$1$I$20231101$20240923$20240926$20240926$EXP$$GB-PFIZER INC-202400261887$PFIZER$$75$YR$$F$Y$70$KG$20240926$$MD$GB$GB
243678671$24367867$1$I$20240901$20240923$20240926$20240926$PER$$US-JNJFOC-20240962187$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20240926$$CN$US$US
243678681$24367868$1$I$20201201$20240923$20240926$20240926$EXP$PL-EMA-DD-20240916-7482677-114845$PL-BAYER-2024A137169$BAYER$$49$YR$A$M$Y$$$20240926$$HP$PL$PL
243678691$24367869$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960178$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240926$$MD$US$US
243678701$24367870$1$I$20240101$20240924$20240926$20240926$EXP$GB-MHRA-MED-202409240920362690-YGTPS$GB-MYLANLABS-2024M1086747$MYLAN$$67$YR$$M$Y$85$KG$20240926$$CN$GB$GB
243678711$24367871$1$I$$20240813$20240926$20240926$PER$$US-LUNDBECK-DKLU4003123$LUNDBECK$$$$$$Y$$$20240926$$HP$US$US
243678721$24367872$1$I$$20240917$20240926$20240926$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001903$BLUEPRINT MEDICINES$$$$$M$Y$$$20240926$$HP$US$US
243678731$24367873$1$I$$20240923$20240926$20240926$EXP$$US-TAKEDA-2024TUS094861$TAKEDA$$24$YR$$M$Y$$$20240926$$CN$US$US
243678751$24367875$1$I$20240802$20240921$20240921$20240921$DIR$FDA-CDER-CTU-2024-66146$$FDA-CTU$$67$YR$$F$N$62.6$KG$20240921$Y$CN$US$
243678761$24367876$1$I$$20240920$20240926$20240926$PER$$US-MYLANLABS-2024M1086753$MYLAN$$$$$F$Y$$$20240926$$CN$US$US
243678771$24367877$1$I$$20240924$20240926$20240926$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409015122$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$JP$JP
243678781$24367878$1$I$$20240917$20240926$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011023$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240926$$CN$US$US
243678791$24367879$1$I$20240912$20240915$20240926$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202409010334$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240926$$CN$US$US
243678801$24367880$1$I$$20240915$20240926$20240926$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202409011082$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240926$$MD$SA$SA
243678811$24367881$1$I$20240920$20240921$20240926$20240926$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409013748$ELI LILLY AND CO$$$$$M$Y$$$20240926$$CN$DE$DE
243678821$24367882$1$I$$20240915$20240926$20240926$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202409010908$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240926$$MD$SA$SA
243678831$24367883$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015538$ELI LILLY AND CO$$32$YR$A$F$Y$$$20240926$$CN$US$US
243678841$24367884$1$I$20231001$20240921$20240926$20240926$EXP$$CO-ELI_LILLY_AND_COMPANY-CO202409014457$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240926$$CN$CO$CO
243678851$24367885$1$I$$20240917$20240926$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011194$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240926$$CN$US$US
243678861$24367886$1$I$20240924$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015378$ELI LILLY AND CO$$32$YR$A$$Y$$$20240926$$CN$US$US
243678871$24367887$1$I$20240916$20240917$20240926$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011322$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240926$$CN$US$US
243678891$24367889$1$I$20240921$20240923$20240926$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202409014703$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240926$$CN$US$US
243678901$24367890$1$I$$20240917$20240926$20240926$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202409014353$ELI LILLY AND CO$$$$$F$Y$$$20240926$$MD$SA$SA
243678911$24367891$1$I$$20240917$20240926$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202409010627$ELI LILLY AND CO$$75$YR$E$$Y$$$20240926$$CN$US$US
243678921$24367892$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015571$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240926$$CN$US$US
243678931$24367893$1$I$$20240919$20240926$20240926$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409012384$ELI LILLY AND CO$$$$$M$Y$90$KG$20240926$$CN$JP$JP
243678941$24367894$1$I$$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024190461$AMGEN$Yu R.; Awan O.; Bosse N. et al.. BALANCING TREATMENTS: A DIFFICULT AIRWAY WITH MYASTHENIA GRAVIS-ACQUIRED HEMOPHILIA AND PNEUMONIA. Chest. 2024;166 (4):A1658-A1659$84$YR$E$M$Y$$$20240926$$HP$US$US
243678951$24367895$1$I$20240917$20240920$20240926$20240926$PER$$US-AMGEN-USASP2024188712$AMGEN$$71$YR$E$M$Y$$$20240926$$CN$US$US
243678961$24367896$1$I$20240914$20240920$20240926$20240926$EXP$FI-FIMEA-202403383$FI-GSK-FI2024116998$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$FI$FI
243678971$24367897$1$I$$20240922$20240926$20240926$EXP$$US-LUNDBECK-DKLU4004625$LUNDBECK$$$$$$Y$$$20240926$$CN$US$US
243678981$24367898$1$I$$20240917$20240926$20240926$PER$$US-MYLANLABS-2024M1084818$MYLAN$$$$$F$Y$65.77$KG$20240926$$HP$US$US
243678991$24367899$1$I$20240401$20240923$20240926$20240926$EXP$$PT-ABBVIE-5934799$ABBVIE$$$$E$M$Y$$$20240926$$MD$PT$PT
243679001$24367900$1$I$20021230$20240912$20240926$20240926$EXP$$GB-JNJFOC-A-CH2003-01874$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20240926$$MD$GB$GB
243679011$24367901$1$I$20240721$20240917$20240926$20240926$EXP$$AU-BEH-2024179120$CSL BEHRING$$1$YR$I$M$Y$$$20240926$$HP$AU$AU
243679021$24367902$1$I$$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189580$AMGEN$Lachowsky P.. ANTISYNTHETASE SYNDROME FOLLOWING COVID BOOSTER: A CASE REPORT. Chest. 2024;166 (4S):A5644$54$YR$A$M$Y$$$20240926$$HP$US$US
243679031$24367903$1$I$20220901$20240916$20240926$20240926$EXP$$US-RDY-SPO/USA/24/0013899$DR REDDYS$Reddy TP, Barrios R, Bernicker E, Qian W, Chang J, Safdar Z. Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension. Pulmonary Circulation. 2024;14(3): 1-8. doi:10.1002/pul2.12426.$52$YR$A$F$Y$$$20240926$$HP$US$US
243679041$24367904$1$I$20240914$20240920$20240926$20240926$EXP$GB-MHRA-TPP27037237C20797556YC1726572370543$GB-GSK-GB2024116923$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$PH$GB$GB
243679051$24367905$1$I$20240501$20240920$20240926$20240926$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-127654$REGENERON$$$$$M$Y$$$20240926$$HP$US$US
243679061$24367906$1$I$$20240919$20240926$20240926$PER$$US-BAYER-2024A134774$BAYER$Simoneau J.; Robertson P.; Muraszko K.; Maher C.O.; Garton H.; Calvert R.; Koschmann C.; Upadhyaya S.A.; Mody R.; Brown N.; Kumar-Sinha C.; Parmar H.; Camelo-Piragua S.; Franson A.T.. Long-Term Tumor Stability After First-Line Treatment With Larotrectinib in an Infant With NTRK2 Fusion-Positive High-Grade Glioma. Journal of the National Comprehensive Cancer Network : JNCCN. 2024;22:7:04$11$MON$I$F$Y$$$20240926$$MD$US$US
243679071$24367907$1$I$$20240813$20240926$20240926$EXP$$AU-SA-2024SA270708$SANOFI AVENTIS$$$$$M$Y$$$20240926$$CN$AU$AU
243679081$24367908$1$I$$20240902$20240926$20240926$30DAY$$CN-JNJFOC-20240904399$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$CN$CN
243679091$24367909$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960284$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240926$$MD$US$US
243679101$24367910$1$I$20240301$20240815$20240926$20240926$EXP$$CA-MYLANLABS-2024M1077640$MYLAN$$58$YR$$F$Y$$$20240926$$CN$CA$CA
243679111$24367911$1$I$$20240917$20240926$20240926$PER$$US-TEVA-VS-3244708$TEVA$$88$YR$$F$Y$$$20240926$$CN$US$US
243679121$24367912$1$I$20240830$20240924$20240926$20240926$EXP$$NVSC2024US190476$NOVARTIS$$29$YR$$F$Y$$$20240926$$CN$US$US
243679131$24367913$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001716$ORGANON$$40$YR$$F$Y$$$20240926$$HP$CA$CA
243679141$24367914$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245524$TEVA$$79$YR$$F$Y$$$20240926$$CN$CA$CA
243679151$24367915$1$I$$20240918$20240926$20240926$EXP$$CA-TEVA-VS-3246295$TEVA$$77$YR$$M$Y$$$20240926$$MD$CA$CA
243679161$24367916$1$I$$20240920$20240926$20240926$PER$$US-JNJFOC-20240955367$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$HP$US$US
243679171$24367917$1$I$20240916$20240916$20240926$20240926$PER$$US-AMGEN-USASP2024185206$AMGEN$$54$YR$A$F$Y$$$20240926$$PH$US$US
243679181$24367918$1$I$20231126$20240924$20240926$20240926$EXP$FR-AFSSAPS-AVBX2024000539$FR-BAUSCH-BL-2024-014352$BAUSCH AND LOMB$$18$YR$$F$Y$$$20240926$$MD$FR$FR
243679191$24367919$1$I$20240706$20240924$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-016120$JAZZ$$63$YR$$F$Y$$$20240926$$CN$US$US
243679201$24367920$1$I$20240715$20240919$20240926$20240926$EXP$IT-MINISAL02-1002104$IT-TEVA-VS-3246109$TEVA$$64$YR$$M$Y$$$20240926$$MD$IT$IT
243679211$24367921$1$I$$20240911$20240926$20240926$EXP$$DE-BRAEBURN-DE-BRA-24-000900$BRAEBURN PHARMACEUTICALS$$28$YR$$F$Y$$$20240926$$MD$DE$DE
243679221$24367922$1$I$$20240920$20240926$20240926$EXP$$DE-PFIZER INC-2018SGN00539$PFIZER$Ruf, S.. CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series.. Pediatric Blood + Cancer. 2018;65 (6)$19$YR$$M$Y$$$20240926$$HP$DE$DE
243679262$24367926$2$F$$20240927$20240926$20240927$EXP$$US-PFIZER INC-2021SGN00128$PFIZER$$$$$$Y$$$20240927$$MD$US$US
243679271$24367927$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-PV202400124131$PFIZER$Shiari, A.. AMANTADINE AS A SALVAGE THERAPY FOR BENZODIAZEPINE-REFRACTORY CATATONIA IN THE ABSENCE OF ECT. Chest. 2024;166(4 Supple):2069A-2070A$39$YR$$F$Y$$$20240926$$HP$US$US
243679281$24367928$1$I$20230911$20240924$20240926$20240926$EXP$$JP-PFIZER INC-PV202400125085$PFIZER$Okemoto, D.. Severe Thrombocytopenia from Trastuzumab and Pertuzumab Combination Therapy in a Patient with HER2-Positive Metastatic Rectal Cancer. Case Reports in Oncology. 2024;17:1001-1007$76$YR$$M$Y$$$20240926$$HP$JP$JP
243679311$24367931$1$I$$20240923$20240926$20240926$EXP$$US-PFIZER INC-2023SGN02966$PFIZER$$58$YR$$M$Y$$$20240926$$CN$US$US
243679341$24367934$1$I$20240921$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189639$AMGEN$$69$YR$E$M$Y$$$20240926$$CN$US$US
243679351$24367935$1$I$20240919$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190634$AMGEN$$60$YR$A$F$Y$$$20240926$$CN$US$US
243679391$24367939$1$I$$20240916$20240926$20240926$PER$$US-JNJFOC-20240942752$JOHNSON AND JOHNSON$$$$$M$Y$$$20240926$$CN$US$US
243679401$24367940$1$I$20240101$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190316$AMGEN$$60$YR$A$F$Y$$$20240926$$CN$US$US
243679411$24367941$1$I$$20240905$20240926$20240926$PER$$US-B.Braun Medical Inc.-2162102$B BRAUN$$52$YR$$M$Y$50$KG$20240926$$$US$US
243679421$24367942$1$I$20240101$20240912$20240926$20240926$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01728$AVADEL CNS PHARMA$$$$$M$Y$$$20240926$$CN$US$US
243679431$24367943$1$I$20240725$20240923$20240926$20240926$EXP$FR-AFSSAPS-LL2024001767$FR-009507513-2409FRA008152$MERCK$$63$YR$$M$Y$$$20240926$$PH$FR$FR
243679441$24367944$1$I$20151215$20240923$20240926$20240926$EXP$PL-URPL-2-53-2019$PL-ABBVIE-5936201$ABBVIE$$66$YR$$F$Y$$$20240926$$CN$PL$PL
243679471$24367947$1$I$$20240918$20240926$20240926$EXP$$US-TAKEDA-2024TUS093542$TAKEDA$$$$$M$Y$24$KG$20240926$$MD$US$US
243679481$24367948$1$I$20240710$20240911$20240926$20240926$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ0720$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240926$$HP$US$US
243679511$24367951$1$I$$20240410$20240926$20240926$PER$$NVSC2024US191186$NOVARTIS$$$$$$Y$$$20240926$$CN$US$US
243679521$24367952$1$I$20240830$20240918$20240926$20240926$PER$$US-JNJFOC-20240954569$JOHNSON AND JOHNSON$$31$YR$A$F$Y$128.8$KG$20240926$$CN$US$US
243679531$24367953$1$I$20240801$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189825$AMGEN$$27$YR$A$M$Y$$$20240926$$HP$US$US
243679541$24367954$1$I$20240924$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190747$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243679561$24367956$1$I$20240916$20240925$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-016261$JAZZ$$53$YR$$M$Y$$$20240926$$CN$US$US
243679571$24367957$1$I$20240712$20240916$20240926$20240926$EXP$GB-MHRA-MED-202409141901183450-DZGRL$GB-ELI_LILLY_AND_COMPANY-GB202409010339$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240926$$CN$GB$GB
243679581$24367958$1$I$20240814$20240916$20240926$20240926$EXP$GB-MHRA-MED-202409151725307270-CBZQK$GB-ELI_LILLY_AND_COMPANY-GB202409010357$ELI LILLY AND CO$$32$YR$A$F$Y$77$KG$20240926$$CN$GB$GB
243679591$24367959$1$I$$20240925$20240926$20240926$EXP$$CA-MYLANLABS-2024M1087114$MYLAN$$30$YR$$M$Y$84$KG$20240926$$HP$CA$CA
243679601$24367960$1$I$20240920$20240921$20240926$20240926$EXP$GB-MHRA-MED-202409210850017300-LFWKZ$GB-ELI_LILLY_AND_COMPANY-GB202409014054$ELI LILLY AND CO$$59$YR$A$F$Y$112$KG$20240926$$CN$GB$GB
243679621$24367962$1$I$20240831$20240920$20240926$20240926$EXP$GB-MHRA-MED-202409191312082750-VDBMC$GB-ELI_LILLY_AND_COMPANY-GB202409014042$ELI LILLY AND CO$$61$YR$A$F$Y$95$KG$20240926$$CN$GB$GB
243679631$24367963$1$I$20230401$20240917$20240926$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011338$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240926$$CN$US$US
243679641$24367964$1$I$20240924$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016941$ELI LILLY AND CO$$27$YR$A$F$Y$$$20240926$$CN$US$US
243679652$24367965$2$F$$20240923$20240926$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015340$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240930$$CN$US$US
243679661$24367966$1$I$20240601$20240917$20240926$20240926$EXP$GB-MHRA-MED-202409171051129220-GCLSZ$GB-ELI_LILLY_AND_COMPANY-GB202409011286$ELI LILLY AND CO$$54$YR$A$M$Y$91$KG$20240926$$CN$GB$GB
243679672$24367967$2$F$$20240926$20240926$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016599$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240930$$CN$US$US
243679691$24367969$1$I$20240918$20240918$20240926$20240926$EXP$$US-TEVA-VS-3246422$TEVA$$$$$$Y$$$20240926$$HP$US$US
243679711$24367971$1$I$$20240920$20240926$20240926$EXP$$US-INCYTE CORPORATION-2024IN010023$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243679721$24367972$1$I$19841026$20240923$20240926$20240926$EXP$$AU-PFIZER INC-PV202400124491$PFIZER$$61$YR$$F$Y$$$20240926$$HP$AU$AU
243679731$24367973$1$I$$20240923$20240926$20240926$PER$$US-JNJFOC-20240962030$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243679741$24367974$1$I$$20240917$20240926$20240926$PER$$US-INCYTE CORPORATION-2024IN009864$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243679751$24367975$1$I$$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024191132$AMGEN$$$$$$Y$$$20240926$$MD$US$US
243679761$24367976$1$I$$20240918$20240926$20240926$PER$$US-AMGEN-USASP2024187009$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243679771$24367977$1$I$$20240917$20240926$20240926$PER$$US-INCYTE CORPORATION-2024IN009863$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243679791$24367979$1$I$$20230905$20240926$20240926$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408439$RANBAXY$$$$$F$Y$$$20240927$$CN$US$US
243679801$24367980$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152091$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240926$$CN$US$US
243679811$24367981$1$I$$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150237$BRISTOL MYERS SQUIBB$$16$YR$T$F$Y$$$20240926$$MD$US$US
243679821$24367982$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152082$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240926$$HP$US$US
243679831$24367983$1$I$20240801$20240926$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152942$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240926$$HP$US$US
243679841$24367984$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152296$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240926$$CN$US$US
243679851$24367985$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152110$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240926$$CN$US$US
243679861$24367986$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152900$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$54.88$KG$20240926$$CN$US$US
243679871$24367987$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152090$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240926$$CN$US$US
243679881$24367988$1$I$$20240916$20240926$20240926$PER$$US-MYLANLABS-2024M1085508$MYLAN$$$$$F$Y$$$20240926$$CN$US$US
243679891$24367989$1$I$$20240919$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149944$BRISTOL MYERS SQUIBB$$$$$F$Y$114$KG$20240926$$HP$US$US
243679901$24367990$1$I$20240508$20240917$20240926$20240926$EXP$JP-PMDA-i2410001521001$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-152006$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$78.8$KG$20240926$$MD$JP$JP
243679911$24367991$1$I$20240403$20240920$20240926$20240926$EXP$FR-AFSSAPS-PB2024001011$FR-009507513-2409FRA007556$MERCK$$74$YR$$F$Y$63.5$KG$20240926$$HP$FR$FR
243679921$24367992$1$I$20240901$20240919$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149859$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240926$$HP$US$US
243679931$24367993$1$I$$20240924$20240926$20240926$EXP$$BR-TAKEDA-2024TUS095203$TAKEDA$$$$$$Y$$$20240926$$CN$BR$BR
243679941$24367994$1$I$20240801$20240926$20240926$20240926$EXP$FR-AFSSAPS-BR2024000760$NVSC2024FR191345$NOVARTIS$$67$YR$$F$Y$90$KG$20240926$$PH$FR$FR
243679951$24367995$1$I$20240906$20240926$20240926$20240926$EXP$FR-AFSSAPS-PV2024000898$NVSC2024FR191273$NOVARTIS$$71$YR$$F$Y$51$KG$20240926$$MD$FR$FR
243679961$24367996$1$I$$20240916$20240926$20240926$EXP$$FR-TEVA-VS-3245957$TEVA$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$29$YR$$M$Y$$$20240926$$HP$FR$FR
243679971$24367997$1$I$$20240916$20240926$20240926$EXP$$FR-TEVA-VS-3245956$TEVA$Brehon A, Lourenco J, Badaoui A, Amsler E, LopezZaragoza JL, Soria A, et al. Doxycycline-induced fixed drug eruption: The new epidemic?. J-Eur-Acad-Dermatol-Venereol 2024;.$28$YR$$F$Y$$$20240926$$HP$FR$FR
243679981$24367998$1$I$$20240923$20240926$20240926$EXP$$US-ALXN-202409USA005433US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240926$$$US$US
243679991$24367999$1$I$20231117$20240918$20240926$20240926$EXP$$NVSC2024US005684$NOVARTIS$$77$YR$$F$Y$$$20240926$$CN$US$US
243680001$24368000$1$I$$20240920$20240926$20240926$EXP$AU-TGA-0000819260$NVSC2024AU190722$NOVARTIS$$79$YR$$F$Y$$$20240926$$MD$AU$AU
243680011$24368001$1$I$20240101$20240916$20240926$20240926$EXP$$US-MALLINCKRODT-MNK202405803$MALLINCKRODT$$60$YR$A$F$Y$$$20240926$$HP$US$US
243680021$24368002$1$I$$20240917$20240926$20240926$EXP$$CA-UCBSA-2024048070$UCB$$40$YR$$M$Y$133$KG$20240926$$HP$CA$CA
243680031$24368003$1$I$20220101$20240923$20240926$20240926$EXP$$NVSC2022EG237196$NOVARTIS$$$$$F$Y$$$20240926$$CN$EG$EG
243680041$24368004$1$I$20240807$20240925$20240926$20240926$EXP$$NVSC2024KR169720$NOVARTIS$$76$YR$$M$Y$60.9$KG$20240926$$HP$KR$KR
243680051$24368005$1$I$20240903$20240918$20240926$20240926$PER$$JP-Eisai-EC-2024-174936$EISAI$$$$E$F$Y$$$20240926$$PH$JP$JP
243680061$24368006$1$I$$20240916$20240926$20240926$PER$$US-MYLANLABS-2024M1085601$MYLAN$$$$$$Y$$$20240926$$CN$US$US
243680071$24368007$1$I$20240812$20240923$20240926$20240926$EXP$FR-AFSSAPS-PP2024001026$FR-INCYTE CORPORATION-2024IN010058$INCYTE$$$$$$Y$$$20240926$$MD$FR$FR
243680081$24368008$1$I$$20240920$20240926$20240926$PER$$US-BAYER-2024A135809$BAYER$$74$YR$E$M$Y$$$20240926$$CN$US$US
243680091$24368009$1$I$$20240910$20240926$20240926$EXP$$CA-PFIZER INC-202400260652$PFIZER$$40$YR$$F$Y$$$20240926$$MD$CA$CA
243680101$24368010$1$I$$20240923$20240926$20240926$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052912$BOEHRINGER INGELHEIM$Wang Y, Zeng D. Afatinib in Advanced Lung Squamous Cancer HarboringHER2 Mutation in Exon 17 Plus Amplification. American Journal of Therapeutics. 2024;31:5: e594-e596.$71$YR$E$M$Y$$$20240926$$HP$CN$CN
243680111$24368011$1$I$$20240917$20240926$20240926$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053704$BOEHRINGER INGELHEIM$$74$YR$E$F$Y$$$20240926$$CN$US$US
243680121$24368012$1$I$20240701$20240917$20240926$20240926$EXP$$JP-Eisai-EC-2024-159929$EISAI$$71$YR$E$M$Y$$$20240926$$MD$JP$JP
243680131$24368013$1$I$20230418$20240919$20240926$20240926$PER$FR-AFSSAPS-ST2024001450$FR-Eisai-EC-2024-174736$EISAI$$59$YR$A$F$Y$50$KG$20240926$$HP$FR$FR
243680141$24368014$1$I$$20240918$20240926$20240926$PER$$US-Eisai-EC-2024-174821$EISAI$$$$$$Y$$$20240926$$MD$US$US
243680151$24368015$1$I$20240910$20240919$20240926$20240926$PER$$CN-Eisai-EC-2024-175007$EISAI$$49$YR$A$F$Y$55$KG$20240926$$HP$CN$CN
243680171$24368017$1$I$$20240924$20240926$20240926$EXP$$US-OTSUKA-2024_026582$OTSUKA$$$$$M$Y$$$20240926$$CN$US$US
243680181$24368018$1$I$20240315$20240923$20240926$20240926$PER$$US-009507513-2409USA008324$MERCK$$$$E$F$Y$$$20240926$$CN$US$US
243680191$24368019$1$I$$20240923$20240926$20240926$PER$$US-PFIZER INC-PV202400125079$PFIZER$$52$YR$$F$Y$$$20240926$$CN$US$US
243680201$24368020$1$I$$20240922$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015054$ELI LILLY AND CO$$$$$$Y$$$20240926$$CN$US$US
243680211$24368021$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016665$ELI LILLY AND CO$$59$YR$A$M$Y$$$20240926$$CN$US$US
243680221$24368022$1$I$$20240915$20240926$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202409010441$ELI LILLY AND CO$Abdullah I.,El Ghousain H.,Alenezi M..TIRZEPATIDE-RELATED ACUTE LIVER INJURY.European Journal of Case Reports in Internal Medicine. 2024;11(9):.DOI:10 12890 2024 004813$37$YR$A$F$Y$$$20240926$$CN$COUNTRY NOT SPECIFIED$US
243680231$24368023$1$I$$20240920$20240926$20240926$EXP$$RO-BRISTOL-MYERS SQUIBB COMPANY-2024-150169$BRISTOL MYERS SQUIBB$Radu-Adamesteanu M-O, Giurcaneanu C, Orzan O, Popa M, Burlacu G, Teodoreanu R-N, et al. Outcomes and characteristics of non melanocitary skin cancers and actinic keratosis in a patient with myelofibrosis on fedratinib. Dermatovenerol. 2024;69(2):15-23.$68$YR$E$M$Y$$$20240926$$HP$RO$RO
243680241$24368024$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152790$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240926$$CN$US$US
243680251$24368025$1$I$20240901$20240919$20240926$20240926$EXP$$JP-BAUSCH-BL-2024-014438$BAUSCH AND LOMB$$5$DEC$$$Y$100$KG$20240926$$MD$JP$JP
243680261$24368026$1$I$$20240920$20240926$20240926$PER$$US-JNJFOC-20240956582$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243680271$24368027$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245473$TEVA$$76$YR$$M$Y$$$20240926$$HP$CA$CA
243680281$24368028$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245538$TEVA$$33$YR$$M$Y$$$20240926$$CN$CA$CA
243680291$24368029$1$I$$20240919$20240926$20240926$PER$$US-MYLANLABS-2024M1086073$MYLAN$$$$$F$Y$$$20240926$$CN$US$US
243680301$24368030$1$I$20240807$20240925$20240926$20240926$EXP$$US-KYOWAKIRIN-2024KK022141$KYOWA$$$$$$Y$$$20240926$$HP$US$US
243680311$24368031$1$I$20240910$20240919$20240926$20240926$EXP$$CN-EMD Serono-2024050456$EMD SERONO INC$$37$YR$A$F$Y$54$KG$20240926$$HP$CN$CN
243680321$24368032$1$I$20240904$20240920$20240926$20240926$PER$$US-BIOMARINAP-US-2024-160723$BIOMARIN$$$$$$Y$$$20240926$$CN$US$US
243680331$24368033$1$I$$20240917$20240926$20240926$EXP$$CA-TEVA-VS-3245476$TEVA$$$$$F$Y$$$20240926$$HP$CA$CA
243680341$24368034$1$I$20240101$20240919$20240926$20240926$EXP$$GB-TEVA-VS-3245414$TEVA$$$$$F$Y$$$20240926$$CN$GB$GB
243680351$24368035$1$I$20240922$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190705$AMGEN$$72$YR$E$F$Y$$$20240926$$HP$US$US
243680361$24368036$1$I$20240717$20240827$20240926$20240926$EXP$$US-IOVANCE BIOTHERAPEUTICS INC.-IOV2024000029$IOVANCE BIOTHERAPEUTICS$$$$$$Y$$$20240926$$MD$US$US
243680371$24368037$1$I$20240101$20240924$20240926$20240926$PER$$JP-Eisai-EC-2024-175411$EISAI$$$$A$M$Y$$$20240926$$MD$JP$JP
243680381$24368038$1$I$$20240918$20240926$20240926$PER$$US-ABBVIE-5930164$ABBVIE$$$$$$Y$$$20240926$$HP$US$US
243680391$24368039$1$I$$20240911$20240926$20240926$EXP$$US-SA-2024SA278353$SANOFI AVENTIS$$$$A$F$Y$108.4$KG$20240926$$MD$US$US
243680402$24368040$2$F$$20240927$20240926$20240930$EXP$$VN-BAYER-2024A131724$BAYER$$56$YR$A$M$Y$$$20240930$$CN$VN$VN
243680411$24368041$1$I$$20240919$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151852$BRISTOL MYERS SQUIBB$$9$DEC$E$M$Y$$$20240926$$MD$JP$JP
243680421$24368042$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152542$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240926$$CN$US$US
243680431$24368043$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152586$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$99.79$KG$20240926$$CN$US$US
243680441$24368044$1$I$20240901$20240925$20240926$20240926$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-152560$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$68.04$KG$20240926$$CN$PR$PR
243680451$24368045$1$I$20240923$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152462$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$64$KG$20240926$$PH$US$US
243680481$24368048$1$I$20230101$20240923$20240926$20240926$EXP$$US-SA-2024SA275990$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240926$$MD$US$US
243680491$24368049$1$I$$20240923$20240926$20240926$EXP$$CN-SA-2024SA275921$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240926$$MD$CN$CN
243680501$24368050$1$I$20240701$20240920$20240926$20240926$EXP$$US-SA-2024SA275760$SANOFI AVENTIS$$70$YR$E$M$Y$90$KG$20240926$$MD$US$US
243680511$24368051$1$I$20240920$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191603$AMGEN$$80$YR$E$F$Y$$$20240926$$CN$US$US
243680521$24368052$1$I$20240812$20240923$20240926$20240926$EXP$$CN-SA-2024SA276902$SANOFI AVENTIS$$50$YR$A$F$Y$46$KG$20240926$$HP$CN$CN
243680541$24368054$1$I$$20240920$20240926$20240926$EXP$$FR-PFIZER INC-PV202400123448$PFIZER$$$$$$Y$$$20240926$$MD$FR$FR
243680551$24368055$1$I$20240918$20240918$20240926$20240926$PER$$US-ABBVIE-5929323$ABBVIE$$48$YR$$F$Y$$$20240926$$CN$US$US
243680561$24368056$1$I$$20240918$20240926$20240926$EXP$$US-Eisai-EC-2024-174817$EISAI$$68$YR$E$F$Y$$$20240926$$CN$US$US
243680571$24368057$1$I$$20240917$20240926$20240926$PER$$US-ABBVIE-5929897$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243680581$24368058$1$I$20240924$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191528$AMGEN$$70$YR$E$F$Y$$$20240926$$CN$US$US
243680591$24368059$1$I$$20240912$20240926$20240926$PER$$US-INCYTE CORPORATION-2024IN009709$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243680611$24368061$1$I$$20240918$20240926$20240926$EXP$$CA-DSJP-DS-2024-101440-CAAA$DAIICHI$$$$$$Y$$$20240926$$MD$CA$CA
243680621$24368062$1$I$$20240917$20240926$20240926$PER$$US-INCYTE CORPORATION-2024IN009877$INCYTE$$$$$$Y$$$20240926$$CN$US$US
243680631$24368063$1$I$$20240916$20240926$20240926$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18798$IPSEN$$$$$$Y$$$20240926$$HP$US$US
243680641$24368064$1$I$$20231018$20240926$20240926$EXP$$CN-PFIZER INC-PV202400125213$PFIZER$$6$YR$$M$Y$$$20240926$$CN$CN$CN
243680651$24368065$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016656$ELI LILLY AND CO$$77$YR$E$M$Y$$$20240926$$CN$US$US
243680661$24368066$1$I$20240705$20240915$20240926$20240926$EXP$$KW-ELI_LILLY_AND_COMPANY-KW202409011363$ELI LILLY AND CO$Abdullah I.,El-Ghousain H.,Alenezi M..Tirzepatide-related acute liver injury..European Journal of Case Reports in Internal Medicine. 2024;11(9):.DOI:10.12890/2024_004813$24$YR$A$F$Y$$$20240926$$HP$KW$KW
243680682$24368068$2$F$$20240918$20240926$20240930$PER$$US-DSJP-DS-2024-101356-US$DAIICHI$$$$A$F$Y$$$20240930$$MD$US$US
243680691$24368069$1$I$20240626$20240719$20240926$20240926$PER$$US-KARYOPHARM-2024KPT001336$KARYOPHARM THERAPEUTICS$$69$YR$$M$Y$$$20240926$$MD$US$US
243680701$24368070$1$I$$20240918$20240926$20240926$PER$$US-INCYTE CORPORATION-2023IN005421$INCYTE$$$$$$Y$$$20240926$$MD$US$US
243680721$24368072$1$I$20240904$20240904$20240926$20240926$EXP$$US-Crown Laboratories, Inc.-2162107$CROWN LABORATORIES$$$$$$Y$$$20240926$$$US$US
243680741$24368074$1$I$$20240924$20240926$20240926$PER$$US-ABBVIE-5938014$ABBVIE$$25$YR$$F$Y$$$20240926$$MD$US$US
243680751$24368075$1$I$20230101$20240923$20240926$20240926$EXP$$US-VERTEX PHARMACEUTICALS-2023-007716$VERTEX$Anani AR, Dickinson JD. Complete phrenic nerve paralysis in a patient with cystic fibrosis. Chest. 2024;166:176A$$$$M$Y$$$20240926$$MD$US$US
243680761$24368076$1$I$20240912$20240920$20240926$20240926$EXP$DE-PEI-CADR2024330515$DE-009507513-2409DEU007653$MERCK$$57$YR$$F$Y$60$KG$20240926$$MD$DE$DE
243680771$24368077$1$I$$20240805$20240926$20240926$PER$$US-HERON THERAPEUTICS, INC-HRTX-2024-001042$HERON$$$$$M$Y$$$20240926$$MD$US$US
243680781$24368078$1$I$$20240916$20240926$20240926$EXP$$DE-TEVA-VS-3245474$TEVA$Polzing P, Erzkamp S, Hage D, Dartsch D, Rose O. A patient with constant fatigue after hospitalization. Deutsche Apotheker Zeitung. 2024;1-9; Polzing P, Erzkamp S, Hage D, Dartsch D, Rose O. Eine patientin mit standiger mudigkeit nach klinikaufenthalt. Deutsche Apotheker Zeitung. 2024$70$YR$$F$Y$51$KG$20240926$$PH$DE$DE
243680791$24368079$1$I$$20240918$20240926$20240926$PER$$US-Calliditas-2024CAL01956$CALLIDITAS THERAPEUTICS$$$$$$Y$$$20240926$$MD$US$US
243680801$24368080$1$I$20240703$20240919$20240926$20240926$EXP$FR-AFSSAPS-GR2024001066$FR-TEVA-VS-3245749$TEVA$$72$YR$$F$Y$$$20240926$$PH$FR$FR
243680811$24368081$1$I$20240101$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191772$AMGEN$$70$YR$E$M$Y$$$20240926$$CN$US$US
243680821$24368082$1$I$20240714$20240920$20240926$20240926$EXP$IE-HPRA-2024-115352$IE-TEVA-VS-3246629$TEVA$$64$YR$$F$Y$74.4$KG$20240926$$CN$IE$IE
243680831$24368083$1$I$20230801$20240917$20240926$20240926$EXP$$US-UCBSA-2024048382$UCB$$42$YR$$F$Y$45.4$KG$20240926$$HP$US$US
243680841$24368084$1$I$$20240923$20240926$20240926$EXP$$NVSC2024US190719$NOVARTIS$$$$$F$Y$$$20240926$$MD$US$US
243680861$24368086$1$I$$20240923$20240926$20240926$PER$$US-HALEON-2198323$Haleon PLC$$$$$$Y$$$20240926$$CN$US$US
243680871$24368087$1$I$20240816$20240916$20240926$20240926$PER$$US-JNJFOC-20240949631$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240926$$CN$US$US
243680881$24368088$1$I$20240101$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024191254$AMGEN$$75$YR$E$F$Y$$$20240926$$CN$US$US
243680891$24368089$1$I$$20240919$20240926$20240926$EXP$GB-MHRA-MED-202409192328498100-GFZHP$GB-TEVA-VS-3246496$TEVA$$24$YR$$F$Y$108$KG$20240926$$CN$GB$GB
243680901$24368090$1$I$$20240918$20240926$20240926$PER$$US-ABBVIE-5932838$ABBVIE$$$$$$Y$$$20240926$$CN$US$US
243680911$24368091$1$I$20230320$20240918$20240926$20240926$EXP$$RO-AMGEN-ROUSP2024187698$AMGEN$Moarcas M.; Mihailescu-marin M.. Advanced cervical cancer in palliative care - a demon we could prevent: case report. Paliatia-Journal of Palliative Care. 2024;17 (3):43-48$34$YR$A$F$Y$$$20240926$$HP$RO$RO
243680921$24368092$1$I$$20240919$20240926$20240926$EXP$GB-MHRA-MED-202409171839019370-RSQBH$GB-TEVA-VS-3245560$TEVA$$$$$F$Y$$$20240926$$CN$GB$GB
243680931$24368093$1$I$$20240921$20240926$20240926$EXP$$AT-ELI_LILLY_AND_COMPANY-AT202409013769$ELI LILLY AND CO$$83$YR$E$M$Y$$$20240926$$CN$DE$AT
243680941$24368094$1$I$$20240917$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409010722$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240926$$CN$US$US
243680951$24368095$1$I$20240917$20240917$20240926$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011486$ELI LILLY AND CO$$$$$$Y$$$20240926$$CN$US$US
243680961$24368096$1$I$$20240917$20240926$20240926$EXP$PT-INFARMED-T202007-368$PT-ELI_LILLY_AND_COMPANY-PT202409011300$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240926$$CN$PT$PT
243680971$24368097$1$I$$20240923$20240926$20240926$EXP$$US-ELI_LILLY_AND_COMPANY-US202409014294$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$US$US
243680981$24368098$1$I$20240501$20240916$20240926$20240926$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409010363$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240926$$CN$FR$FR
243680991$24368099$1$I$20240829$20240920$20240926$20240926$EXP$FR-AFSSAPS-MP2024001367$FR-TEVA-VS-3246624$TEVA$$80$YR$$M$Y$82$KG$20240926$$PH$FR$FR
243681001$24368100$1$I$20240914$20240919$20240926$20240926$EXP$GB-MHRA-MED-202409190927277890-NKLHJ$GB-TEVA-VS-3245958$TEVA$$40$YR$$F$Y$111$KG$20240926$$HP$GB$GB
243681011$24368101$1$I$$20240919$20240926$20240926$EXP$$US-ALXN-202409USA005324US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240926$$$US$US
243681021$24368102$1$I$20240325$20240925$20240926$20240926$EXP$$US-OTSUKA-2024_026671$OTSUKA$$64$YR$$F$Y$$$20240926$$CN$US$US
243681051$24368105$1$I$20240901$20240920$20240926$20240926$EXP$$US-ALKERMES INC.-ALK-2024-002451$ALKERMES$$$$$F$Y$$$20240926$$HP$US$US
243681061$24368106$1$I$$20240926$20240926$20240926$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053711$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240926$$CN$US$US
243681071$24368107$1$I$20240725$20240912$20240926$20240926$PER$$US-McGuff Pharmaceuticals, Inc.-2162108$MCGUFF$$83$YR$$M$Y$93.182$KG$20240926$$MD$US$US
243681081$24368108$1$I$20240625$20240920$20240926$20240926$EXP$$US-009507513-2409USA007872$MERCK$$$$$$Y$$$20240926$$MD$US$US
243681111$24368111$1$I$$20240923$20240926$20240926$EXP$$US-PURDUE PHARMA-USA-2024-0312179$PURDUE$$$$$M$Y$$$20240926$$CN$US$US
243681121$24368112$1$I$20240806$20240919$20240926$20240926$EXP$FR-AFSSAPS-NC2024001061$FR-TEVA-VS-3246118$TEVA$$44$YR$$F$Y$58$KG$20240926$$MD$FR$FR
243681131$24368113$1$I$20240101$20240911$20240926$20240926$EXP$$US-DSJP-DSU-2024-144786AA$DAIICHI$$51$YR$$F$Y$$$20240926$$MD$US$US
243681161$24368116$1$I$20240730$20240920$20240926$20240926$EXP$FR-AFSSAPS-AM2024000734$FR-TEVA-VS-3246644$TEVA$$79$YR$$M$Y$110$KG$20240926$$MD$FR$FR
243681171$24368117$1$I$20240711$20240920$20240926$20240926$EXP$ES-AEMPS-1568908$ES-TEVA-VS-3246417$TEVA$$46$YR$$F$Y$$$20240926$$MD$ES$ES
243681181$24368118$1$I$$20240924$20240926$20240926$PER$$US-PURDUE-USA-2024-0312206$PURDUE$$$$$F$Y$$$20240926$$CN$US$US
243681191$24368119$1$I$$20240917$20240926$20240926$PER$$US-PURDUE-USA-2024-0312163$PURDUE$$45$YR$$F$Y$$$20240926$$CN$US$US
243681201$24368120$1$I$$20240925$20240926$20240926$PER$$US-PURDUE-USA-2024-0312178$PURDUE$$64$YR$$F$Y$$$20240926$$CN$US$US
243681211$24368121$1$I$$20240925$20240926$20240926$PER$$US-PURDUE-USA-2024-0312176$PURDUE$$$$$F$Y$$$20240926$$PH$US$US
243681221$24368122$1$I$20240708$20240920$20240926$20240926$EXP$SE-SEMPA-2024-006711$SE-TEVA-VS-3246603$TEVA$$44$YR$$F$Y$$$20240926$$MD$SE$SE
243681231$24368123$1$I$$20240925$20240926$20240926$PER$$US-PURDUE PHARMA-USA-2024-0312177$PURDUE$$78$YR$$M$Y$$$20240926$$CN$US$US
243681241$24368124$1$I$20240301$20240925$20240926$20240926$EXP$$PK-PFIZER INC-PV202400036590$PFIZER$$59$YR$$F$Y$75$KG$20240926$$CN$PK$PK
243681261$24368126$1$I$20240617$20240923$20240926$20240926$EXP$FR-AFSSAPS-PV2024000848$FR-TEVA-VS-3246721$TEVA$$75$YR$$M$Y$$$20240926$$CN$FR$FR
243681271$24368127$1$I$$20240919$20240926$20240926$EXP$NL-LRB-01000081$NL-TEVA-VS-3246030$TEVA$$71$YR$$F$Y$67$KG$20240926$$CN$NL$NL
243681291$24368129$1$I$20240821$20240920$20240926$20240926$EXP$FR-AFSSAPS-CF2024000466$FR-TEVA-VS-3246642$TEVA$$73$YR$$M$Y$54$KG$20240926$$PH$FR$FR
243681301$24368130$1$I$20240906$20240912$20240926$20240926$PER$$US-McGuff Pharmaceuticals, Inc.-2162109$MCGUFF$$68$YR$$M$Y$55.909$KG$20240926$$MD$US$US
243681321$24368132$1$I$$20240913$20240926$20240926$30DAY$$GT-PFIZER INC-PV202400121302$PFIZER$$10$YR$$F$Y$$$20240926$$HP$GT$GT
243681331$24368133$1$I$20230901$20240924$20240926$20240926$EXP$FR-AFSSAPS-PO2024001011$FR-PFIZER INC-202400262652$PFIZER$$80$YR$$F$Y$72$KG$20240926$$MD$FR$FR
243681341$24368134$1$I$$20240924$20240926$20240926$EXP$$US-PFIZER INC-202400257847$PFIZER$$76$YR$$F$Y$$$20240926$$HP$US$US
243681351$24368135$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016511$ELI LILLY AND CO$$39$YR$A$M$Y$$$20240926$$CN$US$US
243681361$24368136$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016664$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240926$$CN$US$US
243681371$24368137$1$I$$20240919$20240926$20240926$EXP$$CA-PURDUE-USA-2024-0312167$PURDUE$$44$YR$$F$Y$97$KG$20240926$$MD$CA$CA
243681381$24368138$1$I$20240901$20240919$20240926$20240926$PER$$US-JNJFOC-20240954747$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243681391$24368139$1$I$20240709$20240919$20240926$20240926$EXP$FR-AFSSAPS-GR2024001073$FR-TEVA-VS-3246119$TEVA$$73$YR$$F$Y$$$20240926$$PH$FR$FR
243681401$24368140$1$I$20240827$20240912$20240926$20240926$PER$$US-McGuff Pharmaceuticals, Inc.-2162110$MCGUFF$$43$YR$$M$Y$73.636$KG$20240926$$MD$US$US
243681411$24368141$1$I$$20240923$20240926$20240926$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-128501$REGENERON$Hasan W, Omran A, Iqbal U, Aldarayseh M, Noori M, Pullatt R.. CEMIPLIMAB-INDUCED MYOCARDITIS AND HEART BLOCK IN A PATIENT WITH METASTATIC BASAL CELL CARCINOMA: A FATAL CASE REPORT. Chest. 2024;166:4:A4108-A4109$82$YR$$M$Y$$$20240926$$HP$US$US
243681441$24368144$1$I$20210702$20240920$20240926$20240926$EXP$PL-URPL-DML-MLP.4401.1.5071.2021$PL-TEVA-VS-3246536$TEVA$$42$YR$$F$Y$69$KG$20240926$$MD$PL$PL
243681451$24368145$1$I$20240909$20240920$20240926$20240926$EXP$$CO-ABBVIE-5938309$ABBVIE$$77$YR$$F$Y$81$KG$20240926$$HP$CO$CO
243681461$24368146$1$I$20240527$20240925$20240926$20240926$EXP$$US-OTSUKA-2024_026699$OTSUKA$$73$YR$$F$Y$$$20240926$$HP$US$US
243681471$24368147$1$I$20240828$20240925$20240926$20240926$EXP$FR-AFSSAPS-MP2024001372$FR-LUNDBECK-DKLU4004612$LUNDBECK$$$$$$Y$$$20240926$$PH$FR$FR
243681481$24368148$1$I$$20240916$20240926$20240926$30DAY$$GB-PFIZER INC-202400258827$PFIZER$$13$YR$$M$Y$$$20240926$$CN$GB$GB
243681491$24368149$1$I$20191001$20240912$20240926$20240926$EXP$$JP-RECORDATI RARE DISEASE INC.-2024007356$RECORDATI$$$$$$Y$$$20240926$$MD$JP$JP
243681501$24368150$1$I$20201015$20240912$20240926$20240926$EXP$$JP-RECORDATI RARE DISEASE INC.-2024007381$RECORDATI$$$$$$Y$$$20240926$$MD$JP$JP
243681521$24368152$1$I$$20240923$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409014568$ELI LILLY AND CO$$82$YR$E$M$Y$$$20240926$$CN$US$US
243681531$24368153$1$I$20240101$20240920$20240926$20240926$EXP$$JP-009507513-2409JPN000788J$MERCK$$71$YR$$M$Y$$$20240926$$MD$JP$JP
243681541$24368154$1$I$20240516$20240918$20240926$20240926$EXP$FR-AFSSAPS-TO2024001184$FR-TEVA-VS-3245424$TEVA$$$$$$Y$$$20240926$$MD$FR$FR
243681551$24368155$1$I$20240101$20240911$20240926$20240926$EXP$$JP-DAIICHI SANKYO, INC.-DSJ-2024-144655$DAIICHI$$76$YR$$M$Y$$$20240926$$CN$JP$JP
243681571$24368157$1$I$$20240918$20240926$20240926$EXP$$CA-PURDUE-USA-2024-0312168$PURDUE$$$$$F$Y$$$20240926$$HP$CA$CA
243681581$24368158$1$I$20240822$20240828$20240926$20240926$PER$$US-FMCRTG-FMC-2408-001081$FRESENIUS MEDICAL CARE$$79$YR$E$M$Y$$$20240926$$HP$US$US
243681601$24368160$1$I$20240911$20240919$20240926$20240926$PER$$US-ABBVIE-5933061$ABBVIE$$25$YR$$$Y$$$20240926$$HP$US$US
243681611$24368161$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152740$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240926$$HP$US$US
243681621$24368162$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152655$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$45.36$KG$20240926$$CN$US$US
243681651$24368165$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152625$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$70.31$KG$20240926$$CN$US$US
243681661$24368166$1$I$20240821$20240918$20240926$20240926$EXP$$FR-DSJP-DS-2024-100889-FR$DAIICHI$$$$E$F$Y$59$KG$20240926$$MD$FR$FR
243681681$24368168$1$I$20240801$20240925$20240926$20240926$EXP$$PE-PFIZER INC-PV202400112379$PFIZER$$$$A$M$Y$$$20240926$$CN$PE$PE
243681691$24368169$1$I$20240902$20240917$20240926$20240926$EXP$$JP-Eisai-EC-2024-174732$EISAI$$$$$F$Y$$$20240926$$MD$JP$JP
243681701$24368170$1$I$$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150531$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$64.5$KG$20240926$$PH$US$US
243681711$24368171$1$I$$20240918$20240926$20240926$EXP$$US-ALXN-202409USA002054US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240926$$MD$US$US
243681721$24368172$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015839$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$US$US
243681731$24368173$1$I$20240821$20240823$20240926$20240926$PER$$US-ABBVIE-5935988$ABBVIE$$34$YR$$F$Y$$$20240926$$HP$US$US
243681741$24368174$1$I$$20240828$20240926$20240926$PER$$US-SA-2024SA277518$SANOFI AVENTIS$$$$A$$Y$$$20240926$$HP$US$US
243681761$24368176$1$I$$20240828$20240926$20240926$PER$$US-SA-2024SA266991$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240926$$HP$US$US
243681771$24368177$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA274279$SANOFI AVENTIS$$69$YR$E$F$Y$79.83$KG$20240926$$MD$US$US
243681781$24368178$1$I$20240101$20240904$20240926$20240926$PER$$US-SA-2024SA273594$SANOFI AVENTIS$$63$YR$A$F$Y$83.91$KG$20240926$$MD$US$US
243681791$24368179$1$I$20240702$20240904$20240926$20240926$PER$$US-SA-2024SA273609$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240926$$PH$US$US
243681801$24368180$1$I$$20240829$20240926$20240926$PER$$US-SA-2024SA268769$SANOFI AVENTIS$$$$$F$Y$$$20240926$$CN$US$US
243681811$24368181$1$I$$20240830$20240926$20240926$PER$$US-SA-2024SA270906$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
243681821$24368182$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273876$SANOFI AVENTIS$$$$$F$Y$$$20240926$$HP$US$US
243681831$24368183$1$I$20240901$20240903$20240926$20240926$PER$$US-SA-2024SA273716$SANOFI AVENTIS$$17$YR$T$F$Y$102.73$KG$20240926$$MD$US$US
243681841$24368184$1$I$$20240918$20240926$20240926$PER$$US-BIOGEN-2024BI01283494$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243681851$24368185$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273906$SANOFI AVENTIS$$$$$F$Y$$$20240926$$CN$US$US
243681861$24368186$1$I$20210501$20240919$20240926$20240926$EXP$$CR-BIOGEN-2024BI01283665$BIOGEN$$0$YR$$M$Y$$$20240926$$CN$CR$CR
243681871$24368187$1$I$20240816$20240904$20240926$20240926$PER$$US-SA-2024SA273934$SANOFI AVENTIS$$41$YR$A$F$Y$98.02$KG$20240926$$MD$US$US
243681881$24368188$1$I$20231201$20240904$20240926$20240926$PER$$US-SA-2024SA274383$SANOFI AVENTIS$$1$YR$I$M$Y$15.05$KG$20240926$$MD$US$US
243681891$24368189$1$I$20240101$20240829$20240926$20240926$PER$$US-SA-2024SA268107$SANOFI AVENTIS$$73$YR$E$F$Y$80.86$KG$20240926$$MD$US$US
243681901$24368190$1$I$20230101$20240904$20240926$20240926$PER$$US-SA-2024SA276178$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240926$$MD$US$US
243681911$24368191$1$I$20240101$20240904$20240926$20240926$PER$$US-SA-2024SA272592$SANOFI AVENTIS$$23$YR$A$M$Y$56.36$KG$20240926$$MD$US$US
243681921$24368192$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273720$SANOFI AVENTIS$$$$A$M$Y$$$20240926$$HP$US$US
243681931$24368193$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273553$SANOFI AVENTIS$$$$A$M$Y$113.64$KG$20240926$$MD$US$US
243681941$24368194$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273542$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240926$$MD$US$US
243681951$24368195$1$I$20240901$20240904$20240926$20240926$PER$$US-SA-2024SA274080$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240926$$MD$US$US
243681961$24368196$1$I$20240101$20240904$20240926$20240926$PER$$US-SA-2024SA274886$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240926$$CN$US$US
243681971$24368197$1$I$$20240903$20240926$20240926$PER$$US-SA-2024SA270579$SANOFI AVENTIS$$15$YR$T$F$Y$45.45$KG$20240926$$MD$US$US
243681981$24368198$1$I$20240801$20240903$20240926$20240926$PER$$US-SA-2024SA273662$SANOFI AVENTIS$$43$YR$A$F$Y$72.73$KG$20240926$$MD$US$US
243681991$24368199$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA274871$SANOFI AVENTIS$$$$A$M$Y$104$KG$20240926$$MD$US$US
243682001$24368200$1$I$$20240903$20240926$20240926$PER$$US-SA-2024SA275144$SANOFI AVENTIS$$$$A$M$Y$$$20240926$$MD$US$US
243682021$24368202$1$I$$20240903$20240926$20240926$PER$$US-SA-2024SA272730$SANOFI AVENTIS$$$$A$F$Y$77.11$KG$20240926$$MD$US$US
243682031$24368203$1$I$$20240903$20240926$20240926$PER$$US-SA-2024SA273734$SANOFI AVENTIS$$$$A$$Y$$$20240926$$CN$US$US
243682041$24368204$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273544$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240926$$MD$US$US
243682051$24368205$1$I$$20240903$20240926$20240926$PER$$US-SA-2024SA273779$SANOFI AVENTIS$$$$A$F$Y$48.18$KG$20240926$$MD$US$US
243682061$24368206$1$I$$20240903$20240926$20240926$PER$$US-SA-2024SA195469$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240926$$CN$US$US
243682071$24368207$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273910$SANOFI AVENTIS$$$$E$F$Y$75.91$KG$20240926$$MD$US$US
243682081$24368208$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273777$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240926$$MD$US$US
243682091$24368209$1$I$$20240903$20240926$20240926$PER$$US-SA-2024SA275111$SANOFI AVENTIS$$$$E$M$Y$$$20240926$$CN$US$US
243682101$24368210$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273705$SANOFI AVENTIS$$$$T$F$Y$$$20240926$$MD$US$US
243682111$24368211$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273673$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
243682121$24368212$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA275162$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
243682131$24368213$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273907$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240926$$CN$US$US
243682141$24368214$1$I$20240101$20240904$20240926$20240926$PER$$US-SA-2024SA278117$SANOFI AVENTIS$$$$$F$Y$$$20240926$$CN$US$US
243682151$24368215$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA273350$SANOFI AVENTIS$$61$YR$A$M$Y$100$KG$20240926$$MD$US$US
243682161$24368216$1$I$20240822$20240904$20240926$20240926$PER$$US-SA-2024SA273645$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240926$$MD$US$US
243682171$24368217$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273115$SANOFI AVENTIS$$$$A$F$Y$98.43$KG$20240926$$HP$US$US
243682181$24368218$1$I$20240101$20240905$20240926$20240926$PER$$US-SA-2024SA273589$SANOFI AVENTIS$$58$YR$A$F$Y$86.36$KG$20240926$$MD$US$US
243682191$24368219$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273701$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240926$$HP$US$US
243682201$24368220$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA275077$SANOFI AVENTIS$$$$A$M$Y$65.91$KG$20240926$$MD$US$US
243682211$24368221$1$I$20240101$20240903$20240926$20240926$PER$$US-SA-2024SA274064$SANOFI AVENTIS$$60$YR$A$F$Y$90.71$KG$20240926$$HP$US$US
243682221$24368222$1$I$$20240904$20240926$20240926$PER$$US-SA-2024SA273727$SANOFI AVENTIS$$$$E$F$Y$$$20240926$$MD$US$US
243682231$24368223$1$I$20240601$20240904$20240926$20240926$PER$$US-SA-2024SA273661$SANOFI AVENTIS$$56$YR$A$F$Y$70$KG$20240926$$MD$US$US
243682241$24368224$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA273357$SANOFI AVENTIS$$$$A$M$Y$68$KG$20240926$$HP$US$US
243682251$24368225$1$I$20240101$20240905$20240926$20240926$PER$$US-SA-2024SA275587$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240926$$CN$US$US
243682261$24368226$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA273360$SANOFI AVENTIS$$$$$F$Y$$$20240926$$MD$US$US
243682271$24368227$1$I$20240101$20240904$20240926$20240926$PER$$US-SA-2024SA274684$SANOFI AVENTIS$$$$I$$Y$$$20240926$$HP$US$US
243682281$24368228$1$I$20240905$20240905$20240926$20240926$PER$$US-SA-2024SA273621$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240926$$PH$US$US
243682291$24368229$1$I$20240903$20240905$20240926$20240926$PER$$US-SA-2024SA275562$SANOFI AVENTIS$$62$YR$A$F$Y$72.1$KG$20240926$$MD$US$US
243682301$24368230$1$I$20240101$20240905$20240926$20240926$PER$$US-SA-2024SA275023$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240926$$CN$US$US
243682311$24368231$1$I$20240601$20240905$20240926$20240926$PER$$US-SA-2024SA274382$SANOFI AVENTIS$$66$YR$E$M$Y$81.82$KG$20240926$$MD$US$US
243682321$24368232$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA273696$SANOFI AVENTIS$$$$A$M$Y$$$20240926$$MD$US$US
243682331$24368233$1$I$20240101$20240904$20240926$20240926$PER$$US-SA-2024SA270688$SANOFI AVENTIS$$32$YR$A$F$Y$62.73$KG$20240926$$MD$US$US
243682341$24368234$1$I$20240923$20240923$20240926$20240926$PER$$US-GILEAD-2024-0688730$GILEAD$$$$$M$Y$$$20240926$$MD$US$US
243682361$24368236$1$I$20240101$20240905$20240926$20240926$PER$$US-SA-2024SA273435$SANOFI AVENTIS$$23$YR$A$F$Y$51.82$KG$20240926$$MD$US$US
243682371$24368237$1$I$20240801$20240905$20240926$20240926$PER$$US-SA-2024SA277197$SANOFI AVENTIS$$87$YR$E$F$Y$$$20240926$$HP$US$US
243682381$24368238$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA274003$SANOFI AVENTIS$$$$E$F$Y$$$20240926$$CN$US$US
243682391$24368239$1$I$20240616$20240905$20240926$20240926$PER$$US-SA-2024SA276265$SANOFI AVENTIS$$72$YR$E$F$Y$77.27$KG$20240926$$MD$US$US
243682401$24368240$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA274766$SANOFI AVENTIS$$$$E$F$Y$56.36$KG$20240926$$MD$US$US
243682411$24368241$1$I$20240101$20240905$20240926$20240926$PER$$US-SA-2024SA275857$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240926$$MD$US$US
243682421$24368242$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA274217$SANOFI AVENTIS$$$$A$M$Y$$$20240926$$MD$US$US
243682431$24368243$1$I$20240301$20240905$20240926$20240926$PER$$US-SA-2024SA275287$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240926$$MD$US$US
243682441$24368244$1$I$20240101$20240905$20240926$20240926$PER$$US-SA-2024SA273289$SANOFI AVENTIS$$29$YR$A$F$Y$61.23$KG$20240926$$MD$US$US
243682451$24368245$1$I$20230101$20240911$20240926$20240926$EXP$$BR-DSJP-DSE-2024-140076$DAIICHI$$$$$F$Y$93$KG$20240926$$MD$BR$BR
243682461$24368246$1$I$20240101$20240905$20240926$20240926$PER$$US-SA-2024SA274448$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240926$$MD$US$US
243682471$24368247$1$I$20240819$20240906$20240926$20240926$PER$$US-SA-2024SA277847$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240926$$MD$US$US
243682481$24368248$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA274832$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240926$$MD$US$US
243682491$24368249$1$I$$20240906$20240926$20240926$PER$$US-SA-2024SA277366$SANOFI AVENTIS$$$$C$F$Y$$$20240926$$CN$US$US
243682501$24368250$1$I$20240101$20240906$20240926$20240926$PER$$US-SA-2024SA276367$SANOFI AVENTIS$$26$YR$A$M$Y$105.91$KG$20240926$$MD$US$US
243682511$24368251$1$I$20231101$20240905$20240926$20240926$PER$$US-SA-2024SA274672$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240926$$CN$US$US
243682521$24368252$1$I$20240101$20240906$20240926$20240926$PER$$US-SA-2024SA277140$SANOFI AVENTIS$$56$YR$A$F$Y$71.48$KG$20240926$$CN$US$US
243682531$24368253$1$I$20240829$20240905$20240926$20240926$PER$$US-SA-2024SA273206$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240926$$MD$US$US
243682541$24368254$1$I$20240827$20240905$20240926$20240926$PER$$US-SA-2024SA276045$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240926$$MD$US$US
243682551$24368255$1$I$20240101$20240905$20240926$20240926$PER$$US-SA-2024SA273543$SANOFI AVENTIS$$58$YR$A$M$Y$84.09$KG$20240926$$MD$US$US
243682561$24368256$1$I$$20240906$20240926$20240926$PER$$US-SA-2024SA276382$SANOFI AVENTIS$$$$C$M$Y$$$20240926$$MD$US$US
243682571$24368257$1$I$20240101$20240905$20240926$20240926$PER$$US-SA-2024SA275447$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240926$$MD$US$US
243682581$24368258$1$I$20240101$20240905$20240926$20240926$PER$$US-SA-2024SA274638$SANOFI AVENTIS$$51$YR$A$F$Y$113.64$KG$20240926$$MD$US$US
243682591$24368259$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA275066$SANOFI AVENTIS$$$$E$M$Y$$$20240926$$MD$US$US
243682601$24368260$1$I$20240801$20240905$20240926$20240926$PER$$US-SA-2024SA275773$SANOFI AVENTIS$$7$YR$C$M$Y$32.43$KG$20240926$$MD$US$US
243682611$24368261$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA273439$SANOFI AVENTIS$$$$A$M$Y$68.18$KG$20240926$$MD$US$US
243682621$24368262$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA273509$SANOFI AVENTIS$$$$$F$Y$$$20240926$$MD$US$US
243682631$24368263$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA273566$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
243682641$24368264$1$I$20240101$20240905$20240926$20240926$PER$$US-SA-2024SA275089$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240926$$CN$US$US
243682651$24368265$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA274261$SANOFI AVENTIS$$$$E$F$Y$68.03$KG$20240926$$MD$US$US
243682661$24368266$1$I$20240101$20240906$20240926$20240926$PER$$PR-SA-2024SA276373$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240926$$MD$PR$US
243682671$24368267$1$I$20240901$20240905$20240926$20240926$PER$$US-SA-2024SA275285$SANOFI AVENTIS$$7$YR$C$M$Y$32.5$KG$20240926$$MD$US$US
243682681$24368268$1$I$$20240924$20240926$20240926$PER$$US-GILEAD-2024-0688713$GILEAD$$$$$M$Y$$$20240926$$MD$US$US
243682691$24368269$1$I$20240922$20240922$20240926$20240926$EXP$GB-MHRA-MED-202409221602223490-GMRCW$GB-009507513-2409GBR007830$MERCK$$73$YR$$F$Y$77$KG$20240926$$MD$GB$GB
243682701$24368270$1$I$$20240906$20240926$20240926$PER$$US-SA-2024SA276364$SANOFI AVENTIS$$$$A$M$Y$72.73$KG$20240926$$MD$US$US
243682711$24368271$1$I$20240823$20240906$20240926$20240926$PER$$US-SA-2024SA278059$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240926$$MD$US$US
243682721$24368272$1$I$$20240906$20240926$20240926$PER$$US-SA-2024SA276116$SANOFI AVENTIS$$$$A$F$Y$63.64$KG$20240926$$MD$US$US
243682731$24368273$1$I$20040101$20240911$20240926$20240926$PER$$US-SA-2024SA275331$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240926$$CN$US$US
243682741$24368274$1$I$$20240906$20240926$20240926$PER$$US-SA-2024SA277159$SANOFI AVENTIS$$$$A$M$Y$$$20240926$$MD$US$US
243682751$24368275$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA277962$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240926$$MD$US$US
243682761$24368276$1$I$20240906$20240911$20240926$20240926$PER$$US-SA-2024SA278589$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240926$$MD$US$US
243682771$24368277$1$I$$20240909$20240926$20240926$PER$$US-SA-2024SA275951$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$CN$US$US
243682781$24368278$1$I$20240604$20240908$20240926$20240926$PER$$US-SA-2024SA278592$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240926$$MD$US$US
243682791$24368279$1$I$20240907$20240907$20240926$20240926$PER$$US-SA-2024SA275827$SANOFI AVENTIS$$$$$$Y$$$20240926$$CN$US$US
243682801$24368280$1$I$20240101$20240906$20240926$20240926$PER$$US-SA-2024SA277442$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240926$$MD$US$US
243682811$24368281$1$I$$20240907$20240926$20240926$PER$$US-SA-2024SA276812$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240926$$HP$US$US
243682821$24368282$1$I$20240901$20240911$20240926$20240926$PER$$US-SA-2024SA278333$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240926$$MD$US$US
243682831$24368283$1$I$$20240909$20240926$20240926$PER$$US-SA-2024SA277005$SANOFI AVENTIS$$$$C$M$Y$21.36$KG$20240926$$MD$US$US
243682841$24368284$1$I$$20240906$20240926$20240926$PER$$US-SA-2024SA276636$SANOFI AVENTIS$$$$E$F$Y$289$KG$20240926$$HP$US$US
243682851$24368285$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA277315$SANOFI AVENTIS$$$$A$M$Y$$$20240926$$CN$US$US
243682861$24368286$1$I$$20240908$20240926$20240926$PER$$US-SA-2024SA276840$SANOFI AVENTIS$$$$E$M$Y$$$20240926$$MD$US$US
243682871$24368287$1$I$20240911$20240911$20240926$20240926$PER$$US-SA-2024SA277904$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240926$$PH$US$US
243682881$24368288$1$I$20240801$20240908$20240926$20240926$PER$$US-SA-2024SA277234$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240926$$MD$US$US
243682891$24368289$1$I$20240101$20240911$20240926$20240926$PER$$US-SA-2024SA278107$SANOFI AVENTIS$$57$YR$A$F$Y$73.64$KG$20240926$$MD$US$US
243682901$24368290$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA275453$SANOFI AVENTIS$$$$A$M$Y$$$20240926$$MD$US$US
243682911$24368291$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA278477$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240926$$HP$US$US
243682921$24368292$1$I$20240910$20240911$20240926$20240926$PER$$US-SA-2024SA274948$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240926$$CN$US$US
243682931$24368293$1$I$$20240910$20240926$20240926$PER$$US-SA-2024SA276943$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240926$$MD$US$US
243682941$24368294$1$I$20240801$20240909$20240926$20240926$PER$$US-SA-2024SA276377$SANOFI AVENTIS$$67$YR$E$M$Y$97.73$KG$20240926$$MD$US$US
243682951$24368295$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA278440$SANOFI AVENTIS$$$$E$M$Y$120.45$KG$20240926$$MD$US$US
243682961$24368296$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA278400$SANOFI AVENTIS$$$$E$F$Y$$$20240926$$MD$US$US
243682971$24368297$1$I$20240901$20240911$20240926$20240926$PER$$US-SA-2024SA278052$SANOFI AVENTIS$$10$YR$C$F$Y$$$20240926$$MD$US$US
243682981$24368298$1$I$20240909$20240911$20240926$20240926$PER$$US-SA-2024SA275431$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240926$$CN$US$US
243682991$24368299$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA277081$SANOFI AVENTIS$$$$$$Y$$$20240926$$PH$US$US
243683001$24368300$1$I$20240827$20240911$20240926$20240926$PER$$US-SA-2024SA277866$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240926$$MD$US$US
243683011$24368301$1$I$$20240911$20240926$20240926$PER$$US-SA-2022SA488867$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240926$$PH$US$US
243683021$24368302$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA278407$SANOFI AVENTIS$$$$E$F$Y$$$20240926$$MD$US$US
243683031$24368303$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA278402$SANOFI AVENTIS$$$$$F$Y$$$20240926$$CN$US$US
243683041$24368304$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA277601$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240926$$CN$US$US
243683051$24368305$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA278277$SANOFI AVENTIS$$62$YR$A$$Y$$$20240926$$CN$US$US
243683061$24368306$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA278469$SANOFI AVENTIS$$$$E$F$Y$$$20240926$$MD$US$US
243683071$24368307$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA277825$SANOFI AVENTIS$$$$A$F$Y$80.09$KG$20240926$$MD$US$US
243683081$24368308$1$I$20240101$20240911$20240926$20240926$PER$$US-SA-2024SA277029$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240926$$MD$US$US
243683091$24368309$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA278385$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240926$$CN$US$US
243683101$24368310$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA278050$SANOFI AVENTIS$$$$A$F$Y$90.71$KG$20240926$$MD$US$US
243683111$24368311$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA277630$SANOFI AVENTIS$$20$YR$A$$Y$$$20240926$$CN$US$US
243683121$24368312$1$I$20230101$20240911$20240926$20240926$PER$$US-SA-2024SA278004$SANOFI AVENTIS$$$$A$M$Y$104$KG$20240926$$PH$US$US
243683131$24368313$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA058744$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240926$$CN$US$US
243683141$24368314$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA278143$SANOFI AVENTIS$$$$A$M$Y$76.2$KG$20240926$$MD$US$US
243683151$24368315$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA277730$SANOFI AVENTIS$$49$YR$A$$Y$$$20240926$$CN$US$US
243683161$24368316$1$I$20240101$20240911$20240926$20240926$PER$$US-SA-2024SA278476$SANOFI AVENTIS$$57$YR$A$M$Y$72.57$KG$20240926$$MD$US$US
243683171$24368317$1$I$20221220$20240909$20240926$20240926$PER$$US-SA-2024SA277501$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240926$$MD$US$US
243683181$24368318$1$I$20240701$20240911$20240926$20240926$PER$$US-SA-2024SA277773$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240926$$MD$US$US
243683191$24368319$1$I$20240101$20240911$20240926$20240926$PER$$US-SA-2024SA278453$SANOFI AVENTIS$$76$YR$E$M$Y$106.82$KG$20240926$$MD$US$US
243683201$24368320$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA278495$SANOFI AVENTIS$$21$YR$A$F$Y$79.37$KG$20240926$$MD$US$US
243683211$24368321$1$I$20240101$20240911$20240926$20240926$PER$$US-SA-2024SA278111$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240926$$MD$US$US
243683221$24368322$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA274220$SANOFI AVENTIS$$$$A$M$Y$$$20240926$$MD$US$US
243683231$24368323$1$I$20240911$20240912$20240926$20240926$PER$$US-SA-2024SA273820$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240926$$CN$US$US
243683241$24368324$1$I$20240101$20240909$20240926$20240926$PER$$US-SA-2024SA276303$SANOFI AVENTIS$$24$YR$A$M$Y$113.64$KG$20240926$$MD$US$US
243683251$24368325$1$I$20240901$20240911$20240926$20240926$PER$$US-SA-2024SA276152$SANOFI AVENTIS$$7$YR$C$F$Y$22.73$KG$20240926$$MD$US$US
243683261$24368326$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA273087$SANOFI AVENTIS$$$$$M$Y$$$20240926$$CN$US$US
243683271$24368327$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA277540$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240926$$CN$US$US
243683281$24368328$1$I$20240911$20240911$20240926$20240926$PER$$US-SA-2024SA277892$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240926$$PH$US$US
243683291$24368329$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA275905$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240926$$CN$US$US
243683301$24368330$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA278608$SANOFI AVENTIS$$75$YR$E$$Y$$$20240926$$CN$US$US
243683312$24368331$2$F$$20240916$20240926$20240930$PER$$US-SA-2024SA277910$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240930$$HP$US$US
243683321$24368332$1$I$20240912$20240912$20240926$20240926$PER$$US-SA-2024SA276136$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240926$$CN$US$US
243683331$24368333$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA278571$SANOFI AVENTIS$$43$YR$A$$Y$$$20240926$$CN$US$US
243683341$24368334$1$I$20240701$20240912$20240926$20240926$PER$$US-SA-2024SA274116$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240926$$CN$US$US
243683351$24368335$1$I$$20240911$20240926$20240926$PER$$US-SA-2024SA277964$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240926$$HP$US$US
243683361$24368336$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA273220$SANOFI AVENTIS$$$$A$M$Y$$$20240926$$CN$US$US
243683371$24368337$1$I$20231116$20240912$20240926$20240926$PER$$US-SA-2024SA276101$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240926$$CN$US$US
243683381$24368338$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA273359$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240926$$CN$US$US
243683391$24368339$1$I$20240912$20240912$20240926$20240926$PER$$US-SA-2024SA274823$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240926$$MD$US$US
243683401$24368340$1$I$20230101$20240912$20240926$20240926$PER$$US-SA-2024SA274835$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240926$$MD$US$US
243683411$24368341$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA278483$SANOFI AVENTIS$$80$YR$E$$Y$$$20240926$$CN$US$US
243683421$24368342$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA277662$SANOFI AVENTIS$$$$A$F$Y$90.91$KG$20240926$$HP$US$US
243683431$24368343$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA273434$SANOFI AVENTIS$$$$$$Y$$$20240926$$CN$US$US
243683441$24368344$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA276165$SANOFI AVENTIS$$51$YR$A$F$Y$$$20240926$$CN$US$US
243683451$24368345$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA276195$SANOFI AVENTIS$$$$$M$Y$$$20240926$$MD$US$US
243683461$24368346$1$I$20240101$20240912$20240926$20240926$PER$$US-SA-2024SA274844$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240926$$CN$US$US
243683471$24368347$1$I$20240912$20240912$20240926$20240926$PER$$US-SA-2024SA276061$SANOFI AVENTIS$$3$YR$C$F$Y$34$KG$20240926$$CN$US$US
243683491$24368349$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA277613$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240926$$CN$US$US
243683501$24368350$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA276283$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240926$$CN$US$US
243683511$24368351$1$I$20230101$20240912$20240926$20240926$PER$$US-SA-2024SA277468$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240926$$CN$US$US
243683521$24368352$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA277848$SANOFI AVENTIS$$$$$M$Y$$$20240926$$CN$US$US
243683531$24368353$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA278574$SANOFI AVENTIS$$$$E$$Y$$$20240926$$MD$US$US
243683541$24368354$1$I$20240909$20240912$20240926$20240926$PER$$US-SA-2024SA277397$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240926$$CN$US$US
243683551$24368355$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA277954$SANOFI AVENTIS$$$$E$F$Y$$$20240926$$MD$US$US
243683571$24368357$1$I$20240101$20240912$20240926$20240926$PER$$US-SA-2024SA277966$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240926$$MD$US$US
243683581$24368358$1$I$20240812$20240912$20240926$20240926$PER$$US-SA-2024SA226486$SANOFI AVENTIS$$78$YR$E$F$Y$49.09$KG$20240926$$MD$US$US
243683591$24368359$1$I$$20240918$20240926$20240926$EXP$$US-ASTRAZENECA-202409USA001908US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240926$$$US$US
243683601$24368360$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA277497$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240926$$CN$US$US
243683612$24368361$2$F$$20240917$20240926$20240930$PER$$US-SA-2024SA277456$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240930$$CN$US$US
243683631$24368363$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA277600$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240926$$CN$US$US
243683641$24368364$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA277819$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240926$$CN$US$US
243683651$24368365$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA274815$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240926$$CN$US$US
243683661$24368366$1$I$20220101$20240913$20240926$20240926$PER$$US-SA-2024SA274566$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240926$$CN$US$US
243683681$24368368$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA273843$SANOFI AVENTIS$$$$E$F$Y$$$20240926$$CN$US$US
243683691$24368369$1$I$20240101$20240913$20240926$20240926$PER$$US-SA-2024SA278623$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240926$$CN$US$US
243683701$24368370$1$I$20220101$20240913$20240926$20240926$PER$$US-SA-2024SA278018$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240926$$CN$US$US
243683711$24368371$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA274708$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$HP$US$US
243683721$24368372$1$I$20240912$20240913$20240926$20240926$PER$$US-SA-2024SA273883$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240926$$CN$US$US
243683731$24368373$1$I$$20240913$20240926$20240926$PER$$US-SA-2024SA249656$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240926$$MD$US$US
243683742$24368374$2$F$$20240917$20240926$20240930$PER$$US-SA-2024SA278063$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240930$$CN$US$US
243683751$24368375$1$I$$20240913$20240926$20240926$PER$$US-SA-2024SA274111$SANOFI AVENTIS$$$$$F$Y$$$20240926$$MD$US$US
243683761$24368376$1$I$20240913$20240913$20240926$20240926$PER$$US-SA-2024SA276123$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240926$$CN$US$US
243683771$24368377$1$I$$20240913$20240926$20240926$PER$$US-SA-2024SA274372$SANOFI AVENTIS$$$$$$Y$$$20240926$$HP$US$US
243683781$24368378$1$I$$20240913$20240926$20240926$PER$$US-SA-2024SA274020$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240926$$CN$US$US
243683791$24368379$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA278555$SANOFI AVENTIS$$24$YR$A$$Y$$$20240926$$CN$US$US
243683801$24368380$1$I$$20240916$20240926$20240926$PER$$US-SA-2024SA276723$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240926$$CN$US$US
243683811$24368381$1$I$20240409$20240911$20240926$20240926$EXP$IT-MINISAL02-1001618$IT-DSJP-DSE-2024-144598$DAIICHI$$81$YR$$M$Y$$$20240926$$PH$IT$IT
243683821$24368382$1$I$20240910$20240916$20240926$20240926$PER$$US-SA-2024SA276331$SANOFI AVENTIS$$$$$F$Y$$$20240926$$CN$US$US
243683831$24368383$1$I$$20240914$20240926$20240926$PER$$US-SA-2024SA271892$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240926$$HP$US$US
243683841$24368384$1$I$$20240917$20240926$20240926$PER$$US-SA-2024SA193829$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240926$$MD$US$US
243683861$24368386$1$I$20240101$20240917$20240926$20240926$PER$$US-SA-2024SA271571$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240926$$MD$US$US
243683871$24368387$1$I$20240101$20240913$20240926$20240926$PER$$US-SA-2024SA273916$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240926$$HP$US$US
243683891$24368389$1$I$$20240917$20240926$20240926$PER$$US-SA-2024SA271456$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
243683902$24368390$2$F$20240916$20240916$20240926$20240930$PER$$US-SA-2024SA276447$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240930$$CN$US$US
243683911$24368391$1$I$20240901$20240916$20240926$20240926$PER$$US-SA-2024SA269051$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240926$$HP$US$US
243683921$24368392$1$I$$20240918$20240926$20240926$PER$$US-SA-2024SA271744$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240926$$HP$US$US
243683931$24368393$1$I$$20240917$20240926$20240926$PER$$US-SA-2024SA271525$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240926$$MD$US$US
243683941$24368394$1$I$20240801$20240917$20240926$20240926$PER$$US-SA-2024SA271494$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240926$$MD$US$US
243683951$24368395$1$I$$20240918$20240926$20240926$PER$$US-SA-2024SA276189$SANOFI AVENTIS$$$$A$F$Y$54.43$KG$20240926$$MD$US$US
243683961$24368396$1$I$$20240918$20240926$20240926$PER$$US-SA-2024SA272456$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
243683971$24368397$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA272426$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240926$$HP$US$US
243683991$24368399$1$I$20240801$20240917$20240926$20240926$PER$$US-SA-2024SA232632$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240926$$CN$US$US
243684001$24368400$1$I$20240701$20240916$20240926$20240926$PER$$US-SA-2024SA276409$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240926$$CN$US$US
243684011$24368401$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA272171$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240926$$HP$US$US
243684021$24368402$1$I$$20240916$20240926$20240926$PER$$US-SA-2024SA270541$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240926$$CN$US$US
243684031$24368403$1$I$20240914$20240917$20240926$20240926$PER$$US-SA-2024SA270121$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240926$$HP$US$US
243684041$24368404$1$I$20240901$20240917$20240926$20240926$PER$$US-SA-2024SA271602$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240926$$HP$US$US
243684051$24368405$1$I$20240101$20240917$20240926$20240926$PER$$US-SA-2024SA271676$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$HP$US$US
243684061$24368406$1$I$20240901$20240918$20240926$20240926$PER$$US-SA-2024SA271278$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240926$$HP$US$US
243684071$24368407$1$I$20240901$20240918$20240926$20240926$PER$$US-SA-2024SA271255$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240926$$MD$US$US
243684081$24368408$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA272336$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240926$$MD$US$US
243684091$24368409$1$I$$20240916$20240926$20240926$PER$$US-SA-2024SA274573$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240926$$MD$US$US
243684101$24368410$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA271948$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240926$$HP$US$US
243684111$24368411$1$I$20240101$20240916$20240926$20240926$PER$$US-SA-2022SA516248$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240926$$HP$US$US
243684121$24368412$1$I$20240916$20240916$20240926$20240926$PER$$US-SA-2024SA276390$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240926$$CN$US$US
243684131$24368413$1$I$20240101$20240917$20240926$20240926$PER$$US-SA-2024SA271581$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240926$$MD$US$US
243684141$24368414$1$I$20240801$20240918$20240926$20240926$PER$$US-SA-2024SA272479$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240926$$MD$US$US
243684161$24368416$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA272867$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240926$$MD$US$US
243684172$24368417$2$F$20240101$20240925$20240926$20240930$PER$$US-SA-2024SA270939$SANOFI AVENTIS$$35$YR$A$M$Y$$$20240930$$MD$US$US
243684181$24368418$1$I$$20240918$20240926$20240926$PER$$US-SA-2024SA271705$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
243684191$24368419$1$I$20240501$20240917$20240926$20240926$PER$$US-SA-2024SA271002$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240926$$HP$US$US
243684201$24368420$1$I$20240401$20240917$20240926$20240926$PER$$US-SA-2024SA271346$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240926$$PH$US$US
243684211$24368421$1$I$$20240917$20240926$20240926$PER$$US-SA-2024SA271555$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240926$$MD$US$US
243684221$24368422$1$I$20240101$20240918$20240926$20240926$PER$$US-SA-2024SA272012$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240926$$MD$US$US
243684231$24368423$1$I$20240101$20240917$20240926$20240926$PER$$US-SA-2024SA271412$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240926$$HP$US$US
243684241$24368424$1$I$20240101$20240917$20240926$20240926$PER$$US-SA-2024SA270808$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240926$$HP$US$US
243684251$24368425$1$I$20240901$20240919$20240926$20240926$PER$$US-SA-2024SA272346$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240926$$MD$US$US
243684261$24368426$1$I$20240101$20240919$20240926$20240926$PER$$US-SA-2024SA272788$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240926$$HP$US$US
243684271$24368427$1$I$20240601$20240919$20240926$20240926$PER$$US-SA-2024SA272589$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240926$$HP$US$US
243684281$24368428$1$I$20240801$20240917$20240926$20240926$PER$$US-SA-2024SA271541$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$HP$US$US
243684291$24368429$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272603$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240926$$HP$US$US
243684301$24368430$1$I$20240701$20240919$20240926$20240926$PER$$US-SA-2024SA272795$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240926$$HP$US$US
243684321$24368432$1$I$20240101$20240919$20240926$20240926$PER$$US-SA-2024SA272899$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240926$$MD$US$US
243684331$24368433$1$I$20240901$20240919$20240926$20240926$PER$$US-SA-2024SA272702$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240926$$HP$US$US
243684341$24368434$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272511$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240926$$MD$US$US
243684351$24368435$1$I$$20240918$20240926$20240926$PER$$US-SA-2024SA275301$SANOFI AVENTIS$$$$$F$Y$$$20240926$$HP$US$US
243684361$24368436$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272391$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240926$$MD$US$US
243684371$24368437$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272933$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240926$$MD$US$US
243684381$24368438$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272732$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240926$$MD$US$US
243684391$24368439$1$I$20240901$20240919$20240926$20240926$PER$$US-SA-2024SA272976$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240926$$CN$US$US
243684401$24368440$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272801$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240926$$HP$US$US
243684411$24368441$1$I$20240801$20240919$20240926$20240926$PER$$US-SA-2024SA272949$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240926$$HP$US$US
243684421$24368442$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272674$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
243684431$24368443$1$I$20230101$20240919$20240926$20240926$PER$$US-SA-2024SA272446$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240926$$MD$US$US
243684441$24368444$1$I$20240714$20240919$20240926$20240926$PER$$US-SA-2024SA273812$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240926$$CN$US$US
243684451$24368445$1$I$20240101$20240919$20240926$20240926$PER$$US-SA-2024SA272905$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240926$$MD$US$US
243684461$24368446$1$I$20240101$20240919$20240926$20240926$PER$$US-SA-2024SA272805$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240926$$HP$US$US
243684471$24368447$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272579$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240926$$MD$US$US
243684482$24368448$2$F$20240901$20240925$20240926$20240930$PER$$US-SA-2024SA272912$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240930$$HP$US$US
243684491$24368449$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272859$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$HP$US$US
243684501$24368450$1$I$20240801$20240919$20240926$20240926$PER$$US-SA-2024SA272797$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240926$$HP$US$US
243684511$24368451$1$I$20240901$20240919$20240926$20240926$PER$$US-SA-2024SA272729$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240926$$MD$US$US
243684521$24368452$1$I$20230901$20240919$20240926$20240926$PER$$US-SA-2024SA272843$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240926$$HP$US$US
243684531$24368453$1$I$20240901$20240924$20240926$20240926$PER$$US-SA-2024SA277137$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240926$$MD$US$US
243684541$24368454$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272525$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240926$$HP$US$US
243684551$24368455$1$I$20240701$20240919$20240926$20240926$PER$$US-SA-2024SA272975$SANOFI AVENTIS$$$$A$F$Y$$$20240926$$MD$US$US
243684571$24368457$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272534$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240926$$HP$US$US
243684581$24368458$1$I$$20240922$20240926$20240926$PER$$US-SA-2024SA275092$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240926$$CN$US$US
243684591$24368459$1$I$$20240919$20240926$20240926$PER$$US-SA-2024SA272869$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240926$$CN$US$US
243684601$24368460$1$I$$20240924$20240926$20240926$PER$$US-SA-2024SA277584$SANOFI AVENTIS$$$$T$F$Y$54.59$KG$20240926$$MD$US$US
243684611$24368461$1$I$20240819$20240924$20240926$20240926$PER$$US-SA-2024SA277921$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240926$$HP$US$US
243684621$24368462$1$I$$20240905$20240926$20240926$PER$$US-SA-2024SA273962$SANOFI AVENTIS$$$$A$F$Y$61.36$KG$20240926$$MD$US$US
243684641$24368464$1$I$$20240912$20240926$20240926$PER$$US-SA-2024SA278882$SANOFI AVENTIS$$65$YR$E$$Y$$$20240926$$CN$US$US
243684651$24368465$1$I$$20240919$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409013360$ELI LILLY AND CO$$49$YR$A$F$Y$$$20240926$$CN$US$US
243684661$24368466$1$I$$20240926$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016957$ELI LILLY AND CO$$$$$M$Y$$$20240926$$CN$US$US
243684671$24368467$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016324$ELI LILLY AND CO$$$$$$Y$$$20240926$$CN$US$US
243684681$24368468$1$I$$20240917$20240926$20240926$PER$$US-ABBVIE-5929103$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243684701$24368470$1$I$20240101$20240920$20240926$20240926$PER$$US-AMGEN-USASP2024188631$AMGEN$$86$YR$E$F$Y$$$20240926$$CN$US$US
243684711$24368471$1$I$20230301$20240917$20240926$20240926$EXP$$GB-TAKEDA-2024TUS093152$TAKEDA$$33$YR$$F$Y$$$20240926$$MD$GB$GB
243684721$24368472$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152352$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240926$$CN$US$US
243684731$24368473$1$I$$20240924$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-152524$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240926$$MD$JP$JP
243684741$24368474$1$I$20240918$20240919$20240926$20240926$EXP$$CZ-SAMSUNG BIOEPIS-SB-2024-28887$SAMSUNG BIOEPIS$$53$YR$A$F$Y$$$20240926$$CN$CZ$CZ
243684751$24368475$1$I$$20240924$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152868$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240926$$CN$US$US
243684761$24368476$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153002$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240926$$CN$US$US
243684771$24368477$1$I$20240919$20240920$20240926$20240926$EXP$$GB-SAMSUNG BIOEPIS-SB-2024-28813$SAMSUNG BIOEPIS$$35$YR$A$F$Y$$$20240926$$CN$GB$GB
243684781$24368478$1$I$20240830$20240831$20240926$20240926$PER$$US-SA-2024SA272208$SANOFI AVENTIS$$89$YR$E$F$Y$$$20240927$$MD$US$US
243684791$24368479$1$I$20240919$20240919$20240926$20240926$PER$$US-JNJFOC-20240960942$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240926$$CN$US$US
243684801$24368480$1$I$$20240918$20240926$20240926$EXP$$SK-TAKEDA-2024TUS090149$TAKEDA$$8$DEC$$M$Y$96$KG$20240926$$MD$SK$SK
243684811$24368481$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153024$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240926$$CN$US$US
243684821$24368482$1$I$$20240918$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-152136$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240926$$MD$JP$JP
243684831$24368483$1$I$20240826$20240923$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152121$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240926$$CN$US$US
243684841$24368484$1$I$$20240919$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149692$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240926$$CN$US$US
243684851$24368485$1$I$$20240926$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152952$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240926$$CN$US$US
243684861$24368486$1$I$20240924$20240925$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152669$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240926$$HP$US$US
243684871$24368487$1$I$$20240923$20240926$20240926$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-151997$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240926$$MD$FR$FR
243684881$24368488$1$I$$20240919$20240926$20240926$EXP$$US-BIOGEN-2024BI01283510$BIOGEN$$$$$M$Y$95.8$KG$20240926$$CN$US$US
243684892$24368489$2$F$20240901$20240923$20240926$20240928$PER$$US-ABBVIE-5937506$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243684901$24368490$1$I$$20240411$20240926$20240926$30DAY$$PA-PFIZER INC-PV202400049164$PFIZER$$13$YR$$F$Y$$$20240926$$HP$PA$PA
243684911$24368491$1$I$$20240911$20240926$20240926$PER$$US-JNJFOC-20240934808$JOHNSON AND JOHNSON$$$$$F$Y$$$20240926$$CN$US$US
243684921$24368492$1$I$20220420$20240919$20240926$20240926$EXP$$KR-009507513-2409KOR008282$MERCK$$37$YR$$F$Y$75.5$KG$20240926$$MD$KR$KR
243684931$24368493$1$I$$20240923$20240926$20240926$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-016003$JAZZ$$$$$M$Y$$$20240926$$MD$US$US
243684941$24368494$1$I$20240901$20240920$20240926$20240926$EXP$$NVSC2024DE179680$NOVARTIS$$$$A$F$Y$$$20240927$$CN$DE$DE
243684951$24368495$1$I$$20240924$20240926$20240926$PER$$US-JNJFOC-20240966574$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240926$$CN$US$US
243684961$24368496$1$I$$20240924$20240926$20240926$PER$$US-JNJFOC-20240966581$JOHNSON AND JOHNSON$$$$$$Y$$$20240926$$CN$US$US
243684971$24368497$1$I$20240420$20240926$20240926$20240926$EXP$FR-AFSSAPS-NC2024001134$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053601$BOEHRINGER INGELHEIM$$61$YR$A$M$Y$80$KG$20240926$$CN$FR$FR
243684991$24368499$1$I$20240101$20240910$20240926$20240926$PER$$US-009507513-2409USA003455$MERCK$$$$$M$Y$$$20240926$$CN$US$US
243685001$24368500$1$I$20240917$20240919$20240926$20240926$EXP$$AR-BIOGEN-2024BI01283587$BIOGEN$$29$YR$$M$Y$$$20240926$$CN$AR$AR
243685011$24368501$1$I$20240516$20240826$20240926$20240926$EXP$$SG-GSK-SG2024APC118395$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$CN$SG$SG
243685021$24368502$1$I$20240916$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016963$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240926$$CN$US$US
243685031$24368503$1$I$20240901$20240920$20240926$20240926$EXP$$DE-BIOGEN-2024BI01282895$BIOGEN$$35$YR$$F$Y$$$20240926$$CN$DE$DE
243685041$24368504$1$I$20240820$20240917$20240926$20240926$PER$$JP-Eisai-EC-2024-174724$EISAI$$$$E$M$Y$$$20240926$$MD$JP$JP
243685051$24368505$1$I$20230131$20240916$20240926$20240926$EXP$FR-AFSSAPS-MA2024001484$FR-Eisai-EC-2024-174386$EISAI$$68$YR$E$F$Y$$$20240926$$CN$FR$FR
243685061$24368506$1$I$$20240925$20240926$20240926$PER$$US-DAIICHI SANKYO, INC.-DS-2024-101408-US$DAIICHI$$$$$F$Y$$$20240926$$MD$US$US
243685081$24368508$1$I$$20240918$20240926$20240926$EXP$$US-ASTRAZENECA-202409USA001991US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240926$$$US$US
243685091$24368509$1$I$$20240911$20240926$20240926$PER$$US-JNJFOC-20240933629$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240926$$CN$US$US
243685101$24368510$1$I$20240101$20240920$20240926$20240926$PER$$US-JNJFOC-20240960101$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240926$$CN$US$US
243685121$24368512$1$I$$20240920$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150199$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240927$$CN$US$US
243685131$24368513$1$I$$20240923$20240926$20240926$PER$$US-ABBVIE-5936598$ABBVIE$$$$$F$Y$$$20240926$$HP$US$US
243685141$24368514$1$I$$20240919$20240926$20240926$PER$$IT-GSK-IT2024GSK117819$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$IT$IT
243685151$24368515$1$I$$20240919$20240926$20240926$PER$$IT-GSK-IT2024GSK118230$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$HP$IT$IT
243685161$24368516$1$I$$20240923$20240926$20240926$EXP$$US-GSK-US2024GSK117989$GLAXOSMITHKLINE$Raghavan S, Gillespie Ct, Mehta Ac, Farooq S. Look Before You Nebulize: Endobronchial Nocardiosis. Chest. 2024;166 (4):A20$$$$$Y$$$20240926$$HP$US$US
243685171$24368517$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152644$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$$$20240927$$CN$US$US
243685181$24368518$1$I$$20240924$20240926$20240926$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-151864$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240927$$CN$PR$PR
243685191$24368519$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5936218$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243685201$24368520$1$I$$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152047$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240927$$CN$US$US
243685211$24368521$1$I$20160101$20240920$20240926$20240926$PER$$US-AMGEN-USASP2024188792$AMGEN$$58$YR$A$F$Y$$$20240926$$CN$US$US
243685221$24368522$1$I$20240912$20240919$20240926$20240926$EXP$$CA-JNJFOC-20240957350$JOHNSON AND JOHNSON$$13$YR$T$F$Y$$$20240927$$HP$CA$CA
243685231$24368523$1$I$20240906$20240913$20240926$20240926$EXP$GB-MHRA-TPP19400070C711449YC1726142714525$GB-ESPERION THERAPEUTICS, INC-2024GBR01468$ESPERION THERAPEUTICS$$77$YR$$M$Y$88$KG$20240927$$MD$GB$GB
243685241$24368524$1$I$$20240918$20240926$20240926$EXP$$US-GSK-US2024GSK116919$GLAXOSMITHKLINE$Prucnal CK, Jansson PS, Chai PR, Hallisey SD, Monette DL, Wittels KA. A Young Woman with Apparent Brain Death. The Journal of emergency medicine. 2024;1-7$$$$$Y$$$20240926$$MD$US$US
243685251$24368525$1$I$$20240913$20240926$20240926$PER$$US-SA-2024SA273994$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240927$$CN$US$US
243685261$24368526$1$I$$20240918$20240926$20240926$EXP$PL-LESVI-2024004732$PL-GSK-PL2024108237$GLAXOSMITHKLINE$$$$$$Y$$$20240926$$MD$PL$PL
243685271$24368527$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191311$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
243685281$24368528$1$I$$20240920$20240926$20240926$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-152397$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240927$$MD$JP$JP
243685291$24368529$1$I$$20240918$20240926$20240926$PER$$US-ABBVIE-5929479$ABBVIE$$$$A$F$Y$$$20240926$$CN$US$US
243685301$24368530$1$I$20240912$20240924$20240926$20240926$EXP$$CN-ROCHE-10000091654$ROCHE$$75$YR$E$F$Y$54$KG$20240927$$HP$CN$CN
243685321$24368532$1$I$$20240925$20240926$20240926$PER$$NVSC2024US191608$NOVARTIS$$$$$$Y$$$20240927$$CN$US$US
243685331$24368533$1$I$$20240920$20240926$20240926$EXP$$NVSJ2024JP011281$NOVARTIS$Miyagawa H, Hara H, Araya J, Minagawa S, Numata T, Umezawa Y, et al. Characteristics of anti-IL-17/23 biologicsinduced interstitial pneumonia in patients with psoriasis. PLOS ONE. 2021$77$YR$$M$Y$$$20240927$$HP$JP$JP
243685351$24368535$1$I$20240101$20240918$20240926$20240926$PER$$US-AMGEN-USASP2024186798$AMGEN$$$$E$F$Y$$$20240926$$CN$US$US
243685361$24368536$1$I$$20240924$20240926$20240926$EXP$$JP-TAKEDA-2022TJP079127$TAKEDA$$7$DEC$$F$Y$$$20240926$$PH$JP$JP
243685371$24368537$1$I$$20240826$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2024US083109$SANDOZ$$$$$$Y$$$20240926$$HP$US$US
243685381$24368538$1$I$$20240923$20240926$20240926$30DAY$$US-SANDOZ INC.-SDZ2024US082387$SANDOZ$$$$$F$Y$$$20240926$$CN$US$US
243685391$24368539$1$I$20240918$20240918$20240926$20240926$PER$$US-JNJFOC-20240958060$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$MD$US$US
243685401$24368540$1$I$$20240925$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2024US083071$SANDOZ$$$$$F$Y$$$20240926$$CN$US$US
243685431$24368543$1$I$$20240917$20240926$20240926$EXP$$JP-AMGEN-JPNSP2024191093$AMGEN$$$$$$Y$$$20240926$$MD$JP$JP
243685441$24368544$1$I$20240920$20240924$20240926$20240926$EXP$$NVSJ2024JP011256$NOVARTIS$$$$$M$Y$$$20240927$$MD$JP$JP
243685451$24368545$1$I$$20240916$20240926$20240926$EXP$GB-NORGINE LIMITED-NOR202104286$GB-SANDOZ INC.-NVSC2022GB106137$SANDOZ$$$$E$F$Y$$$20240926$$HP$GB$GB
243685471$24368547$1$I$20240919$20240919$20240926$20240926$PER$$US-GSK-US2024116645$GLAXOSMITHKLINE$$63$YR$$M$Y$$$20240926$$CN$US$US
243685481$24368548$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001679$ORGANON$$$$$F$Y$97$KG$20240926$$HP$CA$CA
243685491$24368549$1$I$20240101$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189752$AMGEN$$$$A$F$Y$$$20240926$$HP$US$US
243685501$24368550$1$I$$20240919$20240926$20240926$PER$$US-BIOGEN-2024BI01283761$BIOGEN$$$$$M$Y$$$20240926$$CN$US$US
243685511$24368551$1$I$$20240917$20240926$20240926$EXP$$US-JNJFOC-20240944897$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243685521$24368552$1$I$20240814$20240904$20240926$20240926$30DAY$$US-JNJFOC-20240850489$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240927$$CN$US$US
243685531$24368553$1$I$$20240904$20240926$20240926$30DAY$$DE-JNJFOC-20240927252$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$DE$DE
243685551$24368555$1$I$$20240925$20240926$20240926$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053464$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240927$$CN$DE$DE
243685561$24368556$1$I$20240923$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190165$AMGEN$$67$YR$E$F$Y$$$20240926$$CN$US$US
243685571$24368557$1$I$$20240920$20240926$20240926$PER$$US-AMGEN-USASP2024188397$AMGEN$Hawwa,N. lvabradine and Milrinone-Bridge to Recovery in New HFrEF With Low-Output Heart Failure. Case Reports in Cardiology. 2024;2024:1-13$44$YR$A$M$Y$$$20240926$$HP$US$US
243685581$24368558$1$I$20240201$20240923$20240926$20240926$EXP$$US-ABBVIE-5936163$ABBVIE$$33$YR$$F$Y$$$20240926$$CN$US$US
243685591$24368559$1$I$$20240916$20240926$20240926$EXP$$CA-PRINSTON PHARMACEUTICAL INC.-2024PRN00352$PRINSTON PHARMACEUTICAL$Alenezi A.F, Alnuaimi A, Liberman D. SIADH and mixed delirium following the abrupt cessation of long-acting benzodiazepines: a case report. Oxford Medical Case Reports. 2024;9:381-383$85$YR$$F$Y$$$20240926$$HP$CA$CA
243685601$24368560$1$I$$20240209$20240926$20240926$EXP$$ES-ABBVIE-5939046$ABBVIE$Pocurull A, Moreta MJ, Heitman D, Olivas I, Collazos C, Canga E, et al. Anticancer drugs are the first cause of drug induced liver injury in a reference hospital. Liver International. 2024;44(2):286-92.$$$$$Y$$$20240926$$HP$ES$ES
243685621$24368562$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960305$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20240927$$MD$US$US
243685631$24368563$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016589$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$US$US
243685641$24368564$1$I$20240923$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191743$AMGEN$$59$YR$A$F$Y$$$20240926$$CN$US$US
243685651$24368565$1$I$20240920$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190991$AMGEN$$72$YR$E$F$Y$$$20240926$$CN$US$US
243685661$24368566$1$I$20240909$20240919$20240926$20240926$EXP$$CO-ABBVIE-5939980$ABBVIE$$59$YR$$F$Y$50$KG$20240926$$HP$CO$CO
243685671$24368567$1$I$$20240904$20240926$20240926$30DAY$$BR-JNJFOC-20240930745$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$BR$BR
243685691$24368569$1$I$20240901$20240920$20240926$20240926$EXP$$US-ABBVIE-5934294$ABBVIE$$79$YR$$F$Y$$$20240926$$CN$US$US
243685701$24368570$1$I$$20240904$20240926$20240926$30DAY$$HR-JNJFOC-20240930929$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$HR$HR
243685712$24368571$2$F$20240728$20240926$20240926$20240928$EXP$$PR-ABBVIE-5940126$ABBVIE$$70$YR$$F$Y$$$20240928$$CN$PR$PR
243685721$24368572$1$I$$20240920$20240926$20240926$EXP$$NVSJ2024JP011285$NOVARTIS$Miyagawa H, hara H, Araya J, Minagawa S, Numata T, Umezawa Y, et al. Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis. PLOS ONE. 2021$56$YR$$F$Y$$$20240927$$HP$JP$JP
243685731$24368573$1$I$20240101$20240923$20240926$20240926$30DAY$$US-AMGEN-USASP2024189417$AMGEN$$52$YR$A$M$Y$80.9$KG$20240926$$PH$US$US
243685742$24368574$2$F$20240101$20240925$20240926$20240930$PER$$US-AMGEN-USASP2024187635$AMGEN$$28$YR$A$M$Y$$$20240930$$CN$US$US
243685751$24368575$1$I$$20240916$20240926$20240926$EXP$$US-JNJFOC-20240947722$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240927$$MD$US$US
243685761$24368576$1$I$20240321$20240926$20240926$20240926$EXP$ES-AEMPS-1571768$ES-JNJFOC-20240970343$JOHNSON AND JOHNSON$$93$YR$E$M$Y$70$KG$20240927$$MD$ES$ES
243685771$24368577$1$I$20230803$20240923$20240926$20240926$EXP$$DE-ABBVIE-5937378$ABBVIE$$69$YR$$F$Y$$$20240926$$MD$DE$DE
243685781$24368578$1$I$20240910$20240920$20240926$20240926$EXP$$AR-BIOGEN-2024BI01283830$BIOGEN$$38$YR$$F$Y$$$20240926$$CN$AR$AR
243685792$24368579$2$F$$20240925$20240926$20240930$EXP$$US-BIOGEN-2024BI01284135$BIOGEN$$$$$F$Y$77.7$KG$20240930$$CN$US$US
243685801$24368580$1$I$$20240920$20240926$20240926$EXP$$US-BIOGEN-2024BI01283737$BIOGEN$$$$$M$Y$$$20240926$$CN$US$US
243685811$24368581$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001681$ORGANON$$$$$F$Y$$$20240926$$HP$CA$CA
243685851$24368585$1$I$$20240925$20240926$20240926$EXP$$NVSJ2024JP011274$NOVARTIS$$$$$$Y$$$20240927$$MD$JP$JP
243685861$24368586$1$I$$20240916$20240926$20240926$PER$$US-JNJFOC-20240939316$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20240927$$CN$US$US
243685871$24368587$1$I$$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190886$AMGEN$$$$$M$Y$$$20240926$$CN$US$US
243685881$24368588$1$I$20240101$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190665$AMGEN$$56$YR$A$F$Y$$$20240926$$CN$US$US
243685891$24368589$1$I$$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150833$BRISTOL MYERS SQUIBB$Wagmeister S, Shadrix A, Khalid S, Sundaram RK. Gasoline on a fire: a case of group a streptococci necrotizing pneumonia. Chest. 2024;166(4S):1001A-2A. doi:10.1016/j.chest.2024.06.666.$51$YR$A$M$Y$$$20240927$$HP$US$US
243685901$24368590$1$I$20180101$20240911$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153029$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$85.3$KG$20240927$$MD$US$US
243685921$24368592$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960125$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20240927$$HP$US$US
243685931$24368593$1$I$$20240924$20240926$20240926$EXP$$US-SANDOZ INC.-SDZ2024US082846$SANDOZ$$$$$F$Y$$$20240926$$CN$US$US
243685941$24368594$1$I$20240801$20240917$20240926$20240926$EXP$$CO-JNJFOC-20240863706$JOHNSON AND JOHNSON$$81$YR$E$M$Y$78$KG$20240927$$HP$CO$CO
243685951$24368595$1$I$$20240923$20240926$20240926$EXP$$GB-ABBVIE-5937388$ABBVIE$$$$$$Y$$$20240926$$HP$GB$GB
243685961$24368596$1$I$$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024189746$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243685981$24368598$1$I$$20240905$20240926$20240926$30DAY$$BE-JNJFOC-20240914949$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$BE$BE
243685991$24368599$1$I$$20240919$20240926$20240926$EXP$$IN-AMGEN-INDSP2024188425$AMGEN$Garg K.; Kale S.S.; Mishra S. et al.. Surgical Management of Extradural Tumors at the Craniovertebral Junction - Insights from a Tertiary Care  Center. World Neurosurgery. 2024;189:e652-e661$20$YR$A$M$Y$$$20240926$$HP$IN$IN
243686001$24368600$1$I$20240901$20240917$20240926$20240926$PER$$US-AMGEN-USASP2024186698$AMGEN$$$$A$M$Y$$$20240926$$MD$US$US
243686021$24368602$1$I$20240915$20240916$20240926$20240926$PER$$US-BAUSCHBL-2024BNL033575$BAUSCH AND LOMB$$68$YR$$F$Y$$$20240927$$CN$US$US
243686031$24368603$1$I$$20240921$20240926$20240926$EXP$$BR-TAKEDA-2024TUS095097$TAKEDA$$$$$$Y$$$20240926$$CN$BR$BR
243686041$24368604$1$I$$20240915$20240926$20240926$PER$$US-BAUSCHBL-2024BNL033667$BAUSCH AND LOMB$$$$$F$Y$$$20240927$$CN$US$US
243686052$24368605$2$F$20240903$20240917$20240926$20240930$EXP$$US-ABBVIE-5928462$ABBVIE$$57$YR$$F$Y$$$20240930$$CN$US$US
243686071$24368607$1$I$20240902$20240924$20240926$20240926$EXP$FR-AFSSAPS-BS2024000668$FR-ABBVIE-5937104$ABBVIE$$68$YR$$F$Y$62$KG$20240926$$MD$FR$FR
243686081$24368608$1$I$$20240923$20240926$20240926$PER$$US-ABBVIE-5937687$ABBVIE$$$$$F$Y$$$20240926$$HP$US$US
243686091$24368609$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960164$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240927$$MD$US$US
243686101$24368610$1$I$20230101$20240923$20240926$20240926$PER$$US-ABBVIE-5935718$ABBVIE$$$$$M$Y$68$KG$20240926$$CN$US$US
243686112$24368611$2$F$20240619$20240926$20240926$20240927$EXP$$CO-ABBVIE-5935573$ABBVIE$$38$YR$$F$Y$$$20240927$$MD$CO$CO
243686121$24368612$1$I$20231012$20240830$20240926$20240926$EXP$FR-AFSSAPS-AN2024000213$FR-CELLTRION INC.-2024FR022711$CELLTRION$$$$$$Y$$$20240927$$MD$FR$FR
243686171$24368617$1$I$$20240918$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150696$BRISTOL MYERS SQUIBB$$96$YR$E$M$Y$71.21$KG$20240927$$MD$US$US
243686181$24368618$1$I$20240911$20240923$20240926$20240926$EXP$$US-ABBVIE-5936672$ABBVIE$$83$YR$$M$Y$$$20240926$$CN$US$US
243686191$24368619$1$I$20240101$20240920$20240926$20240926$EXP$$CA-ABBVIE-5938259$ABBVIE$$$$E$F$Y$$$20240926$$CN$CA$CA
243686201$24368620$1$I$$20240924$20240926$20240926$EXP$$JP-TAKEDA-2024TJP014066$TAKEDA$$$$$M$Y$$$20240926$$CN$JP$JP
243686211$24368621$1$I$$20240920$20240926$20240926$EXP$$US-ABBVIE-5933515$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243686221$24368622$1$I$20240101$20240920$20240926$20240926$EXP$$US-ABBVIE-5933551$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243686231$24368623$1$I$$20240923$20240926$20240926$EXP$$CA-ABBVIE-5935978$ABBVIE$$9$YR$$M$Y$22$KG$20240926$$HP$CA$CA
243686241$24368624$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152884$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240927$$CN$US$US
243686251$24368625$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151998$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240927$$HP$US$US
243686301$24368630$1$I$20231101$20240923$20240926$20240926$EXP$$CA-ABBVIE-5937164$ABBVIE$$$$A$M$Y$$$20240926$$CN$CA$CA
243686311$24368631$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960206$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240927$$MD$US$US
243686321$24368632$1$I$20240924$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191291$AMGEN$$33$YR$A$F$Y$$$20240926$$CN$US$US
243686331$24368633$1$I$$20240925$20240926$20240926$PER$$US-AMGEN-USASP2024191463$AMGEN$$$$E$F$Y$$$20240926$$HP$US$US
243686341$24368634$1$I$20240904$20240923$20240926$20240926$EXP$$CA-ABBVIE-5936596$ABBVIE$$62$YR$$M$Y$$$20240926$$CN$CA$CA
243686351$24368635$1$I$$20240923$20240926$20240926$PER$$US-AMGEN-USASP2024190558$AMGEN$Davisc, K. L.; Matusov G.. PAP IN THE PASTA FACTORY: A CASE OF AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS. Chest. 2024;166 (4):A3409-A3410$61$YR$A$M$Y$$$20240926$$HP$US$US
243686361$24368636$1$I$20240922$20240923$20240926$20240926$EXP$$US-ABBVIE-5936827$ABBVIE$$48$YR$$F$Y$$$20240926$$CN$US$US
243686371$24368637$1$I$$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152961$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240927$$HP$US$US
243686391$24368639$1$I$$20240905$20240926$20240926$PER$$US-BEIGENE-BGN-2024-014237$BEIGENE$$$$$$Y$$$20240926$$CN$US$US
243686401$24368640$1$I$$20240920$20240926$20240926$EXP$$US-JNJFOC-20240959664$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240927$$HP$US$US
243686421$24368642$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960208$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240927$$MD$US$US
243686441$24368644$1$I$20130101$20240920$20240926$20240926$PER$$US-JNJFOC-20240962436$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20240927$$HP$US$US
243686451$24368645$1$I$20230101$20240917$20240926$20240926$EXP$$US-ABBVIE-5929317$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243686461$24368646$1$I$$20240924$20240926$20240926$EXP$$US-BIOGEN-2024BI01284154$BIOGEN$$$$$F$Y$$$20240926$$CN$US$US
243686471$24368647$1$I$$20240921$20240926$20240926$EXP$$BR-BIOGEN-2024BI01284117$BIOGEN$$$$$F$Y$105$KG$20240926$$CN$BR$BR
243686481$24368648$1$I$20231015$20240902$20240926$20240926$EXP$IT-MINISAL02-976211$IT-CELLTRION INC.-2024IT022685$CELLTRION$$$$$$Y$$$20240927$$MD$IT$IT
243686491$24368649$1$I$20140920$20240920$20240926$20240926$EXP$$US-ABBVIE-5935836$ABBVIE$$53$YR$$F$Y$$$20240926$$CN$US$US
243686501$24368650$1$I$$20240920$20240926$20240926$EXP$$GB-JNJFOC-20240963776$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20240927$$HP$GB$GB
243686511$24368651$1$I$$20240924$20240926$20240926$EXP$$DE-ABBVIE-5939127$ABBVIE$$81$YR$$M$Y$$$20240926$$CN$DE$DE
243686521$24368652$1$I$$20240921$20240926$20240926$EXP$$GB-ABBVIE-5936794$ABBVIE$$$$E$F$Y$$$20240926$$CN$GB$GB
243686531$24368653$1$I$20240919$20240920$20240926$20240926$EXP$$KR-BIOGEN-2024BI01284121$BIOGEN$$$$$F$Y$$$20240926$$CN$KR$KR
243686551$24368655$1$I$$20240924$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409015143$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240926$$CN$US$US
243686561$24368656$1$I$$20240919$20240926$20240926$EXP$$US-JNJFOC-20240960263$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240927$$MD$US$US
243686581$24368658$1$I$$20240923$20240926$20240926$EXP$$CA-ABBVIE-5939563$ABBVIE$$$$$M$Y$$$20240926$$HP$CA$CA
243686601$24368660$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10583$CIPLA$$$$$$Y$$$20240927$$CN$AU$AU
243686621$24368662$1$I$20240101$20240920$20240926$20240926$EXP$$US-ABBVIE-5821793$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243686631$24368663$1$I$$20240918$20240926$20240926$EXP$$CA-DAIICHI SANKYO, INC.-DS-2024-101463-CA$DAIICHI$$$$$F$Y$$$20240927$$CN$CA$CA
243686641$24368664$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10488$CIPLA$Borchmann P, Ferdinandus J, Schneider G, Moccia A, Greil R, Hertzberg M et al. Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised multicentre, parallel, open-label, phase 3 trial. The Lancet. 2024;1 to 12$$$$$Y$$$20240927$$HP$AU$AU
243686651$24368665$1$I$20240918$20240924$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152885$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240927$$CN$US$US
243686661$24368666$1$I$$20240909$20240926$20240926$PER$$US-JNJFOC-20240921727$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$HP$US$US
243686671$24368667$1$I$$20240912$20240926$20240926$EXP$$AU-CIPLA LTD.-2024AU10554$CIPLA$$$$$$Y$$$20240927$$CN$AU$AU
243686681$24368668$1$I$$20240906$20240926$20240926$PER$$US-BEIGENE-BGN-2024-014317$BEIGENE$$$$$$Y$$$20240926$$CN$US$US
243686691$24368669$1$I$$20240908$20240926$20240926$PER$$US-BEIGENE-BGN-2024-014334$BEIGENE$$$$$$Y$$$20240926$$CN$US$US
243686711$24368671$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5936926$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243686721$24368672$1$I$20240918$20240918$20240926$20240926$EXP$$US-JNJFOC-20240958663$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240927$$HP$US$US
243686731$24368673$1$I$$20240909$20240926$20240926$PER$$US-JNJFOC-20240921637$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$HP$US$US
243686741$24368674$1$I$20240101$20240924$20240926$20240926$PER$$US-AMGEN-USASP2024190821$AMGEN$$77$YR$E$F$Y$$$20240926$$CN$US$US
243686761$24368676$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152926$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$$$20240927$$CN$US$US
243686771$24368677$1$I$20230910$20240912$20240926$20240926$EXP$$GB-CIPLA LTD.-2024GB10373$CIPLA$$$$$$Y$$$20240927$$MD$GB$GB
243686781$24368678$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152701$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$68$KG$20240927$$PH$US$US
243686791$24368679$1$I$20240101$20240920$20240926$20240926$EXP$$US-ABBVIE-5935284$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243686801$24368680$1$I$20130701$20240920$20240926$20240926$PER$$US-JNJFOC-20240962804$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20240927$$HP$US$US
243686811$24368681$1$I$$20240917$20240926$20240926$EXP$$US-JNJFOC-20240944434$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$CN$US$US
243686821$24368682$1$I$20240101$20240923$20240926$20240926$EXP$$US-ABBVIE-5936015$ABBVIE$$$$$M$Y$$$20240926$$CN$US$US
243686831$24368683$1$I$20240917$20240918$20240926$20240926$EXP$$US-JNJFOC-20240957708$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20240927$$MD$US$US
243686841$24368684$1$I$20240101$20240918$20240926$20240926$EXP$$BR-JNJFOC-20240843199$JOHNSON AND JOHNSON$$56$YR$A$F$Y$59$KG$20240927$$CN$BR$BR
243686851$24368685$1$I$20240101$20240923$20240926$20240926$EXP$$GB-ABBVIE-5937394$ABBVIE$$69$YR$$M$Y$$$20240926$$CN$GB$GB
243686871$24368687$1$I$$20240917$20240926$20240926$EXP$$CA-ABBVIE-5939799$ABBVIE$$$$$M$Y$$$20240926$$HP$CA$CA
243686881$24368688$1$I$$20240923$20240926$20240926$EXP$$US-ABBVIE-5937380$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243686891$24368689$1$I$$20240920$20240926$20240926$EXP$$US-ALXN-202409USA002085US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240926$$$US$US
243686901$24368690$1$I$20240923$20240922$20240926$20240926$EXP$$AU-ABBVIE-5937358$ABBVIE$$78$YR$$M$Y$$$20240926$$HP$AU$AU
243686921$24368692$1$I$$20240924$20240926$20240926$EXP$$CA-ABBVIE-5939931$ABBVIE$$$$E$M$Y$$$20240926$$HP$CA$CA
243686931$24368693$1$I$20240922$20240925$20240926$20240926$EXP$$US-ABBVIE-5939263$ABBVIE$$61$YR$$F$Y$$$20240926$$CN$US$US
243686941$24368694$1$I$20240304$20240918$20240926$20240926$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152282$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$51.26$KG$20240927$$HP$US$US
243686961$24368696$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001710$ORGANON$$44$YR$$F$Y$$$20240926$$HP$CA$CA
243686971$24368697$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153047$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240927$$CN$US$US
243686981$24368698$1$I$$20240908$20240926$20240926$PER$$US-TEVA-VS-3241837$TEVA$$$$$$Y$$$20240926$$CN$US$US
243686991$24368699$1$I$20240827$20240920$20240926$20240926$EXP$$NVSC2024CN179295$NOVARTIS$$32$YR$$M$Y$100$KG$20240927$$CN$CN$CN
243687001$24368700$1$I$$20240918$20240926$20240926$PER$$US-ABBVIE-5931592$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243687021$24368702$1$I$$20240923$20240926$20240926$PER$$US-HALEON-2198455$Haleon PLC$$$$$$Y$$$20240926$$CN$US$US
243687041$24368704$1$I$$20240923$20240926$20240926$PER$$US-HALEON-2198430$Haleon PLC$$$$$$Y$$$20240926$$CN$US$US
243687061$24368706$1$I$20240101$20240705$20240926$20240926$EXP$$US-CIPLA LTD.-2024US06621$CIPLA$$$$$$Y$$$20240927$$MD$US$US
243687071$24368707$1$I$20240610$20240729$20240926$20240926$EXP$$US-CIPLA LTD.-2024US07144$CIPLA$$$$$$Y$$$20240927$$CN$US$US
243687081$24368708$1$I$$20240808$20240926$20240926$PER$$US-CIPLA LTD.-2024US09074$CIPLA$$$$$$Y$$$20240927$$PH$US$US
243687091$24368709$1$I$20240101$20240710$20240926$20240926$EXP$$US-CIPLA LTD.-2024US07642$CIPLA$$$$$$Y$$$20240927$$PH$US$US
243687101$24368710$1$I$20240612$20240612$20240926$20240926$PER$$US-CIPLA LTD.-2024US06316$CIPLA$$$$$$Y$$$20240927$$MD$US$US
243687111$24368711$1$I$$20240725$20240926$20240926$PER$$US-CIPLA LTD.-2024US07528$CIPLA$$$$$$Y$$$20240927$$HP$US$US
243687121$24368712$1$I$20240626$20240721$20240926$20240926$PER$$US-CIPLA LTD.-2024US06948$CIPLA$$$$$$Y$$$20240927$$PH$US$US
243687131$24368713$1$I$20240812$20240813$20240926$20240926$PER$$US-CIPLA LTD.-2024US09042$CIPLA$$$$$$Y$$$20240927$$MD$US$US
243687141$24368714$1$I$$20240805$20240926$20240926$PER$$US-CIPLA LTD.-2024US08733$CIPLA$$$$$$Y$$$20240927$$MD$US$US
243687151$24368715$1$I$20240805$20240806$20240926$20240926$PER$$US-CIPLA LTD.-2024US08795$CIPLA$$$$$$Y$$$20240927$$MD$US$US
243687161$24368716$1$I$20240801$20240806$20240926$20240926$PER$$US-CIPLA LTD.-2024US08911$CIPLA$$$$$$Y$$$20240927$$HP$US$US
243687171$24368717$1$I$$20240812$20240926$20240926$PER$$US-CIPLA LTD.-2024US09019$CIPLA$$$$$$Y$$$20240927$$MD$US$US
243687181$24368718$1$I$20230802$20240913$20240926$20240926$EXP$$CZ-ABBVIE-5353561$ABBVIE$$42$YR$$M$Y$$$20240926$$MD$CZ$CZ
243687191$24368719$1$I$20240801$20240917$20240926$20240926$PER$$US-ABBVIE-5930262$ABBVIE$$$$A$$Y$$$20240926$$HP$US$US
243687201$24368720$1$I$$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152491$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240927$$HP$US$US
243687211$24368721$1$I$$20240916$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409009696$ELI LILLY AND CO$$$$$F$Y$$$20240926$$CN$US$US
243687221$24368722$1$I$20240922$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152301$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240927$$PH$US$US
243687231$24368723$1$I$20240708$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152502$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240927$$HP$US$US
243687241$24368724$1$I$$20240925$20240926$20240926$PER$$US-ELI_LILLY_AND_COMPANY-US202409016397$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240926$$CN$US$US
243687251$24368725$1$I$$20240924$20240926$20240926$EXP$$AR-ABBVIE-5939247$ABBVIE$$$$$F$Y$$$20240926$$CN$AR$AR
243687261$24368726$1$I$$20240917$20240926$20240926$EXP$$JP-ASTELLAS-2024-AER-007955$ASTELLAS$Ueno M, Sando Y, Kondo A, Matsuda M, Yoshioka T, Sunami K. A case of repeated serious infections due to decreased IgG during chronic GVHD treatment. The 63rd Annual Meeting of the Chugoku-Shikoku Regional Meeting of the Japanese Society of Hematology Program and Abstracts (2024.03.16). 2024;2.$23$YR$A$M$Y$$$20240927$$MD$JP$JP
243687272$24368727$2$F$20240923$20240926$20240926$20240928$PER$$US-AMGEN-USASP2024192023$AMGEN$$81$YR$E$M$Y$$$20240928$$CN$US$US
243687281$24368728$1$I$20111101$20240921$20240926$20240926$EXP$$EG-ABBVIE-5934992$ABBVIE$$26$YR$$M$Y$$$20240926$$CN$EG$EG
243687291$24368729$1$I$20240101$20240923$20240926$20240926$PER$$US-ABBVIE-5936435$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243687301$24368730$1$I$$20240920$20240926$20240926$PER$$NVSC2024US191654$NOVARTIS$$7$YR$$F$Y$$$20240927$$CN$US$US
243687321$24368732$1$I$20220412$20240919$20240926$20240926$EXP$$NVSC2024IN029493$NOVARTIS$$75$YR$$F$Y$$$20240927$$CN$IN$IN
243687331$24368733$1$I$20240120$20240918$20240926$20240926$EXP$$CN-BEIGENE-BGN-2024-014847$BEIGENE$$$$$$Y$$$20240926$$HP$CN$CN
243687341$24368734$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001746$ORGANON$$40$YR$$F$Y$$$20240926$$MD$CA$CA
243687371$24368737$1$I$20240101$20240925$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152895$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240927$$CN$US$US
243687381$24368738$1$I$20240101$20240919$20240926$20240926$EXP$$US-ABBVIE-5820061$ABBVIE$$79$YR$$F$Y$87.09$KG$20240926$$CN$US$US
243687391$24368739$1$I$20240911$20240923$20240926$20240926$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151484$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240927$$CN$US$US
243687401$24368740$1$I$20240101$20240918$20240926$20240926$PER$$US-BAUSCHBL-2024BNL033776$BAUSCH AND LOMB$$60$YR$$M$Y$$$20240927$$CN$US$US
243687411$24368741$1$I$$20240916$20240926$20240926$PER$$US-BAUSCHBL-2024BNL033671$BAUSCH AND LOMB$$$$$F$Y$$$20240927$$CN$US$US
243687421$24368742$1$I$$20240914$20240926$20240926$EXP$$GB-CIPLA LTD.-2024GB10443$CIPLA$$$$$$Y$$$20240927$$CN$GB$GB
243687432$24368743$2$F$$20240924$20240926$20240927$EXP$$JP-SA-2024SA274938$SANOFI AVENTIS$$$$$$Y$$$20240927$$PH$JP$JP
243687441$24368744$1$I$$20240923$20240926$20240926$PER$$US-ABBVIE-5937500$ABBVIE$$$$$M$Y$$$20240926$$HP$US$US
243687451$24368745$1$I$$20240920$20240926$20240926$EXP$$CN-ABBVIE-5938887$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240926$$HP$CN$CN
243687461$24368746$1$I$$20240923$20240926$20240926$EXP$$CA-ORGANON-O2409CAN001769$ORGANON$$44$YR$$F$Y$$$20240926$$HP$CA$CA
243687471$24368747$1$I$$20240920$20240926$20240926$EXP$$CN-ABBVIE-5938889$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240926$$HP$CN$CN
243687481$24368748$1$I$$20240920$20240926$20240926$EXP$$CN-ABBVIE-5938892$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240926$$HP$CN$CN
243687491$24368749$1$I$$20240920$20240926$20240926$EXP$$CN-ABBVIE-5938890$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240926$$HP$CN$CN
243687501$24368750$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938888$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240926$$HP$CN$CN
243687511$24368751$1$I$20240101$20240924$20240927$20240927$EXP$$US-ABBVIE-5939094$ABBVIE$$$$$F$Y$$$20240926$$CN$US$US
243687521$24368752$1$I$$20240918$20240927$20240927$PER$$US-009507513-2409USA006926$MERCK$$$$$M$Y$$$20240926$$HP$US$US
243687541$24368754$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938362$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240926$$HP$CN$CN
243687551$24368755$1$I$20240923$20240925$20240927$20240927$PER$$US-ABBVIE-5940108$ABBVIE$$$$A$F$Y$$$20240927$$CN$US$US
243687561$24368756$1$I$$20240919$20240927$20240927$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP012457$STRIDES$Acharya S, Thakurathi P, Plocharczyk E, Arbach A, Gupta SS.. Minocycline-Associated Fatal Liver Injury.. Am-J-Ther. 2024;31 (2):e195-e197$55$YR$$M$Y$$$20240927$$MD$US$US
243687571$24368757$1$I$$20240919$20240927$20240927$EXP$$TR-STRIDES ARCOLAB LIMITED-2024SP012445$STRIDES$Atalay F, Yesilaltay A.. Long-term successful use of belinostat in a patient with relapsed-refractory angioimmunoblastic lymphoma who has previously been heavily treated.. J-Cancer-Res-Ther. 2024;20 (3):1049-1052$79$YR$$F$Y$$$20240927$$HP$TR$TR
243687581$24368758$1$I$$20240912$20240927$20240927$EXP$$IL-ABBVIE-5931723$ABBVIE$$$$$M$Y$$$20240927$$CN$IL$IL
243687591$24368759$1$I$20231123$20240926$20240927$20240927$EXP$FR-AFSSAPS-PA2024001568$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-152966$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$49$KG$20240927$$CN$FR$FR
243687601$24368760$1$I$20240731$20240919$20240927$20240927$EXP$$JO-EMD Serono-2024045185$EMD SERONO INC$$23$YR$A$F$Y$$$20240927$$CN$JO$JO
243687612$24368761$2$F$$20240925$20240927$20240930$PER$$NVSC2024US191871$NOVARTIS$$$$$$Y$$$20240930$$PH$US$US
243687621$24368762$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938356$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687631$24368763$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938619$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687641$24368764$1$I$20240801$20240916$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148226$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$105$KG$20240927$$PH$US$US
243687651$24368765$1$I$20240826$20240910$20240927$20240927$PER$$US-JNJFOC-20240925261$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240927$$HP$US$US
243687661$24368766$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938620$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687671$24368767$1$I$$20240918$20240927$20240927$EXP$$JP-ASTELLAS-2024-AER-008078$ASTELLAS$$84$YR$E$F$Y$$$20240927$$MD$JP$JP
243687681$24368768$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938621$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687691$24368769$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938623$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687701$24368770$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938624$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687711$24368771$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938875$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687721$24368772$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191442$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243687731$24368773$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938363$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687741$24368774$1$I$20230701$20240920$20240927$20240927$EXP$$JP-ASTELLAS-2024-AER-007975$ASTELLAS$$76$YR$E$F$Y$40$KG$20240927$$MD$JP$JP
243687751$24368775$1$I$20221201$20240919$20240927$20240927$EXP$$BR-ABBVIE-5933459$ABBVIE$$56$YR$$F$Y$$$20240927$$CN$BR$BR
243687761$24368776$1$I$20240913$20240923$20240927$20240927$EXP$$US-ABBVIE-5936866$ABBVIE$$62$YR$$F$Y$$$20240927$$CN$US$US
243687771$24368777$1$I$20240101$20240923$20240927$20240927$EXP$$US-ABBVIE-5936875$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243687781$24368778$1$I$$20240923$20240927$20240927$EXP$$US-MTPC-MTDA2024-0019985$MITSUBISHI TANABE PHARMA$$$$A$F$Y$$$20240927$$CN$US$US
243687791$24368779$1$I$20240101$20240920$20240927$20240927$EXP$$US-ABBVIE-5938526$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243687811$24368781$1$I$$20240926$20240927$20240927$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053786$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240927$$CN$US$US
243687821$24368782$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938358$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687831$24368783$1$I$20240915$20240924$20240927$20240927$EXP$$US-ABBVIE-5938721$ABBVIE$$84$YR$$M$Y$$$20240927$$CN$US$US
243687841$24368784$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938359$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687851$24368785$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938360$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687861$24368786$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938361$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687872$24368787$2$F$20240920$20240927$20240927$20240928$PER$$US-AMGEN-USASP2024192096$AMGEN$$57$YR$A$F$Y$$$20240928$$CN$US$US
243687881$24368788$1$I$20240101$20240920$20240927$20240927$EXP$$GB-AMGEN-GBRSL2024145795$AMGEN$$80$YR$E$F$Y$$$20240926$$CN$GB$GB
243687891$24368789$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938364$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687901$24368790$1$I$20240901$20240923$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152149$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240927$$CN$US$US
243687911$24368791$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938876$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687921$24368792$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938365$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687931$24368793$1$I$20240919$20240921$20240927$20240927$PER$$US-AVET LIFESCIENCES LTD-2024-AVET-000338$EMCURE$$$$$$Y$$$20240927$$CN$US$US
243687941$24368794$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938367$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687951$24368795$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938877$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687961$24368796$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938368$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687971$24368797$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938370$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687981$24368798$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938369$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243687991$24368799$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938878$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688001$24368800$1$I$$20240924$20240927$20240927$EXP$$CA-CHATTEMPRD-2018SA327051$CHATTEM$$49$YR$A$F$Y$$$20240927$$MD$CA$CA
243688011$24368801$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938879$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688021$24368802$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938371$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688031$24368803$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938880$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688041$24368804$1$I$20240701$20240920$20240927$20240927$EXP$$US-ABBVIE-5935734$ABBVIE$$64$YR$$M$Y$$$20240927$$CN$US$US
243688051$24368805$1$I$20240920$20240920$20240927$20240927$EXP$$FR-ABBVIE-5936396$ABBVIE$$86$YR$$F$Y$$$20240927$$HP$FR$FR
243688061$24368806$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938882$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688071$24368807$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938883$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688081$24368808$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938885$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688092$24368809$2$F$$20240919$20240927$20240927$EXP$GB-MHRA-MED-202409172157598550-HKFDN$GB-TEVA-VS-3246074$TEVA$$21$YR$$M$Y$$$20240926$$CN$GB$GB
243688101$24368810$1$I$$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024189832$AMGEN$$$$$$Y$$$20240926$$PH$US$US
243688121$24368812$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938886$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688131$24368813$1$I$$20240922$20240927$20240927$EXP$$CA-ASTELLAS-2024-AER-008513$ASTELLAS$$40$YR$A$F$Y$$$20240927$$HP$CA$CA
243688141$24368814$1$I$$20240916$20240927$20240927$EXP$$US-Oxford Pharmaceuticals, LLC-2162114$OXFORD PHARMACEUTICALS$Source document$27$YR$$M$Y$$$20240927$$$US$US
243688151$24368815$1$I$$20240925$20240927$20240927$PER$$US-ABBVIE-5941140$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243688161$24368816$1$I$20240922$20240924$20240927$20240927$EXP$$FR-ABBVIE-5939211$ABBVIE$$65$YR$$F$Y$$$20240927$$HP$FR$FR
243688171$24368817$1$I$20240323$20240924$20240927$20240927$EXP$$US-ABBVIE-5938868$ABBVIE$$69$YR$$F$Y$$$20240927$$CN$US$US
243688181$24368818$1$I$20240914$20240923$20240927$20240927$EXP$$US-ABBVIE-5936883$ABBVIE$$73$YR$$F$Y$$$20240927$$CN$US$US
243688191$24368819$1$I$20230815$20240920$20240927$20240927$EXP$$CN-ABBVIE-5393549$ABBVIE$$35$YR$$M$Y$65$KG$20240927$$MD$CN$CN
243688201$24368820$1$I$$20240920$20240927$20240927$EXP$$US-ABBVIE-5933554$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243688211$24368821$1$I$$20240917$20240927$20240927$EXP$$JP-AMGEN-JPNSP2024191534$AMGEN$$$$$$Y$$$20240926$$MD$JP$JP
243688221$24368822$1$I$20220101$20240919$20240927$20240927$EXP$$CA-ABBVIE-5934584$ABBVIE$$$$A$F$Y$$$20240927$$CN$CA$CA
243688231$24368823$1$I$20240901$20240920$20240927$20240927$EXP$$CN-ABBVIE-5939596$ABBVIE$$14$YR$$M$Y$39$KG$20240927$$HP$CN$CN
243688241$24368824$1$I$$20240926$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017069$ELI LILLY AND CO$$88$YR$E$F$Y$$$20240927$$CN$US$US
243688251$24368825$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938626$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688261$24368826$1$I$20240101$20240923$20240927$20240927$EXP$$US-ABBVIE-5937151$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243688281$24368828$1$I$20240603$20240923$20240927$20240927$EXP$$US-ABBVIE-5936693$ABBVIE$$71$YR$$M$Y$84$KG$20240927$$HP$US$US
243688291$24368829$1$I$$20240924$20240927$20240927$EXP$$US-ABBVIE-5938072$ABBVIE$$$$$M$Y$$$20240927$$HP$US$US
243688301$24368830$1$I$$20240924$20240927$20240927$EXP$$GB-ABBVIE-5937424$ABBVIE$$$$A$F$Y$$$20240927$$CN$GB$GB
243688311$24368831$1$I$20240101$20240923$20240927$20240927$EXP$$US-ABBVIE-5936013$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243688321$24368832$1$I$$20240920$20240927$20240927$EXP$$US-GSK-US2024117011$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
243688331$24368833$1$I$20240923$20240923$20240927$20240927$PER$$US-ABBVIE-5936000$ABBVIE$$39$YR$$F$Y$$$20240927$$MD$US$US
243688341$24368834$1$I$$20240924$20240927$20240927$EXP$$US-ABBVIE-5938758$ABBVIE$$$$$F$Y$$$20240927$$HP$US$US
243688351$24368835$1$I$20220101$20240923$20240927$20240927$EXP$$US-ABBVIE-5936265$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243688361$24368836$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938627$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688371$24368837$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5936627$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243688381$24368838$1$I$20230101$20240923$20240927$20240927$EXP$$US-ABBVIE-5935588$ABBVIE$$$$$F$Y$92.532$KG$20240927$$CN$US$US
243688391$24368839$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938629$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688401$24368840$1$I$20240901$20240923$20240927$20240927$EXP$$US-ABBVIE-5936881$ABBVIE$$68$YR$$F$Y$$$20240927$$CN$US$US
243688411$24368841$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153016$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240927$$CN$US$US
243688421$24368842$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152841$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240927$$HP$US$US
243688431$24368843$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938630$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688441$24368844$1$I$20240701$20240924$20240927$20240927$EXP$$JP-ASTELLAS-2024JP005599$ASTELLAS$$78$YR$E$M$Y$$$20240927$$MD$JP$JP
243688451$24368845$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938631$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688461$24368846$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938884$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688471$24368847$1$I$$20240925$20240927$20240927$EXP$$ZA-ROCHE-10000057011$ROCHE$$$$E$$Y$$$20240927$$MD$ZA$ZA
243688481$24368848$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938625$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688491$24368849$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938633$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688501$24368850$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938634$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688511$24368851$1$I$20240919$20240925$20240927$20240927$PER$$US-ABBVIE-5940204$ABBVIE$$27$YR$$F$Y$$$20240927$$HP$US$US
243688521$24368852$1$I$$20240917$20240927$20240927$EXP$$US-ALXN-202409USA002269US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240927$$$US$US
243688531$24368853$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938636$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688541$24368854$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938355$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688561$24368856$1$I$20240901$20240919$20240927$20240927$EXP$$CA-ABBVIE-5933406$ABBVIE$$57$YR$$M$Y$$$20240927$$CN$CA$CA
243688571$24368857$1$I$$20240920$20240927$20240927$EXP$$JP-GENMAB-2024-03461$GENMAB$$8$DEC$$$Y$$$20240927$$MD$JP$JP
243688581$24368858$1$I$20240101$20240920$20240927$20240927$EXP$$JP-GENMAB-2024-03462$GENMAB$$$$$$Y$$$20240927$$MD$JP$JP
243688601$24368860$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938353$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688611$24368861$1$I$20240101$20240916$20240927$20240927$EXP$SE-SEMPA-2024-006607$SE-STRIDES ARCOLAB LIMITED-2024SP011959$STRIDES$$64$YR$$M$Y$$$20240927$$MD$SE$SE
243688621$24368862$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191611$AMGEN$$$$$$Y$$$20240926$$MD$US$US
243688631$24368863$1$I$20240902$20240925$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024AU083228$SANDOZ$$54$YR$$F$Y$50$KG$20240927$$CN$US$AU
243688641$24368864$1$I$$20240919$20240927$20240927$PER$$US-ABBVIE-5931820$ABBVIE$$$$$$Y$$$20240927$$HP$US$US
243688651$24368865$1$I$$20240920$20240927$20240927$EXP$$US-CHATTEMPRD-2024OHG033181$CHATTEM$$$$A$$Y$$$20240927$$CN$US$US
243688661$24368866$1$I$$20240925$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2023US004433$SANDOZ$$$$$$Y$$$20240927$$CN$US$US
243688671$24368867$1$I$20240701$20240918$20240927$20240927$PER$$US-ABBVIE-5930220$ABBVIE$$$$$$Y$$$20240927$$MD$US$US
243688681$24368868$1$I$$20240913$20240927$20240927$EXP$$US-UCBSA-2024047684$UCB$$$$$F$Y$$$20240927$$CN$US$US
243688691$24368869$1$I$20240825$20240924$20240927$20240927$EXP$$IT-ABBVIE-5939180$ABBVIE$$83$YR$$F$Y$$$20240927$$CN$IT$IT
243688701$24368870$1$I$20220101$20240925$20240927$20240927$EXP$$US-ABBVIE-5939140$ABBVIE$$$$$M$Y$81.64$KG$20240927$$CN$US$US
243688711$24368871$1$I$20240919$20240924$20240927$20240927$EXP$$US-ABBVIE-5939130$ABBVIE$$78$YR$$M$Y$$$20240927$$CN$US$US
243688721$24368872$1$I$$20240924$20240927$20240927$EXP$$US-ABBVIE-5938898$ABBVIE$$$$$F$Y$$$20240927$$HP$US$US
243688731$24368873$1$I$20221201$20240924$20240927$20240927$EXP$$CA-ABBVIE-5938910$ABBVIE$$51$YR$$F$Y$$$20240927$$CN$CA$CA
243688741$24368874$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938628$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688751$24368875$1$I$$20240917$20240927$20240927$EXP$$RU-Oxford Pharmaceuticals, LLC-2162115$OXFORD PHARMACEUTICALS$$29$YR$$M$Y$67$KG$20240927$$$RU$RU
243688761$24368876$1$I$20240904$20240916$20240927$20240927$EXP$SE-SEMPA-2024-006723$SE-STRIDES ARCOLAB LIMITED-2024SP012074$STRIDES$$16$YR$$F$Y$$$20240927$$MD$SE$SE
243688781$24368878$1$I$20240925$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191483$AMGEN$$65$YR$E$F$Y$$$20240926$$CN$US$US
243688791$24368879$1$I$$20240913$20240927$20240927$EXP$$CA-UCBSA-2024047588$UCB$$$$$M$Y$$$20240927$$CN$CA$CA
243688801$24368880$1$I$20240913$20240913$20240927$20240927$EXP$$CA-UCBSA-2024047660$UCB$$55$YR$$M$Y$$$20240927$$CN$CA$CA
243688811$24368881$1$I$$20240920$20240927$20240927$EXP$$US-GSK-US2024AMR118005$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
243688821$24368882$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938635$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688831$24368883$1$I$20240907$20240918$20240927$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029844$UNITED THERAPEUTICS$$1$YR$$M$Y$9.977$KG$20240927$$$US$US
243688841$24368884$1$I$$20240924$20240927$20240927$EXP$$JP-SANDOZ INC.-SDZ2024JP062989$SANDOZ$Miura T, Morohashi H, Sakamoto Y, Kagiya T, Hasebe T, Nakayama Y, et al.. Neoadjuvant S-1 and oxaliplatin plus bevacizumab therapy for high-risk locally advanced rectal cancer: A prospective multicenter phase II study. Annals of Gastroenterological Surgery. 2024;8(1):71-9$$$$$Y$$$20240927$$MD$JP$JP
243688861$24368886$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938366$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688871$24368887$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938357$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243688881$24368888$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5935655$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243688891$24368889$1$I$$20240905$20240927$20240927$30DAY$$CO-JNJFOC-20240934658$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$HP$CO$CO
243688911$24368891$1$I$20240101$20240923$20240927$20240927$EXP$$US-ABBVIE-5936818$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243688921$24368892$1$I$20240101$20240924$20240927$20240927$EXP$$US-ABBVIE-5937940$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243688931$24368893$1$I$20240601$20240917$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-046845$AUROBINDO$$73$YR$$M$Y$64$KG$20240927$$MD$FR$FR
243688941$24368894$1$I$$20240924$20240927$20240927$EXP$$JP-TAKEDA-2024TJP012361$TAKEDA$$$$$M$Y$$$20240927$$PH$JP$JP
243688951$24368895$1$I$20240525$20240917$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-046771$AUROBINDO$$51$YR$$M$Y$$$20240927$$PH$FR$FR
243688962$24368896$2$F$$20240925$20240927$20240927$EXP$$US-ABBVIE-5939455$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243688971$24368897$1$I$$20240925$20240927$20240927$PER$$US-ROCHE-10000091342$ROCHE$$20$YR$A$F$Y$$$20240927$$CN$US$US
243688981$24368898$1$I$20240808$20240923$20240927$20240927$EXP$$US-ABBVIE-5897175$ABBVIE$$70$YR$$M$Y$99$KG$20240927$$CN$US$US
243688991$24368899$1$I$20240101$20240913$20240927$20240927$EXP$$US-UCBSA-2024047484$UCB$$$$$F$Y$$$20240927$$CN$US$US
243689001$24368900$1$I$$20240905$20240927$20240927$30DAY$$MY-JNJFOC-20240934730$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$MY$MY
243689011$24368901$1$I$$20240924$20240927$20240927$EXP$$US-JNJFOC-20240965007$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$CN$US$US
243689031$24368903$1$I$20240808$20240923$20240927$20240927$EXP$$US-ABBVIE-5936989$ABBVIE$$77$YR$$M$Y$$$20240927$$CN$US$US
243689051$24368905$1$I$20240101$20240923$20240927$20240927$EXP$$US-ABBVIE-5937291$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243689061$24368906$1$I$20240716$20240917$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-046823$AUROBINDO$$82$YR$$F$Y$74.7$KG$20240927$$MD$FR$FR
243689071$24368907$1$I$$20240925$20240927$20240927$PER$$NVSC2024US191899$NOVARTIS$$$$$$Y$$$20240927$$CN$US$US
243689081$24368908$1$I$20240822$20240918$20240927$20240927$EXP$$FR-JNJFOC-20240959538$JOHNSON AND JOHNSON$$69$YR$E$M$Y$72$KG$20240927$$MD$FR$FR
243689091$24368909$1$I$$20240920$20240927$20240927$EXP$$US-ABBVIE-5938872$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243689101$24368910$1$I$$20240919$20240927$20240927$PER$$US-ROCHE-10000088644$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243689111$24368911$1$I$20230101$20240917$20240927$20240927$EXP$$US-ABBVIE-5929232$ABBVIE$$$$$M$Y$107$KG$20240927$$CN$US$US
243689121$24368912$1$I$20240101$20240924$20240927$20240927$EXP$$US-ABBVIE-5937770$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243689131$24368913$1$I$$20240923$20240927$20240927$PER$$US-ABBVIE-5935379$ABBVIE$$$$$M$Y$$$20240927$$MD$US$US
243689141$24368914$1$I$20240917$20240918$20240927$20240927$PER$$US-ROCHE-10000085969$ROCHE$$$$$$Y$$$20240927$$HP$US$US
243689151$24368915$1$I$20240901$20240924$20240927$20240927$EXP$$US-ABBVIE-5938076$ABBVIE$$59$YR$$M$Y$$$20240927$$CN$US$US
243689161$24368916$1$I$$20240924$20240927$20240927$EXP$$GB-ABBVIE-5938077$ABBVIE$$$$E$M$Y$$$20240927$$CN$GB$GB
243689171$24368917$1$I$$20240405$20240927$20240927$PER$$US-CATALENT PHARMA SOLUTIONS-CAT-000491-2024$CATALENT PHARMA$$$$$F$Y$$$20240924$$CN$US$US
243689181$24368918$1$I$20240910$20240912$20240927$20240927$PER$$US-CATALENT PHARMA SOLUTIONS-CAT-001388-2024$CATALENT PHARMA$$85$YR$E$F$Y$$$20240924$$CN$US$US
243689191$24368919$1$I$20240920$20240924$20240927$20240927$EXP$$TW-ABBVIE-5938225$ABBVIE$$46$YR$$F$Y$82$KG$20240927$$MD$TW$TW
243689201$24368920$1$I$$20240920$20240927$20240927$EXP$$US-ABBVIE-5936437$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243689211$24368921$1$I$$20240923$20240927$20240927$PER$$US-ROCHE-10000089345$ROCHE$$64$YR$A$F$Y$$$20240927$$CN$US$US
243689221$24368922$1$I$$20240920$20240927$20240927$PER$$US-ROCHE-10000087529$ROCHE$$$$E$F$Y$$$20240927$$CN$US$US
243689231$24368923$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015673$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240927$$CN$US$US
243689241$24368924$1$I$$20240923$20240927$20240927$PER$$US-ROCHE-10000089799$ROCHE$$59$YR$A$F$Y$$$20240927$$CN$US$US
243689251$24368925$1$I$$20240923$20240927$20240927$PER$$US-ROCHE-10000090033$ROCHE$$64$YR$A$F$Y$$$20240927$$CN$US$US
243689261$24368926$1$I$$20240915$20240927$20240927$PER$$US-APOTEX-2024AP010715$APOTEX$$$$$F$Y$$$20240927$$HP$US$US
243689271$24368927$1$I$$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190974$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243689281$24368928$1$I$$20240919$20240927$20240927$EXP$$JP-AMGEN-JPNSP2024187360$AMGEN$$$$$$Y$$$20240926$$MD$JP$JP
243689291$24368929$1$I$20240917$20240918$20240927$20240927$PER$$US-AMGEN-USASP2024189538$AMGEN$$67$YR$E$F$Y$$$20240926$$CN$US$US
243689301$24368930$1$I$$20240919$20240927$20240927$PER$$US-TAKEDA-2024TUS093743$TAKEDA$$47$YR$$M$Y$$$20240927$$MD$US$US
243689311$24368931$1$I$20240923$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191233$AMGEN$$75$YR$E$F$Y$$$20240926$$CN$US$US
243689321$24368932$1$I$20240901$20240923$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016015$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240927$$CN$US$US
243689331$24368933$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011357$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240927$$HP$CA$CA
243689341$24368934$1$I$$20240924$20240927$20240927$PER$$US-ROCHE-10000090933$ROCHE$$66$YR$E$F$Y$$$20240927$$CN$US$US
243689351$24368935$1$I$$20240917$20240927$20240927$EXP$$CA-APOTEX-2024AP011116$APOTEX$$9$YR$$M$Y$34$KG$20240927$$HP$CA$CA
243689371$24368937$1$I$20240922$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024190090$AMGEN$$82$YR$E$F$Y$$$20240926$$CN$US$US
243689381$24368938$1$I$20240903$20240913$20240927$20240927$EXP$$IT-CIPLA LTD.-2024IT10431$CIPLA$$$$$$Y$$$20240927$$MD$IT$IT
243689411$24368941$1$I$$20240917$20240927$20240927$EXP$$JP-ROCHE-10000091238$ROCHE$$36$YR$A$M$Y$$$20240927$$CN$JP$JP
243689421$24368942$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152914$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240927$$CN$US$US
243689431$24368943$1$I$$20240923$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152861$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240927$$MD$US$US
243689441$24368944$1$I$20240801$20240920$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152237$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$79.38$KG$20240927$$CN$US$US
243689451$24368945$1$I$20231025$20240919$20240927$20240927$EXP$$US-ABBVIE-5934067$ABBVIE$$49$YR$$F$Y$48$KG$20240927$$CN$US$US
243689461$24368946$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151470$BRISTOL MYERS SQUIBB$$92$YR$E$$Y$38.56$KG$20240927$$MD$US$US
243689481$24368948$1$I$20240914$20240916$20240927$20240927$EXP$GB-MHRA-MED-202409141025092440-WNLPG$GB-Accord-447974$ACCORD$$38$YR$A$F$Y$70$KG$20240927$$MD$GB$GB
243689491$24368949$1$I$$20240916$20240927$20240927$EXP$GB-CELLTRION INC.-2024GB011858$GB-Accord-447976$ACCORD$$$$$$Y$$$20240927$$CN$GB$GB
243689501$24368950$1$I$$20240918$20240927$20240927$EXP$$PL-AUROBINDO-AUR-APL-2024-047062$AUROBINDO$$28$YR$$M$Y$92$KG$20240927$$MD$PL$PL
243689511$24368951$1$I$20240920$20240923$20240927$20240927$PER$$US-ABBVIE-5935614$ABBVIE$$57$YR$$F$Y$$$20240927$$CN$US$US
243689521$24368952$1$I$20240611$20240918$20240927$20240927$EXP$$JP-GALDERMA-JP2024011153$GALDERMA$$$$$$Y$$$20240927$$MD$JP$JP
243689531$24368953$1$I$$20240917$20240927$20240927$EXP$$US-APOTEX-2024AP011264$APOTEX$Gibson CL, Abdallah SB, Neumann NR, Millard H, Riley S. Methemoglobinemia in a Patient Presenting with an Undisclosed Intentional Overdose. Harvard Review of Psychiatry. 2022;30 (6):361-368$18$YR$$F$Y$$$20240927$$MD$US$US
243689541$24368954$1$I$20240101$20240919$20240927$20240927$EXP$$US-ABBVIE-5934290$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243689551$24368955$1$I$20240801$20240919$20240927$20240927$EXP$$JP-GALDERMA-JP2024012434$GALDERMA$$$$$$Y$$$20240927$$MD$JP$JP
243689561$24368956$1$I$20240913$20240916$20240927$20240927$PER$$US-ABBVIE-5927783$ABBVIE$$36$YR$$F$Y$$$20240927$$CN$US$US
243689571$24368957$1$I$$20240919$20240927$20240927$EXP$$US-ABBVIE-5933080$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243689581$24368958$1$I$20240701$20240925$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152982$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240927$$CN$US$US
243689591$24368959$1$I$$20240925$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152977$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$$$20240927$$HP$US$US
243689601$24368960$1$I$20240624$20240925$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152999$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240927$$CN$US$US
243689611$24368961$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015298$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240927$$CN$US$US
243689621$24368962$1$I$$20240919$20240927$20240927$EXP$$US-JNJFOC-20240958502$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243689631$24368963$1$I$$20240923$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409014321$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240927$$CN$US$US
243689641$24368964$1$I$$20240925$20240927$20240927$PER$$NVSC2024US191837$NOVARTIS$$$$$F$Y$76$KG$20240927$$CN$US$US
243689661$24368966$1$I$20230913$20231012$20240927$20240927$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000160-2023$QILU PHARMACEUTICAL$$54$YR$A$F$Y$$$20240923$$HP$US$US
243689671$24368967$1$I$20210101$20240919$20240927$20240927$EXP$$US-ABBVIE-5935535$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243689691$24368969$1$I$$20240924$20240927$20240927$PER$$US-ABBVIE-5937681$ABBVIE$$$$$$Y$$$20240927$$MD$US$US
243689701$24368970$1$I$20240920$20240921$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-029958$UNITED THERAPEUTICS$$67$YR$$F$Y$71.202$KG$20240927$$$US$US
243689711$24368971$1$I$$20240924$20240927$20240927$EXP$$PT-SANDOZ INC.-SDZ2024PT082856$SANDOZ$$$$E$$Y$$$20240927$$HP$PT$PT
243689731$24368973$1$I$$20240917$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR117974$VIIV$$$$$$Y$$$20240927$$HP$US$US
243689741$24368974$1$I$20240901$20240917$20240927$20240927$EXP$$US-INSMED-2024-02854-USAA$INSMED$$68$YR$$M$Y$$$20240927$$CN$US$US
243689751$24368975$1$I$20240626$20240918$20240927$20240927$EXP$DE-BFARM-24006435$DE-EMD Serono-2024049967$EMD SERONO INC$$40$YR$A$F$Y$$$20240927$$MD$DE$DE
243689761$24368976$1$I$20240922$20240922$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-030052$UNITED THERAPEUTICS$$68$YR$$F$Y$82.993$KG$20240927$$$US$US
243689771$24368977$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152671$BRISTOL MYERS SQUIBB$$88$YR$E$F$Y$$$20240927$$HP$US$US
243689781$24368978$1$I$$20240925$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152915$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240927$$CN$US$US
243689791$24368979$1$I$$20240925$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152940$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240927$$CN$US$US
243689801$24368980$1$I$$20240924$20240927$20240927$PER$$US-ABBVIE-5939402$ABBVIE$$$$$$Y$$$20240927$$CN$US$US
243689811$24368981$1$I$$20240916$20240927$20240927$EXP$CA-MHPD-E2B_07205339$CA-Accord-447279$ACCORD$$$$E$F$Y$$$20240927$$MD$CA$CA
243689821$24368982$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191646$AMGEN$$78$YR$E$M$Y$$$20240926$$MD$US$US
243689831$24368983$1$I$20240919$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024192018$AMGEN$$34$YR$A$F$Y$$$20240926$$CN$US$US
243689841$24368984$1$I$$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024190191$AMGEN$$79$YR$E$F$Y$$$20240926$$PH$US$US
243689851$24368985$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011358$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240927$$HP$CA$CA
243689871$24368987$1$I$20240725$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-046916$AUROBINDO$$63$YR$$M$Y$$$20240927$$PH$FR$FR
243689881$24368988$1$I$20240708$20240904$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005343$ACADIA PHARMACEUTICALS$$67$YR$$F$Y$$$20240927$$CN$US$US
243689891$24368989$1$I$$20240913$20240927$20240927$EXP$$VN-NOVOPROD-1287757$NOVO NORDISK$$26$YR$$F$Y$54$KG$20240927$$CN$VN$GB
243689901$24368990$1$I$$20240916$20240927$20240927$EXP$$ES-ROCHE-10000087769$ROCHE$Carvajal R, Rodriguez B, Garcia-Vasco L, Zabalza A, Arino H, Bollo L. Secondary organizing pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies [Abstract No: P1643/2079]. Multiple Sclerosis Journal. 2024;30 (3S):681-1137.$$$$$Y$$$20240927$$HP$ES$ES
243689911$24368991$1$I$20240809$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024190057$AMGEN$$67$YR$E$M$Y$$$20240926$$CN$US$US
243689921$24368992$1$I$20240802$20240924$20240927$20240927$EXP$FR-AFSSAPS-TS2024001040$FR-ORGANON-O2409FRA001891$ORGANON$$37$YR$$F$Y$$$20240927$$MD$FR$FR
243689931$24368993$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191231$AMGEN$$$$$F$Y$$$20240926$$CN$US$US
243689941$24368994$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017079$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240927$$CN$US$US
243689951$24368995$1$I$20220101$20240916$20240927$20240927$EXP$$US-NOVOPROD-1286696$NOVO NORDISK$$$$$F$Y$$$20240927$$CN$US$US
243689961$24368996$1$I$$20240916$20240927$20240927$EXP$$US-NOVOPROD-1287374$NOVO NORDISK$$$$$F$Y$$$20240927$$CN$US$US
243689971$24368997$1$I$$20240916$20240927$20240927$EXP$$IN-NOVOPROD-1286386$NOVO NORDISK$Dhiran Sivasubramanian. A Case Report of Verheij Syndrome. Cureus. 2024;16(8):1-5$11$YR$$F$Y$$$20240927$$MD$IN$IN
243689981$24368998$1$I$20221206$20240916$20240927$20240927$EXP$$US-NOVOPROD-1011580$NOVO NORDISK$$78$YR$$M$Y$$$20240927$$CN$US$US
243689991$24368999$1$I$$20240916$20240927$20240927$EXP$$US-NOVOPROD-1286545$NOVO NORDISK$Farhana Begum et al.. Semaglutide-associated kidney injury. Clinical Kidney Journal. 2024;17(9):1-6$49$YR$$F$Y$$$20240927$$HP$US$US
243690001$24369000$1$I$$20240917$20240927$20240927$EXP$$GB-NOVOPROD-1151498$NOVO NORDISK$$45$YR$$F$Y$$$20240927$$CN$GB$GB
243690011$24369001$1$I$$20240916$20240927$20240927$EXP$$AU-NOVOPROD-1288491$NOVO NORDISK$Hana A. Kawatu,Lavinia Hallam, Miriam Blackburn. Insulin amyloidosis: an under-recognised entity. Internal Medicine Journal. 2024;54:1581?1582$54$YR$$F$Y$$$20240927$$MD$AU$AU
243690021$24369002$1$I$20150501$20240916$20240927$20240927$EXP$$CO-NOVOPROD-1287106$NOVO NORDISK$$39$YR$$M$Y$$$20240927$$CN$CO$CO
243690031$24369003$1$I$20240501$20240916$20240927$20240927$EXP$$CO-NOVOPROD-1287170$NOVO NORDISK$$59$YR$$F$Y$48$KG$20240927$$CN$CO$CO
243690041$24369004$1$I$$20240916$20240927$20240927$EXP$$US-NOVOPROD-1286504$NOVO NORDISK$Farhana Begum et al.. Semaglutide-associated kidney injury. Clinical Kidney Journal. 2024;17(9):1-6$68$YR$$F$Y$$$20240927$$HP$US$US
243690051$24369005$1$I$20240719$20240916$20240927$20240927$EXP$$US-NOVOPROD-1286703$NOVO NORDISK$$68$YR$$M$Y$103.8$KG$20240927$$HP$US$US
243690061$24369006$1$I$$20240918$20240927$20240927$EXP$$MY-AMNEAL PHARMACEUTICALS-2024-AMRX-03499$AMNEAL$Zakaria ER, Wan Ghazali WS, Sazali H, Shahril NS, Md Salleh S, et al.. Acrocyanosis as a rare presentation of druginduced cutaneous vasculitis: a case report. BMC Rheumatology. 2024;8(41)$68$YR$$M$Y$$$20240927$$HP$MY$MY
243690071$24369007$1$I$$20240917$20240927$20240927$EXP$$US-NOVOPROD-1287182$NOVO NORDISK$$$$$F$Y$$$20240927$$CN$US$US
243690081$24369008$1$I$20240822$20240917$20240927$20240927$EXP$$US-NOVOPROD-1287486$NOVO NORDISK$$73$YR$$F$Y$$$20240927$$CN$US$US
243690091$24369009$1$I$$20240917$20240927$20240927$EXP$$US-NOVOPROD-1287229$NOVO NORDISK$$75$YR$$F$Y$$$20240927$$CN$US$US
243690101$24369010$1$I$$20240917$20240927$20240927$EXP$$US-NOVOPROD-1287344$NOVO NORDISK$$$$A$F$Y$$$20240927$$CN$US$US
243690111$24369011$1$I$$20240917$20240927$20240927$EXP$$US-NOVOPROD-1287249$NOVO NORDISK$$$$$F$Y$$$20240927$$HP$US$US
243690121$24369012$1$I$$20240917$20240927$20240927$EXP$CA-MHPD-E2B_001092617$CA-Accord-447554$ACCORD$$82$YR$E$M$Y$102$KG$20240927$$MD$CA$CA
243690131$24369013$1$I$20240801$20240917$20240927$20240927$EXP$SE-SEMPA-2024-006802$SE-NOVOPROD-1284409$NOVO NORDISK$$66$YR$$F$Y$88$KG$20240927$$MD$SE$SE
243690141$24369014$1$I$20140701$20240917$20240927$20240927$EXP$$US-NOVOPROD-1287198$NOVO NORDISK$$56$YR$$M$Y$$$20240927$$CN$US$US
243690151$24369015$1$I$20240101$20240923$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-030190$UNITED THERAPEUTICS$$$$$M$Y$72.109$KG$20240927$$$US$US
243690161$24369016$1$I$20240101$20240923$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-019543$UNITED THERAPEUTICS$$$$$F$Y$83.447$KG$20240927$$$US$US
243690171$24369017$1$I$20240913$20240917$20240927$20240927$EXP$$US-NOVOPROD-1287177$NOVO NORDISK$$66$YR$$F$Y$$$20240927$$CN$US$US
243690181$24369018$1$I$20240823$20240917$20240927$20240927$EXP$$GB-NOVOPROD-1285231$NOVO NORDISK$$23$YR$$M$Y$$$20240927$$CN$GB$GB
243690191$24369019$1$I$20240601$20240917$20240927$20240927$EXP$DK-DKMA-30736107$DK-NOVOPROD-1284240$NOVO NORDISK$$56$YR$$F$Y$94$KG$20240927$$CN$DK$DK
243690211$24369021$1$I$$20240917$20240927$20240927$EXP$$US-NOVOPROD-1287392$NOVO NORDISK$$$$$M$Y$$$20240927$$PH$US$US
243690221$24369022$1$I$20240830$20240917$20240927$20240927$EXP$$DE-NOVOPROD-1284403$NOVO NORDISK$$52$YR$$M$Y$91$KG$20240927$$MD$DE$DE
243690231$24369023$1$I$$20240917$20240927$20240927$EXP$$US-NOVOPROD-1287220$NOVO NORDISK$$$$$M$Y$$$20240927$$HP$US$US
243690241$24369024$1$I$$20240917$20240927$20240927$EXP$$EG-NOVOPROD-1278632$NOVO NORDISK$$858$MON$$F$Y$75$KG$20240927$$CN$EG$EG
243690251$24369025$1$I$$20240920$20240927$20240927$EXP$$CA-JNJFOC-20240962907$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20240927$$HP$CA$CA
243690261$24369026$1$I$$20240917$20240927$20240927$EXP$$US-NOVOPROD-1287507$NOVO NORDISK$$$$$F$Y$$$20240927$$CN$US$US
243690271$24369027$1$I$20240904$20240917$20240927$20240927$EXP$$CA-CELLTRION INC.-2024CA018339$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
243690281$24369028$1$I$$20240917$20240927$20240927$EXP$$US-NOVOPROD-1288724$NOVO NORDISK$$36$YR$$$Y$$$20240927$$CN$US$US
243690291$24369029$1$I$$20240917$20240927$20240927$EXP$$CO-NOVOPROD-1288241$NOVO NORDISK$$$$$M$Y$$$20240927$$CN$CO$CO
243690301$24369030$1$I$$20240918$20240927$20240927$EXP$$IN-Oxford Pharmaceuticals, LLC-2162116$OXFORD PHARMACEUTICALS$Source document$$$$F$Y$$$20240927$$MD$IN$IN
243690311$24369031$1$I$$20240920$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-030138$UNITED THERAPEUTICS$$$$$F$Y$69.841$KG$20240927$$$US$US
243690321$24369032$1$I$20220120$20240923$20240927$20240927$EXP$$CO-SANDOZ INC.-NVSC2020CO343761$SANDOZ$$50$YR$$F$Y$53$KG$20240927$$CN$CO$CO
243690331$24369033$1$I$20240101$20240923$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-030249$UNITED THERAPEUTICS$$$$$F$Y$77.098$KG$20240927$$$US$US
243690361$24369036$1$I$$20240923$20240927$20240927$EXP$$TW-AMGEN-TWNSP2024189720$AMGEN$$$$$M$Y$$$20240926$$CN$TW$TW
243690371$24369037$1$I$20240816$20240919$20240927$20240927$EXP$$US-AMGEN-CHNSP2024189208$AMGEN$$64$YR$A$F$Y$61$KG$20240926$$HP$US$CN
243690381$24369038$1$I$$20240917$20240927$20240927$EXP$CA-MHPD-E2B_07234162$CA-Accord-447316$ACCORD$$63$YR$A$M$Y$$$20240927$$MD$CA$CA
243690391$24369039$1$I$$20240918$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-047139$AUROBINDO$$$$$M$Y$$$20240927$$MD$ES$ES
243690411$24369041$1$I$$20240911$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005554$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243690421$24369042$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011369$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240927$$HP$CA$CA
243690431$24369043$1$I$20240101$20240923$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-030286$UNITED THERAPEUTICS$$$$$F$Y$85.261$KG$20240927$$$US$US
243690441$24369044$1$I$$20240924$20240927$20240927$EXP$$CA-ABBVIE-5938193$ABBVIE$$53$YR$$M$Y$$$20240927$$HP$CA$CA
243690451$24369045$1$I$$20240918$20240927$20240927$EXP$$JP-AMGEN-JPNSP2024190402$AMGEN$$$$$$Y$$$20240926$$MD$JP$JP
243690461$24369046$1$I$$20231023$20240927$20240927$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415723$RANBAXY$$$$$F$Y$$$20240927$$CN$US$US
243690471$24369047$1$I$$20240124$20240927$20240927$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-430063$RANBAXY$$$$$F$Y$$$20240927$$MD$US$US
243690481$24369048$1$I$$20230913$20240927$20240927$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-408771$RANBAXY$$$$E$F$Y$$$20240927$$CN$US$US
243690491$24369049$1$I$$20240918$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-046945$AUROBINDO$$$$$F$Y$$$20240927$$MD$ES$ES
243690501$24369050$1$I$$20240925$20240927$20240927$EXP$$US-TAKEDA-2024TUS095470$TAKEDA$$$$$M$Y$$$20240927$$MD$US$US
243690511$24369051$1$I$$20240916$20240927$20240927$EXP$CA-MHPD-001095668$CA-Accord-447851$ACCORD$$67$YR$E$F$Y$74$KG$20240927$$HP$CA$CA
243690521$24369052$1$I$20240907$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-046995$AUROBINDO$$69$YR$$M$Y$76$KG$20240927$$MD$FR$FR
243690531$24369053$1$I$$20240925$20240927$20240927$PER$$US-ABBVIE-5940496$ABBVIE$$$$$$Y$$$20240927$$HP$US$US
243690541$24369054$1$I$20240912$20240919$20240927$20240927$EXP$$CN-BEIGENE-BGN-2024-014904$BEIGENE$$$$$$Y$$$20240927$$HP$CN$CN
243690561$24369056$1$I$20240801$20240913$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409009189$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240927$$CN$US$US
243690571$24369057$1$I$20240101$20240923$20240927$20240927$PER$$US-ABBVIE-5939818$ABBVIE$$$$$$Y$$$20240927$$HP$US$US
243690581$24369058$1$I$$20240917$20240927$20240927$EXP$CA-MHPD-E2B_07226512$CA-Accord-447308$ACCORD$$53$YR$A$F$Y$$$20240927$$HP$CA$CA
243690591$24369059$1$I$20231110$20240917$20240927$20240927$EXP$GB-MHRA-MED-202409160834156140-WPZYT$GB-AMAROX PHARMA-AMR2024GB03202$HETERO$$75$YR$$$Y$105$KG$20240927$$CN$GB$GB
243690601$24369060$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011370$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240927$$HP$CA$CA
243690611$24369061$1$I$20240502$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-047227$AUROBINDO$$87$YR$$F$Y$$$20240927$$PH$FR$FR
243690631$24369063$1$I$$20240911$20240927$20240927$PER$$US-JNJFOC-20240965884$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20240927$$CN$US$US
243690641$24369064$1$I$20240819$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-047026$AUROBINDO$$30$YR$$M$Y$$$20240927$$MD$FR$FR
243690651$24369065$1$I$$20240916$20240927$20240927$EXP$CA-MHPD-001094735$CA-Accord-447848$ACCORD$$72$YR$E$M$Y$76$KG$20240927$$HP$CA$CA
243690661$24369066$1$I$20240401$20240603$20240927$20240927$PER$$US-ENDO PHARMACEUTICALS INC-2024-001853$ENDO$$$$$M$Y$$$20240927$$CN$US$US
243690671$24369067$1$I$$20240925$20240927$20240927$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053481$BOEHRINGER INGELHEIM$Iwuagwu CC, Moh^d Mari A, Johnson M, Iwuagwu CC. Euglycemic diabetic ketoacidosis, recurrent genital abscess, and proximal renal tubular acidosis with concurrent SGLT-2 inhibitor: more than an association. Cureus. 2024 Aug 22;16 : 8: 67481. doi:10.7759/cureus.67481.$42$YR$A$F$Y$$$20240927$$HP$US$US
243690681$24369068$1$I$20240912$20240912$20240927$20240927$PER$$US-JNJFOC-20240933254$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240927$$CN$US$US
243690691$24369069$1$I$$20240910$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09114$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243690701$24369070$1$I$20240917$20240918$20240927$20240927$EXP$$CO-NOVOPROD-1288335$NOVO NORDISK$$77$YR$$F$Y$$$20240927$$CN$CO$CO
243690711$24369071$1$I$20240902$20240918$20240927$20240927$EXP$$DE-NOVOPROD-1286485$NOVO NORDISK$$$$$M$Y$$$20240927$$MD$DE$DE
243690721$24369072$1$I$$20240918$20240927$20240927$EXP$$US-NOVOPROD-1287882$NOVO NORDISK$$$$$M$Y$$$20240927$$CN$US$US
243690731$24369073$1$I$20240919$20240918$20240927$20240927$EXP$$US-NOVOPROD-1287884$NOVO NORDISK$$68$YR$$F$Y$$$20240927$$CN$US$US
243690741$24369074$1$I$$20240918$20240927$20240927$EXP$$DE-NOVOPROD-1286448$NOVO NORDISK$$62$YR$$M$Y$$$20240927$$MD$DE$DE
243690751$24369075$1$I$20240701$20240918$20240927$20240927$EXP$$US-NOVOPROD-1287306$NOVO NORDISK$$66$YR$$$Y$$$20240927$$CN$US$US
243690761$24369076$1$I$$20240920$20240927$20240927$EXP$$IN-Bion-013919$BIONPHARMA$$$$A$F$Y$$$20240927$$HP$IN$IN
243690771$24369077$1$I$$20240920$20240927$20240927$EXP$$IN-Bion-013922$BIONPHARMA$$$$A$F$Y$$$20240927$$HP$IN$IN
243690781$24369078$1$I$20231110$20240917$20240927$20240927$EXP$GB-MHRA-MED-202409160834156140-WPZYT$GB-Accord-447378$ACCORD$$75$YR$E$$Y$105$KG$20240927$$CN$GB$GB
243690791$24369079$1$I$$20240917$20240927$20240927$EXP$CA-MHPD-E2B_07225711$CA-Accord-447332$ACCORD$$81$YR$E$F$Y$57$KG$20240927$$HP$CA$CA
243690801$24369080$1$I$$20240920$20240927$20240927$PER$$US-GSK-US2024117163$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$HP$US$US
243690811$24369081$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011031$APOTEX$$77$YR$$F$Y$102$KG$20240927$$PH$CA$CA
243690821$24369082$1$I$$20240923$20240927$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029968$UNITED THERAPEUTICS$$$$$$Y$$$20240927$$$US$US
243690831$24369083$1$I$$20240919$20240927$20240927$EXP$$CA-TOLMAR, INC.-24CA052746$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243690841$24369084$1$I$$20240920$20240927$20240927$EXP$$CA-TOLMAR, INC.-24CA052788$TOLMAR$$$$$M$Y$$$20240927$$MD$CA$CA
243690851$24369085$1$I$$20240922$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052792$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243690861$24369086$1$I$20210301$20240919$20240927$20240927$EXP$$US-TOLMAR, INC.-24US052808$TOLMAR$Viscardi C.M., Rho J.Y., Blake C.R.. Bilateral neovascular glaucoma associated with Radium-223 infusions for prostate cancer. American Journal of Ophthalmology Case Reports. 2024;36$65$YR$$M$Y$$$20240927$$MD$US$US
243690871$24369087$1$I$$20240919$20240927$20240927$EXP$$US-TOLMAR, INC.-24US052810$TOLMAR$Viscardi C.M., Rho J.Y., Blake C.R.. Bilateral neovascular glaucoma associated with Radium-223 infusions for prostate cancer. American Journal of Ophthalmology Case Reports. 2024;36:1-3$74$YR$$M$Y$$$20240927$$MD$US$US
243690881$24369088$1$I$$20240916$20240927$20240927$PER$$US-APOTEX-2024AP011142$APOTEX$Guy DR, Mizes A, Richardson CT.. Rapid response of omalizumab-resistant chronic urticaria to acalabrutinib. JAAD Case Reports. 2024;47 (0):47-49$49$YR$$F$Y$$$20240927$$HP$US$US
243690891$24369089$1$I$$20240918$20240927$20240927$EXP$$JP-NOVOPROD-1285933$NOVO NORDISK$$8$DEC$$F$Y$$$20240927$$PH$JP$JP
243690911$24369091$1$I$20170101$20240918$20240927$20240927$EXP$$EG-NOVOPROD-1286430$NOVO NORDISK$$507$MON$$F$Y$130$KG$20240927$$CN$EG$EG
243690921$24369092$1$I$20240901$20240917$20240927$20240927$30DAY$$US-NOVOPROD-1287473$NOVO NORDISK$$51$YR$$F$Y$$$20240927$$CN$US$US
243690931$24369093$1$I$$20240918$20240927$20240927$EXP$$JP-NOVOPROD-1286416$NOVO NORDISK$$50$YR$$M$Y$$$20240927$$PH$JP$JP
243690941$24369094$1$I$20240101$20240917$20240927$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026822$UNITED THERAPEUTICS$$$$$M$Y$89.478$KG$20240927$$$US$US
243690951$24369095$1$I$20240101$20240917$20240927$20240927$30DAY$$DZ-NOVOPROD-1284877$NOVO NORDISK$$36$YR$$F$Y$74$KG$20240927$$CN$DZ$DZ
243690961$24369096$1$I$20240823$20240918$20240927$20240927$EXP$CN-NMPA-4304011002683202400233$CN-NOVOPROD-1286413$NOVO NORDISK$$54$YR$$M$Y$76$KG$20240927$$HP$CN$CN
243690971$24369097$1$I$$20240920$20240927$20240927$EXP$$BR-NOVOPROD-1289249$NOVO NORDISK$$$$$F$Y$$$20240927$$CN$BR$BR
243690991$24369099$1$I$$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024190252$AMGEN$$$$$$Y$$$20240926$$HP$US$US
243691001$24369100$1$I$20240917$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190734$AMGEN$$$$$$Y$$$20240926$$HP$US$US
243691011$24369101$1$I$20240901$20240920$20240927$20240927$EXP$$BR-AMGEN-BRASP2024188749$AMGEN$$66$YR$E$F$Y$$$20240926$$CN$BR$BR
243691031$24369103$1$I$20240831$20240914$20240927$20240927$EXP$$CN-OCTA-ALB15924$OCTAPHARMA$$72$YR$E$M$Y$$$20240926$$HP$CN$CN
243691051$24369105$1$I$$20240920$20240927$20240927$PER$$US-LEO Pharma-373754$LEO PHARM$$47$YR$$F$Y$68$KG$20240927$$CN$US$US
243691061$24369106$1$I$20231104$20240924$20240927$20240927$PER$$US-009507513-2409USA008826$MERCK$$64$YR$$F$Y$$$20240927$$CN$US$US
243691071$24369107$1$I$$20240917$20240927$20240927$EXP$CA-MHPD-E2B_07234164$CA-Accord-447475$ACCORD$$35$YR$A$F$Y$64$KG$20240927$$HP$CA$CA
243691092$24369109$2$F$$20240927$20240927$20240930$PER$$US-JNJFOC-20240962710$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243691101$24369110$1$I$20240409$20240923$20240927$20240927$EXP$FR-AFSSAPS-NY2024001078$FR-JNJFOC-20240965984$JOHNSON AND JOHNSON$$72$YR$E$F$Y$49$KG$20240927$$MD$FR$FR
243691111$24369111$1$I$20240101$20240903$20240927$20240927$PER$$US-SA-2024SA273460$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240927$$MD$US$US
243691121$24369112$1$I$$20240903$20240927$20240927$PER$$US-SA-2024SA273035$SANOFI AVENTIS$$$$A$M$Y$100$KG$20240927$$MD$US$US
243691131$24369113$1$I$$20240903$20240927$20240927$PER$$US-SA-2024SA273501$SANOFI AVENTIS$$$$A$F$Y$55.91$KG$20240927$$MD$US$US
243691141$24369114$1$I$20240101$20240904$20240927$20240927$PER$$US-SA-2024SA273491$SANOFI AVENTIS$$43$YR$A$M$Y$$$20240927$$CN$US$US
243691151$24369115$1$I$20240101$20240904$20240927$20240927$PER$$US-SA-2024SA214556$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240927$$CN$US$US
243691161$24369116$1$I$20240101$20240829$20240927$20240927$PER$$US-SA-2024SA235477$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240927$$HP$US$US
243691171$24369117$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA274297$SANOFI AVENTIS$$87$YR$E$M$Y$72.73$KG$20240927$$MD$US$US
243691181$24369118$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024115636$GLAXOSMITHKLINE$$$$$M$Y$$$20240927$$CN$US$US
243691191$24369119$1$I$20240901$20240913$20240927$20240927$PER$$US-SA-2024SA269448$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240927$$HP$US$US
243691201$24369120$1$I$20240913$20240913$20240927$20240927$PER$$US-SA-2024SA274288$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240927$$CN$US$US
243691211$24369121$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276431$SANOFI AVENTIS$$$$E$F$Y$84.36$KG$20240927$$MD$US$US
243691221$24369122$1$I$20170101$20240905$20240927$20240927$PER$$US-SA-2024SA277040$SANOFI AVENTIS$$35$YR$A$M$Y$94.55$KG$20240927$$MD$US$US
243691231$24369123$1$I$$20240919$20240927$20240927$PER$$US-SA-2024SA272633$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240927$$HP$US$US
243691241$24369124$1$I$20240601$20240918$20240927$20240927$PER$$US-SA-2024SA277826$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240927$$MD$US$US
243691251$24369125$1$I$20240801$20240919$20240927$20240927$PER$$US-SA-2024SA272724$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240927$$MD$US$US
243691261$24369126$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA278295$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
243691271$24369127$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA276074$SANOFI AVENTIS$$$$A$M$Y$$$20240927$$MD$US$US
243691281$24369128$1$I$20240701$20240910$20240927$20240927$PER$$US-SA-2024SA277625$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240927$$CN$US$US
243691291$24369129$1$I$20240101$20240909$20240927$20240927$PER$$US-SA-2024SA275653$SANOFI AVENTIS$$26$YR$A$F$Y$56.69$KG$20240927$$MD$US$US
243691301$24369130$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA267498$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240927$$MD$US$US
243691311$24369131$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA275291$SANOFI AVENTIS$$$$T$F$Y$86.36$KG$20240927$$MD$US$US
243691321$24369132$1$I$20240101$20240919$20240927$20240927$PER$$US-SA-2024SA276238$SANOFI AVENTIS$$$$$F$Y$$$20240927$$PH$US$US
243691331$24369133$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA275459$SANOFI AVENTIS$$$$A$M$Y$$$20240927$$MD$US$US
243691341$24369134$1$I$20240101$20240923$20240927$20240927$PER$$US-SA-2024SA276359$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240927$$MD$US$US
243691351$24369135$1$I$$20240919$20240927$20240927$PER$$US-SA-2024SA272963$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240927$$MD$US$US
243691361$24369136$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016620$ELI LILLY AND CO$$$$$$Y$$$20240927$$CN$US$US
243691371$24369137$1$I$20240916$20240917$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409012943$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243691381$24369138$1$I$$20240923$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409014789$ELI LILLY AND CO$$$$$M$Y$$$20240927$$CN$US$US
243691391$24369139$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015292$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240927$$CN$US$US
243691401$24369140$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015486$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243691411$24369141$1$I$20240921$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016224$ELI LILLY AND CO$$$$$$Y$$$20240927$$CN$US$US
243691421$24369142$1$I$$20240916$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409011109$ELI LILLY AND CO$$45$YR$A$M$Y$$$20240927$$CN$US$US
243691431$24369143$1$I$20240101$20240918$20240927$20240927$EXP$$CA-CELLTRION INC.-2024CA019055$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
243691441$24369144$1$I$$20240923$20240927$20240927$PER$$US-ROCHE-10000089538$ROCHE$$15$YR$T$F$Y$$$20240927$$CN$US$US
243691451$24369145$1$I$$20240919$20240927$20240927$EXP$$AU-BIOGEN-2024BI01283492$BIOGEN$$44$YR$$M$Y$$$20240927$$CN$AU$AU
243691471$24369147$1$I$$20240921$20240927$20240927$EXP$$CA-ROCHE-10000091798$ROCHE$$52$YR$A$M$Y$$$20240927$$MD$CA$CA
243691481$24369148$1$I$$20240923$20240927$20240927$PER$$US-ROCHE-10000091858$ROCHE$$$$A$M$Y$$$20240927$$CN$US$US
243691491$24369149$1$I$20240821$20240925$20240927$20240927$PER$$US-ABBVIE-5939688$ABBVIE$$$$$F$Y$$$20240927$$HP$US$US
243691501$24369150$1$I$$20240923$20240927$20240927$EXP$$CA-JNJFOC-20240965762$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$HP$CA$CA
243691511$24369151$1$I$20240901$20240926$20240927$20240927$PER$$US-ABBVIE-5941508$ABBVIE$$$$$F$Y$$$20240927$$MD$US$US
243691531$24369153$1$I$20240919$20240925$20240927$20240927$EXP$$CN-BEIGENE-BGN-2024-015275$BEIGENE$$$$$$Y$$$20240927$$CN$CN$CN
243691541$24369154$1$I$$20240920$20240927$20240927$EXP$$GB-TAKEDA-2021TUS066140$TAKEDA$$$$E$F$Y$$$20240927$$HP$GB$GB
243691551$24369155$1$I$$20240919$20240927$20240927$EXP$$CA-APOTEX-2024AP011296$APOTEX$$54$YR$$F$Y$$$20240927$$CN$CA$CA
243691561$24369156$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5935537$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243691571$24369157$1$I$20240902$20240912$20240927$20240927$PER$$US-JNJFOC-20240959796$JOHNSON AND JOHNSON$$61$YR$A$F$Y$74.8$KG$20240927$$CN$US$US
243691581$24369158$1$I$$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024190489$AMGEN$$$$$$Y$$$20240926$$MD$US$US
243691591$24369159$1$I$$20240921$20240927$20240927$EXP$$CA-ROCHE-10000091694$ROCHE$$37$YR$A$M$Y$$$20240927$$MD$CA$CA
243691601$24369160$1$I$20240801$20240923$20240927$20240927$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-052694$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20240927$$MD$AU$AU
243691611$24369161$1$I$$20231023$20240927$20240927$PER$$US-ROCHE-3445401$ROCHE$$42$YR$A$M$Y$$$20240927$$PH$US$US
243691621$24369162$1$I$$20240424$20240927$20240927$PER$$US-ROCHE-3441976$ROCHE$$60$YR$A$M$Y$$$20240927$$MD$US$US
243691631$24369163$1$I$$20240917$20240927$20240927$EXP$CA-MHPD-E2B_07205584$CA-Accord-447579$ACCORD$$$$A$F$Y$$$20240927$$HP$CA$CA
243691641$24369164$1$I$$20231006$20240927$20240927$PER$$US-ROCHE-3436783$ROCHE$$79$YR$E$M$Y$$$20240927$$MD$US$US
243691651$24369165$1$I$$20240416$20240927$20240927$PER$$US-ROCHE-3246095$ROCHE$$65$YR$E$M$Y$$$20240927$$MD$US$US
243691661$24369166$1$I$$20240403$20240927$20240927$PER$$US-ROCHE-3030172$ROCHE$$67$YR$E$F$Y$$$20240927$$MD$US$US
243691671$24369167$1$I$20230101$20231009$20240927$20240927$PER$$US-ROCHE-3420453$ROCHE$$79$YR$E$F$Y$106.59$KG$20240927$$CN$US$US
243691681$24369168$1$I$$20240419$20240927$20240927$PER$$US-ROCHE-3316809$ROCHE$$42$YR$A$F$Y$$$20240927$$MD$US$US
243691691$24369169$1$I$$20231030$20240927$20240927$PER$$US-ROCHE-3450901$ROCHE$$58$YR$A$M$Y$$$20240927$$MD$US$US
243691711$24369171$1$I$$20231102$20240927$20240927$PER$$US-ROCHE-3442446$ROCHE$$53$YR$A$F$Y$$$20240927$$HP$US$US
243691721$24369172$1$I$$20231024$20240927$20240927$PER$$US-ROCHE-3446148$ROCHE$$3$YR$C$F$Y$$$20240927$$MD$US$US
243691731$24369173$1$I$$20231027$20240927$20240927$PER$$US-ROCHE-3161923$ROCHE$$55$YR$A$F$Y$$$20240927$$MD$US$US
243691741$24369174$1$I$$20231006$20240927$20240927$PER$$US-ROCHE-3436459$ROCHE$$50$YR$A$M$Y$$$20240927$$MD$US$US
243691751$24369175$1$I$$20240913$20240927$20240927$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09257$LUPIN$Stark JE, Montgomery CM. Administering a soda beverage with the hepatitis C treatment sofosbuvir/velpatasvir and the proton-pump inhibitor pantoprazole: a case report. Journal of Pharmacy Practice. 2024;37 (4):1011-1014$64$YR$$M$Y$$$20240927$$PH$US$US
243691761$24369176$1$I$$20231027$20240927$20240927$PER$$US-ROCHE-3448263$ROCHE$$74$YR$E$F$Y$$$20240927$$CN$US$US
243691771$24369177$1$I$$20231027$20240927$20240927$PER$$US-ROCHE-3448213$ROCHE$$59$YR$A$F$Y$$$20240927$$CN$US$US
243691781$24369178$1$I$$20231020$20240927$20240927$PER$$US-ROCHE-3444642$ROCHE$$80$YR$E$F$Y$$$20240927$$MD$US$US
243691791$24369179$1$I$$20231016$20240927$20240927$PER$$US-ROCHE-3440950$ROCHE$$79$YR$E$F$Y$$$20240927$$MD$US$US
243691801$24369180$1$I$$20231009$20240927$20240927$PER$$US-ROCHE-3437480$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243691811$24369181$1$I$$20231017$20240927$20240927$PER$$US-ROCHE-3419329$ROCHE$$61$YR$A$F$Y$$$20240927$$MD$US$US
243691821$24369182$1$I$$20231016$20240927$20240927$PER$$US-ROCHE-3441564$ROCHE$$47$YR$A$M$Y$$$20240927$$MD$US$US
243691841$24369184$1$I$$20231016$20240927$20240927$PER$$US-ROCHE-3440926$ROCHE$$73$YR$E$M$Y$$$20240927$$MD$US$US
243691851$24369185$1$I$$20231010$20240927$20240927$PER$$US-ROCHE-3370917$ROCHE$$51$YR$A$M$Y$$$20240927$$MD$US$US
243691861$24369186$1$I$$20240924$20240927$20240927$EXP$$US-ABBVIE-5937377$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243691871$24369187$1$I$20230101$20240917$20240927$20240927$EXP$$US-Accord-447417$ACCORD$Gwynn N, Lindenmayer J, Boes T, Pitalo C. Late Recognition of Cholinergic Delirium in Patient on Donepezil Combination Treatment. Journal of Clinical Psychopharmacology. 2024;44(5):521-2.$70$YR$E$M$Y$$$20240927$$MD$US$US
243691881$24369188$1$I$$20231016$20240927$20240927$PER$$US-ROCHE-3374776$ROCHE$$66$YR$E$M$Y$$$20240927$$MD$US$US
243691891$24369189$1$I$$20231130$20240927$20240927$PER$$DE-ROCHE-3448368$ROCHE$$72$YR$E$$Y$$$20240927$$HP$DE$DE
243691901$24369190$1$I$$20240118$20240927$20240927$PER$$US-ROCHE-2930435$ROCHE$$61$YR$A$F$Y$$$20240927$$MD$US$US
243691911$24369191$1$I$$20240227$20240927$20240927$PER$$US-ROCHE-3421915$ROCHE$$41$YR$A$M$Y$$$20240927$$MD$US$US
243691921$24369192$1$I$$20231023$20240927$20240927$PER$$US-ROCHE-3446508$ROCHE$$72$YR$E$F$Y$80.7$KG$20240927$$MD$US$US
243691931$24369193$1$I$$20240115$20240927$20240927$PER$$US-ROCHE-2845920$ROCHE$$86$YR$E$M$Y$$$20240927$$CN$US$US
243691941$24369194$1$I$$20231017$20240927$20240927$PER$$US-ROCHE-3442089$ROCHE$$55$YR$A$F$Y$$$20240927$$MD$US$US
243691951$24369195$1$I$$20240206$20240927$20240927$PER$$US-ROCHE-2673146$ROCHE$$37$YR$A$F$Y$$$20240927$$MD$US$US
243691961$24369196$1$I$$20231024$20240927$20240927$PER$$US-ROCHE-3446886$ROCHE$$47$YR$A$F$Y$$$20240927$$MD$US$US
243691971$24369197$1$I$20240924$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191635$AMGEN$$$$$$Y$$$20240926$$PH$US$US
243691981$24369198$1$I$20240101$20240906$20240927$20240927$PER$$US-SA-2024SA277622$SANOFI AVENTIS$$$$$F$Y$$$20240927$$CN$US$US
243691991$24369199$1$I$20240101$20240906$20240927$20240927$PER$$US-SA-2024SA275137$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240927$$MD$US$US
243692001$24369200$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276515$SANOFI AVENTIS$$$$T$M$Y$118.18$KG$20240927$$MD$US$US
243692011$24369201$1$I$20240101$20240903$20240927$20240927$PER$$US-SA-2024SA273675$SANOFI AVENTIS$$$$E$F$Y$58.64$KG$20240927$$MD$US$US
243692021$24369202$1$I$20240912$20240913$20240927$20240927$PER$$US-SA-2024SA278767$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240927$$HP$US$US
243692031$24369203$1$I$20240101$20240903$20240927$20240927$PER$$US-SA-2024SA273643$SANOFI AVENTIS$$$$$$Y$$$20240927$$MD$US$US
243692051$24369205$1$I$20240101$20240903$20240927$20240927$PER$$US-SA-2024SA273423$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240927$$MD$US$US
243692061$24369206$1$I$20240101$20240906$20240927$20240927$PER$$US-SA-2024SA276569$SANOFI AVENTIS$$46$YR$A$M$Y$104.3$KG$20240927$$HP$US$US
243692071$24369207$1$I$20240425$20240909$20240927$20240927$PER$$US-SA-2024SA278667$SANOFI AVENTIS$$56$YR$A$F$Y$95$KG$20240927$$MD$US$US
243692081$24369208$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA274150$SANOFI AVENTIS$$$$$M$Y$$$20240927$$CN$US$US
243692091$24369209$1$I$20240101$20240913$20240927$20240927$PER$$US-SA-2024SA275216$SANOFI AVENTIS$$$$$M$Y$$$20240927$$CN$US$US
243692101$24369210$1$I$20240101$20240912$20240927$20240927$PER$$US-SA-2024SA277923$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240927$$CN$US$US
243692111$24369211$1$I$20240401$20240909$20240927$20240927$PER$$US-SA-2024SA276564$SANOFI AVENTIS$$32$YR$A$M$Y$124.73$KG$20240927$$MD$US$US
243692121$24369212$1$I$20240701$20240913$20240927$20240927$PER$$US-SA-2024SA272337$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240927$$MD$US$US
243692131$24369213$1$I$20240901$20240912$20240927$20240927$PER$$US-SA-2024SA273151$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240927$$MD$US$US
243692141$24369214$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA273600$SANOFI AVENTIS$$$$E$F$Y$$$20240927$$MD$US$US
243692151$24369215$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA278127$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240927$$CN$US$US
243692161$24369216$1$I$20240101$20240903$20240927$20240927$PER$$US-SA-2024SA273731$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240927$$HP$US$US
243692171$24369217$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA278662$SANOFI AVENTIS$$$$E$M$Y$$$20240927$$MD$US$US
243692181$24369218$1$I$20240101$20240918$20240927$20240927$PER$$US-SA-2024SA271908$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240927$$HP$US$US
243692191$24369219$1$I$20240901$20240917$20240927$20240927$PER$$US-SA-2024SA270338$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240927$$HP$US$US
243692201$24369220$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011356$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240927$$HP$CA$CA
243692211$24369221$1$I$20240101$20240923$20240927$20240927$EXP$$US-ABBVIE-5936906$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243692221$24369222$1$I$20231107$20231107$20240927$20240927$PER$$US-ROCHE-3454620$ROCHE$$78$YR$E$M$Y$$$20240927$$CN$US$US
243692231$24369223$1$I$$20240118$20240927$20240927$PER$$US-ROCHE-3006925$ROCHE$$68$YR$E$F$Y$$$20240927$$MD$US$US
243692241$24369224$1$I$$20240117$20240927$20240927$PER$$US-ROCHE-3140431$ROCHE$$60$YR$A$F$Y$$$20240927$$MD$US$US
243692251$24369225$1$I$20230619$20240920$20240927$20240927$EXP$$KR-009507513-2409KOR007037$MERCK$$71$YR$$F$Y$$$20240927$$PH$KR$KR
243692271$24369227$1$I$20240901$20240925$20240927$20240927$PER$$US-SA-2024SA278543$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240927$$MD$US$US
243692291$24369229$1$I$20240916$20240919$20240927$20240927$PER$$US-SA-2024SA272840$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240927$$MD$US$US
243692301$24369230$1$I$20240901$20240923$20240927$20240927$EXP$$US-ABBVIE-5936893$ABBVIE$$60$YR$$F$Y$$$20240927$$CN$US$US
243692311$24369231$1$I$20240101$20240923$20240927$20240927$EXP$$US-ABBVIE-5937461$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243692321$24369232$1$I$20231001$20240907$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005446$ACADIA PHARMACEUTICALS$$67$YR$$F$Y$$$20240927$$CN$US$US
243692331$24369233$1$I$$20240923$20240927$20240927$EXP$$CA-ABBVIE-5937447$ABBVIE$$$$E$F$Y$$$20240927$$CN$CA$CA
243692341$24369234$1$I$20240321$20240328$20240927$20240927$PER$$US-ROCHE-3296546$ROCHE$$60$YR$A$F$Y$$$20240927$$MD$US$US
243692351$24369235$1$I$$20240110$20240927$20240927$PER$$US-ROCHE-3236730$ROCHE$$46$YR$A$M$Y$$$20240927$$MD$US$US
243692361$24369236$1$I$$20231118$20240927$20240927$PER$$US-ROCHE-2674950$ROCHE$$90$YR$E$F$Y$81.19$KG$20240927$$CN$US$US
243692371$24369237$1$I$$20240915$20240927$20240927$EXP$$US-Nexus Pharma-000314$NEXUS PHARMACEUTICALS$Romero KN, O^Brien MC, Agrawal A, Hasan I. Creatine Kinase Surge: Levetiracetam-Induced Rhabdomyolysis. Cureus. 2024 Aug 12;16(8):e66715.$27$YR$A$M$Y$$$20240927$$HP$US$US
243692381$24369238$1$I$$20240116$20240927$20240927$PER$$US-ROCHE-3046117$ROCHE$$39$YR$A$M$Y$158.76$KG$20240927$$CN$US$US
243692391$24369239$1$I$$20231121$20240927$20240927$PER$$US-ROCHE-3204057$ROCHE$$42$YR$A$F$Y$$$20240927$$MD$US$US
243692401$24369240$1$I$$20240123$20240927$20240927$PER$$US-ROCHE-3298240$ROCHE$$64$YR$A$F$Y$$$20240927$$MD$US$US
243692411$24369241$1$I$20221101$20231120$20240927$20240927$PER$$US-ROCHE-3404029$ROCHE$$63$YR$A$M$Y$$$20240927$$CN$US$US
243692421$24369242$1$I$$20231114$20240927$20240927$PER$$US-ROCHE-3235417$ROCHE$$59$YR$A$F$Y$$$20240927$$MD$US$US
243692431$24369243$1$I$$20240223$20240927$20240927$PER$$US-ROCHE-3131482$ROCHE$$66$YR$E$F$Y$$$20240927$$MD$US$US
243692441$24369244$1$I$$20231221$20240927$20240927$PER$$US-ROCHE-2498671$ROCHE$$94$YR$E$M$Y$$$20240927$$MD$US$US
243692451$24369245$1$I$$20231109$20240927$20240927$PER$$US-ROCHE-2815009$ROCHE$$90$YR$E$F$Y$$$20240927$$MD$US$US
243692461$24369246$1$I$$20240116$20240927$20240927$PER$$US-ROCHE-2873239$ROCHE$$63$YR$A$F$Y$$$20240927$$MD$US$US
243692471$24369247$1$I$$20240916$20240927$20240927$PER$$US-JNJFOC-20240949856$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243692491$24369249$1$I$$20231121$20240927$20240927$PER$$US-ROCHE-3179804$ROCHE$$61$YR$A$M$Y$$$20240927$$MD$US$US
243692501$24369250$1$I$$20240212$20240927$20240927$PER$$US-ROCHE-3410847$ROCHE$$74$YR$E$F$Y$$$20240927$$MD$US$US
243692521$24369252$1$I$$20240318$20240927$20240927$PER$$US-ROCHE-3265402$ROCHE$$86$YR$E$F$Y$$$20240927$$MD$US$US
243692531$24369253$1$I$$20240206$20240927$20240927$PER$$US-ROCHE-3298496$ROCHE$$80$YR$E$M$Y$$$20240927$$MD$US$US
243692541$24369254$1$I$$20231130$20240927$20240927$PER$$US-ROCHE-2781426$ROCHE$$57$YR$A$F$Y$$$20240927$$HP$US$US
243692551$24369255$1$I$$20240123$20240927$20240927$PER$$US-ROCHE-3416399$ROCHE$$61$YR$A$F$Y$$$20240927$$MD$US$US
243692561$24369256$1$I$$20240123$20240927$20240927$PER$$US-ROCHE-3273836$ROCHE$$65$YR$E$M$Y$$$20240927$$MD$US$US
243692571$24369257$1$I$$20240202$20240927$20240927$PER$$US-ROCHE-1977836$ROCHE$$61$YR$A$F$Y$$$20240927$$MD$US$US
243692581$24369258$1$I$$20240129$20240927$20240927$PER$$US-ROCHE-3136621$ROCHE$$72$YR$E$M$Y$$$20240927$$MD$US$US
243692591$24369259$1$I$$20231107$20240927$20240927$PER$$US-ROCHE-3454797$ROCHE$$69$YR$E$M$Y$$$20240927$$MD$US$US
243692611$24369261$1$I$20240901$20240912$20240927$20240927$EXP$$CN-Techdow-J2024HPR000578$SHENZHEN TECHDOW PHARMACEUTICAL$$79$YR$E$M$Y$$$20240927$$MD$CN$CN
243692621$24369262$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005372$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243692631$24369263$1$I$$20231101$20240927$20240927$PER$$US-ROCHE-3451423$ROCHE$$35$YR$A$F$Y$$$20240927$$MD$US$US
243692641$24369264$1$I$$20240223$20240927$20240927$PER$$US-ROCHE-2906193$ROCHE$$69$YR$E$F$Y$$$20240927$$MD$US$US
243692651$24369265$1$I$$20231026$20240927$20240927$PER$$US-ROCHE-3434369$ROCHE$$67$YR$E$F$Y$$$20240927$$MD$US$US
243692661$24369266$1$I$$20231030$20240927$20240927$PER$$US-ROCHE-3449806$ROCHE$$53$YR$A$M$Y$$$20240927$$MD$US$US
243692671$24369267$1$I$$20231011$20240927$20240927$PER$$US-ROCHE-3439653$ROCHE$$63$YR$A$F$Y$$$20240927$$MD$US$US
243692681$24369268$1$I$$20231106$20240927$20240927$PER$$US-ROCHE-3452916$ROCHE$$67$YR$E$F$Y$$$20240927$$CN$US$US
243692691$24369269$1$I$20231019$20231106$20240927$20240927$PER$$US-ROCHE-3453526$ROCHE$$31$YR$A$M$Y$76.2$KG$20240927$$MD$US$US
243692701$24369270$1$I$$20231023$20240927$20240927$PER$$US-ROCHE-3445566$ROCHE$$90$YR$E$M$Y$$$20240927$$MD$US$US
243692711$24369271$1$I$20070301$20240923$20240927$20240927$EXP$SE-EMA-DD-20240816-7482711-121902$SE-SA-2024SA276999$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240927$$MD$SE$SE
243692731$24369273$1$I$20150303$20240923$20240927$20240927$EXP$$CO-UCBSA-2024049515$UCB$$77$YR$$F$Y$$$20240927$$CN$CO$CO
243692751$24369275$1$I$$20231023$20240927$20240927$PER$$US-ROCHE-3445382$ROCHE$$52$YR$A$F$Y$$$20240927$$MD$US$US
243692761$24369276$1$I$$20231020$20240927$20240927$PER$$US-ROCHE-3445550$ROCHE$$86$YR$E$F$Y$$$20240927$$MD$US$US
243692771$24369277$1$I$$20240507$20240927$20240927$PER$$US-ROCHE-2187609$ROCHE$$54$YR$A$M$Y$$$20240927$$MD$US$US
243692781$24369278$1$I$$20231103$20240927$20240927$PER$$US-ROCHE-3453010$ROCHE$$60$YR$A$F$Y$$$20240927$$MD$US$US
243692791$24369279$1$I$$20231009$20240927$20240927$PER$$US-ROCHE-3363953$ROCHE$$77$YR$E$F$Y$$$20240927$$MD$US$US
243692801$24369280$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011363$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240927$$HP$CA$CA
243692811$24369281$1$I$20230919$20230922$20240927$20240927$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000162-2023$QILU PHARMACEUTICAL$$51$YR$A$F$Y$$$20240923$$HP$US$US
243692821$24369282$1$I$20240823$20240919$20240927$20240927$EXP$$CN-BEIGENE-BGN-2024-014923$BEIGENE$$$$$$Y$$$20240927$$HP$CN$CN
243692831$24369283$1$I$$20231115$20240927$20240927$PER$$US-ROCHE-3084066$ROCHE$$60$YR$A$F$Y$$$20240927$$MD$US$US
243692841$24369284$1$I$$20231118$20240927$20240927$PER$$US-ROCHE-3331606$ROCHE$$56$YR$A$F$Y$$$20240927$$MD$US$US
243692851$24369285$1$I$$20231115$20240927$20240927$PER$$US-ROCHE-3247138$ROCHE$$51$YR$A$F$Y$$$20240927$$MD$US$US
243692861$24369286$1$I$$20231221$20240927$20240927$PER$$US-ROCHE-3259714$ROCHE$$33$YR$A$M$Y$$$20240927$$MD$US$US
243692871$24369287$1$I$$20240117$20240927$20240927$PER$$US-ROCHE-3236440$ROCHE$$91$YR$E$M$Y$$$20240927$$MD$US$US
243692881$24369288$1$I$20240701$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005367$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240927$$CN$US$US
243692891$24369289$1$I$20231006$20231108$20240927$20240927$PER$$US-ROCHE-3445973$ROCHE$$84$YR$E$F$Y$$$20240927$$CN$US$US
243692901$24369290$1$I$$20231127$20240927$20240927$PER$$US-ROCHE-3414670$ROCHE$$55$YR$A$F$Y$$$20240927$$MD$US$US
243692911$24369291$1$I$$20231130$20240927$20240927$PER$$US-ROCHE-2631446$ROCHE$$40$YR$A$F$Y$$$20240927$$MD$US$US
243692921$24369292$1$I$$20240228$20240927$20240927$PER$$US-ROCHE-3358592$ROCHE$$62$YR$A$M$Y$$$20240927$$MD$US$US
243692931$24369293$1$I$$20240220$20240927$20240927$PER$$US-ROCHE-3373303$ROCHE$$56$YR$A$F$Y$$$20240927$$MD$US$US
243692941$24369294$1$I$$20231017$20240927$20240927$PER$$US-ROCHE-3146146$ROCHE$$57$YR$A$M$Y$$$20240927$$MD$US$US
243692951$24369295$1$I$$20231121$20240927$20240927$PER$$US-ROCHE-3026425$ROCHE$$68$YR$E$F$Y$$$20240927$$MD$US$US
243692961$24369296$1$I$$20231105$20240927$20240927$PER$$US-ROCHE-3439785$ROCHE$$77$YR$E$F$Y$$$20240927$$MD$US$US
243692971$24369297$1$I$$20231124$20240927$20240927$PER$$US-ROCHE-3435411$ROCHE$$54$YR$A$F$Y$$$20240927$$MD$US$US
243692981$24369298$1$I$$20240122$20240927$20240927$PER$$US-ROCHE-2971833$ROCHE$$52$YR$A$M$Y$$$20240927$$MD$US$US
243692991$24369299$1$I$$20231102$20240927$20240927$PER$$US-ROCHE-3451874$ROCHE$$65$YR$E$F$Y$$$20240927$$MD$US$US
243693001$24369300$1$I$$20240123$20240927$20240927$PER$$US-ROCHE-3439276$ROCHE$$53$YR$A$F$Y$$$20240927$$CN$US$US
243693011$24369301$1$I$$20240112$20240927$20240927$PER$$US-ROCHE-2999897$ROCHE$$48$YR$A$F$Y$$$20240927$$MD$US$US
243693021$24369302$1$I$$20240416$20240927$20240927$PER$$US-ROCHE-3346941$ROCHE$$50$YR$A$M$Y$$$20240927$$MD$US$US
243693031$24369303$1$I$$20240919$20240927$20240927$PER$$US-SA-2024SA276044$SANOFI AVENTIS$$$$A$F$Y$86.36$KG$20240927$$HP$US$US
243693041$24369304$1$I$$20231229$20240927$20240927$PER$$US-ROCHE-3347336$ROCHE$$51$YR$A$F$Y$$$20240927$$HP$US$US
243693051$24369305$1$I$$20240916$20240927$20240927$EXP$$CA-BAUSCH-BL-2024-014004$BAUSCH AND LOMB$$44$YR$$F$Y$97$KG$20240927$$MD$CA$CA
243693081$24369308$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA275133$SANOFI AVENTIS$$$$A$F$Y$52.1$KG$20240927$$MD$US$US
243693091$24369309$1$I$20240912$20240915$20240927$20240927$PER$$US-SA-2024SA267919$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240927$$CN$US$US
243693101$24369310$1$I$$20240104$20240927$20240927$PER$$US-ROCHE-3373848$ROCHE$$54$YR$A$M$Y$$$20240927$$MD$US$US
243693111$24369311$1$I$20240627$20240904$20240927$20240927$PER$$US-SA-2024SA273454$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240927$$HP$US$US
243693121$24369312$1$I$$20240203$20240927$20240927$PER$$US-ROCHE-2880307$ROCHE$$71$YR$E$F$Y$$$20240927$$MD$US$US
243693131$24369313$1$I$$20240209$20240927$20240927$PER$$US-ROCHE-3264311$ROCHE$$65$YR$E$$Y$$$20240927$$MD$US$US
243693141$24369314$1$I$$20240918$20240927$20240927$PER$$US-SA-2024SA252359$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240927$$MD$US$US
243693151$24369315$1$I$$20231218$20240927$20240927$PER$$US-ROCHE-3151884$ROCHE$$45$YR$A$F$Y$$$20240927$$MD$US$US
243693161$24369316$1$I$$20231129$20240927$20240927$PER$$US-ROCHE-3089971$ROCHE$$63$YR$A$F$Y$$$20240927$$MD$US$US
243693171$24369317$1$I$$20231116$20240927$20240927$PER$$US-ROCHE-3190249$ROCHE$$82$YR$E$M$Y$$$20240927$$MD$US$US
243693181$24369318$1$I$$20231024$20240927$20240927$PER$$US-ROCHE-3238398$ROCHE$$51$YR$A$M$Y$$$20240927$$MD$US$US
243693221$24369322$1$I$$20240327$20240927$20240927$PER$$US-ROCHE-2921374$ROCHE$$72$YR$E$M$Y$$$20240927$$MD$US$US
243693231$24369323$1$I$$20240321$20240927$20240927$PER$$US-ROCHE-3283485$ROCHE$$76$YR$E$F$Y$$$20240927$$MD$US$US
243693241$24369324$1$I$$20240402$20240927$20240927$PER$$US-ROCHE-3127354$ROCHE$$37$YR$A$M$Y$$$20240927$$MD$US$US
243693251$24369325$1$I$$20240925$20240927$20240927$EXP$$CA-HALEON-2198593$Haleon PLC$$45$YR$$M$Y$$$20240926$$HP$CA$CA
243693261$24369326$1$I$20230801$20240412$20240927$20240927$PER$$US-ROCHE-2981327$ROCHE$$79$YR$E$F$Y$71.21$KG$20240927$$CN$US$US
243693271$24369327$1$I$$20231206$20240927$20240927$PER$$US-ROCHE-3371948$ROCHE$$64$YR$A$M$Y$$$20240927$$MD$US$US
243693281$24369328$1$I$$20240329$20240927$20240927$PER$$US-ROCHE-3298793$ROCHE$$48$YR$A$F$Y$$$20240927$$MD$US$US
243693301$24369330$1$I$$20231024$20240927$20240927$PER$$US-ROCHE-3446008$ROCHE$$81$YR$E$F$Y$$$20240927$$MD$US$US
243693311$24369331$1$I$$20231013$20240927$20240927$PER$$US-ROCHE-3440449$ROCHE$$27$YR$A$M$Y$$$20240927$$MD$US$US
243693321$24369332$1$I$$20231106$20240927$20240927$PER$$US-ROCHE-3454022$ROCHE$$$$$F$Y$$$20240927$$CN$US$US
243693331$24369333$1$I$$20240918$20240927$20240927$EXP$IE-JNJFOC-20240913258$IE-ROCHE-10000084917$ROCHE$$77$YR$E$M$Y$$$20240927$$MD$IE$IE
243693341$24369334$1$I$$20240104$20240927$20240927$PER$$US-ROCHE-2918265$ROCHE$$90$YR$E$M$Y$$$20240927$$MD$US$US
243693351$24369335$1$I$$20231010$20240927$20240927$PER$$US-ROCHE-3439274$ROCHE$$72$YR$E$F$Y$$$20240927$$CN$US$US
243693361$24369336$1$I$$20231012$20240927$20240927$PER$$US-ROCHE-3439450$ROCHE$$72$YR$E$M$Y$$$20240927$$MD$US$US
243693371$24369337$1$I$$20231009$20240927$20240927$PER$$US-ROCHE-3437024$ROCHE$$90$YR$E$F$Y$$$20240927$$MD$US$US
243693381$24369338$1$I$$20231012$20240927$20240927$PER$$US-ROCHE-3439090$ROCHE$$53$YR$A$M$Y$$$20240927$$MD$US$US
243693391$24369339$1$I$$20231114$20240927$20240927$PER$$US-ROCHE-2979985$ROCHE$$52$YR$A$F$Y$$$20240927$$MD$US$US
243693401$24369340$1$I$$20231009$20240927$20240927$PER$$US-ROCHE-3427369$ROCHE$$60$YR$A$$Y$$$20240927$$MD$US$US
243693411$24369341$1$I$$20231020$20240927$20240927$PER$$US-ROCHE-3445100$ROCHE$$56$YR$A$M$Y$$$20240927$$MD$US$US
243693421$24369342$1$I$20240923$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015519$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240927$$CN$US$US
243693431$24369343$1$I$20240901$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015586$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240927$$CN$US$US
243693441$24369344$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016402$ELI LILLY AND CO$$72$YR$E$F$Y$$$20240927$$CN$US$US
243693461$24369346$1$I$$20240917$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409012007$ELI LILLY AND CO$$37$YR$A$$Y$$$20240927$$LW$US$US
243693471$24369347$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016470$ELI LILLY AND CO$$65$YR$E$$Y$$$20240927$$CN$US$US
243693481$24369348$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016473$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243693491$24369349$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015941$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240927$$CN$US$US
243693501$24369350$1$I$20231020$20240924$20240927$20240927$EXP$$JP-009507513-2409JPN003387J$MERCK$$30$YR$$F$Y$$$20240927$$PH$JP$JP
243693511$24369351$1$I$20231005$20231013$20240927$20240927$PER$$US-ROCHE-3440334$ROCHE$$84$YR$E$F$Y$83.91$KG$20240927$$CN$US$US
243693521$24369352$1$I$$20231011$20240927$20240927$PER$$US-ROCHE-3438985$ROCHE$$82$YR$E$F$Y$$$20240927$$MD$US$US
243693531$24369353$1$I$$20231006$20240927$20240927$PER$$US-ROCHE-3437397$ROCHE$$73$YR$E$F$Y$$$20240927$$MD$US$US
243693541$24369354$1$I$20240912$20240919$20240927$20240927$EXP$$CN-BEIGENE-BGN-2024-014907$BEIGENE$$$$$$Y$$$20240927$$HP$CN$CN
243693551$24369355$1$I$20231010$20231012$20240927$20240927$PER$$US-ROCHE-3439453$ROCHE$$68$YR$E$F$Y$$$20240927$$CN$US$US
243693561$24369356$1$I$$20231019$20240927$20240927$PER$$US-ROCHE-3342010$ROCHE$$80$YR$E$F$Y$$$20240927$$MD$US$US
243693571$24369357$1$I$$20231009$20240927$20240927$PER$$US-ROCHE-3438269$ROCHE$$58$YR$A$M$Y$$$20240927$$MD$US$US
243693581$24369358$1$I$$20240918$20240927$20240927$EXP$$RO-AUROBINDO-AUR-APL-2024-046668$AUROBINDO$Dulamea OA, Arbune AA, Andronache A, Zurini LG, Anghel D. Exploring the diverse phenotypes of anti-GAD 65 encephalitis, diagnosis and treatment challenges. Romanian Journal of Neurology. 2024;23(2):111-118$32$YR$$F$Y$$$20240927$$HP$RO$RO
243693591$24369359$1$I$$20231010$20240927$20240927$PER$$US-ROCHE-3437362$ROCHE$$83$YR$E$$Y$$$20240927$$CN$US$US
243693601$24369360$1$I$$20231009$20240927$20240927$PER$$US-ROCHE-3438090$ROCHE$$61$YR$A$F$Y$$$20240927$$MD$US$US
243693611$24369361$1$I$20210701$20231103$20240927$20240927$PER$$US-ROCHE-3452398$ROCHE$$35$YR$A$F$Y$$$20240927$$CN$US$US
243693621$24369362$1$I$20230901$20231031$20240927$20240927$PER$$US-ROCHE-3450401$ROCHE$$86$YR$E$F$Y$$$20240927$$CN$US$US
243693631$24369363$1$I$$20231010$20240927$20240927$PER$$US-ROCHE-3437914$ROCHE$$78$YR$E$M$Y$$$20240927$$CN$US$US
243693641$24369364$1$I$20170101$20231012$20240927$20240927$PER$$US-ROCHE-3325333$ROCHE$$61$YR$A$M$Y$$$20240927$$CN$US$US
243693651$24369365$1$I$$20231027$20240927$20240927$PER$$US-ROCHE-3449728$ROCHE$$$$$M$Y$$$20240927$$CN$US$US
243693661$24369366$1$I$$20231027$20240927$20240927$PER$$US-ROCHE-3448844$ROCHE$$1$YR$I$F$Y$$$20240927$$MD$US$US
243693671$24369367$1$I$20231011$20231013$20240927$20240927$PER$$US-ROCHE-3439773$ROCHE$$65$YR$E$F$Y$$$20240927$$CN$US$US
243693681$24369368$1$I$$20231009$20240927$20240927$PER$$US-ROCHE-3437803$ROCHE$$70$YR$E$F$Y$$$20240927$$MD$US$US
243693691$24369369$1$I$$20231006$20240927$20240927$PER$$US-ROCHE-3436038$ROCHE$$42$YR$A$F$Y$$$20240927$$MD$US$US
243693701$24369370$1$I$$20231103$20240927$20240927$PER$$US-ROCHE-3223610$ROCHE$$65$YR$E$M$Y$$$20240927$$MD$US$US
243693711$24369371$1$I$$20231023$20240927$20240927$PER$$US-ROCHE-3446566$ROCHE$$79$YR$E$F$Y$$$20240927$$MD$US$US
243693721$24369372$1$I$$20231026$20240927$20240927$PER$$US-ROCHE-2836979$ROCHE$$61$YR$A$F$Y$$$20240927$$CN$US$US
243693731$24369373$1$I$20230905$20230922$20240927$20240927$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO., LTD.-QLH-000161-2023$QILU PHARMACEUTICAL$$46$YR$A$M$Y$$$20240923$$HP$US$US
243693751$24369375$1$I$20210101$20240923$20240927$20240927$EXP$$US-ABBVIE-5936724$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243693761$24369376$1$I$$20240918$20240927$20240927$EXP$$ES-TAKEDA-2024TUS093400$TAKEDA$$$$A$$Y$$$20240927$$CN$ES$ES
243693771$24369377$1$I$$20231009$20240927$20240927$PER$$US-ROCHE-3194714$ROCHE$$91$YR$E$M$Y$52.62$KG$20240927$$CN$US$US
243693781$24369378$1$I$$20231006$20240927$20240927$PER$$US-ROCHE-3436072$ROCHE$$$$E$F$Y$$$20240927$$MD$US$US
243693791$24369379$1$I$20220520$20231026$20240927$20240927$PER$$US-ROCHE-3104011$ROCHE$$78$YR$E$M$Y$86.18$KG$20240927$$CN$US$US
243693801$24369380$1$I$20231107$20231107$20240927$20240927$PER$$US-ROCHE-3454259$ROCHE$$$$$M$Y$$$20240927$$CN$US$US
243693811$24369381$1$I$$20231030$20240927$20240927$PER$$US-ROCHE-2907872$ROCHE$$45$YR$A$M$Y$$$20240927$$MD$US$US
243693821$24369382$1$I$$20231026$20240927$20240927$PER$$US-ROCHE-3447593$ROCHE$$78$YR$E$F$Y$$$20240927$$CN$US$US
243693831$24369383$1$I$20231011$20231011$20240927$20240927$PER$$US-ROCHE-3440465$ROCHE$$80$YR$E$F$Y$$$20240927$$CN$US$US
243693841$24369384$1$I$$20231012$20240927$20240927$PER$$US-ROCHE-3439320$ROCHE$$54$YR$A$F$Y$$$20240927$$MD$US$US
243693851$24369385$1$I$$20231019$20240927$20240927$PER$$US-ROCHE-3443314$ROCHE$$92$YR$E$M$Y$$$20240927$$CN$US$US
243693861$24369386$1$I$20231016$20231106$20240927$20240927$PER$$US-ROCHE-3444510$ROCHE$$89$YR$E$F$Y$$$20240927$$CN$US$US
243693871$24369387$1$I$$20231012$20240927$20240927$PER$$US-ROCHE-3190175$ROCHE$$65$YR$E$M$Y$$$20240927$$MD$US$US
243693881$24369388$1$I$20240829$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005384$ACADIA PHARMACEUTICALS$$4$YR$$F$Y$$$20240927$$CN$US$US
243693891$24369389$1$I$$20240911$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09152$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243693901$24369390$1$I$$20240919$20240927$20240927$PER$$US-GSK-US2024117678$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243693911$24369391$1$I$$20240918$20240927$20240927$EXP$$CA-CELLTRION INC.-2024CA022973$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
243693921$24369392$1$I$$20240229$20240927$20240927$PER$$US-ROCHE-3367624$ROCHE$$83$YR$E$M$Y$$$20240927$$CN$US$US
243693931$24369393$1$I$$20231011$20240927$20240927$PER$$US-ROCHE-3438678$ROCHE$$61$YR$A$F$Y$$$20240927$$MD$US$US
243693941$24369394$1$I$$20240130$20240927$20240927$PER$$US-ROCHE-3164293$ROCHE$$62$YR$A$F$Y$$$20240927$$HP$US$US
243693951$24369395$1$I$$20231229$20240927$20240927$PER$$US-ROCHE-2568393$ROCHE$$35$YR$A$F$Y$$$20240927$$MD$US$US
243693961$24369396$1$I$20210801$20240226$20240927$20240927$PER$$US-ROCHE-2295913$ROCHE$$42$YR$A$F$Y$$$20240927$$MD$US$US
243693971$24369397$1$I$$20231024$20240927$20240927$PER$$US-ROCHE-3446082$ROCHE$$52$YR$A$M$Y$$$20240927$$MD$US$US
243693981$24369398$1$I$$20231025$20240927$20240927$PER$$US-ROCHE-3447199$ROCHE$$56$YR$A$F$Y$$$20240927$$CN$US$US
243693991$24369399$1$I$$20240924$20240927$20240927$PER$$US-ABBVIE-5937767$ABBVIE$$$$$$Y$$$20240927$$CN$US$US
243694001$24369400$1$I$$20240829$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG032955$CHATTEM$$$$A$F$Y$$$20240927$$CN$US$US
243694011$24369401$1$I$$20240408$20240927$20240927$PER$$US-ROCHE-2568218$ROCHE$$76$YR$E$F$Y$$$20240927$$MD$US$US
243694021$24369402$1$I$$20240426$20240927$20240927$PER$$US-ROCHE-3029096$ROCHE$$86$YR$E$F$Y$$$20240927$$CN$US$US
243694031$24369403$1$I$$20240514$20240927$20240927$PER$$US-ROCHE-3424886$ROCHE$$56$YR$A$F$Y$$$20240927$$MD$US$US
243694051$24369405$1$I$$20240319$20240927$20240927$PER$$US-ROCHE-2986447$ROCHE$$74$YR$E$F$Y$$$20240927$$HP$US$US
243694061$24369406$1$I$$20240423$20240927$20240927$PER$$US-ROCHE-2945021$ROCHE$$47$YR$A$F$Y$$$20240927$$MD$US$US
243694071$24369407$1$I$$20240506$20240927$20240927$PER$$US-ROCHE-2958563$ROCHE$$50$YR$A$F$Y$$$20240927$$MD$US$US
243694081$24369408$1$I$$20240502$20240927$20240927$PER$$US-ROCHE-3344525$ROCHE$$56$YR$A$F$Y$$$20240927$$HP$US$US
243694091$24369409$1$I$20230210$20240406$20240927$20240927$PER$$US-ROCHE-3298883$ROCHE$$26$YR$A$F$Y$93.44$KG$20240927$$CN$US$US
243694101$24369410$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005362$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243694111$24369411$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005387$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$MD$US$US
243694121$24369412$1$I$$20240919$20240927$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000821$DECIPHERA PHARMACEUTICALS$$79$YR$E$F$Y$$$20240927$$CN$US$US
243694131$24369413$1$I$$20240918$20240927$20240927$EXP$$CA-APOTEX-2024AP011236$APOTEX$$86$YR$$M$Y$$$20240927$$CN$CA$CA
243694141$24369414$1$I$$20240517$20240927$20240927$PER$$US-ROCHE-3316576$ROCHE$$43$YR$A$F$Y$$$20240927$$MD$US$US
243694161$24369416$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004887$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243694181$24369418$1$I$20210821$20240513$20240927$20240927$PER$$US-ROCHE-2840221$ROCHE$$63$YR$A$F$Y$$$20240927$$HP$US$US
243694191$24369419$1$I$20240901$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005357$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20240927$$CN$US$US
243694201$24369420$1$I$$20240911$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09163$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243694211$24369421$1$I$20240901$20240924$20240927$20240927$EXP$$US-ABBVIE-5938525$ABBVIE$$35$YR$$F$Y$$$20240927$$CN$US$US
243694221$24369422$1$I$$20240917$20240927$20240927$EXP$$PK-AUROBINDO-AUR-APL-2024-046573$AUROBINDO$Moin M, Malik TG, Siddiq L. Clinical patterns and outcomes of retinoblastoma in a tertiary care centre of a developing country. J-Pak-Med-Assoc. 2023;73(9):1881-1883$$$$M$Y$$$20240927$$HP$PK$PK
243694231$24369423$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3173296$ROCHE$$49$YR$A$M$Y$$$20240927$$MD$US$US
243694241$24369424$1$I$$20240523$20240927$20240927$PER$$US-ROCHE-2881814$ROCHE$$48$YR$A$M$Y$$$20240927$$MD$US$US
243694251$24369425$1$I$$20240517$20240927$20240927$PER$$US-ROCHE-3068453$ROCHE$$72$YR$E$F$Y$47.17$KG$20240927$$HP$US$US
243694271$24369427$1$I$$20240522$20240927$20240927$PER$$US-ROCHE-3190252$ROCHE$$68$YR$E$F$Y$$$20240927$$MD$US$US
243694281$24369428$1$I$$20240522$20240927$20240927$PER$$US-ROCHE-3024183$ROCHE$$83$YR$E$M$Y$$$20240927$$HP$US$US
243694291$24369429$1$I$20200101$20240521$20240927$20240927$PER$$US-ROCHE-3339374$ROCHE$$64$YR$A$F$Y$64.86$KG$20240927$$CN$US$US
243694331$24369433$1$I$$20240517$20240927$20240927$PER$$US-ROCHE-2786237$ROCHE$$56$YR$A$F$Y$$$20240927$$MD$US$US
243694341$24369434$1$I$$20240917$20240927$20240927$EXP$$JP-AUROBINDO-AUR-APL-2024-046286$AUROBINDO$Aiba M, Okada K, Funakoshi T, Nozu R, Takahashi T, Ozu S, et al.. Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma. J-Infect-Chemother. 2024;30 (10):1065-1068$$$A$F$Y$$$20240927$$HP$JP$JP
243694351$24369435$1$I$$20240531$20240927$20240927$PER$$US-ROCHE-2831048$ROCHE$$18$YR$A$M$Y$$$20240927$$CN$US$US
243694361$24369436$1$I$$20240605$20240927$20240927$PER$$US-ROCHE-3374562$ROCHE$$58$YR$A$M$Y$$$20240927$$HP$US$US
243694371$24369437$1$I$$20240605$20240927$20240927$PER$$US-ROCHE-2970633$ROCHE$$61$YR$A$M$Y$$$20240927$$HP$US$US
243694391$24369439$1$I$20240101$20240918$20240927$20240927$EXP$$CA-CELLTRION INC.-2024CA019878$CELLTRION$$$$$$Y$$$20240927$$MD$CA$CA
243694401$24369440$1$I$$20240829$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG033308$CHATTEM$$$$$F$Y$$$20240927$$CN$US$US
243694411$24369441$1$I$$20240910$20240927$20240927$PER$$US-TEVA-VS-3244786$TEVA$$$$$$Y$$$20240927$$HP$US$US
243694421$24369442$1$I$$20240605$20240927$20240927$PER$$US-ROCHE-3360565$ROCHE$$37$YR$A$F$Y$$$20240927$$HP$US$US
243694431$24369443$1$I$$20240605$20240927$20240927$PER$$US-ROCHE-3053632$ROCHE$$79$YR$E$F$Y$$$20240927$$MD$US$US
243694441$24369444$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024AMR116207$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243694451$24369445$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152770$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240927$$HP$US$US
243694461$24369446$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152163$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240927$$CN$US$US
243694471$24369447$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153063$BRISTOL MYERS SQUIBB$$53$YR$A$F$Y$$$20240927$$HP$US$US
243694481$24369448$1$I$$20240605$20240927$20240927$PER$$US-ROCHE-2791477$ROCHE$$48$YR$A$M$Y$$$20240927$$MD$US$US
243694491$24369449$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153059$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$$$20240927$$HP$US$US
243694501$24369450$1$I$$20240919$20240927$20240927$EXP$GB-MHRA-MED-202409130914122390-YLHTD$GB-EMD Serono-2024050383$EMD SERONO INC$$29$YR$A$M$Y$86$KG$20240927$$HP$GB$GB
243694511$24369451$1$I$$20240920$20240927$20240927$EXP$$US-EMD Serono-2024050659$EMD SERONO INC$$64$YR$A$F$Y$$$20240927$$CN$US$US
243694521$24369452$1$I$$20240911$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09208$LUPIN$$$$$$Y$$$20240927$$PH$US$US
243694531$24369453$1$I$$20240924$20240927$20240927$PER$$US-009507513-2409USA009012$MERCK$KAUR D, VYAS A, SAGIREDDY S, KYEI-NIMAKO E. BEYOND THE SURFACE: DELVING INTO DAPTOMYCIN^S RESPIRATORY RISKS. Chest. 2024;166 (4):A4556-7$82$YR$$F$Y$$$20240927$$HP$US$US
243694551$24369455$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005411$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243694561$24369456$1$I$$20240917$20240927$20240927$EXP$CA-MHPD-E2B_001101486$CA-Accord-447366$ACCORD$$14$YR$T$M$Y$$$20240927$$HP$CA$CA
243694571$24369457$1$I$$20240829$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG033320$CHATTEM$$$$$M$Y$$$20240927$$CN$US$US
243694581$24369458$1$I$$20240911$20240927$20240927$EXP$$CA-AMGEN-CANSP2024189034$AMGEN$$56$YR$A$F$Y$$$20240926$$HP$CA$CA
243694591$24369459$1$I$20240911$20240918$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-029647$UNITED THERAPEUTICS$$43$YR$$F$Y$77.098$KG$20240927$$$US$US
243694601$24369460$1$I$$20240829$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG033306$CHATTEM$$$$$F$Y$$$20240927$$CN$US$US
243694611$24369461$1$I$$20240829$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG033309$CHATTEM$$$$$F$Y$$$20240927$$CN$US$US
243694621$24369462$1$I$$20240924$20240927$20240927$PER$$US-ABBVIE-5939230$ABBVIE$$$$$$Y$$$20240927$$HP$US$US
243694631$24369463$1$I$$20240926$20240927$20240927$EXP$$NVSJ2024JP011335$NOVARTIS$$$$$$Y$$$20240927$$MD$JP$JP
243694641$24369464$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005398$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243694651$24369465$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005406$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243694661$24369466$1$I$20240601$20240923$20240927$20240927$EXP$$US-ABBVIE-5935874$ABBVIE$$68$YR$$F$Y$$$20240927$$CN$US$US
243694671$24369467$1$I$$20240916$20240927$20240927$30DAY$$US-UCBSA-2024049153$UCB$$$$$F$Y$$$20240927$$CN$US$US
243694681$24369468$1$I$20211114$20240919$20240927$20240927$EXP$$JP-EMD Serono-2024050559$EMD SERONO INC$$74$YR$E$F$Y$$$20240927$$PH$JP$JP
243694691$24369469$1$I$20240910$20240919$20240927$20240927$EXP$$CN-BEIGENE-BGN-2024-014914$BEIGENE$$$$$$Y$$$20240927$$HP$CN$CN
243694711$24369471$1$I$$20240917$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR118379$VIIV$$$$$$Y$$$20240927$$HP$US$US
243694722$24369472$2$F$20230901$20240917$20240927$20240927$EXP$NL-LRB-00960677$NL-CELLTRION INC.-2024NL022896$CELLTRION$$$$$$Y$$$20240927$$PH$NL$NL
243694731$24369473$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005401$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243694741$24369474$1$I$20240604$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005396$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240927$$CN$US$US
243694751$24369475$1$I$20240907$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005404$ACADIA PHARMACEUTICALS$$11$YR$$F$Y$$$20240927$$CN$US$US
243694761$24369476$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005403$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243694771$24369477$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-004355$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243694781$24369478$1$I$20240101$20240923$20240927$20240927$EXP$$US-JNJFOC-20240961758$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243694791$24369479$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191998$AMGEN$$$$$$Y$$$20240926$$CN$US$US
243694801$24369480$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153064$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240927$$HP$US$US
243694811$24369481$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153065$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240927$$CN$US$US
243694821$24369482$1$I$20240911$20240926$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153058$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240927$$CN$US$US
243694831$24369483$1$I$$20240912$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09307$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243694841$24369484$1$I$$20240925$20240927$20240927$PER$$US-HALEON-2198901$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243694851$24369485$1$I$$20240923$20240927$20240927$EXP$NL-LRB-01003955$NL-BIOCON-BCN-2024-000195$BIOCON$$56$YR$A$F$Y$73$KG$20240927$$CN$NL$NL
243694861$24369486$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005412$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243694881$24369488$1$I$$20240920$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046932$AUROBINDO$Romero KN, O^Brien MC, Agrawal A, Hasan I.. Creatine Kinase Surge: Levetiracetam-Induced Rhabdomyolysis.. Cureus. 2024;16(8):e66715$27$YR$$M$Y$$$20240927$$MD$US$US
243694891$24369489$1$I$$20240923$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-047182$AUROBINDO$Patel S, Sivananthan M.. Hypersensitivity to Psychotropic Medications in a Patient With 17q12 Microdeletion Syndrome: A Case Report. J-Clin-Psychopharmacol. 2024;44:69-71$29$YR$$M$Y$$$20240927$$HP$US$US
243694901$24369490$1$I$20240101$20240917$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-029594$UNITED THERAPEUTICS$$$$$F$Y$63.039$KG$20240927$$$US$US
243694931$24369493$1$I$$20240917$20240927$20240927$PER$$US-JNJFOC-20240958910$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$HP$US$US
243694941$24369494$1$I$$20240830$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG032824$CHATTEM$$$$A$M$Y$$$20240927$$CN$US$US
243694961$24369496$1$I$$20240830$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG033315$CHATTEM$$$$$F$Y$$$20240927$$CN$US$US
243694971$24369497$1$I$$20240201$20240927$20240927$PER$$US-ROCHE-3503593$ROCHE$$57$YR$A$M$Y$$$20240927$$MD$US$US
243694981$24369498$1$I$$20240213$20240927$20240927$PER$$US-ROCHE-3510839$ROCHE$$63$YR$A$M$Y$$$20240927$$MD$US$US
243694991$24369499$1$I$$20240128$20240927$20240927$PER$$US-ROCHE-3501397$ROCHE$$61$YR$A$F$Y$$$20240927$$MD$US$US
243695001$24369500$1$I$$20231214$20240927$20240927$PER$$US-ROCHE-3476823$ROCHE$$54$YR$A$F$Y$$$20240927$$MD$US$US
243695011$24369501$1$I$$20240424$20240927$20240927$PER$$US-ROCHE-3484271$ROCHE$$62$YR$A$F$Y$$$20240927$$MD$US$US
243695021$24369502$1$I$$20231121$20240927$20240927$PER$$US-ROCHE-3462799$ROCHE$$75$YR$E$$Y$$$20240927$$MD$US$US
243695031$24369503$1$I$$20231130$20240927$20240927$PER$$US-ROCHE-3468127$ROCHE$$82$YR$E$F$Y$$$20240927$$CN$US$US
243695041$24369504$1$I$$20240123$20240927$20240927$PER$$US-ROCHE-3497793$ROCHE$$54$YR$A$M$Y$$$20240927$$MD$US$US
243695051$24369505$1$I$$20231213$20240927$20240927$PER$$US-ROCHE-3477079$ROCHE$$32$YR$A$$Y$$$20240927$$MD$US$US
243695061$24369506$1$I$$20240222$20240927$20240927$PER$$US-ROCHE-3514865$ROCHE$$86$YR$E$F$Y$$$20240927$$CN$US$US
243695071$24369507$1$I$$20240212$20240927$20240927$PER$$US-ROCHE-3509729$ROCHE$$54$YR$A$F$Y$$$20240927$$MD$US$US
243695081$24369508$1$I$$20240119$20240927$20240927$PER$$US-ROCHE-3496461$ROCHE$$$$A$F$Y$$$20240927$$MD$US$US
243695091$24369509$1$I$$20231228$20240927$20240927$PER$$US-ROCHE-3483816$ROCHE$$62$YR$A$M$Y$$$20240927$$MD$US$US
243695101$24369510$1$I$$20240920$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046914$AUROBINDO$$$$$M$Y$$$20240927$$CN$GB$GB
243695121$24369512$1$I$20231220$20231220$20240927$20240927$PER$$US-ROCHE-3479587$ROCHE$$66$YR$E$F$Y$$$20240927$$CN$US$US
243695131$24369513$1$I$$20231208$20240927$20240927$PER$$US-ROCHE-3473595$ROCHE$$58$YR$A$M$Y$$$20240927$$MD$US$US
243695141$24369514$1$I$$20240130$20240927$20240927$PER$$SG-ROCHE-3502291$ROCHE$$60$YR$A$M$Y$$$20240927$$HP$SG$SG
243695151$24369515$1$I$$20231220$20240927$20240927$PER$$US-ROCHE-3480011$ROCHE$$50$YR$A$F$Y$$$20240927$$MD$US$US
243695161$24369516$1$I$$20240221$20240927$20240927$PER$$US-ROCHE-3508450$ROCHE$$87$YR$E$F$Y$$$20240927$$MD$US$US
243695171$24369517$1$I$$20231120$20240927$20240927$PER$$US-ROCHE-3462015$ROCHE$$86$YR$E$F$Y$$$20240927$$CN$US$US
243695181$24369518$1$I$$20231107$20240927$20240927$PER$$US-ROCHE-3454844$ROCHE$$48$YR$A$M$Y$$$20240927$$MD$US$US
243695201$24369520$1$I$$20240103$20240927$20240927$PER$$US-ROCHE-3485778$ROCHE$$76$YR$E$F$Y$$$20240927$$MD$US$US
243695211$24369521$1$I$$20240115$20240927$20240927$PER$$US-ROCHE-3493494$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243695221$24369522$1$I$$20240208$20240927$20240927$PER$$US-ROCHE-3502244$ROCHE$$90$YR$E$F$Y$$$20240927$$CN$US$US
243695231$24369523$1$I$20201001$20231108$20240927$20240927$PER$$US-ROCHE-3455102$ROCHE$$67$YR$E$M$Y$$$20240927$$MD$US$US
243695241$24369524$1$I$$20240830$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG032971$CHATTEM$$$$A$M$Y$$$20240927$$CN$US$US
243695251$24369525$1$I$20240801$20240912$20240927$20240927$EXP$$AU-CIPLA LTD.-2024AU10558$CIPLA$$$$$$Y$$$20240927$$CN$AU$AU
243695271$24369527$1$I$20240910$20240923$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-047367$AUROBINDO$$$$$$Y$$$20240927$$PH$GB$GB
243695281$24369528$1$I$$20231219$20240927$20240927$PER$$US-ROCHE-3478978$ROCHE$$69$YR$E$M$Y$$$20240927$$MD$US$US
243695291$24369529$1$I$$20231121$20240927$20240927$PER$$US-ROCHE-3463483$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243695301$24369530$1$I$$20231207$20240927$20240927$PER$$US-ROCHE-3472799$ROCHE$$60$YR$A$M$Y$$$20240927$$MD$US$US
243695311$24369531$1$I$$20231121$20240927$20240927$PER$$US-ROCHE-3463490$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243695321$24369532$1$I$$20240122$20240927$20240927$PER$$US-ROCHE-3478472$ROCHE$$58$YR$A$F$Y$68.04$KG$20240927$$CN$US$US
243695331$24369533$1$I$20221101$20231227$20240927$20240927$PER$$US-ROCHE-3483102$ROCHE$$24$YR$A$F$Y$65.77$KG$20240927$$CN$US$US
243695341$24369534$1$I$$20231109$20240927$20240927$PER$$US-ROCHE-3456136$ROCHE$$79$YR$E$M$Y$$$20240927$$MD$US$US
243695351$24369535$1$I$$20240212$20240927$20240927$PER$$US-ROCHE-3509710$ROCHE$$63$YR$A$M$Y$$$20240927$$MD$US$US
243695361$24369536$1$I$$20240301$20240927$20240927$PER$$US-ROCHE-3511929$ROCHE$$76$YR$E$F$Y$$$20240927$$HP$US$US
243695371$24369537$1$I$20211001$20240111$20240927$20240927$PER$$US-ROCHE-3468284$ROCHE$$61$YR$A$M$Y$$$20240927$$CN$US$US
243695391$24369539$1$I$20240101$20240909$20240927$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000782$DECIPHERA PHARMACEUTICALS$$71$YR$E$F$Y$$$20240927$$CN$US$US
243695401$24369540$1$I$$20240912$20240927$20240927$EXP$$AU-CIPLA LTD.-2024AU10586$CIPLA$$$$$$Y$$$20240927$$CN$AU$AU
243695411$24369541$1$I$$20240122$20240927$20240927$PER$$US-ROCHE-3490204$ROCHE$$66$YR$E$M$Y$$$20240927$$MD$US$US
243695421$24369542$1$I$$20240924$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-047455$AUROBINDO$$$$$$Y$64$KG$20240927$$CN$GB$GB
243695431$24369543$1$I$$20240102$20240927$20240927$PER$$US-ROCHE-3485222$ROCHE$$42$YR$A$M$Y$$$20240927$$MD$US$US
243695451$24369545$1$I$$20240114$20240927$20240927$PER$$US-ROCHE-3489521$ROCHE$$77$YR$E$M$Y$$$20240927$$CN$US$US
243695461$24369546$1$I$$20240206$20240927$20240927$PER$$US-ROCHE-3506521$ROCHE$$$$A$F$Y$$$20240927$$CN$US$US
243695471$24369547$1$I$$20231118$20240927$20240927$PER$$US-ROCHE-3456585$ROCHE$$49$YR$A$M$Y$$$20240927$$CN$US$US
243695481$24369548$1$I$$20231121$20240927$20240927$PER$$US-ROCHE-3462589$ROCHE$$42$YR$A$F$Y$$$20240927$$MD$US$US
243695491$24369549$1$I$$20240118$20240927$20240927$PER$$US-ROCHE-3495704$ROCHE$$86$YR$E$F$Y$$$20240927$$MD$US$US
243695501$24369550$1$I$$20240129$20240927$20240927$PER$$US-ROCHE-3502942$ROCHE$$58$YR$A$M$Y$$$20240927$$MD$US$US
243695511$24369551$1$I$$20240220$20240927$20240927$PER$$US-ROCHE-3513802$ROCHE$$76$YR$E$F$Y$$$20240927$$MD$US$US
243695521$24369552$1$I$$20231204$20240927$20240927$PER$$US-ROCHE-3470344$ROCHE$$68$YR$E$M$Y$$$20240927$$MD$US$US
243695531$24369553$1$I$$20240831$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG032909$CHATTEM$$$$A$F$Y$$$20240927$$CN$US$US
243695541$24369554$1$I$$20231108$20240927$20240927$PER$$US-ROCHE-3455289$ROCHE$$54$YR$A$F$Y$95.25$KG$20240927$$CN$US$US
243695551$24369555$1$I$20230101$20240924$20240927$20240927$EXP$$US-ABBVIE-5929533$ABBVIE$$$$$F$Y$82$KG$20240927$$CN$US$US
243695561$24369556$1$I$$20240831$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG032927$CHATTEM$$$$A$M$Y$$$20240927$$CN$US$US
243695571$24369557$1$I$$20240213$20240927$20240927$PER$$US-ROCHE-3510118$ROCHE$$54$YR$A$F$Y$$$20240927$$MD$US$US
243695581$24369558$1$I$$20240112$20240927$20240927$PER$$US-ROCHE-3491719$ROCHE$$15$YR$T$F$Y$$$20240927$$MD$US$US
243695591$24369559$1$I$$20240220$20240927$20240927$PER$$US-ROCHE-3512654$ROCHE$$57$YR$A$M$Y$$$20240927$$MD$US$US
243695601$24369560$1$I$$20240123$20240927$20240927$PER$$US-ROCHE-3497791$ROCHE$$65$YR$E$F$Y$$$20240927$$MD$US$US
243695611$24369561$1$I$$20240112$20240927$20240927$PER$$US-ROCHE-3493512$ROCHE$$72$YR$E$M$Y$$$20240927$$MD$US$US
243695621$24369562$1$I$$20240104$20240927$20240927$PER$$US-ROCHE-3486447$ROCHE$$76$YR$E$F$Y$$$20240927$$CN$US$US
243695631$24369563$1$I$$20231211$20240927$20240927$PER$$US-ROCHE-3475206$ROCHE$$63$YR$A$F$Y$$$20240927$$HP$US$US
243695641$24369564$1$I$$20231218$20240927$20240927$PER$$US-ROCHE-3479179$ROCHE$$95$YR$E$F$Y$$$20240927$$MD$US$US
243695651$24369565$1$I$$20240109$20240927$20240927$PER$$US-ROCHE-3489541$ROCHE$$35$YR$A$M$Y$$$20240927$$MD$US$US
243695661$24369566$1$I$$20240212$20240927$20240927$PER$$US-ROCHE-3510027$ROCHE$$79$YR$E$M$Y$$$20240927$$CN$US$US
243695671$24369567$1$I$$20240205$20240927$20240927$PER$$US-ROCHE-3504677$ROCHE$$64$YR$A$F$Y$$$20240927$$MD$US$US
243695681$24369568$1$I$$20231128$20240927$20240927$PER$$US-ROCHE-3468621$ROCHE$$41$YR$A$F$Y$$$20240927$$HP$US$US
243695691$24369569$1$I$$20240119$20240927$20240927$PER$$US-ROCHE-3495912$ROCHE$$24$YR$A$F$Y$$$20240927$$MD$US$US
243695701$24369570$1$I$$20240215$20240927$20240927$PER$$US-ROCHE-3511338$ROCHE$$72$YR$E$F$Y$$$20240927$$MD$US$US
243695711$24369571$1$I$$20231222$20240927$20240927$PER$$US-ROCHE-3481527$ROCHE$$62$YR$A$M$Y$$$20240927$$MD$US$US
243695721$24369572$1$I$$20240130$20240927$20240927$PER$$US-ROCHE-3501964$ROCHE$$61$YR$A$M$Y$$$20240927$$CN$US$US
243695741$24369574$1$I$$20240305$20240927$20240927$PER$$US-ROCHE-3460049$ROCHE$$63$YR$A$F$Y$$$20240927$$CN$US$US
243695751$24369575$1$I$$20240102$20240927$20240927$PER$$US-ROCHE-3485961$ROCHE$$68$YR$E$M$Y$$$20240927$$MD$US$US
243695761$24369576$1$I$$20231115$20240927$20240927$PER$$US-ROCHE-3459381$ROCHE$$47$YR$A$F$Y$$$20240927$$MD$US$US
243695771$24369577$1$I$20230101$20231109$20240927$20240927$PER$$US-ROCHE-3456125$ROCHE$$79$YR$E$F$Y$$$20240927$$CN$US$US
243695781$24369578$1$I$$20240115$20240927$20240927$PER$$US-ROCHE-3492619$ROCHE$$52$YR$A$M$Y$$$20240927$$MD$US$US
243695791$24369579$1$I$20240814$20240917$20240927$20240927$EXP$$CA-APOTEX-2024AP011226$APOTEX$$86$YR$E$M$Y$$$20240927$$PH$CA$CA
243695801$24369580$1$I$$20240922$20240927$20240927$EXP$$ZA-HALEON-2198682$Haleon PLC$$$$$$Y$$$20240927$$CN$ZA$ZA
243695811$24369581$1$I$$20240904$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG032922$CHATTEM$$$$A$F$Y$$$20240927$$CN$US$US
243695821$24369582$1$I$$20240831$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG032908$CHATTEM$$$$A$F$Y$$$20240927$$CN$US$US
243695831$24369583$1$I$$20240919$20240927$20240927$PER$$US-JNJFOC-20240963903$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243695841$24369584$1$I$20240903$20240918$20240927$20240927$EXP$$US-JNJFOC-20240965501$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$HP$US$US
243695851$24369585$1$I$$20240924$20240927$20240927$PER$$US-HALEON-2198658$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243695861$24369586$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192004$NOVARTIS$$$$$F$Y$$$20240927$$HP$US$US
243695871$24369587$1$I$$20240331$20240927$20240927$PER$$SG-ROCHE-3502177$ROCHE$$$$$$Y$$$20240927$$HP$SG$SG
243695881$24369588$1$I$$20231214$20240927$20240927$PER$$US-ROCHE-3477575$ROCHE$$77$YR$E$M$Y$$$20240927$$MD$US$US
243695891$24369589$1$I$20231025$20231117$20240927$20240927$PER$$US-ROCHE-3461081$ROCHE$$89$YR$E$F$Y$$$20240927$$CN$US$US
243695901$24369590$1$I$20210101$20240123$20240927$20240927$PER$$US-ROCHE-3465956$ROCHE$$81$YR$E$F$Y$77.11$KG$20240927$$CN$US$US
243695911$24369591$1$I$$20231211$20240927$20240927$PER$$US-ROCHE-3474301$ROCHE$$$$A$F$Y$$$20240927$$CN$US$US
243695921$24369592$1$I$$20240319$20240927$20240927$PER$$US-ROCHE-3476055$ROCHE$$50$YR$A$M$Y$$$20240927$$MD$US$US
243695931$24369593$1$I$$20240124$20240927$20240927$PER$$US-ROCHE-3498924$ROCHE$$61$YR$A$M$Y$$$20240927$$CN$US$US
243695941$24369594$1$I$$20231209$20240927$20240927$PER$$US-ROCHE-3474118$ROCHE$$77$YR$E$M$Y$$$20240927$$MD$US$US
243695951$24369595$1$I$$20240403$20240927$20240927$PER$$US-ROCHE-3476067$ROCHE$$52$YR$A$M$Y$$$20240927$$MD$US$US
243695961$24369596$1$I$$20240916$20240927$20240927$EXP$$JP-AUROBINDO-AUR-APL-2024-046058$AUROBINDO$Yoshida M, Matsuda K, Endo K, Honda A, Maki H, Taoka K, et al.. Toxic shock like syndrome caused by Streptococcus agalactiae bacteremia during treatment for multiple myeloma. J-InfectChemother. 2023;29(4):407-409$$$A$F$Y$$$20240927$$HP$JP$JP
243695971$24369597$1$I$$20240223$20240927$20240927$PER$$US-ROCHE-3515926$ROCHE$$65$YR$E$F$Y$$$20240927$$MD$US$US
243695981$24369598$1$I$$20240321$20240927$20240927$PER$$US-ROCHE-3481130$ROCHE$$57$YR$A$F$Y$$$20240927$$MD$US$US
243696001$24369600$1$I$$20240911$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09215$LUPIN$$$$$$Y$$$20240927$$MD$US$US
243696011$24369601$1$I$20231227$20240104$20240927$20240927$PER$$US-ROCHE-3486505$ROCHE$$71$YR$E$M$Y$$$20240927$$CN$US$US
243696021$24369602$1$I$$20231110$20240927$20240927$PER$$US-ROCHE-3456942$ROCHE$$47$YR$A$M$Y$$$20240927$$MD$US$US
243696031$24369603$1$I$$20240201$20240927$20240927$PER$$US-ROCHE-3503767$ROCHE$$$$A$M$Y$$$20240927$$MD$US$US
243696041$24369604$1$I$$20231204$20240927$20240927$PER$$US-ROCHE-3469986$ROCHE$$85$YR$E$F$Y$56.25$KG$20240927$$CN$US$US
243696051$24369605$1$I$$20240122$20240927$20240927$PER$$US-ROCHE-3496950$ROCHE$$52$YR$A$M$Y$$$20240927$$MD$US$US
243696061$24369606$1$I$$20240212$20240927$20240927$PER$$US-ROCHE-3509723$ROCHE$$62$YR$A$M$Y$$$20240927$$MD$US$US
243696071$24369607$1$I$$20231227$20240927$20240927$PER$$US-ROCHE-3483056$ROCHE$$67$YR$E$M$Y$$$20240927$$MD$US$US
243696081$24369608$1$I$$20231220$20240927$20240927$PER$$US-ROCHE-3479422$ROCHE$$71$YR$E$F$Y$$$20240927$$MD$US$US
243696091$24369609$1$I$$20231125$20240927$20240927$PER$$US-ROCHE-3465352$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243696101$24369610$1$I$$20240103$20240927$20240927$PER$$US-ROCHE-3485794$ROCHE$$$$$M$Y$$$20240927$$CN$US$US
243696111$24369611$1$I$$20240219$20240927$20240927$PER$$US-ROCHE-3513006$ROCHE$$38$YR$A$F$Y$$$20240927$$MD$US$US
243696121$24369612$1$I$$20240912$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG031926$CHATTEM$$64$YR$A$F$Y$$$20240927$$CN$US$US
243696131$24369613$1$I$$20240923$20240927$20240927$EXP$$DE-AUROBINDO-AUR-APL-2024-047466$AUROBINDO$Metzner B, Muller TH, Casper J, Kimmich C, Kohne C-H, Petershofen E, et al. Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation. Eur-J-Haematol. 2023;111(2):220-228$$$$M$Y$$$20240927$$HP$DE$DE
243696141$24369614$1$I$20240830$20240925$20240927$20240927$EXP$$JP-ASTELLAS-2024-AER-008835$ASTELLAS$$9$DEC$E$M$Y$$$20240927$$PH$JP$JP
243696151$24369615$1$I$20240101$20240918$20240927$20240927$PER$$US-ABBVIE-5930968$ABBVIE$$$$$$Y$$$20240927$$CN$US$US
243696161$24369616$1$I$$20231206$20240927$20240927$PER$$US-ROCHE-3471840$ROCHE$$80$YR$E$M$Y$$$20240927$$MD$US$US
243696171$24369617$1$I$20240901$20240920$20240927$20240927$EXP$$JP-009507513-2409JPN002466J$MERCK$$68$YR$$M$Y$$$20240927$$MD$JP$JP
243696181$24369618$1$I$$20240116$20240927$20240927$PER$$US-ROCHE-3494347$ROCHE$$60$YR$A$F$Y$$$20240927$$MD$US$US
243696191$24369619$1$I$$20231214$20240927$20240927$PER$$US-ROCHE-3476955$ROCHE$$56$YR$A$F$Y$$$20240927$$MD$US$US
243696201$24369620$1$I$$20231122$20240927$20240927$PER$$US-ROCHE-3463263$ROCHE$$78$YR$E$M$Y$$$20240927$$CN$US$US
243696221$24369622$1$I$$20231227$20240927$20240927$PER$$US-ROCHE-3483398$ROCHE$$59$YR$A$F$Y$$$20240927$$HP$US$US
243696231$24369623$1$I$$20231214$20240927$20240927$PER$$US-ROCHE-3476816$ROCHE$$$$$M$Y$$$20240927$$MD$US$US
243696241$24369624$1$I$$20231119$20240927$20240927$PER$$US-ROCHE-3462081$ROCHE$$39$YR$A$F$Y$$$20240927$$MD$US$US
243696251$24369625$1$I$$20240123$20240927$20240927$PER$$US-ROCHE-3498315$ROCHE$$69$YR$E$F$Y$$$20240927$$MD$US$US
243696261$24369626$1$I$$20240920$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046879$AUROBINDO$$66$YR$$F$Y$76$KG$20240927$$MD$GB$GB
243696271$24369627$1$I$$20240920$20240927$20240927$PER$$NVSC2024US191656$NOVARTIS$$21$YR$$F$Y$$$20240927$$MD$US$US
243696281$24369628$1$I$$20240129$20240927$20240927$PER$$US-ROCHE-3501585$ROCHE$$55$YR$A$M$Y$$$20240927$$MD$US$US
243696291$24369629$1$I$$20240208$20240927$20240927$PER$$US-ROCHE-3507671$ROCHE$$84$YR$E$M$Y$74.84$KG$20240927$$CN$US$US
243696301$24369630$1$I$$20240130$20240927$20240927$PER$$SG-ROCHE-3502158$ROCHE$$$$$M$Y$$$20240927$$HP$SG$SG
243696311$24369631$1$I$$20231115$20240927$20240927$PER$$US-ROCHE-3459182$ROCHE$$29$YR$A$F$Y$87$KG$20240927$$MD$US$US
243696321$24369632$1$I$$20231113$20240927$20240927$PER$$US-ROCHE-3457701$ROCHE$$53$YR$A$F$Y$$$20240927$$MD$US$US
243696331$24369633$1$I$20230301$20231215$20240927$20240927$PER$$US-ROCHE-3477426$ROCHE$$82$YR$E$M$Y$83.01$KG$20240927$$CN$US$US
243696341$24369634$1$I$$20231115$20240927$20240927$PER$$US-ROCHE-3457531$ROCHE$$63$YR$A$F$Y$$$20240927$$HP$US$US
243696351$24369635$1$I$20230101$20231227$20240927$20240927$PER$$US-ROCHE-3483116$ROCHE$$48$YR$A$F$Y$78.93$KG$20240927$$CN$US$US
243696361$24369636$1$I$$20240207$20240927$20240927$PER$$US-ROCHE-3506001$ROCHE$$69$YR$E$F$Y$80.29$KG$20240927$$CN$US$US
243696371$24369637$1$I$$20231109$20240927$20240927$PER$$US-ROCHE-3455786$ROCHE$$61$YR$A$F$Y$$$20240927$$CN$US$US
243696381$24369638$1$I$$20240131$20240927$20240927$PER$$US-ROCHE-3502954$ROCHE$$69$YR$E$F$Y$$$20240927$$MD$US$US
243696391$24369639$1$I$$20231227$20240927$20240927$PER$$US-ROCHE-3482134$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243696401$24369640$1$I$$20231211$20240927$20240927$PER$$US-ROCHE-3474152$ROCHE$$72$YR$E$F$Y$$$20240927$$MD$US$US
243696411$24369641$1$I$$20240222$20240927$20240927$PER$$US-ROCHE-3514946$ROCHE$$51$YR$A$F$Y$$$20240927$$MD$US$US
243696421$24369642$1$I$$20240923$20240927$20240927$EXP$$JP-AUROBINDO-AUR-APL-2024-047390$AUROBINDO$Okada N, Yamamoto R, Maruoka H, Himeno M, Hiramoto N, Ishikawa T. Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report. Case reports in Oncology. 2023;16:604-612$66$YR$$M$Y$$$20240927$$HP$JP$JP
243696431$24369643$1$I$$20240919$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG032796$CHATTEM$$$$$$Y$$$20240927$$CN$US$US
243696441$24369644$1$I$$20240919$20240927$20240927$PER$$US-CHATTEMPRD-2024OHG033073$CHATTEM$$$$$M$Y$$$20240927$$CN$US$US
243696451$24369645$1$I$$20240828$20240927$20240927$PER$$US-STRIDES ARCOLAB LIMITED-2024SP011108$STRIDES$D^Netto M, Kuhn A, Ferdjallah A, Joshi A.. ALPS like: Trekking Sirolimus and its Fallouts. Clin-Immunol. 2023;250 (Suppl.)$3$YR$$M$Y$$$20240927$$HP$US$US
243696461$24369646$1$I$$20240719$20240927$20240927$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009248$STRIDES$Khachatryan A, Isseh I, Vavilin I, Saeed IM, Harutyunyan H, Bansro V, et al.. RECURRENT PERIMYOCARDITIS ASSOCIATED WITH LONG-TERM METHYLPHENIDATE USE.. J-Am-Coll-Cardiol. 2024;83(Suppl.2)(13):3543$19$YR$$M$Y$$$20240927$$HP$US$US
243696471$24369647$1$I$$20240806$20240927$20240927$PER$$US-STRIDES PHARMA UK LTD.-2024SP009922$STRIDES$Peralta I, Hubbard E, Nodit L. An Unusual Cause of Longstanding Diarrhea.. Cureus. 2024;16(1):e52161$$$$$Y$$$20240927$$HP$US$US
243696481$24369648$1$I$20240921$20240924$20240927$20240927$EXP$$US-ABBVIE-5938055$ABBVIE$$73$YR$$F$Y$$$20240927$$CN$US$US
243696491$24369649$1$I$$20231127$20240927$20240927$PER$$US-ROCHE-3465843$ROCHE$$75$YR$E$F$Y$$$20240927$$MD$US$US
243696501$24369650$1$I$$20240202$20240927$20240927$PER$$US-ROCHE-3504942$ROCHE$$70$YR$E$F$Y$$$20240927$$MD$US$US
243696511$24369651$1$I$$20240130$20240927$20240927$PER$$PL-ROCHE-3504155$ROCHE$Sirek S, Woszczek D, Leszczynski R and Mukwa-Kominek E. Vitrectomy 23 G with Vascular Endothelial Growth Factor Injection in a Patient with Neovascular Glaucoma with Total Retinal Detachment, Haemorrhage into Anterior Chamber and Vitreous Chamber of the Right Eye - Case Report. Biological therapies for the treatment of posterior uveitis: state-of-the-art and perspectives 12199 2023;20:27-9.$61$YR$A$M$Y$$$20240927$$MD$PL$PL
243696521$24369652$1$I$$20240123$20240927$20240927$PER$$US-ROCHE-3498767$ROCHE$$55$YR$A$F$Y$$$20240927$$MD$US$US
243696531$24369653$1$I$$20240209$20240927$20240927$PER$$US-ROCHE-3508777$ROCHE$$67$YR$E$$Y$$$20240927$$MD$US$US
243696541$24369654$1$I$$20240123$20240927$20240927$PER$$US-ROCHE-3497537$ROCHE$$79$YR$E$M$Y$$$20240927$$MD$US$US
243696551$24369655$1$I$$20231218$20240927$20240927$PER$$US-ROCHE-3478412$ROCHE$$74$YR$E$M$Y$$$20240927$$CN$US$US
243696561$24369656$1$I$$20240213$20240927$20240927$PER$$US-ROCHE-3510117$ROCHE$$46$YR$A$F$Y$$$20240927$$MD$US$US
243696571$24369657$1$I$$20231109$20240927$20240927$PER$$US-ROCHE-3455381$ROCHE$$61$YR$A$F$Y$$$20240927$$MD$US$US
243696581$24369658$1$I$$20231120$20240927$20240927$PER$$US-ROCHE-3462498$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243696591$24369659$1$I$$20240918$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-029810$UNITED THERAPEUTICS$$$$$F$Y$60.771$KG$20240927$$$US$US
243696601$24369660$1$I$20220101$20240122$20240927$20240927$PER$$US-ROCHE-3496726$ROCHE$$57$YR$A$M$Y$86.18$KG$20240927$$CN$US$US
243696611$24369661$1$I$$20231204$20240927$20240927$PER$$US-ROCHE-3471639$ROCHE$$64$YR$A$F$Y$$$20240927$$HP$US$US
243696621$24369662$1$I$$20231119$20240927$20240927$PER$$US-ROCHE-3460836$ROCHE$$$$$F$Y$$$20240927$$CN$US$US
243696631$24369663$1$I$$20240612$20240927$20240927$EXP$$TH-ROCHE-10000088046$ROCHE$$$$$M$Y$$$20240927$$MD$TH$TH
243696641$24369664$1$I$$20240215$20240927$20240927$PER$$US-ROCHE-3511964$ROCHE$$52$YR$A$F$Y$$$20240927$$MD$US$US
243696651$24369665$1$I$20230206$20240226$20240927$20240927$PER$$US-ROCHE-3510482$ROCHE$$17$YR$T$M$Y$$$20240927$$CN$US$US
243696661$24369666$1$I$$20240118$20240927$20240927$PER$$US-ROCHE-3495124$ROCHE$$49$YR$A$F$Y$$$20240927$$MD$US$US
243696671$24369667$1$I$$20240215$20240927$20240927$PER$$US-ROCHE-3512468$ROCHE$$93$YR$E$F$Y$$$20240927$$MD$US$US
243696681$24369668$1$I$$20240201$20240927$20240927$PER$$US-ROCHE-3504034$ROCHE$$75$YR$E$M$Y$$$20240927$$MD$US$US
243696691$24369669$1$I$$20231219$20240927$20240927$PER$$US-ROCHE-3478985$ROCHE$$84$YR$E$F$Y$60.33$KG$20240927$$CN$US$US
243696701$24369670$1$I$$20240119$20240927$20240927$PER$$US-ROCHE-3495400$ROCHE$$90$YR$E$F$Y$$$20240927$$MD$US$US
243696711$24369671$1$I$$20240201$20240927$20240927$PER$$US-ROCHE-3503798$ROCHE$$70$YR$E$M$Y$$$20240927$$CN$US$US
243696721$24369672$1$I$$20231212$20240927$20240927$PER$$US-ROCHE-3474664$ROCHE$$77$YR$E$M$Y$104.33$KG$20240927$$CN$US$US
243696731$24369673$1$I$$20231128$20240927$20240927$PER$$US-ROCHE-3467560$ROCHE$$54$YR$A$M$Y$$$20240927$$HP$US$US
243696741$24369674$1$I$20231001$20231206$20240927$20240927$PER$$US-ROCHE-3471712$ROCHE$$$$$F$Y$$$20240927$$MD$US$US
243696751$24369675$1$I$20240910$20240926$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153050$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$$$20240927$$CN$US$US
243696761$24369676$1$I$$20240924$20240927$20240927$EXP$$ZA-HALEON-2198765$Haleon PLC$$$$$$Y$$$20240926$$CN$ZA$ZA
243696771$24369677$1$I$$20240918$20240927$20240927$EXP$$CA-CELLTRION INC.-2024CA022735$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
243696791$24369679$1$I$$20240917$20240927$20240927$PER$$US-JNJFOC-20240946441$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243696801$24369680$1$I$$20231205$20240927$20240927$PER$$US-ROCHE-3470683$ROCHE$$71$YR$E$F$Y$$$20240927$$CN$US$US
243696811$24369681$1$I$$20240126$20240927$20240927$PER$$US-ROCHE-3501350$ROCHE$$59$YR$A$M$Y$$$20240927$$MD$US$US
243696821$24369682$1$I$20230101$20231115$20240927$20240927$PER$$US-ROCHE-3459313$ROCHE$$69$YR$E$F$Y$$$20240927$$CN$US$US
243696831$24369683$1$I$$20240208$20240927$20240927$PER$$US-ROCHE-3508052$ROCHE$$54$YR$A$M$Y$$$20240927$$MD$US$US
243696841$24369684$1$I$$20240129$20240927$20240927$PER$$US-ROCHE-3501352$ROCHE$$54$YR$A$F$Y$$$20240927$$MD$US$US
243696851$24369685$1$I$$20240926$20240927$20240927$EXP$$CA-ROCHE-10000092452$ROCHE$$68$YR$E$M$Y$$$20240927$$CN$CA$CA
243696861$24369686$1$I$$20231110$20240927$20240927$PER$$US-ROCHE-3457025$ROCHE$$48$YR$A$F$Y$67.7$KG$20240927$$MD$US$US
243696871$24369687$1$I$$20231201$20240927$20240927$PER$$US-ROCHE-3470390$ROCHE$$43$YR$A$M$Y$$$20240927$$MD$US$US
243696881$24369688$1$I$$20240212$20240927$20240927$PER$$US-ROCHE-3471709$ROCHE$$78$YR$E$F$Y$$$20240927$$MD$US$US
243696891$24369689$1$I$20220501$20231211$20240927$20240927$PER$$US-ROCHE-3474922$ROCHE$$90$YR$E$F$Y$68.04$KG$20240927$$CN$US$US
243696901$24369690$1$I$$20231218$20240927$20240927$PER$$US-ROCHE-3475529$ROCHE$$61$YR$A$M$Y$$$20240927$$MD$US$US
243696911$24369691$1$I$$20231113$20240927$20240927$PER$$US-ROCHE-3457663$ROCHE$$68$YR$E$M$Y$$$20240927$$CN$US$US
243696921$24369692$1$I$20230101$20240108$20240927$20240927$PER$$US-ROCHE-3488749$ROCHE$$84$YR$E$F$Y$61.23$KG$20240927$$CN$US$US
243696931$24369693$1$I$$20240124$20240927$20240927$PER$$US-ROCHE-3498499$ROCHE$$63$YR$A$M$Y$$$20240927$$MD$US$US
243696941$24369694$1$I$$20231129$20240927$20240927$PER$$US-ROCHE-3466698$ROCHE$$58$YR$A$F$Y$$$20240927$$CN$US$US
243696951$24369695$1$I$$20240223$20240927$20240927$PER$$US-ROCHE-3513590$ROCHE$$49$YR$A$F$Y$$$20240927$$MD$US$US
243696961$24369696$1$I$$20231129$20240927$20240927$PER$$US-ROCHE-3459370$ROCHE$$72$YR$E$F$Y$$$20240927$$CN$US$US
243696971$24369697$1$I$20160101$20240125$20240927$20240927$PER$$US-ROCHE-3499678$ROCHE$$58$YR$A$M$Y$170.1$KG$20240927$$CN$US$US
243696981$24369698$1$I$$20231120$20240927$20240927$PER$$US-ROCHE-3461810$ROCHE$$75$YR$E$F$Y$$$20240927$$CN$US$US
243696991$24369699$1$I$$20240219$20240927$20240927$PER$$US-ROCHE-3513072$ROCHE$$63$YR$A$F$Y$$$20240927$$MD$US$US
243697001$24369700$1$I$$20240112$20240927$20240927$PER$$US-ROCHE-3491904$ROCHE$$53$YR$A$F$Y$$$20240927$$MD$US$US
243697011$24369701$1$I$20231201$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190796$AMGEN$$59$YR$A$F$Y$$$20240927$$CN$US$US
243697021$24369702$1$I$20230801$20240111$20240927$20240927$PER$$CN-ROCHE-3487077$ROCHE$$56$YR$A$M$Y$60$KG$20240927$$CN$CN$CN
243697031$24369703$1$I$$20240918$20240927$20240927$EXP$$CA-APOTEX-2024AP011240$APOTEX$$90$YR$$F$Y$$$20240927$$CN$CA$CA
243697041$24369704$1$I$$20231201$20240927$20240927$PER$$US-ROCHE-3469394$ROCHE$$40$YR$A$M$Y$$$20240927$$MD$US$US
243697051$24369705$1$I$$20240126$20240927$20240927$PER$$US-ROCHE-3504089$ROCHE$$56$YR$A$F$Y$$$20240927$$MD$US$US
243697061$24369706$1$I$$20240110$20240927$20240927$PER$$US-ROCHE-3491859$ROCHE$$53$YR$A$F$Y$$$20240927$$MD$US$US
243697071$24369707$1$I$$20231222$20240927$20240927$PER$$US-ROCHE-3481623$ROCHE$$63$YR$A$$Y$$$20240927$$MD$US$US
243697081$24369708$1$I$20231001$20231122$20240927$20240927$PER$$US-ROCHE-3460446$ROCHE$$87$YR$E$F$Y$$$20240927$$CN$US$US
243697101$24369710$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005429$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243697111$24369711$1$I$$20231115$20240927$20240927$PER$$US-ROCHE-3459596$ROCHE$$72$YR$E$F$Y$$$20240927$$MD$US$US
243697121$24369712$1$I$$20231114$20240927$20240927$PER$$US-ROCHE-3458452$ROCHE$$50$YR$A$M$Y$$$20240927$$MD$US$US
243697131$24369713$1$I$20231130$20231204$20240927$20240927$PER$$US-ROCHE-3469953$ROCHE$$64$YR$A$F$Y$110.45$KG$20240927$$CN$US$US
243697141$24369714$1$I$$20231204$20240927$20240927$PER$$US-ROCHE-3471339$ROCHE$$60$YR$A$M$Y$$$20240927$$MD$US$US
243697151$24369715$1$I$$20231206$20240927$20240927$PER$$US-ROCHE-3471730$ROCHE$$43$YR$A$M$Y$99.79$KG$20240927$$CN$US$US
243697161$24369716$1$I$$20240920$20240927$20240927$EXP$$JP-GSK-JP2024064211$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$JP$JP
243697171$24369717$1$I$20190701$20240213$20240927$20240927$PER$$US-ROCHE-3467699$ROCHE$$50$YR$A$M$Y$66.68$KG$20240927$$MD$US$US
243697181$24369718$1$I$$20240902$20240927$20240927$PER$$US-STRIDES PHARMA UK LTD.-2024SP011405$STRIDES$Santistevan L, Lonergan D, Eyvazzadeh AD.. First case report of serous otitis media as a complication of severe ovarian hyperstimulation syndrome: Case report and literature review. [Review].. Int-J-Gynaecol-Obstet. 2024;164 (3):843-847$$$$$Y$$$20240927$$HP$US$US
243697191$24369719$1$I$$20240215$20240927$20240927$PER$$US-ROCHE-3511527$ROCHE$$88$YR$E$F$Y$$$20240927$$MD$US$US
243697201$24369720$1$I$$20240213$20240927$20240927$PER$$US-ROCHE-3510015$ROCHE$$83$YR$E$F$Y$$$20240927$$CN$US$US
243697211$24369721$1$I$$20231129$20240927$20240927$PER$$US-ROCHE-3467340$ROCHE$$$$$$Y$$$20240927$$MD$US$US
243697221$24369722$1$I$20231030$20240205$20240927$20240927$PER$$US-ROCHE-3505630$ROCHE$$71$YR$E$F$Y$$$20240927$$CN$US$US
243697231$24369723$1$I$$20240209$20240927$20240927$PER$$US-ROCHE-3508329$ROCHE$$77$YR$E$F$Y$$$20240927$$CN$US$US
243697241$24369724$1$I$$20240925$20240927$20240927$PER$$US-ABBVIE-5941261$ABBVIE$$$$$$Y$$$20240927$$CN$US$US
243697251$24369725$1$I$20240913$20240917$20240927$20240927$PER$$US-JNJFOC-20240945634$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$CN$US$US
243697261$24369726$1$I$$20240905$20240927$20240927$PER$$US-STRIDES ARCOLAB LIMITED-2024SP011614$STRIDES$Heyman HM, Alberts NM, Rees M, Puri L, Frett MJ, Anghelescu DL.. COVID-19 infection and pain in adolescents with sickle cell disease: A case series.. EJHaem. 2022;3 (4):1310-1315$14$YR$$F$Y$$$20240927$$HP$US$US
243697281$24369728$1$I$20120301$20240918$20240927$20240927$EXP$$SK-JNJFOC-20240960072$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240927$$MD$SK$SK
243697291$24369729$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005431$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243697301$24369730$1$I$$20240516$20240927$20240927$PER$$US-ROCHE-3514807$ROCHE$$48$YR$A$M$Y$$$20240927$$HP$US$US
243697311$24369731$1$I$$20240215$20240927$20240927$PER$$US-ROCHE-3512335$ROCHE$$66$YR$E$M$Y$$$20240927$$HP$US$US
243697321$24369732$1$I$$20240530$20240927$20240927$PER$$US-ROCHE-3495152$ROCHE$$42$YR$A$M$Y$$$20240927$$HP$US$US
243697331$24369733$1$I$$20240219$20240927$20240927$PER$$US-ROCHE-3513157$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243697341$24369734$1$I$$20240507$20240927$20240927$PER$$US-ROCHE-3479747$ROCHE$$85$YR$E$M$Y$$$20240927$$CN$US$US
243697351$24369735$1$I$$20240215$20240927$20240927$PER$$US-ROCHE-3505395$ROCHE$$76$YR$E$F$Y$72.57$KG$20240927$$CN$US$US
243697361$24369736$1$I$20240101$20240918$20240927$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029670$UNITED THERAPEUTICS$$$$$M$Y$65.76$KG$20240927$$$US$US
243697371$24369737$1$I$$20240924$20240927$20240927$EXP$$US-ABBVIE-5937859$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243697391$24369739$1$I$20240401$20240918$20240927$20240927$EXP$$BR-EMD Serono-2024050549$EMD SERONO INC$$80$YR$E$F$Y$$$20240927$$MD$BR$BR
243697401$24369740$1$I$$20240917$20240927$20240927$EXP$$VN-ROCHE-10000086746$ROCHE$Tran M, Phuong N, Doan N, Hang V. Characteristics Of Infections in patients with Systemic Lupus Erythematosus. Medical Research Journal. 2024;180 (7):62-72.$$$$$Y$$$20240927$$HP$VN$VN
243697411$24369741$1$I$$20240919$20240927$20240927$EXP$$CA-APOTEX-2024AP011301$APOTEX$$$$$$Y$$$20240927$$CN$CA$CA
243697421$24369742$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016441$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243697431$24369743$1$I$20240901$20240917$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-148478$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240927$$CN$US$US
243697441$24369744$1$I$20240924$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016447$ELI LILLY AND CO$$$$$$Y$$$20240927$$CN$US$US
243697451$24369745$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016429$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240927$$CN$US$US
243697461$24369746$1$I$$20240919$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017114$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240927$$CN$US$US
243697471$24369747$1$I$20240923$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015435$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240927$$CN$US$US
243697481$24369748$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016464$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243697491$24369749$1$I$20240909$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016500$ELI LILLY AND CO$$$$A$F$Y$$$20240927$$CN$US$US
243697501$24369750$1$I$20240901$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016191$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240927$$CN$US$US
243697511$24369751$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016137$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240927$$CN$US$US
243697531$24369753$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016469$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240927$$CN$US$US
243697541$24369754$1$I$$20240916$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409010762$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240927$$CN$US$US
243697551$24369755$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016346$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240927$$CN$US$US
243697561$24369756$1$I$20240901$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017096$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240927$$CN$US$US
243697571$24369757$1$I$20230101$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015520$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240927$$CN$US$US
243697581$24369758$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016468$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243697591$24369759$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016114$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240927$$CN$US$US
243697601$24369760$1$I$$20240917$20240927$20240927$EXP$$CA-UCBSA-2024048023$UCB$$68$YR$$F$Y$$$20240927$$HP$CA$CA
243697611$24369761$1$I$$20240925$20240927$20240927$EXP$GB-MHRA-MED-202409251647124520-PWTYV$GB-JNJFOC-20240967431$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20240927$$HP$GB$GB
243697621$24369762$1$I$$20240918$20240927$20240927$EXP$$CA-APOTEX-2024AP011242$APOTEX$$70$YR$$M$Y$$$20240927$$CN$CA$CA
243697631$24369763$1$I$$20240924$20240927$20240927$EXP$$JP-ROCHE-10000092146$ROCHE$$49$YR$A$F$Y$$$20240927$$PH$JP$JP
243697641$24369764$1$I$$20240918$20240927$20240927$EXP$$US-UCBSA-2024048163$UCB$$$$$M$Y$$$20240927$$CN$US$US
243697661$24369766$1$I$$20240917$20240927$20240927$EXP$$US-APOTEX-2024AP011272$APOTEX$$$$$F$Y$$$20240927$$CN$US$US
243697671$24369767$1$I$$20240920$20240927$20240927$PER$$US-JNJFOC-20240964566$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$HP$US$US
243697681$24369768$1$I$$20240917$20240927$20240927$EXP$CA-MHPD-E2B_07232903$CA-Accord-447361$ACCORD$$12$MON$I$M$Y$$$20240927$$HP$CA$CA
243697691$24369769$1$I$$20240919$20240927$20240927$EXP$$US-JNJFOC-20240960128$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20240927$$HP$US$US
243697711$24369771$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005432$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243697721$24369772$1$I$20240911$20240919$20240927$20240927$EXP$$CN-BEIGENE-BGN-2024-014920$BEIGENE$$$$$$Y$$$20240927$$HP$CN$CN
243697731$24369773$1$I$20240912$20240919$20240927$20240927$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2162119$JIANGSU HANSOH PHARMACEUTICAL$$58$YR$$F$Y$53$KG$20240927$$MD$CN$CN
243697741$24369774$1$I$$20240730$20240927$20240927$PER$$US-Mundipharma Research Limited-2162120$MUNDIPHARMA EDO$$78$YR$$M$Y$$$20240927$$$US$US
243697751$24369775$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA273446$SANOFI AVENTIS$$$$A$F$Y$113.18$KG$20240927$$MD$US$US
243697761$24369776$1$I$20240909$20240917$20240927$20240927$EXP$GB-MHRA-MIDB-18cdaf15-40d7-4bda-add1-2939c568fba9$GB-CELLTRION INC.-2024GB022517$CELLTRION$$$$$$Y$$$20240927$$PH$GB$GB
243697771$24369777$1$I$$20240924$20240927$20240927$EXP$$JP-ASTELLAS-2024-AER-008527$ASTELLAS$$9$DEC$E$F$Y$$$20240927$$MD$JP$JP
243697781$24369778$1$I$$20240920$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008342$ASTELLAS$$5$DEC$A$F$Y$$$20240927$$HP$US$US
243697791$24369779$1$I$20240712$20240912$20240927$20240927$EXP$$JP-SA-2024SA211910$SANOFI AVENTIS$$15$YR$T$$Y$$$20240927$$PH$JP$JP
243697801$24369780$1$I$20240725$20240924$20240927$20240927$EXP$FR-AFSSAPS-GR20191790$FR-SANDOZ INC.-NVSC2020FR023002$SANDOZ$$63$YR$$M$Y$$$20240927$$PH$FR$FR
243697821$24369782$1$I$$20240915$20240927$20240927$EXP$$CA-Accord-448224$ACCORD$Shukla V, Cheng S, Hukin J, Huh L, Datta AN. Developmental and epileptic encephalopathies after successful treatment of pediatric ALL: A case series and review of literature. Epileptic Disorders. 2024:1-10.$7$YR$C$M$Y$$$20240927$$HP$CA$CA
243697841$24369784$1$I$$20240918$20240927$20240927$EXP$$CA-APOTEX-2024AP011252$APOTEX$$72$YR$$F$Y$$$20240927$$CN$CA$CA
243697851$24369785$1$I$$20240925$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152946$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240927$$CN$US$US
243697861$24369786$1$I$20230530$20240918$20240927$20240927$EXP$FR-AFSSAPS-LL2023000996$FR-CELLTRION INC.-2024FR022648$CELLTRION$$$$$$Y$$$20240927$$MD$FR$FR
243697871$24369787$1$I$20240131$20240917$20240927$20240927$EXP$AT-BASGAGES-2024-001584$AT-CELLTRION INC.-2024AT022919$CELLTRION$$$$$$Y$$$20240927$$PH$AT$AT
243697891$24369789$1$I$$20240924$20240927$20240927$PER$$NVSC2024US191727$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
243697901$24369790$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005447$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243697921$24369792$1$I$20240922$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191607$AMGEN$$45$YR$A$F$Y$$$20240927$$HP$US$US
243697931$24369793$1$I$$20240917$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR118378$VIIV$$$$$$Y$$$20240927$$HP$US$US
243697941$24369794$1$I$$20240925$20240927$20240927$PER$$US-GILEAD-2024-0688958$GILEAD$$$$A$M$Y$$$20240927$$CN$US$US
243697951$24369795$1$I$20240101$20240913$20240927$20240927$EXP$$US-UCBSA-2024040620$UCB$$$$$M$Y$$$20240927$$CN$US$US
243697961$24369796$1$I$20240625$20240922$20240927$20240927$EXP$$SA-EMD Serono-2024050643$EMD SERONO INC$$39$YR$A$F$Y$$$20240927$$CN$SA$SA
243697971$24369797$1$I$$20240916$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046081$AUROBINDO$Tabaac BJ, Arenas A, Beutler BD, Cherian K, Evans VD, Shinozuka K, et al. Psychedelic Therapy: A Primer for Primary Care Clinicians - Historical Perspective and Overview. American Journal of Therapeutics. 2024;31(2):E97-E103$29$YR$$M$Y$$$20240927$$MD$US$US
243697981$24369798$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005439$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243697991$24369799$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005433$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243698001$24369800$1$I$$20240904$20240927$20240927$30DAY$$DE-JNJFOC-20240930959$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$DE$DE
243698011$24369801$1$I$$20240919$20240927$20240927$EXP$$DE-ESPERIONTHERAPEUTICS-2024DEU01484$ESPERION THERAPEUTICS$$$$$M$Y$$$20240927$$MD$DE$DE
243698021$24369802$1$I$20240618$20240918$20240927$20240927$EXP$GB-MHRA-TPP20009422C8756385YC1726572798179$GB-ESPERIONTHERAPEUTICS-2024GBR01473$ESPERION THERAPEUTICS$$63$YR$$M$Y$92$KG$20240927$$PH$GB$GB
243698041$24369804$1$I$$20240916$20240927$20240927$EXP$GB-MHRA-TPP37129013C8356888YC1726225098046$GB-ESPERIONTHERAPEUTICS-2024GBR01461$ESPERION THERAPEUTICS$$60$YR$$M$Y$95$KG$20240927$$PH$GB$GB
243698051$24369805$1$I$20240917$20240919$20240927$20240927$EXP$GB-MHRA-TPP1503173C9715460YC1726564854126$GB-ESPERIONTHERAPEUTICS-2024GBR01472$ESPERION THERAPEUTICS$$72$YR$$F$Y$80$KG$20240927$$PH$GB$GB
243698061$24369806$1$I$$20240801$20240927$20240927$PER$$US-TEVA-VS-3230388$TEVA$$66$YR$$M$Y$$$20240927$$CN$US$US
243698071$24369807$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016121$ELI LILLY AND CO$$$$$$Y$$$20240927$$CN$US$US
243698081$24369808$1$I$20240925$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016212$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240927$$CN$US$US
243698091$24369809$1$I$20240925$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016640$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243698101$24369810$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016105$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240927$$CN$US$US
243698121$24369812$1$I$20200401$20240917$20240927$20240927$EXP$$BE-TAKEDA-2024TUS095212$TAKEDA$$6$DEC$$$Y$$$20240927$$MD$BE$BE
243698141$24369814$1$I$$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005454$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243698151$24369815$1$I$20240907$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005451$ACADIA PHARMACEUTICALS$$88$YR$$M$Y$$$20240927$$CN$US$US
243698161$24369816$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005449$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243698181$24369818$1$I$$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005456$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243698201$24369820$1$I$20240901$20240910$20240927$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000793$DECIPHERA PHARMACEUTICALS$$74$YR$E$F$Y$$$20240927$$CN$US$US
243698211$24369821$1$I$$20231012$20240927$20240927$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000172-2023$QILU PHARMACEUTICAL$$49$YR$A$M$Y$$$20240919$$HP$US$US
243698221$24369822$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005583$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243698231$24369823$1$I$20240908$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005457$ACADIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240927$$CN$US$US
243698251$24369825$1$I$20240101$20240910$20240927$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000794$DECIPHERA PHARMACEUTICALS$$69$YR$E$F$Y$$$20240927$$CN$US$US
243698261$24369826$1$I$$20231130$20240927$20240927$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO.  LTD.-QLH-000200-2023$QILU PHARMACEUTICAL$$$$A$F$Y$$$20240919$$PH$US$US
243698271$24369827$1$I$20240923$20240923$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-047286$AUROBINDO$$57$YR$$M$Y$80$KG$20240927$$MD$GB$GB
243698281$24369828$1$I$20240913$20240916$20240927$20240927$EXP$$US-Accord-447616$ACCORD$$29$YR$A$M$Y$$$20240927$$PH$US$US
243698291$24369829$1$I$20230515$20240918$20240927$20240927$EXP$FR-AFSSAPS-BS2023000475$FR-CELLTRION INC.-2024FR022635$CELLTRION$$$$$$Y$$$20240927$$MD$FR$FR
243698301$24369830$1$I$$20240924$20240927$20240927$EXP$$JP-SA-2024SA275127$SANOFI AVENTIS$$$$$$Y$$$20240927$$PH$JP$JP
243698311$24369831$1$I$20240914$20240919$20240927$20240927$EXP$$CN-BEIGENE-BGN-2024-014921$BEIGENE$$$$$$Y$$$20240927$$HP$CN$CN
243698321$24369832$1$I$$20240918$20240927$20240927$EXP$$CA-APOTEX-2024AP011155$APOTEX$$62$YR$$M$Y$$$20240927$$CN$CA$CA
243698331$24369833$1$I$20240824$20240903$20240927$20240927$PER$$US-009507513-2409USA001616$MERCK$$78$YR$$F$Y$$$20240927$$CN$US$US
243698341$24369834$1$I$20240819$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005436$ACADIA PHARMACEUTICALS$$52$YR$$F$Y$$$20240927$$CN$US$US
243698351$24369835$1$I$$20240917$20240927$20240927$EXP$$US-Merz Pharmaceuticals GmbH-2024090000151$MERZ$$$$$$Y$$$20240927$$HP$US$US
243698361$24369836$1$I$$20240925$20240927$20240927$EXP$$NVSC2024ZA191415$NOVARTIS$$41$YR$$F$Y$73$KG$20240927$$HP$ZA$ZA
243698371$24369837$1$I$20230913$20230922$20240927$20240927$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO., LTD.-QLH-000163-2023$QILU PHARMACEUTICAL$$61$YR$A$F$Y$$$20240923$$HP$US$US
243698381$24369838$1$I$$20240918$20240927$20240927$EXP$$CA-TAKEDA-2024TUS029905$TAKEDA$$$$$F$Y$$$20240927$$MD$CA$CA
243698391$24369839$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938881$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243698401$24369840$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938891$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243698411$24369841$1$I$$20240922$20240927$20240927$EXP$JP-MMM-5YB4TCX3$JP-GSK-JP2024117223$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$JP$JP
243698421$24369842$1$I$$20240922$20240927$20240927$EXP$JP-MMM-PKL9QW1E$JP-GSK-JP2024117225$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$JP$JP
243698431$24369843$1$I$20240815$20240917$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024116659$VIIV$$4$DEC$$M$Y$$$20240927$$HP$US$US
243698441$24369844$1$I$$20240910$20240927$20240927$EXP$$US-SA-2024SA277193$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240927$$PH$US$US
243698451$24369845$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938622$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243698461$24369846$1$I$20220725$20240918$20240927$20240927$EXP$FR-AFSSAPS-LL2023001051$FR-CELLTRION INC.-2024FR022646$CELLTRION$$$$$$Y$$$20240927$$MD$FR$FR
243698471$24369847$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938632$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243698481$24369848$1$I$$20240917$20240927$20240927$EXP$$EG-GE HEALTHCARE-2024CSU010857$GE HEALTHCARE$$$$$M$Y$$$20240927$$HP$EG$EG
243698491$24369849$1$I$20240320$20240920$20240927$20240927$30DAY$$US-AMGEN-USASP2024188658$AMGEN$$71$YR$E$F$Y$$$20240927$$PH$US$US
243698501$24369850$1$I$$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192285$AMGEN$$$$A$M$Y$$$20240927$$CN$US$US
243698511$24369851$1$I$20240101$20240910$20240927$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000795$DECIPHERA PHARMACEUTICALS$$76$YR$E$M$Y$$$20240927$$CN$US$US
243698521$24369852$1$I$20240910$20240924$20240927$20240927$PER$$US-HALEON-2198878$Haleon PLC$$77$YR$$F$Y$$$20240927$$CN$US$US
243698531$24369853$1$I$$20240920$20240927$20240927$EXP$$US-GALDERMA-US2024014359$GALDERMA$Goldin MR, Petry R, Goyal P. Doxycycline-associated acute pancreatitis: a rare adverse effect of a commonly prescribed antibiotic. BMJ Case Rep. 2024;17(9):e261364$$$$$Y$$$20240927$$HP$US$US
243698541$24369854$1$I$$20240924$20240927$20240927$EXP$$US-SA-2024SA277559$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240927$$HP$US$US
243698551$24369855$1$I$$20240921$20240927$20240927$EXP$$DE-EXELIXIS-EXL-2024-000610$EXELIXIS$Hilser T., Darr C., Niegisch G., et.al. Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project. Cancers (Basel). 2024;16(17):2998$$$$$Y$$$20240927$$MD$DE$DE
243698561$24369856$1$I$$20240925$20240927$20240927$PER$$US-ROCHE-10000092704$ROCHE$$19$YR$A$F$Y$$$20240927$$MD$US$US
243698571$24369857$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005491$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243698581$24369858$1$I$20240905$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005462$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20240927$$HP$US$US
243698591$24369859$1$I$$20240920$20240927$20240927$EXP$$CN-ABBVIE-5938354$ABBVIE$Peng X, Yu J, Tang F, Li Y, Bai J, Li L, et al. Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia. Discov Onc. 2024;15(1):451.$$$A$$Y$$$20240927$$HP$CN$CN
243698601$24369860$1$I$$20240913$20240927$20240927$EXP$$AU-GENERIC HEALTH PTY. LTD.-2024-09266$LUPIN$Xian E, Morrison T, Wong J. Hyperacute in-stent thrombosis causing large vessel occlusion after stent-assisted aneurysm coiling secondary to complete clopidogrel and prasugrel resistance: A case report. Journal of Neurological Surgery-Part A. 2024;85 (5):531-533$5$DEC$$M$Y$$$20240927$$HP$AU$AU
243698621$24369862$1$I$20240123$20240917$20240927$20240927$EXP$$JP-AMGEN-JPNSP2024166401$AMGEN$$44$YR$A$M$Y$$$20240927$$MD$JP$JP
243698641$24369864$1$I$20230101$20240110$20240927$20240927$EXP$$US-KHC-000102$Kilitch Healthcare$$$$$M$Y$$$20240927$$CN$US$US
243698651$24369865$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152987$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20240927$$CN$US$US
243698661$24369866$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150862$BRISTOL MYERS SQUIBB$Abdullah M, Kim SM, Krvavac A. Navigating the perils of pulmonary artery pseudoaneurysm: insights from a case of aspergillus-associated complication. Chest. 2024;166(4S):6120A-1A. doi:10.1016/j.chest.2024.06.3620.$66$YR$E$F$Y$$$20240927$$HP$US$US
243698671$24369867$1$I$20240909$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005463$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243698681$24369868$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153073$BRISTOL MYERS SQUIBB$$35$YR$A$M$Y$$$20240927$$CN$US$US
243698691$24369869$1$I$$20240924$20240927$20240927$PER$$US-HALEON-2198659$Haleon PLC$$$$$F$Y$$$20240927$$CN$US$US
243698701$24369870$1$I$$20240920$20240927$20240927$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-151439$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240927$$MD$PL$PL
243698711$24369871$1$I$$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005468$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243698721$24369872$1$I$$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005474$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243698731$24369873$1$I$$20240919$20240927$20240927$EXP$$CO-ROCHE-10000090636$ROCHE$$68$YR$E$F$Y$67$KG$20240927$$CN$CO$CO
243698741$24369874$1$I$20240909$20240919$20240927$20240927$EXP$GB-MHRA-MED-202409161222572420-TMDZF$GB-Accord-447784$ACCORD$$53$YR$A$M$Y$100$KG$20240927$$CN$GB$GB
243698751$24369875$1$I$20240912$20240913$20240927$20240927$EXP$$US-UCBSA-2024047158$UCB$$59$YR$$F$Y$$$20240927$$CN$US$US
243698761$24369876$1$I$20240716$20240919$20240927$20240927$EXP$$JP-ROCHE-10000078756$ROCHE$$8$DEC$E$F$Y$$$20240927$$PH$JP$JP
243698771$24369877$1$I$20230514$20240918$20240927$20240927$EXP$FR-AFSSAPS-PP2023000919$FR-CELLTRION INC.-2024FR022650$CELLTRION$$$$$$Y$$$20240927$$MD$FR$FR
243698781$24369878$1$I$$20240920$20240927$20240927$EXP$$US-VIIV HEALTHCARE LIMITED-US2024AMR117793$VIIV$$$$$$Y$$$20240927$$CN$US$US
243698791$24369879$1$I$20240912$20240913$20240927$20240927$EXP$$US-UCBSA-2024047209$UCB$$70$YR$$F$Y$$$20240927$$HP$US$US
243698801$24369880$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5936778$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243698821$24369882$1$I$20240917$20240917$20240927$20240927$PER$$US-DECIPHERA PHARMACEUTICALS LLC-2024US000807$DECIPHERA PHARMACEUTICALS$$62$YR$A$F$Y$$$20240927$$HP$US$US
243698831$24369883$1$I$20230401$20240926$20240927$20240927$EXP$$BR-SANDOZ INC.-SDZ2023BR003953$SANDOZ$$42$YR$$F$Y$$$20240927$$CN$BR$BR
243698841$24369884$1$I$20240913$20240920$20240927$20240927$EXP$SE-SEMPA-2024-006895$SE-JUBILANT CADISTA PHARMACEUTICALS-2024SE001352$JUBILANT$$50$YR$$F$Y$$$20240927$$MD$SE$SE
243698851$24369885$1$I$$20240920$20240927$20240927$EXP$$US-JUBILANT CADISTA PHARMACEUTICALS-2024US001356$JUBILANT$Romero KN, O^Brien MC, Agrawal A, Hasan I.. Creatine Kinase Surge: Levetiracetam-Induced Rhabdomyolysis.. Cureus. 2024;16(8):e66715$27$YR$$M$Y$$$20240927$$MD$US$US
243698861$24369886$1$I$$20240917$20240927$20240927$EXP$$IT-JUBILANT CADISTA PHARMACEUTICALS-2024IT001335$JUBILANT$Burgalassi A, Vigani G, Boccalini A, De Cesaris F, Mannaioni G, Chiarugi A, et al.. Rimegepant as an acute  treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations. Ceph-Rep. 2024;71-19$$$A$F$Y$$$20240927$$HP$IT$IT
243698871$24369887$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5936051$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243698881$24369888$1$I$20231101$20240923$20240927$20240927$EXP$$US-ROCHE-3562542$ROCHE$$48$YR$A$M$Y$$$20240927$$CN$US$US
243698891$24369889$1$I$$20240917$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR115852$VIIV$$$$A$M$Y$$$20240927$$CN$US$US
243698901$24369890$1$I$20240924$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190788$AMGEN$$59$YR$A$F$Y$$$20240927$$CN$US$US
243698911$24369891$1$I$$20240921$20240927$20240927$PER$$US-ROCHE-10000088448$ROCHE$$7$YR$C$F$Y$$$20240927$$HP$US$US
243698921$24369892$1$I$$20240920$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151192$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240927$$CN$US$US
243698941$24369894$1$I$20240921$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191268$AMGEN$$60$YR$A$F$Y$$$20240927$$CN$US$US
243698951$24369895$1$I$$20240911$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09138$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243698961$24369896$1$I$$20240924$20240927$20240927$EXP$$JP-ABBVIE-5936910$ABBVIE$$$$$$Y$$$20240927$$PH$JP$JP
243698971$24369897$1$I$20240410$20240923$20240927$20240927$EXP$DE-BFARM-24003437$DE-ORGANON-O2409DEU000776$ORGANON$$28$YR$$F$Y$$$20240927$$MD$DE$DE
243698991$24369899$1$I$$20231130$20240927$20240927$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO., LTD.-QLH-000201-2023$QILU PHARMACEUTICAL$$$$A$F$Y$$$20240919$$PH$US$US
243699001$24369900$1$I$20240905$20240924$20240927$20240927$EXP$$CA-ABBVIE-5938742$ABBVIE$$82$YR$$M$Y$$$20240927$$HP$CA$CA
243699011$24369901$1$I$20240828$20240924$20240927$20240927$PER$$US-ABBVIE-5939157$ABBVIE$$75$YR$$F$Y$58.966$KG$20240927$$CN$US$US
243699021$24369902$1$I$$20231130$20240927$20240927$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO., LTD.-QLH-000202-2023$QILU PHARMACEUTICAL$$$$A$F$Y$$$20240919$$PH$US$US
243699041$24369904$1$I$$20240919$20240927$20240927$PER$$US-ROCHE-10000086598$ROCHE$Hall A, Huaman M, LaPorta J, Luckett K. Case Report: Disseminated Tuberculosis After Kidney Transplantation. American Journal of Tropical Medicine and Hygiene. 2024-Sep;111 (3):535-539. doi:10.4269/ajtmh.23-0358.$54$YR$A$F$Y$$$20240927$$HP$US$US
243699051$24369905$1$I$20240819$20240920$20240927$20240927$EXP$$BR-AUROBINDO-AUR-APL-2024-047213$AUROBINDO$$31$YR$$M$Y$76$KG$20240927$$HP$BR$BR
243699061$24369906$1$I$20200401$20240917$20240927$20240927$EXP$$BE-JNJFOC-20240957657$JOHNSON AND JOHNSON$$53$YR$A$$Y$$$20240927$$MD$BE$BE
243699071$24369907$1$I$$20240920$20240927$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-017207$UNITED THERAPEUTICS$$$$$F$Y$72.562$KG$20240927$$$US$US
243699081$24369908$1$I$$20240916$20240927$20240927$EXP$$CA-UCBSA-2024049662$UCB$$$$$F$Y$$$20240927$$HP$CA$CA
243699091$24369909$1$I$20240919$20240919$20240927$20240927$PER$$US-RDY-SPO/USA/24/0013911$DR REDDYS$$93$YR$E$F$Y$$$20240927$$HP$US$US
243699101$24369910$1$I$$20240918$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013833$DR REDDYS$$54$YR$A$M$Y$$$20240927$$MD$US$US
243699111$24369911$1$I$$20240918$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013837$DR REDDYS$$40$YR$A$$Y$$$20240927$$PH$US$US
243699121$24369912$1$I$$20231130$20240927$20240927$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO., LTD.-QLH-000203-2023$QILU PHARMACEUTICAL$$$$A$F$Y$$$20240919$$PH$US$US
243699131$24369913$1$I$$20240919$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013864$DR REDDYS$$31$YR$A$M$Y$$$20240927$$HP$US$US
243699141$24369914$1$I$$20240916$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013873$DR REDDYS$Joshi T, Rahman Y, Yeung H. Primary lung adenocarcinoma mimicking recurrent pneumonia in a young adult. BMJ Case Reports. 2023 Aug 18;(16): doi:10.1136/bcr-2023-255693.$3$DEC$A$M$Y$$$20240927$$HP$US$US
243699151$24369915$1$I$20240801$20240920$20240927$20240927$EXP$$US-BIOCRYST PHARMACEUTICALS, INC.-2024BCR00979$BIOCRYST PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243699161$24369916$1$I$$20240923$20240927$20240927$EXP$$US-BIOCON-BCN-2024-000194$BIOCON$Hashemi S, Hod-Dvorai R, Tong R, Suo L. Successful Treatment of Plasma Cell-Rich Acute Rejection Using Bortezomib: A Case Report. Case Reports in Transplantation. 06-Sep-2024; Vol 2024; 1-6. doi:10.1155/2024/9226321.$37$YR$A$F$Y$$$20240927$$HP$US$US
243699171$24369917$1$I$20240820$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005658$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240927$$CN$US$US
243699181$24369918$1$I$$20240925$20240927$20240927$EXP$$IL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053590$BOEHRINGER INGELHEIM$$56$YR$A$F$Y$$$20240927$$MD$IL$IL
243699191$24369919$1$I$$20240925$20240927$20240927$EXP$$AU-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053532$BOEHRINGER INGELHEIM$$75$YR$E$F$Y$$$20240927$$MD$AU$AU
243699201$24369920$1$I$20240924$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191292$AMGEN$$55$YR$A$M$Y$$$20240927$$CN$US$US
243699211$24369921$1$I$20240924$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190348$AMGEN$$66$YR$E$M$Y$$$20240927$$CN$US$US
243699221$24369922$1$I$20240922$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024189317$AMGEN$$69$YR$E$F$Y$$$20240927$$CN$US$US
243699241$24369924$1$I$$20240919$20240927$20240927$EXP$$CA-APOTEX-2024AP011275$APOTEX$$$$$$Y$$$20240927$$MD$CA$CA
243699251$24369925$1$I$$20240916$20240927$20240927$EXP$$US-ROCHE-10000083896$ROCHE$$76$YR$E$F$Y$$$20240927$$CN$US$US
243699261$24369926$1$I$20240101$20240919$20240927$20240927$EXP$SE-SEMPA-2024-006675$SE-TEVA-VS-3246150$TEVA$$20$YR$$F$Y$57$KG$20240927$$CN$SE$SE
243699271$24369927$1$I$20240827$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005672$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20240927$$CN$US$US
243699281$24369928$1$I$$20240923$20240927$20240927$EXP$FI-FIMEA-202403297$FI-UCBSA-2024048813$UCB$$$$I$$Y$$$20240927$$HP$FI$FI
243699291$24369929$1$I$$20240913$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-08837$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243699301$24369930$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153041$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$$$20240927$$HP$US$US
243699311$24369931$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016315$ELI LILLY AND CO$$60$YR$A$M$Y$$$20240927$$CN$US$US
243699331$24369933$1$I$20240924$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016496$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240927$$CN$US$US
243699341$24369934$1$I$20240924$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016372$ELI LILLY AND CO$$34$YR$A$$Y$$$20240927$$CN$US$US
243699351$24369935$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016361$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243699361$24369936$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016510$ELI LILLY AND CO$$40$YR$A$$Y$$$20240927$$CN$US$US
243699371$24369937$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016495$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240927$$HP$US$US
243699381$24369938$1$I$20240918$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015624$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240927$$CN$US$US
243699391$24369939$1$I$20240924$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016666$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243699401$24369940$1$I$$20240923$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409014810$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240927$$CN$US$US
243699421$24369942$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016512$ELI LILLY AND CO$$74$YR$E$F$Y$$$20240927$$CN$US$US
243699431$24369943$1$I$20240726$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016459$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240927$$CN$US$US
243699441$24369944$1$I$$20240919$20240927$20240927$PER$$US-GSK-US2024116611$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243699461$24369946$1$I$$20240913$20240927$20240927$PER$$US-JNJFOC-20240935529$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$CN$US$US
243699471$24369947$1$I$$20240918$20240927$20240927$PER$$US-GSK-US2024AMR116349$GLAXOSMITHKLINE$$$$$M$Y$$$20240927$$CN$US$US
243699481$24369948$1$I$$20240919$20240927$20240927$EXP$$US-JNJFOC-20240960273$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20240927$$MD$US$US
243699491$24369949$1$I$20240907$20240909$20240927$20240927$PER$$US-JNJFOC-20240922301$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240927$$CN$US$US
243699501$24369950$1$I$20240813$20240920$20240927$20240927$EXP$FR-AFSSAPS-TO2024001713$FR-TEVA-VS-3246626$TEVA$$92$YR$$F$Y$70$KG$20240927$$MD$FR$FR
243699521$24369952$1$I$20240801$20240917$20240927$20240927$EXP$$CA-JNJFOC-20240947716$JOHNSON AND JOHNSON$$81$YR$E$F$Y$68.1$KG$20240927$$HP$CA$CA
243699541$24369954$1$I$$20240906$20240927$20240927$30DAY$$US-JNJFOC-20240931171$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$HP$US$US
243699551$24369955$1$I$$20240919$20240927$20240927$PER$$US-JNJFOC-20240954975$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$CN$US$US
243699561$24369956$1$I$20240924$20240924$20240927$20240927$EXP$$JP-JNJFOC-20240969019$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$MD$JP$JP
243699571$24369957$1$I$$20240904$20240927$20240927$30DAY$$CZ-JNJFOC-20240919409$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$CZ$CZ
243699581$24369958$1$I$$20240920$20240927$20240927$PER$$US-JNJFOC-20240964894$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$HP$US$US
243699592$24369959$2$F$$20240919$20240927$20240927$PER$$US-JNJFOC-20240954780$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20240927$$CN$US$US
243699601$24369960$1$I$20240101$20240918$20240927$20240927$EXP$$JP-009507513-2409JPN002851J$MERCK$$$$$M$Y$$$20240927$$MD$JP$JP
243699621$24369962$1$I$20220601$20240916$20240927$20240927$EXP$RO-AMGEN-ROUSP2024176878$RO-ROCHE-10000082668$ROCHE$$70$YR$E$M$Y$$$20240927$$MD$RO$RO
243699631$24369963$1$I$$20240917$20240927$20240927$EXP$$ZA-HETERO-HET2024ZA03227$HETERO$$$$$M$Y$2.9$KG$20240927$$HP$ZA$ZA
243699642$24369964$2$F$20240925$20240927$20240927$20240930$PER$$US-AMGEN-USASP2024191308$AMGEN$$59$YR$A$M$Y$$$20240929$$PH$US$US
243699651$24369965$1$I$$20240917$20240927$20240927$EXP$$IN-GLENMARK PHARMACEUTICALS-2024GMK094140$GLENMARK$Gaur L, Duggal R, Singhal MK.. Herpes Simplex Virus Type-2 Nephritis: An Unexpected Plot Twist in a Kidney Transplant Recipient.. Indian Journal of Nephrology. 2024;34 (5):512-3$$$$$Y$$$20240927$$MD$IN$IN
243699661$24369966$1$I$20240826$20240923$20240927$20240927$EXP$FR-AFSSAPS-MA2024001512$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112691$ZYDUS PHARM$$$$$$Y$$$20240927$$MD$FR$FR
243699671$24369967$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011349$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240927$$HP$CA$CA
243699691$24369969$1$I$20240924$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024191911$AMGEN$$$$$F$Y$$$20240927$$CN$US$US
243699701$24369970$1$I$$20240906$20240927$20240927$30DAY$$GR-JNJFOC-20240941101$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$GR$GR
243699711$24369971$1$I$20240820$20240917$20240927$20240927$EXP$$BR-Accord-447958$ACCORD$$55$YR$A$F$Y$$$20240927$$PH$BR$BR
243699741$24369974$1$I$20240910$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-002942$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240927$$CN$US$US
243699761$24369976$1$I$20240923$20240923$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152072$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240927$$CN$US$US
243699771$24369977$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151239$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240927$$CN$US$US
243699781$24369978$1$I$20240918$20240918$20240927$20240927$PER$$US-ABBVIE-5930122$ABBVIE$$52$YR$$F$Y$$$20240927$$CN$US$US
243699791$24369979$1$I$20230922$20230925$20240927$20240927$PER$$US-QILU PHARMACEUTICAL (HAINAN) CO., LTD.-QLH-000164-2023$QILU PHARMACEUTICAL$$73$YR$E$F$Y$$$20240923$$HP$US$US
243699801$24369980$1$I$20240904$20240920$20240927$20240927$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001939$BLUEPRINT MEDICINES$$71$YR$E$F$Y$$$20240927$$CN$US$US
243699811$24369981$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011350$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240927$$HP$CA$CA
243699821$24369982$1$I$$20240919$20240927$20240927$EXP$$US-JNJFOC-20240960205$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240927$$MD$US$US
243699831$24369983$1$I$$20240917$20240927$20240927$EXP$$ES-CELLTRION INC.-2024ES022931$CELLTRION$Parra CS, Perez EG, Vidal MJ, Noguera RM, Perez PV, Almela EL et al.. 790 - Bevacizumab (BVZ): Evolution one year of treatment in 3 siblings with hereditary hemorrhagic telangiectasia (HHT) with ENT and gastrointestinal affection. Revista Clinica Espanola. 2023;223(2):S276-S277$$$$$Y$$$20240927$$HP$ES$ES
243699841$24369984$1$I$20210101$20240926$20240927$20240927$PER$$US-ROCHE-10000093033$ROCHE$$53$YR$A$M$Y$$$20240927$$MD$US$US
243699851$24369985$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005441$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$HP$US$US
243699861$24369986$1$I$20240923$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191104$AMGEN$$74$YR$E$F$Y$$$20240927$$HP$US$US
243699871$24369987$1$I$$20240922$20240927$20240927$PER$$US-ABBVIE-5939084$ABBVIE$$$$$M$Y$$$20240927$$MD$US$US
243699891$24369989$1$I$$20240924$20240927$20240927$EXP$$US-ABBVIE-5938132$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243699911$24369991$1$I$$20240920$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0014037$DR REDDYS$$50$YR$A$F$Y$$$20240927$$HP$US$US
243699921$24369992$1$I$20240820$20240920$20240927$20240927$PER$$US-RDY-SPO/USA/24/0014041$DR REDDYS$$37$YR$A$F$Y$$$20240927$$MD$US$US
243699931$24369993$1$I$$20240920$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0014025$DR REDDYS$$53$YR$A$M$Y$$$20240927$$MD$US$US
243699941$24369994$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5936816$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243699951$24369995$1$I$20240706$20240919$20240927$20240927$EXP$$NVSC2024CN188593$NOVARTIS$$87$YR$$F$Y$66$KG$20240927$$HP$CN$CN
243699971$24369997$1$I$$20240925$20240927$20240927$EXP$$US-JNJFOC-20240970534$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243699991$24369999$1$I$$20240318$20240927$20240927$PER$$US-ROCHE-3529164$ROCHE$$36$YR$A$M$Y$$$20240927$$MD$US$US
243700001$24370000$1$I$$20240501$20240927$20240927$PER$$US-ROCHE-3557280$ROCHE$$68$YR$E$M$Y$$$20240927$$MD$US$US
243700011$24370001$1$I$20240201$20240326$20240927$20240927$PER$$US-ROCHE-3533746$ROCHE$$81$YR$E$F$Y$66.68$KG$20240927$$CN$US$US
243700021$24370002$1$I$$20240408$20240927$20240927$PER$$US-ROCHE-3543383$ROCHE$$46$YR$A$F$Y$$$20240927$$MD$US$US
243700031$24370003$1$I$$20240503$20240927$20240927$PER$$US-ROCHE-3558802$ROCHE$$28$YR$A$F$Y$$$20240927$$MD$US$US
243700041$24370004$1$I$$20240404$20240927$20240927$PER$$US-ROCHE-3539091$ROCHE$$53$YR$A$F$Y$$$20240927$$CN$US$US
243700051$24370005$1$I$$20240314$20240927$20240927$PER$$US-ROCHE-3527632$ROCHE$$50$YR$A$M$Y$$$20240927$$MD$US$US
243700061$24370006$1$I$$20240325$20240927$20240927$PER$$US-ROCHE-3533384$ROCHE$$71$YR$E$F$Y$$$20240927$$MD$US$US
243700071$24370007$1$I$$20240406$20240927$20240927$PER$$US-ROCHE-3541697$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243700081$24370008$1$I$$20240305$20240927$20240927$PER$$US-ROCHE-3522382$ROCHE$$84$YR$E$M$Y$$$20240927$$MD$US$US
243700091$24370009$1$I$$20240222$20240927$20240927$PER$$US-ROCHE-3515936$ROCHE$$66$YR$E$M$Y$$$20240927$$MD$US$US
243700101$24370010$1$I$$20240319$20240927$20240927$PER$$US-ROCHE-3530278$ROCHE$$73$YR$E$M$Y$$$20240927$$MD$US$US
243700111$24370011$1$I$$20240307$20240927$20240927$PER$$US-ROCHE-3523338$ROCHE$$49$YR$A$F$Y$$$20240927$$MD$US$US
243700121$24370012$1$I$$20240319$20240927$20240927$PER$$US-ROCHE-3531766$ROCHE$$63$YR$A$F$Y$$$20240927$$MD$US$US
243700131$24370013$1$I$$20240405$20240927$20240927$PER$$US-ROCHE-3542530$ROCHE$$64$YR$A$M$Y$$$20240927$$MD$US$US
243700141$24370014$1$I$$20240319$20240927$20240927$PER$$US-ROCHE-3530037$ROCHE$$86$YR$E$F$Y$$$20240927$$MD$US$US
243700151$24370015$1$I$$20240426$20240927$20240927$PER$$US-ROCHE-3554749$ROCHE$$31$YR$A$F$Y$$$20240927$$MD$US$US
243700161$24370016$1$I$$20240417$20240927$20240927$PER$$US-ROCHE-3548568$ROCHE$$86$YR$E$M$Y$104.33$KG$20240927$$CN$US$US
243700171$24370017$1$I$20210226$20240312$20240927$20240927$PER$$US-ROCHE-3559056$ROCHE$$47$YR$A$F$Y$$$20240927$$MD$US$US
243700181$24370018$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005443$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243700191$24370019$1$I$$20240312$20240927$20240927$PER$$US-ROCHE-3525391$ROCHE$$$$E$F$Y$$$20240927$$CN$US$US
243700201$24370020$1$I$$20240312$20240927$20240927$PER$$US-ROCHE-3525926$ROCHE$$$$$$Y$$$20240927$$HP$US$US
243700211$24370021$1$I$$20240308$20240927$20240927$PER$$US-ROCHE-3523969$ROCHE$$$$$F$Y$$$20240927$$CN$US$US
243700221$24370022$1$I$$20240307$20240927$20240927$PER$$US-ROCHE-3523542$ROCHE$$73$YR$E$F$Y$$$20240927$$MD$US$US
243700231$24370023$1$I$$20240229$20240927$20240927$PER$$US-ROCHE-3519946$ROCHE$$75$YR$E$M$Y$$$20240927$$MD$US$US
243700241$24370024$1$I$$20240910$20240927$20240927$PER$$US-TEVA-VS-3243710$TEVA$$42$YR$$F$Y$$$20240927$$HP$US$US
243700251$24370025$1$I$$20240315$20240927$20240927$PER$$US-ROCHE-3528781$ROCHE$$64$YR$A$F$Y$$$20240927$$MD$US$US
243700261$24370026$1$I$$20240229$20240927$20240927$PER$$US-ROCHE-3520158$ROCHE$$58$YR$A$F$Y$45.36$KG$20240927$$CN$US$US
243700271$24370027$1$I$$20240311$20240927$20240927$PER$$US-ROCHE-3525207$ROCHE$$28$YR$A$$Y$$$20240927$$MD$US$US
243700281$24370028$1$I$$20240424$20240927$20240927$PER$$US-ROCHE-3553128$ROCHE$$57$YR$A$M$Y$$$20240927$$MD$US$US
243700291$24370029$1$I$$20240301$20240927$20240927$PER$$US-ROCHE-3520868$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243700301$24370030$1$I$$20240312$20240927$20240927$PER$$US-ROCHE-3525595$ROCHE$$34$YR$A$F$Y$$$20240927$$CN$US$US
243700311$24370031$1$I$$20240416$20240927$20240927$PER$$US-ROCHE-3548402$ROCHE$$15$YR$T$F$Y$$$20240927$$MD$US$US
243700321$24370032$1$I$$20240313$20240927$20240927$PER$$US-ROCHE-3527502$ROCHE$$52$YR$A$M$Y$$$20240927$$MD$US$US
243700331$24370033$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153057$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240927$$CN$US$US
243700341$24370034$1$I$20070101$20240308$20240927$20240927$PER$$US-ROCHE-3524278$ROCHE$$65$YR$E$F$Y$81.65$KG$20240927$$CN$US$US
243700351$24370035$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153105$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240927$$CN$US$US
243700361$24370036$1$I$20240920$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016498$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240927$$CN$US$US
243700371$24370037$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015480$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240927$$CN$US$US
243700381$24370038$1$I$20240925$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016522$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240927$$CN$US$US
243700391$24370039$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016328$ELI LILLY AND CO$$68$YR$E$$Y$$$20240927$$CN$US$US
243700401$24370040$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015633$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240927$$CN$US$US
243700411$24370041$1$I$20240401$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016219$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240927$$CN$US$US
243700421$24370042$1$I$20240919$20240920$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409013529$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240927$$CN$US$US
243700431$24370043$1$I$20240923$20240923$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409014501$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240927$$CN$US$US
243700441$24370044$1$I$$20240426$20240927$20240927$PER$$US-ROCHE-3553824$ROCHE$$64$YR$A$F$Y$$$20240927$$MD$US$US
243700451$24370045$1$I$$20240924$20240927$20240927$EXP$$US-ABBVIE-5938206$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243700461$24370046$1$I$$20240301$20240927$20240927$PER$$US-ROCHE-3520796$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243700471$24370047$1$I$20240331$20240412$20240927$20240927$PER$$US-ROCHE-3545890$ROCHE$$85$YR$E$F$Y$$$20240927$$CN$US$US
243700481$24370048$1$I$20240403$20240404$20240927$20240927$PER$$US-ROCHE-3539245$ROCHE$$88$YR$E$F$Y$$$20240927$$CN$US$US
243700491$24370049$1$I$$20240430$20240927$20240927$PER$$US-ROCHE-3555965$ROCHE$$64$YR$A$M$Y$$$20240927$$MD$US$US
243700501$24370050$1$I$$20240410$20240927$20240927$PER$$US-ROCHE-3544910$ROCHE$$55$YR$A$F$Y$$$20240927$$MD$US$US
243700511$24370051$1$I$$20240304$20240927$20240927$PER$$US-ROCHE-3521042$ROCHE$$62$YR$A$F$Y$$$20240927$$MD$US$US
243700521$24370052$1$I$$20240416$20240927$20240927$PER$$US-ROCHE-3547321$ROCHE$$$$E$F$Y$$$20240927$$CN$US$US
243700531$24370053$1$I$20240319$20240319$20240927$20240927$PER$$US-ROCHE-3529996$ROCHE$$$$E$$Y$$$20240927$$CN$US$US
243700541$24370054$1$I$$20240320$20240927$20240927$PER$$US-ROCHE-3530466$ROCHE$$48$YR$A$F$Y$86.18$KG$20240927$$CN$US$US
243700551$24370055$1$I$$20240405$20240927$20240927$PER$$US-ROCHE-3539108$ROCHE$$65$YR$E$F$Y$$$20240927$$CN$US$US
243700561$24370056$1$I$$20240503$20240927$20240927$PER$$US-ROCHE-3559809$ROCHE$$47$YR$A$M$Y$$$20240927$$MD$US$US
243700571$24370057$1$I$$20240415$20240927$20240927$PER$$US-ROCHE-3546810$ROCHE$$67$YR$E$M$Y$$$20240927$$MD$US$US
243700581$24370058$1$I$20130101$20240410$20240927$20240927$PER$$US-ROCHE-3544098$ROCHE$$76$YR$E$F$Y$81.65$KG$20240927$$CN$US$US
243700591$24370059$1$I$$20240502$20240927$20240927$PER$$US-ROCHE-3557822$ROCHE$$63$YR$A$M$Y$$$20240927$$MD$US$US
243700601$24370060$1$I$$20240301$20240927$20240927$PER$$US-ROCHE-3520835$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243700611$24370061$1$I$$20240327$20240927$20240927$PER$$US-ROCHE-3535705$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243700621$24370062$1$I$$20240409$20240927$20240927$PER$$US-ROCHE-3545012$ROCHE$$42$YR$A$M$Y$$$20240927$$MD$US$US
243700631$24370063$1$I$$20240312$20240927$20240927$PER$$US-ROCHE-3525843$ROCHE$$44$YR$A$F$Y$$$20240927$$MD$US$US
243700641$24370064$1$I$$20240506$20240927$20240927$PER$$US-ROCHE-3559519$ROCHE$$69$YR$E$M$Y$$$20240927$$MD$US$US
243700651$24370065$1$I$$20240322$20240927$20240927$PER$$US-ROCHE-3532053$ROCHE$$81$YR$E$F$Y$$$20240927$$CN$US$US
243700661$24370066$1$I$$20240227$20240927$20240927$PER$$US-ROCHE-3528749$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243700671$24370067$1$I$$20240507$20240927$20240927$PER$$US-ROCHE-3560155$ROCHE$$81$YR$E$F$Y$$$20240927$$MD$US$US
243700681$24370068$1$I$$20240229$20240927$20240927$PER$$US-ROCHE-3528746$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243700691$24370069$1$I$$20240403$20240927$20240927$PER$$US-ROCHE-3538795$ROCHE$$74$YR$E$F$Y$$$20240927$$MD$US$US
243700701$24370070$1$I$$20240301$20240927$20240927$PER$$US-ROCHE-3520824$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243700711$24370071$1$I$$20240325$20240927$20240927$PER$$US-ROCHE-3524294$ROCHE$$66$YR$E$M$Y$$$20240927$$MD$US$US
243700721$24370072$1$I$$20240502$20240927$20240927$PER$$US-ROCHE-3557245$ROCHE$$88$YR$E$F$Y$$$20240927$$MD$US$US
243700731$24370073$1$I$$20240415$20240927$20240927$PER$$US-ROCHE-3546862$ROCHE$$66$YR$E$$Y$$$20240927$$MD$US$US
243700741$24370074$1$I$$20240311$20240927$20240927$PER$$US-ROCHE-3526329$ROCHE$$53$YR$A$M$Y$$$20240927$$MD$US$US
243700751$24370075$1$I$$20240917$20240927$20240927$EXP$$US-INSMED, INC.-2024-03776-US$INSMED$$$$$$Y$$$20240927$$CN$US$US
243700761$24370076$1$I$$20240919$20240927$20240927$EXP$$US-JNJFOC-20240960239$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20240927$$MD$US$US
243700771$24370077$1$I$$20240301$20240927$20240927$PER$$US-ROCHE-3520196$ROCHE$$46$YR$A$M$Y$$$20240927$$MD$US$US
243700781$24370078$1$I$$20240223$20240927$20240927$PER$$US-ROCHE-3515950$ROCHE$$85$YR$E$F$Y$$$20240927$$MD$US$US
243700791$24370079$1$I$$20240306$20240927$20240927$PER$$US-ROCHE-3522685$ROCHE$$50$YR$A$M$Y$$$20240927$$MD$US$US
243700801$24370080$1$I$$20240429$20240927$20240927$PER$$US-ROCHE-3556010$ROCHE$$58$YR$A$F$Y$$$20240927$$MD$US$US
243700811$24370081$1$I$20200101$20240311$20240927$20240927$PER$$US-ROCHE-3525173$ROCHE$$79$YR$E$F$Y$57.15$KG$20240927$$CN$US$US
243700821$24370082$1$I$20240101$20240307$20240927$20240927$PER$$US-ROCHE-3523040$ROCHE$$63$YR$A$M$Y$$$20240927$$CN$US$US
243700831$24370083$1$I$$20240311$20240927$20240927$PER$$US-ROCHE-3525169$ROCHE$$44$YR$A$F$Y$$$20240927$$MD$US$US
243700841$24370084$1$I$$20240401$20240927$20240927$PER$$US-ROCHE-3537991$ROCHE$$83$YR$E$F$Y$$$20240927$$MD$US$US
243700851$24370085$1$I$$20240409$20240927$20240927$PER$$US-ROCHE-3543341$ROCHE$$75$YR$E$M$Y$$$20240927$$MD$US$US
243700861$24370086$1$I$$20240325$20240927$20240927$PER$$US-ROCHE-3533260$ROCHE$$78$YR$E$M$Y$$$20240927$$CN$US$US
243700871$24370087$1$I$20240329$20240401$20240927$20240927$PER$$US-ROCHE-3537001$ROCHE$$$$$$Y$$$20240927$$HP$US$US
243700881$24370088$1$I$$20240306$20240927$20240927$PER$$US-ROCHE-3522389$ROCHE$$66$YR$E$M$Y$$$20240927$$MD$US$US
243700891$24370089$1$I$$20240226$20240927$20240927$PER$$US-ROCHE-3517265$ROCHE$$65$YR$E$M$Y$$$20240927$$CN$US$US
243700901$24370090$1$I$20240807$20240923$20240927$20240927$EXP$FR-AFSSAPS-TO2024001774$FR-ABBVIE-5934629$ABBVIE$$10$YR$$F$Y$28$KG$20240927$$MD$FR$FR
243700911$24370091$1$I$20201102$20240923$20240927$20240927$EXP$PL-URPL-1-3178-2020$PL-TEVA-VS-3246890$TEVA$$66$YR$$F$Y$83.6$KG$20240927$$HP$PL$PL
243700921$24370092$1$I$$20240227$20240927$20240927$PER$$US-ROCHE-3518504$ROCHE$$69$YR$E$F$Y$$$20240927$$MD$US$US
243700931$24370093$1$I$$20240306$20240927$20240927$PER$$US-ROCHE-3524363$ROCHE$$69$YR$E$M$Y$$$20240927$$MD$US$US
243700941$24370094$1$I$$20240414$20240927$20240927$PER$$US-ROCHE-3546488$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243700951$24370095$1$I$$20240319$20240927$20240927$PER$$US-ROCHE-3529832$ROCHE$$81$YR$E$M$Y$$$20240927$$CN$US$US
243700961$24370096$1$I$$20240301$20240927$20240927$PER$$US-ROCHE-3521061$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243700971$24370097$1$I$$20240313$20240927$20240927$PER$$US-ROCHE-3526338$ROCHE$$$$A$M$Y$$$20240927$$CN$US$US
243700981$24370098$1$I$$20240314$20240927$20240927$PER$$US-ROCHE-3527397$ROCHE$$82$YR$E$F$Y$$$20240927$$MD$US$US
243700991$24370099$1$I$$20240311$20240927$20240927$PER$$US-ROCHE-3526099$ROCHE$$67$YR$E$F$Y$$$20240927$$MD$US$US
243701001$24370100$1$I$$20240327$20240927$20240927$PER$$US-ROCHE-3534853$ROCHE$$49$YR$A$M$Y$$$20240927$$MD$US$US
243701011$24370101$1$I$$20240326$20240927$20240927$PER$$US-ROCHE-3534164$ROCHE$$79$YR$E$F$Y$$$20240927$$MD$US$US
243701021$24370102$1$I$$20240430$20240927$20240927$PER$$US-ROCHE-3557190$ROCHE$$29$YR$A$M$Y$$$20240927$$MD$US$US
243701031$24370103$1$I$$20240318$20240927$20240927$PER$$US-ROCHE-3528903$ROCHE$$$$$$Y$$$20240927$$HP$US$US
243701041$24370104$1$I$$20240229$20240927$20240927$PER$$US-ROCHE-3528753$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243701051$24370105$1$I$$20240419$20240927$20240927$PER$$US-ROCHE-3550165$ROCHE$$93$YR$E$F$Y$$$20240927$$CN$US$US
243701061$24370106$1$I$$20240416$20240927$20240927$PER$$US-ROCHE-3547834$ROCHE$$68$YR$E$F$Y$$$20240927$$MD$US$US
243701071$24370107$1$I$$20240415$20240927$20240927$PER$$US-ROCHE-3531458$ROCHE$$$$E$F$Y$$$20240927$$CN$US$US
243701081$24370108$1$I$$20240426$20240927$20240927$PER$$US-ROCHE-3554790$ROCHE$$60$YR$A$F$Y$$$20240927$$MD$US$US
243701091$24370109$1$I$$20240315$20240927$20240927$PER$$US-ROCHE-3528493$ROCHE$$56$YR$A$F$Y$$$20240927$$MD$US$US
243701101$24370110$1$I$$20240326$20240927$20240927$PER$$US-ROCHE-3534182$ROCHE$$71$YR$E$M$Y$$$20240927$$CN$US$US
243701111$24370111$1$I$$20240425$20240927$20240927$PER$$US-ROCHE-3553573$ROCHE$$79$YR$E$M$Y$$$20240927$$MD$US$US
243701121$24370112$1$I$$20240501$20240927$20240927$PER$$US-ROCHE-3557433$ROCHE$$95$YR$E$F$Y$$$20240927$$MD$US$US
243701131$24370113$1$I$$20240417$20240927$20240927$PER$$US-ROCHE-3549692$ROCHE$$89$YR$E$F$Y$$$20240927$$MD$US$US
243701141$24370114$1$I$$20240507$20240927$20240927$PER$$US-ROCHE-3561287$ROCHE$$81$YR$E$F$Y$$$20240927$$MD$US$US
243701151$24370115$1$I$$20240318$20240927$20240927$PER$$US-ROCHE-3529269$ROCHE$$50$YR$A$M$Y$$$20240927$$MD$US$US
243701171$24370117$1$I$$20240416$20240927$20240927$PER$$US-ROCHE-3548583$ROCHE$$$$A$M$Y$88.9$KG$20240927$$CN$US$US
243701181$24370118$1$I$$20240404$20240927$20240927$PER$$US-ROCHE-3540292$ROCHE$$60$YR$A$F$Y$$$20240927$$MD$US$US
243701191$24370119$1$I$$20240402$20240927$20240927$PER$$US-ROCHE-3537704$ROCHE$$65$YR$E$M$Y$$$20240927$$MD$US$US
243701201$24370120$1$I$$20240724$20240927$20240927$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001948$BLUEPRINT MEDICINES$$$$$M$Y$$$20240927$$CN$US$US
243701211$24370121$1$I$20240910$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190699$AMGEN$$68$YR$E$M$Y$$$20240927$$CN$US$US
243701221$24370122$1$I$$20240411$20240927$20240927$PER$$US-ROCHE-3545308$ROCHE$$87$YR$E$M$Y$$$20240927$$MD$US$US
243701231$24370123$1$I$20240315$20240315$20240927$20240927$PER$$US-ROCHE-3529148$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243701241$24370124$1$I$$20240315$20240927$20240927$PER$$US-ROCHE-3528475$ROCHE$$59$YR$A$F$Y$$$20240927$$MD$US$US
243701251$24370125$1$I$20231228$20240318$20240927$20240927$PER$$US-ROCHE-3528862$ROCHE$$54$YR$A$M$Y$118.39$KG$20240927$$CN$US$US
243701261$24370126$1$I$$20240430$20240927$20240927$PER$$US-ROCHE-3555918$ROCHE$$70$YR$E$M$Y$92.53$KG$20240927$$CN$US$US
243701271$24370127$1$I$$20240325$20240927$20240927$PER$$US-ROCHE-3533439$ROCHE$$30$YR$A$M$Y$$$20240927$$MD$US$US
243701281$24370128$1$I$$20240226$20240927$20240927$PER$$US-ROCHE-3516444$ROCHE$$52$YR$A$F$Y$73.48$KG$20240927$$HP$US$US
243701291$24370129$1$I$$20240405$20240927$20240927$PER$$US-ROCHE-3542441$ROCHE$$72$YR$E$M$Y$$$20240927$$MD$US$US
243701301$24370130$1$I$$20240401$20240927$20240927$PER$$US-ROCHE-3537219$ROCHE$$36$YR$A$M$Y$$$20240927$$MD$US$US
243701311$24370131$1$I$$20240228$20240927$20240927$PER$$US-ROCHE-3519553$ROCHE$$$$A$M$Y$$$20240927$$MD$US$US
243701321$24370132$1$I$$20240402$20240927$20240927$PER$$US-ROCHE-3537948$ROCHE$$56$YR$A$M$Y$$$20240927$$MD$US$US
243701331$24370133$1$I$$20240503$20240927$20240927$PER$$US-ROCHE-3558536$ROCHE$$47$YR$A$F$Y$$$20240927$$MD$US$US
243701341$24370134$1$I$$20240502$20240927$20240927$PER$$US-ROCHE-3557808$ROCHE$$21$YR$A$F$Y$$$20240927$$MD$US$US
243701351$24370135$1$I$$20240229$20240927$20240927$PER$$US-ROCHE-3519449$ROCHE$$71$YR$E$F$Y$$$20240927$$CN$US$US
243701361$24370136$1$I$$20240906$20240927$20240927$30DAY$$BR-JNJFOC-20240937555$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$HP$BR$BR
243701381$24370138$1$I$$20240304$20240927$20240927$PER$$US-ROCHE-3521406$ROCHE$$56$YR$A$M$Y$$$20240927$$MD$US$US
243701391$24370139$1$I$20230301$20240314$20240927$20240927$PER$$US-ROCHE-3527020$ROCHE$$57$YR$A$F$Y$$$20240927$$CN$US$US
243701401$24370140$1$I$20231001$20240320$20240927$20240927$PER$$US-ROCHE-3530863$ROCHE$$88$YR$E$F$Y$64.41$KG$20240927$$CN$US$US
243701411$24370141$1$I$20240312$20240319$20240927$20240927$PER$$US-ROCHE-3529812$ROCHE$$84$YR$E$F$Y$$$20240927$$CN$US$US
243701421$24370142$1$I$20210101$20240301$20240927$20240927$PER$$US-ROCHE-3520190$ROCHE$$58$YR$A$M$Y$$$20240927$$CN$US$US
243701431$24370143$1$I$$20240321$20240927$20240927$PER$$US-ROCHE-3518199$ROCHE$$72$YR$E$M$Y$$$20240927$$MD$US$US
243701441$24370144$1$I$$20240301$20240927$20240927$PER$$US-ROCHE-3521283$ROCHE$$59$YR$A$F$Y$$$20240927$$MD$US$US
243701451$24370145$1$I$20240101$20240923$20240927$20240927$EXP$$US-ABBVIE-5936151$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243701461$24370146$1$I$$20240912$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09161$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243701471$24370147$1$I$20240801$20240923$20240927$20240927$EXP$$US-ABBVIE-5936892$ABBVIE$$87$YR$$F$Y$$$20240927$$CN$US$US
243701481$24370148$1$I$$20240412$20240927$20240927$PER$$US-ROCHE-3545953$ROCHE$$87$YR$E$F$Y$$$20240927$$CN$US$US
243701491$24370149$1$I$$20240430$20240927$20240927$PER$$US-ROCHE-3556385$ROCHE$$81$YR$E$F$Y$$$20240927$$CN$US$US
243701501$24370150$1$I$$20240424$20240927$20240927$PER$$US-ROCHE-3554130$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243701511$24370151$1$I$$20240402$20240927$20240927$PER$$US-ROCHE-3538030$ROCHE$$56$YR$A$M$Y$$$20240927$$MD$US$US
243701521$24370152$1$I$$20240925$20240927$20240927$EXP$$PL-GILEAD-2024-0688902$GILEAD$$$$$F$Y$$$20240927$$MD$PL$PL
243701531$24370153$1$I$20240423$20240425$20240927$20240927$PER$$US-ROCHE-3553504$ROCHE$$44$YR$A$F$Y$83.91$KG$20240927$$CN$US$US
243701541$24370154$1$I$$20240423$20240927$20240927$PER$$US-ROCHE-3552930$ROCHE$$73$YR$E$F$Y$$$20240927$$CN$US$US
243701551$24370155$1$I$$20240425$20240927$20240927$PER$$US-ROCHE-3553400$ROCHE$$53$YR$A$F$Y$$$20240927$$MD$US$US
243701561$24370156$1$I$20180901$20240424$20240927$20240927$PER$$US-ROCHE-3552982$ROCHE$$59$YR$A$F$Y$65.77$KG$20240927$$CN$US$US
243701571$24370157$1$I$20220719$20240423$20240927$20240927$PER$$US-ROCHE-3552031$ROCHE$$91$YR$E$F$Y$47.17$KG$20240927$$CN$US$US
243701581$24370158$1$I$20240112$20240409$20240927$20240927$PER$$US-ROCHE-3543263$ROCHE$$51$YR$A$F$Y$74.84$KG$20240927$$CN$US$US
243701591$24370159$1$I$20240301$20240429$20240927$20240927$PER$$US-ROCHE-3555675$ROCHE$$63$YR$A$M$Y$89.81$KG$20240927$$CN$US$US
243701601$24370160$1$I$$20240429$20240927$20240927$PER$$US-ROCHE-3537455$ROCHE$$78$YR$E$M$Y$$$20240927$$CN$US$US
243701611$24370161$1$I$20240401$20240426$20240927$20240927$PER$$US-ROCHE-3554631$ROCHE$$28$YR$A$M$Y$$$20240927$$CN$US$US
243701621$24370162$1$I$$20240412$20240927$20240927$PER$$US-ROCHE-3545668$ROCHE$$63$YR$A$M$Y$$$20240927$$CN$US$US
243701631$24370163$1$I$$20240326$20240927$20240927$PER$$US-ROCHE-3534997$ROCHE$$76$YR$E$F$Y$$$20240927$$MD$US$US
243701641$24370164$1$I$20240425$20240501$20240927$20240927$PER$$US-ROCHE-3555342$ROCHE$$88$YR$E$F$Y$$$20240927$$CN$US$US
243701651$24370165$1$I$$20240417$20240927$20240927$PER$$US-ROCHE-3548245$ROCHE$$80$YR$E$M$Y$$$20240927$$HP$US$US
243701681$24370168$1$I$$20240501$20240927$20240927$PER$$US-ROCHE-3556923$ROCHE$$$$$F$Y$$$20240927$$CN$US$US
243701691$24370169$1$I$$20240408$20240927$20240927$PER$$AU-ROCHE-3536682$ROCHE$$$$E$M$Y$$$20240927$$MD$AU$AU
243701701$24370170$1$I$$20240507$20240927$20240927$PER$$US-ROCHE-3560742$ROCHE$$59$YR$A$F$Y$$$20240927$$MD$US$US
243701711$24370171$1$I$$20240503$20240927$20240927$PER$$US-ROCHE-3560457$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243701721$24370172$1$I$$20240507$20240927$20240927$PER$$US-ROCHE-3560131$ROCHE$$49$YR$A$F$Y$$$20240927$$MD$US$US
243701731$24370173$1$I$$20240507$20240927$20240927$PER$$US-ROCHE-3560341$ROCHE$$52$YR$A$M$Y$$$20240927$$MD$US$US
243701741$24370174$1$I$$20240508$20240927$20240927$PER$$US-ROCHE-3560191$ROCHE$$59$YR$A$F$Y$$$20240927$$MD$US$US
243701751$24370175$1$I$$20240507$20240927$20240927$PER$$US-ROCHE-3516787$ROCHE$$$$$M$Y$$$20240927$$MD$US$US
243701761$24370176$1$I$$20240503$20240927$20240927$PER$$US-ROCHE-3559171$ROCHE$$57$YR$A$M$Y$$$20240927$$MD$US$US
243701774$24370177$4$F$$20240924$20240927$20240930$PER$$US-ROCHE-10000089964$ROCHE$Deshpande Y, Sabir S, Kaur L, Kaur R, Deshpande A. Choked by growth: a dramatic presentation of superior vena cava syndrome and respiratory failure caused by an anterior mediastinal mass. Chest. 2024-Oct;166 (4):A6087-8. doi:10.1016/j.chest.2024.06.3603.$25$YR$A$M$Y$$$20240929$$HP$US$US
243701781$24370178$1$I$$20240502$20240927$20240927$PER$$US-ROCHE-3558328$ROCHE$$65$YR$E$M$Y$$$20240927$$HP$US$US
243701791$24370179$1$I$$20240506$20240927$20240927$PER$$US-ROCHE-3560182$ROCHE$$57$YR$A$$Y$$$20240927$$MD$US$US
243701801$24370180$1$I$$20240502$20240927$20240927$PER$$US-ROCHE-3557980$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243701811$24370181$1$I$$20240505$20240927$20240927$PER$$DE-ROCHE-3540591$ROCHE$$$$$$Y$$$20240927$$CN$DE$DE
243701821$24370182$1$I$$20240506$20240927$20240927$PER$$US-ROCHE-3555288$ROCHE$$61$YR$A$M$Y$$$20240927$$CN$US$US
243701831$24370183$1$I$$20240508$20240927$20240927$PER$$US-ROCHE-3560917$ROCHE$$71$YR$E$M$Y$$$20240927$$MD$US$US
243701841$24370184$1$I$$20240508$20240927$20240927$PER$$US-ROCHE-3561624$ROCHE$$56$YR$A$M$Y$$$20240927$$HP$US$US
243701851$24370185$1$I$$20240507$20240927$20240927$PER$$US-ROCHE-3558789$ROCHE$$27$YR$A$F$Y$$$20240927$$HP$US$US
243701861$24370186$1$I$$20240508$20240927$20240927$PER$$US-ROCHE-3561145$ROCHE$$75$YR$E$M$Y$$$20240927$$MD$US$US
243701871$24370187$1$I$$20240508$20240927$20240927$PER$$US-ROCHE-3560832$ROCHE$$65$YR$E$F$Y$$$20240927$$CN$US$US
243701881$24370188$1$I$$20240508$20240927$20240927$PER$$US-ROCHE-3516728$ROCHE$$63$YR$A$M$Y$$$20240927$$HP$US$US
243701891$24370189$1$I$$20240509$20240927$20240927$PER$$US-ROCHE-3562244$ROCHE$$61$YR$A$F$Y$45.36$KG$20240927$$CN$US$US
243701901$24370190$1$I$$20240509$20240927$20240927$PER$$US-ROCHE-3562090$ROCHE$$60$YR$A$M$Y$$$20240927$$MD$US$US
243701911$24370191$1$I$$20240509$20240927$20240927$PER$$US-ROCHE-3562155$ROCHE$$64$YR$A$F$Y$$$20240927$$MD$US$US
243701921$24370192$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151434$BRISTOL MYERS SQUIBB$Sabir S, Deshpande Y, Jeyapaulraj J, Djekidel K. Spontaneous retropharyngeal hematoma with the use of apixaban. Chest. 2024;166(4S):2931A-2A. doi:10.1016/j.chest.2024.06.1767.$87$YR$E$M$Y$$$20240927$$HP$US$US
243701931$24370193$1$I$$20240509$20240927$20240927$PER$$US-ROCHE-3562175$ROCHE$$55$YR$A$M$Y$$$20240927$$MD$US$US
243701941$24370194$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152649$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240927$$HP$US$US
243701951$24370195$1$I$$20240515$20240927$20240927$PER$$US-ROCHE-3564943$ROCHE$$42$YR$A$F$Y$$$20240927$$MD$US$US
243701961$24370196$1$I$$20240513$20240927$20240927$PER$$US-ROCHE-3563658$ROCHE$$55$YR$A$M$Y$$$20240927$$MD$US$US
243701971$24370197$1$I$$20240513$20240927$20240927$PER$$US-ROCHE-3563687$ROCHE$$67$YR$E$F$Y$$$20240927$$MD$US$US
243701981$24370198$1$I$$20240923$20240927$20240927$PER$$US-ROCHE-10000088790$ROCHE$Nedunchezhian S, Alam M, Lefebvre D, Milojevic I. A case of primary pulmonary pulmonary nocardiosis in a patient with diffuse large b-cell lymphoma (dlbcl). Chest. 2024-Oct;166 (4):A1362-3. doi:10.1016/j.chest.2024.06.875.$66$YR$E$F$Y$$$20240927$$HP$US$US
243701991$24370199$1$I$$20240515$20240927$20240927$PER$$US-ROCHE-3564506$ROCHE$$82$YR$E$F$Y$$$20240927$$MD$US$US
243702001$24370200$1$I$$20240513$20240927$20240927$PER$$US-ROCHE-3563386$ROCHE$$52$YR$A$F$Y$$$20240927$$CN$US$US
243702011$24370201$1$I$$20240514$20240927$20240927$PER$$US-ROCHE-3565166$ROCHE$$56$YR$A$F$Y$$$20240927$$HP$US$US
243702021$24370202$1$I$20240101$20240514$20240927$20240927$PER$$US-ROCHE-3564441$ROCHE$$64$YR$A$F$Y$72.57$KG$20240927$$CN$US$US
243702031$24370203$1$I$$20240515$20240927$20240927$PER$$US-ROCHE-3564640$ROCHE$$60$YR$A$F$Y$$$20240927$$MD$US$US
243702041$24370204$1$I$$20240515$20240927$20240927$PER$$US-ROCHE-3565222$ROCHE$$63$YR$A$F$Y$$$20240927$$CN$US$US
243702051$24370205$1$I$$20240513$20240927$20240927$PER$$US-ROCHE-3563668$ROCHE$$38$YR$A$F$Y$$$20240927$$MD$US$US
243702061$24370206$1$I$$20240925$20240927$20240927$PER$$US-ROCHE-10000091434$ROCHE$$$$$F$Y$$$20240927$$MD$US$US
243702071$24370207$1$I$$20240515$20240927$20240927$PER$$US-ROCHE-3561020$ROCHE$$56$YR$A$M$Y$$$20240927$$MD$US$US
243702081$24370208$1$I$20221117$20240514$20240927$20240927$PER$$US-ROCHE-3564587$ROCHE$$43$YR$A$M$Y$$$20240927$$MD$US$US
243702091$24370209$1$I$$20240514$20240927$20240927$PER$$US-ROCHE-3543097$ROCHE$$48$YR$A$M$Y$$$20240927$$HP$US$US
243702102$24370210$2$F$$20240924$20240927$20240930$PER$$US-BIOGEN-2024BI01283945$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243702111$24370211$1$I$$20240924$20240927$20240927$PER$$US-BIOGEN-2024BI01280697$BIOGEN$$$$$F$Y$$$20240927$$CN$US$US
243702121$24370212$1$I$$20240517$20240927$20240927$PER$$US-ROCHE-3566628$ROCHE$$90$YR$E$F$Y$$$20240927$$MD$US$US
243702131$24370213$1$I$$20240515$20240927$20240927$PER$$US-ROCHE-3565421$ROCHE$$69$YR$E$M$Y$$$20240927$$MD$US$US
243702141$24370214$1$I$$20240516$20240927$20240927$PER$$US-ROCHE-3565363$ROCHE$$59$YR$A$F$Y$$$20240927$$CN$US$US
243702151$24370215$1$I$20240101$20240516$20240927$20240927$PER$$US-ROCHE-3565800$ROCHE$$75$YR$E$F$Y$$$20240927$$CN$US$US
243702161$24370216$1$I$$20240925$20240927$20240927$PER$$US-ROCHE-10000091801$ROCHE$$$$A$F$Y$$$20240927$$CN$US$US
243702171$24370217$1$I$$20240515$20240927$20240927$PER$$US-ROCHE-3565379$ROCHE$$$$$$Y$$$20240927$$HP$US$US
243702181$24370218$1$I$$20240516$20240927$20240927$PER$$US-ROCHE-3566409$ROCHE$$66$YR$E$M$Y$$$20240927$$MD$US$US
243702191$24370219$1$I$$20240517$20240927$20240927$PER$$US-ROCHE-3566749$ROCHE$$41$YR$A$M$Y$$$20240927$$MD$US$US
243702201$24370220$1$I$$20240514$20240927$20240927$PER$$US-ROCHE-3564401$ROCHE$$59$YR$A$F$Y$$$20240927$$CN$US$US
243702211$24370221$1$I$$20240515$20240927$20240927$PER$$US-ROCHE-3565336$ROCHE$$56$YR$A$M$Y$$$20240927$$MD$US$US
243702221$24370222$1$I$$20240515$20240927$20240927$PER$$US-ROCHE-3565380$ROCHE$$75$YR$E$M$Y$$$20240927$$MD$US$US
243702231$24370223$1$I$$20240510$20240927$20240927$PER$$US-ROCHE-3562698$ROCHE$$79$YR$E$F$Y$$$20240927$$CN$US$US
243702241$24370224$1$I$20230605$20240520$20240927$20240927$PER$$US-ROCHE-3566631$ROCHE$$57$YR$A$F$Y$$$20240927$$MD$US$US
243702251$24370225$1$I$$20240515$20240927$20240927$PER$$US-ROCHE-3565409$ROCHE$$41$YR$A$F$Y$$$20240927$$MD$US$US
243702261$24370226$1$I$20240101$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024192145$AMGEN$$60$YR$A$F$Y$$$20240927$$CN$US$US
243702271$24370227$1$I$$20240521$20240927$20240927$PER$$US-ROCHE-3568347$ROCHE$$76$YR$E$F$Y$$$20240927$$MD$US$US
243702281$24370228$1$I$20240522$20240522$20240927$20240927$PER$$US-ROCHE-3568853$ROCHE$$84$YR$E$M$Y$$$20240927$$CN$US$US
243702291$24370229$1$I$$20240517$20240927$20240927$PER$$US-ROCHE-3567688$ROCHE$$$$A$M$Y$$$20240927$$HP$US$US
243702301$24370230$1$I$$20240522$20240927$20240927$PER$$US-ROCHE-3569353$ROCHE$$48$YR$A$F$Y$$$20240927$$MD$US$US
243702311$24370231$1$I$$20240521$20240927$20240927$PER$$US-ROCHE-3568590$ROCHE$$91$YR$E$M$Y$$$20240927$$MD$US$US
243702321$24370232$1$I$$20240522$20240927$20240927$PER$$US-ROCHE-3569031$ROCHE$$63$YR$A$F$Y$$$20240927$$MD$US$US
243702331$24370233$1$I$$20240517$20240927$20240927$PER$$US-ROCHE-3567398$ROCHE$$61$YR$A$F$Y$$$20240927$$MD$US$US
243702341$24370234$1$I$$20240520$20240927$20240927$PER$$US-ROCHE-3567698$ROCHE$$91$YR$E$M$Y$$$20240927$$MD$US$US
243702351$24370235$1$I$$20240521$20240927$20240927$PER$$US-ROCHE-3568397$ROCHE$$57$YR$A$F$Y$$$20240927$$MD$US$US
243702361$24370236$1$I$$20240520$20240927$20240927$PER$$US-ROCHE-3538070$ROCHE$$70$YR$E$M$Y$$$20240927$$HP$US$US
243702371$24370237$1$I$$20240522$20240927$20240927$PER$$US-ROCHE-3569003$ROCHE$$57$YR$A$F$Y$$$20240927$$MD$US$US
243702381$24370238$1$I$$20240521$20240927$20240927$PER$$US-ROCHE-3530009$ROCHE$$67$YR$E$F$Y$$$20240927$$MD$US$US
243702391$24370239$1$I$$20240521$20240927$20240927$PER$$US-ROCHE-3568523$ROCHE$$66$YR$E$F$Y$$$20240927$$MD$US$US
243702401$24370240$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5936941$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243702411$24370241$1$I$$20240523$20240927$20240927$PER$$US-ROCHE-3569384$ROCHE$$56$YR$A$F$Y$$$20240927$$MD$US$US
243702421$24370242$1$I$$20240923$20240927$20240927$EXP$$US-AMGEN-USASP2024190529$AMGEN$Chena E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$$$$$Y$$$20240927$$HP$US$US
243702431$24370243$1$I$$20240523$20240927$20240927$PER$$US-ROCHE-3570217$ROCHE$$44$YR$A$F$Y$$$20240927$$MD$US$US
243702451$24370245$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571147$ROCHE$$$$$F$Y$81.65$KG$20240927$$HP$US$US
243702461$24370246$1$I$$20240522$20240927$20240927$PER$$US-ROCHE-3569769$ROCHE$$73$YR$E$M$Y$$$20240927$$CN$US$US
243702471$24370247$1$I$$20240523$20240927$20240927$PER$$US-ROCHE-3570054$ROCHE$$64$YR$A$$Y$$$20240927$$MD$US$US
243702481$24370248$1$I$$20240523$20240927$20240927$PER$$US-ROCHE-3570032$ROCHE$$17$YR$T$F$Y$$$20240927$$MD$US$US
243702491$24370249$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571129$ROCHE$$60$YR$A$F$Y$$$20240927$$MD$US$US
243702501$24370250$1$I$$20240517$20240927$20240927$PER$$US-ROCHE-3569471$ROCHE$$$$$$Y$$$20240927$$MD$US$US
243702511$24370251$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3562803$ROCHE$$50$YR$A$M$Y$$$20240927$$MD$US$US
243702521$24370252$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571096$ROCHE$$62$YR$A$M$Y$$$20240927$$MD$US$US
243702531$24370253$1$I$$20240522$20240927$20240927$PER$$US-ROCHE-3570714$ROCHE$$52$YR$A$M$Y$$$20240927$$HP$US$US
243702541$24370254$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571033$ROCHE$$60$YR$A$M$Y$$$20240927$$MD$US$US
243702551$24370255$1$I$$20240523$20240927$20240927$PER$$US-ROCHE-3570192$ROCHE$$83$YR$E$F$Y$$$20240927$$MD$US$US
243702561$24370256$1$I$$20240523$20240927$20240927$PER$$US-ROCHE-3569838$ROCHE$$59$YR$A$F$Y$$$20240927$$MD$US$US
243702571$24370257$1$I$$20240523$20240927$20240927$PER$$US-ROCHE-3570077$ROCHE$$57$YR$A$F$Y$$$20240927$$MD$US$US
243702581$24370258$1$I$$20240523$20240927$20240927$PER$$US-ROCHE-3570034$ROCHE$$84$YR$E$F$Y$$$20240927$$MD$US$US
243702591$24370259$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571115$ROCHE$$45$YR$A$M$Y$$$20240927$$MD$US$US
243702601$24370260$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571508$ROCHE$$49$YR$A$M$Y$$$20240927$$MD$US$US
243702611$24370261$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571204$ROCHE$$63$YR$A$M$Y$$$20240927$$MD$US$US
243702621$24370262$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571299$ROCHE$$60$YR$A$F$Y$$$20240927$$MD$US$US
243702631$24370263$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571435$ROCHE$$63$YR$A$M$Y$$$20240927$$MD$US$US
243702641$24370264$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571266$ROCHE$$55$YR$A$M$Y$$$20240927$$MD$US$US
243702651$24370265$1$I$$20240528$20240927$20240927$PER$$US-ROCHE-3572807$ROCHE$$57$YR$A$F$Y$$$20240927$$MD$US$US
243702661$24370266$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571268$ROCHE$$40$YR$A$F$Y$$$20240927$$MD$US$US
243702671$24370267$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571171$ROCHE$$88$YR$E$F$Y$$$20240927$$MD$US$US
243702681$24370268$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571308$ROCHE$$26$YR$A$F$Y$$$20240927$$MD$US$US
243702691$24370269$1$I$$20240523$20240927$20240927$PER$$US-ROCHE-3568567$ROCHE$$53$YR$A$F$Y$$$20240927$$MD$US$US
243702701$24370270$1$I$$20240524$20240927$20240927$PER$$US-ROCHE-3571320$ROCHE$$46$YR$A$F$Y$$$20240927$$MD$US$US
243702711$24370271$1$I$$20240528$20240927$20240927$PER$$US-ROCHE-3572359$ROCHE$$58$YR$A$M$Y$$$20240927$$MD$US$US
243702721$24370272$1$I$$20240529$20240927$20240927$PER$$US-ROCHE-3573122$ROCHE$$$$$F$Y$$$20240927$$CN$US$US
243702731$24370273$1$I$$20240528$20240927$20240927$PER$$US-ROCHE-3566572$ROCHE$$62$YR$A$F$Y$$$20240927$$HP$US$US
243702751$24370275$1$I$$20240530$20240927$20240927$PER$$US-ROCHE-3574041$ROCHE$$84$YR$E$F$Y$$$20240927$$MD$US$US
243702761$24370276$1$I$$20240531$20240927$20240927$PER$$US-ROCHE-3575227$ROCHE$$78$YR$E$M$Y$$$20240927$$MD$US$US
243702771$24370277$1$I$$20240529$20240927$20240927$PER$$US-ROCHE-3573659$ROCHE$$56$YR$A$F$Y$$$20240927$$MD$US$US
243702781$24370278$1$I$$20240531$20240927$20240927$PER$$US-ROCHE-3573976$ROCHE$$61$YR$A$F$Y$$$20240927$$MD$US$US
243702791$24370279$1$I$$20240603$20240927$20240927$PER$$US-ROCHE-3575564$ROCHE$$69$YR$E$F$Y$$$20240927$$MD$US$US
243702801$24370280$1$I$$20240531$20240927$20240927$PER$$US-ROCHE-3575665$ROCHE$$65$YR$E$M$Y$$$20240927$$MD$US$US
243702811$24370281$1$I$$20240530$20240927$20240927$PER$$US-ROCHE-3573998$ROCHE$$61$YR$A$M$Y$$$20240927$$MD$US$US
243702821$24370282$1$I$20240118$20240603$20240927$20240927$PER$$US-ROCHE-3576341$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243702831$24370283$1$I$$20240603$20240927$20240927$PER$$US-ROCHE-3575996$ROCHE$$28$YR$A$F$Y$$$20240927$$MD$US$US
243702841$24370284$1$I$20240531$20240603$20240927$20240927$PER$$US-ROCHE-3576269$ROCHE$$$$$$Y$$$20240927$$MD$US$US
243702851$24370285$1$I$20230101$20240603$20240927$20240927$PER$$US-ROCHE-3567279$ROCHE$$82$YR$E$F$Y$$$20240927$$CN$US$US
243702861$24370286$1$I$20230401$20240924$20240927$20240927$PER$$US-BIOGEN-2023BI01242153$BIOGEN$$59$YR$$F$Y$$$20240927$$CN$US$US
243702871$24370287$1$I$20240923$20240924$20240927$20240927$PER$$US-BIOGEN-2018BI00572948$BIOGEN$$47$YR$$F$Y$$$20240927$$CN$US$US
243702881$24370288$1$I$20230101$20240529$20240927$20240927$PER$$US-ROCHE-3573359$ROCHE$$74$YR$E$F$Y$57.61$KG$20240927$$CN$US$US
243702891$24370289$1$I$$20240531$20240927$20240927$PER$$US-ROCHE-3576503$ROCHE$$31$YR$A$M$Y$$$20240927$$MD$US$US
243702901$24370290$1$I$$20240529$20240927$20240927$PER$$US-ROCHE-3573492$ROCHE$$58$YR$A$M$Y$$$20240927$$MD$US$US
243702911$24370291$1$I$20230101$20240925$20240927$20240927$PER$$US-BIOGEN-2024BI01283646$BIOGEN$$$$$M$Y$$$20240927$$CN$US$US
243702921$24370292$1$I$$20240923$20240927$20240927$PER$$US-ROCHE-10000089783$ROCHE$$$$A$F$Y$$$20240927$$PH$US$US
243702931$24370293$1$I$$20231024$20240927$20240927$PER$$US-ROCHE-3578176$ROCHE$$22$YR$A$M$Y$$$20240927$$MD$US$US
243702941$24370294$1$I$$20240604$20240927$20240927$PER$$US-ROCHE-3577003$ROCHE$$52$YR$A$F$Y$$$20240927$$MD$US$US
243702951$24370295$1$I$$20240605$20240927$20240927$PER$$US-ROCHE-3577713$ROCHE$$69$YR$E$$Y$$$20240927$$MD$US$US
243702961$24370296$1$I$$20240605$20240927$20240927$PER$$US-ROCHE-3574907$ROCHE$$38$YR$A$M$Y$$$20240927$$MD$US$US
243702971$24370297$1$I$$20240531$20240927$20240927$PER$$JO-ROCHE-3578411$ROCHE$Fawwaz A. The Use of Intravitreal Steroid Implant for Treatment of Refractory Cystoid Macular Edema Secondary to Retinitis Pigmentosa. OPHTHALMIC-RES 2015;54:30-1.$24$YR$A$M$Y$$$20240927$$HP$JO$JO
243702981$24370298$1$I$$20240604$20240927$20240927$PER$$US-ROCHE-3576991$ROCHE$$66$YR$E$M$Y$$$20240927$$MD$US$US
243703001$24370300$1$I$$20240926$20240927$20240927$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053770$BOEHRINGER INGELHEIM$$$$$$Y$$$20240927$$MD$US$US
243703011$24370301$1$I$$20240604$20240927$20240927$PER$$US-ROCHE-3577252$ROCHE$$62$YR$A$F$Y$$$20240927$$MD$US$US
243703021$24370302$1$I$$20240605$20240927$20240927$PER$$US-ROCHE-3578246$ROCHE$$40$YR$A$M$Y$$$20240927$$MD$US$US
243703031$24370303$1$I$$20240605$20240927$20240927$PER$$US-ROCHE-3558337$ROCHE$$57$YR$A$M$Y$$$20240927$$HP$US$US
243703041$24370304$1$I$$20240605$20240927$20240927$PER$$US-ROCHE-3578187$ROCHE$$64$YR$A$F$Y$$$20240927$$MD$US$US
243703051$24370305$1$I$20240916$20240918$20240927$20240927$PER$$US-ABBVIE-5930940$ABBVIE$$41$YR$$F$Y$$$20240927$$CN$US$US
243703061$24370306$1$I$$20240531$20240927$20240927$PER$$US-ROCHE-3559045$ROCHE$$64$YR$A$M$Y$$$20240927$$HP$US$US
243703071$24370307$1$I$$20240604$20240927$20240927$PER$$US-ROCHE-3561449$ROCHE$$43$YR$A$M$Y$$$20240927$$MD$US$US
243703081$24370308$1$I$$20240923$20240927$20240927$EXP$$IT-GILEAD-2024-0688456$GILEAD$$$$$F$Y$$$20240927$$MD$IT$IT
243703091$24370309$1$I$$20240606$20240927$20240927$PER$$US-ROCHE-3578943$ROCHE$$39$YR$A$F$Y$$$20240927$$MD$US$US
243703101$24370310$1$I$$20240606$20240927$20240927$PER$$US-ROCHE-3565272$ROCHE$$50$YR$A$M$Y$$$20240927$$MD$US$US
243703111$24370311$1$I$$20240605$20240927$20240927$PER$$US-ROCHE-3578784$ROCHE$$65$YR$E$M$Y$$$20240927$$HP$US$US
243703121$24370312$1$I$$20240606$20240927$20240927$PER$$US-ROCHE-3579625$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243703131$24370313$1$I$$20240606$20240927$20240927$PER$$US-ROCHE-3578974$ROCHE$$59$YR$A$M$Y$$$20240927$$MD$US$US
243703141$24370314$1$I$$20240606$20240927$20240927$PER$$US-ROCHE-3578834$ROCHE$$74$YR$E$M$Y$$$20240927$$MD$US$US
243703161$24370316$1$I$20240911$20240920$20240927$20240927$EXP$$CN-SA-2024SA277016$SANOFI AVENTIS$$57$YR$A$M$Y$68$KG$20240927$$HP$CN$CN
243703171$24370317$1$I$$20240923$20240927$20240927$EXP$$US-AMGEN-USASP2024190545$AMGEN$Chena E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$$$$$Y$$$20240927$$HP$US$US
243703181$24370318$1$I$$20240919$20240927$20240927$EXP$$MA-EMD Serono-2024050541$EMD SERONO INC$$35$YR$A$F$Y$$$20240927$$MD$MA$MA
243703191$24370319$1$I$20240911$20240917$20240927$20240927$PER$$US-GSK-US2024115657$GLAXOSMITHKLINE$$38$YR$$F$Y$$$20240927$$CN$US$US
243703201$24370320$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152142$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240927$$HP$US$US
243703211$24370321$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152066$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$63$KG$20240927$$PH$US$US
243703221$24370322$1$I$$20240924$20240927$20240927$EXP$$IT-GSK-IT2024EME118043$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$IT$IT
243703231$24370323$1$I$$20240923$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008619$ASTELLAS$$86$YR$E$F$Y$$$20240927$$CN$US$US
243703241$24370324$1$I$$20240916$20240927$20240927$EXP$$US-INSMED, INC.-2024-03751-US$INSMED$$$$$$Y$$$20240927$$CN$US$US
243703251$24370325$1$I$20240624$20240913$20240927$20240927$EXP$$FR-CIPLA LTD.-2024FR10448$CIPLA$$$$$$Y$$$20240927$$MD$FR$FR
243703261$24370326$1$I$$20240923$20240927$20240927$PER$$US-HALEON-2198664$Haleon PLC$$6$YR$$M$Y$$$20240927$$CN$US$US
243703271$24370327$1$I$20240724$20240923$20240927$20240927$EXP$HR-HALMED-300086549$HR-TEVA-VS-3247014$TEVA$$$$A$F$Y$$$20240927$$MD$HR$HR
243703291$24370329$1$I$20240910$20240919$20240927$20240927$EXP$$IN-ROCHE-10000086911$ROCHE$$42$YR$A$M$Y$$$20240927$$CN$IN$IN
243703301$24370330$1$I$$20240923$20240927$20240927$EXP$$US-AMGEN-USASP2024190547$AMGEN$Chena E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$$$$$Y$$$20240927$$HP$US$US
243703311$24370331$1$I$$20240923$20240927$20240927$EXP$$US-AMGEN-USASP2024190546$AMGEN$Chen E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$$$$$Y$$$20240927$$HP$US$US
243703321$24370332$1$I$20240609$20240923$20240927$20240927$EXP$IT-MINISAL02-1002659$IT-TEVA-VS-3246761$TEVA$$74$YR$$M$Y$84$KG$20240927$$MD$IT$IT
243703331$24370333$1$I$20240828$20240913$20240927$20240927$EXP$$IT-CIPLA LTD.-2024IT10398$CIPLA$$$$$$Y$$$20240927$$PH$IT$IT
243703341$24370334$1$I$$20240922$20240927$20240927$PER$$US-HALEON-2198301$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243703351$24370335$1$I$$20240923$20240927$20240927$EXP$$CA-ORGANON-O2409CAN001742$ORGANON$$$$$F$Y$$$20240927$$MD$CA$CA
243703361$24370336$1$I$20240802$20240918$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-046904$AUROBINDO$$89$YR$$F$Y$$$20240927$$MD$ES$ES
243703371$24370337$1$I$20240801$20240913$20240927$20240927$EXP$$FR-CIPLA LTD.-2024FR10449$CIPLA$$$$$$Y$$$20240927$$MD$FR$FR
243703381$24370338$1$I$20240326$20240917$20240927$20240927$EXP$GR-GREOF-202400277$GR-CELLTRION INC.-2024GR022895$CELLTRION$$$$$$Y$$$20240927$$MD$GR$GR
243703391$24370339$1$I$$20240917$20240927$20240927$PER$$US-BIOGEN-2024BI01283610$BIOGEN$$$$$F$Y$$$20240927$$MD$US$US
243703401$24370340$1$I$20200101$20240920$20240927$20240927$EXP$$KR-BIOGEN-2020BI00840515$BIOGEN$$50$YR$$F$Y$53$KG$20240927$$CN$KR$KR
243703411$24370341$1$I$20240301$20240918$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-046905$AUROBINDO$$42$YR$$F$Y$$$20240927$$MD$ES$ES
243703421$24370342$1$I$20180701$20240913$20240927$20240927$EXP$$GB-CIPLA LTD.-2024GB10460$CIPLA$$$$$$Y$$$20240927$$CN$GB$GB
243703431$24370343$1$I$$20240918$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013816$DR REDDYS$$32$YR$A$M$Y$$$20240927$$HP$US$US
243703441$24370344$1$I$20230926$20240918$20240927$20240927$PER$$US-RDY-SPO/USA/23/0179089$DR REDDYS$$27$YR$A$M$Y$$$20240927$$MD$US$US
243703451$24370345$1$I$$20240918$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013826$DR REDDYS$$29$YR$A$M$Y$$$20240927$$MD$US$US
243703461$24370346$1$I$20231016$20240918$20240927$20240927$PER$$US-RDY-SPO/USA/23/0180719$DR REDDYS$$36$YR$A$F$Y$$$20240927$$HP$US$US
243703471$24370347$1$I$20220521$20240917$20240927$20240927$PER$$US-RDY-OTH/USA/23/0181813$DR REDDYS$$62$YR$A$M$Y$$$20240927$$MD$US$US
243703481$24370348$1$I$$20240918$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013832$DR REDDYS$$42$YR$A$M$Y$$$20240927$$MD$US$US
243703491$24370349$1$I$$20240918$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013830$DR REDDYS$$35$YR$A$M$Y$$$20240927$$MD$US$US
243703501$24370350$1$I$20240815$20240923$20240927$20240927$EXP$CZ-CZSUKL-24002600$CZ-SERVIER-S24012139$SERVIER$$$$$$Y$$$20240927$$PH$CZ$CZ
243703511$24370351$1$I$$20240915$20240927$20240927$EXP$$DE-Accord-448385$ACCORD$Dannenberg F, Von Moers A, Bittigau P, Lange J, Wiegand S, Torok F et al. A Novel De Novo Gain-of-Function CACNA1D Variant in Neurodevelopmental Disease With Congenital Tremor, Seizures, and Hypotonia. Neurol Genet. 2024 Sep 6;10(5):e200186.$$$$M$Y$$$20240927$$HP$DE$DE
243703521$24370352$1$I$$20231108$20240927$20240927$PER$$US-ENDO PHARMACEUTICALS INC-2023-005249$ENDO$$$$$M$Y$$$20240927$$CN$US$US
243703531$24370353$1$I$20240917$20240918$20240927$20240927$PER$$US-EMD Serono-2024050120$EMD SERONO INC$$58$YR$A$F$Y$$$20240927$$HP$US$US
243703541$24370354$1$I$$20240918$20240927$20240927$EXP$$PL-AUROBINDO-AUR-APL-2024-047344$AUROBINDO$$64$YR$$F$Y$$$20240927$$MD$PL$PL
243703551$24370355$1$I$20240919$20240919$20240927$20240927$PER$$US-JNJFOC-20240952901$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20240927$$CN$US$US
243703561$24370356$1$I$20240909$20240918$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046357$AUROBINDO$$28$YR$$F$Y$$$20240927$$CN$GB$GB
243703571$24370357$1$I$$20240918$20240927$20240927$PER$$US-TAKEDA-2024TUS093264$TAKEDA$$$$$$Y$$$20240927$$CN$US$US
243703581$24370358$1$I$20240915$20240916$20240927$20240927$PER$$US-JNJFOC-20240940615$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$US$US
243703591$24370359$1$I$20240603$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-046966$AUROBINDO$$32$YR$$M$Y$$$20240927$$MD$FR$FR
243703611$24370361$1$I$20240601$20240923$20240927$20240927$EXP$$PL-AMGEN-POLSP2024189535$AMGEN$$69$YR$E$F$Y$$$20240927$$MD$PL$PL
243703621$24370362$1$I$20240729$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-047031$AUROBINDO$$79$YR$$M$Y$106$KG$20240927$$PH$FR$FR
243703641$24370364$1$I$20240917$20240920$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008308$ASTELLAS$$70$YR$E$F$Y$$$20240927$$MD$US$US
243703651$24370365$1$I$20240921$20240923$20240927$20240927$EXP$$US-ABBVIE-5937379$ABBVIE$$71$YR$$M$Y$$$20240927$$CN$US$US
243703661$24370366$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011365$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240927$$HP$CA$CA
243703671$24370367$1$I$20220829$20240918$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-046909$AUROBINDO$$60$YR$$F$Y$$$20240927$$PH$ES$ES
243703681$24370368$1$I$20231008$20240918$20240927$20240927$EXP$$IE-AUROBINDO-AUR-APL-2024-047061$AUROBINDO$$91$YR$$F$Y$$$20240927$$LW$IE$IE
243703691$24370369$1$I$$20240920$20240927$20240927$EXP$$SK-ROCHE-10000087784$ROCHE$$$$$F$Y$$$20240927$$MD$SK$SK
243703701$24370370$1$I$$20240918$20240927$20240927$EXP$$PL-AUROBINDO-AUR-APL-2024-047082$AUROBINDO$$34$YR$$M$Y$$$20240927$$MD$PL$PL
243703722$24370372$2$F$20240921$20240923$20240927$20240930$EXP$$CA-ABBVIE-5938852$ABBVIE$$67$YR$$M$Y$$$20240930$$CN$CA$CA
243703731$24370373$1$I$$20240912$20240927$20240927$EXP$$US-SMPA-2024SPA002701$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243703741$24370374$1$I$20240305$20240918$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-046896$AUROBINDO$$75$YR$$M$Y$$$20240927$$MD$ES$ES
243703751$24370375$1$I$20240812$20240923$20240927$20240927$EXP$$CN-SA-2024SA277026$SANOFI AVENTIS$$52$YR$A$F$Y$70.1$KG$20240927$$HP$CN$CN
243703771$24370377$1$I$$20240920$20240927$20240927$PER$$US-AMGEN-USASP2024189310$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243703781$24370378$1$I$$20240923$20240927$20240927$EXP$$GB-AMGEN-GBRSP2024189246$AMGEN$$$$$$Y$$$20240927$$MD$GB$GB
243703801$24370380$1$I$20240914$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-047152$AUROBINDO$$24$YR$$F$Y$48$KG$20240927$$MD$FR$FR
243703811$24370381$1$I$20231101$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-046938$AUROBINDO$$78$YR$$F$Y$56$KG$20240927$$MD$FR$FR
243703821$24370382$1$I$$20240923$20240927$20240927$EXP$$ZA-HALEON-2198509$Haleon PLC$$$$$$Y$$$20240927$$CN$ZA$ZA
243703831$24370383$1$I$20240101$20240924$20240927$20240927$EXP$$US-SA-2024SA277677$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240927$$HP$US$US
243703861$24370386$1$I$20220201$20240918$20240927$20240927$EXP$FR-AFSSAPS-RS20221495$FR-CELLTRION INC.-2024FR022791$CELLTRION$$$$$$Y$$$20240927$$MD$FR$FR
243703871$24370387$1$I$20240813$20240917$20240927$20240927$EXP$$GB-BIOCON BIOLOGICS LIMITED-BBL2024006936$BIOCON$$$$$$Y$$$20240927$$CN$GB$GB
243703881$24370388$1$I$$20240918$20240927$20240927$PER$$US-TAKEDA-2024TUS093352$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
243703891$24370389$1$I$$20240917$20240927$20240927$EXP$$FR-JNJFOC-20240952076$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20240927$$MD$FR$FR
243703901$24370390$1$I$$20240918$20240927$20240927$EXP$$PL-AUROBINDO-AUR-APL-2024-047063$AUROBINDO$$27$YR$$F$Y$63$KG$20240927$$MD$PL$PL
243703911$24370391$1$I$$20240924$20240927$20240927$EXP$$CA-JNJFOC-20240966736$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$HP$CA$CA
243703921$24370392$1$I$20240701$20240912$20240927$20240927$EXP$$US-SMPA-2024SPA002709$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243703931$24370393$1$I$$20240920$20240927$20240927$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08842$HIKMA$Huang Y, Loo NM, Chang AY, Yu Z, McKenna AL, Ritchie C, Metcalfe AM, Nakhleh RE, Krishna M, Taner CB, Yang L. Huang Y, Loo NM, Chang AY, Yu Z, McKenna AL, Ritchie C, et al. Hepatic Adenomatosis in a Transgender Man on Gender-Affirming Testosterone Therapy.. ACG Case Rep J. 2024;11(9):e01483$22$YR$$F$Y$$$20240927$$MD$US$US
243703941$24370394$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151522$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240927$$HP$US$US
243703951$24370395$1$I$20240925$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016561$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243703961$24370396$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016440$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243703971$24370397$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016451$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243703991$24370399$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015172$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240927$$CN$US$US
243704001$24370400$1$I$$20240911$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409007292$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240927$$CN$US$US
243704011$24370401$1$I$$20240923$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409014478$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240927$$CN$US$US
243704021$24370402$1$I$20240925$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016540$ELI LILLY AND CO$$40$YR$A$$Y$$$20240927$$CN$US$US
243704031$24370403$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016331$ELI LILLY AND CO$$44$YR$A$M$Y$$$20240927$$CN$US$US
243704041$24370404$1$I$20240925$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016358$ELI LILLY AND CO$$61$YR$A$$Y$$$20240927$$CN$US$US
243704051$24370405$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016243$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243704061$24370406$1$I$$20240926$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017119$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240927$$CN$US$US
243704071$24370407$1$I$20240801$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016549$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240927$$CN$US$US
243704081$24370408$1$I$$20240924$20240927$20240927$PER$$US-ABBVIE-5939713$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243704091$24370409$1$I$20240920$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024189668$AMGEN$$$$$$Y$$$20240927$$HP$US$US
243704101$24370410$1$I$20240901$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015301$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240927$$CN$US$US
243704121$24370412$1$I$$20240913$20240927$20240927$EXP$$DK-SERVIER-S24011728$SERVIER$Toksvang LN, De Pietri S, Nielsen SN, Nersting J, Albertsen BK, Wehner PS, et al.. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites. Pediatric Blood and  Cancer. 2017;64(9):e26519$$$$$Y$$$20240927$$MD$DK$DK
243704151$24370415$1$I$$20240924$20240927$20240927$PER$$US-HALEON-2198569$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243704161$24370416$1$I$20240801$20240912$20240927$20240927$EXP$$US-SMPA-2024SPA002725$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243704171$24370417$1$I$$20240923$20240927$20240927$EXP$$GB-ABBVIE-5939238$ABBVIE$$$$A$F$Y$$$20240927$$CN$GB$GB
243704181$24370418$1$I$$20240923$20240927$20240927$EXP$$US-TAKEDA-2024TUS085730$TAKEDA$$$$$M$Y$112$KG$20240927$$HP$US$US
243704191$24370419$1$I$$20240919$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-047193$AUROBINDO$$$$E$$Y$$$20240927$$PH$US$US
243704201$24370420$1$I$20240926$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192433$AMGEN$$75$YR$E$F$Y$$$20240927$$CN$US$US
243704211$24370421$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191569$AMGEN$$$$A$F$Y$$$20240927$$HP$US$US
243704231$24370423$1$I$$20240916$20240927$20240927$PER$$US-JNJFOC-20240953810$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$CN$US$US
243704241$24370424$1$I$$20240924$20240927$20240927$30DAY$$ES-SANDOZ INC.-SDZ2024ES043426$SANDOZ$$8$YR$$F$Y$$$20240927$$CN$ES$ES
243704251$24370425$1$I$20240925$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192081$AMGEN$$76$YR$E$M$Y$$$20240927$$CN$US$US
243704271$24370427$1$I$$20240909$20240927$20240927$PER$$AU-TOLMAR, INC.-24AU052495$TOLMAR$$$$$M$Y$$$20240927$$CN$AU$AU
243704301$24370430$1$I$$20240909$20240927$20240927$PER$$AU-TOLMAR, INC.-24AU052508$TOLMAR$$$$$M$Y$$$20240927$$CN$AU$AU
243704311$24370431$1$I$$20240921$20240927$20240927$EXP$$CA-ROCHE-10000091669$ROCHE$$50$YR$A$F$Y$$$20240927$$MD$CA$CA
243704321$24370432$1$I$$20240912$20240927$20240927$EXP$$US-SMPA-2024SPA002714$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243704331$24370433$1$I$$20240923$20240927$20240927$EXP$$GB-SANDOZ INC.-SDZ2024GB081597$SANDOZ$$$$$F$Y$$$20240927$$CN$GB$GB
243704341$24370434$1$I$$20240924$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083074$SANDOZ$SLAGLE D., UPPAL A.M.I.T., ZAHID S.. FUSARIUM FUNGEMIA PRESENTING AS SEPTIC SHOCK AND ADRENAL CRISIS IN PATIENT WITH AIDS. Chest. 2024;166:A2664$40$YR$$M$Y$$$20240927$$HP$US$US
243704351$24370435$1$I$$20240918$20240927$20240927$EXP$NL-LRB-01001136$NL-Accord-448235$ACCORD$$70$YR$E$M$Y$99$KG$20240927$$CN$NL$NL
243704361$24370436$1$I$$20240924$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083087$SANDOZ$CRISTIANA SALVATORI ,NIKIL PRASAD. USE OF CRRT AND VA-ECMO FOR METFORMIN-ASSOCIATED LACTIC ACIDOSIS AND SHOCK WITH NORMAL CARDIAC FUNCTION. Chest. 2024;166:A2843-A2844$59$YR$$M$Y$$$20240927$$HP$US$US
243704371$24370437$1$I$$20240911$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA050344$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243704381$24370438$1$I$20240908$20240908$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052477$TOLMAR$$80$YR$$M$Y$$$20240927$$CN$CA$CA
243704391$24370439$1$I$$20240907$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052494$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243704401$24370440$1$I$20240908$20240908$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052543$TOLMAR$$67$YR$$M$Y$$$20240927$$CN$CA$CA
243704411$24370441$1$I$20240904$20240907$20240927$20240927$PER$$FR-TOLMAR, INC.-24FR052393$TOLMAR$$67$YR$$M$Y$$$20240927$$PH$FR$FR
243704431$24370443$1$I$20231108$20240924$20240927$20240927$EXP$$NVSC2023GB250740$NOVARTIS$$33$YR$$F$Y$$$20240927$$CN$GB$GB
243704441$24370444$1$I$20240601$20240924$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US082745$SANDOZ$$80$YR$$F$Y$$$20240927$$CN$US$US
243704451$24370445$1$I$$20240924$20240927$20240927$EXP$$GB-TAKEDA-2024TUS095729$TAKEDA$$$$$F$Y$$$20240927$$CN$GB$GB
243704461$24370446$1$I$20240906$20240915$20240927$20240927$EXP$$CN-JNJFOC-20240940063$JOHNSON AND JOHNSON$$14$YR$T$M$Y$50.7$KG$20240927$$HP$CN$CN
243704471$24370447$1$I$20240902$20240925$20240927$20240927$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-140961$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240927$$PH$FR$FR
243704481$24370448$1$I$$20240913$20240927$20240927$EXP$$DK-SERVIER-S24011747$SERVIER$Toksvang LN, De Pietri S, Nielsen SN, Nersting J, Albertsen BK, Wehner PS, et al.. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites. Pediatric Blood and Cancer. 2017;64(9):e26519$$$$$Y$$$20240927$$MD$DK$DK
243704491$24370449$1$I$20240925$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153257$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240927$$PH$US$US
243704501$24370450$1$I$$20240925$20240927$20240927$PER$$US-ROCHE-10000092789$ROCHE$$50$YR$A$F$Y$$$20240927$$CN$US$US
243704511$24370451$1$I$20240813$20240923$20240927$20240927$EXP$FR-AFSSAPS-BX2024001812$FR-ORGANON-O2409FRA001790$ORGANON$$68$YR$$M$Y$78$KG$20240927$$MD$FR$FR
243704521$24370452$1$I$20240101$20240919$20240927$20240927$EXP$$US-ABBVIE-5932616$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243704531$24370453$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011364$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240927$$HP$CA$CA
243704541$24370454$1$I$$20240918$20240927$20240927$EXP$$PL-AUROBINDO-AUR-APL-2024-047012$AUROBINDO$$58$YR$$M$Y$92$KG$20240927$$MD$PL$PL
243704551$24370455$1$I$$20240918$20240927$20240927$PER$$US-AMGEN-USASL2024190421$AMGEN$$$$$F$Y$$$20240927$$CN$US$US
243704561$24370456$1$I$20240201$20240913$20240927$20240927$EXP$$IN-CIPLA LTD.-2024IN05130$CIPLA$$$$$$Y$$$20240927$$CN$IN$IN
243704571$24370457$1$I$20240801$20240924$20240927$20240927$EXP$$JP-SANDOZ INC.-SDZ2024JP083367$SANDOZ$$89$YR$$M$Y$$$20240927$$CN$JP$JP
243704581$24370458$1$I$20240915$20240920$20240927$20240927$EXP$$US-RECORDATI RARE DISEASE INC.-2024007385$RECORDATI$$$$$$Y$$$20240927$$CN$US$US
243704591$24370459$1$I$20240915$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005689$ACADIA PHARMACEUTICALS$$97$YR$$M$Y$$$20240927$$CN$US$US
243704601$24370460$1$I$$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005681$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243704611$24370461$1$I$20240913$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005687$ACADIA PHARMACEUTICALS$$72$YR$$F$Y$$$20240927$$CN$US$US
243704621$24370462$1$I$$20240918$20240927$20240927$EXP$$HU-JNJFOC-20240961157$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20240927$$MD$HU$HU
243704651$24370465$1$I$20240701$20240923$20240927$20240927$EXP$FR-AFSSAPS-RE2024000908$FR-AMGEN-FRASP2024189323$AMGEN$$47$YR$A$F$Y$59$KG$20240927$$MD$FR$FR
243704661$24370466$1$I$$20240919$20240927$20240927$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27741$SAMSUNG BIOEPIS$$71$YR$E$F$Y$77$KG$20240927$$CN$CA$CA
243704671$24370467$1$I$20240720$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005693$ACADIA PHARMACEUTICALS$$84$YR$$F$Y$$$20240927$$HP$US$US
243704681$24370468$1$I$20230101$20240920$20240927$20240927$EXP$$US-EXELIXIS-EXL-2024-000469$EXELIXIS$$$$$F$Y$$$20240927$$CN$US$US
243704691$24370469$1$I$$20240918$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR118380$VIIV$$$$$$Y$$$20240927$$HP$US$US
243704701$24370470$1$I$$20240920$20240927$20240927$EXP$$US-EXELIXIS-EXL-2024-000450$EXELIXIS$$$$$$Y$$$20240927$$MD$US$US
243704711$24370471$1$I$20240913$20240920$20240927$20240927$EXP$$US-EXELIXIS-EXL-2024-000206$EXELIXIS$$79$YR$$M$Y$65.76$KG$20240927$$CN$US$US
243704721$24370472$1$I$$20240920$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008349$ASTELLAS$$$$$F$Y$$$20240927$$MD$US$US
243704731$24370473$1$I$20240101$20240926$20240927$20240927$EXP$$FI-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053625$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240927$$HP$FI$FI
243704741$24370474$1$I$$20240924$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083067$SANDOZ$AIMALLA ? MEDHAVANI D CHANDRA. UNVEILING PARANEOPLASTIC SWEET SYNDROME: A RARE PRESENTATION ON THE FOOT. chest journel. 2024;A149$80$YR$$F$Y$$$20240927$$HP$US$US
243704751$24370475$1$I$20220503$20240918$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-046392$AUROBINDO$$55$YR$$F$Y$$$20240927$$PH$ES$ES
243704761$24370476$1$I$20240609$20240923$20240927$20240927$EXP$FR-AFSSAPS-RS2024000873$FR-ROCHE-10000089347$ROCHE$$58$YR$A$F$Y$63$KG$20240927$$MD$FR$FR
243704771$24370477$1$I$$20240913$20240927$20240927$EXP$$GB-Provepharm-2162122$PROVEPHARM$$1$DY$$$Y$$$20240927$$MD$GB$GB
243704781$24370478$1$I$$20240912$20240927$20240927$EXP$$JP-PHATHOM PHARMACEUTICALS INC.-2024PHT00908$Phathom Pharmaceuticals$$8$DEC$$M$Y$$$20240927$$MD$JP$JP
243704791$24370479$1$I$20240101$20240918$20240927$20240927$EXP$$FR-INSMED, INC.-2024-00987-FR$INSMED$$$$$$Y$$$20240927$$CN$FR$FR
243704801$24370480$1$I$20240801$20240909$20240927$20240927$30DAY$$ZA-JNJFOC-20240924376$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20240927$$CN$ZA$ZA
243704811$24370481$1$I$$20240913$20240927$20240927$EXP$$US-JNJFOC-20240936329$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243704821$24370482$1$I$20221201$20240918$20240927$20240927$PER$$US-ABBVIE-5929926$ABBVIE$$43$YR$$F$Y$64$KG$20240927$$CN$US$US
243704831$24370483$1$I$20240918$20240924$20240927$20240927$EXP$$US-TAKEDA-2024TUS086477$TAKEDA$$79$YR$$F$Y$$$20240927$$CN$US$US
243704841$24370484$1$I$$20240923$20240927$20240927$PER$$US-HALEON-2198342$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243704851$24370485$1$I$20240912$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005673$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240927$$CN$US$US
243704862$24370486$2$F$20240912$20240927$20240927$20240928$PER$$US-AMGEN-USASP2024192333$AMGEN$$67$YR$E$F$Y$$$20240928$$CN$US$US
243704871$24370487$1$I$$20240913$20240927$20240927$EXP$$DK-SERVIER-S24011745$SERVIER$Toksvang LN, De Pietri S, Nielsen SN, Nersting J, Albertsen BK, Wehner PS, et al.. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.. Pediatr-Blood-Cancer. 2017;64(9):e26519$$$$$Y$$$20240927$$HP$DK$DK
243704891$24370489$1$I$$20240920$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150211$BRISTOL MYERS SQUIBB$$87$YR$E$M$Y$62.6$KG$20240927$$MD$US$US
243704901$24370490$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153000$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240927$$CN$US$US
243704911$24370491$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153178$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240927$$PH$US$US
243704921$24370492$1$I$20240901$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016200$ELI LILLY AND CO$$57$YR$A$$Y$$$20240927$$CN$US$US
243704931$24370493$1$I$$20240923$20240927$20240927$PER$$US-ABBVIE-5938308$ABBVIE$$$$$$Y$$$20240927$$CN$US$US
243704951$24370495$1$I$$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005488$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243704961$24370496$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011374$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240927$$HP$CA$CA
243704971$24370497$1$I$20240909$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005477$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240927$$CN$US$US
243704981$24370498$1$I$$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005480$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$HP$US$US
243704991$24370499$1$I$$20240920$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008326$ASTELLAS$$$$$F$Y$$$20240927$$MD$US$US
243705001$24370500$1$I$$20240923$20240927$20240927$EXP$$US-TAKEDA-2024TUS095134$TAKEDA$$$$$M$Y$$$20240927$$CN$US$US
243705011$24370501$1$I$20240822$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005482$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20240927$$CN$US$US
243705031$24370503$1$I$$20240916$20240927$20240927$EXP$$GB-IPCA LABORATORIES LIMITED-IPC-2024-GB-002267$IPCA$Abdalrazag OA, Okoye AO and Muniyappa SM. Title to be provided. British Journal of Diabetes. 2024;24(1)$$$$$Y$$$20240927$$MD$GB$GB
243705041$24370504$1$I$$20240924$20240927$20240927$EXP$$NVSC2024AR191761$NOVARTIS$$$$$F$Y$$$20240927$$CN$AR$AR
243705051$24370505$1$I$20240718$20240923$20240927$20240927$EXP$HR-HALMED-300086528$HR-TEVA-VS-3246989$TEVA$$68$YR$$M$Y$$$20240927$$MD$HR$HR
243705061$24370506$1$I$20230720$20231019$20240927$20240927$PER$$US-Indivior Limited-INDV-140474-2023$RECKITT BENCKISER$$21$YR$$F$Y$$$20240927$$MD$US$US
243705071$24370507$1$I$20240814$20240918$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-047008$AUROBINDO$$74$YR$$F$Y$$$20240927$$MD$ES$ES
243705081$24370508$1$I$$20240918$20240927$20240927$EXP$$JP-AMNEAL PHARMACEUTICALS-2024-AMRX-03485$AMNEAL$Nishino S, Yunokawa M, Matsuura Y, Fusegi A, Misaka S, et al.. Secondary spontaneous pneumothorax during chemotherapy with bevacizumab for cervical cancer: a case report and literature review. Int. Canc. Conf. J. 2024$57$YR$$F$Y$$$20240927$$HP$JP$JP
243705091$24370509$1$I$20240901$20240926$20240927$20240927$PER$$NVSC2024US192103$NOVARTIS$$65$YR$$F$Y$$$20240927$$CN$US$US
243705101$24370510$1$I$$20240909$20240927$20240927$PER$$AU-TOLMAR, INC.-24AU052510$TOLMAR$$$$$M$Y$$$20240927$$CN$AU$AU
243705111$24370511$1$I$20240801$20240909$20240927$20240927$PER$$BR-TOLMAR, INC.-24BR051585$TOLMAR$$17$YR$$M$Y$$$20240927$$CN$BR$BR
243705121$24370512$1$I$20240828$20240909$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052486$TOLMAR$$73$YR$$M$Y$$$20240927$$CN$CA$CA
243705131$24370513$1$I$20240909$20240909$20240927$20240927$PER$$TR-TOLMAR, INC.-24TR052546$TOLMAR$$75$YR$$M$Y$$$20240927$$MD$TR$TR
243705141$24370514$1$I$20240909$20240909$20240927$20240927$PER$$TR-TOLMAR, INC.-24TR052565$TOLMAR$$69$YR$$M$Y$$$20240927$$PH$TR$TR
243705151$24370515$1$I$20240814$20240909$20240927$20240927$PER$$US-TOLMAR, INC.-24US051955$TOLMAR$$64$YR$$M$Y$$$20240927$$HP$US$US
243705161$24370516$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011375$APOTEX$Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, et al.. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score weighted, retrospective assessment. Supportive Care in Cancer. 2024;32 (552):1-8$$$C$$Y$$$20240927$$HP$CA$CA
243705171$24370517$1$I$$20240913$20240927$20240927$EXP$$TN-ACI HealthCare Limited-2162123$ACI HEALTHCARE$Full text$20$YR$$M$Y$$$20240927$$$TN$TN
243705181$24370518$1$I$20230521$20240919$20240927$20240927$EXP$$FR-JNJFOC-20231129793$JOHNSON AND JOHNSON$$75$YR$E$F$Y$51$KG$20240927$$HP$FR$FR
243705201$24370520$1$I$$20240918$20240927$20240927$PER$$US-GSK-US2024116609$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$HP$US$US
243705211$24370521$1$I$20240924$20240925$20240927$20240927$EXP$$RO-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053384$BOEHRINGER INGELHEIM$$68$YR$E$F$Y$$$20240927$$MD$RO$RO
243705221$24370522$1$I$$20240924$20240927$20240927$PER$$US-HALEON-2198463$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243705231$24370523$1$I$20240722$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005442$ACADIA PHARMACEUTICALS$$60$YR$$M$Y$$$20240927$$CN$US$US
243705241$24370524$1$I$20240906$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005444$ACADIA PHARMACEUTICALS$$54$YR$$F$Y$$$20240927$$CN$US$US
243705251$24370525$1$I$$20240925$20240927$20240927$EXP$$US-ROCHE-10000092349$ROCHE$$35$YR$A$F$Y$$$20240927$$MD$US$US
243705261$24370526$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005434$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$MD$US$US
243705271$24370527$1$I$20240101$20240920$20240927$20240927$EXP$$US-RECORDATI RARE DISEASE INC.-2024007407$RECORDATI$$$$$$Y$$$20240927$$CN$US$US
243705281$24370528$1$I$$20240923$20240927$20240927$PER$$US-ROCHE-10000089158$ROCHE$$$$$$Y$$$20240927$$HP$US$US
243705291$24370529$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152988$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240927$$HP$US$US
243705301$24370530$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153207$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$68.49$KG$20240927$$HP$US$US
243705311$24370531$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152899$BRISTOL MYERS SQUIBB$$27$YR$A$F$Y$$$20240927$$HP$US$US
243705321$24370532$1$I$$20240919$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152309$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240927$$CN$US$US
243705331$24370533$1$I$20230501$20240918$20240927$20240927$EXP$$TW-BRISTOL-MYERS SQUIBB COMPANY-2024-152823$BRISTOL MYERS SQUIBB$Hsieh C-Y, Hsieh H-Y. Bullous pemphigoid associated with programmed cell death protein 1 inhibitor for oral cavity cancer. Formosan Journal of Medicine. 2024;28(5):537-41. doi:10.6320/FJM.202409_28(5).0004.$67$YR$E$M$Y$$$20240927$$HP$TW$TW
243705341$24370534$1$I$20240429$20240926$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153279$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240927$$CN$US$US
243705371$24370537$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005394$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243705381$24370538$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005397$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243705391$24370539$1$I$20240731$20240921$20240927$20240927$EXP$$IN-GSK-IN2024APC099860$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$IN$IN
243705401$24370540$1$I$$20240924$20240927$20240927$EXP$$CA-TAKEDA-2024TUS095358$TAKEDA$$$$$F$Y$$$20240927$$MD$CA$CA
243705411$24370541$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005395$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243705421$24370542$1$I$$20240913$20240927$20240927$EXP$$DK-SERVIER-S24011749$SERVIER$Toksvang LN, De Pietri S, Nielsen SN, Nersting J, Albertsen BK, Wehner PS, et al.. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites. Pediatric Blood and Cancer. 2017;64 (9):e26519$$$$$Y$$$20240927$$MD$DK$DK
243705431$24370543$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005389$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243705441$24370544$1$I$$20240919$20240927$20240927$EXP$$US-JNJFOC-20240960033$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240927$$MD$US$US
243705451$24370545$1$I$20230901$20230925$20240927$20240927$PER$$US-Indivior Limited-INDV-141108-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243705471$24370547$1$I$$20240912$20240927$20240927$EXP$$US-Nuvo Pharmaceuticals Inc-2162124$NUVO PHARMACEUTICALS$Abstract$60$YR$$M$Y$$$20240927$$$US$US
243705481$24370548$1$I$$20240913$20240927$20240927$EXP$$FR-ACI HealthCare Limited-2162125$ACI HEALTHCARE$Abstract$55$YR$$F$Y$$$20240927$$$FR$FR
243705491$24370549$1$I$$20240924$20240927$20240927$EXP$$GB-SA-2024SA278374$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240927$$CN$GB$GB
243705501$24370550$1$I$20240803$20240916$20240927$20240927$EXP$FR-AFSSAPS-LL2024001722$FR-Accord-447776$ACCORD$$63$YR$A$M$Y$$$20240927$$PH$FR$FR
243705511$24370551$1$I$20240201$20240924$20240927$20240927$EXP$FR-AFSSAPS-BX2024001668$FR-SA-2024SA276625$SANOFI AVENTIS$$66$YR$E$M$Y$67.846$KG$20240927$$MD$FR$FR
243705521$24370552$1$I$$20240925$20240927$20240927$EXP$$GB-TAKEDA-2024TUS095266$TAKEDA$$54$YR$$F$Y$$$20240927$$HP$GB$GB
243705531$24370553$1$I$$20240906$20240927$20240927$EXP$$FR-AMGEN-FRASP2024118943$AMGEN$Unknown. Impact of Switch to Glycerol Phenylbutyrate in Patients with Urea Cycle Disorders. Unknown$$$$$Y$$$20240927$$MD$FR$FR
243705541$24370554$1$I$20240830$20240923$20240927$20240927$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03513$AMNEAL$$77$YR$$M$Y$88.435$KG$20240927$$CN$US$US
243705551$24370555$1$I$20240101$20240925$20240927$20240927$EXP$$US-SA-2024SA277940$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240927$$MD$US$US
243705562$24370556$2$F$$20240926$20240927$20240930$PER$$NVSC2024US191602$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
243705571$24370557$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005471$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243705581$24370558$1$I$$20240925$20240927$20240927$PER$$US-ROCHE-10000091759$ROCHE$$$$$$Y$$$20240927$$HP$US$US
243705591$24370559$1$I$$20240924$20240927$20240927$EXP$$CA-TAKEDA-2024TUS095265$TAKEDA$$$$$M$Y$$$20240927$$CN$CA$CA
243705601$24370560$1$I$$20240922$20240927$20240927$PER$$US-TAKEDA-2024TUS094771$TAKEDA$$$$$$Y$$$20240927$$CN$US$US
243705611$24370561$1$I$20240409$20240920$20240927$20240927$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-151676$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240927$$MD$DE$DE
243705621$24370562$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152695$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240927$$CN$US$US
243705631$24370563$1$I$20240801$20240926$20240927$20240927$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-153022$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$83.46$KG$20240927$$CN$PR$PR
243705641$24370564$1$I$20240916$20240917$20240927$20240927$PER$$US-TRIS PHARMA, INC.-24US011652$TRIS PHARM$$$$$$Y$$$20240927$$CN$US$US
243705651$24370565$1$I$$20240925$20240927$20240927$EXP$$US-ROCHE-10000091957$ROCHE$$39$YR$A$F$Y$$$20240927$$CN$US$US
243705671$24370567$1$I$$20240918$20240927$20240927$EXP$$US-BAUSCHBL-2024BNL009504$BAUSCH AND LOMB$$$$$F$Y$$$20240927$$CN$US$US
243705681$24370568$1$I$20240901$20240923$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008622$ASTELLAS$$71$YR$E$F$Y$$$20240927$$CN$US$US
243705691$24370569$1$I$$20240926$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017335$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240927$$CN$US$US
243705701$24370570$1$I$20240925$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016965$ELI LILLY AND CO$$54$YR$A$M$Y$$$20240927$$CN$US$US
243705711$24370571$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016598$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240927$$CN$US$US
243705721$24370572$1$I$20240901$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016606$ELI LILLY AND CO$$38$YR$A$F$Y$$$20240927$$CN$US$US
243705731$24370573$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016254$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240927$$CN$US$US
243705742$24370574$2$F$20240925$20240927$20240927$20240928$PER$$US-AMGEN-USASP2024192033$AMGEN$$63$YR$A$M$Y$$$20240928$$CN$US$US
243705751$24370575$1$I$20240701$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016216$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240927$$CN$US$US
243705761$24370576$1$I$20231001$20240918$20240927$20240927$EXP$IT-MINISAL02-978589$IT-CELLTRION INC.-2024IT022954$CELLTRION$$$$$$Y$$$20240927$$MD$IT$IT
243705781$24370578$1$I$20240101$20240909$20240927$20240927$PER$$US-TOLMAR, INC.-24US052476$TOLMAR$$$$$M$Y$$$20240927$$CN$US$US
243705801$24370580$1$I$$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192330$AMGEN$$$$$F$Y$$$20240927$$HP$US$US
243705811$24370581$1$I$$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190786$AMGEN$$$$$F$Y$$$20240927$$CN$US$US
243705821$24370582$1$I$20221027$20240923$20240927$20240927$EXP$$ES-AMGEN-ESPSP2024189385$AMGEN$$40$YR$A$F$Y$77.9$KG$20240927$$MD$ES$ES
243705831$24370583$1$I$20221228$20240909$20240927$20240927$PER$$US-TOLMAR, INC.-24US052467$TOLMAR$$74$YR$$M$Y$96.6$KG$20240927$$MD$US$US
243705841$24370584$1$I$$20240925$20240927$20240927$PER$$US-ABBVIE-5939921$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243705851$24370585$1$I$$20240917$20240927$20240927$EXP$$JP-TAKEDA-2024TUS095568$TAKEDA$$59$YR$$F$Y$66$KG$20240927$$MD$JP$JP
243705871$24370587$1$I$$20240912$20240927$20240927$EXP$$GB-Nuvo Pharmaceuticals Inc-2162126$NUVO PHARMACEUTICALS$Full text$75$YR$$M$Y$$$20240927$$$GB$GB
243705881$24370588$1$I$20240801$20240920$20240927$20240927$EXP$$NL-SERVIER-S24009925$SERVIER$$$$$$Y$$$20240927$$MD$NL$NL
243705891$24370589$1$I$$20240923$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008588$ASTELLAS$$55$YR$A$F$Y$$$20240927$$CN$US$US
243705901$24370590$1$I$20220430$20240924$20240927$20240927$PER$$US-ABBVIE-5937558$ABBVIE$$74$YR$$M$Y$82$KG$20240927$$CN$US$US
243705931$24370593$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005475$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243705941$24370594$1$I$$20240917$20240927$20240927$PER$$US-BAUSCHBL-2024BNL034149$BAUSCH AND LOMB$$$$$F$Y$$$20240927$$CN$US$US
243705961$24370596$1$I$20230721$20230822$20240927$20240927$PER$$US-Indivior Limited-INDV-140677-2023$RECKITT BENCKISER$$21$YR$$M$Y$$$20240927$$MD$US$US
243705971$24370597$1$I$$20240917$20240927$20240927$PER$$US-BAUSCHBL-2024BNL033859$BAUSCH AND LOMB$$$$$F$Y$$$20240927$$CN$US$US
243705981$24370598$1$I$20230824$20230824$20240927$20240927$PER$$US-Indivior Limited-INDV-140711-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$PH$US$US
243705991$24370599$1$I$20230101$20231016$20240927$20240927$PER$$US-Indivior Limited-INDV-140961-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243706001$24370600$1$I$20230909$20230911$20240927$20240927$PER$$US-INDIVIOR US-INDV-140950-2023$RECKITT BENCKISER$$23$YR$$M$Y$$$20240927$$HP$US$US
243706011$24370601$1$I$$20230926$20240927$20240927$PER$$US-Indivior Limited-INDV-141141-2023$RECKITT BENCKISER$$25$YR$$M$Y$$$20240927$$HP$US$US
243706021$24370602$1$I$20230724$20230802$20240927$20240927$PER$$US-Indivior Limited- INDV-140427-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243706031$24370603$1$I$20221001$20230823$20240927$20240927$PER$$US-Indivior Limited-INDV-140697-2023$RECKITT BENCKISER$$43$YR$$F$Y$$$20240927$$HP$US$US
243706041$24370604$1$I$20230601$20230817$20240927$20240927$PER$$US-Indivior Limited-INDV-140627-2023$RECKITT BENCKISER$$29$YR$$M$Y$$$20240927$$HP$US$US
243706051$24370605$1$I$20230901$20230918$20240927$20240927$PER$$US-Indivior Limited-INDV-141027-2023$RECKITT BENCKISER$$44$YR$$M$Y$$$20240927$$HP$US$US
243706061$24370606$1$I$$20230913$20240927$20240927$PER$$US-INDIVIOR US-INDV-140970-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$CN$US$US
243706071$24370607$1$I$20230101$20230905$20240927$20240927$PER$$US-Indivior Limited-INDV-140512-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$PH$US$US
243706081$24370608$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005476$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$HP$US$US
243706091$24370609$1$I$$20240920$20240927$20240927$PER$$US-JNJFOC-20240957098$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20240927$$CN$US$US
243706101$24370610$1$I$$20240920$20240927$20240927$PER$$US-JNJFOC-20240964462$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$HP$US$US
243706111$24370611$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024115653$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243706121$24370612$1$I$20240901$20240923$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008644$ASTELLAS$$81$YR$E$M$Y$$$20240927$$CN$US$US
243706131$24370613$1$I$20240925$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153259$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240927$$CN$US$US
243706141$24370614$1$I$20240917$20240919$20240927$20240927$EXP$GB-MHRA-MED-202409191718247350-GPLMN$GB-BAXTER-2024BAX024972$BAXTER$$$$$$Y$$$20240927$$PH$GB$GB
243706151$24370615$1$I$20240901$20240926$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152992$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$$$20240927$$HP$US$US
243706161$24370616$1$I$$20240919$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149989$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240927$$CN$US$US
243706171$24370617$1$I$$20240918$20240927$20240927$PER$$US-TAKEDA-2024TUS093969$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
243706181$24370618$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005479$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243706201$24370620$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024AMR115757$GLAXOSMITHKLINE$$$$$M$Y$$$20240927$$CN$US$US
243706211$24370621$1$I$20240908$20240925$20240927$20240927$PER$$US-ROCHE-10000091965$ROCHE$$69$YR$E$F$Y$70.67$KG$20240927$$CN$US$US
243706221$24370622$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191570$AMGEN$$$$$$Y$$$20240927$$CN$US$US
243706231$24370623$1$I$20240918$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190731$AMGEN$$33$YR$A$M$Y$$$20240927$$PH$US$US
243706241$24370624$1$I$$20240916$20240927$20240927$PER$$US-ROCHE-10000084316$ROCHE$$$$E$M$Y$$$20240927$$CN$US$US
243706251$24370625$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005481$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243706261$24370626$1$I$20240101$20240923$20240927$20240927$EXP$$US-ABBVIE-5936705$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243706271$24370627$1$I$20240701$20240918$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-003537$ACADIA PHARMACEUTICALS$$88$YR$$F$Y$$$20240927$$HP$US$US
243706281$24370628$1$I$$20240925$20240927$20240927$PER$$NVSC2024US191869$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
243706291$24370629$1$I$20240914$20240924$20240927$20240927$EXP$$CN-ABBVIE-5938069$ABBVIE$$67$YR$$M$Y$62$KG$20240927$$MD$CN$CN
243706301$24370630$1$I$20240717$20240923$20240927$20240927$EXP$ES-AEMPS-1570103$ES-TEVA-VS-3247270$TEVA$$71$YR$$F$Y$42$KG$20240927$$PH$ES$ES
243706311$24370631$1$I$$20240918$20240927$20240927$EXP$$US-AMGEN-USASP2024187224$AMGEN$$$$$$Y$$$20240927$$MD$US$US
243706321$24370632$1$I$20230531$20230921$20240927$20240927$PER$$US-Indivior Limited-INDV-141081-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243706331$24370633$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5936271$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243706341$24370634$1$I$20230219$20240925$20240927$20240927$EXP$$DE-SANDOZ INC.-SDZ2024DE039441$SANDOZ$$$$$F$Y$$$20240927$$CN$DE$DE
243706351$24370635$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5938544$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243706361$24370636$1$I$20240908$20240918$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005751$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$$$20240927$$HP$US$US
243706371$24370637$1$I$20240918$20240918$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005754$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240927$$CN$US$US
243706381$24370638$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005484$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243706391$24370639$1$I$20240902$20240918$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005494$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240927$$CN$US$US
243706411$24370641$1$I$20240101$20240925$20240927$20240927$PER$$US-BIOGEN-2024BI01284189$BIOGEN$$$$$F$Y$$$20240927$$CN$US$US
243706421$24370642$1$I$20240519$20240918$20240927$20240927$EXP$GB-MHRA-MED-202409182331166280-PBYTC$GB-862174955-ML2024-05012$Unknown Manufacturer$$$$$F$Y$$$20240927$$CN$GB$GB
243706431$24370643$1$I$20240917$20240919$20240927$20240927$EXP$GB-MHRA-MED-202409180947199770-YMGQC$GB-862174955-ML2024-05026$MICRO LABS$$38$YR$A$M$Y$73$KG$20240927$$CN$GB$GB
243706441$24370644$1$I$20240908$20240911$20240927$20240927$EXP$$US-862174955-ML2024-04895$MICRO LABS$$66$YR$E$M$Y$106.6$KG$20240927$$PH$US$US
243706451$24370645$1$I$20240901$20240912$20240927$20240927$EXP$$US-862174955-ML2024-04913$MICRO LABS$$26$YR$A$F$Y$68$KG$20240927$$CN$US$US
243706461$24370646$1$I$$20240919$20240927$20240927$EXP$GB-MHRA-MED-202409130914122390-YLHTD$GB-862174955-ML2024-05028$MICRO LABS$$29$YR$A$M$Y$86$KG$20240927$$HP$GB$GB
243706471$24370647$1$I$20240914$20240919$20240927$20240927$EXP$GB-MHRA-MED-202409161420374990-ZFWGV$GB-862174955-ML2024-05022$MICRO LABS$$$$$$Y$$$20240927$$PH$GB$GB
243706481$24370648$1$I$$20240924$20240927$20240927$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053123$BOEHRINGER INGELHEIM$Rathore A, Qadir N, Kronen T, Izzo CS, Mirsaeidi M, Rathore A. Septic shock following recent initiation of empagliflozin in an elderly patient: a case report.. Chest. 2024;166:4: 1662A-1663A. doi:10.1016/j.chest.2024.06.1051.$65$YR$E$F$Y$$$20240927$$HP$US$US
243706491$24370649$1$I$$20240918$20240927$20240927$EXP$$PT-AUROBINDO-AUR-APL-2024-047159$AUROBINDO$UNKNOWN.. Horner^s Syndrome and Limb Sympathectomy Ipsilateral Superior after Lumbar Epidural Block.. Journal of the Portuguese Society of Anesthesiology.. 2024;33:43$29$YR$$F$Y$$$20240927$$HP$PT$PT
243706501$24370650$1$I$$20240917$20240927$20240927$PER$$US-ABBVIE-5929886$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243706511$24370651$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005487$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243706531$24370653$1$I$20240705$20240926$20240927$20240927$EXP$$NVSC2024DE191351$NOVARTIS$$$$$F$Y$$$20240927$$MD$DE$DE
243706541$24370654$1$I$$20231017$20240927$20240927$PER$$US-INDIVIOR US-INDV-141448-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$PH$US$US
243706551$24370655$1$I$$20240916$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046065$AUROBINDO$Tarantino MD, Hardesty B, Metjian A, Ortel TL, Chen J, Badejo K, et al.. Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A noninterventional, post-authorization safety study.. Haemophilia. 2023;29(5):1259-1268$60$YR$$M$Y$$$20240927$$HP$US$US
243706561$24370656$1$I$$20231114$20240927$20240927$PER$$US-Indivior Limited-INDV-141818-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243706571$24370657$1$I$20230101$20231107$20240927$20240927$PER$$US-INDIVIOR US-INDV-141725-2023$RECKITT BENCKISER$$$$$F$Y$$$20240927$$HP$US$US
243706581$24370658$1$I$20231204$20231204$20240927$20240927$PER$$US-Indivior Limited-INDV-142134-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$PH$US$US
243706591$24370659$1$I$20230901$20231009$20240927$20240927$PER$$US-Indivior Limited-INDV-141280-2023$RECKITT BENCKISER$$$$$F$Y$$$20240927$$MD$US$US
243706601$24370660$1$I$20230101$20231204$20240927$20240927$PER$$US-INDIVIOR US-INDV-142127-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$PH$US$US
243706611$24370661$1$I$20231101$20231128$20240927$20240927$PER$$US-INDIVIOR US-INDV-142043-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$CN$US$US
243706621$24370662$1$I$20231101$20231128$20240927$20240927$PER$$US-Indivior Limited-INDV-142063-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$MD$US$US
243706631$24370663$1$I$$20231107$20240927$20240927$PER$$US-Indivior Limited-INDV-141738-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$MD$US$US
243706641$24370664$1$I$20231016$20231213$20240927$20240927$PER$$US-Indivior Limited-INDV-141813-2023$RECKITT BENCKISER$$31$YR$$M$Y$$$20240927$$MD$US$US
243706651$24370665$1$I$$20230929$20240927$20240927$PER$$US-INDIVIOR US-INDV-141184-2023$RECKITT BENCKISER$$$$$F$Y$$$20240927$$CN$US$US
243706661$24370666$1$I$$20231003$20240927$20240927$PER$$US-Indivior Limited-INDV-141226-2023$RECKITT BENCKISER$$$$$F$Y$$$20240927$$HP$US$US
243706671$24370667$1$I$20231101$20231113$20240927$20240927$PER$$US-INDIVIOR US-INDV-141795-2023$RECKITT BENCKISER$$30$YR$$M$Y$$$20240927$$PH$US$US
243706691$24370669$1$I$20230901$20230926$20240927$20240927$PER$$US-INDIVIOR US-INDV-141136-2023$RECKITT BENCKISER$$35$YR$$M$Y$$$20240927$$CN$US$US
243706701$24370670$1$I$$20231102$20240927$20240927$PER$$US-Indivior Limited-INDV-141654-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243706711$24370671$1$I$20231001$20231019$20240927$20240927$PER$$US-Indivior Limited-INDV-141494-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243706721$24370672$1$I$$20240916$20240927$20240927$PER$$US-BAUSCHBL-2024BNL033601$BAUSCH AND LOMB$$$$$F$Y$$$20240927$$CN$US$US
243706732$24370673$2$F$20240902$20240927$20240927$20240928$PER$$US-AMGEN-USASP2024192321$AMGEN$$76$YR$E$F$Y$$$20240928$$CN$US$US
243706741$24370674$1$I$20231101$20231212$20240927$20240927$PER$$US-Indivior Limited-INDV-141842-2023$RECKITT BENCKISER$$52$YR$$F$Y$$$20240927$$HP$US$US
243706751$24370675$1$I$20240918$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191438$AMGEN$$69$YR$E$F$Y$$$20240927$$CN$US$US
243706761$24370676$1$I$$20240919$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-047187$AUROBINDO$$$$E$$Y$$$20240927$$PH$US$US
243706771$24370677$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005486$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243706781$24370678$1$I$$20240918$20240927$20240927$EXP$$TW-AMGEN-TWNSP2024187692$AMGEN$Sheu B.C.; Huang K.J.; Chang W.C. et al.. Urine Protein to Creatinine Ratio for the Assessment of Bevacizumab-Associated Proteinuria in Patients with Gynecologic Cancers: A Diagnostic and Quality Improvement Study. Diagnostics. 2024;14 (17):1-10$$$$$Y$$$20240927$$HP$TW$TW
243706791$24370679$1$I$20240918$20240918$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149282$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20240927$$CN$US$US
243706801$24370680$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153231$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$53.52$KG$20240927$$CN$US$US
243706811$24370681$1$I$$20240922$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015621$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240927$$CN$US$US
243706821$24370682$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016622$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240927$$CN$US$US
243706841$24370684$1$I$$20240920$20240927$20240927$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-03500$AMNEAL$$$$$F$Y$$$20240927$$CN$US$US
243706851$24370685$1$I$$20240925$20240927$20240927$EXP$$GB-SANDOZ INC.-SDZ2024GB083000$SANDOZ$$$$$M$Y$$$20240927$$CN$GB$GB
243706861$24370686$1$I$20240910$20240916$20240927$20240927$PER$$US-ABBVIE-5930413$ABBVIE$$21$YR$$F$Y$$$20240927$$MD$US$US
243706871$24370687$1$I$$20240920$20240927$20240927$EXP$$DE-TERSERA THERAPEUTICS LLC-2024TRS004805$TERSERA THERAPEUTICS$$$$$$Y$$$20240927$$MD$DE$DE
243706881$24370688$1$I$$20240916$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046090$AUROBINDO$Peshin S, Kapadia C, Krishnadasan R.. CML-401 Insights into Neulasta-Associated Splenic Infarction: Unveiling a Rare Complication in Chemotherapy for Chronic Myelomonocytic Leukemia. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S372$67$YR$$M$Y$$$20240927$$HP$US$US
243706891$24370689$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005489$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243706902$24370690$2$F$20240922$20240925$20240927$20240928$PER$$US-AMGEN-USASP2024190271$AMGEN$$71$YR$E$F$Y$$$20240928$$CN$US$US
243706911$24370691$1$I$20240101$20240920$20240927$20240927$EXP$$JP-AMGEN-JPNSP2024189975$AMGEN$$60$YR$A$F$Y$$$20240927$$MD$JP$JP
243706921$24370692$1$I$$20240708$20240927$20240927$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008617$STRIDES$Young KZ, Guan LL, Friedman BJ, Rambhatla PV.. Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil. Int-J-Womens-Dermatol. 2022;8(3)$47$YR$$F$Y$$$20240927$$MD$US$US
243706931$24370693$1$I$20240825$20240918$20240927$20240927$EXP$CN-HENLIUS-24CN017267$CN-Accord-448199$ACCORD$$30$YR$A$F$Y$56$KG$20240927$$MD$CN$CN
243706941$24370694$1$I$$20240712$20240927$20240927$PER$$US-STRIDES ARCOLAB LIMITED-2024SP008903$STRIDES$Aikins KA, Anderson ZN, Bosse BL, Knowles S. Pulmonary artery involvement in Beh?et^s disease: A challenging case and comprehensive management approach. Case Report.. Radiology Case Reports. 2024;19:2093-2096$26$YR$$M$Y$$$20240927$$HP$US$US
243706951$24370695$1$I$$20240806$20240927$20240927$PER$$US-STRIDES ARCOLAB LIMITED-2024SP009965$STRIDES$Tarabanis C, Banco D, Keller NM, Bangalore S, Alviar CL.. A case report of sodium azide-induced myopericarditis.. European Heart Journal - Case Reports. 2024;8:ytae134$31$YR$$F$Y$$$20240927$$HP$US$US
243706961$24370696$1$I$$20240920$20240927$20240927$PER$$US-JNJFOC-20240964636$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$HP$US$US
243706971$24370697$1$I$20210609$20240917$20240927$20240927$EXP$$DE-TEVA-VS-3245910$TEVA$$52$YR$$F$Y$$$20240927$$MD$DE$DE
243706981$24370698$1$I$$20240913$20240927$20240927$EXP$$DK-SERVIER-S24011750$SERVIER$Toksvang LN, De Pietri S, Nielsen SN, Nersting J, Albertsen BK, Wehner PS, et al.. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.. Pediatric Blood and Cancer. 2017;64 (9):e26519$$$$$Y$$$20240927$$MD$DK$DK
243706991$24370699$1$I$$20240919$20240927$20240927$EXP$$US-BEH-2024179164$CSL BEHRING$$$$E$M$Y$$$20240927$$HP$US$US
243707001$24370700$1$I$$20240916$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046426$AUROBINDO$Melody M, Franco S, Odetola O, Lin A, Moreira J, Carson K, et al.. CT-630 No Impact of Prophylactic Corticosteroid Use in Patients Receiving Axicabtagene Ciloleucel for Large B-Cell Lymphoma. Clin-Lymphoma-Myeloma-Leuk. 2024;24 (Suppl. 1):S611-S612$$$$$Y$$$20240927$$HP$US$US
243707021$24370702$1$I$$20240920$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152839$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$107.23$KG$20240927$$PH$US$US
243707031$24370703$1$I$$20240920$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150404$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$$$20240927$$CN$US$US
243707041$24370704$1$I$$20231206$20240927$20240927$PER$$US-Indivior Limited-INDV-142179-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$PH$US$US
243707051$24370705$1$I$$20231206$20240927$20240927$PER$$US-Indivior Limited-INDV-142180-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$PH$US$US
243707061$24370706$1$I$20240810$20240918$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-047007$AUROBINDO$$18$YR$$F$Y$$$20240927$$MD$ES$ES
243707071$24370707$1$I$20230101$20231205$20240927$20240927$PER$$US-Indivior Limited-INDV-142157-2023$RECKITT BENCKISER$$40$YR$$F$Y$$$20240927$$HP$US$US
243707081$24370708$1$I$$20231206$20240927$20240927$PER$$US-Indivior Limited-INDV-142178-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$PH$US$US
243707091$24370709$1$I$$20231206$20240927$20240927$PER$$US-Indivior Limited-INDV-142175-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$PH$US$US
243707101$24370710$1$I$$20231206$20240927$20240927$PER$$US-Indivior Limited-INDV-142177-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$PH$US$US
243707111$24370711$1$I$20231204$20231204$20240927$20240927$PER$$US-Indivior Limited-INDV-142156-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$PH$US$US
243707121$24370712$1$I$$20231206$20240927$20240927$PER$$US-Indivior Limited-INDV-142176-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$PH$US$US
243707131$24370713$1$I$20231102$20231115$20240927$20240927$PER$$US-Indivior Limited-INDV-141841-2023$RECKITT BENCKISER$$30$YR$$M$Y$$$20240927$$HP$US$US
243707141$24370714$1$I$$20240917$20240927$20240927$EXP$CA-MHPD-E2B_07228243$CA-Accord-447334$ACCORD$$$$$$Y$$$20240927$$HP$CA$CA
243707151$24370715$1$I$20240920$20240920$20240927$20240927$PER$$US-AMGEN-USASP2024191478$AMGEN$$$$$$Y$$$20240927$$CN$US$US
243707161$24370716$1$I$$20240918$20240927$20240927$EXP$$GB-TEVA-VS-3245203$TEVA$$64$YR$$F$Y$$$20240927$$HP$GB$GB
243707171$24370717$1$I$$20240923$20240927$20240927$EXP$$US-AMGEN-USASP2024190548$AMGEN$Chen E.C.; Flamand Y.; Tiao E.; et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$$$$$Y$$$20240927$$HP$US$US
243707181$24370718$1$I$$20240923$20240927$20240927$EXP$$US-BBU-2024000286$BIOGEN$Percic N, Mucha S. RSV-Mediated HLH in the setting of multiple myeloma: a diagnostic and therapeutic conundrum. Chest. 166 (4S):2071A-2A. doi:10.1016/j.chest.2024.06.1282$59$YR$$M$Y$$$20240927$$HP$US$US
243707191$24370719$1$I$$20240917$20240927$20240927$EXP$$IN-RDY-SPO/IND/24/0014051$DR REDDYS$Sasidharanpillai S, David EM, Jishna P, Khader A, George N, Sabnam CP, et al. Antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS): A cross-sectional study. Indian Journal of Dermatology, Venereology and Leprology. 2024 Apr;90(3): doi:10.25259/IJDVL_507_2022.$$$$$Y$$$20240927$$HP$IN$IN
243707211$24370721$1$I$20240719$20240920$20240927$20240927$EXP$PT-INFARMED-J202409-255$PT-TEVA-VS-3246444$TEVA$$27$YR$$F$Y$53$KG$20240927$$MD$PT$PT
243707221$24370722$1$I$20240901$20240920$20240927$20240927$EXP$$JP-009507513-2409JPN003108J$MERCK$$$$A$M$Y$$$20240927$$CN$JP$JP
243707231$24370723$1$I$$20240912$20240927$20240927$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-09583$LUPIN$$$$$$Y$$$20240927$$HP$CA$CA
243707251$24370725$1$I$20240601$20240923$20240927$20240927$30DAY$$US-UCBSA-2024031759$UCB$$19$YR$$F$Y$$$20240927$$CN$US$US
243707261$24370726$1$I$20221001$20240916$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-045985$AUROBINDO$Levi D, Horn S, Murphy J, Levin J.. Safety of dexamethasone in transforaminal epidural steroid injections: A case of temporary paraplegia caused by injection of lidocaine and dexamethasone into a lumbar radiculomedullary artery, with no neurologic sequelae.. Interventional pain medicine. 2023;2(1):100240$76$YR$$M$Y$$$20240927$$MD$US$US
243707271$24370727$1$I$20100630$20240920$20240927$20240927$EXP$$GB-ROCHE-10000087881$ROCHE$$43$YR$A$M$Y$$$20240927$$PH$GB$GB
243707281$24370728$1$I$20230204$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-047023$AUROBINDO$$41$YR$$F$Y$61$KG$20240927$$PH$FR$FR
243707291$24370729$1$I$20230330$20240917$20240927$20240927$EXP$ES-AEMPS-1379816$ES-CELLTRION INC.-2024ES022550$CELLTRION$$$$$$Y$$$20240927$$MD$ES$ES
243707301$24370730$1$I$$20240918$20240927$20240927$EXP$$FR-TEVA-202007_00009877$TEVA$$77$YR$$F$Y$$$20240927$$PH$FR$FR
243707311$24370731$1$I$$20240916$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046066$AUROBINDO$Tarantino MD, Hardesty B, Metjian A, Ortel TL, Chen J, Badejo K, et al.. Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A noninterventional, post-authorization safety study. Haemophilia. 2023;29(5):1259-1268$75$YR$$F$Y$$$20240927$$HP$US$US
243707321$24370732$1$I$$20240926$20240927$20240927$PER$$US-HALEON-2199078$Haleon PLC$$86$YR$$F$Y$$$20240927$$CN$US$US
243707331$24370733$1$I$20200309$20240918$20240927$20240927$EXP$$BE-AUROBINDO-AUR-APL-2024-047151$AUROBINDO$$61$YR$$M$Y$83$KG$20240927$$MD$BE$BE
243707341$24370734$1$I$$20240920$20240927$20240927$PER$$US-JNJFOC-20240959626$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240927$$HP$US$US
243707351$24370735$1$I$$20240917$20240927$20240927$30DAY$$JP-JNJFOC-20240969726$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$JP$JP
243707361$24370736$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191663$AMGEN$$$$$$Y$$$20240927$$HP$US$US
243707381$24370738$1$I$20240912$20240925$20240927$20240927$EXP$$US-GILEAD-2024-0689111$GILEAD$$72$YR$E$F$Y$$$20240927$$CN$US$US
243707391$24370739$1$I$$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192154$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243707411$24370741$1$I$20240801$20240923$20240927$20240927$EXP$$NVSC2024MX190923$NOVARTIS$$83$YR$$F$Y$78$KG$20240927$$CN$MX$MX
243707421$24370742$1$I$20240501$20240920$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008330$ASTELLAS$$84$YR$E$M$Y$$$20240927$$CN$US$US
243707431$24370743$1$I$$20240916$20240927$20240927$EXP$$CA-APOTEX-2024AP011020$APOTEX$$73$YR$$M$Y$$$20240927$$HP$CA$CA
243707441$24370744$1$I$20240901$20240923$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US081858$SANDOZ$$60$YR$$F$Y$$$20240927$$CN$US$US
243707452$24370745$2$F$20240923$20240927$20240927$20240928$PER$$US-AMGEN-USASP2024192396$AMGEN$$63$YR$A$M$Y$$$20240927$$CN$US$US
243707461$24370746$1$I$$20240917$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-047113$AUROBINDO$Horblitt A, Jain D, Kabra N, Jolly G, Gupta S, Dhaduk K.. SYNTHETIC ANGIOTENSIN II EXACERBATION OF SEPTIC MYOCARDITIS, CAUTIOUS UTILIZATION OF NOVEL VASOPRESSOR PHARMACEUTICALS. J-Am-Coll-Cardiol. 2019;73 (Suppl.)(9):2600$33$YR$$M$Y$$$20240927$$HP$US$US
243707471$24370747$1$I$20240901$20240923$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008609$ASTELLAS$$$$A$F$Y$$$20240927$$HP$US$US
243707481$24370748$1$I$20240923$20240923$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152140$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240927$$CN$US$US
243707491$24370749$1$I$20240101$20240917$20240927$20240927$EXP$$CA-CELLTRION INC.-2024CA022636$CELLTRION$$$$$$Y$$$20240927$$CN$CA$CA
243707501$24370750$1$I$$20240923$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008611$ASTELLAS$$82$YR$E$M$Y$$$20240927$$CN$US$US
243707511$24370751$1$I$20240820$20240920$20240927$20240927$PER$$US-RDY-SPO/USA/24/0014024$DR REDDYS$$64$YR$A$M$Y$$$20240927$$MD$US$US
243707521$24370752$1$I$20230501$20240918$20240927$20240927$EXP$$AT-CELLTRION INC.-2024AT022810$CELLTRION$$$$$$Y$$$20240927$$MD$AT$AT
243707531$24370753$1$I$$20240925$20240927$20240927$EXP$$NVSC2024MT191670$NOVARTIS$$79$YR$$F$Y$$$20240927$$MD$MT$MT
243707541$24370754$1$I$20240101$20240918$20240927$20240927$EXP$$CA-CELLTRION INC.-2024CA000837$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
243707551$24370755$1$I$20240804$20240919$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-047188$AUROBINDO$$36$YR$$F$Y$$$20240927$$CN$FR$FR
243707561$24370756$1$I$$20240925$20240927$20240927$EXP$$IE-AMGEN-IRLSP2024190959$AMGEN$$52$YR$A$M$Y$$$20240927$$CN$IE$IE
243707571$24370757$1$I$20240924$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191730$AMGEN$$$$$F$Y$$$20240927$$PH$US$US
243707581$24370758$1$I$$20240912$20240927$20240927$PER$$US-JNJFOC-20240932625$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243707601$24370760$1$I$20240910$20240923$20240927$20240927$EXP$$US-GSK-US2024118114$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
243707611$24370761$1$I$20240807$20240919$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-047354$AUROBINDO$$46$YR$$M$Y$$$20240927$$MD$ES$ES
243707621$24370762$1$I$$20240919$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149710$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240927$$CN$US$US
243707631$24370763$1$I$20230101$20240923$20240927$20240927$EXP$$US-BBU-2024000288$BIOGEN$Razia D, Ezekpo A, Ali E, Khokar AI, Saeed AI. ROBOTIC BRONCHOSCOPY FOR DIAGNOSIS OF POLYMORPHOUS, PARENCHYMAL, POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD). Chest. 166(4S):5234A-5A. doi:10.1016/j.chest.2024.06.3115$65$YR$$F$Y$$$20240927$$HP$US$US
243707641$24370764$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153005$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$112.94$KG$20240927$$CN$US$US
243707651$24370765$1$I$20230101$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152681$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240927$$CN$US$US
243707662$24370766$2$F$20240918$20240925$20240927$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016339$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240930$$CN$US$US
243707671$24370767$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015342$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240927$$CN$US$US
243707691$24370769$1$I$20240213$20240228$20240927$20240927$PER$$US-INDIVIOR US-INDV-143135-2024$RECKITT BENCKISER$$32$YR$$M$Y$$$20240927$$PH$US$US
243707701$24370770$1$I$$20240306$20240927$20240927$PER$$US-Indivior Limited-INDV-143481-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243707711$24370771$1$I$20230101$20230823$20240927$20240927$PER$$US-Indivior Limited-INDV-140719-2023$RECKITT BENCKISER$$42$YR$$F$Y$22.676$KG$20240927$$HP$US$US
243707721$24370772$1$I$20230601$20240227$20240927$20240927$PER$$US-Indivior Limited-INDV-143348-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$MD$US$US
243707731$24370773$1$I$20231101$20240201$20240927$20240927$PER$$US-Indivior Limited-INDV-142969-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$HP$US$US
243707741$24370774$1$I$$20240131$20240927$20240927$PER$$US-Indivior Limited-INDV-142937-2024$RECKITT BENCKISER$$$$$$Y$$$20240927$$PH$US$US
243707751$24370775$1$I$20231101$20240131$20240927$20240927$PER$$US-Indivior Limited-INDV-142944-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$PH$US$US
243707761$24370776$1$I$$20240326$20240927$20240927$PER$$US-INDIVIOR US-INDV-143777-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$HP$US$US
243707771$24370777$1$I$20230101$20230912$20240927$20240927$PER$$US-INDIVIOR US-INDV-140973-2023$RECKITT BENCKISER$$$$$F$Y$$$20240927$$CN$US$US
243707781$24370778$1$I$$20231229$20240927$20240927$PER$$US-INDIVIOR US-INDV-142425-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243707791$24370779$1$I$20240130$20240131$20240927$20240927$PER$$US-INDIVIOR US-INDV-142962-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$PH$US$US
243707801$24370780$1$I$20240513$20240816$20240927$20240927$PER$$US-Indivior Limited-INDV-145195-2024$RECKITT BENCKISER$$31$YR$$M$Y$$$20240927$$HP$US$US
243707811$24370781$1$I$$20240111$20240927$20240927$PER$$US-Indivior Limited-INDV-142583-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$PH$US$US
243707821$24370782$1$I$20240301$20240328$20240927$20240927$PER$$US-INDIVIOR US-INDV-143822-2024$RECKITT BENCKISER$$$$$$Y$$$20240927$$CN$US$US
243707831$24370783$1$I$$20240216$20240927$20240927$PER$$US-Indivior Limited-INDV-143186-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$HP$US$US
243707841$24370784$1$I$$20240229$20240927$20240927$PER$$US-Indivior Limited-INDV-143376-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243707851$24370785$1$I$$20240202$20240927$20240927$PER$$US-Indivior Limited-INDV-142985-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$HP$US$US
243707861$24370786$1$I$20230101$20240328$20240927$20240927$PER$$US-Indivior-Limited- INDV-143842-2024$RECKITT BENCKISER$$18$YR$$M$Y$$$20240927$$HP$US$US
243707871$24370787$1$I$$20240306$20240927$20240927$PER$$US-Indivior Limited-INDV-143492-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243707881$24370788$1$I$20231201$20240130$20240927$20240927$PER$$US-INDIVIOR US-INDV-142912-2024$RECKITT BENCKISER$$$$$$Y$$$20240927$$HP$US$US
243707891$24370789$1$I$$20240925$20240927$20240927$PER$$NVSC2024US191682$NOVARTIS$$$$$M$Y$$$20240927$$MD$US$US
243707901$24370790$1$I$$20240915$20240927$20240927$EXP$$NL-Inventia-000752$INVENTIA HEALTHCARE$Brouwer M, Offermans M, van Nuil L, Poukens A, van Oijen B, Dormans T. Effective Extracorporeal Treatment of Metformin-Associated Lactic Acidosis using Continuous Venovenous Hemodiafiltration. Eur J Case Rep Intern Med. 2024 Sep 3;11(9):004784.$57$YR$A$F$Y$$$20240927$$HP$NL$NL
243707911$24370791$1$I$$20240915$20240927$20240927$EXP$$CN-Nexus Pharma-000315$NEXUS PHARMACEUTICALS$Luo J, Zhou B, Yang J, Qian H, Zhao Y, She F, et.al. Recurrent ventricular arrhythmias and heart failure induced by osimertinib- a case report. Front Cardiovasc Med. 2024 Aug 29;11:1423647.$70$YR$E$F$Y$$$20240927$$HP$CN$CN
243707921$24370792$1$I$$20240919$20240927$20240927$PER$$US-TAKEDA-2024TUS093755$TAKEDA$$10$YR$$M$Y$$$20240927$$CN$US$US
243707941$24370794$1$I$20240804$20240917$20240927$20240927$PER$$US-GSK-US2024115664$GLAXOSMITHKLINE$$52$YR$$M$Y$$$20240927$$CN$US$US
243707961$24370796$1$I$$20240925$20240927$20240927$PER$$US-JNJFOC-20240969679$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243707981$24370798$1$I$$20240919$20240927$20240927$EXP$$US-ASTRAZENECA-202409USA003325US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240927$$$US$US
243707991$24370799$1$I$$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005502$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243708001$24370800$1$I$$20240912$20240927$20240927$EXP$$US-SMPA-2024SPA002781$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243708011$24370801$1$I$$20231025$20240927$20240927$PER$$US-Indivior Limited-INDV-141551-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$MD$US$US
243708021$24370802$1$I$$20231026$20240927$20240927$PER$$US-INDIVIOR US-INDV-141178-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$CN$US$US
243708031$24370803$1$I$$20240402$20240927$20240927$PER$$US-Indivior Limited-INDV-143965-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$MD$US$US
243708041$24370804$1$I$20240328$20240328$20240927$20240927$PER$$US-INDIVIOR US-INDV-143833-2024$RECKITT BENCKISER$$50$YR$$M$Y$$$20240927$$HP$US$US
243708051$24370805$1$I$20240328$20240329$20240927$20240927$PER$$US-INDIVIOR US-INDV-143911-2024$RECKITT BENCKISER$$$$$$Y$$$20240927$$HP$US$US
243708061$24370806$1$I$20240328$20240418$20240927$20240927$PER$$US-Indivior Limited-INDV-143896-2024$RECKITT BENCKISER$$23$YR$$F$Y$$$20240927$$HP$US$US
243708071$24370807$1$I$20230925$20230928$20240927$20240927$PER$$US-Indivior Limited-INDV-141167-2023$RECKITT BENCKISER$$$$$F$Y$$$20240927$$HP$US$US
243708081$24370808$1$I$20220101$20231002$20240927$20240927$PER$$US-Indivior Limited- INDV-141209-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243708091$24370809$1$I$$20240917$20240927$20240927$PER$$US-ABBVIE-5932620$ABBVIE$$$$$$Y$$$20240927$$HP$US$US
243708101$24370810$1$I$$20240913$20240927$20240927$EXP$$GB-CIPLA LTD.-2024GB10428$CIPLA$$$$$$Y$$$20240927$$CN$GB$GB
243708111$24370811$1$I$20240829$20240913$20240927$20240927$EXP$$IN-CIPLA LTD.-2024IN10432$CIPLA$$$$$$Y$$$20240927$$CN$IN$IN
243708121$24370812$1$I$20210801$20240925$20240927$20240927$EXP$$VN-SANDOZ INC.-SDZ2023VN002687$SANDOZ$$$$A$F$Y$$$20240927$$MD$VN$VN
243708131$24370813$1$I$20240913$20240914$20240927$20240927$EXP$GB-MHRA-MED-202409131626034710-KSPZF$GB-LUPIN PHARMACEUTICALS INC.-2024-09167$LUPIN$$$$$$Y$$$20240927$$PH$GB$GB
243708141$24370814$1$I$$20240919$20240927$20240927$EXP$$US-SECURA BIO, INC.-2024-SECUR-US000100$PAREXEL$$$$$$Y$$$20240927$$CN$US$US
243708151$24370815$1$I$20240401$20240423$20240927$20240927$PER$$US-INDIVIOR US-INDV-144509-2024$RECKITT BENCKISER$$36$YR$$F$Y$$$20240927$$HP$US$US
243708161$24370816$1$I$$20240306$20240927$20240927$PER$$US-Indivior Limited-INDV-143484-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243708171$24370817$1$I$$20240410$20240927$20240927$PER$$US-Indivior Limited-INDV-144216-2024$RECKITT BENCKISER$$48$YR$$M$Y$$$20240927$$MD$US$US
243708181$24370818$1$I$$20240503$20240927$20240927$PER$$US-Indivior Limited-INDV-144818-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$HP$US$US
243708191$24370819$1$I$$20240912$20240927$20240927$EXP$$CA-LUPIN HEALTHCARE (UK) LIMITED-2024-09524$LUPIN$$$$$$Y$$$20240927$$HP$CA$CA
243708201$24370820$1$I$20240221$20240226$20240927$20240927$PER$$US-Indivior Limited-INDV-143304-2024$RECKITT BENCKISER$$35$YR$$M$Y$$$20240927$$HP$US$US
243708211$24370821$1$I$$20240220$20240927$20240927$PER$$US-Indivior Limited-INDV-143230-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243708221$24370822$1$I$20240501$20240516$20240927$20240927$PER$$US-Indivior Limited-INDV-145124-2024$RECKITT BENCKISER$$45$YR$$F$Y$$$20240927$$HP$US$US
243708231$24370823$1$I$$20240307$20240927$20240927$PER$$US-INDIVIOR US-INDV-143509-2024$RECKITT BENCKISER$$19$YR$$M$Y$$$20240927$$HP$US$US
243708241$24370824$1$I$20230101$20240123$20240927$20240927$PER$$US-Indivior Limited-INDV-142729-2024$RECKITT BENCKISER$$42$YR$$M$Y$$$20240927$$HP$US$US
243708251$24370825$1$I$20230101$20240102$20240927$20240927$PER$$US-INDIVIOR US-INDV-142432-2024$RECKITT BENCKISER$$$$$F$Y$98.9$KG$20240927$$CN$US$US
243708261$24370826$1$I$$20240417$20240927$20240927$PER$$US-Indivior Limited-INDV-144376-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$MD$US$US
243708271$24370827$1$I$$20240409$20240927$20240927$PER$$US-Indivior Limited-INDV-144123-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243708281$24370828$1$I$20240201$20240425$20240927$20240927$PER$$US-Indivior Limited-INDV-144598-2024$RECKITT BENCKISER$$$$A$M$Y$$$20240927$$HP$US$US
243708291$24370829$1$I$20240401$20240422$20240927$20240927$PER$$US-Indivior Limited-INDV-144495-2024$RECKITT BENCKISER$$32$YR$$M$Y$$$20240927$$HP$US$US
243708301$24370830$1$I$20231201$20231219$20240927$20240927$PER$$US-INDIVIOR US-INDV-142333-2023$RECKITT BENCKISER$$60$YR$$F$Y$$$20240927$$CN$US$US
243708311$24370831$1$I$$20240424$20240927$20240927$PER$$US-Indivior Limited-INDV-144583-2024$RECKITT BENCKISER$$40$YR$$M$Y$$$20240927$$HP$US$US
243708321$24370832$1$I$$20231017$20240927$20240927$PER$$US-Indivior Limited-INDV-141429-2023$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243708331$24370833$1$I$$20240409$20240927$20240927$PER$$US-Indivior Limited-INDV-144126-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$HP$US$US
243708341$24370834$1$I$$20240515$20240927$20240927$PER$$US-Indivior Limited-INDV-145054-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$HP$US$US
243708381$24370838$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5936766$ABBVIE$$$$$M$Y$$$20240927$$HP$US$US
243708391$24370839$1$I$20230101$20240921$20240927$20240927$EXP$$GB-AMGEN-MLTSP2024191155$AMGEN$$83$YR$E$F$Y$$$20240927$$CN$GB$MT
243708401$24370840$1$I$$20240920$20240927$20240927$EXP$$IT-AMGEN-ITASP2024189526$AMGEN$$$$$$Y$$$20240927$$MD$IT$IT
243708411$24370841$1$I$20240924$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190479$AMGEN$$84$YR$E$F$Y$$$20240927$$CN$US$US
243708421$24370842$1$I$20240924$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190707$AMGEN$$65$YR$E$F$Y$$$20240927$$CN$US$US
243708431$24370843$1$I$20240101$20240918$20240927$20240927$EXP$$CA-CELLTRION INC.-2024CA022638$CELLTRION$$$$$$Y$$$20240927$$HP$CA$CA
243708441$24370844$1$I$$20240925$20240927$20240927$EXP$$AU-Orion Corporation ORION PHARMA-TREX2024-0232$ORION$$42$YR$A$F$Y$$$20240927$$HP$AU$
243708461$24370846$1$I$$20240925$20240927$20240927$EXP$$NVSJ2024JP011307$NOVARTIS$$$$A$F$Y$$$20240927$$MD$JP$JP
243708481$24370848$1$I$$20240920$20240927$20240927$EXP$$US-ABBVIE-5933802$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243708501$24370850$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152814$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240927$$CN$US$US
243708521$24370852$1$I$$20240911$20240927$20240927$PER$$AU-TOLMAR, INC.-24AU052573$TOLMAR$$$$$M$Y$$$20240927$$CN$AU$AU
243708531$24370853$1$I$$20240911$20240927$20240927$PER$$AU-TOLMAR, INC.-24AU052578$TOLMAR$$$$$M$Y$$$20240927$$CN$AU$AU
243708551$24370855$1$I$$20240912$20240927$20240927$PER$$AU-TOLMAR, INC.-24AU052594$TOLMAR$$$$$M$Y$$$20240927$$CN$AU$AU
243708561$24370856$1$I$$20240912$20240927$20240927$PER$$AU-TOLMAR, INC.-24AU052627$TOLMAR$$$$$M$Y$$$20240927$$CN$AU$AU
243708571$24370857$1$I$$20240904$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052055$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243708581$24370858$1$I$20230101$20240903$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA051667$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243708591$24370859$1$I$20240819$20240906$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052078$TOLMAR$$89$YR$$M$Y$$$20240927$$CN$CA$CA
243708601$24370860$1$I$$20240905$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052112$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243708611$24370861$1$I$$20240905$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052079$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243708621$24370862$1$I$20240822$20240905$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052126$TOLMAR$$68$YR$$M$Y$$$20240927$$HP$CA$CA
243708631$24370863$1$I$20240822$20240905$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052155$TOLMAR$$74$YR$$M$Y$$$20240927$$CN$CA$CA
243708641$24370864$1$I$$20240903$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052349$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243708651$24370865$1$I$$20240903$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052354$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243708661$24370866$1$I$$20240903$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052387$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243708671$24370867$1$I$$20240903$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052389$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243708681$24370868$1$I$$20240904$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052397$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243708691$24370869$1$I$$20240904$20240927$20240927$PER$$CA-TOLMAR, INC.-24CA052399$TOLMAR$$$$$M$Y$$$20240927$$CN$CA$CA
243708701$24370870$1$I$20240101$20240924$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008868$ASTELLAS$$$$$M$Y$$$20240927$$CN$US$US
243708711$24370871$1$I$$20240913$20240927$20240927$EXP$$DK-SERVIER-S24011756$SERVIER$Toksvang LN, De Pietri S, Nielsen SN, Nersting J, Albertsen BK, Wehner PS, et al.. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites. Pediatr-Blood-Cancer. 2017;64(9):e26519$$$$$Y$$$20240927$$HP$DK$DK
243708721$24370872$1$I$$20240916$20240927$20240927$EXP$$US-APOTEX-2024AP011143$APOTEX$Cook C, Patel NJ, D^Silva KM, Hsu TY-T, DiIorio M, Prisco L, Wallace Z. S et al.. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann-Rheum-Dis. 2022;81:289-291$$$A$$Y$$$20240927$$HP$US$US
243708731$24370873$1$I$$20240528$20240927$20240927$PER$$US-INDIVIOR US-INDV-145285-2024$RECKITT BENCKISER$$$$$$Y$$$20240927$$PH$US$US
243708741$24370874$1$I$$20240529$20240927$20240927$PER$$US-Indivior Limited-INDV-145313-2024$RECKITT BENCKISER$$$$$$Y$$$20240927$$HP$US$US
243708751$24370875$1$I$$20240529$20240927$20240927$PER$$US-INDIVIOR US-INDV-145298-2024$RECKITT BENCKISER$$$$$$Y$$$20240927$$HP$US$US
243708761$24370876$1$I$20230101$20240521$20240927$20240927$PER$$US-Indivior-Limited- INDV-145190-2024$RECKITT BENCKISER$$52$YR$$M$Y$$$20240927$$HP$US$US
243708771$24370877$1$I$20240201$20240522$20240927$20240927$PER$$US-Indivior Limited-INDV-145237-2024$RECKITT BENCKISER$$$$A$M$Y$78.458$KG$20240927$$HP$US$US
243708781$24370878$1$I$$20240411$20240927$20240927$PER$$US-Indivior Limited-INDV-144226-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$PH$US$US
243708791$24370879$1$I$$20240318$20240927$20240927$PER$$US-Indivior Limited-INDV-143680-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$HP$US$US
243708801$24370880$1$I$20240528$20240528$20240927$20240927$PER$$US-INDIVIOR US-INDV-145277-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243708811$24370881$1$I$$20240529$20240927$20240927$PER$$US-Indivior Limited-INDV-145312-2024$RECKITT BENCKISER$$$$$$Y$$$20240927$$HP$US$US
243708821$24370882$1$I$$20240402$20240927$20240927$PER$$US-INDIVIOR US-INDV-143910-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$CN$US$US
243708841$24370884$1$I$$20240918$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR118389$VIIV$$$$$$Y$$$20240927$$HP$US$US
243708851$24370885$1$I$$20240913$20240927$20240927$EXP$$US-SMPA-2024SPA002842$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243708861$24370886$1$I$$20240923$20240927$20240927$EXP$$US-TAKEDA-2024TUS094300$TAKEDA$$$$$M$Y$$$20240927$$CN$US$US
243708871$24370887$1$I$$20240924$20240927$20240927$EXP$$NVSC2024US190842$NOVARTIS$$$$$M$Y$$$20240927$$MD$US$US
243708881$24370888$1$I$$20240918$20240927$20240927$EXP$CA-MHPD-E2B_07238187$CA-Accord-447432$ACCORD$$69$YR$E$M$Y$$$20240927$$PH$CA$CA
243708891$24370889$1$I$$20240924$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008847$ASTELLAS$$$$E$F$Y$$$20240927$$MD$US$US
243708901$24370890$1$I$$20240913$20240927$20240927$EXP$$US-SMPA-2024SPA002881$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243708911$24370891$1$I$20240720$20240918$20240927$20240927$EXP$FR-AFSSAPS-AN2024001217$FR-Accord-448177$ACCORD$$80$YR$E$F$Y$70.5$KG$20240927$$MD$FR$FR
243708921$24370892$1$I$$20240923$20240927$20240927$PER$$US-ABBVIE-5937655$ABBVIE$$$$$$Y$$$20240927$$HP$US$US
243708931$24370893$1$I$$20240919$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR055372$VIIV$$$$$$Y$$$20240927$$HP$US$US
243708951$24370895$1$I$$20240918$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR118384$VIIV$$$$$$Y$$$20240927$$HP$US$US
243708971$24370897$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024AMR115882$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243708981$24370898$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5936105$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243708991$24370899$1$I$20240923$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190748$AMGEN$$82$YR$E$F$Y$$$20240927$$CN$US$US
243709001$24370900$1$I$$20240923$20240927$20240927$PER$$US-JNJFOC-20240960818$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$CN$US$US
243709011$24370901$1$I$20240901$20240920$20240927$20240927$PER$$US-JNJFOC-20240960121$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240927$$CN$US$US
243709021$24370902$1$I$20220912$20240918$20240927$20240927$EXP$FR-AFSSAPS-DJ20221822$FR-CELLTRION INC.-2024FR022793$CELLTRION$$$$$$Y$$$20240927$$MD$FR$FR
243709031$24370903$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5936915$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243709041$24370904$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245564$TEVA$$26$YR$$F$Y$$$20240927$$HP$CA$CA
243709051$24370905$1$I$20240916$20240923$20240927$20240927$EXP$$US-ABBVIE-5938838$ABBVIE$$50$YR$$F$Y$$$20240927$$CN$US$US
243709061$24370906$1$I$20240925$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017052$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240927$$CN$US$US
243709071$24370907$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016164$ELI LILLY AND CO$$81$YR$E$$Y$$$20240927$$CN$US$US
243709081$24370908$1$I$$20240926$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017409$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240927$$CN$US$US
243709091$24370909$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015332$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240927$$CN$US$US
243709101$24370910$1$I$20240901$20240918$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005686$ACADIA PHARMACEUTICALS$$20$YR$$F$Y$$$20240927$$CN$US$US
243709131$24370913$1$I$$20240918$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005552$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243709141$24370914$1$I$20231107$20240925$20240927$20240927$EXP$$NVSC2024IN191668$NOVARTIS$$49$YR$$F$Y$$$20240927$$CN$IN$IN
243709161$24370916$1$I$$20240913$20240927$20240927$EXP$$US-SMPA-2024SPA002908$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243709171$24370917$1$I$$20240924$20240927$20240927$PER$$NVSC2024US191557$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
243709181$24370918$1$I$$20240917$20240927$20240927$EXP$$CA-APOTEX-2024AP011141$APOTEX$$$$$$Y$$$20240927$$CN$CA$CA
243709201$24370920$1$I$$20240919$20240927$20240927$EXP$$PE-STRIDES ARCOLAB LIMITED-2024SP012444$STRIDES$Torres-Nolasco MF, Arquinio Estremadoyro L, Valenzuela-Rodriguez G.. Streptococcus anginosus spondylodiscitis causing incapacitating back pain in an immunocompetent patient: A case report.. SAGE-Open-Med-Case-Rep. 2024;12$45$YR$$M$Y$$$20240927$$HP$PE$PE
243709211$24370921$1$I$20240901$20240925$20240927$20240927$PER$$US-ABBVIE-5940927$ABBVIE$$$$$F$Y$$$20240927$$HP$US$US
243709221$24370922$1$I$$20240913$20240927$20240927$EXP$$DK-SERVIER-S24011754$SERVIER$Toksvang LN, De Pietri S, Nielsen SN, Nersting J, Albertsen BK, Wehner PS, et al.. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites. Pediatric Blood + Cancer. 2017;64(9):e26519$$$$$Y$$$20240927$$MD$DK$DK
243709231$24370923$1$I$$20240923$20240927$20240927$PER$$US-ABBVIE-5938602$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243709241$24370924$1$I$$20240919$20240927$20240927$EXP$$RO-STRIDES ARCOLAB LIMITED-2024SP012429$STRIDES$Sorohan BM, Ismail G, Oprea C, Tacu D, Constantinescu I, Domnisor L, et al.. HIV and kidney transplantation in Romania: The index case.. Rom-J-Intern-Med. 2024;62 (3):362-368$29$YR$$F$Y$$$20240927$$HP$RO$RO
243709251$24370925$1$I$$20240920$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005837$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243709261$24370926$1$I$$20240920$20240927$20240927$EXP$$CN-STRIDES ARCOLAB LIMITED-2024SP012494$STRIDES$Jiang Y, Mou L, Li X.. A triple SLC12A3 heterozygous mutations in Gitelman syndrome with renal calculi.. Hippokratia. 2023;27 (2):64-68$33$YR$$M$Y$$$20240927$$MD$CN$CN
243709282$24370928$2$F$20240101$20240924$20240927$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-030029$UNITED THERAPEUTICS$$$$$F$Y$53.741$KG$20240928$$$US$US
243709301$24370930$1$I$$20240912$20240927$20240927$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-09497$LUPIN$$53$YR$$M$Y$$$20240927$$HP$CA$CA
243709331$24370933$1$I$$20240923$20240927$20240927$EXP$$US-BBU-2024000287$BIOGEN$Wade A, Clancy C, Hill N, Kinniry P. Secondary polymicrobial empyema in an immunocompetent patient following tocilizumab for COVID-19 pneumonia. Chest. 166 (4S):1248A-9A. doi:10.1016/j.chest.2024.06.811$69$YR$$M$Y$$$20240927$$HP$US$US
243709341$24370934$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005408$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243709351$24370935$1$I$20240909$20240923$20240927$20240927$PER$$US-RDY-SPO/USA/24/0014071$DR REDDYS$$54$YR$A$F$Y$$$20240927$$HP$US$US
243709361$24370936$1$I$$20240918$20240927$20240927$EXP$CA-MHPD-E2B_07238853$CA-Accord-447429$ACCORD$$68$YR$E$F$Y$$$20240927$$HP$CA$CA
243709371$24370937$1$I$20240920$20240922$20240927$20240927$PER$$US-RDY-SPO/USA/24/0014090$DR REDDYS$$32$YR$A$F$Y$$$20240927$$HP$US$US
243709381$24370938$1$I$20240920$20240920$20240927$20240927$PER$$US-RDY-SPO/USA/24/0014039$DR REDDYS$$14$YR$T$F$Y$$$20240927$$HP$US$US
243709391$24370939$1$I$$20240919$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013916$DR REDDYS$$56$YR$A$M$Y$$$20240927$$HP$US$US
243709401$24370940$1$I$$20240920$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0014036$DR REDDYS$$26$YR$A$M$Y$$$20240927$$HP$US$US
243709411$24370941$1$I$20240919$20240923$20240927$20240927$PER$$US-RDY-SPO/USA/24/0014072$DR REDDYS$$52$YR$A$M$Y$$$20240927$$HP$US$US
243709421$24370942$1$I$20240916$20240920$20240927$20240927$PER$$US-RDY-SPO/USA/24/0013955$DR REDDYS$$63$YR$A$M$Y$$$20240927$$MD$US$US
243709431$24370943$1$I$20240101$20240731$20240927$20240927$PER$$US-INDIVIOR US-INDV-146204-2024$RECKITT BENCKISER$$$$$$Y$$$20240927$$HP$US$US
243709441$24370944$1$I$20240101$20240625$20240927$20240927$PER$$US-Indivior Limited-INDV-145763-2024$RECKITT BENCKISER$$57$YR$$F$Y$$$20240927$$HP$US$US
243709451$24370945$1$I$$20240612$20240927$20240927$PER$$US-Indivior Limited-INDV-145549-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$MD$US$US
243709461$24370946$1$I$$20240701$20240927$20240927$PER$$US-Indivior Limited-INDV-145835-2024$RECKITT BENCKISER$$$$$$Y$$$20240927$$HP$US$US
243709471$24370947$1$I$20240101$20240703$20240927$20240927$PER$$US-Indivior Limited-INDV-145872-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$MD$US$US
243709481$24370948$1$I$20230601$20240604$20240927$20240927$PER$$US-Indivior Limited-INDV-145398-2024$RECKITT BENCKISER$$20$YR$$F$Y$$$20240927$$HP$US$US
243709491$24370949$1$I$20240603$20240711$20240927$20240927$PER$$US-INDIVIOR US-INDV-145405-2024$RECKITT BENCKISER$$65$YR$$F$Y$$$20240927$$PH$US$US
243709501$24370950$1$I$$20240530$20240927$20240927$PER$$US-Indivior Limited-INDV-145335-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243709511$24370951$1$I$20240101$20240712$20240927$20240927$PER$$US-INDIVIOR US-INDV-145983-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$PH$US$US
243709521$24370952$1$I$$20240918$20240927$20240927$PER$$US-GSK-US2024116152$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243709541$24370954$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153104$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240927$$CN$US$US
243709571$24370957$1$I$$20240917$20240927$20240927$PER$$US-ABBVIE-5930640$ABBVIE$$$$$$Y$$$20240927$$CN$US$US
243709591$24370959$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024115676$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243709601$24370960$1$I$$20240924$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US057328$SANDOZ$$$$$F$Y$$$20240927$$CN$US$US
243709611$24370961$1$I$20240712$20240924$20240927$20240927$EXP$$ES-EMD Serono-2024038571$EMD SERONO INC$$78$YR$E$M$Y$82$KG$20240927$$MD$ES$ES
243709621$24370962$1$I$20120522$20230919$20240927$20240927$PER$$US-CHIESI-2023CHF04885$CHIESI$$59$YR$$M$Y$45$KG$20240927$$CN$US$US
243709631$24370963$1$I$20180812$20230911$20240927$20240927$PER$$US-CHIESI-2023CHF04687$CHIESI$$3$YR$$F$Y$33$KG$20240927$$CN$US$US
243709641$24370964$1$I$$20230927$20240927$20240927$PER$$US-CHIESI-2023CHF05093$CHIESI$$$$$M$Y$22$KG$20240927$$CN$US$US
243709651$24370965$1$I$20220628$20230912$20240927$20240927$PER$$US-CHIESI-2023CHF04755$CHIESI$$3$YR$$M$Y$15$KG$20240927$$CN$US$US
243709661$24370966$1$I$20200721$20230927$20240927$20240927$PER$$US-CHIESI-2023CHF05024$CHIESI$$6$YR$$F$Y$27$KG$20240927$$CN$US$US
243709671$24370967$1$I$$20230927$20240927$20240927$PER$$US-CHIESI-2023CHF05086$CHIESI$$$$$M$Y$$$20240927$$HP$US$US
243709681$24370968$1$I$$20230927$20240927$20240927$PER$$US-CHIESI-2023CHF05077$CHIESI$$$$$F$Y$$$20240927$$HP$US$US
243709691$24370969$1$I$$20230920$20240927$20240927$PER$$US-CHIESI-2023CHF04950$CHIESI$$$$$$Y$$$20240927$$MD$US$US
243709701$24370970$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005409$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243709711$24370971$1$I$$20240923$20240927$20240927$EXP$$GB-ABBVIE-5937470$ABBVIE$$$$$$Y$$$20240927$$HP$GB$GB
243709721$24370972$1$I$$20240918$20240927$20240927$EXP$$US-JNJFOC-20240951443$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$HP$US$US
243709731$24370973$1$I$$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005503$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243709741$24370974$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192246$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
243709751$24370975$1$I$$20240920$20240927$20240927$EXP$$NVSC2024BR077271$NOVARTIS$$$$$F$Y$$$20240927$$CN$BR$BR
243709761$24370976$1$I$$20240919$20240927$20240927$EXP$GB-MHRA-MED-202409161356594380-FBTGZ$GB-TEVA-VS-3245652$TEVA$$$$$$Y$$$20240927$$PH$GB$GB
243709771$24370977$1$I$$20240924$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083057$SANDOZ$SHAHID R., KO E., UMRANI R.. BATTLING THE BLOCKADE:A CASE OF MULTIFACTORIAL SHOCK IN POLYSUBSTANCE OVERDOSE. chest journel. 2024;A2520-A2521$59$YR$$F$Y$$$20240927$$HP$US$US
243709781$24370978$1$I$20240909$20240923$20240927$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-030282$UNITED THERAPEUTICS$$46$YR$$M$Y$91.61$KG$20240927$$$US$US
243709801$24370980$1$I$$20240919$20240927$20240927$EXP$$CA-TAKEDA-2024TUS093659$TAKEDA$$53$YR$$F$Y$$$20240927$$HP$CA$CA
243709811$24370981$1$I$$20240913$20240927$20240927$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-09193$LUPIN$Malani SK, Chigullapalli S, Sujanyal S, Sharma V. Rosuvastatin-induced myopathy: A case series. Cureus. 2024;16(8):e66180:1-5$78$YR$$F$Y$$$20240927$$HP$IN$IN
243709821$24370982$1$I$$20240917$20240927$20240927$PER$$US-ABBVIE-5929621$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243709831$24370983$1$I$$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005506$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243709841$24370984$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192283$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
243709851$24370985$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192213$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
243709861$24370986$1$I$$20240921$20240927$20240927$PER$$US-JNJFOC-20240963610$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240927$$CN$US$US
243709871$24370987$1$I$20210826$20240918$20240927$20240927$EXP$$CA-TAKEDA-2024TUS093700$TAKEDA$$17$YR$$F$Y$$$20240927$$CN$CA$CA
243709881$24370988$1$I$$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005509$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243709901$24370990$1$I$$20240919$20240927$20240927$EXP$GB-MHRA-MED-202409191353341120-QLNYD$GB-TEVA-VS-3246299$TEVA$$38$YR$$F$Y$57$KG$20240927$$CN$GB$GB
243709921$24370992$1$I$$20240923$20240927$20240927$EXP$$US-UCBSA-2024048973$UCB$ATALAY R, AYELE G, PODDAR VA. KEPPRA-INDUCED RHABDODMYOLYSIS. Chest. 2024;166(4):A3162$47$YR$$M$Y$$$20240927$$HP$US$US
243709931$24370993$1$I$$20240924$20240927$20240927$EXP$GB-MHRA-MIDB-df9a5f5d-17a8-4fdd-860d-51aec1628f1f$GB-MYLANLABS-2024M1086963$MYLAN$$66$YR$$F$Y$$$20240927$$PH$GB$GB
243709941$24370994$1$I$$20240924$20240927$20240927$EXP$$GB-MYLANLABS-2024M1084880$MYLAN$$$$$M$Y$85.6$KG$20240927$$MD$GB$GB
243709951$24370995$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152026$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240927$$CN$US$US
243709961$24370996$1$I$20240724$20240918$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-046999$AUROBINDO$$11$DY$$F$Y$4.6$KG$20240927$$MD$ES$ES
243709971$24370997$1$I$20240814$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152660$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240927$$PH$US$US
243709982$24370998$2$F$20240919$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024190019$AMGEN$$67$YR$E$F$Y$$$20240927$$CN$US$US
243709992$24370999$2$F$$20240926$20240927$20240930$PER$$US-AMGEN-USASP2024192192$AMGEN$$$$$$Y$$$20240930$$CN$US$US
243710011$24371001$1$I$$20240917$20240927$20240927$EXP$$CA-TAKEDA-2024TUS093103$TAKEDA$$$$$F$Y$$$20240927$$CN$CA$CA
243710021$24371002$1$I$20240228$20240919$20240927$20240927$EXP$GB-MHRA-MED-202409171124586580-FTHPR$GB-TEVA-VS-3245451$TEVA$$63$YR$$M$Y$99$KG$20240927$$PH$GB$GB
243710031$24371003$1$I$20240813$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-046917$AUROBINDO$$68$YR$$F$Y$86$KG$20240927$$MD$FR$FR
243710041$24371004$1$I$20240924$20240924$20240927$20240927$EXP$$JP-PFIZER INC-202400263120$PFIZER$$63$YR$$F$Y$$$20240927$$PH$JP$JP
243710051$24371005$1$I$20150101$20240923$20240927$20240927$EXP$ES-AEMPS-1571660$ES-PFIZER INC-202400261414$PFIZER$$85$YR$$M$Y$$$20240927$$HP$ES$ES
243710071$24371007$1$I$$20240918$20240927$20240927$EXP$$JP-ASTELLAS-2024-AER-008079$ASTELLAS$$65$YR$E$M$Y$$$20240927$$MD$JP$JP
243710081$24371008$1$I$20240201$20240425$20240927$20240927$PER$$US-Indivior-Limited-INDV-144712-2024$RECKITT BENCKISER$$$$$M$Y$$$20240927$$HP$US$US
243710091$24371009$1$I$20240401$20240508$20240927$20240927$PER$$US-INDIVIOR US-INDV-144905-2024$RECKITT BENCKISER$$20$YR$$M$Y$$$20240927$$CN$US$US
243710101$24371010$1$I$$20240617$20240927$20240927$PER$$US-Indivior Limited-INDV-145619-2024$RECKITT BENCKISER$$26$YR$$F$Y$$$20240927$$HP$US$US
243710111$24371011$1$I$20240430$20240430$20240927$20240927$PER$$US-INDIVIOR US-INDV-144699-2024$RECKITT BENCKISER$$40$YR$$F$Y$$$20240927$$HP$US$US
243710121$24371012$1$I$20240101$20240701$20240927$20240927$PER$$US-INDIVIOR US-INDV-145900-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$CN$US$US
243710131$24371013$1$I$20240524$20240524$20240927$20240927$PER$$US-INDIVIOR US-INDV-145248-2024$RECKITT BENCKISER$$20$YR$$F$Y$$$20240927$$HP$US$US
243710141$24371014$1$I$20240618$20240621$20240927$20240927$PER$$US-INDIVIOR US-INDV-145712-2024$RECKITT BENCKISER$$28$YR$$F$Y$$$20240927$$PH$US$US
243710151$24371015$1$I$20240903$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192198$AMGEN$$77$YR$E$$Y$$$20240927$$CN$US$US
243710161$24371016$1$I$20240925$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191745$AMGEN$$68$YR$E$F$Y$$$20240927$$CN$US$US
243710171$24371017$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005413$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243710181$24371018$1$I$20240909$20240919$20240927$20240927$EXP$$GB-JUBILANT CADISTA PHARMACEUTICALS-2024GB001350$JUBILANT$$$$A$F$Y$$$20240927$$MD$GB$GB
243710191$24371019$1$I$20240615$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005699$ACADIA PHARMACEUTICALS$$95$YR$$F$Y$$$20240927$$CN$US$US
243710201$24371020$1$I$20240601$20240919$20240927$20240927$EXP$$CA-SMPA-2024MYSCI0700980$SUNOVION$$$$$$Y$$$20240927$$HP$CA$CA
243710211$24371021$1$I$$20240916$20240927$20240927$PER$$US-JNJFOC-20240944096$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$HP$US$US
243710241$24371024$1$I$20240908$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046523$AUROBINDO$$79$YR$$F$Y$$$20240927$$MD$GB$GB
243710251$24371025$1$I$20240730$20240923$20240927$20240927$EXP$$DE-TAKEDA-2024TUS094868$TAKEDA$$46$YR$$F$Y$$$20240927$$CN$DE$DE
243710261$24371026$1$I$$20240918$20240927$20240927$EXP$$CA-TAKEDA-2024TUS083971$TAKEDA$$$$$M$Y$$$20240927$$CN$CA$CA
243710271$24371027$1$I$$20240917$20240927$20240927$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000093$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243710281$24371028$1$I$$20240918$20240927$20240927$EXP$$CA-TAKEDA-2024TUS093497$TAKEDA$$$$$M$Y$$$20240927$$CN$CA$CA
243710291$24371029$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192247$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
243710301$24371030$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005416$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$HP$US$US
243710311$24371031$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024115652$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243710321$24371032$1$I$20240917$20240918$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024116005$VIIV$$40$YR$$F$Y$$$20240927$$CN$US$US
243710341$24371034$1$I$$20240916$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046063$AUROBINDO$Tarantino MD, Hardesty B, Metjian A, Ortel TL, Chen J, Badejo K, et al.. Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A noninterventional, post-authorization safety study. Haemophilia. 2023;29(5):1259-1268$77$YR$$F$Y$$$20240927$$HP$US$US
243710361$24371036$1$I$20200916$20231012$20240927$20240927$PER$$US-CHIESI-2023CHF05384$CHIESI$$7$YR$$F$Y$28$KG$20240927$$HP$US$US
243710371$24371037$1$I$20200808$20231011$20240927$20240927$PER$$US-CHIESI-2023CHF05344$CHIESI$$63$YR$$F$Y$82$KG$20240927$$HP$US$US
243710381$24371038$1$I$20210921$20231004$20240927$20240927$PER$$US-CHIESI-2023CHF05177$CHIESI$$40$YR$$F$Y$68$KG$20240927$$CN$US$US
243710391$24371039$1$I$20230101$20231102$20240927$20240927$PER$$US-CHIESI-2023CHF05814$CHIESI$$$$$F$Y$31$KG$20240927$$CN$US$US
243710401$24371040$1$I$20210508$20231016$20240927$20240927$PER$$US-CHIESI-2023CHF05415$CHIESI$$47$YR$$F$Y$138$KG$20240927$$CN$US$US
243710411$24371041$1$I$$20231018$20240927$20240927$PER$$US-CHIESI-2023CHF05497$CHIESI$$$$$F$Y$76$KG$20240927$$CN$US$US
243710421$24371042$1$I$20190710$20231006$20240927$20240927$PER$$US-CHIESI-2023CHF05256$CHIESI$$19$YR$$F$Y$57$KG$20240927$$CN$US$US
243710431$24371043$1$I$$20240913$20240927$20240927$EXP$$GB-UCBSA-2024047326$UCB$$$$$F$Y$$$20240927$$CN$GB$GB
243710441$24371044$1$I$$20240926$20240927$20240927$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-153248$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240927$$HP$PR$PR
243710451$24371045$1$I$20240801$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152683$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240927$$HP$US$US
243710461$24371046$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152759$BRISTOL MYERS SQUIBB$$46$YR$A$M$Y$100.6$KG$20240927$$PH$US$US
243710481$24371048$1$I$$20240917$20240927$20240927$EXP$$AE-AMGEN-ARENI2024189328$AMGEN$$62$YR$A$M$Y$$$20240927$$CN$AE$AE
243710491$24371049$1$I$20240101$20240924$20240927$20240927$EXP$$US-ABBVIE-5939251$ABBVIE$$50$YR$$M$Y$$$20240927$$MD$US$US
243710501$24371050$1$I$$20240603$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108213$ZYDUS PHARM$$$$$$Y$$$20240927$$HP$US$US
243710511$24371051$1$I$$20240922$20240927$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029916$UNITED THERAPEUTICS$Cheek A, Purta P, Landeen C, Staller AR. Pericardial effusion in pulmonary arterial hypertension: A perplexing presentation. Chest. 2024;166(4):A5921-A5922$65$YR$$M$Y$$$20240927$$$US$US
243710521$24371052$1$I$20240401$20240521$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-107643$ZYDUS PHARM$$$$$$Y$$$20240927$$CN$US$US
243710531$24371053$1$I$20240101$20240531$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108214$ZYDUS PHARM$$$$$$Y$$$20240927$$CN$US$US
243710541$24371054$1$I$20230801$20240603$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108421$ZYDUS PHARM$$$$$$Y$$$20240927$$HP$US$US
243710551$24371055$1$I$20240511$20240607$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108567$ZYDUS PHARM$$$$$$Y$$$20240927$$CN$US$US
243710561$24371056$1$I$20230101$20240611$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108641$ZYDUS PHARM$$$$$$Y$$$20240927$$HP$US$US
243710571$24371057$1$I$20240601$20240618$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108914$ZYDUS PHARM$$$$$$Y$$$20240927$$HP$US$US
243710581$24371058$1$I$20240601$20240617$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108884$ZYDUS PHARM$$$$$$Y$$$20240927$$CN$US$US
243710591$24371059$1$I$$20240614$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108758$ZYDUS PHARM$$$$$$Y$$$20240927$$HP$US$US
243710601$24371060$1$I$20240601$20240621$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108945$ZYDUS PHARM$$$$$$Y$$$20240927$$CN$US$US
243710611$24371061$1$I$20240801$20240914$20240927$20240927$EXP$$IN-CIPLA LTD.-2024IN10524$CIPLA$$$$$$Y$$$20240927$$CN$IN$IN
243710621$24371062$1$I$$20240919$20240927$20240927$PER$$US-TAKEDA-2024TUS093735$TAKEDA$$$$$$Y$$$20240927$$CN$US$US
243710651$24371065$1$I$$20240916$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046067$AUROBINDO$Tarantino MD, Hardesty B, Metjian A, Ortel TL, Chen J, Badejo K, et al. Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A noninterventional, post-authorization safety study. Haemophilia. 2023;29(5):1259-1268$$$E$F$Y$$$20240927$$HP$US$US
243710662$24371066$2$F$20240924$20240925$20240927$20240930$EXP$$US-AMGEN-USASP2024191025$AMGEN$$90$YR$E$F$Y$$$20240930$$HP$US$US
243710671$24371067$1$I$$20240923$20240927$20240927$EXP$$CA-ORGANON-O2409CAN001745$ORGANON$$48$YR$$F$Y$$$20240927$$HP$CA$CA
243710701$24371070$1$I$20240912$20240918$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024116111$VIIV$$32$YR$$M$Y$$$20240927$$HP$US$US
243710711$24371071$1$I$20221115$20240924$20240927$20240927$EXP$$RO-GILEAD-2024-0689017$GILEAD$$44$YR$A$F$Y$$$20240927$$MD$RO$RO
243710721$24371072$1$I$$20240913$20240927$20240927$EXP$$DK-SERVIER-S24011755$SERVIER$Toksvang LN, De Pietri S, Nielsen SN, Nersting J, Albertsen BK, Wehner PS, et al.. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites. Pediatr-Blood-Cancer. 2017;64(9):e26519$$$$$Y$$$20240927$$HP$DK$DK
243710731$24371073$1$I$$20240917$20240927$20240927$EXP$CA-MHPD-E2B_001091379$CA-Accord-447388$ACCORD$$61$YR$A$M$Y$$$20240927$$MD$CA$CA
243710741$24371074$1$I$20230626$20240917$20240927$20240927$EXP$$AU-BEH-2024179138$CSL BEHRING$$12$YR$T$F$Y$$$20240927$$HP$AU$AU
243710751$24371075$1$I$20240901$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005504$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240927$$CN$US$US
243710761$24371076$1$I$$20240925$20240927$20240927$PER$$US-TAKEDA-2024TUS095601$TAKEDA$$$$$F$Y$57$KG$20240927$$MD$US$US
243710771$24371077$1$I$20240922$20240924$20240927$20240927$EXP$$NVSC2024US190522$NOVARTIS$$65$YR$$F$Y$$$20240927$$CN$US$US
243710781$24371078$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192209$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
243710791$24371079$1$I$$20240916$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046173$AUROBINDO$Hernandez CL, Lynch DM, Golash AJ, Marquis K, Besz KM, Oxnard G, et al. Anaphylaxis and systemic mastocytosis controlled with KIT inhibitors in a patient with metastatic lung adenocarcinoma. Ann-Allergy-Asthma-Immunol. 2023;131:668-670$58$YR$$F$Y$$$20240927$$HP$US$US
243710801$24371080$1$I$$20240918$20240927$20240927$EXP$$CA-APOTEX-2024AP011157$APOTEX$$62$YR$$F$Y$$$20240927$$CN$CA$CA
243710811$24371081$1$I$$20240920$20240927$20240927$EXP$$CA-TAKEDA-2023TUS123270$TAKEDA$$$$$F$Y$$$20240927$$CN$CA$CA
243710821$24371082$1$I$20240828$20240914$20240927$20240927$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2162130$JIANGSU HANSOH PHARMACEUTICAL$$69$YR$$F$Y$60$KG$20240927$$MD$CN$CN
243710831$24371083$1$I$$20240916$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046078$AUROBINDO$Jeunesse E, Miller N, Carroll L, Arbuthnot M. Cat scratch disease requiring incision and drainage: A case report. Journal of Pediatric Surgery Case Reports. 2024;108:102851$13$YR$$M$Y$$$20240927$$HP$US$US
243710841$24371084$1$I$20231109$20240918$20240927$20240927$EXP$IT-MINISAL02-978449$IT-CELLTRION INC.-2024IT022805$CELLTRION$$$$$$Y$$$20240927$$MD$IT$IT
243710851$24371085$1$I$$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024192020$AMGEN$$66$YR$E$F$Y$$$20240927$$MD$US$US
243710861$24371086$1$I$$20240917$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-046568$AUROBINDO$Copete S, Garcia-Garcia JG, Judez E. Dexamethasone intravitreal implant in the treatment of macular edema secondary to necrotizing retinitis.. Eur-J-Ophthalmol. 2024$37$YR$$M$Y$$$20240927$$HP$ES$ES
243710871$24371087$1$I$$20240912$20240927$20240927$EXP$$US-Nuvo Pharmaceuticals Inc-2162128$NUVO PHARMACEUTICALS$Full text$28$YR$$F$Y$$$20240927$$$US$US
243710881$24371088$1$I$$20240913$20240927$20240927$EXP$$TR-ACI HealthCare Limited-2162131$ACI HEALTHCARE$Full text$16$YR$$F$Y$$$20240927$$$US$TR
243710891$24371089$1$I$20240916$20240917$20240927$20240927$PER$$US-GSK-US2024AMR115917$GLAXOSMITHKLINE$$7$YR$$F$Y$$$20240927$$CN$US$US
243710901$24371090$1$I$20240915$20240917$20240927$20240927$PER$$US-GSK-US2024115642$GLAXOSMITHKLINE$$52$YR$$M$Y$$$20240927$$CN$US$US
243710911$24371091$1$I$$20240919$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR118390$VIIV$$$$$$Y$$$20240927$$HP$US$US
243710921$24371092$1$I$$20240913$20240927$20240927$EXP$$TR-ACI HealthCare Limited-2162134$ACI HEALTHCARE$Full text$20$YR$$F$Y$$$20240927$$$TR$TR
243710931$24371093$1$I$$20240920$20240927$20240927$EXP$$NVSC2024CN191284$NOVARTIS$Gao N, Tian M, Sun Y, Wang D, Sun G.. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. WEST CHINA JOURNAL OF STOMATOLOGY. 2024;1-7$70$YR$$M$Y$$$20240927$$HP$CN$CN
243710941$24371094$1$I$$20240920$20240927$20240927$EXP$$NVSC2024CN191317$NOVARTIS$Na G, Mei T, Yawei S, Danni W, Guowen S.. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. WEST CHINA JOURNAL OF STOMATOLOGY. 2024;1-7$73$YR$$M$Y$$$20240927$$HP$CN$CN
243710951$24371095$1$I$$20240913$20240927$20240927$EXP$$US-ACI HealthCare Limited-2162129$ACI HEALTHCARE$Abstract$24$YR$$$Y$$$20240927$$$US$US
243710961$24371096$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192229$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
243710971$24371097$1$I$$20240920$20240927$20240927$EXP$$NVSC2024CN191234$NOVARTIS$Gao N, Tian M, Sun Y, Wang D, Sun G. Application of bone perforation in the surgery of medication-related osteonecrosis of the jaw in stage II.. WEST CHINA JOURNAL OF STOMATOLOGY.. 2024;1-7$65$YR$$M$Y$$$20240927$$HP$CN$CN
243710981$24371098$1$I$$20240920$20240927$20240927$EXP$$NVSC2024CN191338$NOVARTIS$Na G, Mei T, Yawei S, Danni W, Guowen S. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw.. WEST CHINA JOURNAL OF STOMATOLOGY. 2024;1-7$$$$M$Y$$$20240927$$HP$CN$CN
243710991$24371099$1$I$$20240920$20240927$20240927$EXP$$NVSC2024CN191258$NOVARTIS$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw.. WEST CHINA JOURNAL OF STOMATOLOGY.. 2024;1-7$64$YR$$F$Y$$$20240927$$HP$CN$CN
243711001$24371100$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016671$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240927$$CN$US$US
243711011$24371101$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016861$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243711021$24371102$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015411$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240927$$CN$US$US
243711031$24371103$1$I$20240916$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015359$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243711041$24371104$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016294$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240927$$CN$US$US
243711051$24371105$1$I$20240907$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016192$ELI LILLY AND CO$$57$YR$A$$Y$$$20240927$$PH$US$US
243711061$24371106$1$I$20240923$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015563$ELI LILLY AND CO$$74$YR$E$M$Y$$$20240927$$CN$US$US
243711071$24371107$1$I$$20240923$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409014827$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240927$$CN$US$US
243711081$24371108$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016596$ELI LILLY AND CO$$66$YR$E$F$Y$$$20240927$$CN$US$US
243711091$24371109$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016467$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240927$$CN$US$US
243711101$24371110$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016645$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240927$$CN$US$US
243711111$24371111$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016169$ELI LILLY AND CO$$$$A$F$Y$$$20240927$$CN$US$US
243711121$24371112$1$I$$20240913$20240927$20240927$EXP$$IN-ACI HealthCare Limited-2162133$ACI HEALTHCARE$Full text$66$YR$$M$Y$$$20240927$$$IN$IN
243711131$24371113$1$I$$20240919$20240927$20240927$EXP$$CA-ROCHE-10000086245$ROCHE$$68$YR$E$F$Y$69$KG$20240927$$CN$CA$CA
243711141$24371114$1$I$$20240919$20240927$20240927$EXP$$CA-ROCHE-10000086266$ROCHE$$54$YR$A$F$Y$61$KG$20240927$$MD$CA$CA
243711151$24371115$1$I$20240101$20240918$20240927$20240927$EXP$$DE-AUROBINDO-AUR-APL-2024-047134$AUROBINDO$$84$YR$$M$Y$75$KG$20240927$$CN$DE$DE
243711161$24371116$1$I$$20240917$20240927$20240927$EXP$$US-JNJFOC-20240947532$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243711171$24371117$1$I$$20240919$20240927$20240927$EXP$$US-JNJFOC-20240960283$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240927$$MD$US$US
243711181$24371118$1$I$20240101$20240918$20240927$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-007889$UNITED THERAPEUTICS$$$$$F$Y$$$20240927$$$US$US
243711191$24371119$1$I$20240101$20240919$20240927$20240927$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000198$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243711201$24371120$1$I$$20240920$20240927$20240927$EXP$$NVSC2024CN191170$NOVARTIS$Gao N, Tian M, Sun Y, Wang D, Sun G. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. WEST CHINA JOURNAL OF STOMATOLOGY. 2024;1-7$79$YR$$M$Y$$$20240927$$HP$CN$CN
243711211$24371121$1$I$$20240920$20240927$20240927$EXP$$NVSC2024CN191175$NOVARTIS$Gao N, Tian M, Sun Y, Wang D, Sun Guowen A. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. WEST CHINA JOURNAL OF STOMATOLOGY. 2024;1-7$62$YR$$M$Y$$$20240927$$HP$CN$CN
243711221$24371122$1$I$$20240920$20240927$20240927$EXP$$NVSC2024CN191167$NOVARTIS$Na G, Mei T, Yawei S, Danni W, Guowen S. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. WEST CHINA JOURNAL OF STOMATOLOGY. 2024;1-7$63$YR$$M$Y$$$20240927$$HP$CN$CN
243711231$24371123$1$I$$20240920$20240927$20240927$EXP$$NVSC2024CN191225$NOVARTIS$Gao N, Tian M, Sun Y, Wang D, Sun G. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. WEST CHINA JOURNAL OF STOMATOLOGY. 2024;1-7$$$$M$Y$$$20240927$$HP$CN$CN
243711251$24371125$1$I$20240910$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005418$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20240927$$CN$US$US
243711261$24371126$1$I$20240911$20240917$20240927$20240927$PER$$US-GSK-US2024113525$GLAXOSMITHKLINE$$61$YR$$F$Y$$$20240927$$CN$US$US
243711271$24371127$1$I$20240701$20240917$20240927$20240927$PER$$US-GSK-US2024115446$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20240927$$CN$US$US
243711291$24371129$1$I$20200831$20240918$20240927$20240927$EXP$$PL-AUROBINDO-AUR-APL-2024-047107$AUROBINDO$$46$YR$$F$Y$70$KG$20240927$$MD$PL$PL
243711301$24371130$1$I$20240201$20240918$20240927$20240927$EXP$$CO-REGENERON PHARMACEUTICALS, INC.-2024-032007$REGENERON$$88$YR$$M$Y$$$20240927$$HP$CO$CO
243711321$24371132$1$I$$20240917$20240927$20240927$EXP$$IN-RDY-LIT/IND/24/0014141$DR REDDYS$Sasidharanpillai S, David EM, Jishna P, Khader A, George N, Sabnam CP, et al. Antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS): A cross-sectional study. Indian Journal of Dermatology, Venereology and Leprology. 2024 Apr;90(3): doi:10.25259/IJDVL_507_2022.$$$$$Y$$$20240927$$HP$IN$IN
243711341$24371134$1$I$20240904$20240919$20240927$20240927$EXP$CN-HENLIUS-24CN017293$CN-Accord-448782$ACCORD$$76$YR$E$M$Y$$$20240927$$MD$CN$CN
243711351$24371135$1$I$$20240920$20240927$20240927$PER$$US-ASTELLAS-2024-AER-008279$ASTELLAS$$56$YR$A$F$Y$$$20240927$$MD$US$US
243711371$24371137$1$I$$20240918$20240927$20240927$EXP$$CA-APOTEX-2024AP011166$APOTEX$$63$YR$$$Y$$$20240927$$CN$CA$CA
243711381$24371138$1$I$20240813$20240919$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005772$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240927$$CN$US$US
243711391$24371139$1$I$$20240919$20240927$20240927$EXP$$PT-AUROBINDO-AUR-APL-2024-047357$AUROBINDO$Correa, J. POSA-049 - (2564) - INVASIVE PNEUMOCOCCAL DISEASE COMPLICATED WITH BILATERAL EMPIEMA.. Medicina Interna - Congressos Nacionais. 30CNMI.. 2024;1121$38$YR$$M$Y$$$20240927$$MD$PT$PT
243711402$24371140$2$F$$20240923$20240927$20240927$EXP$$US-ROCHE-10000088581$ROCHE$SONNINO A, Halaseh R, Chacon D, Ward P, Al-Tarbsheh A, Piotrkowski J. ULCERATIVE ASPERGILLUS TRACHEOBRONCHITIS IN A PATIENT WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOCYTIC LEUKEMIA: A CASE REPORT. Chest. 2024-Oct;166 (4):1202A. doi:10.1016/j.chest.2024.06.786.$66$YR$E$M$Y$$$20240927$$HP$US$US
243711411$24371141$1$I$20240921$20240926$20240927$20240927$EXP$$CN-ROCHE-10000092845$ROCHE$$30$YR$A$F$Y$36$KG$20240927$$HP$CN$CN
243711421$24371142$1$I$20240619$20240924$20240927$20240927$EXP$SE-SEMPA-2024-006735$SE-ROCHE-10000089578$ROCHE$$88$YR$E$F$Y$$$20240927$$MD$SE$SE
243711431$24371143$1$I$20240911$20240918$20240927$20240927$PER$$US-GSK-US2024116139$GLAXOSMITHKLINE$$65$YR$$F$Y$$$20240927$$CN$US$US
243711441$24371144$1$I$20230411$20240918$20240927$20240927$EXP$$GR-CELLTRION INC.-2024GR022637$CELLTRION$$$$$$Y$$$20240927$$MD$GR$GR
243711461$24371146$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005421$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243711471$24371147$1$I$20240917$20240919$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005806$ACADIA PHARMACEUTICALS$$78$YR$$F$Y$$$20240927$$CN$US$US
243711481$24371148$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151269$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240927$$CN$US$US
243711491$24371149$1$I$$20240924$20240927$20240927$PER$$US-009507513-2409USA008869$MERCK$Choudhury Z, Mukherjee A. DAPTOMYCIN-INDUCED ACUTE EOSINOPHILIC PNEUMONIA: DIFFICULT TO DIAGNOSE, BUT OFTEN SIMPLE TO TREAT. Chest. 2024;166(4):A3293-4$53$YR$$M$Y$$$20240927$$HP$US$US
243711501$24371150$1$I$20240717$20240920$20240927$20240927$EXP$ES-AEMPS-1570720$ES-ABBVIE-5939608$ABBVIE$$28$YR$$M$Y$$$20240927$$MD$ES$ES
243711511$24371151$1$I$20220427$20240920$20240927$20240927$EXP$$AU-TAKEDA-2021TUS057570$TAKEDA$$75$YR$$F$Y$$$20240927$$HP$AU$AU
243711521$24371152$1$I$20240917$20240923$20240927$20240927$EXP$$NVSC2024CN191516$NOVARTIS$$72$YR$$F$Y$54$KG$20240927$$HP$CN$CN
243711541$24371154$1$I$20240820$20240925$20240927$20240927$EXP$FR-AFSSAPS-PP2024001062$FR-ABBVIE-5939093$ABBVIE$$73$YR$$F$Y$$$20240927$$HP$FR$FR
243711561$24371156$1$I$$20240927$20240927$20240927$PER$$US-ROCHE-10000093139$ROCHE$$43$YR$A$F$Y$$$20240927$$HP$US$US
243711581$24371158$1$I$20230201$20240921$20240927$20240927$EXP$$US-ORGANON-O2409USA001662$ORGANON$$72$YR$$F$Y$76$KG$20240927$$CN$US$US
243711601$24371160$1$I$20240905$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66163$$FDA-CTU$$69$YR$$M$N$$$20240926$N$HP$US$
243711611$24371161$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66238$$FDA-CTU$$78$YR$$M$N$$$20240926$N$$US$
243711621$24371162$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66199$$FDA-CTU$$80$YR$$M$N$185$LBS$20240926$N$$US$
243711631$24371163$1$I$20240920$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66221$$FDA-CTU$$61$YR$$F$N$$$20240925$N$HP$US$
243711641$24371164$1$I$$20240924$20240927$20240927$EXP$$AU-ASTELLAS-2024-AER-008437$ASTELLAS$$$$$F$Y$$$20240927$$MD$AU$AU
243711651$24371165$1$I$20240101$20240924$20240927$20240927$PER$$US-ABBVIE-5937561$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243711671$24371167$1$I$$20240920$20240927$20240927$EXP$$US-NOVAST LABORATORIES INC.-2024NOV000304$NOVAST$Singh G, Canton C, Langworthy D. Probable chlorthalidone-induced hypokalemic rhabdomyolysis. J Am Pharm Assoc. 2024$52$YR$$M$Y$79.4$KG$20240927$$MD$US$US
243711681$24371168$1$I$$20240918$20240927$20240927$EXP$$CA-APOTEX-2024AP011178$APOTEX$$65$YR$$$Y$$$20240927$$CN$CA$CA
243711691$24371169$1$I$20220101$20240916$20240927$20240927$EXP$$DE-STERISCIENCE B.V.-2024-ST-001458$Steriscience PTE$Dietze N, Trawinski H, Schonherr SG, Lippmann N, Ranft D, Fichtner F, et al.. Infektionsmedizinische und chirurgische Herausforderungen durch Carbapenem-resistente bakterielle Erreger bei der Versorgung Kriegsverletzter aus der Ukraine.. Epid Bull. 2022;36:3-10$60$YR$$F$Y$$$20240927$$MD$DE$DE
243711701$24371170$1$I$20240701$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005703$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240927$$CN$US$US
243711721$24371172$1$I$20240623$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190667$AMGEN$$78$YR$E$F$Y$$$20240927$$CN$US$US
243711731$24371173$1$I$20240925$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191677$AMGEN$$87$YR$E$F$Y$$$20240927$$PH$US$US
243711742$24371174$2$F$20240926$20240927$20240927$20240928$PER$$US-AMGEN-USASP2024192381$AMGEN$$77$YR$E$M$Y$$$20240928$$CN$US$US
243711751$24371175$1$I$20240101$20240917$20240927$20240927$EXP$$JP-AMGEN-JPNSP2024191171$AMGEN$Takanaka H. et al.. Peripartum cardiomyopathy in patients with psychiatric disorders successfully treated with bromocriptine: Two case reports.. Journal of Cardiology Cases.. 2024;29 (3):136-139$42$YR$A$F$Y$$$20240927$$MD$JP$JP
243711761$24371176$1$I$20240922$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192309$AMGEN$$62$YR$A$F$Y$$$20240927$$CN$US$US
243711771$24371177$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005424$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$HP$US$US
243711781$24371178$1$I$20240919$20240919$20240927$20240927$EXP$$CA-JNJFOC-20240955468$JOHNSON AND JOHNSON$$20$YR$A$M$Y$70$KG$20240927$$HP$CA$CA
243711791$24371179$1$I$$20240920$20240927$20240927$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-039683$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$$$20240927$$CN$US$US
243711801$24371180$1$I$$20240926$20240927$20240927$EXP$$CN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053777$BOEHRINGER INGELHEIM$$90$YR$E$F$Y$$$20240927$$CN$CN$CN
243711811$24371181$1$I$20240826$20240919$20240927$20240927$EXP$$ES-VANTIVE-2024VAN019576$Vantive US Healthcare$$48$YR$$M$Y$83.9$KG$20240927$$HP$ES$ES
243711821$24371182$1$I$20240829$20240919$20240927$20240927$EXP$$JP-VANTIVE-2024VAN019839$Vantive US Healthcare$$55$YR$$M$Y$$$20240927$$MD$JP$JP
243711841$24371184$1$I$20240910$20240913$20240927$20240927$PER$$US-JNJFOC-20240936443$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240927$$PH$US$US
243711851$24371185$1$I$$20240919$20240927$20240927$EXP$$CN-VANTIVE-2024VAN019914$Vantive US Healthcare$$60$YR$$$Y$83$KG$20240927$$CN$CN$CN
243711861$24371186$1$I$$20240923$20240927$20240927$EXP$$DE-GILEAD-2024-0688417$GILEAD$$$$$M$Y$$$20240927$$MD$DE$DE
243711871$24371187$1$I$$20240913$20240927$20240927$EXP$$DK-SERVIER-S24011752$SERVIER$Toksvang LN, De Pietri S, Nielsen SN, Nersting J, Albertsen BK, Wehner PS, et al.. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites. Pediatric Blood and Cancer. 2017;64 (9):e26519$$$$$Y$$$20240927$$MD$DK$DK
243711881$24371188$1$I$$20240923$20240927$20240927$EXP$$IL-ROCHE-10000093260$ROCHE$Shadur B, NasserEddin A, Zaidman I, Schejter Y, Even-Or E, Berkun Y, et al. Successful Haematopoietic Stem Cell Transplantation for LRBA Deficiency with Fludarabine, Treosulfan, and Thiotepa-Based Conditioning. Journal of Clinical Immunology.45 (3):1-8. doi:10.1007/s10875-024-01770-1.$26$YR$A$M$Y$$$20240927$$HP$IL$IL
243711891$24371189$1$I$$20240906$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005425$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243711901$24371190$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024192054$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243711911$24371191$1$I$20240707$20240920$20240927$20240927$EXP$FR-AFSSAPS-MA2024001388$FR-AMGEN-FRASP2024188387$AMGEN$$26$YR$A$M$Y$$$20240927$$MD$FR$FR
243711922$24371192$2$F$$20240926$20240927$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017286$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240930$$CN$US$US
243711931$24371193$1$I$$20240917$20240927$20240927$EXP$$US-BIOCODEX2-2024001350$BIOCODEX$$$$$F$Y$40.6$KG$20240927$$CN$US$US
243711941$24371194$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153175$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$68.95$KG$20240927$$CN$US$US
243711951$24371195$1$I$$20240925$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152764$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240927$$CN$US$US
243711981$24371198$1$I$20210606$20240925$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-047615$AUROBINDO$$58$YR$$F$Y$95$KG$20240927$$CN$GB$GB
243711991$24371199$1$I$20231106$20240917$20240927$20240927$EXP$$US-UCBSA-2024048434$UCB$$$$I$$Y$$$20240927$$CN$US$US
243712001$24371200$1$I$20240820$20240925$20240927$20240927$EXP$$US-TAKEDA-2024TUS095508$TAKEDA$$72$YR$$M$Y$$$20240927$$CN$US$US
243712011$24371201$1$I$20240906$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66209$$FDA-CTU$$52$YR$$F$N$$$20240926$Y$PH$US$
243712021$24371202$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66314$$FDA-CTU$$$$$$N$$$20240925$N$CN$US$
243712031$24371203$1$I$20240605$20240919$20240927$20240927$EXP$$DE-AUROBINDO-AUR-APL-2024-047270$AUROBINDO$$$$A$F$Y$75$KG$20240927$$MD$DE$DE
243712041$24371204$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66212$$FDA-CTU$$$$$F$N$$$20240926$N$HP$US$
243712051$24371205$1$I$$20240918$20240927$20240927$EXP$$GB-CELLTRION INC.-2024GB022938$CELLTRION$$$$$$Y$$$20240927$$HP$GB$GB
243712071$24371207$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66173$$FDA-CTU$$$$$F$N$$$20240926$N$HP$US$
243712081$24371208$1$I$$20240924$20240927$20240927$PER$$US-LEO Pharma-373782$LEO PHARM$$19$YR$$F$Y$$$20240927$$HP$US$US
243712101$24371210$1$I$$20240919$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-030049$UNITED THERAPEUTICS$$$$$M$Y$102.04$KG$20240927$$$US$US
243712111$24371211$1$I$20240822$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66241$$FDA-CTU$$52$YR$$F$N$$$20240925$N$HP$US$
243712171$24371217$1$I$$20240912$20240927$20240927$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-09574$LUPIN$$$$$$Y$$$20240927$$HP$CA$CA
243712211$24371221$1$I$$20240926$20240927$20240927$PER$$US-HALEON-2199027$Haleon PLC$$86$YR$$$Y$$$20240927$$CN$US$US
243712221$24371222$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024115645$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243712231$24371223$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024115639$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243712241$24371224$1$I$$20240923$20240927$20240927$PER$$US-GSK-US2024117740$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243712251$24371225$1$I$20240919$20240920$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR117326$VIIV$$$$$M$Y$$$20240927$$PH$US$US
243712261$24371226$1$I$20240901$20240919$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-030157$UNITED THERAPEUTICS$$52$YR$$F$Y$99.773$KG$20240927$$$US$US
243712271$24371227$1$I$$20240924$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083058$SANDOZ$RODE S., CHAIRMAN D.B., GUBELADZE T. A RARE CASE OF GEOTRICHUM CANDIDEMIA IN AN IMMUNOCOMPROMISED PATIENT. CHEST. 2024;166(4):A2729 - A2730$65$YR$$F$Y$$$20240927$$MD$US$US
243712281$24371228$1$I$20240914$20240925$20240927$20240927$EXP$$US-TAKEDA-2024TUS095796$TAKEDA$$83$YR$$F$Y$$$20240927$$CN$US$US
243712301$24371230$1$I$$20240920$20240927$20240927$EXP$$US-ABBVIE-5933564$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243712311$24371231$1$I$20240314$20240919$20240927$20240927$EXP$IT-MINISAL02-1002405$IT-ROCHE-10000086226$ROCHE$$73$YR$E$F$Y$$$20240927$$MD$IT$IT
243712321$24371232$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66311$$FDA-CTU$$$$$$N$$$20240925$N$CN$US$
243712341$24371234$1$I$$20240828$20240927$20240927$30DAY$$US-VEROBIOTECH-2024USVEROSPO00228$VERO BIOTECH$$$$$$Y$$$20240927$$HP$US$US
243712361$24371236$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66329$$FDA-CTU$$$$$$N$$$20240925$N$CN$US$
243712381$24371238$1$I$20240920$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024189437$AMGEN$$76$YR$E$M$Y$$$20240927$$CN$US$US
243712391$24371239$1$I$20240717$20240923$20240927$20240927$EXP$FR-AFSSAPS-GR2024001115$FR-AMGEN-FRASP2024189339$AMGEN$$72$YR$E$M$Y$$$20240927$$PH$FR$FR
243712401$24371240$1$I$$20240920$20240927$20240927$EXP$$US-PHARMING-PHAUS2024000834$PHARMING GROUP$$$$$$Y$$$20240927$$CN$US$US
243712411$24371241$1$I$$20240102$20240927$20240927$PER$$US-Lavipharm SA-2162139$LAVIPHARM$$$$$$Y$$$20240927$$$US$US
243712421$24371242$1$I$20240901$20240923$20240927$20240927$EXP$$US-PHARMING-PHAUS2024000833$PHARMING GROUP$$$$$$Y$$$20240927$$CN$US$US
243712431$24371243$1$I$$20240923$20240927$20240927$PER$$CA-Eisai-EC-2024-175155$EISAI$$$$$M$Y$98$KG$20240927$$HP$CA$CA
243712441$24371244$1$I$20231106$20240917$20240927$20240927$EXP$$US-UCBSA-2023052712$UCB$$28$YR$$F$Y$$$20240927$$CN$US$US
243712451$24371245$1$I$20230822$20240124$20240927$20240927$PER$$US-CHIESI-2024CHF00464$CHIESI$$18$YR$$F$Y$54$KG$20240927$$CN$US$US
243712461$24371246$1$I$$20240918$20240927$20240927$EXP$$US-UCBSA-2024048431$UCB$$$$$F$Y$$$20240927$$HP$US$US
243712471$24371247$1$I$$20240923$20240927$20240927$EXP$$CA-ROCHE-10000088585$ROCHE$$57$YR$A$F$Y$101$KG$20240927$$HP$CA$CA
243712481$24371248$1$I$20210413$20240112$20240927$20240927$PER$$US-CHIESI-2024CHF00150$CHIESI$$13$YR$$F$Y$52.16$KG$20240927$$CN$US$US
243712491$24371249$1$I$20200627$20240119$20240927$20240927$PER$$US-CHIESI-2024CHF00321$CHIESI$$24$YR$$F$Y$54$KG$20240927$$CN$US$US
243712501$24371250$1$I$20211111$20240123$20240927$20240927$PER$$US-CHIESI-2024CHF00420$CHIESI$$50$YR$$F$Y$100$KG$20240927$$CN$US$US
243712511$24371251$1$I$$20240924$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2023US000674$SANDOZ$$$$$$Y$$$20240927$$CN$US$US
243712521$24371252$1$I$20230808$20240702$20240927$20240927$PER$$US-CHIESI-2024CHF00434$CHIESI$$15$YR$$M$Y$45.2$KG$20240927$$HP$US$US
243712531$24371253$1$I$20201022$20240126$20240927$20240927$PER$$US-CHIESI-2024CHF00447$CHIESI$$55$YR$$F$Y$47$KG$20240927$$CN$US$US
243712541$24371254$1$I$20240904$20240918$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005737$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20240927$$HP$US$US
243712561$24371256$1$I$$20240925$20240927$20240927$EXP$$NVSC2024CL191695$NOVARTIS$$$$$F$Y$$$20240927$$MD$CL$CL
243712571$24371257$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153113$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20240927$$HP$US$US
243712581$24371258$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153077$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240927$$HP$US$US
243712591$24371259$1$I$$20240925$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152878$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240927$$HP$US$US
243712601$24371260$1$I$20240925$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191696$AMGEN$$64$YR$A$F$Y$$$20240927$$CN$US$US
243712611$24371261$1$I$20240912$20240913$20240927$20240927$30DAY$$US-AMGEN-USASP2024183879$AMGEN$$42$YR$A$$Y$$$20240927$$PH$US$US
243712621$24371262$1$I$20240918$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191917$AMGEN$$70$YR$E$F$Y$$$20240927$$CN$US$US
243712631$24371263$1$I$$20240924$20240927$20240927$EXP$GB-MHRA-MED-202409241914457570-HRVFM$GB-MYLANLABS-2024M1087218$MYLAN$$$$$M$Y$$$20240927$$CN$GB$GB
243712641$24371264$1$I$$20240828$20240927$20240927$30DAY$$US-VEROBIOTECH-2024USVEROSPO00229$VERO BIOTECH$$$$$$Y$$$20240927$$HP$US$US
243712651$24371265$1$I$20240802$20240924$20240927$20240927$EXP$FR-AFSSAPS-LY2024001348$FR-MYLANLABS-2024M1086593$MYLAN$$91$YR$$M$Y$67$KG$20240927$$PH$FR$FR
243712661$24371266$1$I$20240909$20240918$20240927$20240927$EXP$$CA-BAYER-2024A130258$BAYER$$26$YR$A$F$Y$$$20240927$$CN$CA$CA
243712671$24371267$1$I$20240101$20240924$20240927$20240927$EXP$$US-ABBVIE-5938864$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243712681$24371268$1$I$$20240918$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005755$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243712691$24371269$1$I$20240101$20240913$20240927$20240927$EXP$$US-UCBSA-2024047432$UCB$$$$$F$Y$$$20240927$$CN$US$US
243712701$24371270$1$I$20240519$20240925$20240927$20240927$EXP$$CN-ROCHE-10000091710$ROCHE$$78$YR$E$F$Y$59$KG$20240927$$HP$CN$CN
243712711$24371271$1$I$$20240921$20240927$20240927$EXP$$US-ARGENX-2024-ARGX-US008104$ARGENX BVBA$$$$$$Y$$$20240927$$CN$US$US
243712721$24371272$1$I$20180129$20240923$20240927$20240927$EXP$$DE-ORGANON-1807DEU004261$ORGANON$$16$YR$$F$Y$65$KG$20240927$$MD$DE$DE
243712731$24371273$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245837$TEVA$$76$YR$$M$Y$75$KG$20240927$$HP$CA$CA
243712741$24371274$1$I$$20240919$20240927$20240927$PER$$US-ABBVIE-5932134$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243712751$24371275$1$I$20240101$20240924$20240927$20240927$EXP$$US-ABBVIE-5937934$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243712761$24371276$1$I$20240101$20240919$20240927$20240927$EXP$$TH-BAYER-2024A135078$BAYER$$$$$M$Y$$$20240927$$MD$TH$TH
243712771$24371277$1$I$20240904$20240918$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US082404$SANDOZ$$$$$$Y$$$20240927$$HP$US$US
243712781$24371278$1$I$$20240924$20240927$20240927$EXP$$JP-ASTELLAS-2024-AER-009057$ASTELLAS$Sato J, Wagatsuma K, Akutsu N, Numada Y, Onuma K, Nakamura T, et al. A case of sudden transformation due to steatohepatitis and liver failure that occurred during prostate cancer endocrine therapy. The 135th Meeting of the Hokkaido Branch of the Japanese Gastroenterological Society / the 129th Meeting of the Hokkaido Branch of the Japanese Gastroenterological Endoscopy Society Program and abstract (Hybrid)(2024.08.31-2024.09.01).$8$DEC$E$M$Y$$$20240927$$MD$JP$JP
243712791$24371279$1$I$20240908$20240926$20240927$20240927$EXP$$NVSC2024GB191814$NOVARTIS$$38$YR$$M$Y$$$20240927$$CN$GB$GB
243712801$24371280$1$I$$20240223$20240927$20240927$PER$$US-Lavipharm SA-2162140$LAVIPHARM$$69$YR$$F$Y$$$20240927$$$US$US
243712811$24371281$1$I$20240101$20240918$20240927$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025405$UNITED THERAPEUTICS$$$$$F$Y$104.31$KG$20240927$$$US$US
243712871$24371287$1$I$$20240917$20240927$20240927$EXP$$JP-MYLANLABS-2024M1086417$MYLAN$Okada N, Yamamoto R, Maruoka H, Himeno M, Hiramoto N, Ishikawa T. Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report. Case-Rep-Oncol 2023; 16 (1): 604-612.. 2023;16 (1):604-612$66$YR$$M$Y$$$20240927$$HP$JP$JP
243712881$24371288$1$I$$20240912$20240927$20240927$EXP$$IN-LUPIN HEALTHCARE (UK) LIMITED-2021-20148$LUPIN$Ray S, Srijithesh PR,  Kulkarni GB, Alladi S. Prolonged magnesium sulphate infusion in the management of super-refractory status epilepticus in a probable Anti-Gaba-B autoimmune encephalitis. Neurology India. 2024;72 (4):877-880$28$YR$$F$Y$$$20240927$$HP$IN$IN
243712891$24371289$1$I$$20240917$20240927$20240927$EXP$$JP-MYLANLABS-2024M1086422$MYLAN$Sakamoto T, Obara N, Maruyama Y, Kato T, Kurita N, Hattori K, et al. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia. Eur-J-Haematol 2023; 111 (5): 768-776.. 2023;111 (5):768-776$51$YR$$M$Y$$$20240927$$HP$JP$JP
243712901$24371290$1$I$$20240917$20240927$20240927$EXP$$FR-MYLANLABS-2024M1086211$MYLAN$Altandi SA, Apoil PA, Mazereeuw-Hautier J, Severino-Freire M. Cardio-facio-cutaneous Syndrome with Severe Inflammatory Cutaneous Lesions: Dramatic Effect of Dupilumab. Acta-Derm-Venereol 2024; 104.$$$$F$Y$$$20240927$$HP$FR$FR
243712911$24371291$1$I$$20240917$20240927$20240927$EXP$$JP-MYLANLABS-2024M1086420$MYLAN$Sakamoto T, Obara N, Maruyama Y, Kato T, Kurita N, Hattori K, et al. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia. Eur-J-Haematol 2023; 111 (5): 768-776.. 2023;111 (5):768-776$42$YR$$F$Y$$$20240927$$HP$JP$JP
243712921$24371292$1$I$$20240917$20240927$20240927$EXP$$BE-MYLANLABS-2024M1085778$MYLAN$Zorzi S, Ayako Minemura Ordinola A, Cunha De Souza Lima E, Martins Teixeira G, Salvagno M, Sterchele ED, et al. A glimpse into multimodal neuromonitoring in acute liver failure: A case report. Ann-Med-Surgery 2024; 86 (1): 539-544.$56$YR$$M$Y$$$20240927$$MD$BE$BE
243712931$24371293$1$I$$20240917$20240927$20240927$EXP$$JP-MYLANLABS-2024M1086424$MYLAN$Sakamoto T, Obara N, Maruyama Y, Kato T, Kurita N, Hattori K, et al. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia. Eur-J-Haematol 2023; 111 (5): 768-776.. 2023;111 (5):768-776$22$YR$$F$Y$$$20240927$$HP$JP$JP
243712941$24371294$1$I$$20240917$20240927$20240927$EXP$$JP-MYLANLABS-2024M1086415$MYLAN$Sakamoto T, Obara N, Maruyama Y, Kato T, Kurita N, Hattori K, et al. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia. Eur-J-Haematol 2023; 111 (5): 768-776.. 2023;111 (5):768-776$20$YR$$M$Y$$$20240927$$HP$JP$JP
243712951$24371295$1$I$$20240917$20240927$20240927$EXP$$US-MYLANLABS-2024M1086191$MYLAN$Smith CN, Eisenschenk S, Wang Y. Tiagabine-induced encephalopathy suppressed by vagus nerve stimulation: A case report. Epilepsy-Behav-Rep 2024; 28.$23$YR$$M$Y$$$20240927$$HP$US$US
243712961$24371296$1$I$$20240917$20240927$20240927$EXP$$JP-MYLANLABS-2024M1086416$MYLAN$Kawasaki Y, Matsubara K, Hori M, Isome K. Liver injury and cytopenia after BNT162b2 COVID-19 vaccination in an adolescent. Pediatr-Int 2022; 64 (1):.. 2022;64 (1)$15$YR$$F$Y$$$20240927$$MD$JP$JP
243712971$24371297$1$I$$20240917$20240927$20240927$EXP$$JP-MYLANLABS-2024M1086418$MYLAN$Sakamoto T, Obara N, Maruyama Y, Kato T, Kurita N, Hattori K, et al. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia. Eur-J-Haematol 2023; 111 (5): 768-776.. 2023;111 (5):768-776$42$YR$$F$Y$$$20240927$$HP$JP$JP
243712981$24371298$1$I$$20240917$20240927$20240927$EXP$$ES-MYLANLABS-2024M1085680$MYLAN$Aguilar Gonzalez M, Marin Paya E, Garcia Gil R, Feliciano Sanchez A, Gomez-Lechon Quiros L, Espana Gregori E. Antireconverin antibodies in ocular chronic graft versus host disease: A new cause of nonparaneoplasic autoimmune retinopathy. Eur-J-Ophthalmol 2023; 33 (4): NP105-NP110.$48$YR$$M$Y$$$20240927$$HP$ES$ES
243712991$24371299$1$I$$20240917$20240927$20240927$EXP$$GB-MYLANLABS-2024M1086156$MYLAN$Coid F, Dima A, Livermore C, Das P, Kabra N. Buprenorphine-Associated Behavioral and Psychotic Side Effects A Case Report. J-Clin-Psychopharmacol 2024.$56$YR$$F$Y$$$20240927$$MD$GB$GB
243713021$24371302$1$I$20240728$20240923$20240927$20240927$PER$$CA-Eisai-EC-2024-175348$EISAI$$64$YR$A$M$Y$$$20240927$$CN$CA$CA
243713031$24371303$1$I$$20240917$20240927$20240927$EXP$$JP-MYLANLABS-2024M1085632$MYLAN$Morita Y, Osaki Y, Shogase T, Yoshimoto D, Terada T, Ohtsuru S, et al. Effective efgartigimod treatment for severe thymoma-associated myasthenia gravis experiencing myasthenic crisis: A case report. Neurol-Clin-Neurosci 2024; 12 (5): 312-315.. 2024;12 (5):312-315$38$YR$$M$Y$$$20240927$$HP$JP$JP
243713051$24371305$1$I$20240901$20240923$20240927$20240927$PER$$US-Eisai-EC-2024-175315$EISAI$$75$YR$E$F$Y$65.9$KG$20240927$$MD$US$US
243713061$24371306$1$I$$20240923$20240927$20240927$PER$$US-ABBVIE-5936251$ABBVIE$$$$$$Y$$$20240927$$CN$US$US
243713101$24371310$1$I$$20240828$20240927$20240927$30DAY$$US-VEROBIOTECH-2024USVEROSPO00230$VERO BIOTECH$$$$$$Y$$$20240927$$CN$US$US
243713121$24371312$1$I$$20240924$20240927$20240927$30DAY$$US-SANDOZ INC.-SDZ2024US082809$SANDOZ$$$$$$Y$$$20240927$$CN$US$US
243713131$24371313$1$I$20240101$20240920$20240927$20240927$EXP$FR-AFSSAPS-TS2024001021$FR-EMD Serono-2024050421$EMD SERONO INC$$80$YR$E$M$Y$$$20240927$$MD$FR$FR
243713141$24371314$1$I$$20240920$20240927$20240927$EXP$$US-ASTELLAS-2024-AER-008395$ASTELLAS$Deanda S. The story of the unremitting rash in a lung transplant recipient. Chest. 2024;166(4): A1146-7.$51$YR$A$M$Y$$$20240927$$HP$US$US
243713151$24371315$1$I$$20240921$20240927$20240927$PER$$US-ABBVIE-5935445$ABBVIE$$63$YR$$F$Y$$$20240927$$MD$US$US
243713161$24371316$1$I$$20240919$20240927$20240927$EXP$$JP-ROCHE-10000086812$ROCHE$Tanaka Y, Ikeda N, Niho S, Ishida K. Effectiveness of trastuzumab deruxtecan rechallenge in a patient with HER2-positive metastatic breast cancer: a case report. International Cancer Conference Journal. 2024-Jan; doi:10.1007/s13691-024-00723-0.$70$YR$E$F$Y$$$20240927$$HP$JP$JP
243713171$24371317$1$I$$20240918$20240927$20240927$EXP$$TN-ROCHE-10000085927$ROCHE$$7$YR$C$F$Y$$$20240927$$MD$TN$TN
243713181$24371318$1$I$20240901$20240918$20240927$20240927$PER$$US-JNJFOC-20240949875$JOHNSON AND JOHNSON$$10$YR$C$F$Y$$$20240927$$HP$US$US
243713191$24371319$1$I$$20240920$20240927$20240927$EXP$ES-EMA-DD-20240919-7482655-093834$ES-AMAROX PHARMA-AMR2024ES03304$HETERO$Lizondo Lopez T, Font I Barcelo A, Garcia Gutierrez C, Blasco M, Grafia I, Bastida C, et al.. Clopidogrel-induced thrombotic microangiopathy: a case report.. European journal of hospital pharmacy : science and practice.. 2024;1-4$75$YR$$M$Y$$$20240927$$PH$ES$ES
243713201$24371320$1$I$20240711$20240924$20240927$20240927$EXP$FR-AFSSAPS-TS2024001033$FR-JNJFOC-20240969586$JOHNSON AND JOHNSON$$72$YR$E$M$Y$61$KG$20240927$$HP$FR$FR
243713211$24371321$1$I$$20240918$20240927$20240927$EXP$$CN-AMGEN-CHNSP2024187004$AMGEN$Wang F.. Intravenous immunoglobulin improves live birth rates in patients with unexplained recurrent pregnancy loss. Journal of Reproductive Immunology. 2024;166:1-7$$$$$Y$$$20240927$$HP$CN$CN
243713221$24371322$1$I$20240601$20240923$20240927$20240927$EXP$FR-AFSSAPS-PB2024001004$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112716$ZYDUS PHARM$$$$$$Y$$$20240927$$MD$FR$FR
243713231$24371323$1$I$$20240916$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046126$AUROBINDO$Guarro Carreras MT, Su?rez LJ, Garc?a LL, Reula LM, Del Rosario AN, Rodr?guez Batista FA, et al. Towards full recovery with lurasidone: effective doses in the treatment of agitation, affective, positive, and cognitive symptoms in schizophrenia and of dual psychosis. Drugs in Context. 2024;13:1-18$29$YR$$F$Y$$$20240927$$MD$US$ES
243713241$24371324$1$I$$20240918$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005773$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243713251$24371325$1$I$20230701$20240913$20240927$20240927$EXP$FR-AFSSAPS-LM2024000494$FR-BAXTER-2024BAX024668$BAXTER$$58$YR$$M$Y$$$20240927$$MD$FR$FR
243713271$24371327$1$I$$20240923$20240927$20240927$EXP$$US-MYLANLABS-2024M1086820$MYLAN$$$$$F$Y$$$20240927$$MD$US$US
243713281$24371328$1$I$20240917$20240917$20240927$20240927$PER$$US-GSK-US2024115532$GLAXOSMITHKLINE$$50$YR$$F$Y$$$20240927$$CN$US$US
243713291$24371329$1$I$20240901$20240917$20240927$20240927$PER$$US-GSK-US2024116073$GLAXOSMITHKLINE$$39$YR$$F$Y$$$20240927$$CN$US$US
243713301$24371330$1$I$$20240919$20240927$20240927$PER$$US-GSK-US2024AMR116779$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243713311$24371331$1$I$20240925$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016338$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240927$$CN$US$US
243713321$24371332$1$I$$20240926$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017274$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243713331$24371333$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016318$ELI LILLY AND CO$$20$YR$A$F$Y$$$20240927$$CN$US$US
243713341$24371334$1$I$$20240918$20240927$20240927$PER$$US-MYLANLABS-2024M1085584$MYLAN$$$$$F$Y$74.39$KG$20240927$$CN$US$US
243713351$24371335$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015439$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240927$$CN$US$US
243713361$24371336$1$I$$20240923$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015024$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240927$$CN$US$US
243713371$24371337$1$I$$20240917$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046537$AUROBINDO$Hill A, Wallace R, Balsara K, Papolos A, Hockstein M, Gupta R, et al.. Breaking Away from Ischemia: A Rare Case of Myocarditis-associated Papillary Muscle Rupture Causing Acute Mitral Regurgitation. US-Cardiol. 2024;18 (Suppl.)36$57$YR$$F$Y$$$20240927$$HP$US$US
243713381$24371338$1$I$20240922$20240925$20240927$20240927$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005309$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243713391$24371339$1$I$$20240920$20240927$20240927$EXP$$JP-JNJFOC-20240970328$JOHNSON AND JOHNSON$$5$DEC$A$M$Y$$$20240927$$MD$JP$JP
243713401$24371340$1$I$20240901$20240916$20240927$20240927$PER$$US-JNJFOC-20240942798$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243713411$24371341$1$I$$20240919$20240927$20240927$EXP$$US-BAYER-2024A135083$BAYER$$73$YR$E$F$Y$$$20240927$$CN$US$US
243713421$24371342$1$I$20230324$20240918$20240927$20240927$EXP$FR-AFSSAPS-NY2023000882$FR-CELLTRION INC.-2024FR022751$CELLTRION$$$$$$Y$$$20240927$$MD$FR$FR
243713431$24371343$1$I$$20240912$20240927$20240927$30DAY$$KR-JNJFOC-20240956700$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$KR$KR
243713451$24371345$1$I$20240801$20240918$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005771$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$$$20240927$$CN$US$US
243713461$24371346$1$I$$20240916$20240927$20240927$EXP$$JP-MSNLABS-2024MSNLIT02091$MSN LABORATORIES$Tsujinaka H, Imoto S, Ueda T, Wakuta M, Yamada Y, Sugisawa T,Murao F,Hirano T,Yoshida S,Kato K,Sasaki M,Matsumoto R,Ishigooka G,Ogata N.Incidence and prognosis of taxane-induced macular edema: a retrospective study from the Japan Clinical REtina Study Group (J-CREST).Scientific Reports.2024;14 (1):19530$$$$$Y$$$20240927$$HP$JP$JP
243713471$24371347$1$I$20240201$20240222$20240927$20240927$PER$$US-CHIESI-2024CHF00981$CHIESI$$4$YR$$F$Y$12.2$KG$20240927$$CN$US$US
243713481$24371348$1$I$$20240214$20240927$20240927$PER$$US-CHIESI-2024CHF00828$CHIESI$$$$$F$Y$37$KG$20240927$$CN$US$US
243713491$24371349$1$I$$20240923$20240927$20240927$EXP$$US-HALEON-2198699$Haleon PLC$$64$YR$$M$Y$$$20240927$$HP$US$US
243713501$24371350$1$I$20201119$20240220$20240927$20240927$PER$$US-CHIESI-2024CHF01015$CHIESI$$58$YR$$M$Y$77$KG$20240927$$CN$US$US
243713511$24371351$1$I$20211109$20240129$20240927$20240927$PER$$US-CHIESI-2024CHF00493$CHIESI$$69$YR$$M$Y$45$KG$20240927$$CN$US$US
243713521$24371352$1$I$20230118$20240208$20240927$20240927$PER$$US-CHIESI-2024CHF00715$CHIESI$$18$YR$$F$Y$61.6$KG$20240927$$CN$US$US
243713531$24371353$1$I$20230101$20240202$20240927$20240927$PER$$US-CHIESI-2024CHF00625$CHIESI$$$$$F$Y$75.7$KG$20240927$$CN$US$US
243713541$24371354$1$I$$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024189794$AMGEN$Almasri T.; Desai H. H.; Kubbara A. et al.. NAVIGATING COMPLEXITY: A CASE OF POLYANGIITIS OVERLAP SYNDROME PRESENTING WITH CARDIAC INVOLVEMENT. Chest. 2024;166 (4S):A5534-A5535$45$YR$A$M$Y$$$20240927$$HP$US$US
243713551$24371355$1$I$20240801$20240918$20240927$20240927$EXP$$CA-UCBSA-2024048921$UCB$$42$YR$$F$Y$$$20240927$$CN$CA$CA
243713571$24371357$1$I$20240626$20240919$20240927$20240927$EXP$FR-AFSSAPS-AVMA2024000402$FR-TEVA-VS-3245963$TEVA$$35$YR$$M$Y$$$20240927$$PH$FR$FR
243713581$24371358$1$I$20240901$20240919$20240927$20240927$EXP$$US-RECORDATI RARE DISEASE INC.-2024007357$RECORDATI$$$$$$Y$$$20240927$$CN$US$US
243713591$24371359$1$I$$20240916$20240927$20240927$EXP$$FI-Accord-447940$ACCORD$Kerokoski S, Hofmann N, Laurila S. Elvytykseen johtaneen runsaan oksentelun aiheuttama hypokaleeminen, hypokloreeminen metabolinen alkaloosi. Duodecim. 2020 FEB,136:390-395.$64$YR$A$M$Y$$$20240927$$MD$FI$FI
243713601$24371360$1$I$$20240916$20240927$20240927$PER$$US-MSNLABS-2024MSNSPO02049$MSN LABORATORIES$$$$$$Y$$$20240927$$CN$US$US
243713611$24371361$1$I$20240311$20240917$20240927$20240927$EXP$$JP-ROCHE-10000089924$ROCHE$$7$DEC$E$M$Y$$$20240927$$MD$JP$JP
243713621$24371362$1$I$20230807$20240919$20240927$20240927$EXP$$IN-SANDOZ INC.-SDZ2024IN083283$SANDOZ$$$$$M$Y$$$20240927$$CN$IN$IN
243713631$24371363$1$I$$20240925$20240927$20240927$EXP$$US-TAKEDA-2024TUS095459$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
243713651$24371365$1$I$20230101$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152493$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240927$$CN$US$US
243713661$24371366$1$I$$20240920$20240927$20240927$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001920$BLUEPRINT MEDICINES$$$$$F$Y$$$20240927$$CN$US$US
243713671$24371367$1$I$$20240729$20240927$20240927$PER$$US-Lavipharm SA-2162142$LAVIPHARM$$$$$$Y$$$20240927$$MD$US$US
243713681$24371368$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245829$TEVA$$74$YR$$M$Y$$$20240927$$PH$CA$CA
243713691$24371369$1$I$$20240917$20240927$20240927$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112440$ZYDUS PHARM$$$$$$Y$$$20240927$$CN$US$US
243713701$24371370$1$I$$20240621$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109057$ZYDUS PHARM$$$$$$Y$$$20240927$$CN$US$US
243713711$24371371$1$I$$20240621$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109139$ZYDUS PHARM$$$$$$Y$$$20240927$$HP$US$US
243713721$24371372$1$I$20240806$20240923$20240927$20240927$EXP$FR-AFSSAPS-LY2024001322$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112647$ZYDUS PHARM$$$$$$Y$$$20240927$$PH$FR$FR
243713731$24371373$1$I$$20240624$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-108946$ZYDUS PHARM$$$$$$Y$$$20240927$$CN$US$US
243713741$24371374$1$I$20240501$20240705$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109442$ZYDUS PHARM$$$$$$Y$$$20240927$$CN$US$US
243713751$24371375$1$I$20240101$20240701$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109538$ZYDUS PHARM$$$$$$Y$$$20240927$$HP$US$US
243713761$24371376$1$I$20240614$20240710$20240927$20240927$PER$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-109807$ZYDUS PHARM$$$$$$Y$$$20240927$$CN$US$US
243713771$24371377$1$I$$20240918$20240927$20240927$EXP$$US-LEO Pharma-373637$LEO PHARM$$47$YR$$F$Y$$$20240927$$CN$US$US
243713781$24371378$1$I$$20240913$20240927$20240927$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-09192$LUPIN$Malani SK, Chigullapalli S, Sujanyal S, Sharma V. Rosuvastatin-induced myopathy: A case series. Cureus. 2024;16(8): e66180:1-5$62$YR$$M$Y$$$20240927$$HP$IN$IN
243713791$24371379$1$I$$20240822$20240927$20240927$EXP$$US-CIPLA LTD.-2024US09559$CIPLA$$$$$$Y$$$20240927$$CN$US$US
243713801$24371380$1$I$20240917$20240918$20240927$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029556$UNITED THERAPEUTICS$$53$YR$$F$Y$$$20240927$$$US$US
243713811$24371381$1$I$20240819$20240910$20240927$20240927$PER$$US-TEVA-VS-3242614$TEVA$$75$YR$$F$Y$$$20240927$$HP$US$US
243713821$24371382$1$I$$20240911$20240927$20240927$EXP$$NVSC2024DE191733$NOVARTIS$$42$YR$$F$Y$$$20240927$$MD$DE$DE
243713831$24371383$1$I$20240101$20240912$20240927$20240927$PER$$US-GRANULES-US-2024GRASPO00425$GRANULES INDIA$$$$$F$Y$$$20240927$$CN$US$US
243713841$24371384$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66189$$FDA-CTU$$64$YR$$F$N$94.35$KG$20240926$N$$US$
243713861$24371386$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66442$$FDA-CTU$$65$YR$$M$N$83.46$KG$20240926$N$$US$
243713911$24371391$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66168$$FDA-CTU$$71$YR$$M$N$$$20240926$N$$US$
243713951$24371395$1$I$$20240913$20240927$20240927$EXP$$CA-UCBSA-2024047463$UCB$$$$$F$Y$$$20240927$$CN$CA$CA
243713971$24371397$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66211$$FDA-CTU$$54$YR$$F$N$90.72$KG$20240926$N$$US$
243713991$24371399$1$I$$20240920$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083185$SANDOZ$$$$$$Y$$$20240927$$PH$US$US
243714001$24371400$1$I$$20240917$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046431$AUROBINDO$Asif H, Braman SS.. Combined Pulmonary Fibrosis and Emphysema in a Patient With Chronic Occupational Exposure to Trichloroethylene. Mil-Med. 2024;189e907-e910$84$YR$$M$Y$$$20240927$$HP$US$US
243714011$24371401$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66219$$FDA-CTU$$75$YR$$M$N$$$20240926$N$$US$
243714041$24371404$1$I$$20240913$20240927$20240927$EXP$$TN-QUAGEN-2024QUALIT00304$QUAGEN PHARMACEUTICALS$Khouloud Razki.^From levetiracetam to lithium^: A journey of hope to manage suicidality and depression.Journal of the Neurological Sciences.2023;455:119-120$20$YR$A$M$Y$$$20240927$$HP$TN$TN
243714061$24371406$1$I$20240926$20240926$20240926$20240926$DIR$720174$$FDA-CTU$$$$$UNK$N$$$20240926$N$CN$US$
243714071$24371407$1$I$20240101$20240920$20240927$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-152432$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$67$KG$20240927$$MD$JP$JP
243714081$24371408$1$I$20240918$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046774$AUROBINDO$$$$$$Y$$$20240927$$PH$GB$GB
243714101$24371410$1$I$$20240922$20240927$20240927$EXP$$CA-ASTELLAS-2024-AER-008552$ASTELLAS$$43$YR$A$F$Y$$$20240927$$HP$CA$CA
243714121$24371412$1$I$20240920$20240920$20240927$20240927$EXP$$CA-TAKEDA-2024TUS094537$TAKEDA$$41$YR$$F$Y$$$20240927$$CN$CA$CA
243714131$24371413$1$I$$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192296$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243714141$24371414$1$I$20240924$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024192311$AMGEN$$$$$$Y$$$20240927$$CN$US$US
243714151$24371415$1$I$20221027$20240923$20240927$20240927$EXP$$ES-PFIZER INC-202400261421$PFIZER$$40$YR$$F$Y$77.9$KG$20240927$$MD$ES$ES
243714171$24371417$1$I$20240920$20240923$20240927$20240927$EXP$GB-MHRA-MED-202409231118387060-QKPHT$GB-PFIZER INC-202400261669$PFIZER$$32$YR$$F$Y$130$KG$20240927$$HP$GB$GB
243714181$24371418$1$I$20240701$20240924$20240927$20240927$EXP$$US-PFIZER INC-PV202400125637$PFIZER$$$$$M$Y$$$20240927$$CN$US$US
243714191$24371419$1$I$20240816$20240923$20240927$20240927$EXP$FR-AFSSAPS-BX2024001810$FR-PFIZER INC-202400261451$PFIZER$$22$YR$$M$Y$$$20240927$$PH$FR$FR
243714201$24371420$1$I$20240405$20240923$20240927$20240927$EXP$$FR-PFIZER INC-202400261450$PFIZER$$80$YR$$M$Y$$$20240927$$MD$FR$FR
243714211$24371421$1$I$20240921$20240923$20240927$20240927$EXP$$US-PFIZER INC-202400263043$PFIZER$$70$YR$$M$Y$$$20240927$$CN$US$US
243714221$24371422$1$I$$20240916$20240927$20240927$EXP$GB-MHRA-MED-202409140958417690-DKJSH$GB-LUPIN PHARMACEUTICALS INC.-2024-09286$LUPIN$$$$$F$Y$$$20240927$$CN$GB$GB
243714231$24371423$1$I$20240823$20240925$20240927$20240927$EXP$$US-TAKEDA-US202030122$TAKEDA$$74$YR$$F$Y$63$KG$20240927$$CN$US$US
243714241$24371424$1$I$$20240319$20240927$20240927$PER$$US-Lavipharm SA-2162143$LAVIPHARM$$25$YR$$F$Y$$$20240927$$MD$US$US
243714251$24371425$1$I$$20240920$20240927$20240927$EXP$$CN-SANDOZ INC.-SDZ2024CN082506$SANDOZ$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. West China Journal of Stomatology. 2024;1-7$81$YR$$F$Y$$$20240927$$HP$CN$CN
243714261$24371426$1$I$20240919$20240919$20240927$20240927$EXP$$CO-ABBVIE-5939761$ABBVIE$$69$YR$$M$Y$45$KG$20240927$$HP$CO$CO
243714271$24371427$1$I$$20240922$20240927$20240927$EXP$$TR-BAYER-2024A138241$BAYER$Bulut I.; Katran Z.Y.; Babalik A.; Keren M.; Tepetam F.M.. Delayed drug hypersensitivity to anti-tuberculosis drug: a new desensitization scheme. Postepy Dermatologii i Alergologii. 2024;41:4:400-407$65$YR$E$F$Y$$$20240927$$HP$TR$TR
243714291$24371429$1$I$20240918$20240920$20240927$20240927$EXP$$CN-ROCHE-10000088574$ROCHE$$64$YR$A$F$Y$60$KG$20240927$$HP$CN$CN
243714301$24371430$1$I$$20240913$20240927$20240927$EXP$$US-QUAGEN-2024QUALIT00305$QUAGEN PHARMACEUTICALS$AM Torrie.Apparent Reversal of a Successful Peripheral Neural Blockade With Intravenous Lipid Emulsion After Treatment for Local Anesthetic Systemic Toxicity: A Case Report.A and A Practice.NOV-2020;14$42$YR$A$F$Y$56.7$KG$20240927$$HP$US$US
243714321$24371432$1$I$$20240925$20240927$20240927$EXP$$US-GILEAD-2024-0689131$GILEAD$$$$A$M$Y$$$20240927$$CN$US$US
243714331$24371433$1$I$$20240925$20240927$20240927$EXP$$GB-SANDOZ INC.-SDZ2024GB083311$SANDOZ$$$$$M$Y$$$20240927$$CN$GB$GB
243714341$24371434$1$I$20240826$20240924$20240927$20240927$EXP$$US-ABBVIE-5938419$ABBVIE$$84$YR$$M$Y$$$20240927$$CN$US$US
243714351$24371435$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245835$TEVA$$80$YR$$M$Y$86$KG$20240927$$HP$CA$CA
243714361$24371436$1$I$20240701$20240920$20240927$20240927$EXP$$US-ABBVIE-5933533$ABBVIE$$42$YR$$M$Y$$$20240927$$CN$US$US
243714381$24371438$1$I$$20240924$20240927$20240927$EXP$$CA-MYLANLABS-2024M1087414$MYLAN$$$$$F$Y$$$20240927$$HP$CA$CA
243714391$24371439$1$I$$20240912$20240927$20240927$PER$$US-COSETTE-CP2024US000258$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243714401$24371440$1$I$$20240919$20240927$20240927$PER$$US-TAKEDA-2024TUS093741$TAKEDA$$$$$$Y$$$20240927$$CN$US$US
243714411$24371441$1$I$$20240918$20240927$20240927$PER$$US-MYLANLABS-2024M1086772$MYLAN$$$$$F$Y$$$20240927$$HP$US$US
243714421$24371442$1$I$$20240918$20240927$20240927$EXP$$CA-APOTEX-2024AP011197$APOTEX$$3$YR$$M$Y$$$20240927$$HP$CA$CA
243714431$24371443$1$I$$20240918$20240927$20240927$PER$$US-GSK-US2024116157$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$HP$US$US
243714441$24371444$1$I$20240813$20240813$20240926$20240926$DIR$FDA-CDER-CTU-2024-66497$$FDA-CTU$$67$YR$$F$N$$$20240813$N$HP$US$
243714451$24371445$1$I$20240918$20240926$20240926$20240926$DIR$720172$$FDA-CTU$$58$YR$$F$N$$$20240926$N$PH$US$
243714461$24371446$1$I$20240401$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66526$$FDA-CTU$$51$YR$$F$N$$$20240926$N$HP$US$
243714471$24371447$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400263264$PFIZER$$26$YR$$M$Y$$$20240927$$CN$US$US
243714481$24371448$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400263757$PFIZER$$$$$$Y$$$20240927$$CN$US$US
243714491$24371449$1$I$$20240924$20240927$20240927$EXP$$BR-PFIZER INC-202400262824$PFIZER$$31$YR$$F$Y$$$20240927$$CN$BR$BR
243714501$24371450$1$I$20180101$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400263538$PFIZER$$84$YR$$F$Y$$$20240927$$MD$US$US
243714521$24371452$1$I$20240619$20240924$20240927$20240927$EXP$FR-AFSSAPS-LY2024001445$FR-PFIZER INC-202400262660$PFIZER$$68$YR$$M$Y$60$KG$20240927$$PH$FR$FR
243714571$24371457$1$I$$20240910$20240927$20240927$EXP$$NVSC2024CA190786$NOVARTIS$$44$YR$$F$Y$97$KG$20240927$$CN$CA$CA
243714581$24371458$1$I$20240909$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046701$AUROBINDO$$31$YR$$F$Y$150$KG$20240927$$CN$GB$GB
243714591$24371459$1$I$$20240924$20240927$20240927$EXP$$US-ABBVIE-5938559$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243714601$24371460$1$I$$20240925$20240927$20240927$EXP$$NVSC2024IN191514$NOVARTIS$$$$$F$Y$$$20240927$$CN$IN$IN
243714621$24371462$1$I$$20240913$20240927$20240927$EXP$$TW-QUAGEN-2024QUALIT00306$QUAGEN PHARMACEUTICALS$Zhi-Fu Wu.Self limiting Skin Rash Found in a Patient with Suspected Malignant Hyperthermia Attack - A Case Report .Journal of Medical Sciences.12-APR-2024;44:185-187$3$YR$C$F$Y$13.6$KG$20240927$$HP$TW$TW
243714631$24371463$1$I$$20240916$20240927$20240927$PER$$US-RDY-CLI/USA/24/0013792$DR REDDYS$$30$YR$A$F$Y$62.6$KG$20240927$$CN$US$US
243714651$24371465$1$I$$20240913$20240927$20240927$EXP$$DK-SERVIER-S24011753$SERVIER$Toksvang LN, De Pietri S, Nielsen SN, Nersting J, Albertsen BK, Wehner PS, et al.. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites. Pediatric Blood and Cancer. 2017;64 (9):e26519$$$$$Y$$$20240927$$MD$DK$DK
243714661$24371466$1$I$$20240911$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09156$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243714671$24371467$1$I$$20240913$20240927$20240927$30DAY$$BR-JNJFOC-20240956672$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$BR$BR
243714681$24371468$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005452$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243714691$24371469$1$I$20240901$20240925$20240927$20240927$PER$$US-ABBVIE-5939774$ABBVIE$$40$YR$$F$Y$$$20240927$$HP$US$US
243714701$24371470$1$I$$20240415$20240927$20240927$PER$$US-Lavipharm SA-2162144$LAVIPHARM$$$$$M$Y$$$20240927$$MD$US$US
243714711$24371471$1$I$$20240918$20240927$20240927$EXP$$CA-APOTEX-2024AP011151$APOTEX$$61$YR$$M$Y$$$20240927$$CN$CA$CA
243714721$24371472$1$I$$20240917$20240927$20240927$EXP$$BR-CELLTRION INC.-2023BR005981$CELLTRION$$$$$$Y$$$20240927$$CN$BR$BR
243714731$24371473$1$I$20240917$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046767$AUROBINDO$$39$YR$$F$Y$$$20240927$$CN$GB$GB
243714741$24371474$1$I$$20240917$20240927$20240927$EXP$$AU-ROCHE-10000088290$ROCHE$$59$YR$A$M$Y$$$20240927$$CN$AU$AU
243714751$24371475$1$I$20240920$20240925$20240927$20240927$EXP$$CA-PFIZER INC-202400264733$PFIZER$$99$YR$$F$Y$$$20240927$$HP$CA$CA
243714761$24371476$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400263175$PFIZER$$46$YR$$F$Y$$$20240927$$HP$US$US
243714781$24371478$1$I$20240725$20240924$20240927$20240927$EXP$FR-AFSSAPS-PP2024000994$FR-PFIZER INC-202400262653$PFIZER$$63$YR$$M$Y$72.3$KG$20240927$$MD$FR$FR
243714791$24371479$1$I$20240101$20240924$20240927$20240927$EXP$$US-PFIZER INC-PV202400045333$PFIZER$$69$YR$$F$Y$$$20240927$$MD$US$US
243714802$24371480$2$F$20240714$20240929$20240927$20240930$EXP$$EG-PFIZER INC-PV202400124717$PFIZER$$18$DY$$F$Y$2.4$KG$20240930$$PH$EG$EG
243714811$24371481$1$I$$20240924$20240927$20240927$EXP$$CA-PFIZER INC-202400263039$PFIZER$$73$YR$$M$Y$$$20240927$$MD$CA$CA
243714821$24371482$1$I$20240601$20240924$20240927$20240927$EXP$IT-MINISAL02-1003257$IT-PFIZER INC-202400262675$PFIZER$$40$YR$$F$Y$73$KG$20240927$$MD$IT$IT
243714831$24371483$1$I$20240915$20240924$20240927$20240927$EXP$$CN-PFIZER INC-PV202400124954$PFIZER$$16$YR$$M$Y$93$KG$20240927$$HP$CN$CN
243714841$24371484$1$I$20240401$20240924$20240927$20240927$EXP$$PR-PFIZER INC-202400263434$PFIZER$$75$YR$$F$Y$$$20240927$$MD$PR$PR
243714861$24371486$1$I$$20240919$20240927$20240927$EXP$$US-UCBSA-2024048603$UCB$$$$$$Y$$$20240927$$CN$US$US
243714871$24371487$1$I$20220101$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400263962$PFIZER$$64$YR$$F$Y$$$20240927$$HP$US$US
243714881$24371488$1$I$20240604$20240924$20240927$20240927$EXP$$CN-PFIZER INC-PV202400124932$PFIZER$$64$YR$$F$Y$46$KG$20240927$$HP$CN$CN
243714891$24371489$1$I$20240817$20240924$20240927$20240927$EXP$FR-AFSSAPS-AM2024000770$FR-PFIZER INC-202400262527$PFIZER$$73$YR$$F$Y$60$KG$20240927$$PH$FR$FR
243714911$24371491$1$I$$20240916$20240927$20240927$EXP$$GB-MSNLABS-2024MSNLIT02119$MSN LABORATORIES$Katis G, Srinivasan S, Eleftheriou P, Walker M, Demetriades P.Characterizing left ventricular systolic dysfunction in sickle cell disease: three contrasting case reports.European Heart Journal-Case Reports.2024;8(8):ytae383$$$$$Y$$$20240927$$HP$GB$GB
243714921$24371492$1$I$20240908$20240923$20240927$20240927$EXP$$US-BAYER-2024A132506$BAYER$$72$YR$E$F$Y$$$20240927$$CN$US$US
243714931$24371493$1$I$20240907$20240918$20240927$20240927$EXP$$US-ETON PHARMACEUTICALS, INC-2024ETO000245$ETON PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243714941$24371494$1$I$20240803$20240916$20240927$20240927$EXP$FR-AFSSAPS-LL2024001722$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08732$HIKMA$$63$YR$$M$Y$$$20240927$$PH$FR$FR
243714951$24371495$1$I$$20240913$20240927$20240927$EXP$$GB-QUAGEN-2024QUALIT00302$QUAGEN PHARMACEUTICALS$Layla Thurston.The complexities of managing neuropathic pain.British Journal of Diabetes.JUN-2024;24:114$75$YR$E$M$Y$$$20240927$$HP$GB$GB
243714961$24371496$1$I$$20240915$20240927$20240927$EXP$$US-SAGENT PHARMACEUTICALS-2024SAG000149$SAGENT$Romero K N, O^Brien M C, Agrawal A, et al.. Creatine Kinase Surge: Levetiracetam-Induced Rhabdomyolysis. Cureus. 2024;16(8):e66715$27$YR$$M$Y$$$20240927$$HP$US$US
243714971$24371497$1$I$20240918$20240918$20240927$20240927$EXP$$US-UCBSA-2024048630$UCB$$49$YR$$M$Y$$$20240927$$MD$US$US
243714981$24371498$1$I$20240706$20240921$20240927$20240927$EXP$FR-AFSSAPS-PP2024000997$FR-ROCHE-10000088054$ROCHE$$71$YR$E$M$Y$65$KG$20240927$$MD$FR$FR
243715001$24371500$1$I$20240922$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024190052$AMGEN$$79$YR$E$F$Y$$$20240927$$CN$US$US
243715031$24371503$1$I$20221019$20240923$20240927$20240927$EXP$$GR-AMGEN-GRCSP2023099706$AMGEN$$90$YR$E$F$Y$67$KG$20240927$$MD$GR$GR
243715051$24371505$1$I$$20240925$20240927$20240927$EXP$$NVSC2024US191710$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
243715061$24371506$1$I$$20240926$20240926$20240926$DIR$720215$$FDA-CTU$$49$YR$$F$N$59.4$KG$20240926$N$CN$US$
243715091$24371509$1$I$20240925$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192319$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243715111$24371511$1$I$$20240925$20240927$20240927$EXP$$NVSC2024TH191661$NOVARTIS$$44$YR$$F$Y$$$20240927$$MD$TH$TH
243715122$24371512$2$F$$20240930$20240927$20240930$EXP$$DK-BAYER-2024A135838$BAYER$$$$$F$Y$$$20240930$$CN$DK$DK
243715131$24371513$1$I$20240101$20240919$20240927$20240927$EXP$$US-UCBSA-2024048574$UCB$$$$$F$Y$131.5$KG$20240927$$HP$US$US
243715171$24371517$1$I$$20240912$20240927$20240927$PER$$US-COSETTE-CP2024US000256$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243715181$24371518$1$I$$20240913$20240927$20240927$EXP$$NL-Unichem Pharmaceuticals (USA) Inc-UCM202409-001186$UNICHEM$$57$YR$A$F$Y$$$20240927$$HP$NL$
243715191$24371519$1$I$$20240925$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083338$SANDOZ$$$$$M$Y$$$20240927$$CN$US$US
243715201$24371520$1$I$$20240923$20240927$20240927$EXP$$AU-EMD Serono-2023459915$EMD SERONO INC$$$$E$M$Y$$$20240927$$MD$AU$AU
243715211$24371521$1$I$$20240919$20240927$20240927$PER$$US-GSK-US2024116657$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243715221$24371522$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024115662$GLAXOSMITHKLINE$$$$$M$Y$$$20240927$$CN$US$US
243715241$24371524$1$I$20240801$20240822$20240927$20240927$EXP$$GB-UCBSA-2024048763$UCB$$72$YR$$F$Y$$$20240927$$CN$GB$GB
243715251$24371525$1$I$$20240925$20240927$20240927$EXP$$AU-ABBVIE-5940832$ABBVIE$$$$E$M$Y$$$20240927$$MD$AU$AU
243715261$24371526$1$I$$20240917$20240927$20240927$EXP$$GB-MSNLABS-2024MSNSPO02080$MSN LABORATORIES$$$$$$Y$$$20240927$$PH$GB$GB
243715271$24371527$1$I$20240615$20240920$20240927$20240927$EXP$ES-AEMPS-1571658$ES-HETERO-AMR2024ES03305$HETERO$$57$YR$$M$Y$$$20240927$$MD$ES$ES
243715281$24371528$1$I$20240914$20240923$20240927$20240927$EXP$$US-BAYER-2024A137196$BAYER$$78$YR$E$M$Y$101.59$KG$20240927$$CN$US$US
243715291$24371529$1$I$20230701$20240917$20240927$20240927$EXP$$BR-ROCHE-10000086874$ROCHE$$54$YR$A$F$Y$$$20240927$$MD$BR$BR
243715301$24371530$1$I$20240905$20240919$20240927$20240927$PER$$CN-Eisai-EC-2024-175015$EISAI$$51$YR$A$M$Y$64$KG$20240927$$HP$CN$CN
243715311$24371531$1$I$20240901$20240918$20240927$20240927$PER$$US-Eisai-EC-2024-174847$EISAI$$$$$M$Y$$$20240927$$MD$US$US
243715321$24371532$1$I$$20240918$20240927$20240927$PER$$US-JNJFOC-20240960401$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243715331$24371533$1$I$$20240917$20240927$20240927$EXP$$AR-JNJFOC-20240952996$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$MD$AR$AR
243715341$24371534$1$I$20210301$20240920$20240927$20240927$EXP$FR-AFSSAPS-AVPO2024000182$FR-TEVA-VS-3246608$TEVA$$57$YR$$M$Y$$$20240927$$PH$FR$FR
243715351$24371535$1$I$20240901$20240918$20240927$20240927$EXP$$US-UCBSA-2024048290$UCB$$35$YR$$M$Y$$$20240927$$HP$US$US
243715361$24371536$1$I$$20240923$20240927$20240927$EXP$$US-UCBSA-2024049280$UCB$Richard C, Schriger D, Weingrow D,. Rapid Electroencephalography and Artificial Intelligence in the Detection and Management of Nonconvulsive Seizures. Annals of Emergency Medicine. 2024;84(4):422-427$$$$$Y$$$20240927$$MD$US$US
243715371$24371537$1$I$$20240916$20240927$20240927$EXP$$CA-ROCHE-10000083449$ROCHE$$$$A$M$Y$$$20240927$$CN$CA$CA
243715381$24371538$1$I$$20240924$20240927$20240927$EXP$$US-VIIV HEALTHCARE LIMITED-US2024118341$VIIV$$$$$$Y$$$20240927$$MD$US$US
243715391$24371539$1$I$$20240925$20240927$20240927$EXP$$GB-GSK-GB2024EME119113$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$GB$GB
243715471$24371547$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66207$$FDA-CTU$$59$YR$$F$N$$$20240926$N$HP$US$
243715491$24371549$1$I$20240701$20240926$20240926$20240926$DIR$720154$$FDA-CTU$$30$YR$$M$N$67.95$KG$20240926$N$CN$US$
243715521$24371552$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66195$$FDA-CTU$$69$YR$$F$N$$$20240926$N$$US$
243715561$24371556$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66228$$FDA-CTU$$71$YR$$F$N$72.57$KG$20240926$N$HP$US$
243715571$24371557$1$I$$20240923$20240926$20240926$DIR$FDA-CDER-CTU-2024-66174$$FDA-CTU$$$$$M$N$$$20240923$N$HP$US$
243715611$24371561$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66172$$FDA-CTU$$69$YR$$M$N$$$20240926$N$HP$US$
243715621$24371562$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66192$$FDA-CTU$$67$YR$$F$N$67.13$KG$20240926$N$$US$
243715631$24371563$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66200$$FDA-CTU$$62$YR$$F$N$$$20240926$N$$US$
243715651$24371565$1$I$$20240916$20240927$20240927$PER$$US-ROCHE-10000083373$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243715661$24371566$1$I$$20240916$20240927$20240927$PER$$US-ROCHE-10000083359$ROCHE$$$$$$Y$$$20240927$$PH$US$US
243715671$24371567$1$I$$20240813$20240927$20240927$PER$$US-LUNDBECK-DKLU4003519$LUNDBECK$$$$$$Y$$$20240927$$CN$US$US
243715681$24371568$1$I$20240515$20240905$20240927$20240927$EXP$$NL-SA-2024SA151715$SANOFI AVENTIS$$$$$$Y$$$20240927$$HP$NL$NL
243715701$24371570$1$I$$20240913$20240927$20240927$EXP$$FR-QUAGEN-2024QUALIT00298$QUAGEN PHARMACEUTICALS$A Baudriller.Deaths related to pharmacobezoars: A report on two cases..Toxicologie Analytique et Clinique.JAN-2024$55$YR$A$F$Y$$$20240927$$HP$FR$FR
243715711$24371571$1$I$20240829$20240926$20240927$20240927$EXP$$US-PFIZER INC-202400264996$PFIZER$$70$YR$$F$Y$$$20240927$$HP$US$US
243715721$24371572$1$I$20240705$20240925$20240927$20240927$EXP$$JP-PFIZER INC-PV202400093694$PFIZER$$57$YR$$M$Y$$$20240927$$MD$JP$JP
243715741$24371574$1$I$$20240925$20240927$20240927$EXP$$CA-PFIZER INC-202400264703$PFIZER$$69$YR$$M$Y$$$20240927$$CN$CA$CA
243715751$24371575$1$I$20240925$20240925$20240927$20240927$EXP$$CA-PFIZER INC-202400264537$PFIZER$$78$YR$$F$Y$$$20240927$$HP$CA$CA
243715761$24371576$1$I$$20240925$20240927$20240927$EXP$$US-PFIZER INC-202400264563$PFIZER$$83$YR$$M$Y$$$20240927$$CN$US$US
243715771$24371577$1$I$$20240925$20240927$20240927$EXP$$US-PFIZER INC-202400264320$PFIZER$$83$YR$$F$Y$$$20240927$$CN$US$US
243715781$24371578$1$I$20240916$20240925$20240927$20240927$EXP$$US-PFIZER INC-202400264973$PFIZER$$33$YR$$F$Y$$$20240927$$HP$US$US
243715791$24371579$1$I$20240906$20240925$20240927$20240927$EXP$$GB-PFIZER INC-PV202400125990$PFIZER$$80$YR$$M$Y$$$20240927$$CN$GB$GB
243715801$24371580$1$I$$20240926$20240927$20240927$EXP$$NL-PFIZER INC-PV202400125977$PFIZER$$$$$$Y$$$20240927$$MD$NL$NL
243715821$24371582$1$I$$20240925$20240927$20240927$EXP$$GB-PFIZER INC-PV202400126079$PFIZER$$83$YR$$M$Y$$$20240927$$CN$GB$GB
243715831$24371583$1$I$$20240925$20240927$20240927$EXP$$GB-PFIZER INC-PV202400126043$PFIZER$$83$YR$$F$Y$$$20240927$$CN$GB$GB
243715841$24371584$1$I$$20240925$20240927$20240927$EXP$$CA-PFIZER INC-202400264698$PFIZER$$38$YR$$M$Y$$$20240927$$MD$CA$CA
243715851$24371585$1$I$$20240925$20240927$20240927$EXP$$IE-PFIZER INC-202400263827$PFIZER$$$$$M$Y$$$20240927$$MD$IE$IE
243715861$24371586$1$I$$20240925$20240927$20240927$EXP$$CA-PFIZER INC-202400264722$PFIZER$$69$YR$$F$Y$$$20240927$$MD$CA$CA
243715871$24371587$1$I$$20240926$20240927$20240927$EXP$$US-PFIZER INC-202400265072$PFIZER$$60$YR$$F$Y$$$20240927$$CN$US$US
243715891$24371589$1$I$20240729$20240925$20240927$20240927$EXP$ES-AEMPS-1572925$ES-PFIZER INC-202400263525$PFIZER$$71$YR$$M$Y$$$20240927$$MD$ES$ES
243715901$24371590$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245847$TEVA$$83$YR$$M$Y$$$20240927$$PH$CA$CA
243715921$24371592$1$I$$20240925$20240927$20240927$EXP$$CA-PFIZER INC-202400264707$PFIZER$$68$YR$$F$Y$$$20240927$$MD$CA$CA
243715931$24371593$1$I$$20240912$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09200$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243715941$24371594$1$I$20240922$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190915$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243715951$24371595$1$I$20240909$20240925$20240927$20240927$EXP$$US-PFIZER INC-202400264530$PFIZER$$60$YR$$M$Y$$$20240927$$HP$US$US
243715971$24371597$1$I$$20240920$20240927$20240927$EXP$$CO-TAKEDA-2024TUS095461$TAKEDA$$$$$M$Y$89$KG$20240927$$CN$CO$CO
243715981$24371598$1$I$20240902$20240924$20240927$20240927$EXP$$NVSC2024US191294$NOVARTIS$$66$YR$$M$Y$85.28$KG$20240927$$CN$US$US
243715991$24371599$1$I$$20240919$20240927$20240927$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-01044$CATALYST PHARMA$$$$A$$Y$$$20240927$$MD$US$US
243716001$24371600$1$I$20240801$20240920$20240927$20240927$EXP$$US-CATALYST PHARMACEUTICALS, INC-US-CATA-24-01059$CATALYST PHARMA$$47$YR$$F$Y$112.47$KG$20240927$$CN$US$US
243716011$24371601$1$I$$20240919$20240927$20240927$EXP$$US-CATALYSTPHARMACEUTICALPARTNERS-US-CATA-24-01043$CATALYST PHARMA$$30$YR$$$Y$$$20240927$$MD$US$US
243716021$24371602$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005465$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243716041$24371604$1$I$$20240920$20240927$20240927$EXP$$US-GSK-US2024117177$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$HP$US$US
243716051$24371605$1$I$$20240918$20240927$20240927$EXP$$GB-MACLEODS PHARMA-MAC2024049491$MACLEODS$Abdalrazag OA, Okoye AO, Muniyappa SM.Title to be provided..British Journal of Diabetes.2024;24(1)$$$$$Y$$$20240927$$MD$GB$GB
243716061$24371606$1$I$20240801$20240920$20240927$20240927$EXP$$US-TAKEDA-2020TUS056808$TAKEDA$$72$YR$$F$Y$$$20240927$$HP$US$US
243716071$24371607$1$I$$20240918$20240927$20240927$EXP$$IT-MYLANLABS-2024M1086509$MYLAN$Giorgia G, Alberto G, Marta Z, Iacopo C, Maura A, Giovanna M et.al. Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than Single Infusion?. The Journal of Clinical Endocrinology and Metabolism. 2024;109:1817?e1826$74$YR$$F$Y$$$20240927$$MD$IT$IT
243716081$24371608$1$I$$20240918$20240927$20240927$EXP$$US-MYLANLABS-2024M1086530$MYLAN$Szeto CH, Enabi J, Garcia Fernandez A. Warfarin induced spontaneous gastric intramural haematoma presenting with palpitations. BMJ-Case-Rep 2024; 17 (3): 1-4.$8$DEC$$M$Y$$$20240927$$HP$US$US
243716091$24371609$1$I$20240101$20240910$20240927$20240927$EXP$$US-SA-2024SA277471$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240927$$PH$US$US
243716101$24371610$1$I$$20240918$20240927$20240927$EXP$$IT-MYLANLABS-2024M1086510$MYLAN$Giorgia G, Alberto G, Marta Z, Iacopo C, Maura A, Giovanna M et.al. Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than Single Infusion?. The Journal of Clinical Endocrinology and Metabolism. 2024;109:1817?e1826$81$YR$$F$Y$$$20240927$$MD$IT$IT
243716111$24371611$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66525$$FDA-CTU$$72$YR$$M$N$$$20240927$N$$US$
243716151$24371615$1$I$$20240918$20240927$20240927$EXP$$US-MYLANLABS-2024M1086525$MYLAN$Rezigh A, Rezigh A, Sherman S. Lessons in clinical reasoning - Pitfalls, myths, and pearls: A woman brought to a halt. Diagn 2024; 11 (2): 205-211.$60$YR$$F$Y$$$20240927$$MD$US$US
243716161$24371616$1$I$20240315$20240920$20240927$20240927$EXP$GB-MHRA-MED-202409200810225960-FCHTQ$GB-TEVA-VS-3246526$TEVA$$$$$M$Y$$$20240927$$CN$GB$GB
243716191$24371619$1$I$$20240918$20240927$20240927$PER$$US-009507513-2409USA008465$MERCK$$$$$F$Y$$$20240927$$HP$US$US
243716231$24371623$1$I$$20240918$20240927$20240927$EXP$$US-MYLANLABS-2024M1086284$MYLAN$Sama S, Weickhardt A, Subramanian P, Reddy P. Phospholipase A2 receptor-negative membranous nephropathy presenting as a rare renal manifestation of IgG4-related disease. SAGE-Open-Med-Case-Rep 2024; 12.$75$YR$$M$Y$$$20240927$$HP$US$US
243716281$24371628$1$I$$20240913$20240927$20240927$30DAY$$ES-JNJFOC-20240956578$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$ES$ES
243716291$24371629$1$I$$20240923$20240927$20240927$EXP$$US-BAYER-2024A136715$BAYER$$$$$M$Y$$$20240927$$CN$US$US
243716301$24371630$1$I$$20240913$20240927$20240927$EXP$$US-SMPA-2024SPA002758$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243716311$24371631$1$I$$20240913$20240927$20240927$EXP$$US-SMPA-2024SPA002764$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243716321$24371632$1$I$$20240913$20240927$20240927$EXP$$US-SMPA-2024SPA002754$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243716341$24371634$1$I$20240917$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046754$AUROBINDO$$$$$$Y$$$20240927$$PH$GB$GB
243716361$24371636$1$I$$20240912$20240927$20240927$EXP$$US-SMPA-2024SPA002734$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243716371$24371637$1$I$20240913$20240913$20240927$20240927$EXP$$US-SA-2024SA275415$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240927$$CN$US$US
243716381$24371638$1$I$$20240923$20240927$20240927$EXP$$US-BAYER-2024A136939$BAYER$$$$$$Y$$$20240927$$CN$US$US
243716391$24371639$1$I$$20240913$20240927$20240927$EXP$$US-SMPA-2024SPA002777$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243716401$24371640$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015680$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240927$$CN$US$US
243716411$24371641$1$I$$20240926$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017599$ELI LILLY AND CO$$63$YR$A$$Y$$$20240927$$LW$US$US
243716421$24371642$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016342$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240927$$CN$US$US
243716431$24371643$1$I$$20240920$20240927$20240927$EXP$$US-SMPA-2024SPA003136$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243716441$24371644$1$I$$20240918$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409013354$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$US$US
243716461$24371646$1$I$$20240919$20240927$20240927$EXP$$CA-ROCHE-10000062807$ROCHE$$44$YR$A$F$Y$60$KG$20240927$$HP$CA$CA
243716471$24371647$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66521$$FDA-CTU$$56$YR$$F$N$$$20240926$N$$US$
243716501$24371650$1$I$20230817$20240924$20240927$20240927$EXP$$CA-TAKEDA-2024TUS095260$TAKEDA$$22$YR$$F$Y$$$20240927$$CN$CA$CA
243716511$24371651$1$I$$20240923$20240927$20240927$EXP$$US-TAKEDA-2024TUS094615$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
243716531$24371653$1$I$20240925$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66450$$FDA-CTU$$54$YR$$M$N$180$KG$20240926$N$PH$US$
243716541$24371654$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66532$$FDA-CTU$$77$YR$$M$N$$$20240926$N$$US$
243716551$24371655$1$I$20200131$20240925$20240927$20240927$EXP$PL-URPL-1-988-2020$PL-ABBVIE-5938268$ABBVIE$$29$YR$$F$Y$55$KG$20240927$$MD$PL$PL
243716561$24371656$1$I$$20240919$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024116523$VIIV$$$$$M$Y$$$20240927$$PH$US$US
243716571$24371657$1$I$20240922$20240924$20240927$20240927$EXP$$NVSC2024GB191065$NOVARTIS$$80$YR$$F$Y$$$20240927$$HP$GB$GB
243716581$24371658$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192239$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
243716591$24371659$1$I$20240801$20240919$20240927$20240927$EXP$$US-UCBSA-2024048576$UCB$$37$YR$$F$Y$$$20240927$$HP$US$US
243716601$24371660$1$I$20231201$20240923$20240927$20240927$EXP$AT-BASGAGES-2024-006749$AT-ORGANON-O2409AUT001783$ORGANON$$68$YR$$M$Y$$$20240927$$MD$AT$AT
243716611$24371661$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66179$$FDA-CTU$$76$YR$$M$N$$$20240926$N$$US$
243716621$24371662$1$I$$20240829$20240927$20240927$30DAY$$US-VEROBIOTECH-2024USVEROSPO00231$VERO BIOTECH$$$$$$Y$$$20240927$$HP$US$US
243716631$24371663$1$I$$20240912$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09202$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243716641$24371664$1$I$20180101$20240923$20240927$20240927$EXP$$US-AMGEN-USASP2024189684$AMGEN$$58$YR$A$M$Y$$$20240927$$HP$US$US
243716661$24371666$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66216$$FDA-CTU$$50$YR$$F$N$$$20240926$N$$US$
243716671$24371667$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66170$$FDA-CTU$$64$YR$$F$N$$$20240926$N$$US$
243716691$24371669$1$I$20231201$20240923$20240927$20240927$EXP$DK-DKMA-30731833$DK-TEVA-VS-3246993$TEVA$$50$YR$$F$Y$79$KG$20240927$$MD$DK$DK
243716701$24371670$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66233$$FDA-CTU$$$$$F$N$$$20240926$N$HP$US$
243716721$24371672$1$I$20240810$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66177$$FDA-CTU$$69$YR$$F$N$$$20240926$N$HP$US$
243716731$24371673$1$I$20240908$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66398$$FDA-CTU$$78$YR$$M$N$$$20240926$Y$PH$US$
243716741$24371674$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66160$$FDA-CTU$$$$$M$N$$$20240926$N$HP$US$
243716751$24371675$1$I$20240926$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66523$$FDA-CTU$$69$YR$$F$N$$$20240926$Y$PH$US$
243716761$24371676$1$I$20240925$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66527$$FDA-CTU$$71$YR$$F$N$$$20240926$Y$PH$US$
243716781$24371678$1$I$20240822$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66240$$FDA-CTU$$52$YR$$F$N$$$20240925$N$HP$US$
243716791$24371679$1$I$$20240924$20240927$20240927$EXP$$CA-TAKEDA-2024TUS095287$TAKEDA$$$$$M$Y$$$20240927$$CN$CA$CA
243716801$24371680$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005466$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243716811$24371681$1$I$20240101$20240919$20240927$20240927$EXP$$US-UCBSA-2024048486$UCB$$$$$M$Y$$$20240927$$CN$US$US
243716841$24371684$1$I$$20240920$20240927$20240927$30DAY$$US-PFIZER INC-202400261137$PFIZER$$13$YR$$M$Y$$$20240927$$CN$US$US
243716851$24371685$1$I$20210101$20240923$20240927$20240927$30DAY$$US-PFIZER INC-202400262092$PFIZER$$49$YR$$M$Y$97.52$KG$20240927$$CN$US$US
243716901$24371690$1$I$$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66213$$FDA-CTU$$$$$F$N$$$20240925$N$HP$US$
243716911$24371691$1$I$20240926$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66535$$FDA-CTU$$65$YR$$F$N$$$20240926$Y$PH$US$
243716921$24371692$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66530$$FDA-CTU$$50$YR$$M$N$$$20240926$N$$US$
243716931$24371693$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66396$$FDA-CTU$$62$YR$$F$N$$$20240926$N$$US$
243716941$24371694$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005470$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243716961$24371696$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66229$$FDA-CTU$$$$$M$N$$$20240926$N$HP$US$
243716981$24371698$1$I$$20240924$20240927$20240927$PER$$US-ROCHE-10000090516$ROCHE$$$$$F$Y$$$20240927$$MD$US$US
243716991$24371699$1$I$20240921$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190878$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243717001$24371700$1$I$20240912$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66156$$FDA-CTU$$42$YR$$F$N$$$20240925$N$HP$US$
243717011$24371701$1$I$$20240924$20240926$20240926$DIR$FDA-CDER-CTU-2024-66158$$FDA-CTU$$$$$F$N$$$20240924$N$HP$US$
243717021$24371702$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66537$$FDA-CTU$$82$YR$$F$N$$$20240926$N$$US$
243717041$24371704$1$I$$20240910$20240927$20240927$30DAY$$BE-JNJFOC-20240930545$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$PH$BE$BE
243717051$24371705$1$I$$20240917$20240927$20240927$EXP$$US-FARMAPROD-202408-2967$DOMPE FARMACEUTICI$$$$E$M$Y$$$20240927$$CN$US$US
243717071$24371707$1$I$20240926$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66534$$FDA-CTU$$90$YR$$M$N$$$20240926$Y$PH$US$
243717091$24371709$1$I$20240926$20240926$20240926$20240926$DIR$720200$$FDA-CTU$$65$YR$$F$N$78.3$KG$20240926$N$$US$
243717101$24371710$1$I$$20240829$20240927$20240927$30DAY$$US-VEROBIOTECH-2024USVEROSPO00232$VERO BIOTECH$$$$A$$Y$$$20240927$$HP$US$US
243717121$24371712$1$I$$20240919$20240927$20240927$30DAY$$US-PFIZER INC-202400260894$PFIZER$$15$YR$$M$Y$$$20240927$$HP$US$US
243717151$24371715$1$I$$20240919$20240927$20240927$30DAY$$CA-PFIZER INC-202400260746$PFIZER$$$$$F$Y$$$20240927$$HP$CA$CA
243717171$24371717$1$I$$20240917$20240927$20240927$30DAY$$US-PFIZER INC-202400258419$PFIZER$$14$YR$$M$Y$$$20240927$$CN$US$US
243717221$24371722$1$I$$20240918$20240927$20240927$30DAY$$US-PFIZER INC-202400259238$PFIZER$$13$YR$$F$Y$$$20240927$$CN$US$US
243717231$24371723$1$I$$20240926$20240926$20240926$DIR$720163$$FDA-CTU$$$$$UNK$N$$$20240926$N$CN$US$
243717251$24371725$1$I$$20240916$20240927$20240927$30DAY$$US-PFIZER INC-202400257563$PFIZER$$$$$$Y$$$20240927$$CN$US$US
243717261$24371726$1$I$$20240924$20240927$20240927$30DAY$$FR-PFIZER INC-PV202400124753$PFIZER$$6$YR$$F$Y$$$20240927$$CN$FR$FR
243717281$24371728$1$I$$20240920$20240927$20240927$30DAY$$US-PFIZER INC-202400261719$PFIZER$$15$YR$$M$Y$$$20240927$$CN$US$US
243717301$24371730$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66409$$FDA-CTU$$98$YR$$F$N$$$20240926$N$$US$
243717311$24371731$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66484$$FDA-CTU$$75$YR$$F$N$$$20240926$N$$US$
243717321$24371732$1$I$$20240923$20240927$20240927$30DAY$$US-PFIZER INC-202400262938$PFIZER$$13$YR$$M$Y$$$20240927$$CN$US$US
243717331$24371733$1$I$$20240917$20240927$20240927$30DAY$$US-PFIZER INC-202400258427$PFIZER$$15$YR$$M$Y$$$20240927$$CN$US$US
243717351$24371735$1$I$$20240911$20240927$20240927$30DAY$$KW-PFIZER INC-202400258011$PFIZER$$$$$$Y$$$20240927$$PH$KW$KW
243717361$24371736$1$I$$20240923$20240927$20240927$30DAY$$US-PFIZER INC-202400262447$PFIZER$$$$$M$Y$$$20240927$$CN$US$US
243717371$24371737$1$I$$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66470$$FDA-CTU$$58$YR$$M$N$$$20240925$N$HP$US$
243717381$24371738$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66167$$FDA-CTU$$67$YR$$F$N$$$20240926$N$$US$
243717391$24371739$1$I$20240901$20240920$20240927$20240927$30DAY$$US-PFIZER INC-202400260294$PFIZER$$14$YR$$M$Y$45.36$KG$20240927$$CN$US$US
243717411$24371741$1$I$$20240924$20240927$20240927$EXP$$IN-ROCHE-10000047779$ROCHE$$75$YR$E$F$Y$68$KG$20240927$$CN$IN$IN
243717421$24371742$1$I$$20240909$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005469$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243717431$24371743$1$I$$20240918$20240927$20240927$EXP$$US-Merz Pharmaceuticals GmbH-2024090000164$MERZ$$$$$$Y$$$20240927$$HP$US$US
243717451$24371745$1$I$$20240926$20240926$20240926$DIR$720247$$FDA-CTU$$55$YR$$F$N$81$KG$20240926$N$CN$US$
243717461$24371746$1$I$$20240925$20240927$20240927$EXP$$US-TAKEDA-2024TUS095104$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
243717471$24371747$1$I$20240817$20240924$20240927$20240927$EXP$$CN-BAYER-2024A137160$BAYER$$86$YR$E$M$Y$52$KG$20240927$$HP$CN$CN
243717481$24371748$1$I$$20240913$20240927$20240927$EXP$$CA-UCBSA-2024047802$UCB$$$$$M$Y$$$20240927$$CN$CA$CA
243717491$24371749$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153075$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240927$$HP$US$US
243717501$24371750$1$I$20240901$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152909$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$77.56$KG$20240927$$CN$US$US
243717511$24371751$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152968$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240927$$HP$US$US
243717521$24371752$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153087$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240927$$CN$US$US
243717531$24371753$1$I$20240901$20240920$20240927$20240927$EXP$$JP-009507513-2409JPN003099J$MERCK$$8$DEC$$$Y$$$20240927$$MD$JP$JP
243717541$24371754$1$I$20240801$20240924$20240927$20240927$EXP$$US-SA-2024SA277857$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240927$$MD$US$US
243717551$24371755$1$I$$20240918$20240927$20240927$PER$$US-TRAVERE-2024TVT00937$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240927$$CN$US$US
243717571$24371757$1$I$$20240829$20240927$20240927$30DAY$$US-VEROBIOTECH-2024USVEROSPO00233$VERO BIOTECH$$$$$$Y$$$20240927$$HP$US$US
243717581$24371758$1$I$20240101$20240924$20240927$20240927$EXP$$US-SA-2024SA278583$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240927$$CN$US$US
243717601$24371760$1$I$$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005508$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243717611$24371761$1$I$$20240926$20240927$20240927$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053796$BOEHRINGER INGELHEIM$$$$$F$Y$$$20240927$$MD$US$US
243717621$24371762$1$I$$20240924$20240927$20240927$EXP$$IN-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053204$BOEHRINGER INGELHEIM$Bhure AS, Joshi AD, Ade A, Agashe A. Acneiform eruptions associated with nintedanib ? A case report. National Journal of Physiology, Pharmacy + Pharmacology. 2024;14(9): 2017-2019. doi:dx.doi.org/10.5455/njppp .2024.14.04173202419042024.$40$YR$A$F$Y$$$20240927$$HP$IN$IN
243717632$24371763$2$F$$20240927$20240927$20240930$PER$$US-JNJFOC-20240973348$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243717641$24371764$1$I$20240612$20240926$20240927$20240927$EXP$$GB-JNJFOC-20240971101$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$GB$GB
243717661$24371766$1$I$20231008$20240924$20240927$20240927$EXP$IE-HPRA-2024-115457$IE-MYLANLABS-2024M1086577$MYLAN$$91$YR$$F$Y$$$20240927$$LW$IE$IE
243717671$24371767$1$I$$20240919$20240927$20240927$EXP$GB-MHRA-MED-202409161356594380-FBTGZ$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-08803$HIKMA$$$$$$Y$$$20240927$$PH$GB$GB
243717681$24371768$1$I$20240923$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66502$$FDA-CTU$$71$YR$$M$N$$$20240926$Y$PH$US$
243717691$24371769$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66224$$FDA-CTU$$63$YR$$F$N$113.85$KG$20240926$N$$US$
243717701$24371770$1$I$20240608$20240926$20240926$20240926$DIR$720201$$FDA-CTU$$33$YR$$F$N$50.4$KG$20240926$N$CN$US$
243717711$24371771$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66393$$FDA-CTU$$64$YR$$F$N$164$LBS$20240926$N$$US$
243717721$24371772$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66453$$FDA-CTU$$74$YR$$F$N$$$20240926$N$$US$
243717731$24371773$1$I$20240805$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66529$$FDA-CTU$$64$YR$$M$N$$$20240926$Y$PH$US$
243717741$24371774$1$I$20170608$20240926$20240926$20240926$DIR$720206$$FDA-CTU$$66$YR$$M$N$63$KG$20240926$N$CN$US$
243717751$24371775$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66235$$FDA-CTU$$15$YR$$M$N$103.42$KG$20240926$N$$US$
243717761$24371776$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66182$$FDA-CTU$$68$YR$$F$N$108.86$KG$20240926$N$$US$
243717771$24371777$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66520$$FDA-CTU$$57$YR$$F$N$92.99$KG$20240926$N$$US$
243717801$24371780$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66176$$FDA-CTU$$49$YR$$F$N$67.13$KG$20240926$N$$US$
243717811$24371781$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66239$$FDA-CTU$$51$YR$$M$N$$$20240926$N$$US$
243717841$24371784$1$I$$20240926$20240926$20240926$DIR$720210$$FDA-CTU$$29$YR$$F$N$$$20240926$Y$PH$US$
243717901$24371790$1$I$$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66178$$FDA-CTU$$$$$M$N$$$20240925$N$HP$US$
243717931$24371793$1$I$$20240920$20240927$20240927$EXP$$CN-SANDOZ INC.-SDZ2024CN082502$SANDOZ$Gao Na, Tian Mei, Sun Yawei, Wang Danni, Sun Guowen. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. West China Journal of Stomatology. 2024;1-7$36$YR$$M$Y$$$20240927$$HP$CN$CN
243717941$24371794$1$I$$20240831$20240927$20240927$30DAY$$US-VEROBIOTECH-2024USVEROSPO00234$VERO BIOTECH$$$$$$Y$$$20240927$$HP$US$US
243717951$24371795$1$I$$20240916$20240927$20240927$EXP$$JP-MSNLABS-2024MSNLIT02105$MSN LABORATORIES$Miyajima T, Ogasawara R, Tsukamoto S, Ishio T, Yokoyama E, Izumiyama K, et al.Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis.International Journal of Hematology.2023;118(1):141-145$$$$$Y$$$20240927$$HP$JP$JP
243717961$24371796$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024192078$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243717971$24371797$1$I$20240802$20240920$20240927$20240927$EXP$$CN-BEIGENE-BGN-2024-014939$BEIGENE$$$$$$Y$$$20240927$$HP$CN$CN
243717991$24371799$1$I$$20240916$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046070$AUROBINDO$Lester SC, Johnson EF, Breen WG, Khurana A. Taming the Lion: A Report of Pencil Beam Scanning Proton Therapy for Severe Leonine Facies. Advances in Radiation Oncology. 2024;9No. 9:1-4$70$YR$$M$Y$$$20240927$$MD$US$US
243718001$24371800$1$I$$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192552$AMGEN$$$$$$Y$$$20240927$$HP$US$US
243718011$24371801$1$I$$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190993$AMGEN$$$$$M$Y$$$20240927$$PH$US$US
243718031$24371803$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66180$$FDA-CTU$$67$YR$$M$N$$$20240926$N$$US$
243718041$24371804$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66203$$FDA-CTU$$$$$F$N$$$20240926$N$HP$US$
243718051$24371805$1$I$20240101$20240925$20240927$20240927$EXP$$HK-BAYER-2024A137129$BAYER$$30$YR$A$F$Y$$$20240927$$CN$HK$HK
243718071$24371807$1$I$20240830$20240919$20240927$20240927$EXP$$JP-MYLANLABS-2024M1085266$MYLAN$$40$YR$$F$Y$75$KG$20240927$$PH$JP$JP
243718081$24371808$1$I$20240920$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66155$$FDA-CTU$$51$YR$$F$N$$$20240926$N$$US$
243718101$24371810$1$I$$20240923$20240927$20240927$EXP$$US-AMGEN-USASP2024191043$AMGEN$Lee A.; O^flaherty N.; Murphy D. et al.. A RARE CASE OF NODULAR LUNG DISEASE ON A BACKGROUND OF LYMPHOMA. Chest. 2024;166 (4):A3321$73$YR$E$F$Y$$$20240927$$HP$US$US
243718111$24371811$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66169$$FDA-CTU$$70$YR$$M$N$$$20240926$N$$US$
243718121$24371812$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016223$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240927$$CN$US$US
243718131$24371813$1$I$20240924$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016439$ELI LILLY AND CO$$80$YR$E$F$Y$$$20240927$$CN$US$US
243718141$24371814$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015414$ELI LILLY AND CO$$39$YR$A$F$Y$$$20240927$$CN$US$US
243718161$24371816$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66421$$FDA-CTU$$31$YR$$F$N$$$20240926$N$$US$
243718171$24371817$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66171$$FDA-CTU$$58$YR$$F$N$$$20240926$N$$US$
243718191$24371819$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017570$ELI LILLY AND CO$$$$$$Y$$$20240927$$CN$US$US
243718201$24371820$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016347$ELI LILLY AND CO$$$$$M$Y$$$20240927$$CN$US$US
243718211$24371821$1$I$20240901$20240926$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017201$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240927$$CN$US$US
243718261$24371826$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152921$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240927$$CN$US$US
243718291$24371829$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152503$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240927$$MD$US$US
243718301$24371830$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153114$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$$$20240927$$CN$US$US
243718311$24371831$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024AMR116279$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243718321$24371832$1$I$$20240919$20240927$20240927$PER$$US-GSK-US2024AMR119091$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$HP$US$US
243718331$24371833$1$I$$20240919$20240927$20240927$PER$$US-GSK-US2024116623$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243718351$24371835$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66206$$FDA-CTU$$40$YR$$F$N$$$20240926$N$$US$
243718381$24371838$1$I$$20240916$20240927$20240927$EXP$$IT-AUROBINDO-AUR-APL-2024-046102$AUROBINDO$Dasara M, Dono F, Evangelista G, Quintieri P, Liviello D, Cipollone S, et al. Status epilepticus as a complication of SARS-CoV-2 vaccination: Two case reports and systematic review with individual patients^ data analysis. Seizure: European Journal of Epilepsy. 2024;12:18 to 16$80$YR$$F$Y$$$20240927$$HP$IT$IT
243718391$24371839$1$I$20240923$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024192342$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243718401$24371840$1$I$20240926$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192115$AMGEN$$57$YR$A$F$Y$$$20240927$$CN$US$US
243718421$24371842$1$I$$20240923$20240927$20240927$EXP$$US-AMGEN-USASP2024191480$AMGEN$Williams A.; Krosin M.; Iannazzo N.S.. ^I^M COUGHING UP ALIENS^: THORACIC DUCT DISRUPTION AS A TREATMENT FOR PLASTIC BRONCHITIS. Chest. 2024;166 (4):5120A$34$YR$A$F$Y$$$20240927$$HP$US$US
243718441$24371844$1$I$$20240831$20240927$20240927$30DAY$$US-VEROBIOTECH-2024USVEROSPO00235$VERO BIOTECH$$$$N$$Y$$$20240927$$HP$US$US
243718461$24371846$1$I$$20240916$20240927$20240927$EXP$$DE-AUROBINDO-AUR-APL-2024-046106$AUROBINDO$Berger M, Schumacher F, Wollsching-Strobel M, Kroppen D, Stanzel SB, Majorski DS, et al. A clinical phenotype of VEXAS syndrome with pleural effusion, infiltrates, and systemic inflammation in a 76-year-old patient: a case report. Journal of Medical Case Reports. 2024;18:392$76$YR$$M$Y$$$20240927$$HP$DE$DE
243718471$24371847$1$I$$20240918$20240927$20240927$PER$$US-009507513-2409USA008466$MERCK$$$$$F$Y$$$20240927$$HP$US$US
243718481$24371848$1$I$$20240918$20240927$20240927$PER$$NVSC2024US190895$NOVARTIS$$$$$M$Y$$$20240927$$MD$US$US
243718491$24371849$1$I$20240914$20240920$20240927$20240927$EXP$$CN-BEIGENE-BGN-2024-014940$BEIGENE$$$$$$Y$$$20240927$$HP$CN$CN
243718501$24371850$1$I$$20240920$20240927$20240927$PER$$US-PHARMING-PHAUS2024000827$PHARMING GROUP$$$$$$Y$$$20240927$$CN$US$US
243718511$24371851$1$I$$20240923$20240927$20240927$PER$$US-PHARMING-PHAUS2024000829$PHARMING GROUP$$$$$$Y$$$20240927$$CN$US$US
243718521$24371852$1$I$$20240920$20240927$20240927$PER$$US-PHARMING-PHAUS2024000835$PHARMING GROUP$$$$$$Y$$$20240927$$CN$US$US
243718531$24371853$1$I$$20240923$20240927$20240927$PER$$US-PHARMING-PHAUS2024000838$PHARMING GROUP$$$$$$Y$$$20240927$$CN$US$US
243718541$24371854$1$I$20190308$20240924$20240927$20240927$EXP$$US-PFIZER INC-2019SGN00934$PFIZER$$15$YR$$M$Y$$$20240927$$PH$US$US
243718551$24371855$1$I$$20240923$20240927$20240927$PER$$US-PHARMING-PHAUS2024000831$PHARMING GROUP$$$$$$Y$$$20240927$$CN$US$US
243718561$24371856$1$I$20240920$20240925$20240927$20240927$EXP$RU-RZN-2578458$RU-BAYER-2024A137908$BAYER$$2$MON$I$M$Y$6$KG$20240927$$HP$RU$RU
243718571$24371857$1$I$$20240917$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046442$AUROBINDO$Wang M, Reynolds KL, Montazeri K, Schaefer EA, Sullivan RJ, Dougan M.. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clinical Gastroenterology and Hepatology. 2024;22 (7):1539?1541$61$YR$$F$Y$$$20240927$$MD$US$US
243718581$24371858$1$I$$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005519$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243718591$24371859$1$I$$20240925$20240927$20240927$EXP$$NVSC2024US191564$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
243718601$24371860$1$I$$20240925$20240927$20240927$EXP$$US-BAYER-2024A137971$BAYER$$$$$F$Y$$$20240927$$CN$US$US
243718611$24371861$1$I$$20240923$20240927$20240927$PER$$US-TAKEDA-2024TUS094783$TAKEDA$$$$$M$Y$139$KG$20240927$$MD$US$US
243718621$24371862$1$I$$20240925$20240927$20240927$EXP$$US-BAYER-2024A138013$BAYER$$17$YR$T$M$Y$$$20240927$$CN$US$US
243718631$24371863$1$I$20220411$20240917$20240927$20240927$EXP$$CN-RDY-SPO/CHN/24/0013994$DR REDDYS$Zhang H, Yang L. Ureaplasma urealyticum infection following organ transplantation: a case report and narrative review. Renal Failure. 2024;46(2): 1-11. doi:10.1080/0886022X.2024.2395466.$65$YR$E$M$Y$$$20240927$$HP$CN$CN
243718651$24371865$1$I$20240813$20240920$20240927$20240927$EXP$$CN-BEIGENE-BGN-2024-014941$BEIGENE$$$$$$Y$$$20240927$$HP$CN$CN
243718681$24371868$1$I$$20240923$20240927$20240927$EXP$$CA-ORGANON-O2409CAN001766$ORGANON$$40$YR$$F$Y$96$KG$20240927$$CN$CA$CA
243718701$24371870$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66536$$FDA-CTU$$58$YR$$F$N$$$20240926$N$$US$
243718711$24371871$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66237$$FDA-CTU$$62$YR$$F$N$$$20240926$N$$US$
243718751$24371875$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66151$$FDA-CTU$$61$YR$$F$N$$$20240926$N$$US$
243718801$24371880$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66223$$FDA-CTU$$58$YR$$M$N$$$20240926$N$$US$
243718831$24371883$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66438$$FDA-CTU$$46$YR$$F$N$204.12$KG$20240926$N$$US$
243718841$24371884$1$I$$20240917$20240927$20240927$EXP$$CA-AUROBINDO-AUR-APL-2024-046558$AUROBINDO$Neves Briard J, Duquette A, Cayrol R, Lapalme-Remis S. Refractory Status Epilepticus in a Patient With Aducanumab-Induced Amyloid-Related Imaging Abnormalities. Neurology. 2024;103 (5)$75$YR$$F$Y$$$20240927$$HP$CA$CA
243718881$24371888$1$I$20240822$20240925$20240926$20240926$DIR$FDA-CDER-CTU-2024-66242$$FDA-CTU$$52$YR$$F$N$$$20240925$N$HP$US$
243718891$24371889$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66528$$FDA-CTU$$87$YR$$M$N$$$20240926$N$$US$
243718901$24371890$1$I$20240923$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66392$$FDA-CTU$$75$YR$$M$N$$$20240926$N$HP$US$
243718911$24371891$1$I$20240922$20240926$20240926$20240926$DIR$720161$$FDA-CTU$$68$YR$$F$N$62.1$KG$20240926$N$CN$US$
243718921$24371892$1$I$20240926$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66471$$FDA-CTU$$56$YR$$F$N$$$20240926$N$HP$US$
243718941$24371894$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66533$$FDA-CTU$$81$YR$$M$N$$$20240926$N$$US$
243718951$24371895$1$I$20240918$20240926$20240926$20240926$DIR$720205$$FDA-CTU$$66$YR$$F$N$53.55$KG$20240926$N$CN$US$
243718962$24371896$2$F$$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400263457$PFIZER$Metersky, M.. Current challenges in pulmonary nontuberculous mycobacterial infection: a case series with literature review. Postgraduate Medicine. 2024;1-12$65$YR$$M$Y$$$20240927$$HP$US$US
243718971$24371897$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245834$TEVA$$82$YR$$M$Y$$$20240927$$PH$CA$CA
243718981$24371898$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192407$NOVARTIS$$$$$F$Y$$$20240927$$HP$US$US
243718991$24371899$1$I$$20240917$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046500$AUROBINDO$Perez CA, Ruiz ME.. Bloody Diarrhea and Rash in a 6-month-old.. Pediatr-Rev. 2024;45(7):406-410$6$MON$$M$Y$$$20240927$$HP$US$US
243719001$24371900$1$I$20240901$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024190673$AMGEN$$71$YR$E$F$Y$$$20240927$$CN$US$US
243719011$24371901$1$I$20240101$20240920$20240927$20240927$EXP$$US-RECORDATI RARE DISEASE INC.-2024007386$RECORDATI$$$$$$Y$$$20240927$$CN$US$US
243719031$24371903$1$I$$20240917$20240927$20240927$PER$$US-JNJFOC-20240949176$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20240927$$CN$US$US
243719041$24371904$1$I$$20240917$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046440$AUROBINDO$Wang M, Reynolds KL, Montazeri K, Schaefer EA, Sullivan RJ, Dougan M.. Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis. Clinical Gastroenterology and Hepatology. 2024;22 (7):1539?1541$63$YR$$M$Y$$$20240927$$MD$US$US
243719051$24371905$1$I$20240919$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153315$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240927$$CN$US$US
243719061$24371906$1$I$$20240917$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046191$AUROBINDO$Sakunchotpanit G, Rohan TZ, Moran J, Russell-Goldman E, Walters M, Nambudiri VE.. Cutaneous Scedosporium apiospermum infection in a patient with metastatic renal cell carcinoma.. JAAD Case Reports.. 2024;52:60-2$68$YR$$M$Y$$$20240927$$MD$US$US
243719071$24371907$1$I$20240919$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151325$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$104.87$KG$20240927$$HP$US$US
243719081$24371908$1$I$20240916$20240920$20240927$20240927$EXP$GB-MHRA-TPP24621773C9038262YC1726484936738$GB-GSK-GB2024116967$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$GB$GB
243719091$24371909$1$I$$20240918$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-030016$UNITED THERAPEUTICS$$$$$M$Y$$$20240927$$$US$US
243719101$24371910$1$I$$20240917$20240927$20240927$EXP$$ES-AUROBINDO-AUR-APL-2024-046520$AUROBINDO$Delgadillo BE, DeFrancisis JS, Henwood L, Federico JR.. Left Pubic Symphysis Fracture With Undiagnosed Ipsilateral Femoral Neck Fracture in an Elderly Female With Osteoporosis: A Case Report. Cureus. 2024;16(9):e69203$68$YR$$F$Y$$$20240927$$HP$ES$US
243719111$24371911$1$I$20240802$20240910$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005521$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20240927$$CN$US$US
243719121$24371912$1$I$$20240925$20240927$20240927$EXP$$NVSC2024US191844$NOVARTIS$$73$YR$$M$Y$$$20240927$$MD$US$US
243719131$24371913$1$I$20240101$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024191343$AMGEN$$$$$F$Y$$$20240927$$CN$US$US
243719142$24371914$2$F$$20240923$20240927$20240927$EXP$$US-ROCHE-10000089573$ROCHE$Nathani A, Lum J, Gadre S, Lane C, Akindipe O, Sethi S, et al. Kaposi Sarcoma in Two Lung Transplant Recipients: A Single-Center Experience. Transplantation Proceedings. 2024-Sep;56 (7):1639-45. doi:10.1016/j.transproceed.2024.07.004.$33$YR$A$M$Y$$$20240927$$HP$US$US
243719161$24371916$1$I$$20240920$20240927$20240927$EXP$$IN-VER-202400001$VERITY PHARMACEUTICALS$$58$YR$A$M$Y$$$20240927$$HP$IN$IN
243719171$24371917$1$I$20240601$20240910$20240927$20240927$PER$$US-AGIOS-2409US03880$AGIOS PHARMACEUTICALS$$42$YR$$M$Y$$$20240927$$CN$US$US
243719181$24371918$1$I$20240919$20240920$20240927$20240927$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000977$PAREXEL$$$$$$Y$$$20240927$$HP$CN$CN
243719191$24371919$1$I$$20240920$20240927$20240927$PER$$US-ABBVIE-5935161$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243719201$24371920$1$I$20240917$20240918$20240927$20240927$EXP$$US-GALDERMA-US2024014237$GALDERMA$$$$$$Y$$$20240927$$MD$US$US
243719211$24371921$1$I$$20240923$20240927$20240927$EXP$$NVSC2024DE191805$NOVARTIS$$$$A$F$Y$$$20240927$$MD$DE$DE
243719231$24371923$1$I$20240821$20240923$20240927$20240927$EXP$FR-AFSSAPS-RN2024001030$FR-ABBVIE-5934531$ABBVIE$$21$YR$$M$Y$$$20240927$$CN$FR$FR
243719271$24371927$1$I$20240920$20240926$20240926$20240926$DIR$720169$$FDA-CTU$$65$YR$$UNK$N$99$KG$20240926$N$CN$US$
243719281$24371928$1$I$20220621$20240923$20240927$20240927$EXP$$CN-Eisai-EC-2024-175304$EISAI$Han X. Case report: is necrotizing fasciitis in a rectal cancer patient after targeted systemic therapy related to the tumor site? - evidence from a hepatocellular carcinoma patient. Infectious Agents and Cancer. 2024;(19:45): 1-10. doi:10.1186/s13027-024-00607-1.$60$YR$A$M$Y$$$20240927$$MD$CN$CN
243719291$24371929$1$I$20240101$20240919$20240927$20240927$EXP$$US-UCBSA-2024048445$UCB$$$$$F$Y$$$20240927$$HP$US$US
243719301$24371930$1$I$20240601$20240919$20240927$20240927$EXP$$US-UCBSA-2024048619$UCB$$67$YR$$M$Y$$$20240927$$HP$US$US
243719311$24371931$1$I$$20240923$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-030175$UNITED THERAPEUTICS$$$$$F$Y$108.84$KG$20240927$$$US$US
243719321$24371932$1$I$20240101$20240920$20240927$20240927$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-014447$JAZZ$$$$$M$Y$$$20240927$$CN$US$US
243719331$24371933$1$I$20231126$20240923$20240927$20240927$EXP$FR-AFSSAPS-AVBX2024000539$FR-Waylis Therapeutics LLC-ATNAHS20240902685$Waylis$$18$YR$A$F$Y$$$20240927$$MD$FR$FR
243719341$24371934$1$I$20240101$20240923$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-030209$UNITED THERAPEUTICS$$$$$F$Y$47.166$KG$20240927$$$US$US
243719351$24371935$1$I$$20240926$20240927$20240927$EXP$$US-PFIZER INC-2019SGN01288$PFIZER$$72$YR$$M$Y$$$20240927$$MD$US$US
243719361$24371936$1$I$$20240913$20240927$20240927$PER$$US-COSETTE-CP2024US000257$COSETTE PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243719371$24371937$1$I$$20240915$20240927$20240927$EXP$$SG-JNJFOC-20240946887$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20240927$$HP$SG$SG
243719381$24371938$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016389$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240927$$CN$US$US
243719401$24371940$1$I$$20240926$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017315$ELI LILLY AND CO$$67$YR$E$M$Y$$$20240927$$CN$US$US
243719412$24371941$2$F$20240923$20240927$20240927$20240928$PER$$US-AMGEN-USASP2024192162$AMGEN$$73$YR$E$F$Y$$$20240928$$CN$US$US
243719421$24371942$1$I$$20240919$20240927$20240927$EXP$$GB-ALIMERA SCIENCES INC.-GB-A16013-24-000563$ALIMERA$$$$$$Y$$$20240927$$MD$GB$GB
243719431$24371943$1$I$$20240920$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153265$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$76.66$KG$20240927$$CN$US$US
243719441$24371944$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152662$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20240927$$HP$US$US
243719451$24371945$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153317$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240927$$HP$US$US
243719461$24371946$1$I$20240926$20240926$20240926$20240926$DIR$720170$$FDA-CTU$$57$YR$$F$N$$$20240926$Y$$US$
243719471$24371947$1$I$$20240910$20240927$20240927$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02591$AMNEAL$$$$$$Y$$$20240927$$CN$US$US
243719481$24371948$1$I$20240925$20240926$20240926$20240926$DIR$720188$$FDA-CTU$$68$YR$$F$N$$$20240926$N$$US$
243719491$24371949$1$I$20240716$20240724$20240927$20240927$EXP$$US-AMNEAL PHARMACEUTICALS-2024-AMRX-02667$AMNEAL$$13$YR$$F$Y$$$20240927$$CN$US$US
243719501$24371950$1$I$$20240926$20240927$20240927$EXP$$CA-BEIGENE-BGN-2024-015420$BEIGENE$$$$$$Y$$$20240927$$MD$CA$CA
243719511$24371951$1$I$$20240918$20240927$20240927$EXP$$CN-ROCHE-10000091191$ROCHE$Deng Y, Niu T, Li X, Liu Y, Zhou Y, Lei D. Systemic analysis of adverse drug events in patients with diabetes complicated  by cataract treated with rizumab after surgery. CHIN J DRUG APPL + MONIT. 2024;21(4):494-8. doi:10.3969/j.issn.1672-8157.2024.04.042$$$$$Y$$$20240927$$HP$CN$CN
243719521$24371952$1$I$20240117$20240906$20240927$20240927$EXP$IT-MINISAL02-977079$IT-CELLTRION INC.-2024IT022786$CELLTRION$$$$$$Y$$$20240927$$MD$IT$IT
243719531$24371953$1$I$$20240913$20240927$20240927$EXP$$IL-QUAGEN-2024QUALIT00301$QUAGEN PHARMACEUTICALS$I Gazit.Systemic Treatment With Cyclosporine A in Children With Severe Vernal Keratoconjunctivitis..Cornea.JUN-2024$6$YR$C$M$Y$$$20240927$$HP$IL$IL
243719541$24371954$1$I$$20240925$20240927$20240927$EXP$$US-GILEAD-2024-0689081$GILEAD$$56$YR$A$M$Y$$$20240927$$CN$US$US
243719551$24371955$1$I$$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005718$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243719561$24371956$1$I$20240229$20240926$20240927$20240927$EXP$FR-AFSSAPS-BS2024000660$FR-009507513-2409FRA009508$MERCK$$18$YR$$F$Y$45$KG$20240927$$MD$FR$FR
243719571$24371957$1$I$$20240924$20240927$20240927$PER$$US-BIOGEN-2024BI01284111$BIOGEN$$$$$M$Y$$$20240927$$MD$US$US
243719581$24371958$1$I$20240907$20240911$20240927$20240927$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000928$PAREXEL$$$$$$Y$$$20240927$$PH$US$US
243719591$24371959$1$I$20240919$20240923$20240927$20240927$PER$$US-JNJFOC-20240961921$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20240927$$CN$US$US
243719601$24371960$1$I$20240917$20240917$20240927$20240927$PER$$US-JNJFOC-20240946439$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243719611$24371961$1$I$$20240920$20240927$20240927$PER$$US-ROCHE-10000089606$ROCHE$$$$$$Y$$$20240927$$HP$US$US
243719621$24371962$1$I$20240501$20240909$20240927$20240927$EXP$$CA-SK LIFE SCIENCE, INC-SKPVG-2024-002265$SK LIFE SCIENCE$$$$$$Y$$$20240927$$MD$CA$CA
243719631$24371963$1$I$$20240917$20240927$20240927$EXP$$US-EMD Serono-2024049902$EMD SERONO INC$Malani KA, Finn A. Metformin-associated lactic acidosis: a serious complication of a common drug. BMJ case reports. 2024 Sep 10;17(9): 1-5. doi:10.1136/bcr-2024-260592.$8$DEC$E$M$Y$$$20240927$$HP$US$US
243719641$24371964$1$I$$20240918$20240927$20240927$EXP$$VN-ROCHE-10000087873$ROCHE$$43$YR$A$M$Y$$$20240927$$MD$VN$VN
243719651$24371965$1$I$$20240913$20240927$20240927$PER$$US-GRANULES-US-2024GRASPO00423$GRANULES INDIA$$$$$F$Y$$$20240927$$CN$US$US
243719661$24371966$1$I$$20240909$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09056$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243719681$24371968$1$I$20231201$20240920$20240927$20240927$EXP$$US-ABBVIE-5927462$ABBVIE$$65$YR$$F$Y$54$KG$20240927$$CN$US$US
243719691$24371969$1$I$$20240919$20240927$20240927$EXP$$US-RDY-LIT/USA/24/0014159$DR REDDYS$Oyama G, Thompson A, Foote KD, Limotai N, Abd-El-Barr M, Maling N, et al. Deep brain stimulation for tremor associated with underlying ataxia syndromes: A case series and discussion of issues. Tremor and Other Hyperkinetic Movements. 2014;4: doi:10.7916/D8542KQ5.$41$YR$A$F$Y$$$20240927$$HP$US$US
243719701$24371970$1$I$20240101$20240904$20240927$20240927$PER$$US-Eisai-EC-2024-173772$EISAI$$69$YR$E$F$Y$72$KG$20240927$$CN$US$US
243719711$24371971$1$I$20211001$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005722$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20240927$$CN$US$US
243719721$24371972$1$I$$20240920$20240927$20240927$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US002636$PAREXEL$$$$$$Y$$$20240927$$CN$US$US
243719731$24371973$1$I$$20240924$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-030427$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240927$$$US$US
243719741$24371974$1$I$20240101$20240923$20240927$20240927$PER$$US-UNITED THERAPEUTICS-UNT-2024-030412$UNITED THERAPEUTICS$$$$$F$Y$54.422$KG$20240927$$$US$US
243719761$24371976$1$I$20240904$20240926$20240926$20240926$DIR$720171$$FDA-CTU$$65$YR$$F$N$79.5$KG$20240926$N$$US$
243719771$24371977$1$I$20240828$20240926$20240926$20240926$DIR$720214$$FDA-CTU$$78$YR$$F$N$73.8$KG$20240926$Y$CN$US$
243719781$24371978$1$I$20240903$20240926$20240926$20240926$DIR$720168$$FDA-CTU$$64$YR$$F$N$57.8$KG$20240926$Y$$US$
243719791$24371979$1$I$$20240926$20240926$20240926$DIR$720162$$FDA-CTU$$$$$F$N$65.7$KG$20240926$$CN$US$
243719821$24371982$1$I$$20240830$20240927$20240927$30DAY$$US-Kaleo, Inc.-2024KL000046$KALEO$$7$YR$C$M$Y$$$20240926$$CN$US$US
243719831$24371983$1$I$20240917$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005736$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240927$$CN$US$US
243719841$24371984$1$I$$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192230$AMGEN$$$$$M$Y$$$20240927$$PH$US$US
243719851$24371985$1$I$$20240918$20240927$20240927$EXP$$CA-APOTEX-2024AP011195$APOTEX$$77$YR$$F$Y$$$20240927$$CN$CA$CA
243719861$24371986$1$I$$20240904$20240927$20240927$EXP$$US-SA-2024SA258165$SANOFI AVENTIS$$$$A$F$Y$85.45$KG$20240927$$MD$US$US
243719871$24371987$1$I$$20240925$20240927$20240927$EXP$$US-BAYER-2024A137904$BAYER$$93$YR$E$M$Y$$$20240927$$CN$US$US
243719881$24371988$1$I$20240901$20240916$20240927$20240927$PER$$US-JNJFOC-20240942475$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20240927$$CN$US$US
243719901$24371990$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152534$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240927$$CN$US$US
243719911$24371991$1$I$$20240913$20240927$20240927$EXP$$US-GRANULES-US-2024GRASPO00424$GRANULES INDIA$$$$$F$Y$$$20240927$$CN$US$US
243719921$24371992$1$I$20240907$20240925$20240927$20240927$EXP$$CN-GILEAD-2024-0689020$GILEAD$$38$YR$A$M$Y$67$KG$20240927$$HP$CN$CN
243719931$24371993$1$I$$20240920$20240927$20240927$EXP$$CA-GSK-CA2023115528$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$HP$CA$CA
243719941$24371994$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153297$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20240927$$HP$US$US
243719951$24371995$1$I$$20240920$20240927$20240927$EXP$$NVSC2024CN192040$NOVARTIS$Gao N, Tian M, Sun Y, Wang D, Sun G. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. WEST CHINA JOURNAL OF STOMATOLOGY. 2024;1-7$$$$M$Y$$$20240927$$HP$CN$CN
243719961$24371996$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192416$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
243719971$24371997$1$I$$20240924$20240927$20240927$EXP$$US-ABBVIE-5938917$ABBVIE$$$$$$Y$$$20240927$$CN$US$US
243719981$24371998$1$I$20240901$20240920$20240927$20240927$EXP$$GB-TEVA-VS-3246614$TEVA$$$$$F$Y$$$20240927$$CN$GB$GB
243719991$24371999$1$I$$20240913$20240927$20240927$EXP$$RU-QUAGEN-2024QUALIT00303$QUAGEN PHARMACEUTICALS$Malyshev SM.Status epilepticus in a  pregnant patient with a  previously  unrecognized POLG-associated disease.Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova.JAN-2023;123:129-135$33$YR$A$F$Y$$$20240927$$HP$RU$RU
243720001$24372000$1$I$$20240920$20240927$20240927$EXP$$US-MYLANLABS-2024M1087228$MYLAN$Uludag G, Karaca I, Akhavanrezayat A, Yasar C, Matsumiya W, Pham BH, et al. Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFalpha Therapies. Ocular-Immunol-Inflamm 2024; 32 (6): 891-897.$13$YR$$F$Y$$$20240927$$MD$US$US
243720011$24372001$1$I$$20240920$20240927$20240927$EXP$$IT-MYLANLABS-2024M1087003$MYLAN$Toti MS, Zammarchi L, Pasquini L, Campolmi I, Modi G, Borchi B, et al. Asymptomatic CMV infection at birth following maternal primary infection despite valacyclovir treatment and a subsequent negative amniocentesis. Case report. Eur-J-Obstet-Gynecol-Reprod-Biol 2023; 291 128-130.$$$N$$Y$$$20240927$$HP$IT$IT
243720021$24372002$1$I$$20240917$20240927$20240927$EXP$$JP-EMD Serono-2024050242$EMD SERONO INC$Murata, Murata. An elderly type 2 diabetes mellitus patient experienced type B2 lactic acidosis caused by metformin hydrochloride triggered bycholinergic crisis with distigmine bromide. The 697th Japanese Society of Internal Medicine Kanto Regional Meeting. 2024;76-76.$89$YR$E$M$Y$$$20240927$$HP$JP$JP
243720031$24372003$1$I$$20240920$20240927$20240927$EXP$$US-MYLANLABS-2024M1087197$MYLAN$Uludag G, Karaca I, Akhavanrezayat A, Yasar C, Matsumiya W, Pham BH, et al. Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFalpha Therapies. Ocular-Immunol-Inflamm 2024; 32 (6): 891-897.$15$YR$$F$Y$$$20240927$$MD$US$US
243720041$24372004$1$I$$20240909$20240927$20240927$EXP$$US-SA-2024SA278605$SANOFI AVENTIS$$$$A$M$Y$83.18$KG$20240927$$MD$US$US
243720051$24372005$1$I$$20240919$20240927$20240927$EXP$$US-JNJFOC-20240962449$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240927$$MD$US$US
243720061$24372006$1$I$20240917$20240926$20240926$20240926$DIR$720207$$FDA-CTU$$79$YR$$M$N$$$20240926$N$$US$
243720081$24372008$1$I$$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190475$AMGEN$$$$$$Y$$$20240927$$CN$US$US
243720101$24372010$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152449$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240927$$CN$US$US
243720131$24372013$1$I$$20240918$20240927$20240927$EXP$$JP-UCBSA-2024049416$UCB$$6$DEC$$M$Y$$$20240927$$MD$JP$JP
243720141$24372014$1$I$20240801$20240918$20240927$20240927$EXP$$US-UCBSA-2024048327$UCB$$47$YR$$F$Y$$$20240927$$HP$US$US
243720161$24372016$1$I$20240912$20240925$20240927$20240927$EXP$$CN-ROCHE-10000091739$ROCHE$$63$YR$A$F$Y$$$20240927$$HP$CN$CN
243720171$24372017$1$I$$20240829$20240927$20240927$PER$$US-SMPA-2024SPA002152$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243720181$24372018$1$I$$20240927$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2023US001760$SANDOZ$$$$$M$Y$$$20240927$$MD$US$US
243720201$24372020$1$I$$20240926$20240927$20240927$EXP$$US-GILEAD-2024-0689059$GILEAD$$$$$M$Y$$$20240927$$HP$US$US
243720211$24372021$1$I$20201118$20240919$20240927$20240927$EXP$$FR-BLUEPRINT MEDICINES CORPORATION-2024BUS002442$Unknown Manufacturer$$$$$$Y$$$20240926$$MD$FR$FR
243720221$24372022$1$I$20240925$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192331$AMGEN$$$$$$Y$$$20240927$$CN$US$US
243720241$24372024$1$I$$20240916$20240927$20240927$EXP$$ES-ROCHE-10000086750$ROCHE$Somovilla A, Aguirre C G. Organizing Pneumonia in Multiple Sclerosis Patients Treated with Ocrelizumab following SARS-CoV-2 Infection: A Case Series Report (Abstract number: P1153/2242). Multiple Sclerosis Journal. 2024;30 (3(S)):763.$38$YR$A$F$Y$$$20240927$$HP$ES$ES
243720251$24372025$1$I$$20240920$20240927$20240927$EXP$$US-Sprout Pharmaceuticals, Inc.-2024SP000294$SPROUT PHARMACEUTICALS$$$$A$F$Y$$$20240926$$CN$US$US
243720261$24372026$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66306$$FDA-CTU$$$$$$N$$$20240925$N$CN$US$
243720271$24372027$1$I$$20240916$20240927$20240927$PER$$US-MYLANLABS-2024M1085595$MYLAN$$$$$$Y$$$20240927$$CN$US$US
243720281$24372028$1$I$$20240924$20240927$20240927$PER$$US-009507513-2409USA008742$MERCK$Lowe A, Abdelhabib M, Sista RR. A CASE REPORT: TSUKAMURELLA MEETS SILICONE, CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTION IN A PULMONARY HYPERTENSION PATIENT. Chest. 2024;166(4):A1507-8$39$YR$$F$Y$$$20240927$$HP$US$US
243720291$24372029$1$I$$20240916$20240927$20240927$EXP$$US-MYLANLABS-2024M1085862$MYLAN$Guy DR, Mizes A, Richardson CT. Rapid response of omalizumab-resistant chronic urticaria to acalabrutinib. JAAD-Case-Rep 2024; 47 47-49.$47$YR$$F$Y$$$20240927$$MD$US$US
243720301$24372030$1$I$$20240917$20240927$20240927$EXP$$GB-EMD Serono-2024050147$EMD SERONO INC$Abdalrazag O, Okoye A, Muniyappa S. Title to be provided.. British Journal of Diabetes. 2024 Jun 01;24(1):$77$YR$E$M$Y$$$20240927$$HP$GB$GB
243720321$24372032$1$I$$20240920$20240927$20240927$EXP$$US-TAKEDA-2024TUS094634$TAKEDA$$$$$M$Y$67.12$KG$20240927$$MD$US$US
243720331$24372033$1$I$$20240913$20240927$20240927$EXP$$US-UCBSA-2024047183$UCB$$$$$M$Y$$$20240927$$CN$US$US
243720341$24372034$1$I$20240722$20240923$20240927$20240927$EXP$HR-HALMED-300086544$HR-TEVA-VS-3246985$TEVA$$37$YR$$M$Y$$$20240927$$MD$HR$HR
243720351$24372035$1$I$20240307$20240923$20240927$20240927$EXP$$CN-PFIZER INC-PV202400124443$PFIZER$$48$YR$$F$Y$$$20240927$$CN$CN$CN
243720361$24372036$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150852$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240927$$HP$US$US
243720381$24372038$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016230$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240927$$CN$US$US
243720391$24372039$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151356$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240927$$CN$US$US
243720401$24372040$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66332$$FDA-CTU$$$$$$N$$$20240925$N$CN$US$
243720421$24372042$1$I$$20240924$20240927$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151810$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240927$$MD$JP$JP
243720431$24372043$1$I$20240726$20240921$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152447$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$101.6$KG$20240927$$CN$US$US
243720441$24372044$1$I$20240925$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66310$$FDA-CTU$$69$YR$$F$N$$$20240925$N$HP$US$
243720451$24372045$1$I$20230423$20240925$20240927$20240927$DIR$FDA-CDER-CTU-2024-66540$$FDA-CTU$$$$$F$N$108$KG$20240925$N$$US$
243720461$24372046$1$I$$20240916$20240927$20240927$EXP$$US-MYLANLABS-2024M1085591$MYLAN$$$$$$Y$$$20240927$$CN$US$US
243720471$24372047$1$I$20240901$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192627$AMGEN$$$$$F$Y$$$20240927$$HP$US$US
243720481$24372048$1$I$20240801$20240919$20240927$20240927$EXP$$US-UCBSA-2024048582$UCB$$54$YR$$F$Y$$$20240927$$HP$US$US
243720491$24372049$1$I$20240926$20240926$20240926$20240926$DIR$720175$$FDA-CTU$$71$YR$$F$N$83.25$KG$20240926$N$PH$US$
243720501$24372050$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66289$$FDA-CTU$$31$YR$$F$N$$$20240925$N$HP$US$
243720511$24372051$1$I$20240101$20240913$20240927$20240927$EXP$$US-UCBSA-2024047213$UCB$$$$$F$Y$$$20240927$$CN$US$US
243720521$24372052$1$I$20240823$20240913$20240927$20240927$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000942$PAREXEL$$$$$$Y$$$20240927$$PH$US$US
243720551$24372055$1$I$20240903$20240926$20240926$20240926$DIR$720202$$FDA-CTU$$65$YR$$F$N$$$20240926$Y$PH$US$
243720561$24372056$1$I$$20240918$20240927$20240927$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US005052$PAREXEL$$$$$$Y$$$20240927$$HP$US$US
243720571$24372057$1$I$$20240918$20240927$20240927$EXP$$US-TEVA-VS-3246447$TEVA$$66$YR$$F$Y$$$20240927$$CN$US$US
243720581$24372058$1$I$$20240923$20240927$20240927$EXP$$RU-ASTELLAS-2024-AER-008578$ASTELLAS$$$$$M$Y$$$20240927$$MD$RU$RU
243720591$24372059$1$I$20240827$20240925$20240927$20240927$EXP$$CN-ROCHE-10000091927$ROCHE$$52$YR$A$F$Y$65$KG$20240927$$HP$CN$CN
243720601$24372060$1$I$20240101$20240913$20240927$20240927$EXP$$CA-UCBSA-2024047770$UCB$$$$$F$Y$$$20240927$$CN$CA$CA
243720621$24372062$1$I$20240816$20240926$20240926$20240926$DIR$720156$$FDA-CTU$$57$YR$$F$N$$$20240926$N$PH$US$
243720631$24372063$1$I$20230401$20240926$20240926$20240926$DIR$720211$$FDA-CTU$$69$YR$$M$N$87.75$KG$20240926$N$CN$US$
243720641$24372064$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66283$$FDA-CTU$$$$$$N$$$20240925$N$CN$US$
243720661$24372066$1$I$20240815$20240927$20240927$20240927$DIR$720249$$FDA-CTU$$64$YR$$M$N$65.25$KG$20240927$N$CN$US$
243720671$24372067$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66323$$FDA-CTU$$$$$$N$$$20240925$$CN$US$
243720681$24372068$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66321$$FDA-CTU$$$$$$N$$$20240925$$CN$US$
243720691$24372069$1$I$$20240923$20240927$20240927$30DAY$$US-PFIZER INC-202400263025$PFIZER$$$$$F$Y$$$20240927$$CN$US$US
243720701$24372070$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192427$NOVARTIS$$$$$$Y$$$20240927$$PH$US$US
243720711$24372071$1$I$$20240920$20240927$20240927$EXP$$NVSC2024MY189200$NOVARTIS$$74$YR$$M$Y$55$KG$20240927$$MD$MY$MY
243720721$24372072$1$I$$20240909$20240927$20240927$PER$$US-TEVA-VS-3241902$TEVA$$63$YR$$M$Y$$$20240927$$CN$US$US
243720731$24372073$1$I$20240901$20240916$20240927$20240927$EXP$$US-RADIUS HEALTH INC.-2024US007366$RADIUS PHARM$$64$YR$$F$Y$64.399$KG$20240927$$CN$US$US
243720741$24372074$1$I$20240801$20240917$20240927$20240927$PER$$US-GSK-US2024115673$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243720751$24372075$1$I$$20240926$20240927$20240927$PER$$US-HALEON-2199058$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243720761$24372076$1$I$$20240925$20240927$20240927$EXP$CA-LEO Pharma-373769$CA-LEO Pharma-373769$LEO PHARM$$51$YR$$F$Y$$$20240927$$CN$CA$CA
243720781$24372078$1$I$20240922$20240924$20240927$20240927$EXP$$CN-PFIZER INC-PV202400124960$PFIZER$$28$YR$$M$Y$68$KG$20240927$$HP$CN$CN
243720791$24372079$1$I$20230901$20240923$20240927$20240927$EXP$$AT-PFIZER INC-202400261411$PFIZER$$64$YR$$F$Y$$$20240927$$MD$AT$AT
243720801$24372080$1$I$20240922$20240925$20240927$20240927$EXP$GB-MHRA-MED-202409251850070480-SYDQG$GB-PFIZER INC-202400263930$PFIZER$$$$$F$Y$$$20240927$$CN$GB$GB
243720811$24372081$1$I$20240101$20240923$20240927$20240927$EXP$$US-PFIZER INC-202400257539$PFIZER$$62$YR$$F$Y$$$20240927$$MD$US$US
243720821$24372082$1$I$$20240919$20240927$20240927$EXP$PT-EMA-DD-20240912-7482655-071711$PT-BAYER-2024A134596$BAYER$$62$YR$A$M$Y$$$20240927$$HP$PT$PT
243720831$24372083$1$I$$20240923$20240927$20240927$EXP$$US-MYLANLABS-2024M1087553$MYLAN$Maredia H, Hand JL, Tollefson MM. Pathogenesis-directed treatment of linear porokeratosis with topical cholesterol-lovastatin. Pediatr-Dermatol 2024; 41 (2): 296-297.$$$I$M$Y$$$20240927$$MD$US$US
243720841$24372084$1$I$$20240923$20240927$20240927$EXP$GB-MHRA-MED-202409101813088250-ZPVFQ$GB-MYLANLABS-2024M1086559$MYLAN$$85$YR$$F$Y$$$20240927$$CN$GB$GB
243720851$24372085$1$I$$20240923$20240927$20240927$EXP$$IT-MYLANLABS-2024M1086668$MYLAN$$62$YR$$F$Y$$$20240927$$CN$IT$IT
243720861$24372086$1$I$$20240923$20240927$20240927$EXP$$IN-MYLANLABS-2024M1087546$MYLAN$Shanmugam S, Sandhya PA. When Ewing Sarcoma Feigns to be a Brown Tumor: A Report on Rare Case Scenario. World-J-Endocrine-Surg 2023; 15 (2): 53-55.$17$YR$$F$Y$$$20240927$$HP$IN$IN
243720871$24372087$1$I$$20240923$20240927$20240927$EXP$GB-MHRA-MED-202409231042085550-VWGRJ$GB-MYLANLABS-2024M1086564$MYLAN$$$$$F$Y$$$20240927$$MD$GB$GB
243720881$24372088$1$I$$20240923$20240927$20240927$EXP$$US-MYLANLABS-2024M1087571$MYLAN$Connors JS, Zhang L, Sasaki K, DiNardo CD, Short NJ, Daver N, et al. Protective Role of Oxaliplatin Among Platinum-Based Therapies in the Development of Therapy-Related Myeloid Neoplasms. Blood 2023; 142 (Suppl.) 4220-4221.$$$$$Y$$$20240927$$MD$US$US
243720891$24372089$1$I$20240812$20240923$20240927$20240927$PER$$US-BIOVITRUM-2024-US-012467$BIOVITRUM$$77$YR$$M$Y$$$20240927$$CN$US$US
243720901$24372090$1$I$20240905$20240916$20240927$20240927$30DAY$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000951$PAREXEL$$$$$$Y$$$20240927$$HP$US$US
243720911$24372091$1$I$$20240920$20240927$20240927$EXP$$IN-VER-202400003$VERITY PHARMACEUTICALS$$57$YR$A$M$Y$$$20240927$$HP$IN$IN
243720921$24372092$1$I$20240906$20240918$20240927$20240927$EXP$$DE-ROCHE-10000086563$ROCHE$$61$YR$A$F$Y$$$20240927$$MD$DE$DE
243720931$24372093$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66264$$FDA-CTU$$$$$$N$$$20240925$N$CN$US$
243720941$24372094$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66278$$FDA-CTU$$70$YR$$M$N$$$20240925$N$CN$US$
243720971$24372097$1$I$20240801$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152954$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240927$$HP$US$US
243720981$24372098$1$I$20240101$20240919$20240927$20240927$EXP$$US-UCBSA-2024048579$UCB$$$$$F$Y$87.075$KG$20240927$$HP$US$US
243721001$24372100$1$I$$20240917$20240927$20240927$EXP$$JP-ROCHE-10000090764$ROCHE$Hasegawa Y, Sakano Y, Kidaka S. Bronchoalveolar lavage was effective in diagnosing two cases of organising pneumonia induced by chronic SARS-CoV-2 infection following rituximab administration. The 245th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2024;$55$YR$A$F$Y$$$20240927$$MD$JP$JP
243721011$24372101$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024115654$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243721021$24372102$1$I$$20240913$20240927$20240927$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-09194$LUPIN$Malani SK, Chigullapalli S, Sujanyal S, Sharma V. Rosuvastatin-induced myopathy: A case series. Cureus. 2024;16(8): e66180:1-5$70$YR$$F$Y$$$20240927$$HP$IN$IN
243721031$24372103$1$I$$20240924$20240927$20240927$EXP$$CA-ABBVIE-5938940$ABBVIE$$$$E$M$Y$$$20240927$$HP$CA$CA
243721051$24372105$1$I$$20240918$20240927$20240927$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001904$BLUEPRINT MEDICINES$$$$$M$Y$$$20240927$$CN$US$US
243721061$24372106$1$I$20240901$20240926$20240927$20240927$EXP$$US-BAYER-2024A138200$BAYER$$88$YR$E$F$Y$$$20240927$$CN$US$US
243721071$24372107$1$I$$20240923$20240927$20240927$EXP$$SE-MYLANLABS-2012S1014338$MYLAN$Lindh J. Possible connection between lymphocytic colitis and sertraline treatment. Lakartidningen 2012; 109 38$7$DEC$$F$Y$$$20240927$$HP$SE$SE
243721081$24372108$1$I$20240827$20240919$20240927$20240927$EXP$IT-MINISAL02-1002656$IT-EMD Serono-2024050309$EMD SERONO INC$$62$YR$A$F$Y$85$KG$20240927$$MD$IT$IT
243721101$24372110$1$I$$20240925$20240927$20240927$PER$$US-009507513-2409USA009119$MERCK$$$$$F$Y$76.2$KG$20240927$$CN$US$US
243721131$24372113$1$I$20240926$20240927$20240927$20240927$DIR$720250$$FDA-CTU$$64$YR$$UNK$N$69.3$KG$20240927$Y$CN$US$
243721151$24372115$1$I$$20240912$20240927$20240927$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2023-10813$LUPIN$$41$YR$$F$Y$$$20240927$$HP$CA$CA
243721171$24372117$1$I$$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024191086$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243721181$24372118$1$I$$20240919$20240927$20240927$PER$$US-JNJFOC-20240955290$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20240927$$CN$US$US
243721191$24372119$1$I$$20240919$20240927$20240927$PER$$US-JNJFOC-20240957813$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$HP$US$US
243721201$24372120$1$I$20240923$20240924$20240927$20240927$EXP$$US-SA-2024SA277111$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240927$$MD$US$US
243721211$24372121$1$I$$20240926$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083297$SANDOZ$$70$YR$$F$Y$$$20240927$$HP$US$US
243721221$24372122$1$I$$20240919$20240927$20240927$EXP$$SA-ASTELLAS-2024-AER-008383$ASTELLAS$Abdulrahim O, Alanezi T. Is there an association between arteriovenous fistulas and axillary artery aneurysms? A report of two cases. International Journal of Surgery Case Reports. 2024;123: 1-6. doi:10.1016/j.ijscr.2024.110289.$38$YR$A$M$Y$$$20240927$$HP$SA$SA
243721231$24372123$1$I$20240722$20240924$20240927$20240927$EXP$FR-AFSSAPS-LM2024000459$FR-SA-2024SA279123$SANOFI AVENTIS$$66$YR$E$F$Y$79$KG$20240927$$CN$FR$FR
243721241$24372124$1$I$$20240919$20240927$20240927$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US005069$PAREXEL$$$$$$Y$$$20240927$$CN$US$US
243721251$24372125$1$I$$20240917$20240927$20240927$EXP$$JP-ROCHE-10000091053$ROCHE$$87$YR$E$M$Y$$$20240927$$HP$JP$JP
243721261$24372126$1$I$$20240926$20240927$20240927$EXP$$JP-SA-2024SA273374$SANOFI AVENTIS$Yagi T, Takano K, Umehara T, Arita H, Maeda N, Nakanishi K.. Catheter embolization for pulmonary arteriovenous malformations during chemotherapy for appendiceal adenocarcinoma: A case report of associated brain abscess.. Radiology Case Reports. 2024;19(11):5507-12$68$YR$E$F$Y$$$20240927$$MD$JP$JP
243721271$24372127$1$I$20230101$20240924$20240927$20240927$PER$$US-BAYER-2024A136530$BAYER$$40$YR$A$F$Y$$$20240927$$CN$US$US
243721281$24372128$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152594$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$$$20240927$$HP$US$US
243721301$24372130$1$I$20240801$20240911$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152756$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$85.3$KG$20240927$$MD$US$US
243721311$24372131$1$I$$20240923$20240927$20240927$PER$$US-BAYER-2024A136527$BAYER$$$$$F$Y$$$20240927$$CN$US$US
243721321$24372132$1$I$$20240923$20240927$20240927$PER$$US-KEDRION-009638$KEDRION$Alam A., Keena D.T. SEVERE?ANAPHYLACTIC SHOCK DUE TO HUMAN SERUM ALBUMIN INFUSION. Chest 2024 166:4 (A8).$84$YR$$M$Y$$$20240927$$HP$US$US
243721331$24372133$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016136$ELI LILLY AND CO$$$$E$M$Y$$$20240927$$CN$US$US
243721371$24372137$1$I$20220602$20240920$20240927$20240927$EXP$ES-AEMPS-1569940$ES-CHEPLA-2024012141$CHEPLAPHARM$$71$YR$$M$Y$$$20240927$$PH$COUNTRY NOT SPECIFIED$ES
243721381$24372138$1$I$20240923$20240926$20240927$20240927$EXP$$CN-BAYER-2024A138318$BAYER$$85$YR$E$F$Y$$$20240927$$HP$CN$CN
243721391$24372139$1$I$20240501$20240923$20240927$20240927$EXP$FR-AFSSAPS-AN2024001285$FR-CHEPLA-2024012186$CHEPLAPHARM$$30$YR$$M$Y$$$20240927$$MD$COUNTRY NOT SPECIFIED$FR
243721401$24372140$1$I$$20240917$20240927$20240927$EXP$$US-ROCHE-10000085146$ROCHE$$74$YR$E$M$Y$$$20240927$$CN$US$US
243721411$24372141$1$I$20240924$20240924$20240927$20240927$PER$$US-BAYER-2024A137408$BAYER$$50$YR$A$F$Y$$$20240927$$MD$US$US
243721421$24372142$1$I$20240814$20240923$20240927$20240927$EXP$FR-AFSSAPS-GR2024001122$FR-CHEPLA-2024012146$CHEPLAPHARM$$73$YR$$M$Y$67$KG$20240927$$PH$COUNTRY NOT SPECIFIED$FR
243721431$24372143$1$I$$20240923$20240927$20240927$EXP$FR-AFSSAPS-AVBX2024000537$FR-CHEPLA-2024012219$CHEPLAPHARM$$22$YR$$M$Y$$$20240927$$PH$COUNTRY NOT SPECIFIED$FR
243721441$24372144$1$I$20240101$20240924$20240927$20240927$EXP$$US-CHEPLA-2024012225$CHEPLAPHARM$$66$YR$$M$Y$$$20240927$$CN$COUNTRY NOT SPECIFIED$US
243721451$24372145$1$I$$20240918$20240927$20240927$PER$$US-GSK-US2024116145$GLAXOSMITHKLINE$$$$C$F$Y$$$20240927$$CN$US$US
243721461$24372146$1$I$20211021$20240921$20240927$20240927$EXP$$CA-CHEPLA-2021004899$CHEPLAPHARM$$67$YR$$F$Y$34$KG$20240927$$MD$COUNTRY NOT SPECIFIED$CA
243721471$24372147$1$I$$20240923$20240927$20240927$EXP$$US-PFIZER INC-PV202400124204$PFIZER$Sasso, G.. STATUS EPILEPTICUS INDUCED BY TRANEXAMIC ACID IRRIGATION.. Chest. 2024;166(4 Suppl):A2777-A2778$62$YR$$M$Y$$$20240927$$HP$US$US
243721481$24372148$1$I$20240601$20240926$20240927$20240927$EXP$$US-PFIZER INC-PV202300099899$PFIZER$$83$YR$$M$Y$$$20240927$$HP$US$US
243721491$24372149$1$I$$20240926$20240927$20240927$EXP$$US-PFIZER INC-PV202400126422$PFIZER$$26$YR$$F$Y$$$20240927$$HP$US$US
243721501$24372150$1$I$20240914$20240927$20240927$20240927$EXP$$TH-PFIZER INC-PV202400126548$PFIZER$$33$YR$$F$Y$$$20240927$$CN$TH$TH
243721521$24372152$1$I$20240101$20240925$20240927$20240927$EXP$$CN-PFIZER INC-PV202400125694$PFIZER$$45$YR$$F$Y$55$KG$20240927$$HP$CN$CN
243721531$24372153$1$I$20240101$20240924$20240927$20240927$EXP$$US-PFIZER INC-PV202400086550$PFIZER$$78$YR$$F$Y$$$20240927$$HP$US$US
243721541$24372154$1$I$20240811$20240926$20240927$20240927$EXP$$IN-PFIZER INC-PV202400126496$PFIZER$$48$YR$$M$Y$$$20240927$$CN$IN$IN
243721551$24372155$1$I$$20240920$20240927$20240927$PER$$US-BAYER-2024A135010$BAYER$$$$$$Y$$$20240927$$CN$US$US
243721561$24372156$1$I$$20240924$20240927$20240927$PER$$US-BAYER-2024A137637$BAYER$$22$YR$A$F$Y$$$20240927$$MD$US$US
243721581$24372158$1$I$$20240911$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09160$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243721591$24372159$1$I$20090827$20240925$20240927$20240927$EXP$$GB-BAYER-2024A137123$BAYER$$69$YR$E$F$Y$46$KG$20240927$$HP$GB$GB
243721601$24372160$1$I$$20240912$20240927$20240927$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-09586$LUPIN$$$$$$Y$$$20240927$$CN$CA$CA
243721611$24372161$1$I$$20240918$20240927$20240927$PER$$US-ABBVIE-5930788$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243721621$24372162$1$I$20240903$20240918$20240927$20240927$EXP$$JP-MYE-2024M1084916AA$MYLAN$$42$YR$$F$Y$$$20240927$$CN$JP$JP
243721631$24372163$1$I$$20240926$20240927$20240927$PER$$US-BAYER-2024A138284$BAYER$$46$YR$A$F$Y$$$20240927$$HP$US$US
243721641$24372164$1$I$20240315$20240923$20240927$20240927$EXP$$DE-MYLANLABS-2024M1086754$MYLAN$$$$$M$Y$$$20240927$$CN$DE$DE
243721651$24372165$1$I$$20240918$20240927$20240927$EXP$$IT-MYLANLABS-2024M1086475$MYLAN$Giorgia G, Alberto G, Marta Z, Iacopo C, Maura A, Giovanna M et.al. Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than Single Infusion?. The Journal of Clinical Endocrinology and Metabolism. 2024;109:1817?e1826$75$YR$$F$Y$$$20240927$$MD$IT$IT
243721661$24372166$1$I$$20240918$20240927$20240927$EXP$$IT-MYLANLABS-2024M1086198$MYLAN$De Leo S, Trevisan M, Re Sarto GV, Moneta C, Pirovano M, Colombo C, et al. Letter to the Editor: Tumor Lysis Syndrome During Selpercatinib Treatment in a Patient with Medullary Thyroid Cancer. Thyroid 2023; 33 (9): 1130-1132.$84$YR$$M$Y$$$20240927$$HP$IT$IT
243721671$24372167$1$I$$20240918$20240927$20240927$EXP$$US-MYLANLABS-2024M1086496$MYLAN$Measer J, Gray A, Braehler M. Subdural Spread of Local Anesthetic Mimicking Cerebrovascular Accident: A Case Report of Horner^s Syndrome, Upper Limb Paresthesia, and Motor Weakness After Thoracic Epidural Analgesia. A-A-Pract 2024; 18 (7):.$53$YR$$F$Y$$$20240927$$MD$US$US
243721701$24372170$1$I$$20240918$20240927$20240927$EXP$$IT-MYLANLABS-2024M1086186$MYLAN$Mannelli F, Crupi F, Zanotti R, Pagano L, Rapezzi D, Tanasi I, et al. The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis. Ther-Adv-Hematol 2023; 14.$61$YR$$M$Y$$$20240927$$HP$IT$IT
243721711$24372171$1$I$$20240918$20240927$20240927$EXP$$IT-MYLANLABS-2024M1086195$MYLAN$Mannelli F, Crupi F, Zanotti R, Pagano L, Rapezzi D, Tanasi I, et al. The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis. Ther-Adv-Hematol 2023; 14 no pagination.$66$YR$$M$Y$$$20240927$$HP$IT$IT
243721721$24372172$1$I$20240805$20240918$20240927$20240927$EXP$$AR-AMGEN-ARGSP2024187592$AMGEN$$43$YR$A$F$Y$$$20240927$$MD$AR$AR
243721732$24372173$2$F$20240926$20240927$20240927$20240928$PER$$US-AMGEN-USASP2024192435$AMGEN$$78$YR$E$F$Y$$$20240928$$CN$US$US
243721741$24372174$1$I$$20240918$20240927$20240927$PER$$US-JNJFOC-20240951799$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$HP$US$US
243721761$24372176$1$I$$20240924$20240927$20240927$PER$$US-BAYER-2024A137644$BAYER$$$$$F$Y$$$20240927$$CN$US$US
243721771$24372177$1$I$$20240911$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09144$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243721781$24372178$1$I$20240101$20240925$20240927$20240927$EXP$$TR-PFIZER INC-PV202400121460$PFIZER$$14$YR$$F$Y$40$KG$20240927$$MD$TR$TR
243721791$24372179$1$I$$20240923$20240927$20240927$EXP$$US-PFIZER INC-2022SGN03432$PFIZER$$22$YR$$F$Y$$$20240927$$CN$US$US
243721821$24372182$1$I$$20240920$20240927$20240927$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001931$BLUEPRINT MEDICINES$$$$$M$Y$$$20240927$$CN$US$US
243721831$24372183$1$I$$20240923$20240927$20240927$EXP$$CA-PFIZER INC-202400263918$PFIZER$$49$YR$$F$Y$102$KG$20240927$$HP$CA$CA
243721841$24372184$1$I$$20240912$20240927$20240927$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2024-09435$LUPIN$$43$YR$$F$Y$96$KG$20240927$$HP$CA$CA
243721851$24372185$1$I$20240920$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152158$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240927$$PH$US$US
243721861$24372186$1$I$20240823$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151551$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$156.94$KG$20240927$$HP$US$US
243721871$24372187$1$I$$20240919$20240927$20240927$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001910$BLUEPRINT MEDICINES$$$$$M$Y$$$20240927$$CN$US$US
243721891$24372189$1$I$20240701$20240920$20240927$20240927$EXP$$CN-009507513-2409CHN008485$MERCK$$54$YR$$M$Y$60$KG$20240927$$HP$CN$CN
243721901$24372190$1$I$$20231026$20240927$20240927$EXP$$ES-BAYER-2024A137167$BAYER$Argiz L.; Crespo J.; Toscano T.; Liano G.; Fraile C.; Gastaminza G.; Vega F.. Good Tolerance to Iobitridol in a Patient with Sialadenitis Induced by Iohexol and Iopromide: A Case Report. The journal of allergy and clinical immunology. In practice. 2023$65$YR$E$M$Y$$$20240927$$MD$ES$ES
243721911$24372191$1$I$$20240911$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09222$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243721921$24372192$1$I$$20240923$20240927$20240927$PER$$US-JNJFOC-20240961663$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243721941$24372194$1$I$20240101$20240830$20240927$20240927$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000187$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243721961$24372196$1$I$$20240925$20240927$20240927$PER$$US-BAYER-2024A137436$BAYER$$$$$F$Y$$$20240927$$CN$US$US
243721971$24372197$1$I$$20240911$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09142$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243721981$24372198$1$I$$20240924$20240927$20240927$EXP$$GB-VERTEX PHARMACEUTICALS-2024-015159$VERTEX$$$$A$F$Y$$$20240927$$CN$GB$GB
243721991$24372199$1$I$$20240919$20240927$20240927$PER$$US-VERTEX PHARMACEUTICALS-2018-008043$VERTEX$$$$A$$Y$$$20240927$$CN$US$US
243722001$24372200$1$I$$20240923$20240927$20240927$EXP$$FR-VERTEX PHARMACEUTICALS-2024-010566$VERTEX$Bergeron S, Audousset C, Gautier S.. Elexacaftor/tezacaftor/ivacaftor and breastfeeding: 3 cases of liver enzymes abnormalities in breastfeed children. J Cyst Fibros. 2024;23:S83-4$30$YR$$F$Y$$$20240927$$HP$FR$FR
243722021$24372202$1$I$$20240923$20240927$20240927$EXP$$IT-VERTEX PHARMACEUTICALS-2024-015117$VERTEX$$$$$F$Y$$$20240927$$HP$IT$IT
243722031$24372203$1$I$20240101$20240923$20240927$20240927$EXP$$GB-VERTEX PHARMACEUTICALS-2024-015079$VERTEX$$$$C$F$Y$$$20240927$$CN$GB$GB
243722051$24372205$1$I$20240401$20240923$20240927$20240927$EXP$$IT-VERTEX PHARMACEUTICALS-2024-015116$VERTEX$$$$C$F$Y$$$20240927$$MD$IT$IT
243722061$24372206$1$I$$20240923$20240927$20240927$PER$$US-VERTEX PHARMACEUTICALS-2024-015106$VERTEX$$$$$$Y$$$20240927$$CN$US$US
243722081$24372208$1$I$$20240923$20240927$20240927$EXP$$GB-VERTEX PHARMACEUTICALS-2024-015087$VERTEX$$$$A$M$Y$$$20240927$$CN$GB$GB
243722091$24372209$1$I$20240101$20240901$20240927$20240927$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000188$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243722101$24372210$1$I$$20240920$20240927$20240927$EXP$$US-ROCHE-10000088415$ROCHE$$77$YR$E$M$Y$$$20240927$$CN$US$US
243722121$24372212$1$I$20240926$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192616$AMGEN$$17$YR$T$M$Y$$$20240927$$CN$US$US
243722131$24372213$1$I$$20240920$20240927$20240927$EXP$$HU-ABBVIE-5938728$ABBVIE$Magocs D, Elek I. Pharmacobezoars and the holistic approach. Clinical Toxicology. 2024 01;62(1):46.$47$YR$$F$Y$$$20240927$$HP$HU$HU
243722141$24372214$1$I$20240920$20240926$20240927$20240927$PER$$US-BAYER-2024A138035$BAYER$$39$YR$A$F$Y$$$20240927$$HP$US$US
243722151$24372215$1$I$$20240919$20240927$20240927$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006750$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243722161$24372216$1$I$$20240926$20240927$20240927$PER$$US-BAYER-2024A138146$BAYER$$38$YR$A$F$Y$$$20240927$$HP$US$US
243722171$24372217$1$I$20230216$20240924$20240927$20240927$EXP$FR-AFSSAPS-MA2024001366$FR-009507513-2409FRA008775$MERCK$$43$YR$$F$Y$73$KG$20240927$$PH$FR$FR
243722181$24372218$1$I$20240831$20240920$20240927$20240927$EXP$$DE-GLENMARK PHARMACEUTICALS-2024GMK094213$GLENMARK$$$$$$Y$$$20240927$$MD$DE$DE
243722192$24372219$2$F$$20240926$20240927$20240930$EXP$$IN-PFIZER INC-202400263357$PFIZER$Ahuja, V.. Combined or High Dose Immunosuppression in Inflammatory Bowel Disease patients who are NUDT15 Homozygous Harbors Risk of Developing Invasive Fungal Infections: A Case Series. Inflammatory Bowel Diseases. 2024;30(9):1623-5$40$YR$$M$Y$$$20240930$$MD$IN$IN
243722201$24372220$1$I$$20240920$20240927$20240927$EXP$$US-PFIZER INC-PV202400123252$PFIZER$Brenner, B.. Heparin insensitivity and thrombotic risk associated with sequential uses of prothrombin complex concentrate and andexanet alfa for apixaban reversal during acute type a aortic dissection repair: a case report. A + A Practice. 2022;16 (11):e01636$67$YR$$M$Y$80$KG$20240927$$MD$US$US
243722221$24372222$1$I$$20240924$20240927$20240927$EXP$$SD-TAKEDA-2024TUS095318$TAKEDA$$4$YR$$$Y$$$20240927$$CN$SD$SD
243722231$24372223$1$I$20240115$20240916$20240927$20240927$EXP$$US-UCBSA-2024048394$UCB$$29$YR$$F$Y$$$20240927$$CN$US$US
243722241$24372224$1$I$20240716$20240904$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005322$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20240927$$CN$US$US
243722251$24372225$1$I$20100201$20240920$20240927$20240927$EXP$$GB-TEVA-VS-3246637$TEVA$$43$YR$$M$Y$$$20240927$$PH$GB$GB
243722261$24372226$1$I$$20240921$20240927$20240927$PER$$US-GSK-US2024AMR118049$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$US$US
243722271$24372227$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191520$AMGEN$$$$$F$Y$$$20240927$$CN$US$US
243722311$24372231$1$I$20161007$20240918$20240927$20240927$EXP$$US-TAKEDA-2016BLT007350$TAKEDA$$12$YR$$M$Y$47$KG$20240927$$CN$US$US
243722321$24372232$1$I$$20240925$20240927$20240927$EXP$$NVSC2024US191794$NOVARTIS$$$$$M$Y$$$20240927$$MD$US$US
243722331$24372233$1$I$20240701$20240916$20240927$20240927$EXP$$US-HQ SPECIALTY-US-2024INT000087$INTERCHEM$$$$$M$Y$$$20240927$$HP$US$US
243722351$24372235$1$I$20240716$20240925$20240927$20240927$PER$$NVSC2024US191680$NOVARTIS$$73$YR$$M$Y$$$20240927$$CN$US$US
243722371$24372237$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152316$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240927$$HP$US$US
243722381$24372238$1$I$$20240918$20240927$20240927$EXP$$CA-DSJP-DS-2024-101631-CAAA$DAIICHI$$63$YR$$F$Y$$$20240927$$CN$CA$CA
243722391$24372239$1$I$20240919$20240919$20240927$20240927$PER$$US-ROCHE-10000087087$ROCHE$$$$$F$Y$$$20240927$$HP$US$US
243722401$24372240$1$I$$20240925$20240927$20240927$PER$$US-009507513-2409USA009576$MERCK$Sathe P, Munagala R, Kim D, Wong K.. Drug-induced eosinophilic pneumonia: a case of delayed onset eosinophilic pneumonia from prolonged use of daptomycin.. Chest. 2024;166 (4):A3163-4$75$YR$$M$Y$$$20240927$$HP$US$US
243722411$24372241$1$I$$20240920$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151453$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240927$$CN$US$US
243722421$24372242$1$I$20240919$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151874$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$53.4$KG$20240927$$PH$US$US
243722431$24372243$1$I$$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-66541$$FDA-CTU$$$$$M$N$$$20240926$N$HP$US$
243722461$24372246$1$I$$20240924$20240927$20240927$EXP$$JP-BAYER-2024A136889$BAYER$$$$$M$Y$$$20240927$$MD$JP$JP
243722471$24372247$1$I$20240101$20240926$20240927$20240927$PER$$US-BAYER-2024A138187$BAYER$$32$YR$A$F$Y$$$20240927$$MD$US$US
243722481$24372248$1$I$20240921$20240923$20240927$20240927$EXP$$MX-BAYER-2024A137821$BAYER$$$$$$Y$$$20240927$$HP$MX$MX
243722491$24372249$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016259$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240927$$CN$US$US
243722501$24372250$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016405$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240927$$CN$US$US
243722511$24372251$1$I$$20240918$20240927$20240927$30DAY$$AR-PFIZER INC-202400258930$PFIZER$$6$YR$$F$Y$$$20240927$$HP$AR$AR
243722521$24372252$1$I$$20240916$20240927$20240927$EXP$$CA-JNJFOC-20240944467$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$MD$CA$CA
243722531$24372253$1$I$$20240925$20240927$20240927$EXP$$US-JNJFOC-20240971679$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$MD$US$US
243722541$24372254$1$I$$20240924$20240927$20240927$EXP$$US-BAYER-2024A137515$BAYER$$45$YR$A$M$Y$$$20240927$$CN$US$US
243722551$24372255$1$I$20240601$20240919$20240927$20240927$EXP$FR-AFSSAPS-BR2024000702$FR-TEVA-VS-3246175$TEVA$$49$YR$$M$Y$96$KG$20240927$$MD$FR$FR
243722561$24372256$1$I$20240601$20240918$20240927$20240927$PER$$US-GSK-US2024116096$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243722571$24372257$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245201$TEVA$$$$$$Y$$$20240927$$HP$CA$CA
243722581$24372258$1$I$$20240925$20240927$20240927$PER$$US-009507513-2409USA009010$MERCK$Dollar K. IMMUNE CHECKPOINT INHIBITOR INDUCED SEVERE OVERLAP SYNDROME: A CASE REPORT. Chest. 2024;166(4):A1940-1$81$YR$$M$Y$$$20240927$$HP$US$US
243722591$24372259$1$I$20240909$20240925$20240927$20240927$EXP$$US-BAYER-2024A138017$BAYER$$58$YR$A$M$Y$$$20240927$$CN$US$US
243722601$24372260$1$I$$20240904$20240927$20240927$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005323$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243722611$24372261$1$I$20240101$20240918$20240927$20240927$PER$$US-ABBVIE-5931943$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243722651$24372265$1$I$$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-66546$$FDA-CTU$$$$$F$N$$$20240926$N$HP$US$
243722691$24372269$1$I$20240914$20240920$20240927$20240927$EXP$$CN-ROCHE-10000088112$ROCHE$$47$YR$A$F$Y$76$KG$20240927$$HP$CN$CN
243722701$24372270$1$I$$20240925$20240927$20240927$PER$$US-TAKEDA-2024TUS095799$TAKEDA$$$$$$Y$$$20240927$$HP$US$US
243722711$24372271$1$I$$20240919$20240927$20240927$EXP$$JP-MYE-2024M1085379AA$MYLAN$Yas uda K, Morimoto N, Mizobe T, Tsubomura M, Tato W, and Nishitani Y. A case of acute interstitial nephritis due to acetaminophen. The 245th Kinki Regional Meeting of the Japanese Society of Internal Medicine. 2024$25$YR$$M$Y$$$20240927$$MD$JP$JP
243722721$24372272$1$I$20170101$20240923$20240927$20240927$PER$$US-ROCHE-10000089747$ROCHE$$88$YR$E$F$Y$$$20240927$$MD$US$US
243722731$24372273$1$I$$20240918$20240927$20240927$PER$$US-ABBVIE-5931912$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243722741$24372274$1$I$$20240919$20240927$20240927$EXP$$IT-MYLANLABS-2024M1086901$MYLAN$Licata G, Rizzo D, Frazzitta M, Zichichi L. Successful treatment of sub-erythrodermic psoriasis with bimekizumab: a case report and literature review. Int-J-Dermatol 2024; 63 (8): 1105-1107.$54$YR$$M$Y$$$20240927$$HP$IT$IT
243722751$24372275$1$I$$20240919$20240927$20240927$EXP$$DE-MYLANLABS-2024M1086893$MYLAN$Baquet-Walscheid K, Heinz C, Heiligenhaus A. Beneficial Effect of Upadacitinib in a Refractory Course of Scleritis: A Case Report. Ocular-Immunol-Inflamm 2024; 32 (6): 1076-1078.$42$YR$$F$Y$$$20240927$$MD$DE$DE
243722761$24372276$1$I$20240925$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191736$AMGEN$$77$YR$E$F$Y$$$20240927$$CN$US$US
243722771$24372277$1$I$$20240923$20240927$20240927$PER$$US-ROCHE-10000088836$ROCHE$Pham J, France A, Ellett T, Ahmad Y. Development of herpes meningitis while managing for treatment for treatment-resistant immune thrombocytopenia. Chest. 2024;166 (4S):A2860-1. doi:10.1016/j.chest.2024.06.1731.$70$YR$E$F$Y$$$20240927$$HP$US$US
243722791$24372279$1$I$20240925$20240926$20240927$20240927$PER$$US-BAYER-2024A138220$BAYER$$21$YR$A$F$Y$$$20240927$$HP$US$US
243722801$24372280$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245145$TEVA$$64$YR$$F$Y$$$20240927$$HP$CA$CA
243722811$24372281$1$I$$20240916$20240927$20240927$EXP$$US-LUPIN PHARMACEUTICALS INC.-2024-09321$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243722821$24372282$1$I$$20240923$20240927$20240927$PER$$US-ROCHE-10000088902$ROCHE$Federbush M, Shah D, Murn M. Migrating pulmonary opacities in a patient with neuromyelitis optica taking rituximab with recent covid19 infection. Chest. 2024-Oct;166 (4):A3295-6. doi:10.1016/j.chest.2024.06.1971.$36$YR$A$M$Y$$$20240927$$HP$US$US
243722841$24372284$1$I$$20240923$20240927$20240927$EXP$$US-OTSUKA-2024_026551$OTSUKA$$$$$M$Y$$$20240927$$HP$US$US
243722851$24372285$1$I$20240524$20240920$20240927$20240927$EXP$$JP-ROCHE-10000090777$ROCHE$$52$YR$A$M$Y$65$KG$20240927$$PH$JP$JP
243722861$24372286$1$I$$20240919$20240927$20240927$EXP$$DK-MYLANLABS-2024M1086624$MYLAN$Hansen CKK, Ozdemir CM, Maassen Van Den Brink A, Amin FM. Effect of Sumatriptan in an Adult with Meningitis-Induced Severe Headache: a Case Report. SN-Compr-Clin-Med 2024; 6 (1).$59$YR$$M$Y$$$20240927$$HP$DK$DK
243722871$24372287$1$I$$20240920$20240927$20240927$PER$$US-EMD Serono-2024050799$EMD SERONO INC$$$$A$F$Y$$$20240927$$HP$US$US
243722881$24372288$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245150$TEVA$$70$YR$$F$Y$$$20240927$$HP$CA$CA
243722901$24372290$1$I$20240901$20240904$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005324$ACADIA PHARMACEUTICALS$$77$YR$$F$Y$$$20240927$$CN$US$US
243722911$24372291$1$I$20240101$20240920$20240927$20240927$PER$$JP-Eisai-EC-2024-174008$EISAI$$71$YR$E$M$Y$$$20240927$$MD$JP$JP
243722921$24372292$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245088$TEVA$$60$YR$$F$Y$$$20240927$$PH$CA$CA
243722931$24372293$1$I$$20240917$20240927$20240927$EXP$$IN-TORRENT-00003673$TORRENT$$$$$F$Y$$$20240927$$MD$IN$IN
243722941$24372294$1$I$20240909$20240918$20240927$20240927$EXP$GB-MHRA-MED-202409181137080160-CZTLG$GB-TORRENT-00037994$TORRENT$$28$YR$A$F$Y$$$20240927$$CN$GB$GB
243722951$24372295$1$I$20240911$20240916$20240927$20240927$EXP$GB-MHRA-MED-202409141644302610-KFVZN$GB-TORRENT-00038000$TORRENT$$39$YR$A$F$Y$$$20240927$$CN$GB$GB
243722971$24372297$1$I$20240919$20240919$20240927$20240927$EXP$GB-MHRA-TPP55220572C9802744YC1726732613565$GB-TORRENT-00038017$TORRENT$$57$YR$A$F$Y$70$KG$20240927$$PH$GB$GB
243722981$24372298$1$I$$20240916$20240927$20240927$EXP$$US-TORRENT-00013758$TORRENT$$43$YR$A$F$Y$$$20240927$$CN$US$US
243722991$24372299$1$I$20240816$20240916$20240927$20240927$EXP$$US-TORRENT-00013759$TORRENT$$25$YR$A$F$Y$$$20240927$$CN$US$US
243723001$24372300$1$I$20240717$20240927$20240927$20240927$EXP$FR-AFSSAPS-AM2024000783$NVSC2024FR192084$NOVARTIS$$34$YR$$F$Y$60.8$KG$20240927$$MD$FR$FR
243723011$24372301$1$I$20230101$20240917$20240927$20240927$EXP$$US-TORRENT-00013757$TORRENT$$70$YR$E$M$Y$$$20240927$$MD$US$US
243723021$24372302$1$I$$20240916$20240927$20240927$EXP$$US-TORRENT-00013703$TORRENT$$$$I$F$Y$$$20240927$$HP$US$US
243723031$24372303$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66596$$FDA-CTU$$28$YR$$F$N$$$20240927$N$$US$
243723041$24372304$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66254$$FDA-CTU$$$$$$N$$$20240925$N$CN$US$
243723121$24372312$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66572$$FDA-CTU$$54$YR$$M$N$$$20240927$N$$US$
243723161$24372316$1$I$$20240921$20240927$20240927$PER$$US-ROCHE-10000089114$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243723171$24372317$1$I$$20240923$20240927$20240927$PER$$US-ROCHE-10000090147$ROCHE$$$$E$M$Y$$$20240927$$CN$US$US
243723201$24372320$1$I$20240717$20240919$20240927$20240927$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-146913$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240927$$MD$DE$DE
243723211$24372321$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153294$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240927$$MD$US$US
243723221$24372322$1$I$$20240918$20240927$20240927$EXP$$GB-CELLTRION INC.-2024GB020890$CELLTRION$$$$$$Y$$$20240927$$CN$GB$GB
243723241$24372324$1$I$$20240920$20240927$20240927$EXP$GB-MHRA-MED-202409201341331650-JYFQG$GB-GE HEALTHCARE-2024CSU010803$GE HEALTHCARE$$66$YR$$F$Y$$$20240927$$HP$GB$GB
243723251$24372325$1$I$20240917$20240920$20240927$20240927$EXP$$US-ABBVIE-5934300$ABBVIE$$60$YR$$F$Y$$$20240927$$CN$US$US
243723261$24372326$1$I$20240101$20240920$20240927$20240927$EXP$$US-ABBVIE-5933803$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243723271$24372327$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192451$NOVARTIS$$$$$$Y$$$20240927$$MD$US$US
243723281$24372328$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192179$NOVARTIS$$$$$$Y$$$20240927$$HP$US$US
243723291$24372329$1$I$$20240911$20240927$20240927$EXP$$JP-SA-2024SA279293$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240927$$CN$JP$JP
243723311$24372331$1$I$$20240920$20240927$20240927$EXP$$US-ABBVIE-5936407$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243723331$24372333$1$I$$20240912$20240927$20240927$EXP$$CY-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469983$RANBAXY$Bazoukis G, Efthymiou P, Yiannikourides A, Khattab E, Dimitriades V, Tse G, et al. Flecainide toxicity-Clinical diagnosis and management of an urgent condition. Clin Case Rep. 2024;12 (9):e9371(1-6)$49$YR$$F$Y$$$20240927$$HP$CY$CY
243723341$24372334$1$I$20240611$20240912$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469252$RANBAXY$$66$YR$$F$Y$52$KG$20240927$$HP$GB$GB
243723351$24372335$1$I$20240726$20240912$20240927$20240927$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469162$RANBAXY$$$$E$M$Y$$$20240927$$CN$IT$IT
243723361$24372336$1$I$$20240912$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469847$RANBAXY$Cox L, Craig S, Douek I, Whitehead D. Managing diabetic nephropathy in the preconception diabetes clinic: when to stop angiotensin blockade ? A case report. Br J Diabetes. 2024;24 (1):507$28$YR$$F$Y$$$20240927$$HP$GB$GB
243723371$24372337$1$I$$20240912$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470077$RANBAXY$$70$YR$$F$Y$98$KG$20240927$$HP$GB$GB
243723382$24372338$2$F$20240425$20240917$20240927$20240927$EXP$$US-ROCHE-10000084906$ROCHE$$74$YR$E$F$Y$63.5$KG$20240927$$CN$US$US
243723391$24372339$1$I$$20240916$20240927$20240927$EXP$$IN-ROCHE-10000084291$ROCHE$$71$YR$E$M$Y$$$20240927$$CN$IN$IN
243723401$24372340$1$I$$20240912$20240927$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469772$RANBAXY$Furuya C, Yasuda H, Hiki M, Shirane S, Yamana T, Uchimura A, et al. Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases. Front Immunol. 2024;15:1-5$78$YR$$M$Y$$$20240927$$HP$JP$JP
243723411$24372341$1$I$$20240912$20240927$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-466748$RANBAXY$$$$E$M$Y$$$20240927$$CN$US$US
243723421$24372342$1$I$$20240912$20240927$20240927$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470308$RANBAXY$Chatzellis E, Angelousi A, Daskalakis K, Tsoli M, Alexandraki KI, Wachula E, et al. Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms. Neuroendocrinology. 2019;0 (0)$$$$$Y$$$20240927$$HP$GR$GR
243723431$24372343$1$I$$20240912$20240927$20240927$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470207$RANBAXY$Rubio-Mora E, Rodriguez JG, Carrascoso GR. Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?. Transpl Infect Dis. 2024;Apr; 26 (3):e14276$4$YR$$F$Y$$$20240927$$HP$ES$ES
243723441$24372344$1$I$$20240912$20240927$20240927$EXP$$GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470309$RANBAXY$Chatzellis E, Angelousi A, Daskalakis K, Tsoli M, Alexandraki KI, Wachula E, et al. Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms. Neuroendocrinology. 2019;0 (0)$$$$$Y$$$20240927$$HP$GR$GR
243723451$24372345$1$I$20240831$20240912$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470001$RANBAXY$$76$YR$$M$Y$$$20240927$$MD$GB$GB
243723461$24372346$1$I$$20240912$20240927$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470008$RANBAXY$Takada N, Fukui T, Irie H, Funatsu Y, Koh H. Immune Checkpoint Inhibitor-induced Sclerosing Cholangitis: Three Cases Reported from Our Hospital. Japanese Journal of Lung Cancer. 2024;Jun;64(3):193-199$69$YR$$M$Y$$$20240927$$HP$JP$JP
243723471$24372347$1$I$20191125$20240912$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469922$RANBAXY$$41$YR$$M$Y$144$KG$20240927$$CN$GB$GB
243723481$24372348$1$I$$20240923$20240927$20240927$EXP$$US-ARGENX-2024-ARGX-US008237$ARGENX BVBA$DESAI K, Sharma R, Yanoshak R, Naik S. Refractory Seropositive Nonthymomatous Myasthenia Gravis In Myasthenic Crisis: A Case Report. Ann Clin Transl Neurol. 2022;9:122-31$$$$$Y$$$20240927$$HP$US$US
243723491$24372349$1$I$$20240912$20240927$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468555$RANBAXY$$$$E$F$Y$$$20240927$$CN$US$US
243723501$24372350$1$I$20240730$20240912$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469885$RANBAXY$$72$YR$$M$Y$$$20240927$$MD$GB$GB
243723511$24372351$1$I$$20240912$20240927$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469687$RANBAXY$Neisewander B, Trapp N. Electroconvulsive therapy complicated by ventricular fibrillation: A case report. Ann Clin Psychiatry. 2023;35(2):133-134$37$YR$$F$Y$$$20240927$$MD$US$US
243723521$24372352$1$I$$20240913$20240927$20240927$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-354823$RANBAXY$Singh E, Singh S. Inadvertent Therapeutic Error Involving Spinal Anesthesia during Cesarean Section: A Case Report. J SAFOG. 2022;May-Jun; 14(3):323-324$$$N$$Y$2.4$KG$20240927$$HP$IN$IN
243723531$24372353$1$I$20240503$20240919$20240927$20240927$EXP$$US-TAKEDA-2023TUS111767$TAKEDA$$27$YR$$M$Y$$$20240927$$MD$US$US
243723541$24372354$1$I$$20240912$20240927$20240927$EXP$$TN-RANBAXY-2015RR-93448$RANBAXY$Charfi O, Zaiem A, Sahnoun R, Lakhoua G, Zayani H, Daghfous R, et al. Multiple drug hypersensitivity in an epileptic woman. Fundam-Clin-Pharmacol. 2014;2858-59$50$YR$$F$Y$$$20240927$$HP$TN$TN
243723551$24372355$1$I$$20240912$20240927$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469721$RANBAXY$Ho H, Mohan S. Tissue injury secondary to peripheral xenobiotic administration. J Am Coll Emerg Physicians Open. 2023;4 (3):e12972 (1-2)$57$YR$$F$Y$$$20240927$$MD$US$US
243723561$24372356$1$I$$20240923$20240927$20240927$PER$$US-ROCHE-10000089994$ROCHE$$$$A$F$Y$$$20240927$$CN$US$US
243723571$24372357$1$I$$20240912$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469987$RANBAXY$Katis G, Srinivasan S, Eleftheriou P, Walker M, Demetriades P. Characterizing left ventricular systolic dysfunction in sickle cell disease: three contrasting case reports. Eur Heart J Case Rep. 2024;8:ytae383/1-5$37$YR$$F$Y$$$20240927$$HP$GB$GB
243723591$24372359$1$I$$20240912$20240927$20240927$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-460901$RANBAXY$Wang C-L, Zhang Q, Huang X-M. Electrocardiographic manifestations of a fatal case of oral propafenone poisoning. Acad J Nav Med Univ. 2023;MAR; 44 (3):382-384$10$YR$$F$Y$$$20240927$$HP$CN$CN
243723601$24372360$1$I$$20240913$20240927$20240927$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-467692$RANBAXY$Dogan SE, Kuskonmaz SM, Koc G, Aypar E, Culha C. Exposure to Glucagon-like Peptide-1 Receptor Agonist t in the First Trimester of Pregnancy in Two Siblings. Endocr Metab Immune Disord Drug Targets. 2024;24 (10):1237-1239$40$YR$$F$Y$110$KG$20240927$$HP$TR$TR
243723611$24372361$1$I$$20240912$20240927$20240927$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469900$RANBAXY$Gao J, Li M, Liu C, Jing H. Pembrolizumab Combined With GDP Regimen Inducing Sustained Remission in Histiocytic Sarcoma: A Case Report. J Investig Med High Impact Case Rep. 2024;12 (0):1-4$66$YR$$F$Y$$$20240927$$MD$CN$CN
243723621$24372362$1$I$$20240918$20240927$20240927$EXP$$CA-DSJP-DS-2024-101624-CAAA$DAIICHI$$$$$F$Y$$$20240927$$CN$CA$CA
243723631$24372363$1$I$$20240912$20240927$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470092$RANBAXY$Ebisawa K, Iwashita T, Uchiyama K, Kitayama Y, Takeuchi T. Epstein-Barr virus-positive mucocutaneous ulcer resulting in severe methotrexate intoxication: a case report. J Med Case Rep. 2024;18(1):1-5$8$DEC$$M$Y$$$20240927$$HP$JP$JP
243723641$24372364$1$I$$20240912$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469989$RANBAXY$Katis G, Srinivasan S, Eleftheriou P, Walker M, Demetriades P. Characterizing left ventricular systolic dysfunction in sickle cell disease: three contrasting case reports. Eur Heart J Case Rep. 2024;8:ytae383(1-5)$52$YR$$M$Y$$$20240927$$HP$GB$GB
243723651$24372365$1$I$$20240912$20240927$20240927$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470200$RANBAXY$Bazargan AS, Roohaninasab M, Kahjoogh HA, Aghdam SB, Taheri A, Jafarzadeh A. From drug therapy failures to laser therapy victory: A case report and literature review of lupus miliaris disseminatus faciei resolution. Clinical Case Reports. 2024;12 (9):1-7$28$YR$$M$Y$$$20240927$$HP$IR$IR
243723661$24372366$1$I$$20240912$20240927$20240927$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469738$RANBAXY$Ianhez M, Miot HA, Caetano LV, de Paula HM, Freire GG,  et al. Sarcoidosis and Polymethyl Methacrylate (PMMA) Granulomas following COVID?19 Vaccination (ChAdOx1): Successful Treatment with Tofacitinib. Indian J Dermatol. 2024;69:328-332$59$YR$$F$Y$$$20240927$$HP$BR$BR
243723671$24372367$1$I$$20240912$20240927$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469711$RANBAXY$Chen CB, Badri M, Kelly E. Case report: dyslipidaemia-dramatic increase in haemoglobin A1c following statin initiation. Eur Heart J Case Rep. 2024;8 (8):ytae436 (1-3)$52$YR$$M$Y$$$20240927$$HP$US$US
243723681$24372368$1$I$$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470405$RANBAXY$$42$YR$$M$Y$$$20240927$$PH$FR$FR
243723691$24372369$1$I$$20240912$20240927$20240927$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-462318$RANBAXY$$54$YR$$M$Y$$$20240927$$CN$CA$CA
243723701$24372370$1$I$$20240913$20240927$20240927$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470454$RANBAXY$Zhang Q, Yan X, Tian T-L, Wu X. Case report: outcome of anlotinib treatment in breast cancer patient with brain metastases. Front Pharmacol. 2024;15 (0):1381478 (1-8)$57$YR$$F$Y$$$20240927$$HP$CN$CN
243723711$24372371$1$I$20240917$20240920$20240927$20240927$DIR$FDA-CDER-CTU-2024-66539$$FDA-CTU$$$$$F$N$79.5$KG$20240920$N$$US$
243723731$24372373$1$I$$20240913$20240927$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468316$RANBAXY$Ikejiri F, Yokomizo K, Tamura K. Successful treatment with nivolumab in a patient with gastric cancer with severe liver failure resulting from multiple liver metastases: A case report. Oncol Lett. 2024;27 (6):271/1-5$57$YR$$M$Y$$$20240927$$HP$JP$JP
243723741$24372374$1$I$$20240912$20240927$20240927$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469854$RANBAXY$Araujo DABS, Ribeiro RM, Lima PLGSB, de Queiroz DC, Pitombeira MS, Martins B, et al. Spinal cord compression by cystic IgG4-related spinal pachymeningitis mimicking neurocysticercosis: a case report. BMC Neurol. 2024;24:318; 1-7$40$YR$$F$Y$$$20240927$$HP$BR$BR
243723751$24372375$1$I$$20240912$20240927$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470362$RANBAXY$Takada N, Fukui T, Irie H, Funatsu Y, Koh H.. Immune Checkpoint Inhibitor-induced Sclerosing Cholangitis: Three Cases Reported from Our Hospital.. Haigan. 2024;64 (3):193-199$68$YR$$M$Y$$$20240927$$HP$JP$JP
243723771$24372377$1$I$$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-66620$$FDA-CTU$$50$YR$$M$N$$$20240926$N$$US$
243723791$24372379$1$I$20240515$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470235$RANBAXY$$9$YR$$M$Y$$$20240927$$MD$FR$FR
243723811$24372381$1$I$$20240913$20240927$20240927$EXP$$NP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470393$RANBAXY$Bade S, Sharma G, Bhurtel N, Singh Y, Paudel S, Magar FP, et al. Transformative weight loss with Dulaglutide: A case report of success in a challenging patient profile of an ex-sumo wrestler. Clin Case Rep. 2024;12 (9)$27$YR$$M$Y$$$20240927$$HP$NP$NP
243723841$24372384$1$I$$20240913$20240927$20240927$EXP$$BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470160$RANBAXY$Lima Leal CA, Barroso Viana CHDO, Andrade Dantas G, Pipolo Milan E. Foot Amputation Due to Actinomycetoma: A Case Report of Challenging Diagnosis and Treatment. braz j infect dis. 2023;27:357-358$59$YR$$M$Y$$$20240927$$HP$BR$BR
243723851$24372385$1$I$$20240913$20240927$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469941$RANBAXY$Gerges M, Bathobakae L, Mahmoud A, Saad R, Elkattawy S, Shamoon F, et al.. THE GREAT MIMICKER: A UNIQUE CASE OF DIFFUSE SUBARACHNOID HAEMORRHAGE SIMULATING ACUTE MYOCARDIAL INFARCTION. Eur J Case Rep Intern Med. 2024;11 (8):-$44$YR$$F$Y$$$20240927$$HP$US$US
243723861$24372386$1$I$$20240913$20240927$20240927$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469930$RANBAXY$Buyukkal U, Temelturk RD, Tekin D. Acute Dystonic Reaction Following Methylphenidate Discontinuation During Combination Therapy with Risperidone: A Case Study. J Ankara Univ Fac Med. 2024;77 (2):222-226$6$YR$$M$Y$$$20240927$$HP$TR$TR
243723871$24372387$1$I$$20240913$20240927$20240927$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470187$RANBAXY$Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. J Oncol Pharm Practice. 2024;0 (0):1-4$69$YR$$F$Y$$$20240927$$HP$US$US
243723881$24372388$1$I$20240509$20240913$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470357$RANBAXY$$85$YR$$F$Y$$$20240927$$MD$GB$GB
243723891$24372389$1$I$$20240913$20240927$20240927$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470038$RANBAXY$Bondalapati S, Yeldandi VV, Eshwaragari B, Vikranth KN. Clinical and laboratory findings of Brucella bacteremia in a tertiary care hospital from India. Eur J Cardiovasc Med. 2023;13(4):1-5$48$YR$$M$Y$$$20240927$$MD$IN$IN
243723901$24372390$1$I$$20240926$20240927$20240927$PER$$US-HALEON-2199030$Haleon PLC$$90$YR$$M$Y$$$20240927$$CN$US$US
243723911$24372391$1$I$20240617$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470107$RANBAXY$$42$YR$$M$Y$58.5$KG$20240927$$MD$FR$FR
243723921$24372392$1$I$20230911$20240913$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470254$RANBAXY$$$$E$M$Y$$$20240927$$CN$GB$GB
243723931$24372393$1$I$20240605$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470169$RANBAXY$$22$YR$$F$Y$$$20240927$$HP$FR$FR
243723941$24372394$1$I$20240625$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470290$RANBAXY$$73$YR$$M$Y$$$20240927$$PH$FR$FR
243723951$24372395$1$I$20240514$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470220$RANBAXY$$59$YR$$F$Y$$$20240927$$MD$FR$FR
243723961$24372396$1$I$20240713$20240913$20240927$20240927$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470166$RANBAXY$$35$YR$$F$Y$$$20240927$$MD$DE$DE
243723971$24372397$1$I$20240911$20240913$20240927$20240927$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468896$RANBAXY$$33$YR$$F$Y$76$KG$20240927$$HP$CN$CN
243723981$24372398$1$I$$20240913$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470263$RANBAXY$$37$YR$$F$Y$56$KG$20240927$$CN$GB$GB
243723991$24372399$1$I$20240614$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470224$RANBAXY$$1$MON$$M$Y$2.87$KG$20240927$$MD$FR$FR
243724001$24372400$1$I$$20240914$20240927$20240927$EXP$$CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468608$RANBAXY$$59$YR$$M$Y$$$20240927$$CN$CA$CA
243724011$24372401$1$I$20230101$20240923$20240927$20240927$PER$$US-ROCHE-10000089935$ROCHE$$$$$M$Y$81.65$KG$20240927$$CN$US$US
243724021$24372402$1$I$20240611$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470065$RANBAXY$$23$YR$$M$Y$$$20240927$$PH$FR$FR
243724031$24372403$1$I$20240413$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470143$RANBAXY$$59$YR$$M$Y$$$20240927$$MD$FR$FR
243724041$24372404$1$I$$20240913$20240927$20240927$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469776$RANBAXY$Gamarra AMA, Segovia FJ, Olleros CL, Garcia CA, Garcia MVV, Sala Walthe LAA. MORE THAN JUST HIVES. Eur J Case Rep. 2024;-:1040(Abs;1955)$57$YR$$F$Y$$$20240927$$HP$ES$ES
243724051$24372405$1$I$20240209$20240913$20240927$20240927$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470155$RANBAXY$$46$YR$$F$Y$$$20240927$$MD$ES$ES
243724061$24372406$1$I$$20240914$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470377$RANBAXY$$82$YR$$F$Y$$$20240927$$CN$GB$GB
243724071$24372407$1$I$$20240913$20240927$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-468918$RANBAXY$Koshibu M, Watanabe N, Suzuki N, Takahashi Y, Onda H, Kozaki A et al. Exacerbation of Thyroid Eye Disease and Dysthyroid Optic Neuropathy During Pregnancy: A Case Report. Intern Med. 2024;Sep 11:Online ahead of print(13)$37$YR$$F$Y$$$20240927$$HP$JP$JP
243724081$24372408$1$I$20231101$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470117$RANBAXY$$50$YR$$M$Y$64$KG$20240927$$MD$FR$FR
243724101$24372410$1$I$$20240913$20240927$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469946$RANBAXY$Niimoto T, Todaka T, Kimura H, Suzuki S, Yoshino S, Hoashi K, et al. Cytokine release syndrome following COVID-19 infection during treatment with nivolumab for cancer of esophagogastric junction carcinoma: a case report and review. Int J Emerg Med. 2024;17 (1):1-10$60$YR$$M$Y$$$20240927$$HP$JP$JP
243724111$24372411$1$I$20240620$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470023$RANBAXY$$65$YR$$F$Y$55$KG$20240927$$MD$FR$FR
243724121$24372412$1$I$$20240913$20240927$20240927$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-354348$RANBAXY$Singh E, Singh S. Inadvertent Therapeutic Error Involving Spinal Anesthesia during Cesarean Section: A Case Report. J SAFOG. 2022;May-Jun; 14(3):323-324$32$YR$$F$Y$$$20240927$$HP$IN$IN
243724131$24372413$1$I$20240616$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470104$RANBAXY$$22$YR$$F$Y$59$KG$20240927$$MD$FR$FR
243724141$24372414$1$I$20231025$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470161$RANBAXY$$72$YR$$M$Y$$$20240927$$MD$FR$FR
243724151$24372415$1$I$$20240913$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469510$RANBAXY$Hussain K, Khalil N, Carton J, Flora R, Calonje E, Patel NP. A case of human T-lymphotropic virus-1-associated lichenoid dermatitis. Clin Exp Dermatol. 2024;49 (8):916-918$61$YR$$F$Y$$$20240927$$HP$GB$GB
243724161$24372416$1$I$$20240913$20240927$20240927$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470158$RANBAXY$McInerney C, McNally O, Cade TJ, Jones A, Neesham D, Naaman Y. Low-risk gestational trophoblastic neoplasia- 20 years experience of a state registry. Aust N Z J Obstet Gynaecol. 2024;64(3):223-229$24$YR$$F$Y$$$20240927$$HP$AU$AU
243724181$24372418$1$I$20240901$20240925$20240927$20240927$PER$$US-JNJFOC-20240969408$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243724191$24372419$1$I$20240404$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470163$RANBAXY$$69$YR$$F$Y$54.6$KG$20240927$$HP$FR$FR
243724201$24372420$1$I$20240614$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470036$RANBAXY$$58$YR$$M$Y$100$KG$20240927$$PH$FR$FR
243724211$24372421$1$I$$20240913$20240927$20240927$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-418789$RANBAXY$Dogan SE, Kuskonmaz SM, Koc G, Aypar E, Culha C. Case Series: Exposure to Glucagon-like Peptide-1 Receptor Agonist in the First Trimester of Pregnancy in Two Siblings. Endocr Metab Immune Disord Drug Targets. 2024;Nov 2; 24(10):1237-1239$$$N$F$Y$$$20240927$$HP$TR$TR
243724221$24372422$1$I$20240521$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470110$RANBAXY$$17$YR$$F$Y$49$KG$20240927$$MD$FR$FR
243724231$24372423$1$I$20240608$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470228$RANBAXY$$37$YR$$M$Y$70$KG$20240927$$MD$FR$FR
243724241$24372424$1$I$$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470090$RANBAXY$$14$YR$$M$Y$32$KG$20240927$$MD$FR$FR
243724251$24372425$1$I$20240627$20240913$20240927$20240927$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470392$RANBAXY$$76$YR$$M$Y$$$20240927$$MD$ES$ES
243724261$24372426$1$I$20240420$20240913$20240927$20240927$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470063$RANBAXY$$75$YR$$M$Y$$$20240927$$MD$ES$ES
243724271$24372427$1$I$20240618$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470080$RANBAXY$$21$YR$$F$Y$55$KG$20240927$$PH$FR$FR
243724281$24372428$1$I$$20240913$20240927$20240927$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470028$RANBAXY$Tripathi S, Balraam V, Ranjan Nayak A, Naranje P, Chauhan R, Dass J, et al. Ischemic Stroke as a Presenting Feature of Promyelocytic Blast Phase in Chronic Myeloid Leukemia -an Uncommon Presentation of an Exceptionally Rare Blastic Transformation of Myeloproliferative Neoplasm. Clin Lymphoma Myeloma Leuk. 2024;Sep,24(Suppl):S384/CML-754$45$YR$$F$Y$$$20240927$$MD$IN$IN
243724291$24372429$1$I$20240913$20240913$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470267$RANBAXY$$$$$$Y$$$20240927$$HP$GB$GB
243724301$24372430$1$I$$20240913$20240927$20240927$EXP$$IR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470318$RANBAXY$Atapour A, Momenzadeh M, Panahishokouh M, Badri S. Rosuvastatin-induced rhabdomyolysis as a result of drug interaction with Sitagliptin: a case report. Clin Med Insights Case Rep. 2024;17:1-4$64$YR$$F$Y$65$KG$20240927$$HP$IR$IR
243724311$24372431$1$I$$20240913$20240927$20240927$EXP$$CH-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469992$RANBAXY$Nagele K, Battig V, Gosert R, Walti CS, Prince SS, Halter J, et al. Revealing the Unseen: Next-Generation Sequencing for Early Detection of Drug-Resistant Cytomegalovirus. J Infect Dis. 2024;0(0):1-6$63$YR$$M$Y$$$20240927$$HP$CH$CH
243724321$24372432$1$I$$20240913$20240927$20240927$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469912$RANBAXY$de Val II, Castillo HM, Mele MDCD. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter type 2 inhibitors. Med Clin. 2024;163:100-105$42$YR$$F$Y$$$20240927$$HP$ES$ES
243724331$24372433$1$I$$20240913$20240927$20240927$EXP$$AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470113$RANBAXY$Lee E, Bosi I, Peacock K, Lau C, Ford LS, Wong M, et al. Novel infantile presentations of chronic granulomatous disease. Pediatr Allergy Immunol. 2024;35 (7):e14190 (1-5)$5$WK$$M$Y$$$20240927$$HP$AU$AU
243724351$24372435$1$I$20240223$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470329$RANBAXY$$63$YR$$M$Y$$$20240927$$PH$FR$FR
243724361$24372436$1$I$20240829$20240920$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005828$ACADIA PHARMACEUTICALS$$54$YR$$F$Y$$$20240927$$CN$US$US
243724371$24372437$1$I$20240101$20240911$20240927$20240927$PER$$US-INSUD PHARMA-2409US07111$INSUD PHARMA$$$$$$Y$$$20240927$$CN$US$US
243724381$24372438$1$I$$20240926$20240927$20240927$PER$$NVSC2024US192258$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
243724391$24372439$1$I$20240909$20240914$20240927$20240927$EXP$$CN-SA-2024SA278906$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240927$$HP$CN$CN
243724401$24372440$1$I$$20240919$20240927$20240927$EXP$$CA-GLENMARK PHARMACEUTICALS-2024GMK094178$GLENMARK$$$$$$Y$$$20240927$$MD$CA$CA
243724411$24372441$1$I$$20240920$20240927$20240927$EXP$$US-TAKEDA-2024TUS058587$TAKEDA$$$$$M$Y$$$20240927$$MD$US$US
243724421$24372442$1$I$$20240923$20240927$20240927$EXP$$US-VANTIVE-2024VAN019979$Vantive US Healthcare$$$$$M$Y$$$20240927$$HP$US$US
243724431$24372443$1$I$$20240920$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149877$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240927$$MD$US$US
243724441$24372444$1$I$$20240923$20240927$20240927$EXP$$ZA-BRISTOL-MYERS SQUIBB COMPANY-2024-153194$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240927$$HP$ZA$ZA
243724451$24372445$1$I$$20240919$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149847$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20240927$$HP$US$US
243724461$24372446$1$I$$20240919$20240927$20240927$EXP$$GR-VANTIVE-2024VAN020003$Vantive US Healthcare$$$$$M$Y$$$20240927$$HP$GR$GR
243724471$24372447$1$I$20240816$20240920$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005833$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20240927$$HP$US$US
243724491$24372449$1$I$$20240917$20240927$20240927$EXP$$JP-DSJP-DS-2024-100310-JP$DAIICHI$$80$YR$$M$Y$$$20240927$$HP$JP$JP
243724501$24372450$1$I$20230401$20240927$20240927$20240927$EXP$$CN-TAKEDA-2024TUS095887$TAKEDA$$77$YR$$F$Y$$$20240927$$CN$CN$CN
243724511$24372451$1$I$20240922$20240925$20240927$20240927$EXP$$US-TAKEDA-2024TUS095321$TAKEDA$$65$YR$$M$Y$$$20240927$$CN$US$US
243724521$24372452$1$I$$20240922$20240927$20240927$PER$$US-AMGEN-USASP2024190417$AMGEN$$$$$F$Y$$$20240927$$HP$US$US
243724531$24372453$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191582$AMGEN$$$$$F$Y$$$20240927$$HP$US$US
243724541$24372454$1$I$20240101$20240916$20240927$20240927$EXP$$US-UCBSA-2024035540$UCB$$$$$F$Y$143.2$KG$20240927$$CN$US$US
243724551$24372455$1$I$$20240924$20240927$20240927$PER$$US-ROCHE-10000090321$ROCHE$$$$$F$Y$$$20240927$$HP$US$US
243724571$24372457$1$I$$20240912$20240927$20240927$EXP$$NG-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469829$RANBAXY$Dike CM, Okere PCN. PROMETHAZINE-INDUCED THROMBOPHLEBITIS IN THROMBOPHLEBITIS INA NIGERIAN MAN. West Afr J Med. 2023;Dec;40 (12)(S1):S38$29$YR$$M$Y$$$20240927$$HP$NG$NG
243724581$24372458$1$I$$20240912$20240927$20240927$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469849$RANBAXY$Petrea CL, Ciortea D-A, Miulescu M, Candussi I-L, Chirila SI, Verga GI, et al. A New Case of Paediatric Systemic Lupus Erythematosus with Onset after SARS-CoV-2 and Epstein-Barr Infection-A Case Report and Literature Review. Curr Issues Mol Biol. 2024;46(8):8642-8657$$$T$$Y$$$20240927$$HP$RO$RO
243724601$24372460$1$I$$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192177$AMGEN$$$$$M$Y$$$20240927$$PH$US$US
243724621$24372462$1$I$20240925$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191787$AMGEN$$72$YR$E$F$Y$$$20240927$$CN$US$US
243724631$24372463$1$I$$20240918$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013857$DR REDDYS$$61$YR$A$M$Y$$$20240927$$HP$US$US
243724641$24372464$1$I$20240917$20240918$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013823$DR REDDYS$$32$YR$A$M$Y$$$20240927$$MD$US$US
243724651$24372465$1$I$$20240919$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013865$DR REDDYS$$34$YR$A$F$Y$$$20240927$$MD$US$US
243724661$24372466$1$I$20240904$20240912$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469880$RANBAXY$$44$YR$$M$Y$75$KG$20240927$$PH$GB$GB
243724671$24372467$1$I$$20240912$20240927$20240927$EXP$$KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469497$RANBAXY$Kim H, Hong J, Won EJ, Sung H, Kim M. A Case Report of Breakthrough Nocardiosis Presenting with Periorbital Abscess Caused by Nocardia cyriacigeorgica in a Kidney Transplant Recipient. Infect Chemother. 2024;Apr;56 (Suppl1):S155; P2CC-004$60$YR$$M$Y$$$20240927$$HP$KR$KR
243724681$24372468$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66604$$FDA-CTU$$70$YR$$F$N$$$20240927$N$$US$
243724691$24372469$1$I$$20240912$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470086$RANBAXY$$37$YR$$F$Y$57$KG$20240927$$CN$GB$GB
243724701$24372470$1$I$$20240919$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013918$DR REDDYS$$44$YR$A$F$Y$$$20240927$$HP$US$US
243724711$24372471$1$I$20240901$20240919$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013866$DR REDDYS$$69$YR$E$M$Y$$$20240927$$HP$US$US
243724721$24372472$1$I$20240919$20240920$20240927$20240927$EXP$$CO-ABBVIE-5940542$ABBVIE$$71$YR$$F$Y$56$KG$20240927$$HP$CO$CO
243724731$24372473$1$I$$20240913$20240927$20240927$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469855$RANBAXY$Tao Y, Du R, Mao H. Tropheryma whipplei pneumonia revealed by Metagenomic next-generation sequencing: Report of two cases. Diagn Microbiol Infect Dis. 2024;110(1):116427;1-4$60$YR$$F$Y$$$20240927$$HP$CN$CN
243724741$24372474$1$I$20240226$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470131$RANBAXY$$43$YR$$M$Y$73$KG$20240927$$MD$FR$FR
243724751$24372475$1$I$$20240913$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470106$RANBAXY$Madenidou A-V, Kither H, Bruce IN. A vasculitis mimic during pregnancy : autoimmune progesterone dermatitis. Rheumatol Adv Pract. 2024;8 (2):1-2$41$YR$$F$Y$$$20240927$$HP$GB$GB
243724761$24372476$1$I$20240614$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469374$RANBAXY$$11$YR$$M$Y$31.6$KG$20240927$$MD$FR$FR
243724771$24372477$1$I$$20240913$20240927$20240927$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470373$RANBAXY$Mitoma R, Hirano S, Nakao T. Successful management of ECT-resistant interictal psychosis with clozapine a case report. J Clin Psychopharmacol. 2024;44(5):527-528$28$YR$$M$Y$$$20240927$$HP$JP$JP
243724781$24372478$1$I$$20240913$20240927$20240927$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-469306$RANBAXY$$$$A$M$Y$79$KG$20240927$$MD$DE$DE
243724791$24372479$1$I$$20240913$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469791$RANBAXY$Wallace B, Doran N, Vincent C. Management of isopropyl nitrate -induced methaemoglobinaemia in pregnancy. BMJ Case Rep. 2024;17(7):e260357$30$YR$$F$Y$$$20240927$$MD$GB$GB
243724801$24372480$1$I$20240610$20240913$20240927$20240927$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470222$RANBAXY$$14$YR$$M$Y$75$KG$20240927$$MD$FR$FR
243724811$24372481$1$I$$20240913$20240927$20240927$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469859$RANBAXY$Tao Y, Du R, Mao H. Tropheryma whipplei pneumonia revealed by Metagenomic next-generation sequencing: Report of two cases. Diagn Microbiol Infect Dis. 2024;110(1):1-4$34$YR$$F$Y$$$20240927$$HP$CN$CN
243724821$24372482$1$I$20240708$20240913$20240927$20240927$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2024RR-470287$RANBAXY$$39$YR$$M$Y$80$KG$20240927$$PH$DE$DE
243724831$24372483$1$I$$20240913$20240927$20240927$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469999$RANBAXY$Zhang X, Huang D, Lou D, Si X, Mao J. Stevens-Johnson Syndrome/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review. BMC Endocr Disord. 2024;24(1):172; 1-6$73$YR$$F$Y$$$20240927$$HP$CN$CN
243724841$24372484$1$I$$20240919$20240927$20240927$PER$$US-GSK-US2024116948$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$HP$US$US
243724851$24372485$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024115668$GLAXOSMITHKLINE$$$$$M$Y$$$20240927$$CN$US$US
243724861$24372486$1$I$$20240917$20240927$20240927$EXP$$CA-JNJFOC-20240953402$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240927$$MD$CA$CA
243724871$24372487$1$I$20240809$20240916$20240927$20240927$EXP$$US-BAXTER-2024BAX024783$BAXTER$$63$YR$$F$Y$72.3$KG$20240927$$MD$US$US
243724881$24372488$1$I$20240101$20240923$20240927$20240927$EXP$$CA-ABBVIE-5936779$ABBVIE$$52$YR$$F$Y$$$20240927$$CN$CA$CA
243724891$24372489$1$I$$20240924$20240927$20240927$PER$$US-ROCHE-10000091702$ROCHE$$$$A$F$Y$$$20240927$$CN$US$US
243724901$24372490$1$I$$20240919$20240927$20240927$PER$$US-ROCHE-10000087334$ROCHE$$$$E$F$Y$$$20240927$$CN$US$US
243724911$24372491$1$I$$20240924$20240927$20240927$PER$$US-ROCHE-10000090611$ROCHE$$$$A$F$Y$$$20240927$$CN$US$US
243724921$24372492$1$I$20240101$20240920$20240927$20240927$EXP$$US-ABBVIE-5920565$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243724931$24372493$1$I$$20240920$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151366$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240927$$CN$US$US
243724941$24372494$1$I$$20240923$20240927$20240927$EXP$$MX-ELI_LILLY_AND_COMPANY-MX202409014131$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240927$$CN$MX$MX
243724961$24372496$1$I$20240925$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016410$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240927$$CN$US$US
243724971$24372497$1$I$20240924$20240926$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017211$ELI LILLY AND CO$$79$YR$E$M$Y$$$20240927$$CN$US$US
243724991$24372499$1$I$20240401$20240920$20240927$20240927$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202409012404$ELI LILLY AND CO$$87$YR$E$M$Y$$$20240927$$CN$AU$AU
243725001$24372500$1$I$$20240923$20240927$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202409015569$ELI LILLY AND CO$$56$YR$A$M$Y$$$20240927$$CN$US$US
243725011$24372501$1$I$$20240917$20240927$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202409012988$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240927$$CN$US$US
243725021$24372502$1$I$$20240916$20240927$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011550$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240927$$CN$US$US
243725031$24372503$1$I$20240401$20240917$20240927$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011999$ELI LILLY AND CO$$65$YR$E$M$Y$$$20240927$$CN$US$US
243725041$24372504$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016605$ELI LILLY AND CO$$$$A$M$Y$$$20240927$$CN$US$US
243725051$24372505$1$I$20240801$20240916$20240927$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202409010030$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240927$$CN$US$US
243725061$24372506$1$I$$20240917$20240927$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202409014062$ELI LILLY AND CO$$76$YR$E$F$Y$$$20240927$$CN$US$US
243725071$24372507$1$I$20240801$20240916$20240927$20240927$EXP$GB-MHRA-MED-202409131646081940-DTKRP$GB-ELI_LILLY_AND_COMPANY-GB202409010327$ELI LILLY AND CO$$36$YR$A$F$Y$135$KG$20240927$$CN$GB$GB
243725081$24372508$1$I$$20240913$20240927$20240927$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-469794$RANBAXY$Wallace B, Doran N, Vincent C. Management of isopropyl nitrate-induced methaemoglobinaemia in pregnancy. BMJ Case Rep. 2024;17(7):e260357(1-5)$$$I$$Y$2.32$KG$20240927$$HP$GB$GB
243725091$24372509$1$I$20240918$20240926$20240927$20240927$EXP$$US-PFIZER INC-202400265008$PFIZER$$40$YR$$F$Y$$$20240927$$HP$US$US
243725111$24372511$1$I$$20240925$20240927$20240927$EXP$$US-PFIZER INC-PV202400126110$PFIZER$$42$YR$$F$Y$$$20240927$$HP$US$US
243725121$24372512$1$I$$20240926$20240927$20240927$EXP$$US-PFIZER INC-202400264978$PFIZER$$61$YR$$M$Y$$$20240927$$CN$US$US
243725131$24372513$1$I$20220613$20240924$20240927$20240927$EXP$$KR-PFIZER INC-202400262118$PFIZER$$29$YR$$F$Y$$$20240927$$HP$KR$KR
243725141$24372514$1$I$$20240926$20240927$20240927$EXP$$US-PFIZER INC-202400264920$PFIZER$$7$DEC$$F$Y$$$20240927$$MD$US$US
243725151$24372515$1$I$$20240923$20240927$20240927$EXP$$US-GENMAB-2024-03481$GENMAB$$$$$$Y$$$20240927$$MD$US$US
243725171$24372517$1$I$$20240925$20240927$20240927$PER$$US-ROCHE-10000091792$ROCHE$$$$A$F$Y$$$20240927$$CN$US$US
243725181$24372518$1$I$$20240925$20240927$20240927$PER$$US-ROCHE-10000091719$ROCHE$$$$E$F$Y$$$20240927$$CN$US$US
243725191$24372519$1$I$$20240925$20240927$20240927$PER$$US-ROCHE-10000091659$ROCHE$$$$$$Y$$$20240927$$CN$US$US
243725211$24372521$1$I$20240901$20240927$20240927$20240927$EXP$$CN-TAKEDA-2024TUS095886$TAKEDA$$64$YR$$M$Y$$$20240927$$CN$CN$CN
243725221$24372522$1$I$$20240917$20240927$20240927$EXP$$GB-MYLANLABS-2022M1120645$MYLAN$VanDolah H, Crossley JR, Kim HJ. Three Cases of Uncommon Medication- Induced Osteonecrosis of Temporal Bone. Otolaryngol-Head-Neck-Surg 2022;167 (Suppl.)(1):P245-P246.$69$YR$$M$Y$$$20240927$$HP$US$US
243725231$24372523$1$I$20240919$20240925$20240927$20240927$EXP$$BG-ABBVIE-5941522$ABBVIE$$75$YR$$M$Y$$$20240927$$HP$BG$BG
243725241$24372524$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66583$$FDA-CTU$$75$YR$$F$N$$$20240927$N$HP$US$
243725251$24372525$1$I$$20240919$20240927$20240927$PER$$US-JNJFOC-20240953394$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$MD$US$US
243725271$24372527$1$I$$20240924$20240927$20240927$PER$$NVSC2024US191645$NOVARTIS$$$$$M$Y$$$20240927$$CN$US$US
243725301$24372530$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66635$$FDA-CTU$$28$YR$$F$N$$$20240927$N$$US$
243725331$24372533$1$I$$20240924$20240927$20240927$PER$$US-BAYER-2024A137377$BAYER$$$$$F$Y$$$20240927$$CN$US$US
243725351$24372535$1$I$$20240918$20240927$20240927$EXP$$RO-ABBVIE-5928594$ABBVIE$Onisor D, Brusnic O, Mocan S, Stoian M, Avram C, Boicean A, et al. Cytomegalovirus in ulcerative colitis: an unwanted guest. Pathogens. 2024;13(8):650.$25$YR$$M$Y$$$20240927$$HP$RO$RO
243725362$24372536$2$F$$20240920$20240927$20240930$EXP$$CA-CELLTRION INC.-2024CA022328$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
243725381$24372538$1$I$$20240921$20240927$20240927$EXP$$US-BEH-2024179215$CSL BEHRING$$$$C$M$Y$$$20240927$$HP$US$US
243725391$24372539$1$I$$20240925$20240927$20240927$PER$$US-BAYER-2024A138116$BAYER$$36$YR$A$F$Y$$$20240927$$MD$US$US
243725401$24372540$1$I$20240101$20240923$20240927$20240927$EXP$$CA-ABBVIE-5936920$ABBVIE$$27$YR$$M$Y$$$20240927$$MD$CA$CA
243725411$24372541$1$I$$20240530$20240927$20240927$PER$$US-CHIESI-2024CHF03296$CHIESI$$$$$F$Y$44$KG$20240927$$CN$US$US
243725451$24372545$1$I$20240101$20240925$20240927$20240927$EXP$$US-SA-2024SA250911$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240927$$MD$US$US
243725461$24372546$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66636$$FDA-CTU$$64$YR$$F$N$170$LBS$20240927$N$$US$
243725471$24372547$1$I$20240923$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-66552$$FDA-CTU$$8$YR$$F$N$$$20240926$N$HP$US$
243725501$24372550$1$I$20240723$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-66542$$FDA-CTU$$67$YR$$F$N$$$20240926$N$HP$US$
243725511$24372551$1$I$$20240918$20240927$20240927$EXP$818130$AU-LUPIN PHARMACEUTICALS INC.-2024-09482$LUPIN$$$$$$Y$$$20240927$$CN$AU$AU
243725521$24372552$1$I$$20240919$20240927$20240927$EXP$$GB-TAKEDA-2024TUS076639$TAKEDA$$$$$F$Y$$$20240927$$CN$GB$GB
243725531$24372553$1$I$20240901$20240926$20240927$20240927$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053808$BOEHRINGER INGELHEIM$$61$YR$A$F$Y$$$20240927$$CN$US$US
243725551$24372555$1$I$$20240919$20240927$20240927$EXP$$BR-UCBSA-2024048929$UCB$$$$$F$Y$$$20240927$$CN$BR$BR
243725571$24372557$1$I$$20240925$20240927$20240927$PER$$US-JNJFOC-20240971840$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$MD$US$US
243725581$24372558$1$I$$20240918$20240927$20240927$EXP$$CA-BIOCON BIOLOGICS LIMITED-2022M1013821$BIOCON$$$$$$Y$$$20240927$$MD$CA$CA
243725591$24372559$1$I$$20240923$20240927$20240927$EXP$$US-PFIZER INC-2019SGN01769$PFIZER$$56$YR$$F$Y$$$20240927$$CN$US$US
243725601$24372560$1$I$20240822$20240925$20240927$20240927$EXP$FR-AFSSAPS-PA2024001532$FR-ABBVIE-5938671$ABBVIE$$53$YR$$F$Y$$$20240927$$PH$FR$FR
243725611$24372561$1$I$$20240923$20240927$20240927$EXP$$CA-BAUSCH-BL-2024-014285$BAUSCH AND LOMB$$34$YR$$F$Y$81$KG$20240927$$MD$CA$CA
243725621$24372562$1$I$$20240926$20240927$20240927$PER$$US-HALEON-2198916$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243725631$24372563$1$I$20240919$20240921$20240927$20240927$EXP$GB-MHRA-MED-202409211316584520-YVKJF$GB-BAUSCH-BL-2024-014536$BAUSCH AND LOMB$$46$YR$$F$Y$52$KG$20240927$$CN$GB$GB
243725641$24372564$1$I$20240101$20240916$20240927$20240927$EXP$$CA-UCBSA-2024047830$UCB$$$$$F$Y$$$20240927$$CN$CA$CA
243725661$24372566$1$I$$20240924$20240927$20240927$EXP$$HR-JNJFOC-20240970816$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240927$$MD$HR$HR
243725681$24372568$1$I$$20240918$20240927$20240927$PER$$US-JNJFOC-20240948201$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243725691$24372569$1$I$$20240920$20240927$20240927$EXP$$US-GSK-US2024AMR117403$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
243725701$24372570$1$I$20221019$20240918$20240927$20240927$EXP$$CA-TAKEDA-2024TUS093870$TAKEDA$$76$YR$$F$Y$$$20240927$$MD$CA$CA
243725711$24372571$1$I$$20240925$20240927$20240927$EXP$$GT-TAKEDA-2024TUS095527$TAKEDA$$$$$M$Y$$$20240927$$MD$GT$GT
243725721$24372572$1$I$20240701$20240923$20240927$20240927$EXP$FR-AFSSAPS-RE2024000900$FR-ASTELLAS-2024-AER-008385$ASTELLAS$$66$YR$E$M$Y$$$20240927$$MD$FR$FR
243725731$24372573$1$I$20240801$20240919$20240927$20240927$EXP$$GB-TEVA-VS-3246352$TEVA$$42$YR$$F$Y$$$20240927$$CN$GB$GB
243725741$24372574$1$I$20240101$20240916$20240927$20240927$EXP$$CA-UCBSA-2024047876$UCB$$$$$F$Y$$$20240927$$CN$CA$CA
243725751$24372575$1$I$$20240923$20240927$20240927$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-128507$REGENERON$Dereddi R. Reddy, John A. Cuenca, Ankit Hanmandlu, Robert Wegner, Joshua Botdorf, Sudhakar Tummala et al. Management of respiratory failure  in immune checkpoint inhibitors-induced  overlap syndrome: a case series and review  of the literature. BMC Anesthesiology. 2023;23:1:1-8$72$YR$$M$Y$$$20240927$$MD$US$US
243725761$24372576$1$I$$20240926$20240927$20240927$PER$$US-ROCHE-10000092891$ROCHE$$$$$$Y$$$20240927$$MD$US$US
243725771$24372577$1$I$20240820$20240923$20240927$20240927$EXP$DK-DKMA-30738522$DK-TEVA-VS-3246737$TEVA$$69$YR$$F$Y$50$KG$20240927$$MD$DK$DK
243725781$24372578$1$I$$20240926$20240927$20240927$PER$$US-HALEON-2199073$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243725801$24372580$1$I$$20240918$20240927$20240927$EXP$$US-AMGEN-USASP2024189553$AMGEN$$$$$$Y$$$20240927$$MD$US$US
243725832$24372583$2$F$$20240924$20240927$20240927$EXP$$US-ASTELLAS-2024-AER-008890$ASTELLAS$$87$YR$E$M$Y$$$20240927$$CN$US$US
243725851$24372585$1$I$$20240927$20240927$20240927$DIR$720298$$FDA-CTU$$$$$UNK$N$$$20240927$$CN$US$
243725861$24372586$1$I$20240901$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-66544$$FDA-CTU$$92$YR$$F$N$$$20240926$N$HP$US$
243725871$24372587$1$I$$20240923$20240927$20240927$PER$$US-LEO Pharma-373750$LEO PHARM$$60$YR$$M$Y$$$20240927$$CN$US$US
243725881$24372588$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152153$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$78.93$KG$20240927$$CN$US$US
243725891$24372589$1$I$$20240924$20240927$20240927$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-150964$BRISTOL MYERS SQUIBB$$85$YR$E$F$Y$$$20240927$$CN$GB$GB
243725901$24372590$1$I$$20240921$20240927$20240927$EXP$$US-GSK-US2024AMR118362$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
243725911$24372591$1$I$$20240918$20240927$20240927$PER$$US-BAYER-2024A134040$BAYER$$$$$$Y$$$20240927$$CN$US$US
243725921$24372592$1$I$20200101$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015222$ELI LILLY AND CO$$41$YR$A$M$Y$$$20240927$$CN$US$US
243725941$24372594$1$I$$20230828$20240927$20240927$PER$$US-APOTEX-2023AP013351$APOTEX$Clowse MEB, Rajendran A, Eudy A, Giattino S, Swaminathan A, James AH.. Pregnancy Outcomes in Patients With Interstitial Lung Disease. Arthritis Care + Research. 2023;75(5):1166-1174$$$A$F$Y$$$20240927$$MD$US$US
243725961$24372596$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66597$$FDA-CTU$$59$YR$$F$N$$$20240927$N$$US$
243725971$24372597$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66575$$FDA-CTU$$52$YR$$F$N$$$20240927$N$$US$
243725981$24372598$1$I$$20230828$20240927$20240927$PER$$US-APOTEX-2023AP013474$APOTEX$Clowse MEB, Rajendran A, Eudy A, Giattino S, Swaminathan A, James AH.. Pregnancy Outcomes in Patients With Interstitial Lung Disease. Arthritis Care + Research. 2023;75(5):1166-1174$$$A$F$Y$$$20240927$$MD$US$US
243725991$24372599$1$I$$20230828$20240927$20240927$PER$$US-APOTEX-2023AP013352$APOTEX$Clowse MEB, Rajendran A, Eudy A, Giattino S, Swaminathan A, James AH.. Pregnancy Outcomes in Patients With Interstitial Lung Disease. Arthritis Care + Research. 2023;75(5):1166-1174$$$A$F$Y$$$20240927$$MD$US$US
243726001$24372600$1$I$$20231018$20240927$20240927$PER$$US-APOTEX-2023AP016039$APOTEX$Fan W, Obiakor B, Jacobson R, Haemel A, Gandelman J. Clinical and therapeutic course in head variants of linear morphea in adults: a retrospective review. Archives of Dermatological Research. 2023;315 (5):1161-1170$$$A$$Y$$$20240927$$HP$US$US
243726011$24372601$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66590$$FDA-CTU$$85$YR$$F$N$$$20240927$N$$US$
243726021$24372602$1$I$$20230907$20240927$20240927$PER$$US-APOTEX-2023AP013629$APOTEX$Hoang P, Hurtubise B, Muppidi S.. Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection. Neurology. 2020;95(18):840-843$45$YR$$F$Y$$$20240927$$MD$US$US
243726031$24372603$1$I$$20230927$20240927$20240927$PER$$US-APOTEX-2023AP015069$APOTEX$Coscia L, Cohen D, Dube GK, Hofmann RM, Moritz MJ, Gattis S, Basu A.. Outcomes With Belatacept Exposure During Pregnancy in Kidney Transplant Recipients: A Case Series.. Transplantation. 2023;107(9):2047-2054$$$$$Y$2.28$KG$20240927$$HP$US$US
243726041$24372604$1$I$$20230927$20240927$20240927$PER$$US-APOTEX-2023AP014865$APOTEX$Coscia L, Cohen D, Dube GK, Hofmann RM, Moritz MJ, Gattis S, Basu A.. Outcomes With Belatacept Exposure During Pregnancy in Kidney Transplant Recipients: A Case Series.. Transplantation. 2023;107(9):2047-2054$$$A$F$Y$$$20240927$$HP$US$US
243726051$24372605$1$I$$20230927$20240927$20240927$PER$$US-APOTEX-2023AP014975$APOTEX$Coscia L, Cohen D, Dube GK, Hofmann RM, Moritz MJ, Gattis S, Basu A.. Outcomes With Belatacept Exposure During Pregnancy in Kidney Transplant Recipients: A Case Series.. Transplantation. 2023;107(9):2047-2054$$$A$F$Y$$$20240927$$HP$US$US
243726061$24372606$1$I$$20230927$20240927$20240927$PER$$US-APOTEX-2023AP014976$APOTEX$Coscia L, Cohen D, Dube GK, Hofmann RM, Moritz MJ, Gattis S, Basu A.. Outcomes With Belatacept Exposure During Pregnancy in Kidney Transplant Recipients: A Case Series.. Transplantation. 2023;107(9):2047-2054$$$A$F$Y$$$20240927$$HP$US$US
243726071$24372607$1$I$$20231018$20240927$20240927$PER$$US-APOTEX-2023AP015831$APOTEX$Fan W, Obiakor B, Jacobson R, Haemel A, Gandelman J. Clinical and therapeutic course in head variants of linear morphea in adults: a retrospective review. Archives of Dermatological Research. 2023;315 (5):1161-1170$$$A$$Y$$$20240927$$HP$US$US
243726081$24372608$1$I$20180607$20240926$20240927$20240927$EXP$$US-PFIZER INC-2018SGN01707$PFIZER$$73$YR$$M$Y$$$20240927$$MD$US$US
243726101$24372610$1$I$$20240926$20240927$20240927$EXP$$US-PFIZER INC-2022SGN11792$PFIZER$$18$YR$$F$Y$$$20240927$$MD$US$US
243726112$24372611$2$F$$20240923$20240927$20240927$EXP$$US-ROCHE-10000092915$ROCHE$$41$YR$A$F$Y$$$20240927$$CN$US$US
243726121$24372612$1$I$20240925$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192422$AMGEN$$68$YR$E$F$Y$$$20240927$$CN$US$US
243726131$24372613$1$I$$20240925$20240927$20240927$EXP$$CA-ROCHE-10000092825$ROCHE$$$$A$M$Y$$$20240927$$CN$CA$CA
243726151$24372615$1$I$20240810$20240924$20240927$20240927$EXP$ES-AEMPS-1570732$ES-MYLANLABS-2024M1086934$MYLAN$$18$YR$$F$Y$$$20240927$$MD$ES$ES
243726161$24372616$1$I$$20240920$20240927$20240927$30DAY$$US-PFIZER INC-202400261086$PFIZER$$14$YR$$M$Y$$$20240927$$CN$US$US
243726171$24372617$1$I$$20240925$20240927$20240927$30DAY$$GR-PFIZER INC-PV202400125941$PFIZER$$7$YR$$$Y$$$20240927$$MD$GR$GR
243726181$24372618$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66600$$FDA-CTU$$$$$F$N$$$20240927$N$HP$US$
243726191$24372619$1$I$$20240927$20240927$20240927$30DAY$$US-PFIZER INC-202400260223$PFIZER$$46$YR$$F$Y$$$20240927$$PH$US$US
243726201$24372620$1$I$$20240923$20240927$20240927$30DAY$$US-PFIZER INC-202400262752$PFIZER$$15$YR$$M$Y$56.689$KG$20240927$$MD$US$US
243726211$24372621$1$I$$20240918$20240927$20240927$EXP$$CA-DSJP-DS-2024-101594-CAAA$DAIICHI$$$$$F$Y$$$20240927$$HP$CA$CA
243726221$24372622$1$I$$20240918$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009956$INCYTE$$$$$$Y$$$20240927$$MD$US$US
243726231$24372623$1$I$20240926$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192491$AMGEN$$66$YR$E$M$Y$$$20240927$$HP$US$US
243726241$24372624$1$I$$20240926$20240927$20240927$PER$$US-ROCHE-10000093133$ROCHE$$$$$$Y$$$20240927$$HP$US$US
243726251$24372625$1$I$$20240918$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009929$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243726261$24372626$1$I$$20240919$20240927$20240927$EXP$$JP-ROCHE-10000090569$ROCHE$$8$DEC$E$$Y$$$20240927$$MD$JP$JP
243726271$24372627$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245844$TEVA$$80$YR$$F$Y$86$KG$20240927$$PH$CA$CA
243726291$24372629$1$I$$20240922$20240927$20240927$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001928$BLUEPRINT MEDICINES$$$$$M$Y$$$20240927$$CN$US$US
243726311$24372631$1$I$20240918$20240924$20240927$20240927$PER$$US-BIOVITRUM-2024-US-012473$BIOVITRUM$$90$YR$$F$Y$$$20240927$$CN$US$US
243726341$24372634$1$I$$20240925$20240927$20240927$PER$$US-LEO Pharma-373803$LEO PHARM$$63$YR$$F$Y$$$20240927$$CN$US$US
243726351$24372635$1$I$$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192163$AMGEN$$$$$M$Y$$$20240927$$HP$US$US
243726371$24372637$1$I$$20240924$20240927$20240927$EXP$GB-MHRA-MED-202409241724464070-JGSPB$GB-MYLANLABS-2024M1086883$MYLAN$$$$$$Y$64$KG$20240927$$CN$GB$GB
243726391$24372639$1$I$$20240925$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152916$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240927$$CN$US$US
243726411$24372641$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152117$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240927$$MD$US$US
243726421$24372642$1$I$20240910$20240920$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150716$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$89.81$KG$20240927$$PH$US$US
243726431$24372643$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152171$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240927$$HP$US$US
243726471$24372647$1$I$20240925$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191495$AMGEN$$76$YR$E$M$Y$$$20240927$$CN$US$US
243726481$24372648$1$I$$20240927$20240927$20240927$DIR$720278$$FDA-CTU$$$$$UNK$N$$$20240927$N$CN$US$
243726491$24372649$1$I$$20240920$20240927$20240927$EXP$$BE-AMGEN-BELSP2024188429$AMGEN$$$$$F$Y$$$20240927$$MD$BE$BE
243726501$24372650$1$I$20240101$20240919$20240927$20240927$EXP$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000199$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243726521$24372652$1$I$$20240920$20240927$20240927$EXP$$US-BIOGEN-2024BI01283685$BIOGEN$$$$$M$Y$$$20240927$$MD$US$US
243726531$24372653$1$I$$20240923$20240927$20240927$EXP$$CA-GSK-CA2024079783$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$PH$CA$CA
243726571$24372657$1$I$$20240923$20240927$20240927$PER$$US-PFIZER INC-202400262670$PFIZER$$$$E$M$Y$$$20240927$$MD$US$US
243726581$24372658$1$I$$20240923$20240927$20240927$PER$$US-PFIZER INC-PV202400124381$PFIZER$$55$YR$$M$Y$$$20240927$$CN$US$US
243726591$24372659$1$I$20240905$20240924$20240927$20240927$EXP$DE-BFARM-24006653$DE-ORGANON-O2409DEU001947$ORGANON$$34$YR$$F$Y$$$20240927$$MD$DE$DE
243726601$24372660$1$I$20240307$20240920$20240927$20240927$PER$$US-PFIZER INC-PV202300097670$PFIZER$$70$YR$$F$Y$92.9$KG$20240927$$MD$US$US
243726621$24372662$1$I$$20240923$20240927$20240927$PER$$US-PFIZER INC-202400260802$PFIZER$$57$YR$$F$Y$$$20240927$$MD$US$US
243726631$24372663$1$I$20230427$20240927$20240927$20240927$DIR$720318$$FDA-CTU$$78$YR$$M$N$67.5$KG$20240927$N$CN$US$
243726641$24372664$1$I$20240901$20240923$20240927$20240927$PER$$US-PFIZER INC-202400262022$PFIZER$$8$YR$$F$Y$76$KG$20240927$$CN$US$US
243726651$24372665$1$I$$20240923$20240927$20240927$PER$$US-PFIZER INC-PV202400124664$PFIZER$$$$E$M$Y$$$20240927$$HP$US$US
243726661$24372666$1$I$20240801$20240919$20240927$20240927$EXP$$US-ABBVIE-5933732$ABBVIE$$45$YR$$F$Y$$$20240927$$CN$US$US
243726671$24372667$1$I$$20240926$20240927$20240927$PER$$US-HALEON-2199095$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243726691$24372669$1$I$$20240923$20240927$20240927$EXP$$CA-FreseniusKabi-FK202414281$FRESENIUS KABI$$2$YR$C$M$Y$$$20240927$$HP$CA$CA
243726701$24372670$1$I$$20240923$20240927$20240927$EXP$$PL-FreseniusKabi-FK202414296$FRESENIUS KABI$$64$YR$A$$Y$$$20240927$$MD$PL$PL
243726711$24372671$1$I$$20240923$20240927$20240927$EXP$$CA-FreseniusKabi-FK202414279$FRESENIUS KABI$$$$$$Y$$$20240927$$HP$CA$CA
243726721$24372672$1$I$$20240918$20240927$20240927$EXP$$US-ASTRAZENECA-202409USA002185US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240927$$$US$US
243726731$24372673$1$I$20240823$20240830$20240927$20240927$PER$$US-FMCRTG-FMC-2409-001107$FRESENIUS MEDICAL CARE$$57$YR$A$M$Y$105$KG$20240927$$HP$US$US
243726741$24372674$1$I$$20240923$20240927$20240927$EXP$$ES-PFM-2024-05207$PIERRE FABRE MEDICAMENT$Menendez-Albarracin A, Ramo C, Lourdes Ispierto Gonzales M, Tardaguila M, Munoz J, Gonzalez T et al. Magnetic resonance-guided focused ultrasounds thalamotomy for disabling tremor secondary to multiple sclerosis. 40th Congress of the European Committee for Treatment and Research in (ECTRIMS). 2024$34$YR$$M$Y$$$20240927$$$ES$ES
243726751$24372675$1$I$20240819$20240829$20240927$20240927$PER$$US-FMCRTG-FMC-2409-001086$FRESENIUS MEDICAL CARE$$62$YR$A$M$Y$99.5$KG$20240927$$HP$US$US
243726761$24372676$1$I$$20240903$20240927$20240927$PER$$US-FMCRTG-FMC-2409-001133$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240927$$HP$US$US
243726771$24372677$1$I$$20240904$20240927$20240927$PER$$US-FMCRTG-FMC-2409-001110$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240927$$HP$US$US
243726781$24372678$1$I$$20240824$20240927$20240927$PER$$US-FMCRTG-FMC-2409-001088$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240927$$CN$US$US
243726791$24372679$1$I$$20240905$20240927$20240927$PER$$US-FMCRTG-FMC-2409-001142$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240927$$CN$US$US
243726801$24372680$1$I$$20240902$20240927$20240927$PER$$US-FMCRTG-FMC-2409-001095$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240927$$CN$US$US
243726811$24372681$1$I$$20240902$20240927$20240927$PER$$US-FMCRTG-FMC-2409-001131$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240927$$CN$US$US
243726821$24372682$1$I$20240824$20240902$20240927$20240927$PER$$US-FMCRTG-FMC-2409-001092$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240927$$HP$US$US
243726831$24372683$1$I$$20240814$20240927$20240927$PER$$US-FMCRTG-FMC-2408-001065$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240927$$CN$US$US
243726841$24372684$1$I$20240821$20240828$20240927$20240927$PER$$US-FMCRTG-FMC-2408-001083$FRESENIUS MEDICAL CARE$$44$YR$A$M$Y$$$20240927$$HP$US$US
243726861$24372686$1$I$$20240903$20240927$20240927$PER$$US-FMCRTG-FMC-2409-001104$FRESENIUS MEDICAL CARE$$68$YR$E$F$Y$$$20240927$$HP$US$US
243726871$24372687$1$I$20240918$20240918$20240927$20240927$EXP$$US-FMCRTG-FMC-2409-001179$FRESENIUS MEDICAL CARE$$72$YR$E$M$Y$$$20240927$$HP$US$US
243726881$24372688$1$I$$20240903$20240927$20240927$PER$$US-FMCRTG-FMC-2409-001130$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240927$$HP$US$US
243726891$24372689$1$I$$20240818$20240927$20240927$PER$$US-FMCRTG-FMC-2408-001036$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240927$$HP$US$US
243726901$24372690$1$I$20240822$20240830$20240927$20240927$PER$$US-FMCRTG-FMC-2409-001102$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240927$$CN$US$US
243726911$24372691$1$I$$20240920$20240927$20240927$EXP$$US-ASTRAZENECA-202409USA004157US$ALEXION PHARMACEUTICALS$$77$YR$$$Y$$$20240927$$$US$US
243726921$24372692$1$I$$20240925$20240927$20240927$PER$$US-HALEON-2198886$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243726931$24372693$1$I$$20240917$20240927$20240927$EXP$$US-RADIUS HEALTH INC.-2024US007302$RADIUS PHARM$$$$$F$Y$$$20240927$$CN$US$US
243726942$24372694$2$F$20240924$20240926$20240927$20240928$PER$$US-AMGEN-USASP2024191774$AMGEN$$68$YR$E$F$Y$$$20240928$$CN$US$US
243726951$24372695$1$I$$20240924$20240927$20240927$PER$$US-PFIZER INC-202400263816$PFIZER$$10$YR$$M$Y$$$20240927$$CN$US$US
243726961$24372696$1$I$20240827$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66659$$FDA-CTU$$58$YR$$M$N$$$20240927$N$$US$
243726971$24372697$1$I$$20240923$20240927$20240927$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001929$BLUEPRINT MEDICINES$$$$$M$Y$$$20240927$$CN$US$US
243726981$24372698$1$I$20231101$20240920$20240927$20240927$PER$$US-PFIZER INC-PV202400007137$PFIZER$$27$YR$$F$Y$$$20240927$$MD$US$US
243726991$24372699$1$I$20240918$20240918$20240927$20240927$PER$$US-JNJFOC-20240949792$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243727001$24372700$1$I$$20240924$20240927$20240927$EXP$$GB-SANDOZ INC.-SDZ2024GB079637$SANDOZ$$$$$M$Y$$$20240927$$CN$GB$GB
243727011$24372701$1$I$20240828$20240920$20240927$20240927$EXP$$CN-AMGEN-CHNSP2024189204$AMGEN$$5$YR$C$F$Y$$$20240927$$HP$CN$CN
243727021$24372702$1$I$$20240924$20240927$20240927$PER$$US-JNJFOC-20240969023$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240927$$CN$US$US
243727041$24372704$1$I$$20240920$20240927$20240927$PER$$US-PFIZER INC-202400264158$PFIZER$$$$$$Y$$$20240927$$PH$US$US
243727051$24372705$1$I$$20240923$20240927$20240927$PER$$US-PFIZER INC-202400262627$PFIZER$$8$YR$$F$Y$$$20240927$$CN$US$US
243727071$24372707$1$I$20240101$20240916$20240927$20240927$EXP$$CA-UCBSA-2024047882$UCB$$$$$M$Y$$$20240927$$HP$CA$CA
243727081$24372708$1$I$$20240920$20240927$20240927$PER$$US-PFIZER INC-202400261476$PFIZER$$$$$$Y$$$20240927$$PH$US$US
243727091$24372709$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152022$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240927$$HP$US$US
243727111$24372711$1$I$$20230926$20240927$20240927$PER$$US-APOTEX-2023AP014735$APOTEX$Bains R, Patel D, Chaudhari G. Urinary Retention as a Rare Adverse Effect of Clozapine. The Primary Care Companion for CNS Disorders. 2023;25(5):22cr03448$65$YR$$M$Y$$$20240927$$MD$US$US
243727121$24372712$1$I$$20240917$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409012016$ELI LILLY AND CO$$50$YR$A$$Y$$$20240927$$LW$US$US
243727131$24372713$1$I$20240918$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016886$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240927$$CN$US$US
243727141$24372714$1$I$$20240925$20240927$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA083104$SANDOZ$$75$YR$$$Y$$$20240927$$CN$CA$CA
243727151$24372715$1$I$$20240925$20240927$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA082957$SANDOZ$$$$$F$Y$$$20240927$$HP$CA$CA
243727161$24372716$1$I$$20240923$20240927$20240927$EXP$$GB-AMGEN-GBRSP2024189244$AMGEN$$$$$$Y$$$20240927$$MD$GB$GB
243727171$24372717$1$I$$20240916$20240927$20240927$EXP$$CA-UCBSA-2024047842$UCB$$$$$M$Y$$$20240927$$CN$CA$CA
243727181$24372718$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400263060$PFIZER$Mohammed, A.. RAPIDLY PROGRESSIVE BACILLUS CEREUS CENTRAL NERVOUS SYSTEM INFECTION IN THE SETTING OF ACUTE MYELOID LEUKEMIA. Chest. 2024;166(4 Supple):A1919-A1920$57$YR$$F$Y$$$20240927$$HP$US$US
243727201$24372720$1$I$20230501$20240924$20240927$20240927$EXP$$DE-PFIZER INC-PV202400124853$PFIZER$Madzar, D.. Meningitis and intracranial abscess due to Mycoplasma pneumoniae in a B cell-depleted patient with multiple sclerosis. European Journal of Clinical Microbiology and Infectious Diseases. 2024;10.1007/s10096-024-04935-3$21$YR$$F$Y$$$20240927$$HP$DE$DE
243727221$24372722$1$I$20240911$20240918$20240927$20240927$PER$$US-JNJFOC-20240949388$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243727231$24372723$1$I$$20240919$20240927$20240927$PER$$US-AMGEN-USASP2024189992$AMGEN$$$$$$Y$$$20240927$$CN$US$US
243727241$24372724$1$I$$20240910$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09109$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243727251$24372725$1$I$20240829$20240923$20240927$20240927$EXP$$GB-MYLANLABS-2024M1086524$MYLAN$$59$YR$$M$Y$100$KG$20240927$$MD$GB$GB
243727261$24372726$1$I$20240726$20240923$20240927$20240927$EXP$FR-AFSSAPS-GR2024001087$FR-MYLANLABS-2024M1086350$MYLAN$$21$YR$$M$Y$86$KG$20240927$$PH$FR$FR
243727271$24372727$1$I$$20240923$20240927$20240927$EXP$$GB-MYLANLABS-2024M1086908$MYLAN$$$$$M$Y$$$20240927$$HP$GB$GB
243727281$24372728$1$I$20230601$20240923$20240927$20240927$EXP$GR-GREOF-202401001$GR-MYLANLABS-2024M1086576$MYLAN$$41$YR$$M$Y$74$KG$20240927$$MD$GR$GR
243727291$24372729$1$I$$20240918$20240927$20240927$EXP$FR-AFSSAPS-AVPO2024000176$FR-PFM-2024-05244$PIERRE FABRE MEDICAMENT$$37$YR$$M$Y$$$20240927$$PH$FR$FR
243727301$24372730$1$I$20240101$20240917$20240927$20240927$EXP$$US-SAREPTA THERAPEUTICS INC.-SRP2024-005079$SAREPTA THERAPEUTICS$$$$$M$Y$$$20240927$$HP$US$US
243727311$24372731$1$I$20240920$20240923$20240927$20240927$30DAY$$US-PFIZER INC-202400262410$PFIZER$$9$YR$$F$Y$$$20240927$$CN$US$US
243727321$24372732$1$I$$20231018$20240927$20240927$PER$$US-APOTEX-2023AP015983$APOTEX$Rothenberg KG, McRae SG, Dominguez-Colman LM, Shutes-David A, Tsuang DW. Pimavanserin Treatment for Psychosis in Patients with Dementia with Lewy Bodies: A Case Series. American Journal of Case reports. 2023;24: e939806:1-9$80$YR$$M$Y$$$20240927$$HP$US$US
243727332$24372733$2$F$$20240412$20240927$20240927$PER$$US-INDIVIOR US-INDV-144286-2024$RECKITT BENCKISER$$$$$F$Y$$$20240927$$HP$US$US
243727351$24372735$1$I$20240726$20240923$20240927$20240927$EXP$$CZ-ABBVIE-5936914$ABBVIE$$14$YR$$M$Y$$$20240927$$MD$CZ$CZ
243727361$24372736$1$I$$20240923$20240927$20240927$EXP$$US-INCYTE CORPORATION-2024IN010077$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243727371$24372737$1$I$$20240923$20240927$20240927$EXP$$US-INCYTE CORPORATION-2024IN010075$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243727381$24372738$1$I$20240101$20240924$20240927$20240927$EXP$$US-TG THERAPEUTICS INC.-TGT004034$TG THERAPEUTICS$$$$$$Y$$$20240927$$CN$US$US
243727391$24372739$1$I$20240101$20240923$20240927$20240927$EXP$FR-AFSSAPS-AN2024001284$FR-FreseniusKabi-FK202414309$FRESENIUS KABI$$67$YR$E$F$Y$56$KG$20240927$$MD$FR$FR
243727401$24372740$1$I$$20240910$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09199$LUPIN$$$$$$Y$$$20240927$$PH$US$US
243727411$24372741$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245845$TEVA$$83$YR$$F$Y$$$20240927$$PH$CA$CA
243727431$24372743$1$I$20240717$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66662$$FDA-CTU$$67$YR$$F$N$77.11$KG$20240927$$CN$US$
243727441$24372744$1$I$$20240904$20240927$20240927$PER$$US-THEA-2024001978$Thea Pharma$$$$$M$Y$$$20240927$$HP$US$US
243727451$24372745$1$I$$20240924$20240927$20240927$EXP$$CA-HALEON-2198432$Haleon PLC$$65$YR$$F$Y$$$20240927$$HP$CA$CA
243727461$24372746$1$I$20240101$20240703$20240927$20240927$PER$$US-THEA-2024001509$Thea Pharma$$$$$F$Y$$$20240927$$CN$US$US
243727471$24372747$1$I$$20240803$20240927$20240927$PER$$US-THEA-2024001727$Thea Pharma$$$$$F$Y$$$20240927$$CN$US$US
243727501$24372750$1$I$20230810$20240927$20240927$20240927$DIR$720312$$FDA-CTU$$60$YR$$F$N$81$KG$20240927$N$$US$
243727511$24372751$1$I$$20240923$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151234$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$120$KG$20240927$$PH$US$US
243727521$24372752$1$I$$20240717$20240927$20240927$PER$$US-THEA-2024001601$Thea Pharma$$$$$M$Y$$$20240927$$CN$US$US
243727531$24372753$1$I$$20240918$20240927$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-153106$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240927$$MD$JP$JP
243727541$24372754$1$I$20240824$20240826$20240927$20240927$PER$$US-THEA-2024001887$Thea Pharma$$81$YR$$F$Y$$$20240927$$CN$US$US
243727561$24372756$1$I$20240820$20240927$20240927$20240927$DIR$720320$$FDA-CTU$$68$YR$$F$N$$$20240927$Y$HP$US$
243727581$24372758$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66677$$FDA-CTU$$53$YR$$F$N$75.3$KG$20240927$N$$US$
243727591$24372759$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153275$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240927$$HP$US$US
243727601$24372760$1$I$20240101$20240722$20240927$20240927$PER$$US-THEA-2024001358$Thea Pharma$$$$$F$Y$$$20240927$$CN$US$US
243727621$24372762$1$I$20200101$20240917$20240927$20240927$PER$$US-JNJFOC-20240946201$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$CN$US$US
243727631$24372763$1$I$$20240923$20240927$20240927$EXP$$FR-INCYTE CORPORATION-2024IN010067$INCYTE$$$$$$Y$$$20240927$$MD$FR$FR
243727641$24372764$1$I$20240101$20240822$20240927$20240927$PER$$US-THEA-2024001838$Thea Pharma$$$$$F$Y$$$20240927$$CN$US$US
243727651$24372765$1$I$$20240809$20240927$20240927$PER$$US-THEA-2024001796$Thea Pharma$$$$$F$Y$$$20240927$$CN$US$US
243727661$24372766$1$I$$20240823$20240927$20240927$PER$$US-THEA-2024001870$Thea Pharma$$$$$F$Y$$$20240927$$HP$US$US
243727681$24372768$1$I$$20240919$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009995$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243727691$24372769$1$I$$20240923$20240927$20240927$EXP$$US-TAKEDA-2024TUS094874$TAKEDA$$25$YR$$F$Y$$$20240927$$CN$US$US
243727741$24372774$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66678$$FDA-CTU$$53$YR$$M$N$$$20240927$N$$US$
243727751$24372775$1$I$$20240927$20240927$20240927$DIR$720311$$FDA-CTU$$82$YR$$M$N$$$20240927$N$$US$
243727771$24372777$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66682$$FDA-CTU$$57$YR$$F$N$81.65$KG$20240927$N$$US$
243727791$24372779$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66683$$FDA-CTU$$51$YR$$F$N$72.57$KG$20240927$N$$US$
243727801$24372780$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66567$$FDA-CTU$$63$YR$$F$N$76.66$KG$20240927$N$$US$
243727821$24372782$1$I$20240927$20240927$20240927$20240927$DIR$720315$$FDA-CTU$$82$YR$$F$N$67.95$KG$20240927$N$HP$US$
243727831$24372783$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191808$AMGEN$$$$$M$Y$$$20240927$$CN$US$US
243727841$24372784$1$I$$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191433$AMGEN$$$$$F$Y$$$20240927$$CN$US$US
243727851$24372785$1$I$20240916$20240917$20240927$20240927$EXP$$US-RADIUS HEALTH INC.-2024US007381$RADIUS PHARM$$66$YR$$F$Y$$$20240927$$CN$US$US
243727881$24372788$1$I$$20240919$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009994$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243727901$24372790$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66687$$FDA-CTU$$75$YR$$F$N$$$20240927$N$$US$
243727931$24372793$1$I$20211006$20240910$20240927$20240927$EXP$$US-SA-2024SA277536$SANOFI AVENTIS$$59$YR$A$F$Y$70$KG$20240927$$MD$US$US
243727951$24372795$1$I$20240719$20240923$20240927$20240927$PER$FR-AFSSAPS-RN2024000932$FR-Blueprint Medicines Corporation-SP-FR-2024-001940$BLUEPRINT MEDICINES$$45$YR$A$F$Y$$$20240927$$PH$FR$FR
243727961$24372796$1$I$20240101$20240917$20240927$20240927$EXP$$FR-JNJFOC-20240618172$JOHNSON AND JOHNSON$$$$$$Y$69$KG$20240927$$PH$FR$FR
243727971$24372797$1$I$$20240925$20240927$20240927$PER$$US-HALEON-2198917$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243727981$24372798$1$I$$20240912$20240927$20240927$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09204$LUPIN$$$$$$Y$$$20240927$$CN$US$US
243727991$24372799$1$I$20240703$20240924$20240927$20240927$EXP$$US-TAKEDA-2024TUS071476$TAKEDA$$74$YR$$F$Y$$$20240927$$CN$US$US
243728001$24372800$1$I$20240913$20240920$20240927$20240927$EXP$$CO-FreseniusKabi-FK202414212$FRESENIUS KABI$$77$YR$E$F$Y$57$KG$20240927$$CN$CO$CO
243728011$24372801$1$I$$20240924$20240927$20240927$EXP$$ZA-HALEON-2198989$Haleon PLC$$$$$$Y$$$20240927$$CN$ZA$ZA
243728021$24372802$1$I$$20240920$20240927$20240927$EXP$$US-TAKEDA-2024TUS094602$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
243728031$24372803$1$I$$20240911$20240927$20240927$PER$$AU-TOLMAR, INC.-24AU052551$TOLMAR$$$$$M$Y$$$20240927$$CN$AU$AU
243728041$24372804$1$I$20240916$20240920$20240927$20240927$EXP$$GB-TEVA-VS-3246605$TEVA$$25$YR$$F$Y$95$KG$20240927$$MD$GB$GB
243728051$24372805$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5938278$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243728061$24372806$1$I$$20240924$20240927$20240927$EXP$$US-BAYER-2024A137654$BAYER$$$$$$Y$$$20240927$$CN$US$US
243728071$24372807$1$I$20240601$20240920$20240927$20240927$EXP$$US-VIIV HEALTHCARE LIMITED-US2024117119$VIIV$$$$$$Y$$$20240927$$HP$US$US
243728081$24372808$1$I$20240911$20240920$20240927$20240927$EXP$$US-UPSHER-SMITH LABORATORIES, LLC-20240900147$UPSHER SMITH LABORATORIES$$0$YR$$$Y$$$20240927$$$US$US
243728092$24372809$2$F$20240925$20240927$20240927$20240928$PER$$US-AMGEN-USASP2024192080$AMGEN$$83$YR$E$F$Y$$$20240928$$CN$US$US
243728101$24372810$1$I$20240823$20240912$20240927$20240927$EXP$ES-AEMPS-1565724$ES-BAXTER-2024BAX024611$BAXTER$$79$YR$$F$Y$$$20240927$$MD$ES$ES
243728111$24372811$1$I$$20240917$20240927$20240927$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202409011765$ELI LILLY AND CO$$$$$F$Y$$$20240927$$MD$SA$SA
243728121$24372812$1$I$$20240919$20240927$20240927$EXP$$DE-JNJFOC-20240960350$JOHNSON AND JOHNSON$$25$YR$A$F$Y$$$20240927$$PH$DE$DE
243728131$24372813$1$I$$20240917$20240927$20240927$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202409014071$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$SA$SA
243728141$24372814$1$I$$20240917$20240927$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011469$ELI LILLY AND CO$$55$YR$A$$Y$$$20240927$$LW$US$US
243728151$24372815$1$I$$20240916$20240927$20240927$EXP$$AE-ELI_LILLY_AND_COMPANY-AE202409010163$ELI LILLY AND CO$$$$$$Y$$$20240927$$MD$AE$AE
243728161$24372816$1$I$$20240926$20240927$20240927$EXP$$US-TAKEDA-2024TUS095702$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
243728171$24372817$1$I$$20240924$20240927$20240927$PER$$US-BAUSCH-BL-2024-014525$BAUSCH AND LOMB$$47$YR$$M$Y$$$20240927$$MD$US$US
243728181$24372818$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-PV202400125337$PFIZER$Mielke, N.. Thyroid Storm-Induced Nonischemic Cardiomyopathy and Cardiogenic Shock Successfully Treated with Beta-Blockade. Chest. 2024;166(4):2054A-2055A$52$YR$$F$Y$$$20240927$$HP$US$US
243728191$24372819$1$I$$20240924$20240927$20240927$PER$$US-BAUSCH-BL-2024-011413$BAUSCH AND LOMB$$$$$F$Y$$$20240927$$CN$US$US
243728201$24372820$1$I$$20240924$20240927$20240927$EXP$$ES-PFIZER INC-PV202400125216$PFIZER$Cobo, F.. Two cases of fungemia due to Lomentospora prolificans in haematological patients with different outcome. Diagnostic Microbiology and Infectious Disease. 2024;110(4):10.1016/j.diagmicrobio.2024.11$60$YR$$M$Y$$$20240927$$HP$ES$ES
243728211$24372821$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-PV202400125166$PFIZER$Chawla, R.. A CASE OF VIBRYO VULNIFICUS SEPTIC SHOCK IN LANDLOCKED NORTH GEORGIA. Chest. 2024;166(4 Suppl):2309A-2310A$55$YR$$M$Y$$$20240927$$HP$US$US
243728241$24372824$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-PV202400124854$PFIZER$Mohammed, A.. RAPIDLY PROGRESSIVE BACILLUS CEREUS CENTRAL NERVOUS SYSTEM INFECTION IN THE SETTING OF ACUTE MYELOID LEUKEMIA. Chest. 2024;166(4 Supple):A1919-A1920$57$YR$$F$Y$$$20240927$$HP$US$US
243728261$24372826$1$I$20240101$20240920$20240927$20240927$EXP$$US-KARYOPHARM-2024KPT001563$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240927$$MD$US$US
243728271$24372827$1$I$$20240923$20240927$20240927$EXP$$SI-REGENERON PHARMACEUTICALS, INC.-2024-129717$REGENERON$Sokolova A., Andlovic A., Unk M., Turnsek N.. Neurological immune related adverse events associated with immune checkpoint inhibitors - Real world data from single cancer center. Libri Oncologici. 2023;51 Supplement 2:78-79$$$$$Y$$$20240927$$MD$SI$SI
243728281$24372828$1$I$$20240920$20240927$20240927$EXP$$US-GSK-US2024AMR117938$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
243728291$24372829$1$I$$20240920$20240927$20240927$EXP$$US-JNJFOC-20240956157$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243728301$24372830$1$I$$20240917$20240927$20240927$PER$$US-JNJFOC-20240965724$JOHNSON AND JOHNSON$$$$$F$Y$76.4$KG$20240927$$CN$US$US
243728311$24372831$1$I$$20240924$20240927$20240927$EXP$$CA-HALEON-2198313$Haleon PLC$$65$YR$$F$Y$34$KG$20240927$$MD$CA$CA
243728321$24372832$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66693$$FDA-CTU$$75$YR$$F$N$$$20240927$N$$US$
243728341$24372834$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66705$$FDA-CTU$$64$YR$$F$N$$$20240927$N$$US$
243728351$24372835$1$I$$20240915$20240927$20240927$EXP$$US-SMPA-2024SPA002877$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243728361$24372836$1$I$$20240912$20240927$20240927$EXP$$US-SMPA-2024SPA003001$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243728371$24372837$1$I$20240801$20240920$20240927$20240927$EXP$GB-MHRA-MED-202409201611062720-BDCKV$GB-TEVA-VS-3246705$TEVA$$64$YR$$M$Y$$$20240927$$MD$GB$GB
243728391$24372839$1$I$20240301$20240916$20240927$20240927$PER$$US-MYLANLABS-2024M1085205$MYLAN$$$$$$Y$$$20240927$$CN$US$US
243728411$24372841$1$I$$20240919$20240927$20240927$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006755$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243728421$24372842$1$I$$20240913$20240927$20240927$EXP$EU-AFSSAPS-AVPO2024000177$EU-ETHYPHARM-2024002482$ETHYPHARM$$$$$$Y$$$20240927$$PH$EU$EU
243728431$24372843$1$I$$20240913$20240927$20240927$EXP$EU-AFSSAPS-AVPO2024000174$EU-ETHYPHARM-2024002483$ETHYPHARM$$$$$$Y$$$20240927$$PH$EU$EU
243728441$24372844$1$I$20240920$20240920$20240927$20240927$EXP$$GB-TEVA-VS-3246612$TEVA$$78$YR$$F$Y$103$KG$20240927$$MD$GB$GB
243728451$24372845$1$I$$20240918$20240927$20240927$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18970$IPSEN$$$$$F$Y$122.5$KG$20240927$$CN$US$US
243728461$24372846$1$I$$20240921$20240927$20240927$PER$$DE-Blueprint Medicines Corporation-SO-DE-2024-001934$BLUEPRINT MEDICINES$$$$$$Y$$$20240927$$HP$DE$DE
243728471$24372847$1$I$$20240917$20240927$20240927$EXP$$AU-RK PHARMA, INC-20240900056$RK PHARMA$Keith Harris. Rationalising the dose threshold for severe carbamazepine toxicity: a retrospective series. Clin Toxicol (Phila). 2024;62(8):533-535$$$$$Y$$$20240927$$HP$AU$AU
243728481$24372848$1$I$$20240917$20240927$20240927$EXP$$AU-RK PHARMA, INC-20240900063$RK PHARMA$Keith Harris. Rationalising the dose threshold for severe carbamazepine toxicity: a retrospective series. Clin Toxicol (Phila). 2024;62(8):533-535$$$$$Y$$$20240927$$HP$AU$AU
243728491$24372849$1$I$$20240917$20240927$20240927$EXP$$AU-RK PHARMA, INC-20240900059$RK PHARMA$Keith Harris. Rationalising the dose threshold for severe carbamazepine toxicity: a retrospective series. Clin Toxicol (Phila). 2024;62(8):533-535$$$$$Y$$$20240927$$HP$AU$AU
243728501$24372850$1$I$$20240913$20240927$20240927$EXP$$BR-RK PHARMA, INC-20240900057$RK PHARMA$Paulo Phillipe do Vale Ricardo Moreira. Anterior lamellar corneoscleral keratoplasty for the management of corneal thinning following treatment with mitomycin-C and interferon to treat highly suspected ocular surface squamous neoplasia: a case report. Arq Bras Oftalmol. 2024;88(1):e2023-0027$$$$$Y$$$20240927$$HP$BR$BR
243728511$24372851$1$I$$20240917$20240927$20240927$EXP$$AU-RK PHARMA, INC-20240900062$RK PHARMA$Keith Harris. Rationalising the dose threshold for severe carbamazepine toxicity: a retrospective series. Clin Toxicol (Phila). 2024;62(8):533-535$$$$$Y$$$20240927$$HP$AU$AU
243728521$24372852$1$I$$20240913$20240927$20240927$EXP$$PT-RK PHARMA, INC-20240900054$RK PHARMA$David Mestre. Central Venous Catheter Misplacement Presenting With Parotid Gland Swelling: A Case Report. Cureus. 2024;16(8):e66245$84$YR$$F$Y$$$20240927$$HP$PT$PT
243728531$24372853$1$I$$20240916$20240927$20240927$EXP$$US-RK PHARMA, INC-20240900065$RK PHARMA$Kanika Ajay Malani. Metformin- associated lactic acidosis: a serious complication of a common drug. BMJ Case Rep. 2024;17(9):e260592$$$$$Y$$$20240927$$HP$US$US
243728541$24372854$1$I$20240806$20240920$20240927$20240927$EXP$$GB-TEVA-VS-3246598$TEVA$$68$YR$$F$Y$115$KG$20240927$$PH$GB$GB
243728571$24372857$1$I$20240721$20240919$20240927$20240927$EXP$FR-AFSSAPS-DJ2024001034$FR-SA-2024SA277618$SANOFI AVENTIS$$74$YR$E$F$Y$95$KG$20240927$$MD$FR$FR
243728581$24372858$1$I$$20240923$20240927$20240927$EXP$$US-SA-2024SA278545$SANOFI AVENTIS$Bazhenov A, Menendez A.. Refractory pericardial effusion with tamponade after a single dose of docetaxel.. Chest. 2024;166(4):A1687-8$61$YR$A$F$Y$$$20240927$$HP$US$US
243728591$24372859$1$I$$20240925$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2023US001585$SANDOZ$$$$$F$Y$$$20240927$$CN$US$US
243728601$24372860$1$I$$20240926$20240927$20240927$EXP$$PL-BRISTOL-MYERS SQUIBB COMPANY-2024-152949$BRISTOL MYERS SQUIBB$$84$YR$E$$Y$$$20240927$$MD$PL$PL
243728611$24372861$1$I$20231106$20240917$20240927$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-152767$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$54.7$KG$20240927$$MD$JP$JP
243728621$24372862$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153329$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240927$$CN$US$US
243728631$24372863$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153181$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$91.63$KG$20240927$$CN$US$US
243728651$24372865$1$I$20240828$20240924$20240927$20240927$EXP$$EG-SA-2024SA278479$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240927$$CN$EG$EG
243728661$24372866$1$I$20240301$20240924$20240927$20240927$EXP$$RU-SA-2024SA123489$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240927$$MD$RU$RU
243728671$24372867$1$I$20240603$20240924$20240927$20240927$EXP$GB-MHRA-MED-202409241024000270-VTZGH$GB-SA-2024SA276754$SANOFI AVENTIS$$$$$F$Y$$$20240927$$MD$GB$GB
243728681$24372868$1$I$$20240925$20240927$20240927$EXP$$JP-SA-2024SA279080$SANOFI AVENTIS$Motohiro H et al.. Treatment strategies and surgery for acute peritonitis II. Treatment strategies according to causative disease 2) Surgery forperforated peritonitis due to gastric cancer. Operation. 2024;78(3):297-305$80$YR$E$M$Y$$$20240927$$MD$JP$JP
243728691$24372869$1$I$$20240924$20240927$20240927$PER$$US-HALEON-2198651$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243728701$24372870$1$I$$20240919$20240927$20240927$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US005062$PAREXEL$$$$$$Y$$$20240927$$CN$US$US
243728711$24372871$1$I$$20240926$20240927$20240927$PER$$US-HALEON-2199113$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243728721$24372872$1$I$$20240918$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR116280$VIIV$$$$A$M$Y$$$20240927$$CN$US$US
243728731$24372873$1$I$$20240918$20240927$20240927$EXP$$US-RADIUS HEALTH INC.-2024US007306$RADIUS PHARM$$$$$F$Y$$$20240927$$CN$US$US
243728751$24372875$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66715$$FDA-CTU$$56$YR$$F$N$$$20240927$N$$US$
243728761$24372876$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66709$$FDA-CTU$$60$YR$$F$N$113.4$KG$20240927$N$$US$
243728771$24372877$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66725$$FDA-CTU$$77$YR$$M$N$90.72$KG$20240927$N$$US$
243728781$24372878$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66246$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243728791$24372879$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66711$$FDA-CTU$$$$$F$N$$$20240927$N$HP$US$
243728801$24372880$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66717$$FDA-CTU$$41$YR$$F$N$95.71$KG$20240927$N$$US$
243728811$24372881$1$I$20240626$20240923$20240927$20240927$EXP$DK-DKMA-30738136$DK-TEVA-VS-3246734$TEVA$$73$YR$$F$Y$57$KG$20240927$$HP$DK$DK
243728821$24372882$1$I$$20240923$20240927$20240927$EXP$$CA-Eisai-EC-2024-175197$EISAI$$43$YR$A$M$Y$53$KG$20240927$$HP$CA$CA
243728831$24372883$1$I$$20240918$20240927$20240927$PER$$US-MYLANLABS-2024M1085971$MYLAN$$49$YR$$F$Y$$$20240927$$CN$US$US
243728841$24372884$1$I$20240920$20240920$20240927$20240927$EXP$$US-ZENPEP LLC-2024AIMT01368$AIMMUNE$$$$$$Y$$$20240927$$CN$US$US
243728851$24372885$1$I$20240731$20240920$20240927$20240927$EXP$$CN-009507513-2409CHN008512$MERCK$$60$YR$$F$Y$65$KG$20240927$$HP$CN$CN
243728881$24372888$1$I$20240921$20240925$20240927$20240927$PER$$US-JNJFOC-20240969271$JOHNSON AND JOHNSON$$87$YR$E$M$Y$$$20240927$$CN$US$US
243728891$24372889$1$I$20210101$20240925$20240927$20240927$EXP$$US-PFIZER INC-2021SGN04074$PFIZER$$3$DEC$$M$Y$$$20240927$$MD$US$US
243728921$24372892$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024117675$GLAXOSMITHKLINE$$$$$M$Y$$$20240927$$CN$US$US
243728931$24372893$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015878$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240927$$CN$US$US
243728941$24372894$1$I$20240502$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409017499$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240927$$CN$US$US
243728961$24372896$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66707$$FDA-CTU$$56$YR$$M$N$$$20240927$N$$US$
243728971$24372897$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66695$$FDA-CTU$$52$YR$$F$N$$$20240927$N$$US$
243728981$24372898$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016448$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240927$$CN$US$US
243728991$24372899$1$I$20230101$20240607$20240927$20240927$PER$$US-INDIVIOR US-INDV-145501-2024$RECKITT BENCKISER$$$$A$F$Y$$$20240927$$HP$US$US
243729001$24372900$1$I$$20230811$20240927$20240927$PER$$US-INDIVIOR US-INDV-140570-2023$RECKITT BENCKISER$$$$$$Y$$$20240927$$MD$US$US
243729011$24372901$1$I$$20240919$20240927$20240927$EXP$$US-PERRIGO-24US009007$PERRIGO$$$$A$$Y$$$20240927$$CN$US$US
243729021$24372902$1$I$$20240917$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046448$AUROBINDO$Neisewander B, Trapp N.. Electroconvulsive therapy complicated by ventricular fibrillation: A case report.. Ann-Clin-Psychiatry. 2023;35133-134$37$YR$$F$Y$$$20240927$$HP$US$US
243729031$24372903$1$I$20240301$20240925$20240927$20240927$EXP$$BG-TAKEDA-2024TUS096068$TAKEDA$$$$$F$Y$$$20240927$$CN$BG$BG
243729061$24372906$1$I$20240925$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66730$$FDA-CTU$$83$YR$$F$N$$$20240927$N$$US$
243729071$24372907$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66371$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243729081$24372908$1$I$20240901$20240919$20240927$20240927$EXP$$US-STEMLINE THERAPEUTICS, INC-2024-STML-US005074$PAREXEL$$$$$$Y$$$20240927$$CN$US$US
243729091$24372909$1$I$20240912$20240926$20240927$20240927$EXP$$DE-GILEAD-2024-0688737$GILEAD$$$$$M$Y$$$20240927$$MD$DE$DE
243729111$24372911$1$I$$20240924$20240927$20240927$PER$$US-JNJFOC-20240967268$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$CN$US$US
243729121$24372912$1$I$$20240917$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046294$AUROBINDO$Abdalrazag OA, Okoye AO, Muniyappa SM. Title to be provided. Br-J-Diabetes. 2024;24(1):512$77$YR$$M$Y$$$20240927$$MD$GB$GB
243729131$24372913$1$I$$20240920$20240927$20240927$PER$$DE-Blueprint Medicines Corporation-SO-DE-2024-001935$BLUEPRINT MEDICINES$$$$$$Y$$$20240927$$HP$DE$DE
243729141$24372914$1$I$$20240916$20240927$20240927$EXP$$CN-RDY-SPO/CHN/24/0013985$DR REDDYS$Li W, Fu Y, Wang W. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. Annals of Hematology. 2024 Aug;103(8): 3207-3217. doi:10.1007/s00277-024-05691-2.$65$YR$E$F$Y$54.7$KG$20240927$$HP$CN$CN
243729181$24372918$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66356$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243729191$24372919$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66594$$FDA-CTU$$74$YR$$F$N$$$20240927$N$$US$
243729251$24372925$1$I$$20240917$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046276$AUROBINDO$Ward J, Portnof J, Barreto V, Freedman P, Reich R, Kerpel S. Two cases of imatinib induced oral pigmentation affecting the palate. Oral-Surg-Oral-Med-Oral-Pathol-Oral-Radiol. 2024;138(4):e79-e84$69$YR$$F$Y$$$20240927$$HP$US$US
243729281$24372928$1$I$$20240919$20240927$20240927$EXP$$US-JNJFOC-20240960180$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240927$$MD$US$US
243729301$24372930$1$I$20240904$20240926$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153020$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240927$$HP$US$US
243729311$24372931$1$I$20220101$20240917$20240927$20240927$EXP$$US-AUROBINDO-AUR-APL-2024-046202$AUROBINDO$Gwynn N, Lindenmayer J, Boes T, Pitalo C.. Gwynn N, Lindenmayer J, Boes T, Pitalo C. Late Recognition of Cholinergic Delirium in Patient on Donepezil Combination Treatment.. Journal of Clinical Psychopharmacology.. 2024;44(5):521-2$69$YR$$M$Y$$$20240927$$MD$US$US
243729321$24372932$1$I$20240712$20240920$20240927$20240927$EXP$$JP-EMD Serono-2024042659$EMD SERONO INC$$80$YR$E$M$Y$$$20240927$$MD$JP$JP
243729331$24372933$1$I$$20240924$20240927$20240927$EXP$$US-TAKEDA-2024TUS095037$TAKEDA$$$$$F$Y$$$20240927$$CN$US$US
243729341$24372934$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002460$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729351$24372935$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002004$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729361$24372936$1$I$$20240913$20240927$20240927$PER$$US-SMPA-2024SPA000243$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729371$24372937$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002524$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729381$24372938$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002472$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729391$24372939$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002443$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729401$24372940$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002481$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729411$24372941$1$I$$20240905$20240927$20240927$PER$$US-SMPA-2024SPA002440$SUNOVION$$$$$$Y$$$20240927$$MD$US$US
243729421$24372942$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002479$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729431$24372943$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002520$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729441$24372944$1$I$$20240828$20240927$20240927$PER$$US-SMPA-2024MYSCI0401049$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729451$24372945$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002466$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729461$24372946$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002401$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729481$24372948$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002502$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729491$24372949$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002513$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729511$24372951$1$I$$20240905$20240927$20240927$PER$$US-SMPA-2024MYSCI0500317$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729521$24372952$1$I$$20240904$20240927$20240927$PER$$US-SMPA-2024SPA002331$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729531$24372953$1$I$$20240913$20240927$20240927$PER$$US-SMPA-2024MYSCI0600731$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729541$24372954$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002470$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729551$24372955$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA000660$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729571$24372957$1$I$$20240905$20240927$20240927$PER$$US-SMPA-2024SPA002432$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729581$24372958$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002475$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729591$24372959$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002491$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729601$24372960$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002503$SUNOVION$$$$$$Y$$$20240927$$MD$US$US
243729611$24372961$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002471$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729621$24372962$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002507$SUNOVION$$$$$$Y$$$20240927$$MD$US$US
243729641$24372964$1$I$$20240904$20240927$20240927$PER$$US-SMPA-2024SPA000499$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729651$24372965$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002467$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729661$24372966$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002508$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729671$24372967$1$I$$20240904$20240927$20240927$PER$$US-SMPA-2024MYSCI0300835$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729691$24372969$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002450$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729701$24372970$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002458$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729711$24372971$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA000172$SUNOVION$$$$$$Y$$$20240927$$MD$US$US
243729721$24372972$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002528$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729731$24372973$1$I$$20240918$20240927$20240927$PER$$US-SMPA-2024SPA003032$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729741$24372974$1$I$$20240917$20240927$20240927$EXP$$CO-AUROBINDO-AUR-APL-2024-046435$AUROBINDO$Rivera Martinez WA, Pantoja Rosero ME, Chaves Cabrera HA, Yory Montalvo N, Velasquez Garcia F, Ocampo Posada M. Severe Manifestation of Peritoneal Tuberculosis: Clinical Case Report.. Revista. colomb. Gastroenterol. 2023;38(3):368-372$61$YR$$M$Y$$$20240927$$HP$CO$CO
243729751$24372975$1$I$$20240917$20240927$20240927$PER$$US-SMPA-2024SPA002970$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729761$24372976$1$I$$20240918$20240927$20240927$PER$$US-SMPA-2024SPA003033$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729771$24372977$1$I$$20240919$20240927$20240927$PER$$US-SMPA-2024SPA003091$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729781$24372978$1$I$$20240920$20240927$20240927$PER$$US-SMPA-2024SPA003128$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729791$24372979$1$I$$20240918$20240927$20240927$PER$$US-SMPA-2024SPA002999$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729801$24372980$1$I$$20240920$20240927$20240927$PER$$US-SMPA-2024SPA003172$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729811$24372981$1$I$$20240917$20240927$20240927$PER$$US-SMPA-2024SPA003025$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729821$24372982$1$I$$20240919$20240927$20240927$PER$$US-SMPA-2024SPA003090$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729831$24372983$1$I$$20240917$20240927$20240927$PER$$US-SMPA-2024SPA002936$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729841$24372984$1$I$$20240916$20240927$20240927$PER$$US-SMPA-2024SPA002947$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729851$24372985$1$I$$20240919$20240927$20240927$PER$$US-SMPA-2024SPA003104$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729861$24372986$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66741$$FDA-CTU$$67$YR$$F$N$$$20240927$N$$US$
243729871$24372987$1$I$$20240918$20240927$20240927$PER$$US-SMPA-2024SPA003054$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729881$24372988$1$I$$20240917$20240927$20240927$PER$$US-SMPA-2024SPA002976$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729891$24372989$1$I$$20240911$20240927$20240927$PER$$US-SMPA-2024SPA002694$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729901$24372990$1$I$$20240916$20240927$20240927$PER$$US-SMPA-2024SPA002987$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729911$24372991$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002563$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729921$24372992$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002562$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729941$24372994$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002646$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729951$24372995$1$I$$20240919$20240927$20240927$PER$$US-SMPA-2024SPA003095$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729971$24372997$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002645$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729981$24372998$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002580$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243729991$24372999$1$I$$20240917$20240927$20240927$PER$$US-SMPA-2024SPA002973$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730001$24373000$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002541$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730011$24373001$1$I$$20240913$20240927$20240927$PER$$US-SMPA-2024SPA002742$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730021$24373002$1$I$$20240923$20240927$20240927$PER$$US-SMPA-2024SPA003206$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730031$24373003$1$I$$20240911$20240927$20240927$PER$$US-SMPA-2024SPA002668$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730041$24373004$1$I$$20240918$20240927$20240927$PER$$US-SMPA-2024SPA003048$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730051$24373005$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002658$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730061$24373006$1$I$20240501$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002568$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730071$24373007$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002546$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730081$24373008$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002525$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730091$24373009$1$I$$20240924$20240927$20240927$PER$$US-SMPA-2024SPA003267$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730101$24373010$1$I$$20240912$20240927$20240927$PER$$US-SMPA-2024SPA002782$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730111$24373011$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002599$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730121$24373012$1$I$$20240911$20240927$20240927$PER$$US-SMPA-2024SPA002676$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730151$24373015$1$I$$20240923$20240927$20240927$PER$$US-SMPA-2024SPA003204$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730161$24373016$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002620$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730171$24373017$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002594$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730181$24373018$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002586$SUNOVION$$$$$$Y$$$20240927$$HP$US$US
243730191$24373019$1$I$$20240919$20240927$20240927$PER$$US-SMPA-2024SPA003070$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730201$24373020$1$I$$20240913$20240927$20240927$PER$$US-SMPA-2024SPA002760$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730211$24373021$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002636$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730231$24373023$1$I$$20240912$20240927$20240927$PER$$US-SMPA-2024SPA002727$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730241$24373024$1$I$$20240912$20240927$20240927$PER$$US-SMPA-2024SPA002729$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730261$24373026$1$I$$20240918$20240927$20240927$PER$$US-SMPA-2024SPA003228$SUNOVION$$$$$$Y$$$20240927$$MD$US$US
243730271$24373027$1$I$20240918$20240918$20240927$20240927$PER$$US-SMPA-2024SPA003053$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730281$24373028$1$I$$20240912$20240927$20240927$PER$$US-SMPA-2024SPA002690$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730291$24373029$1$I$$20240920$20240927$20240927$PER$$US-SMPA-2024SPA003127$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730311$24373031$1$I$$20240919$20240927$20240927$PER$$US-SMPA-2024SPA003097$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730321$24373032$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002604$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730341$24373034$1$I$$20240918$20240927$20240927$PER$$US-SMPA-2024SPA003043$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730351$24373035$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002579$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730361$24373036$1$I$$20240925$20240927$20240927$PER$$US-SMPA-2024SPA003313$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730371$24373037$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66744$$FDA-CTU$$35$YR$$F$N$$$20240927$N$$US$
243730381$24373038$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66357$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243730401$24373040$1$I$$20240919$20240927$20240927$PER$$US-SMPA-2024SPA003094$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730411$24373041$1$I$$20240913$20240927$20240927$PER$$US-SMPA-2024SPA002761$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730421$24373042$1$I$$20240920$20240927$20240927$PER$$US-SMPA-2024SPA003170$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730431$24373043$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66697$$FDA-CTU$$71$YR$$F$N$73.48$KG$20240927$N$$US$
243730461$24373046$1$I$$20240919$20240927$20240927$PER$$US-SMPA-2024SPA003076$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730471$24373047$1$I$$20240920$20240927$20240927$PER$$US-SMPA-2024SPA003120$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730481$24373048$1$I$$20240913$20240927$20240927$PER$$US-SMPA-2024SPA002830$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730501$24373050$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66749$$FDA-CTU$$20$YR$$F$N$$$20240927$N$$US$
243730511$24373051$1$I$$20240923$20240927$20240927$PER$$US-SMPA-2024SPA003169$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730521$24373052$1$I$$20240912$20240927$20240927$PER$$US-SMPA-2024SPA002745$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730531$24373053$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002545$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730551$24373055$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66753$$FDA-CTU$$53$YR$$F$N$81.19$KG$20240927$N$$US$
243730571$24373057$1$I$$20240920$20240927$20240927$PER$$US-SMPA-2024SPA003124$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730581$24373058$1$I$$20240913$20240927$20240927$PER$$US-SMPA-2024SPA002850$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730591$24373059$1$I$$20240917$20240927$20240927$PER$$US-SMPA-2024SPA003020$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730601$24373060$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002601$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730611$24373061$1$I$$20240911$20240927$20240927$PER$$US-SMPA-2024SPA002675$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730621$24373062$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002529$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730631$24373063$1$I$$20240924$20240927$20240927$PER$$US-SMPA-2024SPA003251$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730671$24373067$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002617$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730681$24373068$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002677$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730701$24373070$1$I$20240901$20240918$20240927$20240927$PER$$US-JNJFOC-20240947592$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243730711$24373071$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002551$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730731$24373073$1$I$$20240913$20240927$20240927$PER$$US-SMPA-2024SPA002774$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730741$24373074$1$I$$20240919$20240927$20240927$PER$$US-SMPA-2024SPA003093$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730751$24373075$1$I$$20240913$20240927$20240927$PER$$US-SMPA-2024SPA002840$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730761$24373076$1$I$$20240912$20240927$20240927$PER$$US-SMPA-2024SPA002739$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730771$24373077$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002610$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730781$24373078$1$I$$20240909$20240927$20240927$PER$$US-SMPA-2024SPA002558$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730791$24373079$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002608$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730801$24373080$1$I$$20240918$20240927$20240927$PER$$US-SMPA-2024SPA003049$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730811$24373081$1$I$$20240906$20240927$20240927$PER$$US-SMPA-2024SPA002578$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730821$24373082$1$I$$20240919$20240927$20240927$PER$$US-SMPA-2024SPA003078$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730831$24373083$1$I$$20240919$20240927$20240927$PER$$US-SMPA-2024SPA003089$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730841$24373084$1$I$20240922$20240923$20240927$20240927$PER$$US-JNJFOC-20240963580$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243730851$24373085$1$I$$20240912$20240927$20240927$PER$$US-SMPA-2024SPA002816$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730861$24373086$1$I$$20240917$20240927$20240927$PER$$US-SMPA-2024SPA002989$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730871$24373087$1$I$$20240924$20240927$20240927$PER$$US-SMPA-2024SPA003288$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730881$24373088$1$I$$20240913$20240927$20240927$PER$$US-SMPA-2024SPA002833$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730891$24373089$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002683$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730901$24373090$1$I$$20240923$20240927$20240927$PER$$US-SMPA-2024SPA003269$SUNOVION$$$$$$Y$$$20240927$$MD$US$US
243730911$24373091$1$I$$20240924$20240927$20240927$PER$$US-SMPA-2024SPA003235$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730931$24373093$1$I$$20240913$20240927$20240927$PER$$US-SMPA-2024SPA002768$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730941$24373094$1$I$$20240910$20240927$20240927$PER$$US-SMPA-2024SPA002600$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730951$24373095$1$I$$20240919$20240927$20240927$PER$$US-SMPA-2024SPA003100$SUNOVION$$$$$$Y$$$20240927$$CN$US$US
243730962$24373096$2$F$20240926$20240927$20240927$20240928$PER$$US-AMGEN-USASP2024192459$AMGEN$$65$YR$E$M$Y$$$20240928$$CN$US$US
243730971$24373097$1$I$$20240925$20240927$20240927$EXP$$BR-BIOMARINAP-BR-2024-160804$BIOMARIN$$$$$$Y$$$20240927$$CN$BR$BR
243730991$24373099$1$I$$20240918$20240927$20240927$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-016339$JAZZ$$$$A$F$Y$$$20240927$$MD$JP$JP
243731001$24373100$1$I$$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192454$AMGEN$$$$E$F$Y$$$20240927$$HP$US$US
243731011$24373101$1$I$$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192179$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243731031$24373103$1$I$20240606$20240924$20240927$20240927$EXP$$US-OTSUKA-2024_017891$OTSUKA$$$$$F$Y$$$20240927$$CN$US$US
243731051$24373105$1$I$$20240913$20240927$20240927$EXP$$GB-BRAEBURN-GB-BRA-24-000891$BRAEBURN PHARMACEUTICALS$$$$$M$Y$$$20240927$$MD$GB$GB
243731061$24373106$1$I$$20230530$20240927$20240927$PER$$US-THEA-2023000933$Thea Pharma$$$$$F$Y$$$20240927$$CN$US$US
243731071$24373107$1$I$$20240919$20240927$20240927$EXP$$US-JNJFOC-20240960006$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20240927$$HP$US$US
243731091$24373109$1$I$20240924$20240925$20240927$20240927$EXP$GB-MHRA-MED-202409251655414220-DBKSP$GB-PERRIGO-24GB009053$PERRIGO$$$$$$Y$$$20240927$$PH$GB$GB
243731111$24373111$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153045$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$114.31$KG$20240927$$CN$US$US
243731121$24373112$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153200$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20240927$$HP$US$US
243731131$24373113$1$I$20240830$20240926$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153471$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240927$$CN$US$US
243731141$24373114$1$I$$20230530$20240927$20240927$PER$$US-THEA-2023000934$Thea Pharma$$$$$F$Y$$$20240927$$CN$US$US
243731151$24373115$1$I$$20240923$20240927$20240927$PER$$US-AMGEN-USASP2024190240$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243731161$24373116$1$I$$20240919$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024116524$VIIV$$$$$$Y$$$20240927$$PH$US$US
243731191$24373119$1$I$$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024191096$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243731201$24373120$1$I$20240717$20240925$20240927$20240927$EXP$GB-EMA-DD-20240925-7482663-061004$GB-PERRIGO-24GB008578$PERRIGO$$27$YR$$M$Y$96$KG$20240927$$MD$GB$GB
243731211$24373121$1$I$20230602$20230602$20240927$20240927$PER$$US-THEA-2023000960$Thea Pharma$$$$$F$Y$$$20240927$$CN$US$US
243731221$24373122$1$I$$20240919$20240927$20240927$EXP$$CA-ROCHE-10000086128$ROCHE$$$$$F$Y$87$KG$20240927$$MD$CA$CA
243731231$24373123$1$I$20230601$20230608$20240927$20240927$PER$$US-THEA-2023001003$Thea Pharma$$48$YR$$F$Y$$$20240927$$CN$US$US
243731241$24373124$1$I$$20240913$20240927$20240927$EXP$$US-MYLANLABS-2024M1084036$MYLAN$$$$$F$Y$$$20240927$$CN$US$US
243731261$24373126$1$I$$20240924$20240927$20240927$EXP$$CA-MYLANLABS-2024M1086827$MYLAN$$$$$F$Y$$$20240927$$CN$CA$CA
243731321$24373132$1$I$20230605$20230608$20240927$20240927$PER$$US-THEA-2023001004$Thea Pharma$$32$YR$$F$Y$$$20240927$$CN$US$US
243731331$24373133$1$I$20240101$20240923$20240927$20240927$EXP$$US-LUNDBECK-DKLU4004677$LUNDBECK$$$$$$Y$$$20240927$$CN$US$US
243731341$24373134$1$I$$20230712$20240927$20240927$PER$$US-THEA-2023001248$Thea Pharma$$$$$M$Y$$$20240927$$CN$US$US
243731351$24373135$1$I$$20240919$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005767$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243731361$24373136$1$I$$20230719$20240927$20240927$PER$$US-THEA-2023001304$Thea Pharma$$$$$F$Y$$$20240927$$CN$US$US
243731371$24373137$1$I$20200101$20240920$20240927$20240927$EXP$$DE-BIOGEN-2024BI01283771$BIOGEN$$54$YR$$F$Y$$$20240927$$MD$DE$DE
243731381$24373138$1$I$20230101$20230720$20240927$20240927$PER$$US-THEA-2023001305$Thea Pharma$$$$$M$Y$$$20240927$$CN$US$US
243731401$24373140$1$I$$20230821$20240927$20240927$PER$$US-THEA-2023001501$Thea Pharma$$$$$F$Y$$$20240927$$CN$US$US
243731411$24373141$1$I$$20240919$20240927$20240927$EXP$$GR-TEVA-VS-3246903$TEVA$C. Koyas, L. Damianidou , M. Lamprou , S. Savvoukidou, V. Eleftheriadou, K. Kotsoglanidou et al, CASE OF A PEDIATRIC PATIENT WITH OSTEOSARCOMA AND PATHOLOGICAL FEMURAL FRACTURE, PEDIATRIC CLINIC, G.N.TH. HIPPOCRATES, 2024, P 19-20.$10$YR$$F$Y$$$20240927$$MD$GR$GR
243731421$24373142$1$I$$20240924$20240927$20240927$EXP$$US-ABBVIE-5938659$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243731431$24373143$1$I$$20231010$20240927$20240927$PER$$US-THEA-2023001708$Thea Pharma$$$$$M$Y$$$20240927$$CN$US$US
243731441$24373144$1$I$20230907$20230927$20240927$20240927$PER$$US-THEA-2023001735$Thea Pharma$$69$YR$$F$Y$$$20240927$$CN$US$US
243731451$24373145$1$I$20240613$20240924$20240927$20240927$EXP$$CA-OTSUKA-2024_026630$OTSUKA$$50$YR$$F$Y$$$20240927$$HP$CA$CA
243731471$24373147$1$I$20240101$20240925$20240927$20240927$EXP$$CA-ABBVIE-5941219$ABBVIE$$77$YR$$F$Y$$$20240927$$CN$CA$CA
243731501$24373150$1$I$$20240920$20240927$20240927$EXP$$TH-JNJFOC-20240965586$JOHNSON AND JOHNSON$$13$YR$T$F$Y$$$20240927$$HP$TH$TH
243731521$24373152$1$I$$20240924$20240927$20240927$EXP$$DE-ORGANON-O2409DEU000118$ORGANON$$67$YR$$M$Y$58$KG$20240927$$PH$DE$DE
243731531$24373153$1$I$$20240919$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005783$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243731541$24373154$1$I$20231020$20231121$20240927$20240927$PER$$US-THEA-2023002078$Thea Pharma$$43$YR$$M$Y$$$20240927$$CN$US$US
243731551$24373155$1$I$20240301$20240314$20240927$20240927$PER$$US-THEA-2024000506$Thea Pharma$$79$YR$$M$Y$$$20240927$$CN$US$US
243731561$24373156$1$I$$20240923$20240927$20240927$PER$$DE-Blueprint Medicines Corporation-SO-DE-2024-001943$BLUEPRINT MEDICINES$$$$$$Y$$$20240927$$HP$DE$DE
243731571$24373157$1$I$20240905$20240918$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013858$DR REDDYS$$47$YR$A$M$Y$$$20240927$$HP$US$US
243731581$24373158$1$I$20230730$20240919$20240927$20240927$EXP$$JP-DSJP-DSJ-2024-138929$DAIICHI$$60$YR$$F$Y$38.6$KG$20240927$$MD$JP$JP
243731591$24373159$1$I$20240820$20240920$20240927$20240927$PER$$US-RDY-SPO/USA/24/0013963$DR REDDYS$$65$YR$E$M$Y$$$20240927$$MD$US$US
243731601$24373160$1$I$$20240920$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013958$DR REDDYS$$40$YR$A$M$Y$$$20240927$$MD$US$US
243731611$24373161$1$I$$20240917$20240927$20240927$EXP$$DE-RDY-SPO/DEU/24/0013996$DR REDDYS$Bieneck V, Decker A, Schmitt-Graeff A, Kreisel W, Schauer F. Remission of refractory esophageal lichen planus induced by tofacitinib. Zeitschrift fur Gastroenterologie. 2024;62(9): 1384-1388. doi:10.1055/a-2300-0375.$56$YR$A$F$Y$$$20240927$$HP$DE$DE
243731621$24373162$1$I$$20240919$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013860$DR REDDYS$$47$YR$A$F$Y$$$20240927$$PH$US$US
243731631$24373163$1$I$$20240919$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013859$DR REDDYS$$37$YR$A$M$Y$$$20240927$$MD$US$US
243731641$24373164$1$I$20240601$20240923$20240927$20240927$EXP$IT-MINISAL02-1002521$IT-MYLANLABS-2024M1086286$MYLAN$$72$YR$$F$Y$75$KG$20240927$$MD$IT$IT
243731651$24373165$1$I$20231106$20240924$20240927$20240927$EXP$$IE-MYLANLABS-2023M1136333$MYLAN$$53$YR$$M$Y$$$20240927$$MD$IE$IE
243731671$24373167$1$I$20240917$20240919$20240927$20240927$EXP$$US-HETERO-HET2024US03348$HETERO$$56$YR$$F$Y$52.1$KG$20240927$$CN$US$US
243731681$24373168$1$I$$20240919$20240927$20240927$EXP$$NO-ROCHE-10000087866$ROCHE$$$$E$M$Y$$$20240927$$MD$NO$NO
243731691$24373169$1$I$$20230816$20240927$20240927$PER$$US-THEA-2023001464$Thea Pharma$$$$$M$Y$$$20240927$$PH$US$US
243731701$24373170$1$I$$20240919$20240927$20240927$EXP$$IL-TAKEDA-2024TUS095697$TAKEDA$$$$$M$Y$$$20240927$$CN$IL$IL
243731711$24373171$1$I$20230207$20240918$20240927$20240927$EXP$$CN-TEVA-VS-3245505$TEVA$Ding Sihua, Li Weina, A Case of Kounis Syndrome Induced by Azithromycin,  Chin J Gen Pract, 2024-Aug, Vol. 23, P.No. 878-884.$72$YR$$F$Y$$$20240927$$MD$CN$CN
243731731$24373173$1$I$$20240923$20240927$20240927$EXP$$AE-LUNDBECK-DKLU4004675$LUNDBECK$$$$$$Y$$$20240927$$CN$AE$AE
243731751$24373175$1$I$$20231130$20240927$20240927$PER$$US-THEA-2023002320$Thea Pharma$$$$$$Y$$$20240927$$MD$US$US
243731761$24373176$1$I$20240301$20240919$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005784$ACADIA PHARMACEUTICALS$$89$YR$$M$Y$$$20240927$$CN$US$US
243731771$24373177$1$I$$20240917$20240927$20240927$EXP$$VN-JNJFOC-20240971510$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20240927$$HP$VN$VN
243731781$24373178$1$I$$20240916$20240927$20240927$EXP$$JP-NOVOPROD-1289667$NOVO NORDISK$Yoshito Itoh et al.. Food-induced small bowel obstruction observed in a patient with inappropriate use of semaglutide. Diabetology International. 2024;1-5$30$YR$$F$Y$50$KG$20240927$$HP$JP$JP
243731801$24373180$1$I$$20240916$20240927$20240927$EXP$$CN-JNJFOC-20240951701$JOHNSON AND JOHNSON$$$$A$$Y$$$20240927$$MD$CN$CN
243731811$24373181$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400264084$PFIZER$$69$YR$$F$Y$$$20240927$$HP$US$US
243731821$24373182$1$I$$20240913$20240927$20240927$EXP$$NO-BRAEBURN-NO-BRA-24-000890$BRAEBURN PHARMACEUTICALS$$$$$$Y$$$20240927$$HP$NO$NO
243731831$24373183$1$I$$20240910$20240927$20240927$EXP$$JP-SA-2024SA270416$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240927$$PH$JP$JP
243731841$24373184$1$I$$20240923$20240927$20240927$EXP$$FR-JNJFOC-20231121608$JOHNSON AND JOHNSON$$56$YR$A$F$Y$60$KG$20240927$$MD$FR$FR
243731851$24373185$1$I$$20240913$20240927$20240927$EXP$$US-SA-2024SA274980$SANOFI AVENTIS$$$$E$M$Y$$$20240927$$MD$US$US
243731861$24373186$1$I$$20231116$20240927$20240927$PER$$US-THEA-2023002049$Thea Pharma$$$$$F$Y$$$20240927$$PH$US$US
243731871$24373187$1$I$20240908$20240920$20240927$20240927$EXP$$US-ABBVIE-5933088$ABBVIE$$11$YR$$M$Y$$$20240927$$CN$US$US
243731881$24373188$1$I$$20240921$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153191$BRISTOL MYERS SQUIBB$$43$YR$A$M$Y$102.51$KG$20240927$$CN$US$US
243731891$24373189$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150567$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240927$$HP$US$US
243731901$24373190$1$I$$20240920$20240927$20240927$EXP$AU-TGA-0000817951$NVSC2024AU191202$NOVARTIS$$56$YR$$F$Y$$$20240927$$HP$AU$AU
243731921$24373192$1$I$20230101$20230321$20240927$20240927$PER$$US-THEA-2023000523$Thea Pharma$$89$YR$$F$Y$$$20240927$$CN$US$US
243731951$24373195$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66358$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243731961$24373196$1$I$20240831$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66776$$FDA-CTU$$58$YR$$F$N$$$20240927$N$$US$
243731981$24373198$1$I$20230324$20230404$20240927$20240927$PER$$US-THEA-2023000569$Thea Pharma$$$$$F$Y$$$20240927$$CN$US$US
243732011$24373201$1$I$20240101$20240909$20240927$20240927$PER$$US-TEVA-VS-3241981$TEVA$$53$YR$$F$Y$$$20240927$$CN$US$US
243732031$24373203$1$I$$20230414$20240927$20240927$PER$$US-THEA-2023000677$Thea Pharma$$$$$F$Y$$$20240927$$CN$US$US
243732051$24373205$1$I$$20240919$20240927$20240927$EXP$$US-BIOCON BIOLOGICS LIMITED-BBL2024007056$BIOCON$$$$$$Y$$$20240927$$CN$US$US
243732061$24373206$1$I$20240722$20240925$20240927$20240927$EXP$FR-AFSSAPS-MP2024001305$FR-SA-2024SA279867$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$FR$FR
243732071$24373207$1$I$20240915$20240918$20240927$20240927$PER$$US-JNJFOC-20240948277$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243732081$24373208$1$I$$20240917$20240927$20240927$PER$$US-ABBVIE-5929666$ABBVIE$$$$$$Y$$$20240927$$HP$US$US
243732101$24373210$1$I$$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190509$AMGEN$$$$$F$Y$$$20240927$$HP$US$US
243732111$24373211$1$I$$20240925$20240927$20240927$PER$$US-HALEON-2198804$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243732121$24373212$1$I$20240830$20240919$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005801$ACADIA PHARMACEUTICALS$$91$YR$$M$Y$$$20240927$$CN$US$US
243732131$24373213$1$I$$20240919$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005742$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$CN$US$US
243732141$24373214$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245497$TEVA$$63$YR$$M$Y$86$KG$20240927$$HP$CA$CA
243732151$24373215$1$I$20240901$20240919$20240927$20240927$EXP$$US-BEH-2024179230$CSL BEHRING$$65$YR$E$F$Y$$$20240927$$HP$US$US
243732181$24373218$1$I$20240712$20240916$20240927$20240927$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK094128$GLENMARK$$$$$$Y$$$20240927$$HP$US$US
243732191$24373219$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153126$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240927$$CN$US$US
243732211$24373221$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152146$BRISTOL MYERS SQUIBB$Srikaram P, Gupta S, Elshawwaf M, Singhal S. The clotting conundrum: fatal recurrent hematomas in a critically ill patient - a rare care of acquired hemophilia. Chest. 2024;166(4S):1878A-9A. doi:10.1016/j.chest.2024.06.1176.$72$YR$E$F$Y$$$20240927$$HP$US$US
243732221$24373222$1$I$20240726$20240925$20240927$20240927$EXP$FR-AFSSAPS-SE2024000738$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-152652$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$98$KG$20240927$$MD$FR$FR
243732231$24373223$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245197$TEVA$$51$YR$$F$Y$54$KG$20240927$$HP$CA$CA
243732241$24373224$1$I$$20240917$20240927$20240927$EXP$$CA-APOTEX-2024AP011110$APOTEX$$68$YR$$M$Y$$$20240927$$HP$CA$CA
243732251$24373225$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152025$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240927$$HP$US$US
243732261$24373226$1$I$20240603$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005709$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20240927$$CN$US$US
243732281$24373228$1$I$20240615$20240920$20240927$20240927$EXP$ES-AEMPS-1571658$ES-HETERO-AMR2024ES03324$HETERO$$57$YR$$M$Y$$$20240927$$MD$ES$ES
243732291$24373229$1$I$20240815$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005714$ACADIA PHARMACEUTICALS$$60$YR$$F$Y$$$20240927$$CN$US$US
243732301$24373230$1$I$$20240919$20240927$20240927$PER$$US-TEVA-VS-3245611$TEVA$$36$YR$$M$Y$$$20240927$$CN$US$US
243732311$24373231$1$I$$20240917$20240927$20240927$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005716$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243732321$24373232$1$I$$20240911$20240927$20240927$PER$$US-BIOMARINAP-US-2024-160801$BIOMARIN$$$$$$Y$$$20240927$$CN$US$US
243732341$24373234$1$I$20240920$20240924$20240927$20240927$EXP$$US-ABBVIE-5937979$ABBVIE$$28$YR$$M$Y$$$20240927$$CN$US$US
243732381$24373238$1$I$$20240923$20240927$20240927$EXP$$CA-ORGANON-O2409CAN001711$ORGANON$$44$YR$$F$Y$$$20240927$$HP$CA$CA
243732391$24373239$1$I$20240909$20240923$20240927$20240927$EXP$$US-ABBVIE-5937213$ABBVIE$$60$YR$$F$Y$$$20240927$$CN$US$US
243732401$24373240$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245471$TEVA$$70$YR$$M$Y$62$KG$20240927$$HP$CA$CA
243732411$24373241$1$I$$20240923$20240927$20240927$PER$$US-BIOMARINAP-US-2024-159731$BIOMARIN$$$$$$Y$$$20240927$$CN$US$US
243732421$24373242$1$I$20240819$20240917$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013884$DR REDDYS$$69$YR$E$F$Y$68.04$KG$20240927$$PH$US$US
243732431$24373243$1$I$$20240917$20240927$20240927$EXP$$CA-APOTEX-2024AP011109$APOTEX$$72$YR$$F$Y$42$KG$20240927$$PH$CA$CA
243732441$24373244$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5936392$ABBVIE$$$$$F$Y$$$20240927$$HP$US$US
243732451$24373245$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245610$TEVA$$72$YR$$M$Y$76$KG$20240927$$HP$CA$CA
243732461$24373246$1$I$$20240917$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0013990$DR REDDYS$Robinson W, McLellan BN. Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus. JAAD Case Reports. 2023 Dec;42: 31-34. doi:10.1016/j.jdcr.2023.09.006.$68$YR$E$M$Y$$$20240927$$HP$US$US
243732471$24373247$1$I$20240603$20240923$20240927$20240927$EXP$$US-ABBVIE-5935376$ABBVIE$$82$YR$$M$Y$58.51$KG$20240927$$CN$US$US
243732481$24373248$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245602$TEVA$$$$$F$Y$$$20240927$$LW$CA$CA
243732491$24373249$1$I$$20240925$20240927$20240927$PER$$US-GILEAD-2024-0689013$GILEAD$$52$YR$A$F$Y$$$20240927$$CN$US$US
243732501$24373250$1$I$$20240920$20240927$20240927$EXP$$US-GSK-US2024117023$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
243732511$24373251$1$I$20240101$20240923$20240927$20240927$EXP$$CH-ABBVIE-5935692$ABBVIE$$$$$F$Y$$$20240927$$HP$CH$CH
243732531$24373253$1$I$$20240925$20240927$20240927$EXP$$CR-009507513-2409CRI009691$MERCK$$$$$F$Y$$$20240927$$HP$CR$CR
243732541$24373254$1$I$20240916$20240917$20240927$20240927$EXP$$CA-HLS-202402246$HLS THERAPEUTICS$$73$YR$E$M$Y$$$20240927$$PH$CA$CA
243732551$24373255$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245518$TEVA$$74$YR$$M$Y$$$20240927$$CN$CA$CA
243732571$24373257$1$I$20240101$20240919$20240927$20240927$EXP$GB-SANDOZ-SDZ2024GB080530$GB-ROCHE-10000086921$ROCHE$$$$$F$Y$$$20240927$$CN$GB$GB
243732581$24373258$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245209$TEVA$$$$$F$Y$$$20240927$$MD$CA$CA
243732591$24373259$1$I$$20240925$20240927$20240927$EXP$$US-PFIZER INC-PV202400126031$PFIZER$Martinez, M.. DUAL CHECKPOINT INHIBITOR: BRENTUXIMAB- AND NIVOLUMAB-INDUCED CYTOKINE RELEASE SYNDROME PRESENTING AS DIABETIC KETOACIDOSIS. Chest. 2024;166(4Supplement:A2187-A2188$20$YR$$M$Y$$$20240927$$HP$US$US
243732621$24373262$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-PV202400125477$PFIZER$Hall, A.. Clostridial gas gangrene involving the brain, gallbladder, heart, and soft tissue: A case report and literature review.. IDCases. 2024;38:10.1016/j.idcr.2024.e02073$73$YR$$F$Y$$$20240927$$HP$US$US
243732631$24373263$1$I$20240621$20240924$20240927$20240927$EXP$FR-AFSSAPS-LM2024000524$FR-PFIZER INC-202400262526$PFIZER$$62$YR$$M$Y$72$KG$20240927$$MD$FR$FR
243732661$24373266$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-PV202400125965$PFIZER$Freeman, H.. ORGANIZING PNEUMONIA: AN ETIOLOGICAL DILEMMA IN PATIENTS ON RITUXIMAB FOR TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDER. Chest. 2024;166(4 Supplemen:A5626-A5627$62$YR$$M$Y$$$20240927$$HP$US$US
243732671$24373267$1$I$20230101$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400263490$PFIZER$Metersky, M.. Current challenges in pulmonary nontuberculous mycobacterial infection: a case series with literature review. Postgraduate Medicine. 2024;1-12$36$YR$$F$Y$$$20240927$$HP$US$US
243732701$24373270$1$I$20240913$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400264087$PFIZER$$52$YR$$F$Y$$$20240927$$HP$US$US
243732711$24373271$1$I$$20240924$20240927$20240927$EXP$$CL-ROCHE-10000091399$ROCHE$$$$$M$Y$$$20240927$$MD$CL$CL
243732721$24373272$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245460$TEVA$$70$YR$$F$Y$$$20240927$$HP$CA$CA
243732731$24373273$1$I$$20240926$20240927$20240927$PER$$US-GILEAD-2024-0689164$GILEAD$$$$$$Y$$$20240927$$HP$US$US
243732741$24373274$1$I$20240831$20240920$20240927$20240927$EXP$$TW-DSJP-DS-2024-100865-TW$DAIICHI$$59$YR$$F$Y$$$20240927$$CN$TW$TW
243732751$24373275$1$I$$20240925$20240927$20240927$EXP$$BR-GSK-BR2024AMR119224$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$BR$BR
243732761$24373276$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66338$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243732771$24373277$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245621$TEVA$$$$$$Y$$$20240927$$HP$CA$CA
243732781$24373278$1$I$$20240925$20240927$20240927$EXP$$US-GILEAD-2024-0689023$GILEAD$$$$$M$Y$$$20240927$$MD$US$US
243732801$24373280$1$I$20240805$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66259$$FDA-CTU$$70$YR$$M$N$72.6$KG$20240925$N$HP$US$
243732811$24373281$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66272$$FDA-CTU$$$$$$N$$$20240926$$CN$US$
243732821$24373282$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66351$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243732831$24373283$1$I$$20240925$20240925$20240925$DIR$FDA-CDER-CTU-2024-66277$$FDA-CTU$$$$$$N$$$20240925$$CN$US$
243732841$24373284$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66250$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243732851$24373285$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66364$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243732861$24373286$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66280$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243732871$24373287$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66359$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243732881$24373288$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66382$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243732891$24373289$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66362$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243732901$24373290$1$I$$20240924$20240927$20240927$EXP$$US-ROCHE-10000090867$ROCHE$$$$A$F$Y$$$20240927$$HP$US$US
243732931$24373293$1$I$$20240916$20240927$20240927$EXP$$CA-BAXTER-2024BAX024908$BAXTER$$5$MON$$F$Y$$$20240927$$HP$CA$CA
243732961$24373296$1$I$$20240920$20240927$20240927$EXP$$US-ABBVIE-5937178$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243732971$24373297$1$I$20240809$20240918$20240927$20240927$EXP$$RU-BAYER-2024A133498$BAYER$$64$YR$A$F$Y$61$KG$20240927$$MD$RU$RU
243732981$24373298$1$I$$20240925$20240927$20240927$EXP$$US-GILEAD-2024-0689026$GILEAD$$$$$M$Y$$$20240927$$MD$US$US
243732991$24373299$1$I$20240903$20240918$20240927$20240927$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-016353$JAZZ$$$$E$$Y$$$20240927$$MD$JP$JP
243733001$24373300$1$I$$20240813$20240927$20240927$PER$$US-LUNDBECK-DKLU4002983$LUNDBECK$$$$$$Y$$$20240927$$CN$US$US
243733011$24373301$1$I$20240608$20240918$20240927$20240927$30DAY$$US-PFIZER INC-PV202400122492$PFIZER$$10$YR$$M$Y$31.6$KG$20240927$$HP$US$US
243733021$24373302$1$I$$20240917$20240927$20240927$30DAY$$CO-PFIZER INC-PV202400122218$PFIZER$$10$YR$$F$Y$$$20240927$$CN$CO$CO
243733031$24373303$1$I$20240905$20240917$20240927$20240927$30DAY$$US-PFIZER INC-202400258366$PFIZER$$$$$$Y$$$20240927$$HP$US$US
243733041$24373304$1$I$20240527$20240924$20240927$20240927$EXP$FR-AFSSAPS-DJ2024001001$FR-ABBVIE-5941600$ABBVIE$$64$YR$$M$Y$$$20240927$$MD$FR$FR
243733051$24373305$1$I$$20240919$20240927$20240927$EXP$$JP-AMGEN-JPNSP2024188019$AMGEN$$$$$$Y$$$20240927$$PH$JP$JP
243733062$24373306$2$F$$20240926$20240927$20240930$EXP$$CA-BAYER-2024A138206$BAYER$$56$YR$A$M$Y$$$20240930$$CN$CA$CA
243733071$24373307$1$I$$20240925$20240927$20240927$EXP$$US-GILEAD-2024-0689028$GILEAD$$$$$M$Y$$$20240927$$MD$US$US
243733081$24373308$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152200$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$128.82$KG$20240927$$CN$US$US
243733091$24373309$1$I$$20240924$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152214$BRISTOL MYERS SQUIBB$$70$YR$E$F$Y$60.33$KG$20240927$$CN$US$US
243733101$24373310$1$I$20240914$20240926$20240927$20240927$EXP$IT-MINISAL02-1003910$IT-BRISTOL-MYERS SQUIBB COMPANY-2024-153494$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240927$$PH$IT$IT
243733111$24373311$1$I$$20240923$20240927$20240927$EXP$$IE-ABBVIE-5938907$ABBVIE$$$$E$M$Y$$$20240927$$CN$IE$IE
243733121$24373312$1$I$20240901$20240917$20240927$20240927$PER$$US-GSK-US2024115683$GLAXOSMITHKLINE$$91$YR$$F$Y$$$20240927$$CN$US$US
243733131$24373313$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016457$ELI LILLY AND CO$$43$YR$A$M$Y$$$20240927$$CN$US$US
243733141$24373314$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016543$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240927$$CN$US$US
243733151$24373315$1$I$20240803$20240917$20240927$20240927$EXP$$US-JNJFOC-20240945145$JOHNSON AND JOHNSON$$46$YR$A$$Y$$$20240927$$CN$US$US
243733171$24373317$1$I$20240924$20240924$20240927$20240927$EXP$$GB-TAKEDA-2024TUS095843$TAKEDA$$69$YR$$F$Y$$$20240927$$CN$GB$GB
243733181$24373318$1$I$$20240923$20240927$20240927$EXP$$CO-ROCHE-10000090377$ROCHE$$$$$F$Y$$$20240927$$MD$CO$CO
243733191$24373319$1$I$$20240924$20240927$20240927$EXP$$IT-ROCHE-10000092313$ROCHE$$$$$$Y$$$20240927$$MD$IT$IT
243733201$24373320$1$I$20240706$20240919$20240927$20240927$EXP$FR-AFSSAPS-PP2024000997$FR-INCYTE CORPORATION-2024IN009979$INCYTE$$$$$$Y$$$20240927$$MD$FR$FR
243733211$24373321$1$I$$20240923$20240927$20240927$PER$$US-TAKEDA-2024TUS094926$TAKEDA$$$$$M$Y$111$KG$20240927$$PH$US$US
243733221$24373322$1$I$$20240926$20240927$20240927$EXP$$ES-GILEAD-2024-0689123$GILEAD$$$$$M$Y$$$20240927$$PH$ES$ES
243733231$24373323$1$I$$20240922$20240927$20240927$EXP$GB-MHRA-WEBRADR-202409220018284410-NRVDY$GB-GSK-GB2024117206$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$GB$GB
243733241$24373324$1$I$$20240927$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2023US058102$SANDOZ$$$$$$Y$$$20240927$$CN$US$US
243733271$24373327$1$I$$20240924$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083077$SANDOZ$KHANM H.. SAME DOSE, ADDED IMPACT: UNDERSTANDING BRASH SYNDROME. Boston Chest 2024 - Cardiovascular Disease - chestjournal.org. 2024;Case Report Pos:535A$77$YR$$F$Y$$$20240927$$HP$US$US
243733281$24373328$1$I$$20240926$20240927$20240927$EXP$$CA-ROCHE-10000092416$ROCHE$$71$YR$E$M$Y$90$KG$20240927$$PH$CA$CA
243733291$24373329$1$I$$20240927$20240927$20240927$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053942$BOEHRINGER INGELHEIM$$$$A$F$Y$$$20240927$$CN$US$US
243733301$24373330$1$I$20240917$20240920$20240927$20240927$EXP$$US-RDY-SPO/USA/24/0014026$DR REDDYS$$67$YR$E$M$Y$$$20240927$$PH$US$US
243733321$24373332$1$I$20240924$20240924$20240927$20240927$EXP$$SA-GILEAD-2024-0688710$GILEAD$$$$$F$Y$$$20240927$$MD$SA$SA
243733341$24373334$1$I$20240925$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191930$AMGEN$$$$$M$Y$$$20240927$$CN$US$US
243733351$24373335$1$I$$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192794$AMGEN$$$$$F$Y$$$20240927$$PH$US$US
243733361$24373336$1$I$20240926$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192191$AMGEN$$74$YR$E$M$Y$$$20240927$$CN$US$US
243733391$24373339$1$I$20240820$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66367$$FDA-CTU$$8$YR$$M$N$43.54$KG$20240926$N$CN$US$
243733401$24373340$1$I$$20240923$20240927$20240927$EXP$$CA-ORGANON-O2409CAN001728$ORGANON$$$$$F$Y$$$20240927$$MD$CA$CA
243733411$24373341$1$I$20240819$20240926$20240926$20240926$DIR$720160$$FDA-CTU$$45$YR$$F$N$75.8$KG$20240926$N$PH$US$
243733421$24373342$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66340$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243733441$24373344$1$I$20240920$20240926$20240926$20240926$DIR$720019$$FDA-CTU$$32$YR$$F$N$$$20240926$Y$CN$US$
243733471$24373347$1$I$20240916$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66388$$FDA-CTU$$66$YR$$UNK$N$$$20240926$N$PH$US$
243733481$24373348$1$I$$20240926$20240926$20240926$DIR$720065$$FDA-CTU$$$$$UNK$N$$$20240926$N$CN$US$
243733501$24373350$1$I$20240101$20240923$20240927$20240927$PER$$US-009507513-2409USA008769$MERCK$$$$$M$Y$$$20240927$$CN$US$US
243733511$24373351$1$I$$20240925$20240927$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA083137$SANDOZ$$46$YR$$F$Y$$$20240927$$CN$CA$CA
243733521$24373352$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153052$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$76.66$KG$20240927$$CN$US$US
243733531$24373353$1$I$$20240923$20240927$20240927$EXP$$FR-INCYTE CORPORATION-2024IN010120$INCYTE$$$$$$Y$$$20240927$$MD$FR$FR
243733561$24373356$1$I$$20240924$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083178$SANDOZ$WITTROCK E., NASSAR B.S.. TARDIVE DYSKINESIA OF THE VOCAL CORDS: AN UNCOMMON CAUSE OF TACHYPNEA. Chest. 2024;166:A2554$65$YR$$F$Y$$$20240927$$HP$US$US
243733571$24373357$1$I$20240716$20240920$20240927$20240927$EXP$$IN-SANDOZ INC.-SDZ2024IN083349$SANDOZ$$54$YR$$M$Y$$$20240927$$CN$IN$IN
243733581$24373358$1$I$$20240926$20240927$20240927$EXP$$PL-GILEAD-2024-0689117$GILEAD$$$$$F$Y$$$20240927$$MD$PL$PL
243733591$24373359$1$I$20190718$20240924$20240927$20240927$EXP$$FR-ABBVIE-19K-056-2938236-00$ABBVIE$$88$YR$$M$Y$53$KG$20240927$$MD$FR$FR
243733611$24373361$1$I$$20240913$20240927$20240927$EXP$GB-MHRA-MED-202406181041240220-FHGYC$GB-DSJP-DSE-2024-127396$DAIICHI$$82$YR$$M$Y$$$20240927$$MD$GB$GB
243733621$24373362$1$I$$20240924$20240927$20240927$PER$$US-BIOGEN-2024BI01284108$BIOGEN$$$$$$Y$$$20240927$$CN$US$US
243733631$24373363$1$I$20120101$20240925$20240927$20240927$PER$$US-BIOGEN-2012BI042237$BIOGEN$$$$$F$Y$$$20240927$$CN$US$US
243733661$24373366$1$I$$20240924$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151811$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$59.42$KG$20240927$$HP$US$US
243733671$24373367$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152800$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240927$$CN$US$US
243733691$24373369$1$I$$20240918$20240927$20240927$EXP$$JP-BIOCON BIOLOGICS LIMITED-BBL2024007150$BIOCON$Toru Sugimoto, Azusa Ogita, Fumiko Tamayose, Yuri Ishihara, Yuri Kinoshita, Keigo Ito et al.. A case of hidradenitis suppurativa with rapid worsening of HbA1c immediately after adalimumab administration.. The 76th Annual Meeting of the Western Division of JDA.. 2024;141$$$$$Y$$$20240927$$HP$JP$JP
243733701$24373370$1$I$20230807$20240923$20240927$20240927$EXP$$KR-009507513-2409KOR007643$MERCK$$$$$M$Y$$$20240927$$HP$KR$KR
243733711$24373371$1$I$20240913$20240918$20240927$20240927$PER$$US-RDY-SPO/USA/24/0013852$DR REDDYS$$34$YR$A$F$Y$$$20240927$$MD$US$US
243733721$24373372$1$I$$20240925$20240927$20240927$EXP$$IT-SANDOZ INC.-SDZ2024IT082886$SANDOZ$$83$YR$$M$Y$$$20240927$$MD$IT$IT
243733731$24373373$1$I$$20240925$20240927$20240927$30DAY$$US-SANDOZ INC.-SDZ2024US083062$SANDOZ$$$$$M$Y$$$20240927$$CN$US$US
243733741$24373374$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151436$BRISTOL MYERS SQUIBB$Orabueze I, Cluzet V. Chronic extrapleural hemothorax: a case of chronic pulmonary disability in a patient with asbestos exposure and therapeutic anticoagulation. Chest. 2024;166(4S):4442A-3A. doi:10.1016/j.chest.2024.06.2696.$67$YR$E$M$Y$$$20240927$$HP$US$US
243733751$24373375$1$I$$20240908$20240927$20240927$PER$$US-TEVA-VS-3246252$TEVA$$$$$F$Y$$$20240927$$CN$US$US
243733761$24373376$1$I$$20230801$20240927$20240927$PER$$US-VIVUS LLC-2022V1000188$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243733771$24373377$1$I$$20230731$20240927$20240927$PER$$US-VIVUS LLC-2023V1000766$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243733781$24373378$1$I$$20230731$20240927$20240927$PER$$US-VIVUS LLC-2023V1000767$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243733791$24373379$1$I$$20230801$20240927$20240927$PER$$US-VIVUS LLC-2023V1000769$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243733801$24373380$1$I$$20230801$20240927$20240927$PER$$US-VIVUS LLC-2023V1000770$VIVUS$$$$E$$Y$$$20240912$$HP$US$US
243733821$24373382$1$I$$20230801$20240927$20240927$PER$$US-VIVUS LLC-2023V1000772$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243733831$24373383$1$I$$20230801$20240927$20240927$PER$$US-VIVUS LLC-2023V1000773$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243733841$24373384$1$I$$20230801$20240927$20240927$PER$$US-VIVUS LLC-2023V1000774$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243733851$24373385$1$I$$20230802$20240927$20240927$PER$$US-VIVUS LLC-2023V1000775$VIVUS$$$$$$Y$$$20240912$$PH$US$US
243733861$24373386$1$I$$20230802$20240927$20240927$PER$$US-VIVUS LLC-2023V1000777$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243733871$24373387$1$I$20230501$20230801$20240927$20240927$PER$$US-VIVUS LLC-2023V1000776$VIVUS$$35$YR$A$F$Y$82.174$KG$20240912$$CN$US$US
243733881$24373388$1$I$$20230803$20240927$20240927$PER$$US-VIVUS LLC-2023V1000783$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243733891$24373389$1$I$$20230802$20240927$20240927$PER$$US-VIVUS LLC-2023V1000785$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243733901$24373390$1$I$$20230802$20240927$20240927$PER$$US-VIVUS LLC-2023V1000786$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243733911$24373391$1$I$$20230804$20240927$20240927$PER$$US-VIVUS LLC-2023V1000791$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243733921$24373392$1$I$$20230804$20240927$20240927$PER$$US-VIVUS LLC-2023V1000792$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243733931$24373393$1$I$$20230802$20240927$20240927$PER$$US-VIVUS LLC-2023V1000778$VIVUS$$$$A$M$Y$111.23$KG$20240912$$CN$US$US
243733941$24373394$1$I$20230724$20230804$20240927$20240927$PER$$US-VIVUS LLC-2023V1000793$VIVUS$$66$YR$E$F$Y$83.536$KG$20240912$$MD$US$US
243733951$24373395$1$I$$20230804$20240927$20240927$PER$$US-VIVUS LLC-2023V1000794$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243733961$24373396$1$I$$20230804$20240927$20240927$PER$$US-VIVUS LLC-2023V1000795$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243733971$24373397$1$I$$20230807$20240927$20240927$PER$$US-VIVUS LLC-2023V1000796$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243733981$24373398$1$I$$20230807$20240927$20240927$PER$$US-VIVUS LLC-2023V1000800$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243733991$24373399$1$I$$20230807$20240927$20240927$PER$$US-VIVUS LLC-2023V1000801$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243734001$24373400$1$I$20230501$20230807$20240927$20240927$PER$$US-VIVUS LLC-2023V1000802$VIVUS$$53$YR$A$F$Y$$$20240912$$CN$US$US
243734011$24373401$1$I$$20230808$20240927$20240927$PER$$US-VIVUS LLC-2023V1000804$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734021$24373402$1$I$$20230808$20240927$20240927$PER$$US-VIVUS LLC-2023V1000805$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734031$24373403$1$I$$20230808$20240927$20240927$PER$$US-VIVUS LLC-2023V1000806$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734041$24373404$1$I$$20230809$20240927$20240927$PER$$US-VIVUS LLC-2023V1000809$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243734051$24373405$1$I$20230807$20230809$20240927$20240927$PER$$US-VIVUS LLC-2023V1000810$VIVUS$$64$YR$A$F$Y$98.972$KG$20240912$$CN$US$US
243734061$24373406$1$I$20230809$20230809$20240927$20240927$PER$$US-VIVUS LLC-2023V1000812$VIVUS$$71$YR$E$M$Y$$$20240912$$CN$US$US
243734071$24373407$1$I$$20230809$20240927$20240927$PER$$US-VIVUS LLC-2023V1000813$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243734081$24373408$1$I$$20230809$20240927$20240927$PER$$US-VIVUS LLC-2023V1000814$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243734091$24373409$1$I$$20230809$20240927$20240927$PER$$US-VIVUS LLC-2023V1000815$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734101$24373410$1$I$$20230809$20240927$20240927$PER$$US-VIVUS LLC-2023V1000816$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243734111$24373411$1$I$$20230809$20240927$20240927$PER$$US-VIVUS LLC-2023V1000817$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243734121$24373412$1$I$$20230809$20240927$20240927$PER$$US-VIVUS LLC-2023V1000818$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243734131$24373413$1$I$$20230810$20240927$20240927$PER$$US-VIVUS LLC-2023V1000819$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243734141$24373414$1$I$20230710$20230810$20240927$20240927$PER$$US-VIVUS LLC-2023V1000821$VIVUS$$59$YR$A$F$Y$139.38$KG$20240912$$CN$US$US
243734151$24373415$1$I$$20230810$20240927$20240927$PER$$US-VIVUS LLC-2023V1000825$VIVUS$$$$A$F$Y$$$20240912$$MD$US$US
243734161$24373416$1$I$$20230821$20240927$20240927$PER$$US-VIVUS LLC-2023V1000862$VIVUS$$$$A$$Y$$$20240913$$CN$US$US
243734171$24373417$1$I$$20230821$20240927$20240927$PER$$US-VIVUS LLC-2023V1000863$VIVUS$$$$A$$Y$$$20240913$$CN$US$US
243734181$24373418$1$I$$20230821$20240927$20240927$PER$$US-VIVUS LLC-2023V1000864$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243734191$24373419$1$I$20230821$20230821$20240927$20240927$PER$$US-VIVUS LLC-2023V1000865$VIVUS$$67$YR$E$F$Y$$$20240913$$CN$US$US
243734201$24373420$1$I$$20230821$20240927$20240927$PER$$US-VIVUS LLC-2023V1000866$VIVUS$$38$YR$A$F$Y$$$20240913$$CN$US$US
243734211$24373421$1$I$$20230822$20240927$20240927$PER$$US-VIVUS LLC-2023V1000867$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243734221$24373422$1$I$$20230822$20240927$20240927$PER$$US-VIVUS LLC-2023V1000868$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243734231$24373423$1$I$$20230822$20240927$20240927$PER$$US-VIVUS LLC-2023V1000869$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243734241$24373424$1$I$20230818$20230822$20240927$20240927$PER$$US-VIVUS LLC-2023V1000870$VIVUS$$56$YR$A$F$Y$$$20240913$$CN$US$US
243734251$24373425$1$I$20230801$20230822$20240927$20240927$PER$$US-VIVUS LLC-2023V1000871$VIVUS$$56$YR$A$F$Y$$$20240913$$CN$US$US
243734261$24373426$1$I$$20230822$20240927$20240927$PER$$US-VIVUS LLC-2023V1000873$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243734271$24373427$1$I$$20230822$20240927$20240927$PER$$US-VIVUS LLC-2023V1000874$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243734281$24373428$1$I$$20230822$20240927$20240927$PER$$US-VIVUS LLC-2023V1000875$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243734291$24373429$1$I$$20230822$20240927$20240927$PER$$US-VIVUS LLC-2023V1000877$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243734301$24373430$1$I$$20230823$20240927$20240927$PER$$US-VIVUS LLC-2023V1000879$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243734311$24373431$1$I$$20230823$20240927$20240927$PER$$US-VIVUS LLC-2023V1000880$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243734321$24373432$1$I$$20230823$20240927$20240927$PER$$US-VIVUS LLC-2023V1000882$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243734331$24373433$1$I$$20230823$20240927$20240927$PER$$US-VIVUS LLC-2023V1000884$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243734341$24373434$1$I$$20230824$20240927$20240927$PER$$US-VIVUS LLC-2023V1000885$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243734351$24373435$1$I$$20230824$20240927$20240927$PER$$US-VIVUS LLC-2023V1000887$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243734361$24373436$1$I$$20230718$20240927$20240927$PER$$US-VIVUS LLC-2023V1000714$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734371$24373437$1$I$$20230718$20240927$20240927$PER$$US-VIVUS LLC-2023V1000715$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734381$24373438$1$I$$20230718$20240927$20240927$PER$$US-VIVUS LLC-2023V1000716$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734391$24373439$1$I$$20230718$20240927$20240927$PER$$US-VIVUS LLC-2023V1000717$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734401$24373440$1$I$$20230718$20240927$20240927$PER$$US-VIVUS LLC-2023V1000718$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243734411$24373441$1$I$$20230719$20240927$20240927$PER$$US-VIVUS LLC-2023V1000719$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734421$24373442$1$I$$20230719$20240927$20240927$PER$$US-VIVUS LLC-2023V1000722$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734431$24373443$1$I$$20230719$20240927$20240927$PER$$US-VIVUS LLC-2023V1000724$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734441$24373444$1$I$$20230720$20240927$20240927$PER$$US-VIVUS LLC-2023V1000726$VIVUS$$$$A$F$Y$123.03$KG$20240912$$CN$US$US
243734451$24373445$1$I$$20230721$20240927$20240927$PER$$US-VIVUS LLC-2023V1000727$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734461$24373446$1$I$$20230721$20240927$20240927$PER$$US-VIVUS LLC-2023V1000728$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734471$24373447$1$I$$20230721$20240927$20240927$PER$$US-VIVUS LLC-2023V1000729$VIVUS$$66$YR$E$F$Y$76.272$KG$20240912$$CN$US$US
243734481$24373448$1$I$$20230721$20240927$20240927$PER$$US-VIVUS LLC-2023V1000732$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734491$24373449$1$I$$20230721$20240927$20240927$PER$$US-VIVUS LLC-2023V1000733$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243734501$24373450$1$I$$20230721$20240927$20240927$PER$$US-VIVUS LLC-2023V1000734$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734511$24373451$1$I$$20230724$20240927$20240927$PER$$US-VIVUS LLC-2023V1000735$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243734521$24373452$1$I$$20230724$20240927$20240927$PER$$US-VIVUS LLC-2023V1000736$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734531$24373453$1$I$$20230724$20240927$20240927$PER$$US-VIVUS LLC-2023V1000737$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734541$24373454$1$I$$20230724$20240927$20240927$PER$$US-VIVUS LLC-2023V1000739$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243734551$24373455$1$I$$20230811$20240927$20240927$PER$$US-VIVUS LLC-2023V1000826$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734561$24373456$1$I$20230810$20230811$20240927$20240927$PER$$US-VIVUS LLC-2023V1000827$VIVUS$$47$YR$A$F$Y$73.548$KG$20240912$$CN$US$US
243734571$24373457$1$I$20230801$20230811$20240927$20240927$PER$$US-VIVUS LLC-2023V1000831$VIVUS$$41$YR$A$F$Y$$$20240912$$CN$US$US
243734581$24373458$1$I$$20230811$20240927$20240927$PER$$US-VIVUS LLC-2023V1000832$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734591$24373459$1$I$$20230811$20240927$20240927$PER$$US-VIVUS LLC-2023V1000833$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734601$24373460$1$I$$20230814$20240927$20240927$PER$$US-VIVUS LLC-2023V1000834$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243734611$24373461$1$I$20230720$20230814$20240927$20240927$PER$$US-VIVUS LLC-2023V1000836$VIVUS$$55$YR$A$F$Y$101.24$KG$20240912$$CN$US$US
243734621$24373462$1$I$$20230815$20240927$20240927$PER$$US-VIVUS LLC-2023V1000838$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734631$24373463$1$I$$20230815$20240927$20240927$PER$$US-VIVUS LLC-2023V1000839$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734641$24373464$1$I$$20230815$20240927$20240927$PER$$US-VIVUS LLC-2023V1000840$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734651$24373465$1$I$$20230815$20240927$20240927$PER$$US-VIVUS LLC-2023V1000841$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734661$24373466$1$I$$20230815$20240927$20240927$PER$$US-VIVUS LLC-2023V1000844$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734671$24373467$1$I$$20230816$20240927$20240927$PER$$US-VIVUS LLC-2023V1000845$VIVUS$$$$A$F$Y$$$20240912$$HP$US$US
243734681$24373468$1$I$$20230817$20240927$20240927$PER$$US-VIVUS LLC-2023V1000849$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734691$24373469$1$I$$20230817$20240927$20240927$PER$$US-VIVUS LLC-2023V1000851$VIVUS$$$$A$M$Y$92.616$KG$20240912$$CN$US$US
243734701$24373470$1$I$$20230817$20240927$20240927$PER$$US-VIVUS LLC-2023V1000852$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734711$24373471$1$I$$20230817$20240927$20240927$PER$$US-VIVUS LLC-2023V1000855$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734721$24373472$1$I$$20230817$20240927$20240927$PER$$US-VIVUS LLC-2023V1000856$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734731$24373473$1$I$$20230818$20240927$20240927$PER$$US-VIVUS LLC-2023V1000858$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734741$24373474$1$I$$20230821$20240927$20240927$PER$$US-VIVUS LLC-2023V1000861$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734761$24373476$1$I$$20230828$20240927$20240927$PER$$US-VIVUS LLC-2023V1000890$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243734771$24373477$1$I$$20230824$20240927$20240927$PER$$US-VIVUS LLC-2023V1000891$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734781$24373478$1$I$$20230825$20240927$20240927$PER$$US-VIVUS LLC-2023V1000893$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734791$24373479$1$I$$20230825$20240927$20240927$PER$$US-VIVUS LLC-2023V1000894$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243734801$24373480$1$I$$20230825$20240927$20240927$PER$$US-VIVUS LLC-2023V1000895$VIVUS$$$$E$$Y$$$20240912$$CN$US$US
243734811$24373481$1$I$$20230828$20240927$20240927$PER$$US-VIVUS LLC-2023V1000896$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243734821$24373482$1$I$20230820$20230828$20240927$20240927$PER$$US-VIVUS LLC-2023V1000897$VIVUS$$73$YR$E$F$Y$107.14$KG$20240912$$CN$US$US
243734831$24373483$1$I$$20230828$20240927$20240927$PER$$US-VIVUS LLC-2023V1000899$VIVUS$$$$A$$Y$$$20240912$$CN$US$US
243734841$24373484$1$I$$20230828$20240927$20240927$PER$$US-VIVUS LLC-2023V1000900$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734851$24373485$1$I$$20230828$20240927$20240927$PER$$US-VIVUS LLC-2023V1000902$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243734861$24373486$1$I$$20230828$20240927$20240927$PER$$US-VIVUS LLC-2023V1000903$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734871$24373487$1$I$$20230719$20240927$20240927$PER$$US-VIVUS LLC-2023V1000723$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243734881$24373488$1$I$20230401$20230828$20240927$20240927$PER$$US-VIVUS LLC-2023V1000905$VIVUS$$67$YR$E$F$Y$$$20240912$$CN$US$US
243734891$24373489$1$I$$20230828$20240927$20240927$PER$$US-VIVUS LLC-2023V1000906$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734901$24373490$1$I$$20230829$20240927$20240927$PER$$US-VIVUS LLC-2023V1000907$VIVUS$$38$YR$A$F$Y$67.192$KG$20240912$$CN$US$US
243734911$24373491$1$I$$20230829$20240927$20240927$PER$$US-VIVUS LLC-2023V1000908$VIVUS$$$$T$F$Y$$$20240912$$HP$US$US
243734921$24373492$1$I$$20230829$20240927$20240927$PER$$US-VIVUS LLC-2023V1000911$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734931$24373493$1$I$$20230831$20240927$20240927$PER$$US-VIVUS LLC-2023V1000916$VIVUS$$35$YR$A$F$Y$92.344$KG$20240912$$CN$US$US
243734941$24373494$1$I$$20230831$20240927$20240927$PER$$US-VIVUS LLC-2023V1000918$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243734951$24373495$1$I$$20230830$20240927$20240927$PER$$US-VIVUS LLC-2023V1000913$VIVUS$$$$E$F$Y$69.28$KG$20240912$$CN$US$US
243734961$24373496$1$I$$20230907$20240927$20240927$PER$$US-VIVUS LLC-2023V1000951$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734971$24373497$1$I$$20230907$20240927$20240927$PER$$US-VIVUS LLC-2023V1000954$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243734981$24373498$1$I$$20230911$20240927$20240927$PER$$US-VIVUS LLC-2023V1000995$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243734991$24373499$1$I$$20230911$20240927$20240927$PER$$US-VIVUS LLC-2023V1000996$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735001$24373500$1$I$$20230911$20240927$20240927$PER$$US-VIVUS LLC-2023V1000997$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735011$24373501$1$I$$20230911$20240927$20240927$PER$$US-VIVUS LLC-2023V1000998$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735021$24373502$1$I$$20230911$20240927$20240927$PER$$US-VIVUS LLC-2023V1001000$VIVUS$$$$E$F$Y$105.33$KG$20240912$$CN$US$US
243735031$24373503$1$I$$20230912$20240927$20240927$PER$$US-VIVUS LLC-2023V1001003$VIVUS$$$$A$F$Y$$$20240912$$HP$US$US
243735041$24373504$1$I$$20230913$20240927$20240927$PER$$US-VIVUS LLC-2023V1001005$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735051$24373505$1$I$$20230913$20240927$20240927$PER$$US-VIVUS LLC-2023V1001007$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735061$24373506$1$I$$20230913$20240927$20240927$PER$$US-VIVUS LLC-2023V1001008$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735071$24373507$1$I$$20230913$20240927$20240927$PER$$US-VIVUS LLC-2023V1001009$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735081$24373508$1$I$$20230914$20240927$20240927$PER$$US-VIVUS LLC-2023V1001013$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735091$24373509$1$I$$20230915$20240927$20240927$PER$$US-VIVUS LLC-2023V1001017$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735101$24373510$1$I$$20230918$20240927$20240927$PER$$US-VIVUS LLC-2023V1001019$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735111$24373511$1$I$$20230918$20240927$20240927$PER$$US-VIVUS LLC-2023V1001020$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735121$24373512$1$I$$20230918$20240927$20240927$PER$$US-VIVUS LLC-2023V1001021$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735131$24373513$1$I$$20230919$20240927$20240927$PER$$US-VIVUS LLC-2023V1001022$VIVUS$$$$E$F$Y$182$KG$20240912$$HP$US$US
243735141$24373514$1$I$$20230918$20240927$20240927$PER$$US-VIVUS LLC-2023V1001023$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735151$24373515$1$I$$20230919$20240927$20240927$PER$$US-VIVUS LLC-2023V1001025$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735161$24373516$1$I$$20230919$20240927$20240927$PER$$US-VIVUS LLC-2023V1001026$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735171$24373517$1$I$$20230919$20240927$20240927$PER$$US-VIVUS LLC-2023V1001028$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735181$24373518$1$I$$20230919$20240927$20240927$PER$$US-VIVUS LLC-2023V1001029$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735191$24373519$1$I$$20230919$20240927$20240927$PER$$US-VIVUS LLC-2023V1001030$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735201$24373520$1$I$$20230920$20240927$20240927$PER$$US-VIVUS LLC-2023V1001033$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735211$24373521$1$I$$20230920$20240927$20240927$PER$$US-VIVUS LLC-2023V1001034$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735221$24373522$1$I$$20230920$20240927$20240927$PER$$US-VIVUS LLC-2023V1001035$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735231$24373523$1$I$$20230920$20240927$20240927$PER$$US-VIVUS LLC-2023V1001036$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735241$24373524$1$I$$20230921$20240927$20240927$EXP$$US-VIVUS LLC-2023V1001040$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735251$24373525$1$I$$20230921$20240927$20240927$PER$$US-VIVUS LLC-2023V1001041$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735261$24373526$1$I$$20230922$20240927$20240927$PER$$US-VIVUS LLC-2023V1001043$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243735271$24373527$1$I$$20230922$20240927$20240927$PER$$US-VIVUS LLC-2023V1001044$VIVUS$$$$$F$Y$92.616$KG$20240912$$CN$US$US
243735281$24373528$1$I$$20230922$20240927$20240927$PER$$US-VIVUS LLC-2023V1001046$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735291$24373529$1$I$$20230922$20240927$20240927$PER$$US-VIVUS LLC-2023V1001047$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735301$24373530$1$I$$20230922$20240927$20240927$PER$$US-VIVUS LLC-2023V1001049$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735311$24373531$1$I$$20230925$20240927$20240927$PER$$US-VIVUS LLC-2023V1001050$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735321$24373532$1$I$$20230925$20240927$20240927$PER$$US-VIVUS LLC-2023V1001052$VIVUS$$$$E$$Y$$$20240912$$CN$US$US
243735331$24373533$1$I$$20230925$20240927$20240927$PER$$US-VIVUS LLC-2023V1001053$VIVUS$$$$A$F$Y$98.972$KG$20240912$$CN$US$US
243735341$24373534$1$I$$20230925$20240927$20240927$PER$$US-VIVUS LLC-2023V1001054$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735351$24373535$1$I$$20230801$20240927$20240927$PER$$US-VIVUS LLC-2023V1000768$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243735361$24373536$1$I$$20230831$20240927$20240927$PER$$US-VIVUS LLC-2023V1000923$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735371$24373537$1$I$$20230831$20240927$20240927$PER$$US-VIVUS LLC-2023V1000925$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735381$24373538$1$I$$20230901$20240927$20240927$PER$$US-VIVUS LLC-2023V1000928$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735391$24373539$1$I$$20230901$20240927$20240927$PER$$US-VIVUS LLC-2023V1000929$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243735401$24373540$1$I$$20230905$20240927$20240927$PER$$US-VIVUS LLC-2023V1000931$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735411$24373541$1$I$$20230905$20240927$20240927$PER$$US-VIVUS LLC-2023V1000932$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735421$24373542$1$I$$20230905$20240927$20240927$PER$$US-VIVUS LLC-2023V1000934$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243735431$24373543$1$I$$20230906$20240927$20240927$PER$$US-VIVUS LLC-2023V1000935$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243735441$24373544$1$I$$20230907$20240927$20240927$PER$$US-VIVUS LLC-2023V1000938$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735451$24373545$1$I$$20230906$20240927$20240927$PER$$US-VIVUS LLC-2023V1000939$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735461$24373546$1$I$$20230906$20240927$20240927$PER$$US-VIVUS LLC-2023V1000940$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735471$24373547$1$I$$20230906$20240927$20240927$PER$$US-VIVUS LLC-2023V1000941$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243735481$24373548$1$I$$20230906$20240927$20240927$PER$$US-VIVUS LLC-2023V1000943$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735491$24373549$1$I$$20230907$20240927$20240927$PER$$US-VIVUS LLC-2023V1000944$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735501$24373550$1$I$$20230906$20240927$20240927$PER$$US-VIVUS LLC-2023V1000946$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735511$24373551$1$I$$20230907$20240927$20240927$PER$$US-VIVUS LLC-2023V1000947$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243735521$24373552$1$I$$20230907$20240927$20240927$PER$$US-VIVUS LLC-2023V1000948$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735531$24373553$1$I$$20230724$20240927$20240927$PER$$US-VIVUS LLC-2023V1000740$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735541$24373554$1$I$$20230925$20240927$20240927$PER$$US-VIVUS LLC-2023V1001056$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243735551$24373555$1$I$$20230905$20240927$20240927$PER$$US-VIVUS LLC-2023V1000933$VIVUS$$$$A$F$Y$113.5$KG$20240912$$CN$US$US
243735561$24373556$1$I$$20230720$20240927$20240927$PER$$US-VIVUS LLC-2023V1000741$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735571$24373557$1$I$$20230720$20240927$20240927$PER$$US-VIVUS LLC-2023V1000742$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735581$24373558$1$I$20230724$20230725$20240927$20240927$PER$$US-VIVUS LLC-2023V1000743$VIVUS$$48$YR$A$F$Y$68.554$KG$20240912$$CN$US$US
243735591$24373559$1$I$$20230725$20240927$20240927$PER$$US-VIVUS LLC-2023V1000744$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735601$24373560$1$I$20230501$20230725$20240927$20240927$PER$$US-VIVUS LLC-2023V1000745$VIVUS$$40$YR$A$F$Y$$$20240912$$CN$US$US
243735611$24373561$1$I$$20230725$20240927$20240927$PER$$US-VIVUS LLC-2023V1000746$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735621$24373562$1$I$20230721$20230725$20240927$20240927$PER$$US-VIVUS LLC-2023V1000747$VIVUS$$41$YR$A$M$Y$90.8$KG$20240912$$CN$US$US
243735631$24373563$1$I$$20230725$20240927$20240927$PER$$US-VIVUS LLC-2023V1000748$VIVUS$$43$YR$A$F$Y$97.156$KG$20240912$$CN$US$US
243735641$24373564$1$I$$20230725$20240927$20240927$PER$$US-VIVUS LLC-2023V1000749$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735651$24373565$1$I$$20230726$20240927$20240927$PER$$US-VIVUS LLC-2023V1000750$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243735661$24373566$1$I$$20230727$20240927$20240927$PER$$US-VIVUS LLC-2023V1000751$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735671$24373567$1$I$$20230726$20240927$20240927$PER$$US-VIVUS LLC-2023V1000752$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735681$24373568$1$I$$20230726$20240927$20240927$PER$$US-VIVUS LLC-2023V1000753$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735691$24373569$1$I$$20230726$20240927$20240927$PER$$US-VIVUS LLC-2023V1000754$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735701$24373570$1$I$$20230726$20240927$20240927$PER$$US-VIVUS LLC-2023V1000756$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243735711$24373571$1$I$$20230727$20240927$20240927$PER$$US-VIVUS LLC-2023V1000757$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735721$24373572$1$I$$20230727$20240927$20240927$PER$$US-VIVUS LLC-2023V1000759$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735731$24373573$1$I$$20230728$20240927$20240927$PER$$US-VIVUS LLC-2023V1000761$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735741$24373574$1$I$$20230731$20240927$20240927$PER$$US-VIVUS LLC-2023V1000763$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735751$24373575$1$I$$20240923$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409015193$ELI LILLY AND CO$$$$$$Y$$$20240927$$CN$US$US
243735761$24373576$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016462$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240927$$CN$US$US
243735772$24373577$2$F$$20240918$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409011051$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240927$$CN$US$US
243735781$24373578$1$I$$20230925$20240927$20240927$PER$$US-VIVUS LLC-2023V1001057$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735791$24373579$1$I$$20230925$20240927$20240927$PER$$US-VIVUS LLC-2023V1001058$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735801$24373580$1$I$$20230925$20240927$20240927$PER$$US-VIVUS LLC-2023V1001059$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243735811$24373581$1$I$$20230925$20240927$20240927$PER$$US-VIVUS LLC-2023V1001060$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735821$24373582$1$I$$20230926$20240927$20240927$PER$$US-VIVUS LLC-2023V1001063$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243735831$24373583$1$I$$20230926$20240927$20240927$PER$$US-VIVUS LLC-2023V1001064$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735841$24373584$1$I$$20230926$20240927$20240927$PER$$US-VIVUS LLC-2023V1001065$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735851$24373585$1$I$$20230926$20240927$20240927$PER$$US-VIVUS LLC-2023V1001067$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243735861$24373586$1$I$$20230927$20240927$20240927$PER$$US-VIVUS LLC-2023V1001069$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735871$24373587$1$I$$20230927$20240927$20240927$PER$$US-VIVUS LLC-2023V1001070$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735881$24373588$1$I$$20230927$20240927$20240927$PER$$US-VIVUS LLC-2023V1001071$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243735891$24373589$1$I$$20230927$20240927$20240927$PER$$US-VIVUS LLC-2023V1001073$VIVUS$$$$A$F$Y$$$20240912$$HP$US$US
243735901$24373590$1$I$20230919$20230927$20240927$20240927$PER$$US-VIVUS LLC-2023V1001074$VIVUS$$57$YR$A$F$Y$76.272$KG$20240912$$HP$US$US
243735911$24373591$1$I$$20230928$20240927$20240927$PER$$US-VIVUS LLC-2023V1001076$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735921$24373592$1$I$20240827$20240917$20240927$20240927$EXP$$CA-GSK-CA2023175875$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$CA$CA
243735931$24373593$1$I$$20230929$20240927$20240927$PER$$US-VIVUS LLC-2023V1001078$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735941$24373594$1$I$$20230929$20240927$20240927$PER$$US-VIVUS LLC-2023V1001080$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735951$24373595$1$I$$20230929$20240927$20240927$PER$$US-VIVUS LLC-2023V1001082$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735961$24373596$1$I$$20231002$20240927$20240927$PER$$US-VIVUS LLC-2023V1001085$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243735971$24373597$1$I$$20231002$20240927$20240927$PER$$US-VIVUS LLC-2023V1001088$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243735981$24373598$1$I$$20231002$20240927$20240927$PER$$US-VIVUS LLC-2023V1001089$VIVUS$$$$A$F$Y$95.794$KG$20240912$$CN$US$US
243735991$24373599$1$I$$20231002$20240927$20240927$PER$$US-VIVUS LLC-2023V1001090$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736001$24373600$1$I$$20231003$20240927$20240927$PER$$US-VIVUS LLC-2023V1001092$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736011$24373601$1$I$$20231003$20240927$20240927$PER$$US-VIVUS LLC-2023V1001093$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736021$24373602$1$I$$20231003$20240927$20240927$PER$$US-VIVUS LLC-2023V1001095$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736031$24373603$1$I$$20231004$20240927$20240927$PER$$US-VIVUS LLC-2023V1001096$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736041$24373604$1$I$$20231004$20240927$20240927$PER$$US-VIVUS LLC-2023V1001099$VIVUS$$$$A$F$Y$$$20240912$$HP$US$US
243736051$24373605$1$I$$20231004$20240927$20240927$PER$$US-VIVUS LLC-2023V1001100$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736061$24373606$1$I$$20231005$20240927$20240927$PER$$US-VIVUS LLC-2023V1001101$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736071$24373607$1$I$$20231004$20240927$20240927$PER$$US-VIVUS LLC-2023V1001102$VIVUS$$$$A$F$Y$$$20240912$$HP$US$US
243736081$24373608$1$I$$20231005$20240927$20240927$PER$$US-VIVUS LLC-2023V1001103$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736091$24373609$1$I$$20231005$20240927$20240927$PER$$US-VIVUS LLC-2023V1001106$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736101$24373610$1$I$$20231005$20240927$20240927$PER$$US-VIVUS LLC-2023V1001108$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736111$24373611$1$I$$20231004$20240927$20240927$PER$$US-VIVUS LLC-2023V1001098$VIVUS$$$$A$F$Y$63.106$KG$20240912$$CN$US$US
243736121$24373612$1$I$$20231006$20240927$20240927$PER$$US-VIVUS LLC-2023V1001109$VIVUS$$29$YR$A$F$Y$98.064$KG$20240912$$CN$US$US
243736131$24373613$1$I$20230917$20231006$20240927$20240927$PER$$US-VIVUS LLC-2023V1001110$VIVUS$$63$YR$A$F$Y$77.18$KG$20240912$$CN$US$US
243736141$24373614$1$I$$20231005$20240927$20240927$PER$$US-VIVUS LLC-2023V1001111$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736151$24373615$1$I$$20231006$20240927$20240927$PER$$US-VIVUS LLC-2023V1001115$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736161$24373616$1$I$$20231006$20240927$20240927$PER$$US-VIVUS LLC-2023V1001116$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736171$24373617$1$I$$20231006$20240927$20240927$PER$$US-VIVUS LLC-2023V1001118$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736181$24373618$1$I$$20231009$20240927$20240927$PER$$US-VIVUS LLC-2023V1001119$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736191$24373619$1$I$$20231102$20240927$20240927$PER$$US-VIVUS LLC-2023V1001213$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736201$24373620$1$I$$20231102$20240927$20240927$PER$$US-VIVUS LLC-2023V1001216$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243736211$24373621$1$I$$20231103$20240927$20240927$PER$$US-VIVUS LLC-2023V1001218$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736221$24373622$1$I$$20231103$20240927$20240927$PER$$US-VIVUS LLC-2023V1001219$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736231$24373623$1$I$$20231103$20240927$20240927$PER$$US-VIVUS LLC-2023V1001222$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736241$24373624$1$I$20230801$20231103$20240927$20240927$PER$$US-VIVUS LLC-2023V1001223$VIVUS$$42$YR$A$F$Y$116.68$KG$20240912$$CN$US$US
243736251$24373625$1$I$$20231106$20240927$20240927$PER$$US-VIVUS LLC-2023V1001224$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736261$24373626$1$I$$20231106$20240927$20240927$PER$$US-VIVUS LLC-2023V1001226$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736271$24373627$1$I$$20231106$20240927$20240927$PER$$US-VIVUS LLC-2023V1001227$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243736281$24373628$1$I$$20231107$20240927$20240927$PER$$US-VIVUS LLC-2023V1001230$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736291$24373629$1$I$$20231106$20240927$20240927$PER$$US-VIVUS LLC-2023V1001231$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243736301$24373630$1$I$$20231107$20240927$20240927$PER$$US-VIVUS LLC-2023V1001233$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736311$24373631$1$I$$20231107$20240927$20240927$PER$$US-VIVUS LLC-2023V1001236$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736321$24373632$1$I$$20231107$20240927$20240927$PER$$US-VIVUS LLC-2023V1001237$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736331$24373633$1$I$20231013$20231108$20240927$20240927$EXP$$US-VIVUS LLC-2023V1001240$VIVUS$$32$YR$A$F$Y$68.1$KG$20240912$$CN$US$US
243736341$24373634$1$I$$20231108$20240927$20240927$PER$$US-VIVUS LLC-2023V1001241$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736351$24373635$1$I$$20231110$20240927$20240927$PER$$US-VIVUS LLC-2023V1001244$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736361$24373636$1$I$$20231110$20240927$20240927$PER$$US-VIVUS LLC-2023V1001246$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736371$24373637$1$I$$20231113$20240927$20240927$PER$$US-VIVUS LLC-2023V1001249$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736381$24373638$1$I$$20231113$20240927$20240927$PER$$US-VIVUS LLC-2023V1001250$VIVUS$$$$$F$Y$73.548$KG$20240912$$CN$US$US
243736391$24373639$1$I$$20231023$20240927$20240927$PER$$US-VIVUS LLC-2023V1001174$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736401$24373640$1$I$$20231023$20240927$20240927$PER$$US-VIVUS LLC-2023V1001176$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736411$24373641$1$I$$20231024$20240927$20240927$PER$$US-VIVUS LLC-2023V1001177$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243736421$24373642$1$I$$20231024$20240927$20240927$PER$$US-VIVUS LLC-2023V1001178$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736431$24373643$1$I$$20231024$20240927$20240927$PER$$US-VIVUS LLC-2023V1001180$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243736441$24373644$1$I$$20231024$20240927$20240927$PER$$US-VIVUS LLC-2023V1001181$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243736451$24373645$1$I$$20231024$20240927$20240927$PER$$US-VIVUS LLC-2023V1001182$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736461$24373646$1$I$$20231024$20240927$20240927$PER$$US-VIVUS LLC-2023V1001183$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736471$24373647$1$I$$20231025$20240927$20240927$PER$$US-VIVUS LLC-2023V1001185$VIVUS$$$$A$F$Y$65.83$KG$20240912$$CN$US$US
243736481$24373648$1$I$$20231025$20240927$20240927$PER$$US-VIVUS LLC-2023V1001186$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736491$24373649$1$I$$20231026$20240927$20240927$PER$$US-VIVUS LLC-2023V1001190$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736501$24373650$1$I$$20231026$20240927$20240927$PER$$US-VIVUS LLC-2023V1001193$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243736511$24373651$1$I$$20231026$20240927$20240927$PER$$US-VIVUS LLC-2023V1001195$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736521$24373652$1$I$20230101$20231027$20240927$20240927$PER$$US-VIVUS LLC-2023V1001200$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736531$24373653$1$I$$20231030$20240927$20240927$PER$$US-VIVUS LLC-2023V1001202$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736541$24373654$1$I$$20231030$20240927$20240927$PER$$US-VIVUS LLC-2023V1001203$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736551$24373655$1$I$$20231030$20240927$20240927$PER$$US-VIVUS LLC-2023V1001204$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736561$24373656$1$I$$20231031$20240927$20240927$PER$$US-VIVUS LLC-2023V1001205$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736571$24373657$1$I$$20231101$20240927$20240927$PER$$US-VIVUS LLC-2023V1001208$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243736581$24373658$1$I$20231023$20231101$20240927$20240927$PER$$US-VIVUS LLC-2023V1001210$VIVUS$$63$YR$A$F$Y$$$20240912$$CN$US$US
243736591$24373659$1$I$$20231220$20240927$20240927$PER$$US-VIVUS LLC-2023V1001348$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243736601$24373660$1$I$$20231220$20240927$20240927$PER$$US-VIVUS LLC-2023V1001349$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736611$24373661$1$I$$20231222$20240927$20240927$PER$$US-VIVUS LLC-2023V1001355$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736621$24373662$1$I$$20231222$20240927$20240927$PER$$US-VIVUS LLC-2023V1001356$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736631$24373663$1$I$$20231222$20240927$20240927$PER$$US-VIVUS LLC-2023V1001357$VIVUS$$64$YR$A$F$Y$$$20240912$$CN$US$US
243736641$24373664$1$I$$20231226$20240927$20240927$PER$$US-VIVUS LLC-2023V1001360$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736651$24373665$1$I$$20231227$20240927$20240927$PER$$US-VIVUS LLC-2023V1001363$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736661$24373666$1$I$$20231227$20240927$20240927$PER$$US-VIVUS LLC-2023V1001364$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736671$24373667$1$I$$20231226$20240927$20240927$PER$$US-VIVUS LLC-2023V1001365$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736681$24373668$1$I$$20231229$20240927$20240927$PER$$US-VIVUS LLC-2024V1000003$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243736691$24373669$1$I$$20240102$20240927$20240927$PER$$US-VIVUS LLC-2024V1000005$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736701$24373670$1$I$$20240102$20240927$20240927$PER$$US-VIVUS LLC-2024V1000006$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736711$24373671$1$I$$20240103$20240927$20240927$PER$$US-VIVUS LLC-2024V1000007$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736721$24373672$1$I$$20240103$20240927$20240927$PER$$US-VIVUS LLC-2024V1000008$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736731$24373673$1$I$$20240103$20240927$20240927$PER$$US-VIVUS LLC-2024V1000010$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736741$24373674$1$I$$20240103$20240927$20240927$PER$$US-VIVUS LLC-2024V1000011$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243736751$24373675$1$I$$20240104$20240927$20240927$PER$$US-VIVUS LLC-2024V1000012$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736761$24373676$1$I$$20240107$20240927$20240927$PER$$US-VIVUS LLC-2024V1000014$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243736771$24373677$1$I$$20240107$20240927$20240927$PER$$US-VIVUS LLC-2024V1000015$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736781$24373678$1$I$$20240107$20240927$20240927$PER$$US-VIVUS LLC-2024V1000016$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736791$24373679$1$I$$20231013$20240927$20240927$PER$$US-VIVUS LLC-2023V1001144$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736801$24373680$1$I$$20231013$20240927$20240927$PER$$US-VIVUS LLC-2023V1001145$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736811$24373681$1$I$$20231016$20240927$20240927$PER$$US-VIVUS LLC-2023V1001146$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736821$24373682$1$I$$20231016$20240927$20240927$PER$$US-VIVUS LLC-2023V1001147$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243736831$24373683$1$I$$20231016$20240927$20240927$PER$$US-VIVUS LLC-2023V1001150$VIVUS$$$$A$F$Y$$$20240912$$HP$US$US
243736841$24373684$1$I$20230101$20231017$20240927$20240927$PER$$US-VIVUS LLC-2023V1001152$VIVUS$$57$YR$A$F$Y$81.266$KG$20240912$$CN$US$US
243736851$24373685$1$I$$20231017$20240927$20240927$PER$$US-VIVUS LLC-2023V1001153$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736861$24373686$1$I$$20231016$20240927$20240927$PER$$US-VIVUS LLC-2023V1001155$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736871$24373687$1$I$$20231017$20240927$20240927$PER$$US-VIVUS LLC-2023V1001156$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736881$24373688$1$I$$20231018$20240927$20240927$PER$$US-VIVUS LLC-2023V1001160$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736891$24373689$1$I$$20231018$20240927$20240927$PER$$US-VIVUS LLC-2023V1001162$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736901$24373690$1$I$$20231018$20240927$20240927$PER$$US-VIVUS LLC-2023V1001163$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736911$24373691$1$I$$20231019$20240927$20240927$PER$$US-VIVUS LLC-2023V1001164$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736921$24373692$1$I$$20231019$20240927$20240927$PER$$US-VIVUS LLC-2023V1001165$VIVUS$$76$YR$E$M$Y$$$20240912$$HP$US$US
243736931$24373693$1$I$$20231020$20240927$20240927$PER$$US-VIVUS LLC-2023V1001166$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243736941$24373694$1$I$$20231020$20240927$20240927$PER$$US-VIVUS LLC-2023V1001168$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736951$24373695$1$I$$20231020$20240927$20240927$PER$$US-VIVUS LLC-2023V1001170$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243736961$24373696$1$I$$20231023$20240927$20240927$PER$$US-VIVUS LLC-2023V1001171$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243736971$24373697$1$I$$20231023$20240927$20240927$PER$$US-VIVUS LLC-2023V1001172$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736981$24373698$1$I$$20231208$20240927$20240927$EXP$$US-VIVUS LLC-2023V1001317$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243736991$24373699$1$I$$20231208$20240927$20240927$PER$$US-VIVUS LLC-2023V1001318$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737001$24373700$1$I$$20231211$20240927$20240927$PER$$US-VIVUS LLC-2023V1001319$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737011$24373701$1$I$$20231211$20240927$20240927$PER$$US-VIVUS LLC-2023V1001320$VIVUS$$72$YR$E$F$Y$$$20240912$$CN$US$US
243737021$24373702$1$I$$20231211$20240927$20240927$PER$$US-VIVUS LLC-2023V1001321$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737031$24373703$1$I$$20231212$20240927$20240927$PER$$US-VIVUS LLC-2023V1001322$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737041$24373704$1$I$$20231214$20240927$20240927$PER$$US-VIVUS LLC-2023V1001328$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737051$24373705$1$I$$20231214$20240927$20240927$PER$$US-VIVUS LLC-2023V1001330$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737061$24373706$1$I$$20231214$20240927$20240927$PER$$US-VIVUS LLC-2023V1001331$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243737071$24373707$1$I$20230301$20231215$20240927$20240927$PER$$US-VIVUS LLC-2023V1001332$VIVUS$$37$YR$A$F$Y$70.37$KG$20240912$$CN$US$US
243737081$24373708$1$I$$20231215$20240927$20240927$PER$$US-VIVUS LLC-2023V1001333$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737091$24373709$1$I$20230828$20231215$20240927$20240927$PER$$US-VIVUS LLC-2023V1001334$VIVUS$$41$YR$A$F$Y$$$20240912$$CN$US$US
243737101$24373710$1$I$$20231215$20240927$20240927$PER$$US-VIVUS LLC-2023V1001335$VIVUS$$48$YR$A$F$Y$$$20240912$$CN$US$US
243737111$24373711$1$I$$20231218$20240927$20240927$PER$$US-VIVUS LLC-2023V1001336$VIVUS$$70$YR$E$F$Y$$$20240912$$CN$US$US
243737121$24373712$1$I$$20231218$20240927$20240927$PER$$US-VIVUS LLC-2023V1001337$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737131$24373713$1$I$$20231218$20240927$20240927$PER$$US-VIVUS LLC-2023V1001339$VIVUS$$75$YR$E$F$Y$$$20240912$$CN$US$US
243737141$24373714$1$I$$20231218$20240927$20240927$PER$$US-VIVUS LLC-2023V1001340$VIVUS$$47$YR$A$F$Y$$$20240912$$CN$US$US
243737151$24373715$1$I$$20231219$20240927$20240927$PER$$US-VIVUS LLC-2023V1001342$VIVUS$$68$YR$E$F$Y$$$20240912$$CN$US$US
243737161$24373716$1$I$$20231219$20240927$20240927$PER$$US-VIVUS LLC-2023V1001344$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243737171$24373717$1$I$$20231220$20240927$20240927$PER$$US-VIVUS LLC-2023V1001346$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737181$24373718$1$I$$20231116$20240927$20240927$PER$$US-VIVUS LLC-2023V1000822$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737191$24373719$1$I$$20231113$20240927$20240927$PER$$US-VIVUS LLC-2023V1001251$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737201$24373720$1$I$$20231113$20240927$20240927$PER$$US-VIVUS LLC-2023V1001252$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737211$24373721$1$I$$20231114$20240927$20240927$PER$$US-VIVUS LLC-2023V1001253$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737221$24373722$1$I$$20231114$20240927$20240927$PER$$US-VIVUS LLC-2023V1001254$VIVUS$$59$YR$A$F$Y$78.088$KG$20240912$$MD$US$US
243737231$24373723$1$I$$20231116$20240927$20240927$PER$$US-VIVUS LLC-2023V1001260$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737241$24373724$1$I$$20231116$20240927$20240927$PER$$US-VIVUS LLC-2023V1001261$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737251$24373725$1$I$$20231116$20240927$20240927$PER$$US-VIVUS LLC-2023V1001262$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737261$24373726$1$I$$20231116$20240927$20240927$PER$$US-VIVUS LLC-2023V1001263$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737271$24373727$1$I$$20231117$20240927$20240927$PER$$US-VIVUS LLC-2023V1001264$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243737281$24373728$1$I$$20231117$20240927$20240927$PER$$US-VIVUS LLC-2023V1001265$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737291$24373729$1$I$$20231120$20240927$20240927$PER$$US-VIVUS LLC-2023V1001266$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737301$24373730$1$I$$20231121$20240927$20240927$PER$$US-VIVUS LLC-2023V1001268$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737311$24373731$1$I$$20231122$20240927$20240927$PER$$US-VIVUS LLC-2023V1001273$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737321$24373732$1$I$$20231122$20240927$20240927$PER$$US-VIVUS LLC-2023V1001278$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737331$24373733$1$I$$20231126$20240927$20240927$PER$$US-VIVUS LLC-2023V1001279$VIVUS$$$$A$F$Y$95.34$KG$20240912$$CN$US$US
243737341$24373734$1$I$$20231127$20240927$20240927$EXP$$US-VIVUS LLC-2023V1001281$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737351$24373735$1$I$$20231127$20240927$20240927$PER$$US-VIVUS LLC-2023V1001282$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737361$24373736$1$I$$20231127$20240927$20240927$PER$$US-VIVUS LLC-2023V1001283$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737371$24373737$1$I$$20231121$20240927$20240927$PER$$US-VIVUS LLC-2023V1001284$VIVUS$Alqaisi S, Doerfler W, Latif T, Bandi A. GLP-1RA Therapy And Intussusception: A Case Report Of Bowel Telescoping In Anobese Patient After Successful Weight Loss On Therapy.. Journal of the Endocrine Society. 2023 OCT;7(SUPPLEMENT 1):A-67.$54$YR$A$F$Y$$$20240912$$HP$US$US
243737381$24373738$1$I$$20231127$20240927$20240927$EXP$$US-VIVUS LLC-2023V1001285$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737391$24373739$1$I$$20231127$20240927$20240927$PER$$US-VIVUS LLC-2023V1001286$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737401$24373740$1$I$$20231128$20240927$20240927$PER$$US-VIVUS LLC-2023V1001287$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243737411$24373741$1$I$$20231128$20240927$20240927$PER$$US-VIVUS LLC-2023V1001288$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737421$24373742$1$I$20231113$20231127$20240927$20240927$PER$$US-VIVUS LLC-2023V1001289$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243737431$24373743$1$I$$20231128$20240927$20240927$PER$$US-VIVUS LLC-2023V1001290$VIVUS$$$$A$F$Y$93.978$KG$20240912$$CN$US$US
243737441$24373744$1$I$$20231128$20240927$20240927$PER$$US-VIVUS LLC-2023V1001291$VIVUS$$$$A$F$Y$$$20240912$$HP$US$US
243737451$24373745$1$I$$20231129$20240927$20240927$PER$$US-VIVUS LLC-2023V1001292$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737461$24373746$1$I$$20231129$20240927$20240927$PER$$US-VIVUS LLC-2023V1001293$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737471$24373747$1$I$$20231130$20240927$20240927$PER$$US-VIVUS LLC-2023V1001296$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243737481$24373748$1$I$$20231129$20240927$20240927$PER$$US-VIVUS LLC-2023V1001297$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243737491$24373749$1$I$20231102$20231204$20240927$20240927$PER$$US-VIVUS LLC-2023V1001300$VIVUS$$64$YR$A$F$Y$$$20240912$$CN$US$US
243737501$24373750$1$I$$20231204$20240927$20240927$PER$$US-VIVUS LLC-2023V1001302$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737511$24373751$1$I$$20231204$20240927$20240927$PER$$US-VIVUS LLC-2023V1001303$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737521$24373752$1$I$$20231206$20240927$20240927$PER$$US-VIVUS LLC-2023V1001307$VIVUS$$$$$F$Y$$$20240912$$MD$US$US
243737531$24373753$1$I$20231127$20231206$20240927$20240927$PER$$US-VIVUS LLC-2023V1001308$VIVUS$$39$YR$A$F$Y$$$20240912$$CN$US$US
243737541$24373754$1$I$$20231208$20240927$20240927$PER$$US-VIVUS LLC-2023V1001314$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737551$24373755$1$I$$20231208$20240927$20240927$PER$$US-VIVUS LLC-2023V1001315$VIVUS$$$$A$F$Y$$$20240912$$PH$US$US
243737561$24373756$1$I$$20231208$20240927$20240927$PER$$US-VIVUS LLC-2023V1001316$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737571$24373757$1$I$$20230918$20240927$20240927$PER$$US-VIVUS LLC-2023V1001024$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737581$24373758$1$I$$20231009$20240927$20240927$PER$$US-VIVUS LLC-2023V1001120$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737591$24373759$1$I$$20231010$20240927$20240927$PER$$US-VIVUS LLC-2023V1001122$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737601$24373760$1$I$$20231010$20240927$20240927$PER$$US-VIVUS LLC-2023V1001123$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737611$24373761$1$I$$20231010$20240927$20240927$PER$$US-VIVUS LLC-2023V1001124$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737621$24373762$1$I$$20231010$20240927$20240927$PER$$US-VIVUS LLC-2023V1001125$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737631$24373763$1$I$$20231010$20240927$20240927$PER$$US-VIVUS LLC-2023V1001127$VIVUS$$$$A$F$Y$77.18$KG$20240912$$CN$US$US
243737641$24373764$1$I$$20231010$20240927$20240927$PER$$US-VIVUS LLC-2023V1001128$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737651$24373765$1$I$$20231011$20240927$20240927$PER$$US-VIVUS LLC-2023V1001129$VIVUS$$$$A$F$Y$82.628$KG$20240912$$CN$US$US
243737661$24373766$1$I$$20231011$20240927$20240927$PER$$US-VIVUS LLC-2023V1001130$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243737671$24373767$1$I$$20231011$20240927$20240927$PER$$US-VIVUS LLC-2023V1001132$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737681$24373768$1$I$$20231011$20240927$20240927$PER$$US-VIVUS LLC-2023V1001133$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737691$24373769$1$I$$20231012$20240927$20240927$PER$$US-VIVUS LLC-2023V1001135$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737701$24373770$1$I$$20231012$20240927$20240927$PER$$US-VIVUS LLC-2023V1001136$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737711$24373771$1$I$20230101$20231012$20240927$20240927$PER$$US-VIVUS LLC-2023V1001138$VIVUS$$$$$F$Y$$$20240912$$HP$US$US
243737721$24373772$1$I$$20231013$20240927$20240927$PER$$US-VIVUS LLC-2023V1001139$VIVUS$$$$$F$Y$119.4$KG$20240912$$CN$US$US
243737731$24373773$1$I$$20231012$20240927$20240927$PER$$US-VIVUS LLC-2023V1001140$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737741$24373774$1$I$$20231012$20240927$20240927$PER$$US-VIVUS LLC-2023V1001141$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243737751$24373775$1$I$$20231012$20240927$20240927$PER$$US-VIVUS LLC-2023V1001142$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243737761$24373776$1$I$$20231013$20240927$20240927$PER$$US-VIVUS LLC-2023V1001143$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243737771$24373777$1$I$$20240918$20240927$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA081216$SANDOZ$$50$YR$$F$Y$$$20240927$$HP$CA$CA
243737781$24373778$1$I$$20240919$20240927$20240927$EXP$$US-JNJFOC-20240960078$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$CN$US$US
243737791$24373779$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66372$$FDA-CTU$$$$$$N$$$20240926$$CN$US$
243737801$24373780$1$I$$20240820$20240927$20240927$EXP$$GB-JNJFOC-20240966747$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$HP$GB$GB
243737811$24373781$1$I$20240826$20240926$20240926$20240926$DIR$720199$$FDA-CTU$$71$YR$$F$N$$$20240926$Y$PH$US$
243737841$24373784$1$I$20240516$20240926$20240926$20240926$DIR$720114$$FDA-CTU$$41$YR$$F$N$60.75$KG$20240926$N$CN$US$
243737861$24373786$1$I$$20240924$20240927$20240927$EXP$$US-AMGEN-USASP2024190580$AMGEN$$$$$$Y$$$20240927$$MD$US$US
243737871$24373787$1$I$$20240920$20240927$20240927$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006765$AURINIA PHARMACEUTICALS$$$$$F$Y$$$20240927$$MD$US$US
243737881$24373788$1$I$$20240112$20240927$20240927$PER$$US-VIVUS LLC-2024V1000047$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243737891$24373789$1$I$$20240115$20240927$20240927$PER$$US-VIVUS LLC-2024V1000048$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243737901$24373790$1$I$$20240116$20240927$20240927$PER$$US-VIVUS LLC-2024V1000050$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243737911$24373791$1$I$$20240116$20240927$20240927$PER$$US-VIVUS LLC-2024V1000051$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243737921$24373792$1$I$$20240116$20240927$20240927$PER$$US-VIVUS LLC-2024V1000053$VIVUS$$$$$M$Y$$$20240913$$CN$US$US
243737931$24373793$1$I$$20240116$20240927$20240927$PER$$US-VIVUS LLC-2024V1000054$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243737941$24373794$1$I$$20240118$20240927$20240927$PER$$US-VIVUS LLC-2024V1000058$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243737951$24373795$1$I$$20240118$20240927$20240927$PER$$US-VIVUS LLC-2024V1000059$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243737961$24373796$1$I$$20240118$20240927$20240927$PER$$US-VIVUS LLC-2024V1000060$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243737971$24373797$1$I$$20240119$20240927$20240927$PER$$US-VIVUS LLC-2024V1000062$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243737981$24373798$1$I$$20240119$20240927$20240927$PER$$US-VIVUS LLC-2024V1000063$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243737991$24373799$1$I$$20240122$20240927$20240927$PER$$US-VIVUS LLC-2024V1000064$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738001$24373800$1$I$$20240122$20240927$20240927$PER$$US-VIVUS LLC-2024V1000065$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738011$24373801$1$I$$20240122$20240927$20240927$PER$$US-VIVUS LLC-2024V1000066$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738021$24373802$1$I$$20240123$20240927$20240927$PER$$US-VIVUS LLC-2024V1000072$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738031$24373803$1$I$$20240123$20240927$20240927$PER$$US-VIVUS LLC-2024V1000073$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738041$24373804$1$I$$20240124$20240927$20240927$PER$$US-VIVUS LLC-2024V1000074$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738051$24373805$1$I$$20240124$20240927$20240927$PER$$US-VIVUS LLC-2024V1000077$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738061$24373806$1$I$$20240124$20240927$20240927$PER$$US-VIVUS LLC-2024V1000078$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738071$24373807$1$I$$20240125$20240927$20240927$PER$$US-VIVUS LLC-2024V1000081$VIVUS$$$$A$F$Y$75.818$KG$20240913$$CN$US$US
243738081$24373808$1$I$20240925$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66355$$FDA-CTU$$$$$$N$$$20240926$Y$HP$US$
243738091$24373809$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66816$$FDA-CTU$$62$YR$$M$N$131.54$KG$20240927$N$$US$
243738101$24373810$1$I$$20240108$20240927$20240927$PER$$US-VIVUS LLC-2024V1000017$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243738111$24373811$1$I$$20240108$20240927$20240927$PER$$US-VIVUS LLC-2024V1000020$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243738121$24373812$1$I$$20240109$20240927$20240927$PER$$US-VIVUS LLC-2024V1000023$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243738131$24373813$1$I$$20240109$20240927$20240927$PER$$US-VIVUS LLC-2024V1000024$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243738141$24373814$1$I$$20240109$20240927$20240927$PER$$US-VIVUS LLC-2024V1000029$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243738151$24373815$1$I$$20240110$20240927$20240927$PER$$US-VIVUS LLC-2024V1000031$VIVUS$$32$YR$A$F$Y$$$20240912$$CN$US$US
243738161$24373816$1$I$20240101$20240111$20240927$20240927$PER$$US-VIVUS LLC-2024V1000040$VIVUS$$66$YR$E$F$Y$$$20240912$$CN$US$US
243738171$24373817$1$I$$20240109$20240927$20240927$PER$$US-VIVUS LLC-2024V1000026$VIVUS$$$$E$M$Y$$$20240912$$CN$US$US
243738181$24373818$1$I$$20240109$20240927$20240927$PER$$US-VIVUS LLC-2024V1000027$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243738191$24373819$1$I$$20240109$20240927$20240927$PER$$US-VIVUS LLC-2024V1000028$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243738201$24373820$1$I$$20240110$20240927$20240927$PER$$US-VIVUS LLC-2024V1000030$VIVUS$$$$$F$Y$$$20240912$$PH$US$US
243738211$24373821$1$I$$20240110$20240927$20240927$PER$$US-VIVUS LLC-2024V1000032$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243738221$24373822$1$I$$20240110$20240927$20240927$PER$$US-VIVUS LLC-2024V1000033$VIVUS$$$$$F$Y$$$20240912$$CN$US$US
243738231$24373823$1$I$$20240110$20240927$20240927$PER$$US-VIVUS LLC-2024V1000034$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243738241$24373824$1$I$$20240110$20240927$20240927$PER$$US-VIVUS LLC-2024V1000035$VIVUS$$74$YR$E$F$Y$$$20240912$$CN$US$US
243738251$24373825$1$I$$20240111$20240927$20240927$PER$$US-VIVUS LLC-2024V1000041$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243738261$24373826$1$I$$20240111$20240927$20240927$PER$$US-VIVUS LLC-2024V1000042$VIVUS$$$$E$F$Y$$$20240912$$CN$US$US
243738271$24373827$1$I$$20240111$20240927$20240927$PER$$US-VIVUS LLC-2024V1000043$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243738281$24373828$1$I$$20240111$20240927$20240927$PER$$US-VIVUS LLC-2024V1000044$VIVUS$$$$A$F$Y$$$20240912$$CN$US$US
243738291$24373829$1$I$$20240112$20240927$20240927$PER$$US-VIVUS LLC-2024V1000045$VIVUS$$$$A$M$Y$$$20240912$$CN$US$US
243738301$24373830$1$I$$20240206$20240927$20240927$PER$$US-VIVUS LLC-2024V1000121$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738311$24373831$1$I$$20240206$20240927$20240927$PER$$US-VIVUS LLC-2024V1000123$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738321$24373832$1$I$$20240206$20240927$20240927$PER$$US-VIVUS LLC-2024V1000124$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738331$24373833$1$I$$20240206$20240927$20240927$PER$$US-VIVUS LLC-2024V1000125$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738341$24373834$1$I$$20240206$20240927$20240927$EXP$$US-VIVUS LLC-2024V1000126$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243738351$24373835$1$I$$20240207$20240927$20240927$PER$$US-VIVUS LLC-2024V1000128$VIVUS$$62$YR$A$F$Y$115.68$KG$20240913$$CN$US$US
243738361$24373836$1$I$$20240207$20240927$20240927$PER$$US-VIVUS LLC-2024V1000130$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738371$24373837$1$I$$20240207$20240927$20240927$PER$$US-VIVUS LLC-2024V1000131$VIVUS$$$$E$F$Y$$$20240913$$HP$US$US
243738381$24373838$1$I$$20240207$20240927$20240927$PER$$US-VIVUS LLC-2024V1000133$VIVUS$$$$A$$Y$$$20240913$$CN$US$US
243738391$24373839$1$I$$20240207$20240927$20240927$PER$$US-VIVUS LLC-2024V1000134$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738401$24373840$1$I$$20240207$20240927$20240927$PER$$US-VIVUS LLC-2024V1000135$VIVUS$$$$A$F$Y$80.358$KG$20240913$$CN$US$US
243738411$24373841$1$I$$20240208$20240927$20240927$PER$$US-VIVUS LLC-2024V1000137$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738421$24373842$1$I$$20240208$20240927$20240927$PER$$US-VIVUS LLC-2024V1000138$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738431$24373843$1$I$$20240208$20240927$20240927$PER$$US-VIVUS LLC-2024V1000139$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738441$24373844$1$I$$20240208$20240927$20240927$PER$$US-VIVUS LLC-2024V1000140$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738451$24373845$1$I$$20240209$20240927$20240927$PER$$US-VIVUS LLC-2024V1000141$VIVUS$$$$$$Y$$$20240913$$HP$US$US
243738461$24373846$1$I$$20240209$20240927$20240927$PER$$US-VIVUS LLC-2024V1000143$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738471$24373847$1$I$$20240209$20240927$20240927$PER$$US-VIVUS LLC-2024V1000144$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738481$24373848$1$I$$20240209$20240927$20240927$PER$$US-VIVUS LLC-2024V1000145$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738491$24373849$1$I$$20240212$20240927$20240927$PER$$US-VIVUS LLC-2024V1000146$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738501$24373850$1$I$$20240223$20240927$20240927$PER$$US-VIVUS LLC-2024V1000203$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738511$24373851$1$I$$20240223$20240927$20240927$PER$$US-VIVUS LLC-2024V1000205$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738521$24373852$1$I$$20240223$20240927$20240927$PER$$US-VIVUS LLC-2024V1000206$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738531$24373853$1$I$$20240223$20240927$20240927$PER$$US-VIVUS LLC-2024V1000207$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738541$24373854$1$I$$20240223$20240927$20240927$PER$$US-VIVUS LLC-2024V1000209$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738551$24373855$1$I$$20240223$20240927$20240927$PER$$US-VIVUS LLC-2024V1000210$VIVUS$$$$E$M$Y$$$20240913$$CN$US$US
243738561$24373856$1$I$$20240226$20240927$20240927$PER$$US-VIVUS LLC-2024V1000211$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738571$24373857$1$I$$20240226$20240927$20240927$PER$$US-VIVUS LLC-2024V1000212$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738581$24373858$1$I$$20240226$20240927$20240927$PER$$US-VIVUS LLC-2024V1000213$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738591$24373859$1$I$$20240226$20240927$20240927$PER$$US-VIVUS LLC-2024V1000214$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738601$24373860$1$I$$20240226$20240927$20240927$PER$$US-VIVUS LLC-2024V1000216$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738611$24373861$1$I$$20240226$20240927$20240927$PER$$US-VIVUS LLC-2024V1000218$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738621$24373862$1$I$$20240226$20240927$20240927$PER$$US-VIVUS LLC-2024V1000219$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738631$24373863$1$I$$20240227$20240927$20240927$PER$$US-VIVUS LLC-2024V1000222$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243738641$24373864$1$I$$20240227$20240927$20240927$PER$$US-VIVUS LLC-2024V1000223$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738651$24373865$1$I$$20240227$20240927$20240927$PER$$US-VIVUS LLC-2024V1000226$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738661$24373866$1$I$$20240228$20240927$20240927$PER$$US-VIVUS LLC-2024V1000229$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738671$24373867$1$I$$20240228$20240927$20240927$PER$$US-VIVUS LLC-2024V1000230$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738681$24373868$1$I$$20240229$20240927$20240927$PER$$US-VIVUS LLC-2024V1000233$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243738691$24373869$1$I$$20240228$20240927$20240927$PER$$US-VIVUS LLC-2024V1000235$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738701$24373870$1$I$20240926$20240927$20240927$20240927$DIR$720301$$FDA-CTU$$63$YR$$M$N$$$20240927$N$CN$US$
243738901$24373890$1$I$$20240308$20240927$20240927$PER$$US-VIVUS LLC-2024V1000272$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738911$24373891$1$I$$20240308$20240927$20240927$PER$$US-VIVUS LLC-2024V1000274$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738921$24373892$1$I$$20240308$20240927$20240927$PER$$US-VIVUS LLC-2024V1000275$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243738931$24373893$1$I$$20240308$20240927$20240927$PER$$US-VIVUS LLC-2024V1000277$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738941$24373894$1$I$$20240308$20240927$20240927$PER$$US-VIVUS LLC-2024V1000278$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738951$24373895$1$I$$20240308$20240927$20240927$PER$$US-VIVUS LLC-2024V1000279$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738961$24373896$1$I$$20240311$20240927$20240927$PER$$US-VIVUS LLC-2024V1000280$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243738971$24373897$1$I$$20240311$20240927$20240927$PER$$US-VIVUS LLC-2024V1000281$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738981$24373898$1$I$$20240311$20240927$20240927$PER$$US-VIVUS LLC-2024V1000282$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243738991$24373899$1$I$$20240312$20240927$20240927$PER$$US-VIVUS LLC-2024V1000283$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739001$24373900$1$I$$20240312$20240927$20240927$PER$$US-VIVUS LLC-2024V1000284$VIVUS$$$$A$F$Y$76.045$KG$20240913$$CN$US$US
243739011$24373901$1$I$$20240312$20240927$20240927$PER$$US-VIVUS LLC-2024V1000285$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739041$24373904$1$I$$20240312$20240927$20240927$PER$$US-VIVUS LLC-2024V1000286$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739051$24373905$1$I$$20240312$20240927$20240927$PER$$US-VIVUS LLC-2024V1000287$VIVUS$$$$A$F$Y$76.272$KG$20240913$$CN$US$US
243739061$24373906$1$I$$20240312$20240927$20240927$PER$$US-VIVUS LLC-2024V1000288$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739071$24373907$1$I$$20240313$20240927$20240927$PER$$US-VIVUS LLC-2024V1000290$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739081$24373908$1$I$$20240313$20240927$20240927$PER$$US-VIVUS LLC-2024V1000291$VIVUS$$$$$M$Y$$$20240913$$CN$US$US
243739091$24373909$1$I$$20240313$20240927$20240927$PER$$US-VIVUS LLC-2024V1000293$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243739101$24373910$1$I$$20240314$20240927$20240927$PER$$US-VIVUS LLC-2024V1000295$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739111$24373911$1$I$$20240314$20240927$20240927$PER$$US-VIVUS LLC-2024V1000296$VIVUS$$$$A$$Y$$$20240913$$CN$US$US
243739121$24373912$1$I$$20240219$20240927$20240927$PER$$US-VIVUS LLC-2024V1000176$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739131$24373913$1$I$$20240219$20240927$20240927$PER$$US-VIVUS LLC-2024V1000177$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739141$24373914$1$I$$20240219$20240927$20240927$PER$$US-VIVUS LLC-2024V1000178$VIVUS$$$$E$M$Y$$$20240913$$CN$US$US
243739151$24373915$1$I$$20240219$20240927$20240927$PER$$US-VIVUS LLC-2024V1000179$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243739161$24373916$1$I$$20240523$20240927$20240927$EXP$$US-VIVUS LLC-2024V1000180$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739171$24373917$1$I$$20240220$20240927$20240927$PER$$US-VIVUS LLC-2024V1000181$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739181$24373918$1$I$$20240220$20240927$20240927$PER$$US-VIVUS LLC-2024V1000182$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739191$24373919$1$I$$20240220$20240927$20240927$PER$$US-VIVUS LLC-2024V1000184$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243739201$24373920$1$I$$20240220$20240927$20240927$PER$$US-VIVUS LLC-2024V1000185$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739211$24373921$1$I$$20240220$20240927$20240927$PER$$US-VIVUS LLC-2024V1000186$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739221$24373922$1$I$$20240220$20240927$20240927$PER$$US-VIVUS LLC-2024V1000187$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739231$24373923$1$I$$20240221$20240927$20240927$PER$$US-VIVUS LLC-2024V1000188$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243739241$24373924$1$I$$20240221$20240927$20240927$PER$$US-VIVUS LLC-2024V1000189$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739251$24373925$1$I$20240222$20240222$20240927$20240927$PER$$US-VIVUS LLC-2024V1000192$VIVUS$$65$YR$E$F$Y$$$20240913$$CN$US$US
243739261$24373926$1$I$$20240222$20240927$20240927$PER$$US-VIVUS LLC-2024V1000193$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739271$24373927$1$I$$20240222$20240927$20240927$PER$$US-VIVUS LLC-2024V1000194$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243739281$24373928$1$I$$20240222$20240927$20240927$PER$$US-VIVUS LLC-2024V1000197$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739291$24373929$1$I$$20240222$20240927$20240927$PER$$US-VIVUS LLC-2024V1000198$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739301$24373930$1$I$$20240222$20240927$20240927$PER$$US-VIVUS LLC-2024V1000201$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739311$24373931$1$I$$20240222$20240927$20240927$PER$$US-VIVUS LLC-2024V1000202$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739321$24373932$1$I$20240228$20240229$20240927$20240927$PER$$US-VIVUS LLC-2024V1000236$VIVUS$$49$YR$A$F$Y$$$20240913$$CN$US$GB
243739331$24373933$1$I$$20240228$20240927$20240927$PER$$US-VIVUS LLC-2024V1000239$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739341$24373934$1$I$$20240301$20240927$20240927$PER$$US-VIVUS LLC-2024V1000243$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739351$24373935$1$I$$20240304$20240927$20240927$PER$$US-VIVUS LLC-2024V1000246$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243739361$24373936$1$I$$20240304$20240927$20240927$PER$$US-VIVUS LLC-2024V1000247$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243739371$24373937$1$I$$20240304$20240927$20240927$PER$$US-VIVUS LLC-2024V1000248$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243739381$24373938$1$I$$20240304$20240927$20240927$PER$$US-VIVUS LLC-2024V1000251$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739391$24373939$1$I$$20240304$20240927$20240927$PER$$US-VIVUS LLC-2024V1000252$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739401$24373940$1$I$$20240305$20240927$20240927$PER$$US-VIVUS LLC-2024V1000253$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739411$24373941$1$I$$20240305$20240927$20240927$PER$$US-VIVUS LLC-2024V1000256$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739421$24373942$1$I$$20240305$20240927$20240927$PER$$US-VIVUS LLC-2024V1000258$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739431$24373943$1$I$$20240305$20240927$20240927$PER$$US-VIVUS LLC-2024V1000260$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243739441$24373944$1$I$$20240306$20240927$20240927$PER$$US-VIVUS LLC-2024V1000262$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739451$24373945$1$I$$20240307$20240927$20240927$PER$$US-VIVUS LLC-2024V1000263$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739461$24373946$1$I$20240201$20240307$20240927$20240927$PER$$US-VIVUS LLC-2024V1000264$VIVUS$$30$YR$A$F$Y$$$20240913$$CN$US$US
243739471$24373947$1$I$$20240307$20240927$20240927$PER$$US-VIVUS LLC-2024V1000265$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739481$24373948$1$I$$20240307$20240927$20240927$PER$$US-VIVUS LLC-2024V1000266$VIVUS$$$$$F$Y$$$20240913$$MD$US$US
243739491$24373949$1$I$$20240307$20240927$20240927$PER$$US-VIVUS LLC-2024V1000267$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739501$24373950$1$I$$20240307$20240927$20240927$PER$$US-VIVUS LLC-2024V1000268$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739511$24373951$1$I$$20240308$20240927$20240927$PER$$US-VIVUS LLC-2024V1000270$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739521$24373952$1$I$$20240325$20240927$20240927$PER$$US-VIVUS LLC-2024V1000019$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739531$24373953$1$I$$20240314$20240927$20240927$PER$$US-VIVUS LLC-2024V1000297$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243739541$24373954$1$I$$20240314$20240927$20240927$PER$$US-VIVUS LLC-2024V1000298$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739551$24373955$1$I$$20240318$20240927$20240927$PER$$US-VIVUS LLC-2024V1000302$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739561$24373956$1$I$$20240318$20240927$20240927$PER$$US-VIVUS LLC-2024V1000303$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243739571$24373957$1$I$$20240318$20240927$20240927$PER$$US-VIVUS LLC-2024V1000304$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739581$24373958$1$I$$20240320$20240927$20240927$PER$$US-VIVUS LLC-2024V1000316$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739591$24373959$1$I$$20240320$20240927$20240927$PER$$US-VIVUS LLC-2024V1000317$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739601$24373960$1$I$$20240320$20240927$20240927$PER$$US-VIVUS LLC-2024V1000319$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739611$24373961$1$I$$20240320$20240927$20240927$PER$$US-VIVUS LLC-2024V1000320$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739621$24373962$1$I$$20240321$20240927$20240927$PER$$US-VIVUS LLC-2024V1000321$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739631$24373963$1$I$$20240321$20240927$20240927$PER$$US-VIVUS LLC-2024V1000324$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739641$24373964$1$I$$20240321$20240927$20240927$PER$$US-VIVUS LLC-2024V1000325$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739651$24373965$1$I$$20240321$20240927$20240927$PER$$US-VIVUS LLC-2024V1000326$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739661$24373966$1$I$$20240322$20240927$20240927$PER$$US-VIVUS LLC-2024V1000330$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243739671$24373967$1$I$$20240325$20240927$20240927$PER$$US-VIVUS LLC-2024V1000332$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739681$24373968$1$I$$20240321$20240927$20240927$PER$$US-VIVUS LLC-2024V1000333$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739691$24373969$1$I$$20240326$20240927$20240927$PER$$US-VIVUS LLC-2024V1000334$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739701$24373970$1$I$$20240325$20240927$20240927$PER$$US-VIVUS LLC-2024V1000335$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739711$24373971$1$I$$20240126$20240927$20240927$PER$$US-VIVUS LLC-2024V1000082$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739721$24373972$1$I$$20240126$20240927$20240927$PER$$US-VIVUS LLC-2024V1000086$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243739731$24373973$1$I$$20240129$20240927$20240927$PER$$US-VIVUS LLC-2024V1000088$VIVUS$$69$YR$E$F$Y$66.284$KG$20240913$$CN$US$US
243739741$24373974$1$I$$20240129$20240927$20240927$PER$$US-VIVUS LLC-2024V1000091$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739751$24373975$1$I$$20240130$20240927$20240927$PER$$US-VIVUS LLC-2024V1000094$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739761$24373976$1$I$20240129$20240130$20240927$20240927$PER$$US-VIVUS LLC-2024V1000095$VIVUS$$24$YR$A$F$Y$88.53$KG$20240913$$CN$US$US
243739771$24373977$1$I$$20240130$20240927$20240927$PER$$US-VIVUS LLC-2024V1000096$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739781$24373978$1$I$$20240130$20240927$20240927$PER$$US-VIVUS LLC-2024V1000097$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739791$24373979$1$I$$20240130$20240927$20240927$PER$$US-VIVUS LLC-2024V1000098$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739801$24373980$1$I$$20240130$20240927$20240927$PER$$US-VIVUS LLC-2024V1000101$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739811$24373981$1$I$$20240201$20240927$20240927$PER$$US-VIVUS LLC-2024V1000107$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739821$24373982$1$I$$20240201$20240927$20240927$PER$$US-VIVUS LLC-2024V1000108$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739831$24373983$1$I$20240127$20240201$20240927$20240927$PER$$US-VIVUS LLC-2024V1000109$VIVUS$$55$YR$A$F$Y$$$20240913$$CN$US$US
243739841$24373984$1$I$$20240201$20240927$20240927$PER$$US-VIVUS LLC-2024V1000111$VIVUS$$$$A$F$Y$$$20240913$$HP$US$US
243739851$24373985$1$I$$20240202$20240927$20240927$PER$$US-VIVUS LLC-2024V1000114$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243739861$24373986$1$I$$20240205$20240927$20240927$PER$$US-VIVUS LLC-2024V1000115$VIVUS$$$$A$F$Y$86.26$KG$20240913$$CN$US$US
243739871$24373987$1$I$$20240205$20240927$20240927$PER$$US-VIVUS LLC-2024V1000117$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243739881$24373988$1$I$$20240205$20240927$20240927$PER$$US-VIVUS LLC-2024V1000118$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243739891$24373989$1$I$$20240205$20240927$20240927$PER$$US-VIVUS LLC-2024V1000120$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243739901$24373990$1$I$$20240920$20240927$20240927$EXP$GB-MHRA-MED-202409201622238240-PZHSN$GB-TEVA-VS-3246806$TEVA$$$$$F$Y$$$20240927$$PH$GB$GB
243739911$24373991$1$I$20240901$20240923$20240927$20240927$PER$$US-ABBVIE-5936851$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243739921$24373992$1$I$$20240515$20240927$20240927$PER$$US-VIVUS LLC-2024V1000584$VIVUS$$$$$F$Y$$$20240927$$CN$US$US
243739931$24373993$1$I$$20240520$20240927$20240927$PER$$US-VIVUS LLC-2024V1000617$VIVUS$$$$E$F$Y$$$20240927$$CN$US$US
243739941$24373994$1$I$$20240521$20240927$20240927$PER$$US-VIVUS LLC-2024V1000619$VIVUS$$$$A$M$Y$$$20240927$$CN$US$US
243739951$24373995$1$I$$20240521$20240927$20240927$PER$$US-VIVUS LLC-2024V1000621$VIVUS$$54$YR$A$F$Y$61.29$KG$20240927$$CN$US$US
243739961$24373996$1$I$$20240522$20240927$20240927$PER$$US-VIVUS LLC-2024V1000623$VIVUS$$$$A$F$Y$$$20240927$$CN$US$US
243739971$24373997$1$I$$20240522$20240927$20240927$PER$$US-VIVUS LLC-2024V1000624$VIVUS$$$$A$F$Y$$$20240927$$CN$US$US
243739981$24373998$1$I$$20240522$20240927$20240927$PER$$US-VIVUS LLC-2024V1000625$VIVUS$$$$A$F$Y$$$20240927$$CN$US$US
243739991$24373999$1$I$$20240523$20240927$20240927$PER$$US-VIVUS LLC-2024V1000627$VIVUS$$$$A$F$Y$$$20240927$$CN$US$US
243740001$24374000$1$I$$20240522$20240927$20240927$PER$$US-VIVUS LLC-2024V1000629$VIVUS$$$$E$F$Y$$$20240927$$CN$US$US
243740011$24374001$1$I$$20240523$20240927$20240927$PER$$US-VIVUS LLC-2024V1000630$VIVUS$$$$A$M$Y$$$20240927$$CN$US$US
243740021$24374002$1$I$$20240524$20240927$20240927$PER$$US-VIVUS LLC-2024V1000631$VIVUS$$$$A$F$Y$$$20240927$$CN$US$US
243740031$24374003$1$I$$20240524$20240927$20240927$PER$$US-VIVUS LLC-2024V1000632$VIVUS$$$$A$F$Y$$$20240927$$CN$US$US
243740041$24374004$1$I$$20240524$20240927$20240927$PER$$US-VIVUS LLC-2024V1000633$VIVUS$$$$E$F$Y$$$20240927$$CN$US$US
243740051$24374005$1$I$$20240524$20240927$20240927$PER$$US-VIVUS LLC-2024V1000634$VIVUS$$$$A$F$Y$$$20240927$$CN$US$US
243740061$24374006$1$I$$20240524$20240927$20240927$PER$$US-VIVUS LLC-2024V1000636$VIVUS$$$$A$F$Y$$$20240927$$CN$US$US
243740071$24374007$1$I$$20240524$20240927$20240927$PER$$US-VIVUS LLC-2024V1000635$VIVUS$$$$E$F$Y$$$20240927$$CN$US$US
243740081$24374008$1$I$$20240524$20240927$20240927$PER$$US-VIVUS LLC-2024V1000638$VIVUS$$63$YR$A$F$Y$63.106$KG$20240927$$CN$US$US
243740091$24374009$1$I$$20240524$20240927$20240927$PER$$US-VIVUS LLC-2024V1000639$VIVUS$$$$A$F$Y$$$20240927$$CN$US$US
243740101$24374010$1$I$$20240415$20240927$20240927$PER$$US-VIVUS LLC-2024V1000423$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740111$24374011$1$I$$20240415$20240927$20240927$PER$$US-VIVUS LLC-2024V1000424$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740121$24374012$1$I$$20240416$20240927$20240927$PER$$US-VIVUS LLC-2024V1000425$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740131$24374013$1$I$$20240417$20240927$20240927$PER$$US-VIVUS LLC-2024V1000429$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243740141$24374014$1$I$$20240417$20240927$20240927$PER$$US-VIVUS LLC-2024V1000430$VIVUS$$35$YR$A$F$Y$$$20240913$$MD$US$US
243740151$24374015$1$I$$20240417$20240927$20240927$PER$$US-VIVUS LLC-2024V1000433$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740161$24374016$1$I$$20240417$20240927$20240927$PER$$US-VIVUS LLC-2024V1000435$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740171$24374017$1$I$$20240418$20240927$20240927$PER$$US-VIVUS LLC-2024V1000436$VIVUS$$$$A$F$Y$75.364$KG$20240913$$CN$US$US
243740181$24374018$1$I$$20240418$20240927$20240927$PER$$US-VIVUS LLC-2024V1000437$VIVUS$$$$$F$Y$$$20240913$$MD$US$US
243740191$24374019$1$I$$20240418$20240927$20240927$PER$$US-VIVUS LLC-2024V1000438$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740201$24374020$1$I$$20240418$20240927$20240927$PER$$US-VIVUS LLC-2024V1000439$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740211$24374021$1$I$20200101$20240419$20240927$20240927$PER$$US-VIVUS LLC-2024V1000445$VIVUS$$71$YR$E$F$Y$75.818$KG$20240913$$CN$US$US
243740221$24374022$1$I$$20240419$20240927$20240927$PER$$US-VIVUS LLC-2024V1000446$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740231$24374023$1$I$$20240419$20240927$20240927$PER$$US-VIVUS LLC-2024V1000450$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740241$24374024$1$I$$20240422$20240927$20240927$PER$$US-VIVUS LLC-2024V1000453$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740251$24374025$1$I$$20240422$20240927$20240927$PER$$US-VIVUS LLC-2024V1000455$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740261$24374026$1$I$$20240422$20240927$20240927$PER$$US-VIVUS LLC-2024V1000456$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740271$24374027$1$I$$20240422$20240927$20240927$PER$$US-VIVUS LLC-2024V1000457$VIVUS$$$$A$F$Y$$$20240913$$HP$US$US
243740281$24374028$1$I$$20240422$20240927$20240927$PER$$US-VIVUS LLC-2024V1000458$VIVUS$$31$YR$A$F$Y$101.24$KG$20240913$$HP$US$US
243740291$24374029$1$I$$20240422$20240927$20240927$PER$$US-VIVUS LLC-2024V1000459$VIVUS$$$$A$F$Y$101.7$KG$20240913$$CN$US$US
243740301$24374030$1$I$$20240422$20240927$20240927$PER$$US-VIVUS LLC-2024V1000461$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740311$24374031$1$I$$20240422$20240927$20240927$PER$$US-VIVUS LLC-2024V1000462$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740321$24374032$1$I$$20240422$20240927$20240927$PER$$US-VIVUS LLC-2024V1000465$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740331$24374033$1$I$$20240423$20240927$20240927$PER$$US-VIVUS LLC-2024V1000468$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740341$24374034$1$I$$20240424$20240927$20240927$PER$$US-VIVUS LLC-2024V1000469$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243740351$24374035$1$I$$20240424$20240927$20240927$PER$$US-VIVUS LLC-2024V1000471$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740361$24374036$1$I$$20240424$20240927$20240927$PER$$US-VIVUS LLC-2024V1000473$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243740371$24374037$1$I$$20240425$20240927$20240927$PER$$US-VIVUS LLC-2024V1000474$VIVUS$$$$A$M$Y$$$20240913$$HP$US$US
243740381$24374038$1$I$$20240425$20240927$20240927$PER$$US-VIVUS LLC-2024V1000475$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740391$24374039$1$I$$20240423$20240927$20240927$PER$$US-VIVUS LLC-2024V1000464$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740401$24374040$1$I$20240420$20240424$20240927$20240927$PER$$US-VIVUS LLC-2024V1000470$VIVUS$$29$YR$A$F$Y$117.13$KG$20240913$$CN$US$US
243740411$24374041$1$I$$20240424$20240927$20240927$PER$$US-VIVUS LLC-2024V1000472$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243740421$24374042$1$I$$20240425$20240927$20240927$PER$$US-VIVUS LLC-2024V1000476$VIVUS$$63$YR$A$F$Y$93.07$KG$20240913$$CN$US$US
243740431$24374043$1$I$$20240425$20240927$20240927$PER$$US-VIVUS LLC-2024V1000477$VIVUS$$$$A$F$Y$$$20240913$$HP$US$US
243740441$24374044$1$I$20240424$20240425$20240927$20240927$PER$$US-VIVUS LLC-2024V1000478$VIVUS$$61$YR$A$F$Y$$$20240913$$CN$US$US
243740451$24374045$1$I$$20240425$20240927$20240927$PER$$US-VIVUS LLC-2024V1000479$VIVUS$$$$A$M$Y$121.67$KG$20240913$$CN$US$US
243740461$24374046$1$I$$20240425$20240927$20240927$PER$$US-VIVUS LLC-2024V1000480$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740471$24374047$1$I$$20240425$20240927$20240927$PER$$US-VIVUS LLC-2024V1000482$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740481$24374048$1$I$$20240425$20240927$20240927$PER$$US-VIVUS LLC-2024V1000483$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740491$24374049$1$I$$20240426$20240927$20240927$PER$$US-VIVUS LLC-2024V1000485$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740501$24374050$1$I$$20240502$20240927$20240927$PER$$US-VIVUS LLC-2024V1000250$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740511$24374051$1$I$$20240502$20240927$20240927$PER$$US-VIVUS LLC-2024V1000356$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740521$24374052$1$I$$20240423$20240927$20240927$PER$$US-VIVUS LLC-2024V1000460$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243740531$24374053$1$I$$20240427$20240927$20240927$PER$$US-VIVUS LLC-2024V1000488$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740541$24374054$1$I$$20240329$20240927$20240927$PER$$US-VIVUS LLC-2024V1000489$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740551$24374055$1$I$$20240429$20240927$20240927$PER$$US-VIVUS LLC-2024V1000492$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740561$24374056$1$I$$20240329$20240927$20240927$PER$$US-VIVUS LLC-2024V1000493$VIVUS$$$$A$M$Y$$$20240913$$HP$US$US
243740571$24374057$1$I$$20240429$20240927$20240927$PER$$US-VIVUS LLC-2024V1000495$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740581$24374058$1$I$$20240430$20240927$20240927$PER$$US-VIVUS LLC-2024V1000497$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740591$24374059$1$I$$20240430$20240927$20240927$EXP$$US-VIVUS LLC-2024V1000499$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740601$24374060$1$I$$20240501$20240927$20240927$PER$$US-VIVUS LLC-2024V1000500$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740611$24374061$1$I$$20240501$20240927$20240927$PER$$US-VIVUS LLC-2024V1000501$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243740621$24374062$1$I$$20240501$20240927$20240927$PER$$US-VIVUS LLC-2024V1000502$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740631$24374063$1$I$$20240501$20240927$20240927$PER$$US-VIVUS LLC-2024V1000505$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243740641$24374064$1$I$$20240501$20240927$20240927$EXP$$US-VIVUS LLC-2024V1000507$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740651$24374065$1$I$$20240501$20240927$20240927$PER$$US-VIVUS LLC-2024V1000508$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740661$24374066$1$I$$20240430$20240927$20240927$PER$$US-VIVUS LLC-2024V1000509$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740671$24374067$1$I$$20240501$20240927$20240927$PER$$US-VIVUS LLC-2024V1000511$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740681$24374068$1$I$$20240502$20240927$20240927$PER$$US-VIVUS LLC-2024V1000513$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740691$24374069$1$I$$20240502$20240927$20240927$EXP$$US-VIVUS LLC-2024V1000514$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740701$24374070$1$I$$20240403$20240927$20240927$PER$$US-VIVUS LLC-2024V1000373$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740711$24374071$1$I$$20240404$20240927$20240927$PER$$US-VIVUS LLC-2024V1000376$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243740721$24374072$1$I$$20240405$20240927$20240927$PER$$US-VIVUS LLC-2024V1000384$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740731$24374073$1$I$$20240408$20240927$20240927$PER$$US-VIVUS LLC-2024V1000388$VIVUS$$$$$M$Y$$$20240913$$CN$US$US
243740741$24374074$1$I$$20240408$20240927$20240927$PER$$US-VIVUS LLC-2024V1000389$VIVUS$$$$A$M$Y$125.3$KG$20240913$$CN$US$US
243740751$24374075$1$I$$20240409$20240927$20240927$PER$$US-VIVUS LLC-2024V1000393$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740761$24374076$1$I$$20240409$20240927$20240927$PER$$US-VIVUS LLC-2024V1000395$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740771$24374077$1$I$$20240411$20240927$20240927$PER$$US-VIVUS LLC-2024V1000397$VIVUS$$$$A$F$Y$72.64$KG$20240913$$CN$US$US
243740781$24374078$1$I$$20240411$20240927$20240927$PER$$US-VIVUS LLC-2024V1000399$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740791$24374079$1$I$$20240412$20240927$20240927$PER$$US-VIVUS LLC-2024V1000403$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740801$24374080$1$I$$20240412$20240927$20240927$PER$$US-VIVUS LLC-2024V1000405$VIVUS$$$$A$M$Y$$$20240913$$CN$US$US
243740811$24374081$1$I$$20240412$20240927$20240927$PER$$US-VIVUS LLC-2024V1000406$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740821$24374082$1$I$$20240412$20240927$20240927$PER$$US-VIVUS LLC-2024V1000410$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740831$24374083$1$I$$20240415$20240927$20240927$PER$$US-VIVUS LLC-2024V1000413$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740841$24374084$1$I$$20240415$20240927$20240927$PER$$US-VIVUS LLC-2024V1000414$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243740851$24374085$1$I$$20240415$20240927$20240927$PER$$US-VIVUS LLC-2024V1000415$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740861$24374086$1$I$$20240415$20240927$20240927$PER$$US-VIVUS LLC-2024V1000416$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740871$24374087$1$I$$20240415$20240927$20240927$PER$$US-VIVUS LLC-2024V1000417$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740881$24374088$1$I$$20240415$20240927$20240927$PER$$US-VIVUS LLC-2024V1000419$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740891$24374089$1$I$$20240415$20240927$20240927$PER$$US-VIVUS LLC-2024V1000421$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740901$24374090$1$I$$20240326$20240927$20240927$PER$$US-VIVUS LLC-2024V1000336$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740911$24374091$1$I$$20240326$20240927$20240927$PER$$US-VIVUS LLC-2024V1000337$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243740921$24374092$1$I$$20240325$20240927$20240927$PER$$US-VIVUS LLC-2024V1000338$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740931$24374093$1$I$$20240327$20240927$20240927$PER$$US-VIVUS LLC-2024V1000341$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740941$24374094$1$I$$20240327$20240927$20240927$PER$$US-VIVUS LLC-2024V1000344$VIVUS$$$$$M$Y$$$20240913$$CN$US$US
243740951$24374095$1$I$$20240327$20240927$20240927$PER$$US-VIVUS LLC-2024V1000346$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740961$24374096$1$I$$20240329$20240927$20240927$PER$$US-VIVUS LLC-2024V1000347$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243740971$24374097$1$I$$20240329$20240927$20240927$PER$$US-VIVUS LLC-2024V1000348$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740981$24374098$1$I$$20240329$20240927$20240927$PER$$US-VIVUS LLC-2024V1000349$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243740991$24374099$1$I$$20240329$20240927$20240927$PER$$US-VIVUS LLC-2024V1000352$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243741001$24374100$1$I$$20240401$20240927$20240927$PER$$US-VIVUS LLC-2024V1000354$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243741011$24374101$1$I$$20240401$20240927$20240927$PER$$US-VIVUS LLC-2024V1000359$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243741021$24374102$1$I$$20240401$20240927$20240927$PER$$US-VIVUS LLC-2024V1000360$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243741031$24374103$1$I$$20240401$20240927$20240927$PER$$US-VIVUS LLC-2024V1000363$VIVUS$$$$E$F$Y$80.449$KG$20240913$$CN$US$US
243741041$24374104$1$I$$20240402$20240927$20240927$PER$$US-VIVUS LLC-2024V1000366$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243741051$24374105$1$I$$20240402$20240927$20240927$PER$$US-VIVUS LLC-2024V1000367$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243741061$24374106$1$I$$20240402$20240927$20240927$PER$$US-VIVUS LLC-2024V1000368$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243741071$24374107$1$I$$20240402$20240927$20240927$PER$$US-VIVUS LLC-2024V1000369$VIVUS$$$$A$F$Y$$$20240913$$CN$US$US
243741081$24374108$1$I$$20240403$20240927$20240927$PER$$US-VIVUS LLC-2024V1000371$VIVUS$$$$$F$Y$$$20240913$$CN$US$US
243741091$24374109$1$I$$20240403$20240927$20240927$PER$$US-VIVUS LLC-2024V1000372$VIVUS$$$$E$F$Y$$$20240913$$CN$US$US
243741111$24374111$1$I$$20240924$20240927$20240927$EXP$$PL-BAUSCH-BL-2024-014344$BAUSCH AND LOMB$$31$YR$$F$Y$$$20240927$$MD$PL$PL
243741121$24374112$1$I$$20240926$20240927$20240927$EXP$$US-BAUSCH-BL-2024-014515$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240927$$CN$US$US
243741131$24374113$1$I$$20240924$20240927$20240927$EXP$GB-MHRA-MED-202409241206044200-YTGPN$GB-SANDOZ INC.-SDZ2024GB082946$SANDOZ$$55$YR$$F$Y$$$20240927$$CN$GB$GB
243741141$24374114$1$I$20240923$20240925$20240927$20240927$PER$$US-BAUSCH-BL-2024-014486$BAUSCH AND LOMB$$$$$M$Y$$$20240927$$CN$US$US
243741151$24374115$1$I$20240912$20240917$20240927$20240927$EXP$$CA-BIOCON BIOLOGICS LIMITED-BBL2024003280$BIOCON$$$$$$Y$$$20240927$$CN$CA$CA
243741181$24374118$1$I$20210625$20240926$20240927$20240927$EXP$$DE-BAUSCH-BL-2024-014518$BAUSCH AND LOMB$$$$E$F$Y$$$20240927$$MD$DE$DE
243741191$24374119$1$I$$20240922$20240927$20240927$EXP$$US-TAKEDA-2024TUS025604$TAKEDA$$$$$F$Y$$$20240927$$HP$US$US
243741201$24374120$1$I$20240917$20240920$20240927$20240927$EXP$$CN-VIIV HEALTHCARE LIMITED-CN2024APC117289$VIIV$$$$$$Y$$$20240927$$HP$CN$CN
243741211$24374121$1$I$20240401$20240926$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083465$SANDOZ$$67$YR$$M$Y$$$20240927$$MD$US$US
243741221$24374122$1$I$$20240925$20240927$20240927$PER$$US-BAYER-2024A137391$BAYER$$$$$$Y$$$20240927$$CN$US$US
243741231$24374123$1$I$$20240918$20240927$20240927$EXP$$US-TEVA-VS-3246472$TEVA$$28$YR$$F$Y$$$20240927$$HP$US$US
243741241$24374124$1$I$$20240919$20240927$20240927$EXP$$US-JNJFOC-20240960291$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240927$$MD$US$US
243741251$24374125$1$I$$20240925$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083175$SANDOZ$$$$$F$Y$$$20240927$$MD$US$US
243741261$24374126$1$I$$20240926$20240927$20240927$30DAY$$US-SANDOZ INC.-SDZ2024US083380$SANDOZ$$$$$F$Y$$$20240927$$CN$US$US
243741271$24374127$1$I$$20240922$20240927$20240927$EXP$$GB-JNJFOC-20240965820$JOHNSON AND JOHNSON$$4$DEC$A$F$Y$$$20240927$$MD$GB$GB
243741281$24374128$1$I$$20240920$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083237$SANDOZ$$65$YR$$F$Y$$$20240927$$CN$US$US
243741311$24374131$1$I$$20240919$20240927$20240927$PER$$US-BIOGEN-2024BI01253766$BIOGEN$$$$$F$Y$$$20240927$$CN$US$US
243741321$24374132$1$I$$20240927$20240927$20240927$DIR$720319$$FDA-CTU$$68$YR$$F$N$60.75$KG$20240927$Y$CN$US$
243741371$24374137$1$I$20240831$20240927$20240927$20240927$DIR$720316$$FDA-CTU$$15$YR$$F$N$63$KG$20240927$N$MD$GB$
243741381$24374138$1$I$$20240919$20240927$20240927$EXP$$JP-JNJFOC-20240972829$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$MD$JP$JP
243741421$24374142$1$I$$20240925$20240927$20240927$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-129676$REGENERON$$$$$F$Y$$$20240927$$HP$US$US
243741431$24374143$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245522$TEVA$$67$YR$$F$Y$74$KG$20240927$$HP$CA$CA
243741471$24374147$1$I$$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-66823$$FDA-CTU$$$$$M$N$$$20240926$N$HP$US$
243741481$24374148$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66341$$FDA-CTU$$$$$$N$$$20240926$$CN$US$
243741491$24374149$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66266$$FDA-CTU$$$$$$N$$$20240926$$CN$US$
243741501$24374150$1$I$20240927$20240927$20240927$20240927$DIR$720348$$FDA-CTU$$65$YR$$M$N$79.65$KG$20240927$N$CN$US$
243741511$24374151$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66336$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243741521$24374152$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66276$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243741531$24374153$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66376$$FDA-CTU$$$$$$N$$$20240926$$CN$US$
243741541$24374154$1$I$20240926$20240927$20240927$20240927$DIR$720327$$FDA-CTU$$54$YR$$F$N$62.55$KG$20240927$N$PH$US$
243741551$24374155$1$I$20240415$20240925$20240927$20240927$EXP$FR-AFSSAPS-PB2024001017$FR-GILEAD-2024-0688922$GILEAD$$64$YR$A$F$Y$$$20240927$$HP$FR$FR
243741561$24374156$1$I$20240726$20240813$20240927$20240927$PER$$US-LUNDBECK-DKLU4002982$LUNDBECK$$$$$$Y$$$20240927$$HP$US$US
243741571$24374157$1$I$$20240925$20240927$20240927$EXP$$NVSC2024US020352$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
243741581$24374158$1$I$$20240924$20240927$20240927$EXP$$PL-SANDOZ INC.-PHHY2014PL151965$SANDOZ$$34$YR$$M$Y$$$20240927$$MD$PL$PL
243741591$24374159$1$I$$20240920$20240927$20240927$EXP$$US-PFIZER INC-PV202400123250$PFIZER$Watson, C.. Difficult intraoperative heparinization following andexanet alfa administration. Clinical Practice and Cases in Emergency Medicine. 2019;3(4):390-394$70$YR$$M$Y$85$KG$20240927$$MD$US$US
243741611$24374161$1$I$20240901$20240926$20240927$20240927$EXP$$AR-PFIZER INC-202400265610$PFIZER$$64$YR$$F$Y$$$20240927$$CN$AR$AR
243741621$24374162$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-PV202400125174$PFIZER$Hon, S.. BREAKING BOUNDARIES: OVERCOMING TYROSINE KINASE INHIBITOR HURDLES IN CHRONIC MYELOID LEUKEMIA: A LIFESAVING ODYSSEY FROM RV RESCUE TO RENAL RECOVERY WITH IV EPOPROSTENOL. Chest. 2024;166(4 Suppl):5919A-5920A$53$YR$$F$Y$$$20240927$$HP$US$US
243741641$24374164$1$I$20240814$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400264053$PFIZER$$77$YR$$M$Y$$$20240927$$HP$US$US
243741651$24374165$1$I$20240601$20240926$20240927$20240927$EXP$$MA-PFIZER INC-PV202400126586$PFIZER$$$$$F$Y$$$20240927$$CN$MA$MA
243741661$24374166$1$I$$20240924$20240927$20240927$EXP$$CN-PFIZER INC-PV202400125240$PFIZER$Lai, R.. Ofatumumab treatment for severe refractory anti-NMDAR encephalitis: A case series. Journal of Neuroimmunology. 2024;396:10.1016/j.jneuroim.2024.578458$18$YR$$F$Y$$$20240927$$HP$CN$CN
243741681$24374168$1$I$20240910$20240920$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083236$SANDOZ$$$$$$Y$$$20240927$$HP$US$US
243741692$24374169$2$F$$20240925$20240927$20240930$EXP$$GB-PFIZER INC-202400263309$PFIZER$Fawaris, N.. An Extremely Rare Presentation of Mucinous Adenocarcinoma Originating From Meckel Diverticulum Masquerading in a Young Woman With Crohn^s Disease. ACG case reports journal. 2024;11(9):e01487$4$DEC$$F$Y$$$20240930$$MD$GB$GB
243741701$24374170$1$I$$20240916$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009795$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243741711$24374171$1$I$20200117$20240925$20240927$20240927$EXP$$CA-TAKEDA-2024TUS095748$TAKEDA$$83$YR$$M$Y$$$20240927$$CN$CA$CA
243741721$24374172$1$I$20240918$20240920$20240927$20240927$EXP$$DK-FreseniusKabi-FK202414174$FRESENIUS KABI$$58$YR$A$F$Y$$$20240927$$HP$DK$DK
243741731$24374173$1$I$$20240920$20240927$20240927$PER$$US-009507513-2409USA007825$MERCK$$50$YR$$F$Y$$$20240927$$MD$US$US
243741741$24374174$1$I$20180802$20240920$20240927$20240927$EXP$$DE-TEVA-2018-DE-970352$TEVA$$51$YR$$M$Y$90$KG$20240927$$HP$DE$DE
243741751$24374175$1$I$20221001$20240918$20240927$20240927$EXP$$FR-SA-2024SA276937$SANOFI AVENTIS$$74$YR$E$M$Y$58$KG$20240927$$MD$FR$FR
243741761$24374176$1$I$$20240924$20240927$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA071916$SANDOZ$$$$$F$Y$$$20240927$$CN$CA$CA
243741771$24374177$1$I$20230101$20240920$20240927$20240927$EXP$$US-SA-2024SA277751$SANOFI AVENTIS$$54$YR$A$F$Y$44.452$KG$20240927$$MD$US$US
243741781$24374178$1$I$20240101$20240920$20240927$20240927$EXP$$US-SA-2024SA279366$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240927$$CN$US$US
243741791$24374179$1$I$20240803$20240925$20240927$20240927$EXP$$NVSC2024CA192253$NOVARTIS$$78$YR$$F$Y$$$20240927$$CN$CA$CA
243741801$24374180$1$I$20231113$20240924$20240927$20240927$EXP$$US-TAKEDA-2023TUS110586$TAKEDA$$67$YR$$F$Y$$$20240927$$CN$US$US
243741811$24374181$1$I$$20240923$20240927$20240927$EXP$$US-SA-2024SA276109$SANOFI AVENTIS$Saffari P, Aylia F, Alderwish E.. EOSINOPHILIC MYOCARDITIS CAUSED BY DUPILUMAB-INDUCED HYPEREOSINOPHILIC SYNDROME.. Chest.. 2024;166(4):A720-1.$25$YR$A$F$Y$$$20240927$$HP$US$US
243741831$24374183$1$I$20240922$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016711$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240927$$CN$US$US
243741841$24374184$1$I$20240101$20240917$20240927$20240927$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409010976$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$DE$DE
243741851$24374185$1$I$$20240917$20240927$20240927$EXP$$SA-ELI_LILLY_AND_COMPANY-SA202409011986$ELI LILLY AND CO$$$$$F$Y$$$20240927$$MD$SA$SA
243741861$24374186$1$I$20240901$20240916$20240927$20240927$EXP$GB-MHRA-MED-202409141308593840-PBYZN$GB-ELI_LILLY_AND_COMPANY-GB202409010331$ELI LILLY AND CO$$39$YR$A$F$Y$82$KG$20240927$$CN$GB$GB
243741881$24374188$1$I$$20240920$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024117048$VIIV$$$$$M$Y$$$20240927$$CN$US$US
243741891$24374189$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024AMR115888$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
243741911$24374191$1$I$$20240926$20240927$20240927$EXP$GB-MHRA-MED-202409262227565140-BYZTC$GB-SANDOZ INC.-SDZ2024GB083452$SANDOZ$$$$$F$Y$$$20240927$$HP$GB$GB
243741932$24374193$2$F$$20240920$20240927$20240930$PER$$NVSC2024US192060$NOVARTIS$$$$$M$Y$$$20240930$$HP$US$US
243741941$24374194$1$I$$20240924$20240927$20240927$EXP$$NVSC2024US191344$NOVARTIS$$$$$F$Y$$$20240927$$CN$US$US
243741951$24374195$1$I$20240701$20240916$20240927$20240927$EXP$$US-MYLANLABS-2024M1087388$MYLAN$$$$$F$Y$$$20240927$$CN$US$US
243741961$24374196$1$I$$20240923$20240927$20240927$EXP$$DE-TAKEDA-2024TUS095338$TAKEDA$Kramp LJ, Heydrick-karsten C, Sembill S, Karow A, Lion T, Chitadze G, et al.. CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase. Annals of Hematology. 2024$16$YR$$M$Y$$$20240927$$MD$DE$DE
243741971$24374197$1$I$20010915$20240927$20240927$20240927$DIR$720344$$FDA-CTU$$19$YR$$M$N$165.6$KG$20240927$Y$CN$US$
243741981$24374198$1$I$$20240917$20240927$20240927$EXP$CA-drreddys-USA/CAN/19/0114591$CA-RDY-USA/CAN/19/0114591$DR REDDYS$$58$YR$A$F$Y$$$20240927$$CN$CA$CA
243742001$24374200$1$I$$20240927$20240927$20240927$DIR$720353$$FDA-CTU$$$$$UNK$N$$$20240927$N$CN$US$
243742011$24374201$1$I$$20240927$20240927$20240927$DIR$720341$$FDA-CTU$$50$YR$$F$N$$$20240927$N$HP$US$
243742021$24374202$1$I$20240926$20240927$20240927$20240927$DIR$720349$$FDA-CTU$$$$$UNK$N$$$20240927$N$CN$US$
243742031$24374203$1$I$20240911$20240927$20240927$20240927$DIR$720334$$FDA-CTU$$79$YR$$UNK$N$$$20240927$Y$HP$US$
243742041$24374204$1$I$$20240926$20240927$20240927$EXP$$AR-PFIZER INC-202400265618$PFIZER$$84$YR$$F$Y$$$20240927$$CN$AR$AR
243742071$24374207$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400263374$PFIZER$$90$YR$$F$Y$$$20240927$$MD$US$US
243742081$24374208$1$I$$20240925$20240927$20240927$EXP$$JP-PFIZER INC-202400263580$PFIZER$$79$YR$$F$Y$$$20240927$$PH$JP$JP
243742091$24374209$1$I$$20240926$20240927$20240927$EXP$$US-PFIZER INC-2018SGN02895$PFIZER$$8$DEC$$M$Y$$$20240927$$HP$US$US
243742101$24374210$1$I$20220901$20240926$20240927$20240927$EXP$$US-PFIZER INC-PV202400126379$PFIZER$$75$YR$$M$Y$$$20240927$$HP$US$US
243742111$24374211$1$I$20210222$20240924$20240927$20240927$EXP$$AT-PFIZER INC-2023SGN09937$PFIZER$$47$YR$$F$Y$58$KG$20240927$$MD$AT$AT
243742141$24374214$1$I$$20240923$20240927$20240927$30DAY$$US-SANDOZ INC.-SDZ2024US081008$SANDOZ$$$$$M$Y$$$20240927$$CN$US$US
243742171$24374217$1$I$20240927$20240927$20240927$20240927$DIR$720354$$FDA-CTU$$33$YR$$M$N$111$KG$20240927$N$PH$US$
243742181$24374218$1$I$20240905$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66256$$FDA-CTU$$28$YR$$M$N$171.1$KG$20240926$Y$$US$
243742191$24374219$1$I$$20240920$20240927$20240927$EXP$$US-GSK-US2024116917$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
243742201$24374220$1$I$$20240918$20240927$20240927$PER$$US-GSK-US2024116156$GLAXOSMITHKLINE$$$$$M$Y$$$20240927$$CN$US$US
243742211$24374221$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66262$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243742221$24374222$1$I$20240925$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66350$$FDA-CTU$$75$YR$$F$N$$$20240926$N$PH$US$
243742231$24374223$1$I$$20240918$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083478$SANDOZ$$$$$F$Y$$$20240927$$PH$US$US
243742251$24374225$1$I$$20240927$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2023US062851$SANDOZ$$$$$$Y$$$20240927$$CN$US$US
243742281$24374228$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245593$TEVA$$74$YR$$M$Y$76$KG$20240927$$PH$CA$CA
243742291$24374229$1$I$$20240919$20240927$20240927$EXP$$US-TG THERAPEUTICS INC.-TGT004022$TG THERAPEUTICS$$$$$$Y$$$20240927$$CN$US$US
243742301$24374230$1$I$$20240923$20240927$20240927$30DAY$$GB-MYLANLABS-2024M1086864$MYLAN$$$$$M$Y$$$20240927$$PH$GB$GB
243742311$24374231$1$I$20240920$20240923$20240927$20240927$30DAY$$GB-MYLANLABS-2024M1086921$MYLAN$$$$$$Y$$$20240927$$HP$GB$GB
243742321$24374232$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245272$TEVA$$$$A$F$Y$$$20240927$$HP$CA$CA
243742331$24374233$1$I$20200503$20240920$20240927$20240927$EXP$$US-GSK-US2024GSK096650$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$MD$US$US
243742341$24374234$1$I$$20240909$20240927$20240927$PER$$US-TEVA-VS-3242028$TEVA$$$$$F$Y$$$20240927$$HP$US$US
243742351$24374235$1$I$20240810$20240920$20240927$20240927$EXP$$US-AURINIA PHARMACEUTICALS INC.-AUR-006759$AURINIA PHARMACEUTICALS$$63$YR$$F$Y$$$20240927$$CN$US$US
243742361$24374236$1$I$20240901$20240917$20240927$20240927$PER$$US-ABBVIE-5942495$ABBVIE$$41$YR$$F$Y$45$KG$20240927$$HP$US$US
243742371$24374237$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245283$TEVA$$$$A$F$Y$$$20240927$$HP$CA$CA
243742381$24374238$1$I$20240916$20240920$20240927$20240927$EXP$$GB-HETERO-AMR2024GB03331$HETERO$$$$$F$Y$$$20240927$$PH$GB$GB
243742391$24374239$1$I$20230528$20240925$20240927$20240927$EXP$$NVSC2024KR191618$NOVARTIS$$$$$F$Y$$$20240927$$CN$KR$KR
243742401$24374240$1$I$20240701$20240918$20240927$20240927$PER$$US-JNJFOC-20240960495$JOHNSON AND JOHNSON$$62$YR$A$M$Y$107$KG$20240927$$CN$US$US
243742411$24374241$1$I$$20240918$20240927$20240927$EXP$$CA-OTSUKA-2024_026307$OTSUKA$$$$$F$Y$$$20240927$$HP$CA$CA
243742421$24374242$1$I$$20240918$20240927$20240927$EXP$$US-ALXN-202409USA002605US$ALEXION PHARMACEUTICALS$$77$YR$E$$Y$$$20240927$$$US$US
243742431$24374243$1$I$20240916$20240919$20240927$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-030152$UNITED THERAPEUTICS$$71$YR$$F$Y$103.4$KG$20240927$$$US$US
243742441$24374244$1$I$20240925$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66386$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243742451$24374245$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66369$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243742461$24374246$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66381$$FDA-CTU$$$$$$N$$$20240926$$CN$US$
243742481$24374248$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66270$$FDA-CTU$$$$$$N$$$20240926$$CN$US$
243742491$24374249$1$I$20240925$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66373$$FDA-CTU$$$$$$N$$$20240926$N$CN$US$
243742501$24374250$1$I$$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66352$$FDA-CTU$$$$$$N$$$20240926$$CN$US$
243742511$24374251$1$I$20240927$20240927$20240927$20240927$DIR$720342$$FDA-CTU$$67$YR$$F$N$$$20240927$N$CN$US$
243742541$24374254$1$I$20200901$20240920$20240927$20240927$EXP$$US-GSK-US2024117041$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
243742561$24374256$1$I$$20240924$20240927$20240927$EXP$$US-JNJFOC-20240968407$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243742571$24374257$1$I$20240915$20240916$20240927$20240927$PER$$US-JNJFOC-20240941358$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$CN$US$US
243742591$24374259$1$I$$20240916$20240927$20240927$EXP$$CA-BAXTER-2024BAX024912$BAXTER$$48$YR$$F$Y$106$KG$20240927$$HP$CA$CA
243742601$24374260$1$I$$20240920$20240927$20240927$EXP$$NVSC2024AU191371$NOVARTIS$$40$YR$$F$Y$$$20240927$$MD$AU$AU
243742611$24374261$1$I$$20240920$20240927$20240927$EXP$$NVSC2024AU190695$NOVARTIS$$31$YR$$F$Y$$$20240927$$MD$AU$AU
243742621$24374262$1$I$20240101$20240924$20240927$20240927$PER$$US-PFIZER INC-PV202400125556$PFIZER$$67$YR$$F$Y$$$20240927$$HP$US$US
243742631$24374263$1$I$20240901$20240924$20240927$20240927$PER$$US-PFIZER INC-PV202400125734$PFIZER$$$$$M$Y$$$20240927$$CN$US$US
243742651$24374265$1$I$$20240924$20240927$20240927$EXP$$IE-MYLANLABS-2024M1078580$MYLAN$$$$$M$Y$$$20240927$$PH$IE$IE
243742661$24374266$1$I$$20240916$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409010643$ELI LILLY AND CO$$65$YR$E$$Y$$$20240927$$LW$US$US
243742681$24374268$1$I$20240101$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016329$ELI LILLY AND CO$$83$YR$E$F$Y$$$20240927$$CN$US$US
243742691$24374269$1$I$20240101$20240913$20240927$20240927$EXP$$US-OTTER-US-2024AST000294$Unknown Manufacturer$$$$$F$Y$$$20240927$$CN$US$US
243742701$24374270$1$I$$20240916$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009791$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243742731$24374273$1$I$$20240923$20240927$20240927$EXP$$IT-MYLANLABS-2024M1087285$MYLAN$Pengo V, Bracco A, Denas G, Iliceto S. Coronary Thrombosis with Distal Embolization in a Young Patient after Orthopaedic Surgery: An Informative Case Report. Semin Thromb Hemost. 2023;50(6):894-896$40$YR$$M$Y$$$20240927$$HP$IT$IT
243742751$24374275$1$I$$20240923$20240927$20240927$EXP$$PL-MYLANLABS-2024M1086764$MYLAN$Bleszynska-Marunowska E, Jagiello K, Wierucki L, Renke M, Grodzicki T, Kalarus Z et al. Potentially Inappropriate Medications Involved in Drug-Drug Interactions in a Polish Population over 80 Years Old: An Observational, Cross-Sectional Study. Pharmaceuticals. 2024;17 (8):1-9$$$E$$Y$$$20240927$$HP$PL$PL
243742761$24374276$1$I$20240926$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192492$AMGEN$$74$YR$E$M$Y$$$20240927$$CN$US$US
243742791$24374279$1$I$$20240924$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083060$SANDOZ$Cervantes, G., Cervantes, W., Ahmed, M. U., + Jesmajian, S. A complicated case of serotonin syndrome in an elderly patient with preexisting polypharmacy and drug-drug interaction. Chest. 2024;166(4):A2179$67$YR$$M$Y$$$20240927$$HP$US$US
243742801$24374280$1$I$$20240913$20240927$20240927$EXP$$BR-MELINTA THERAPEUTICS, LLC-BR-MLNT-24-00452$Unknown Manufacturer$$$$$$Y$$$20240927$$CN$BR$BR
243742811$24374281$1$I$20240101$20240917$20240927$20240927$EXP$$JP-RADIUS HEALTH INC.-2024JP007281$RADIUS PHARM$$76$YR$$F$Y$$$20240927$$CN$JP$JP
243742821$24374282$1$I$20240919$20240919$20240927$20240927$PER$$US-MYLANLABS-2024M1086084$MYLAN$$75$YR$$F$Y$$$20240927$$CN$US$US
243742831$24374283$1$I$20240801$20240916$20240927$20240927$PER$$US-FreseniusKabi-FK202413971$FRESENIUS KABI$$57$YR$A$M$Y$70.3$KG$20240927$$CN$US$US
243742841$24374284$1$I$$20240920$20240927$20240927$EXP$$JP-ASTRAZENECA-202409GLO008142JP$ALEXION PHARMACEUTICALS$$$$A$$Y$$$20240927$$MD$JP$JP
243742851$24374285$1$I$20240816$20240919$20240927$20240927$EXP$$US-BEH-2024179104$CSL BEHRING$$4$YR$C$M$Y$$$20240927$$HP$US$US
243742861$24374286$1$I$20240927$20240927$20240927$20240927$DIR$720362$$FDA-CTU$$44$YR$$F$N$110.25$KG$20240927$Y$CN$US$
243742871$24374287$1$I$$20240927$20240927$20240927$DIR$720328$$FDA-CTU$$$$$UNK$N$$$20240927$$CN$US$
243742881$24374288$1$I$$20240923$20240927$20240927$PER$$US-IMP-2024000779$Harrow Health$$$$E$M$Y$$$20240927$$CN$US$US
243742891$24374289$1$I$$20240924$20240927$20240927$PER$$US-009507513-2409USA008845$MERCK$$$$$F$Y$$$20240927$$CN$US$US
243742901$24374290$1$I$$20240924$20240927$20240927$EXP$$TR-GILEAD-2024-0688721$GILEAD$$$$$F$Y$$$20240927$$MD$TR$TR
243742911$24374291$1$I$$20240924$20240927$20240927$EXP$$CA-MYLANLABS-2024M1086825$MYLAN$$65$YR$$M$Y$$$20240927$$CN$CA$CA
243742921$24374292$1$I$20240801$20240920$20240927$20240927$EXP$$US-BIOGEN-2024BI01283775$BIOGEN$$41$YR$$F$Y$$$20240927$$MD$US$US
243742941$24374294$1$I$$20240920$20240927$20240927$EXP$$DE-HETERO-AMR2024DE03328$HETERO$Gallinger A, Osei-Davies R, Hennersdorf F.. Reversibility of critical intraventricular conduction delay under flecainide and lacosamide by sodium bicarbonate. Internal Medicine. 2024;1-4$72$YR$$F$Y$$$20240927$$HP$DE$DE
243742951$24374295$1$I$$20240925$20240927$20240927$PER$$US-ABBVIE-5939672$ABBVIE$$$$$M$Y$$$20240927$$HP$US$US
243742961$24374296$1$I$$20240925$20240927$20240927$EXP$$AR-JNJFOC-20240970227$JOHNSON AND JOHNSON$$93$YR$E$F$Y$67$KG$20240927$$CN$AR$AR
243742971$24374297$1$I$$20240924$20240927$20240927$EXP$$CA-MYLANLABS-2024M1087358$MYLAN$$$$$M$Y$$$20240927$$CN$CA$CA
243742981$24374298$1$I$20231202$20240923$20240927$20240927$EXP$ES-AEMPS-1568896$ES-MYLANLABS-2024M1086706$MYLAN$$89$YR$$F$Y$$$20240927$$MD$ES$ES
243742991$24374299$1$I$20240801$20240831$20240927$20240927$PER$$US-IMP-2024000698$Harrow Health$$$$E$M$Y$$$20240927$$CN$US$US
243743001$24374300$1$I$20240910$20240924$20240927$20240927$EXP$$US-ABBVIE-5938083$ABBVIE$$25$YR$$F$Y$$$20240927$$CN$US$US
243743011$24374301$1$I$$20240926$20240927$20240927$EXP$GB-MHRA-MED-202409262213043090-JLVYM$GB-SANDOZ INC.-SDZ2024GB083446$SANDOZ$$$$$F$Y$$$20240927$$HP$GB$GB
243743021$24374302$1$I$$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024192052$AMGEN$$68$YR$E$F$Y$$$20240927$$MD$US$US
243743031$24374303$1$I$$20240920$20240927$20240927$EXP$$ES-APELLIS-2024-APL-0001074$APELLIS PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$ES$ES
243743041$24374304$1$I$20240920$20240925$20240927$20240927$EXP$GB-MHRA-MED-202409251541455940-FQZDK$GB-MYLANLABS-2024M1087248$MYLAN$$55$YR$$F$Y$$$20240927$$PH$GB$GB
243743051$24374305$1$I$20240802$20240925$20240927$20240927$EXP$$US-ABBVIE-5940682$ABBVIE$$66$YR$$M$Y$$$20240927$$CN$US$US
243743061$24374306$1$I$20240901$20240916$20240927$20240927$PER$$US-ALKERMES INC.-ALK-2024-002399$ALKERMES$$49$YR$$M$Y$$$20240927$$MD$US$US
243743071$24374307$1$I$$20240921$20240927$20240927$EXP$$US-INCYTE CORPORATION-2024IN010090$INCYTE$$$$$$Y$$$20240927$$MD$US$US
243743101$24374310$1$I$$20240920$20240927$20240927$EXP$$DK-AMGEN-DNKSP2024189015$AMGEN$Lund C.. Physical decline, falls, and hospitalization among vulnerable older patients in the trajectory of colorectal cancer treatment. Journal of Geriatric Oncology. 2024;15 (7):1-7$$$$$Y$$$20240927$$HP$DK$DK
243743111$24374311$1$I$20240926$20240927$20240927$20240927$DIR$720336$$FDA-CTU$$77$YR$$M$N$$$20240927$N$$US$
243743121$24374312$1$I$$20240917$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009867$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243743131$24374313$1$I$20240101$20240916$20240927$20240927$PER$$US-ALKERMES INC.-ALK-2024-002433$ALKERMES$$$$$F$Y$$$20240927$$CN$US$US
243743141$24374314$1$I$$20240917$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009866$INCYTE$$$$$$Y$$$20240927$$MD$US$US
243743151$24374315$1$I$20240916$20240918$20240927$20240927$PER$$US-MYLANLABS-2024M1085613$MYLAN$$65$YR$$F$Y$86.18$KG$20240927$$PH$US$US
243743161$24374316$1$I$20240101$20240906$20240927$20240927$EXP$$US-MYLANLABS-2024M1087289$MYLAN$$$$$F$Y$62.14$KG$20240927$$CN$US$US
243743171$24374317$1$I$$20240918$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009961$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243743181$24374318$1$I$20240507$20240924$20240927$20240927$EXP$IE-HPRA-2024-114610$IE-MYLANLABS-2024M1074649$MYLAN$$77$YR$$F$Y$$$20240927$$CN$IE$IE
243743191$24374319$1$I$$20240917$20240927$20240927$PER$$US-ALKERMES INC.-ALK-2024-002414$ALKERMES$$$$$F$Y$77.098$KG$20240927$$MD$US$US
243743201$24374320$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3247021$TEVA$$31$YR$$F$Y$71$KG$20240927$$MD$CA$CA
243743211$24374321$1$I$20240604$20240924$20240927$20240927$EXP$FR-AFSSAPS-MP2024001390$FR-PFIZER INC-202400263660$PFIZER$$42$YR$$M$Y$$$20240927$$PH$FR$FR
243743241$24374324$1$I$20240917$20240917$20240927$20240927$PER$$US-ABBVIE-5929733$ABBVIE$$48$YR$$F$Y$$$20240927$$CN$US$US
243743251$24374325$1$I$20231001$20240923$20240927$20240927$EXP$$AE-LUNDBECK-DKLU4002666$LUNDBECK$$$$$$Y$$$20240927$$CN$AE$AE
243743261$24374326$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024115648$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243743271$24374327$1$I$20240701$20240917$20240927$20240927$EXP$$US-MELINTA THERAPEUTICS, LLC-US-MLNT-24-00463$Unknown Manufacturer$$$$$$Y$$$20240927$$CN$US$US
243743281$24374328$1$I$$20240924$20240927$20240927$EXP$$US-PURDUE-USA-2024-0312199$PURDUE$Gibbons K, Morris J.. Delta-8 Tetrahydrocannabinol in the Emergency Department: A Case Series. WMJ : official publication of the State Medical Society of Wisconsin. 2024;123(4):300-303$36$YR$$F$Y$$$20240927$$PH$US$US
243743291$24374329$1$I$$20240924$20240927$20240927$EXP$CA-HEALTHCANVIG-E2B_07310492$CA-PURDUE-USA-2024-0312208$PURDUE$$$$$$Y$$$20240927$$MD$CA$CA
243743301$24374330$1$I$$20240924$20240927$20240927$EXP$$US-PURDUE-USA-2024-0312207$PURDUE$Gibbons K, Morris J. Delta-8 Tetrahydrocannabinol in the Emergency  Department: A Case Series. WMJ:official publication of the State Medical Society of Wisconsin. 2024;123:300-303$5$YR$$F$Y$$$20240927$$PH$US$US
243743311$24374331$1$I$20240101$20240919$20240927$20240927$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-016184$JAZZ$$60$YR$$M$Y$$$20240927$$MD$JP$JP
243743321$24374332$1$I$$20240918$20240927$20240927$EXP$$JP-RADIUS HEALTH INC.-2024JP007350$RADIUS PHARM$$8$DEC$$F$Y$$$20240927$$MD$JP$JP
243743331$24374333$1$I$20240801$20240920$20240927$20240927$EXP$FR-AFSSAPS-MP2024001362$FR-TEVA-VS-3246634$TEVA$$65$YR$$F$Y$42$KG$20240927$$PH$FR$FR
243743341$24374334$1$I$$20240924$20240927$20240927$EXP$$CZ-MYLANLABS-2024M1086923$MYLAN$$$$A$M$Y$$$20240927$$MD$CZ$CZ
243743371$24374337$1$I$$20240917$20240927$20240927$EXP$$US-JNJFOC-20240945299$JOHNSON AND JOHNSON$$$$$M$Y$$$20240927$$CN$US$US
243743381$24374338$1$I$20240923$20240924$20240927$20240927$EXP$$US-TAKEDA-2024TUS078710$TAKEDA$$58$YR$$F$Y$69$KG$20240927$$CN$US$US
243743411$24374341$1$I$20240101$20240923$20240927$20240927$EXP$$US-AMGEN-USASL2024189708$AMGEN$$75$YR$E$M$Y$$$20240927$$CN$US$US
243743421$24374342$1$I$$20240918$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024115995$VIIV$$$$$M$Y$$$20240927$$PH$US$US
243743431$24374343$1$I$20240822$20240924$20240927$20240927$EXP$FR-AFSSAPS-AN2024001264$FR-MYLANLABS-2024M1086561$MYLAN$$51$YR$$M$Y$$$20240927$$MD$FR$FR
243743441$24374344$1$I$20240913$20240918$20240927$20240927$PER$$US-GSK-US2024115981$GLAXOSMITHKLINE$$79$YR$$F$Y$$$20240927$$CN$US$US
243743461$24374346$1$I$$20240912$20240927$20240927$EXP$$GB-DSJP-DSE-2024-144800$DAIICHI$$$$$F$Y$$$20240927$$MD$GB$GB
243743471$24374347$1$I$$20240920$20240927$20240927$PER$$US-JNJFOC-20240960408$JOHNSON AND JOHNSON$$$$$F$Y$$$20240927$$CN$US$US
243743481$24374348$1$I$20240910$20240927$20240927$20240927$DIR$720352$$FDA-CTU$$81$YR$$M$N$93.7$KG$20240927$Y$$US$
243743491$24374349$1$I$20240927$20240927$20240927$20240927$DIR$720365$$FDA-CTU$$74$YR$$M$N$$$20240927$N$$US$
243743501$24374350$1$I$20240923$20240927$20240927$20240927$DIR$720322$$FDA-CTU$$33$YR$$M$N$126$KG$20240927$N$CN$US$
243743511$24374351$1$I$20240918$20240927$20240927$20240927$DIR$720330$$FDA-CTU$$76$YR$$M$N$$$20240927$Y$PH$US$
243743531$24374353$1$I$$20240918$20240927$20240927$PER$$US-TEVA-VS-3246524$TEVA$$$$$F$Y$$$20240927$$MD$US$US
243743541$24374354$1$I$20240718$20240923$20240927$20240927$EXP$HR-HALMED-300086528$HR-MYLANLABS-2024M1086580$MYLAN$$68$YR$$M$Y$$$20240927$$MD$HR$HR
243743551$24374355$1$I$$20240923$20240927$20240927$EXP$$FR-MYLANLABS-2024M1086541$MYLAN$Charbit-Henrion F, Lacaille F, McKiernan P, Girard M, De Lonlay P, Valayannopoulos V et al... Early and late complications after liver transplantation for Propionic acidemia in children: a two centers study.. AMERICAN JOURNAL OF TRANSPLANTATION.. 2015;15(3):786-791$6$YR$$F$Y$$$20240927$$HP$FR$FR
243743561$24374356$1$I$20240630$20240920$20240927$20240927$EXP$FR-AFSSAPS-AVLY2024000133$FR-MYLANLABS-2024M1086358$MYLAN$$27$YR$$M$Y$57$KG$20240927$$MD$FR$FR
243743571$24374357$1$I$$20240918$20240927$20240927$EXP$$US-UCBSA-2024048198$UCB$$$$$$Y$$$20240927$$CN$US$US
243743591$24374359$1$I$$20240924$20240927$20240927$PER$$US-009507513-2409USA008694$MERCK$Chigurupati HD, Neppala S, Keesari PR, Shaaban H.. Acute pneumonitis unmasked: a rare case of pembrolizumba-induced pulmonary complication. Chest. 2024;166 (4):1959A-60$59$YR$$F$Y$$$20240927$$HP$US$US
243743601$24374360$1$I$$20240920$20240927$20240927$EXP$$DE-AMAROX PHARMA-AMR2024DE03327$HETERO$$$$$M$Y$$$20240927$$PH$DE$DE
243743611$24374361$1$I$$20240917$20240927$20240927$EXP$$US-RADIUS HEALTH INC.-2024US007380$RADIUS PHARM$$$$$F$Y$71.293$KG$20240927$$CN$US$US
243743622$24374362$2$F$20240101$20240912$20240927$20240927$EXP$$DE-DSJP-DS-2024-100060-DE$DAIICHI$$88$YR$$F$Y$46.5$KG$20240927$$CN$DE$DE
243743631$24374363$1$I$$20240923$20240927$20240927$EXP$$US-OTSUKA PHARMACEUTICAL NETHERLANDS B.V.-AUR-006778$AURINIA PHARMACEUTICALS$$$$$M$Y$$$20240927$$CN$US$US
243743641$24374364$1$I$20240801$20240917$20240927$20240927$EXP$GB-MHRA-MED-202409151830404000-QPBDC$GB-ELI_LILLY_AND_COMPANY-GB202409011285$ELI LILLY AND CO$$44$YR$A$F$Y$84$KG$20240927$$CN$GB$GB
243743651$24374365$1$I$20240601$20240920$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409013601$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240927$$CN$US$US
243743661$24374366$1$I$20240918$20240918$20240927$20240927$PER$$US-ABBVIE-5930890$ABBVIE$$59$YR$$M$Y$$$20240927$$CN$US$US
243743681$24374368$1$I$20240901$20240927$20240927$20240927$DIR$720356$$FDA-CTU$$25$YR$$F$N$61.2$KG$20240927$N$PH$US$
243743691$24374369$1$I$$20240927$20240927$20240927$DIR$720332$$FDA-CTU$$$$$F$N$55.8$KG$20240927$Y$CN$US$
243743701$24374370$1$I$20240925$20240927$20240927$20240927$DIR$720326$$FDA-CTU$$37$YR$$F$N$29.5$KG$20240927$N$PH$US$
243743711$24374371$1$I$$20240926$20240927$20240927$PER$$US-PFIZER INC-202400264753$PFIZER$$$$$F$Y$$$20240927$$HP$US$US
243743721$24374372$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264503$PFIZER$$$$$$Y$$$20240927$$PH$US$US
243743731$24374373$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264210$PFIZER$$70$YR$$M$Y$$$20240927$$CN$US$US
243743751$24374375$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-PV202400125863$PFIZER$$67$YR$$F$Y$$$20240927$$HP$US$US
243743761$24374376$1$I$$20240926$20240927$20240927$PER$$US-PFIZER INC-202400264751$PFIZER$$$$A$F$Y$$$20240927$$MD$US$US
243743771$24374377$1$I$$20240926$20240927$20240927$PER$$US-PFIZER INC-202400265057$PFIZER$$65$YR$$M$Y$$$20240927$$CN$US$US
243743781$24374378$1$I$20240917$20240924$20240927$20240927$PER$$US-PFIZER INC-202400263572$PFIZER$$72$YR$$F$Y$$$20240927$$CN$US$US
243743791$24374379$1$I$20240926$20240926$20240927$20240927$PER$$US-PFIZER INC-202400265236$PFIZER$$38$YR$$M$Y$$$20240927$$CN$US$US
243743811$24374381$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-PV202400125883$PFIZER$$$$$F$Y$$$20240927$$HP$US$US
243743821$24374382$1$I$$20240924$20240927$20240927$PER$$US-PFIZER INC-202400263326$PFIZER$$77$YR$$M$Y$$$20240927$$CN$US$US
243743831$24374383$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264245$PFIZER$$75$YR$$M$Y$$$20240927$$HP$US$US
243743851$24374385$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264544$PFIZER$$33$YR$$M$Y$$$20240927$$CN$US$US
243743861$24374386$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-PV202400125770$PFIZER$$76$YR$$F$Y$$$20240927$$MD$US$US
243743871$24374387$1$I$20240922$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264468$PFIZER$$48$YR$$F$Y$$$20240927$$HP$US$US
243743891$24374389$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-PV202300044112$PFIZER$$72$YR$$M$Y$$$20240927$$CN$US$US
243743911$24374391$1$I$$20240926$20240927$20240927$PER$$US-PFIZER INC-202400264932$PFIZER$$$$$F$Y$$$20240927$$CN$US$US
243743921$24374392$1$I$$20240926$20240927$20240927$PER$$US-PFIZER INC-202400264933$PFIZER$$$$$$Y$$$20240927$$HP$US$US
243743931$24374393$1$I$$20240926$20240927$20240927$PER$$US-PFIZER INC-202400264960$PFIZER$$69$YR$$F$Y$$$20240927$$CN$US$US
243743941$24374394$1$I$20240926$20240926$20240927$20240927$PER$$US-PFIZER INC-202400265141$PFIZER$$66$YR$$F$Y$$$20240927$$CN$US$US
243743951$24374395$1$I$$20240926$20240927$20240927$PER$$US-PFIZER INC-202400265033$PFIZER$$47$YR$$F$Y$$$20240927$$CN$US$US
243743961$24374396$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-PV202400126107$PFIZER$$$$$$Y$$$20240927$$CN$US$US
243743991$24374399$1$I$20240701$20240926$20240927$20240927$PER$$US-PFIZER INC-PV202400126320$PFIZER$$61$YR$$F$Y$$$20240927$$HP$US$US
243744001$24374400$1$I$$20240926$20240927$20240927$PER$$US-PFIZER INC-PV202400126331$PFIZER$$82$YR$$F$Y$$$20240927$$HP$US$US
243744011$24374401$1$I$20240923$20240924$20240927$20240927$PER$$US-PFIZER INC-202400264140$PFIZER$$$$A$$Y$$$20240927$$MD$US$US
243744031$24374403$1$I$20240923$20240926$20240927$20240927$PER$$US-PFIZER INC-202400264988$PFIZER$$86$YR$$M$Y$$$20240927$$CN$US$US
243744051$24374405$1$I$20240925$20240926$20240927$20240927$PER$$US-PFIZER INC-202400265137$PFIZER$$60$YR$$F$Y$$$20240927$$CN$US$US
243744061$24374406$1$I$20240926$20240926$20240927$20240927$PER$$US-PFIZER INC-202400264953$PFIZER$$64$YR$$F$Y$$$20240927$$PH$US$US
243744071$24374407$1$I$20240918$20240924$20240927$20240927$PER$$US-PFIZER INC-202400263567$PFIZER$$58$YR$$F$Y$$$20240927$$HP$US$US
243744081$24374408$1$I$20240101$20240925$20240927$20240927$PER$$US-PFIZER INC-202400250193$PFIZER$$21$YR$$M$Y$$$20240927$$HP$US$US
243744091$24374409$1$I$20240925$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264124$PFIZER$$48$YR$$F$Y$$$20240927$$CN$US$US
243744101$24374410$1$I$20240921$20240924$20240927$20240927$PER$$US-PFIZER INC-202400262982$PFIZER$$69$YR$$M$Y$$$20240927$$CN$US$US
243744111$24374411$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264740$PFIZER$$63$YR$$F$Y$$$20240927$$CN$US$US
243744121$24374412$1$I$20240912$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264128$PFIZER$$54$YR$$F$Y$$$20240927$$CN$US$US
243744131$24374413$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-PV202400125950$PFIZER$$$$$$Y$$$20240927$$MD$US$US
243744151$24374415$1$I$$20240926$20240927$20240927$PER$$US-PFIZER INC-202400264901$PFIZER$$7$YR$$F$Y$$$20240927$$CN$US$US
243744161$24374416$1$I$$20240926$20240927$20240927$PER$$US-PFIZER INC-202400265025$PFIZER$$72$YR$$F$Y$$$20240927$$CN$US$US
243744171$24374417$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-PV202400126159$PFIZER$$61$YR$$F$Y$$$20240927$$HP$US$US
243744181$24374418$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-202400096466$PFIZER$$72$YR$$F$Y$$$20240927$$CN$US$US
243744191$24374419$1$I$20240923$20240924$20240927$20240927$PER$$US-PFIZER INC-202400264138$PFIZER$$$$A$$Y$$$20240927$$MD$US$US
243744201$24374420$1$I$20240924$20240926$20240927$20240927$PER$$US-PFIZER INC-202400265036$PFIZER$$67$YR$$F$Y$$$20240927$$CN$US$US
243744211$24374421$1$I$20240901$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264962$PFIZER$$66$YR$$M$Y$$$20240927$$HP$US$US
243744221$24374422$1$I$20240801$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264571$PFIZER$$61$YR$$F$Y$$$20240927$$HP$US$US
243744231$24374423$1$I$$20240924$20240927$20240927$PER$$US-PFIZER INC-202400263375$PFIZER$$53$YR$$F$Y$$$20240927$$CN$US$US
243744241$24374424$1$I$$20240924$20240927$20240927$PER$$US-PFIZER INC-PV202400125038$PFIZER$$$$$F$Y$$$20240927$$CN$US$US
243744251$24374425$1$I$$20240925$20240927$20240927$PER$$US-HALEON-2198822$Haleon PLC$$$$$M$Y$$$20240927$$CN$US$US
243744261$24374426$1$I$20240101$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264260$PFIZER$$68$YR$$F$Y$$$20240927$$PH$US$US
243744271$24374427$1$I$$20240918$20240927$20240927$PER$$US-GSK-US2024116144$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243744281$24374428$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264963$PFIZER$$77$YR$$F$Y$$$20240927$$HP$US$US
243744291$24374429$1$I$20240901$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264102$PFIZER$$$$$M$Y$$$20240927$$CN$US$US
243744301$24374430$1$I$$20240926$20240927$20240927$PER$$US-PFIZER INC-2018SGN01804$PFIZER$$$$$M$Y$$$20240927$$HP$US$US
243744311$24374431$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-202400264404$PFIZER$$37$YR$$F$Y$$$20240927$$MD$US$US
243744321$24374432$1$I$20240920$20240926$20240927$20240927$PER$$US-PFIZER INC-202400265220$PFIZER$$$$$F$Y$$$20240927$$HP$US$US
243744331$24374433$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-2023SGN12707$PFIZER$$$$$M$Y$$$20240927$$HP$US$US
243744341$24374434$1$I$$20240925$20240927$20240927$EXP$$IL-REGENERON PHARMACEUTICALS, INC.-2024-129553$REGENERON$Keren Rouvinov. Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience$$$$M$Y$$$20240927$$MD$IL$IL
243744351$24374435$1$I$20240101$20240923$20240927$20240927$PER$$US-ORGANON-O2408USA001915$ORGANON$$$$$F$Y$136.51$KG$20240927$$MD$US$US
243744361$24374436$1$I$20240917$20240920$20240927$20240927$PER$$US-RDY-SPO/USA/24/0014031$DR REDDYS$$54$YR$A$F$Y$$$20240927$$HP$US$US
243744371$24374437$1$I$$20240920$20240927$20240927$EXP$US-MLMSERVICE-20240913-PI191938-00217-1$US-RDY-SPO/USA/24/0014049$DR REDDYS$Malani KA, Finn A. Metformin-associated lactic acidosis: a serious complication of a common drug. BMJ case reports. 2024;17(9): e260592. DOI: 10.1136/bcr-2024-260592.$8$DEC$E$M$Y$$$20240927$$MD$US$US
243744381$24374438$1$I$$20240925$20240927$20240927$EXP$$JP-PFIZER INC-PV202400125635$PFIZER$$$$$$Y$$$20240927$$MD$JP$JP
243744391$24374439$1$I$20220913$20240925$20240927$20240927$EXP$$DE-PFIZER INC-202400263976$PFIZER$$63$YR$$M$Y$124$KG$20240927$$HP$DE$DE
243744401$24374440$1$I$20240828$20240926$20240927$20240927$EXP$FR-AFSSAPS-GR2024001150$FR-PFIZER INC-202400264362$PFIZER$$68$YR$$F$Y$38$KG$20240927$$PH$FR$FR
243744411$24374441$1$I$20240701$20240925$20240927$20240927$PER$$US-ABBVIE-5941102$ABBVIE$$$$$$Y$$$20240927$$CN$US$US
243744421$24374442$1$I$$20240916$20240927$20240927$EXP$$US-BAXTER-2024BAX024766$BAXTER$$12$YR$$M$Y$$$20240927$$MD$US$US
243744441$24374444$1$I$20240731$20240924$20240927$20240927$EXP$HR-HALMED-300086568$HR-MYLANLABS-2024M1086949$MYLAN$$72$YR$$F$Y$70$KG$20240927$$MD$HR$HR
243744451$24374445$1$I$$20240919$20240927$20240927$EXP$$US-TAKEDA-2024TUS093343$TAKEDA$$$$$$Y$$$20240927$$CN$US$US
243744461$24374446$1$I$$20240913$20240927$20240927$EXP$$AU-PHARMAAND GMBH-2024PHR00535$pharmaAND$$$$$M$Y$$$20240927$$MD$AU$AU
243744471$24374447$1$I$20240101$20240912$20240927$20240927$EXP$$US-AVADEL CNS PHARMACEUTICALS, LLC-2024AVA01730$AVADEL CNS PHARMA$$$$$F$Y$$$20240927$$CN$US$US
243744481$24374448$1$I$$20240924$20240927$20240927$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-016112$JAZZ$$$$$F$Y$$$20240927$$CN$US$US
243744491$24374449$1$I$$20240926$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083421$SANDOZ$$$$$F$Y$$$20240927$$CN$US$US
243744501$24374450$1$I$20240315$20240918$20240927$20240927$EXP$$US-UCBSA-2024048278$UCB$$64$YR$$M$Y$$$20240927$$CN$US$US
243744511$24374451$1$I$$20240920$20240927$20240927$EXP$$GB-ABBVIE-5935653$ABBVIE$$$$E$M$Y$$$20240927$$MD$GB$GB
243744521$24374452$1$I$$20240913$20240927$20240927$EXP$$ES-FENNEC PHARMACEUTICALS, INC.-2024FEN00043$FENNEC PHARMACEUTICALS$Cucchiari D, Guillen-olmos E, Torregrosa JV, et al. Development of calciphylaxis in kidney trans-plant recipients with a functioning graft. Clinical Kidney Journal. 2022;15(Issue_4):663-671$49$YR$$F$Y$$$20240927$$HP$ES$ES
243744531$24374453$1$I$$20240927$20240927$20240927$DIR$720335$$FDA-CTU$$45$YR$$M$N$$$20240927$N$PH$US$
243744541$24374454$1$I$20240811$20240917$20240927$20240927$PER$$US-Eisai-EC-2024-175497$EISAI$$78$YR$E$F$Y$$$20240927$$CN$US$US
243744551$24374455$1$I$$20240916$20240927$20240927$EXP$$US-CHIESI-2024CHF06182$CHIESI$Hernandez CL, Lynch DM, Golash AJ, Marquis K, Besz KM, Oxnard G, et al.. Anaphylaxis and systemic mastocytosis controlled with KIT inhibitors in a patient with metastatic lung adenocarcinoma. Ann-Allergy-Asthma-Immunol. 2023;131668-670$58$YR$$F$Y$$$20240927$$HP$US$US
243744561$24374456$1$I$$20240917$20240927$20240927$PER$$US-TEVA-VS-3245436$TEVA$$$$$M$Y$$$20240927$$HP$US$US
243744571$24374457$1$I$20240923$20240923$20240927$20240927$30DAY$$US-SANDOZ INC.-SDZ2024US082572$SANDOZ$$41$YR$$F$Y$$$20240927$$HP$US$US
243744581$24374458$1$I$20240801$20240920$20240927$20240927$EXP$FR-AFSSAPS-RN2024001010$FR-TEVA-VS-3246625$TEVA$$62$YR$$M$Y$111$KG$20240927$$MD$FR$FR
243744591$24374459$1$I$$20240917$20240927$20240927$EXP$$CA-TEVA-VS-3245284$TEVA$$$$A$F$Y$$$20240927$$HP$CA$CA
243744611$24374461$1$I$$20240926$20240927$20240927$PER$$US-HALEON-2199096$Haleon PLC$$$$$$Y$$$20240927$$CN$US$US
243744621$24374462$1$I$$20240924$20240927$20240927$EXP$$JP-ABBVIE-5937904$ABBVIE$$$$$$Y$$$20240927$$PH$JP$JP
243744631$24374463$1$I$$20240925$20240927$20240927$EXP$$CN-PAIPHARMA-2024-CN-000399$PHARMACEUTICAL ASSOC$Dai R, Niu Z, Yang Y, et al.Case report: Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by ceftazidime in a connective tissue disease (CTD) patient..Frontiers in Pharmacology.2024;15.$58$YR$$F$Y$$$20240927$$HP$CN$CN
243744641$24374464$1$I$$20240911$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN010097$INCYTE$Greenzaid J, Hrin M, Feldman S, Strowd L. 51654 JAK-inhibitors for moderate-severe atopic dermatitis non-responsive to dupilumab: a retrospective study of 12 patient. J AM ACAD DERMATOL. 2024;91(3):AB246$$$$$Y$$$20240927$$HP$US$US
243744651$24374465$1$I$$20240917$20240927$20240927$EXP$$US-ALXN-202409USA000852US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240927$$$US$US
243744661$24374466$1$I$$20240925$20240927$20240927$EXP$$CA-SANDOZ INC.-SDZ2024CA083145$SANDOZ$$17$YR$$M$Y$$$20240927$$HP$CA$CA
243744671$24374467$1$I$20170101$20240920$20240927$20240927$EXP$$US-TAKEDA-2024TUS095185$TAKEDA$$$$$F$Y$88$KG$20240927$$CN$US$US
243744691$24374469$1$I$$20240925$20240927$20240927$PER$$US-PFIZER INC-PV202400126354$PFIZER$$$$A$F$Y$$$20240927$$MD$US$US
243744701$24374470$1$I$$20240920$20240927$20240927$EXP$$DE-TEVA-VS-3246163$TEVA$$84$YR$$F$Y$$$20240927$$CN$DE$DE
243744721$24374472$1$I$$20240916$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009783$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243744731$24374473$1$I$$20240924$20240927$20240927$EXP$$US-SANDOZ INC.-SDZ2024US083045$SANDOZ$HAAG AL, CHEN E, MCCARVER SC. HYPERAMMONEMIA IN THE ICU: A CASE OF FATAL DISCOVERY. CHEST. 2024;166(4):A1874-5.$65$YR$$M$Y$$$20240927$$HP$US$US
243744741$24374474$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024115644$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243744751$24374475$1$I$$20240904$20240927$20240927$PER$$US-Eisai-EC-2024-173706$EISAI$Kong BL, Stommel JM, Keck JM, Kilburn D, Streblow A, Egger J, et al. Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Garcinoma With Human Epidermal Growth Factor Receptor 2 Expression. JCO Precision Oncology. 2024;1-7. doi:https://doi.org/10.1200/PO.23.00686.$67$YR$E$F$Y$$$20240927$$PH$US$US
243744761$24374476$1$I$$20240920$20240927$20240927$EXP$$JP-JAZZ PHARMACEUTICALS-2024-JP-016473$JAZZ$$68$YR$$$Y$$$20240927$$MD$JP$JP
243744771$24374477$1$I$20230101$20240921$20240927$20240927$EXP$$PL-ABBVIE-5904787$ABBVIE$$74$YR$$M$Y$$$20240927$$MD$PL$PL
243744781$24374478$1$I$20240922$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016245$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240927$$CN$US$US
243744791$24374479$1$I$20240401$20240920$20240927$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202212003566$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240927$$CN$US$US
243744801$24374480$1$I$20240924$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016309$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240927$$CN$US$US
243744821$24374482$1$I$$20240925$20240927$20240927$EXP$$JP-PAIPHARMA-2024-JP-000266$PHARMACEUTICAL ASSOC$Fujii M, Fujimoto Y, Hiranuma N, Ohashi Y.Refractory vasospastic angina in a patient with autoimmune hepatitis managed by using combined non-invasive provocation tests: A case report..Journal of Cardiology Cases.2024;.$49$YR$$M$Y$61$KG$20240927$$MD$JP$JP
243744831$24374483$1$I$$20240923$20240927$20240927$EXP$$DE-MYLANLABS-2024M1086599$MYLAN$$$$$M$Y$$$20240927$$CN$DE$DE
243744851$24374485$1$I$20240918$20240919$20240927$20240927$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR117236$VIIV$$37$YR$$M$Y$$$20240927$$CN$US$US
243744861$24374486$1$I$20240901$20240925$20240927$20240927$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-016391$JAZZ$$18$YR$$F$Y$28.9$KG$20240927$$CN$US$US
243744871$24374487$1$I$20240904$20240917$20240927$20240927$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005337$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240927$$HP$US$US
243744891$24374489$1$I$$20240924$20240927$20240927$EXP$$US-PFIZER INC-202400263278$PFIZER$Dhillon, J.. A BRIDGE TO LUNG TRANSPLANT: A CASE OF BLEOMYCIN-INDUCED LUNG INJURY TREATED WITH VENO-VENOUS ECMO IN A YOUNG FEMALE. Chest. 2024;166 (4 Suppl):A6276-A6277$27$YR$$F$Y$$$20240927$$HP$US$US
243744901$24374490$1$I$20240801$20240924$20240927$20240927$EXP$FR-AFSSAPS-LM2024000520$FR-PFIZER INC-202400262661$PFIZER$$54$YR$$F$Y$$$20240927$$MD$FR$FR
243744911$24374491$1$I$$20240924$20240927$20240927$EXP$$US-AMGEN-USASP2024191260$AMGEN$$78$YR$E$F$Y$$$20240927$$PH$US$US
243744921$24374492$1$I$$20240925$20240927$20240927$PER$$US-ABBVIE-5938680$ABBVIE$$$$$$Y$$$20240927$$HP$US$US
243744931$24374493$1$I$$20240923$20240927$20240927$EXP$$CA-BAUSCH-BL-2024-014322$BAUSCH AND LOMB$$43$YR$$F$Y$$$20240927$$HP$CA$CA
243744941$24374494$1$I$20171127$20240924$20240927$20240927$EXP$$CA-PFIZER INC-2017524184$PFIZER$$59$YR$$F$Y$$$20240927$$CN$CA$CA
243744951$24374495$1$I$20240922$20240925$20240927$20240927$EXP$$CN-PFIZER INC-PV202400125685$PFIZER$$35$YR$$F$Y$55$KG$20240927$$HP$CN$CN
243744981$24374498$1$I$20240914$20240923$20240927$20240927$EXP$$CN-SA-2024SA277100$SANOFI AVENTIS$$80$YR$E$M$Y$66$KG$20240927$$CN$CN$CN
243745021$24374502$1$I$20240901$20240924$20240927$20240927$EXP$$US-SA-2024SA277124$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240927$$MD$US$US
243745031$24374503$1$I$$20240919$20240927$20240927$EXP$$US-MYLANLABS-2024M1086638$MYLAN$Hagstrom M, Kabbur G, Schultz B, Bigliardi P, Giubellino A. Immune Checkpoint Inhibitor-Induced Lichen Planus Pemphigoides: Report of Two Cases. Dermatitis 2023; 34 (6): 557-559.$60$YR$$M$Y$$$20240927$$HP$US$US
243745041$24374504$1$I$$20240924$20240927$20240927$EXP$$CA-MYLANLABS-2024M1086824$MYLAN$$$$$M$Y$3$KG$20240927$$HP$CA$CA
243745061$24374506$1$I$$20240918$20240927$20240927$EXP$$JP-UCBSA-2024048489$UCB$$9$YR$$M$Y$$$20240927$$MD$JP$JP
243745071$24374507$1$I$20240831$20240903$20240927$20240927$PER$$US-Eisai-EC-2024-173710$EISAI$$$$$F$Y$$$20240927$$CN$US$US
243745081$24374508$1$I$20240101$20240911$20240927$20240927$PER$$US-MYLANLABS-2024M1083825$MYLAN$$$$$$Y$$$20240927$$CN$US$US
243745101$24374510$1$I$20240901$20240912$20240927$20240927$PER$$US-MYLANLABS-2024M1083969$MYLAN$$81$YR$$F$Y$69.4$KG$20240927$$CN$US$US
243745111$24374511$1$I$20240902$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016423$ELI LILLY AND CO$$63$YR$A$M$Y$$$20240927$$CN$US$US
243745121$24374512$1$I$20240908$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016413$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240927$$CN$US$US
243745131$24374513$1$I$20240914$20240920$20240927$20240927$EXP$GB-MHRA-TPP27037237C20797556YC1726572370543$GB-TEVA-VS-3246595$TEVA$$11$YR$$F$Y$37$KG$20240927$$PH$GB$GB
243745141$24374514$1$I$$20240923$20240927$20240927$EXP$$CA-BAUSCH-BL-2024-014330$BAUSCH AND LOMB$$50$YR$$F$Y$$$20240927$$HP$CA$CA
243745151$24374515$1$I$$20240927$20240927$20240927$PER$$US-BAUSCH-BL-2024-014530$BAUSCH AND LOMB$$91$YR$$F$Y$$$20240927$$HP$US$US
243745161$24374516$1$I$$20240924$20240927$20240927$EXP$$US-PURDUE-USA-2024-0312202$PURDUE$Gibbons K, Morris J.. Delta-8 Tetrahydrocannabinol in the Emergency Department: A Case Series. WMJ : official publication of the State Medical Society of Wisconsin. 2023;123(4):300-303$45$YR$$F$Y$$$20240927$$PH$US$US
243745171$24374517$1$I$$20240924$20240927$20240927$EXP$$US-PURDUE PHARMA-USA-2024-0312200$PURDUE$SALABASHEVA A, LADNIER E, ISLAM MM. A rare case of methemoglobinemia from over-the-counter medication use. Chest. 2024;166(4):A2298$40$YR$$F$Y$$$20240927$$HP$US$US
243745181$24374518$1$I$$20240923$20240927$20240927$EXP$$CA-BAUSCH-BL-2024-014370$BAUSCH AND LOMB$$52$YR$$F$Y$$$20240927$$HP$CA$CA
243745211$24374521$1$I$$20240925$20240927$20240927$EXP$$CA-PFIZER INC-202400264717$PFIZER$$63$YR$$M$Y$$$20240927$$HP$CA$CA
243745221$24374522$1$I$20240804$20240920$20240927$20240927$EXP$FR-AFSSAPS-AM2024000737$FR-TEVA-VS-3246618$TEVA$$60$YR$$F$Y$80$KG$20240927$$PH$FR$FR
243745231$24374523$1$I$$20240926$20240927$20240927$EXP$$US-OTSUKA-2024_026827$OTSUKA$$$$$F$Y$$$20240927$$HP$US$US
243745241$24374524$1$I$$20240920$20240927$20240927$EXP$$US-VERTEX PHARMACEUTICALS-2024-015203$VERTEX$Cohen LA, Ratti GA, Gorman AR, Garcia B, Mingora CM.. Long-term clinical efficacy of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis + pre-existing advanced lung disease at treatment initiation. Chest Pulm. 2024;100099$$$A$$Y$$$20240927$$MD$US$US
243745251$24374525$1$I$20240701$20240924$20240927$20240927$EXP$FR-AFSSAPS-PV2024000860$FR-VERTEX PHARMACEUTICALS-2024-015081$VERTEX$$2$YR$$F$Y$13$KG$20240927$$MD$FR$FR
243745261$24374526$1$I$$20240924$20240927$20240927$30DAY$$FR-PFIZER INC-PV202400125420$PFIZER$$13$YR$$M$Y$$$20240927$$CN$FR$FR
243745271$24374527$1$I$20230101$20240917$20240927$20240927$EXP$$GB-TAKEDA-2024TUS093696$TAKEDA$$85$YR$$M$Y$$$20240927$$CN$GB$GB
243745281$24374528$1$I$$20240920$20240927$20240927$EXP$GB-MHRA-TPP22185896C8670791YC1726738025150$GB-TEVA-VS-3246481$TEVA$$66$YR$$F$Y$76$KG$20240927$$MD$GB$GB
243745301$24374530$1$I$$20240920$20240927$20240927$EXP$GB-MHRA-MED-202409202318273010-BDVRT$GB-TEVA-VS-3246855$TEVA$$43$YR$$F$Y$$$20240927$$CN$GB$GB
243745311$24374531$1$I$20240815$20240924$20240927$20240927$EXP$GB-MHRA-MED-202409241304265060-JWCRF$GB-MYLANLABS-2024M1086950$MYLAN$$74$YR$$M$Y$74$KG$20240927$$MD$GB$GB
243745321$24374532$1$I$20240101$20240924$20240927$20240927$PER$$US-009507513-2409USA008754$MERCK$$$$$F$Y$86.2$KG$20240927$$CN$US$US
243745331$24374533$1$I$$20240926$20240927$20240927$PER$$US-PURDUE PHARMA-USA-2024-0312221$PURDUE$$$$$M$Y$$$20240927$$CN$US$US
243745341$24374534$1$I$20240922$20240922$20240927$20240927$EXP$GB-MHRA-MED-202409222216251410-MQVSB$GB-TEVA-VS-3246787$TEVA$$41$YR$$F$Y$167$KG$20240927$$CN$GB$GB
243745351$24374535$1$I$$20240924$20240927$20240927$EXP$$US-JAZZ PHARMACEUTICALS-2024-US-016233$JAZZ$$$$$F$Y$$$20240927$$CN$US$US
243745361$24374536$1$I$$20240921$20240927$20240927$EXP$$GB-TEVA-VS-3246955$TEVA$$90$YR$$F$Y$$$20240927$$CN$GB$GB
243745381$24374538$1$I$$20240904$20240927$20240927$PER$$US-Eisai-EC-2024-173740$EISAI$$$$$F$Y$$$20240927$$HP$US$US
243745391$24374539$1$I$$20240924$20240927$20240927$EXP$$CA-MYLANLABS-2024M1086822$MYLAN$$82$YR$$F$Y$54$KG$20240927$$HP$CA$CA
243745401$24374540$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245702$TEVA$$10$YR$$F$Y$37$KG$20240927$$HP$CA$CA
243745411$24374541$1$I$$20240922$20240927$20240927$EXP$$EU-BAUSCHBL-2024BNL033851$BAUSCH AND LOMB$$54$YR$$M$Y$$$20240927$$CN$EU$EU
243745431$24374543$1$I$$20240919$20240927$20240927$EXP$$GH-GE HEALTHCARE-2024CSU010782$GE HEALTHCARE$$$$$M$Y$$$20240927$$HP$GH$GH
243745441$24374544$1$I$$20240920$20240927$20240927$PER$$US-JNJFOC-20240959954$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20240927$$HP$US$US
243745451$24374545$1$I$$20240917$20240927$20240927$EXP$$EG-GE HEALTHCARE-2024CSU010860$GE HEALTHCARE$$$$$F$Y$$$20240927$$HP$EG$EG
243745461$24374546$1$I$$20240919$20240927$20240927$EXP$$CA-BAUSCHBL-2024BNL034078$BAUSCH AND LOMB$$73$YR$$F$Y$$$20240927$$CN$CA$CA
243745471$24374547$1$I$$20240918$20240927$20240927$30DAY$$US-SA-2024SA272670$SANOFI AVENTIS$$$$A$$Y$$$20240927$$PH$US$US
243745481$24374548$1$I$$20240913$20240927$20240927$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01505$INTRA-CELLULAR THERAPIES$$$$$F$Y$$$20240927$$MD$US$US
243745491$24374549$1$I$$20240923$20240927$20240927$EXP$$GB-GILEAD-2024-0688584$GILEAD$$$$E$M$Y$$$20240927$$HP$GB$GB
243745501$24374550$1$I$20230609$20240920$20240927$20240927$EXP$FR-AFSSAPS-AM2024000732$FR-TEVA-VS-3246495$TEVA$$18$YR$$M$Y$105$KG$20240927$$MD$FR$FR
243745511$24374551$1$I$$20240926$20240927$20240927$EXP$$US-BAUSCH-BL-2024-014555$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240927$$CN$US$US
243745581$24374558$1$I$$20240919$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009976$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243745591$24374559$1$I$$20240919$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009967$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243745601$24374560$1$I$20240101$20240829$20240927$20240927$PER$$US-SA-2024SA268948$SANOFI AVENTIS$$29$YR$A$M$Y$82.27$KG$20240927$$MD$US$US
243745611$24374561$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA273336$SANOFI AVENTIS$$22$YR$A$M$Y$85$KG$20240927$$HP$US$US
243745641$24374564$1$I$$20240829$20240927$20240927$PER$$US-SA-2024SA277265$SANOFI AVENTIS$$$$E$F$Y$52.27$KG$20240927$$MD$US$US
243745651$24374565$1$I$20240831$20240904$20240927$20240927$PER$$US-SA-2024SA275533$SANOFI AVENTIS$$$$$F$Y$$$20240927$$MD$US$US
243745661$24374566$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA273450$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240927$$CN$US$US
243745671$24374567$1$I$20240801$20240904$20240927$20240927$PER$$US-SA-2024SA273442$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240927$$MD$US$US
243745681$24374568$1$I$20240101$20240830$20240927$20240927$PER$$US-SA-2024SA270919$SANOFI AVENTIS$$2$YR$C$F$Y$13$KG$20240927$$MD$US$US
243745691$24374569$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA273409$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
243745701$24374570$1$I$20240101$20240829$20240927$20240927$PER$$US-SA-2024SA268278$SANOFI AVENTIS$$39$YR$A$F$Y$95.59$KG$20240927$$MD$US$US
243745711$24374571$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA273383$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
243745721$24374572$1$I$20240101$20240904$20240927$20240927$PER$$US-SA-2024SA274786$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240927$$HP$US$US
243745731$24374573$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA277232$SANOFI AVENTIS$$$$A$M$Y$97$KG$20240927$$MD$US$US
243745741$24374574$1$I$$20240903$20240927$20240927$PER$$US-SA-2024SA273755$SANOFI AVENTIS$$$$C$M$Y$$$20240927$$MD$US$US
243745751$24374575$1$I$$20240903$20240927$20240927$PER$$US-SA-2024SA271078$SANOFI AVENTIS$$46$YR$A$F$Y$65.24$KG$20240927$$MD$US$US
243745761$24374576$1$I$20240301$20240903$20240927$20240927$PER$$US-SA-2024SA273565$SANOFI AVENTIS$$48$YR$A$M$Y$54.88$KG$20240927$$HP$US$US
243745771$24374577$1$I$20240101$20240904$20240927$20240927$PER$$US-SA-2024SA266607$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240927$$MD$US$US
243745781$24374578$1$I$20240101$20240830$20240927$20240927$PER$$US-SA-2024SA274849$SANOFI AVENTIS$$44$YR$A$F$Y$71.6$KG$20240927$$MD$US$US
243745791$24374579$1$I$$20240903$20240927$20240927$PER$$UM-SA-2024SA273593$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
243745801$24374580$1$I$$20240919$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009960$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243745811$24374581$1$I$20240601$20240920$20240927$20240927$EXP$$US-GSK-US2024117136$GLAXOSMITHKLINE$$$$$$Y$$$20240927$$CN$US$US
243745821$24374582$1$I$$20240903$20240927$20240927$PER$$US-SA-2024SA273958$SANOFI AVENTIS$$$$A$M$Y$86.36$KG$20240927$$MD$US$US
243745831$24374583$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA274990$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$HP$US$US
243745841$24374584$1$I$$20240912$20240927$20240927$EXP$$US-SAMSUNG BIOEPIS-SB-2024-28097$SAMSUNG BIOEPIS$Mahtani R, Harpalani N. Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series. Frontiers in Oncology. 2024 Aug 16;1-7. doi:10.3389/fonc.2024.1419246.$72$YR$E$F$Y$$$20240927$$HP$US$US
243745861$24374586$1$I$20240101$20240905$20240927$20240927$PER$$US-SA-2024SA274300$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240927$$CN$US$US
243745871$24374587$1$I$20240101$20240905$20240927$20240927$PER$$US-SA-2024SA276287$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240927$$CN$US$US
243745881$24374588$1$I$20240903$20240905$20240927$20240927$PER$$US-SA-2024SA273531$SANOFI AVENTIS$$42$YR$A$F$Y$70.45$KG$20240927$$MD$US$US
243745891$24374589$1$I$20240801$20240905$20240927$20240927$PER$$US-SA-2024SA274106$SANOFI AVENTIS$$40$YR$A$F$Y$70.91$KG$20240927$$MD$US$US
243745901$24374590$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA273054$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240927$$CN$US$US
243745911$24374591$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA273473$SANOFI AVENTIS$$$$A$M$Y$$$20240927$$MD$US$US
243745921$24374592$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA273927$SANOFI AVENTIS$$$$$M$Y$$$20240927$$CN$US$US
243745931$24374593$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA272818$SANOFI AVENTIS$$62$YR$A$$Y$$$20240927$$MD$US$US
243745941$24374594$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA273415$SANOFI AVENTIS$$$$A$F$Y$56.82$KG$20240927$$MD$US$US
243745951$24374595$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA275850$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240927$$CN$US$US
243745961$24374596$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA278156$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240927$$HP$US$US
243745971$24374597$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA273096$SANOFI AVENTIS$$$$E$M$Y$$$20240927$$MD$US$US
243745981$24374598$1$I$20240401$20240903$20240927$20240927$PER$$US-SA-2024SA273724$SANOFI AVENTIS$$66$YR$E$M$Y$108$KG$20240927$$MD$US$US
243745991$24374599$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA272819$SANOFI AVENTIS$$37$YR$A$$Y$$$20240927$$MD$US$US
243746001$24374600$1$I$20240801$20240903$20240927$20240927$PER$$US-SA-2024SA273622$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240927$$MD$US$US
243746011$24374601$1$I$20240101$20240905$20240927$20240927$PER$$US-SA-2024SA279053$SANOFI AVENTIS$$$$A$$Y$$$20240927$$HP$US$US
243746021$24374602$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA272945$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240927$$MD$US$US
243746031$24374603$1$I$20240427$20240903$20240927$20240927$PER$$US-SA-2024SA276046$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240927$$PH$US$US
243746041$24374604$1$I$20240801$20240905$20240927$20240927$PER$$US-SA-2024SA273406$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240927$$MD$US$US
243746051$24374605$1$I$20240101$20240905$20240927$20240927$PER$$US-SA-2024SA273797$SANOFI AVENTIS$$$$A$F$Y$84.8$KG$20240927$$MD$US$US
243746061$24374606$1$I$20220101$20240903$20240927$20240927$PER$$US-SA-2024SA275496$SANOFI AVENTIS$$8$YR$C$M$Y$27.27$KG$20240927$$MD$US$US
243746071$24374607$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA278329$SANOFI AVENTIS$$39$YR$A$F$Y$131$KG$20240927$$HP$US$US
243746081$24374608$1$I$20240901$20240919$20240927$20240927$PER$$US-009507513-2409USA007293$MERCK$$68$YR$$M$Y$$$20240927$$CN$US$US
243746091$24374609$1$I$20240801$20240904$20240927$20240927$PER$$US-SA-2024SA273332$SANOFI AVENTIS$$41$YR$A$M$Y$84.09$KG$20240927$$MD$US$US
243746101$24374610$1$I$20240101$20240904$20240927$20240927$PER$$US-SA-2024SA276471$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240927$$MD$US$US
243746111$24374611$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA274047$SANOFI AVENTIS$$$$C$M$Y$$$20240927$$HP$US$US
243746121$24374612$1$I$$20240904$20240927$20240927$PER$$US-SA-2024SA273838$SANOFI AVENTIS$$$$A$F$Y$89.09$KG$20240927$$MD$US$US
243746131$24374613$1$I$20240901$20240905$20240927$20240927$PER$$US-SA-2024SA276233$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240927$$MD$US$US
243746141$24374614$1$I$20240801$20240905$20240927$20240927$PER$$US-SA-2024SA274374$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240927$$CN$US$US
243746151$24374615$1$I$20240101$20240905$20240927$20240927$PER$$US-SA-2024SA274918$SANOFI AVENTIS$$81$YR$E$F$Y$77.27$KG$20240927$$MD$US$US
243746161$24374616$1$I$20240101$20240905$20240927$20240927$PER$$US-SA-2024SA277130$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240927$$CN$US$US
243746171$24374617$1$I$20240101$20240905$20240927$20240927$PER$$US-SA-2024SA279220$SANOFI AVENTIS$$74$YR$E$M$Y$79.55$KG$20240927$$MD$US$US
243746181$24374618$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA273549$SANOFI AVENTIS$$$$E$F$Y$$$20240927$$MD$US$US
243746191$24374619$1$I$20240101$20240905$20240927$20240927$PER$$US-SA-2024SA274362$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240927$$CN$US$US
243746201$24374620$1$I$$20240919$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009966$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243746211$24374621$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA273255$SANOFI AVENTIS$$$$E$M$Y$$$20240927$$MD$US$US
243746231$24374623$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276446$SANOFI AVENTIS$$$$E$M$Y$120.91$KG$20240927$$MD$US$US
243746241$24374624$1$I$$20240905$20240927$20240927$PER$$US-SA-2024SA274162$SANOFI AVENTIS$$$$$$Y$$$20240927$$CN$US$US
243746251$24374625$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276186$SANOFI AVENTIS$$78$YR$E$F$Y$38.18$KG$20240927$$CN$US$US
243746261$24374626$1$I$20240101$20240906$20240927$20240927$PER$$US-SA-2024SA277810$SANOFI AVENTIS$$54$YR$A$M$Y$88.4$KG$20240927$$MD$US$US
243746271$24374627$1$I$20240101$20240906$20240927$20240927$PER$$US-SA-2024SA274585$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240927$$HP$US$US
243746281$24374628$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA274305$SANOFI AVENTIS$$32$YR$A$F$Y$77.27$KG$20240927$$MD$US$US
243746291$24374629$1$I$20240906$20240906$20240927$20240927$PER$$US-SA-2024SA277239$SANOFI AVENTIS$$43$YR$A$F$Y$104.55$KG$20240927$$MD$US$US
243746301$24374630$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA274622$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240927$$MD$US$US
243746311$24374631$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276990$SANOFI AVENTIS$$$$A$F$Y$60$KG$20240927$$MD$US$US
243746321$24374632$1$I$20240101$20240906$20240927$20240927$PER$$US-SA-2024SA274231$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240927$$HP$US$US
243746331$24374633$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276259$SANOFI AVENTIS$$$$E$F$Y$$$20240927$$MD$US$US
243746351$24374635$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276587$SANOFI AVENTIS$$$$A$F$Y$74.38$KG$20240927$$MD$US$US
243746361$24374636$1$I$20240905$20240906$20240927$20240927$PER$$US-SA-2024SA276291$SANOFI AVENTIS$$59$YR$A$M$Y$101.82$KG$20240927$$MD$US$US
243746371$24374637$1$I$20240701$20240906$20240927$20240927$PER$$US-SA-2024SA278322$SANOFI AVENTIS$$56$YR$A$F$Y$66.36$KG$20240927$$MD$US$US
243746381$24374638$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276811$SANOFI AVENTIS$$$$A$F$Y$72.45$KG$20240927$$MD$US$US
243746391$24374639$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276580$SANOFI AVENTIS$$$$E$M$Y$92.68$KG$20240927$$MD$US$US
243746401$24374640$1$I$20240101$20240906$20240927$20240927$PER$$US-SA-2024SA276791$SANOFI AVENTIS$$48$YR$A$F$Y$77.11$KG$20240927$$MD$US$US
243746411$24374641$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA274604$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240927$$HP$US$US
243746421$24374642$1$I$20240101$20240906$20240927$20240927$PER$$US-SA-2024SA277952$SANOFI AVENTIS$$$$$F$Y$$$20240927$$MD$US$US
243746431$24374643$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276692$SANOFI AVENTIS$$$$E$F$Y$65.91$KG$20240927$$MD$US$US
243746441$24374644$1$I$20240801$20240906$20240927$20240927$PER$$US-SA-2024SA274713$SANOFI AVENTIS$$27$YR$A$F$Y$60.91$KG$20240927$$HP$US$US
243746451$24374645$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276841$SANOFI AVENTIS$$$$A$F$Y$54.55$KG$20240927$$MD$US$US
243746461$24374646$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA274540$SANOFI AVENTIS$$65$YR$E$F$Y$100.45$KG$20240927$$HP$US$US
243746471$24374647$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA275286$SANOFI AVENTIS$$$$E$F$Y$$$20240927$$MD$US$US
243746481$24374648$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276680$SANOFI AVENTIS$$65$YR$E$F$Y$58.9$KG$20240927$$MD$US$US
243746491$24374649$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA274243$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240927$$HP$US$US
243746501$24374650$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA274695$SANOFI AVENTIS$$$$A$M$Y$$$20240927$$MD$US$US
243746511$24374651$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA274995$SANOFI AVENTIS$$$$A$F$Y$81.6$KG$20240927$$MD$US$US
243746521$24374652$1$I$20240101$20240906$20240927$20240927$PER$$US-SA-2024SA274498$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240927$$MD$US$US
243746531$24374653$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA275110$SANOFI AVENTIS$$$$A$M$Y$57.45$KG$20240927$$MD$US$US
243746541$24374654$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA278038$SANOFI AVENTIS$$$$C$M$Y$$$20240927$$MD$US$US
243746551$24374655$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA277095$SANOFI AVENTIS$$82$YR$E$M$Y$$$20240927$$CN$US$US
243746571$24374657$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA274675$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240927$$MD$US$US
243746581$24374658$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276322$SANOFI AVENTIS$$$$A$F$Y$52.73$KG$20240927$$MD$US$US
243746591$24374659$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA275132$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
243746601$24374660$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276875$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240927$$CN$US$US
243746611$24374661$1$I$20240101$20240906$20240927$20240927$PER$$US-SA-2024SA276803$SANOFI AVENTIS$$$$A$F$Y$77.27$KG$20240927$$HP$US$US
243746621$24374662$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA277626$SANOFI AVENTIS$$$$E$F$Y$$$20240927$$MD$US$US
243746631$24374663$1$I$20240829$20240906$20240927$20240927$PER$$US-SA-2024SA276016$SANOFI AVENTIS$$54$YR$A$F$Y$69.841$KG$20240927$$MD$US$US
243746641$24374664$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276779$SANOFI AVENTIS$$$$E$M$Y$79.55$KG$20240927$$MD$US$US
243746651$24374665$1$I$20240801$20240906$20240927$20240927$PER$$US-SA-2024SA277449$SANOFI AVENTIS$$68$YR$E$F$Y$90.91$KG$20240927$$MD$US$US
243746661$24374666$1$I$20240101$20240907$20240927$20240927$PER$$US-SA-2024SA278901$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
243746671$24374667$1$I$$20240907$20240927$20240927$PER$$US-SA-2024SA276596$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240927$$MD$US$US
243746681$24374668$1$I$20240101$20240907$20240927$20240927$PER$$US-SA-2024SA274637$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240927$$MD$US$US
243746691$24374669$1$I$$20240906$20240927$20240927$PER$$US-SA-2024SA276225$SANOFI AVENTIS$$$$A$M$Y$74.55$KG$20240927$$MD$US$US
243746701$24374670$1$I$20240905$20240906$20240927$20240927$PER$$US-SA-2024SA276795$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240927$$MD$US$US
243746711$24374671$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA275719$SANOFI AVENTIS$$65$YR$E$$Y$$$20240927$$CN$US$US
243746721$24374672$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277400$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
243746731$24374673$1$I$20240101$20240911$20240927$20240927$PER$$US-SA-2024SA278916$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240927$$CN$US$US
243746741$24374674$1$I$20240101$20240911$20240927$20240927$PER$$US-SA-2024SA278838$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240927$$MD$US$US
243746751$24374675$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277447$SANOFI AVENTIS$$38$YR$A$M$Y$93.18$KG$20240927$$MD$US$US
243746761$24374676$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277880$SANOFI AVENTIS$$$$C$F$Y$$$20240927$$MD$US$US
243746771$24374677$1$I$$20240911$20240927$20240927$PER$$US-SA-2024SA278684$SANOFI AVENTIS$$$$E$F$Y$$$20240927$$MD$US$US
243746781$24374678$1$I$20231209$20240911$20240927$20240927$PER$$PR-SA-2024SA278922$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240927$$MD$PR$PR
243746791$24374679$1$I$20240701$20240909$20240927$20240927$PER$$US-SA-2024SA277523$SANOFI AVENTIS$$3$YR$C$F$Y$14.55$KG$20240927$$MD$US$US
243746811$24374681$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276836$SANOFI AVENTIS$$71$YR$E$$Y$$$20240927$$CN$US$US
243746821$24374682$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276787$SANOFI AVENTIS$$70$YR$E$$Y$$$20240927$$CN$US$US
243746831$24374683$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA277250$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
243746841$24374684$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA278101$SANOFI AVENTIS$$$$E$F$Y$$$20240927$$MD$US$US
243746851$24374685$1$I$20240101$20240909$20240927$20240927$PER$$US-SA-2024SA277462$SANOFI AVENTIS$$23$YR$A$F$Y$59.09$KG$20240927$$CN$US$US
243746861$24374686$1$I$20240101$20240909$20240927$20240927$PER$$US-SA-2024SA276793$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240927$$CN$US$US
243746871$24374687$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA278737$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240927$$HP$US$US
243746881$24374688$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276995$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240927$$CN$US$US
243746891$24374689$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277034$SANOFI AVENTIS$$54$YR$A$$Y$$$20240927$$CN$US$US
243746901$24374690$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277658$SANOFI AVENTIS$$$$A$M$Y$$$20240927$$MD$US$US
243746921$24374692$1$I$20240101$20240910$20240927$20240927$PER$$US-SA-2024SA277620$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240927$$MD$US$US
243746931$24374693$1$I$20240101$20240909$20240927$20240927$PER$$US-SA-2024SA277424$SANOFI AVENTIS$$20$YR$A$M$Y$131.5$KG$20240927$$MD$US$US
243746941$24374694$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277008$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
243746951$24374695$1$I$20240904$20240909$20240927$20240927$PER$$US-SA-2024SA277485$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240927$$CN$US$US
243746961$24374696$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276316$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240927$$CN$US$US
243746971$24374697$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276610$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
243746981$24374698$1$I$20240801$20240909$20240927$20240927$PER$$US-SA-2024SA277281$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240927$$HP$US$US
243746991$24374699$1$I$$20240911$20240927$20240927$PER$$US-SA-2024SA279046$SANOFI AVENTIS$$$$E$M$Y$81.36$KG$20240927$$MD$US$US
243747001$24374700$1$I$$20240919$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009955$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243747011$24374701$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276883$SANOFI AVENTIS$$$$A$F$Y$68$KG$20240927$$HP$US$US
243747021$24374702$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA278173$SANOFI AVENTIS$$14$YR$T$F$Y$63.9$KG$20240927$$MD$US$US
243747031$24374703$1$I$20240801$20240909$20240927$20240927$PER$$US-SA-2024SA278183$SANOFI AVENTIS$$62$YR$A$M$Y$95$KG$20240927$$MD$US$US
243747041$24374704$1$I$$20240911$20240927$20240927$PER$$US-SA-2024SA279601$SANOFI AVENTIS$$$$$$Y$$$20240927$$HP$US$US
243747051$24374705$1$I$20240101$20240911$20240927$20240927$PER$$US-SA-2024SA278893$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240927$$MD$US$US
243747061$24374706$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277305$SANOFI AVENTIS$$$$I$M$Y$$$20240927$$MD$US$US
243747071$24374707$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276202$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$HP$US$US
243747081$24374708$1$I$20240101$20240910$20240927$20240927$PER$$US-SA-2024SA278730$SANOFI AVENTIS$$54$YR$A$F$Y$90.91$KG$20240927$$MD$US$US
243747091$24374709$1$I$$20240911$20240927$20240927$PER$$US-SA-2024SA278821$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240927$$CN$US$US
243747101$24374710$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA278467$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240927$$HP$US$US
243747111$24374711$1$I$20240101$20240909$20240927$20240927$PER$$US-SA-2024SA277087$SANOFI AVENTIS$$83$YR$E$F$Y$$$20240927$$CN$US$US
243747121$24374712$1$I$20240701$20240909$20240927$20240927$PER$$US-SA-2024SA276174$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240927$$MD$US$US
243747131$24374713$1$I$20240701$20240909$20240927$20240927$PER$$US-SA-2024SA277398$SANOFI AVENTIS$$6$YR$C$M$Y$21.05$KG$20240927$$MD$US$US
243747141$24374714$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276026$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240927$$MD$US$US
243747151$24374715$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276340$SANOFI AVENTIS$$63$YR$A$$Y$$$20240927$$CN$US$US
243747161$24374716$1$I$$20240910$20240927$20240927$PER$$AE-SA-2024SA278560$SANOFI AVENTIS$$$$A$F$Y$55.79$KG$20240927$$MD$US$US
243747171$24374717$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA279062$SANOFI AVENTIS$$67$YR$E$M$Y$75$KG$20240927$$MD$US$US
243747181$24374718$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276219$SANOFI AVENTIS$$44$YR$A$$Y$$$20240927$$CN$US$US
243747191$24374719$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277085$SANOFI AVENTIS$$$$$M$Y$$$20240927$$MD$US$US
243747201$24374720$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277564$SANOFI AVENTIS$$$$T$F$Y$61.82$KG$20240927$$MD$US$US
243747211$24374721$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA277562$SANOFI AVENTIS$$65$YR$E$$Y$$$20240927$$CN$US$US
243747221$24374722$1$I$20240101$20240909$20240927$20240927$PER$$US-SA-2024SA276080$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240927$$MD$US$US
243747231$24374723$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277435$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240927$$MD$US$US
243747241$24374724$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA277701$SANOFI AVENTIS$$60$YR$A$$Y$$$20240927$$CN$US$US
243747251$24374725$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276971$SANOFI AVENTIS$$$$A$M$Y$$$20240927$$MD$US$US
243747261$24374726$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA277808$SANOFI AVENTIS$$$$A$F$Y$85.45$KG$20240927$$MD$US$US
243747271$24374727$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276726$SANOFI AVENTIS$$$$A$M$Y$96.16$KG$20240927$$MD$US$US
243747281$24374728$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277508$SANOFI AVENTIS$$$$A$F$Y$72.73$KG$20240927$$CN$US$US
243747291$24374729$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277274$SANOFI AVENTIS$$$$A$F$Y$26.36$KG$20240927$$CN$US$US
243747301$24374730$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA278682$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240927$$CN$US$US
243747311$24374731$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA277223$SANOFI AVENTIS$$68$YR$E$$Y$$$20240927$$CN$US$US
243747321$24374732$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277294$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240927$$HP$US$US
243747341$24374734$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA277185$SANOFI AVENTIS$$53$YR$A$$Y$$$20240927$$CN$US$US
243747351$24374735$1$I$20240905$20240909$20240927$20240927$PER$$US-SA-2024SA279144$SANOFI AVENTIS$$60$YR$A$M$Y$84.09$KG$20240927$$MD$US$US
243747361$24374736$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA276131$SANOFI AVENTIS$$$$A$M$Y$68.027$KG$20240927$$MD$US$US
243747381$24374738$1$I$20240902$20240909$20240927$20240927$PER$$US-SA-2024SA278448$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240927$$HP$US$US
243747391$24374739$1$I$$20240909$20240927$20240927$PER$$US-SA-2024SA277472$SANOFI AVENTIS$$$$A$F$Y$113.64$KG$20240927$$MD$US$US
243747401$24374740$1$I$20240101$20240910$20240927$20240927$PER$$US-SA-2024SA278355$SANOFI AVENTIS$$85$YR$E$F$Y$79.55$KG$20240927$$MD$US$US
243747411$24374741$1$I$20230119$20240910$20240927$20240927$PER$$US-SA-2024SA277241$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240927$$PH$US$US
243747421$24374742$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA277862$SANOFI AVENTIS$$$$A$M$Y$83.91$KG$20240927$$MD$US$US
243747431$24374743$1$I$20240901$20240909$20240927$20240927$PER$$US-SA-2024SA277883$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240927$$MD$US$US
243747441$24374744$1$I$20240901$20240910$20240927$20240927$PER$$US-SA-2024SA278186$SANOFI AVENTIS$$23$YR$A$M$Y$50$KG$20240927$$MD$US$US
243747461$24374746$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA280024$SANOFI AVENTIS$$60$YR$A$$Y$$$20240927$$CN$US$US
243747471$24374747$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA279175$SANOFI AVENTIS$$$$$M$Y$$$20240927$$CN$US$US
243747481$24374748$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA277457$SANOFI AVENTIS$$$$A$$Y$$$20240927$$MD$US$US
243747491$24374749$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA279793$SANOFI AVENTIS$$64$YR$A$$Y$$$20240927$$CN$US$US
243747501$24374750$1$I$20240301$20240909$20240927$20240927$PER$$US-SA-2024SA277144$SANOFI AVENTIS$$$$A$F$Y$85.91$KG$20240927$$MD$US$US
243747511$24374751$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA265414$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240927$$MD$US$US
243747521$24374752$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA278905$SANOFI AVENTIS$$$$A$M$Y$$$20240927$$MD$US$US
243747531$24374753$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA279363$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240927$$CN$US$US
243747541$24374754$1$I$$20240923$20240927$20240927$EXP$$GR-REGENERON PHARMACEUTICALS, INC.-2024-129725$REGENERON$I. Koukourakis, P. Mamalis, A. Giaktzidis, A. Zygogianni, M. Koukourakis. Anti-PD1 immunotherapy and hypofractionated RT for locally advanced squamous cell skin cancer. Radiotherapy and Oncology. 2023;182:S1257-S1258$$$$$Y$$$20240927$$MD$GR$GR
243747561$24374756$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA276159$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240927$$PH$US$US
243747571$24374757$1$I$20240913$20240913$20240927$20240927$PER$$US-SA-2024SA278600$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240927$$CN$US$US
243747581$24374758$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA278947$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240927$$CN$US$US
243747591$24374759$1$I$20230101$20240912$20240927$20240927$PER$$US-SA-2024SA275593$SANOFI AVENTIS$$$$$M$Y$$$20240927$$HP$US$US
243747601$24374760$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA279624$SANOFI AVENTIS$$$$E$F$Y$$$20240927$$HP$US$US
243747611$24374761$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA279627$SANOFI AVENTIS$$79$YR$E$$Y$$$20240927$$CN$US$US
243747621$24374762$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA279686$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240927$$HP$US$US
243747631$24374763$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA279764$SANOFI AVENTIS$$$$$F$Y$$$20240927$$CN$US$US
243747641$24374764$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA274829$SANOFI AVENTIS$$$$$$Y$$$20240927$$MD$US$US
243747651$24374765$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA279297$SANOFI AVENTIS$$82$YR$E$$Y$$$20240927$$CN$US$US
243747661$24374766$1$I$20240910$20240913$20240927$20240927$PER$$US-SA-2024SA277587$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240927$$MD$US$US
243747671$24374767$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA274028$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$HP$US$US
243747691$24374769$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA279679$SANOFI AVENTIS$$41$YR$A$$Y$$$20240927$$MD$US$US
243747701$24374770$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA279028$SANOFI AVENTIS$$55$YR$A$$Y$$$20240927$$CN$US$US
243747721$24374772$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA278507$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240927$$CN$US$US
243747731$24374773$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA279191$SANOFI AVENTIS$$65$YR$E$$Y$$$20240927$$CN$US$US
243747741$24374774$1$I$20240301$20240913$20240927$20240927$PER$$US-SA-2024SA275093$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240927$$MD$US$US
243747751$24374775$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA279189$SANOFI AVENTIS$$62$YR$A$$Y$$$20240927$$CN$US$US
243747761$24374776$1$I$$20240912$20240927$20240927$PER$$US-SA-2024SA243925$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240927$$CN$US$US
243747771$24374777$1$I$20240901$20240913$20240927$20240927$PER$$US-SA-2024SA274679$SANOFI AVENTIS$$47$YR$A$F$Y$90.71$KG$20240927$$MD$US$US
243747781$24374778$1$I$20240101$20240912$20240927$20240927$PER$$US-SA-2024SA279644$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240927$$PH$US$US
243747791$24374779$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA279135$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240927$$CN$US$US
243747801$24374780$1$I$20240901$20240913$20240927$20240927$PER$$US-SA-2024SA279401$SANOFI AVENTIS$$$$$F$Y$$$20240927$$CN$US$US
243747811$24374781$1$I$20240901$20240913$20240927$20240927$PER$$US-SA-2024SA278989$SANOFI AVENTIS$$$$$F$Y$$$20240927$$CN$US$US
243747821$24374782$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA278175$SANOFI AVENTIS$$$$$$Y$$$20240927$$HP$US$US
243747831$24374783$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA279024$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240927$$CN$US$US
243747841$24374784$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA274796$SANOFI AVENTIS$$17$MON$I$M$Y$$$20240927$$MD$US$US
243747851$24374785$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA278025$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240927$$CN$US$US
243747861$24374786$1$I$20240913$20240913$20240927$20240927$PER$$US-SA-2024SA277591$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240927$$MD$US$US
243747871$24374787$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA274767$SANOFI AVENTIS$$$$A$$Y$$$20240927$$MD$US$US
243747881$24374788$1$I$20240501$20240913$20240927$20240927$PER$$US-SA-2024SA278244$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240927$$CN$US$US
243747891$24374789$1$I$20240101$20240913$20240927$20240927$PER$$US-SA-2024SA274130$SANOFI AVENTIS$$$$$M$Y$$$20240927$$CN$US$US
243747901$24374790$1$I$20230101$20240913$20240927$20240927$PER$$US-SA-2024SA278755$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240927$$CN$US$US
243747911$24374791$1$I$20240912$20240913$20240927$20240927$PER$$US-SA-2024SA276132$SANOFI AVENTIS$$50$YR$A$M$Y$$$20240927$$CN$US$US
243747921$24374792$1$I$20240913$20240913$20240927$20240927$PER$$US-SA-2024SA278287$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240927$$CN$US$US
243747931$24374793$1$I$$20240917$20240927$20240927$PER$$US-SA-2024SA271107$SANOFI AVENTIS$$$$A$M$Y$$$20240927$$MD$US$US
243747941$24374794$1$I$20240101$20240918$20240927$20240927$PER$$US-SA-2024SA274097$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240927$$MD$US$US
243747951$24374795$1$I$20240913$20240913$20240927$20240927$PER$$US-SA-2024SA276169$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240927$$CN$US$US
243747961$24374796$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA278544$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$MD$US$US
243747981$24374798$1$I$20240401$20240918$20240927$20240927$PER$$US-SA-2024SA272720$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240927$$MD$US$US
243748001$24374800$1$I$20240901$20240918$20240927$20240927$PER$$US-SA-2024SA271138$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240927$$MD$US$US
243748011$24374801$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA279757$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240927$$CN$US$US
243748021$24374802$1$I$20240910$20240913$20240927$20240927$PER$$US-SA-2024SA274779$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240927$$PH$US$US
243748031$24374803$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA244343$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240927$$MD$US$US
243748051$24374805$1$I$20240101$20240913$20240927$20240927$PER$$US-SA-2024SA279004$SANOFI AVENTIS$$80$YR$E$M$Y$$$20240927$$CN$US$US
243748061$24374806$1$I$20240913$20240913$20240927$20240927$PER$$US-SA-2024SA279026$SANOFI AVENTIS$$$$$M$Y$$$20240927$$CN$US$US
243748071$24374807$1$I$20240601$20240917$20240927$20240927$PER$$US-SA-2024SA271534$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240927$$MD$US$US
243748091$24374809$1$I$$20240914$20240927$20240927$PER$$US-SA-2024SA278031$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240927$$CN$US$US
243748101$24374810$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA279103$SANOFI AVENTIS$$$$$M$Y$$$20240927$$CN$US$US
243748111$24374811$1$I$20240101$20240918$20240927$20240927$PER$$US-SA-2024SA271963$SANOFI AVENTIS$$40$YR$A$M$Y$$$20240927$$HP$US$US
243748121$24374812$1$I$20240101$20240914$20240927$20240927$PER$$US-SA-2024SA277829$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240927$$MD$US$US
243748131$24374813$1$I$20240912$20240913$20240927$20240927$PER$$US-SA-2024SA273961$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240927$$CN$US$US
243748141$24374814$1$I$20240201$20240918$20240927$20240927$PER$$US-SA-2024SA272081$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240927$$MD$US$US
243748151$24374815$1$I$20240501$20240914$20240927$20240927$PER$$US-SA-2024SA276171$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240927$$MD$US$US
243748161$24374816$1$I$$20240913$20240927$20240927$PER$$US-SA-2024SA278298$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240927$$CN$US$US
243748171$24374817$1$I$$20240918$20240927$20240927$PER$$US-SA-2024SA271157$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240927$$HP$US$US
243748181$24374818$1$I$20240301$20240919$20240927$20240927$PER$$US-INCYTE CORPORATION-2024IN009913$INCYTE$$$$$$Y$$$20240927$$CN$US$US
243748201$24374820$1$I$20240905$20240918$20240927$20240927$PER$$US-SA-2024SA277360$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240927$$MD$US$US
243748211$24374821$1$I$$20240918$20240927$20240927$PER$$US-SA-2024SA271220$SANOFI AVENTIS$$91$YR$E$F$Y$$$20240927$$HP$US$US
243748221$24374822$1$I$20240101$20240918$20240927$20240927$PER$$US-SA-2024SA272566$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240927$$MD$US$US
243748231$24374823$1$I$20240101$20240918$20240927$20240927$PER$$US-SA-2024SA276760$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240927$$MD$US$US
243748241$24374824$1$I$$20240917$20240927$20240927$PER$$US-SA-2024SA274907$SANOFI AVENTIS$$$$A$F$Y$$$20240927$$CN$US$US
243748251$24374825$1$I$20240101$20240919$20240927$20240927$EXP$$US-UNITED THERAPEUTICS-UNT-2024-024964$UNITED THERAPEUTICS$$$$$M$Y$58.957$KG$20240927$$$US$US
243748261$24374826$1$I$20240901$20240918$20240927$20240927$PER$$US-SA-2024SA271173$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240927$$MD$US$US
243748271$24374827$1$I$20240915$20240917$20240927$20240927$PER$$US-SA-2024SA271258$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240927$$HP$US$US
243748281$24374828$1$I$$20240916$20240927$20240927$PER$$US-SA-2024SA278365$SANOFI AVENTIS$$35$YR$A$$Y$$$20240927$$CN$US$US
243748311$24374831$1$I$20240101$20240918$20240927$20240927$PER$$US-SA-2024SA273333$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240927$$MD$US$US
243748321$24374832$1$I$$20240918$20240927$20240927$PER$$US-SA-2024SA271121$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240927$$MD$US$US
243748341$24374834$1$I$$20240918$20240927$20240927$PER$$US-SA-2024SA272665$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240927$$MD$US$US
243748351$24374835$1$I$$20240918$20240927$20240927$PER$$US-SA-2024SA270994$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240927$$MD$US$US
243748361$24374836$1$I$20240916$20240916$20240927$20240927$PER$$US-SA-2024SA277659$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240927$$CN$US$US
243748371$24374837$1$I$20240201$20240918$20240927$20240927$PER$$US-SA-2024SA163426$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240927$$MD$US$US
243748381$24374838$1$I$20240101$20240918$20240927$20240927$PER$$US-SA-2024SA272752$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240927$$HP$US$US
243748391$24374839$1$I$20240916$20240916$20240927$20240927$PER$$US-SA-2024SA279295$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240927$$MD$US$US
243748411$24374841$1$I$20240801$20240918$20240927$20240927$PER$$US-SA-2024SA194649$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240927$$HP$US$US
243748421$24374842$1$I$20240101$20240918$20240927$20240927$PER$$US-SA-2024SA272993$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240927$$HP$US$US
243748431$24374843$1$I$20240101$20240918$20240927$20240927$PER$$US-SA-2024SA272830$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240927$$HP$US$US
243748441$24374844$1$I$$20240918$20240927$20240927$PER$$US-SA-2024SA271156$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240927$$HP$US$US
243748451$24374845$1$I$$20240923$20240927$20240927$PER$$US-JNJFOC-20240962041$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20240927$$HP$US$US
243748461$24374846$1$I$20210101$20240919$20240927$20240927$PER$$US-SA-2024SA272983$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240927$$MD$US$US
243748471$24374847$1$I$20240901$20240919$20240927$20240927$PER$$US-SA-2024SA272714$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240927$$HP$US$US
243748481$24374848$1$I$20240101$20240919$20240927$20240927$PER$$US-SA-2024SA272916$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240927$$MD$US$US
243748491$24374849$1$I$20240131$20240918$20240927$20240927$PER$$US-SA-2024SA271067$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240927$$MD$US$US
243748501$24374850$1$I$20240101$20240919$20240927$20240927$PER$$US-SA-2024SA272890$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240927$$HP$US$US
243748511$24374851$1$I$$20240919$20240927$20240927$PER$$US-SA-2024SA272957$SANOFI AVENTIS$$$$T$F$Y$$$20240927$$MD$US$US
243748521$24374852$1$I$20240101$20240919$20240927$20240927$PER$$US-SA-2024SA272959$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240927$$MD$US$US
243748531$24374853$1$I$$20240919$20240927$20240927$PER$$US-SA-2024SA272807$SANOFI AVENTIS$$$$A$M$Y$$$20240927$$HP$US$US
243748541$24374854$1$I$20240601$20240919$20240927$20240927$PER$$US-SA-2024SA272968$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240927$$MD$US$US
243748551$24374855$1$I$$20240919$20240927$20240927$PER$$US-SA-2024SA273018$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240927$$MD$US$US
243748561$24374856$1$I$20240101$20240921$20240927$20240927$PER$$US-SA-2024SA275043$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240927$$CN$US$US
243748571$24374857$1$I$20240101$20240921$20240927$20240927$PER$$US-SA-2024SA274834$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240927$$HP$US$US
243748581$24374858$1$I$20230801$20240923$20240927$20240927$PER$$US-SA-2024SA275198$SANOFI AVENTIS$$53$YR$A$M$Y$$$20240927$$HP$US$US
243748591$24374859$1$I$$20240920$20240927$20240927$PER$$US-SA-2024SA273226$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240927$$MD$US$US
243748601$24374860$1$I$20240101$20240923$20240927$20240927$PER$$US-SA-2024SA275090$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240927$$HP$US$US
243748611$24374861$1$I$20240901$20240919$20240927$20240927$PER$$US-SA-2024SA272182$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240927$$MD$US$US
243748621$24374862$1$I$$20240921$20240927$20240927$PER$$US-SA-2024SA274736$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240927$$MD$US$US
243748631$24374863$1$I$20240101$20240919$20240927$20240927$PER$$US-SA-2024SA273752$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240927$$HP$US$US
243748641$24374864$1$I$20240801$20240920$20240927$20240927$PER$$US-SA-2024SA275485$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240927$$HP$US$US
243748651$24374865$1$I$20240901$20240919$20240927$20240927$PER$$US-SA-2024SA272778$SANOFI AVENTIS$$$$T$F$Y$$$20240927$$HP$US$US
243748661$24374866$1$I$20240901$20240919$20240927$20240927$PER$$US-SA-2024SA272932$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240927$$MD$US$US
243748671$24374867$1$I$$20240923$20240927$20240927$PER$$US-SA-2024SA275228$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240927$$HP$US$US
243748681$24374868$1$I$20120101$20240921$20240927$20240927$PER$$US-SA-2024SA278926$SANOFI AVENTIS$$$$$M$Y$$$20240927$$CN$US$US
243748691$24374869$1$I$20240901$20240919$20240927$20240927$PER$$US-SA-2024SA272782$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240927$$HP$US$US
243748711$24374871$1$I$$20240903$20240927$20240927$PER$$US-Eisai-EC-2024-173913$EISAI$Tadros M, Lavastida DR. Therapeutic Potential of Intravenous Ketamine in Early-Onset Dementia: A Case Report. Cureus. 2024 Jul;1-6. doi:10.7759/cureus.65261.$56$YR$A$F$Y$$$20240927$$MD$US$US
243748721$24374872$1$I$$20240911$20240927$20240927$PER$$US-SA-2024SA279734$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240927$$HP$US$US
243748731$24374873$1$I$20230901$20240923$20240927$20240927$PER$$US-SA-2024SA275802$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240927$$MD$US$US
243748741$24374874$1$I$$20240923$20240927$20240927$PER$$US-SA-2024SA275823$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240927$$MD$US$US
243748751$24374875$1$I$$20240916$20240927$20240927$PER$$US-SA-2024SA279675$SANOFI AVENTIS$$$$$M$Y$$$20240927$$CN$US$US
243748771$24374877$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245816$TEVA$$81$YR$$M$Y$$$20240927$$PH$CA$CA
243748781$24374878$1$I$20230905$20240920$20240927$20240927$EXP$FR-AFSSAPS-MP2024001389$FR-TEVA-VS-3246512$TEVA$$38$YR$$M$Y$72$KG$20240927$$PH$FR$FR
243748791$24374879$1$I$20230101$20240923$20240927$20240927$EXP$$US-ABBVIE-5937663$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243748801$24374880$1$I$20240909$20240910$20240927$20240927$PER$$US-BIOMARINAP-US-2024-160766$BIOMARIN$$$$$$Y$$$20240927$$CN$US$US
243748811$24374881$1$I$20240901$20240916$20240927$20240927$EXP$$GB-ADVANZ PHARMA-202409007647$ADVANZ PHARMA$$$$$$Y$$$20240927$$CN$GB$GB
243748821$24374882$1$I$20240301$20240905$20240927$20240927$PER$$US-Eisai-EC-2024-173939$EISAI$$$$E$F$Y$$$20240927$$MD$US$US
243748831$24374883$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245832$TEVA$$74$YR$$F$Y$$$20240927$$PH$CA$CA
243748841$24374884$1$I$$20240924$20240927$20240927$EXP$$US-009507513-2409USA008756$MERCK$Distefano N, Rizly S, Liu M.. Check yourself before you wreck yourself: A case of pembrolizumab-induced pneumonitis. Chest. 2024;166 (4):A4407-08$68$YR$$M$Y$$$20240927$$HP$US$US
243748851$24374885$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245690$TEVA$$$$$$Y$$$20240927$$MD$CA$CA
243748861$24374886$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245836$TEVA$$68$YR$$F$Y$52$KG$20240927$$HP$CA$CA
243748871$24374887$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245718$TEVA$$79$YR$$M$Y$$$20240927$$CN$CA$CA
243748891$24374889$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245773$TEVA$$27$YR$$F$Y$$$20240927$$PH$CA$CA
243748901$24374890$1$I$20240901$20240923$20240927$20240927$PER$$US-SA-2024SA275824$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240927$$MD$US$US
243748911$24374891$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245861$TEVA$$54$YR$$M$Y$$$20240927$$HP$CA$CA
243748921$24374892$1$I$$20240924$20240927$20240927$EXP$CA-ALLERGAN-2132448US$CA-ABBVIE-2132448US$ABBVIE$$41$YR$$M$Y$$$20240927$$HP$CA$CA
243748931$24374893$1$I$20240918$20240918$20240927$20240927$EXP$$US-UCBSA-2024048722$UCB$$8$YR$$M$Y$16$KG$20240927$$MD$US$US
243748941$24374894$1$I$20240712$20240920$20240927$20240927$EXP$IT-MINISAL02-1002259$IT-TEVA-VS-3246501$TEVA$$44$YR$$F$Y$$$20240927$$PH$IT$IT
243748951$24374895$1$I$$20240925$20240927$20240927$EXP$ES-AEMPS-1568904$ES-ASTRAZENECA-202409GLO006316ES$ALEXION PHARMACEUTICALS$$61$YR$A$$Y$$$20240927$$MD$ES$ES
243748961$24374896$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245813$TEVA$$10$YR$$F$Y$$$20240927$$HP$CA$CA
243748971$24374897$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245814$TEVA$$6$YR$$M$Y$$$20240927$$HP$CA$CA
243748982$24374898$2$F$20240926$20240927$20240927$20240930$PER$$US-AMGEN-USASP2024192413$AMGEN$$84$YR$E$F$Y$$$20240929$$CN$US$US
243748991$24374899$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245815$TEVA$$33$YR$$M$Y$$$20240927$$HP$CA$CA
243749001$24374900$1$I$$20240920$20240927$20240927$EXP$$US-ZENPEP LLC-2024AIMT01364$AIMMUNE$$$$$$Y$$$20240927$$CN$US$US
243749011$24374901$1$I$$20240925$20240927$20240927$EXP$$DE-SANDOZ INC.-SDZ2024DE082930$SANDOZ$$$$$M$Y$$$20240927$$CN$DE$DE
243749031$24374903$1$I$$20240906$20240927$20240927$PER$$US-Eisai-EC-2024-173967$EISAI$$$$$$Y$$$20240927$$MD$US$US
243749051$24374905$1$I$$20240924$20240927$20240927$EXP$$CA-ABBVIE-5938146$ABBVIE$$18$YR$$M$Y$$$20240927$$CN$CA$CA
243749081$24374908$1$I$$20240923$20240927$20240927$PER$$US-JNJFOC-20240962116$JOHNSON AND JOHNSON$$$$$$Y$$$20240927$$HP$US$US
243749101$24374910$1$I$20220101$20240920$20240927$20240927$EXP$FR-AFSSAPS-SE2024000694$FR-TEVA-VS-3246395$TEVA$$56$YR$$M$Y$$$20240927$$MD$FR$FR
243749111$24374911$1$I$20240907$20240918$20240927$20240927$EXP$$CN-009507513-2409CHN007623$MERCK$$93$YR$$M$Y$62$KG$20240927$$HP$CN$CN
243749121$24374912$1$I$20240902$20240919$20240927$20240927$EXP$$US-UCBSA-2024048363$UCB$$68$YR$$F$Y$$$20240927$$CN$US$US
243749131$24374913$1$I$20240621$20240923$20240927$20240927$EXP$ES-AEMPS-1570735$ES-009507513-2409ESP008419$MERCK$$25$YR$$M$Y$$$20240927$$PH$ES$ES
243749141$24374914$1$I$20240501$20240913$20240927$20240927$EXP$$BR-BIOGEN-2024BI01284497$BIOGEN$$46$YR$$M$Y$76$KG$20240927$$CN$BR$BR
243749151$24374915$1$I$$20240923$20240927$20240927$EXP$$GR-REGENERON PHARMACEUTICALS, INC.-2024-130002$REGENERON$I. Koukourakis, P. Mamalis, A. Giaktzidis, A. Zygogianni, M. Koukourakis. Anti-PD1 immunotherapy and hypofractionated RT for locally advanced squamous cell skin cancer. Radiotherapy and Oncology. 2023;182:S1257-S1258$$$$$Y$$$20240927$$MD$GR$GR
243749161$24374916$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3246141$TEVA$$57$YR$$M$Y$$$20240927$$CN$CA$CA
243749171$24374917$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245680$TEVA$$52$YR$$F$Y$$$20240927$$PH$CA$CA
243749181$24374918$1$I$20240430$20240918$20240927$20240927$EXP$$JP-Rigel Pharmaceuticals, Inc.-20240900137$RIGEL PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$JP$JP
243749191$24374919$1$I$20240801$20240919$20240927$20240927$EXP$$US-UCBSA-2024048462$UCB$$32$YR$$F$Y$$$20240928$$HP$US$US
243749201$24374920$1$I$$20240918$20240927$20240927$EXP$$CA-TEVA-VS-3245685$TEVA$$61$YR$$F$Y$74$KG$20240927$$HP$CA$CA
243749211$24374921$1$I$20230501$20240915$20240927$20240927$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409014859$ELI LILLY AND CO$$46$YR$A$M$Y$$$20240927$$CN$DE$DE
243749221$24374922$1$I$20240822$20240924$20240927$20240927$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409015739$ELI LILLY AND CO$$52$YR$A$F$Y$39$KG$20240927$$CN$CN$CN
243749231$24374923$1$I$20240729$20240923$20240927$20240927$EXP$ES-AEMPS-1572925$ES-ELI_LILLY_AND_COMPANY-ES202409015021$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240927$$CN$ES$ES
243749241$24374924$1$I$$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016962$ELI LILLY AND CO$$$$A$F$Y$$$20240927$$CN$US$US
243749251$24374925$1$I$20240917$20240925$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016437$ELI LILLY AND CO$$42$YR$A$M$Y$$$20240927$$CN$US$US
243749271$24374927$1$I$$20240923$20240927$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202409014585$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240927$$CN$US$US
243749281$24374928$1$I$$20240924$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409016119$ELI LILLY AND CO$$$$$$Y$$$20240927$$CN$US$US
243749291$24374929$1$I$20221221$20240916$20240927$20240927$EXP$$LT-ELI_LILLY_AND_COMPANY-LT202409010197$ELI LILLY AND CO$$90$YR$E$F$Y$$$20240927$$MD$LT$LT
243749301$24374930$1$I$20240101$20240916$20240927$20240927$EXP$FR-AFSSAPS-LY2024001387$FR-ELI_LILLY_AND_COMPANY-FR202409010295$ELI LILLY AND CO$$47$YR$A$F$Y$110$KG$20240927$$CN$FR$FR
243749321$24374932$1$I$$20240917$20240927$20240927$PER$$US-GSK-US2024AMR094135$GLAXOSMITHKLINE$$$$$F$Y$$$20240927$$CN$US$US
243749331$24374933$1$I$$20240905$20240927$20240927$30DAY$$FR-JNJFOC-20240917738$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240927$$PH$FR$FR
243749351$24374935$1$I$$20240917$20240927$20240927$EXP$$FR-ELI_LILLY_AND_COMPANY-FR202409012827$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240927$$CN$FR$FR
243749361$24374936$1$I$$20240917$20240927$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011923$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240927$$MD$US$US
243749371$24374937$1$I$20240914$20240918$20240927$20240927$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409012971$ELI LILLY AND CO$$72$YR$E$M$Y$58$KG$20240927$$CN$DE$CN
243749381$24374938$1$I$$20240917$20240927$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011067$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240927$$CN$US$US
243749391$24374939$1$I$20240501$20240917$20240927$20240927$EXP$DK-DKMA-30731827$DK-ELI_LILLY_AND_COMPANY-DK202409011273$ELI LILLY AND CO$$25$YR$A$F$Y$$$20240927$$CN$DK$DK
243749401$24374940$1$I$$20240923$20240927$20240927$EXP$$AU-ELI_LILLY_AND_COMPANY-AU202409013412$ELI LILLY AND CO$$$$$F$Y$$$20240927$$CN$AU$AU
243749411$24374941$1$I$20240728$20240916$20240927$20240927$EXP$FR-AFSSAPS-PV2024000868$FR-ELI_LILLY_AND_COMPANY-FR202409010300$ELI LILLY AND CO$$56$YR$A$M$Y$70$KG$20240927$$CN$FR$FR
243749431$24374943$1$I$20240802$20240917$20240927$20240927$EXP$RO-NMA-2024-SP0573$RO-ELI_LILLY_AND_COMPANY-RO202409011235$ELI LILLY AND CO$$76$YR$E$F$Y$80$KG$20240927$$CN$RO$RO
243749441$24374944$1$I$$20240923$20240927$20240927$EXP$$US-ELI_LILLY_AND_COMPANY-US202409017053$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240927$$CN$US$US
243749461$24374946$1$I$$20240923$20240927$20240927$EXP$$US-GILEAD-2024-0688781$GILEAD$$$$E$F$Y$$$20240927$$CN$US$US
243749481$24374948$1$I$$20240925$20240927$20240927$EXP$$US-GILEAD-2024-0689000$GILEAD$$$$$F$Y$$$20240927$$MD$US$US
243749491$24374949$1$I$20240919$20240919$20240927$20240927$PER$$US-ELI_LILLY_AND_COMPANY-US202409013126$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240927$$CN$US$US
243749501$24374950$1$I$20240901$20240925$20240927$20240927$EXP$$CA-TAKEDA-2023TUS034354$TAKEDA$$71$YR$$M$Y$$$20240927$$CN$CA$CA
243749511$24374951$1$I$$20240924$20240927$20240927$EXP$$US-MFDS-2021000061-2409USA008882$MERCK$Aiman A, Sta Cruz JP.. ANAPHYLACTIC SHOCK SECONDARY TO DPP-4 AND ACE-I USE. Chest. 2024;3A$78$YR$$F$Y$$$20240927$$HP$US$US
243749551$24374955$1$I$$20240926$20240927$20240927$PER$$US-AMGEN-USASP2024192730$AMGEN$$$$$$Y$$$20240927$$CN$US$US
243749561$24374956$1$I$$20240924$20240927$20240927$PER$$US-DAIICHI SANKYO, INC.-DS-2024-101389-US$DAIICHI$$$$$F$Y$$$20240928$$MD$US$US
243749581$24374958$1$I$$20240923$20240927$20240927$PER$$US-DSJP-DS-2024-101428-US$DAIICHI$$$$$F$Y$$$20240928$$CN$US$US
243749591$24374959$1$I$$20240923$20240927$20240927$PER$$US-DSJP-DS-2024-101430-US$DAIICHI$$$$A$F$Y$$$20240928$$HP$US$US
243749601$24374960$1$I$$20240925$20240927$20240927$PER$$US-DAIICHI SANKYO, INC.-DS-2024-101558-US$DAIICHI$$$$$F$Y$$$20240928$$HP$US$US
243749611$24374961$1$I$$20240925$20240927$20240927$EXP$$AU-ABBVIE-5940826$ABBVIE$$$$E$M$Y$$$20240927$$MD$AU$AU
243749621$24374962$1$I$$20240924$20240927$20240927$EXP$$US-ABBVIE-5937666$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243749631$24374963$1$I$20240101$20240924$20240927$20240927$EXP$$US-ABBVIE-5937981$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243749641$24374964$1$I$20240101$20240923$20240927$20240927$EXP$$US-ABBVIE-5936685$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243749651$24374965$1$I$$20240925$20240927$20240927$EXP$$US-ABBVIE-5940753$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243749661$24374966$1$I$$20240925$20240927$20240927$PER$$US-ABBVIE-5939479$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243749671$24374967$1$I$20240903$20240920$20240927$20240927$EXP$$US-009507513-2409USA007949$MERCK$$$$$M$Y$$$20240927$$HP$US$US
243749681$24374968$1$I$$20240925$20240927$20240927$EXP$$DE-ABBVIE-5941541$ABBVIE$$$$E$F$Y$$$20240927$$HP$DE$DE
243749691$24374969$1$I$$20240918$20240927$20240927$PER$$US-ABBVIE-5931578$ABBVIE$$$$$M$Y$$$20240927$$CN$US$US
243749701$24374970$1$I$20240101$20240924$20240927$20240927$EXP$$US-ABBVIE-5938105$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243749711$24374971$1$I$20240801$20240910$20240927$20240927$PER$$US-SA-2024SA279094$SANOFI AVENTIS$$24$YR$A$F$Y$60$KG$20240928$$MD$US$US
243749721$24374972$1$I$20240101$20240910$20240927$20240927$PER$$US-SA-2024SA279071$SANOFI AVENTIS$$14$YR$T$F$Y$$$20240928$$CN$US$US
243749731$24374973$1$I$20240101$20240924$20240927$20240927$EXP$$CA-ABBVIE-5939225$ABBVIE$$70$YR$$F$Y$$$20240927$$HP$CA$CA
243749751$24374975$1$I$$20240926$20240927$20240927$EXP$GB-MHRA-TPP35723415C10380005YC1727281723632$GB-009507513-2409GBR009434$MERCK$$52$YR$$M$Y$70$KG$20240927$$MD$GB$GB
243749761$24374976$1$I$20240101$20240920$20240927$20240927$EXP$$CA-ABBVIE-5933797$ABBVIE$$28$YR$$F$Y$$$20240927$$HP$CA$CA
243749781$24374978$1$I$$20240923$20240927$20240927$EXP$$US-ABBVIE-5936814$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243749791$24374979$1$I$20240201$20240924$20240927$20240927$EXP$$US-ABBVIE-5938603$ABBVIE$$52$YR$$F$Y$$$20240927$$CN$US$US
243749801$24374980$1$I$20240914$20240923$20240927$20240927$EXP$$NL-ABBVIE-5941242$ABBVIE$$88$YR$$F$Y$$$20240927$$MD$NL$NL
243749811$24374981$1$I$20240901$20240925$20240927$20240927$EXP$$CA-ABBVIE-5940599$ABBVIE$$49$YR$$F$Y$$$20240927$$PH$CA$CA
243749831$24374983$1$I$20170101$20240924$20240927$20240927$EXP$$DE-ABBVIE-5941403$ABBVIE$$$$E$M$Y$$$20240927$$CN$DE$DE
243749841$24374984$1$I$20240901$20240923$20240927$20240927$EXP$$US-ABBVIE-5936104$ABBVIE$$65$YR$$M$Y$$$20240927$$CN$US$US
243749851$24374985$1$I$$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-046913$AUROBINDO$$66$YR$$M$Y$$$20240928$$CN$FR$FR
243749861$24374986$1$I$20240806$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-046950$AUROBINDO$$58$YR$$M$Y$$$20240928$$MD$FR$FR
243749871$24374987$1$I$$20240924$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152275$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240928$$CN$US$US
243749881$24374988$1$I$20240801$20240918$20240927$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-151223$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240928$$PH$JP$JP
243749901$24374990$1$I$$20240920$20240927$20240927$PER$$US-EMD Serono-2024050821$EMD SERONO INC$$$$E$M$Y$$$20240928$$HP$US$US
243749911$24374991$1$I$$20240919$20240927$20240927$PER$$US-EMD Serono-2024050620$EMD SERONO INC$$$$$F$Y$$$20240928$$CN$US$US
243749921$24374992$1$I$$20240916$20240927$20240927$EXP$$US-ASTELLAS-2024-AER-007669$ASTELLAS$Hall AD, Luckett KM. Case Report: Disseminated Tuberculosis After Kidney Transplantation. American Journal of Tropical Medicine and Hygiene. 2024;111(3): 535-9. doi:10.4269/ajtmh.23-0358.$54$YR$A$F$Y$$$20240928$$HP$US$US
243749931$24374993$1$I$20240817$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-046989$AUROBINDO$$86$YR$$M$Y$89$KG$20240928$$MD$FR$FR
243749951$24374995$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152311$BRISTOL MYERS SQUIBB$Vo PU, Gao D, Hepburn M. Anticoagulation dilemma of atrial fibrillation management in a stroke patient with hemorrhagic conversion: when the cure is also the culprit. Chest. 2024;166(4S):728A-9A. doi:10.1016/j.chest.2024.06.488.$59$YR$A$M$Y$$$20240928$$HP$US$US
243749961$24374996$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152970$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240928$$CN$US$US
243749971$24374997$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153283$BRISTOL MYERS SQUIBB$$47$YR$A$M$Y$$$20240928$$CN$US$US
243749981$24374998$1$I$20240901$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153236$BRISTOL MYERS SQUIBB$$29$YR$A$F$Y$$$20240928$$HP$US$US
243749991$24374999$1$I$$20240924$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152406$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240928$$MD$US$US
243750001$24375000$1$I$20240901$20240924$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152893$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240928$$CN$US$US
243750011$24375001$1$I$20240918$20240925$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153419$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240928$$CN$US$US
243750031$24375003$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151733$BRISTOL MYERS SQUIBB$Islam I, Soleiman A, Wright J, Mayo PH. Myasthenia gravis unmasked in a case of immune checkpoint inhibitor-induced myocarditis and myositis. Chest. 2024;166(4S):A2171-2. doi:10.1016/j.chest.2024.06.1339.$64$YR$A$M$Y$$$20240928$$HP$US$US
243750041$24375004$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153426$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240928$$HP$US$US
243750051$24375005$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153066$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$$$20240928$$HP$US$US
243750061$24375006$1$I$$20240924$20240927$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-152464$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240928$$CN$JP$JP
243750071$24375007$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153334$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240928$$CN$US$US
243750081$24375008$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153604$BRISTOL MYERS SQUIBB$$75$YR$E$$Y$$$20240928$$CN$US$US
243750091$24375009$1$I$20240911$20240920$20240927$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-153415$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240928$$MD$JP$JP
243750101$24375010$1$I$20240413$20240918$20240927$20240927$EXP$$FR-AUROBINDO-AUR-APL-2024-047078$AUROBINDO$$77$YR$$F$Y$72$KG$20240928$$PH$FR$FR
243750111$24375011$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA279167$SANOFI AVENTIS$$20$YR$A$F$Y$63.95$KG$20240928$$MD$US$US
243750121$24375012$1$I$20240901$20240920$20240927$20240927$EXP$$US-ABBVIE-5933595$ABBVIE$$45$YR$$F$Y$$$20240927$$CN$US$US
243750131$24375013$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152864$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240928$$CN$US$US
243750141$24375014$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152112$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240928$$CN$US$US
243750151$24375015$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152882$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20240928$$CN$US$US
243750161$24375016$1$I$20240918$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153388$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$103.42$KG$20240928$$HP$US$US
243750171$24375017$1$I$$20240923$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151729$BRISTOL MYERS SQUIBB$Martinez M, Zaver S, karime C, Call J. Dual checkpoint inhibitor: brentuximab- and nivolumab-induced cytokine release syndrome presenting as diabetic ketoacidosis. Chest. 2024;166(4S):A2187-8. doi:10.1016/j.chest.2024.06.1347.$20$YR$A$M$Y$$$20240928$$HP$US$US
243750181$24375018$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153370$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$61.23$KG$20240928$$CN$US$US
243750191$24375019$1$I$20240921$20240925$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152385$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240928$$CN$US$US
243750201$24375020$1$I$$20240924$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152863$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240928$$HP$US$US
243750211$24375021$1$I$$20240917$20240927$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-152976$BRISTOL MYERS SQUIBB$Yokoyama T, et al. Two cases of myelodysplastic syndrome with poor glycemic control after azacitidine alone. The 245th Kinki Regional Council of the Japan Society of Internal Medicine.$75$YR$E$F$Y$$$20240928$$HP$JP$JP
243750231$24375023$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153539$BRISTOL MYERS SQUIBB$$$$$F$Y$76.2$KG$20240928$$PH$US$US
243750241$24375024$1$I$20180601$20240924$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152221$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240928$$CN$US$US
243750251$24375025$1$I$$20240924$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151921$BRISTOL MYERS SQUIBB$$82$YR$E$F$Y$$$20240928$$CN$US$US
243750261$24375026$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152604$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20240928$$HP$US$US
243750271$24375027$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151396$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240928$$CN$US$US
243750281$24375028$1$I$$20240923$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152031$BRISTOL MYERS SQUIBB$Khan F, Khan M, Jarrell G, Martinez J, Douglas J, France A, et al. Putting theory to practice: resolving large intrabronchial clot burden with the use of endobronchial tissue plasminogen activator lavage. Chest. 2024;166(4S):2201A-2A.doi:10.1016/j.chest.2024.06.1354.$65$YR$E$F$Y$$$20240928$$HP$US$US
243750291$24375029$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152587$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240928$$HP$US$US
243750301$24375030$1$I$$20240926$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153143$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240928$$CN$US$US
243750311$24375031$1$I$20240910$20240924$20240927$20240927$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-153434$BRISTOL MYERS SQUIBB$$8$DEC$E$M$Y$$$20240928$$MD$JP$JP
243750321$24375032$1$I$$20240925$20240927$20240927$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152569$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240928$$PH$US$US
243750331$24375033$1$I$$20240925$20240927$20240927$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152310$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240928$$HP$US$US
243750341$24375034$1$I$20240801$20240920$20240927$20240927$EXP$$US-ABBVIE-5933122$ABBVIE$$70$YR$$F$Y$$$20240927$$CN$US$US
243750371$24375037$1$I$20240914$20240925$20240927$20240927$EXP$$CO-ABBVIE-5941237$ABBVIE$$63$YR$$F$Y$67$KG$20240927$$CN$CO$CO
243750381$24375038$1$I$$20240924$20240927$20240927$PER$$US-AMGEN-USASP2024190633$AMGEN$$$$$M$Y$$$20240927$$CN$US$US
243750391$24375039$1$I$$20240919$20240927$20240927$EXP$$CA-NOVITIUMPHARMA-2024CANVP02006$NOVITIUM PHARMA$Joel Neves Briard.Refractory Status Epilepticus in a Patient With Aducanumab-Induced Amyloid-Related Imaging Abnormalities.Neurology.10-SEP-2024;103 (5):1-5$75$YR$E$F$Y$$$20240928$$HP$CA$CA
243750401$24375040$1$I$20240101$20240925$20240927$20240927$EXP$$DE-ABBVIE-5941404$ABBVIE$$80$YR$$F$Y$$$20240927$$CN$DE$DE
243750411$24375041$1$I$$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046486$AUROBINDO$$$$$F$Y$$$20240928$$HP$GB$GB
243750421$24375042$1$I$20240914$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046535$AUROBINDO$$$$$$Y$$$20240928$$PH$GB$GB
243750441$24375044$1$I$20240909$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046540$AUROBINDO$$53$YR$$M$Y$100$KG$20240928$$CN$GB$GB
243750451$24375045$1$I$20240228$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046596$AUROBINDO$$63$YR$$M$Y$99$KG$20240928$$PH$GB$GB
243750461$24375046$1$I$20240401$20240917$20240927$20240927$PER$$US-ABBVIE-5929495$ABBVIE$$54$YR$$F$Y$77.11$KG$20240927$$CN$US$US
243750471$24375047$1$I$20240301$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046606$AUROBINDO$$77$YR$$M$Y$82$KG$20240928$$CN$GB$GB
243750481$24375048$1$I$$20240920$20240927$20240927$PER$$US-ROCHE-10000088307$ROCHE$$$$$$Y$$$20240928$$CN$US$US
243750491$24375049$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA279171$SANOFI AVENTIS$$65$YR$E$F$Y$80.91$KG$20240928$$MD$US$US
243750501$24375050$1$I$$20240918$20240927$20240927$EXP$$CA-APOTEX-2024AP011176$APOTEX$$73$YR$$F$Y$$$20240927$$CN$CA$CA
243750511$24375051$1$I$$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046615$AUROBINDO$$$$$F$Y$$$20240928$$HP$GB$GB
243750521$24375052$1$I$$20240919$20240927$20240927$EXP$$CO-NOVITIUMPHARMA-2024CONVP02007$NOVITIUM PHARMA$Wilfredo Antonio Rivera-Martinez.Severe Manifestation of Peritoneal Tuberculosis: Clinical Case Report.Revista colombiana de Gastroenterologia.27-SEP-2023;38(3):368-372$61$YR$A$M$Y$$$20240928$$HP$CO$CO
243750531$24375053$1$I$$20240926$20240927$20240927$EXP$$US-009507513-2409USA009429$MERCK$Vu M, Duong C, Maksymyuk Y, Assavarittirong C, Szumowski B.. Pembrolizumab-induced myositis and respiratory failure: case report. Chest. 2024;166(4):A5389-90$72$YR$$M$Y$$$20240927$$HP$US$US
243750541$24375054$1$I$$20240925$20240927$20240927$PER$$US-ABBVIE-5941456$ABBVIE$$$$$F$Y$$$20240927$$HP$US$US
243750551$24375055$1$I$20240829$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046626$AUROBINDO$$42$YR$$F$Y$$$20240928$$MD$GB$GB
243750561$24375056$1$I$$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046682$AUROBINDO$$$$$F$Y$$$20240928$$PH$GB$GB
243750571$24375057$1$I$20240902$20240923$20240927$20240927$EXP$EE-SAM-2562409031$EE-009507513-2409EST008008$MERCK$$63$YR$$F$Y$$$20240927$$MD$EE$EE
243750581$24375058$1$I$$20240912$20240927$20240927$PER$$US-JNJFOC-20240968581$JOHNSON AND JOHNSON$$39$YR$A$M$Y$50$KG$20240928$$PH$US$US
243750591$24375059$1$I$20240915$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046699$AUROBINDO$$26$YR$$F$Y$94$KG$20240928$$CN$GB$GB
243750601$24375060$1$I$$20240919$20240927$20240927$PER$$US-ABBVIE-5932342$ABBVIE$$$$$F$Y$$$20240927$$CN$US$US
243750611$24375061$1$I$20240917$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046710$AUROBINDO$$38$YR$$M$Y$73$KG$20240928$$CN$GB$GB
243750621$24375062$1$I$20240909$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046712$AUROBINDO$$$$$F$Y$$$20240928$$MD$GB$GB
243750631$24375063$1$I$20240913$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046756$AUROBINDO$$60$YR$$F$Y$$$20240928$$HP$GB$GB
243750641$24375064$1$I$$20240918$20240927$20240927$PER$$US-GSK-US2024116662$GLAXOSMITHKLINE$$54$YR$$M$Y$$$20240927$$MD$US$US
243750651$24375065$1$I$$20240919$20240927$20240927$EXP$$IE-ABBVIE-5940583$ABBVIE$$$$$M$Y$$$20240927$$HP$IE$IE
243750661$24375066$1$I$$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046763$AUROBINDO$$$$$F$Y$$$20240928$$CN$GB$GB
243750671$24375067$1$I$20240901$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191436$AMGEN$$85$YR$E$F$Y$$$20240927$$CN$US$US
243750681$24375068$1$I$$20240924$20240927$20240927$EXP$$US-ROCHE-10000090963$ROCHE$$73$YR$E$F$Y$$$20240928$$CN$US$US
243750691$24375069$1$I$20240918$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046770$AUROBINDO$$$$$F$Y$$$20240928$$CN$GB$GB
243750701$24375070$1$I$20240918$20240919$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046777$AUROBINDO$$$$$$Y$$$20240928$$PH$GB$GB
243750711$24375071$1$I$20230414$20240902$20240927$20240927$EXP$$IT-CELLTRION INC.-2024IT022756$CELLTRION$$$$$$Y$$$20240928$$MD$IT$IT
243750721$24375072$1$I$20240721$20240918$20240927$20240927$EXP$$IT-JNJFOC-20240959523$JOHNSON AND JOHNSON$$$$A$F$Y$49$KG$20240928$$MD$IT$IT
243750731$24375073$1$I$20240925$20240925$20240927$20240927$PER$$US-AMGEN-USASP2024191814$AMGEN$$60$YR$A$F$Y$$$20240927$$CN$US$US
243750741$24375074$1$I$20240801$20240920$20240927$20240927$EXP$$GB-AUROBINDO-AUR-APL-2024-046924$AUROBINDO$$64$YR$$M$Y$$$20240928$$MD$GB$GB
243750751$24375075$1$I$20240901$20240919$20240927$20240927$PER$$US-SA-2024SA274151$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240928$$HP$US$US
243750761$24375076$1$I$$20240910$20240927$20240927$PER$$US-SA-2024SA279216$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240928$$CN$US$US
243750771$24375077$1$I$$20240924$20240928$20240928$EXP$$US-ABBVIE-5937642$ABBVIE$$$$$$Y$$$20240927$$CN$US$US
243750781$24375078$1$I$$20240918$20240928$20240928$PER$$US-GSK-US2024116168$GLAXOSMITHKLINE$$$$$F$Y$$$20240928$$CN$US$US
243750791$24375079$1$I$20240301$20240918$20240928$20240928$EXP$$US-ABBVIE-5931744$ABBVIE$$52$YR$$M$Y$$$20240928$$CN$US$US
243750801$24375080$1$I$$20240924$20240928$20240928$EXP$$IT-ROCHE-10000092603$ROCHE$$$$$F$Y$$$20240928$$MD$IT$IT
243750811$24375081$1$I$$20240917$20240928$20240928$EXP$$MY-NOVITIUMPHARMA-2024MYNVP02034$NOVITIUM PHARMA$W. Fadhlina W. Adnan.Large placental chorioangioma with maternal and perinatal morbidity.The European Journal of Obstetrics + Gynecology and Reproductive Biology.14-AUG-2024;300:351-354$$$N$F$Y$2.6$KG$20240928$$HP$MY$MY
243750821$24375082$1$I$20240901$20240916$20240928$20240928$PER$$US-ABBVIE-5931295$ABBVIE$$75$YR$$F$Y$$$20240928$$CN$US$US
243750831$24375083$1$I$$20240919$20240928$20240928$EXP$$TH-ROCHE-10000086551$ROCHE$$71$YR$E$M$Y$$$20240928$$CN$TH$TH
243750841$24375084$1$I$$20240924$20240928$20240928$PER$$US-ABBVIE-5938794$ABBVIE$$$$$$Y$$$20240928$$CN$US$US
243750851$24375085$1$I$20240101$20240910$20240928$20240928$PER$$US-SA-2024SA279224$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240928$$CN$US$US
243750861$24375086$1$I$20240821$20240924$20240928$20240928$EXP$$DE-ABBVIE-5937095$ABBVIE$$36$YR$$M$Y$$$20240928$$MD$DE$DE
243750871$24375087$1$I$$20240926$20240928$20240928$PER$$US-HALEON-2199041$Haleon PLC$$$$$F$Y$$$20240928$$CN$US$US
243750881$24375088$1$I$$20240919$20240928$20240928$EXP$$JP-ROCHE-10000089628$ROCHE$$84$YR$E$M$Y$$$20240928$$MD$JP$JP
243750891$24375089$1$I$$20240918$20240928$20240928$EXP$$CA-APOTEX-2024AP011186$APOTEX$$66$YR$$M$Y$$$20240928$$CN$CA$CA
243750901$24375090$1$I$20240907$20240922$20240928$20240928$EXP$$CN-ABBVIE-5934505$ABBVIE$$75$YR$$M$Y$60$KG$20240928$$MD$CN$CN
243750911$24375091$1$I$20240620$20240925$20240928$20240928$EXP$$CZ-ABBVIE-5941162$ABBVIE$$97$YR$$M$Y$$$20240928$$MD$CZ$CZ
243750921$24375092$1$I$$20240910$20240928$20240928$PER$$US-SA-2024SA277378$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240928$$MD$US$US
243750931$24375093$1$I$20240101$20240924$20240928$20240928$EXP$$US-ABBVIE-5937719$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243750941$24375094$1$I$$20240909$20240928$20240928$PER$$US-SA-2024SA277089$SANOFI AVENTIS$$$$C$M$Y$$$20240928$$MD$US$US
243750951$24375095$1$I$$20240910$20240928$20240928$PER$$US-SA-2024SA279235$SANOFI AVENTIS$$$$A$M$Y$104.55$KG$20240928$$MD$US$US
243750961$24375096$1$I$20240701$20240920$20240928$20240928$PER$$US-SA-2024SA275267$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240928$$MD$US$US
243750971$24375097$1$I$20240101$20240918$20240928$20240928$EXP$$US-JNJFOC-20240959068$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240928$$CN$US$US
243750981$24375098$1$I$$20240918$20240928$20240928$EXP$$CA-APOTEX-2024AP011200$APOTEX$$55$YR$$$Y$$$20240928$$CN$CA$CA
243750991$24375099$1$I$$20240909$20240928$20240928$PER$$US-SA-2024SA276119$SANOFI AVENTIS$$64$YR$A$$Y$$$20240928$$CN$US$US
243751001$24375100$1$I$20230101$20240910$20240928$20240928$PER$$US-SA-2024SA277649$SANOFI AVENTIS$$$$$F$Y$$$20240928$$HP$US$US
243751011$24375101$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA273895$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240928$$HP$US$US
243751021$24375102$1$I$$20240919$20240928$20240928$EXP$$TH-ROCHE-10000086545$ROCHE$$78$YR$E$M$Y$$$20240928$$CN$TH$TH
243751041$24375104$1$I$$20240921$20240928$20240928$PER$$US-HALEON-2198433$Haleon PLC$$$$$$Y$$$20240928$$CN$US$US
243751051$24375105$1$I$$20240919$20240928$20240928$EXP$$CA-APOTEX-2024AP011278$APOTEX$$52$YR$$M$Y$$$20240928$$PH$CA$CA
243751061$24375106$1$I$$20240919$20240928$20240928$EXP$$AU-JNJFOC-20240959650$JOHNSON AND JOHNSON$$$$$F$Y$$$20240928$$MD$AU$AU
243751071$24375107$1$I$$20240925$20240928$20240928$EXP$$PL-SANDOZ INC.-SDZ2024PL083200$SANDOZ$$31$YR$$F$Y$$$20240928$$MD$PL$PL
243751081$24375108$1$I$20240101$20240920$20240928$20240928$EXP$$CN-ABBVIE-5933054$ABBVIE$$$$$M$Y$65$KG$20240928$$MD$CN$CN
243751091$24375109$1$I$$20240923$20240928$20240928$EXP$$CA-ABBVIE-5939071$ABBVIE$$$$A$F$Y$$$20240928$$CN$CA$CA
243751101$24375110$1$I$$20240917$20240928$20240928$EXP$CA-MHPD-001101717$CA-Accord-447450$ACCORD$$14$YR$T$M$Y$$$20240928$$HP$CA$CA
243751111$24375111$1$I$20230101$20240920$20240928$20240928$EXP$$CA-ABBVIE-5933719$ABBVIE$$76$YR$$F$Y$$$20240928$$PH$CA$CA
243751121$24375112$1$I$20240905$20240909$20240928$20240928$PER$$US-NOVITIUMPHARMA-2024USNVP02018$NOVITIUM PHARMA$$50$YR$A$F$Y$113.4$KG$20240928$$CN$US$US
243751131$24375113$1$I$$20240918$20240928$20240928$PER$$US-GSK-US2024116170$GLAXOSMITHKLINE$$$$$F$Y$$$20240928$$CN$US$US
243751151$24375115$1$I$20240807$20240920$20240928$20240928$EXP$$CN-ABBVIE-5940124$ABBVIE$$77$YR$$F$Y$45$KG$20240928$$HP$CN$CN
243751161$24375116$1$I$$20240926$20240928$20240928$PER$$US-HALEON-2199042$Haleon PLC$$$$$$Y$$$20240928$$CN$US$US
243751181$24375118$1$I$$20240916$20240928$20240928$EXP$$US-Accord-447477$ACCORD$$$$$M$Y$$$20240928$$HP$US$US
243751191$24375119$1$I$20200701$20240926$20240928$20240928$EXP$$PL-SANDOZ INC.-SDZ2023PL033707$SANDOZ$$60$YR$$F$Y$$$20240928$$MD$PL$PL
243751201$24375120$1$I$$20240917$20240928$20240928$EXP$$NL-CELLTRION INC.-2024NL022906$CELLTRION$Vries E, Duijvestein M, Meijer A, et.al.. A severe rectal bleeding. Unknown. 2024$$$$$Y$$$20240928$$HP$NL$NL
243751211$24375121$1$I$$20240926$20240928$20240928$PER$$US-ABBVIE-5942958$ABBVIE$$$$$$Y$$$20240928$$CN$US$US
243751221$24375122$1$I$20240101$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047246$AUROBINDO$$89$YR$$F$Y$79$KG$20240928$$PH$FR$FR
243751231$24375123$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA275311$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240928$$MD$US$US
243751241$24375124$1$I$20240701$20240919$20240928$20240928$PER$$US-SA-2024SA274355$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240928$$MD$US$US
243751251$24375125$1$I$20240922$20240923$20240928$20240928$EXP$$US-AMGEN-USASP2024189401$AMGEN$$73$YR$E$$Y$$$20240927$$CN$US$US
243751261$24375126$1$I$20240205$20240920$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047451$AUROBINDO$$21$YR$$F$Y$57$KG$20240928$$MD$FR$FR
243751281$24375128$1$I$$20240926$20240928$20240928$PER$$US-HALEON-2199137$Haleon PLC$$$$$$Y$$$20240928$$CN$US$US
243751291$24375129$1$I$$20240924$20240928$20240928$EXP$$BE-ROCHE-10000091364$ROCHE$$66$YR$E$F$Y$$$20240928$$MD$BE$BE
243751301$24375130$1$I$20220101$20240919$20240928$20240928$EXP$$CA-CELLTRION INC.-2022CA004536$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
243751311$24375131$1$I$20240607$20240918$20240928$20240928$EXP$IT-MINISAL02-1001848$IT-Accord-447711$ACCORD$$57$YR$A$F$Y$75$KG$20240928$$PH$IT$IT
243751321$24375132$1$I$20240924$20240924$20240928$20240928$PER$$US-AMGEN-USASP2024190648$AMGEN$$71$YR$E$F$Y$$$20240927$$CN$US$US
243751331$24375133$1$I$20240611$20240919$20240928$20240928$EXP$$DE-AUROBINDO-AUR-APL-2024-047140$AUROBINDO$$71$YR$$F$Y$69$KG$20240928$$MD$DE$DE
243751341$24375134$1$I$$20240926$20240928$20240928$PER$$US-ABBVIE-5942861$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243751351$24375135$1$I$$20240925$20240928$20240928$PER$$US-AMGEN-USASP2024191827$AMGEN$$$$$$Y$$$20240927$$CN$US$US
243751361$24375136$1$I$20240919$20240925$20240928$20240928$EXP$GB-MHRA-WEBCOVID-202409231214283790-PRVSW$GB-009507513-2409GBR008954$MERCK$$$$$F$Y$$$20240928$$HP$GB$GB
243751371$24375137$1$I$$20240916$20240928$20240928$EXP$$ES-CELLTRION INC.-2024ES022976$CELLTRION$Legaza ES, Sanchez AP.. Complicated oropharyngeal actinomycosis secondary to pharmacotherapy. Salud(i)Ciencia$$$$$Y$$$20240928$$HP$ES$ES
243751382$24375138$2$F$$20240923$20240928$20240930$EXP$$US-AMGEN-USASP2024191795$AMGEN$$$$E$M$Y$$$20240930$$MD$US$US
243751391$24375139$1$I$$20240924$20240928$20240928$EXP$$KR-ABBVIE-5942270$ABBVIE$$$$E$$Y$$$20240928$$MD$KR$KR
243751401$24375140$1$I$20240701$20240919$20240928$20240928$PER$$US-SA-2024SA278505$SANOFI AVENTIS$$62$YR$A$F$Y$77.27$KG$20240928$$MD$US$US
243751411$24375141$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA274759$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240928$$MD$US$US
243751421$24375142$1$I$$20240830$20240928$20240928$EXP$$FR-CELLTRION INC.-2024FR022753$CELLTRION$$$$$$Y$$$20240928$$HP$FR$FR
243751441$24375144$1$I$20240918$20240919$20240928$20240928$PER$$US-SA-2024SA275114$SANOFI AVENTIS$$$$$F$Y$$$20240928$$MD$US$US
243751451$24375145$1$I$20240101$20240921$20240928$20240928$PER$$US-SA-2024SA275143$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240928$$MD$US$US
243751461$24375146$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA273942$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240928$$MD$US$US
243751471$24375147$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA273631$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240928$$HP$US$US
243751481$24375148$1$I$20240923$20240923$20240928$20240928$PER$$US-ABBVIE-5939794$ABBVIE$$27$YR$$$Y$$$20240928$$HP$US$US
243751491$24375149$1$I$20240101$20240923$20240928$20240928$PER$$US-SA-2024SA275839$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240928$$MD$US$US
243751501$24375150$1$I$20240101$20240910$20240928$20240928$PER$$US-SA-2024SA278423$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240928$$CN$US$US
243751511$24375151$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA273921$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240928$$MD$US$US
243751521$24375152$1$I$20240905$20240919$20240928$20240928$PER$$US-SA-2024SA273911$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240928$$HP$US$US
243751531$24375153$1$I$20240101$20240910$20240928$20240928$PER$$US-SA-2024SA278185$SANOFI AVENTIS$$94$YR$E$F$Y$$$20240928$$MD$US$US
243751541$24375154$1$I$$20240923$20240928$20240928$PER$$US-SA-2024SA275853$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240928$$MD$US$US
243751551$24375155$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA275750$SANOFI AVENTIS$$60$YR$A$M$Y$120$KG$20240928$$MD$US$US
243751561$24375156$1$I$20240909$20240917$20240928$20240928$EXP$$GB-CELLTRION INC.-2024GB023038$CELLTRION$$$$$$Y$$$20240928$$CN$GB$GB
243751571$24375157$1$I$20211224$20240919$20240928$20240928$EXP$$IT-AUROBINDO-AUR-APL-2024-047319$AUROBINDO$$36$YR$$M$Y$$$20240928$$MD$IT$IT
243751591$24375159$1$I$20240101$20240919$20240928$20240928$PER$$US-ABBVIE-5931205$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243751601$24375160$1$I$$20240925$20240928$20240928$EXP$$GB-AMGEN-GBRSP2024191684$AMGEN$$$$$F$Y$$$20240927$$CN$GB$GB
243751611$24375161$1$I$20240912$20240912$20240928$20240928$PER$$US-JNJFOC-20240938690$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240928$$CN$US$US
243751621$24375162$1$I$20240101$20240918$20240928$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026820$UNITED THERAPEUTICS$$$$$F$Y$88.435$KG$20240928$$$US$US
243751631$24375163$1$I$20240911$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047205$AUROBINDO$$21$YR$$F$Y$24$KG$20240928$$MD$FR$FR
243751641$24375164$1$I$20240914$20240916$20240928$20240928$PER$$US-SA-2024SA278216$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240928$$CN$US$US
243751651$24375165$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA274040$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240928$$HP$US$US
243751661$24375166$1$I$20240801$20240923$20240928$20240928$PER$$US-SA-2024SA275798$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240928$$MD$US$US
243751691$24375169$1$I$$20240920$20240928$20240928$EXP$$US-AMGEN-USASP2024188384$AMGEN$Majeed U.; Kuhlman J. J.; Garza-ramos C. D. et al.. Reduction in Lung Shunt Fraction after Bevacizumab to Allow for Radioembolization in a Patient with Hepatocellular Carcinoma. Journal of vascular and interventional radiology : JVIR. 2024;1-5$74$YR$E$M$Y$$$20240927$$MD$US$US
243751701$24375170$1$I$$20240917$20240928$20240928$EXP$$US-AUROBINDO-AUR-APL-2024-047700$AUROBINDO$Ward J, Portnof J, Barreto V, Freedman P, Reich R, Kerpel S. Two cases of imatinib induced oral pigmentation affecting the palate. Oral-Surg-Oral-Med-Oral-Pathol-Oral-Radiol. 2024;138(4):e79-e84$69$YR$$F$Y$$$20240928$$HP$US$US
243751721$24375172$1$I$20240830$20240923$20240928$20240928$EXP$FR-AFSSAPS-NT2024001148$FR-ROCHE-10000088604$ROCHE$$65$YR$E$M$Y$83$KG$20240928$$MD$FR$FR
243751731$24375173$1$I$20240101$20240923$20240928$20240928$EXP$$US-ABBVIE-5935999$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243751741$24375174$1$I$20240801$20240918$20240928$20240928$PER$$US-ABBVIE-5932026$ABBVIE$$$$A$M$Y$$$20240928$$HP$US$US
243751751$24375175$1$I$$20240919$20240928$20240928$PER$$US-JNJFOC-20240952910$JOHNSON AND JOHNSON$$25$YR$A$F$Y$54$KG$20240928$$MD$US$US
243751762$24375176$2$F$$20240919$20240928$20240928$EXP$$US-ROCHE-10000087381$ROCHE$$$$$M$Y$$$20240928$$CN$US$US
243751771$24375177$1$I$20240920$20240925$20240928$20240928$PER$$US-AMGEN-USASP2024192816$AMGEN$$75$YR$E$F$Y$$$20240927$$HP$US$US
243751781$24375178$1$I$20240901$20240917$20240928$20240928$EXP$$US-UCBSA-2024048025$UCB$$22$YR$$F$Y$95.238$KG$20240928$$MD$US$US
243751791$24375179$1$I$20240821$20240918$20240928$20240928$EXP$CN-HENLIUS-24CN017264$CN-Accord-448453$ACCORD$$37$YR$A$F$Y$70$KG$20240928$$MD$CN$CN
243751811$24375181$1$I$20240920$20240920$20240928$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-030117$UNITED THERAPEUTICS$$81$YR$$M$Y$77.551$KG$20240928$$$US$US
243751821$24375182$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA273955$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240928$$HP$US$US
243751831$24375183$1$I$$20240916$20240928$20240928$PER$$US-SA-2024SA279212$SANOFI AVENTIS$$$$E$F$Y$$$20240928$$MD$US$US
243751841$24375184$1$I$20240905$20240919$20240928$20240928$EXP$$JP-AMGEN-JPNSP2024192545$AMGEN$$39$YR$A$F$Y$$$20240927$$MD$JP$JP
243751851$24375185$1$I$$20240918$20240928$20240928$EXP$$CN-ROCHE-10000091063$ROCHE$Deng Y, Niu T, Li X, Liu Y, Zhou Y, Lei D. Systemic analysis of adverse drug events in patients with diabetes complicated by cataract treated with rizumab after surgery. CHIN J DRUG APPL AND MONIT. 2024;21(4):494-8. doi:10.3969/j.issn.1672-8157.2024.04.042$$$$$Y$$$20240928$$HP$CN$CN
243751861$24375186$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA274589$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240928$$HP$US$US
243751871$24375187$1$I$20240918$20240919$20240928$20240928$PER$$US-SA-2024SA273947$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240928$$HP$US$US
243751881$24375188$1$I$20240401$20240923$20240928$20240928$PER$$US-SA-2024SA275841$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240928$$MD$US$US
243751891$24375189$1$I$$20240923$20240928$20240928$PER$$US-AMGEN-USASP2024190510$AMGEN$Chen E.C.; Flamand Y.; Tiao E.; et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$69$YR$E$F$Y$$$20240927$$HP$US$US
243751911$24375191$1$I$20240101$20240923$20240928$20240928$PER$$US-ABBVIE-5937473$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243751921$24375192$1$I$$20240924$20240928$20240928$EXP$$CA-ROCHE-10000089678$ROCHE$$33$YR$A$M$Y$$$20240928$$MD$CA$CA
243751931$24375193$1$I$$20240926$20240928$20240928$PER$$US-HALEON-2199144$Haleon PLC$$$$$$Y$$$20240928$$CN$US$US
243751941$24375194$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245805$TEVA$$71$YR$$$Y$$$20240928$$PH$CA$CA
243751951$24375195$1$I$20240101$20240917$20240928$20240928$PER$$US-JNJFOC-20240943969$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243751961$24375196$1$I$$20240925$20240928$20240928$EXP$$US-ABBVIE-5939340$ABBVIE$$$$$$Y$$$20240928$$CN$US$US
243751971$24375197$1$I$20240904$20240923$20240928$20240928$PER$$US-AMGEN-USASP2024189409$AMGEN$$$$$$Y$$$20240927$$HP$US$US
243751981$24375198$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245686$TEVA$$66$YR$$M$Y$74$KG$20240928$$PH$CA$CA
243752001$24375200$1$I$20240901$20240918$20240928$20240928$PER$$US-ABBVIE-5932355$ABBVIE$$74$YR$$M$Y$$$20240928$$MD$US$US
243752011$24375201$1$I$$20240916$20240928$20240928$PER$$US-JNJFOC-20240942209$JOHNSON AND JOHNSON$$$$$M$Y$$$20240928$$CN$US$US
243752021$24375202$1$I$20240101$20240925$20240928$20240928$PER$$US-JNJFOC-20240968586$JOHNSON AND JOHNSON$$$$$F$Y$$$20240928$$CN$US$US
243752031$24375203$1$I$20230101$20240924$20240928$20240928$EXP$$US-ABBVIE-5930412$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243752041$24375204$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245863$TEVA$$38$YR$$M$Y$$$20240928$$HP$CA$CA
243752051$24375205$1$I$$20240924$20240928$20240928$EXP$$CA-ROCHE-10000089703$ROCHE$$67$YR$E$M$Y$$$20240928$$HP$CA$CA
243752061$24375206$1$I$20240901$20240926$20240928$20240928$PER$$US-JNJFOC-20240971547$JOHNSON AND JOHNSON$$$$$F$Y$$$20240928$$CN$US$US
243752071$24375207$1$I$20240621$20240919$20240928$20240928$EXP$$ES-AUROBINDO-AUR-APL-2024-047036$AUROBINDO$$78$YR$$F$Y$$$20240928$$MD$ES$ES
243752081$24375208$1$I$20240912$20240925$20240928$20240928$EXP$$PK-ROCHE-10000091137$ROCHE$$53$YR$A$F$Y$$$20240928$$CN$PK$PK
243752091$24375209$1$I$20240101$20240920$20240928$20240928$EXP$$DE-ABBVIE-5939242$ABBVIE$$81$YR$$M$Y$$$20240928$$MD$DE$DE
243752101$24375210$1$I$$20240919$20240928$20240928$EXP$$CA-NOVITIUMPHARMA-2024CANVP02004$NOVITIUM PHARMA$Kayla M Cameron-Coffill.A Case of Delayed and Persistent Carbamazepine Overdose Treated With Hemodialysis, Plasmapheresis, and Neostigmine.Journal of Pharmacy Practice.14-AUG-2024;NA:1-4$61$YR$A$F$Y$$$20240928$$HP$CA$CA
243752111$24375211$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-046912$AUROBINDO$$89$YR$$M$Y$$$20240928$$PH$CA$CA
243752121$24375212$1$I$$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192775$AMGEN$$$$$$Y$$$20240927$$PH$US$US
243752131$24375213$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245679$TEVA$$12$YR$$F$Y$$$20240928$$HP$CA$CA
243752141$24375214$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245676$TEVA$$12$YR$$M$Y$$$20240928$$HP$CA$CA
243752151$24375215$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245691$TEVA$$3$YR$$F$Y$$$20240928$$HP$CA$CA
243752161$24375216$1$I$20240916$20240916$20240928$20240928$PER$$US-SA-2024SA279384$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240928$$CN$US$US
243752171$24375217$1$I$$20240923$20240928$20240928$EXP$$FR-JNJFOC-20240943696$JOHNSON AND JOHNSON$$71$YR$E$M$Y$70$KG$20240928$$MD$FR$FR
243752181$24375218$1$I$20240912$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192482$AMGEN$$65$YR$E$M$Y$$$20240927$$CN$US$US
243752191$24375219$1$I$20240101$20240921$20240928$20240928$PER$$US-SA-2024SA275255$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240928$$HP$US$US
243752201$24375220$1$I$20240924$20240924$20240928$20240928$PER$$US-AMGEN-USASP2024190986$AMGEN$$76$YR$E$F$Y$$$20240927$$CN$US$US
243752211$24375221$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245812$TEVA$$53$YR$$F$Y$$$20240928$$HP$CA$CA
243752221$24375222$1$I$$20240918$20240928$20240928$PER$$US-JNJFOC-20240957980$JOHNSON AND JOHNSON$$$$$M$Y$$$20240928$$HP$US$US
243752231$24375223$1$I$$20240924$20240928$20240928$EXP$$GR-ABBVIE-5938952$ABBVIE$$$$$M$Y$$$20240928$$MD$GR$GR
243752271$24375227$1$I$20240903$20240918$20240928$20240928$PER$$US-SA-2024SA271010$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240928$$HP$US$US
243752281$24375228$1$I$$20240921$20240928$20240928$PER$$US-SA-2024SA275305$SANOFI AVENTIS$$$$A$M$Y$$$20240928$$HP$US$US
243752291$24375229$1$I$$20240918$20240928$20240928$EXP$$ES-ABBVIE-5941065$ABBVIE$$$$$$Y$$$20240928$$MD$ES$ES
243752301$24375230$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245714$TEVA$$$$$F$Y$$$20240928$$MD$CA$CA
243752321$24375232$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245852$TEVA$$70$YR$$F$Y$$$20240928$$HP$CA$CA
243752331$24375233$1$I$20240101$20240910$20240928$20240928$PER$$US-TEVA-VS-3242647$TEVA$$$$$F$Y$$$20240928$$PH$US$US
243752341$24375234$1$I$20240911$20240911$20240928$20240928$PER$$US-ABBVIE-5935064$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243752351$24375235$1$I$$20240920$20240928$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-029275$UNITED THERAPEUTICS$$$$$F$Y$76.19$KG$20240928$$$US$US
243752361$24375236$1$I$$20240919$20240928$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-030101$UNITED THERAPEUTICS$$$$$F$Y$81.633$KG$20240928$$$US$US
243752371$24375237$1$I$$20240918$20240928$20240928$EXP$$FR-ABBVIE-5941952$ABBVIE$Stephan P, Guillermin Y, Michallet A, Grinberg-Bleyer Y, Bouherrou K. Immunophenotyping of Peripheral Blood Cells in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. Cells. 2024;13,1458:1-14.$61$YR$$M$Y$$$20240928$$HP$FR$FR
243752381$24375238$1$I$20240912$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047175$AUROBINDO$$79$YR$$F$Y$$$20240928$$PH$FR$FR
243752391$24375239$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA273986$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240928$$HP$US$US
243752401$24375240$1$I$$20240911$20240928$20240928$PER$$US-SA-2024SA279678$SANOFI AVENTIS$$$$C$F$Y$$$20240928$$MD$US$US
243752411$24375241$1$I$20240514$20240918$20240928$20240928$EXP$$CA-CELLTRION INC.-2024CA013249$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
243752421$24375242$1$I$$20240919$20240928$20240928$EXP$$NL-AUROBINDO-AUR-APL-2024-047346$AUROBINDO$Hermes NEG. Et al.. C3 glomerulopathy in the context of monoclonal gammopathy of renal significance successfully treated with daratumumab.. Ned. Tijdschr voor Hematologie. 2024;21:277-82$59$YR$$$Y$$$20240928$$MD$NL$NL
243752441$24375244$1$I$20240508$20240919$20240928$20240928$EXP$$ES-AUROBINDO-AUR-APL-2024-047038$AUROBINDO$$32$YR$$M$Y$$$20240928$$MD$ES$ES
243752451$24375245$1$I$20240906$20240923$20240928$20240928$PER$$US-AMGEN-USASP2024190389$AMGEN$$$$$F$Y$$$20240928$$MD$US$US
243752461$24375246$1$I$20230101$20240923$20240928$20240928$PER$$US-SA-2024SA275843$SANOFI AVENTIS$$$$A$F$Y$$$20240928$$MD$US$US
243752471$24375247$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA273954$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240928$$MD$US$US
243752481$24375248$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA274405$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240928$$HP$US$US
243752491$24375249$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA274063$SANOFI AVENTIS$$$$N$M$Y$$$20240928$$HP$US$US
243752531$24375253$1$I$$20240919$20240928$20240928$EXP$$CA-ROCHE-10000086313$ROCHE$$70$YR$E$M$Y$$$20240928$$HP$CA$CA
243752541$24375254$1$I$20240101$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192589$AMGEN$$$$A$F$Y$$$20240928$$MD$US$US
243752571$24375257$1$I$$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047128$AUROBINDO$$$$$M$Y$$$20240928$$MD$FR$FR
243752581$24375258$1$I$20240909$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047255$AUROBINDO$$72$YR$$F$Y$$$20240928$$MD$FR$FR
243752591$24375259$1$I$20240925$20240925$20240928$20240928$PER$$US-AMGEN-USASP2024191306$AMGEN$$62$YR$A$M$Y$$$20240928$$CN$US$US
243752601$24375260$1$I$20240101$20240920$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047460$AUROBINDO$$22$YR$$F$Y$$$20240928$$PH$FR$FR
243752611$24375261$1$I$20240826$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047130$AUROBINDO$$79$YR$$F$Y$$$20240928$$MD$FR$FR
243752621$24375262$1$I$$20240917$20240928$20240928$EXP$CA-MHPD-E2B_07225703$CA-Accord-447832$ACCORD$$3$YR$C$F$Y$$$20240928$$HP$CA$CA
243752631$24375263$1$I$20240801$20240920$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047430$AUROBINDO$$54$YR$$M$Y$55$KG$20240928$$MD$FR$FR
243752641$24375264$1$I$20240922$20240923$20240928$20240928$EXP$$US-AMGEN-USASP2024189316$AMGEN$$73$YR$E$M$Y$$$20240928$$CN$US$US
243752651$24375265$1$I$$20240919$20240928$20240928$PER$$US-GSK-US2024116622$GLAXOSMITHKLINE$$$$$F$Y$$$20240928$$CN$US$US
243752671$24375267$1$I$$20240924$20240928$20240928$PER$$US-ABBVIE-5937847$ABBVIE$$$$$$Y$$$20240928$$HP$US$US
243752681$24375268$1$I$$20240918$20240928$20240928$EXP$CA-MHPD-E2B_07243515$CA-Accord-447662$ACCORD$$35$YR$A$M$Y$$$20240928$$HP$CA$CA
243752691$24375269$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA274183$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240928$$CN$US$US
243752701$24375270$1$I$20240101$20240921$20240928$20240928$PER$$US-SA-2024SA275588$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240928$$HP$US$US
243752711$24375271$1$I$20240901$20240920$20240928$20240928$PER$$US-SA-2024SA274084$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240928$$MD$US$US
243752721$24375272$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA273997$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240928$$MD$US$US
243752731$24375273$1$I$20240714$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047198$AUROBINDO$$87$YR$$F$Y$72$KG$20240928$$PH$FR$FR
243752741$24375274$1$I$$20240920$20240928$20240928$EXP$$RU-ROCHE-10000087917$ROCHE$$$$$F$Y$$$20240928$$MD$RU$RU
243752781$24375278$1$I$$20240919$20240928$20240928$EXP$$NL-AUROBINDO-AUR-APL-2024-047293$AUROBINDO$$56$YR$$F$Y$73$KG$20240928$$CN$NL$NL
243752801$24375280$1$I$20240828$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192584$AMGEN$$87$YR$E$M$Y$$$20240928$$CN$US$US
243752811$24375281$1$I$20240925$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192801$AMGEN$$55$YR$A$M$Y$$$20240928$$CN$US$US
243752821$24375282$1$I$$20240919$20240928$20240928$EXP$$CA-ROCHE-10000086292$ROCHE$$$$$F$Y$101$KG$20240928$$CN$CA$CA
243752831$24375283$1$I$$20240926$20240928$20240928$PER$$US-ABBVIE-5943060$ABBVIE$$$$$$Y$$$20240928$$CN$US$US
243752841$24375284$1$I$20240101$20240925$20240928$20240928$EXP$$US-ABBVIE-5939944$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243752851$24375285$1$I$20161201$20240920$20240928$20240928$EXP$$JP-AMGEN-JPNSP2024189924$AMGEN$$43$YR$A$F$Y$$$20240928$$MD$JP$JP
243752861$24375286$1$I$20140101$20240914$20240928$20240928$PER$$US-GRANULES-US-2024GRASPO00422$GRANULES INDIA$$34$YR$A$M$Y$220$KG$20240928$$CN$US$US
243752871$24375287$1$I$20201117$20240920$20240928$20240928$EXP$$PL-AUROBINDO-AUR-APL-2024-047510$AUROBINDO$$42$YR$$M$Y$98$KG$20240928$$MD$PL$PL
243752881$24375288$1$I$$20240919$20240928$20240928$PER$$US-ABBVIE-5933747$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243752891$24375289$1$I$20230101$20240919$20240928$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2023-028572$UNITED THERAPEUTICS$$$$$M$Y$55.329$KG$20240928$$$US$US
243752901$24375290$1$I$20240101$20240920$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047435$AUROBINDO$$55$YR$$F$Y$$$20240928$$PH$FR$FR
243752911$24375291$1$I$20231101$20240920$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047446$AUROBINDO$$44$YR$$F$Y$$$20240928$$PH$FR$FR
243752921$24375292$1$I$$20240926$20240928$20240928$PER$$US-ABBVIE-5942232$ABBVIE$$$$$$Y$$$20240928$$HP$US$US
243752931$24375293$1$I$$20240916$20240928$20240928$PER$$US-GRANULES-US-2024GRASPO00426$GRANULES INDIA$$$$$F$Y$$$20240928$$CN$US$US
243752941$24375294$1$I$20240822$20240920$20240928$20240928$EXP$$CN-AUROBINDO-AUR-APL-2024-047545$AUROBINDO$$68$YR$$F$Y$$$20240928$$HP$CN$CN
243752951$24375295$1$I$20240909$20240909$20240928$20240928$PER$$US-CSL-2024-008325$CSL Plasma$$50$YR$$M$Y$$$20240928$$HP$US$US
243752961$24375296$1$I$$20240919$20240928$20240928$PER$$US-ABBVIE-5931715$ABBVIE$$$$$$Y$$$20240928$$MD$US$US
243752971$24375297$1$I$20230409$20240923$20240928$20240928$EXP$IT-MINISAL02-1002891$IT-ABBVIE-5942435$ABBVIE$$75$YR$$M$Y$78$KG$20240928$$MD$IT$IT
243752981$24375298$1$I$20240701$20240920$20240928$20240928$PER$$US-SA-2024SA275567$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240928$$HP$US$US
243752991$24375299$1$I$20240924$20240925$20240928$20240928$PER$$US-AMGEN-USASP2024191307$AMGEN$$79$YR$E$M$Y$$$20240928$$HP$US$US
243753001$24375300$1$I$20240923$20240924$20240928$20240928$PER$$US-AMGEN-USASP2024190885$AMGEN$$82$YR$E$F$Y$$$20240928$$CN$US$US
243753011$24375301$1$I$20230127$20240918$20240928$20240928$EXP$FR-AFSSAPS-AN2023000794$FR-CELLTRION INC.-2024FR022799$CELLTRION$$$$$$Y$$$20240928$$MD$FR$FR
243753021$24375302$1$I$$20240923$20240928$20240928$EXP$$US-ABBVIE-5936741$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243753031$24375303$1$I$$20240918$20240928$20240928$EXP$$GB-CELLTRION INC.-2024GB023040$CELLTRION$$$$$$Y$$$20240928$$HP$GB$GB
243753051$24375305$1$I$20240901$20240919$20240928$20240928$PER$$US-SA-2024SA274802$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240928$$HP$US$US
243753081$24375308$1$I$20240926$20240926$20240928$20240928$30DAY$$US-SANDOZ INC.-SDZ2024US083441$SANDOZ$$62$YR$$F$Y$$$20240928$$CN$US$US
243753101$24375310$1$I$$20240916$20240928$20240928$EXP$$PL-Accord-447951$ACCORD$Woron J, Siwek M. Bol gardla jako niepozadana konsekwencja interakcji lekow stosowanych w leczeniu pacjentki chorej na depresje i otylosc. (Sore?throat as an adverse consequence of drug interactions used in the treatment of a patient suffering from depression and obesity). Medycyna Praktyczna - Psychiatria 4/2024, s. 37-39.$31$YR$A$F$Y$$$20240928$$MD$PL$PL
243753121$24375312$1$I$20240925$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192593$AMGEN$$$$$M$Y$$$20240928$$CN$US$US
243753131$24375313$1$I$$20240917$20240928$20240928$EXP$$JP-ROCHE-10000090538$ROCHE$Kitade M, Nakajima H. O1-5 A case of a patient with rheumatoid arthritis in which iliopsoas abscess and hip prosthesis infection triggered by easy dislocations were revealed. Joint Surgery / The 53rd Annual Meeting of the Japan Society for Rheumatism and. 2024;51(2):83$73$YR$E$F$Y$$$20240928$$MD$JP$JP
243753141$24375314$1$I$$20240920$20240928$20240928$PER$$US-AMGEN-USASP2024190530$AMGEN$$$$$M$Y$$$20240928$$CN$US$US
243753151$24375315$1$I$20240925$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192595$AMGEN$$$$$F$Y$$$20240928$$CN$US$US
243753161$24375316$1$I$20240801$20240920$20240928$20240928$PER$$US-SA-2024SA275315$SANOFI AVENTIS$$7$YR$C$M$Y$$$20240928$$MD$US$US
243753171$24375317$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA274079$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240928$$MD$US$US
243753181$24375318$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA275970$SANOFI AVENTIS$$35$YR$A$M$Y$99.55$KG$20240928$$MD$US$US
243753191$24375319$1$I$20240714$20240916$20240928$20240928$EXP$FR-AFSSAPS-LL2024001723$FR-Accord-447773$ACCORD$$85$YR$E$M$Y$$$20240928$$MD$FR$FR
243753201$24375320$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274690$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240928$$HP$US$US
243753211$24375321$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274776$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240928$$HP$US$US
243753221$24375322$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA275478$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240928$$MD$US$US
243753231$24375323$1$I$20240910$20240924$20240928$20240928$PER$$US-JNJFOC-20240964487$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20240928$$CN$US$US
243753241$24375324$1$I$20240101$20240920$20240928$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-029374$UNITED THERAPEUTICS$$$$$F$Y$68.934$KG$20240928$$$US$US
243753251$24375325$1$I$$20240917$20240928$20240928$EXP$$IN-Accord-447420$ACCORD$Gaur L, Duggal R, Singhal MK. Herpes Simplex Virus Type-2 Nephritis: An Unexpected Plot Twist in a Kidney Transplant Recipient. Indian Journal of Nephrology. 2024;34(5):512-3.$32$YR$A$M$Y$$$20240928$$MD$IN$IN
243753261$24375326$1$I$$20240924$20240928$20240928$EXP$$ES-ABBVIE-5939190$ABBVIE$$$$$$Y$$$20240928$$CN$ES$ES
243753271$24375327$1$I$20240516$20240918$20240928$20240928$EXP$FR-AFSSAPS-AN2024001251$FR-Accord-448182$ACCORD$$71$YR$E$M$Y$64$KG$20240928$$PH$FR$FR
243753281$24375328$1$I$$20240910$20240928$20240928$PER$$US-SA-2024SA277719$SANOFI AVENTIS$$73$YR$E$$Y$$$20240928$$MD$US$US
243753291$24375329$1$I$$20240923$20240928$20240928$PER$$US-ROCHE-10000088952$ROCHE$SASIKUMAR S, RAI G, ANEES Z, GARCIA V, BUDDE J. I GOT SEPTIC PULMONARY EMBOLI FROM MY ACNE?!. Chest. 2024-Oct;166 (4): doi:10.1016/j.chest.2024.06.795.$26$YR$A$F$Y$$$20240928$$HP$US$US
243753301$24375330$1$I$$20240925$20240928$20240928$PER$$US-JNJFOC-20240971038$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243753311$24375331$1$I$$20240920$20240928$20240928$PER$$US-ROCHE-10000087913$ROCHE$$58$YR$A$M$Y$$$20240928$$CN$US$US
243753321$24375332$1$I$$20240923$20240928$20240928$EXP$$US-ABBVIE-5937284$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243753331$24375333$1$I$20240101$20240923$20240928$20240928$EXP$$US-ABBVIE-5937283$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243753341$24375334$1$I$$20240923$20240928$20240928$EXP$$US-ABBVIE-5936998$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243753351$24375335$1$I$20240701$20240919$20240928$20240928$PER$$US-ABBVIE-5931837$ABBVIE$$50$YR$$F$Y$116.11$KG$20240928$$CN$US$US
243753361$24375336$1$I$$20240903$20240928$20240928$PER$$US-009507513-2409USA002181$MERCK$Boppana L, Sluzevich J, Katsolis J, Narula T, Alvarez F, Sareyyupoglu B, et al.. Chromoblastomycosis: A Potential Mimic of Squamous Cell Carcinoma in Transplant Recipients. Transplantation Proceedings. 2024;56:1454-6$75$YR$$M$Y$$$20240928$$HP$US$US
243753371$24375337$1$I$$20240923$20240928$20240928$EXP$$US-ABBVIE-5936016$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243753381$24375338$1$I$$20240924$20240928$20240928$PER$$US-ROCHE-10000091525$ROCHE$$$$C$M$Y$$$20240928$$CN$US$US
243753391$24375339$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA275246$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240928$$CN$US$US
243753401$24375340$1$I$$20240906$20240928$20240928$PER$$US-SA-2024SA276739$SANOFI AVENTIS$$$$A$F$Y$65.31$KG$20240928$$MD$US$US
243753411$24375341$1$I$20240915$20240924$20240928$20240928$PER$$US-ROCHE-10000092871$ROCHE$$39$YR$A$M$Y$$$20240928$$CN$US$US
243753421$24375342$1$I$$20240918$20240928$20240928$PER$$US-JNJFOC-20240949010$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$MD$US$US
243753441$24375344$1$I$$20240923$20240928$20240928$EXP$$KR-ROCHE-10000088732$ROCHE$$74$YR$E$F$Y$$$20240928$$HP$KR$KR
243753451$24375345$1$I$$20240924$20240928$20240928$PER$$US-ROCHE-10000091014$ROCHE$$$$A$M$Y$$$20240928$$CN$US$US
243753471$24375347$1$I$$20240925$20240928$20240928$PER$$US-ROCHE-10000092335$ROCHE$$$$T$M$Y$$$20240928$$CN$US$US
243753501$24375350$1$I$$20240925$20240928$20240928$PER$$US-ROCHE-10000091877$ROCHE$$$$A$M$Y$$$20240928$$CN$US$US
243753511$24375351$1$I$$20240505$20240928$20240928$EXP$$TH-ROCHE-10000087663$ROCHE$$$$$$Y$$$20240928$$MD$TH$TH
243753521$24375352$1$I$20240921$20240925$20240928$20240928$PER$$US-ROCHE-10000092460$ROCHE$$32$YR$A$M$Y$$$20240928$$CN$US$US
243753531$24375353$1$I$$20240925$20240928$20240928$PER$$US-ROCHE-10000092463$ROCHE$$$$T$M$Y$$$20240928$$CN$US$US
243753541$24375354$1$I$20240918$20240918$20240928$20240928$EXP$$US-CADILA HEALTHCARE LIMITED-US-ZYDUS-112442$ZYDUS PHARM$$$$$$Y$$$20240928$$HP$US$US
243753551$24375355$1$I$$20240925$20240928$20240928$PER$$US-ROCHE-10000092111$ROCHE$$$$T$M$Y$$$20240928$$CN$US$US
243753561$24375356$1$I$20240716$20240923$20240928$20240928$EXP$FR-AFSSAPS-NC2024001079$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112758$ZYDUS PHARM$$$$$$Y$$$20240928$$MD$FR$FR
243753571$24375357$1$I$20240806$20240923$20240928$20240928$EXP$FR-AFSSAPS-RN2024001012$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112663$ZYDUS PHARM$$$$$$Y$$$20240928$$MD$FR$FR
243753581$24375358$1$I$20240813$20240923$20240928$20240928$EXP$FR-AFSSAPS-BX2024001812$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112689$ZYDUS PHARM$$$$$$Y$$$20240928$$MD$FR$FR
243753591$24375359$1$I$20240729$20240923$20240928$20240928$EXP$FR-AFSSAPS-GR2024001110$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112659$ZYDUS PHARM$$$$$$Y$$$20240928$$PH$FR$FR
243753611$24375361$1$I$20240901$20240924$20240928$20240928$PER$$US-AMGEN-USASP2024190321$AMGEN$$$$$$Y$$$20240928$$CN$US$US
243753621$24375362$1$I$20240923$20240926$20240928$20240928$PER$$US-ROCHE-10000093103$ROCHE$$14$YR$T$M$Y$$$20240928$$CN$US$US
243753641$24375364$1$I$20240917$20240926$20240928$20240928$PER$$US-ROCHE-10000093190$ROCHE$$15$YR$T$M$Y$$$20240928$$CN$US$US
243753651$24375365$1$I$20240901$20240919$20240928$20240928$PER$$US-SA-2024SA274368$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240928$$MD$US$US
243753661$24375366$1$I$20240201$20240924$20240928$20240928$EXP$$US-ABBVIE-5939051$ABBVIE$$57$YR$$M$Y$$$20240928$$CN$US$US
243753671$24375367$1$I$20240920$20240924$20240928$20240928$EXP$$CN-ABBVIE-5937947$ABBVIE$$71$YR$$M$Y$51$KG$20240928$$MD$CN$CN
243753681$24375368$1$I$20240101$20240426$20240928$20240928$PER$$US-TEVA-VS-3248110$TEVA$$72$YR$$M$Y$$$20240928$$PH$US$US
243753691$24375369$1$I$$20240923$20240928$20240928$EXP$$US-ABBVIE-5937395$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243753701$24375370$1$I$20230615$20240919$20240928$20240928$EXP$FR-AFSSAPS-AN2023000911$FR-CELLTRION INC.-2024FR023015$CELLTRION$$$$$$Y$$$20240928$$MD$FR$FR
243753711$24375371$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA278128$SANOFI AVENTIS$$84$YR$E$$Y$$$20240928$$CN$US$US
243753721$24375372$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA274190$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240928$$HP$US$US
243753731$24375373$1$I$$20240920$20240928$20240928$PER$$US-ABBVIE-5934703$ABBVIE$$$$$$Y$$$20240928$$MD$US$US
243753751$24375375$1$I$20240903$20240926$20240928$20240928$EXP$$US-ABBVIE-5941961$ABBVIE$$89$YR$$F$Y$$$20240928$$CN$US$US
243753761$24375376$1$I$20240101$20240924$20240928$20240928$EXP$$US-ABBVIE-5937654$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243753771$24375377$1$I$$20240926$20240928$20240928$EXP$$US-ABBVIE-5941881$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243753791$24375379$1$I$20240912$20240919$20240928$20240928$PER$$US-ABBVIE-5933249$ABBVIE$$$$$$Y$$$20240928$$CN$US$US
243753801$24375380$1$I$$20240919$20240928$20240928$PER$$US-JNJFOC-20240951958$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243753811$24375381$1$I$20240917$20240918$20240928$20240928$PER$$US-JNJFOC-20240949100$JOHNSON AND JOHNSON$$62$YR$A$M$Y$117$KG$20240928$$PH$US$US
243753821$24375382$1$I$20240101$20240919$20240928$20240928$PER$$US-ABBVIE-5932121$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243753831$24375383$1$I$20240101$20240924$20240928$20240928$EXP$$US-ABBVIE-5938726$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243753851$24375385$1$I$$20240924$20240928$20240928$EXP$$US-ABBVIE-5937646$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243753861$24375386$1$I$20240601$20240920$20240928$20240928$PER$$US-SA-2024SA274281$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240928$$MD$US$US
243753871$24375387$1$I$20230606$20240919$20240928$20240928$EXP$ES-AEMPS-1393395$ES-CELLTRION INC.-2024ES022989$CELLTRION$$$$$$Y$$$20240928$$PH$ES$ES
243753881$24375388$1$I$$20240919$20240928$20240928$EXP$$GB-GLENMARK PHARMACEUTICALS-2024GMK094218$GLENMARK$$$$$$Y$$$20240928$$CN$GB$GB
243753891$24375389$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274144$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240928$$MD$US$US
243753901$24375390$1$I$20240901$20240924$20240928$20240928$EXP$$US-ABBVIE-5938608$ABBVIE$$79$YR$$F$Y$$$20240928$$CN$US$US
243753911$24375391$1$I$20240823$20240924$20240928$20240928$EXP$$US-ABBVIE-5939896$ABBVIE$$69$YR$$F$Y$$$20240928$$CN$US$US
243753931$24375393$1$I$$20240924$20240928$20240928$EXP$$CA-ABBVIE-5938735$ABBVIE$$$$E$$Y$$$20240928$$HP$CA$CA
243753941$24375394$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245811$TEVA$$80$YR$$M$Y$68$KG$20240928$$HP$CA$CA
243753951$24375395$1$I$20240820$20240916$20240928$20240928$EXP$FR-AFSSAPS-BS2024000623$FR-Accord-447771$ACCORD$$67$YR$E$F$Y$61$KG$20240928$$MD$FR$FR
243753961$24375396$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245733$TEVA$$62$YR$$F$Y$$$20240928$$HP$CA$CA
243753971$24375397$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245719$TEVA$$27$MON$$F$Y$12$KG$20240928$$HP$CA$CA
243753981$24375398$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA275808$SANOFI AVENTIS$$8$YR$C$F$Y$26.36$KG$20240928$$HP$US$US
243753991$24375399$1$I$$20240926$20240928$20240928$PER$$US-ABBVIE-5942162$ABBVIE$$15$YR$$$Y$$$20240928$$CN$US$US
243754001$24375400$1$I$$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3245725$TEVA$$68$YR$$F$Y$61$KG$20240928$$HP$CA$CA
243754011$24375401$1$I$20240926$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192662$AMGEN$$70$YR$E$M$Y$$$20240928$$CN$US$US
243754021$24375402$1$I$20240922$20240924$20240928$20240928$PER$$US-AMGEN-USASP2024190759$AMGEN$$56$YR$A$F$Y$$$20240928$$CN$US$US
243754031$24375403$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274367$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240928$$MD$US$US
243754041$24375404$1$I$20240901$20240919$20240928$20240928$PER$$US-SA-2024SA276006$SANOFI AVENTIS$$23$YR$A$M$Y$158.64$KG$20240928$$MD$US$US
243754061$24375406$1$I$$20240917$20240928$20240928$EXP$$US-Accord-447824$ACCORD$$$$$M$Y$$$20240928$$MD$US$US
243754071$24375407$1$I$$20240917$20240928$20240928$EXP$$US-Accord-447821$ACCORD$$$$$F$Y$$$20240928$$HP$US$US
243754081$24375408$1$I$20240821$20240924$20240928$20240928$PER$$US-AMGEN-USASP2024190247$AMGEN$$54$YR$A$F$Y$$$20240928$$CN$US$US
243754091$24375409$1$I$$20240925$20240928$20240928$EXP$$JP-ABBVIE-5939901$ABBVIE$$67$YR$$F$Y$$$20240928$$MD$JP$JP
243754101$24375410$1$I$20240724$20240923$20240928$20240928$EXP$$US-ABBVIE-5936974$ABBVIE$$61$YR$$M$Y$$$20240928$$CN$US$US
243754111$24375411$1$I$20240101$20240925$20240928$20240928$EXP$$US-ABBVIE-5939177$ABBVIE$$$$$F$Y$79$KG$20240928$$CN$US$US
243754131$24375413$1$I$20240925$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192892$AMGEN$$$$$F$Y$$$20240928$$HP$US$US
243754141$24375414$1$I$20240812$20240925$20240928$20240928$EXP$FR-AFSSAPS-PP2024001026$FR-ROCHE-10000090629$ROCHE$$59$YR$A$F$Y$$$20240928$$MD$FR$FR
243754151$24375415$1$I$20240916$20240923$20240928$20240928$PER$$US-JNJFOC-20240965657$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20240928$$CN$US$US
243754161$24375416$1$I$$20240917$20240928$20240928$EXP$$US-Accord-447924$ACCORD$$$$$$Y$$$20240928$$PH$US$US
243754171$24375417$1$I$$20240918$20240928$20240928$PER$$US-ABBVIE-5931443$ABBVIE$$$$$$Y$$$20240928$$CN$US$US
243754181$24375418$1$I$$20240919$20240928$20240928$PER$$US-GSK-US2024116950$GLAXOSMITHKLINE$$$$$$Y$$$20240928$$MD$US$US
243754191$24375419$1$I$20240922$20240923$20240928$20240928$PER$$US-AMGEN-USASP2024189733$AMGEN$$74$YR$E$F$Y$$$20240928$$CN$US$US
243754201$24375420$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA274616$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240928$$HP$US$US
243754211$24375421$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA274477$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240928$$MD$US$US
243754231$24375423$1$I$20240101$20240917$20240928$20240928$EXP$$BR-Accord-447927$ACCORD$$47$YR$A$M$Y$$$20240928$$PH$BR$BR
243754241$24375424$1$I$$20240918$20240928$20240928$EXP$$US-AUROBINDO-AUR-APL-2024-046685$AUROBINDO$Mehta P, Ngo D, Tinajero J.. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies.. J-Oncol-Pharm-Pract. 2024$61$YR$$M$Y$$$20240928$$HP$US$US
243754251$24375425$1$I$$20240916$20240928$20240928$EXP$CA-MHPD-E2B_07253760$CA-Accord-447179$ACCORD$$$$A$M$Y$$$20240928$$MD$CA$CA
243754261$24375426$1$I$$20240917$20240928$20240928$EXP$$US-Accord-447819$ACCORD$$$$$F$Y$$$20240928$$HP$US$US
243754271$24375427$1$I$20240101$20240924$20240928$20240928$EXP$$US-ABBVIE-5938752$ABBVIE$$85$YR$$F$Y$$$20240928$$CN$US$US
243754281$24375428$1$I$$20240923$20240928$20240928$EXP$$US-ABBVIE-5937393$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243754291$24375429$1$I$$20240925$20240928$20240928$PER$$US-JNJFOC-20240971279$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243754301$24375430$1$I$$20240917$20240928$20240928$EXP$CA-MHPD-001101039$CA-Accord-447333$ACCORD$$$$$F$Y$$$20240928$$MD$CA$CA
243754311$24375431$1$I$20240917$20240919$20240928$20240928$EXP$$GB-AUROBINDO-AUR-APL-2024-046768$AUROBINDO$$39$YR$$F$Y$$$20240928$$CN$GB$GB
243754331$24375433$1$I$20240101$20240923$20240928$20240928$EXP$$GB-ABBVIE-5938332$ABBVIE$$37$YR$$M$Y$$$20240928$$CN$GB$GB
243754341$24375434$1$I$20240301$20240922$20240928$20240928$PER$$US-SA-2024SA274592$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240928$$HP$US$US
243754351$24375435$1$I$20230101$20240906$20240928$20240928$PER$$US-SA-2024SA276386$SANOFI AVENTIS$$58$YR$A$M$Y$94.55$KG$20240928$$MD$US$US
243754361$24375436$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274408$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240928$$HP$US$US
243754381$24375438$1$I$20240525$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047214$AUROBINDO$$70$YR$$M$Y$75.5$KG$20240928$$MD$FR$FR
243754411$24375441$1$I$20240807$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047204$AUROBINDO$$70$YR$$F$Y$75$KG$20240928$$MD$FR$FR
243754421$24375442$1$I$20240801$20240921$20240928$20240928$PER$$US-SA-2024SA276150$SANOFI AVENTIS$$$$E$M$Y$$$20240928$$HP$US$US
243754431$24375443$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA274409$SANOFI AVENTIS$$$$A$M$Y$$$20240928$$HP$US$US
243754441$24375444$1$I$20240101$20240910$20240928$20240928$PER$$US-SA-2024SA279846$SANOFI AVENTIS$$48$YR$A$F$Y$95.27$KG$20240928$$MD$US$US
243754451$24375445$1$I$20240802$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047194$AUROBINDO$$67$YR$$M$Y$$$20240928$$MD$FR$FR
243754471$24375447$1$I$20240424$20240919$20240928$20240928$EXP$$DE-AUROBINDO-AUR-APL-2024-047116$AUROBINDO$$81$YR$$F$Y$$$20240928$$MD$DE$DE
243754481$24375448$1$I$$20240925$20240928$20240928$PER$$US-JNJFOC-20240969253$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243754491$24375449$1$I$20230101$20240923$20240928$20240928$EXP$$IE-JNJFOC-20230120579$JOHNSON AND JOHNSON$$9$DEC$E$M$Y$$$20240928$$HP$IE$IE
243754501$24375450$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA273208$SANOFI AVENTIS$$13$YR$T$M$Y$46.6$KG$20240928$$MD$US$US
243754511$24375451$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA272917$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240928$$MD$US$US
243754531$24375453$1$I$$20240923$20240928$20240928$PER$$US-ROCHE-10000088601$ROCHE$GLICK L, LO G, VERSTOVSEK G, BANDI V. PULMONARY MUCORALES IN A PATIENT WITH FELTY SYNDROME. Chest. 2024-Oct;166 (4): doi:10.1016/j.chest.2024.06.635.$64$YR$A$M$Y$$$20240928$$HP$US$US
243754541$24375454$1$I$20240605$20240823$20240928$20240928$EXP$$RS-TEVA-VS-3237668$TEVA$$71$YR$$F$Y$70$KG$20240928$$PH$RS$RS
243754551$24375455$1$I$$20240919$20240928$20240928$EXP$$GB-AUROBINDO-AUR-APL-2024-046481$AUROBINDO$$39$YR$$M$Y$$$20240928$$CN$GB$GB
243754561$24375456$1$I$$20240923$20240928$20240928$EXP$$CA-SANDOZ INC.-NVSC2022CA132656$SANDOZ$$$$$M$Y$$$20240928$$CN$CA$CA
243754571$24375457$1$I$$20240917$20240928$20240928$EXP$$US-Accord-447930$ACCORD$$48$YR$A$F$Y$$$20240928$$HP$US$US
243754581$24375458$1$I$20240615$20240919$20240928$20240928$EXP$$ES-AUROBINDO-AUR-APL-2024-047032$AUROBINDO$$57$YR$$M$Y$$$20240928$$MD$ES$ES
243754591$24375459$1$I$$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192578$AMGEN$$$$$M$Y$$$20240928$$CN$US$US
243754601$24375460$1$I$$20240906$20240928$20240928$PER$$US-SA-2024SA275729$SANOFI AVENTIS$$19$YR$A$M$Y$47.73$KG$20240928$$MD$US$US
243754611$24375461$1$I$20240101$20240909$20240928$20240928$PER$$US-SA-2024SA277293$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240928$$MD$US$US
243754621$24375462$1$I$20240101$20240910$20240928$20240928$PER$$US-SA-2024SA278301$SANOFI AVENTIS$$$$A$F$Y$125$KG$20240928$$MD$US$US
243754631$24375463$1$I$20240101$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047180$AUROBINDO$$70$YR$$F$Y$$$20240928$$MD$FR$FR
243754641$24375464$1$I$$20240917$20240928$20240928$EXP$CA-MHPD-E2B_07231391$CA-Accord-447339$ACCORD$$$$$F$Y$$$20240928$$HP$CA$CA
243754651$24375465$1$I$20240319$20240922$20240928$20240928$EXP$GB-MHRA-MED-202409220831067940-BCQNJ$GB-862174955-ML2024-05078$MICRO LABS$$66$YR$E$F$Y$62$KG$20240928$$CN$GB$GB
243754661$24375466$1$I$20240101$20240904$20240928$20240928$PER$$US-SA-2024SA273878$SANOFI AVENTIS$$58$YR$A$M$Y$94.09$KG$20240928$$MD$US$US
243754681$24375468$1$I$20240501$20240919$20240928$20240928$EXP$$DE-AUROBINDO-AUR-APL-2024-047118$AUROBINDO$$62$YR$$M$Y$61$KG$20240928$$MD$DE$DE
243754691$24375469$1$I$20000916$20240919$20240928$20240928$EXP$$DE-AUROBINDO-AUR-APL-2018-055572$AUROBINDO$$86$YR$$F$Y$56$KG$20240928$$MD$DE$DE
243754701$24375470$1$I$20240921$20240921$20240928$20240928$PER$$US-AMGEN-USASP2024189469$AMGEN$$45$YR$A$F$Y$$$20240928$$CN$US$US
243754711$24375471$1$I$$20240919$20240928$20240928$EXP$$GB-AUROBINDO-AUR-APL-2024-046583$AUROBINDO$$72$YR$$M$Y$$$20240928$$HP$GB$GB
243754721$24375472$1$I$$20240919$20240928$20240928$EXP$$GB-AUROBINDO-AUR-APL-2024-046603$AUROBINDO$$$$$F$Y$$$20240928$$HP$GB$GB
243754731$24375473$1$I$$20240918$20240928$20240928$EXP$$GB-CELLTRION INC.-2024GB023103$CELLTRION$$$$$$Y$$$20240928$$CN$GB$GB
243754741$24375474$1$I$20240910$20240919$20240928$20240928$EXP$$GB-AUROBINDO-AUR-APL-2024-046717$AUROBINDO$$79$YR$$F$Y$$$20240928$$PH$GB$GB
243754751$24375475$1$I$20240910$20240919$20240928$20240928$EXP$$IT-AUROBINDO-AUR-APL-2024-047224$AUROBINDO$$59$YR$$F$Y$$$20240928$$MD$IT$IT
243754761$24375476$1$I$$20240917$20240928$20240928$EXP$$BR-Accord-448251$ACCORD$$53$YR$A$$Y$$$20240928$$PH$BR$BR
243754771$24375477$1$I$20240130$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-008506$AUROBINDO$$58$YR$$F$Y$65$KG$20240928$$MD$FR$FR
243754791$24375479$1$I$20210101$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047266$AUROBINDO$$14$YR$$F$Y$$$20240928$$MD$FR$FR
243754811$24375481$1$I$$20240925$20240928$20240928$PER$$US-009507513-2409USA009388$MERCK$SASIKUMAR S, RAI G, ANEES Z, GARCIA A, BUDDE J. I GOT SEPTIC PULMONARY EMBOLI FROM MY ACNE?!. Chest. 2024;166 (4)::1220A-1221A$26$YR$$F$Y$$$20240928$$HP$US$US
243754821$24375482$1$I$$20240919$20240928$20240928$EXP$$GB-AUROBINDO-AUR-APL-2024-046703$AUROBINDO$$29$YR$$M$Y$86$KG$20240928$$HP$GB$GB
243754831$24375483$1$I$$20240919$20240928$20240928$EXP$$GB-CELLTRION INC.-2024GB022478$CELLTRION$$$$$$Y$$$20240928$$CN$GB$GB
243754841$24375484$1$I$$20240917$20240928$20240928$EXP$$US-Accord-442037$ACCORD$$28$YR$A$F$Y$$$20240928$$PH$US$US
243754851$24375485$1$I$20240101$20240921$20240928$20240928$PER$$US-ABBVIE-5937591$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243754861$24375486$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-047138$AUROBINDO$$78$YR$$M$Y$$$20240928$$HP$CA$CA
243754871$24375487$1$I$20240901$20240920$20240928$20240928$PER$$US-SA-2024SA274505$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240928$$HP$US$US
243754881$24375488$1$I$$20240401$20240928$20240928$EXP$$US-TEVA-VS-3227341$TEVA$$$$$M$Y$$$20240928$$PH$US$US
243754891$24375489$1$I$20240813$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047257$AUROBINDO$$68$YR$$M$Y$78$KG$20240928$$MD$FR$FR
243754931$24375493$1$I$20240918$20240918$20240928$20240928$EXP$$GB-CELLTRION INC.-2024GB023105$CELLTRION$$$$$$Y$$$20240928$$CN$GB$GB
243754941$24375494$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA273678$SANOFI AVENTIS$$$$E$F$Y$$$20240928$$MD$US$US
243754951$24375495$1$I$$20240923$20240928$20240928$PER$$US-JNJFOC-20240962428$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243754961$24375496$1$I$20201114$20240920$20240928$20240928$EXP$$PL-AUROBINDO-AUR-APL-2024-047509$AUROBINDO$$35$YR$$F$Y$90$KG$20240928$$MD$PL$PL
243754981$24375498$1$I$20240101$20240919$20240928$20240928$EXP$IT-MINISAL02-1002558$IT-AMGEN-ITASP2024187423$AMGEN$$74$YR$E$M$Y$$$20240928$$MD$IT$IT
243754991$24375499$1$I$20240924$20240925$20240928$20240928$PER$$US-AMGEN-USASP2024191529$AMGEN$$55$YR$A$M$Y$$$20240928$$CN$US$US
243755001$24375500$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-047115$AUROBINDO$Wang T-F, Hill M, Mallick R, Chaudry H, Unachukwu U, Delluc A, et al. The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies. Thrombosis Research. 2023;231:128-34$58$YR$$F$Y$$$20240928$$HP$CA$CA
243755011$24375501$1$I$$20240918$20240928$20240928$EXP$CA-MHPD-E2B_07246457$CA-Accord-447436$ACCORD$$70$YR$E$F$Y$$$20240928$$HP$CA$CA
243755021$24375502$1$I$$20240920$20240928$20240928$EXP$$GB-AUROBINDO-AUR-APL-2024-046991$AUROBINDO$$42$YR$$M$Y$102$KG$20240928$$CN$GB$GB
243755031$24375503$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-047093$AUROBINDO$$70$YR$$M$Y$$$20240928$$PH$CA$CA
243755041$24375504$1$I$20240814$20240919$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047244$AUROBINDO$$62$YR$$M$Y$67$KG$20240928$$PH$FR$FR
243755051$24375505$1$I$$20240927$20240928$20240928$PER$$US-ABBVIE-5943033$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243755061$24375506$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA275955$SANOFI AVENTIS$$24$YR$A$M$Y$77.27$KG$20240928$$HP$US$US
243755071$24375507$1$I$20240101$20240910$20240928$20240928$PER$$US-SA-2024SA278985$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240928$$MD$US$US
243755081$24375508$1$I$$20240906$20240928$20240928$PER$$US-SA-2024SA276501$SANOFI AVENTIS$$$$A$M$Y$100$KG$20240928$$MD$US$US
243755091$24375509$1$I$20240901$20240923$20240928$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-029689$UNITED THERAPEUTICS$$76$YR$$F$Y$65.306$KG$20240928$$$US$US
243755101$24375510$1$I$$20240923$20240928$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-030435$UNITED THERAPEUTICS$$$$$F$Y$105.67$KG$20240928$$$US$US
243755121$24375512$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274218$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240928$$MD$US$US
243755131$24375513$1$I$20230113$20240919$20240928$20240928$EXP$FR-AFSSAPS-LY2023000935$FR-CELLTRION INC.-2024FR023007$CELLTRION$$$$$$Y$$$20240928$$PH$FR$FR
243755141$24375514$1$I$$20240920$20240928$20240928$EXP$$PL-AUROBINDO-AUR-APL-2024-047528$AUROBINDO$$24$YR$$F$Y$94$KG$20240928$$MD$PL$PL
243755151$24375515$1$I$20240924$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192473$AMGEN$$76$YR$E$F$Y$$$20240928$$CN$US$US
243755161$24375516$1$I$$20240920$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047452$AUROBINDO$$70$YR$$F$Y$$$20240928$$MD$FR$FR
243755171$24375517$1$I$20240101$20240903$20240928$20240928$PER$$US-SA-2024SA052439$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240928$$CN$US$US
243755182$24375518$2$F$$20240923$20240928$20240928$PER$$US-ROCHE-10000089555$ROCHE$Faiq S, Channick J, Fretz A, Melamed K. The role of connective tissue disease in lung cancer and utility of bronchoscopic cryobiopsy. Chest. 2024;166 (4S):4260A-4261A. doi:10.1016/j.chest.2024.06.2583.$23$YR$A$M$Y$$$20240928$$HP$US$US
243755191$24375519$1$I$20231031$20240926$20240928$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-030527$UNITED THERAPEUTICS$$94$YR$$F$Y$$$20240928$$$US$US
243755201$24375520$1$I$20240826$20240923$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047356$AUROBINDO$$24$YR$$M$Y$74$KG$20240928$$MD$FR$FR
243755221$24375522$1$I$20231001$20240920$20240928$20240928$PER$$US-SA-2024SA273885$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240928$$MD$US$US
243755231$24375523$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA275234$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240928$$MD$US$US
243755241$24375524$1$I$$20240920$20240928$20240928$PER$$US-JNJFOC-20240959875$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243755251$24375525$1$I$$20240909$20240928$20240928$PER$$US-SA-2024SA277735$SANOFI AVENTIS$$$$E$F$Y$61.36$KG$20240928$$HP$US$US
243755261$24375526$1$I$20240901$20240920$20240928$20240928$PER$$US-SA-2024SA274668$SANOFI AVENTIS$$38$YR$A$M$Y$$$20240928$$MD$US$US
243755271$24375527$1$I$20240101$20240910$20240928$20240928$PER$$US-SA-2024SA278356$SANOFI AVENTIS$$47$YR$A$F$Y$65.91$KG$20240928$$MD$US$US
243755281$24375528$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA273184$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240928$$HP$US$US
243755291$24375529$1$I$$20240926$20240928$20240928$EXP$$US-ABBVIE-5941937$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243755301$24375530$1$I$20240920$20240920$20240928$20240928$PER$$US-AMGEN-USASP2024188527$AMGEN$$62$YR$A$$Y$$$20240928$$CN$US$US
243755311$24375531$1$I$$20240919$20240928$20240928$PER$$US-GSK-US2024116638$GLAXOSMITHKLINE$$$$$F$Y$$$20240928$$CN$US$US
243755321$24375532$1$I$20240101$20240923$20240928$20240928$EXP$$US-ABBVIE-5792503$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243755331$24375533$1$I$20240101$20240924$20240928$20240928$EXP$$US-ABBVIE-5938307$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243755341$24375534$1$I$20240229$20240920$20240928$20240928$EXP$$ES-AUROBINDO-AUR-APL-2024-037919$AUROBINDO$$75$YR$$F$Y$$$20240928$$CN$ES$ES
243755351$24375535$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-047237$AUROBINDO$$85$YR$$F$Y$86$KG$20240928$$MD$CA$CA
243755361$24375536$1$I$$20240923$20240928$20240928$EXP$$US-ABBVIE-5936783$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243755371$24375537$1$I$20240923$20240923$20240928$20240928$PER$$US-AMGEN-USASP2024189971$AMGEN$$81$YR$E$F$Y$$$20240928$$PH$US$US
243755381$24375538$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2023-053718$AUROBINDO$Ramandt M, Dool P. Fatigue, Anxiety and Irritability with Apixaban. Can-J-Hosp-Pharm. 2007;60(1):85-86$76$YR$$M$Y$$$20240928$$HP$CA$CA
243755391$24375539$1$I$$20240919$20240928$20240928$PER$$US-ABBVIE-5931804$ABBVIE$$$$$M$Y$66$KG$20240928$$CN$US$US
243755411$24375541$1$I$20240101$20240925$20240928$20240928$EXP$$US-ABBVIE-5939320$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243755421$24375542$1$I$20240801$20240926$20240928$20240928$EXP$$TR-ABBVIE-5941534$ABBVIE$$77$YR$$F$Y$$$20240928$$CN$TR$TR
243755431$24375543$1$I$$20240917$20240928$20240928$EXP$$US-862174955-ML2024-05055$MICRO LABS$Darnell H, Brenner A, Kern C, Flomenhoft D, Lee E. Sevelamer-Induced Ischemic Enteritis. ACG-Case-Rep-J 2024;11No. 7.$35$YR$A$M$Y$$$20240928$$MD$US$US
243755441$24375544$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-047123$AUROBINDO$$84$YR$$F$Y$65$KG$20240928$$PH$CA$CA
243755451$24375545$1$I$$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192844$AMGEN$$$$$$Y$$$20240928$$PH$US$US
243755461$24375546$1$I$$20240906$20240928$20240928$PER$$US-SA-2024SA274587$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240928$$MD$US$US
243755471$24375547$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-046983$AUROBINDO$$80$YR$$M$Y$72$KG$20240928$$HP$CA$CA
243755481$24375548$1$I$$20240917$20240928$20240928$EXP$$US-Accord-447418$ACCORD$Hussein G, Krastev P, Mallari AJ, El Labban M, Yadav S, Hassan M, et al. Stone heart syndrome: A curious case of digoxin toxicity and calcium infusion. Clinical Case Reports. 2024;12(9).$78$YR$E$F$Y$$$20240928$$MD$US$US
243755491$24375549$1$I$20240925$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192132$AMGEN$$$$A$F$Y$$$20240928$$PH$US$US
243755501$24375550$1$I$$20240920$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047399$AUROBINDO$Groh M, Masciocco G, Kirchner E, Kristen E, Pellegrini C,  Varnous S et al. Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).. JOURNAL OF HEART AND LUNG TRANSPLANTATION (F). 2014;1-9$35$YR$$F$Y$$$20240928$$HP$FR$FR
243755511$24375551$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-047321$AUROBINDO$$61$YR$$M$Y$$$20240928$$PH$CA$CA
243755521$24375552$1$I$20240601$20240919$20240928$20240928$PER$$US-SA-2024SA276731$SANOFI AVENTIS$$4$YR$C$F$Y$22.73$KG$20240928$$HP$US$US
243755531$24375553$1$I$$20240918$20240928$20240928$EXP$$US-CELLTRION INC.-2024US018391$CELLTRION$$$$$$Y$$$20240928$$MD$US$US
243755541$24375554$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA275939$SANOFI AVENTIS$$70$YR$E$F$Y$90.91$KG$20240928$$HP$US$US
243755551$24375555$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA273312$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240928$$MD$US$US
243755561$24375556$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA275694$SANOFI AVENTIS$$$$T$M$Y$61.36$KG$20240928$$HP$US$US
243755571$24375557$1$I$20240828$20240920$20240928$20240928$PER$$US-SA-2024SA274091$SANOFI AVENTIS$$1$YR$I$F$Y$$$20240928$$MD$US$US
243755581$24375558$1$I$$20240917$20240928$20240928$EXP$$US-Accord-447416$ACCORD$Hussein G, Krastev P, Mallari AJ, El Labban M, Yadav S, Hassan M, et al. Stone heart syndrome: A curious case of digoxin toxicity and calcium infusion. Clinical Case Reports. 2024;12(9):e9376.$78$YR$E$F$Y$$$20240928$$MD$US$US
243755591$24375559$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA276163$SANOFI AVENTIS$$$$E$M$Y$77.18$KG$20240928$$MD$US$US
243755611$24375561$1$I$20240901$20240920$20240928$20240928$PER$$US-SA-2024SA274233$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240928$$HP$US$US
243755621$24375562$1$I$$20240925$20240928$20240928$EXP$$US-ROCHE-10000091870$ROCHE$$$$A$F$Y$$$20240928$$CN$US$US
243755651$24375565$1$I$20230220$20240919$20240928$20240928$EXP$$IT-CELLTRION INC.-2024IT023057$CELLTRION$$$$$$Y$$$20240928$$MD$IT$IT
243755681$24375568$1$I$20240911$20240919$20240928$20240928$PER$$US-SA-2024SA275879$SANOFI AVENTIS$$19$YR$A$F$Y$44.09$KG$20240928$$HP$US$US
243755691$24375569$1$I$20240801$20240920$20240928$20240928$PER$$US-SA-2024SA273977$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240928$$MD$US$US
243755701$24375570$1$I$$20240925$20240928$20240928$EXP$$CA-ABBVIE-5941391$ABBVIE$$$$E$M$Y$$$20240928$$MD$CA$CA
243755721$24375572$1$I$20240926$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192303$AMGEN$$57$YR$A$F$Y$$$20240928$$CN$US$US
243755731$24375573$1$I$20240101$20240919$20240928$20240928$PER$$US-ABBVIE-5931865$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243755741$24375574$1$I$$20240918$20240928$20240928$PER$$US-ABBVIE-5931679$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243755751$24375575$1$I$20240101$20240920$20240928$20240928$EXP$$US-ABBVIE-5934321$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243755761$24375576$1$I$$20240918$20240928$20240928$EXP$CA-MHPD-E2B_07239627$CA-Accord-447649$ACCORD$$3$YR$C$F$Y$$$20240928$$HP$CA$CA
243755771$24375577$1$I$20240101$20240919$20240928$20240928$EXP$$JP-UNITED THERAPEUTICS-UNT-2024-017251$UNITED THERAPEUTICS$$45$YR$$F$Y$$$20240928$$$JP$JP
243755781$24375578$1$I$$20240918$20240928$20240928$EXP$CA-MHPD-E2B_07239658$CA-Accord-447444$ACCORD$$$$$M$Y$$$20240928$$HP$CA$CA
243755791$24375579$1$I$$20240917$20240928$20240928$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK094142$GLENMARK$Hussein G, Krastev P, Mallari AJ, El Labban M, Yadav S, Hassan M, et al.. Stone heart syndrome: A curious case of digoxin toxicity and calcium infusion.. Clinical Case Reports.. 2024;12 (9)$$$$$Y$$$20240928$$MD$US$US
243755801$24375580$1$I$20240914$20240918$20240928$20240928$PER$$US-GSK-US2024116127$GLAXOSMITHKLINE$$42$YR$$F$Y$$$20240928$$CN$US$US
243755811$24375581$1$I$20240926$20240927$20240928$20240928$PER$$US-AMGEN-USASP2024193257$AMGEN$$84$YR$E$M$Y$$$20240928$$CN$US$US
243755831$24375583$1$I$20240925$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192643$AMGEN$$80$YR$E$M$Y$$$20240928$$CN$US$US
243755851$24375585$1$I$$20240917$20240928$20240928$EXP$$PT-Accord-447979$ACCORD$Fonseca AM, Almeida J, Pereira S. POSA-206 - (5071) - NON CIRRHOTIC PORTAL HYPERTENSION DUE TO OXALIPLATIN LIVER INJURY. 30 CNMI. Gastroenterological diseases and liver diseases. Clinical case.$61$YR$A$F$Y$$$20240928$$HP$PT$PT
243755861$24375586$1$I$$20240917$20240928$20240928$EXP$$NL-ABBVIE-5942834$ABBVIE$$$$E$F$Y$$$20240928$$CN$NL$NL
243755871$24375587$1$I$$20240925$20240928$20240928$EXP$$DE-ABBVIE-5940802$ABBVIE$$$$E$M$Y$$$20240928$$CN$DE$DE
243755881$24375588$1$I$$20240917$20240928$20240928$EXP$$US-GLENMARK PHARMACEUTICALS-2024GMK094160$GLENMARK$$$$$$Y$$$20240928$$CN$US$US
243755891$24375589$1$I$$20240925$20240928$20240928$PER$$US-JNJFOC-20240971024$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243755901$24375590$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA273200$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240928$$HP$US$US
243755911$24375591$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274002$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240928$$HP$US$US
243755941$24375594$1$I$20240916$20240919$20240928$20240928$PER$$US-ABBVIE-5935408$ABBVIE$$22$YR$$F$Y$$$20240928$$HP$US$US
243755951$24375595$1$I$$20240918$20240928$20240928$EXP$$JP-CELLTRION INC.-2024JP023020$CELLTRION$Natsumi T, Shinichiro T, Tomonori S, Tetsuo N, Takahiro F, Tomonori K, et. al.. Cases Changes in cardiac functions over time and apical strain in patients with cancer therapy-related cardiac dysfunction due to a human epidermal growth factor receptor 2 inhibitor.. Therapeutic Research.. 2024;45(8):537-544$$$$$Y$$$20240928$$MD$JP$JP
243755961$24375596$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274113$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240928$$MD$US$US
243755971$24375597$1$I$20210101$20240919$20240928$20240928$PER$$US-SA-2024SA274132$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240928$$HP$US$US
243755981$24375598$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA274034$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240928$$HP$US$US
243755991$24375599$1$I$20240501$20240919$20240928$20240928$PER$$US-SA-2024SA274613$SANOFI AVENTIS$$$$N$M$Y$$$20240928$$HP$US$US
243756001$24375600$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA272987$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240928$$HP$US$US
243756011$24375601$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA274295$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240928$$HP$US$US
243756021$24375602$1$I$20240101$20240924$20240928$20240928$EXP$$GB-ABBVIE-5937440$ABBVIE$$59$YR$$F$Y$93$KG$20240928$$HP$GB$GB
243756031$24375603$1$I$20240916$20240920$20240928$20240928$PER$$US-SA-2024SA275217$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240928$$HP$US$US
243756041$24375604$1$I$20240101$20240919$20240928$20240928$PER$$US-ABBVIE-5932882$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243756051$24375605$1$I$20240131$20240918$20240928$20240928$EXP$IT-MINISAL02-1001940$IT-Accord-448035$ACCORD$$65$YR$E$M$Y$103$KG$20240928$$MD$IT$IT
243756071$24375607$1$I$$20240924$20240928$20240928$EXP$$US-JNJFOC-20240969759$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240928$$HP$US$US
243756081$24375608$1$I$$20240924$20240928$20240928$EXP$$US-JNJFOC-20240967629$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243756091$24375609$1$I$20211201$20240919$20240928$20240928$EXP$$DK-CELLTRION INC.-2024DK023023$CELLTRION$$$$$$Y$$$20240928$$MD$DK$DK
243756101$24375610$1$I$20221010$20240920$20240928$20240928$EXP$$DE-AUROBINDO-AUR-APL-2024-047389$AUROBINDO$$$$E$F$Y$$$20240928$$MD$DE$DE
243756111$24375611$1$I$20220501$20240920$20240928$20240928$EXP$$FR-AUROBINDO-AUR-APL-2024-047595$AUROBINDO$$$$E$M$Y$$$20240928$$MD$FR$FR
243756121$24375612$1$I$$20240919$20240928$20240928$EXP$$CN-NOVITIUMPHARMA-2024CNNVP02002$NOVITIUM PHARMA$Xiaofang Zhang.Stevens-Johnson Syndrome/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review. BMC Endocrine Disorders.02-SEP-2024;24:1-6$73$YR$E$F$Y$$$20240928$$HP$CN$CN
243756131$24375613$1$I$$20240921$20240928$20240928$EXP$$GB-AUROBINDO-AUR-APL-2024-047126$AUROBINDO$$64$YR$$M$Y$80$KG$20240928$$CN$GB$GB
243756141$24375614$1$I$$20240918$20240928$20240928$EXP$$FR-ABBVIE-5941889$ABBVIE$Stephan P, Bouherrou K, Guillermin Y, Michallet AS, Grinberg-Bleyer Y. Immunophenotyping of peripheral blood cells in patients with chronic lymphocytic leukemia treated with ibrutinib. Cells. 2024;13(17):1458.$45$YR$$F$Y$$$20240928$$HP$FR$FR
243756151$24375615$1$I$$20240918$20240928$20240928$EXP$$FR-ABBVIE-5941965$ABBVIE$Stephan P, Bouherrou K, Guillermin Y, Michallet AS, Grinberg-Bleyer Y. Immunophenotyping of peripheral blood cells in patients with chronic lymphocytic leukemia treated with ibrutinib. Cells. 2024;13(17):1458.$76$YR$$M$Y$$$20240928$$HP$FR$FR
243756161$24375616$1$I$$20240924$20240928$20240928$EXP$$US-ABBVIE-5938265$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243756171$24375617$1$I$$20240920$20240928$20240928$EXP$$NL-ROCHE-10000092977$ROCHE$$40$YR$A$F$Y$$$20240928$$MD$NL$NL
243756181$24375618$1$I$20240801$20240924$20240928$20240928$EXP$$US-ABBVIE-5938170$ABBVIE$$55$YR$$F$Y$$$20240928$$CN$US$US
243756191$24375619$1$I$20240101$20240910$20240928$20240928$EXP$$US-SA-2024SA279900$SANOFI AVENTIS$$69$YR$E$M$Y$100.23$KG$20240928$$CN$US$US
243756201$24375620$1$I$$20240923$20240928$20240928$PER$$US-JNJFOC-20240962019$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$HP$US$US
243756211$24375621$1$I$20240920$20240924$20240928$20240928$EXP$$CN-ABBVIE-5937673$ABBVIE$$66$YR$$M$Y$50$KG$20240928$$MD$CN$CN
243756221$24375622$1$I$20240922$20240922$20240928$20240928$PER$$US-SA-2024SA275048$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240928$$HP$US$US
243756241$24375624$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA275727$SANOFI AVENTIS$$$$A$F$Y$64.55$KG$20240928$$HP$US$US
243756261$24375626$1$I$20240801$20240920$20240928$20240928$PER$$US-SA-2024SA275374$SANOFI AVENTIS$$$$$F$Y$$$20240928$$MD$US$US
243756271$24375627$1$I$20240101$20240909$20240928$20240928$PER$$US-SA-2024SA277541$SANOFI AVENTIS$$61$YR$A$F$Y$72.73$KG$20240928$$MD$US$US
243756281$24375628$1$I$20240821$20240904$20240928$20240928$PER$$US-SA-2024SA272544$SANOFI AVENTIS$$47$YR$A$M$Y$84.09$KG$20240928$$HP$US$US
243756291$24375629$1$I$20240101$20240907$20240928$20240928$PER$$US-SA-2024SA276674$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240928$$CN$US$US
243756311$24375631$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-047197$AUROBINDO$$71$YR$$M$Y$$$20240928$$PH$CA$CA
243756321$24375632$1$I$20240101$20240907$20240928$20240928$PER$$US-SA-2024SA277021$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240928$$CN$US$US
243756331$24375633$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA274286$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240928$$MD$US$US
243756341$24375634$1$I$20240101$20240922$20240928$20240928$PER$$US-SA-2024SA275281$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240928$$HP$US$US
243756351$24375635$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA275404$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240928$$MD$US$US
243756361$24375636$1$I$20240917$20240924$20240928$20240928$PER$$US-AMGEN-USASP2024190932$AMGEN$$$$A$F$Y$$$20240928$$PH$US$US
243756371$24375637$1$I$$20240920$20240928$20240928$EXP$$RO-AUROBINDO-AUR-APL-2024-047541$AUROBINDO$Oprean AM, Epure DA, Perjoc R-S, Paslaru AC, Teleanu RI. Neurodevelopmental disorder related to TANC2 gene. Romanian Journal of Child and Adolescent Neurology and Psychiatry. 2024;30(1):65-9$$$C$F$Y$$$20240928$$HP$RO$RO
243756391$24375639$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274160$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240928$$MD$US$US
243756401$24375640$1$I$$20240923$20240928$20240928$EXP$$US-JNJFOC-20240962626$JOHNSON AND JOHNSON$$$$$F$Y$$$20240928$$HP$US$US
243756411$24375641$1$I$20240101$20240920$20240928$20240928$PER$$US-JNJFOC-20240956766$JOHNSON AND JOHNSON$$$$T$M$Y$$$20240928$$CN$US$US
243756421$24375642$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-047114$AUROBINDO$Wu J-J, Jiang J, Ye J, Turgeon RD, Wang EHZ.. Direct oral anticoagulant use early after cardiac surgery: a retrospective cohort study.. CJC Open. 2024;6(2):65- 71$$$$$Y$$$20240928$$HP$CA$CA
243756441$24375644$1$I$20240901$20240927$20240928$20240928$PER$$US-ABBVIE-5943680$ABBVIE$$$$$F$Y$$$20240928$$HP$US$US
243756461$24375646$1$I$20240718$20240918$20240928$20240928$EXP$$CN-ROCHE-10000086827$ROCHE$$$$$F$Y$$$20240928$$HP$CN$CN
243756471$24375647$1$I$20240901$20240919$20240928$20240928$PER$$US-SA-2024SA275822$SANOFI AVENTIS$$64$YR$A$M$Y$140$KG$20240928$$HP$US$US
243756481$24375648$1$I$$20240916$20240928$20240928$PER$$US-SA-2024SA279642$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240928$$CN$US$US
243756491$24375649$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA275209$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240928$$HP$US$US
243756501$24375650$1$I$$20240916$20240928$20240928$PER$$US-SA-2024SA276724$SANOFI AVENTIS$$$$A$F$Y$$$20240928$$HP$US$US
243756511$24375651$1$I$20240101$20240909$20240928$20240928$PER$$US-SA-2024SA277571$SANOFI AVENTIS$$73$YR$E$M$Y$86.36$KG$20240928$$MD$US$US
243756541$24375654$1$I$$20240918$20240928$20240928$EXP$$GB-CELLTRION INC.-2023GB006917$CELLTRION$$$$$$Y$$$20240928$$CN$GB$GB
243756551$24375655$1$I$$20240917$20240928$20240928$EXP$$GB-862174955-ML2024-05082$MICRO LABS$Abdalrazag OA, Okoye AO, Muniyappa SM. Title to be provided. British Journal of Diabetes. 2024;24(1): doi:10.15277/bjd.2024.454.$77$YR$E$M$Y$$$20240928$$MD$GB$GB
243756561$24375656$1$I$20240801$20240923$20240928$20240928$EXP$$BR-JNJFOC-20240967103$JOHNSON AND JOHNSON$$65$YR$E$M$Y$64$KG$20240928$$CN$BR$BR
243756571$24375657$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-046942$AUROBINDO$$85$YR$$M$Y$135$KG$20240928$$PH$CA$CA
243756581$24375658$1$I$20240508$20240919$20240928$20240928$EXP$GB-MHRA-MED-202409181059096350-GZFWB$GB-TEVA-VS-3245927$TEVA$$$$$M$Y$$$20240928$$MD$GB$GB
243756591$24375659$1$I$$20240923$20240928$20240928$EXP$$CA-JNJFOC-20240968444$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240928$$HP$CA$CA
243756611$24375661$1$I$20240101$20240925$20240928$20240928$EXP$$US-ABBVIE-5939499$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243756621$24375662$1$I$20240101$20240924$20240928$20240928$EXP$$US-ABBVIE-5937932$ABBVIE$$48$YR$$F$Y$$$20240928$$CN$US$US
243756631$24375663$1$I$$20240918$20240928$20240928$PER$$US-JNJFOC-20240953696$JOHNSON AND JOHNSON$$$$$F$Y$$$20240928$$CN$US$US
243756641$24375664$1$I$$20240926$20240928$20240928$EXP$$TR-ABBVIE-5942287$ABBVIE$$$$$M$Y$$$20240928$$CN$TR$TR
243756651$24375665$1$I$$20240924$20240928$20240928$EXP$$US-ABBVIE-5937879$ABBVIE$$$$$F$Y$$$20240928$$HP$US$US
243756661$24375666$1$I$20240419$20240916$20240928$20240928$EXP$FR-AFSSAPS-AN2024001269$FR-BAXTER-2024BAX024826$BAXTER$$29$YR$$F$Y$79$KG$20240928$$MD$FR$FR
243756681$24375668$1$I$20240316$20240917$20240928$20240928$EXP$FR-AFSSAPS-PB2024000982$FR-BAXTER-2024BAX024834$BAXTER$$38$YR$$F$Y$60$KG$20240928$$HP$FR$FR
243756691$24375669$1$I$$20240924$20240928$20240928$EXP$$US-ABBVIE-5939099$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243756701$24375670$1$I$20211001$20240924$20240928$20240928$EXP$$CA-ABBVIE-5938914$ABBVIE$$63$YR$$F$Y$$$20240928$$CN$CA$CA
243756711$24375671$1$I$20240101$20240922$20240928$20240928$PER$$US-SA-2024SA275441$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240928$$HP$US$US
243756721$24375672$1$I$20240901$20240920$20240928$20240928$PER$$US-SA-2024SA273897$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240928$$MD$US$US
243756731$24375673$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA273957$SANOFI AVENTIS$$47$YR$A$F$Y$$$20240928$$HP$US$US
243756741$24375674$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA272637$SANOFI AVENTIS$$11$YR$C$F$Y$$$20240928$$HP$US$US
243756751$24375675$1$I$20240901$20240910$20240928$20240928$PER$$US-SA-2024SA278302$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240928$$MD$US$US
243756761$24375676$1$I$$20240918$20240928$20240928$PER$$US-GSK-US2024116138$GLAXOSMITHKLINE$$$$$F$Y$$$20240928$$CN$US$US
243756771$24375677$1$I$20240913$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192780$AMGEN$$53$YR$A$F$Y$$$20240928$$CN$US$US
243756781$24375678$1$I$$20240920$20240928$20240928$EXP$$GB-AUROBINDO-AUR-APL-2024-047050$AUROBINDO$$57$YR$$F$Y$57$KG$20240928$$CN$GB$GB
243756791$24375679$1$I$20240101$20240923$20240928$20240928$EXP$$CN-ABBVIE-5936879$ABBVIE$$$$A$F$Y$$$20240928$$CN$CN$CN
243756801$24375680$1$I$$20240920$20240928$20240928$EXP$$PL-AUROBINDO-AUR-APL-2024-047478$AUROBINDO$$37$YR$$F$Y$80$KG$20240928$$MD$PL$PL
243756831$24375683$1$I$20240401$20240829$20240928$20240928$EXP$$FI-TEVA-VS-3186662$TEVA$$77$YR$$M$Y$$$20240928$$CN$FI$FI
243756841$24375684$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-047073$AUROBINDO$$82$YR$$M$Y$$$20240928$$PH$CA$CA
243756851$24375685$1$I$$20240919$20240928$20240928$PER$$US-GSK-US2024116646$GLAXOSMITHKLINE$$$$$F$Y$$$20240928$$CN$US$US
243756881$24375688$1$I$20240701$20240919$20240928$20240928$PER$$US-SA-2024SA274045$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240928$$MD$US$US
243756901$24375690$1$I$20240101$20240925$20240928$20240928$EXP$$US-JNJFOC-20240971330$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240928$$CN$US$US
243756911$24375691$1$I$20240901$20240918$20240928$20240928$EXP$$CA-CELLTRION INC.-2021CA019468$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
243756921$24375692$1$I$20240912$20240919$20240928$20240928$PER$$US-TEVA-VS-3246436$TEVA$$62$YR$$M$Y$$$20240928$$CN$US$US
243756931$24375693$1$I$$20240919$20240928$20240928$EXP$$CA-ABBVIE-5941919$ABBVIE$Kuruvilla J, Rushton C, Villa D, Aslam M, Prica A, Abdel Samad N, et al. A randomized trial of ibrutinib and R  GDP prior to stem cell transplant in re-lapsed diffuse large B cell lymphoma. Br J Haematol. 2024;bjh.19764.$$$$$Y$$$20240928$$HP$CA$CA
243756941$24375694$1$I$$20240918$20240928$20240928$EXP$$PT-CELLTRION INC.-2024PT022984$CELLTRION$Araujo Costa, Mariana. Infectious Sacroiliitis in a Patient with Crohn^s Disease: Case Report. Gazeta Medica. 2024;doi:https://orcid.org/0009-0009-1654-1876$$$$$Y$$$20240928$$MD$PT$PT
243756951$24375695$1$I$20240101$20240924$20240928$20240928$EXP$$US-ABBVIE-5939457$ABBVIE$$$$$M$Y$$$20240928$$MD$US$US
243756991$24375699$1$I$$20240920$20240928$20240928$EXP$$RU-ABBVIE-5942154$ABBVIE$$54$YR$$M$Y$$$20240928$$MD$RU$RU
243757001$24375700$1$I$$20240918$20240928$20240928$EXP$$CA-CELLTRION INC.-2024CA022915$CELLTRION$$$$$$Y$$$20240928$$PH$CA$CA
243757011$24375701$1$I$20240918$20240919$20240928$20240928$PER$$US-ABBVIE-5931418$ABBVIE$$59$YR$$F$Y$$$20240928$$CN$US$US
243757021$24375702$1$I$20231201$20240918$20240928$20240928$EXP$$CA-TEVA-VS-3246862$TEVA$$69$YR$$M$Y$$$20240928$$CN$CA$CA
243757051$24375705$1$I$$20240924$20240928$20240928$EXP$$US-ABBVIE-5938070$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243757061$24375706$1$I$20240901$20240920$20240928$20240928$PER$$US-SA-2024SA274674$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240928$$MD$US$US
243757071$24375707$1$I$$20240925$20240928$20240928$PER$$US-AMGEN-USASP2024191256$AMGEN$$68$YR$E$F$Y$$$20240928$$CN$US$US
243757081$24375708$1$I$$20240925$20240928$20240928$EXP$$PE-JNJFOC-20240970942$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20240928$$HP$PE$PE
243757111$24375711$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA273968$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240928$$HP$US$US
243757121$24375712$1$I$20240101$20240909$20240928$20240928$PER$$US-SA-2024SA279210$SANOFI AVENTIS$$27$YR$A$F$Y$70.45$KG$20240928$$MD$US$US
243757131$24375713$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA273246$SANOFI AVENTIS$$25$YR$A$M$Y$$$20240928$$HP$US$US
243757141$24375714$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274224$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240928$$MD$US$US
243757151$24375715$1$I$$20240918$20240928$20240928$PER$$US-ABBVIE-5932033$ABBVIE$$$$$F$Y$$$20240928$$HP$US$US
243757161$24375716$1$I$20240925$20240925$20240928$20240928$PER$$US-AMGEN-USASP2024191318$AMGEN$$85$YR$E$F$Y$$$20240928$$CN$US$US
243757171$24375717$1$I$20240924$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192703$AMGEN$$$$$$Y$$$20240928$$PH$US$US
243757181$24375718$1$I$$20240924$20240928$20240928$PER$$US-ABBVIE-5939173$ABBVIE$$$$$$Y$$$20240928$$MD$US$US
243757191$24375719$1$I$20240101$20240909$20240928$20240928$PER$$US-SA-2024SA277524$SANOFI AVENTIS$$33$YR$A$M$Y$115.91$KG$20240928$$MD$US$US
243757201$24375720$1$I$$20240924$20240928$20240928$PER$$US-DAIICHI SANKYO, INC.-DS-2024-101417-US$DAIICHI$$$$$F$Y$$$20240928$$CN$US$US
243757211$24375721$1$I$20240101$20240926$20240928$20240928$PER$$US-ABBVIE-5941922$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243757221$24375722$1$I$$20240917$20240928$20240928$EXP$$JP-ROCHE-10000088342$ROCHE$Enomoto S, Takanami Y, Ando S, Ishimatsu Y, Komota K, Mitsuiki K. 21 A case of a patient who presented acute kidney injury and nephrotic syndrome after the administration of bevacizumab. The 346th Kyushu Regional Meeting of the Japanese Society of Internal Medicine. 2024$62$YR$A$M$Y$$$20240928$$MD$JP$JP
243757231$24375723$1$I$20240908$20240925$20240928$20240928$PER$$US-AMGEN-USASP2024191598$AMGEN$$73$YR$E$F$Y$$$20240928$$CN$US$US
243757251$24375725$1$I$20231128$20240924$20240928$20240928$EXP$$AU-TAKEDA-2023TUS116635$TAKEDA$$41$YR$$F$Y$$$20240928$$CN$AU$AU
243757261$24375726$1$I$$20240918$20240928$20240928$PER$$US-ABBVIE-5931135$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243757271$24375727$1$I$20240901$20240924$20240928$20240928$EXP$$US-ABBVIE-5939149$ABBVIE$$87$YR$$F$Y$$$20240928$$CN$US$US
243757281$24375728$1$I$$20240917$20240928$20240928$EXP$CA-MHPD-E2B_07244915$CA-Accord-447117$ACCORD$$60$YR$A$F$Y$$$20240928$$HP$CA$CA
243757331$24375733$1$I$20130321$20240920$20240928$20240928$EXP$PT-INFARMED-J202408-693$PT-ABBVIE-5937908$ABBVIE$$$$$F$Y$$$20240928$$CN$PT$PT
243757341$24375734$1$I$20240101$20240919$20240928$20240928$EXP$$CA-CELLTRION INC.-2024CA016406$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
243757361$24375736$1$I$$20240924$20240928$20240928$EXP$$US-ABBVIE-5938913$ABBVIE$$$$$M$Y$$$20240928$$HP$US$US
243757371$24375737$1$I$$20240924$20240928$20240928$EXP$$US-AMGEN-USASP2024192848$AMGEN$$$$$$Y$$$20240928$$MD$US$US
243757381$24375738$1$I$20230610$20240919$20240928$20240928$EXP$FR-AFSSAPS-LM2023000399$FR-CELLTRION INC.-2024FR022996$CELLTRION$$$$$$Y$$$20240928$$CN$FR$FR
243757391$24375739$1$I$20240101$20240903$20240928$20240928$PER$$US-SA-2024SA241601$SANOFI AVENTIS$$13$YR$T$M$Y$$$20240928$$CN$US$US
243757401$24375740$1$I$20240913$20240913$20240928$20240928$PER$$US-SA-2024SA278361$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240928$$CN$US$US
243757411$24375741$1$I$20240701$20240909$20240928$20240928$PER$$US-SA-2024SA277545$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240928$$CN$US$US
243757431$24375743$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA276066$SANOFI AVENTIS$$$$A$F$Y$77.68$KG$20240928$$HP$US$US
243757441$24375744$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA274487$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240928$$MD$US$US
243757451$24375745$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA275207$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240928$$MD$US$US
243757461$24375746$1$I$$20240910$20240928$20240928$PER$$US-SA-2024SA277478$SANOFI AVENTIS$$8$YR$C$M$Y$42.68$KG$20240928$$MD$US$US
243757481$24375748$1$I$$20240917$20240928$20240928$PER$$US-009507513-2409USA007677$MERCK$Phillipps J, Nassief G Morecroft R, Adeyelu T, Elliott A, Abdulla F, et al.. Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma. npj Precision Oncology. 2024;8 (1)::1-7$55$YR$$F$Y$$$20240928$$HP$US$US
243757501$24375750$1$I$20240724$20240923$20240928$20240928$EXP$$TW-JNJFOC-20240972875$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20240928$$CN$TW$TW
243757511$24375751$1$I$20230501$20240919$20240928$20240928$EXP$IT-MINISAL02-978894$IT-CELLTRION INC.-2024IT023034$CELLTRION$$$$$$Y$$$20240928$$MD$IT$IT
243757521$24375752$1$I$20240501$20240923$20240928$20240928$PER$$US-SA-2024SA275010$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240928$$MD$US$US
243757531$24375753$1$I$20240801$20240923$20240928$20240928$PER$$US-SA-2024SA274949$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240928$$HP$US$US
243757551$24375755$1$I$20240101$20240904$20240928$20240928$PER$$US-SA-2024SA273587$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240928$$MD$US$US
243757561$24375756$1$I$20240915$20240923$20240928$20240928$PER$$US-ABBVIE-5935765$ABBVIE$$77$YR$$M$Y$$$20240928$$CN$US$US
243757571$24375757$1$I$20240901$20240919$20240928$20240928$PER$$US-SA-2024SA275625$SANOFI AVENTIS$$69$YR$E$M$Y$104.55$KG$20240928$$MD$US$US
243757591$24375759$1$I$$20240924$20240928$20240928$PER$$US-JNJFOC-20240972183$JOHNSON AND JOHNSON$$$$$F$Y$$$20240928$$CN$US$US
243757601$24375760$1$I$20240925$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192707$AMGEN$$81$YR$E$M$Y$$$20240928$$CN$US$US
243757611$24375761$1$I$20240101$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192678$AMGEN$$66$YR$E$F$Y$$$20240928$$CN$US$US
243757621$24375762$1$I$$20240924$20240928$20240928$EXP$$US-AMGEN-USASP2024192854$AMGEN$$$$$$Y$$$20240928$$MD$US$US
243757631$24375763$1$I$20240915$20240920$20240928$20240928$PER$$US-JNJFOC-20240960023$JOHNSON AND JOHNSON$$$$$F$Y$$$20240928$$CN$US$US
243757641$24375764$1$I$$20240920$20240928$20240928$EXP$GB-MHRA-MED-202409201153186570-VSLQC$GB-TEVA-VS-3246486$TEVA$$81$YR$$F$Y$$$20240928$$PH$GB$GB
243757651$24375765$1$I$$20240920$20240928$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-030012$UNITED THERAPEUTICS$$$$$F$Y$88.435$KG$20240928$$$US$US
243757661$24375766$1$I$20240901$20240909$20240928$20240928$PER$$US-SA-2024SA277484$SANOFI AVENTIS$$18$YR$A$M$Y$54.43$KG$20240928$$HP$US$US
243757671$24375767$1$I$$20240909$20240928$20240928$PER$$US-SA-2024SA276151$SANOFI AVENTIS$$$$A$F$Y$$$20240928$$MD$US$US
243757681$24375768$1$I$$20240919$20240928$20240928$EXP$$US-JNJFOC-20240960259$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20240928$$MD$US$US
243757691$24375769$1$I$$20240919$20240928$20240928$EXP$$GB-CELLTRION INC.-2024GB022483$CELLTRION$$$$$$Y$$$20240928$$HP$GB$GB
243757701$24375770$1$I$$20240927$20240928$20240928$PER$$US-AMGEN-USASP2024193229$AMGEN$$$$$M$Y$$$20240928$$CN$US$US
243757711$24375771$1$I$20240901$20240920$20240928$20240928$PER$$US-SA-2024SA274860$SANOFI AVENTIS$$32$YR$A$M$Y$$$20240928$$MD$US$US
243757721$24375772$1$I$$20240918$20240928$20240928$PER$$US-ABBVIE-5932085$ABBVIE$$$$$$Y$$$20240928$$HP$US$US
243757731$24375773$1$I$$20240924$20240928$20240928$EXP$$GR-JNJFOC-20240972040$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20240928$$MD$GR$GR
243757761$24375776$1$I$20240101$20240924$20240928$20240928$PER$$US-AMGEN-USASP2024190612$AMGEN$$67$YR$E$F$Y$$$20240928$$HP$US$US
243757801$24375780$1$I$20240831$20240904$20240928$20240928$PER$$US-SA-2024SA264185$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240928$$CN$US$US
243757811$24375781$1$I$$20240910$20240928$20240928$PER$$US-SA-2024SA279875$SANOFI AVENTIS$$$$E$M$Y$95.45$KG$20240928$$MD$US$US
243757821$24375782$1$I$$20240926$20240928$20240928$PER$$US-HALEON-2199099$Haleon PLC$$$$$$Y$$$20240928$$CN$US$US
243757831$24375783$1$I$$20240919$20240928$20240928$PER$$US-ABBVIE-5931876$ABBVIE$$$$$$Y$$$20240928$$CN$US$US
243757841$24375784$1$I$$20240925$20240928$20240928$PER$$US-009507513-2409USA009175$MERCK$$$$$$Y$$$20240928$$CN$US$US
243757851$24375785$1$I$$20240919$20240928$20240928$EXP$$US-TEVA-VS-3246398$TEVA$$36$YR$$F$Y$$$20240928$$HP$US$US
243757861$24375786$1$I$20240917$20240918$20240928$20240928$PER$$US-GSK-US2024115974$GLAXOSMITHKLINE$$58$YR$$M$Y$$$20240928$$CN$US$US
243757871$24375787$1$I$20220113$20240917$20240928$20240928$EXP$$CA-CELLTRION INC.-2022CA004239$CELLTRION$$$$$$Y$$$20240928$$CN$CA$CA
243757891$24375789$1$I$20240427$20240920$20240928$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-013448$UNITED THERAPEUTICS$$77$YR$$F$Y$68.027$KG$20240928$$$US$US
243757911$24375791$1$I$$20240919$20240928$20240928$PER$$US-ABBVIE-5934166$ABBVIE$$$$$M$Y$$$20240928$$CN$US$US
243757921$24375792$1$I$$20240910$20240928$20240928$EXP$$US-SA-2024SA278935$SANOFI AVENTIS$$$$A$M$Y$83.18$KG$20240928$$MD$US$US
243757931$24375793$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274869$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240928$$HP$US$US
243757961$24375796$1$I$20240901$20240919$20240928$20240928$PER$$US-GSK-US2024116455$GLAXOSMITHKLINE$$55$YR$$M$Y$$$20240928$$CN$US$US
243757971$24375797$1$I$$20240918$20240928$20240928$PER$$US-GSK-US2024116660$GLAXOSMITHKLINE$$$$$$Y$$$20240928$$MD$US$US
243757981$24375798$1$I$$20240925$20240928$20240928$EXP$$JP-009507513-2409JPN003948J$MERCK$$79$YR$$M$Y$$$20240928$$MD$JP$JP
243757991$24375799$1$I$$20240920$20240928$20240928$EXP$$GB-TEVA-VS-3246622$TEVA$$51$YR$$F$Y$58$KG$20240928$$MD$GB$GB
243758001$24375800$1$I$$20240917$20240928$20240928$EXP$$US-KOANAAP-SML-US-2024-00971$UNKNOWN$Lester SC, Johnson EF, Breen WG, Khurana AG. Taming the Lion: A Report of Pencil BeamScanning Proton Therapy for Severe Leonine Facies. Advances in Radiation Oncology. 2024;9: 1-4. doi:10.1016/j.adro.2024.101559.$70$YR$E$M$Y$$$20240928$$MD$US$US
243758031$24375803$1$I$$20240917$20240928$20240928$EXP$$US-KOANAAP-SML-US-2024-00969$UNKNOWN$Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Stieglitz E. Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies. Pediatr Blood Cancer. 2023 Jun;70(6): e30335. doi:10.1002/pbc.30335..$17$YR$T$F$Y$$$20240928$$MD$US$US
243758041$24375804$1$I$$20240916$20240928$20240928$PER$$US-SA-2024SA276765$SANOFI AVENTIS$$$$$$Y$$$20240928$$MD$US$US
243758051$24375805$1$I$$20240916$20240928$20240928$PER$$US-SA-2024SA279861$SANOFI AVENTIS$$$$$F$Y$$$20240928$$CN$US$US
243758061$24375806$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA273239$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240928$$MD$US$US
243758071$24375807$1$I$$20240919$20240928$20240928$EXP$$CA-TEVA-VS-3248483$TEVA$$$$$F$Y$$$20240928$$PH$CA$CA
243758092$24375809$2$F$20240927$20240930$20240928$20240930$PER$$US-AMGEN-USASP2024193271$AMGEN$$75$YR$E$$Y$$$20240930$$CN$US$US
243758101$24375810$1$I$20240903$20240904$20240928$20240928$PER$$US-SA-2024SA273668$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240928$$PH$US$US
243758111$24375811$1$I$20240924$20240925$20240928$20240928$PER$$US-AMGEN-USASP2024191455$AMGEN$$20$YR$A$F$Y$$$20240928$$CN$US$US
243758131$24375813$1$I$20230701$20240920$20240928$20240928$PER$$US-SA-2024SA275528$SANOFI AVENTIS$$27$YR$A$M$Y$$$20240928$$HP$US$US
243758141$24375814$1$I$20240101$20240923$20240928$20240928$PER$$US-SA-2024SA275071$SANOFI AVENTIS$$$$I$M$Y$$$20240928$$HP$US$US
243758151$24375815$1$I$$20240925$20240928$20240928$EXP$$US-SA-2024SA279254$SANOFI AVENTIS$$$$E$F$Y$$$20240928$$HP$US$US
243758161$24375816$1$I$20240717$20240919$20240928$20240928$PER$$US-SA-2024SA274011$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240928$$MD$US$US
243758171$24375817$1$I$20190802$20240919$20240928$20240928$EXP$PL-URPL-1-1876-2019$PL-CELLTRION INC.-2024PL022993$CELLTRION$$$$$$Y$$$20240928$$MD$PL$PL
243758181$24375818$1$I$$20240923$20240928$20240928$EXP$$US-AMGEN-USASP2024190001$AMGEN$$$$$M$Y$$$20240928$$MD$US$US
243758191$24375819$1$I$20240901$20240918$20240928$20240928$PER$$US-GSK-US2024116155$GLAXOSMITHKLINE$$78$YR$$F$Y$$$20240928$$CN$US$US
243758201$24375820$1$I$$20240906$20240928$20240928$EXP$$GR-CELLTRION INC.-2024GR022736$CELLTRION$Unknown. Extradermal manifestations in a patient with psoriasis. Do we change treatment?. 3rd PANHELLENIC SUMMER SYMPOSIUM ON MUSCULOSKELETAL HEALTH-INTERACTIVE CASE. 2023$$$$$Y$$$20240928$$HP$GR$GR
243758211$24375821$1$I$20240901$20240920$20240928$20240928$PER$$US-SA-2024SA273194$SANOFI AVENTIS$$46$YR$A$M$Y$$$20240928$$MD$US$US
243758221$24375822$1$I$$20240909$20240928$20240928$PER$$US-SA-2024SA277467$SANOFI AVENTIS$$12$YR$T$M$Y$$$20240928$$HP$US$US
243758231$24375823$1$I$20240901$20240904$20240928$20240928$PER$$US-SA-2024SA273728$SANOFI AVENTIS$$35$YR$A$F$Y$65.91$KG$20240928$$MD$US$US
243758251$24375825$1$I$20240919$20240919$20240928$20240928$PER$$US-GSK-US2024117147$GLAXOSMITHKLINE$$$$$F$Y$$$20240928$$MD$US$US
243758261$24375826$1$I$$20240923$20240928$20240928$EXP$$US-AMGEN-USASP2024189551$AMGEN$Rode S.; Chairman D.B.; Gubeladze T. et al.. A RARE CASE OF GEOTRICHUM CANDIDEMIA IN AN IMMUNOCOMPROMISED PATIENT. Chest. 2024;166 (4S):A2729-A2730$65$YR$E$F$Y$$$20240928$$HP$US$US
243758271$24375827$1$I$20240101$20240918$20240928$20240928$EXP$$CA-CELLTRION INC.-2024CA022555$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
243758281$24375828$1$I$$20240923$20240928$20240928$EXP$$US-AMGEN-USASP2024190431$AMGEN$DESCHENES E.; GOODWIN M.; Regule D.. A FOX IN THE HENHOUSE: FOXP3 TREG DYSFUNCTION PRESENTING AS OPPORTUNISTIC PNEUMONIA AND STEVEN-JOHNSON SYNDROME. Chest. 2024;166 (4):108A-109A$25$YR$A$M$Y$$$20240928$$HP$US$US
243758291$24375829$1$I$$20240923$20240928$20240928$PER$$US-AMGEN-USASP2024190443$AMGEN$MAHARAJ D.; PRAVACHAN K.; Hegde P.. HISTIOCYTIC SARCOMA PRESENTING AS MEDIASTINAL LYMPHADENOPATHY. Chest. 2024;166 (4):3614A-3615A$36$YR$A$F$Y$$$20240928$$HP$US$US
243758301$24375830$1$I$$20240920$20240928$20240928$PER$$US-009507513-2409USA007893$MERCK$$$$$M$Y$$$20240928$$HP$US$US
243758311$24375831$1$I$20240101$20240830$20240928$20240928$PER$$US-009507513-2409USA001339$MERCK$$$$$F$Y$$$20240928$$MD$US$US
243758321$24375832$1$I$20240917$20240919$20240928$20240928$PER$$US-SA-2024SA276318$SANOFI AVENTIS$$64$YR$A$F$Y$58.18$KG$20240928$$HP$US$US
243758331$24375833$1$I$20240701$20240919$20240928$20240928$PER$$US-SA-2024SA274743$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240928$$HP$US$US
243758341$24375834$1$I$20240801$20240920$20240928$20240928$PER$$US-SA-2024SA273635$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240928$$MD$US$US
243758361$24375836$1$I$$20240923$20240928$20240928$EXP$$US-AMGEN-USASP2024190776$AMGEN$Rai G.K.; Sasikumar S.; Ghosh K. et.al.. THE INTERPRETATION OF NEGATIVE OR INDETERMINATE INTERFERON -GAMMA RELEASE ASSAYS AMIDST A CASE OF FATAL ACTIVE TUBERCULOSIS. Chest. 2024;166 (4):A1324-A1325$76$YR$E$F$Y$$$20240928$$HP$US$US
243758371$24375837$1$I$$20240923$20240928$20240928$EXP$$US-AMGEN-USASP2024192421$AMGEN$Mulaikal B.; Sesemann L.; Boyeinpally M.et.al. FATAL KYTOCOCCUS SCHROETERI PNEUMONIA INA PATIENT WITH AML. Chest. 2024;166 (4):1279A-1280A$77$YR$E$F$Y$$$20240928$$HP$US$US
243758381$24375838$1$I$$20240923$20240928$20240928$EXP$$US-AMGEN-USASP2024192457$AMGEN$Fujiuchi B.; Devendra G. INFECTION-RELATED GLOMERULONEPHRITIS IN A PATIENT WITH BILATERAL ENDOCARDITIS AND LEGIONNAIRES DISEASE. Chest. 2024;166 (4):1590A-1591A$48$YR$A$M$Y$$$20240928$$HP$US$US
243758391$24375839$1$I$$20240909$20240928$20240928$PER$$US-TEVA-VS-3242318$TEVA$$76$YR$$F$Y$$$20240928$$CN$US$US
243758401$24375840$1$I$20240101$20240919$20240928$20240928$EXP$$CA-CELLTRION INC.-2024CA022744$CELLTRION$$$$$$Y$$$20240928$$MD$CA$CA
243758411$24375841$1$I$20240101$20240918$20240928$20240928$EXP$$CA-CELLTRION INC.-2024CA022752$CELLTRION$$$$$$Y$$$20240928$$HP$CA$CA
243758421$24375842$1$I$$20240914$20240928$20240928$EXP$$US-JNJFOC-20240974101$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$HP$US$US
243758431$24375843$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274720$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240928$$CN$US$US
243758441$24375844$1$I$$20240926$20240928$20240928$PER$$US-JNJFOC-20240972010$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243758451$24375845$1$I$20240917$20240920$20240928$20240928$PER$$US-SA-2024SA274878$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240928$$HP$US$US
243758461$24375846$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274830$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240928$$HP$US$US
243758471$24375847$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA274085$SANOFI AVENTIS$$$$C$F$Y$$$20240928$$HP$US$US
243758481$24375848$1$I$$20240921$20240928$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-029948$UNITED THERAPEUTICS$$$$$F$Y$85.261$KG$20240928$$$US$US
243758491$24375849$1$I$20240901$20240920$20240928$20240928$PER$$US-SA-2024SA274127$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240928$$HP$US$US
243758502$24375850$2$F$20240920$20240930$20240928$20240930$PER$$US-AMGEN-USASP2024193183$AMGEN$$69$YR$E$M$Y$$$20240930$$CN$US$US
243758511$24375851$1$I$20240921$20240923$20240928$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-030252$UNITED THERAPEUTICS$$72$YR$$F$Y$58.503$KG$20240928$$$US$US
243758521$24375852$1$I$20240319$20240922$20240928$20240928$EXP$GB-MHRA-MED-202409220831067940-BCQNJ$GB-TEVA-VS-3246959$TEVA$$66$YR$$F$Y$62$KG$20240928$$CN$GB$GB
243758531$24375853$1$I$$20240923$20240928$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-030344$UNITED THERAPEUTICS$$$$$F$Y$70.295$KG$20240928$$$US$US
243758551$24375855$1$I$$20240920$20240928$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028426$UNITED THERAPEUTICS$$$$$F$Y$63.492$KG$20240928$$$US$US
243758561$24375856$1$I$20240820$20240924$20240928$20240928$EXP$$US-SA-2024SA279579$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240928$$CN$US$US
243758571$24375857$1$I$$20240925$20240928$20240928$PER$$US-JNJFOC-20240968322$JOHNSON AND JOHNSON$$$$$F$Y$$$20240928$$CN$US$US
243758581$24375858$1$I$$20240904$20240928$20240928$PER$$US-009507513-2409USA002457$MERCK$$75$YR$$M$Y$$$20240928$$CN$US$US
243758591$24375859$1$I$20240925$20240925$20240928$20240928$PER$$US-AMGEN-USASP2024191714$AMGEN$$76$YR$E$F$Y$$$20240928$$CN$US$US
243758601$24375860$1$I$$20240917$20240928$20240928$EXP$$CA-TAKEDA-2020TUS051872$TAKEDA$$$$$F$Y$$$20240928$$CN$CA$CA
243758611$24375861$1$I$20240101$20240927$20240928$20240928$PER$$US-AMGEN-USASP2024193361$AMGEN$$75$YR$E$F$Y$$$20240928$$CN$US$US
243758631$24375863$1$I$20240705$20240920$20240928$20240928$EXP$GB-MHRA-MED-202409171353166980-SJGRP$GB-TEVA-VS-3246594$TEVA$$53$YR$$M$Y$$$20240928$$PH$GB$GB
243758641$24375864$1$I$20240923$20240923$20240928$20240928$PER$$US-JNJFOC-20240960693$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243758651$24375865$1$I$20240101$20240925$20240928$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-030582$UNITED THERAPEUTICS$$$$$F$Y$149.66$KG$20240928$$$US$US
243758671$24375867$1$I$20240101$20240923$20240928$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-024980$UNITED THERAPEUTICS$$$$$F$Y$81.179$KG$20240928$$$US$US
243758681$24375868$1$I$20240101$20240925$20240928$20240928$PER$$US-UNITED THERAPEUTICS-UNT-2024-030577$UNITED THERAPEUTICS$$$$$M$Y$93.878$KG$20240928$$$US$US
243758701$24375870$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274199$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240928$$MD$US$US
243758711$24375871$1$I$20240801$20240920$20240928$20240928$PER$$US-SA-2024SA274469$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240928$$HP$US$US
243758731$24375873$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274242$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240928$$HP$US$US
243758741$24375874$1$I$20240701$20240920$20240928$20240928$PER$$US-SA-2024SA274335$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240928$$MD$US$US
243758751$24375875$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA274647$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240928$$MD$US$US
243758771$24375877$1$I$20240101$20240926$20240928$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-028296$UNITED THERAPEUTICS$$$$$F$Y$54.875$KG$20240928$$$US$US
243758781$24375878$1$I$20240101$20240920$20240928$20240928$PER$$US-009507513-2409USA007711$MERCK$$$$$M$Y$$$20240928$$CN$US$US
243758802$24375880$2$F$20240922$20240930$20240928$20240930$PER$$US-AMGEN-USASP2024193421$AMGEN$$72$YR$E$F$Y$$$20240930$$CN$US$US
243758811$24375881$1$I$$20240925$20240928$20240928$EXP$$US-009507513-2409USA009676$MERCK$Barefield J., Hendrix A., Carlyle J. Carlyle L., Parikh A.. DAPTOMYCIN-INDUCED PNEUMONIA: WHERE ARE THE EOSINOPHILS?. Chest. 2024;166 (4):3208A-9A$43$YR$$F$Y$$$20240928$$HP$US$US
243758831$24375883$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274142$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240928$$MD$US$US
243758841$24375884$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274035$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240928$$HP$US$US
243758851$24375885$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA273842$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240928$$MD$US$US
243758861$24375886$1$I$20240901$20240909$20240928$20240928$PER$$US-SA-2024SA277436$SANOFI AVENTIS$$74$YR$E$F$Y$77.73$KG$20240928$$MD$US$US
243758871$24375887$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274275$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240928$$MD$US$US
243758881$24375888$1$I$20240101$20240919$20240928$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-027334$UNITED THERAPEUTICS$$$$$M$Y$78.005$KG$20240928$$$US$US
243758891$24375889$1$I$20240829$20240925$20240928$20240928$PER$$US-JNJFOC-20240971102$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243758901$24375890$1$I$$20240925$20240928$20240928$PER$$US-JNJFOC-20240971968$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$MD$US$US
243758911$24375891$1$I$20240101$20240919$20240928$20240928$EXP$$CA-JNJFOC-20240957497$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240928$$HP$CA$CA
243758921$24375892$1$I$20240830$20240918$20240928$20240928$EXP$CN-NMPACDR-4401041008729202400441$CN-BAXTER-2024BAX025037$BAXTER$$5$YR$$M$Y$13.6$KG$20240928$$MD$CN$CN
243758941$24375894$1$I$20221031$20240917$20240928$20240928$EXP$$PH-BAXTER-2024BAX024896$BAXTER$$56$YR$$F$Y$48$KG$20240928$$MD$PH$PH
243758951$24375895$1$I$$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192705$AMGEN$$$$$$Y$$$20240928$$CN$US$US
243758961$24375896$1$I$20240101$20240909$20240928$20240928$PER$$US-SA-2024SA277553$SANOFI AVENTIS$$34$YR$A$F$Y$105.91$KG$20240928$$MD$US$US
243758971$24375897$1$I$$20240925$20240928$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-030519$UNITED THERAPEUTICS$Kerstein JS, Valencia E, Collins S, Ferraro AM, Harrild DM, Gauvreau K, et al.. Transcatheter Ductus Arteriosus Stenting for Acute Pediatric Pulmonary Arterial Hypertension is Associated with Improved Right Ventricular Echocardiography Strain. Pediatr Cardiol. 2024;45(7):1573-1580$4$YR$$$Y$$$20240928$$$US$US
243758981$24375898$1$I$$20240916$20240928$20240928$PER$$US-SA-2024SA279081$SANOFI AVENTIS$$$$$$Y$$$20240928$$CN$US$US
243758991$24375899$1$I$20240808$20240918$20240928$20240928$PER$$US-VIIV HEALTHCARE LIMITED-US2024116403$VIIV$$3$DEC$$M$Y$$$20240928$$MD$US$US
243759001$24375900$1$I$$20240919$20240928$20240928$PER$$US-ABBVIE-5931245$ABBVIE$$$$$$Y$$$20240928$$MD$US$US
243759011$24375901$1$I$$20240919$20240928$20240928$PER$$US-GSK-US2024116547$GLAXOSMITHKLINE$$$$$M$Y$$$20240928$$HP$US$US
243759021$24375902$1$I$20240911$20240916$20240928$20240928$EXP$$US-Accord-447846$ACCORD$$66$YR$E$M$Y$78.02$KG$20240928$$CN$US$US
243759031$24375903$1$I$20240201$20240924$20240928$20240928$EXP$$US-ABBVIE-5938489$ABBVIE$$31$YR$$M$Y$$$20240928$$CN$US$US
243759051$24375905$1$I$$20240923$20240928$20240928$PER$$US-AMGEN-USASP2024189878$AMGEN$$$$$M$Y$$$20240928$$CN$US$US
243759061$24375906$1$I$$20240925$20240928$20240928$EXP$$US-009507513-2409USA009398$MERCK$Mahajan K, Acharya D, Abdreyev N, Costabile C, Sullivan D, Ramonell R.. CARDIAC COMPLICATIONS FOLLOWING UNINTENTIONAL MOLNUPIRAVIR OVERDOSE: A CASE REPORT. Chest. 2024;166(4S):1856A-7A$84$YR$$F$Y$$$20240928$$HP$US$US
243759071$24375907$1$I$$20240918$20240928$20240928$PER$$US-009507513-2409USA007417$MERCK$Dermawan JK, Malik F, Gross JM, Baraban E, Pratilas C, Mneimneh W, et al.. Novel PAX3::MAML3 Fusion Identified in Alveolar Rhabdomyosarcoma, Using DNA Methylation Profiling to Expand the Genetic Spectrum of ?Fusion-Positive? Cases. Modern Pathology. 2024;37$$$T$F$Y$$$20240928$$HP$US$US
243759081$24375908$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA275466$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240928$$MD$US$US
243759091$24375909$1$I$20240910$20240919$20240928$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-026621$UNITED THERAPEUTICS$$71$YR$$M$Y$73.923$KG$20240928$$$US$US
243759101$24375910$1$I$20231001$20240919$20240928$20240928$EXP$$AU-JNJFOC-20240959605$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$MD$AU$AU
243759131$24375913$1$I$20240907$20240918$20240928$20240928$EXP$CN-NMPACDR-3401011514505202400136$CN-BAXTER-2024BAX025019$BAXTER$$60$YR$$F$Y$66$KG$20240928$$MD$CN$CN
243759141$24375914$1$I$20240923$20240924$20240928$20240928$EXP$$US-ABBVIE-5937376$ABBVIE$$69$YR$$M$Y$$$20240928$$CN$US$US
243759151$24375915$1$I$20240117$20240924$20240928$20240928$EXP$$US-ABBVIE-5939141$ABBVIE$$67$YR$$F$Y$$$20240928$$CN$US$US
243759161$24375916$1$I$$20240924$20240928$20240928$EXP$$FR-TAKEDA-2024TUS095235$TAKEDA$$$$$$Y$$$20240928$$MD$FR$FR
243759171$24375917$1$I$20240917$20240919$20240928$20240928$PER$$US-JNJFOC-20240951896$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243759181$24375918$1$I$$20240924$20240928$20240928$EXP$$US-AMGEN-USASP2024190258$AMGEN$$$$$M$Y$$$20240928$$CN$US$US
243759191$24375919$1$I$20240801$20240919$20240928$20240928$EXP$$US-ABBVIE-5932088$ABBVIE$$34$YR$$F$Y$$$20240928$$CN$US$US
243759201$24375920$1$I$$20240924$20240928$20240928$EXP$$US-AMGEN-USASP2024192460$AMGEN$Khoury R.; Grimley M.S.; Nelson A. et al.. Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant. American Journal of Transplantation. 2024;24 (9):1634-1643$$$$$Y$$$20240928$$HP$US$US
243759211$24375921$1$I$20240910$20240910$20240928$20240928$PER$$US-SA-2024SA277482$SANOFI AVENTIS$$40$YR$A$M$Y$68.18$KG$20240928$$MD$US$US
243759221$24375922$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274912$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240928$$HP$US$US
243759231$24375923$1$I$20220701$20240920$20240928$20240928$EXP$$JP-009507513-2311JPN004145J$MERCK$Higuchi K, Kondo S, Yamamoto S, Makinouchi S, Nakajima M, Sonehara K, et al.. 14 A case of fulminant type 1 diabetes mellitus as immune-related adverse events associated with pembrolizumab and lenvatinib combination therapy. The 148th Congress/Academic Meeting of Shinshu Society of Obstetrics and Gynecol$72$YR$$F$Y$45$KG$20240928$$MD$JP$JP
243759241$24375924$1$I$$20240913$20240928$20240928$EXP$$IN-Zhejiang Yongtai pharmaceuticals Co..,Ltd.-2162147$ZHEJIANG YONGTAI$Full text$66$YR$$M$Y$$$20240928$$$IN$IN
243759251$24375925$1$I$$20240913$20240928$20240928$EXP$$US-Zhejiang Yongtai pharmaceuticals Co..,Ltd.-2162148$ZHEJIANG YONGTAI$Full text$24$YR$$$Y$$$20240928$$$US$US
243759261$24375926$1$I$$20240918$20240928$20240928$EXP$$US-Kindeva Drug Delivery L.P.-2162150$KINDEVA DRUG DELIVERY$$12$YR$$F$Y$$$20240928$$MD$US$US
243759271$24375927$1$I$$20240916$20240928$20240928$EXP$$LB-B.Braun Medical Inc.-2162151$B BRAUN$Literature Article$73$YR$$M$Y$$$20240928$$$LB$LB
243759281$24375928$1$I$$20240916$20240928$20240928$EXP$$CN-B.Braun Medical Inc.-2162163$B BRAUN$$77$YR$$M$Y$50$KG$20240928$$$CN$CN
243759291$24375929$1$I$$20240913$20240928$20240928$EXP$$GB-Provepharm-2162157$PROVEPHARM$$$$$F$Y$$$20240928$$PH$GB$GB
243759301$24375930$1$I$$20240913$20240928$20240928$EXP$$GB-Provepharm-2162159$PROVEPHARM$$73$YR$$F$Y$$$20240928$$PH$GB$GB
243759311$24375931$1$I$$20240920$20240928$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-030773$UNITED THERAPEUTICS$$$$$F$Y$85.261$KG$20240928$$$US$US
243759321$24375932$1$I$$20240916$20240928$20240928$EXP$$CA-Knight Therapeutics (USA) Inc.-2162156$KNIGHT THERAPEUTICS$Literature article$74$YR$$F$Y$$$20240928$$MD$CA$CA
243759331$24375933$1$I$$20240710$20240928$20240928$EXP$$GB-Provepharm-2162165$PROVEPHARM$$72$YR$$F$Y$$$20240928$$MD$GB$GB
243759341$24375934$1$I$$20240710$20240928$20240928$EXP$$GB-Provepharm-2162170$PROVEPHARM$$62$YR$$F$Y$$$20240928$$MD$GB$GB
243759351$24375935$1$I$$20240916$20240928$20240928$EXP$$JP-B.Braun Medical Inc.-2162161$B BRAUN$Literature Article$21$YR$$F$Y$57$KG$20240928$$$JP$JP
243759361$24375936$1$I$$20240710$20240928$20240928$EXP$$GB-Provepharm-2162168$PROVEPHARM$$75$YR$$F$Y$$$20240928$$MD$GB$GB
243759371$24375937$1$I$$20240916$20240928$20240928$EXP$$US-Spectra Medical Devices, LLC-2162182$Spectra Medical Devices$Abstract$42$YR$$F$Y$56.7$KG$20240928$$$US$US
243759381$24375938$1$I$$20240916$20240928$20240928$EXP$$TW-Spectra Medical Devices, LLC-2162183$Spectra Medical Devices$Full text$3$YR$$F$Y$13.6$KG$20240928$$$TW$TW
243759391$24375939$1$I$20240101$20240926$20240928$20240928$EXP$$US-UNITED THERAPEUTICS-UNT-2024-025169$UNITED THERAPEUTICS$$$$$F$Y$$$20240928$$$US$US
243759401$24375940$1$I$$20240923$20240928$20240928$PER$$US-SA-2024SA275197$SANOFI AVENTIS$$28$YR$A$M$Y$$$20240928$$HP$US$US
243759411$24375941$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA275558$SANOFI AVENTIS$$$$A$F$Y$57.73$KG$20240928$$MD$US$US
243759422$24375942$2$F$$20240913$20240928$20240928$EXP$$US-AstraZeneca-2024A210591$ALEXION PHARMACEUTICALS$$61$YR$A$$Y$$$20240928$$$US$US
243759431$24375943$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274924$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240928$$HP$US$US
243759441$24375944$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA276715$SANOFI AVENTIS$$12$YR$T$F$Y$49.09$KG$20240928$$MD$US$US
243759452$24375945$2$F$$20240913$20240928$20240928$EXP$$US-AstraZeneca-2024A211638$ALEXION PHARMACEUTICALS$$$$$$Y$68.027$KG$20240928$$MD$US$US
243759471$24375947$1$I$$20240923$20240928$20240928$EXP$$IL-TAKEDA-2024TUS081814$TAKEDA$$$$E$M$Y$$$20240928$$CN$GB$IL
243759481$24375948$1$I$$20240925$20240928$20240928$EXP$$US-009507513-2409USA009361$MERCK$Peddi V, Siddique M, Jones C, Waleed M.. PEMBROLIZUMAB-INDUCED CAPILLARY LEAK SYNDROME AND RECURRENT PLEURAL EFFUSIONS: A RARE COMPLICATION. Chest. 2024;166(4S):4162A-3A$65$YR$$M$Y$$$20240928$$HP$US$US
243759491$24375949$1$I$$20240923$20240928$20240928$EXP$$US-AMGEN-USASP2024191435$AMGEN$PATEL A.; Courtney J.D.; Guo Y.. BILATERAL PASTEURELLA MULTICODA EMPYEMA. Chest. 2024;166 (4):1575A-1576A$69$YR$E$M$Y$$$20240928$$HP$US$US
243759501$24375950$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274940$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240928$$CN$US$US
243759511$24375951$1$I$20240101$20240925$20240928$20240928$PER$$US-AMGEN-USASP2024191512$AMGEN$$$$$M$Y$$$20240928$$CN$US$US
243759521$24375952$1$I$$20240917$20240928$20240928$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-19002$IPSEN$$$$$F$Y$$$20240928$$MD$US$US
243759531$24375953$1$I$20240101$20240917$20240928$20240928$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-19036$IPSEN$$56$YR$A$F$Y$$$20240928$$HP$US$US
243759541$24375954$1$I$20240915$20240926$20240928$20240928$PER$$US-AMGEN-USASP2024192749$AMGEN$$55$YR$A$F$Y$$$20240928$$CN$US$US
243759551$24375955$1$I$20221222$20240920$20240928$20240928$EXP$$US-AMGEN-USASP2024189495$AMGEN$Borja-montes O.F.; Toro-pedroza A.; Horton D.D. et.al. MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA POST-RITUXIMAB TBERAPY: A CASE SERIES. European journal of case reports in internal medicine. 2024;11$47$YR$A$F$Y$$$20240928$$HP$US$US
243759561$24375956$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA274580$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240928$$HP$US$US
243759571$24375957$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274937$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240928$$HP$US$US
243759581$24375958$1$I$$20240918$20240928$20240928$PER$$US-GSK-US2024116150$GLAXOSMITHKLINE$$$$$$Y$$$20240928$$CN$US$US
243759591$24375959$1$I$20230901$20240923$20240928$20240928$PER$$US-SA-2024SA277539$SANOFI AVENTIS$$15$YR$T$F$Y$$$20240928$$MD$US$US
243759601$24375960$1$I$$20240918$20240928$20240928$EXP$$US-AMGEN-USASP2024188798$AMGEN$Sheth M. S.; Hale D.E.; Mcarthur J.C. et.al. A 79-Year-Old Woman With Worsening Headaches and Pachymeningeal Enhancement A Case Report From the National Multiple Sclerosis Society Case Conference Proceeding. Neurology Neuroimmunology + Neuroinflammation. 2024;11:e200308(1) - e200308(6)$79$YR$E$F$Y$$$20240928$$MD$US$US
243759611$24375961$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA274959$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240928$$HP$US$US
243759621$24375962$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA275687$SANOFI AVENTIS$$$$A$M$Y$60.45$KG$20240928$$HP$US$US
243759631$24375963$1$I$$20240921$20240928$20240928$EXP$GB-MHRA-WEBRADR-202409220018284410-NRVDY$GB-RDY-SPO/GBR/24/0014044$DR REDDYS$$10$DEC$A$F$Y$$$20240928$$CN$GB$GB
243759641$24375964$1$I$$20240920$20240928$20240928$EXP$$CA-TAKEDA-2024TUS096192$TAKEDA$$43$YR$$F$Y$68$KG$20240928$$HP$CA$CA
243759661$24375966$1$I$20240101$20240916$20240928$20240928$PER$$US-SA-2024SA278067$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240928$$CN$US$US
243759671$24375967$1$I$20240801$20240910$20240928$20240928$PER$$US-SA-2024SA279284$SANOFI AVENTIS$$38$YR$A$F$Y$74$KG$20240928$$MD$US$US
243759681$24375968$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274969$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240928$$HP$US$US
243759691$24375969$1$I$$20240914$20240928$20240928$EXP$GB-MHRA-MED-202409131236254910-ZPVYR$GB-ASTRAZENECA-202409GLO001767GB$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240928$$$GB$GB
243759701$24375970$1$I$20240101$20240910$20240928$20240928$PER$$US-SA-2024SA279314$SANOFI AVENTIS$$54$YR$A$M$Y$76.36$KG$20240928$$MD$US$US
243759711$24375971$1$I$$20240926$20240928$20240928$PER$$US-ELI_LILLY_AND_COMPANY-US202409017418$ELI LILLY AND CO$$$$$$Y$$$20240928$$HP$US$US
243759721$24375972$1$I$$20240926$20240928$20240928$PER$$US-ELI_LILLY_AND_COMPANY-US202409017830$ELI LILLY AND CO$$$$$$Y$$$20240928$$HP$US$US
243759731$24375973$1$I$20240919$20240919$20240928$20240928$PER$$US-ABBVIE-5934407$ABBVIE$$72$YR$$F$Y$$$20240928$$CN$US$US
243759741$24375974$1$I$$20240925$20240928$20240928$PER$$US-009507513-2409USA009338$MERCK$$$$E$F$Y$$$20240928$$MD$US$US
243759751$24375975$1$I$$20240924$20240928$20240928$PER$$US-009507513-2409USA008799$MERCK$Singh P, Aurshina A, Atiq I, Javed A, Patil P, Marwat A et al.. LEMIERRE SYNDROME: A RARE ENTITY WITH PROLONGED CLINICAL RAMIFICATIONS. Chest. 2024;166(4S):1536A-7A$47$YR$$M$Y$$$20240928$$HP$US$US
243759761$24375976$1$I$$20240902$20240928$20240928$PER$$US-009507513-2409USA000835$MERCK$$$$$M$Y$68.027$KG$20240928$$CN$US$US
243759771$24375977$1$I$20240301$20240904$20240928$20240928$PER$$US-SA-2024SA273970$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240928$$CN$US$US
243759782$24375978$2$F$20240101$20240916$20240928$20240930$PER$$US-SA-2024SA276915$SANOFI AVENTIS$$38$YR$A$M$Y$$$20241001$$MD$US$US
243759801$24375980$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274952$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240928$$HP$US$US
243759811$24375981$1$I$20240906$20240923$20240928$20240928$PER$$US-SA-2024SA275172$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240928$$MD$US$US
243759821$24375982$1$I$20240101$20240919$20240928$20240928$PER$$US-SA-2024SA274210$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240928$$HP$US$US
243759831$24375983$1$I$$20240918$20240928$20240928$PER$$US-ABBVIE-5934413$ABBVIE$$$$$F$Y$$$20240928$$CN$US$US
243759841$24375984$1$I$20240921$20240921$20240928$20240928$PER$$US-RDY-SPO/USA/24/0014050$DR REDDYS$$33$YR$A$M$Y$$$20240928$$MD$US$US
243759851$24375985$1$I$20240918$20240918$20240928$20240928$PER$$US-009507513-2409USA006765$MERCK$$95$YR$$M$Y$$$20240928$$CN$US$US
243759861$24375986$1$I$$20240906$20240928$20240928$PER$$US-SA-2024SA276347$SANOFI AVENTIS$$$$T$M$Y$95.45$KG$20240928$$MD$US$US
243759871$24375987$1$I$20240907$20240909$20240928$20240928$PER$$US-SA-2024SA278099$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240928$$CN$US$US
243759881$24375988$1$I$$20240927$20240928$20240928$PER$$US-AMGEN-USASP2024193512$AMGEN$$$$$$Y$$$20240928$$HP$US$US
243759891$24375989$1$I$$20240924$20240928$20240928$EXP$$US-JNJFOC-20240968269$JOHNSON AND JOHNSON$$$$$M$Y$$$20240928$$CN$US$US
243759911$24375991$1$I$$20240909$20240928$20240928$PER$$US-SA-2024SA277840$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240928$$HP$US$US
243759921$24375992$1$I$20240101$20240906$20240928$20240928$PER$$US-SA-2024SA274740$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240928$$MD$US$US
243759931$24375993$1$I$20240501$20240904$20240928$20240928$PER$$US-SA-2024SA272617$SANOFI AVENTIS$$28$YR$A$F$Y$113.8$KG$20240928$$MD$US$US
243759951$24375995$1$I$20240101$20240909$20240928$20240928$PER$$US-SA-2024SA277433$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240928$$CN$US$US
243759961$24375996$1$I$$20240920$20240928$20240928$PER$$US-SA-2024SA274234$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240928$$MD$US$US
243759971$24375997$1$I$$20240904$20240928$20240928$PER$$US-SA-2024SA274400$SANOFI AVENTIS$$$$A$F$Y$$$20240928$$MD$US$US
243759981$24375998$1$I$20240101$20240920$20240928$20240928$PER$$US-SA-2024SA273795$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240928$$MD$US$US
243759991$24375999$1$I$$20240922$20240928$20240928$PER$$US-JNJFOC-20240962573$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243760001$24376000$1$I$$20240910$20240928$20240928$PER$$US-SA-2024SA277531$SANOFI AVENTIS$$$$E$M$Y$$$20240928$$MD$US$US
243760011$24376001$1$I$$20240924$20240928$20240928$PER$$US-ELI_LILLY_AND_COMPANY-US202409015417$ELI LILLY AND CO$$$$$M$Y$$$20240928$$CN$US$US
243760021$24376002$1$I$20240101$20240909$20240928$20240928$PER$$US-SA-2024SA277121$SANOFI AVENTIS$$13$YR$T$F$Y$81.633$KG$20240928$$MD$US$US
243760031$24376003$1$I$$20240918$20240928$20240928$EXP$$BR-BAYER-2024A134212$BAYER$$$$$M$Y$$$20240928$$CN$BR$BR
243760041$24376004$1$I$$20240920$20240928$20240928$PER$$US-JNJFOC-20240956382$JOHNSON AND JOHNSON$$$$$$Y$$$20240928$$CN$US$US
243760051$24376005$1$I$$20240923$20240928$20240928$PER$$US-JNJFOC-20240961036$JOHNSON AND JOHNSON$$$$$F$Y$$$20240928$$CN$US$US
243760061$24376006$1$I$$20240927$20240928$20240928$PER$$US-AMGEN-USASP2024193377$AMGEN$$$$A$F$Y$$$20240928$$CN$US$US
243760081$24376008$1$I$20240318$20240919$20240928$20240928$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR117454$VIIV$$67$YR$$F$Y$$$20240928$$MD$US$US
243760091$24376009$1$I$$20240924$20240928$20240928$EXP$$JP-BAYER-2024A136891$BAYER$$$$$M$Y$$$20240928$$MD$JP$JP
243760101$24376010$1$I$20240601$20240925$20240928$20240928$PER$$US-BAYER-2024A137735$BAYER$$75$YR$E$F$Y$$$20240928$$CN$US$US
243760111$24376011$1$I$20240101$20240910$20240928$20240928$PER$$US-SA-2024SA277452$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240928$$MD$US$US
243760121$24376012$1$I$$20240926$20240928$20240928$PER$$US-BAYER-2024A138143$BAYER$$$$A$F$Y$$$20240928$$MD$US$US
243760131$24376013$1$I$$20240919$20240928$20240928$PER$$US-SA-2024SA273505$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240928$$HP$US$US
243760141$24376014$1$I$20240901$20240919$20240928$20240928$PER$$US-SA-2024SA273472$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240928$$HP$US$US
243760151$24376015$1$I$$20240925$20240928$20240928$EXP$$US-009507513-2409USA009773$MERCK$DESHPANDE Y, SABIR S, KAUR R, KAUR L, DESHPANDE A. BEYOND CANCER CONTROL: PEMBROLIZUMAB^S ROLE IN CARDIAC ARREST CASE. Chest. 2024;166 (4):A830$75$YR$$M$Y$$$20240928$$HP$US$US
243760161$24376016$1$I$20240922$20240925$20240928$20240928$PER$$US-009507513-2409USA009219$MERCK$$70$YR$$F$Y$$$20240928$$CN$US$US
243760171$24376017$1$I$20240801$20240909$20240928$20240928$PER$$US-SA-2024SA276170$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240928$$PH$US$US
243760181$24376018$1$I$20240101$20240922$20240928$20240928$EXP$$JP-009507513-2405JPN003457J$MERCK$$7$DEC$$F$Y$$$20240928$$MD$JP$JP
243760191$24376019$1$I$20240801$20240906$20240928$20240928$PER$$US-SA-2024SA274555$SANOFI AVENTIS$$27$YR$A$F$Y$60.91$KG$20240928$$MD$US$US
243760201$24376020$1$I$$20240909$20240928$20240928$PER$$US-SA-2024SA276114$SANOFI AVENTIS$$43$YR$A$F$Y$46.82$KG$20240928$$MD$US$US
243760211$24376021$1$I$$20240906$20240928$20240928$PER$$US-SA-2024SA276361$SANOFI AVENTIS$$$$A$F$Y$63.5$KG$20240928$$MD$US$US
243760221$24376022$1$I$20240901$20240919$20240928$20240928$PER$$US-SA-2024SA273627$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240928$$HP$US$US
243760401$24376040$1$I$20240925$20240927$20240927$20240927$DIR$720350$$FDA-CTU$$9$YR$$F$N$29.7$KG$20240927$Y$CN$US$
243760441$24376044$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67066$$FDA-CTU$$68$YR$$M$N$$$20240927$N$$US$
243760451$24376045$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67058$$FDA-CTU$$67$YR$$M$N$107.95$KG$20240927$N$$US$
243760461$24376046$1$I$$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-67106$$FDA-CTU$$$$$F$N$$$20240926$N$HP$US$
243760471$24376047$1$I$$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-67059$$FDA-CTU$$72$YR$$M$N$$$20240926$N$$US$
243760501$24376050$1$I$20240926$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67138$$FDA-CTU$$29$YR$$F$N$54.3$KG$20240927$N$HP$US$
243760521$24376052$1$I$20240926$20240926$20240926$20240926$DIR$FDA-CDER-CTU-2024-66870$$FDA-CTU$$69$YR$$M$N$$$20240926$N$$US$
243760531$24376053$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66863$$FDA-CTU$$$$$$N$$$20240927$$CN$US$
243760541$24376054$1$I$20240826$20240826$20240927$20240927$DIR$FDA-CDER-CTU-2024-67088$$FDA-CTU$$45$YR$$M$N$$$20240826$N$PH$US$
243760551$24376055$1$I$20230221$20240925$20240925$20240925$DIR$719822$$FDA-CTU$$59$YR$$M$N$85$KG$20240925$N$PH$US$
243760561$24376056$1$I$20230410$20240925$20240925$20240925$DIR$719829$$FDA-CTU$$64$YR$$M$N$67$KG$20240925$N$PH$US$
243760571$24376057$1$I$20210315$20240925$20240925$20240925$DIR$719821$$FDA-CTU$$62$YR$$M$N$187$KG$20240925$N$PH$US$
243760581$24376058$1$I$20230418$20240925$20240925$20240925$DIR$719832$$FDA-CTU$$79$YR$$M$N$53$KG$20240925$N$PH$US$
243760591$24376059$1$I$20230411$20240925$20240925$20240925$DIR$719831$$FDA-CTU$$43$YR$$M$N$$$20240925$N$PH$US$
243760601$24376060$1$I$20230413$20240925$20240925$20240925$DIR$719833$$FDA-CTU$$85$YR$$M$N$67$KG$20240925$N$PH$US$
243760611$24376061$1$I$20230418$20240925$20240925$20240925$DIR$719818$$FDA-CTU$$67$YR$$M$N$71$KG$20240925$N$HP$US$
243760621$24376062$1$I$20230418$20240925$20240925$20240925$DIR$719820$$FDA-CTU$$67$YR$$M$N$71$KG$20240925$N$HP$US$
243760631$24376063$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67007$$FDA-CTU$$62$YR$$M$N$$$20240927$N$MD$US$
243760641$24376064$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66974$$FDA-CTU$$72$YR$$F$N$$$20240927$N$$US$
243760651$24376065$1$I$20230429$20240925$20240925$20240925$DIR$719828$$FDA-CTU$$62$YR$$M$N$77$KG$20240925$N$PH$US$
243760661$24376066$1$I$20230213$20240925$20240925$20240925$DIR$719819$$FDA-CTU$$73$YR$$M$N$96$KG$20240925$N$HP$US$
243760671$24376067$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66873$$FDA-CTU$$$$$$N$$$20240927$N$CN$US$
243760681$24376068$1$I$20060101$20240925$20240925$20240925$DIR$719817$$FDA-CTU$$63$YR$$M$N$112$KG$20240925$N$PH$US$
243760691$24376069$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66978$$FDA-CTU$$64$YR$$F$N$$$20240927$N$$US$
243760711$24376071$1$I$20230802$20240926$20240926$20240926$DIR$720024$$FDA-CTU$$73$YR$$M$N$204$KG$20240926$N$HP$US$
243760721$24376072$1$I$20240905$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66879$$FDA-CTU$$8$YR$$F$N$28.3$KG$20240927$N$$US$
243760731$24376073$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67031$$FDA-CTU$$$$$F$N$$$20240927$N$HP$US$
243760741$24376074$1$I$20240903$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67093$$FDA-CTU$$66$YR$$M$N$50.8$KG$20240927$N$HP$US$
243760751$24376075$1$I$20230926$20240926$20240926$20240926$DIR$720025$$FDA-CTU$$68$YR$$M$N$$$20240926$N$PH$US$
243760761$24376076$1$I$20231120$20240926$20240926$20240926$DIR$720026$$FDA-CTU$$44$YR$$M$N$107$KG$20240926$N$PH$US$
243760771$24376077$1$I$20231114$20240926$20240926$20240926$DIR$720027$$FDA-CTU$$76$YR$$M$N$221$KG$20240926$N$PH$US$
243760781$24376078$1$I$20230810$20240926$20240926$20240926$DIR$720028$$FDA-CTU$$71$YR$$M$N$$$20240926$N$PH$US$
243760791$24376079$1$I$20230818$20240926$20240926$20240926$DIR$720029$$FDA-CTU$$69$YR$$M$N$48$KG$20240926$N$HP$US$
243760801$24376080$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66887$$FDA-CTU$$$$$$N$$$20240927$$CN$US$
243760811$24376081$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66889$$FDA-CTU$$$$$$N$$$20240927$$CN$US$
243760821$24376082$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66999$$FDA-CTU$$13$YR$$M$N$37.65$KG$20240927$N$HP$US$
243760861$24376086$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66909$$FDA-CTU$$$$$$N$$$20240927$$CN$US$
243760871$24376087$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66913$$FDA-CTU$$$$$$N$$$20240927$$CN$US$
243760921$24376092$1$I$$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-66987$$FDA-CTU$$$$$M$N$$$20240926$N$HP$US$
243760931$24376093$1$I$20240926$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66919$$FDA-CTU$$84$YR$$F$N$$$20240927$N$$US$
243760961$24376096$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67137$$FDA-CTU$$69$YR$$F$N$77.11$KG$20240927$N$$US$
243760971$24376097$1$I$20230813$20240926$20240926$20240926$DIR$720068$$FDA-CTU$$82$YR$$M$N$87$KG$20240926$N$PH$US$
243760981$24376098$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67133$$FDA-CTU$$59$YR$$F$N$$$20240927$N$$US$
243760991$24376099$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66921$$FDA-CTU$$$$$$N$$$20240927$N$CN$US$
243761001$24376100$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67004$$FDA-CTU$$64$YR$$F$N$83.46$KG$20240927$N$$US$
243761011$24376101$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67127$$FDA-CTU$$45$YR$$F$N$73.48$KG$20240927$N$$US$
243761081$24376108$1$I$20231114$20240926$20240926$20240926$DIR$720049$$FDA-CTU$$72$YR$$M$N$$$20240926$N$HP$US$
243761101$24376110$1$I$20230508$20240926$20240926$20240926$DIR$720071$$FDA-CTU$$86$YR$$M$N$85$KG$20240926$N$PH$US$
243761111$24376111$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66908$$FDA-CTU$$$$$$N$$$20240927$N$CN$US$
243761131$24376113$1$I$20230912$20240926$20240926$20240926$DIR$720041$$FDA-CTU$$80$YR$$M$N$66$KG$20240926$N$PH$US$
243761151$24376115$1$I$20230803$20240926$20240926$20240926$DIR$720036$$FDA-CTU$$87$YR$$M$N$135$KG$20240926$N$PH$US$
243761181$24376118$1$I$20230731$20240926$20240926$20240926$DIR$720051$$FDA-CTU$$84$YR$$M$N$65$KG$20240926$N$PH$US$
243761231$24376123$1$I$20231109$20240926$20240926$20240926$DIR$720042$$FDA-CTU$$79$YR$$M$N$92$KG$20240926$N$PH$US$
243761291$24376129$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67063$$FDA-CTU$$83$YR$$M$N$$$20240927$N$$US$
243761311$24376131$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67069$$FDA-CTU$$55$YR$$F$N$$$20240927$N$$US$
243761331$24376133$1$I$20230424$20240926$20240926$20240926$DIR$720055$$FDA-CTU$$79$YR$$M$N$63$KG$20240926$N$PH$US$
243761401$24376140$1$I$20240927$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66883$$FDA-CTU$$$$$$N$$$20240927$N$CN$US$
243761411$24376141$1$I$20240927$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66881$$FDA-CTU$$$$$$N$$$20240927$N$CN$US$
243761431$24376143$1$I$20240927$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66907$$FDA-CTU$$$$$$N$$$20240927$N$CN$US$
243761441$24376144$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66911$$FDA-CTU$$$$$$N$$$20240927$$CN$US$
243761461$24376146$1$I$20230806$20240926$20240926$20240926$DIR$720030$$FDA-CTU$$54$YR$$M$N$119$KG$20240926$N$PH$US$
243761491$24376149$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67126$$FDA-CTU$$71$YR$$F$N$$$20240927$N$$US$
243761511$24376151$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67082$$FDA-CTU$$63$YR$$F$N$$$20240927$N$$US$
243761551$24376155$1$I$20230814$20240926$20240926$20240926$DIR$720059$$FDA-CTU$$75$YR$$M$N$79$KG$20240926$N$PH$US$
243761581$24376158$1$I$20230402$20240926$20240926$20240926$DIR$720040$$FDA-CTU$$61$YR$$M$N$124$KG$20240926$N$PH$US$
243761601$24376160$1$I$20230622$20240926$20240926$20240926$DIR$720048$$FDA-CTU$$62$YR$$M$N$83$KG$20240926$N$PH$US$
243761621$24376162$1$I$20230520$20240926$20240926$20240926$DIR$720052$$FDA-CTU$$78$YR$$M$N$$$20240926$N$PH$US$
243761651$24376165$1$I$20230213$20240926$20240926$20240926$DIR$720046$$FDA-CTU$$37$YR$$M$N$$$20240926$N$PH$US$
243761721$24376172$1$I$20230919$20240926$20240926$20240926$DIR$720060$$FDA-CTU$$69$YR$$M$N$76$KG$20240926$N$PH$US$
243761841$24376184$1$I$20230929$20240926$20240926$20240926$DIR$720031$$FDA-CTU$$74$YR$$M$N$$$20240926$N$PH$US$
243761851$24376185$1$I$20231016$20240926$20240926$20240926$DIR$720061$$FDA-CTU$$76$YR$$M$N$98$KG$20240926$N$PH$US$
243761871$24376187$1$I$20230620$20240926$20240926$20240926$DIR$720072$$FDA-CTU$$84$YR$$M$N$81$KG$20240926$N$HP$US$
243761881$24376188$1$I$20230522$20240926$20240926$20240926$DIR$720069$$FDA-CTU$$67$YR$$M$N$$$20240926$N$PH$US$
243761941$24376194$1$I$20231125$20240926$20240926$20240926$DIR$720045$$FDA-CTU$$62$YR$$M$N$102$KG$20240926$N$PH$US$
243761971$24376197$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67065$$FDA-CTU$$51$YR$$M$N$124.28$KG$20240927$N$$US$
243761981$24376198$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66960$$FDA-CTU$$17$YR$$F$N$64.41$KG$20240927$N$$US$
243761991$24376199$1$I$20240927$20240927$20240927$20240927$DIR$720382$$FDA-CTU$$$$$UNK$N$$$20240927$N$CN$US$
243762021$24376202$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67021$$FDA-CTU$$82$YR$$F$N$$$20240927$N$$US$
243762071$24376207$1$I$20231029$20240926$20240926$20240926$DIR$720058$$FDA-CTU$$88$YR$$M$N$86$KG$20240926$N$PH$US$
243762221$24376222$1$I$20221024$20240927$20240927$20240927$DIR$720409$$FDA-CTU$$50$YR$$M$N$74.25$KG$20240927$N$MD$US$
243762241$24376224$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67119$$FDA-CTU$$71$YR$$F$N$$$20240927$N$$US$
243762251$24376225$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66927$$FDA-CTU$$72$YR$$F$N$$$20240927$N$$US$
243762261$24376226$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67064$$FDA-CTU$$50$YR$$M$N$$$20240927$N$$US$
243762321$24376232$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67020$$FDA-CTU$$$$$F$N$$$20240927$N$HP$US$
243762341$24376234$1$I$20240923$20240927$20240927$20240927$DIR$720435$$FDA-CTU$$37$YR$$F$N$63$KG$20240927$N$CN$US$
243762351$24376235$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67010$$FDA-CTU$$44$YR$$F$N$$$20240927$N$$US$
243762381$24376238$1$I$20240429$20240927$20240927$20240927$DIR$720376$$FDA-CTU$$39$YR$$F$N$96.6$KG$20240927$N$PH$US$
243762391$24376239$1$I$20240917$20240927$20240927$20240927$DIR$720406$$FDA-CTU$$35$YR$$F$N$$$20240927$N$PH$US$
243762401$24376240$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67098$$FDA-CTU$$$$$M$N$$$20240927$N$HP$US$
243762411$24376241$1$I$20240926$20240927$20240927$20240927$DIR$720370$$FDA-CTU$$67$YR$$F$N$61.6$KG$20240927$Y$HP$US$
243762431$24376243$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67109$$FDA-CTU$$79$YR$$M$N$$$20240927$N$$US$
243762441$24376244$1$I$20240926$20240927$20240927$20240927$DIR$720378$$FDA-CTU$$$$$UNK$N$$$20240927$N$CN$US$
243762451$24376245$1$I$20240927$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67070$$FDA-CTU$$74$YR$$M$N$$$20240927$Y$HP$US$
243762461$24376246$1$I$20240912$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67044$$FDA-CTU$$61$YR$$M$N$105$KG$20240927$Y$PH$US$
243762491$24376249$1$I$$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-67112$$FDA-CTU$$$$$M$N$$$20240926$N$HP$US$
243762511$24376251$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005551$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243762531$24376253$1$I$20240514$20240919$20240930$20240930$EXP$DE-EMA-2024910-AUTODUP-1725997788362$DE-Accord-448354$ACCORD$$$$A$F$Y$108$KG$20240930$$CN$DE$DE
243762541$24376254$1$I$20240822$20240905$20240930$20240930$EXP$$US-NEBO-668726$PHARMACOSMOS$$$$$$Y$$$20240930$$HP$US$US
243762551$24376255$1$I$20230914$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409161200570960-VCLGD$GB-Accord-448003$ACCORD$$56$YR$A$M$Y$75$KG$20240930$$CN$GB$GB
243762561$24376256$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005559$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243762571$24376257$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5940754$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243762581$24376258$1$I$$20240911$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052172$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
243762591$24376259$1$I$20240701$20240913$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052153$TOLMAR$$77$YR$$M$Y$$$20240930$$CN$CA$CA
243762601$24376260$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5940816$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243762611$24376261$1$I$$20240920$20240930$20240930$EXP$GB-MHRA-MED-202409202127308070-KLQDR$GB-RDY-SPO/GBR/24/0014001$DR REDDYS$$$$$M$Y$94$KG$20240930$$CN$GB$GB
243762621$24376262$1$I$$20240911$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052206$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
243762631$24376263$1$I$20240828$20240912$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052216$TOLMAR$$77$YR$$M$Y$$$20240930$$CN$CA$CA
243762641$24376264$1$I$$20240913$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052270$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
243762651$24376265$1$I$20240920$20240920$20240930$20240930$PER$$US-ABBVIE-5934199$ABBVIE$$69$YR$$F$Y$87$KG$20240930$$CN$US$US
243762661$24376266$1$I$20240826$20240912$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052356$TOLMAR$$90$YR$$M$Y$$$20240930$$CN$CA$CA
243762671$24376267$1$I$20240801$20240911$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052355$TOLMAR$$81$YR$$M$Y$$$20240930$$CN$CA$CA
243762681$24376268$1$I$20230101$20240913$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052346$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
243762691$24376269$1$I$$20240920$20240930$20240930$EXP$$US-JNJFOC-20240959809$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$HP$US$US
243762701$24376270$1$I$20240924$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017273$ELI LILLY AND CO$$52$YR$A$M$Y$$$20240930$$CN$US$US
243762711$24376271$1$I$$20240923$20240930$20240930$EXP$$US-EXELIXIS-EXL-2024-000513$EXELIXIS$$$$$F$Y$$$20240930$$CN$US$US
243762721$24376272$1$I$20240901$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017741$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240930$$CN$US$US
243762731$24376273$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153845$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240930$$HP$US$US
243762741$24376274$1$I$20240926$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192706$AMGEN$$52$YR$A$F$Y$$$20240930$$CN$US$US
243762751$24376275$1$I$$20240925$20240930$20240930$EXP$$AR-BEIGENE-BGN-2024-015466$BEIGENE$$$$$$Y$$$20240930$$MD$AR$AR
243762761$24376276$1$I$$20240923$20240930$20240930$EXP$$US-SA-2024SA278743$SANOFI AVENTIS$$79$YR$E$F$Y$$$20240930$$CN$US$US
243762791$24376279$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5939470$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243762801$24376280$1$I$20240101$20240905$20240930$20240930$PER$$US-AJANTA-2024AJA00154$AJANTA PHARMA$$76$YR$E$M$Y$182$KG$20240927$$CN$US$US
243762811$24376281$1$I$20240101$20240924$20240930$20240930$EXP$$US-JNJFOC-20240968178$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240930$$HP$US$US
243762821$24376282$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5939591$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243762841$24376284$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67047$$FDA-CTU$$87$YR$$F$N$$$20240927$N$CN$US$
243762871$24376287$1$I$$20240924$20240930$20240930$EXP$$JP-SA-2024SA275430$SANOFI AVENTIS$$$$$F$Y$$$20240930$$MD$JP$JP
243762881$24376288$1$I$$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024191884$AMGEN$$$$$$Y$$$20240930$$CN$US$US
243762891$24376289$1$I$20240701$20240920$20240930$20240930$PER$$US-GSK-US2024117031$GLAXOSMITHKLINE$$59$YR$$F$Y$72.57$KG$20240930$$HP$US$US
243762901$24376290$1$I$$20240910$20240930$20240930$EXP$$CA-HALEON-2199121$Haleon PLC$$44$YR$$F$Y$97$KG$20240930$$CN$CA$CA
243762911$24376291$1$I$$20240911$20240930$20240930$EXP$$CA-HALEON-2197836$Haleon PLC$$$$$F$Y$$$20240930$$HP$CA$CA
243762931$24376293$1$I$20240101$20240927$20240927$20240927$DIR$720379$$FDA-CTU$$$$$UNK$N$$$20240927$N$CN$US$
243762951$24376295$1$I$20240910$20240927$20240927$20240927$DIR$720442$$FDA-CTU$$69$YR$$F$N$58.5$KG$20240927$N$CN$US$
243762991$24376299$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151115$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240930$$CN$US$US
243763001$24376300$1$I$20240927$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193190$AMGEN$$91$YR$E$$Y$$$20240930$$PH$US$US
243763031$24376303$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5940815$ABBVIE$$46$YR$$M$Y$$$20240930$$CN$US$US
243763041$24376304$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5939630$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243763051$24376305$1$I$$20240916$20240930$20240930$PER$$US-JNJFOC-20240947608$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
243763061$24376306$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005581$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243763071$24376307$1$I$20240807$20240920$20240930$20240930$EXP$$UY-EMD Serono-2024043187$EMD SERONO INC$$34$YR$A$F$Y$$$20240930$$CN$UY$UY
243763081$24376308$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005535$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243763091$24376309$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005534$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243763101$24376310$1$I$$20240923$20240930$20240930$EXP$IT-MINISAL02-1002938$IT-ASTRAZENECA-202409GLO006348IT$ALEXION PHARMACEUTICALS$$47$YR$A$$Y$60$KG$20240930$$MD$IT$IT
243763111$24376311$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024AMR117270$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$MD$US$US
243763121$24376312$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117702$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243763131$24376313$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024AMR118418$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243763141$24376314$1$I$20220520$20240920$20240930$20240930$EXP$ES-AEMPS-1569582$ES-TEVA-VS-3246633$TEVA$$57$YR$$F$Y$$$20240930$$PH$ES$ES
243763151$24376315$1$I$$20240918$20240930$20240930$EXP$CA-MHPD-E2B_07237075$CA-Accord-447442$ACCORD$$77$YR$E$F$Y$73$KG$20240930$$HP$CA$CA
243763161$24376316$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017268$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240930$$CN$US$US
243763171$24376317$1$I$20240101$20240920$20240930$20240930$EXP$$CA-CELLTRION INC.-2024CA009675$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
243763181$24376318$1$I$20190101$20240919$20240930$20240930$EXP$$US-ROCHE-2624050$ROCHE$$52$YR$A$F$Y$$$20240930$$CN$US$US
243763191$24376319$1$I$20240926$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017348$ELI LILLY AND CO$$41$YR$A$F$Y$$$20240930$$CN$US$US
243763201$24376320$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152244$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240930$$CN$US$US
243763211$24376321$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153735$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240930$$HP$US$US
243763221$24376322$1$I$$20240922$20240930$20240930$EXP$$US-PADAGIS-2024PAD01523$PADAGIS$$$$$$Y$$$20240930$$CN$US$US
243763231$24376323$1$I$20240922$20240923$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015660$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240930$$CN$US$US
243763241$24376324$1$I$20230101$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017431$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243763251$24376325$1$I$$20240923$20240930$20240930$EXP$$US-ROCHE-10000089253$ROCHE$Hoerle R, Hesselbacher S, Madren L. PJP with tree-in-bud nodularity: An abnormal PJP imaging finding. Chest. 2024;166 (4):1327A. doi:10.1016/j.chest.2024.06.856.$73$YR$E$M$Y$$$20240930$$HP$US$US
243763261$24376326$1$I$$20240916$20240930$20240930$EXP$$US-PADAGIS-2024PAD01506$PADAGIS$Blush R R. ?-Adrenergic Agonist-Induced Lactic Acidosis: A Case Report. AACN advanced critical care. 2024;35(3):222-227$$$$$Y$$$20240930$$HP$US$US
243763271$24376327$1$I$$20240920$20240930$20240930$EXP$$GB-JNJFOC-20240964507$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20240930$$HP$GB$GB
243763281$24376328$1$I$20240921$20240924$20240930$20240930$PER$$US-AMGEN-USASP2024191019$AMGEN$$59$YR$A$M$Y$$$20240930$$CN$US$US
243763291$24376329$1$I$$20240920$20240930$20240930$EXP$$US-PADAGIS-2024PAD01521$PADAGIS$Sakunchotpanit G, Rohan T Z, Moran J, Russell-Goldman E, Walters M, Nambudiri V E. Cutaneous Scedosporium apiospermum infection in a patient with metastatic renal cell carcinoma. JAAD Case Reports. 2024;52:60-62$$$$$Y$$$20240930$$HP$US$US
243763302$24376330$2$F$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005600$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243763311$24376331$1$I$20240913$20240919$20240930$20240930$EXP$$US-JNJFOC-20240958441$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240930$$HP$US$US
243763321$24376332$1$I$$20240911$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09216$LUPIN$$$$$$Y$$$20240930$$MD$US$US
243763331$24376333$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093005$ROCHE$$59$YR$A$F$Y$$$20240930$$HP$US$US
243763341$24376334$1$I$$20240927$20240930$20240930$EXP$$US-JNJFOC-20240975772$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
243763351$24376335$1$I$20231013$20240923$20240930$20240930$EXP$$US-CHIESI-2024CHF06318$CHIESI$$38$YR$$M$Y$64$KG$20240930$$CN$US$US
243763361$24376336$1$I$20180824$20240920$20240930$20240930$EXP$$FR-CELLTRION INC.-2024FR023205$CELLTRION$$$$$$Y$$$20240930$$MD$FR$FR
243763371$24376337$1$I$20200107$20240923$20240930$20240930$EXP$$KR-ROCHE-10000088733$ROCHE$$78$YR$E$F$Y$38$KG$20240930$$MD$KR$KR
243763381$24376338$1$I$20240101$20240920$20240930$20240930$EXP$$CA-862174955-ML2024-05125$MICRO LABS$$85$YR$E$M$Y$$$20240930$$HP$CA$CA
243763391$24376339$1$I$$20240923$20240930$20240930$EXP$$RO-AUROBINDO-AUR-APL-2024-047706$AUROBINDO$? Bratu. A 62-year-old woman with depressive disorder due to a medical condition-rheumatoid arthritis. Ro J Psychiatry. 2022;24(1)$62$YR$$F$Y$$$20240930$$MD$RO$RO
243763401$24376340$1$I$$20240925$20240930$20240930$PER$$US-TAKEDA-2024TUS096123$TAKEDA$$8$YR$$M$Y$$$20240930$$CN$US$US
243763411$24376341$1$I$20240917$20240917$20240930$20240930$PER$$US-JNJFOC-20240945013$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20240930$$CN$US$US
243763421$24376342$1$I$$20240924$20240930$20240930$EXP$$FI-UCBSA-2024049384$UCB$Ojanen P, Kertesz C, Peltola J. Characteristics of motion signal profiles of tonic-clonic, tonic, hyperkinetic, and motor seizures extracted from nocturnal video recordings. Epileptic Disorders. 2024;1-10$61$YR$$$Y$$$20240930$$HP$FI$FI
243763431$24376343$1$I$$20240918$20240930$20240930$EXP$$US-AUROBINDO-AUR-APL-2024-046598$AUROBINDO$Agarwal A, Diaz A, Al-Dehneem R, Pineda RM, Khattri S. Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases. J-Drugs-Dermatol. 2023;22:1183-1190$30$YR$$F$Y$$$20240930$$HP$US$US
243763441$24376344$1$I$$20230911$20240930$20240930$EXP$$US-AMNEAL PHARMACEUTICALS-2023-AMRX-03215$AMNEAL$$$$$$Y$$$20240930$$CN$US$US
243763451$24376345$1$I$20240701$20240919$20240930$20240930$EXP$$US-PHARMING-PHAUS2024000825$PHARMING GROUP$$$$$$Y$$$20240930$$MD$US$US
243763461$24376346$1$I$$20240920$20240930$20240930$PER$$US-JNJFOC-20240959787$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243763471$24376347$1$I$$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153170$BRISTOL MYERS SQUIBB$Modugula SR, Ranganatha RS, Barber S, Gutierrez L, Disilvio BE. A rare case of apixaban-induced angioedema. Chest. 2024;166(4S):2986A-7A. doi:10.1016/j.chest.2024.06.1800.$58$YR$A$M$Y$$$20240930$$HP$US$US
243763481$24376348$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005582$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243763491$24376349$1$I$$20240920$20240930$20240930$EXP$CA-MHPD-001094399$CA-Accord-447792$ACCORD$$14$YR$T$M$Y$41$KG$20240930$$HP$CA$CA
243763501$24376350$1$I$20240913$20240914$20240930$20240930$EXP$$CN-SA-2024SA278858$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240930$$HP$CN$CN
243763511$24376351$1$I$$20240924$20240930$20240930$PER$$US-ABBVIE-5941389$ABBVIE$$$$A$F$Y$$$20240930$$CN$US$US
243763521$24376352$1$I$20240927$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193269$AMGEN$$83$YR$E$F$Y$$$20240930$$CN$US$US
243763531$24376353$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024191358$AMGEN$$$$$F$Y$$$20240930$$CN$US$US
243763541$24376354$1$I$$20240919$20240930$20240930$EXP$$CA-APOTEX-2024AP011295$APOTEX$$54$YR$$F$Y$$$20240930$$HP$CA$CA
243763551$24376355$1$I$20230901$20240920$20240930$20240930$EXP$$NL-AUROBINDO-AUR-APL-2024-047523$AUROBINDO$$78$YR$$M$Y$$$20240930$$CN$NL$NL
243763561$24376356$1$I$20240901$20240926$20240930$20240930$EXP$$NVSJ2024JP011373$NOVARTIS$$$$A$M$Y$$$20240930$$MD$JP$JP
243763581$24376358$1$I$20240901$20240921$20240930$20240930$EXP$$US-SA-2024SA274618$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240930$$MD$US$US
243763591$24376359$1$I$$20240924$20240930$20240930$EXP$$US-BIOGEN-2024BI01284170$BIOGEN$$$$$M$Y$$$20240930$$CN$US$US
243763601$24376360$1$I$$20240925$20240930$20240930$EXP$$ID-ROCHE-10000093077$ROCHE$$63$YR$A$$Y$$$20240930$$MD$ID$ID
243763611$24376361$1$I$20240730$20240923$20240930$20240930$EXP$IT-MINISAL02-1002940$IT-ESPERIONTHERAPEUTICS-2024ITA01492$ESPERION THERAPEUTICS$$73$YR$$F$Y$$$20240930$$PH$IT$IT
243763631$24376363$1$I$20240201$20240924$20240930$20240930$EXP$$US-BIOGEN-2024BI01284307$BIOGEN$$61$YR$$F$Y$$$20240930$$CN$US$US
243763641$24376364$1$I$$20240920$20240930$20240930$EXP$$NVSC2024KR191646$NOVARTIS$Im Y, Kim S-Y, Kim DH, Jhun BW. Outcomes of intermittent multidrug iv therapy for refractory mycobacterium abscessus pulmonary disease. CHEST. 2024;165(2):288-302$$$A$$Y$$$20240930$$HP$KR$KR
243763651$24376365$1$I$$20240920$20240930$20240930$EXP$GB-MHRA-MED-202409201037528070-KBPYR$GB-ESPERIONTHERAPEUTICS-2024GBR01495$ESPERION THERAPEUTICS$$76$YR$$F$Y$57$KG$20240930$$CN$GB$GB
243763661$24376366$1$I$20240914$20240920$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-046863$AUROBINDO$$11$YR$$F$Y$37$KG$20240930$$PH$GB$GB
243763671$24376367$1$I$$20240903$20240930$20240930$PER$$US-HALEON-2199314$Haleon PLC$$$$$$Y$$$20240930$$CN$US$US
243763691$24376369$1$I$$20240920$20240930$20240930$PER$$US-ABBVIE-5938950$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243763701$24376370$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117037$GLAXOSMITHKLINE$$71$YR$$F$Y$$$20240930$$CN$US$US
243763711$24376371$1$I$$20240927$20240927$20240927$DIR$720401$$FDA-CTU$$$$$F$N$$$20240927$$CN$US$
243763721$24376372$1$I$20240927$20240927$20240927$20240927$DIR$720460$$FDA-CTU$$$$$F$N$$$20240927$$CN$US$
243763731$24376373$1$I$20240923$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017329$ELI LILLY AND CO$$33$YR$A$$Y$$$20240930$$CN$US$US
243763741$24376374$1$I$$20240925$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153617$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240930$$CN$US$US
243763751$24376375$1$I$20240601$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017200$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243763761$24376376$1$I$20240921$20240923$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409014704$ELI LILLY AND CO$$78$YR$E$M$Y$$$20240930$$CN$US$US
243763771$24376377$1$I$20240101$20240924$20240930$20240930$EXP$$CA-AMGEN-CANSP2024190298$AMGEN$$$$$$Y$$$20240930$$CN$CA$CA
243763781$24376378$1$I$$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-67027$$FDA-CTU$$$$$F$N$$$20240926$N$HP$US$
243763791$24376379$1$I$20230814$20240926$20240926$20240926$DIR$720032$$FDA-CTU$$80$YR$$M$N$60$KG$20240926$N$PH$US$
243763801$24376380$1$I$20231022$20240926$20240926$20240926$DIR$720034$$FDA-CTU$$65$YR$$M$N$$$20240926$N$PH$US$
243763811$24376381$1$I$20230920$20240926$20240926$20240926$DIR$720039$$FDA-CTU$$65$YR$$M$N$93$KG$20240926$N$PH$US$
243763821$24376382$1$I$20240922$20240922$20240930$20240930$EXP$$CN-ROCHE-10000088484$ROCHE$$$$$M$Y$$$20240930$$CN$CN$CN
243763831$24376383$1$I$$20240920$20240930$20240930$EXP$$US-AUROBINDO-AUR-APL-2024-046868$AUROBINDO$Huang Y, Loo NM, Chang AY, Yu Z, McKenna AL, Ritchie C, et al. Hepatic Adenomatosis in a Transgender Man on Gender-Affirming Testosterone Therapy. ACG case reports journal. 2024;11(9):e01483$22$YR$$F$Y$$$20240930$$MD$US$US
243763841$24376384$1$I$20240101$20240916$20240930$20240930$EXP$$US-ENDO USA, INC.-2024-003488$ENDO$$$$$M$Y$$$20240930$$CN$US$US
243763851$24376385$1$I$20240904$20240923$20240930$20240930$EXP$RO-NMA-2024-SP0577$RO-TEVA-VS-3246891$TEVA$$66$YR$$F$Y$$$20240930$$PH$RO$RO
243763861$24376386$1$I$20240708$20240924$20240930$20240930$EXP$$EG-SA-2024SA279373$SANOFI AVENTIS$$68$YR$E$M$Y$$$20240930$$HP$EG$EG
243763871$24376387$1$I$$20240925$20240930$20240930$EXP$$US-SHIRE-US201922691AA$TAKEDA$$$$$F$Y$$$20240930$$HP$US$US
243763881$24376388$1$I$20230829$20240926$20240926$20240926$DIR$720033$$FDA-CTU$$93$YR$$M$N$90$KG$20240926$N$PH$US$
243763891$24376389$1$I$20230915$20240926$20240926$20240926$DIR$720053$$FDA-CTU$$68$YR$$M$N$84$KG$20240926$N$PH$US$
243763901$24376390$1$I$20230627$20240926$20240926$20240926$DIR$720056$$FDA-CTU$$37$YR$$M$N$$$20240926$N$PH$US$
243763911$24376391$1$I$20240828$20240923$20240930$20240930$EXP$FR-AFSSAPS-LM2024000514$FR-TEVA-VS-3246789$TEVA$$45$YR$$F$Y$$$20240930$$PH$FR$FR
243763921$24376392$1$I$$20240925$20240930$20240930$EXP$$CA-JNJFOC-20240970774$JOHNSON AND JOHNSON$$88$YR$E$M$Y$$$20240930$$PH$CA$CA
243763931$24376393$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011165$APOTEX$$33$YR$$F$Y$$$20240930$$CN$CA$CA
243763941$24376394$1$I$20240101$20240920$20240930$20240930$EXP$$US-ABBVIE-5938709$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243763951$24376395$1$I$$20240913$20240930$20240930$30DAY$$TR-JNJFOC-20240973240$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$TR$TR
243763961$24376396$1$I$20240701$20240922$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-047149$AUROBINDO$$66$YR$$M$Y$87$KG$20240930$$CN$GB$GB
243763971$24376397$1$I$$20240926$20240930$20240930$EXP$$US-SA-2024SA280283$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240930$$HP$US$US
243763981$24376398$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000093763$ROCHE$$58$YR$A$F$Y$$$20240930$$HP$US$US
243764001$24376400$1$I$$20240924$20240930$20240930$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001952$BLUEPRINT MEDICINES$$$$$F$Y$$$20240930$$CN$US$US
243764011$24376401$1$I$20201030$20240920$20240930$20240930$EXP$$IT-AUROBINDO-AUR-APL-2024-047524$AUROBINDO$$64$YR$$M$Y$77$KG$20240930$$MD$IT$IT
243764022$24376402$2$F$$20240927$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US083733$SANDOZ$$$$$M$Y$$$20240930$$CN$US$US
243764031$24376403$1$I$$20240927$20240930$20240930$EXP$GB-MHRA-MED-202409271424381580-VFKQY$GB-SANDOZ INC.-SDZ2024GB083680$SANDOZ$$24$YR$$M$Y$79$KG$20240930$$HP$GB$GB
243764051$24376405$1$I$20240822$20240918$20240930$20240930$EXP$$FR-TAKEDA-2024TUS095857$TAKEDA$$69$YR$$M$Y$72$KG$20240930$$MD$FR$FR
243764061$24376406$1$I$$20231213$20240930$20240930$PER$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-425718$RANBAXY$$$$$F$Y$$$20240930$$MD$US$US
243764071$24376407$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153698$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240930$$CN$US$US
243764081$24376408$1$I$20240926$20240927$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153921$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240930$$CN$US$US
243764091$24376409$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024AMR117956$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243764111$24376411$1$I$$20240924$20240930$20240930$EXP$$CA-HALEON-2198449$Haleon PLC$$53$YR$$M$Y$$$20240928$$HP$CA$CA
243764121$24376412$1$I$$20240913$20240930$20240930$30DAY$$ES-JNJFOC-20240956654$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$ES$ES
243764131$24376413$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093150$ROCHE$$45$YR$A$M$Y$$$20240930$$HP$US$US
243764141$24376414$1$I$$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024191683$AMGEN$$$$$F$Y$$$20240930$$MD$US$US
243764151$24376415$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117111$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$CN$US$US
243764161$24376416$1$I$20240901$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153644$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240930$$PH$US$US
243764171$24376417$1$I$20240811$20240924$20240930$20240930$EXP$$US-ABBVIE-5938514$ABBVIE$$71$YR$$F$Y$$$20240930$$CN$US$US
243764181$24376418$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5940684$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243764191$24376419$1$I$20240917$20240925$20240930$20240930$EXP$$US-ABBVIE-5940803$ABBVIE$$49$YR$$F$Y$$$20240930$$CN$US$US
243764201$24376420$1$I$$20240924$20240930$20240930$EXP$$US-TAKEDA-2024TUS095197$TAKEDA$$$$$F$Y$$$20240930$$CN$US$US
243764211$24376421$1$I$20230129$20240926$20240930$20240930$EXP$$GR-ABBVIE-5943461$ABBVIE$$86$YR$$M$Y$45$KG$20240930$$MD$GR$GR
243764221$24376422$1$I$20231001$20240923$20240930$20240930$EXP$$EG-SANDOZ INC.-SDZ2024EG061203$SANDOZ$$13$YR$$F$Y$54$KG$20240930$$CN$EG$EG
243764231$24376423$1$I$$20240924$20240930$20240930$EXP$$DE-GSK-DE2024GSK118961$GLAXOSMITHKLINE$Alexander T. Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus. New England Journal of Medicine-2024. 2024$$$$$Y$$$20240930$$MD$DE$DE
243764241$24376424$1$I$20240801$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153757$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240930$$CN$US$US
243764251$24376425$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153446$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$69.85$KG$20240930$$CN$US$US
243764261$24376426$1$I$$20240924$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US083094$SANDOZ$CHERABUDDI M., ALJBOUR ALMAJALI D.I.N.A., CHAO S., COHEN A.V.I.. CAN METHOTREXATE TOXICITY OCCUR DESPITE A LOW-DOSE REGIMEN AND NORMAL THERAPEUTIC LEVELS?. CHEST 2024 Annual Meeting Abstracts. 2024;Issue 4, Vol: 1:A2779$$$E$M$Y$$$20240930$$HP$US$US
243764271$24376427$1$I$20220101$20240920$20240930$20240930$EXP$$RO-AUROBINDO-AUR-APL-2024-047386$AUROBINDO$$59$YR$$$Y$$$20240930$$MD$RO$RO
243764281$24376428$1$I$20240923$20240926$20240930$20240930$PER$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-153350$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240930$$PH$PR$PR
243764291$24376429$1$I$$20240924$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US083191$SANDOZ$ARMIJO-ALBA J., RADAELLI M., HOLLEY A.B. INVASIVE PULMONARY ASPERGILLOSIS LEADING TO ACUTE HYPOXIC RESPIRATORY FAILURE AND POLYMORPHIC VENTRICULARTACHYCARDIA IN A HEART TRANSPLANT PATIENT. Chest. 2024;166:A6322$62$YR$$F$Y$$$20240930$$HP$US$US
243764301$24376430$1$I$$20240923$20240930$20240930$EXP$$US-GSK-US2024GSK118415$GLAXOSMITHKLINE$Rahman A, Hansen CK, Pikman P. Pneumocystis pneumonia despite atovaquone prophylaxis in a patient on long-term corticosteroids. Chest. 2024;166(4):A931-A932$$$$$Y$$$20240930$$HP$US$US
243764311$24376431$1$I$20240816$20240920$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-046875$AUROBINDO$$84$YR$$M$Y$$$20240930$$MD$GB$GB
243764321$24376432$1$I$$20240923$20240930$20240930$PER$$US-ROCHE-10000088714$ROCHE$Usman S, Cheema M, Ghuman Z, Mustafa S, Iftikhar A. Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma Concurrent With Nonalcoholic Steatohepatitis: Coincidence Or Causal Connection?. Chest. 2024;166 (4):A2321-2. doi:10.1016/j.chest.2024.06.1423.$53$YR$A$F$Y$$$20240930$$HP$US$US
243764331$24376433$1$I$20230925$20231010$20240930$20240930$EXP$$US-SSPHARMA-US-VDP-2023-017108$SS PHARMA$$$$$$Y$$$20240930$$CN$US$US
243764341$24376434$1$I$20240101$20240926$20240930$20240930$PER$$US-GILEAD-2024-0689128$GILEAD$$45$YR$A$F$Y$$$20240930$$MD$US$US
243764351$24376435$1$I$$20240923$20240930$20240930$EXP$$CA-TOLMAR, INC.-24CA052790$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
243764361$24376436$1$I$$20240920$20240930$20240930$EXP$$CA-TOLMAR, INC.-24CA052741$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
243764371$24376437$1$I$$20240918$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005766$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243764381$24376438$1$I$20240923$20240924$20240930$20240930$30DAY$$BR-AMGEN-BRASP2024191140$AMGEN$$$$$$Y$$$20240930$$PH$BR$BR
243764391$24376439$1$I$20240925$20240925$20240930$20240930$EXP$$JP-ABBVIE-5939904$ABBVIE$$$$$$Y$$$20240930$$PH$JP$JP
243764401$24376440$1$I$$20240925$20240930$20240930$PER$$NVSC2024US191853$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
243764411$24376441$1$I$20200101$20240321$20240930$20240930$EXP$$BG-TEVA-VS-3241274$TEVA$Keratinocyte cancers, dysplastic nevi and cutaneous melanoma ?development after intake of potentially nitrosamine/NDSRIs con- ?taminated drugs: new data. Important links to photo-(nitroso-) car- cinogenesis and pharmaco-oncogenesis$88$YR$$F$Y$$$20240930$$HP$BG$BG
243764421$24376442$1$I$20240428$20240919$20240930$20240930$EXP$$JP-AMGEN-JPNNI2024193078$AMGEN$$84$YR$E$F$Y$47.7$KG$20240930$$MD$JP$JP
243764451$24376445$1$I$20240909$20240922$20240930$20240930$EXP$GB-MHRA-MED-202409220457409950-CTYMK$GB-HIKMA PHARMACEUTICALS USA INC.-GB-H14001-24-08889$HIKMA$$84$YR$$F$Y$$$20240930$$MD$GB$GB
243764471$24376447$1$I$$20240918$20240930$20240930$EXP$$PL-Accord-448412$ACCORD$Jankowski, T. Long-term response of a patient with metastatic lung squamous cell carcinoma with PD-L1 expression below 1% to pembrolizumab therapy. W PRAKTYCE KLINICZNEJ - EDUKACJA. 2024;10(Supl. C):C55-C58$69$YR$E$M$Y$$$20240930$$MD$PL$PL
243764481$24376448$1$I$$20240918$20240930$20240930$EXP$$US-SANDOZ INC.-NVSC2023US080690$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
243764491$24376449$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154054$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240930$$CN$US$US
243764501$24376450$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-046974$AUROBINDO$$59$YR$$M$Y$$$20240930$$CN$CA$CA
243764511$24376451$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005539$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243764521$24376452$1$I$$20240925$20240930$20240930$EXP$$PL-SANDOZ INC.-SDZ2024PL082906$SANDOZ$$31$YR$$F$Y$$$20240930$$MD$PL$PL
243764531$24376453$1$I$20230318$20240926$20240926$20240926$DIR$720037$$FDA-CTU$$83$YR$$M$N$87$KG$20240926$N$PH$US$
243764541$24376454$1$I$20230820$20240926$20240926$20240926$DIR$720075$$FDA-CTU$$70$YR$$M$N$87$KG$20240926$N$PH$US$
243764551$24376455$1$I$20240909$20240920$20240930$20240930$EXP$ES-AEMPS-1571605$ES-BIOCON BIOLOGICS LIMITED-BBL2024007074$BIOCON$$$$$$Y$$$20240930$$PH$ES$ES
243764561$24376456$1$I$$20240916$20240930$20240930$EXP$$US-INSMED, INC.-2024-03767-US$INSMED$$$$$F$Y$$$20240930$$CN$US$US
243764571$24376457$1$I$20230803$20240926$20240926$20240926$DIR$720054$$FDA-CTU$$64$YR$$M$N$68$KG$20240926$N$HP$US$
243764581$24376458$1$I$$20240917$20240930$20240930$EXP$$US-PADAGIS-2024PAD01517$PADAGIS$$$$$$Y$$$20240930$$CN$US$US
243764591$24376459$1$I$$20240916$20240930$20240930$EXP$$US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-08763$HIKMA$$$$$F$Y$$$20240930$$CN$US$US
243764601$24376460$1$I$20230513$20240926$20240926$20240926$DIR$720044$$FDA-CTU$$67$YR$$M$N$$$20240926$N$HP$US$
243764611$24376461$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66936$$FDA-CTU$$62$YR$$F$N$$$20240927$N$HP$US$
243764631$24376463$1$I$20231101$20240924$20240930$20240930$EXP$$BR-EMD Serono-2024051497$EMD SERONO INC$$67$YR$E$M$Y$$$20240930$$MD$BR$BR
243764641$24376464$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66959$$FDA-CTU$$41$YR$$M$N$$$20240927$N$HP$US$
243764651$24376465$1$I$20230610$20240926$20240926$20240926$DIR$720035$$FDA-CTU$$76$YR$$M$N$107$KG$20240926$N$HP$US$
243764661$24376466$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67092$$FDA-CTU$$60$YR$$M$N$$$20240927$N$$US$
243764671$24376467$1$I$$20240924$20240930$20240930$EXP$$CA-ROCHE-10000089766$ROCHE$$52$YR$A$F$Y$$$20240930$$HP$CA$CA
243764681$24376468$1$I$20240919$20240919$20240930$20240930$PER$$US-ABBVIE-5934233$ABBVIE$$47$YR$$M$Y$$$20240930$$CN$US$US
243764691$24376469$1$I$20230518$20240926$20240926$20240926$DIR$720073$$FDA-CTU$$67$YR$$M$N$$$20240926$N$HP$US$
243764701$24376470$1$I$20240920$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67036$$FDA-CTU$$75$YR$$M$N$$$20240927$N$HP$US$
243764721$24376472$1$I$20240927$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67072$$FDA-CTU$$74$YR$$M$N$$$20240927$Y$HP$US$
243764731$24376473$1$I$$20240926$20240930$20240930$PER$$ZA-REGENERON PHARMACEUTICALS, INC.-2024-129756$REGENERON$$$$$M$Y$$$20240930$$MD$ZA$ZA
243764741$24376474$1$I$$20240924$20240930$20240930$PER$$US-ROCHE-10000091016$ROCHE$$$$$$Y$$$20240930$$CN$US$US
243764751$24376475$1$I$$20240927$20240930$20240930$EXP$$US-MYLANLABS-2024M1087872$MYLAN$$$$$$Y$$$20240930$$LW$US$US
243764761$24376476$1$I$20240911$20240927$20240930$20240930$EXP$$SE-MYLANLABS-2024M1086653$MYLAN$$71$YR$$M$Y$$$20240930$$MD$SE$SE
243764771$24376477$1$I$$20240920$20240930$20240930$PER$$US-ROCHE-10000088964$ROCHE$$$$E$F$Y$$$20240930$$CN$US$US
243764781$24376478$1$I$$20240919$20240930$20240930$EXP$$CA-ASTRAZENECA-202409CAN004345CA$ALEXION PHARMACEUTICALS$$23$YR$A$$Y$$$20240930$$$CA$CA
243764791$24376479$1$I$20240616$20240924$20240930$20240930$EXP$$US-MYLANLABS-2024M1087392$MYLAN$$36$YR$$F$Y$$$20240930$$MD$US$US
243764801$24376480$1$I$20240901$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024192300$AMGEN$$$$$M$Y$$$20240930$$MD$US$US
243764811$24376481$1$I$$20240924$20240930$20240930$EXP$$JP-AMGEN-JPNSP2024190782$AMGEN$$$$$$Y$$$20240930$$MD$JP$JP
243764831$24376483$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247123$TEVA$$62$YR$$M$Y$$$20240930$$HP$CA$CA
243764841$24376484$1$I$$20240910$20240930$20240930$EXP$$US-SA-2024SA278362$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
243764851$24376485$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153424$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20240930$$HP$US$US
243764861$24376486$1$I$$20240927$20240930$20240930$PER$$US-TAKEDA-2024TUS096417$TAKEDA$$$$$F$Y$$$20240930$$CN$US$US
243764871$24376487$1$I$20240901$20240924$20240930$20240930$EXP$$CN-BAYER-2024A137475$BAYER$$43$YR$A$F$Y$55$KG$20240930$$HP$CN$CN
243764881$24376488$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000092079$ROCHE$$91$YR$E$M$Y$$$20240930$$CN$US$US
243764911$24376491$1$I$$20240924$20240930$20240930$EXP$$US-AMGEN-USASP2024192055$AMGEN$$$$E$F$Y$$$20240930$$MD$US$US
243764921$24376492$1$I$$20240916$20240930$20240930$EXP$$BR-EPICPHARMA-BR-2024EPCLIT01138$EPIC PHARM$Luiz Euribel Prestes-Carneiro.Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report.Pathogens.SEP-2023;12 No.9:1-8$33$YR$A$M$Y$$$20240930$$HP$BR$BR
243764931$24376493$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5940617$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243764941$24376494$1$I$20240813$20240927$20240930$20240930$EXP$$US-GILEAD-2024-0689258$GILEAD$$27$YR$A$M$Y$$$20240930$$HP$US$US
243764981$24376498$1$I$$20240924$20240930$20240930$EXP$FR-AFSSAPS-GR2024001107$FR-MYLANLABS-2024M1086830$MYLAN$$58$YR$$M$Y$$$20240930$$MD$FR$FR
243765001$24376500$1$I$$20240925$20240930$20240930$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-129687$REGENERON$$$$$M$Y$$$20240930$$MD$US$US
243765011$24376501$1$I$$20240920$20240930$20240930$EXP$$PL-REGENERON PHARMACEUTICALS, INC.-2024-130205$REGENERON$$80$YR$$M$Y$$$20240930$$MD$PL$PL
243765021$24376502$1$I$20230801$20240926$20240926$20240926$DIR$720064$$FDA-CTU$$79$YR$$M$N$134$KG$20240926$N$HP$US$
243765051$24376505$1$I$20240605$20240610$20240930$20240930$PER$$US-PERRIGO-24US005648$PERRIGO$$$$$M$Y$$$20240930$$CN$US$US
243765061$24376506$1$I$$20240625$20240930$20240930$PER$$US-PERRIGO-24US006223$PERRIGO$$$$$F$Y$$$20240930$$CN$US$US
243765071$24376507$1$I$$20240927$20240927$20240927$DIR$720372$$FDA-CTU$$46$YR$$F$N$$$20240927$N$CN$US$
243765081$24376508$1$I$20231101$20240926$20240926$20240926$DIR$720050$$FDA-CTU$$71$YR$$M$N$97$KG$20240926$N$HP$US$
243765101$24376510$1$I$20230101$20231113$20240930$20240930$PER$$US-PERRIGO-23US013079$PERRIGO$$$$$F$Y$$$20240930$$CN$US$US
243765111$24376511$1$I$20231114$20231116$20240930$20240930$PER$$US-PERRIGO-23US013265$PERRIGO$$$$A$$Y$$$20240930$$CN$US$US
243765121$24376512$1$I$20240107$20240108$20240930$20240930$PER$$US-PERRIGO-24US000280$PERRIGO$$$$A$$Y$$$20240930$$CN$US$US
243765131$24376513$1$I$20240716$20240716$20240930$20240930$PER$$US-PERRIGO-24US006769$PERRIGO$$89$YR$$F$Y$61.224$KG$20240930$$CN$US$US
243765141$24376514$1$I$$20240927$20240927$20240927$DIR$720388$$FDA-CTU$$$$$UNK$N$$$20240927$$CN$US$
243765151$24376515$1$I$20230512$20240926$20240926$20240926$DIR$720047$$FDA-CTU$$73$YR$$M$N$$$20240926$N$HP$US$
243765171$24376517$1$I$20230321$20240926$20240926$20240926$DIR$720067$$FDA-CTU$$52$YR$$M$N$107$KG$20240926$N$HP$US$
243765181$24376518$1$I$20240516$20240516$20240930$20240930$PER$$US-PERRIGO-24US004815$PERRIGO$$80$YR$$M$Y$58.957$KG$20240930$$CN$US$US
243765191$24376519$1$I$$20240610$20240930$20240930$PER$$US-PERRIGO-24US005669$PERRIGO$$$$A$$Y$$$20240930$$CN$US$US
243765201$24376520$1$I$20230101$20231010$20240930$20240930$PER$$US-PERRIGO-23US011918$PERRIGO$$$$A$$Y$$$20240930$$CN$US$US
243765221$24376522$1$I$20230918$20240926$20240926$20240926$DIR$720076$$FDA-CTU$$79$YR$$M$N$93$KG$20240926$N$PH$US$
243765231$24376523$1$I$20231004$20240926$20240926$20240926$DIR$720057$$FDA-CTU$$61$YR$$F$N$86$KG$20240926$N$PH$US$
243765241$24376524$1$I$20240502$20240619$20240930$20240930$PER$$US-PERRIGO-24US005944$PERRIGO$$89$YR$$F$Y$56.689$KG$20240930$$CN$US$US
243765251$24376525$1$I$20240201$20240215$20240930$20240930$PER$$US-PERRIGO-24US001708$PERRIGO$$$$A$$Y$$$20240930$$CN$US$US
243765271$24376527$1$I$20230828$20240926$20240926$20240926$DIR$720038$$FDA-CTU$$65$YR$$M$N$78$KG$20240926$N$PH$US$
243765281$24376528$1$I$20230901$20240321$20240930$20240930$PER$$US-PERRIGO-24US002920$PERRIGO$$84$YR$$F$Y$72.562$KG$20240930$$CN$US$US
243765291$24376529$1$I$20240502$20240516$20240930$20240930$PER$$US-PERRIGO-24US004821$PERRIGO$$$$$M$Y$$$20240930$$CN$US$US
243765301$24376530$1$I$20240220$20240221$20240930$20240930$PER$$US-PERRIGO-24US001883$PERRIGO$$$$$$Y$$$20240930$$CN$US$US
243765321$24376532$1$I$20231201$20240205$20240930$20240930$PER$$US-PERRIGO-24US001350$PERRIGO$$80$YR$$F$Y$66.667$KG$20240930$$CN$US$US
243765331$24376533$1$I$$20240919$20240930$20240930$EXP$$FR-Merck Healthcare KGaA-2023495334$MERCK KGAA$$$$$F$Y$$$20240925$$CN$FR$FR
243765341$24376534$1$I$$20240916$20240930$20240930$EXP$$FR-Merck Healthcare KGaA-2024049784$MERCK KGAA$$$$$F$Y$$$20240924$$CN$FR$FR
243765351$24376535$1$I$$20240922$20240930$20240930$EXP$$IL-Merck Healthcare KGaA-2024050695$MERCK KGAA$$$$$F$Y$$$20240926$$CN$IL$IL
243765361$24376536$1$I$$20240919$20240930$20240930$EXP$$DE-TAKEDA-2024TUS094272$TAKEDA$$22$YR$$F$Y$90$KG$20240930$$CN$DE$DE
243765381$24376538$1$I$20230601$20240919$20240930$20240930$EXP$$CN-BLUEPRINT MEDICINES CORPORATION-2024BUS004550$Unknown Manufacturer$$$$$$Y$$$20240927$$CN$CN$CN
243765391$24376539$1$I$20201102$20240923$20240930$20240930$EXP$PL-URPL-1-3178-2020$PL-FreseniusKabi-FK202414287$FRESENIUS KABI$$66$YR$E$F$Y$83.6$KG$20240930$$HP$PL$PL
243765401$24376540$1$I$20240806$20240923$20240930$20240930$EXP$FR-AFSSAPS-LY2024001322$FR-FreseniusKabi-FK202414298$FRESENIUS KABI$$31$YR$A$F$Y$41.5$KG$20240930$$PH$FR$FR
243765411$24376541$1$I$$20240925$20240930$20240930$PER$$US-009507513-2409USA009036$MERCK$Chilingarashvili G, Mohan A, Lazar R. Daptomycin-induced acute eosinophilic pneumonia. Chest. 2024;166(4):A3473-4$81$YR$$M$Y$$$20240930$$HP$US$US
243765421$24376542$1$I$$20240923$20240930$20240930$EXP$$US-HALEON-2198648$Haleon PLC$$30$YR$$F$Y$$$20240928$$HP$US$US
243765431$24376543$1$I$$20240905$20240930$20240930$PER$$US-Eisai-EC-2024-174247$EISAI$$$$E$F$Y$$$20240930$$MD$US$US
243765441$24376544$1$I$$20240923$20240930$20240930$EXP$$CA-FreseniusKabi-FK202414331$FRESENIUS KABI$$50$YR$A$M$Y$55$KG$20240930$$HP$CA$CA
243765451$24376545$1$I$20240701$20240905$20240930$20240930$PER$$US-Eisai-EC-2024-173959$EISAI$$73$YR$E$F$Y$$$20240930$$MD$US$US
243765461$24376546$1$I$20240710$20240923$20240930$20240930$PER$$US-ABBVIE-5940234$ABBVIE$$28$YR$$F$Y$$$20240930$$MD$US$US
243765471$24376547$1$I$20240812$20240924$20240930$20240930$PER$$US-ABBVIE-5939684$ABBVIE$$27$YR$$F$Y$$$20240930$$MD$US$US
243765491$24376549$1$I$$20240910$20240930$20240930$PER$$US-TEVA-VS-3242636$TEVA$$78$YR$$F$Y$$$20240930$$CN$US$US
243765501$24376550$1$I$20230901$20240924$20240930$20240930$EXP$FR-AFSSAPS-AN2024001270$FR-MYLANLABS-2024M1087453$MYLAN$$19$YR$$M$Y$71.4$KG$20240930$$PH$FR$FR
243765521$24376552$1$I$$20240923$20240930$20240930$EXP$$SE-TEVA-VS-3248267$TEVA$Adra J, Giglio D, Karlsson P, Zetterberg H, Einbeigi Z. Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy. Acta-Oncol 2024; 63 636-641.$$$$F$Y$$$20240930$$HP$SE$SE
243765531$24376553$1$I$$20240926$20240930$20240930$PER$$US-ABBVIE-5942526$ABBVIE$$$$$$Y$$$20240930$$CN$US$US
243765551$24376555$1$I$$20240920$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09564$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243765561$24376556$1$I$$20240925$20240930$20240930$EXP$$US-BAYER-2024A137778$BAYER$$$$$$Y$$$20240930$$CN$US$US
243765571$24376557$1$I$20240221$20240923$20240930$20240930$EXP$FR-AFSSAPS-BR2024000754$FR-TEVA-VS-3246902$TEVA$$80$YR$$M$Y$79$KG$20240930$$MD$FR$FR
243765581$24376558$1$I$20240101$20240925$20240930$20240930$EXP$$US-SA-2024SA278799$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240930$$HP$US$US
243765591$24376559$1$I$20240701$20240925$20240930$20240930$EXP$$US-SA-2024SA279658$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240930$$CN$US$US
243765601$24376560$1$I$$20240926$20240930$20240930$EXP$GB-MHRA-MED-202409262219435580-MVCFK$GB-SANDOZ INC.-SDZ2024GB083442$SANDOZ$$$$$F$Y$$$20240930$$HP$GB$GB
243765611$24376561$1$I$$20240918$20240930$20240930$PER$$US-ALKERMES INC.-ALK-2024-002437$ALKERMES$$55$YR$$M$Y$$$20240930$$MD$US$US
243765621$24376562$1$I$20240101$20240925$20240930$20240930$EXP$$US-SA-2024SA278768$SANOFI AVENTIS$$$$E$M$Y$$$20240930$$MD$US$US
243765631$24376563$1$I$20240701$20240925$20240930$20240930$EXP$$US-SA-2024SA278777$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240930$$HP$US$US
243765641$24376564$1$I$$20240924$20240930$20240930$EXP$PL-URPL-2-881-2019$PL-MYLANLABS-2024M1086945$MYLAN$$58$YR$$M$Y$92$KG$20240930$$CN$PL$PL
243765651$24376565$1$I$20230701$20240927$20240930$20240930$PER$$US-JNJFOC-20240980418$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243765661$24376566$1$I$20240501$20240925$20240930$20240930$EXP$$US-SA-2024SA280295$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240930$$HP$US$US
243765671$24376567$1$I$20240907$20240923$20240930$20240930$EXP$$CN-FreseniusKabi-FK202414349$FRESENIUS KABI$$66$YR$E$F$Y$$$20240930$$HP$CN$CN
243765681$24376568$1$I$20240910$20240910$20240930$20240930$30DAY$$CA-JNJFOC-20240950452$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240930$$HP$CA$CA
243765691$24376569$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247102$TEVA$$$$$$Y$$$20240930$$PH$CA$CA
243765701$24376570$1$I$$20240905$20240930$20240930$PER$$US-Eisai-EC-2024-174031$EISAI$$72$YR$E$$Y$$$20240930$$MD$US$US
243765711$24376571$1$I$20240624$20240925$20240930$20240930$EXP$FR-AFSSAPS-NT2024001064$FR-SA-2024SA281017$SANOFI AVENTIS$$60$YR$A$M$Y$82$KG$20240930$$PH$FR$FR
243765721$24376572$1$I$20240901$20240925$20240930$20240930$EXP$$US-SA-2024SA279543$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240930$$HP$US$US
243765731$24376573$1$I$$20240920$20240930$20240930$EXP$$US-BEH-2024179165$CSL BEHRING$$$$E$M$Y$$$20240930$$HP$US$US
243765741$24376574$1$I$20240901$20240925$20240930$20240930$EXP$$US-Eisai-EC-2024-175502$EISAI$$64$YR$A$M$Y$114$KG$20240930$$CN$US$US
243765751$24376575$1$I$$20240925$20240930$20240930$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005329$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240930$$CN$US$US
243765771$24376577$1$I$20240901$20240925$20240930$20240930$EXP$$US-AMGEN-USASP2024191267$AMGEN$$$$$F$Y$$$20240930$$CN$US$US
243765781$24376578$1$I$$20240925$20240930$20240930$PER$$US-009507513-2409USA009172$MERCK$Sultan M, Fazeel HM, Afzal MS, Salahuddin ESSA, Chaudhary SM. An unusual case of daptomycin-induced acute eosinophilic pneumonia. Chest. 2024;166(4):A3497-8$69$YR$$M$Y$$$20240930$$HP$US$US
243765791$24376579$1$I$$20240924$20240930$20240930$PER$$US-AMGEN-USASP2024191135$AMGEN$$$$$M$Y$$$20240930$$PH$US$US
243765801$24376580$1$I$$20240924$20240930$20240930$PER$$US-AMGEN-USASP2024191562$AMGEN$$$$$$Y$$$20240930$$PH$US$US
243765811$24376581$1$I$$20240922$20240930$20240930$EXP$$IL-TAKEDA-2024TUS095497$TAKEDA$$$$$F$Y$$$20240930$$CN$IL$IL
243765821$24376582$1$I$20240101$20240926$20240930$20240930$EXP$$US-SA-2024SA279915$SANOFI AVENTIS$$$$A$M$Y$$$20240930$$MD$US$US
243765831$24376583$1$I$$20240925$20240930$20240930$EXP$$CN-BAYER-2024A137781$BAYER$$67$YR$E$M$Y$$$20240930$$HP$CN$CN
243765841$24376584$1$I$$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153240$BRISTOL MYERS SQUIBB$Viggiano M, Li S. Cytokine storm: hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia and non-small cell lung cancer on immune checkpoint inhibitor. Chest. 2024;166(4S):A3016-7. doi:10.1016/j.chest.2024.06.1815.$71$YR$E$F$Y$$$20240930$$HP$US$US
243765851$24376585$1$I$20240601$20240924$20240930$20240930$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-152929$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240930$$MD$DE$DE
243765861$24376586$1$I$$20240923$20240930$20240930$EXP$$IN-BRISTOL-MYERS SQUIBB COMPANY-2024-151561$BRISTOL MYERS SQUIBB$Bhatt N, Nepal S, Tejani M. Are immune-related toxicities good news in disguise? a rare occurrence of nivolumab-induced pericardial effusion in metastatic esophageal cancer. Chest. 2024;166(4S):628A.doi:10.1016/j.chest.2024.06.427.$73$YR$E$M$Y$$$20240930$$HP$IN$IN
243765871$24376587$1$I$20240828$20240917$20240930$20240930$EXP$IT-MINISAL02-1001958$IT-HIKMA PHARMACEUTICALS USA INC.-IT-H14001-24-08781$HIKMA$$54$YR$$M$Y$69$KG$20240930$$MD$IT$IT
243765881$24376588$1$I$$20240919$20240930$20240930$EXP$$IE-ROCHE-10000086478$ROCHE$$$$$M$Y$$$20240930$$CN$IE$IE
243765901$24376590$1$I$$20240919$20240930$20240930$EXP$$BR-OTSUKA-2024_026701$OTSUKA$$$$$$Y$$$20240930$$MD$BR$BR
243765921$24376592$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5939465$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243765931$24376593$1$I$20240912$20240923$20240930$20240930$EXP$$BR-GSK-BR2024AMR118320$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$BR$BR
243765941$24376594$1$I$20240718$20240923$20240930$20240930$EXP$$SG-GSK-SG2024APC117937$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$SG$SG
243765951$24376595$1$I$$20240906$20240930$20240930$EXP$$GB-ACRAF SpA-2024-035713$SK LIFE SCIENCE$$$$$$Y$$$20240930$$HP$GB$GB
243765961$24376596$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247100$TEVA$$$$$$Y$$$20240930$$PH$CA$CA
243765971$24376597$1$I$20240331$20240927$20240930$20240930$EXP$$US-ABBVIE-5943973$ABBVIE$$72$YR$$M$Y$$$20240930$$CN$US$US
243765991$24376599$1$I$20240101$20240924$20240930$20240930$EXP$$US-ABBVIE-5939125$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243766001$24376600$1$I$20240101$20240925$20240930$20240930$PER$$US-ABBVIE-5941272$ABBVIE$$63$YR$$M$Y$$$20240930$$MD$US$US
243766011$24376601$1$I$$20240925$20240930$20240930$PER$$US-009507513-2409USA009287$MERCK$Vaqar M, Kharkongor N, Aravind C, Baby D, Singh S. PROSTHETIC VALVE ENDOCARDITIS COMPLICATED BY POLYMICROBIAL INFECTION: A CHALLENGING CLINICAL SCENARIO. Chest. 2024;166 (4):650A-1A$71$YR$$F$Y$$$20240930$$HP$US$US
243766021$24376602$1$I$$20240916$20240930$20240930$EXP$$SI-MYLANLABS-2024M1084558$MYLAN$$$$$F$Y$$$20240930$$MD$SI$SI
243766031$24376603$1$I$$20240915$20240930$20240930$PER$$US-LEADINGPHARMA-US-2024LEASPO00437$LEADING PHARMA$$78$YR$E$F$Y$$$20240930$$CN$US$US
243766071$24376607$1$I$20231101$20240924$20240930$20240930$EXP$$US-ABBVIE-5930235$ABBVIE$$75$YR$$M$Y$91.171$KG$20240930$$CN$US$US
243766081$24376608$1$I$$20240920$20240930$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409013968$ELI LILLY AND CO$$67$YR$E$F$Y$$$20240930$$CN$US$US
243766091$24376609$1$I$20220920$20240920$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409014022$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240930$$CN$US$US
243766101$24376610$1$I$$20240918$20240930$20240930$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409012350$ELI LILLY AND CO$$$$$$Y$$$20240930$$CN$JP$JP
243766111$24376611$1$I$$20240916$20240930$20240930$EXP$GB-MHRA-MED-202409151253334500-LBWYH$GB-ELI_LILLY_AND_COMPANY-GB202409010355$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240930$$CN$GB$GB
243766121$24376612$1$I$20240925$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018108$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240930$$CN$US$US
243766131$24376613$1$I$20240817$20240918$20240930$20240930$EXP$$ES-ELI_LILLY_AND_COMPANY-ES202409004964$ELI LILLY AND CO$$68$YR$E$M$Y$90.6$KG$20240930$$CN$ES$ES
243766141$24376614$1$I$20240912$20240916$20240930$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409010324$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240930$$CN$US$US
243766161$24376616$1$I$$20240917$20240930$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011746$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240930$$CN$US$US
243766171$24376617$1$I$$20240918$20240930$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409012146$ELI LILLY AND CO$$66$YR$E$$Y$$$20240930$$CN$US$US
243766181$24376618$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016618$ELI LILLY AND CO$$19$YR$A$M$Y$$$20240930$$CN$US$US
243766201$24376620$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151357$BRISTOL MYERS SQUIBB$Guzik G, Bruno D. Pseudo progression of lung adenocarcinoma after neoadjuvant treatment with immunotherapy. Chest. 2024;166(4S):4241A-2A. doi:10.1016/j.chest.2024.06.2572.$79$YR$E$F$Y$$$20240930$$HP$US$US
243766211$24376621$1$I$$20240926$20240930$20240930$EXP$$US-JNJFOC-20240974011$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20240930$$CN$US$US
243766221$24376622$1$I$20240101$20240923$20240930$20240930$EXP$FR-AFSSAPS-AN2024001284$FR-Merck Healthcare KGaA-2024050795$MERCK KGAA$$67$YR$E$F$Y$56$KG$20240930$$MD$FR$FR
243766231$24376623$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247091$TEVA$$$$$$Y$$$20240930$$PH$CA$CA
243766241$24376624$1$I$20240915$20240927$20240930$20240930$EXP$$BG-ABBVIE-5944256$ABBVIE$$61$YR$$M$Y$$$20240930$$HP$BG$BG
243766251$24376625$1$I$$20240925$20240930$20240930$EXP$$IN-SANDOZ INC.-SDZ2024IN083649$SANDOZ$$$$$M$Y$$$20240930$$CN$IN$IN
243766261$24376626$1$I$$20240916$20240930$20240930$EXP$$GB-EPICPHARMA-GB-2024EPCLIT01136$EPIC PHARM$Layla Thurston.The complexities of managing neuropathic pain.British Journal of Diabetes.JUN-2024;24(1):114$75$YR$E$M$Y$$$20240930$$HP$GB$GB
243766271$24376627$1$I$$20240916$20240930$20240930$EXP$$US-SMPA-2024SPA002981$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243766281$24376628$1$I$$20240916$20240930$20240930$EXP$$US-Central Admixture Pharmacy Services, Inc.-2162219$CENTRAL ADMIXTURE PHARMACY SERVICES, INC$$$$$M$Y$2.0455$KG$20240930$$PH$US$US
243766301$24376630$1$I$20240907$20240925$20240930$20240930$EXP$ES-AEMPS-1569621$ES-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2409ES07409$INSUD PHARMA$$30$YR$$F$Y$61$KG$20240930$$CN$ES$ES
243766311$24376631$1$I$20240801$20240920$20240930$20240930$EXP$$PL-EXELTIS PHARMACEUTICAL HOLDING, S.L.-2409PL07319$INSUD PHARMA$$$$$F$Y$$$20240930$$MD$PL$PL
243766321$24376632$1$I$20240925$20240925$20240930$20240930$PER$$US-PFIZER INC-202400264693$PFIZER$$12$YR$$M$Y$$$20240930$$CN$US$US
243766331$24376633$1$I$20240421$20240925$20240930$20240930$EXP$$KR-AMGEN-KORNI2024190976$AMGEN$$66$YR$E$F$Y$$$20240930$$MD$KR$KR
243766351$24376635$1$I$$20240923$20240930$20240930$PER$$US-MYLANLABS-2024M1086987$MYLAN$$$$$F$Y$$$20240930$$CN$US$US
243766361$24376636$1$I$20240912$20240920$20240930$20240930$EXP$$CN-FreseniusKabi-FK202414165$FRESENIUS KABI$$51$YR$A$M$Y$70$KG$20240930$$HP$CN$CN
243766371$24376637$1$I$20231101$20240923$20240930$20240930$EXP$FR-AFSSAPS-DJ2024001013$FR-FreseniusKabi-FK202414351$FRESENIUS KABI$$78$YR$E$F$Y$56$KG$20240930$$MD$FR$FR
243766391$24376639$1$I$20240911$20240924$20240930$20240930$30DAY$$US-AMGEN-USASP2024191057$AMGEN$$37$YR$A$F$Y$$$20240930$$PH$US$US
243766401$24376640$1$I$$20240926$20240930$20240930$PER$$US-JNJFOC-20240973394$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240930$$CN$US$US
243766411$24376641$1$I$20240101$20240925$20240930$20240930$PER$$US-PFIZER INC-202400263810$PFIZER$$40$YR$$F$Y$72.57$KG$20240930$$CN$US$US
243766421$24376642$1$I$$20240920$20240930$20240930$PER$$US-AMGEN-USASP2024190484$AMGEN$Angeles-han S.T.; Maccora I.; Ebert J.J. et al.. Treatment and Visual Outcomes in Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy: A Cohort Study. Ocular Immunology and Inflammation. 2024;1-8$13$YR$T$M$Y$$$20240930$$MD$US$US
243766431$24376643$1$I$20240101$20240926$20240930$20240930$PER$$US-PFIZER INC-202400264883$PFIZER$$$$$F$Y$$$20240930$$CN$US$US
243766441$24376644$1$I$20240925$20240925$20240930$20240930$EXP$$CA-PFIZER INC-202400264865$PFIZER$$64$YR$$M$Y$$$20240930$$HP$CA$CA
243766451$24376645$1$I$$20240924$20240930$20240930$30DAY$$US-PFIZER INC-202400265755$PFIZER$$9$YR$$M$Y$$$20240930$$CN$US$US
243766471$24376647$1$I$$20240909$20240930$20240930$PER$$US-Eisai-EC-2024-174132$EISAI$$$$$F$Y$$$20240930$$HP$US$US
243766481$24376648$1$I$20230622$20240910$20240930$20240930$PER$$US-Eisai-EC-2023-143515$EISAI$$80$YR$E$M$Y$$$20240930$$CN$US$US
243766491$24376649$1$I$$20240920$20240930$20240930$EXP$$NVSC2024CA192203$NOVARTIS$$57$YR$$$Y$$$20240930$$MD$CA$CA
243766501$24376650$1$I$$20240920$20240930$20240930$EXP$$BR-UCBSA-2024049738$UCB$$$$$F$Y$$$20240930$$CN$BR$BR
243766511$24376651$1$I$20240801$20240919$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN009993$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243766521$24376652$1$I$$20240916$20240930$20240930$PER$$US-MARINUS PHARMACEUTICALS, INC.-MAR2024000195$MARINUS PHARMACEUTICALS$$$$$$Y$$$20240930$$CN$US$US
243766531$24376653$1$I$$20240918$20240930$20240930$EXP$$US-SANDOZ INC.-NVSC2023US138474$SANDOZ$$$$$F$Y$57.61$KG$20240930$$MD$US$US
243766541$24376654$1$I$20240101$20240924$20240930$20240930$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053133$BOEHRINGER INGELHEIM$$77$YR$E$M$Y$80$KG$20240930$$CN$ES$ES
243766551$24376655$1$I$20231126$20240923$20240930$20240930$EXP$FR-AFSSAPS-AVBX2024000539$FR-INDIVIOR UK LIMITED-INDV-156568-2024$RECKITT BENCKISER$$$$$$Y$$$20240930$$MD$FR$FR
243766571$24376657$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67057$$FDA-CTU$$59$YR$$F$N$$$20240927$N$$US$
243766581$24376658$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66984$$FDA-CTU$$$$$M$N$$$20240927$N$HP$US$
243766591$24376659$1$I$20240222$20240927$20240927$20240927$DIR$720412$$FDA-CTU$$41$YR$$F$N$90$KG$20240927$N$CN$US$
243766601$24376660$1$I$20240917$20240917$20240930$20240930$EXP$$US-Accord-447823$ACCORD$$57$YR$A$F$Y$$$20240928$$PH$US$US
243766611$24376661$1$I$20230714$20240926$20240926$20240926$DIR$720074$$FDA-CTU$$73$YR$$M$N$69$KG$20240926$N$PH$US$
243766621$24376662$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66951$$FDA-CTU$$49$YR$$F$N$$$20240927$N$$US$
243766631$24376663$1$I$$20240909$20240930$20240930$PER$$US-009507513-2409USA003444$MERCK$$$$$F$Y$$$20240928$$CN$US$US
243766641$24376664$1$I$20240906$20240924$20240930$20240930$EXP$$JP-009507513-2409JPN003547J$MERCK$$63$YR$$F$Y$$$20240928$$PH$JP$JP
243766661$24376666$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67055$$FDA-CTU$$71$YR$$F$N$$$20240927$N$$US$
243766671$24376667$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66935$$FDA-CTU$$54$YR$$M$N$$$20240927$N$$US$
243766681$24376668$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA273650$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240929$$HP$US$US
243766711$24376671$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA273680$SANOFI AVENTIS$$$$A$F$Y$$$20240929$$HP$US$US
243766721$24376672$1$I$$20240920$20240930$20240930$EXP$$DE-AMGEN-DEUSP2024189010$AMGEN$Grabenbaue, GG. Spinal and cervical nodal metastases in a patient with glioblastoma. Strahlentherapie und Onkologie. 2024;200 (9):838-843$54$YR$A$M$Y$$$20240928$$HP$DE$DE
243766731$24376673$1$I$$20240925$20240930$20240930$PER$$US-009507513-2409USA009309$MERCK$$$$$F$Y$$$20240928$$CN$US$US
243766741$24376674$1$I$$20240919$20240930$20240930$EXP$$CO-ALXN-202409SAM008907CO$ALEXION PHARMACEUTICALS$$11$YR$C$$Y$27$KG$20240928$$$CO$CO
243766771$24376677$1$I$20240923$20240927$20240927$20240927$DIR$720373$$FDA-CTU$$60$YR$$M$N$69.9$KG$20240927$N$HP$US$
243766811$24376681$1$I$$20240920$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015004$BEIGENE$$$$$$Y$$$20240928$$HP$CN$CN
243766821$24376682$1$I$20240912$20240920$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015006$BEIGENE$$$$$$Y$$$20240928$$HP$CN$CN
243766831$24376683$1$I$20240815$20240920$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015022$BEIGENE$$$$$$Y$$$20240928$$HP$CN$CN
243766841$24376684$1$I$$20240927$20240927$20240927$DIR$720375$$FDA-CTU$$60$YR$$M$N$$$20240927$N$HP$US$
243766851$24376685$1$I$$20240919$20240930$20240930$EXP$$GB-ASTRAZENECA-202409GBR004546GB$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240928$$$GB$GB
243766861$24376686$1$I$20240830$20240920$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015023$BEIGENE$$$$$$Y$$$20240928$$HP$CN$CN
243766871$24376687$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA277444$SANOFI AVENTIS$$$$A$F$Y$$$20240929$$MD$US$US
243766881$24376688$1$I$$20240919$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US083177$SANDOZ$$$$$$Y$$$20240928$$PH$US$US
243766891$24376689$1$I$$20240925$20240930$20240930$EXP$$US-UNITED THERAPEUTICS-UNT-2024-030520$UNITED THERAPEUTICS$Kerstein JS, Valencia E, Collins S, Ferraro AM, Harrild DM, Gauvreau K, et al.. Transcatheter Ductus Arteriosus Stenting for Acute Pediatric Pulmonary Arterial Hypertension is Associated with Improved Right Ventricular Echocardiography Strain. Pediatr Cardiol. 2024;45(7):1573-1580$3$YR$$$Y$$$20240928$$$US$US
243766901$24376690$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA279562$SANOFI AVENTIS$$$$A$F$Y$78.64$KG$20240929$$MD$US$US
243766911$24376691$1$I$20240829$20240919$20240930$20240930$PER$$US-ABBVIE-5933008$ABBVIE$$39$YR$$F$Y$$$20240929$$HP$US$US
243766921$24376692$1$I$$20240918$20240930$20240930$PER$$US-SA-2024SA272693$SANOFI AVENTIS$$$$T$F$Y$$$20240929$$HP$US$US
243766931$24376693$1$I$20240701$20240923$20240930$20240930$EXP$FR-AFSSAPS-RE2024000908$FR-SANDOZ INC.-SDZ2024FR083324$SANDOZ$$47$YR$$F$Y$59$KG$20240929$$MD$FR$FR
243766941$24376694$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA279580$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240929$$MD$US$US
243766961$24376696$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA277827$SANOFI AVENTIS$$51$YR$A$M$Y$105$KG$20240929$$MD$US$US
243766971$24376697$1$I$$20240923$20240930$20240930$EXP$$US-RDY-SPO/USA/24/0014091$DR REDDYS$$15$YR$T$F$Y$$$20240929$$MD$US$US
243766981$24376698$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA279537$SANOFI AVENTIS$$$$A$F$Y$$$20240929$$MD$US$US
243766991$24376699$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA273764$SANOFI AVENTIS$$26$YR$A$M$Y$$$20240929$$HP$US$US
243767001$24376700$1$I$20240907$20240927$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015407$BEIGENE$$$$$$Y$$$20240929$$HP$CN$CN
243767011$24376701$1$I$20240801$20240906$20240930$20240930$PER$$US-SA-2024SA275338$SANOFI AVENTIS$$74$YR$E$F$Y$86.36$KG$20240929$$MD$US$US
243767021$24376702$1$I$20240923$20240923$20240930$20240930$PER$$US-RDY-SPO/USA/24/0014124$DR REDDYS$$74$YR$E$M$Y$$$20240929$$PH$US$US
243767031$24376703$1$I$$20240920$20240930$20240930$EXP$$HU-ASTRAZENECA-202409EEA003864HU$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240929$$MD$HU$HU
243767041$24376704$1$I$20240904$20240921$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015017$BEIGENE$$$$$$Y$$$20240929$$HP$CN$CN
243767061$24376706$1$I$20240920$20240927$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015406$BEIGENE$$$$$$Y$$$20240929$$HP$CN$CN
243767071$24376707$1$I$20240101$20240909$20240930$20240930$PER$$US-SA-2024SA277384$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240929$$MD$US$US
243767081$24376708$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA273949$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240929$$MD$US$US
243767091$24376709$1$I$20240905$20240918$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013853$DR REDDYS$$$$$$Y$$$20240929$$HP$US$US
243767101$24376710$1$I$20240301$20240916$20240930$20240930$PER$$US-SA-2024SA278351$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240929$$MD$US$US
243767111$24376711$1$I$20240101$20240909$20240930$20240930$PER$$US-SA-2024SA277206$SANOFI AVENTIS$$60$YR$A$F$Y$82.77$KG$20240929$$HP$US$US
243767121$24376712$1$I$20240917$20240918$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013909$DR REDDYS$$61$YR$A$M$Y$$$20240929$$MD$US$US
243767131$24376713$1$I$$20240923$20240930$20240930$EXP$$US-JNJFOC-20240961754$JOHNSON AND JOHNSON$$$$$M$Y$$$20240929$$CN$US$US
243767141$24376714$1$I$$20240918$20240930$20240930$EXP$$US-SANDOZ INC.-NVSC2023US096027$SANDOZ$$$$$M$Y$$$20240929$$MD$US$US
243767151$24376715$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA274856$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240929$$HP$US$US
243767161$24376716$1$I$$20240926$20240930$20240930$PER$$US-HALEON-2199103$Haleon PLC$$$$$$Y$$$20240929$$CN$US$US
243767171$24376717$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA276886$SANOFI AVENTIS$$$$A$M$Y$$$20240929$$CN$US$US
243767181$24376718$1$I$$20240919$20240930$20240930$EXP$$SK-TEVA-VS-3247892$TEVA$Litvin I., Kohutek F. Endovascular embolization of advanced bleeding tumors. Slov. radiol. 2023; 30 (1): 18-24 (Slovak:Litvin I., Kohutek F. Endovaskularna embolizacia pokrocilych krvacajucich nadorov. Slov. radiol. 2023; 30 (1): 18-24).$80$YR$$M$Y$$$20240929$$MD$SK$SK
243767201$24376720$1$I$$20240919$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013861$DR REDDYS$$42$YR$A$F$Y$$$20240929$$MD$US$US
243767211$24376721$1$I$$20240924$20240930$20240930$PER$$US-HALEON-2198918$Haleon PLC$$$$$M$Y$$$20240929$$MD$US$US
243767241$24376724$1$I$$20240912$20240930$20240930$PER$$US-JNJFOC-20240939276$JOHNSON AND JOHNSON$$$$$M$Y$$$20240929$$CN$US$US
243767261$24376726$1$I$20240815$20240919$20240930$20240930$PER$$US-SA-2024SA275714$SANOFI AVENTIS$$59$YR$A$M$Y$73.64$KG$20240929$$MD$US$US
243767271$24376727$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA277743$SANOFI AVENTIS$$$$$F$Y$$$20240929$$CN$US$US
243767281$24376728$1$I$20240101$20240911$20240930$20240930$PER$$US-SA-2024SA279426$SANOFI AVENTIS$$$$$$Y$$$20240929$$CN$US$US
243767291$24376729$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA273138$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240929$$MD$US$US
243767301$24376730$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA277012$SANOFI AVENTIS$$$$A$F$Y$86.63$KG$20240929$$MD$US$US
243767311$24376731$1$I$20230101$20240924$20240930$20240930$PER$$US-JNJFOC-20240968360$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240929$$CN$US$US
243767331$24376733$1$I$$20240909$20240930$20240930$PER$$PR-SA-2024SA276912$SANOFI AVENTIS$$$$T$F$Y$$$20240929$$MD$PR$PR
243767341$24376734$1$I$$20240920$20240930$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR117405$VIIV$$$$A$M$Y$$$20240929$$CN$US$US
243767351$24376735$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA278283$SANOFI AVENTIS$$$$C$F$Y$29.09$KG$20240929$$MD$US$US
243767361$24376736$1$I$20240101$20240924$20240930$20240930$PER$$US-JNJFOC-20240969361$JOHNSON AND JOHNSON$$$$$$Y$$$20240929$$CN$US$US
243767371$24376737$1$I$$20240920$20240930$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR117414$VIIV$$$$A$M$Y$$$20240929$$CN$US$US
243767381$24376738$1$I$20230101$20240909$20240930$20240930$PER$$US-SA-2024SA276522$SANOFI AVENTIS$$62$YR$A$M$Y$127.27$KG$20240929$$MD$US$US
243767391$24376739$1$I$20240914$20240926$20240930$20240930$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2162191$JIANGSU HANSOH PHARMACEUTICAL$$36$YR$$M$Y$79$KG$20240929$$MD$CN$CN
243767401$24376740$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA274981$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240929$$HP$US$US
243767411$24376741$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA277417$SANOFI AVENTIS$$$$A$M$Y$125$KG$20240929$$HP$US$US
243767421$24376742$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA274018$SANOFI AVENTIS$$$$A$M$Y$$$20240929$$MD$US$US
243767431$24376743$1$I$20240801$20240920$20240930$20240930$PER$$US-SA-2024SA274205$SANOFI AVENTIS$$84$YR$E$M$Y$$$20240929$$CN$US$US
243767441$24376744$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274588$SANOFI AVENTIS$$$$E$M$Y$$$20240929$$HP$US$US
243767451$24376745$1$I$20240814$20240924$20240930$20240930$PER$$US-JNJFOC-20240965712$JOHNSON AND JOHNSON$$$$$M$Y$$$20240929$$HP$US$US
243767461$24376746$1$I$20240923$20240923$20240930$20240930$PER$$US-RDY-SPO/USA/24/0014126$DR REDDYS$$57$YR$A$F$Y$$$20240929$$HP$US$US
243767471$24376747$1$I$20220801$20240919$20240930$20240930$PER$$US-SA-2024SA274490$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240929$$MD$US$US
243767481$24376748$1$I$20240901$20240909$20240930$20240930$PER$$US-SA-2024SA276690$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240929$$MD$US$US
243767511$24376751$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA278632$SANOFI AVENTIS$$$$E$F$Y$$$20240929$$MD$US$US
243767521$24376752$1$I$$20240919$20240930$20240930$EXP$$US-RDY-LIT/USA/24/0014158$DR REDDYS$Wachuku CI, Barrera T, Jackson T, Sow Y, Mollanazar N, Taylor SC. Upadacitinib as a treatment for chronic pruritus secondary to polycythemia vera after failure with dupilumab. JAAD Case Reports. 2023 May;35: 87-89. doi:10.1016/j.jdcr.2023.02.024.$40$YR$A$F$Y$$$20240929$$HP$US$US
243767531$24376753$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA276486$SANOFI AVENTIS$$$$A$F$Y$$$20240929$$CN$US$US
243767541$24376754$1$I$$20240920$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA004021US$ALEXION PHARMACEUTICALS$$$$A$$Y$$$20240929$$$US$US
243767551$24376755$1$I$$20240923$20240930$20240930$PER$$US-JNJFOC-20240966773$JOHNSON AND JOHNSON$$$$$F$Y$$$20240929$$CN$US$US
243767561$24376756$1$I$$20240924$20240930$20240930$PER$$US-JNJFOC-20240965180$JOHNSON AND JOHNSON$$$$$$Y$$$20240929$$HP$US$US
243767571$24376757$1$I$$20240909$20240930$20240930$PER$$US-TEVA-VS-3243682$TEVA$$58$YR$$M$Y$$$20240929$$CN$US$US
243767581$24376758$1$I$20240916$20240927$20240927$20240927$DIR$720377$$FDA-CTU$$41$YR$$F$N$$$20240927$Y$HP$US$
243767601$24376760$1$I$20240925$20240927$20240927$20240927$DIR$720374$$FDA-CTU$$68$YR$$F$N$67.05$KG$20240927$N$CN$US$
243767611$24376761$1$I$$20240923$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409014608$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240929$$CN$US$US
243767621$24376762$1$I$$20240917$20240930$20240930$EXP$$BE-JNJFOC-20240957395$JOHNSON AND JOHNSON$$$$A$$Y$$$20240929$$MD$BE$BE
243767641$24376764$1$I$$20240923$20240930$20240930$EXP$$US-RDY-SPO/USA/24/0014129$DR REDDYS$$60$YR$A$F$Y$$$20240929$$PH$US$US
243767651$24376765$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274821$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240929$$MD$US$US
243767661$24376766$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA277586$SANOFI AVENTIS$$$$A$M$Y$105.45$KG$20240929$$MD$US$US
243767671$24376767$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA279176$SANOFI AVENTIS$$$$A$F$Y$104.09$KG$20240929$$MD$US$US
243767681$24376768$1$I$20240101$20240910$20240930$20240930$PER$$US-SA-2024SA277909$SANOFI AVENTIS$$$$T$F$Y$51.3$KG$20240929$$MD$US$US
243767691$24376769$1$I$$20240919$20240930$20240930$EXP$$US-RDY-LIT/USA/24/0014160$DR REDDYS$Acharya S, Thakurathi P, Plocharczyk E, Arbach A, Gupta SS. Minocycline-Associated Fatal Liver Injury. American Journal of Therapeutics. 2024;31(2): e195-e197. doi:10.1097/MJT.0000000000001585.$55$YR$A$M$Y$$$20240929$$MD$US$US
243767701$24376770$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274707$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240929$$MD$US$US
243767711$24376771$1$I$20240801$20240904$20240930$20240930$PER$$US-SA-2024SA274822$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240929$$CN$US$US
243767721$24376772$1$I$$20240920$20240930$20240930$EXP$$US-RDY-LIT/USA/24/0014229$DR REDDYS$Chau LQ, Crawford JR. Neuroimaging features of accidental fentanyl overdose in a toddler. BMJ Case Reports. 2024 Jan 08;17: doi:10.1136/bcr-2023-258524.$$$$M$Y$$$20240929$$HP$US$US
243767731$24376773$1$I$$20240925$20240930$20240930$PER$$US-HALEON-2198928$Haleon PLC$$$$$F$Y$$$20240929$$CN$US$US
243767741$24376774$1$I$20240920$20240920$20240930$20240930$PER$$US-JNJFOC-20240956488$JOHNSON AND JOHNSON$$$$$$Y$$$20240929$$CN$US$US
243767751$24376775$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274634$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240929$$MD$US$US
243767761$24376776$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA277788$SANOFI AVENTIS$$$$A$M$Y$$$20240929$$MD$US$US
243767771$24376777$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA273081$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240929$$HP$US$US
243767781$24376778$1$I$20240907$20240910$20240930$20240930$PER$$US-SA-2024SA278305$SANOFI AVENTIS$$13$YR$T$M$Y$64.86$KG$20240929$$MD$US$US
243767791$24376779$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA278917$SANOFI AVENTIS$$$$A$F$Y$95.45$KG$20240929$$MD$US$US
243767801$24376780$1$I$$20240924$20240930$20240930$EXP$$CN-RDY-LIT/CHN/24/0014223$DR REDDYS$Li W, Fu Y, Wang W. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. Annals of Hematology. 2024 Aug;103(8): 3207-3217. doi:10.1007/s00277-024-05691-2.$64$YR$A$M$Y$$$20240929$$HP$CN$CN
243767811$24376781$1$I$$20240920$20240930$20240930$EXP$$CA-GSK-CA2024029038$GLAXOSMITHKLINE$$$$$$Y$$$20240929$$HP$CA$CA
243767821$24376782$1$I$$20240924$20240930$20240930$EXP$$CN-RDY-LIT/CHN/24/0014222$DR REDDYS$Li W, Fu Y, Wang W. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. Annals of Hematology. 2024 Aug;103(8): 3207-3217. doi:10.1007/s00277-024-05691-2.$59$YR$A$M$Y$58$KG$20240929$$HP$CN$CN
243767831$24376783$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000091777$ROCHE$$65$YR$E$F$Y$$$20240929$$HP$US$US
243767841$24376784$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA278617$SANOFI AVENTIS$$$$A$F$Y$60.14$KG$20240929$$MD$US$US
243767851$24376785$1$I$$20240921$20240930$20240930$PER$$US-SA-2024SA275004$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240929$$HP$US$US
243767861$24376786$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA273016$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240929$$MD$US$US
243767871$24376787$1$I$$20240924$20240930$20240930$PER$$US-JNJFOC-20240966476$JOHNSON AND JOHNSON$$$$$$Y$$$20240929$$CN$US$US
243767891$24376789$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016273$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240929$$CN$US$US
243767901$24376790$1$I$20240918$20240917$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013923$DR REDDYS$$22$YR$A$F$Y$$$20240929$$MD$US$US
243767911$24376791$1$I$20240918$20240917$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013968$DR REDDYS$$17$YR$T$F$Y$$$20240929$$MD$US$US
243767921$24376792$1$I$$20240917$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013800$DR REDDYS$$$$$F$Y$$$20240929$$CN$US$US
243767931$24376793$1$I$$20240917$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013891$DR REDDYS$$15$YR$T$M$Y$$$20240929$$MD$US$US
243767941$24376794$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA277172$SANOFI AVENTIS$$$$A$F$Y$60.32$KG$20240929$$MD$US$US
243767951$24376795$1$I$$20240926$20240930$20240930$PER$$NVSC2024US192583$NOVARTIS$$45$YR$$F$Y$$$20240929$$MD$US$US
243767971$24376797$1$I$20240717$20240922$20240930$20240930$EXP$$NVSC2024EG186940$NOVARTIS$$61$YR$$M$Y$95$KG$20240929$$CN$EG$EG
243767991$24376799$1$I$20220101$20240909$20240930$20240930$PER$$US-SA-2024SA277657$SANOFI AVENTIS$$12$YR$T$M$Y$41.09$KG$20240929$$MD$US$US
243768001$24376800$1$I$$20240920$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA004774US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240929$$PH$US$US
243768011$24376801$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA277723$SANOFI AVENTIS$$$$A$F$Y$$$20240929$$MD$US$US
243768021$24376802$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA273782$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240929$$HP$US$US
243768031$24376803$1$I$$20240906$20240930$20240930$PER$$US-SA-2024SA274988$SANOFI AVENTIS$$$$T$F$Y$63.64$KG$20240929$$MD$US$US
243768041$24376804$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA273903$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240929$$HP$US$US
243768051$24376805$1$I$20240918$20240921$20240930$20240930$PER$$US-SA-2024SA275086$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240929$$HP$US$US
243768061$24376806$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA278950$SANOFI AVENTIS$$$$A$F$Y$$$20240929$$MD$US$US
243768071$24376807$1$I$20240101$20240909$20240930$20240930$PER$$US-SA-2024SA278075$SANOFI AVENTIS$$8$YR$C$F$Y$36.82$KG$20240929$$MD$US$US
243768081$24376808$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016260$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240929$$CN$US$US
243768091$24376809$1$I$20240914$20240917$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013890$DR REDDYS$$16$YR$T$F$Y$$$20240929$$PH$US$US
243768101$24376810$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016298$ELI LILLY AND CO$$55$YR$A$$Y$$$20240929$$CN$US$US
243768111$24376811$1$I$$20240919$20240930$20240930$EXP$$IE-ROCHE-3535819$ROCHE$$$$$M$Y$$$20240929$$CN$IE$IE
243768121$24376812$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA279005$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240929$$HP$US$US
243768131$24376813$1$I$$20240920$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA004413US$ALEXION PHARMACEUTICALS$$$$A$$Y$$$20240929$$$US$US
243768141$24376814$1$I$20240901$20240909$20240930$20240930$PER$$US-SA-2024SA277106$SANOFI AVENTIS$$21$YR$A$F$Y$70.3$KG$20240929$$MD$US$US
243768151$24376815$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA277500$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240929$$CN$US$US
243768161$24376816$1$I$20240901$20240910$20240930$20240930$PER$$US-SA-2024SA277929$SANOFI AVENTIS$$60$YR$A$M$Y$90.91$KG$20240929$$MD$US$US
243768171$24376817$1$I$$20240919$20240930$20240930$PER$$US-GSK-US2024AMR117298$GLAXOSMITHKLINE$$$$$M$Y$$$20240929$$MD$US$US
243768181$24376818$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA273430$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240929$$HP$US$US
243768191$24376819$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA275878$SANOFI AVENTIS$$$$A$M$Y$$$20240929$$MD$US$US
243768201$24376820$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA274098$SANOFI AVENTIS$$$$A$M$Y$$$20240929$$MD$US$US
243768221$24376822$1$I$20240301$20240919$20240930$20240930$PER$$US-GSK-US2024116627$GLAXOSMITHKLINE$$82$YR$$F$Y$$$20240929$$CN$US$US
243768231$24376823$1$I$20240101$20240906$20240930$20240930$PER$$US-SA-2024SA277207$SANOFI AVENTIS$$61$YR$A$M$Y$118.18$KG$20240929$$MD$US$US
243768241$24376824$1$I$20230101$20240924$20240930$20240930$EXP$$US-ABBVIE-5939115$ABBVIE$$$$$M$Y$$$20240929$$CN$US$US
243768251$24376825$1$I$$20240906$20240930$20240930$PER$$US-SA-2024SA275704$SANOFI AVENTIS$$4$YR$C$F$Y$18.45$KG$20240929$$MD$US$US
243768261$24376826$1$I$$20240920$20240930$20240930$EXP$$US-ALXN-202409USA000674US$ALEXION PHARMACEUTICALS$$$$C$$Y$$$20240929$$$US$US
243768271$24376827$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA273205$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240929$$HP$US$US
243768281$24376828$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA273202$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240929$$HP$US$US
243768291$24376829$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA275972$SANOFI AVENTIS$$35$YR$A$$Y$$$20240929$$CN$US$US
243768301$24376830$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA278470$SANOFI AVENTIS$$$$C$M$Y$36.36$KG$20240929$$MD$US$US
243768311$24376831$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA278990$SANOFI AVENTIS$$$$A$M$Y$$$20240929$$MD$US$US
243768321$24376832$1$I$20240908$20240919$20240930$20240930$PER$$US-SA-2024SA273798$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240929$$HP$US$US
243768331$24376833$1$I$20240801$20240910$20240930$20240930$PER$$US-SA-2024SA278235$SANOFI AVENTIS$$81$YR$E$M$Y$97.73$KG$20240929$$MD$US$US
243768341$24376834$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA280250$SANOFI AVENTIS$$$$E$F$Y$$$20240929$$CN$US$US
243768351$24376835$1$I$20230901$20240919$20240930$20240930$PER$$US-SA-2024SA273786$SANOFI AVENTIS$$3$YR$C$F$Y$$$20240929$$HP$US$US
243768361$24376836$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA277632$SANOFI AVENTIS$$76$YR$E$M$Y$$$20240929$$CN$US$US
243768371$24376837$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274723$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240929$$HP$US$US
243768391$24376839$1$I$$20240924$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016122$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240929$$MD$US$US
243768401$24376840$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017404$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240929$$CN$US$US
243768411$24376841$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA274029$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240929$$HP$US$US
243768421$24376842$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA273219$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240929$$HP$US$US
243768431$24376843$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA273908$SANOFI AVENTIS$$11$YR$C$M$Y$$$20240929$$HP$US$US
243768441$24376844$1$I$$20240925$20240930$20240930$EXP$$CA-JNJFOC-20240972083$JOHNSON AND JOHNSON$$$$$F$Y$$$20240929$$HP$CA$CA
243768451$24376845$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274824$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240929$$HP$US$US
243768461$24376846$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274012$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240929$$HP$US$US
243768471$24376847$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA276553$SANOFI AVENTIS$$$$A$$Y$126.36$KG$20240929$$MD$US$US
243768481$24376848$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117156$GLAXOSMITHKLINE$$$$$F$Y$$$20240929$$CN$US$US
243768501$24376850$1$I$20230101$20240924$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015965$ELI LILLY AND CO$$35$YR$A$F$Y$$$20240929$$CN$US$US
243768511$24376851$1$I$$20240918$20240930$20240930$PER$$US-JNJFOC-20240969338$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20240929$$HP$US$US
243768521$24376852$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA278758$SANOFI AVENTIS$$$$E$M$Y$$$20240929$$CN$US$US
243768531$24376853$1$I$20240901$20240905$20240930$20240930$PER$$US-SA-2024SA273396$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240929$$CN$US$US
243768541$24376854$1$I$20240901$20240920$20240930$20240930$PER$$US-SA-2024SA274134$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240929$$HP$US$US
243768551$24376855$1$I$20240101$20240921$20240930$20240930$PER$$US-JNJFOC-20240963857$JOHNSON AND JOHNSON$$35$YR$A$M$Y$$$20240929$$CN$US$US
243768561$24376856$1$I$$20240919$20240930$20240930$PER$$US-JNJFOC-20240959900$JOHNSON AND JOHNSON$$$$$$Y$$$20240929$$CN$US$US
243768571$24376857$1$I$$20240919$20240930$20240930$PER$$US-JNJFOC-20240954806$JOHNSON AND JOHNSON$$$$$$Y$$$20240929$$CN$US$US
243768581$24376858$1$I$$20240918$20240930$20240930$PER$$US-JNJFOC-20240954418$JOHNSON AND JOHNSON$$$$$F$Y$$$20240929$$CN$US$US
243768611$24376861$1$I$$20240919$20240930$20240930$EXP$$RU-ROCHE-10000087773$ROCHE$$73$YR$E$F$Y$$$20240929$$MD$RU$RU
243768641$24376864$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA277216$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240929$$MD$US$US
243768651$24376865$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA277254$SANOFI AVENTIS$$56$YR$A$M$Y$$$20240929$$HP$US$US
243768661$24376866$1$I$20240901$20240919$20240930$20240930$PER$$US-SA-2024SA273270$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240929$$HP$US$US
243768681$24376868$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA273863$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240929$$MD$US$US
243768691$24376869$1$I$$20240917$20240930$20240930$EXP$$US-ARDELYX-2024ARDX007030$ARDELYX$$$$$M$Y$$$20240929$$MD$US$US
243768721$24376872$1$I$20240101$20240909$20240930$20240930$PER$$US-SA-2024SA277646$SANOFI AVENTIS$$33$YR$A$M$Y$79.55$KG$20240929$$MD$US$US
243768731$24376873$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274710$SANOFI AVENTIS$$$$A$F$Y$$$20240929$$HP$US$US
243768741$24376874$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA276921$SANOFI AVENTIS$$$$C$F$Y$18.68$KG$20240929$$MD$US$US
243768751$24376875$1$I$20240401$20240920$20240930$20240930$PER$$US-SA-2024SA275049$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240929$$MD$US$US
243768761$24376876$1$I$$20240927$20240930$20240930$EXP$$FR-JNJFOC-20240977322$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20240929$$MD$FR$FR
243768771$24376877$1$I$$20240830$20240930$20240930$EXP$$US-NEBO-668321$PHARMACOSMOS$$$$$F$Y$$$20240929$$HP$US$US
243768792$24376879$2$F$$20240923$20240930$20240930$PER$$US-JNJFOC-20240960958$JOHNSON AND JOHNSON$$$$$$Y$$$20241001$$HP$US$US
243768801$24376880$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA275054$SANOFI AVENTIS$$88$YR$E$F$Y$$$20240929$$HP$US$US
243768811$24376881$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA272990$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240929$$HP$US$US
243768821$24376882$1$I$$20240919$20240930$20240930$PER$$US-GSK-US2024AMR117288$GLAXOSMITHKLINE$$$$$F$Y$$$20240929$$CN$US$US
243768831$24376883$1$I$20240903$20240903$20240930$20240930$30DAY$$US-JNJFOC-20240904349$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20240929$$$US$US
243768841$24376884$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA275084$SANOFI AVENTIS$$65$YR$E$M$Y$$$20240929$$HP$US$US
243768851$24376885$1$I$20240917$20240919$20240930$20240930$PER$$US-SA-2024SA273875$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240929$$HP$US$US
243768881$24376888$1$I$20240923$20240924$20240930$20240930$PER$$US-SA-2024SA277295$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240929$$MD$US$US
243768891$24376889$1$I$20240915$20240920$20240930$20240930$PER$$US-SA-2024SA274237$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240929$$HP$US$US
243768901$24376890$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA275067$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240929$$HP$US$US
243768911$24376891$1$I$$20240924$20240930$20240930$PER$$US-ROCHE-10000092087$ROCHE$ELDEIRY D, Gumbleton R, Simenek S. Intra-cerebral hemorrhage following catheter-directed alteplase: ekos,but at what cost. Chest. 2024;(166): doi:doi:10.1016/J.CHEST.2024.06.1086.$79$YR$E$M$Y$$$20240929$$HP$US$US
243768921$24376892$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274313$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240929$$HP$US$US
243768931$24376893$1$I$20230101$20240910$20240930$20240930$PER$$US-SA-2024SA277582$SANOFI AVENTIS$$$$A$F$Y$81.69$KG$20240929$$MD$US$US
243768941$24376894$1$I$20240901$20240910$20240930$20240930$PER$$US-SA-2024SA278141$SANOFI AVENTIS$$14$YR$T$M$Y$43$KG$20240929$$MD$US$US
243768951$24376895$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA276984$SANOFI AVENTIS$$$$A$M$Y$$$20240929$$HP$US$US
243768961$24376896$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153507$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240929$$HP$US$US
243768971$24376897$1$I$$20240918$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149229$BRISTOL MYERS SQUIBB$$52$YR$A$M$Y$112.9$KG$20240929$$PH$US$US
243768981$24376898$1$I$$20240919$20240930$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024116976$VIIV$$$$$$Y$$$20240929$$HP$US$US
243769001$24376900$1$I$20240801$20240920$20240930$20240930$PER$$US-SA-2024SA274451$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240929$$MD$US$US
243769011$24376901$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA277181$SANOFI AVENTIS$$4$YR$C$F$Y$$$20240929$$PH$US$US
243769021$24376902$1$I$20240919$20240919$20240930$20240930$PER$$US-JNJFOC-20240951767$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20240929$$CN$US$US
243769041$24376904$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA275673$SANOFI AVENTIS$$79$YR$E$M$Y$64.09$KG$20240929$$MD$US$US
243769051$24376905$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA275122$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240929$$MD$US$US
243769061$24376906$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152936$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240929$$HP$US$US
243769071$24376907$1$I$$20240917$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013926$DR REDDYS$$23$YR$A$F$Y$$$20240929$$MD$US$US
243769081$24376908$1$I$20240201$20240926$20240930$20240930$PER$$US-JNJFOC-20240973120$JOHNSON AND JOHNSON$$$$$F$Y$$$20240929$$CN$US$US
243769091$24376909$1$I$$20240910$20240930$20240930$PER$$CN-009507513-2409USA003757$MERCK$Li N, Bowling J, de Hoog S, Aneke CI, Youn JH, Shahegh S, et al.. Mucor germinans, a novel dimorphic species resembling Paracoccidioides in a clinical sample: questions on ecological strategy. mBio. 2024;15 (8):1-19$32$YR$$M$Y$$$20240929$$HP$CN$US
243769101$24376910$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152896$BRISTOL MYERS SQUIBB$$$$$F$Y$48.08$KG$20240929$$CN$US$US
243769111$24376911$1$I$$20240926$20240930$20240930$PER$$US-JNJFOC-20240971893$JOHNSON AND JOHNSON$$$$$F$Y$$$20240929$$CN$US$US
243769121$24376912$1$I$20240801$20240920$20240930$20240930$PER$$US-SA-2024SA275147$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240929$$HP$US$US
243769131$24376913$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA278639$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240929$$CN$US$US
243769151$24376915$1$I$$20240903$20240930$20240930$EXP$$US-ROCHE-10000071225$ROCHE$Crawford J, Roe A, Brumit J, Wilson V, Tharp J. Tenecteplase Versus Alteplase: A Comparison of Bleeding Outcomes in Massive Pulmonary Embolism (TACO-PE). Annals of Pharmacotherapy. 2024;1-6. doi:10.1177/10600280241271264.$$$A$$Y$$$20240929$$PH$US$US
243769161$24376916$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA277045$SANOFI AVENTIS$$$$C$M$Y$16.78$KG$20240929$$MD$US$US
243769171$24376917$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016949$ELI LILLY AND CO$$71$YR$E$F$Y$$$20240929$$CN$US$US
243769181$24376918$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016409$ELI LILLY AND CO$$48$YR$A$F$Y$$$20240929$$CN$US$US
243769191$24376919$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152905$BRISTOL MYERS SQUIBB$$35$YR$A$F$Y$$$20240929$$CN$US$US
243769201$24376920$1$I$$20240919$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150738$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240929$$PH$US$US
243769211$24376921$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA274630$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240929$$HP$US$US
243769231$24376923$1$I$20240101$20240910$20240930$20240930$PER$$US-SA-2024SA277526$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240929$$MD$US$US
243769241$24376924$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274699$SANOFI AVENTIS$$39$YR$A$M$Y$$$20240929$$HP$US$US
243769251$24376925$1$I$20240901$20240920$20240930$20240930$PER$$US-SA-2024SA275177$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240929$$HP$US$US
243769261$24376926$1$I$$20240926$20240930$20240930$EXP$$CA-ROCHE-10000092273$ROCHE$$37$YR$A$M$Y$$$20240929$$CN$CA$CA
243769271$24376927$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274114$SANOFI AVENTIS$$50$YR$A$F$Y$$$20240929$$HP$US$US
243769281$24376928$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA275163$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240929$$HP$US$US
243769291$24376929$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA275738$SANOFI AVENTIS$$63$YR$A$M$Y$$$20240929$$MD$US$US
243769301$24376930$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017389$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240929$$CN$US$US
243769311$24376931$1$I$$20240916$20240930$20240930$PER$$US-JNJFOC-20240970306$JOHNSON AND JOHNSON$$$$$$Y$$$20240929$$PH$US$US
243769331$24376933$1$I$20240901$20240919$20240930$20240930$PER$$US-SA-2024SA273148$SANOFI AVENTIS$$10$MON$I$F$Y$$$20240929$$CN$US$US
243769341$24376934$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA274858$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240929$$HP$US$US
243769351$24376935$1$I$20240801$20240910$20240930$20240930$PER$$US-SA-2024SA277941$SANOFI AVENTIS$$46$YR$A$F$Y$93.64$KG$20240929$$MD$US$US
243769361$24376936$1$I$20240906$20240906$20240930$20240930$PER$$US-SA-2024SA276876$SANOFI AVENTIS$$42$YR$A$F$Y$68.18$KG$20240929$$MD$US$US
243769371$24376937$1$I$20240601$20240920$20240930$20240930$PER$$US-SA-2024SA274172$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240929$$MD$US$US
243769381$24376938$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274307$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240929$$HP$US$US
243769391$24376939$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA273267$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240929$$MD$US$US
243769401$24376940$1$I$20230601$20240910$20240930$20240930$PER$$US-SA-2024SA278126$SANOFI AVENTIS$$$$C$M$Y$11.33$KG$20240929$$MD$US$US
243769411$24376941$1$I$$20240924$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015625$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240929$$CN$US$US
243769421$24376942$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274923$SANOFI AVENTIS$$30$YR$A$M$Y$$$20240929$$HP$US$US
243769431$24376943$1$I$20240925$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017319$ELI LILLY AND CO$$$$$F$Y$$$20240929$$CN$US$US
243769441$24376944$1$I$$20240925$20240930$20240930$PER$$US-009507513-2409USA009220$MERCK$$$$$F$Y$$$20240929$$HP$US$US
243769451$24376945$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA274057$SANOFI AVENTIS$$30$YR$A$F$Y$$$20240929$$HP$US$US
243769461$24376946$1$I$20240806$20240903$20240930$20240930$30DAY$$BR-JNJFOC-20240908935$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20240929$$HP$BR$BR
243769471$24376947$1$I$$20240925$20240930$20240930$PER$$US-009507513-2409USA009320$MERCK$Ahn J, Munir M, Song J, El-Mahdy S. PEMBROLIZUMAB: TO CAVITATE OR NOT TO CAVITATE. Chest. 2024;166 (4):A4494-5$42$YR$$F$Y$$$20240929$$HP$US$US
243769481$24376948$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA274375$SANOFI AVENTIS$$$$A$M$Y$$$20240929$$HP$US$US
243769491$24376949$1$I$20240901$20240920$20240930$20240930$PER$$US-SA-2024SA274527$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240929$$HP$US$US
243769501$24376950$1$I$$20240906$20240930$20240930$PER$$US-SA-2024SA279064$SANOFI AVENTIS$$$$T$M$Y$37.32$KG$20240929$$MD$US$US
243769511$24376951$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA276128$SANOFI AVENTIS$$$$A$M$Y$94.32$KG$20240929$$MD$US$US
243769521$24376952$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274623$SANOFI AVENTIS$$33$YR$A$F$Y$$$20240929$$MD$US$US
243769531$24376953$1$I$$20240919$20240930$20240930$PER$$US-ABBVIE-5933177$ABBVIE$$$$$$Y$$$20240929$$CN$US$US
243769541$24376954$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA274692$SANOFI AVENTIS$$$$C$F$Y$$$20240929$$MD$US$US
243769551$24376955$1$I$20240925$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153614$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240929$$CN$US$US
243769561$24376956$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016387$ELI LILLY AND CO$$$$$F$Y$$$20240929$$CN$US$US
243769571$24376957$1$I$20220617$20240923$20240930$20240930$EXP$$CZ-009507513-2409CZE009182$MERCK$$61$YR$$F$Y$54$KG$20240929$$MD$CZ$CZ
243769581$24376958$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA273987$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240930$$MD$US$US
243769591$24376959$1$I$20240601$20240911$20240930$20240930$PER$$US-SA-2024SA278559$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240929$$MD$US$US
243769601$24376960$1$I$20240901$20240919$20240930$20240930$PER$$US-SA-2024SA276035$SANOFI AVENTIS$$57$YR$A$F$Y$70.91$KG$20240929$$HP$US$US
243769611$24376961$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA273889$SANOFI AVENTIS$$6$YR$C$F$Y$$$20240930$$HP$US$US
243769621$24376962$1$I$$20240920$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA003974US$ALEXION PHARMACEUTICALS$$$$A$$Y$$$20240929$$$US$US
243769631$24376963$1$I$$20240925$20240930$20240930$EXP$$NVSC2024US191873$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
243769641$24376964$1$I$20240601$20240920$20240930$20240930$PER$$US-SA-2024SA274609$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240930$$HP$US$US
243769651$24376965$1$I$20240919$20240925$20240930$20240930$PER$$US-JNJFOC-20240969355$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20240929$$HP$US$US
243769661$24376966$1$I$20240801$20240905$20240930$20240930$PER$$US-SA-2024SA273660$SANOFI AVENTIS$$29$YR$A$F$Y$52.6$KG$20240930$$MD$US$US
243769671$24376967$1$I$20240801$20240920$20240930$20240930$PER$$US-SA-2024SA274397$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240930$$HP$US$US
243769681$24376968$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003140$SUNOVION$$$$$$Y$$$20240929$$CN$US$US
243769691$24376969$1$I$$20240919$20240930$20240930$PER$$US-SMPA-2024SPA003073$SUNOVION$$$$$$Y$$$20240929$$CN$US$US
243769701$24376970$1$I$$20240919$20240930$20240930$PER$$US-SMPA-2024SPA003099$SUNOVION$$$$$$Y$$$20240929$$CN$US$US
243769711$24376971$1$I$$20240925$20240930$20240930$PER$$US-SMPA-2024SPA003316$SUNOVION$$$$$$Y$$$20240929$$CN$US$US
243769721$24376972$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003130$SUNOVION$$$$$$Y$$$20240929$$CN$US$US
243769741$24376974$1$I$20240901$20240927$20240930$20240930$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054021$BOEHRINGER INGELHEIM$$79$YR$E$F$Y$$$20240930$$CN$US$US
243769761$24376976$1$I$$20240925$20240930$20240930$EXP$$NVSC2024US191569$NOVARTIS$$$$$F$Y$58.059$KG$20240930$$CN$US$US
243769771$24376977$1$I$$20240926$20240930$20240930$EXP$$US-JNJFOC-20240971523$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243769801$24376980$1$I$20240419$20240928$20240928$20240928$DIR$720500$$FDA-CTU$$10$YR$$F$N$$$20240928$N$CN$US$
243769831$24376983$1$I$$20240923$20240930$20240930$EXP$$IQ-ORGANON-O2409IRQ001909$ORGANON$Asaad S.K, Salih N.M, Hassan M.N, Abid M.S, Hamid H.F, Ameen?Ahmed N.H, et al. Contraceptive implant migration to the ulnar nerve: A case report with literature review.. Clinical Case Reports. 2024;12$32$YR$$F$Y$$$20240929$$HP$IQ$IQ
243769851$24376985$1$I$20240701$20240910$20240930$20240930$PER$$US-SA-2024SA278719$SANOFI AVENTIS$$67$YR$E$F$Y$61.36$KG$20240930$$MD$US$US
243769891$24376989$1$I$20240101$20240923$20240930$20240930$EXP$$BE-ABBVIE-5937310$ABBVIE$$68$YR$$F$Y$$$20240929$$CN$BE$BE
243769901$24376990$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5938895$ABBVIE$$$$$M$Y$$$20240929$$CN$US$US
243769911$24376991$1$I$20240924$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153118$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240930$$HP$US$US
243769921$24376992$1$I$$20240923$20240930$20240930$EXP$$AT-ABBVIE-5938651$ABBVIE$$$$$$Y$$$20240929$$MD$AT$AT
243769941$24376994$1$I$20240922$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153322$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240930$$PH$US$US
243769951$24376995$1$I$$20240920$20240930$20240930$EXP$$CA-ABBVIE-5933849$ABBVIE$$45$YR$$M$Y$$$20240929$$CN$CA$CA
243769961$24376996$1$I$$20240921$20240930$20240930$PER$$US-BIOGEN-2024BI01283986$BIOGEN$$$$$M$Y$$$20240929$$CN$US$US
243769981$24376998$1$I$20240912$20240923$20240930$20240930$EXP$$PL-BIOGEN-2024BI01284067$BIOGEN$$39$YR$$F$Y$$$20240929$$MD$PL$PL
243769991$24376999$1$I$20180921$20240919$20240930$20240930$EXP$$JP-ABBVIE-5358138$ABBVIE$$60$YR$$M$Y$60$KG$20240929$$MD$JP$JP
243770001$24377000$1$I$$20240923$20240930$20240930$EXP$$US-BIOGEN-2024BI01284021$BIOGEN$$$$$F$Y$$$20240929$$HP$US$US
243770011$24377001$1$I$20240528$20240920$20240930$20240930$EXP$$US-ABBVIE-5933651$ABBVIE$$82$YR$$F$Y$$$20240929$$CN$US$US
243770021$24377002$1$I$$20240923$20240930$20240930$EXP$$US-BIOGEN-2024BI01254402$BIOGEN$$$$$M$Y$$$20240929$$CN$US$US
243770041$24377004$1$I$$20240918$20240930$20240930$PER$$US-BAUSCHBL-2024BNL033780$BAUSCH AND LOMB$$$$$F$Y$$$20240930$$CN$US$US
243770051$24377005$1$I$20240101$20240923$20240930$20240930$EXP$$CA-ABBVIE-5936728$ABBVIE$$33$YR$$M$Y$$$20240929$$MD$CA$CA
243770071$24377007$1$I$20240101$20240924$20240930$20240930$EXP$$CA-ABBVIE-5938905$ABBVIE$$71$YR$$M$Y$$$20240929$$CN$CA$CA
243770081$24377008$1$I$20231201$20240920$20240930$20240930$EXP$$IE-ABBVIE-5553967$ABBVIE$$64$YR$$F$Y$$$20240929$$HP$IE$IE
243770091$24377009$1$I$20240101$20240925$20240930$20240930$EXP$$CA-ABBVIE-5941550$ABBVIE$$34$YR$$M$Y$$$20240929$$CN$CA$CA
243770101$24377010$1$I$20240510$20240924$20240930$20240930$EXP$$US-ABBVIE-5939899$ABBVIE$$47$YR$$F$Y$$$20240929$$CN$US$US
243770111$24377011$1$I$20240901$20240924$20240930$20240930$EXP$$US-ABBVIE-5938919$ABBVIE$$24$YR$$M$Y$$$20240929$$CN$US$US
243770121$24377012$1$I$20240908$20240909$20240930$20240930$PER$$US-SA-2024SA277413$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240930$$CN$US$US
243770131$24377013$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA278349$SANOFI AVENTIS$$72$YR$E$F$Y$101.82$KG$20240930$$MD$US$US
243770141$24377014$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA277477$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240930$$HP$US$US
243770151$24377015$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA273108$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240930$$MD$US$US
243770161$24377016$1$I$20240901$20240921$20240930$20240930$PER$$US-SA-2024SA274763$SANOFI AVENTIS$$42$YR$A$M$Y$$$20240930$$MD$US$US
243770171$24377017$1$I$20240612$20240925$20240930$20240930$EXP$$AU-ABBVIE-5941350$ABBVIE$$75$YR$$F$Y$$$20240929$$HP$AU$AU
243770181$24377018$1$I$20240911$20240920$20240930$20240930$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2162199$JIANGSU HENGRUI MEDICINE$$51$YR$$M$Y$87.5$KG$20240929$$MD$CN$CN
243770191$24377019$1$I$20240101$20240924$20240930$20240930$EXP$$US-TAKEDA-2024TUS070498$TAKEDA$$$$$F$Y$$$20240929$$MD$US$US
243770201$24377020$1$I$20230917$20240924$20240930$20240930$EXP$ES-AEMPS-1571718$ES-JNJFOC-20240970186$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240930$$MD$ES$ES
243770211$24377021$1$I$20240101$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153145$BRISTOL MYERS SQUIBB$$23$YR$A$F$Y$$$20240930$$HP$US$US
243770221$24377022$1$I$20240918$20240924$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015217$BEIGENE$$$$$$Y$$$20240929$$HP$CN$CN
243770231$24377023$1$I$20240701$20240919$20240930$20240930$EXP$$CO-JNJFOC-20240912782$JOHNSON AND JOHNSON$$36$YR$A$M$Y$55$KG$20240930$$HP$CO$CO
243770241$24377024$1$I$20240911$20240924$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015218$BEIGENE$$$$$$Y$$$20240929$$HP$CN$CN
243770251$24377025$1$I$20240101$20240925$20240930$20240930$EXP$$US-ORGANON-O2409USA002105$ORGANON$$$$$F$Y$$$20240929$$CN$US$US
243770261$24377026$1$I$20240828$20240924$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015219$BEIGENE$$$$$$Y$$$20240929$$HP$CN$CN
243770271$24377027$1$I$20240604$20240924$20240930$20240930$EXP$$JP-SA-2024SA203872$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240930$$MD$JP$JP
243770281$24377028$1$I$$20240923$20240930$20240930$PER$$US-JNJFOC-20240961638$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
243770291$24377029$1$I$$20240923$20240930$20240930$EXP$$CN-Jiangsu Hengrui Medicine Co., Ltd.-2162200$JIANGSU HENGRUI MEDICINE$$57$YR$$M$Y$$$20240929$$MD$CN$CN
243770301$24377030$1$I$20240101$20240919$20240930$20240930$EXP$$US-JNJFOC-20240956244$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240930$$HP$US$US
243770311$24377031$1$I$20210101$20240924$20240930$20240930$PER$$US-ORGANON-O2409USA001978$ORGANON$$$$$F$Y$$$20240929$$CN$US$US
243770321$24377032$1$I$$20240924$20240930$20240930$EXP$$GB-AMGEN-GBRSP2024190577$AMGEN$$$$$M$Y$$$20240929$$HP$GB$GB
243770331$24377033$1$I$$20240918$20240930$20240930$PER$$US-JNJFOC-20240948491$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$HP$US$US
243770341$24377034$1$I$$20240926$20240930$20240930$EXP$$AT-BEIGENE-BGN-2024-015439$BEIGENE$$$$$$Y$$$20240929$$MD$AT$AT
243770351$24377035$1$I$$20240925$20240930$20240930$EXP$$US-009507513-2409USA009260$MERCK$Velo A, Bandler I, Welsh C, Brimah I, Mohanraj E.. Daptomycin-induced Eosinophilic Pneumonia: a Case Report. Chest. 2024;166 (4):3363A-64A$70$YR$$F$Y$$$20240929$$HP$US$US
243770361$24377036$1$I$20240101$20240924$20240930$20240930$EXP$$US-ABBVIE-5938904$ABBVIE$$$$$F$Y$$$20240929$$CN$US$US
243770371$24377037$1$I$20240101$20240924$20240930$20240930$EXP$$CA-ABBVIE-5938660$ABBVIE$$43$YR$$F$Y$$$20240929$$CN$CA$CA
243770421$24377042$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66949$$FDA-CTU$$$$$F$N$$$20240927$N$HP$US$
243770431$24377043$1$I$20240101$20240916$20240930$20240930$EXP$$US-UCBSA-2024014053$UCB$$$$$M$Y$$$20240930$$MD$US$US
243770451$24377045$1$I$20240801$20240920$20240930$20240930$EXP$$IE-ABBVIE-5942005$ABBVIE$$71$YR$$M$Y$$$20240929$$CN$IE$IE
243770461$24377046$1$I$20240822$20240924$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015233$BEIGENE$$$$$$Y$$$20240929$$HP$CN$CN
243770471$24377047$1$I$20240922$20240926$20240930$20240930$PER$$US-MTPC-MTDA2024-0020256$MITSUBISHI TANABE PHARMA$$60$YR$$F$Y$$$20240929$$CN$US$US
243770481$24377048$1$I$$20240920$20240930$20240930$EXP$$JP-MTPC-MTPC2024-0019999$MITSUBISHI TANABE PHARMA$$7$DEC$$M$Y$$$20240929$$MD$JP$JP
243770491$24377049$1$I$20240901$20240920$20240930$20240930$PER$$US-SA-2024SA276843$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240930$$MD$US$US
243770501$24377050$1$I$$20240926$20240930$20240930$PER$$US-ABBVIE-5943564$ABBVIE$$$$$$Y$$$20240929$$CN$US$US
243770511$24377051$1$I$20240901$20240919$20240930$20240930$PER$$US-SA-2024SA273149$SANOFI AVENTIS$$1$YR$I$M$Y$$$20240930$$MD$US$US
243770521$24377052$1$I$20240101$20240921$20240930$20240930$PER$$US-SA-2024SA275220$SANOFI AVENTIS$$45$YR$A$F$Y$$$20240930$$MD$US$US
243770531$24377053$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA276721$SANOFI AVENTIS$$$$A$F$Y$222.27$KG$20240930$$HP$US$US
243770551$24377055$1$I$20240919$20240920$20240930$20240930$PER$$US-ABBVIE-5936131$ABBVIE$$$$$F$Y$$$20240929$$MD$US$US
243770561$24377056$1$I$$20240923$20240930$20240930$EXP$$US-JNJFOC-20240964222$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$HP$US$US
243770581$24377058$1$I$20230601$20240925$20240930$20240930$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-153649$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240930$$MD$DE$DE
243770601$24377060$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5938531$ABBVIE$$$$$F$Y$$$20240929$$CN$US$US
243770611$24377061$1$I$20240910$20240924$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015234$BEIGENE$$$$$$Y$$$20240929$$HP$CN$CN
243770621$24377062$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151831$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240930$$HP$US$US
243770631$24377063$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5938508$ABBVIE$$$$$M$Y$$$20240929$$CN$US$US
243770641$24377064$1$I$$20240927$20240930$20240930$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054026$BOEHRINGER INGELHEIM$$71$YR$E$F$Y$$$20240930$$CN$US$US
243770651$24377065$1$I$20240923$20240927$20240930$20240930$EXP$$BG-ABBVIE-5943303$ABBVIE$$69$YR$$M$Y$$$20240929$$HP$BG$BG
243770661$24377066$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA273131$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240930$$MD$US$US
243770671$24377067$1$I$20230101$20240920$20240930$20240930$PER$$US-SA-2024SA276691$SANOFI AVENTIS$$$$E$M$Y$$$20240930$$HP$US$US
243770681$24377068$1$I$$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153641$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240930$$CN$US$US
243770691$24377069$1$I$$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024191640$AMGEN$$$$$F$Y$$$20240929$$MD$US$US
243770701$24377070$1$I$$20240918$20240930$20240930$PER$$US-JNJFOC-20240954183$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
243770711$24377071$1$I$20240919$20240923$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015097$BEIGENE$$$$$$Y$$$20240929$$HP$CN$CN
243770721$24377072$1$I$20240901$20240920$20240930$20240930$PER$$US-SA-2024SA279161$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240930$$CN$US$US
243770731$24377073$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA278081$SANOFI AVENTIS$$$$A$F$Y$87.5$KG$20240930$$MD$US$US
243770741$24377074$1$I$$20240923$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA004982US$ALEXION PHARMACEUTICALS$$$$A$$Y$$$20240929$$$US$US
243770751$24377075$1$I$$20240924$20240930$20240930$EXP$$JP-SANDOZ INC.-SDZ2024JP062990$SANDOZ$Miura T, Morohashi H, Sakamoto Y, Kagiya T, Hasebe T, Nakayama Y, et al.. Neoadjuvant S-1 and oxaliplatin plus bevacizumab therapy for high-risk locally advanced rectal cancer: A prospective multicenter phase II study. Annals of Gastroenterological Surgery. 2024;8(1):71-79$$$$$Y$$$20240929$$MD$JP$JP
243770761$24377076$1$I$20220101$20240921$20240930$20240930$PER$$US-SA-2024SA275294$SANOFI AVENTIS$$$$A$M$Y$$$20240930$$MD$US$US
243770771$24377077$1$I$$20240923$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA004444US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240929$$$US$US
243770781$24377078$1$I$20240801$20240925$20240930$20240930$EXP$$US-ABBVIE-5939462$ABBVIE$$68$YR$$M$Y$$$20240929$$CN$US$US
243770791$24377079$1$I$$20240924$20240930$20240930$EXP$$DE-SANDOZ INC.-SDZ2024DE082941$SANDOZ$$$$A$$Y$$$20240929$$HP$DE$DE
243770811$24377081$1$I$$20240916$20240930$20240930$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-470376$RANBAXY$Zhang X, Wang H, Li J, Zhou F, Zhao M, Su T. Sunitinib-induced endocapillary proliferative glomerulonephritis with IgA2 deposit in addition to thrombotic microangiopathy: a case report. BMC Nephrol. 2024;25 (1):284(1-6)$59$YR$$M$Y$$$20240930$$HP$CN$CN
243770821$24377082$1$I$$20240920$20240930$20240930$PER$$US-ROCHE-10000090387$ROCHE$$81$YR$E$F$Y$$$20240930$$CN$US$US
243770831$24377083$1$I$$20240921$20240930$20240930$PER$$US-ROCHE-10000091368$ROCHE$$$$$$Y$$$20240930$$CN$US$US
243770841$24377084$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5940465$ABBVIE$$$$$M$Y$$$20240929$$CN$US$US
243770851$24377085$1$I$$20240923$20240930$20240930$PER$$US-ROCHE-10000089706$ROCHE$$44$YR$A$F$Y$$$20240930$$CN$US$US
243770861$24377086$1$I$20240921$20240924$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015236$BEIGENE$$$$$$Y$$$20240929$$HP$CN$CN
243770871$24377087$1$I$20230522$20240920$20240930$20240930$EXP$$JP-ABBVIE-5941630$ABBVIE$$62$YR$$M$Y$60$KG$20240929$$MD$JP$JP
243770881$24377088$1$I$20240901$20240920$20240930$20240930$PER$$US-BAUSCHBL-2024BNL033906$BAUSCH AND LOMB$$$$$F$Y$$$20240930$$CN$US$US
243770891$24377089$1$I$$20240924$20240930$20240930$EXP$$NL-ABBVIE-5941252$ABBVIE$$$$E$M$Y$$$20240929$$CN$NL$NL
243770911$24377091$1$I$20240101$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192588$AMGEN$$71$YR$E$F$Y$$$20240929$$CN$US$US
243770921$24377092$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA277896$SANOFI AVENTIS$$70$YR$E$F$Y$$$20240930$$MD$US$US
243770931$24377093$1$I$20240221$20240923$20240930$20240930$EXP$$FR-AMGEN-FRASP2024190350$AMGEN$$73$YR$E$M$Y$77.01$KG$20240929$$MD$FR$FR
243770941$24377094$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5938601$ABBVIE$$$$$F$Y$$$20240929$$CN$US$US
243770951$24377095$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5939064$ABBVIE$$$$$F$Y$$$20240929$$CN$US$US
243770961$24377096$1$I$20240101$20240924$20240930$20240930$EXP$$GB-ABBVIE-5939137$ABBVIE$$56$YR$$M$Y$$$20240929$$CN$GB$GB
243770971$24377097$1$I$$20240924$20240930$20240930$PER$$US-ROCHE-10000090782$ROCHE$$55$YR$A$F$Y$$$20240930$$CN$US$US
243770981$24377098$1$I$20240918$20240918$20240930$20240930$PER$$US-ABBVIE-5934664$ABBVIE$$75$YR$$F$Y$$$20240929$$MD$US$US
243770991$24377099$1$I$20231011$20240927$20240927$20240927$DIR$720253$$FDA-CTU$$75$YR$$M$N$57$KG$20240927$N$HP$US$
243771001$24377100$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA279281$SANOFI AVENTIS$$$$$F$Y$$$20240930$$CN$US$US
243771011$24377101$1$I$$20240918$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US083536$SANDOZ$$61$YR$$F$Y$$$20240929$$CN$US$US
243771021$24377102$1$I$20240914$20240925$20240930$20240930$EXP$$US-ABBVIE-5939516$ABBVIE$$63$YR$$F$Y$$$20240929$$CN$US$US
243771041$24377104$1$I$20231205$20240927$20240927$20240927$DIR$720254$$FDA-CTU$$94$YR$$M$N$66$KG$20240927$N$HP$US$
243771061$24377106$1$I$20240803$20240924$20240930$20240930$EXP$$CA-ABBVIE-5938900$ABBVIE$$61$YR$$F$Y$$$20240929$$CN$CA$CA
243771071$24377107$1$I$20220908$20240919$20240930$20240930$EXP$$BR-TAKEDA-2022TUS085913$TAKEDA$$32$YR$$F$Y$$$20240929$$CN$BR$BR
243771081$24377108$1$I$20200101$20240924$20240930$20240930$EXP$$DE-BIOGEN-2024BI01283959$BIOGEN$$32$YR$$F$Y$$$20240929$$MD$DE$DE
243771091$24377109$1$I$20230401$20240919$20240930$20240930$EXP$$US-ABBVIE-5408863$ABBVIE$$85$YR$$F$Y$54$KG$20240929$$CN$US$US
243771101$24377110$1$I$20240517$20240924$20240930$20240930$EXP$$GB-PFIZER INC-202400262451$PFIZER$$53$YR$$M$Y$108$KG$20240929$$MD$GB$GB
243771111$24377111$1$I$20240919$20240924$20240930$20240930$EXP$$CN-PFIZER INC-PV202400124975$PFIZER$$69$YR$$F$Y$61$KG$20240929$$HP$CN$CN
243771121$24377112$1$I$20240912$20240925$20240930$20240930$EXP$$IN-PFIZER INC-202101191379$PFIZER$$61$YR$$F$Y$$$20240929$$CN$IN$IN
243771131$24377113$1$I$$20240923$20240930$20240930$EXP$$AU-PFIZER INC-PV202400124488$PFIZER$$$$$M$Y$$$20240929$$MD$AU$AU
243771151$24377115$1$I$20240101$20240924$20240930$20240930$EXP$$CA-PFIZER INC-202400063651$PFIZER$$71$YR$$F$Y$$$20240929$$HP$CA$CA
243771181$24377118$1$I$$20240923$20240930$20240930$PER$$US-JNJFOC-20240961790$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243771191$24377119$1$I$$20240919$20240930$20240930$EXP$$US-JNJFOC-20240953132$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
243771201$24377120$1$I$$20240919$20240930$20240930$EXP$$US-JNJFOC-20240964328$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240930$$HP$US$US
243771211$24377121$1$I$20240901$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192603$AMGEN$$16$YR$T$F$Y$$$20240929$$CN$US$US
243771221$24377122$1$I$$20240924$20240930$20240930$EXP$$JP-SAKK-2024SA275274AA$SANOFI AVENTIS$$78$YR$E$M$Y$$$20240930$$MD$JP$JP
243771241$24377124$1$I$20240912$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153079$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$$$20240930$$HP$US$US
243771251$24377125$1$I$20240829$20240925$20240930$20240930$EXP$GB-MHRA-TPP54855304C7519580YC1726490392301$GB-STRIDES ARCOLAB LIMITED-2024SP012471$STRIDES$$59$YR$$M$Y$100$KG$20240930$$MD$GB$GB
243771261$24377126$1$I$$20240916$20240930$20240930$EXP$$US-KVK-TECH, INC-20240900140$KVK-TECH$Unknown. Morphine. Drugs and Lactation Database (LactMed) [Internet]. 2024$$$$$Y$$$20240929$$HP$US$US
243771271$24377127$1$I$$20240226$20240930$20240930$PER$$US-KVK-TECH, INC-20240200020$KVK-TECH$$$$$F$Y$$$20240928$$CN$US$US
243771281$24377128$1$I$20240904$20240910$20240930$20240930$PER$$US-SA-2024SA277782$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240930$$HP$US$US
243771291$24377129$1$I$20231021$20231026$20240930$20240930$PER$$US-KVK-TECH, INC-20231000144$KVK-TECH$$$$$$Y$$$20240928$$CN$US$US
243771301$24377130$1$I$$20240918$20240930$20240930$EXP$$GR-TAKEDA-2024TUS095126$TAKEDA$$$$$F$Y$$$20240930$$CN$GR$GR
243771311$24377131$1$I$$20240927$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2023US001937$SANDOZ$$53$YR$$M$Y$180$KG$20240930$$MD$US$US
243771321$24377132$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA273228$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240930$$HP$US$US
243771331$24377133$1$I$20240101$20240921$20240930$20240930$PER$$US-SA-2024SA274574$SANOFI AVENTIS$$32$YR$A$F$Y$$$20240930$$MD$US$US
243771341$24377134$1$I$$20240917$20240930$20240930$EXP$$US-UCBSA-2024048017$UCB$$$$$M$Y$$$20240930$$CN$US$US
243771351$24377135$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153677$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240930$$CN$US$US
243771361$24377136$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA273776$SANOFI AVENTIS$$37$YR$A$M$Y$$$20240930$$HP$US$US
243771371$24377137$1$I$$20240923$20240930$20240930$EXP$RO-FMX-PCT-09-24-LIT$RO-ORGANON-O2409ROM001843$ORGANON$Bratu I.. A 62-year-old woman with depressive disorder due to a medical condition-rheumatoid arthritis. Ro J Psychiatry. 2022;24(1)$62$YR$$F$Y$$$20240929$$MD$RO$RO
243771381$24377138$1$I$20240101$20240910$20240930$20240930$PER$$US-SA-2024SA278178$SANOFI AVENTIS$$35$YR$A$F$Y$86.36$KG$20240930$$MD$US$US
243771391$24377139$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA102675$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240930$$HP$US$US
243771401$24377140$1$I$20240101$20240921$20240930$20240930$PER$$US-SA-2024SA275536$SANOFI AVENTIS$$57$YR$A$F$Y$$$20240930$$MD$US$US
243771411$24377141$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA277192$SANOFI AVENTIS$$5$YR$C$M$Y$$$20240930$$MD$US$US
243771421$24377142$1$I$20231001$20240923$20240930$20240930$PER$$US-SA-2024SA276736$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240930$$MD$US$US
243771431$24377143$1$I$20230101$20240916$20240930$20240930$EXP$$BE-ABBVIE-5525619$ABBVIE$$84$YR$$F$Y$$$20240930$$HP$BE$BE
243771441$24377144$1$I$20240101$20240924$20240930$20240930$EXP$$US-ABBVIE-5939364$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243771451$24377145$1$I$$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153432$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240930$$CN$US$US
243771461$24377146$1$I$20240914$20240920$20240930$20240930$EXP$$CO-ABBVIE-5935773$ABBVIE$$61$YR$$M$Y$94$KG$20240930$$CN$CO$CO
243771471$24377147$1$I$$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153622$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240930$$CN$US$US
243771481$24377148$1$I$20240913$20240913$20240930$20240930$PER$$US-JNJFOC-20240943607$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240930$$CN$US$US
243771491$24377149$1$I$$20240924$20240930$20240930$EXP$$GB-AMGEN-GBRSP2024191561$AMGEN$$$$$F$Y$$$20240929$$CN$GB$GB
243771521$24377152$1$I$$20240925$20240930$20240930$EXP$$NL-ABBVIE-5940613$ABBVIE$$$$E$M$Y$$$20240930$$CN$NL$NL
243771531$24377153$1$I$$20240924$20240930$20240930$EXP$$US-ASTELLAS-2024-AER-009435$ASTELLAS$Ansari Z. Malakoplakia in a transplanted liver. ACG Case Reports Journal. 2024;11(9): 1-5. doi:10.14309/crj.0000000000001486.$63$YR$A$M$Y$$$20240930$$MD$US$US
243771541$24377154$1$I$20240701$20240919$20240930$20240930$EXP$$FR-AUROBINDO-AUR-APL-2024-047398$AUROBINDO$$47$YR$$F$Y$59$KG$20240930$$MD$FR$FR
243771561$24377156$1$I$20240725$20240925$20240930$20240930$EXP$$GB-ABBVIE-5943394$ABBVIE$$69$YR$$M$Y$$$20240930$$HP$GB$GB
243771571$24377157$1$I$20231231$20240924$20240930$20240930$EXP$$US-ABBVIE-5881967$ABBVIE$$56$YR$$F$Y$78.017$KG$20240930$$CN$US$US
243771581$24377158$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153664$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$68.04$KG$20240930$$CN$US$US
243771591$24377159$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5938510$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243771601$24377160$1$I$20240427$20240925$20240930$20240930$EXP$GB-MHRA-MED-202409251229298740-DNMFG$GB-AMGEN-GBRSP2024191572$AMGEN$$$$$F$Y$$$20240929$$HP$GB$GB
243771611$24377161$1$I$20240924$20240926$20240930$20240930$EXP$$DE-ABBVIE-5943113$ABBVIE$$71$YR$$F$Y$$$20240930$$CN$DE$DE
243771621$24377162$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152958$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$99.79$KG$20240930$$CN$US$US
243771631$24377163$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153640$BRISTOL MYERS SQUIBB$$89$YR$E$M$Y$$$20240930$$HP$US$US
243771661$24377166$1$I$20240901$20240920$20240930$20240930$PER$$US-SA-2024SA274475$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240930$$HP$US$US
243771671$24377167$1$I$20240806$20240920$20240930$20240930$PER$$US-SA-2024SA275751$SANOFI AVENTIS$$72$YR$E$F$Y$47.73$KG$20240930$$MD$US$US
243771681$24377168$1$I$$20240918$20240930$20240930$EXP$$US-ALVOTECHPMS-2024-ALVOTECHPMS-002337$Alvotech$Ok MT, Googe PB, Sayed CJ, Burkhart C, Gulati AS, Nieman EL. The Successful Use of Upadacitinib as Monotherapy for Hidradenitis Suppurativa and Ulcerative Colitis in the Setting of Refractory Disease. Pediatr Dermatol. 2024 Sep 11. doi: 10.1111/pde.15759. Epub ahead of print. PMID: 39258318.$15$YR$$F$Y$$$20240930$$HP$US$
243771691$24377169$1$I$20240801$20240925$20240930$20240930$EXP$$GB-ABBVIE-5940258$ABBVIE$$$$E$M$Y$$$20240930$$CN$GB$GB
243771701$24377170$1$I$20240801$20240925$20240930$20240930$EXP$$US-ABBVIE-5939570$ABBVIE$$72$YR$$F$Y$$$20240930$$CN$US$US
243771711$24377171$1$I$$20240924$20240930$20240930$EXP$$DE-BIOGEN-2024BI01284159$BIOGEN$$60$YR$$F$Y$$$20240930$$MD$DE$DE
243771741$24377174$1$I$20231107$20240927$20240927$20240927$DIR$720277$$FDA-CTU$$86$YR$$M$N$111$KG$20240927$N$HP$US$
243771751$24377175$1$I$20231224$20240927$20240927$20240927$DIR$720255$$FDA-CTU$$78$YR$$M$N$85$KG$20240927$N$HP$US$
243771771$24377177$1$I$20231027$20240927$20240927$20240927$DIR$720262$$FDA-CTU$$73$YR$$M$N$94$KG$20240927$N$HP$US$
243771781$24377178$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5939430$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243771791$24377179$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5939798$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243771811$24377181$1$I$$20240923$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017062$ELI LILLY AND CO$$79$YR$E$F$Y$68.027$KG$20240930$$CN$US$US
243771821$24377182$1$I$$20240920$20240930$20240930$EXP$$US-EMD Serono-2024050735$EMD SERONO INC$$65$YR$E$F$Y$$$20240930$$CN$US$US
243771831$24377183$1$I$$20240924$20240930$20240930$PER$$US-ABBVIE-5939357$ABBVIE$$36$YR$$F$Y$$$20240930$$CN$US$US
243771841$24377184$1$I$20240926$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193545$AMGEN$$29$YR$A$F$Y$$$20240929$$CN$US$US
243771861$24377186$1$I$$20240918$20240930$20240930$EXP$CA-MHPD-E2B_07193441$CA-Accord-447307$ACCORD$$57$YR$A$M$Y$$$20240930$$HP$CA$CA
243771891$24377189$1$I$20240101$20240918$20240930$20240930$PER$$US-ABBVIE-5931255$ABBVIE$$$$$M$Y$$$20240930$$MD$US$US
243771921$24377192$1$I$$20240904$20240930$20240930$PER$$US-SA-2024SA236388$SANOFI AVENTIS$$21$YR$A$F$Y$$$20240930$$MD$US$US
243771941$24377194$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5937939$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243771951$24377195$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5939159$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243771961$24377196$1$I$$20240814$20240930$20240930$PER$$US-NOVAST LABORATORIES INC.-2024RIC000059$NOVAST$$$$$$Y$$$20240927$$PH$US$US
243771971$24377197$1$I$20240101$20240920$20240930$20240930$EXP$$US-JNJFOC-20240901818$JOHNSON AND JOHNSON$$6$DEC$A$F$Y$$$20240930$$HP$US$US
243771981$24377198$1$I$$20240924$20240930$20240930$EXP$$CA-ABBVIE-5940791$ABBVIE$$73$YR$$F$Y$$$20240930$$CN$CA$CA
243771991$24377199$1$I$20240830$20240926$20240930$20240930$EXP$FR-AFSSAPS-AN2024001324$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-153006$BRISTOL MYERS SQUIBB$$84$YR$E$M$Y$68$KG$20240930$$MD$FR$FR
243772011$24377201$1$I$20240918$20240920$20240930$20240930$EXP$$CN-ALCON LABORATORIES-ALC2024CN004375$ALCON$$58$YR$$F$Y$62$KG$20240930$$HP$CN$CN
243772021$24377202$1$I$$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192171$AMGEN$$52$YR$A$F$Y$82.64$KG$20240929$$PH$US$US
243772031$24377203$1$I$$20240923$20240930$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR118865$VIIV$$$$$$Y$$$20240930$$HP$US$US
243772041$24377204$1$I$$20240923$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409014108$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240930$$CN$US$US
243772081$24377208$1$I$$20240923$20240930$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR118931$VIIV$$$$$F$Y$65.351$KG$20240930$$CN$US$US
243772091$24377209$1$I$$20231205$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00623$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240925$$PH$US$US
243772101$24377210$1$I$$20240212$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00072$PRINSTON PHARMACEUTICAL$$76$YR$$F$Y$$$20240925$$CN$US$US
243772111$24377211$1$I$$20240313$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00124$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240925$$CN$US$US
243772121$24377212$1$I$$20240703$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00268$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240925$$CN$US$US
243772131$24377213$1$I$20240720$20240726$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00288$PRINSTON PHARMACEUTICAL$$65$YR$$M$Y$$$20240925$$CN$US$US
243772141$24377214$1$I$20230906$20230914$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00461$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240925$$CN$US$US
243772151$24377215$1$I$$20230918$20240930$20240930$EXP$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00466$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240925$$CN$US$US
243772161$24377216$1$I$20240301$20240320$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00134$PRINSTON PHARMACEUTICAL$$62$YR$$F$Y$$$20240925$$CN$US$US
243772171$24377217$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011229$APOTEX$$60$YR$$M$Y$$$20240930$$CN$CA$CA
243772181$24377218$1$I$$20240327$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00148$PRINSTON PHARMACEUTICAL$$$$$F$Y$$$20240925$$CN$US$US
243772191$24377219$1$I$20221201$20240506$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00207$PRINSTON PHARMACEUTICAL$$79$YR$$F$Y$$$20240925$$CN$US$US
243772201$24377220$1$I$$20230913$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00453$PRINSTON PHARMACEUTICAL$$$$$$Y$$$20240925$$CN$US$US
243772211$24377221$1$I$20230901$20230915$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00463$PRINSTON PHARMACEUTICAL$$33$YR$$M$Y$$$20240925$$CN$US$US
243772221$24377222$1$I$$20231010$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00531$PRINSTON PHARMACEUTICAL$$$$$F$Y$49.433$KG$20240925$$CN$US$US
243772231$24377223$1$I$20231101$20231127$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00605$PRINSTON PHARMACEUTICAL$$24$YR$$M$Y$$$20240925$$CN$US$US
243772241$24377224$1$I$20230101$20231129$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00614$PRINSTON PHARMACEUTICAL$$$$$M$Y$$$20240925$$CN$US$US
243772251$24377225$1$I$20230901$20230930$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00492$PRINSTON PHARMACEUTICAL$$43$YR$$F$Y$68.027$KG$20240925$$CN$US$US
243772261$24377226$1$I$20231101$20231108$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00571$PRINSTON PHARMACEUTICAL$$71$YR$$F$Y$$$20240925$$CN$US$US
243772271$24377227$1$I$20240723$20240801$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00305$PRINSTON PHARMACEUTICAL$$43$YR$$F$Y$86.168$KG$20240925$$CN$US$US
243772281$24377228$1$I$20240411$20240919$20240930$20240930$EXP$$GB-AMGEN-GBRSP2024193066$AMGEN$$81$YR$E$F$Y$62.65$KG$20240929$$HP$GB$GB
243772291$24377229$1$I$20230101$20240212$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2024PRN00073$PRINSTON PHARMACEUTICAL$$$$$F$Y$107.96$KG$20240925$$CN$US$US
243772301$24377230$1$I$20240101$20240925$20240930$20240930$EXP$$CA-ABBVIE-5750076$ABBVIE$$$$$M$Y$$$20240930$$MD$CA$CA
243772311$24377231$1$I$20231001$20231128$20240930$20240930$PER$$US-PRINSTON PHARMACEUTICAL INC.-2023PRN00615$PRINSTON PHARMACEUTICAL$$64$YR$$M$Y$103.4$KG$20240925$$CN$US$US
243772321$24377232$1$I$20240705$20240920$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-046861$AUROBINDO$$53$YR$$M$Y$$$20240930$$PH$GB$GB
243772341$24377234$1$I$20220831$20221204$20240930$20240930$EXP$IT-MINISAL02-895774$IT-Accord-426853$ACCORD$$75$YR$E$M$Y$$$20240930$$MD$IT$IT
243772351$24377235$1$I$$20240924$20240930$20240930$PER$$US-JNJFOC-20240965343$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20240930$$MD$US$US
243772361$24377236$1$I$20240719$20240923$20240930$20240930$EXP$$JP-ARGENX-2024-ARGX-JP005785AA$ARGENX BVBA$$$$$$Y$$$20240930$$MD$JP$JP
243772371$24377237$1$I$20231207$20240927$20240927$20240927$DIR$720258$$FDA-CTU$$90$YR$$M$N$94$KG$20240927$N$HP$US$
243772381$24377238$1$I$20240111$20240927$20240927$20240927$DIR$720256$$FDA-CTU$$78$YR$$M$N$85$KG$20240927$N$HP$US$
243772391$24377239$1$I$20231205$20240927$20240927$20240927$DIR$720257$$FDA-CTU$$94$YR$$M$N$66$KG$20240927$N$HP$US$
243772401$24377240$1$I$$20240925$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153587$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240930$$CN$US$US
243772411$24377241$1$I$20231221$20240927$20240927$20240927$DIR$720297$$FDA-CTU$$66$YR$$F$N$$$20240927$N$HP$US$
243772451$24377245$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA276729$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
243772461$24377246$1$I$20210101$20240917$20240930$20240930$EXP$$US-NOVOPROD-1287736$NOVO NORDISK$$72$YR$$F$Y$$$20240930$$CN$US$US
243772471$24377247$1$I$$20240917$20240930$20240930$EXP$$FR-NOVOPROD-1287954$NOVO NORDISK$$$$$F$Y$$$20240930$$PH$FR$FR
243772481$24377248$1$I$20240101$20240903$20240930$20240930$PER$$US-SA-2024SA273026$SANOFI AVENTIS$$7$YR$C$M$Y$21.315$KG$20240930$$MD$US$US
243772491$24377249$1$I$20231222$20240927$20240927$20240927$DIR$720296$$FDA-CTU$$59$YR$$M$N$$$20240927$N$HP$US$
243772501$24377250$1$I$20240928$20240928$20240928$20240928$DIR$720490$$FDA-CTU$$61$YR$$F$N$99.9$KG$20240928$N$CN$US$
243772511$24377251$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA275755$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240930$$MD$US$US
243772531$24377253$1$I$$20240924$20240930$20240930$EXP$$US-JNJFOC-20240969880$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
243772541$24377254$1$I$20240101$20240919$20240930$20240930$EXP$$US-UCBSA-2024043495$UCB$$$$$M$Y$$$20240930$$CN$US$US
243772551$24377255$1$I$20231216$20240928$20240928$20240928$DIR$720508$$FDA-CTU$$34$YR$$F$N$56.25$KG$20240928$N$CN$US$
243772561$24377256$1$I$$20240917$20240930$20240930$EXP$$GB-NOVOPROD-1286956$NOVO NORDISK$$$$$M$Y$$$20240930$$HP$GB$GB
243772571$24377257$1$I$20240101$20240918$20240930$20240930$EXP$$BR-NOVOPROD-1285740$NOVO NORDISK$$44$YR$$F$Y$91$KG$20240930$$CN$BR$BR
243772581$24377258$1$I$20221205$20240917$20240930$20240930$EXP$SE-SEMPA-2024-006682$SE-NOVOPROD-1284247$NOVO NORDISK$$$$$M$Y$93$KG$20240930$$HP$SE$SE
243772591$24377259$1$I$20240902$20240918$20240930$20240930$EXP$GB-MHRA-MED-202409061024203940-QSDZP$GB-NOVOPROD-1285523$NOVO NORDISK$$73$YR$$M$Y$70$KG$20240930$$CN$GB$GB
243772601$24377260$1$I$$20240917$20240930$20240930$EXP$$US-NOVOPROD-1287191$NOVO NORDISK$$$$$F$Y$$$20240930$$CN$US$US
243772611$24377261$1$I$20240904$20240924$20240930$20240930$PER$$US-AMGEN-USASP2024190571$AMGEN$$78$YR$E$F$Y$$$20240929$$CN$US$US
243772621$24377262$1$I$20240915$20240918$20240930$20240930$EXP$CN-NMPA-4418821005954202400018$CN-NOVOPROD-1286405$NOVO NORDISK$$71$YR$$M$Y$76$KG$20240930$$HP$CN$CN
243772631$24377263$1$I$20240913$20240918$20240930$20240930$EXP$CN-NMPA-4419001005629202400112$CN-NOVOPROD-1286406$NOVO NORDISK$$87$YR$$F$Y$58$KG$20240930$$HP$CN$CN
243772641$24377264$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA279392$SANOFI AVENTIS$$$$A$$Y$$$20240930$$CN$US$US
243772651$24377265$1$I$$20240918$20240930$20240930$EXP$CA-MHPD-E2B_07210682$CA-Accord-447314$ACCORD$$4$YR$C$M$Y$$$20240930$$HP$CA$CA
243772661$24377266$1$I$$20240924$20240930$20240930$EXP$$BE-SANDOZ INC.-SDZ2024BE081750$SANDOZ$$$$I$F$Y$$$20240930$$HP$BE$BE
243772671$24377267$1$I$$20240919$20240930$20240930$EXP$$US-JNJFOC-20240960285$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240930$$HP$US$US
243772691$24377269$1$I$20240101$20240920$20240930$20240930$EXP$$CA-CELLTRION INC.-2023CA022672$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
243772711$24377271$1$I$20240917$20240917$20240930$20240930$EXP$$US-UCBSA-2024047866$UCB$$53$YR$$F$Y$$$20240930$$CN$US$US
243772721$24377272$1$I$$20240920$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-047065$AUROBINDO$$69$YR$$F$Y$76$KG$20240930$$HP$GB$GB
243772731$24377273$1$I$20240615$20240924$20240930$20240930$PER$$US-ROCHE-10000090567$ROCHE$$21$YR$A$F$Y$$$20240930$$CN$US$US
243772741$24377274$1$I$20240917$20240924$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US082824$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
243772751$24377275$1$I$$20240917$20240930$20240930$EXP$$GB-UCBSA-2024047791$UCB$$$$$F$Y$$$20240930$$CN$GB$GB
243772761$24377276$1$I$20240918$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409180906584710-RMLZB$GB-Accord-448004$ACCORD$$57$YR$A$F$Y$70$KG$20240930$$CN$GB$GB
243772791$24377279$1$I$20240922$20240923$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409014354$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240930$$CN$US$US
243772801$24377280$1$I$20220525$20240924$20240930$20240930$EXP$$CA-TAKEDA-2024TUS095368$TAKEDA$$59$YR$$F$Y$$$20240930$$CN$CA$CA
243772811$24377281$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017865$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240930$$CN$US$US
243772821$24377282$1$I$$20240910$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202405000303$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240930$$CN$US$US
243772831$24377283$1$I$$20240920$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-046880$AUROBINDO$$51$YR$$F$Y$58$KG$20240930$$MD$GB$GB
243772841$24377284$1$I$$20240918$20240930$20240930$EXP$CA-MHPD-E2B_07215614$CA-Accord-447317$ACCORD$$$$C$M$Y$22$KG$20240930$$PH$CA$CA
243772851$24377285$1$I$20230727$20240925$20240930$20240930$EXP$$JP-TAKEDA-2024TJP014122$TAKEDA$$12$YR$$M$Y$36.2$KG$20240930$$MD$JP$JP
243772861$24377286$1$I$$20240916$20240930$20240930$EXP$$GB-AMNEAL PHARMACEUTICALS-2024-AMRX-03537$AMNEAL$$$$$$Y$$$20240930$$CN$GB$GB
243772871$24377287$1$I$20240904$20240926$20240930$20240930$PER$$US-ROCHE-10000093386$ROCHE$$52$YR$A$M$Y$$$20240930$$CN$US$US
243772881$24377288$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5939620$ABBVIE$$$$$$Y$$$20240930$$CN$US$US
243772902$24377290$2$F$20240831$20240924$20240930$20240930$EXP$$US-ROCHE-10000091533$ROCHE$$51$YR$A$F$Y$$$20240930$$CN$US$US
243772911$24377291$1$I$$20240918$20240930$20240930$EXP$$US-NOVOPROD-1287953$NOVO NORDISK$$$$$F$Y$$$20240930$$CN$US$US
243772921$24377292$1$I$$20240918$20240930$20240930$EXP$$TR-NOVOPROD-1287850$NOVO NORDISK$$$$$F$Y$$$20240930$$CN$TR$TR
243772931$24377293$1$I$$20240927$20240930$20240930$PER$$US-ROCHE-10000093423$ROCHE$$43$YR$A$F$Y$$$20240930$$HP$US$US
243772941$24377294$1$I$20231207$20240927$20240927$20240927$DIR$720259$$FDA-CTU$$63$YR$$M$N$145$KG$20240927$N$PH$US$
243772951$24377295$1$I$$20240918$20240930$20240930$EXP$$US-NOVOPROD-1289123$NOVO NORDISK$$54$YR$$M$Y$$$20240930$$CN$US$US
243772961$24377296$1$I$$20240918$20240930$20240930$EXP$$FR-NOVOPROD-1287866$NOVO NORDISK$$$$A$F$Y$$$20240930$$MD$FR$FR
243772971$24377297$1$I$$20240926$20240930$20240930$EXP$$US-JNJFOC-20240972088$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$US$US
243773001$24377300$1$I$20240124$20240927$20240927$20240927$DIR$720265$$FDA-CTU$$67$YR$$M$N$122$KG$20240927$N$HP$US$
243773011$24377301$1$I$20231218$20240927$20240927$20240927$DIR$720261$$FDA-CTU$$66$YR$$M$N$118$KG$20240927$N$HP$US$
243773021$24377302$1$I$20240307$20240923$20240930$20240930$EXP$FR-AFSSAPS-PV2024000871$FR-GSK-FR2024117914$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$FR$FR
243773031$24377303$1$I$$20240919$20240930$20240930$EXP$$BR-NOVOPROD-1286392$NOVO NORDISK$$456$MON$$M$Y$69$KG$20240930$$CN$BR$BR
243773041$24377304$1$I$20240919$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192683$AMGEN$$$$$$Y$$$20240929$$HP$US$US
243773061$24377306$1$I$20210901$20240928$20240928$20240928$DIR$720493$$FDA-CTU$$48$YR$$F$N$113.4$KG$20240928$N$CN$US$
243773081$24377308$1$I$20240901$20240928$20240928$20240928$DIR$720468$$FDA-CTU$$62$YR$$F$N$69.75$KG$20240928$N$CN$US$
243773091$24377309$1$I$$20240817$20240930$20240930$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053729$BOEHRINGER INGELHEIM$$$$$M$Y$$$20240930$$MD$PL$PL
243773101$24377310$1$I$20240112$20240927$20240927$20240927$DIR$720271$$FDA-CTU$$78$YR$$M$N$85$KG$20240927$N$HP$US$
243773121$24377312$1$I$$20240918$20240930$20240930$EXP$CA-MHPD-E2B_07208591$CA-Accord-447423$ACCORD$$$$$$Y$$$20240930$$HP$CA$CA
243773131$24377313$1$I$$20240918$20240930$20240930$EXP$CA-MHPD-E2B_07235998$CA-Accord-447456$ACCORD$$45$YR$A$M$Y$$$20240930$$CN$CA$CA
243773141$24377314$1$I$20231120$20240927$20240927$20240927$DIR$720272$$FDA-CTU$$69$YR$$M$N$$$20240927$N$HP$US$
243773161$24377316$1$I$20240901$20240919$20240930$20240930$EXP$$JP-TAKEDA-2024TUS095755$TAKEDA$$5$DEC$$$Y$100$KG$20240930$$MD$JP$JP
243773171$24377317$1$I$20231107$20240927$20240927$20240927$DIR$720274$$FDA-CTU$$61$YR$$M$N$$$20240927$N$HP$US$
243773181$24377318$1$I$20200101$20240925$20240930$20240930$EXP$DE-002147023-NVSC2024DE184942$DE-ROCHE-10000090546$ROCHE$$32$YR$A$F$Y$$$20240930$$MD$DE$DE
243773191$24377319$1$I$20240101$20240916$20240930$20240930$EXP$$US-UCBSA-2024030819$UCB$$$$$F$Y$$$20240930$$CN$US$US
243773201$24377320$1$I$20230901$20240923$20240930$20240930$EXP$FR-AFSSAPS-AN2024001270$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112655$ZYDUS PHARM$$$$$$Y$$$20240928$$PH$FR$FR
243773211$24377321$1$I$20231104$20240927$20240927$20240927$DIR$720260$$FDA-CTU$$89$YR$$M$N$77$KG$20240927$N$HP$US$
243773221$24377322$1$I$$20240926$20240930$20240930$EXP$$US-JNJFOC-20240972557$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
243773231$24377323$1$I$20240901$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192436$AMGEN$$65$YR$E$M$Y$$$20240929$$CN$US$US
243773241$24377324$1$I$20240915$20240925$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152678$BRISTOL MYERS SQUIBB$$$$$M$Y$72.12$KG$20240930$$CN$US$US
243773251$24377325$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017370$ELI LILLY AND CO$$57$YR$A$M$Y$$$20240930$$CN$US$US
243773261$24377326$1$I$20240919$20240920$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409013567$ELI LILLY AND CO$$59$YR$A$F$Y$$$20240930$$CN$US$US
243773271$24377327$1$I$20240101$20240920$20240930$20240930$EXP$$CA-CELLTRION INC.-2024CA003111$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
243773281$24377328$1$I$20240319$20240922$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-047142$AUROBINDO$$66$YR$$F$Y$62$KG$20240930$$CN$GB$GB
243773291$24377329$1$I$20200930$20240919$20240930$20240930$EXP$$PL-TWI PHARMACEUTICAL, INC-20240900142$TWI PHARMACEUTICALS$$31$YR$$F$Y$60$KG$20240928$$MD$PL$PL
243773301$24377330$1$I$20240920$20240920$20240930$20240930$PER$$US-ABBVIE-5934126$ABBVIE$$48$YR$$M$Y$$$20240930$$CN$US$US
243773321$24377332$1$I$$20240927$20240930$20240930$PER$$US-ROCHE-10000094066$ROCHE$$$$E$M$Y$$$20240930$$CN$US$US
243773331$24377333$1$I$$20240916$20240930$20240930$EXP$$IN-PBT-009718$PANACEA BIOTEC$Anitha V, Patwardhan V, Ravindran M. Long-term prognosis of penetrating keratoplasty in a patient with limited form of Scleroderma- a case report. Eur J Ophthalmol. 2024 Sep 13:11206721241284405. doi: 10.1177/11206721241284405.$47$YR$A$F$Y$$$20240930$$HP$IN$IN
243773351$24377335$1$I$20240101$20240920$20240930$20240930$PER$$US-BIOGEN-2024BI01283729$BIOGEN$$$$$F$Y$$$20240930$$PH$US$US
243773361$24377336$1$I$20240101$20240912$20240930$20240930$EXP$$IT-AMGEN-ITASP2024190998$AMGEN$$62$YR$A$F$Y$$$20240929$$HP$IT$IT
243773371$24377337$1$I$$20240925$20240930$20240930$EXP$PL-URPL-1-3566-2020$PL-ROCHE-10000090707$ROCHE$$64$YR$A$F$Y$77$KG$20240930$$MD$PL$PL
243773381$24377338$1$I$20240904$20240924$20240930$20240930$EXP$$PK-ROCHE-10000090128$ROCHE$$43$YR$A$F$Y$$$20240930$$CN$PK$PK
243773391$24377339$1$I$$20240830$20240930$20240930$PER$$US-CHATTEMPRD-2024OHG033319$CHATTEM$$$$$F$Y$$$20240930$$CN$US$US
243773401$24377340$1$I$20230101$20240919$20240930$20240930$EXP$$CA-UCBSA-2024048584$UCB$$$$$M$Y$$$20240930$$CN$CA$CA
243773411$24377341$1$I$$20240919$20240930$20240930$PER$$US-JNJFOC-20240955273$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243773431$24377343$1$I$20240701$20240920$20240930$20240930$EXP$$JP-EXELIXIS-EXL-2024-000615$EXELIXIS$$$$$$Y$$$20240929$$PH$JP$JP
243773441$24377344$1$I$20211101$20240923$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409014255$ELI LILLY AND CO$$61$YR$A$F$Y$$$20240930$$MD$US$US
243773451$24377345$1$I$$20240926$20240930$20240930$PER$$US-HALEON-2199264$Haleon PLC$$$$$M$Y$$$20240930$$CN$US$US
243773461$24377346$1$I$$20240919$20240930$20240930$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005805$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243773471$24377347$1$I$$20240923$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409014721$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243773481$24377348$1$I$$20240919$20240930$20240930$EXP$CA-MHPD-E2B_07250059$CA-Accord-447900$ACCORD$$63$YR$A$F$Y$$$20240930$$HP$CA$CA
243773491$24377349$1$I$$20240920$20240930$20240930$EXP$$US-862174955-ML2024-05101$MICRO LABS$Malani KA, Finn A. Metformin-associated lactic acidosis: a serious complication of a common drug. BMJ case reports. 2024;17(9): e260592. DOI: 10.1136/bcr-2024-260592.$8$DEC$E$M$Y$$$20240930$$MD$US$US
243773501$24377350$1$I$$20240917$20240930$20240930$EXP$$FR-862174955-ML2024-05080$MICRO LABS$Toutain J, Fares S, Cochereau I, Titah C, Gargouri MA. Severe Vaso-Occlusive and Ocular Decompression Retinopathy Revealing a Sickle Cell Trait in a Patient with Herpetic Uveitis. Ocular Immunology and Inflammation. 2022 Nov 28;32(6): 1079-1082. doi:10.1080/09273948.2022.2147545.$24$YR$A$M$Y$$$20240930$$MD$FR$FR
243773521$24377352$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152677$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240930$$HP$US$US
243773531$24377353$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011146$APOTEX$$62$YR$$M$Y$$$20240930$$HP$CA$CA
243773541$24377354$1$I$20240813$20240923$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015110$BEIGENE$$$$$$Y$$$20240930$$HP$CN$CN
243773551$24377355$1$I$$20240917$20240930$20240930$EXP$$US-KOANAAP-SML-US-2024-00970$SHILPA MEDICARE$Popat D, Sanghavi N, Singh A, Sawhney R. MM-657 Parsonage Turner Syndrome Complicating Multiple Myeloma Therapy: Nothing to Shrug your Shoulders at. clinical lymphoma myeloma and leukemia. 2024 Sep;24(1): S578-S578. doi:10.1016/S2152-2650(24)01720-8.$66$YR$E$M$Y$$$20240930$$MD$US$US
243773561$24377356$1$I$20240915$20240923$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015125$BEIGENE$$$$$$Y$$$20240930$$HP$CN$CN
243773571$24377357$1$I$$20240919$20240930$20240930$EXP$$RO-ABBVIE-5941936$ABBVIE$Mihalcea RM. A case of rapid cognitive decline in a patient known with bipolar disorder. Ro J Psychiatry Psychother. 2022;24(3):78-80.$59$YR$$F$Y$$$20240930$$HP$RO$RO
243773581$24377358$1$I$20240801$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017475$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240930$$CN$US$US
243773591$24377359$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152360$BRISTOL MYERS SQUIBB$Sudadi S, Wu H, Hoskote A, Wu H. The shocking case of a bleeding heart: obstructive shock in spontaneous hemorrhagic pericardial effusion with apixaban therapy. Chest. 2024;166(4S):3040A-1A.doi:10.1016/j.chest.2024.06.1830.$78$YR$E$M$Y$$$20240930$$HP$US$US
243773601$24377360$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017847$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240930$$CN$US$US
243773621$24377362$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017358$ELI LILLY AND CO$$50$YR$A$F$Y$$$20240930$$CN$US$US
243773631$24377363$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117064$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243773641$24377364$1$I$$20240921$20240930$20240930$EXP$$US-BEH-2024179211$CSL BEHRING$$$$E$F$Y$$$20240930$$HP$US$US
243773661$24377366$1$I$$20230820$20240930$20240930$PER$$US-AUROBINDO-AUR-APL-2023-056439$AUROBINDO$$$$$F$Y$$$20240930$$CN$US$US
243773681$24377368$1$I$$20230911$20240930$20240930$PER$$US-AUROBINDO-AUR-APL-2023-059622$AUROBINDO$$$$$F$Y$$$20240930$$CN$US$US
243773691$24377369$1$I$20240101$20240923$20240930$20240930$EXP$$US-009507513-2409USA007996$MERCK$$78$YR$$F$Y$$$20240930$$CN$US$US
243773711$24377371$1$I$$20240924$20240930$20240930$PER$$US-BIOGEN-2024BI01284040$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243773721$24377372$1$I$20130108$20240925$20240930$20240930$PER$$US-BIOGEN-2013BI012276$BIOGEN$$34$YR$$F$Y$$$20240930$$CN$US$US
243773731$24377373$1$I$$20231113$20240930$20240930$PER$$US-AUROBINDO-AUR-APL-2023-067310$AUROBINDO$$$$$F$Y$$$20240930$$CN$US$US
243773761$24377376$1$I$$20240920$20240930$20240930$EXP$$US-EMD Serono-2024050852$EMD SERONO INC$$$$A$F$Y$$$20240930$$HP$US$US
243773771$24377377$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005545$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243773781$24377378$1$I$20240919$20240924$20240930$20240930$PER$$US-ROCHE-10000090987$ROCHE$$72$YR$E$F$Y$$$20240930$$CN$US$US
243773791$24377379$1$I$$20240920$20240930$20240930$EXP$$BR-EMD Serono-2024050664$EMD SERONO INC$$$$E$M$Y$$$20240930$$CN$BR$BR
243773801$24377380$1$I$20230901$20231101$20240930$20240930$PER$$US-AUROBINDO-AUR-APL-2023-067505$AUROBINDO$$79$YR$$F$Y$88$KG$20240930$$CN$US$US
243773811$24377381$1$I$$20240326$20240930$20240930$PER$$US-AUROBINDO-AUR-APL-2024-009281$AUROBINDO$$80$YR$$F$Y$72.57$KG$20240930$$CN$US$US
243773821$24377382$1$I$$20240919$20240930$20240930$EXP$$US-NOVOPROD-1288003$NOVO NORDISK$$$$$F$Y$$$20240930$$HP$US$US
243773831$24377383$1$I$20240914$20240919$20240930$20240930$EXP$$US-NOVOPROD-1287968$NOVO NORDISK$$40$YR$$M$Y$$$20240930$$HP$US$US
243773841$24377384$1$I$$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409160912479180-GTLVH$GB-NOVOPROD-1286900$NOVO NORDISK$$45$YR$$F$Y$92$KG$20240930$$PH$GB$GB
243773851$24377385$1$I$20240912$20240919$20240930$20240930$EXP$$CA-NOVOPROD-1288500$NOVO NORDISK$$$$$F$Y$$$20240930$$CN$CA$CA
243773861$24377386$1$I$$20240923$20240930$20240930$PER$$US-CHATTEMPRD-2024OHG033299$CHATTEM$$$$$$Y$$$20240930$$CN$US$US
243773881$24377388$1$I$$20240919$20240930$20240930$EXP$$US-NOVOPROD-1287908$NOVO NORDISK$$$$A$M$Y$$$20240930$$CN$US$US
243773891$24377389$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005546$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243773901$24377390$1$I$20231102$20240418$20240930$20240930$PER$$US-AUROBINDO-AUR-APL-2024-017865$AUROBINDO$$7$YR$$M$Y$28$KG$20240930$$CN$US$US
243773911$24377391$1$I$20240801$20240923$20240930$20240930$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053069$BOEHRINGER INGELHEIM$$81$YR$E$F$Y$$$20240930$$CN$US$US
243773921$24377392$1$I$$20240919$20240930$20240930$EXP$$DK-NOVOPROD-1290843$NOVO NORDISK$$70$YR$$F$Y$$$20240930$$MD$DK$DK
243773931$24377393$1$I$$20240412$20240930$20240930$PER$$US-AUROBINDO-AUR-APL-2024-019717$AUROBINDO$$$$$M$Y$$$20240930$$PH$US$US
243773941$24377394$1$I$$20240412$20240930$20240930$PER$$US-AUROBINDO-AUR-APL-2024-016713$AUROBINDO$$$$$M$Y$$$20240930$$HP$US$US
243773951$24377395$1$I$20240308$20240510$20240930$20240930$PER$$US-AUROBINDO-AUR-APL-2024-021916$AUROBINDO$$70$YR$$F$Y$58.96$KG$20240930$$HP$US$US
243773961$24377396$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047144$AUROBINDO$$64$YR$$F$Y$115$KG$20240930$$HP$CA$CA
243773971$24377397$1$I$$20240531$20240930$20240930$PER$$US-AUROBINDO-AUR-APL-2024-019510$AUROBINDO$$$$$F$Y$$$20240930$$CN$US$US
243773981$24377398$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093200$ROCHE$$$$A$M$Y$$$20240930$$CN$US$US
243773991$24377399$1$I$20240901$20240926$20240930$20240930$EXP$$US-SA-2024SA279771$SANOFI AVENTIS$$$$$F$Y$$$20240930$$CN$US$US
243774001$24377400$1$I$20240906$20240923$20240930$20240930$EXP$$US-SA-2024SA276942$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240930$$CN$US$US
243774011$24377401$1$I$20240918$20240924$20240930$20240930$EXP$$CN-SA-2024SA278676$SANOFI AVENTIS$$72$YR$E$M$Y$53$KG$20240930$$HP$CN$CN
243774021$24377402$1$I$$20240920$20240930$20240930$EXP$$CA-TAKEDA-2015TUS018138$TAKEDA$$$$$M$Y$$$20240930$$MD$CA$CA
243774031$24377403$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093282$ROCHE$$$$$$Y$$$20240930$$CN$US$US
243774041$24377404$1$I$20230101$20240917$20240930$20240930$EXP$$JP-ROCHE-10000088313$ROCHE$Maruki T, Nomoto H, Iwamoto N, Yamamoto K, Kurokawa M, Ohmagari N. Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for fol. Journal of Infection and Chemotherapy. 2024;30 (8):793-5. doi:10.1016/j.jiac.2024.01.008.$59$YR$A$F$Y$$$20240930$$MD$JP$JP
243774061$24377406$1$I$$20240920$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153451$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240930$$MD$US$US
243774071$24377407$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017406$ELI LILLY AND CO$$$$$M$Y$$$20240930$$CN$US$US
243774081$24377408$1$I$20240925$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017381$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240930$$CN$US$US
243774091$24377409$1$I$20240925$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017437$ELI LILLY AND CO$$49$YR$A$$Y$$$20240930$$MD$US$US
243774101$24377410$1$I$20240910$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017513$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240930$$CN$US$US
243774111$24377411$1$I$20240101$20240905$20240930$20240930$PER$$US-SA-2024SA273401$SANOFI AVENTIS$$45$YR$A$M$Y$86.82$KG$20240930$$MD$US$US
243774121$24377412$1$I$20240901$20240909$20240930$20240930$PER$$US-SA-2024SA277359$SANOFI AVENTIS$$57$YR$A$M$Y$84.09$KG$20240930$$MD$US$US
243774131$24377413$1$I$$20240910$20240930$20240930$PER$$US-TEVA-VS-3243890$TEVA$$56$YR$$F$Y$$$20240930$$MD$US$US
243774141$24377414$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000092499$ROCHE$$47$YR$A$F$Y$$$20240930$$MD$US$US
243774151$24377415$1$I$20240907$20240910$20240930$20240930$PER$$US-SA-2024SA278650$SANOFI AVENTIS$$10$YR$C$M$Y$$$20240930$$MD$US$US
243774161$24377416$1$I$$20240910$20240930$20240930$PER$$FI-SA-2024SA278225$SANOFI AVENTIS$$8$YR$C$F$Y$$$20240930$$CN$US$FI
243774171$24377417$1$I$20220101$20240920$20240930$20240930$PER$$US-SA-2024SA275803$SANOFI AVENTIS$$34$YR$A$M$Y$$$20240930$$MD$US$US
243774181$24377418$1$I$20240902$20240927$20240930$20240930$EXP$$CN-ROCHE-10000094204$ROCHE$$7$YR$C$M$Y$22$KG$20240930$$HP$CN$CN
243774201$24377420$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA278102$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
243774211$24377421$1$I$20240801$20240909$20240930$20240930$PER$$US-SA-2024SA276905$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240930$$MD$US$US
243774221$24377422$1$I$$20240907$20240930$20240930$PER$$US-SA-2024SA276317$SANOFI AVENTIS$$$$E$M$Y$92$KG$20240930$$MD$US$US
243774231$24377423$1$I$20240101$20240910$20240930$20240930$PER$$US-SA-2024SA279447$SANOFI AVENTIS$$25$YR$A$F$Y$104$KG$20240930$$MD$US$US
243774241$24377424$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA273851$SANOFI AVENTIS$$69$YR$E$F$Y$$$20240930$$HP$US$US
243774251$24377425$1$I$20240919$20240919$20240930$20240930$PER$$US-SA-2024SA274982$SANOFI AVENTIS$$64$YR$A$M$Y$77.27$KG$20240930$$PH$US$US
243774261$24377426$1$I$20240101$20240910$20240930$20240930$PER$$US-SA-2024SA279333$SANOFI AVENTIS$$49$YR$A$F$Y$66.36$KG$20240930$$MD$US$US
243774271$24377427$1$I$20240310$20240923$20240930$20240930$PER$$US-SA-2024SA276477$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240930$$MD$US$US
243774281$24377428$1$I$20240801$20240920$20240930$20240930$PER$$US-SA-2024SA274553$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240930$$HP$US$US
243774291$24377429$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA276489$SANOFI AVENTIS$$72$YR$E$F$Y$$$20240930$$HP$US$US
243774301$24377430$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA276582$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240930$$MD$US$US
243774311$24377431$1$I$20240101$20240924$20240930$20240930$PER$$US-SA-2024SA276801$SANOFI AVENTIS$$39$YR$A$F$Y$$$20240930$$MD$US$US
243774321$24377432$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011224$APOTEX$$67$YR$$F$Y$$$20240930$$CN$CA$CA
243774331$24377433$1$I$$20240920$20240930$20240930$EXP$$CN-ROCHE-10000088487$ROCHE$$70$YR$E$F$Y$58$KG$20240930$$MD$CN$CN
243774351$24377435$1$I$$20240924$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA007021US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$MD$US$US
243774361$24377436$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153137$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240930$$HP$US$US
243774371$24377437$1$I$$20240926$20240930$20240930$PER$$US-JNJFOC-20240971763$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$HP$US$US
243774381$24377438$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047097$AUROBINDO$$90$YR$$M$Y$$$20240930$$CN$CA$CA
243774391$24377439$1$I$20240701$20240916$20240930$20240930$PER$FR-AFSSAPS-RS2024000845$FR-IGSA-BIG0030718$GRIFOLS$$61$YR$$M$Y$72$KG$20240930$$MD$FR$FR
243774401$24377440$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA274331$SANOFI AVENTIS$$31$YR$A$M$Y$$$20240930$$MD$US$US
243774411$24377441$1$I$$20240927$20240930$20240930$EXP$$US-ROCHE-10000093451$ROCHE$$$$$F$Y$$$20240930$$MD$US$US
243774421$24377442$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA276462$SANOFI AVENTIS$$47$YR$A$M$Y$$$20240930$$HP$US$US
243774431$24377443$1$I$$20240927$20240930$20240930$EXP$$US-ROCHE-10000093979$ROCHE$$$$$$Y$$$20240930$$CN$US$US
243774441$24377444$1$I$20240101$20240925$20240930$20240930$EXP$$US-JNJFOC-20240970638$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20240930$$HP$US$US
243774451$24377445$1$I$$20240919$20240930$20240930$EXP$CN-MLMSERVICE-20240917-PI190083-00052-1$CN-JUBILANT CADISTA PHARMACEUTICALS-2024CN001351$JUBILANT$Ning Y, Xiao M, Perlin DS, Zhao Y, Lu M, Li YI et al.. Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China. Emerging microbes + infections. 2023;12(1):2153086$$$I$M$Y$$$20240930$$MD$CN$CN
243774461$24377446$1$I$20230120$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005528$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20240930$$CN$US$US
243774471$24377447$1$I$20240725$20240920$20240930$20240930$EXP$$CA-CELLTRION INC.-2024CA003848$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
243774491$24377449$1$I$20240916$20240923$20240930$20240930$EXP$$CN-BEIGENE-BGN-2024-015107$BEIGENE$$$$$$Y$$$20240930$$HP$CN$CN
243774511$24377451$1$I$20240601$20240925$20240930$20240930$EXP$$JP-ABBVIE-5797011$ABBVIE$$84$YR$$M$Y$$$20240930$$MD$JP$JP
243774521$24377452$1$I$20230526$20240926$20240926$20240926$DIR$720043$$FDA-CTU$$81$YR$$M$N$61$KG$20240926$N$PH$US$
243774531$24377453$1$I$20240120$20240927$20240927$20240927$DIR$720267$$FDA-CTU$$64$YR$$M$N$121$KG$20240927$N$HP$US$
243774541$24377454$1$I$$20240927$20240930$20240930$EXP$$NVSC2024CN192457$NOVARTIS$$82$YR$$M$Y$$$20240930$$CN$CN$CN
243774551$24377455$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024AMR117949$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243774561$24377456$1$I$20240401$20240920$20240930$20240930$EXP$$TR-ASTELLAS-2024-AER-008136$ASTELLAS$$74$YR$E$M$Y$$$20240930$$MD$TR$TR
243774571$24377457$1$I$$20240924$20240930$20240930$EXP$$CA-ROCHE-10000091559$ROCHE$$$$$$Y$$$20240930$$MD$CA$CA
243774591$24377459$1$I$20240731$20240928$20240928$20240928$DIR$720488$$FDA-CTU$$71$YR$$F$N$44.1$KG$20240928$N$CN$US$
243774631$24377463$1$I$$20240923$20240930$20240930$EXP$$US-AMGEN-USASP2024190423$AMGEN$Paulino A.M.; Paulino S.; Roshan F.et.al. WHEN FUNGI AND AUTOIMMUNITY COLLIDE: A RARE CASE OF NONENDEMIC PULMONARY TALAROMYCOSIS IN A PATIENT WITH RHEUMATOID ARTHRITIS. Chest. 2024;166 (4):A1306-A1307$82$YR$E$F$Y$$$20240930$$HP$US$US
243774641$24377464$1$I$20240101$20240925$20240930$20240930$EXP$$US-ROCHE-10000091608$ROCHE$$70$YR$E$F$Y$$$20240930$$CN$US$US
243774651$24377465$1$I$$20240927$20240930$20240930$EXP$$US-BAUSCH-BL-2024-014588$BAUSCH AND LOMB$$72$YR$$F$Y$$$20240930$$CN$US$US
243774661$24377466$1$I$$20240923$20240930$20240930$EXP$$US-AMGEN-USASP2024191418$AMGEN$Shastri D.D.; Misra S.; Dave P et.al.. Daratumumab-induced subacute fibrinous organizing pneumonia. Chest. 2024;166 (4):3499A-3500A$75$YR$E$F$Y$$$20240930$$HP$US$US
243774671$24377467$1$I$$20240923$20240930$20240930$EXP$$US-AMGEN-USASP2024191840$AMGEN$Iyer A.; Chan P.. PULMONARY COCCIDIOIDOMYCOSIS PRESENTING AS A PULMONARY ABSCESS. Chest. 2024;166 (4):1397A-1398A$47$YR$A$M$Y$$$20240930$$HP$US$US
243774681$24377468$1$I$$20240919$20240930$20240930$EXP$$CA-APOTEX-2024AP011287$APOTEX$$36$YR$$M$Y$$$20240930$$CN$CA$CA
243774691$24377469$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047076$AUROBINDO$$58$YR$$F$Y$$$20240930$$HP$CA$CA
243774701$24377470$1$I$$20240925$20240930$20240930$EXP$$CA-HALEON-2198653$Haleon PLC$$55$YR$$F$Y$$$20240927$$HP$CA$CA
243774711$24377471$1$I$$20240924$20240930$20240930$PER$$US-ROCHE-10000091024$ROCHE$$$$$M$Y$$$20240930$$MD$US$US
243774731$24377473$1$I$20240910$20240929$20240930$20240930$EXP$$CN-ROCHE-10000094268$ROCHE$$67$YR$E$F$Y$$$20240930$$HP$CN$CN
243774741$24377474$1$I$20240925$20240926$20240930$20240930$PER$$US-ROCHE-10000093397$ROCHE$$67$YR$E$M$Y$$$20240930$$CN$US$US
243774751$24377475$1$I$$20240903$20240930$20240930$EXP$$US-SA-2024SA275640$SANOFI AVENTIS$$$$E$F$Y$$$20240930$$HP$US$US
243774761$24377476$1$I$20240917$20240924$20240930$20240930$EXP$$CA-ROCHE-10000091537$ROCHE$$26$YR$A$M$Y$$$20240930$$CN$CA$CA
243774771$24377477$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000092340$ROCHE$$$$$$Y$$$20240930$$CN$US$US
243774781$24377478$1$I$$20240926$20240930$20240930$EXP$$DE-ROCHE-10000093357$ROCHE$$54$YR$A$F$Y$$$20240930$$CN$DE$DE
243774791$24377479$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047100$AUROBINDO$$91$YR$$M$Y$$$20240930$$CN$CA$CA
243774801$24377480$1$I$$20240924$20240930$20240930$PER$$US-AMGEN-USASP2024190801$AMGEN$$$$$F$Y$$$20240930$$HP$US$US
243774811$24377481$1$I$$20240925$20240930$20240930$EXP$DE-ABBVIE-5927405$DE-ROCHE-10000090968$ROCHE$$$$A$M$Y$$$20240930$$MD$DE$DE
243774831$24377483$1$I$20240701$20240926$20240930$20240930$EXP$$US-ROCHE-10000083353$ROCHE$$56$YR$A$M$Y$147$KG$20240930$$MD$US$US
243774841$24377484$1$I$$20240923$20240930$20240930$EXP$$US-ROCHE-10000089445$ROCHE$$79$YR$E$F$Y$$$20240930$$CN$US$US
243774861$24377486$1$I$20240920$20240923$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015296$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243774871$24377487$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017226$ELI LILLY AND CO$$57$YR$A$F$Y$$$20240930$$CN$US$US
243774881$24377488$1$I$20240925$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017238$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240930$$HP$US$US
243774901$24377490$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005555$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243774911$24377491$1$I$20220601$20240823$20240930$20240930$EXP$$BR-TEVA-VS-3248275$TEVA$$32$YR$$M$Y$$$20240930$$CN$BR$BR
243774921$24377492$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005557$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243774931$24377493$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005500$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243774941$24377494$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005501$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243774951$24377495$1$I$20240917$20240919$20240930$20240930$EXP$$US-JNJFOC-20240953314$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20240930$$CN$US$US
243774971$24377497$1$I$$20240919$20240930$20240930$PER$$US-TAKEDA-2024TUS093924$TAKEDA$$$$$$Y$77$KG$20240930$$MD$US$US
243774982$24377498$2$F$20230825$20240924$20240930$20240930$EXP$$JP-009507513-2308JPN004068J$MERCK$Ooe S, Mori Y, Kageyama N. EP-0491 Experience with Preoperative/Postoperative Use of Immune Checkpoint Inhibitors (ICI) for Triple Negative (TN) Breast Cancer in Our Hospital. The 32nd Annual Meeting of the Japanese Breast Cancer Society. 300$6$DEC$$F$Y$$$20240930$$MD$JP$JP
243774991$24377499$1$I$20240926$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192474$AMGEN$$$$$$Y$$$20240930$$HP$US$US
243775001$24377500$1$I$$20240927$20240930$20240930$PER$$US-ABBVIE-5943566$ABBVIE$$38$YR$$M$Y$$$20240930$$CN$US$US
243775011$24377501$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005564$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243775021$24377502$1$I$$20240917$20240930$20240930$EXP$$GB-MSNLABS-2024MSNSPO02082$MSN LABORATORIES$$$$$$Y$$$20240930$$MD$GB$GB
243775031$24377503$1$I$$20240920$20240930$20240930$PER$$US-TAKEDA-2024TUS094246$TAKEDA$$$$$F$Y$70$KG$20240930$$MD$US$US
243775041$24377504$1$I$20220101$20240925$20240930$20240930$EXP$$US-AMGEN-USASL2024191367$AMGEN$$61$YR$A$F$Y$$$20240930$$CN$US$US
243775051$24377505$1$I$20210913$20240923$20240930$20240930$EXP$$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-053113$BOEHRINGER INGELHEIM$$72$YR$E$F$Y$$$20240930$$MD$PL$PL
243775071$24377507$1$I$20231101$20240927$20240927$20240927$DIR$720263$$FDA-CTU$$71$YR$$M$N$$$20240927$N$HP$US$
243775101$24377510$1$I$20240921$20240921$20240930$20240930$EXP$$RU-ROCHE-10000090263$ROCHE$$29$YR$A$F$Y$$$20240930$$CN$RU$RU
243775121$24377512$1$I$$20240924$20240930$20240930$PER$$US-TAKEDA-2024TUS095165$TAKEDA$$$$$$Y$$$20240930$$HP$US$US
243775131$24377513$1$I$20231113$20240927$20240927$20240927$DIR$720264$$FDA-CTU$$59$YR$$F$N$51$KG$20240927$N$HP$US$
243775161$24377516$1$I$20230425$20240927$20240927$20240927$DIR$720266$$FDA-CTU$$65$YR$$M$N$115$KG$20240927$N$HP$US$
243775171$24377517$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017101$ELI LILLY AND CO$$$$A$F$Y$$$20240930$$CN$US$US
243775181$24377518$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017228$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240930$$CN$US$US
243775191$24377519$1$I$$20240923$20240930$20240930$PER$$US-TAKEDA-2024TUS094765$TAKEDA$$$$$F$Y$66$KG$20240930$$MD$US$US
243775201$24377520$1$I$$20240923$20240930$20240930$PER$$US-TAKEDA-2024TUS094778$TAKEDA$$$$$M$Y$$$20240930$$MD$US$US
243775211$24377521$1$I$20240801$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017628$ELI LILLY AND CO$$16$YR$T$M$Y$$$20240930$$CN$US$US
243775231$24377523$1$I$20240901$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67049$$FDA-CTU$$21$YR$$M$N$$$20240927$N$PH$US$
243775241$24377524$1$I$$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151614$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240930$$CN$US$US
243775251$24377525$1$I$$20240926$20240930$20240930$EXP$$SK-ABBVIE-5943171$ABBVIE$$$$$M$Y$$$20240930$$MD$SK$SK
243775261$24377526$1$I$$20240924$20240930$20240930$PER$$US-TAKEDA-2024TUS095176$TAKEDA$$$$$F$Y$60$KG$20240930$$MD$US$US
243775271$24377527$1$I$$20240910$20240930$20240930$PER$$US-TEVA-VS-3244061$TEVA$$27$YR$$F$Y$$$20240930$$MD$US$US
243775291$24377529$1$I$$20240924$20240930$20240930$PER$$US-TAKEDA-2024TUS095626$TAKEDA$$$$$M$Y$$$20240930$$CN$US$US
243775301$24377530$1$I$$20240924$20240930$20240930$EXP$$US-JNJFOC-20240967648$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$PH$US$US
243775351$24377535$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005595$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243775361$24377536$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153785$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20240930$$CN$US$US
243775371$24377537$1$I$20240910$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409181040506270-ZQSMD$GB-Accord-448074$ACCORD$$79$YR$E$F$Y$$$20240930$$PH$GB$GB
243775381$24377538$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005585$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243775391$24377539$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005598$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243775401$24377540$1$I$20240521$20240923$20240930$20240930$EXP$$US-EXELIXIS-CABO-24080705$EXELIXIS$$82$YR$$M$Y$$$20240930$$CN$US$US
243775411$24377541$1$I$$20240924$20240930$20240930$EXP$$FI-UCBSA-2024049376$UCB$Ojanen P, Kertesz C, Peltola J. Characteristics of motion signal profiles of tonic-clonic, tonic, hyperkinetic, and motor seizures extracted from nocturnal video recordings. Epileptic Disorders. 2024;1-10$36$YR$$$Y$$$20240930$$HP$FI$FI
243775421$24377542$1$I$$20240917$20240930$20240930$EXP$$DK-ENDO USA, INC.-2024-003493$ENDO$Norup S, Rosenquist SB, Knudsen TR, Thorgaard MV.. Quetiapine-induced urinary retention. Danish Medical Journal. 2024;186 (35):1-3$22$YR$$F$Y$35$KG$20240930$$HP$DK$DK
243775431$24377543$1$I$20240615$20240619$20240930$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000514$PAREXEL$$$$$$Y$$$20240930$$CN$US$US
243775451$24377545$1$I$20240710$20240718$20240930$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000636$PAREXEL$$$$$$Y$$$20240930$$CN$US$US
243775461$24377546$1$I$20240910$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024190779$AMGEN$$55$YR$A$F$Y$$$20240930$$CN$US$US
243775471$24377547$1$I$20240926$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024192975$AMGEN$$70$YR$E$M$Y$$$20240930$$CN$US$US
243775481$24377548$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017236$ELI LILLY AND CO$$$$$$Y$$$20240930$$CN$US$US
243775491$24377549$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016388$ELI LILLY AND CO$$$$$$Y$$$20240930$$MD$US$US
243775501$24377550$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117174$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243775511$24377551$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152797$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240930$$HP$US$US
243775531$24377553$1$I$$20240926$20240930$20240930$PER$$US-BIOVITRUM-2024-US-012544$BIOVITRUM$$68$YR$$M$Y$$$20240930$$CN$US$US
243775571$24377557$1$I$20240709$20240919$20240930$20240930$EXP$FR-AFSSAPS-2024079521$FR-Accord-448120$ACCORD$$73$YR$E$F$Y$$$20240930$$PH$FR$FR
243775591$24377559$1$I$20240928$20240928$20240928$20240928$DIR$720505$$FDA-CTU$$27$YR$$M$N$81$KG$20240928$N$CN$US$
243775601$24377560$1$I$20240701$20240923$20240930$20240930$EXP$FR-AFSSAPS-PP2024001005$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112763$ZYDUS PHARM$$$$$$Y$$$20240930$$MD$FR$FR
243775611$24377561$1$I$20240823$20240923$20240930$20240930$EXP$FR-AFSSAPS-AM2024000748$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112770$ZYDUS PHARM$$$$$$Y$$$20240930$$PH$FR$FR
243775621$24377562$1$I$20240725$20240923$20240930$20240930$EXP$FR-AFSSAPS-PP2024001015$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112752$ZYDUS PHARM$$$$$$Y$$$20240930$$MD$FR$FR
243775631$24377563$1$I$20240101$20240923$20240930$20240930$EXP$FR-AFSSAPS-SE2024000729$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112760$ZYDUS PHARM$$$$$$Y$$$20240930$$MD$FR$FR
243775641$24377564$1$I$20240101$20240923$20240930$20240930$EXP$FR-AFSSAPS-TS2024001021$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112761$ZYDUS PHARM$$$$$$Y$$$20240930$$MD$FR$FR
243775651$24377565$1$I$20240822$20240923$20240930$20240930$EXP$FR-AFSSAPS-AN2024001264$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112656$ZYDUS PHARM$$$$$$Y$$$20240930$$MD$FR$FR
243775661$24377566$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005587$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243775671$24377567$1$I$20240730$20240916$20240930$20240930$EXP$FR-AFSSAPS-AM2024000734$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112464$ZYDUS PHARM$$$$$$Y$$$20240930$$MD$FR$FR
243775681$24377568$1$I$$20240923$20240930$20240930$EXP$$DE-JNJFOC-20240961209$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$MD$DE$DE
243775691$24377569$1$I$20230101$20240925$20240930$20240930$PER$$US-JNJFOC-20240968745$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243775701$24377570$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005567$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$HP$US$US
243775711$24377571$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005590$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243775721$24377572$1$I$$20240923$20240930$20240930$EXP$$US-ADIENNEP-2024AD000770$ADIENNE PHARMA + BIOTECH$Akhtar OS, Arshad S, Lian Q, Ahn KW, D^Souza A, Dhakal B et al. Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation. Transplant Cell Ther. 2024 Sep 18:S2666-6367(24)00668-7. doi: 10.1016/j.jtct.2024.09.015. Online ahead of print.$$$E$$Y$$$20240926$$MD$US$
243775751$24377575$1$I$$20240923$20240930$20240930$EXP$$US-ADIENNEP-2024AD000771$ADIENNE PHARMA + BIOTECH$Akhtar OS, Arshad S, Lian Q, Ahn KW, D^Souza A, Dhakal B et al. Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation. Transplant Cell Ther. 2024 Sep 18:S2666-6367(24)00668-7. doi: 10.1016/j.jtct.2024.09.015. Online ahead of print.$$$E$$Y$$$20240926$$MD$US$
243775761$24377576$1$I$20240901$20240923$20240930$20240930$EXP$$FR-RECORDATI RARE DISEASE INC.-2024007429$RECORDATI$$$$$$Y$$$20240930$$PH$FR$FR
243775771$24377577$1$I$$20240923$20240930$20240930$EXP$$US-TAKEDA-US201835163$TAKEDA$$$$$F$Y$$$20240930$$HP$US$US
243775781$24377578$1$I$$20240923$20240930$20240930$EXP$$US-ADIENNEP-2024AD000762$ADIENNE PHARMA + BIOTECH$Akhtar OS, Arshad S, Lian Q, Ahn KW, D^Souza A, Dhakal B et al. Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation. Transplant Cell Ther. 2024 Sep 18:S2666-6367(24)00668-7. doi: 10.1016/j.jtct.2024.09.015. Online ahead of print.$$$E$$Y$$$20240926$$MD$US$
243775791$24377579$1$I$$20240919$20240930$20240930$EXP$$CA-RDY-CLI/CAN/24/0014033$DR REDDYS$$87$YR$E$F$Y$$$20240930$$CN$CA$CA
243775801$24377580$1$I$$20240917$20240930$20240930$30DAY$$FR-UCBSA-2024049471$UCB$$$$$$Y$$$20240930$$CN$FR$FR
243775811$24377581$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024AMR117430$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$CN$US$US
243775821$24377582$1$I$$20240923$20240930$20240930$EXP$$US-ADIENNEP-2024AD000772$ADIENNE PHARMA + BIOTECH$Akhtar OS, Arshad S, Lian Q, Ahn KW, D^Souza A, Dhakal B et al. Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation. Transplant Cell Ther. 2024 Sep 18:S2666-6367(24)00668-7. doi: 10.1016/j.jtct.2024.09.015. Online ahead of print.$$$E$$Y$$$20240926$$MD$US$
243775831$24377583$1$I$20240905$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153393$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240930$$CN$US$US
243775841$24377584$1$I$20240918$20240923$20240930$20240930$EXP$GB-MHRA-MED-202409231809398010-LVBYT$GB-HIKMA PHARMACEUTICALS-GB-H14001-24-08907$HIKMA$$46$YR$$F$Y$66$KG$20240930$$HP$GB$GB
243775851$24377585$1$I$$20240920$20240930$20240930$EXP$US-MLMSERVICE-20240913-PI193132-00129-1$US-RDY-SPO/USA/24/0014066$DR REDDYS$Goldin MR, Petry R, Goyal P. Doxycycline-associated acute pancreatitis: a rare adverse effect of a commonly prescribed antibiotic. BMJ Case Rep. 2024;17(9):e261364. DOI:10.1136/bcr-2024-261364.$9$DEC$E$F$Y$$$20240930$$HP$US$US
243775861$24377586$1$I$20101223$20240927$20240930$20240930$EXP$DE-Boehringer Ingelheim GmbH, Germany-2010-DE-07178DE$DE-SANDOZ INC.-SDZ2024DE083569$SANDOZ$$43$YR$$F$Y$65$KG$20240930$$HP$DE$DE
243775871$24377587$1$I$$20240923$20240930$20240930$EXP$$US-CHATTEMPRD-2024OHG033363$CHATTEM$$$$A$F$Y$$$20240930$$LW$US$US
243775881$24377588$1$I$20230101$20240219$20240930$20240930$PER$$US-ENDO PHARMACEUTICALS INC-2023-006165$ENDO$$$$$M$Y$$$20240930$$CN$US$US
243775891$24377589$1$I$$20240311$20240930$20240930$PER$$US-ENDO PHARMACEUTICALS INC-2024-001349$ENDO$$$$$F$Y$$$20240930$$CN$US$US
243775901$24377590$1$I$$20240618$20240930$20240930$PER$$US-ENDO PHARMACEUTICALS INC-2021-011999$ENDO$$$$$F$Y$$$20240930$$CN$US$US
243775921$24377592$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005594$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243775931$24377593$1$I$20240906$20240920$20240930$20240930$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-29000$SAMSUNG BIOEPIS$$66$YR$E$F$Y$$$20240930$$CN$CA$CA
243775941$24377594$1$I$$20240923$20240930$20240930$EXP$$US-ADIENNEP-2024AD000767$ADIENNE PHARMA + BIOTECH$Akhtar OS, Arshad S, Lian Q, Ahn KW, D^Souza A, Dhakal B et al. Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation. Transplant Cell Ther. 2024 Sep 18:S2666-6367(24)00668-7. doi: 10.1016/j.jtct.2024.09.015. Online ahead of print.$$$E$$Y$$$20240926$$MD$US$
243775951$24377595$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005616$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$HP$US$US
243775961$24377596$1$I$20240101$20240917$20240930$20240930$PER$$US-APOTEX-2024AP011136$APOTEX$$$$E$M$Y$$$20240930$$MD$US$US
243775971$24377597$1$I$$20240926$20240930$20240930$EXP$$MX-GILEAD-2024-0689079$GILEAD$$$$$F$Y$$$20240930$$MD$MX$MX
243775981$24377598$1$I$$20240923$20240930$20240930$EXP$$US-ADIENNEP-2024AD000768$ADIENNE PHARMA + BIOTECH$Akhtar OS, Arshad S, Lian Q, Ahn KW, D^Souza A, Dhakal B et al. Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation. Transplant Cell Ther. 2024 Sep 18:S2666-6367(24)00668-7. doi: 10.1016/j.jtct.2024.09.015. Online ahead of print.$$$E$$Y$$$20240926$$MD$US$
243775991$24377599$1$I$$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409191953079190-VCTPM$GB-Accord-447731$ACCORD$$39$YR$A$M$Y$$$20240930$$CN$GB$GB
243776001$24377600$1$I$20240816$20240921$20240930$20240930$EXP$GB-MHRA-MED-202409191834544870-JCKLP$GB-ACS-20240378$ACS DOBFAR$$84$YR$E$M$Y$$$20240923$$MD$GB$
243776011$24377601$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017667$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240930$$CN$US$US
243776021$24377602$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017509$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240930$$CN$US$US
243776031$24377603$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017262$ELI LILLY AND CO$$40$YR$A$F$Y$$$20240930$$CN$US$US
243776041$24377604$1$I$20240919$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016517$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240930$$CN$US$US
243776051$24377605$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3248177$TEVA$$21$YR$$F$Y$$$20240930$$CN$CA$CA
243776071$24377607$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005578$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243776081$24377608$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005617$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243776091$24377609$1$I$20240801$20240925$20240930$20240930$EXP$$US-ABBVIE-5940259$ABBVIE$$66$YR$$F$Y$$$20240930$$CN$US$US
243776101$24377610$1$I$20240101$20240927$20240930$20240930$EXP$$US-ABBVIE-5944318$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243776111$24377611$1$I$20240729$20240730$20240930$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000698$PAREXEL$$$$$$Y$$$20240930$$HP$US$US
243776121$24377612$1$I$$20240926$20240930$20240930$EXP$$MX-GILEAD-2024-0689076$GILEAD$$$$$F$Y$$$20240930$$MD$MX$MX
243776131$24377613$1$I$$20240628$20240930$20240930$PER$$US-ARDELYX-2024ARDX004742$ARDELYX$$$$$F$Y$$$20240930$$CN$US$US
243776141$24377614$1$I$$20240618$20240930$20240930$PER$$US-ARDELYX-2024ARDX004481$ARDELYX$$$$$F$Y$$$20240930$$HP$US$US
243776151$24377615$1$I$$20240701$20240930$20240930$PER$$US-ARDELYX-2024ARDX004851$ARDELYX$$47$YR$$F$Y$62$KG$20240930$$CN$US$US
243776161$24377616$1$I$20240715$20240716$20240930$20240930$PER$$US-ARDELYX-2024ARDX005436$ARDELYX$$57$YR$$F$Y$50$KG$20240930$$CN$US$US
243776171$24377617$1$I$20240708$20240711$20240930$20240930$PER$$US-ARDELYX-2024ARDX005267$ARDELYX$$73$YR$$F$Y$$$20240930$$CN$US$US
243776181$24377618$1$I$$20240728$20240930$20240930$PER$$US-ARDELYX-2024ARDX005825$ARDELYX$$$$$$Y$$$20240930$$CN$US$US
243776191$24377619$1$I$20240101$20240625$20240930$20240930$PER$$US-ARDELYX-2024ARDX004452$ARDELYX$$$$$F$Y$$$20240930$$CN$US$US
243776201$24377620$1$I$$20240927$20240930$20240930$PER$$US-ABBVIE-5943889$ABBVIE$$$$$$Y$$$20240930$$CN$US$US
243776211$24377621$1$I$20230801$20240911$20240930$20240930$PER$$US-ARDELYX-2024ARDX006217$ARDELYX$$50$YR$$F$Y$$$20240930$$CN$US$US
243776221$24377622$1$I$20240716$20240717$20240930$20240930$PER$$US-ARDELYX-2024ARDX005469$ARDELYX$$80$YR$$F$Y$$$20240930$$CN$US$US
243776231$24377623$1$I$20240801$20240826$20240930$20240930$PER$$US-ARDELYX-2024ARDX006264$ARDELYX$$52$YR$$F$Y$$$20240930$$PH$US$US
243776241$24377624$1$I$20240101$20240819$20240930$20240930$PER$$US-ARDELYX-2024ARDX006262$ARDELYX$$71$YR$$F$Y$$$20240930$$HP$US$US
243776251$24377625$1$I$20240101$20240816$20240930$20240930$PER$$US-ARDELYX-2024ARDX006242$ARDELYX$$$$$F$Y$$$20240930$$CN$US$US
243776261$24377626$1$I$20240815$20240816$20240930$20240930$PER$$US-ARDELYX-2024ARDX006252$ARDELYX$$70$YR$$F$Y$73$KG$20240930$$CN$US$US
243776271$24377627$1$I$20240810$20240816$20240930$20240930$PER$$US-ARDELYX-2024ARDX006140$ARDELYX$$68$YR$$M$Y$57$KG$20240930$$CN$US$US
243776281$24377628$1$I$$20240820$20240930$20240930$PER$$US-ARDELYX-2024ARDX006294$ARDELYX$$$$A$$Y$$$20240930$$CN$US$US
243776291$24377629$1$I$20240630$20240923$20240930$20240930$EXP$FR-AFSSAPS-AVLY2024000133$FR-TEVA-VS-3246888$TEVA$$27$YR$$M$Y$57$KG$20240930$$MD$FR$FR
243776301$24377630$1$I$20240915$20240928$20240928$20240928$DIR$720489$$FDA-CTU$$69$YR$$F$N$77.85$KG$20240928$Y$CN$US$
243776311$24377631$1$I$$20240904$20240930$20240930$PER$$US-ARDELYX-2024ARDX006739$ARDELYX$$$$$F$Y$$$20240930$$CN$US$US
243776321$24377632$1$I$20240101$20240909$20240930$20240930$PER$$US-ARDELYX-2024ARDX006864$ARDELYX$$$$$F$Y$54$KG$20240930$$CN$US$US
243776331$24377633$1$I$$20240905$20240930$20240930$PER$$US-ARDELYX-2024ARDX006760$ARDELYX$$$$A$F$Y$$$20240930$$HP$US$US
243776341$24377634$1$I$20240901$20240906$20240930$20240930$PER$$US-ARDELYX-2024ARDX006807$ARDELYX$$$$$F$Y$$$20240930$$CN$US$US
243776351$24377635$1$I$20240903$20240926$20240930$20240930$PER$$US-GILEAD-2024-0686174$GILEAD$$59$YR$A$M$Y$$$20240930$$PH$US$US
243776361$24377636$1$I$$20240919$20240930$20240930$PER$$US-ABBVIE-5934430$ABBVIE$$17$YR$$F$Y$$$20240930$$HP$US$US
243776371$24377637$1$I$20240928$20240928$20240928$20240928$DIR$720511$$FDA-CTU$$23$YR$$F$N$87.75$KG$20240928$N$$US$
243776391$24377639$1$I$$20231106$20240930$20240930$EXP$$US-KHC-000062$Kilitch Healthcare$$58$YR$$M$Y$$$20240930$$CN$US$US
243776401$24377640$1$I$$20240926$20240930$20240930$EXP$$CA-ROCHE-10000092466$ROCHE$$75$YR$E$M$Y$94$KG$20240930$$HP$CA$CA
243776411$24377641$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011194$APOTEX$$75$YR$$M$Y$$$20240930$$CN$CA$CA
243776421$24377642$1$I$20240822$20240823$20240930$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000853$PAREXEL$$$$$$Y$$$20240930$$CN$US$US
243776431$24377643$1$I$20240101$20240905$20240930$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000906$PAREXEL$$$$$$Y$$$20240930$$HP$US$US
243776441$24377644$1$I$20240719$20240816$20240930$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000675$PAREXEL$$$$$$Y$$$20240930$$CN$US$US
243776451$24377645$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005052$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243776461$24377646$1$I$20240828$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005405$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20240930$$CN$US$US
243776471$24377647$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005610$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243776491$24377649$1$I$20200301$20240920$20240930$20240930$EXP$$FR-AUROBINDO-AUR-APL-2024-047530$AUROBINDO$$78$YR$$F$Y$$$20240930$$MD$FR$FR
243776511$24377651$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005634$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243776521$24377652$1$I$20240905$20240924$20240930$20240930$EXP$GB-MHRA-MED-202409221632043990-HGBCJ$GB-ORGANON-O2409GBR001904$ORGANON$$77$YR$$M$Y$60$KG$20240930$$CN$GB$GB
243776531$24377653$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011220$APOTEX$$82$YR$$M$Y$$$20240930$$CN$CA$CA
243776541$24377654$1$I$20240801$20240926$20240930$20240930$EXP$$US-AMGEN-USASP2024192495$AMGEN$$68$YR$E$F$Y$$$20240930$$HP$US$US
243776551$24377655$1$I$$20240917$20240930$20240930$PER$$US-ROCHE-10000085543$ROCHE$$$$$F$Y$$$20240930$$CN$US$US
243776561$24377656$1$I$$20240927$20240930$20240930$PER$$US-HALEON-2199322$Haleon PLC$$$$$$Y$$$20240930$$CN$US$US
243776571$24377657$1$I$$20240924$20240930$20240930$EXP$CA-MHPD-001095946$CA-Accord-448429$ACCORD$$74$YR$E$M$Y$97$KG$20240930$$PH$CA$CA
243776581$24377658$1$I$20240918$20240920$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-046882$AUROBINDO$$71$YR$$M$Y$99$KG$20240930$$MD$GB$GB
243776591$24377659$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005613$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243776631$24377663$1$I$$20240924$20240930$20240930$EXP$$US-JNJFOC-20240969293$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243776641$24377664$1$I$20240101$20240924$20240930$20240930$EXP$$US-JNJFOC-20240966415$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20240930$$HP$US$US
243776661$24377666$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153324$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240930$$HP$US$US
243776671$24377667$1$I$$20240919$20240930$20240930$EXP$$CA-APOTEX-2024AP011306$APOTEX$$68$YR$$M$Y$$$20240930$$HP$CA$CA
243776681$24377668$1$I$20190101$20240926$20240930$20240930$EXP$$US-ABBVIE-5941518$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243776691$24377669$1$I$$20240920$20240930$20240930$EXP$$NL-AUROBINDO-AUR-APL-2024-047520$AUROBINDO$Peeters W. Skin and soft tissue infections due to non-tuberculous mycobacteria. Journal of infectious diseases. 2024;19(3):100-107$65$YR$$F$Y$$$20240930$$HP$NL$NL
243776711$24377671$1$I$$20240924$20240930$20240930$EXP$$CH-ROCHE-10000091366$ROCHE$$$$A$$Y$$$20240930$$MD$CH$CH
243776721$24377672$1$I$$20240924$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154011$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240930$$HP$US$US
243776731$24377673$1$I$$20240918$20240930$20240930$EXP$CA-MHPD-001093290$CA-Accord-447303$ACCORD$$12$YR$T$F$Y$$$20240930$$MD$CA$CA
243776741$24377674$1$I$$20240919$20240930$20240930$EXP$$ZA-ROCHE-10000087037$ROCHE$$$$A$F$Y$$$20240930$$CN$ZA$ZA
243776751$24377675$1$I$20240301$20240924$20240930$20240930$EXP$$US-ABBVIE-5938618$ABBVIE$$58$YR$$M$Y$$$20240930$$CN$US$US
243776761$24377676$1$I$20240917$20240924$20240930$20240930$EXP$$CN-ORGANON-O2409CHN001960$ORGANON$$37$YR$$F$Y$57.5$KG$20240930$$HP$CN$CN
243776771$24377677$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017104$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240930$$CN$US$US
243776781$24377678$1$I$20240926$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017417$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240930$$CN$US$US
243776791$24377679$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2023-033262$AUROBINDO$$66$YR$$M$Y$$$20240930$$CN$CA$CA
243776801$24377680$1$I$$20240920$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017310$ELI LILLY AND CO$$69$YR$E$F$Y$$$20240930$$CN$US$US
243776811$24377681$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017490$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240930$$CN$US$US
243776821$24377682$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5941730$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243776831$24377683$1$I$20240827$20240925$20240930$20240930$EXP$$US-ABBVIE-5939540$ABBVIE$$45$YR$$F$Y$$$20240930$$CN$US$US
243776841$24377684$1$I$20240924$20240924$20240930$20240930$EXP$$IN-ROCHE-10000091152$ROCHE$$84$YR$E$M$Y$$$20240930$$CN$IN$IN
243776851$24377685$1$I$$20240925$20240930$20240930$EXP$$CA-JNJFOC-20240970773$JOHNSON AND JOHNSON$$13$YR$T$M$Y$45$KG$20240930$$HP$CA$CA
243776871$24377687$1$I$20240101$20240924$20240930$20240930$EXP$$US-ABBVIE-5939045$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243776881$24377688$1$I$20240901$20240924$20240930$20240930$EXP$$CA-ABBVIE-5938679$ABBVIE$$88$YR$$M$Y$$$20240930$$CN$CA$CA
243776901$24377690$1$I$$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193394$AMGEN$$$$$F$Y$$$20240930$$CN$US$US
243776911$24377691$1$I$20240917$20240917$20240930$20240930$PER$$US-AMGEN-USASP2024185676$AMGEN$$59$YR$A$F$Y$$$20240930$$PH$US$US
243776931$24377693$1$I$$20240923$20240930$20240930$EXP$$US-AMGEN-USASP2024192864$AMGEN$Toth S.; Jackson I.P.; Krajicek B. J.. HYPERCALCEMIA AS TBE INITIAL PRESENTATION OF PNEUMOCYSTIS PNEUMONIA. Chest. 2024;166 (4):1240A-1241A$74$YR$E$F$Y$$$20240930$$HP$US$US
243776941$24377694$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153779$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$$$20240930$$HP$US$US
243776961$24377696$1$I$$20240923$20240930$20240930$EXP$JP-MLMSERVICE-20240912-PI190515-00077-1$JP-CHEPLA-2024012226$CHEPLAPHARM$Yagi T, Takano K, Umehara T, Arita H, Maeda N, Nakanishi K. Catheter embolization for pulmonary arteriovenous malformations during chemotherapy for appendiceal adenocarcinoma: A case report of associated brain abscess. Radiology Case Reports. 2024;19:5507?5512. DOI:10.1016/j.radcr.2024.08.066.$68$YR$$F$Y$$$20240930$$MD$COUNTRY NOT SPECIFIED$JP
243776971$24377697$1$I$20240920$20240925$20240930$20240930$EXP$$TW-JNJFOC-20240974266$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$MD$TW$TW
243776981$24377698$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005576$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243776991$24377699$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005606$ACADIA PHARMACEUTICALS$$$$$M$Y$57$KG$20240930$$CN$US$US
243777001$24377700$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005569$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243777011$24377701$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005605$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243777031$24377703$1$I$$20240916$20240930$20240930$PER$$US-JNJFOC-20240976435$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243777041$24377704$1$I$$20240923$20240930$20240930$EXP$$PL-CHEPLA-2024012229$CHEPLAPHARM$Turno-Krecicka A, Tomczyk-Socha M, Zimny A. Progressive outer retinal necrosis syndrome in the course of systemic lupus erythematosus. Lupus. 2016;25:1610?1614.$44$YR$$F$Y$$$20240930$$MD$COUNTRY NOT SPECIFIED$PL
243777051$24377705$1$I$$20240920$20240930$20240930$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-25901$SAMSUNG BIOEPIS$$61$YR$A$F$Y$$$20240930$$HP$CA$CA
243777061$24377706$1$I$20240919$20240920$20240930$20240930$PER$$US-JNJFOC-20240956368$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243777071$24377707$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005618$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243777082$24377708$2$F$$20240920$20240930$20240930$EXP$$US-CHATTEMPRD-2024OHG033007$CHATTEM$$$$$F$Y$$$20240930$$LW$US$US
243777091$24377709$1$I$20240924$20240924$20240930$20240930$PER$$US-JNJFOC-20240968345$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20240930$$HP$US$US
243777101$24377710$1$I$$20240919$20240930$20240930$30DAY$$DE-UCBSA-2024049570$UCB$$$$E$F$Y$$$20240930$$PH$DE$DE
243777111$24377711$1$I$20240613$20240828$20240930$20240930$EXP$$DE-SAMSUNG BIOEPIS-SB-2024-26573$SAMSUNG BIOEPIS$$$$$M$Y$87.9$KG$20240930$$MD$DE$DE
243777121$24377712$1$I$$20240924$20240930$20240930$EXP$GB-MHRA-MED-202409241914457570-HRVFM$GB-RDY-SPO/GBR/24/0014197$DR REDDYS$$$$$M$Y$$$20240930$$CN$GB$GB
243777141$24377714$1$I$$20240918$20240930$20240930$PER$$US-ROCHE-10000086805$ROCHE$$$$$$Y$$$20240930$$HP$US$US
243777151$24377715$1$I$$20240913$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09312$LUPIN$$$$$$Y$$$20240930$$MD$US$US
243777161$24377716$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153782$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$50.35$KG$20240930$$CN$US$US
243777181$24377718$1$I$$20240925$20240930$20240930$EXP$$IN-ROCHE-10000092506$ROCHE$$61$YR$A$M$Y$$$20240930$$CN$IN$IN
243777191$24377719$1$I$$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153601$BRISTOL MYERS SQUIBB$$62$YR$A$M$Y$$$20240930$$CN$US$US
243777201$24377720$1$I$20240101$20240921$20240930$20240930$EXP$$GB-TEVA-VS-3247558$TEVA$$60$YR$$M$Y$$$20240930$$CN$GB$GB
243777221$24377722$1$I$20240705$20240918$20240930$20240930$EXP$FR-AFSSAPS-CN2024000854$FR-Accord-448103$ACCORD$$53$YR$A$M$Y$104$KG$20240930$$MD$FR$FR
243777232$24377723$2$F$$20240919$20240930$20240930$EXP$$US-ROCHE-10000088919$ROCHE$$$$I$F$Y$$$20240930$$CN$US$US
243777241$24377724$1$I$$20240621$20240930$20240930$PER$$US-AJANTA-2024AJA00122$AJANTA PHARMA$$$$$F$Y$$$20240930$$CN$US$US
243777251$24377725$1$I$$20240926$20240930$20240930$EXP$$CN-TAKEDA-2024TUS096089$TAKEDA$$$$$M$Y$$$20240930$$CN$CN$CN
243777261$24377726$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011163$APOTEX$$63$YR$$F$Y$$$20240930$$CN$CA$CA
243777271$24377727$1$I$20240501$20240927$20240930$20240930$EXP$GB-MHRA-MED-202409271654597190-GTJHQ$GB-SANDOZ INC.-SDZ2024GB083685$SANDOZ$$10$YR$$F$Y$$$20240930$$MD$GB$GB
243777301$24377730$1$I$20240904$20240906$20240930$20240930$30DAY$$GB-JNJFOC-20240917413$JOHNSON AND JOHNSON$$$$E$F$Y$$$20240930$$CN$GB$GB
243777311$24377731$1$I$$20240924$20240930$20240930$EXP$$US-TAKEDA-2024TUS073290$TAKEDA$$$$$M$Y$$$20240930$$CN$US$US
243777321$24377732$1$I$$20240925$20240930$20240930$PER$$NVSC2024US192176$NOVARTIS$$$$$M$Y$$$20240930$$MD$US$US
243777331$24377733$1$I$$20240920$20240930$20240930$EXP$$AE-STRIDES ARCOLAB LIMITED-2024SP012487$STRIDES$Alrashid MHR, Thomas N, Idnani DD, ALkhaleefa FA.. Pseudomelanosis of the duodenum and stomach.. Arab-J-Gastroenterol. 2024;25 (3):320-322$75$YR$$M$Y$$$20240930$$HP$AE$AE
243777351$24377735$1$I$$20240925$20240930$20240930$EXP$GB-MHRA-MIDB-fe068b56-0690-4c08-b396-62ba8c2b1a2f$GB-STRIDES ARCOLAB LIMITED-2024SP012478$STRIDES$$74$YR$$M$Y$$$20240930$$PH$GB$GB
243777364$24377736$4$F$$20240925$20240930$20240930$EXP$$US-ROCHE-10000090089$ROCHE$Stein S, Oza D. Why won^t it end? a case of persistent COVID-19. Chest. 2024;166 (4):A5552. doi:10.1016/j.chest.2024.06.3295.$37$YR$A$F$Y$$$20240930$$HP$US$US
243777371$24377737$1$I$$20240925$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153594$BRISTOL MYERS SQUIBB$$79$YR$E$M$Y$$$20240930$$CN$US$US
243777381$24377738$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153586$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$$$20240930$$CN$US$US
243777391$24377739$1$I$$20240927$20240930$20240930$EXP$$CA-SANDOZ INC.-SDZ2024CA083616$SANDOZ$$76$YR$$M$Y$$$20240930$$PH$CA$CA
243777401$24377740$1$I$20240801$20240924$20240930$20240930$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP012480$STRIDES$$65$YR$$M$Y$74.83$KG$20240930$$HP$US$US
243777411$24377741$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017532$ELI LILLY AND CO$$24$YR$A$M$Y$$$20240930$$CN$US$US
243777421$24377742$1$I$$20240917$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409011857$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240930$$CN$US$US
243777431$24377743$1$I$$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018020$ELI LILLY AND CO$$$$$M$Y$$$20240930$$CN$US$US
243777451$24377745$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017340$ELI LILLY AND CO$$58$YR$A$F$Y$$$20240930$$CN$US$US
243777461$24377746$1$I$20240924$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017553$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240930$$CN$US$US
243777471$24377747$1$I$20240919$20240919$20240930$20240930$EXP$$US-JNJFOC-20240959118$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20240930$$HP$US$US
243777481$24377748$1$I$20240604$20240923$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015066$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240930$$CN$US$US
243777491$24377749$1$I$$20240919$20240930$20240930$PER$$US-JNJFOC-20240959724$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243777501$24377750$1$I$20240921$20240925$20240930$20240930$EXP$$CN-ROCHE-10000091839$ROCHE$$60$YR$A$M$Y$70$KG$20240930$$CN$CN$CN
243777511$24377751$1$I$20190305$20240920$20240930$20240930$EXP$PL-URPL-1-1472-2019$PL-CELLTRION INC.-2024PL023127$CELLTRION$$$$$$Y$$$20240930$$MD$PL$PL
243777521$24377752$1$I$$20240918$20240930$20240930$EXP$$IE-ASTRAZENECA-202409EEA003871IE$ALEXION PHARMACEUTICALS$$69$YR$E$$Y$$$20240930$$$IE$IE
243777531$24377753$1$I$$20240921$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-047119$AUROBINDO$$10$DEC$$F$Y$$$20240930$$CN$GB$GB
243777541$24377754$1$I$20240904$20240925$20240930$20240930$EXP$$US-TAKEDA-2024TUS095619$TAKEDA$$35$YR$$F$Y$$$20240930$$MD$US$US
243777551$24377755$1$I$$20240923$20240930$20240930$EXP$$AU-TEVA-VS-3247545$TEVA$$$$$$Y$$$20240930$$HP$AU$AU
243777561$24377756$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011230$APOTEX$$83$YR$$$Y$$$20240930$$CN$CA$CA
243777571$24377757$1$I$20240825$20240924$20240930$20240930$EXP$$CN-JNJFOC-20240969119$JOHNSON AND JOHNSON$$26$YR$A$F$Y$50$KG$20240930$$HP$CN$CN
243777581$24377758$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011203$APOTEX$$3$YR$$M$Y$$$20240930$$HP$CA$CA
243777591$24377759$1$I$20240722$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005566$ACADIA PHARMACEUTICALS$$78$YR$$M$Y$$$20240930$$CN$US$US
243777601$24377760$1$I$$20240925$20240930$20240930$EXP$$US-JNJFOC-20240971828$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20240930$$CN$US$US
243777611$24377761$1$I$20240607$20240926$20240930$20240930$EXP$$US-GILEAD-2024-0689241$GILEAD$$66$YR$E$M$Y$$$20240930$$CN$US$US
243777621$24377762$1$I$20240901$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153876$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20240930$$HP$US$US
243777631$24377763$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154144$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240930$$CN$US$US
243777641$24377764$1$I$$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153630$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240930$$CN$US$US
243777651$24377765$1$I$20240830$20240916$20240930$20240930$EXP$$US-ROCHE-10000083748$ROCHE$$43$YR$A$F$Y$105.23$KG$20240930$$CN$US$US
243777661$24377766$1$I$20240914$20240916$20240930$20240930$EXP$GB-MHRA-MED-202409141025092440-WNLPG$GB-LUPIN PHARMACEUTICALS INC.-2024-09287$LUPIN$$38$YR$$F$Y$70$KG$20240930$$MD$GB$GB
243777681$24377768$1$I$$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018325$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240930$$CN$US$US
243777691$24377769$1$I$20240906$20240927$20240930$20240930$PER$$NVSC2024US193135$NOVARTIS$$88$YR$$F$Y$56.7$KG$20240930$$CN$US$US
243777711$24377771$1$I$$20240924$20240930$20240930$EXP$GB-MHRA-MED-202409241724464070-JGSPB$GB-RDY-SPO/GBR/24/0014202$DR REDDYS$$$$$$Y$64$KG$20240930$$CN$GB$GB
243777721$24377772$1$I$20240927$20240927$20240930$20240930$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054029$BOEHRINGER INGELHEIM$$60$YR$A$F$Y$$$20240930$$MD$JP$JP
243777731$24377773$1$I$$20240926$20240930$20240930$EXP$$GB-SANDOZ INC.-SDZ2024GB083641$SANDOZ$$$$$F$Y$$$20240930$$CN$GB$GB
243777741$24377774$1$I$20240101$20240924$20240930$20240930$EXP$$US-ABBVIE-5939606$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243777751$24377775$1$I$20240830$20240925$20240930$20240930$EXP$FR-AFSSAPS-GR2024001129$FR-JNJFOC-20240972908$JOHNSON AND JOHNSON$$46$YR$A$F$Y$85$KG$20240930$$PH$FR$FR
243777761$24377776$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000091616$ROCHE$$$$$$Y$$$20240930$$MD$US$US
243777771$24377777$1$I$20240815$20240924$20240930$20240930$EXP$GB-MHRA-MED-202409241304265060-JWCRF$GB-RDY-SPO/GBR/24/0014178$DR REDDYS$$74$YR$E$M$Y$74$KG$20240930$$MD$GB$GB
243777781$24377778$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011167$APOTEX$$63$YR$$M$Y$$$20240930$$CN$CA$CA
243777791$24377779$1$I$$20240926$20240930$20240930$EXP$$US-TAKEDA-2024TUS095744$TAKEDA$$$$$F$Y$$$20240930$$CN$US$US
243777801$24377780$1$I$$20240923$20240930$20240930$EXP$$US-JNJFOC-20240960711$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$US$US
243777811$24377781$1$I$20240829$20240916$20240930$20240930$EXP$$FR-CIPLA LTD.-2024FR10568$CIPLA$$$$$$Y$$$20240930$$MD$FR$FR
243777821$24377782$1$I$20240628$20240926$20240930$20240930$EXP$FR-AFSSAPS-DJ2024001031$FR-SA-2024SA279984$SANOFI AVENTIS$$61$YR$A$M$Y$92$KG$20240930$$MD$FR$FR
243777831$24377783$1$I$20240901$20240925$20240930$20240930$EXP$ES-AEMPS-1571781$ES-JNJFOC-20240971419$JOHNSON AND JOHNSON$$57$YR$A$F$Y$58.8$KG$20240930$$MD$ES$ES
243777861$24377786$1$I$20240513$20240925$20240930$20240930$EXP$$JP-ROCHE-10000094403$ROCHE$$$$E$$Y$$$20240930$$MD$JP$JP
243777871$24377787$1$I$$20240925$20240930$20240930$30DAY$$FR-SANDOZ INC.-SDZ2024FR083002$SANDOZ$$16$YR$$M$Y$$$20240930$$CN$FR$FR
243777881$24377788$1$I$$20240925$20240930$20240930$PER$$NVSC2024US192531$NOVARTIS$$$$$M$Y$$$20240930$$HP$US$US
243777891$24377789$1$I$20220529$20240921$20240930$20240930$EXP$$AU-TAKEDA-2022TUS036226$TAKEDA$$41$YR$$M$Y$$$20240930$$CN$AU$AU
243777901$24377790$1$I$$20240926$20240930$20240930$EXP$$CA-HALEON-2199124$Haleon PLC$$40$YR$$F$Y$$$20240928$$HP$CA$CA
243777911$24377791$1$I$20240908$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024191727$AMGEN$$72$YR$E$F$Y$$$20240930$$CN$US$US
243777921$24377792$1$I$20240502$20240923$20240930$20240930$EXP$$US-AMGEN-USANI2024189606$AMGEN$$61$YR$A$M$Y$$$20240930$$MD$US$US
243777931$24377793$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153701$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240930$$CN$US$US
243777961$24377796$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153848$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240930$$HP$US$US
243777971$24377797$1$I$20240806$20240916$20240930$20240930$EXP$FR-AFSSAPS-NC2024001061$FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-112433$ZYDUS PHARM$$$$$$Y$$$20240930$$MD$FR$FR
243777981$24377798$1$I$20240508$20240929$20240930$20240930$EXP$GB-MHRA-MED-202409290919292740-ZFRTL$GB-SANDOZ INC.-SDZ2024GB083723$SANDOZ$$$$$F$Y$$$20240930$$CN$GB$GB
243777991$24377799$1$I$$20240925$20240930$20240930$EXP$CA-LEO Pharma-373790$CA-LEO Pharma-373790$LEO PHARM$$60$YR$$F$Y$$$20240930$$CN$CA$CA
243778001$24377800$1$I$20240919$20240923$20240930$20240930$EXP$RU-RZN-2577975$RU-SERVIER-S24012059$SERVIER$$$$$$Y$$$20240930$$HP$RU$RU
243778011$24377801$1$I$$20240923$20240930$20240930$EXP$$US-HALEON-2198695$Haleon PLC$$31$YR$$M$Y$$$20240930$$HP$US$US
243778021$24377802$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017547$ELI LILLY AND CO$$35$YR$A$M$Y$$$20240930$$MD$US$US
243778041$24377804$1$I$20240801$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017231$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240930$$HP$US$US
243778051$24377805$1$I$20240701$20240926$20240930$20240930$EXP$$US-GILEAD-2024-0689249$GILEAD$$50$YR$A$M$Y$$$20240930$$CN$US$US
243778061$24377806$1$I$$20240919$20240930$20240930$EXP$$US-JNJFOC-20240953209$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243778071$24377807$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024AMR117942$GLAXOSMITHKLINE$$$$$F$Y$81.633$KG$20240930$$CN$US$US
243778111$24377811$1$I$$20240916$20240930$20240930$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-09344$LUPIN$Prakash S, Patel H, Shah CS. Medication-overuse headache overlapping with serotonin syndrome. British Medical Journal Case Reports. 2024;17(1):1-5$$$A$F$Y$$$20240930$$MD$IN$IN
243778121$24377812$1$I$$20240923$20240930$20240930$EXP$$GB-JNJFOC-20240972715$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20240930$$CN$GB$GB
243778131$24377813$1$I$20240101$20240917$20240930$20240930$EXP$$US-UCBSA-2024025622$UCB$$$$$F$Y$$$20240930$$CN$US$US
243778141$24377814$1$I$$20240925$20240930$20240930$EXP$$US-009507513-2409USA009035$MERCK$Ahmed O, See X, Tang Z, Ahmed A, Chow M.. A CASE OF PEMBROLIZUMAB-INDUCED PULMONARY HYPERTENSION AND PLEURAL EFFUSION. Pulmonary Vascular Disease. 2024;166(4):A5851-2$43$YR$$F$Y$$$20240930$$HP$US$US
243778151$24377815$1$I$20240301$20240924$20240930$20240930$PER$$US-009507513-2409USA009054$MERCK$$81$YR$$M$Y$$$20240930$$CN$US$US
243778161$24377816$1$I$20240501$20240923$20240930$20240930$EXP$$CA-GSK-CA2024043434$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$CA$CA
243778181$24377818$1$I$$20240918$20240930$20240930$PER$$US-EMD Serono-2024050324$EMD SERONO INC$$66$YR$E$F$Y$$$20240930$$CN$US$US
243778191$24377819$1$I$$20240926$20240930$20240930$PER$$US-ABBVIE-5941605$ABBVIE$$$$$$Y$$$20240930$$CN$US$US
243778201$24377820$1$I$$20240925$20240930$20240930$EXP$$NVSC2024GR192495$NOVARTIS$$$$A$M$Y$$$20240930$$MD$GR$GR
243778211$24377821$1$I$$20240924$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016541$ELI LILLY AND CO$$$$A$F$Y$$$20240930$$CN$US$US
243778221$24377822$1$I$$20240802$20240930$20240930$PER$$US-TEVA-VS-3230696$TEVA$$82$YR$$M$Y$$$20240930$$CN$US$US
243778231$24377823$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018432$ELI LILLY AND CO$$70$YR$E$F$Y$$$20240930$$HP$US$US
243778241$24377824$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011212$APOTEX$$79$YR$$M$Y$$$20240930$$HP$CA$CA
243778251$24377825$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117143$GLAXOSMITHKLINE$$$$A$M$Y$$$20240930$$CN$US$US
243778261$24377826$1$I$$20240918$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409012315$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240930$$CN$US$US
243778271$24377827$1$I$20240823$20240920$20240930$20240930$PER$$US-GSK-US2024117069$GLAXOSMITHKLINE$$59$YR$$F$Y$$$20240930$$HP$US$US
243778291$24377829$1$I$$20240918$20240930$20240930$EXP$$US-ULTRAGENYX PHARMACEUTICAL INC.-US-UGX-24-01775$ULTRAGENYX PHARMACEUTICAL$$$$$F$Y$$$20240930$$PH$US$US
243778301$24377830$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011159$APOTEX$$62$YR$$F$Y$$$20240930$$CN$CA$CA
243778311$24377831$1$I$20240917$20240918$20240930$20240930$EXP$$JP-ROCHE-10000088432$ROCHE$$$$$$Y$$$20240930$$MD$JP$JP
243778321$24377832$1$I$$20240919$20240930$20240930$EXP$$US-TAKEDA-2024TUS093488$TAKEDA$$$$$$Y$$$20240930$$CN$US$US
243778331$24377833$1$I$$20240927$20240930$20240930$EXP$GB-MHRA-MED-202409122319399810-RNTKP$GB-SANDOZ INC.-SDZ2024GB083663$SANDOZ$$$$$$Y$$$20240930$$HP$GB$GB
243778341$24377834$1$I$20240501$20240924$20240930$20240930$EXP$$BR-SANDOZ INC.-SDZ2024BR082997$SANDOZ$$$$$M$Y$$$20240930$$CN$BR$BR
243778351$24377835$1$I$$20240923$20240930$20240930$EXP$$IT-ROCHE-10000088988$ROCHE$Marchetti G, Suardi L, Tiseo G, Del Ricco V, Riccardi N, Rindi L, et al. Fatal disseminated Mycobacterium avium infection with bone marrow infiltration and hemophagocytic syndrome. Diagnostic Microbiology and Infectious Disease. 2024;110 (4):1-4. doi:10.1016/j.diagmicrobio.2024.116528.$63$YR$A$F$Y$$$20240930$$HP$IT$IT
243778361$24377836$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093253$ROCHE$$25$YR$A$F$Y$$$20240930$$MD$US$US
243778381$24377838$1$I$20240905$20240912$20240930$20240930$PER$$US-TOLMAR, INC.-24US052601$TOLMAR$$68$YR$$M$Y$$$20240930$$PH$US$US
243778391$24377839$1$I$20240903$20240911$20240930$20240930$PER$$US-TOLMAR, INC.-24US052628$TOLMAR$$64$YR$$M$Y$$$20240930$$PH$US$US
243778401$24377840$1$I$20240911$20240912$20240930$20240930$PER$$US-TOLMAR, INC.-24US052602$TOLMAR$$80$YR$$M$Y$$$20240930$$HP$US$US
243778411$24377841$1$I$20240829$20240912$20240930$20240930$PER$$US-TOLMAR, INC.-24US052667$TOLMAR$$75$YR$$M$Y$$$20240930$$HP$US$US
243778421$24377842$1$I$20130101$20240912$20240930$20240930$PER$$US-TOLMAR, INC.-24US052668$TOLMAR$$$$$M$Y$$$20240930$$HP$US$US
243778431$24377843$1$I$$20240913$20240930$20240930$PER$$US-TOLMAR, INC.-24US052677$TOLMAR$$$$$$Y$$$20240930$$HP$US$US
243778441$24377844$1$I$$20240925$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US083429$SANDOZ$$68$YR$$F$Y$$$20240930$$HP$US$US
243778451$24377845$1$I$20240830$20240919$20240930$20240930$PER$$US-JNJFOC-20240959834$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20240930$$HP$US$US
243778461$24377846$1$I$20201113$20240923$20240930$20240930$EXP$FI-FIMEA-202403367$FI-CHEPLA-2024012217$CHEPLAPHARM$$34$YR$$F$Y$$$20240930$$MD$COUNTRY NOT SPECIFIED$FI
243778471$24377847$1$I$$20240927$20240930$20240930$EXP$$TR-GILEAD-2024-0689210$GILEAD$$57$YR$A$M$Y$$$20240930$$MD$TR$TR
243778481$24377848$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047079$AUROBINDO$$88$YR$$M$Y$66.667$KG$20240930$$MD$CA$CA
243778501$24377850$1$I$20240905$20240927$20240930$20240930$EXP$FR-AFSSAPS-GR2024001152$FR-SANDOZ INC.-SDZ2024FR083606$SANDOZ$$48$YR$$F$Y$73$KG$20240930$$PH$FR$FR
243778511$24377851$1$I$$20240912$20240930$20240930$PER$$US-JNJFOC-20240934968$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20240930$$CN$US$US
243778521$24377852$1$I$20230101$20240926$20240930$20240930$EXP$$AR-ABBVIE-5941278$ABBVIE$$$$$F$Y$$$20240930$$CN$AR$AR
243778531$24377853$1$I$20240912$20240920$20240930$20240930$PER$$US-GSK-US2024117017$GLAXOSMITHKLINE$$66$YR$$F$Y$$$20240930$$CN$US$US
243778551$24377855$1$I$$20240920$20240930$20240930$EXP$$US-AMGEN-USASP2024190485$AMGEN$Angeles-han S.T.; Maccora I.; Ebert J.J. et al.. Treatment and Visual Outcomes in Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy: A Cohort Study. Ocular Immunology and Inflammation. 2024;1-8$9$YR$C$F$Y$$$20240930$$MD$US$US
243778561$24377856$1$I$$20240920$20240930$20240930$EXP$$US-AMGEN-USASP2024190483$AMGEN$Angeles-han S.T.; Maccora I.; Ebert J.J. et al.. Treatment and Visual Outcomes in Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy: A Cohort Study. Ocular Immunology and Inflammation. 2024;1-8$10$YR$C$F$Y$$$20240930$$MD$US$US
243778571$24377857$1$I$20240101$20240925$20240930$20240930$EXP$$NVSC2024US192049$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
243778581$24377858$1$I$20240710$20240927$20240930$20240930$EXP$FR-AFSSAPS-LL2024001785$NVSC2024FR192151$NOVARTIS$$74$YR$$M$Y$85$KG$20240930$$MD$FR$FR
243778591$24377859$1$I$20240914$20240923$20240930$20240930$EXP$$NVSC2024CN191250$NOVARTIS$$75$YR$$F$Y$$$20240930$$HP$CN$CN
243778601$24377860$1$I$20240101$20240925$20240930$20240930$EXP$$US-AMGEN-USASP2024191875$AMGEN$$$$A$M$Y$$$20240930$$PH$US$US
243778611$24377861$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5941741$ABBVIE$$$$$$Y$$$20240930$$MD$US$US
243778621$24377862$1$I$$20240923$20240930$20240930$PER$$US-BIOGEN-2024BI01283889$BIOGEN$$62$YR$$M$Y$$$20240930$$MD$US$US
243778631$24377863$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5940326$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243778641$24377864$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153356$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20240930$$CN$US$US
243778651$24377865$1$I$$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192930$AMGEN$$$$$$Y$$$20240930$$PH$US$US
243778661$24377866$1$I$20240801$20240925$20240930$20240930$EXP$$CA-JNJFOC-20240972402$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20240930$$HP$CA$CA
243778671$24377867$1$I$20240101$20240920$20240930$20240930$PER$$US-ABBVIE-5934615$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243778681$24377868$1$I$$20240621$20240930$20240930$PER$$US-ROCHE-10000073150$ROCHE$Jhaveri K, Shah HH C. Glomerular diseases seen with cancer and chemotherapy: a narrative review. International Society of Nephrology. 2013-Jan-30;84:34-44. doi:10.1038/ki.2012.484.$$$$$Y$$$20240930$$MD$US$US
243778691$24377869$1$I$$20240925$20240930$20240930$EXP$GB-MHRA-MED-202409241724464070-JGSPB$GB-ORGANON-O2409GBR001908$ORGANON$$$$$$Y$64$KG$20240930$$CN$GB$GB
243778701$24377870$1$I$$20240910$20240930$20240930$EXP$$US-SA-2024SA277981$SANOFI AVENTIS$$$$A$F$Y$85.09$KG$20240930$$HP$US$US
243778711$24377871$1$I$20240712$20240926$20240930$20240930$EXP$$PL-TAKEDA-2024TUS096177$TAKEDA$$76$YR$$M$Y$$$20240930$$CN$PL$PL
243778721$24377872$1$I$$20240927$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US083805$SANDOZ$$$$$M$Y$$$20240930$$MD$US$US
243778731$24377873$1$I$$20240920$20240930$20240930$EXP$$AU-SANDOZ INC.-SDZ2024AU083709$SANDOZ$$40$YR$$F$Y$$$20240930$$MD$AU$AU
243778741$24377874$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011234$APOTEX$$69$YR$$M$Y$$$20240930$$CN$CA$CA
243778751$24377875$1$I$$20240926$20240930$20240930$EXP$$US-GILEAD-2024-0686292$GILEAD$$$$E$F$Y$$$20240930$$CN$US$US
243778761$24377876$1$I$$20240924$20240930$20240930$PER$$US-ABBVIE-5943544$ABBVIE$$$$$M$Y$$$20240930$$MD$US$US
243778771$24377877$1$I$$20240925$20240930$20240930$PER$$US-ABBVIE-5942627$ABBVIE$$$$$$Y$$$20240930$$CN$US$US
243778781$24377878$1$I$$20240906$20240930$20240930$PER$$US-009507513-2409USA002663$MERCK$$$$$M$Y$$$20240930$$HP$US$US
243778791$24377879$1$I$$20240924$20240930$20240930$EXP$$US-SERVIER-S24012277$SERVIER$Fridlyand DM, Chandrakasan S, Aljudi A, Aumann WK, Westfall E, Kirwan B et al.. Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation Rescues Marrow Failure from Acute Leukemia Therapy in a Patient with Previously Undiagnosed Ligase IV Syndrome. Journal of Pediatric Hematology/Oncology. 2023;45 (1):e139-e141$$$$$Y$$$20240930$$MD$US$US
243778801$24377880$1$I$$20240912$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052413$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
243778811$24377881$1$I$20240702$20240913$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052417$TOLMAR$$55$YR$$M$Y$$$20240930$$CN$CA$CA
243778821$24377882$1$I$20240701$20240912$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052428$TOLMAR$$67$YR$$M$Y$$$20240930$$CN$CA$CA
243778831$24377883$1$I$20240701$20240913$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052489$TOLMAR$$81$YR$$M$Y$$$20240930$$CN$CA$CA
243778841$24377884$1$I$$20240911$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052579$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
243778851$24377885$1$I$$20240918$20240930$20240930$EXP$$GB-SPC-000494$SOLARIS PHARMA$George A, Thomas J, Welikumbura S, Achhapalia Y. Lemierre^s Syndrome: An Atypical Case of Fusobacterium necrophorum Bacteraemia in the Absence of Internal Jugular Vein Thrombosis. Cureus. 2024 Aug 14;16(8):e66867. doi: 10.7759/cureus.66867.$$$$F$Y$$$20240930$$HP$GB$GB
243778861$24377886$1$I$20240810$20240923$20240930$20240930$EXP$IT-MINISAL02-1002598$IT-TEVA-VS-3246867$TEVA$$28$YR$$M$Y$$$20240930$$MD$IT$IT
243778871$24377887$1$I$20240918$20240919$20240930$20240930$EXP$$MX-JNJFOC-20240959351$JOHNSON AND JOHNSON$$27$YR$A$M$Y$70$KG$20240930$$MD$MX$MX
243778881$24377888$1$I$20240921$20240921$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-047137$AUROBINDO$$60$YR$$F$Y$6$KG$20240930$$CN$GB$GB
243778891$24377889$1$I$$20240926$20240930$20240930$EXP$$NL-ROCHE-10000019257$ROCHE$$$$$M$Y$$$20240930$$MD$NL$NL
243778911$24377891$1$I$20240911$20240911$20240930$20240930$PER$$US-TOLMAR, INC.-24US052599$TOLMAR$$$$$$Y$$$20240930$$HP$US$US
243778931$24377893$1$I$20230101$20240920$20240930$20240930$EXP$$US-AUROBINDO-AUR-APL-2024-046893$AUROBINDO$Metersky ML, Fraulino D, Monday L, Chopra T. Current challenges in pulmonary nontuberculous mycobacterial infection: A case series with literature review. Postgraduate medicine. 2024;1-12$64$YR$$M$Y$$$20240930$$MD$US$US
243778941$24377894$1$I$$20240925$20240930$20240930$EXP$$CA-HALEON-2198686$Haleon PLC$$71$YR$$F$Y$69$KG$20240930$$HP$CA$CA
243778971$24377897$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67050$$FDA-CTU$$37$YR$$F$N$$$20240927$N$$US$
243778981$24377898$1$I$20240926$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67067$$FDA-CTU$$74$YR$$F$N$$$20240927$N$$US$
243778991$24377899$1$I$20240810$20240928$20240928$20240928$DIR$720475$$FDA-CTU$$62$YR$$F$N$63.9$KG$20240928$N$CN$US$
243779001$24377900$1$I$20231203$20240928$20240928$20240928$DIR$720496$$FDA-CTU$$71$YR$$M$N$78.75$KG$20240928$N$CN$US$
243779011$24377901$1$I$20240920$20240928$20240928$20240928$DIR$720482$$FDA-CTU$$$$$UNK$N$$$20240928$N$$US$
243779021$24377902$1$I$$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-67029$$FDA-CTU$$$$$F$N$53.98$KG$20240926$N$PH$US$
243779031$24377903$1$I$20240927$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67038$$FDA-CTU$$59$YR$$F$N$$$20240927$N$HP$US$
243779041$24377904$1$I$20240105$20240927$20240927$20240927$DIR$720291$$FDA-CTU$$76$YR$$M$N$98$KG$20240927$N$HP$US$
243779051$24377905$1$I$20231117$20240927$20240927$20240927$DIR$720287$$FDA-CTU$$67$YR$$M$N$$$20240927$N$HP$US$
243779061$24377906$1$I$20240824$20240926$20240927$20240927$DIR$FDA-CDER-CTU-2024-67043$$FDA-CTU$$37$YR$$F$N$$$20240926$Y$HP$US$
243779071$24377907$1$I$20231102$20240927$20240927$20240927$DIR$720284$$FDA-CTU$$77$YR$$M$N$83$KG$20240927$N$HP$US$
243779091$24377909$1$I$20240715$20240921$20240921$20240921$DIR$719314$$FDA-CTU$$49$YR$$F$N$48.6$KG$20240921$Y$$US$
243779101$24377910$1$I$20231215$20240927$20240927$20240927$DIR$720276$$FDA-CTU$$48$YR$$M$N$94$KG$20240927$N$PH$US$
243779111$24377911$1$I$20240201$20240927$20240927$20240927$DIR$720310$$FDA-CTU$$65$YR$$M$N$53$KG$20240927$N$HP$US$
243779121$24377912$1$I$20240122$20240927$20240927$20240927$DIR$720305$$FDA-CTU$$75$YR$$M$N$82$KG$20240927$N$HP$US$
243779131$24377913$1$I$20231117$20240927$20240927$20240927$DIR$720283$$FDA-CTU$$37$YR$$M$N$114$KG$20240927$N$HP$US$
243779141$24377914$1$I$20231103$20240927$20240927$20240927$DIR$720308$$FDA-CTU$$35$YR$$M$N$$$20240927$N$HP$US$
243779151$24377915$1$I$20231114$20240927$20240927$20240927$DIR$720306$$FDA-CTU$$68$YR$$M$N$87$KG$20240927$N$HP$US$
243779161$24377916$1$I$20240927$20240929$20240929$20240929$DIR$720560$$FDA-CTU$$62$YR$$UNK$N$67.5$KG$20240929$N$CN$US$
243779171$24377917$1$I$20231013$20240927$20240927$20240927$DIR$720294$$FDA-CTU$$55$YR$$M$N$85$KG$20240927$N$HP$US$
243779181$24377918$1$I$$20240920$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150235$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$$$20240930$$CN$US$US
243779191$24377919$1$I$20110101$20240923$20240930$20240930$EXP$NO-NOMAADVRE-RELISM-2024-Vrqbag$NO-CHEPLA-2024012188$CHEPLAPHARM$$63$YR$$M$Y$$$20240930$$MD$COUNTRY NOT SPECIFIED$NO
243779201$24377920$1$I$20240520$20240920$20240930$20240930$EXP$$DE-AUROBINDO-AUR-APL-2024-047488$AUROBINDO$$67$YR$$F$Y$85$KG$20240930$$MD$DE$DE
243779221$24377922$1$I$20240806$20240920$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-046822$AUROBINDO$$68$YR$$F$Y$115$KG$20240930$$PH$GB$GB
243779231$24377923$1$I$$20240925$20240930$20240930$EXP$$CA-ABBVIE-5942540$ABBVIE$$76$YR$$F$Y$$$20240930$$CN$CA$CA
243779241$24377924$1$I$20240927$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024192978$AMGEN$$54$YR$A$F$Y$$$20240930$$CN$US$US
243779251$24377925$1$I$$20240925$20240930$20240930$EXP$$US-SA-2024SA279914$SANOFI AVENTIS$$58$YR$A$M$Y$$$20240930$$HP$US$US
243779261$24377926$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017487$ELI LILLY AND CO$$37$YR$A$F$Y$$$20240930$$CN$US$US
243779281$24377928$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154034$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240930$$CN$US$US
243779291$24377929$1$I$$20240917$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409011389$ELI LILLY AND CO$$14$YR$T$M$Y$$$20240930$$CN$US$US
243779301$24377930$1$I$$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150850$BRISTOL MYERS SQUIBB$Kramer PJ, Eisinger G. Tamponade, just in time: novel use of thoracentesis catheter for emergent pericardiocentesis. Chest. 2024;166(4S):2846A. doi:10.1016/j.chest.2024.06.1723.$40$YR$A$F$Y$$$20240930$$HP$US$US
243779321$24377932$1$I$20230101$20240919$20240930$20240930$EXP$$US-TAKEDA-2024TUS084789$TAKEDA$$$$$F$Y$$$20240930$$CN$US$US
243779331$24377933$1$I$$20240918$20240930$20240930$EXP$$US-AUROBINDO-AUR-APL-2024-046597$AUROBINDO$Agarwal A, Diaz A, Al-Dehneem R, Pineda RM, Khattri S. Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases. J-Drugs-Dermatol. 2023;22:1183-1190$75$YR$$M$Y$$$20240930$$HP$US$US
243779341$24377934$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-046907$AUROBINDO$Shukla V, Cheng S, Hukin J, Huh L, Datta AN. Developmental and epileptic encephalopathies after successful treatment of pediatric ALL: A case series and review of literature. Epileptic Disorders. 2024;00:1-10$7$YR$$M$Y$$$20240930$$MD$CA$CA
243779351$24377935$1$I$20240719$20240925$20240930$20240930$EXP$$US-ABBVIE-5940705$ABBVIE$$71$YR$$F$Y$$$20240930$$CN$US$US
243779371$24377937$1$I$20240801$20240920$20240930$20240930$EXP$$IT-ROCHE-10000089154$ROCHE$$36$YR$A$F$Y$$$20240930$$CN$IT$IT
243779381$24377938$1$I$$20240923$20240930$20240930$EXP$$IN-ROCHE-10000089973$ROCHE$Raja P, Dhamija K, Samim M, Saini J, Manjappaiah M, Kandavel T, et al. A Real-World Experience of Rituximab: A Panacea in Therapy of Multiple Sclerosis in Low- and Middle-Income Setting. Clinical neuropharmacology. 2024-Sep-12; doi:10.1097/WNF.0000000000000612.$$$$$Y$$$20240930$$MD$IN$IN
243779411$24377941$1$I$20240918$20240919$20240930$20240930$EXP$$US-SHIRE-US201603164$TAKEDA$$43$YR$$M$Y$140$KG$20240930$$PH$US$US
243779421$24377942$1$I$$20240923$20240930$20240930$EXP$$CA-TAKEDA-2024TUS094855$TAKEDA$$$$$M$Y$$$20240930$$CN$CA$CA
243779451$24377945$1$I$20240909$20240927$20240930$20240930$EXP$FR-AFSSAPS-BX2024001830$FR-SANDOZ INC.-SDZ2024FR083561$SANDOZ$$26$YR$$M$Y$75$KG$20240930$$HP$FR$FR
243779461$24377946$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153942$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240930$$CN$US$US
243779471$24377947$1$I$$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151646$BRISTOL MYERS SQUIBB$Ahmed-Khan M, Luna DD, Walgamage T, Walgamage M, Nathani Z. A liver in crisis: acute liver failure following immunotherapy in a stage IV uveal melanoma patient. Chest. 2024;166(4S):3043A-4A. doi:10.1016/j.chest.2024.06.1833.$58$YR$A$F$Y$$$20240930$$HP$US$US
243779481$24377948$1$I$20230208$20240925$20240930$20240930$EXP$$CA-TAKEDA-2023TUS096035$TAKEDA$$6$YR$$M$Y$$$20240930$$CN$CA$CA
243779491$24377949$1$I$20240815$20240924$20240930$20240930$EXP$GB-MHRA-MED-202409241304265060-JWCRF$GB-ORGANON-O2409GBR001888$ORGANON$$74$YR$$M$Y$74$KG$20240930$$MD$GB$GB
243779501$24377950$1$I$20240925$20240925$20240930$20240930$EXP$$CA-Orion Corporation ORION PHARMA-24_00031901$ORION$$78$YR$E$F$Y$$$20240930$$HP$CA$
243779511$24377951$1$I$$20240923$20240930$20240930$PER$$US-GSK-US2024117720$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243779531$24377953$1$I$$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409161356594380-FBTGZ$GB-MACLEODS PHARMA-MAC2024049521$MACLEODS$$$$$$Y$$$20240930$$PH$GB$GB
243779541$24377954$1$I$$20240924$20240930$20240930$EXP$$NVSC2024VN190496$NOVARTIS$Ngon H T, Man HV. ??nh gi? hi?u qu? ?i?u tr? gh?p t? b?o g?c ??ng lo?i tr?n ng??i b?nh suy t?y x??ng t?i b?nh vi?n truy?n m?u huy?t h?c [Assessment of the efficacy of allogeneic stem cell transplantation in patients with acquired aplastic anemia at blood transfusion and hematology hospital]. VIETNAM MEDICAL JOURNAL$$$$$Y$$$20240930$$HP$VN$VN
243779551$24377955$1$I$$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409161413313110-HFLSQ$GB-MACLEODS PHARMA-MAC2024049522$MACLEODS$$$$$$Y$$$20240930$$PH$GB$GB
243779561$24377956$1$I$20231106$20240927$20240927$20240927$DIR$720292$$FDA-CTU$$69$YR$$M$N$77$KG$20240927$N$HP$US$
243779571$24377957$1$I$$20240923$20240930$20240930$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-19347$IPSEN$$$$$F$Y$$$20240930$$CN$US$US
243779591$24377959$1$I$$20240919$20240930$20240930$EXP$$CN-MACLEODS PHARMA-MAC2024049513$MACLEODS$Ning Y, Xiao M, Perlin DS, Zhao Y, Lu M, Li YI et al.Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China..Emerging microbes + infections..2023;12(1):2153086$$$$$Y$$$20240930$$MD$CN$CN
243779601$24377960$1$I$$20240918$20240930$20240930$EXP$$US-MACLEODS PHARMA-MAC2024049504$MACLEODS$$$$$$Y$$$20240930$$CN$US$US
243779621$24377962$1$I$$20240814$20240930$20240930$PER$$US-LUNDBECK-DKLU4002975$LUNDBECK$$$$$$Y$$$20240930$$HP$US$US
243779631$24377963$1$I$20240920$20240921$20240930$20240930$EXP$$US-JNJFOC-20240961090$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243779661$24377966$1$I$$20240924$20240930$20240930$EXP$$US-TAKEDA-US201602851$TAKEDA$$$$$M$Y$$$20240930$$HP$US$US
243779681$24377968$1$I$20240821$20240920$20240930$20240930$EXP$$GB-MYLANLABS-2024M1086094$MYLAN$$$$$M$Y$$$20240930$$MD$GB$GB
243779701$24377970$1$I$$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192806$AMGEN$$$$$$Y$$$20240930$$HP$US$US
243779711$24377971$1$I$20240101$20240919$20240930$20240930$EXP$$US-UCBSA-2024048590$UCB$$$$$F$Y$$$20240930$$CN$US$US
243779721$24377972$1$I$20240920$20240923$20240930$20240930$PER$$US-Eisai-EC-2024-175352$EISAI$$77$YR$E$M$Y$88.9$KG$20240930$$MD$US$US
243779741$24377974$1$I$$20240919$20240930$20240930$EXP$$CA-APOTEX-2024AP011307$APOTEX$$68$YR$$M$Y$$$20240930$$HP$CA$CA
243779751$24377975$1$I$20230930$20240909$20240930$20240930$EXP$$AE-ROCHE-10000094087$ROCHE$$$$$F$Y$$$20240930$$CN$AE$AE
243779761$24377976$1$I$20240923$20240925$20240930$20240930$EXP$$IN-ROCHE-10000092610$ROCHE$$69$YR$E$M$Y$$$20240930$$CN$IN$IN
243779771$24377977$1$I$$20240919$20240930$20240930$EXP$$NVSC2024FR190023$NOVARTIS$De Alcubierre D, Gkasdaris G, Mordrel M, Joncour A, Briet C, Almairac F et al.. BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2024;191(2):251-61$71$YR$$F$Y$$$20240930$$HP$FR$FR
243779781$24377978$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017449$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240930$$CN$US$US
243779791$24377979$1$I$$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018240$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240930$$PH$US$US
243779801$24377980$1$I$$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018175$ELI LILLY AND CO$$73$YR$E$M$Y$$$20240930$$CN$US$US
243779811$24377981$1$I$20240801$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017968$ELI LILLY AND CO$$$$$M$Y$$$20240930$$CN$US$US
243779821$24377982$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153967$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20240930$$CN$US$US
243779831$24377983$1$I$20240909$20240919$20240930$20240930$EXP$$CN-ROCHE-10000086246$ROCHE$$52$YR$A$M$Y$60$KG$20240930$$HP$CN$CN
243779841$24377984$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153983$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$$$20240930$$CN$US$US
243779851$24377985$1$I$20231226$20240927$20240927$20240927$DIR$720281$$FDA-CTU$$70$YR$$M$N$162$KG$20240927$N$HP$US$
243779861$24377986$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011175$APOTEX$$64$YR$$F$Y$$$20240930$$CN$CA$CA
243779871$24377987$1$I$$20240917$20240930$20240930$EXP$$US-BAYER-2024A133653$BAYER$$77$YR$E$F$Y$58.957$KG$20240930$$CN$US$US
243779881$24377988$1$I$$20240917$20240930$20240930$EXP$$BE-STERISCIENCE B.V.-2024-ST-001477$Steriscience PTE$Mastrodicasa E.. SULFURIC ACID INGESTION: MAY THE SEVERITY OF THE METABOLIC ACIDOSIS BE CONSIDERED AS A PREDICTIVE SIGN OF LATE DAMAGE TO THE GASTROINTESTINAL TRACT?.. Eur-J-Case-Rep-Intern-Med. 2024;11 (5)$66$YR$$F$Y$$$20240930$$HP$BE$BE
243779891$24377989$1$I$20170914$20240923$20240930$20240930$EXP$$FR-AFSSAPS-PC20180352$Haleon PLC$$1$DY$$M$Y$1.89$KG$20240930$$PH$FR$FR
243779901$24377990$1$I$$20240923$20240930$20240930$EXP$$US-AUROBINDO-AUR-APL-2024-047337$AUROBINDO$Zabel KM, Rebbe R, Vasef M, Foucar C. . Case of B-acute lymphoblastic leukaemia with t(1;19)(q23;p13.3) TCF3::PBX1 and co-occurring CBL mutation in an elderly patient. BMJ case reports. 2024;17(9):e260617$8$DEC$$F$Y$$$20240930$$MD$US$US
243779911$24377991$1$I$20240907$20240920$20240930$20240930$EXP$$CN-ABBVIE-5939526$ABBVIE$$6$YR$$M$Y$$$20240930$$HP$CN$CN
243779921$24377992$1$I$$20240918$20240930$20240930$EXP$$US-MYLANLABS-2024M1086527$MYLAN$Fiske HW, Roussel B, Winkler M, Hall B. A case report of lactobacillus bacteremia in a patient on chronic parenteral nutrition. Clin-Nutr-ESPEN 2024; 60 281-284.$60$YR$$F$Y$$$20240930$$HP$US$US
243779931$24377993$1$I$$20240920$20240930$20240930$EXP$$US-MYLANLABS-2024M1086877$MYLAN$Konisky H, Kortz A, Huho A, Gregory AN. Multiple pigmented squamous cell carcinoma in situ on the volar hands after chronic use of topical tacrolimus. JAAD-Case-Rep 2024; 52 66-67.$55$YR$$M$Y$$$20240930$$HP$US$US
243779941$24377994$1$I$$20240926$20240930$20240930$EXP$$US-ABBVIE-5942845$ABBVIE$$$$$F$Y$$$20240930$$MD$US$US
243779951$24377995$1$I$$20240918$20240930$20240930$EXP$$IT-MYLANLABS-2024M1086177$MYLAN$Mannelli F, Crupi F, Zanotti R, Pagano L, Rapezzi D, Tanasi I, et al. The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis. Ther-Adv-Hematol 2023; 14.$48$YR$$M$Y$$$20240930$$HP$IT$IT
243779961$24377996$1$I$20231127$20240927$20240927$20240927$DIR$720288$$FDA-CTU$$80$YR$$M$N$85$KG$20240927$N$HP$US$
243779971$24377997$1$I$20231127$20240927$20240927$20240927$DIR$720295$$FDA-CTU$$75$YR$$M$N$74$KG$20240927$N$PH$US$
243779981$24377998$1$I$$20240918$20240930$20240930$EXP$$DE-MYLANLABS-2024M1086228$MYLAN$Ong P, Hill S, Bierbaum D, Geiger N, Wunder C, Franke U, et al. Successful TAVI Despite Sudden Low Output and Ventricular Fibrillation in a Patient with Cardiac Amyloidosis. Cardiovasc-Innov-Appl 2023; 8 (1):.$79$YR$$M$Y$$$20240930$$MD$DE$DE
243779991$24377999$1$I$20240719$20240924$20240930$20240930$30DAY$$US-AMGEN-USASP2024191053$AMGEN$$74$YR$E$M$Y$$$20240930$$PH$US$US
243780001$24378000$1$I$$20240917$20240930$20240930$EXP$$SG-STERISCIENCE B.V.-2024-ST-001484$Steriscience PTE$Lee BH, Leong YH, Kwek Beng Kee E. Atypical Presentation of Klebsiella pneumoniae Necrotizing Fasciitis of the Lower Extremities: Silent but Deadly: A Case Report. JBJS-Case-Connect. 2023;13:no pagination.$50$YR$$F$Y$$$20240930$$MD$SG$SG
243780011$24378001$1$I$$20240923$20240930$20240930$EXP$$US-SANDOZ INC.-NVSC2021US188684$SANDOZ$$$$$F$Y$48.526$KG$20240930$$CN$US$US
243780021$24378002$1$I$20231002$20240927$20240927$20240927$DIR$720286$$FDA-CTU$$74$YR$$M$N$84$KG$20240927$N$HP$US$
243780031$24378003$1$I$20231212$20240927$20240927$20240927$DIR$720270$$FDA-CTU$$67$YR$$M$N$72$KG$20240927$N$HP$US$
243780041$24378004$1$I$20240808$20240925$20240930$20240930$PER$$NVSC2024US191478$NOVARTIS$$$$$F$Y$$$20240930$$HP$US$US
243780051$24378005$1$I$$20240927$20240930$20240930$EXP$GB-MHRA-MED-202409271343361070-TFGZC$GB-SANDOZ INC.-SDZ2024GB083670$SANDOZ$$79$YR$$F$Y$$$20240930$$CN$GB$GB
243780071$24378007$1$I$20240823$20240926$20240930$20240930$PER$$US-HALEON-2199056$Haleon PLC$$57$YR$$F$Y$$$20240930$$CN$US$US
243780081$24378008$1$I$$20240925$20240930$20240930$EXP$$EG-AMGEN-EGYSP2024193388$AMGEN$$30$YR$A$F$Y$$$20240930$$CN$EG$EG
243780091$24378009$1$I$$20240919$20240930$20240930$EXP$$FR-MYLANLABS-2024M1086625$MYLAN$Robert M, Le Moigne M, Cribier B, Cassagnau E, Barbarot S. Treatment of facial and axillary lupus miliaris with adalimumab. Ann-Dermatol-Venereol 2024; 151 (3):.$46$YR$$F$Y$$$20240930$$HP$FR$FR
243780101$24378010$1$I$20240101$20240917$20240930$20240930$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-18828$IPSEN$$68$YR$E$F$Y$56.69$KG$20240930$$CN$US$US
243780111$24378011$1$I$20211022$20240916$20240930$20240930$EXP$$US-MYLANLABS-2024M1084386$MYLAN$$49$YR$$M$Y$102.05$KG$20240930$$LW$US$US
243780121$24378012$1$I$$20240919$20240930$20240930$EXP$$US-MYLANLABS-2024M1086635$MYLAN$Acharya S, Thakurathi P, Plocharczyk E, Arbach A, Gupta SS. Minocycline-Associated Fatal Liver Injury. Am-J-Ther 2024; 31 (2): e195-e197.$55$YR$$M$Y$$$20240930$$MD$US$US
243780131$24378013$1$I$$20240919$20240930$20240930$EXP$$US-MYLANLABS-2024M1086872$MYLAN$Fu J, Sia T, Solecki R, Mallik S, Khuda R, Headen M, et al. Clinical and histologic remission achieved with upadacitinib in a patient with refractory eosinophilic gastritis and duodenitis. J-Allergy-Clin-Immunol-Pract 2024; 12 (6): 1649-1651.$59$YR$$F$Y$$$20240930$$MD$US$US
243780141$24378014$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024AMR117272$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$CN$US$US
243780151$24378015$1$I$$20240926$20240930$20240930$EXP$$AT-TAKEDA-2024TUS096183$TAKEDA$$$$$F$Y$$$20240930$$CN$GB$AT
243780161$24378016$1$I$$20240917$20240930$20240930$EXP$$NL-BEH-2024179119$CSL BEHRING$$$$$$Y$$$20240930$$MD$NL$NL
243780171$24378017$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2022AMR182572$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243780181$24378018$1$I$20240901$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3248147$TEVA$$21$YR$$F$Y$$$20240930$$CN$CA$CA
243780191$24378019$1$I$$20240924$20240930$20240930$EXP$$US-JNJFOC-20240973762$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243780201$24378020$1$I$$20240925$20240930$20240930$PER$$US-JNJFOC-20240971204$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243780221$24378022$1$I$20240920$20240927$20240930$20240930$EXP$$US-JNJFOC-20240975183$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240930$$CN$US$US
243780231$24378023$1$I$$20240919$20240930$20240930$EXP$$CA-ASTRAZENECA-202409CAN003145CA$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$CA$CA
243780241$24378024$1$I$$20240927$20240930$20240930$PER$$NVSC2024US193098$NOVARTIS$$$$$F$Y$$$20240930$$HP$US$US
243780251$24378025$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093158$ROCHE$$$$E$M$Y$$$20240930$$HP$US$US
243780261$24378026$1$I$20240922$20240926$20240930$20240930$EXP$$US-GILEAD-2024-0689170$GILEAD$$64$YR$A$M$Y$$$20240930$$CN$US$US
243780271$24378027$1$I$$20240927$20240930$20240930$PER$$US-ROCHE-10000094629$ROCHE$$76$YR$E$F$Y$$$20240930$$HP$US$US
243780281$24378028$1$I$20240919$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192522$AMGEN$$61$YR$A$F$Y$$$20240930$$PH$US$US
243780291$24378029$1$I$$20240920$20240930$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR119081$VIIV$$$$$M$Y$$$20240930$$CN$US$US
243780311$24378031$1$I$$20240924$20240930$20240930$EXP$$BE-ROCHE-10000091254$ROCHE$$$$$$Y$$$20240930$$MD$BE$BE
243780321$24378032$1$I$$20240920$20240930$20240930$EXP$$US-AMGEN-USASP2024190481$AMGEN$Angeles-han S.T.; Maccora I.; Ebert J.J. et al.. Treatment and Visual Outcomes in Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy: A Cohort Study. Ocular Immunology and Inflammation. 2024;1-8$14$YR$T$F$Y$$$20240930$$MD$US$US
243780331$24378033$1$I$$20240920$20240930$20240930$EXP$$US-JNJFOC-20240959673$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$HP$US$US
243780351$24378035$1$I$$20240920$20240930$20240930$EXP$$PL-JNJFOC-20240968398$JOHNSON AND JOHNSON$$34$YR$A$M$Y$$$20240930$$MD$PL$PL
243780361$24378036$1$I$20240906$20240924$20240930$20240930$EXP$$KR-CHEPLA-2024012198$CHEPLAPHARM$$54$YR$$F$Y$49.5$KG$20240930$$MD$COUNTRY NOT SPECIFIED$KR
243780371$24378037$1$I$$20240917$20240930$20240930$EXP$$IN-STERISCIENCE B.V.-2024-ST-001491$Steriscience PTE$Sasidharanpillai S, David EM, Jishna P, Khader A, George N, Sabnam CP, et al.. Antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS): A cross-sectional study.. Indian-J-Dermatol-Venereol-Leprol. 2024;90 (3)$$$$$Y$$$20240930$$HP$IN$IN
243780381$24378038$1$I$20210701$20240923$20240930$20240930$EXP$$CN-CHEPLA-2024012239$CHEPLAPHARM$Wang Y, Fang Y, Yan Z, Xia R, Zeng W, Deng W. Fatal BK polyomavirus-associated pneumonia: report of two cases with literature review. BMC Infectious Diseases. 2023;23:592. DOI: 3:592 https://doi.org/10.1186/s12879-023-08577-2.$19$YR$$M$Y$$$20240930$$HP$COUNTRY NOT SPECIFIED$CN
243780391$24378039$1$I$20240729$20240920$20240930$20240930$PER$$US-TAKEDA-2024TUS094878$TAKEDA$$$$$M$Y$$$20240930$$CN$US$US
243780421$24378042$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093413$ROCHE$$42$YR$A$F$Y$$$20240930$$HP$US$US
243780431$24378043$1$I$$20240920$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409013687$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240930$$CN$US$US
243780451$24378045$1$I$20240822$20240920$20240930$20240930$PER$$US-GSK-US2024117101$GLAXOSMITHKLINE$$46$YR$$F$Y$54.43$KG$20240930$$CN$US$US
243780461$24378046$1$I$$20240917$20240930$20240930$EXP$$JP-STERISCIENCE B.V.-2024-ST-001493$Steriscience PTE$Kitazawa T, Yamamoto A, Nakayama S, Kawase K, Wakabayashi Y.. Disseminated Nontuberculous Mycobacterium Infection During Treatment of Multiple Myeloma: A Case Report and Review of the Literature.. Intern-Med. 2024;1-5$$$E$M$Y$$$20240930$$HP$JP$JP
243780471$24378047$1$I$20240920$20240920$20240930$20240930$EXP$$US-THERATECHNOLOGIES INC.-2024-THE-TES-000384$THERATECHNOLOGIES$$$$$$Y$$$20240930$$CN$US$US
243780491$24378049$1$I$20240801$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016371$ELI LILLY AND CO$$63$YR$A$F$Y$$$20240930$$CN$US$US
243780501$24378050$1$I$20240701$20240920$20240930$20240930$PER$$US-ROCHE-10000088076$ROCHE$$27$YR$A$F$Y$61.23$KG$20240930$$CN$US$US
243780511$24378051$1$I$$20240918$20240930$20240930$EXP$$US-AUROBINDO-AUR-APL-2024-046683$AUROBINDO$Mehta P, Ngo D, Tinajero J.. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. J-Oncol-Pharm-Pract. 2024$69$YR$$F$Y$$$20240930$$HP$US$US
243780521$24378052$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011199$APOTEX$$54$YR$$F$Y$$$20240930$$CN$CA$CA
243780551$24378055$1$I$$20240923$20240930$20240930$EXP$$US-BAYER-2024A135490$BAYER$$66$YR$E$F$Y$$$20240930$$CN$US$US
243780561$24378056$1$I$20230815$20240924$20240930$20240930$EXP$$AU-TAKEDA-2023TUS080286$TAKEDA$$34$YR$$M$Y$$$20240930$$CN$AU$AU
243780571$24378057$1$I$20240911$20240924$20240930$20240930$PER$$US-AMGEN-USASP2024191185$AMGEN$$65$YR$E$F$Y$$$20240930$$PH$US$US
243780591$24378059$1$I$20230204$20240923$20240930$20240930$EXP$FR-AFSSAPS-MA2024001360$FR-009507513-2409FRA008010$MERCK$$41$YR$$F$Y$61$KG$20240930$$PH$FR$FR
243780611$24378061$1$I$$20231027$20240930$20240930$PER$$US-STRIDES ARCOLAB LIMITED-2023SP016479$STRIDES$Vanderhoof T, Reitz JJ, Tang Y-L.. Off-label medications for addictive disorders.. Curr-Psychiat. 2023;22(8):36-47.$67$YR$$F$Y$$$20240930$$MD$US$US
243780621$24378062$1$I$$20240930$20240930$20240930$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054048$BOEHRINGER INGELHEIM$$$$$$Y$$$20240930$$PH$JP$JP
243780631$24378063$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117121$GLAXOSMITHKLINE$$$$$F$Y$81.19$KG$20240930$$CN$US$US
243780641$24378064$1$I$$20240926$20240930$20240930$EXP$$US-GILEAD-2024-0689244$GILEAD$$$$A$M$Y$$$20240930$$CN$US$US
243780661$24378066$1$I$$20240918$20240930$20240930$PER$$US-ROCHE-10000086517$ROCHE$$$$$F$Y$$$20240930$$CN$US$US
243780671$24378067$1$I$$20240924$20240930$20240930$EXP$$BE-MYLANLABS-2024M1087719$MYLAN$Balthasar Y, Gheysens T, Loos C, De Picker L. [RCVS: case-study and role of substance abuse, Covid and psychotropic drugs]. [Dutch]. Tijdschr-Psychiatr 2024; 66 (6): 296-300.$27$YR$$M$Y$$$20240930$$MD$BE$BE
243780681$24378068$1$I$20240101$20240924$20240930$20240930$EXP$FR-AFSSAPS-TS2024001021$FR-MYLANLABS-2024M1086967$MYLAN$$80$YR$$M$Y$$$20240930$$MD$FR$FR
243780691$24378069$1$I$$20240918$20240930$20240930$EXP$$NVSC2024US012095$NOVARTIS$$$$$M$Y$107.48$KG$20240930$$CN$US$US
243780701$24378070$1$I$$20240923$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US082861$SANDOZ$$$$$$Y$$$20240930$$CN$US$US
243780711$24378071$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152271$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20240930$$CN$US$US
243780721$24378072$1$I$$20240909$20240930$20240930$EXP$$US-SA-2024SA277888$SANOFI AVENTIS$$$$E$M$Y$81.64$KG$20240930$$MD$US$US
243780731$24378073$1$I$$20240927$20240930$20240930$EXP$$CA-SANDOZ INC.-SDZ2023CA003077$SANDOZ$$3$YR$$F$Y$64$KG$20240930$$CN$CA$CA
243780741$24378074$1$I$$20240923$20240930$20240930$EXP$$NVSC2024AT191008$NOVARTIS$$60$YR$$F$Y$$$20240930$$MD$AT$AT
243780751$24378075$1$I$$20240927$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US083793$SANDOZ$$89$YR$$F$Y$$$20240930$$CN$US$US
243780761$24378076$1$I$20240826$20240924$20240930$20240930$EXP$FR-AFSSAPS-LY2024001367$FR-MYLANLABS-2024M1086654$MYLAN$$65$YR$$M$Y$81$KG$20240930$$PH$FR$FR
243780771$24378077$1$I$$20240919$20240930$20240930$EXP$$US-UCBSA-2024048343$UCB$$$$$M$Y$$$20240930$$CN$US$US
243780781$24378078$1$I$20240101$20240925$20240930$20240930$EXP$$CA-PFIZER INC-202400233202$PFIZER$$75$YR$$M$Y$$$20240930$$HP$CA$CA
243780791$24378079$1$I$$20240918$20240930$20240930$30DAY$$US-PFIZER INC-PV202400047158$PFIZER$$7$YR$$M$Y$$$20240930$$HP$US$US
243780801$24378080$1$I$$20240919$20240930$20240930$30DAY$$US-PFIZER INC-202400260099$PFIZER$$11$YR$$M$Y$$$20240930$$CN$US$US
243780821$24378082$1$I$$20240918$20240930$20240930$30DAY$$US-PFIZER INC-202400259527$PFIZER$$15$YR$$M$Y$$$20240930$$CN$US$US
243780831$24378083$1$I$20240920$20240927$20240927$20240927$DIR$720417$$FDA-CTU$$41$YR$$F$N$50.4$KG$20240927$N$CN$US$
243780841$24378084$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5938912$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243780851$24378085$1$I$20240918$20240927$20240927$20240927$DIR$720414$$FDA-CTU$$41$YR$$F$N$47.7$KG$20240927$N$CN$US$
243780861$24378086$1$I$20240926$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192696$AMGEN$$$$A$$Y$$$20240930$$CN$US$US
243780891$24378089$1$I$20240927$20240927$20240927$20240927$DIR$720404$$FDA-CTU$$51$YR$$M$N$$$20240927$N$HP$US$
243780901$24378090$1$I$20240902$20240930$20240930$20240930$EXP$$CN-ROCHE-10000094667$ROCHE$$60$YR$A$F$Y$54$KG$20240930$$HP$CN$CN
243780911$24378091$1$I$$20240920$20240930$20240930$PER$$US-RDY-LIT/USA/24/0014247$DR REDDYS$Chau LQ, Crawford JR. Neuroimaging features of accidental fentanyl overdose in a toddler. BMJ Case Reports. 2024 Jan 08;17: doi:10.1136/bcr-2023-258524.$$$$F$Y$$$20240930$$HP$US$US
243780921$24378092$1$I$20240901$20240924$20240930$20240930$EXP$$US-ABBVIE-5939845$ABBVIE$$51$YR$$F$Y$$$20240930$$CN$US$US
243780931$24378093$1$I$20240701$20240925$20240930$20240930$EXP$$US-SMPA-2024SPA003328$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243780941$24378094$1$I$$20240925$20240930$20240930$EXP$$US-SMPA-2024SPA003311$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243780951$24378095$1$I$20240921$20240929$20240930$20240930$EXP$$CN-ROCHE-10000094293$ROCHE$$67$YR$E$M$Y$$$20240930$$HP$CN$CN
243780971$24378097$1$I$20240820$20240916$20240930$20240930$EXP$DE-CADRBFARM-2024330338$HU-SMPA-2024SPA002917$SUNOVION$$$$$$Y$$$20240930$$MD$DE$DE
243780981$24378098$1$I$$20240924$20240930$20240930$PER$$US-BAYER-2024A136999$BAYER$$$$$F$Y$$$20240930$$HP$US$US
243780991$24378099$1$I$$20240916$20240930$20240930$EXP$$US-SMPA-2024SPA002922$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243781001$24378100$1$I$$20240922$20240930$20240930$EXP$$CN-ROCHE-10000093252$ROCHE$$$$$$Y$$$20240930$$MD$CN$CN
243781011$24378101$1$I$$20240924$20240930$20240930$EXP$$CA-MYLANLABS-2024M1087029$MYLAN$$74$YR$$M$Y$$$20240930$$MD$CA$CA
243781021$24378102$1$I$$20240918$20240930$20240930$EXP$$CA-SA-2024SA279441$SANOFI AVENTIS$$$$E$M$Y$$$20240930$$CN$CA$CA
243781031$24378103$1$I$$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024192870$AMGEN$$$$$M$Y$$$20240930$$CN$US$US
243781041$24378104$1$I$$20240924$20240930$20240930$PER$$US-BAYER-2024A137938$BAYER$$$$$F$Y$$$20240930$$HP$US$US
243781061$24378106$1$I$20240101$20240924$20240930$20240930$30DAY$$CA-PFIZER INC-202400263835$PFIZER$$9$YR$$F$Y$$$20240930$$HP$CA$CA
243781081$24378108$1$I$$20240925$20240930$20240930$EXP$$US-PFIZER INC-202400263210$PFIZER$$21$YR$$M$Y$$$20240930$$MD$US$US
243781101$24378110$1$I$$20240925$20240930$20240930$EXP$$RS-PFIZER INC-PV202300160548$PFIZER$$28$YR$$F$Y$$$20240930$$MD$RS$RS
243781111$24378111$1$I$$20240925$20240930$20240930$EXP$$JP-PFIZER INC-202400264135$PFIZER$$8$DEC$$M$Y$$$20240930$$MD$JP$JP
243781121$24378112$1$I$20230301$20240926$20240930$20240930$EXP$FR-AFSSAPS-TS2024001041$FR-PFIZER INC-202400264423$PFIZER$$72$YR$$M$Y$74$KG$20240930$$MD$FR$FR
243781131$24378113$1$I$$20240926$20240930$20240930$EXP$$CA-PFIZER INC-202400264928$PFIZER$$72$YR$$M$Y$$$20240930$$CN$CA$CA
243781141$24378114$1$I$20240901$20240926$20240930$20240930$EXP$$CN-PFIZER INC-PV202400126263$PFIZER$$26$YR$$M$Y$47$KG$20240930$$HP$CN$CN
243781151$24378115$1$I$20220101$20240925$20240930$20240930$EXP$$US-PFIZER INC-202400263904$PFIZER$$59$YR$$F$Y$57.15$KG$20240930$$HP$US$US
243781161$24378116$1$I$$20240924$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015712$ELI LILLY AND CO$$71$YR$E$M$Y$$$20240930$$PH$US$US
243781171$24378117$1$I$$20240925$20240930$20240930$EXP$$GB-PFIZER INC-202400263396$PFIZER$$54$YR$$F$Y$$$20240930$$CN$GB$GB
243781201$24378120$1$I$20240723$20240927$20240930$20240930$EXP$$JP-PFIZER INC-202400265151$PFIZER$$48$YR$$F$Y$$$20240930$$MD$JP$JP
243781211$24378121$1$I$20240705$20240926$20240930$20240930$EXP$$DE-PFIZER INC-202400264390$PFIZER$$$$$F$Y$$$20240930$$MD$DE$DE
243781231$24378123$1$I$20240801$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153251$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20240930$$HP$US$US
243781241$24378124$1$I$$20240924$20240930$20240930$EXP$$US-GILEAD-2024-0688913$GILEAD$$$$E$F$Y$$$20240930$$HP$US$US
243781251$24378125$1$I$$20240925$20240930$20240930$EXP$$CA-PFIZER INC-202400264731$PFIZER$$65$YR$$M$Y$66$KG$20240930$$MD$CA$CA
243781261$24378126$1$I$$20240924$20240930$20240930$EXP$$CA-PFIZER INC-2020202530$MYLAN$$74$YR$$F$Y$$$20240930$$HP$CA$CA
243781271$24378127$1$I$$20240924$20240930$20240930$30DAY$$US-PFIZER INC-202400263534$PFIZER$$12$YR$$M$Y$$$20240930$$CN$US$US
243781281$24378128$1$I$$20240926$20240930$20240930$EXP$$US-PFIZER INC-202400265235$PFIZER$$68$YR$$F$Y$$$20240930$$CN$US$US
243781291$24378129$1$I$$20240924$20240930$20240930$PER$$US-BAYER-2024A137939$BAYER$$$$$F$Y$$$20240930$$HP$US$US
243781301$24378130$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011249$APOTEX$$71$YR$$F$Y$$$20240930$$CN$CA$CA
243781311$24378131$1$I$20240917$20240923$20240930$20240930$PER$$US-GSK-US2024117497$GLAXOSMITHKLINE$$63$YR$$M$Y$$$20240930$$CN$US$US
243781321$24378132$1$I$$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192785$AMGEN$$39$YR$A$F$Y$$$20240930$$CN$US$US
243781331$24378133$1$I$$20240925$20240930$20240930$PER$$US-ASTRAZENECA-202409USA007206US$ALEXION PHARMACEUTICALS$$46$YR$A$$Y$$$20240930$$MD$US$US
243781341$24378134$1$I$$20240923$20240930$20240930$EXP$$BR-MYLANLABS-2024M1086812$MYLAN$$$$$$Y$$$20240930$$CN$BR$BR
243781361$24378136$1$I$20240731$20240923$20240930$20240930$EXP$$GB-MYLANLABS-2024M1087604$MYLAN$$$$$F$Y$$$20240930$$PH$GB$IE
243781371$24378137$1$I$$20240923$20240930$20240930$EXP$$US-MYLANLABS-2024M1087062$MYLAN$$$$$M$Y$$$20240930$$MD$US$US
243781381$24378138$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024191192$AMGEN$Mundanchira G.; Murn M.; Agrawal A. et al.. BRONCHOSCOPIC INTERVENTIONS FOR TRACHEAL STENOSIS SECONDARY TO RELAPSING POLYCHONDRITIS. Chest. 2024;166 (4):A5216-A5217$50$YR$A$F$Y$$$20240930$$HP$US$US
243781391$24378139$1$I$20240925$20240930$20240930$20240930$PER$$US-BAYER-2024A137409$BAYER$$24$YR$A$F$Y$$$20240930$$MD$US$US
243781401$24378140$1$I$20240801$20240918$20240930$20240930$PER$$US-MYLANLABS-2024M1086392$MYLAN$$46$YR$$F$Y$92.99$KG$20240930$$CN$US$US
243781411$24378141$1$I$20180402$20240923$20240930$20240930$EXP$FR-AFSSAPS-RE2024000881$FR-SA-2024SA280048$SANOFI AVENTIS$$69$YR$E$M$Y$109$KG$20240930$$MD$FR$FR
243781421$24378142$1$I$20240925$20240926$20240930$20240930$EXP$$US-HALEON-2199038$Haleon PLC$$$$$F$Y$$$20240930$$CN$US$US
243781431$24378143$1$I$20240517$20240924$20240930$20240930$EXP$FR-AFSSAPS-LL2024001781$FR-LEO Pharma-373711$LEO PHARM$$26$YR$$F$Y$$$20240930$$MD$FR$FR
243781451$24378145$1$I$$20240920$20240930$20240930$EXP$$CA-EMD Serono-2024050778$EMD SERONO INC$$$$C$M$Y$$$20240930$$CN$CA$CA
243781471$24378147$1$I$20240808$20240924$20240930$20240930$EXP$FR-AFSSAPS-AN2024001153$FR-SA-2024SA278609$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240930$$MD$FR$FR
243781491$24378149$1$I$20240811$20240924$20240930$20240930$EXP$$US-SA-2024SA277895$SANOFI AVENTIS$$27$YR$A$F$Y$$$20240930$$HP$US$US
243781501$24378150$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153034$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240930$$HP$US$US
243781511$24378151$1$I$20240915$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153528$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$53.98$KG$20240930$$PH$US$US
243781521$24378152$1$I$$20240925$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152595$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20240930$$CN$US$US
243781531$24378153$1$I$$20240917$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153695$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$87.09$KG$20240930$$CN$US$US
243781541$24378154$1$I$20230101$20240923$20240930$20240930$EXP$$NVSC2024BE167729$NOVARTIS$$$$E$F$Y$$$20240930$$MD$BE$BE
243781551$24378155$1$I$$20240924$20240930$20240930$EXP$$US-BAYER-2024A136632$BAYER$$73$YR$E$F$Y$$$20240930$$CN$US$US
243781561$24378156$1$I$20240901$20240920$20240930$20240930$EXP$$US-CHIESI-2024CHF06324$CHIESI$$$$$M$Y$$$20240930$$MD$US$US
243781581$24378158$1$I$20240801$20240905$20240930$20240930$PER$$US-Eisai-EC-2024-173854$EISAI$$80$YR$E$F$Y$$$20240930$$CN$US$US
243781591$24378159$1$I$$20240926$20240930$20240930$EXP$$NVSC2024US192310$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
243781601$24378160$1$I$$20240925$20240930$20240930$EXP$$US-MYLANLABS-2024M1088175$MYLAN$Shahid R, KO E, Umrani R. Battling the blockade: a case of multifactorial shock in polysubstance overdose. Chest 2024; 166 (Suppl.) (4): A2520-A2521.$59$YR$$F$Y$$$20240930$$HP$US$US
243781611$24378161$1$I$$20240927$20240927$20240927$DIR$720416$$FDA-CTU$$$$$F$N$72$KG$20240927$N$CN$US$
243781621$24378162$1$I$$20240917$20240930$20240930$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002775$CORCEPT$$$$$$Y$$$20240930$$MD$US$US
243781631$24378163$1$I$$20240920$20240930$20240930$PER$$US-JNJFOC-20240959859$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243781641$24378164$1$I$$20240430$20240930$20240930$PER$$US-Lavipharm SA-2162145$LAVIPHARM$$15$MON$$M$Y$$$20240930$$MD$US$US
243781651$24378165$1$I$20240501$20240926$20240930$20240930$EXP$GB-MHRA-MED-202409262338240740-DMNCS$GB-SANDOZ INC.-SDZ2024GB083526$SANDOZ$$40$YR$$F$Y$65$KG$20240930$$CN$GB$GB
243781661$24378166$1$I$20240831$20240924$20240930$20240930$EXP$$DE-TEVA-VS-3247522$TEVA$$64$YR$$F$Y$45$KG$20240930$$MD$DE$DE
243781671$24378167$1$I$$20240927$20240930$20240930$PER$$US-TAKEDA-2024TUS096425$TAKEDA$$$$$F$Y$$$20240930$$CN$US$US
243781691$24378169$1$I$$20240920$20240930$20240930$EXP$$US-ROCHE-10000087983$ROCHE$$36$YR$A$M$Y$$$20240930$$CN$US$US
243781701$24378170$1$I$$20240916$20240930$20240930$EXP$$TR-EPICPHARMA-TR-2024EPCLIT01135$EPIC PHARM$Erensu Baysak.Acute laryngeal dystonia: a case report. Psychiatry and Clinical Psychopharmacology.jan-2019;29:259$21$YR$A$M$Y$$$20240930$$HP$TR$TR
243781711$24378171$1$I$$20240926$20240930$20240930$EXP$$FR-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00509$VELOXIS PHARMACEUTICALS$Hamine S, Morel A.. Extensive thigh pyomyositis secondary to cystic fistulae due to anaerobic-bacterial infection in a kidney transplant recipient. BMC Infectious Diseases. 2024;24(1):1-4$84$YR$$M$Y$$$20240930$$HP$FR$FR
243781721$24378172$1$I$20240901$20240918$20240930$20240930$PER$$US-MYLANLABS-2024M1085959$MYLAN$$75$YR$$F$Y$$$20240930$$CN$US$US
243781731$24378173$1$I$$20240918$20240930$20240930$EXP$DE-MLMSERVICE-20240912-PI191169-00053-1$DE-STERISCIENCE B.V.-2024-ST-001506$Steriscience PTE$Traidl S, Wedi B. Case of multiple drug Hypersensitivity syndromes - Challenges allergological diagnostics.. Allergology. 2023;46(2):94-8$52$YR$$M$Y$$$20240930$$MD$DE$DE
243781751$24378175$1$I$$20240926$20240930$20240930$EXP$$NVSC2024US192594$NOVARTIS$$$$$$Y$$$20240930$$MD$US$US
243781761$24378176$1$I$20240914$20240919$20240930$20240930$EXP$$US-JNJFOC-20240958388$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20240930$$CN$US$US
243781772$24378177$2$F$20190101$20240918$20240930$20240930$PER$$US-ROCHE-10000085775$ROCHE$$57$YR$A$M$Y$111.13$KG$20240930$$CN$US$US
243781781$24378178$1$I$$20240917$20240930$20240930$EXP$$CO-ASTRAZENECA-202409SAM004371CO$ALEXION PHARMACEUTICALS$$66$YR$E$$Y$$$20240930$$$CO$CO
243781791$24378179$1$I$20240919$20240919$20240930$20240930$PER$$US-RDY-SPO/USA/24/0014058$DR REDDYS$$47$YR$A$F$Y$$$20240930$$CN$US$US
243781811$24378181$1$I$$20240923$20240930$20240930$EXP$$GB-MYLANLABS-2024M1086694$MYLAN$$$$$M$Y$$$20240930$$CN$GB$GB
243781821$24378182$1$I$$20240925$20240930$20240930$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-19568$IPSEN$$59$YR$A$F$Y$$$20240930$$HP$US$US
243781831$24378183$1$I$20240719$20240923$20240930$20240930$EXP$FR-AFSSAPS-CN2024000815$FR-MYLANLABS-2024M1086361$MYLAN$$66$YR$$F$Y$49$KG$20240930$$MD$FR$FR
243781841$24378184$1$I$20240729$20240923$20240930$20240930$EXP$FR-AFSSAPS-LY2024001351$FR-MYLANLABS-2024M1086371$MYLAN$$82$YR$$M$Y$63.2$KG$20240930$$PH$FR$FR
243781851$24378185$1$I$$20240916$20240930$20240930$EXP$$CA-APOTEX-2024AP011035$APOTEX$$59$YR$$M$Y$$$20240930$$HP$CA$CA
243781861$24378186$1$I$$20240924$20240930$20240930$EXP$$US-PFIZER INC-PV202400126062$PFIZER$Deora, K.. AN UNUSUAL THEATRIC PRELUDE BETWEEN ZOLEDRONIC ACID AND ATRIAL FIBRILLATION. Chest. 2024;166(4 Suppl):A774$76$YR$$M$Y$$$20240930$$HP$US$US
243781881$24378188$1$I$$20240924$20240930$20240930$EXP$$US-PFIZER INC-PV202400125432$PFIZER$MAJOR, J.. EOSINOPHILIC PNEUMONIA, SPONTANEOUS PNEUMOMEDIASTINUM, AND HYPEROXIA ACCELERATED PNEUMONITIS AND PULMONARY FIBROSIS: A CASE REPORT OF CONCURRENT BLEOMYCIN TOXICITIES. Chest. 2024;166(4 Supple):3471A-3472A$23$YR$$M$Y$$$20240930$$HP$US$US
243781911$24378191$1$I$$20240925$20240930$20240930$EXP$$US-AMGEN-USASP2024193651$AMGEN$Yaghmour G.; Ashouri K.; Hom B. et al.. Philadelphia-like B-cell acute lymphoblastic Leukaemia: Disease features and outcomes in the era of immunotherapy. British Journal of Haematology. 2024;1-14$$$$$Y$$$20240930$$HP$US$US
243781921$24378192$1$I$$20240925$20240930$20240930$EXP$$US-AMGEN-USASP2024193654$AMGEN$Yaghmour G.; Ashouri K.; Hom B. et al.. Philadelphia-like B-cell acute lymphoblastic Leukaemia: Disease features and outcomes in the era of immunotherapy. British Journal of Haematology. 2024;1-14$$$$$Y$$$20240930$$HP$US$US
243781931$24378193$1$I$$20240916$20240930$20240930$EXP$$CH-EPICPHARMA-CH-2024EPCLIT01153$EPIC PHARM$Elisabeth A. Kappos.The value of perforator flap reconstruction in painful soft tissue calcifications.Clinical and Experimental Medicine.13-AUG-2024;24:1-10$65$YR$A$F$Y$$$20240930$$HP$CH$CH
243781941$24378194$1$I$20240925$20240927$20240930$20240930$PER$$US-TAKEDA-2024TUS096419$TAKEDA$$65$YR$$F$Y$$$20240930$$CN$US$US
243781961$24378196$1$I$$20240918$20240930$20240930$PER$$US-AVEVA-000748$AVEVA$$$$$M$Y$$$20240930$$CN$US$US
243781972$24378197$2$F$20240829$20240904$20240930$20240930$PER$$US-AVEVA-000734$AVEVA$$$$$M$Y$$$20240930$$CN$US$US
243781981$24378198$1$I$20240920$20240925$20240930$20240930$PER$$US-AVEVA-000751$AVEVA$$$$$M$Y$$$20240930$$CN$US$US
243781991$24378199$1$I$$20240916$20240930$20240930$PER$$US-AVEVA-000746$AVEVA$$$$E$F$Y$$$20240930$$CN$US$US
243782001$24378200$1$I$$20240903$20240930$20240930$PER$$GB-AVEVA-000735$AVEVA$Thomson R, Phillips L, Orton S, Naughton F, Coleman T. Using nicotine replacement therapy for smoking reduction in pregnancy: a qualitative study of pregnant women in the UK who smoke. BMJ Open. 2024, 14(8):e085945. doi: 10.1136/bmjopen-2024-085945. PMID: 39214654.$$$$F$Y$$$20240930$$HP$GB$GB
243782011$24378201$1$I$$20240903$20240930$20240930$PER$$GB-AVEVA-000736$AVEVA$Thomson R, Phillips L, Orton S, Naughton F, Coleman T. Using nicotine replacement therapy for smoking reduction in pregnancy: a qualitative study of pregnant women in the UK who smoke. BMJ Open. 2024, 14(8):e085945. doi: 10.1136/bmjopen-2024-085945. PMID: 39214654.$$$$F$Y$$$20240930$$HP$GB$GB
243782021$24378202$1$I$20240907$20240909$20240930$20240930$PER$$US-AVEVA-000740$AVEVA$$64$YR$A$F$Y$$$20240930$$CN$CA$CA
243782042$24378204$2$F$$20240917$20240930$20240930$PER$$US-AVEVA-000744$AVEVA$$$$$$Y$$$20240930$$CN$US$US
243782051$24378205$1$I$$20240926$20240930$20240930$EXP$$GB-MYLANLABS-2024M1087951$MYLAN$$$$$F$Y$$$20240930$$PH$GB$GB
243782061$24378206$1$I$$20240916$20240930$20240930$EXP$$CN-Hisun Pharmaceuticals USA Inc.-000002$ZHEJIANG XIANJU PHARMA$Yang S, Zhang N, Li X, Li Y, Zhou L, Wei Y, Zhou K, Pan H, Kang L. A Case of Autoimmune Hepatitis Initially Manifesting as Hepatic Encephalopathy. Cureus. 2024 Jun 22;16(6):e62890. doi: 10.7759/cureus.62890.$66$YR$E$F$Y$$$20240930$$HP$CN$CN
243782091$24378209$1$I$$20240923$20240930$20240930$EXP$$CA-FreseniusKabi-FK202414199$FRESENIUS KABI$$73$YR$E$F$Y$$$20240930$$HP$CA$CA
243782101$24378210$1$I$$20240924$20240930$20240930$EXP$$JP-AMGEN-JPNSP2024190980$AMGEN$$75$YR$E$F$Y$$$20240930$$MD$JP$JP
243782111$24378211$1$I$20240819$20240923$20240930$20240930$EXP$$AR-MYLANLABS-2024M1079080$MYLAN$$15$YR$$M$Y$$$20240930$$CN$AR$AR
243782121$24378212$1$I$20240918$20240920$20240930$20240930$EXP$$DK-FreseniusKabi-FK202414172$FRESENIUS KABI$$59$YR$A$M$Y$$$20240930$$HP$DK$DK
243782131$24378213$1$I$20240909$20240923$20240930$20240930$EXP$$GB-MYLANLABS-2024M1082480$MYLAN$$21$YR$$F$Y$62$KG$20240930$$MD$GB$GB
243782141$24378214$1$I$20240101$20240919$20240930$20240930$EXP$FR-AFSSAPS-SE2024000729$FR-KOANAAP-SML-FR-2024-00981$UNKNOWN$$70$YR$E$F$Y$$$20240930$$MD$FR$FR
243782151$24378215$1$I$$20240923$20240930$20240930$PER$$US-ASTRAZENECA-202409USA005117US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$PH$US$US
243782171$24378217$1$I$$20240921$20240930$20240930$EXP$$US-BEH-2024179216$CSL BEHRING$$78$YR$E$M$Y$$$20240930$$PH$US$US
243782181$24378218$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000094144$ROCHE$$$$C$M$Y$$$20240930$$CN$US$US
243782191$24378219$1$I$20240708$20240920$20240930$20240930$EXP$$JP-ROCHE-10000070234$ROCHE$$23$YR$A$M$Y$$$20240930$$PH$JP$JP
243782201$24378220$1$I$20240101$20240924$20240930$20240930$EXP$SE-SEMPA-2024-006794$SE-TEVA-VS-3247431$TEVA$$51$YR$$F$Y$60$KG$20240930$$MD$SE$SE
243782211$24378221$1$I$20240801$20240923$20240930$20240930$EXP$FR-AFSSAPS-TO2024001540$FR-MYLANLABS-2024M1076138$MYLAN$$78$YR$$F$Y$51$KG$20240930$$PH$FR$FR
243782221$24378222$1$I$20240106$20240920$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409014124$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240930$$CN$US$US
243782231$24378223$1$I$$20240926$20240930$20240930$PER$$NVSC2024US192223$NOVARTIS$$$$$$Y$$$20240930$$CN$US$US
243782241$24378224$1$I$20240812$20240924$20240930$20240930$EXP$SE-SEMPA-2024-006776$SE-TEVA-VS-3247410$TEVA$$33$YR$$F$Y$$$20240930$$MD$SE$SE
243782271$24378227$1$I$20240912$20240925$20240930$20240930$EXP$$SE-JNJFOC-20240973431$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20240930$$MD$SE$SE
243782291$24378229$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024190521$AMGEN$Chen E.C.; Flamand Y.; Tiao E.; et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$58$YR$A$M$Y$$$20240930$$HP$US$US
243782301$24378230$1$I$$20240916$20240930$20240930$EXP$$JP-EPICPHARMA-JP-2024EPCLIT01148$EPIC PHARM$Dr Takuya Sadahira.Bladder tuberculosis with ureteral strictures after bacillus  Calmette-Guerin therapy for urinary bladder cancer: A case report.MOLECULAR AND CLINICAL ONCOLOGY.FEB-2023;18:1-5$73$YR$E$M$Y$$$20240930$$HP$JP$JP
243782311$24378231$1$I$20210501$20240922$20240930$20240930$EXP$$FI-AMGEN-FINSP2024189585$AMGEN$$17$YR$T$M$Y$$$20240930$$CN$FI$FI
243782321$24378232$1$I$20240813$20240920$20240930$20240930$EXP$DE-DCGMA-24203920$DE-TORRENT-00027347$TORRENT$$81$YR$E$M$Y$52$KG$20240930$$MD$DE$DE
243782331$24378233$1$I$$20240927$20240930$20240930$EXP$GB-MHRA-MED-202409271343361070-TFGZC$GB-MYLANLABS-2024M1087952$MYLAN$$79$YR$$F$Y$$$20240930$$CN$GB$GB
243782341$24378234$1$I$20090101$20240918$20240930$20240930$EXP$$GR-KOANAAP-SML-GR-2024-00980$SHILPA MEDICARE$$62$YR$A$F$Y$$$20240930$$MD$GR$GR
243782351$24378235$1$I$20240101$20240924$20240930$20240930$PER$$US-Prasco Laboratories-PRAS20241165$PRASCO$$72$YR$E$F$Y$$$20240930$$CN$US$US
243782361$24378236$1$I$20240918$20240919$20240930$20240930$PER$$US-CSL-2024-008683$CSL Plasma$$47$YR$$F$Y$$$20240930$$HP$US$US
243782371$24378237$1$I$20240912$20240918$20240930$20240930$PER$$US-Bion-013905$BIONPHARMA$$63$YR$A$F$Y$$$20240930$$CN$US$US
243782381$24378238$1$I$$20240919$20240930$20240930$EXP$$US-ALXN-202405USA001710US$ALEXION PHARMACEUTICALS$$$$A$$Y$$$20240930$$$US$US
243782391$24378239$1$I$$20240923$20240930$20240930$EXP$$SE-TEVA-VS-3248264$TEVA$Adra J, Giglio D, Karlsson P, Zetterberg H, Einbeigi Z. Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy. Acta-Oncol 2024; 63 636-641.$$$$F$Y$$$20240930$$HP$SE$SE
243782401$24378240$1$I$$20240920$20240930$20240930$PER$$US-Bion-013906$BIONPHARMA$$$$$M$Y$$$20240930$$CN$US$US
243782411$24378241$1$I$20240916$20240917$20240930$20240930$PER$$US-Bion-013907$BIONPHARMA$$51$YR$A$F$Y$$$20240930$$CN$US$US
243782421$24378242$1$I$20240924$20240925$20240930$20240930$EXP$$GB-PFIZER INC-PV202400125928$PFIZER$$78$YR$$M$Y$$$20240930$$CN$GB$GB
243782431$24378243$1$I$$20240927$20240930$20240930$EXP$$US-PFIZER INC-202400265852$PFIZER$$89$YR$$M$Y$$$20240930$$CN$US$US
243782441$24378244$1$I$$20240926$20240930$20240930$EXP$$CL-PFIZER INC-PV202400126714$PFIZER$$82$YR$$F$Y$$$20240930$$CN$CL$CL
243782451$24378245$1$I$$20240917$20240930$20240930$PER$$US-Bion-013908$BIONPHARMA$$$$E$F$Y$$$20240930$$CN$US$US
243782461$24378246$1$I$$20240924$20240930$20240930$EXP$$US-PFIZER INC-PV202400124845$PFIZER$Federbush, M.. MIGRATING PULMONARY OPACITIES IN A PATIENT WITH NEUROMYELITIS OPTICA TAKING RITUXIMAB WITH RECENT COVID19 INFECTION. Chest. 2024;166(4 Supp):A3295-A3296$36$YR$$M$Y$$$20240930$$HP$US$US
243782471$24378247$1$I$$20240925$20240930$20240930$EXP$$CA-PFIZER INC-202400264631$PFIZER$$15$YR$$F$Y$64$KG$20240930$$PH$CA$CA
243782491$24378249$1$I$20240822$20240926$20240930$20240930$EXP$FR-AFSSAPS-PO2024001021$FR-PFIZER INC-202400264419$PFIZER$$96$YR$$M$Y$$$20240930$$MD$FR$FR
243782501$24378250$1$I$20240917$20240925$20240930$20240930$EXP$$CN-PFIZER INC-PV202400125658$PFIZER$$12$YR$$M$Y$$$20240930$$HP$CN$CN
243782531$24378253$1$I$$20240924$20240930$20240930$EXP$$US-PFIZER INC-PV202400125970$PFIZER$Liao, C.. Endometriosis in a 22-Year-Old with Premature Ovarian Insufficiency Secondary to Pre-Pubertal Bone Marrow Transplant: a Case Report. Reproductive Sciences. 2024;31 (9):2700-2705$13$YR$$F$Y$$$20240930$$HP$US$US
243782551$24378255$1$I$20230628$20240925$20240930$20240930$EXP$IT-MINISAL02-1003492$IT-PFIZER INC-202400263623$PFIZER$$69$YR$$M$Y$$$20240930$$MD$IT$IT
243782561$24378256$1$I$20240731$20240924$20240930$20240930$EXP$$EG-PFIZER INC-PV202400124745$PFIZER$$34$YR$$F$Y$$$20240930$$PH$EG$EG
243782571$24378257$1$I$$20240923$20240930$20240930$EXP$$SE-TEVA-VS-3248265$TEVA$Adra J, Giglio D, Karlsson P, Zetterberg H, Einbeigi Z. Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy. Acta-Oncol 2024; 63 636-641.$$$$F$Y$$$20240930$$HP$SE$SE
243782581$24378258$1$I$20240826$20240903$20240930$20240930$PER$$US-TRAVERE-2024TVT00884$TRAVERE THERAPEUTICS$$70$YR$E$M$Y$$$20240930$$CN$US$US
243782591$24378259$1$I$20230101$20240925$20240930$20240930$EXP$$CA-PFIZER INC-202300331289$PFIZER$$59$YR$$F$Y$$$20240930$$CN$CA$CA
243782601$24378260$1$I$20240903$20240923$20240930$20240930$EXP$PT-INFARMED-J202409-271$PT-FreseniusKabi-FK202414249$FRESENIUS KABI$$68$YR$E$M$Y$$$20240930$$PH$PT$PT
243782611$24378261$1$I$20230501$20240923$20240930$20240930$EXP$$PT-FreseniusKabi-FK202414251$FRESENIUS KABI$$70$YR$E$F$Y$$$20240930$$MD$PT$PT
243782621$24378262$1$I$$20240923$20240930$20240930$EXP$$CA-FreseniusKabi-FK202414270$FRESENIUS KABI$$14$YR$T$M$Y$$$20240930$$PH$CA$CA
243782631$24378263$1$I$$20240924$20240930$20240930$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-129076$REGENERON$$$$$F$Y$$$20240930$$HP$US$US
243782641$24378264$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024191491$AMGEN$AURSHMA  A.; ATIQ  I.; SINGH P. et.al. EPICARDIAL ADIPOSE TISSUE NECROSIS: AN UNDERDIAGNOSED CONDITION MIMICKING ACUTE CORONARY SYNDROME. Chest. 2024;166 (4):823A-824A$36$YR$A$F$Y$$$20240930$$HP$US$US
243782651$24378265$1$I$$20240917$20240930$20240930$EXP$$AU-RDY-SPO/AUS/24/0013783$DR REDDYS$$1$YR$I$M$Y$$$20240930$$HP$AU$AU
243782661$24378266$1$I$20170301$20240923$20240930$20240930$EXP$FR-EMA-DD-20171219-hjainp-121314$FR-FreseniusKabi-FK201710598$FRESENIUS KABI$$27$YR$A$M$Y$72$KG$20240930$$HP$FR$FR
243782671$24378267$1$I$$20240918$20240930$20240930$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2024-09363$LUPIN$$1$YR$$F$Y$$$20240930$$CN$AU$AU
243782681$24378268$1$I$$20240923$20240930$20240930$EXP$$CA-FreseniusKabi-FK202414278$FRESENIUS KABI$$30$YR$A$M$Y$$$20240930$$PH$CA$CA
243782691$24378269$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154272$BRISTOL MYERS SQUIBB$$63$YR$A$M$Y$$$20240930$$CN$US$US
243782701$24378270$1$I$$20240916$20240930$20240930$EXP$$IL-EPICPHARMA-IL-2024EPCLIT01163$EPIC PHARM$Rotem Liran.A Severe Acute Kidney Injury Following Zoledronic Acid Therapy Leading to Chronic Hemodialysis Treatment: A Case Report.Israel Medical Association Journal.DEC-2023;25:828-829$78$YR$E$F$Y$$$20240930$$MD$IL$IL
243782711$24378271$1$I$$20240925$20240930$20240930$EXP$$US-BAYER-2024A137703$BAYER$$$$$$Y$$$20240930$$CN$US$US
243782721$24378272$1$I$$20240919$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409013371$ELI LILLY AND CO$$55$YR$A$F$Y$$$20240930$$CN$US$US
243782731$24378273$1$I$20240916$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017691$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243782741$24378274$1$I$20240814$20240923$20240930$20240930$PER$$US-DSJP-DS-2024-101560-US$DAIICHI$$61$YR$$F$Y$62.142$KG$20240930$$PH$US$US
243782751$24378275$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154264$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$69.49$KG$20240930$$CN$US$US
243782771$24378277$1$I$$20240925$20240930$20240930$EXP$$US-BAYER-2024A137756$BAYER$$$$$$Y$$$20240930$$CN$US$US
243782791$24378279$1$I$20220214$20240920$20240930$20240930$EXP$$DE-JNJFOC-20240964860$JOHNSON AND JOHNSON$$$$A$F$Y$95$KG$20240930$$MD$DE$DE
243782801$24378280$1$I$$20240913$20240930$20240930$PER$$US-JNJFOC-20240935926$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$PH$US$US
243782811$24378281$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024190526$AMGEN$Chen E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$26$YR$A$M$Y$$$20240930$$HP$US$US
243782821$24378282$1$I$20230101$20240925$20240930$20240930$EXP$$US-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005328$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240930$$CN$US$US
243782831$24378283$1$I$$20240923$20240930$20240930$EXP$$FR-ALNYLAM PHARMACEUTICALS, INC.-ALN-2024-005355$ALNYLAM PHARMACEUTICALS$$$$$$Y$$$20240930$$HP$FR$FR
243782841$24378284$1$I$$20240916$20240930$20240930$PER$$US-MYLANLABS-2024M1085104$MYLAN$$91$YR$$F$Y$$$20240930$$CN$US$US
243782851$24378285$1$I$20240907$20240924$20240930$20240930$EXP$FR-AFSSAPS-RS2024000882$FR-MYLANLABS-2024M1087170$MYLAN$$69$YR$$M$Y$76$KG$20240930$$MD$FR$FR
243782861$24378286$1$I$$20240917$20240930$20240930$PER$$US-MYLANLABS-2024M1085474$MYLAN$$$$$F$Y$49.9$KG$20240930$$CN$US$US
243782881$24378288$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117144$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$CN$US$US
243782891$24378289$1$I$$20240919$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN009980$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243782901$24378290$1$I$$20240924$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154147$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240930$$PH$US$US
243782921$24378292$1$I$$20240923$20240930$20240930$EXP$$CN-VANTIVE-2024VAN019978$Vantive US Healthcare$$55$YR$$M$Y$104$KG$20240930$$HP$CN$CN
243782931$24378293$1$I$20230728$20240920$20240927$20240927$DIR$FDA-CDER-CTU-2024-66966$$FDA-CTU$$68$YR$$F$N$$$20240920$N$CN$US$
243782941$24378294$1$I$$20240921$20240930$20240930$EXP$$ES-VANTIVE-2024VAN019969$Vantive US Healthcare$$$$$F$Y$$$20240930$$HP$ES$ES
243782951$24378295$1$I$$20240924$20240930$20240930$PER$$US-BAYER-2024A136856$BAYER$$$$$F$Y$$$20240930$$CN$US$US
243782961$24378296$1$I$20240920$20240927$20240927$20240927$DIR$720418$$FDA-CTU$$33$YR$$M$N$103.5$KG$20240927$Y$CN$US$
243782971$24378297$1$I$20240725$20240927$20240927$20240927$DIR$720408$$FDA-CTU$$76$YR$$M$N$63.9$KG$20240927$Y$HP$US$
243782981$24378298$1$I$$20240925$20240930$20240930$EXP$$GB-SANDOZ INC.-SDZ2023GB064637$SANDOZ$$$$$M$Y$$$20240930$$CN$GB$GB
243782991$24378299$1$I$$20240920$20240930$20240930$PER$$US-ROCHE-10000088064$ROCHE$$66$YR$E$F$Y$$$20240930$$CN$US$US
243783001$24378300$1$I$$20240911$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09270$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243783011$24378301$1$I$20220101$20240924$20240930$20240930$PER$$US-BAYER-2024A136526$BAYER$$40$YR$A$F$Y$$$20240930$$CN$US$US
243783041$24378304$1$I$20240101$20240924$20240930$20240930$EXP$$US-AMGEN-USASP2024190756$AMGEN$$69$YR$E$M$Y$$$20240930$$CN$US$US
243783051$24378305$1$I$20240920$20240920$20240930$20240930$EXP$$IE-TEVA-VS-3246966$TEVA$$38$YR$$F$Y$$$20240930$$CN$IE$IE
243783061$24378306$1$I$$20240927$20240930$20240930$PER$$NVSC2024US193413$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
243783081$24378308$1$I$20240918$20240919$20240930$20240930$PER$$US-BAYER-2024A134453$BAYER$$71$YR$E$M$Y$$$20240930$$CN$US$US
243783091$24378309$1$I$$20240925$20240930$20240930$EXP$$US-TAKEDA-US201846021$TAKEDA$$$$$F$Y$$$20240930$$HP$US$US
243783101$24378310$1$I$20240715$20240925$20240930$20240930$EXP$$DE-MYLANLABS-2024M1087467$MYLAN$$$$$M$Y$$$20240930$$CN$DE$DE
243783111$24378311$1$I$20240824$20240924$20240930$20240930$EXP$FR-AFSSAPS-MP2024001417$FR-MYLANLABS-2024M1086769$MYLAN$$61$YR$$M$Y$49.6$KG$20240930$$PH$FR$FR
243783131$24378313$1$I$20240703$20240918$20240930$20240930$EXP$FR-AFSSAPS-GR2024001066$FR-HIKMA PHARMACEUTICALS USA INC.-FR-H14001-24-08826$HIKMA$$72$YR$$F$Y$$$20240930$$PH$FR$FR
243783141$24378314$1$I$20240715$20240924$20240930$20240930$EXP$$US-INCYTE CORPORATION-2024IN010133$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243783151$24378315$1$I$$20240918$20240930$20240930$PER$$US-ALKERMES INC.-ALK-2024-002440$ALKERMES$$$$$F$Y$$$20240930$$CN$US$US
243783161$24378316$1$I$$20240925$20240930$20240930$PER$$US-BIOGEN-2024BI01284269$BIOGEN$$$$$$Y$$$20240930$$CN$US$US
243783171$24378317$1$I$$20240920$20240930$20240930$PER$$US-ROCHE-10000087806$ROCHE$$$$$$Y$$$20240930$$MD$US$US
243783191$24378319$1$I$$20240910$20240930$20240930$PER$$US-Eisai-EC-2024-174166$EISAI$$70$YR$E$M$Y$$$20240930$$MD$US$US
243783201$24378320$1$I$$20240926$20240930$20240930$EXP$$US-BAYER-2024A138263$BAYER$$$$$F$Y$$$20240930$$CN$US$US
243783211$24378321$1$I$20230101$20240925$20240930$20240930$EXP$$US-REGENERON PHARMACEUTICALS, INC.-2024-129632$REGENERON$$$$$F$Y$$$20240930$$CN$US$US
243783221$24378322$1$I$20240924$20240924$20240930$20240930$EXP$$US-INCYTE CORPORATION-2024IN010130$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243783231$24378323$1$I$$20240924$20240930$20240930$EXP$$NL-MYLANLABS-2024M1086916$MYLAN$$$$$M$Y$$$20240930$$CN$NL$NL
243783241$24378324$1$I$20240716$20240924$20240930$20240930$EXP$FR-AFSSAPS-NC2024001079$FR-MYLANLABS-2024M1086855$MYLAN$$82$YR$$F$Y$74.7$KG$20240930$$MD$FR$FR
243783251$24378325$1$I$20240522$20240924$20240930$20240930$EXP$FR-AFSSAPS-BS2024000646$FR-MYLANLABS-2024M1086732$MYLAN$$81$YR$$M$Y$68$KG$20240930$$MD$FR$FR
243783261$24378326$1$I$20240823$20240924$20240930$20240930$EXP$FR-AFSSAPS-AM2024000748$FR-MYLANLABS-2024M1086697$MYLAN$$32$YR$$M$Y$$$20240930$$PH$FR$FR
243783281$24378328$1$I$20240917$20240917$20240930$20240930$PER$$US-JNJFOC-20240945824$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20240930$$CN$US$US
243783291$24378329$1$I$$20240919$20240930$20240930$EXP$$IE-ASTRAZENECA-202409EEA003775IE$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$IE$IE
243783301$24378330$1$I$20230601$20240924$20240930$20240930$EXP$$DE-INCYTE CORPORATION-2024IN010113$INCYTE$$$$$$Y$$$20240930$$HP$DE$DE
243783321$24378332$1$I$$20240923$20240930$20240930$EXP$$US-OTSUKA-2024_026468$OTSUKA$$$$$F$Y$$$20240930$$MD$US$US
243783331$24378333$1$I$$20240926$20240930$20240930$PER$$US-BAYER-2024A138277$BAYER$$46$YR$A$F$Y$$$20240930$$HP$US$US
243783341$24378334$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017842$ELI LILLY AND CO$$61$YR$A$M$Y$$$20240930$$CN$US$US
243783351$24378335$1$I$20240926$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018147$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240930$$CN$US$US
243783371$24378337$1$I$20240806$20240924$20240930$20240930$EXP$FR-AFSSAPS-RN2024001012$FR-MYLANLABS-2024M1087101$MYLAN$$45$YR$$M$Y$$$20240930$$MD$FR$FR
243783381$24378338$1$I$20240507$20240929$20240930$20240930$EXP$$CN-BAYER-2024A139251$BAYER$$37$YR$A$F$Y$81$KG$20240930$$HP$CN$CN
243783401$24378340$1$I$$20240923$20240930$20240930$EXP$$NVSC2024ES191014$NOVARTIS$$$$$M$Y$$$20240930$$MD$ES$ES
243783411$24378341$1$I$$20240923$20240930$20240930$PER$$NVSC2024US190272$NOVARTIS$$$$$$Y$$$20240930$$CN$US$US
243783421$24378342$1$I$20231127$20240202$20240930$20240930$EXP$$NVSC2024US026260$NOVARTIS$$$$A$F$Y$78.2$KG$20240930$$MD$US$US
243783431$24378343$1$I$$20240920$20240930$20240930$PER$$US-ROCHE-10000088096$ROCHE$$14$YR$T$M$Y$$$20240930$$CN$US$US
243783441$24378344$1$I$$20240924$20240930$20240930$PER$$US-ROCHE-10000090324$ROCHE$$44$YR$A$$Y$$$20240930$$CN$US$US
243783451$24378345$1$I$20240101$20240920$20240930$20240930$EXP$$US-OTSUKA-2024_026367$OTSUKA$$$$$F$Y$58.97$KG$20240930$$CN$US$US
243783461$24378346$1$I$$20240523$20240930$20240930$EXP$$NVSC2024CL114122$NOVARTIS$$59$YR$$F$Y$$$20240930$$CN$CL$CL
243783471$24378347$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024AMR118849$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$US$US
243783481$24378348$1$I$20240901$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024191508$AMGEN$$$$$F$Y$$$20240930$$PH$US$US
243783501$24378350$1$I$20240924$20240928$20240928$20240928$DIR$720470$$FDA-CTU$$31$YR$$M$N$$$20240928$Y$CN$US$
243783511$24378351$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247096$TEVA$$$$$$Y$$$20240930$$PH$CA$CA
243783521$24378352$1$I$$20240910$20240930$20240930$PER$$US-Eisai-EC-2024-174292$EISAI$$$$A$F$Y$$$20240930$$CN$US$US
243783531$24378353$1$I$20240917$20240916$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013889$DR REDDYS$$24$YR$A$F$Y$$$20240930$$MD$US$US
243783541$24378354$1$I$20240910$20240925$20240930$20240930$EXP$CZ-CZSUKL-24002629$CZ-AMGEN-CZESP2024191309$AMGEN$$79$YR$E$F$Y$67$KG$20240930$$MD$CZ$CZ
243783561$24378356$1$I$$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024192951$AMGEN$$$$$M$Y$$$20240930$$CN$US$US
243783571$24378357$1$I$20240923$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153392$BRISTOL MYERS SQUIBB$$67$YR$E$M$Y$$$20240930$$CN$US$US
243783581$24378358$1$I$$20240916$20240930$20240930$PER$$US-COSETTE-CP2024US000259$COSETTE PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243783601$24378360$1$I$$20240919$20240930$20240930$EXP$$GB-JNJFOC-20240980679$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$GB$GB
243783611$24378361$1$I$$20240925$20240930$20240930$EXP$$US-KYOWAKIRIN-2024KK022148$KYOWA$$$$$$Y$$$20240930$$HP$US$US
243783631$24378363$1$I$$20240920$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN010052$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243783651$24378365$1$I$$20240926$20240930$20240930$EXP$$CA-PFIZER INC-202400264910$PFIZER$$$$$M$Y$$$20240930$$HP$CA$CA
243783671$24378367$1$I$$20240925$20240930$20240930$EXP$$CA-SANDOZ INC.-SDZ2024CA083159$SANDOZ$$43$YR$$F$Y$70$KG$20240930$$HP$CA$CA
243783681$24378368$1$I$20231129$20240925$20240930$20240930$EXP$ES-AEMPS-1568890$ES-PFIZER INC-202400263521$PFIZER$$56$YR$$F$Y$$$20240930$$MD$ES$ES
243783701$24378370$1$I$$20240925$20240930$20240930$EXP$$US-PFIZER INC-2023SGN13231$PFIZER$$$$$$Y$$$20240930$$MD$US$US
243783731$24378373$1$I$$20240925$20240930$20240930$EXP$$CA-PFIZER INC-202400264915$PFIZER$$83$YR$$F$Y$72$KG$20240930$$HP$CA$CA
243783741$24378374$1$I$$20240918$20240927$20240927$DIR$FDA-CDER-CTU-2024-66967$$FDA-CTU$$$$$$N$$$20240918$N$CN$US$
243783751$24378375$1$I$20240101$20240919$20240930$20240930$EXP$$US-SA-2024SA274157$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240930$$MD$US$US
243783761$24378376$1$I$20240205$20240920$20240930$20240930$EXP$$CA-CELLTRION INC.-2024CA003892$CELLTRION$$$$$$Y$$$20240930$$HP$CA$CA
243783771$24378377$1$I$20240814$20240920$20240930$20240930$EXP$FR-AFSSAPS-AM2024000736$FR-TEVA-VS-3246620$TEVA$$66$YR$$M$Y$90$KG$20240930$$PH$FR$FR
243783781$24378378$1$I$$20240924$20240930$20240930$EXP$$GB-JNJFOC-20240966004$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20240930$$CN$GB$GB
243783801$24378380$1$I$$20240924$20240930$20240930$EXP$$CA-ROCHE-10000091593$ROCHE$$$$A$M$Y$$$20240930$$CN$CA$CA
243783831$24378383$1$I$20240923$20240924$20240930$20240930$EXP$$US-SA-2024SA279672$SANOFI AVENTIS$$11$YR$C$M$Y$54.23$KG$20240930$$MD$US$US
243783841$24378384$1$I$$20240910$20240930$20240930$PER$$US-Merz Pharmaceuticals GmbH-2024090000121$MERZ$$$$$$Y$$$20240930$$CN$US$US
243783851$24378385$1$I$$20240920$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN010040$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243783861$24378386$1$I$20240101$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192494$AMGEN$$$$A$F$Y$$$20240930$$HP$US$US
243783871$24378387$1$I$20240901$20240925$20240930$20240930$EXP$$US-SA-2024SA280384$SANOFI AVENTIS$$72$YR$E$F$Y$56.82$KG$20240930$$MD$US$US
243783891$24378389$1$I$20240612$20240924$20240930$20240930$EXP$SE-SEMPA-2024-006205$SE-SA-2024SA279895$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240930$$MD$SE$SE
243783911$24378391$1$I$$20240919$20240930$20240930$PER$$US-MYLANLABS-2024M1086059$MYLAN$$$$$M$Y$$$20240930$$MD$US$US
243783921$24378392$1$I$20240701$20240923$20240930$20240930$EXP$FR-AFSSAPS-GR2024001103$FR-FreseniusKabi-FK202414350$FRESENIUS KABI$$78$YR$E$F$Y$$$20240930$$PH$FR$FR
243783941$24378394$1$I$20230303$20240923$20240930$20240930$EXP$FR-AFSSAPS-ST2024001451$FR-FreseniusKabi-FK202414361$FRESENIUS KABI$$71$YR$E$F$Y$$$20240930$$MD$FR$FR
243783951$24378395$1$I$20240722$20240926$20240930$20240930$EXP$FR-AFSSAPS-TS2024000935$FR-SA-2024SA280545$SANOFI AVENTIS$$83$YR$E$M$Y$$$20240930$$MD$FR$FR
243783961$24378396$1$I$20240909$20240923$20240930$20240930$EXP$FR-AFSSAPS-PV2024000884$FR-FreseniusKabi-FK202414371$FRESENIUS KABI$$16$YR$T$F$Y$37$KG$20240930$$MD$FR$FR
243783971$24378397$1$I$$20240911$20240930$20240930$PER$$US-Eisai-EC-2024-174248$EISAI$$$$$F$Y$$$20240930$$HP$US$US
243783981$24378398$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247099$TEVA$$$$$$Y$$$20240930$$PH$CA$CA
243783991$24378399$1$I$20240901$20240923$20240930$20240930$EXP$$HU-EMD Serono-2024051110$EMD SERONO INC$$40$YR$A$F$Y$$$20240930$$MD$HU$HU
243784001$24378400$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000092974$ROCHE$$$$$F$Y$$$20240930$$HP$US$US
243784011$24378401$1$I$$20240926$20240930$20240930$EXP$$BR-SA-2024SA281476$SANOFI AVENTIS$$$$$M$Y$$$20240930$$CN$BR$BR
243784021$24378402$1$I$$20240910$20240930$20240930$PER$$AU-TOLMAR, INC.-24AU052490$TOLMAR$$$$$M$Y$$$20240930$$CN$AU$AU
243784031$24378403$1$I$$20240910$20240930$20240930$PER$$AR-TOLMAR, INC.-24AR052541$TOLMAR$$$$$M$Y$$$20240930$$CN$AR$AR
243784041$24378404$1$I$20240101$20240926$20240930$20240930$EXP$$US-SA-2024SA279976$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240930$$MD$US$US
243784051$24378405$1$I$20240201$20240920$20240930$20240930$EXP$$CA-TAKEDA-2024TUS094442$TAKEDA$$61$YR$$M$Y$$$20240930$$CN$CA$CA
243784061$24378406$1$I$$20240910$20240930$20240930$PER$$AU-TOLMAR, INC.-24AU052542$TOLMAR$$$$$M$Y$$$20240930$$CN$AU$AU
243784071$24378407$1$I$$20240910$20240930$20240930$PER$$AU-TOLMAR, INC.-24AU052544$TOLMAR$$$$$M$Y$$$20240930$$CN$AU$AU
243784081$24378408$1$I$$20240910$20240930$20240930$PER$$AU-TOLMAR, INC.-24AU052545$TOLMAR$$$$$M$Y$$$20240930$$CN$AU$AU
243784091$24378409$1$I$20240101$20240923$20240930$20240930$EXP$FR-AFSSAPS-NY2024001068$FR-TEVA-VS-3246972$TEVA$$52$YR$$F$Y$91.65$KG$20240930$$MD$FR$FR
243784111$24378411$1$I$20240910$20240910$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052564$TOLMAR$$91$YR$$M$Y$$$20240930$$CN$CA$CA
243784121$24378412$1$I$20240910$20240910$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052571$TOLMAR$$60$YR$$M$Y$$$20240930$$CN$CA$CA
243784131$24378413$1$I$$20240910$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052596$TOLMAR$$$$$M$Y$$$20240930$$CN$CA$CA
243784141$24378414$1$I$20240828$20240920$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN010039$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243784151$24378415$1$I$$20240917$20240930$20240930$PER$$US-EMD Serono-2024049969$EMD SERONO INC$$26$YR$A$F$Y$49$KG$20240930$$CN$US$US
243784161$24378416$1$I$$20240926$20240930$20240930$EXP$$US-SA-2024SA280567$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240930$$HP$US$US
243784171$24378417$1$I$$20240911$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09252$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243784181$24378418$1$I$$20240920$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN010034$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243784191$24378419$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024190525$AMGEN$Chen E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$21$YR$A$M$Y$$$20240930$$HP$US$US
243784201$24378420$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024190528$AMGEN$Chen E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$71$YR$E$M$Y$$$20240930$$HP$US$US
243784211$24378421$1$I$20240915$20240916$20240930$20240930$PER$$US-MYLANLABS-2024M1084732$MYLAN$$63$YR$$F$Y$71.67$KG$20240930$$CN$US$US
243784221$24378422$1$I$$20240917$20240930$20240930$PER$$US-MYLANLABS-2024M1085201$MYLAN$$$$$F$Y$$$20240930$$CN$US$US
243784231$24378423$1$I$20240720$20240924$20240930$20240930$EXP$FR-AFSSAPS-NC2024001107$FR-MYLANLABS-2024M1086857$MYLAN$$79$YR$$F$Y$$$20240930$$MD$FR$FR
243784241$24378424$1$I$20240901$20240926$20240930$20240930$EXP$SE-SEMPA-2024-006874$SE-JNJFOC-20240976499$JOHNSON AND JOHNSON$$38$YR$A$F$Y$65$KG$20240930$$CN$SE$SE
243784251$24378425$1$I$$20240924$20240930$20240930$EXP$$US-JNJFOC-20240967735$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243784261$24378426$1$I$20240901$20240926$20240930$20240930$EXP$$US-ROCHE-10000093449$ROCHE$$48$YR$A$F$Y$$$20240930$$CN$US$US
243784271$24378427$1$I$20230801$20240920$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN010005$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243784281$24378428$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153646$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240930$$CN$US$US
243784291$24378429$1$I$$20240922$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA007530US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
243784301$24378430$1$I$20240701$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016716$ELI LILLY AND CO$$24$YR$A$F$Y$$$20240930$$CN$US$US
243784311$24378431$1$I$$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018376$ELI LILLY AND CO$$75$YR$E$M$Y$$$20240930$$CN$US$US
243784321$24378432$1$I$20240908$20240927$20240930$20240930$EXP$$GB-SANDOZ INC.-SDZ2024GB083688$SANDOZ$$$$$$Y$$$20240930$$CN$GB$GB
243784331$24378433$1$I$$20240925$20240930$20240930$PER$$NVSC2024US191886$NOVARTIS$$60$YR$$F$Y$$$20240930$$CN$US$US
243784341$24378434$1$I$20240701$20240925$20240930$20240930$EXP$FR-AFSSAPS-GR2024001103$FR-TEVA-VS-3247928$TEVA$$78$YR$$F$Y$$$20240930$$PH$FR$FR
243784351$24378435$1$I$$20240916$20240930$20240930$EXP$$FR-EPICPHARMA-FR-2024EPCLIT01150$EPIC PHARM$Baudriller A.Deaths related to pharmacobezoars: A report on two cases.Toxicologie Analytique et Clinique .JAN-2024$55$YR$A$F$Y$$$20240930$$HP$FR$FR
243784361$24378436$1$I$$20240926$20240930$20240930$EXP$$CA-ROCHE-10000093878$ROCHE$$$$A$F$Y$$$20240930$$CN$CA$CA
243784381$24378438$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093820$ROCHE$$$$$F$Y$$$20240930$$HP$US$US
243784391$24378439$1$I$20231101$20240925$20240930$20240930$EXP$$BR-UCBSA-2024050059$UCB$$34$YR$$F$Y$71$KG$20240930$$CN$BR$BR
243784401$24378440$1$I$20240101$20240926$20240930$20240930$PER$$US-BAYER-2024A138134$BAYER$$27$YR$A$F$Y$$$20240930$$HP$US$US
243784411$24378441$1$I$$20240926$20240930$20240930$PER$$US-BAYER-2024A138110$BAYER$$38$YR$A$F$Y$$$20240930$$MD$US$US
243784421$24378442$1$I$20240226$20240915$20240927$20240927$DIR$FDA-CDER-CTU-2024-66968$$FDA-CTU$$67$YR$$F$N$83.91$KG$20240915$N$CN$US$
243784431$24378443$1$I$$20240919$20240930$20240930$30DAY$$US-PFIZER INC-202400260392$PFIZER$$40$YR$$M$Y$$$20240930$$CN$US$US
243784441$24378444$1$I$20240928$20240928$20240928$20240928$DIR$720499$$FDA-CTU$$41$YR$$F$N$$$20240928$N$CN$US$
243784451$24378445$1$I$$20240924$20240930$20240930$30DAY$$BR-PFIZER INC-202400258263$PFIZER$$45$YR$$F$Y$$$20240930$$CN$BR$BR
243784461$24378446$1$I$$20240916$20240930$20240930$30DAY$$US-PFIZER INC-202400258412$PFIZER$$13$YR$$F$Y$47.17$KG$20240930$$CN$US$US
243784471$24378447$1$I$$20240924$20240930$20240930$30DAY$$US-PFIZER INC-202400263231$PFIZER$$53$YR$$M$Y$$$20240930$$CN$US$US
243784481$24378448$1$I$$20240920$20240930$20240930$EXP$$JP-OTSUKA-2024_026406AA$OTSUKA$$6$DEC$$M$Y$$$20240930$$MD$JP$JP
243784501$24378450$1$I$$20240923$20240930$20240930$EXP$$IN-TAKEDA-2024TUS095485$TAKEDA$Karthikeyan A, Jain. A path less taken: intubation to facilitate multi dose-activated charcoal in toxic overdose. Chest. 166(4):A1903$56$YR$$F$Y$$$20240930$$HP$IN$IN
243784521$24378452$1$I$20240101$20240924$20240930$20240930$PER$$US-ABBVIE-5937694$ABBVIE$$82$YR$$F$Y$63$KG$20240930$$CN$US$US
243784531$24378453$1$I$20240101$20240927$20240930$20240930$EXP$$US-ROCHE-10000094865$ROCHE$$48$YR$A$F$Y$92.53$KG$20240930$$CN$US$US
243784541$24378454$1$I$$20240925$20240930$20240930$EXP$$US-TAKEDA-2024TUS096366$TAKEDA$Davis, Rachel, Burk, et al.. A RARE CASE OF VEDOLIZUMAB -INDUCED PNEUMONITIS. European Journal of Gastroenterology + Hepatology. 2021;4:1057-1059$72$YR$$M$Y$$$20240930$$MD$US$US
243784551$24378455$1$I$20240830$20240920$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN010020$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243784561$24378456$1$I$$20240923$20240930$20240930$EXP$$CA-TAKEDA-2024TUS095089$TAKEDA$$$$$F$Y$$$20240930$$MD$CA$CA
243784571$24378457$1$I$$20240923$20240930$20240930$PER$$US-MYLANLABS-2024M1086989$MYLAN$$$$$F$Y$$$20240930$$CN$US$US
243784581$24378458$1$I$20240925$20240926$20240930$20240930$PER$$US-ROCHE-10000092951$ROCHE$$25$YR$A$F$Y$$$20240930$$CN$US$US
243784601$24378460$1$I$$20240919$20240930$20240930$PER$$US-ABBVIE-5932846$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243784611$24378461$1$I$$20240925$20240930$20240930$PER$$US-ABBVIE-5940431$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243784621$24378462$1$I$$20240919$20240930$20240930$EXP$$CA-APOTEX-2024AP011273$APOTEX$$71$YR$$F$Y$62$KG$20240930$$HP$CA$CA
243784631$24378463$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011219$APOTEX$$58$YR$$F$Y$$$20240930$$CN$CA$CA
243784641$24378464$1$I$$20240926$20240930$20240930$EXP$$CA-002147023-NVSC2022CA109820$Haleon PLC$$43$YR$$F$Y$68$KG$20240928$$HP$CA$CA
243784651$24378465$1$I$$20240919$20240930$20240930$EXP$$CA-APOTEX-2024AP011284$APOTEX$$32$YR$$F$Y$66$KG$20240930$$MD$CA$CA
243784661$24378466$1$I$20240601$20240919$20240930$20240930$PER$$US-JNJFOC-20240951933$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20240930$$CN$US$US
243784671$24378467$1$I$$20240921$20240930$20240930$PER$$US-JNJFOC-20240960471$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243784681$24378468$1$I$$20240924$20240930$20240930$EXP$$DE-ORGANON-O2409DEU002111$ORGANON$$80$YR$$M$Y$69$KG$20240930$$HP$DE$DE
243784691$24378469$1$I$20240907$20240927$20240930$20240930$EXP$FR-AFSSAPS-NT2024001192$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-153519$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$81$KG$20240930$$PH$FR$FR
243784701$24378470$1$I$20240926$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018026$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240930$$CN$US$US
243784721$24378472$1$I$$20240924$20240930$20240930$EXP$$DE-ASTELLAS-2024-AER-008668$ASTELLAS$$$$$F$Y$$$20240930$$MD$DE$DE
243784731$24378473$1$I$20240826$20240926$20240930$20240930$EXP$FR-AFSSAPS-PP2024001076$FR-ABBVIE-5940469$ABBVIE$$42$YR$$F$Y$$$20240930$$HP$FR$FR
243784741$24378474$1$I$$20240903$20240930$20240930$PER$$US-SA-2024SA274682$SANOFI AVENTIS$$$$E$M$Y$64.55$KG$20240930$$MD$US$US
243784751$24378475$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA279541$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240930$$MD$US$US
243784761$24378476$1$I$$20240905$20240930$20240930$PER$$US-SA-2024SA275096$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
243784771$24378477$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA275807$SANOFI AVENTIS$$67$YR$E$M$Y$75$KG$20240930$$MD$US$US
243784781$24378478$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274464$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240930$$MD$US$US
243784791$24378479$1$I$20240919$20240920$20240930$20240930$PER$$US-SA-2024SA275763$SANOFI AVENTIS$$55$YR$A$F$Y$49.55$KG$20240930$$MD$US$US
243784801$24378480$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA273867$SANOFI AVENTIS$$15$YR$T$M$Y$$$20240930$$HP$US$US
243784811$24378481$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA275654$SANOFI AVENTIS$$76$YR$E$$Y$$$20240930$$CN$US$US
243784821$24378482$1$I$20240701$20240919$20240930$20240930$PER$$US-SA-2024SA276059$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240930$$HP$US$US
243784831$24378483$1$I$20240827$20240910$20240930$20240930$PER$$US-SA-2024SA278211$SANOFI AVENTIS$$57$YR$A$M$Y$107.5$KG$20240930$$MD$US$US
243784841$24378484$1$I$20240901$20240917$20240930$20240930$PER$$US-SA-2024SA276192$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240930$$MD$US$US
243784851$24378485$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA276510$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240930$$CN$US$US
243784861$24378486$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA276656$SANOFI AVENTIS$$72$YR$E$M$Y$$$20240930$$HP$US$US
243784871$24378487$1$I$20240629$20240929$20240929$20240929$DIR$720542$$FDA-CTU$$52$YR$$F$N$53.55$KG$20240929$N$CN$US$
243784881$24378488$1$I$$20240917$20240927$20240927$DIR$FDA-CDER-CTU-2024-66971$$FDA-CTU$$96$YR$$F$N$85.73$KG$20240917$N$CN$US$
243784891$24378489$1$I$20240101$20240921$20240930$20240930$PER$$US-SA-2024SA275645$SANOFI AVENTIS$$$$A$M$Y$$$20240930$$HP$US$US
243784901$24378490$1$I$20221101$20240920$20240930$20240930$PER$$US-SA-2024SA275826$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240930$$MD$US$US
243784911$24378491$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA276619$SANOFI AVENTIS$$18$YR$A$F$Y$$$20240930$$HP$US$US
243784921$24378492$1$I$$20240920$20240930$20240930$EXP$$US-JNJFOC-20240955677$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$US$US
243784941$24378494$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5939553$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243784951$24378495$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005522$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243784961$24378496$1$I$20210601$20240925$20240930$20240930$EXP$$JP-TAKEDA-2021TJP066257$TAKEDA$Nakayama T, Ogawa M. An usage experience of vonicog alfa in Aichi Medical University Hospital. The Japanese Journal of Clinical Hematology. 2022;63(8):959$28$YR$$F$Y$57$KG$20240930$$$COUNTRY NOT SPECIFIED$JP
243784971$24378497$1$I$20240922$20240923$20240930$20240930$EXP$$US-SA-2024SA279045$SANOFI AVENTIS$$90$YR$E$F$Y$$$20240930$$MD$US$US
243784981$24378498$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005524$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243784991$24378499$1$I$20231120$20240923$20240930$20240930$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-2024-152456$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$$$20240930$$CN$CN$CN
243785011$24378501$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047054$AUROBINDO$$77$YR$$M$Y$$$20240930$$HP$CA$CA
243785021$24378502$1$I$20240901$20240925$20240930$20240930$PER$$US-JNJFOC-20240971199$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20240930$$CN$US$US
243785031$24378503$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-046878$AUROBINDO$Shukla V, Cheng S, Hukin J, Huh L, Datta AN. Developmental and epileptic encephalopathies after successful treatment of pediatric ALL: A case series and review of literature. Epileptic Disorders. 2024;00:1-10$6$YR$$M$Y$$$20240930$$MD$CA$CA
243785041$24378504$1$I$20240708$20240926$20240930$20240930$EXP$FR-AFSSAPS-PP2024001017$FR-ROCHE-10000092482$ROCHE$$20$YR$A$M$Y$59$KG$20240930$$MD$FR$FR
243785051$24378505$1$I$20240923$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024189423$AMGEN$$77$YR$E$F$Y$$$20240930$$CN$US$US
243785061$24378506$1$I$$20240925$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US083623$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
243785071$24378507$1$I$$20240927$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2023US002682$SANDOZ$$$$$F$Y$$$20240930$$HP$US$US
243785081$24378508$1$I$$20240919$20240930$20240930$EXP$$CA-APOTEX-2024AP011297$APOTEX$$75$YR$$M$Y$$$20240930$$PH$CA$CA
243785091$24378509$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017432$ELI LILLY AND CO$$$$A$F$Y$$$20240930$$CN$US$US
243785101$24378510$1$I$$20240923$20240930$20240930$PER$$US-JNJFOC-20240961394$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243785111$24378511$1$I$20240925$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016390$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243785121$24378512$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017425$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240930$$CN$US$US
243785131$24378513$1$I$20240926$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193266$AMGEN$$$$$$Y$$$20240930$$PH$US$US
243785141$24378514$1$I$20240916$20240923$20240930$20240930$PER$$US-JNJFOC-20240963473$JOHNSON AND JOHNSON$$56$YR$A$$Y$$$20240930$$CN$US$US
243785151$24378515$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047347$AUROBINDO$$86$YR$$M$Y$$$20240930$$PH$CA$CA
243785161$24378516$1$I$$20240924$20240930$20240930$PER$$US-ROCHE-10000090659$ROCHE$$$$$$Y$$$20240930$$CN$US$US
243785171$24378517$1$I$20240919$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192472$AMGEN$$83$YR$E$M$Y$$$20240930$$CN$US$US
243785181$24378518$1$I$20240310$20240926$20240930$20240930$EXP$FR-AFSSAPS-CN2024000327$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-153039$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$98.1$KG$20240930$$MD$FR$FR
243785191$24378519$1$I$20240101$20240920$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151179$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$117.48$KG$20240930$$MD$US$US
243785201$24378520$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000093356$ROCHE$$$$$$Y$$$20240930$$CN$US$US
243785211$24378521$1$I$$20240923$20240930$20240930$EXP$$US-AMGEN-USASP2024192029$AMGEN$Ogawa L.; Multani A.; Beaird O. E..et.al. Risk Factors and Outcomes of Mucorales Infection in a Modern Cohort of Solid Organ Transplant, Hematopoietic Cell Transplant, and Chimeric Antigen Receptor T-cell Therapy Recipients. Transplantation Proceedings. 2024;56 (7):1683-1690$$$$$Y$$$20240930$$HP$US$US
243785221$24378522$1$I$$20240924$20240930$20240930$PER$$US-JNJFOC-20240968065$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$MD$US$US
243785231$24378523$1$I$20240920$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192570$AMGEN$$$$$$Y$$$20240930$$CN$US$US
243785241$24378524$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409003454$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240930$$CN$US$US
243785251$24378525$1$I$20231225$20240927$20240927$20240927$DIR$720307$$FDA-CTU$$77$YR$$M$N$102$KG$20240927$N$HP$US$
243785261$24378526$1$I$20240905$20240925$20240930$20240930$EXP$$CN-ROCHE-10000091595$ROCHE$$40$YR$A$F$Y$$$20240930$$HP$CN$CN
243785271$24378527$1$I$20240601$20240928$20240928$20240928$DIR$720476$$FDA-CTU$$81$YR$$M$N$$$20240928$N$HP$US$
243785281$24378528$1$I$20240926$20240926$20240930$20240930$EXP$GB-MHRA-MED-202409261635561690-CDLZG$GB-ROCHE-10000092890$ROCHE$$$$$F$Y$$$20240930$$HP$GB$GB
243785291$24378529$1$I$20231101$20240927$20240927$20240927$DIR$720302$$FDA-CTU$$77$YR$$M$N$156$KG$20240927$N$HP$US$
243785301$24378530$1$I$20231230$20240927$20240927$20240927$DIR$720269$$FDA-CTU$$70$YR$$M$N$94$KG$20240927$N$HP$US$
243785311$24378531$1$I$20230601$20240927$20240927$20240927$DIR$720304$$FDA-CTU$$73$YR$$M$N$114$KG$20240927$N$HP$US$
243785331$24378533$1$I$$20240918$20240930$20240930$EXP$CA-MHPD-E2B_07236341$CA-Accord-447643$ACCORD$$12$MON$I$M$Y$$$20240930$$HP$CA$CA
243785341$24378534$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005560$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243785351$24378535$1$I$20240101$20240923$20240930$20240930$EXP$$US-SA-2024SA279348$SANOFI AVENTIS$$38$YR$A$F$Y$121.36$KG$20240930$$MD$US$US
243785361$24378536$1$I$$20240924$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153719$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240930$$CN$US$US
243785371$24378537$1$I$$20240918$20240930$20240930$EXP$$US-Accord-448260$ACCORD$$$$$F$Y$$$20240930$$MD$US$US
243785381$24378538$1$I$20240911$20240911$20240930$20240930$PER$$US-JNJFOC-20240929397$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240930$$CN$US$US
243785391$24378539$1$I$$20240920$20240930$20240930$PER$$US-TAKEDA-2024TUS094234$TAKEDA$$$$$M$Y$68$KG$20240930$$MD$US$US
243785401$24378540$1$I$$20240923$20240930$20240930$EXP$$US-GSK-US2024117782$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$US$US
243785411$24378541$1$I$$20230912$20240930$20240930$PER$$US-LEO Pharma-362818$LEO PHARM$$$$$F$Y$$$20240927$$CN$US$US
243785441$24378544$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016834$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240930$$CN$US$US
243785451$24378545$1$I$$20240920$20240930$20240930$EXP$$FR-AUROBINDO-AUR-APL-2024-047461$AUROBINDO$$79$YR$$F$Y$$$20240930$$MD$FR$FR
243785461$24378546$1$I$$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409170920428330-QRVDJ$GB-Accord-447796$ACCORD$$$$$F$Y$$$20240930$$HP$GB$GB
243785471$24378547$1$I$20240915$20240916$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005641$ACADIA PHARMACEUTICALS$$70$YR$$F$Y$$$20240930$$CN$US$US
243785481$24378548$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024AMR114614$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$CN$US$US
243785491$24378549$1$I$$20240917$20240930$20240930$EXP$$CN-ENDO USA, INC.-2024-003492$ENDO$Zhang ZR, Shen YY, Yi RQ, Feng W, Chen W, Li CE, et al.. When anaphylactic shock meets epinephrine and blood lactate increases: A case report. Medicine. 2024;103(36):1-4$26$YR$$F$Y$$$20240930$$MD$CN$CN
243785511$24378551$1$I$$20240925$20240930$20240930$EXP$$IN-ROCHE-10000092228$ROCHE$$75$YR$E$F$Y$$$20240930$$CN$IN$IN
243785521$24378552$1$I$$20240924$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152910$BRISTOL MYERS SQUIBB$$51$YR$A$M$Y$$$20240930$$CN$US$US
243785531$24378553$1$I$$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153478$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$96.16$KG$20240930$$CN$US$US
243785551$24378555$1$I$$20240926$20240930$20240930$PER$$NVSC2024US192815$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
243785561$24378556$1$I$20240711$20240923$20240930$20240930$EXP$$US-EXELIXIS-CABO-24080786$EXELIXIS$$58$YR$$F$Y$$$20240930$$CN$US$US
243785571$24378557$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005584$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243785581$24378558$1$I$20240523$20240919$20240930$20240930$EXP$$DE-ROCHE-10000089020$ROCHE$$44$YR$A$F$Y$71$KG$20240930$$MD$DE$DE
243785591$24378559$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005573$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243785601$24378560$1$I$$20240924$20240930$20240930$EXP$$FI-UCBSA-2024049505$UCB$Ojanen P, Kertesz C, Peltola J. Characteristics of motion signal profiles of tonic-clonic, tonic, hyperkinetic, and motor seizures extracted from nocturnal video recordings. Epileptic Disorders. 2024;1-10$35$YR$$$Y$$$20240930$$HP$FI$FI
243785631$24378563$1$I$$20240924$20240930$20240930$PER$$US-AMGEN-USASP2024191393$AMGEN$$73$YR$E$F$Y$$$20240930$$HP$US$US
243785641$24378564$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024190522$AMGEN$Chen E.C.; Flamand Y.; Tiao E.; et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$62$YR$A$M$Y$$$20240930$$HP$US$US
243785651$24378565$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005586$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243785671$24378567$1$I$20240926$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153464$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240930$$MD$US$US
243785681$24378568$1$I$$20240917$20240930$20240930$PER$$US-JNJFOC-20240945329$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$US$US
243785691$24378569$1$I$20231226$20240927$20240927$20240927$DIR$720285$$FDA-CTU$$68$YR$$M$N$163$KG$20240927$N$HP$US$
243785701$24378570$1$I$20240307$20240923$20240930$20240930$EXP$ES-AEMPS-1572873$ES-CADILA HEALTHCARE LIMITED-ES-ZYDUS-112775$ZYDUS PHARM$$$$$$Y$$$20240930$$MD$ES$ES
243785711$24378571$1$I$20231129$20240927$20240927$20240927$DIR$720280$$FDA-CTU$$78$YR$$M$N$63$KG$20240927$N$PH$US$
243785731$24378573$1$I$$20240923$20240930$20240930$EXP$$BR-JNJFOC-20240967171$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$BR$BR
243785741$24378574$1$I$$20240923$20240930$20240930$EXP$$US-ADIENNEP-2024AD000769$ADIENNE PHARMA + BIOTECH$Akhtar OS, Arshad S, Lian Q, Ahn KW, D^Souza A, Dhakal B et al. Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation. Transplant Cell Ther. 2024 Sep 18:S2666-6367(24)00668-7. doi: 10.1016/j.jtct.2024.09.015. Online ahead of print.$$$E$$Y$$$20240926$$MD$US$
243785751$24378575$1$I$20231207$20240927$20240927$20240927$DIR$720282$$FDA-CTU$$70$YR$$M$N$101$KG$20240927$N$HP$US$
243785781$24378578$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005588$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243785791$24378579$1$I$20231124$20240927$20240927$20240927$DIR$720289$$FDA-CTU$$37$YR$$M$N$104$KG$20240927$N$HP$US$
243785811$24378581$1$I$20231222$20240927$20240927$20240927$DIR$720309$$FDA-CTU$$53$YR$$M$N$179$KG$20240927$N$HP$US$
243785821$24378582$1$I$20240915$20240917$20240928$20240928$DIR$FDA-CDER-CTU-2024-67102$$FDA-CTU$$69$YR$$F$N$68.5$KG$20240917$N$$US$
243785831$24378583$1$I$$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024191211$AMGEN$$$$$F$Y$$$20240930$$CN$US$US
243785841$24378584$1$I$$20240916$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09337$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243785851$24378585$1$I$$20240910$20240930$20240930$PER$$US-BEIGENE-BGN-2024-014421$BEIGENE$$$$$$Y$$$20240930$$CN$US$US
243785861$24378586$1$I$20240903$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005568$ACADIA PHARMACEUTICALS$$89$YR$$F$Y$$$20240930$$CN$US$US
243785871$24378587$1$I$20231130$20240927$20240927$20240927$DIR$720293$$FDA-CTU$$77$YR$$M$N$85$KG$20240927$N$HP$US$
243785881$24378588$1$I$20240105$20240927$20240927$20240927$DIR$720275$$FDA-CTU$$77$YR$$M$N$119$KG$20240927$N$HP$US$
243785901$24378590$1$I$$20240923$20240930$20240930$EXP$$US-ADIENNEP-2024AD000766$ADIENNE PHARMA + BIOTECH$Akhtar OS, Arshad S, Lian Q, Ahn KW, D^Souza A, Dhakal B et al. Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation. Transplant Cell Ther. 2024 Sep 18:S2666-6367(24)00668-7. doi: 10.1016/j.jtct.2024.09.015. Online ahead of print.$$$E$$Y$$$20240926$$MD$US$
243785911$24378591$1$I$$20240925$20240930$20240930$EXP$GB-BRISTOL-MYERS SQUIBB COMPANY-2024-150431$GB-SANDOZ INC.-SDZ2024GB082828$SANDOZ$$54$YR$$F$Y$$$20240930$$CN$GB$GB
243785921$24378592$1$I$20240905$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153368$BRISTOL MYERS SQUIBB$$80$YR$E$F$Y$62.14$KG$20240930$$CN$US$US
243785931$24378593$1$I$$20240919$20240930$20240930$EXP$CA-MHPD-E2B_07229877$CA-Accord-447811$ACCORD$$41$YR$A$F$Y$$$20240930$$CN$CA$CA
243785941$24378594$1$I$20230101$20240205$20240930$20240930$PER$$US-ENDO PHARMACEUTICALS INC-2022-002431$ENDO$$$$$F$Y$$$20240930$$CN$US$US
243785951$24378595$1$I$20240802$20240926$20240930$20240930$EXP$FR-AFSSAPS-TS2024001040$FR-JNJFOC-20240976859$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20240930$$MD$FR$FR
243785961$24378596$1$I$20240601$20240910$20240930$20240930$PER$$US-ENDO USA, INC.-2024-003068$ENDO$$94$YR$$F$Y$$$20240930$$CN$US$US
243785971$24378597$1$I$$20231011$20240930$20240930$PER$$US-ENDO PHARMACEUTICALS INC-2023-005413$ENDO$$$$$F$Y$$$20240930$$CN$US$US
243785981$24378598$1$I$20240926$20240927$20240930$20240930$EXP$$US-GILEAD-2024-0689251$GILEAD$$62$YR$A$F$Y$$$20240930$$HP$US$US
243785991$24378599$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005571$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243786001$24378600$1$I$$20240917$20240930$20240930$PER$$US-ALMUS-US-2024-2479$ALMUS$$$$$F$Y$$$20240930$$HP$US$US
243786011$24378601$1$I$20240919$20240924$20240930$20240930$EXP$$CA-JNJFOC-20240969007$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20240930$$HP$CA$CA
243786021$24378602$1$I$20240619$20240627$20240930$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000536$PAREXEL$$$$$$Y$$$20240930$$CN$US$US
243786031$24378603$1$I$$20240927$20240930$20240930$EXP$$US-SANDOZ INC.-NVSC2023US118879$SANDOZ$$$$$M$Y$67.6$KG$20240930$$HP$US$US
243786041$24378604$1$I$20240719$20240719$20240930$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000641$PAREXEL$$$$$$Y$$$20240930$$CN$US$US
243786051$24378605$1$I$20240924$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024191740$AMGEN$$66$YR$E$F$Y$$$20240930$$CN$US$US
243786061$24378606$1$I$20240101$20240613$20240930$20240930$PER$$US-ARDELYX-2024ARDX004363$ARDELYX$$$$$M$Y$$$20240930$$CN$US$US
243786071$24378607$1$I$20240101$20240614$20240930$20240930$PER$$US-ARDELYX-2024ARDX004409$ARDELYX$$$$$F$Y$$$20240930$$MD$US$US
243786081$24378608$1$I$20240101$20240731$20240930$20240930$PER$$US-ARDELYX-2024ARDX005879$ARDELYX$$$$$F$Y$$$20240930$$CN$US$US
243786091$24378609$1$I$20240627$20240801$20240930$20240930$PER$$US-ARDELYX-2024ARDX005948$ARDELYX$$$$$F$Y$$$20240930$$MD$US$US
243786101$24378610$1$I$20240501$20240819$20240930$20240930$PER$$US-ARDELYX-2024ARDX006013$ARDELYX$$80$YR$$F$Y$45$KG$20240930$$CN$US$US
243786111$24378611$1$I$$20240923$20240930$20240930$EXP$$US-HALEON-2198663$Haleon PLC$$75$YR$$F$Y$$$20240928$$HP$US$US
243786121$24378612$1$I$$20240812$20240930$20240930$PER$$US-ARDELYX-2024ARDX006127$ARDELYX$$$$$F$Y$$$20240930$$HP$US$US
243786131$24378613$1$I$20240101$20240819$20240930$20240930$PER$$US-ARDELYX-2024ARDX006296$ARDELYX$$$$$$Y$$$20240930$$CN$US$US
243786141$24378614$1$I$20240610$20240820$20240930$20240930$PER$$US-ARDELYX-2024ARDX006309$ARDELYX$$$$$$Y$$$20240930$$CN$US$US
243786151$24378615$1$I$$20240820$20240930$20240930$PER$$US-ARDELYX-2024ARDX006310$ARDELYX$$$$$$Y$$$20240930$$CN$US$US
243786161$24378616$1$I$$20240830$20240930$20240930$PER$$US-ARDELYX-2024ARDX006637$ARDELYX$$$$$$Y$$$20240930$$PH$US$US
243786171$24378617$1$I$20240101$20240828$20240930$20240930$PER$$US-ARDELYX-2024ARDX006583$ARDELYX$$73$YR$$F$Y$$$20240930$$CN$US$US
243786181$24378618$1$I$20240824$20240827$20240930$20240930$PER$$US-ARDELYX-2024ARDX006588$ARDELYX$$53$YR$$F$Y$$$20240930$$HP$US$US
243786191$24378619$1$I$20240101$20240808$20240930$20240930$PER$$US-ARDELYX-2024ARDX006091$ARDELYX$$$$$F$Y$88$KG$20240930$$CN$US$US
243786201$24378620$1$I$20240701$20240807$20240930$20240930$PER$$US-ARDELYX-2024ARDX006059$ARDELYX$$46$YR$$F$Y$59$KG$20240930$$CN$US$US
243786211$24378621$1$I$20240701$20240805$20240930$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000696$PAREXEL$$47$YR$$F$Y$79.378$KG$20240930$$HP$US$US
243786221$24378622$1$I$20240808$20240812$20240930$20240930$PER$$US-COHERUS BIOSCIENCES, INC-2024-COH-US000791$PAREXEL$$$$$$Y$$$20240930$$CN$US$US
243786231$24378623$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005536$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243786241$24378624$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005531$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243786251$24378625$1$I$$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005548$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243786261$24378626$1$I$$20240924$20240930$20240930$EXP$$US-JNJFOC-20240972673$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20240930$$HP$US$US
243786271$24378627$1$I$$20240923$20240930$20240930$EXP$$BR-JNJFOC-20240967671$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$BR$BR
243786281$24378628$1$I$20240506$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005563$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20240930$$CN$US$US
243786291$24378629$1$I$$20240924$20240930$20240930$EXP$$FI-UCBSA-2024049364$UCB$Ojanen P, Kertesz C, Peltola J. Characteristics of motion signal profiles of tonic?clonic, tonic, hyperkinetic, and motor seizures extracted from nocturnal video recordings. Epileptic Disorders. 2024;1-10$29$YR$$$Y$$$20240930$$HP$FI$FI
243786301$24378630$1$I$$20240904$20240930$20240930$EXP$$US-SA-2024SA273047$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240930$$MD$US$US
243786311$24378631$1$I$20240917$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409192231435280-VGZBH$GB-Accord-447741$ACCORD$$39$YR$A$F$Y$$$20240930$$CN$GB$GB
243786321$24378632$1$I$20210721$20240919$20240930$20240930$EXP$$CA-TAKEDA-2024TUS094012$TAKEDA$$53$YR$$F$Y$$$20240930$$CN$CA$CA
243786331$24378633$1$I$20240902$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005550$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20240930$$CN$US$US
243786341$24378634$1$I$$20240923$20240930$20240930$EXP$$CA-GSK-CA2023AMR050483$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$CA$CA
243786351$24378635$1$I$$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409181201145070-RCVNW$GB-Accord-447932$ACCORD$$55$YR$A$F$Y$64$KG$20240930$$CN$GB$GB
243786361$24378636$1$I$20240824$20240910$20240930$20240930$EXP$$US-SA-2024SA277516$SANOFI AVENTIS$$87$YR$E$M$Y$$$20240930$$MD$US$US
243786371$24378637$1$I$20240901$20240920$20240930$20240930$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-27980$SAMSUNG BIOEPIS$$44$YR$A$M$Y$$$20240930$$HP$CA$CA
243786381$24378638$1$I$$20240923$20240930$20240930$EXP$$US-HALEON-2198693$Haleon PLC$$61$YR$$M$Y$$$20240928$$HP$US$US
243786391$24378639$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005575$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243786401$24378640$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005579$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243786411$24378641$1$I$20230501$20240919$20240930$20240930$EXP$IT-MINISAL02-1002657$IT-AMGEN-ITASP2024187493$AMGEN$$$$$M$Y$$$20240930$$CN$IT$IT
243786431$24378643$1$I$20240820$20240918$20240930$20240930$EXP$$US-Accord-448257$ACCORD$$72$YR$E$M$Y$$$20240930$$HP$US$US
243786441$24378644$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005621$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243786451$24378645$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005599$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243786461$24378646$1$I$20240912$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005608$ACADIA PHARMACEUTICALS$$95$YR$$F$Y$$$20240930$$HP$US$US
243786471$24378647$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005589$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243786481$24378648$1$I$20240919$20240920$20240930$20240930$PER$$US-AMGEN-USASP2024188810$AMGEN$$66$YR$E$M$Y$83.9$KG$20240930$$PH$US$US
243786491$24378649$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005611$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20240930$$CN$US$US
243786511$24378651$1$I$20190701$20240924$20240930$20240930$EXP$$US-SANDOZ INC.-PHEH2019US031558$SANDOZ$$64$YR$$M$Y$69.8$KG$20240930$$CN$US$US
243786521$24378652$1$I$20240908$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005604$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20240930$$CN$US$US
243786531$24378653$1$I$$20240924$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015715$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240930$$CN$US$US
243786541$24378654$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047248$AUROBINDO$$68$YR$$M$Y$$$20240930$$HP$CA$CA
243786561$24378656$1$I$$20240126$20240930$20240930$PER$$US-ROCHE-3502346$ROCHE$$$$$$Y$$$20240930$$MD$US$US
243786571$24378657$1$I$$20240926$20240930$20240930$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-2024-153486$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240930$$PH$BR$BR
243786581$24378658$1$I$20240925$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192585$AMGEN$$46$YR$A$F$Y$$$20240930$$CN$US$US
243786601$24378660$1$I$20240827$20240918$20240930$20240930$EXP$IT-MINISAL02-1001307$IT-Accord-447697$ACCORD$$60$YR$A$F$Y$68$KG$20240930$$MD$IT$IT
243786611$24378661$1$I$$20240920$20240930$20240930$PER$$US-ABBVIE-5935000$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243786621$24378662$1$I$$20240919$20240930$20240930$EXP$$US-UCBSA-2024049150$UCB$$$$$F$Y$$$20240930$$CN$US$US
243786631$24378663$1$I$20240524$20240920$20240930$20240930$EXP$$ES-AUROBINDO-AUR-APL-2024-047405$AUROBINDO$$46$YR$$F$Y$$$20240930$$MD$ES$ES
243786641$24378664$1$I$$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005615$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243786651$24378665$1$I$20240101$20240925$20240930$20240930$EXP$DK-DKMA-30738946$DK-ROCHE-10000091807$ROCHE$$86$YR$E$F$Y$62$KG$20240930$$MD$DK$DK
243786661$24378666$1$I$20240917$20240923$20240930$20240930$EXP$$CL-JNJFOC-20240965318$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20240930$$CN$CL$CL
243786681$24378668$1$I$20240218$20240929$20240929$20240929$DIR$720576$$FDA-CTU$$39$YR$$F$N$108$KG$20240929$N$CN$US$
243786691$24378669$1$I$20240914$20240929$20240929$20240929$DIR$720578$$FDA-CTU$$64$YR$$M$N$$$20240929$N$CN$US$
243786701$24378670$1$I$20240901$20240924$20240930$20240930$PER$$US-ABBVIE-5937477$ABBVIE$$82$YR$$F$Y$68.038$KG$20240930$$CN$US$US
243786711$24378671$1$I$20231212$20240927$20240927$20240927$DIR$720290$$FDA-CTU$$77$YR$$M$N$146$KG$20240927$N$PH$US$
243786721$24378672$1$I$20240901$20240920$20240930$20240930$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900118$RIGEL PHARMACEUTICALS$$73$YR$$M$Y$109.77$KG$20240930$$CN$US$US
243786731$24378673$1$I$20210619$20240929$20240929$20240929$DIR$720540$$FDA-CTU$$57$YR$$M$N$112.5$KG$20240929$Y$CN$US$
243786751$24378675$1$I$20240830$20240913$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005631$ACADIA PHARMACEUTICALS$$63$YR$$M$Y$$$20240930$$CN$US$US
243786761$24378676$1$I$$20240919$20240930$20240930$EXP$$CA-APOTEX-2024AP011417$APOTEX$$$$E$M$Y$$$20240930$$HP$CA$CA
243786771$24378677$1$I$20240301$20240923$20240930$20240930$EXP$$CH-ROCHE-10000088979$ROCHE$$59$YR$A$$Y$$$20240930$$MD$CH$CH
243786781$24378678$1$I$$20240919$20240930$20240930$PER$$US-JNJFOC-20240952982$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$MD$US$US
243786791$24378679$1$I$20240911$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024192452$AMGEN$$$$$F$Y$$$20240930$$PH$US$US
243786821$24378682$1$I$20240827$20240912$20240930$20240930$PER$$CA-TOLMAR, INC.-24CA052164$TOLMAR$$73$YR$$M$Y$$$20240930$$CN$CA$CA
243786831$24378683$1$I$$20240916$20240930$20240930$PER$$US-ITALFARMACO SPA-2162207$ITALFARMACO$$$$$M$Y$35$KG$20240930$$$US$US
243786841$24378684$1$I$20240101$20240924$20240930$20240930$PER$$US-ORGANON-O2409USA002003$ORGANON$$17$YR$$F$Y$54.422$KG$20240930$$HP$US$US
243786851$24378685$1$I$20240924$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017407$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240930$$CN$US$US
243786861$24378686$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153716$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$113.4$KG$20240930$$CN$US$US
243786871$24378687$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151564$BRISTOL MYERS SQUIBB$Naeem A, Kamran A, Sebastian W, Omar KO. Navigating hypophysitis in the wake of immunotherapy: a dual-agent perspective with pembrolizumab and ipilimumab: a case report. Chest. 2024;166(4S):3156A-7A. doi:10.1016/j.chest.2024.06.3828.$71$YR$E$M$Y$$$20240930$$HP$US$US
243786881$24378688$1$I$$20240926$20240930$20240930$EXP$$US-ABBVIE-5942046$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243786891$24378689$1$I$20110601$20240924$20240930$20240930$EXP$$US-ABBVIE-5937411$ABBVIE$$68$YR$$F$Y$64.864$KG$20240930$$HP$US$US
243786901$24378690$1$I$$20240925$20240930$20240930$EXP$$DE-ABBVIE-5940828$ABBVIE$$$$E$M$Y$$$20240930$$CN$DE$DE
243786921$24378692$1$I$$20240924$20240930$20240930$EXP$$CA-HALEON-2198438$Haleon PLC$$58$YR$$F$Y$$$20240930$$CN$CA$CA
243786931$24378693$1$I$20240925$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193261$AMGEN$$$$$$Y$$$20240930$$PH$US$US
243786951$24378695$1$I$$20240916$20240930$20240930$EXP$$IT-SAMSUNG BIOEPIS-SB-2024-28473$SAMSUNG BIOEPIS$Ossato A, Tessari R. Rapid Desensitization to Antitumoral Agents. Result from a Retrospective Study, DESARCh. Hospital Pharmacy. 2024 Sep 05;1-8. doi:10.1177/00185787241278702.$65$YR$E$F$Y$$$20240930$$HP$IT$IT
243786961$24378696$1$I$$20240917$20240930$20240930$EXP$$DE-ROCHE-10000084104$ROCHE$Wesener L, Hagelstein V, Terheyden P, Langan E. A Retrospective Analysis of the Prognostic Factors and Adverse Events in the Treatment of Mucosal Melanoma in a Single Centre. Journal of Clinical Medicine. 2024-Aug;13 (16):1-13. doi:10.3390/jcm13164741.$$$$$Y$$$20240930$$HP$DE$DE
243786971$24378697$1$I$$20240624$20240930$20240930$PER$$US-AJANTA-2024AJA00119$AJANTA PHARMA$$$$$F$Y$$$20240927$$PH$US$US
243786981$24378698$1$I$$20240919$20240930$20240930$PER$$US-ROCHE-10000087151$ROCHE$$45$YR$A$$Y$$$20240930$$CN$US$US
243786991$24378699$1$I$20231001$20240923$20240930$20240930$EXP$$ES-BIOGEN-2024BI01284074$BIOGEN$$31$YR$$F$Y$$$20240930$$MD$ES$ES
243787001$24378700$1$I$$20240923$20240930$20240930$EXP$$ES-BIOGEN-2024BI01284075$BIOGEN$$$$$$Y$$$20240930$$MD$ES$ES
243787011$24378701$1$I$$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151023$BRISTOL MYERS SQUIBB$Lord M, Healey LA, Sandilya V. Immunotherapy-induced diabetic ketoacidosis. Chest. 2024;166(4S):A2631-2. doi:10.1016/j.chest.2024.06.1601.$67$YR$E$F$Y$$$20240930$$HP$US$US
243787021$24378702$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-046996$AUROBINDO$$52$YR$$M$Y$$$20240930$$HP$CA$CA
243787031$24378703$1$I$$20240919$20240930$20240930$PER$$US-ABBVIE-5932747$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243787041$24378704$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117157$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$CN$US$US
243787051$24378705$1$I$20240723$20240916$20240930$20240930$EXP$$FR-CIPLA LTD.-2024FR10567$CIPLA$$$$$$Y$$$20240930$$PH$FR$FR
243787061$24378706$1$I$20240916$20240920$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-047068$AUROBINDO$$62$YR$$F$Y$$$20240930$$PH$GB$GB
243787071$24378707$1$I$$20240926$20240930$20240930$EXP$$US-ABBVIE-5942045$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243787081$24378708$1$I$20240920$20240929$20240929$20240929$DIR$720566$$FDA-CTU$$51$YR$$F$N$82.26$KG$20240929$N$CN$US$
243787091$24378709$1$I$20110101$20240929$20240929$20240929$DIR$720579$$FDA-CTU$$$$$F$N$$$20240929$N$CN$US$
243787101$24378710$1$I$20240928$20240929$20240929$20240929$DIR$720513$$FDA-CTU$$12$YR$$F$N$50.4$KG$20240929$N$CN$US$
243787111$24378711$1$I$20240919$20240923$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-047369$AUROBINDO$$$$$$Y$$$20240930$$PH$GB$GB
243787121$24378712$1$I$20240911$20240912$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-TRF-005533$ACADIA PHARMACEUTICALS$$6$YR$$F$Y$$$20240930$$CN$US$US
243787131$24378713$1$I$$20240916$20240930$20240930$PER$$US-JNJFOC-20240944039$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20240930$$CN$US$US
243787141$24378714$1$I$20240824$20240923$20240930$20240930$EXP$FR-AFSSAPS-MP2024001395$FR-TEVA-VS-3246957$TEVA$$78$YR$$F$Y$49$KG$20240930$$PH$FR$FR
243787151$24378715$1$I$$20240919$20240930$20240930$EXP$CA-MHPD-001102606$CA-Accord-447736$ACCORD$$47$YR$A$F$Y$$$20240930$$HP$CA$CA
243787161$24378716$1$I$20240528$20240920$20240930$20240930$EXP$$MX-EMD Serono-2024050855$EMD SERONO INC$$16$YR$T$M$Y$$$20240930$$CN$MX$MX
243787171$24378717$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017234$ELI LILLY AND CO$$72$YR$E$M$Y$$$20240930$$CN$US$US
243787181$24378718$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017363$ELI LILLY AND CO$$26$YR$A$F$Y$$$20240930$$CN$US$US
243787201$24378720$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017412$ELI LILLY AND CO$$77$YR$E$F$Y$$$20240930$$CN$US$US
243787211$24378721$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153734$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240930$$CN$US$US
243787231$24378723$1$I$$20240925$20240930$20240930$PER$$US-TAKEDA-2024TUS095781$TAKEDA$$$$$M$Y$113$KG$20240930$$MD$US$US
243787241$24378724$1$I$20240912$20240924$20240930$20240930$EXP$$PT-AUROBINDO-AUR-APL-2024-047507$AUROBINDO$$53$YR$$F$Y$$$20240930$$PH$PT$PT
243787251$24378725$1$I$$20240924$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151714$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$80$KG$20240930$$PH$US$US
243787261$24378726$1$I$$20240927$20240930$20240930$PER$$US-GILEAD-2024-0689253$GILEAD$$67$YR$E$M$Y$$$20240930$$MD$US$US
243787281$24378728$1$I$$20240920$20240930$20240930$EXP$$PT-ASPEN-GLO2024PT006622$ASPEN$Rosa M, Menezes B, Lopes C, Mendes J, Pires M, Wahnon A.. Lymphoplasmacytic lymphoma associated with hodgkin lymphoma: a case report.. Haematologic Diseases. PO4471:1069$$$$$Y$$$20240930$$HP$PT$PT
243787291$24378729$1$I$$20240924$20240930$20240930$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001947$BLUEPRINT MEDICINES$$$$$M$Y$$$20240930$$CN$US$US
243787301$24378730$1$I$$20240906$20240930$20240930$EXP$$US-SA-2024SA277226$SANOFI AVENTIS$$$$$F$Y$$$20240930$$CN$US$US
243787311$24378731$1$I$$20240906$20240930$20240930$EXP$$US-SA-2024SA275945$SANOFI AVENTIS$$$$E$F$Y$$$20240930$$MD$US$US
243787321$24378732$1$I$$20240918$20240930$20240930$EXP$$NL-AUROBINDO-AUR-APL-2024-046654$AUROBINDO$Aerts L, den Uijl DW, Luermans JGL, Maesen B. Temporary sinus node dysfunction following ablation of atrial fibrillation in patients with aberrancy of the sinus node artery: a case series. Interdisciplinary CardioVascular and Thoracic Surgery. 2024;39(1):1-4$59$YR$$M$Y$$$20240930$$HP$NL$NL
243787331$24378733$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153460$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$$$20240930$$MD$US$US
243787341$24378734$1$I$$20240919$20240930$20240930$EXP$$CA-APOTEX-2024AP011317$APOTEX$$65$YR$$M$Y$$$20240930$$HP$CA$CA
243787361$24378736$1$I$$20240920$20240930$20240930$EXP$$US-AMGEN-USASP2024190482$AMGEN$Angeles-han S.T.; Maccora I.; Ebert J.J. et al.. Treatment and Visual Outcomes in Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy: A Cohort Study. Ocular Immunology and Inflammation. 2024;1-8$13$YR$T$F$Y$$$20240930$$MD$US$US
243787371$24378737$1$I$20240619$20240926$20240930$20240930$EXP$FR-AFSSAPS-LY2024001445$FR-ROCHE-10000092326$ROCHE$$68$YR$E$M$Y$60$KG$20240930$$PH$FR$FR
243787381$24378738$1$I$$20240923$20240930$20240930$EXP$$GB-UCBSA-2024049283$UCB$McConville C, Lastakchi S, Al Amri A, Ngoga D, Fayeye O, Cruickshank G.. Local Delivery of Irinotecan to Recurrent GBM Patients at Reoperation Offers a Safe Route of Administration. Cancers. 2024;16(17)$$$$$Y$$$20240930$$HP$GB$GB
243787391$24378739$1$I$$20240927$20240930$20240930$PER$$NVSC2024US193205$NOVARTIS$$$$$$Y$$$20240930$$HP$US$US
243787401$24378740$1$I$20240919$20240920$20240930$20240930$EXP$$US-Rigel Pharmaceuticals, Inc.-20240900120$RIGEL PHARMACEUTICALS$$73$YR$$F$Y$81.647$KG$20240930$$CN$US$US
243787411$24378741$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047135$AUROBINDO$$70$YR$$F$Y$$$20240930$$HP$CA$CA
243787421$24378742$1$I$$20240926$20240930$20240930$EXP$$NVSC2024US192091$NOVARTIS$$$$$M$Y$88$KG$20240930$$CN$US$US
243787431$24378743$1$I$$20240911$20240930$20240930$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2024-PIM-005517$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20240930$$HP$US$US
243787441$24378744$1$I$$20240920$20240930$20240930$EXP$$NVSC2024PT190215$NOVARTIS$$68$YR$$M$Y$$$20240930$$MD$PT$PT
243787451$24378745$1$I$$20240922$20240930$20240930$EXP$GB-MHRA-MED-202409221025304760-DVKZQ$GB-ESPERIONTHERAPEUTICS-2024GBR01493$ESPERION THERAPEUTICS$$68$YR$$F$Y$58$KG$20240930$$CN$GB$GB
243787461$24378746$1$I$$20240920$20240930$20240930$EXP$GB-MHRA-TPP13961752C202234YC1726740761642$GB-ESPERIONTHERAPEUTICS-2024GBR01494$ESPERION THERAPEUTICS$$$$$$Y$$$20240930$$MD$GB$GB
243787471$24378747$1$I$20240926$20240927$20240928$20240928$DIR$FDA-CDER-CTU-2024-67094$$FDA-CTU$$$$$M$N$98.4$KG$20240927$N$$US$
243787481$24378748$1$I$20230720$20240929$20240929$20240929$DIR$720575$$FDA-CTU$$29$YR$$F$N$85.5$KG$20240929$N$CN$US$
243787491$24378749$1$I$$20240924$20240930$20240930$PER$$US-ABBVIE-5938224$ABBVIE$$$$$$Y$$$20240930$$CN$US$US
243787501$24378750$1$I$$20240918$20240930$20240930$EXP$$IE-AUROBINDO-AUR-APL-2024-046651$AUROBINDO$Soh BWT, Salim A, O^Riordan R, Owens P, Matiullah S. Unveiling the devastations of Streptococcus sanguinis infective endocarditis masquerading as iron deficiency anaemia: A case report. European Heart Journal - Case Reports. 2024;8 (8):ytae388$19$YR$$F$Y$$$20240930$$HP$IE$IE
243787511$24378751$1$I$20240916$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017272$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243787521$24378752$1$I$$20240923$20240930$20240930$EXP$$US-AMGEN-USASP2024192544$AMGEN$Hwang S.; Kingsley C.D.. A RARE AND RAPID DEVELOPMENT OF A PENETRATING THORACIC AORTIC ULCER FOLLOWING EXPOSURE TO CHEMOTHERAPY. Chest. 2024;166 (4):A238-A239$74$YR$E$F$Y$$$20240930$$HP$US$US
243787531$24378753$1$I$20240901$20240924$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152076$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240930$$CN$US$US
243787541$24378754$1$I$$20240923$20240930$20240930$PER$$US-JNJFOC-20240963759$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243787551$24378755$1$I$20240912$20240920$20240930$20240930$EXP$$FR-AUROBINDO-AUR-APL-2024-047521$AUROBINDO$$66$YR$$M$Y$$$20240930$$PH$FR$FR
243787561$24378756$1$I$$20240923$20240930$20240930$PER$$US-JNJFOC-20240967913$JOHNSON AND JOHNSON$$$$E$$Y$$$20240930$$MD$US$US
243787571$24378757$1$I$$20240911$20240930$20240930$PER$$US-TEVA-VS-3244449$TEVA$$31$YR$$M$Y$$$20240930$$CN$US$US
243787581$24378758$1$I$20240625$20240924$20240930$20240930$EXP$FR-AFSSAPS-RN2024000876$FR-SA-2024SA278576$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240930$$MD$FR$FR
243787591$24378759$1$I$20240901$20240920$20240930$20240930$PER$$US-GSK-US2024117043$GLAXOSMITHKLINE$$52$YR$$M$Y$$$20240930$$CN$US$US
243787601$24378760$1$I$20240101$20240925$20240930$20240930$EXP$$US-SA-2024SA278381$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240930$$MD$US$US
243787611$24378761$1$I$20240904$20240927$20240930$20240930$EXP$FR-AFSSAPS-GR2024001153$FR-SANDOZ INC.-SDZ2024FR083584$SANDOZ$$29$YR$$M$Y$75$KG$20240930$$PH$FR$FR
243787621$24378762$1$I$$20240923$20240930$20240930$EXP$$DE-SANDOZ INC.-SDZ2024DE082596$SANDOZ$Nau R, Schmidt-Schweda S, Frank T, Gossner J, Djukic M, Eiffert H. Ceftriaxone-induced neutropenia successfully overcome by a switch to penicillin G in Cardiobacterium hominisendocarditis. Clinical Case Reports. 2023;11:e7462$77$YR$$F$Y$52$KG$20240930$$HP$DE$DE
243787631$24378763$1$I$$20240924$20240930$20240930$EXP$GB-MHRA-MED-202409241909050280-MQSDG$GB-HALEON-2198722$Haleon PLC$$$$$F$Y$$$20240928$$CN$GB$GB
243787641$24378764$1$I$$20240911$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09263$LUPIN$$$$$$Y$$$20240930$$MD$US$US
243787651$24378765$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5939169$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243787671$24378767$1$I$$20240923$20240930$20240930$EXP$$US-AUROBINDO-AUR-APL-2024-047331$AUROBINDO$Zabel KM, Rebbe R, Vasef M, Foucar C. Case of B-acute lymphoblastic leukaemia with t(1;19)(q23;p13.3) TCF3::PBX1 and co-occurring CBL mutation in an elderly patient. BMJ case reports. 2024;17(9):e260617$8$DEC$$F$Y$$$20240930$$MD$US$US
243787691$24378769$1$I$$20240924$20240930$20240930$EXP$$AR-SANDOZ INC.-SDZ2024AR078896$SANDOZ$$$$$F$Y$$$20240930$$CN$AR$AR
243787701$24378770$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5941756$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243787711$24378771$1$I$$20240924$20240930$20240930$PER$$US-ROCHE-10000091752$ROCHE$$17$YR$T$M$Y$$$20240930$$MD$US$US
243787722$24378772$2$F$20240918$20240923$20240930$20240930$EXP$$US-AMGEN-USASL2024188535$AMGEN$$65$YR$E$F$Y$$$20240930$$CN$US$US
243787731$24378773$1$I$20240726$20240926$20240930$20240930$EXP$$FR-AUROBINDO-AUR-APL-2024-047893$AUROBINDO$$86$YR$$M$Y$$$20240930$$HP$FR$FR
243787751$24378775$1$I$$20240923$20240930$20240930$PER$$US-JNJFOC-20240965788$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243787761$24378776$1$I$$20240920$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150657$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20240930$$PH$US$US
243787771$24378777$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153818$BRISTOL MYERS SQUIBB$$88$YR$E$M$Y$$$20240930$$CN$US$US
243787781$24378778$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011222$APOTEX$$59$YR$$F$Y$$$20240930$$CN$CA$CA
243787801$24378780$1$I$20240915$20240920$20240930$20240930$EXP$$IT-AUROBINDO-AUR-APL-2024-047449$AUROBINDO$$73$YR$$F$Y$$$20240930$$MD$IT$IT
243787811$24378781$1$I$20240916$20240920$20240930$20240930$EXP$$GB-AUROBINDO-AUR-APL-2024-046857$AUROBINDO$$25$YR$$F$Y$95$KG$20240930$$MD$GB$GB
243787821$24378782$1$I$$20240923$20240930$20240930$EXP$$US-GSK-US2024GSK119600$GLAXOSMITHKLINE$Alam M. Pneumocystic jirovecii: always a differential. Chest. 2024;166(4):A5652-A5653$$$$$Y$$$20240930$$HP$US$US
243787831$24378783$1$I$$20240919$20240930$20240930$PER$$US-BAUSCHBL-2024BNL033918$BAUSCH AND LOMB$$94$YR$$F$Y$$$20240930$$CN$US$US
243787841$24378784$1$I$20240405$20240920$20240930$20240930$EXP$$FR-AUROBINDO-AUR-APL-2024-047426$AUROBINDO$$80$YR$$M$Y$$$20240930$$MD$FR$FR
243787851$24378785$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5896500$ABBVIE$$$$$F$Y$110$KG$20240930$$CN$US$US
243787861$24378786$1$I$$20240923$20240930$20240930$PER$$US-ABBVIE-5937952$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243787871$24378787$1$I$$20240917$20240930$20240930$EXP$$JP-Indicus Pharma-001039$INDICUS$Hara K, Miura E, Umeda Y, Umeda M, Oyake M, Fujita N. (A case of Parkinson^s disease with marked head drop after administration of donepezil hydrochloride). Rinsho Shinkeigaku. 2024 Aug 24. Japanese.$76$YR$E$F$Y$39.2$KG$20240930$$HP$JP$JP
243787881$24378788$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153794$BRISTOL MYERS SQUIBB$$50$YR$A$M$Y$$$20240930$$CN$US$US
243787901$24378790$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093219$ROCHE$$73$YR$E$F$Y$$$20240930$$CN$US$US
243787911$24378791$1$I$$20240924$20240930$20240930$EXP$$CA-ROCHE-10000089955$ROCHE$$40$YR$A$F$Y$96$KG$20240930$$HP$CA$CA
243787921$24378792$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011184$APOTEX$$48$YR$$F$Y$$$20240930$$CN$CA$CA
243787931$24378793$1$I$$20240926$20240930$20240930$EXP$GB-MHRA-MED-202409262200580010-WRLZC$GB-SANDOZ INC.-SDZ2024GB083658$SANDOZ$$$$$F$Y$$$20240930$$HP$GB$GB
243787951$24378795$1$I$$20240923$20240930$20240930$EXP$$US-JNJFOC-20240765570$JOHNSON AND JOHNSON$$$$A$F$Y$$$20240930$$HP$US$US
243787961$24378796$1$I$$20240912$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09268$LUPIN$$62$YR$$F$Y$$$20240930$$PH$US$US
243787971$24378797$1$I$$20240927$20240930$20240930$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054038$BOEHRINGER INGELHEIM$$$$$$Y$$$20240930$$CN$US$US
243787981$24378798$1$I$$20240925$20240930$20240930$EXP$$US-JNJFOC-20240972942$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243787991$24378799$1$I$$20240924$20240930$20240930$EXP$$CA-ROCHE-10000091560$ROCHE$$65$YR$E$F$Y$$$20240930$$HP$CA$CA
243788001$24378800$1$I$20240728$20240923$20240930$20240930$EXP$FR-AFSSAPS-PV2024000868$FR-TEVA-VS-3246914$TEVA$$56$YR$$M$Y$70$KG$20240930$$MD$FR$FR
243788021$24378802$1$I$$20240923$20240930$20240930$EXP$$AU-TEVA-VS-3247547$TEVA$$$$$$Y$$$20240930$$HP$AU$AU
243788031$24378803$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017164$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240930$$CN$US$US
243788041$24378804$1$I$20240101$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153827$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$70.31$KG$20240930$$MD$US$US
243788051$24378805$1$I$20240806$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153932$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240930$$CN$US$US
243788061$24378806$1$I$$20240916$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147883$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20240930$$CN$US$US
243788071$24378807$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153829$BRISTOL MYERS SQUIBB$$78$YR$E$F$Y$$$20240930$$CN$US$US
243788081$24378808$1$I$$20240923$20240930$20240930$EXP$$AU-TEVA-VS-3247757$TEVA$$56$YR$$F$Y$$$20240930$$HP$AU$AU
243788091$24378809$1$I$$20240926$20240930$20240930$EXP$$CA-ROCHE-10000093892$ROCHE$$$$A$F$Y$$$20240930$$MD$CA$CA
243788111$24378811$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011235$APOTEX$$61$YR$$$Y$$$20240930$$CN$CA$CA
243788121$24378812$1$I$20240916$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193037$AMGEN$$58$YR$A$F$Y$$$20240930$$HP$US$US
243788131$24378813$1$I$20240801$20240924$20240930$20240930$PER$$US-JNJFOC-20240967292$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243788141$24378814$1$I$$20240920$20240930$20240930$EXP$$US-TEVA-VS-3246818$TEVA$$$$E$M$Y$$$20240930$$CN$US$US
243788151$24378815$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011211$APOTEX$$66$YR$$F$Y$$$20240930$$CN$CA$CA
243788161$24378816$1$I$$20240926$20240930$20240930$EXP$$NVSC2024FR192678$NOVARTIS$$82$YR$$M$Y$$$20240930$$MD$FR$FR
243788171$24378817$1$I$$20240927$20240930$20240930$PER$$US-ROCHE-10000094119$ROCHE$$68$YR$E$M$Y$$$20240930$$HP$US$US
243788181$24378818$1$I$$20240919$20240930$20240930$EXP$$US-STRIDES ARCOLAB LIMITED-2024SP012459$STRIDES$Acharya S, Thakurathi P, Plocharczyk E, Arbach A, Gupta SS.. Minocycline-Associated Fatal Liver Injury.. Am-J-Ther. 2024;31 (2):e195-e197$55$YR$$M$Y$$$20240930$$MD$US$US
243788191$24378819$1$I$$20240917$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09402$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243788201$24378820$1$I$20240918$20240926$20240930$20240930$PER$$NVSC2024US192739$NOVARTIS$$75$YR$$M$Y$86.18$KG$20240930$$CN$US$US
243788211$24378821$1$I$20240801$20240925$20240930$20240930$EXP$$US-ABBVIE-5941114$ABBVIE$$80$YR$$F$Y$$$20240930$$CN$US$US
243788221$24378822$1$I$20240918$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153465$BRISTOL MYERS SQUIBB$$93$YR$E$F$Y$$$20240930$$CN$US$US
243788231$24378823$1$I$20240819$20240929$20240929$20240929$DIR$720583$$FDA-CTU$$47$YR$$M$N$$$20240929$N$CN$US$
243788241$24378824$1$I$20240920$20240923$20240928$20240928$DIR$FDA-CDER-CTU-2024-67100$$FDA-CTU$$61$YR$$F$N$50.3$KG$20240923$N$$US$
243788251$24378825$1$I$20240916$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153806$BRISTOL MYERS SQUIBB$$87$YR$E$F$Y$53.52$KG$20240930$$PH$US$US
243788261$24378826$1$I$$20240919$20240930$20240930$EXP$$KW-JNJFOC-20240958925$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$MD$KW$KW
243788271$24378827$1$I$$20240926$20240930$20240930$PER$$NVSC2024US192561$NOVARTIS$$$$$M$Y$$$20240930$$HP$US$US
243788281$24378828$1$I$$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024191431$AMGEN$$$$$F$Y$$$20240930$$CN$US$US
243788291$24378829$1$I$20240927$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193384$AMGEN$$60$YR$A$F$Y$$$20240930$$CN$US$US
243788301$24378830$1$I$20240920$20240927$20240928$20240928$DIR$FDA-CDER-CTU-2024-67096$$FDA-CTU$$$$$M$N$76.4$KG$20240927$N$$US$
243788311$24378831$1$I$20240920$20240927$20240928$20240928$DIR$FDA-CDER-CTU-2024-67099$$FDA-CTU$$33$YR$$M$N$70$KG$20240927$N$$US$
243788321$24378832$1$I$20240911$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193288$AMGEN$$75$YR$E$M$Y$$$20240930$$CN$US$US
243788331$24378833$1$I$20240901$20240923$20240930$20240930$EXP$$CA-AMGEN-CANSL2024190214$AMGEN$$79$YR$E$M$Y$$$20240930$$CN$CA$CA
243788341$24378834$1$I$$20240924$20240930$20240930$EXP$$VN-SANDOZ INC.-SDZ2024VN083748$SANDOZ$$$$$$Y$$$20240930$$HP$VN$VN
243788351$24378835$1$I$20240101$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152551$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$117.9$KG$20240930$$CN$US$US
243788361$24378836$1$I$$20240916$20240930$20240930$EXP$$GB-CIPLA (EU) LIMITED-2024GB10510$CIPLA$$$$$$Y$$$20240930$$CN$GB$GB
243788371$24378837$1$I$$20240924$20240930$20240930$PER$$US-JNJFOC-20240968199$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243788381$24378838$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047044$AUROBINDO$$87$YR$$M$Y$72$KG$20240930$$PH$CA$CA
243788391$24378839$1$I$20240501$20240927$20240930$20240930$EXP$FR-AFSSAPS-TO2024001685$FR-HALEON-2199169$Haleon PLC$$21$YR$$M$Y$$$20240930$$PH$FR$FR
243788411$24378841$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016488$ELI LILLY AND CO$$$$$$Y$$$20240930$$CN$US$US
243788421$24378842$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017575$ELI LILLY AND CO$$54$YR$A$F$Y$$$20240930$$CN$US$US
243788431$24378843$1$I$20240730$20240920$20240930$20240930$EXP$$AR-SA-2024SA233043$SANOFI AVENTIS$$45$YR$A$M$Y$$$20240930$$MD$AR$AR
243788441$24378844$1$I$$20240925$20240930$20240930$EXP$CA-LEO Pharma-373768$CA-LEO Pharma-373768$LEO PHARM$$63$YR$$M$Y$$$20240930$$CN$CA$CA
243788451$24378845$1$I$20240430$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017792$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243788461$24378846$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017393$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240930$$CN$US$US
243788471$24378847$1$I$20240101$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017362$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243788481$24378848$1$I$20240923$20240924$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017078$ELI LILLY AND CO$$44$YR$A$F$Y$$$20240930$$CN$US$US
243788491$24378849$1$I$20240923$20240924$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015424$ELI LILLY AND CO$$82$YR$E$F$Y$$$20240930$$CN$US$US
243788501$24378850$1$I$$20240923$20240930$20240930$EXP$$CN-SA-2024SA277267$SANOFI AVENTIS$$$$$$Y$$$20240930$$HP$CN$CN
243788531$24378853$1$I$20240830$20240913$20240930$20240930$PER$$US-TOLMAR, INC.-24US052451$TOLMAR$$75$YR$$M$Y$$$20240930$$HP$US$US
243788541$24378854$1$I$20240912$20240912$20240930$20240930$PER$$US-TOLMAR, INC.-24US052576$TOLMAR$$79$YR$$M$Y$$$20240930$$HP$US$US
243788551$24378855$1$I$$20240911$20240930$20240930$PER$$US-TOLMAR, INC.-24US052595$TOLMAR$$$$$M$Y$100.23$KG$20240930$$HP$US$US
243788561$24378856$1$I$20240829$20240912$20240930$20240930$PER$$US-TOLMAR, INC.-24US052581$TOLMAR$$69$YR$$M$Y$$$20240930$$HP$US$US
243788571$24378857$1$I$20240901$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193094$AMGEN$$$$$F$Y$$$20240930$$CN$US$US
243788591$24378859$1$I$20240922$20240922$20240930$20240930$EXP$$US-VANTIVE-2024VAN019938$Vantive US Healthcare$$$$$$Y$$$20240930$$HP$US$US
243788601$24378860$1$I$$20240924$20240930$20240930$EXP$$IT-ROCHE-10000093329$ROCHE$$$$$$Y$$$20240930$$MD$IT$IT
243788611$24378861$1$I$20240913$20240924$20240930$20240930$EXP$$CN-EMD Serono-2024051218$EMD SERONO INC$$55$YR$A$F$Y$50$KG$20240930$$HP$CN$CN
243788621$24378862$1$I$$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192770$AMGEN$$$$$$Y$$$20240930$$MD$US$US
243788631$24378863$1$I$20230121$20240927$20240930$20240930$EXP$FR-AFSSAPS-ST2024001413$NVSC2024FR192191$NOVARTIS$$70$YR$$F$Y$$$20240930$$PH$FR$FR
243788641$24378864$1$I$$20240925$20240930$20240930$PER$$NVSC2024US192160$NOVARTIS$$$$$M$Y$$$20240930$$MD$US$US
243788651$24378865$1$I$$20240927$20240930$20240930$EXP$$US-TAKEDA-2024TUS096309$TAKEDA$$$$$M$Y$$$20240930$$CN$US$US
243788671$24378867$1$I$$20240917$20240930$20240930$EXP$$US-UCBSA-2024048336$UCB$$$$A$M$Y$$$20240930$$CN$US$US
243788681$24378868$1$I$$20240921$20240930$20240930$EXP$$IN-ROCHE-10000087969$ROCHE$$55$YR$A$F$Y$$$20240930$$MD$IN$IN
243788691$24378869$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011207$APOTEX$$66$YR$$F$Y$$$20240930$$CN$CA$CA
243788701$24378870$1$I$20240724$20240927$20240930$20240930$EXP$$DE-009507513-2409DEU009956$MERCK$$69$YR$$F$Y$$$20240930$$MD$DE$DE
243788711$24378871$1$I$$20240926$20240930$20240930$EXP$$US-ABBVIE-5943922$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243788721$24378872$1$I$20231201$20240916$20240930$20240930$EXP$$US-INSMED, INC.-2024-00015-US$INSMED$$62$YR$$M$Y$$$20240930$$CN$US$US
243788731$24378873$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011208$APOTEX$$57$YR$$F$Y$$$20240930$$CN$CA$CA
243788741$24378874$1$I$20240813$20240927$20240928$20240928$DIR$FDA-CDER-CTU-2024-67083$$FDA-CTU$$46$YR$$F$N$$$20240927$N$HP$US$
243788751$24378875$1$I$20240501$20240929$20240929$20240929$DIR$720567$$FDA-CTU$$86$YR$$F$N$$$20240929$N$CN$US$
243788761$24378876$1$I$20230731$20240927$20240928$20240928$DIR$FDA-CDER-CTU-2024-67073$$FDA-CTU$$82$YR$$F$N$91.6$KG$20240927$N$$US$
243788771$24378877$1$I$20240801$20240916$20240930$20240930$EXP$$US-INSMED, INC.-2024-03258-US$INSMED$$72$YR$$F$Y$$$20240930$$CN$US$US
243788791$24378879$1$I$20240904$20240928$20240928$20240928$DIR$720484$$FDA-CTU$$64$YR$$UNK$N$$$20240928$N$CN$US$
243788811$24378881$1$I$$20240927$20240930$20240930$EXP$$CN-GILEAD-2024-0689191$GILEAD$$$$$$Y$$$20240930$$CN$CN$CN
243788821$24378882$1$I$20240715$20240916$20240930$20240930$EXP$GB-MHRA-MED-202408161236046940-MTNSF$GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2024-19519$ALKEM$$72$YR$$M$Y$66$KG$20240930$$CN$GB$GB
243788831$24378883$1$I$20240902$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017331$ELI LILLY AND CO$$$$A$M$Y$$$20240930$$CN$US$US
243788871$24378887$1$I$$20240916$20240930$20240930$EXP$$CA-ALKEM LABORATORIES LIMITED-CA-ALKEM-2024-22131$ALKEM$Alphonsus L, Zhang Q, Jairath V.. Multifocal Epstein-Barr Virus-Positive Mucocutaneous Ulcers in a Patient With Crohn^s Disease. ACG Case Reports Journal. 2024;11:e01468$48$YR$$F$Y$$$20240930$$HP$CA$CA
243788881$24378888$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017629$ELI LILLY AND CO$$$$$$Y$$$20240930$$CN$US$US
243788891$24378889$1$I$$20240916$20240930$20240930$EXP$$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2024-20300$ALKEM$Shrestha P, Garrahy I, Rahimian S. Eosinophilic granulomatosis with polyangiitis (EGPA) on remission with a new neuropathy: a rare case of Mycophenolate induced primary CNS lymphoproliferative disease. Journal Of Community Hospital Internal Medicine Perspectives. 2020;10(6):600-603$81$YR$$F$Y$$$20240930$$MD$US$US
243788911$24378891$1$I$$20240916$20240930$20240930$EXP$$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2024-21888$ALKEM$Wagner C, Montecino A. Suicidal thoughts of a bipolar patient after ingestion of Pregabalin: a case report. Advances in neurology, psychiatry. 2024;unk:unk$37$YR$$F$Y$$$20240930$$HP$DE$DE
243788921$24378892$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016373$ELI LILLY AND CO$$29$YR$A$F$Y$$$20240930$$CN$US$US
243788931$24378893$1$I$$20240926$20240930$20240930$EXP$$NVSC2024GB155739$NOVARTIS$$57$YR$$F$Y$$$20240930$$CN$GB$GB
243788941$24378894$1$I$20240201$20240919$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150322$BRISTOL MYERS SQUIBB$$30$YR$A$F$Y$56.7$KG$20240930$$CN$US$US
243788951$24378895$1$I$20240327$20240923$20240930$20240930$EXP$$CA-GSK-CA2024039866$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$CA$CA
243788961$24378896$1$I$$20240923$20240930$20240930$EXP$$NVSC2024US189638$NOVARTIS$$$$$$Y$$$20240930$$CN$US$US
243788971$24378897$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5943133$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243788981$24378898$1$I$$20240926$20240930$20240930$PER$$US-BIOGEN-2024BI01284373$BIOGEN$$$$$F$Y$$$20240930$$HP$US$US
243788991$24378899$1$I$20240101$20240924$20240930$20240930$PER$$US-ABBVIE-5938644$ABBVIE$$$$$F$Y$$$20240930$$HP$US$US
243789001$24378900$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153752$BRISTOL MYERS SQUIBB$$51$YR$A$F$Y$60.78$KG$20240930$$CN$US$US
243789011$24378901$1$I$$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024192255$AMGEN$$$$$F$Y$$$20240930$$HP$US$US
243789021$24378902$1$I$$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193051$AMGEN$$27$YR$A$F$Y$$$20240930$$MD$US$US
243789031$24378903$1$I$$20240916$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US081564$SANDOZ$$$$$$Y$$$20240930$$HP$US$US
243789041$24378904$1$I$$20240927$20240930$20240930$EXP$$CA-SANDOZ INC.-NVSC2023CA034556$SANDOZ$$72$YR$$F$Y$$$20240930$$CN$CA$CA
243789051$24378905$1$I$20240926$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192591$AMGEN$$58$YR$A$F$Y$$$20240930$$CN$US$US
243789061$24378906$1$I$$20240925$20240930$20240930$PER$$US-ABBVIE-5941660$ABBVIE$$$$$$Y$$$20240930$$HP$US$US
243789071$24378907$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153645$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$$$20240930$$CN$US$US
243789091$24378909$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047283$AUROBINDO$$74$YR$$M$Y$$$20240930$$PH$CA$CA
243789101$24378910$1$I$20240101$20240917$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US075378$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
243789111$24378911$1$I$20190803$20240923$20240930$20240930$EXP$$US-TAKEDA-2024TUS094905$TAKEDA$$68$YR$$M$Y$$$20240930$$MD$US$US
243789121$24378912$1$I$$20240924$20240930$20240930$EXP$$US-SERVIER-S24012275$SERVIER$Yee A., Karim F., Giashuddin S., Grutman G.. A Rare Case of Aggressive Disseminated Nasal Type Epstein-Barr Virus-Positive Extranodal Natural Killer/T-Cell Lymphoma with Bone Marrow Involvement. American Journal of Case Reports. 2023;24:e939286-1$$$$$Y$$$20240930$$MD$US$US
243789131$24378913$1$I$$20240925$20240930$20240930$PER$$NVSC2024US192167$NOVARTIS$$$$$$Y$$$20240930$$MD$US$US
243789141$24378914$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011214$APOTEX$$80$YR$$M$Y$$$20240930$$CN$CA$CA
243789151$24378915$1$I$$20240923$20240930$20240930$PER$$US-ABBVIE-5936790$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243789161$24378916$1$I$$20240923$20240930$20240930$EXP$$PL-CHEPLA-2024012236$CHEPLAPHARM$Richert-Przygonska M, Milewska M, Debski R, Cisek J, Czyzewski K, et al. Sclerodermatous manifestation of chronic graft-versus-host disease: therapy challenges. Acta Haematologica Polonica.2023;54:308?312.DOI: 10.5603/ahp.96817.$14$DY$$M$Y$$$20240930$$HP$COUNTRY NOT SPECIFIED$PL
243789171$24378917$1$I$20240912$20240918$20240930$20240930$EXP$$US-UCBSA-2024048316$UCB$$77$YR$$F$Y$$$20240930$$CN$US$US
243789191$24378919$1$I$20200908$20240929$20240929$20240929$DIR$720568$$FDA-CTU$$42$YR$$M$N$166.05$KG$20240929$N$CN$US$
243789201$24378920$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011216$APOTEX$$81$YR$$M$Y$$$20240930$$CN$CA$CA
243789211$24378921$1$I$20230618$20240926$20240930$20240930$EXP$$GR-ABBVIE-5943376$ABBVIE$$75$YR$$F$Y$85$KG$20240930$$MD$GR$GR
243789221$24378922$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016288$ELI LILLY AND CO$$40$YR$A$M$Y$$$20240930$$CN$US$US
243789231$24378923$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016407$ELI LILLY AND CO$$36$YR$A$F$Y$$$20240930$$CN$US$US
243789241$24378924$1$I$$20240927$20240930$20240930$PER$$US-GILEAD-2024-0689308$GILEAD$$$$$F$Y$$$20240930$$MD$US$US
243789251$24378925$1$I$$20240917$20240930$20240930$PER$$US-JNJFOC-20240950165$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
243789261$24378926$1$I$$20240925$20240930$20240930$EXP$$US-JNJFOC-20240972692$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243789281$24378928$1$I$$20240918$20240930$20240930$PER$$US-GSK-US2024AMR116210$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243789291$24378929$1$I$$20240919$20240930$20240930$EXP$CA-MHPD-E2B_07250109$CA-Accord-447916$ACCORD$$81$YR$E$F$Y$$$20240930$$HP$CA$CA
243789311$24378931$1$I$20240101$20240918$20240930$20240930$EXP$$US-Emmaus Medical, Inc.-EMM202409-000468$EMMAUS LIFE SCIENCES$$50$YR$A$F$Y$$$20240930$$CN$US$
243789321$24378932$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011161$APOTEX$$63$YR$$F$Y$$$20240930$$CN$CA$CA
243789331$24378933$1$I$$20240918$20240930$20240930$EXP$CA-MHPD-E2B_07245777$CA-Accord-447448$ACCORD$$$$$F$Y$$$20240930$$HP$CA$CA
243789341$24378934$1$I$20240901$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154160$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240930$$CN$US$US
243789351$24378935$1$I$20240708$20240925$20240930$20240930$EXP$$JP-ROCHE-10000094576$ROCHE$$$$E$$Y$$$20240930$$MD$JP$JP
243789361$24378936$1$I$$20240919$20240930$20240930$EXP$$SG-ROCHE-10000087695$ROCHE$$$$$$Y$$$20240930$$MD$SG$SG
243789371$24378937$1$I$20240901$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153861$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240930$$HP$US$US
243789381$24378938$1$I$20240904$20240906$20240930$20240930$EXP$$US-NEBO-668861$PHARMACOSMOS$$47$YR$$F$Y$$$20240930$$HP$US$US
243789401$24378940$1$I$$20240923$20240930$20240930$PER$$US-JNJFOC-20240962214$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$US$US
243789411$24378941$1$I$$20240916$20240930$20240930$EXP$$US-MSNLABS-2024MSNLIT02120$MSN LABORATORIES$Romero KN, O Brien MC, Agrawal A, Hasan I.Creatine Kinase Surge: Levetiracetam-Induced Rhabdomyolysis.Cureus.12-AUG-2024;16(8):e66715$$$$$Y$$$20240930$$HP$US$US
243789421$24378942$1$I$19840101$20240927$20240930$20240930$EXP$FR-AFSSAPS-DJ2024000973$FR-SANDOZ INC.-SDZ2024FR083582$SANDOZ$$63$YR$$F$Y$$$20240930$$MD$FR$FR
243789431$24378943$1$I$$20240926$20240930$20240930$EXP$GB-MHRA-MED-202409262231061230-YKZPQ$GB-SANDOZ INC.-SDZ2024GB083523$SANDOZ$$$$$M$Y$$$20240930$$HP$GB$GB
243789441$24378944$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011245$APOTEX$$71$YR$$F$Y$$$20240930$$CN$CA$CA
243789451$24378945$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047345$AUROBINDO$$77$YR$$M$Y$$$20240930$$MD$CA$CA
243789461$24378946$1$I$20180909$20240920$20240930$20240930$EXP$$GR-CELLTRION INC.-2024GR023200$CELLTRION$$$$$$Y$$$20240930$$MD$GR$GR
243789481$24378948$1$I$$20240919$20240930$20240930$PER$$US-JNJFOC-20240955061$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$PH$US$US
243789491$24378949$1$I$$20240916$20240930$20240930$EXP$$IN-LUPIN PHARMACEUTICALS INC.-2024-09343$LUPIN$Prakash S, Patel H, Shah CS. Medication-overuse headache overlapping with serotonin syndrome. British Medical Journal Case Report. 2024;17(1):1-5$$$A$F$Y$$$20240930$$MD$IN$IN
243789501$24378950$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017301$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240930$$CN$US$US
243789511$24378951$1$I$$20240919$20240930$20240930$EXP$$US-AUROBINDO-AUR-APL-2024-046480$AUROBINDO$Gale AM, Nachreiner D, Kumar A, Sell P, Gauguet S.. Acute Toxic Cerebellar Leukoencephalopathy in an Eight-Year-Old Child Following Illicit Fentanyl and Cocaine Ingestion: A Case Report of Full Clinical Recovery. Cureus. 2024;16(8):e66573$8$YR$$$Y$$$20240930$$MD$US$US
243789531$24378953$1$I$$20240603$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017928$ELI LILLY AND CO$$$$$$Y$$$20240930$$MD$US$US
243789541$24378954$1$I$$20240921$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015404$ELI LILLY AND CO$$$$$$Y$$$20240930$$CN$US$US
243789551$24378955$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153817$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$108.41$KG$20240930$$CN$US$US
243789561$24378956$1$I$$20240919$20240930$20240930$EXP$$US-ROCHE-10000087275$ROCHE$$70$YR$E$M$Y$$$20240930$$CN$US$US
243789571$24378957$1$I$$20240918$20240930$20240930$EXP$CA-MHPD-E2B_07229838$CA-Accord-447810$ACCORD$$14$YR$T$M$Y$$$20240930$$HP$CA$CA
243789581$24378958$1$I$$20240925$20240930$20240930$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-19588$IPSEN$$75$YR$E$M$Y$$$20240930$$CN$US$US
243789601$24378960$1$I$20240723$20240919$20240930$20240930$EXP$FR-AFSSAPS-LL2024001748$FR-Accord-448267$ACCORD$$53$YR$A$F$Y$58$KG$20240930$$PH$FR$FR
243789611$24378961$1$I$20240101$20240925$20240930$20240930$PER$$US-BIOGEN-2024BI01284276$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243789621$24378962$1$I$$20240927$20240930$20240930$EXP$GB-MHRA-MED-202409271705576490-JKPVR$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054073$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$$$20240930$$HP$GB$GB
243789631$24378963$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117141$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$CN$US$US
243789641$24378964$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153562$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240930$$CN$US$US
243789651$24378965$1$I$$20240923$20240930$20240930$EXP$$US-JNJFOC-20240960920$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243789691$24378969$1$I$$20240929$20240929$20240929$DIR$720536$$FDA-CTU$$22$YR$$F$N$46$KG$20240929$N$CN$NG$
243789701$24378970$1$I$$20240813$20240930$20240930$PER$$US-LUNDBECK-DKLU4003024$LUNDBECK$$$$$$Y$$$20240930$$PH$US$US
243789711$24378971$1$I$20240605$20240926$20240930$20240930$EXP$$NVSC2024CN192277$NOVARTIS$$52$YR$$M$Y$65$KG$20240930$$HP$CN$CN
243789721$24378972$1$I$20240918$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409191722320910-BPRNZ$GB-MACLEODS PHARMA-MAC2024049528$MACLEODS$$$$$$Y$$$20240930$$PH$GB$GB
243789731$24378973$1$I$20240919$20240920$20240930$20240930$EXP$$US-MYLANLABS-2024M1087133$MYLAN$$76$YR$$F$Y$$$20240930$$CN$US$US
243789751$24378975$1$I$$20240925$20240930$20240930$EXP$$PK-ROCHE-10000091141$ROCHE$$53$YR$A$F$Y$$$20240930$$CN$PK$PK
243789761$24378976$1$I$$20240919$20240930$20240930$EXP$$US-ROCHE-10000087492$ROCHE$$73$YR$E$M$Y$$$20240930$$CN$US$US
243789771$24378977$1$I$$20240918$20240930$20240930$EXP$CA-MHPD-E2B_07193523$CA-Accord-447529$ACCORD$$21$YR$A$F$Y$$$20240930$$HP$CA$CA
243789781$24378978$1$I$$20240813$20240930$20240930$PER$$US-LUNDBECK-DKLU4002980$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
243789791$24378979$1$I$$20240920$20240930$20240930$EXP$$US-AMGEN-USASP2024190486$AMGEN$Angeles-han S.T.; Maccora I.; Ebert J.J. et al.. Treatment and Visual Outcomes in Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy: A Cohort Study. Ocular Immunology and Inflammation. 2024;1-8$$$$$Y$$$20240930$$MD$US$US
243789801$24378980$1$I$$20240926$20240930$20240930$EXP$$NVSC2024VE192723$NOVARTIS$$$$A$F$Y$$$20240930$$CN$VE$VE
243789821$24378982$1$I$20240916$20240922$20240930$20240930$EXP$$CN-Jiangsu Hansoh Pharmaceutical Co., Ltd-2162208$JIANGSU HANSOH PHARMACEUTICAL$$53$YR$$F$Y$61$KG$20240930$$MD$CN$CN
243789831$24378983$1$I$20240706$20240921$20240930$20240930$EXP$FR-AFSSAPS-PP2024000963$FR-Accord-448496$ACCORD$$67$YR$E$F$Y$59$KG$20240930$$MD$FR$FR
243789841$24378984$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011201$APOTEX$$78$YR$$F$Y$$$20240930$$CN$CA$CA
243789851$24378985$1$I$$20240923$20240930$20240930$EXP$$BR-AUROBINDO-AUR-APL-2024-047265$AUROBINDO$Tolentino A, Santaella F, Barros FM, Barnes L, Torre OD, Schlittler L, et al. Extreme Agitation in Mania Treated With Intravenous Continuous Infusion of Dexmedetomidine and ECT. Journal of ECT. 2024;40(3):e12-3$30$YR$$M$Y$$$20240930$$MD$BR$BR
243789862$24378986$2$F$$20240922$20240930$20240930$PER$$US-ROCHE-10000088856$ROCHE$$$$A$F$Y$$$20240930$$HP$US$US
243789871$24378987$1$I$$20240920$20240930$20240930$EXP$$NVSC2024AU191312$NOVARTIS$$59$YR$$M$Y$$$20240930$$CN$AU$AU
243789881$24378988$1$I$$20240923$20240930$20240930$EXP$$MX-ROCHE-10000090291$ROCHE$Rios-Olais F, Gil-Lopez F, Mora-Canas A, Demichelis-Gomez R. Tumor Lysis Syndrome Is Associated with Worse Outcomes in Adult Patients with Acute Lymphoblastic Leukemia.. Acta Haematol.. 2024-Jan;147 (4):391-401. doi:10.1159/000534453.$$$$$Y$$$20240930$$HP$MX$MX
243789891$24378989$1$I$$20240918$20240930$20240930$EXP$$NVSC2024US008022$NOVARTIS$$$$$F$Y$12.9$KG$20240930$$MD$US$US
243789901$24378990$1$I$20201201$20240920$20240930$20240930$EXP$PL-EMA-DD-20240916-7482677-114845$NVSC2024PL190701$NOVARTIS$$49$YR$$M$Y$$$20240930$$HP$PL$PL
243789911$24378991$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017545$ELI LILLY AND CO$$19$YR$A$$Y$$$20240930$$CN$US$US
243789921$24378992$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153123$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240930$$HP$US$US
243789931$24378993$1$I$20240501$20240920$20240930$20240930$PER$$US-GSK-US2024116970$GLAXOSMITHKLINE$$67$YR$$F$Y$$$20240930$$CN$US$US
243789941$24378994$1$I$$20240925$20240930$20240930$EXP$$PT-EMD Serono-2024051716$EMD SERONO INC$$70$YR$E$M$Y$$$20240930$$MD$PT$PT
243789951$24378995$1$I$20240714$20240927$20240930$20240930$EXP$$IN-TAKEDA-2024TUS096178$TAKEDA$$51$YR$$M$Y$$$20240930$$CN$IN$IN
243789961$24378996$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093465$ROCHE$$$$A$F$Y$$$20240930$$MD$US$US
243789971$24378997$1$I$20240812$20240924$20240930$20240930$PER$$US-AMGEN-USASP2024191060$AMGEN$$$$$M$Y$$$20240930$$PH$US$US
243789981$24378998$1$I$$20240919$20240930$20240930$EXP$$CA-TAKEDA-2024TUS093863$TAKEDA$$$$$F$Y$$$20240930$$MD$CA$CA
243790001$24379000$1$I$$20240925$20240930$20240930$EXP$$CN-Hisun Pharmaceuticals-2162209$HISUN PHARMACEUTICALS$Source document$13$YR$$M$Y$$$20240930$$$CN$CN
243790011$24379001$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011171$APOTEX$$47$YR$$M$Y$$$20240930$$CN$CA$CA
243790021$24379002$1$I$20220701$20240916$20240930$20240930$EXP$$US-MYLANLABS-2024M1084388$MYLAN$$79$YR$$F$Y$78.92$KG$20240930$$LW$US$US
243790041$24379004$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3248526$TEVA$$41$YR$$F$Y$$$20240930$$HP$CA$CA
243790051$24379005$1$I$$20240917$20240930$20240930$EXP$$BE-STERISCIENCE B.V.-2024-ST-001486$Steriscience PTE$Zorzi S, Ayako Minemura Ordinola A, Cunha De Souza Lima E, Martins Teixeira G, Salvagno M, Sterchele ED, et al. A glimpse into multimodal neuromonitoring in acute liver failure: A case report. Ann-Med-Surgery. 2024;86 (1):539-544$56$YR$$M$Y$$$20240930$$MD$BE$BE
243790061$24379006$1$I$20221216$20240920$20240930$20240930$EXP$$CA-GSK-CA2023006317$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$CA$CA
243790081$24379008$1$I$20240718$20240925$20240930$20240930$EXP$$AR-MYLANLABS-2024M1087548$MYLAN$$16$YR$$M$Y$$$20240930$$CN$AR$AR
243790091$24379009$1$I$20240914$20240918$20240930$20240930$PER$$US-JNJFOC-20240947753$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20240930$$PH$US$US
243790101$24379010$1$I$20230731$20240927$20240928$20240928$DIR$FDA-CDER-CTU-2024-67104$$FDA-CTU$$82$YR$$F$N$91.6$KG$20240927$N$$US$
243790111$24379011$1$I$20240927$20240928$20240928$20240928$DIR$FDA-CDER-CTU-2024-67079$$FDA-CTU$$62$YR$$M$N$$$20240928$N$$US$
243790121$24379012$1$I$20240926$20240928$20240928$20240928$DIR$FDA-CDER-CTU-2024-67087$$FDA-CTU$$71$YR$$F$N$$$20240928$N$$US$
243790131$24379013$1$I$$20240926$20240930$20240930$EXP$GB-MHRA-MED-202409262239474130-TGYFW$GB-SANDOZ INC.-SDZ2024GB083448$SANDOZ$$$$$F$Y$$$20240930$$HP$GB$GB
243790141$24379014$1$I$$20240918$20240930$20240930$EXP$$ES-MSNLABS-2024MSNLIT02095$MSN LABORATORIES$Rubio-Mora E, Rodriguez JG, Carrascoso GR.Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?.Transplant Infectious Disease.2024;26(3):e14276$$$$$Y$$$20240930$$MD$ES$ES
243790151$24379015$1$I$20240922$20240923$20240928$20240928$DIR$FDA-CDER-CTU-2024-67095$$FDA-CTU$$53$YR$$$N$59.6$KG$20240923$N$$US$
243790161$24379016$1$I$$20240928$20240928$20240928$DIR$FDA-CDER-CTU-2024-67085$$FDA-CTU$$48$YR$$F$N$$$20240928$N$$US$
243790181$24379018$1$I$$20240917$20240930$20240930$EXP$$CN-STERISCIENCE B.V.-2024-ST-001490$Steriscience PTE$Chi S, Ning J.. Paradoxical reactions to midazolam: A case report.. Asian-J-Surg. 2024$1$DY$$F$Y$$$20240930$$HP$CN$CN
243790191$24379019$1$I$$20240919$20240930$20240930$EXP$$CZ-MYLANLABS-2024M1086235$MYLAN$Sitina M, Sramek V. Euglycemic ketoacidosis associated with SGLT2 inhibitors and DPP4 inhibitors - discussion of case reports. Anesteziol-Intenz-Med 2024; 35 (2): 116-121.$65$YR$$M$Y$$$20240930$$HP$CZ$CZ
243790201$24379020$1$I$20240918$20240920$20240930$20240930$PER$$US-GSK-US2024117162$GLAXOSMITHKLINE$$38$YR$$F$Y$$$20240930$$MD$US$US
243790211$24379021$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117151$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243790221$24379022$1$I$$20240926$20240930$20240930$PER$$US-TAKEDA-2024TUS095860$TAKEDA$$27$YR$$F$Y$40$KG$20240930$$PH$US$US
243790231$24379023$1$I$20240923$20240923$20240930$20240930$EXP$$MX-SANDOZ INC.-SDZ2024MX083707$SANDOZ$$87$YR$$F$Y$$$20240930$$CN$MX$MX
243790241$24379024$1$I$$20240923$20240930$20240930$EXP$NL-LRB-01003454$NL-TEVA-VS-3246877$TEVA$$30$YR$$M$Y$70$KG$20240930$$MD$NL$NL
243790251$24379025$1$I$20240108$20240923$20240930$20240930$EXP$IT-MINISAL02-1002557$IT-TEVA-VS-3246810$TEVA$$72$YR$$M$Y$61$KG$20240930$$PH$IT$IT
243790261$24379026$1$I$20171201$20240910$20240930$20240930$PER$$US-009507513-2409USA003665$MERCK$$$$$F$Y$$$20240930$$CN$US$US
243790271$24379027$1$I$20230101$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192140$AMGEN$$$$$F$Y$$$20240930$$MD$US$US
243790291$24379029$1$I$$20240926$20240930$20240930$PER$$US-JNJFOC-20240974314$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243790301$24379030$1$I$$20240906$20240930$20240930$PER$$US-ASTRAZENECA-202409USA003935US$ALEXION PHARMACEUTICALS$$72$YR$E$$Y$$$20240930$$$US$US
243790321$24379032$1$I$$20240922$20240930$20240930$EXP$$US-BAYER-2024A135124$BAYER$$$$$M$Y$$$20240930$$CN$US$US
243790331$24379033$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017073$ELI LILLY AND CO$$64$YR$A$F$Y$$$20240930$$CN$US$US
243790341$24379034$1$I$$20240916$20240930$20240930$EXP$$MX-Unichem Pharmaceuticals (USA) Inc-UCM202409-001196$UNICHEM$$72$YR$E$M$Y$$$20240930$$HP$MX$
243790361$24379036$1$I$$20240918$20240930$20240930$EXP$$US-FARMAPROD-202409-3324$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240930$$CN$US$US
243790371$24379037$1$I$$20240918$20240930$20240930$EXP$CA-MHPD-E2B_07238228$CA-Accord-447466$ACCORD$$62$YR$A$M$Y$$$20240930$$HP$CA$CA
243790391$24379039$1$I$$20240926$20240930$20240930$EXP$$SE-ORGANON-O2409SWE002138$ORGANON$$$$$F$Y$$$20240930$$HP$SE$SE
243790401$24379040$1$I$20240101$20240923$20240930$20240930$EXP$$CA-Orion Corporation ORION PHARMA-24_00031776$ORION$$4$YR$C$M$Y$$$20240930$$HP$CA$
243790421$24379042$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024AMR117276$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243790431$24379043$1$I$20240101$20240927$20240930$20240930$EXP$$AU-AMGEN-AUSSP2024192475$AMGEN$$81$YR$E$F$Y$$$20240930$$PH$AU$AU
243790441$24379044$1$I$$20240920$20240930$20240930$EXP$$CA-AUROBINDO-AUR-APL-2024-047534$AUROBINDO$$81$YR$$F$Y$$$20240930$$HP$CA$CA
243790461$24379046$1$I$$20240926$20240930$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024119331$VIIV$$$$$$Y$$$20240930$$PH$US$US
243790471$24379047$1$I$20240809$20240920$20240930$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024AMR117463$VIIV$$$$$$Y$$$20240930$$CN$US$US
243790481$24379048$1$I$20240402$20240920$20240930$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024117176$VIIV$$$$$$Y$$$20240930$$HP$US$US
243790491$24379049$1$I$$20240920$20240930$20240930$EXP$BR-MLMSERVICE-20220919-3805018-1$BR-JUBILANT CADISTA PHARMACEUTICALS-2022BR000846$JUBILANT$Ferreira GDSA, Watanabe ALC, Trevizoli NC, Figueira AVF, Caja GON, Murta MCB, et al. Refractory Hypernatremia and Osmotic Demyelination Syndrome After Liver Transplantation: A Case Report.. Transplantation Proceedings. 2022;54(5):1376-9$40$YR$$M$Y$$$20240930$$MD$BR$BR
243790501$24379050$1$I$20240830$20240926$20240930$20240930$EXP$$IN-ROCHE-10000093528$ROCHE$$72$YR$E$M$Y$$$20240930$$CN$IN$IN
243790511$24379051$1$I$$20240926$20240930$20240930$PER$$US-HALEON-2198946$Haleon PLC$$$$$$Y$$$20240930$$CN$US$US
243790521$24379052$1$I$$20240920$20240930$20240930$PER$$US-ASTRAZENECA-202409USA004141US$ALEXION PHARMACEUTICALS$$$$$$Y$104.32$KG$20240930$$PH$US$US
243790531$24379053$1$I$$20240926$20240930$20240930$PER$$NVSC2024US192606$NOVARTIS$$$$$$Y$$$20240930$$HP$US$US
243790541$24379054$1$I$$20240920$20240930$20240930$EXP$$FR-RDY-LIT/FRA/24/0014192$DR REDDYS$Ghanem R, Glaisner S, Bobin A, Ronchetti A, Cereja S, Joly B, et al. Posterior reversible encephalopathy syndrome (PRES) and myeloma. Leukemia Research Reports. 2024 Jan;21: doi:10.1016/j.lrr.2023.100407.$76$YR$E$F$Y$$$20240930$$HP$FR$FR
243790561$24379056$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5940878$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243790571$24379057$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011205$APOTEX$$79$YR$$F$Y$$$20240930$$CN$CA$CA
243790581$24379058$1$I$20240909$20240909$20240930$20240930$PER$$US-CSL-2024-008384$CSL Plasma$$65$YR$$F$Y$$$20240930$$HP$US$US
243790591$24379059$1$I$20240820$20240924$20240930$20240930$EXP$FR-AFSSAPS-CN2024000873$FR-MYLANLABS-2024M1086552$MYLAN$$35$YR$$M$Y$72$KG$20240930$$PH$FR$FR
243790601$24379060$1$I$20240912$20240924$20240930$20240930$EXP$GB-MHRA-MED-202409241054160250-SZKTW$GB-MYLANLABS-2024M1086966$MYLAN$$78$YR$$F$Y$60$KG$20240930$$PH$GB$GB
243790621$24379062$1$I$20240909$20240924$20240930$20240930$EXP$$US-ABBVIE-5939055$ABBVIE$$58$YR$$F$Y$$$20240930$$CN$US$US
243790631$24379063$1$I$$20240920$20240930$20240930$30DAY$$US-PFIZER INC-202400260982$PFIZER$$11$YR$$M$Y$$$20240930$$CN$US$US
243790642$24379064$2$F$$20240930$20240930$20240930$30DAY$$DE-PFIZER INC-202400261617$PFIZER$$$$$F$Y$$$20240930$$MD$DE$DE
243790651$24379065$1$I$$20240920$20240930$20240930$EXP$$US-PFIZER INC-202400261805$PFIZER$$68$YR$$F$Y$58.06$KG$20240930$$CN$US$US
243790661$24379066$1$I$20240311$20240920$20240930$20240930$EXP$$GR-ABBVIE-5935433$ABBVIE$$67$YR$$F$Y$76$KG$20240930$$MD$GR$GR
243790671$24379067$1$I$$20240920$20240930$20240930$30DAY$$US-PFIZER INC-202400260914$PFIZER$$13$YR$$M$Y$$$20240930$$CN$US$US
243790681$24379068$1$I$20240831$20240917$20240930$20240930$30DAY$$GB-PFIZER INC-202400258985$PFIZER$$37$YR$$M$Y$$$20240930$$CN$GB$GB
243790701$24379070$1$I$20240925$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192206$AMGEN$$49$YR$A$F$Y$$$20240930$$CN$US$US
243790711$24379071$1$I$20210101$20240919$20240930$20240930$EXP$$NVSC2024CN190434$NOVARTIS$Wang X, Zhao C, Gong Y, Wang Y, Guo F. Multidrug resistance in the standardized treatment of colon cancer harboring a rare fibrosarcoma B-type (BRAF) p.N581I mutation: a case report. FRONTIERS IN ONCOLOGY. 2023;13:1-6$41$YR$$F$Y$$$20240930$$HP$CN$CN
243790721$24379072$1$I$20240101$20240924$20240930$20240930$PER$$US-009507513-2409USA008758$MERCK$$$$$F$Y$69.388$KG$20240930$$HP$US$US
243790761$24379076$1$I$$20240920$20240930$20240930$PER$$US-RDY-LIT/USA/24/0014245$DR REDDYS$Chau LQ, Crawford JR. Neuroimaging features of accidental fentanyl overdose in a toddler. BMJ Case Reports. 2024 Jan 08;17: doi:10.1136/bcr-2023-258524.$$$$M$Y$$$20240930$$HP$US$US
243790771$24379077$1$I$$20240930$20240930$20240930$EXP$$CN-ROCHE-10000094671$ROCHE$$54$YR$A$F$Y$60$KG$20240930$$HP$CN$CN
243790791$24379079$1$I$$20240925$20240930$20240930$EXP$$US-SMPA-2024SPA003324$SUNOVION$$$$$$Y$$$20240930$$HP$US$US
243790801$24379080$1$I$$20240911$20240930$20240930$PER$$US-IMP-2024000735$Harrow Health$$$$$F$Y$$$20240930$$CN$US$US
243790811$24379081$1$I$$20240924$20240930$20240930$EXP$$CA-MYLANLABS-2024M1086826$MYLAN$$70$YR$$M$Y$$$20240930$$MD$CA$CA
243790831$24379083$1$I$$20240925$20240930$20240930$EXP$$US-PFIZER INC-202400264987$PFIZER$$75$YR$$F$Y$$$20240930$$HP$US$US
243790841$24379084$1$I$20240101$20240927$20240930$20240930$EXP$$US-ABBVIE-5943843$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243790851$24379085$1$I$$20240924$20240930$20240930$EXP$$CA-MYLANLABS-2024M1086828$MYLAN$$$$$F$Y$$$20240930$$CN$CA$CA
243790871$24379087$1$I$20240927$20240929$20240929$20240929$DIR$720555$$FDA-CTU$$65$YR$$UNK$N$$$20240929$N$PH$US$
243790881$24379088$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017196$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243790891$24379089$1$I$$20240925$20240930$20240930$EXP$$GB-PFIZER INC-202400263511$PFIZER$$76$YR$$F$Y$$$20240930$$HP$GB$GB
243790911$24379091$1$I$$20240928$20240928$20240928$DIR$FDA-CDER-CTU-2024-67075$$FDA-CTU$$61$YR$$M$N$$$20240928$N$$US$
243790921$24379092$1$I$$20240926$20240930$20240930$EXP$$NL-PFIZER INC-PV202400125978$PFIZER$$$$$M$Y$$$20240930$$MD$NL$NL
243790941$24379094$1$I$$20240924$20240930$20240930$30DAY$$JP-PFIZER INC-202400262599$PFIZER$$7$DEC$$F$Y$$$20240930$$CN$JP$JP
243790961$24379096$1$I$20240920$20240927$20240928$20240928$DIR$FDA-CDER-CTU-2024-67097$$FDA-CTU$$56$YR$$M$N$104.1$KG$20240927$N$$US$
243790971$24379097$1$I$$20240928$20240928$20240928$DIR$FDA-CDER-CTU-2024-67077$$FDA-CTU$$61$YR$$M$N$$$20240928$N$$US$
243790981$24379098$1$I$20240925$20240929$20240929$20240929$DIR$720577$$FDA-CTU$$49$YR$$M$N$72$KG$20240929$N$CN$US$
243790991$24379099$1$I$20220421$20240925$20240930$20240930$EXP$$GB-PFIZER INC-202400263854$PFIZER$$64$YR$$M$Y$56$KG$20240930$$HP$GB$GB
243791001$24379100$1$I$20240901$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152768$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$$$20240930$$HP$US$US
243791011$24379101$1$I$20240801$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153780$BRISTOL MYERS SQUIBB$$43$YR$A$F$Y$$$20240930$$HP$US$US
243791021$24379102$1$I$$20240920$20240930$20240930$EXP$$US-MERZ PHARMACEUTICALS, LLC-ACO_178024_2024$MERZ$$$$$F$Y$$$20240930$$CN$US$US
243791041$24379104$1$I$20230101$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153955$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240930$$CN$US$US
243791051$24379105$1$I$20230101$20240923$20240930$20240930$EXP$$TW-AMGEN-TWNSP2024189184$AMGEN$$$$E$F$Y$$$20240930$$CN$TW$TW
243791061$24379106$1$I$$20240923$20240930$20240930$EXP$$PT-MYLANLABS-2024M1086805$MYLAN$Anesthetic Management of Maternal Brain Tumor Diagnosed During Pregnancy: A Case Report. Supplement of Journal of the Portuguese Society of Anesthesiology. 2024;33$38$YR$$F$Y$$$20240930$$MD$PT$PT
243791071$24379107$1$I$$20240923$20240930$20240930$EXP$$US-MYLANLABS-2024M1087408$MYLAN$$$$$F$Y$$$20240930$$MD$US$US
243791081$24379108$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153945$BRISTOL MYERS SQUIBB$$90$YR$E$F$Y$73$KG$20240930$$PH$US$US
243791091$24379109$1$I$$20240923$20240930$20240930$EXP$PL-URPL-2-811-2019$PL-MYLANLABS-2024M1086813$MYLAN$$$$$M$Y$$$20240930$$CN$PL$PL
243791101$24379110$1$I$$20240923$20240930$20240930$EXP$$TR-MYLANLABS-2024M1087630$MYLAN$Ozden HC, Gurel SC. Neuroleptic Malignant Syndrome with Low-dose Quetiapine After Venlafaxine Withdrawal: A Case Report. . Turk-Psikiyatri-Dergisi 2024;.$40$YR$$M$Y$$$20240930$$HP$TR$TR
243791111$24379111$1$I$$20240923$20240930$20240930$PER$$US-JNJFOC-20240962344$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243791121$24379112$1$I$$20240923$20240930$20240930$EXP$$HN-MYLANLABS-2024M1087115$MYLAN$$$$$M$Y$75.74$KG$20240930$$CN$HN$HN
243791141$24379114$1$I$$20240906$20240930$20240930$PER$$US-ASTRAZENECA-202409USA004097US$ALEXION PHARMACEUTICALS$$71$YR$E$$Y$$$20240930$$PH$US$US
243791151$24379115$1$I$$20240925$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US069769$SANDOZ$$$$$$Y$$$20240930$$HP$US$US
243791161$24379116$1$I$20240606$20240924$20240930$20240930$EXP$$RU-SA-2024SA280246$SANOFI AVENTIS$$55$YR$A$M$Y$81$KG$20240930$$MD$RU$RU
243791181$24379118$1$I$$20240916$20240930$20240930$EXP$$US-EPICPHARMA-US-2024EPCLIT01134$EPIC PHARM$S Mukherji.Brief case report: A case of FOLFIRI-Induced psychosis.Psycho-Oncology.OCT-2023;32 (No.10):1625-1627$72$YR$E$M$Y$$$20240930$$HP$US$US
243791201$24379120$1$I$20240101$20240924$20240930$20240930$EXP$$CN-SA-2024SA278516$SANOFI AVENTIS$$64$YR$A$$Y$$$20240930$$CN$CN$CN
243791211$24379121$1$I$20240916$20240924$20240930$20240930$PER$$US-009507513-2409USA009130$MERCK$$81$YR$$M$Y$$$20240930$$CN$US$US
243791221$24379122$1$I$$20240913$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-147235$BRISTOL MYERS SQUIBB$$91$YR$E$F$Y$$$20240930$$CN$US$US
243791231$24379123$1$I$$20240916$20240930$20240930$EXP$$US-EPICPHARMA-US-2024EPCLIT01147$EPIC PHARM$Samuel Reinfeld.Diagnostic overshadowing clouding the efficient recognition of pediatric catatonia: A case series.CNS Spectrums.22-DEC-2022;28:587-591$15$YR$T$M$Y$$$20240930$$HP$US$US
243791241$24379124$1$I$20240901$20240924$20240930$20240930$PER$$US-JNJFOC-20240968231$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20240930$$CN$US$US
243791251$24379125$1$I$$20240925$20240930$20240930$EXP$$GB-MYLANLABS-2024M1087274$MYLAN$$54$YR$$F$Y$$$20240930$$CN$GB$GB
243791261$24379126$1$I$$20240924$20240930$20240930$EXP$$US-KYOWAKIRIN-2024KK022013$KYOWA$$$$$$Y$$$20240930$$HP$US$US
243791271$24379127$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016278$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243791281$24379128$1$I$$20240924$20240930$20240930$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-2024-153713$BRISTOL MYERS SQUIBB$$91$YR$E$$Y$$$20240930$$MD$JP$JP
243791291$24379129$1$I$$20240918$20240930$20240930$EXP$$US-STERISCIENCE B.V.-2024-ST-001501$Steriscience PTE$Measer J, Gray A, Braehler M.. Subdural Spread of Local Anesthetic Mimicking Cerebrovascular Accident: A Case Report of Horner^s Syndrome, Upper Limb Paresthesia, and Motor Weakness After Thoracic Epidural Analgesia.. A-A-Pract. 2024;18 (7)$53$YR$$F$Y$$$20240930$$MD$US$US
243791301$24379130$1$I$$20240925$20240930$20240930$EXP$$JP-JNJFOC-20240972911$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20240930$$MD$JP$JP
243791311$24379131$1$I$$20240906$20240930$20240930$PER$$US-Ascend Therapeutics US, LLC-2162212$ASCEND$$$$$F$Y$$$20240930$$$US$US
243791321$24379132$1$I$$20240917$20240930$20240930$EXP$$JP-ROCHE-10000088306$ROCHE$Tsugita N, Tanaka S, Segawa T, Noda T, Fuseya T, Kawaguchi T et al.. Evaluation of Cardiac Function and the Role of Apical Strain in Cancer Therapy-Related Cardiac Dysfunction Induced by HER2 Inhibitor Treatment. Therapeutic Research. 2024;45(8):537-544$6$DEC$A$$Y$$$20240930$$MD$JP$JP
243791351$24379135$1$I$$20240926$20240930$20240930$PER$$US-TAKEDA-2024TUS096360$TAKEDA$$33$YR$$F$Y$$$20240930$$CN$US$US
243791361$24379136$1$I$$20240925$20240930$20240930$EXP$$US-AMGEN-USASP2024193655$AMGEN$Yaghmour G.; Ashouri K.; Hom B. et al.. Philadelphia-like B-cell acute lymphoblastic Leukaemia: Disease features and outcomes in the era of immunotherapy. British Journal of Haematology. 2024;1-14$$$$$Y$$$20240930$$HP$US$US
243791371$24379137$1$I$$20240927$20240930$20240930$EXP$$CA-SANDOZ INC.-SDZ2024CA083744$SANDOZ$$76$YR$$F$Y$$$20240930$$CN$CA$CA
243791381$24379138$1$I$20240830$20240929$20240929$20240929$DIR$FDA-CDER-CTU-2024-67089$$FDA-CTU$$20$YR$$F$N$$$20240929$N$$US$
243791391$24379139$1$I$$20240929$20240929$20240929$DIR$FDA-CDER-CTU-2024-67091$$FDA-CTU$$58$YR$$F$N$$$20240929$N$$US$
243791401$24379140$1$I$20231101$20240916$20240930$20240930$PER$$US-MYLANLABS-2024M1084820$MYLAN$$69$YR$$F$Y$83.91$KG$20240930$$CN$US$US
243791431$24379143$1$I$$20240923$20240930$20240930$EXP$$PL-MYLANLABS-2024M1086539$MYLAN$Mozdzen K, Murawska A, Hypnar J, Pedziwiatr E, Pospiech J, Bosak M. Status epilepticus in pregnant patients two case reports and literature review. Polish Neurological Review. 2024;20(2):115-128$28$YR$$F$Y$$$20240930$$HP$PL$PL
243791441$24379144$1$I$$20240919$20240930$20240930$PER$$US-ROCHE-10000087880$ROCHE$$$$$F$Y$$$20240930$$CN$US$US
243791451$24379145$1$I$20110928$20240923$20240930$20240930$EXP$$AR-MYLANLABS-2024M1086032$MYLAN$$23$YR$$F$Y$$$20240930$$CN$AR$AR
243791461$24379146$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093104$ROCHE$$$$$F$Y$$$20240930$$MD$US$US
243791471$24379147$1$I$20240901$20240923$20240930$20240930$EXP$FR-AFSSAPS-SE2024000719$FR-MYLANLABS-2024M1086542$MYLAN$$94$YR$$F$Y$62$KG$20240930$$MD$FR$FR
243791501$24379150$1$I$$20240924$20240930$20240930$EXP$$DE-PFIZER INC-202400243835$PFIZER$Wobser, M.. PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA, LEG-TYPE, TREATED WITH A MODIFIED R-CHOP IMMUNOCHEMOTHERAPY - DIAGNOSTIC AND THERAPEUTIC CHALLENGES.. JOURNAL OF THE GERMAN SOCIETY OF DERMATOLOGY.. 2011;9(3):204-210$81$YR$$M$Y$$$20240930$$HP$DE$DE
243791511$24379151$1$I$$20240924$20240930$20240930$EXP$$US-PFIZER INC-PV202400125571$PFIZER$Nauffal, M.. Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation. Case Reports in Hematology. 2024;2024:10.1155/2024/5790011$75$YR$$F$Y$$$20240930$$HP$US$US
243791521$24379152$1$I$$20240924$20240930$20240930$EXP$$US-PFIZER INC-PV202400124895$PFIZER$Geller, A. DOUBLE TROUBLE: RITUXIMAB AND BENDAMUSTINE CHEMOTHERAPY-INDUCED PULMONARY HYPERTENSION FOLLOWING TREATMENT OF NODAL MARGINAL ZONE LYMPHOMA. Chest. 2024;166(4 Supple):5752A-5753A$77$YR$$F$Y$$$20240930$$HP$US$US
243791541$24379154$1$I$$20240924$20240930$20240930$EXP$$US-PFIZER INC-202400263079$PFIZER$Reddy, A.. HSV PNEUMONITIS: THE COVID MASQUERADER. Chest. 2024;166(4 Supple):A1078-A1079$59$YR$$M$Y$$$20240930$$HP$US$US
243791551$24379155$1$I$$20240924$20240930$20240930$PER$$US-AVEVA-000750$AVEVA$Terplan M, O^Grady KE, Monico LB, Schwartz RP, Gryczynski J, Fishman MJ, Mitchell SG. Adverse Events at 1 Month Following Medication Initiation for Opioid Use Disorder Among Adolescents and Young Adults. Subst Use Addctn J. 2024 Sep 19:29767342241275738$$$$$Y$$$20240930$$HP$US$US
243791561$24379156$1$I$$20240828$20240930$20240930$PER$$US-AVEVA-000732$AVEVA$$$$$F$Y$$$20240930$$CN$US$US
243791571$24379157$1$I$$20240909$20240930$20240930$PER$$US-AVEVA-000741$AVEVA$$$$$M$Y$$$20240930$$MD$US$US
243791581$24379158$1$I$$20240903$20240930$20240930$PER$$GB-AVEVA-000737$AVEVA$Thomson R, Phillips L, Orton S, Naughton F, Coleman T. Using nicotine replacement therapy for smoking reduction in pregnancy: a qualitative study of pregnant women in the UK who smoke. BMJ Open. 2024, 14(8):e085945. doi: 10.1136/bmjopen-2024-085945. PMID: 39214654.$$$$F$Y$$$20240930$$HP$GB$GB
243791591$24379159$1$I$$20240915$20240930$20240930$PER$$US-AVEVA-000745$AVEVA$$$$$M$Y$$$20240930$$CN$US$US
243791601$24379160$1$I$$20240917$20240930$20240930$PER$$US-AVEVA-000747$AVEVA$Nam S, Von Stein EL, Meador KJ, Levy RJ, Gallentine W, Li Y. Pearls +amp; Oy-sters: Exquisite Response of Sleep-Related Hypermotor Epilepsy to a Nicotine Patch. Neurology. 2024 Oct 8;103(7):e209790.$23$YR$A$M$Y$$$20240930$$MD$US$
243791611$24379161$1$I$$20240924$20240930$20240930$PER$$CA-AVEVA-000749$AVEVA$Skorzewska A, Younger WA, Dempster KS, Nazarov A, Richardson JD. Buprenorphine for the Treatment of Military-related PTSD With Treatment-resistant Depression and Unexpected Benefit for Chronic Pain: Case Report. Mil Med. 2024 Sep 18:usae416.$36$YR$A$M$Y$$$20240930$$HP$CA$US
243791621$24379162$1$I$$20240903$20240930$20240930$PER$$GB-AVEVA-000738$AVEVA$Thomson R, Phillips L, Orton S, Naughton F, Coleman T. Using nicotine replacement therapy for smoking reduction in pregnancy: a qualitative study of pregnant women in the UK who smoke. BMJ Open. 2024, 14(8):e085945. doi: 10.1136/bmjopen-2024-085945. PMID: 39214654.$$$$F$Y$$$20240930$$HP$GB$GB
243791631$24379163$1$I$$20240920$20240930$20240930$EXP$$JP-BIOGEN-2024BI01279964$BIOGEN$$$$$M$Y$$$20240930$$MD$JP$JP
243791641$24379164$1$I$$20240926$20240930$20240930$EXP$$US-MYLANLABS-2024M1088184$MYLAN$Bailey AC, Dossett C, Rabulinski DJ, Esparza Monzavi Y, Khan AA. Hemophagocytic lymphohistiocytosis (hlh) in an immunosuppressed patient with rheumatoid arthritis: a case report. Chest 2024; 166 (Suppl.) (4): A1991-A1992.$58$YR$$F$Y$$$20240930$$HP$US$US
243791651$24379165$1$I$$20240920$20240930$20240930$PER$$US-JNJFOC-20240964077$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243791661$24379166$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117181$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$CN$US$US
243791671$24379167$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117081$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243791691$24379169$1$I$$20240923$20240930$20240930$EXP$$US-AMGEN-USASP2024190507$AMGEN$Geller A.; Manuel J.; Manzano M et.al.. Tue perennial pneumonia: a case report of organizing pneumonia secondary to chronic aspiration following roux-en-y gastric bypass. Chest. 2024;166 (4):3226A-3227A$65$YR$E$F$Y$$$20240930$$HP$US$US
243791701$24379170$1$I$20240926$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192214$AMGEN$$55$YR$A$F$Y$$$20240930$$CN$US$US
243791711$24379171$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093342$ROCHE$$$$A$F$Y$$$20240930$$CN$US$US
243791721$24379172$1$I$20240901$20240926$20240930$20240930$PER$$US-ROCHE-10000093187$ROCHE$$$$$F$Y$$$20240930$$CN$US$US
243791731$24379173$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093250$ROCHE$$$$A$F$Y$$$20240930$$CN$US$US
243791741$24379174$1$I$$20240923$20240930$20240930$EXP$$CA-ROCHE-10000088877$ROCHE$$56$YR$A$F$Y$$$20240930$$HP$CA$CA
243791751$24379175$1$I$20240201$20240920$20240930$20240930$EXP$$US-TEVA-VS-3246509$TEVA$$69$YR$$M$Y$$$20240930$$CN$US$US
243791761$24379176$1$I$$20240927$20240930$20240930$EXP$$CA-SANDOZ INC.-SDZ2024CA083652$SANDOZ$$32$YR$$F$Y$$$20240930$$CN$CA$CA
243791771$24379177$1$I$$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193803$AMGEN$$$$$$Y$$$20240930$$HP$US$US
243791781$24379178$1$I$$20240929$20240929$20240929$DIR$FDA-CDER-CTU-2024-67139$$FDA-CTU$$25$YR$$F$N$$$20240929$N$$US$
243791791$24379179$1$I$20240709$20240920$20240930$20240930$EXP$$US-TEVA-VS-3246794$TEVA$$11$YR$$M$Y$56.7$KG$20240930$$CN$US$US
243791801$24379180$1$I$20240917$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409192231435280-VGZBH$GB-TORRENT-00038016$TORRENT$$39$YR$A$F$Y$$$20240930$$CN$GB$GB
243791811$24379181$1$I$20240705$20240920$20240930$20240930$EXP$GB-MHRA-MED-202409171353166980-SJGRP$GB-TORRENT-00038030$TORRENT$$53$YR$A$M$Y$$$20240930$$PH$GB$GB
243791821$24379182$1$I$20240315$20240920$20240930$20240930$EXP$GB-MHRA-MED-202409200810225960-FCHTQ$GB-TORRENT-00038034$TORRENT$$$$$M$Y$$$20240930$$CN$GB$GB
243791831$24379183$1$I$20240910$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409181040506270-ZQSMD$GB-TORRENT-00038021$TORRENT$$79$YR$E$F$Y$$$20240930$$PH$GB$GB
243791841$24379184$1$I$20240921$20240929$20240929$20240929$DIR$720561$$FDA-CTU$$26$YR$$M$N$210$KG$20240929$N$CN$US$
243791851$24379185$1$I$20240405$20240929$20240929$20240929$DIR$720582$$FDA-CTU$$10$YR$$F$N$29.75$KG$20240929$N$CN$US$
243791871$24379187$1$I$$20240929$20240929$20240929$DIR$720515$$FDA-CTU$$$$$F$N$85.5$KG$20240929$N$CN$US$
243791901$24379190$1$I$$20240924$20240930$20240930$EXP$$US-PFIZER INC-202400263554$PFIZER$Glick, L.. PULMONARY MUCORALES IN A PATIENT WITH FELTY SYNDROME. Chest. 2024;166(4 Suppl):943A-944A$64$YR$$M$Y$$$20240930$$HP$US$US
243791932$24379193$2$F$$20240910$20240930$20240930$PER$$US-TRAVERE-2024TVT00883$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243791941$24379194$1$I$20240917$20240919$20240930$20240930$PER$$US-Bion-013909$BIONPHARMA$$89$YR$E$F$Y$$$20240930$$CN$US$US
243791951$24379195$1$I$$20240925$20240930$20240930$EXP$$CA-PFIZER INC-202400264630$PFIZER$$13$YR$$F$Y$74$KG$20240930$$PH$CA$CA
243791961$24379196$1$I$20240416$20240919$20240930$20240930$EXP$$CA-OTSUKA-2024_011369$OTSUKA$$29$YR$$M$Y$$$20240930$$HP$CA$CA
243791971$24379197$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024190527$AMGEN$Chen E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$61$YR$A$F$Y$$$20240930$$HP$US$US
243791981$24379198$1$I$$20240926$20240930$20240930$PER$$US-BAYER-2024A138147$BAYER$$$$$$Y$$$20240930$$CN$US$US
243791991$24379199$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024190524$AMGEN$Chen E.C.; Flamand Y.; Tiao E.. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$65$YR$E$M$Y$$$20240930$$HP$US$US
243792001$24379200$1$I$$20240917$20240930$20240930$30DAY$$GB-PFIZER INC-PV202400121575$PFIZER$$36$YR$$M$Y$$$20240930$$CN$GB$GB
243792011$24379201$1$I$$20240925$20240930$20240930$PER$$NVSC2024US192124$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
243792021$24379202$1$I$20210303$20240927$20240930$20240930$EXP$$NVSC2021AT061674$NOVARTIS$$$$A$F$Y$58$KG$20240930$$MD$AT$AT
243792031$24379203$1$I$$20240916$20240930$20240930$EXP$$TW-EPICPHARMA-TW-2024EPCLIT01151$EPIC PHARM$Dr. Zhi-Fu Wu.Self limiting Skin Rash Found in a Patient with Suspected Malignant Hyperthermia Attack - A Case Report.Journal of Medical Sciences.12-APR-2024;44 (4):185-187$3$YR$C$F$Y$13.6$KG$20240930$$HP$TW$TW
243792041$24379204$1$I$20240923$20240924$20240930$20240930$PER$$US-AMGEN-USASP2024190772$AMGEN$$51$YR$A$F$Y$$$20240930$$CN$US$US
243792051$24379205$1$I$$20240923$20240930$20240930$EXP$$US-AMGEN-USASP2024192067$AMGEN$Rode S.; Parker W. A.; Reed M. et al.. CANCER-ASSOCIATED THROMBOTIC MICROANGIOPATHY. Chest. 2024;166 (4):A2317-A2318$55$YR$A$M$Y$$$20240930$$HP$US$US
243792061$24379206$1$I$$20240923$20240930$20240930$EXP$$US-AMGEN-USASP2024190554$AMGEN$Chen E. C.; Flamand Y.; Tiao E. et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$$$$$Y$$$20240930$$HP$US$US
243792071$24379207$1$I$$20240926$20240930$20240930$PER$$US-BAYER-2024A138148$BAYER$$$$$$Y$$$20240930$$CN$US$US
243792091$24379209$1$I$$20240920$20240930$20240930$EXP$$NVSC2024AU168056$NOVARTIS$Montarello NL, Irvine I, Warner V, Hare J, Kaye D, Cloud GC. Reversible cerebral vasoconstriction syndrome post-cardiac transplantation: a therapeutic dilemma: case report.. BMC NEUROLOGY. 2024;24(1):1-6$51$YR$$F$Y$$$20240930$$HP$AU$AU
243792101$24379210$1$I$$20240912$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09253$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243792111$24379211$1$I$20240913$20240924$20240930$20240930$EXP$$CN-FreseniusKabi-FK202414417$FRESENIUS KABI$$75$YR$E$M$Y$76.5$KG$20240930$$HP$CN$CN
243792121$24379212$1$I$20240909$20240923$20240930$20240930$EXP$ES-AEMPS-1571605$ES-FreseniusKabi-FK202414381$FRESENIUS KABI$$15$YR$T$F$Y$78$KG$20240930$$PH$ES$ES
243792131$24379213$1$I$20240913$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409191653360440-WBLYK$GB-Atnahs Limited-ATNAHS20240902682$Atnahs Healthcare$$60$YR$A$F$Y$$$20240930$$HP$GB$GB
243792141$24379214$1$I$20240801$20240920$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN010007$INCYTE$$$$$$Y$$$20240930$$HP$US$US
243792151$24379215$1$I$20240910$20240911$20240930$20240930$PER$$US-Eisai-EC-2024-174258$EISAI$$79$YR$E$F$Y$$$20240930$$CN$US$US
243792161$24379216$1$I$20240917$20240917$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013969$DR REDDYS$$18$YR$T$$Y$$$20240930$$MD$US$US
243792171$24379217$1$I$$20240916$20240930$20240930$EXP$$US-CorePharma LLC-2162222$COREPHARMA$Abstract$71$YR$$F$Y$$$20240930$$$US$US
243792181$24379218$1$I$20240916$20240923$20240930$20240930$EXP$$US-STEMLINE THERAPEUTICS B.V.-2024-STML-US005114$PAREXEL$$$$$$Y$$$20240930$$CN$US$US
243792191$24379219$1$I$$20240923$20240930$20240930$PER$$US-MYLANLABS-2024M1087059$MYLAN$$$$$F$Y$$$20240930$$CN$US$US
243792201$24379220$1$I$$20240920$20240930$20240930$PER$$US-MYLANLABS-2024M1086768$MYLAN$$$$$F$Y$$$20240930$$CN$US$US
243792211$24379221$1$I$$20240926$20240930$20240930$PER$$US-ABBVIE-5943466$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243792221$24379222$1$I$$20240920$20240930$20240930$EXP$$JP-ROCHE-10000093244$ROCHE$$$$E$F$Y$$$20240930$$MD$JP$JP
243792231$24379223$1$I$20240924$20240925$20240930$20240930$PER$$US-ROCHE-10000092900$ROCHE$$73$YR$E$F$Y$58.96$KG$20240930$$CN$US$US
243792241$24379224$1$I$20240918$20240918$20240930$20240930$PER$$US-JNJFOC-20240948711$JOHNSON AND JOHNSON$$61$YR$A$$Y$$$20240930$$CN$US$US
243792261$24379226$1$I$20240903$20240920$20240930$20240930$EXP$$NVSC2024GR178101$NOVARTIS$$74$YR$$M$Y$$$20240930$$PH$GR$GR
243792271$24379227$1$I$20230614$20240920$20240930$20240930$EXP$$CA-CELLTRION INC.-2023CA007687$CELLTRION$$$$$$Y$$$20240930$$MD$CA$CA
243792281$24379228$1$I$20200831$20240925$20240930$20240930$EXP$PL-URPL-1-4337-2020$PL-TEVA-VS-3247974$TEVA$$46$YR$$F$Y$70$KG$20240930$$MD$PL$PL
243792291$24379229$1$I$20240917$20240918$20240930$20240930$EXP$GB-MHRA-MED-202409181720390300-VDQSL$GB-ADVANZ PHARMA-202409007686$ADVANZ PHARMA$$$$$$Y$$$20240930$$HP$GB$GB
243792301$24379230$1$I$$20240916$20240930$20240930$EXP$$CN-EPICPHARMA-CN-2024EPCLIT01159$EPIC PHARM$J Tang.Death due to severe hypoglycemia caused by diclofenac sodium and lidocaine injection..Adverse drug reactions journal.20-NOV-2020;23:324-325$53$YR$A$M$Y$$$20240930$$HP$CN$CN
243792311$24379231$1$I$$20240919$20240930$20240930$PER$$US-VERTEX PHARMACEUTICALS-2024-014916$VERTEX$$$$$$Y$$$20240930$$CN$US$US
243792331$24379233$1$I$20221101$20240922$20240930$20240930$PER$$US-VERTEX PHARMACEUTICALS-2024-015027$VERTEX$$$$$$Y$$$20240930$$CN$US$US
243792341$24379234$1$I$$20240924$20240930$20240930$EXP$$GB-VERTEX PHARMACEUTICALS-2024-015154$VERTEX$$$$A$F$Y$$$20240930$$CN$GB$GB
243792351$24379235$1$I$$20240923$20240930$20240930$EXP$$GB-VERTEX PHARMACEUTICALS-2024-015157$VERTEX$$$$$M$Y$$$20240930$$CN$GB$GB
243792361$24379236$1$I$20240101$20240925$20240930$20240930$EXP$$GB-VERTEX PHARMACEUTICALS-2024-015239$VERTEX$$$$A$F$Y$$$20240930$$CN$GB$GB
243792371$24379237$1$I$$20240924$20240930$20240930$PER$$US-VERTEX PHARMACEUTICALS-2024-015187$VERTEX$$4$YR$$$Y$$$20240930$$HP$US$US
243792381$24379238$1$I$20240910$20240920$20240930$20240930$EXP$$CN-GE HEALTHCARE-2024CSU010878$GE HEALTHCARE$$53$YR$$F$Y$55$KG$20240930$$HP$CN$CN
243792391$24379239$1$I$20240101$20240924$20240930$20240930$EXP$$GB-VERTEX PHARMACEUTICALS-2024-015149$VERTEX$$$$A$M$Y$$$20240930$$CN$GB$GB
243792401$24379240$1$I$20240901$20240920$20240930$20240930$EXP$$US-TEVA-VS-3246529$TEVA$$77$YR$$F$Y$$$20240930$$CN$US$US
243792411$24379241$1$I$$20240924$20240930$20240930$EXP$$GB-TAKEDA-2024TUS095449$TAKEDA$$$$$$Y$$$20240930$$MD$GB$GB
243792421$24379242$1$I$20230101$20240926$20240930$20240930$PER$$US-BAYER-2024A138158$BAYER$$32$YR$A$F$Y$$$20240930$$HP$US$US
243792431$24379243$1$I$$20240925$20240930$20240930$EXP$$CA-TAKEDA-2024TUS095756$TAKEDA$$$$$M$Y$$$20240930$$MD$CA$CA
243792441$24379244$1$I$20200101$20240923$20240930$20240930$EXP$$AU-Waylis Therapeutics LLC-ATNAHS20240902514$Waylis$$58$YR$A$M$Y$65$KG$20240930$$HP$AU$AU
243792451$24379245$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093114$ROCHE$$$$$$Y$$$20240930$$CN$US$US
243792461$24379246$1$I$20240924$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024192812$AMGEN$$$$$$Y$$$20240930$$HP$US$US
243792481$24379248$1$I$20240314$20240929$20240929$20240929$DIR$720545$$FDA-CTU$$65$YR$$F$N$52.65$KG$20240929$N$CN$US$
243792491$24379249$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67266$$FDA-CTU$$45$YR$$F$N$106.59$KG$20240930$N$HP$US$
243792501$24379250$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67279$$FDA-CTU$$84$YR$$F$N$61.69$KG$20240930$N$HP$US$
243792521$24379252$1$I$20240923$20240926$20240930$20240930$PER$$US-BAYER-2024A138160$BAYER$$31$YR$A$F$Y$$$20240930$$MD$US$US
243792531$24379253$1$I$20240802$20240924$20240930$20240930$EXP$FR-AFSSAPS-TS2024001040$FR-Waylis Therapeutics LLC-ATNAHS20240902692$Waylis$$37$YR$A$F$Y$$$20240930$$MD$FR$FR
243792541$24379254$1$I$20240926$20240929$20240929$20240929$DIR$720562$$FDA-CTU$$18$YR$$M$N$106.1$KG$20240929$N$HP$US$
243792551$24379255$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67286$$FDA-CTU$$61$YR$$M$N$85.28$KG$20240930$N$$US$
243792561$24379256$1$I$20240911$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67365$$FDA-CTU$$1$YR$$M$N$$$20240930$Y$PH$US$
243792571$24379257$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000092986$ROCHE$$$$$$Y$$$20240930$$MD$US$US
243792581$24379258$1$I$20240801$20240925$20240928$20240928$DIR$FDA-CDER-CTU-2024-67081$$FDA-CTU$$61$YR$$F$N$61.23$KG$20240925$N$CN$US$
243792591$24379259$1$I$$20240912$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09162$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243792601$24379260$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000092882$ROCHE$$$$T$F$Y$$$20240930$$CN$US$US
243792611$24379261$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000085930$ROCHE$$$$E$F$Y$43.09$KG$20240930$$CN$US$US
243792621$24379262$1$I$20240825$20240925$20240930$20240930$EXP$FR-AFSSAPS-AVGR2024000159$FR-Waylis Therapeutics LLC-ATNAHS20240902700$Waylis$$32$YR$A$F$Y$56.5$KG$20240930$$PH$FR$FR
243792631$24379263$1$I$$20240927$20240930$20240930$EXP$$US-ABBVIE-5944158$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243792641$24379264$1$I$20230510$20240926$20240930$20240930$PER$$US-BAYER-2024A138199$BAYER$$22$YR$A$F$Y$$$20240930$$CN$US$US
243792651$24379265$1$I$20220216$20240925$20240930$20240930$EXP$$PT-ROCHE-10000092139$ROCHE$$34$YR$A$F$Y$$$20240930$$MD$PT$PT
243792661$24379266$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000092993$ROCHE$$$$$$Y$$$20240930$$MD$US$US
243792671$24379267$1$I$$20240916$20240930$20240930$EXP$$US-EPICPHARMA-US-2024EPCLIT01142$EPIC PHARM$Torrie AM.Apparent Reversal of a Successful Peripheral Neural Blockade With Intravenous Lipid Emulsion After Treatment for Local Anesthetic Systemic Toxicity: A Case Report.A and A Practice.NOV-2020;14$42$YR$A$F$Y$56.7$KG$20240930$$HP$US$US
243792681$24379268$1$I$20240101$20240926$20240930$20240930$EXP$$JP-ABBVIE-5942127$ABBVIE$$$$$$Y$$$20240930$$PH$JP$JP
243792691$24379269$1$I$$20240926$20240930$20240930$EXP$$US-GSK-US2024119882$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
243792701$24379270$1$I$$20240926$20240930$20240930$PER$$US-BAYER-2024A138430$BAYER$$$$$F$Y$$$20240930$$CN$US$US
243792711$24379271$1$I$20240901$20240924$20240930$20240930$EXP$$JP-009507513-2409JPN003589J$MERCK$$52$YR$$M$Y$$$20240930$$MD$JP$JP
243792721$24379272$1$I$20240901$20240925$20240930$20240930$EXP$$US-ABBVIE-5932287$ABBVIE$$66$YR$$F$Y$99.79$KG$20240930$$CN$US$US
243792731$24379273$1$I$20240101$20240919$20240930$20240930$EXP$$US-JNJFOC-20240959721$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20240930$$CN$US$US
243792741$24379274$1$I$$20240926$20240930$20240930$EXP$GB-MHRA-MED-202407241537464880-WNKLP$NVSC2024GB193001$NOVARTIS$$55$YR$$F$Y$44$KG$20240930$$MD$GB$GB
243792761$24379276$1$I$20240101$20240920$20240930$20240930$EXP$$US-TEVA-VS-3246790$TEVA$$69$YR$$M$Y$$$20240930$$PH$US$US
243792781$24379278$1$I$$20240927$20240930$20240930$DIR$FDA-CDER-CTU-2024-67347$$FDA-CTU$$$$$F$N$$$20240927$N$HP$US$
243792791$24379279$1$I$$20240927$20240930$20240930$DIR$FDA-CDER-CTU-2024-67276$$FDA-CTU$$$$$F$N$$$20240927$N$HP$US$
243792801$24379280$1$I$20240101$20240926$20240930$20240930$EXP$$CA-ABBVIE-5943515$ABBVIE$$67$YR$$F$Y$$$20240930$$CN$CA$CA
243792811$24379281$1$I$$20240925$20240930$20240930$PER$$US-BAYER-2024A138462$BAYER$$$$$F$Y$$$20240930$$CN$US$US
243792831$24379283$1$I$$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018164$ELI LILLY AND CO$$$$$M$Y$$$20240930$$CN$US$US
243792841$24379284$1$I$$20240919$20240930$20240930$EXP$$JP-ROCHE-10000092121$ROCHE$$$$$F$Y$27$KG$20240930$$CN$JP$JP
243792851$24379285$1$I$20240101$20240927$20240930$20240930$EXP$$PR-ABBVIE-5944074$ABBVIE$$$$$F$Y$$$20240930$$CN$PR$PR
243792861$24379286$1$I$$20240927$20240930$20240930$EXP$$US-ABBVIE-5944371$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243792871$24379287$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117175$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243792891$24379289$1$I$20240822$20240925$20240930$20240930$PER$FR-AFSSAPS-MP2024001425$FR-BRACCO-2024FR06009$BRACCO$$64$YR$$M$Y$$$20240930$$PH$FR$FR
243792901$24379290$1$I$20190609$20240926$20240930$20240930$EXP$$AR-SANDOZ INC.-SDZ2024AR083647$SANDOZ$$9$YR$$F$Y$$$20240930$$CN$AR$AR
243792911$24379291$1$I$20240601$20240920$20240930$20240930$PER$$US-ABBVIE-5933412$ABBVIE$$66$YR$$F$Y$54.884$KG$20240930$$CN$US$US
243792921$24379292$1$I$$20240918$20240930$20240930$EXP$$IL-ABBVIE-5940584$ABBVIE$$82$YR$$F$Y$$$20240930$$CN$IL$IL
243792931$24379293$1$I$20240824$20240927$20240930$20240930$EXP$$US-ABBVIE-5944411$ABBVIE$$72$YR$$M$Y$$$20240930$$CN$US$US
243792941$24379294$1$I$$20240923$20240930$20240930$EXP$$US-UCBSA-2024049580$UCB$DANIEL J, SMITH C, THOMAS A, MARLETTE Z. MILIARY HISTOPLASMOSIS IN A PATIENT WITH PSORIATIC ARTHRITIS. American College of Chest Physicians. 2024;1592A-1593A$66$YR$$M$Y$$$20240930$$HP$US$US
243792951$24379295$1$I$$20240913$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09248$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243792961$24379296$1$I$20240903$20240925$20240930$20240930$EXP$$JP-009507513-2409JPN000594J$MERCK$$78$YR$$M$Y$$$20240930$$PH$JP$JP
243792971$24379297$1$I$$20240924$20240930$20240930$PER$$US-009507513-2409USA008975$MERCK$XIONG J, EMBRY E, PRASAD S, SINGH S, ABDELGHANI L.. DISSEMINATED NOCARDIOSIS WITH SEPTIC EMBOLI. Chest. 2024;166 (4):A1108-9$50$YR$$F$Y$$$20240930$$HP$US$US
243792981$24379298$1$I$20240701$20240927$20240930$20240930$PER$$US-BAYER-2024A139036$BAYER$$35$YR$A$F$Y$$$20240930$$MD$US$US
243792991$24379299$1$I$20240101$20240909$20240930$20240930$EXP$$US-ACS-20240355$ACS DOBFAR$$71$YR$$M$Y$$$20240912$$CN$US$
243793001$24379300$1$I$$20240923$20240930$20240930$EXP$$GR-INFO-20240297$INFORLIFE$Tsoleridis T. The Use of Transdermal Buprenorphine for Acute Postherpetic Neuralgia: A Case Report. Cureus. 2023;15(2):e34886. DOI: 10.7759/cureus.34886$78$YR$E$F$Y$$$20240924$$MD$GR$
243793011$24379301$1$I$$20240926$20240930$20240930$PER$$US-BAYER-2024A139248$BAYER$$$$$$Y$$$20240930$$CN$US$US
243793021$24379302$1$I$$20240916$20240930$20240930$EXP$$IN-EPICPHARMA-IN-2024EPCLIT01137$EPIC PHARM$Somarajan Anandan.A Very Rare Side Effect of a Very Commonly Used Drug Pantoprazole induced Seizure.Association of Physicians of India.AUG-2024;72(8):89$69$YR$E$F$Y$$$20240930$$HP$IN$IN
243793031$24379303$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5939586$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243793051$24379305$1$I$$20240923$20240930$20240930$EXP$$SE-TEVA-VS-3248266$TEVA$Adra J, Giglio D, Karlsson P, Zetterberg H, Einbeigi Z. Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy. Acta-Oncol 2024; 63 636-641.$$$$F$Y$$$20240930$$HP$SE$SE
243793061$24379306$1$I$20240101$20240924$20240930$20240930$EXP$$NL-ABBVIE-5872745$ABBVIE$$$$E$M$Y$$$20240930$$CN$NL$NL
243793071$24379307$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247097$TEVA$$$$$$Y$$$20240930$$PH$CA$CA
243793081$24379308$1$I$20240101$20240924$20240930$20240930$EXP$$US-TG THERAPEUTICS INC.-TGT004033$TG THERAPEUTICS$$$$$$Y$$$20240930$$CN$US$US
243793091$24379309$1$I$$20240923$20240930$20240930$EXP$$SE-TEVA-VS-3248268$TEVA$Adra J, Giglio D, Karlsson P, Zetterberg H, Einbeigi Z. Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy. Acta-Oncol 2024; 63 636-641.$$$$F$Y$$$20240930$$HP$SE$SE
243793101$24379310$1$I$20240901$20240920$20240930$20240930$EXP$$ES-TEVA-VS-3246828$TEVA$$63$YR$$M$Y$80$KG$20240930$$MD$ES$ES
243793111$24379311$1$I$20240813$20240920$20240930$20240930$EXP$AU-TGA-0000818253$AU-ROCHE-10000092980$ROCHE$$32$YR$A$M$Y$$$20240930$$HP$AU$AU
243793121$24379312$1$I$$20240919$20240930$20240930$EXP$$JP-ROCHE-10000092067$ROCHE$$$$$F$Y$$$20240930$$CN$JP$JP
243793131$24379313$1$I$$20240920$20240930$20240930$PER$$US-ASTRAZENECA-202409USA003472US$ALEXION PHARMACEUTICALS$$71$YR$E$$Y$90.703$KG$20240930$$$US$US
243793141$24379314$1$I$20240603$20240924$20240930$20240930$EXP$FR-AFSSAPS-AVMA2024000416$FR-MYLANLABS-2024M1086944$MYLAN$$32$YR$$M$Y$$$20240930$$MD$FR$FR
243793161$24379316$1$I$$20240923$20240930$20240930$PER$$US-BAYER-2024A135760$BAYER$$81$YR$E$M$Y$$$20240930$$CN$US$US
243793171$24379317$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5940681$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243793181$24379318$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154107$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240930$$MD$US$US
243793201$24379320$1$I$$20240926$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA009992US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
243793221$24379322$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151377$BRISTOL MYERS SQUIBB$Arian M, Lodhi S. A cold case of mistaken identity. Chest. 2024;166(4):4517A. doi:10.1016/j.chest.2024.06.2744.$70$YR$E$M$Y$$$20240930$$HP$US$US
243793241$24379324$1$I$$20240913$20240930$20240930$PER$$US-JNJFOC-20240937037$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$PH$US$US
243793251$24379325$1$I$20230201$20240917$20240930$20240930$EXP$$HU-SMPA-2024SPA003092$SUNOVION$$$$$$Y$$$20240930$$MD$DE$DE
243793261$24379326$1$I$20240908$20240917$20240930$20240930$EXP$$US-SMPA-2024SPA003013$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243793271$24379327$1$I$$20240918$20240930$20240930$EXP$$US-SMPA-2024SPA000398$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243793281$24379328$1$I$20240712$20240919$20240930$20240930$EXP$$ZA-BAXTER-2024BAX021998$BAXTER$$36$YR$$M$Y$71.3$KG$20240930$$MD$ZA$ZA
243793291$24379329$1$I$20240810$20240917$20240930$20240930$EXP$$HU-SMPA-2024SPA003142$SUNOVION$$$$$$Y$$$20240930$$CN$AU$AU
243793301$24379330$1$I$$20240917$20240930$20240930$EXP$$US-SMPA-2024SPA001823$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243793311$24379331$1$I$20240914$20240920$20240930$20240930$EXP$CN-NMPACDR-4403051928901202400723$CN-BAXTER-2024BAX025202$BAXTER$$51$YR$$M$Y$71$KG$20240930$$MD$CN$CN
243793321$24379332$1$I$20231111$20240923$20240930$20240930$EXP$$CA-TAKEDA-2023TUS111044$TAKEDA$$38$YR$$M$Y$$$20240930$$CN$CA$CA
243793331$24379333$1$I$$20240917$20240930$20240930$EXP$$US-SMPA-2024SPA003019$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243793371$24379337$1$I$$20240916$20240930$20240930$EXP$$US-EPICPHARMA-US-2024EPCLIT01152$EPIC PHARM$Ravi Salgia.Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.Cancer Immunology Immunotherapy.06-AUG-2024;73:1-9$71$YR$E$F$Y$$$20240930$$HP$US$US
243793381$24379338$1$I$20240101$20240828$20240930$20240930$PER$$US-KARYOPHARM-2024KPT001486$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240930$$CN$US$US
243793401$24379340$1$I$20240901$20240926$20240930$20240930$PER$$US-KARYOPHARM-2024KPT001588$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240930$$CN$US$US
243793421$24379342$1$I$$20240923$20240930$20240930$EXP$$NVSC2024FR192699$NOVARTIS$$$$$$Y$$$20240930$$MD$FR$FR
243793431$24379343$1$I$$20240926$20240930$20240930$PER$$US-BIOGEN-2024BI01284383$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243793441$24379344$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117149$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243793451$24379345$1$I$$20240919$20240930$20240930$EXP$$AU-TAKEDA-2024TUS096434$TAKEDA$$$$$M$Y$$$20240930$$CN$AU$AU
243793461$24379346$1$I$20240729$20240923$20240930$20240930$EXP$$ES-AUROBINDO-AUR-APL-2024-047473$AUROBINDO$$71$YR$$M$Y$$$20240930$$MD$ES$ES
243793471$24379347$1$I$20200401$20240924$20240930$20240930$EXP$$AT-MYLANLABS-2024M1087017$MYLAN$$51$YR$$M$Y$73$KG$20240930$$HP$AT$AT
243793481$24379348$1$I$$20240929$20240930$20240930$PER$$US-BAYER-2024A139565$BAYER$$$$$$Y$$$20240930$$CN$US$US
243793491$24379349$1$I$$20240916$20240930$20240930$EXP$$CN-EPICPHARMA-CN-2024EPCLIT01158$EPIC PHARM$Liwen Zhang.Antibiotic-induced severe cutaneous adverse reactions: a single-center retrospective study over ten years.Frontiers in Immunology.18-JUL-2024;15:1-13$67$YR$E$M$Y$$$20240930$$HP$CN$CN
243793501$24379350$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000092366$ROCHE$$$$A$M$Y$$$20240930$$CN$US$US
243793511$24379351$1$I$$20240926$20240930$20240930$PER$$US-BAYER-2024A138345$BAYER$$$$$F$Y$$$20240930$$CN$US$US
243793521$24379352$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000092725$ROCHE$$51$YR$A$F$Y$65.8$KG$20240930$$CN$US$US
243793531$24379353$1$I$$20240923$20240930$20240930$EXP$$US-TEVA-VS-3248085$TEVA$$$$A$$Y$$$20240930$$PH$US$US
243793551$24379355$1$I$$20240920$20240930$20240930$EXP$$US-FreseniusKabi-FK202414391$FRESENIUS KABI$Sole J, Jiang S, Gunther M. Steroid-Induced Musical Hallucinosis. The primary care companion for CNS disorders. 2024 Aug 08;26(4): doi:https://dx.doi.org/10.4088/PCC.24cr03705.$59$YR$A$M$Y$$$20240930$$MD$US$US
243793561$24379356$1$I$$20240927$20240930$20240930$PER$$US-HALEON-2199317$Haleon PLC$$$$$$Y$$$20240930$$CN$US$US
243793571$24379357$1$I$$20240925$20240930$20240930$EXP$$NVSC2024GR192590$NOVARTIS$$$$$M$Y$$$20240930$$MD$GR$GR
243793591$24379359$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67346$$FDA-CTU$$49$YR$$M$N$$$20240930$N$$US$
243793601$24379360$1$I$$20240916$20240930$20240930$EXP$$US-EPICPHARMA-US-2024EPCLIT01160$EPIC PHARM$Ali M. Hassan.Potential anaphylactoid reaction to nicardipine.Journal of the American College of Emergency Physicians Open.29-JUL-2024;5:1-3$52$YR$A$M$Y$$$20240930$$MD$US$US
243793611$24379361$1$I$$20240923$20240930$20240930$EXP$$CA-TAKEDA-2024TUS094877$TAKEDA$$$$$M$Y$$$20240930$$CN$CA$CA
243793621$24379362$1$I$20240813$20240924$20240930$20240930$EXP$FR-AFSSAPS-MA2024001497$FR-MYLANLABS-2024M1086761$MYLAN$$68$YR$$F$Y$86$KG$20240930$$MD$FR$FR
243793631$24379363$1$I$$20240927$20240930$20240930$PER$$US-BAYER-2024A138978$BAYER$$$$$$Y$$$20240930$$CN$US$US
243793661$24379366$1$I$20240830$20240929$20240929$20240929$DIR$720565$$FDA-CTU$$16$YR$$M$N$60.75$KG$20240929$N$CN$US$
243793671$24379367$1$I$$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153661$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240930$$CN$US$US
243793681$24379368$1$I$$20240920$20240930$20240930$PER$$US-ABBVIE-5934355$ABBVIE$$$$$$Y$$$20240930$$HP$US$US
243793701$24379370$1$I$$20240919$20240930$20240930$EXP$$CA-APOTEX-2024AP011285$APOTEX$$3$YR$$M$Y$$$20240930$$HP$CA$CA
243793711$24379371$1$I$$20240924$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151940$BRISTOL MYERS SQUIBB$$54$YR$A$M$Y$$$20240930$$CN$US$US
243793721$24379372$1$I$20240814$20240923$20240930$20240930$PER$$US-JNJFOC-20240961707$JOHNSON AND JOHNSON$$86$YR$E$$Y$$$20240930$$PH$US$US
243793731$24379373$1$I$$20240926$20240930$20240930$EXP$$ZA-HALEON-2199276$Haleon PLC$$$$$$Y$$$20240930$$CN$ZA$ZA
243793741$24379374$1$I$$20240925$20240930$20240930$PER$$US-BAYER-2024A138038$BAYER$$$$$F$Y$$$20240930$$CN$US$US
243793751$24379375$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017661$ELI LILLY AND CO$$$$A$F$Y$$$20240930$$CN$US$US
243793771$24379377$1$I$$20240928$20240930$20240930$DIR$FDA-CDER-CTU-2024-67283$$FDA-CTU$$$$$M$N$$$20240928$N$HP$US$
243793791$24379379$1$I$20240827$20240923$20240930$20240930$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409016651$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240930$$CN$DE$CN
243793801$24379380$1$I$$20240917$20240930$20240930$PER$$US-FARMAPROD-202409-3312$DOMPE FARMACEUTICI$$$$E$F$Y$$$20240930$$CN$US$US
243793811$24379381$1$I$20240808$20240926$20240930$20240930$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409000891$ELI LILLY AND CO$$75$YR$E$F$Y$$$20240930$$CN$JP$JP
243793821$24379382$1$I$$20240919$20240930$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202408010589$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240930$$MD$US$US
243793831$24379383$1$I$$20240919$20240930$20240930$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409013056$ELI LILLY AND CO$$$$$F$Y$$$20240930$$MD$GB$GB
243793841$24379384$1$I$20240225$20240925$20240930$20240930$EXP$ES-AEMPS-1572871$ES-ELI_LILLY_AND_COMPANY-ES202409016693$ELI LILLY AND CO$$65$YR$E$F$Y$$$20240930$$CN$ES$ES
243793851$24379385$1$I$$20240920$20240930$20240930$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409013891$ELI LILLY AND CO$$68$YR$E$M$Y$62.5$KG$20240930$$CN$CN$CN
243793861$24379386$1$I$$20240918$20240930$20240930$EXP$$BE-ELI_LILLY_AND_COMPANY-BE202409013724$ELI LILLY AND CO$$$$$F$Y$$$20240930$$MD$BE$BE
243793871$24379387$1$I$20240909$20240920$20240930$20240930$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409015540$ELI LILLY AND CO$$63$YR$A$M$Y$57$KG$20240930$$CN$DE$CN
243793881$24379388$1$I$20240905$20240919$20240930$20240930$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409013895$ELI LILLY AND CO$$51$YR$A$M$Y$72$KG$20240930$$CN$DE$CN
243793891$24379389$1$I$20240911$20240918$20240930$20240930$EXP$$JP-ELI_LILLY_AND_COMPANY-JP202409017077$ELI LILLY AND CO$$70$YR$E$M$Y$72.6$KG$20240930$$CN$JP$JP
243793901$24379390$1$I$20240906$20240918$20240930$20240930$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409012024$ELI LILLY AND CO$$56$YR$A$F$Y$61$KG$20240930$$CN$CN$CN
243793911$24379391$1$I$20240926$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018295$ELI LILLY AND CO$$23$YR$A$M$Y$$$20240930$$CN$US$US
243793921$24379392$1$I$20240901$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018102$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243793931$24379393$1$I$20240701$20240918$20240930$20240930$EXP$FR-AFSSAPS-GR2024001103$FR-ELI_LILLY_AND_COMPANY-FR202409012195$ELI LILLY AND CO$$78$YR$E$F$Y$$$20240930$$CN$FR$FR
243793941$24379394$1$I$20240912$20240918$20240930$20240930$EXP$$CN-ELI_LILLY_AND_COMPANY-CN202409015735$ELI LILLY AND CO$$54$YR$A$M$Y$70$KG$20240930$$CN$DE$CN
243793951$24379395$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247095$TEVA$$$$$$Y$$$20240930$$PH$CA$CA
243793961$24379396$1$I$$20240926$20240930$20240930$PER$$US-BAYER-2024A138047$BAYER$$$$$F$Y$$$20240930$$CN$US$US
243793971$24379397$1$I$$20240927$20240930$20240930$PER$$US-BAYER-2024A139042$BAYER$$80$YR$E$M$Y$$$20240930$$CN$US$US
243793991$24379399$1$I$20230101$20240927$20240930$20240930$EXP$DE-DCGMA-24203964$NVSC2024DE192129$NOVARTIS$$62$YR$$F$Y$55$KG$20240930$$MD$DE$DE
243794001$24379400$1$I$$20240925$20240930$20240930$PER$$US-BIOGEN-2024BI01284236$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243794011$24379401$1$I$20240101$20240926$20240930$20240930$PER$$US-BIOGEN-2024BI01256035$BIOGEN$$$$$M$Y$$$20240930$$CN$US$US
243794031$24379403$1$I$$20240925$20240930$20240930$EXP$AU-TGA-0000818137$AU-ORGANON-O2409AUS002197$ORGANON$Unknown. Unknown. CLINICAL TOXICOLOGY$$$$$Y$$$20240930$$HP$AU$AU
243794041$24379404$1$I$$20240916$20240930$20240930$EXP$$US-EPICPHARMA-US-2024EPCLIT01161$EPIC PHARM$Shawn M. Varney.An Analysis of Clinical Outcomes  of Exploratory Pediatric Metformin  Ingestions Reported to the Texas Poison  Center Network From 2011 to 2021.Hospital Pharmacy.AUG-2024;59:465-470$$$$$Y$$$20240930$$HP$US$US
243794061$24379406$1$I$20240812$20240925$20240930$20240930$PER$$US-BAYER-2024A138381$BAYER$$34$YR$A$F$Y$$$20240930$$HP$US$US
243794071$24379407$1$I$$20240925$20240930$20240930$EXP$NL-LRB-01003691$NL-TEVA-VS-3247972$TEVA$$71$YR$$M$Y$78$KG$20240930$$MD$NL$NL
243794091$24379409$1$I$$20240916$20240930$20240930$EXP$$IN-LUPIN PHARMA CANADA-2024-09470$LUPIN$$$$$$Y$$$20240930$$CN$IN$IN
243794101$24379410$1$I$$20240920$20240930$20240930$EXP$$PL-REGENERON PHARMACEUTICALS, INC.-2024-130162$REGENERON$$74$YR$$F$Y$$$20240930$$HP$PL$PL
243794111$24379411$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247094$TEVA$$$$$$Y$$$20240930$$PH$CA$CA
243794121$24379412$1$I$20240401$20240923$20240930$20240930$PER$$CA-Eisai-EC-2024-164888$EISAI$$73$YR$E$F$Y$$$20240930$$CN$CA$CA
243794141$24379414$1$I$20200918$20240920$20240930$20240930$EXP$$IT-TAKEDA-2024TUS096071$TAKEDA$$61$YR$$M$Y$$$20240930$$MD$IT$IT
243794151$24379415$1$I$$20240926$20240930$20240930$EXP$$US-BAYER-2024A138930$BAYER$$$$$$Y$$$20240930$$CN$US$US
243794181$24379418$1$I$20240301$20240530$20240930$20240930$EXP$FR-AFSSAPS-BX2024001433$FR-SA-2024SA280264$SANOFI AVENTIS$$36$YR$A$F$Y$92$KG$20240930$$MD$FR$FR
243794211$24379421$1$I$20240901$20240924$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152094$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240930$$PH$US$US
243794221$24379422$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153813$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240930$$CN$US$US
243794231$24379423$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153878$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$$$20240930$$HP$US$US
243794251$24379425$1$I$20240101$20240919$20240930$20240930$EXP$$SG-MYLANLABS-2024M1085439$MYLAN$$41$YR$$F$Y$$$20240930$$HP$SG$SG
243794261$24379426$1$I$$20240924$20240930$20240930$EXP$$JP-JNJFOC-20240980331$JOHNSON AND JOHNSON$Takashi FUJISHIRO, et al.; Department of Endocrine, Metabolism and Diabetes (Third Department of Internal Medicine), Kyushu University Hospital. A case of prolactinoma that required diagnosis and treatment while receiving antipsychotic drugs. Proceedings of the 24th Congress of Kyusyu Branch of the Japan Endocrine Society;2024.9.7; Kitakyushu, Fukuoka:2024.p.44$19$YR$A$F$Y$$$20240930$$MD$JP$JP
243794281$24379428$1$I$20100101$20240920$20240930$20240930$PER$$US-JNJFOC-20240963916$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20240930$$HP$US$US
243794291$24379429$1$I$$20240923$20240930$20240930$EXP$$IT-REGENERON PHARMACEUTICALS, INC.-2024-129092$REGENERON$Croce E., Boutros A., Tanda E.T., Cecchi F., Arecco L., Genova C., Baldelli I., Lambertini M., Raposio E., Del Mastro L., Spagnolo F. Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma. Annals of Oncology. 2023;34 Supplement 2:S684$$$$$Y$$$20240930$$MD$IT$IT
243794301$24379430$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011183$APOTEX$$66$YR$$F$Y$$$20240930$$CN$CA$CA
243794311$24379431$1$I$$20240926$20240930$20240930$EXP$DE-SANDOZ-SDZ2024DE075550$DE-GSK-DE2024119363$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$DE$DE
243794321$24379432$1$I$20240901$20240924$20240930$20240930$PER$$US-BAYER-2024A137012$BAYER$$88$YR$E$M$Y$$$20240930$$CN$US$US
243794331$24379433$1$I$20240825$20240924$20240930$20240930$EXP$$US-EXELIXIS-EXL-2024-000573$EXELIXIS$$21$YR$$M$Y$55.4$KG$20240930$$CN$US$US
243794341$24379434$1$I$$20240924$20240930$20240930$EXP$$NVSC2024FR192743$NOVARTIS$$83$YR$$M$Y$$$20240930$$MD$FR$FR
243794361$24379436$1$I$20240530$20240924$20240930$20240930$EXP$$US-EXELIXIS-CABO-24078630$EXELIXIS$$69$YR$$F$Y$$$20240930$$CN$US$US
243794381$24379438$1$I$$20240923$20240930$20240930$EXP$$SE-TEVA-VS-3248191$TEVA$Adra J, Giglio D, Karlsson P, Zetterberg H, Einbeigi Z. Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy. Acta-Oncol 2024; 63 636-641.$$$$F$Y$$$20240930$$HP$SE$SE
243794391$24379439$1$I$20240101$20240926$20240930$20240930$EXP$$US-ORGANON-O2409USA002193$ORGANON$$$$$F$Y$$$20240930$$MD$US$US
243794401$24379440$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67390$$FDA-CTU$$78$YR$$F$N$$$20240930$N$$US$
243794431$24379443$1$I$$20240923$20240930$20240930$EXP$$SE-TEVA-VS-3248193$TEVA$Adra J, Giglio D, Karlsson P, Zetterberg H, Einbeigi Z. Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy. Acta-Oncol 2024; 63 636-641.$$$$F$Y$$$20240930$$HP$SE$SE
243794441$24379444$1$I$$20240918$20240930$20240930$EXP$$US-SA-2024SA280479$SANOFI AVENTIS$$74$YR$E$M$Y$$$20240930$$CN$US$US
243794451$24379445$1$I$20240413$20240923$20240930$20240930$EXP$ES-AEMPS-1568509$ES-Merck Healthcare KGaA-2024050770$MERCK KGAA$$43$YR$A$F$Y$67$KG$20240930$$CN$ES$ES
243794461$24379446$1$I$20240101$20240923$20240930$20240930$EXP$$CA-ABBVIE-5937985$ABBVIE$$60$YR$$M$Y$$$20240930$$MD$CA$CA
243794471$24379447$1$I$20240101$20240920$20240930$20240930$EXP$$US-SA-2024SA280181$SANOFI AVENTIS$$49$YR$A$F$Y$$$20240930$$MD$US$US
243794481$24379448$1$I$$20240920$20240930$20240930$PER$$US-009507513-2409USA007823$MERCK$$$$$F$Y$$$20240930$$MD$US$US
243794501$24379450$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5939592$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243794511$24379451$1$I$$20240919$20240930$20240930$EXP$$CN-SA-2024SA280196$SANOFI AVENTIS$Wang C, Qiu J, Huang X, Xu J, Pan L.. Hemophagocytic lymphohistiocytosis secondary to rifampin treatment: A case report. Medicine. 2024;103(29):1-6$53$YR$A$F$Y$$$20240930$$HP$CN$CN
243794541$24379454$1$I$$20240920$20240930$20240930$PER$$US-JNJFOC-20240964754$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$HP$US$US
243794561$24379456$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000092164$ROCHE$$64$YR$A$F$Y$$$20240930$$CN$US$US
243794571$24379457$1$I$$20240919$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA003231US$ALEXION PHARMACEUTICALS$$$$A$$Y$$$20240930$$$US$US
243794581$24379458$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011233$APOTEX$$84$YR$$$Y$$$20240930$$CN$CA$CA
243794601$24379460$1$I$20240101$20240926$20240930$20240930$EXP$$US-AMGEN-USASL2024192142$AMGEN$$52$YR$A$F$Y$$$20240930$$CN$US$US
243794611$24379461$1$I$$20240920$20240930$20240930$EXP$$GB-AMGEN-GBRSP2024189127$AMGEN$Ramanathan, S. CD3+TCR alpha beta/CDl9+-depleted stem cell boost and CD45RO+ memory T-cell add-back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCT. Pediatric Blood + Cancer. 2024;71 (10):1-3$17$YR$T$F$Y$$$20240930$$HP$GB$GB
243794631$24379463$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153903$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240930$$HP$US$US
243794641$24379464$1$I$20230101$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409014356$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240930$$HP$US$US
243794651$24379465$1$I$20240901$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018610$ELI LILLY AND CO$$$$$$Y$$$20240930$$CN$US$US
243794661$24379466$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247093$TEVA$$$$$$Y$$$20240930$$PH$CA$CA
243794671$24379467$1$I$$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018210$ELI LILLY AND CO$$37$YR$A$M$Y$$$20240930$$CN$US$US
243794681$24379468$1$I$$20240918$20240930$20240930$PER$$US-Calliditas-2024CAL01999$CALLIDITAS THERAPEUTICS$$$$$$Y$$$20240930$$MD$US$US
243794691$24379469$1$I$$20240909$20240930$20240930$30DAY$$JP-MYLANLABS-2024M1082194$MYLAN$$$$$$Y$$$20240930$$HP$JP$JP
243794711$24379471$1$I$20160101$20240923$20240930$20240930$EXP$$BR-TAKEDA-2024TUS095712$TAKEDA$$$$$M$Y$$$20240930$$CN$BR$BR
243794722$24379472$2$F$$20240918$20240930$20240930$PER$$US-ROCHE-10000086074$ROCHE$$$$E$F$Y$58.51$KG$20240930$$CN$US$US
243794731$24379473$1$I$20240828$20240923$20240930$20240930$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001927$BLUEPRINT MEDICINES$$61$YR$A$F$Y$$$20240930$$CN$US$US
243794741$24379474$1$I$$20240919$20240930$20240930$EXP$$FR-ASTRAZENECA-202409EEA003754FR$ALEXION PHARMACEUTICALS$$73$YR$E$$Y$$$20240930$$MD$FR$FR
243794751$24379475$1$I$20240101$20240925$20240930$20240930$EXP$$US-SA-2024SA281003$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240930$$MD$US$US
243794761$24379476$1$I$$20240923$20240930$20240930$EXP$$US-TAKEDA-2024TUS095158$TAKEDA$Anani, A.R., Chaaban.. A case of bronchiectasis following chimeric antigen receptor T cell therapy. Chest. 2024;166 (4):A189$73$YR$$F$Y$$$20240930$$MD$US$US
243794771$24379477$1$I$20240101$20240926$20240930$20240930$EXP$$US-SA-2024SA280120$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240930$$MD$US$US
243794781$24379478$1$I$20240911$20240917$20240930$20240930$PER$$US-JNJFOC-20240953300$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
243794791$24379479$1$I$20200507$20240927$20240930$20240930$EXP$PL-URPL-1-3697-2020$PL-JNJFOC-20240973321$JOHNSON AND JOHNSON$$23$YR$A$F$Y$79$KG$20240930$$MD$PL$PL
243794801$24379480$1$I$20240918$20240918$20240930$20240930$PER$$US-JNJFOC-20240952408$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243794811$24379481$1$I$$20240925$20240930$20240930$EXP$$US-JNJFOC-20240972671$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243794821$24379482$1$I$$20240912$20240930$20240930$PER$$US-JNJFOC-20240933466$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243794831$24379483$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247089$TEVA$$$$$$Y$$$20240930$$PH$CA$CA
243794841$24379484$1$I$$20240917$20240930$20240930$EXP$$US-TRAVERE-2024TVT00926$TRAVERE THERAPEUTICS$$53$YR$A$$Y$$$20240930$$MD$US$US
243794851$24379485$1$I$$20240913$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09224$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243794861$24379486$1$I$20240101$20240510$20240930$20240930$PER$$US-THEA-2024000843$Thea Pharma$$$$$F$Y$$$20240930$$CN$US$US
243794871$24379487$1$I$$20240925$20240930$20240930$EXP$$DE-ABBVIE-5941263$ABBVIE$$$$E$M$Y$$$20240930$$HP$DE$DE
243794881$24379488$1$I$20240501$20240524$20240930$20240930$PER$$US-THEA-2024001123$Thea Pharma$$$$$F$Y$$$20240930$$CN$US$US
243794891$24379489$1$I$$20240517$20240930$20240930$PER$$US-THEA-2024000693$Thea Pharma$$$$$M$Y$$$20240930$$CN$US$US
243794901$24379490$1$I$$20240524$20240930$20240930$PER$$US-THEA-2024001124$Thea Pharma$$$$$F$Y$$$20240930$$PH$US$US
243794911$24379491$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67298$$FDA-CTU$$54$YR$$F$N$118.84$KG$20240930$N$$US$
243794921$24379492$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67343$$FDA-CTU$$44$YR$$F$N$68.04$KG$20240930$N$$US$
243794931$24379493$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67348$$FDA-CTU$$85$YR$$F$N$64.41$KG$20240930$N$$US$
243794941$24379494$1$I$20240927$20240929$20240929$20240929$DIR$720564$$FDA-CTU$$73$YR$$F$N$66.6$KG$20240929$Y$CN$US$
243794951$24379495$1$I$20240929$20240929$20240929$20240929$DIR$720574$$FDA-CTU$$$$$F$N$$$20240929$N$CN$US$
243794961$24379496$1$I$$20240927$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2023US002209$SANDOZ$$$$$F$Y$$$20240930$$MD$US$US
243794971$24379497$1$I$20240925$20240925$20240930$20240930$PER$$US-ASTELLAS-2024-AER-009117$ASTELLAS$$89$YR$E$M$Y$$$20240930$$CN$US$US
243794981$24379498$1$I$$20240929$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154176$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$47.17$KG$20240930$$CN$US$US
243794991$24379499$1$I$$20240920$20240930$20240930$PER$$US-JNJFOC-20240964988$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$HP$US$US
243795021$24379502$1$I$$20240927$20240930$20240930$EXP$$US-ABBVIE-5944721$ABBVIE$$25$YR$$F$Y$$$20240930$$MD$US$US
243795031$24379503$1$I$$20240922$20240930$20240930$EXP$$ES-JNJFOC-20240965864$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$ES$ES
243795041$24379504$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247087$TEVA$$$$$$Y$$$20240930$$PH$CA$CA
243795051$24379505$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024AMR117274$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243795061$24379506$1$I$$20240815$20240930$20240930$PER$$US-LUNDBECK-DKLU4003103$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
243795081$24379508$1$I$20240911$20240923$20240930$20240930$EXP$$CN-OTSUKA-2024_026498$OTSUKA$$80$YR$$M$Y$52.5$KG$20240930$$HP$CN$CN
243795111$24379511$1$I$$20240913$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09225$LUPIN$$$$$$Y$$$20240930$$PH$US$US
243795121$24379512$1$I$$20240923$20240930$20240930$EXP$$US-OTSUKA-2024_026508$OTSUKA$Liao C, Ramani S, Parkash V, Kodaman PH.. Endometriosis in a 22-Year-Old with Premature Ovarian Insufficiency Secondary to Pre-Pubertal Bone Marrow Transplant: a Case Report. Reproductive Sciences. 2024;31(9):2700-2705$7$YR$$F$Y$$$20240930$$HP$US$US
243795131$24379513$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011173$APOTEX$$64$YR$$M$Y$$$20240930$$CN$CA$CA
243795141$24379514$1$I$$20240923$20240930$20240930$EXP$$GB-MYLANLABS-2024M1088207$MYLAN$Mohidin B, Needleman A, Fernando R, Lowe DM, Wechalekar A, Sheaff M, et al. Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab. J-Clin-Med 2024; 13 (14).$59$YR$$M$Y$$$20240930$$HP$GB$GB
243795151$24379515$1$I$20240101$20240924$20240930$20240930$PER$$US-AMGEN-USASP2024190763$AMGEN$$71$YR$E$F$Y$$$20240930$$CN$US$US
243795161$24379516$1$I$$20240924$20240930$20240930$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001958$BLUEPRINT MEDICINES$$$$$F$Y$$$20240930$$CN$US$US
243795171$24379517$1$I$$20240913$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09239$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243795181$24379518$1$I$$20240924$20240930$20240930$EXP$$AU-INCYTE CORPORATION-2024IN010296$INCYTE$$$$$$Y$$$20240930$$MD$AU$AU
243795191$24379519$1$I$$20240920$20240930$20240930$EXP$$NVSC2024CN193014$NOVARTIS$Gao N, Tian M, Sun Y, Wang D, Sun G. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. WEST CHINA JOURNAL OF STOMATOLOGY. 2024;1-7$81$YR$$F$Y$$$20240930$$HP$CN$CN
243795201$24379520$1$I$$20240920$20240930$20240930$EXP$$NVSC2024CN193035$NOVARTIS$Gao N, Tian M, Sun Y, Wang D, Sun G. A preliminary study on the application of bone canal technique in the surgery of stage II drug-related osteonecrosis of the jaw. WEST CHINA JOURNAL OF STOMATOLOGY. 2024;1-7$36$YR$$M$Y$$$20240930$$HP$CN$CN
243795211$24379521$1$I$$20240923$20240930$20240930$EXP$$CA-JNJFOC-20240965666$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20240930$$CN$CA$CA
243795221$24379522$1$I$$20240923$20240930$20240930$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001942$BLUEPRINT MEDICINES$$$$$F$Y$$$20240930$$CN$US$US
243795231$24379523$1$I$$20240920$20240930$20240930$PER$$US-JNJFOC-20240965089$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$LW$US$US
243795251$24379525$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153886$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$106.59$KG$20240930$$MD$US$US
243795261$24379526$1$I$$20240918$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409012432$ELI LILLY AND CO$$51$YR$A$$Y$$$20240930$$LW$US$US
243795271$24379527$1$I$$20240924$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016838$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240930$$CN$US$US
243795281$24379528$1$I$20230101$20240924$20240930$20240930$EXP$$AU-INCYTE CORPORATION-2024IN010292$INCYTE$$$$$$Y$$$20240930$$MD$AU$AU
243795291$24379529$1$I$$20240923$20240930$20240930$EXP$$US-OTSUKA-2024_026511$OTSUKA$Mehta M, Foster R, Greer MK.. All that and a bag of b12: five pressor refractory vasoplegic shock treated with high-dose hydroxocobalamin. Chest. 2024;166(4):A2662-63$26$YR$$M$Y$$$20240930$$HP$US$US
243795321$24379532$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247086$TEVA$$$$$$Y$$$20240930$$PH$CA$CA
243795331$24379533$1$I$$20240913$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09240$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243795341$24379534$1$I$20240930$20240930$20240930$20240930$DIR$720596$$FDA-CTU$$82$YR$$UNK$N$$$20240930$N$$US$
243795371$24379537$1$I$20240920$20240920$20240930$20240930$PER$$US-ABBVIE-5935136$ABBVIE$$51$YR$$M$Y$$$20240930$$HP$US$US
243795381$24379538$1$I$20240919$20240928$20240930$20240930$EXP$$CN-BAYER-2024A138798$BAYER$$60$YR$A$M$Y$65$KG$20240930$$HP$CN$CN
243795401$24379540$1$I$20240429$20240927$20240930$20240930$EXP$DE-DCGMA-24203893$DE-ROCHE-10000093479$ROCHE$$78$YR$E$F$Y$$$20240930$$MD$DE$DE
243795411$24379541$1$I$$20240923$20240930$20240930$EXP$$SE-TEVA-VS-3248192$TEVA$Adra J, Giglio D, Karlsson P, Zetterberg H, Einbeigi Z. Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy. Acta-Oncol 2024; 63 636-641.$$$$F$Y$$$20240930$$HP$SE$SE
243795421$24379542$1$I$20240501$20240924$20240930$20240930$EXP$$RU-INCYTE CORPORATION-2024IN010272$INCYTE$$$$$$Y$$$20240930$$CN$RU$RU
243795441$24379544$1$I$$20240913$20240930$20240930$PER$$US-LUPIN PHARMACEUTICALS INC.-2024-09246$LUPIN$$$$$$Y$$$20240930$$CN$US$US
243795451$24379545$1$I$20240923$20240923$20240930$20240930$PER$$US-RDY-SPO/USA/24/0014164$DR REDDYS$$39$YR$A$M$Y$$$20240930$$HP$US$US
243795461$24379546$1$I$$20240923$20240930$20240930$EXP$$US-RDY-SPO/USA/24/0014130$DR REDDYS$$60$YR$A$F$Y$$$20240930$$MD$US$US
243795471$24379547$1$I$20230101$20240910$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013440$DR REDDYS$$60$YR$E$F$Y$$$20240930$$CN$US$US
243795481$24379548$1$I$$20240923$20240930$20240930$EXP$$US-RDY-SPO/USA/24/0014194$DR REDDYS$$37$YR$A$F$Y$$$20240930$$MD$US$US
243795491$24379549$1$I$20240627$20240913$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013791$DR REDDYS$$37$YR$A$F$Y$$$20240930$$CN$US$US
243795501$24379550$1$I$20240924$20240926$20240930$20240930$EXP$$CN-BAYER-2024A138867$BAYER$$61$YR$A$F$Y$$$20240930$$HP$CN$CN
243795511$24379551$1$I$20240901$20240925$20240930$20240930$EXP$$US-ABBVIE-5939546$ABBVIE$$82$YR$$M$Y$$$20240930$$CN$US$US
243795531$24379553$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5940592$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243795541$24379554$1$I$$20240926$20240930$20240930$EXP$$PL-ROCHE-3574777$ROCHE$$32$YR$A$F$Y$$$20240930$$CN$PL$PL
243795551$24379555$1$I$20240324$20240916$20240930$20240930$EXP$$US-COOPERSURGICAL, INC.-2024CPS002824$COOPERSURGICAL$$$$$F$Y$$$20240930$$LW$US$US
243795571$24379557$1$I$20230403$20240925$20240930$20240930$EXP$FR-AFSSAPS-PC2024000740$FR-BRISTOL-MYERS SQUIBB COMPANY-2024-152892$BRISTOL MYERS SQUIBB$$55$YR$A$M$Y$85$KG$20240930$$PH$FR$FR
243795581$24379558$1$I$20240901$20240923$20240930$20240930$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001944$BLUEPRINT MEDICINES$$39$YR$A$F$Y$$$20240930$$CN$US$US
243795591$24379559$1$I$$20240927$20240930$20240930$EXP$$US-PFIZER INC-202400265972$PFIZER$$$$$$Y$$$20240930$$MD$US$US
243795601$24379560$1$I$20231201$20240926$20240930$20240930$EXP$$CA-PFIZER INC-PV202300146834$PFIZER$$63$YR$$M$Y$$$20240930$$HP$CA$CA
243795621$24379562$1$I$$20240918$20240930$20240930$PER$$US-Calliditas-2024CAL01953$CALLIDITAS THERAPEUTICS$$72$YR$E$M$Y$$$20240930$$CN$US$US
243795631$24379563$1$I$$20240927$20240930$20240930$EXP$$US-PFIZER INC-PV202400126863$PFIZER$$81$YR$$F$Y$$$20240930$$HP$US$US
243795641$24379564$1$I$$20240925$20240930$20240930$EXP$$US-PFIZER INC-2022SGN01597$PFIZER$$$$A$F$Y$$$20240930$$MD$US$US
243795651$24379565$1$I$20231212$20240925$20240930$20240930$EXP$$US-PFIZER INC-2023SGN13180$PFIZER$$57$YR$$F$Y$$$20240930$$MD$US$US
243795661$24379566$1$I$$20240925$20240930$20240930$EXP$$US-PFIZER INC-2023SGN09079$PFIZER$$35$YR$$F$Y$$$20240930$$MD$US$US
243795671$24379567$1$I$$20240923$20240930$20240930$EXP$$US-GSK-US2024117709$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
243795691$24379569$1$I$$20240920$20240930$20240930$PER$$US-VIIV HEALTHCARE LIMITED-US2024117164$VIIV$$$$$$Y$$$20240930$$CN$US$US
243795701$24379570$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117129$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243795711$24379571$1$I$$20240925$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153924$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20240930$$CN$US$US
243795721$24379572$1$I$20240909$20240929$20240930$20240930$EXP$$CN-BAYER-2024A139018$BAYER$$48$YR$A$M$Y$86.4$KG$20240930$$HP$CN$CN
243795731$24379573$1$I$20230501$20240924$20240930$20240930$EXP$FR-AFSSAPS-AVCN2024000723$FR-MYLANLABS-2024M1086954$MYLAN$$42$YR$$M$Y$$$20240930$$MD$FR$FR
243795741$24379574$1$I$$20240920$20240930$20240930$PER$$US-JNJFOC-20240965583$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$HP$US$US
243795751$24379575$1$I$$20240925$20240930$20240930$PER$$US-ASTELLAS-2024-AER-009137$ASTELLAS$$80$YR$E$F$Y$$$20240930$$PH$US$US
243795761$24379576$1$I$20240701$20240924$20240930$20240930$EXP$FR-AFSSAPS-PV2024000888$FR-MYLANLABS-2024M1086985$MYLAN$$66$YR$$M$Y$68.5$KG$20240930$$MD$FR$FR
243795771$24379577$1$I$$20240922$20240930$20240930$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-28986$SAMSUNG BIOEPIS$$9$YR$C$F$Y$$$20240930$$CN$CA$CA
243795781$24379578$1$I$$20240920$20240930$20240930$PER$$JP-Eisai-EC-2024-175191$EISAI$Junichi Aratake et al.. Does the number of prior treatment regimens affect the therapeutic effect of lenvatinib plus pembrolizumab combination therapy for advanced recurrent endometrial cancer? - A single-center experience of 21 cases. Advances in Obstetrics and Gynecology. 2023; 76(3): 222-228.$$$$F$Y$$$20240930$$MD$JP$JP
243795791$24379579$1$I$$20240920$20240930$20240930$PER$$JP-Eisai-EC-2024-175185$EISAI$Junichi Aratake, et al.. Does the number of prior regimens affect treatment response in combination therapy with lenvatinib and pembrolizumab for advanced recurrent endometrial cancer?  - A single-center experience with 21 patients -. Advances in Obstetrics and Gynecology. 2024; 76(3): 222-228.$$$$F$Y$$$20240930$$MD$JP$JP
243795801$24379580$1$I$$20240924$20240930$20240930$EXP$$US-OTSUKA-2024_026554$OTSUKA$$$$$F$Y$$$20240930$$MD$US$US
243795811$24379581$1$I$20240101$20240916$20240930$20240930$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01517$INTRA-CELLULAR THERAPIES$$39$YR$$M$Y$$$20240930$$HP$US$US
243795821$24379582$1$I$$20240916$20240930$20240930$EXP$$US-INTRA-CELLULAR THERAPIES, INC.-2024ICT01512$INTRA-CELLULAR THERAPIES$$42$YR$$F$Y$$$20240930$$MD$US$US
243795831$24379583$1$I$20240927$20240929$20240930$20240930$EXP$$CN-BAYER-2024A139029$BAYER$$69$YR$E$F$Y$62$KG$20240930$$HP$CN$CN
243795851$24379585$1$I$20240901$20240923$20240930$20240930$PER$$US-ASTELLAS-2024-AER-008593$ASTELLAS$$84$YR$E$F$Y$46$KG$20240930$$CN$US$US
243795861$24379586$1$I$20240901$20240924$20240930$20240930$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001945$BLUEPRINT MEDICINES$$62$YR$A$F$Y$$$20240930$$CN$US$US
243795871$24379587$1$I$20240927$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017990$ELI LILLY AND CO$$34$YR$A$F$Y$$$20240930$$CN$US$US
243795881$24379588$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017518$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240930$$CN$US$US
243795891$24379589$1$I$20240830$20240924$20240930$20240930$EXP$$US-KYOWAKIRIN-2024KK022005$KYOWA$$$$$$Y$$$20240930$$HP$US$US
243795901$24379590$1$I$$20240924$20240930$20240930$EXP$$NVSC2024MX192546$NOVARTIS$Salas MA, Benitez MJS, Tostado DMI, Torres JMZ, Martinez VMT, Marquez APS. Fatal invasive trichosporonosis in a  patient with systemic lupus  erythematosus: case report. INF DIS + MICROBIOL. 2023;44(2):75-7$52$YR$$F$Y$$$20240930$$HP$MX$MX
243795911$24379591$1$I$$20240918$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-149344$BRISTOL MYERS SQUIBB$$83$YR$E$F$Y$76.2$KG$20240930$$CN$US$US
243795922$24379592$2$F$$20240927$20240930$20240930$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-152874$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20241001$$MD$DE$DE
243795931$24379593$1$I$$20240927$20240930$20240930$PER$$US-BIOVITRUM-2024-US-012564$BIOVITRUM$$67$YR$$F$Y$$$20240930$$CN$US$US
243795941$24379594$1$I$20240101$20240924$20240930$20240930$EXP$$US-AMGEN-USASP2024190842$AMGEN$$61$YR$A$F$Y$$$20240930$$CN$US$US
243795951$24379595$1$I$$20240923$20240930$20240930$EXP$GB-MHRA-TPP17540250C8429938YC1726041168290$GB-RDY-SPO/GBR/24/0014114$DR REDDYS$$62$YR$A$F$Y$61$KG$20240930$$MD$GB$GB
243795981$24379598$1$I$$20240930$20240930$20240930$DIR$720639$$FDA-CTU$$$$$UNK$N$$$20240930$$CN$US$
243795991$24379599$1$I$$20240930$20240930$20240930$DIR$720587$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243796011$24379601$1$I$$20240920$20240930$20240930$PER$$US-ASTELLAS-2024-AER-008336$ASTELLAS$$51$YR$A$F$Y$$$20240930$$MD$US$US
243796051$24379605$1$I$$20240930$20240930$20240930$DIR$720641$$FDA-CTU$$$$$UNK$N$$$20240930$N$$US$
243796081$24379608$1$I$$20240923$20240930$20240930$EXP$$CN-GSK-CN2024APC117334$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$CN$CN
243796091$24379609$1$I$20240612$20240926$20240930$20240930$EXP$$PK-ROCHE-10000007243$ROCHE$$67$YR$E$F$Y$$$20240930$$CN$PK$PK
243796101$24379610$1$I$20230810$20240930$20240930$20240930$DIR$720651$$FDA-CTU$$60$YR$$F$N$81$KG$20240930$N$MD$US$
243796111$24379611$1$I$20240912$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192798$AMGEN$$66$YR$E$F$Y$$$20240930$$CN$US$US
243796121$24379612$1$I$$20240923$20240930$20240930$EXP$$DE-GSK-DE2024117666$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$DE$DE
243796131$24379613$1$I$20240901$20240920$20240930$20240930$EXP$$US-BAYER-2024A135833$BAYER$$65$YR$E$F$Y$$$20240930$$CN$US$US
243796141$24379614$1$I$$20240924$20240930$20240930$EXP$$IN-VANTIVE-2024VAN020069$Vantive US Healthcare$$58$YR$$M$Y$$$20240930$$CN$IN$IN
243796152$24379615$2$F$20240909$20240923$20240930$20240930$EXP$$CN-COHERUS BIOSCIENCES, INC-2024-COH-CN000981$PAREXEL$$$$$$Y$$$20240930$$HP$CN$CN
243796161$24379616$1$I$20240901$20240923$20240930$20240930$PER$$US-BAYER-2024A135754$BAYER$$$$$M$Y$$$20240930$$CN$US$US
243796171$24379617$1$I$$20240925$20240930$20240930$EXP$$US-JNJFOC-20240972172$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243796181$24379618$1$I$20220101$20240919$20240930$20240930$EXP$$ES-ASTELLAS-2024-AER-008902$ASTELLAS$Sempere A, Bodro M. Successful BK virus-specific T cell therapy in a kidney transplant recipient with progressive multifocal leukoencephalopathy. American Journal of Transplantation. 2024;24(9): 1698-702.$64$YR$A$M$Y$$$20240930$$HP$ES$ES
243796191$24379619$1$I$$20240924$20240930$20240930$EXP$$US-INCYTE CORPORATION-2024IN010145$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243796201$24379620$1$I$$20240916$20240930$20240930$EXP$$US-SA-2024SA281076$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240930$$CN$US$US
243796211$24379621$1$I$20240901$20240924$20240930$20240930$EXP$$US-ABBVIE-5938908$ABBVIE$$78$YR$$F$Y$$$20240930$$CN$US$US
243796221$24379622$1$I$20240916$20240923$20240930$20240930$EXP$$CN-ABBVIE-5942261$ABBVIE$$50$YR$$F$Y$42.8$KG$20240930$$HP$CN$CN
243796231$24379623$1$I$$20240920$20240930$20240930$EXP$$JP-SA-2024SA267244$SANOFI AVENTIS$$90$YR$E$M$Y$66$KG$20240930$$MD$JP$JP
243796241$24379624$1$I$20240409$20240923$20240930$20240930$EXP$$CZ-GSK-CZ2024EME118146$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$MD$CZ$CZ
243796251$24379625$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011180$APOTEX$$74$YR$$M$Y$$$20240930$$CN$CA$CA
243796261$24379626$1$I$$20240903$20240930$20240930$PER$$US-TEVA-VS-3219064$TEVA$$77$YR$$F$Y$$$20240930$$CN$US$US
243796271$24379627$1$I$$20240923$20240930$20240930$EXP$$US-AMGEN-USASP2024191200$AMGEN$Miller A.; Muthyala K.; Sidahmed S.. Acute pericarditis caused by differentiation syndrome in treatment of APML relapse. Chest. 2024;166(4):585A$23$YR$A$M$Y$$$20240930$$HP$US$US
243796281$24379628$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151330$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20240930$$PH$US$US
243796301$24379630$1$I$20240926$20240921$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN010022$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243796311$24379631$1$I$$20240926$20240930$20240930$EXP$$AR-SA-2024SA280792$SANOFI AVENTIS$$$$$M$Y$$$20240930$$MD$AR$AR
243796321$24379632$1$I$20240801$20240926$20240930$20240930$EXP$FR-AFSSAPS-TO2024001636$FR-SA-2024SA281678$SANOFI AVENTIS$$62$YR$A$F$Y$156$KG$20240930$$MD$FR$FR
243796331$24379633$1$I$$20240925$20240930$20240930$EXP$$CA-SAMSUNG BIOEPIS-SB-2024-29149$SAMSUNG BIOEPIS$$$$$F$Y$60$KG$20240930$$CN$CA$CA
243796351$24379635$1$I$$20240920$20240930$20240930$PER$$US-RDY-SPO/USA/24/0013944$DR REDDYS$$31$YR$A$M$Y$$$20240930$$PH$US$US
243796371$24379637$1$I$$20240923$20240930$20240930$EXP$$US-AMGEN-USASP2024191788$AMGEN$Deshpande Y.; Sabir S.; Kaur L. et al.. CHOKED BY GROWTH: A DRAMATIC PRESENTATION OF SUPERIOR VENA CAVA SYNDROME AND RESPIRATORY FAILURE CAUSED BY AN ANTERIOR MEDIASTINAL MASS. Chest. 2024;166 (4):A6087-A6088$25$YR$A$M$Y$$$20240930$$HP$US$US
243796391$24379639$1$I$$20240930$20240930$20240930$DIR$720610$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243796401$24379640$1$I$$20240920$20240930$20240930$EXP$$BR-TEVA-VS-3247456$TEVA$$$$$$Y$$$20240930$$PH$BR$BR
243796411$24379641$1$I$20240301$20240925$20240930$20240930$EXP$$CO-ABBVIE-5882500$ABBVIE$$69$YR$$F$Y$66$KG$20240930$$CN$CO$CO
243796421$24379642$1$I$20240925$20240925$20240930$20240930$EXP$$US-OTSUKA-2024_026714$OTSUKA$$$$$$Y$$$20240930$$HP$US$US
243796431$24379643$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67397$$FDA-CTU$$32$YR$$F$N$$$20240930$N$$US$
243796441$24379644$1$I$20240929$20240930$20240930$20240930$DIR$720585$$FDA-CTU$$$$$F$N$$$20240930$$CN$US$
243796451$24379645$1$I$$20240923$20240930$20240930$PER$$US-BAYER-2024A136714$BAYER$$$$$$Y$$$20240930$$CN$US$US
243796461$24379646$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016155$ELI LILLY AND CO$$$$$M$Y$$$20240930$$CN$US$US
243796471$24379647$1$I$20240926$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016894$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240930$$CN$US$US
243796481$24379648$1$I$20240912$20240930$20240930$20240930$DIR$720623$$FDA-CTU$$62$YR$$M$N$103.5$KG$20240930$N$CN$US$
243796491$24379649$1$I$20240908$20240920$20240930$20240930$EXP$CN-NMPACDR-6501011027109202400769$CN-BAXTER-2024BAX025215$BAXTER$$13$YR$$M$Y$54$KG$20240930$$MD$CN$CN
243796501$24379650$1$I$$20240930$20240930$20240930$DIR$720619$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243796511$24379651$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67371$$FDA-CTU$$32$YR$$F$N$$$20240930$N$$US$
243796521$24379652$1$I$$20240924$20240930$20240930$EXP$$US-PURDUE-USA-2024-0312225$PURDUE$Le A, Bruce S, Tran D, Bellamkonda DP.. Aortic dissection in the setting of methamphetamine use: A case report. Chest. 2024;166(4):A229-A230$44$YR$$M$Y$$$20240930$$HP$US$US
243796531$24379653$1$I$$20240924$20240930$20240930$EXP$$US-PURDUE-USA-2024-0312198$PURDUE$Steinwehr D, Raymond M, Lababidi H, Thompson G.. Parainfluenza Virus-induced Acute Respiratory Distress Syndrome With Background Of Vaping In Immunocompetent Host. Chest. 2024;166(4):A2513-A2$21$YR$$M$Y$$$20240930$$HP$US$US
243796541$24379654$1$I$20230207$20240924$20240930$20240930$EXP$$GB-PURDUE-USA-2024-0312236$PURDUE$$64$YR$$M$Y$$$20240930$$CN$GB$GB
243796551$24379655$1$I$$20240924$20240930$20240930$EXP$$US-PURDUE-USA-2024-0312190$PURDUE$Talanian M, Almeqdadi M, Chen HH.. From dark bile to bright insight: A liver biopsy with advanced fibrosis and severe cholestasis. Journal of Hepatology. 2024;81(4):e147-e150$41$YR$$F$Y$$$20240930$$HP$US$US
243796571$24379657$1$I$$20240918$20240930$20240930$EXP$$CA-APOTEX-2024AP011190$APOTEX$$49$YR$$M$Y$$$20240930$$CN$CA$CA
243796581$24379658$1$I$$20240925$20240930$20240930$EXP$$US-Ipsen Biopharmaceuticals, Inc.-2024-19567$IPSEN$$89$YR$E$F$Y$82.55$KG$20240930$$CN$US$US
243796591$24379659$1$I$$20240925$20240930$20240930$EXP$$US-OTSUKA-2024_026760$OTSUKA$$$$$F$Y$$$20240930$$HP$US$US
243796601$24379660$1$I$$20240923$20240930$20240930$PER$$US-GSK-US2024117745$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243796621$24379662$1$I$20240923$20240924$20240930$20240930$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-2024-153624$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240930$$CN$CO$CO
243796631$24379663$1$I$20240805$20240924$20240930$20240930$EXP$FR-AFSSAPS-PO2024001005$FR-MYLANLABS-2024M1086912$MYLAN$$24$YR$$M$Y$$$20240930$$PH$FR$FR
243796641$24379664$1$I$20240923$20240925$20240930$20240930$PER$$US-ROCHE-10000092908$ROCHE$$14$YR$T$M$Y$$$20240930$$CN$US$US
243796661$24379666$1$I$20240814$20240925$20240930$20240930$EXP$$JP-Taiho Oncology Inc-2024-008237$TAIHO ONCOLOGY INC$$64$YR$A$M$Y$$$20240930$$MD$JP$JP
243796671$24379667$1$I$$20240923$20240930$20240930$EXP$$CA-TAKEDA-2024TUS094943$TAKEDA$$$$$M$Y$$$20240930$$MD$CA$CA
243796681$24379668$1$I$20240524$20240925$20240930$20240930$EXP$ES-AEMPS-1571909$ES-JNJFOC-20240973650$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20240930$$MD$ES$ES
243796691$24379669$1$I$$20240919$20240930$20240930$EXP$$CA-PURDUE-USA-2024-0312185$PURDUE$$36$YR$$F$Y$$$20240930$$HP$CA$CA
243796701$24379670$1$I$20240923$20240924$20240930$20240930$PER$$US-RDY-SPO/USA/24/0014168$DR REDDYS$$55$YR$A$M$Y$$$20240930$$MD$US$US
243796711$24379671$1$I$20240921$20240924$20240930$20240930$EXP$$US-RDY-SPO/USA/24/0014207$DR REDDYS$$78$YR$E$$Y$$$20240930$$PH$US$US
243796721$24379672$1$I$20240923$20240924$20240930$20240930$PER$$US-RDY-SPO/USA/24/0014166$DR REDDYS$$45$YR$A$F$Y$$$20240930$$MD$US$US
243796731$24379673$1$I$20220701$20240924$20240930$20240930$EXP$$US-OTSUKA-2023_006813$OTSUKA$$35$YR$$F$Y$90.6$KG$20240930$$MD$US$US
243796741$24379674$1$I$20240923$20240924$20240930$20240930$PER$$US-RDY-SPO/USA/24/0014142$DR REDDYS$$70$YR$E$F$Y$$$20240930$$HP$US$US
243796751$24379675$1$I$20240923$20240924$20240930$20240930$PER$$US-RDY-SPO/USA/24/0014165$DR REDDYS$$37$YR$A$F$Y$$$20240930$$MD$US$US
243796771$24379677$1$I$$20240921$20240930$20240930$PER$$US-RDY-SPO/USA/24/0014027$DR REDDYS$$72$YR$E$M$Y$$$20240930$$MD$US$US
243796781$24379678$1$I$$20240926$20240930$20240930$EXP$$IT-BIOVITRUM-2023-IT-020676$BIOVITRUM$Caorsi R, Rosina, et.al. Relapsing macrophage activation syndrome rescued by treatment with MAS825, an anti-il1 and Il-18 monoclonal antibody, in two patients with systemic onset juvenile idiopathic arthritis. Pediatric Rheumatology. 21: doi:10.1186/s12969-023-00879-8.$20$YR$$M$Y$$$20240930$$HP$IT$IT
243796811$24379681$1$I$20240807$20240923$20240930$20240930$EXP$$US-GSK-US2024117588$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
243796821$24379682$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093300$ROCHE$$$$A$M$Y$$$20240930$$CN$US$US
243796831$24379683$1$I$20230411$20240924$20240930$20240930$EXP$$CA-TAKEDA-2024TUS095229$TAKEDA$$50$YR$$M$Y$$$20240930$$CN$CA$CA
243796841$24379684$1$I$20240828$20240923$20240930$20240930$EXP$SE-SEMPA-2024-006692$SE-EMD Serono-2024050814$EMD SERONO INC$$79$YR$E$F$Y$$$20240930$$MD$SE$SE
243796861$24379686$1$I$$20240923$20240930$20240930$EXP$$US-RDY-LIT/USA/24/0014300$DR REDDYS$Peters KS, Schuman SG, Sengupta S, Maheswaranathan M, Gospe III SM. Papilledema and Combined Central Retinal Artery and Central Retinal Vein Occlusion as a Manifestation of Behcet Disease. Journal of Neuro-Ophthalmology. 2024 Sep;44(3): e371-e373. doi:10.1097/WNO.0000000000001941.$51$YR$A$M$Y$$$20240930$$MD$US$US
243796871$24379687$1$I$20240221$20240923$20240930$20240930$EXP$$DE-TEVA-VS-3246851$TEVA$$$$E$F$Y$81$KG$20240930$$HP$DE$DE
243796881$24379688$1$I$$20240328$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089849$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243796891$24379689$1$I$$20240622$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091087$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243796901$24379690$1$I$$20240525$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090574$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243796911$24379691$1$I$$20240320$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089685$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243796921$24379692$1$I$$20240427$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089781$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243796931$24379693$1$I$$20240308$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089372$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243796941$24379694$1$I$$20240614$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091743$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243796951$24379695$1$I$$20240117$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088443$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243796961$24379696$1$I$$20240307$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089338$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243796971$24379697$1$I$$20240122$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088634$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243796981$24379698$1$I$$20240130$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088789$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243796991$24379699$1$I$$20240426$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089193$GLENMARK$$$$$$Y$$$20240930$$PH$US$US
243797001$24379700$1$I$20240124$20240201$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089184$GLENMARK$$$$$$Y$$$20240930$$HP$US$US
243797011$24379701$1$I$$20240301$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088790$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797021$24379702$1$I$$20240122$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2023GMK087967$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797031$24379703$1$I$$20240807$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK093256$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797041$24379704$1$I$$20240426$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK088858$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797051$24379705$1$I$$20240909$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK093962$GLENMARK$$$$$$Y$$$20240930$$PH$US$US
243797061$24379706$1$I$$20240729$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092962$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797071$24379707$1$I$20231001$20240715$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092461$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797081$24379708$1$I$$20240827$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK093734$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797091$24379709$1$I$$20240726$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092107$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797101$24379710$1$I$$20240618$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091107$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797111$24379711$1$I$$20240528$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091241$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797121$24379712$1$I$$20240716$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091903$GLENMARK$$$$$$Y$$$20240930$$PH$US$US
243797131$24379713$1$I$$20240530$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091320$GLENMARK$$$$$$Y$$$20240930$$HP$US$US
243797141$24379714$1$I$$20240829$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK093223$GLENMARK$$$$$$Y$$$20240930$$PH$US$US
243797151$24379715$1$I$$20240701$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092110$GLENMARK$$$$$$Y$$$20240930$$PH$US$US
243797161$24379716$1$I$20240705$20240709$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK092287$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797171$24379717$1$I$20240220$20240621$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089192$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797181$24379718$1$I$$20240520$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091015$GLENMARK$$$$$$Y$$$20240930$$HP$US$US
243797191$24379719$1$I$$20240321$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089640$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797201$24379720$1$I$$20240516$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK090357$GLENMARK$$$$$$Y$$$20240930$$HP$US$US
243797211$24379721$1$I$$20240318$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089570$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797221$24379722$1$I$$20240528$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK091247$GLENMARK$$$$$$Y$$$20240930$$CN$US$US
243797231$24379723$1$I$$20240402$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089917$GLENMARK$$$$$$Y$$$20240930$$HP$US$US
243797241$24379724$1$I$20240324$20240326$20240930$20240930$PER$$US-GLENMARK PHARMACEUTICALS-2024GMK089808$GLENMARK$$$$$$Y$$$20240930$$HP$US$US
243797251$24379725$1$I$20230511$20240924$20240930$20240930$EXP$FR-AFSSAPS-MA2024001504$FR-MYLANLABS-2024M1086766$MYLAN$$27$YR$$F$Y$55$KG$20240930$$CN$FR$FR
243797261$24379726$1$I$$20240923$20240930$20240930$EXP$$US-GSK-US2024AMR117810$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
243797271$24379727$1$I$20240101$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193289$AMGEN$$24$YR$A$M$Y$$$20240930$$PH$US$US
243797281$24379728$1$I$20240901$20240924$20240930$20240930$PER$$US-AMGEN-USASP2024191613$AMGEN$$$$A$M$Y$$$20240930$$HP$US$US
243797301$24379730$1$I$$20240919$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA002933US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
243797311$24379731$1$I$$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151501$BRISTOL MYERS SQUIBB$Huynh T, Salim K, Allonce J, Ruthman C. Potentiation of PD-L1- and PD-1-induced pneumonitis. Chest. 2024;166(4S):3243A-4A. doi:10.1016/j.chest.2024.06.1943.$65$YR$E$M$Y$$$20240930$$HP$US$US
243797321$24379732$1$I$$20240923$20240930$20240930$EXP$$IT-TEVA-VS-3247732$TEVA$Mannelli F, Crupi F, Zanotti R, Pagano L, Rapezzi D, Tanasi I, et al. The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis. Ther-Adv-Hematol 2023; 14.; Mannelli F, Crupi F, Zanotti R, Pagano L, Rapezzi D, Tanasi I, et al. The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis. Ther-Adv-Hema...$66$YR$$M$Y$$$20240930$$HP$IT$IT
243797331$24379733$1$I$$20240927$20240930$20240930$PER$$US-ROCHE-10000094836$ROCHE$$$$A$M$Y$$$20240930$$CN$US$US
243797341$24379734$1$I$$20240923$20240930$20240930$EXP$$US-BIOGEN-2024BI01284534$BIOGEN$$$$$M$Y$$$20240930$$CN$US$US
243797361$24379736$1$I$$20240928$20240930$20240930$PER$$US-ROCHE-10000094698$ROCHE$$86$YR$E$F$Y$$$20240930$$CN$US$US
243797371$24379737$1$I$$20240923$20240930$20240930$EXP$$CA-GSK-CA2024118152$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$HP$CA$CA
243797381$24379738$1$I$$20240221$20240930$20240930$EXP$$IT-BAYER-2024A138458$BAYER$Cecchi R.; Pavesi M.; Bartoli L.; Brunetti L.. Successful treatment of localized pyoderma gangrenosum with topical pimecrolimus. Journal of Cutaneous Medicine and Surgery. 2012;16:5:295-297$56$YR$A$F$Y$$$20240930$$HP$IT$IT
243797391$24379739$1$I$20240604$20240920$20240930$20240930$EXP$$US-UCBSA-2024033506$UCB$$33$YR$$F$Y$$$20240930$$CN$US$US
243797401$24379740$1$I$20240801$20240923$20240930$20240930$PER$$US-ORGANON-O2409USA001994$ORGANON$$21$YR$$F$Y$90.703$KG$20240930$$CN$US$US
243797411$24379741$1$I$20230823$20240928$20240930$20240930$EXP$$CN-BAYER-2024A138853$BAYER$$56$YR$A$M$Y$58$KG$20240930$$HP$CN$CN
243797421$24379742$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153657$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240930$$CN$US$US
243797441$24379744$1$I$$20240924$20240930$20240930$PER$$US-BIOGEN-2024BI01284033$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243797451$24379745$1$I$$20240925$20240930$20240930$PER$$US-BIOGEN-2024BI01284238$BIOGEN$$$$$M$Y$$$20240930$$CN$US$US
243797461$24379746$1$I$$20240925$20240930$20240930$PER$$US-BIOVITRUM-2024-US-012505$BIOVITRUM$$85$YR$$M$Y$$$20240930$$CN$US$US
243797471$24379747$1$I$$20240828$20240930$20240930$EXP$$US-ASTELLAS-2024-AER-004514$ASTELLAS$Thibodeau, A.. Bilateral anterior subcapsular cataract developmentfollowing initiation of enfortumab vedotin. International Medical CaseReports Journal. 2021;14:707-709$62$YR$A$M$Y$$$20240930$$HP$US$US
243797481$24379748$1$I$$20240910$20240930$20240930$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054120$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$$$20240930$$CN$CA$CA
243797501$24379750$1$I$$20240923$20240930$20240930$EXP$$US-GSK-US2024117703$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$US$US
243797521$24379752$1$I$20240801$20240924$20240930$20240930$EXP$$US-Blueprint Medicines Corporation-SP-US-2024-001950$BLUEPRINT MEDICINES$$27$YR$A$M$Y$$$20240930$$CN$US$US
243797531$24379753$1$I$20240831$20240920$20240930$20240930$EXP$$CN-PARATEK PHARMACEUTICALS, INC.-2024PTK00866$PARATEK PHARMACEUTICALS$$78$YR$$M$Y$50$KG$20240930$$HP$CN$CN
243797541$24379754$1$I$20240901$20240923$20240930$20240930$EXP$$US-ABBVIE-5936293$ABBVIE$$54$YR$$F$Y$$$20240930$$CN$US$US
243797571$24379757$1$I$$20240924$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153336$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240930$$CN$US$US
243797581$24379758$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154223$BRISTOL MYERS SQUIBB$$89$YR$E$F$Y$$$20240930$$PH$US$US
243797591$24379759$1$I$20240930$20240930$20240930$20240930$DIR$720608$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243797601$24379760$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153381$BRISTOL MYERS SQUIBB$$32$YR$A$F$Y$$$20240930$$CN$US$US
243797611$24379761$1$I$20240101$20240923$20240930$20240930$EXP$$AT-TEVA-VS-3246736$TEVA$$34$YR$$$Y$$$20240930$$MD$AT$AT
243797621$24379762$1$I$20240930$20240930$20240930$20240930$DIR$720633$$FDA-CTU$$51$YR$$M$N$$$20240930$N$$US$
243797631$24379763$1$I$20240705$20240930$20240930$20240930$DIR$720609$$FDA-CTU$$34$YR$$F$N$102.6$KG$20240930$N$HP$US$
243797641$24379764$1$I$$20240918$20240930$20240930$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-150365$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240930$$MD$DE$DE
243797651$24379765$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017270$ELI LILLY AND CO$$47$YR$A$M$Y$$$20240930$$CN$US$US
243797661$24379766$1$I$20240926$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016896$ELI LILLY AND CO$$62$YR$A$$Y$$$20240930$$CN$US$US
243797671$24379767$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017354$ELI LILLY AND CO$$64$YR$A$M$Y$$$20240930$$CN$US$US
243797691$24379769$1$I$$20240915$20240930$20240930$EXP$$US-BAYER-2024A131982$BAYER$$$$$$Y$$$20240930$$CN$US$US
243797701$24379770$1$I$$20240923$20240930$20240930$EXP$$US-INDIVIOR US-INDV-156605-2024$RECKITT BENCKISER$Cassondra Cramer-Bour, Krista Wahby, Zahia Esber, Bram Dolcourt, Ayman O Soubani, and Andrew King. Difficult to wean: Our buprenorphine protocol for iatrogenic opiate withdrawal. Chest. 2024;166 (4):2888A-2889A$$$$$Y$$$20240930$$MD$US$US
243797711$24379771$1$I$20240924$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016852$ELI LILLY AND CO$$56$YR$A$F$Y$$$20240930$$CN$US$US
243797721$24379772$1$I$$20240923$20240930$20240930$EXP$$US-BAYER-2024A137886$BAYER$Wang H.; Dummer K.; Tremoulet A.H.; Newburger J.; Burns J.C.; VanderPluym C.. A Thrombolytic Protocol of Bivalirudin for Giant Coronary Artery Aneurysms and Thrombosis in Kawasaki Disease. Journal of Pediatrics. 2024;275:Article Number: 114233$6$MON$I$M$Y$$$20240930$$MD$US$US
243797741$24379774$1$I$20240905$20240923$20240930$20240930$EXP$FR-AFSSAPS-MA2024001483$FR-TEVA-VS-3246981$TEVA$$8$YR$$F$Y$20$KG$20240930$$MD$FR$FR
243797751$24379775$1$I$$20240923$20240930$20240930$EXP$$AU-BIOCON BIOLOGICS LIMITED-BBL2024007115$BIOCON$Kawatu HA,  Hallam L, Blackburn M.. Insulin amyloidosis: an under-recognised entity.. Internal Medicine Journal. 2024;54(9):1581-1582$$$$$Y$$$20240930$$HP$AU$AU
243797761$24379776$1$I$$20240927$20240930$20240930$EXP$$US-BIOVITRUM-2024-US-012570$BIOVITRUM$$$$I$M$Y$$$20240930$$CN$US$US
243797781$24379778$1$I$20240925$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266421$PFIZER$$61$YR$$F$Y$$$20240930$$CN$US$US
243797791$24379779$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-PV202400126865$PFIZER$$70$YR$$M$Y$$$20240930$$HP$US$US
243797801$24379780$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265486$PFIZER$$73$YR$$M$Y$$$20240930$$CN$US$US
243797811$24379781$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265804$PFIZER$$72$YR$$F$Y$$$20240930$$CN$US$US
243797821$24379782$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-202400266005$PFIZER$$$$$$Y$$$20240930$$MD$US$US
243797831$24379783$1$I$20240928$20240929$20240930$20240930$PER$$US-PFIZER INC-202400266494$PFIZER$$78$YR$$F$Y$$$20240930$$CN$US$US
243797841$24379784$1$I$$20240924$20240930$20240930$PER$$US-PFIZER INC-202400264051$PFIZER$$43$YR$$F$Y$$$20240930$$MD$US$US
243797851$24379785$1$I$20240929$20240929$20240930$20240930$PER$$US-PFIZER INC-202400266475$PFIZER$$75$YR$$F$Y$$$20240930$$CN$US$US
243797861$24379786$1$I$20240901$20240927$20240930$20240930$PER$$US-PFIZER INC-202400266038$PFIZER$$83$YR$$M$Y$$$20240930$$CN$US$US
243797871$24379787$1$I$$20240924$20240930$20240930$PER$$US-PFIZER INC-PV202400125293$PFIZER$$19$YR$$F$Y$$$20240930$$CN$US$US
243797881$24379788$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265871$PFIZER$$62$YR$$F$Y$$$20240930$$HP$US$US
243797901$24379790$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-PV202400126466$PFIZER$$54$YR$$F$Y$$$20240930$$HP$US$US
243797911$24379791$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-202400266022$PFIZER$$43$YR$$M$Y$$$20240930$$CN$US$US
243797931$24379793$1$I$20240924$20240927$20240930$20240930$PER$$US-PFIZER INC-202400265955$PFIZER$$70$YR$$M$Y$$$20240930$$CN$US$US
243797941$24379794$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-202400249686$PFIZER$$83$YR$$F$Y$$$20240930$$CN$US$US
243797951$24379795$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-PV202400127037$PFIZER$$39$YR$$F$Y$$$20240930$$HP$US$US
243797961$24379796$1$I$20240101$20240924$20240930$20240930$PER$$US-PFIZER INC-202400263029$PFIZER$$$$$F$Y$$$20240930$$HP$US$US
243797971$24379797$1$I$20240924$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266393$PFIZER$$75$YR$$F$Y$$$20240930$$CN$US$US
243797981$24379798$1$I$20240925$20240927$20240930$20240930$PER$$US-PFIZER INC-202400266043$PFIZER$$58$YR$$M$Y$$$20240930$$CN$US$US
243797991$24379799$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-PV202400126405$PFIZER$$56$YR$$F$Y$$$20240930$$HP$US$US
243798001$24379800$1$I$20240926$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265856$PFIZER$$$$$F$Y$$$20240930$$CN$US$US
243798011$24379801$1$I$20240924$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266293$PFIZER$$75$YR$$M$Y$$$20240930$$CN$US$US
243798021$24379802$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265050$PFIZER$$90$YR$$F$Y$50$KG$20240930$$PH$US$US
243798031$24379803$1$I$20240927$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266446$PFIZER$$51$YR$$M$Y$$$20240930$$CN$US$US
243798051$24379805$1$I$20240901$20240927$20240930$20240930$PER$$US-PFIZER INC-202400265947$PFIZER$$60$YR$$F$Y$$$20240930$$PH$US$US
243798061$24379806$1$I$20240301$20240927$20240930$20240930$PER$$US-PFIZER INC-202400266037$PFIZER$$$$E$F$Y$$$20240930$$CN$US$US
243798071$24379807$1$I$20240927$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266087$PFIZER$$38$YR$$F$Y$$$20240930$$HP$US$US
243798081$24379808$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-202400266121$PFIZER$$$$T$M$Y$$$20240930$$MD$US$US
243798091$24379809$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265059$PFIZER$$$$$M$Y$$$20240930$$HP$US$US
243798101$24379810$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-PV202400126295$PFIZER$$74$YR$$M$Y$$$20240930$$CN$US$US
243798111$24379811$1$I$$20240925$20240930$20240930$PER$$US-PFIZER INC-202400265717$PFIZER$$$$$$Y$$$20240930$$CN$US$US
243798121$24379812$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-202400266047$PFIZER$$$$$$Y$$$20240930$$MD$US$US
243798131$24379813$1$I$20240927$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266412$PFIZER$$55$YR$$F$Y$$$20240930$$CN$US$US
243798141$24379814$1$I$$20240925$20240930$20240930$PER$$US-PFIZER INC-202200299802$PFIZER$$70$YR$$F$Y$$$20240930$$CN$US$US
243798151$24379815$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-PV202400126813$PFIZER$$77$YR$$M$Y$$$20240930$$PH$US$US
243798161$24379816$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-PV202400126806$PFIZER$$57$YR$$F$Y$$$20240930$$CN$US$US
243798171$24379817$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-PV202400126837$PFIZER$$70$YR$$F$Y$$$20240930$$HP$US$US
243798181$24379818$1$I$20240920$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266089$PFIZER$$71$YR$$M$Y$$$20240930$$CN$US$US
243798191$24379819$1$I$$20240924$20240930$20240930$PER$$US-PFIZER INC-202400243558$PFIZER$$74$YR$$F$Y$$$20240930$$CN$US$US
243798201$24379820$1$I$20220101$20240924$20240930$20240930$PER$$US-PFIZER INC-202400263388$PFIZER$$60$YR$$M$Y$70.31$KG$20240930$$CN$US$US
243798211$24379821$1$I$20240928$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266085$PFIZER$$89$YR$$M$Y$77.11$KG$20240930$$CN$US$US
243798221$24379822$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265440$PFIZER$$75$YR$$F$Y$$$20240930$$PH$US$US
243798231$24379823$1$I$$20240924$20240930$20240930$PER$$US-PFIZER INC-202400263188$PFIZER$$70$YR$$M$Y$102.06$KG$20240930$$CN$US$US
243798241$24379824$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265210$PFIZER$$66$YR$$F$Y$$$20240930$$MD$US$US
243798251$24379825$1$I$20240923$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265836$PFIZER$$$$$M$Y$$$20240930$$HP$US$US
243798261$24379826$1$I$20240927$20240927$20240930$20240930$PER$$US-PFIZER INC-202400266001$PFIZER$$45$YR$$F$Y$$$20240930$$CN$US$US
243798271$24379827$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-202400265775$PFIZER$$71$YR$$M$Y$$$20240930$$CN$US$US
243798291$24379829$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265524$PFIZER$$85$YR$$F$Y$$$20240930$$HP$US$US
243798301$24379830$1$I$20240928$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266419$PFIZER$$57$YR$$M$Y$$$20240930$$CN$US$US
243798311$24379831$1$I$20240601$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67311$$FDA-CTU$$20$YR$$F$N$60.78$KG$20240930$N$CN$US$
243798321$24379832$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265488$PFIZER$$65$YR$$F$Y$$$20240930$$CN$US$US
243798331$24379833$1$I$20240901$20240927$20240930$20240930$PER$$US-PFIZER INC-PV202400127104$PFIZER$$71$YR$$F$Y$$$20240930$$HP$US$US
243798341$24379834$1$I$$20240924$20240930$20240930$PER$$US-PFIZER INC-PV202400112986$PFIZER$$71$YR$$F$Y$$$20240930$$CN$US$US
243798361$24379836$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400264724$PFIZER$$39$YR$$F$Y$$$20240930$$HP$US$US
243798371$24379837$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-PV202400126829$PFIZER$$54$YR$$F$Y$$$20240930$$HP$US$US
243798381$24379838$1$I$20240921$20240929$20240930$20240930$PER$$US-PFIZER INC-202400266511$PFIZER$$71$YR$$M$Y$$$20240930$$CN$US$US
243798391$24379839$1$I$20240928$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266169$PFIZER$$89$YR$$F$Y$78.93$KG$20240930$$CN$US$US
243798421$24379842$1$I$$20240925$20240930$20240930$PER$$US-PFIZER INC-202400265758$PFIZER$$$$$F$Y$$$20240930$$MD$US$US
243798441$24379844$1$I$$20240925$20240930$20240930$PER$$US-PFIZER INC-PV202400126752$PFIZER$$51$YR$$F$Y$$$20240930$$CN$US$US
243798451$24379845$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-PV202400126828$PFIZER$$48$YR$$M$Y$$$20240930$$HP$US$US
243798481$24379848$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-202400265862$PFIZER$$$$$$Y$$$20240930$$MD$US$US
243798501$24379850$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-202400265705$PFIZER$$$$$F$Y$$$20240930$$CN$US$US
243798511$24379851$1$I$20240901$20240926$20240930$20240930$PER$$US-PFIZER INC-202400264985$PFIZER$$85$YR$$F$Y$60.78$KG$20240930$$CN$US$US
243798521$24379852$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-PV202400126773$PFIZER$$$$$$Y$$$20240930$$CN$US$US
243798531$24379853$1$I$20240801$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265227$PFIZER$$33$YR$$M$Y$$$20240930$$HP$US$US
243798541$24379854$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265099$PFIZER$$77$YR$$F$Y$$$20240930$$CN$US$US
243798551$24379855$1$I$20240304$20240918$20240930$20240930$PER$$US-PFIZER INC-202400265112$PFIZER$$45$YR$$F$Y$51.26$KG$20240930$$HP$US$US
243798571$24379857$1$I$20240928$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266084$PFIZER$$30$YR$$F$Y$$$20240930$$HP$US$US
243798581$24379858$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-PV202400127049$PFIZER$$41$YR$$F$Y$$$20240930$$HP$US$US
243798591$24379859$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-PV202400126349$PFIZER$$22$YR$$F$Y$$$20240930$$HP$US$US
243798601$24379860$1$I$20240101$20240925$20240930$20240930$PER$$US-PFIZER INC-202400265001$PFIZER$$80$YR$$F$Y$$$20240930$$CN$US$US
243798611$24379861$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265079$PFIZER$$$$$$Y$$$20240930$$PH$US$US
243798621$24379862$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265747$PFIZER$$63$YR$$M$Y$$$20240930$$CN$US$US
243798631$24379863$1$I$$20240927$20240930$20240930$PER$$US-PFIZER INC-202400265853$PFIZER$$$$A$F$Y$$$20240930$$MD$US$US
243798641$24379864$1$I$20240925$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266342$PFIZER$$46$YR$$M$Y$$$20240930$$CN$US$US
243798651$24379865$1$I$$20240923$20240930$20240930$PER$$US-PFIZER INC-202400263173$PFIZER$$30$YR$$F$Y$$$20240930$$CN$US$US
243798671$24379867$1$I$20240929$20240929$20240930$20240930$PER$$US-PFIZER INC-202400266489$PFIZER$$59$YR$$F$Y$$$20240930$$CN$US$US
243798681$24379868$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265446$PFIZER$$29$YR$$F$Y$$$20240930$$HP$US$US
243798691$24379869$1$I$20240926$20240927$20240930$20240930$PER$$US-PFIZER INC-202400265982$PFIZER$$76$YR$$M$Y$$$20240930$$CN$US$US
243798701$24379870$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265061$PFIZER$$$$A$M$Y$$$20240930$$HP$US$US
243798711$24379871$1$I$20240901$20240929$20240930$20240930$PER$$US-PFIZER INC-202400266297$PFIZER$$71$YR$$F$Y$$$20240930$$CN$US$US
243798721$24379872$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-PV202400126424$PFIZER$$56$YR$$F$Y$$$20240930$$HP$US$US
243798731$24379873$1$I$20240928$20240929$20240930$20240930$PER$$US-PFIZER INC-202400266291$PFIZER$$34$YR$$M$Y$$$20240930$$CN$US$US
243798741$24379874$1$I$$20240925$20240930$20240930$PER$$US-PFIZER INC-202400264957$PFIZER$$45$YR$$F$Y$$$20240930$$HP$US$US
243798751$24379875$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400265335$PFIZER$$35$YR$$M$Y$$$20240930$$CN$US$US
243798781$24379878$1$I$$20240924$20240930$20240930$PER$$US-BAYER-2024A137029$BAYER$$$$$M$Y$$$20240930$$HP$US$US
243798791$24379879$1$I$20240101$20240911$20240930$20240930$PER$$US-009507513-2409USA004493$MERCK$$17$YR$$M$Y$$$20240930$$CN$US$US
243798801$24379880$1$I$$20240924$20240930$20240930$PER$$US-JNJFOC-20240970045$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
243798811$24379881$1$I$20240910$20240920$20240930$20240930$EXP$$US-LANTHEUS-LMI-2024-01209$LANTHEUS MEDICAL IMAGING$$51$YR$$F$Y$55$KG$20240930$$MD$US$US
243798821$24379882$1$I$20240809$20240920$20240930$20240930$PER$$US-ABBVIE-5935658$ABBVIE$$66$YR$$M$Y$$$20240930$$MD$US$US
243798831$24379883$1$I$$20240923$20240930$20240930$EXP$$US-GSK-US2024117644$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$PH$US$US
243798841$24379884$1$I$$20240918$20240930$20240930$EXP$$US-BELCHER PHARMACEUTICALS, LLC-2024US003195$PAREXEL$$$$$$Y$$$20240927$$HP$US$US
243798861$24379886$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67380$$FDA-CTU$$32$YR$$F$N$$$20240930$N$$US$
243798881$24379888$1$I$20240826$20240919$20240930$20240930$EXP$$US-ARDELYX-2024ARDX007169$ARDELYX$$60$YR$$M$Y$$$20240929$$HP$US$US
243798891$24379889$1$I$20240101$20240919$20240930$20240930$EXP$$US-ARDELYX-2024ARDX007147$ARDELYX$$$$$F$Y$117.01$KG$20240929$$CN$US$US
243798901$24379890$1$I$$20240919$20240930$20240930$EXP$$US-ARDELYX-2024ARDX007188$ARDELYX$$$$$M$Y$$$20240929$$CN$US$US
243798911$24379891$1$I$$20240923$20240930$20240930$EXP$$NVSC2024KZ191707$NOVARTIS$$$$$F$Y$160$KG$20240930$$MD$KZ$KZ
243798921$24379892$1$I$$20240925$20240930$20240930$PER$$US-BAYER-2024A137483$BAYER$$88$YR$E$M$Y$$$20240930$$MD$US$US
243798941$24379894$1$I$$20240926$20240930$20240930$PER$$NVSC2024US193293$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
243798951$24379895$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117018$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243798961$24379896$1$I$20201124$20240930$20240930$20240930$EXP$PL-URPL-1-3518-2020$NVSC2024PL193120$NOVARTIS$$52$YR$$F$Y$82$KG$20240930$$MD$PL$PL
243798971$24379897$1$I$$20240920$20240930$20240930$PER$$US-ASTRAZENECA-202409USA004802US$ALEXION PHARMACEUTICALS$$70$YR$E$$Y$$$20240930$$$US$US
243799001$24379900$1$I$$20240923$20240930$20240930$EXP$$US-MYLANLABS-2024M1087550$MYLAN$Connors JS, Zhang L, Sasaki K, DiNardo CD, Short NJ, Daver N, et al. Protective Role of Oxaliplatin Among Platinum-Based Therapies in the Development of Therapy-Related Myeloid Neoplasms. Blood 2023; 142 (Suppl.) 4220-4221.$$$$$Y$$$20240930$$MD$US$US
243799011$24379901$1$I$20191001$20240901$20240930$20240930$EXP$$FR-ROCHE-10000090812$ROCHE$Briane A, Horvais V, Sigaud M, Trossaert M, Drillaud N, Ternisien C, et al. Bleedingmanagement in type 3 von Willebrand disease with anti-von Willebrand factor inhibitor: A literature review and case report. eJHaem. 2024;1-7. doi:10.1002/jha2.984.$47$YR$A$F$Y$$$20240930$$HP$FR$FR
243799031$24379903$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67413$$FDA-CTU$$53$YR$$F$N$113.4$KG$20240930$N$$US$
243799051$24379905$1$I$20230101$20240813$20240930$20240930$PER$$US-LUNDBECK-DKLU4003033$LUNDBECK$$$$$$Y$$$20240930$$PH$US$US
243799071$24379907$1$I$$20240926$20240930$20240930$EXP$$GB-SANDOZ INC.-NVSC2020GB105058$SANDOZ$$$$$F$Y$$$20240930$$CN$GB$GB
243799081$24379908$1$I$20240801$20240925$20240930$20240930$EXP$$DE-BAYER-2024A137331$BAYER$$36$YR$A$F$Y$$$20240930$$CN$DE$DE
243799091$24379909$1$I$$20240927$20240930$20240930$EXP$$US-PFIZER INC-2018SGN02022$PFIZER$$$$$$Y$$$20240930$$HP$US$US
243799101$24379910$1$I$$20240923$20240930$20240930$EXP$$CA-BAUSCH-BL-2024-014301$BAUSCH AND LOMB$$43$YR$$F$Y$96$KG$20240930$$HP$CA$CA
243799111$24379911$1$I$$20240925$20240930$20240930$EXP$$CA-BAUSCH-BL-2024-014467$BAUSCH AND LOMB$$$$$M$Y$$$20240930$$HP$CA$CA
243799151$24379915$1$I$$20240926$20240930$20240930$EXP$$US-PFIZER INC-2018SGN02773$PFIZER$$$$$M$Y$$$20240930$$MD$US$US
243799161$24379916$1$I$$20240926$20240930$20240930$EXP$$US-PFIZER INC-2023SGN01105$PFIZER$$$$$M$Y$$$20240930$$MD$US$US
243799171$24379917$1$I$20240921$20240924$20240930$20240930$EXP$$JP-009507513-2409JPN003366J$MERCK$$77$YR$$F$Y$$$20240930$$CN$JP$JP
243799191$24379919$1$I$20190623$20240926$20240930$20240930$EXP$$US-PFIZER INC-2019SGN02359$PFIZER$$69$YR$$F$Y$$$20240930$$MD$US$US
243799211$24379921$1$I$20240925$20240926$20240930$20240930$30DAY$$CL-PFIZER INC-PV202400126121$PFIZER$$13$YR$$M$Y$$$20240930$$CN$CL$CL
243799231$24379923$1$I$$20240925$20240930$20240930$EXP$$IN-PFIZER INC-202400264814$PFIZER$Kunnumbrath, A.. Near missed aggressive natural killer cell leukaemia - importance of extensive immunophenotyping. Argentine hematology society. 2024;28 (2):57-61$32$YR$$M$Y$$$20240930$$MD$IN$IN
243799251$24379925$1$I$$20240924$20240930$20240930$EXP$$US-PFIZER INC-PV202400125962$PFIZER$Anani, A.. COMPLETE PHRENIC NERVE PARALYSIS IN A PATIENT WITH CYSTIC FIBROSIS. Chest. 2024;166(4 Supplemen:A176$45$YR$$M$Y$$$20240930$$HP$US$US
243799261$24379926$1$I$$20240923$20240930$20240930$EXP$$CA-BAUSCH-BL-2024-014334$BAUSCH AND LOMB$$40$YR$$F$Y$96$KG$20240930$$CN$CA$CA
243799271$24379927$1$I$$20240925$20240930$20240930$EXP$$CA-PFIZER INC-202400265656$PFIZER$$61$YR$$F$Y$95$KG$20240930$$HP$CA$CA
243799281$24379928$1$I$20240911$20240927$20240930$20240930$EXP$$US-BAYER-2024A139088$BAYER$$39$YR$A$M$Y$$$20240930$$CN$US$US
243799301$24379930$1$I$$20240925$20240930$20240930$EXP$$CA-BAUSCH-BL-2024-014469$BAUSCH AND LOMB$$64$YR$$F$Y$55$KG$20240930$$HP$CA$CA
243799311$24379931$1$I$$20240926$20240930$20240930$EXP$$US-BAYER-2024A138002$BAYER$$63$YR$A$M$Y$$$20240930$$CN$US$US
243799321$24379932$1$I$$20240925$20240930$20240930$EXP$$CA-BAUSCH-BL-2024-014462$BAUSCH AND LOMB$$$$$M$Y$$$20240930$$HP$CA$CA
243799331$24379933$1$I$$20240919$20240930$20240930$PER$$US-JNJFOC-20240951679$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$US$US
243799341$24379934$1$I$20240828$20240925$20240930$20240930$EXP$$JP-GILEAD-2024-0688932$GILEAD$$7$DEC$E$F$Y$$$20240930$$MD$JP$JP
243799351$24379935$1$I$$20240926$20240930$20240930$EXP$$BR-GSK-BR2024AMR119742$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$CN$BR$BR
243799361$24379936$1$I$$20240814$20240930$20240930$PER$$US-LUNDBECK-DKLU4003016$LUNDBECK$$$$$$Y$$$20240930$$HP$US$US
243799371$24379937$1$I$20240820$20240918$20240930$20240930$EXP$$DE-TG THERAPEUTICS INC.-TGT004017$TG THERAPEUTICS$$$$$$Y$$$20240930$$HP$DE$DE
243799381$24379938$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153869$BRISTOL MYERS SQUIBB$$$$E$$Y$$$20240930$$MD$US$US
243799391$24379939$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153748$BRISTOL MYERS SQUIBB$$57$YR$A$F$Y$$$20240930$$CN$US$US
243799401$24379940$1$I$$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153928$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240930$$CN$US$US
243799411$24379941$1$I$20230216$20240923$20240930$20240930$EXP$$CA-TAKEDA-2024TUS004458$TAKEDA$$38$YR$$F$Y$$$20240930$$HP$CA$CA
243799421$24379942$1$I$$20240920$20240930$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409013803$ELI LILLY AND CO$$53$YR$A$$Y$$$20240930$$CN$US$US
243799431$24379943$1$I$20240924$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017630$ELI LILLY AND CO$$70$YR$E$M$Y$$$20240930$$HP$US$US
243799441$24379944$1$I$20240806$20240918$20240930$20240930$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409012175$ELI LILLY AND CO$$19$YR$A$M$Y$100$KG$20240930$$CN$DE$DE
243799451$24379945$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016897$ELI LILLY AND CO$$46$YR$A$F$Y$$$20240930$$CN$US$US
243799481$24379948$1$I$$20240919$20240930$20240930$EXP$$US-ASCENT-2024ASLIT00039$ASCENT$Medina AR, et al..Complex ADHD Challenging Case: Managing Co-Occurring Attention-Deficit Hyperactivity Disorder and Congenital Heart Disease with a Limited Medication Formulary: A Case from Mexico.Journal of Developmental and Behavioral Pediatrics.Jun-2024;45 (3):e271-3$8$YR$C$M$Y$$$20240930$$MD$US$US
243799491$24379949$1$I$$20240925$20240930$20240930$EXP$$US-RIGEL-20240900144$RIGEL PHARMACEUTICALS$$$$$M$Y$$$20240930$$CN$US$US
243799501$24379950$1$I$$20240919$20240930$20240930$PER$$US-ROCHE-10000088472$ROCHE$$$$$F$Y$$$20240930$$PH$US$US
243799511$24379951$1$I$$20240919$20240930$20240930$PER$$US-Calliditas-2024CAL02003$CALLIDITAS THERAPEUTICS$$58$YR$A$F$Y$$$20240930$$CN$US$US
243799521$24379952$1$I$20240626$20240925$20240930$20240930$EXP$$JP-GILEAD-2024-0688947$GILEAD$$51$YR$A$F$Y$$$20240930$$HP$JP$JP
243799531$24379953$1$I$20240916$20240919$20240930$20240930$PER$$US-Calliditas-2024CAL02007$CALLIDITAS THERAPEUTICS$$58$YR$A$F$Y$$$20240930$$CN$US$US
243799541$24379954$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117158$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243799551$24379955$1$I$20240101$20240924$20240930$20240930$EXP$FR-AFSSAPS-AN2024001284$FR-MYLANLABS-2024M1086983$MYLAN$$67$YR$$F$Y$56$KG$20240930$$MD$FR$FR
243799581$24379958$1$I$$20240920$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153352$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240930$$CN$US$US
243799601$24379960$1$I$$20240815$20240930$20240930$PER$$US-LUNDBECK-DKLU4003108$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
243799611$24379961$1$I$20240801$20240920$20240930$20240930$EXP$$US-UCBSA-2024048657$UCB$$62$YR$$F$Y$$$20240930$$HP$US$US
243799621$24379962$1$I$$20240912$20240930$20240930$PER$$US-Eisai-EC-2024-174515$EISAI$$$$$F$Y$$$20240930$$MD$US$US
243799631$24379963$1$I$$20240919$20240930$20240930$EXP$$US-RDY-SPO/USA/23/0180162$DR REDDYS$$69$YR$E$M$Y$$$20240930$$MD$US$US
243799641$24379964$1$I$$20240923$20240930$20240930$PER$$US-ROCHE-10000090077$ROCHE$$59$YR$A$F$Y$$$20240930$$CN$US$US
243799651$24379965$1$I$$20240924$20240930$20240930$PER$$US-ROCHE-10000090907$ROCHE$$71$YR$E$F$Y$$$20240930$$CN$US$US
243799661$24379966$1$I$$20240919$20240930$20240930$EXP$$PL-ASTRAZENECA-202409GLO010775PL$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$PL$PL
243799671$24379967$1$I$20240926$20240926$20240930$20240930$EXP$$US-BAYER-2024A138180$BAYER$$75$YR$E$M$Y$$$20240930$$CN$US$US
243799681$24379968$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5940291$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243799701$24379970$1$I$$20240920$20240930$20240930$EXP$$ZA-ROCHE-10000087447$ROCHE$$$$A$F$Y$$$20240930$$CN$ZA$ZA
243799711$24379971$1$I$$20240926$20240930$20240930$EXP$$GB-ABBVIE-5943410$ABBVIE$$$$$M$Y$$$20240930$$CN$GB$GB
243799721$24379972$1$I$20240925$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153865$BRISTOL MYERS SQUIBB$$45$YR$A$F$Y$$$20240930$$CN$US$US
243799731$24379973$1$I$$20240923$20240930$20240930$PER$$US-ROCHE-10000089148$ROCHE$$62$YR$A$F$Y$$$20240930$$MD$US$US
243799741$24379974$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150813$BRISTOL MYERS SQUIBB$Guevara N, Chapiolkina V, Tole MC, Perez E, Sanchez J, Mekonen Y, et al. A challenging diagnosis of gastrointestinal bleeding in a patient with chronic myelogenous leukemia on chronic treatment with dasatinib and cytomegalovirus (CMV) colitis. Chest. 2024;166(4S):2152A-3A. doi:10.1016/j.chest.2024.06.1328.$69$YR$E$F$Y$$$20240930$$HP$US$US
243799751$24379975$1$I$$20240906$20240930$20240930$PER$$US-ASTRAZENECA-202409USA004276US$ALEXION PHARMACEUTICALS$$58$YR$A$$Y$$$20240930$$PH$US$US
243799761$24379976$1$I$$20240925$20240930$20240930$PER$$US-ROCHE-10000091842$ROCHE$$$$A$F$Y$$$20240930$$CN$US$US
243799771$24379977$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093499$ROCHE$$$$E$F$Y$$$20240930$$CN$US$US
243799781$24379978$1$I$$20240924$20240930$20240930$EXP$$NVSC2024CO191828$NOVARTIS$$$$$$Y$$$20240930$$MD$CO$CO
243799791$24379979$1$I$$20240923$20240930$20240930$EXP$$NVSC2024US190241$NOVARTIS$$19$YR$$M$Y$$$20240930$$MD$US$US
243799801$24379980$1$I$20240101$20240925$20240930$20240930$EXP$$NVSC2024CA192701$NOVARTIS$$76$YR$$F$Y$$$20240930$$HP$CA$CA
243799811$24379981$1$I$20240628$20240925$20240930$20240930$EXP$$NVSC2024US165975$NOVARTIS$$91$YR$$F$Y$75.5$KG$20240930$$CN$US$US
243799821$24379982$1$I$20240918$20240919$20240930$20240930$PER$$US-ABBVIE-5934189$ABBVIE$$8$YR$$F$Y$$$20240930$$CN$US$US
243799841$24379984$1$I$$20240815$20240930$20240930$PER$$US-LUNDBECK-DKLU4003097$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
243799851$24379985$1$I$$20240928$20240930$20240930$PER$$US-HALEON-2199410$Haleon PLC$$$$$$Y$$$20240930$$CN$US$US
243799861$24379986$1$I$$20240925$20240930$20240930$EXP$$AU-AMGEN-AUSSP2024192879$AMGEN$$51$YR$A$M$Y$$$20240930$$MD$AU$AU
243799871$24379987$1$I$20240921$20240921$20240930$20240930$PER$$US-CSL-2024-008682$CSL Plasma$$22$YR$$M$Y$$$20240930$$HP$US$US
243799881$24379988$1$I$20240923$20240923$20240930$20240930$PER$$US-ROCHE-10000089937$ROCHE$$64$YR$A$F$Y$99.79$KG$20240930$$CN$US$US
243799891$24379989$1$I$$20240924$20240930$20240930$EXP$$US-ROCHE-10000094565$ROCHE$GOGOLASHVILI A, Im S, Rasla S. Thrombus in transit through patent foramen ovale with large pulmonary embolism-therapeutic challenges in high-risk surgical individuals. Chest. 2024;166 (4):1834A-1835A. doi:10.1016/j.chest.2024.06.1151.$75$YR$E$F$Y$$$20240930$$HP$US$US
243799901$24379990$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002921$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243799911$24379991$1$I$20240901$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003126$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243799921$24379992$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003177$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243799931$24379993$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003144$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243799941$24379994$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003135$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243799951$24379995$1$I$$20240911$20240930$20240930$PER$$US-SMPA-2024SPA002628$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243799961$24379996$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002900$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243799971$24379997$1$I$$20240913$20240930$20240930$PER$$US-SMPA-2024SPA002886$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243799981$24379998$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002910$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243799991$24379999$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003171$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800001$24380000$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002956$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800011$24380001$1$I$$20240912$20240930$20240930$PER$$US-SMPA-2024SPA002744$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800021$24380002$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA000290$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800031$24380003$1$I$$20240919$20240930$20240930$PER$$US-SMPA-2024SPA003084$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800041$24380004$1$I$$20240911$20240930$20240930$PER$$US-SMPA-2024SPA002681$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800051$24380005$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002932$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800071$24380007$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003123$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800081$24380008$1$I$$20240913$20240930$20240930$PER$$US-SMPA-2024SPA002941$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800091$24380009$1$I$$20240910$20240930$20240930$PER$$US-SMPA-2024SPA002651$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800101$24380010$1$I$$20240911$20240930$20240930$PER$$US-SMPA-2024SPA003051$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800121$24380012$1$I$$20240917$20240930$20240930$PER$$US-SMPA-2024SPA000769$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800131$24380013$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003132$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800141$24380014$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002926$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800151$24380015$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002854$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800161$24380016$1$I$$20240913$20240930$20240930$PER$$US-SMPA-2024SPA002880$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800171$24380017$1$I$$20240912$20240930$20240930$PER$$US-SMPA-2024SPA002759$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800181$24380018$1$I$$20240923$20240930$20240930$PER$$US-SMPA-2024SPA003168$SUNOVION$$$$$$Y$$$20240930$$$US$US
243800191$24380019$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002960$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800201$24380020$1$I$$20240911$20240930$20240930$PER$$US-SMPA-2024SPA002626$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800211$24380021$1$I$$20240910$20240930$20240930$PER$$US-SMPA-2024SPA002680$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800221$24380022$1$I$$20240910$20240930$20240930$PER$$US-SMPA-2024SPA001242$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800231$24380023$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002903$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800241$24380024$1$I$$20240911$20240930$20240930$PER$$US-SMPA-2024SPA002799$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800251$24380025$1$I$$20240910$20240930$20240930$PER$$US-SMPA-2024SPA002644$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800261$24380026$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002954$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800271$24380027$1$I$$20240911$20240930$20240930$PER$$US-SMPA-2024SPA002593$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800281$24380028$1$I$$20240919$20240930$20240930$PER$$US-SMPA-2024SPA002452$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800291$24380029$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002920$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800301$24380030$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003133$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800311$24380031$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003143$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800321$24380032$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002939$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800331$24380033$1$I$$20240913$20240930$20240930$PER$$US-SMPA-2024SPA002733$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800341$24380034$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002971$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800361$24380036$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003150$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800371$24380037$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003131$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800381$24380038$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024MYSCI0200128$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800391$24380039$1$I$$20240913$20240930$20240930$PER$$US-SMPA-2024SPA002906$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800401$24380040$1$I$20240901$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002901$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800411$24380041$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003112$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800421$24380042$1$I$$20240913$20240930$20240930$PER$$US-SMPA-2024SPA002841$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800431$24380043$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003141$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800441$24380044$1$I$$20240911$20240930$20240930$PER$$US-SMPA-2024SPA002665$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800451$24380045$1$I$$20240913$20240930$20240930$PER$$US-SMPA-2024SPA002831$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800461$24380046$1$I$$20240911$20240930$20240930$PER$$US-SMPA-2024SPA002652$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800471$24380047$1$I$$20240916$20240930$20240930$PER$$US-SMPA-2024SPA002951$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800481$24380048$1$I$$20240913$20240930$20240930$PER$$US-SMPA-2024SPA002940$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800491$24380049$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003156$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800501$24380050$1$I$$20240909$20240930$20240930$PER$$US-SMPA-2024SPA002642$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800511$24380051$1$I$20231001$20240913$20240930$20240930$PER$$US-SMPA-2024SPA000508$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800521$24380052$1$I$$20240926$20240930$20240930$PER$$US-BIOGEN-2023BI01188333$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243800531$24380053$1$I$$20240924$20240930$20240930$PER$$US-SMPA-2024SPA003275$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800551$24380055$1$I$$20240924$20240930$20240930$PER$$US-SMPA-2024SPA003299$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800561$24380056$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003180$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800571$24380057$1$I$$20240920$20240930$20240930$PER$$US-SMPA-2024SPA003246$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800581$24380058$1$I$$20240919$20240930$20240930$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09464$NEUROCRINE BIOSCIENCES$$56$YR$$$Y$$$20240930$$HP$US$US
243800591$24380059$1$I$$20240921$20240930$20240930$PER$$US-SMPA-2024SPA003210$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243800601$24380060$1$I$$20240912$20240930$20240930$PER$$US-Eisai-EC-2024-174340$EISAI$$$$$F$Y$$$20240930$$HP$US$US
243800611$24380061$1$I$$20240913$20240930$20240930$PER$$US-Eisai-EC-2024-174414$EISAI$$$$$F$Y$$$20240930$$CN$US$US
243800621$24380062$1$I$20240911$20240912$20240930$20240930$PER$$US-Eisai-EC-2024-174351$EISAI$$84$YR$E$M$Y$$$20240930$$CN$US$US
243800631$24380063$1$I$$20240923$20240930$20240930$EXP$$DE-Eisai-EC-2024-175252$EISAI$$$$$F$Y$$$20240930$$HP$DE$JP
243800641$24380064$1$I$$20240919$20240930$20240930$PER$$US-Calliditas-2024CAL01988$CALLIDITAS THERAPEUTICS$$52$YR$A$M$Y$$$20240930$$HP$US$US
243800651$24380065$1$I$20240920$20240923$20240930$20240930$PER$$US-JNJFOC-20240962261$JOHNSON AND JOHNSON$$41$YR$$F$Y$$$20240930$$CN$US$US
243800661$24380066$1$I$20240725$20240923$20240930$20240930$EXP$$CA-JNJFOC-20240844344$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20240930$$CN$CA$CA
243800671$24380067$1$I$$20240920$20240930$20240930$30DAY$$CA-JNJFOC-20240979357$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$CA$CA
243800681$24380068$1$I$20240101$20240919$20240930$20240930$EXP$$US-UCBSA-2024048612$UCB$$$$$F$Y$62.585$KG$20240930$$HP$US$US
243800691$24380069$1$I$20240101$20240925$20240930$20240930$EXP$$US-SA-2024SA178116$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240930$$MD$US$US
243800711$24380071$1$I$$20240815$20240930$20240930$PER$$US-LUNDBECK-DKLU4003094$LUNDBECK$$$$$$Y$$$20240930$$MD$US$US
243800721$24380072$1$I$20240621$20240924$20240930$20240930$EXP$$FR-MYLANLABS-2024M1086720$MYLAN$$16$YR$$F$Y$$$20240930$$MD$FR$FR
243800731$24380073$1$I$20240919$20240925$20240930$20240930$EXP$$NVSC2024CN192046$NOVARTIS$$70$YR$$F$Y$50$KG$20240930$$HP$CN$CN
243800741$24380074$1$I$20240921$20240922$20240930$20240930$EXP$$CN-TAKEDA-2024TUS094779$TAKEDA$$49$YR$$M$Y$$$20240930$$HP$CN$CN
243800751$24380075$1$I$20240917$20240919$20240930$20240930$EXP$$US-UCBSA-2024048696$UCB$$16$YR$$M$Y$62$KG$20240930$$HP$US$US
243800761$24380076$1$I$$20240925$20240930$20240930$PER$$US-BAYER-2024A137595$BAYER$$$$$M$Y$$$20240930$$HP$US$US
243800771$24380077$1$I$20210701$20240920$20240930$20240930$EXP$$JP-Vifor (International) Inc.-VIT-2024-05366$VIFOR$$56$YR$$M$Y$81$KG$20240930$$MD$JP$JP
243800781$24380078$1$I$20240601$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016944$ELI LILLY AND CO$$22$YR$A$F$Y$$$20240930$$CN$US$US
243800801$24380080$1$I$$20240918$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409012618$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240930$$CN$US$US
243800811$24380081$1$I$$20240923$20240930$20240930$PER$$US-TAKEDA-2024TUS094785$TAKEDA$$$$$M$Y$68$KG$20240930$$MD$US$US
243800821$24380082$1$I$$20240924$20240930$20240930$PER$$US-TAKEDA-2024TUS095644$TAKEDA$$$$$$Y$$$20240930$$CN$US$US
243800831$24380083$1$I$$20240927$20240930$20240930$PER$$US-TAKEDA-2024TUS096378$TAKEDA$$$$$$Y$$$20240930$$CN$US$US
243800841$24380084$1$I$$20240923$20240930$20240930$PER$$US-TAKEDA-2024TUS094940$TAKEDA$$$$$M$Y$$$20240930$$CN$US$US
243800851$24380085$1$I$20230808$20240926$20240930$20240930$PER$$US-BIOVITRUM-2024-US-012533$BIOVITRUM$$58$YR$$F$Y$$$20240930$$CN$US$US
243800861$24380086$1$I$$20240927$20240930$20240930$PER$$US-TAKEDA-2024TUS096403$TAKEDA$$$$$$Y$$$20240930$$CN$US$US
243800871$24380087$1$I$$20240927$20240930$20240930$PER$$US-TAKEDA-2024TUS096375$TAKEDA$$$$$$Y$$$20240930$$CN$US$US
243800881$24380088$1$I$$20240923$20240930$20240930$EXP$$NVSC2024US190021$NOVARTIS$$71$YR$$F$Y$$$20240930$$HP$US$US
243800891$24380089$1$I$20240809$20240924$20240930$20240930$EXP$$CN-009507513-2409CHN009904$MERCK$$61$YR$$F$Y$40$KG$20240930$$HP$CN$CN
243800901$24380090$1$I$$20240926$20240930$20240930$EXP$GB-BIOVITRUM-2024-GB-012536$GB-BIOVITRUM-2024-GB-012536$BIOVITRUM$$69$YR$$M$Y$$$20240930$$HP$GB$GB
243800911$24380091$1$I$20240901$20240920$20240930$20240930$EXP$$MX-ROCHE-10000090142$ROCHE$$40$YR$A$F$Y$67.5$KG$20240930$$CN$MX$MX
243800921$24380092$1$I$$20240925$20240930$20240930$PER$$US-BAYER-2024A137302$BAYER$$88$YR$E$$Y$$$20240930$$CN$US$US
243800931$24380093$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024AMR117983$GLAXOSMITHKLINE$$$$$M$Y$$$20240930$$CN$US$US
243800951$24380095$1$I$$20240923$20240930$20240930$EXP$GB-MHRA-MIDB-6808704b-b687-4bc7-b805-723c3285b5a9$GB-TEVA-VS-3246837$TEVA$$46$YR$$$Y$$$20240930$$PH$GB$GB
243800961$24380096$1$I$20240410$20240920$20240930$20240930$PER$$US-JNJFOC-20240976890$JOHNSON AND JOHNSON$$$$$F$Y$69.2$KG$20240930$$MD$US$US
243800971$24380097$1$I$20230901$20240925$20240930$20240930$EXP$SE-SEMPA-2024-006766$SE-JNJFOC-20240972830$JOHNSON AND JOHNSON$$12$YR$T$M$Y$39$KG$20240930$$CN$SE$SE
243800991$24380099$1$I$$20240920$20240930$20240930$EXP$$CA-TAKEDA-2024TUS094451$TAKEDA$$$$$F$Y$$$20240930$$CN$CA$CA
243801001$24380100$1$I$$20240929$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154085$BRISTOL MYERS SQUIBB$$74$YR$E$F$Y$60.78$KG$20240930$$CN$US$US
243801011$24380101$1$I$$20240924$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153665$BRISTOL MYERS SQUIBB$$83$YR$E$M$Y$$$20240930$$CN$US$US
243801021$24380102$1$I$$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151027$BRISTOL MYERS SQUIBB$Afzaal H, Anwar A. Immune check point inhibitor use causing a fulminant DKA case in ICU. Chest. 2024;166(4S):2960A. doi:10.1016/j.chest.2024.06.1784.$46$YR$A$M$Y$$$20240930$$HP$US$US
243801031$24380103$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154024$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240930$$PH$US$US
243801041$24380104$1$I$20240612$20240925$20240930$20240930$EXP$$JP-GILEAD-2024-0688948$GILEAD$$50$YR$A$M$Y$$$20240930$$HP$JP$JP
243801051$24380105$1$I$$20240926$20240930$20240930$EXP$$US-AMGEN-USASP2024192747$AMGEN$$56$YR$A$F$Y$$$20240930$$HP$US$US
243801061$24380106$1$I$20240904$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024190704$AMGEN$$39$YR$A$F$Y$147$KG$20240930$$HP$US$US
243801081$24380108$1$I$$20240925$20240930$20240930$EXP$$CA-MYLANLABS-2024M1087495$MYLAN$$$$$F$Y$$$20240930$$CN$CA$CA
243801091$24380109$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5939443$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243801101$24380110$1$I$$20240920$20240930$20240930$EXP$$US-BEH-2024179140$CSL BEHRING$$$$A$M$Y$$$20240930$$HP$US$US
243801111$24380111$1$I$$20240924$20240930$20240930$EXP$$CN-009507513-2409CHN010018$MERCK$Liu S, Lu P, Yang B, Yang Y, Zhou H, Yang M,. Single-cell RNA sequencing analysis of peripheral blood mononuclear cells in PD-1-induced renal toxicity in patients with lung cancer. BMC nephrology. 2024;25 (1)::307$62$YR$$M$Y$$$20240930$$HP$CN$CN
243801121$24380112$1$I$$20240920$20240930$20240930$EXP$$US-ALXN-202409USA002245US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
243801131$24380113$1$I$20240916$20240924$20240930$20240930$PER$GB-MHRA-MED-202409241248593280-CHJWV$GB-Eisai-EC-2024-175296$EISAI$$$$$F$Y$$$20240930$$MD$GB$GB
243801141$24380114$1$I$20211001$20240923$20240930$20240930$EXP$DE-PFIZER INC-202200430024$DE-RDY-SPO/DEU/24/0014069$DR REDDYS$$45$YR$A$F$Y$109$KG$20240930$$MD$DE$DE
243801151$24380115$1$I$20240906$20240926$20240930$20240930$EXP$$JP-Eisai-EC-2024-175443$EISAI$$70$YR$E$F$Y$$$20240930$$MD$JP$JP
243801161$24380116$1$I$20240725$20240923$20240930$20240930$EXP$FR-AFSSAPS-PP2024000994$FR-RDY-SPO/FRA/24/0014052$DR REDDYS$$63$YR$A$M$Y$72.3$KG$20240930$$MD$FR$FR
243801171$24380117$1$I$20180101$20240910$20240930$20240930$PER$$US-TEVA-VS-3243320$TEVA$$$$A$F$Y$$$20240930$$CN$US$US
243801181$24380118$1$I$$20240923$20240930$20240930$EXP$$US-BAUSCH-BL-2024-014307$BAUSCH AND LOMB$$$$$$Y$$$20240930$$PH$US$US
243801191$24380119$1$I$$20240924$20240930$20240930$EXP$$CN-009507513-2409CHN010017$MERCK$Liu S, Lu P, Yang B, Yang Y, Zhou H, Yang M,. Single-cell RNA sequencing analysis of peripheral blood mononuclear cells in PD-1-induced renal toxicity in patients with lung cancer. BMC nephrology. 2024;25 (1)::307$50$YR$$M$Y$$$20240930$$HP$CN$CN
243801201$24380120$1$I$20240301$20240918$20240930$20240930$EXP$$US-BIOMARINAP-US-2024-160836$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243801211$24380121$1$I$$20240926$20240930$20240930$EXP$$JP-EXELIXIS-EXL-2024-000669$EXELIXIS$$83$YR$$M$Y$$$20240930$$MD$JP$JP
243801221$24380122$1$I$20210101$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153847$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240930$$HP$US$US
243801231$24380123$1$I$20240922$20240926$20240930$20240930$EXP$$ES-ABBVIE-5941234$ABBVIE$$67$YR$$M$Y$$$20240930$$CN$ES$ES
243801261$24380126$1$I$$20240918$20240930$20240930$PER$$US-BAUSCHBL-2024BNL033785$BAUSCH AND LOMB$$$$$F$Y$$$20240930$$CN$US$US
243801271$24380127$1$I$$20240916$20240930$20240930$PER$$US-ASTRAZENECA-202409GLO007114US$ALEXION PHARMACEUTICALS$$56$YR$A$$Y$$$20240930$$$US$US
243801281$24380128$1$I$$20240906$20240930$20240930$PER$$US-ASTRAZENECA-202409GLO006893US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$MD$US$US
243801291$24380129$1$I$20180522$20240919$20240930$20240930$EXP$$AT-DSJP-DSE-2024-101726$DAIICHI$$37$YR$$F$Y$$$20240930$$MD$AT$AT
243801301$24380130$1$I$20201117$20240926$20240930$20240930$EXP$PL-URPL-1-4231-2020$PL-MYLANLABS-2024M1087283$MYLAN$$42$YR$$M$Y$98$KG$20240930$$MD$PL$PL
243801311$24380131$1$I$20240928$20240928$20240930$20240930$EXP$GB-MHRA-MED-202409282110280450-RSLMV$GB-MYLANLABS-2024M1088190$MYLAN$$48$YR$$M$Y$80$KG$20240930$$MD$GB$GB
243801331$24380133$1$I$$20240918$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA002021US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240930$$$US$US
243801341$24380134$1$I$20240920$20240923$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US082175$SANDOZ$$11$YR$$M$Y$$$20240930$$CN$US$US
243801361$24380136$1$I$$20240925$20240930$20240930$PER$$US-JNJFOC-20240972566$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240930$$CN$US$US
243801371$24380137$1$I$$20240919$20240930$20240930$EXP$$TR-MEITHEAL-2024MPLIT00297$MEITHEAL PHARMACEUTICALS$Uyaroglu OA, et al. .Keep In Mind! Drug-Associated Vasculitis: Zoledronic Acid-Induced Large Vessel Vasculitis Diagnosed By Computerized Tomography.European Journal of Case Reports in Internal Medicine.2024;11 (1):1071-2$50$YR$A$F$Y$$$20240930$$HP$TR$TR
243801381$24380138$1$I$$20240913$20240930$20240930$PER$$US-ASTRAZENECA-202409GLO007357US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240930$$MD$US$US
243801391$24380139$1$I$$20240920$20240930$20240930$PER$$US-Calliditas-2024CAL01268$CALLIDITAS THERAPEUTICS$$17$YR$T$M$Y$132$KG$20240930$$CN$US$US
243801401$24380140$1$I$$20240924$20240930$20240930$EXP$$DE-ORGANON-O2409DEU001938$ORGANON$$80$YR$$M$Y$69$KG$20240930$$HP$DE$DE
243801411$24380141$1$I$$20240925$20240930$20240930$PER$$US-PFIZER INC-2022SGN00328$PFIZER$$$$$M$Y$$$20240930$$HP$US$US
243801421$24380142$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-2019SGN00749$PFIZER$$80$YR$$M$Y$$$20240930$$HP$US$US
243801441$24380144$1$I$$20240925$20240930$20240930$EXP$$JP-GILEAD-2024-0688945$GILEAD$$24$YR$A$M$Y$$$20240930$$HP$JP$JP
243801451$24380145$1$I$$20240921$20240930$20240930$EXP$$CN-MEITHEAL-2024MPLIT00296$MEITHEAL PHARMACEUTICALS$Zhou X, et al..Childhood acute lymphoblastic leukemia complicated with cytokine release syndrome: report of 1 case and review of the literature. Journal of Leukemia and Lymphoma .dec-2022;31 (12):730-33$71$DY$$F$Y$6$KG$20240930$$HP$CN$CN
243801461$24380146$1$I$20230714$20240921$20240930$20240930$EXP$$JP-SANDOZ INC.-SDZ2023JP007459$SANDOZ$Nishikawa K. . A case of drug-induced interstitial nephritis caused by clozapine. The 8th Annual Meeting of the Japanese Society of Psychiatric Pharmacy. 2024;P-8:95$52$YR$$M$Y$54.9$KG$20240930$$MD$JP$JP
243801471$24380147$1$I$$20240920$20240930$20240930$PER$$US-AGIOS-2409US03895$AGIOS PHARMACEUTICALS$$$$$M$Y$$$20240930$$MD$US$US
243801481$24380148$1$I$$20240815$20240930$20240930$PER$$US-LUNDBECK-DKLU4003110$LUNDBECK$$$$$$Y$$$20240930$$CN$US$US
243801501$24380150$1$I$$20240912$20240930$20240930$EXP$$NVSC2024IN193282$NOVARTIS$$$$E$F$Y$$$20240930$$MD$IN$IN
243801511$24380151$1$I$$20240927$20240930$20240930$PER$$NVSC2024US193044$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
243801521$24380152$1$I$$20240927$20240930$20240930$PER$$NVSC2024US193686$NOVARTIS$$$$$$Y$$$20240930$$HP$US$US
243801531$24380153$1$I$$20240924$20240930$20240930$EXP$$CN-009507513-2409CHN009890$MERCK$Liu S, Lu P, Yang B, Yang Y, Zhou H, Yang M.. Single-cell RNA sequencing analysis of peripheral blood mononuclear cells in PD-1-induced renal toxicity in patients with lung cancer. BMC nephrology. 2024;25 (1)::307$71$YR$$M$Y$$$20240930$$HP$CN$CN
243801541$24380154$1$I$20230101$20240920$20240930$20240930$EXP$$CA-UCBSA-2023058358$UCB$$$$$F$Y$$$20240930$$CN$CA$CA
243801551$24380155$1$I$$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153177$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20240930$$CN$US$US
243801561$24380156$1$I$$20240926$20240930$20240930$EXP$$GB-SANDOZ INC.-SDZ2024GB083290$SANDOZ$$73$YR$$F$Y$70$KG$20240930$$MD$GB$GB
243801581$24380158$1$I$$20240917$20240930$20240930$PER$$US-ASTRAZENECA-202409USA001826US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$MD$US$US
243801591$24380159$1$I$20240911$20240911$20240930$20240930$PER$$US-Eisai-EC-2024-174265$EISAI$$80$YR$E$M$Y$$$20240930$$CN$US$US
243801611$24380161$1$I$20240526$20240918$20240930$20240930$EXP$$NVSC2024US193422$NOVARTIS$$0$YR$$F$Y$$$20240930$$CN$US$US
243801621$24380162$1$I$$20240925$20240930$20240930$PER$$US-JNJFOC-20240971083$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243801631$24380163$1$I$20240101$20240923$20240930$20240930$EXP$$BR-BAYER-2024A136517$BAYER$$54$YR$A$F$Y$$$20240930$$CN$BR$BR
243801641$24380164$1$I$20240101$20240920$20240930$20240930$EXP$$CA-UCBSA-2024040066$UCB$$$$$F$Y$$$20240930$$CN$CA$CA
243801651$24380165$1$I$$20240918$20240930$20240930$EXP$$US-APOTEX-2024AP011322$APOTEX$Zreik J, LaPage MJ, Zreik H.. Congenital Long QT Syndrome Unmasked by Albuterol in an Adolescent with Asthma. The Journal of Emergency Medicine. 2024;1-5$12$YR$$F$Y$$$20240930$$HP$US$US
243801661$24380166$1$I$$20240917$20240930$20240930$PER$$US-ASTRAZENECA-202409USA002756US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
243801671$24380167$1$I$$20240918$20240930$20240930$PER$$US-ASTRAZENECA-202409USA001942US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
243801681$24380168$1$I$20230413$20240918$20240930$20240930$EXP$$US-SANDOZ INC.-NVSC2023US089258$SANDOZ$$61$YR$$M$Y$$$20240930$$CN$US$US
243801691$24380169$1$I$20230201$20240928$20240930$20240930$PER$$US-ROCHE-10000094904$ROCHE$$96$YR$E$F$Y$$$20240930$$CN$US$US
243801711$24380171$1$I$20240802$20240917$20240930$20240930$EXP$$US-AMERICAN REGENT INC-2024003561$AMERICAN REGENT$$63$YR$$M$Y$79.6$KG$20240930$$HP$US$US
243801721$24380172$1$I$$20240916$20240930$20240930$PER$$US-MYLANLABS-2024M1085499$MYLAN$$$$$$Y$$$20240930$$CN$US$US
243801731$24380173$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017147$ELI LILLY AND CO$$30$YR$A$F$Y$$$20240930$$CN$US$US
243801741$24380174$1$I$20240901$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017165$ELI LILLY AND CO$$33$YR$A$M$Y$$$20240930$$CN$US$US
243801751$24380175$1$I$20240720$20240920$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409014126$ELI LILLY AND CO$$$$$$Y$$$20240930$$CN$US$US
243801761$24380176$1$I$$20240925$20240930$20240930$EXP$$JP-009507513-2409JPN003754J$MERCK$$76$YR$$M$Y$$$20240930$$MD$JP$JP
243801771$24380177$1$I$$20240918$20240930$20240930$EXP$$US-SANDOZ INC.-NVSC2023US058796$SANDOZ$$$$$M$Y$$$20240930$$CN$US$US
243801781$24380178$1$I$$20240926$20240930$20240930$EXP$$GR-INCYTE CORPORATION-2024IN010320$INCYTE$$$$$$Y$$$20240930$$MD$GR$GR
243801791$24380179$1$I$$20240906$20240930$20240930$PER$$US-ASTRAZENECA-202409USA004003US$ALEXION PHARMACEUTICALS$$56$YR$A$$Y$$$20240930$$MD$US$US
243801801$24380180$1$I$$20240926$20240930$20240930$PER$$US-BIOGEN-2024BI01280385$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243801811$24380181$1$I$$20240925$20240930$20240930$PER$$US-BIOGEN-2024BI01284249$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243801821$24380182$1$I$$20240925$20240930$20240930$EXP$$CA-SANDOZ INC.-SDZ2024CA082933$SANDOZ$$$$$F$Y$$$20240930$$HP$CA$CA
243801831$24380183$1$I$$20240927$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US083760$SANDOZ$$$$$M$Y$$$20240930$$CN$US$US
243801841$24380184$1$I$$20240917$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN009935$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243801851$24380185$1$I$$20240926$20240930$20240930$PER$$US-JNJFOC-20240974610$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243801861$24380186$1$I$$20240813$20240930$20240930$PER$$US-LUNDBECK-DKLU4002979$LUNDBECK$$$$$$Y$$$20240930$$HP$US$US
243801871$24380187$1$I$$20240917$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN009855$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243801881$24380188$1$I$$20240906$20240930$20240930$PER$$US-ASTRAZENECA-202409USA004096US$ALEXION PHARMACEUTICALS$$80$YR$E$$Y$$$20240930$$PH$US$US
243801891$24380189$1$I$20220413$20240928$20240930$20240930$PER$$US-ROCHE-10000094897$ROCHE$$96$YR$E$F$Y$$$20240930$$HP$US$US
243801901$24380190$1$I$$20240918$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN009938$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243801921$24380192$1$I$$20240923$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA004570US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
243801941$24380194$1$I$20240926$20240927$20240930$20240930$EXP$$PR-BRISTOL-MYERS SQUIBB COMPANY-2024-153761$BRISTOL MYERS SQUIBB$$60$YR$A$M$Y$$$20240930$$HP$PR$PR
243801951$24380195$1$I$$20240927$20240930$20240930$EXP$$BE-BRISTOL-MYERS SQUIBB COMPANY-2024-154284$BRISTOL MYERS SQUIBB$$75$YR$E$F$Y$$$20240930$$MD$BE$BE
243801961$24380196$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154268$BRISTOL MYERS SQUIBB$$56$YR$A$F$Y$$$20240930$$CN$US$US
243801981$24380198$1$I$$20240918$20240930$20240930$EXP$$US-SANDOZ INC.-NVSC2023US099465$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
243801991$24380199$1$I$$20240925$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US083323$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
243802001$24380200$1$I$20240905$20240920$20240930$20240930$EXP$$US-UCBSA-2024048119$UCB$$8$YR$$M$Y$$$20240930$$HP$US$US
243802011$24380201$1$I$20240906$20240918$20240930$20240930$EXP$$US-AMERICAN REGENT INC-2024003564$AMERICAN REGENT$$61$YR$$F$Y$74.5$KG$20240930$$HP$US$US
243802021$24380202$1$I$$20240912$20240930$20240930$PER$$US-Eisai-EC-2024-174375$EISAI$$$$$M$Y$$$20240930$$HP$US$US
243802031$24380203$1$I$$20240923$20240930$20240930$PER$$US-RDY-SPO/USA/24/0014097$DR REDDYS$$52$YR$A$F$Y$$$20240930$$HP$US$US
243802041$24380204$1$I$20240701$20240920$20240930$20240930$PER$$US-Calliditas-2024CAL01349$CALLIDITAS THERAPEUTICS$$56$YR$A$M$Y$83.5$KG$20240930$$CN$US$US
243802051$24380205$1$I$$20240916$20240930$20240930$PER$$US-AstraZeneca-2024A211565$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
243802061$24380206$1$I$$20240909$20240930$20240930$PER$$US-AstraZeneca-2024A211067$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
243802071$24380207$1$I$$20240926$20240930$20240930$PER$$US-JNJFOC-20240973499$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243802081$24380208$1$I$20240701$20240906$20240930$20240930$30DAY$$US-JNJFOC-20240912172$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20240930$$CN$US$US
243802091$24380209$1$I$$20240926$20240930$20240930$EXP$GB-MHRA-MED-202409262224475950-SJNZC$GB-SANDOZ INC.-SDZ2024GB083515$SANDOZ$$$$$M$Y$$$20240930$$HP$GB$GB
243802101$24380210$1$I$20240817$20240926$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US083439$SANDOZ$$58$YR$$M$Y$$$20240930$$HP$US$US
243802111$24380211$1$I$$20240918$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN009912$INCYTE$$$$$$Y$$$20240930$$CN$US$US
243802121$24380212$1$I$$20240916$20240930$20240930$PER$$US-AstraZeneca-2024A211596$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
243802131$24380213$1$I$$20240920$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150780$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240930$$PH$US$US
243802141$24380214$1$I$20220511$20240923$20240930$20240930$EXP$$CA-TAKEDA-2024TUS094980$TAKEDA$$63$YR$$F$Y$$$20240930$$HP$CA$CA
243802151$24380215$1$I$20240925$20240927$20240930$20240930$EXP$$US-GILEAD-2024-0689264$GILEAD$$$$$M$Y$$$20240930$$HP$US$US
243802161$24380216$1$I$20240729$20240926$20240930$20240930$EXP$$JP-ABBVIE-5942090$ABBVIE$$72$YR$$M$Y$$$20240930$$MD$JP$JP
243802171$24380217$1$I$20240801$20240919$20240930$20240930$EXP$$US-UCBSA-2024048628$UCB$$10$YR$$M$Y$$$20240930$$CN$US$US
243802211$24380221$1$I$20240914$20240925$20240930$20240930$EXP$$CN-PFIZER INC-PV202400125663$PFIZER$$47$YR$$F$Y$64$KG$20240930$$HP$CN$CN
243802221$24380222$1$I$$20240924$20240930$20240930$EXP$$CA-BAUSCHBL-BL-2021-013217$BAUSCH AND LOMB$$61$YR$$F$Y$70$KG$20240930$$CN$CA$CA
243802241$24380224$1$I$$20240926$20240930$20240930$EXP$$CN-PFIZER INC-202400245535$PFIZER$$73$YR$$M$Y$$$20240930$$MD$CN$CN
243802251$24380225$1$I$$20240926$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US083853$SANDOZ$$$$$$Y$$$20240930$$HP$US$US
243802261$24380226$1$I$$20240926$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US083581$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
243802271$24380227$1$I$$20240916$20240930$20240930$PER$$US-AstraZeneca-2024A212109$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
243802281$24380228$1$I$$20240923$20240930$20240930$PER$$US-TAKEDA-2024TUS094781$TAKEDA$$$$C$F$Y$$$20240930$$MD$US$US
243802291$24380229$1$I$20240716$20240925$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US083877$SANDOZ$$73$YR$$M$Y$$$20240930$$MD$US$US
243802301$24380230$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247080$TEVA$$65$YR$$$Y$$$20240930$$PH$CA$CA
243802311$24380231$1$I$20221201$20240924$20240930$20240930$EXP$DK-DKMA-30738471$DK-TEVA-VS-3247442$TEVA$$28$YR$$M$Y$$$20240930$$CN$DK$DK
243802331$24380233$1$I$20240101$20240925$20240930$20240930$EXP$$US-TG THERAPEUTICS INC.-TGT004042$TG THERAPEUTICS$$$$$$Y$$$20240930$$CN$US$US
243802341$24380234$1$I$$20240927$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US026798$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
243802351$24380235$1$I$$20240925$20240930$20240930$EXP$$CR-009507513-2409CRI009732$MERCK$$$$$M$Y$$$20240930$$MD$CR$CR
243802361$24380236$1$I$$20240926$20240930$20240930$EXP$$JP-SANDOZ INC.-SDZ2024JP083537$SANDOZ$$87$YR$$F$Y$$$20240930$$CN$JP$JP
243802371$24380237$1$I$20240101$20240920$20240930$20240930$EXP$$AT-TAKEDA-2024TUS096184$TAKEDA$$74$YR$$F$Y$$$20240930$$HP$AT$AT
243802381$24380238$1$I$20240923$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192251$AMGEN$$75$YR$E$M$Y$$$20240930$$CN$US$US
243802391$24380239$1$I$20240915$20240919$20240930$20240930$PER$$US-ABBVIE-5933792$ABBVIE$$52$YR$$F$Y$$$20240930$$CN$US$US
243802401$24380240$1$I$$20240916$20240930$20240930$EXP$$US-NIPPON SHINYAKU-NIP-2024-000051$NIPPON SHINYAKU$$$$$$Y$$$20240930$$CN$US$US
243802411$24380241$1$I$$20240917$20240930$20240930$30DAY$$IT-SA-2024SA280010$SANOFI AVENTIS$$$$A$$Y$$$20240930$$PH$IT$IT
243802421$24380242$1$I$20240829$20240918$20240930$20240930$PER$$US-Ipsen Biopharmaceuticals, Inc.-2024-19108$IPSEN$$49$YR$A$F$Y$$$20240930$$HP$US$US
243802441$24380244$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154122$BRISTOL MYERS SQUIBB$$71$YR$E$F$Y$$$20240930$$HP$US$US
243802451$24380245$1$I$20240330$20240924$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152601$BRISTOL MYERS SQUIBB$$70$YR$E$M$Y$97$KG$20240930$$HP$US$US
243802461$24380246$1$I$$20240918$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409012640$ELI LILLY AND CO$$47$YR$A$$Y$$$20240930$$LW$US$US
243802471$24380247$1$I$$20240928$20240930$20240930$PER$$US-AMGEN-USASP2024193837$AMGEN$$$$$$Y$$$20240930$$PH$US$US
243802481$24380248$1$I$$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018166$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240930$$CN$US$US
243802491$24380249$1$I$$20240930$20240930$20240930$EXP$$CN-ANIPHARMA-2024-CN-000406$ANI$Wei, C, Zhai, F, Jia, C, et al.Immunochemotherapy triggered reversible cerebral vasoconstriction syndrome in a patient with intravascular large B-cell lymphoma..Leukemia + Lymphoma.2024;65(6):848-851.$43$YR$$F$Y$$$20240930$$HP$CN$CN
243802501$24380250$1$I$$20240927$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US032118$SANDOZ$$9$YR$$F$Y$$$20240930$$HP$US$US
243802511$24380251$1$I$20170901$20240925$20240930$20240930$EXP$$FI-SANDOZ INC.-SDZ2024FI082911$SANDOZ$$$$A$$Y$$$20240930$$MD$FI$FI
243802541$24380254$1$I$$20240927$20240930$20240930$EXP$$JP-ABBVIE-5945134$ABBVIE$$$$$$Y$$$20240930$$MD$JP$JP
243802551$24380255$1$I$$20240924$20240930$20240930$EXP$NL-LRB-01003848$NL-TEVA-VS-3247517$TEVA$$63$YR$$M$Y$70$KG$20240930$$CN$NL$NL
243802561$24380256$1$I$$20240918$20240930$20240930$EXP$$US-SANDOZ INC.-NVSC2023US102594$SANDOZ$$$$$M$Y$67.12$KG$20240930$$MD$US$US
243802591$24380259$1$I$$20240930$20240930$20240930$EXP$$IT-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054111$BOEHRINGER INGELHEIM$$$$$$Y$$$20240930$$MD$IT$IT
243802601$24380260$1$I$$20240904$20240930$20240930$PER$$US-TRAVERE-2024TVT00885$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$PH$US$US
243802611$24380261$1$I$20240903$20240904$20240930$20240930$PER$$US-TRAVERE-2024TVT00886$TRAVERE THERAPEUTICS$$27$YR$A$M$Y$$$20240930$$CN$US$US
243802621$24380262$1$I$$20240905$20240930$20240930$PER$$US-TRAVERE-2024TVT00888$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243802631$24380263$1$I$$20240905$20240930$20240930$PER$$US-TRAVERE-2024TVT00893$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243802641$24380264$1$I$20240102$20240209$20240930$20240930$EXP$FR-AFSSAPS-PV2024000105$FR-MYLANLABS-2024M1013481$MYLAN$$15$YR$$F$Y$67.7$KG$20240930$$PH$FR$FR
243802651$24380265$1$I$$20240930$20240930$20240930$EXP$$CN-BAYER-2024A139392$BAYER$$60$YR$A$M$Y$$$20240930$$CN$CN$CN
243802661$24380266$1$I$$20240923$20240930$20240930$EXP$DE-SANDOZ-SDZ2024DE080522$DE-RDY-SPO/DEU/24/0014021$DR REDDYS$$$$$M$Y$$$20240930$$PH$DE$DE
243802681$24380268$1$I$20230101$20240917$20240930$20240930$EXP$$JP-EAGLE PHARMACEUTICALS, INC.-JP-2024EAG000232$EAGLE$Atsuta M, et al.. A case of persistent infection with SARS-CoV-2 during treatment for follicular lymphoma. The 130th Meeting of Chugoku Branch of the Japanese Society of Internal Medicine. 2024;8$68$YR$$F$Y$$$20240930$$MD$JP$JP
243802691$24380269$1$I$$20240919$20240930$20240930$PER$$US-INCYTE CORPORATION-2024IN010096$INCYTE$Fogel LA, Bigley TM, Cole JJ, Estabrook MM, Kitcharoensakkul M. Aicardi-Goutieres syndrome presenting with pneumocystis jirovecii pneumonia. PEDIATR ALLERGY IMMUNOL. 2023;34(e13968):1-4$$$$$Y$$$20240930$$HP$US$US
243802701$24380270$1$I$20240101$20240924$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154061$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240930$$CN$US$US
243802711$24380271$1$I$$20240926$20240930$20240930$EXP$$CA-PFIZER INC-202400264851$PFIZER$$67$YR$$M$Y$$$20240930$$HP$CA$CA
243802721$24380272$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154377$BRISTOL MYERS SQUIBB$$56$YR$A$M$Y$$$20240930$$CN$US$US
243802731$24380273$1$I$$20240924$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154215$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20240930$$HP$US$US
243802741$24380274$1$I$$20240923$20240930$20240930$PER$$US-ASTRAZENECA-202409USA005364US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240930$$MD$US$US
243802751$24380275$1$I$20240101$20240925$20240930$20240930$PER$$US-BIOGEN-2024BI01284251$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243802781$24380278$1$I$$20240923$20240930$20240930$30DAY$$GB-PFIZER INC-PV202400124106$PFIZER$$9$YR$$M$Y$$$20240930$$CN$GB$GB
243802791$24380279$1$I$$20240923$20240930$20240930$30DAY$$US-PFIZER INC-202400262542$PFIZER$$4$YR$$F$Y$$$20240930$$CN$US$US
243802811$24380281$1$I$$20240917$20240930$20240930$EXP$$US-SA-2024SA280350$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240930$$CN$US$US
243802821$24380282$1$I$$20240924$20240930$20240930$EXP$$GB-AMGEN-GBRSL2024191145$AMGEN$$66$YR$E$F$Y$$$20240930$$CN$GB$GB
243802831$24380283$1$I$$20240918$20240930$20240930$PER$$US-JNJFOC-20240954151$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$HP$US$US
243802841$24380284$1$I$20240901$20240925$20240930$20240930$PER$$US-JNJFOC-20240969211$JOHNSON AND JOHNSON$$$$$F$Y$$$20240930$$CN$US$US
243802851$24380285$1$I$20240924$20240925$20240930$20240930$PER$$US-JNJFOC-20240972294$JOHNSON AND JOHNSON$$65$YR$E$$Y$$$20240930$$CN$US$US
243802861$24380286$1$I$$20240923$20240930$20240930$EXP$$US-SA-2024SA278782$SANOFI AVENTIS$Nadeem S, Abdulelah M, Khalid H, Abbas R, Haider O, Wojnowski K.. Beyond expected: a case of severe hypereosinophilia induced by dupilumab therapy. Chest. 2024;166(4):A53-4.$44$YR$A$M$Y$$$20240930$$HP$US$US
243802871$24380287$1$I$$20240920$20240930$20240930$EXP$$CA-TEVA-VS-3247082$TEVA$$69$YR$$M$Y$70$KG$20240930$$PH$CA$CA
243802881$24380288$1$I$$20240926$20240930$20240930$EXP$$GB-Ipsen Biopharmaceuticals, Inc.-2024-19569$IPSEN$$$$$$Y$$$20240930$$HP$GB$GB
243802891$24380289$1$I$$20240923$20240930$20240930$EXP$$US-BEH-2024174593$CSL BEHRING$$44$YR$A$F$Y$64.853$KG$20240930$$CN$US$US
243802901$24380290$1$I$20221201$20240924$20240930$20240930$EXP$DK-DKMA-30738471$DK-MYLANLABS-2024M1087113$MYLAN$$28$YR$$M$Y$$$20240930$$CN$DK$DK
243802913$24380291$3$F$$20240913$20240930$20240930$PER$$US-TRAVERE-2024TVT00899$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243802922$24380292$2$F$20240917$20240917$20240930$20240930$PER$$US-TRAVERE-2024TVT00894$TRAVERE THERAPEUTICS$$36$YR$A$M$Y$$$20240930$$CN$US$US
243802931$24380293$1$I$20240826$20240926$20240930$20240930$EXP$GB-MHRA-MED-202409261145269560-NWBSH$GB-MYLANLABS-2024M1087568$MYLAN$$79$YR$$F$Y$$$20240930$$HP$GB$GB
243802941$24380294$1$I$$20240924$20240930$20240930$EXP$$PL-MYLANLABS-2024M1087043$MYLAN$$64$YR$$F$Y$$$20240930$$MD$PL$PL
243802951$24380295$1$I$$20240924$20240930$20240930$EXP$$ES-MYLANLABS-2024M1087600$MYLAN$$$$$F$Y$$$20240930$$MD$ES$ES
243802961$24380296$1$I$20230501$20240909$20240930$20240930$PER$$US-TRAVERE-2024TVT00900$TRAVERE THERAPEUTICS$$63$YR$A$M$Y$$$20240930$$CN$US$US
243802971$24380297$1$I$20240301$20240906$20240930$20240930$PER$$US-TRAVERE-2024TVT00897$TRAVERE THERAPEUTICS$$65$YR$E$M$Y$$$20240930$$CN$US$US
243802981$24380298$1$I$$20240906$20240930$20240930$PER$$US-TRAVERE-2024TVT00890$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243802991$24380299$1$I$$20240906$20240930$20240930$PER$$US-TRAVERE-2024TVT00889$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243803001$24380300$1$I$$20240906$20240930$20240930$PER$$US-TRAVERE-2024TVT00891$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243803011$24380301$1$I$20240101$20240919$20240930$20240930$EXP$$US-UCBSA-2024048724$UCB$$$$$F$Y$90.703$KG$20240930$$HP$US$US
243803021$24380302$1$I$$20240909$20240930$20240930$PER$$US-TRAVERE-2024TVT00898$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243803031$24380303$1$I$$20240926$20240930$20240930$PER$$US-PFIZER INC-202400264805$PFIZER$$38$YR$$F$Y$$$20240930$$CN$US$US
243803041$24380304$1$I$20240927$20240927$20240930$20240930$PER$$JP-PFIZER INC-PV202400126442$PFIZER$$$$$$Y$$$20240930$$MD$JP$JP
243803051$24380305$1$I$$20240920$20240930$20240930$PER$$US-PFIZER INC-PV202400126561$PFIZER$$$$$M$Y$$$20240930$$CN$US$US
243803071$24380307$1$I$20240101$20240924$20240930$20240930$EXP$$US-SA-2024SA280495$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240930$$CN$US$US
243803081$24380308$1$I$$20240913$20240930$20240930$PER$$US-Eisai-EC-2024-174537$EISAI$$$$$F$Y$$$20240930$$HP$US$US
243803091$24380309$1$I$$20240925$20240930$20240930$EXP$$US-SA-2024SA280287$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240930$$HP$US$US
243803101$24380310$1$I$$20240928$20240930$20240930$PER$$US-PFIZER INC-202400266413$PFIZER$$80$YR$$F$Y$$$20240930$$CN$US$US
243803111$24380311$1$I$20231001$20240924$20240930$20240930$EXP$$DE-SA-2024SA280195$SANOFI AVENTIS$$$$E$M$Y$$$20240930$$MD$DE$DE
243803121$24380312$1$I$$20240925$20240930$20240930$EXP$$DE-SA-2024SA281408$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$DE$DE
243803131$24380313$1$I$$20240926$20240930$20240930$EXP$$US-BAYER-2024A138434$BAYER$$$$$F$Y$$$20240930$$CN$US$US
243803151$24380315$1$I$$20240925$20240930$20240930$EXP$$GB-SA-2024SA281099$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240930$$HP$GB$GB
243803161$24380316$1$I$20240101$20240925$20240930$20240930$EXP$$US-SA-2024SA280521$SANOFI AVENTIS$$7$YR$C$F$Y$$$20240930$$HP$US$US
243803171$24380317$1$I$$20240925$20240930$20240930$EXP$$US-SA-2024SA280421$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240930$$MD$US$US
243803181$24380318$1$I$20060101$20240926$20240930$20240930$EXP$$US-SA-2024SA280443$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240930$$CN$US$US
243803191$24380319$1$I$20220612$20240927$20240930$20240930$EXP$FR-AFSSAPS-MA2024001410$FR-SA-2024SA280566$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240930$$PH$FR$FR
243803201$24380320$1$I$20240701$20240926$20240930$20240930$EXP$$US-SA-2024SA280354$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240930$$MD$US$US
243803211$24380321$1$I$20231011$20240926$20240930$20240930$EXP$FR-AFSSAPS-LL2024001631$FR-SA-2024SA281194$SANOFI AVENTIS$$2$MON$I$M$Y$$$20240930$$MD$FR$FR
243803221$24380322$1$I$20240920$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154132$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$$$20240930$$PH$US$US
243803231$24380323$1$I$$20240919$20240930$20240930$EXP$$US-UCBSA-2024048900$UCB$$$$$F$Y$$$20240930$$HP$US$US
243803241$24380324$1$I$20240901$20240920$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409013984$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240930$$CN$US$US
243803251$24380325$1$I$$20240916$20240930$20240930$PER$$US-MYLANLABS-2024M1085216$MYLAN$$$$$M$Y$86.18$KG$20240930$$CN$US$US
243803271$24380327$1$I$$20240916$20240930$20240930$EXP$$US-ALXN-202409USA001206US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$MD$US$US
243803281$24380328$1$I$20240919$20240923$20240930$20240930$EXP$GB-MHRA-MED-202409231137246970-PVRDM$GB-TEVA-VS-3247112$TEVA$$$$$$Y$$$20240930$$PH$GB$GB
243803291$24380329$1$I$$20240903$20240930$20240930$PER$$US-SA-2024SA097182$SANOFI AVENTIS$$$$T$F$Y$72.562$KG$20240930$$MD$US$US
243803301$24380330$1$I$$20240902$20240930$20240930$PER$$US-SA-2024SA272154$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
243803311$24380331$1$I$20240801$20240904$20240930$20240930$PER$$US-SA-2024SA273393$SANOFI AVENTIS$$47$YR$A$F$Y$111$KG$20240930$$MD$US$US
243803321$24380332$1$I$20240101$20240830$20240930$20240930$PER$$US-SA-2024SA281066$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240930$$MD$US$US
243803341$24380334$1$I$$20240904$20240930$20240930$PER$$US-SA-2023SA373499$SANOFI AVENTIS$$33$YR$A$M$Y$$$20240930$$CN$US$US
243803351$24380335$1$I$$20240814$20240930$20240930$PER$$US-LUNDBECK-DKLU4003008$LUNDBECK$$$$$$Y$$$20240930$$HP$US$US
243803361$24380336$1$I$20240518$20240927$20240930$20240930$EXP$$CN-ORGANON-O2409CHN002337$ORGANON$$24$YR$$F$Y$52$KG$20240930$$HP$CN$CN
243803371$24380337$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA280361$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
243803381$24380338$1$I$20240101$20240910$20240930$20240930$PER$$US-SA-2024SA280385$SANOFI AVENTIS$$33$YR$A$F$Y$61.36$KG$20240930$$MD$US$US
243803391$24380339$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA278678$SANOFI AVENTIS$$$$E$F$Y$60.45$KG$20240930$$MD$US$US
243803401$24380340$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA280341$SANOFI AVENTIS$$$$A$F$Y$54.55$KG$20240930$$MD$US$US
243803411$24380341$1$I$20240101$20240908$20240930$20240930$PER$$US-SA-2024SA277557$SANOFI AVENTIS$$55$YR$A$M$Y$$$20240930$$MD$US$US
243803421$24380342$1$I$20240801$20240904$20240930$20240930$PER$$US-SA-2024SA273536$SANOFI AVENTIS$$$$A$M$Y$$$20240930$$MD$US$US
243803431$24380343$1$I$$20240905$20240930$20240930$PER$$US-SA-2024SA274291$SANOFI AVENTIS$$$$E$F$Y$68.18$KG$20240930$$MD$US$US
243803441$24380344$1$I$$20240906$20240930$20240930$PER$$US-SA-2024SA276011$SANOFI AVENTIS$$$$A$F$Y$61.36$KG$20240930$$MD$US$US
243803451$24380345$1$I$$20240906$20240930$20240930$PER$$US-SA-2024SA274432$SANOFI AVENTIS$$$$E$M$Y$$$20240930$$MD$US$US
243803461$24380346$1$I$20240101$20240905$20240930$20240930$PER$$US-SA-2024SA215314$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240930$$CN$US$US
243803471$24380347$1$I$20231101$20240906$20240930$20240930$PER$$US-SA-2024SA276069$SANOFI AVENTIS$$$$E$M$Y$64.55$KG$20240930$$MD$US$US
243803481$24380348$1$I$20240101$20240911$20240930$20240930$PER$$US-SA-2024SA280478$SANOFI AVENTIS$$53$YR$A$F$Y$72.57$KG$20240930$$MD$US$US
243803491$24380349$1$I$$20240905$20240930$20240930$PER$$US-SA-2024SA273302$SANOFI AVENTIS$$$$C$M$Y$22.27$KG$20240930$$MD$US$US
243803501$24380350$1$I$20240101$20240911$20240930$20240930$PER$$US-SA-2024SA279398$SANOFI AVENTIS$$51$YR$A$M$Y$$$20240930$$CN$US$US
243803511$24380351$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA280280$SANOFI AVENTIS$$$$E$F$Y$61.36$KG$20240930$$MD$US$US
243803521$24380352$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA281120$SANOFI AVENTIS$$$$A$$Y$$$20240930$$CN$US$US
243803531$24380353$1$I$$20240906$20240930$20240930$PER$$US-SA-2024SA276134$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240930$$HP$US$US
243803541$24380354$1$I$$20240906$20240930$20240930$PER$$US-SA-2024SA276337$SANOFI AVENTIS$$19$YR$A$F$Y$$$20240930$$MD$US$US
243803561$24380356$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA278190$SANOFI AVENTIS$$$$A$F$Y$63.64$KG$20240930$$MD$US$US
243803571$24380357$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA280371$SANOFI AVENTIS$$$$A$M$Y$127.27$KG$20240930$$MD$US$US
243803581$24380358$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA280568$SANOFI AVENTIS$$$$E$M$Y$115.66$KG$20240930$$HP$US$US
243803591$24380359$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA280541$SANOFI AVENTIS$$20$YR$A$M$Y$129.2$KG$20240930$$HP$US$US
243803601$24380360$1$I$20240101$20240910$20240930$20240930$PER$$US-SA-2024SA278187$SANOFI AVENTIS$$$$E$F$Y$69.09$KG$20240930$$MD$US$US
243803611$24380361$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA281820$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240930$$MD$US$US
243803621$24380362$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA280447$SANOFI AVENTIS$$$$E$F$Y$63.64$KG$20240930$$MD$US$US
243803631$24380363$1$I$20240801$20240911$20240930$20240930$PER$$US-SA-2024SA278953$SANOFI AVENTIS$$$$A$M$Y$$$20240930$$MD$US$US
243803641$24380364$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA280394$SANOFI AVENTIS$$$$A$F$Y$68.49$KG$20240930$$MD$US$US
243803651$24380365$1$I$20240828$20240909$20240930$20240930$PER$$US-SA-2024SA276042$SANOFI AVENTIS$$$$$M$Y$$$20240930$$CN$US$US
243803661$24380366$1$I$$20240910$20240930$20240930$PER$$US-SA-2024SA278266$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240930$$CN$US$US
243803671$24380367$1$I$20240101$20240909$20240930$20240930$PER$$US-SA-2024SA277460$SANOFI AVENTIS$$85$YR$E$F$Y$72.73$KG$20240930$$MD$US$US
243803681$24380368$1$I$$20240920$20240930$20240930$EXP$$US-AMGEN-USASP2024190480$AMGEN$Angeles-han S. T.; Maccora I.; Ebert J. J. et al.. Treatment and Visual Outcomes in Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy: A Cohort Study. Ocular Immunology and Inflammation. 2024;1-8$13$YR$T$M$Y$$$20240930$$MD$US$US
243803691$24380369$1$I$20240101$20240910$20240930$20240930$PER$$US-SA-2024SA278522$SANOFI AVENTIS$$34$YR$A$F$Y$69.55$KG$20240930$$MD$US$US
243803701$24380370$1$I$$20240910$20240930$20240930$PER$$US-TRAVERE-2024TVT00902$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243803711$24380371$1$I$$20240911$20240930$20240930$PER$$US-TRAVERE-2024TVT00906$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243803721$24380372$1$I$$20240911$20240930$20240930$PER$$US-TRAVERE-2024TVT00905$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243803741$24380374$1$I$$20240913$20240930$20240930$PER$$US-SA-2024SA280682$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240930$$CN$US$US
243803751$24380375$1$I$20240301$20240916$20240930$20240930$PER$$US-SA-2024SA281404$SANOFI AVENTIS$$52$YR$A$M$Y$$$20240930$$CN$US$US
243803761$24380376$1$I$$20240913$20240930$20240930$PER$$US-SA-2024SA280525$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
243803771$24380377$1$I$20240101$20240916$20240930$20240930$PER$$US-SA-2024SA278982$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240930$$CN$US$US
243803781$24380378$1$I$20240701$20240917$20240930$20240930$PER$$US-SA-2024SA281226$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240930$$CN$US$US
243803791$24380379$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA280638$SANOFI AVENTIS$$69$YR$E$M$Y$$$20240930$$CN$US$US
243803801$24380380$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA279754$SANOFI AVENTIS$$$$E$F$Y$$$20240930$$MD$US$US
243803811$24380381$1$I$$20240913$20240930$20240930$PER$$US-SA-2024SA281781$SANOFI AVENTIS$$74$YR$E$$Y$$$20240930$$CN$US$US
243803821$24380382$1$I$20240916$20240916$20240930$20240930$PER$$US-SA-2024SA281050$SANOFI AVENTIS$$86$YR$E$M$Y$$$20240930$$CN$US$US
243803831$24380383$1$I$20240101$20240912$20240930$20240930$PER$$US-SA-2024SA280509$SANOFI AVENTIS$$51$YR$A$F$Y$36.37$KG$20240930$$MD$US$US
243803841$24380384$1$I$$20240912$20240930$20240930$PER$$US-SA-2024SA280562$SANOFI AVENTIS$$$$A$M$Y$$$20240930$$MD$US$US
243803851$24380385$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA218712$SANOFI AVENTIS$$79$YR$E$M$Y$$$20240930$$HP$US$US
243803861$24380386$1$I$20240913$20240916$20240930$20240930$PER$$US-SA-2024SA279439$SANOFI AVENTIS$$81$YR$E$F$Y$$$20240930$$CN$US$US
243803871$24380387$1$I$20240101$20240916$20240930$20240930$PER$$US-SA-2024SA281176$SANOFI AVENTIS$$74$YR$E$F$Y$$$20240930$$CN$US$US
243803881$24380388$1$I$20190101$20240913$20240930$20240930$PER$$US-SA-2024SA280650$SANOFI AVENTIS$$66$YR$E$F$Y$$$20240930$$CN$US$US
243803901$24380390$1$I$$20240918$20240930$20240930$PER$$US-SA-2024SA280572$SANOFI AVENTIS$$$$$M$Y$$$20240930$$CN$US$US
243803911$24380391$1$I$20240529$20240913$20240930$20240930$PER$$US-SA-2024SA281813$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240930$$MD$US$US
243803931$24380393$1$I$$20240913$20240930$20240930$PER$$US-SA-2024SA281868$SANOFI AVENTIS$$26$YR$A$$Y$$$20240930$$CN$US$US
243803941$24380394$1$I$$20240912$20240930$20240930$PER$$US-SA-2024SA280906$SANOFI AVENTIS$$$$$F$Y$$$20240930$$CN$US$US
243803951$24380395$1$I$20240917$20240917$20240930$20240930$PER$$US-SA-2024SA280427$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240930$$MD$US$US
243803961$24380396$1$I$$20240912$20240930$20240930$PER$$US-SA-2024SA281228$SANOFI AVENTIS$$$$$F$Y$$$20240930$$CN$US$US
243803971$24380397$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA275581$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
243803981$24380398$1$I$$20240912$20240930$20240930$PER$$US-SA-2024SA281051$SANOFI AVENTIS$$65$YR$E$$Y$$$20240930$$CN$US$US
243804001$24380400$1$I$20240901$20240912$20240930$20240930$PER$$US-SA-2024SA280465$SANOFI AVENTIS$$29$YR$A$M$Y$95.45$KG$20240930$$MD$US$US
243804011$24380401$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA281799$SANOFI AVENTIS$$29$YR$A$M$Y$$$20240930$$PH$US$US
243804021$24380402$1$I$$20240913$20240930$20240930$PER$$US-SA-2024SA281001$SANOFI AVENTIS$$80$YR$E$$Y$$$20240930$$CN$US$US
243804031$24380403$1$I$20240830$20240916$20240930$20240930$PER$$US-SA-2024SA273378$SANOFI AVENTIS$$58$YR$A$F$Y$$$20240930$$HP$US$US
243804041$24380404$1$I$20240101$20240916$20240930$20240930$PER$$US-SA-2024SA280732$SANOFI AVENTIS$$$$$F$Y$$$20240930$$CN$US$US
243804061$24380406$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA279021$SANOFI AVENTIS$$59$YR$A$M$Y$$$20240930$$CN$US$US
243804071$24380407$1$I$$20240918$20240930$20240930$PER$$US-SA-2024SA280627$SANOFI AVENTIS$$6$YR$C$M$Y$32.7$KG$20240930$$CN$US$US
243804081$24380408$1$I$20240916$20240916$20240930$20240930$PER$$US-SA-2024SA281043$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240930$$CN$US$US
243804091$24380409$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA280945$SANOFI AVENTIS$$$$$F$Y$$$20240930$$CN$US$US
243804101$24380410$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA280109$SANOFI AVENTIS$$64$YR$A$M$Y$$$20240930$$CN$US$US
243804111$24380411$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA276848$SANOFI AVENTIS$$20$YR$A$F$Y$$$20240930$$CN$US$US
243804121$24380412$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA279019$SANOFI AVENTIS$$73$YR$E$M$Y$$$20240930$$CN$US$US
243804131$24380413$1$I$20240916$20240916$20240930$20240930$PER$$US-SA-2024SA280546$SANOFI AVENTIS$$30$YR$A$F$Y$104.33$KG$20240930$$MD$US$US
243804141$24380414$1$I$20240701$20240916$20240930$20240930$PER$$US-SA-2024SA279335$SANOFI AVENTIS$$$$E$M$Y$$$20240930$$CN$US$US
243804151$24380415$1$I$20240801$20240924$20240930$20240930$EXP$$US-Eisai-EC-2024-175484$EISAI$$73$YR$E$M$Y$88$KG$20240930$$CN$US$US
243804161$24380416$1$I$$20240928$20240930$20240930$PER$$NVSC2024US193471$NOVARTIS$$$$$M$Y$$$20240930$$CN$US$US
243804171$24380417$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA273193$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240930$$MD$US$US
243804181$24380418$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA273848$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240930$$MD$US$US
243804191$24380419$1$I$20240916$20240916$20240930$20240930$PER$$US-SA-2024SA279970$SANOFI AVENTIS$$$$I$M$Y$$$20240930$$CN$US$US
243804211$24380421$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA280091$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240930$$CN$US$US
243804221$24380422$1$I$20240910$20240916$20240930$20240930$PER$$US-SA-2024SA276664$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240930$$CN$US$US
243804231$24380423$1$I$20240901$20240919$20240930$20240930$PER$$US-SA-2024SA273181$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240930$$MD$US$US
243804241$24380424$1$I$$20240919$20240930$20240930$PER$$US-SA-2021SA213976$SANOFI AVENTIS$$10$YR$C$F$Y$28$KG$20240930$$MD$US$US
243804251$24380425$1$I$20200101$20240916$20240930$20240930$PER$$US-SA-2024SA280444$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240930$$CN$US$US
243804271$24380427$1$I$$20240916$20240930$20240930$PER$$US-SA-2024SA281088$SANOFI AVENTIS$$$$A$M$Y$$$20240930$$CN$US$US
243804281$24380428$1$I$20240901$20240916$20240930$20240930$PER$$US-SA-2024SA279027$SANOFI AVENTIS$$88$YR$E$M$Y$$$20240930$$MD$US$US
243804291$24380429$1$I$20240901$20240919$20240930$20240930$PER$$US-SA-2024SA174396$SANOFI AVENTIS$$82$YR$E$F$Y$$$20240930$$HP$US$US
243804301$24380430$1$I$$20240919$20240930$20240930$PER$$US-SA-2023SA404503$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240930$$MD$US$US
243804311$24380431$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA083676$SANOFI AVENTIS$$20$YR$A$M$Y$$$20240930$$HP$US$US
243804321$24380432$1$I$20240601$20240919$20240930$20240930$PER$$US-SA-2024SA273093$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240930$$MD$US$US
243804331$24380433$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA273242$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240930$$MD$US$US
243804341$24380434$1$I$$20240916$20240930$20240930$EXP$$AU-ALXN-202409OCE001230AU$ALEXION PHARMACEUTICALS$$$$A$$Y$85$KG$20240930$$$AU$AU
243804351$24380435$1$I$$20240916$20240930$20240930$EXP$$US-ALXN-202409USA001271US$ALEXION PHARMACEUTICALS$$$$A$$Y$$$20240930$$$US$US
243804361$24380436$1$I$$20240916$20240930$20240930$EXP$$US-ALXN-202409USA001293US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240930$$$US$US
243804371$24380437$1$I$$20240916$20240930$20240930$EXP$$US-ALXN-202409USA001180US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240930$$$US$US
243804381$24380438$1$I$$20240916$20240930$20240930$EXP$$US-ALXN-202312USA001304US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240930$$$US$US
243804391$24380439$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA273480$SANOFI AVENTIS$$12$YR$T$F$Y$$$20240930$$MD$US$US
243804401$24380440$1$I$$20240916$20240930$20240930$EXP$$FR-ALXN-202409GLO001150FR$ALEXION PHARMACEUTICALS$$57$YR$A$$Y$64$KG$20240930$$MD$FR$FR
243804411$24380441$1$I$$20240916$20240930$20240930$EXP$$IT-ALXN-202408EEA001235IT$ALEXION PHARMACEUTICALS$$82$YR$E$$Y$62.5$KG$20240930$$$IT$IT
243804421$24380442$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA273841$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240930$$MD$US$US
243804431$24380443$1$I$20240601$20240920$20240930$20240930$PER$$US-SA-2024SA275061$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240930$$MD$US$US
243804441$24380444$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274749$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240930$$HP$US$US
243804451$24380445$1$I$$20240922$20240930$20240930$PER$$US-SA-2021SA115671$SANOFI AVENTIS$$43$YR$A$F$Y$$$20240930$$MD$US$US
243804461$24380446$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA180900$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240930$$HP$US$US
243804471$24380447$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA273924$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240930$$HP$US$US
243804481$24380448$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274186$SANOFI AVENTIS$$22$YR$A$F$Y$$$20240930$$HP$US$US
243804491$24380449$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA274027$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$HP$US$US
243804501$24380450$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274859$SANOFI AVENTIS$$44$YR$A$M$Y$$$20240930$$HP$US$US
243804511$24380451$1$I$20240724$20240919$20240930$20240930$PER$$US-SA-2024SA273832$SANOFI AVENTIS$$77$YR$E$M$Y$$$20240930$$MD$US$US
243804521$24380452$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA275420$SANOFI AVENTIS$$$$E$F$Y$$$20240930$$MD$US$US
243804531$24380453$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA274125$SANOFI AVENTIS$$$$A$M$Y$$$20240930$$HP$US$US
243804541$24380454$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA273859$SANOFI AVENTIS$$4$YR$C$M$Y$$$20240930$$MD$US$US
243804551$24380455$1$I$$20240919$20240930$20240930$PER$$US-SA-2024SA273190$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240930$$MD$US$US
243804561$24380456$1$I$20240901$20240920$20240930$20240930$PER$$US-SA-2024SA275865$SANOFI AVENTIS$$67$YR$E$F$Y$$$20240930$$MD$US$US
243804571$24380457$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274734$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240930$$HP$US$US
243804581$24380458$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA274689$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240930$$HP$US$US
243804591$24380459$1$I$20230701$20240920$20240930$20240930$PER$$US-SA-2024SA275592$SANOFI AVENTIS$$28$YR$A$F$Y$$$20240930$$HP$US$US
243804601$24380460$1$I$20240918$20240923$20240930$20240930$EXP$$US-BEH-2024179238$CSL BEHRING$$51$YR$A$F$Y$72.562$KG$20240930$$HP$US$US
243804611$24380461$1$I$20240701$20240923$20240930$20240930$PER$$US-SA-2024SA275768$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240930$$HP$US$US
243804621$24380462$1$I$20240101$20240921$20240930$20240930$PER$$US-SA-2024SA274655$SANOFI AVENTIS$$49$YR$A$M$Y$$$20240930$$MD$US$US
243804641$24380464$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275342$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240930$$HP$US$US
243804651$24380465$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA276823$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240930$$MD$US$US
243804661$24380466$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA275283$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240930$$MD$US$US
243804671$24380467$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277065$SANOFI AVENTIS$$16$YR$T$M$Y$$$20240930$$MD$US$US
243804681$24380468$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA275701$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240930$$CN$US$US
243804691$24380469$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275569$SANOFI AVENTIS$$35$YR$A$F$Y$$$20240930$$MD$US$US
243804701$24380470$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA276740$SANOFI AVENTIS$$22$YR$A$M$Y$$$20240930$$HP$US$US
243804711$24380471$1$I$20240801$20240923$20240930$20240930$PER$$US-SA-2024SA275256$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240930$$MD$US$US
243804731$24380473$1$I$20240801$20240923$20240930$20240930$PER$$US-SA-2024SA276445$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240930$$HP$US$US
243804751$24380475$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277330$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240930$$MD$US$US
243804761$24380476$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA276404$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240930$$MD$US$US
243804771$24380477$1$I$20240801$20240923$20240930$20240930$PER$$US-SA-2024SA276778$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240930$$MD$US$US
243804781$24380478$1$I$20240701$20240923$20240930$20240930$PER$$US-SA-2024SA275474$SANOFI AVENTIS$$3$YR$C$M$Y$$$20240930$$MD$US$US
243804791$24380479$1$I$20240101$20240924$20240930$20240930$PER$$US-SA-2024SA276961$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240930$$HP$US$US
243804801$24380480$1$I$20240201$20240923$20240930$20240930$PER$$US-SA-2024SA276695$SANOFI AVENTIS$$77$YR$E$F$Y$$$20240930$$MD$US$US
243804811$24380481$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA275316$SANOFI AVENTIS$$73$YR$E$F$Y$$$20240930$$MD$US$US
243804821$24380482$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA275508$SANOFI AVENTIS$$66$YR$E$M$Y$$$20240930$$HP$US$US
243804831$24380483$1$I$$20240925$20240930$20240930$PER$$US-SA-2024SA280185$SANOFI AVENTIS$$23$YR$A$F$Y$$$20240930$$HP$US$US
243804841$24380484$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275275$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240930$$MD$US$US
243804851$24380485$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275397$SANOFI AVENTIS$$29$YR$A$F$Y$$$20240930$$HP$US$US
243804861$24380486$1$I$20240801$20240923$20240930$20240930$PER$$US-SA-2024SA276968$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240930$$HP$US$US
243804871$24380487$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277099$SANOFI AVENTIS$$54$YR$A$M$Y$$$20240930$$MD$US$US
243804881$24380488$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA275323$SANOFI AVENTIS$$6$YR$C$M$Y$$$20240930$$HP$US$US
243804891$24380489$1$I$20240801$20240923$20240930$20240930$PER$$US-SA-2024SA276852$SANOFI AVENTIS$$60$YR$A$M$Y$$$20240930$$HP$US$US
243804901$24380490$1$I$20240101$20240924$20240930$20240930$PER$$US-SA-2024SA277325$SANOFI AVENTIS$$17$YR$T$F$Y$$$20240930$$MD$US$US
243804911$24380491$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA276889$SANOFI AVENTIS$$75$YR$E$M$Y$$$20240930$$MD$US$US
243804921$24380492$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA275260$SANOFI AVENTIS$$11$MON$I$M$Y$$$20240930$$MD$US$US
243804931$24380493$1$I$20240901$20240924$20240930$20240930$PER$$US-SA-2024SA277067$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240930$$MD$US$US
243804941$24380494$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277574$SANOFI AVENTIS$$$$E$M$Y$$$20240930$$HP$US$US
243804951$24380495$1$I$20240101$20240924$20240930$20240930$PER$$US-SA-2024SA277377$SANOFI AVENTIS$$$$T$F$Y$$$20240930$$HP$US$US
243804961$24380496$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275416$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240930$$HP$US$US
243804971$24380497$1$I$20240921$20240924$20240930$20240930$PER$$US-SA-2024SA276717$SANOFI AVENTIS$$48$YR$A$F$Y$$$20240930$$HP$US$US
243804981$24380498$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275749$SANOFI AVENTIS$$75$YR$E$F$Y$$$20240930$$HP$US$US
243804991$24380499$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA275458$SANOFI AVENTIS$$36$YR$A$M$Y$$$20240930$$HP$US$US
243805001$24380500$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277175$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240930$$MD$US$US
243805011$24380501$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA276711$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240930$$MD$US$US
243805021$24380502$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA275627$SANOFI AVENTIS$$26$YR$A$F$Y$$$20240930$$MD$US$US
243805031$24380503$1$I$$20240927$20240930$20240930$PER$$US-USAntibiotics-000340$USAntibiotics$$$$$F$Y$$$20240930$$CN$US$
243805041$24380504$1$I$$20240912$20240930$20240930$PER$$US-USAntibiotics-000339$USAntibiotics$$64$YR$A$F$Y$$$20240926$$MD$US$
243805051$24380505$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277136$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240930$$MD$US$US
243805061$24380506$1$I$20240601$20240924$20240930$20240930$PER$$US-SA-2024SA277003$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240930$$MD$US$US
243805071$24380507$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA277597$SANOFI AVENTIS$$67$YR$E$M$Y$$$20240930$$HP$US$US
243805081$24380508$1$I$20240101$20240924$20240930$20240930$PER$$US-SA-2024SA277177$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240930$$MD$US$US
243805091$24380509$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA276908$SANOFI AVENTIS$$61$YR$A$F$Y$$$20240930$$MD$US$US
243805101$24380510$1$I$20240909$20240923$20240930$20240930$PER$$US-SA-2024SA276541$SANOFI AVENTIS$$9$YR$C$M$Y$$$20240930$$HP$US$US
243805111$24380511$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154172$BRISTOL MYERS SQUIBB$$94$YR$E$F$Y$$$20240930$$CN$US$US
243805121$24380512$1$I$$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152107$BRISTOL MYERS SQUIBB$$50$YR$A$F$Y$$$20240930$$CN$US$US
243805131$24380513$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154202$BRISTOL MYERS SQUIBB$$76$YR$E$M$Y$$$20240930$$CN$US$US
243805141$24380514$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277390$SANOFI AVENTIS$$48$YR$A$M$Y$$$20240930$$HP$US$US
243805151$24380515$1$I$20240901$20240924$20240930$20240930$PER$$US-SA-2024SA277643$SANOFI AVENTIS$$63$YR$A$F$Y$$$20240930$$HP$US$US
243805161$24380516$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277474$SANOFI AVENTIS$$59$YR$A$F$Y$$$20240930$$HP$US$US
243805171$24380517$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA275758$SANOFI AVENTIS$$37$YR$A$F$Y$$$20240930$$HP$US$US
243805181$24380518$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA275432$SANOFI AVENTIS$$61$YR$A$M$Y$$$20240930$$HP$US$US
243805191$24380519$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA275493$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240930$$HP$US$US
243805201$24380520$1$I$20240912$20240923$20240930$20240930$PER$$US-SA-2024SA276934$SANOFI AVENTIS$$2$YR$C$M$Y$$$20240930$$HP$US$US
243805211$24380521$1$I$20240101$20240924$20240930$20240930$PER$$US-SA-2024SA277261$SANOFI AVENTIS$$81$YR$E$M$Y$$$20240930$$HP$US$US
243805221$24380522$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA275736$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240930$$MD$US$US
243805231$24380523$1$I$20240801$20240923$20240930$20240930$PER$$US-SA-2024SA275539$SANOFI AVENTIS$$90$YR$E$F$Y$$$20240930$$HP$US$US
243805251$24380525$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA277297$SANOFI AVENTIS$$41$YR$A$F$Y$$$20240930$$HP$US$US
243805261$24380526$1$I$20240801$20240923$20240930$20240930$PER$$US-SA-2024SA275549$SANOFI AVENTIS$$2$YR$C$F$Y$$$20240930$$MD$US$US
243805271$24380527$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA275691$SANOFI AVENTIS$$42$YR$A$F$Y$$$20240930$$HP$US$US
243805281$24380528$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA277066$SANOFI AVENTIS$$$$T$M$Y$$$20240930$$HP$US$US
243805291$24380529$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA276863$SANOFI AVENTIS$$17$YR$T$M$Y$$$20240930$$MD$US$US
243805301$24380530$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277345$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240930$$HP$US$US
243805311$24380531$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA276514$SANOFI AVENTIS$$70$YR$E$M$Y$$$20240930$$HP$US$US
243805321$24380532$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA276901$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240930$$HP$US$US
243805331$24380533$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA276667$SANOFI AVENTIS$$$$A$M$Y$$$20240930$$HP$US$US
243805341$24380534$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA277157$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$HP$US$US
243805351$24380535$1$I$20240101$20240924$20240930$20240930$PER$$US-SA-2024SA222342$SANOFI AVENTIS$$46$YR$A$F$Y$$$20240930$$MD$US$US
243805361$24380536$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA278380$SANOFI AVENTIS$$$$A$M$Y$$$20240930$$HP$US$US
243805371$24380537$1$I$20240901$20240924$20240930$20240930$PER$$US-SA-2024SA276870$SANOFI AVENTIS$$16$YR$T$F$Y$$$20240930$$MD$US$US
243805381$24380538$1$I$20240701$20240923$20240930$20240930$PER$$US-SA-2024SA276873$SANOFI AVENTIS$$55$YR$A$F$Y$$$20240930$$MD$US$US
243805391$24380539$1$I$20240901$20240924$20240930$20240930$PER$$US-SA-2024SA276592$SANOFI AVENTIS$$40$YR$A$F$Y$$$20240930$$HP$US$US
243805401$24380540$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA276967$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240930$$HP$US$US
243805411$24380541$1$I$20230101$20240923$20240930$20240930$PER$$US-SA-2024SA275200$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240930$$MD$US$US
243805421$24380542$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275753$SANOFI AVENTIS$$62$YR$A$F$Y$$$20240930$$HP$US$US
243805431$24380543$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277038$SANOFI AVENTIS$$54$YR$A$F$Y$$$20240930$$MD$US$US
243805441$24380544$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277379$SANOFI AVENTIS$$71$YR$E$F$Y$$$20240930$$HP$US$US
243805451$24380545$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA276867$SANOFI AVENTIS$$24$YR$A$F$Y$$$20240930$$MD$US$US
243805461$24380546$1$I$20240901$20240924$20240930$20240930$PER$$US-SA-2024SA278658$SANOFI AVENTIS$$56$YR$A$F$Y$$$20240930$$MD$US$US
243805471$24380547$1$I$20240101$20240924$20240930$20240930$PER$$US-SA-2024SA277161$SANOFI AVENTIS$$9$YR$C$F$Y$$$20240930$$MD$US$US
243805481$24380548$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275337$SANOFI AVENTIS$$80$YR$E$F$Y$$$20240930$$HP$US$US
243805491$24380549$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA277112$SANOFI AVENTIS$$44$YR$A$F$Y$$$20240930$$MD$US$US
243805501$24380550$1$I$20240923$20240923$20240930$20240930$PER$$US-JNJFOC-20240962913$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20240930$$PH$US$US
243805511$24380551$1$I$$20240925$20240930$20240930$PER$$US-JNJFOC-20240969975$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20240930$$CN$US$US
243805521$24380552$1$I$$20240924$20240930$20240930$PER$$US-JNJFOC-20240966649$JOHNSON AND JOHNSON$$33$YR$A$F$Y$67.6$KG$20240930$$CN$US$US
243805531$24380553$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA275362$SANOFI AVENTIS$$71$YR$E$M$Y$$$20240930$$HP$US$US
243805541$24380554$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA277602$SANOFI AVENTIS$$$$C$M$Y$$$20240930$$HP$US$US
243805551$24380555$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA275304$SANOFI AVENTIS$$5$YR$C$F$Y$$$20240930$$MD$US$US
243805561$24380556$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275473$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240930$$HP$US$US
243805571$24380557$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA276846$SANOFI AVENTIS$$52$YR$A$F$Y$$$20240930$$MD$US$US
243805581$24380558$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA275377$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240930$$HP$US$US
243805591$24380559$1$I$20240701$20240923$20240930$20240930$PER$$US-SA-2024SA276504$SANOFI AVENTIS$$36$YR$A$F$Y$$$20240930$$HP$US$US
243805601$24380560$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA275359$SANOFI AVENTIS$$78$YR$E$F$Y$$$20240930$$HP$US$US
243805611$24380561$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA276528$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$HP$US$US
243805621$24380562$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275561$SANOFI AVENTIS$$76$YR$E$F$Y$$$20240930$$HP$US$US
243805631$24380563$1$I$20240324$20240924$20240930$20240930$PER$$US-SA-2024SA276776$SANOFI AVENTIS$$34$YR$A$F$Y$$$20240930$$MD$US$US
243805641$24380564$1$I$20240916$20240924$20240930$20240930$PER$$US-SA-2024SA277373$SANOFI AVENTIS$$25$YR$A$F$Y$$$20240930$$HP$US$US
243805651$24380565$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA277006$SANOFI AVENTIS$$$$A$F$Y$$$20240930$$MD$US$US
243805661$24380566$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA275464$SANOFI AVENTIS$$19$YR$A$M$Y$$$20240930$$MD$US$US
243805671$24380567$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA276927$SANOFI AVENTIS$$60$YR$A$F$Y$$$20240930$$HP$US$US
243805681$24380568$1$I$20240920$20240923$20240930$20240930$PER$$US-SA-2024SA276906$SANOFI AVENTIS$$31$YR$A$F$Y$$$20240930$$HP$US$US
243805691$24380569$1$I$20240801$20240923$20240930$20240930$PER$$US-SA-2024SA276548$SANOFI AVENTIS$$$$$M$Y$$$20240930$$HP$US$US
243805701$24380570$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA277416$SANOFI AVENTIS$$24$YR$A$M$Y$$$20240930$$HP$US$US
243805711$24380571$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA277343$SANOFI AVENTIS$$$$E$F$Y$$$20240930$$HP$US$US
243805721$24380572$1$I$20240901$20240925$20240930$20240930$PER$$US-SA-2024SA280561$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240930$$MD$US$US
243805741$24380574$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275268$SANOFI AVENTIS$$23$YR$A$M$Y$$$20240930$$MD$US$US
243805751$24380575$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA276588$SANOFI AVENTIS$$68$YR$E$F$Y$$$20240930$$MD$US$US
243805761$24380576$1$I$$20240923$20240930$20240930$EXP$$AU-GILEAD-2024-0689211$GILEAD$$85$YR$E$F$Y$$$20240930$$HP$AU$AU
243805771$24380577$1$I$$20240916$20240930$20240930$EXP$$US-ALXN-202409USA001207US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$MD$US$US
243805781$24380578$1$I$$20240925$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US083400$SANDOZ$$$$$F$Y$$$20240930$$HP$US$US
243805791$24380579$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275871$SANOFI AVENTIS$$14$YR$T$M$Y$$$20240930$$HP$US$US
243805801$24380580$1$I$$20240926$20240930$20240930$EXP$$US-BAYER-2024A138395$BAYER$$72$YR$E$M$Y$$$20240930$$MD$US$US
243805811$24380581$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA276681$SANOFI AVENTIS$$62$YR$A$M$Y$$$20240930$$HP$US$US
243805821$24380582$1$I$$20240923$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA007499US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240930$$$US$US
243805841$24380584$1$I$$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192784$AMGEN$$$$$M$Y$$$20240930$$CN$US$US
243805851$24380585$1$I$20240914$20240926$20240930$20240930$EXP$IT-MINISAL02-1003063$IT-BAYER-2024A137802$BAYER$$64$YR$A$F$Y$59$KG$20240930$$CN$IT$IT
243805861$24380586$1$I$$20240925$20240930$20240930$EXP$$BR-GENMAB-2024-03547$GENMAB$$$$$M$Y$$$20240930$$MD$BR$BR
243805871$24380587$1$I$20201217$20240920$20240930$20240930$EXP$$FR-CHIESI LTD.-AEGR007427$AEGERION$$$$$$Y$$$20240930$$MD$FR$FR
243805881$24380588$1$I$20240911$20240912$20240930$20240930$PER$$US-TRAVERE-2024TVT00912$TRAVERE THERAPEUTICS$$48$YR$A$F$Y$$$20240930$$CN$US$US
243805891$24380589$1$I$$20240912$20240930$20240930$PER$$US-TRAVERE-2024TVT00910$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243805901$24380590$1$I$$20240912$20240930$20240930$PER$$US-TRAVERE-2024TVT00908$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243805911$24380591$1$I$$20240912$20240930$20240930$PER$$US-TRAVERE-2024TVT00909$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243805921$24380592$1$I$20220801$20240923$20240930$20240930$EXP$$GB-DSJP-DS-2024-101201-GB$DAIICHI$$43$YR$$F$Y$$$20240930$$HP$GB$GB
243805931$24380593$1$I$20240101$20240921$20240930$20240930$PER$$US-JNJFOC-20240965462$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20240930$$CN$US$US
243805941$24380594$1$I$$20240906$20240930$20240930$PER$$US-ASTRAZENECA-202409USA004171US$ALEXION PHARMACEUTICALS$$68$YR$E$$Y$$$20240930$$PH$US$US
243805951$24380595$1$I$$20240918$20240930$20240930$EXP$$CA-DAIICHI SANKYO, INC.-DS-2024-101647-CA$DAIICHI$$$$$F$Y$$$20240930$$CN$CA$CA
243805961$24380596$1$I$$20240918$20240930$20240930$EXP$$CA-DSJP-DS-2024-101620-CAAA$DAIICHI$$68$YR$$F$Y$$$20240930$$MD$CA$CA
243805981$24380598$1$I$$20240917$20240930$20240930$PER$$US-FARMAPROD-202407-2551$DOMPE FARMACEUTICI$$87$YR$E$F$Y$$$20240930$$HP$US$US
243805991$24380599$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154386$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240930$$MD$US$US
243806011$24380601$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154189$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240930$$CN$US$US
243806021$24380602$1$I$$20240918$20240930$20240930$EXP$$CA-DSJP-DS-2024-101701-CAAA$DAIICHI$$$$$F$Y$$$20240930$$CN$CA$CA
243806031$24380603$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409016699$ELI LILLY AND CO$$75$YR$E$$Y$$$20240930$$CN$US$US
243806051$24380605$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017246$ELI LILLY AND CO$$51$YR$A$F$Y$$$20240930$$CN$US$US
243806061$24380606$1$I$$20240924$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151999$BRISTOL MYERS SQUIBB$$60$YR$A$F$Y$59$KG$20240930$$PH$US$US
243806071$24380607$1$I$20240912$20240919$20240930$20240930$PER$$US-SA-2024SA273380$SANOFI AVENTIS$$65$YR$E$F$Y$$$20240930$$HP$US$US
243806081$24380608$1$I$$20240924$20240930$20240930$EXP$$US-JNJFOC-20240979144$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$HP$US$US
243806091$24380609$1$I$$20240924$20240930$20240930$EXP$$JP-ABBVIE-5944507$ABBVIE$$15$YR$$M$Y$$$20240930$$CN$JP$JP
243806101$24380610$1$I$$20240920$20240930$20240930$EXP$$US-RADIUS HEALTH INC.-2024US006813$RADIUS PHARM$$$$$M$Y$$$20240930$$CN$US$US
243806111$24380611$1$I$$20240925$20240930$20240930$EXP$$AU-MYLANLABS-2024M1086972$MYLAN$$$$$F$Y$$$20240930$$CN$AU$AU
243806121$24380612$1$I$20240525$20240924$20240930$20240930$EXP$FR-AFSSAPS-AVMA2024000421$FR-MYLANLABS-2024M1086728$MYLAN$$51$YR$$M$Y$$$20240930$$PH$FR$FR
243806131$24380613$1$I$$20240913$20240930$20240930$PER$$US-TRAVERE-2024TVT00915$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243806141$24380614$1$I$$20240916$20240930$20240930$EXP$$CA-CIPHER-2024-CA-000784$CIPHER$$40$YR$$F$Y$$$20240930$$HP$CA$CA
243806152$24380615$2$F$$20240917$20240930$20240930$PER$$US-TRAVERE-2024TVT00914$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243806161$24380616$1$I$$20240913$20240930$20240930$PER$$US-TRAVERE-2024TVT00916$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243806171$24380617$1$I$$20240913$20240930$20240930$PER$$US-TRAVERE-2024TVT00913$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243806181$24380618$1$I$20240713$20240920$20240930$20240930$EXP$$US-ARDELYX-2024ARDX006586$ARDELYX$$73$YR$$F$Y$61$KG$20241001$$HP$US$US
243806211$24380621$1$I$$20240914$20240930$20240930$PER$$US-JNJFOC-20240947834$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20240930$$CN$US$US
243806231$24380623$1$I$$20240925$20240930$20240930$EXP$$US-LUNDBECK-DKLU4004728$LUNDBECK$$$$$$Y$$$20240930$$HP$US$US
243806241$24380624$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152075$BRISTOL MYERS SQUIBB$Roperia V. Checkpoint confusion, aseptic encephalitis after immune checkpoint inhibitor therapy. Chest. 2024;166(4S):2342A-3A. doi:10.1016/j.chest.2024.06.1435.$67$YR$E$M$Y$$$20240930$$HP$US$US
243806251$24380625$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154388$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20240930$$CN$US$US
243806261$24380626$1$I$$20240916$20240930$20240930$PER$$US-MYLANLABS-2024M1085597$MYLAN$$43$YR$$$Y$$$20240930$$CN$US$US
243806271$24380627$1$I$$20240917$20240930$20240930$PER$$US-JNJFOC-20240972936$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240930$$CN$US$US
243806301$24380630$1$I$20180224$20240924$20240930$20240930$EXP$FR-AFSSAPS-RE2024000879$FR-TEVA-VS-3247358$TEVA$$69$YR$$M$Y$109$KG$20240930$$MD$FR$FR
243806311$24380631$1$I$$20240918$20240930$20240930$EXP$$CA-DAIICHI SANKYO, INC.-DS-2024-101779-CA$DAIICHI$$67$YR$$F$Y$$$20240930$$CN$CA$CA
243806321$24380632$1$I$$20240814$20240930$20240930$PER$$US-LUNDBECK-DKLU4002977$LUNDBECK$$$$$$Y$$$20240930$$HP$US$US
243806331$24380633$1$I$$20240918$20240930$20240930$EXP$$CA-DSJP-DS-2024-101818-CAAA$DAIICHI$$$$$F$Y$$$20240930$$CN$CA$CA
243806341$24380634$1$I$20240717$20240928$20240930$20240930$EXP$$HR-BAUSCH-BL-2024-014625$BAUSCH AND LOMB$$74$YR$$F$Y$$$20240930$$MD$HR$HR
243806351$24380635$1$I$$20240929$20240930$20240930$EXP$$BE-BAUSCH-BL-2024-014654$BAUSCH AND LOMB$$75$YR$$F$Y$$$20240930$$MD$BE$BE
243806361$24380636$1$I$$20240929$20240930$20240930$EXP$$BE-BAUSCH-BL-2024-014656$BAUSCH AND LOMB$$62$YR$$F$Y$$$20240930$$MD$BE$BE
243806371$24380637$1$I$20240101$20240919$20240930$20240930$PER$$US-IMP-2024000768$Harrow Health$$78$YR$E$F$Y$$$20240930$$CN$US$US
243806381$24380638$1$I$$20240921$20240930$20240930$PER$$US-IMP-2024000771$Harrow Health$$$$E$M$Y$$$20240930$$CN$US$US
243806391$24380639$1$I$20240905$20240923$20240930$20240930$EXP$$GB-BAUSCH-BL-2024-014608$BAUSCH AND LOMB$$77$YR$$M$Y$$$20240930$$HP$GB$GB
243806401$24380640$1$I$20240901$20240923$20240930$20240930$PER$$US-IMP-2024000772$Harrow Health$$$$$M$Y$$$20240930$$CN$US$US
243806411$24380641$1$I$$20240915$20240930$20240930$EXP$$FR-DSJP-DS-2024-100184-FR$DAIICHI$$$$$F$Y$$$20240930$$MD$FR$FR
243806421$24380642$1$I$$20240923$20240930$20240930$PER$$US-IMP-2024000776$Harrow Health$$$$E$F$Y$$$20240930$$CN$US$US
243806431$24380643$1$I$20230101$20240925$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152990$BRISTOL MYERS SQUIBB$$86$YR$E$M$Y$$$20240930$$CN$US$US
243806441$24380644$1$I$$20240929$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154093$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$84.82$KG$20240930$$CN$US$US
243806452$24380645$2$F$$20240923$20240930$20240930$PER$$US-TRAVERE-2024TVT00927$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$HP$US$US
243806461$24380646$1$I$$20240916$20240930$20240930$PER$$US-TRAVERE-2024TVT00920$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243806471$24380647$1$I$$20240916$20240930$20240930$PER$$US-TRAVERE-2024TVT00919$TRAVERE THERAPEUTICS$$46$YR$A$M$Y$$$20240930$$CN$US$US
243806481$24380648$1$I$$20240916$20240930$20240930$PER$$US-TRAVERE-2024TVT00921$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243806491$24380649$1$I$$20240916$20240930$20240930$PER$$US-TRAVERE-2024TVT00924$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243806511$24380651$1$I$$20240916$20240930$20240930$PER$$US-TRAVERE-2024TVT00923$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243806521$24380652$1$I$$20240924$20240930$20240930$EXP$$IT-MYLANLABS-2024M1087565$MYLAN$Torre D, Mangino D, Macchi V, De Caro R, Pirri C, Stecco C, Porzionato A.. Ibrutinib?Induced Ventricular Electrical Storm SuccessfullyManaged with Veno?Arterial ECMO and IntralipidAdministration: A Rare Case Report.. Ann Card Anaesth.$55$YR$$M$Y$$$20240930$$HP$IT$IT
243806541$24380654$1$I$$20240918$20240930$20240930$PER$$US-JNJFOC-20240974398$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240930$$CN$US$US
243806551$24380655$1$I$$20240919$20240930$20240930$PER$$US-JNJFOC-20240973849$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$PH$US$US
243806561$24380656$1$I$$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193907$AMGEN$$$$$$Y$$$20240930$$CN$US$US
243806571$24380657$1$I$$20240928$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153922$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$74.84$KG$20240930$$CN$US$US
243806581$24380658$1$I$20240920$20240928$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154199$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$57.61$KG$20240930$$CN$US$US
243806591$24380659$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154412$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240930$$HP$US$US
243806601$24380660$1$I$20240918$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154175$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240930$$PH$US$US
243806611$24380661$1$I$$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152965$BRISTOL MYERS SQUIBB$Bashir Z, Alamin FA, Ly V. Immune checkpoint inhibitor-induced sarcoidosis in a patient with high-grade urothelial carcinoma. Chest. 2024;166(4S):5477A-8A. doi:10.1016/j.chest.2024.06.3254.$75$YR$E$M$Y$$$20240930$$HP$US$US
243806621$24380662$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154101$BRISTOL MYERS SQUIBB$$58$YR$A$M$Y$73.48$KG$20240930$$CN$US$US
243806631$24380663$1$I$$20240923$20240930$20240930$EXP$$SE-BRISTOL-MYERS SQUIBB COMPANY-2024-152354$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20240930$$CN$SE$SE
243806641$24380664$1$I$20240922$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152399$BRISTOL MYERS SQUIBB$$77$YR$E$M$Y$$$20240930$$CN$US$US
243806651$24380665$1$I$$20240926$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153304$BRISTOL MYERS SQUIBB$$64$YR$A$M$Y$$$20240930$$PH$US$US
243806661$24380666$1$I$$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018165$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243806671$24380667$1$I$20240925$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017582$ELI LILLY AND CO$$57$YR$A$$Y$$$20240930$$CN$US$US
243806681$24380668$1$I$$20240924$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202408017274$ELI LILLY AND CO$$52$YR$A$F$Y$$$20240930$$CN$US$US
243806691$24380669$1$I$$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409171437498150-WKQPR$GB-ELI_LILLY_AND_COMPANY-GB202409013195$ELI LILLY AND CO$$48$YR$A$F$Y$90$KG$20240930$$CN$GB$GB
243806701$24380670$1$I$$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018136$ELI LILLY AND CO$$63$YR$A$$Y$$$20240930$$CN$US$US
243806711$24380671$1$I$20240902$20240918$20240930$20240930$EXP$GB-MHRA-MED-202409061903377160-BPZVL$GB-ELI_LILLY_AND_COMPANY-GB202409012216$ELI LILLY AND CO$$$$$M$Y$108$KG$20240930$$CN$GB$GB
243806721$24380672$1$I$$20240925$20240930$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409016208$ELI LILLY AND CO$$62$YR$A$F$Y$$$20240930$$CN$US$US
243806731$24380673$1$I$20240919$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017671$ELI LILLY AND CO$$45$YR$A$F$Y$$$20240930$$CN$US$US
243806741$24380674$1$I$$20240919$20240930$20240930$EXP$$PT-ELI_LILLY_AND_COMPANY-PT202409012282$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$PT$PT
243806751$24380675$1$I$$20240925$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017413$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$US$US
243806761$24380676$1$I$20240808$20240919$20240930$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409013164$ELI LILLY AND CO$$80$YR$E$M$Y$$$20240930$$CN$US$US
243806771$24380677$1$I$$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409171515175460-HCQWD$GB-ELI_LILLY_AND_COMPANY-GB202409013253$ELI LILLY AND CO$$31$YR$A$F$Y$$$20240930$$CN$GB$GB
243806781$24380678$1$I$$20240918$20240930$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409012945$ELI LILLY AND CO$$$$$$Y$$$20240930$$CN$US$US
243806791$24380679$1$I$$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409171455405880-BKTFP$GB-ELI_LILLY_AND_COMPANY-GB202409013227$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$GB$GB
243806801$24380680$1$I$$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409181107517960-HZTRQ$GB-ELI_LILLY_AND_COMPANY-GB202409013241$ELI LILLY AND CO$$$$$F$Y$$$20240930$$CN$GB$GB
243806811$24380681$1$I$20240801$20240918$20240930$20240930$EXP$GB-MHRA-MED-202409181508190800-MZBNJ$GB-ELI_LILLY_AND_COMPANY-GB202409012308$ELI LILLY AND CO$$58$YR$A$M$Y$167$KG$20240930$$CN$GB$GB
243806821$24380682$1$I$20240701$20240918$20240930$20240930$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409011819$ELI LILLY AND CO$$51$YR$A$M$Y$$$20240930$$CN$DE$DE
243806831$24380683$1$I$$20240918$20240930$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409013353$ELI LILLY AND CO$$53$YR$A$F$Y$$$20240930$$HP$US$US
243806841$24380684$1$I$$20240918$20240930$20240930$EXP$$PL-ELI_LILLY_AND_COMPANY-PL202409013751$ELI LILLY AND CO$$$$$M$Y$$$20240930$$CN$PL$PL
243806851$24380685$1$I$20240925$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017433$ELI LILLY AND CO$$$$$$Y$$$20240930$$CN$US$US
243806861$24380686$1$I$$20240923$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015928$ELI LILLY AND CO$$60$YR$A$F$Y$$$20240930$$MD$US$US
243806871$24380687$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017473$ELI LILLY AND CO$$49$YR$A$M$Y$$$20240930$$CN$US$US
243806881$24380688$1$I$20240605$20240924$20240930$20240930$EXP$$DE-ELI_LILLY_AND_COMPANY-DE202409015841$ELI LILLY AND CO$$$$N$$Y$2.84$KG$20240930$$PH$DE$DE
243806901$24380690$1$I$$20240916$20240930$20240930$EXP$$CA-CIPHER-2024-CA-000783$CIPHER$$54$YR$A$F$Y$$$20240930$$HP$CA$CA
243806921$24380692$1$I$$20240926$20240930$20240930$EXP$$US-PFIZER INC-202400265694$PFIZER$$47$YR$$F$Y$$$20240930$$MD$US$US
243806951$24380695$1$I$$20240920$20240930$20240930$PER$$US-GSK-US2024117108$GLAXOSMITHKLINE$$$$$F$Y$$$20240930$$CN$US$US
243806961$24380696$1$I$$20240918$20240930$20240930$PER$$US-TRAVERE-2024TVT00933$TRAVERE THERAPEUTICS$$$$$$Y$$$20240930$$CN$US$US
243806971$24380697$1$I$$20240918$20240930$20240930$PER$$US-TRAVERE-2024TVT00928$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$MD$US$US
243806981$24380698$1$I$$20240918$20240930$20240930$PER$$US-TRAVERE-2024TVT00931$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243806991$24380699$1$I$$20240916$20240930$20240930$EXP$$CA-CIPHER-2024-CA-000785$CIPHER$$44$YR$A$F$Y$70$KG$20240930$$HP$CA$CA
243807001$24380700$1$I$20240101$20240920$20240930$20240930$EXP$$NVSC2024US189513$NOVARTIS$$$$$F$Y$80.3$KG$20240930$$CN$US$US
243807011$24380701$1$I$$20240917$20240930$20240930$PER$$US-TRAVERE-2024TVT00934$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243807021$24380702$1$I$$20240918$20240930$20240930$PER$$US-TRAVERE-2024TVT00930$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243807041$24380704$1$I$$20240928$20240930$20240930$PER$$US-HALEON-2199418$Haleon PLC$$$$$$Y$$$20240930$$CN$US$US
243807051$24380705$1$I$20240920$20240926$20240930$20240930$PER$$US-BAYER-2024A138321$BAYER$$35$YR$A$F$Y$$$20240930$$HP$US$US
243807061$24380706$1$I$20240920$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153282$BRISTOL MYERS SQUIBB$$81$YR$E$F$Y$$$20240930$$CN$US$US
243807071$24380707$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153856$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$$$20240930$$HP$US$US
243807081$24380708$1$I$20240926$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154374$BRISTOL MYERS SQUIBB$$92$YR$E$F$Y$$$20240930$$CN$US$US
243807091$24380709$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153342$BRISTOL MYERS SQUIBB$$39$YR$A$F$Y$$$20240930$$HP$US$US
243807101$24380710$1$I$$20240927$20240930$20240930$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-2024-154155$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20240930$$HP$CA$CA
243807121$24380712$1$I$20210101$20240925$20240930$20240930$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-152953$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240930$$MD$DE$DE
243807131$24380713$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154066$BRISTOL MYERS SQUIBB$$81$YR$E$M$Y$70.76$KG$20240930$$CN$US$US
243807141$24380714$1$I$20240201$20240925$20240930$20240930$EXP$$US-ABBVIE-5939257$ABBVIE$$60$YR$$M$Y$$$20240930$$CN$US$US
243807151$24380715$1$I$$20240923$20240930$20240930$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-2024-154070$BRISTOL MYERS SQUIBB$Pieterse E, Van Ingen J, Van der Meijden W. Pneumocystis jirovecii pneumonia in kidney transplant recipients receiving belatacept: a report of two cases with atypical presentations. Kidney Medicine. 2024;6(10):1-4. doi:10.1016/j.xkme.2024.100891.$5$DEC$A$F$Y$$$20240930$$MD$NL$NL
243807161$24380716$1$I$20240101$20240927$20240930$20240930$EXP$$US-KYOWAKIRIN-2024KK022303$KYOWA$$$$$$Y$$$20240930$$HP$US$US
243807171$24380717$1$I$20240622$20240924$20240930$20240930$EXP$FR-AFSSAPS-AVMA2024000414$FR-MYLANLABS-2024M1086995$MYLAN$$23$YR$$$Y$$$20240930$$MD$FR$FR
243807181$24380718$1$I$$20240927$20240930$20240930$EXP$$BG-BAUSCH-BL-2024-014602$BAUSCH AND LOMB$$52$YR$$F$Y$$$20240930$$MD$BG$BG
243807191$24380719$1$I$20240927$20240927$20240930$20240930$PER$$US-BAUSCH-BL-2024-014605$BAUSCH AND LOMB$$70$YR$$M$Y$$$20240930$$CN$US$US
243807201$24380720$1$I$20240813$20240924$20240930$20240930$EXP$$CA-LUNDBECK-DKLU4004663$LUNDBECK$$$$$$Y$$$20240930$$CN$CA$CA
243807211$24380721$1$I$20240831$20240926$20240930$20240930$PER$$US-ROCHE-10000092939$ROCHE$$24$YR$A$M$Y$$$20240930$$CN$US$US
243807221$24380722$1$I$$20240928$20240930$20240930$EXP$$BE-BAUSCH-BL-2024-014617$BAUSCH AND LOMB$$53$YR$$$Y$$$20240930$$MD$BE$BE
243807241$24380724$1$I$20180216$20240924$20240930$20240930$EXP$FR-AFSSAPS-AM2024000750$FR-TEVA-VS-3247330$TEVA$$5$YR$$M$Y$26$KG$20240930$$MD$FR$FR
243807251$24380725$1$I$20240904$20240918$20240930$20240930$PER$$US-TRAVERE-2024TVT00935$TRAVERE THERAPEUTICS$$45$YR$A$F$Y$$$20240930$$CN$US$US
243807271$24380727$1$I$$20240920$20240930$20240930$PER$$US-TRAVERE-2024TVT00940$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$MD$US$US
243807281$24380728$1$I$$20240925$20240930$20240930$EXP$$CA-BAUSCH-BL-2024-014466$BAUSCH AND LOMB$$$$$M$Y$$$20240930$$CN$CA$CA
243807292$24380729$2$F$20240801$20240924$20240930$20240930$PER$$US-TRAVERE-2024TVT00944$TRAVERE THERAPEUTICS$$67$YR$E$M$Y$$$20240930$$CN$US$US
243807301$24380730$1$I$$20240919$20240930$20240930$PER$$US-TRAVERE-2024TVT00938$TRAVERE THERAPEUTICS$$42$YR$A$F$Y$$$20240930$$CN$US$US
243807311$24380731$1$I$$20240920$20240930$20240930$PER$$US-TRAVERE-2024TVT00943$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243807321$24380732$1$I$$20240920$20240930$20240930$PER$$US-TRAVERE-2024TVT00945$TRAVERE THERAPEUTICS$$$$$F$Y$$$20240930$$CN$US$US
243807341$24380734$1$I$20240101$20240926$20240930$20240930$EXP$$US-KARYOPHARM-2024KPT001590$KARYOPHARM THERAPEUTICS$$$$$$Y$$$20240930$$CN$US$US
243807361$24380736$1$I$$20240919$20240930$20240930$PER$$US-TRAVERE-2024TVT00941$TRAVERE THERAPEUTICS$$52$YR$A$M$Y$$$20240930$$CN$US$US
243807381$24380738$1$I$20240918$20240924$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409015934$ELI LILLY AND CO$$47$YR$A$F$Y$$$20240930$$CN$US$US
243807391$24380739$1$I$$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018036$ELI LILLY AND CO$$62$YR$A$M$Y$$$20240930$$CN$US$US
243807401$24380740$1$I$$20240929$20240930$20240930$PER$$US-AMGEN-USASP2024193910$AMGEN$$$$$$Y$$$20240930$$MD$US$US
243807411$24380741$1$I$20240914$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153061$BRISTOL MYERS SQUIBB$$82$YR$E$M$Y$$$20240930$$CN$US$US
243807421$24380742$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153765$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20240930$$HP$US$US
243807431$24380743$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154364$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20240930$$CN$US$US
243807441$24380744$1$I$20240901$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024191385$AMGEN$$63$YR$A$M$Y$$$20240930$$CN$US$US
243807451$24380745$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153927$BRISTOL MYERS SQUIBB$$69$YR$E$M$Y$$$20240930$$CN$US$US
243807461$24380746$1$I$20240927$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154280$BRISTOL MYERS SQUIBB$$79$YR$E$F$Y$$$20240930$$MD$US$US
243807471$24380747$1$I$20240101$20240924$20240930$20240930$EXP$SE-SEMPA-2024-006611$SE-MYLANLABS-2024M1087091$MYLAN$$82$YR$$F$Y$$$20240930$$MD$SE$SE
243807481$24380748$1$I$$20240926$20240930$20240930$PER$$US-ABBVIE-5942264$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243807491$24380749$1$I$$20240920$20240930$20240930$EXP$$US-VERTEX PHARMACEUTICALS-2024-015202$VERTEX$Cohen LA, Ratti GA, Gorman AR, Garcia B, Mingora CM.. Long-term clinical efficacy of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis + pre-existing advanced lung disease at treatment initiation. Chest Pulm. 2024;100099$$$A$$Y$$$20240930$$MD$US$US
243807501$24380750$1$I$$20240924$20240930$20240930$PER$$US-TRAVERE-2024TVT00954$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243807511$24380751$1$I$$20240923$20240930$20240930$PER$$US-TRAVERE-2024TVT00950$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243807521$24380752$1$I$$20240923$20240930$20240930$PER$$US-TRAVERE-2024TVT00952$TRAVERE THERAPEUTICS$$27$YR$A$M$Y$$$20240930$$CN$US$US
243807531$24380753$1$I$$20240923$20240930$20240930$PER$$US-TRAVERE-2024TVT00956$TRAVERE THERAPEUTICS$$$$$M$Y$$$20240930$$CN$US$US
243807551$24380755$1$I$20240201$20240920$20240930$20240930$PER$$US-TRAVERE-2024TVT00947$TRAVERE THERAPEUTICS$$43$YR$A$F$Y$$$20240930$$CN$US$US
243807561$24380756$1$I$$20240920$20240930$20240930$PER$$US-TRAVERE-2024TVT00946$TRAVERE THERAPEUTICS$$44$YR$A$M$Y$$$20240930$$CN$US$US
243807571$24380757$1$I$20240924$20240924$20240930$20240930$PER$$US-HALEON-2198591$Haleon PLC$$64$YR$$F$Y$$$20240930$$CN$US$US
243807581$24380758$1$I$20240920$20240924$20240930$20240930$PER$$US-Eisai-EC-2024-175302$EISAI$$60$YR$A$F$Y$$$20240930$$CN$US$US
243807591$24380759$1$I$20240101$20240924$20240930$20240930$PER$$US-Eisai-EC-2024-172155$EISAI$$75$YR$E$M$Y$68.6$KG$20240930$$CN$US$US
243807601$24380760$1$I$20240101$20240918$20240930$20240930$EXP$$PT-Vifor (International) Inc.-VIT-2024-08822$VIFOR$$$$E$M$Y$$$20240930$$HP$PT$PT
243807611$24380761$1$I$$20240920$20240930$20240930$EXP$$NVSC2024AU192339$NOVARTIS$Yeoh K, Lass-Florl C, Lamoth F, Slavin MA, Williams E, Neofytos D. Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual. TRANSPL-INFECT-DIS. 2024;412-8$53$YR$$F$Y$$$20240930$$HP$AU$AU
243807621$24380762$1$I$$20240923$20240930$20240930$EXP$GB-MHRA-MIDB-2296d7fc-595e-4c4d-ba09-75b4c72d24ae$GB-RDY-SPO/GBR/24/0014104$DR REDDYS$$74$YR$E$$Y$$$20240930$$PH$GB$GB
243807631$24380763$1$I$$20240920$20240930$20240930$PER$$US-ABBVIE-5933859$ABBVIE$$$$$$Y$$$20240930$$CN$US$US
243807641$24380764$1$I$$20240924$20240930$20240930$PER$$US-BIOMARINAP-US-2024-160778$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243807651$24380765$1$I$$20240926$20240930$20240930$PER$$US-BIOMARINAP-US-2024-160828$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243807661$24380766$1$I$$20240926$20240930$20240930$PER$$US-BIOMARINAP-US-2024-160834$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243807671$24380767$1$I$$20240925$20240930$20240930$EXP$$US-BIOMARINAP-US-2024-160835$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243807681$24380768$1$I$$20240923$20240930$20240930$EXP$$CO-BIOMARINAP-CO-2024-160809$BIOMARIN$$$$$$Y$$$20240930$$CN$CO$CO
243807691$24380769$1$I$$20240924$20240930$20240930$EXP$$BR-BIOMARINAP-BR-2024-160807$BIOMARIN$$$$$$Y$$$20240930$$CN$BR$BR
243807701$24380770$1$I$$20240925$20240930$20240930$PER$$US-BIOMARINAP-US-2024-160775$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243807711$24380771$1$I$$20240926$20240930$20240930$PER$$US-BIOMARINAP-US-2024-160813$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243807721$24380772$1$I$$20240924$20240930$20240930$PER$$US-BIOMARINAP-US-2024-160761$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243807741$24380774$1$I$20240801$20240926$20240930$20240930$EXP$$US-BIOMARINAP-US-2024-160616$BIOMARIN$$$$$$Y$$$20240930$$HP$US$US
243807751$24380775$1$I$$20240926$20240930$20240930$EXP$$US-BIOMARINAP-US-2024-160811$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243807761$24380776$1$I$$20240925$20240930$20240930$PER$$US-BIOMARINAP-US-2024-160595$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243807771$24380777$1$I$20240921$20240925$20240930$20240930$EXP$$US-BIOMARINAP-US-2024-160798$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243807781$24380778$1$I$$20240926$20240930$20240930$EXP$PL-URPL-1-4234-2020$PL-MYLANLABS-2024M1087287$MYLAN$$24$YR$$F$Y$94$KG$20240930$$MD$PL$PL
243807791$24380779$1$I$20240701$20240926$20240930$20240930$EXP$$IT-MYLANLABS-2024M1088220$MYLAN$$$$E$M$Y$$$20240930$$CN$IT$IT
243807811$24380781$1$I$$20240916$20240930$20240930$PER$$US-Merz Pharmaceuticals GmbH-2024090000122$MERZ$$$$$$Y$$$20240930$$CN$US$US
243807821$24380782$1$I$$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-151216$BRISTOL MYERS SQUIBB$$8$DEC$E$F$Y$$$20240930$$HP$US$US
243807831$24380783$1$I$$20240926$20240930$20240930$EXP$$US-GILEAD-2024-0689196$GILEAD$$67$YR$E$M$Y$$$20240930$$HP$US$US
243807841$24380784$1$I$$20240919$20240930$20240930$EXP$$JP-SMPA-2024SMP013388$SUNOVION$$$$$$Y$$$20240930$$CN$JP$JP
243807851$24380785$1$I$$20240920$20240930$20240930$EXP$$US-PHARMING-PHAUS2024000836$PHARMING GROUP$$$$$$Y$$$20240930$$CN$US$US
243807861$24380786$1$I$20240901$20240918$20240930$20240930$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2024CRT002815$CORCEPT$$$$$$Y$$$20240930$$HP$US$US
243807871$24380787$1$I$$20240925$20240930$20240930$EXP$$NVSC2024GR192510$NOVARTIS$$75$YR$$F$Y$$$20240930$$MD$GR$GR
243807881$24380788$1$I$$20240926$20240930$20240930$EXP$$US-PHARMING-PHAUS2024000843$PHARMING GROUP$$$$$$Y$$$20240930$$CN$US$US
243807891$24380789$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5938839$ABBVIE$$$$$$Y$$$20240930$$HP$US$US
243807901$24380790$1$I$20240917$20240925$20240930$20240930$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2024-19528$IPSEN$$74$YR$E$F$Y$$$20240930$$CN$CA$CA
243807911$24380791$1$I$$20240929$20240930$20240930$PER$$US-ABBVIE-5945164$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243807921$24380792$1$I$20240610$20240925$20240930$20240930$EXP$FR-AFSSAPS-RN2024001015$FR-TEVA-VS-3247915$TEVA$$89$YR$$M$Y$$$20240930$$MD$FR$FR
243807941$24380794$1$I$$20240924$20240930$20240930$EXP$$US-PHARMING-PHAUS2024000840$PHARMING GROUP$$$$$$Y$$$20240930$$CN$US$US
243807951$24380795$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153354$BRISTOL MYERS SQUIBB$$$$$$Y$$$20240930$$PH$US$US
243807961$24380796$1$I$$20240924$20240930$20240930$PER$$US-Blueprint Medicines Corporation-SP-US-2024-001957$BLUEPRINT MEDICINES$$$$$F$Y$$$20240930$$CN$US$US
243807971$24380797$1$I$$20240910$20240930$20240930$PER$$US-Merz Pharmaceuticals GmbH-2024090000080$MERZ$$$$$$Y$$$20240930$$MD$US$US
243807981$24380798$1$I$$20240924$20240930$20240930$EXP$$FR-AMGEN-FRASP2024190492$AMGEN$$65$YR$E$F$Y$$$20240930$$PH$FR$FR
243808001$24380800$1$I$$20240909$20240930$20240930$PER$$US-Merz Pharmaceuticals GmbH-2024090000119$MERZ$$$$$$Y$$$20240930$$MD$US$US
243808011$24380801$1$I$20240920$20240924$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152781$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240930$$CN$US$US
243808021$24380802$1$I$20240615$20240923$20240930$20240930$EXP$$RS-BRISTOL-MYERS SQUIBB COMPANY-2024-150598$BRISTOL MYERS SQUIBB$$44$YR$A$M$Y$$$20240930$$MD$RS$RS
243808031$24380803$1$I$20200917$20240924$20240930$20240930$EXP$PL-URPL-1-2269-2020$PL-TEVA-VS-3247463$TEVA$$66$YR$$F$Y$$$20240930$$MD$PL$PL
243808041$24380804$1$I$$20240926$20240930$20240930$PER$$US-JNJFOC-20240973116$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$CN$US$US
243808051$24380805$1$I$20240901$20240923$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-150932$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20240930$$PH$US$US
243808061$24380806$1$I$20240411$20240924$20240930$20240930$EXP$GR-GREOF-202401011$GR-TEVA-VS-3247318$TEVA$$31$YR$$M$Y$80$KG$20240930$$MD$GR$GR
243808071$24380807$1$I$20220602$20240923$20240930$20240930$EXP$ES-AEMPS-1569940$ES-TEVA-VS-3247008$TEVA$$71$YR$$M$Y$$$20240930$$PH$ES$ES
243808081$24380808$1$I$20240901$20240924$20240930$20240930$EXP$$US-AMGEN-USASP2024190304$AMGEN$$$$$F$Y$$$20240930$$CN$US$US
243808091$24380809$1$I$20240101$20240926$20240930$20240930$EXP$$US-ABBVIE-5943821$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243808101$24380810$1$I$20240101$20240924$20240930$20240930$EXP$$GB-Genus_Lifesciences-USA-POI0580202400147$GENUS LIFESCIENCES$Chean C. Bilateral simultaneous acute angle closure glaucoma triggered by an over the counter cold and influenza medication. BMJ Case Reports. 2024 AUG 30;17(8):E260950.$$$E$F$Y$$$20240930$$MD$GB$GB
243808111$24380811$1$I$20240901$20240924$20240930$20240930$EXP$$US-BIOGEN-2024BI01284163$BIOGEN$$19$YR$$F$Y$$$20240930$$CN$US$US
243808121$24380812$1$I$20240731$20240925$20240930$20240930$EXP$HR-HALMED-300086568$HR-TEVA-VS-3247813$TEVA$$72$YR$$F$Y$70$KG$20240930$$MD$HR$HR
243808131$24380813$1$I$$20240923$20240930$20240930$EXP$PL-URPL-2-811-2019$PL-TEVA-VS-3247286$TEVA$$$$$M$Y$$$20240930$$CN$PL$PL
243808151$24380815$1$I$$20240925$20240930$20240930$PER$$US-009507513-2409USA009784$MERCK$Luepiyapanich T, Teerapuncharoen K. Unmasking The Hidden Threat: Multiple Lung Cavities In A Post-Kidney Transplant Recipient. Chest. 2024;166(4):A1233-34$61$YR$$M$Y$$$20240930$$HP$US$US
243808171$24380817$1$I$$20240924$20240930$20240930$EXP$$US-KYOWAKIRIN-2024KK022193$KYOWA$$$$$$Y$$$20240930$$HP$US$US
243808181$24380818$1$I$20210702$20240924$20240930$20240930$EXP$PL-URPL-DML-MLP.4401.1.5074.2021$PL-TEVA-VS-3247301$TEVA$$36$YR$$F$Y$60$KG$20240930$$MD$PL$PL
243808191$24380819$1$I$20221201$20240924$20240930$20240930$EXP$FR-AFSSAPS-PO2024000999$FR-TEVA-VS-3247360$TEVA$$62$YR$$F$Y$$$20240930$$MD$FR$FR
243808201$24380820$1$I$$20240930$20240930$20240930$EXP$$CZ-PFIZER INC-202400266286$PFIZER$$43$YR$$M$Y$$$20240930$$MD$CZ$CZ
243808211$24380821$1$I$$20240929$20240930$20240930$EXP$$US-PFIZER INC-2019SGN03518$PFIZER$$$$$$Y$$$20240930$$HP$US$US
243808221$24380822$1$I$$20240926$20240930$20240930$PER$$US-ROCHE-10000093001$ROCHE$$$$I$M$Y$$$20240930$$CN$US$US
243808231$24380823$1$I$$20240927$20240930$20240930$PER$$US-BAUSCH-BL-2024-014559$BAUSCH AND LOMB$$73$YR$$M$Y$$$20240930$$MD$US$US
243808241$24380824$1$I$$20240923$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152509$BRISTOL MYERS SQUIBB$Patel B, Siddiqui A, Pham S, Taylor D, Milojevic I, Kouomegne SO. Unraveling the link: lynch syndrome masquerading as recurrent venous and arterial thromboembolic events. Chest. 2024;166(4S):A5475-6. doi:10.1016/j.chest.2024.06.3253.$46$YR$A$F$Y$$$20240930$$HP$US$US
243808251$24380825$1$I$$20240925$20240930$20240930$EXP$$CA-BAUSCH-BL-2024-014460$BAUSCH AND LOMB$$42$YR$$M$Y$$$20240930$$HP$CA$CA
243808261$24380826$1$I$$20240925$20240930$20240930$EXP$$CA-BAUSCH-BL-2024-014465$BAUSCH AND LOMB$$69$YR$$F$Y$70$KG$20240930$$MD$CA$CA
243808271$24380827$1$I$$20240924$20240930$20240930$EXP$$US-PURDUE-USA-2024-0312214$PURDUE$NOTTA S., AL AKEEL M., MOORE S., NOTTA N., JAGADISH A., DANISI J.. Unveiling surgical mastery: pioneering prophylactic coronary artery bypass grafting (cabg) in complex endocarditis for an intravenous drug user with mitral valve involvement. Chest. 2024;166(4):A256-A257$42$YR$$M$Y$$$20240930$$HP$US$US
243808281$24380828$1$I$$20240924$20240930$20240930$EXP$$DE-PURDUE-USA-2024-0312219$PURDUE$Bickel J, M?ller A, Jungen H, Szewczyk A, Teske J, K?pper U, Andresen-Streichert H,  Ondruschka B, Iwersen-Bergmann S.. Post mortem chiral analysis of MDMA and MDA in human blood and hair. Forensic Science International.. 2024;364:112226$16$YR$$M$Y$$$20240930$$HP$DE$DE
243808291$24380829$1$I$$20240924$20240930$20240930$EXP$$US-PURDUE-USA-2024-0312224$PURDUE$Brahmandam BS, Brahmandam S, Brahmandam S, Brahmandam S.. Fatal case of theophylline toxicity. Chest. 2024;166(4):A3047$61$YR$$M$Y$$$20240930$$HP$US$US
243808301$24380830$1$I$$20240924$20240930$20240930$EXP$$DE-PURDUE-USA-2024-0312215$PURDUE$Bickel J., M?ller A., Jungen H., Szewczyk A., Teske J., K?pper U., Andresen-Streichert H.,  Ondruschka B., Iwersen-Bergmann S.. Post mortem chiral analysis of MDMA and MDA in human blood and hair. Forensic Science International. 2024;364:112226$19$YR$$M$Y$$$20240930$$HP$DE$DE
243808311$24380831$1$I$$20240925$20240930$20240930$EXP$$CA-BAUSCH-BL-2024-014456$BAUSCH AND LOMB$$$$$M$Y$$$20240930$$CN$CA$CA
243808321$24380832$1$I$$20240924$20240930$20240930$EXP$$US-PURDUE PHARMA-USA-2024-0312191$PURDUE$Davuluri H, Vaqar M, Kaur K, Singh S.. Acute chest syndrome and sickle cell disease in a primigravida: A case complicated by retroperitoneal hematoma. Chest. 2024;166(4):A5597-A5$34$YR$$F$Y$$$20240930$$HP$US$US
243808331$24380833$1$I$$20240924$20240930$20240930$EXP$$US-PURDUE-USA-2024-0312205$PURDUE$Gibbons K, Morris J.. Delta-8 Tetrahydrocannabinol in the Emergency Department: A Case Series.. WMJ : official publication of the State Medical Society of Wisconsin. 2024;123(4):300-303$21$YR$$F$Y$$$20240930$$HP$US$US
243808341$24380834$1$I$$20240924$20240930$20240930$EXP$$DE-PURDUE-USA-2024-0312223$PURDUE$Bickel J, M?ller A, Jungen H, Szewczyk A, Teske J, K?pper U, Andresen-Streichert H, Ondruschka B, Iwersen-Bergmann S.. Post mortem chiral analysis of MDMA and MDA in human blood and hair. Forensic Science International. 2024;364:112226$16$YR$$F$Y$$$20240930$$HP$DE$DE
243808351$24380835$1$I$$20240924$20240930$20240930$EXP$$US-PURDUE-USA-2024-0312204$PURDUE$Gibbons K., Morris J.. Delta-8 Tetrahydrocannabinol in the Emergency Department: A Case Series. WMJ : official publication of the State Medical Society of Wisconsin. 2024;123(4):300-303$25$YR$$M$Y$$$20240930$$HP$US$US
243808361$24380836$1$I$20230718$20240916$20240930$20240930$EXP$$JP-PURDUE-USA-2024-0312252$PURDUE$$65$YR$$M$Y$$$20240930$$HP$JP$JP
243808371$24380837$1$I$$20240924$20240930$20240930$EXP$$US-PURDUE-USA-2024-0312211$PURDUE$Shahid R, Ko E, Umrani R.. Battling the blockade: A case of multifactorial shock in polysubstance overdose. Chest. 2024;166(4):A2520-A2521$59$YR$$F$Y$$$20240930$$HP$US$US
243808381$24380838$1$I$$20240919$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409013358$ELI LILLY AND CO$$43$YR$A$F$Y$$$20240930$$CN$US$US
243808391$24380839$1$I$20220824$20240925$20240930$20240930$EXP$$CA-Ipsen Biopharmaceuticals, Inc.-2022-25596$IPSEN$$51$YR$A$M$Y$$$20240930$$CN$CA$CA
243808401$24380840$1$I$$20240926$20240930$20240930$PER$$US-PURDUE PHARMA-USA-2024-0312218$PURDUE$$$$$M$Y$117.91$KG$20240930$$CN$US$US
243808411$24380841$1$I$$20240926$20240930$20240930$PER$$US-PURDUE PHARMA-USA-2024-0312233$PURDUE$$$$$M$Y$$$20240930$$CN$US$US
243808431$24380843$1$I$20240304$20240925$20240930$20240930$EXP$FR-AFSSAPS-AN2024001276$FR-TEVA-VS-3247956$TEVA$$81$YR$$M$Y$$$20240930$$PH$FR$FR
243808441$24380844$1$I$$20240925$20240930$20240930$EXP$$CA-BAUSCH-BL-2024-014464$BAUSCH AND LOMB$$72$YR$$F$Y$61$KG$20240930$$HP$CA$CA
243808451$24380845$1$I$$20240925$20240930$20240930$EXP$$CA-BAUSCH-BL-2024-014473$BAUSCH AND LOMB$$70$YR$$F$Y$$$20240930$$HP$CA$CA
243808461$24380846$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154422$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$$$20240930$$CN$US$US
243808471$24380847$1$I$20240101$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154423$BRISTOL MYERS SQUIBB$$66$YR$E$M$Y$$$20240930$$CN$US$US
243808481$24380848$1$I$$20240925$20240930$20240930$PER$$US-PURDUE PHARMA-USA-2024-0312217$PURDUE$$$$$M$Y$$$20240930$$CN$US$US
243808501$24380850$1$I$$20240919$20240930$20240930$PER$$US-JNJFOC-20240974821$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$PH$US$US
243808511$24380851$1$I$20240919$20240920$20240930$20240930$PER$$US-JNJFOC-20240973656$JOHNSON AND JOHNSON$$$$$M$Y$$$20240930$$PH$US$US
243808521$24380852$1$I$$20240920$20240930$20240930$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09477$NEUROCRINE BIOSCIENCES$$3$DEC$$M$Y$$$20240930$$MD$US$US
243808531$24380853$1$I$$20240924$20240930$20240930$EXP$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09600$NEUROCRINE BIOSCIENCES$$44$YR$$$Y$$$20240930$$PH$US$US
243808541$24380854$1$I$$20240923$20240930$20240930$30DAY$$GB-PFIZER INC-PV202400124808$PFIZER$$22$YR$$F$Y$$$20240930$$CN$GB$GB
243808551$24380855$1$I$$20240925$20240930$20240930$PER$$NVSC2024US191448$NOVARTIS$$78$YR$$F$Y$$$20240930$$CN$US$US
243808561$24380856$1$I$$20240920$20240930$20240930$PER$$US-JNJFOC-20240978975$JOHNSON AND JOHNSON$$$$A$M$Y$$$20240930$$CN$US$US
243808571$24380857$1$I$$20240920$20240930$20240930$EXP$$US-RADIUS HEALTH INC.-2024US007427$RADIUS PHARM$$$$$F$Y$$$20240930$$CN$US$US
243808581$24380858$1$I$$20201127$20240930$20240930$EXP$$AT-NOVOPROD-770839$NOVO NORDISK$$$$$F$Y$$$20240930$$MD$AT$AT
243808591$24380859$1$I$$20240916$20240930$20240930$EXP$$IN-NOVOPROD-1288192$NOVO NORDISK$Anirban De et al.. Diagnostic and Management Challenges of Acute Fatty Liver of Pregnancy: A Case Series. Acta Medica International. 2024;11(2):172-178$24$YR$$F$Y$$$20240930$$HP$IN$IN
243808601$24380860$1$I$$20240916$20240930$20240930$EXP$$GB-NOVOPROD-1291557$NOVO NORDISK$$$$$F$Y$$$20240930$$CN$GB$GB
243808611$24380861$1$I$$20240918$20240930$20240930$EXP$$GB-ELI_LILLY_AND_COMPANY-GB202409012206$ELI LILLY AND CO$$65$YR$E$F$Y$77$KG$20240930$$CN$GB$GB
243808621$24380862$1$I$20240824$20240918$20240930$20240930$EXP$GB-MHRA-MED-202409182207091730-LJWQS$GB-ELI_LILLY_AND_COMPANY-GB202409012214$ELI LILLY AND CO$$38$YR$A$M$Y$$$20240930$$CN$GB$GB
243808631$24380863$1$I$20240903$20240918$20240930$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409011890$ELI LILLY AND CO$$42$YR$A$F$Y$$$20240930$$HP$US$US
243808641$24380864$1$I$$20240919$20240930$20240930$EXP$$US-ELI_LILLY_AND_COMPANY-US202409013350$ELI LILLY AND CO$$63$YR$A$$Y$$$20240930$$LW$US$US
243808651$24380865$1$I$20240407$20240919$20240930$20240930$EXP$GB-MHRA-MED-202409171432526690-NMJZG$GB-ELI_LILLY_AND_COMPANY-GB202409013194$ELI LILLY AND CO$$46$YR$A$F$Y$85$KG$20240930$$CN$GB$GB
243808661$24380866$1$I$$20240928$20240930$20240930$PER$$NVSC2024US193538$NOVARTIS$$$$$F$Y$$$20240930$$CN$US$US
243808671$24380867$1$I$20240916$20240917$20240930$20240930$PER$$US-SA-2024SA280367$SANOFI AVENTIS$$53$YR$A$F$Y$$$20240930$$CN$US$US
243808681$24380868$1$I$$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193844$AMGEN$$$$$$Y$$$20240930$$CN$US$US
243808701$24380870$1$I$$20240919$20240930$20240930$EXP$$US-BIOGEN-2024BI01283625$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243808711$24380871$1$I$$20240920$20240930$20240930$EXP$$US-BIOGEN-2024BI01283636$BIOGEN$$20$YR$$F$Y$$$20240930$$MD$US$US
243808721$24380872$1$I$$20240924$20240930$20240930$PER$$US-JNJFOC-20240966227$JOHNSON AND JOHNSON$$$$$$Y$$$20240930$$CN$US$US
243808731$24380873$1$I$$20240930$20240930$20240930$EXP$GB-MHRA-MED-202409300908061680-KGMRT$GB-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054137$BOEHRINGER INGELHEIM$$75$YR$E$M$Y$$$20240930$$PH$GB$GB
243808761$24380876$1$I$20240101$20240919$20240930$20240930$PER$$US-SA-2024SA273355$SANOFI AVENTIS$$38$YR$A$F$Y$$$20240930$$HP$US$US
243808771$24380877$1$I$20240901$20240924$20240930$20240930$EXP$$GB-BIOGEN-2024BI01284292$BIOGEN$$49$YR$$F$Y$$$20240930$$CN$GB$GB
243808781$24380878$1$I$20240827$20240903$20240930$20240930$PER$$US-FMCRTG-FMC-2409-001100$FRESENIUS MEDICAL CARE$$72$YR$E$M$Y$$$20240930$$HP$US$US
243808791$24380879$1$I$20240904$20240920$20240930$20240930$EXP$$US-FMCRTG-FMC-2409-001191$FRESENIUS MEDICAL CARE$$71$YR$E$F$Y$87$KG$20240930$$HP$US$US
243808801$24380880$1$I$$20240901$20240930$20240930$PER$$US-FMCRTG-FMC-2409-001128$FRESENIUS MEDICAL CARE$$$$$M$Y$$$20240930$$CN$US$US
243808811$24380881$1$I$$20240908$20240930$20240930$PER$$US-FMCRTG-FMC-2409-001125$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240930$$CN$US$US
243808821$24380882$1$I$$20240908$20240930$20240930$PER$$US-FMCRTG-FMC-2409-001124$FRESENIUS MEDICAL CARE$$37$YR$A$F$Y$73.94$KG$20240930$$CN$US$US
243808831$24380883$1$I$20240921$20240920$20240930$20240930$EXP$$US-FMCRTG-FMC-2409-001199$FRESENIUS MEDICAL CARE$$$$$F$Y$$$20240930$$HP$US$US
243808841$24380884$1$I$20240805$20240830$20240930$20240930$PER$$US-FMCRTG-FMC-2409-001084$FRESENIUS MEDICAL CARE$$54$YR$A$M$Y$108.5$KG$20240930$$HP$US$US
243808851$24380885$1$I$$20240926$20240930$20240930$PER$$NVSC2024US193684$NOVARTIS$$$$$F$Y$$$20240930$$HP$US$US
243808861$24380886$1$I$20240701$20240925$20240930$20240930$EXP$$US-BIOGEN-2024BI01284268$BIOGEN$$74$YR$$F$Y$$$20240930$$CN$US$US
243808871$24380887$1$I$20240803$20240926$20240930$20240930$EXP$FR-AFSSAPS-LM2024000525$FR-009507513-2409FRA009642$MERCK$$68$YR$$M$Y$$$20240930$$PH$FR$FR
243808881$24380888$1$I$20200101$20240925$20240930$20240930$EXP$$US-BIOGEN-2024BI01284274$BIOGEN$$$$$F$Y$$$20240930$$CN$US$US
243808901$24380890$1$I$20210708$20240925$20240930$20240930$EXP$FR-AFSSAPS-MA2024001506$FR-009507513-2409FRA008952$MERCK$$67$YR$$F$Y$$$20240930$$PH$FR$FR
243808911$24380891$1$I$20240901$20240923$20240930$20240930$EXP$$US-009507513-2409USA008388$MERCK$$67$YR$$F$Y$$$20240930$$CN$US$IN
243808921$24380892$1$I$$20240923$20240930$20240930$EXP$$US-BEH-2024179299$CSL BEHRING$$75$YR$E$M$Y$$$20240930$$PH$US$US
243808931$24380893$1$I$20240725$20240926$20240930$20240930$EXP$FR-AFSSAPS-PP2024000994$FR-009507513-2409FRA009571$MERCK$$63$YR$$M$Y$72.3$KG$20240930$$MD$FR$FR
243808961$24380896$1$I$$20240820$20240930$20240930$PER$$US-LUNDBECK-DKLU4003222$LUNDBECK$$$$$$Y$$$20240930$$HP$US$US
243808971$24380897$1$I$20201202$20240930$20240930$20240930$EXP$PL-URPL-1-3496-2020$PL-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054168$BOEHRINGER INGELHEIM$$90$YR$E$F$Y$$$20240930$$PH$PL$PL
243808981$24380898$1$I$$20240917$20240930$20240930$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09387$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20240930$$MD$US$US
243808991$24380899$1$I$20240927$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154383$BRISTOL MYERS SQUIBB$$92$YR$E$M$Y$$$20240930$$CN$US$US
243809001$24380900$1$I$$20240923$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA007678US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240930$$$US$US
243809011$24380901$1$I$$20240814$20240930$20240930$PER$$US-LUNDBECK-DKLU4003009$LUNDBECK$$$$$$Y$$$20240930$$HP$US$US
243809021$24380902$1$I$$20240920$20240930$20240930$PER$$US-009507513-2409USA007744$MERCK$$$$$$Y$$$20240930$$HP$US$US
243809031$24380903$1$I$$20240924$20240930$20240930$PER$$US-DSJP-DS-2024-101416-US$DAIICHI$$$$$F$Y$$$20240930$$CN$US$US
243809041$24380904$1$I$$20240814$20240930$20240930$PER$$US-LUNDBECK-DKLU4003013$LUNDBECK$$$$$$Y$$$20240930$$HP$US$US
243809051$24380905$1$I$$20240927$20240930$20240930$PER$$US-DAIICHI SANKYO, INC.-DS-2024-101751-US$DAIICHI$$$$$F$Y$$$20240930$$MD$US$US
243809061$24380906$1$I$$20240926$20240930$20240930$PER$$US-DAIICHI SANKYO, INC.-DS-2024-101742-US$DAIICHI$$$$$$Y$$$20240930$$HP$US$US
243809071$24380907$1$I$20240101$20240926$20240930$20240930$EXP$$IL-009507513-2409ISR009652$MERCK$$71$YR$$M$Y$$$20240930$$PH$IL$IL
243809081$24380908$1$I$$20240813$20240930$20240930$PER$$US-LUNDBECK-DKLU4003032$LUNDBECK$$$$$$Y$$$20240930$$HP$US$US
243809101$24380910$1$I$$20240918$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409012997$ELI LILLY AND CO$$41$YR$A$$Y$$$20240930$$LW$US$US
243809122$24380912$2$F$20240928$20240930$20240930$20240930$PER$$US-BIOMARINAP-US-2024-160865$BIOMARIN$$$$$$Y$$$20240930$$CN$US$US
243809131$24380913$1$I$20240907$20240924$20240930$20240930$EXP$FR-AFSSAPS-TO2024001762$FR-009507513-2409FRA008557$MERCK$$77$YR$$M$Y$$$20240930$$MD$FR$FR
243809141$24380914$1$I$$20240924$20240930$20240930$PER$$US-009507513-2409USA009363$MERCK$Thakkar A, Gupta S, Shastri DD, Magacha H and Diaz A.. CLIP-HANGER: CANDIDA PARAPSILOSIS TAKES CENTER STAGE IN MITRAL MAYHEM. Chest. 2024;166 (166):1574A$74$YR$$M$Y$$$20240930$$HP$US$US
243809151$24380915$1$I$20240101$20240823$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1416$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$US$US
243809161$24380916$1$I$20240826$20240826$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1435$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$HP$US$US
243809171$24380917$1$I$$20240923$20240930$20240930$EXP$$US-LUNDBECK-DKLU4004693$LUNDBECK$Amal, T; Billups, TT; Brennan, M; jameel, O; Sharif, A; Meireles, J; Workman, L; Li, S; Misra, D. Recurrent Metabolic Encephalopathy in an Adult with Angelman Syndrome, Lennox-Gastaut Syndrome, and VLCAD Deficiency: When Remedy for One Malady is the Catalyst for Another. Chest. 2024;Suppl 166.4:A2800-A2801$$$$$Y$$$20241001$$HP$US$US
243809181$24380918$1$I$20240101$20240827$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1449$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243809191$24380919$1$I$20240101$20240826$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1460$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$HP$US$US
243809201$24380920$1$I$20240101$20240826$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1462$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$HP$US$US
243809211$24380921$1$I$20240101$20240828$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1475$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$HP$US$US
243809221$24380922$1$I$20240101$20240828$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1477$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$US$US
243809231$24380923$1$I$$20240924$20240930$20240930$PER$$US-JNJFOC-20240972173$JOHNSON AND JOHNSON$$$$$M$Y$$$20241001$$MD$US$US
243809241$24380924$1$I$$20240926$20240930$20240930$PER$$US-JNJFOC-20240972308$JOHNSON AND JOHNSON$$$$$$Y$$$20241001$$CN$US$US
243809251$24380925$1$I$20240801$20240829$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1483$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243809261$24380926$1$I$20240101$20240830$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1505$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$US$US
243809271$24380927$1$I$20240101$20240830$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1572$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243809281$24380928$1$I$20240101$20240905$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1634$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243809291$24380929$1$I$20240801$20240830$20240930$20240930$PER$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1527$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243809311$24380931$1$I$20240101$20240906$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1649$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$US$US
243809321$24380932$1$I$$20240927$20240930$20240930$EXP$$JP-ABBVIE-5944851$ABBVIE$$$$$F$Y$$$20240930$$MD$JP$JP
243809331$24380933$1$I$$20240925$20240930$20240930$EXP$$CA-SAMSUNG BIOEPIS-SB-2023-26035$SAMSUNG BIOEPIS$$61$YR$A$M$Y$$$20241001$$CN$CA$CA
243809341$24380934$1$I$20240101$20240905$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1663$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$US$US
243809351$24380935$1$I$20240101$20240905$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1665$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$US$US
243809361$24380936$1$I$20240101$20240905$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1666$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$US$US
243809371$24380937$1$I$20240101$20240909$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1678$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$US$US
243809381$24380938$1$I$20240912$20240913$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1808$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243809391$24380939$1$I$20240101$20240911$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1740$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$CN$US$US
243809401$24380940$1$I$20240101$20240913$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1816$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$US$US
243809411$24380941$1$I$20240101$20240911$20240930$20240930$EXP$$US-MADRIGAL PHARMACEUTICALS, INC-2024REZ1819$MADRIGAL PHARMACEUTICALS$$$$$$Y$$$20240927$$MD$US$US
243809421$24380942$1$I$$20240927$20240930$20240930$EXP$$NVSJ2024JP011433$NOVARTIS$$50$YR$$M$Y$$$20241001$$MD$JP$JP
243809431$24380943$1$I$$20240927$20240930$20240930$EXP$$NVSJ2024JP011436$NOVARTIS$$$$E$$Y$$$20241001$$MD$JP$JP
243809441$24380944$1$I$$20240923$20240930$20240930$EXP$$SE-TEVA-VS-3248197$TEVA$Adra J, Giglio D, Karlsson P, Zetterberg H, Einbeigi Z. Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy. Acta-Oncol 2024; 63 636-641.$$$$F$Y$$$20240930$$HP$SE$SE
243809451$24380945$1$I$20240101$20240918$20240930$20240930$EXP$$US-UCBSA-2024040858$UCB$$$$$M$Y$$$20241001$$CN$US$US
243809461$24380946$1$I$$20240928$20240930$20240930$PER$$US-ABBVIE-5944757$ABBVIE$$$$$$Y$$$20240930$$CN$US$US
243809471$24380947$1$I$$20240923$20240930$20240930$EXP$$SE-TEVA-VS-3248196$TEVA$Adra J, Giglio D, Karlsson P, Zetterberg H, Einbeigi Z. Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy. Acta-Oncol 2024; 63 636-641.$$$$F$Y$$$20240930$$HP$SE$SE
243809481$24380948$1$I$$20240815$20240930$20240930$PER$$US-LUNDBECK-DKLU4003107$LUNDBECK$$$$$$Y$$$20241001$$HP$US$US
243809491$24380949$1$I$20240901$20240919$20240930$20240930$EXP$$CA-UCBSA-2024049401$UCB$$61$YR$$F$Y$$$20241001$$CN$CA$CA
243809501$24380950$1$I$20240819$20240918$20240930$20240930$EXP$$US-UCBSA-2024048188$UCB$$67$YR$$F$Y$$$20241001$$CN$US$US
243809511$24380951$1$I$$20240819$20240930$20240930$PER$$US-LUNDBECK-DKLU4003224$LUNDBECK$$$$$$Y$$$20241001$$CN$US$US
243809521$24380952$1$I$$20240925$20240930$20240930$EXP$$NVSJ2024JP011350$NOVARTIS$Yamamura S, Kanai M, Takeuchi Y, Okita N, Kondo T, Yoshioka M, et al. Response to capmatinib in a patient with neuroendocrine carcinoma of the gallbladder origin harboring MET amplification. International Cancer Conference Journal. 2024;13(2):83-87$72$YR$$F$Y$$$20241001$$HP$JP$JP
243809541$24380954$1$I$20240808$20240926$20240930$20240930$EXP$$AR-SANDOZ INC.-SDZ2024AR083655$SANDOZ$$3$YR$$F$Y$11.4$KG$20240930$$CN$AR$AR
243809551$24380955$1$I$$20240819$20240930$20240930$PER$$US-LUNDBECK-DKLU4003252$LUNDBECK$$$$$$Y$$$20241001$$CN$US$US
243809561$24380956$1$I$$20240918$20240930$20240930$EXP$$CA-UCBSA-2024048480$UCB$$$$$F$Y$$$20241001$$CN$CA$CA
243809571$24380957$1$I$20240101$20240919$20240930$20240930$EXP$$US-UCBSA-2024048543$UCB$$$$$M$Y$$$20241001$$CN$US$US
243809581$24380958$1$I$20230701$20240924$20240930$20240930$EXP$$MX-JNJFOC-20240980659$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20241001$$CN$MX$MX
243809591$24380959$1$I$20240823$20240930$20240930$20240930$EXP$PT-INFARMED-B202409-603$NVSC2024PT193165$NOVARTIS$$59$YR$$F$Y$$$20241001$$PH$PT$PT
243809601$24380960$1$I$20240101$20240919$20240930$20240930$EXP$$US-UCBSA-2024048959$UCB$$$$$F$Y$$$20241001$$HP$US$US
243809611$24380961$1$I$$20240917$20240930$20240930$PER$$US-NEUROCRINE BIOSCIENCES INC.-2024NBI09318$NEUROCRINE BIOSCIENCES$$$$$$Y$$$20241001$$HP$US$US
243809621$24380962$1$I$20240101$20240926$20240930$20240930$PER$$US-LUNDBECK-DKLU4004818$LUNDBECK$$$$$$Y$$$20241001$$CN$US$US
243809641$24380964$1$I$$20240923$20240930$20240930$EXP$$US-BIOGEN-2024BI01284082$BIOGEN$$$$$F$Y$$$20240930$$HP$US$US
243809651$24380965$1$I$20240901$20240927$20240930$20240930$EXP$$CA-ABBVIE-5944334$ABBVIE$$81$YR$$M$Y$$$20240930$$CN$CA$CA
243809661$24380966$1$I$20240924$20240925$20240930$20240930$PER$$US-AMGEN-USASP2024192094$AMGEN$$6$YR$C$M$Y$$$20240930$$CN$US$US
243809671$24380967$1$I$$20240816$20240930$20240930$PER$$US-LUNDBECK-DKLU4003184$LUNDBECK$$$$$$Y$$$20241001$$CN$US$US
243809681$24380968$1$I$$20240816$20240930$20240930$PER$$US-LUNDBECK-DKLU4003190$LUNDBECK$$$$$$Y$$$20241001$$CN$US$US
243809691$24380969$1$I$20240101$20240925$20240930$20240930$PER$$US-ORGANON-O2409USA002048$ORGANON$$$$$F$Y$$$20240930$$MD$US$US
243809711$24380971$1$I$$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193057$AMGEN$$$$$F$Y$$$20240930$$PH$US$US
243809721$24380972$1$I$20240822$20240822$20240930$20240930$PER$$US-LUNDBECK-DKLU4003337$LUNDBECK$$$$$$Y$$$20241001$$HP$US$US
243809731$24380973$1$I$20240927$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018401$ELI LILLY AND CO$$68$YR$E$F$Y$$$20240930$$CN$US$US
243809741$24380974$1$I$20200401$20240929$20240930$20240930$EXP$$BE-BAUSCH-BL-2024-014649$BAUSCH AND LOMB$$6$DEC$$$Y$$$20241001$$MD$BE$BE
243809751$24380975$1$I$20240829$20240920$20240930$20240930$PER$$US-AMGEN-USASP2024188679$AMGEN$$58$YR$A$F$Y$65.7$KG$20240930$$HP$US$US
243809771$24380977$1$I$$20240928$20240930$20240930$PER$$US-AMGEN-USASP2024193701$AMGEN$$$$$$Y$$$20240930$$CN$US$US
243809781$24380978$1$I$$20240928$20240930$20240930$EXP$$PL-BAUSCH-BL-2024-014627$BAUSCH AND LOMB$$84$YR$$$Y$$$20241001$$MD$PL$PL
243809791$24380979$1$I$$20240930$20240930$20240930$EXP$$JP-LUNDBECK-DKLU4004842$LUNDBECK$Takeda Y, Sakakibara T, Nogami K, Ochi T, Miyasaka T. Vigabatrin-associated brain abnormalities on magnetic resonance imaging (VABAM) are frequently, but some of them may be reversible. Journal of the Japan Epilepsy Society. 2024;42:587-587$$$$$Y$$$20241001$$MD$JP$JP
243809801$24380980$1$I$20240907$20240927$20240930$20240930$EXP$GB-MHRA-MED-202409271938218850-NZGMV$GB-ABBVIE-5943445$ABBVIE$$23$YR$$F$Y$99$KG$20240930$$CN$GB$GB
243809811$24380981$1$I$20240901$20240926$20240930$20240930$EXP$$AR-JNJFOC-20240975038$JOHNSON AND JOHNSON$$69$YR$E$F$Y$68$KG$20241001$$CN$AR$AR
243809821$24380982$1$I$20240101$20240926$20240930$20240930$EXP$$CN-JNJFOC-20240973432$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20241001$$HP$CN$CN
243809831$24380983$1$I$$20240820$20240930$20240930$PER$$US-LUNDBECK-DKLU4003355$LUNDBECK$$$$$$Y$$$20241001$$CN$US$US
243809841$24380984$1$I$20240822$20240925$20240930$20240930$30DAY$$US-AMGEN-USASP2024191643$AMGEN$$66$YR$E$M$Y$139$KG$20240930$$HP$US$US
243809851$24380985$1$I$20240901$20240926$20240930$20240930$EXP$$GB-AMGEN-GBRSP2024192569$AMGEN$$74$YR$E$M$Y$$$20240930$$CN$GB$GB
243809861$24380986$1$I$$20240926$20240930$20240930$EXP$$GB-AMGEN-GBRSP2024192691$AMGEN$$$$$M$Y$$$20240930$$CN$GB$GB
243809881$24380988$1$I$20240901$20240919$20240930$20240930$PER$$US-BAUSCHBL-2024BNL033932$BAUSCH AND LOMB$$$$$F$Y$$$20241001$$CN$US$US
243809891$24380989$1$I$20240801$20240925$20240930$20240930$EXP$$PE-AMGEN-PERSL2024179206$AMGEN$$62$YR$A$M$Y$$$20240930$$MD$PE$PE
243809911$24380991$1$I$$20240930$20240930$20240930$PER$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054256$BOEHRINGER INGELHEIM$$$$A$M$Y$$$20241001$$CN$US$US
243809921$24380992$1$I$20240910$20240927$20240930$20240930$EXP$FR-AFSSAPS-AN2024001298$FR-JNJFOC-20240980865$JOHNSON AND JOHNSON$$34$YR$A$F$Y$87.7$KG$20241001$$MD$FR$FR
243809931$24380993$1$I$20240819$20240821$20240930$20240930$PER$$US-LUNDBECK-DKLU4003345$LUNDBECK$$$$$$Y$$$20241001$$HP$US$US
243809941$24380994$1$I$20240101$20240923$20240930$20240930$EXP$$US-ABBVIE-5847739$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243809951$24380995$1$I$$20240822$20240930$20240930$PER$$US-LUNDBECK-DKLU4003409$LUNDBECK$$$$$$Y$$$20241001$$CN$US$US
243809961$24380996$1$I$$20240923$20240930$20240930$EXP$$CA-ABBVIE-5937452$ABBVIE$$$$A$M$Y$79$KG$20240930$$CN$CA$CA
243809971$24380997$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5938896$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243809981$24380998$1$I$$20240921$20240930$20240930$EXP$$US-ZENPEP LLC-2024AIMT01369$AIMMUNE$$$$$$Y$$$20241001$$CN$US$US
243809991$24380999$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5939165$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243810001$24381000$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5939579$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243810011$24381001$1$I$$20240927$20240930$20240930$EXP$$US-ABBVIE-5943816$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243810021$24381002$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5939585$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243810031$24381003$1$I$$20240821$20240930$20240930$PER$$US-LUNDBECK-DKLU4003300$LUNDBECK$$$$$$Y$$$20241001$$HP$US$US
243810041$24381004$1$I$$20240925$20240930$20240930$EXP$$FR-ASTRAZENECA-202409EEA006629FR$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$MD$FR$FR
243810051$24381005$1$I$20220101$20240925$20240930$20240930$EXP$$US-ABBVIE-5941317$ABBVIE$$52$YR$$M$Y$$$20240930$$CN$US$US
243810061$24381006$1$I$20120101$20240920$20240930$20240930$PER$$US-JNJFOC-20240963914$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20241001$$LW$US$US
243810071$24381007$1$I$20240815$20240816$20240930$20240930$PER$$US-LUNDBECK-DKLU4003096$LUNDBECK$$$$$$Y$$$20241001$$HP$US$US
243810081$24381008$1$I$20220101$20240920$20240930$20240930$PER$$US-BAUSCHBL-2024BNL033911$BAUSCH AND LOMB$$$$$M$Y$$$20241001$$CN$US$US
243810091$24381009$1$I$$20240924$20240930$20240930$PER$$US-009507513-2409USA008450$MERCK$Purcell M, Kuch B, Brady JE. Recurrent Pneumonitis In A 72-Year-Old Male. Boston Chest. 2024;166 (4):A3378-9$72$YR$$M$Y$$$20240930$$HP$US$US
243810101$24381010$1$I$20240901$20240918$20240930$20240930$PER$$US-BAUSCHBL-2024BNL033727$BAUSCH AND LOMB$$79$YR$$F$Y$$$20241001$$CN$US$US
243810111$24381011$1$I$$20240920$20240930$20240930$PER$$US-BAUSCHBL-2024BNL033914$BAUSCH AND LOMB$$68$YR$$F$Y$$$20241001$$CN$US$US
243810121$24381012$1$I$$20240926$20240930$20240930$EXP$$US-SMPA-2024SPA003363$SUNOVION$$$$$$Y$$$20240930$$CN$US$US
243810131$24381013$1$I$20240101$20240920$20240930$20240930$PER$$US-BAUSCHBL-2024BNL033916$BAUSCH AND LOMB$$70$YR$$M$Y$$$20241001$$CN$US$US
243810141$24381014$1$I$$20240919$20240930$20240930$PER$$US-BAUSCHBL-2024BNL033836$BAUSCH AND LOMB$$$$$F$Y$$$20241001$$CN$US$US
243810161$24381016$1$I$$20240926$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154090$BRISTOL MYERS SQUIBB$$77$YR$E$F$Y$$$20241001$$CN$US$US
243810181$24381018$1$I$20240301$20240903$20240930$20240930$PER$$US-SA-2024SA273560$SANOFI AVENTIS$$40$YR$A$M$Y$$$20241001$$MD$US$US
243810191$24381019$1$I$20240101$20240822$20240930$20240930$PER$$US-LUNDBECK-DKLU4003422$LUNDBECK$$$$$$Y$$$20241001$$CN$US$US
243810211$24381021$1$I$$20240919$20240930$20240930$EXP$$US-UCBSA-2024048685$UCB$$$$$$Y$$$20241001$$CN$US$US
243810221$24381022$1$I$20240801$20240903$20240930$20240930$PER$$US-SA-2024SA273513$SANOFI AVENTIS$$52$YR$A$F$Y$$$20241001$$MD$US$US
243810241$24381024$1$I$20240101$20240924$20240930$20240930$EXP$$US-AMGEN-USASP2024191036$AMGEN$$41$YR$A$M$Y$$$20240930$$HP$US$US
243810251$24381025$1$I$$20240918$20240930$20240930$PER$$US-JNJFOC-20240951573$JOHNSON AND JOHNSON$$$$$$Y$$$20241001$$HP$US$US
243810261$24381026$1$I$$20240920$20240930$20240930$EXP$$US-JNJFOC-20240956572$JOHNSON AND JOHNSON$$$$$$Y$$$20241001$$CN$US$US
243810271$24381027$1$I$$20240926$20240930$20240930$EXP$GB-MHRA-MED-202409262204033140-QTLGZ$GB-SANDOZ INC.-SDZ2024GB083517$SANDOZ$$$$$F$Y$$$20240930$$HP$GB$GB
243810291$24381029$1$I$$20240927$20240930$20240930$PER$$US-TAKEDA-2024TUS096527$TAKEDA$$$$$$Y$$$20240930$$HP$US$US
243810301$24381030$1$I$$20240912$20240930$20240930$PER$$US-NATCOUSA-2024-NATCOUSA-000226$NATCO PHARMA$$64$YR$$F$Y$$$20241001$$CN$US$
243810311$24381031$1$I$20240924$20240927$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153816$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20241001$$CN$US$US
243810321$24381032$1$I$20240101$20240924$20240930$20240930$EXP$$US-ABBVIE-5939201$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243810331$24381033$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5940719$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243810341$24381034$1$I$$20240920$20240930$20240930$PER$$US-ABBVIE-5933521$ABBVIE$$$$$$Y$$$20240930$$HP$US$US
243810351$24381035$1$I$20240101$20240925$20240930$20240930$EXP$$CA-ABBVIE-5941824$ABBVIE$$53$YR$$F$Y$$$20240930$$CN$CA$CA
243810361$24381036$1$I$$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153796$BRISTOL MYERS SQUIBB$$65$YR$E$F$Y$$$20241001$$HP$US$US
243810371$24381037$1$I$$20240916$20240930$20240930$EXP$$US-Unichem Pharmaceuticals (USA) Inc-UCM202409-001227$UNICHEM$$32$YR$A$F$Y$$$20241001$$HP$US$
243810381$24381038$1$I$$20240923$20240930$20240930$EXP$$US-TAKEDA-2024TUS095919$TAKEDA$$$$$$Y$$$20240930$$HP$IN$US
243810391$24381039$1$I$$20240925$20240930$20240930$EXP$$JP-GSK-JP2024JPN118766$GLAXOSMITHKLINE$$$$$$Y$$$20240930$$PH$JP$JP
243810401$24381040$1$I$20240909$20240917$20240930$20240930$EXP$$US-UCBSA-2024047979$UCB$$74$YR$$F$Y$$$20241001$$CN$US$US
243810411$24381041$1$I$20240701$20240925$20240930$20240930$EXP$$CA-AMGEN-CANSP2024191205$AMGEN$$18$YR$A$M$Y$$$20240930$$MD$CA$CA
243810421$24381042$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5940827$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243810431$24381043$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5828345$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243810441$24381044$1$I$20240101$20240919$20240930$20240930$EXP$$US-UCBSA-2024048833$UCB$$$$$F$Y$$$20241001$$CN$US$US
243810461$24381046$1$I$20240920$20240924$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US082900$SANDOZ$$$$$$Y$$$20240930$$HP$US$US
243810471$24381047$1$I$$20240927$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US083857$SANDOZ$$$$$$Y$$$20240930$$HP$US$US
243810502$24381050$2$F$$20240924$20240930$20240930$30DAY$$US-SANDOZ INC.-SDZ2024US083271$SANDOZ$$$$$F$Y$$$20240930$$CN$US$US
243810511$24381051$1$I$$20240927$20240930$20240930$EXP$$GB-SANDOZ INC.-SDZ2024GB083681$SANDOZ$$42$YR$$F$Y$84$KG$20240930$$PH$GB$GB
243810521$24381052$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275320$SANOFI AVENTIS$$20$YR$A$F$Y$$$20241001$$MD$US$US
243810531$24381053$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA276872$SANOFI AVENTIS$$66$YR$E$F$Y$$$20241001$$MD$US$US
243810541$24381054$1$I$$20240929$20240930$20240930$EXP$$EG-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054068$BOEHRINGER INGELHEIM$$70$YR$E$M$Y$$$20241001$$MD$EG$EG
243810551$24381055$1$I$$20240927$20240930$20240930$EXP$$US-TAKEDA-2022TUS085074$TAKEDA$$$$$M$Y$$$20240930$$CN$US$US
243810561$24381056$1$I$$20240927$20240930$20240930$PER$$NVSC2024US193261$NOVARTIS$$$$$M$Y$116$KG$20241001$$CN$US$US
243810571$24381057$1$I$$20240925$20240930$20240930$EXP$$US-ABBVIE-5905611$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243810581$24381058$1$I$$20240926$20240930$20240930$EXP$GB-MHRA-MED-202409262237275850-TMHVD$GB-SANDOZ INC.-SDZ2024GB083524$SANDOZ$$$$$F$Y$$$20240930$$HP$GB$GB
243810591$24381059$1$I$20240701$20240925$20240930$20240930$EXP$$CO-AMGEN-COLSP2024193446$AMGEN$$73$YR$E$M$Y$$$20240930$$CN$CO$CO
243810601$24381060$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024193282$AMGEN$LOWENHAAR G.; GONZALEZ J.; PATEL Y.. CARDIAC SARCOIDOSIS PRESENTING AS RECURRENT VENTRICULAR TACHYCARDIA. Chest. 2024;166 (4):A838$42$YR$A$M$Y$$$20240930$$HP$US$US
243810611$24381061$1$I$$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017492$ELI LILLY AND CO$$55$YR$A$M$Y$$$20240930$$CN$US$US
243810621$24381062$1$I$20240927$20240927$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153755$BRISTOL MYERS SQUIBB$$90$YR$E$M$Y$$$20241001$$CN$US$US
243810641$24381064$1$I$$20240923$20240930$20240930$EXP$$EG-AMGEN-EGYSP2024192636$AMGEN$$39$YR$A$F$Y$$$20240930$$CN$EG$EG
243810661$24381066$1$I$20240701$20240925$20240930$20240930$EXP$$US-BIOGEN-2024BI01284482$BIOGEN$$51$YR$$F$Y$$$20240930$$CN$US$GB
243810671$24381067$1$I$$20240917$20240930$20240930$EXP$$US-UCBSA-2024048301$UCB$$$$$F$Y$107.95$KG$20241001$$MD$US$US
243810681$24381068$1$I$$20240927$20240930$20240930$EXP$$IT-JNJFOC-20240977314$JOHNSON AND JOHNSON$$12$YR$T$F$Y$$$20241001$$HP$IT$IT
243810691$24381069$1$I$20240920$20240920$20240930$20240930$EXP$$US-JNJFOC-20240968405$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20241001$$HP$US$US
243810701$24381070$1$I$$20240925$20240930$20240930$EXP$$CA-ALXN-202408CAN000217CA$ALEXION PHARMACEUTICALS$$51$YR$A$$Y$$$20240930$$PH$CA$CA
243810721$24381072$1$I$20240101$20240917$20240930$20240930$EXP$$CA-UCBSA-2024048548$UCB$$$$$M$Y$$$20241001$$MD$CA$CA
243810731$24381073$1$I$$20240927$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153852$BRISTOL MYERS SQUIBB$$106$YR$E$F$Y$$$20241001$$CN$US$US
243810741$24381074$1$I$$20240927$20240930$20240930$EXP$$US-SANDOZ INC.-SDZ2024US083816$SANDOZ$$$$$$Y$$$20240930$$CN$US$US
243810751$24381075$1$I$$20240920$20240930$20240930$EXP$$JP-TAKEDA-2024TUS096281$TAKEDA$Maezumi S, Okada T, Kishida T, Ogawa Y, Tsukahara K. Renal immune-related adverse event difficult to diagnose during nivolumab treatment for hypopharyngeal carcinoma: case report. Case Reports in Oncology. 2024;17:966-72$64$YR$$M$Y$$$20240930$$MD$JP$JP
243810761$24381076$1$I$20240101$20240924$20240930$20240930$EXP$$MX-ABBVIE-5942028$ABBVIE$$$$$M$Y$70$KG$20240930$$CN$MX$MX
243810771$24381077$1$I$20240902$20240925$20240930$20240930$EXP$$US-BIOGEN-2024BI01283168$BIOGEN$$54$YR$$M$Y$$$20240930$$HP$US$US
243810781$24381078$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277528$SANOFI AVENTIS$$27$YR$A$M$Y$$$20241001$$HP$US$US
243810791$24381079$1$I$$20240926$20240930$20240930$EXP$$JP-009507513-2409JPN009686$MERCK$Takehara H, Kodama K, Momozane T, Takeda M, Shigetsu K, Kishima H.. Possible thoracic metastasis from squamous cell carcinoma of the external auditory canal: A case report. Clinical Case Reports. 2024;12 (9):1-5$80$YR$$F$Y$$$20240930$$HP$JP$JP
243810801$24381080$1$I$20240921$20240921$20240930$20240930$PER$$US-CYCLE PHARMACEUTICALS LTD-2024-CYC-000095$CYCLE PHARMACEUTICALS$$$$$$Y$$$20240930$$CN$US$US
243810811$24381081$1$I$20240923$20240927$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153634$BRISTOL MYERS SQUIBB$$80$YR$E$M$Y$$$20241001$$HP$US$US
243810821$24381082$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA277023$SANOFI AVENTIS$$34$YR$A$F$Y$$$20241001$$CN$US$US
243810831$24381083$1$I$$20240923$20240930$20240930$PER$$US-TAKEDA-2024TUS094770$TAKEDA$$46$YR$$F$Y$$$20240930$$CN$US$US
243810851$24381085$1$I$$20240925$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-152469$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$$$20241001$$HP$US$US
243810861$24381086$1$I$20240812$20240925$20240930$20240930$EXP$$CN-JNJFOC-20240972832$JOHNSON AND JOHNSON$$73$YR$E$F$Y$51$KG$20241001$$HP$CN$CN
243810871$24381087$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277590$SANOFI AVENTIS$$24$YR$A$M$Y$$$20241001$$HP$US$US
243810881$24381088$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA275639$SANOFI AVENTIS$$$$A$M$Y$$$20241001$$MD$US$US
243810891$24381089$1$I$$20240924$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA005618US$ALEXION PHARMACEUTICALS$$52$YR$A$$Y$$$20240930$$$US$US
243810901$24381090$1$I$$20240920$20240930$20240930$EXP$$JP-JNJFOC-20240964157$JOHNSON AND JOHNSON$$$$$$Y$$$20241001$$PH$JP$JP
243810931$24381093$1$I$$20240927$20240930$20240930$PER$$US-ROCHE-10000094843$ROCHE$$86$YR$E$F$Y$$$20241001$$CN$US$US
243810951$24381095$1$I$$20240918$20240930$20240930$EXP$$US-PFIZER INC-PV202400127584$PFIZER$$78$YR$$M$Y$$$20240930$$CN$US$US
243810961$24381096$1$I$20240912$20240925$20240930$20240930$EXP$FR-AFSSAPS-CF2024000472$FR-PFIZER INC-202400265589$PFIZER$$78$YR$$M$Y$$$20240930$$PH$FR$FR
243810971$24381097$1$I$$20240924$20240930$20240930$PER$$US-DSJP-DS-2024-101433-US$DAIICHI$$$$$F$Y$$$20241001$$CN$US$US
243810981$24381098$1$I$20231122$20240925$20240930$20240930$EXP$ES-AEMPS-1573296$ES-PFIZER INC-202400263526$PFIZER$$64$YR$$M$Y$$$20240930$$MD$ES$ES
243810991$24381099$1$I$20240829$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017820$ELI LILLY AND CO$$18$YR$A$M$Y$$$20240930$$CN$US$US
243811001$24381100$1$I$20240901$20240923$20240930$20240930$PER$$US-SA-2024SA276833$SANOFI AVENTIS$$10$YR$C$M$Y$$$20241001$$MD$US$US
243811011$24381101$1$I$20240409$20240919$20240930$20240930$EXP$$FR-DSJP-DS-2024-100918-FR$DAIICHI$$71$YR$$F$Y$59$KG$20241001$$MD$FR$FR
243811021$24381102$1$I$20240813$20240918$20240930$20240930$EXP$$US-UCBSA-2024044075$UCB$$43$YR$$F$Y$$$20241001$$CN$US$US
243811031$24381103$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA275966$SANOFI AVENTIS$$2$YR$C$F$Y$$$20241001$$HP$US$US
243811041$24381104$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275236$SANOFI AVENTIS$$41$YR$A$F$Y$$$20241001$$MD$US$US
243811051$24381105$1$I$$20240925$20240930$20240930$EXP$$JP-ABBVIE-5939053$ABBVIE$$$$$M$Y$$$20240930$$MD$JP$JP
243811061$24381106$1$I$20240924$20240926$20240930$20240930$EXP$$US-TAKEDA-2024TUS095691$TAKEDA$$21$YR$$M$Y$$$20240930$$MD$US$US
243811071$24381107$1$I$$20240920$20240930$20240930$EXP$$FR-DSJP-DS-2024-101205-FR$DAIICHI$$$$E$F$Y$50$KG$20241001$$MD$FR$FR
243811081$24381108$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024190523$AMGEN$Chen E.C.; Flamand Y.; Tiao E.; et al.. Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidation. Leukemia + Lymphoma. 2024;1-8$80$YR$E$F$Y$$$20240930$$HP$US$US
243811091$24381109$1$I$20240901$20240925$20240930$20240930$EXP$$US-ABBVIE-5942688$ABBVIE$$23$YR$$M$Y$$$20240930$$CN$US$US
243811101$24381110$1$I$$20240926$20240930$20240930$EXP$$US-TAKEDA-2023TUS098093$TAKEDA$$$$$M$Y$$$20240930$$CN$US$US
243811111$24381111$1$I$20240901$20240926$20240930$20240930$EXP$$US-ABBVIE-5942502$ABBVIE$$48$YR$$F$Y$$$20240930$$CN$US$US
243811121$24381112$1$I$$20240926$20240930$20240930$EXP$$US-ABBVIE-5941488$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243811131$24381113$1$I$$20240923$20240930$20240930$PER$$US-SA-2024SA275146$SANOFI AVENTIS$$11$YR$C$M$Y$$$20241001$$MD$US$US
243811141$24381114$1$I$$20240926$20240930$20240930$EXP$$US-ABBVIE-5915254$ABBVIE$$$$$M$Y$$$20240930$$CN$US$US
243811151$24381115$1$I$20240916$20240925$20240930$20240930$EXP$$US-ABBVIE-5941050$ABBVIE$$46$YR$$F$Y$$$20240930$$CN$US$US
243811161$24381116$1$I$20171001$20240918$20240930$20240930$EXP$$JP-ABBVIE-18P-087-2250728-00$ABBVIE$$48$YR$$M$Y$54.7$KG$20240930$$MD$JP$JP
243811171$24381117$1$I$20240924$20240926$20240930$20240930$PER$$US-AMGEN-USASP2024192715$AMGEN$$57$YR$A$M$Y$$$20240930$$CN$US$US
243811181$24381118$1$I$$20240923$20240930$20240930$PER$$US-AMGEN-USASP2024192714$AMGEN$Dev J.; Mahindra A.; Miret R.. AIRWAY INJURY FROM ZINC TABLET ASPIRATION. Chest. 2024;166 (4):A6097-A6098$61$YR$A$F$Y$$$20240930$$HP$US$US
243811191$24381119$1$I$$20240923$20240930$20240930$EXP$$IT-TEVA-VS-3247698$TEVA$Levi V, Stanziano M, Pinto C, Zibordi F, Fedeli D, Caldiera V, et al. Bilateral Simultaneous Magnetic Resonance-Guided Focused Ultrasound Pallidotomy for Life-Threatening Status Dystonicus. Mov-Disord 2024; 39 (8): 1408-1412.; Levi V, Stanziano M, Pinto C, Zibordi F, Fedeli D, Caldiera V, et al. Bilateral Simultaneous Magnetic Resonance-Guided Focused Ultrasound Pallidotomy for Life-Threatening Status Dystonicus. Mov-Disord 2024; 39 (8): 1408-1412.$19$YR$$F$Y$$$20240930$$MD$IT$IT
243811211$24381121$1$I$$20240924$20240930$20240930$EXP$$US-ABBVIE-5937984$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243811221$24381122$1$I$20240101$20240926$20240930$20240930$PER$$US-ORGANON-O2409USA002191$ORGANON$$$$$F$Y$90.703$KG$20240930$$CN$US$US
243811231$24381123$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5939569$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243811251$24381125$1$I$$20240930$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018768$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240930$$CN$US$US
243811261$24381126$1$I$$20240927$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409018726$ELI LILLY AND CO$$$$$$Y$$$20240930$$MD$US$US
243811271$24381127$1$I$$20240924$20240930$20240930$EXP$$US-ASTRAZENECA-202409USA005901US$ALEXION PHARMACEUTICALS$$$$E$$Y$$$20240930$$$US$US
243811281$24381128$1$I$$20240918$20240930$20240930$PER$$US-JNJFOC-20240949151$JOHNSON AND JOHNSON$$$$$$Y$$$20241001$$CN$US$US
243811291$24381129$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5939828$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243811301$24381130$1$I$20240731$20240926$20240930$20240930$EXP$$US-ABBVIE-5941683$ABBVIE$$52$YR$$F$Y$$$20240930$$CN$US$US
243811311$24381131$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA277661$SANOFI AVENTIS$$51$YR$A$F$Y$$$20241001$$HP$US$US
243811321$24381132$1$I$20240601$20240923$20240930$20240930$PER$$US-SA-2024SA275273$SANOFI AVENTIS$$43$YR$A$M$Y$$$20241001$$MD$US$US
243811331$24381133$1$I$$20240920$20240930$20240930$PER$$US-SA-2024SA275503$SANOFI AVENTIS$$$$A$M$Y$$$20241001$$MD$US$US
243811351$24381135$1$I$$20240927$20240930$20240930$PER$$US-AMGEN-USASP2024193010$AMGEN$$72$YR$E$M$Y$$$20240930$$CN$US$US
243811361$24381136$1$I$$20240926$20240930$20240930$EXP$GB-MHRA-MED-202409262217084180-FTPVB$GB-SANDOZ INC.-SDZ2024GB083520$SANDOZ$$$$$F$Y$$$20240930$$HP$GB$GB
243811371$24381137$1$I$20240923$20240924$20240930$20240930$EXP$$US-TAKEDA-2024TUS095292$TAKEDA$$45$YR$$F$Y$$$20240930$$MD$US$US
243811381$24381138$1$I$$20240926$20240930$20240930$PER$$NVSC2024US193591$NOVARTIS$$$$$M$Y$$$20241001$$HP$US$US
243811391$24381139$1$I$20230101$20240927$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-153697$BRISTOL MYERS SQUIBB$$36$YR$A$M$Y$$$20241001$$HP$US$US
243811401$24381140$1$I$$20240926$20240930$20240930$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-2024-153732$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20241001$$MD$DE$DE
243811411$24381141$1$I$20240101$20240913$20240930$20240930$PER$$US-SA-2024SA280657$SANOFI AVENTIS$$66$YR$E$F$Y$$$20241001$$CN$US$US
243811421$24381142$1$I$20240801$20240923$20240930$20240930$PER$$US-SA-2024SA277153$SANOFI AVENTIS$$5$YR$C$F$Y$$$20241001$$HP$US$US
243811431$24381143$1$I$20240101$20240923$20240930$20240930$PER$$US-SA-2024SA277204$SANOFI AVENTIS$$47$YR$A$F$Y$$$20241001$$HP$US$US
243811441$24381144$1$I$20240922$20240926$20240930$20240930$EXP$$US-TAKEDA-2024TUS010224$TAKEDA$$77$YR$$F$Y$83$KG$20240930$$CN$US$US
243811451$24381145$1$I$$20240927$20240930$20240930$EXP$$BR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-054152$BOEHRINGER INGELHEIM$$89$YR$E$F$Y$$$20241001$$MD$BR$BR
243811461$24381146$1$I$20240829$20240924$20240930$20240930$EXP$$US-JNJFOC-20240968230$JOHNSON AND JOHNSON$$10$YR$C$M$Y$19.1$KG$20241001$$HP$US$US
243811471$24381147$1$I$$20240924$20240930$20240930$PER$$US-SA-2024SA276860$SANOFI AVENTIS$$10$YR$C$M$Y$$$20241001$$MD$US$US
243811481$24381148$1$I$$20240911$20240930$20240930$PER$$US-SA-2024SA280522$SANOFI AVENTIS$$$$A$F$Y$122.47$KG$20241001$$MD$US$US
243811491$24381149$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA277074$SANOFI AVENTIS$$$$E$F$Y$61.36$KG$20241001$$MD$US$US
243811501$24381150$1$I$20240919$20240919$20240930$20240930$PER$$US-SA-2024SA275896$SANOFI AVENTIS$$30$YR$A$F$Y$47.73$KG$20241001$$MD$US$US
243811511$24381151$1$I$$20240925$20240930$20240930$PER$$US-ASTRAZENECA-202409USA006977US$ALEXION PHARMACEUTICALS$$$$$$Y$$$20240930$$$US$US
243811521$24381152$1$I$20240925$20240926$20240930$20240930$PER$$US-ELI_LILLY_AND_COMPANY-US202409017770$ELI LILLY AND CO$$38$YR$A$$Y$$$20240930$$CN$US$US
243811541$24381154$1$I$$20240928$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154238$BRISTOL MYERS SQUIBB$$73$YR$E$M$Y$74.84$KG$20241001$$CN$US$US
243811551$24381155$1$I$$20240927$20240930$20240930$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-154433$BRISTOL MYERS SQUIBB$$91$YR$E$M$Y$$$20241001$$CN$US$US
243811561$24381156$1$I$20240818$20240924$20240930$20240930$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-2024-133610$BRISTOL MYERS SQUIBB$$37$YR$A$M$Y$$$20241001$$CN$US$US
243811571$24381157$1$I$20210901$20240924$20240930$20240930$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-2024-153541$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20241001$$MD$KR$KR
243811591$24381159$1$I$20231218$20240928$20240930$20240930$EXP$GB-MHRA-TPP43572381C22275880YC1727347061896$GB-ORGANON-O2409GBR002274$ORGANON$$67$YR$$F$Y$72$KG$20240930$$MD$GB$GB
243811611$24381161$1$I$20240101$20240925$20240930$20240930$EXP$$US-ABBVIE-5940771$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243811621$24381162$1$I$20240920$20240920$20240930$20240930$EXP$$US-JNJFOC-20240956716$JOHNSON AND JOHNSON$$$$$$Y$$$20241001$$PH$US$US
243811631$24381163$1$I$20110101$20240920$20240930$20240930$PER$$US-JNJFOC-20240965701$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20241001$$HP$US$US
243811641$24381164$1$I$20240101$20240923$20240930$20240930$EXP$$US-ABBVIE-5936826$ABBVIE$$$$$F$Y$$$20240930$$CN$US$US
243811661$24381166$1$I$$20240909$20240930$20240930$PER$$US-SA-2024SA275775$SANOFI AVENTIS$$$$A$$Y$$$20241001$$CN$US$US
243811671$24381167$1$I$20240101$20240920$20240930$20240930$PER$$US-SA-2024SA275908$SANOFI AVENTIS$$45$YR$A$F$Y$$$20241001$$MD$US$US
243811681$24381168$1$I$20240701$20240919$20240930$20240930$PER$$US-SA-2024SA274087$SANOFI AVENTIS$$21$YR$A$F$Y$$$20241001$$MD$US$US
243825511$24382551$1$I$20231109$20240923$20240930$20240930$EXP$ES-AEMPS-1572829$ES-ABBVIE-5936002$ABBVIE$$63$YR$$F$Y$$$20240930$$MD$ES$ES
243826491$24382649$1$I$20240901$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67448$$FDA-CTU$$87$YR$$M$N$199$KG$20240930$N$$US$
243826501$24382650$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67470$$FDA-CTU$$57$YR$$F$N$$$20240930$N$HP$US$
243826521$24382652$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67466$$FDA-CTU$$$$$M$N$$$20240930$N$$US$
243827371$24382737$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67488$$FDA-CTU$$49$YR$$F$N$$$20240930$N$$US$
243827421$24382742$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67496$$FDA-CTU$$$$$F$N$$$20240930$N$$US$
243827451$24382745$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67498$$FDA-CTU$$82$YR$$F$N$$$20240930$N$$US$
243827711$24382771$1$I$20240919$20240924$20240930$20240930$DIR$FDA-CDER-CTU-2024-67439$$FDA-CTU$$29$YR$$F$N$$$20240924$N$HP$US$
243827721$24382772$1$I$20240807$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67499$$FDA-CTU$$33$YR$$M$N$$$20240930$N$HP$US$
243827731$24382773$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67475$$FDA-CTU$$$$$M$N$$$20240930$N$HP$US$
243827741$24382774$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67481$$FDA-CTU$$61$YR$$M$N$$$20240930$N$$US$
243827751$24382775$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67442$$FDA-CTU$$66$YR$$M$N$108.86$KG$20240930$N$$US$
243827791$24382779$1$I$$20240929$20240930$20240930$DIR$FDA-CDER-CTU-2024-67451$$FDA-CTU$$$$$M$N$$$20240929$N$HP$US$
243827801$24382780$1$I$20240911$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67438$$FDA-CTU$$71$YR$$F$N$$$20240930$N$HP$US$
243827811$24382781$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67458$$FDA-CTU$$24$YR$$F$N$$$20240930$N$$US$
243828111$24382811$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67459$$FDA-CTU$$55$YR$$M$N$$$20240930$N$$US$
243828551$24382855$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67493$$FDA-CTU$$$$$F$N$$$20240930$N$HP$US$
243828561$24382856$1$I$20240815$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67456$$FDA-CTU$$62$YR$$M$N$$$20240930$N$PH$US$
243828591$24382859$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67487$$FDA-CTU$$$$$F$N$$$20240930$N$HP$US$
243828621$24382862$1$I$20240918$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67444$$FDA-CTU$$63$YR$$M$N$$$20240930$N$HP$US$
243829801$24382980$1$I$20240904$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-66961$$FDA-CTU$$74$YR$$M$N$98.88$KG$20241001$N$CN$US$
243829931$24382993$1$I$$20240927$20240930$20240930$DIR$FDA-CDER-CTU-2024-67198$$FDA-CTU$$$$$M$N$$$20240927$N$HP$US$
243830041$24383004$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67468$$FDA-CTU$$42$YR$$F$N$$$20240930$N$$US$
243830061$24383006$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67368$$FDA-CTU$$30$YR$$F$N$$$20240930$N$$US$
243830091$24383009$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67460$$FDA-CTU$$24$YR$$F$N$$$20240930$N$$US$
243830101$24383010$1$I$20240927$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67485$$FDA-CTU$$$$$M$N$$$20240930$N$$US$
243830141$24383014$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67462$$FDA-CTU$$50$YR$$F$N$$$20240930$N$$US$
243830671$24383067$1$I$20240928$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67404$$FDA-CTU$$47$YR$$M$N$$$20240930$N$$US$
243830761$24383076$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67497$$FDA-CTU$$74$YR$$M$N$$$20240930$N$$US$
243830771$24383077$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67492$$FDA-CTU$$76$YR$$M$N$$$20240930$N$$US$
243830801$24383080$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67474$$FDA-CTU$$$$$F$N$$$20240930$N$HP$US$
243830951$24383095$1$I$20240831$20240927$20240930$20240930$DIR$FDA-CDER-CTU-2024-67219$$FDA-CTU$$50$YR$$M$N$$$20240927$N$HP$US$
243830961$24383096$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67374$$FDA-CTU$$32$YR$$F$N$$$20240930$N$$US$
243830991$24383099$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67399$$FDA-CTU$$32$YR$$F$N$$$20240930$N$$US$
243831011$24383101$1$I$$20240928$20240930$20240930$DIR$FDA-CDER-CTU-2024-67340$$FDA-CTU$$$$$F$N$$$20240928$N$HP$US$
243831061$24383106$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67331$$FDA-CTU$$61$YR$$F$N$$$20240930$N$$US$
243831071$24383107$1$I$$20240929$20240930$20240930$DIR$FDA-CDER-CTU-2024-67379$$FDA-CTU$$$$$F$N$$$20240929$N$HP$US$
243831081$24383108$1$I$$20240927$20240930$20240930$DIR$FDA-CDER-CTU-2024-67385$$FDA-CTU$$$$$F$N$$$20240927$N$HP$US$
243831141$24383114$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67317$$FDA-CTU$$34$YR$$F$N$86.18$KG$20240930$N$HP$US$
243831151$24383115$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67271$$FDA-CTU$$50$YR$$F$N$104.33$KG$20240930$N$$US$
243831161$24383116$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67441$$FDA-CTU$$54$YR$$F$N$$$20240930$N$HP$US$
243831781$24383178$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67420$$FDA-CTU$$74$YR$$F$N$$$20240930$N$HP$US$
243831791$24383179$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67282$$FDA-CTU$$45$YR$$M$N$$$20240930$N$$US$
243831801$24383180$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67220$$FDA-CTU$$44$YR$$F$N$$$20240930$N$HP$US$
243831821$24383182$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67296$$FDA-CTU$$80$YR$$F$N$$$20240930$N$$US$
243831851$24383185$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67310$$FDA-CTU$$32$YR$$F$N$$$20240930$N$$US$
243831861$24383186$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67477$$FDA-CTU$$85$YR$$F$N$$$20240930$N$$US$
243831891$24383189$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67410$$FDA-CTU$$49$YR$$F$N$$$20240930$N$$US$
243831901$24383190$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67287$$FDA-CTU$$50$YR$$F$N$$$20240930$N$$US$
243831911$24383191$1$I$$20240928$20240930$20240930$DIR$FDA-CDER-CTU-2024-67443$$FDA-CTU$$$$$M$N$$$20240928$N$HP$US$
243831931$24383193$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67478$$FDA-CTU$$50$YR$$F$N$$$20240930$N$$US$
243831951$24383195$1$I$20240926$20240930$20240930$20240930$DIR$720632$$FDA-CTU$$48$YR$$F$N$72$KG$20240930$N$CN$US$
243831961$24383196$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67422$$FDA-CTU$$69$YR$$F$N$$$20240930$N$$US$
243831971$24383197$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67299$$FDA-CTU$$79$YR$$F$N$$$20240930$N$$US$
243831991$24383199$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67387$$FDA-CTU$$62$YR$$F$N$127.01$KG$20240930$N$$US$
243832001$24383200$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67359$$FDA-CTU$$$$$F$N$$$20240930$N$HP$US$
243832011$24383201$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67280$$FDA-CTU$$21$YR$$F$N$$$20240930$N$$US$
243832021$24383202$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67336$$FDA-CTU$$77$YR$$M$N$87.09$KG$20240930$N$$US$
243832031$24383203$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67290$$FDA-CTU$$56$YR$$F$N$108.86$KG$20240930$N$$US$
243832041$24383204$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67376$$FDA-CTU$$74$YR$$F$N$$$20240930$N$$US$
243832261$24383226$1$I$$20240929$20240930$20240930$DIR$FDA-CDER-CTU-2024-67269$$FDA-CTU$$$$$F$N$$$20240929$N$HP$US$
243832271$24383227$1$I$$20240927$20240930$20240930$DIR$FDA-CDER-CTU-2024-67277$$FDA-CTU$$$$$F$N$$$20240927$N$HP$US$
243832331$24383233$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67449$$FDA-CTU$$77$YR$$F$N$$$20240930$N$$US$
243832341$24383234$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67419$$FDA-CTU$$45$YR$$F$N$$$20240930$N$$US$
243832411$24383241$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67353$$FDA-CTU$$$$$F$N$$$20240930$N$HP$US$
243832451$24383245$1$I$$20240927$20240930$20240930$DIR$FDA-CDER-CTU-2024-67381$$FDA-CTU$$$$$F$N$$$20240927$N$HP$US$
243832531$24383253$1$I$$20240928$20240930$20240930$DIR$FDA-CDER-CTU-2024-67268$$FDA-CTU$$$$$F$N$$$20240928$N$HP$US$
243833621$24383362$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67307$$FDA-CTU$$$$$F$N$$$20240930$N$HP$US$
243833661$24383366$1$I$$20240927$20240930$20240930$DIR$FDA-CDER-CTU-2024-67330$$FDA-CTU$$$$$M$N$$$20240927$N$HP$US$
243833741$24383374$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67395$$FDA-CTU$$55$YR$$M$N$420$LBS$20240930$N$$US$
243833831$24383383$1$I$$20240927$20240930$20240930$DIR$FDA-CDER-CTU-2024-67467$$FDA-CTU$$$$$F$N$$$20240927$N$HP$US$
243833851$24383385$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67455$$FDA-CTU$$88$YR$$F$N$170$LBS$20240930$N$$US$
243833861$24383386$1$I$20240904$20240930$20240930$20240930$DIR$720592$$FDA-CTU$$75$YR$$UNK$N$$$20240930$N$HP$US$
243833891$24383389$1$I$20240828$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67417$$FDA-CTU$$29$YR$$F$N$$$20240930$N$$US$
243833921$24383392$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67429$$FDA-CTU$$60$YR$$F$N$$$20240930$N$$US$
243833931$24383393$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67409$$FDA-CTU$$69$YR$$F$N$179$LBS$20240930$N$$US$
243834191$24383419$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67454$$FDA-CTU$$88$YR$$F$N$170$LBS$20240930$N$$US$
243834291$24383429$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67465$$FDA-CTU$$43$YR$$M$N$$$20240930$N$$US$
243834321$24383432$1$I$20240924$20240930$20240930$20240930$DIR$720618$$FDA-CTU$$38$YR$$M$N$75.4$KG$20240930$Y$$US$
243834361$24383436$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67440$$FDA-CTU$$75$YR$$F$N$115$LBS$20240930$N$HP$US$
243834481$24383448$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67402$$FDA-CTU$$88$YR$$F$N$$$20240930$N$$US$
243834491$24383449$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67469$$FDA-CTU$$66$YR$$M$N$$$20240930$N$$US$
243834561$24383456$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67463$$FDA-CTU$$91$YR$$M$N$$$20240930$N$$US$
243834611$24383461$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67491$$FDA-CTU$$75$YR$$F$N$$$20240930$N$$US$
243834621$24383462$1$I$20170701$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67403$$FDA-CTU$$27$YR$$F$N$95.25$KG$20240930$N$HP$US$
243834631$24383463$1$I$$20240928$20240930$20240930$DIR$FDA-CDER-CTU-2024-67341$$FDA-CTU$$$$$F$N$67.59$KG$20240928$N$PH$US$
243834671$24383467$1$I$20240823$20240824$20240930$20240930$DIR$FDA-CDER-CTU-2024-67284$$FDA-CTU$$42$YR$$F$N$$$20240824$N$HP$US$
243834681$24383468$1$I$20240930$20240930$20240930$20240930$DIR$720667$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243834691$24383469$1$I$20240706$20240930$20240930$20240930$DIR$720613$$FDA-CTU$$60$YR$$F$N$56.2$KG$20240930$N$PH$US$
243834721$24383472$1$I$$20240930$20240930$20240930$DIR$720675$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243835201$24383520$1$I$20240913$20240930$20240930$20240930$DIR$720657$$FDA-CTU$$71$YR$$F$N$81$KG$20240930$N$CN$US$
243835631$24383563$1$I$$20240930$20240930$20240930$DIR$720655$$FDA-CTU$$57$YR$$F$N$74.25$KG$20240930$N$CN$US$
243835841$24383584$1$I$20240910$20240930$20240930$20240930$DIR$720699$$FDA-CTU$$79$YR$$F$N$62.1$KG$20240930$N$CN$US$
243836111$24383611$1$I$20240927$20240930$20240930$20240930$DIR$720712$$FDA-CTU$$56$YR$$F$N$101.25$KG$20240930$N$HP$US$
243836231$24383623$1$I$20240930$20240930$20240930$20240930$DIR$720711$$FDA-CTU$$78$YR$$M$N$70.65$KG$20240930$N$HP$US$
243836241$24383624$1$I$20240930$20240930$20240930$20240930$DIR$720703$$FDA-CTU$$68$YR$$M$N$108.9$KG$20240930$N$MD$US$
243836261$24383626$1$I$20240930$20240930$20240930$20240930$DIR$720652$$FDA-CTU$$62$YR$$F$N$65$KG$20240930$N$CN$ZA$
243836301$24383630$1$I$20211108$20240930$20240930$20240930$DIR$720706$$FDA-CTU$$34$YR$$F$N$$$20240930$N$CN$US$
243836981$24383698$1$I$20240930$20240930$20240930$20240930$DIR$720629$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243837161$24383716$1$I$20240613$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67526$$FDA-CTU$$$$$$N$$$20240927$Y$PH$US$
243837171$24383717$1$I$20230822$20240930$20240930$20240930$DIR$720719$$FDA-CTU$$66$YR$$F$N$51.75$KG$20240930$N$HP$US$
243837181$24383718$1$I$20240930$20240930$20240930$20240930$DIR$720732$$FDA-CTU$$45$YR$$F$N$135$KG$20240930$N$PH$US$
243837191$24383719$1$I$20240930$20240930$20240930$20240930$DIR$720704$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243837201$24383720$1$I$$20240927$20240927$20240927$DIR$FDA-CDER-CTU-2024-67523$$FDA-CTU$$$$$$N$$$20240927$N$CN$US$
243838241$24383824$1$I$20240930$20240930$20240930$20240930$DIR$720729$$FDA-CTU$$23$YR$$F$N$58.5$KG$20240930$N$CN$US$
243838281$24383828$1$I$20240930$20240930$20240930$20240930$DIR$720742$$FDA-CTU$$32$YR$$F$N$63$KG$20240930$N$CN$US$
243838331$24383833$1$I$20240928$20240930$20240930$20240930$DIR$720737$$FDA-CTU$$62$YR$$M$N$87.3$KG$20240930$N$CN$US$
243838381$24383838$1$I$20240715$20240930$20240930$20240930$DIR$720665$$FDA-CTU$$49$YR$$M$N$90$KG$20240930$N$CN$US$
243839331$24383933$1$I$20240925$20240930$20240930$20240930$DIR$720666$$FDA-CTU$$82$YR$$F$N$$$20240930$N$PH$US$
243839341$24383934$1$I$20240814$20240930$20240930$20240930$DIR$720728$$FDA-CTU$$69$YR$$M$N$$$20240930$Y$HP$US$
243839881$24383988$1$I$20240928$20240930$20240930$20240930$DIR$720720$$FDA-CTU$$55$YR$$M$N$88.65$KG$20240930$N$CN$US$
243839901$24383990$1$I$20240924$20240928$20240928$20240928$DIR$FDA-CDER-CTU-2024-67577$$FDA-CTU$$31$YR$$M$N$$$20240928$Y$CN$US$
243839911$24383991$1$I$$20240930$20240930$20240930$DIR$720683$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243841061$24384106$1$I$20240906$20240930$20240930$20240930$DIR$720589$$FDA-CTU$$84$YR$$F$N$54.36$KG$20240930$N$HP$US$
243841581$24384158$1$I$$20240930$20240930$20240930$DIR$720622$$FDA-CTU$$56$YR$$F$N$$$20240930$N$CN$US$
243842011$24384201$1$I$20240930$20240930$20240930$20240930$DIR$720707$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243842771$24384277$1$I$20231101$20240930$20240930$20240930$DIR$720640$$FDA-CTU$$$$$F$N$$$20240930$N$CN$US$
243842781$24384278$1$I$20240930$20240930$20240930$20240930$DIR$720637$$FDA-CTU$$51$YR$$F$N$$$20240930$N$HP$US$
243842861$24384286$1$I$20240927$20240930$20240930$20240930$DIR$720605$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243843031$24384303$1$I$20240930$20240930$20240930$20240930$DIR$720701$$FDA-CTU$$73$YR$$M$N$$$20240930$N$$US$
243843041$24384304$1$I$20240930$20240930$20240930$20240930$DIR$720634$$FDA-CTU$$32$YR$$F$N$$$20240930$N$$US$
243843051$24384305$1$I$20240930$20240930$20240930$20240930$DIR$720631$$FDA-CTU$$70$YR$$M$N$$$20240930$N$$US$
243843451$24384345$1$I$20240930$20240930$20240930$20240930$DIR$720736$$FDA-CTU$$28$YR$$F$N$80.1$KG$20240930$N$CN$US$
243843481$24384348$1$I$20240821$20240930$20240930$20240930$DIR$720671$$FDA-CTU$$55$YR$$F$N$114.75$KG$20240930$N$CN$US$
243843491$24384349$1$I$20240930$20240930$20240930$20240930$DIR$720624$$FDA-CTU$$45$YR$$F$N$$$20240930$N$CN$US$
243843511$24384351$1$I$$20240930$20240930$20240930$DIR$720672$$FDA-CTU$$64$YR$$M$N$105.2$KG$20240930$N$$US$
243843521$24384352$1$I$$20240930$20240930$20240930$DIR$720642$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243844071$24384407$1$I$20240925$20240930$20240930$20240930$DIR$720656$$FDA-CTU$$53$YR$$F$N$$$20240930$Y$HP$US$
243844181$24384418$1$I$20240929$20240930$20240930$20240930$DIR$720718$$FDA-CTU$$78$YR$$F$N$$$20240930$N$$US$
243844231$24384423$1$I$$20240930$20240930$20240930$DIR$720741$$FDA-CTU$$50$YR$$M$N$$$20240930$N$$US$
243844251$24384425$1$I$20220714$20240930$20240930$20240930$DIR$720708$$FDA-CTU$$18$YR$$F$N$$$20240930$N$PH$US$
243844641$24384464$1$I$20240928$20240930$20240930$20240930$DIR$720584$$FDA-CTU$$48$YR$$M$N$106$KG$20240930$N$HP$US$
243844671$24384467$1$I$20240911$20240929$20240929$20240929$DIR$FDA-CDER-CTU-2024-67603$$FDA-CTU$$56$YR$$F$N$81.65$KG$20240929$N$CN$US$
243844681$24384468$1$I$$20240930$20240930$20240930$DIR$720688$$FDA-CTU$$$$$UNK$N$$$20240930$$CN$US$
243845011$24384501$1$I$20240901$20240930$20240930$20240930$DIR$720724$$FDA-CTU$$67$YR$$M$N$117$KG$20240930$N$CN$US$
243845051$24384505$1$I$20240929$20240930$20240930$20240930$DIR$720686$$FDA-CTU$$74$YR$$M$N$83.7$KG$20240930$N$MD$US$
243845061$24384506$1$I$$20240930$20240930$20240930$DIR$720709$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243845071$24384507$1$I$$20240930$20240930$20240930$DIR$720607$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243846041$24384604$1$I$$20240930$20240930$20240930$DIR$720689$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243848371$24384837$1$I$20240926$20240930$20240930$20240930$DIR$720614$$FDA-CTU$$83$YR$$M$N$67.05$KG$20240930$Y$CN$US$
243848631$24384863$1$I$20240930$20240930$20240930$20240930$DIR$720673$$FDA-CTU$$$$$UNK$N$$$20240930$N$CN$US$
243849511$24384951$1$I$20210408$20240930$20240930$20240930$DIR$720717$$FDA-CTU$$36$YR$$F$N$76.5$KG$20240930$N$CN$US$
243849531$24384953$1$I$20240929$20240930$20240930$20240930$DIR$720591$$FDA-CTU$$33$YR$$M$N$56.2$KG$20240930$N$HP$US$
243849841$24384984$1$I$20240923$20240930$20240930$20240930$DIR$720714$$FDA-CTU$$36$YR$$M$N$65.25$KG$20240930$N$CN$US$
243850211$24385021$1$I$20240925$20240930$20240930$20240930$DIR$720606$$FDA-CTU$$17$YR$$M$N$$$20240930$$CN$US$
243850221$24385022$1$I$20240925$20240930$20240930$20240930$DIR$720658$$FDA-CTU$$15$YR$$F$N$$$20240930$N$CN$US$
243850231$24385023$1$I$$20240930$20240930$20240930$DIR$720630$$FDA-CTU$$$$$F$N$$$20240930$N$PH$US$
243850641$24385064$1$I$20240927$20240929$20240929$20240929$DIR$FDA-CDER-CTU-2024-67594$$FDA-CTU$$$$$$N$$$20240929$$CN$US$
243851141$24385114$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67629$$FDA-CTU$$$$$$N$$$20240930$$CN$US$
243851151$24385115$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67740$$FDA-CTU$$$$$$N$$$20240930$N$CN$US$
243851161$24385116$1$I$$20240930$20240930$20240930$DIR$720617$$FDA-CTU$$$$$UNK$N$$$20240930$N$$US$
243851171$24385117$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67738$$FDA-CTU$$$$$$N$$$20240930$N$CN$US$
243851181$24385118$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67729$$FDA-CTU$$$$$$N$$$20240930$N$CN$US$
243851231$24385123$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67617$$FDA-CTU$$$$$$N$$$20240930$N$CN$US$
243851301$24385130$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67623$$FDA-CTU$$$$$$N$$$20240930$N$CN$US$
243851311$24385131$1$I$20240906$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67732$$FDA-CTU$$62$YR$$M$N$130$LBS$20240930$Y$HP$US$
243851321$24385132$1$I$20240927$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67610$$FDA-CTU$$$$$$N$$$20240930$N$CN$US$
243852561$24385256$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67628$$FDA-CTU$$$$$$N$$$20240930$$CN$US$
243852591$24385259$1$I$20240923$20240930$20240930$20240930$DIR$720744$$FDA-CTU$$31$YR$$F$N$69.75$KG$20240930$Y$HP$US$
243852621$24385262$1$I$$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67745$$FDA-CTU$$$$$$N$$$20240930$$CN$US$
243852641$24385264$1$I$20240930$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67630$$FDA-CTU$$78$YR$$M$N$94.8$KG$20240930$Y$HP$US$
243855721$24385572$1$I$20240925$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67626$$FDA-CTU$$24$YR$$F$N$68.04$KG$20240930$N$CN$US$
243856411$24385641$1$I$20240905$20240930$20240930$20240930$DIR$FDA-CDER-CTU-2024-67730$$FDA-CTU$$41$YR$$F$N$$$20240930$N$HP$US$
243935231$24393523$1$I$$20240916$20240928$20240928$EXP$$GB-TEVA-VS-3219477$TEVA$$67$YR$$F$Y$$$20240928$$HP$GB$GB
243935241$24393524$1$I$20231228$20240920$20240928$20240928$EXP$$DE-AUROBINDO-AUR-APL-2024-047442$AUROBINDO$$64$YR$$F$Y$120$KG$20240928$$MD$DE$DE
243935261$24393526$1$I$$20240920$20240928$20240928$EXP$$CA-AUROBINDO-AUR-APL-2024-046955$AUROBINDO$$61$YR$$M$Y$117$KG$20240928$$PH$CA$CA
244244761$24424476$1$I$20240930$20240930$20240930$20240930$DIR$720733$$FDA-CTU$$34$YR$$UNK$N$$$20240930$N$CN$GB$
244245281$24424528$1$I$20240930$20240930$20240930$20240930$DIR$720733$$FDA-CTU$$$$$$N$$$20240930$N$CN$GB$
56716915$5671691$5$F$$20190708$20041112$20240917$EXP$$PHBS2004GR14917$NOVARTIS$Andreadis C, Charalampidou M, Diamontopoulos N, Chouchos N, Mouratidou D. Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a women with metastatic breast cancer. GYNECOLOGIC ONCOLOGY. 2004;95(1):252-5$33$YR$$F$Y$$$20240917$$HP$GR$GR
61003497$6100349$7$F$20040730$20240802$20060807$20240806$EXP$$AT-AVENTIS-200617969GDDC$SANOFI AVENTIS$$64$YR$A$F$Y$$$20240806$$MD$AT$AT
61619904$6161990$4$F$20060401$20240911$20061106$20240921$EXP$$DE-ROCHE-447400$ROCHE$$43$YR$A$F$Y$67$KG$20240921$$HP$DE$DE
63534124$6353412$4$F$$20240822$20070710$20240828$EXP$$SE-ROCHE-504662$ROCHE$$45$YR$A$F$Y$$$20240828$$HP$SE$SE
65025106$6502510$6$F$20071118$20240912$20071214$20240918$EXP$$JP-PFIZER INC-2007103966$PFIZER$$72$YR$$F$Y$48$KG$20240918$$MD$JP$JP
659555826$6595558$26$F$$20240710$20070424$20240711$EXP$$US-PFIZER INC-2007106768$PFIZER$Francis, L.. Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin. Clinical Rheumatology. 2007;27(1):129-131$66$YR$$M$Y$$$20240711$$HP$US$US
66358926$6635892$6$F$20051101$20240806$20080508$20240808$EXP$$US-BAXTER-2008BH004607$TAKEDA$$0$YR$$M$Y$$$20240808$$PH$US$US
67179434$6717943$4$F$$20240913$20080804$20240919$EXP$$PHBS2008NL05232$NOVARTIS$Raphael MF, Versluys AB, Boelens JJ. EBV post transplantation lymphoproliferative disease-associated pneumomediastinum in a pediatric patient with long-lasting low loads of plasma EBV-DNA positivity. BONE MARROW TRANSPLANTATION. 2008;1-2$3$YR$$M$Y$$$20240919$$HP$NL$NL
67270143$6727014$3$F$$20240701$20080814$20240707$EXP$$PHBS2008GR05341$NOVARTIS$Metakopoulos I,  Karageorgopoutos DE, Christodoutou C, Skarlos DV,  Falagas ME. Tooth and Consequences. THE AMERICAN JOURNAL OF MEDICINE. 2008;121(7):577-9$61$YR$$M$Y$$$20240707$$HP$GR$GR
67980995$6798099$5$F$$20240913$20081016$20240924$EXP$NL-EMA-DD-20201105-KUMARVN_P-112409$GXKR2008NL09483$NOVARTIS$Bakker NA, van Dijk JMC, Slart RHJA, Coppes MH, van Imhoff GW, Verschuuren EAM. Extradural thoracic spinal cord compression: unusual initial presentation of post-transplant lymphoproliferative disorder. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2008;27(10):1165-8$44$YR$$M$Y$$$20240924$$HP$NL$NL
69653873$6965387$3$F$$20240705$20090409$20240715$EXP$$KR-PFIZER INC-2009192020$PFIZER$Kim, S.. Post-steroid Panniculitis in an Adult. Journal of Dermatology. 2008;35:12:786-788$60$YR$$M$Y$$$20240715$$HP$KR$KR
69677525$6967752$5$F$20090206$20240909$20090413$20240917$EXP$$PHHY2009DE13174$NOVARTIS$$66$YR$$F$Y$70$KG$20240917$$MD$DE$DE
69888382$6988838$2$F$20081106$20240920$20090507$20240925$EXP$$FR-PFIZER INC-2009208695$PFIZER$$67$YR$$F$Y$$$20240925$$HP$FR$FR
699556136$6995561$36$F$20090201$20240923$20090515$20240930$EXP$$PHHY2009CA17803$NOVARTIS$$9$YR$$M$Y$$$20240930$$HP$CA$CA
707325515$7073255$15$F$20090109$20240730$20090805$20240805$EXP$$DE-MYLANLABS-2009S1013184$MYLAN$$68$YR$$F$Y$53$KG$20240805$$MD$DE$DE
71016912$7101691$2$F$$20240904$20090831$20240909$EXP$$DK-MYLANLABS-2009S1014553$MYLAN$Pedersen LM, Petersen M, Sondergaard I.. Seizure triggered by benzodiazepine receptor antagonist.. Ugeskr Laeger. 2009;171(23):1942-1943$75$YR$$F$Y$$$20240909$$HP$DK$DK
71543042$7154304$2$F$20070601$20240813$20091021$20240816$EXP$FR-JNJFOC-20091004522$FR-JNJFOC-20091004522$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20240816$$HP$FR$FR
71554572$7155457$2$F$$20240815$20091022$20240824$EXP$$FR-ROCHE-662020$ROCHE$Kluger N, Poirier P, Guilpain P, Baixench M, Cohen P, Paugamb A. Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for behcet^s disease. International journal of infectious diseases. 2009;13 (5):E325. doi:0.1016/j.ijid.2008.11.007.$46$YR$A$M$Y$$$20240824$$HP$FR$FR
715592116$7155921$16$F$$20240611$20091022$20240708$EXP$$CA-ROCHE-663583$ROCHE$PFEFFER G, Pfeffer G, Cote H, Montaner J, Li C, Jitratkosol M and Mezei M. OPHTHALMOPLEGIA AND PTOSIS: MITOCHONDRIAL TOXICITY IN PATIENTS RECEIVING HIV THERAPY. NEUROLOGY 2009 Jul 07;73 (1):71-72.$52$YR$A$M$Y$$$20240709$$MD$CA$CA
71754574$7175457$4$F$20090909$20200123$20091112$20240718$EXP$$PHHY2009MX48523$NOVARTIS$$29$YR$$F$Y$60$KG$20240718$$CN$MX$MX
71922015$7192201$5$F$$20240913$20091129$20240919$EXP$$PHHY2009GR51495$NOVARTIS$Archontoulis NK, Staikou CV. Therapeutic failure in a renal transplant patient with pneumocystis jiroveci pneumonia: A case report. EXPERIMENTAL AND CLINICAL TRANSPLANTATION. 2009;7(2):129-32$44$YR$$M$Y$$$20240919$$HP$GR$GR
72282633$7228263$3$F$20090101$20240827$20091222$20240909$EXP$$FR-GILEAD-2009-0026071$GILEAD$$59$YR$A$M$Y$59$KG$20240909$$PH$FR$FR
72286296$7228629$6$F$20090101$20240913$20091223$20240923$EXP$FR-BRISTOL-MYERS SQUIBB COMPANY-14900278$FR-BRISTOL-MYERS SQUIBB COMPANY-14900278$BRISTOL MYERS SQUIBB$$59$YR$A$M$Y$59$KG$20240923$$PH$FR$FR
72611803$7261180$3$F$20090101$20240821$20100129$20240828$EXP$$FR-JNJFOC-20100109316$JOHNSON AND JOHNSON$$59$YR$A$M$Y$59$KG$20240828$$HP$FR$FR
72854403$7285440$3$F$20090101$20240709$20100219$20240712$EXP$$FI-GENZYME-FABR-1001195$SANOFI AVENTIS$$57$YR$A$M$Y$$$20240712$$MD$FI$FI
73251303$7325130$3$F$$20240815$20100319$20240819$EXP$$JP-JNJFOC-20100304886$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20240819$$HP$JP$JP
74069657$7406965$7$F$20121113$20240910$20100602$20240918$EXP$$PHHY2010CA08665$NOVARTIS$$63$YR$$M$Y$$$20240918$$CN$CA$CA
75019822$7501982$2$F$$20240830$20100727$20240904$PER$$US-PFIZER INC-2003172028US$PFIZER$$45$YR$$F$Y$$$20240904$$CN$US$US
75148892$7514889$2$F$20090101$20240910$20100731$20240917$PER$$US-PFIZER INC-2009171626$MYLAN$$$$$M$Y$$$20240917$$CN$US$US
75398567$7539856$7$F$20071001$20240816$20100813$20240819$EXP$$PHHY2010FR52885$NOVARTIS$Salmon A, Debourgogne A, Vasbien M, Clement L, Collomb J, Plenat F et al.. Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature. CLINICAL MICROBIOLOGY AND INFECTION. 2010;16(5):508-12$38$YR$$F$Y$$$20240819$$HP$FR$FR
75681094$7568109$4$F$$20240809$20100819$20240821$EXP$$US-Accord-005863$ACCORD$Adams B et al. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis. Am J Hematol. 2010 Aug;85(8):627-9$42$YR$A$F$Y$$$20240821$$HP$US$US
75818367$7581836$7$F$$20240819$20100913$20240903$EXP$$SE-RANBAXY-2010RR-38032$RANBAXY$Knudsen K, Jonsson U, Abrahamsson J.. Twenty-three deaths with -hydroxybutyrate overdose in western Sweden between 2000 and 2007.. Acta Anaesthesiologica Scandinavica. 2010;54:987-992$30$YR$$M$Y$$$20240903$$HP$SE$SE
75832582$7583258$2$F$$20240717$20100914$20240801$EXP$$DE-RANBAXY-2010US-37916$RANBAXY$Lassnig R. Akute Psychose induziert durch eine Helikobakter pylori (H. pylori) - Eradikationstherapie mit Amoxicillin, Clarithromycin und Pantoprazole. Neuropsychiatrie. 2010;24 (2):144-150$42$YR$$M$Y$$$20240801$$MD$AT$AT
76451535$7645153$5$F$20090311$20240726$20090423$20240802$EXP$$US-AstraZeneca-2009UW09452$ASTRAZENECA$$22317$DY$$M$Y$97$KG$20240802$$MD$CA$
768679327$7686793$27$F$20070423$20240902$20101130$20240911$EXP$$JP-JNJFOC-20101108379$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20240911$$MD$JP$JP
76895264$7689526$4$F$20101003$20240626$20101202$20240703$EXP$$US-JNJFOC-20101109023$JOHNSON AND JOHNSON$$26$YR$A$M$Y$108.7$KG$20240703$$MD$US$US
76961363$7696136$3$F$$20240819$20101207$20240822$EXP$$PHHY2010PL76877$NOVARTIS$Fornalczyk K, Kilis-Pstrusinska K, Medynska A, Zwolinska D et al.. Acute kidney injury in a child with idiopathic nephrotic syndrome in the course of drug interaction between cyclosporine A and macrolide. FAMILY MEDICINE AND PRIMARY CARE REVIEW. 2010;12(2):530-2$12$YR$$F$Y$$$20240822$$HP$PL$PL
776621613$7766216$13$F$20110102$20240813$20110119$20240816$EXP$$JP-PFIZER INC-2011010579$PFIZER$$65$YR$$M$Y$$$20240816$$MD$JP$JP
78730253$7873025$3$F$20100506$20240829$20110328$20240913$EXP$$AU-RANBAXY-2011RR-42883$RANBAXY$$48$YR$$M$Y$$$20240913$$HP$AU$AU
789812538$7898125$38$F$20130101$20240726$20110413$20240802$EXP$$PHHY2011CA28088$NOVARTIS$$$$$F$Y$$$20240802$$MD$CA$CA
79367855$7936785$5$F$20101201$20240722$20110509$20240821$EXP$$US-ALEXION-A201001648$ALEXION PHARMACEUTICALS$$22$YR$$M$Y$$$20240821$$HP$US$US
79421072$7942107$2$F$$20240703$20110512$20240708$EXP$$GB-PFIZER INC-2011099697$PFIZER$Gupta, N.. An unusual cause of acute obstructive jaundice in an HIV-infected patient.. International Journal of STD and AIDS.. 2011;22:110-111$33$YR$$F$Y$$$20240708$$MD$GB$GB
79770722$7977072$2$F$20110418$20240903$20110607$20240907$EXP$$US-ASTELLAS-2011US002689$ASTELLAS$$56$YR$A$F$Y$53$KG$20240907$$MD$US$US
80134463$8013446$3$F$20101101$20240805$20110628$20240812$EXP$$DE-MYLANLABS-2011S1012296$MYLAN$Schott-Seidenschwanz I, Wille H, Muehlbauer B. Death Trap Metamizole? (Todesfalle Metamizol?). Bremen Medical Journal. 2011;64:20$25$YR$$F$Y$$$20240812$$HP$DE$DE
80317694$8031769$4$F$$20240702$20110712$20240709$EXP$$FR-MYLANLABS-2011S1013624$AUROBINDO$VAYSSADE M, MAKARAWIEZ C, MATHIEU S, SOUBRIER M, TOURNADRE A.. IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS) IN WHIPPLE DISEASE (WD). 12th Annual Congress of the European League Against Rheumatism. 2011;AB0263$73$YR$$M$Y$$$20240709$$HP$FR$FR
80357992$8035799$2$F$$20240822$20110714$20240826$EXP$$PL-MYLANLABS-2011S1014011$MYLAN$Fornalczyk K, Kilis-Pstrusinska K, Medynska A, Zwolinskae D. Acute kidney injury in a child with idiopathic nephrotic syndrome in the course of drug interaction between cyclosporine A and macrolide - Case report. Fam-Med-Prim-Care-Rev 2010; 12(2) 530-532$12$YR$$F$Y$$$20240826$$HP$PL$PL
805682656$8056826$56$F$20131101$20240722$20110727$20240730$EXP$$PHHY2011CA64186$NOVARTIS$$59$YR$$M$Y$$$20240730$$HP$CA$CA
80601062$8060106$2$F$$20240828$20110729$20240906$EXP$$US-JNJFOC-20110709244$JOHNSON AND JOHNSON$$2$YR$C$$Y$$$20240906$$MD$US$US
80706573$8070657$3$F$20100331$20240621$20110805$20240716$EXP$$BR-ASTELLAS-2011US004465$ASTELLAS$$36$YR$$M$Y$$$20240716$$CN$GB$BR
80816533$8081653$3$F$20100414$20240621$20110809$20240715$EXP$$BR-ASTELLAS-2011US004479$ASTELLAS$$58$YR$$M$Y$$$20240715$$CN$GB$BR
81257123$8125712$3$F$20110831$20240621$20110908$20240708$EXP$$BR-ASTELLAS-2011US005574$ASTELLAS$$61$YR$$M$Y$$$20240708$$CN$GB$BR
81420524$8142052$4$F$19980512$20240904$20110919$20240905$EXP$$JP-PFIZER INC-2011214148$PFIZER$Sato, T.. A case of prolonged muscle paralysis resulting from acute striated muscle necrosis caused by administration of high-dose steroids and muscle relaxant to an elderly patient. Japanese Journal of Geriatrics. 000;37:250-254$82$YR$$M$Y$96$KG$20240905$$MD$JP$JP
81912186$8191218$6$F$$20240813$20111020$20240819$EXP$$PHHY2011NL91444$NOVARTIS$Oosten M, Schrama Y, Boeve E, Hamberg P.. Thrombotic thrombocytopenic purpura - haemolytic uremic syndrome (ttp-hus) following administration of docetaxel and zoledronic acid in a patient with castrate refractory prostate cancer (crpc). ABSTRACTS FROM 10TH CONGRESS OF THE EUROPEAN FEDERATION OF INTERNAL MEDICINE/EUR. 2011;22S S1- S112:S97$66$YR$$M$Y$$$20240819$$HP$NL$NL
81963523$8196352$3$F$$20240830$20111024$20240903$EXP$$GB-PFIZER INC-2011253012$PFIZER$Bache, S.. LATE-ONSET RHABDOMYOLYSIS IN BURN PATIENTS IN THE INTENSIVE CARE UNIT. Burns. 2011;37:1241-1247$47$YR$$M$Y$$$20240903$$HP$GB$GB
81991153$8199115$3$F$$20240830$20111025$20240903$EXP$$GB-PFIZER INC-2011254800$PFIZER$Sarah E. Bache, Ian Taggart, Charlotte Gilhooly. Late-onset rhabdomyolysis in burn patients in the intensive care unit. Burns. 2011;37:1241-1247$35$YR$$$Y$$$20240903$$HP$GB$GB
82005373$8200537$3$F$$20240830$20111026$20240904$EXP$$GB-PFIZER INC-2011254774$PFIZER$Bache, S. Late-onset rhabdomyolysis in burn patients in the intensive care unit. Burns. 2011;37:1241-1247$18$YR$$$Y$$$20240904$$HP$GB$GB
820340265$8203402$65$F$20110501$20240704$20111027$20240725$EXP$$CA-ROCHE-1005605$ROCHE$$36$YR$A$F$Y$68$KG$20240725$$HP$CA$CA
82156142$8215614$2$F$20050101$20240807$20111031$20240812$PER$$US-AMGEN-USASP2011054893$AMGEN$$51$YR$A$F$Y$$$20240812$$CN$US$US
822950824$8229508$24$F$20131122$20240720$20111104$20240725$EXP$$PHHY2011CA95797$NOVARTIS$$62$YR$$F$Y$$$20240725$$PH$CA$CA
82352024$8235202$4$F$$20240909$20111108$20240912$EXP$$CZ-PFIZER INC-2011262236$MYLAN$Vojt??ek Petr, Nalos Daniel. Serotoninergic syndrome - a case report. Anesteziologie a intenzivni medicina. 2011;3:159-162$70$YR$$F$Y$$$20240912$$MD$CZ$CZ
82425476$8242547$6$F$20111021$20240723$20111114$20240726$EXP$DK-DKMA-EFO1451$DK-MYLANLABS-2011S1022479$MYLAN$$72$YR$$F$Y$103$KG$20240726$$MD$DK$DK
82673573$8267357$3$F$$20240912$20111121$20240924$EXP$$PL-Accord-011340$ACCORD$Czubkowski P, Pawlowska J, Jankowska I, Teisseyre M, Kaminska D, Markiewicz M, et al. Successful sirolimus rescue in tacrolimus-induced thrombotic microangiopathy after living-related liver transplantation. Pediatr Transplant. 2011 Nov 8.$1$YR$I$F$Y$$$20240924$$HP$PL$PL
828579140$8285791$40$F$20111028$20240829$20111213$20240905$EXP$$PHHY2011CA101638$NOVARTIS$$12$YR$$M$Y$$$20240906$$HP$CA$CA
83367243$8336724$3$F$20101001$20240923$20120113$20240927$EXP$$SE-PFIZER INC-2012009073$MYLAN$Jonatan Lindh. Possible relationship between lymphocytic colitis and sertraline therapy. Lakartidningen. 2012;1:38$61$YR$$F$Y$$$20240927$$HP$SE$SE
84043215$8404321$5$F$20120201$20240621$20120214$20240715$EXP$$TW-ASTELLAS-2012US001640$ASTELLAS$$66$YR$$M$Y$57$KG$20240715$$CN$GB$TW
84065625$8406562$5$F$20111011$20240621$20120215$20240715$EXP$$BR-ASTELLAS-2012US001756$ASTELLAS$$69$YR$$M$Y$56$KG$20240715$$CN$GB$BR
84107693$8410769$3$F$20100918$20240621$20120217$20240717$EXP$$BR-ASTELLAS-2012US001770$ASTELLAS$$68$YR$$M$Y$60$KG$20240717$$CN$GB$BR
850153210$8501532$10$F$20120309$20240716$20120410$20240726$EXP$$CA-ROCHE-1055860$ROCHE$$65$YR$E$F$Y$$$20240726$$CN$CA$CA
851451829$8514518$29$F$20120206$20240802$20120416$20240812$EXP$$CA-ROCHE-1058192$ROCHE$$52$YR$A$M$Y$$$20240812$$CN$CA$CA
85550815$8555081$5$F$20120204$20230213$20120510$20240921$EXP$$ES-JNJFOC-20120506579$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20240921$$MD$ES$ES
86473662$8647366$2$F$20120510$20240812$20120703$20240818$EXP$$FR-SANOFI-AVENTIS-2012SA045068$SANOFI AVENTIS$$41$YR$A$M$Y$$$20240818$$HP$FR$FR
86531329$8653132$9$F$20111021$20240821$20120706$20240903$EXP$DK-DKMA-EFO1451$DK-FRI-1000025398$ABBVIE$$72$YR$$F$Y$102$KG$20240901$$MD$DK$DK
86585819$8658581$9$F$20120417$20240717$20120710$20240723$EXP$$PHHY2012AT055568$NOVARTIS$$36$YR$$M$Y$$$20240723$$MD$AT$AT
866102761$8661027$61$F$20120618$20240910$20120711$20240916$EXP$$CA-ROCHE-1085962$ROCHE$$78$YR$E$F$Y$$$20240916$$MD$CA$CA
867933225$8679332$25$F$20140210$20240826$20120724$20240902$EXP$$PHHY2012CA055322$NOVARTIS$$48$YR$$F$Y$$$20240902$$HP$CA$CA
86941394$8694139$4$F$20120723$20240621$20120731$20240712$EXP$$AU-ASTELLAS-2012US006499$ASTELLAS$$65$YR$$F$Y$$$20240712$$CN$GB$AU
87482274$8748227$4$F$20060101$20240729$20120827$20240805$EXP$$HU-PFIZER INC-2012208459$PFIZER$Irsai, G.. Complications of systemic cytomegalovirus infection in therapy-resistant Hodgkin^s lymphoma. Orvosi hetilap. 2012;153(19):751-755$29$YR$$F$Y$$$20240805$$MD$HU$HU
879556810$8795568$10$F$20170501$20240719$20120917$20240730$EXP$$CA-ROCHE-1126988$ROCHE$$14$YR$T$M$Y$78$KG$20240730$$MD$CA$CA
882628540$8826285$40$F$20120101$20240809$20121005$20240821$EXP$$CA-ROCHE-1139928$ROCHE$$66$YR$E$F$Y$$$20240821$$CN$CA$CA
883619470$8836194$70$F$20120101$20240808$20121011$20240819$EXP$$CA-ROCHE-1130266$ROCHE$$46$YR$A$F$Y$90.6$KG$20240819$$HP$CA$CA
885781417$8857814$17$F$20120901$20240916$20121024$20240923$EXP$$CA-ROCHE-1147722$ROCHE$$45$YR$A$F$Y$73$KG$20240923$$CN$CA$CA
885925792$8859257$92$F$20200715$20240923$20121024$20240926$EXP$$CA-ROCHE-1109752$ROCHE$$67$YR$E$F$Y$58$KG$20240926$$HP$CA$CA
885951831$8859518$31$F$20121016$20240617$20121024$20240709$EXP$$CA-ROCHE-1131671$ROCHE$$63$YR$A$M$Y$88$KG$20240701$$CN$CA$CA
88746493$8874649$3$F$$20240906$20121031$20240920$EXP$$FR-RANBAXY-2012RR-61572$RANBAXY$Guerry M-J, Lemyze M. Acute skin failure. BMJ [Online]. 2012;345 (7871):5 pages$54$YR$$M$Y$$$20240920$$HP$FR$FR
88788573$8878857$3$F$20100210$20240919$20121026$20240926$EXP$DE-BFARM-12248839$DE-MYLANLABS-2012S1022256$MYLAN$$31$YR$$F$Y$150$KG$20240926$$MD$DE$DE
89165882$8916588$2$F$20111205$20240716$20121120$20240729$EXP$$FR-009507513-1201USA03373$MERCK$A.L. Ruellan, B. Dreno, M. Saint-Jean, C. Joyau,1 J. Mahe,. Interaction between Bexarotene and Aprepitant:The First Case of Death. Drug Saf (Abstract). 2012;35:897 (#PO45)$65$YR$$M$Y$58$KG$20240729$$HP$FR$FR
89578312$8957831$2$F$$20240704$20121210$20240710$EXP$$US-PFIZER INC-2012306529$PFIZER$Nellan, A.. Hepatic sinusoidal obstruction syndrome in a child during treatment for medulloblastoma. Neuro-Oncology. 2012;14:vi113$6$YR$$M$Y$$$20240710$$HP$US$US
89909593$8990959$3$F$$20240816$20121221$20240828$EXP$$DE-Accord-015571$ACCORD$Rau S, Wollenberg A, Weiss M, Fischereder M, Schonermarck U. Cutaneous vasculitis after renal transplantation: a case report. Transplant Proc. 2012 Dec;44(10):3048-50$69$YR$E$M$Y$$$20240828$$MD$DE$DE
899125921$8991259$21$F$20130513$20240716$20121231$20240729$EXP$$CA-ROCHE-1170752$ROCHE$$62$YR$A$M$Y$88$KG$20240729$$CN$CA$CA
89912843$8991284$3$F$$20240821$20121231$20240902$EXP$$HR-Accord-015787$ACCORD$Piljac A, Fiala D, Prkacin I, Skegro D, Vojtusek IK, Gracin S, et al. (Disseminated aspergillosis in a?patient with simultaneous pancreas and kidney transplant). Acta Med Croatica. 2011 Sep;65 Suppl 1:203-6.$31$YR$A$F$Y$$$20240902$$MD$HR$HR
91045552$9104555$2$F$$20240813$20130220$20240823$EXP$$GR-ROCHE-1190917$ROCHE$TRIANTAFYLLIDOU M, Tzimagiorgis, I. Faltaka, A. Konstantinidou, M. Papantoniou, S. Krokidis, X. Chelis, L. Kakoliris, S. Zekeridis, Th. and Papadopoulou, P. Pelvic venous thrombosis (PVT) and Acute non-lithiasic cholecystitis- An interesting case. 32nd Panhellenic congress of Gastroeneterology: 29 November-1 December 2012 ;:-.$39$YR$A$F$Y$$$20240823$$MD$GR$GR
91221842$9122184$2$F$$20130109$20130114$20240926$EXP$$PHEH2013US000919$NOVARTIS$$$$$M$Y$$$20240926$$CN$US$US
91357024$9135702$4$F$20121011$20240716$20130304$20240802$EXP$$FR-009507513-1302FRA013287$MERCK$$60$YR$$M$Y$$$20240802$$HP$FR$FR
916333716$9163337$16$F$20141223$20180720$20130314$20240709$EXP$$CA-ROCHE-GNE299406$ROCHE$$58$YR$A$M$Y$78$KG$20240705$$MD$CA$CA
92024902$9202490$2$F$$20240829$20130401$20240913$EXP$$US-AstraZeneca-2013SE19333$ASTRAZENECA$Neyra J, Rocha N, Bhargava R, Vaidya O, Hendricks A, Rodan A.. Rhabdomyolysis-induced acute kidney injury in a cancer patient exposed to denosumab and abiraterone: A case report.. BMC Nephrol. 2015;16((1)):A70.$76$YR$$M$Y$$$20240913$$HP$US$
92075599$9207559$9$F$20111201$20240918$20130403$20240930$EXP$$CA-ROCHE-1208884$ROCHE$$46$YR$A$F$Y$$$20240930$$MD$CA$CA
92242197$9224219$7$F$20130101$20240716$20130411$20240730$EXP$$US-009507513-1304USA004406$MERCK$$$$$F$Y$69.841$KG$20240730$$MD$US$US
92329573$9232957$3$F$$20240904$20130416$20240912$EXP$$CA-JNJFOC-20130401885$JOHNSON AND JOHNSON$$52$YR$A$F$Y$54.48$KG$20240912$$CN$CA$CA
92468212$9246821$2$F$$20240812$20130422$20240819$EXP$$PHHY2013PL037727$NOVARTIS$Jeleniewicz R, Majdan M, Wielosz E, Targonska-Stepniak B. Selected problems of biologic therapy in rheumatoid arthritis patients - inefficacy of several biologic therapies. Case reports. Reumatologia. 2013;51/1:89-92$35$YR$$F$Y$$$20240819$$HP$PL$PL
926654715$9266547$15$F$20130401$20240915$20130502$20240923$EXP$$CA-ROCHE-1219498$ROCHE$$67$YR$E$M$Y$81$KG$20240923$$CN$CA$CA
92668732$9266873$2$F$$20240814$20130502$20240820$EXP$$FR-SANOFI-AVENTIS-2013SA000055$SANOFI AVENTIS$Deleuze C.. Docetaxel : 48 deces en 20 ans.... la Revue du praticien.. unk. 2017;31:346$60$YR$A$F$Y$103$KG$20240820$$HP$FR$FR
93013708$9301370$8$F$20070516$20210901$20130521$20240824$EXP$$FR-SHIRE-SPV1-2009-00649$TAKEDA$$9$YR$$M$Y$32$KG$20240824$$HP$FR$FR
93078279$9307827$9$F$20120926$20240802$20130524$20240807$EXP$$CA-ROCHE-1139298$ROCHE$$32$YR$A$F$Y$77$KG$20240807$$HP$CA$CA
93108564$9310856$4$F$20130224$20240819$20130528$20240903$EXP$$DE-RANBAXY-2013RR-69356$RANBAXY$$30$YR$$M$Y$70$KG$20240903$$MD$DE$DE
93455623$9345562$3$F$$20240819$20130613$20240821$EXP$DE-JNJFOC-20130603665$DE-JNJFOC-20130603665$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20240821$$HP$DE$DE
93590994$9359099$4$F$$20240716$20130620$20240729$EXP$$US-009507513-1306USA008419$MERCK$M. Shindorf. The Interaction of Ifosfamide and Aprepitant in Gynecologic Malignancies. Gynecologic Oncology Reports. 2013;34-5$41$YR$$F$Y$$$20240729$$MD$US$US
93619392$9361939$2$F$20080101$20240923$20130621$20240924$EXP$$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2013-FF-01667FF$BOEHRINGER INGELHEIM$$61$YR$A$F$Y$$$20240924$$HP$FR$FR
938319655$9383196$55$F$20120511$20240704$20130704$20240724$EXP$$CA-ROCHE-1074293$ROCHE$$50$YR$A$F$Y$51$KG$20240724$$CN$CA$CA
94094853$9409485$3$F$$20240913$20130719$20240927$EXP$$FR-RANBAXY-2013RR-71383$RANBAXY$Descamps Vicent, Ranger-Rogez Sylvie. Amoxicillin and DRESS: an explosive cocktail. Images en Dermatologie. 2013;VI (2-3):54-56$62$YR$$M$Y$$$20240927$$HP$FR$FR
94358685$9435868$5$F$19900101$20240717$20130801$20240729$EXP$$US-ELI_LILLY_AND_COMPANY-US201307008101$ELI LILLY AND CO$$73$YR$E$F$Y$$$20240729$$CN$US$US
94449368$9444936$8$F$20130730$20240904$20130807$20240911$EXP$$CA-ROCHE-1257967$ROCHE$$52$YR$A$F$Y$$$20240911$$MD$CA$CA
945929328$9459293$28$F$20120101$20240724$20130815$20240801$EXP$$CA-ROCHE-1162770$ROCHE$$45$YR$A$F$Y$104$KG$20240801$$CN$CA$CA
946785860$9467858$60$F$20120924$20240716$20130821$20240723$EXP$$PHHY2012CA085827$NOVARTIS$$74$YR$$M$Y$$$20240723$$HP$CA$CA
954663237$9546632$37$F$20130626$20240814$20130924$20240826$EXP$$CA-ROCHE-1279569$ROCHE$$66$YR$E$M$Y$87$KG$20240826$$CN$CA$CA
955014428$9550144$28$F$20130716$20240909$20130924$20240921$EXP$$CA-ROCHE-1279581$ROCHE$$35$YR$A$F$Y$66$KG$20240921$$CN$CA$CA
956327124$9563271$24$F$20120201$20240815$20130927$20240825$EXP$$CA-MERCK-1309CAN011160$MERCK$$56$YR$$F$Y$89$KG$20240825$$HP$CA$CA
960838064$9608380$64$F$20110101$20240924$20131009$20240927$EXP$$PHHY2013CA026241$NOVARTIS$$47$YR$$F$Y$$$20240927$$HP$CA$CA
97032774$9703277$4$F$20110120$20230719$20131122$20240801$EXP$$CA-ROCHE-1112220$ROCHE$$79$YR$E$F$Y$60$KG$20240801$$MD$CA$CA
970369630$9703696$30$F$20140918$20240816$20131122$20240822$EXP$$CA-ROCHE-1203828$ROCHE$$56$YR$A$M$Y$122.47$KG$20240822$$CN$CA$CA
973719324$9737193$24$F$20130802$20240722$20131206$20240801$EXP$$CA-ROCHE-1311894$ROCHE$$53$YR$A$F$Y$76$KG$20240801$$CN$CA$CA
974502770$9745027$70$F$20100122$20240619$20131211$20240704$EXP$$CA-ROCHE-681181$ROCHE$$31$YR$A$F$Y$104$KG$20240704$$HP$CA$CA
97581012$9758101$2$F$20120601$20240716$20131216$20240721$EXP$$US-BAYER-2013-150901$BAYER$$23$YR$A$F$Y$$$20240719$$CN$US$US
98575323$9857532$3$F$$20240812$20140131$20240816$EXP$$PHHY2014GR008569$NOVARTIS$Dimitrios M, Christina D, Spyridon V, Garbis S, Liapis G, John B et al.. A rare occurrence of skin non-hodgkin lymphoma in patient with kindey transplantation$44$YR$$F$Y$$$20240816$$HP$GR$GR
98593514$9859351$4$F$$20240523$20140131$20240913$EXP$$NZ-PFIZER INC-2014024802$MYLAN$Gale, J, Danesh-Meyer HV. Statins can induce myasthenia gravis.. Journal of Clinical Neuroscience. 2014;21(2):195-197$48$YR$$M$Y$$$20240913$$HP$NZ$NZ
986185311$9861853$11$F$$20240827$20140203$20240830$PER$$US-PFIZER INC-2014027810$PFIZER$$74$YR$$F$Y$62.14$KG$20240830$$CN$US$US
986902735$9869027$35$F$20121008$20240828$20140205$20240905$EXP$$CA-ROCHE-1342678$ROCHE$$25$YR$A$M$Y$99$KG$20240905$$HP$CA$CA
989327138$9893271$38$F$20130603$20240307$20140213$20240730$EXP$$CA-ROCHE-1281492$ROCHE$$35$YR$A$F$Y$74$KG$20240730$$MD$CA$CA
98974507$9897450$7$F$20120123$20231018$20140214$20240919$EXP$$ES-JNJFOC-20140204021$JOHNSON AND JOHNSON$$64$YR$A$M$Y$72$KG$20240919$$MD$ES$ES
98994952$9899495$2$F$$20240927$20140214$20240927$EXP$$IT-MYLANLABS-2014S1002661$MYLAN$Ginanneschi F, Volpi N, Giannini F, Rocchi R, Donati D, Agliano M, et al. Rhabdomyolysis in an elderly multitreated patient: Multiple drug interactions after statin withdrawal. J-Neurol-Sci 2014; 336 284-287$72$YR$$M$Y$$$20240927$$HP$IT$IT
99199918$9919991$8$F$20131203$20240822$20140224$20240903$EXP$$GB-ELI_LILLY_AND_COMPANY-GB201402004715$ELI LILLY AND CO$$60$YR$A$F$Y$55.4$KG$20240903$$CN$GB$GB
99571342$9957134$2$F$20130525$20240726$20140304$20240805$EXP$$US-ABBVIE-13P-163-1097680-00$ABBVIE$$20$YR$$M$Y$$$20240803$$CN$US$US
